id|nct_id|mesh_term|downcase_mesh_term|mesh_type
110943032|NCT05605964|Leuprolide|leuprolide|mesh-list
110953903|NCT05419830|Antihypertensive Agents|antihypertensive agents|mesh-list
110954057|NCT05005897|Hematinics|hematinics|mesh-ancestor
110954287|NCT04483544|Pembrolizumab|pembrolizumab|mesh-list
110954663|NCT03127267|Riluzole|riluzole|mesh-list
110954719|NCT02781519|Hallucinogens|hallucinogens|mesh-ancestor
110954872|NCT00977691|Cyclophosphamide|cyclophosphamide|mesh-list
110955023|NCT02097147|Serotonin Agents|serotonin agents|mesh-ancestor
110955099|NCT02097459|Anastrozole|anastrozole|mesh-list
110944391|NCT04807517|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110944466|NCT04771026|Hormones|hormones|mesh-ancestor
110944769|NCT04604353|Calcium|calcium|mesh-list
110955996|NCT02104011|Propranolol|propranolol|mesh-list
110958111|NCT05543122|Atenolol|atenolol|mesh-list
110958317|NCT04076826|Anesthetics|anesthetics|mesh-ancestor
111203845|NCT01811953|Metformin|metformin|mesh-list
111204172|NCT04259398|Propofol|propofol|mesh-list
111204241|NCT02134210|Etanercept|etanercept|mesh-list
111204467|NCT00489346|Xhance|xhance|mesh-list
111204775|NCT00600340|Paclitaxel|paclitaxel|mesh-list
111205209|NCT01792102|Dexamethasone|dexamethasone|mesh-list
111205436|NCT02995330|Hormones|hormones|mesh-ancestor
111205494|NCT04270708|Dexmedetomidine|dexmedetomidine|mesh-list
111205849|NCT04386850|Calcifediol|calcifediol|mesh-list
111205916|NCT00733096|Etanercept|etanercept|mesh-list
111205972|NCT01276288|Diuretics|diuretics|mesh-ancestor
111206084|NCT03916341|Nicotine|nicotine|mesh-list
111206321|NCT03588351|Antimetabolites|antimetabolites|mesh-ancestor
111206775|NCT03154515|Antiviral Agents|antiviral agents|mesh-ancestor
111206832|NCT05701059|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
111206909|NCT01670955|Folic Acid|folic acid|mesh-list
111207031|NCT01279954|Immunologic Factors|immunologic factors|mesh-ancestor
111207846|NCT05742568|Antacids|antacids|mesh-ancestor
111207995|NCT01781611|Antipyretics|antipyretics|mesh-ancestor
111208359|NCT01973231|Liraglutide|liraglutide|mesh-list
111208508|NCT01774903|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111209634|NCT01718353|Hormones|hormones|mesh-ancestor
111209708|NCT01363349|Risperidone|risperidone|mesh-list
111209927|NCT00820612|Gout Suppressants|gout suppressants|mesh-ancestor
111210148|NCT01913639|Antidotes|antidotes|mesh-ancestor
111210312|NCT01921829|Diuretics|diuretics|mesh-list
111210526|NCT00883168|Xhance|xhance|mesh-list
111210672|NCT04381234|Dialysis Solutions|dialysis solutions|mesh-list
111210896|NCT00904618|Lidocaine|lidocaine|mesh-list
111211049|NCT01672047|Vitamin D|vitamin d|mesh-list
111211122|NCT03152955|Sufentanil|sufentanil|mesh-list
111211267|NCT01835236|Pertuzumab|pertuzumab|mesh-list
111211315|NCT01706198|Xhance|xhance|mesh-list
111211344|NCT04378972|Anticonvulsants|anticonvulsants|mesh-ancestor
111211418|NCT01836328|Sensory System Agents|sensory system agents|mesh-ancestor
111211603|NCT04377646|Zinc|zinc|mesh-list
111211718|NCT03407872|Esketamine|esketamine|mesh-list
111212173|NCT01702298|Simvastatin|simvastatin|mesh-list
111212542|NCT02243566|Diuretics|diuretics|mesh-ancestor
111212766|NCT01567826|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111212914|NCT04371874|Aspirin|aspirin|mesh-list
111212988|NCT04371406|Antimalarials|antimalarials|mesh-ancestor
111213072|NCT04364464|Riociguat|riociguat|mesh-list
111213215|NCT04363216|Vitamins|vitamins|mesh-ancestor
111213320|NCT01696214|Hormones|hormones|mesh-ancestor
111213436|NCT04362124|BCG Vaccine|bcg vaccine|mesh-list
111213516|NCT04361188|Anesthetics|anesthetics|mesh-list
111213588|NCT04361422|Isotretinoin|isotretinoin|mesh-list
111213665|NCT04359862|Propofol|propofol|mesh-list
111214115|NCT05153590|Hormones|hormones|mesh-ancestor
111214490|NCT00946270|Leprostatic Agents|leprostatic agents|mesh-ancestor
111215029|NCT00812032|Aspirin|aspirin|mesh-list
111215238|NCT05613153|Parasympatholytics|parasympatholytics|mesh-ancestor
111215315|NCT01027468|Bevacizumab|bevacizumab|mesh-list
111215538|NCT03329001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111215690|NCT04606797|Nicotine|nicotine|mesh-list
111215759|NCT04757571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111215836|NCT04817956|Trastuzumab|trastuzumab|mesh-list
111216290|NCT01892189|Ketamine|ketamine|mesh-list
111216502|NCT03013036|Fentanyl|fentanyl|mesh-list
111216739|NCT01993719|Vidarabine|vidarabine|mesh-list
111217171|NCT01163656|Cobalt|cobalt|mesh-list
111217252|NCT01133158|Dexamethasone|dexamethasone|mesh-list
111217470|NCT01180036|Rituximab|rituximab|mesh-list
111217999|NCT03460470|Sildenafil Citrate|sildenafil citrate|mesh-list
111218075|NCT04488978|Amlodipine|amlodipine|mesh-list
111218527|NCT01209442|Bevacizumab|bevacizumab|mesh-list
111218752|NCT01232920|Methotrexate|methotrexate|mesh-list
111219800|NCT01928511|Lamivudine|lamivudine|mesh-list
111220025|NCT03427554|Dermatologic Agents|dermatologic agents|mesh-ancestor
111220178|NCT01350388|Febuxostat|febuxostat|mesh-list
111220552|NCT03029169|Amiodarone|amiodarone|mesh-list
111220706|NCT01265446|Lidocaine|lidocaine|mesh-list
111220996|NCT04595045|Cholinergic Agents|cholinergic agents|mesh-ancestor
111221298|NCT01316770|Hormones|hormones|mesh-ancestor
111221447|NCT01843205|Methamphetamine|methamphetamine|mesh-list
111222058|NCT03399708|Analgesics|analgesics|mesh-ancestor
111222354|NCT01436266|Folic Acid|folic acid|mesh-list
111222654|NCT03390972|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111223105|NCT03613506|Captopril|captopril|mesh-list
111223238|NCT01514734|Timolol|timolol|mesh-list
111223464|NCT03383406|Abortifacient Agents|abortifacient agents|mesh-ancestor
111223908|NCT01580410|Mitomycin|mitomycin|mesh-list
111224057|NCT01586962|Adrenergic Agents|adrenergic agents|mesh-ancestor
111224293|NCT01595854|Dabigatran|dabigatran|mesh-list
111225107|NCT02519400|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
111225197|NCT03363984|Midazolam|midazolam|mesh-list
111225261|NCT03355638|Aflibercept|aflibercept|mesh-list
111225412|NCT03187210|Immunologic Factors|immunologic factors|mesh-ancestor
111225641|NCT05584878|Calcium|calcium|mesh-list
111225937|NCT01795547|Dopamine Agonists|dopamine agonists|mesh-ancestor
111226085|NCT04500678|Metformin|metformin|mesh-list
111226313|NCT02237950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111227218|NCT02497638|Biguanides|biguanides|mesh-list
111227295|NCT02245672|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111227742|NCT06033729|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111227819|NCT06032858|Apremilast|apremilast|mesh-list
111228052|NCT05976763|Rituximab|rituximab|mesh-list
111228119|NCT05965219|Analgesics|analgesics|mesh-ancestor
111228645|NCT05661578|Atezolizumab|atezolizumab|mesh-list
111228795|NCT05593757|Antimalarials|antimalarials|mesh-ancestor
111228869|NCT05548283|Lactams|lactams|mesh-list
111229012|NCT05315479|Meloxicam|meloxicam|mesh-list
111229163|NCT05180097|Dexamethasone|dexamethasone|mesh-list
111229325|NCT05053867|Hemostatics|hemostatics|mesh-ancestor
111229385|NCT04980222|Glucocorticoids|glucocorticoids|mesh-ancestor
111229538|NCT04916548|Anesthetics, General|anesthetics, general|mesh-ancestor
111229767|NCT04689828|177Lu-PSMA-617|177lu-psma-617|mesh-list
111229843|NCT04625283|Anesthetics|anesthetics|mesh-ancestor
111230138|NCT04274426|Gemcitabine|gemcitabine|mesh-list
111230214|NCT04245748|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111230291|NCT04208516|Hormones|hormones|mesh-ancestor
111230759|NCT03869190|Niraparib|niraparib|mesh-list
111230820|NCT03829254|Pembrolizumab|pembrolizumab|mesh-list
111230895|NCT03708341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111231045|NCT03452332|Durvalumab|durvalumab|mesh-list
111231126|NCT03412565|Hormones|hormones|mesh-ancestor
111231274|NCT03255174|Hemostatics|hemostatics|mesh-ancestor
111231353|NCT03159897|Doxorubicin|doxorubicin|mesh-list
111231654|NCT02632448|Gemcitabine|gemcitabine|mesh-list
111232104|NCT01902173|Antioxidants|antioxidants|mesh-ancestor
111232332|NCT01081262|Paclitaxel|paclitaxel|mesh-list
111232665|NCT03330132|Vaccines|vaccines|mesh-list
111233090|NCT05463822|Cholinergic Agents|cholinergic agents|mesh-ancestor
111233236|NCT02990962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111233464|NCT01752712|Oxytocin|oxytocin|mesh-list
111233989|NCT02725710|Gabapentin|gabapentin|mesh-list
111234433|NCT02266810|Dermatologic Agents|dermatologic agents|mesh-ancestor
111234809|NCT01869634|Antiviral Agents|antiviral agents|mesh-ancestor
111235027|NCT00557440|Mometasone Furoate|mometasone furoate|mesh-list
111235101|NCT04491474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111235252|NCT00553462|Paclitaxel|paclitaxel|mesh-list
111235475|NCT04058470|Alkylating Agents|alkylating agents|mesh-ancestor
111235697|NCT01772147|Xhance|xhance|mesh-list
111236075|NCT04127019|Alkylating Agents|alkylating agents|mesh-ancestor
111236225|NCT01937260|Brodalumab|brodalumab|mesh-list
111236454|NCT01734395|Parasympathomimetics|parasympathomimetics|mesh-ancestor
111236529|NCT03826875|Fluoxetine|fluoxetine|mesh-list
111236982|NCT04273035|Anesthetics|anesthetics|mesh-ancestor
111237132|NCT01756079|Ribavirin|ribavirin|mesh-list
111237203|NCT05826821|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111237501|NCT04911166|Growth Substances|growth substances|mesh-ancestor
111237883|NCT03409367|Emollients|emollients|mesh-list
111238252|NCT05740150|Taurolidine|taurolidine|mesh-list
111238412|NCT01728077|Brivaracetam|brivaracetam|mesh-list
111238786|NCT05382364|Tucatinib|tucatinib|mesh-list
111238860|NCT01750697|Rituximab|rituximab|mesh-list
111239155|NCT05072704|Sufentanil|sufentanil|mesh-list
111239187|NCT03195478|Nivolumab|nivolumab|mesh-list
111239230|NCT03578146|Anticoagulants|anticoagulants|mesh-ancestor
111239455|NCT01991860|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111239531|NCT03296982|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111239614|NCT02059642|Metadoxine|metadoxine|mesh-list
111240143|NCT02460510|Mannitol|mannitol|mesh-list
111240367|NCT03286764|Peppermint oil|peppermint oil|mesh-list
111240522|NCT03475134|Nivolumab|nivolumab|mesh-list
111240664|NCT01966978|Insulin|insulin|mesh-list
111240738|NCT02458716|Fertility Agents|fertility agents|mesh-ancestor
111240828|NCT02456844|Vitamins|vitamins|mesh-ancestor
111241497|NCT03245970|Sympathomimetics|sympathomimetics|mesh-ancestor
111241645|NCT03254628|Abortifacient Agents|abortifacient agents|mesh-ancestor
111242002|NCT03248700|Vitamin A|vitamin a|mesh-list
111242151|NCT03237936|Cyclosporins|cyclosporins|mesh-list
111242233|NCT00057681|GABA Agents|gaba agents|mesh-ancestor
111242299|NCT03237624|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111242450|NCT02028754|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
111242632|NCT05606055|Tenofovir|tenofovir|mesh-list
111242678|NCT00158223|Pimozide|pimozide|mesh-list
111242823|NCT03120234|Anesthetics|anesthetics|mesh-ancestor
111242964|NCT03229668|Pregabalin|pregabalin|mesh-list
111243381|NCT00085839|Paclitaxel|paclitaxel|mesh-list
111243529|NCT02051686|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111243676|NCT01740089|Antimetabolites|antimetabolites|mesh-ancestor
111243752|NCT04645719|Analgesics|analgesics|mesh-ancestor
111244062|NCT03834688|Rituximab|rituximab|mesh-list
111244266|NCT03200964|Anesthetics|anesthetics|mesh-list
111244496|NCT05156632|Vaccines|vaccines|mesh-list
111244981|NCT01704755|Ribavirin|ribavirin|mesh-list
111245210|NCT00030147|Estradiol|estradiol|mesh-list
111245522|NCT00039195|Hormones|hormones|mesh-ancestor
111245808|NCT02097849|Interferons|interferons|mesh-list
111245884|NCT05279092|Dexamethasone acetate|dexamethasone acetate|mesh-list
111246111|NCT04907110|Vitamins|vitamins|mesh-ancestor
111246416|NCT04670224|Anesthetics|anesthetics|mesh-list
111246868|NCT02424552|Vitamin D|vitamin d|mesh-list
111247094|NCT03106818|Anticonvulsants|anticonvulsants|mesh-ancestor
111247166|NCT03178422|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111247244|NCT02414568|Prednisone|prednisone|mesh-list
111247467|NCT00363376|Zonisamide|zonisamide|mesh-list
111247842|NCT02522104|Hydroxyurea|hydroxyurea|mesh-list
111248008|NCT02409186|Paclitaxel|paclitaxel|mesh-list
111248066|NCT02701764|Pregabalin|pregabalin|mesh-list
111248141|NCT02416752|Remifentanil|remifentanil|mesh-list
111248589|NCT02406690|Hormones|hormones|mesh-ancestor
111248822|NCT02395458|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111249042|NCT02397486|Vitamin E|vitamin e|mesh-list
111249434|NCT01691885|Xhance|xhance|mesh-list
111249573|NCT02654860|Acetaminophen|acetaminophen|mesh-list
111249644|NCT02662036|Anesthetics, Local|anesthetics, local|mesh-ancestor
111249794|NCT04707742|Povidone|povidone|mesh-list
111249871|NCT00368602|Timolol|timolol|mesh-list
111249954|NCT04134442|Bupivacaine|bupivacaine|mesh-list
111250019|NCT03417388|Protease Inhibitors|protease inhibitors|mesh-ancestor
111250245|NCT03164694|Apatinib|apatinib|mesh-list
111250322|NCT04756271|Antibodies|antibodies|mesh-list
111250548|NCT03028571|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
111250850|NCT03161340|Sirolimus|sirolimus|mesh-list
111251080|NCT01529645|Vaccines|vaccines|mesh-list
111251152|NCT00246519|Atenolol|atenolol|mesh-list
111251301|NCT00272337|Aspirin|aspirin|mesh-list
111251649|NCT02662764|Dsuvia|dsuvia|mesh-list
111251683|NCT02391636|Oxytocin|oxytocin|mesh-list
111251895|NCT01510769|Uricosuric Agents|uricosuric agents|mesh-ancestor
111252120|NCT00326781|Nicotine|nicotine|mesh-list
111252868|NCT05800587|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111252944|NCT05799729|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111253242|NCT04929626|Magnesium Sulfate|magnesium sulfate|mesh-list
111253393|NCT04436731|Phentolamine|phentolamine|mesh-list
111253750|NCT01505569|Mesna|mesna|mesh-list
111254159|NCT00304707|Bupropion|bupropion|mesh-list
111254450|NCT02360826|Simvastatin|simvastatin|mesh-list
111254534|NCT03911557|Durvalumab|durvalumab|mesh-list
111254905|NCT03159078|Imipenem|imipenem|mesh-list
111255207|NCT01549951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111255505|NCT00400803|Growth Substances|growth substances|mesh-ancestor
111255810|NCT02334150|Sufentanil|sufentanil|mesh-list
111255881|NCT02333682|Vitamin D|vitamin d|mesh-list
111256103|NCT01488487|Hormones|hormones|mesh-ancestor
111256105|NCT03027115|Tamsulosin|tamsulosin|mesh-list
111256177|NCT00411411|Protease Inhibitors|protease inhibitors|mesh-ancestor
111256326|NCT00420771|Anticonvulsants|anticonvulsants|mesh-ancestor
111256403|NCT04088305|Vancomycin|vancomycin|mesh-list
111257064|NCT04618523|Artesunate|artesunate|mesh-list
111257142|NCT01506271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111257295|NCT00534417|Antimetabolites|antimetabolites|mesh-ancestor
111257592|NCT00464685|Glucocorticoids|glucocorticoids|mesh-ancestor
111257665|NCT01690520|Dermatologic Agents|dermatologic agents|mesh-ancestor
111258635|NCT01451827|Tolvaptan|tolvaptan|mesh-list
111258864|NCT01556438|Bortezomib|bortezomib|mesh-list
111259088|NCT01552772|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111259829|NCT01551212|Everolimus|everolimus|mesh-list
111260275|NCT01532648|Hormones|hormones|mesh-ancestor
111260500|NCT00668811|Sunitinib|sunitinib|mesh-list
111260869|NCT01571453|Vortioxetine|vortioxetine|mesh-list
111260943|NCT01418365|Metronidazole|metronidazole|mesh-list
111261025|NCT01799109|Albuterol|albuterol|mesh-list
111261236|NCT01418209|Progesterone|progesterone|mesh-list
111261311|NCT01436201|Protective Agents|protective agents|mesh-ancestor
111261387|NCT01436305|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111261608|NCT01435577|Analgesics|analgesics|mesh-ancestor
111261984|NCT04051957|Isosorbide|isosorbide|mesh-list
111262382|NCT01404949|Tretinoin|tretinoin|mesh-list
111262666|NCT05088330|Daratumumab|daratumumab|mesh-list
111262747|NCT02990403|Aspirin|aspirin|mesh-list
111262893|NCT03110172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111263119|NCT04335084|Vitamin D|vitamin d|mesh-list
111263491|NCT02993835|Iron|iron|mesh-list
111263878|NCT03599791|Histamine Agents|histamine agents|mesh-ancestor
111263959|NCT01431287|Tiotropium Bromide|tiotropium bromide|mesh-list
111264319|NCT03592069|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111264394|NCT04197739|Amikacin|amikacin|mesh-list
111264618|NCT06012175|Melatonin|melatonin|mesh-list
111264767|NCT05996133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111264994|NCT05458765|Tenofovir|tenofovir|mesh-list
111265140|NCT05010772|Antimetabolites|antimetabolites|mesh-ancestor
111265298|NCT04603911|Hormones|hormones|mesh-ancestor
111265372|NCT04156087|Durvalumab|durvalumab|mesh-list
111265828|NCT00792948|Vitamins|vitamins|mesh-ancestor
111265973|NCT03973489|Adrenergic Agents|adrenergic agents|mesh-ancestor
111266358|NCT03022201|Domperidone|domperidone|mesh-list
111266504|NCT00723099|Cyclosporine|cyclosporine|mesh-list
111266694|NCT04144933|Dsuvia|dsuvia|mesh-list
111266890|NCT02080819|Levodopa|levodopa|mesh-list
111266956|NCT03476317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111267109|NCT01482962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111267182|NCT03587779|Sevoflurane|sevoflurane|mesh-list
111267331|NCT03586141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111267488|NCT03158857|Sofosbuvir|sofosbuvir|mesh-list
111267783|NCT03156829|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111267933|NCT05220319|Glucocorticoids|glucocorticoids|mesh-ancestor
111268085|NCT00698022|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111268155|NCT02467153|Vitamin D|vitamin d|mesh-list
111268454|NCT03751423|Anesthetics|anesthetics|mesh-ancestor
111268683|NCT01279551|Lidocaine|lidocaine|mesh-list
111268834|NCT01274403|Prednisone|prednisone|mesh-list
111268910|NCT02117076|Gabapentin|gabapentin|mesh-list
111269061|NCT01275183|Cisplatin|cisplatin|mesh-list
111269456|NCT00758667|Mesna|mesna|mesh-list
111269888|NCT03805503|Chloroprocaine|chloroprocaine|mesh-list
111270487|NCT00799227|Hormones|hormones|mesh-ancestor
111270785|NCT00083941|Interleukin-2|interleukin-2|mesh-list
110995290|NCT03641053|Iodine|iodine|mesh-list
111271461|NCT00804609|Lidocaine|lidocaine|mesh-list
111271909|NCT04681430|Gabexate|gabexate|mesh-list
111272008|NCT04401007|Lidocaine|lidocaine|mesh-list
111272061|NCT00818337|Antipyretics|antipyretics|mesh-ancestor
111272198|NCT00818961|Fludarabine|fludarabine|mesh-list
111272576|NCT00831987|Vaccines|vaccines|mesh-list
111272653|NCT04399525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111272876|NCT00871689|Analgesics|analgesics|mesh-ancestor
111272957|NCT03995004|Dexamethasone|dexamethasone|mesh-list
111273102|NCT03600090|Paclitaxel|paclitaxel|mesh-list
111273249|NCT04133532|Metoprolol|metoprolol|mesh-list
111273549|NCT04032119|Autonomic Agents|autonomic agents|mesh-ancestor
111273624|NCT05314569|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111274015|NCT00114517|Hormones|hormones|mesh-list
111274170|NCT01381679|Ezetimibe|ezetimibe|mesh-list
111274227|NCT04007393|Sympathomimetics|sympathomimetics|mesh-ancestor
111274452|NCT00795522|Desloratadine|desloratadine|mesh-list
111274721|NCT05249725|Antacids|antacids|mesh-ancestor
111274901|NCT04474002|Cathartics|cathartics|mesh-ancestor
111275209|NCT04377789|Quercetin|quercetin|mesh-list
111275392|NCT05054322|Xhance|xhance|mesh-list
111275433|NCT01725243|Carbetocin|carbetocin|mesh-list
111275505|NCT01360866|Analgesics|analgesics|mesh-ancestor
111276103|NCT03593291|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
111276562|NCT05022186|GABA Agents|gaba agents|mesh-ancestor
111276640|NCT04466280|Hydroxychloroquine|hydroxychloroquine|mesh-list
111276713|NCT00919503|Antimetabolites|antimetabolites|mesh-ancestor
111276799|NCT04373967|Metformin|metformin|mesh-list
111277167|NCT02242695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111277248|NCT04365309|Aspirin|aspirin|mesh-list
111277464|NCT04999176|Enoxaparin|enoxaparin|mesh-list
111277541|NCT04025567|Vancomycin|vancomycin|mesh-list
111277832|NCT04361643|Lenalidomide|lenalidomide|mesh-list
111277984|NCT04146155|Hormones|hormones|mesh-ancestor
111278138|NCT05620641|Gabapentin|gabapentin|mesh-list
111278413|NCT03021629|Vitamin D|vitamin d|mesh-list
111278611|NCT05702957|Letrozole|letrozole|mesh-list
111279193|NCT00956085|Memantine|memantine|mesh-list
111279794|NCT02246049|Vitamins|vitamins|mesh-ancestor
111280103|NCT03710603|Bortezomib|bortezomib|mesh-list
111280174|NCT03685331|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111280319|NCT00986583|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111280541|NCT00929253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111280733|NCT01023711|Vaccines|vaccines|mesh-list
111280769|NCT01024335|Hormones|hormones|mesh-ancestor
111280846|NCT01004991|Antimetabolites|antimetabolites|mesh-ancestor
111281571|NCT05702970|Vitamin D|vitamin d|mesh-list
111281937|NCT05081583|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111282017|NCT04928664|Bupivacaine|bupivacaine|mesh-list
111282616|NCT03070054|Mydriatics|mydriatics|mesh-ancestor
111282998|NCT00492999|Leucovorin|leucovorin|mesh-list
111283085|NCT05307003|Trazodone|trazodone|mesh-list
111283153|NCT02085161|Parasympatholytics|parasympatholytics|mesh-ancestor
111283226|NCT01101867|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111283463|NCT03015675|Ascorbic Acid|ascorbic acid|mesh-list
111283673|NCT01181349|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111284573|NCT03080675|Vitamins|vitamins|mesh-list
111284725|NCT01149759|Cyclosporine|cyclosporine|mesh-list
111284871|NCT05277623|Mannitol|mannitol|mesh-list
111285085|NCT04399187|Eusol|eusol|mesh-list
111285105|NCT04399343|Analgesics|analgesics|mesh-ancestor
111285172|NCT03226301|Venetoclax|venetoclax|mesh-list
111285321|NCT01246791|Ethinyl Estradiol|ethinyl estradiol|mesh-list
111285648|NCT01257087|Insulin|insulin|mesh-list
111286148|NCT03422731|Alovudine|alovudine|mesh-list
111286746|NCT02943733|Temozolomide|temozolomide|mesh-list
111287216|NCT01924481|Caffeine|caffeine|mesh-list
111287350|NCT01929161|Oxytocin|oxytocin|mesh-list
111287430|NCT04161599|Metronidazole|metronidazole|mesh-list
111287577|NCT05793359|Hormones|hormones|mesh-ancestor
111287874|NCT04729101|Dexlansoprazole|dexlansoprazole|mesh-list
111288257|NCT02697253|Incretins|incretins|mesh-ancestor
111288477|NCT01455025|Plerixafor|plerixafor|mesh-list
111288555|NCT01455883|Incretins|incretins|mesh-ancestor
111288703|NCT04961268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111288858|NCT01890889|Ezetimibe|ezetimibe|mesh-list
111288929|NCT01458301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111289300|NCT04844905|Ivermectin|ivermectin|mesh-list
111289418|NCT04407390|Niacin|niacin|mesh-list
111289455|NCT04921566|Torsemide|torsemide|mesh-list
111289677|NCT04037241|Micronutrients|micronutrients|mesh-ancestor
111289829|NCT02549833|Antiviral Agents|antiviral agents|mesh-ancestor
111289907|NCT03053544|Metformin|metformin|mesh-list
111290054|NCT02349217|Hydrocortisone|hydrocortisone|mesh-list
111290277|NCT05872568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111290734|NCT04211987|Etoposide|etoposide|mesh-list
111290883|NCT03780673|Simvastatin|simvastatin|mesh-list
111291032|NCT05909293|Antiemetics|antiemetics|mesh-list
111291858|NCT05303636|Diuretics|diuretics|mesh-ancestor
111291931|NCT05089370|Nivolumab|nivolumab|mesh-list
111292159|NCT04618289|Vitamin D|vitamin d|mesh-list
111292976|NCT02299518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111293060|NCT02058693|Adderall|adderall|mesh-list
111293136|NCT01843556|Donepezil|donepezil|mesh-list
111293206|NCT01328171|Hematinics|hematinics|mesh-ancestor
111293279|NCT00217425|Alkylating Agents|alkylating agents|mesh-ancestor
111293427|NCT02851303|Morphine|morphine|mesh-list
111293585|NCT01332357|Fluticasone|fluticasone|mesh-list
111293649|NCT00986921|Abortifacient Agents|abortifacient agents|mesh-ancestor
111293732|NCT04884516|Vitamin A|vitamin a|mesh-list
111294166|NCT04881942|Menthol|menthol|mesh-list
111294256|NCT01595646|Insulin|insulin|mesh-list
111294614|NCT05257902|Lipotropic Agents|lipotropic agents|mesh-ancestor
111294691|NCT04121819|Antiviral Agents|antiviral agents|mesh-ancestor
111295517|NCT04873284|Aprepitant|aprepitant|mesh-list
111296886|NCT01891175|Anesthetics|anesthetics|mesh-list
111297108|NCT02661503|Vincristine|vincristine|mesh-list
111297263|NCT01488279|Hormones|hormones|mesh-ancestor
111297561|NCT01495923|Gabapentin|gabapentin|mesh-list
111297758|NCT01568073|Carbidopa|carbidopa|mesh-list
111297837|NCT02049047|Everolimus|everolimus|mesh-list
111298084|NCT01456143|Proflavine|proflavine|mesh-list
111298207|NCT01431755|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111298811|NCT01587027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111298965|NCT04427826|Morphine|morphine|mesh-list
111299260|NCT00585559|Antipyretics|antipyretics|mesh-ancestor
111299359|NCT05606315|Midazolam|midazolam|mesh-list
111299414|NCT05605301|Deoxyglucose|deoxyglucose|mesh-list
111299641|NCT00078559|Antiviral Agents|antiviral agents|mesh-ancestor
111299790|NCT01535001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111299948|NCT01538745|Ketamine|ketamine|mesh-list
111300247|NCT04799184|Autonomic Agents|autonomic agents|mesh-ancestor
111300466|NCT04784988|BAX 855|bax 855|mesh-list
111300612|NCT02995083|Hormones|hormones|mesh-ancestor
111300841|NCT00084409|Iloprost|iloprost|mesh-list
111301068|NCT00091273|Sargramostim|sargramostim|mesh-list
111301140|NCT00194779|Tamoxifen|tamoxifen|mesh-list
111301673|NCT01660893|Tetracaine|tetracaine|mesh-list
111301742|NCT01662297|Serotonin Agents|serotonin agents|mesh-ancestor
111301973|NCT01607853|Vitamins|vitamins|mesh-ancestor
111302043|NCT03089567|Listerine|listerine|mesh-list
111302420|NCT00110461|Aripiprazole|aripiprazole|mesh-list
111302505|NCT00116857|Sertraline|sertraline|mesh-list
111302713|NCT04756661|Oxytocin|oxytocin|mesh-list
111302791|NCT01466270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111303470|NCT00253513|Fludarabine|fludarabine|mesh-list
111303617|NCT01717053|Prednisone|prednisone|mesh-list
111303707|NCT04639843|Romidepsin|romidepsin|mesh-list
111303840|NCT00267085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111303994|NCT01729845|Decitabine|decitabine|mesh-list
111304078|NCT05679102|Amlodipine|amlodipine|mesh-list
111304521|NCT02250807|Sofosbuvir|sofosbuvir|mesh-list
111304631|NCT00112151|Hormones|hormones|mesh-ancestor
111304748|NCT05609682|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111304823|NCT00125957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111305278|NCT01465802|Doxycycline|doxycycline|mesh-list
111305426|NCT01817907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111305570|NCT01444742|Antiviral Agents|antiviral agents|mesh-ancestor
111305649|NCT00210353|Rituximab|rituximab|mesh-list
111305794|NCT01419236|Androgens|androgens|mesh-ancestor
111306091|NCT01786161|Vancomycin|vancomycin|mesh-list
111306318|NCT02989623|Copper|copper|mesh-list
111306565|NCT01847469|Zonisamide|zonisamide|mesh-list
111306692|NCT01853553|Spironolactone|spironolactone|mesh-list
111306843|NCT02117141|Analgesics|analgesics|mesh-ancestor
111307066|NCT05950204|Antacids|antacids|mesh-ancestor
111307288|NCT05593627|Antacids|antacids|mesh-ancestor
111307514|NCT05016947|Dexamethasone|dexamethasone|mesh-list
111307891|NCT03374956|Naltrexone|naltrexone|mesh-list
111308041|NCT02213107|Hormone Antagonists|hormone antagonists|mesh-ancestor
111308133|NCT00559845|Paclitaxel|paclitaxel|mesh-list
111308188|NCT01393964|Autonomic Agents|autonomic agents|mesh-ancestor
111308711|NCT00353119|Etanercept|etanercept|mesh-list
111309398|NCT05487456|Menthol|menthol|mesh-list
111309469|NCT00558285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111309543|NCT02988921|Paclitaxel|paclitaxel|mesh-list
111309841|NCT01794533|Anesthetics|anesthetics|mesh-ancestor
111310813|NCT00383747|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111310888|NCT00407381|Ranibizumab|ranibizumab|mesh-list
111311336|NCT05358535|Etomidate|etomidate|mesh-list
111311788|NCT04150965|Dexamethasone|dexamethasone|mesh-list
111312608|NCT00485953|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111312685|NCT00488059|Enfuvirtide|enfuvirtide|mesh-list
111312830|NCT01395758|Docetaxel|docetaxel|mesh-list
111312984|NCT00535925|Diuretics|diuretics|mesh-ancestor
111313514|NCT00542971|Antiviral Agents|antiviral agents|mesh-ancestor
111313662|NCT03970382|Aldesleukin|aldesleukin|mesh-list
111313812|NCT00442013|Dexlansoprazole|dexlansoprazole|mesh-list
111313963|NCT04195100|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
111314047|NCT00521989|Hormones|hormones|mesh-ancestor
111314332|NCT03830918|Temozolomide|temozolomide|mesh-list
111314858|NCT00452543|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111314935|NCT04148846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111315092|NCT02120261|Hormones|hormones|mesh-ancestor
111315236|NCT00550277|Panobinostat|panobinostat|mesh-list
111315314|NCT01796951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111315389|NCT01798459|Methylphenidate|methylphenidate|mesh-list
111315538|NCT02985086|Cefoxitin|cefoxitin|mesh-list
111316583|NCT03155048|Estradiol|estradiol|mesh-list
111316805|NCT00515411|Leucovorin|leucovorin|mesh-list
111317105|NCT00641563|Analgesics|analgesics|mesh-ancestor
111317491|NCT03844256|Capecitabine|capecitabine|mesh-list
111317560|NCT00659737|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111317787|NCT03779048|Adrenergic Agents|adrenergic agents|mesh-ancestor
111318687|NCT00595231|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111318762|NCT04912115|Midazolam|midazolam|mesh-list
111319001|NCT03472586|Nivolumab|nivolumab|mesh-list
111319058|NCT02987985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111319434|NCT01275859|Hormone Antagonists|hormone antagonists|mesh-ancestor
111319661|NCT01276717|Vorinostat|vorinostat|mesh-list
111319735|NCT01277107|Zaleplon|zaleplon|mesh-list
111319805|NCT01277731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111320106|NCT05739045|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111320181|NCT01927887|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
111320404|NCT05346146|Paclitaxel|paclitaxel|mesh-list
111320618|NCT00668525|Dexetimide|dexetimide|mesh-list
111320917|NCT00247273|Etidronic Acid|etidronic acid|mesh-list
111320986|NCT00246259|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111321214|NCT05539053|Antidotes|antidotes|mesh-ancestor
111321287|NCT00680459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111321364|NCT01279213|Dopamine Agents|dopamine agents|mesh-ancestor
111321510|NCT04998032|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111321675|NCT03333668|Guanfacine|guanfacine|mesh-list
111321735|NCT04027361|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111321954|NCT03235232|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111322179|NCT00756405|Antioxidants|antioxidants|mesh-list
111322251|NCT03822351|Durvalumab|durvalumab|mesh-list
111322478|NCT00659165|Insulin|insulin|mesh-list
111322625|NCT01799057|Metformin|metformin|mesh-list
111322775|NCT01973205|Antipyretics|antipyretics|mesh-ancestor
111322844|NCT04397510|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111322921|NCT03173612|Cytarabine|cytarabine|mesh-list
111323068|NCT00602225|Cytarabine|cytarabine|mesh-list
111323212|NCT00721513|Docetaxel|docetaxel|mesh-list
111323364|NCT02428205|Adrenergic Agents|adrenergic agents|mesh-ancestor
111323438|NCT00706589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111323743|NCT01272089|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111324339|NCT00780715|Metformin|metformin|mesh-list
111324427|NCT00742313|Hemostatics|hemostatics|mesh-list
111324644|NCT01278173|Vigabatrin|vigabatrin|mesh-list
111324798|NCT02991131|Linezolid|linezolid|mesh-list
111324949|NCT01275547|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111325326|NCT03809767|Immunologic Factors|immunologic factors|mesh-ancestor
111325700|NCT00243347|Cediranib|cediranib|mesh-list
111325999|NCT02065479|Purinergic Agents|purinergic agents|mesh-ancestor
111326221|NCT00823303|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111326372|NCT02025075|Rocuronium|rocuronium|mesh-list
111327211|NCT04876131|Cephalexin|cephalexin|mesh-list
111327426|NCT03782103|Disinfectants|disinfectants|mesh-ancestor
111327871|NCT00850889|Anesthetics|anesthetics|mesh-ancestor
111328092|NCT00853333|Anesthetics, General|anesthetics, general|mesh-ancestor
111328614|NCT03540355|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111328710|NCT05587426|Iproplatin|iproplatin|mesh-list
111328765|NCT00867217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111328840|NCT00868309|Antivenins|antivenins|mesh-list
111329700|NCT01834885|Hormones|hormones|mesh-ancestor
111329969|NCT02494180|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111330413|NCT02153723|(T,G)-A-L|(t,g)-a-l|mesh-list
111330487|NCT00913003|Anesthetics, Local|anesthetics, local|mesh-ancestor
111331017|NCT04996134|Dopamine Agents|dopamine agents|mesh-ancestor
111331090|NCT00370630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111331172|NCT04295850|Aspirin|aspirin|mesh-list
111331244|NCT04337632|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111331465|NCT01048333|Autonomic Agents|autonomic agents|mesh-ancestor
111331914|NCT05314127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111332262|NCT01832363|Xenon|xenon|mesh-list
111332448|NCT01832987|Trimethoprim|trimethoprim|mesh-list
111332515|NCT02240719|Alkylating Agents|alkylating agents|mesh-ancestor
111332597|NCT03213353|Expectorants|expectorants|mesh-ancestor
111332739|NCT01835639|Micronutrients|micronutrients|mesh-ancestor
111332820|NCT01837043|Abatacept|abatacept|mesh-list
111332887|NCT03403777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111333335|NCT01721135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111333410|NCT01722227|Incretins|incretins|mesh-ancestor
111334531|NCT04359823|Antimetabolites|antimetabolites|mesh-ancestor
111334680|NCT01042535|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111334756|NCT03400709|Protective Agents|protective agents|mesh-ancestor
111334899|NCT03408119|Calcium|calcium|mesh-list
111334981|NCT04374071|Prednisolone|prednisolone|mesh-list
111335203|NCT00358293|Anticonvulsants|anticonvulsants|mesh-ancestor
111335579|NCT00968071|Gemtuzumab|gemtuzumab|mesh-list
111335732|NCT02989714|Nivolumab|nivolumab|mesh-list
111335883|NCT03054844|GABA Agents|gaba agents|mesh-ancestor
111336044|NCT03023059|Levodopa|levodopa|mesh-list
111336330|NCT01019707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111336406|NCT03020329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111337049|NCT03102736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111337269|NCT03127137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111337491|NCT00635102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111337795|NCT01030783|Sorafenib|sorafenib|mesh-list
111338096|NCT01924286|Hormones|hormones|mesh-ancestor
111338697|NCT03014713|Analgesics|analgesics|mesh-ancestor
111338776|NCT00376324|Tigecycline|tigecycline|mesh-list
111338972|NCT03378076|FX006|fx006|mesh-list
111338985|NCT03520348|Vitamins|vitamins|mesh-ancestor
111339586|NCT04744623|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111340114|NCT03017807|Antibodies|antibodies|mesh-list
111340418|NCT00953849|Analgesics|analgesics|mesh-ancestor
111341772|NCT01016483|Gemcitabine|gemcitabine|mesh-list
111341922|NCT02569242|Paclitaxel|paclitaxel|mesh-list
111342143|NCT04128878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111342675|NCT03821714|Hormones|hormones|mesh-ancestor
111342756|NCT01454804|Lapatinib|lapatinib|mesh-list
111343051|NCT01450046|Tocopherols|tocopherols|mesh-list
111343130|NCT04066426|Hormones|hormones|mesh-ancestor
111343211|NCT04272788|Infliximab|infliximab|mesh-list
111343278|NCT01187017|Fludarabine|fludarabine|mesh-list
111343729|NCT04423926|Glucocorticoids|glucocorticoids|mesh-ancestor
111343805|NCT01891526|Tretinoin|tretinoin|mesh-list
111343875|NCT05021978|Sensory System Agents|sensory system agents|mesh-ancestor
111343956|NCT05499234|Meperidine|meperidine|mesh-list
111344027|NCT01662648|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111344179|NCT02518750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111344252|NCT05507398|Metformin|metformin|mesh-list
111344331|NCT05342974|Oxytocics|oxytocics|mesh-ancestor
111344403|NCT05484648|Analgesics|analgesics|mesh-ancestor
111344482|NCT01188421|Clonidine|clonidine|mesh-list
111344621|NCT00970606|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111345001|NCT00678574|Fluoxetine|fluoxetine|mesh-list
111345082|NCT02598778|Listerine|listerine|mesh-list
111345159|NCT00500890|Carboplatin|carboplatin|mesh-list
111345304|NCT00000796|Antimetabolites|antimetabolites|mesh-ancestor
111345382|NCT00000814|Antiviral Agents|antiviral agents|mesh-ancestor
111345792|NCT00000160|Xenon|xenon|mesh-list
111345834|NCT00001906|Antacids|antacids|mesh-ancestor
111345989|NCT00000238|Analgesics|analgesics|mesh-ancestor
111346289|NCT01188577|Autonomic Agents|autonomic agents|mesh-ancestor
111346586|NCT00001132|Abacavir|abacavir|mesh-list
111346740|NCT01894334|Edaravone|edaravone|mesh-list
111347042|NCT00000496|Antipyretics|antipyretics|mesh-ancestor
111347348|NCT00000628|Zidovudine|zidovudine|mesh-list
111347411|NCT00000658|Cyclophosphamide|cyclophosphamide|mesh-list
111347490|NCT04389554|Fibrin fragment D|fibrin fragment d|mesh-list
111347720|NCT00002176|Antimetabolites|antimetabolites|mesh-ancestor
111347948|NCT00002368|Lamivudine|lamivudine|mesh-list
111348098|NCT01938248|Apixaban|apixaban|mesh-list
111348330|NCT01243567|Timolol|timolol|mesh-list
111348484|NCT00002434|Vitamins|vitamins|mesh-ancestor
111348631|NCT01003769|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
111349254|NCT04094207|Antioxidants|antioxidants|mesh-ancestor
111349319|NCT01313702|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111349629|NCT00199082|Antiviral Agents|antiviral agents|mesh-ancestor
111349877|NCT05271292|Chiauranib|chiauranib|mesh-list
111350046|NCT00002740|Cobalt|cobalt|mesh-list
111350583|NCT04896658|Hormones|hormones|mesh-ancestor
111350617|NCT04156828|Antimetabolites|antimetabolites|mesh-ancestor
111350689|NCT04038970|Immunologic Factors|immunologic factors|mesh-ancestor
111350775|NCT01205503|Doxorubicin|doxorubicin|mesh-list
111350876|NCT00002896|Cobalt|cobalt|mesh-list
111351144|NCT01555268|Cytarabine|cytarabine|mesh-list
111352102|NCT01258855|Sensory System Agents|sensory system agents|mesh-ancestor
111352484|NCT00003682|Antiemetics|antiemetics|mesh-ancestor
111352706|NCT00003268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111352857|NCT00003742|Paclitaxel|paclitaxel|mesh-list
111353026|NCT00003340|Topotecan|topotecan|mesh-list
111353080|NCT00096122|Antimetabolites|antimetabolites|mesh-ancestor
111353228|NCT00003382|Antimetabolites|antimetabolites|mesh-ancestor
111353304|NCT02972866|Hormones|hormones|mesh-ancestor
111353609|NCT05776940|Protease Inhibitors|protease inhibitors|mesh-ancestor
111353836|NCT05493475|Anesthetics|anesthetics|mesh-ancestor
111354069|NCT04500158|Lidocaine|lidocaine|mesh-list
111354741|NCT03009799|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
111354829|NCT00005050|Eniluracil|eniluracil|mesh-list
111355126|NCT00005626|Irinotecan|irinotecan|mesh-list
111355422|NCT00004474|Antilymphocyte Serum|antilymphocyte serum|mesh-list
111355495|NCT01290913|Omalizumab|omalizumab|mesh-list
111355645|NCT00386074|Fe(III)-EDTA|fe(iii)-edta|mesh-list
111356104|NCT01063907|Bortezomib|bortezomib|mesh-list
111356251|NCT00166166|Bradykinin|bradykinin|mesh-list
111356419|NCT00118742|Sirolimus|sirolimus|mesh-list
111356476|NCT01899170|Narcotics|narcotics|mesh-ancestor
111356558|NCT01427881|Cyclosporine|cyclosporine|mesh-list
111356630|NCT00262964|Niacin|niacin|mesh-list
111356707|NCT01429987|Plecanatide|plecanatide|mesh-list
111357084|NCT00265850|Vitamins|vitamins|mesh-ancestor
111357230|NCT01121939|Pertuzumab|pertuzumab|mesh-list
111357379|NCT03013127|Pembrolizumab|pembrolizumab|mesh-list
111357820|NCT00210470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111358198|NCT04071977|Antioxidants|antioxidants|mesh-list
111358336|NCT03465527|Hormones|hormones|mesh-ancestor
111358575|NCT03783416|Ixazomib|ixazomib|mesh-list
111358644|NCT02099006|Ketoprofen|ketoprofen|mesh-list
111358714|NCT01480219|Voriconazole|voriconazole|mesh-list
111359165|NCT01650350|Naltrexone|naltrexone|mesh-list
111359235|NCT00352976|Mycophenolic Acid|mycophenolic acid|mesh-list
111359765|NCT05901441|Narcotics|narcotics|mesh-ancestor
111359837|NCT05897151|Anesthetics|anesthetics|mesh-list
111359908|NCT05837000|Anticonvulsants|anticonvulsants|mesh-ancestor
111360054|NCT05463133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111360281|NCT04716712|Azithromycin|azithromycin|mesh-list
111360581|NCT03789110|Ipilimumab|ipilimumab|mesh-list
111360806|NCT00392834|Ifosfamide|ifosfamide|mesh-list
111361331|NCT00379574|Doxorubicin|doxorubicin|mesh-list
111361414|NCT00407966|Analgesics|analgesics|mesh-ancestor
111361857|NCT00462020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111362082|NCT00534794|Analgesics|analgesics|mesh-ancestor
111362156|NCT03463460|Sunitinib|sunitinib|mesh-list
111363211|NCT00511706|Autonomic Agents|autonomic agents|mesh-ancestor
111363505|NCT00526292|Alkylating Agents|alkylating agents|mesh-ancestor
111363880|NCT01558063|Anesthetics|anesthetics|mesh-ancestor
111364028|NCT03008083|Purinergic Agents|purinergic agents|mesh-ancestor
111364775|NCT02138006|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111365077|NCT03007303|Dopamine Agents|dopamine agents|mesh-ancestor
111365150|NCT00619970|Rifaximin|rifaximin|mesh-list
111365296|NCT00624416|Hormones|hormones|mesh-ancestor
111365452|NCT04707625|Aflibercept|aflibercept|mesh-list
111365595|NCT00630734|Ritonavir|ritonavir|mesh-list
111365744|NCT00588536|Leucovorin|leucovorin|mesh-list
111366044|NCT00603044|Xhance|xhance|mesh-list
111366430|NCT00703976|Cetuximab|cetuximab|mesh-list
111366643|NCT02990858|Leronlimab|leronlimab|mesh-list
111367015|NCT02992340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111367389|NCT00744848|Epinephrine|epinephrine|mesh-list
111367691|NCT00762320|Ritonavir|ritonavir|mesh-list
111368012|NCT00781898|Naltrexone|naltrexone|mesh-list
111368069|NCT01303835|Naltrexone|naltrexone|mesh-list
111368142|NCT03808142|Interferon beta-1b|interferon beta-1b|mesh-list
111368662|NCT00789776|Tacrolimus|tacrolimus|mesh-list
111368758|NCT01342523|Nicotine|nicotine|mesh-list
111368809|NCT00776594|Growth Substances|growth substances|mesh-ancestor
111369038|NCT00802100|Antiemetics|antiemetics|mesh-ancestor
111369107|NCT01355705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111370692|NCT00887510|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
111370885|NCT05945979|Biotin|biotin|mesh-list
111371738|NCT02764762|Antimetabolites|antimetabolites|mesh-ancestor
111372171|NCT03215966|Tadalafil|tadalafil|mesh-list
111372547|NCT01833728|Antipyretics|antipyretics|mesh-ancestor
111372692|NCT03218852|Immunologic Factors|immunologic factors|mesh-ancestor
111372847|NCT01457885|Busulfan|busulfan|mesh-list
111372935|NCT01462565|Tezosentan|tezosentan|mesh-list
111373147|NCT01566539|Lorazepam|lorazepam|mesh-list
111373597|NCT03835442|GABA Agents|gaba agents|mesh-ancestor
111373749|NCT01724372|Dopamine Agonists|dopamine agonists|mesh-ancestor
111374497|NCT04373018|Chlorhexidine|chlorhexidine|mesh-list
111375019|NCT02459964|Fentanyl|fentanyl|mesh-list
111375096|NCT01555697|Memantine|memantine|mesh-list
111375467|NCT04942626|Capecitabine|capecitabine|mesh-list
111375617|NCT01652495|Antiemetics|antiemetics|mesh-ancestor
111375702|NCT00943202|Vaccines|vaccines|mesh-list
111375763|NCT01704521|Antimetabolites|antimetabolites|mesh-ancestor
111376361|NCT01680653|Glucagon|glucagon|mesh-list
111376817|NCT01774487|Antioxidants|antioxidants|mesh-ancestor
111377198|NCT02170376|Levodopa|levodopa|mesh-list
111102212|NCT02402465|Xhance|xhance|mesh-list
111377939|NCT02424357|Plasma Substitutes|plasma substitutes|mesh-ancestor
111378236|NCT02481219|Erythromycin Estolate|erythromycin estolate|mesh-list
111378464|NCT01171118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111378621|NCT01178528|Carvedilol|carvedilol|mesh-list
111378766|NCT04573322|Antioxidants|antioxidants|mesh-ancestor
111379061|NCT03010202|Hormones|hormones|mesh-ancestor
111379134|NCT01154192|Antiemetics|antiemetics|mesh-ancestor
111379284|NCT00363753|Antipyretics|antipyretics|mesh-ancestor
111379508|NCT05785195|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111379583|NCT05584007|Floxacillin|floxacillin|mesh-list
111379822|NCT04616313|Xenon|xenon|mesh-list
111380032|NCT03435458|Oxytocics|oxytocics|mesh-ancestor
111380108|NCT03018366|Progestins|progestins|mesh-ancestor
111380264|NCT01530373|Sympatholytics|sympatholytics|mesh-ancestor
111380340|NCT01217970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111380412|NCT01212302|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111380961|NCT01217840|Vitamin D|vitamin d|mesh-list
111381236|NCT02615535|Vasodilator Agents|vasodilator agents|mesh-ancestor
111381687|NCT01312844|Parasympatholytics|parasympatholytics|mesh-ancestor
111382208|NCT04351724|Lopinavir|lopinavir|mesh-list
111382486|NCT02251379|Xhance|xhance|mesh-list
111382811|NCT01811147|Sympathomimetics|sympathomimetics|mesh-ancestor
111382894|NCT01332500|Naproxen|naproxen|mesh-list
111383033|NCT01378520|Ketoconazole|ketoconazole|mesh-list
111383706|NCT01836029|Carboplatin|carboplatin|mesh-list
111383804|NCT03206151|Leucovorin|leucovorin|mesh-list
111383861|NCT02578641|Carboplatin|carboplatin|mesh-list
111383932|NCT02724033|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111384032|NCT04226495|Dsuvia|dsuvia|mesh-list
111384465|NCT00553319|Dopamine Agents|dopamine agents|mesh-ancestor
111384690|NCT02683161|Varenicline|varenicline|mesh-list
111384989|NCT04306965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111385283|NCT01555281|Lenalidomide|lenalidomide|mesh-list
111385803|NCT02770365|Estrogens|estrogens|mesh-ancestor
111385953|NCT05437965|Glucocorticoids|glucocorticoids|mesh-list
111387005|NCT01595516|Metoprolol|metoprolol|mesh-list
111387326|NCT02921061|Cytarabine|cytarabine|mesh-list
111387542|NCT03028467|Vitamins|vitamins|mesh-ancestor
111387691|NCT01891331|Fluconazole|fluconazole|mesh-list
111388176|NCT01338740|Adalimumab|adalimumab|mesh-list
111388520|NCT01695668|Loteprednol Etabonate|loteprednol etabonate|mesh-list
111388671|NCT03078075|Dopamine Agents|dopamine agents|mesh-ancestor
111388819|NCT03093207|Aspirin|aspirin|mesh-list
111388896|NCT02389998|Autonomic Agents|autonomic agents|mesh-ancestor
111389054|NCT02978157|Antacids|antacids|mesh-ancestor
111389116|NCT01602692|Anesthetics, Local|anesthetics, local|mesh-ancestor
111389937|NCT05325099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111390161|NCT03978767|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111390309|NCT01769027|Immunologic Factors|immunologic factors|mesh-ancestor
111390612|NCT01999985|Dasatinib|dasatinib|mesh-list
111390764|NCT02067416|Taxane|taxane|mesh-list
111391061|NCT02399345|Antimetabolites|antimetabolites|mesh-ancestor
111391209|NCT02037893|Anesthetics|anesthetics|mesh-ancestor
111391505|NCT02365961|Autonomic Agents|autonomic agents|mesh-ancestor
111391593|NCT02368457|Vitamins|vitamins|mesh-ancestor
111391806|NCT01769222|Ipilimumab|ipilimumab|mesh-list
111391882|NCT05235191|Analgesics|analgesics|mesh-ancestor
111392176|NCT01877642|Loxapine|loxapine|mesh-list
111392253|NCT03974789|Dexamethasone|dexamethasone|mesh-list
111392327|NCT02340000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111392477|NCT00376077|Immunologic Factors|immunologic factors|mesh-ancestor
111393165|NCT01859078|Digoxin|digoxin|mesh-list
111393236|NCT01863134|Eptifibatide|eptifibatide|mesh-list
111393330|NCT03701061|Vaccines|vaccines|mesh-list
111394079|NCT00378729|Metformin|metformin|mesh-list
111394283|NCT01885910|Dapsone|dapsone|mesh-list
111394510|NCT01118013|Antimetabolites|antimetabolites|mesh-ancestor
111395256|NCT01548651|Hormones|hormones|mesh-ancestor
111395551|NCT00118053|Docetaxel|docetaxel|mesh-list
111396157|NCT00000285|Phenytoin|phenytoin|mesh-list
111396235|NCT00359879|Exenatide|exenatide|mesh-list
111396472|NCT00000987|Zidovudine|zidovudine|mesh-list
111396610|NCT00001053|Aluminum Hydroxide|aluminum hydroxide|mesh-list
111396840|NCT05270057|Hormones|hormones|mesh-ancestor
111396916|NCT05031455|Aspirin|aspirin|mesh-list
111396988|NCT00002079|Miglustat|miglustat|mesh-list
111397061|NCT00001437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111397436|NCT00002361|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111397515|NCT00002391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111397599|NCT00002211|Nelfinavir|nelfinavir|mesh-list
111398199|NCT00002547|Immunologic Factors|immunologic factors|mesh-ancestor
111398352|NCT00360815|Insulin|insulin|mesh-list
111398505|NCT00002241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111398732|NCT05690646|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111399196|NCT02975492|Vitamin D|vitamin d|mesh-list
111399708|NCT04972513|Vasodilator Agents|vasodilator agents|mesh-ancestor
111400540|NCT01940276|Prednisone|prednisone|mesh-list
111400754|NCT01608295|Paroxetine|paroxetine|mesh-list
111400823|NCT01925144|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111401271|NCT04752033|Morphine|morphine|mesh-list
111401719|NCT03340727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111402021|NCT03166761|Antiemetics|antiemetics|mesh-ancestor
111402499|NCT03083405|Opipramol|opipramol|mesh-list
111402852|NCT00003093|Cyclophosphamide|cyclophosphamide|mesh-list
111403018|NCT03439891|Nivolumab|nivolumab|mesh-list
111403156|NCT01754623|Gemcitabine|gemcitabine|mesh-list
111403229|NCT04062097|Hemostatics|hemostatics|mesh-ancestor
111403300|NCT01767103|Sequestering Agents|sequestering agents|mesh-ancestor
111403456|NCT02452931|Leuprolide|leuprolide|mesh-list
111403605|NCT02694809|Bazedoxifene|bazedoxifene|mesh-list
111404387|NCT02437253|Adalimumab|adalimumab|mesh-list
111404433|NCT02439281|Clonidine|clonidine|mesh-list
111404503|NCT02508077|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111404681|NCT02576249|Hormones|hormones|mesh-ancestor
111404814|NCT05249231|Fluorides|fluorides|mesh-list
111404876|NCT02289456|Tubulin Modulators|tubulin modulators|mesh-ancestor
111404950|NCT01839799|Paclitaxel|paclitaxel|mesh-list
111405183|NCT02647099|Antipyretics|antipyretics|mesh-ancestor
111405701|NCT01930747|Rocuronium|rocuronium|mesh-list
111406149|NCT04817969|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111406452|NCT03833921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111406748|NCT05449145|Vitamins|vitamins|mesh-ancestor
111406984|NCT01894555|Antipyretics|antipyretics|mesh-ancestor
111407052|NCT05364515|Clobetasol|clobetasol|mesh-list
111407275|NCT03029533|Leuprolide|leuprolide|mesh-list
111407502|NCT05349071|Methylprednisolone|methylprednisolone|mesh-list
111407573|NCT02287909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111407724|NCT04337099|Tempol|tempol|mesh-list
111408408|NCT02803229|Amphetamine|amphetamine|mesh-list
111408717|NCT02823431|Lidocaine|lidocaine|mesh-list
111409011|NCT02014363|Antidepressive Agents|antidepressive agents|mesh-ancestor
111409100|NCT02839889|Naloxegol|naloxegol|mesh-list
111409163|NCT02023411|Teriparatide|teriparatide|mesh-list
111409763|NCT02403830|Morphine|morphine|mesh-list
111410057|NCT03048383|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111410128|NCT02412644|Apremilast|apremilast|mesh-list
111410348|NCT02054156|Tobramycin|tobramycin|mesh-list
111410351|NCT03159143|Docetaxel|docetaxel|mesh-list
111410505|NCT03086213|Lidocaine|lidocaine|mesh-list
111410876|NCT03789097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111411027|NCT03296345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111411103|NCT02792465|Fulvestrant|fulvestrant|mesh-list
111411329|NCT05993767|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111411631|NCT05986968|Analgesics|analgesics|mesh-ancestor
111411857|NCT05969756|Fluorides, Topical|fluorides, topical|mesh-list
111412157|NCT05804162|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111412851|NCT05378555|Ketamine|ketamine|mesh-list
111413345|NCT05105841|Venetoclax|venetoclax|mesh-list
111413725|NCT04892264|Hormones|hormones|mesh-ancestor
111414843|NCT03719326|Antimitotic Agents|antimitotic agents|mesh-ancestor
111415067|NCT03515837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111415211|NCT03326245|Dopamine Agents|dopamine agents|mesh-ancestor
111415529|NCT02568618|Analgesics|analgesics|mesh-list
111415666|NCT02389036|Ciprofloxacin|ciprofloxacin|mesh-list
111415818|NCT01770145|Levodopa|levodopa|mesh-list
111416349|NCT01349192|Rifampin|rifampin|mesh-list
111416495|NCT02376283|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
111416577|NCT05664139|Paclitaxel|paclitaxel|mesh-list
111416653|NCT05419297|Buprenorphine|buprenorphine|mesh-list
111416723|NCT00357422|Ethanol|ethanol|mesh-list
111416957|NCT01445067|Calcitonin|calcitonin|mesh-list
111141700|NCT02489903|Taxane|taxane|mesh-list
111417321|NCT00003261|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111417397|NCT00376727|Cetuximab|cetuximab|mesh-list
111417472|NCT03403517|Prednisolone|prednisolone|mesh-list
111417772|NCT05924971|Aspirin|aspirin|mesh-list
111417883|NCT05922761|Xhance|xhance|mesh-list
111418146|NCT05919745|Analgesics|analgesics|mesh-ancestor
111418298|NCT05832398|Vitamins|vitamins|mesh-ancestor
111418372|NCT05764733|Diphosphonates|diphosphonates|mesh-list
111418899|NCT04865029|Estradiol|estradiol|mesh-list
111418973|NCT04717089|Anesthetics|anesthetics|mesh-list
111419054|NCT04632992|Immunotoxins|immunotoxins|mesh-ancestor
111419124|NCT04490057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111420027|NCT02992522|Venetoclax|venetoclax|mesh-list
111420111|NCT02586038|Ixazomib|ixazomib|mesh-list
111420252|NCT02020707|Mitosis Modulators|mitosis modulators|mesh-ancestor
111420403|NCT01160107|Alkylating Agents|alkylating agents|mesh-ancestor
111420484|NCT00783510|Adalimumab|adalimumab|mesh-list
111420702|NCT00070291|Immunologic Factors|immunologic factors|mesh-ancestor
111420775|NCT00049530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111420929|NCT00357019|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111421012|NCT03472469|Analgesics|analgesics|mesh-ancestor
111421306|NCT02976194|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111421392|NCT05334108|Ecopipam|ecopipam|mesh-list
111421830|NCT04343144|Nivolumab|nivolumab|mesh-list
111421903|NCT03674294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111422207|NCT04023695|Lidocaine|lidocaine|mesh-list
111422276|NCT03778554|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111423019|NCT05648058|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111423409|NCT02412306|Blinatumomab|blinatumomab|mesh-list
111423475|NCT03518034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111424162|NCT04530487|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111424235|NCT00003375|Alkylating Agents|alkylating agents|mesh-ancestor
111424385|NCT00003555|Protective Agents|protective agents|mesh-ancestor
111424693|NCT00421915|Immunologic Factors|immunologic factors|mesh-ancestor
111424769|NCT00003639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111424856|NCT00004095|Gemcitabine|gemcitabine|mesh-list
111425036|NCT00004209|Mitomycins|mitomycins|mesh-list
111425725|NCT00004695|Interleukin-2|interleukin-2|mesh-list
111426093|NCT01689987|Antiemetics|antiemetics|mesh-ancestor
111426244|NCT01761877|Sulindac|sulindac|mesh-list
111426321|NCT02974387|Glucocorticoids|glucocorticoids|mesh-ancestor
111427151|NCT02561702|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111427301|NCT03119012|Aspirin|aspirin|mesh-list
111427457|NCT02607254|Pregabalin|pregabalin|mesh-list
111427674|NCT02620904|Mifepristone|mifepristone|mesh-list
111427751|NCT04289792|Paclitaxel|paclitaxel|mesh-list
111427897|NCT00366938|Analgesics|analgesics|mesh-ancestor
111428042|NCT02564029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111428583|NCT00534469|Cytarabine|cytarabine|mesh-list
111153143|NCT01772368|Xhance|xhance|mesh-list
111428810|NCT04743193|Sevoflurane|sevoflurane|mesh-list
111429193|NCT00367471|Paclitaxel|paclitaxel|mesh-list
111429259|NCT02641561|Gout Suppressants|gout suppressants|mesh-ancestor
111429423|NCT02609828|Tanezumab|tanezumab|mesh-list
111429636|NCT04740086|Calcium|calcium|mesh-list
111429858|NCT02698735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111430088|NCT02722837|Sofosbuvir|sofosbuvir|mesh-list
111430158|NCT05261672|GABA Agents|gaba agents|mesh-ancestor
111430309|NCT03609008|Cromakalim|cromakalim|mesh-list
111430384|NCT05445661|Mannitol|mannitol|mesh-list
111430458|NCT05448001|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111430534|NCT05243953|Cromakalim|cromakalim|mesh-list
111430684|NCT04338919|Aspirin|aspirin|mesh-list
111430757|NCT05441150|Anesthetics, General|anesthetics, general|mesh-ancestor
111430908|NCT05448937|Eugenol|eugenol|mesh-list
111431052|NCT00370370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111431718|NCT02768558|Nivolumab|nivolumab|mesh-list
111431794|NCT02747186|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111431869|NCT02192190|Celecoxib|celecoxib|mesh-list
111432166|NCT04209140|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111432320|NCT04208347|Oxaliplatin|oxaliplatin|mesh-list
111432472|NCT00373646|Thalidomide|thalidomide|mesh-list
111432547|NCT03003949|Estradiol|estradiol|mesh-list
111432790|NCT03022526|Fentanyl|fentanyl|mesh-list
111433380|NCT05593939|Niacin|niacin|mesh-list
111433453|NCT05462730|Glucocorticoids|glucocorticoids|mesh-ancestor
111433528|NCT05323435|Vaccines|vaccines|mesh-list
111434066|NCT03043430|GABA Agents|gaba agents|mesh-ancestor
111434219|NCT02964416|Tramadol|tramadol|mesh-list
111434356|NCT03065179|Nivolumab|nivolumab|mesh-list
111434589|NCT02874092|Ticagrelor|ticagrelor|mesh-list
111434653|NCT03118466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111434810|NCT02858713|Hormones|hormones|mesh-ancestor
111435556|NCT00375661|Interferon alpha-2|interferon alpha-2|mesh-list
111436086|NCT03437564|Serotonin Agents|serotonin agents|mesh-ancestor
111436392|NCT02213094|Niacin|niacin|mesh-list
111436538|NCT03395990|Anesthetics|anesthetics|mesh-ancestor
111436713|NCT04501640|Mirabegron|mirabegron|mesh-list
111436844|NCT03572972|Apixaban|apixaban|mesh-list
111436999|NCT03670160|GABA Modulators|gaba modulators|mesh-ancestor
111437372|NCT03820388|Etomidate|etomidate|mesh-list
111437829|NCT03565328|Niacinamide|niacinamide|mesh-list
111437902|NCT01155518|Fertility Agents|fertility agents|mesh-ancestor
111438119|NCT04327843|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111438418|NCT00726830|Analgesics|analgesics|mesh-ancestor
111438648|NCT00379418|Abciximab|abciximab|mesh-list
111438818|NCT01055756|Loratadine|loratadine|mesh-list
111439023|NCT00448682|Vitamins|vitamins|mesh-ancestor
111439246|NCT00089414|Contraceptive Agents|contraceptive agents|mesh-ancestor
111439854|NCT00001964|Cyclosporine|cyclosporine|mesh-list
111440008|NCT00002006|Zidovudine|zidovudine|mesh-list
111440078|NCT00001094|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111440457|NCT00380822|Miglitol|miglitol|mesh-list
111440531|NCT03189433|Dantrolene|dantrolene|mesh-list
111440904|NCT00001520|Autonomic Agents|autonomic agents|mesh-ancestor
111441202|NCT00002360|Antimetabolites|antimetabolites|mesh-ancestor
111441359|NCT02589145|Pyridoxine|pyridoxine|mesh-list
111441581|NCT02436265|Antiemetics|antiemetics|mesh-ancestor
111442207|NCT00002654|Cobalt|cobalt|mesh-list
111442262|NCT00002678|Dexamethasone|dexamethasone|mesh-list
111442643|NCT01126801|Estradiol|estradiol|mesh-list
111442803|NCT00002792|Antimetabolites|antimetabolites|mesh-ancestor
111443023|NCT05467514|Hormones|hormones|mesh-ancestor
111443848|NCT00000337|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111444529|NCT00000703|Antidotes|antidotes|mesh-ancestor
111444838|NCT00001963|Analgesics|analgesics|mesh-ancestor
111444984|NCT00002053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111445066|NCT00002419|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111445135|NCT02335424|Pembrolizumab|pembrolizumab|mesh-list
111445212|NCT00001579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111446091|NCT00002816|Cytarabine|cytarabine|mesh-list
111446177|NCT00003152|Glucocorticoids|glucocorticoids|mesh-ancestor
111446320|NCT00003158|Mitosis Modulators|mitosis modulators|mesh-ancestor
111446400|NCT05751031|Raltegravir Potassium|raltegravir potassium|mesh-list
111446542|NCT00002593|Levamisole|levamisole|mesh-list
111446855|NCT05664061|Fluticasone|fluticasone|mesh-list
111447472|NCT00003602|Cytarabine|cytarabine|mesh-list
111447768|NCT00002761|Cytarabine|cytarabine|mesh-list
111448077|NCT00004190|Antimetabolites|antimetabolites|mesh-ancestor
111448460|NCT00004316|Capsaicin|capsaicin|mesh-list
111448842|NCT00004442|Cholic Acids|cholic acids|mesh-list
111449448|NCT00005648|Gemcitabine|gemcitabine|mesh-list
111449674|NCT04379635|Paclitaxel|paclitaxel|mesh-list
111449751|NCT02210858|Tipifarnib|tipifarnib|mesh-list
111449906|NCT03351361|Nivolumab|nivolumab|mesh-list
111449972|NCT00002905|Antimetabolites|antimetabolites|mesh-ancestor
111450052|NCT00002953|Paclitaxel|paclitaxel|mesh-list
111451048|NCT00003103|Docetaxel|docetaxel|mesh-list
111451345|NCT00004039|Hormones|hormones|mesh-ancestor
111451604|NCT00003187|Hormones|hormones|mesh-ancestor
111451730|NCT00003811|Etoposide|etoposide|mesh-list
111451813|NCT00003217|Hormones|hormones|mesh-ancestor
111452106|NCT00004255|Tacrolimus|tacrolimus|mesh-list
111452348|NCT00004903|Antiviral Agents|antiviral agents|mesh-ancestor
111452416|NCT00004981|Lamivudine|lamivudine|mesh-list
111452506|NCT00004399|Nimodipine|nimodipine|mesh-list
111452564|NCT00005035|Oxaliplatin|oxaliplatin|mesh-list
111452785|NCT00005119|Calcium|calcium|mesh-list
111453093|NCT02106156|Ribavirin|ribavirin|mesh-list
111453316|NCT02097108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111453632|NCT02109744|Decitabine|decitabine|mesh-list
111453687|NCT01624974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111453910|NCT02059278|Latanoprost|latanoprost|mesh-list
111454063|NCT02057250|Analgesics|analgesics|mesh-ancestor
111454136|NCT02034162|Piperazine|piperazine|mesh-list
111454505|NCT01986114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111454967|NCT01975272|Iron|iron|mesh-list
111455189|NCT01222871|Hormones|hormones|mesh-ancestor
111455399|NCT01074437|Adrenergic Agents|adrenergic agents|mesh-ancestor
111455469|NCT01009931|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111455546|NCT02075411|Sensory System Agents|sensory system agents|mesh-ancestor
111455621|NCT00808769|Omeprazole|omeprazole|mesh-list
111455765|NCT00673595|Varenicline|varenicline|mesh-list
111456038|NCT00500045|Niacin|niacin|mesh-list
111456068|NCT00428207|Insulin|insulin|mesh-list
111456147|NCT00281879|Cytarabine|cytarabine|mesh-list
111456222|NCT00205049|Pentoxifylline|pentoxifylline|mesh-list
111456451|NCT00000215|Pergolide|pergolide|mesh-list
111456527|NCT00000269|Dopamine Agents|dopamine agents|mesh-ancestor
111456762|NCT00000311|Methadone|methadone|mesh-list
111457351|NCT00002069|Antiviral Agents|antiviral agents|mesh-ancestor
111457802|NCT00002465|Megestrol|megestrol|mesh-list
111458103|NCT00381251|Hormones|hormones|mesh-ancestor
111459031|NCT00382889|Hormones|hormones|mesh-ancestor
111459399|NCT00003035|Tamoxifen|tamoxifen|mesh-list
111459471|NCT00003101|Vincristine|vincristine|mesh-list
111459775|NCT00002801|Tegafur|tegafur|mesh-list
111460080|NCT02972723|Metformin|metformin|mesh-list
111460396|NCT00004067|Paclitaxel|paclitaxel|mesh-list
111460762|NCT00004229|Endostatins|endostatins|mesh-list
111460917|NCT00004403|Anthelmintics|anthelmintics|mesh-ancestor
111461297|NCT00005117|Pravastatin|pravastatin|mesh-list
111461384|NCT00005585|Vitamins|vitamins|mesh-ancestor
111462344|NCT04272606|Hemostatics|hemostatics|mesh-ancestor
111462515|NCT03600155|Nivolumab|nivolumab|mesh-list
111462941|NCT00003893|Doxorubicin|doxorubicin|mesh-list
111463172|NCT01946880|Prednisone|prednisone|mesh-list
111463278|NCT01915914|Xhance|xhance|mesh-list
111463407|NCT01907100|Cisplatin|cisplatin|mesh-list
111463468|NCT01881126|Timolol|timolol|mesh-list
111463541|NCT01862250|Sensory System Agents|sensory system agents|mesh-ancestor
111463778|NCT01869192|Docetaxel|docetaxel|mesh-list
111464062|NCT01798056|Vaccines|vaccines|mesh-list
111464288|NCT04592016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111464437|NCT01813422|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111464511|NCT01810302|Vasodilator Agents|vasodilator agents|mesh-ancestor
111464698|NCT01762800|Xhance|xhance|mesh-list
111464810|NCT01775124|Ranibizumab|ranibizumab|mesh-list
111464914|NCT01755234|Propofol|propofol|mesh-list
111465190|NCT01721772|Nivolumab|nivolumab|mesh-list
111465263|NCT01700946|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111465410|NCT01739790|Expectorants|expectorants|mesh-ancestor
111465567|NCT01681212|Ipilimumab|ipilimumab|mesh-list
111466017|NCT01580670|Infliximab|infliximab|mesh-list
111466904|NCT01498068|Antiviral Agents|antiviral agents|mesh-ancestor
111466977|NCT01473732|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111467205|NCT01439880|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111467279|NCT01441440|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111467504|NCT04044222|Carboplatin|carboplatin|mesh-list
111468031|NCT05361330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111468250|NCT03599466|Protective Agents|protective agents|mesh-ancestor
111468561|NCT04193592|Pirfenidone|pirfenidone|mesh-list
111468784|NCT04020588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111468859|NCT04026282|Hormones|hormones|mesh-ancestor
111468940|NCT05581992|Sotorasib|sotorasib|mesh-list
111469082|NCT04148820|Analgesics|analgesics|mesh-ancestor
111469312|NCT03584178|Hormones|hormones|mesh-ancestor
111469381|NCT03159234|Autonomic Agents|autonomic agents|mesh-ancestor
111469828|NCT03748134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111470061|NCT03825198|Glucocorticoids|glucocorticoids|mesh-ancestor
111470213|NCT03458598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111470287|NCT03774732|Paclitaxel|paclitaxel|mesh-list
111470439|NCT00085098|Immunologic Factors|immunologic factors|mesh-ancestor
111470588|NCT00088452|Anticonvulsants|anticonvulsants|mesh-ancestor
111471714|NCT00634920|Basiliximab|basiliximab|mesh-list
111472174|NCT03423342|Niacin|niacin|mesh-list
111472762|NCT01453920|Ranibizumab|ranibizumab|mesh-list
111472922|NCT02983344|Fentanyl|fentanyl|mesh-list
111472988|NCT01451658|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111473071|NCT01456260|Lansoprazole|lansoprazole|mesh-list
111473295|NCT01459146|Anthelmintics|anthelmintics|mesh-ancestor
111473665|NCT01989780|Fertility Agents|fertility agents|mesh-ancestor
111473816|NCT05586126|Anesthetics, General|anesthetics, general|mesh-ancestor
111473967|NCT01896336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111474195|NCT04779762|Ustekinumab|ustekinumab|mesh-list
111474352|NCT04772352|Febuxostat|febuxostat|mesh-list
111474798|NCT00255684|Antimetabolites|antimetabolites|mesh-ancestor
111474873|NCT00176826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111474960|NCT00193128|Docetaxel|docetaxel|mesh-list
111475472|NCT00234078|Antioxidants|antioxidants|mesh-ancestor
111475557|NCT00240162|Vatalanib|vatalanib|mesh-list
111475771|NCT01790022|Autonomic Agents|autonomic agents|mesh-ancestor
111476004|NCT00338598|Glycine|glycine|mesh-list
111476152|NCT00353652|Diuretics|diuretics|mesh-ancestor
111476492|NCT00318708|Xhance|xhance|mesh-list
111476598|NCT00391716|Anticonvulsants|anticonvulsants|mesh-ancestor
111476846|NCT00382590|Cytarabine|cytarabine|mesh-list
111477053|NCT02115750|Immunologic Factors|immunologic factors|mesh-ancestor
111477129|NCT00472056|Antimetabolites|antimetabolites|mesh-ancestor
111477584|NCT00439374|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
111477748|NCT00449748|Everolimus|everolimus|mesh-list
111477811|NCT00549042|Analgesics|analgesics|mesh-ancestor
111478035|NCT03158376|Anticonvulsants|anticonvulsants|mesh-ancestor
111478867|NCT01168219|Alkylating Agents|alkylating agents|mesh-ancestor
110943315|NCT05476952|Rocuronium|rocuronium|mesh-list
110945660|NCT04078568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110947635|NCT02453282|Paclitaxel|paclitaxel|mesh-list
110947910|NCT01920932|Glucocorticoids|glucocorticoids|mesh-ancestor
110660336|NCT00466947|Vaccines|vaccines|mesh-list
110660628|NCT00977756|Ritonavir|ritonavir|mesh-list
110660710|NCT00982436|Docetaxel|docetaxel|mesh-list
110661091|NCT00538902|Adalimumab|adalimumab|mesh-list
110661536|NCT04004234|Antimetabolites|antimetabolites|mesh-ancestor
110661690|NCT05589584|Antiviral Agents|antiviral agents|mesh-ancestor
110661766|NCT03905096|Donepezil|donepezil|mesh-list
110661915|NCT00991250|Temozolomide|temozolomide|mesh-list
110662068|NCT00403234|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110662140|NCT00767975|Isoniazid|isoniazid|mesh-list
110662595|NCT00398632|Dopamine Agents|dopamine agents|mesh-ancestor
110662672|NCT00393718|Incretins|incretins|mesh-ancestor
110662819|NCT02556905|Glucocorticoids|glucocorticoids|mesh-ancestor
110662970|NCT00776477|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110663195|NCT00057811|Methylprednisolone|methylprednisolone|mesh-list
110663347|NCT01976390|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110663495|NCT00781157|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110663725|NCT00782093|Volociximab|volociximab|mesh-list
111479164|NCT05708183|Trace Elements|trace elements|mesh-list
110664994|NCT00035815|Mitogens|mitogens|mesh-list
110665071|NCT00661193|Tubulin Modulators|tubulin modulators|mesh-ancestor
110665147|NCT00797927|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110665227|NCT00802139|Iron|iron|mesh-list
110665298|NCT03953287|Acetaminophen|acetaminophen|mesh-list
110665374|NCT00803699|Trace Elements|trace elements|mesh-ancestor
110665907|NCT00646451|Analgesics|analgesics|mesh-ancestor
110666209|NCT00059839|Prednisone|prednisone|mesh-list
110666283|NCT01046500|Inositol|inositol|mesh-list
110666436|NCT01017939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110666508|NCT00463047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110666813|NCT02551133|Dexamethasone|dexamethasone|mesh-list
110666890|NCT00452361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110666968|NCT00819377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110668470|NCT00996060|GABA Agents|gaba agents|mesh-ancestor
110668696|NCT00441441|Fluticasone|fluticasone|mesh-list
110668778|NCT00376246|Ezetimibe|ezetimibe|mesh-list
110929738|NCT02175888|Iron|iron|mesh-list
110669398|NCT05889390|Paclitaxel|paclitaxel|mesh-list
110669755|NCT05180773|Dopamine Agents|dopamine agents|mesh-ancestor
110669980|NCT04374461|Respiratory System Agents|respiratory system agents|mesh-ancestor
110670234|NCT03735563|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110670304|NCT03464136|Adalimumab|adalimumab|mesh-list
110670379|NCT03048825|Natriuretic Agents|natriuretic agents|mesh-ancestor
110671282|NCT00837239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110671432|NCT00837941|Histamine Agents|histamine agents|mesh-ancestor
110671799|NCT00844337|Amoxicillin|amoxicillin|mesh-list
110671872|NCT00528528|Ribavirin|ribavirin|mesh-list
110672025|NCT01564680|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110672096|NCT00842933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110672546|NCT00858455|Antiviral Agents|antiviral agents|mesh-ancestor
110672775|NCT04732182|Donepezil|donepezil|mesh-list
110673362|NCT00873509|Buspirone|buspirone|mesh-list
110673664|NCT00878657|Gemcitabine|gemcitabine|mesh-list
110674191|NCT05880017|Morphine|morphine|mesh-list
110674413|NCT05826327|Sufentanil|sufentanil|mesh-list
110674567|NCT05667324|Glucocorticoids|glucocorticoids|mesh-ancestor
110674714|NCT05541471|Anesthetics|anesthetics|mesh-ancestor
110674947|NCT06013423|Thiotepa|thiotepa|mesh-list
110675051|NCT06012916|Esketamine|esketamine|mesh-list
110675225|NCT05631886|Antibodies|antibodies|mesh-list
110675386|NCT05081479|Antidotes|antidotes|mesh-ancestor
110675467|NCT04777357|Cariprazine|cariprazine|mesh-list
110675572|NCT04336098|Gemcitabine|gemcitabine|mesh-list
110675872|NCT02675465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110676037|NCT05293964|Everolimus|everolimus|mesh-list
110676114|NCT05195619|Vaccines|vaccines|mesh-list
110676206|NCT04998786|Glucocorticoids|glucocorticoids|mesh-ancestor
110676354|NCT04848792|Sulforaphane|sulforaphane|mesh-list
110676451|NCT04614194|Letrozole|letrozole|mesh-list
110676586|NCT04319627|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110676659|NCT04021108|Nivolumab|nivolumab|mesh-list
110676734|NCT03865290|Dermatologic Agents|dermatologic agents|mesh-ancestor
110676807|NCT03659136|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110948404|NCT04822012|Antibodies|antibodies|mesh-list
110948472|NCT04525898|Sensory System Agents|sensory system agents|mesh-ancestor
110948549|NCT02235402|Lacidipine|lacidipine|mesh-list
110948698|NCT01434498|Ribavirin|ribavirin|mesh-list
110948921|NCT01478178|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110948995|NCT01336686|Gout Suppressants|gout suppressants|mesh-ancestor
110949151|NCT05370716|Pregabalin|pregabalin|mesh-list
110949373|NCT02522078|Misoprostol|misoprostol|mesh-list
110949741|NCT00871182|Respiratory System Agents|respiratory system agents|mesh-ancestor
110949813|NCT00858702|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
110949888|NCT00805350|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110950035|NCT00939276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110950109|NCT04697940|Decitabine|decitabine|mesh-list
110950182|NCT00836004|Clindamycin|clindamycin|mesh-list
110950258|NCT04819438|Riluzole|riluzole|mesh-list
110950327|NCT02602288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110950478|NCT03036202|Autonomic Agents|autonomic agents|mesh-ancestor
110950704|NCT03129542|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110950780|NCT01377194|Milnacipran|milnacipran|mesh-list
110950856|NCT02063139|Glucocorticoids|glucocorticoids|mesh-ancestor
110950931|NCT00734292|Fluticasone|fluticasone|mesh-list
110951151|NCT04809142|Antimetabolites|antimetabolites|mesh-ancestor
110951598|NCT04472832|Mitapivat|mitapivat|mesh-list
110951747|NCT02080377|Glyburide|glyburide|mesh-list
110951831|NCT02278692|Vitamin K|vitamin k|mesh-list
110952039|NCT02282280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110952190|NCT00434226|Sunitinib|sunitinib|mesh-list
110952413|NCT01369641|Cisplatin|cisplatin|mesh-list
110952558|NCT00507936|Dopamine Agents|dopamine agents|mesh-ancestor
110953157|NCT02087631|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110953307|NCT03428906|Oxytocin|oxytocin|mesh-list
111498025|NCT02538042|Nicotine|nicotine|mesh-list
111320660|NCT05736549|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111320661|NCT05736549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111320662|NCT05736549|Anesthetics, Local|anesthetics, local|mesh-ancestor
111320663|NCT05736549|Anesthetics|anesthetics|mesh-ancestor
111320664|NCT05736549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111320665|NCT05736549|Sensory System Agents|sensory system agents|mesh-ancestor
111320666|NCT05736549|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111320667|NCT05736549|Protective Agents|protective agents|mesh-ancestor
111320668|NCT05736549|Protease Inhibitors|protease inhibitors|mesh-ancestor
111320669|NCT05736549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111320670|NCT05736549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111320671|NCT05688488|Curcumin|curcumin|mesh-list
111320672|NCT05688488|Mitomycins|mitomycins|mesh-list
111320673|NCT05688488|Mitomycin|mitomycin|mesh-list
111320674|NCT05688488|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111320675|NCT05688488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111320676|NCT05688488|Alkylating Agents|alkylating agents|mesh-ancestor
111320677|NCT05688488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111320678|NCT05688488|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111320679|NCT05688488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111320680|NCT05688488|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111320681|NCT05688488|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111320682|NCT05688488|Analgesics|analgesics|mesh-ancestor
111320683|NCT05688488|Sensory System Agents|sensory system agents|mesh-ancestor
111320684|NCT05688488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111320685|NCT05688488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111320686|NCT05688488|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111320687|NCT05688488|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111320688|NCT00669383|Betamethasone|betamethasone|mesh-list
111320689|NCT00669383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111320690|NCT00669383|Glucocorticoids|glucocorticoids|mesh-ancestor
111320691|NCT00669383|Hormones|hormones|mesh-ancestor
111320692|NCT00669383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111320693|NCT00669383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111320694|NCT00669383|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111320695|NCT00669383|Respiratory System Agents|respiratory system agents|mesh-ancestor
111320696|NCT00733993|Caffeine|caffeine|mesh-list
111320697|NCT00733993|Amphetamine|amphetamine|mesh-list
111320698|NCT00733993|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111320699|NCT00733993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111320700|NCT00733993|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111320701|NCT00733993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111320702|NCT00733993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111320703|NCT00733993|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
111320704|NCT00733993|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111320705|NCT00733993|Purinergic Agents|purinergic agents|mesh-ancestor
111320706|NCT00733993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111320707|NCT00733993|Sympathomimetics|sympathomimetics|mesh-ancestor
111320708|NCT00733993|Autonomic Agents|autonomic agents|mesh-ancestor
111320709|NCT00733993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111320710|NCT00733993|Dopamine Agents|dopamine agents|mesh-ancestor
111320711|NCT00733993|Adrenergic Agents|adrenergic agents|mesh-ancestor
111320712|NCT00733993|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111320713|NCT00733993|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111320714|NCT00733993|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111320715|NCT00733993|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111320716|NCT01271257|Misoprostol|misoprostol|mesh-list
111320717|NCT01271257|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111320718|NCT01271257|Abortifacient Agents|abortifacient agents|mesh-ancestor
111320719|NCT01271257|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111320720|NCT01271257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111320721|NCT01271257|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111320722|NCT01271257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111320723|NCT01271257|Oxytocics|oxytocics|mesh-ancestor
111320724|NCT03082352|Metoprolol|metoprolol|mesh-list
111320725|NCT03082352|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111320726|NCT03082352|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111320727|NCT03082352|Sympatholytics|sympatholytics|mesh-ancestor
111320728|NCT03082352|Autonomic Agents|autonomic agents|mesh-ancestor
110773675|NCT01379560|Oxytocics|oxytocics|mesh-ancestor
111498696|NCT05510856|Anticonvulsants|anticonvulsants|mesh-ancestor
111499143|NCT05444088|Bevacizumab|bevacizumab|mesh-list
111499503|NCT03341676|Dexamethasone|dexamethasone|mesh-list
111499948|NCT02821338|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111320729|NCT03082352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111320730|NCT03082352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111320731|NCT03082352|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
111320732|NCT03082352|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111320733|NCT03082352|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111320734|NCT03082352|Adrenergic Agents|adrenergic agents|mesh-ancestor
111320735|NCT03082352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111320736|NCT03082352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111320737|NCT03431168|Azithromycin|azithromycin|mesh-list
111320738|NCT03431168|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
111320739|NCT03431168|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111320740|NCT03431168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111320741|NCT03431168|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111320742|NCT03431168|Antimalarials|antimalarials|mesh-ancestor
111320743|NCT03431168|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111320744|NCT03431168|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111320745|NCT05737563|Capecitabine|capecitabine|mesh-list
111320746|NCT05737563|Irinotecan|irinotecan|mesh-list
111320747|NCT05737563|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
111320748|NCT05737563|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111320749|NCT05737563|Antimetabolites|antimetabolites|mesh-ancestor
111320750|NCT05737563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111320751|NCT05737563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111320752|NCT05737563|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111320753|NCT05737563|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111320754|NCT05737563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111320755|NCT05737563|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111320756|NCT03398252|Doxazosin|doxazosin|mesh-list
111320757|NCT03398252|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111320758|NCT03398252|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111320759|NCT03398252|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111320760|NCT03398252|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111320761|NCT03398252|Adrenergic Agents|adrenergic agents|mesh-ancestor
111320762|NCT03398252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111320763|NCT03398252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111320764|NCT03398252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111320765|NCT02285283|Itraconazole|itraconazole|mesh-list
110942733|NCT05707208|Lidocaine|lidocaine|mesh-list
110953532|NCT02098785|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110953533|NCT02098785|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110953534|NCT02098785|Purinergic Agents|purinergic agents|mesh-ancestor
110953535|NCT02098785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110953536|NCT02521064|Prednisone|prednisone|mesh-list
110953537|NCT02521064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110953538|NCT02521064|Glucocorticoids|glucocorticoids|mesh-ancestor
110953539|NCT02521064|Hormones|hormones|mesh-ancestor
110953540|NCT02521064|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110953541|NCT02521064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110953542|NCT02521064|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110953543|NCT02521064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110953544|NCT02096913|Ibuprofen|ibuprofen|mesh-list
110953545|NCT02096913|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110953546|NCT02096913|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110953547|NCT02096913|Analgesics|analgesics|mesh-ancestor
110953548|NCT02096913|Sensory System Agents|sensory system agents|mesh-ancestor
110953549|NCT02096913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110953550|NCT02096913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110953551|NCT02096913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110953552|NCT02096913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110953553|NCT02096913|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110953554|NCT02096913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110953555|NCT02096913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110953556|NCT03418610|Azelaic acid|azelaic acid|mesh-list
110953557|NCT03418610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110953558|NCT03418610|Dermatologic Agents|dermatologic agents|mesh-ancestor
110953559|NCT04604366|Alprostadil|alprostadil|mesh-list
110953560|NCT04604366|Misoprostol|misoprostol|mesh-list
110953561|NCT04604366|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110953562|NCT04604366|Abortifacient Agents|abortifacient agents|mesh-ancestor
110953563|NCT04604366|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110953564|NCT04604366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110953565|NCT04604366|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110953566|NCT04604366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110953567|NCT04604366|Oxytocics|oxytocics|mesh-ancestor
110953568|NCT04604366|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110953569|NCT04604366|Vasodilator Agents|vasodilator agents|mesh-ancestor
110953570|NCT04604366|Urological Agents|urological agents|mesh-ancestor
110953571|NCT02099253|Dexmedetomidine|dexmedetomidine|mesh-list
110953572|NCT02099253|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110953573|NCT02099253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110953574|NCT02099253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110953575|NCT02099253|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110953576|NCT02099253|Analgesics|analgesics|mesh-ancestor
110953577|NCT02099253|Sensory System Agents|sensory system agents|mesh-ancestor
110953578|NCT02099253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110953579|NCT02099253|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110953580|NCT02099253|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110953581|NCT02099253|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110953582|NCT02099253|Adrenergic Agents|adrenergic agents|mesh-ancestor
110953583|NCT02099253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110953584|NCT02099253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110953585|NCT05818111|Lidocaine|lidocaine|mesh-list
110953586|NCT05818111|Anesthetics, Local|anesthetics, local|mesh-ancestor
110953587|NCT05818111|Anesthetics|anesthetics|mesh-ancestor
110953588|NCT05818111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110953589|NCT05818111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110953590|NCT05818111|Sensory System Agents|sensory system agents|mesh-ancestor
110953591|NCT05818111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110953592|NCT05818111|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110953593|NCT05818111|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110953594|NCT05818111|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110953595|NCT05818111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110953596|NCT05818111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110953597|NCT05818007|Hyaluronic Acid|hyaluronic acid|mesh-list
110953598|NCT05818007|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110953599|NCT05818007|Immunologic Factors|immunologic factors|mesh-ancestor
110953600|NCT05818007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110953601|NCT05818007|Viscosupplements|viscosupplements|mesh-ancestor
110953602|NCT05818007|Protective Agents|protective agents|mesh-ancestor
110953603|NCT05817955|Azacitidine|azacitidine|mesh-list
110022414|NCT00002802|Vincristine|vincristine|mesh-list
111498009|NCT02530554|Chlorhexidine|chlorhexidine|mesh-list
110953604|NCT05817955|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110953605|NCT05817955|Antimetabolites|antimetabolites|mesh-ancestor
110953606|NCT05817955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110953607|NCT05817955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110953608|NCT05817955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110953609|NCT05817409|Baclofen|baclofen|mesh-list
110953610|NCT05817409|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110953611|NCT05817409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110953612|NCT05817409|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110953613|NCT05817409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110953614|NCT05817409|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
110953615|NCT05817409|GABA Agonists|gaba agonists|mesh-ancestor
110953616|NCT05817409|GABA Agents|gaba agents|mesh-ancestor
110953617|NCT05817409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110953618|NCT05817409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110953619|NCT05817253|Coal Tar|coal tar|mesh-list
110953620|NCT05817253|Keratolytic Agents|keratolytic agents|mesh-ancestor
110953621|NCT05817253|Dermatologic Agents|dermatologic agents|mesh-ancestor
110953622|NCT05817201|Tegafur|tegafur|mesh-list
110953623|NCT05817201|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110953624|NCT05817201|Antimetabolites|antimetabolites|mesh-ancestor
110953625|NCT05817201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110953626|NCT05817201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110953627|NCT05817019|Neostigmine|neostigmine|mesh-list
110665614|NCT00809705|Incretins|incretins|mesh-ancestor
110953628|NCT05817019|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110953629|NCT05817019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110953630|NCT05817019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110953631|NCT05817019|Cholinergic Agents|cholinergic agents|mesh-ancestor
110953632|NCT05817019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110953633|NCT05817019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110953634|NCT05817019|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110953636|NCT05817019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110953637|NCT05816772|Calcium|calcium|mesh-list
110953638|NCT05816772|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110953639|NCT05816772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110953640|NCT05816733|Dapagliflozin|dapagliflozin|mesh-list
110953641|NCT05816733|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110953642|NCT05816733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110953643|NCT05816733|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110953644|NCT05816733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110953645|NCT05816720|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
110953646|NCT05816720|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110953647|NCT05816720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110953648|NCT05816707|Turmeric extract|turmeric extract|mesh-list
110953649|NCT05816707|Antioxidants|antioxidants|mesh-ancestor
110953650|NCT05816707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110953651|NCT05816707|Protective Agents|protective agents|mesh-ancestor
110953652|NCT05816707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110953653|NCT05816694|Paclitaxel|paclitaxel|mesh-list
110953654|NCT05816694|Cyclophosphamide|cyclophosphamide|mesh-list
110953655|NCT05816694|Cisplatin|cisplatin|mesh-list
110953656|NCT05816694|Epirubicin|epirubicin|mesh-list
110953657|NCT05816694|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110953658|NCT05816694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110953659|NCT05816694|Tubulin Modulators|tubulin modulators|mesh-ancestor
110953660|NCT05816694|Antimitotic Agents|antimitotic agents|mesh-ancestor
110953661|NCT05816694|Mitosis Modulators|mitosis modulators|mesh-ancestor
110953662|NCT05816694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110953663|NCT05816694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110953664|NCT05816694|Immunologic Factors|immunologic factors|mesh-ancestor
110953665|NCT05816694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110953666|NCT05816694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110953667|NCT05816694|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110953668|NCT05816694|Alkylating Agents|alkylating agents|mesh-ancestor
110953669|NCT05816694|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110953670|NCT05816694|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110953671|NCT05816694|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110953672|NCT05816694|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110953673|NCT05816694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110953674|NCT05816668|Tranexamic Acid|tranexamic acid|mesh-list
110953675|NCT05816668|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110953676|NCT05816668|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110953677|NCT05816668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110953678|NCT05816668|Hemostatics|hemostatics|mesh-ancestor
110953679|NCT05816668|Coagulants|coagulants|mesh-ancestor
110953680|NCT05816655|Fulvestrant|fulvestrant|mesh-list
110953681|NCT05816655|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110953682|NCT05816655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110953683|NCT05816655|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110953684|NCT05816655|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110953685|NCT05816655|Hormone Antagonists|hormone antagonists|mesh-ancestor
110953686|NCT05816655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110953687|NCT05816655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110953688|NCT05816642|Sunitinib|sunitinib|mesh-list
110953689|NCT05816642|Axitinib|axitinib|mesh-list
110953690|NCT05816642|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
110953691|NCT05816642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110953692|NCT05816642|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110953693|NCT05816642|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110953694|NCT05816642|Growth Substances|growth substances|mesh-ancestor
110953695|NCT05816642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110953696|NCT05816642|Growth Inhibitors|growth inhibitors|mesh-ancestor
110953697|NCT05816642|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110953698|NCT05816642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110953699|NCT05816642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110665688|NCT00651755|Aprepitant|aprepitant|mesh-list
110665761|NCT02552459|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110953700|NCT05816642|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110953701|NCT05816538|Anesthetics|anesthetics|mesh-list
110953702|NCT05816538|Levobupivacaine|levobupivacaine|mesh-list
110953703|NCT05816538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110953704|NCT05816538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110953705|NCT05816538|Anesthetics, Local|anesthetics, local|mesh-ancestor
110953706|NCT05816538|Sensory System Agents|sensory system agents|mesh-ancestor
110953707|NCT05816538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110953708|NCT05809583|Ozanimod|ozanimod|mesh-list
110953709|NCT05809583|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
110953710|NCT05809583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110953711|NCT05809583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110953712|NCT05809583|Immunologic Factors|immunologic factors|mesh-ancestor
110953713|NCT05809583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110953714|NCT05803629|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110953715|NCT05803629|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110953716|NCT05803629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110953717|NCT05803434|Cannabidiol|cannabidiol|mesh-list
110953718|NCT05803434|Anticonvulsants|anticonvulsants|mesh-ancestor
110953719|NCT05777226|Epalrestat|epalrestat|mesh-list
110953720|NCT05777226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110953721|NCT05777226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110953722|NCT05776160|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
110953723|NCT05776160|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110953724|NCT05776160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110953725|NCT05769920|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110953726|NCT05769920|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110953727|NCT05769010|Bevacizumab|bevacizumab|mesh-list
110953728|NCT05769010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110953729|NCT05769010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110953730|NCT05769010|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110953731|NCT05769010|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110953732|NCT05769010|Growth Substances|growth substances|mesh-ancestor
110953733|NCT05769010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110953734|NCT05769010|Growth Inhibitors|growth inhibitors|mesh-ancestor
110953735|NCT05716607|Hydrocortisone|hydrocortisone|mesh-list
110953736|NCT05716607|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
110953737|NCT05716607|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
110953738|NCT05716607|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
110953739|NCT05716607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110953740|NCT05688579|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
110953741|NCT05688579|Mineralocorticoids|mineralocorticoids|mesh-list
110953742|NCT05688579|Hormone Antagonists|hormone antagonists|mesh-ancestor
110953743|NCT05688579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110953744|NCT05688579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110953745|NCT05688579|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110953746|NCT05688579|Diuretics|diuretics|mesh-ancestor
110953747|NCT05688579|Natriuretic Agents|natriuretic agents|mesh-ancestor
110953748|NCT05688579|Hormones|hormones|mesh-ancestor
110953749|NCT05675501|Benzoyl Peroxide|benzoyl peroxide|mesh-list
110953750|NCT05675501|Dermatologic Agents|dermatologic agents|mesh-ancestor
110953751|NCT05662111|Etidronic Acid|etidronic acid|mesh-list
110953752|NCT05662111|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110953753|NCT05662111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110953754|NCT05659927|Antibodies|antibodies|mesh-list
110953755|NCT05659927|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110953756|NCT05659927|Immunologic Factors|immunologic factors|mesh-ancestor
110953757|NCT05659927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110953758|NCT05659823|Fentanyl|fentanyl|mesh-list
110953759|NCT05659823|Morphine|morphine|mesh-list
110953760|NCT05659823|Bupivacaine|bupivacaine|mesh-list
110953761|NCT05659823|Anesthetics, Local|anesthetics, local|mesh-ancestor
110953762|NCT05659823|Anesthetics|anesthetics|mesh-ancestor
110953763|NCT05659823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110953764|NCT05659823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110953765|NCT05659823|Sensory System Agents|sensory system agents|mesh-ancestor
110953766|NCT05659823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110953767|NCT05659823|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110953768|NCT05659823|Narcotics|narcotics|mesh-ancestor
110953769|NCT05659823|Analgesics|analgesics|mesh-ancestor
110953770|NCT05659823|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110953771|NCT05659823|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110953772|NCT05659823|Anesthetics, General|anesthetics, general|mesh-ancestor
110953773|NCT05640453|Pregabalin|pregabalin|mesh-list
110953774|NCT05640453|Dexmedetomidine|dexmedetomidine|mesh-list
110953775|NCT05640453|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110953776|NCT05640453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110953777|NCT05640453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110953778|NCT05640453|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110953779|NCT05640453|Analgesics|analgesics|mesh-ancestor
110953780|NCT05640453|Sensory System Agents|sensory system agents|mesh-ancestor
110953781|NCT05640453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110953782|NCT05640453|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110953783|NCT05640453|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110953784|NCT05640453|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110953785|NCT05640453|Adrenergic Agents|adrenergic agents|mesh-ancestor
110953786|NCT05640453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110953787|NCT05640453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110953788|NCT05640453|Anticonvulsants|anticonvulsants|mesh-ancestor
110953789|NCT05640453|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110953790|NCT05640453|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110953791|NCT05640453|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110953792|NCT05640453|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110953793|NCT05640453|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110953794|NCT05640453|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110953795|NCT05635851|Nitroglycerin|nitroglycerin|mesh-list
110953796|NCT05635851|Vasodilator Agents|vasodilator agents|mesh-ancestor
110953797|NCT05599789|Docetaxel|docetaxel|mesh-list
110953798|NCT05599789|Pembrolizumab|pembrolizumab|mesh-list
110953799|NCT05599789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110953800|NCT05599789|Tubulin Modulators|tubulin modulators|mesh-ancestor
110953801|NCT05599789|Antimitotic Agents|antimitotic agents|mesh-ancestor
110953802|NCT05599789|Mitosis Modulators|mitosis modulators|mesh-ancestor
110953803|NCT05599789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110953804|NCT05599789|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110953805|NCT05599789|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110953806|NCT05581901|Methadone|methadone|mesh-list
110953807|NCT05581901|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110953808|NCT05581901|Narcotics|narcotics|mesh-ancestor
110953809|NCT05581901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110953810|NCT05581901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110953811|NCT05581901|Analgesics|analgesics|mesh-ancestor
110953812|NCT05581901|Sensory System Agents|sensory system agents|mesh-ancestor
110953813|NCT05581901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110953814|NCT05581901|Antitussive Agents|antitussive agents|mesh-ancestor
110953815|NCT05581901|Respiratory System Agents|respiratory system agents|mesh-ancestor
110953816|NCT05564637|Treprostinil|treprostinil|mesh-list
110953817|NCT05564637|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110953818|NCT05508061|Insulin|insulin|mesh-list
110953819|NCT05508061|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110953820|NCT05508061|Insulin Lispro|insulin lispro|mesh-list
110953821|NCT05508061|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110953822|NCT05508061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110953823|NCT05504642|Nivolumab|nivolumab|mesh-list
110953824|NCT05504642|Ipilimumab|ipilimumab|mesh-list
110953825|NCT05504642|Immunomodulating Agents|immunomodulating agents|mesh-list
110953826|NCT05504642|Immunologic Factors|immunologic factors|mesh-list
110953827|NCT05504642|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110953828|NCT05504642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110953829|NCT05504642|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110953830|NCT05504642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110953831|NCT05504642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110953832|NCT05490953|Pentoxifylline|pentoxifylline|mesh-list
110953833|NCT05490953|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110953834|NCT05490953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110953835|NCT05490953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110953836|NCT05490953|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110953837|NCT05490953|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110953838|NCT05490953|Protective Agents|protective agents|mesh-ancestor
110953839|NCT05490953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110953840|NCT05490953|Vasodilator Agents|vasodilator agents|mesh-ancestor
110953841|NCT05490953|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110953842|NCT05490953|Antioxidants|antioxidants|mesh-ancestor
110953843|NCT05475483|Bevantolol|bevantolol|mesh-list
110953844|NCT05475483|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110953845|NCT05475483|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110953846|NCT05475483|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110953847|NCT05475483|Adrenergic Agents|adrenergic agents|mesh-ancestor
110953848|NCT05475483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110665840|NCT00654095|Antimetabolites|antimetabolites|mesh-ancestor
110953849|NCT05475483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110953850|NCT05475483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110953851|NCT05474729|Minocycline|minocycline|mesh-list
110953852|NCT05474729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110953853|NCT05474729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110953854|NCT05474001|Fentanyl|fentanyl|mesh-list
110953855|NCT05474001|Bupivacaine|bupivacaine|mesh-list
110953856|NCT05474001|Anesthetics, Local|anesthetics, local|mesh-ancestor
110953857|NCT05474001|Anesthetics|anesthetics|mesh-ancestor
110953858|NCT05474001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110953859|NCT05474001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110953860|NCT05474001|Sensory System Agents|sensory system agents|mesh-ancestor
110953861|NCT05474001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110953862|NCT05474001|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110953863|NCT05474001|Narcotics|narcotics|mesh-ancestor
110953864|NCT05474001|Analgesics|analgesics|mesh-ancestor
110953865|NCT05474001|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110953866|NCT05474001|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110953867|NCT05474001|Anesthetics, General|anesthetics, general|mesh-ancestor
110953868|NCT05445232|Midazolam|midazolam|mesh-list
110953869|NCT05445232|Caffeine|caffeine|mesh-list
110953870|NCT05445232|Warfarin|warfarin|mesh-list
110953871|NCT05445232|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110953872|NCT05445232|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110953873|NCT05445232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110953874|NCT05445232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110953875|NCT05445232|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110953876|NCT05445232|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110953877|NCT05445232|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110953878|NCT05445232|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110953879|NCT05445232|Anesthetics, General|anesthetics, general|mesh-ancestor
110953880|NCT05445232|Anesthetics|anesthetics|mesh-ancestor
110953881|NCT05445232|GABA Modulators|gaba modulators|mesh-ancestor
110953882|NCT05445232|GABA Agents|gaba agents|mesh-ancestor
110953883|NCT05445232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110953884|NCT05445232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110953885|NCT05445232|Anticoagulants|anticoagulants|mesh-ancestor
110953886|NCT05445232|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110953887|NCT05445232|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110953888|NCT05445232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110953889|NCT05445232|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110953890|NCT05445232|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110953891|NCT05445232|Purinergic Agents|purinergic agents|mesh-ancestor
110953892|NCT05420805|Zinc Oxide|zinc oxide|mesh-list
110953893|NCT05420805|Butyric Acid|butyric acid|mesh-list
110953894|NCT05420805|Dermatologic Agents|dermatologic agents|mesh-ancestor
110953895|NCT05420805|Sunscreening Agents|sunscreening agents|mesh-ancestor
110953896|NCT05420805|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110953897|NCT05420805|Protective Agents|protective agents|mesh-ancestor
110953898|NCT05420805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110953899|NCT05420805|Histamine Antagonists|histamine antagonists|mesh-ancestor
110953900|NCT05420805|Histamine Agents|histamine agents|mesh-ancestor
110953901|NCT05420805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110953902|NCT05420805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110953904|NCT05406583|Dolutegravir|dolutegravir|mesh-list
110953905|NCT05406583|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110953906|NCT05406583|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110953907|NCT05406583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110953908|NCT05406583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110953909|NCT05406583|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110953910|NCT05406583|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110953911|NCT05406583|Antiviral Agents|antiviral agents|mesh-ancestor
110953912|NCT05406583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110953913|NCT05395533|Antibodies|antibodies|mesh-list
110953914|NCT05395533|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110953915|NCT05395533|Immunologic Factors|immunologic factors|mesh-ancestor
110953916|NCT05395533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110953917|NCT05358522|Analgesics, Opioid|analgesics, opioid|mesh-list
110953918|NCT05358522|Narcotics|narcotics|mesh-ancestor
110953919|NCT05358522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110953920|NCT05358522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110953921|NCT05358522|Analgesics|analgesics|mesh-ancestor
110953922|NCT05358522|Sensory System Agents|sensory system agents|mesh-ancestor
110953923|NCT05358522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110953924|NCT05355974|Norepinephrine|norepinephrine|mesh-list
110953925|NCT05355974|Plasma-lyte 148|plasma-lyte 148|mesh-list
110953926|NCT05355974|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110953927|NCT05355974|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110953928|NCT05355974|Adrenergic Agents|adrenergic agents|mesh-ancestor
110953929|NCT05355974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110953930|NCT05355974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110953931|NCT05355974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110953932|NCT05355974|Sympathomimetics|sympathomimetics|mesh-ancestor
110953933|NCT05355974|Autonomic Agents|autonomic agents|mesh-ancestor
110953934|NCT05355974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110953935|NCT05355974|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110953936|NCT05355974|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110953937|NCT05355974|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110953938|NCT05340413|Olaparib|olaparib|mesh-list
110953939|NCT05340413|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110953940|NCT05340413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110953941|NCT05340413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110953942|NCT05340413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110953943|NCT05323955|Trastuzumab|trastuzumab|mesh-list
110953944|NCT05323955|Pertuzumab|pertuzumab|mesh-list
110953945|NCT05323955|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
110953946|NCT05323955|Maytansine|maytansine|mesh-list
110953947|NCT05323955|Tucatinib|tucatinib|mesh-list
110953948|NCT05323955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110953949|NCT05323955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110953950|NCT05323955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110953951|NCT05323955|Tubulin Modulators|tubulin modulators|mesh-ancestor
110953952|NCT05323955|Antimitotic Agents|antimitotic agents|mesh-ancestor
110953953|NCT05323955|Mitosis Modulators|mitosis modulators|mesh-ancestor
110953954|NCT05323955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110953955|NCT05323955|Immunotoxins|immunotoxins|mesh-ancestor
110953956|NCT05323955|Immunoconjugates|immunoconjugates|mesh-ancestor
110953957|NCT05323955|Immunologic Factors|immunologic factors|mesh-ancestor
110953958|NCT05323955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110953959|NCT05323955|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110953960|NCT05323955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110953961|NCT05312385|Propofol|propofol|mesh-list
110953962|NCT05312385|Isoflurane|isoflurane|mesh-list
110953963|NCT05312385|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110953964|NCT05312385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110953965|NCT05312385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110953966|NCT05312385|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110953967|NCT05312385|Anesthetics, General|anesthetics, general|mesh-ancestor
110953968|NCT05312385|Anesthetics|anesthetics|mesh-ancestor
110953969|NCT05312385|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110953970|NCT05289193|Nivolumab|nivolumab|mesh-list
110953971|NCT05289193|Ipilimumab|ipilimumab|mesh-list
110953972|NCT05289193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110953973|NCT05289193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110953974|NCT05289193|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110953975|NCT05289193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110953976|NCT05259137|Enalaprilat|enalaprilat|mesh-list
110953977|NCT05259137|Enalapril|enalapril|mesh-list
111498010|NCT02530554|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110953978|NCT05259137|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110953979|NCT05259137|Protease Inhibitors|protease inhibitors|mesh-ancestor
110953980|NCT05259137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110953981|NCT05259137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110953982|NCT05259137|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110953983|NCT05225558|Vancomycin|vancomycin|mesh-list
110953984|NCT05225558|Delpazolid|delpazolid|mesh-list
110953985|NCT05225558|Oxazolidinones|oxazolidinones|mesh-list
110953986|NCT05225558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110953987|NCT05225558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110953988|NCT05225558|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110953989|NCT05225558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110953990|NCT05225558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110953991|NCT05159830|Cannabidiol|cannabidiol|mesh-list
110953992|NCT05159830|Anticonvulsants|anticonvulsants|mesh-ancestor
110953993|NCT05148715|Tacrolimus|tacrolimus|mesh-list
110953994|NCT05148715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110953995|NCT05148715|Immunologic Factors|immunologic factors|mesh-ancestor
110953996|NCT05148715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110953997|NCT05148715|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110953998|NCT05148715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110953999|NCT05148715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110954000|NCT05112211|Doxycycline|doxycycline|mesh-list
110954001|NCT05112211|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110954002|NCT05112211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110954003|NCT05112211|Antimalarials|antimalarials|mesh-ancestor
110954004|NCT05112211|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110954005|NCT05112211|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110954006|NCT05110040|Immunosuppressive Agents|immunosuppressive agents|mesh-list
110954007|NCT05110040|Immunologic Factors|immunologic factors|mesh-ancestor
110954008|NCT05110040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110954009|NCT05107427|Avelumab|avelumab|mesh-list
110954010|NCT05107427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110954011|NCT05107427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110954012|NCT05036226|Metformin|metformin|mesh-list
110954013|NCT05036226|Sirolimus|sirolimus|mesh-list
110954014|NCT05036226|Hydroxychloroquine|hydroxychloroquine|mesh-list
110954015|NCT05036226|Nelfinavir|nelfinavir|mesh-list
110954016|NCT05036226|Temsirolimus|temsirolimus|mesh-list
110954017|NCT05036226|Dasatinib|dasatinib|mesh-list
110954018|NCT05036226|MTOR Inhibitors|mtor inhibitors|mesh-list
110954019|NCT05036226|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110954020|NCT05036226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110954021|NCT05036226|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110954022|NCT05036226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110954023|NCT05036226|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110954024|NCT05036226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110954025|NCT05036226|Antifungal Agents|antifungal agents|mesh-ancestor
110954026|NCT05036226|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110954027|NCT05036226|Immunologic Factors|immunologic factors|mesh-ancestor
110954028|NCT05036226|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110954029|NCT05036226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110954030|NCT05036226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110954031|NCT05036226|Antimalarials|antimalarials|mesh-ancestor
110954032|NCT05036226|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110954033|NCT05036226|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110954034|NCT05036226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110954035|NCT05036226|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110954036|NCT05036226|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110954037|NCT05036226|Protease Inhibitors|protease inhibitors|mesh-ancestor
110954038|NCT05036226|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110954039|NCT05036226|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110954040|NCT05036226|Antiviral Agents|antiviral agents|mesh-ancestor
110954041|NCT05035745|Talazoparib|talazoparib|mesh-list
110954042|NCT05035745|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110954043|NCT05035745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110954044|NCT05035745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110954045|NCT05035745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110954046|NCT05033080|Ivacaftor|ivacaftor|mesh-list
110954047|NCT05033080|Elexacaftor|elexacaftor|mesh-list
110954048|NCT05033080|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
110954049|NCT05033080|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110954050|NCT05033080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110954051|NCT05005897|Vitamin B 12|vitamin b 12|mesh-list
110954052|NCT05005897|Hydroxocobalamin|hydroxocobalamin|mesh-list
110954053|NCT05005897|Vitamins|vitamins|mesh-ancestor
110954054|NCT05005897|Micronutrients|micronutrients|mesh-ancestor
110954055|NCT05005897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110954056|NCT05005897|Vitamin B Complex|vitamin b complex|mesh-ancestor
110954058|NCT04994977|Carboplatin|carboplatin|mesh-list
110954059|NCT04994977|Melphalan|melphalan|mesh-list
110954060|NCT04994977|Topotecan|topotecan|mesh-list
110954061|NCT04994977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110954062|NCT04994977|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110954063|NCT04994977|Alkylating Agents|alkylating agents|mesh-ancestor
110954064|NCT04994977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110954065|NCT04994977|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110954066|NCT04994977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110954067|NCT04994977|Immunologic Factors|immunologic factors|mesh-ancestor
110954068|NCT04994977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110954069|NCT04994977|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110954070|NCT04994977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110954071|NCT04994977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110954072|NCT04931615|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
110954073|NCT04931615|Thrombin|thrombin|mesh-list
110954074|NCT04931615|Hemostatics|hemostatics|mesh-ancestor
110954075|NCT04931615|Coagulants|coagulants|mesh-ancestor
110954076|NCT04866706|Hyaluronic Acid|hyaluronic acid|mesh-list
110954077|NCT04866706|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110954078|NCT04866706|Immunologic Factors|immunologic factors|mesh-ancestor
110954079|NCT04866706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110954080|NCT04866706|Viscosupplements|viscosupplements|mesh-ancestor
110954081|NCT04866706|Protective Agents|protective agents|mesh-ancestor
110954082|NCT04846478|Talazoparib|talazoparib|mesh-list
110954084|NCT04846478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110954085|NCT04846478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110954086|NCT04846478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110954087|NCT04844606|Mirikizumab|mirikizumab|mesh-list
110954088|NCT04844606|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110954089|NCT04844606|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110954090|NCT04844606|Analgesics|analgesics|mesh-ancestor
110954091|NCT04844606|Sensory System Agents|sensory system agents|mesh-ancestor
110954092|NCT04844606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110954093|NCT04844606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110954094|NCT04844606|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110954095|NCT04844606|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110954096|NCT04844606|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110954097|NCT04844606|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110954098|NCT04834973|Pembrolizumab|pembrolizumab|mesh-list
110954099|NCT04834973|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110954100|NCT04834973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110954101|NCT04834973|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110954102|NCT04834973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110954103|NCT04798781|Pembrolizumab|pembrolizumab|mesh-list
110954104|NCT04798781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110954105|NCT04798781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110954106|NCT04798781|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110954107|NCT04798781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110954108|NCT04764825|Morphine|morphine|mesh-list
110954109|NCT04764825|Methadone|methadone|mesh-list
110954110|NCT04764825|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110954111|NCT04764825|Narcotics|narcotics|mesh-ancestor
110954112|NCT04764825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110954113|NCT04764825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110954114|NCT04764825|Analgesics|analgesics|mesh-ancestor
110954115|NCT04764825|Sensory System Agents|sensory system agents|mesh-ancestor
110954116|NCT04764825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110954117|NCT04764825|Antitussive Agents|antitussive agents|mesh-ancestor
110954118|NCT04764825|Respiratory System Agents|respiratory system agents|mesh-ancestor
110954119|NCT04760743|Aluminum sulfate|aluminum sulfate|mesh-list
110954120|NCT04760743|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110954121|NCT04760743|Immunologic Factors|immunologic factors|mesh-ancestor
110954122|NCT04760743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110954123|NCT04756687|Dimethyl Fumarate|dimethyl fumarate|mesh-list
110954124|NCT04756687|Dermatologic Agents|dermatologic agents|mesh-ancestor
110954125|NCT04756687|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110954126|NCT04756687|Immunologic Factors|immunologic factors|mesh-ancestor
110954127|NCT04756687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110954128|NCT04742738|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110954129|NCT04742738|Aluminum sulfate|aluminum sulfate|mesh-list
110954130|NCT04742738|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110954131|NCT04742738|Immunologic Factors|immunologic factors|mesh-ancestor
110954132|NCT04742738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110954133|NCT04706910|Furosemide|furosemide|mesh-list
110954134|NCT04706910|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
110954135|NCT04706910|Diuretics|diuretics|mesh-ancestor
110954136|NCT04706910|Natriuretic Agents|natriuretic agents|mesh-ancestor
110954137|NCT04706910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110954138|NCT04706910|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110954139|NCT04706910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110954140|NCT04706910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110954141|NCT04706910|Dopamine Agents|dopamine agents|mesh-ancestor
110954142|NCT04706910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110954143|NCT04704271|Dronabinol|dronabinol|mesh-list
110954144|NCT04704271|Hallucinogens|hallucinogens|mesh-ancestor
110954145|NCT04704271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110954146|NCT04704271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110954147|NCT04704271|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110954148|NCT04704271|Analgesics|analgesics|mesh-ancestor
110954149|NCT04704271|Sensory System Agents|sensory system agents|mesh-ancestor
110954150|NCT04704271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110954151|NCT04704271|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
110954152|NCT04704271|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110954153|NCT04704271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110954154|NCT04704271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110954155|NCT04704271|Hormones|hormones|mesh-ancestor
110954156|NCT04704271|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110954157|NCT04693234|Tislelizumab|tislelizumab|mesh-list
110954158|NCT04693234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110954159|NCT04693234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110954160|NCT04680286|Methadone|methadone|mesh-list
110954161|NCT04680286|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110954162|NCT04680286|Narcotics|narcotics|mesh-ancestor
110954163|NCT04680286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110954164|NCT04680286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110954165|NCT04680286|Analgesics|analgesics|mesh-ancestor
110954166|NCT04680286|Sensory System Agents|sensory system agents|mesh-ancestor
110954167|NCT04680286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110954168|NCT04680286|Antitussive Agents|antitussive agents|mesh-ancestor
110954169|NCT04680286|Respiratory System Agents|respiratory system agents|mesh-ancestor
110954170|NCT04675762|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
110954171|NCT04675762|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
110954172|NCT04675762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110954173|NCT04675762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110954174|NCT04675762|Immunologic Factors|immunologic factors|mesh-ancestor
110954175|NCT04675762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110954176|NCT04672018|Omeprazole|omeprazole|mesh-list
110954177|NCT04672018|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110954178|NCT04672018|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110954179|NCT04672018|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110954180|NCT04672018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110954181|NCT04672018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110954182|NCT04656184|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
110954183|NCT04656184|Immunoglobulins|immunoglobulins|mesh-list
110954184|NCT04656184|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110954185|NCT04656184|Antibodies|antibodies|mesh-list
110954186|NCT04656184|gamma-Globulins|gamma-globulins|mesh-list
110954187|NCT04656184|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110954188|NCT04656184|Immunologic Factors|immunologic factors|mesh-ancestor
110954189|NCT04656184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110954190|NCT04656184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110954191|NCT04638881|Magnesium Sulfate|magnesium sulfate|mesh-list
110954192|NCT04638881|Analgesics|analgesics|mesh-ancestor
110954193|NCT04638881|Sensory System Agents|sensory system agents|mesh-ancestor
110954194|NCT04638881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110954195|NCT04638881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110954196|NCT04638881|Anesthetics|anesthetics|mesh-ancestor
110954197|NCT04638881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110954198|NCT04638881|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110954199|NCT04638881|Anticonvulsants|anticonvulsants|mesh-ancestor
110954200|NCT04638881|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110954201|NCT04638881|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110954202|NCT04638881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111320766|NCT02285283|Antifungal Agents|antifungal agents|mesh-ancestor
110954203|NCT04638881|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111203411|NCT01819129|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
110954204|NCT04638881|Tocolytic Agents|tocolytic agents|mesh-ancestor
110954205|NCT04638881|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110954206|NCT04627753|Rituximab|rituximab|mesh-list
110954207|NCT04627753|Lenalidomide|lenalidomide|mesh-list
110954208|NCT04627753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110954209|NCT04627753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110954210|NCT04627753|Immunologic Factors|immunologic factors|mesh-ancestor
110954211|NCT04627753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110954212|NCT04627753|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110954213|NCT04627753|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110954214|NCT04627753|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110954215|NCT04627753|Growth Substances|growth substances|mesh-ancestor
110954216|NCT04627753|Growth Inhibitors|growth inhibitors|mesh-ancestor
110954217|NCT04564612|Itraconazole|itraconazole|mesh-list
110954218|NCT04564612|Rabeprazole|rabeprazole|mesh-list
110954219|NCT04564612|Antifungal Agents|antifungal agents|mesh-ancestor
110954220|NCT04564612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110954221|NCT04564612|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110954222|NCT04564612|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110954223|NCT04564612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110954224|NCT04564612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110954225|NCT04564612|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110954226|NCT04564612|Hormone Antagonists|hormone antagonists|mesh-ancestor
110954227|NCT04564612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110954228|NCT04564612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110954229|NCT04564612|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110954230|NCT04564612|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110954231|NCT04564612|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110954232|NCT04564612|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110954233|NCT04549311|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110954235|NCT04549311|Metronidazole|metronidazole|mesh-list
110954236|NCT04549311|Ciprofloxacin|ciprofloxacin|mesh-list
110954237|NCT04549311|Clavulanic Acids|clavulanic acids|mesh-list
110954238|NCT04549311|Clavulanic Acid|clavulanic acid|mesh-list
110954239|NCT04549311|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
110954240|NCT04549311|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
110954241|NCT04549311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110954242|NCT04549311|Antitubercular Agents|antitubercular agents|mesh-ancestor
110954243|NCT04549311|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110954244|NCT04549311|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110954245|NCT04549311|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110954246|NCT04549311|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110954247|NCT04549311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110954248|NCT04549311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110954249|NCT04549311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110954250|NCT04549311|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110954251|NCT04549311|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110954252|NCT04549311|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110954253|NCT04518319|Olanzapine|olanzapine|mesh-list
110954254|NCT04518319|Antiemetics|antiemetics|mesh-ancestor
110954255|NCT04518319|Autonomic Agents|autonomic agents|mesh-ancestor
110954256|NCT04518319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110954257|NCT04518319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110954258|NCT04518319|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110954259|NCT04518319|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110954260|NCT04518319|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110954261|NCT04518319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110954262|NCT04518319|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110954263|NCT04518319|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110954264|NCT04518319|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110954265|NCT04518319|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110954266|NCT04518319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110954267|NCT04518319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110954268|NCT04518319|Serotonin Agents|serotonin agents|mesh-ancestor
110954269|NCT04516226|Chlorhexidine|chlorhexidine|mesh-list
110954270|NCT04516226|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110954271|NCT04516226|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110954272|NCT04516226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110954273|NCT04516226|Disinfectants|disinfectants|mesh-ancestor
110954274|NCT04516226|Dermatologic Agents|dermatologic agents|mesh-ancestor
110954275|NCT04495868|Lidocaine|lidocaine|mesh-list
110954276|NCT04495868|Anesthetics, Local|anesthetics, local|mesh-ancestor
110954277|NCT04495868|Anesthetics|anesthetics|mesh-ancestor
110954278|NCT04495868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110954279|NCT04495868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110954280|NCT04495868|Sensory System Agents|sensory system agents|mesh-ancestor
110954281|NCT04495868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110954282|NCT04495868|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110954283|NCT04495868|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110954284|NCT04495868|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110954285|NCT04495868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110954286|NCT04495868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110954288|NCT04483544|Olaparib|olaparib|mesh-list
110954289|NCT04483544|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110954290|NCT04483544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110954291|NCT04483544|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110954292|NCT04483544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110954293|NCT04483544|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110954294|NCT04483544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110954295|NCT04475029|Morphine|morphine|mesh-list
110954296|NCT04475029|Methadone|methadone|mesh-list
110954297|NCT04475029|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110954298|NCT04475029|Narcotics|narcotics|mesh-ancestor
110954299|NCT04475029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110954300|NCT04475029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110954301|NCT04475029|Analgesics|analgesics|mesh-ancestor
110666300|NCT00372424|Docetaxel|docetaxel|mesh-list
110954302|NCT04475029|Sensory System Agents|sensory system agents|mesh-ancestor
110954303|NCT04475029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110954304|NCT04475029|Antitussive Agents|antitussive agents|mesh-ancestor
110954305|NCT04475029|Respiratory System Agents|respiratory system agents|mesh-ancestor
110954306|NCT04457089|Simvastatin|simvastatin|mesh-list
110954307|NCT04457089|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110954308|NCT04457089|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110954309|NCT04457089|Antimetabolites|antimetabolites|mesh-ancestor
110954310|NCT04457089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110954311|NCT04457089|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110954312|NCT04457089|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110954313|NCT04457089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110954314|NCT04443062|177Lu-PSMA-617|177lu-psma-617|mesh-list
110954315|NCT04443062|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110954316|NCT04443062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110954317|NCT04307485|Ticagrelor|ticagrelor|mesh-list
110954318|NCT04307485|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110954319|NCT04307485|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110954320|NCT04307485|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110954321|NCT04307485|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110954322|NCT04307485|Purinergic Agents|purinergic agents|mesh-ancestor
110954323|NCT04307485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110954324|NCT04307485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110954325|NCT04307485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110954326|NCT04289467|Fenfluramine|fenfluramine|mesh-list
110954327|NCT04289467|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110954328|NCT04289467|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110954329|NCT04289467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110954330|NCT04289467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110954331|NCT04289467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110954332|NCT04289467|Serotonin Agents|serotonin agents|mesh-ancestor
110954333|NCT04289467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110954334|NCT04279574|Lithium Carbonate|lithium carbonate|mesh-list
110954335|NCT04279574|Antidepressive Agents|antidepressive agents|mesh-ancestor
110954336|NCT04279574|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110954337|NCT04279574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110954338|NCT04279574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110954339|NCT04279574|Antimanic Agents|antimanic agents|mesh-ancestor
110954340|NCT04279574|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110954341|NCT04279574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110954342|NCT04279574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110954343|NCT04253561|Trastuzumab|trastuzumab|mesh-list
110954344|NCT04253561|Pertuzumab|pertuzumab|mesh-list
110954345|NCT04253561|Ipatasertib|ipatasertib|mesh-list
110980439|NCT00468975|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110954346|NCT04253561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110954347|NCT04253561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110954348|NCT04253561|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110954349|NCT04253561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110954350|NCT04253561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110954351|NCT04240171|Dapagliflozin|dapagliflozin|mesh-list
110954352|NCT04240171|Glimepiride|glimepiride|mesh-list
110954353|NCT04240171|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110954354|NCT04240171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110954355|NCT04240171|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110954356|NCT04240171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110954357|NCT04240171|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110954358|NCT04240171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110954359|NCT04240171|Immunologic Factors|immunologic factors|mesh-ancestor
110954360|NCT04191616|Dexamethasone|dexamethasone|mesh-list
110954361|NCT04191616|Pomalidomide|pomalidomide|mesh-list
110954362|NCT04191616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110954363|NCT04191616|Antiemetics|antiemetics|mesh-ancestor
110954364|NCT04191616|Autonomic Agents|autonomic agents|mesh-ancestor
110954365|NCT04191616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110954366|NCT04191616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110954367|NCT04191616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110954368|NCT04191616|Glucocorticoids|glucocorticoids|mesh-ancestor
110954369|NCT04191616|Hormones|hormones|mesh-ancestor
110954370|NCT04191616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110954371|NCT04191616|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110954372|NCT04191616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110954373|NCT04191616|Immunologic Factors|immunologic factors|mesh-ancestor
110666371|NCT02688790|Dalbavancin|dalbavancin|mesh-list
110954374|NCT04191616|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110954375|NCT04191616|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110954376|NCT04191616|Growth Substances|growth substances|mesh-ancestor
110954377|NCT04191616|Growth Inhibitors|growth inhibitors|mesh-ancestor
110954379|NCT04170738|Adderall|adderall|mesh-list
110954380|NCT04170738|Dextroamphetamine|dextroamphetamine|mesh-list
110954381|NCT04170738|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110954382|NCT04170738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110954383|NCT04170738|Sympathomimetics|sympathomimetics|mesh-ancestor
110954384|NCT04170738|Autonomic Agents|autonomic agents|mesh-ancestor
110954385|NCT04170738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110954386|NCT04170738|Dopamine Agents|dopamine agents|mesh-ancestor
110954387|NCT04170738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110954388|NCT04170738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110954389|NCT04170738|Adrenergic Agents|adrenergic agents|mesh-ancestor
110954390|NCT04170738|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110954391|NCT04170738|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110954392|NCT04170738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110954393|NCT04170738|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110954394|NCT04094142|Lenalidomide|lenalidomide|mesh-list
110954395|NCT04094142|Acalabrutinib|acalabrutinib|mesh-list
110954396|NCT04094142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110954397|NCT04094142|Immunologic Factors|immunologic factors|mesh-ancestor
110954398|NCT04094142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110954399|NCT04094142|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110954400|NCT04094142|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110954401|NCT04094142|Growth Substances|growth substances|mesh-ancestor
110954402|NCT04094142|Growth Inhibitors|growth inhibitors|mesh-ancestor
110954403|NCT04089514|Adalimumab|adalimumab|mesh-list
110954404|NCT04089514|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110954405|NCT04089514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110954406|NCT04089514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110954407|NCT04088409|Adalimumab|adalimumab|mesh-list
110954408|NCT04088409|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110954409|NCT04088409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110954410|NCT04088409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110954411|NCT04084314|Erenumab|erenumab|mesh-list
110954412|NCT04084314|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
110954413|NCT04084314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110954414|NCT04084314|Analgesics|analgesics|mesh-ancestor
110954415|NCT04084314|Sensory System Agents|sensory system agents|mesh-ancestor
110954416|NCT04084314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110954417|NCT04084314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110954418|NCT04068207|Minocycline|minocycline|mesh-list
110954419|NCT04068207|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110954420|NCT04068207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110954421|NCT04024761|Cyclophosphamide|cyclophosphamide|mesh-list
110954422|NCT04024761|Fludarabine|fludarabine|mesh-list
110954423|NCT04024761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110954424|NCT04024761|Immunologic Factors|immunologic factors|mesh-ancestor
110954425|NCT04024761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110954426|NCT04024761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110954427|NCT04024761|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110954428|NCT04024761|Alkylating Agents|alkylating agents|mesh-ancestor
110954429|NCT04024761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110954430|NCT04024761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110954431|NCT04024761|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110954432|NCT04004988|Tirzepatide|tirzepatide|mesh-list
110954433|NCT04004988|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110954434|NCT04004988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110954435|NCT04004988|Incretins|incretins|mesh-ancestor
110954436|NCT04004988|Hormones|hormones|mesh-ancestor
110954437|NCT04004988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110954438|NCT03934840|Prednisone|prednisone|mesh-list
110954439|NCT03934840|Carboplatin|carboplatin|mesh-list
110954440|NCT03934840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110954441|NCT03934840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110954442|NCT03934840|Glucocorticoids|glucocorticoids|mesh-ancestor
110954443|NCT03934840|Hormones|hormones|mesh-ancestor
110954444|NCT03934840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110954445|NCT03934840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110954446|NCT03934840|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110954447|NCT03879538|Nitrous Oxide|nitrous oxide|mesh-list
110954448|NCT03879538|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110954449|NCT03879538|Anesthetics, General|anesthetics, general|mesh-ancestor
110954450|NCT03879538|Anesthetics|anesthetics|mesh-ancestor
110954451|NCT03879538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110954452|NCT03879538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110954453|NCT03879538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110954454|NCT03879538|Analgesics|analgesics|mesh-ancestor
110954455|NCT03879538|Sensory System Agents|sensory system agents|mesh-ancestor
110954456|NCT03879538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110954457|NCT03783442|Paclitaxel|paclitaxel|mesh-list
110954458|NCT03783442|Fluorouracil|fluorouracil|mesh-list
110954459|NCT03783442|Capecitabine|capecitabine|mesh-list
110954460|NCT03783442|Oxaliplatin|oxaliplatin|mesh-list
110954461|NCT03783442|Tislelizumab|tislelizumab|mesh-list
110954462|NCT03783442|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110954463|NCT03783442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110954464|NCT03783442|Tubulin Modulators|tubulin modulators|mesh-ancestor
110954465|NCT03783442|Antimitotic Agents|antimitotic agents|mesh-ancestor
110954466|NCT03783442|Mitosis Modulators|mitosis modulators|mesh-ancestor
110954467|NCT03783442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110954468|NCT03783442|Antimetabolites|antimetabolites|mesh-ancestor
110954469|NCT03783442|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110954470|NCT03783442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110954471|NCT03783442|Immunologic Factors|immunologic factors|mesh-ancestor
110954472|NCT03783442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110954473|NCT03783442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110954474|NCT03781765|Methylphenidate|methylphenidate|mesh-list
110954475|NCT03781765|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
110954476|NCT03781765|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110954477|NCT03781765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110954478|NCT03781765|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110954479|NCT03781765|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110954480|NCT03781765|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110954481|NCT03781765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110954482|NCT03781765|Dopamine Agents|dopamine agents|mesh-ancestor
110954483|NCT03781765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110954484|NCT03781765|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110954485|NCT03781765|Adrenergic Agents|adrenergic agents|mesh-ancestor
110954486|NCT03781752|Methylphenidate|methylphenidate|mesh-list
110954487|NCT03781752|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110954488|NCT03781752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110954489|NCT03781752|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110954490|NCT03781752|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110954491|NCT03781752|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110954492|NCT03781752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110954493|NCT03781752|Dopamine Agents|dopamine agents|mesh-ancestor
110954494|NCT03781752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110954495|NCT03772457|Rivaroxaban|rivaroxaban|mesh-list
110954496|NCT03772457|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110954497|NCT03772457|Antithrombins|antithrombins|mesh-ancestor
110954498|NCT03772457|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110943702|NCT05169658|Antibodies, Bispecific|antibodies, bispecific|mesh-list
110954499|NCT03772457|Protease Inhibitors|protease inhibitors|mesh-ancestor
110954500|NCT03772457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110954501|NCT03772457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110954502|NCT03772457|Anticoagulants|anticoagulants|mesh-ancestor
110954503|NCT03714958|Trametinib|trametinib|mesh-list
110954504|NCT03714958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110954505|NCT03714958|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110954506|NCT03714958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110954507|NCT03714958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110954508|NCT03708315|Dexmedetomidine|dexmedetomidine|mesh-list
110954509|NCT03708315|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110954510|NCT03708315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110954511|NCT03708315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110954512|NCT03708315|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110954513|NCT03708315|Analgesics|analgesics|mesh-ancestor
110954514|NCT03708315|Sensory System Agents|sensory system agents|mesh-ancestor
110954515|NCT03708315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110954516|NCT03708315|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110954517|NCT03708315|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110954518|NCT03708315|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110954519|NCT03708315|Adrenergic Agents|adrenergic agents|mesh-ancestor
110954520|NCT03708315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110954521|NCT03708315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110954523|NCT03693300|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110954524|NCT03693300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110954525|NCT03582033|Dexamethasone|dexamethasone|mesh-list
110954526|NCT03582033|Pomalidomide|pomalidomide|mesh-list
110954527|NCT03582033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110954528|NCT03582033|Antiemetics|antiemetics|mesh-ancestor
110954529|NCT03582033|Autonomic Agents|autonomic agents|mesh-ancestor
110954530|NCT03582033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110954531|NCT03582033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110954532|NCT03582033|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110954533|NCT03582033|Glucocorticoids|glucocorticoids|mesh-ancestor
110954534|NCT03582033|Hormones|hormones|mesh-ancestor
110954535|NCT03582033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110954536|NCT03582033|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110954537|NCT03582033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110954538|NCT03582033|Immunologic Factors|immunologic factors|mesh-ancestor
110954539|NCT03582033|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110954540|NCT03582033|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110954541|NCT03582033|Growth Substances|growth substances|mesh-ancestor
110954542|NCT03582033|Growth Inhibitors|growth inhibitors|mesh-ancestor
110954543|NCT03579966|Amifampridine|amifampridine|mesh-list
110954544|NCT03579966|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110954545|NCT03579966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110954546|NCT03579966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110954547|NCT03579966|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
110954548|NCT03579966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110954549|NCT03579966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110954550|NCT03551691|Omeprazole|omeprazole|mesh-list
110954551|NCT03551691|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110954552|NCT03551691|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110954553|NCT03551691|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110954554|NCT03551691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110954555|NCT03551691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110954556|NCT03510208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110954557|NCT03510208|Panitumumab|panitumumab|mesh-list
110954558|NCT03510208|Antibodies|antibodies|mesh-list
110954559|NCT03510208|Immunoglobulins|immunoglobulins|mesh-list
110954560|NCT03510208|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110954561|NCT03510208|Immunologic Factors|immunologic factors|mesh-ancestor
110954562|NCT03510208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110954563|NCT03510208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110954564|NCT03508869|Brimonidine Tartrate|brimonidine tartrate|mesh-list
110954565|NCT03508869|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110954566|NCT03508869|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110954567|NCT03508869|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110954568|NCT03508869|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110954569|NCT03508869|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110954570|NCT03508869|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110954571|NCT03508869|Adrenergic Agents|adrenergic agents|mesh-ancestor
111203412|NCT01819129|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110954572|NCT03508869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110954573|NCT03508869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110954574|NCT03508869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110954575|NCT03508869|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110954576|NCT03508869|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110954577|NCT03508869|Cholinergic Agents|cholinergic agents|mesh-ancestor
110954578|NCT03508869|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110954579|NCT03508869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110954580|NCT03507699|Nivolumab|nivolumab|mesh-list
110954581|NCT03507699|Ipilimumab|ipilimumab|mesh-list
110954582|NCT03507699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110954583|NCT03507699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110954584|NCT03507699|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110954585|NCT03507699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110954586|NCT03497923|Magnesium Sulfate|magnesium sulfate|mesh-list
110954587|NCT03497923|Analgesics|analgesics|mesh-ancestor
110954588|NCT03497923|Sensory System Agents|sensory system agents|mesh-ancestor
110954589|NCT03497923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110954590|NCT03497923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110954591|NCT03497923|Anesthetics|anesthetics|mesh-ancestor
110954592|NCT03497923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110954593|NCT03497923|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110954594|NCT03497923|Anticonvulsants|anticonvulsants|mesh-ancestor
110954595|NCT03497923|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110954596|NCT03497923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110954597|NCT03497923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110954598|NCT03497923|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110954599|NCT03497923|Tocolytic Agents|tocolytic agents|mesh-ancestor
110954600|NCT03497923|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110954601|NCT03377387|Capecitabine|capecitabine|mesh-list
110954602|NCT03377387|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110954603|NCT03377387|Antimetabolites|antimetabolites|mesh-ancestor
110954604|NCT03377387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110954605|NCT03377387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110954606|NCT03372837|Rituximab|rituximab|mesh-list
110954607|NCT03372837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110954608|NCT03372837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110954609|NCT03372837|Immunologic Factors|immunologic factors|mesh-ancestor
110954610|NCT03372837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110954611|NCT03372837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110954612|NCT03312699|Vaccines|vaccines|mesh-list
110954613|NCT03312699|Immunologic Factors|immunologic factors|mesh-ancestor
110954614|NCT03312699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110954615|NCT03300557|Exemestane|exemestane|mesh-list
110954616|NCT03300557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110954617|NCT03300557|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110954618|NCT03300557|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110954619|NCT03300557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110954620|NCT03300557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110954621|NCT03300557|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110954622|NCT03300557|Hormone Antagonists|hormone antagonists|mesh-ancestor
110954623|NCT03300557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110954624|NCT03300557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110954625|NCT03261284|Heparin|heparin|mesh-list
110954626|NCT03261284|Calcium heparin|calcium heparin|mesh-list
110954627|NCT03261284|Anticoagulants|anticoagulants|mesh-ancestor
110954628|NCT03261284|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110954629|NCT03261284|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110954630|NCT03261284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110954631|NCT03219450|Cyclophosphamide|cyclophosphamide|mesh-list
110954632|NCT03219450|Pembrolizumab|pembrolizumab|mesh-list
110954633|NCT03219450|Immunologic Factors|immunologic factors|mesh-ancestor
110954634|NCT03219450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110954635|NCT03219450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110954636|NCT03219450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110954637|NCT03219450|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110954638|NCT03219450|Alkylating Agents|alkylating agents|mesh-ancestor
110954639|NCT03219450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110954640|NCT03219450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110954641|NCT03219450|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110954642|NCT03219450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110954643|NCT03219450|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110954644|NCT03198078|Aripiprazole|aripiprazole|mesh-list
110954645|NCT03198078|Brexpiprazole|brexpiprazole|mesh-list
110954646|NCT03198078|Antidepressive Agents|antidepressive agents|mesh-ancestor
110954647|NCT03198078|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110954648|NCT03198078|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110954649|NCT03198078|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110954650|NCT03198078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110954651|NCT03198078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110954652|NCT03198078|Dopamine Agonists|dopamine agonists|mesh-ancestor
110954653|NCT03198078|Dopamine Agents|dopamine agents|mesh-ancestor
110954654|NCT03198078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110954655|NCT03198078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110954656|NCT03198078|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110954657|NCT03198078|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110954658|NCT03198078|Serotonin Agents|serotonin agents|mesh-ancestor
110954659|NCT03198078|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110954660|NCT03198078|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110954661|NCT03198078|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110954662|NCT03198078|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110954664|NCT03127267|Anticonvulsants|anticonvulsants|mesh-ancestor
110954665|NCT03127267|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110954666|NCT03127267|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110954667|NCT03127267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110954668|NCT03127267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110954669|NCT03127267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110954670|NCT03127267|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110954671|NCT03127267|Protective Agents|protective agents|mesh-ancestor
110954672|NCT03092466|Ropivacaine|ropivacaine|mesh-list
110954673|NCT03092466|Anesthetics, Local|anesthetics, local|mesh-ancestor
110954674|NCT03092466|Anesthetics|anesthetics|mesh-ancestor
110954675|NCT03092466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110954676|NCT03092466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110954677|NCT03092466|Sensory System Agents|sensory system agents|mesh-ancestor
110954678|NCT03092466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110954679|NCT03017872|Ritonavir|ritonavir|mesh-list
110954680|NCT03017872|Darunavir|darunavir|mesh-list
110954681|NCT03017872|Dolutegravir|dolutegravir|mesh-list
110954682|NCT03017872|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110954683|NCT03017872|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110954684|NCT03017872|Protease Inhibitors|protease inhibitors|mesh-ancestor
110954685|NCT03017872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110954686|NCT03017872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110954687|NCT03017872|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110954688|NCT03017872|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110954689|NCT03017872|Antiviral Agents|antiviral agents|mesh-ancestor
110954690|NCT03017872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110954691|NCT03017872|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110954692|NCT03017872|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110954693|NCT03017872|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110954694|NCT03017872|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110954695|NCT03000205|Lidocaine|lidocaine|mesh-list
110954696|NCT03000205|Anesthetics, Local|anesthetics, local|mesh-ancestor
110954697|NCT03000205|Anesthetics|anesthetics|mesh-ancestor
110954698|NCT03000205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110954699|NCT03000205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110954700|NCT03000205|Sensory System Agents|sensory system agents|mesh-ancestor
110954701|NCT03000205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110954702|NCT03000205|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110954703|NCT03000205|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110954704|NCT03000205|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110954705|NCT03000205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110954706|NCT03000205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110954707|NCT02942095|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110954708|NCT02942095|Ixazomib|ixazomib|mesh-list
110954709|NCT02942095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110954710|NCT02942095|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110954711|NCT02942095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110954712|NCT02942095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110954713|NCT02942095|Protease Inhibitors|protease inhibitors|mesh-ancestor
110954714|NCT02872467|Oxytocin|oxytocin|mesh-list
110954715|NCT02872467|Oxytocics|oxytocics|mesh-ancestor
110954716|NCT02872467|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110954717|NCT02872467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110954718|NCT02781519|Dronabinol|dronabinol|mesh-list
110954720|NCT02781519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110954721|NCT02781519|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110954722|NCT02781519|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110954723|NCT02781519|Analgesics|analgesics|mesh-ancestor
110954724|NCT02781519|Sensory System Agents|sensory system agents|mesh-ancestor
110954725|NCT02781519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110954726|NCT02781519|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
110954727|NCT02781519|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110954728|NCT02781519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110954729|NCT02781519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110954730|NCT02781519|Hormones|hormones|mesh-ancestor
110954731|NCT02781519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110954732|NCT02706353|Pembrolizumab|pembrolizumab|mesh-list
110954733|NCT02706353|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110954734|NCT02706353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110954735|NCT02706353|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110954736|NCT02706353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110954737|NCT02617277|Durvalumab|durvalumab|mesh-list
110954738|NCT02617277|Adavosertib|adavosertib|mesh-list
110954739|NCT02617277|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110954740|NCT02617277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110954741|NCT02617277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110954742|NCT02617277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110954743|NCT02536664|Rituximab|rituximab|mesh-list
110954744|NCT02536664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110954745|NCT02536664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110954746|NCT02536664|Immunologic Factors|immunologic factors|mesh-ancestor
110954747|NCT02536664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110954748|NCT02536664|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110954749|NCT02426892|Nivolumab|nivolumab|mesh-list
110954750|NCT02426892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110954751|NCT02426892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110954752|NCT02426892|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110954753|NCT02426892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110954754|NCT02375555|Dexamethasone|dexamethasone|mesh-list
110954755|NCT02375555|Lenalidomide|lenalidomide|mesh-list
110954756|NCT02375555|Bortezomib|bortezomib|mesh-list
110954757|NCT02375555|Elotuzumab|elotuzumab|mesh-list
110954758|NCT02375555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110954759|NCT02375555|Antiemetics|antiemetics|mesh-ancestor
110954760|NCT02375555|Autonomic Agents|autonomic agents|mesh-ancestor
110954761|NCT02375555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110954762|NCT02375555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110954763|NCT02375555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110954764|NCT02375555|Glucocorticoids|glucocorticoids|mesh-ancestor
110954765|NCT02375555|Hormones|hormones|mesh-ancestor
110954766|NCT02375555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110954767|NCT02375555|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110954768|NCT02375555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110954769|NCT02375555|Immunologic Factors|immunologic factors|mesh-ancestor
110954770|NCT02375555|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110954771|NCT02375555|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110954772|NCT02375555|Growth Substances|growth substances|mesh-ancestor
110954773|NCT02375555|Growth Inhibitors|growth inhibitors|mesh-ancestor
110954774|NCT02364713|Paclitaxel|paclitaxel|mesh-list
110954775|NCT02364713|Bevacizumab|bevacizumab|mesh-list
110954776|NCT02364713|Gemcitabine|gemcitabine|mesh-list
110954777|NCT02364713|Doxorubicin|doxorubicin|mesh-list
110954778|NCT02364713|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110954779|NCT02364713|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110954780|NCT02364713|Topotecan|topotecan|mesh-list
110954781|NCT02364713|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110954782|NCT02364713|Endothelial Growth Factors|endothelial growth factors|mesh-list
110954783|NCT02364713|Antibodies|antibodies|mesh-list
110954784|NCT02364713|Immunoglobulins|immunoglobulins|mesh-list
110954785|NCT02364713|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110954786|NCT02364713|Immunoglobulin G|immunoglobulin g|mesh-list
110954787|NCT02364713|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110954788|NCT02364713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110954789|NCT02364713|Tubulin Modulators|tubulin modulators|mesh-ancestor
110954790|NCT02364713|Antimitotic Agents|antimitotic agents|mesh-ancestor
110954791|NCT02364713|Mitosis Modulators|mitosis modulators|mesh-ancestor
110954792|NCT02364713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110954793|NCT02364713|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110954794|NCT02364713|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110954795|NCT02364713|Growth Substances|growth substances|mesh-ancestor
110954796|NCT02364713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110954797|NCT02364713|Growth Inhibitors|growth inhibitors|mesh-ancestor
110954798|NCT02364713|Immunologic Factors|immunologic factors|mesh-ancestor
110954799|NCT02364713|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110954800|NCT02364713|Antimetabolites|antimetabolites|mesh-ancestor
110954801|NCT02364713|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110954802|NCT02364713|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110954803|NCT02364713|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110954804|NCT02364713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110954805|NCT02364713|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110954806|NCT02107703|Fulvestrant|fulvestrant|mesh-list
110954807|NCT02107703|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110954808|NCT02107703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110954809|NCT02107703|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110954810|NCT02107703|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110954811|NCT02107703|Hormone Antagonists|hormone antagonists|mesh-ancestor
110954812|NCT02107703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110954813|NCT02107703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110954814|NCT02094625|Acetylcysteine|acetylcysteine|mesh-list
110954815|NCT02094625|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110954816|NCT02094625|Antiviral Agents|antiviral agents|mesh-ancestor
110954817|NCT02094625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110954818|NCT02094625|Expectorants|expectorants|mesh-ancestor
110954819|NCT02094625|Respiratory System Agents|respiratory system agents|mesh-ancestor
110954820|NCT02094625|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110954821|NCT02094625|Antioxidants|antioxidants|mesh-ancestor
110954822|NCT02094625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110954823|NCT02094625|Protective Agents|protective agents|mesh-ancestor
110954824|NCT02094625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110954825|NCT02094625|Antidotes|antidotes|mesh-ancestor
110954826|NCT02054520|Pembrolizumab|pembrolizumab|mesh-list
110954827|NCT02054520|Nivolumab|nivolumab|mesh-list
110954828|NCT02054520|Ipilimumab|ipilimumab|mesh-list
110954829|NCT02054520|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110954830|NCT02054520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110954831|NCT02054520|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110954832|NCT02054520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110954833|NCT01922921|polysaccharide-K|polysaccharide-k|mesh-list
110954834|NCT01922921|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110954835|NCT01922921|Trastuzumab|trastuzumab|mesh-list
110954836|NCT01922921|Pertuzumab|pertuzumab|mesh-list
110954837|NCT01922921|Antibodies|antibodies|mesh-list
110954838|NCT01922921|Immunoglobulins|immunoglobulins|mesh-list
110954839|NCT01922921|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110954840|NCT01922921|Immunologic Factors|immunologic factors|mesh-ancestor
110954841|NCT01922921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110954842|NCT01922921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110954843|NCT01922921|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110954844|NCT01922921|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110954845|NCT01922921|Antiviral Agents|antiviral agents|mesh-ancestor
110954846|NCT01922921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110954847|NCT01922921|Interferon Inducers|interferon inducers|mesh-ancestor
110954848|NCT01922921|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110954849|NCT01922921|Protective Agents|protective agents|mesh-ancestor
110954850|NCT01546987|Leuprolide|leuprolide|mesh-list
110954851|NCT01546987|Goserelin|goserelin|mesh-list
110954852|NCT01546987|Triptorelin Pamoate|triptorelin pamoate|mesh-list
110954853|NCT01546987|Flutamide|flutamide|mesh-list
110954854|NCT01546987|Bicalutamide|bicalutamide|mesh-list
110954855|NCT01546987|Buserelin|buserelin|mesh-list
110954856|NCT01546987|Androgens|androgens|mesh-list
110954857|NCT01546987|Androgen Antagonists|androgen antagonists|mesh-list
110954858|NCT01546987|Hormones|hormones|mesh-ancestor
110954859|NCT01546987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110954860|NCT01546987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110954861|NCT01546987|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110954862|NCT01546987|Fertility Agents|fertility agents|mesh-ancestor
110954863|NCT01546987|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110954864|NCT01546987|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110954865|NCT01546987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110954866|NCT01546987|Hormone Antagonists|hormone antagonists|mesh-ancestor
110954867|NCT01546987|Luteolytic Agents|luteolytic agents|mesh-ancestor
110954868|NCT01546987|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110954869|NCT01546987|Contraceptive Agents|contraceptive agents|mesh-ancestor
110954870|NCT01546987|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110954871|NCT00977691|Sirolimus|sirolimus|mesh-list
110954873|NCT00977691|Alemtuzumab|alemtuzumab|mesh-list
110954874|NCT00977691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110954875|NCT00977691|Immunologic Factors|immunologic factors|mesh-ancestor
110954876|NCT00977691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110954877|NCT00977691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110954878|NCT00977691|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110954879|NCT00977691|Alkylating Agents|alkylating agents|mesh-ancestor
110954880|NCT00977691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110954881|NCT00977691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110954882|NCT00977691|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110954883|NCT00977691|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110954884|NCT00977691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110954885|NCT00977691|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110954886|NCT00977691|Antifungal Agents|antifungal agents|mesh-ancestor
110954887|NCT00977691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110954888|NCT00588185|Deoxyglucose|deoxyglucose|mesh-list
110954889|NCT00588185|Testosterone|testosterone|mesh-list
110954890|NCT00588185|Dihydrotestosterone|dihydrotestosterone|mesh-list
110954891|NCT00588185|Androgens|androgens|mesh-ancestor
110954892|NCT00588185|Hormones|hormones|mesh-ancestor
110954893|NCT00588185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110954894|NCT00588185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110954895|NCT00588185|Antimetabolites|antimetabolites|mesh-ancestor
110666905|NCT03877809|Sirolimus|sirolimus|mesh-list
110954896|NCT00588185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110954897|NCT00588185|Antiviral Agents|antiviral agents|mesh-ancestor
110954898|NCT00588185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110954899|NCT00268476|Zoledronic Acid|zoledronic acid|mesh-list
110954900|NCT00268476|Metformin|metformin|mesh-list
110954901|NCT00268476|Prednisone|prednisone|mesh-list
110954902|NCT00268476|Prednisolone|prednisolone|mesh-list
110954903|NCT00268476|Celecoxib|celecoxib|mesh-list
110954904|NCT00268476|Docetaxel|docetaxel|mesh-list
110954905|NCT00268476|Estradiol|estradiol|mesh-list
110954906|NCT00268476|Androgens|androgens|mesh-list
110954907|NCT00268476|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110954908|NCT00268476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110954909|NCT00268476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110954910|NCT00268476|Tubulin Modulators|tubulin modulators|mesh-ancestor
110954911|NCT00268476|Antimitotic Agents|antimitotic agents|mesh-ancestor
110954912|NCT00268476|Mitosis Modulators|mitosis modulators|mesh-ancestor
110954913|NCT00268476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110954914|NCT00268476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110954915|NCT00268476|Glucocorticoids|glucocorticoids|mesh-ancestor
110954916|NCT00268476|Hormones|hormones|mesh-ancestor
110954917|NCT00268476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110954918|NCT00268476|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110954919|NCT00268476|Estrogens|estrogens|mesh-ancestor
110954920|NCT00268476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110954921|NCT00268476|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110954922|NCT00268476|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110954923|NCT00268476|Analgesics|analgesics|mesh-ancestor
110954924|NCT00268476|Sensory System Agents|sensory system agents|mesh-ancestor
110954925|NCT00268476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110954926|NCT00268476|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110954927|NCT00268476|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110954928|NCT00268476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110954929|NCT00268476|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110954930|NCT00261443|Valproic Acid|valproic acid|mesh-list
110954931|NCT00261443|Aripiprazole|aripiprazole|mesh-list
110954932|NCT00261443|Lithium Carbonate|lithium carbonate|mesh-list
110954933|NCT00261443|Antidepressive Agents|antidepressive agents|mesh-ancestor
110954934|NCT00261443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110954935|NCT00261443|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110954936|NCT00261443|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110954937|NCT00261443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110954938|NCT00261443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110954939|NCT00261443|Dopamine Agonists|dopamine agonists|mesh-ancestor
110954940|NCT00261443|Dopamine Agents|dopamine agents|mesh-ancestor
110954941|NCT00261443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110954942|NCT00261443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110954943|NCT00261443|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110954944|NCT00261443|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110954945|NCT00261443|Serotonin Agents|serotonin agents|mesh-ancestor
110954946|NCT00261443|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110954947|NCT00261443|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110954948|NCT00261443|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110954949|NCT00261443|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110954950|NCT00261443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110954951|NCT00261443|Antimanic Agents|antimanic agents|mesh-ancestor
110954952|NCT00261443|Anticonvulsants|anticonvulsants|mesh-ancestor
110954953|NCT00261443|GABA Agents|gaba agents|mesh-ancestor
110954954|NCT00093379|Capecitabine|capecitabine|mesh-list
110954955|NCT00093379|Oxaliplatin|oxaliplatin|mesh-list
110954956|NCT00093379|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110954957|NCT00093379|Antimetabolites|antimetabolites|mesh-ancestor
110954958|NCT00093379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110954959|NCT00093379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110954960|NCT00000524|Cyclosporine|cyclosporine|mesh-list
110954961|NCT00000524|Prednisone|prednisone|mesh-list
110954962|NCT00000524|Cyclosporins|cyclosporins|mesh-list
110954963|NCT00000524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110954964|NCT00000524|Glucocorticoids|glucocorticoids|mesh-ancestor
110954965|NCT00000524|Hormones|hormones|mesh-ancestor
110954966|NCT00000524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110954967|NCT00000524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110954968|NCT00000524|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110954969|NCT00000524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110954970|NCT00000524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110954971|NCT00000524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110954972|NCT00000524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110954973|NCT00000524|Immunologic Factors|immunologic factors|mesh-ancestor
110954974|NCT00000524|Antifungal Agents|antifungal agents|mesh-ancestor
110954975|NCT00000524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110954976|NCT00000524|Dermatologic Agents|dermatologic agents|mesh-ancestor
110954977|NCT00000524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110954978|NCT00000524|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110954979|NCT02099331|Melatonin|melatonin|mesh-list
110954980|NCT02099331|Antioxidants|antioxidants|mesh-ancestor
110954981|NCT02099331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110954982|NCT02099331|Protective Agents|protective agents|mesh-ancestor
110954983|NCT02099331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110954984|NCT02099331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110954985|NCT05328388|Lycopene|lycopene|mesh-list
110954986|NCT05328388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110954987|NCT05328388|Antioxidants|antioxidants|mesh-ancestor
110954988|NCT05328388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110954989|NCT05328388|Protective Agents|protective agents|mesh-ancestor
110954990|NCT05328388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110954991|NCT05328388|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110954992|NCT05328388|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110954993|NCT05328388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110954994|NCT02097069|Folic Acid|folic acid|mesh-list
110954995|NCT02097069|Inositol|inositol|mesh-list
110954996|NCT02097069|Hematinics|hematinics|mesh-ancestor
110954997|NCT02097069|Vitamin B Complex|vitamin b complex|mesh-ancestor
110954998|NCT02097069|Vitamins|vitamins|mesh-ancestor
110954999|NCT02097069|Micronutrients|micronutrients|mesh-ancestor
110955000|NCT02097069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110955001|NCT03424226|Acetazolamide|acetazolamide|mesh-list
110955002|NCT03424226|Anticonvulsants|anticonvulsants|mesh-ancestor
110955003|NCT03424226|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110955004|NCT03424226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110955005|NCT03424226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110955006|NCT03424226|Diuretics|diuretics|mesh-ancestor
110955007|NCT03424226|Natriuretic Agents|natriuretic agents|mesh-ancestor
110955008|NCT03424226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110955009|NCT02250729|Pholcodine|pholcodine|mesh-list
110955010|NCT02250729|Analgesics|analgesics|mesh-ancestor
110955011|NCT02250729|Sensory System Agents|sensory system agents|mesh-ancestor
110955012|NCT02250729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110955013|NCT02250729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110955014|NCT02250729|Antitussive Agents|antitussive agents|mesh-ancestor
110955015|NCT02250729|Respiratory System Agents|respiratory system agents|mesh-ancestor
110955016|NCT02097147|Paroxetine|paroxetine|mesh-list
110955017|NCT02097147|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
110955018|NCT02097147|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110955019|NCT02097147|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110955020|NCT02097147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110955021|NCT02097147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110955022|NCT02097147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110955024|NCT02097147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110955025|NCT02097147|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110955026|NCT02097147|Antidepressive Agents|antidepressive agents|mesh-ancestor
110955027|NCT02097147|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110955028|NCT02097147|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110955029|NCT02097147|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110955030|NCT02097147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110955031|NCT02097147|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110955032|NCT02097147|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110955033|NCT03556839|Paclitaxel|paclitaxel|mesh-list
110955034|NCT03556839|Bevacizumab|bevacizumab|mesh-list
110955035|NCT03556839|Carboplatin|carboplatin|mesh-list
110955036|NCT03556839|Atezolizumab|atezolizumab|mesh-list
110955037|NCT03556839|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110955038|NCT03556839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110955039|NCT03556839|Tubulin Modulators|tubulin modulators|mesh-ancestor
110955040|NCT03556839|Antimitotic Agents|antimitotic agents|mesh-ancestor
110955041|NCT03556839|Mitosis Modulators|mitosis modulators|mesh-ancestor
110955042|NCT03556839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110955043|NCT03556839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110955044|NCT03556839|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110955045|NCT03556839|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110955046|NCT03556839|Growth Substances|growth substances|mesh-ancestor
110955047|NCT03556839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110955048|NCT03556839|Growth Inhibitors|growth inhibitors|mesh-ancestor
110955049|NCT03556839|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110955050|NCT03415802|Paclitaxel|paclitaxel|mesh-list
110955051|NCT03415802|Tegafur|tegafur|mesh-list
110955052|NCT03415802|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110955053|NCT03415802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110955054|NCT03415802|Tubulin Modulators|tubulin modulators|mesh-ancestor
110955055|NCT03415802|Antimitotic Agents|antimitotic agents|mesh-ancestor
110955056|NCT03415802|Mitosis Modulators|mitosis modulators|mesh-ancestor
110955057|NCT03415802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110955058|NCT03415802|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110955059|NCT03415802|Antimetabolites|antimetabolites|mesh-ancestor
110955060|NCT02099877|Fentanyl|fentanyl|mesh-list
110955061|NCT02099877|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110955062|NCT02099877|Narcotics|narcotics|mesh-ancestor
110955063|NCT02099877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110955064|NCT02099877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110955065|NCT02099877|Analgesics|analgesics|mesh-ancestor
110955066|NCT02099877|Sensory System Agents|sensory system agents|mesh-ancestor
110955067|NCT02099877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110955068|NCT02099877|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110955069|NCT02099877|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110955070|NCT02099877|Anesthetics, General|anesthetics, general|mesh-ancestor
110955071|NCT02099877|Anesthetics|anesthetics|mesh-ancestor
110955072|NCT02097381|Ritonavir|ritonavir|mesh-list
110955073|NCT02097381|Lopinavir|lopinavir|mesh-list
110955074|NCT02097381|Darunavir|darunavir|mesh-list
110955075|NCT02097381|Tenofovir|tenofovir|mesh-list
110955076|NCT02097381|Emtricitabine|emtricitabine|mesh-list
110955077|NCT02097381|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110955078|NCT02097381|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110955079|NCT02097381|Protease Inhibitors|protease inhibitors|mesh-ancestor
110955080|NCT02097381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110955081|NCT02097381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110955082|NCT02097381|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110955083|NCT02097381|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110955084|NCT02097381|Antiviral Agents|antiviral agents|mesh-ancestor
110955085|NCT02097381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110955086|NCT02097381|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110955087|NCT02097381|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110955088|NCT02097381|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110955089|NCT02097381|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110955090|NCT02099955|Vitamin D|vitamin d|mesh-list
110955091|NCT02099955|Cholecalciferol|cholecalciferol|mesh-list
110955092|NCT02099955|Vitamins|vitamins|mesh-ancestor
110955093|NCT02099955|Micronutrients|micronutrients|mesh-ancestor
110955094|NCT02099955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110955095|NCT02099955|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110955096|NCT02099955|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110955097|NCT02097459|Tamoxifen|tamoxifen|mesh-list
110955098|NCT02097459|Toremifene|toremifene|mesh-list
110955100|NCT02097459|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110955101|NCT02097459|Hormone Antagonists|hormone antagonists|mesh-ancestor
110955102|NCT02097459|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110955103|NCT02097459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110955104|NCT02097459|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110955105|NCT02097459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110955106|NCT02097459|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110955107|NCT02097459|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110955108|NCT02097459|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110955109|NCT02097459|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110955110|NCT02097459|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110955111|NCT02097459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110955112|NCT02097459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110955113|NCT02097615|Chlorhexidine|chlorhexidine|mesh-list
110955114|NCT02097615|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110955115|NCT02097615|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110955116|NCT02097615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110955117|NCT02097615|Disinfectants|disinfectants|mesh-ancestor
110955118|NCT02097615|Dermatologic Agents|dermatologic agents|mesh-ancestor
110955119|NCT02590432|Linaclotide|linaclotide|mesh-list
110687687|NCT00453180|Antiviral Agents|antiviral agents|mesh-ancestor
110955120|NCT02590432|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
110955121|NCT02590432|Enzyme Activators|enzyme activators|mesh-ancestor
110955122|NCT02590432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110955123|NCT02590432|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110955124|NCT02094339|Analgesics|analgesics|mesh-list
110955125|NCT02094339|Ropivacaine|ropivacaine|mesh-list
110955126|NCT02094339|Anesthetics, Local|anesthetics, local|mesh-ancestor
110955127|NCT02094339|Anesthetics|anesthetics|mesh-ancestor
110955128|NCT02094339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110955129|NCT02094339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110955130|NCT02094339|Sensory System Agents|sensory system agents|mesh-ancestor
110955131|NCT02094339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110955132|NCT03415646|Morphine|morphine|mesh-list
110955133|NCT03415646|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110955134|NCT03415646|Narcotics|narcotics|mesh-ancestor
110955135|NCT03415646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110955136|NCT03415646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110955137|NCT03415646|Analgesics|analgesics|mesh-ancestor
110955138|NCT03415646|Sensory System Agents|sensory system agents|mesh-ancestor
110955139|NCT03415646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110955140|NCT03417518|Propofol|propofol|mesh-list
110955141|NCT03417518|Desflurane|desflurane|mesh-list
110955142|NCT03417518|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110955143|NCT03417518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110955144|NCT03417518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110955145|NCT03417518|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110955146|NCT03417518|Anesthetics, General|anesthetics, general|mesh-ancestor
110955147|NCT03417518|Anesthetics|anesthetics|mesh-ancestor
110955148|NCT03417518|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110955149|NCT02094651|Valproic Acid|valproic acid|mesh-list
110955150|NCT02094651|Anticonvulsants|anticonvulsants|mesh-ancestor
110955151|NCT02094651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110955152|NCT02094651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110955153|NCT02094651|GABA Agents|gaba agents|mesh-ancestor
110955154|NCT02094651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110955155|NCT02094651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110955156|NCT02094651|Antimanic Agents|antimanic agents|mesh-ancestor
110955157|NCT02094651|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110955158|NCT02094651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110955159|NCT02094651|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110955160|NCT02094807|Acetaminophen|acetaminophen|mesh-list
110955161|NCT02094807|Diclofenac|diclofenac|mesh-list
110955162|NCT02094807|Oxycodone|oxycodone|mesh-list
110955163|NCT02094807|Tramadol|tramadol|mesh-list
110955164|NCT02094807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110955165|NCT02094807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110955166|NCT02094807|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110955167|NCT02094807|Analgesics|analgesics|mesh-ancestor
110955168|NCT02094807|Sensory System Agents|sensory system agents|mesh-ancestor
110955169|NCT02094807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110955170|NCT02094807|Antipyretics|antipyretics|mesh-ancestor
110955171|NCT02094807|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110955172|NCT02094807|Narcotics|narcotics|mesh-ancestor
110955173|NCT02094807|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110955174|NCT02094807|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110955175|NCT02094807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110955176|NCT02094807|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110955177|NCT02094807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110955178|NCT02094807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110955179|NCT05139472|Empagliflozin|empagliflozin|mesh-list
110955180|NCT05139472|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110955181|NCT05139472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110955182|NCT05139472|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110955183|NCT05139472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110955184|NCT04757090|Trastuzumab|trastuzumab|mesh-list
110955185|NCT04757090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110955186|NCT04757090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110955187|NCT03397862|Donepezil|donepezil|mesh-list
110955188|NCT03397862|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110955189|NCT03397862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110955190|NCT03397862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110955191|NCT03397862|Cholinergic Agents|cholinergic agents|mesh-ancestor
110955192|NCT03397862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110955193|NCT03397862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110955194|NCT03397862|Nootropic Agents|nootropic agents|mesh-ancestor
110955195|NCT02100267|Methacholine Chloride|methacholine chloride|mesh-list
110955196|NCT02100267|Miotics|miotics|mesh-ancestor
110955197|NCT02100267|Autonomic Agents|autonomic agents|mesh-ancestor
110955198|NCT02100267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110955199|NCT02100267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110955200|NCT02100267|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110955201|NCT02100267|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
110955202|NCT02100267|Respiratory System Agents|respiratory system agents|mesh-ancestor
110955204|NCT02100267|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110955205|NCT02100267|Cholinergic Agents|cholinergic agents|mesh-ancestor
110955206|NCT02100267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110955207|NCT02100267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110955208|NCT02094963|Clopidogrel|clopidogrel|mesh-list
110955209|NCT02094963|Ticagrelor|ticagrelor|mesh-list
110955210|NCT02094963|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110955211|NCT02094963|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110955212|NCT02094963|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110955213|NCT02094963|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110955214|NCT02094963|Purinergic Agents|purinergic agents|mesh-ancestor
110955215|NCT02094963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110955216|NCT02094963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110955217|NCT02094963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110955218|NCT03982810|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110955219|NCT03982810|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
110955220|NCT03982810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110955221|NCT03982810|Antitubercular Agents|antitubercular agents|mesh-ancestor
110955222|NCT02098317|Vitamin D|vitamin d|mesh-list
110955223|NCT02098317|Vitamins|vitamins|mesh-ancestor
110955224|NCT02098317|Micronutrients|micronutrients|mesh-ancestor
110955225|NCT02098317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110955226|NCT02098317|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110955227|NCT02100423|Vitamin D|vitamin d|mesh-list
110955228|NCT02100423|Cholecalciferol|cholecalciferol|mesh-list
110955229|NCT02100423|Curcumin|curcumin|mesh-list
110955230|NCT02100423|Vitamins|vitamins|mesh-ancestor
110955231|NCT02100423|Micronutrients|micronutrients|mesh-ancestor
110955232|NCT02100423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110955233|NCT02100423|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110955234|NCT02100423|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110955235|NCT02100423|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110955236|NCT02100423|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110955237|NCT02100423|Analgesics|analgesics|mesh-ancestor
110955238|NCT02100423|Sensory System Agents|sensory system agents|mesh-ancestor
110955239|NCT02100423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110955240|NCT02100423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110955241|NCT02100423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110955242|NCT02100423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110955243|NCT02100423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110955244|NCT02100423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110955245|NCT05614648|Clonidine|clonidine|mesh-list
110955246|NCT05614648|Analgesics|analgesics|mesh-ancestor
110022415|NCT00002802|Vindesine|vindesine|mesh-list
110955247|NCT05614648|Sensory System Agents|sensory system agents|mesh-ancestor
110955248|NCT05614648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110955249|NCT05614648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110955250|NCT05614648|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110955251|NCT05614648|Sympatholytics|sympatholytics|mesh-ancestor
110955252|NCT05614648|Autonomic Agents|autonomic agents|mesh-ancestor
110955253|NCT05614648|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110955254|NCT05614648|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110955255|NCT05614648|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110955256|NCT05614648|Adrenergic Agents|adrenergic agents|mesh-ancestor
110955257|NCT05614648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110955258|NCT05614648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110955259|NCT02520752|Midazolam|midazolam|mesh-list
110955260|NCT02520752|Caffeine|caffeine|mesh-list
110955261|NCT02520752|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110955262|NCT02520752|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110955263|NCT02520752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110955264|NCT02520752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110955265|NCT02520752|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110955266|NCT02520752|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110955267|NCT02520752|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110955268|NCT02520752|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110955269|NCT02520752|Anesthetics, General|anesthetics, general|mesh-ancestor
110955270|NCT02520752|Anesthetics|anesthetics|mesh-ancestor
110955271|NCT02520752|GABA Modulators|gaba modulators|mesh-ancestor
110955272|NCT02520752|GABA Agents|gaba agents|mesh-ancestor
110955273|NCT02520752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110955274|NCT02520752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110667284|NCT00820547|Docetaxel|docetaxel|mesh-list
110955275|NCT02520752|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110955276|NCT02520752|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110955277|NCT02520752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110955278|NCT02520752|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110955279|NCT02520752|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110955280|NCT02520752|Purinergic Agents|purinergic agents|mesh-ancestor
110955281|NCT02095119|Gemcitabine|gemcitabine|mesh-list
110955282|NCT02095119|Nimotuzumab|nimotuzumab|mesh-list
110955283|NCT02095119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110955284|NCT02095119|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110955285|NCT02095119|Antimetabolites|antimetabolites|mesh-ancestor
110955286|NCT02095119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110955287|NCT02095119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110955288|NCT02098629|Milrinone|milrinone|mesh-list
110955289|NCT02098629|Esmolol|esmolol|mesh-list
110955290|NCT02098629|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110955291|NCT02098629|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110955292|NCT02098629|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110955293|NCT02098629|Adrenergic Agents|adrenergic agents|mesh-ancestor
110955294|NCT02098629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110955295|NCT02098629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110955296|NCT02098629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110955297|NCT02098629|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110955298|NCT02098629|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110955299|NCT02098629|Vasodilator Agents|vasodilator agents|mesh-ancestor
110955300|NCT02098629|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110955301|NCT02098629|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110955302|NCT02098629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110955303|NCT02098629|Protective Agents|protective agents|mesh-ancestor
110955304|NCT02095509|Enoxaparin|enoxaparin|mesh-list
110955305|NCT02095509|Anticoagulants|anticoagulants|mesh-ancestor
110955306|NCT02095509|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110955307|NCT02095509|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110955308|NCT02095509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110955309|NCT03397082|Lidocaine|lidocaine|mesh-list
110955310|NCT03397082|Anesthetics, Local|anesthetics, local|mesh-ancestor
110955311|NCT03397082|Anesthetics|anesthetics|mesh-ancestor
110955312|NCT03397082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110955313|NCT03397082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110955314|NCT03397082|Sensory System Agents|sensory system agents|mesh-ancestor
110955315|NCT03397082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110955316|NCT03397082|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110955317|NCT03397082|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110955318|NCT03397082|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110955319|NCT03397082|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110955320|NCT03397082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110955321|NCT02101047|Phenylephrine|phenylephrine|mesh-list
110955322|NCT02101047|Oxymetazoline|oxymetazoline|mesh-list
110955323|NCT02101047|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110955324|NCT02101047|Mydriatics|mydriatics|mesh-ancestor
110955325|NCT02101047|Autonomic Agents|autonomic agents|mesh-ancestor
110955326|NCT02101047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110955327|NCT02101047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110955328|NCT02101047|Sympathomimetics|sympathomimetics|mesh-ancestor
110955329|NCT02101047|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110955330|NCT02101047|Nasal Decongestants|nasal decongestants|mesh-ancestor
110955331|NCT02101047|Respiratory System Agents|respiratory system agents|mesh-ancestor
110955332|NCT02101047|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110955333|NCT02101047|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110955334|NCT02101047|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110955335|NCT02101047|Adrenergic Agents|adrenergic agents|mesh-ancestor
110955336|NCT02101047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110955337|NCT02101047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110955338|NCT02101047|Protective Agents|protective agents|mesh-ancestor
110955339|NCT02095665|Acetaminophen|acetaminophen|mesh-list
110955340|NCT02095665|Tamsulosin|tamsulosin|mesh-list
110955341|NCT02095665|Mirabegron|mirabegron|mesh-list
110955342|NCT02095665|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110955343|NCT02095665|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110955344|NCT02095665|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110955345|NCT02095665|Adrenergic Agents|adrenergic agents|mesh-ancestor
110955346|NCT02095665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110955347|NCT02095665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110667344|NCT00647699|Vitamins|vitamins|mesh-ancestor
110955348|NCT02095665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110955349|NCT02095665|Urological Agents|urological agents|mesh-ancestor
110955350|NCT02095665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110955351|NCT02095665|Analgesics|analgesics|mesh-ancestor
110955352|NCT02095665|Sensory System Agents|sensory system agents|mesh-ancestor
110955353|NCT02095665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110955354|NCT02095665|Antipyretics|antipyretics|mesh-ancestor
110955355|NCT02095665|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
110955356|NCT02095665|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110955357|NCT02095665|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110955358|NCT03548428|Atezolizumab|atezolizumab|mesh-list
110955359|NCT03548428|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110955360|NCT03548428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110955361|NCT03548428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110955362|NCT03548428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110955363|NCT02101125|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110955364|NCT02101125|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110955365|NCT02101125|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110955366|NCT02101125|Antimetabolites|antimetabolites|mesh-ancestor
110955367|NCT02101125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110955368|NCT02101125|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110955369|NCT02101125|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110955370|NCT02101125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110955371|NCT02101203|Buspirone|buspirone|mesh-list
110955372|NCT02101203|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110955373|NCT02101203|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110955374|NCT02101203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110955375|NCT02101203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110955376|NCT02101203|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110955377|NCT02101203|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110955378|NCT02101203|Serotonin Agents|serotonin agents|mesh-ancestor
110955379|NCT02101203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110955380|NCT02101203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110955381|NCT04523246|Vaccines|vaccines|mesh-list
110955382|NCT04523246|Immunologic Factors|immunologic factors|mesh-ancestor
110955383|NCT04523246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110955384|NCT03396380|Calcium, Dietary|calcium, dietary|mesh-list
110955385|NCT03396380|Vitamin D|vitamin d|mesh-list
110955386|NCT03396380|Citric Acid|citric acid|mesh-list
110955387|NCT03396380|Sodium Citrate|sodium citrate|mesh-list
110955388|NCT03396380|Clomiphene|clomiphene|mesh-list
110955389|NCT03396380|Enclomiphene|enclomiphene|mesh-list
110955390|NCT03396380|Zuclomiphene|zuclomiphene|mesh-list
110955391|NCT03396380|Calcium|calcium|mesh-list
110955392|NCT03396380|Vitamins|vitamins|mesh-ancestor
110955393|NCT03396380|Micronutrients|micronutrients|mesh-ancestor
110022572|NCT00002970|Methotrexate|methotrexate|mesh-list
110955394|NCT03396380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110955395|NCT03396380|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110955396|NCT03396380|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110955397|NCT03396380|Anticoagulants|anticoagulants|mesh-ancestor
110955398|NCT03396380|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110955399|NCT03396380|Chelating Agents|chelating agents|mesh-ancestor
110955400|NCT03396380|Sequestering Agents|sequestering agents|mesh-ancestor
110955401|NCT03396380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110955402|NCT03396380|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110955403|NCT03396380|Hormone Antagonists|hormone antagonists|mesh-ancestor
110955404|NCT03396380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110955405|NCT03396380|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110955406|NCT03396380|Fertility Agents|fertility agents|mesh-ancestor
110955407|NCT03396380|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110955408|NCT03396380|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110955409|NCT03396380|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110955410|NCT03414164|Procyanidin|procyanidin|mesh-list
110955411|NCT03414164|Antioxidants|antioxidants|mesh-ancestor
110955412|NCT03414164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110955413|NCT03414164|Protective Agents|protective agents|mesh-ancestor
110955414|NCT03414164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110955415|NCT05613478|Apatinib|apatinib|mesh-list
110955416|NCT05613478|Chlorotrianisene|chlorotrianisene|mesh-list
110955417|NCT05613478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110955418|NCT05613478|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110955419|NCT05613478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110667421|NCT02551367|Hormones|hormones|mesh-list
110955420|NCT05613478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110955421|NCT05613478|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
110955422|NCT05613478|Estrogens|estrogens|mesh-ancestor
110955423|NCT05613478|Hormones|hormones|mesh-ancestor
110955424|NCT05613478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110955425|NCT05613478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110955426|NCT05613478|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110955427|NCT04412018|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
110955428|NCT04412018|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110955429|NCT04412018|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110955430|NCT03406988|Nifedipine|nifedipine|mesh-list
110955431|NCT03406988|Iloprost|iloprost|mesh-list
110955432|NCT03406988|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110955433|NCT03406988|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110955434|NCT03406988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110955435|NCT03406988|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110955436|NCT03406988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110955437|NCT03406988|Vasodilator Agents|vasodilator agents|mesh-ancestor
110955438|NCT03406988|Tocolytic Agents|tocolytic agents|mesh-ancestor
110955439|NCT03406988|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110955440|NCT03406988|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110955441|NCT03406832|Nitroprusside|nitroprusside|mesh-list
110955442|NCT03406832|Tirofiban|tirofiban|mesh-list
110955443|NCT03406832|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110955444|NCT03406832|Vasodilator Agents|vasodilator agents|mesh-ancestor
110955445|NCT03406832|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
110955446|NCT03406832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110955447|NCT03406832|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110955448|NCT03406832|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110955449|NCT03406832|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110955450|NCT03405974|Aspirin|aspirin|mesh-list
110955451|NCT03405974|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110955452|NCT03405974|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110955453|NCT03405974|Analgesics|analgesics|mesh-ancestor
110955454|NCT03405974|Sensory System Agents|sensory system agents|mesh-ancestor
110955455|NCT03405974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110955456|NCT03405974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110955457|NCT03405974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110955458|NCT03405974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110955459|NCT03405974|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110955460|NCT03405974|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110955461|NCT03405974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110955462|NCT03405974|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110955463|NCT03405974|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110955464|NCT03405974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110955465|NCT03405974|Antipyretics|antipyretics|mesh-ancestor
110955466|NCT04337060|Lidocaine|lidocaine|mesh-list
110955467|NCT04337060|Morphine|morphine|mesh-list
110955468|NCT04337060|Bupivacaine|bupivacaine|mesh-list
110955469|NCT04337060|Anesthetics, Local|anesthetics, local|mesh-ancestor
110955470|NCT04337060|Anesthetics|anesthetics|mesh-ancestor
110955471|NCT04337060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110955472|NCT04337060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110955473|NCT04337060|Sensory System Agents|sensory system agents|mesh-ancestor
110955474|NCT04337060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110955475|NCT04337060|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110955476|NCT04337060|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110955477|NCT04337060|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110955478|NCT04337060|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110955479|NCT04337060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110955480|NCT04337060|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110955481|NCT04337060|Narcotics|narcotics|mesh-ancestor
110955482|NCT04337060|Analgesics|analgesics|mesh-ancestor
110955483|NCT04447274|Apatinib|apatinib|mesh-list
110955484|NCT04447274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110955485|NCT04447274|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110955486|NCT04447274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110955487|NCT04447274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110955488|NCT02977156|Ipilimumab|ipilimumab|mesh-list
110955489|NCT02977156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110955490|NCT02977156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110955491|NCT02977156|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110955492|NCT02977156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110955493|NCT02413138|Hormones|hormones|mesh-list
110955494|NCT02413138|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110955495|NCT02413138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110955496|NCT01014598|Cisplatin|cisplatin|mesh-list
110955497|NCT01014598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110955498|NCT03404804|Amoxicillin|amoxicillin|mesh-list
110955499|NCT03404804|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110955500|NCT03404804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110955501|NCT03403946|Pyrithione zinc|pyrithione zinc|mesh-list
110955502|NCT03403946|Keratolytic Agents|keratolytic agents|mesh-ancestor
110955503|NCT03403946|Dermatologic Agents|dermatologic agents|mesh-ancestor
110955504|NCT05611372|Rasagiline|rasagiline|mesh-list
110955505|NCT05611372|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
110955506|NCT05611372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110955507|NCT05611372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110955508|NCT05611372|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110955509|NCT05611372|Protective Agents|protective agents|mesh-ancestor
110955510|NCT05611372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110955511|NCT03395756|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
110955512|NCT03395756|Medroxyprogesterone|medroxyprogesterone|mesh-list
110955513|NCT03395756|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110955514|NCT03395756|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110955515|NCT03395756|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110955516|NCT03395756|Contraceptive Agents|contraceptive agents|mesh-ancestor
110955517|NCT03395756|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110955518|NCT03395756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110955519|NCT03395756|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110955520|NCT03395756|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110955521|NCT03395756|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110955522|NCT03395756|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110955523|NCT03395756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110955524|NCT05613166|Everolimus|everolimus|mesh-list
110955525|NCT05613166|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110955526|NCT05613166|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110955527|NCT05613166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110955528|NCT05613166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110955529|NCT05613166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110955530|NCT05613166|Immunologic Factors|immunologic factors|mesh-ancestor
110955531|NCT05613166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110955532|NCT05613166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110955533|NCT05166668|Letrozole|letrozole|mesh-list
110955534|NCT05166668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110955535|NCT05166668|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110955536|NCT05166668|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110955537|NCT05166668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110955538|NCT05166668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110955539|NCT05166668|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110955540|NCT05166668|Hormone Antagonists|hormone antagonists|mesh-ancestor
110955541|NCT05166668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110955542|NCT05166668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110955543|NCT05558176|Sildenafil Citrate|sildenafil citrate|mesh-list
110955544|NCT05558176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110955545|NCT05558176|Vasodilator Agents|vasodilator agents|mesh-ancestor
110955546|NCT05558176|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110955547|NCT05558176|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110955548|NCT05558176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110955549|NCT05558176|Urological Agents|urological agents|mesh-ancestor
110955550|NCT04748224|Dexmedetomidine|dexmedetomidine|mesh-list
110955551|NCT04748224|Bupivacaine|bupivacaine|mesh-list
110955552|NCT04748224|Anesthetics, Local|anesthetics, local|mesh-ancestor
110955553|NCT04748224|Anesthetics|anesthetics|mesh-ancestor
110955554|NCT04748224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110955555|NCT04748224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110955556|NCT04748224|Sensory System Agents|sensory system agents|mesh-ancestor
110955557|NCT04748224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110955558|NCT04748224|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110955559|NCT04748224|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110955560|NCT04748224|Analgesics|analgesics|mesh-ancestor
110955561|NCT04748224|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110955562|NCT04748224|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110955563|NCT04748224|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110955564|NCT04748224|Adrenergic Agents|adrenergic agents|mesh-ancestor
110955565|NCT04748224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110955566|NCT04748224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110955567|NCT03413150|Amiodarone|amiodarone|mesh-list
110955568|NCT03413150|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110955569|NCT03413150|Vasodilator Agents|vasodilator agents|mesh-ancestor
110955570|NCT03413150|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
110955571|NCT03413150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110955572|NCT03413150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110955573|NCT03413150|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110955574|NCT03413150|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110955575|NCT03413150|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110955576|NCT03413150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110955577|NCT03413150|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110955578|NCT03413150|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110955579|NCT03413150|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110955580|NCT05474716|Brimonidine Tartrate|brimonidine tartrate|mesh-list
110955581|NCT05474716|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110955582|NCT05474716|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110955583|NCT05474716|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110955584|NCT05474716|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110955585|NCT05474716|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110955586|NCT05474716|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110955587|NCT05474716|Adrenergic Agents|adrenergic agents|mesh-ancestor
110955588|NCT05474716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110955589|NCT05474716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110955590|NCT05474716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110955591|NCT03126578|Midazolam|midazolam|mesh-list
110955592|NCT03126578|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110955593|NCT03126578|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110955594|NCT03126578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110955595|NCT03126578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110955596|NCT03126578|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110955597|NCT03126578|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110955598|NCT03126578|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110955599|NCT03126578|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110955600|NCT03126578|Anesthetics, General|anesthetics, general|mesh-ancestor
110955601|NCT03126578|Anesthetics|anesthetics|mesh-ancestor
110955602|NCT03126578|GABA Modulators|gaba modulators|mesh-ancestor
110955603|NCT03126578|GABA Agents|gaba agents|mesh-ancestor
110955604|NCT03126578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110955605|NCT03126578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110955606|NCT03412994|Apatinib|apatinib|mesh-list
110955607|NCT03412994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110955608|NCT03412994|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110955609|NCT03412994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110955610|NCT03412994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110955611|NCT02588248|Peppermint oil|peppermint oil|mesh-list
110955612|NCT02588248|Menthol|menthol|mesh-list
110955613|NCT02588248|Antipruritics|antipruritics|mesh-ancestor
110955614|NCT02588248|Dermatologic Agents|dermatologic agents|mesh-ancestor
110955615|NCT02588248|Antiemetics|antiemetics|mesh-ancestor
110955616|NCT02588248|Autonomic Agents|autonomic agents|mesh-ancestor
110955617|NCT02588248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110955618|NCT02588248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110955619|NCT02588248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110955620|NCT02588248|Parasympatholytics|parasympatholytics|mesh-ancestor
110955621|NCT03412682|Budesonide|budesonide|mesh-list
110955622|NCT03412682|Mesalamine|mesalamine|mesh-list
110955623|NCT03412682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110955624|NCT03412682|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110955625|NCT03412682|Autonomic Agents|autonomic agents|mesh-ancestor
110955626|NCT03412682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110955627|NCT03412682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110955628|NCT03412682|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110955629|NCT03412682|Respiratory System Agents|respiratory system agents|mesh-ancestor
110955630|NCT03412682|Glucocorticoids|glucocorticoids|mesh-ancestor
110955631|NCT03412682|Hormones|hormones|mesh-ancestor
110955632|NCT03412682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110955633|NCT03412682|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110955634|NCT03412682|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110955635|NCT03412682|Analgesics|analgesics|mesh-ancestor
110955636|NCT03412682|Sensory System Agents|sensory system agents|mesh-ancestor
110955637|NCT03412682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110955638|NCT03412526|Fludarabine|fludarabine|mesh-list
110955639|NCT03412526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110955640|NCT03126422|Dexmedetomidine|dexmedetomidine|mesh-list
110955641|NCT03126422|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110955642|NCT03126422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110955643|NCT03126422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110955644|NCT03126422|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110955645|NCT03126422|Analgesics|analgesics|mesh-ancestor
110955646|NCT03126422|Sensory System Agents|sensory system agents|mesh-ancestor
110955647|NCT03126422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110955648|NCT03126422|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110955649|NCT03126422|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110955650|NCT03126422|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110955651|NCT03126422|Adrenergic Agents|adrenergic agents|mesh-ancestor
110955652|NCT03126422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110955653|NCT03126422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110955654|NCT03395132|Fusidic Acid|fusidic acid|mesh-list
110955655|NCT03395132|Betamethasone|betamethasone|mesh-list
110955656|NCT03395132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110955657|NCT03395132|Glucocorticoids|glucocorticoids|mesh-ancestor
110955658|NCT03395132|Hormones|hormones|mesh-ancestor
110955659|NCT03395132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110955660|NCT03395132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110955661|NCT03395132|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110955662|NCT03395132|Respiratory System Agents|respiratory system agents|mesh-ancestor
110955663|NCT03395132|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110955664|NCT03395132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110955665|NCT03395132|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110955666|NCT03395132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110955667|NCT03395132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110955668|NCT03127124|Leucovorin|leucovorin|mesh-list
110955669|NCT03127124|Fluorouracil|fluorouracil|mesh-list
110955670|NCT03127124|Bevacizumab|bevacizumab|mesh-list
110955671|NCT03127124|Oxaliplatin|oxaliplatin|mesh-list
110955672|NCT03127124|Calcium|calcium|mesh-list
110955673|NCT03127124|Levoleucovorin|levoleucovorin|mesh-list
110955674|NCT03127124|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110955675|NCT03127124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110955676|NCT03127124|Antimetabolites|antimetabolites|mesh-ancestor
110955677|NCT03127124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110955678|NCT03127124|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110955679|NCT03127124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110955680|NCT03127124|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110955681|NCT03127124|Immunologic Factors|immunologic factors|mesh-ancestor
110955682|NCT03127124|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110955683|NCT03127124|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110955684|NCT03127124|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110955685|NCT03127124|Growth Substances|growth substances|mesh-ancestor
111203413|NCT01819129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110955686|NCT03127124|Growth Inhibitors|growth inhibitors|mesh-ancestor
110955687|NCT03127124|Antidotes|antidotes|mesh-ancestor
110955688|NCT03127124|Protective Agents|protective agents|mesh-ancestor
110955689|NCT03127124|Vitamin B Complex|vitamin b complex|mesh-ancestor
110955690|NCT03127124|Vitamins|vitamins|mesh-ancestor
110955691|NCT03127124|Micronutrients|micronutrients|mesh-ancestor
110955692|NCT03399110|Capecitabine|capecitabine|mesh-list
110955693|NCT03399110|Oxaliplatin|oxaliplatin|mesh-list
110955694|NCT03399110|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110955695|NCT03399110|Antimetabolites|antimetabolites|mesh-ancestor
110955696|NCT03399110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110955697|NCT03399110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110955698|NCT03127046|Aceclofenac|aceclofenac|mesh-list
110955699|NCT03127046|Diclofenac|diclofenac|mesh-list
110955700|NCT03127046|Esomeprazole|esomeprazole|mesh-list
110955701|NCT03127046|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110955702|NCT03127046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110955703|NCT03127046|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110955704|NCT03127046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110955705|NCT03127046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110955706|NCT03127046|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110955707|NCT03127046|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110955708|NCT03127046|Analgesics|analgesics|mesh-ancestor
110955709|NCT03127046|Sensory System Agents|sensory system agents|mesh-ancestor
110955710|NCT03127046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110955711|NCT03127046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110955712|NCT03127046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110955713|NCT03127046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110955714|NCT03127046|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110955715|NCT05105672|Cisplatin|cisplatin|mesh-list
110955716|NCT05105672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110955717|NCT03399032|Caspofungin|caspofungin|mesh-list
110955718|NCT03399032|Antifungal Agents|antifungal agents|mesh-ancestor
110955719|NCT03399032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110955720|NCT03399032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110955721|NCT03399032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110955722|NCT03394820|Dexamethasone|dexamethasone|mesh-list
110955723|NCT03394820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110955724|NCT03394820|Antiemetics|antiemetics|mesh-ancestor
110955725|NCT03394820|Autonomic Agents|autonomic agents|mesh-ancestor
110955726|NCT03394820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110955727|NCT03394820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110955728|NCT03394820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110955729|NCT03394820|Glucocorticoids|glucocorticoids|mesh-ancestor
110955730|NCT03394820|Hormones|hormones|mesh-ancestor
110955731|NCT03394820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110955732|NCT03394820|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110955733|NCT03394820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110955734|NCT01328054|Lapatinib|lapatinib|mesh-list
110955735|NCT01328054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110955736|NCT01328054|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110955737|NCT01328054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110955738|NCT01328054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110955739|NCT05067920|Antibodies|antibodies|mesh-list
110955740|NCT05067920|Immunologic Factors|immunologic factors|mesh-ancestor
110955741|NCT05067920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110955742|NCT05002244|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110955743|NCT05002244|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
110955744|NCT05002244|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110955745|NCT05002244|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110955746|NCT05002244|Antimetabolites|antimetabolites|mesh-ancestor
110955747|NCT05002244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110955748|NCT05002244|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110955749|NCT05002244|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110955750|NCT05002244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110955751|NCT05002244|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110955752|NCT05002244|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110955753|NCT03398876|Nicotine|nicotine|mesh-list
110955754|NCT03398876|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110955755|NCT03398876|Autonomic Agents|autonomic agents|mesh-ancestor
110955756|NCT03398876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110955757|NCT03398876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110955758|NCT03398876|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110955759|NCT03398876|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110955760|NCT03398876|Cholinergic Agents|cholinergic agents|mesh-ancestor
110955761|NCT03398876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110955762|NCT03398876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110955763|NCT03394586|Golimumab|golimumab|mesh-list
110955764|NCT03394586|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110955765|NCT03394586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110955766|NCT03394586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110955767|NCT03394586|Immunologic Factors|immunologic factors|mesh-ancestor
110955768|NCT03394586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110955769|NCT03394430|Midazolam|midazolam|mesh-list
110955770|NCT03394430|Dexmedetomidine|dexmedetomidine|mesh-list
110955771|NCT03394430|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110955772|NCT03394430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110955773|NCT03394430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110955774|NCT03394430|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110955775|NCT03394430|Analgesics|analgesics|mesh-ancestor
110955776|NCT03394430|Sensory System Agents|sensory system agents|mesh-ancestor
110955777|NCT03394430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110955778|NCT03394430|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110955779|NCT03394430|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110955780|NCT03394430|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110955781|NCT03394430|Adrenergic Agents|adrenergic agents|mesh-ancestor
110955782|NCT03394430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110955783|NCT03394430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110955784|NCT03394430|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110955785|NCT03394430|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110955786|NCT03394430|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110955787|NCT03394430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110955788|NCT03394430|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110955789|NCT03394430|Anesthetics, General|anesthetics, general|mesh-ancestor
110955790|NCT03394430|Anesthetics|anesthetics|mesh-ancestor
110955791|NCT03394430|GABA Modulators|gaba modulators|mesh-ancestor
110955792|NCT03394430|GABA Agents|gaba agents|mesh-ancestor
110955793|NCT03394196|Ritonavir|ritonavir|mesh-list
110955794|NCT03394196|Lopinavir|lopinavir|mesh-list
110955795|NCT03394196|Darunavir|darunavir|mesh-list
110955796|NCT03394196|Tenofovir|tenofovir|mesh-list
110955797|NCT03394196|Lamivudine|lamivudine|mesh-list
110955798|NCT03394196|Emtricitabine|emtricitabine|mesh-list
110955799|NCT03394196|Zidovudine|zidovudine|mesh-list
110955800|NCT03394196|Raltegravir Potassium|raltegravir potassium|mesh-list
110955801|NCT03394196|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110955802|NCT03394196|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110955803|NCT03394196|Protease Inhibitors|protease inhibitors|mesh-ancestor
110955804|NCT03394196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110955805|NCT03394196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110955806|NCT03394196|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110955807|NCT03394196|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110955808|NCT03394196|Antiviral Agents|antiviral agents|mesh-ancestor
110955809|NCT03394196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110955810|NCT03394196|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110955811|NCT03394196|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110955812|NCT03394196|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110955813|NCT03394196|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110955814|NCT03394196|Antimetabolites|antimetabolites|mesh-ancestor
110955815|NCT03394196|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110955816|NCT03394196|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110955817|NCT03398018|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
110955818|NCT03398018|Hormones|hormones|mesh-ancestor
110955819|NCT03398018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110955820|NCT03398018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110955821|NCT03411434|Methylphenidate|methylphenidate|mesh-list
110955822|NCT03411434|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110955823|NCT03411434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110955824|NCT03411434|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110955825|NCT03411434|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110955826|NCT03411434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110955827|NCT03411434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110955828|NCT03411434|Dopamine Agents|dopamine agents|mesh-ancestor
110955829|NCT03411434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110955830|NCT03126656|Methyltestosterone|methyltestosterone|mesh-list
110955831|NCT03126656|Testosterone|testosterone|mesh-list
110955832|NCT03126656|Testosterone undecanoate|testosterone undecanoate|mesh-list
110955833|NCT03126656|Testosterone enanthate|testosterone enanthate|mesh-list
110955834|NCT03126656|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
110955835|NCT03126656|Androgens|androgens|mesh-ancestor
110955836|NCT03126656|Hormones|hormones|mesh-ancestor
110959293|NCT04217356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110955837|NCT03126656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110955838|NCT03126656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110955839|NCT03126656|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110955840|NCT03126656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110955841|NCT03126656|Anabolic Agents|anabolic agents|mesh-ancestor
110955842|NCT03385382|Dexamethasone|dexamethasone|mesh-list
110955843|NCT03385382|Ranibizumab|ranibizumab|mesh-list
110955844|NCT03385382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110955845|NCT03385382|Antiemetics|antiemetics|mesh-ancestor
110955846|NCT03385382|Autonomic Agents|autonomic agents|mesh-ancestor
110955847|NCT03385382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110955848|NCT03385382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110955849|NCT03385382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110955850|NCT03385382|Glucocorticoids|glucocorticoids|mesh-ancestor
110955851|NCT03385382|Hormones|hormones|mesh-ancestor
110955852|NCT03385382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110955853|NCT03385382|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110955854|NCT03385382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110955855|NCT03385382|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110955856|NCT03385382|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110955857|NCT03385382|Growth Substances|growth substances|mesh-ancestor
110955858|NCT03385382|Growth Inhibitors|growth inhibitors|mesh-ancestor
110955859|NCT03394118|Osimertinib|osimertinib|mesh-list
110955860|NCT03394118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110955861|NCT03394118|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110955862|NCT03394118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110955863|NCT03394118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110955864|NCT03389672|Anesthetics|anesthetics|mesh-list
110955865|NCT03389672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110955866|NCT03389672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110955867|NCT01941446|Moxifloxacin|moxifloxacin|mesh-list
110955868|NCT01941446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110955869|NCT01941446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110955870|NCT01941446|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110955871|NCT01941446|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110955872|NCT01941446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110955873|NCT01941446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110955874|NCT01941446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110955875|NCT01907360|Methylphenidate|methylphenidate|mesh-list
110955876|NCT01907360|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110955877|NCT01907360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110955878|NCT01907360|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110955879|NCT01907360|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110955880|NCT01907360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110955881|NCT01907360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110955882|NCT01907360|Dopamine Agents|dopamine agents|mesh-ancestor
110955883|NCT01907360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110955884|NCT03126188|Sertraline|sertraline|mesh-list
110955885|NCT03126188|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
110955886|NCT03126188|Antidepressive Agents|antidepressive agents|mesh-ancestor
110955887|NCT03126188|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110955888|NCT03126188|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110955889|NCT03126188|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110955890|NCT03126188|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110955891|NCT03126188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110955892|NCT03126188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110955893|NCT03126188|Serotonin Agents|serotonin agents|mesh-ancestor
110955894|NCT03126188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110955895|NCT03126188|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110955896|NCT03126188|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110955897|NCT04446338|Antibodies|antibodies|mesh-list
110955898|NCT04446338|Immunologic Factors|immunologic factors|mesh-ancestor
110955899|NCT04446338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110955900|NCT03393728|Propranolol|propranolol|mesh-list
110955901|NCT03393728|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110955902|NCT03393728|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110955903|NCT03393728|Adrenergic Agents|adrenergic agents|mesh-ancestor
110955904|NCT03393728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110955905|NCT03393728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110955906|NCT03393728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110955907|NCT03393728|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110022801|NCT00003120|Mitosis Modulators|mitosis modulators|mesh-ancestor
110955908|NCT03393728|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110955909|NCT03393728|Vasodilator Agents|vasodilator agents|mesh-ancestor
110955910|NCT03393572|Magnesium Sulfate|magnesium sulfate|mesh-list
110955911|NCT03393572|Nalbuphine|nalbuphine|mesh-list
110955912|NCT03393572|Bupivacaine|bupivacaine|mesh-list
110955913|NCT03393572|Anesthetics, Local|anesthetics, local|mesh-ancestor
110955914|NCT03393572|Anesthetics|anesthetics|mesh-ancestor
110955915|NCT03393572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110955916|NCT03393572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110955917|NCT03393572|Sensory System Agents|sensory system agents|mesh-ancestor
110955918|NCT03393572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110955919|NCT03393572|Analgesics|analgesics|mesh-ancestor
110955920|NCT03393572|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110955921|NCT03393572|Anticonvulsants|anticonvulsants|mesh-ancestor
110955922|NCT03393572|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110955923|NCT03393572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110955924|NCT03393572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110955925|NCT03393572|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110955926|NCT03393572|Tocolytic Agents|tocolytic agents|mesh-ancestor
110955927|NCT03393572|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110955928|NCT03393572|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110955929|NCT03393572|Narcotics|narcotics|mesh-ancestor
110955930|NCT03393416|Antibodies|antibodies|mesh-list
110955931|NCT03393416|Immunologic Factors|immunologic factors|mesh-ancestor
110955932|NCT03393416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110955933|NCT04445948|Amoxicillin|amoxicillin|mesh-list
110955934|NCT04445948|Metronidazole|metronidazole|mesh-list
110955935|NCT04445948|Clarithromycin|clarithromycin|mesh-list
110955936|NCT04445948|Lactoferrin|lactoferrin|mesh-list
110955937|NCT04445948|Esomeprazole|esomeprazole|mesh-list
110955938|NCT04445948|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110955939|NCT04445948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110955940|NCT04445948|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110955941|NCT04445948|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110955942|NCT04445948|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110955943|NCT04445948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110955944|NCT04445948|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110955945|NCT04445948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110955946|NCT04445948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110955947|NCT04445948|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110955948|NCT04445948|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110955949|NCT04445948|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110955951|NCT02479646|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110955952|NCT02479646|Immunologic Factors|immunologic factors|mesh-ancestor
110955953|NCT02479646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110955954|NCT02467868|Lenograstim|lenograstim|mesh-list
110955955|NCT02467868|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110955956|NCT02467868|Immunologic Factors|immunologic factors|mesh-ancestor
110955957|NCT02467868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110955958|NCT02103465|Rotigotine|rotigotine|mesh-list
110955959|NCT02103465|Dopamine Agonists|dopamine agonists|mesh-ancestor
110955960|NCT02103465|Dopamine Agents|dopamine agents|mesh-ancestor
110955961|NCT02103465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110955962|NCT02103465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110955963|NCT02103465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110955964|NCT02102139|Propofol|propofol|mesh-list
110955965|NCT02102139|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110955966|NCT02102139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110955967|NCT02102139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110955968|NCT02102139|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110955969|NCT02102139|Anesthetics, General|anesthetics, general|mesh-ancestor
110955970|NCT02102139|Anesthetics|anesthetics|mesh-ancestor
110955971|NCT02102295|Ascorbic Acid|ascorbic acid|mesh-list
110955972|NCT02102295|Ascorbate-2-phosphate|ascorbate-2-phosphate|mesh-list
110955973|NCT02102295|Fluorides|fluorides|mesh-list
110955974|NCT02102295|Cariostatic Agents|cariostatic agents|mesh-ancestor
110955975|NCT02102295|Protective Agents|protective agents|mesh-ancestor
110955976|NCT02102295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110955977|NCT02102295|Antioxidants|antioxidants|mesh-ancestor
110955978|NCT02102295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110955979|NCT02102295|Vitamins|vitamins|mesh-ancestor
110955980|NCT02102295|Micronutrients|micronutrients|mesh-ancestor
110955981|NCT02102295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110955982|NCT02102373|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
110955983|NCT02102373|Laxatives|laxatives|mesh-ancestor
110955984|NCT02102373|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110955985|NCT02103777|Caffeine|caffeine|mesh-list
110955986|NCT02103777|Caffeine citrate|caffeine citrate|mesh-list
110955987|NCT02103777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110955988|NCT02103777|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110955989|NCT02103777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110955990|NCT02103777|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110955991|NCT02103777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110955992|NCT02103777|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110955993|NCT02103777|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110955994|NCT02103777|Purinergic Agents|purinergic agents|mesh-ancestor
110955995|NCT02103777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110955997|NCT02104011|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110955998|NCT02104011|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110955999|NCT02104011|Adrenergic Agents|adrenergic agents|mesh-ancestor
110956000|NCT02104011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110956001|NCT02104011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110956002|NCT02104011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110956003|NCT02104011|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110956004|NCT02104011|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110956005|NCT02104011|Vasodilator Agents|vasodilator agents|mesh-ancestor
110956006|NCT03554889|Nimotuzumab|nimotuzumab|mesh-list
110956007|NCT03554889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110956008|NCT03554889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110956009|NCT02251041|Tocopherols|tocopherols|mesh-list
110956010|NCT02251041|Vitamin E|vitamin e|mesh-list
110956011|NCT02251041|alpha-Tocopherol|alpha-tocopherol|mesh-list
110956012|NCT02251041|Infliximab|infliximab|mesh-list
110956013|NCT02251041|Epoprostenol|epoprostenol|mesh-list
110956014|NCT02251041|Tezosentan|tezosentan|mesh-list
110956015|NCT02251041|Melatonin|melatonin|mesh-list
110956016|NCT02251041|Antithrombins|antithrombins|mesh-list
110956017|NCT02251041|Antithrombin III|antithrombin iii|mesh-list
110956018|NCT02251041|Epoetin Alfa|epoetin alfa|mesh-list
110956019|NCT02251041|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
110956020|NCT02251041|Antioxidants|antioxidants|mesh-ancestor
110956021|NCT02251041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110956022|NCT02251041|Protective Agents|protective agents|mesh-ancestor
110956023|NCT02251041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110956024|NCT02251041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110956025|NCT02251041|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110956026|NCT02251041|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110956027|NCT02251041|Dermatologic Agents|dermatologic agents|mesh-ancestor
110956028|NCT02251041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110956029|NCT02251041|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110956030|NCT02251041|Hematinics|hematinics|mesh-ancestor
110956031|NCT02251041|Vitamins|vitamins|mesh-ancestor
110956032|NCT02251041|Micronutrients|micronutrients|mesh-ancestor
110956033|NCT02251041|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110956034|NCT02251041|Protease Inhibitors|protease inhibitors|mesh-ancestor
110956035|NCT02251041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110956036|NCT02251041|Anticoagulants|anticoagulants|mesh-ancestor
110956037|NCT02251041|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110956038|NCT02251041|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110956039|NCT02251041|Vasodilator Agents|vasodilator agents|mesh-ancestor
110956040|NCT02251041|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
110956041|NCT02251041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110956042|NCT02251041|Immunologic Factors|immunologic factors|mesh-ancestor
110956043|NCT02104323|Endostatins|endostatins|mesh-list
110956044|NCT02104323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110956045|NCT02104323|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110956046|NCT02104323|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110956047|NCT02104323|Growth Substances|growth substances|mesh-ancestor
110956048|NCT02104323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110956049|NCT02104323|Growth Inhibitors|growth inhibitors|mesh-ancestor
110956050|NCT02107365|Interferons|interferons|mesh-list
110956051|NCT02107365|Ribavirin|ribavirin|mesh-list
110956052|NCT02107365|Interferon-alpha|interferon-alpha|mesh-list
110956053|NCT02107365|Interferon alpha-2|interferon alpha-2|mesh-list
110956054|NCT02107365|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110956055|NCT02107365|Asunaprevir|asunaprevir|mesh-list
110956056|NCT02107365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110956057|NCT02107365|Antiviral Agents|antiviral agents|mesh-ancestor
110956058|NCT02107365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110956059|NCT02107365|Antimetabolites|antimetabolites|mesh-ancestor
110956060|NCT02107365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110956061|NCT02107365|Immunologic Factors|immunologic factors|mesh-ancestor
110956062|NCT02107365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110956063|NCT02107365|Protease Inhibitors|protease inhibitors|mesh-ancestor
110956064|NCT02107365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110956065|NCT02110719|Acetaminophen|acetaminophen|mesh-list
110956066|NCT02110719|Dexamethasone|dexamethasone|mesh-list
110956067|NCT02110719|Ibuprofen|ibuprofen|mesh-list
110956068|NCT02110719|Celecoxib|celecoxib|mesh-list
110956069|NCT02110719|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
110956070|NCT02110719|Oxycodone|oxycodone|mesh-list
110956071|NCT02110719|Gabapentin|gabapentin|mesh-list
110956072|NCT02110719|Hydromorphone|hydromorphone|mesh-list
110956073|NCT02110719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110956074|NCT02110719|Antiemetics|antiemetics|mesh-ancestor
110956075|NCT02110719|Autonomic Agents|autonomic agents|mesh-ancestor
110956076|NCT02110719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110956077|NCT02110719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110956078|NCT02110719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110956079|NCT02110719|Glucocorticoids|glucocorticoids|mesh-ancestor
110956080|NCT02110719|Hormones|hormones|mesh-ancestor
110956081|NCT02110719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110956082|NCT02110719|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110956083|NCT02110719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110956084|NCT02110719|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110956085|NCT02110719|Analgesics|analgesics|mesh-ancestor
110956086|NCT02110719|Sensory System Agents|sensory system agents|mesh-ancestor
110956087|NCT02110719|Antipyretics|antipyretics|mesh-ancestor
110956088|NCT02110719|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110956089|NCT02110719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110956090|NCT02110719|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110956091|NCT02110719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110956092|NCT02110719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110956093|NCT02110719|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110956094|NCT02110719|Narcotics|narcotics|mesh-ancestor
110956095|NCT02110719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110956096|NCT02110719|Anticonvulsants|anticonvulsants|mesh-ancestor
110668105|NCT04001712|Caffeine|caffeine|mesh-list
110956097|NCT02110719|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110956098|NCT02110719|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110956099|NCT02110719|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110956100|NCT02110719|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110956101|NCT02110719|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110956102|NCT02110719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110956103|NCT02110719|Antimanic Agents|antimanic agents|mesh-ancestor
110956104|NCT02110719|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110956106|NCT02105103|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110956107|NCT02105103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110956108|NCT03012165|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110956109|NCT03012165|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110956110|NCT02107755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110956111|NCT02107755|Ipilimumab|ipilimumab|mesh-list
110956112|NCT02107755|Antibodies|antibodies|mesh-list
110956113|NCT02107755|Immunoglobulins|immunoglobulins|mesh-list
110956114|NCT02107755|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110956115|NCT02107755|Immunologic Factors|immunologic factors|mesh-ancestor
110956116|NCT02107755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110956117|NCT02107755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110956118|NCT02107755|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110956119|NCT02107755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110956120|NCT02110953|Irinotecan|irinotecan|mesh-list
110956121|NCT02110953|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110956122|NCT02110953|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110956123|NCT02110953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110956124|NCT02110953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110956125|NCT02110953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110956126|NCT03554109|Leucovorin|leucovorin|mesh-list
110956127|NCT03554109|Paclitaxel|paclitaxel|mesh-list
110956128|NCT03554109|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110956129|NCT03554109|Cyclophosphamide|cyclophosphamide|mesh-list
110956130|NCT03554109|Doxorubicin|doxorubicin|mesh-list
110956131|NCT03554109|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110956132|NCT03554109|Fluorouracil|fluorouracil|mesh-list
110956133|NCT03554109|Avelumab|avelumab|mesh-list
110956134|NCT03554109|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110956135|NCT03554109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110956136|NCT03554109|Tubulin Modulators|tubulin modulators|mesh-ancestor
110956137|NCT03554109|Antimitotic Agents|antimitotic agents|mesh-ancestor
111203414|NCT04025775|Insulin|insulin|mesh-list
110956138|NCT03554109|Mitosis Modulators|mitosis modulators|mesh-ancestor
110956139|NCT03554109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110956140|NCT03554109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110956141|NCT03554109|Immunologic Factors|immunologic factors|mesh-ancestor
110956142|NCT03554109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110956143|NCT03554109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110956144|NCT03554109|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110956145|NCT03554109|Alkylating Agents|alkylating agents|mesh-ancestor
110956146|NCT03554109|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110956147|NCT03554109|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110956148|NCT03554109|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110956149|NCT03554109|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110956150|NCT03554109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110956151|NCT03554109|Antimetabolites|antimetabolites|mesh-ancestor
110956152|NCT03554109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110956153|NCT03554109|Antidotes|antidotes|mesh-ancestor
110956154|NCT03554109|Protective Agents|protective agents|mesh-ancestor
110956155|NCT03554109|Vitamin B Complex|vitamin b complex|mesh-ancestor
110956156|NCT03554109|Vitamins|vitamins|mesh-ancestor
110956157|NCT03554109|Micronutrients|micronutrients|mesh-ancestor
110956158|NCT03554109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110956159|NCT03554031|Hormones|hormones|mesh-list
110956160|NCT03554031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110956161|NCT03554031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110956162|NCT02111265|Sufentanil|sufentanil|mesh-list
110956163|NCT02111265|Remifentanil|remifentanil|mesh-list
110956164|NCT02111265|Cisatracurium|cisatracurium|mesh-list
110956165|NCT02111265|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110956166|NCT02111265|Narcotics|narcotics|mesh-ancestor
110956167|NCT02111265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110956168|NCT02111265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110956169|NCT02111265|Analgesics|analgesics|mesh-ancestor
110956170|NCT02111265|Sensory System Agents|sensory system agents|mesh-ancestor
110956171|NCT02111265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110668178|NCT03339258|Doxazosin|doxazosin|mesh-list
110956172|NCT02111265|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110956173|NCT02111265|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110956174|NCT02111265|Anesthetics, General|anesthetics, general|mesh-ancestor
110956175|NCT02111265|Anesthetics|anesthetics|mesh-ancestor
110956176|NCT02111265|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110956177|NCT02111265|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110956178|NCT02251119|Ritonavir|ritonavir|mesh-list
110956179|NCT02251119|Tipranavir|tipranavir|mesh-list
110956180|NCT02251119|Loperamide|loperamide|mesh-list
110956181|NCT02251119|Antidiarrheals|antidiarrheals|mesh-list
110956182|NCT02251119|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110956183|NCT02251119|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110956184|NCT02251119|Protease Inhibitors|protease inhibitors|mesh-ancestor
110956185|NCT02251119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110956186|NCT02251119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110956187|NCT02251119|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110956188|NCT02251119|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110956189|NCT02251119|Antiviral Agents|antiviral agents|mesh-ancestor
110956190|NCT02251119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110956191|NCT02251119|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110956192|NCT02251119|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110956193|NCT02251119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110956194|NCT02105493|Nitroglycerin|nitroglycerin|mesh-list
110956195|NCT02105493|Vasodilator Agents|vasodilator agents|mesh-ancestor
110956196|NCT02111421|Dexmedetomidine|dexmedetomidine|mesh-list
110956197|NCT02111421|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110956198|NCT02111421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110956199|NCT02111421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110956200|NCT02111421|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110956201|NCT02111421|Analgesics|analgesics|mesh-ancestor
110956202|NCT02111421|Sensory System Agents|sensory system agents|mesh-ancestor
110956203|NCT02111421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110956204|NCT02111421|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110956205|NCT02111421|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110956206|NCT02111421|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110956207|NCT02111421|Adrenergic Agents|adrenergic agents|mesh-ancestor
110956208|NCT02111421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110956209|NCT02111421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110956210|NCT02108301|Cyclosporine|cyclosporine|mesh-list
110956211|NCT02108301|Tacrolimus|tacrolimus|mesh-list
110956212|NCT02108301|Cyclosporins|cyclosporins|mesh-list
110956213|NCT02108301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110956214|NCT02108301|Immunologic Factors|immunologic factors|mesh-ancestor
110956215|NCT02108301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110956216|NCT02108301|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110956217|NCT02108301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110956218|NCT02108301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110956219|NCT02108301|Antifungal Agents|antifungal agents|mesh-ancestor
110956220|NCT02108301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110956221|NCT02108301|Dermatologic Agents|dermatologic agents|mesh-ancestor
110956222|NCT02108301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110956223|NCT02108535|Sulfadiazine|sulfadiazine|mesh-list
110956224|NCT02108535|Silver Sulfadiazine|silver sulfadiazine|mesh-list
110956225|NCT02108535|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110956226|NCT02108535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110956227|NCT02108535|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110956228|NCT02108535|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110956229|NCT02108535|Coccidiostats|coccidiostats|mesh-ancestor
110956230|NCT02108535|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110956231|NCT02114073|Cyclosporine|cyclosporine|mesh-list
110956232|NCT02114073|Betamethasone|betamethasone|mesh-list
110956233|NCT02114073|Cyclosporins|cyclosporins|mesh-list
110956234|NCT02114073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110956235|NCT02114073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110956236|NCT02114073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110956237|NCT02114073|Immunologic Factors|immunologic factors|mesh-ancestor
110956238|NCT02114073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110956239|NCT02114073|Antifungal Agents|antifungal agents|mesh-ancestor
110956240|NCT02114073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110956241|NCT02114073|Dermatologic Agents|dermatologic agents|mesh-ancestor
110956242|NCT02114073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110956243|NCT02114073|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110956244|NCT02114073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110956245|NCT02114073|Glucocorticoids|glucocorticoids|mesh-ancestor
110956246|NCT02114073|Hormones|hormones|mesh-ancestor
110956247|NCT02114073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110956248|NCT02114073|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110956249|NCT02114073|Respiratory System Agents|respiratory system agents|mesh-ancestor
110956250|NCT02114463|Flurbiprofen|flurbiprofen|mesh-list
110956252|NCT02114463|Ropivacaine|ropivacaine|mesh-list
110956253|NCT02114463|Anesthetics, Local|anesthetics, local|mesh-ancestor
110956254|NCT02114463|Anesthetics|anesthetics|mesh-ancestor
110956255|NCT02114463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110956256|NCT02114463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110956257|NCT02114463|Sensory System Agents|sensory system agents|mesh-ancestor
110956258|NCT02114463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110956259|NCT02114463|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110956260|NCT02114463|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110956261|NCT02114463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110956262|NCT02114463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110956263|NCT02114463|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110956264|NCT02114463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110956265|NCT02114463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110956266|NCT02114697|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110956267|NCT02114697|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110956268|NCT02114697|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110956269|NCT02114697|Antimetabolites|antimetabolites|mesh-ancestor
110956270|NCT02114697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110956271|NCT02114697|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110956272|NCT02114697|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110956273|NCT02114697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110956274|NCT02114775|Sildenafil Citrate|sildenafil citrate|mesh-list
110956275|NCT02114775|Hormones|hormones|mesh-list
110956276|NCT02114775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110956277|NCT02114775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110956278|NCT02114775|Vasodilator Agents|vasodilator agents|mesh-ancestor
110956279|NCT02114775|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110956280|NCT02114775|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110956281|NCT02114775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110956282|NCT02114775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110956283|NCT02114775|Urological Agents|urological agents|mesh-ancestor
110956284|NCT02108847|Ropivacaine|ropivacaine|mesh-list
110956285|NCT02108847|Anesthetics, Local|anesthetics, local|mesh-ancestor
110956286|NCT02108847|Anesthetics|anesthetics|mesh-ancestor
110956287|NCT02108847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110956288|NCT02108847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110956289|NCT02108847|Sensory System Agents|sensory system agents|mesh-ancestor
110956290|NCT02108847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110956291|NCT03553329|Trametinib|trametinib|mesh-list
110956292|NCT03553329|Dabrafenib|dabrafenib|mesh-list
110956293|NCT03553329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110956294|NCT03553329|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110956295|NCT03553329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110956296|NCT03553329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110956297|NCT02115087|Morphine|morphine|mesh-list
110956298|NCT02115087|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110956299|NCT02115087|Narcotics|narcotics|mesh-ancestor
110956300|NCT02115087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110956301|NCT02115087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110956302|NCT02115087|Analgesics|analgesics|mesh-ancestor
110956303|NCT02115087|Sensory System Agents|sensory system agents|mesh-ancestor
110956304|NCT02115087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110956305|NCT02115243|Ipilimumab|ipilimumab|mesh-list
110956306|NCT02115243|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110956307|NCT02115243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110956308|NCT02115243|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110956309|NCT02115243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110956310|NCT02109315|Liraglutide|liraglutide|mesh-list
110956311|NCT02109315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110956312|NCT02109315|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110956313|NCT02109315|Incretins|incretins|mesh-ancestor
110956314|NCT02109315|Hormones|hormones|mesh-ancestor
110956315|NCT02109315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110956316|NCT02112903|Vortioxetine|vortioxetine|mesh-list
110956317|NCT02112903|Antidepressive Agents|antidepressive agents|mesh-ancestor
110956318|NCT02112903|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110956319|NCT02112903|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110956320|NCT02112903|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110956321|NCT02112903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110956322|NCT02112903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110956323|NCT02112903|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110956324|NCT02112903|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110956325|NCT02112903|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110956326|NCT02112903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110956327|NCT02112903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110956328|NCT02112903|Serotonin Agents|serotonin agents|mesh-ancestor
110956329|NCT02112903|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110956330|NCT02112903|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110956331|NCT02112903|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110956332|NCT02112903|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110956333|NCT02112981|Sirolimus|sirolimus|mesh-list
110956334|NCT02112981|Everolimus|everolimus|mesh-list
110956335|NCT02112981|MTOR Inhibitors|mtor inhibitors|mesh-list
110956336|NCT02112981|Temsirolimus|temsirolimus|mesh-list
110956337|NCT02112981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110956338|NCT02112981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110956339|NCT02112981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110956340|NCT02112981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110956341|NCT02112981|Immunologic Factors|immunologic factors|mesh-ancestor
110956342|NCT02112981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110956343|NCT02112981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110956344|NCT02112981|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110956345|NCT02112981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110956346|NCT02112981|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110956347|NCT02112981|Antifungal Agents|antifungal agents|mesh-ancestor
110956348|NCT02113137|Chlorine dioxide|chlorine dioxide|mesh-list
110956349|NCT02113137|Dental Disinfectants|dental disinfectants|mesh-ancestor
110956350|NCT02113137|Disinfectants|disinfectants|mesh-ancestor
110956351|NCT02113137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110956352|NCT02116257|Propacetamol|propacetamol|mesh-list
110956353|NCT02116257|Analgesics|analgesics|mesh-ancestor
110956354|NCT02116257|Sensory System Agents|sensory system agents|mesh-ancestor
110956355|NCT02116257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110956356|NCT02116257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110956357|NCT02116257|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110956358|NCT02116257|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110956359|NCT02116257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110956360|NCT02116257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110956361|NCT02109627|Cytarabine|cytarabine|mesh-list
110956362|NCT02109627|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110956363|NCT02109627|Antimetabolites|antimetabolites|mesh-ancestor
110956364|NCT02109627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110956365|NCT02109627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110956366|NCT02109627|Antiviral Agents|antiviral agents|mesh-ancestor
110956367|NCT02109627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110956368|NCT02109627|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110956369|NCT02109627|Immunologic Factors|immunologic factors|mesh-ancestor
110956370|NCT02109627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110956371|NCT02116569|Daratumumab|daratumumab|mesh-list
110956372|NCT02116569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110956373|NCT02109783|Caffeine|caffeine|mesh-list
110956374|NCT02109783|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110956375|NCT02109783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110956376|NCT02109783|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110956377|NCT02109783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110956378|NCT02109783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110956379|NCT02109783|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110956380|NCT02109783|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110956381|NCT02109783|Purinergic Agents|purinergic agents|mesh-ancestor
110956382|NCT02109783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110956383|NCT02109861|Dexamethasone|dexamethasone|mesh-list
110956384|NCT02109861|Bortezomib|bortezomib|mesh-list
110956385|NCT02109861|Melphalan|melphalan|mesh-list
110956386|NCT02109861|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110956387|NCT02109861|Antiemetics|antiemetics|mesh-ancestor
110956388|NCT02109861|Autonomic Agents|autonomic agents|mesh-ancestor
110956389|NCT02109861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110956390|NCT02109861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110956391|NCT02109861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110956392|NCT02109861|Glucocorticoids|glucocorticoids|mesh-ancestor
110956393|NCT02109861|Hormones|hormones|mesh-ancestor
110956394|NCT02109861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110956395|NCT02109861|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110956396|NCT02109861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110956397|NCT02109861|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110668399|NCT00999180|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110956398|NCT02109861|Alkylating Agents|alkylating agents|mesh-ancestor
110956399|NCT02109861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110956400|NCT02109861|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110956401|NCT02109861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110956402|NCT02109861|Immunologic Factors|immunologic factors|mesh-ancestor
110956403|NCT02118753|Eplerenone|eplerenone|mesh-list
110956404|NCT02118753|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110956405|NCT02118753|Hormone Antagonists|hormone antagonists|mesh-ancestor
110956406|NCT02118753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110956407|NCT02118753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110956408|NCT02118753|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110956409|NCT02118753|Diuretics|diuretics|mesh-ancestor
110956410|NCT02118753|Natriuretic Agents|natriuretic agents|mesh-ancestor
110956411|NCT02118753|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110956412|NCT02118909|Itraconazole|itraconazole|mesh-list
110956413|NCT02118909|Ciprofloxacin|ciprofloxacin|mesh-list
110956414|NCT02118909|Antifungal Agents|antifungal agents|mesh-ancestor
110956415|NCT02118909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110956416|NCT02118909|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110956417|NCT02118909|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110956418|NCT02118909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110956419|NCT02118909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110956420|NCT02118909|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110956421|NCT02118909|Hormone Antagonists|hormone antagonists|mesh-ancestor
110956422|NCT02118909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110778622|NCT03727646|Niacinamide|niacinamide|mesh-list
110956423|NCT02118909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110956424|NCT02118909|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110956425|NCT02118909|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110956426|NCT02118909|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110956427|NCT02118909|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110956428|NCT02118909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110956429|NCT02118909|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110956430|NCT02118987|Omalizumab|omalizumab|mesh-list
110956431|NCT02118987|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110956432|NCT02118987|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110956433|NCT02118987|Respiratory System Agents|respiratory system agents|mesh-ancestor
110956434|NCT02119143|Vitamins|vitamins|mesh-list
110956435|NCT02119143|Micronutrients|micronutrients|mesh-ancestor
110956436|NCT02119143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110956437|NCT02116959|Carboplatin|carboplatin|mesh-list
110956438|NCT02116959|Etoposide|etoposide|mesh-list
110956439|NCT02116959|Vincristine|vincristine|mesh-list
110956440|NCT02116959|Melphalan|melphalan|mesh-list
110956441|NCT02116959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110956442|NCT02116959|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110956443|NCT02116959|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110956444|NCT02116959|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110956445|NCT02116959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110956446|NCT02116959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110956447|NCT02116959|Tubulin Modulators|tubulin modulators|mesh-ancestor
110956448|NCT02116959|Antimitotic Agents|antimitotic agents|mesh-ancestor
110956449|NCT02116959|Mitosis Modulators|mitosis modulators|mesh-ancestor
110956450|NCT02116959|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110956451|NCT02116959|Alkylating Agents|alkylating agents|mesh-ancestor
110956452|NCT02116959|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110956453|NCT02116959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110956454|NCT02116959|Immunologic Factors|immunologic factors|mesh-ancestor
110956455|NCT02116959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110956456|NCT03553173|Bupropion|bupropion|mesh-list
110956457|NCT03553173|Varenicline|varenicline|mesh-list
110956458|NCT03553173|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110956459|NCT03553173|Antidepressive Agents|antidepressive agents|mesh-ancestor
110956460|NCT03553173|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110956461|NCT03553173|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110956462|NCT03553173|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110956463|NCT03553173|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110956464|NCT03553173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110956465|NCT03553173|Dopamine Agents|dopamine agents|mesh-ancestor
110956466|NCT03553173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110956467|NCT03553173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110956468|NCT03553173|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110956469|NCT03553173|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110956470|NCT03553173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110956471|NCT03553173|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110956472|NCT03553173|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110956473|NCT03553173|Cholinergic Agents|cholinergic agents|mesh-ancestor
110956475|NCT01330017|Phenylephrine|phenylephrine|mesh-list
110956476|NCT01330017|Oxymetazoline|oxymetazoline|mesh-list
110956477|NCT01330017|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110956478|NCT01330017|Mydriatics|mydriatics|mesh-ancestor
110956479|NCT01330017|Autonomic Agents|autonomic agents|mesh-ancestor
110956480|NCT01330017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110956481|NCT01330017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110956482|NCT01330017|Sympathomimetics|sympathomimetics|mesh-ancestor
110956483|NCT01330017|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110956484|NCT01330017|Nasal Decongestants|nasal decongestants|mesh-ancestor
110956485|NCT01330017|Respiratory System Agents|respiratory system agents|mesh-ancestor
110956486|NCT01330017|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110956487|NCT01330017|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110956488|NCT01330017|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110956489|NCT01330017|Adrenergic Agents|adrenergic agents|mesh-ancestor
110956490|NCT01330017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110956491|NCT01330017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110956492|NCT01330017|Protective Agents|protective agents|mesh-ancestor
110956493|NCT01330017|Antipruritics|antipruritics|mesh-ancestor
110956494|NCT01330017|Dermatologic Agents|dermatologic agents|mesh-ancestor
110956495|NCT01330017|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110956496|NCT01330017|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110956497|NCT01330017|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110956498|NCT01330017|Histamine Antagonists|histamine antagonists|mesh-ancestor
110956499|NCT01330017|Histamine Agents|histamine agents|mesh-ancestor
110956500|NCT02117583|Oxycodone|oxycodone|mesh-list
110956501|NCT02117583|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110956502|NCT02117583|Narcotics|narcotics|mesh-ancestor
110956503|NCT02117583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110956504|NCT02117583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110956505|NCT02117583|Analgesics|analgesics|mesh-ancestor
110956506|NCT02117583|Sensory System Agents|sensory system agents|mesh-ancestor
110956507|NCT02117583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110956508|NCT02117739|Dapsone|dapsone|mesh-list
110956509|NCT02117739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110956510|NCT02117739|Antimalarials|antimalarials|mesh-ancestor
110956511|NCT02117739|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110956512|NCT02117739|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110956513|NCT02117739|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110956514|NCT02117739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110956515|NCT02117739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110956516|NCT02117739|Leprostatic Agents|leprostatic agents|mesh-ancestor
110956517|NCT02117739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110956518|NCT02251509|Metoprolol|metoprolol|mesh-list
110956519|NCT02251509|Carvedilol|carvedilol|mesh-list
110956520|NCT02251509|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110956521|NCT02251509|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110956522|NCT02251509|Sympatholytics|sympatholytics|mesh-ancestor
110956523|NCT02251509|Autonomic Agents|autonomic agents|mesh-ancestor
110956524|NCT02251509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110956525|NCT02251509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110956526|NCT02251509|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110956527|NCT02251509|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110956528|NCT02251509|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110956529|NCT02251509|Adrenergic Agents|adrenergic agents|mesh-ancestor
110956530|NCT02251509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110956531|NCT02251509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110956532|NCT02251509|Antioxidants|antioxidants|mesh-ancestor
110956533|NCT02251509|Protective Agents|protective agents|mesh-ancestor
110956534|NCT02251509|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110956535|NCT02251509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110956536|NCT02251509|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110956537|NCT02251509|Vasodilator Agents|vasodilator agents|mesh-ancestor
110956538|NCT02251509|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110956539|NCT02251509|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110956540|NCT02986659|Metformin|metformin|mesh-list
110956541|NCT02986659|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110956542|NCT02986659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110956543|NCT02118051|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
110956544|NCT02118051|Progesterone|progesterone|mesh-list
110956545|NCT02118051|Ganirelix|ganirelix|mesh-list
110956546|NCT02118051|Progestins|progestins|mesh-ancestor
110956547|NCT02118051|Hormones|hormones|mesh-ancestor
110956548|NCT02118051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110956549|NCT02118051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110956550|NCT02118051|Hormone Antagonists|hormone antagonists|mesh-ancestor
110956551|NCT02118051|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110956552|NCT02123355|Dexmedetomidine|dexmedetomidine|mesh-list
110956553|NCT02123355|Remifentanil|remifentanil|mesh-list
110956554|NCT02123355|Sevoflurane|sevoflurane|mesh-list
110956555|NCT02123355|Vecuronium Bromide|vecuronium bromide|mesh-list
110956556|NCT02123355|Anesthetics|anesthetics|mesh-ancestor
110956557|NCT02123355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110956558|NCT02123355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110956559|NCT02123355|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110956560|NCT02123355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110956561|NCT02123355|Analgesics|analgesics|mesh-ancestor
110956562|NCT02123355|Sensory System Agents|sensory system agents|mesh-ancestor
110956563|NCT02123355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110956564|NCT02123355|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110956565|NCT02123355|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110956566|NCT02123355|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110956567|NCT02123355|Adrenergic Agents|adrenergic agents|mesh-ancestor
110956568|NCT02123355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110956569|NCT02123355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110956570|NCT02123355|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110956571|NCT02123355|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110956572|NCT02123355|Anesthetics, General|anesthetics, general|mesh-ancestor
110956573|NCT02123355|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110956574|NCT02123355|Narcotics|narcotics|mesh-ancestor
110956575|NCT02123355|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110956576|NCT02123355|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110956577|NCT02123355|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110956578|NCT02123355|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
110956579|NCT02123355|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110956580|NCT02123355|Cholinergic Agents|cholinergic agents|mesh-ancestor
110956581|NCT02123433|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110956582|NCT02123433|Immunologic Factors|immunologic factors|mesh-ancestor
110956583|NCT02123433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110956584|NCT02123589|Fentanyl|fentanyl|mesh-list
110956585|NCT02123589|Midazolam|midazolam|mesh-list
110956586|NCT02123589|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110956587|NCT02123589|Narcotics|narcotics|mesh-ancestor
110956588|NCT02123589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110956589|NCT02123589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110956590|NCT02123589|Analgesics|analgesics|mesh-ancestor
110956591|NCT02123589|Sensory System Agents|sensory system agents|mesh-ancestor
110956592|NCT02123589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110956593|NCT02123589|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110956594|NCT02123589|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110956595|NCT02123589|Anesthetics, General|anesthetics, general|mesh-ancestor
110956596|NCT02123589|Anesthetics|anesthetics|mesh-ancestor
110956597|NCT02123589|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110956598|NCT02123589|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110956599|NCT02123589|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110956600|NCT02123589|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110956601|NCT02123589|GABA Modulators|gaba modulators|mesh-ancestor
110956602|NCT02123589|GABA Agents|gaba agents|mesh-ancestor
110956603|NCT02123589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110956604|NCT02123589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110956605|NCT02120547|Cenicriviroc|cenicriviroc|mesh-list
110956606|NCT02120547|Liver Extracts|liver extracts|mesh-list
110956607|NCT02120547|Hematinics|hematinics|mesh-ancestor
110956608|NCT02120547|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
110956609|NCT02120547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110956610|NCT02120547|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110956611|NCT02120547|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110956612|NCT02120547|Antiviral Agents|antiviral agents|mesh-ancestor
110956613|NCT02120547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110956614|NCT02120703|Pregabalin|pregabalin|mesh-list
110956615|NCT02120703|Gabapentin|gabapentin|mesh-list
110956616|NCT02120703|Analgesics|analgesics|mesh-ancestor
110956617|NCT02120703|Sensory System Agents|sensory system agents|mesh-ancestor
110956618|NCT02120703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110956619|NCT02120703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110956620|NCT02120703|Anticonvulsants|anticonvulsants|mesh-ancestor
110956621|NCT02120703|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110956622|NCT02120703|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110956623|NCT02120703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110956624|NCT02120703|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110956625|NCT02120703|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110956626|NCT02120703|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110956627|NCT02120703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110956628|NCT02120703|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110956629|NCT02120703|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110956630|NCT02120703|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110956631|NCT02120703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110956632|NCT02120703|Antimanic Agents|antimanic agents|mesh-ancestor
110956633|NCT02118285|Cyclophosphamide|cyclophosphamide|mesh-list
110956634|NCT02118285|Fludarabine|fludarabine|mesh-list
110956635|NCT02118285|Interleukin-2|interleukin-2|mesh-list
110956636|NCT02118285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110956637|NCT02118285|Immunologic Factors|immunologic factors|mesh-ancestor
110956638|NCT02118285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110956639|NCT02118285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110956640|NCT02118285|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110956641|NCT02118285|Alkylating Agents|alkylating agents|mesh-ancestor
110956642|NCT02118285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110956643|NCT02118285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110956644|NCT02118285|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110956645|NCT02118285|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110956646|NCT02118285|Analgesics|analgesics|mesh-ancestor
110956647|NCT02118285|Sensory System Agents|sensory system agents|mesh-ancestor
110956648|NCT02118285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110956649|NCT02118675|Deuterium Oxide|deuterium oxide|mesh-list
110956650|NCT02118675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110956651|NCT02118675|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110956652|NCT02118675|Protective Agents|protective agents|mesh-ancestor
110956653|NCT02118675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110956654|NCT02123979|Rotigotine|rotigotine|mesh-list
110956655|NCT02123979|Dopamine Agonists|dopamine agonists|mesh-ancestor
110956656|NCT02123979|Dopamine Agents|dopamine agents|mesh-ancestor
110956657|NCT02123979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110956658|NCT02123979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110956659|NCT02123979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110956660|NCT03552315|Chromium|chromium|mesh-list
110956661|NCT03552315|Trace Elements|trace elements|mesh-ancestor
110956662|NCT03552315|Micronutrients|micronutrients|mesh-ancestor
110956663|NCT03552315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110956664|NCT02120859|Paclitaxel|paclitaxel|mesh-list
110956665|NCT02120859|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110956666|NCT02120859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110956667|NCT02120859|Tubulin Modulators|tubulin modulators|mesh-ancestor
110956668|NCT02120859|Antimitotic Agents|antimitotic agents|mesh-ancestor
110956669|NCT02120859|Mitosis Modulators|mitosis modulators|mesh-ancestor
110956670|NCT02120859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110956671|NCT02126943|Macitentan|macitentan|mesh-list
110956672|NCT02126943|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
110956673|NCT02126943|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
110956674|NCT02126943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110956675|NCT02126943|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
110956676|NCT03551847|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110956677|NCT03551847|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
110956678|NCT03551847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110956679|NCT03551847|Antitubercular Agents|antitubercular agents|mesh-ancestor
110956680|NCT00150462|Dexamethasone|dexamethasone|mesh-list
110956681|NCT00150462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110956682|NCT00150462|Antiemetics|antiemetics|mesh-ancestor
110956683|NCT00150462|Autonomic Agents|autonomic agents|mesh-ancestor
110956684|NCT00150462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110956685|NCT00150462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110956686|NCT00150462|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110956687|NCT00150462|Glucocorticoids|glucocorticoids|mesh-ancestor
110956688|NCT00150462|Hormones|hormones|mesh-ancestor
110956689|NCT00150462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110956690|NCT00150462|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110956691|NCT00150462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110956692|NCT00095550|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110956693|NCT00095550|Irbesartan|irbesartan|mesh-list
110956694|NCT00095550|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110956695|NCT00095550|Diuretics|diuretics|mesh-ancestor
110956696|NCT00095550|Natriuretic Agents|natriuretic agents|mesh-ancestor
110956697|NCT00095550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110956698|NCT00095550|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110956699|NCT00095550|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110956700|NCT00095550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110956701|NCT00095550|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110956702|NCT00095550|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110956703|NCT00095394|Irbesartan|irbesartan|mesh-list
110956704|NCT00095394|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110956705|NCT00095394|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110956706|NCT00095394|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110956707|NCT00095394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110956708|NCT00093132|Satraplatin|satraplatin|mesh-list
110956709|NCT00093132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110956710|NCT05717400|Ribavirin|ribavirin|mesh-list
110956711|NCT05717400|Sofosbuvir|sofosbuvir|mesh-list
110956712|NCT05717400|Velpatasvir|velpatasvir|mesh-list
110956713|NCT05717400|Bevacizumab|bevacizumab|mesh-list
110956714|NCT05717400|Atezolizumab|atezolizumab|mesh-list
110956715|NCT05717400|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110956716|NCT05717400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110956717|NCT05717400|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110956718|NCT05717400|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110956719|NCT05717400|Growth Substances|growth substances|mesh-ancestor
110956720|NCT05717400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110956721|NCT05717400|Growth Inhibitors|growth inhibitors|mesh-ancestor
110956722|NCT05717400|Antimetabolites|antimetabolites|mesh-ancestor
110956723|NCT05717400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110956724|NCT05717400|Antiviral Agents|antiviral agents|mesh-ancestor
110956725|NCT05717400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110956726|NCT05717400|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110956727|NCT00080106|Vaccines|vaccines|mesh-list
110956728|NCT00080106|Immunologic Factors|immunologic factors|mesh-ancestor
110956729|NCT00080106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110956730|NCT00333216|Hydrocortisone|hydrocortisone|mesh-list
110956731|NCT00333216|Anecortave|anecortave|mesh-list
110956732|NCT00333216|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110956733|NCT00333216|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110956734|NCT00333216|Growth Substances|growth substances|mesh-ancestor
110956735|NCT00333216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110956736|NCT00333216|Growth Inhibitors|growth inhibitors|mesh-ancestor
110956737|NCT00333216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110956738|NCT00333216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110956739|NCT00332748|Taxane|taxane|mesh-list
110956740|NCT00332748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110956741|NCT03530436|Curcumin|curcumin|mesh-list
110956742|NCT03530436|Turmeric extract|turmeric extract|mesh-list
110956743|NCT03530436|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110956744|NCT03530436|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110956745|NCT03530436|Analgesics|analgesics|mesh-ancestor
110956746|NCT03530436|Sensory System Agents|sensory system agents|mesh-ancestor
110956747|NCT03530436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110956748|NCT03530436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110956749|NCT03530436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110956750|NCT03530436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110956751|NCT03530436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110956752|NCT03530436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110956753|NCT03530436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110956754|NCT03530436|Antioxidants|antioxidants|mesh-ancestor
110956755|NCT03530436|Protective Agents|protective agents|mesh-ancestor
110956756|NCT03530280|Pregabalin|pregabalin|mesh-list
110956757|NCT03530280|Bupivacaine|bupivacaine|mesh-list
110956758|NCT03530280|Anesthetics, Local|anesthetics, local|mesh-ancestor
110956759|NCT03530280|Anesthetics|anesthetics|mesh-ancestor
110956760|NCT03530280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110956761|NCT03530280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110956762|NCT03530280|Sensory System Agents|sensory system agents|mesh-ancestor
110956763|NCT03530280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110956764|NCT03530280|Analgesics|analgesics|mesh-ancestor
110956765|NCT03530280|Anticonvulsants|anticonvulsants|mesh-ancestor
110956766|NCT03530280|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110956767|NCT03530280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110956768|NCT03530280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110956769|NCT03530280|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110956770|NCT03530280|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110956771|NCT03530280|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110956772|NCT03530280|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110956773|NCT00079482|Cytarabine|cytarabine|mesh-list
110956774|NCT00079482|Etoposide|etoposide|mesh-list
110956776|NCT00079482|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110956777|NCT00079482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110956778|NCT00079482|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110956779|NCT00079482|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110956780|NCT00079482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110956781|NCT00079482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110956782|NCT00079482|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110956783|NCT00079482|Antimetabolites|antimetabolites|mesh-ancestor
110956784|NCT00079482|Antiviral Agents|antiviral agents|mesh-ancestor
110956785|NCT00079482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110956786|NCT00079482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110956787|NCT00079482|Immunologic Factors|immunologic factors|mesh-ancestor
110956788|NCT00079482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110956789|NCT00079482|Analgesics|analgesics|mesh-ancestor
110956790|NCT00079482|Sensory System Agents|sensory system agents|mesh-ancestor
110956791|NCT00079482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110956792|NCT00073866|Celecoxib|celecoxib|mesh-list
110956793|NCT00073866|Docetaxel|docetaxel|mesh-list
110956794|NCT00073866|Irinotecan|irinotecan|mesh-list
110956795|NCT00073866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110956796|NCT00073866|Tubulin Modulators|tubulin modulators|mesh-ancestor
110956797|NCT00073866|Antimitotic Agents|antimitotic agents|mesh-ancestor
110956798|NCT00073866|Mitosis Modulators|mitosis modulators|mesh-ancestor
110956799|NCT00073866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110956800|NCT00073866|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110956801|NCT00073866|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110956802|NCT00073866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110956803|NCT00073866|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110956804|NCT00073866|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110956805|NCT00073866|Analgesics|analgesics|mesh-ancestor
110956806|NCT00073866|Sensory System Agents|sensory system agents|mesh-ancestor
110956807|NCT00073866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110956808|NCT00073866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110956809|NCT00073866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110956810|NCT00073866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110956811|NCT00073866|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110956812|NCT00073866|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110956813|NCT00325650|Rimonabant|rimonabant|mesh-list
110956814|NCT00325650|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110956815|NCT00325650|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
110956816|NCT00325650|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110956817|NCT00325650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110956818|NCT00325650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110956819|NCT00325650|Hormones|hormones|mesh-ancestor
110956820|NCT00325650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110956821|NCT00325650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110956822|NCT00070590|Bosentan|bosentan|mesh-list
110956823|NCT00070590|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110956824|NCT00070590|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
110956825|NCT00070590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110956826|NCT00067782|Atazanavir Sulfate|atazanavir sulfate|mesh-list
110956827|NCT00067782|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110956828|NCT00067782|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110956829|NCT00067782|Protease Inhibitors|protease inhibitors|mesh-ancestor
110956830|NCT00067782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110956831|NCT00067782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110956832|NCT00067782|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110956833|NCT00067782|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110956834|NCT00067782|Antiviral Agents|antiviral agents|mesh-ancestor
110956835|NCT00067782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110956836|NCT00058266|Genistein|genistein|mesh-list
110956837|NCT00058266|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110956838|NCT00058266|Protective Agents|protective agents|mesh-ancestor
110956839|NCT00058266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110956840|NCT00058266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110956841|NCT00058266|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110956842|NCT00058266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110956843|NCT00058266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110956844|NCT00058266|Phytoestrogens|phytoestrogens|mesh-ancestor
110956845|NCT00058266|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
110956846|NCT00058266|Estrogens|estrogens|mesh-ancestor
110956847|NCT00058266|Hormones|hormones|mesh-ancestor
110668852|NCT00816959|Alkylating Agents|alkylating agents|mesh-ancestor
110956848|NCT00058266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110956849|NCT00313794|Tremelimumab|tremelimumab|mesh-list
110956850|NCT00313794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110956851|NCT00313248|Sagopilone|sagopilone|mesh-list
110956852|NCT00313248|Epothilones|epothilones|mesh-list
110956853|NCT00313248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110956854|NCT00313248|Tubulin Modulators|tubulin modulators|mesh-ancestor
110956855|NCT00313248|Antimitotic Agents|antimitotic agents|mesh-ancestor
110956856|NCT00313248|Mitosis Modulators|mitosis modulators|mesh-ancestor
110956857|NCT00313248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110956858|NCT00310830|Bosentan|bosentan|mesh-list
110956859|NCT00310830|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110956860|NCT00310830|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
110956861|NCT00310830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110956862|NCT00035568|Metformin|metformin|mesh-list
110956863|NCT00035568|Glyburide|glyburide|mesh-list
110956864|NCT00035568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110956865|NCT00035568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110956866|NCT00031512|Pleconaril|pleconaril|mesh-list
110956867|NCT00031512|Antiviral Agents|antiviral agents|mesh-ancestor
110956868|NCT00031512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110956869|NCT00307398|Hydrocortisone|hydrocortisone|mesh-list
110956870|NCT00307398|Anecortave|anecortave|mesh-list
110956871|NCT00307398|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110956872|NCT00307398|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110956873|NCT00307398|Growth Substances|growth substances|mesh-ancestor
110956874|NCT00307398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110956875|NCT00307398|Growth Inhibitors|growth inhibitors|mesh-ancestor
110956876|NCT00307398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110956877|NCT00307398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110956878|NCT01368081|Metformin|metformin|mesh-list
110956879|NCT01368081|Empagliflozin|empagliflozin|mesh-list
110956880|NCT01368081|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110956881|NCT01368081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110956882|NCT01368081|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110956883|NCT01368081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110956884|NCT02127489|Bupivacaine|bupivacaine|mesh-list
110956885|NCT02127489|Anesthetics, Local|anesthetics, local|mesh-ancestor
110956886|NCT02127489|Anesthetics|anesthetics|mesh-ancestor
110956887|NCT02127489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110956888|NCT02127489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110956889|NCT02127489|Sensory System Agents|sensory system agents|mesh-ancestor
110956890|NCT02127489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110956891|NCT00004914|Epoetin Alfa|epoetin alfa|mesh-list
110956892|NCT00004914|Hematinics|hematinics|mesh-ancestor
110956893|NCT00286806|Gossypol acetic acid|gossypol acetic acid|mesh-list
110956894|NCT00286806|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110956895|NCT00286806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110956896|NCT00286806|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110956897|NCT00286806|Contraceptive Agents|contraceptive agents|mesh-ancestor
110956898|NCT00286806|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110956899|NCT00286806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110956900|NCT00286806|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
110956901|NCT00286806|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
110956902|NCT00286806|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110956903|NCT00004908|Cyclophosphamide|cyclophosphamide|mesh-list
110956904|NCT00004908|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110956905|NCT00004908|Immunologic Factors|immunologic factors|mesh-ancestor
110956906|NCT00004908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110956907|NCT00004908|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110956908|NCT00004908|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110956909|NCT00004908|Alkylating Agents|alkylating agents|mesh-ancestor
110956910|NCT00004908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110956911|NCT00004908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110956912|NCT00004908|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110956913|NCT00004902|8-chloro-cyclic adenosine monophosphate|8-chloro-cyclic adenosine monophosphate|mesh-list
110956914|NCT00004902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110956915|NCT00004902|Immunologic Factors|immunologic factors|mesh-ancestor
110956916|NCT00004902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110956917|NCT04441398|Nitazoxanide|nitazoxanide|mesh-list
110956918|NCT04441398|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110956919|NCT04441398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110956920|NCT03551067|Midazolam|midazolam|mesh-list
110956921|NCT03551067|Dexmedetomidine|dexmedetomidine|mesh-list
110956922|NCT03551067|Ketamine|ketamine|mesh-list
110956923|NCT03551067|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110956924|NCT03551067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110956925|NCT03551067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110956926|NCT03551067|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110956927|NCT03551067|Analgesics|analgesics|mesh-ancestor
110956928|NCT03551067|Sensory System Agents|sensory system agents|mesh-ancestor
110956929|NCT03551067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110956930|NCT03551067|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110956931|NCT03551067|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110956932|NCT03551067|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110956933|NCT03551067|Adrenergic Agents|adrenergic agents|mesh-ancestor
110956934|NCT03551067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110956935|NCT03551067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110956936|NCT03551067|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110956937|NCT03551067|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110956938|NCT03551067|Anesthetics, General|anesthetics, general|mesh-ancestor
110956939|NCT03551067|Anesthetics|anesthetics|mesh-ancestor
110956940|NCT03551067|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110956941|NCT03551067|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110956942|NCT03551067|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110956943|NCT03551067|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110956944|NCT03551067|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110956945|NCT03551067|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110956946|NCT03551067|GABA Modulators|gaba modulators|mesh-ancestor
110956947|NCT03551067|GABA Agents|gaba agents|mesh-ancestor
110956948|NCT03529266|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
110956949|NCT03529266|Hemostatics|hemostatics|mesh-ancestor
110956950|NCT03529266|Coagulants|coagulants|mesh-ancestor
110956951|NCT02128191|Ibuprofen|ibuprofen|mesh-list
110956952|NCT02128191|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110956953|NCT02128191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110956954|NCT02128191|Analgesics|analgesics|mesh-ancestor
110956955|NCT02128191|Sensory System Agents|sensory system agents|mesh-ancestor
110956956|NCT02128191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110956957|NCT02128191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110956958|NCT02128191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110956959|NCT02128191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110956960|NCT02128191|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110956961|NCT02128191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110956962|NCT02128191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110956963|NCT00004896|Cyclophosphamide|cyclophosphamide|mesh-list
110956964|NCT00004896|Busulfan|busulfan|mesh-list
110956965|NCT00004896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110956966|NCT00004896|Immunologic Factors|immunologic factors|mesh-ancestor
110956967|NCT00004896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110956968|NCT00004896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110956969|NCT00004896|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110956970|NCT00004896|Alkylating Agents|alkylating agents|mesh-ancestor
110956971|NCT00004896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110956972|NCT00004896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110956973|NCT00004896|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110956974|NCT02121951|Lidocaine|lidocaine|mesh-list
110956975|NCT02121951|Fentanyl|fentanyl|mesh-list
110956976|NCT02121951|Midazolam|midazolam|mesh-list
110956977|NCT02121951|Anesthetics|anesthetics|mesh-list
110956978|NCT02121951|Levobupivacaine|levobupivacaine|mesh-list
110956979|NCT02121951|Anesthetics, Local|anesthetics, local|mesh-list
110956980|NCT02121951|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110956981|NCT02121951|Narcotics|narcotics|mesh-ancestor
110956982|NCT02121951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110956983|NCT02121951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110956984|NCT02121951|Analgesics|analgesics|mesh-ancestor
110956985|NCT02121951|Sensory System Agents|sensory system agents|mesh-ancestor
110956986|NCT02121951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110956987|NCT02121951|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110956988|NCT02121951|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110956989|NCT02121951|Anesthetics, General|anesthetics, general|mesh-ancestor
110956990|NCT02121951|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110956991|NCT02121951|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110956992|NCT02121951|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110956993|NCT02121951|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110956994|NCT02121951|GABA Modulators|gaba modulators|mesh-ancestor
110956995|NCT02121951|GABA Agents|gaba agents|mesh-ancestor
110956996|NCT02121951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110956997|NCT02121951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110956998|NCT02121951|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110956999|NCT02121951|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110957000|NCT02121951|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110957001|NCT02121951|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110957002|NCT05473858|Phentolamine|phentolamine|mesh-list
110957003|NCT05473858|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110957004|NCT05473858|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110957005|NCT05473858|Adrenergic Agents|adrenergic agents|mesh-ancestor
110957006|NCT05473858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110957007|NCT05473858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110957008|NCT05473858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110957009|NCT05473858|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110957010|NCT00004584|Ritonavir|ritonavir|mesh-list
110957011|NCT00004584|Atazanavir Sulfate|atazanavir sulfate|mesh-list
110957012|NCT00004584|Saquinavir|saquinavir|mesh-list
110957013|NCT00004584|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110957014|NCT00004584|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110957015|NCT00004584|Protease Inhibitors|protease inhibitors|mesh-ancestor
110957016|NCT00004584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110957017|NCT00004584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110957018|NCT00004584|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110957019|NCT00004584|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110957020|NCT00004584|Antiviral Agents|antiviral agents|mesh-ancestor
110697542|NCT03982173|Durvalumab|durvalumab|mesh-list
110957021|NCT00004584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110957022|NCT00004584|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110957023|NCT00004584|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110957024|NCT00004230|Cyclophosphamide|cyclophosphamide|mesh-list
110957025|NCT00004230|Captopril|captopril|mesh-list
110957026|NCT00004230|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110957027|NCT00004230|Immunologic Factors|immunologic factors|mesh-ancestor
110957028|NCT00004230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110957029|NCT00004230|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110957030|NCT00004230|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110957031|NCT00004230|Alkylating Agents|alkylating agents|mesh-ancestor
110957032|NCT00004230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110957033|NCT00004230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110957034|NCT00004230|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110957035|NCT00004230|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110957036|NCT00004230|Protease Inhibitors|protease inhibitors|mesh-ancestor
110957037|NCT00004230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110957038|NCT00004230|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110957039|NCT02252367|Tadalafil|tadalafil|mesh-list
110957040|NCT02252367|Vasodilator Agents|vasodilator agents|mesh-ancestor
110957041|NCT02252367|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110957042|NCT02252367|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110957043|NCT02252367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110022959|NCT00003240|Vinorelbine|vinorelbine|mesh-list
111203415|NCT04025775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110957044|NCT02252367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110957045|NCT02252367|Urological Agents|urological agents|mesh-ancestor
110957046|NCT00004182|Irinotecan|irinotecan|mesh-list
110957047|NCT00004182|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110957048|NCT00004182|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110957049|NCT00004182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110957050|NCT00004182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110957051|NCT00004182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110957052|NCT02124525|Acetylcysteine|acetylcysteine|mesh-list
110957053|NCT02124525|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110957054|NCT02124525|Antiviral Agents|antiviral agents|mesh-ancestor
110957055|NCT02124525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110957056|NCT02124525|Expectorants|expectorants|mesh-ancestor
110957057|NCT02124525|Respiratory System Agents|respiratory system agents|mesh-ancestor
110957058|NCT02124525|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110957059|NCT02124525|Antioxidants|antioxidants|mesh-ancestor
110957060|NCT02124525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110957061|NCT02124525|Protective Agents|protective agents|mesh-ancestor
110957062|NCT02124525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110957063|NCT02124525|Antidotes|antidotes|mesh-ancestor
110957064|NCT05725512|Prednisolone|prednisolone|mesh-list
110957065|NCT05725512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110957066|NCT05725512|Glucocorticoids|glucocorticoids|mesh-ancestor
110957067|NCT05725512|Hormones|hormones|mesh-ancestor
110957068|NCT05725512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110957069|NCT05725512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110957070|NCT05725512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110957071|NCT05725512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110957072|NCT02124681|Hydroxychloroquine|hydroxychloroquine|mesh-list
110957073|NCT02124681|Antimalarials|antimalarials|mesh-ancestor
110957074|NCT02124681|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110957075|NCT02124681|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110957076|NCT02124681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110957077|NCT02124681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110957078|NCT02124681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110957079|NCT02124681|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110957081|NCT02128425|Fluorouracil|fluorouracil|mesh-list
110957082|NCT02128425|Oxaliplatin|oxaliplatin|mesh-list
110957083|NCT02128425|Irinotecan|irinotecan|mesh-list
110957084|NCT02128425|Levoleucovorin|levoleucovorin|mesh-list
110957085|NCT02128425|Antimetabolites|antimetabolites|mesh-ancestor
110957086|NCT02128425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110957087|NCT02128425|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110957088|NCT02128425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110957089|NCT02128425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110957090|NCT02128425|Immunologic Factors|immunologic factors|mesh-ancestor
110957091|NCT02128425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110957092|NCT02128425|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110957093|NCT02128425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110957094|NCT02128425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110957095|NCT02128425|Antidotes|antidotes|mesh-ancestor
110957096|NCT02128425|Protective Agents|protective agents|mesh-ancestor
110957097|NCT02128425|Vitamin B Complex|vitamin b complex|mesh-ancestor
110957098|NCT02128425|Vitamins|vitamins|mesh-ancestor
110957099|NCT02128425|Micronutrients|micronutrients|mesh-ancestor
110957100|NCT03532620|Calcium, Dietary|calcium, dietary|mesh-list
110957101|NCT03532620|Atorvastatin|atorvastatin|mesh-list
110957102|NCT03532620|Pitavastatin|pitavastatin|mesh-list
110957103|NCT03532620|Calcium|calcium|mesh-list
110957104|NCT03532620|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110957105|NCT03532620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110957106|NCT03532620|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110957107|NCT03532620|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110957108|NCT03532620|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110957109|NCT03532620|Antimetabolites|antimetabolites|mesh-ancestor
110957110|NCT03532620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110957111|NCT03532620|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110957112|NCT03532620|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110957113|NCT03532620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110957114|NCT02288130|Ulipristal acetate|ulipristal acetate|mesh-list
110957115|NCT02288130|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110957116|NCT02288130|Contraceptive Agents|contraceptive agents|mesh-ancestor
110957117|NCT02288130|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110957118|NCT02288130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110957119|NCT02288130|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110957120|NCT03529032|Methadone|methadone|mesh-list
110957121|NCT03529032|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110957122|NCT03529032|Narcotics|narcotics|mesh-ancestor
110957123|NCT03529032|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110957124|NCT03529032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110957125|NCT03529032|Analgesics|analgesics|mesh-ancestor
110957126|NCT03529032|Sensory System Agents|sensory system agents|mesh-ancestor
110957127|NCT03529032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110957128|NCT03529032|Antitussive Agents|antitussive agents|mesh-ancestor
110957129|NCT03529032|Respiratory System Agents|respiratory system agents|mesh-ancestor
110957130|NCT02122731|Amiloride|amiloride|mesh-list
110957131|NCT02122731|Diuretics|diuretics|mesh-ancestor
110957132|NCT02122731|Natriuretic Agents|natriuretic agents|mesh-ancestor
110957133|NCT02122731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110957134|NCT02122731|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
110957135|NCT02122731|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110957136|NCT02122731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110957137|NCT02122731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110957138|NCT02122731|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
110957139|NCT02122731|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110957140|NCT05458726|Paclitaxel|paclitaxel|mesh-list
110957141|NCT05458726|Carboplatin|carboplatin|mesh-list
110957142|NCT05458726|Pemetrexed|pemetrexed|mesh-list
110957143|NCT05458726|Osimertinib|osimertinib|mesh-list
110957144|NCT05458726|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110957145|NCT05458726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110957146|NCT05458726|Tubulin Modulators|tubulin modulators|mesh-ancestor
110957147|NCT05458726|Antimitotic Agents|antimitotic agents|mesh-ancestor
110957148|NCT05458726|Mitosis Modulators|mitosis modulators|mesh-ancestor
110957149|NCT05458726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110957150|NCT05458726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110957151|NCT05458726|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110957152|NCT05458726|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110957153|NCT05458726|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110957154|NCT02122809|Chiauranib|chiauranib|mesh-list
110957155|NCT02122809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110957156|NCT02122809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110957157|NCT02122809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110957158|NCT02122809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110957159|NCT00150618|Guanfacine|guanfacine|mesh-list
110957160|NCT00150618|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110957161|NCT00150618|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110957162|NCT00150618|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110957163|NCT00150618|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110957164|NCT00150618|Adrenergic Agents|adrenergic agents|mesh-ancestor
110957165|NCT00150618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110957166|NCT00150618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110957167|NCT00150618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110957168|NCT03532464|Azithromycin|azithromycin|mesh-list
110957169|NCT03532464|Doxycycline|doxycycline|mesh-list
110957170|NCT03532464|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110957171|NCT03532464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110957172|NCT03532464|Antimalarials|antimalarials|mesh-ancestor
110957173|NCT03532464|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110957174|NCT03532464|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110957175|NCT02128893|Isavuconazole|isavuconazole|mesh-list
110957176|NCT02128893|Esomeprazole|esomeprazole|mesh-list
110957177|NCT02128893|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110957178|NCT02128893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110957179|NCT02128893|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110957180|NCT02128893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110957181|NCT02128893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110957182|NCT02128893|Antifungal Agents|antifungal agents|mesh-ancestor
110957183|NCT02128893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110957184|NCT02124369|Paclitaxel|paclitaxel|mesh-list
110957185|NCT02124369|Gemcitabine|gemcitabine|mesh-list
110957186|NCT02124369|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110957187|NCT02124369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110957188|NCT02124369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110957189|NCT02124369|Tubulin Modulators|tubulin modulators|mesh-ancestor
110957190|NCT02124369|Antimitotic Agents|antimitotic agents|mesh-ancestor
110957191|NCT02124369|Mitosis Modulators|mitosis modulators|mesh-ancestor
110957192|NCT02124369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110957193|NCT02124369|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110957194|NCT02124369|Antimetabolites|antimetabolites|mesh-ancestor
110957195|NCT02128971|Ferrous fumarate|ferrous fumarate|mesh-list
110957196|NCT02128971|Trace Elements|trace elements|mesh-ancestor
110957197|NCT02128971|Micronutrients|micronutrients|mesh-ancestor
110957198|NCT02128971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110957199|NCT02288208|Tenofovir|tenofovir|mesh-list
110957200|NCT02288208|Entecavir|entecavir|mesh-list
110957201|NCT02288208|Antiviral Agents|antiviral agents|mesh-list
110957202|NCT02288208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110957203|NCT02288208|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110957204|NCT02288208|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110957205|NCT02288208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110957206|NCT02288208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110957207|NCT02288208|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110957208|NCT02288208|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110957209|NCT02288286|Vaccines|vaccines|mesh-list
110957210|NCT02288286|Immunologic Factors|immunologic factors|mesh-ancestor
110957211|NCT02288286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110957212|NCT02251977|Leucovorin|leucovorin|mesh-list
110957213|NCT02251977|Fluorouracil|fluorouracil|mesh-list
110957214|NCT02251977|Capecitabine|capecitabine|mesh-list
110957215|NCT02251977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110957216|NCT02251977|Antimetabolites|antimetabolites|mesh-ancestor
110957217|NCT02251977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110957218|NCT02251977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110957219|NCT02251977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110957220|NCT02251977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110957221|NCT02251977|Immunologic Factors|immunologic factors|mesh-ancestor
110957222|NCT02251977|Antidotes|antidotes|mesh-ancestor
110957223|NCT02251977|Protective Agents|protective agents|mesh-ancestor
110957224|NCT02251977|Vitamin B Complex|vitamin b complex|mesh-ancestor
110669222|NCT00826553|GABA Agonists|gaba agonists|mesh-list
110957225|NCT02251977|Vitamins|vitamins|mesh-ancestor
110957227|NCT03528954|Propofol|propofol|mesh-list
110957228|NCT03528954|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110957229|NCT03528954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110957230|NCT03528954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110957231|NCT03528954|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110957232|NCT03528954|Anesthetics, General|anesthetics, general|mesh-ancestor
110957233|NCT03528954|Anesthetics|anesthetics|mesh-ancestor
110957234|NCT02125227|Metformin|metformin|mesh-list
110957235|NCT02125227|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110957236|NCT02125227|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110957237|NCT02125227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110957238|NCT02125227|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110957239|NCT02125227|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110957240|NCT02125227|Antimetabolites|antimetabolites|mesh-ancestor
110957241|NCT02125227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110957242|NCT02125227|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110957243|NCT02125227|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110957244|NCT02125227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110957245|NCT02129127|Paclitaxel|paclitaxel|mesh-list
110957246|NCT02129127|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110957247|NCT02129127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110957248|NCT02129127|Tubulin Modulators|tubulin modulators|mesh-ancestor
110957249|NCT02129127|Antimitotic Agents|antimitotic agents|mesh-ancestor
110957250|NCT02129127|Mitosis Modulators|mitosis modulators|mesh-ancestor
110957251|NCT02129127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110957252|NCT05554822|Aspirin|aspirin|mesh-list
110957253|NCT05554822|Clopidogrel|clopidogrel|mesh-list
110957254|NCT05554822|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110957255|NCT05554822|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110957256|NCT05554822|Analgesics|analgesics|mesh-ancestor
110957257|NCT05554822|Sensory System Agents|sensory system agents|mesh-ancestor
110957258|NCT05554822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110957259|NCT05554822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110957260|NCT05554822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110957261|NCT05554822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110957262|NCT05554822|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110957263|NCT05554822|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110957264|NCT05554822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110957265|NCT05554822|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110957266|NCT05554822|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110957267|NCT05554822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110957268|NCT05554822|Antipyretics|antipyretics|mesh-ancestor
110957269|NCT05554822|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110957270|NCT05554822|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110957271|NCT05554822|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110957272|NCT05554822|Purinergic Agents|purinergic agents|mesh-ancestor
110957273|NCT05554822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110957274|NCT02125305|Metformin|metformin|mesh-list
110957275|NCT02125305|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110957276|NCT02125305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110957277|NCT00254904|Cisplatin|cisplatin|mesh-list
110957278|NCT00254904|Gemcitabine|gemcitabine|mesh-list
110957279|NCT00254904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110957280|NCT00254904|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110957281|NCT00254904|Antimetabolites|antimetabolites|mesh-ancestor
110957282|NCT00254904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110957283|NCT05725122|Tamsulosin|tamsulosin|mesh-list
110957284|NCT05725122|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110957285|NCT05725122|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110957286|NCT05725122|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110957287|NCT05725122|Adrenergic Agents|adrenergic agents|mesh-ancestor
110957288|NCT05725122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110957289|NCT05725122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110957290|NCT05725122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110957291|NCT05725122|Urological Agents|urological agents|mesh-ancestor
110957292|NCT03880396|Cisplatin|cisplatin|mesh-list
110957293|NCT03880396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110957294|NCT00253968|SR 46349B|sr 46349b|mesh-list
110957295|NCT00253968|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110957296|NCT00253968|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110957297|NCT00253968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110669298|NCT02549651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110957298|NCT00253968|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110957299|NCT00253968|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110957300|NCT00253968|Serotonin Agents|serotonin agents|mesh-ancestor
110957301|NCT00253968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110957302|NCT00253968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110957303|NCT03544606|Pyridoxine|pyridoxine|mesh-list
110957304|NCT03544606|Isosorbide|isosorbide|mesh-list
110957305|NCT03544606|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
110957306|NCT03544606|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
110957307|NCT03544606|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110957308|NCT03544606|Diuretics|diuretics|mesh-ancestor
110957309|NCT03544606|Natriuretic Agents|natriuretic agents|mesh-ancestor
110957310|NCT03544606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110957311|NCT03544606|Vasodilator Agents|vasodilator agents|mesh-ancestor
110957312|NCT03544606|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
110957313|NCT03544606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110957314|NCT03544606|Vitamin B Complex|vitamin b complex|mesh-ancestor
110957315|NCT03544606|Vitamins|vitamins|mesh-ancestor
110957316|NCT03544606|Micronutrients|micronutrients|mesh-ancestor
110957317|NCT02741310|Sumatriptan|sumatriptan|mesh-list
110957318|NCT02741310|Erenumab|erenumab|mesh-list
110957319|NCT02741310|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110957320|NCT02741310|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110957321|NCT02741310|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110957322|NCT02741310|Serotonin Agents|serotonin agents|mesh-ancestor
110957323|NCT02741310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110957324|NCT02741310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110957325|NCT02741310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110957326|NCT02741310|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
110957327|NCT02741310|Analgesics|analgesics|mesh-ancestor
110957328|NCT02741310|Sensory System Agents|sensory system agents|mesh-ancestor
110957329|NCT02741310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110957330|NCT05700448|Gemcitabine|gemcitabine|mesh-list
110957331|NCT05700448|Oxaliplatin|oxaliplatin|mesh-list
110957332|NCT05700448|Pegaspargase|pegaspargase|mesh-list
110957333|NCT05700448|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110957334|NCT05700448|Antimetabolites|antimetabolites|mesh-ancestor
110957335|NCT05700448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110957336|NCT05700448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110957337|NCT00243906|Plasminogen|plasminogen|mesh-list
110957338|NCT00243906|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
110957339|NCT00243906|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110957340|NCT00243906|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110957341|NCT00243906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110957342|NCT03532360|Immunomodulating Agents|immunomodulating agents|mesh-list
110957343|NCT03532360|Immunologic Factors|immunologic factors|mesh-ancestor
110957344|NCT03532360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110957345|NCT01367457|Sirolimus|sirolimus|mesh-list
110957346|NCT01367457|Temsirolimus|temsirolimus|mesh-list
110957347|NCT01367457|MTOR Inhibitors|mtor inhibitors|mesh-list
110957348|NCT01367457|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110957349|NCT01367457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110957350|NCT01367457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110957351|NCT01367457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110957352|NCT01367457|Immunologic Factors|immunologic factors|mesh-ancestor
110957353|NCT01367457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110957354|NCT01367457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110957355|NCT01367457|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110957356|NCT01367457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110957357|NCT01367457|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110957358|NCT01367457|Antifungal Agents|antifungal agents|mesh-ancestor
110957359|NCT05553496|Cyclosporine|cyclosporine|mesh-list
110957360|NCT05553496|Dexamethasone|dexamethasone|mesh-list
110957361|NCT05553496|Dexamethasone acetate|dexamethasone acetate|mesh-list
110957362|NCT05553496|Cyclophosphamide|cyclophosphamide|mesh-list
110957363|NCT05553496|Rituximab|rituximab|mesh-list
110957364|NCT05553496|Tacrolimus|tacrolimus|mesh-list
110957365|NCT05553496|Cyclosporins|cyclosporins|mesh-list
110957366|NCT05553496|BB 1101|bb 1101|mesh-list
110957367|NCT05553496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110957368|NCT05553496|Immunologic Factors|immunologic factors|mesh-ancestor
110957369|NCT05553496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110957370|NCT05553496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110957371|NCT05553496|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110957372|NCT05553496|Alkylating Agents|alkylating agents|mesh-ancestor
110669376|NCT05889871|Apatinib|apatinib|mesh-list
110957373|NCT05553496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110957374|NCT05553496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110957376|NCT05553496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110957377|NCT05553496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110957378|NCT05553496|Antiemetics|antiemetics|mesh-ancestor
110957379|NCT05553496|Autonomic Agents|autonomic agents|mesh-ancestor
110957380|NCT05553496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110957381|NCT05553496|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110957382|NCT05553496|Glucocorticoids|glucocorticoids|mesh-ancestor
110957383|NCT05553496|Hormones|hormones|mesh-ancestor
110957384|NCT05553496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110957385|NCT05553496|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110957386|NCT05553496|Protease Inhibitors|protease inhibitors|mesh-ancestor
110957387|NCT05553496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110957388|NCT05553496|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110957389|NCT05553496|Antifungal Agents|antifungal agents|mesh-ancestor
110957390|NCT05553496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110957391|NCT05553496|Dermatologic Agents|dermatologic agents|mesh-ancestor
110957392|NCT00239694|Vaccines|vaccines|mesh-list
110957393|NCT00239694|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110957394|NCT00239694|Immunologic Factors|immunologic factors|mesh-ancestor
110497267|NCT00788749|Xhance|xhance|mesh-list
110957395|NCT00239694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110957396|NCT05549284|Rituximab|rituximab|mesh-list
110957397|NCT05549284|Methotrexate|methotrexate|mesh-list
110957398|NCT05549284|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110957399|NCT05549284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110957400|NCT05549284|Immunologic Factors|immunologic factors|mesh-ancestor
110957401|NCT05549284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110957402|NCT05549284|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110957403|NCT05549284|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110957404|NCT05549284|Abortifacient Agents|abortifacient agents|mesh-ancestor
110957405|NCT05549284|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110957406|NCT05549284|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110957407|NCT05549284|Antimetabolites|antimetabolites|mesh-ancestor
110957408|NCT05549284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110957409|NCT05549284|Dermatologic Agents|dermatologic agents|mesh-ancestor
110957410|NCT05549284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110957411|NCT05549284|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110957412|NCT05549284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110957413|NCT05549284|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110957414|NCT03065218|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
110957415|NCT03065218|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110957416|NCT03065218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110957417|NCT00232752|Sirolimus|sirolimus|mesh-list
110957418|NCT00232752|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110957419|NCT00232752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110957420|NCT00232752|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110957421|NCT00232752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110957422|NCT00232752|Antifungal Agents|antifungal agents|mesh-ancestor
110957423|NCT00232752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110957424|NCT00232752|Immunologic Factors|immunologic factors|mesh-ancestor
110957425|NCT00232752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110957426|NCT02125617|Prednisolone|prednisolone|mesh-list
110957427|NCT02125617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110957428|NCT02125617|Glucocorticoids|glucocorticoids|mesh-ancestor
110957429|NCT02125617|Hormones|hormones|mesh-ancestor
110957430|NCT02125617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110957431|NCT02125617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110957432|NCT02125617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110957433|NCT02125617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110957434|NCT02131545|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110957435|NCT02131545|Antidepressive Agents|antidepressive agents|mesh-ancestor
110957436|NCT02131545|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110957437|NCT02131545|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110957438|NCT02131545|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110957439|NCT02131545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110957440|NCT02131545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110957441|NCT00229008|Linezolid|linezolid|mesh-list
110957442|NCT00229008|Ceftazidime|ceftazidime|mesh-list
110957443|NCT00229008|Ceftobiprole|ceftobiprole|mesh-list
110957444|NCT00229008|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
110957445|NCT00229008|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110957446|NCT00229008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110957447|NCT00229008|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110957448|NCT00229008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110957449|NCT00229008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110957450|NCT05553184|Niacin|niacin|mesh-list
110957451|NCT05553184|Nicotinic Acids|nicotinic acids|mesh-list
110957452|NCT05553184|Niacinamide|niacinamide|mesh-list
110957453|NCT05553184|Formoterol Fumarate|formoterol fumarate|mesh-list
110957454|NCT05553184|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110957455|NCT05553184|Autonomic Agents|autonomic agents|mesh-ancestor
110957456|NCT05553184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110957457|NCT05553184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110957458|NCT05553184|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110957459|NCT05553184|Respiratory System Agents|respiratory system agents|mesh-ancestor
110957460|NCT05553184|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110957461|NCT05553184|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110957462|NCT05553184|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110957463|NCT05553184|Adrenergic Agents|adrenergic agents|mesh-ancestor
110957464|NCT05553184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110957465|NCT05553184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110957466|NCT05553184|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110957467|NCT05553184|Antimetabolites|antimetabolites|mesh-ancestor
110957468|NCT05553184|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110957469|NCT05553184|Vasodilator Agents|vasodilator agents|mesh-ancestor
110957470|NCT05553184|Vitamin B Complex|vitamin b complex|mesh-ancestor
110957471|NCT05553184|Vitamins|vitamins|mesh-ancestor
110957472|NCT05553184|Micronutrients|micronutrients|mesh-ancestor
110957473|NCT03059992|Ibrexafungerp|ibrexafungerp|mesh-list
110957474|NCT03059992|Antifungal Agents|antifungal agents|mesh-ancestor
110957475|NCT03059992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110957476|NCT05242029|Psilocybin|psilocybin|mesh-list
110957477|NCT05242029|Hallucinogens|hallucinogens|mesh-ancestor
110957478|NCT05242029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110957479|NCT05242029|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110957480|NCT03528564|Epoetin Alfa|epoetin alfa|mesh-list
110957481|NCT03528564|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
110957482|NCT03528564|Hematinics|hematinics|mesh-ancestor
110957483|NCT03531372|Antacids|antacids|mesh-list
110957484|NCT03531372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110957485|NCT03531372|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110957486|NCT02129595|Resveratrol|resveratrol|mesh-list
110957487|NCT02129595|Antioxidants|antioxidants|mesh-ancestor
110957488|NCT02129595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110957489|NCT02129595|Protective Agents|protective agents|mesh-ancestor
110957490|NCT02129595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110957491|NCT02129595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110957492|NCT02129595|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110957493|NCT02129673|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110957494|NCT02129673|Latanoprost|latanoprost|mesh-list
110957495|NCT02129673|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110957496|NCT02260557|Selexipag|selexipag|mesh-list
111203416|NCT04025775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110957497|NCT02260557|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110957498|NCT02129829|Tenofovir|tenofovir|mesh-list
110957499|NCT02129829|Antiviral Agents|antiviral agents|mesh-ancestor
110957500|NCT02129829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110957501|NCT02129829|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110957502|NCT02129829|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110957503|NCT02129829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110957504|NCT02129829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110957505|NCT02129829|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110957506|NCT02129829|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110957507|NCT02129985|Metformin|metformin|mesh-list
110957508|NCT02129985|Exenatide|exenatide|mesh-list
110957509|NCT02129985|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110957510|NCT02129985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110957511|NCT02129985|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110957512|NCT02129985|Incretins|incretins|mesh-ancestor
110957513|NCT02129985|Hormones|hormones|mesh-ancestor
110957514|NCT02129985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110957515|NCT01730638|Histamine|histamine|mesh-list
110957516|NCT01730638|Glycine|glycine|mesh-list
110957517|NCT01730638|Histamine Agonists|histamine agonists|mesh-ancestor
110957518|NCT01730638|Histamine Agents|histamine agents|mesh-ancestor
110957519|NCT01730638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110957520|NCT01730638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110957521|NCT01730638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110957522|NCT01730638|Glycine Agents|glycine agents|mesh-ancestor
110957523|NCT02252523|Dexmedetomidine|dexmedetomidine|mesh-list
110957524|NCT02252523|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110957525|NCT02252523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110669529|NCT05881382|Lenograstim|lenograstim|mesh-list
110957526|NCT02252523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110957527|NCT02252523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110957528|NCT02252523|Analgesics|analgesics|mesh-ancestor
110957529|NCT02252523|Sensory System Agents|sensory system agents|mesh-ancestor
110957530|NCT02252523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110957531|NCT02252523|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110957532|NCT02252523|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110957533|NCT02252523|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110957534|NCT02252523|Adrenergic Agents|adrenergic agents|mesh-ancestor
110957535|NCT02252523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110957536|NCT02252523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110957537|NCT02132091|Vitamins|vitamins|mesh-list
110957538|NCT02132091|Vitamin E|vitamin e|mesh-list
110957539|NCT02132091|Micronutrients|micronutrients|mesh-ancestor
110957540|NCT02132091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110957541|NCT02132091|Antioxidants|antioxidants|mesh-ancestor
110957542|NCT02132091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110957543|NCT02132091|Protective Agents|protective agents|mesh-ancestor
110957544|NCT05548348|Aflutinib|aflutinib|mesh-list
110957545|NCT05548348|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110957546|NCT05548348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110957547|NCT05548348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110957548|NCT05726370|Carboplatin|carboplatin|mesh-list
110957549|NCT05726370|Docetaxel|docetaxel|mesh-list
110957550|NCT05726370|Pembrolizumab|pembrolizumab|mesh-list
110957551|NCT05726370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110957552|NCT05726370|Tubulin Modulators|tubulin modulators|mesh-ancestor
110957553|NCT05726370|Antimitotic Agents|antimitotic agents|mesh-ancestor
110957554|NCT05726370|Mitosis Modulators|mitosis modulators|mesh-ancestor
110957555|NCT05726370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110957556|NCT05726370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110957557|NCT05726370|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110957558|NCT04469010|Iron|iron|mesh-list
110957559|NCT04469010|Chelating Agents|chelating agents|mesh-list
110957560|NCT04469010|Micronutrients|micronutrients|mesh-ancestor
110957561|NCT04469010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110957562|NCT04469010|Trace Elements|trace elements|mesh-ancestor
110957563|NCT04469010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110957564|NCT04469010|Sequestering Agents|sequestering agents|mesh-ancestor
110957565|NCT01121224|Clopidogrel|clopidogrel|mesh-list
110957566|NCT01121224|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110957567|NCT01121224|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110957568|NCT01121224|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110957569|NCT01121224|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110957570|NCT01121224|Purinergic Agents|purinergic agents|mesh-ancestor
110957571|NCT01121224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110957572|NCT01121224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110957573|NCT01121224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110957574|NCT00138762|Atorvastatin|atorvastatin|mesh-list
110957575|NCT00138762|Torcetrapib|torcetrapib|mesh-list
110957576|NCT00138762|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110957577|NCT00138762|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110957578|NCT00138762|Antimetabolites|antimetabolites|mesh-ancestor
110957579|NCT00138762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110957580|NCT00138762|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110957581|NCT00138762|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110957582|NCT00138762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110957583|NCT03531294|Aflibercept|aflibercept|mesh-list
110957584|NCT03531294|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110957585|NCT03531294|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110957586|NCT03531294|Growth Substances|growth substances|mesh-ancestor
110957587|NCT03531294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110957588|NCT03531294|Growth Inhibitors|growth inhibitors|mesh-ancestor
110957589|NCT03531294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110957590|NCT03549975|Botulinum Toxins|botulinum toxins|mesh-list
110957591|NCT03549975|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110957592|NCT03549975|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110957593|NCT03549975|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110957594|NCT03549975|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110957595|NCT03549975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110957596|NCT03549975|Cholinergic Agents|cholinergic agents|mesh-ancestor
110957597|NCT03549975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110957598|NCT03549975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110957599|NCT03549975|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110957600|NCT03549975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110957601|NCT05551624|Acetylcysteine|acetylcysteine|mesh-list
110957602|NCT05551624|Atorvastatin|atorvastatin|mesh-list
110957603|NCT05551624|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110957604|NCT05551624|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110957605|NCT05551624|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110957606|NCT05551624|Antimetabolites|antimetabolites|mesh-ancestor
110957607|NCT05551624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110957608|NCT05551624|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110957609|NCT05551624|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110957610|NCT05551624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110957611|NCT05551624|Antiviral Agents|antiviral agents|mesh-ancestor
110957612|NCT05551624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110957613|NCT05551624|Expectorants|expectorants|mesh-ancestor
110957614|NCT05551624|Respiratory System Agents|respiratory system agents|mesh-ancestor
110957615|NCT05551624|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110957616|NCT05551624|Antioxidants|antioxidants|mesh-ancestor
110957617|NCT05551624|Protective Agents|protective agents|mesh-ancestor
110957618|NCT05551624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110957619|NCT05551624|Antidotes|antidotes|mesh-ancestor
110957620|NCT00134238|Atorvastatin|atorvastatin|mesh-list
110957621|NCT00134238|Torcetrapib|torcetrapib|mesh-list
110957622|NCT00134238|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110957623|NCT00134238|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110957624|NCT00134238|Antimetabolites|antimetabolites|mesh-ancestor
110957625|NCT00134238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110957626|NCT00134238|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110957627|NCT00134238|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110957628|NCT00134238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110957629|NCT02786901|Loteprednol Etabonate|loteprednol etabonate|mesh-list
110957630|NCT02786901|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110957631|NCT03550677|Anesthetics|anesthetics|mesh-list
110957632|NCT03550677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110957633|NCT03550677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110957634|NCT02132403|Milk fat globule|milk fat globule|mesh-list
110957635|NCT02132403|Gemcitabine|gemcitabine|mesh-list
110957636|NCT02132403|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110957637|NCT02132403|Antimetabolites|antimetabolites|mesh-ancestor
110957638|NCT02132403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110957639|NCT02132403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110957640|NCT02132403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110957641|NCT04264806|Azacitidine|azacitidine|mesh-list
110957642|NCT04264806|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110957643|NCT04264806|Antimetabolites|antimetabolites|mesh-ancestor
110957644|NCT04264806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110957645|NCT04264806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110957646|NCT04264806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110957647|NCT02132559|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
110957648|NCT02132559|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110946881|NCT03326921|Antiviral Agents|antiviral agents|mesh-ancestor
110957649|NCT02132559|Immunologic Factors|immunologic factors|mesh-ancestor
110957650|NCT02132559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110957651|NCT00126984|Vaccines|vaccines|mesh-list
110957652|NCT00126984|Immunologic Factors|immunologic factors|mesh-ancestor
110957653|NCT00126984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110957654|NCT02136147|Guanfacine|guanfacine|mesh-list
110957655|NCT02136147|Methylphenidate|methylphenidate|mesh-list
110957656|NCT02136147|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
110957657|NCT02136147|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
110957658|NCT02136147|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110957659|NCT02136147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110957660|NCT02136147|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110957661|NCT02136147|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110957662|NCT02136147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110957663|NCT02136147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110957664|NCT02136147|Dopamine Agents|dopamine agents|mesh-ancestor
110957665|NCT02136147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110957666|NCT02136147|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110957667|NCT02136147|Adrenergic Agents|adrenergic agents|mesh-ancestor
110957668|NCT02136147|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110957669|NCT02136147|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110957670|NCT02136147|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110957671|NCT02136147|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110957672|NCT05699746|Capecitabine|capecitabine|mesh-list
110957673|NCT05699746|Oxaliplatin|oxaliplatin|mesh-list
110957674|NCT05699746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110957675|NCT05699746|Antimetabolites|antimetabolites|mesh-ancestor
110957676|NCT05699746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110957677|NCT05699746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110957678|NCT03549897|Albuterol|albuterol|mesh-list
110957679|NCT03549897|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110957680|NCT03549897|Autonomic Agents|autonomic agents|mesh-ancestor
110957681|NCT03549897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110957682|NCT03549897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110957683|NCT03549897|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110957684|NCT03549897|Respiratory System Agents|respiratory system agents|mesh-ancestor
110957685|NCT03549897|Tocolytic Agents|tocolytic agents|mesh-ancestor
110957686|NCT03549897|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110957687|NCT03549897|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110957688|NCT03549897|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110957689|NCT03549897|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110957690|NCT03549897|Adrenergic Agents|adrenergic agents|mesh-ancestor
110957691|NCT03549897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110957692|NCT03549897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110957693|NCT02133105|Simendan|simendan|mesh-list
110957694|NCT02133105|Dobutamine|dobutamine|mesh-list
110957695|NCT02133105|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110957696|NCT02133105|Vasodilator Agents|vasodilator agents|mesh-ancestor
110957697|NCT02133105|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110957698|NCT02133105|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110957699|NCT02133105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110957700|NCT02133105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110957701|NCT02133105|Protective Agents|protective agents|mesh-ancestor
110957702|NCT02133105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110957703|NCT02133105|Sympathomimetics|sympathomimetics|mesh-ancestor
110957704|NCT02133105|Autonomic Agents|autonomic agents|mesh-ancestor
110957705|NCT02133105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110957706|NCT02133105|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
110957707|NCT02133105|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110957708|NCT02133105|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110957709|NCT02133105|Adrenergic Agents|adrenergic agents|mesh-ancestor
110957710|NCT02133105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110957711|NCT04468464|Salicylic Acid|salicylic acid|mesh-list
110957712|NCT04468464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110957713|NCT04468464|Antifungal Agents|antifungal agents|mesh-ancestor
110957714|NCT04468464|Keratolytic Agents|keratolytic agents|mesh-ancestor
110957715|NCT04468464|Dermatologic Agents|dermatologic agents|mesh-ancestor
110957716|NCT02136693|Psyllium|psyllium|mesh-list
110957717|NCT02136693|Cathartics|cathartics|mesh-ancestor
110957718|NCT02136693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110957719|NCT02136771|Vitamin D|vitamin d|mesh-list
110957720|NCT02136771|Cholecalciferol|cholecalciferol|mesh-list
110957721|NCT02136771|Vitamins|vitamins|mesh-ancestor
110957722|NCT02136771|Micronutrients|micronutrients|mesh-ancestor
111203417|NCT04022811|Tobramycin|tobramycin|mesh-list
111203418|NCT04022811|Dexamethasone|dexamethasone|mesh-list
110957723|NCT02136771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110957724|NCT02136771|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110957725|NCT02136771|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110957726|NCT00125970|Vaccines|vaccines|mesh-list
110957727|NCT00125970|Immunologic Factors|immunologic factors|mesh-ancestor
110957728|NCT00125970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110957729|NCT03549663|Prednisone|prednisone|mesh-list
110957730|NCT03549663|Glucocorticoids|glucocorticoids|mesh-list
110957731|NCT03549663|Tacrolimus|tacrolimus|mesh-list
110957732|NCT03549663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110957733|NCT03549663|Hormones|hormones|mesh-ancestor
110957734|NCT03549663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110957735|NCT03549663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110957736|NCT03549663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110957737|NCT03549663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110957738|NCT03549663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110957739|NCT03549663|Immunologic Factors|immunologic factors|mesh-ancestor
110957740|NCT03549663|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110957741|NCT03549663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110957742|NCT03549663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110957743|NCT02137083|Docetaxel|docetaxel|mesh-list
110957744|NCT02137083|Fulvestrant|fulvestrant|mesh-list
110957745|NCT02137083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110957746|NCT02137083|Tubulin Modulators|tubulin modulators|mesh-ancestor
110957747|NCT02137083|Antimitotic Agents|antimitotic agents|mesh-ancestor
110957748|NCT02137083|Mitosis Modulators|mitosis modulators|mesh-ancestor
110957749|NCT02137083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110957750|NCT02137083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110957751|NCT02137083|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110957752|NCT02137083|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110957753|NCT02137083|Hormone Antagonists|hormone antagonists|mesh-ancestor
110957754|NCT02137083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110957755|NCT02137083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110957757|NCT02137161|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
110957758|NCT02137161|Dexamethasone|dexamethasone|mesh-list
110957759|NCT02137161|Bromfenac|bromfenac|mesh-list
110957760|NCT02137161|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110957761|NCT02137161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110957762|NCT02137161|Antiemetics|antiemetics|mesh-ancestor
110957763|NCT02137161|Autonomic Agents|autonomic agents|mesh-ancestor
110957764|NCT02137161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110957765|NCT02137161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110957766|NCT02137161|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110957767|NCT02137161|Glucocorticoids|glucocorticoids|mesh-ancestor
110957768|NCT02137161|Hormones|hormones|mesh-ancestor
110957769|NCT02137161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110957770|NCT02137161|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110957771|NCT02137161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110957772|NCT02137161|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110957773|NCT02137161|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110957774|NCT02137161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110957775|NCT02137161|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110957776|NCT02137161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110957777|NCT02137161|Analgesics|analgesics|mesh-ancestor
110957778|NCT02137161|Sensory System Agents|sensory system agents|mesh-ancestor
110957779|NCT02137161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110957780|NCT02253069|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
110957781|NCT02253069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110957782|NCT03527628|Cyclophosphamide|cyclophosphamide|mesh-list
110957783|NCT03527628|Dacarbazine|dacarbazine|mesh-list
110957784|NCT03527628|Doxorubicin|doxorubicin|mesh-list
110957785|NCT03527628|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110957786|NCT03527628|Bleomycin|bleomycin|mesh-list
110957787|NCT03527628|Brentuximab Vedotin|brentuximab vedotin|mesh-list
110957788|NCT03527628|Vinblastine|vinblastine|mesh-list
110957789|NCT03527628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110957790|NCT03527628|Immunologic Factors|immunologic factors|mesh-ancestor
110957791|NCT03527628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110957792|NCT03527628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110957793|NCT03527628|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110957794|NCT03527628|Alkylating Agents|alkylating agents|mesh-ancestor
110957795|NCT03527628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110957796|NCT03527628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110957797|NCT03527628|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110957798|NCT03527628|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110957799|NCT03527628|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110957800|NCT03527628|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110957801|NCT03527628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110957802|NCT03527628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110957803|NCT03527628|Immunotoxins|immunotoxins|mesh-ancestor
110957804|NCT03527628|Immunoconjugates|immunoconjugates|mesh-ancestor
110957805|NCT03527628|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110957806|NCT03527628|Tubulin Modulators|tubulin modulators|mesh-ancestor
110957807|NCT03527628|Antimitotic Agents|antimitotic agents|mesh-ancestor
110957808|NCT03527628|Mitosis Modulators|mitosis modulators|mesh-ancestor
110957809|NCT04466670|Aspirin|aspirin|mesh-list
110957810|NCT04466670|Heparin|heparin|mesh-list
110957811|NCT04466670|Calcium heparin|calcium heparin|mesh-list
110957812|NCT04466670|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110957813|NCT04466670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110957814|NCT04466670|Analgesics|analgesics|mesh-ancestor
110957815|NCT04466670|Sensory System Agents|sensory system agents|mesh-ancestor
110957816|NCT04466670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110957817|NCT04466670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110957818|NCT04466670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110957819|NCT04466670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110957820|NCT04466670|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110957821|NCT04466670|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110957822|NCT04466670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110957823|NCT04466670|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110957824|NCT04466670|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110669826|NCT04827134|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110957825|NCT04466670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110957826|NCT04466670|Antipyretics|antipyretics|mesh-ancestor
110957827|NCT04466670|Anticoagulants|anticoagulants|mesh-ancestor
110957828|NCT04468542|Triamcinolone|triamcinolone|mesh-list
110957829|NCT04468542|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110957830|NCT04468542|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110957831|NCT04468542|Bupivacaine|bupivacaine|mesh-list
110957832|NCT04468542|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110957833|NCT04468542|Anesthetics, Local|anesthetics, local|mesh-ancestor
110957834|NCT04468542|Anesthetics|anesthetics|mesh-ancestor
110957835|NCT04468542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110957836|NCT04468542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110957837|NCT04468542|Sensory System Agents|sensory system agents|mesh-ancestor
110957838|NCT04468542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110957839|NCT04468542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110957840|NCT04468542|Glucocorticoids|glucocorticoids|mesh-ancestor
110957841|NCT04468542|Hormones|hormones|mesh-ancestor
110957842|NCT04468542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110957843|NCT04468542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110957844|NCT04468542|Immunologic Factors|immunologic factors|mesh-ancestor
110957845|NCT04468542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110957846|NCT04468542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110957847|NCT03525522|Betamethasone|betamethasone|mesh-list
110957848|NCT03525522|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
110957849|NCT03525522|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110957850|NCT03525522|Glucocorticoids|glucocorticoids|mesh-ancestor
110957851|NCT03525522|Hormones|hormones|mesh-ancestor
110957852|NCT03525522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110957853|NCT03525522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110957854|NCT03525522|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110957855|NCT03525522|Respiratory System Agents|respiratory system agents|mesh-ancestor
110957856|NCT03228732|Fluoxetine|fluoxetine|mesh-list
110957857|NCT03228732|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
110957858|NCT03228732|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110957859|NCT03228732|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110957860|NCT03228732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110957861|NCT03228732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110957862|NCT03228732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110957863|NCT03228732|Serotonin Agents|serotonin agents|mesh-ancestor
110957864|NCT03228732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110957865|NCT03228732|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110957866|NCT03228732|Antidepressive Agents|antidepressive agents|mesh-ancestor
110957867|NCT03228732|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110957868|NCT03228732|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110957869|NCT03228732|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110957870|NCT03228732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110957871|NCT03228732|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110957872|NCT03228732|Immunologic Factors|immunologic factors|mesh-ancestor
110957873|NCT04466436|Tryptophan|tryptophan|mesh-list
110957874|NCT04466436|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110957875|NCT04466436|Antidepressive Agents|antidepressive agents|mesh-ancestor
110957876|NCT04466436|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110957877|NCT04467450|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110957878|NCT04467450|Botulinum Toxins|botulinum toxins|mesh-list
110957879|NCT04467450|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110957880|NCT04467450|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110957881|NCT04467450|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110957882|NCT04467450|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110957883|NCT04467450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110957884|NCT04467450|Cholinergic Agents|cholinergic agents|mesh-ancestor
110957885|NCT04467450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110957886|NCT04467450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110957887|NCT04467450|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110957888|NCT04467450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110957889|NCT04467450|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110957890|NCT05230758|Metformin|metformin|mesh-list
110957891|NCT05230758|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110957892|NCT05230758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110957893|NCT03008382|Metoprolol|metoprolol|mesh-list
110957894|NCT03008382|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110957895|NCT03008382|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110957896|NCT03008382|Sympatholytics|sympatholytics|mesh-ancestor
110957897|NCT03008382|Autonomic Agents|autonomic agents|mesh-ancestor
110669900|NCT04602533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110957898|NCT03008382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110957899|NCT03008382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110957900|NCT03008382|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110957901|NCT03008382|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110957902|NCT03008382|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110957903|NCT03008382|Adrenergic Agents|adrenergic agents|mesh-ancestor
110957904|NCT03008382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110957905|NCT03008382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110957906|NCT02137239|Mycophenolic Acid|mycophenolic acid|mesh-list
110957907|NCT02137239|Prednisone|prednisone|mesh-list
110957908|NCT02137239|Methylprednisolone|methylprednisolone|mesh-list
110957909|NCT02137239|Everolimus|everolimus|mesh-list
110957910|NCT02137239|Abatacept|abatacept|mesh-list
110957911|NCT02137239|Tacrolimus|tacrolimus|mesh-list
110957912|NCT02137239|Thymoglobulin|thymoglobulin|mesh-list
110957913|NCT02137239|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110957914|NCT02137239|Glucocorticoids|glucocorticoids|mesh-ancestor
110957915|NCT02137239|Hormones|hormones|mesh-ancestor
110957916|NCT02137239|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110957917|NCT02137239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110957918|NCT02137239|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110957919|NCT02137239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110957920|NCT02137239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110957921|NCT02137239|Immunologic Factors|immunologic factors|mesh-ancestor
110957922|NCT02137239|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110957923|NCT02137239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110957924|NCT02137239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110957925|NCT02137239|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110957926|NCT02137239|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110957927|NCT02137239|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110957928|NCT02137239|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110957929|NCT02137239|Antitubercular Agents|antitubercular agents|mesh-ancestor
110957930|NCT02137239|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110957931|NCT02137239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110957932|NCT02137239|Antiemetics|antiemetics|mesh-ancestor
110957933|NCT02137239|Autonomic Agents|autonomic agents|mesh-ancestor
110957934|NCT02137239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110957935|NCT02137239|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110957936|NCT02137239|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110957937|NCT02137239|Protective Agents|protective agents|mesh-ancestor
110957938|NCT02137239|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110957939|NCT02137239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110957940|NCT02137239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110957941|NCT02137395|Dexamethasone|dexamethasone|mesh-list
110957942|NCT02137395|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110957943|NCT02137395|Antiemetics|antiemetics|mesh-ancestor
110957944|NCT02137395|Autonomic Agents|autonomic agents|mesh-ancestor
110957945|NCT02137395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110957946|NCT02137395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110957947|NCT02137395|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110957948|NCT02137395|Glucocorticoids|glucocorticoids|mesh-ancestor
110957949|NCT02137395|Hormones|hormones|mesh-ancestor
110957950|NCT02137395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110957951|NCT02137395|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110957952|NCT02137395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110957953|NCT02137629|Azacitidine|azacitidine|mesh-list
110957954|NCT02137629|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110957955|NCT02137629|Antimetabolites|antimetabolites|mesh-ancestor
110957956|NCT02137629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110957957|NCT02137629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110957958|NCT02137629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110957959|NCT02137707|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
110957960|NCT02137707|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
110957961|NCT02137707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110957962|NCT02137707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110957963|NCT02137707|Immunologic Factors|immunologic factors|mesh-ancestor
110957964|NCT02137707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110957965|NCT02261025|Aspirin|aspirin|mesh-list
110957966|NCT02261025|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110957967|NCT02261025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110957968|NCT02261025|Analgesics|analgesics|mesh-ancestor
110957969|NCT02261025|Sensory System Agents|sensory system agents|mesh-ancestor
110957970|NCT02261025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110669975|NCT04374461|Acetylcysteine|acetylcysteine|mesh-list
110957971|NCT02261025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110957972|NCT02261025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110957973|NCT02261025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110957974|NCT02261025|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110957975|NCT02261025|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110957976|NCT02261025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110957977|NCT02261025|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110957978|NCT02261025|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110957979|NCT02261025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110957980|NCT02261025|Antipyretics|antipyretics|mesh-ancestor
110957981|NCT02925234|Bevacizumab|bevacizumab|mesh-list
110957982|NCT02925234|Pembrolizumab|pembrolizumab|mesh-list
110957983|NCT02925234|Nivolumab|nivolumab|mesh-list
110957984|NCT02925234|Trastuzumab|trastuzumab|mesh-list
110957985|NCT02925234|Ipilimumab|ipilimumab|mesh-list
110957986|NCT02925234|Atezolizumab|atezolizumab|mesh-list
110957987|NCT02925234|Durvalumab|durvalumab|mesh-list
110957988|NCT02925234|Pertuzumab|pertuzumab|mesh-list
110957989|NCT02925234|Panitumumab|panitumumab|mesh-list
110957990|NCT02925234|Sunitinib|sunitinib|mesh-list
110957991|NCT02925234|Lenvatinib|lenvatinib|mesh-list
110957992|NCT02925234|Olaparib|olaparib|mesh-list
110957993|NCT02925234|Palbociclib|palbociclib|mesh-list
110957994|NCT02925234|Trametinib|trametinib|mesh-list
110957995|NCT02925234|Axitinib|axitinib|mesh-list
110957996|NCT02925234|Afatinib|afatinib|mesh-list
110957997|NCT02925234|Vemurafenib|vemurafenib|mesh-list
110957998|NCT02925234|Dabrafenib|dabrafenib|mesh-list
110957999|NCT02925234|Crizotinib|crizotinib|mesh-list
110958000|NCT02925234|Talazoparib|talazoparib|mesh-list
110958001|NCT02925234|Rucaparib|rucaparib|mesh-list
110958002|NCT02925234|Entrectinib|entrectinib|mesh-list
110958003|NCT02925234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110958004|NCT02925234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110958005|NCT02925234|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110958006|NCT02925234|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110958007|NCT02925234|Growth Substances|growth substances|mesh-ancestor
110958008|NCT02925234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110958009|NCT02925234|Growth Inhibitors|growth inhibitors|mesh-ancestor
110958010|NCT02925234|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110958011|NCT02925234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110958012|NCT02925234|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110958013|NCT02925234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110958014|NCT02925234|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110958015|NCT02137863|Dexmedetomidine|dexmedetomidine|mesh-list
110958016|NCT02137863|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110958017|NCT02137863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110958018|NCT02137863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110958019|NCT02137863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110958020|NCT02137863|Analgesics|analgesics|mesh-ancestor
110958021|NCT02137863|Sensory System Agents|sensory system agents|mesh-ancestor
110958022|NCT02137863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110022960|NCT00003240|Ifosfamide|ifosfamide|mesh-list
111203419|NCT04022811|Bromfenac|bromfenac|mesh-list
110958023|NCT02137863|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110958024|NCT02137863|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110958025|NCT02137863|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110958026|NCT02137863|Adrenergic Agents|adrenergic agents|mesh-ancestor
110958027|NCT02137863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110958028|NCT02137863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110958029|NCT02138019|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
110958030|NCT02138019|Hemostatics|hemostatics|mesh-ancestor
110958031|NCT02138019|Coagulants|coagulants|mesh-ancestor
110958032|NCT02133885|Minocycline|minocycline|mesh-list
110958033|NCT02133885|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110958034|NCT02133885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110958035|NCT02138409|Fentanyl|fentanyl|mesh-list
110958036|NCT02138409|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110958037|NCT02138409|Narcotics|narcotics|mesh-ancestor
110958038|NCT02138409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110958039|NCT02138409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110958040|NCT02138409|Analgesics|analgesics|mesh-ancestor
110958041|NCT02138409|Sensory System Agents|sensory system agents|mesh-ancestor
110958042|NCT02138409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110958043|NCT02138409|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110958044|NCT02138409|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110670068|NCT04191096|Androgens|androgens|mesh-list
110958045|NCT02138409|Anesthetics, General|anesthetics, general|mesh-ancestor
110958046|NCT02138409|Anesthetics|anesthetics|mesh-ancestor
110958047|NCT02138799|Rifampin|rifampin|mesh-list
110958048|NCT02138799|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110958049|NCT02138799|Antitubercular Agents|antitubercular agents|mesh-ancestor
110958050|NCT02138799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110958051|NCT02138799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110958052|NCT02138799|Leprostatic Agents|leprostatic agents|mesh-ancestor
110958053|NCT02138799|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110958054|NCT02138799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110958055|NCT02138799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110958056|NCT02138799|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110958057|NCT02138799|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110958058|NCT02138799|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110958059|NCT02138799|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110958060|NCT02138799|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110958061|NCT02138799|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110958062|NCT05578287|Celecoxib|celecoxib|mesh-list
110958063|NCT05578287|Tislelizumab|tislelizumab|mesh-list
110958064|NCT05578287|Disitamab vedotin|disitamab vedotin|mesh-list
110958065|NCT05578287|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110958066|NCT05578287|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110958067|NCT05578287|Analgesics|analgesics|mesh-ancestor
110958068|NCT05578287|Sensory System Agents|sensory system agents|mesh-ancestor
110958069|NCT05578287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110958070|NCT05578287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110958071|NCT05578287|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110958072|NCT05578287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110958073|NCT05578287|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110958074|NCT05578287|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110958075|NCT05578287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110958076|NCT05578287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110958077|NCT05578287|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110958078|NCT05578287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110958079|NCT05578287|Immunoconjugates|immunoconjugates|mesh-ancestor
110958080|NCT05578287|Immunologic Factors|immunologic factors|mesh-ancestor
110958081|NCT02975271|Serlopitant|serlopitant|mesh-list
110958082|NCT02975271|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110958083|NCT02975271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110958084|NCT02975271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110958085|NCT02975271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110958086|NCT02741076|Oxymorphone|oxymorphone|mesh-list
110958087|NCT02741076|Morphine|morphine|mesh-list
110958088|NCT02741076|Oxycodone|oxycodone|mesh-list
110958089|NCT02741076|Analgesics, Opioid|analgesics, opioid|mesh-list
110958090|NCT02741076|Narcotics|narcotics|mesh-ancestor
110958091|NCT02741076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110958092|NCT02741076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110958093|NCT02741076|Analgesics|analgesics|mesh-ancestor
110958094|NCT02741076|Sensory System Agents|sensory system agents|mesh-ancestor
110958095|NCT02741076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110958096|NCT02741076|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110958097|NCT02973633|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
110958098|NCT02973633|Chelating Agents|chelating agents|mesh-ancestor
110958099|NCT02973633|Sequestering Agents|sequestering agents|mesh-ancestor
110958100|NCT02973633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110958101|NCT01666444|Doxorubicin|doxorubicin|mesh-list
110958102|NCT01666444|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110958103|NCT01666444|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110958104|NCT01666444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110958105|NCT01666444|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110958106|NCT01666444|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110958107|NCT01666444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110958108|NCT01666444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110958109|NCT05543122|Fluconazole|fluconazole|mesh-list
110958110|NCT05543122|Methotrexate|methotrexate|mesh-list
110958112|NCT05543122|Lamotrigine|lamotrigine|mesh-list
110958113|NCT05543122|Lacosamide|lacosamide|mesh-list
110958114|NCT05543122|Levetiracetam|levetiracetam|mesh-list
110670128|NCT04072952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110670129|NCT04072952|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110670130|NCT04072952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110670131|NCT04072952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110670142|NCT04032418|Pembrolizumab|pembrolizumab|mesh-list
110670143|NCT04032418|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110670144|NCT04032418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110670145|NCT04032418|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110670146|NCT04032418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110958115|NCT05543122|Brivaracetam|brivaracetam|mesh-list
110958116|NCT05543122|Bupropion|bupropion|mesh-list
110958117|NCT05543122|Ezetimibe|ezetimibe|mesh-list
110958118|NCT05543122|Escitalopram|escitalopram|mesh-list
110958119|NCT05543122|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110958120|NCT05543122|Abortifacient Agents|abortifacient agents|mesh-ancestor
110958121|NCT05543122|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110958122|NCT05543122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110958123|NCT05543122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110958124|NCT05543122|Antimetabolites|antimetabolites|mesh-ancestor
110958125|NCT05543122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110958126|NCT05543122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110958127|NCT05543122|Dermatologic Agents|dermatologic agents|mesh-ancestor
110958128|NCT05543122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110958129|NCT05543122|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110958130|NCT05543122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110958131|NCT05543122|Immunologic Factors|immunologic factors|mesh-ancestor
110958132|NCT05543122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110958133|NCT05543122|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110958134|NCT05543122|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110958135|NCT05543122|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110958136|NCT05543122|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110958137|NCT05543122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110958138|NCT05543122|Serotonin Agents|serotonin agents|mesh-ancestor
110958139|NCT05543122|Autonomic Agents|autonomic agents|mesh-ancestor
110958140|NCT05543122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110958141|NCT05543122|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110958142|NCT05543122|Antidepressive Agents|antidepressive agents|mesh-ancestor
110958143|NCT05543122|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110958144|NCT05543122|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110958145|NCT05543122|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110958146|NCT05543122|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110958147|NCT05543122|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110958148|NCT05543122|Dopamine Agents|dopamine agents|mesh-ancestor
110958149|NCT05543122|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110958150|NCT05543122|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110958151|NCT05543122|Anticonvulsants|anticonvulsants|mesh-ancestor
110958152|NCT05543122|Nootropic Agents|nootropic agents|mesh-ancestor
110958153|NCT05543122|Antifungal Agents|antifungal agents|mesh-ancestor
110958154|NCT05543122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110958155|NCT05543122|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110958156|NCT05543122|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110958157|NCT05543122|Hormone Antagonists|hormone antagonists|mesh-ancestor
110958158|NCT05543122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110958159|NCT05543122|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111203420|NCT04022811|Hyaluronic Acid|hyaluronic acid|mesh-list
110958160|NCT05543122|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110958161|NCT05543122|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110958162|NCT05543122|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110958163|NCT05543122|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110958164|NCT05543122|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110958165|NCT05543122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110958166|NCT05543122|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110958167|NCT05543122|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110958168|NCT05543122|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110958169|NCT05543122|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110958170|NCT05543122|Sympatholytics|sympatholytics|mesh-ancestor
110958171|NCT05543122|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110958172|NCT05543122|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110958173|NCT05543122|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110958174|NCT05543122|Adrenergic Agents|adrenergic agents|mesh-ancestor
110958175|NCT05120934|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110958176|NCT05120934|Amitriptyline|amitriptyline|mesh-list
110958177|NCT05120934|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110958178|NCT05120934|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110958179|NCT05120934|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110958180|NCT05120934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110958181|NCT05120934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110958182|NCT05120934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110958183|NCT05120934|Analgesics|analgesics|mesh-ancestor
110958184|NCT05120934|Sensory System Agents|sensory system agents|mesh-ancestor
110958185|NCT05120934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110958186|NCT05120934|Antidepressive Agents|antidepressive agents|mesh-ancestor
110958187|NCT05120934|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110958188|NCT05120934|Dopamine Agents|dopamine agents|mesh-ancestor
110958189|NCT05120934|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110958190|NCT05120934|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110958191|NCT05120934|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110958192|NCT05120934|Adrenergic Agents|adrenergic agents|mesh-ancestor
110958193|NCT03548493|Magnesium Sulfate|magnesium sulfate|mesh-list
110958194|NCT03548493|Fentanyl|fentanyl|mesh-list
110958195|NCT03548493|Propofol|propofol|mesh-list
110958196|NCT03548493|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110958197|NCT03548493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110958198|NCT03548493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110958199|NCT03548493|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110958200|NCT03548493|Anesthetics, General|anesthetics, general|mesh-ancestor
110958201|NCT03548493|Anesthetics|anesthetics|mesh-ancestor
110958202|NCT03548493|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110958203|NCT03548493|Narcotics|narcotics|mesh-ancestor
110958204|NCT03548493|Analgesics|analgesics|mesh-ancestor
110958205|NCT03548493|Sensory System Agents|sensory system agents|mesh-ancestor
110958206|NCT03548493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110958207|NCT03548493|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110958208|NCT03548493|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110958209|NCT03548493|Anticonvulsants|anticonvulsants|mesh-ancestor
110958210|NCT03548493|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110958211|NCT03548493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110958212|NCT03548493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110958213|NCT03548493|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110958214|NCT03548493|Tocolytic Agents|tocolytic agents|mesh-ancestor
110958215|NCT03548493|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110958216|NCT02139267|Vaccines|vaccines|mesh-list
110958217|NCT02139267|Immunologic Factors|immunologic factors|mesh-ancestor
110958218|NCT02139267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110958219|NCT02139345|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110958220|NCT03549819|Cannabidiol|cannabidiol|mesh-list
110958221|NCT03549819|Anticonvulsants|anticonvulsants|mesh-ancestor
110958222|NCT03549741|Cabergoline|cabergoline|mesh-list
110958223|NCT03549741|Clomiphene|clomiphene|mesh-list
110958224|NCT03549741|Enclomiphene|enclomiphene|mesh-list
110958225|NCT03549741|Zuclomiphene|zuclomiphene|mesh-list
110958226|NCT03549741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110958227|NCT03549741|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110958228|NCT03549741|Hormone Antagonists|hormone antagonists|mesh-ancestor
110958229|NCT03549741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110958230|NCT03549741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110958231|NCT03549741|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110958232|NCT03549741|Fertility Agents|fertility agents|mesh-ancestor
111203421|NCT04022811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110947505|NCT02633059|Ixazomib|ixazomib|mesh-list
110958233|NCT03549741|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110958234|NCT03549741|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110958235|NCT03549741|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110958236|NCT03549741|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110958237|NCT03549741|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110958238|NCT03549741|Dopamine Agonists|dopamine agonists|mesh-ancestor
110958239|NCT03549741|Dopamine Agents|dopamine agents|mesh-ancestor
110958240|NCT03549741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110958241|NCT03522402|Sevoflurane|sevoflurane|mesh-list
110958242|NCT03522402|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110958243|NCT03522402|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110958244|NCT03522402|Anesthetics, General|anesthetics, general|mesh-ancestor
110958245|NCT03522402|Anesthetics|anesthetics|mesh-ancestor
110958246|NCT03522402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110958247|NCT03522402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110958248|NCT02134899|Everolimus|everolimus|mesh-list
110958249|NCT02134899|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
110958250|NCT02134899|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110958251|NCT02134899|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110958252|NCT02134899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110958253|NCT02134899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110958254|NCT02134899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110958255|NCT02134899|Immunologic Factors|immunologic factors|mesh-ancestor
110958256|NCT02134899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110958257|NCT02134899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110958258|NCT05577819|Technetium Tc 99m Pyrophosphate|technetium tc 99m pyrophosphate|mesh-list
110958259|NCT05577819|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110958260|NCT05577819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110958261|NCT02135055|Midazolam|midazolam|mesh-list
110958262|NCT02135055|Morphine|morphine|mesh-list
110958263|NCT02135055|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110958265|NCT02135055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110958266|NCT02135055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110958267|NCT02135055|Analgesics|analgesics|mesh-ancestor
110958268|NCT02135055|Sensory System Agents|sensory system agents|mesh-ancestor
110958269|NCT02135055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110958270|NCT02135055|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110958271|NCT02135055|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110958272|NCT02135055|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110958273|NCT02135055|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110958274|NCT02135055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110958275|NCT02135055|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110958276|NCT02135055|Anesthetics, General|anesthetics, general|mesh-ancestor
110958277|NCT02135055|Anesthetics|anesthetics|mesh-ancestor
110958278|NCT02135055|GABA Modulators|gaba modulators|mesh-ancestor
110958279|NCT02135055|GABA Agents|gaba agents|mesh-ancestor
110958280|NCT02135055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110958281|NCT02135055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110958282|NCT05546710|Anesthetics|anesthetics|mesh-list
110958283|NCT05546710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110958284|NCT05546710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110958285|NCT02139579|Bevacizumab|bevacizumab|mesh-list
110958286|NCT02139579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110958287|NCT02139579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110958288|NCT02139579|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110958289|NCT02139579|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110958290|NCT02139579|Growth Substances|growth substances|mesh-ancestor
110958291|NCT02139579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110958292|NCT02139579|Growth Inhibitors|growth inhibitors|mesh-ancestor
110958293|NCT02139657|Immunoglobulins|immunoglobulins|mesh-list
110958294|NCT02139657|Immunologic Factors|immunologic factors|mesh-ancestor
110958295|NCT02139657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110958296|NCT05550064|Contraceptive Agents|contraceptive agents|mesh-list
110958297|NCT05550064|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110958298|NCT05550064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110958299|NCT04076826|Midazolam|midazolam|mesh-list
110958300|NCT04076826|Dexmedetomidine|dexmedetomidine|mesh-list
110958301|NCT04076826|Propofol|propofol|mesh-list
110958302|NCT04076826|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110958303|NCT04076826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110958304|NCT04076826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110958305|NCT04076826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110958306|NCT04076826|Analgesics|analgesics|mesh-ancestor
111203422|NCT04022811|Antiemetics|antiemetics|mesh-ancestor
111203423|NCT04022811|Autonomic Agents|autonomic agents|mesh-ancestor
110958307|NCT04076826|Sensory System Agents|sensory system agents|mesh-ancestor
110958308|NCT04076826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110958309|NCT04076826|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110958310|NCT04076826|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110958311|NCT04076826|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110958312|NCT04076826|Adrenergic Agents|adrenergic agents|mesh-ancestor
110958313|NCT04076826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110958314|NCT04076826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110958315|NCT04076826|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110958316|NCT04076826|Anesthetics, General|anesthetics, general|mesh-ancestor
110958318|NCT04076826|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110958319|NCT04076826|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110958320|NCT04076826|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110958321|NCT04076826|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110958322|NCT04076826|GABA Modulators|gaba modulators|mesh-ancestor
110958323|NCT04076826|GABA Agents|gaba agents|mesh-ancestor
110958324|NCT05577585|Midazolam|midazolam|mesh-list
110958325|NCT05577585|Ketamine|ketamine|mesh-list
110958326|NCT05577585|Analgesics|analgesics|mesh-ancestor
110958327|NCT05577585|Sensory System Agents|sensory system agents|mesh-ancestor
110958328|NCT05577585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110958329|NCT05577585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110958330|NCT05577585|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110958331|NCT05577585|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110958332|NCT05577585|Anesthetics, General|anesthetics, general|mesh-ancestor
110958333|NCT05577585|Anesthetics|anesthetics|mesh-ancestor
110958334|NCT05577585|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110958335|NCT05577585|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110958336|NCT05577585|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110958337|NCT05577585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110670364|NCT03048825|Colchicine|colchicine|mesh-list
110958338|NCT05577585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110958339|NCT05577585|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110958340|NCT05577585|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110958341|NCT05577585|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110958342|NCT05577585|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110958343|NCT05577585|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110958344|NCT05577585|GABA Modulators|gaba modulators|mesh-ancestor
110958345|NCT05577585|GABA Agents|gaba agents|mesh-ancestor
110958346|NCT04465968|Durvalumab|durvalumab|mesh-list
110958347|NCT04465968|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110958348|NCT04465968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110958349|NCT04465968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110958350|NCT04465968|Immunologic Factors|immunologic factors|mesh-ancestor
110958351|NCT04465968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110958352|NCT03526770|Chlorhexidine|chlorhexidine|mesh-list
110958353|NCT03526770|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110958354|NCT03526770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110958355|NCT03526770|Disinfectants|disinfectants|mesh-ancestor
110958356|NCT05577507|Calcium Carbonate|calcium carbonate|mesh-list
110958357|NCT05577507|Cholestyramine Resin|cholestyramine resin|mesh-list
110958358|NCT05577507|Calcium|calcium|mesh-list
110958359|NCT05577507|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110958360|NCT05577507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110958361|NCT05577507|Antacids|antacids|mesh-ancestor
110958362|NCT05577507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110958363|NCT05577507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110958364|NCT05577507|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110958365|NCT05577507|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110958366|NCT05577507|Antimetabolites|antimetabolites|mesh-ancestor
110958367|NCT05577507|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110958368|NCT01565655|Peficitinib|peficitinib|mesh-list
110958369|NCT01565655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110958370|NCT01565655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110958371|NCT01565655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110958372|NCT01565655|Immunologic Factors|immunologic factors|mesh-ancestor
110958373|NCT01565655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110958374|NCT05535322|Insulin|insulin|mesh-list
110958375|NCT05535322|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110958376|NCT05535322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110958377|NCT05577273|Trimethoprim|trimethoprim|mesh-list
110958378|NCT05577273|Sulfamethoxazole|sulfamethoxazole|mesh-list
110958379|NCT05577273|Penicillins|penicillins|mesh-list
110958380|NCT05577273|Cefuroxime|cefuroxime|mesh-list
110958381|NCT05577273|Cefuroxime axetil|cefuroxime axetil|mesh-list
110958382|NCT05577273|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110958383|NCT05577273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110958384|NCT05577273|Antimalarials|antimalarials|mesh-ancestor
110958385|NCT05577273|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110958386|NCT05577273|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110958387|NCT05577273|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110958388|NCT05577273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110958389|NCT05577273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110958390|NCT05577273|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110958391|NCT05577273|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
110958392|NCT05577273|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110958393|NCT05577273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110958394|NCT02252913|Docetaxel|docetaxel|mesh-list
110958395|NCT02252913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110958396|NCT02252913|Tubulin Modulators|tubulin modulators|mesh-ancestor
110958397|NCT02252913|Antimitotic Agents|antimitotic agents|mesh-ancestor
110958398|NCT02252913|Mitosis Modulators|mitosis modulators|mesh-ancestor
110958399|NCT02252913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110958400|NCT02253459|Capecitabine|capecitabine|mesh-list
110958401|NCT02253459|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110958402|NCT02253459|Antimetabolites|antimetabolites|mesh-ancestor
110958403|NCT02253459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110958404|NCT02253459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110958405|NCT02140047|Vaccines|vaccines|mesh-list
110958406|NCT02140047|Immunologic Factors|immunologic factors|mesh-ancestor
110958407|NCT02140047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110958408|NCT02135913|Vitamin D|vitamin d|mesh-list
110958409|NCT02135913|Vitamins|vitamins|mesh-ancestor
110958410|NCT02135913|Micronutrients|micronutrients|mesh-ancestor
110958411|NCT02135913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110958412|NCT02135913|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110958413|NCT02140125|ASP2408|asp2408|mesh-list
110958414|NCT02140125|Immunoconjugates|immunoconjugates|mesh-ancestor
110958416|NCT02140125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110958417|NCT05505279|Nicotine|nicotine|mesh-list
110958418|NCT05505279|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110958419|NCT05505279|Autonomic Agents|autonomic agents|mesh-ancestor
110958420|NCT05505279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110958421|NCT05505279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110958422|NCT05505279|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110958423|NCT05505279|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110958424|NCT05505279|Cholinergic Agents|cholinergic agents|mesh-ancestor
110958425|NCT05505279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110958426|NCT05505279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110958427|NCT05541640|Lidocaine|lidocaine|mesh-list
110958428|NCT05541640|Anesthetics, Local|anesthetics, local|mesh-ancestor
110958429|NCT05541640|Anesthetics|anesthetics|mesh-ancestor
110958430|NCT05541640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110958431|NCT05541640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110958432|NCT05541640|Sensory System Agents|sensory system agents|mesh-ancestor
110958433|NCT05541640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110958434|NCT05541640|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110958435|NCT05541640|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110958436|NCT05541640|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110958437|NCT05541640|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110958438|NCT05541640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110958439|NCT02739594|Ibandronic Acid|ibandronic acid|mesh-list
110958440|NCT02739594|Zoledronic Acid|zoledronic acid|mesh-list
110958441|NCT02739594|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110958442|NCT02739594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110958443|NCT05545618|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110958444|NCT05545618|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110958445|NCT05545618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110958446|NCT02140281|Cefadroxil|cefadroxil|mesh-list
110958447|NCT02140281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110958448|NCT02140281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110958449|NCT05541328|Tisagenlecleucel|tisagenlecleucel|mesh-list
110958450|NCT05541328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110958451|NCT05541328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110958452|NCT05545462|Doxycycline|doxycycline|mesh-list
110958453|NCT05545462|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110958454|NCT05545462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110958455|NCT05545462|Antimalarials|antimalarials|mesh-ancestor
110958456|NCT05545462|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110958457|NCT05545462|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110958458|NCT05541172|Methyltestosterone|methyltestosterone|mesh-list
110958459|NCT05541172|Testosterone|testosterone|mesh-list
110958460|NCT05541172|Testosterone undecanoate|testosterone undecanoate|mesh-list
110958461|NCT05541172|Testosterone enanthate|testosterone enanthate|mesh-list
110958462|NCT05541172|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
110958463|NCT05541172|Androgens|androgens|mesh-ancestor
110958464|NCT05541172|Hormones|hormones|mesh-ancestor
110958465|NCT05541172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110958466|NCT05541172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110958467|NCT05541172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110958468|NCT05541172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110958469|NCT05541172|Anabolic Agents|anabolic agents|mesh-ancestor
110958470|NCT05478993|Dexamethasone|dexamethasone|mesh-list
110958471|NCT05478993|Pomalidomide|pomalidomide|mesh-list
110958472|NCT05478993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110958473|NCT05478993|Antiemetics|antiemetics|mesh-ancestor
110958474|NCT05478993|Autonomic Agents|autonomic agents|mesh-ancestor
110958475|NCT05478993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110958476|NCT05478993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110958477|NCT05478993|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110958478|NCT05478993|Glucocorticoids|glucocorticoids|mesh-ancestor
110958479|NCT05478993|Hormones|hormones|mesh-ancestor
110958480|NCT05478993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110958481|NCT05478993|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110958482|NCT05478993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110958483|NCT05478993|Immunologic Factors|immunologic factors|mesh-ancestor
110958484|NCT05478993|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110958485|NCT05478993|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110958486|NCT05478993|Growth Substances|growth substances|mesh-ancestor
110958487|NCT05478993|Growth Inhibitors|growth inhibitors|mesh-ancestor
110958488|NCT05699356|Estrogens|estrogens|mesh-list
110958489|NCT05699356|Aromatase Inhibitors|aromatase inhibitors|mesh-list
110958490|NCT05699356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110958491|NCT05699356|Hormones|hormones|mesh-ancestor
110958492|NCT05699356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110958493|NCT05699356|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110958494|NCT05699356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110958495|NCT05699356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110958496|NCT05699356|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110958497|NCT05699356|Hormone Antagonists|hormone antagonists|mesh-ancestor
110958498|NCT02140437|Fulvestrant|fulvestrant|mesh-list
110958499|NCT02140437|Anastrozole|anastrozole|mesh-list
110958500|NCT02140437|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110958501|NCT02140437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110958502|NCT02140437|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110958503|NCT02140437|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110958504|NCT02140437|Hormone Antagonists|hormone antagonists|mesh-ancestor
110958505|NCT02140437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110958506|NCT02140437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110958507|NCT02140437|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110958508|NCT02140437|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110958509|NCT02140437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110958510|NCT02140437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110958511|NCT05591560|Itraconazole|itraconazole|mesh-list
110958512|NCT05591560|Antifungal Agents|antifungal agents|mesh-ancestor
110958513|NCT05591560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110958514|NCT05591560|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110958515|NCT05591560|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110958516|NCT05591560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110958517|NCT05591560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110958518|NCT05591560|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110958519|NCT05591560|Hormone Antagonists|hormone antagonists|mesh-ancestor
110958520|NCT05591560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110958521|NCT05591560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110958522|NCT05591560|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110958523|NCT05540470|Chloroquine|chloroquine|mesh-list
110958524|NCT05540470|Primaquine|primaquine|mesh-list
110958525|NCT05540470|Tafenoquine|tafenoquine|mesh-list
110958526|NCT05540470|Amebicides|amebicides|mesh-ancestor
110958527|NCT05540470|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110958528|NCT05540470|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110958529|NCT05540470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110958530|NCT05540470|Antimalarials|antimalarials|mesh-ancestor
110958531|NCT05540470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110958532|NCT05575167|Vitamin D|vitamin d|mesh-list
110958533|NCT05575167|Alendronate|alendronate|mesh-list
110958534|NCT05575167|Zoledronic Acid|zoledronic acid|mesh-list
110958535|NCT05575167|Vitamins|vitamins|mesh-ancestor
110958536|NCT05575167|Micronutrients|micronutrients|mesh-ancestor
110958537|NCT05575167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110958538|NCT05575167|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110958539|NCT02140515|Hormones|hormones|mesh-list
110958540|NCT02140515|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
110958541|NCT02140515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110958542|NCT02140515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110958543|NCT02260947|Ibuprofen|ibuprofen|mesh-list
110958544|NCT02260947|Pregabalin|pregabalin|mesh-list
110958545|NCT02260947|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110958546|NCT02260947|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110958547|NCT02260947|Analgesics|analgesics|mesh-ancestor
110958548|NCT02260947|Sensory System Agents|sensory system agents|mesh-ancestor
110958549|NCT02260947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110958550|NCT02260947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110958551|NCT02260947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110958552|NCT02260947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110958553|NCT02260947|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110958554|NCT02260947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110958555|NCT02260947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110958556|NCT02260947|Anticonvulsants|anticonvulsants|mesh-ancestor
110958557|NCT02260947|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110958558|NCT02260947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110958559|NCT02260947|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110958560|NCT02260947|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110958561|NCT02260947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110958562|NCT02260947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110670601|NCT02425826|Apremilast|apremilast|mesh-list
110958563|NCT02260947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110958564|NCT03547791|Betamethasone|betamethasone|mesh-list
110958565|NCT03547791|Betamethasone Valerate|betamethasone valerate|mesh-list
110958566|NCT03547791|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
110958567|NCT03547791|Betamethasone benzoate|betamethasone benzoate|mesh-list
110958568|NCT03547791|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
110958569|NCT03547791|Glucocorticoids|glucocorticoids|mesh-ancestor
110958570|NCT03547791|Hormones|hormones|mesh-ancestor
110958571|NCT03547791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110958572|NCT03547791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110958573|NCT03547791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110958574|NCT03547791|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110958575|NCT03547791|Respiratory System Agents|respiratory system agents|mesh-ancestor
110958576|NCT04818177|Immunoglobulins|immunoglobulins|mesh-list
110958577|NCT04818177|Antibodies|antibodies|mesh-list
110958578|NCT04818177|gamma-Globulins|gamma-globulins|mesh-list
110958579|NCT04818177|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110958580|NCT04818177|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110958581|NCT04818177|Immunologic Factors|immunologic factors|mesh-ancestor
110958582|NCT04818177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110958583|NCT05544292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
110958584|NCT04425460|Favipiravir|favipiravir|mesh-list
110958585|NCT04425460|Antiviral Agents|antiviral agents|mesh-ancestor
110958586|NCT04425460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110958587|NCT05576272|Gemcitabine|gemcitabine|mesh-list
110958588|NCT05576272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110958589|NCT05576272|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110958590|NCT05576272|Antimetabolites|antimetabolites|mesh-ancestor
110958591|NCT05576272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110958592|NCT05576116|Pancrelipase|pancrelipase|mesh-list
110958593|NCT05576116|Pancreatin|pancreatin|mesh-list
110958594|NCT05576116|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110958595|NCT04765137|Atorvastatin|atorvastatin|mesh-list
110958596|NCT04765137|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110958597|NCT04765137|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110958598|NCT04765137|Antimetabolites|antimetabolites|mesh-ancestor
110958599|NCT04765137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110958600|NCT04765137|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110958601|NCT04765137|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110958602|NCT04765137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110958603|NCT05543824|Levobupivacaine|levobupivacaine|mesh-list
110958604|NCT05543824|Anesthetics, Local|anesthetics, local|mesh-ancestor
110958605|NCT05543824|Anesthetics|anesthetics|mesh-ancestor
110958606|NCT05543824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110958607|NCT05543824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110022961|NCT00003240|Mitomycins|mitomycins|mesh-list
110947875|NCT01996865|Growth Substances|growth substances|mesh-ancestor
110958608|NCT05543824|Sensory System Agents|sensory system agents|mesh-ancestor
110958609|NCT05543824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110958610|NCT04703673|Nasal Decongestants|nasal decongestants|mesh-list
110958611|NCT04703673|Pseudoephedrine|pseudoephedrine|mesh-list
110958612|NCT04703673|Ephedrine|ephedrine|mesh-list
110958613|NCT04703673|Sympathomimetics|sympathomimetics|mesh-list
110958614|NCT04703673|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110958615|NCT04703673|Respiratory System Agents|respiratory system agents|mesh-ancestor
110958616|NCT04703673|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110958617|NCT04703673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110958618|NCT04703673|Autonomic Agents|autonomic agents|mesh-ancestor
110958619|NCT04703673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110958620|NCT04703673|Adrenergic Agents|adrenergic agents|mesh-ancestor
110958621|NCT04703673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110958622|NCT04703673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110958623|NCT04703673|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110958624|NCT04703673|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110958625|NCT05543746|Brexanolone|brexanolone|mesh-list
110958626|NCT05543746|Neurosteroids|neurosteroids|mesh-ancestor
110958627|NCT05543746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110958628|NCT05543746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110958629|NCT05543746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110958630|NCT05543746|GABA Modulators|gaba modulators|mesh-ancestor
110958631|NCT05543746|GABA Agents|gaba agents|mesh-ancestor
110958632|NCT03526536|Insulin|insulin|mesh-list
110958633|NCT03526536|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110958634|NCT03526536|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110958635|NCT03526536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110958636|NCT05306301|Ponatinib|ponatinib|mesh-list
110958637|NCT05306301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110958638|NCT05306301|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110670663|NCT02057107|Docetaxel|docetaxel|mesh-list
110958639|NCT05306301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110958640|NCT05306301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110958641|NCT05543434|Hyaluronic Acid|hyaluronic acid|mesh-list
110958642|NCT05543434|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110958643|NCT05543434|Immunologic Factors|immunologic factors|mesh-ancestor
110958644|NCT05543434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110958645|NCT05543434|Viscosupplements|viscosupplements|mesh-ancestor
110958646|NCT05543434|Protective Agents|protective agents|mesh-ancestor
110958647|NCT01858896|Glucagon|glucagon|mesh-list
110958648|NCT01858896|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
110958649|NCT01858896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110958650|NCT01858896|Hormones|hormones|mesh-ancestor
110958651|NCT01858896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110958652|NCT01858896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110958653|NCT01858896|Incretins|incretins|mesh-ancestor
110958654|NCT04940286|Paclitaxel|paclitaxel|mesh-list
110958655|NCT04940286|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110958656|NCT04940286|Gemcitabine|gemcitabine|mesh-list
110958657|NCT04940286|Durvalumab|durvalumab|mesh-list
110958658|NCT04940286|Immunoglobulins|immunoglobulins|mesh-list
110958659|NCT04940286|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110958660|NCT04940286|Immunoglobulin G|immunoglobulin g|mesh-list
110958661|NCT04940286|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110958662|NCT04940286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110958663|NCT04940286|Tubulin Modulators|tubulin modulators|mesh-ancestor
110958664|NCT04940286|Antimitotic Agents|antimitotic agents|mesh-ancestor
110958665|NCT04940286|Mitosis Modulators|mitosis modulators|mesh-ancestor
110958666|NCT04940286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110958667|NCT04940286|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110958668|NCT04940286|Antimetabolites|antimetabolites|mesh-ancestor
110958669|NCT04940286|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110958670|NCT04940286|Immunologic Factors|immunologic factors|mesh-ancestor
110958671|NCT04940286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110958672|NCT05538988|Cemiplimab|cemiplimab|mesh-list
110958673|NCT05538988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110958674|NCT05538988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110958675|NCT04667637|Edaravone|edaravone|mesh-list
110958676|NCT04667637|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110958677|NCT04667637|Antioxidants|antioxidants|mesh-ancestor
110958678|NCT04667637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110958679|NCT04667637|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110958680|NCT04667637|Protective Agents|protective agents|mesh-ancestor
110022962|NCT00003240|Mitomycin|mitomycin|mesh-list
111203424|NCT04022811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110958681|NCT04667637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110958682|NCT02253927|Ritonavir|ritonavir|mesh-list
110958683|NCT02253927|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110958684|NCT02253927|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110958685|NCT02253927|Protease Inhibitors|protease inhibitors|mesh-ancestor
110958686|NCT02253927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110958687|NCT02253927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110958688|NCT02253927|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110958689|NCT02253927|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110958690|NCT02253927|Antiviral Agents|antiviral agents|mesh-ancestor
110958691|NCT02253927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110958692|NCT02253927|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110958693|NCT02253927|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110958694|NCT03745144|Cladribine|cladribine|mesh-list
110958695|NCT03745144|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
110958696|NCT03745144|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
110958697|NCT03745144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110958698|NCT03745144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110958699|NCT03745144|Immunologic Factors|immunologic factors|mesh-ancestor
110958700|NCT03745144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110958701|NCT03745144|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110958702|NCT03745144|Contraceptive Agents|contraceptive agents|mesh-ancestor
110958703|NCT03745144|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110958704|NCT03745144|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110958705|NCT03745144|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110958706|NCT03745144|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110958707|NCT03745144|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110958708|NCT03745144|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110958709|NCT03745144|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
110958710|NCT03745144|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
110958711|NCT03745144|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
110958712|NCT05697016|Sivelestat|sivelestat|mesh-list
110958713|NCT05697016|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110958714|NCT05697016|Protease Inhibitors|protease inhibitors|mesh-ancestor
110958715|NCT05697016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110958716|NCT05697016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110958717|NCT04634877|Paclitaxel|paclitaxel|mesh-list
110958718|NCT04634877|Docetaxel|docetaxel|mesh-list
110958719|NCT04634877|Cisplatin|cisplatin|mesh-list
110958720|NCT04634877|Carboplatin|carboplatin|mesh-list
110958721|NCT04634877|Pembrolizumab|pembrolizumab|mesh-list
110958722|NCT04634877|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110958723|NCT04634877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110958724|NCT04634877|Tubulin Modulators|tubulin modulators|mesh-ancestor
110958725|NCT04634877|Antimitotic Agents|antimitotic agents|mesh-ancestor
110958726|NCT04634877|Mitosis Modulators|mitosis modulators|mesh-ancestor
110958727|NCT04634877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110958728|NCT04634877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110958729|NCT04634877|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110958730|NCT04629495|Sirolimus|sirolimus|mesh-list
110958731|NCT04629495|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110958732|NCT04629495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110958733|NCT04629495|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110958734|NCT04629495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110958735|NCT04629495|Antifungal Agents|antifungal agents|mesh-ancestor
110958736|NCT04629495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110958737|NCT04629495|Immunologic Factors|immunologic factors|mesh-ancestor
110958738|NCT04629495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110958739|NCT01567995|Clobetasone butyrate|clobetasone butyrate|mesh-list
110958740|NCT01567995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110958741|NCT01567995|Glucocorticoids|glucocorticoids|mesh-ancestor
110958742|NCT01567995|Hormones|hormones|mesh-ancestor
110958743|NCT01567995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110958744|NCT01567995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110958745|NCT05567523|Midazolam|midazolam|mesh-list
110958746|NCT05567523|Dexmedetomidine|dexmedetomidine|mesh-list
110958747|NCT05567523|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110958748|NCT05567523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110958749|NCT05567523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110958750|NCT05567523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110958751|NCT05567523|Analgesics|analgesics|mesh-ancestor
110958752|NCT05567523|Sensory System Agents|sensory system agents|mesh-ancestor
110958753|NCT05567523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110958754|NCT05567523|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110948024|NCT01059071|Etoposide|etoposide|mesh-list
110958755|NCT05567523|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110958756|NCT05567523|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110958757|NCT05567523|Adrenergic Agents|adrenergic agents|mesh-ancestor
110958758|NCT05567523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110958759|NCT05567523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110958760|NCT05567523|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110958761|NCT05567523|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110958762|NCT05567523|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110958763|NCT05567523|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110958764|NCT05567523|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110958765|NCT05567523|Anesthetics, General|anesthetics, general|mesh-ancestor
110958766|NCT05567523|Anesthetics|anesthetics|mesh-ancestor
110958767|NCT05567523|GABA Modulators|gaba modulators|mesh-ancestor
110958768|NCT05567523|GABA Agents|gaba agents|mesh-ancestor
110958769|NCT02584504|Atorvastatin|atorvastatin|mesh-list
110958770|NCT02584504|Alirocumab|alirocumab|mesh-list
110958771|NCT02584504|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110958772|NCT02584504|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110958773|NCT02584504|Antimetabolites|antimetabolites|mesh-ancestor
110958774|NCT02584504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110958775|NCT02584504|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110958776|NCT02584504|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110958777|NCT02584504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110958778|NCT02584504|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
110958779|NCT02584504|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110958780|NCT02584504|Protease Inhibitors|protease inhibitors|mesh-ancestor
110958781|NCT04599777|Sorafenib|sorafenib|mesh-list
110958782|NCT04599777|Tislelizumab|tislelizumab|mesh-list
110958783|NCT04599777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110958784|NCT04599777|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110670834|NCT00623363|Piclozotan|piclozotan|mesh-list
110958785|NCT04599777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110958786|NCT04599777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110958787|NCT04599777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110958788|NCT05007262|Calcium Dobesilate|calcium dobesilate|mesh-list
110958790|NCT05007262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110958791|NCT05007262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110958792|NCT05007262|Hemostatics|hemostatics|mesh-ancestor
110958793|NCT05007262|Coagulants|coagulants|mesh-ancestor
110958794|NCT03546075|Resveratrol|resveratrol|mesh-list
110958795|NCT03546075|Antioxidants|antioxidants|mesh-ancestor
110958796|NCT03546075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110958797|NCT03546075|Protective Agents|protective agents|mesh-ancestor
110958798|NCT03546075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110958799|NCT03546075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110958800|NCT03546075|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110958801|NCT05537584|Bupropion|bupropion|mesh-list
110958802|NCT05537584|Sertraline|sertraline|mesh-list
110958803|NCT05537584|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110958804|NCT05537584|Antidepressive Agents|antidepressive agents|mesh-ancestor
110958805|NCT05537584|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110958806|NCT05537584|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110958807|NCT05537584|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110958808|NCT05537584|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110958809|NCT05537584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110958810|NCT05537584|Dopamine Agents|dopamine agents|mesh-ancestor
110958811|NCT05537584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110958812|NCT05537584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110958813|NCT05537584|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110958814|NCT05537584|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110958815|NCT05537584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110958816|NCT05537584|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110958817|NCT05537584|Serotonin Agents|serotonin agents|mesh-ancestor
110958818|NCT01801072|Levetiracetam|levetiracetam|mesh-list
110958819|NCT01801072|Anticonvulsants|anticonvulsants|mesh-ancestor
110958820|NCT01801072|Nootropic Agents|nootropic agents|mesh-ancestor
110958821|NCT04459377|Ketamine|ketamine|mesh-list
110958822|NCT04459377|Esketamine|esketamine|mesh-list
110958823|NCT04459377|Analgesics|analgesics|mesh-ancestor
110958824|NCT04459377|Sensory System Agents|sensory system agents|mesh-ancestor
110958825|NCT04459377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110958826|NCT04459377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111203425|NCT04022811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110958827|NCT04459377|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110958828|NCT04459377|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110958829|NCT04459377|Anesthetics, General|anesthetics, general|mesh-ancestor
110958830|NCT04459377|Anesthetics|anesthetics|mesh-ancestor
110958831|NCT04459377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110958832|NCT04459377|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110958833|NCT04459377|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110958834|NCT04459377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110958835|NCT04459377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110958836|NCT04459377|Antidepressive Agents|antidepressive agents|mesh-ancestor
110958837|NCT04459377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110958838|NCT00748618|Vitamin D|vitamin d|mesh-list
110958839|NCT00748618|Ergocalciferols|ergocalciferols|mesh-list
110958840|NCT00748618|Cholecalciferol|cholecalciferol|mesh-list
110958841|NCT00748618|Vitamins|vitamins|mesh-list
110958842|NCT00748618|Micronutrients|micronutrients|mesh-ancestor
110958843|NCT00748618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110958844|NCT00748618|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110958845|NCT00748618|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110958846|NCT04447755|Lenvatinib|lenvatinib|mesh-list
110958847|NCT04447755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110958848|NCT04447755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110958849|NCT04447755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110958850|NCT04447755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110958851|NCT02254005|Maytansine|maytansine|mesh-list
110958852|NCT02254005|Bivatuzumab mertansine|bivatuzumab mertansine|mesh-list
110958853|NCT02254005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110958854|NCT02254005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110958855|NCT02254005|Tubulin Modulators|tubulin modulators|mesh-ancestor
110958856|NCT02254005|Antimitotic Agents|antimitotic agents|mesh-ancestor
110958857|NCT02254005|Mitosis Modulators|mitosis modulators|mesh-ancestor
110958858|NCT02254005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110958859|NCT02254005|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110958860|NCT02254005|Immunotoxins|immunotoxins|mesh-ancestor
110958861|NCT02254005|Immunoconjugates|immunoconjugates|mesh-ancestor
110958862|NCT02254005|Immunologic Factors|immunologic factors|mesh-ancestor
110958863|NCT02254005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110958864|NCT04404387|Ascorbic Acid|ascorbic acid|mesh-list
110958865|NCT04404387|Vitamins|vitamins|mesh-ancestor
110958866|NCT04404387|Micronutrients|micronutrients|mesh-ancestor
110781093|NCT03568500|Risperidone|risperidone|mesh-list
110958867|NCT04404387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110958868|NCT04404387|Antioxidants|antioxidants|mesh-ancestor
110958869|NCT04404387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110958870|NCT04404387|Protective Agents|protective agents|mesh-ancestor
110958871|NCT03546855|Apatinib|apatinib|mesh-list
110958872|NCT03546855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110958873|NCT03546855|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110958874|NCT03546855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110958875|NCT03546855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110958876|NCT05679310|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
110958877|NCT05679310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110958878|NCT05679310|Antioxidants|antioxidants|mesh-ancestor
110958879|NCT05679310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110958880|NCT05679310|Protective Agents|protective agents|mesh-ancestor
110958881|NCT05679310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110958882|NCT05679310|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110958883|NCT05537272|Ascorbic Acid|ascorbic acid|mesh-list
110958884|NCT05537272|Tadalafil|tadalafil|mesh-list
110958885|NCT05537272|Tamsulosin|tamsulosin|mesh-list
110958886|NCT05537272|Vitamins|vitamins|mesh-ancestor
110958887|NCT05537272|Micronutrients|micronutrients|mesh-ancestor
110958888|NCT05537272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110958889|NCT05537272|Antioxidants|antioxidants|mesh-ancestor
110958890|NCT05537272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110958891|NCT05537272|Protective Agents|protective agents|mesh-ancestor
110958892|NCT05537272|Vasodilator Agents|vasodilator agents|mesh-ancestor
110958893|NCT05537272|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110958894|NCT05537272|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110958895|NCT05537272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110958896|NCT05537272|Urological Agents|urological agents|mesh-ancestor
110958897|NCT05537272|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110958898|NCT05537272|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110958899|NCT05537272|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110958900|NCT05537272|Adrenergic Agents|adrenergic agents|mesh-ancestor
110958901|NCT05537272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110958902|NCT05537194|1,4-dihydropyridine|1,4-dihydropyridine|mesh-list
110958903|NCT05537194|Calcium|calcium|mesh-list
110022963|NCT00003240|Vinblastine|vinblastine|mesh-list
111203426|NCT04022811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111203427|NCT04022811|Glucocorticoids|glucocorticoids|mesh-ancestor
111203428|NCT04022811|Hormones|hormones|mesh-ancestor
111203429|NCT04022811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111203430|NCT04022811|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111203431|NCT04022811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111203432|NCT04022811|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111203433|NCT04022811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111203434|NCT04022811|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111203435|NCT04022811|Immunologic Factors|immunologic factors|mesh-ancestor
111203436|NCT04022811|Viscosupplements|viscosupplements|mesh-ancestor
111203437|NCT04022811|Protective Agents|protective agents|mesh-ancestor
111203438|NCT04022811|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111203439|NCT04022811|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111203440|NCT04022811|Analgesics|analgesics|mesh-ancestor
110948183|NCT00479128|Gemcitabine|gemcitabine|mesh-list
110948184|NCT00479128|Doxorubicin|doxorubicin|mesh-list
110948185|NCT00479128|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110948186|NCT00479128|Bortezomib|bortezomib|mesh-list
110948187|NCT00479128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110948188|NCT00479128|Antimetabolites|antimetabolites|mesh-ancestor
110948189|NCT00479128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110948190|NCT00479128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110948191|NCT00479128|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110948192|NCT00479128|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110948193|NCT00479128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110948194|NCT00479128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110958904|NCT05537194|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110958905|NCT05537194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110958906|NCT05537194|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110958907|NCT05537194|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110958908|NCT05537194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110958909|NCT05536882|Adapalene|adapalene|mesh-list
110958910|NCT05536882|Benzoyl Peroxide|benzoyl peroxide|mesh-list
110958911|NCT05536882|Dermatologic Agents|dermatologic agents|mesh-ancestor
110958912|NCT05536882|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110958913|NCT05536882|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110958914|NCT05536882|Analgesics|analgesics|mesh-ancestor
111203441|NCT04022811|Sensory System Agents|sensory system agents|mesh-ancestor
111203442|NCT04022811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111203443|NCT04145583|Voriconazole|voriconazole|mesh-list
111203444|NCT04145583|Antifungal Agents|antifungal agents|mesh-ancestor
111203445|NCT04145583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111203446|NCT04145583|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111203447|NCT04145583|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111203448|NCT04145583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111203449|NCT04145583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111203450|NCT04145583|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111203451|NCT04145583|Hormone Antagonists|hormone antagonists|mesh-ancestor
111498011|NCT02530554|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110958915|NCT05536882|Sensory System Agents|sensory system agents|mesh-ancestor
110958916|NCT05536882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110958917|NCT05536882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110958918|NCT05536882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110958919|NCT05536882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110958920|NCT03931161|Evolocumab|evolocumab|mesh-list
110958921|NCT03931161|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
110958922|NCT03931161|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110958923|NCT03931161|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110958924|NCT03931161|Antimetabolites|antimetabolites|mesh-ancestor
110958925|NCT03931161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110958926|NCT03931161|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110958927|NCT03931161|Protease Inhibitors|protease inhibitors|mesh-ancestor
110958928|NCT03931161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110958929|NCT03931161|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110958930|NCT05037123|Ketamine|ketamine|mesh-list
110958931|NCT05037123|Analgesics|analgesics|mesh-ancestor
110958932|NCT05037123|Sensory System Agents|sensory system agents|mesh-ancestor
110958933|NCT05037123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110958934|NCT05037123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110958935|NCT05037123|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110958936|NCT05037123|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110958937|NCT05037123|Anesthetics, General|anesthetics, general|mesh-ancestor
110958938|NCT05037123|Anesthetics|anesthetics|mesh-ancestor
110942734|NCT05707208|Anesthetics, Local|anesthetics, local|mesh-ancestor
111203452|NCT04145583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111203453|NCT04145583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111203454|NCT04145583|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111203455|NCT04022421|Hydroxychloroquine|hydroxychloroquine|mesh-list
111203456|NCT04022421|Antimalarials|antimalarials|mesh-ancestor
111203457|NCT04022421|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111203458|NCT04022421|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111203459|NCT04022421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111203460|NCT04022421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111203461|NCT04022421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111203462|NCT04022421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111203463|NCT04145193|Leucovorin|leucovorin|mesh-list
111203464|NCT04145193|Fluorouracil|fluorouracil|mesh-list
111203465|NCT04145193|Oxaliplatin|oxaliplatin|mesh-list
111203466|NCT04145193|Durvalumab|durvalumab|mesh-list
111203467|NCT04145193|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111203468|NCT04145193|Antimetabolites|antimetabolites|mesh-ancestor
111203469|NCT04145193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111203470|NCT04145193|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111203471|NCT04145193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111203472|NCT04145193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111203473|NCT04145193|Immunologic Factors|immunologic factors|mesh-ancestor
111203474|NCT04145193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111203475|NCT04145193|Antidotes|antidotes|mesh-ancestor
111203476|NCT04145193|Protective Agents|protective agents|mesh-ancestor
111203477|NCT04145193|Vitamin B Complex|vitamin b complex|mesh-ancestor
111203478|NCT04145193|Vitamins|vitamins|mesh-ancestor
111203479|NCT04145193|Micronutrients|micronutrients|mesh-ancestor
111203480|NCT04145193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111203481|NCT04147845|Triamcinolone|triamcinolone|mesh-list
111203482|NCT04147845|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
111203483|NCT04147845|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
111203484|NCT04147845|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
111203485|NCT04147845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111203486|NCT04147845|Glucocorticoids|glucocorticoids|mesh-ancestor
111203487|NCT04147845|Hormones|hormones|mesh-ancestor
111203488|NCT04147845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111203489|NCT04147845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111203490|NCT04147845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111203491|NCT04147845|Immunologic Factors|immunologic factors|mesh-ancestor
111203492|NCT04147845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111203493|NCT04147845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111203494|NCT01849783|Thalidomide|thalidomide|mesh-list
111203495|NCT01849783|Dexamethasone|dexamethasone|mesh-list
111203496|NCT01849783|Cyclophosphamide|cyclophosphamide|mesh-list
111203497|NCT01849783|Melphalan|melphalan|mesh-list
111203498|NCT01849783|Doxorubicin|doxorubicin|mesh-list
111203499|NCT01849783|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111203500|NCT01849783|Etoposide|etoposide|mesh-list
111203501|NCT01849783|Etoposide phosphate|etoposide phosphate|mesh-list
111203502|NCT01849783|Bortezomib|bortezomib|mesh-list
111203503|NCT01849783|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111203504|NCT01849783|Immunologic Factors|immunologic factors|mesh-ancestor
111203505|NCT01849783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111203506|NCT01849783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111203507|NCT01849783|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111203508|NCT01849783|Alkylating Agents|alkylating agents|mesh-ancestor
111203509|NCT01849783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111203510|NCT01849783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111203511|NCT01849783|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111203512|NCT01849783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111203513|NCT01849783|Antiemetics|antiemetics|mesh-ancestor
111203514|NCT01849783|Autonomic Agents|autonomic agents|mesh-ancestor
111203515|NCT01849783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111203516|NCT01849783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111203517|NCT01849783|Glucocorticoids|glucocorticoids|mesh-ancestor
110942735|NCT05707208|Anesthetics|anesthetics|mesh-ancestor
110942736|NCT05707208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110942737|NCT05707208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110942738|NCT05707208|Sensory System Agents|sensory system agents|mesh-ancestor
110942739|NCT05707208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110942740|NCT05707208|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110942741|NCT05707208|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111203518|NCT01849783|Hormones|hormones|mesh-ancestor
111203519|NCT01849783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111203520|NCT01849783|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111203521|NCT01849783|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111203522|NCT01849783|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111203523|NCT01849783|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111203524|NCT01849783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111203525|NCT01849783|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111203526|NCT01849783|Leprostatic Agents|leprostatic agents|mesh-ancestor
111203527|NCT01849783|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111203528|NCT01849783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111203529|NCT01849783|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111203530|NCT01849783|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111203531|NCT01849783|Growth Substances|growth substances|mesh-ancestor
111203532|NCT01849783|Growth Inhibitors|growth inhibitors|mesh-ancestor
111203533|NCT01611883|Ezetimibe|ezetimibe|mesh-list
111203534|NCT01611883|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111203535|NCT01611883|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111203536|NCT01611883|Antimetabolites|antimetabolites|mesh-ancestor
111203537|NCT01611883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111203538|NCT01611883|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111203539|NCT04170517|Progesterone|progesterone|mesh-list
111203540|NCT04170517|Progestins|progestins|mesh-ancestor
111203541|NCT04170517|Hormones|hormones|mesh-ancestor
111203542|NCT04170517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111203543|NCT04170517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111203544|NCT01848457|Methotrexate|methotrexate|mesh-list
111203545|NCT01848457|Pantoprazole|pantoprazole|mesh-list
111203546|NCT01848457|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111203547|NCT01848457|Abortifacient Agents|abortifacient agents|mesh-ancestor
111203548|NCT01848457|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111203549|NCT01848457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111203550|NCT01848457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111203551|NCT01848457|Antimetabolites|antimetabolites|mesh-ancestor
111203552|NCT01848457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111203553|NCT01848457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111203554|NCT01848457|Dermatologic Agents|dermatologic agents|mesh-ancestor
111203555|NCT01848457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111203556|NCT01848457|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111203557|NCT01848457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111203558|NCT01848457|Immunologic Factors|immunologic factors|mesh-ancestor
111203559|NCT01848457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111203560|NCT01848457|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111203561|NCT01848457|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111203562|NCT01848457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111203563|NCT01848457|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111203564|NCT01870999|Aripiprazole|aripiprazole|mesh-list
111203565|NCT01870999|Antidepressive Agents|antidepressive agents|mesh-ancestor
111203566|NCT01870999|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111203567|NCT01870999|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111203568|NCT01870999|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111203569|NCT01870999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111203570|NCT01870999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111203571|NCT01870999|Dopamine Agonists|dopamine agonists|mesh-ancestor
111203572|NCT01870999|Dopamine Agents|dopamine agents|mesh-ancestor
111203573|NCT01870999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111203574|NCT01870999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111203575|NCT01870999|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111203576|NCT01870999|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111203577|NCT01870999|Serotonin Agents|serotonin agents|mesh-ancestor
111203578|NCT01870999|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111203579|NCT01870999|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111203580|NCT01870999|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111203581|NCT01870999|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111203582|NCT01870921|Ticagrelor|ticagrelor|mesh-list
111203583|NCT01870921|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111203584|NCT01870921|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111203585|NCT01870921|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111203586|NCT01870921|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110942857|NCT05665595|Pembrolizumab|pembrolizumab|mesh-list
110942858|NCT05665595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110942859|NCT05665595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110942860|NCT05665595|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110942861|NCT05665595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110665845|NCT00811967|Ribavirin|ribavirin|mesh-list
111203587|NCT01870921|Purinergic Agents|purinergic agents|mesh-ancestor
111203588|NCT01870921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111203589|NCT01870921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111203590|NCT01870921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111203591|NCT00526474|Vorapaxar|vorapaxar|mesh-list
111203592|NCT00526474|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111203593|NCT01848145|Ofatumumab|ofatumumab|mesh-list
111203594|NCT01848145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111203595|NCT00527644|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
111203596|NCT00527644|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
111203597|NCT00527644|beta-Endorphin|beta-endorphin|mesh-list
111203598|NCT00527644|Hormones|hormones|mesh-ancestor
111498012|NCT02530554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110942898|NCT05652205|Linaclotide|linaclotide|mesh-list
110942899|NCT05652205|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
110942900|NCT05652205|Enzyme Activators|enzyme activators|mesh-ancestor
110942901|NCT05652205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110942902|NCT05652205|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110942905|NCT05643573|Apixaban|apixaban|mesh-list
110942906|NCT05643573|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110942907|NCT05643573|Antithrombins|antithrombins|mesh-ancestor
110942908|NCT05643573|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110942909|NCT05643573|Protease Inhibitors|protease inhibitors|mesh-ancestor
110942910|NCT05643573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110942911|NCT05643573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110942912|NCT05643573|Anticoagulants|anticoagulants|mesh-ancestor
110958939|NCT05037123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110958940|NCT05037123|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110958941|NCT05037123|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110958942|NCT05037123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110958943|NCT05037123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110958944|NCT04354155|Enoxaparin|enoxaparin|mesh-list
110958945|NCT04354155|Anticoagulants|anticoagulants|mesh-ancestor
110958946|NCT04354155|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110958947|NCT04354155|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110958948|NCT04354155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110958949|NCT04450654|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110958950|NCT04450654|Immunologic Factors|immunologic factors|mesh-ancestor
110958951|NCT04450654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110958952|NCT04350021|Cyclophosphamide|cyclophosphamide|mesh-list
110958953|NCT04350021|Capecitabine|capecitabine|mesh-list
110958954|NCT04350021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110958955|NCT04350021|Immunologic Factors|immunologic factors|mesh-ancestor
110958956|NCT04350021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110958957|NCT04350021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110958958|NCT04350021|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110958959|NCT04350021|Alkylating Agents|alkylating agents|mesh-ancestor
110958960|NCT04350021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110958961|NCT04350021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110958962|NCT04350021|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110958963|NCT04350021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110958964|NCT04350021|Antimetabolites|antimetabolites|mesh-ancestor
110958965|NCT05536570|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
110958966|NCT05536570|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110958967|NCT05536570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110958968|NCT05536570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110958969|NCT05536570|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110958970|NCT05536570|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110958971|NCT05536570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110958972|NCT05536570|Cholinergic Agents|cholinergic agents|mesh-ancestor
110958973|NCT05536570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110958974|NCT03877965|Digoxin|digoxin|mesh-list
110958975|NCT03877965|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110958976|NCT03877965|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110958977|NCT03877965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110958978|NCT03877965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110958979|NCT03877965|Protective Agents|protective agents|mesh-ancestor
110958980|NCT03877965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110958981|NCT02253849|Ritonavir|ritonavir|mesh-list
110958982|NCT02253849|Tipranavir|tipranavir|mesh-list
110958983|NCT02253849|Carbamazepine|carbamazepine|mesh-list
110958984|NCT02253849|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111203599|NCT00527644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111203600|NCT00527644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111203601|NCT00527644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111203602|NCT00527644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111203603|NCT01847443|Nicotine|nicotine|mesh-list
111203604|NCT01847443|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111203605|NCT01847443|Autonomic Agents|autonomic agents|mesh-ancestor
111203606|NCT01847443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111203607|NCT01847443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111203608|NCT01847443|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111203609|NCT01847443|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111203610|NCT01847443|Cholinergic Agents|cholinergic agents|mesh-ancestor
111203611|NCT01847443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111203612|NCT01847443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111203613|NCT00527878|Ranitidine|ranitidine|mesh-list
111203614|NCT00527878|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
111203615|NCT00527878|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111203616|NCT00527878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111203617|NCT00527878|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
111203618|NCT00527878|Histamine Antagonists|histamine antagonists|mesh-ancestor
111203619|NCT00527878|Histamine Agents|histamine agents|mesh-ancestor
111203620|NCT00527878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111203621|NCT00527878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111203622|NCT00527878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111203623|NCT05558878|Ambroxol|ambroxol|mesh-list
111203624|NCT05558878|Expectorants|expectorants|mesh-ancestor
111203625|NCT05558878|Respiratory System Agents|respiratory system agents|mesh-ancestor
111203626|NCT05621434|Maleic acid|maleic acid|mesh-list
111203627|NCT05621434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111203628|NCT05621434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111203629|NCT01870843|Escitalopram|escitalopram|mesh-list
111203630|NCT01870843|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111203631|NCT01870843|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111203632|NCT01870843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111203633|NCT01870843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111203634|NCT01870843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111203635|NCT01870843|Serotonin Agents|serotonin agents|mesh-ancestor
111203636|NCT01870843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111203637|NCT01816477|Ropivacaine|ropivacaine|mesh-list
111203638|NCT01816477|Anesthetics, Local|anesthetics, local|mesh-ancestor
111203639|NCT01816477|Anesthetics|anesthetics|mesh-ancestor
111203640|NCT01816477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111498013|NCT02530554|Disinfectants|disinfectants|mesh-ancestor
110942952|NCT05629585|Pembrolizumab|pembrolizumab|mesh-list
110942953|NCT05629585|Durvalumab|durvalumab|mesh-list
110942954|NCT05629585|Capecitabine|capecitabine|mesh-list
110942955|NCT05629585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110942956|NCT05629585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110942957|NCT05629585|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110942958|NCT05629585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110942959|NCT05629585|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110942960|NCT05629585|Antimetabolites|antimetabolites|mesh-ancestor
110942973|NCT05624554|Cyclophosphamide|cyclophosphamide|mesh-list
110942974|NCT05624554|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110942975|NCT05624554|Rituximab|rituximab|mesh-list
110942976|NCT05624554|Fludarabine|fludarabine|mesh-list
110942977|NCT05624554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110942978|NCT05624554|Immunologic Factors|immunologic factors|mesh-ancestor
110942979|NCT05624554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110942980|NCT05624554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110942981|NCT05624554|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110942982|NCT05624554|Alkylating Agents|alkylating agents|mesh-ancestor
110942983|NCT05624554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110942984|NCT05624554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110942985|NCT05624554|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110942986|NCT05624554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110022964|NCT00003240|Vindesine|vindesine|mesh-list
110022965|NCT00003240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110022966|NCT00003240|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110022967|NCT00003240|Tubulin Modulators|tubulin modulators|mesh-ancestor
110022968|NCT00003240|Antimitotic Agents|antimitotic agents|mesh-ancestor
110022969|NCT00003240|Mitosis Modulators|mitosis modulators|mesh-ancestor
110023144|NCT00003408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111203641|NCT01816477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111203642|NCT01816477|Sensory System Agents|sensory system agents|mesh-ancestor
111203643|NCT01816477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111203644|NCT01846507|Tranexamic Acid|tranexamic acid|mesh-list
111203645|NCT01846507|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111203646|NCT01846507|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111203647|NCT01846507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111203648|NCT01846507|Hemostatics|hemostatics|mesh-ancestor
111203649|NCT01846507|Coagulants|coagulants|mesh-ancestor
111203650|NCT01846039|Hyaluronic Acid|hyaluronic acid|mesh-list
111203651|NCT01846039|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111203652|NCT01846039|Immunologic Factors|immunologic factors|mesh-ancestor
111203653|NCT01846039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111203654|NCT01846039|Viscosupplements|viscosupplements|mesh-ancestor
111203655|NCT01846039|Protective Agents|protective agents|mesh-ancestor
111203656|NCT01610167|Listerine|listerine|mesh-list
111203657|NCT01610167|Fluorides|fluorides|mesh-list
111203658|NCT01610167|Sodium Fluoride|sodium fluoride|mesh-list
111203659|NCT01610167|Cariostatic Agents|cariostatic agents|mesh-ancestor
111203660|NCT01610167|Protective Agents|protective agents|mesh-ancestor
111203661|NCT01610167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111203662|NCT01610167|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111203663|NCT01610167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111203664|NCT04478500|Minocycline|minocycline|mesh-list
111203665|NCT04478500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111203666|NCT04478500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111203667|NCT01816243|Fentanyl|fentanyl|mesh-list
111203668|NCT01816243|Morphine|morphine|mesh-list
111203669|NCT01816243|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111203670|NCT01816243|Narcotics|narcotics|mesh-ancestor
111203671|NCT01816243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111203672|NCT01816243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111203673|NCT01816243|Analgesics|analgesics|mesh-ancestor
111203674|NCT01816243|Sensory System Agents|sensory system agents|mesh-ancestor
111203675|NCT01816243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111203676|NCT01816243|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111203677|NCT01816243|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111203678|NCT01816243|Anesthetics, General|anesthetics, general|mesh-ancestor
111203679|NCT01816243|Anesthetics|anesthetics|mesh-ancestor
111203680|NCT05576896|Hydroxychloroquine|hydroxychloroquine|mesh-list
111203681|NCT05576896|Cetuximab|cetuximab|mesh-list
111203682|NCT05576896|Panitumumab|panitumumab|mesh-list
111203683|NCT05576896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111203684|NCT05576896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111203685|NCT05576896|Antimalarials|antimalarials|mesh-ancestor
111203686|NCT05576896|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111203687|NCT05576896|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111203688|NCT05576896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111203689|NCT05576896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111203690|NCT05576896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111203691|NCT05576896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111203692|NCT01845805|Azacitidine|azacitidine|mesh-list
111203693|NCT01845805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111203694|NCT01845805|Antimetabolites|antimetabolites|mesh-ancestor
111203695|NCT01845805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111203696|NCT01845805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111203697|NCT01845805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111203698|NCT05575804|Capecitabine|capecitabine|mesh-list
111203699|NCT05575804|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111203700|NCT05575804|Antimetabolites|antimetabolites|mesh-ancestor
111203701|NCT05575804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111203702|NCT05575804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111203703|NCT01845025|Fluticasone|fluticasone|mesh-list
110943033|NCT05605964|Relugolix|relugolix|mesh-list
110943034|NCT05605964|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110943035|NCT05605964|Fertility Agents|fertility agents|mesh-ancestor
110943036|NCT05605964|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110943037|NCT05605964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110943038|NCT05605964|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110943039|NCT05605964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110943040|NCT05605964|Androgen Antagonists|androgen antagonists|mesh-ancestor
110943041|NCT05605964|Hormone Antagonists|hormone antagonists|mesh-ancestor
110943042|NCT05605964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110943043|NCT05593341|Analgesics, Opioid|analgesics, opioid|mesh-list
110943044|NCT05593341|Narcotics|narcotics|mesh-ancestor
110943045|NCT05593341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110943047|NCT05593341|Analgesics|analgesics|mesh-ancestor
111203704|NCT01845025|Xhance|xhance|mesh-list
111203705|NCT01845025|Formoterol Fumarate|formoterol fumarate|mesh-list
111203706|NCT01845025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111203707|NCT01845025|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111203708|NCT01845025|Autonomic Agents|autonomic agents|mesh-ancestor
111203709|NCT01845025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111203710|NCT01845025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111203711|NCT01845025|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111203712|NCT01845025|Respiratory System Agents|respiratory system agents|mesh-ancestor
111203713|NCT01845025|Dermatologic Agents|dermatologic agents|mesh-ancestor
111203714|NCT01845025|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111203715|NCT01845025|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111203716|NCT01845025|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111203717|NCT01845025|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111203718|NCT01845025|Adrenergic Agents|adrenergic agents|mesh-ancestor
111203719|NCT01845025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111203720|NCT01845025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111203721|NCT04148872|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111203722|NCT04148872|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111203723|NCT04148872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111203724|NCT04148872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111203725|NCT04148872|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111203726|NCT04148872|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111203727|NCT04148872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111203728|NCT04148872|Cholinergic Agents|cholinergic agents|mesh-ancestor
111203729|NCT04148872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111203730|NCT05072236|Lidocaine|lidocaine|mesh-list
111203731|NCT05072236|Anesthetics, Local|anesthetics, local|mesh-ancestor
111203732|NCT05072236|Anesthetics|anesthetics|mesh-ancestor
111203733|NCT05072236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111203734|NCT05072236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111203735|NCT05072236|Sensory System Agents|sensory system agents|mesh-ancestor
111203736|NCT05072236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111203737|NCT05072236|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111203738|NCT05072236|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111203739|NCT05072236|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111203740|NCT05072236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111203741|NCT05072236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111203742|NCT04847440|Tenofovir|tenofovir|mesh-list
111203743|NCT04847440|Antiviral Agents|antiviral agents|mesh-ancestor
111203744|NCT04847440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111203745|NCT04847440|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111203746|NCT04847440|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111203747|NCT04847440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111203748|NCT04847440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111203749|NCT04847440|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111203750|NCT04847440|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111203751|NCT01870297|Liraglutide|liraglutide|mesh-list
111203752|NCT01870297|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111203753|NCT01870297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111203754|NCT01870297|Incretins|incretins|mesh-ancestor
111203755|NCT01870297|Hormones|hormones|mesh-ancestor
111203756|NCT01870297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111203757|NCT01814761|Bimatoprost|bimatoprost|mesh-list
111203758|NCT01814761|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111203759|NCT04616248|Poly I-C|poly i-c|mesh-list
111203760|NCT04616248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111203761|NCT04616248|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
111203762|NCT04616248|Antibodies|antibodies|mesh-list
111203763|NCT04616248|Immunoglobulins|immunoglobulins|mesh-list
111203764|NCT04616248|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110943151|NCT05562466|Budesonide|budesonide|mesh-list
110943152|NCT05562466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110943153|NCT05562466|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110943154|NCT05562466|Autonomic Agents|autonomic agents|mesh-ancestor
110943155|NCT05562466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110943156|NCT05562466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110943157|NCT05562466|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110943158|NCT05562466|Respiratory System Agents|respiratory system agents|mesh-ancestor
110943159|NCT05562466|Glucocorticoids|glucocorticoids|mesh-ancestor
110943160|NCT05562466|Hormones|hormones|mesh-ancestor
110943161|NCT05562466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110943162|NCT05561959|Nitroglycerin|nitroglycerin|mesh-list
110943163|NCT05561959|Vasodilator Agents|vasodilator agents|mesh-ancestor
111203765|NCT04616248|Poly ICLC|poly iclc|mesh-list
111203766|NCT04616248|Flt3 ligand protein|flt3 ligand protein|mesh-list
111203767|NCT04616248|Immunologic Factors|immunologic factors|mesh-ancestor
111203768|NCT04616248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111203769|NCT04616248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111203770|NCT04616248|Interferon Inducers|interferon inducers|mesh-ancestor
111203771|NCT04616248|Laxatives|laxatives|mesh-ancestor
111203772|NCT04616248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111203773|NCT04616248|Antiviral Agents|antiviral agents|mesh-ancestor
111203774|NCT04616248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111203775|NCT04616248|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111203776|NCT04616248|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111203777|NCT04616248|Protective Agents|protective agents|mesh-ancestor
111203778|NCT01798030|Vitamin D|vitamin d|mesh-list
111203779|NCT01798030|Vitamins|vitamins|mesh-ancestor
111203780|NCT01798030|Micronutrients|micronutrients|mesh-ancestor
111203781|NCT01798030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111203782|NCT01798030|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111203783|NCT03329950|Pembrolizumab|pembrolizumab|mesh-list
111203784|NCT03329950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111203785|NCT03329950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111203786|NCT03329950|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111203787|NCT03329950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111203788|NCT01814371|Mupirocin|mupirocin|mesh-list
111203789|NCT01814371|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111203790|NCT01814371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111203791|NCT01814371|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111203792|NCT01814371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111203793|NCT01814371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111203794|NCT03232138|Sulforaphane|sulforaphane|mesh-list
111203795|NCT03232138|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
111203796|NCT03232138|Protective Agents|protective agents|mesh-ancestor
111203797|NCT03232138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111203798|NCT03232138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111203799|NCT01814137|Insulin|insulin|mesh-list
111203800|NCT01814137|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111203801|NCT01814137|Insulin Aspart|insulin aspart|mesh-list
111203802|NCT01814137|Insulin, Long-Acting|insulin, long-acting|mesh-list
111203803|NCT01814137|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
111203804|NCT01814137|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111203805|NCT01814137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111203806|NCT01813435|Aspirin|aspirin|mesh-list
111203807|NCT01813435|Clopidogrel|clopidogrel|mesh-list
111203808|NCT01813435|Ticagrelor|ticagrelor|mesh-list
111203809|NCT01813435|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111203810|NCT01813435|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111203811|NCT01813435|Analgesics|analgesics|mesh-ancestor
111203812|NCT01813435|Sensory System Agents|sensory system agents|mesh-ancestor
111203813|NCT01813435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111203814|NCT01813435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111203815|NCT01813435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111203816|NCT01813435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111203817|NCT01813435|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111203818|NCT01813435|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111203819|NCT01813435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111203820|NCT01813435|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111203821|NCT01813435|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111203822|NCT01813435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111203823|NCT01813435|Antipyretics|antipyretics|mesh-ancestor
111203824|NCT01813435|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111203825|NCT01813435|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111203826|NCT01813435|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111203827|NCT01813435|Purinergic Agents|purinergic agents|mesh-ancestor
111203828|NCT01813435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110943224|NCT05537740|Pembrolizumab|pembrolizumab|mesh-list
110943225|NCT05537740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110943226|NCT05537740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110943227|NCT05537740|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110943228|NCT05537740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110943252|NCT05526755|Osimertinib|osimertinib|mesh-list
110943253|NCT05526755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110943254|NCT05526755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110660738|NCT00979160|Dasatinib|dasatinib|mesh-list
110943255|NCT05526755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111203829|NCT01798498|Hyaluronic Acid|hyaluronic acid|mesh-list
111203830|NCT01798498|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110943256|NCT05526755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111203831|NCT01798498|Immunologic Factors|immunologic factors|mesh-ancestor
111203832|NCT01798498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111203833|NCT01798498|Viscosupplements|viscosupplements|mesh-ancestor
111203834|NCT01798498|Protective Agents|protective agents|mesh-ancestor
111203835|NCT01813357|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111203836|NCT01813357|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111203837|NCT01813357|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111203838|NCT01813357|Antimetabolites|antimetabolites|mesh-ancestor
111203839|NCT01813357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111203840|NCT01813357|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111203841|NCT01813357|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111203842|NCT01813357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111203843|NCT02346526|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
111203844|NCT02346526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111203846|NCT01811953|Empagliflozin|empagliflozin|mesh-list
111203847|NCT01811953|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111203848|NCT01811953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111203849|NCT01811953|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111203850|NCT01811953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111203851|NCT03895762|Fentanyl|fentanyl|mesh-list
111203852|NCT03895762|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111203853|NCT03895762|Narcotics|narcotics|mesh-ancestor
111203854|NCT03895762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111203855|NCT03895762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111203856|NCT03895762|Analgesics|analgesics|mesh-ancestor
111203857|NCT03895762|Sensory System Agents|sensory system agents|mesh-ancestor
111203858|NCT03895762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111203859|NCT03895762|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111203860|NCT03895762|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111203861|NCT03895762|Anesthetics, General|anesthetics, general|mesh-ancestor
111203862|NCT03895762|Anesthetics|anesthetics|mesh-ancestor
111203863|NCT01033552|Cyclosporine|cyclosporine|mesh-list
111203864|NCT01033552|Mycophenolic Acid|mycophenolic acid|mesh-list
111203865|NCT01033552|Cyclophosphamide|cyclophosphamide|mesh-list
111203866|NCT01033552|Fludarabine|fludarabine|mesh-list
111203867|NCT01033552|Cyclosporins|cyclosporins|mesh-list
111203868|NCT01033552|Antilymphocyte Serum|antilymphocyte serum|mesh-list
111203869|NCT01033552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111203870|NCT01033552|Immunologic Factors|immunologic factors|mesh-ancestor
111203871|NCT01033552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111203872|NCT01033552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111203873|NCT01033552|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111203874|NCT01033552|Alkylating Agents|alkylating agents|mesh-ancestor
111203875|NCT01033552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111203876|NCT01033552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111203877|NCT01033552|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111203878|NCT01033552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110943277|NCT05507541|Pembrolizumab|pembrolizumab|mesh-list
110943278|NCT05507541|Immunoglobulin G|immunoglobulin g|mesh-list
110943279|NCT05507541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110943280|NCT05507541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110943281|NCT05507541|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110943282|NCT05507541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110943283|NCT05507541|Immunologic Factors|immunologic factors|mesh-ancestor
110943284|NCT05507541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110943290|NCT05487755|Tadalafil|tadalafil|mesh-list
110943291|NCT05487755|Pentoxifylline|pentoxifylline|mesh-list
110943292|NCT05487755|Vasodilator Agents|vasodilator agents|mesh-ancestor
110943293|NCT05487755|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110943294|NCT05487755|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110943295|NCT05487755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110943296|NCT05487755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110943297|NCT05487755|Urological Agents|urological agents|mesh-ancestor
110943298|NCT05487755|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110943299|NCT05487755|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110943300|NCT05487755|Protective Agents|protective agents|mesh-ancestor
110943301|NCT05487755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110943302|NCT05487755|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110943303|NCT05487755|Antioxidants|antioxidants|mesh-ancestor
110943304|NCT05478837|Cyclophosphamide|cyclophosphamide|mesh-list
110943305|NCT05478837|Fludarabine|fludarabine|mesh-list
111203879|NCT01033552|Antifungal Agents|antifungal agents|mesh-ancestor
111203880|NCT01033552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111203881|NCT01033552|Dermatologic Agents|dermatologic agents|mesh-ancestor
111203882|NCT01033552|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111203883|NCT01033552|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111203884|NCT01033552|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111203885|NCT01033552|Antitubercular Agents|antitubercular agents|mesh-ancestor
111203886|NCT01033552|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111203887|NCT00997906|Paclitaxel|paclitaxel|mesh-list
111203888|NCT00997906|Carboplatin|carboplatin|mesh-list
111203889|NCT00997906|Gemcitabine|gemcitabine|mesh-list
111203890|NCT00997906|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111203891|NCT00997906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111203892|NCT00997906|Tubulin Modulators|tubulin modulators|mesh-ancestor
111203893|NCT00997906|Antimitotic Agents|antimitotic agents|mesh-ancestor
111203894|NCT00997906|Mitosis Modulators|mitosis modulators|mesh-ancestor
111203895|NCT00997906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111203896|NCT00997906|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111203897|NCT00997906|Antimetabolites|antimetabolites|mesh-ancestor
111203898|NCT05246644|Acetaminophen|acetaminophen|mesh-list
111203899|NCT05246644|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111203900|NCT05246644|Analgesics|analgesics|mesh-ancestor
111203901|NCT05246644|Sensory System Agents|sensory system agents|mesh-ancestor
111203902|NCT05246644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111203903|NCT05246644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111203904|NCT05246644|Antipyretics|antipyretics|mesh-ancestor
111203905|NCT01798576|Interferons|interferons|mesh-list
111203906|NCT01798576|Ribavirin|ribavirin|mesh-list
111203907|NCT01798576|Interferon-alpha|interferon-alpha|mesh-list
111203908|NCT01798576|Interferon alpha-2|interferon alpha-2|mesh-list
111203909|NCT01798576|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
111203910|NCT01798576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111203911|NCT01798576|Antiviral Agents|antiviral agents|mesh-ancestor
111203912|NCT01798576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111203913|NCT01798576|Antimetabolites|antimetabolites|mesh-ancestor
111203914|NCT01798576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111203915|NCT01798576|Immunologic Factors|immunologic factors|mesh-ancestor
111203916|NCT01798576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111203917|NCT00565084|Ibuprofen|ibuprofen|mesh-list
111203918|NCT00565084|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111203919|NCT00565084|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111203920|NCT00565084|Analgesics|analgesics|mesh-ancestor
111203921|NCT00565084|Sensory System Agents|sensory system agents|mesh-ancestor
111203922|NCT00565084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111203923|NCT00565084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111203924|NCT00565084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111203925|NCT00565084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111203926|NCT00565084|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111203927|NCT00565084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111203928|NCT00565084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111203929|NCT01810783|Brexpiprazole|brexpiprazole|mesh-list
111203930|NCT01810783|Serotonin Agents|serotonin agents|mesh-ancestor
111203931|NCT01810783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111203932|NCT01810783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111203933|NCT01810783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111203934|NCT01810783|Dopamine Agonists|dopamine agonists|mesh-ancestor
111203935|NCT01810783|Dopamine Agents|dopamine agents|mesh-ancestor
111203936|NCT01807117|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
111203937|NCT01807117|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111203938|NCT01807117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111203939|NCT01613131|Estradiol|estradiol|mesh-list
111203940|NCT01613131|Estrogens|estrogens|mesh-ancestor
111203941|NCT01613131|Hormones|hormones|mesh-ancestor
111203942|NCT01613131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111203943|NCT01613131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110943329|NCT05467176|Hormone Antagonists|hormone antagonists|mesh-ancestor
110943330|NCT05467176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110943331|NCT05467176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110943345|NCT05443035|Anti-Infective Agents|anti-infective agents|mesh-list
110943346|NCT05443035|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110943364|NCT05432388|Remibrutinib|remibrutinib|mesh-list
110943365|NCT05432388|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110943366|NCT05432388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110943367|NCT05432388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110943390|NCT05426174|Vaccines|vaccines|mesh-list
110943391|NCT05426174|Immunologic Factors|immunologic factors|mesh-ancestor
111203944|NCT05362942|Cytarabine|cytarabine|mesh-list
111203945|NCT05362942|Azacitidine|azacitidine|mesh-list
111203946|NCT05362942|Decitabine|decitabine|mesh-list
111203947|NCT05362942|Venetoclax|venetoclax|mesh-list
111203948|NCT05362942|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111203949|NCT05362942|Antimetabolites|antimetabolites|mesh-ancestor
111203950|NCT05362942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111203951|NCT05362942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111203952|NCT05362942|Antiviral Agents|antiviral agents|mesh-ancestor
111203953|NCT05362942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111203954|NCT05362942|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111203955|NCT05362942|Immunologic Factors|immunologic factors|mesh-ancestor
111203956|NCT05362942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111203957|NCT05362942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111203958|NCT01868893|Obinutuzumab|obinutuzumab|mesh-list
111203959|NCT01868893|Chlorambucil|chlorambucil|mesh-list
111203960|NCT01868893|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111203961|NCT01868893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111203962|NCT01868893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111203963|NCT01868893|Alkylating Agents|alkylating agents|mesh-ancestor
111203964|NCT01868893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111203965|NCT01868503|Lapatinib|lapatinib|mesh-list
111203966|NCT01868503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111203967|NCT01868503|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111203968|NCT01868503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111203969|NCT01868503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111203970|NCT05204368|Meropenem|meropenem|mesh-list
111203971|NCT05204368|Imipenem|imipenem|mesh-list
111203972|NCT05204368|Cilastatin|cilastatin|mesh-list
111203973|NCT05204368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111203974|NCT05204368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111203975|NCT05204368|Protease Inhibitors|protease inhibitors|mesh-ancestor
111203976|NCT05204368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111203977|NCT05204368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111203978|NCT01868035|Tositumomab I-131|tositumomab i-131|mesh-list
111203979|NCT01868035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111203980|NCT04414969|Asparaginase|asparaginase|mesh-list
111203981|NCT04414969|Pegaspargase|pegaspargase|mesh-list
111203982|NCT04414969|Antibodies|antibodies|mesh-list
111203983|NCT04414969|Immunoglobulins|immunoglobulins|mesh-list
111203984|NCT04414969|Immunologic Factors|immunologic factors|mesh-ancestor
110943406|NCT05414838|Vitamins|vitamins|mesh-ancestor
110943407|NCT05414838|Micronutrients|micronutrients|mesh-ancestor
110943408|NCT05414838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110943409|NCT05414838|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110943410|NCT05414838|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110943411|NCT05414838|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110943412|NCT05414838|Analgesics|analgesics|mesh-ancestor
110943413|NCT05414838|Sensory System Agents|sensory system agents|mesh-ancestor
110943414|NCT05414838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110943415|NCT05414838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110943416|NCT05414838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110943417|NCT05414838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110943418|NCT05414838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110943419|NCT05414838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110943438|NCT05383495|Midazolam|midazolam|mesh-list
110943439|NCT05383495|Dexmedetomidine|dexmedetomidine|mesh-list
110943440|NCT05383495|Nitrous Oxide|nitrous oxide|mesh-list
110943441|NCT05383495|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110943442|NCT05383495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110943443|NCT05383495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110943444|NCT05383495|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110943445|NCT05383495|Analgesics|analgesics|mesh-ancestor
110943446|NCT05383495|Sensory System Agents|sensory system agents|mesh-ancestor
110943447|NCT05383495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110943448|NCT05383495|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110943449|NCT05383495|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110943450|NCT05383495|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110943451|NCT05383495|Adrenergic Agents|adrenergic agents|mesh-ancestor
110943452|NCT05383495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110943453|NCT05383495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110943454|NCT05383495|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110943455|NCT05383495|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110943456|NCT05383495|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110943457|NCT05383495|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111498014|NCT02530554|Dermatologic Agents|dermatologic agents|mesh-ancestor
111203985|NCT04414969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111203986|NCT04414969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111203987|NCT01609933|Interferons|interferons|mesh-list
111203988|NCT01609933|Ritonavir|ritonavir|mesh-list
111203989|NCT01609933|Ribavirin|ribavirin|mesh-list
111203990|NCT01609933|Interferon-alpha|interferon-alpha|mesh-list
111203991|NCT01609933|Interferon alpha-2|interferon alpha-2|mesh-list
111203992|NCT01609933|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
111203993|NCT01609933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111203994|NCT01609933|Antiviral Agents|antiviral agents|mesh-ancestor
111203995|NCT01609933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111203996|NCT01609933|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111203997|NCT01609933|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111203998|NCT01609933|Protease Inhibitors|protease inhibitors|mesh-ancestor
111203999|NCT01609933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111204000|NCT01609933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111204001|NCT01609933|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111204002|NCT01609933|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111204003|NCT01609933|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111204004|NCT01609933|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111204005|NCT01609933|Antimetabolites|antimetabolites|mesh-ancestor
111204006|NCT01609933|Immunologic Factors|immunologic factors|mesh-ancestor
111204007|NCT01609933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111204008|NCT05361772|Colchicine|colchicine|mesh-list
111204009|NCT05361772|Gout Suppressants|gout suppressants|mesh-ancestor
111204010|NCT05361772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111204011|NCT05361772|Tubulin Modulators|tubulin modulators|mesh-ancestor
111204012|NCT05361772|Antimitotic Agents|antimitotic agents|mesh-ancestor
111204013|NCT05361772|Mitosis Modulators|mitosis modulators|mesh-ancestor
111204014|NCT05361772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111204015|NCT05361772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111204016|NCT03031210|Amoxicillin|amoxicillin|mesh-list
111204017|NCT03031210|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111204018|NCT03031210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111204019|NCT02958514|Tobramycin|tobramycin|mesh-list
111204020|NCT02958514|Dexamethasone|dexamethasone|mesh-list
111204021|NCT02958514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111204022|NCT02958514|Antiemetics|antiemetics|mesh-ancestor
111204023|NCT02958514|Autonomic Agents|autonomic agents|mesh-ancestor
111204024|NCT02958514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111204025|NCT02958514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111204026|NCT02958514|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111204027|NCT02958514|Glucocorticoids|glucocorticoids|mesh-ancestor
111204028|NCT02958514|Hormones|hormones|mesh-ancestor
111204029|NCT02958514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111204030|NCT02958514|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111204031|NCT02958514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111204032|NCT02958514|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111204033|NCT02958514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111204034|NCT01867021|Vaccines|vaccines|mesh-list
111204035|NCT01867021|Immunologic Factors|immunologic factors|mesh-ancestor
111204036|NCT01867021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111204037|NCT01866709|Polystyrene sulfonic acid|polystyrene sulfonic acid|mesh-list
111204038|NCT01866709|Chelating Agents|chelating agents|mesh-ancestor
111204039|NCT01866709|Sequestering Agents|sequestering agents|mesh-ancestor
110943499|NCT05368012|Dexamethasone|dexamethasone|mesh-list
110943500|NCT05368012|Bupivacaine|bupivacaine|mesh-list
110943501|NCT05368012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110943502|NCT05368012|Antiemetics|antiemetics|mesh-ancestor
110943503|NCT05368012|Autonomic Agents|autonomic agents|mesh-ancestor
110943504|NCT05368012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110943505|NCT05368012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110943506|NCT05368012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110943507|NCT05368012|Glucocorticoids|glucocorticoids|mesh-ancestor
110943508|NCT05368012|Hormones|hormones|mesh-ancestor
110943509|NCT05368012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110943510|NCT05368012|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110943511|NCT05368012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110943512|NCT05368012|Anesthetics, Local|anesthetics, local|mesh-ancestor
110943513|NCT05368012|Anesthetics|anesthetics|mesh-ancestor
110943514|NCT05368012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110943515|NCT05368012|Sensory System Agents|sensory system agents|mesh-ancestor
110943525|NCT05343702|Rocuronium|rocuronium|mesh-list
111204040|NCT01866709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111204041|NCT01841593|Raltegravir Potassium|raltegravir potassium|mesh-list
111204042|NCT01841593|Amlodipine|amlodipine|mesh-list
111204043|NCT01841593|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111204044|NCT01841593|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111204045|NCT01841593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111204046|NCT01841593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111204047|NCT01841593|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111204048|NCT01841593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111204049|NCT01841593|Vasodilator Agents|vasodilator agents|mesh-ancestor
111204050|NCT01841593|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111204051|NCT01841593|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111204052|NCT01841593|Antiviral Agents|antiviral agents|mesh-ancestor
111204053|NCT01841593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111204054|NCT01841593|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111204055|NCT01841593|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111204056|NCT01841593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111204057|NCT02454322|Magnesium Sulfate|magnesium sulfate|mesh-list
111204058|NCT02454322|Analgesics|analgesics|mesh-ancestor
111204059|NCT02454322|Sensory System Agents|sensory system agents|mesh-ancestor
111204060|NCT02454322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111204061|NCT02454322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111204062|NCT02454322|Anesthetics|anesthetics|mesh-ancestor
111204063|NCT02454322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111204064|NCT02454322|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111204065|NCT02454322|Anticonvulsants|anticonvulsants|mesh-ancestor
111204066|NCT02454322|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111204067|NCT02454322|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111204068|NCT02454322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111204069|NCT02454322|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111204070|NCT02454322|Tocolytic Agents|tocolytic agents|mesh-ancestor
111204071|NCT02454322|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111204072|NCT04505566|Ketorolac|ketorolac|mesh-list
111204073|NCT04505566|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111204074|NCT04505566|Lubricant Eye Drops|lubricant eye drops|mesh-list
111204075|NCT04505566|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111204076|NCT04505566|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111204077|NCT04505566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111204078|NCT04505566|Analgesics|analgesics|mesh-ancestor
111204079|NCT04505566|Sensory System Agents|sensory system agents|mesh-ancestor
111204080|NCT04505566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111204081|NCT04505566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111204082|NCT04505566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111204083|NCT04505566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111204084|NCT04505566|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111204085|NCT04505566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111204086|NCT04505566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111204087|NCT05076292|Glucagon|glucagon|mesh-list
111204088|NCT05076292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111204089|NCT05076292|Hormones|hormones|mesh-ancestor
111204090|NCT05076292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111204091|NCT05076292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111204092|NCT04789330|Phenylephrine|phenylephrine|mesh-list
111204093|NCT04789330|Oxymetazoline|oxymetazoline|mesh-list
111204094|NCT04789330|Norepinephrine|norepinephrine|mesh-list
111204095|NCT04789330|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111204096|NCT04789330|Mydriatics|mydriatics|mesh-ancestor
111204097|NCT04789330|Autonomic Agents|autonomic agents|mesh-ancestor
111204098|NCT04789330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111204099|NCT04789330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111204100|NCT04789330|Sympathomimetics|sympathomimetics|mesh-ancestor
111204101|NCT04789330|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110943571|NCT05280548|Venglustat|venglustat|mesh-list
110943572|NCT05280548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110943573|NCT05280548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110943604|NCT05251948|Capecitabine|capecitabine|mesh-list
110943605|NCT05251948|Oxaliplatin|oxaliplatin|mesh-list
110943606|NCT05251948|Atezolizumab|atezolizumab|mesh-list
110943607|NCT05251948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110943608|NCT05251948|Antimetabolites|antimetabolites|mesh-ancestor
110943609|NCT05251948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110943610|NCT05251948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110943611|NCT05251948|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110943612|NCT05251948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110943615|NCT05238025|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
110943616|NCT05238025|Antiviral Agents|antiviral agents|mesh-ancestor
110943617|NCT05238025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111204102|NCT04789330|Nasal Decongestants|nasal decongestants|mesh-ancestor
111204103|NCT04789330|Respiratory System Agents|respiratory system agents|mesh-ancestor
111204104|NCT04789330|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111204105|NCT04789330|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111204106|NCT04789330|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111204107|NCT04789330|Adrenergic Agents|adrenergic agents|mesh-ancestor
111204108|NCT04789330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111204109|NCT04789330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111204110|NCT04789330|Protective Agents|protective agents|mesh-ancestor
111204111|NCT02339038|Sofosbuvir|sofosbuvir|mesh-list
111204112|NCT02339038|Ledipasvir|ledipasvir|mesh-list
111204113|NCT02339038|Antiviral Agents|antiviral agents|mesh-ancestor
111204114|NCT02339038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111204115|NCT04497298|Vaccines|vaccines|mesh-list
111204116|NCT04497298|Immunologic Factors|immunologic factors|mesh-ancestor
111204117|NCT04497298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111204118|NCT04387786|Albuterol|albuterol|mesh-list
111204119|NCT04387786|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111204120|NCT04387786|Autonomic Agents|autonomic agents|mesh-ancestor
111204121|NCT04387786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111204122|NCT04387786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111204123|NCT04387786|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111204124|NCT04387786|Respiratory System Agents|respiratory system agents|mesh-ancestor
111204125|NCT04387786|Tocolytic Agents|tocolytic agents|mesh-ancestor
111204126|NCT04387786|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111204127|NCT04387786|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111204128|NCT04387786|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111204129|NCT04387786|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111204130|NCT04387786|Adrenergic Agents|adrenergic agents|mesh-ancestor
111204131|NCT04387786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111204132|NCT04387786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111204133|NCT00569530|Calfactant|calfactant|mesh-list
111204134|NCT00569530|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
111204135|NCT00569530|Respiratory System Agents|respiratory system agents|mesh-ancestor
111204136|NCT04509622|Cytarabine|cytarabine|mesh-list
111204137|NCT04509622|Venetoclax|venetoclax|mesh-list
111204138|NCT04509622|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111204139|NCT04509622|Antimetabolites|antimetabolites|mesh-ancestor
111204140|NCT04509622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111204141|NCT04509622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111204142|NCT04509622|Antiviral Agents|antiviral agents|mesh-ancestor
111204143|NCT04509622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111204144|NCT04509622|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111204145|NCT04509622|Immunologic Factors|immunologic factors|mesh-ancestor
111204146|NCT04509622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111204147|NCT00570700|Dasatinib|dasatinib|mesh-list
111204148|NCT00570700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111204149|NCT00570700|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111204150|NCT00570700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111204151|NCT00570700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111204152|NCT00573508|Solifenacin Succinate|solifenacin succinate|mesh-list
111204153|NCT00573508|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111204154|NCT00573508|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111204155|NCT00573508|Cholinergic Agents|cholinergic agents|mesh-ancestor
111204156|NCT00573508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111204157|NCT00573508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111204158|NCT00573508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111204159|NCT00573508|Urological Agents|urological agents|mesh-ancestor
111204160|NCT00574834|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
111204161|NCT00574834|Ramipril|ramipril|mesh-list
111204162|NCT00574834|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110943635|NCT05222906|Venglustat|venglustat|mesh-list
110943636|NCT05222906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110943637|NCT05222906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110943645|NCT05219513|Obinutuzumab|obinutuzumab|mesh-list
110943646|NCT05219513|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110943647|NCT05219513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110943655|NCT05206773|Venglustat|venglustat|mesh-list
110943656|NCT05206773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110943657|NCT05206773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110943672|NCT05182164|Pembrolizumab|pembrolizumab|mesh-list
110943673|NCT05182164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110943674|NCT05182164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110943675|NCT05182164|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111204163|NCT00574834|Diuretics|diuretics|mesh-ancestor
111204164|NCT00574834|Natriuretic Agents|natriuretic agents|mesh-ancestor
111204165|NCT00574834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111204166|NCT00574834|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
111204167|NCT00574834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111204168|NCT00574834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111204169|NCT00574834|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
111204170|NCT00574834|Protease Inhibitors|protease inhibitors|mesh-ancestor
111204171|NCT00574834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111204173|NCT04259398|Sevoflurane|sevoflurane|mesh-list
111204174|NCT04259398|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111204175|NCT04259398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111204176|NCT04259398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111204177|NCT04259398|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111204178|NCT04259398|Anesthetics, General|anesthetics, general|mesh-ancestor
111204179|NCT04259398|Anesthetics|anesthetics|mesh-ancestor
111204180|NCT04259398|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111204181|NCT04259398|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111204182|NCT01592110|Risperidone|risperidone|mesh-list
111204183|NCT01592110|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111204184|NCT01592110|Serotonin Agents|serotonin agents|mesh-ancestor
111204185|NCT01592110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111204186|NCT01592110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111204187|NCT01592110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111204188|NCT01592110|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111204189|NCT01592110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111204190|NCT01592110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111204191|NCT01592110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111204192|NCT01592110|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111204193|NCT01592110|Dopamine Agents|dopamine agents|mesh-ancestor
111204194|NCT00578734|Pulmonary Surfactants|pulmonary surfactants|mesh-list
111204195|NCT00578734|Respiratory System Agents|respiratory system agents|mesh-ancestor
111204196|NCT00578968|Tiotropium Bromide|tiotropium bromide|mesh-list
111204197|NCT00578968|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111204198|NCT00578968|Autonomic Agents|autonomic agents|mesh-ancestor
111204199|NCT00578968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111204200|NCT00578968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111204201|NCT00578968|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111204202|NCT00578968|Respiratory System Agents|respiratory system agents|mesh-ancestor
111204203|NCT00578968|Parasympatholytics|parasympatholytics|mesh-ancestor
111204204|NCT00578968|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111204205|NCT00578968|Cholinergic Agents|cholinergic agents|mesh-ancestor
111204206|NCT00578968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111204207|NCT00578968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111204208|NCT00579280|Valproic Acid|valproic acid|mesh-list
111204209|NCT00579280|Quetiapine Fumarate|quetiapine fumarate|mesh-list
111204210|NCT00579280|Antidepressive Agents|antidepressive agents|mesh-ancestor
111204211|NCT00579280|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111204212|NCT00579280|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111204213|NCT00579280|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111204214|NCT00579280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111204215|NCT00579280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111204216|NCT00579280|Anticonvulsants|anticonvulsants|mesh-ancestor
111204217|NCT00579280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111204218|NCT00579280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111204219|NCT00579280|GABA Agents|gaba agents|mesh-ancestor
111204220|NCT00579280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111204221|NCT00579280|Antimanic Agents|antimanic agents|mesh-ancestor
111204222|NCT00580294|Oxymorphone|oxymorphone|mesh-list
111204223|NCT00580294|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111204224|NCT00580294|Narcotics|narcotics|mesh-ancestor
111204225|NCT00580294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111204226|NCT00580294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110943705|NCT05169658|Immunologic Factors|immunologic factors|mesh-ancestor
110943706|NCT05169658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110943707|NCT05169658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110943735|NCT05113251|Paclitaxel|paclitaxel|mesh-list
110943736|NCT05113251|Cyclophosphamide|cyclophosphamide|mesh-list
110943737|NCT05113251|Doxorubicin|doxorubicin|mesh-list
110943738|NCT05113251|Trastuzumab|trastuzumab|mesh-list
110943739|NCT05113251|Pertuzumab|pertuzumab|mesh-list
110943740|NCT05113251|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
110943741|NCT05113251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110943742|NCT05113251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111204227|NCT00580294|Analgesics|analgesics|mesh-ancestor
111204228|NCT00580294|Sensory System Agents|sensory system agents|mesh-ancestor
111204229|NCT00580294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111204230|NCT00580294|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111204231|NCT00580372|Cyclophosphamide|cyclophosphamide|mesh-list
111204232|NCT00580372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111204233|NCT00580372|Immunologic Factors|immunologic factors|mesh-ancestor
111204234|NCT00580372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111204235|NCT00580372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111204236|NCT00580372|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111204237|NCT00580372|Alkylating Agents|alkylating agents|mesh-ancestor
111204238|NCT00580372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111204239|NCT00580372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111204240|NCT00580372|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111204242|NCT02134210|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111204243|NCT02134210|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111204244|NCT02134210|Analgesics|analgesics|mesh-ancestor
111204245|NCT02134210|Sensory System Agents|sensory system agents|mesh-ancestor
111204246|NCT02134210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111204247|NCT02134210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111204248|NCT02134210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110782284|NCT00025155|Epothilones|epothilones|mesh-list
111204249|NCT02134210|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111204250|NCT02134210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111204251|NCT02134210|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111204252|NCT02134210|Immunologic Factors|immunologic factors|mesh-ancestor
111204253|NCT00607594|Saracatinib|saracatinib|mesh-list
111204254|NCT00607594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111204255|NCT00607594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111204256|NCT00607594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111204257|NCT01866319|Pembrolizumab|pembrolizumab|mesh-list
111204258|NCT01866319|Ipilimumab|ipilimumab|mesh-list
111204259|NCT01866319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111204260|NCT01866319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111204261|NCT01866319|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111204262|NCT01866319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111204263|NCT00607672|Candesartan|candesartan|mesh-list
111204264|NCT00607672|Candesartan cilexetil|candesartan cilexetil|mesh-list
111204265|NCT00607672|Ramipril|ramipril|mesh-list
111204266|NCT00607672|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111204267|NCT00607672|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111204268|NCT00607672|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111204269|NCT00607672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111204270|NCT00607672|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
111204271|NCT00607672|Protease Inhibitors|protease inhibitors|mesh-ancestor
111204272|NCT00607672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111204273|NCT01802515|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
111204274|NCT01802515|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111204275|NCT01802515|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111204276|NCT01802515|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111204277|NCT01802515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110943782|NCT05103605|Osimertinib|osimertinib|mesh-list
110943783|NCT05103605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110943784|NCT05103605|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110943785|NCT05103605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110943786|NCT05103605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110943803|NCT05098938|Acyclovir|acyclovir|mesh-list
110943804|NCT05098938|Antiviral Agents|antiviral agents|mesh-ancestor
110943805|NCT05098938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110943806|NCT05093621|Torsemide|torsemide|mesh-list
110943807|NCT05093621|Furosemide|furosemide|mesh-list
110943808|NCT05093621|Diuretics|diuretics|mesh-ancestor
110943809|NCT05093621|Natriuretic Agents|natriuretic agents|mesh-ancestor
110943810|NCT05093621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110943811|NCT05093621|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110943812|NCT05093621|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110943813|NCT05093621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110943814|NCT05093621|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110943821|NCT05089630|Vaccines|vaccines|mesh-list
110943822|NCT05089630|Adjuvants, Vaccine|adjuvants, vaccine|mesh-list
110943823|NCT05089630|Immunologic Factors|immunologic factors|mesh-ancestor
110943824|NCT05089630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110943825|NCT05089630|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111204278|NCT01802515|Adrenergic Agents|adrenergic agents|mesh-ancestor
111204279|NCT01802515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111204280|NCT01802515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111204281|NCT01802437|Fluoxetine|fluoxetine|mesh-list
111204282|NCT01802437|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111204283|NCT01802437|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111204284|NCT01802437|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111204285|NCT01802437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111204286|NCT01802437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111204287|NCT01802437|Serotonin Agents|serotonin agents|mesh-ancestor
111204288|NCT01802437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111204289|NCT01802437|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111204290|NCT01802437|Antidepressive Agents|antidepressive agents|mesh-ancestor
111204291|NCT01802437|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111204292|NCT01802437|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111204293|NCT01802437|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111204294|NCT01802437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111204295|NCT00608062|Estradiol|estradiol|mesh-list
111204296|NCT00608062|Ganirelix|ganirelix|mesh-list
111204297|NCT00608062|Estrogens|estrogens|mesh-ancestor
111204298|NCT00608062|Hormones|hormones|mesh-ancestor
110782387|NCT04056754|Prednisone|prednisone|mesh-list
111204299|NCT00608062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111204300|NCT00608062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111204301|NCT00608062|Hormone Antagonists|hormone antagonists|mesh-ancestor
111204302|NCT02135146|Plasma-lyte 148|plasma-lyte 148|mesh-list
111204303|NCT02135146|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
111204304|NCT02135146|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111204305|NCT02829268|Dantrolene|dantrolene|mesh-list
111204306|NCT02829268|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
111204307|NCT02829268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111204308|NCT02829268|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111204309|NCT02829268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111204310|NCT02202772|Cisplatin|cisplatin|mesh-list
111204311|NCT02202772|Gemcitabine|gemcitabine|mesh-list
111204312|NCT02202772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111204313|NCT02202772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111204314|NCT02202772|Antimetabolites|antimetabolites|mesh-ancestor
111204315|NCT02202772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111204316|NCT00582400|Arsenic Trioxide|arsenic trioxide|mesh-list
111204317|NCT00582400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111204318|NCT01801735|Meloxicam|meloxicam|mesh-list
111204319|NCT01801735|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111204320|NCT01801735|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111204321|NCT01801735|Analgesics|analgesics|mesh-ancestor
111204322|NCT01801735|Sensory System Agents|sensory system agents|mesh-ancestor
111204323|NCT01801735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111204324|NCT01801735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111204325|NCT01801735|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111204326|NCT01801735|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111204327|NCT01801735|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111204328|NCT01801735|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110943864|NCT05067283|Leucovorin|leucovorin|mesh-list
110943865|NCT05067283|Carboplatin|carboplatin|mesh-list
110943866|NCT05067283|Pembrolizumab|pembrolizumab|mesh-list
110943867|NCT05067283|Fluorouracil|fluorouracil|mesh-list
110943868|NCT05067283|Oxaliplatin|oxaliplatin|mesh-list
110943869|NCT05067283|Pemetrexed|pemetrexed|mesh-list
110943870|NCT05067283|Cetuximab|cetuximab|mesh-list
110943871|NCT05067283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110943872|NCT05067283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110943873|NCT05067283|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110943874|NCT05067283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110943875|NCT05067283|Antimetabolites|antimetabolites|mesh-ancestor
110943876|NCT05067283|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110943877|NCT05067283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110943878|NCT05067283|Immunologic Factors|immunologic factors|mesh-ancestor
110943879|NCT05067283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110943880|NCT05067283|Antidotes|antidotes|mesh-ancestor
110943881|NCT05067283|Protective Agents|protective agents|mesh-ancestor
110943882|NCT05067283|Vitamin B Complex|vitamin b complex|mesh-ancestor
110943883|NCT05067283|Vitamins|vitamins|mesh-ancestor
110943884|NCT05067283|Micronutrients|micronutrients|mesh-ancestor
110943885|NCT05067283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110943886|NCT05067283|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110943887|NCT05067283|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111204329|NCT01801735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111204330|NCT01801735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111204331|NCT00612430|Bevacizumab|bevacizumab|mesh-list
111204332|NCT00612430|Etoposide|etoposide|mesh-list
111204333|NCT00612430|Etoposide phosphate|etoposide phosphate|mesh-list
111204334|NCT00612430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111204335|NCT00612430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111204336|NCT00612430|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111204337|NCT00612430|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111204338|NCT00612430|Growth Substances|growth substances|mesh-ancestor
111204339|NCT00612430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111204340|NCT00612430|Growth Inhibitors|growth inhibitors|mesh-ancestor
111204341|NCT00612430|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111204342|NCT00612430|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111204343|NCT00612430|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111204344|NCT00612430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111204345|NCT00612430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111204346|NCT01571128|Tenofovir|tenofovir|mesh-list
111204347|NCT01571128|Emtricitabine|emtricitabine|mesh-list
111204348|NCT01571128|Antiviral Agents|antiviral agents|mesh-ancestor
111204349|NCT01571128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111204350|NCT01571128|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111204351|NCT01571128|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111204352|NCT01571128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111204353|NCT01571128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111204354|NCT01571128|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111204355|NCT01571128|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111204356|NCT00614458|Raltegravir Potassium|raltegravir potassium|mesh-list
111204357|NCT00614458|Valproic Acid|valproic acid|mesh-list
111204358|NCT00614458|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111204359|NCT00614458|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111204360|NCT00614458|Antiviral Agents|antiviral agents|mesh-ancestor
111204361|NCT00614458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111204362|NCT00614458|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111204363|NCT00614458|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111204364|NCT00614458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111204365|NCT00614458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111204366|NCT00614458|Anticonvulsants|anticonvulsants|mesh-ancestor
111204367|NCT00614458|GABA Agents|gaba agents|mesh-ancestor
111204368|NCT00614458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111204369|NCT00614458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111204370|NCT00614458|Antimanic Agents|antimanic agents|mesh-ancestor
111204371|NCT00614458|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111204372|NCT00614458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111204373|NCT00614458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111204374|NCT01429168|Etoricoxib|etoricoxib|mesh-list
111204375|NCT01429168|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111204376|NCT01429168|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111204377|NCT01429168|Analgesics|analgesics|mesh-ancestor
111204378|NCT01429168|Sensory System Agents|sensory system agents|mesh-ancestor
111204379|NCT01429168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111204380|NCT01429168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111204381|NCT01429168|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111204382|NCT01429168|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111204383|NCT01429168|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111204384|NCT01429168|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111204385|NCT01429168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111204386|NCT01429168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111204387|NCT00771160|Montelukast|montelukast|mesh-list
111204388|NCT00771160|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111204389|NCT00771160|Respiratory System Agents|respiratory system agents|mesh-ancestor
111204390|NCT00771160|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
111204391|NCT00771160|Hormone Antagonists|hormone antagonists|mesh-ancestor
111498015|NCT02536248|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110943973|NCT05052801|Bemarituzumab|bemarituzumab|mesh-list
110943974|NCT05052801|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110943975|NCT05052801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110943992|NCT05016310|Vitamin D|vitamin d|mesh-list
110943993|NCT05016310|Ergocalciferols|ergocalciferols|mesh-list
110943994|NCT05016310|Cholecalciferol|cholecalciferol|mesh-list
110943995|NCT05016310|Vitamins|vitamins|mesh-list
110943996|NCT05016310|Micronutrients|micronutrients|mesh-ancestor
110943997|NCT05016310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110943998|NCT05016310|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110943999|NCT05016310|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111204392|NCT00771160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111204393|NCT00771160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111204394|NCT00771160|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
111204395|NCT00771160|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111204396|NCT00771160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111204397|NCT00756418|Theophylline|theophylline|mesh-list
111204398|NCT00756418|Montelukast|montelukast|mesh-list
111204399|NCT00756418|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111204400|NCT00756418|Respiratory System Agents|respiratory system agents|mesh-ancestor
111204401|NCT00756418|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
111204402|NCT00756418|Hormone Antagonists|hormone antagonists|mesh-ancestor
111204403|NCT00756418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111204404|NCT00756418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111204405|NCT00756418|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
111204406|NCT00756418|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111204407|NCT00756418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111204408|NCT00756418|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111204409|NCT00756418|Autonomic Agents|autonomic agents|mesh-ancestor
110980485|NCT00468117|Etanercept|etanercept|mesh-list
111204410|NCT00756418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111204411|NCT00756418|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111204412|NCT00756418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111204413|NCT00756418|Vasodilator Agents|vasodilator agents|mesh-ancestor
111204414|NCT00756418|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
111204415|NCT00756418|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111204416|NCT00756418|Purinergic Agents|purinergic agents|mesh-ancestor
111204417|NCT00756418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111204418|NCT00615472|Remifentanil|remifentanil|mesh-list
111204419|NCT00615472|Propofol|propofol|mesh-list
111204420|NCT00615472|Isoflurane|isoflurane|mesh-list
111204421|NCT00615472|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111204422|NCT00615472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111204423|NCT00615472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111204424|NCT00615472|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111204425|NCT00615472|Anesthetics, General|anesthetics, general|mesh-ancestor
111204426|NCT00615472|Anesthetics|anesthetics|mesh-ancestor
111204427|NCT00615472|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111204428|NCT00615472|Narcotics|narcotics|mesh-ancestor
111204429|NCT00615472|Analgesics|analgesics|mesh-ancestor
111204430|NCT00615472|Sensory System Agents|sensory system agents|mesh-ancestor
111204431|NCT00615472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111204432|NCT00615472|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111204433|NCT00615784|Bexarotene|bexarotene|mesh-list
111204434|NCT00615784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111204435|NCT00755794|Montelukast|montelukast|mesh-list
111204436|NCT00755794|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111204437|NCT00755794|Respiratory System Agents|respiratory system agents|mesh-ancestor
111204438|NCT00755794|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
111204439|NCT00755794|Hormone Antagonists|hormone antagonists|mesh-ancestor
111204440|NCT00755794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111204441|NCT00755794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110944012|NCT05007106|Docetaxel|docetaxel|mesh-list
110944013|NCT05007106|Bevacizumab|bevacizumab|mesh-list
110944014|NCT05007106|Carboplatin|carboplatin|mesh-list
110944015|NCT05007106|Gemcitabine|gemcitabine|mesh-list
110944016|NCT05007106|Pembrolizumab|pembrolizumab|mesh-list
110944017|NCT05007106|Fluorouracil|fluorouracil|mesh-list
110944018|NCT05007106|Capecitabine|capecitabine|mesh-list
110944019|NCT05007106|Oxaliplatin|oxaliplatin|mesh-list
110944020|NCT05007106|Lenvatinib|lenvatinib|mesh-list
110944021|NCT05007106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110944022|NCT05007106|Tubulin Modulators|tubulin modulators|mesh-ancestor
110944023|NCT05007106|Antimitotic Agents|antimitotic agents|mesh-ancestor
110944024|NCT05007106|Mitosis Modulators|mitosis modulators|mesh-ancestor
110944025|NCT05007106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110944026|NCT05007106|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110944027|NCT05007106|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110944028|NCT05007106|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110944029|NCT05007106|Growth Substances|growth substances|mesh-ancestor
110944030|NCT05007106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110944031|NCT05007106|Growth Inhibitors|growth inhibitors|mesh-ancestor
110944032|NCT05007106|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110944033|NCT05007106|Antimetabolites|antimetabolites|mesh-ancestor
110944034|NCT05007106|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110944039|NCT05006794|Docetaxel|docetaxel|mesh-list
111204442|NCT00755794|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
111204443|NCT00755794|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111204444|NCT00755794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111204445|NCT00652444|Simvastatin|simvastatin|mesh-list
111204446|NCT00652444|Ezetimibe|ezetimibe|mesh-list
111204447|NCT00652444|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111204448|NCT00652444|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111204449|NCT00652444|Antimetabolites|antimetabolites|mesh-ancestor
111204450|NCT00652444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111204451|NCT00652444|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111204452|NCT00652444|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111204453|NCT00652444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111204454|NCT00585910|Methylphenidate|methylphenidate|mesh-list
111204455|NCT00585910|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
111204456|NCT00585910|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111204457|NCT00585910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111204458|NCT00585910|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111204459|NCT00585910|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111204460|NCT00585910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111204461|NCT00585910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111204462|NCT00585910|Dopamine Agents|dopamine agents|mesh-ancestor
111204463|NCT00585910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111204464|NCT00585910|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111204465|NCT00585910|Adrenergic Agents|adrenergic agents|mesh-ancestor
111204466|NCT00489346|Fluticasone|fluticasone|mesh-list
111204468|NCT00489346|Montelukast|montelukast|mesh-list
111204469|NCT00489346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111204470|NCT00489346|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111204471|NCT00489346|Autonomic Agents|autonomic agents|mesh-ancestor
111204472|NCT00489346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111204473|NCT00489346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111204474|NCT00489346|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111204475|NCT00489346|Respiratory System Agents|respiratory system agents|mesh-ancestor
111204476|NCT00489346|Dermatologic Agents|dermatologic agents|mesh-ancestor
111204477|NCT00489346|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111204478|NCT00489346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111204479|NCT00489346|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
111204480|NCT00489346|Hormone Antagonists|hormone antagonists|mesh-ancestor
111204481|NCT00489346|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111204482|NCT00489346|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
111204483|NCT00489346|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111204484|NCT00617188|Fulvestrant|fulvestrant|mesh-list
111204485|NCT00617188|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111204486|NCT00617188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111204487|NCT00617188|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
111204488|NCT00617188|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110944115|NCT04977453|Pembrolizumab|pembrolizumab|mesh-list
110944116|NCT04977453|Lenvatinib|lenvatinib|mesh-list
110944117|NCT04977453|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110944118|NCT04977453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110944119|NCT04977453|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110944120|NCT04977453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110944121|NCT04977453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110944122|NCT04977453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110944123|NCT04976634|Pembrolizumab|pembrolizumab|mesh-list
110944124|NCT04976634|Lenvatinib|lenvatinib|mesh-list
110944125|NCT04976634|Belzutifan|belzutifan|mesh-list
110944126|NCT04976634|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110944127|NCT04976634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110944128|NCT04976634|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110944129|NCT04976634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110944130|NCT04976634|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110944131|NCT04976634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110944154|NCT04960930|Minocycline|minocycline|mesh-list
110944155|NCT04960930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110944156|NCT04960930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110944157|NCT04958785|Paclitaxel|paclitaxel|mesh-list
110944158|NCT04958785|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110944159|NCT04958785|Magrolimab|magrolimab|mesh-list
110944160|NCT04958785|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
110944161|NCT04958785|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111204489|NCT00617188|Hormone Antagonists|hormone antagonists|mesh-ancestor
111204490|NCT00617188|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111204491|NCT00617188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111204492|NCT00618436|Phenytoin|phenytoin|mesh-list
111204493|NCT00618436|Levetiracetam|levetiracetam|mesh-list
111204494|NCT00618436|Anticonvulsants|anticonvulsants|mesh-ancestor
111204495|NCT00618436|Nootropic Agents|nootropic agents|mesh-ancestor
111204496|NCT00618436|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111204497|NCT00618436|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111204498|NCT00618436|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111204499|NCT00618436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111204500|NCT00618436|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
111204501|NCT00618436|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111204502|NCT00619060|Niacin|niacin|mesh-list
111204503|NCT00619060|Nicotinic Acids|nicotinic acids|mesh-list
111204504|NCT00619060|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111204505|NCT00619060|Antimetabolites|antimetabolites|mesh-ancestor
111204506|NCT00619060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111204507|NCT00619060|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111204508|NCT00619060|Vasodilator Agents|vasodilator agents|mesh-ancestor
111204509|NCT00619060|Vitamin B Complex|vitamin b complex|mesh-ancestor
111204510|NCT00619060|Vitamins|vitamins|mesh-ancestor
111204511|NCT00619060|Micronutrients|micronutrients|mesh-ancestor
111204512|NCT00619060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111204513|NCT05247424|Heparin|heparin|mesh-list
111204514|NCT05247424|Calcium heparin|calcium heparin|mesh-list
111204515|NCT05247424|Anticoagulants|anticoagulants|mesh-ancestor
111204516|NCT05247424|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111204517|NCT05247424|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111204518|NCT05247424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111204519|NCT00092716|Atorvastatin|atorvastatin|mesh-list
111204520|NCT00092716|Ezetimibe|ezetimibe|mesh-list
111204521|NCT00092716|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111204522|NCT00092716|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111204523|NCT00092716|Antimetabolites|antimetabolites|mesh-ancestor
111204524|NCT00092716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111204525|NCT00092716|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111204526|NCT00092716|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111204527|NCT00092716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111204528|NCT00619684|Lenalidomide|lenalidomide|mesh-list
111204529|NCT00619684|Immunologic Factors|immunologic factors|mesh-ancestor
111204530|NCT00619684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111204531|NCT00619684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111204532|NCT00619684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111204533|NCT00619684|Growth Substances|growth substances|mesh-ancestor
111204534|NCT00619684|Growth Inhibitors|growth inhibitors|mesh-ancestor
111204535|NCT00619684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111204536|NCT00588406|Prednisone|prednisone|mesh-list
111204537|NCT00588406|Budesonide|budesonide|mesh-list
111204538|NCT00588406|Bromides|bromides|mesh-list
111204539|NCT00588406|Albuterol|albuterol|mesh-list
111204540|NCT00588406|Ipratropium|ipratropium|mesh-list
111204541|NCT00588406|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111204542|NCT00588406|Glucocorticoids|glucocorticoids|mesh-ancestor
111204543|NCT00588406|Hormones|hormones|mesh-ancestor
111204544|NCT00588406|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111204545|NCT00588406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111204546|NCT00588406|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111204547|NCT00588406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111204548|NCT00588406|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110944166|NCT04958785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110944167|NCT04958785|Immunoconjugates|immunoconjugates|mesh-ancestor
110944168|NCT04958785|Immunologic Factors|immunologic factors|mesh-ancestor
110944169|NCT04958785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110944170|NCT04958785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110944171|NCT04956640|Carboplatin|carboplatin|mesh-list
110944172|NCT04956640|Pembrolizumab|pembrolizumab|mesh-list
110944173|NCT04956640|Pemetrexed|pemetrexed|mesh-list
110944174|NCT04956640|Cetuximab|cetuximab|mesh-list
110944175|NCT04956640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110944176|NCT04956640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110944177|NCT04956640|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110944178|NCT04956640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110944179|NCT04956640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111204549|NCT00588406|Autonomic Agents|autonomic agents|mesh-ancestor
111498016|NCT02536248|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111204550|NCT00588406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111204551|NCT00588406|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111204552|NCT00588406|Respiratory System Agents|respiratory system agents|mesh-ancestor
111204553|NCT00588406|Anticonvulsants|anticonvulsants|mesh-ancestor
111204554|NCT00588406|Tocolytic Agents|tocolytic agents|mesh-ancestor
111204555|NCT00588406|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111204556|NCT00588406|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111204557|NCT00588406|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111204558|NCT00588406|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111204559|NCT00588406|Adrenergic Agents|adrenergic agents|mesh-ancestor
111204560|NCT00588406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111204561|NCT00588406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111204562|NCT00588406|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111204563|NCT00588406|Cholinergic Agents|cholinergic agents|mesh-ancestor
111204564|NCT00668434|Prednisone|prednisone|mesh-list
111204565|NCT00668434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111204566|NCT00668434|Glucocorticoids|glucocorticoids|mesh-ancestor
111204567|NCT00668434|Hormones|hormones|mesh-ancestor
111204568|NCT00668434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111204569|NCT00668434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110782727|NCT05973864|Pembrolizumab|pembrolizumab|mesh-list
111204570|NCT00668434|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111204571|NCT00668434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111204572|NCT00668902|Pantoprazole|pantoprazole|mesh-list
111204573|NCT00668902|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111204574|NCT00668902|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111204575|NCT00668902|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111204576|NCT00668902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111204577|NCT00668902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111204578|NCT00589888|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
111204579|NCT00589888|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
111204580|NCT00589888|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
111204581|NCT00589888|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111204582|NCT00621946|Dexetimide|dexetimide|mesh-list
111204583|NCT00621946|Citalopram|citalopram|mesh-list
111204584|NCT00621946|Escitalopram|escitalopram|mesh-list
111204585|NCT00621946|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111204586|NCT00621946|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111204587|NCT00621946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111204588|NCT00621946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111204589|NCT00621946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111204590|NCT00621946|Serotonin Agents|serotonin agents|mesh-ancestor
111204591|NCT00621946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111204592|NCT00621946|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111204593|NCT00621946|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111204594|NCT00621946|Parasympatholytics|parasympatholytics|mesh-ancestor
111204595|NCT00621946|Autonomic Agents|autonomic agents|mesh-ancestor
111204596|NCT00621946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111204597|NCT00621946|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111204598|NCT00621946|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111204599|NCT00621946|Cholinergic Agents|cholinergic agents|mesh-ancestor
111204600|NCT00621946|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111204601|NCT00621946|Antidepressive Agents|antidepressive agents|mesh-ancestor
111204602|NCT00621946|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111204603|NCT02139358|Gemcitabine|gemcitabine|mesh-list
111204604|NCT02139358|Trastuzumab|trastuzumab|mesh-list
111204605|NCT02139358|Pertuzumab|pertuzumab|mesh-list
111204606|NCT02139358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111204607|NCT02139358|Antimetabolites|antimetabolites|mesh-ancestor
111204608|NCT02139358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111204609|NCT02139358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111204610|NCT02139358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110944270|NCT04895722|Pembrolizumab|pembrolizumab|mesh-list
110944271|NCT04895722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110944272|NCT04895722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110944273|NCT04895722|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110944274|NCT04895722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110944311|NCT04883892|Hyaluronic Acid|hyaluronic acid|mesh-list
110661790|NCT00412360|Antifungal Agents|antifungal agents|mesh-ancestor
110944312|NCT04883892|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110944313|NCT04883892|Immunologic Factors|immunologic factors|mesh-ancestor
110944314|NCT04883892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110944315|NCT04883892|Viscosupplements|viscosupplements|mesh-ancestor
110944316|NCT04883892|Protective Agents|protective agents|mesh-ancestor
111204611|NCT02140372|Colchicine|colchicine|mesh-list
111204612|NCT02140372|Gout Suppressants|gout suppressants|mesh-ancestor
111204613|NCT02140372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111204614|NCT02140372|Tubulin Modulators|tubulin modulators|mesh-ancestor
111204615|NCT02140372|Antimitotic Agents|antimitotic agents|mesh-ancestor
111204616|NCT02140372|Mitosis Modulators|mitosis modulators|mesh-ancestor
111204617|NCT02140372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111204618|NCT02140372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111204619|NCT00670774|Eculizumab|eculizumab|mesh-list
111204620|NCT00670774|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
111204621|NCT00670774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111204622|NCT00670774|Immunologic Factors|immunologic factors|mesh-ancestor
111204623|NCT00670774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111204624|NCT00672100|Ropivacaine|ropivacaine|mesh-list
111204625|NCT00672100|Anesthetics, Local|anesthetics, local|mesh-ancestor
111204626|NCT00672100|Anesthetics|anesthetics|mesh-ancestor
111204627|NCT00672100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111204628|NCT00672100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111204629|NCT00672100|Sensory System Agents|sensory system agents|mesh-ancestor
111204630|NCT00672100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111204631|NCT00593866|Gemcitabine|gemcitabine|mesh-list
111204632|NCT00593866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111204633|NCT00593866|Antimetabolites|antimetabolites|mesh-ancestor
111204634|NCT00593866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111204635|NCT00593866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111204636|NCT00624910|Bupivacaine|bupivacaine|mesh-list
111204637|NCT00624910|Anesthetics, Local|anesthetics, local|mesh-ancestor
111204638|NCT00624910|Anesthetics|anesthetics|mesh-ancestor
111204639|NCT00624910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111204640|NCT00624910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111204641|NCT00624910|Sensory System Agents|sensory system agents|mesh-ancestor
111204642|NCT00624910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111204643|NCT00626626|Alemtuzumab|alemtuzumab|mesh-list
111204644|NCT00626626|Clofarabine|clofarabine|mesh-list
111204645|NCT00626626|Cyclophosphamide|cyclophosphamide|mesh-list
111204646|NCT00626626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111204647|NCT00626626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111204648|NCT00626626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111204649|NCT00626626|Antimetabolites|antimetabolites|mesh-ancestor
111204650|NCT00626626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111204651|NCT00626626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110944317|NCT04874311|Doxorubicin|doxorubicin|mesh-list
110944318|NCT04874311|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110944319|NCT04874311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110944320|NCT04874311|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110944321|NCT04874311|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110944322|NCT04874311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110944323|NCT04874311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110944336|NCT04855136|Idecabtagene vicleucel|idecabtagene vicleucel|mesh-list
110944337|NCT04855136|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110944338|NCT04855136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110944339|NCT04848337|Pembrolizumab|pembrolizumab|mesh-list
110944340|NCT04848337|Lenvatinib|lenvatinib|mesh-list
110944341|NCT04848337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110944342|NCT04848337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110944343|NCT04848337|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110944344|NCT04848337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110944345|NCT04848337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110944346|NCT04848337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110944378|NCT04814368|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110944379|NCT04814368|Immunologic Factors|immunologic factors|mesh-ancestor
110944380|NCT04814368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110944381|NCT04807816|Gemcitabine|gemcitabine|mesh-list
110944382|NCT04807816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110944383|NCT04807816|Antimetabolites|antimetabolites|mesh-ancestor
110944384|NCT04807816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110944385|NCT04807816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110944386|NCT04807517|Buspirone|buspirone|mesh-list
110944387|NCT04807517|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110944388|NCT04807517|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110944389|NCT04807517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110944390|NCT04807517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110944392|NCT04807517|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110944393|NCT04807517|Serotonin Agents|serotonin agents|mesh-ancestor
111204652|NCT00626626|Immunologic Factors|immunologic factors|mesh-ancestor
111204653|NCT00626626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111204654|NCT00626626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111204655|NCT00626626|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111204656|NCT00626626|Alkylating Agents|alkylating agents|mesh-ancestor
111204657|NCT00626626|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111204658|NCT00626782|Ranibizumab|ranibizumab|mesh-list
111204659|NCT00626782|Mitomycins|mitomycins|mesh-list
111204660|NCT00626782|Mitomycin|mitomycin|mesh-list
111204661|NCT00626782|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111204662|NCT00626782|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111204663|NCT00626782|Growth Substances|growth substances|mesh-ancestor
111204664|NCT00626782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111204665|NCT00626782|Growth Inhibitors|growth inhibitors|mesh-ancestor
111204666|NCT00626782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111204667|NCT00626782|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111204668|NCT00626782|Alkylating Agents|alkylating agents|mesh-ancestor
111204669|NCT00626782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111204670|NCT00626782|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110980488|NCT00468117|Daclizumab|daclizumab|mesh-list
111204671|NCT00626782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110944394|NCT04807517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110944395|NCT04807517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110944432|NCT04771962|Sevoflurane|sevoflurane|mesh-list
110944433|NCT04771962|Desflurane|desflurane|mesh-list
110944434|NCT04771962|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110944435|NCT04771962|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110944436|NCT04771962|Anesthetics, General|anesthetics, general|mesh-ancestor
110944437|NCT04771962|Anesthetics|anesthetics|mesh-ancestor
110944438|NCT04771962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110944439|NCT04771962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110944458|NCT04771026|Dexamethasone|dexamethasone|mesh-list
110944459|NCT04771026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110944460|NCT04771026|Antiemetics|antiemetics|mesh-ancestor
110944461|NCT04771026|Autonomic Agents|autonomic agents|mesh-ancestor
110944462|NCT04771026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110944463|NCT04771026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110944464|NCT04771026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110944465|NCT04771026|Glucocorticoids|glucocorticoids|mesh-ancestor
110944467|NCT04771026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110958985|NCT02253849|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110958986|NCT02253849|Protease Inhibitors|protease inhibitors|mesh-ancestor
110958987|NCT02253849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110958988|NCT02253849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110958989|NCT02253849|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110958990|NCT02253849|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110958991|NCT02253849|Antiviral Agents|antiviral agents|mesh-ancestor
110958992|NCT02253849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110958993|NCT02253849|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110958994|NCT02253849|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110958995|NCT02253849|Anticonvulsants|anticonvulsants|mesh-ancestor
110958996|NCT02253849|Antimanic Agents|antimanic agents|mesh-ancestor
110958997|NCT02253849|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110958998|NCT02253849|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110958999|NCT02253849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110959000|NCT02253849|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110959001|NCT02253849|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110959002|NCT02253849|Analgesics|analgesics|mesh-ancestor
110959003|NCT02253849|Sensory System Agents|sensory system agents|mesh-ancestor
110959004|NCT02253849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110959005|NCT02253849|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110959006|NCT02253849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110959007|NCT02253849|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110959008|NCT02253849|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110959009|NCT03545997|Montelukast|montelukast|mesh-list
110959010|NCT03545997|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110959011|NCT03545997|Respiratory System Agents|respiratory system agents|mesh-ancestor
110959012|NCT03545997|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110959013|NCT03545997|Hormone Antagonists|hormone antagonists|mesh-ancestor
110959014|NCT03545997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110959015|NCT03545997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110023049|NCT00003342|Gemcitabine|gemcitabine|mesh-list
111204672|NCT00594256|Sodium Oxybate|sodium oxybate|mesh-list
111204673|NCT00594256|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111204674|NCT00594256|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111204675|NCT00594256|Anesthetics, General|anesthetics, general|mesh-ancestor
111204676|NCT00594256|Anesthetics|anesthetics|mesh-ancestor
111204677|NCT00594256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111204678|NCT00594256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111204679|NCT00627406|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
111204680|NCT00627406|Buserelin|buserelin|mesh-list
111204681|NCT00627406|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111204682|NCT00627406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110944468|NCT04771026|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110944469|NCT04771026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110944470|NCT04768010|Misoprostol|misoprostol|mesh-list
110944471|NCT04768010|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110944472|NCT04768010|Abortifacient Agents|abortifacient agents|mesh-ancestor
110944473|NCT04768010|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110944474|NCT04768010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110944475|NCT04768010|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110944476|NCT04768010|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110944477|NCT04768010|Oxytocics|oxytocics|mesh-ancestor
110662021|NCT00403546|Ziprasidone|ziprasidone|mesh-list
110959016|NCT03545997|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110959017|NCT03545997|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110959018|NCT03545997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110959019|NCT05696548|Nivolumab|nivolumab|mesh-list
110959020|NCT05696548|Lenvatinib|lenvatinib|mesh-list
110959021|NCT05696548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110959022|NCT05696548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110959023|NCT05696548|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110959024|NCT05696548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110959025|NCT05696548|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110959026|NCT05696548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110959027|NCT03810495|Naltrexone|naltrexone|mesh-list
110959028|NCT03810495|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110959029|NCT03810495|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110959030|NCT03810495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110959031|NCT03810495|Sensory System Agents|sensory system agents|mesh-ancestor
110959032|NCT03810495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110959033|NCT04980885|Azacitidine|azacitidine|mesh-list
110959034|NCT04980885|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110959035|NCT04980885|Antimetabolites|antimetabolites|mesh-ancestor
110959036|NCT04980885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110959037|NCT04980885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110959038|NCT04980885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110959039|NCT04184505|Azacitidine|azacitidine|mesh-list
110959040|NCT04184505|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110959041|NCT04184505|Antimetabolites|antimetabolites|mesh-ancestor
110959042|NCT04184505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110959043|NCT04184505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110959044|NCT04184505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110959045|NCT03691935|Ropivacaine|ropivacaine|mesh-list
110959046|NCT03691935|Anesthetics|anesthetics|mesh-list
110959047|NCT03691935|Anesthetics, Local|anesthetics, local|mesh-ancestor
110959048|NCT03691935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110959049|NCT03691935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110959050|NCT03691935|Sensory System Agents|sensory system agents|mesh-ancestor
110959051|NCT03691935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110959052|NCT03760458|Lamivudine|lamivudine|mesh-list
110959053|NCT03760458|Abacavir|abacavir|mesh-list
110959054|NCT03760458|Dideoxynucleosides|dideoxynucleosides|mesh-list
110959055|NCT03760458|Dolutegravir|dolutegravir|mesh-list
110959056|NCT03760458|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110959057|NCT03760458|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110959058|NCT03760458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110959059|NCT03760458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110959060|NCT03760458|Antiviral Agents|antiviral agents|mesh-ancestor
110959061|NCT03760458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110959062|NCT03760458|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110959063|NCT03760458|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110959064|NCT03760458|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110959065|NCT03760458|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110959066|NCT03760458|Antimetabolites|antimetabolites|mesh-ancestor
111204683|NCT00627406|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111204684|NCT00627406|Fertility Agents|fertility agents|mesh-ancestor
111204685|NCT00673738|Docetaxel|docetaxel|mesh-list
111204686|NCT00673738|Cetuximab|cetuximab|mesh-list
111204687|NCT00673738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111204688|NCT00673738|Tubulin Modulators|tubulin modulators|mesh-ancestor
111204689|NCT00673738|Antimitotic Agents|antimitotic agents|mesh-ancestor
111204690|NCT00673738|Mitosis Modulators|mitosis modulators|mesh-ancestor
111204691|NCT00673738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111204692|NCT00673738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111204693|NCT00674206|Gemcitabine|gemcitabine|mesh-list
111204694|NCT00674206|Oxaliplatin|oxaliplatin|mesh-list
111204695|NCT00674206|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111204696|NCT00674206|Antimetabolites|antimetabolites|mesh-ancestor
111204697|NCT00674206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111204698|NCT00674206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111204699|NCT00595270|Vaccines|vaccines|mesh-list
111204700|NCT00595270|Immunologic Factors|immunologic factors|mesh-ancestor
111204701|NCT00595270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111204702|NCT00628498|Defibrotide|defibrotide|mesh-list
111204703|NCT00628498|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111204704|NCT00628498|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111204705|NCT00628498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111204706|NCT00628498|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111204707|NCT00629122|Clotrimazole|clotrimazole|mesh-list
111204708|NCT00629122|Miconazole|miconazole|mesh-list
111204709|NCT00629122|Nystatin|nystatin|mesh-list
111204710|NCT00629122|Tacrolimus|tacrolimus|mesh-list
111204711|NCT00629122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111204712|NCT00629122|Immunologic Factors|immunologic factors|mesh-ancestor
111204713|NCT00629122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111204714|NCT00629122|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111204715|NCT00629122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111204716|NCT00629122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111204717|NCT00629122|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111204718|NCT00629122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111204719|NCT00629122|Antifungal Agents|antifungal agents|mesh-ancestor
111204720|NCT00629122|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111204721|NCT00629122|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111204722|NCT00629122|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111204723|NCT00629122|Hormone Antagonists|hormone antagonists|mesh-ancestor
111204724|NCT00629122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111204725|NCT00629122|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111204726|NCT00629122|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111204727|NCT00629122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111204728|NCT00629122|Ionophores|ionophores|mesh-ancestor
111204729|NCT00629122|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111204730|NCT00596440|Nicotine|nicotine|mesh-list
111204731|NCT00596440|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111204732|NCT00596440|Autonomic Agents|autonomic agents|mesh-ancestor
111204733|NCT00596440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111204734|NCT00596440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111204735|NCT00596440|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111204736|NCT00596440|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111204737|NCT00596440|Cholinergic Agents|cholinergic agents|mesh-ancestor
111204738|NCT00596440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111204739|NCT00596440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111204740|NCT00632632|Cycloserine|cycloserine|mesh-list
111204741|NCT00632632|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111204742|NCT00632632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111204743|NCT00632632|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111204744|NCT00632632|Antitubercular Agents|antitubercular agents|mesh-ancestor
111204745|NCT00632632|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110944556|NCT04749108|Folfirinox|folfirinox|mesh-list
110944557|NCT04749108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110944571|NCT04738487|Pembrolizumab|pembrolizumab|mesh-list
110944572|NCT04738487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110944573|NCT04738487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110944574|NCT04738487|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110944575|NCT04738487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110944580|NCT04730544|Nivolumab|nivolumab|mesh-list
110944581|NCT04730544|Ipilimumab|ipilimumab|mesh-list
110944582|NCT04730544|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110944583|NCT04730544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111204746|NCT00632632|Antimetabolites|antimetabolites|mesh-ancestor
110944632|NCT04667234|Sotorasib|sotorasib|mesh-list
111204747|NCT00632632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111204748|NCT00633256|Isoniazid|isoniazid|mesh-list
111204749|NCT00633256|Cycloserine|cycloserine|mesh-list
111204750|NCT00633256|Antitubercular Agents|antitubercular agents|mesh-ancestor
111204751|NCT00633256|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111204752|NCT00633256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111204753|NCT00633256|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
111204754|NCT00633256|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111204755|NCT00633256|Antimetabolites|antimetabolites|mesh-ancestor
111204756|NCT00633256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111204757|NCT00633256|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111204758|NCT00633256|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111204759|NCT00633256|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111204760|NCT00634270|Sirolimus|sirolimus|mesh-list
111204761|NCT00634270|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111204762|NCT00634270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111204763|NCT00634270|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111204764|NCT00634270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111204765|NCT00634270|Antifungal Agents|antifungal agents|mesh-ancestor
111204766|NCT00634270|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111204767|NCT00634270|Immunologic Factors|immunologic factors|mesh-ancestor
111204768|NCT00634270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111204769|NCT00678418|Naltrexone|naltrexone|mesh-list
111204770|NCT00678418|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111204771|NCT00678418|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110944633|NCT04667234|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110944634|NCT04667234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110944635|NCT04667234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110944636|NCT04667234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110944648|NCT04665037|Posaconazole|posaconazole|mesh-list
110944649|NCT04665037|Antifungal Agents|antifungal agents|mesh-ancestor
110944650|NCT04665037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110944651|NCT04665037|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
110944652|NCT04665037|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110944653|NCT04665037|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110944654|NCT04665037|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110944655|NCT04665037|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110944656|NCT04665037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110944657|NCT04665037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110944658|NCT04665037|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110944659|NCT04665037|Hormone Antagonists|hormone antagonists|mesh-ancestor
110944660|NCT04665037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110944661|NCT04665037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110944662|NCT04631185|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110944663|NCT04631185|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
110944664|NCT04631185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110944665|NCT04631185|Antitubercular Agents|antitubercular agents|mesh-ancestor
110959067|NCT02066415|Erenumab|erenumab|mesh-list
110959068|NCT02066415|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
110959069|NCT02066415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110959070|NCT02066415|Analgesics|analgesics|mesh-ancestor
110959071|NCT02066415|Sensory System Agents|sensory system agents|mesh-ancestor
110959072|NCT02066415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110959073|NCT02066415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110959074|NCT04467918|Cannabidiol|cannabidiol|mesh-list
110959075|NCT04467918|Anticonvulsants|anticonvulsants|mesh-ancestor
110959076|NCT04720612|Omalizumab|omalizumab|mesh-list
110959077|NCT04720612|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110959078|NCT04720612|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110959079|NCT04720612|Respiratory System Agents|respiratory system agents|mesh-ancestor
110959080|NCT01981551|Nirogacestat|nirogacestat|mesh-list
110959081|NCT01981551|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
110959082|NCT01981551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110959083|NCT01981551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110959084|NCT02584660|Rivaroxaban|rivaroxaban|mesh-list
110959085|NCT02584660|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110959086|NCT02584660|Antithrombins|antithrombins|mesh-ancestor
110959087|NCT02584660|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110959088|NCT02584660|Protease Inhibitors|protease inhibitors|mesh-ancestor
110959089|NCT02584660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110959090|NCT02584660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111204772|NCT00678418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111204773|NCT00678418|Sensory System Agents|sensory system agents|mesh-ancestor
111204774|NCT00678418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111204776|NCT00600340|Bevacizumab|bevacizumab|mesh-list
111204777|NCT00600340|Capecitabine|capecitabine|mesh-list
111204778|NCT00600340|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111204779|NCT00600340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111204780|NCT00600340|Tubulin Modulators|tubulin modulators|mesh-ancestor
111204781|NCT00600340|Antimitotic Agents|antimitotic agents|mesh-ancestor
111204782|NCT00600340|Mitosis Modulators|mitosis modulators|mesh-ancestor
111204783|NCT00600340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111204784|NCT00600340|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111204785|NCT00600340|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111204786|NCT00600340|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111204787|NCT00600340|Growth Substances|growth substances|mesh-ancestor
111204788|NCT00600340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111204789|NCT00600340|Growth Inhibitors|growth inhibitors|mesh-ancestor
111204790|NCT00600340|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111204791|NCT00600340|Antimetabolites|antimetabolites|mesh-ancestor
110944701|NCT04624204|Pembrolizumab|pembrolizumab|mesh-list
110944702|NCT04624204|Etoposide|etoposide|mesh-list
110944703|NCT04624204|Olaparib|olaparib|mesh-list
110944704|NCT04624204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110944705|NCT04624204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110944706|NCT04624204|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110944707|NCT04624204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110944708|NCT04624204|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110944709|NCT04624204|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110944710|NCT04624204|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110944711|NCT04624204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110944712|NCT04624204|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110944757|NCT04609020|Lidocaine|lidocaine|mesh-list
110944758|NCT04609020|Anesthetics, Local|anesthetics, local|mesh-ancestor
110944759|NCT04609020|Anesthetics|anesthetics|mesh-ancestor
110944760|NCT04609020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110944761|NCT04609020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110944762|NCT04609020|Sensory System Agents|sensory system agents|mesh-ancestor
110944763|NCT04609020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110944764|NCT04609020|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110959091|NCT02584660|Anticoagulants|anticoagulants|mesh-ancestor
110959092|NCT04862286|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110959093|NCT04862286|Immunologic Factors|immunologic factors|mesh-ancestor
110959094|NCT04862286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110959095|NCT02143323|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
110959096|NCT02143323|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110959097|NCT02143323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110959098|NCT02143323|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110959099|NCT02143323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110959100|NCT02143323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110959102|NCT04315558|Ipratropium|ipratropium|mesh-list
110959103|NCT04315558|Anticonvulsants|anticonvulsants|mesh-ancestor
110959104|NCT04315558|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110959105|NCT04315558|Autonomic Agents|autonomic agents|mesh-ancestor
110959106|NCT04315558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110959107|NCT04315558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110959108|NCT04315558|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110959109|NCT04315558|Respiratory System Agents|respiratory system agents|mesh-ancestor
110959110|NCT04315558|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110959111|NCT04315558|Cholinergic Agents|cholinergic agents|mesh-ancestor
110959112|NCT04315558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110959113|NCT04315558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110959114|NCT04466904|Dulaglutide|dulaglutide|mesh-list
110959115|NCT04466904|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110959116|NCT04466904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110959117|NCT03524274|Antibodies|antibodies|mesh-list
110959118|NCT03524274|Antibodies, Bispecific|antibodies, bispecific|mesh-list
110959119|NCT03524274|Immunologic Factors|immunologic factors|mesh-ancestor
110959120|NCT03524274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110959121|NCT02143479|Tacrolimus|tacrolimus|mesh-list
110959122|NCT02143479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110959123|NCT02143479|Immunologic Factors|immunologic factors|mesh-ancestor
111204792|NCT01799356|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111204793|NCT01799356|Moxifloxacin|moxifloxacin|mesh-list
111204794|NCT01799356|Metronidazole|metronidazole|mesh-list
111204795|NCT01799356|Ofloxacin|ofloxacin|mesh-list
111204796|NCT01799356|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
111204797|NCT01799356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111204798|NCT01799356|Antitubercular Agents|antitubercular agents|mesh-ancestor
111204799|NCT01799356|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111204800|NCT01799356|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111204801|NCT01799356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111204802|NCT01799356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111204803|NCT01799356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111204804|NCT01799356|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111204805|NCT01799356|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111204806|NCT01799356|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111204807|NCT01799356|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111204808|NCT01799356|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111204809|NCT00602290|Methylphenidate|methylphenidate|mesh-list
111204810|NCT00602290|Citalopram|citalopram|mesh-list
111204811|NCT00602290|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111204812|NCT00602290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111204813|NCT00602290|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111204814|NCT00602290|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111204815|NCT00602290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111204816|NCT00602290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111204817|NCT00602290|Dopamine Agents|dopamine agents|mesh-ancestor
111204818|NCT00602290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111204819|NCT00602290|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111204820|NCT00602290|Serotonin Agents|serotonin agents|mesh-ancestor
111204821|NCT00602290|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111204822|NCT00602290|Antidepressive Agents|antidepressive agents|mesh-ancestor
111204823|NCT00602290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111204824|NCT00637780|Sulfasalazine|sulfasalazine|mesh-list
111204825|NCT00637780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111204826|NCT00637780|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111204827|NCT00637780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111204828|NCT00637780|Analgesics|analgesics|mesh-ancestor
111204829|NCT00637780|Sensory System Agents|sensory system agents|mesh-ancestor
111204830|NCT00637780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111204831|NCT00637780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111204832|NCT00637780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111204833|NCT00637780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111204834|NCT00637780|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111204835|NCT01799902|Solifenacin Succinate|solifenacin succinate|mesh-list
111204836|NCT01799902|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111204837|NCT01799902|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111204838|NCT01799902|Cholinergic Agents|cholinergic agents|mesh-ancestor
111204839|NCT01799902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111204840|NCT01799902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111204841|NCT01799902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111204842|NCT01799902|Urological Agents|urological agents|mesh-ancestor
111204843|NCT00602446|Deferasirox|deferasirox|mesh-list
111204844|NCT00602446|Iron Chelating Agents|iron chelating agents|mesh-ancestor
111204845|NCT00602446|Chelating Agents|chelating agents|mesh-ancestor
111204846|NCT00602446|Sequestering Agents|sequestering agents|mesh-ancestor
111204847|NCT00602446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111204848|NCT00602836|Cyclophosphamide|cyclophosphamide|mesh-list
111204849|NCT00602836|Rituximab|rituximab|mesh-list
111204850|NCT00602836|Lenalidomide|lenalidomide|mesh-list
111204851|NCT00602836|Pentostatin|pentostatin|mesh-list
110944765|NCT04609020|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110944766|NCT04609020|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110944767|NCT04609020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110944768|NCT04609020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110944770|NCT04604353|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110944771|NCT04604353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110944827|NCT04540861|Siponimod|siponimod|mesh-list
110944828|NCT04540861|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
110944829|NCT04540861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110944830|NCT04540861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110944831|NCT04540861|Immunologic Factors|immunologic factors|mesh-ancestor
110944832|NCT04540861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111204852|NCT00602836|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111204853|NCT00602836|Immunologic Factors|immunologic factors|mesh-ancestor
111204854|NCT00602836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111204855|NCT00602836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111204856|NCT00602836|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111204857|NCT00602836|Alkylating Agents|alkylating agents|mesh-ancestor
111204858|NCT00602836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111204859|NCT00602836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111204860|NCT00602836|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111204861|NCT00602836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111204862|NCT00602836|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111204863|NCT00602836|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111204864|NCT00602836|Growth Substances|growth substances|mesh-ancestor
111204865|NCT00602836|Growth Inhibitors|growth inhibitors|mesh-ancestor
111204866|NCT00602836|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
111204867|NCT00602836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111204868|NCT00683332|Tigecycline|tigecycline|mesh-list
111204869|NCT00683332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111204870|NCT00683332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111204871|NCT00683332|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111204872|NCT00683332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111204873|NCT00683332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111204874|NCT00683410|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
111204875|NCT00683410|Immunologic Factors|immunologic factors|mesh-ancestor
111204876|NCT00683410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111204877|NCT00640822|Calcitriol|calcitriol|mesh-list
111204878|NCT00640822|Hydrocortisone|hydrocortisone|mesh-list
111204879|NCT00640822|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
111204880|NCT00640822|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
111204881|NCT00640822|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
111204882|NCT00640822|1 alpha,24-dihydroxyvitamin D3|1 alpha,24-dihydroxyvitamin d3|mesh-list
111204883|NCT00640822|Calcipotriene|calcipotriene|mesh-list
111204884|NCT00640822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111204885|NCT00640822|Dermatologic Agents|dermatologic agents|mesh-ancestor
111204886|NCT00640822|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111204887|NCT00640822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111204888|NCT00640822|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
111204889|NCT00640822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111204890|NCT00640822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111204891|NCT00640822|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111204892|NCT00640822|Vitamins|vitamins|mesh-ancestor
111204893|NCT00640822|Micronutrients|micronutrients|mesh-ancestor
111204894|NCT00640822|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111204895|NCT00640978|Everolimus|everolimus|mesh-list
111204896|NCT00640978|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111204897|NCT00640978|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111204898|NCT00640978|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111204899|NCT00640978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111204900|NCT00640978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111204901|NCT00640978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111204902|NCT00640978|Immunologic Factors|immunologic factors|mesh-ancestor
111204903|NCT00640978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111204904|NCT00640978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111204905|NCT00642694|Dexetimide|dexetimide|mesh-list
111204906|NCT00642694|Citalopram|citalopram|mesh-list
111204907|NCT00642694|Escitalopram|escitalopram|mesh-list
111204908|NCT00642694|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111204909|NCT00642694|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111204910|NCT00642694|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111204911|NCT00642694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111204912|NCT00642694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111204913|NCT00642694|Serotonin Agents|serotonin agents|mesh-ancestor
111204914|NCT00642694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111204915|NCT00642694|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111204916|NCT00642694|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111204917|NCT00642694|Parasympatholytics|parasympatholytics|mesh-ancestor
111204918|NCT00642694|Autonomic Agents|autonomic agents|mesh-ancestor
111204919|NCT00642694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111204920|NCT00642694|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111204921|NCT00642694|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111204922|NCT00642694|Cholinergic Agents|cholinergic agents|mesh-ancestor
111204923|NCT00642694|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110944917|NCT04521361|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
111204924|NCT00642694|Antidepressive Agents|antidepressive agents|mesh-ancestor
111204925|NCT00642694|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111204926|NCT00705874|Leucovorin|leucovorin|mesh-list
111204927|NCT00705874|Bevacizumab|bevacizumab|mesh-list
111204928|NCT00705874|Sunitinib|sunitinib|mesh-list
111204929|NCT00705874|Gemcitabine|gemcitabine|mesh-list
111204930|NCT00705874|Docetaxel|docetaxel|mesh-list
111204931|NCT00705874|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111204932|NCT00705874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111204933|NCT00705874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111204934|NCT00705874|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111204935|NCT00705874|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111204936|NCT00705874|Growth Substances|growth substances|mesh-ancestor
111204937|NCT00705874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111204938|NCT00705874|Growth Inhibitors|growth inhibitors|mesh-ancestor
111204939|NCT00705874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111204940|NCT00705874|Antimetabolites|antimetabolites|mesh-ancestor
111204941|NCT00705874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111204942|NCT00705874|Tubulin Modulators|tubulin modulators|mesh-ancestor
111204943|NCT00705874|Antimitotic Agents|antimitotic agents|mesh-ancestor
111204944|NCT00705874|Mitosis Modulators|mitosis modulators|mesh-ancestor
111204945|NCT00705874|Antidotes|antidotes|mesh-ancestor
111204946|NCT00705874|Protective Agents|protective agents|mesh-ancestor
111204947|NCT00705874|Vitamin B Complex|vitamin b complex|mesh-ancestor
111204948|NCT00705874|Vitamins|vitamins|mesh-ancestor
111204949|NCT00705874|Micronutrients|micronutrients|mesh-ancestor
111204950|NCT00705874|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111204951|NCT00705874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111204952|NCT00647998|Darbepoetin alfa|darbepoetin alfa|mesh-list
111204953|NCT00647998|Hematinics|hematinics|mesh-ancestor
111204954|NCT00649792|4-Aminopyridine|4-aminopyridine|mesh-list
111204955|NCT00649792|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
111204956|NCT00649792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111204957|NCT00649792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111204958|NCT00687076|Aspirin|aspirin|mesh-list
111204959|NCT00687076|Niacin|niacin|mesh-list
111204960|NCT00687076|Nicotinic Acids|nicotinic acids|mesh-list
111204961|NCT00687076|Clopidogrel|clopidogrel|mesh-list
110944918|NCT04521361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110944919|NCT04521231|Blinatumomab|blinatumomab|mesh-list
110944920|NCT04521231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110944921|NCT04519619|Aflibercept|aflibercept|mesh-list
110944922|NCT04519619|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110944923|NCT04519619|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110944924|NCT04519619|Growth Substances|growth substances|mesh-ancestor
110944925|NCT04519619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110944926|NCT04519619|Growth Inhibitors|growth inhibitors|mesh-ancestor
110944927|NCT04519619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110944946|NCT04508244|Propranolol|propranolol|mesh-list
110944947|NCT04508244|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110944948|NCT04508244|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110944949|NCT04508244|Adrenergic Agents|adrenergic agents|mesh-ancestor
110944950|NCT04508244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110944951|NCT04508244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110944952|NCT04508244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110944953|NCT04508244|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110944954|NCT04508244|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110944955|NCT04508244|Vasodilator Agents|vasodilator agents|mesh-ancestor
110944962|NCT04479241|Pembrolizumab|pembrolizumab|mesh-list
110944963|NCT04479241|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110944964|NCT04479241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110944965|NCT04479241|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110944966|NCT04479241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110944981|NCT04464005|Magnesium Sulfate|magnesium sulfate|mesh-list
110944982|NCT04464005|Analgesics|analgesics|mesh-ancestor
110944983|NCT04464005|Sensory System Agents|sensory system agents|mesh-ancestor
110944984|NCT04464005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110944985|NCT04464005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110944986|NCT04464005|Anesthetics|anesthetics|mesh-ancestor
110944987|NCT04464005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110944988|NCT04464005|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110944989|NCT04464005|Anticonvulsants|anticonvulsants|mesh-ancestor
110944990|NCT04464005|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110944991|NCT04464005|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111204962|NCT00687076|Ezetimibe|ezetimibe|mesh-list
111204963|NCT00687076|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111204964|NCT00687076|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111204965|NCT00687076|Analgesics|analgesics|mesh-ancestor
111204966|NCT00687076|Sensory System Agents|sensory system agents|mesh-ancestor
111204967|NCT00687076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111204968|NCT00687076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111204969|NCT00687076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111204970|NCT00687076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111204971|NCT00687076|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111204972|NCT00687076|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111204973|NCT00687076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111204974|NCT00687076|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111204975|NCT00687076|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111204976|NCT00687076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111204977|NCT00687076|Antipyretics|antipyretics|mesh-ancestor
111204978|NCT00687076|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111204979|NCT00687076|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111204980|NCT00687076|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111204981|NCT00687076|Purinergic Agents|purinergic agents|mesh-ancestor
111204982|NCT00687076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111204983|NCT00687076|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111204984|NCT00687076|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111204985|NCT00687076|Antimetabolites|antimetabolites|mesh-ancestor
111204986|NCT00687076|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111204987|NCT00687076|Vasodilator Agents|vasodilator agents|mesh-ancestor
111204988|NCT00687076|Vitamin B Complex|vitamin b complex|mesh-ancestor
111204989|NCT00687076|Vitamins|vitamins|mesh-ancestor
111204990|NCT00687076|Micronutrients|micronutrients|mesh-ancestor
111204991|NCT00687544|Ribavirin|ribavirin|mesh-list
111204992|NCT00687544|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
111204993|NCT00687544|Antimetabolites|antimetabolites|mesh-ancestor
111204994|NCT00687544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111204995|NCT00687544|Antiviral Agents|antiviral agents|mesh-ancestor
111204996|NCT00687544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111204997|NCT02143648|Nalbuphine|nalbuphine|mesh-list
111204998|NCT02143648|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111204999|NCT02143648|Narcotics|narcotics|mesh-ancestor
111205000|NCT02143648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111205001|NCT02143648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111205002|NCT02143648|Analgesics|analgesics|mesh-ancestor
111205003|NCT02143648|Sensory System Agents|sensory system agents|mesh-ancestor
111205004|NCT02143648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111205005|NCT02997982|Valacyclovir|valacyclovir|mesh-list
111205006|NCT02997982|Antiviral Agents|antiviral agents|mesh-ancestor
111205007|NCT02997982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111205008|NCT00689572|Ondansetron|ondansetron|mesh-list
111205009|NCT00689572|Antiemetics|antiemetics|mesh-ancestor
111205010|NCT00689572|Autonomic Agents|autonomic agents|mesh-ancestor
111205011|NCT00689572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111205012|NCT00689572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111205013|NCT00689572|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111205014|NCT00689572|Antipruritics|antipruritics|mesh-ancestor
111205015|NCT00689572|Dermatologic Agents|dermatologic agents|mesh-ancestor
111205016|NCT00689572|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111205017|NCT00689572|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111205018|NCT00689572|Serotonin Agents|serotonin agents|mesh-ancestor
111205019|NCT00689572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111205020|NCT00689572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111205021|NCT01840579|Paclitaxel|paclitaxel|mesh-list
111205022|NCT01840579|Etoposide|etoposide|mesh-list
111205023|NCT01840579|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111205024|NCT01840579|Carboplatin|carboplatin|mesh-list
111205025|NCT01840579|Pembrolizumab|pembrolizumab|mesh-list
111205026|NCT01840579|Pemetrexed|pemetrexed|mesh-list
111205027|NCT01840579|Ipilimumab|ipilimumab|mesh-list
111205028|NCT01840579|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110944992|NCT04464005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110944993|NCT04464005|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110944994|NCT04464005|Tocolytic Agents|tocolytic agents|mesh-ancestor
110944995|NCT04464005|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110944996|NCT04461639|Factor VIII|factor viii|mesh-list
110944997|NCT04461639|Coagulants|coagulants|mesh-ancestor
110945015|NCT04428151|Paclitaxel|paclitaxel|mesh-list
110945016|NCT04428151|Docetaxel|docetaxel|mesh-list
110945017|NCT04428151|Pembrolizumab|pembrolizumab|mesh-list
110945018|NCT04428151|Capecitabine|capecitabine|mesh-list
110945019|NCT04428151|Cetuximab|cetuximab|mesh-list
110945020|NCT04428151|Lenvatinib|lenvatinib|mesh-list
110945023|NCT04428151|Tubulin Modulators|tubulin modulators|mesh-ancestor
111205029|NCT01840579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111205030|NCT01840579|Tubulin Modulators|tubulin modulators|mesh-ancestor
111205031|NCT01840579|Antimitotic Agents|antimitotic agents|mesh-ancestor
111205032|NCT01840579|Mitosis Modulators|mitosis modulators|mesh-ancestor
111205033|NCT01840579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111205034|NCT01840579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111205035|NCT01840579|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111205036|NCT01840579|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111205037|NCT01840579|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111205038|NCT01840579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111205039|NCT01840579|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111205040|NCT01840579|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111205041|NCT00651040|Prednisone|prednisone|mesh-list
111205042|NCT00651040|Prednisolone|prednisolone|mesh-list
111205043|NCT00651040|Methotrexate|methotrexate|mesh-list
111205044|NCT00651040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111205045|NCT00651040|Glucocorticoids|glucocorticoids|mesh-ancestor
111205046|NCT00651040|Hormones|hormones|mesh-ancestor
111205047|NCT00651040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111205048|NCT00651040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111205049|NCT00651040|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111205050|NCT00651040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111205051|NCT00651040|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111205052|NCT00651040|Abortifacient Agents|abortifacient agents|mesh-ancestor
111205053|NCT00651040|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111205054|NCT00651040|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111205055|NCT00651040|Antimetabolites|antimetabolites|mesh-ancestor
111205056|NCT00651040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111205057|NCT00651040|Dermatologic Agents|dermatologic agents|mesh-ancestor
111205058|NCT00651040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111205059|NCT00651040|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111205060|NCT00651040|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111205061|NCT00651040|Immunologic Factors|immunologic factors|mesh-ancestor
111205062|NCT00651040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111205063|NCT00651040|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111205064|NCT00654784|Idebenone|idebenone|mesh-list
111205065|NCT00654784|Antioxidants|antioxidants|mesh-ancestor
111205066|NCT00654784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111205067|NCT00654784|Protective Agents|protective agents|mesh-ancestor
111205068|NCT00654784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111205069|NCT02997514|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111205070|NCT01801111|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111205071|NCT01801111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111205072|NCT01801111|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111205073|NCT01801111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111205074|NCT01801111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111205075|NCT00691600|Trimethoprim|trimethoprim|mesh-list
111205076|NCT00691600|Sulfamethoxazole|sulfamethoxazole|mesh-list
111205077|NCT00691600|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111205078|NCT00691600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111205079|NCT00691600|Antimalarials|antimalarials|mesh-ancestor
111205080|NCT00691600|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111205081|NCT00691600|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111205082|NCT00691600|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111205083|NCT00691600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111205084|NCT00691600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110945069|NCT04380636|Antimitotic Agents|antimitotic agents|mesh-ancestor
110945070|NCT04380636|Mitosis Modulators|mitosis modulators|mesh-ancestor
110945071|NCT04380636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110945072|NCT04380636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110945073|NCT04380636|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110945074|NCT04380636|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110945075|NCT04380636|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110945076|NCT04380636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110945077|NCT04380636|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110945078|NCT04380636|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110945079|NCT04380636|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110945096|NCT04366050|Ramipril|ramipril|mesh-list
110945097|NCT04366050|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110945098|NCT04366050|Protease Inhibitors|protease inhibitors|mesh-ancestor
110945099|NCT04366050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110945100|NCT04366050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110945101|NCT04366050|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111205085|NCT00691600|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111205086|NCT00691600|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
111205087|NCT00691600|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111205088|NCT00655642|Promethazine|promethazine|mesh-list
111205089|NCT00655642|Diphenhydramine|diphenhydramine|mesh-list
111205090|NCT00655642|Ondansetron|ondansetron|mesh-list
111205091|NCT00655642|Metoclopramide|metoclopramide|mesh-list
111205092|NCT00655642|Antiemetics|antiemetics|mesh-ancestor
111205093|NCT00655642|Autonomic Agents|autonomic agents|mesh-ancestor
111205094|NCT00655642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111205095|NCT00655642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111205096|NCT00655642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111205097|NCT00655642|Antipruritics|antipruritics|mesh-ancestor
111205098|NCT00655642|Dermatologic Agents|dermatologic agents|mesh-ancestor
111205099|NCT00655642|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111205100|NCT00655642|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111205101|NCT00655642|Serotonin Agents|serotonin agents|mesh-ancestor
111205102|NCT00655642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111205103|NCT00655642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111205104|NCT00655642|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111205105|NCT00655642|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111205106|NCT00655642|Dopamine Agents|dopamine agents|mesh-ancestor
111205107|NCT00655642|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111205108|NCT00655642|Histamine Antagonists|histamine antagonists|mesh-ancestor
111205109|NCT00655642|Histamine Agents|histamine agents|mesh-ancestor
111205110|NCT00655642|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111205111|NCT00655642|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111205112|NCT00655642|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111205113|NCT00655642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111205114|NCT00655642|Anesthetics, Local|anesthetics, local|mesh-ancestor
111205115|NCT00655642|Anesthetics|anesthetics|mesh-ancestor
111205116|NCT00655642|Sensory System Agents|sensory system agents|mesh-ancestor
111205117|NCT00656656|Dexamethasone|dexamethasone|mesh-list
111205118|NCT00656656|Rituximab|rituximab|mesh-list
111205119|NCT00656656|Azathioprine|azathioprine|mesh-list
111205120|NCT00656656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111205121|NCT00656656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111205122|NCT00656656|Immunologic Factors|immunologic factors|mesh-ancestor
111205123|NCT00656656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111205124|NCT00656656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111205125|NCT00656656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111205126|NCT00656656|Antiemetics|antiemetics|mesh-ancestor
111205127|NCT00656656|Autonomic Agents|autonomic agents|mesh-ancestor
111205128|NCT00656656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111205129|NCT00656656|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111205130|NCT00656656|Glucocorticoids|glucocorticoids|mesh-ancestor
111205131|NCT00656656|Hormones|hormones|mesh-ancestor
111205132|NCT00656656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111205133|NCT00656656|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111205134|NCT00656656|Antimetabolites|antimetabolites|mesh-ancestor
111205135|NCT00656656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111205136|NCT00656656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111205137|NCT00656656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111205138|NCT01773889|Interferon alpha-2|interferon alpha-2|mesh-list
111205139|NCT01773889|Denileukin diftitox|denileukin diftitox|mesh-list
111205140|NCT01773889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110945161|NCT04325503|Levodopa|levodopa|mesh-list
110945162|NCT04325503|Carbidopa|carbidopa|mesh-list
110945163|NCT04325503|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110945164|NCT04325503|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110945165|NCT04325503|Dopamine Agents|dopamine agents|mesh-ancestor
110945166|NCT04325503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110945167|NCT04325503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110945168|NCT04325503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110945169|NCT04325503|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
110945170|NCT04325503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110945179|NCT04301843|Eflornithine|eflornithine|mesh-list
110945180|NCT04301843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110945181|NCT04301843|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
110945182|NCT04301843|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110945183|NCT04301843|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110945184|NCT04301843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110945185|NCT04301843|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
110945186|NCT04301843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111205141|NCT01773889|Antiviral Agents|antiviral agents|mesh-ancestor
111205142|NCT01773889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110945228|NCT04282031|Letrozole|letrozole|mesh-list
111205143|NCT00656968|Esomeprazole|esomeprazole|mesh-list
111205144|NCT00656968|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111205145|NCT00656968|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111205146|NCT00656968|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111205147|NCT00656968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111205148|NCT00656968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111205149|NCT00657280|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111205150|NCT00657280|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111205151|NCT00657280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111205152|NCT00657280|Incretins|incretins|mesh-ancestor
111205153|NCT00657280|Hormones|hormones|mesh-ancestor
111205154|NCT00657280|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111205155|NCT00657280|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111205156|NCT00657280|Protease Inhibitors|protease inhibitors|mesh-ancestor
111205157|NCT00657280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111205158|NCT00657280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111205159|NCT00693160|Ketorolac|ketorolac|mesh-list
111205160|NCT00693160|Remifentanil|remifentanil|mesh-list
111205161|NCT00693160|Capsaicin|capsaicin|mesh-list
111205162|NCT00693160|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111205163|NCT00693160|Narcotics|narcotics|mesh-ancestor
111205164|NCT00693160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111205165|NCT00693160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111205166|NCT00693160|Analgesics|analgesics|mesh-ancestor
111205167|NCT00693160|Sensory System Agents|sensory system agents|mesh-ancestor
111205168|NCT00693160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111205169|NCT00693160|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111205170|NCT00693160|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111205171|NCT00693160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111205172|NCT00693160|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111205173|NCT00693160|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111205174|NCT00693160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111205175|NCT00693160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111205176|NCT00693160|Antipruritics|antipruritics|mesh-ancestor
111205177|NCT00693160|Dermatologic Agents|dermatologic agents|mesh-ancestor
111205178|NCT00695188|Methotrexate|methotrexate|mesh-list
111205179|NCT00695188|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111205180|NCT00695188|Abortifacient Agents|abortifacient agents|mesh-ancestor
111205181|NCT00695188|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111205182|NCT00695188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111205183|NCT00695188|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111205184|NCT00695188|Antimetabolites|antimetabolites|mesh-ancestor
111205185|NCT00695188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111205186|NCT00695188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111205187|NCT00695188|Dermatologic Agents|dermatologic agents|mesh-ancestor
111205188|NCT00695188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111205189|NCT00695188|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111205190|NCT00695188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111205191|NCT00695188|Immunologic Factors|immunologic factors|mesh-ancestor
111205192|NCT00695188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111205193|NCT00695188|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111205194|NCT00706264|Silicon|silicon|mesh-list
111205195|NCT00706264|Trace Elements|trace elements|mesh-ancestor
111205196|NCT00706264|Micronutrients|micronutrients|mesh-ancestor
111205197|NCT00706264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111205198|NCT00695500|Varenicline|varenicline|mesh-list
111205199|NCT00695500|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111205200|NCT00695500|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111205201|NCT00695500|Cholinergic Agents|cholinergic agents|mesh-ancestor
111205202|NCT00695500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111205203|NCT00695500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111205204|NCT00695500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111205205|NCT00695578|Bacitracin|bacitracin|mesh-list
111205206|NCT00695578|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111205207|NCT00695578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110945229|NCT04282031|Fulvestrant|fulvestrant|mesh-list
110945230|NCT04282031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110945231|NCT04282031|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110945232|NCT04282031|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110945233|NCT04282031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110945234|NCT04282031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110945235|NCT04282031|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110945236|NCT04282031|Hormone Antagonists|hormone antagonists|mesh-ancestor
110945238|NCT04282031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111205208|NCT00695578|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111205210|NCT01792102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111205211|NCT01792102|Antiemetics|antiemetics|mesh-ancestor
111205212|NCT01792102|Autonomic Agents|autonomic agents|mesh-ancestor
111205213|NCT01792102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111205214|NCT01792102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111205215|NCT01792102|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111205216|NCT01792102|Glucocorticoids|glucocorticoids|mesh-ancestor
111205217|NCT01792102|Hormones|hormones|mesh-ancestor
111205218|NCT01792102|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111205219|NCT01792102|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111205220|NCT01792102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111205221|NCT02996734|Denosumab|denosumab|mesh-list
111205222|NCT02996734|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111205223|NCT02996734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111205224|NCT00699010|Oxycodone|oxycodone|mesh-list
111205225|NCT00699010|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111205226|NCT00699010|Narcotics|narcotics|mesh-ancestor
111205227|NCT00699010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111205228|NCT00699010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111205229|NCT00699010|Analgesics|analgesics|mesh-ancestor
111205230|NCT00699010|Sensory System Agents|sensory system agents|mesh-ancestor
111205231|NCT00699010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111205232|NCT00706810|Hydroxyurea|hydroxyurea|mesh-list
111205233|NCT00706810|Verapamil|verapamil|mesh-list
111205234|NCT00706810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111205235|NCT00706810|Antisickling Agents|antisickling agents|mesh-ancestor
111205236|NCT00706810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111205237|NCT00706810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111205238|NCT00706810|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111205239|NCT00706810|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111205240|NCT00706810|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111205241|NCT00706810|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111205242|NCT00706810|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111205243|NCT00706810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111205244|NCT00706810|Vasodilator Agents|vasodilator agents|mesh-ancestor
111205245|NCT00661960|Efavirenz|efavirenz|mesh-list
111205246|NCT00661960|Raltegravir Potassium|raltegravir potassium|mesh-list
111205247|NCT00661960|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111205248|NCT00661960|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111205249|NCT00661960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111205250|NCT00661960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111205251|NCT00661960|Antiviral Agents|antiviral agents|mesh-ancestor
111205252|NCT00661960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111205253|NCT00661960|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111205254|NCT00661960|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110945300|NCT04263038|Rivaroxaban|rivaroxaban|mesh-list
110945301|NCT04263038|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110945302|NCT04263038|Antithrombins|antithrombins|mesh-ancestor
110945303|NCT04263038|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110945304|NCT04263038|Protease Inhibitors|protease inhibitors|mesh-ancestor
110945305|NCT04263038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110945306|NCT04263038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110945307|NCT04263038|Anticoagulants|anticoagulants|mesh-ancestor
110945343|NCT04235816|Azithromycin|azithromycin|mesh-list
110945344|NCT04235816|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110945345|NCT04235816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110945351|NCT04226963|Ketamine|ketamine|mesh-list
110945352|NCT04226963|Analgesics|analgesics|mesh-ancestor
110945353|NCT04226963|Sensory System Agents|sensory system agents|mesh-ancestor
110945354|NCT04226963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110945355|NCT04226963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110945356|NCT04226963|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110945357|NCT04226963|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110945358|NCT04226963|Anesthetics, General|anesthetics, general|mesh-ancestor
110945359|NCT04226963|Anesthetics|anesthetics|mesh-ancestor
110945360|NCT04226963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110945361|NCT04226963|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110945362|NCT04226963|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110945363|NCT04226963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110945364|NCT04226963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110945365|NCT04224987|Azithromycin|azithromycin|mesh-list
111205255|NCT00661960|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111205256|NCT00661960|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111205257|NCT00661960|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111205258|NCT00661960|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111205259|NCT00661960|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111205260|NCT00661960|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111205261|NCT00661960|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111205262|NCT00661960|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111205263|NCT00662818|Acetaminophen|acetaminophen|mesh-list
111205264|NCT00662818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111205265|NCT00662818|Analgesics|analgesics|mesh-ancestor
111205266|NCT00662818|Sensory System Agents|sensory system agents|mesh-ancestor
111205267|NCT00662818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111205268|NCT00662818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111205269|NCT00662818|Antipyretics|antipyretics|mesh-ancestor
111205270|NCT00699556|Nicotine|nicotine|mesh-list
111205271|NCT00699556|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111205272|NCT00699556|Autonomic Agents|autonomic agents|mesh-ancestor
111205273|NCT00699556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111205274|NCT00699556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111205275|NCT00699556|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111205276|NCT00699556|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111205277|NCT00699556|Cholinergic Agents|cholinergic agents|mesh-ancestor
111205278|NCT00699556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111205279|NCT00699556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111205280|NCT00700336|Cisplatin|cisplatin|mesh-list
111205281|NCT00700336|Pemetrexed|pemetrexed|mesh-list
111205282|NCT00700336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111205283|NCT00700336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111205284|NCT00700336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111205285|NCT00700336|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111205286|NCT00700336|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111205287|NCT01795846|Immunomodulating Agents|immunomodulating agents|mesh-list
111205288|NCT01795846|Immunologic Factors|immunologic factors|mesh-ancestor
111205289|NCT01795846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111205290|NCT00701896|Nicotine|nicotine|mesh-list
111205291|NCT00701896|Varenicline|varenicline|mesh-list
111205292|NCT00701896|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111205293|NCT00701896|Autonomic Agents|autonomic agents|mesh-ancestor
111205294|NCT00701896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111205295|NCT00701896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111205296|NCT00701896|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111205297|NCT00701896|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111205298|NCT00701896|Cholinergic Agents|cholinergic agents|mesh-ancestor
111205299|NCT00701896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111205300|NCT00701896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111205301|NCT01839487|Dexamethasone|dexamethasone|mesh-list
111205302|NCT01839487|Paclitaxel|paclitaxel|mesh-list
111205303|NCT01839487|Gemcitabine|gemcitabine|mesh-list
111205304|NCT01839487|Enoxaparin|enoxaparin|mesh-list
111205305|NCT01839487|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111205306|NCT01839487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111205307|NCT01839487|Tubulin Modulators|tubulin modulators|mesh-ancestor
111205308|NCT01839487|Antimitotic Agents|antimitotic agents|mesh-ancestor
111205309|NCT01839487|Mitosis Modulators|mitosis modulators|mesh-ancestor
111205310|NCT01839487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111205311|NCT01839487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111205312|NCT01839487|Antiemetics|antiemetics|mesh-ancestor
111205313|NCT01839487|Autonomic Agents|autonomic agents|mesh-ancestor
111205314|NCT01839487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111205315|NCT01839487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110945366|NCT04224987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110945367|NCT04224987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110945379|NCT04218123|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
110945380|NCT04218123|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110945381|NCT04218123|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110945382|NCT04218123|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110945383|NCT04218123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110945384|NCT04218123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110945385|NCT04218123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110945386|NCT04218123|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110945387|NCT04218123|Antidepressive Agents|antidepressive agents|mesh-ancestor
110945388|NCT04218123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110662923|NCT00074581|Ritonavir|ritonavir|mesh-list
111205316|NCT01839487|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111205317|NCT01839487|Glucocorticoids|glucocorticoids|mesh-ancestor
111205318|NCT01839487|Hormones|hormones|mesh-ancestor
111205319|NCT01839487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111205320|NCT01839487|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111205321|NCT01839487|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111205322|NCT01839487|Antimetabolites|antimetabolites|mesh-ancestor
111205323|NCT01839487|Anticoagulants|anticoagulants|mesh-ancestor
111205324|NCT01839487|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111205325|NCT01839487|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111205326|NCT00665470|Aldesleukin|aldesleukin|mesh-list
111205327|NCT00665470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111205328|NCT00665470|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111205329|NCT00665470|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111205330|NCT00665470|Antiviral Agents|antiviral agents|mesh-ancestor
111205331|NCT00665470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111205332|NCT00666406|Factor VIII|factor viii|mesh-list
111205333|NCT00666406|Coagulants|coagulants|mesh-ancestor
111205334|NCT02995954|Amlodipine|amlodipine|mesh-list
111205335|NCT02995954|Perindopril|perindopril|mesh-list
111205336|NCT02995954|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111205337|NCT02995954|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111205338|NCT02995954|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111205339|NCT02995954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110945443|NCT04205240|Mycophenolic Acid|mycophenolic acid|mesh-list
110945444|NCT04205240|Cyclophosphamide|cyclophosphamide|mesh-list
110945445|NCT04205240|Melphalan|melphalan|mesh-list
110945446|NCT04205240|Mechlorethamine|mechlorethamine|mesh-list
110945447|NCT04205240|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
110945448|NCT04205240|Fludarabine|fludarabine|mesh-list
110945449|NCT04205240|Daratumumab|daratumumab|mesh-list
110945450|NCT04205240|Tacrolimus|tacrolimus|mesh-list
110945451|NCT04205240|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110945452|NCT04205240|Immunologic Factors|immunologic factors|mesh-ancestor
110945453|NCT04205240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110945454|NCT04205240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110945455|NCT04205240|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110945456|NCT04205240|Alkylating Agents|alkylating agents|mesh-ancestor
110945457|NCT04205240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110945458|NCT04205240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110945459|NCT04205240|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110945460|NCT04205240|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110945461|NCT04205240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110945462|NCT04205240|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110945463|NCT04205240|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110945464|NCT04205240|Antitubercular Agents|antitubercular agents|mesh-ancestor
110945465|NCT04205240|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110945466|NCT04205240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110023050|NCT00003342|Doxorubicin|doxorubicin|mesh-list
110023051|NCT00003342|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110023052|NCT00003342|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110023053|NCT00003342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110023054|NCT00003342|Tubulin Modulators|tubulin modulators|mesh-ancestor
110023055|NCT00003342|Antimitotic Agents|antimitotic agents|mesh-ancestor
110023056|NCT00003342|Mitosis Modulators|mitosis modulators|mesh-ancestor
110023057|NCT00003342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110023059|NCT00003342|Antimetabolites|antimetabolites|mesh-ancestor
110023060|NCT00003342|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110023061|NCT00003342|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110023062|NCT00003342|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110023063|NCT00003342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110023064|NCT00003348|Carmustine|carmustine|mesh-list
110023065|NCT00003348|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
110023066|NCT00003348|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110023067|NCT00003348|Alkylating Agents|alkylating agents|mesh-ancestor
110023068|NCT00003348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110023069|NCT00003348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110023070|NCT00003348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110023071|NCT00003360|Antibodies|antibodies|mesh-list
110023072|NCT00003360|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110023073|NCT00003360|Immunologic Factors|immunologic factors|mesh-ancestor
110023074|NCT00003360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110023075|NCT00003372|Topotecan|topotecan|mesh-list
110023076|NCT00003372|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110023077|NCT00003372|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111205340|NCT02995954|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111205341|NCT02995954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111205342|NCT02995954|Vasodilator Agents|vasodilator agents|mesh-ancestor
111205343|NCT02995954|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
111205344|NCT02995954|Protease Inhibitors|protease inhibitors|mesh-ancestor
111205345|NCT02995954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111205346|NCT01799941|Quinidine|quinidine|mesh-list
111205347|NCT01799941|Dextromethorphan|dextromethorphan|mesh-list
111205348|NCT01799941|Antitussive Agents|antitussive agents|mesh-ancestor
111205349|NCT01799941|Respiratory System Agents|respiratory system agents|mesh-ancestor
111205350|NCT01799941|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111205351|NCT01799941|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111205352|NCT01799941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111205353|NCT01799941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111205354|NCT01799941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111205355|NCT01799941|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111205356|NCT01799941|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111205357|NCT01799941|Adrenergic Agents|adrenergic agents|mesh-ancestor
111205358|NCT01799941|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111205359|NCT01799941|Antimalarials|antimalarials|mesh-ancestor
111205360|NCT01799941|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111205361|NCT01799941|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111205362|NCT01799941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111205363|NCT01799941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111205364|NCT01799941|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111205365|NCT01799941|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111205366|NCT01799941|Cholinergic Agents|cholinergic agents|mesh-ancestor
111205367|NCT01799941|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111205368|NCT01799941|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111205369|NCT01799941|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111205370|NCT01799941|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111498017|NCT02536248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111498018|NCT02536248|Incretins|incretins|mesh-ancestor
110945552|NCT04153383|Milrinone|milrinone|mesh-list
110945553|NCT04153383|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110945554|NCT04153383|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110945555|NCT04153383|Vasodilator Agents|vasodilator agents|mesh-ancestor
110945556|NCT04153383|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110945557|NCT04153383|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110945558|NCT04153383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110945559|NCT04153383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110945560|NCT04153383|Protective Agents|protective agents|mesh-ancestor
110945561|NCT04153383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110945568|NCT04140305|Ozanimod|ozanimod|mesh-list
110945569|NCT04140305|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
110945570|NCT04140305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110945571|NCT04140305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110945572|NCT04140305|Immunologic Factors|immunologic factors|mesh-ancestor
110945573|NCT04140305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110945581|NCT04109222|Vaccines|vaccines|mesh-list
110945582|NCT04109222|Immunologic Factors|immunologic factors|mesh-ancestor
110945583|NCT04109222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110663073|NCT03809611|Choline|choline|mesh-list
110023078|NCT00003372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110023079|NCT00003372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110023080|NCT00003372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110023081|NCT00003378|Paclitaxel|paclitaxel|mesh-list
110023082|NCT00003378|Carboplatin|carboplatin|mesh-list
110023083|NCT00003378|Gemcitabine|gemcitabine|mesh-list
110023084|NCT00003378|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110023085|NCT00003378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110023086|NCT00003378|Tubulin Modulators|tubulin modulators|mesh-ancestor
110023087|NCT00003378|Antimitotic Agents|antimitotic agents|mesh-ancestor
110023088|NCT00003378|Mitosis Modulators|mitosis modulators|mesh-ancestor
110023089|NCT00003378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110023090|NCT00003378|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110023091|NCT00003378|Antimetabolites|antimetabolites|mesh-ancestor
110023092|NCT00003390|Irofulven|irofulven|mesh-list
110023093|NCT00003390|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110023094|NCT00003390|Alkylating Agents|alkylating agents|mesh-ancestor
110023095|NCT00003390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110023096|NCT00003390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111205371|NCT01799941|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111205372|NCT00702364|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
111205373|NCT00702364|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111205374|NCT00702364|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111205375|NCT00702364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111205376|NCT00702364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111205377|NCT00702364|Adrenergic Agents|adrenergic agents|mesh-ancestor
111205378|NCT00702364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111205379|NCT00702364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111205380|NCT00713284|Sirolimus|sirolimus|mesh-list
111205381|NCT00713284|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111205382|NCT00713284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111205383|NCT00713284|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111205384|NCT00713284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111205385|NCT00713284|Antifungal Agents|antifungal agents|mesh-ancestor
111205386|NCT00713284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111205387|NCT00713284|Immunologic Factors|immunologic factors|mesh-ancestor
111205388|NCT00713284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111205389|NCT00702754|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
111205390|NCT00702754|Botulinum Toxins|botulinum toxins|mesh-list
111205391|NCT00702754|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111205392|NCT00702754|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111205393|NCT00702754|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111205394|NCT00702754|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111205395|NCT00702754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111205396|NCT00702754|Cholinergic Agents|cholinergic agents|mesh-ancestor
111205397|NCT00702754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111205398|NCT00702754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111205399|NCT00702754|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111205400|NCT00702754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111205401|NCT00702754|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111205402|NCT02995720|Amlodipine|amlodipine|mesh-list
111205403|NCT02995720|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111205404|NCT02995720|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111205405|NCT02995720|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111205406|NCT02995720|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111205407|NCT02995720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111205408|NCT02995720|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111205409|NCT02995720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111205410|NCT02995720|Vasodilator Agents|vasodilator agents|mesh-ancestor
111205411|NCT02995720|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111205412|NCT02995720|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111205413|NCT02995720|Antimetabolites|antimetabolites|mesh-ancestor
111205414|NCT02995720|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111205415|NCT02995720|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111205416|NCT02995720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111205417|NCT02990728|Metformin|metformin|mesh-list
111205418|NCT02990728|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111205419|NCT02990728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111205420|NCT02995330|Cyclophosphamide|cyclophosphamide|mesh-list
111205421|NCT02995330|Methyltestosterone|methyltestosterone|mesh-list
111205422|NCT02995330|Testosterone|testosterone|mesh-list
111205423|NCT02995330|Testosterone undecanoate|testosterone undecanoate|mesh-list
111205424|NCT02995330|Testosterone enanthate|testosterone enanthate|mesh-list
111205425|NCT02995330|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
111205426|NCT02995330|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111205427|NCT02995330|Immunologic Factors|immunologic factors|mesh-ancestor
111205428|NCT02995330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111205429|NCT02995330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111205430|NCT02995330|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111205431|NCT02995330|Alkylating Agents|alkylating agents|mesh-ancestor
111205432|NCT02995330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111205433|NCT02995330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111205434|NCT02995330|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111205435|NCT02995330|Androgens|androgens|mesh-ancestor
110945598|NCT04105920|Hyaluronic Acid|hyaluronic acid|mesh-list
110945599|NCT04105920|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110945600|NCT04105920|Immunologic Factors|immunologic factors|mesh-ancestor
110945601|NCT04105920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110945602|NCT04105920|Viscosupplements|viscosupplements|mesh-ancestor
110945603|NCT04105920|Protective Agents|protective agents|mesh-ancestor
110945648|NCT04078568|Aspirin|aspirin|mesh-list
110945649|NCT04078568|Prednisolone|prednisolone|mesh-list
110945650|NCT04078568|Immunoglobulins|immunoglobulins|mesh-list
111205437|NCT02995330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111205438|NCT02995330|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111205439|NCT02995330|Anabolic Agents|anabolic agents|mesh-ancestor
111205440|NCT02990884|Ketamine|ketamine|mesh-list
111205441|NCT02990884|Analgesics|analgesics|mesh-ancestor
111205442|NCT02990884|Sensory System Agents|sensory system agents|mesh-ancestor
111205443|NCT02990884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111205444|NCT02990884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111205445|NCT02990884|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111205446|NCT02990884|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111205447|NCT02990884|Anesthetics, General|anesthetics, general|mesh-ancestor
111205448|NCT02990884|Anesthetics|anesthetics|mesh-ancestor
111205449|NCT02990884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111205450|NCT02990884|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111205451|NCT02990884|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111205452|NCT02990884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111205453|NCT02990884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111205454|NCT02990416|Pembrolizumab|pembrolizumab|mesh-list
111205455|NCT02990416|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111205456|NCT02990416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111205457|NCT02990416|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111205458|NCT02990416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111205459|NCT02999776|Etanercept|etanercept|mesh-list
111205460|NCT02999776|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111205461|NCT02999776|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111205462|NCT02999776|Analgesics|analgesics|mesh-ancestor
111205463|NCT02999776|Sensory System Agents|sensory system agents|mesh-ancestor
111205464|NCT02999776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111205465|NCT02999776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111205466|NCT02999776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111205467|NCT02999776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111205468|NCT02999776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111205469|NCT02999776|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111205470|NCT02999776|Immunologic Factors|immunologic factors|mesh-ancestor
111205471|NCT02996656|Cefazolin|cefazolin|mesh-list
111205472|NCT02996656|Ceftriaxone|ceftriaxone|mesh-list
111205473|NCT02996656|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111205474|NCT02996656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111205475|NCT04387630|Metformin|metformin|mesh-list
111205476|NCT04387630|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111205477|NCT04387630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111205478|NCT04270318|Pemetrexed|pemetrexed|mesh-list
111205479|NCT04270318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111205480|NCT04270318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111205481|NCT04270318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111205482|NCT04270318|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111205483|NCT04270318|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111205484|NCT02999854|Cyclophosphamide|cyclophosphamide|mesh-list
111205485|NCT02999854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111205486|NCT02999854|Immunologic Factors|immunologic factors|mesh-ancestor
111205487|NCT02999854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111205488|NCT02999854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111205489|NCT02999854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111205490|NCT02999854|Alkylating Agents|alkylating agents|mesh-ancestor
111205491|NCT02999854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111205492|NCT02999854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111205493|NCT02999854|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110945667|NCT04078568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110945668|NCT04078568|Antipyretics|antipyretics|mesh-ancestor
110945669|NCT04078568|Glucocorticoids|glucocorticoids|mesh-ancestor
110945670|NCT04078568|Hormones|hormones|mesh-ancestor
110945671|NCT04078568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110945672|NCT04078568|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110945673|NCT04078568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110945674|NCT04078568|Immunologic Factors|immunologic factors|mesh-ancestor
110945702|NCT04066348|Etanercept|etanercept|mesh-list
110945703|NCT04066348|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110945704|NCT04066348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110945705|NCT04066348|Analgesics|analgesics|mesh-ancestor
110945706|NCT04066348|Sensory System Agents|sensory system agents|mesh-ancestor
110945707|NCT04066348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110945708|NCT04066348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111205495|NCT04270708|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111205496|NCT04270708|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111205497|NCT04270708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111205498|NCT04270708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111205499|NCT04270708|Analgesics|analgesics|mesh-ancestor
111205500|NCT04270708|Sensory System Agents|sensory system agents|mesh-ancestor
111205501|NCT04270708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111205502|NCT04270708|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111205503|NCT04270708|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111205504|NCT04270708|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111205505|NCT04270708|Adrenergic Agents|adrenergic agents|mesh-ancestor
111205506|NCT04270708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111205507|NCT04270708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111205508|NCT00704938|Aldesleukin|aldesleukin|mesh-list
111205509|NCT00704938|Cyclophosphamide|cyclophosphamide|mesh-list
111205510|NCT00704938|Fludarabine|fludarabine|mesh-list
111205511|NCT00704938|Fludarabine phosphate|fludarabine phosphate|mesh-list
111205512|NCT00704938|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111205513|NCT00704938|Immunologic Factors|immunologic factors|mesh-ancestor
111205514|NCT00704938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111205515|NCT00704938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111205516|NCT00704938|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111205517|NCT00704938|Alkylating Agents|alkylating agents|mesh-ancestor
111205518|NCT00704938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111205519|NCT00704938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111205520|NCT00704938|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111205521|NCT00704938|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111205522|NCT00704938|Antimetabolites|antimetabolites|mesh-ancestor
111205523|NCT00704938|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111205524|NCT00704938|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111205525|NCT00704938|Antiviral Agents|antiviral agents|mesh-ancestor
111205526|NCT00704938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111205527|NCT02994082|Bupropion|bupropion|mesh-list
111205528|NCT02994082|Nicotine|nicotine|mesh-list
111205529|NCT02994082|Varenicline|varenicline|mesh-list
111205530|NCT02994082|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111205531|NCT02994082|Autonomic Agents|autonomic agents|mesh-ancestor
111205532|NCT02994082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111205533|NCT02994082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111205534|NCT02994082|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111205535|NCT02994082|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111205536|NCT02994082|Cholinergic Agents|cholinergic agents|mesh-ancestor
111205537|NCT02994082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111205538|NCT02994082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111205539|NCT02994082|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111205540|NCT02994082|Antidepressive Agents|antidepressive agents|mesh-ancestor
111205541|NCT02994082|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111205542|NCT02994082|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111205543|NCT02994082|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111205544|NCT02994082|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111205545|NCT02994082|Dopamine Agents|dopamine agents|mesh-ancestor
111205546|NCT02994082|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111205547|NCT02994082|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111205548|NCT02994082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111205549|NCT02995096|Sirolimus|sirolimus|mesh-list
111205550|NCT02995096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111205551|NCT02995096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111205552|NCT02995096|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111205553|NCT02995096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111205554|NCT02995096|Antifungal Agents|antifungal agents|mesh-ancestor
111205555|NCT02995096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111205556|NCT02995096|Immunologic Factors|immunologic factors|mesh-ancestor
111205557|NCT02995096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111205558|NCT01275976|Complement C1s|complement c1s|mesh-list
111205559|NCT01275976|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
110945779|NCT03989414|Dexamethasone|dexamethasone|mesh-list
110945780|NCT03989414|Bortezomib|bortezomib|mesh-list
110945781|NCT03989414|Daratumumab|daratumumab|mesh-list
110945782|NCT03989414|Elotuzumab|elotuzumab|mesh-list
110945783|NCT03989414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110945784|NCT03989414|Antiemetics|antiemetics|mesh-ancestor
110945785|NCT03989414|Autonomic Agents|autonomic agents|mesh-ancestor
110945786|NCT03989414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110945787|NCT03989414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111205560|NCT01275976|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
111205561|NCT01275976|Immunologic Factors|immunologic factors|mesh-ancestor
111205562|NCT01275976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111205563|NCT01275976|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
111205564|NCT01275976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111205565|NCT01270438|Leucovorin|leucovorin|mesh-list
111205566|NCT01270438|Bevacizumab|bevacizumab|mesh-list
111205567|NCT01270438|Fluorouracil|fluorouracil|mesh-list
111205568|NCT01270438|Oxaliplatin|oxaliplatin|mesh-list
111205569|NCT01270438|Calcium|calcium|mesh-list
111205570|NCT01270438|Levoleucovorin|levoleucovorin|mesh-list
111205571|NCT01270438|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
111205572|NCT01270438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111205573|NCT01270438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111205574|NCT01270438|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111205575|NCT01270438|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111205576|NCT01270438|Growth Substances|growth substances|mesh-ancestor
111205577|NCT01270438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111205578|NCT01270438|Growth Inhibitors|growth inhibitors|mesh-ancestor
111205579|NCT01270438|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111205580|NCT01270438|Antimetabolites|antimetabolites|mesh-ancestor
111205581|NCT01270438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111205582|NCT01270438|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111205583|NCT01270438|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111205584|NCT01270438|Immunologic Factors|immunologic factors|mesh-ancestor
111205585|NCT01270438|Antidotes|antidotes|mesh-ancestor
111205586|NCT01270438|Protective Agents|protective agents|mesh-ancestor
111205587|NCT01270438|Vitamin B Complex|vitamin b complex|mesh-ancestor
111205588|NCT01270438|Vitamins|vitamins|mesh-ancestor
111205589|NCT01270438|Micronutrients|micronutrients|mesh-ancestor
111205590|NCT01270438|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
111205591|NCT01270438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111205592|NCT01270672|Carvedilol|carvedilol|mesh-list
111205593|NCT01270672|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
111205594|NCT01270672|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111205595|NCT01270672|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111205596|NCT01270672|Adrenergic Agents|adrenergic agents|mesh-ancestor
111205597|NCT01270672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111205598|NCT01270672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111205599|NCT01270672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111205600|NCT01270672|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111205601|NCT01270672|Antioxidants|antioxidants|mesh-ancestor
111205602|NCT01270672|Protective Agents|protective agents|mesh-ancestor
111205603|NCT01270672|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111205604|NCT01270672|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111205605|NCT01270672|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111205606|NCT01270672|Vasodilator Agents|vasodilator agents|mesh-ancestor
111205607|NCT01270672|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111205608|NCT01270672|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111205609|NCT01270672|Hallucinogens|hallucinogens|mesh-ancestor
111205610|NCT01270672|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111205611|NCT01270672|Serotonin Agents|serotonin agents|mesh-ancestor
111205612|NCT01270672|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111205613|NCT01270672|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111205614|NCT01276210|Sorafenib|sorafenib|mesh-list
111205615|NCT01276210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111205616|NCT01276210|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111205617|NCT01276210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111205618|NCT01276210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111205619|NCT00727636|Vaccines|vaccines|mesh-list
111205620|NCT00727636|Immunologic Factors|immunologic factors|mesh-ancestor
110945875|NCT03952585|Deoxyglucose|deoxyglucose|mesh-list
110945876|NCT03952585|Cisplatin|cisplatin|mesh-list
110945877|NCT03952585|Nivolumab|nivolumab|mesh-list
110945878|NCT03952585|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110945879|NCT03952585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110945880|NCT03952585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110945881|NCT03952585|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110945882|NCT03952585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110945883|NCT03952585|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110945884|NCT03952585|Antimetabolites|antimetabolites|mesh-ancestor
110945885|NCT03952585|Antiviral Agents|antiviral agents|mesh-ancestor
110945886|NCT03952585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110663368|NCT00780377|Bradykinin|bradykinin|mesh-list
111205621|NCT00727636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111205622|NCT01270750|Bosentan|bosentan|mesh-list
111205623|NCT01270750|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111205624|NCT01270750|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
111205625|NCT01270750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111205626|NCT00709696|Varenicline|varenicline|mesh-list
111205627|NCT00709696|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111205628|NCT00709696|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111205629|NCT00709696|Cholinergic Agents|cholinergic agents|mesh-ancestor
111205630|NCT00709696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111205631|NCT00709696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111205632|NCT00709696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111205633|NCT01270984|Imatinib Mesylate|imatinib mesylate|mesh-list
111205634|NCT01270984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111205635|NCT01270984|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111205636|NCT01270984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111205637|NCT01270984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111205638|NCT02992678|Pentoxifylline|pentoxifylline|mesh-list
111205639|NCT02992678|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111205640|NCT02992678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111205641|NCT02992678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111205642|NCT02992678|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111205643|NCT02992678|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111205644|NCT02992678|Protective Agents|protective agents|mesh-ancestor
111205645|NCT02992678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111205646|NCT02992678|Vasodilator Agents|vasodilator agents|mesh-ancestor
111205647|NCT02992678|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111205648|NCT02992678|Antioxidants|antioxidants|mesh-ancestor
111205649|NCT02992912|Atezolizumab|atezolizumab|mesh-list
111205650|NCT02992912|Antibodies|antibodies|mesh-list
111205651|NCT02992912|Immunologic Factors|immunologic factors|mesh-ancestor
111205652|NCT02992912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111205653|NCT02992912|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111205654|NCT02992912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111205655|NCT02992912|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111205656|NCT02992912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111205657|NCT01271140|Insulin|insulin|mesh-list
111205658|NCT01271140|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111205659|NCT01271140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111205660|NCT01271374|Losartan|losartan|mesh-list
111205661|NCT01271374|Amlodipine|amlodipine|mesh-list
111205662|NCT01271374|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
111205663|NCT01271374|Olmesartan|olmesartan|mesh-list
111205664|NCT01271374|Amlodipine Besylate, Olmesartan Medoxomil Drug Combination|amlodipine besylate, olmesartan medoxomil drug combination|mesh-list
111205665|NCT01271374|Spironolactone|spironolactone|mesh-list
111205666|NCT01271374|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111205667|NCT01271374|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111205668|NCT01271374|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111205669|NCT01271374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111205670|NCT01271374|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110945903|NCT03929640|Acetaminophen|acetaminophen|mesh-list
110945904|NCT03929640|Ibuprofen|ibuprofen|mesh-list
110945905|NCT03929640|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110945906|NCT03929640|Analgesics|analgesics|mesh-ancestor
110945907|NCT03929640|Sensory System Agents|sensory system agents|mesh-ancestor
110945908|NCT03929640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110945909|NCT03929640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110945910|NCT03929640|Antipyretics|antipyretics|mesh-ancestor
110945911|NCT03929640|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110945912|NCT03929640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110945913|NCT03929640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110945914|NCT03929640|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110945915|NCT03929640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110945916|NCT03929640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110945948|NCT03915678|Atezolizumab|atezolizumab|mesh-list
110945949|NCT03915678|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110945950|NCT03915678|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110945951|NCT03915678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110945952|NCT03915678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110945953|NCT03915678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110945954|NCT03915678|Immunologic Factors|immunologic factors|mesh-ancestor
110945955|NCT03915678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111205671|NCT01271374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111205672|NCT01271374|Vasodilator Agents|vasodilator agents|mesh-ancestor
111205673|NCT01271374|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111205674|NCT01271374|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111205675|NCT01271374|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111205676|NCT01271374|Diuretics|diuretics|mesh-ancestor
111205677|NCT01271374|Natriuretic Agents|natriuretic agents|mesh-ancestor
111205678|NCT01271374|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
111205679|NCT01271374|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
111205680|NCT01271374|Hormone Antagonists|hormone antagonists|mesh-ancestor
111205681|NCT01271374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111205682|NCT01271374|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
111205683|NCT01276834|Everolimus|everolimus|mesh-list
111205684|NCT01276834|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111205685|NCT01276834|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111205686|NCT01276834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111205687|NCT01276834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111205688|NCT01276834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111205689|NCT01276834|Immunologic Factors|immunologic factors|mesh-ancestor
111205690|NCT01276834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111205691|NCT01276834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111205692|NCT01276912|Insulin Glargine|insulin glargine|mesh-list
111205693|NCT01276912|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111205694|NCT01276912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111205695|NCT00711490|Sirolimus|sirolimus|mesh-list
111205696|NCT00711490|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111205697|NCT00711490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111205698|NCT00711490|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111205699|NCT00711490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111205700|NCT00711490|Antifungal Agents|antifungal agents|mesh-ancestor
111205701|NCT00711490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111205702|NCT00711490|Immunologic Factors|immunologic factors|mesh-ancestor
111205703|NCT00711490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111205704|NCT01271998|Tedizolid phosphate|tedizolid phosphate|mesh-list
111205705|NCT01271998|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111205706|NCT01271998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111205707|NCT00717418|Cyclosporine|cyclosporine|mesh-list
111205708|NCT00717418|Lubricant Eye Drops|lubricant eye drops|mesh-list
111205709|NCT00717418|Cyclosporins|cyclosporins|mesh-list
111205710|NCT00717418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111205711|NCT00717418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111205712|NCT00717418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111205713|NCT00717418|Immunologic Factors|immunologic factors|mesh-ancestor
111205714|NCT00717418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111205715|NCT00717418|Antifungal Agents|antifungal agents|mesh-ancestor
111205716|NCT00717418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111205717|NCT00717418|Dermatologic Agents|dermatologic agents|mesh-ancestor
111205718|NCT00717418|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111205719|NCT00717418|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111205720|NCT00717418|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
111205721|NCT00717418|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111205722|NCT00717574|Nitrous Oxide|nitrous oxide|mesh-list
111205723|NCT00717574|Propofol|propofol|mesh-list
111205724|NCT00717574|Sevoflurane|sevoflurane|mesh-list
111205725|NCT00717574|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111205726|NCT00717574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111205727|NCT00717574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111205728|NCT00717574|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111205729|NCT00717574|Anesthetics, General|anesthetics, general|mesh-ancestor
111205730|NCT00717574|Anesthetics|anesthetics|mesh-ancestor
111205731|NCT00717574|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111205732|NCT00717574|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111205733|NCT00717574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111205734|NCT00717574|Analgesics|analgesics|mesh-ancestor
111205735|NCT00717574|Sensory System Agents|sensory system agents|mesh-ancestor
111205736|NCT00717574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111205737|NCT00719134|Rizatriptan|rizatriptan|mesh-list
111205738|NCT00719134|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111205739|NCT00719134|Serotonin Agents|serotonin agents|mesh-ancestor
111205740|NCT00719134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110946042|NCT03913442|Colchicine|colchicine|mesh-list
110946043|NCT03913442|Gout Suppressants|gout suppressants|mesh-ancestor
110946044|NCT03913442|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110663525|NCT00778115|Loperamide|loperamide|mesh-list
110946045|NCT03913442|Tubulin Modulators|tubulin modulators|mesh-ancestor
110946046|NCT03913442|Antimitotic Agents|antimitotic agents|mesh-ancestor
111205741|NCT00719134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111205742|NCT00719134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111205743|NCT01277770|Thymoglobulin|thymoglobulin|mesh-list
111205744|NCT01277770|Antilymphocyte Serum|antilymphocyte serum|mesh-list
111205745|NCT01277770|Immunologic Factors|immunologic factors|mesh-ancestor
111205746|NCT01277770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111205747|NCT01277770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111205748|NCT00721162|Ramucirumab|ramucirumab|mesh-list
111205749|NCT00721162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111205750|NCT01838941|Betaine|betaine|mesh-list
111205751|NCT01838941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111205752|NCT01838941|Lipotropic Agents|lipotropic agents|mesh-ancestor
111205753|NCT01838941|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111205754|NCT01838941|Antimetabolites|antimetabolites|mesh-ancestor
111205755|NCT01838941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111205756|NCT01838941|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111205757|NCT01773109|Irinotecan|irinotecan|mesh-list
111205758|NCT01773109|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-list
111205759|NCT01773109|Etirinotecan pegol|etirinotecan pegol|mesh-list
111205760|NCT01773109|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111205761|NCT01773109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111205762|NCT01773109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111205763|NCT01773109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111205764|NCT01773109|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111205765|NCT01772719|Zoledronic Acid|zoledronic acid|mesh-list
111205766|NCT01772719|Simvastatin|simvastatin|mesh-list
111205767|NCT01772719|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111205768|NCT01772719|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111205769|NCT01772719|Antimetabolites|antimetabolites|mesh-ancestor
111205770|NCT01772719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111205771|NCT01772719|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111205772|NCT01772719|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111205773|NCT01772719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111205774|NCT01772719|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111205775|NCT01772719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111205776|NCT05582265|Paclitaxel|paclitaxel|mesh-list
111205777|NCT05582265|Cisplatin|cisplatin|mesh-list
111205778|NCT05582265|Tislelizumab|tislelizumab|mesh-list
111205779|NCT05582265|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111205780|NCT05582265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111205781|NCT05582265|Tubulin Modulators|tubulin modulators|mesh-ancestor
111205782|NCT05582265|Antimitotic Agents|antimitotic agents|mesh-ancestor
111205783|NCT05582265|Mitosis Modulators|mitosis modulators|mesh-ancestor
111205784|NCT05582265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111205785|NCT05582265|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111205786|NCT04144101|Etoricoxib|etoricoxib|mesh-list
111205787|NCT04144101|Aceclofenac|aceclofenac|mesh-list
111205788|NCT04144101|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111205789|NCT04144101|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111205790|NCT04144101|Analgesics|analgesics|mesh-ancestor
111205791|NCT04144101|Sensory System Agents|sensory system agents|mesh-ancestor
111205792|NCT04144101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111205793|NCT04144101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111205794|NCT04144101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111205795|NCT04144101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111205796|NCT04144101|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111205797|NCT04144101|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111205798|NCT04144101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111205799|NCT04144101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111205800|NCT01278004|Ethosuximide|ethosuximide|mesh-list
111205801|NCT01278004|Anticonvulsants|anticonvulsants|mesh-ancestor
111205802|NCT01278238|Phenylephrine|phenylephrine|mesh-list
111205803|NCT01278238|Oxymetazoline|oxymetazoline|mesh-list
111205804|NCT01278238|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111205805|NCT01278238|Mydriatics|mydriatics|mesh-ancestor
111205806|NCT01278238|Autonomic Agents|autonomic agents|mesh-ancestor
111205807|NCT01278238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111205808|NCT01278238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110946047|NCT03913442|Mitosis Modulators|mitosis modulators|mesh-ancestor
110946048|NCT03913442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110946049|NCT03913442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110946085|NCT03896646|Iminodiacetic acid|iminodiacetic acid|mesh-list
110946086|NCT03896646|Chelating Agents|chelating agents|mesh-ancestor
110946087|NCT03896646|Sequestering Agents|sequestering agents|mesh-ancestor
110946088|NCT03896646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111205809|NCT01278238|Sympathomimetics|sympathomimetics|mesh-ancestor
111205810|NCT01278238|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111205811|NCT01278238|Nasal Decongestants|nasal decongestants|mesh-ancestor
111205812|NCT01278238|Respiratory System Agents|respiratory system agents|mesh-ancestor
111205813|NCT01278238|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111205814|NCT01278238|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111205815|NCT01278238|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111205816|NCT01278238|Adrenergic Agents|adrenergic agents|mesh-ancestor
111205817|NCT01278238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111205818|NCT01278238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111205819|NCT01278238|Protective Agents|protective agents|mesh-ancestor
111205820|NCT02706795|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111205821|NCT02706795|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111205822|NCT02706795|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111205823|NCT02706795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111205824|NCT02706795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111205825|NCT02706795|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111205826|NCT02706795|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111205827|NCT02706795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111205828|NCT02706795|Cholinergic Agents|cholinergic agents|mesh-ancestor
111205829|NCT02706795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111205830|NCT01272310|Interferons|interferons|mesh-list
111205831|NCT01272310|Ribavirin|ribavirin|mesh-list
111205832|NCT01272310|Interferon-alpha|interferon-alpha|mesh-list
111205833|NCT01272310|Interferon alpha-2|interferon alpha-2|mesh-list
111205834|NCT01272310|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
111205835|NCT01272310|Hydroxychloroquine|hydroxychloroquine|mesh-list
111205836|NCT01272310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111205837|NCT01272310|Antiviral Agents|antiviral agents|mesh-ancestor
111205838|NCT01272310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111205839|NCT01272310|Antimetabolites|antimetabolites|mesh-ancestor
111205840|NCT01272310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111205841|NCT01272310|Immunologic Factors|immunologic factors|mesh-ancestor
111205842|NCT01272310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111205843|NCT01272310|Antimalarials|antimalarials|mesh-ancestor
111205844|NCT01272310|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111205845|NCT01272310|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111205846|NCT01272310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111205847|NCT01272310|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111205848|NCT04386850|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
110946136|NCT03854110|Gemcitabine|gemcitabine|mesh-list
110946137|NCT03854110|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110946138|NCT03854110|Antimetabolites|antimetabolites|mesh-ancestor
110946139|NCT03854110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110946140|NCT03854110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110946141|NCT03829462|Irinotecan|irinotecan|mesh-list
110946142|NCT03829462|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110946143|NCT03829462|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110946144|NCT03829462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110946145|NCT03829462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110946146|NCT03829462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110946147|NCT03828799|Folfirinox|folfirinox|mesh-list
110946148|NCT03828799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110946149|NCT03825796|Cytarabine|cytarabine|mesh-list
110946150|NCT03825796|Daunorubicin|daunorubicin|mesh-list
110946151|NCT03825796|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110946152|NCT03825796|Antimetabolites|antimetabolites|mesh-ancestor
110946153|NCT03825796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110946154|NCT03825796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110946155|NCT03825796|Antiviral Agents|antiviral agents|mesh-ancestor
110946156|NCT03825796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110946157|NCT03825796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110946158|NCT03825796|Immunologic Factors|immunologic factors|mesh-ancestor
110946159|NCT03825796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110946160|NCT03825796|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110946161|NCT03825796|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110946162|NCT03825796|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110946163|NCT03825796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110946164|NCT03818061|Bevacizumab|bevacizumab|mesh-list
110946165|NCT03818061|Atezolizumab|atezolizumab|mesh-list
110946166|NCT03818061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110946167|NCT03818061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110946168|NCT03818061|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110946169|NCT03818061|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111205850|NCT04386850|Vitamins|vitamins|mesh-ancestor
111205851|NCT04386850|Micronutrients|micronutrients|mesh-ancestor
111205852|NCT04386850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111205853|NCT04386850|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111205854|NCT01272778|Lorazepam|lorazepam|mesh-list
111205855|NCT01272778|Anticonvulsants|anticonvulsants|mesh-ancestor
111205856|NCT01272778|Antiemetics|antiemetics|mesh-ancestor
111205857|NCT01272778|Autonomic Agents|autonomic agents|mesh-ancestor
111205858|NCT01272778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111205859|NCT01272778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111205860|NCT01272778|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111205861|NCT01272778|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111205862|NCT01272778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111205863|NCT01272778|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111205864|NCT01272778|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111205865|NCT01272778|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111205866|NCT01272778|GABA Modulators|gaba modulators|mesh-ancestor
111205867|NCT01272778|GABA Agents|gaba agents|mesh-ancestor
111205868|NCT01272778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111205869|NCT01272778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111205870|NCT01272856|Abatacept|abatacept|mesh-list
111205871|NCT01272856|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111205872|NCT01272856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111205873|NCT01272856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111205874|NCT01272856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111205875|NCT01272856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111205876|NCT01272856|Immunologic Factors|immunologic factors|mesh-ancestor
111205877|NCT01272856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111205878|NCT01272856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111205879|NCT01273090|Imetelstat|imetelstat|mesh-list
111205880|NCT01273090|Motesanib diphosphate|motesanib diphosphate|mesh-list
111205881|NCT01273090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111205882|NCT01273090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111205883|NCT01273090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111205884|NCT01273246|Vaccines|vaccines|mesh-list
111205885|NCT01273246|Immunologic Factors|immunologic factors|mesh-ancestor
111205886|NCT01273246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111205887|NCT00730522|Vigabatrin|vigabatrin|mesh-list
111205888|NCT00730522|Anticonvulsants|anticonvulsants|mesh-ancestor
111205889|NCT00730522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111205890|NCT00730522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111205891|NCT00730522|GABA Agents|gaba agents|mesh-ancestor
111205892|NCT00730522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111205893|NCT00730522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111205894|NCT04345276|Ritonavir|ritonavir|mesh-list
111205895|NCT04345276|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111205896|NCT04345276|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111205897|NCT04345276|Protease Inhibitors|protease inhibitors|mesh-ancestor
111205898|NCT04345276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111205899|NCT04345276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111205900|NCT04345276|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111205901|NCT04345276|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111205902|NCT04345276|Antiviral Agents|antiviral agents|mesh-ancestor
111205903|NCT04345276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111205904|NCT04345276|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111498019|NCT02536248|Hormones|hormones|mesh-ancestor
110946238|NCT03783403|Rituximab|rituximab|mesh-list
110946239|NCT03783403|Cetuximab|cetuximab|mesh-list
110946240|NCT03783403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110946241|NCT03783403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110946242|NCT03783403|Immunologic Factors|immunologic factors|mesh-ancestor
110946243|NCT03783403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110946244|NCT03783403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110946245|NCT03783351|Clopidogrel|clopidogrel|mesh-list
110946246|NCT03783351|Ticagrelor|ticagrelor|mesh-list
110946247|NCT03783351|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110946248|NCT03783351|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110946249|NCT03783351|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110946250|NCT03783351|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110946251|NCT03783351|Purinergic Agents|purinergic agents|mesh-ancestor
110946252|NCT03783351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110946253|NCT03783351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110946254|NCT03783351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110663740|NCT00784589|Rituximab|rituximab|mesh-list
111205905|NCT04345276|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111205906|NCT01273558|Canagliflozin|canagliflozin|mesh-list
111205907|NCT01273558|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111205908|NCT01273558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111205909|NCT01273558|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111205910|NCT01273558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111205911|NCT00733096|Methylprednisolone|methylprednisolone|mesh-list
111205912|NCT00733096|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111205913|NCT00733096|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111205914|NCT00733096|Prednisolone|prednisolone|mesh-list
111205915|NCT00733096|Prednisolone acetate|prednisolone acetate|mesh-list
111205917|NCT00733096|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111205918|NCT00733096|Prednisolone phosphate|prednisolone phosphate|mesh-list
111205919|NCT00733096|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111205920|NCT00733096|Antiemetics|antiemetics|mesh-ancestor
111205921|NCT00733096|Autonomic Agents|autonomic agents|mesh-ancestor
111205922|NCT00733096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111205923|NCT00733096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111205924|NCT00733096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111205925|NCT00733096|Glucocorticoids|glucocorticoids|mesh-ancestor
111205926|NCT00733096|Hormones|hormones|mesh-ancestor
111205927|NCT00733096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111205928|NCT00733096|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111205929|NCT00733096|Protective Agents|protective agents|mesh-ancestor
111205930|NCT00733096|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111205931|NCT00733096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111205932|NCT00733096|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111205933|NCT00733096|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111205934|NCT00733096|Analgesics|analgesics|mesh-ancestor
111205935|NCT00733096|Sensory System Agents|sensory system agents|mesh-ancestor
111205936|NCT00733096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111205937|NCT00733096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111205938|NCT00733096|Immunologic Factors|immunologic factors|mesh-ancestor
111205939|NCT02991196|Nivolumab|nivolumab|mesh-list
111205940|NCT02991196|DS-8273a|ds-8273a|mesh-list
111205941|NCT02991196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111205942|NCT02991196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111205943|NCT02991196|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111205944|NCT02991196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111205945|NCT01278784|Acetylcysteine|acetylcysteine|mesh-list
111205946|NCT01278784|Chitosan|chitosan|mesh-list
111205947|NCT01278784|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111205948|NCT01278784|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111205949|NCT01278784|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111205950|NCT01278784|Antiviral Agents|antiviral agents|mesh-ancestor
111205951|NCT01278784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111205952|NCT01278784|Expectorants|expectorants|mesh-ancestor
111205953|NCT01278784|Respiratory System Agents|respiratory system agents|mesh-ancestor
111205954|NCT01278784|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111205955|NCT01278784|Antioxidants|antioxidants|mesh-ancestor
111205956|NCT01278784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111205957|NCT01278784|Protective Agents|protective agents|mesh-ancestor
111205958|NCT01278784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111205959|NCT01278784|Antidotes|antidotes|mesh-ancestor
111205960|NCT01278784|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111205961|NCT01278784|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111205962|NCT01278784|Antimetabolites|antimetabolites|mesh-ancestor
111205963|NCT01278784|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111205964|NCT01278784|Chelating Agents|chelating agents|mesh-ancestor
111205965|NCT01278784|Sequestering Agents|sequestering agents|mesh-ancestor
111205966|NCT01278784|Hemostatics|hemostatics|mesh-ancestor
111205967|NCT01278784|Coagulants|coagulants|mesh-ancestor
111205968|NCT01276288|Empagliflozin|empagliflozin|mesh-list
111205969|NCT01276288|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
111205970|NCT01276288|Torsemide|torsemide|mesh-list
110946292|NCT03742414|Fluticasone|fluticasone|mesh-list
110946293|NCT03742414|Xhance|xhance|mesh-list
110946294|NCT03742414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110946295|NCT03742414|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110946296|NCT03742414|Autonomic Agents|autonomic agents|mesh-ancestor
110946297|NCT03742414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110946298|NCT03742414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110946299|NCT03742414|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110946300|NCT03742414|Respiratory System Agents|respiratory system agents|mesh-ancestor
110946301|NCT03742414|Dermatologic Agents|dermatologic agents|mesh-ancestor
111205971|NCT01276288|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111205973|NCT01276288|Natriuretic Agents|natriuretic agents|mesh-ancestor
111205974|NCT01276288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111205975|NCT01276288|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
111205976|NCT01276288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111205977|NCT01276288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111205978|NCT01276288|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111205979|NCT01276288|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111205980|NCT01276288|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
111205981|NCT00722566|Bortezomib|bortezomib|mesh-list
111205982|NCT00722566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111205983|NCT00722722|Bortezomib|bortezomib|mesh-list
111205984|NCT00722722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111205985|NCT00723580|Risperidone|risperidone|mesh-list
111205986|NCT00723580|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111205987|NCT00723580|Serotonin Agents|serotonin agents|mesh-ancestor
111205988|NCT00723580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111205989|NCT00723580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111205990|NCT00723580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111205991|NCT00723580|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111205992|NCT00723580|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111205993|NCT00723580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111205994|NCT00723580|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111205995|NCT00723580|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111205996|NCT00723580|Dopamine Agents|dopamine agents|mesh-ancestor
111205997|NCT01273948|Interferons|interferons|mesh-list
111205998|NCT01273948|Bavituximab|bavituximab|mesh-list
111205999|NCT01273948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111206000|NCT01273948|Antiviral Agents|antiviral agents|mesh-ancestor
111206001|NCT01273948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111206002|NCT01273948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111206003|NCT00734344|Tenofovir|tenofovir|mesh-list
111206004|NCT00734344|Efavirenz|efavirenz|mesh-list
111206005|NCT00734344|Raltegravir Potassium|raltegravir potassium|mesh-list
111206006|NCT00734344|Antiviral Agents|antiviral agents|mesh-ancestor
111206007|NCT00734344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111206008|NCT00734344|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111206009|NCT00734344|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111206010|NCT00734344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110946350|NCT03729869|Hormones|hormones|mesh-ancestor
110946351|NCT03729869|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110946352|NCT03729869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110946353|NCT03725059|Paclitaxel|paclitaxel|mesh-list
110946354|NCT03725059|Cyclophosphamide|cyclophosphamide|mesh-list
110946355|NCT03725059|Doxorubicin|doxorubicin|mesh-list
110946356|NCT03725059|Pembrolizumab|pembrolizumab|mesh-list
110946357|NCT03725059|Epirubicin|epirubicin|mesh-list
110946358|NCT03725059|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110946359|NCT03725059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110946360|NCT03725059|Tubulin Modulators|tubulin modulators|mesh-ancestor
110946361|NCT03725059|Antimitotic Agents|antimitotic agents|mesh-ancestor
110946362|NCT03725059|Mitosis Modulators|mitosis modulators|mesh-ancestor
110946363|NCT03725059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110946364|NCT03725059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110946365|NCT03725059|Immunologic Factors|immunologic factors|mesh-ancestor
110946366|NCT03725059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110946367|NCT03725059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110946368|NCT03725059|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110946369|NCT03725059|Alkylating Agents|alkylating agents|mesh-ancestor
110946370|NCT03725059|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110946371|NCT03725059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110946372|NCT03725059|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110946373|NCT03725059|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110946374|NCT03725059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110946375|NCT03725059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110946376|NCT03725059|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110946377|NCT03722420|Imatinib Mesylate|imatinib mesylate|mesh-list
110946378|NCT03722420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110946379|NCT03722420|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110946380|NCT03722420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110946381|NCT03722420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110946382|NCT03713437|Insulin|insulin|mesh-list
110946383|NCT03713437|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111206011|NCT00734344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111206012|NCT00734344|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111206013|NCT00734344|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111206014|NCT00734344|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111206015|NCT00734344|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111206016|NCT00734344|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111206017|NCT00734344|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111206018|NCT00734344|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111206019|NCT00734344|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111206020|NCT00734344|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111206021|NCT00734344|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111206022|NCT04148937|Pembrolizumab|pembrolizumab|mesh-list
111206023|NCT04148937|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111206024|NCT04148937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111206025|NCT04148937|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110946426|NCT03683069|Amlodipine|amlodipine|mesh-list
110946427|NCT03683069|Eplerenone|eplerenone|mesh-list
110946428|NCT03683069|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110946429|NCT03683069|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110946430|NCT03683069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110946431|NCT03683069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110946432|NCT03683069|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110946433|NCT03683069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110946434|NCT03683069|Vasodilator Agents|vasodilator agents|mesh-ancestor
110946435|NCT03683069|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110946436|NCT03683069|Hormone Antagonists|hormone antagonists|mesh-ancestor
110946437|NCT03683069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110946438|NCT03683069|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110946439|NCT03683069|Diuretics|diuretics|mesh-ancestor
110946440|NCT03683069|Natriuretic Agents|natriuretic agents|mesh-ancestor
110663968|NCT02555813|Antimetabolites|antimetabolites|mesh-ancestor
110023097|NCT00003396|Cyclophosphamide|cyclophosphamide|mesh-list
110023098|NCT00003396|Melphalan|melphalan|mesh-list
110023099|NCT00003396|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110023100|NCT00003396|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110023101|NCT00003396|Immunologic Factors|immunologic factors|mesh-ancestor
110023102|NCT00003396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110023103|NCT00003396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110023104|NCT00003396|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110023105|NCT00003396|Alkylating Agents|alkylating agents|mesh-ancestor
110023106|NCT00003396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110023107|NCT00003396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110023108|NCT00003396|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110023109|NCT00003402|Dexamethasone|dexamethasone|mesh-list
110023110|NCT00003402|Paclitaxel|paclitaxel|mesh-list
110023111|NCT00003402|Etoposide|etoposide|mesh-list
110023112|NCT00003402|Cyclophosphamide|cyclophosphamide|mesh-list
110023113|NCT00003402|Melphalan|melphalan|mesh-list
110023114|NCT00003402|Carmustine|carmustine|mesh-list
110023115|NCT00003402|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110023116|NCT00003402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110023117|NCT00003402|Tubulin Modulators|tubulin modulators|mesh-ancestor
110023118|NCT00003402|Antimitotic Agents|antimitotic agents|mesh-ancestor
110023119|NCT00003402|Mitosis Modulators|mitosis modulators|mesh-ancestor
110023120|NCT00003402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110023121|NCT00003402|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110023122|NCT00003402|Immunologic Factors|immunologic factors|mesh-ancestor
110023123|NCT00003402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110023124|NCT00003402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110023125|NCT00003402|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110023126|NCT00003402|Alkylating Agents|alkylating agents|mesh-ancestor
110023127|NCT00003402|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110023128|NCT00003402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110023129|NCT00003402|Antiemetics|antiemetics|mesh-ancestor
110023130|NCT00003402|Autonomic Agents|autonomic agents|mesh-ancestor
110023131|NCT00003402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110023133|NCT00003402|Glucocorticoids|glucocorticoids|mesh-ancestor
110023135|NCT00003402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110023136|NCT00003402|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110023137|NCT00003402|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110023138|NCT00003402|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111206026|NCT04148937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111206027|NCT03021057|Pembrolizumab|pembrolizumab|mesh-list
111206028|NCT03021057|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111206029|NCT03021057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111206030|NCT03021057|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111206031|NCT03021057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111206032|NCT00734500|Anidulafungin|anidulafungin|mesh-list
111206033|NCT00734500|Antifungal Agents|antifungal agents|mesh-ancestor
111206034|NCT00734500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111206035|NCT04143321|Empagliflozin|empagliflozin|mesh-list
111206036|NCT04143321|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111206037|NCT04143321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111206038|NCT04143321|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111206039|NCT04143321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111206040|NCT00734968|Nitrofurantoin|nitrofurantoin|mesh-list
111206041|NCT00734968|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111206042|NCT00734968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111206043|NCT00734968|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111206044|NCT00735436|Bevacizumab|bevacizumab|mesh-list
111206045|NCT00735436|Irinotecan|irinotecan|mesh-list
111206046|NCT00735436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111206047|NCT00735436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111206048|NCT00735436|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111206049|NCT00735436|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111206050|NCT00735436|Growth Substances|growth substances|mesh-ancestor
111206051|NCT00735436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111206052|NCT00735436|Growth Inhibitors|growth inhibitors|mesh-ancestor
111206053|NCT00735436|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111206054|NCT00735436|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111206055|NCT00735436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111320767|NCT02285283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111206056|NCT00735436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111206057|NCT04143165|Lidocaine|lidocaine|mesh-list
111206058|NCT04143165|Anesthetics, Local|anesthetics, local|mesh-ancestor
111206059|NCT04143165|Anesthetics|anesthetics|mesh-ancestor
111206060|NCT04143165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111206061|NCT04143165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111206062|NCT04143165|Sensory System Agents|sensory system agents|mesh-ancestor
111206063|NCT04143165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111206064|NCT04143165|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111206065|NCT04143165|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111206066|NCT04143165|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111206067|NCT04143165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111206068|NCT04143165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111206069|NCT00735670|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
111206070|NCT00735670|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111206071|NCT00735670|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111206072|NCT00735670|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111206073|NCT00735670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111206074|NCT00735670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111206075|NCT00735670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111206076|NCT00735670|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111206077|NCT00735670|Antidepressive Agents|antidepressive agents|mesh-ancestor
111206078|NCT00735670|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111206079|NCT00735826|Vorinostat|vorinostat|mesh-list
111206080|NCT00735826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111206081|NCT00735826|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110946534|NCT03581240|Eflornithine|eflornithine|mesh-list
110946535|NCT03581240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110946536|NCT03581240|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
110946537|NCT03581240|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110946538|NCT03581240|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110946539|NCT03581240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110946540|NCT03581240|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
110946541|NCT03581240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110946542|NCT03581240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110946543|NCT03573297|Cariprazine|cariprazine|mesh-list
110946544|NCT03573297|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110946545|NCT03573297|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110946546|NCT03573297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110946547|NCT03573297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110946548|NCT03573297|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111206082|NCT00735826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111206083|NCT00735826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111206085|NCT03916341|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111206086|NCT03916341|Autonomic Agents|autonomic agents|mesh-ancestor
111206087|NCT03916341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111206088|NCT03916341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111206089|NCT03916341|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111206090|NCT03916341|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111206091|NCT03916341|Cholinergic Agents|cholinergic agents|mesh-ancestor
111206092|NCT03916341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111206093|NCT03916341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111206094|NCT01276054|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111206095|NCT01276054|Methylene Blue|methylene blue|mesh-list
111206096|NCT01276054|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
111206097|NCT01276054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111206098|NCT01276054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111206099|NCT01276054|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111206100|NCT00724594|Acetylcysteine|acetylcysteine|mesh-list
111206101|NCT00724594|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111206102|NCT00724594|Antiviral Agents|antiviral agents|mesh-ancestor
111206103|NCT00724594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111206104|NCT00724594|Expectorants|expectorants|mesh-ancestor
111206105|NCT00724594|Respiratory System Agents|respiratory system agents|mesh-ancestor
111206106|NCT00724594|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111206107|NCT00724594|Antioxidants|antioxidants|mesh-ancestor
111206108|NCT00724594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111206109|NCT00724594|Protective Agents|protective agents|mesh-ancestor
111206110|NCT00724594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111206111|NCT00724594|Antidotes|antidotes|mesh-ancestor
111206112|NCT04142931|Nivolumab|nivolumab|mesh-list
111206113|NCT04142931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111206114|NCT04142931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111206115|NCT04142931|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111206116|NCT04142931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111206117|NCT04143477|Peficitinib|peficitinib|mesh-list
111206118|NCT04143477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111206119|NCT04143477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111206120|NCT04143477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111206121|NCT04143477|Immunologic Factors|immunologic factors|mesh-ancestor
111206122|NCT04143477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111206123|NCT05586009|Cisplatin|cisplatin|mesh-list
111206124|NCT05586009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111206125|NCT03020979|Apatinib|apatinib|mesh-list
111206126|NCT03020979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111206127|NCT03020979|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111206128|NCT03020979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111206129|NCT03020979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111206130|NCT04142151|Aspirin|aspirin|mesh-list
111206131|NCT04142151|Clopidogrel|clopidogrel|mesh-list
111206132|NCT04142151|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111206133|NCT04142151|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111206134|NCT04142151|Analgesics|analgesics|mesh-ancestor
111206135|NCT04142151|Sensory System Agents|sensory system agents|mesh-ancestor
111206136|NCT04142151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111206137|NCT04142151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111206138|NCT04142151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111206139|NCT04142151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111206140|NCT04142151|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111206141|NCT04142151|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110946593|NCT03535116|Ketorolac|ketorolac|mesh-list
110946594|NCT03535116|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110946595|NCT03535116|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110946596|NCT03535116|Analgesics|analgesics|mesh-ancestor
110946597|NCT03535116|Sensory System Agents|sensory system agents|mesh-ancestor
110946598|NCT03535116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110946599|NCT03535116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110946600|NCT03535116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110946601|NCT03535116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110946602|NCT03535116|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110946603|NCT03535116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110946604|NCT03535116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110946623|NCT03519295|Cisplatin|cisplatin|mesh-list
110946624|NCT03519295|Docetaxel|docetaxel|mesh-list
111206142|NCT04142151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111206143|NCT04142151|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111206144|NCT04142151|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111206145|NCT04142151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111206146|NCT04142151|Antipyretics|antipyretics|mesh-ancestor
111206147|NCT04142151|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111206148|NCT04142151|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111206149|NCT04142151|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111206150|NCT04142151|Purinergic Agents|purinergic agents|mesh-ancestor
111206151|NCT04142151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111206152|NCT02985099|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111206153|NCT02985099|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111206154|NCT02985099|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111206155|NCT02985099|Antimetabolites|antimetabolites|mesh-ancestor
111206156|NCT02985099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111206157|NCT02985099|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111206158|NCT02985099|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111206159|NCT02985099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111206160|NCT03904329|Anticoagulants|anticoagulants|mesh-list
111206161|NCT04149483|Atorvastatin|atorvastatin|mesh-list
111206162|NCT04149483|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111206163|NCT04149483|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111206164|NCT04149483|Antimetabolites|antimetabolites|mesh-ancestor
111206165|NCT04149483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111206166|NCT04149483|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111206167|NCT04149483|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111206168|NCT04149483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111206169|NCT04149327|Amoxicillin|amoxicillin|mesh-list
111206170|NCT04149327|Metronidazole|metronidazole|mesh-list
111206171|NCT04149327|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111206172|NCT04149327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111206173|NCT04149327|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111206174|NCT04149327|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111206175|NCT05582577|Bevacizumab|bevacizumab|mesh-list
111206176|NCT05582577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111206177|NCT05582577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111206178|NCT05582577|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111206179|NCT05582577|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111206180|NCT05582577|Growth Substances|growth substances|mesh-ancestor
111206181|NCT05582577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111206182|NCT05582577|Growth Inhibitors|growth inhibitors|mesh-ancestor
111206183|NCT04149015|Paclitaxel|paclitaxel|mesh-list
111206184|NCT04149015|Fluorouracil|fluorouracil|mesh-list
111206185|NCT04149015|Oxaliplatin|oxaliplatin|mesh-list
111206186|NCT04149015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111206187|NCT04149015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111206188|NCT04149015|Tubulin Modulators|tubulin modulators|mesh-ancestor
111206189|NCT04149015|Antimitotic Agents|antimitotic agents|mesh-ancestor
111206190|NCT04149015|Mitosis Modulators|mitosis modulators|mesh-ancestor
111206191|NCT04149015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111206192|NCT04149015|Antimetabolites|antimetabolites|mesh-ancestor
111206193|NCT04149015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111206194|NCT04149015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111206195|NCT04149015|Immunologic Factors|immunologic factors|mesh-ancestor
111206196|NCT04149015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111206197|NCT04149171|Tranexamic Acid|tranexamic acid|mesh-list
111206198|NCT04149171|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111206199|NCT04149171|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111206200|NCT04149171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111206201|NCT04149171|Hemostatics|hemostatics|mesh-ancestor
111206202|NCT04149171|Coagulants|coagulants|mesh-ancestor
111206203|NCT04140591|Propranolol|propranolol|mesh-list
111206204|NCT04140591|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
111206205|NCT04140591|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111206206|NCT04140591|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110946688|NCT03446040|Nivolumab|nivolumab|mesh-list
110946689|NCT03446040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110946690|NCT03446040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110946691|NCT03446040|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110946692|NCT03446040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110023139|NCT00003402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110023140|NCT00003408|Interferons|interferons|mesh-list
110023141|NCT00003408|Interferon-alpha|interferon-alpha|mesh-list
110023142|NCT00003408|Aldesleukin|aldesleukin|mesh-list
110023143|NCT00003408|Sargramostim|sargramostim|mesh-list
111206207|NCT04140591|Adrenergic Agents|adrenergic agents|mesh-ancestor
111206208|NCT04140591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111206209|NCT04140591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111206210|NCT04140591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111206211|NCT04140591|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111206212|NCT04140591|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111206213|NCT04140591|Vasodilator Agents|vasodilator agents|mesh-ancestor
111206214|NCT04140591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111206215|NCT05582109|Lenvatinib|lenvatinib|mesh-list
111206216|NCT05582109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111206217|NCT05582109|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111206218|NCT05582109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111206219|NCT05582109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111206220|NCT03020901|Teicoplanin|teicoplanin|mesh-list
111206221|NCT03020901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111206222|NCT03020901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111206223|NCT04140201|Simvastatin|simvastatin|mesh-list
111206224|NCT04140201|Fenofibrate|fenofibrate|mesh-list
111206225|NCT04140201|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111206226|NCT04140201|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111206227|NCT04140201|Antimetabolites|antimetabolites|mesh-ancestor
111206228|NCT04140201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111206229|NCT04140201|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111206230|NCT04140201|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111206231|NCT04140201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111206232|NCT05581875|Dexamethasone|dexamethasone|mesh-list
111206233|NCT05581875|Daratumumab|daratumumab|mesh-list
111206234|NCT05581875|Pomalidomide|pomalidomide|mesh-list
111206235|NCT05581875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111206236|NCT05581875|Antiemetics|antiemetics|mesh-ancestor
111206237|NCT05581875|Autonomic Agents|autonomic agents|mesh-ancestor
111206238|NCT05581875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111206239|NCT05581875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111206240|NCT05581875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111206241|NCT05581875|Glucocorticoids|glucocorticoids|mesh-ancestor
111206242|NCT05581875|Hormones|hormones|mesh-ancestor
111206243|NCT05581875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111206244|NCT05581875|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111206245|NCT05581875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111206246|NCT05581875|Immunologic Factors|immunologic factors|mesh-ancestor
111206247|NCT05581875|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111206248|NCT05581875|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111206249|NCT05581875|Growth Substances|growth substances|mesh-ancestor
111206250|NCT05581875|Growth Inhibitors|growth inhibitors|mesh-ancestor
111206251|NCT04406025|Anesthetics|anesthetics|mesh-list
111206252|NCT04406025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111206253|NCT04406025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111206254|NCT05587881|Vaccines|vaccines|mesh-list
111206255|NCT05587881|Immunologic Factors|immunologic factors|mesh-ancestor
111206256|NCT05587881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111206257|NCT05582421|Diclofenac|diclofenac|mesh-list
111206258|NCT05582421|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111206259|NCT05582421|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111206260|NCT05582421|Analgesics|analgesics|mesh-ancestor
111206261|NCT05582421|Sensory System Agents|sensory system agents|mesh-ancestor
111206262|NCT05582421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111206263|NCT05582421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111206264|NCT05582421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111206265|NCT05582421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111206266|NCT05582421|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111206267|NCT05582421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111206268|NCT05582421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111206269|NCT03580473|Moxifloxacin|moxifloxacin|mesh-list
111206270|NCT03580473|Dexamethasone|dexamethasone|mesh-list
110946780|NCT03410043|Osimertinib|osimertinib|mesh-list
110946781|NCT03410043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110946782|NCT03410043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110946783|NCT03410043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110946784|NCT03410043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110946788|NCT03406286|Tolvaptan|tolvaptan|mesh-list
110946789|NCT03406286|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
110946790|NCT03406286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110946791|NCT03406286|Natriuretic Agents|natriuretic agents|mesh-ancestor
110946792|NCT03406286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111206271|NCT03580473|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
111206272|NCT03580473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111206273|NCT03580473|Antiemetics|antiemetics|mesh-ancestor
111206274|NCT03580473|Autonomic Agents|autonomic agents|mesh-ancestor
111206275|NCT03580473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111206276|NCT03580473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111206277|NCT03580473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111206278|NCT03580473|Glucocorticoids|glucocorticoids|mesh-ancestor
111206279|NCT03580473|Hormones|hormones|mesh-ancestor
111206280|NCT03580473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111206281|NCT03580473|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111206282|NCT03580473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111206283|NCT03580473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111206284|NCT03580473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111206285|NCT03580473|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111206286|NCT03580473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111206287|NCT03580473|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111206288|NCT03580473|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111206289|NCT03580473|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111206290|NCT03580473|Contraceptive Agents|contraceptive agents|mesh-ancestor
111206291|NCT03580473|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111206292|NCT03580473|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
111206293|NCT03580473|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111206294|NCT03580473|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111206295|NCT03897309|Vaccines|vaccines|mesh-list
111206296|NCT03897309|Immunologic Factors|immunologic factors|mesh-ancestor
111206297|NCT03897309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111206298|NCT03588429|Sevoflurane|sevoflurane|mesh-list
111206299|NCT03588429|Isoflurane|isoflurane|mesh-list
111206300|NCT03588429|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111206301|NCT03588429|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111206302|NCT03588429|Anesthetics, General|anesthetics, general|mesh-ancestor
111206303|NCT03588429|Anesthetics|anesthetics|mesh-ancestor
111206304|NCT03588429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111206305|NCT03588429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111206306|NCT03580161|Sodium Pertechnetate Tc 99m|sodium pertechnetate tc 99m|mesh-list
111206307|NCT03580161|Technetium Tc 99m Medronate|technetium tc 99m medronate|mesh-list
111206308|NCT03580161|Technetium Tc 99m Mertiatide|technetium tc 99m mertiatide|mesh-list
111206309|NCT03580161|Technetium Tc 99m Dimercaptosuccinic Acid|technetium tc 99m dimercaptosuccinic acid|mesh-list
111206310|NCT03580161|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111206311|NCT03580161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111206312|NCT03588351|Chlorhexidine|chlorhexidine|mesh-list
111206313|NCT03588351|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
111206314|NCT03588351|Chitosan|chitosan|mesh-list
111206315|NCT03588351|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111206316|NCT03588351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111206317|NCT03588351|Disinfectants|disinfectants|mesh-ancestor
111206318|NCT03588351|Dermatologic Agents|dermatologic agents|mesh-ancestor
111206319|NCT03588351|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111206320|NCT03588351|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110946849|NCT03337646|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
110946850|NCT03337646|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110946851|NCT03337646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110946852|NCT03337646|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110946853|NCT03337646|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110946854|NCT03337646|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110946855|NCT03337646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110946856|NCT03337646|Dopamine Agents|dopamine agents|mesh-ancestor
110946857|NCT03337646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110946858|NCT03328026|Interferons|interferons|mesh-list
110946859|NCT03328026|Cyclophosphamide|cyclophosphamide|mesh-list
110946860|NCT03328026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110946861|NCT03328026|Immunologic Factors|immunologic factors|mesh-ancestor
110946862|NCT03328026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110946863|NCT03328026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110946864|NCT03328026|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110946865|NCT03328026|Alkylating Agents|alkylating agents|mesh-ancestor
110946866|NCT03328026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110946867|NCT03328026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110946868|NCT03328026|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110946869|NCT03328026|Antiviral Agents|antiviral agents|mesh-ancestor
110946870|NCT03328026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111206322|NCT03588351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111206323|NCT03588351|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111206324|NCT03588351|Chelating Agents|chelating agents|mesh-ancestor
111206325|NCT03588351|Sequestering Agents|sequestering agents|mesh-ancestor
111206326|NCT03588351|Hemostatics|hemostatics|mesh-ancestor
111206327|NCT03588351|Coagulants|coagulants|mesh-ancestor
111206328|NCT03588273|Amoxicillin|amoxicillin|mesh-list
111206329|NCT03588273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111206330|NCT03588273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111206331|NCT02984865|Flurbiprofen|flurbiprofen|mesh-list
111206332|NCT02984865|Sufentanil|sufentanil|mesh-list
111206333|NCT02984865|Nalbuphine|nalbuphine|mesh-list
111206334|NCT02984865|Dsuvia|dsuvia|mesh-list
111206335|NCT02984865|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111206336|NCT02984865|Narcotics|narcotics|mesh-ancestor
111206337|NCT02984865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111206338|NCT02984865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111206339|NCT02984865|Analgesics|analgesics|mesh-ancestor
111206340|NCT02984865|Sensory System Agents|sensory system agents|mesh-ancestor
111206341|NCT02984865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111206342|NCT02984865|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111206343|NCT02984865|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111206344|NCT02984865|Anesthetics, General|anesthetics, general|mesh-ancestor
111206345|NCT02984865|Anesthetics|anesthetics|mesh-ancestor
111206346|NCT02984865|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111206347|NCT02984865|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111206348|NCT02984865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111206349|NCT02984865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111206350|NCT02984865|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111206351|NCT02984865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111206352|NCT02984865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111206353|NCT01797445|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
111206354|NCT01797445|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111206355|NCT01797445|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111206356|NCT01797445|Antiviral Agents|antiviral agents|mesh-ancestor
111206357|NCT01797445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111206358|NCT03935451|Apixaban|apixaban|mesh-list
111206359|NCT03935451|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111206360|NCT03935451|Antithrombins|antithrombins|mesh-ancestor
111206361|NCT03935451|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111206362|NCT03935451|Protease Inhibitors|protease inhibitors|mesh-ancestor
111206363|NCT03935451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111206364|NCT03935451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111206365|NCT03935451|Anticoagulants|anticoagulants|mesh-ancestor
111206366|NCT01611259|Rituximab|rituximab|mesh-list
111206367|NCT01611259|Lenalidomide|lenalidomide|mesh-list
111206368|NCT01611259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111206369|NCT01611259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111206370|NCT01611259|Immunologic Factors|immunologic factors|mesh-ancestor
111206371|NCT01611259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111206372|NCT01611259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111206373|NCT01611259|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111206374|NCT01611259|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111206375|NCT01611259|Growth Substances|growth substances|mesh-ancestor
111206376|NCT01611259|Growth Inhibitors|growth inhibitors|mesh-ancestor
111206377|NCT03586869|Leucovorin|leucovorin|mesh-list
111206378|NCT03586869|Paclitaxel|paclitaxel|mesh-list
111206379|NCT03586869|Cyclophosphamide|cyclophosphamide|mesh-list
111206380|NCT03586869|Bevacizumab|bevacizumab|mesh-list
111206381|NCT03586869|Fluorouracil|fluorouracil|mesh-list
111206382|NCT03586869|Capecitabine|capecitabine|mesh-list
111206383|NCT03586869|Oxaliplatin|oxaliplatin|mesh-list
111206384|NCT03586869|Avelumab|avelumab|mesh-list
111206385|NCT03586869|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111206386|NCT03586869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111206387|NCT03586869|Tubulin Modulators|tubulin modulators|mesh-ancestor
111206388|NCT03586869|Antimitotic Agents|antimitotic agents|mesh-ancestor
110946876|NCT03326921|Antimetabolites|antimetabolites|mesh-ancestor
111206389|NCT03586869|Mitosis Modulators|mitosis modulators|mesh-ancestor
111206390|NCT03586869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110946877|NCT03326921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110664351|NCT01043380|Ezetimibe|ezetimibe|mesh-list
110946878|NCT03326921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110946879|NCT03326921|Immunologic Factors|immunologic factors|mesh-ancestor
110946880|NCT03326921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110946882|NCT03326921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111206391|NCT03586869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111206392|NCT03586869|Immunologic Factors|immunologic factors|mesh-ancestor
111206393|NCT03586869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111206394|NCT03586869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111206395|NCT03586869|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111206396|NCT03586869|Alkylating Agents|alkylating agents|mesh-ancestor
111206397|NCT03586869|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111206398|NCT03586869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111206399|NCT03586869|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111206400|NCT03586869|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111206401|NCT03586869|Growth Substances|growth substances|mesh-ancestor
111206402|NCT03586869|Growth Inhibitors|growth inhibitors|mesh-ancestor
111206403|NCT03586869|Antimetabolites|antimetabolites|mesh-ancestor
111206404|NCT03586869|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111206405|NCT03586869|Antidotes|antidotes|mesh-ancestor
111206406|NCT03586869|Protective Agents|protective agents|mesh-ancestor
111206407|NCT03586869|Vitamin B Complex|vitamin b complex|mesh-ancestor
111206408|NCT03586869|Vitamins|vitamins|mesh-ancestor
111206409|NCT03586869|Micronutrients|micronutrients|mesh-ancestor
111206410|NCT03586791|Anesthetics|anesthetics|mesh-list
111206411|NCT03586791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111206412|NCT03586791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111206413|NCT01795495|Magnesium Sulfate|magnesium sulfate|mesh-list
111206414|NCT01795495|Remifentanil|remifentanil|mesh-list
111206415|NCT01795495|Methadone|methadone|mesh-list
111206416|NCT01795495|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111206417|NCT01795495|Narcotics|narcotics|mesh-ancestor
111206418|NCT01795495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111206419|NCT01795495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111206420|NCT01795495|Analgesics|analgesics|mesh-ancestor
111206421|NCT01795495|Sensory System Agents|sensory system agents|mesh-ancestor
111206422|NCT01795495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111206423|NCT01795495|Anesthetics|anesthetics|mesh-ancestor
111206424|NCT01795495|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111206425|NCT01795495|Anticonvulsants|anticonvulsants|mesh-ancestor
111206426|NCT01795495|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111206427|NCT01795495|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111206428|NCT01795495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111206429|NCT01795495|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111206430|NCT01795495|Tocolytic Agents|tocolytic agents|mesh-ancestor
111206431|NCT01795495|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111206432|NCT01795495|Antitussive Agents|antitussive agents|mesh-ancestor
111206433|NCT01795495|Respiratory System Agents|respiratory system agents|mesh-ancestor
111206434|NCT04765527|Turmeric extract|turmeric extract|mesh-list
111206435|NCT04765527|Antioxidants|antioxidants|mesh-ancestor
111206436|NCT04765527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111206437|NCT04765527|Protective Agents|protective agents|mesh-ancestor
111206438|NCT04765527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111206439|NCT02947503|Metformin|metformin|mesh-list
111206440|NCT02947503|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111206441|NCT02947503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111206442|NCT03586323|Lidocaine|lidocaine|mesh-list
110946985|NCT03189641|Cilostazol|cilostazol|mesh-list
110946986|NCT03189641|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110946987|NCT03189641|Autonomic Agents|autonomic agents|mesh-ancestor
110946988|NCT03189641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110946989|NCT03189641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110946990|NCT03189641|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110946991|NCT03189641|Respiratory System Agents|respiratory system agents|mesh-ancestor
110946992|NCT03189641|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110946993|NCT03189641|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110946994|NCT03189641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110946995|NCT03189641|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110946996|NCT03189641|Vasodilator Agents|vasodilator agents|mesh-ancestor
110946997|NCT03189641|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110946998|NCT03189641|Protective Agents|protective agents|mesh-ancestor
110946999|NCT03189641|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110947000|NCT03189641|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110947001|NCT03189641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110947008|NCT03158389|Sirolimus|sirolimus|mesh-list
110947009|NCT03158389|Atezolizumab|atezolizumab|mesh-list
110947010|NCT03158389|Palbociclib|palbociclib|mesh-list
110947011|NCT03158389|Temsirolimus|temsirolimus|mesh-list
110947012|NCT03158389|MTOR Inhibitors|mtor inhibitors|mesh-list
111206443|NCT03586323|Anesthetics, Local|anesthetics, local|mesh-ancestor
111206444|NCT03586323|Anesthetics|anesthetics|mesh-ancestor
111206445|NCT03586323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111206446|NCT03586323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111206447|NCT03586323|Sensory System Agents|sensory system agents|mesh-ancestor
111206448|NCT03586323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111206449|NCT03586323|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111206450|NCT03586323|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111206451|NCT03586323|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111206452|NCT03586323|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111206453|NCT03586323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111206454|NCT03586089|Diazepam|diazepam|mesh-list
111206455|NCT03586089|Phenobarbital|phenobarbital|mesh-list
111206456|NCT03586089|Anticonvulsants|anticonvulsants|mesh-ancestor
111206457|NCT03586089|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111206458|NCT03586089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111206459|NCT03586089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111206460|NCT03586089|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111206461|NCT03586089|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111206462|NCT03586089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111206463|NCT03586089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111206464|NCT03586089|GABA Modulators|gaba modulators|mesh-ancestor
111206465|NCT03586089|GABA Agents|gaba agents|mesh-ancestor
111206466|NCT03586089|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111206467|NCT03586089|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111206468|NCT03586089|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111206469|NCT03586089|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111206470|NCT03586089|Antiemetics|antiemetics|mesh-ancestor
111206471|NCT03586089|Autonomic Agents|autonomic agents|mesh-ancestor
111206472|NCT03586089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111206473|NCT03586089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111206474|NCT03586089|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
111206475|NCT03586089|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111206476|NCT03586089|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111206477|NCT03586089|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111206478|NCT03586089|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111206479|NCT03586089|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111206480|NCT03586089|Anesthetics, General|anesthetics, general|mesh-ancestor
111206481|NCT03586089|Anesthetics|anesthetics|mesh-ancestor
111206482|NCT01986881|Ertugliflozin|ertugliflozin|mesh-list
111206483|NCT01986881|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111206484|NCT01986881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111206485|NCT01986881|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111206486|NCT01986881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111206487|NCT03580395|Paclitaxel|paclitaxel|mesh-list
111206488|NCT03580395|Apatinib|apatinib|mesh-list
111206489|NCT03580395|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111206490|NCT03580395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111206491|NCT03580395|Tubulin Modulators|tubulin modulators|mesh-ancestor
111206492|NCT03580395|Antimitotic Agents|antimitotic agents|mesh-ancestor
111206493|NCT03580395|Mitosis Modulators|mitosis modulators|mesh-ancestor
111206494|NCT03580395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111206495|NCT03580395|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111206496|NCT03580395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111206497|NCT01609543|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111206498|NCT01609543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111206499|NCT01609543|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111206500|NCT01609543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111206501|NCT01609543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111206502|NCT03580239|Everolimus|everolimus|mesh-list
111206503|NCT03580239|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111206504|NCT03580239|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111206505|NCT03580239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111206506|NCT03580239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111206507|NCT03580239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111206508|NCT03580239|Immunologic Factors|immunologic factors|mesh-ancestor
110947036|NCT03148418|Atezolizumab|atezolizumab|mesh-list
110947037|NCT03148418|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110947038|NCT03148418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110947039|NCT03148418|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110947040|NCT03148418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110947070|NCT03141177|Nivolumab|nivolumab|mesh-list
110947071|NCT03141177|Ipilimumab|ipilimumab|mesh-list
110947072|NCT03141177|Sunitinib|sunitinib|mesh-list
110947073|NCT03141177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111206509|NCT03580239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111206510|NCT03580239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111206511|NCT03156153|Bumetanide|bumetanide|mesh-list
111206512|NCT03156153|Diuretics|diuretics|mesh-ancestor
111206513|NCT03156153|Natriuretic Agents|natriuretic agents|mesh-ancestor
111206514|NCT03156153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111206515|NCT03156153|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
111206516|NCT03156153|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111206517|NCT03156153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111206518|NCT03156231|Acetazolamide|acetazolamide|mesh-list
111206519|NCT03156231|Anticonvulsants|anticonvulsants|mesh-ancestor
111206520|NCT03156231|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
111206521|NCT03156231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111206522|NCT03156231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111206523|NCT03156231|Diuretics|diuretics|mesh-ancestor
111206524|NCT03156231|Natriuretic Agents|natriuretic agents|mesh-ancestor
111206525|NCT03156231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111206526|NCT05702151|Morphine|morphine|mesh-list
111206527|NCT05702151|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111206528|NCT05702151|Narcotics|narcotics|mesh-ancestor
111206529|NCT05702151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111206530|NCT05702151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111206531|NCT05702151|Analgesics|analgesics|mesh-ancestor
111206532|NCT05702151|Sensory System Agents|sensory system agents|mesh-ancestor
111206533|NCT05702151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111206534|NCT01985321|Ethanol|ethanol|mesh-list
111206535|NCT01985321|Glycolic acid|glycolic acid|mesh-list
111206536|NCT01985321|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111206537|NCT01985321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111206538|NCT01985321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111206539|NCT01985321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111206540|NCT01985321|Keratolytic Agents|keratolytic agents|mesh-ancestor
111206541|NCT01985321|Dermatologic Agents|dermatologic agents|mesh-ancestor
111206542|NCT03584919|Doxycycline|doxycycline|mesh-list
111206543|NCT03584919|Cefuroxime|cefuroxime|mesh-list
111206544|NCT03584919|Cefuroxime axetil|cefuroxime axetil|mesh-list
111206545|NCT03584919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111206546|NCT03584919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111206547|NCT03584919|Antimalarials|antimalarials|mesh-ancestor
111206548|NCT03584919|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111206549|NCT03584919|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111206550|NCT03584841|Pilocarpine|pilocarpine|mesh-list
111206551|NCT03584841|Miotics|miotics|mesh-ancestor
111206552|NCT03584841|Autonomic Agents|autonomic agents|mesh-ancestor
111206553|NCT03584841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111206554|NCT03584841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111206555|NCT03584841|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
111206556|NCT03584841|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111206557|NCT03584841|Cholinergic Agents|cholinergic agents|mesh-ancestor
111206558|NCT03584841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111206559|NCT03584841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111206560|NCT02000921|Nicotine|nicotine|mesh-list
111206561|NCT02000921|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111206562|NCT02000921|Autonomic Agents|autonomic agents|mesh-ancestor
111206563|NCT02000921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111206564|NCT02000921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111206565|NCT02000921|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111206566|NCT02000921|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111206567|NCT02000921|Cholinergic Agents|cholinergic agents|mesh-ancestor
111206568|NCT02000921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111206569|NCT02000921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111206570|NCT03586947|Vitamin D|vitamin d|mesh-list
111206571|NCT03586947|Ergocalciferols|ergocalciferols|mesh-list
111206572|NCT03586947|Cholecalciferol|cholecalciferol|mesh-list
111206573|NCT03586947|Vitamins|vitamins|mesh-list
111206574|NCT03586947|Micronutrients|micronutrients|mesh-ancestor
111206575|NCT03586947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111206576|NCT03586947|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111206577|NCT03586947|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111206578|NCT03584529|Vitamin D|vitamin d|mesh-list
111206579|NCT03584529|Cholecalciferol|cholecalciferol|mesh-list
111206580|NCT03584529|Vitamins|vitamins|mesh-ancestor
111206581|NCT03584529|Micronutrients|micronutrients|mesh-ancestor
111206582|NCT03584529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111206583|NCT03584529|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111206584|NCT03584529|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111206585|NCT00724984|Abexinostat|abexinostat|mesh-list
110023145|NCT00003408|Antiviral Agents|antiviral agents|mesh-ancestor
111206586|NCT00724984|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111206587|NCT00724984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111206588|NCT00724984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111206589|NCT03113253|Tranexamic Acid|tranexamic acid|mesh-list
111206590|NCT03113253|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111206591|NCT03113253|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111206592|NCT03113253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111206593|NCT03113253|Hemostatics|hemostatics|mesh-ancestor
111206594|NCT03113253|Coagulants|coagulants|mesh-ancestor
111206595|NCT01836523|Liraglutide|liraglutide|mesh-list
111206596|NCT01836523|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111206597|NCT01836523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111206598|NCT01836523|Incretins|incretins|mesh-ancestor
111206599|NCT01836523|Hormones|hormones|mesh-ancestor
111206600|NCT01836523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111206601|NCT01275196|Imatinib Mesylate|imatinib mesylate|mesh-list
111206602|NCT01275196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111206603|NCT01275196|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111206604|NCT01275196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111206605|NCT01275196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111206606|NCT03583749|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111206607|NCT03583749|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
111206608|NCT03583749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111206609|NCT03583749|Antitubercular Agents|antitubercular agents|mesh-ancestor
111206610|NCT02000531|Cisplatin|cisplatin|mesh-list
111206611|NCT02000531|Gemcitabine|gemcitabine|mesh-list
111206612|NCT02000531|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111206613|NCT02000531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111206614|NCT02000531|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111206615|NCT02000531|Antimetabolites|antimetabolites|mesh-ancestor
111206616|NCT02000531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111206617|NCT02000531|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110785715|NCT01125033|Tocotrienols|tocotrienols|mesh-list
111206618|NCT02000531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111206619|NCT01609231|Irinotecan|irinotecan|mesh-list
111206620|NCT01609231|Cetuximab|cetuximab|mesh-list
111206621|NCT01609231|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111206622|NCT01609231|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111206623|NCT01609231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111206624|NCT01609231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111206625|NCT01609231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111206626|NCT01609231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111206627|NCT04438187|Anti-Infective Agents|anti-infective agents|mesh-list
111206628|NCT04438187|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111206629|NCT02092025|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
111206630|NCT02092025|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110023146|NCT00003408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110023147|NCT00003408|Immunologic Factors|immunologic factors|mesh-ancestor
110023148|NCT00003408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110023149|NCT00003408|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110023150|NCT00003408|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110023151|NCT00003414|Interferons|interferons|mesh-list
110023152|NCT00003414|Aldesleukin|aldesleukin|mesh-list
110023153|NCT00003414|Interferon-gamma|interferon-gamma|mesh-list
110023154|NCT00003414|Cyclosporine|cyclosporine|mesh-list
110023155|NCT00003414|Cyclophosphamide|cyclophosphamide|mesh-list
110023156|NCT00003414|Busulfan|busulfan|mesh-list
110023157|NCT00003414|Cyclosporins|cyclosporins|mesh-list
110023158|NCT00003414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110023159|NCT00003414|Immunologic Factors|immunologic factors|mesh-ancestor
110023160|NCT00003414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110023161|NCT00003414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110023162|NCT00003414|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110023163|NCT00003414|Alkylating Agents|alkylating agents|mesh-ancestor
110023164|NCT00003414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110023165|NCT00003414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110023166|NCT00003414|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110023167|NCT00003414|Antiviral Agents|antiviral agents|mesh-ancestor
110023168|NCT00003414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110023169|NCT00003414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110023170|NCT00003414|Antifungal Agents|antifungal agents|mesh-ancestor
110023171|NCT00003414|Dermatologic Agents|dermatologic agents|mesh-ancestor
110023172|NCT00003414|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110023173|NCT00003414|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110023174|NCT00003414|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111206631|NCT02092025|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111206632|NCT02092025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111206633|NCT04405011|Entecavir|entecavir|mesh-list
111206634|NCT04405011|Antiviral Agents|antiviral agents|mesh-ancestor
111206635|NCT04405011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111206636|NCT01769443|Bortezomib|bortezomib|mesh-list
111206637|NCT01769443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111206638|NCT03154827|Atezolizumab|atezolizumab|mesh-list
111206639|NCT03154827|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111206640|NCT03154827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111206641|NCT03154827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111206642|NCT03154827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111206643|NCT01274182|Rituximab|rituximab|mesh-list
111206644|NCT01274182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111206645|NCT01274182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111206646|NCT01274182|Immunologic Factors|immunologic factors|mesh-ancestor
111206647|NCT01274182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111206648|NCT01274182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111206649|NCT01984229|Posaconazole|posaconazole|mesh-list
111206650|NCT01984229|Antifungal Agents|antifungal agents|mesh-ancestor
111206651|NCT01984229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111206652|NCT01984229|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
111206653|NCT01984229|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111206654|NCT01984229|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111206655|NCT01984229|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111206656|NCT01984229|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111206657|NCT01984229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111206658|NCT01984229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111206659|NCT01984229|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111206660|NCT01984229|Hormone Antagonists|hormone antagonists|mesh-ancestor
111206661|NCT01984229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111206662|NCT01984229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111206663|NCT01274104|Vitamin D|vitamin d|mesh-list
111206664|NCT01274104|Cholecalciferol|cholecalciferol|mesh-list
111206665|NCT01274104|Vitamins|vitamins|mesh-ancestor
111206666|NCT01274104|Micronutrients|micronutrients|mesh-ancestor
111206667|NCT01274104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111206668|NCT01274104|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111206669|NCT01274104|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111206670|NCT01279096|Dexamethasone|dexamethasone|mesh-list
111206671|NCT01279096|Etoposide|etoposide|mesh-list
111206672|NCT01279096|Asparaginase|asparaginase|mesh-list
111206673|NCT01279096|Mitoxantrone|mitoxantrone|mesh-list
111206674|NCT01279096|Clofarabine|clofarabine|mesh-list
111206675|NCT01279096|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111206676|NCT01279096|Antiemetics|antiemetics|mesh-ancestor
111206677|NCT01279096|Autonomic Agents|autonomic agents|mesh-ancestor
111206678|NCT01279096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111206679|NCT01279096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111206680|NCT01279096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111206681|NCT01279096|Glucocorticoids|glucocorticoids|mesh-ancestor
111206682|NCT01279096|Hormones|hormones|mesh-ancestor
111206683|NCT01279096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111206684|NCT01279096|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111206685|NCT01279096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111206686|NCT01279096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111206687|NCT01279096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111206688|NCT01279096|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111206689|NCT01279096|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111206690|NCT01279096|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110947279|NCT02970318|Rituximab|rituximab|mesh-list
110947280|NCT02970318|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110947281|NCT02970318|Acalabrutinib|acalabrutinib|mesh-list
110947282|NCT02970318|Idelalisib|idelalisib|mesh-list
110947283|NCT02970318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110947284|NCT02970318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110947285|NCT02970318|Immunologic Factors|immunologic factors|mesh-ancestor
110947286|NCT02970318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110947287|NCT02970318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110947288|NCT02970318|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110947289|NCT02970318|Alkylating Agents|alkylating agents|mesh-ancestor
110947290|NCT02970318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110947291|NCT02970318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110947292|NCT02945280|Apixaban|apixaban|mesh-list
110947402|NCT02779855|Paclitaxel|paclitaxel|mesh-list
111206691|NCT01279096|Analgesics|analgesics|mesh-ancestor
111206692|NCT01279096|Sensory System Agents|sensory system agents|mesh-ancestor
111206693|NCT01279096|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111206694|NCT01279096|Antimetabolites|antimetabolites|mesh-ancestor
111206695|NCT01272934|Diclofenac|diclofenac|mesh-list
111206696|NCT01272934|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111206697|NCT01272934|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111206698|NCT01272934|Analgesics|analgesics|mesh-ancestor
111206699|NCT01272934|Sensory System Agents|sensory system agents|mesh-ancestor
111206700|NCT01272934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111206701|NCT01272934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111206702|NCT01272934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111206703|NCT01272934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111206704|NCT01272934|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111206705|NCT01272934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111206706|NCT01272934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111206707|NCT01279252|Metronidazole|metronidazole|mesh-list
111206708|NCT01279252|Clarithromycin|clarithromycin|mesh-list
111206709|NCT01279252|Ciprofloxacin|ciprofloxacin|mesh-list
111206710|NCT01279252|Lansoprazole|lansoprazole|mesh-list
111206711|NCT01279252|Dexlansoprazole|dexlansoprazole|mesh-list
111206712|NCT01279252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111206713|NCT01279252|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111206714|NCT01279252|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111206715|NCT01279252|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111206716|NCT01279252|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111206717|NCT01279252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110947403|NCT02779855|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
110947404|NCT02779855|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110947405|NCT02779855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110947406|NCT02779855|Tubulin Modulators|tubulin modulators|mesh-ancestor
110947407|NCT02779855|Antimitotic Agents|antimitotic agents|mesh-ancestor
110947408|NCT02779855|Mitosis Modulators|mitosis modulators|mesh-ancestor
110947409|NCT02779855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110947410|NCT02779855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110959124|NCT02143479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110959125|NCT02143479|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110959126|NCT02143479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110959127|NCT02143479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110959128|NCT02254239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110959129|NCT02254239|Brentuximab Vedotin|brentuximab vedotin|mesh-list
110959130|NCT02254239|Everolimus|everolimus|mesh-list
110959131|NCT02254239|Antibodies|antibodies|mesh-list
110959132|NCT02254239|Immunoglobulins|immunoglobulins|mesh-list
110959133|NCT02254239|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110959134|NCT02254239|Immunoconjugates|immunoconjugates|mesh-list
110959135|NCT02254239|Immunologic Factors|immunologic factors|mesh-ancestor
110959136|NCT02254239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110959137|NCT02254239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110959138|NCT02254239|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110959139|NCT02254239|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110959140|NCT02254239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110959141|NCT02254239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110959142|NCT02254239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110959143|NCT02254239|Immunotoxins|immunotoxins|mesh-ancestor
110959144|NCT05088369|Adrenomedullin|adrenomedullin|mesh-list
110959145|NCT05088369|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110959146|NCT05088369|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110959147|NCT05088369|Autonomic Agents|autonomic agents|mesh-ancestor
110959148|NCT05088369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110959149|NCT05088369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110959150|NCT05088369|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110959151|NCT05088369|Respiratory System Agents|respiratory system agents|mesh-ancestor
110959152|NCT05088369|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110959153|NCT05088369|Vasodilator Agents|vasodilator agents|mesh-ancestor
110959154|NCT05088369|Protective Agents|protective agents|mesh-ancestor
110959155|NCT05681182|Amiodarone|amiodarone|mesh-list
110959156|NCT05681182|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110959157|NCT05681182|Vasodilator Agents|vasodilator agents|mesh-ancestor
110959158|NCT05681182|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
110959159|NCT05681182|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110959160|NCT05681182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110959161|NCT05681182|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111206718|NCT01279252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111206719|NCT01279252|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111206720|NCT01279252|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111206721|NCT01279252|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111206722|NCT01279252|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111206723|NCT01279252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111206724|NCT01279252|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111206725|NCT01279252|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111206726|NCT01279252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111206727|NCT01279252|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111206728|NCT04385836|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
111206729|NCT04385836|Protein C Inhibitor|protein c inhibitor|mesh-list
111206730|NCT04385836|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
111206731|NCT04385836|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111206732|NCT04385836|Protease Inhibitors|protease inhibitors|mesh-ancestor
111206733|NCT04385836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111206734|NCT04385836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111206735|NCT01274260|Methylprednisolone|methylprednisolone|mesh-list
111206736|NCT01274260|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111206737|NCT01274260|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111206738|NCT01274260|Prednisolone|prednisolone|mesh-list
111206739|NCT01274260|Prednisolone acetate|prednisolone acetate|mesh-list
111206740|NCT01274260|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111206741|NCT01274260|Prednisolone phosphate|prednisolone phosphate|mesh-list
111206742|NCT01274260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111206743|NCT01274260|Antiemetics|antiemetics|mesh-ancestor
111206744|NCT01274260|Autonomic Agents|autonomic agents|mesh-ancestor
111206745|NCT01274260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111206746|NCT01274260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111206747|NCT01274260|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111206748|NCT01274260|Glucocorticoids|glucocorticoids|mesh-ancestor
111206749|NCT01274260|Hormones|hormones|mesh-ancestor
111206750|NCT01274260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111206751|NCT01274260|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111206752|NCT01274260|Protective Agents|protective agents|mesh-ancestor
111206753|NCT01274260|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111206754|NCT01274260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111206755|NCT03154983|Docetaxel|docetaxel|mesh-list
111206756|NCT03154983|Apatinib|apatinib|mesh-list
111206757|NCT03154983|Tegafur|tegafur|mesh-list
111206758|NCT03154983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111206759|NCT03154983|Tubulin Modulators|tubulin modulators|mesh-ancestor
111206760|NCT03154983|Antimitotic Agents|antimitotic agents|mesh-ancestor
111206761|NCT03154983|Mitosis Modulators|mitosis modulators|mesh-ancestor
111206762|NCT03154983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111206763|NCT03154983|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111206764|NCT03154983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111206765|NCT03154983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111206766|NCT03154983|Antimetabolites|antimetabolites|mesh-ancestor
111206767|NCT01983683|Vancomycin|vancomycin|mesh-list
111206768|NCT01983683|Oxazolidinones|oxazolidinones|mesh-list
111206769|NCT01983683|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111206770|NCT01983683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111206771|NCT01983683|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111206772|NCT01983683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110664860|NCT00062647|Vancomycin|vancomycin|mesh-list
110947462|NCT02687906|Meropenem|meropenem|mesh-list
110947463|NCT02687906|Vaborbactam|vaborbactam|mesh-list
110947464|NCT02687906|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-list
110947465|NCT02687906|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110947466|NCT02687906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110947467|NCT02687906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110947468|NCT02687906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110947469|NCT02684474|HBOC 201|hboc 201|mesh-list
110947470|NCT02684474|Blood Substitutes|blood substitutes|mesh-ancestor
110947471|NCT02682927|Fenfluramine|fenfluramine|mesh-list
110947472|NCT02682927|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110947473|NCT02682927|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110947474|NCT02682927|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110947475|NCT02682927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110947476|NCT02682927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110947477|NCT02682927|Serotonin Agents|serotonin agents|mesh-ancestor
110947478|NCT02682927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110947479|NCT02677493|Vaccines|vaccines|mesh-list
110947480|NCT02677493|Immunologic Factors|immunologic factors|mesh-ancestor
111206773|NCT01983683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111206774|NCT03154515|Pentanedioic acid imidazolyl ethanamide|pentanedioic acid imidazolyl ethanamide|mesh-list
111206776|NCT03154515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111206777|NCT03158025|Zolpidem|zolpidem|mesh-list
111206778|NCT03158025|Suvorexant|suvorexant|mesh-list
111206779|NCT03158025|Lemborexant|lemborexant|mesh-list
111206780|NCT03158025|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111206781|NCT03158025|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111206782|NCT03158025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111206783|NCT03158025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111206784|NCT03158025|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
111206785|NCT03158025|GABA Agonists|gaba agonists|mesh-ancestor
111206786|NCT03158025|GABA Agents|gaba agents|mesh-ancestor
111206787|NCT03158025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111206788|NCT03158025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111206789|NCT03158025|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
111206790|NCT01998893|Rituximab|rituximab|mesh-list
111206791|NCT01998893|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111206792|NCT01998893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111206793|NCT01998893|Immunologic Factors|immunologic factors|mesh-ancestor
111206794|NCT01998893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111206795|NCT01998893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111206796|NCT01791985|Letrozole|letrozole|mesh-list
111206797|NCT01791985|Anastrozole|anastrozole|mesh-list
111206798|NCT01791985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111206799|NCT01791985|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111206800|NCT01791985|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111206801|NCT01791985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111206802|NCT01791985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111206803|NCT01791985|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111206804|NCT01791985|Hormone Antagonists|hormone antagonists|mesh-ancestor
111206805|NCT01791985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111206806|NCT01791985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110786014|NCT01127529|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111206807|NCT01791985|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111206808|NCT04176497|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
111206809|NCT04176497|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111206810|NCT04176497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111206811|NCT01791517|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111206812|NCT03154281|Everolimus|everolimus|mesh-list
111206813|NCT03154281|Niraparib|niraparib|mesh-list
111206814|NCT03154281|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111206815|NCT03154281|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111206816|NCT03154281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111206817|NCT03154281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111206818|NCT03154281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111206819|NCT03154281|Immunologic Factors|immunologic factors|mesh-ancestor
111206820|NCT03154281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111206821|NCT03154281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111206822|NCT03154281|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111206823|NCT03157791|Simethicone|simethicone|mesh-list
111206824|NCT03157791|Antifoaming Agents|antifoaming agents|mesh-ancestor
111206825|NCT03157791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111206826|NCT03157791|Emollients|emollients|mesh-ancestor
111206827|NCT03157791|Dermatologic Agents|dermatologic agents|mesh-ancestor
111206828|NCT05701059|Meloxicam|meloxicam|mesh-list
111206829|NCT05701059|Cimetidine|cimetidine|mesh-list
111206830|NCT05701059|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111206831|NCT05701059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110947503|NCT02633059|Dexamethasone|dexamethasone|mesh-list
110947504|NCT02633059|Dexamethasone acetate|dexamethasone acetate|mesh-list
110947506|NCT02633059|Ichthammol|ichthammol|mesh-list
110947507|NCT02633059|BB 1101|bb 1101|mesh-list
110947508|NCT02633059|Glycine|glycine|mesh-list
110947509|NCT02633059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110947510|NCT02633059|Antiemetics|antiemetics|mesh-ancestor
110947511|NCT02633059|Autonomic Agents|autonomic agents|mesh-ancestor
110947512|NCT02633059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110947513|NCT02633059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110947514|NCT02633059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110947515|NCT02633059|Glucocorticoids|glucocorticoids|mesh-ancestor
110947516|NCT02633059|Hormones|hormones|mesh-ancestor
110947517|NCT02633059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110947518|NCT02633059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110947532|NCT02630043|Tolcapone|tolcapone|mesh-list
111206833|NCT05701059|Histamine Antagonists|histamine antagonists|mesh-ancestor
111206834|NCT05701059|Histamine Agents|histamine agents|mesh-ancestor
111206835|NCT05701059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111206836|NCT05701059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111206837|NCT05701059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111206838|NCT05701059|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111206839|NCT05701059|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111206840|NCT05701059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111206841|NCT05701059|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111206842|NCT05701059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111206843|NCT05701059|Analgesics|analgesics|mesh-ancestor
111206844|NCT05701059|Sensory System Agents|sensory system agents|mesh-ancestor
111206845|NCT05701059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111206846|NCT05701059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111206847|NCT05701059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111206848|NCT05701059|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111206849|NCT05701059|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111206850|NCT03157479|Anesthetics|anesthetics|mesh-list
111206851|NCT03157479|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
111206852|NCT03157479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111206853|NCT03157479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111206854|NCT03157479|Anesthetics, General|anesthetics, general|mesh-ancestor
111206855|NCT03013491|Ipilimumab|ipilimumab|mesh-list
111206856|NCT03013491|Vemurafenib|vemurafenib|mesh-list
111206857|NCT03013491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111206858|NCT03013491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111206859|NCT03013491|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111206860|NCT03013491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111206861|NCT03013491|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111206862|NCT03013491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111206863|NCT01272232|Liraglutide|liraglutide|mesh-list
111206864|NCT01272232|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111206865|NCT01272232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111206866|NCT01272232|Incretins|incretins|mesh-ancestor
111206867|NCT01272232|Hormones|hormones|mesh-ancestor
111206868|NCT01272232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111206869|NCT03157401|Tranexamic Acid|tranexamic acid|mesh-list
111206870|NCT03157401|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111206871|NCT03157401|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111206872|NCT03157401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111206873|NCT03157401|Hemostatics|hemostatics|mesh-ancestor
111206874|NCT03157401|Coagulants|coagulants|mesh-ancestor
111206875|NCT03153813|Capsaicin|capsaicin|mesh-list
111206876|NCT03153813|Antipruritics|antipruritics|mesh-ancestor
111206877|NCT03153813|Dermatologic Agents|dermatologic agents|mesh-ancestor
111206878|NCT03153813|Sensory System Agents|sensory system agents|mesh-ancestor
111206879|NCT03153813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111206880|NCT03153813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111206881|NCT03156855|Bismuth|bismuth|mesh-list
111206882|NCT03156855|Antacids|antacids|mesh-ancestor
111206883|NCT03156855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111206884|NCT03156855|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111206885|NCT00739960|Abatacept|abatacept|mesh-list
111206886|NCT00739960|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111206887|NCT00739960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111206888|NCT00739960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111206889|NCT00739960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111206890|NCT00739960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111206891|NCT00739960|Immunologic Factors|immunologic factors|mesh-ancestor
111206892|NCT00739960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111206893|NCT00739960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111206894|NCT03153657|Piroxicam|piroxicam|mesh-list
111206895|NCT03153657|Piroxicam-beta-cyclodextrin|piroxicam-beta-cyclodextrin|mesh-list
111206896|NCT03153657|Betadex|betadex|mesh-list
110665011|NCT00792779|Propofol|propofol|mesh-list
110947569|NCT02562235|Riociguat|riociguat|mesh-list
110947570|NCT02562235|Enzyme Activators|enzyme activators|mesh-ancestor
110947571|NCT02562235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110947621|NCT02460692|Dronabinol|dronabinol|mesh-list
110947622|NCT02460692|Hallucinogens|hallucinogens|mesh-ancestor
110947623|NCT02460692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110947624|NCT02460692|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110947626|NCT02460692|Analgesics|analgesics|mesh-ancestor
111206897|NCT03153657|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111206898|NCT03153657|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111206899|NCT03153657|Analgesics|analgesics|mesh-ancestor
111206900|NCT03153657|Sensory System Agents|sensory system agents|mesh-ancestor
111206901|NCT03153657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111206902|NCT03153657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111206903|NCT03153657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111206904|NCT03153657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111206905|NCT03153657|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111206906|NCT03153657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111206907|NCT03153657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111206908|NCT03153657|Sequestering Agents|sequestering agents|mesh-ancestor
111206910|NCT01670955|Hematinics|hematinics|mesh-ancestor
111206911|NCT01670955|Vitamin B Complex|vitamin b complex|mesh-ancestor
111206912|NCT01670955|Vitamins|vitamins|mesh-ancestor
111206913|NCT01670955|Micronutrients|micronutrients|mesh-ancestor
111206914|NCT01670955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111206915|NCT01275274|Tretinoin|tretinoin|mesh-list
111206916|NCT01275274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111206917|NCT01275274|Keratolytic Agents|keratolytic agents|mesh-ancestor
111206918|NCT01275274|Dermatologic Agents|dermatologic agents|mesh-ancestor
111206919|NCT01997333|Capecitabine|capecitabine|mesh-list
111206920|NCT01997333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111206921|NCT01997333|Antimetabolites|antimetabolites|mesh-ancestor
111206922|NCT01997333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111206923|NCT01997333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111206924|NCT01271920|Trastuzumab|trastuzumab|mesh-list
111206925|NCT01271920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111206926|NCT01271920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111206927|NCT01275352|Eplerenone|eplerenone|mesh-list
111206928|NCT01275352|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
111206929|NCT01275352|Hormone Antagonists|hormone antagonists|mesh-ancestor
111206930|NCT01275352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111206931|NCT01275352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111206932|NCT01275352|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
111206933|NCT01275352|Diuretics|diuretics|mesh-ancestor
111206934|NCT01275352|Natriuretic Agents|natriuretic agents|mesh-ancestor
111206935|NCT01275352|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111206936|NCT01676259|Paclitaxel|paclitaxel|mesh-list
111206937|NCT01676259|Gemcitabine|gemcitabine|mesh-list
111206938|NCT01676259|Folfirinox|folfirinox|mesh-list
111206939|NCT01676259|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111206940|NCT01676259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111206941|NCT01676259|Tubulin Modulators|tubulin modulators|mesh-ancestor
111206942|NCT01676259|Antimitotic Agents|antimitotic agents|mesh-ancestor
111206943|NCT01676259|Mitosis Modulators|mitosis modulators|mesh-ancestor
111206944|NCT01676259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111206945|NCT01676259|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111206946|NCT01676259|Antimetabolites|antimetabolites|mesh-ancestor
111206947|NCT02662257|Propofol|propofol|mesh-list
111206948|NCT02662257|Sevoflurane|sevoflurane|mesh-list
111206949|NCT02662257|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111206950|NCT02662257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111206951|NCT02662257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111206952|NCT02662257|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111206953|NCT02662257|Anesthetics, General|anesthetics, general|mesh-ancestor
111206954|NCT02662257|Anesthetics|anesthetics|mesh-ancestor
111206955|NCT02662257|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111206956|NCT02662257|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111206957|NCT03153267|Doxycycline|doxycycline|mesh-list
111206958|NCT03153267|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111206959|NCT03153267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111206960|NCT03153267|Antimalarials|antimalarials|mesh-ancestor
111206961|NCT03153267|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111206962|NCT03153267|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111206963|NCT00746512|Prednisone|prednisone|mesh-list
111206964|NCT00746512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110947645|NCT02453282|Tubulin Modulators|tubulin modulators|mesh-ancestor
110947646|NCT02453282|Antimitotic Agents|antimitotic agents|mesh-ancestor
110947647|NCT02453282|Mitosis Modulators|mitosis modulators|mesh-ancestor
110947648|NCT02453282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110947649|NCT02453282|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110947650|NCT02453282|Antimetabolites|antimetabolites|mesh-ancestor
110947651|NCT02453282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110947652|NCT02453282|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111206965|NCT00746512|Glucocorticoids|glucocorticoids|mesh-ancestor
111206966|NCT00746512|Hormones|hormones|mesh-ancestor
111206967|NCT00746512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111206968|NCT00746512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111206969|NCT00746512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111206970|NCT00746512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111206971|NCT05409027|Cortisone|cortisone|mesh-list
111206972|NCT05409027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
111206973|NCT05409027|Glucocorticoids|glucocorticoids|mesh-list
111206974|NCT05409027|Hormones|hormones|mesh-ancestor
111206975|NCT05409027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111206976|NCT05409027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111206977|NCT01982435|Ranibizumab|ranibizumab|mesh-list
111206978|NCT01982435|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111206979|NCT01982435|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111206980|NCT01982435|Growth Substances|growth substances|mesh-ancestor
111206981|NCT01982435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111206982|NCT01982435|Growth Inhibitors|growth inhibitors|mesh-ancestor
111206983|NCT01982435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111206984|NCT00747214|Prednisolone|prednisolone|mesh-list
111206985|NCT00747214|Antirheumatic Agents|antirheumatic agents|mesh-list
111206986|NCT00747214|Dipyridamole|dipyridamole|mesh-list
111206987|NCT00747214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111206988|NCT00747214|Glucocorticoids|glucocorticoids|mesh-ancestor
111206989|NCT00747214|Hormones|hormones|mesh-ancestor
111206990|NCT00747214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111206991|NCT00747214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111206992|NCT00747214|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111206993|NCT00747214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111206994|NCT00747214|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111206995|NCT00747214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111206996|NCT00747214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111206997|NCT00747214|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111206998|NCT00747214|Vasodilator Agents|vasodilator agents|mesh-ancestor
111206999|NCT00753142|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
111207000|NCT00753142|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
111207001|NCT00753142|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
111207002|NCT00753142|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111207003|NCT01279876|Melatonin|melatonin|mesh-list
111207004|NCT01279876|Antioxidants|antioxidants|mesh-ancestor
111207005|NCT01279876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111207006|NCT01279876|Protective Agents|protective agents|mesh-ancestor
111207007|NCT01279876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111207008|NCT01279876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111207009|NCT01996709|Hydrogen Peroxide|hydrogen peroxide|mesh-list
111207010|NCT01996709|Contact Lens Solutions|contact lens solutions|mesh-list
111207011|NCT01996709|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111207012|NCT01996709|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111207013|NCT01996709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111207014|NCT01996709|Disinfectants|disinfectants|mesh-ancestor
111207015|NCT00753220|Cyclophosphamide|cyclophosphamide|mesh-list
111207016|NCT00753220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111207017|NCT00753220|Immunologic Factors|immunologic factors|mesh-ancestor
111207018|NCT00753220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111207019|NCT00753220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111207020|NCT00753220|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111207021|NCT00753220|Alkylating Agents|alkylating agents|mesh-ancestor
111207022|NCT00753220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111207023|NCT00753220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111207024|NCT00753220|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111207025|NCT01279954|Abatacept|abatacept|mesh-list
111207026|NCT01279954|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110947761|NCT02156739|Edetic Acid|edetic acid|mesh-list
110947762|NCT02156739|Pentetic Acid|pentetic acid|mesh-list
110947763|NCT02156739|Antidotes|antidotes|mesh-ancestor
110947764|NCT02156739|Protective Agents|protective agents|mesh-ancestor
110947765|NCT02156739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110947766|NCT02156739|Chelating Agents|chelating agents|mesh-ancestor
110947767|NCT02156739|Sequestering Agents|sequestering agents|mesh-ancestor
110947768|NCT02156739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110947769|NCT02156739|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110947770|NCT02156739|Anticoagulants|anticoagulants|mesh-ancestor
110947771|NCT02156739|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110947772|NCT02139397|Eflornithine|eflornithine|mesh-list
111207027|NCT01279954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111207028|NCT01279954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111207029|NCT01279954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111207030|NCT01279954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111207032|NCT01279954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111207033|NCT01279954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111207034|NCT00763048|Triclosan|triclosan|mesh-list
111207035|NCT00763048|Fluorides|fluorides|mesh-list
111207036|NCT00763048|Cariostatic Agents|cariostatic agents|mesh-ancestor
111207037|NCT00763048|Protective Agents|protective agents|mesh-ancestor
111207038|NCT00763048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111207039|NCT00763048|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111207040|NCT00763048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111207041|NCT00763048|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
111207042|NCT00763048|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111207043|NCT00763048|Antimetabolites|antimetabolites|mesh-ancestor
111207044|NCT00763048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111207045|NCT00763048|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111207046|NCT01278394|Tavaborole|tavaborole|mesh-list
111207047|NCT01278394|Antifungal Agents|antifungal agents|mesh-ancestor
111207048|NCT01278394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111207049|NCT00240916|Vaccines|vaccines|mesh-list
111207050|NCT00240916|Immunologic Factors|immunologic factors|mesh-ancestor
111207051|NCT00240916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111207052|NCT01278160|Insulin|insulin|mesh-list
111207053|NCT01278160|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111207054|NCT01278160|Metformin|metformin|mesh-list
111207055|NCT01278160|Insulin Aspart|insulin aspart|mesh-list
111207056|NCT01278160|Insulin, Long-Acting|insulin, long-acting|mesh-list
111207057|NCT01278160|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
111207058|NCT01278160|Biphasic Insulins|biphasic insulins|mesh-list
111207059|NCT01278160|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
111207060|NCT01278160|Insulin, Isophane|insulin, isophane|mesh-list
111207061|NCT01278160|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111207062|NCT01278160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111207063|NCT00748072|Vasopressins|vasopressins|mesh-list
111207064|NCT00748072|Hemostatics|hemostatics|mesh-ancestor
111207065|NCT00748072|Coagulants|coagulants|mesh-ancestor
111207066|NCT00748072|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111207067|NCT00748072|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
111207068|NCT00748072|Natriuretic Agents|natriuretic agents|mesh-ancestor
111207069|NCT00748072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111207070|NCT01835587|Cc-486|cc-486|mesh-list
111207071|NCT01835587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111207072|NCT01736917|Dexamethasone|dexamethasone|mesh-list
111207073|NCT01736917|Fosaprepitant|fosaprepitant|mesh-list
111207074|NCT01736917|Aprepitant|aprepitant|mesh-list
111207075|NCT01736917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111207076|NCT01736917|Antiemetics|antiemetics|mesh-ancestor
111207077|NCT01736917|Autonomic Agents|autonomic agents|mesh-ancestor
111207078|NCT01736917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111207079|NCT01736917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111207080|NCT01736917|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111207081|NCT01736917|Glucocorticoids|glucocorticoids|mesh-ancestor
111207082|NCT01736917|Hormones|hormones|mesh-ancestor
111207083|NCT01736917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111207084|NCT01736917|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111207085|NCT01736917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110665251|NCT00802451|Mesalamine|mesalamine|mesh-list
110947802|NCT02031419|Rituximab|rituximab|mesh-list
110947803|NCT02031419|Spebrutinib|spebrutinib|mesh-list
110947804|NCT02031419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110947805|NCT02031419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110947806|NCT02031419|Immunologic Factors|immunologic factors|mesh-ancestor
110947807|NCT02031419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110947808|NCT02031419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110947809|NCT02031419|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110947810|NCT02031419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110947811|NCT02031419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110947866|NCT01996865|Rituximab|rituximab|mesh-list
110947867|NCT01996865|Lenalidomide|lenalidomide|mesh-list
110947868|NCT01996865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110947869|NCT01996865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111207086|NCT01736917|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
111207087|NCT01736917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111207088|NCT01736917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111207089|NCT01277302|Ranibizumab|ranibizumab|mesh-list
111207090|NCT01277302|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111207091|NCT01277302|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111207092|NCT01277302|Growth Substances|growth substances|mesh-ancestor
111207093|NCT01277302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111207094|NCT01277302|Growth Inhibitors|growth inhibitors|mesh-ancestor
111207095|NCT01277302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111207096|NCT04414579|Insulin|insulin|mesh-list
111207097|NCT04414579|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111207098|NCT04414579|Insulin Aspart|insulin aspart|mesh-list
111207099|NCT04414579|Insulin, Long-Acting|insulin, long-acting|mesh-list
111207100|NCT04414579|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
111207101|NCT04414579|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111207102|NCT04414579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111207103|NCT01980875|Obinutuzumab|obinutuzumab|mesh-list
111207104|NCT01980875|Idelalisib|idelalisib|mesh-list
111207105|NCT01980875|Chlorambucil|chlorambucil|mesh-list
111207106|NCT01980875|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111207107|NCT01980875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111207108|NCT01980875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111207109|NCT01980875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111207110|NCT01980875|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111207111|NCT01980875|Alkylating Agents|alkylating agents|mesh-ancestor
111207112|NCT01967225|Linezolid|linezolid|mesh-list
111207113|NCT01967225|Tedizolid|tedizolid|mesh-list
111207114|NCT01967225|Tedizolid phosphate|tedizolid phosphate|mesh-list
111207115|NCT01967225|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111207116|NCT01967225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111207117|NCT01967225|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111207118|NCT01967225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111207119|NCT01967225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111207120|NCT01967147|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111207121|NCT01967147|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111207122|NCT01790503|Temozolomide|temozolomide|mesh-list
111207123|NCT01790503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111207124|NCT01790503|Alkylating Agents|alkylating agents|mesh-ancestor
111320768|NCT02285283|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111207125|NCT01790503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111207126|NCT01790503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111207127|NCT01765543|Rifampin|rifampin|mesh-list
111207128|NCT01765543|Vemurafenib|vemurafenib|mesh-list
111207129|NCT01765543|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111207130|NCT01765543|Antitubercular Agents|antitubercular agents|mesh-ancestor
111207131|NCT01765543|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111207132|NCT01765543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111207133|NCT01765543|Leprostatic Agents|leprostatic agents|mesh-ancestor
111207134|NCT01765543|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111207135|NCT01765543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111207136|NCT01765543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111207137|NCT01765543|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111207138|NCT01765543|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111207139|NCT01765543|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
111207140|NCT01765543|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
111207141|NCT01765543|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
111207142|NCT01765543|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111207143|NCT01765543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111207144|NCT01765543|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111207145|NCT00248170|Letrozole|letrozole|mesh-list
111207146|NCT00248170|Anastrozole|anastrozole|mesh-list
111207147|NCT00248170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111207148|NCT00248170|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111207149|NCT00248170|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111207150|NCT00248170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111207151|NCT00248170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111207152|NCT00248170|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111207153|NCT00248170|Hormone Antagonists|hormone antagonists|mesh-ancestor
110947870|NCT01996865|Immunologic Factors|immunologic factors|mesh-ancestor
110947871|NCT01996865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110947872|NCT01996865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110947873|NCT01996865|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110947874|NCT01996865|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110947876|NCT01996865|Growth Inhibitors|growth inhibitors|mesh-ancestor
110947888|NCT01920932|Prednisone|prednisone|mesh-list
110947889|NCT01920932|Prednisolone|prednisolone|mesh-list
111207154|NCT00248170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111207155|NCT00248170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111207156|NCT00248170|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111207157|NCT01764997|Adalimumab|adalimumab|mesh-list
111207158|NCT01764997|Etanercept|etanercept|mesh-list
111207159|NCT01764997|Methotrexate|methotrexate|mesh-list
111207160|NCT01764997|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111207161|NCT01764997|Abortifacient Agents|abortifacient agents|mesh-ancestor
111207162|NCT01764997|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111207163|NCT01764997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111207164|NCT01764997|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111207165|NCT01764997|Antimetabolites|antimetabolites|mesh-ancestor
111207166|NCT01764997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111207167|NCT01764997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111207168|NCT01764997|Dermatologic Agents|dermatologic agents|mesh-ancestor
111207169|NCT01764997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111207170|NCT01764997|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111207171|NCT01764997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111207172|NCT01764997|Immunologic Factors|immunologic factors|mesh-ancestor
111207173|NCT01764997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111207174|NCT01764997|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111207175|NCT01764997|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111207176|NCT01764997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111207177|NCT01764997|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111207178|NCT01764997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111207179|NCT01764997|Analgesics|analgesics|mesh-ancestor
111207180|NCT01764997|Sensory System Agents|sensory system agents|mesh-ancestor
111207181|NCT01764997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111207182|NCT01764997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111207183|NCT01276756|Interferons|interferons|mesh-list
111207184|NCT01276756|Ribavirin|ribavirin|mesh-list
111207185|NCT01276756|Interferon-alpha|interferon-alpha|mesh-list
111207186|NCT01276756|Interferon alpha-2|interferon alpha-2|mesh-list
111207187|NCT01276756|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
111207188|NCT01276756|Nitazoxanide|nitazoxanide|mesh-list
111207189|NCT01276756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111207190|NCT01276756|Antiviral Agents|antiviral agents|mesh-ancestor
111207191|NCT01276756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111207192|NCT01276756|Antimetabolites|antimetabolites|mesh-ancestor
111207193|NCT01276756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111207194|NCT01276756|Immunologic Factors|immunologic factors|mesh-ancestor
111207195|NCT01276756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111207196|NCT01276756|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111207197|NCT00246376|Niacin|niacin|mesh-list
111207198|NCT00246376|Fenofibrate|fenofibrate|mesh-list
111207199|NCT00246376|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111207200|NCT00246376|Antimetabolites|antimetabolites|mesh-ancestor
111207201|NCT00246376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111207202|NCT00246376|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111207203|NCT00246376|Vasodilator Agents|vasodilator agents|mesh-ancestor
111207204|NCT00246376|Vitamin B Complex|vitamin b complex|mesh-ancestor
111207205|NCT00246376|Vitamins|vitamins|mesh-ancestor
111207206|NCT00246376|Micronutrients|micronutrients|mesh-ancestor
111207207|NCT00246376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111207208|NCT03806062|Domperidone|domperidone|mesh-list
111207209|NCT03806062|Antiemetics|antiemetics|mesh-ancestor
110665392|NCT00794807|Alefacept|alefacept|mesh-list
110947953|NCT01505608|Irinotecan|irinotecan|mesh-list
110947954|NCT01505608|Temozolomide|temozolomide|mesh-list
110947955|NCT01505608|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110947956|NCT01505608|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110947957|NCT01505608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110947958|NCT01505608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110947959|NCT01505608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110947960|NCT01505608|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110947961|NCT01505608|Alkylating Agents|alkylating agents|mesh-ancestor
110947974|NCT01491893|Vaccines|vaccines|mesh-list
110947975|NCT01491893|Immunologic Factors|immunologic factors|mesh-ancestor
110947976|NCT01491893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110947980|NCT01364597|Brivaracetam|brivaracetam|mesh-list
110947981|NCT01364597|Anticonvulsants|anticonvulsants|mesh-ancestor
110947991|NCT01143766|Gabapentin|gabapentin|mesh-list
110947992|NCT01143766|Analgesics|analgesics|mesh-ancestor
110947993|NCT01143766|Sensory System Agents|sensory system agents|mesh-ancestor
110947994|NCT01143766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110947996|NCT01143766|Anticonvulsants|anticonvulsants|mesh-ancestor
111207210|NCT03806062|Autonomic Agents|autonomic agents|mesh-ancestor
111207211|NCT03806062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111207212|NCT03806062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111207213|NCT03806062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111207214|NCT03806062|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111207215|NCT03806062|Dopamine Agents|dopamine agents|mesh-ancestor
111207216|NCT03806062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111207217|NCT03806062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111207218|NCT00754546|Formoterol Fumarate|formoterol fumarate|mesh-list
111207219|NCT00754546|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111207220|NCT00754546|Autonomic Agents|autonomic agents|mesh-ancestor
111207221|NCT00754546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111207222|NCT00754546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111207223|NCT00754546|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111207224|NCT00754546|Respiratory System Agents|respiratory system agents|mesh-ancestor
111207225|NCT00754546|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111207226|NCT00754546|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111207227|NCT00754546|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111207228|NCT00754546|Adrenergic Agents|adrenergic agents|mesh-ancestor
111207229|NCT00754546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111207230|NCT00754546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111207231|NCT01764841|Ciprofloxacin|ciprofloxacin|mesh-list
111207232|NCT01764841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111207233|NCT01764841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111207234|NCT01764841|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111207235|NCT01764841|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111207236|NCT01764841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111207237|NCT01764841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111207238|NCT01764841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111207239|NCT01764841|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111207240|NCT01764841|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111207241|NCT00245050|Pyridoxine|pyridoxine|mesh-list
111207242|NCT00245050|Vitamin B 6|vitamin b 6|mesh-list
111207243|NCT00245050|Doxorubicin|doxorubicin|mesh-list
111207244|NCT00245050|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111207245|NCT00245050|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111207246|NCT00245050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111207247|NCT00245050|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111207248|NCT00245050|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111207249|NCT00245050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111207250|NCT00245050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111207251|NCT00245050|Vitamin B Complex|vitamin b complex|mesh-ancestor
111207252|NCT00245050|Vitamins|vitamins|mesh-ancestor
111207253|NCT00245050|Micronutrients|micronutrients|mesh-ancestor
111207254|NCT00245050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111207255|NCT04345588|Dexamethasone|dexamethasone|mesh-list
111207256|NCT04345588|Dexamethasone acetate|dexamethasone acetate|mesh-list
111207257|NCT04345588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111207258|NCT04345588|Antiemetics|antiemetics|mesh-ancestor
111207259|NCT04345588|Autonomic Agents|autonomic agents|mesh-ancestor
111207260|NCT04345588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111207261|NCT04345588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111207262|NCT04345588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111207263|NCT04345588|Glucocorticoids|glucocorticoids|mesh-ancestor
111207264|NCT04345588|Hormones|hormones|mesh-ancestor
111207265|NCT04345588|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111207266|NCT04345588|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111207267|NCT04345588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111207268|NCT03806374|Lidocaine|lidocaine|mesh-list
111207269|NCT03806374|Fentanyl|fentanyl|mesh-list
111207270|NCT03806374|Ketamine|ketamine|mesh-list
111207271|NCT03806374|Propofol|propofol|mesh-list
111207272|NCT03806374|Cisatracurium|cisatracurium|mesh-list
111207273|NCT03806374|Anesthetics, Local|anesthetics, local|mesh-ancestor
111207274|NCT03806374|Anesthetics|anesthetics|mesh-ancestor
111207275|NCT03806374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111207276|NCT03806374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110948021|NCT01106898|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110948022|NCT01106898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110948023|NCT01059071|Eflornithine|eflornithine|mesh-list
110948025|NCT01059071|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110948026|NCT01059071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110948027|NCT01059071|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110948028|NCT01059071|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110948029|NCT01059071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111207277|NCT03806374|Sensory System Agents|sensory system agents|mesh-ancestor
111207278|NCT03806374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111207279|NCT03806374|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111207280|NCT03806374|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111207281|NCT03806374|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111207282|NCT03806374|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111207283|NCT03806374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111207284|NCT03806374|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111207285|NCT03806374|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111207286|NCT03806374|Anesthetics, General|anesthetics, general|mesh-ancestor
111207287|NCT03806374|Analgesics|analgesics|mesh-ancestor
111207288|NCT03806374|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111207289|NCT03806374|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111207290|NCT03806374|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111207291|NCT03806374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111207292|NCT03806374|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111207293|NCT03806374|Narcotics|narcotics|mesh-ancestor
111207294|NCT03806374|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111207295|NCT03806374|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
111207296|NCT03806374|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111207297|NCT00763360|Hyaluronic Acid|hyaluronic acid|mesh-list
111207298|NCT00763360|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111207299|NCT00763360|Immunologic Factors|immunologic factors|mesh-ancestor
111207300|NCT00763360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111207301|NCT00763360|Viscosupplements|viscosupplements|mesh-ancestor
111207302|NCT00763360|Protective Agents|protective agents|mesh-ancestor
111207303|NCT00756106|Temozolomide|temozolomide|mesh-list
111207304|NCT00756106|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111207305|NCT00756106|Alkylating Agents|alkylating agents|mesh-ancestor
111207306|NCT00756106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111207307|NCT00756106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111207308|NCT00243412|Methylprednisolone|methylprednisolone|mesh-list
111207309|NCT00243412|Rituximab|rituximab|mesh-list
111207310|NCT00243412|Methotrexate|methotrexate|mesh-list
111207311|NCT00243412|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111207312|NCT00243412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111207313|NCT00243412|Immunologic Factors|immunologic factors|mesh-ancestor
111207314|NCT00243412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111207315|NCT00243412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111207316|NCT00243412|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111207317|NCT00243412|Abortifacient Agents|abortifacient agents|mesh-ancestor
111207318|NCT00243412|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111207319|NCT00243412|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111207320|NCT00243412|Antimetabolites|antimetabolites|mesh-ancestor
111207321|NCT00243412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111207322|NCT00243412|Dermatologic Agents|dermatologic agents|mesh-ancestor
111207323|NCT00243412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111207324|NCT00243412|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111207325|NCT00243412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111207326|NCT00243412|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111207327|NCT00243412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111207328|NCT00243412|Antiemetics|antiemetics|mesh-ancestor
111207329|NCT00243412|Autonomic Agents|autonomic agents|mesh-ancestor
111207330|NCT00243412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111207331|NCT00243412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111207332|NCT00243412|Glucocorticoids|glucocorticoids|mesh-ancestor
111207333|NCT00243412|Hormones|hormones|mesh-ancestor
111207334|NCT00243412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111207335|NCT00243412|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111207336|NCT00243412|Protective Agents|protective agents|mesh-ancestor
111207337|NCT00765232|Ketorolac|ketorolac|mesh-list
111207338|NCT00765232|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110948108|NCT00601003|Nifurtimox|nifurtimox|mesh-list
110948109|NCT00601003|Cyclophosphamide|cyclophosphamide|mesh-list
110948110|NCT00601003|Topotecan|topotecan|mesh-list
110948111|NCT00601003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110948112|NCT00601003|Immunologic Factors|immunologic factors|mesh-ancestor
110948113|NCT00601003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110948114|NCT00601003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110948115|NCT00601003|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110948116|NCT00601003|Alkylating Agents|alkylating agents|mesh-ancestor
110948117|NCT00601003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110948118|NCT00601003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110948119|NCT00601003|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110948121|NCT00601003|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111207339|NCT00765232|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111207340|NCT00765232|Analgesics|analgesics|mesh-ancestor
111207341|NCT00765232|Sensory System Agents|sensory system agents|mesh-ancestor
111207342|NCT00765232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111207343|NCT00765232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111207344|NCT00765232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111207345|NCT00765232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111207346|NCT00765232|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111207347|NCT00765232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111207348|NCT00765232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111207349|NCT03805282|Lidocaine|lidocaine|mesh-list
111207350|NCT03805282|Anesthetics, Local|anesthetics, local|mesh-ancestor
111207351|NCT03805282|Anesthetics|anesthetics|mesh-ancestor
111207352|NCT03805282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111207353|NCT03805282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111207354|NCT03805282|Sensory System Agents|sensory system agents|mesh-ancestor
111207355|NCT03805282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111207356|NCT03805282|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111207357|NCT03805282|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111207358|NCT03805282|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111207359|NCT03805282|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111207360|NCT03805282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111207361|NCT03805750|Dronabinol|dronabinol|mesh-list
111207362|NCT03805750|Cannabidiol|cannabidiol|mesh-list
111207363|NCT03805750|Anticonvulsants|anticonvulsants|mesh-ancestor
111207364|NCT03805750|Hallucinogens|hallucinogens|mesh-ancestor
111207365|NCT03805750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111207366|NCT03805750|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111207367|NCT03805750|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111207368|NCT03805750|Analgesics|analgesics|mesh-ancestor
111207369|NCT03805750|Sensory System Agents|sensory system agents|mesh-ancestor
111207370|NCT03805750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111207371|NCT03805750|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
111207372|NCT03805750|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
111207373|NCT03805750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111320769|NCT02285283|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111207374|NCT03805750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111207375|NCT03805750|Hormones|hormones|mesh-ancestor
111207376|NCT03805750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111207377|NCT03804268|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111207378|NCT03804268|Pilocarpine|pilocarpine|mesh-list
111207379|NCT03804268|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111207380|NCT03804268|Miotics|miotics|mesh-ancestor
111207381|NCT03804268|Autonomic Agents|autonomic agents|mesh-ancestor
111207382|NCT03804268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111207383|NCT03804268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111207384|NCT03804268|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
111207385|NCT03804268|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111207386|NCT03804268|Cholinergic Agents|cholinergic agents|mesh-ancestor
111207387|NCT03804268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111207388|NCT03804268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111207389|NCT00765856|Oxymorphone|oxymorphone|mesh-list
110665765|NCT02552459|Analgesics|analgesics|mesh-ancestor
110665920|NCT00809237|Hydroxychloroquine|hydroxychloroquine|mesh-list
110666296|NCT01046578|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110667357|NCT00467649|Insulin|insulin|mesh-list
110667429|NCT02551367|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110667504|NCT01566279|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110667650|NCT01024647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110668255|NCT01028547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110668555|NCT00424827|Gemcitabine|gemcitabine|mesh-list
110668714|NCT00436917|Zoledronic Acid|zoledronic acid|mesh-list
110669388|NCT05889442|Cromakalim|cromakalim|mesh-list
110669465|NCT05888922|Minoxidil|minoxidil|mesh-list
110669686|NCT05465135|Artenimol|artenimol|mesh-list
110669830|NCT04736953|Sirolimus|sirolimus|mesh-list
110669904|NCT04583969|Remdesivir|remdesivir|mesh-list
110670058|NCT04219280|Methylphenidate|methylphenidate|mesh-list
110670204|NCT03764098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110670354|NCT03125642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110670436|NCT02735707|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
110670968|NCT00824135|Rituximab|rituximab|mesh-list
110660291|NCT00990678|Calcium|calcium|mesh-list
110660292|NCT00990678|Vitamins|vitamins|mesh-ancestor
110660293|NCT00990678|Micronutrients|micronutrients|mesh-ancestor
110660294|NCT00990678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110660295|NCT00990678|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110660301|NCT00538590|Mitomycins|mitomycins|mesh-list
111207390|NCT00765856|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111207391|NCT00765856|Narcotics|narcotics|mesh-ancestor
111207392|NCT00765856|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111207393|NCT00765856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111207394|NCT00765856|Analgesics|analgesics|mesh-ancestor
111207395|NCT00765856|Sensory System Agents|sensory system agents|mesh-ancestor
111207396|NCT00765856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111207397|NCT00765856|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111207398|NCT00780208|Methylphenidate|methylphenidate|mesh-list
111207399|NCT00780208|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111207400|NCT00780208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111207401|NCT00780208|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111207402|NCT00780208|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111207403|NCT00780208|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111207404|NCT00780208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111207405|NCT00780208|Dopamine Agents|dopamine agents|mesh-ancestor
111207406|NCT00780208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111207407|NCT00243022|Vitamin B 12|vitamin b 12|mesh-list
111207408|NCT00243022|Hydroxocobalamin|hydroxocobalamin|mesh-list
111207409|NCT00243022|Vitamins|vitamins|mesh-ancestor
111207410|NCT00243022|Micronutrients|micronutrients|mesh-ancestor
111207411|NCT00243022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111207412|NCT00243022|Vitamin B Complex|vitamin b complex|mesh-ancestor
111207413|NCT00243022|Hematinics|hematinics|mesh-ancestor
111207414|NCT03805360|Ropivacaine|ropivacaine|mesh-list
111207415|NCT03805360|Anesthetics, Local|anesthetics, local|mesh-list
111207416|NCT03805360|Anesthetics|anesthetics|mesh-list
111207417|NCT03805360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111207418|NCT03805360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111207419|NCT03805360|Sensory System Agents|sensory system agents|mesh-ancestor
111207420|NCT03805360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111207421|NCT00756964|Rasburicase|rasburicase|mesh-list
111207422|NCT00756964|Gout Suppressants|gout suppressants|mesh-ancestor
111207423|NCT00756964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111207424|NCT00780442|Cycloserine|cycloserine|mesh-list
111207425|NCT00780442|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111207426|NCT00780442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111207427|NCT00780442|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111207428|NCT00780442|Antitubercular Agents|antitubercular agents|mesh-ancestor
111207429|NCT00780442|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111207430|NCT00780442|Antimetabolites|antimetabolites|mesh-ancestor
111207431|NCT00780442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111207432|NCT04384666|Rotigotine|rotigotine|mesh-list
111207433|NCT04384666|Dopamine Agonists|dopamine agonists|mesh-ancestor
111207434|NCT04384666|Dopamine Agents|dopamine agents|mesh-ancestor
111207435|NCT04384666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111207436|NCT04384666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111207437|NCT04384666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111207438|NCT00767572|Atorvastatin|atorvastatin|mesh-list
111207439|NCT00767572|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111207440|NCT00767572|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111207441|NCT00767572|Antimetabolites|antimetabolites|mesh-ancestor
111207442|NCT00767572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111207443|NCT00767572|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111207444|NCT00767572|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111207445|NCT00767572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111207446|NCT00780676|Dasatinib|dasatinib|mesh-list
111207447|NCT00780676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111207448|NCT00780676|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111207449|NCT00780676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111207450|NCT00780676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111207451|NCT00768118|Curcumin|curcumin|mesh-list
111207452|NCT00768118|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111207453|NCT00768118|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111207454|NCT00768118|Analgesics|analgesics|mesh-ancestor
111207455|NCT00768118|Sensory System Agents|sensory system agents|mesh-ancestor
111207456|NCT00768118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111207457|NCT00768118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111207458|NCT00768118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111207459|NCT00768118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111207460|NCT00768118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111207461|NCT00768118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111207462|NCT00768118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111207463|NCT04345432|Gabapentin|gabapentin|mesh-list
111207464|NCT04345432|Analgesics|analgesics|mesh-ancestor
111207465|NCT04345432|Sensory System Agents|sensory system agents|mesh-ancestor
111207466|NCT04345432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111207467|NCT04345432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111207468|NCT04345432|Anticonvulsants|anticonvulsants|mesh-ancestor
111207469|NCT04345432|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111207470|NCT04345432|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111207471|NCT04345432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111207472|NCT04345432|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111207473|NCT04345432|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111207474|NCT04345432|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111207475|NCT04345432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111207476|NCT04345432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111207477|NCT04345432|Antimanic Agents|antimanic agents|mesh-ancestor
111207478|NCT00757822|Dronabinol|dronabinol|mesh-list
111207479|NCT00757822|Ondansetron|ondansetron|mesh-list
111207480|NCT00757822|Antiemetics|antiemetics|mesh-ancestor
111207481|NCT00757822|Autonomic Agents|autonomic agents|mesh-ancestor
111207482|NCT00757822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111207483|NCT00757822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111207484|NCT00757822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111207485|NCT00757822|Antipruritics|antipruritics|mesh-ancestor
111207486|NCT00757822|Dermatologic Agents|dermatologic agents|mesh-ancestor
111207487|NCT00757822|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111207488|NCT00757822|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111207489|NCT00757822|Serotonin Agents|serotonin agents|mesh-ancestor
111207490|NCT00757822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111207491|NCT00757822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111207492|NCT00757822|Hallucinogens|hallucinogens|mesh-ancestor
111207493|NCT00757822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111207494|NCT00757822|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111207495|NCT00757822|Analgesics|analgesics|mesh-ancestor
111207496|NCT00757822|Sensory System Agents|sensory system agents|mesh-ancestor
111207497|NCT00757822|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
111207498|NCT00757822|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
111207499|NCT00757822|Hormones|hormones|mesh-ancestor
111207500|NCT00757822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111207501|NCT00758836|Acetaminophen|acetaminophen|mesh-list
111207502|NCT00758836|Ibuprofen|ibuprofen|mesh-list
111207503|NCT00758836|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111207504|NCT00758836|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111207505|NCT00758836|Analgesics|analgesics|mesh-ancestor
111207506|NCT00758836|Sensory System Agents|sensory system agents|mesh-ancestor
111207507|NCT00758836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111207508|NCT00758836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111207509|NCT00758836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111207510|NCT00758836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111207511|NCT00758836|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111207512|NCT00758836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111207513|NCT00758836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111207514|NCT00758836|Antipyretics|antipyretics|mesh-ancestor
111207515|NCT00769600|Itraconazole|itraconazole|mesh-list
111207516|NCT00769600|Pemetrexed|pemetrexed|mesh-list
111207517|NCT00769600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111207518|NCT00769600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111207519|NCT00769600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111207520|NCT00769600|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111207521|NCT00769600|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111207522|NCT00769600|Antifungal Agents|antifungal agents|mesh-ancestor
111207523|NCT00769600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111207524|NCT00769600|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111207525|NCT00769600|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111207526|NCT00769600|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111207527|NCT00769600|Hormone Antagonists|hormone antagonists|mesh-ancestor
111207528|NCT00769600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111207529|NCT00769600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111207530|NCT00769600|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111207531|NCT03809650|Macitentan|macitentan|mesh-list
111207532|NCT03809650|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
111207533|NCT03809650|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
111207534|NCT03809650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111207535|NCT03809650|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
110671380|NCT00356278|Alprazolam|alprazolam|mesh-list
110660399|NCT00079183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111207536|NCT03809260|Metformin|metformin|mesh-list
111207537|NCT03809260|Vancomycin|vancomycin|mesh-list
111207538|NCT03809260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111207539|NCT03809260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111207540|NCT03809260|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111207541|NCT03809260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111207542|NCT01763905|Ezetimibe|ezetimibe|mesh-list
111207543|NCT01763905|Evolocumab|evolocumab|mesh-list
111207544|NCT01763905|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111207545|NCT01763905|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111207546|NCT01763905|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111207547|NCT01763905|Antimetabolites|antimetabolites|mesh-ancestor
111207548|NCT01763905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111207549|NCT01763905|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111207550|NCT01763905|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
111207551|NCT01763905|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111207552|NCT01763905|Protease Inhibitors|protease inhibitors|mesh-ancestor
111207553|NCT01763905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111207554|NCT01763905|Immunologic Factors|immunologic factors|mesh-ancestor
111207555|NCT01763905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111207556|NCT05743504|Paclitaxel|paclitaxel|mesh-list
111207557|NCT05743504|Cisplatin|cisplatin|mesh-list
111207558|NCT05743504|Atezolizumab|atezolizumab|mesh-list
111207559|NCT05743504|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111207560|NCT05743504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111207561|NCT05743504|Tubulin Modulators|tubulin modulators|mesh-ancestor
111207562|NCT05743504|Antimitotic Agents|antimitotic agents|mesh-ancestor
111207563|NCT05743504|Mitosis Modulators|mitosis modulators|mesh-ancestor
111207564|NCT05743504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111207565|NCT05743504|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111207566|NCT05743504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111207567|NCT03803254|Lenvatinib|lenvatinib|mesh-list
111207568|NCT03803254|Antibodies|antibodies|mesh-list
111207569|NCT03803254|Immunologic Factors|immunologic factors|mesh-ancestor
111207570|NCT03803254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111207571|NCT03803254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111207572|NCT03803254|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111207573|NCT03803254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111207574|NCT03803254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111207575|NCT04730999|Bevacizumab|bevacizumab|mesh-list
111207576|NCT04730999|Atezolizumab|atezolizumab|mesh-list
111207577|NCT04730999|Carboplatin|carboplatin|mesh-list
111207578|NCT04730999|Etoposide|etoposide|mesh-list
111207579|NCT04730999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111207580|NCT04730999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111207581|NCT04730999|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111207582|NCT04730999|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111207583|NCT04730999|Growth Substances|growth substances|mesh-ancestor
111207584|NCT04730999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111207585|NCT04730999|Growth Inhibitors|growth inhibitors|mesh-ancestor
111207586|NCT04730999|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111207587|NCT04730999|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111207588|NCT04730999|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111207589|NCT04730999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111207590|NCT04730999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111207591|NCT04730999|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111207592|NCT00759772|Teriparatide|teriparatide|mesh-list
111207593|NCT00759772|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111207594|NCT00759772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111207595|NCT00759772|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111207596|NCT01977677|Plerixafor|plerixafor|mesh-list
111207597|NCT01977677|Temozolomide|temozolomide|mesh-list
111207598|NCT01977677|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111207599|NCT01977677|Alkylating Agents|alkylating agents|mesh-ancestor
111207600|NCT01977677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111207601|NCT01977677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111207602|NCT01977677|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111207603|NCT01977677|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111207604|NCT01977677|Antiviral Agents|antiviral agents|mesh-ancestor
111207605|NCT01977677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111207606|NCT04384744|Hormones|hormones|mesh-list
111207607|NCT04384744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111207608|NCT04384744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111207609|NCT01736215|Epoetin Alfa|epoetin alfa|mesh-list
110671409|NCT00837941|Anticonvulsants|anticonvulsants|mesh-ancestor
110660472|NCT00077857|Antimetabolites|antimetabolites|mesh-ancestor
111207610|NCT01736215|Hematinics|hematinics|mesh-ancestor
111207611|NCT01786603|Rasagiline|rasagiline|mesh-list
111207612|NCT01786603|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
111207613|NCT01786603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111207614|NCT01786603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111207615|NCT01786603|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111207616|NCT01786603|Protective Agents|protective agents|mesh-ancestor
111207617|NCT01786603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111207618|NCT00786916|Lidocaine|lidocaine|mesh-list
111207619|NCT00786916|Anesthetics, Local|anesthetics, local|mesh-ancestor
111207620|NCT00786916|Anesthetics|anesthetics|mesh-ancestor
111207621|NCT00786916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111207622|NCT00786916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111207623|NCT00786916|Sensory System Agents|sensory system agents|mesh-ancestor
111207624|NCT00786916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111207625|NCT00786916|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111207626|NCT00786916|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111207627|NCT00786916|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111207628|NCT00786916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111207629|NCT00786916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111207630|NCT04414267|Vaccines|vaccines|mesh-list
111207631|NCT04414267|BCG Vaccine|bcg vaccine|mesh-list
111207632|NCT04414267|Immunologic Factors|immunologic factors|mesh-ancestor
111207633|NCT04414267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111207634|NCT04414267|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111207635|NCT01619423|Pyridoxal Phosphate|pyridoxal phosphate|mesh-list
111207636|NCT01619423|Edetic Acid|edetic acid|mesh-list
111207637|NCT01619423|Anticoagulants|anticoagulants|mesh-ancestor
111207638|NCT01619423|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
111207639|NCT01619423|Chelating Agents|chelating agents|mesh-ancestor
111207640|NCT01619423|Sequestering Agents|sequestering agents|mesh-ancestor
111207641|NCT01619423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111207642|NCT01619423|Vitamin B Complex|vitamin b complex|mesh-ancestor
111207643|NCT01619423|Vitamins|vitamins|mesh-ancestor
111207644|NCT01619423|Micronutrients|micronutrients|mesh-ancestor
111207645|NCT01619423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111207646|NCT03802552|Cephalexin|cephalexin|mesh-list
111207647|NCT03802552|Cefadroxil|cefadroxil|mesh-list
111207648|NCT03802552|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111207649|NCT03802552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111207650|NCT01735279|Mineral Oil|mineral oil|mesh-list
111207651|NCT01735279|Emollients|emollients|mesh-ancestor
111207652|NCT01735279|Dermatologic Agents|dermatologic agents|mesh-ancestor
111207653|NCT03802318|Amoxicillin|amoxicillin|mesh-list
111207654|NCT03802318|Rabeprazole|rabeprazole|mesh-list
111207655|NCT03802318|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111207656|NCT03802318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111207657|NCT03802318|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111207658|NCT03802318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111207659|NCT03802318|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111207660|NCT03802318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111207661|NCT03802318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111207662|NCT01758523|Dutasteride|dutasteride|mesh-list
111207663|NCT01758523|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
111207664|NCT01758523|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111207665|NCT01758523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111207666|NCT01758523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111207667|NCT01758523|Hormone Antagonists|hormone antagonists|mesh-ancestor
111207668|NCT01758523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111207669|NCT01758523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111207670|NCT00773422|Naltrexone|naltrexone|mesh-list
111207671|NCT00773422|Varenicline|varenicline|mesh-list
111207672|NCT00773422|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111207673|NCT00773422|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111207674|NCT00773422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111207675|NCT00773422|Sensory System Agents|sensory system agents|mesh-ancestor
111207676|NCT00773422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111207677|NCT00773422|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111207678|NCT00773422|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111207679|NCT00773422|Cholinergic Agents|cholinergic agents|mesh-ancestor
111207680|NCT00773422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111207681|NCT00773422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111207682|NCT00786994|Petrolatum|petrolatum|mesh-list
111207683|NCT00786994|Emollients|emollients|mesh-ancestor
111207684|NCT00786994|Dermatologic Agents|dermatologic agents|mesh-ancestor
111207685|NCT00774202|Prednisone|prednisone|mesh-list
111207686|NCT00774202|Cyclophosphamide|cyclophosphamide|mesh-list
111207687|NCT00774202|Rituximab|rituximab|mesh-list
111207688|NCT00774202|Vincristine|vincristine|mesh-list
111207689|NCT00774202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111207690|NCT00774202|Immunologic Factors|immunologic factors|mesh-ancestor
111207691|NCT00774202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111207692|NCT00774202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111207693|NCT00774202|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111207694|NCT00774202|Alkylating Agents|alkylating agents|mesh-ancestor
111207695|NCT00774202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111207696|NCT00774202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111207697|NCT00774202|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111207698|NCT00774202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111207699|NCT00774202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111207700|NCT00774202|Glucocorticoids|glucocorticoids|mesh-ancestor
111207701|NCT00774202|Hormones|hormones|mesh-ancestor
111207702|NCT00774202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111207703|NCT00774202|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111207704|NCT00774202|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111207705|NCT00774202|Tubulin Modulators|tubulin modulators|mesh-ancestor
111207706|NCT00774202|Antimitotic Agents|antimitotic agents|mesh-ancestor
111207707|NCT00774202|Mitosis Modulators|mitosis modulators|mesh-ancestor
111207708|NCT03808168|Nivolumab|nivolumab|mesh-list
111207709|NCT03808168|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111207710|NCT03808168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111207711|NCT03808168|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111207712|NCT03808168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111207713|NCT03802162|Memantine|memantine|mesh-list
111207714|NCT03802162|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111207715|NCT03802162|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111207716|NCT03802162|Dopamine Agents|dopamine agents|mesh-ancestor
111207717|NCT03802162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111207718|NCT03802162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111207719|NCT03802162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111207720|NCT03802162|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111207721|NCT03802162|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111207722|NCT01757275|Esomeprazole|esomeprazole|mesh-list
111207723|NCT01757275|Cimetidine|cimetidine|mesh-list
111207724|NCT01757275|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111207725|NCT01757275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111207726|NCT01757275|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111207727|NCT01757275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111207728|NCT01757275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111207729|NCT01757275|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
111207730|NCT01757275|Histamine Antagonists|histamine antagonists|mesh-ancestor
111207731|NCT01757275|Histamine Agents|histamine agents|mesh-ancestor
111207732|NCT01757275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111207733|NCT01757275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111207734|NCT01757275|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111207735|NCT01757275|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111207736|NCT00787852|Paclitaxel|paclitaxel|mesh-list
111207737|NCT00787852|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111207738|NCT00787852|Dasatinib|dasatinib|mesh-list
111207739|NCT00787852|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111207740|NCT00787852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111207741|NCT00787852|Tubulin Modulators|tubulin modulators|mesh-ancestor
111207742|NCT00787852|Antimitotic Agents|antimitotic agents|mesh-ancestor
111207743|NCT00787852|Mitosis Modulators|mitosis modulators|mesh-ancestor
111207744|NCT00787852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111207745|NCT00787852|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111207746|NCT00787852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111207747|NCT00788008|Propofol|propofol|mesh-list
111207748|NCT00788008|Isoflurane|isoflurane|mesh-list
111207749|NCT00788008|Anesthetics|anesthetics|mesh-ancestor
111207750|NCT00788008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111207751|NCT00788008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111207752|NCT00788008|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111207753|NCT00788008|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111207754|NCT00788008|Anesthetics, General|anesthetics, general|mesh-ancestor
111207755|NCT00788008|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111207756|NCT00760006|Ampicillin|ampicillin|mesh-list
111207757|NCT00760006|Sulbactam|sulbactam|mesh-list
111207758|NCT00760006|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111207759|NCT00760006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111207760|NCT00760006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111207761|NCT00760006|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
111207762|NCT00760006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111207763|NCT00760006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111207764|NCT01784965|Liraglutide|liraglutide|mesh-list
111207765|NCT01784965|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111207766|NCT01784965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111207767|NCT01784965|Incretins|incretins|mesh-ancestor
111207768|NCT01784965|Hormones|hormones|mesh-ancestor
111207769|NCT01784965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111207770|NCT05742724|Dronabinol|dronabinol|mesh-list
111207771|NCT05742724|Nabiximols|nabiximols|mesh-list
111207772|NCT05742724|Cannabidiol|cannabidiol|mesh-list
111207773|NCT05742724|Anticonvulsants|anticonvulsants|mesh-ancestor
111207774|NCT05742724|Hallucinogens|hallucinogens|mesh-ancestor
111207775|NCT05742724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111207776|NCT05742724|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111207777|NCT05742724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111207778|NCT05742724|Analgesics|analgesics|mesh-ancestor
111207779|NCT05742724|Sensory System Agents|sensory system agents|mesh-ancestor
111207780|NCT05742724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111207781|NCT05742724|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
111207782|NCT05742724|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
111207783|NCT05742724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111207784|NCT05742724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111207785|NCT05742724|Hormones|hormones|mesh-ancestor
111207786|NCT05742724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111207787|NCT01784419|Ivacaftor|ivacaftor|mesh-list
111207788|NCT01784419|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
111207789|NCT01784419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111320770|NCT02285283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111207790|NCT01784419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111207791|NCT01784029|Vitamin D|vitamin d|mesh-list
111207792|NCT01784029|Cholecalciferol|cholecalciferol|mesh-list
111207793|NCT01784029|Vitamins|vitamins|mesh-ancestor
111207794|NCT01784029|Micronutrients|micronutrients|mesh-ancestor
111207795|NCT01784029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111207796|NCT01784029|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111207797|NCT01784029|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111207798|NCT00789256|Bortezomib|bortezomib|mesh-list
111207799|NCT00789256|Melphalan|melphalan|mesh-list
111207800|NCT00789256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111207801|NCT00789256|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111207802|NCT00789256|Alkylating Agents|alkylating agents|mesh-ancestor
111207803|NCT00789256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111207804|NCT00789256|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111207805|NCT00789256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111207806|NCT00789256|Immunologic Factors|immunologic factors|mesh-ancestor
111207807|NCT00789256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111207808|NCT01733329|Folic Acid|folic acid|mesh-list
111207809|NCT01733329|Misoprostol|misoprostol|mesh-list
111207810|NCT01733329|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111207811|NCT01733329|Abortifacient Agents|abortifacient agents|mesh-ancestor
111207812|NCT01733329|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111207813|NCT01733329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111207814|NCT01733329|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111207815|NCT01733329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111207816|NCT01733329|Oxytocics|oxytocics|mesh-ancestor
111207817|NCT01733329|Hematinics|hematinics|mesh-ancestor
111207818|NCT01733329|Vitamin B Complex|vitamin b complex|mesh-ancestor
111207819|NCT01733329|Vitamins|vitamins|mesh-ancestor
111207820|NCT01733329|Micronutrients|micronutrients|mesh-ancestor
111207821|NCT02145676|Botulinum Toxins|botulinum toxins|mesh-list
111207822|NCT02145676|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111207823|NCT02145676|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111207824|NCT02145676|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111207825|NCT02145676|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111207826|NCT02145676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111207827|NCT02145676|Cholinergic Agents|cholinergic agents|mesh-ancestor
111207828|NCT02145676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111207829|NCT02145676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111207830|NCT02145676|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111207831|NCT02145676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111207832|NCT05742568|Amoxicillin|amoxicillin|mesh-list
111207833|NCT05742568|Clarithromycin|clarithromycin|mesh-list
110671633|NCT02533336|Abamectin|abamectin|mesh-list
111207834|NCT05742568|Esomeprazole|esomeprazole|mesh-list
111207835|NCT05742568|Bismuth|bismuth|mesh-list
111207836|NCT05742568|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111207837|NCT05742568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111207838|NCT05742568|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111207839|NCT05742568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111207840|NCT05742568|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111207841|NCT05742568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111207842|NCT05742568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111207843|NCT05742568|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111207844|NCT05742568|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111207845|NCT05742568|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111207847|NCT01607593|Sertraline|sertraline|mesh-list
111207848|NCT01607593|Antidepressive Agents|antidepressive agents|mesh-ancestor
111207849|NCT01607593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111207850|NCT01607593|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111207851|NCT01607593|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111207852|NCT01607593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111207853|NCT01607593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111207854|NCT01607593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111207855|NCT01607593|Serotonin Agents|serotonin agents|mesh-ancestor
111207856|NCT01607593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111207857|NCT00789724|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
111207858|NCT00789724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111207859|NCT01755637|Albendazole|albendazole|mesh-list
111207860|NCT01755637|Anthelmintics|anthelmintics|mesh-ancestor
111207861|NCT01755637|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111207862|NCT01755637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111207863|NCT01755637|Anticestodal Agents|anticestodal agents|mesh-ancestor
111207864|NCT01755637|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
111207865|NCT01755637|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111207866|NCT01755637|Tubulin Modulators|tubulin modulators|mesh-ancestor
111207867|NCT01755637|Antimitotic Agents|antimitotic agents|mesh-ancestor
111207868|NCT01755637|Mitosis Modulators|mitosis modulators|mesh-ancestor
111207869|NCT01755637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111207870|NCT01755637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111207871|NCT03801226|Calcium|calcium|mesh-list
111207872|NCT03801226|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111207873|NCT03801226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111207874|NCT03837808|Nimotuzumab|nimotuzumab|mesh-list
111207875|NCT03837808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111207876|NCT03837808|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111207877|NCT02148874|Vaccines|vaccines|mesh-list
111207878|NCT02148874|Immunologic Factors|immunologic factors|mesh-ancestor
111207879|NCT02148874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111207880|NCT01755091|Dronabinol|dronabinol|mesh-list
111207881|NCT01755091|Hallucinogens|hallucinogens|mesh-ancestor
111207882|NCT01755091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111207883|NCT01755091|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111207884|NCT01755091|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111207885|NCT01755091|Analgesics|analgesics|mesh-ancestor
111207886|NCT01755091|Sensory System Agents|sensory system agents|mesh-ancestor
111207887|NCT01755091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111207888|NCT01755091|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
111207889|NCT01755091|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
111207890|NCT01755091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111207891|NCT01755091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111207892|NCT01755091|Hormones|hormones|mesh-ancestor
111207893|NCT01755091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111207894|NCT00789802|Naproxen|naproxen|mesh-list
111207895|NCT00789802|Estradiol|estradiol|mesh-list
111207896|NCT00789802|Estrogens|estrogens|mesh-ancestor
111207897|NCT00789802|Hormones|hormones|mesh-ancestor
111207898|NCT00789802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111207899|NCT00789802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111207900|NCT00789802|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111207901|NCT00789802|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111207902|NCT00789802|Analgesics|analgesics|mesh-ancestor
111207903|NCT00789802|Sensory System Agents|sensory system agents|mesh-ancestor
111207904|NCT00789802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111207905|NCT00789802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111207906|NCT00789802|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111207907|NCT00789802|Gout Suppressants|gout suppressants|mesh-ancestor
111207908|NCT00789802|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111207909|NCT00789802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111207910|NCT00789802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111207911|NCT04567225|Insulin Glargine|insulin glargine|mesh-list
111207912|NCT04567225|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111207913|NCT04567225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111207914|NCT02149342|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
111207915|NCT02149342|Aminolevulinic Acid|aminolevulinic acid|mesh-list
111207916|NCT02149342|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111207917|NCT02149342|Dermatologic Agents|dermatologic agents|mesh-ancestor
111207918|NCT01783015|Etanercept|etanercept|mesh-list
111207919|NCT01783015|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111207920|NCT01783015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111207921|NCT01783015|Analgesics|analgesics|mesh-ancestor
111207922|NCT01783015|Sensory System Agents|sensory system agents|mesh-ancestor
111207923|NCT01783015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111207924|NCT01783015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111207925|NCT01783015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111207926|NCT01783015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111207927|NCT01783015|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111207928|NCT01783015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111207929|NCT01783015|Immunologic Factors|immunologic factors|mesh-ancestor
111207930|NCT01782859|Prednisone|prednisone|mesh-list
111207931|NCT01782859|Hydrocortisone|hydrocortisone|mesh-list
111207932|NCT01782859|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
111207933|NCT01782859|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
111207934|NCT01782859|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
111207935|NCT01782859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111207936|NCT01782859|Glucocorticoids|glucocorticoids|mesh-ancestor
111207937|NCT01782859|Hormones|hormones|mesh-ancestor
111207938|NCT01782859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111207939|NCT01782859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111207940|NCT01782859|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111207941|NCT01782859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111207942|NCT01782313|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
111207943|NCT01782313|Tivozanib|tivozanib|mesh-list
111207944|NCT01782313|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111207945|NCT01782313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111207946|NCT01782313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111207947|NCT04574947|Lidocaine|lidocaine|mesh-list
111207948|NCT04574947|Anesthetics, Local|anesthetics, local|mesh-ancestor
111207949|NCT04574947|Anesthetics|anesthetics|mesh-ancestor
111207950|NCT04574947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111207951|NCT04574947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111207952|NCT04574947|Sensory System Agents|sensory system agents|mesh-ancestor
111207953|NCT04574947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111207954|NCT04574947|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111207955|NCT04574947|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111207956|NCT04574947|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111207957|NCT04574947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111207958|NCT04574947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111207959|NCT00790192|Quetiapine Fumarate|quetiapine fumarate|mesh-list
111207960|NCT00790192|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
111207961|NCT00790192|Antidepressive Agents|antidepressive agents|mesh-ancestor
111207962|NCT00790192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111207963|NCT00790192|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111207964|NCT00790192|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111207965|NCT00790192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111207966|NCT00790192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111207967|NCT00790192|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
111207968|NCT00790192|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111207969|NCT00790192|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111207970|NCT00790192|Adrenergic Agents|adrenergic agents|mesh-ancestor
111207971|NCT00790192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111207972|NCT00790192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111207973|NCT00790192|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111207974|NCT00790192|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111207975|NCT00790192|Serotonin Agents|serotonin agents|mesh-ancestor
111207976|NCT00790192|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111207977|NCT00790192|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111207978|NCT00790192|Dopamine Agents|dopamine agents|mesh-ancestor
111207979|NCT01781611|Aspirin|aspirin|mesh-list
111207980|NCT01781611|Dipyridamole|dipyridamole|mesh-list
111207981|NCT01781611|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111207982|NCT01781611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111207983|NCT01781611|Analgesics|analgesics|mesh-ancestor
111207984|NCT01781611|Sensory System Agents|sensory system agents|mesh-ancestor
111207985|NCT01781611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111207986|NCT01781611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111207987|NCT01781611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111207988|NCT01781611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111207989|NCT01781611|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111207990|NCT01781611|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111207991|NCT01781611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111207992|NCT01781611|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111207993|NCT01781611|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111207994|NCT01781611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111207996|NCT01781611|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111207997|NCT01781611|Vasodilator Agents|vasodilator agents|mesh-ancestor
111207998|NCT00790270|Ibuprofen|ibuprofen|mesh-list
111207999|NCT00790270|Amitriptyline|amitriptyline|mesh-list
111208000|NCT00790270|Cyclobenzaprine|cyclobenzaprine|mesh-list
111208001|NCT00790270|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111208002|NCT00790270|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111208003|NCT00790270|Analgesics|analgesics|mesh-ancestor
111208004|NCT00790270|Sensory System Agents|sensory system agents|mesh-ancestor
111208005|NCT00790270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111208006|NCT00790270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111208007|NCT00790270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111208008|NCT00790270|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111208009|NCT00790270|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111208010|NCT00790270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111208011|NCT00790270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111208012|NCT00790270|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
111208013|NCT00790270|Antidepressive Agents|antidepressive agents|mesh-ancestor
111208014|NCT00790270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111208015|NCT00790270|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
111208016|NCT00790270|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111208017|NCT00790270|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111208018|NCT00790270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111208019|NCT00790270|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111208020|NCT00790270|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111208021|NCT00790270|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111208022|NCT00790270|Adrenergic Agents|adrenergic agents|mesh-ancestor
111208023|NCT00790270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111208024|NCT01780987|Heparin|heparin|mesh-list
111208025|NCT01780987|Calcium heparin|calcium heparin|mesh-list
111208026|NCT01780987|Warfarin|warfarin|mesh-list
111208027|NCT01780987|Apixaban|apixaban|mesh-list
111208028|NCT01780987|Anticoagulants|anticoagulants|mesh-ancestor
111208029|NCT01780987|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111208030|NCT01780987|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111208031|NCT01780987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111208032|NCT01780987|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111208033|NCT01780987|Antithrombins|antithrombins|mesh-ancestor
111208034|NCT01780987|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111208035|NCT01780987|Protease Inhibitors|protease inhibitors|mesh-ancestor
111208036|NCT01780987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111208037|NCT03800290|Clenbuterol|clenbuterol|mesh-list
111208038|NCT03800290|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111208039|NCT03800290|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111208040|NCT03800290|Adrenergic Agents|adrenergic agents|mesh-ancestor
111208041|NCT03800290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111208042|NCT03800290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111208043|NCT03800290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111208044|NCT03800290|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111208045|NCT03800290|Autonomic Agents|autonomic agents|mesh-ancestor
111208046|NCT03800290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111208047|NCT03800290|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111208048|NCT03800290|Respiratory System Agents|respiratory system agents|mesh-ancestor
111208049|NCT03800290|Sympathomimetics|sympathomimetics|mesh-ancestor
111208050|NCT05709184|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111208051|NCT05709184|Vancomycin|vancomycin|mesh-list
111208052|NCT05709184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111208053|NCT03831334|Minoxidil|minoxidil|mesh-list
111208054|NCT03831334|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111208055|NCT03831334|Vasodilator Agents|vasodilator agents|mesh-ancestor
111208056|NCT00809848|Bimatoprost|bimatoprost|mesh-list
111208057|NCT00809848|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111208058|NCT00809848|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110671906|NCT00845819|Iodine|iodine|mesh-list
110660917|NCT00986336|Serotonin Agents|serotonin agents|mesh-ancestor
111208059|NCT00809848|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111208060|NCT01730053|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111208061|NCT01730053|Ezetimibe|ezetimibe|mesh-list
111208062|NCT01730053|Alirocumab|alirocumab|mesh-list
111208063|NCT01730053|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111208064|NCT01730053|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111208065|NCT01730053|Antimetabolites|antimetabolites|mesh-ancestor
111208066|NCT01730053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111208067|NCT01730053|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111208068|NCT01730053|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111208069|NCT01730053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111208070|NCT01730053|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
111208071|NCT01730053|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111208072|NCT01730053|Protease Inhibitors|protease inhibitors|mesh-ancestor
111208073|NCT01751113|Fluticasone|fluticasone|mesh-list
111208074|NCT01751113|Xhance|xhance|mesh-list
111208075|NCT01751113|Bromides|bromides|mesh-list
111208076|NCT01751113|Tiotropium Bromide|tiotropium bromide|mesh-list
111208077|NCT01751113|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
111208078|NCT01751113|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
111208079|NCT01751113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111208080|NCT01751113|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111208081|NCT01751113|Autonomic Agents|autonomic agents|mesh-ancestor
111208082|NCT01751113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111208083|NCT01751113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111208084|NCT01751113|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111208085|NCT01751113|Respiratory System Agents|respiratory system agents|mesh-ancestor
111208086|NCT01751113|Dermatologic Agents|dermatologic agents|mesh-ancestor
111208087|NCT01751113|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111208088|NCT01751113|Parasympatholytics|parasympatholytics|mesh-ancestor
111208089|NCT01751113|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111208090|NCT01751113|Cholinergic Agents|cholinergic agents|mesh-ancestor
111208091|NCT01751113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111208092|NCT01751113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111208093|NCT01751113|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111208094|NCT01751113|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111208095|NCT01751113|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111208096|NCT01751113|Adrenergic Agents|adrenergic agents|mesh-ancestor
111208097|NCT01751113|Anticonvulsants|anticonvulsants|mesh-ancestor
111208098|NCT01751113|Glucocorticoids|glucocorticoids|mesh-ancestor
111208099|NCT01751113|Hormones|hormones|mesh-ancestor
111208100|NCT01751113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111208101|NCT01751113|Sympathomimetics|sympathomimetics|mesh-ancestor
111208102|NCT01719380|Cetuximab|cetuximab|mesh-list
111208103|NCT01719380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111208104|NCT01719380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111208105|NCT00792142|Thalidomide|thalidomide|mesh-list
111208106|NCT00792142|Dexamethasone|dexamethasone|mesh-list
111208107|NCT00792142|Bortezomib|bortezomib|mesh-list
111208108|NCT00792142|Melphalan|melphalan|mesh-list
111208109|NCT00792142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111208110|NCT00792142|Antiemetics|antiemetics|mesh-ancestor
111208111|NCT00792142|Autonomic Agents|autonomic agents|mesh-ancestor
111208112|NCT00792142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111208113|NCT00792142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111208114|NCT00792142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111208115|NCT00792142|Glucocorticoids|glucocorticoids|mesh-ancestor
111208116|NCT00792142|Hormones|hormones|mesh-ancestor
111208117|NCT00792142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111208118|NCT00792142|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111208119|NCT00792142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111208120|NCT00792142|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111208121|NCT00792142|Alkylating Agents|alkylating agents|mesh-ancestor
111208122|NCT00792142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111208123|NCT00792142|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111208124|NCT00792142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111208125|NCT00792142|Immunologic Factors|immunologic factors|mesh-ancestor
111208126|NCT00792142|Leprostatic Agents|leprostatic agents|mesh-ancestor
111208127|NCT00792142|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111208128|NCT00792142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111208129|NCT00792142|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111208130|NCT00792142|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111208131|NCT00792142|Growth Substances|growth substances|mesh-ancestor
111208132|NCT00792142|Growth Inhibitors|growth inhibitors|mesh-ancestor
111208133|NCT05640778|Cyclophosphamide|cyclophosphamide|mesh-list
111208134|NCT05640778|Taxane|taxane|mesh-list
111208135|NCT05640778|Aromatase Inhibitors|aromatase inhibitors|mesh-list
111208136|NCT05640778|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111208137|NCT05640778|Immunologic Factors|immunologic factors|mesh-ancestor
111208138|NCT05640778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111208139|NCT05640778|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111208140|NCT05640778|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111208141|NCT05640778|Alkylating Agents|alkylating agents|mesh-ancestor
111208142|NCT05640778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111208143|NCT05640778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111208144|NCT05640778|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111208145|NCT05640778|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111208146|NCT05640778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111208147|NCT05640778|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111208148|NCT05640778|Hormone Antagonists|hormone antagonists|mesh-ancestor
111208149|NCT05640778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111208150|NCT01743560|Everolimus|everolimus|mesh-list
111208151|NCT01743560|Exemestane|exemestane|mesh-list
111208152|NCT01743560|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111208153|NCT01743560|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111208154|NCT01743560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111208155|NCT01743560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111208156|NCT01743560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111208157|NCT01743560|Immunologic Factors|immunologic factors|mesh-ancestor
111208158|NCT01743560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111208159|NCT01743560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111208160|NCT01743560|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111208161|NCT01743560|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111208162|NCT01743560|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111208163|NCT01743560|Hormone Antagonists|hormone antagonists|mesh-ancestor
111208164|NCT01743560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111208165|NCT00796744|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
111208166|NCT00796744|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111208167|NCT00796744|Vasodilator Agents|vasodilator agents|mesh-ancestor
111208168|NCT00792922|Azithromycin|azithromycin|mesh-list
111208169|NCT00792922|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111208170|NCT00792922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111208171|NCT01780831|Raltegravir Potassium|raltegravir potassium|mesh-list
111208172|NCT01780831|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111208173|NCT01780831|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111208174|NCT01780831|Antiviral Agents|antiviral agents|mesh-ancestor
111208175|NCT01780831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111208176|NCT01780831|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111208177|NCT01780831|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111208178|NCT01780831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111208179|NCT01780831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111208180|NCT04382170|Dexmedetomidine|dexmedetomidine|mesh-list
111208181|NCT04382170|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111208182|NCT04382170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111208183|NCT04382170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111208184|NCT04382170|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111208185|NCT04382170|Analgesics|analgesics|mesh-ancestor
111208186|NCT04382170|Sensory System Agents|sensory system agents|mesh-ancestor
111208187|NCT04382170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111208188|NCT04382170|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111208189|NCT04382170|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111208190|NCT04382170|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111208191|NCT04382170|Adrenergic Agents|adrenergic agents|mesh-ancestor
111208192|NCT04382170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111208193|NCT04382170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111208194|NCT01753297|Triptorelin Pamoate|triptorelin pamoate|mesh-list
111208195|NCT01753297|Luteolytic Agents|luteolytic agents|mesh-ancestor
111208196|NCT01753297|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111208197|NCT01753297|Contraceptive Agents|contraceptive agents|mesh-ancestor
111208198|NCT01753297|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111208199|NCT01753297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111208200|NCT01753297|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111208201|NCT01753297|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111208202|NCT01753297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111208203|NCT04718350|Simendan|simendan|mesh-list
111208204|NCT04718350|Milrinone|milrinone|mesh-list
111208205|NCT04718350|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111208206|NCT04718350|Vasodilator Agents|vasodilator agents|mesh-ancestor
111208207|NCT04718350|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
111208208|NCT04718350|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111208209|NCT04718350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111208210|NCT04718350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111208211|NCT04718350|Protective Agents|protective agents|mesh-ancestor
111208212|NCT04718350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111208213|NCT04718350|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111208214|NCT01729819|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
111208215|NCT01729819|Tolterodine Tartrate|tolterodine tartrate|mesh-list
111208216|NCT01729819|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111208217|NCT01729819|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111208218|NCT01729819|Cholinergic Agents|cholinergic agents|mesh-ancestor
111208219|NCT01729819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111208220|NCT01729819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111208221|NCT01729819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111208222|NCT01729819|Urological Agents|urological agents|mesh-ancestor
111208223|NCT01729819|Hemostatics|hemostatics|mesh-ancestor
111208224|NCT01729819|Coagulants|coagulants|mesh-ancestor
111208225|NCT01729819|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
111208226|NCT01729819|Natriuretic Agents|natriuretic agents|mesh-ancestor
111208227|NCT00811564|Timolol|timolol|mesh-list
111208228|NCT00811564|Brimonidine Tartrate|brimonidine tartrate|mesh-list
111208229|NCT00811564|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111208230|NCT00811564|Latanoprost|latanoprost|mesh-list
111208231|NCT00811564|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111208232|NCT00811564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111208233|NCT00811564|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111208234|NCT00811564|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111208235|NCT00811564|Adrenergic Agents|adrenergic agents|mesh-ancestor
111208236|NCT00811564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111208237|NCT00811564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111208238|NCT00811564|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111208239|NCT00811564|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111208240|NCT00811564|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111208241|NCT00811564|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111208242|NCT00811564|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111208243|NCT04520776|Meloxicam|meloxicam|mesh-list
111208244|NCT04520776|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111208245|NCT04520776|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111208246|NCT04520776|Analgesics|analgesics|mesh-ancestor
111208247|NCT04520776|Sensory System Agents|sensory system agents|mesh-ancestor
111208248|NCT04520776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111208249|NCT04520776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111208250|NCT04520776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111208251|NCT04520776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111208252|NCT04520776|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111208253|NCT04520776|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111208254|NCT04520776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111208255|NCT04520776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111208256|NCT01709084|Tenofovir|tenofovir|mesh-list
111208257|NCT01709084|Emtricitabine|emtricitabine|mesh-list
111208258|NCT01709084|Efavirenz|efavirenz|mesh-list
111208259|NCT01709084|Rilpivirine|rilpivirine|mesh-list
111208260|NCT01709084|Antiviral Agents|antiviral agents|mesh-ancestor
111208261|NCT01709084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111208262|NCT01709084|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111208263|NCT01709084|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111208264|NCT01709084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111208265|NCT01709084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111208266|NCT01709084|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111208267|NCT01709084|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111208268|NCT01709084|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111208269|NCT01709084|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111208270|NCT01709084|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111208271|NCT01709084|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111208272|NCT01709084|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111208273|NCT01709084|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111208274|NCT01776307|Capecitabine|capecitabine|mesh-list
111208275|NCT01776307|Cetuximab|cetuximab|mesh-list
111208276|NCT01776307|Panitumumab|panitumumab|mesh-list
111208277|NCT01776307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111208278|NCT01776307|Antimetabolites|antimetabolites|mesh-ancestor
111208279|NCT01776307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111208280|NCT01776307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111208281|NCT01776307|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111208282|NCT01741532|Deferiprone|deferiprone|mesh-list
111208283|NCT01741532|Iron Chelating Agents|iron chelating agents|mesh-ancestor
111208284|NCT01741532|Chelating Agents|chelating agents|mesh-ancestor
111208285|NCT01741532|Sequestering Agents|sequestering agents|mesh-ancestor
111208286|NCT01741532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111208287|NCT01727713|Aripiprazole|aripiprazole|mesh-list
111208288|NCT01727713|Antidepressive Agents|antidepressive agents|mesh-ancestor
111208289|NCT01727713|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111208290|NCT01727713|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111208291|NCT01727713|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111208292|NCT01727713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111208293|NCT01727713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111208294|NCT01727713|Dopamine Agonists|dopamine agonists|mesh-ancestor
111208295|NCT01727713|Dopamine Agents|dopamine agents|mesh-ancestor
111208296|NCT01727713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111208297|NCT01727713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111208298|NCT01727713|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111208299|NCT01727713|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111208300|NCT01727713|Serotonin Agents|serotonin agents|mesh-ancestor
111208301|NCT01727713|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111208302|NCT01727713|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111208303|NCT01727713|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111208304|NCT01727713|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111208305|NCT04658927|Dexamethasone|dexamethasone|mesh-list
111208306|NCT04658927|Prednisone|prednisone|mesh-list
111208307|NCT04658927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111208308|NCT04658927|Antiemetics|antiemetics|mesh-ancestor
111208309|NCT04658927|Autonomic Agents|autonomic agents|mesh-ancestor
111208310|NCT04658927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111208311|NCT04658927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111208312|NCT04658927|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111208313|NCT04658927|Glucocorticoids|glucocorticoids|mesh-ancestor
111208314|NCT04658927|Hormones|hormones|mesh-ancestor
111208315|NCT04658927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111208316|NCT04658927|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111208317|NCT04658927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111208318|NCT01965431|Moxifloxacin|moxifloxacin|mesh-list
111208319|NCT01965431|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111208320|NCT01965431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111208321|NCT01965431|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111208322|NCT01965431|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111208323|NCT01965431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111208324|NCT01965431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111208325|NCT01965431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111208326|NCT01976507|Dabigatran|dabigatran|mesh-list
111208327|NCT01976507|Antithrombins|antithrombins|mesh-ancestor
111208328|NCT01976507|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111208329|NCT01976507|Protease Inhibitors|protease inhibitors|mesh-ancestor
111208330|NCT01976507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111208331|NCT01976507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111208332|NCT01976507|Anticoagulants|anticoagulants|mesh-ancestor
111208333|NCT01964963|Alogliptin|alogliptin|mesh-list
111208334|NCT01964963|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111208335|NCT01964963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111208336|NCT01964963|Incretins|incretins|mesh-ancestor
111208337|NCT01964963|Hormones|hormones|mesh-ancestor
111208338|NCT01964963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111208339|NCT01964963|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111208340|NCT01964963|Protease Inhibitors|protease inhibitors|mesh-ancestor
111208341|NCT01964963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111208342|NCT01964963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111208343|NCT01974323|Dapsone|dapsone|mesh-list
111208344|NCT01974323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111208345|NCT01974323|Antimalarials|antimalarials|mesh-ancestor
111208346|NCT01974323|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111208347|NCT01974323|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111208348|NCT01974323|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111208349|NCT01974323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111208350|NCT01974323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111208351|NCT01974323|Leprostatic Agents|leprostatic agents|mesh-ancestor
111208352|NCT01974323|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111208353|NCT01973387|Rituximab|rituximab|mesh-list
111208354|NCT01973387|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111208355|NCT01973387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111208356|NCT01973387|Immunologic Factors|immunologic factors|mesh-ancestor
111208357|NCT01973387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111208358|NCT01973387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111208360|NCT01973231|Lixisenatide|lixisenatide|mesh-list
111208361|NCT01973231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111208362|NCT01973231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111208363|NCT01973231|Incretins|incretins|mesh-ancestor
111208364|NCT01973231|Hormones|hormones|mesh-ancestor
111208365|NCT01973231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111208366|NCT02151994|Zamicastat|zamicastat|mesh-list
111208367|NCT02151994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111208368|NCT02151994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111208369|NCT04382950|Tretinoin|tretinoin|mesh-list
111208370|NCT04382950|Isotretinoin|isotretinoin|mesh-list
111208371|NCT04382950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111208372|NCT04382950|Keratolytic Agents|keratolytic agents|mesh-ancestor
111208373|NCT04382950|Dermatologic Agents|dermatologic agents|mesh-ancestor
111208374|NCT04383418|Dexmedetomidine|dexmedetomidine|mesh-list
111208375|NCT04383418|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111208376|NCT04383418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111208377|NCT04383418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111208378|NCT04383418|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111208379|NCT04383418|Analgesics|analgesics|mesh-ancestor
111208380|NCT04383418|Sensory System Agents|sensory system agents|mesh-ancestor
111208381|NCT04383418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111208382|NCT04383418|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111208383|NCT04383418|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111208384|NCT04383418|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111208385|NCT04383418|Adrenergic Agents|adrenergic agents|mesh-ancestor
111208386|NCT04383418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111208387|NCT04383418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111208388|NCT03414112|Oxytocin|oxytocin|mesh-list
111208389|NCT03414112|Oxytocics|oxytocics|mesh-ancestor
111208390|NCT03414112|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111208391|NCT03414112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111208392|NCT03839134|Lidocaine|lidocaine|mesh-list
111208393|NCT03839134|Epinephrine|epinephrine|mesh-list
111208394|NCT03839134|Racepinephrine|racepinephrine|mesh-list
111208395|NCT03839134|Epinephryl borate|epinephryl borate|mesh-list
111208396|NCT03839134|Anesthetics, Local|anesthetics, local|mesh-ancestor
111208397|NCT03839134|Anesthetics|anesthetics|mesh-ancestor
111208398|NCT03839134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111208399|NCT03839134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111208400|NCT03839134|Sensory System Agents|sensory system agents|mesh-ancestor
111208401|NCT03839134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111208402|NCT03839134|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111208403|NCT03839134|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111208404|NCT03839134|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111208405|NCT03839134|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111208406|NCT03839134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111208407|NCT03839134|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111208408|NCT03839134|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111208409|NCT03839134|Adrenergic Agents|adrenergic agents|mesh-ancestor
111208410|NCT03839134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111208411|NCT03839134|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111208412|NCT03839134|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111208413|NCT03839134|Autonomic Agents|autonomic agents|mesh-ancestor
111208414|NCT03839134|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111208415|NCT03839134|Respiratory System Agents|respiratory system agents|mesh-ancestor
111208416|NCT03839134|Mydriatics|mydriatics|mesh-ancestor
111208417|NCT03839134|Sympathomimetics|sympathomimetics|mesh-ancestor
111208418|NCT03839134|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111208419|NCT03906526|Nivolumab|nivolumab|mesh-list
111208420|NCT03906526|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111208421|NCT03906526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111208422|NCT03906526|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111208423|NCT03906526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111208424|NCT03088930|Crizotinib|crizotinib|mesh-list
111208425|NCT03088930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111208426|NCT03088930|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111208427|NCT03088930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111208428|NCT03088930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111208429|NCT02152696|Methotrexate|methotrexate|mesh-list
111208430|NCT02152696|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111208431|NCT02152696|Abortifacient Agents|abortifacient agents|mesh-ancestor
110672228|NCT02546297|Anticonvulsants|anticonvulsants|mesh-ancestor
111208432|NCT02152696|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111208433|NCT02152696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111208434|NCT02152696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111208435|NCT02152696|Antimetabolites|antimetabolites|mesh-ancestor
111208436|NCT02152696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111208437|NCT02152696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111208438|NCT02152696|Dermatologic Agents|dermatologic agents|mesh-ancestor
111208439|NCT02152696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111208440|NCT02152696|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111208441|NCT02152696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111208442|NCT02152696|Immunologic Factors|immunologic factors|mesh-ancestor
111208443|NCT02152696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111208444|NCT02152696|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111208445|NCT01905436|Ivermectin|ivermectin|mesh-list
111208446|NCT01905436|Albendazole|albendazole|mesh-list
111208447|NCT01905436|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111208448|NCT01905436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111208449|NCT01905436|Anthelmintics|anthelmintics|mesh-ancestor
111208450|NCT01905436|Anticestodal Agents|anticestodal agents|mesh-ancestor
111208451|NCT01905436|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
111208452|NCT01905436|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111208453|NCT01905436|Tubulin Modulators|tubulin modulators|mesh-ancestor
111208454|NCT01905436|Antimitotic Agents|antimitotic agents|mesh-ancestor
111208455|NCT01905436|Mitosis Modulators|mitosis modulators|mesh-ancestor
111208456|NCT01905436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111208457|NCT01905436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111208458|NCT01256086|Formoterol Fumarate|formoterol fumarate|mesh-list
111208459|NCT01256086|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110787811|NCT04484025|Ebselen|ebselen|mesh-list
111208460|NCT01256086|Autonomic Agents|autonomic agents|mesh-ancestor
111208461|NCT01256086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111208462|NCT01256086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111208463|NCT01256086|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111208464|NCT01256086|Respiratory System Agents|respiratory system agents|mesh-ancestor
111208465|NCT01256086|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111208466|NCT01256086|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111208467|NCT01256086|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111208468|NCT01256086|Adrenergic Agents|adrenergic agents|mesh-ancestor
111208469|NCT01256086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111208470|NCT01256086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111208471|NCT01149850|Bevacizumab|bevacizumab|mesh-list
111208472|NCT01149850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111208473|NCT01149850|Temozolomide|temozolomide|mesh-list
111208474|NCT01149850|Antibodies|antibodies|mesh-list
111208475|NCT01149850|Immunoglobulins|immunoglobulins|mesh-list
111208476|NCT01149850|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111208477|NCT01149850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111208478|NCT01149850|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111208479|NCT01149850|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111208480|NCT01149850|Growth Substances|growth substances|mesh-ancestor
111208481|NCT01149850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111208482|NCT01149850|Growth Inhibitors|growth inhibitors|mesh-ancestor
111208483|NCT01149850|Immunologic Factors|immunologic factors|mesh-ancestor
111208484|NCT01149850|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111208485|NCT01149850|Alkylating Agents|alkylating agents|mesh-ancestor
111208486|NCT01149850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111208487|NCT01972841|Solifenacin Succinate|solifenacin succinate|mesh-list
111208488|NCT01972841|Mirabegron|mirabegron|mesh-list
111208489|NCT01972841|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111208490|NCT01972841|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111208491|NCT01972841|Cholinergic Agents|cholinergic agents|mesh-ancestor
111208492|NCT01972841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111208493|NCT01972841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111208494|NCT01972841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111208495|NCT01972841|Urological Agents|urological agents|mesh-ancestor
111208496|NCT01972841|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
111208497|NCT01972841|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111208498|NCT01972841|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111208499|NCT01972841|Adrenergic Agents|adrenergic agents|mesh-ancestor
111208500|NCT01774903|Fentanyl|fentanyl|mesh-list
111208501|NCT01774903|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111208502|NCT01774903|Narcotics|narcotics|mesh-ancestor
111208503|NCT01774903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111208504|NCT01774903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111208505|NCT01774903|Analgesics|analgesics|mesh-ancestor
111208506|NCT01774903|Sensory System Agents|sensory system agents|mesh-ancestor
111208507|NCT01774903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111208509|NCT01774903|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111208510|NCT01774903|Anesthetics, General|anesthetics, general|mesh-ancestor
111208511|NCT01774903|Anesthetics|anesthetics|mesh-ancestor
111208512|NCT01774591|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
111208513|NCT01774591|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111208514|NCT01774591|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111208515|NCT01774591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111208516|NCT01708915|Nicotinic Acids|nicotinic acids|mesh-list
111208517|NCT01708915|Capsaicin|capsaicin|mesh-list
111208518|NCT01708915|Nonivamide|nonivamide|mesh-list
111208519|NCT01708915|Vitamin B Complex|vitamin b complex|mesh-ancestor
111208520|NCT01708915|Vitamins|vitamins|mesh-ancestor
111208521|NCT01708915|Micronutrients|micronutrients|mesh-ancestor
111208522|NCT01708915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111208523|NCT01708915|Sensory System Agents|sensory system agents|mesh-ancestor
111208524|NCT01708915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111208525|NCT01708915|Antipruritics|antipruritics|mesh-ancestor
111208526|NCT01708915|Dermatologic Agents|dermatologic agents|mesh-ancestor
111208527|NCT01708057|Tiotropium Bromide|tiotropium bromide|mesh-list
111208528|NCT01708057|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111208529|NCT01708057|Autonomic Agents|autonomic agents|mesh-ancestor
111208530|NCT01708057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111208531|NCT01708057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111208532|NCT01708057|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111208533|NCT01708057|Respiratory System Agents|respiratory system agents|mesh-ancestor
111208534|NCT01708057|Parasympatholytics|parasympatholytics|mesh-ancestor
111208535|NCT01708057|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111208536|NCT01708057|Cholinergic Agents|cholinergic agents|mesh-ancestor
111208537|NCT01708057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111208538|NCT01708057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111208539|NCT01747915|Pregabalin|pregabalin|mesh-list
111208540|NCT01747915|Analgesics|analgesics|mesh-ancestor
111208541|NCT01747915|Sensory System Agents|sensory system agents|mesh-ancestor
111208542|NCT01747915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111208543|NCT01747915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111208544|NCT01747915|Anticonvulsants|anticonvulsants|mesh-ancestor
111208545|NCT01747915|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111208546|NCT01747915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111208547|NCT01747915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111208548|NCT01747915|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111208549|NCT01747915|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111208550|NCT01747915|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111208551|NCT01747915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111208552|NCT01747915|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111208553|NCT01961297|Sodium Oxybate|sodium oxybate|mesh-list
111208554|NCT01961297|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111208555|NCT01961297|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111208556|NCT01961297|Anesthetics, General|anesthetics, general|mesh-ancestor
111208557|NCT01961297|Anesthetics|anesthetics|mesh-ancestor
111208558|NCT01961297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111208559|NCT01961297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111208560|NCT04656041|Paclitaxel|paclitaxel|mesh-list
111208561|NCT04656041|Carboplatin|carboplatin|mesh-list
111208562|NCT04656041|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111208563|NCT04656041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111208564|NCT04656041|Tubulin Modulators|tubulin modulators|mesh-ancestor
111208565|NCT04656041|Antimitotic Agents|antimitotic agents|mesh-ancestor
111208566|NCT04656041|Mitosis Modulators|mitosis modulators|mesh-ancestor
111208567|NCT04656041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111208568|NCT01971203|Quetiapine Fumarate|quetiapine fumarate|mesh-list
111208569|NCT01971203|Antidepressive Agents|antidepressive agents|mesh-ancestor
111208570|NCT01971203|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111208571|NCT01971203|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111208572|NCT01971203|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111208573|NCT01971203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111208574|NCT01971203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111208575|NCT01970501|Metoprolol|metoprolol|mesh-list
111208576|NCT01970501|Bucindolol|bucindolol|mesh-list
111208577|NCT01970501|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111208578|NCT01970501|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111208579|NCT01970501|Sympatholytics|sympatholytics|mesh-ancestor
111208580|NCT01970501|Autonomic Agents|autonomic agents|mesh-ancestor
111208581|NCT01970501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111208582|NCT01970501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111208583|NCT01970501|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
111208584|NCT01970501|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111208585|NCT01970501|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111208586|NCT01970501|Adrenergic Agents|adrenergic agents|mesh-ancestor
111208587|NCT01970501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111208588|NCT01970501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111208589|NCT01970501|Sympathomimetics|sympathomimetics|mesh-ancestor
111208590|NCT01970501|Vasodilator Agents|vasodilator agents|mesh-ancestor
111208591|NCT01970501|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111208592|NCT01970501|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111208593|NCT01969799|Amikacin|amikacin|mesh-list
111208594|NCT01969799|Fosfomycin|fosfomycin|mesh-list
111208595|NCT01969799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111208596|NCT01969799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111208597|NCT01969721|Fluticasone|fluticasone|mesh-list
111208598|NCT01969721|Xhance|xhance|mesh-list
111208599|NCT01969721|Tiotropium Bromide|tiotropium bromide|mesh-list
111208600|NCT01969721|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
111208601|NCT01969721|Olodaterol|olodaterol|mesh-list
111208602|NCT01969721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111208603|NCT01969721|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111208604|NCT01969721|Autonomic Agents|autonomic agents|mesh-ancestor
111208605|NCT01969721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111208606|NCT01969721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111208607|NCT01969721|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111208608|NCT01969721|Respiratory System Agents|respiratory system agents|mesh-ancestor
111208609|NCT01969721|Dermatologic Agents|dermatologic agents|mesh-ancestor
111208610|NCT01969721|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111208611|NCT01969721|Parasympatholytics|parasympatholytics|mesh-ancestor
111208612|NCT01969721|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111208613|NCT01969721|Cholinergic Agents|cholinergic agents|mesh-ancestor
111208614|NCT01969721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111208615|NCT01969721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111208616|NCT01969721|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111208617|NCT01969721|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111208618|NCT01969721|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111208619|NCT01969721|Adrenergic Agents|adrenergic agents|mesh-ancestor
111208620|NCT01969565|Dexamethasone|dexamethasone|mesh-list
111208621|NCT01969565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111208622|NCT01969565|Antiemetics|antiemetics|mesh-ancestor
111208623|NCT01969565|Autonomic Agents|autonomic agents|mesh-ancestor
111208624|NCT01969565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111208625|NCT01969565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111208626|NCT01969565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111208627|NCT01969565|Glucocorticoids|glucocorticoids|mesh-ancestor
111208628|NCT01969565|Hormones|hormones|mesh-ancestor
111208629|NCT01969565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111208630|NCT01969565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111208631|NCT01969565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111208632|NCT01968707|Ethanol|ethanol|mesh-list
111208633|NCT01968707|Chlorhexidine|chlorhexidine|mesh-list
111208634|NCT01968707|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
111208635|NCT01968707|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111208636|NCT01968707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111208637|NCT01968707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111208638|NCT01968707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111208639|NCT01968707|Disinfectants|disinfectants|mesh-ancestor
111208640|NCT01968707|Dermatologic Agents|dermatologic agents|mesh-ancestor
111208641|NCT01746901|Naltrexone|naltrexone|mesh-list
111208642|NCT01746901|Oxycodone|oxycodone|mesh-list
111208643|NCT01746901|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111208644|NCT01746901|Narcotics|narcotics|mesh-ancestor
111208645|NCT01746901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111208646|NCT01746901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111208647|NCT01746901|Analgesics|analgesics|mesh-ancestor
111208648|NCT01746901|Sensory System Agents|sensory system agents|mesh-ancestor
111208649|NCT01746901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111208650|NCT01746901|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111208651|NCT01746901|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111208652|NCT01968551|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
111208653|NCT01968551|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111208654|NCT01968551|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111208655|NCT01968551|Antiviral Agents|antiviral agents|mesh-ancestor
111208656|NCT01968551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111208657|NCT01946165|Prednisone|prednisone|mesh-list
111208658|NCT01946165|Abiraterone Acetate|abiraterone acetate|mesh-list
111208659|NCT01946165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111208660|NCT01946165|Glucocorticoids|glucocorticoids|mesh-ancestor
111208661|NCT01946165|Hormones|hormones|mesh-ancestor
111208662|NCT01946165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111208663|NCT01946165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111208664|NCT01946165|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111208665|NCT01946165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111208666|NCT01946165|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111208667|NCT01946165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111208668|NCT01946165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111208669|NCT01946165|Hormone Antagonists|hormone antagonists|mesh-ancestor
111208670|NCT01946165|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111208671|NCT01707667|Prucalopride|prucalopride|mesh-list
111208672|NCT01707667|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
111208673|NCT01707667|Laxatives|laxatives|mesh-ancestor
111208674|NCT01707667|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111208675|NCT01707667|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
111208676|NCT01707667|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111208677|NCT01707667|Serotonin Agents|serotonin agents|mesh-ancestor
111208678|NCT01707667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111208679|NCT01707667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111208680|NCT01707667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111208681|NCT01959503|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
111208682|NCT01959503|Hemostatics|hemostatics|mesh-ancestor
111208683|NCT01959503|Coagulants|coagulants|mesh-ancestor
111208684|NCT01706575|Interferons|interferons|mesh-list
111208685|NCT01706575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111208686|NCT01706575|Antiviral Agents|antiviral agents|mesh-ancestor
111208687|NCT01706575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111208688|NCT01725529|Ribavirin|ribavirin|mesh-list
111208689|NCT01725529|Simeprevir|simeprevir|mesh-list
111208690|NCT01725529|Antimetabolites|antimetabolites|mesh-ancestor
111208691|NCT01725529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111208692|NCT01725529|Antiviral Agents|antiviral agents|mesh-ancestor
111208693|NCT01725529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111208694|NCT01725529|Protease Inhibitors|protease inhibitors|mesh-ancestor
111208695|NCT01725529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111208696|NCT01744093|Doxycycline|doxycycline|mesh-list
111208697|NCT01744093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111208698|NCT01744093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111208699|NCT01744093|Antimalarials|antimalarials|mesh-ancestor
111208700|NCT01744093|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111208701|NCT01744093|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111208702|NCT01725451|Testosterone|testosterone|mesh-list
111208703|NCT01725451|Androgens|androgens|mesh-ancestor
111208704|NCT01725451|Hormones|hormones|mesh-ancestor
111208705|NCT01725451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111208706|NCT01725451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111208707|NCT01707290|Ivacaftor|ivacaftor|mesh-list
111208708|NCT01707290|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
111208709|NCT01707290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111208710|NCT01707290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111208711|NCT01717040|Pioglitazone|pioglitazone|mesh-list
111208712|NCT01717040|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111208713|NCT01717040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111208714|NCT00803062|Paclitaxel|paclitaxel|mesh-list
111208715|NCT00803062|Bevacizumab|bevacizumab|mesh-list
111208716|NCT00803062|Cisplatin|cisplatin|mesh-list
111208717|NCT00803062|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111208718|NCT00803062|Topotecan|topotecan|mesh-list
111208719|NCT00803062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111208720|NCT00803062|Endothelial Growth Factors|endothelial growth factors|mesh-list
111208721|NCT00803062|Antibodies|antibodies|mesh-list
111208722|NCT00803062|Immunoglobulins|immunoglobulins|mesh-list
111208723|NCT00803062|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111208724|NCT00803062|Immunoglobulin G|immunoglobulin g|mesh-list
111208725|NCT00803062|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111208726|NCT00803062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111208727|NCT00803062|Tubulin Modulators|tubulin modulators|mesh-ancestor
111208728|NCT00803062|Antimitotic Agents|antimitotic agents|mesh-ancestor
111208729|NCT00803062|Mitosis Modulators|mitosis modulators|mesh-ancestor
111208730|NCT00803062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111208731|NCT00803062|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111208732|NCT00803062|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111208733|NCT00803062|Growth Substances|growth substances|mesh-ancestor
110672532|NCT00854711|Antioxidants|antioxidants|mesh-ancestor
110661599|NCT00990392|Polymyxins|polymyxins|mesh-list
111208734|NCT00803062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111208735|NCT00803062|Growth Inhibitors|growth inhibitors|mesh-ancestor
111208736|NCT00803062|Immunologic Factors|immunologic factors|mesh-ancestor
111208737|NCT00803062|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111208738|NCT00803062|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111208739|NCT00803062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111208740|NCT01743001|Macitentan|macitentan|mesh-list
111208741|NCT01743001|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
111208742|NCT01743001|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
111208743|NCT01743001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111208744|NCT01743001|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
111208745|NCT01704079|Calcifediol|calcifediol|mesh-list
111208746|NCT01704079|Vitamins|vitamins|mesh-ancestor
111208747|NCT01704079|Micronutrients|micronutrients|mesh-ancestor
111208748|NCT01704079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111208749|NCT01704079|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111208750|NCT01703845|Tiotropium Bromide|tiotropium bromide|mesh-list
111208751|NCT01703845|Olodaterol|olodaterol|mesh-list
111208752|NCT01703845|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111208753|NCT01703845|Autonomic Agents|autonomic agents|mesh-ancestor
111208754|NCT01703845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111208755|NCT01703845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111208756|NCT01703845|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111208757|NCT01703845|Respiratory System Agents|respiratory system agents|mesh-ancestor
111208758|NCT01703845|Parasympatholytics|parasympatholytics|mesh-ancestor
111208759|NCT01703845|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111208760|NCT01703845|Cholinergic Agents|cholinergic agents|mesh-ancestor
111208761|NCT01703845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111208762|NCT01703845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111208763|NCT01724359|Paliperidone Palmitate|paliperidone palmitate|mesh-list
111208764|NCT01724359|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111208765|NCT01724359|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111208766|NCT01724359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111208767|NCT01724359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111208768|NCT01724359|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111208769|NCT01724359|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111208770|NCT01724359|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111208771|NCT01724359|Serotonin Agents|serotonin agents|mesh-ancestor
111208772|NCT01724359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111208773|NCT01724359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111208774|NCT01724359|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111208775|NCT01724359|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111208776|NCT01724359|Dopamine Agents|dopamine agents|mesh-ancestor
111208777|NCT01703221|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111208778|NCT01703221|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111208779|NCT01703221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111208780|NCT01703221|Incretins|incretins|mesh-ancestor
111208781|NCT01703221|Hormones|hormones|mesh-ancestor
111208782|NCT01703221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111208783|NCT01703221|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111208784|NCT01703221|Protease Inhibitors|protease inhibitors|mesh-ancestor
111208785|NCT01703221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111208786|NCT01703221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111208787|NCT00803686|Salmon calcitonin|salmon calcitonin|mesh-list
111208788|NCT00803686|Calcitonin|calcitonin|mesh-list
111208789|NCT00803686|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111208790|NCT00803686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111208791|NCT00803686|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111208792|NCT00823966|Delavirdine|delavirdine|mesh-list
111208793|NCT00823966|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111208794|NCT00823966|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111208795|NCT00823966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111208796|NCT00823966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111208797|NCT00823966|Antiviral Agents|antiviral agents|mesh-ancestor
111208798|NCT00823966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111208799|NCT00823966|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111208800|NCT00823966|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111208801|NCT01702987|Coenzyme Q10|coenzyme q10|mesh-list
111208802|NCT01702987|Atorvastatin|atorvastatin|mesh-list
111208803|NCT01702987|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111208804|NCT01702987|Simvastatin|simvastatin|mesh-list
111208805|NCT01702987|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111208806|NCT01702987|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111208807|NCT01702987|Antimetabolites|antimetabolites|mesh-ancestor
111208808|NCT01702987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111208809|NCT01702987|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111208810|NCT01702987|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111208811|NCT01702987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111208812|NCT01702987|Micronutrients|micronutrients|mesh-ancestor
111208813|NCT01702987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111208814|NCT01702987|Vitamins|vitamins|mesh-ancestor
111208815|NCT00824044|Escitalopram|escitalopram|mesh-list
111208816|NCT00824044|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111208817|NCT00824044|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111208818|NCT00824044|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111208819|NCT00824044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111208820|NCT00824044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111208821|NCT00824044|Serotonin Agents|serotonin agents|mesh-ancestor
111208822|NCT00824044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111208823|NCT01702519|Nicotine|nicotine|mesh-list
111208824|NCT01702519|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111208825|NCT01702519|Autonomic Agents|autonomic agents|mesh-ancestor
111208826|NCT01702519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111208827|NCT01702519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111208828|NCT01702519|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111208829|NCT01702519|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111208830|NCT01702519|Cholinergic Agents|cholinergic agents|mesh-ancestor
111208831|NCT01702519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111208832|NCT01702519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111208833|NCT01739335|Mifepristone|mifepristone|mesh-list
111208834|NCT01739335|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
111208835|NCT01739335|Abortifacient Agents|abortifacient agents|mesh-ancestor
111208836|NCT01739335|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111208837|NCT01739335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111208838|NCT01739335|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111208839|NCT01739335|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111208840|NCT01739335|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111208841|NCT01739335|Contraceptive Agents|contraceptive agents|mesh-ancestor
111208842|NCT01739335|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
111208843|NCT01739335|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
111208844|NCT01739335|Hormone Antagonists|hormone antagonists|mesh-ancestor
111208845|NCT01739335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111208846|NCT01739335|Luteolytic Agents|luteolytic agents|mesh-ancestor
111208847|NCT01739335|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111208848|NCT01739335|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
111208849|NCT00824746|Gefitinib|gefitinib|mesh-list
111208850|NCT00824746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111208851|NCT00824746|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111208852|NCT00824746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111208853|NCT00824746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111208854|NCT01722097|Rocuronium|rocuronium|mesh-list
111208855|NCT01722097|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
111208856|NCT01722097|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
111208857|NCT01722097|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111208858|NCT01722097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111208859|NCT01722097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111208860|NCT00824824|Timolol|timolol|mesh-list
111208861|NCT00824824|Brimonidine Tartrate|brimonidine tartrate|mesh-list
111208862|NCT00824824|Dorzolamide|dorzolamide|mesh-list
111208863|NCT00824824|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111208864|NCT00824824|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111208865|NCT00824824|Adrenergic Agents|adrenergic agents|mesh-ancestor
111208866|NCT00824824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111208867|NCT00824824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111208868|NCT00824824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111208869|NCT00824824|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111208870|NCT00824824|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111208871|NCT00824824|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111208872|NCT00824824|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111208873|NCT00824824|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111208874|NCT00824824|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
111208875|NCT00824824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111208876|NCT01701973|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111208877|NCT01701973|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111208878|NCT01701973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110672687|NCT02544191|Goserelin|goserelin|mesh-list
111208879|NCT01701973|Incretins|incretins|mesh-ancestor
111208880|NCT01701973|Hormones|hormones|mesh-ancestor
111208881|NCT01701973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111208882|NCT01701973|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111208883|NCT01701973|Protease Inhibitors|protease inhibitors|mesh-ancestor
111208884|NCT01701973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111208885|NCT01701973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111208886|NCT00825370|Hydromorphone|hydromorphone|mesh-list
111208887|NCT00825370|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111208888|NCT00825370|Narcotics|narcotics|mesh-ancestor
111208889|NCT00825370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111208890|NCT00825370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111208891|NCT00825370|Analgesics|analgesics|mesh-ancestor
111208892|NCT00825370|Sensory System Agents|sensory system agents|mesh-ancestor
111208893|NCT00825370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111208894|NCT01721317|Ezogabine|ezogabine|mesh-list
111208895|NCT01721317|Anticonvulsants|anticonvulsants|mesh-ancestor
111208896|NCT01721317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111208897|NCT01721317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111208898|NCT05014438|Branebrutinib|branebrutinib|mesh-list
111208899|NCT05014438|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111208900|NCT05014438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111208901|NCT05014438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111208902|NCT00828412|Desonide|desonide|mesh-list
111208903|NCT00828412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111208904|NCT01959035|Aripiprazole|aripiprazole|mesh-list
111208905|NCT01959035|Antidepressive Agents|antidepressive agents|mesh-ancestor
111208906|NCT01959035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111208907|NCT01959035|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111208908|NCT01959035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111208909|NCT01959035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111208910|NCT01959035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111208911|NCT01959035|Dopamine Agonists|dopamine agonists|mesh-ancestor
111208912|NCT01959035|Dopamine Agents|dopamine agents|mesh-ancestor
111208913|NCT01959035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111208914|NCT01959035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111208915|NCT01959035|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111208916|NCT01959035|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111208917|NCT01959035|Serotonin Agents|serotonin agents|mesh-ancestor
111208918|NCT01959035|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111208919|NCT01959035|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111208920|NCT01959035|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111208921|NCT01959035|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111208922|NCT01700959|Melatonin|melatonin|mesh-list
111208923|NCT01700959|Antioxidants|antioxidants|mesh-ancestor
111208924|NCT01700959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111208925|NCT01700959|Protective Agents|protective agents|mesh-ancestor
111208926|NCT01700959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111208927|NCT01700959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111208928|NCT00829738|Pantoprazole|pantoprazole|mesh-list
111208929|NCT00829738|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111208930|NCT00829738|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111208931|NCT00829738|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111208932|NCT00829738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111208933|NCT00829738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111208934|NCT01737931|Diphenhydramine|diphenhydramine|mesh-list
111208935|NCT01737931|Promethazine|promethazine|mesh-list
111208936|NCT01737931|Dexamethasone|dexamethasone|mesh-list
111208937|NCT01737931|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
111208938|NCT01737931|Histamine Antagonists|histamine antagonists|mesh-list
111208939|NCT01737931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111208940|NCT01737931|Antiemetics|antiemetics|mesh-ancestor
111208941|NCT01737931|Autonomic Agents|autonomic agents|mesh-ancestor
111208942|NCT01737931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111208943|NCT01737931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111208944|NCT01737931|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111208945|NCT01737931|Glucocorticoids|glucocorticoids|mesh-ancestor
111208946|NCT01737931|Hormones|hormones|mesh-ancestor
111208947|NCT01737931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111208948|NCT01737931|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111208949|NCT01737931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111208950|NCT01737931|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111208951|NCT01737931|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111208952|NCT01737931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111208953|NCT01737931|Anesthetics, Local|anesthetics, local|mesh-ancestor
111208954|NCT01737931|Anesthetics|anesthetics|mesh-ancestor
111208955|NCT01737931|Sensory System Agents|sensory system agents|mesh-ancestor
111208956|NCT01737931|Histamine Agents|histamine agents|mesh-ancestor
111208957|NCT01737931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111208958|NCT01737931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111208959|NCT01737931|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111208960|NCT01737931|Antipruritics|antipruritics|mesh-ancestor
111208961|NCT01737931|Dermatologic Agents|dermatologic agents|mesh-ancestor
111208962|NCT01958489|Pravastatin|pravastatin|mesh-list
111208963|NCT01958489|Evacetrapib|evacetrapib|mesh-list
111208964|NCT01958489|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111208965|NCT01958489|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111208966|NCT01958489|Antimetabolites|antimetabolites|mesh-ancestor
111208967|NCT01958489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111208968|NCT01958489|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111208969|NCT01958489|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111208970|NCT01958489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111208971|NCT00830362|Propranolol|propranolol|mesh-list
111208972|NCT00830362|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111208973|NCT00830362|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111208974|NCT00830362|Adrenergic Agents|adrenergic agents|mesh-ancestor
111208975|NCT00830362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111208976|NCT00830362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111208977|NCT00830362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111208978|NCT00830362|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111208979|NCT00830362|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111208980|NCT00830362|Vasodilator Agents|vasodilator agents|mesh-ancestor
111208981|NCT01944839|Ranibizumab|ranibizumab|mesh-list
111208982|NCT01944839|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111208983|NCT01944839|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111208984|NCT01944839|Growth Substances|growth substances|mesh-ancestor
111208985|NCT01944839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111208986|NCT01944839|Growth Inhibitors|growth inhibitors|mesh-ancestor
111208987|NCT01944839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111208988|NCT01720225|Azacitidine|azacitidine|mesh-list
111208989|NCT01720225|Decitabine|decitabine|mesh-list
111208990|NCT01720225|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111208991|NCT01720225|Antimetabolites|antimetabolites|mesh-ancestor
111208992|NCT01720225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111208993|NCT01720225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111208994|NCT01720225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111208995|NCT01943435|Acetaminophen|acetaminophen|mesh-list
111208996|NCT01943435|Ibuprofen|ibuprofen|mesh-list
111208997|NCT01943435|Celecoxib|celecoxib|mesh-list
111208998|NCT01943435|Diclofenac|diclofenac|mesh-list
111208999|NCT01943435|Gabapentin|gabapentin|mesh-list
111209000|NCT01943435|Tramadol|tramadol|mesh-list
111209001|NCT01943435|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
111209002|NCT01943435|Analgesics|analgesics|mesh-list
111209003|NCT01943435|Mirtazapine|mirtazapine|mesh-list
111209004|NCT01943435|Trazodone|trazodone|mesh-list
111209005|NCT01943435|Sertraline|sertraline|mesh-list
111209006|NCT01943435|Nortriptyline|nortriptyline|mesh-list
111209007|NCT01943435|Antidepressive Agents|antidepressive agents|mesh-list
111209008|NCT01943435|Misoprostol|misoprostol|mesh-list
111209009|NCT01943435|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111209010|NCT01943435|Sensory System Agents|sensory system agents|mesh-ancestor
111209011|NCT01943435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111209012|NCT01943435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111209013|NCT01943435|Antipyretics|antipyretics|mesh-ancestor
111209014|NCT01943435|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111209015|NCT01943435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111209016|NCT01943435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111209017|NCT01943435|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111209018|NCT01943435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111209019|NCT01943435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111209020|NCT01943435|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111209021|NCT01943435|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111209022|NCT01943435|Abortifacient Agents|abortifacient agents|mesh-ancestor
111209023|NCT01943435|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111209024|NCT01943435|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111209025|NCT01943435|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111209026|NCT01943435|Oxytocics|oxytocics|mesh-ancestor
111209027|NCT01943435|Anticonvulsants|anticonvulsants|mesh-ancestor
111209028|NCT01943435|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111209029|NCT01943435|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111209030|NCT01943435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111209031|NCT01943435|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111209032|NCT01943435|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111209033|NCT01943435|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111209034|NCT01943435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111209035|NCT01943435|Antimanic Agents|antimanic agents|mesh-ancestor
111209036|NCT01943435|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111209037|NCT01943435|Narcotics|narcotics|mesh-ancestor
111209038|NCT01943435|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111209039|NCT01943435|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111209040|NCT01943435|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111209041|NCT01943435|Dopamine Agents|dopamine agents|mesh-ancestor
111209042|NCT01943435|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111209043|NCT01943435|Serotonin Agents|serotonin agents|mesh-ancestor
111209044|NCT01943435|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111209045|NCT01943435|Histamine Antagonists|histamine antagonists|mesh-ancestor
111209046|NCT01943435|Histamine Agents|histamine agents|mesh-ancestor
111209047|NCT01943435|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
111209048|NCT01943435|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111209049|NCT01943435|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111209050|NCT01943435|Adrenergic Agents|adrenergic agents|mesh-ancestor
111209051|NCT01943435|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111209052|NCT01943435|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111209053|NCT01943435|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111209054|NCT01943435|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111209055|NCT01943435|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
111209056|NCT01943435|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111209057|NCT01942733|Brexpiprazole|brexpiprazole|mesh-list
111209058|NCT01942733|Serotonin Agents|serotonin agents|mesh-ancestor
111209059|NCT01942733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111209060|NCT01942733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111209061|NCT01942733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111209062|NCT01942733|Dopamine Agonists|dopamine agonists|mesh-ancestor
111209063|NCT01942733|Dopamine Agents|dopamine agents|mesh-ancestor
111209064|NCT00807586|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111209065|NCT00807586|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111209066|NCT00807586|Methylprednisolone|methylprednisolone|mesh-list
111209067|NCT00807586|Prednisolone|prednisolone|mesh-list
111209068|NCT00807586|Prednisolone acetate|prednisolone acetate|mesh-list
111209069|NCT00807586|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111209070|NCT00807586|Prednisolone phosphate|prednisolone phosphate|mesh-list
111209071|NCT00807586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111209072|NCT00807586|Glucocorticoids|glucocorticoids|mesh-ancestor
111209073|NCT00807586|Hormones|hormones|mesh-ancestor
111209074|NCT00807586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111209075|NCT00807586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111209076|NCT00807586|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111209077|NCT00807586|Protective Agents|protective agents|mesh-ancestor
111209078|NCT00807586|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111209079|NCT00807586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111209080|NCT00807586|Antiemetics|antiemetics|mesh-ancestor
111209081|NCT00807586|Autonomic Agents|autonomic agents|mesh-ancestor
111209082|NCT00807586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111209083|NCT00807586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111209084|NCT01698775|Glipizide|glipizide|mesh-list
111209085|NCT01698775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111209086|NCT01698775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111209087|NCT01941095|Hydroxychloroquine|hydroxychloroquine|mesh-list
111209088|NCT01941095|Chloroquine|chloroquine|mesh-list
111209089|NCT01941095|Sulfasalazine|sulfasalazine|mesh-list
111209090|NCT01941095|Methotrexate|methotrexate|mesh-list
111209091|NCT01941095|Azathioprine|azathioprine|mesh-list
111209092|NCT01941095|Leflunomide|leflunomide|mesh-list
111209093|NCT01941095|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111209094|NCT01941095|Abortifacient Agents|abortifacient agents|mesh-ancestor
111209095|NCT01941095|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111209096|NCT01941095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111209097|NCT01941095|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111209098|NCT01941095|Antimetabolites|antimetabolites|mesh-ancestor
111209099|NCT01941095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111209100|NCT01941095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111209101|NCT01941095|Dermatologic Agents|dermatologic agents|mesh-ancestor
111209102|NCT01941095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111209103|NCT01941095|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110672912|NCT00861107|Vaccines|vaccines|mesh-list
110661972|NCT00762671|Antioxidants|antioxidants|mesh-ancestor
111209104|NCT01941095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111209105|NCT01941095|Immunologic Factors|immunologic factors|mesh-ancestor
111209106|NCT01941095|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111209107|NCT01941095|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111209108|NCT01941095|Antimalarials|antimalarials|mesh-ancestor
111209109|NCT01941095|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111209110|NCT01941095|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111209111|NCT01941095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111209112|NCT01941095|Amebicides|amebicides|mesh-ancestor
111209113|NCT01941095|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111209114|NCT01941095|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111209115|NCT01941095|Analgesics|analgesics|mesh-ancestor
111209116|NCT01941095|Sensory System Agents|sensory system agents|mesh-ancestor
111209117|NCT01941095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111209118|NCT01941095|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111209119|NCT01941095|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111209120|NCT00831766|Cytarabine|cytarabine|mesh-list
111209121|NCT00831766|Lenalidomide|lenalidomide|mesh-list
111209122|NCT00831766|Idarubicin|idarubicin|mesh-list
111209123|NCT00831766|Antineoplastic Agents|antineoplastic agents|mesh-list
111209124|NCT00831766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111209125|NCT00831766|Antimetabolites|antimetabolites|mesh-ancestor
111209126|NCT00831766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111209127|NCT00831766|Antiviral Agents|antiviral agents|mesh-ancestor
111209128|NCT00831766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111209129|NCT00831766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111209130|NCT00831766|Immunologic Factors|immunologic factors|mesh-ancestor
111209131|NCT00831766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111209132|NCT00831766|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111209133|NCT00831766|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111209134|NCT00831766|Growth Substances|growth substances|mesh-ancestor
111209135|NCT00831766|Growth Inhibitors|growth inhibitors|mesh-ancestor
111209136|NCT00831766|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111209137|NCT00831766|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111209138|NCT00831766|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111209139|NCT00831766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111209140|NCT01957709|Interferons|interferons|mesh-list
111209141|NCT01957709|Interferon-gamma|interferon-gamma|mesh-list
111209142|NCT01957709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111209143|NCT01957709|Antiviral Agents|antiviral agents|mesh-ancestor
111209144|NCT01957709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111209145|NCT00832390|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111209146|NCT00832390|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111209147|NCT00832390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111209148|NCT00832390|Incretins|incretins|mesh-ancestor
111209149|NCT00832390|Hormones|hormones|mesh-ancestor
111209150|NCT00832390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111209151|NCT00832390|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111209152|NCT00832390|Protease Inhibitors|protease inhibitors|mesh-ancestor
111209153|NCT00832390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111209154|NCT00832390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111209155|NCT00844090|Methylphenidate|methylphenidate|mesh-list
111209156|NCT00844090|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111209157|NCT00844090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111209158|NCT00844090|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111209159|NCT00844090|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111209160|NCT00844090|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111209161|NCT00844090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111209162|NCT00844090|Dopamine Agents|dopamine agents|mesh-ancestor
111209163|NCT00844090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111209164|NCT00844714|Rituximab|rituximab|mesh-list
111209165|NCT00844714|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111209166|NCT00844714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111209167|NCT00844714|Immunologic Factors|immunologic factors|mesh-ancestor
111209168|NCT00844714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111209169|NCT00844714|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111209170|NCT00834652|Metformin|metformin|mesh-list
111209171|NCT00834652|Sertraline|sertraline|mesh-list
111209172|NCT00834652|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111209173|NCT00834652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111209174|NCT00834652|Antidepressive Agents|antidepressive agents|mesh-ancestor
111209175|NCT00834652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111209176|NCT00834652|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111209177|NCT00834652|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111209178|NCT00834652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111209179|NCT00834652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111209180|NCT00834652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111209181|NCT00834652|Serotonin Agents|serotonin agents|mesh-ancestor
111209182|NCT00834808|Tramadol|tramadol|mesh-list
111209183|NCT00834808|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111209184|NCT00834808|Narcotics|narcotics|mesh-ancestor
111209185|NCT00834808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111209186|NCT00834808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111209187|NCT00834808|Analgesics|analgesics|mesh-ancestor
111209188|NCT00834808|Sensory System Agents|sensory system agents|mesh-ancestor
111209189|NCT00834808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111209190|NCT00850096|Insulin|insulin|mesh-list
111209191|NCT00850096|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111209192|NCT00850096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111209193|NCT00834886|Melatonin|melatonin|mesh-list
111209194|NCT00834886|Antioxidants|antioxidants|mesh-ancestor
111209195|NCT00834886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111209196|NCT00834886|Protective Agents|protective agents|mesh-ancestor
111209197|NCT00834886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111209198|NCT00834886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111209199|NCT00835198|Dapsone|dapsone|mesh-list
111209200|NCT00835198|Tretinoin|tretinoin|mesh-list
111209201|NCT00835198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111209202|NCT00835198|Keratolytic Agents|keratolytic agents|mesh-ancestor
111209203|NCT00835198|Dermatologic Agents|dermatologic agents|mesh-ancestor
111209204|NCT00835198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111209205|NCT00835198|Antimalarials|antimalarials|mesh-ancestor
111209206|NCT00835198|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111209207|NCT00835198|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111209208|NCT00835198|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111209209|NCT00835198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111209210|NCT00835198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111209211|NCT00835198|Leprostatic Agents|leprostatic agents|mesh-ancestor
111209212|NCT00835198|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111209213|NCT00835510|Butenafine|butenafine|mesh-list
111209214|NCT00835510|Clotrimazole|clotrimazole|mesh-list
111209215|NCT00835510|Antifungal Agents|antifungal agents|mesh-ancestor
111209216|NCT00835510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111209217|NCT00835510|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111209218|NCT00835510|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111209219|NCT00835510|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111209220|NCT00835510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111209221|NCT00835510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111209222|NCT00835510|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111209223|NCT00835510|Hormone Antagonists|hormone antagonists|mesh-ancestor
111209224|NCT00835510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111209225|NCT00835510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111209226|NCT00835900|Varenicline|varenicline|mesh-list
111209227|NCT00835900|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111209228|NCT00835900|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111209229|NCT00835900|Cholinergic Agents|cholinergic agents|mesh-ancestor
111209230|NCT00835900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111209231|NCT00835900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111209232|NCT00835900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111209233|NCT01954121|Carbamazepine|carbamazepine|mesh-list
111209234|NCT01954121|Levetiracetam|levetiracetam|mesh-list
111209235|NCT01954121|Anticonvulsants|anticonvulsants|mesh-ancestor
111209236|NCT01954121|Nootropic Agents|nootropic agents|mesh-ancestor
111209237|NCT01954121|Antimanic Agents|antimanic agents|mesh-ancestor
111209238|NCT01954121|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111209239|NCT01954121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111209240|NCT01954121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111209241|NCT01954121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111209242|NCT01954121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111209243|NCT01954121|Analgesics|analgesics|mesh-ancestor
111209244|NCT01954121|Sensory System Agents|sensory system agents|mesh-ancestor
111209245|NCT01954121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111209246|NCT01954121|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111209247|NCT01954121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111209248|NCT01954121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111209249|NCT01954121|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111209250|NCT01954121|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111209251|NCT03643744|Celecoxib|celecoxib|mesh-list
111209252|NCT03643744|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111209253|NCT03643744|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111209254|NCT03643744|Analgesics|analgesics|mesh-ancestor
111209255|NCT03643744|Sensory System Agents|sensory system agents|mesh-ancestor
111209256|NCT03643744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111209257|NCT03643744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111209258|NCT03643744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111209259|NCT03643744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111209260|NCT03643744|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111209261|NCT03643744|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111209262|NCT03643744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111209263|NCT03643744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111209264|NCT00838162|Ritonavir|ritonavir|mesh-list
111209265|NCT00838162|TMC-310911|tmc-310911|mesh-list
111209266|NCT00838162|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111209267|NCT00838162|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111209268|NCT00838162|Protease Inhibitors|protease inhibitors|mesh-ancestor
111209269|NCT00838162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111209270|NCT00838162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111209271|NCT00838162|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111209272|NCT00838162|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111209273|NCT00838162|Antiviral Agents|antiviral agents|mesh-ancestor
111209274|NCT00838162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111209275|NCT00838162|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111209276|NCT00838162|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111209277|NCT00841204|Sulindac|sulindac|mesh-list
111209278|NCT00841204|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111209279|NCT00841204|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111209280|NCT00841204|Analgesics|analgesics|mesh-ancestor
111209281|NCT00841204|Sensory System Agents|sensory system agents|mesh-ancestor
111209282|NCT00841204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111209283|NCT00841204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111209284|NCT00841204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111209285|NCT00841204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111209286|NCT00841204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111209287|NCT00841204|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111209288|NCT00841204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111209289|NCT00841204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111209290|NCT00853840|Maraviroc|maraviroc|mesh-list
111209291|NCT00853840|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
111209292|NCT00853840|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
111209293|NCT00853840|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
111209294|NCT00853840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111209295|NCT00853840|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111209296|NCT00853840|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111209297|NCT00853840|Antiviral Agents|antiviral agents|mesh-ancestor
111209298|NCT00853840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111209299|NCT00853840|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
111209300|NCT00853840|Vasodilator Agents|vasodilator agents|mesh-ancestor
111209301|NCT00853840|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111209302|NCT00853840|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111209303|NCT00853840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111209304|NCT00853840|Urological Agents|urological agents|mesh-ancestor
111209305|NCT00841828|Cyclophosphamide|cyclophosphamide|mesh-list
111209306|NCT00841828|Docetaxel|docetaxel|mesh-list
111209307|NCT00841828|Trastuzumab|trastuzumab|mesh-list
111209308|NCT00841828|Epirubicin|epirubicin|mesh-list
111209309|NCT00841828|Lapatinib|lapatinib|mesh-list
111209310|NCT00841828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111209311|NCT00841828|Immunologic Factors|immunologic factors|mesh-ancestor
111209312|NCT00841828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111209313|NCT00841828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111209314|NCT00841828|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111209315|NCT00841828|Alkylating Agents|alkylating agents|mesh-ancestor
111209316|NCT00841828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111209317|NCT00841828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111209318|NCT00841828|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111209319|NCT00841828|Tubulin Modulators|tubulin modulators|mesh-ancestor
111209320|NCT00841828|Antimitotic Agents|antimitotic agents|mesh-ancestor
111209321|NCT00841828|Mitosis Modulators|mitosis modulators|mesh-ancestor
111209322|NCT00841828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111209323|NCT00841828|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111209324|NCT00841828|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111209325|NCT00841828|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111209326|NCT00841828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111209327|NCT00841828|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111209328|NCT00855010|Pioglitazone|pioglitazone|mesh-list
111209329|NCT00855010|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111209330|NCT00855010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111209331|NCT00842608|Haloperidol|haloperidol|mesh-list
111209332|NCT00842608|Haloperidol decanoate|haloperidol decanoate|mesh-list
111209333|NCT00842608|Cholinergic Antagonists|cholinergic antagonists|mesh-list
111209334|NCT00842608|Antiemetics|antiemetics|mesh-ancestor
111209335|NCT00842608|Autonomic Agents|autonomic agents|mesh-ancestor
111209336|NCT00842608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111209337|NCT00842608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111209338|NCT00842608|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111209339|NCT00842608|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111209340|NCT00842608|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111209341|NCT00842608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111209342|NCT00842608|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111209343|NCT00842608|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111209344|NCT00842608|Dopamine Agents|dopamine agents|mesh-ancestor
111209345|NCT00842608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111209346|NCT00842608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111209347|NCT00842608|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111209348|NCT00842608|Cholinergic Agents|cholinergic agents|mesh-ancestor
111209349|NCT00856024|Ribavirin|ribavirin|mesh-list
111209350|NCT00856024|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
111209351|NCT00856024|Antimetabolites|antimetabolites|mesh-ancestor
111209352|NCT00856024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111209353|NCT00856024|Antiviral Agents|antiviral agents|mesh-ancestor
111209354|NCT00856024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111209355|NCT00856414|Botulinum Toxins|botulinum toxins|mesh-list
111209356|NCT00856414|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111209357|NCT00856414|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111209358|NCT00856414|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111209359|NCT00856414|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111209360|NCT00856414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111209361|NCT00856414|Cholinergic Agents|cholinergic agents|mesh-ancestor
111209362|NCT00856414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111209363|NCT00856414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111209364|NCT00856414|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111209365|NCT00856414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111209366|NCT00856726|Parathyroid Hormone|parathyroid hormone|mesh-list
111209367|NCT00856726|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111209368|NCT00856726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111209369|NCT00857272|Bisacodyl|bisacodyl|mesh-list
111209370|NCT00857272|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111209371|NCT00857272|Cathartics|cathartics|mesh-ancestor
111209372|NCT00857272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111209373|NCT00857272|Laxatives|laxatives|mesh-ancestor
111209374|NCT03696784|Cyclophosphamide|cyclophosphamide|mesh-list
111209375|NCT03696784|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
111209376|NCT03696784|Fludarabine|fludarabine|mesh-list
111209377|NCT03696784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111209378|NCT03696784|Immunologic Factors|immunologic factors|mesh-ancestor
111209379|NCT03696784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111209380|NCT03696784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111209381|NCT03696784|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111209382|NCT03696784|Alkylating Agents|alkylating agents|mesh-ancestor
111209383|NCT03696784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111209384|NCT03696784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111209385|NCT03696784|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111209386|NCT01682863|Glycopyrrolate|glycopyrrolate|mesh-list
111209387|NCT01682863|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111209388|NCT01682863|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111209389|NCT01682863|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111209390|NCT01682863|Cholinergic Agents|cholinergic agents|mesh-ancestor
111209391|NCT01682863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111209392|NCT01682863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111209393|NCT01682863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111209394|NCT04400890|Vitamin D|vitamin d|mesh-list
111209395|NCT04400890|Cholecalciferol|cholecalciferol|mesh-list
111209396|NCT04400890|Resveratrol|resveratrol|mesh-list
111209397|NCT04400890|Vitamins|vitamins|mesh-ancestor
111209398|NCT04400890|Micronutrients|micronutrients|mesh-ancestor
111209399|NCT04400890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111209400|NCT04400890|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111209401|NCT04400890|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111209402|NCT04400890|Antioxidants|antioxidants|mesh-ancestor
111209403|NCT04400890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111209404|NCT04400890|Protective Agents|protective agents|mesh-ancestor
111209405|NCT04400890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111209406|NCT04400890|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111209407|NCT01936649|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
111209408|NCT01936649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111209409|NCT01936649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111209410|NCT01936649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111209411|NCT01936649|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111209412|NCT04351438|Heparin|heparin|mesh-list
111209413|NCT04351438|Citric Acid|citric acid|mesh-list
111209414|NCT04351438|Sodium Citrate|sodium citrate|mesh-list
111209415|NCT04351438|Anticoagulants|anticoagulants|mesh-ancestor
111209416|NCT04351438|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
111209417|NCT04351438|Chelating Agents|chelating agents|mesh-ancestor
111209418|NCT04351438|Sequestering Agents|sequestering agents|mesh-ancestor
111209419|NCT04351438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111209420|NCT04351438|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111209421|NCT04351438|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111209422|NCT00890656|Dexamethasone|dexamethasone|mesh-list
111209423|NCT00890656|Cyclophosphamide|cyclophosphamide|mesh-list
111209424|NCT00890656|Doxorubicin|doxorubicin|mesh-list
111209425|NCT00890656|Methotrexate|methotrexate|mesh-list
111209426|NCT00890656|Vincristine|vincristine|mesh-list
111209427|NCT00890656|Asparaginase|asparaginase|mesh-list
111209428|NCT00890656|Pegaspargase|pegaspargase|mesh-list
111209429|NCT00890656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111209430|NCT00890656|Immunologic Factors|immunologic factors|mesh-ancestor
111209431|NCT00890656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111209432|NCT00890656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111209433|NCT00890656|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111209434|NCT00890656|Alkylating Agents|alkylating agents|mesh-ancestor
111209435|NCT00890656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111209436|NCT00890656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111209437|NCT00890656|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111209438|NCT00890656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111209439|NCT00890656|Antiemetics|antiemetics|mesh-ancestor
111209440|NCT00890656|Autonomic Agents|autonomic agents|mesh-ancestor
111209441|NCT00890656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111209442|NCT00890656|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111209443|NCT00890656|Glucocorticoids|glucocorticoids|mesh-ancestor
111209444|NCT00890656|Hormones|hormones|mesh-ancestor
111209445|NCT00890656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111209446|NCT00890656|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111209447|NCT00890656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111209448|NCT00890656|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111209449|NCT00890656|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111209450|NCT00890656|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111209451|NCT00890656|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111209452|NCT00890656|Abortifacient Agents|abortifacient agents|mesh-ancestor
111209453|NCT00890656|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111209454|NCT00890656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111209455|NCT00890656|Antimetabolites|antimetabolites|mesh-ancestor
111209456|NCT00890656|Dermatologic Agents|dermatologic agents|mesh-ancestor
111209457|NCT00890656|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111209458|NCT00890656|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111209459|NCT00890656|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111209460|NCT00890656|Tubulin Modulators|tubulin modulators|mesh-ancestor
111209461|NCT00890656|Antimitotic Agents|antimitotic agents|mesh-ancestor
111209462|NCT00890656|Mitosis Modulators|mitosis modulators|mesh-ancestor
111209463|NCT00814138|Methotrexate|methotrexate|mesh-list
111209464|NCT00814138|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111209465|NCT00814138|Abortifacient Agents|abortifacient agents|mesh-ancestor
111209466|NCT00814138|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111209467|NCT00814138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111209468|NCT00814138|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111209469|NCT00814138|Antimetabolites|antimetabolites|mesh-ancestor
111209470|NCT00814138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111209471|NCT00814138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111209472|NCT00814138|Dermatologic Agents|dermatologic agents|mesh-ancestor
111209473|NCT00814138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111209474|NCT00814138|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111209475|NCT00814138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111209476|NCT00814138|Immunologic Factors|immunologic factors|mesh-ancestor
111209477|NCT00814138|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110673280|NCT00877097|Hormones|hormones|mesh-ancestor
110662343|NCT01037140|Vitamin D|vitamin d|mesh-list
111209478|NCT00814138|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111209479|NCT00860938|Budesonide|budesonide|mesh-list
111209480|NCT00860938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111209481|NCT00860938|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111209482|NCT00860938|Autonomic Agents|autonomic agents|mesh-ancestor
111209483|NCT00860938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111209484|NCT00860938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111209485|NCT00860938|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111209486|NCT00860938|Respiratory System Agents|respiratory system agents|mesh-ancestor
111209487|NCT00860938|Glucocorticoids|glucocorticoids|mesh-ancestor
111209488|NCT00860938|Hormones|hormones|mesh-ancestor
111209489|NCT00860938|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111209490|NCT01719757|Oxycodone|oxycodone|mesh-list
111209491|NCT01719757|Naloxone|naloxone|mesh-list
111209492|NCT01719757|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111209493|NCT01719757|Narcotics|narcotics|mesh-ancestor
111209494|NCT01719757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111209495|NCT01719757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111209496|NCT01719757|Analgesics|analgesics|mesh-ancestor
111209497|NCT01719757|Sensory System Agents|sensory system agents|mesh-ancestor
111209498|NCT01719757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111209499|NCT01719757|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111209500|NCT01718509|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
111209501|NCT01718509|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111209502|NCT01718509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111209503|NCT01718509|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111209504|NCT01718509|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111209505|NCT01718509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111209506|NCT01718509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111209507|NCT01718509|Dopamine Agents|dopamine agents|mesh-ancestor
111209508|NCT01718509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111209509|NCT01857934|Aldesleukin|aldesleukin|mesh-list
111209510|NCT01857934|Cyclophosphamide|cyclophosphamide|mesh-list
111209511|NCT01857934|Melphalan|melphalan|mesh-list
111209512|NCT01857934|Busulfan|busulfan|mesh-list
111209513|NCT01857934|Mechlorethamine|mechlorethamine|mesh-list
111209514|NCT01857934|Doxorubicin|doxorubicin|mesh-list
111209515|NCT01857934|Etoposide|etoposide|mesh-list
111209516|NCT01857934|Vincristine|vincristine|mesh-list
111209517|NCT01857934|Topotecan|topotecan|mesh-list
111209518|NCT01857934|Interleukin-2|interleukin-2|mesh-list
111209519|NCT01857934|Molgramostim|molgramostim|mesh-list
111209520|NCT01857934|Dinutuximab|dinutuximab|mesh-list
111209521|NCT01857934|Levetiracetam|levetiracetam|mesh-list
111209522|NCT01857934|Isotretinoin|isotretinoin|mesh-list
111209523|NCT01857934|Antibodies|antibodies|mesh-list
111209524|NCT01857934|Immunoglobulins|immunoglobulins|mesh-list
111209525|NCT01857934|Sargramostim|sargramostim|mesh-list
111209526|NCT01857934|Lenograstim|lenograstim|mesh-list
111209527|NCT01857934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111209528|NCT01857934|Immunologic Factors|immunologic factors|mesh-ancestor
111209529|NCT01857934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111209530|NCT01857934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111209531|NCT01857934|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111209532|NCT01857934|Alkylating Agents|alkylating agents|mesh-ancestor
111209533|NCT01857934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111209534|NCT01857934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111209535|NCT01857934|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111209536|NCT01857934|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111209537|NCT01857934|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111209538|NCT01857934|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111209539|NCT01857934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111209540|NCT01857934|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111209541|NCT01857934|Tubulin Modulators|tubulin modulators|mesh-ancestor
111209542|NCT01857934|Antimitotic Agents|antimitotic agents|mesh-ancestor
111209543|NCT01857934|Mitosis Modulators|mitosis modulators|mesh-ancestor
111209544|NCT01857934|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111209545|NCT01857934|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111209546|NCT01857934|Analgesics|analgesics|mesh-ancestor
111209547|NCT01857934|Sensory System Agents|sensory system agents|mesh-ancestor
111209548|NCT01857934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111209549|NCT01857934|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111209550|NCT01857934|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111209551|NCT01857934|Antiviral Agents|antiviral agents|mesh-ancestor
111209552|NCT01857934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111209553|NCT01857934|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110662461|NCT01039558|Ecabet|ecabet|mesh-list
111209554|NCT01857934|Anticonvulsants|anticonvulsants|mesh-ancestor
111209555|NCT01857934|Nootropic Agents|nootropic agents|mesh-ancestor
111209556|NCT01857934|Dermatologic Agents|dermatologic agents|mesh-ancestor
111209557|NCT00862810|Vaccines|vaccines|mesh-list
111209558|NCT00862810|Immunologic Factors|immunologic factors|mesh-ancestor
111209559|NCT00862810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111209560|NCT00863122|Lapatinib|lapatinib|mesh-list
111209561|NCT00863122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111209562|NCT00863122|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111209563|NCT00863122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111209564|NCT00863122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111209565|NCT01604785|Dopamine|dopamine|mesh-list
111209566|NCT01604785|Propofol|propofol|mesh-list
111209567|NCT01604785|Dopamine Antagonists|dopamine antagonists|mesh-list
111209568|NCT01604785|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111209569|NCT01604785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111209570|NCT01604785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111209571|NCT01604785|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111209572|NCT01604785|Anesthetics, General|anesthetics, general|mesh-ancestor
111209573|NCT01604785|Anesthetics|anesthetics|mesh-ancestor
111209574|NCT01604785|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111209575|NCT01604785|Sympathomimetics|sympathomimetics|mesh-ancestor
111209576|NCT01604785|Autonomic Agents|autonomic agents|mesh-ancestor
111209577|NCT01604785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111209578|NCT01604785|Dopamine Agents|dopamine agents|mesh-ancestor
111209579|NCT01604785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111209580|NCT01604785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111209581|NCT01604785|Protective Agents|protective agents|mesh-ancestor
111209582|NCT01681849|Paroxetine|paroxetine|mesh-list
111209583|NCT01681849|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111209584|NCT01681849|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111209585|NCT01681849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111209586|NCT01681849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111209587|NCT01681849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111209588|NCT01681849|Serotonin Agents|serotonin agents|mesh-ancestor
111209589|NCT01681849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111209590|NCT01681849|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111209591|NCT01681849|Antidepressive Agents|antidepressive agents|mesh-ancestor
111209592|NCT01681849|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111209593|NCT01681849|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111209594|NCT01681849|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111209595|NCT01681849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111209596|NCT00863356|Hemostatics|hemostatics|mesh-list
111209597|NCT00863356|Chitosan|chitosan|mesh-list
111209598|NCT00863356|Coagulants|coagulants|mesh-ancestor
111209599|NCT00863356|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111209600|NCT00863356|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111209601|NCT00863356|Antimetabolites|antimetabolites|mesh-ancestor
111209602|NCT00863356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111209603|NCT00863356|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111209604|NCT00863356|Chelating Agents|chelating agents|mesh-ancestor
111209605|NCT00863356|Sequestering Agents|sequestering agents|mesh-ancestor
111209606|NCT00863434|Cytarabine|cytarabine|mesh-list
111209607|NCT00863434|Clofarabine|clofarabine|mesh-list
111209608|NCT00863434|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111209609|NCT00863434|Antimetabolites|antimetabolites|mesh-ancestor
111209610|NCT00863434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111209611|NCT00863434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111209612|NCT00863434|Antiviral Agents|antiviral agents|mesh-ancestor
111209613|NCT00863434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111209614|NCT00863434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111209615|NCT00863434|Immunologic Factors|immunologic factors|mesh-ancestor
111209616|NCT00863434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111209617|NCT04209790|Temozolomide|temozolomide|mesh-list
111209618|NCT04209790|Benzolamide|benzolamide|mesh-list
111209619|NCT04209790|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111209620|NCT04209790|Alkylating Agents|alkylating agents|mesh-ancestor
111209621|NCT04209790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111209622|NCT04209790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111209623|NCT04209790|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
111209624|NCT04209790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111209625|NCT01718353|Prednisone|prednisone|mesh-list
111209626|NCT01718353|Docetaxel|docetaxel|mesh-list
111209627|NCT01718353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111209628|NCT01718353|Tubulin Modulators|tubulin modulators|mesh-ancestor
111209629|NCT01718353|Antimitotic Agents|antimitotic agents|mesh-ancestor
111209630|NCT01718353|Mitosis Modulators|mitosis modulators|mesh-ancestor
111209631|NCT01718353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111209632|NCT01718353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111209633|NCT01718353|Glucocorticoids|glucocorticoids|mesh-ancestor
111209635|NCT01718353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111209636|NCT01718353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111209637|NCT01718353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111209638|NCT01716715|Paclitaxel|paclitaxel|mesh-list
111209639|NCT01716715|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111209640|NCT01716715|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111209641|NCT01716715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111209642|NCT01716715|Tubulin Modulators|tubulin modulators|mesh-ancestor
111209643|NCT01716715|Antimitotic Agents|antimitotic agents|mesh-ancestor
111209644|NCT01716715|Mitosis Modulators|mitosis modulators|mesh-ancestor
111209645|NCT01716715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111209646|NCT01696279|Calcium Carbonate|calcium carbonate|mesh-list
111209647|NCT01696279|Calcium|calcium|mesh-list
110980514|NCT01375010|Vitamins|vitamins|mesh-list
111209648|NCT01696279|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111209649|NCT01696279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111209650|NCT01696279|Antacids|antacids|mesh-ancestor
111209651|NCT01696279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111209652|NCT01696279|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111209653|NCT01936181|Infliximab|infliximab|mesh-list
111209654|NCT01936181|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111209655|NCT01936181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111209656|NCT01936181|Dermatologic Agents|dermatologic agents|mesh-ancestor
111209657|NCT01936181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111209658|NCT01936181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111209659|NCT01696045|Ipilimumab|ipilimumab|mesh-list
111209660|NCT01696045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111209661|NCT01696045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111209662|NCT01696045|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111209663|NCT01696045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111209664|NCT01935947|Gemcitabine|gemcitabine|mesh-list
111209665|NCT01935947|Azacitidine|azacitidine|mesh-list
111209666|NCT01935947|Docetaxel|docetaxel|mesh-list
111209667|NCT01935947|Irinotecan|irinotecan|mesh-list
111209668|NCT01935947|Pemetrexed|pemetrexed|mesh-list
111209669|NCT01935947|Camptothecin|camptothecin|mesh-list
111209670|NCT01935947|Entinostat|entinostat|mesh-list
111209671|NCT01935947|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
111209672|NCT01935947|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111209673|NCT01935947|Antimetabolites|antimetabolites|mesh-ancestor
111209674|NCT01935947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111209675|NCT01935947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111209676|NCT01935947|Tubulin Modulators|tubulin modulators|mesh-ancestor
111209677|NCT01935947|Antimitotic Agents|antimitotic agents|mesh-ancestor
111209678|NCT01935947|Mitosis Modulators|mitosis modulators|mesh-ancestor
111209679|NCT01935947|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111209680|NCT01935947|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111209681|NCT01935947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111209682|NCT01935947|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111209683|NCT01935947|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111209684|NCT01935947|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111209685|NCT02986321|Budesonide|budesonide|mesh-list
111209686|NCT02986321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111209687|NCT02986321|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111209688|NCT02986321|Autonomic Agents|autonomic agents|mesh-ancestor
111209689|NCT02986321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111209690|NCT02986321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111209691|NCT02986321|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111209692|NCT02986321|Respiratory System Agents|respiratory system agents|mesh-ancestor
111209693|NCT02986321|Glucocorticoids|glucocorticoids|mesh-ancestor
111209694|NCT02986321|Hormones|hormones|mesh-ancestor
111209695|NCT02986321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111209696|NCT01593787|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
111209697|NCT01593787|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111209698|NCT01593787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111209699|NCT01951157|Gemcitabine|gemcitabine|mesh-list
111209700|NCT01951157|Docetaxel|docetaxel|mesh-list
111209701|NCT01951157|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111209702|NCT01951157|Antimetabolites|antimetabolites|mesh-ancestor
111209703|NCT01951157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111209704|NCT01951157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111209705|NCT01951157|Tubulin Modulators|tubulin modulators|mesh-ancestor
111209706|NCT01951157|Antimitotic Agents|antimitotic agents|mesh-ancestor
111209707|NCT01951157|Mitosis Modulators|mitosis modulators|mesh-ancestor
111209709|NCT01363349|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111209710|NCT01363349|Serotonin Agents|serotonin agents|mesh-ancestor
111209711|NCT01363349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111209712|NCT01363349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111209713|NCT01363349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111209714|NCT01363349|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111209715|NCT01363349|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111209716|NCT01363349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111209717|NCT01363349|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111209718|NCT01363349|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111209719|NCT01363349|Dopamine Agents|dopamine agents|mesh-ancestor
111209720|NCT00818272|Infliximab|infliximab|mesh-list
111209721|NCT00818272|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111209722|NCT00818272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111209723|NCT00818272|Dermatologic Agents|dermatologic agents|mesh-ancestor
111209724|NCT00818272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111209725|NCT00818272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111209726|NCT00868348|Ketorolac|ketorolac|mesh-list
111209727|NCT00868348|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111209728|NCT00868348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111209729|NCT00868348|Analgesics|analgesics|mesh-ancestor
111209730|NCT00868348|Sensory System Agents|sensory system agents|mesh-ancestor
111209731|NCT00868348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111209732|NCT00868348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111209733|NCT00868348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111209734|NCT00868348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111209735|NCT00868348|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111209736|NCT00868348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111209737|NCT00868348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111209738|NCT01933919|Fluvoxamine|fluvoxamine|mesh-list
111209739|NCT01933919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111209740|NCT01933919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111209741|NCT01933919|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111209742|NCT01933919|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111209743|NCT01933919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111209744|NCT01933919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111209745|NCT01933919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111209746|NCT01933919|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111209747|NCT01933919|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111209748|NCT01933919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111209749|NCT01933919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111209750|NCT01933919|Serotonin Agents|serotonin agents|mesh-ancestor
111209751|NCT01933919|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111209752|NCT01933919|Antidepressive Agents|antidepressive agents|mesh-ancestor
111209753|NCT01933919|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111209754|NCT01933919|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111209755|NCT01933919|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111209756|NCT05317468|Contraceptive Agents|contraceptive agents|mesh-list
111209757|NCT05317468|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111209758|NCT05317468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111209759|NCT01933217|Methylphenidate|methylphenidate|mesh-list
111209760|NCT01933217|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111209761|NCT01933217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111209762|NCT01933217|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111209763|NCT01933217|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111209764|NCT01933217|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111209765|NCT01933217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111209766|NCT01933217|Dopamine Agents|dopamine agents|mesh-ancestor
111209767|NCT01933217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111209768|NCT01949051|Levocabastine|levocabastine|mesh-list
111209769|NCT01949051|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
111209770|NCT01949051|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111209771|NCT01949051|Histamine Antagonists|histamine antagonists|mesh-ancestor
111209772|NCT01949051|Histamine Agents|histamine agents|mesh-ancestor
111209773|NCT01949051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111209774|NCT01949051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111209775|NCT01949051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111209776|NCT01692301|Amlodipine|amlodipine|mesh-list
111209777|NCT01692301|Valsartan|valsartan|mesh-list
111209778|NCT01692301|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
111209779|NCT01692301|Olmesartan|olmesartan|mesh-list
111209780|NCT01692301|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
111209781|NCT01692301|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
111209782|NCT01692301|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111209783|NCT01692301|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111209784|NCT01692301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111209785|NCT01692301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111209786|NCT01692301|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111209787|NCT01692301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111209788|NCT01692301|Vasodilator Agents|vasodilator agents|mesh-ancestor
111209789|NCT01692301|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111209790|NCT01692301|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111209791|NCT01692301|Diuretics|diuretics|mesh-ancestor
111209792|NCT01692301|Natriuretic Agents|natriuretic agents|mesh-ancestor
111209793|NCT01692301|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
111209794|NCT01592773|Memantine|memantine|mesh-list
111209795|NCT01592773|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111209796|NCT01592773|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111209797|NCT01592773|Dopamine Agents|dopamine agents|mesh-ancestor
111209798|NCT01592773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111209799|NCT01592773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111209800|NCT01592773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111209801|NCT01592773|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111209802|NCT01592773|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111209803|NCT01592695|Ethanol|ethanol|mesh-list
111209804|NCT01592695|Bupropion|bupropion|mesh-list
111209805|NCT01592695|Nicotine|nicotine|mesh-list
111209806|NCT01592695|Varenicline|varenicline|mesh-list
111209807|NCT01592695|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111209808|NCT01592695|Autonomic Agents|autonomic agents|mesh-ancestor
111209809|NCT01592695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111209810|NCT01592695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111209811|NCT01592695|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111209812|NCT01592695|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111209813|NCT01592695|Cholinergic Agents|cholinergic agents|mesh-ancestor
111209814|NCT01592695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111209815|NCT01592695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111209816|NCT01592695|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111209817|NCT01592695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111209818|NCT01592695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111209819|NCT01592695|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111209820|NCT01592695|Antidepressive Agents|antidepressive agents|mesh-ancestor
111209821|NCT01592695|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111209822|NCT01592695|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111209823|NCT01592695|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111209824|NCT01592695|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111209825|NCT01592695|Dopamine Agents|dopamine agents|mesh-ancestor
111209826|NCT01592695|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111209827|NCT01592695|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111209828|NCT01592695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111209829|NCT01929863|Metformin|metformin|mesh-list
111209830|NCT01929863|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111209831|NCT01929863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111209832|NCT01714609|Sorafenib|sorafenib|mesh-list
111209833|NCT01714609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111209834|NCT01714609|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111209835|NCT01714609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111209836|NCT01714609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111209837|NCT01713283|Sofosbuvir|sofosbuvir|mesh-list
111209838|NCT01713283|Antiviral Agents|antiviral agents|mesh-ancestor
111209839|NCT01713283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111209840|NCT04768075|Paclitaxel|paclitaxel|mesh-list
111209841|NCT04768075|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111209842|NCT04768075|Carboplatin|carboplatin|mesh-list
111209843|NCT04768075|Pemetrexed|pemetrexed|mesh-list
111209844|NCT04768075|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111209845|NCT04768075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111209846|NCT04768075|Tubulin Modulators|tubulin modulators|mesh-ancestor
111209847|NCT04768075|Antimitotic Agents|antimitotic agents|mesh-ancestor
111209848|NCT04768075|Mitosis Modulators|mitosis modulators|mesh-ancestor
111209849|NCT04768075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111209850|NCT04768075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110673650|NCT00875771|Antimetabolites|antimetabolites|mesh-ancestor
111209851|NCT04768075|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111209852|NCT04768075|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111209853|NCT01592383|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111209854|NCT01592383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111209855|NCT01592383|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111209856|NCT01592383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111209857|NCT01592383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111209858|NCT01929317|Ropinirole|ropinirole|mesh-list
111209859|NCT01929317|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111209860|NCT01929317|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111209861|NCT01929317|Dopamine Agonists|dopamine agonists|mesh-ancestor
111209862|NCT01929317|Dopamine Agents|dopamine agents|mesh-ancestor
111209863|NCT01929317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111209864|NCT01929317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111209865|NCT01929317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111209866|NCT01711879|Aflibercept|aflibercept|mesh-list
111209867|NCT01711879|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111209868|NCT01711879|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111209869|NCT01711879|Growth Substances|growth substances|mesh-ancestor
111209870|NCT01711879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111209871|NCT01711879|Growth Inhibitors|growth inhibitors|mesh-ancestor
111209872|NCT01711879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111209873|NCT00869206|Zoledronic Acid|zoledronic acid|mesh-list
111209874|NCT00869206|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111209875|NCT00869206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111209876|NCT01689649|Topiramate|topiramate|mesh-list
111209877|NCT01689649|Anticonvulsants|anticonvulsants|mesh-ancestor
111209878|NCT01689649|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111209879|NCT01689649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111209880|NCT01929083|Ibutilide|ibutilide|mesh-list
111209881|NCT01929083|Progesterone|progesterone|mesh-list
111209882|NCT01929083|Progestins|progestins|mesh-ancestor
111209883|NCT01929083|Hormones|hormones|mesh-ancestor
111209884|NCT01929083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111209885|NCT01929083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111209886|NCT01929083|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111209887|NCT01688635|Insulin Glargine|insulin glargine|mesh-list
111209888|NCT01688635|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111209889|NCT01688635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111209890|NCT00891436|Fluticasone|fluticasone|mesh-list
111209891|NCT00891436|Xhance|xhance|mesh-list
111209892|NCT00891436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111209893|NCT00891436|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111209894|NCT00891436|Autonomic Agents|autonomic agents|mesh-ancestor
111209895|NCT00891436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111209896|NCT00891436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111209897|NCT00891436|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111209898|NCT00891436|Respiratory System Agents|respiratory system agents|mesh-ancestor
111209899|NCT00891436|Dermatologic Agents|dermatologic agents|mesh-ancestor
111209900|NCT00891436|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111209901|NCT01711645|Aluminum phosphate|aluminum phosphate|mesh-list
111209902|NCT01711645|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111209903|NCT01711645|Immunologic Factors|immunologic factors|mesh-ancestor
111209904|NCT01711645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111209905|NCT01711645|Antacids|antacids|mesh-ancestor
111209906|NCT01711645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111209907|NCT01711645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111209908|NCT00820534|Penciclovir|penciclovir|mesh-list
111209909|NCT00820534|Antiviral Agents|antiviral agents|mesh-ancestor
111209910|NCT00820534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111209911|NCT01590433|Exenatide|exenatide|mesh-list
111209912|NCT01590433|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111209913|NCT01590433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111209914|NCT01590433|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111209915|NCT01590433|Incretins|incretins|mesh-ancestor
111209916|NCT01590433|Hormones|hormones|mesh-ancestor
111209917|NCT01590433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111209918|NCT00820612|Indomethacin|indomethacin|mesh-list
111209919|NCT00820612|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111209920|NCT00820612|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111209921|NCT00820612|Analgesics|analgesics|mesh-ancestor
111209922|NCT00820612|Sensory System Agents|sensory system agents|mesh-ancestor
111209923|NCT00820612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111209924|NCT00820612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111209925|NCT00820612|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111209926|NCT00820612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111209928|NCT00820612|Tocolytic Agents|tocolytic agents|mesh-ancestor
111209929|NCT00820612|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111209930|NCT00820612|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111209931|NCT00820612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111209932|NCT00820612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111209933|NCT01928927|Telmisartan|telmisartan|mesh-list
111209934|NCT01928927|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111209935|NCT01928927|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111209936|NCT01928927|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111209937|NCT01928927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111209938|NCT00871624|Dexmedetomidine|dexmedetomidine|mesh-list
111209939|NCT00871624|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111209940|NCT00871624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111209941|NCT00871624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111209942|NCT00871624|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111209943|NCT00871624|Analgesics|analgesics|mesh-ancestor
111209944|NCT00871624|Sensory System Agents|sensory system agents|mesh-ancestor
111209945|NCT00871624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111209946|NCT00871624|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111209947|NCT00871624|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111209948|NCT00871624|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111209949|NCT00871624|Adrenergic Agents|adrenergic agents|mesh-ancestor
111209950|NCT00871624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111209951|NCT00871624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111209952|NCT01710709|Aripiprazole|aripiprazole|mesh-list
111209953|NCT01710709|Antidepressive Agents|antidepressive agents|mesh-ancestor
111209954|NCT01710709|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111209955|NCT01710709|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111209956|NCT01710709|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111209957|NCT01710709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111209958|NCT01710709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111209959|NCT01710709|Dopamine Agonists|dopamine agonists|mesh-ancestor
111209960|NCT01710709|Dopamine Agents|dopamine agents|mesh-ancestor
111209961|NCT01710709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111209962|NCT01710709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111209963|NCT01710709|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111209964|NCT01710709|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111209965|NCT01710709|Serotonin Agents|serotonin agents|mesh-ancestor
111209966|NCT01710709|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111209967|NCT01710709|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111209968|NCT01710709|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111209969|NCT01710709|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111209970|NCT05317546|Cannabidiol|cannabidiol|mesh-list
111209971|NCT05317546|Anticonvulsants|anticonvulsants|mesh-ancestor
111209972|NCT01709695|Guanfacine|guanfacine|mesh-list
111209973|NCT01709695|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111209974|NCT01709695|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111209975|NCT01709695|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111209976|NCT01709695|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111209977|NCT01709695|Adrenergic Agents|adrenergic agents|mesh-ancestor
111209978|NCT01709695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111209979|NCT01709695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111209980|NCT01709695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111209981|NCT05236504|Melatonin|melatonin|mesh-list
111209982|NCT05236504|Antioxidants|antioxidants|mesh-ancestor
111209983|NCT05236504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111209984|NCT05236504|Protective Agents|protective agents|mesh-ancestor
111209985|NCT05236504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111209986|NCT05236504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111209987|NCT01685983|Prednisolone|prednisolone|mesh-list
111209988|NCT01685983|Abiraterone Acetate|abiraterone acetate|mesh-list
111209989|NCT01685983|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111209990|NCT01685983|Glucocorticoids|glucocorticoids|mesh-ancestor
111209991|NCT01685983|Hormones|hormones|mesh-ancestor
111209992|NCT01685983|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111209993|NCT01685983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111209994|NCT01685983|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111209995|NCT01685983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111209996|NCT01685983|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111209997|NCT01685983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110673815|NCT01005758|Hormones|hormones|mesh-ancestor
111209998|NCT01685983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111209999|NCT01685983|Hormone Antagonists|hormone antagonists|mesh-ancestor
111210000|NCT01685983|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111210001|NCT02151448|Interferons|interferons|mesh-list
111210002|NCT02151448|Interferon-alpha|interferon-alpha|mesh-list
111210003|NCT02151448|Interferon alpha-2|interferon alpha-2|mesh-list
111210004|NCT02151448|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
111210005|NCT02151448|Celecoxib|celecoxib|mesh-list
111210006|NCT02151448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111210007|NCT02151448|Antiviral Agents|antiviral agents|mesh-ancestor
111210008|NCT02151448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111210009|NCT02151448|Immunologic Factors|immunologic factors|mesh-ancestor
111210010|NCT02151448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111210011|NCT02151448|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111210012|NCT02151448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111210013|NCT02151448|Analgesics|analgesics|mesh-ancestor
111210014|NCT02151448|Sensory System Agents|sensory system agents|mesh-ancestor
111210015|NCT02151448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111210016|NCT02151448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111210017|NCT02151448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111210018|NCT02151448|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111210019|NCT02151448|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111210020|NCT02151448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111210021|NCT02151448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111210022|NCT00875212|Calcium|calcium|mesh-list
111210023|NCT00875212|Fluorides|fluorides|mesh-list
111210024|NCT00875212|Sodium Fluoride|sodium fluoride|mesh-list
111210025|NCT00875212|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111210026|NCT00875212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111210027|NCT00875212|Cariostatic Agents|cariostatic agents|mesh-ancestor
111210028|NCT00875212|Protective Agents|protective agents|mesh-ancestor
111210029|NCT00875836|Buspirone|buspirone|mesh-list
111210030|NCT00875836|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111210031|NCT00875836|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111210032|NCT00875836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111210033|NCT00875836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111210034|NCT00875836|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111210035|NCT00875836|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111210036|NCT00875836|Serotonin Agents|serotonin agents|mesh-ancestor
111210037|NCT00875836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111210038|NCT00875836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111210039|NCT00891982|Clindamycin, tretinoin drug combination|clindamycin, tretinoin drug combination|mesh-list
111210040|NCT00891982|Dermatologic Agents|dermatologic agents|mesh-ancestor
111210041|NCT05312398|Irinotecan|irinotecan|mesh-list
111210042|NCT05312398|Cetuximab|cetuximab|mesh-list
111210043|NCT05312398|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111210044|NCT05312398|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111210045|NCT05312398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111210046|NCT05312398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111210047|NCT05312398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111210048|NCT05312398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111210049|NCT01685203|Ribavirin|ribavirin|mesh-list
111210050|NCT01685203|Antimetabolites|antimetabolites|mesh-ancestor
111210051|NCT01685203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111210052|NCT01685203|Antiviral Agents|antiviral agents|mesh-ancestor
111210053|NCT01685203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111210054|NCT01928771|Benralizumab|benralizumab|mesh-list
111210055|NCT01928771|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111210056|NCT01928771|Respiratory System Agents|respiratory system agents|mesh-ancestor
111210057|NCT01589653|Insulin|insulin|mesh-list
111210058|NCT01589653|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111210059|NCT01589653|Insulin Aspart|insulin aspart|mesh-list
111210060|NCT01589653|Insulin, Long-Acting|insulin, long-acting|mesh-list
111210061|NCT01589653|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
111210062|NCT01589653|Biphasic Insulins|biphasic insulins|mesh-list
111210063|NCT01589653|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
111210064|NCT01589653|Insulin, Isophane|insulin, isophane|mesh-list
111210065|NCT01589653|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111210066|NCT01589653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111210067|NCT01928615|Trastuzumab|trastuzumab|mesh-list
111210068|NCT01928615|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111210069|NCT01928615|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111210070|NCT01928615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111210071|NCT01589497|Moxifloxacin|moxifloxacin|mesh-list
111210072|NCT01589497|Rifampin|rifampin|mesh-list
111210073|NCT01589497|Isoniazid|isoniazid|mesh-list
111210074|NCT01589497|Pyrazinamide|pyrazinamide|mesh-list
111210075|NCT01589497|Ethambutol|ethambutol|mesh-list
111210076|NCT01589497|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111210077|NCT01589497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111210078|NCT01589497|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111210079|NCT01589497|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111210080|NCT01589497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111210081|NCT01589497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111210082|NCT01589497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111210083|NCT01589497|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111210084|NCT01589497|Antitubercular Agents|antitubercular agents|mesh-ancestor
111210085|NCT01589497|Leprostatic Agents|leprostatic agents|mesh-ancestor
111210086|NCT01589497|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111210087|NCT01589497|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111210088|NCT01589497|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111210089|NCT01589497|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
111210090|NCT01589497|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
111210091|NCT01589497|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
111210092|NCT01589497|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111210093|NCT01589497|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
111210094|NCT01589497|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111210095|NCT01589497|Antimetabolites|antimetabolites|mesh-ancestor
111210096|NCT01589497|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111210097|NCT01928381|Pregabalin|pregabalin|mesh-list
111210098|NCT01928381|Analgesics|analgesics|mesh-ancestor
111210099|NCT01928381|Sensory System Agents|sensory system agents|mesh-ancestor
111210100|NCT01928381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111210101|NCT01928381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111210102|NCT01928381|Anticonvulsants|anticonvulsants|mesh-ancestor
111210103|NCT01928381|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111210104|NCT01928381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111210105|NCT01928381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111210106|NCT01928381|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111210107|NCT01928381|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111210108|NCT01928381|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111210109|NCT01928381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111210110|NCT01928381|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111210111|NCT01928225|Vaccines|vaccines|mesh-list
111210112|NCT01928225|Immunologic Factors|immunologic factors|mesh-ancestor
111210113|NCT01928225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111210114|NCT01927757|Etanercept|etanercept|mesh-list
111210115|NCT01927757|Methotrexate|methotrexate|mesh-list
111210116|NCT01927757|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111210117|NCT01927757|Abortifacient Agents|abortifacient agents|mesh-ancestor
111210118|NCT01927757|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111210119|NCT01927757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111210120|NCT01927757|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111210121|NCT01927757|Antimetabolites|antimetabolites|mesh-ancestor
111210122|NCT01927757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111210123|NCT01927757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111210124|NCT01927757|Dermatologic Agents|dermatologic agents|mesh-ancestor
111210125|NCT01927757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111210126|NCT01927757|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111210127|NCT01927757|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111210128|NCT01927757|Immunologic Factors|immunologic factors|mesh-ancestor
111210129|NCT01927757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111210130|NCT01927757|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111210131|NCT01927757|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111210132|NCT01927757|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111210133|NCT01927757|Analgesics|analgesics|mesh-ancestor
111210134|NCT01927757|Sensory System Agents|sensory system agents|mesh-ancestor
111210135|NCT01927757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111210136|NCT01927757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111210137|NCT01927757|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111210138|NCT01913639|Leucovorin|leucovorin|mesh-list
111210139|NCT01913639|Fluorouracil|fluorouracil|mesh-list
111210140|NCT01913639|Oxaliplatin|oxaliplatin|mesh-list
111210141|NCT01913639|Antimetabolites|antimetabolites|mesh-ancestor
111210142|NCT01913639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111210143|NCT01913639|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111210144|NCT01913639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111210145|NCT01913639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111210146|NCT01913639|Immunologic Factors|immunologic factors|mesh-ancestor
111210147|NCT01913639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111210149|NCT01913639|Protective Agents|protective agents|mesh-ancestor
110789512|NCT03568474|Fluorides|fluorides|mesh-list
111210150|NCT01913639|Vitamin B Complex|vitamin b complex|mesh-ancestor
111210151|NCT01913639|Vitamins|vitamins|mesh-ancestor
111210152|NCT01913639|Micronutrients|micronutrients|mesh-ancestor
111210153|NCT01913483|Heparin|heparin|mesh-list
111210154|NCT01913483|Calcium heparin|calcium heparin|mesh-list
111210155|NCT01913483|Bivalirudin|bivalirudin|mesh-list
111210156|NCT01913483|Anticoagulants|anticoagulants|mesh-ancestor
111210157|NCT01913483|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111210158|NCT01913483|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111210159|NCT01913483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111210160|NCT01913483|Antithrombins|antithrombins|mesh-ancestor
111210161|NCT01913483|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111210162|NCT01913483|Protease Inhibitors|protease inhibitors|mesh-ancestor
111210163|NCT01913483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111210164|NCT01913405|Factor VIII|factor viii|mesh-list
111210165|NCT01913405|BAX 855|bax 855|mesh-list
111210166|NCT01913405|Coagulants|coagulants|mesh-ancestor
111210167|NCT01927055|Mannitol|mannitol|mesh-list
111210168|NCT01927055|Droxidopa|droxidopa|mesh-list
111210169|NCT01927055|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
111210170|NCT01927055|Diuretics|diuretics|mesh-ancestor
111210171|NCT01927055|Natriuretic Agents|natriuretic agents|mesh-ancestor
111210172|NCT01927055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111210173|NCT01927055|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111210174|NCT01927055|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111210175|NCT01913327|Risperidone|risperidone|mesh-list
111210176|NCT01913327|Aripiprazole|aripiprazole|mesh-list
111210177|NCT01913327|Modafinil|modafinil|mesh-list
111210178|NCT01913327|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111210179|NCT01913327|Serotonin Agents|serotonin agents|mesh-ancestor
111210180|NCT01913327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111210181|NCT01913327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111210182|NCT01913327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111210183|NCT01913327|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111210184|NCT01913327|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111210185|NCT01913327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111210186|NCT01913327|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111210187|NCT01913327|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111210188|NCT01913327|Dopamine Agents|dopamine agents|mesh-ancestor
111210189|NCT01913327|Antidepressive Agents|antidepressive agents|mesh-ancestor
111210190|NCT01913327|Dopamine Agonists|dopamine agonists|mesh-ancestor
111210191|NCT01913327|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111210192|NCT01913327|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111210193|NCT01913327|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111210194|NCT01913327|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111210195|NCT01913327|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111210196|NCT01913327|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
111210197|NCT01913327|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111210198|NCT01913327|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111210199|NCT01912781|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111210200|NCT01911845|Ribavirin|ribavirin|mesh-list
111210201|NCT01911845|Antimetabolites|antimetabolites|mesh-ancestor
111210202|NCT01911845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111210203|NCT01911845|Antiviral Agents|antiviral agents|mesh-ancestor
111210204|NCT01911845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111210205|NCT01925183|Interferons|interferons|mesh-list
111210206|NCT01925183|Ribavirin|ribavirin|mesh-list
111210207|NCT01925183|Interferon-alpha|interferon-alpha|mesh-list
111210208|NCT01925183|Interferon alpha-2|interferon alpha-2|mesh-list
111210209|NCT01925183|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
111210210|NCT01925183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111210211|NCT01925183|Antiviral Agents|antiviral agents|mesh-ancestor
111210212|NCT01925183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111210213|NCT01925183|Antimetabolites|antimetabolites|mesh-ancestor
111210214|NCT01925183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111210215|NCT01925183|Immunologic Factors|immunologic factors|mesh-ancestor
111210216|NCT01925183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111210217|NCT01910519|Vaccines|vaccines|mesh-list
111210218|NCT01910519|Immunologic Factors|immunologic factors|mesh-ancestor
111210219|NCT01910519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111210220|NCT01910441|Metformin|metformin|mesh-list
111210221|NCT01910441|Glimepiride|glimepiride|mesh-list
111210222|NCT01910441|Vildagliptin|vildagliptin|mesh-list
111210223|NCT01910441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111210224|NCT01910441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111210225|NCT01910441|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111210226|NCT01910441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111210227|NCT01910441|Immunologic Factors|immunologic factors|mesh-ancestor
111210228|NCT01910441|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111210229|NCT01910441|Protease Inhibitors|protease inhibitors|mesh-ancestor
111210230|NCT01910441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111210231|NCT01910441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111210232|NCT01923467|Nicotine|nicotine|mesh-list
111210233|NCT01923467|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111210234|NCT01923467|Autonomic Agents|autonomic agents|mesh-ancestor
111210235|NCT01923467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111210236|NCT01923467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111210237|NCT01923467|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111210238|NCT01923467|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111210239|NCT01923467|Cholinergic Agents|cholinergic agents|mesh-ancestor
111210240|NCT01923467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111210241|NCT01923467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111210242|NCT01908803|Ciprofloxacin|ciprofloxacin|mesh-list
111210243|NCT01908803|Dexamethasone|dexamethasone|mesh-list
111210244|NCT01908803|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111210245|NCT01908803|Antiemetics|antiemetics|mesh-ancestor
111210246|NCT01908803|Autonomic Agents|autonomic agents|mesh-ancestor
111210247|NCT01908803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111210248|NCT01908803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111210249|NCT01908803|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111210250|NCT01908803|Glucocorticoids|glucocorticoids|mesh-ancestor
111210251|NCT01908803|Hormones|hormones|mesh-ancestor
111210252|NCT01908803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111210253|NCT01908803|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111210254|NCT01908803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111210255|NCT01908803|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111210256|NCT01908803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111210257|NCT01908803|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111210258|NCT01908803|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111210259|NCT01908803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111210260|NCT01908803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111210261|NCT01908803|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111210262|NCT01908803|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111210263|NCT01908101|Halichondrin B|halichondrin b|mesh-list
111210264|NCT01908101|Tubulin Modulators|tubulin modulators|mesh-ancestor
111210265|NCT01908101|Antimitotic Agents|antimitotic agents|mesh-ancestor
111210266|NCT01908101|Mitosis Modulators|mitosis modulators|mesh-ancestor
111210267|NCT01908101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111210268|NCT01908101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111210269|NCT01588951|Cytarabine|cytarabine|mesh-list
111210270|NCT01588951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111210271|NCT01588951|Antimetabolites|antimetabolites|mesh-ancestor
111210272|NCT01588951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111210273|NCT01588951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111210274|NCT01588951|Antiviral Agents|antiviral agents|mesh-ancestor
111210275|NCT01588951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111210276|NCT01588951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111210277|NCT01588951|Immunologic Factors|immunologic factors|mesh-ancestor
111210278|NCT01588951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111210279|NCT01588405|Treprostinil|treprostinil|mesh-list
111210280|NCT01588405|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111210281|NCT01923311|Elvitegravir|elvitegravir|mesh-list
111210282|NCT01923311|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111210283|NCT01923311|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111210284|NCT01923311|Antiviral Agents|antiviral agents|mesh-ancestor
111210285|NCT01923311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111210286|NCT01923311|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111210287|NCT01923311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111210288|NCT01923311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111210289|NCT01603615|Botulinum Toxins|botulinum toxins|mesh-list
111210290|NCT01603615|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111210291|NCT01603615|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111210292|NCT01603615|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111210293|NCT01603615|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111210294|NCT01603615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111210295|NCT01603615|Cholinergic Agents|cholinergic agents|mesh-ancestor
111210296|NCT01603615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111210297|NCT01603615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110674101|NCT05881187|Hormone Antagonists|hormone antagonists|mesh-ancestor
111210298|NCT01603615|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111210299|NCT01603615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111210300|NCT01905683|Botulinum Toxins|botulinum toxins|mesh-list
111210301|NCT01905683|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111210302|NCT01905683|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111210303|NCT01905683|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
111210304|NCT01905683|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111210305|NCT01905683|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111210306|NCT01905683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111210307|NCT01905683|Cholinergic Agents|cholinergic agents|mesh-ancestor
111210308|NCT01905683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111210309|NCT01905683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111210310|NCT01905683|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111210311|NCT01905683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111210313|NCT01921829|Natriuretic Agents|natriuretic agents|mesh-ancestor
111210314|NCT01921829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111210315|NCT01904903|Trastuzumab|trastuzumab|mesh-list
111210316|NCT01904903|Pertuzumab|pertuzumab|mesh-list
111210317|NCT01904903|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
111210318|NCT01904903|Maytansine|maytansine|mesh-list
111210319|NCT01904903|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111210320|NCT01904903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111210321|NCT01904903|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111210322|NCT01904903|Tubulin Modulators|tubulin modulators|mesh-ancestor
111210323|NCT01904903|Antimitotic Agents|antimitotic agents|mesh-ancestor
111210324|NCT01904903|Mitosis Modulators|mitosis modulators|mesh-ancestor
111210325|NCT01904903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111210326|NCT01904903|Immunotoxins|immunotoxins|mesh-ancestor
111210327|NCT01904903|Immunoconjugates|immunoconjugates|mesh-ancestor
111210328|NCT01904903|Immunologic Factors|immunologic factors|mesh-ancestor
111210329|NCT01904903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111210330|NCT01921205|Lacosamide|lacosamide|mesh-list
111210331|NCT01921205|Anticonvulsants|anticonvulsants|mesh-ancestor
111210332|NCT01921205|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111210333|NCT01921205|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111210334|NCT01921205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111210335|NCT01921205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111210336|NCT01920893|Mometasone Furoate|mometasone furoate|mesh-list
111210337|NCT01920893|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111210338|NCT01920893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111210339|NCT01920893|Dermatologic Agents|dermatologic agents|mesh-ancestor
111210340|NCT01920893|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111210341|NCT01920893|Immunologic Factors|immunologic factors|mesh-ancestor
111210342|NCT01920893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111210343|NCT01709305|Metformin|metformin|mesh-list
111210344|NCT01709305|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111210345|NCT01709305|Glimepiride|glimepiride|mesh-list
111210346|NCT01709305|Acarbose|acarbose|mesh-list
111210347|NCT01709305|Repaglinide|repaglinide|mesh-list
111210348|NCT01709305|Gliclazide|gliclazide|mesh-list
111210349|NCT01709305|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111210350|NCT01709305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111210351|NCT01709305|Incretins|incretins|mesh-ancestor
111210352|NCT01709305|Hormones|hormones|mesh-ancestor
111210353|NCT01709305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111210354|NCT01709305|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111210355|NCT01709305|Protease Inhibitors|protease inhibitors|mesh-ancestor
111210356|NCT01709305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111210357|NCT01709305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111210358|NCT01709305|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111210359|NCT01709305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111210360|NCT01709305|Immunologic Factors|immunologic factors|mesh-ancestor
111210361|NCT01709305|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
111210362|NCT01684423|Rivaroxaban|rivaroxaban|mesh-list
111210363|NCT01684423|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111210364|NCT01684423|Antithrombins|antithrombins|mesh-ancestor
111210365|NCT01684423|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111210366|NCT01684423|Protease Inhibitors|protease inhibitors|mesh-ancestor
111210367|NCT01684423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111210368|NCT01684423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111210369|NCT01684423|Anticoagulants|anticoagulants|mesh-ancestor
111210370|NCT01709227|Furosemide|furosemide|mesh-list
111210371|NCT01709227|Diuretics|diuretics|mesh-ancestor
111210372|NCT01709227|Natriuretic Agents|natriuretic agents|mesh-ancestor
111210373|NCT01709227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111210374|NCT01709227|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110674178|NCT05880082|Cisplatin|cisplatin|mesh-list
111210375|NCT01709227|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111210376|NCT01709227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111210377|NCT00879034|Zoledronic Acid|zoledronic acid|mesh-list
111210378|NCT00879034|Pravastatin|pravastatin|mesh-list
111210379|NCT00879034|Lonafarnib|lonafarnib|mesh-list
111210380|NCT00879034|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111210381|NCT00879034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111210382|NCT00879034|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111210383|NCT00879034|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111210384|NCT00879034|Antimetabolites|antimetabolites|mesh-ancestor
111210385|NCT00879034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111210386|NCT00879034|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111210387|NCT00879034|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111210388|NCT00879034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111210389|NCT04088890|Cyclophosphamide|cyclophosphamide|mesh-list
111210390|NCT04088890|Fludarabine|fludarabine|mesh-list
111210391|NCT04088890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111210392|NCT04088890|Immunologic Factors|immunologic factors|mesh-ancestor
111210393|NCT04088890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111210394|NCT04088890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111210395|NCT04088890|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111210396|NCT04088890|Alkylating Agents|alkylating agents|mesh-ancestor
111210397|NCT04088890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111210398|NCT04088890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111210399|NCT04088890|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111210400|NCT00879190|Gentamicins|gentamicins|mesh-list
111210401|NCT00879190|Ampicillin|ampicillin|mesh-list
111210402|NCT00879190|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111210403|NCT00879190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111210404|NCT00879190|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111210405|NCT00879190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111210406|NCT00879190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111210407|NCT01903811|Dexamethasone|dexamethasone|mesh-list
111210408|NCT01903811|Dexamethasone acetate|dexamethasone acetate|mesh-list
111210409|NCT01903811|Ichthammol|ichthammol|mesh-list
111210410|NCT01903811|BB 1101|bb 1101|mesh-list
111210411|NCT01903811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111210412|NCT01903811|Antiemetics|antiemetics|mesh-ancestor
111210413|NCT01903811|Autonomic Agents|autonomic agents|mesh-ancestor
111210414|NCT01903811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111210415|NCT01903811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111210416|NCT01903811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111210417|NCT01903811|Glucocorticoids|glucocorticoids|mesh-ancestor
111210418|NCT01903811|Hormones|hormones|mesh-ancestor
111210419|NCT01903811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111210420|NCT01903811|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111210421|NCT01903811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111210422|NCT01903811|Protease Inhibitors|protease inhibitors|mesh-ancestor
111210423|NCT01903811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111210424|NCT01903811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111210425|NCT01903811|Dermatologic Agents|dermatologic agents|mesh-ancestor
111210426|NCT00880360|Denileukin diftitox|denileukin diftitox|mesh-list
111210427|NCT00880360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111210428|NCT01709149|Riluzole|riluzole|mesh-list
111210429|NCT01709149|Anticonvulsants|anticonvulsants|mesh-ancestor
111210430|NCT01709149|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111210431|NCT01709149|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111210432|NCT01709149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111210433|NCT01709149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111210434|NCT01709149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111210435|NCT01709149|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111210436|NCT01709149|Protective Agents|protective agents|mesh-ancestor
111210437|NCT05214196|Povidone-Iodine|povidone-iodine|mesh-list
111210438|NCT05214196|Povidone|povidone|mesh-list
111210439|NCT05214196|Plasma Substitutes|plasma substitutes|mesh-ancestor
111210440|NCT05214196|Blood Substitutes|blood substitutes|mesh-ancestor
111210441|NCT05214196|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111210442|NCT05214196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111210443|NCT05311228|Azithromycin|azithromycin|mesh-list
111210444|NCT05311228|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111210445|NCT05311228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111210446|NCT04382014|Curcumin|curcumin|mesh-list
111210447|NCT04382014|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111210448|NCT04382014|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111210449|NCT04382014|Analgesics|analgesics|mesh-ancestor
110663322|NCT00992030|Rituximab|rituximab|mesh-list
111210450|NCT04382014|Sensory System Agents|sensory system agents|mesh-ancestor
111210451|NCT04382014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111210452|NCT04382014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111210453|NCT04382014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111210454|NCT04382014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111210455|NCT04382014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111210456|NCT04382014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111210457|NCT04382014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111210458|NCT00892606|Morphine|morphine|mesh-list
111210459|NCT00892606|Methadone|methadone|mesh-list
111210460|NCT00892606|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111210461|NCT00892606|Narcotics|narcotics|mesh-ancestor
111210462|NCT00892606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111210463|NCT00892606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111210464|NCT00892606|Analgesics|analgesics|mesh-ancestor
111210465|NCT00892606|Sensory System Agents|sensory system agents|mesh-ancestor
111210466|NCT00892606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111210467|NCT00892606|Antitussive Agents|antitussive agents|mesh-ancestor
111210468|NCT00892606|Respiratory System Agents|respiratory system agents|mesh-ancestor
111210469|NCT04416035|Paclitaxel|paclitaxel|mesh-list
111210470|NCT04416035|Bevacizumab|bevacizumab|mesh-list
111210471|NCT04416035|Carboplatin|carboplatin|mesh-list
111210472|NCT04416035|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111210473|NCT04416035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111210474|NCT04416035|Tubulin Modulators|tubulin modulators|mesh-ancestor
111210475|NCT04416035|Antimitotic Agents|antimitotic agents|mesh-ancestor
111210476|NCT04416035|Mitosis Modulators|mitosis modulators|mesh-ancestor
111210477|NCT04416035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111210478|NCT04416035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111210479|NCT04416035|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111210480|NCT04416035|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111210481|NCT04416035|Growth Substances|growth substances|mesh-ancestor
111210482|NCT04416035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111210483|NCT04416035|Growth Inhibitors|growth inhibitors|mesh-ancestor
111210484|NCT04381858|Immunoglobulins|immunoglobulins|mesh-list
111210485|NCT04381858|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111210486|NCT04381858|Antibodies|antibodies|mesh-list
111210487|NCT04381858|Immunologic Factors|immunologic factors|mesh-ancestor
111210488|NCT04381858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111210489|NCT01903031|Ritonavir|ritonavir|mesh-list
111210490|NCT01903031|Atazanavir Sulfate|atazanavir sulfate|mesh-list
111210491|NCT01903031|Tenofovir|tenofovir|mesh-list
111210492|NCT01903031|Efavirenz|efavirenz|mesh-list
111210493|NCT01903031|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
111210494|NCT01903031|Ethinyl Estradiol|ethinyl estradiol|mesh-list
111210495|NCT01903031|Etonogestrel|etonogestrel|mesh-list
111210496|NCT01903031|NuvaRing|nuvaring|mesh-list
111210497|NCT01903031|Estradiol|estradiol|mesh-list
111210498|NCT01903031|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111210499|NCT01903031|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111210500|NCT01903031|Protease Inhibitors|protease inhibitors|mesh-ancestor
111210501|NCT01903031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111210502|NCT01903031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111210503|NCT01903031|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111210504|NCT01903031|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111210505|NCT01903031|Antiviral Agents|antiviral agents|mesh-ancestor
111210506|NCT01903031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111210507|NCT01903031|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111210508|NCT01903031|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111210509|NCT01903031|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111210510|NCT01903031|Estrogens|estrogens|mesh-ancestor
111210511|NCT01903031|Hormones|hormones|mesh-ancestor
111210512|NCT01903031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111210513|NCT01903031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111210514|NCT01903031|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111210515|NCT01903031|Contraceptive Agents|contraceptive agents|mesh-ancestor
111210516|NCT01903031|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111210517|NCT01903031|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111210518|NCT01903031|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111210519|NCT01903031|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111210520|NCT01903031|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111210521|NCT01903031|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111210522|NCT01903031|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111210523|NCT01903031|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111210524|NCT01903031|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111210525|NCT00883168|Fluticasone|fluticasone|mesh-list
111210527|NCT00883168|Azelastine|azelastine|mesh-list
111210528|NCT00883168|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111210529|NCT00883168|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111210530|NCT00883168|Autonomic Agents|autonomic agents|mesh-ancestor
111210531|NCT00883168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111210532|NCT00883168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111210533|NCT00883168|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111210534|NCT00883168|Respiratory System Agents|respiratory system agents|mesh-ancestor
111210535|NCT00883168|Dermatologic Agents|dermatologic agents|mesh-ancestor
111210536|NCT00883168|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111210537|NCT00883168|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
111210538|NCT00883168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111210539|NCT00883168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111210540|NCT00883168|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
111210541|NCT00883168|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111210542|NCT00883168|Histamine Antagonists|histamine antagonists|mesh-ancestor
111210543|NCT00883168|Histamine Agents|histamine agents|mesh-ancestor
111210544|NCT00883168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111210545|NCT01616693|Zinc|zinc|mesh-list
111210546|NCT01616693|Vaccines|vaccines|mesh-list
111210547|NCT01616693|Immunologic Factors|immunologic factors|mesh-ancestor
111210548|NCT01616693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111210549|NCT01616693|Trace Elements|trace elements|mesh-ancestor
111210550|NCT01616693|Micronutrients|micronutrients|mesh-ancestor
111210551|NCT00893074|Dronabinol|dronabinol|mesh-list
111210552|NCT00893074|Hallucinogens|hallucinogens|mesh-ancestor
111210553|NCT00893074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111210554|NCT00893074|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111210555|NCT00893074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111210556|NCT00893074|Analgesics|analgesics|mesh-ancestor
111210557|NCT00893074|Sensory System Agents|sensory system agents|mesh-ancestor
111210558|NCT00893074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111210559|NCT00893074|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
111210560|NCT00893074|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
111210561|NCT00893074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111210562|NCT00893074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111210563|NCT00893074|Hormones|hormones|mesh-ancestor
111210564|NCT00893074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111210565|NCT00885742|Fibrinolysin|fibrinolysin|mesh-list
111210566|NCT00885742|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111210567|NCT00885742|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111210568|NCT00885742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111210569|NCT00887458|Itraconazole|itraconazole|mesh-list
111210570|NCT00887458|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
111210571|NCT00887458|Antifungal Agents|antifungal agents|mesh-ancestor
111210572|NCT00887458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111210573|NCT00887458|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111210574|NCT00887458|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111210575|NCT00887458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111210576|NCT00887458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111210577|NCT00887458|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111210578|NCT00887458|Hormone Antagonists|hormone antagonists|mesh-ancestor
111210579|NCT00887458|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111210580|NCT00887458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111210581|NCT00887458|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111210582|NCT03216304|Calcium, Dietary|calcium, dietary|mesh-list
111210583|NCT03216304|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111210584|NCT03216304|Calcium|calcium|mesh-list
111210585|NCT03216304|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111210586|NCT03216304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111210587|NCT03216304|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111210588|NCT03216304|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111210589|NCT03216304|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111210590|NCT03216304|Antimetabolites|antimetabolites|mesh-ancestor
111210591|NCT03216304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111210592|NCT03216304|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111210593|NCT03216304|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111210594|NCT03216304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111210595|NCT03216538|Ammonium trichloro(dioxoethylene-O,O'-)tellurate|ammonium trichloro(dioxoethylene-o,o'-)tellurate|mesh-list
111210596|NCT03216538|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111210597|NCT03216538|Immunologic Factors|immunologic factors|mesh-ancestor
111210598|NCT03216538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111210599|NCT03216538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111210600|NCT03216538|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111210601|NCT03216538|Protective Agents|protective agents|mesh-ancestor
111210602|NCT03216538|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111210603|NCT03216538|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111210604|NCT03216538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111210605|NCT03216538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111210606|NCT03216538|Antiviral Agents|antiviral agents|mesh-ancestor
111210607|NCT03216538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111210608|NCT03218722|Thrombin|thrombin|mesh-list
111210609|NCT03218722|Hemostatics|hemostatics|mesh-ancestor
111210610|NCT03218722|Coagulants|coagulants|mesh-ancestor
111210611|NCT00888628|Etanercept|etanercept|mesh-list
111210612|NCT00888628|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111210613|NCT00888628|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111210614|NCT00888628|Analgesics|analgesics|mesh-ancestor
111210615|NCT00888628|Sensory System Agents|sensory system agents|mesh-ancestor
111210616|NCT00888628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111210617|NCT00888628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111210618|NCT00888628|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111210619|NCT00888628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111210620|NCT00888628|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111210621|NCT00888628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111210622|NCT00888628|Immunologic Factors|immunologic factors|mesh-ancestor
111210623|NCT03837886|Calcium Carbonate|calcium carbonate|mesh-list
111210624|NCT03837886|Calcium|calcium|mesh-list
111210625|NCT03837886|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111210626|NCT03837886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111210627|NCT03837886|Antacids|antacids|mesh-ancestor
111210628|NCT03837886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111210629|NCT03837886|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111210630|NCT03219970|Osimertinib|osimertinib|mesh-list
111210631|NCT03219970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111210632|NCT03219970|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111210633|NCT03219970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111210634|NCT03219970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111210635|NCT00889330|Alcaftadine|alcaftadine|mesh-list
111210636|NCT00889330|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111210637|NCT00889330|Histamine Antagonists|histamine antagonists|mesh-ancestor
111210638|NCT00889330|Histamine Agents|histamine agents|mesh-ancestor
111210639|NCT00889330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111210640|NCT00889330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111210641|NCT00889330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111210642|NCT03219580|Fluorouracil|fluorouracil|mesh-list
111210643|NCT03219580|Antimetabolites|antimetabolites|mesh-ancestor
111210644|NCT03219580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111210645|NCT03219580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111210646|NCT03219580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111210647|NCT03219580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111210648|NCT03219580|Immunologic Factors|immunologic factors|mesh-ancestor
111210649|NCT03219580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111210650|NCT03215446|Anesthetics|anesthetics|mesh-list
111210651|NCT03215446|Propofol|propofol|mesh-list
111210652|NCT03215446|Sevoflurane|sevoflurane|mesh-list
111210653|NCT03215446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111210654|NCT03215446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111210655|NCT03215446|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111210656|NCT03215446|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111210657|NCT03215446|Anesthetics, General|anesthetics, general|mesh-ancestor
111210658|NCT03215446|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111210659|NCT03215446|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111210660|NCT00896038|Aprepitant|aprepitant|mesh-list
111210661|NCT00896038|Antiemetics|antiemetics|mesh-ancestor
111210662|NCT00896038|Autonomic Agents|autonomic agents|mesh-ancestor
111210663|NCT00896038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111210664|NCT00896038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111210665|NCT00896038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111210666|NCT00896038|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
111210667|NCT00896038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111210668|NCT00896038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111210669|NCT02804074|Antihypertensive Agents|antihypertensive agents|mesh-list
111210670|NCT04381234|Citric Acid|citric acid|mesh-list
111210671|NCT04381234|Sodium Citrate|sodium citrate|mesh-list
110674478|NCT05795647|Vitamins|vitamins|mesh-ancestor
111210673|NCT04381234|Anticoagulants|anticoagulants|mesh-ancestor
111210674|NCT04381234|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
111210675|NCT04381234|Chelating Agents|chelating agents|mesh-ancestor
111210676|NCT04381234|Sequestering Agents|sequestering agents|mesh-ancestor
111210677|NCT04381234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111210678|NCT04381234|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111210679|NCT01616459|Vaccines|vaccines|mesh-list
111210680|NCT01616459|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
111210681|NCT01616459|Immunologic Factors|immunologic factors|mesh-ancestor
111210682|NCT01616459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111210683|NCT03218254|Methylphenidate|methylphenidate|mesh-list
111210684|NCT03218254|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111210685|NCT03218254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111210686|NCT03218254|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111210687|NCT03218254|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111210688|NCT03218254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111210689|NCT03218254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111210690|NCT03218254|Dopamine Agents|dopamine agents|mesh-ancestor
111210691|NCT03218254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111210692|NCT03215056|Methoxyflurane|methoxyflurane|mesh-list
111210693|NCT03215056|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111210694|NCT03215056|Anesthetics, General|anesthetics, general|mesh-ancestor
111210695|NCT03215056|Anesthetics|anesthetics|mesh-ancestor
111210696|NCT03215056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111210697|NCT03215056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111210698|NCT01919801|Icatibant|icatibant|mesh-list
111210699|NCT01919801|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111210700|NCT01919801|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111210701|NCT01919801|Analgesics|analgesics|mesh-ancestor
111210702|NCT01919801|Sensory System Agents|sensory system agents|mesh-ancestor
111210703|NCT01919801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111210704|NCT01919801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111210705|NCT01919801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111210706|NCT01919801|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111210707|NCT01919801|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
111210708|NCT01919801|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
111210709|NCT01919801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111210710|NCT01919801|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
111210711|NCT01919801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111210712|NCT01919801|Immunologic Factors|immunologic factors|mesh-ancestor
111210713|NCT01919723|Ticagrelor|ticagrelor|mesh-list
111210714|NCT01919723|Eptifibatide|eptifibatide|mesh-list
111210715|NCT01919723|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111210716|NCT01919723|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111210717|NCT01919723|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111210718|NCT01919723|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111210719|NCT01919723|Purinergic Agents|purinergic agents|mesh-ancestor
111210720|NCT01919723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111210721|NCT01919723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111210722|NCT01919723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111210723|NCT01919489|Insulin Glargine|insulin glargine|mesh-list
111210724|NCT01919489|Liraglutide|liraglutide|mesh-list
111210725|NCT01919489|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111210726|NCT01919489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111210727|NCT01919489|Incretins|incretins|mesh-ancestor
111210728|NCT01919489|Hormones|hormones|mesh-ancestor
111210729|NCT01919489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111210730|NCT01919411|Amoxicillin|amoxicillin|mesh-list
111210731|NCT01919411|Clavulanic Acid|clavulanic acid|mesh-list
111210732|NCT01919411|Clavulanic Acids|clavulanic acids|mesh-list
111210733|NCT01919411|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
111210734|NCT01919411|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111210735|NCT01919411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111210736|NCT01919411|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
111210737|NCT01919411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111210738|NCT01919411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111210739|NCT01901393|Ibuprofen|ibuprofen|mesh-list
111210740|NCT01901393|Ketorolac|ketorolac|mesh-list
111210741|NCT01901393|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
111210742|NCT01901393|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111210743|NCT01901393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111210744|NCT01901393|Analgesics|analgesics|mesh-ancestor
110790121|NCT01250457|Timolol|timolol|mesh-list
111210745|NCT01901393|Sensory System Agents|sensory system agents|mesh-ancestor
111210746|NCT01901393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111210747|NCT01901393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111210748|NCT01901393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111210749|NCT01901393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111210750|NCT01901393|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111210751|NCT01901393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111210752|NCT01901393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111210753|NCT01890707|Anesthetics|anesthetics|mesh-list
111210754|NCT01890707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111210755|NCT01890707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111210756|NCT01890473|Abatacept|abatacept|mesh-list
111210757|NCT01890473|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111210758|NCT01890473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111210759|NCT01890473|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111210760|NCT01890473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111210761|NCT01890473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111210762|NCT01890473|Immunologic Factors|immunologic factors|mesh-ancestor
111210763|NCT01890473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111210764|NCT01890473|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111210765|NCT01889069|Prednisone|prednisone|mesh-list
111210766|NCT01889069|Cyclophosphamide|cyclophosphamide|mesh-list
111210767|NCT01889069|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
111210768|NCT01889069|Rituximab|rituximab|mesh-list
111210769|NCT01889069|Doxorubicin|doxorubicin|mesh-list
111210770|NCT01889069|Vincristine|vincristine|mesh-list
111210771|NCT01889069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111210772|NCT01889069|Immunologic Factors|immunologic factors|mesh-ancestor
111210773|NCT01889069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111210774|NCT01889069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111210775|NCT01889069|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111210776|NCT01889069|Alkylating Agents|alkylating agents|mesh-ancestor
111210777|NCT01889069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111210778|NCT01889069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111210779|NCT01889069|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111210780|NCT01889069|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111210781|NCT01889069|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111210782|NCT01889069|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111210783|NCT01889069|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111210784|NCT01889069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111210785|NCT01889069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111210786|NCT01889069|Glucocorticoids|glucocorticoids|mesh-ancestor
111210787|NCT01889069|Hormones|hormones|mesh-ancestor
111210788|NCT01889069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111210789|NCT01889069|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111210790|NCT01889069|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111210791|NCT01889069|Tubulin Modulators|tubulin modulators|mesh-ancestor
111210792|NCT01889069|Antimitotic Agents|antimitotic agents|mesh-ancestor
111210793|NCT01889069|Mitosis Modulators|mitosis modulators|mesh-ancestor
111210794|NCT00898222|Aspirin|aspirin|mesh-list
111210795|NCT00898222|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111210796|NCT00898222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111210797|NCT00898222|Analgesics|analgesics|mesh-ancestor
111210798|NCT00898222|Sensory System Agents|sensory system agents|mesh-ancestor
111210799|NCT00898222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111210800|NCT00898222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111210801|NCT00898222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111210802|NCT00898222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111210803|NCT00898222|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111210804|NCT00898222|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111210805|NCT00898222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111210806|NCT00898222|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111210807|NCT00898222|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111210808|NCT00898222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111210809|NCT00898222|Antipyretics|antipyretics|mesh-ancestor
111210810|NCT01830556|Cetuximab|cetuximab|mesh-list
111210811|NCT01830556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111210812|NCT01830556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111210813|NCT03214354|Sirolimus|sirolimus|mesh-list
111210814|NCT03214354|Alemtuzumab|alemtuzumab|mesh-list
111210815|NCT03214354|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111210816|NCT03214354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111210817|NCT03214354|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110663701|NCT00774605|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111210818|NCT03214354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111210819|NCT03214354|Antifungal Agents|antifungal agents|mesh-ancestor
111210820|NCT03214354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111210821|NCT03214354|Immunologic Factors|immunologic factors|mesh-ancestor
111210822|NCT03214354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111210823|NCT03214354|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111210824|NCT03217942|Mitogens|mitogens|mesh-list
111210825|NCT03217942|Mitosis Modulators|mitosis modulators|mesh-ancestor
111210826|NCT03217942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111210827|NCT00903448|Omeprazole|omeprazole|mesh-list
111210828|NCT00903448|Lansoprazole|lansoprazole|mesh-list
111210829|NCT00903448|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111210830|NCT00903448|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111210831|NCT00903448|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111210832|NCT00903448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111210833|NCT00903448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111210834|NCT00895180|Ramucirumab|ramucirumab|mesh-list
111210835|NCT00895180|Olaratumab|olaratumab|mesh-list
111210836|NCT00895180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111210837|NCT01830868|Zonisamide|zonisamide|mesh-list
111210838|NCT01830868|Anticonvulsants|anticonvulsants|mesh-ancestor
111210839|NCT01830868|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111210840|NCT01830868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111210841|NCT01830868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111210842|NCT01830868|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111210843|NCT01830868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111210844|NCT03213964|Interleukin-2|interleukin-2|mesh-list
111210845|NCT03213964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111210846|NCT03213964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111210847|NCT03213964|Analgesics|analgesics|mesh-ancestor
111210848|NCT03213964|Sensory System Agents|sensory system agents|mesh-ancestor
111210849|NCT03213964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111210850|NCT03213964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111210851|NCT03217474|Ganciclovir|ganciclovir|mesh-list
111210852|NCT03217474|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
111210853|NCT03217474|Antiviral Agents|antiviral agents|mesh-ancestor
111210854|NCT03217474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111210855|NCT03217474|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111210856|NCT03217474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111210857|NCT03217474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111210858|NCT01830946|Caseins|caseins|mesh-list
111210859|NCT01830946|Chelating Agents|chelating agents|mesh-ancestor
111210860|NCT01830946|Sequestering Agents|sequestering agents|mesh-ancestor
111210861|NCT01830946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111210862|NCT03213886|Vitamin D|vitamin d|mesh-list
111210863|NCT03213886|Calcifediol|calcifediol|mesh-list
111210864|NCT03213886|Vitamins|vitamins|mesh-ancestor
111210865|NCT03213886|Micronutrients|micronutrients|mesh-ancestor
111210866|NCT03213886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111210867|NCT03213886|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111210868|NCT03217084|Fluorides|fluorides|mesh-list
111210869|NCT03217084|Fluorides, Topical|fluorides, topical|mesh-list
111210870|NCT03217084|Cariostatic Agents|cariostatic agents|mesh-ancestor
111210871|NCT03217084|Protective Agents|protective agents|mesh-ancestor
111210872|NCT03217084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111210873|NCT00899470|Metformin|metformin|mesh-list
111210874|NCT00899470|Saxagliptin|saxagliptin|mesh-list
111210875|NCT00899470|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111210876|NCT00899470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111210877|NCT00899470|Incretins|incretins|mesh-ancestor
111210878|NCT00899470|Hormones|hormones|mesh-ancestor
111210879|NCT00899470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111210880|NCT00899470|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111210881|NCT00899470|Protease Inhibitors|protease inhibitors|mesh-ancestor
111210882|NCT00899470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111210883|NCT00899470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111210884|NCT01738646|Bevacizumab|bevacizumab|mesh-list
111210885|NCT01738646|Vorinostat|vorinostat|mesh-list
111210886|NCT01738646|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111210887|NCT01738646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111210888|NCT01738646|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111210889|NCT01738646|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111210890|NCT01738646|Growth Substances|growth substances|mesh-ancestor
110674709|NCT05541471|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111210891|NCT01738646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111210892|NCT01738646|Growth Inhibitors|growth inhibitors|mesh-ancestor
111210893|NCT01738646|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111210894|NCT01738646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111210895|NCT01738646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111210897|NCT00904618|Anesthetics, Local|anesthetics, local|mesh-ancestor
111210898|NCT00904618|Anesthetics|anesthetics|mesh-ancestor
111210899|NCT00904618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111210900|NCT00904618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111210901|NCT00904618|Sensory System Agents|sensory system agents|mesh-ancestor
111210902|NCT00904618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111210903|NCT00904618|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111210904|NCT00904618|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111210905|NCT00904618|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111210906|NCT00904618|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111210907|NCT00904618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111210908|NCT01839370|Pramlintide|pramlintide|mesh-list
111210909|NCT01839370|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111210910|NCT01839370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111210911|NCT00907426|Bimatoprost|bimatoprost|mesh-list
111210912|NCT00907426|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111210913|NCT00907426|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111210914|NCT01832662|Caffeine|caffeine|mesh-list
111210915|NCT01832662|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111210916|NCT01832662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111210917|NCT01832662|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111210918|NCT01832662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111210919|NCT01832662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111210920|NCT01832662|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
111210921|NCT01832662|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111210922|NCT01832662|Purinergic Agents|purinergic agents|mesh-ancestor
111210923|NCT01832662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111210924|NCT00909064|PENTA|penta|mesh-list
111210925|NCT00909064|Fondaparinux|fondaparinux|mesh-list
111210926|NCT00909064|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111210927|NCT00909064|Antithrombins|antithrombins|mesh-ancestor
111210928|NCT00909064|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111210929|NCT00909064|Protease Inhibitors|protease inhibitors|mesh-ancestor
111210930|NCT00909064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111210931|NCT00909064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111210932|NCT00909064|Anticoagulants|anticoagulants|mesh-ancestor
111210933|NCT00909064|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111210934|NCT00909064|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111210935|NCT01832896|Ecallantide|ecallantide|mesh-list
111210936|NCT01832896|Analgesics|analgesics|mesh-ancestor
111210937|NCT01832896|Sensory System Agents|sensory system agents|mesh-ancestor
111210938|NCT01832896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111210939|NCT01832896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111210940|NCT01832896|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111210941|NCT01832896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111210942|NCT01832896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111210943|NCT01832896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111210944|NCT01830400|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
111210945|NCT01830400|Anticonvulsants|anticonvulsants|mesh-ancestor
111210946|NCT01830400|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111210947|NCT01830400|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111210948|NCT01830400|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111210949|NCT01830400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111210950|NCT01830478|Rituximab|rituximab|mesh-list
111210951|NCT01830478|Lenalidomide|lenalidomide|mesh-list
111210952|NCT01830478|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111210953|NCT01830478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111210954|NCT01830478|Immunologic Factors|immunologic factors|mesh-ancestor
111210955|NCT01830478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111210956|NCT01830478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111210957|NCT01830478|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111210958|NCT01830478|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111210959|NCT01830478|Growth Substances|growth substances|mesh-ancestor
111210960|NCT01830478|Growth Inhibitors|growth inhibitors|mesh-ancestor
111210961|NCT04426695|Casirivimab and imdevimab drug combination|casirivimab and imdevimab drug combination|mesh-list
111210962|NCT04426695|Antiviral Agents|antiviral agents|mesh-ancestor
111210963|NCT04426695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111210964|NCT01838200|Isoniazid|isoniazid|mesh-list
111210965|NCT01838200|Ipilimumab|ipilimumab|mesh-list
111210966|NCT01838200|BCG Vaccine|bcg vaccine|mesh-list
111210967|NCT01838200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111210968|NCT01838200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111210969|NCT01838200|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111210970|NCT01838200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111210971|NCT01838200|Antitubercular Agents|antitubercular agents|mesh-ancestor
111210972|NCT01838200|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111210973|NCT01838200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111210974|NCT01838200|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
111210975|NCT01838200|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111210976|NCT01838200|Antimetabolites|antimetabolites|mesh-ancestor
111210977|NCT01838200|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111210978|NCT01838200|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111210979|NCT01838200|Immunologic Factors|immunologic factors|mesh-ancestor
111210980|NCT01838200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111210981|NCT01720030|Simendan|simendan|mesh-list
111210982|NCT01720030|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111210983|NCT01720030|Vasodilator Agents|vasodilator agents|mesh-ancestor
111210984|NCT01720030|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
111210985|NCT01720030|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111210986|NCT01720030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111210987|NCT01720030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111210988|NCT01720030|Protective Agents|protective agents|mesh-ancestor
111210989|NCT01720030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111210990|NCT01720108|Rivaroxaban|rivaroxaban|mesh-list
111210991|NCT01720108|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111210992|NCT01720108|Antithrombins|antithrombins|mesh-ancestor
111210993|NCT01720108|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111210994|NCT01720108|Protease Inhibitors|protease inhibitors|mesh-ancestor
111210995|NCT01720108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111210996|NCT01720108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111210997|NCT01720108|Anticoagulants|anticoagulants|mesh-ancestor
111210998|NCT04380220|Protein C|protein c|mesh-list
111210999|NCT04380220|Antithrombins|antithrombins|mesh-list
111211000|NCT04380220|Protein S|protein s|mesh-list
111211001|NCT04380220|Factor VIII|factor viii|mesh-list
111211002|NCT04380220|Complement C3|complement c3|mesh-list
111211003|NCT04380220|Coagulants|coagulants|mesh-ancestor
111211004|NCT04380220|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111211005|NCT04380220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111211006|NCT04380220|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111211007|NCT04380220|Protease Inhibitors|protease inhibitors|mesh-ancestor
111211008|NCT04380220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111211009|NCT04380220|Anticoagulants|anticoagulants|mesh-ancestor
111211010|NCT04380220|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111211011|NCT04380220|Immunologic Factors|immunologic factors|mesh-ancestor
111211012|NCT04380220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111211013|NCT01832974|Pseudomonas aeruginosa exotoxin A|pseudomonas aeruginosa exotoxin a|mesh-list
111211014|NCT01832974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111211015|NCT01671813|Brentuximab Vedotin|brentuximab vedotin|mesh-list
111211016|NCT01671813|Immunoconjugates|immunoconjugates|mesh-list
111211017|NCT01671813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111211018|NCT01671813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111211019|NCT01671813|Immunotoxins|immunotoxins|mesh-ancestor
111211020|NCT01671813|Immunologic Factors|immunologic factors|mesh-ancestor
111211021|NCT01671813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111211022|NCT03830398|Acetaminophen|acetaminophen|mesh-list
111211023|NCT03830398|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111211024|NCT03830398|Analgesics|analgesics|mesh-ancestor
111211025|NCT03830398|Sensory System Agents|sensory system agents|mesh-ancestor
111211026|NCT03830398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111211027|NCT03830398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111211028|NCT03830398|Antipyretics|antipyretics|mesh-ancestor
111211029|NCT04405323|Itraconazole|itraconazole|mesh-list
111211030|NCT04405323|Antifungal Agents|antifungal agents|mesh-ancestor
111211031|NCT04405323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111211032|NCT04405323|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111211033|NCT04405323|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111211034|NCT04405323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111211035|NCT04405323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111211036|NCT04405323|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111211037|NCT04405323|Hormone Antagonists|hormone antagonists|mesh-ancestor
111211038|NCT04405323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111211039|NCT04405323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110674861|NCT06014528|Doxorubicin|doxorubicin|mesh-list
111211040|NCT04405323|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111211041|NCT01720498|Remifentanil|remifentanil|mesh-list
111211042|NCT01720498|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111211043|NCT01720498|Narcotics|narcotics|mesh-ancestor
111211044|NCT01720498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111211045|NCT01720498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111211046|NCT01720498|Analgesics|analgesics|mesh-ancestor
111211047|NCT01720498|Sensory System Agents|sensory system agents|mesh-ancestor
111211048|NCT01720498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111211050|NCT01672047|Ergocalciferols|ergocalciferols|mesh-list
111211051|NCT01672047|Vitamins|vitamins|mesh-ancestor
111211052|NCT01672047|Micronutrients|micronutrients|mesh-ancestor
111211053|NCT01672047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111211054|NCT01672047|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111211055|NCT01672047|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111211056|NCT00911326|Dextrans|dextrans|mesh-list
111211057|NCT00911326|Technetium Tc 99m Pentetate|technetium tc 99m pentetate|mesh-list
111211058|NCT00911326|Anticoagulants|anticoagulants|mesh-ancestor
111211059|NCT00911326|Plasma Substitutes|plasma substitutes|mesh-ancestor
111211060|NCT00911326|Blood Substitutes|blood substitutes|mesh-ancestor
111211061|NCT00911326|Chelating Agents|chelating agents|mesh-ancestor
111211062|NCT00911326|Sequestering Agents|sequestering agents|mesh-ancestor
111211063|NCT00911326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111211064|NCT00911326|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111211065|NCT01833676|Sevoflurane|sevoflurane|mesh-list
111211066|NCT01833676|Desflurane|desflurane|mesh-list
111211067|NCT01833676|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111211068|NCT01833676|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111211069|NCT01833676|Anesthetics, General|anesthetics, general|mesh-ancestor
111211070|NCT01833676|Anesthetics|anesthetics|mesh-ancestor
111211071|NCT01833676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111211072|NCT01833676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111211073|NCT04380376|Melphalan|melphalan|mesh-list
111211074|NCT04380376|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111211075|NCT04380376|Alkylating Agents|alkylating agents|mesh-ancestor
111211076|NCT04380376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111211077|NCT04380376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111211078|NCT04380376|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111211079|NCT04380376|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111211080|NCT04380376|Immunologic Factors|immunologic factors|mesh-ancestor
111211081|NCT04380376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111211082|NCT04380298|Ketorolac|ketorolac|mesh-list
111211083|NCT04380298|Epinephrine|epinephrine|mesh-list
111211084|NCT04380298|Ropivacaine|ropivacaine|mesh-list
111211085|NCT04380298|Anesthetics, Local|anesthetics, local|mesh-ancestor
111211086|NCT04380298|Anesthetics|anesthetics|mesh-ancestor
111211087|NCT04380298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111211088|NCT04380298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111211089|NCT04380298|Sensory System Agents|sensory system agents|mesh-ancestor
111211090|NCT04380298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111211091|NCT04380298|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111211092|NCT04380298|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111211093|NCT04380298|Adrenergic Agents|adrenergic agents|mesh-ancestor
111211094|NCT04380298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111211095|NCT04380298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111211096|NCT04380298|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111211097|NCT04380298|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111211098|NCT04380298|Autonomic Agents|autonomic agents|mesh-ancestor
111211099|NCT04380298|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111211100|NCT04380298|Respiratory System Agents|respiratory system agents|mesh-ancestor
111211101|NCT04380298|Mydriatics|mydriatics|mesh-ancestor
111211102|NCT04380298|Sympathomimetics|sympathomimetics|mesh-ancestor
111211103|NCT04380298|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111211104|NCT04380298|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111211105|NCT04380298|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111211106|NCT04380298|Analgesics|analgesics|mesh-ancestor
111211107|NCT04380298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111211108|NCT04380298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111211109|NCT04380298|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111211110|NCT04380298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111211111|NCT04164849|Aminolevulinic Acid|aminolevulinic acid|mesh-list
111211112|NCT04164849|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111211113|NCT04164849|Dermatologic Agents|dermatologic agents|mesh-ancestor
111211114|NCT03210610|Colchicine|colchicine|mesh-list
111211115|NCT03210610|Gout Suppressants|gout suppressants|mesh-ancestor
111211116|NCT03210610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111211117|NCT03210610|Tubulin Modulators|tubulin modulators|mesh-ancestor
111211118|NCT03210610|Antimitotic Agents|antimitotic agents|mesh-ancestor
111211119|NCT03210610|Mitosis Modulators|mitosis modulators|mesh-ancestor
111211120|NCT03210610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111211121|NCT03210610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111211123|NCT03152955|Ketamine|ketamine|mesh-list
111211124|NCT03152955|Ondansetron|ondansetron|mesh-list
111211125|NCT03152955|Analgesics|analgesics|mesh-ancestor
111211126|NCT03152955|Sensory System Agents|sensory system agents|mesh-ancestor
111211127|NCT03152955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111211128|NCT03152955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111211129|NCT03152955|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111211130|NCT03152955|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111211131|NCT03152955|Anesthetics, General|anesthetics, general|mesh-ancestor
111211132|NCT03152955|Anesthetics|anesthetics|mesh-ancestor
111211133|NCT03152955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111211134|NCT03152955|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111211135|NCT03152955|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111211136|NCT03152955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111211137|NCT03152955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111211138|NCT03152955|Antiemetics|antiemetics|mesh-ancestor
111211139|NCT03152955|Autonomic Agents|autonomic agents|mesh-ancestor
111211140|NCT03152955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111211141|NCT03152955|Antipruritics|antipruritics|mesh-ancestor
111211142|NCT03152955|Dermatologic Agents|dermatologic agents|mesh-ancestor
111211143|NCT03152955|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111211144|NCT03152955|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111211145|NCT03152955|Serotonin Agents|serotonin agents|mesh-ancestor
111211146|NCT03152955|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111211147|NCT03152955|Narcotics|narcotics|mesh-ancestor
111211148|NCT03152955|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111211149|NCT01676493|Codeine|codeine|mesh-list
111211150|NCT01676493|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111211151|NCT01676493|Narcotics|narcotics|mesh-ancestor
111211152|NCT01676493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111211153|NCT01676493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111211154|NCT01676493|Analgesics|analgesics|mesh-ancestor
111211155|NCT01676493|Sensory System Agents|sensory system agents|mesh-ancestor
111211156|NCT01676493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111211157|NCT01676493|Antitussive Agents|antitussive agents|mesh-ancestor
111211158|NCT01676493|Respiratory System Agents|respiratory system agents|mesh-ancestor
111211159|NCT01721434|Simendan|simendan|mesh-list
111211160|NCT01721434|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111211161|NCT01721434|Vasodilator Agents|vasodilator agents|mesh-ancestor
111211162|NCT01721434|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
111211163|NCT01721434|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111211164|NCT01721434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111211165|NCT01721434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111211166|NCT01721434|Protective Agents|protective agents|mesh-ancestor
111211167|NCT01721434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111211168|NCT03210532|Amlodipine|amlodipine|mesh-list
111211169|NCT03210532|Telmisartan|telmisartan|mesh-list
111211170|NCT03210532|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
111211171|NCT03210532|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111211172|NCT03210532|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111211173|NCT03210532|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111211174|NCT03210532|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111211175|NCT03210532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111211176|NCT03210532|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111211177|NCT03210532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111211178|NCT03210532|Vasodilator Agents|vasodilator agents|mesh-ancestor
111211179|NCT03210532|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111211180|NCT03210532|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111211181|NCT03210532|Antimetabolites|antimetabolites|mesh-ancestor
111211182|NCT03210532|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111211183|NCT03210532|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111211184|NCT03210532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111211185|NCT03210532|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111211186|NCT03210532|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111211187|NCT03152565|Avelumab|avelumab|mesh-list
111211188|NCT03152565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111211189|NCT03152565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111211190|NCT03210064|Fluorouracil|fluorouracil|mesh-list
111211191|NCT03210064|Apatinib|apatinib|mesh-list
110675009|NCT06013111|Cyclophosphamide|cyclophosphamide|mesh-list
111211192|NCT03210064|Antimetabolites|antimetabolites|mesh-ancestor
111211193|NCT03210064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111211194|NCT03210064|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111211195|NCT03210064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111211196|NCT03210064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111211197|NCT03210064|Immunologic Factors|immunologic factors|mesh-ancestor
111211198|NCT03210064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111211199|NCT03210064|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111211200|NCT03210064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111211201|NCT05372991|Atropine|atropine|mesh-list
111211202|NCT05372991|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111211203|NCT05372991|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111211204|NCT05372991|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111211205|NCT05372991|Autonomic Agents|autonomic agents|mesh-ancestor
111211206|NCT05372991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111211207|NCT05372991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111211208|NCT05372991|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111211209|NCT05372991|Respiratory System Agents|respiratory system agents|mesh-ancestor
111211210|NCT05372991|Mydriatics|mydriatics|mesh-ancestor
111211211|NCT05372991|Parasympatholytics|parasympatholytics|mesh-ancestor
111211212|NCT05372991|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111211213|NCT05372991|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111211214|NCT05372991|Cholinergic Agents|cholinergic agents|mesh-ancestor
111211215|NCT05372991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111211216|NCT05372991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111211217|NCT01672593|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111211218|NCT01672593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111211219|NCT01722448|Choline|choline|mesh-list
111211220|NCT01722448|Lipotropic Agents|lipotropic agents|mesh-ancestor
111211221|NCT01722448|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111211222|NCT01722448|Antimetabolites|antimetabolites|mesh-ancestor
111211223|NCT01722448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111211224|NCT01722448|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111211225|NCT01722448|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111211226|NCT01722448|Nootropic Agents|nootropic agents|mesh-ancestor
111211227|NCT01834768|Eplerenone|eplerenone|mesh-list
111211228|NCT01834768|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
111211229|NCT01834768|Hormone Antagonists|hormone antagonists|mesh-ancestor
111211230|NCT01834768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111211231|NCT01834768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111211232|NCT01834768|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
111211233|NCT01834768|Diuretics|diuretics|mesh-ancestor
111211234|NCT01834768|Natriuretic Agents|natriuretic agents|mesh-ancestor
111211235|NCT01834768|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111211236|NCT01672671|Paclitaxel|paclitaxel|mesh-list
111211237|NCT01672671|Doxorubicin|doxorubicin|mesh-list
111211238|NCT01672671|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111211239|NCT01672671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111211240|NCT01672671|Tubulin Modulators|tubulin modulators|mesh-ancestor
111211241|NCT01672671|Antimitotic Agents|antimitotic agents|mesh-ancestor
111211242|NCT01672671|Mitosis Modulators|mitosis modulators|mesh-ancestor
111211243|NCT01672671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111211244|NCT01672671|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111211245|NCT01672671|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111211246|NCT01672671|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111211247|NCT01672671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111211248|NCT02459457|Paclitaxel|paclitaxel|mesh-list
111211249|NCT02459457|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111211250|NCT02459457|Carboplatin|carboplatin|mesh-list
111211251|NCT02459457|Fluorouracil|fluorouracil|mesh-list
111211252|NCT02459457|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111211253|NCT02459457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111211254|NCT02459457|Tubulin Modulators|tubulin modulators|mesh-ancestor
111211255|NCT02459457|Antimitotic Agents|antimitotic agents|mesh-ancestor
111211256|NCT02459457|Mitosis Modulators|mitosis modulators|mesh-ancestor
111211257|NCT02459457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111211258|NCT02459457|Antimetabolites|antimetabolites|mesh-ancestor
111211259|NCT02459457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111211260|NCT02459457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111211261|NCT02459457|Immunologic Factors|immunologic factors|mesh-ancestor
111211262|NCT02459457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111211263|NCT01835236|Paclitaxel|paclitaxel|mesh-list
111211264|NCT01835236|Vinorelbine|vinorelbine|mesh-list
111211265|NCT01835236|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
110664156|NCT00391222|Olanzapine|olanzapine|mesh-list
111211266|NCT01835236|Trastuzumab|trastuzumab|mesh-list
111211268|NCT01835236|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111211269|NCT01835236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111211270|NCT01835236|Tubulin Modulators|tubulin modulators|mesh-ancestor
111211271|NCT01835236|Antimitotic Agents|antimitotic agents|mesh-ancestor
111211272|NCT01835236|Mitosis Modulators|mitosis modulators|mesh-ancestor
111211273|NCT01835236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111211274|NCT01835236|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111211275|NCT01835236|Immunotoxins|immunotoxins|mesh-ancestor
111211276|NCT01835236|Immunoconjugates|immunoconjugates|mesh-ancestor
111211277|NCT01835236|Immunologic Factors|immunologic factors|mesh-ancestor
111211278|NCT01835236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111211279|NCT01671891|Capecitabine|capecitabine|mesh-list
111211280|NCT01671891|Oxaliplatin|oxaliplatin|mesh-list
111211281|NCT01671891|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111211282|NCT01671891|Antimetabolites|antimetabolites|mesh-ancestor
111211283|NCT01671891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111211284|NCT01671891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111211285|NCT03152409|Aspirin|aspirin|mesh-list
111211286|NCT03152409|Salicylic Acid|salicylic acid|mesh-list
111211287|NCT03152409|Salicylates|salicylates|mesh-list
111211288|NCT03152409|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111211289|NCT03152409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111211290|NCT03152409|Analgesics|analgesics|mesh-ancestor
111211291|NCT03152409|Sensory System Agents|sensory system agents|mesh-ancestor
111211292|NCT03152409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111211293|NCT03152409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111211294|NCT03152409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111211295|NCT03152409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111211296|NCT03152409|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111211297|NCT03152409|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111211298|NCT03152409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111211299|NCT03152409|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111211300|NCT03152409|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111211301|NCT03152409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111211302|NCT03152409|Antipyretics|antipyretics|mesh-ancestor
111211303|NCT03152409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111211304|NCT03152409|Antifungal Agents|antifungal agents|mesh-ancestor
111211305|NCT03152409|Keratolytic Agents|keratolytic agents|mesh-ancestor
111211306|NCT03152409|Dermatologic Agents|dermatologic agents|mesh-ancestor
111211307|NCT01830322|Gemcitabine|gemcitabine|mesh-list
111211308|NCT01830322|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111211309|NCT01830322|Antimetabolites|antimetabolites|mesh-ancestor
111211310|NCT01830322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111211311|NCT01830322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111211312|NCT01835314|Stiripentol|stiripentol|mesh-list
111211313|NCT01835314|Anticonvulsants|anticonvulsants|mesh-ancestor
111211314|NCT01706198|Fluticasone|fluticasone|mesh-list
111211316|NCT01706198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111211317|NCT01706198|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111211318|NCT01706198|Autonomic Agents|autonomic agents|mesh-ancestor
111211319|NCT01706198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111211320|NCT01706198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111211321|NCT01706198|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111211322|NCT01706198|Respiratory System Agents|respiratory system agents|mesh-ancestor
111211323|NCT01706198|Dermatologic Agents|dermatologic agents|mesh-ancestor
111211324|NCT01706198|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111211325|NCT04378972|Vitamin D|vitamin d|mesh-list
111211326|NCT04378972|Cholecalciferol|cholecalciferol|mesh-list
111211327|NCT04378972|Curcumin|curcumin|mesh-list
111211328|NCT04378972|Tramiprosate|tramiprosate|mesh-list
111211329|NCT04378972|Vitamins|vitamins|mesh-ancestor
111211330|NCT04378972|Micronutrients|micronutrients|mesh-ancestor
111211331|NCT04378972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111211332|NCT04378972|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111211333|NCT04378972|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111211334|NCT04378972|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111211335|NCT04378972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111211336|NCT04378972|Analgesics|analgesics|mesh-ancestor
111211337|NCT04378972|Sensory System Agents|sensory system agents|mesh-ancestor
111211338|NCT04378972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111211339|NCT04378972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111211340|NCT04378972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111211341|NCT04378972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111211342|NCT04378972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111211343|NCT04378972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111211345|NCT04378972|GABA Agonists|gaba agonists|mesh-ancestor
111211346|NCT04378972|GABA Agents|gaba agents|mesh-ancestor
111211347|NCT04378972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111211348|NCT01723150|Ciprofloxacin|ciprofloxacin|mesh-list
111211349|NCT01723150|Ceftriaxone|ceftriaxone|mesh-list
111211350|NCT01723150|Ertapenem|ertapenem|mesh-list
111211351|NCT01723150|Trimethoprim|trimethoprim|mesh-list
111211352|NCT01723150|Sulfamethoxazole|sulfamethoxazole|mesh-list
111211353|NCT01723150|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111211354|NCT01723150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111211355|NCT01723150|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111211356|NCT01723150|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111211357|NCT01723150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111211358|NCT01723150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111211359|NCT01723150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111211360|NCT01723150|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111211361|NCT01723150|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111211362|NCT01723150|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111211363|NCT01723150|Antimalarials|antimalarials|mesh-ancestor
111211364|NCT01723150|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111211365|NCT01723150|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111211366|NCT01723150|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111211367|NCT01723150|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111211368|NCT01723150|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
111211369|NCT01835938|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111211370|NCT01835938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111211371|NCT01835938|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111211372|NCT01835938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111211373|NCT01835938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111211374|NCT01836016|Fluticasone|fluticasone|mesh-list
111211375|NCT01836016|Xhance|xhance|mesh-list
111211376|NCT01836016|Albuterol|albuterol|mesh-list
111211377|NCT01836016|Formoterol Fumarate|formoterol fumarate|mesh-list
111211378|NCT01836016|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
111211379|NCT01836016|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
111211380|NCT01836016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111211381|NCT01836016|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111211382|NCT01836016|Autonomic Agents|autonomic agents|mesh-ancestor
111211383|NCT01836016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111211384|NCT01836016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111211385|NCT01836016|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111211386|NCT01836016|Respiratory System Agents|respiratory system agents|mesh-ancestor
111211387|NCT01836016|Dermatologic Agents|dermatologic agents|mesh-ancestor
111211388|NCT01836016|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111211389|NCT01836016|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111211390|NCT01836016|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111211391|NCT01836016|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111211392|NCT01836016|Adrenergic Agents|adrenergic agents|mesh-ancestor
111211393|NCT01836016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111211394|NCT01836016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111211395|NCT01836016|Tocolytic Agents|tocolytic agents|mesh-ancestor
111211396|NCT01836016|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111211397|NCT01836016|Glucocorticoids|glucocorticoids|mesh-ancestor
111211398|NCT01836016|Hormones|hormones|mesh-ancestor
111211399|NCT01836016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111211400|NCT01836016|Sympathomimetics|sympathomimetics|mesh-ancestor
111211401|NCT01836094|Methylene Blue|methylene blue|mesh-list
111211402|NCT01836094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111211403|NCT01836094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111211404|NCT01726192|Ropivacaine|ropivacaine|mesh-list
111211405|NCT01726192|Anesthetics, Local|anesthetics, local|mesh-ancestor
111211406|NCT01726192|Anesthetics|anesthetics|mesh-ancestor
111211407|NCT01726192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111211408|NCT01726192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111211409|NCT01726192|Sensory System Agents|sensory system agents|mesh-ancestor
111211410|NCT01726192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111211411|NCT01836328|Methadone|methadone|mesh-list
111211412|NCT01836328|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111211413|NCT01836328|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111211414|NCT01836328|Narcotics|narcotics|mesh-ancestor
111211415|NCT01836328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111211416|NCT01836328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111211417|NCT01836328|Analgesics|analgesics|mesh-ancestor
111211419|NCT01836328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111211420|NCT01836328|Antitussive Agents|antitussive agents|mesh-ancestor
111211421|NCT01836328|Respiratory System Agents|respiratory system agents|mesh-ancestor
111211422|NCT01836406|Ketorolac|ketorolac|mesh-list
111211423|NCT01836406|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
111211424|NCT01836406|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111211425|NCT01836406|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111211426|NCT01836406|Analgesics|analgesics|mesh-ancestor
111211427|NCT01836406|Sensory System Agents|sensory system agents|mesh-ancestor
111211428|NCT01836406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111211429|NCT01836406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111211430|NCT01836406|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111211431|NCT01836406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111211432|NCT01836406|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111211433|NCT01836406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111211434|NCT01836406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111211435|NCT01836484|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
111211436|NCT01836484|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111211437|NCT01836484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111211438|NCT01726816|Probucol|probucol|mesh-list
111211439|NCT01726816|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111211440|NCT01726816|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111211441|NCT01726816|Antimetabolites|antimetabolites|mesh-ancestor
111211442|NCT01726816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111211443|NCT01726816|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111211444|NCT01726816|Antioxidants|antioxidants|mesh-ancestor
111211445|NCT01726816|Protective Agents|protective agents|mesh-ancestor
111211446|NCT01726816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111211447|NCT00915538|Budesonide|budesonide|mesh-list
111211448|NCT00915538|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
111211449|NCT00915538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111211450|NCT00915538|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111211451|NCT00915538|Autonomic Agents|autonomic agents|mesh-ancestor
111211452|NCT00915538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111211453|NCT00915538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111211454|NCT00915538|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111211455|NCT00915538|Respiratory System Agents|respiratory system agents|mesh-ancestor
111211456|NCT00915538|Glucocorticoids|glucocorticoids|mesh-ancestor
111211457|NCT00915538|Hormones|hormones|mesh-ancestor
111211458|NCT00915538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111211459|NCT01724086|Interferons|interferons|mesh-list
111211460|NCT01724086|Ritonavir|ritonavir|mesh-list
111211461|NCT01724086|Ribavirin|ribavirin|mesh-list
111211462|NCT01724086|Interferon-alpha|interferon-alpha|mesh-list
111211463|NCT01724086|Interferon alpha-2|interferon alpha-2|mesh-list
111211464|NCT01724086|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
111211465|NCT01724086|Simeprevir|simeprevir|mesh-list
111211466|NCT01724086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111211467|NCT01724086|Antiviral Agents|antiviral agents|mesh-ancestor
111211468|NCT01724086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111211469|NCT01724086|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111211470|NCT01724086|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111211471|NCT01724086|Protease Inhibitors|protease inhibitors|mesh-ancestor
111211472|NCT01724086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111211473|NCT01724086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111211474|NCT01724086|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111211475|NCT01724086|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111211476|NCT01724086|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111211477|NCT01724086|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111211478|NCT01724086|Antimetabolites|antimetabolites|mesh-ancestor
111211479|NCT01724086|Immunologic Factors|immunologic factors|mesh-ancestor
111211480|NCT01724086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111211481|NCT00913510|Cholinergic Antagonists|cholinergic antagonists|mesh-list
111211482|NCT00913510|Cholinergic Agents|cholinergic agents|mesh-ancestor
111211483|NCT00913510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111211484|NCT00913510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111211485|NCT00913510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111211486|NCT01727050|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
111211487|NCT01727050|Hemostatics|hemostatics|mesh-ancestor
111211488|NCT01727050|Coagulants|coagulants|mesh-ancestor
111211489|NCT03836638|Botulinum Toxins|botulinum toxins|mesh-list
111211490|NCT03836638|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111211491|NCT03836638|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111211492|NCT03836638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111211493|NCT03836638|Cholinergic Agents|cholinergic agents|mesh-ancestor
111211494|NCT03836638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111211495|NCT03836638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111211496|NCT01837108|Eplerenone|eplerenone|mesh-list
111211497|NCT01837108|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
111211498|NCT01837108|Hormone Antagonists|hormone antagonists|mesh-ancestor
111211499|NCT01837108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111211500|NCT01837108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111211501|NCT01837108|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
111211502|NCT01837108|Diuretics|diuretics|mesh-ancestor
111211503|NCT01837108|Natriuretic Agents|natriuretic agents|mesh-ancestor
111211504|NCT01837108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111211505|NCT01724554|Aflibercept|aflibercept|mesh-list
111211506|NCT01724554|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111211507|NCT01724554|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111211508|NCT01724554|Growth Substances|growth substances|mesh-ancestor
111211509|NCT01724554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111211510|NCT01724554|Growth Inhibitors|growth inhibitors|mesh-ancestor
111211511|NCT01724554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111211512|NCT01724788|Furosemide|furosemide|mesh-list
111211513|NCT01724788|Diuretics|diuretics|mesh-ancestor
111211514|NCT01724788|Natriuretic Agents|natriuretic agents|mesh-ancestor
111211515|NCT01724788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111211516|NCT01724788|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
111211517|NCT01724788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111211518|NCT01724788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111211519|NCT01837498|Neostigmine|neostigmine|mesh-list
111211520|NCT01837498|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111211521|NCT01837498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111211522|NCT01837498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111211523|NCT01837498|Cholinergic Agents|cholinergic agents|mesh-ancestor
111211524|NCT01837498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111211525|NCT01837498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111211526|NCT01837498|Parasympathomimetics|parasympathomimetics|mesh-ancestor
111211527|NCT01837498|Autonomic Agents|autonomic agents|mesh-ancestor
111211528|NCT01837498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111211529|NCT01705574|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
111211530|NCT01705574|Antiviral Agents|antiviral agents|mesh-ancestor
111211531|NCT01705574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111211532|NCT01705574|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111211533|NCT01705574|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111211534|NCT01837576|Calcipotriene|calcipotriene|mesh-list
111211535|NCT01837576|Dermatologic Agents|dermatologic agents|mesh-ancestor
111211536|NCT01728298|Immunomodulating Agents|immunomodulating agents|mesh-list
111211537|NCT01728298|Immunologic Factors|immunologic factors|mesh-ancestor
111211538|NCT01728298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111211539|NCT01737710|Vaccines|vaccines|mesh-list
111211540|NCT01737710|Immunologic Factors|immunologic factors|mesh-ancestor
111211541|NCT01737710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111211542|NCT01837810|Ibuprofen|ibuprofen|mesh-list
111211543|NCT01837810|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111211544|NCT01837810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111211545|NCT01837810|Analgesics|analgesics|mesh-ancestor
111211546|NCT01837810|Sensory System Agents|sensory system agents|mesh-ancestor
111211547|NCT01837810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111211548|NCT01837810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111211549|NCT01837810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111211550|NCT01837810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111211551|NCT01837810|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111211552|NCT01837810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111211553|NCT01837810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111211554|NCT01725100|Trametinib|trametinib|mesh-list
111211555|NCT01725100|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
111211556|NCT01725100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111211557|NCT01725100|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111211558|NCT01725100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111211559|NCT01725100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111211560|NCT01725100|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
111211561|NCT01725100|Protective Agents|protective agents|mesh-ancestor
111211562|NCT01725100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111211563|NCT01725100|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111211564|NCT01725100|Antioxidants|antioxidants|mesh-ancestor
111211565|NCT01725412|Thiamine|thiamine|mesh-list
111211566|NCT01725412|Vitamin B Complex|vitamin b complex|mesh-ancestor
111211567|NCT01725412|Vitamins|vitamins|mesh-ancestor
111211568|NCT01725412|Micronutrients|micronutrients|mesh-ancestor
111211569|NCT01725412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111211570|NCT01725490|Metformin|metformin|mesh-list
111211571|NCT01725490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111211572|NCT01725490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111211573|NCT03834766|Amphetamine|amphetamine|mesh-list
111211574|NCT03834766|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111211575|NCT03834766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111211576|NCT03834766|Sympathomimetics|sympathomimetics|mesh-ancestor
111211577|NCT03834766|Autonomic Agents|autonomic agents|mesh-ancestor
111211578|NCT03834766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111211579|NCT03834766|Dopamine Agents|dopamine agents|mesh-ancestor
111211580|NCT03834766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111211581|NCT03834766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111211582|NCT03834766|Adrenergic Agents|adrenergic agents|mesh-ancestor
111211583|NCT03834766|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111211584|NCT03834766|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111211585|NCT03834766|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111211586|NCT03834766|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111211587|NCT01838434|Lenalidomide|lenalidomide|mesh-list
111211588|NCT01838434|Idelalisib|idelalisib|mesh-list
111211589|NCT01838434|Immunologic Factors|immunologic factors|mesh-ancestor
111211590|NCT01838434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111211591|NCT01838434|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111211592|NCT01838434|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111211593|NCT01838434|Growth Substances|growth substances|mesh-ancestor
111211594|NCT01838434|Growth Inhibitors|growth inhibitors|mesh-ancestor
111211595|NCT01838434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111211596|NCT01838434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111211597|NCT01838434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111211598|NCT01838668|Dimethyl Fumarate|dimethyl fumarate|mesh-list
111211599|NCT01838668|Dermatologic Agents|dermatologic agents|mesh-ancestor
111211600|NCT01838668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111211601|NCT01838668|Immunologic Factors|immunologic factors|mesh-ancestor
111211602|NCT01838668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111211604|NCT04377646|Hydroxychloroquine|hydroxychloroquine|mesh-list
111211605|NCT04377646|Antimalarials|antimalarials|mesh-ancestor
111211606|NCT04377646|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111211607|NCT04377646|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111211608|NCT04377646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111211609|NCT04377646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111211610|NCT04377646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111211611|NCT04377646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111211612|NCT04377646|Trace Elements|trace elements|mesh-ancestor
111211613|NCT04377646|Micronutrients|micronutrients|mesh-ancestor
111211614|NCT04377646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111211615|NCT01728922|Vitamin D|vitamin d|mesh-list
111211616|NCT01728922|Ergocalciferols|ergocalciferols|mesh-list
111211617|NCT01728922|Cholecalciferol|cholecalciferol|mesh-list
111211618|NCT01728922|Vitamins|vitamins|mesh-list
111211619|NCT01728922|Micronutrients|micronutrients|mesh-ancestor
111211620|NCT01728922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111211621|NCT01728922|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111211622|NCT01728922|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111211623|NCT01682720|Sofosbuvir|sofosbuvir|mesh-list
111211624|NCT01682720|Antiviral Agents|antiviral agents|mesh-ancestor
111211625|NCT01682720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111211626|NCT01838902|Primaquine|primaquine|mesh-list
111211627|NCT01838902|Antimalarials|antimalarials|mesh-ancestor
111211628|NCT01838902|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111211629|NCT01838902|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111211630|NCT01838902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111211631|NCT01714544|Clocortolone pivalate|clocortolone pivalate|mesh-list
111211632|NCT01714544|Glucocorticoids|glucocorticoids|mesh-ancestor
111211633|NCT01714544|Hormones|hormones|mesh-ancestor
111211634|NCT01714544|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111211635|NCT01714544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111211636|NCT03409432|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111211637|NCT03409432|Brentuximab Vedotin|brentuximab vedotin|mesh-list
111211638|NCT03409432|Lenalidomide|lenalidomide|mesh-list
111211639|NCT03409432|Antibodies|antibodies|mesh-list
111211640|NCT03409432|Immunoglobulins|immunoglobulins|mesh-list
111211641|NCT03409432|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111211642|NCT03409432|Immunoconjugates|immunoconjugates|mesh-list
111211643|NCT03409432|Immunologic Factors|immunologic factors|mesh-ancestor
111211644|NCT03409432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111211645|NCT03409432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111211646|NCT03409432|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111211647|NCT03409432|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111211648|NCT03409432|Growth Substances|growth substances|mesh-ancestor
111211649|NCT03409432|Growth Inhibitors|growth inhibitors|mesh-ancestor
111211650|NCT03409432|Immunotoxins|immunotoxins|mesh-ancestor
111211651|NCT01703858|Pantoprazole|pantoprazole|mesh-list
111211652|NCT01703858|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111211653|NCT01703858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111211654|NCT01703858|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111211655|NCT01703858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111211656|NCT01703858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111211657|NCT01729468|Aspirin|aspirin|mesh-list
111211658|NCT01729468|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111211659|NCT01729468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111211660|NCT01729468|Analgesics|analgesics|mesh-ancestor
111211661|NCT01729468|Sensory System Agents|sensory system agents|mesh-ancestor
111211662|NCT01729468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111211663|NCT01729468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111211664|NCT01729468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111211665|NCT01729468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111211666|NCT01729468|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111211667|NCT01729468|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111211668|NCT01729468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111211669|NCT01729468|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111211670|NCT01729468|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111211671|NCT01729468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111211672|NCT01729468|Antipyretics|antipyretics|mesh-ancestor
111211673|NCT04376788|Methylene Blue|methylene blue|mesh-list
111211674|NCT04376788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111211675|NCT04376788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111211676|NCT01714310|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
111211677|NCT01714310|Fluoxetine|fluoxetine|mesh-list
111211678|NCT01714310|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111211679|NCT01714310|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111211680|NCT01714310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111211681|NCT01714310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111211682|NCT01714310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111211683|NCT01714310|Serotonin Agents|serotonin agents|mesh-ancestor
111211684|NCT01714310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111211685|NCT01714310|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111211686|NCT01714310|Antidepressive Agents|antidepressive agents|mesh-ancestor
111211687|NCT01714310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111211688|NCT01714310|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111211689|NCT01714310|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111211690|NCT01714310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111211691|NCT01714310|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111211692|NCT01714310|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111211693|NCT01714310|Dopamine Agents|dopamine agents|mesh-ancestor
111211694|NCT03401788|Belzutifan|belzutifan|mesh-list
111211695|NCT03401788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111211696|NCT01728064|Ubiquinone|ubiquinone|mesh-list
111211697|NCT01728064|Micronutrients|micronutrients|mesh-ancestor
111211698|NCT01728064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111211699|NCT03405142|Panitumumab|panitumumab|mesh-list
111211700|NCT03405142|Diethylenetriamine|diethylenetriamine|mesh-list
111211701|NCT03405142|Dextrans|dextrans|mesh-list
111211702|NCT03405142|Edetic Acid|edetic acid|mesh-list
111211703|NCT03405142|Pentetic Acid|pentetic acid|mesh-list
111211704|NCT03405142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111211705|NCT03405142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111211706|NCT03405142|Anticoagulants|anticoagulants|mesh-ancestor
111211707|NCT03405142|Plasma Substitutes|plasma substitutes|mesh-ancestor
111211708|NCT03405142|Blood Substitutes|blood substitutes|mesh-ancestor
111211709|NCT03405142|Antidotes|antidotes|mesh-ancestor
111211710|NCT03405142|Protective Agents|protective agents|mesh-ancestor
111211711|NCT03405142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111211712|NCT03405142|Chelating Agents|chelating agents|mesh-ancestor
111211713|NCT03405142|Sequestering Agents|sequestering agents|mesh-ancestor
111211714|NCT03405142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111211715|NCT03405142|Iron Chelating Agents|iron chelating agents|mesh-ancestor
111211716|NCT03405142|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
111211717|NCT03405142|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
111211719|NCT03407872|Antidepressive Agents|antidepressive agents|mesh-ancestor
111211720|NCT03407872|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111211721|NCT03834610|Tadalafil|tadalafil|mesh-list
111211722|NCT03834610|Testosterone|testosterone|mesh-list
111211723|NCT03834610|Androgens|androgens|mesh-ancestor
111211724|NCT03834610|Hormones|hormones|mesh-ancestor
111211725|NCT03834610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111211726|NCT03834610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111211727|NCT03834610|Vasodilator Agents|vasodilator agents|mesh-ancestor
111211728|NCT03834610|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111211729|NCT03834610|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111211730|NCT03834610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111211731|NCT03834610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111211732|NCT03834610|Urological Agents|urological agents|mesh-ancestor
111211733|NCT01681472|Leucovorin|leucovorin|mesh-list
111211734|NCT01681472|Tetrahydrofolates|tetrahydrofolates|mesh-list
111211735|NCT01681472|Levoleucovorin|levoleucovorin|mesh-list
111211736|NCT01681472|Antidotes|antidotes|mesh-ancestor
111211737|NCT01681472|Protective Agents|protective agents|mesh-ancestor
111211738|NCT01681472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111211739|NCT01681472|Vitamin B Complex|vitamin b complex|mesh-ancestor
111211740|NCT01681472|Vitamins|vitamins|mesh-ancestor
111211741|NCT01681472|Micronutrients|micronutrients|mesh-ancestor
111211742|NCT00915928|Perindopril|perindopril|mesh-list
111211743|NCT00915928|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
111211744|NCT00915928|Protease Inhibitors|protease inhibitors|mesh-ancestor
111211745|NCT00915928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111211746|NCT00915928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111211747|NCT00915928|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111211748|NCT03407404|Midazolam|midazolam|mesh-list
111211749|NCT03407404|Ketamine|ketamine|mesh-list
111211750|NCT03407404|Morphine|morphine|mesh-list
111211751|NCT03407404|Analgesics|analgesics|mesh-ancestor
111211752|NCT03407404|Sensory System Agents|sensory system agents|mesh-ancestor
111211753|NCT03407404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111211754|NCT03407404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111211755|NCT03407404|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111211756|NCT03407404|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111211757|NCT03407404|Anesthetics, General|anesthetics, general|mesh-ancestor
111211758|NCT03407404|Anesthetics|anesthetics|mesh-ancestor
111211759|NCT03407404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111211760|NCT03407404|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111211761|NCT03407404|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111211762|NCT03407404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111211763|NCT03407404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111211764|NCT03407404|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111211765|NCT03407404|Narcotics|narcotics|mesh-ancestor
111211766|NCT03407404|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111211767|NCT03407404|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111211768|NCT03407404|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111211769|NCT03407404|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111211770|NCT03407404|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111211771|NCT03407404|GABA Modulators|gaba modulators|mesh-ancestor
111211772|NCT03407404|GABA Agents|gaba agents|mesh-ancestor
111211773|NCT03830086|Midazolam|midazolam|mesh-list
111211774|NCT03830086|Sufentanil|sufentanil|mesh-list
111211775|NCT03830086|Bupivacaine|bupivacaine|mesh-list
111211776|NCT03830086|Propofol|propofol|mesh-list
111211777|NCT03830086|Sevoflurane|sevoflurane|mesh-list
111211778|NCT03830086|Rocuronium|rocuronium|mesh-list
111211779|NCT03830086|Anesthetics, Local|anesthetics, local|mesh-ancestor
111211780|NCT03830086|Anesthetics|anesthetics|mesh-ancestor
111211781|NCT03830086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111211782|NCT03830086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111211783|NCT03830086|Sensory System Agents|sensory system agents|mesh-ancestor
111211784|NCT03830086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111211785|NCT03830086|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111211786|NCT03830086|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111211787|NCT03830086|Anesthetics, General|anesthetics, general|mesh-ancestor
111211788|NCT03830086|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111211789|NCT03830086|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111211790|NCT03830086|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111211791|NCT03830086|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111211792|NCT03830086|GABA Modulators|gaba modulators|mesh-ancestor
110675603|NCT04138277|Antiviral Agents|antiviral agents|mesh-ancestor
111211793|NCT03830086|GABA Agents|gaba agents|mesh-ancestor
110664684|NCT00665561|Maraviroc|maraviroc|mesh-list
111211794|NCT03830086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111211795|NCT03830086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111211796|NCT03830086|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111211797|NCT03830086|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111211798|NCT03830086|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
111211799|NCT03830086|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
111211800|NCT03830086|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111211801|NCT03830086|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111211802|NCT03830086|Narcotics|narcotics|mesh-ancestor
111211803|NCT03830086|Analgesics|analgesics|mesh-ancestor
111211804|NCT02240212|Paclitaxel|paclitaxel|mesh-list
111211805|NCT02240212|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111211806|NCT02240212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111211807|NCT02240212|Tubulin Modulators|tubulin modulators|mesh-ancestor
111211808|NCT02240212|Antimitotic Agents|antimitotic agents|mesh-ancestor
111211809|NCT02240212|Mitosis Modulators|mitosis modulators|mesh-ancestor
111211810|NCT02240212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111211811|NCT01047436|Artemether|artemether|mesh-list
111211812|NCT01047436|Quinine|quinine|mesh-list
111211813|NCT01047436|Antimalarials|antimalarials|mesh-ancestor
111211814|NCT01047436|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111211815|NCT01047436|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111211816|NCT01047436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111211817|NCT01047436|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
111211818|NCT01047436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111211819|NCT01047436|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111211820|NCT01047436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111211821|NCT01047436|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111211822|NCT01047436|Analgesics|analgesics|mesh-ancestor
111211823|NCT01047436|Sensory System Agents|sensory system agents|mesh-ancestor
111211824|NCT03406936|Midazolam|midazolam|mesh-list
111211825|NCT03406936|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111211826|NCT03406936|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111211827|NCT03406936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111211828|NCT03406936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111211829|NCT03406936|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111211830|NCT03406936|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111211831|NCT03406936|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111211832|NCT03406936|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111211833|NCT03406936|Anesthetics, General|anesthetics, general|mesh-ancestor
111211834|NCT03406936|Anesthetics|anesthetics|mesh-ancestor
111211835|NCT03406936|GABA Modulators|gaba modulators|mesh-ancestor
111211836|NCT03406936|GABA Agents|gaba agents|mesh-ancestor
111211837|NCT03406936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111211838|NCT03406936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111211839|NCT02240602|Oxycodone|oxycodone|mesh-list
111211840|NCT02240602|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111211841|NCT02240602|Narcotics|narcotics|mesh-ancestor
111211842|NCT02240602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111211843|NCT02240602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111211844|NCT02240602|Analgesics|analgesics|mesh-ancestor
111211845|NCT02240602|Sensory System Agents|sensory system agents|mesh-ancestor
111211846|NCT02240602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111211847|NCT03406546|Dexmedetomidine|dexmedetomidine|mesh-list
111211848|NCT03406546|Remifentanil|remifentanil|mesh-list
111211849|NCT03406546|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111211850|NCT03406546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111211851|NCT03406546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111211852|NCT03406546|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111211853|NCT03406546|Analgesics|analgesics|mesh-ancestor
111211854|NCT03406546|Sensory System Agents|sensory system agents|mesh-ancestor
111211855|NCT03406546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111211856|NCT03406546|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111211857|NCT03406546|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111211858|NCT03406546|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111211859|NCT03406546|Adrenergic Agents|adrenergic agents|mesh-ancestor
111211860|NCT03406546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111211861|NCT03406546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111211862|NCT03406546|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111211863|NCT03406546|Narcotics|narcotics|mesh-ancestor
111211864|NCT01046110|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111211865|NCT01046110|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111211866|NCT01046110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111211867|NCT01046110|Incretins|incretins|mesh-ancestor
111211868|NCT01046110|Hormones|hormones|mesh-ancestor
111211869|NCT01046110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111211870|NCT01046110|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111211871|NCT01046110|Protease Inhibitors|protease inhibitors|mesh-ancestor
111211872|NCT01046110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111211873|NCT01046110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111211874|NCT01713530|Insulin|insulin|mesh-list
111211875|NCT01713530|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111211876|NCT01713530|Insulin Aspart|insulin aspart|mesh-list
111211877|NCT01713530|Insulin, Long-Acting|insulin, long-acting|mesh-list
111211878|NCT01713530|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
111211879|NCT01713530|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111211880|NCT01713530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111211881|NCT01045798|Caspofungin|caspofungin|mesh-list
111211882|NCT01045798|Antifungal Agents|antifungal agents|mesh-ancestor
111211883|NCT01045798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111211884|NCT01045798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111211885|NCT01045798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111211886|NCT02982694|Bevacizumab|bevacizumab|mesh-list
111211887|NCT02982694|Atezolizumab|atezolizumab|mesh-list
111211888|NCT02982694|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111211889|NCT02982694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111211890|NCT02982694|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111211891|NCT02982694|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111211892|NCT02982694|Growth Substances|growth substances|mesh-ancestor
111211893|NCT02982694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111211894|NCT02982694|Growth Inhibitors|growth inhibitors|mesh-ancestor
111211895|NCT02982694|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111211896|NCT02982694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111211897|NCT01712984|Fluconazole|fluconazole|mesh-list
111211898|NCT01712984|Vaccines|vaccines|mesh-list
111211899|NCT01712984|Immunologic Factors|immunologic factors|mesh-ancestor
111211900|NCT01712984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111211901|NCT01712984|Antifungal Agents|antifungal agents|mesh-ancestor
111211902|NCT01712984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111211903|NCT01712984|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111211904|NCT01712984|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111211905|NCT01712984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111211906|NCT01712984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111211907|NCT01712984|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111211908|NCT01712984|Hormone Antagonists|hormone antagonists|mesh-ancestor
111211909|NCT01712984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111211910|NCT01712984|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111211911|NCT01712984|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111211912|NCT00921310|Sirolimus|sirolimus|mesh-list
111211913|NCT00921310|Pemetrexed|pemetrexed|mesh-list
111211914|NCT00921310|Temsirolimus|temsirolimus|mesh-list
111211915|NCT00921310|MTOR Inhibitors|mtor inhibitors|mesh-list
111211916|NCT00921310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111211917|NCT00921310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111211918|NCT00921310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111211919|NCT00921310|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111211920|NCT00921310|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111211921|NCT00921310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111211922|NCT00921310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111211923|NCT00921310|Immunologic Factors|immunologic factors|mesh-ancestor
111211924|NCT00921310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111211925|NCT00921310|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111211926|NCT00921310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111211927|NCT00921310|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111211928|NCT00921310|Antifungal Agents|antifungal agents|mesh-ancestor
111211929|NCT02241148|Acetaminophen|acetaminophen|mesh-list
111211930|NCT02241148|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111211931|NCT02241148|Analgesics|analgesics|mesh-ancestor
111211932|NCT02241148|Sensory System Agents|sensory system agents|mesh-ancestor
111211933|NCT02241148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111211934|NCT02241148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111211935|NCT02241148|Antipyretics|antipyretics|mesh-ancestor
111211936|NCT01712516|Glycopyrrolate|glycopyrrolate|mesh-list
111211937|NCT01712516|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111211938|NCT01712516|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111211939|NCT01712516|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111211940|NCT01712516|Cholinergic Agents|cholinergic agents|mesh-ancestor
111211941|NCT01712516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111211942|NCT01712516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111211943|NCT01712516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110675753|NCT03270059|Hematinics|hematinics|mesh-ancestor
111211944|NCT01040728|Tiotropium Bromide|tiotropium bromide|mesh-list
111211945|NCT01040728|Olodaterol|olodaterol|mesh-list
111211946|NCT01040728|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111211947|NCT01040728|Autonomic Agents|autonomic agents|mesh-ancestor
111211948|NCT01040728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111211949|NCT01040728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111211950|NCT01040728|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111211951|NCT01040728|Respiratory System Agents|respiratory system agents|mesh-ancestor
111211952|NCT01040728|Parasympatholytics|parasympatholytics|mesh-ancestor
111211953|NCT01040728|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111211954|NCT01040728|Cholinergic Agents|cholinergic agents|mesh-ancestor
111211955|NCT01040728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111211956|NCT01040728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111211957|NCT01593020|Paclitaxel|paclitaxel|mesh-list
111211958|NCT01593020|Cyclophosphamide|cyclophosphamide|mesh-list
111211959|NCT01593020|Doxorubicin|doxorubicin|mesh-list
111211960|NCT01593020|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111211961|NCT01593020|Fluorouracil|fluorouracil|mesh-list
111211962|NCT01593020|Epirubicin|epirubicin|mesh-list
111211963|NCT01593020|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111211964|NCT01593020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111211965|NCT01593020|Tubulin Modulators|tubulin modulators|mesh-ancestor
111211966|NCT01593020|Antimitotic Agents|antimitotic agents|mesh-ancestor
111211967|NCT01593020|Mitosis Modulators|mitosis modulators|mesh-ancestor
111211968|NCT01593020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111211969|NCT01593020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111211970|NCT01593020|Immunologic Factors|immunologic factors|mesh-ancestor
111211971|NCT01593020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111211972|NCT01593020|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111211973|NCT01593020|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111211974|NCT01593020|Alkylating Agents|alkylating agents|mesh-ancestor
111211975|NCT01593020|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111211976|NCT01593020|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111211977|NCT01593020|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111211978|NCT01593020|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111211979|NCT01593020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111211980|NCT01593020|Antimetabolites|antimetabolites|mesh-ancestor
111211981|NCT01593020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111211982|NCT01040260|Nicotine|nicotine|mesh-list
111211983|NCT01040260|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111211984|NCT01040260|Autonomic Agents|autonomic agents|mesh-ancestor
111211985|NCT01040260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111211986|NCT01040260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111211987|NCT01040260|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111211988|NCT01040260|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111211989|NCT01040260|Cholinergic Agents|cholinergic agents|mesh-ancestor
111211990|NCT01040260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111211991|NCT01040260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111211992|NCT01046422|Metformin|metformin|mesh-list
111211993|NCT01046422|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111211994|NCT01046422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111211995|NCT03405376|Aflibercept|aflibercept|mesh-list
111211996|NCT03405376|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111211997|NCT03405376|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111211998|NCT03405376|Growth Substances|growth substances|mesh-ancestor
111211999|NCT03405376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111212000|NCT03405376|Growth Inhibitors|growth inhibitors|mesh-ancestor
111212001|NCT03405376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111212002|NCT02241460|Lidocaine|lidocaine|mesh-list
111212003|NCT02241460|Anesthetics, Local|anesthetics, local|mesh-ancestor
111212004|NCT02241460|Anesthetics|anesthetics|mesh-ancestor
111212005|NCT02241460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111212006|NCT02241460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111212007|NCT02241460|Sensory System Agents|sensory system agents|mesh-ancestor
111212008|NCT02241460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111212009|NCT02241460|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111212010|NCT02241460|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111212011|NCT02241460|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111212012|NCT02241460|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111212013|NCT02241460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111212014|NCT01712204|Febuxostat|febuxostat|mesh-list
111212015|NCT01712204|Gout Suppressants|gout suppressants|mesh-ancestor
111212016|NCT01712204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111212017|NCT01592864|Fluorides|fluorides|mesh-list
111212018|NCT01592864|Tin Fluorides|tin fluorides|mesh-list
111212019|NCT01592864|Fluorophosphate|fluorophosphate|mesh-list
111212020|NCT01592864|Cariostatic Agents|cariostatic agents|mesh-ancestor
111212021|NCT01592864|Protective Agents|protective agents|mesh-ancestor
111212022|NCT01592864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111212023|NCT01592786|Memantine|memantine|mesh-list
111212024|NCT01592786|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111212025|NCT01592786|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111212026|NCT01592786|Dopamine Agents|dopamine agents|mesh-ancestor
111212027|NCT01592786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111212028|NCT01592786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111212029|NCT01592786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111212030|NCT01592786|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111212031|NCT01592786|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111212032|NCT01592708|Erythromycin|erythromycin|mesh-list
111212033|NCT01592708|Ibuprofen|ibuprofen|mesh-list
111212034|NCT01592708|Ketorolac|ketorolac|mesh-list
111212035|NCT01592708|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111212036|NCT01592708|Fentanyl|fentanyl|mesh-list
111212037|NCT01592708|Scopolamine|scopolamine|mesh-list
111212038|NCT01592708|Droperidol|droperidol|mesh-list
111212039|NCT01592708|Remifentanil|remifentanil|mesh-list
111212040|NCT01592708|Hydrocodone|hydrocodone|mesh-list
111212041|NCT01592708|Ondansetron|ondansetron|mesh-list
111212042|NCT01592708|Antiemetics|antiemetics|mesh-list
111212043|NCT01592708|Propofol|propofol|mesh-list
111212044|NCT01592708|Anesthetics|anesthetics|mesh-ancestor
111212045|NCT01592708|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111212046|NCT01592708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111212047|NCT01592708|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111212048|NCT01592708|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111212049|NCT01592708|Anesthetics, General|anesthetics, general|mesh-ancestor
111212050|NCT01592708|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111212051|NCT01592708|Narcotics|narcotics|mesh-ancestor
111212052|NCT01592708|Analgesics|analgesics|mesh-ancestor
111212053|NCT01592708|Sensory System Agents|sensory system agents|mesh-ancestor
111212054|NCT01592708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111212055|NCT01592708|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111212056|NCT01592708|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111212057|NCT01592708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111212058|NCT01592708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111212059|NCT01592708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111212060|NCT01592708|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111212061|NCT01592708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111212062|NCT01592708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111212063|NCT01592708|Autonomic Agents|autonomic agents|mesh-ancestor
111212064|NCT01592708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111212065|NCT01592708|Antipruritics|antipruritics|mesh-ancestor
111212066|NCT01592708|Dermatologic Agents|dermatologic agents|mesh-ancestor
111212067|NCT01592708|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111212068|NCT01592708|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111212069|NCT01592708|Serotonin Agents|serotonin agents|mesh-ancestor
111212070|NCT01592708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111212071|NCT01592708|Antitussive Agents|antitussive agents|mesh-ancestor
111212072|NCT01592708|Respiratory System Agents|respiratory system agents|mesh-ancestor
111212073|NCT01592708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111212074|NCT01592708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111212075|NCT01592708|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111212076|NCT01592708|Mydriatics|mydriatics|mesh-ancestor
111212077|NCT01592708|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111212078|NCT01592708|Cholinergic Agents|cholinergic agents|mesh-ancestor
111212079|NCT01592708|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111212080|NCT01592708|Glucocorticoids|glucocorticoids|mesh-ancestor
111212081|NCT01592708|Hormones|hormones|mesh-ancestor
111212082|NCT01592708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111212083|NCT01592708|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111212084|NCT01592708|Protective Agents|protective agents|mesh-ancestor
111212085|NCT01592708|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111212086|NCT01592708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111212087|NCT01592708|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111212088|NCT01592708|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111212089|NCT01592708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111212090|NCT01592708|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111212091|NCT01592708|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111212092|NCT01592708|Dopamine Agents|dopamine agents|mesh-ancestor
110664981|NCT00661427|Cetuximab|cetuximab|mesh-list
111212093|NCT01042522|Paclitaxel|paclitaxel|mesh-list
111212094|NCT01042522|Etoposide|etoposide|mesh-list
111212095|NCT01042522|Cisplatin|cisplatin|mesh-list
111212096|NCT01042522|Carboplatin|carboplatin|mesh-list
111212097|NCT01042522|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111212098|NCT01042522|Bleomycin|bleomycin|mesh-list
111212099|NCT01042522|Etoposide phosphate|etoposide phosphate|mesh-list
111212100|NCT01042522|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111212101|NCT01042522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111212102|NCT01042522|Tubulin Modulators|tubulin modulators|mesh-ancestor
111212103|NCT01042522|Antimitotic Agents|antimitotic agents|mesh-ancestor
111212104|NCT01042522|Mitosis Modulators|mitosis modulators|mesh-ancestor
111212105|NCT01042522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111212106|NCT01042522|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111212107|NCT01042522|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111212108|NCT01042522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111212109|NCT01042522|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111212110|NCT01702844|Paclitaxel|paclitaxel|mesh-list
111212111|NCT01702844|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111212112|NCT01702844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111212113|NCT01702844|Tubulin Modulators|tubulin modulators|mesh-ancestor
111212114|NCT01702844|Antimitotic Agents|antimitotic agents|mesh-ancestor
111212115|NCT01702844|Mitosis Modulators|mitosis modulators|mesh-ancestor
111212116|NCT01702844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111212117|NCT01702532|Nicotine|nicotine|mesh-list
111212118|NCT01702532|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111212119|NCT01702532|Autonomic Agents|autonomic agents|mesh-ancestor
111212120|NCT01702532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111212121|NCT01702532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111212122|NCT01702532|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111212123|NCT01702532|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111212124|NCT01702532|Cholinergic Agents|cholinergic agents|mesh-ancestor
111212125|NCT01702532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111212126|NCT01702532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111212127|NCT02241616|Entecavir|entecavir|mesh-list
111212128|NCT02241616|Antiviral Agents|antiviral agents|mesh-ancestor
111212129|NCT02241616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111212130|NCT03400306|Paclitaxel|paclitaxel|mesh-list
111212131|NCT03400306|Carboplatin|carboplatin|mesh-list
111212132|NCT03400306|Veliparib|veliparib|mesh-list
111212133|NCT03400306|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111212134|NCT03400306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111212135|NCT03400306|Tubulin Modulators|tubulin modulators|mesh-ancestor
111212136|NCT03400306|Antimitotic Agents|antimitotic agents|mesh-ancestor
111212137|NCT03400306|Mitosis Modulators|mitosis modulators|mesh-ancestor
111212138|NCT03400306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111212139|NCT03400306|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111212140|NCT03400306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111212141|NCT03405064|Linezolid|linezolid|mesh-list
111212142|NCT03405064|Levonadifloxacin|levonadifloxacin|mesh-list
111212143|NCT03405064|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111212144|NCT03405064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111212145|NCT03405064|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111212146|NCT03405064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111212147|NCT03405064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111212148|NCT03405064|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
111212149|NCT03404908|Acetaminophen|acetaminophen|mesh-list
111212150|NCT03404908|Dipyrone|dipyrone|mesh-list
111212151|NCT03404908|Ketoprofen|ketoprofen|mesh-list
111212152|NCT03404908|Morphine|morphine|mesh-list
111212153|NCT03404908|Ropivacaine|ropivacaine|mesh-list
111212154|NCT03404908|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111212155|NCT03404908|Narcotics|narcotics|mesh-ancestor
111212156|NCT03404908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111212157|NCT03404908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111212158|NCT03404908|Analgesics|analgesics|mesh-ancestor
111212159|NCT03404908|Sensory System Agents|sensory system agents|mesh-ancestor
111212160|NCT03404908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111212161|NCT03404908|Anesthetics, Local|anesthetics, local|mesh-ancestor
111212162|NCT03404908|Anesthetics|anesthetics|mesh-ancestor
111212163|NCT03404908|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111212164|NCT03404908|Antipyretics|antipyretics|mesh-ancestor
111212165|NCT03404908|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111212166|NCT03404908|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111212167|NCT03404908|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111212168|NCT03404908|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111212169|NCT03404908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110675979|NCT00993655|Carboplatin|carboplatin|mesh-list
111212170|NCT03404908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111212171|NCT01702298|Metformin|metformin|mesh-list
110980535|NCT03230786|Metformin|metformin|mesh-list
111212172|NCT01702298|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110665048|NCT00793091|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111212174|NCT01702298|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111212175|NCT01702298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111212176|NCT01702298|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111212177|NCT01702298|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111212178|NCT01702298|Antimetabolites|antimetabolites|mesh-ancestor
111212179|NCT01702298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111212180|NCT01702298|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111212181|NCT01702298|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111212182|NCT01702298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111212183|NCT01702298|Incretins|incretins|mesh-ancestor
111212184|NCT01702298|Hormones|hormones|mesh-ancestor
111212185|NCT01702298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111212186|NCT01702298|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111212187|NCT01702298|Protease Inhibitors|protease inhibitors|mesh-ancestor
111212188|NCT03404752|Lenograstim|lenograstim|mesh-list
111212189|NCT03404752|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111212190|NCT03404752|Immunologic Factors|immunologic factors|mesh-ancestor
111212191|NCT03404752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111212192|NCT03401710|Epoetin Alfa|epoetin alfa|mesh-list
111212193|NCT03401710|Hematinics|hematinics|mesh-ancestor
111212194|NCT02242084|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
111212195|NCT02242084|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111212196|NCT02242084|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111212197|NCT02242084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111212198|NCT01701362|Pregabalin|pregabalin|mesh-list
111212199|NCT01701362|Analgesics|analgesics|mesh-ancestor
111212200|NCT01701362|Sensory System Agents|sensory system agents|mesh-ancestor
111212201|NCT01701362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111212202|NCT01701362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111212203|NCT01701362|Anticonvulsants|anticonvulsants|mesh-ancestor
111212204|NCT01701362|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111212205|NCT01701362|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111212206|NCT01701362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111212207|NCT01701362|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111212208|NCT01701362|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111212209|NCT01701362|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111212210|NCT01701362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111212211|NCT01701362|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111212212|NCT00919126|Xenon|xenon|mesh-list
111212213|NCT00919126|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111212214|NCT00919126|Anesthetics, General|anesthetics, general|mesh-ancestor
111212215|NCT00919126|Anesthetics|anesthetics|mesh-ancestor
111212216|NCT00919126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111212217|NCT00919126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111212218|NCT01710800|Esomeprazole|esomeprazole|mesh-list
111212219|NCT01710800|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111212220|NCT01710800|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111212221|NCT01710800|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111212222|NCT01710800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111212223|NCT01710800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111212224|NCT01710020|Tofacitinib|tofacitinib|mesh-list
111212225|NCT01710020|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
111212226|NCT01710020|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111212227|NCT01710020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111212228|NCT01710020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111212229|NCT02982850|Aspirin|aspirin|mesh-list
111212230|NCT02982850|Warfarin|warfarin|mesh-list
111212231|NCT02982850|Dabigatran|dabigatran|mesh-list
111212232|NCT02982850|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111212233|NCT02982850|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111212234|NCT02982850|Analgesics|analgesics|mesh-ancestor
111212235|NCT02982850|Sensory System Agents|sensory system agents|mesh-ancestor
111212236|NCT02982850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111212237|NCT02982850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111212238|NCT02982850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111212239|NCT02982850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111212240|NCT02982850|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111212241|NCT02982850|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111212242|NCT02982850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111212243|NCT02982850|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111212244|NCT02982850|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110676053|NCT05271240|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110665137|NCT00797771|Insulin|insulin|mesh-list
111212245|NCT02982850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111212246|NCT02982850|Antipyretics|antipyretics|mesh-ancestor
111212247|NCT02982850|Anticoagulants|anticoagulants|mesh-ancestor
111212248|NCT02982850|Antithrombins|antithrombins|mesh-ancestor
111212249|NCT02982850|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111212250|NCT02982850|Protease Inhibitors|protease inhibitors|mesh-ancestor
111212251|NCT02242240|Formoterol Fumarate|formoterol fumarate|mesh-list
111212252|NCT02242240|Tiotropium Bromide|tiotropium bromide|mesh-list
111212253|NCT02242240|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111212254|NCT02242240|Autonomic Agents|autonomic agents|mesh-ancestor
111212255|NCT02242240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111212256|NCT02242240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111212257|NCT02242240|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111212258|NCT02242240|Respiratory System Agents|respiratory system agents|mesh-ancestor
111212259|NCT02242240|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111212260|NCT02242240|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111212261|NCT02242240|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111212262|NCT02242240|Adrenergic Agents|adrenergic agents|mesh-ancestor
111212263|NCT02242240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111212264|NCT02242240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111212265|NCT02242240|Parasympatholytics|parasympatholytics|mesh-ancestor
111212266|NCT02242240|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111212267|NCT02242240|Cholinergic Agents|cholinergic agents|mesh-ancestor
111212268|NCT03403972|Vancomycin|vancomycin|mesh-list
111212269|NCT03403972|Simvastatin|simvastatin|mesh-list
111212270|NCT03403972|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111212271|NCT03403972|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111212272|NCT03403972|Antimetabolites|antimetabolites|mesh-ancestor
111212273|NCT03403972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111212274|NCT03403972|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111212275|NCT03403972|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111212276|NCT03403972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111212277|NCT03403972|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111212278|NCT03403972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111212279|NCT02242318|Valsartan|valsartan|mesh-list
111212280|NCT02242318|Telmisartan|telmisartan|mesh-list
111212281|NCT02242318|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111212282|NCT02242318|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111212283|NCT02242318|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111212284|NCT02242318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111212285|NCT01700192|Mometasone Furoate|mometasone furoate|mesh-list
111212286|NCT01700192|Loratadine|loratadine|mesh-list
111212287|NCT01700192|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
111212288|NCT01700192|Epinephrine|epinephrine|mesh-list
111212289|NCT01700192|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111212290|NCT01700192|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111212291|NCT01700192|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111212292|NCT01700192|Adrenergic Agents|adrenergic agents|mesh-ancestor
111212293|NCT01700192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111212294|NCT01700192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111212295|NCT01700192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111212296|NCT01700192|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111212297|NCT01700192|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111212298|NCT01700192|Autonomic Agents|autonomic agents|mesh-ancestor
111212299|NCT01700192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111212300|NCT01700192|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111212301|NCT01700192|Respiratory System Agents|respiratory system agents|mesh-ancestor
111212302|NCT01700192|Mydriatics|mydriatics|mesh-ancestor
111212303|NCT01700192|Sympathomimetics|sympathomimetics|mesh-ancestor
111212304|NCT01700192|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111212305|NCT01700192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111212306|NCT01700192|Dermatologic Agents|dermatologic agents|mesh-ancestor
111212307|NCT01700192|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111212308|NCT01700192|Antipruritics|antipruritics|mesh-ancestor
111212309|NCT01700192|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
111212310|NCT01700192|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111212311|NCT01700192|Histamine Antagonists|histamine antagonists|mesh-ancestor
111212312|NCT01700192|Histamine Agents|histamine agents|mesh-ancestor
111212313|NCT01700192|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111212314|NCT01700192|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111212315|NCT01700192|Analgesics|analgesics|mesh-ancestor
111212316|NCT01700192|Sensory System Agents|sensory system agents|mesh-ancestor
111212317|NCT01700192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111212318|NCT01700192|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111212319|NCT02242396|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110665200|NCT00801905|Nepafenac|nepafenac|mesh-list
111212320|NCT02242396|Telmisartan|telmisartan|mesh-list
111212321|NCT02242396|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
111212322|NCT02242396|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111212323|NCT02242396|Diuretics|diuretics|mesh-ancestor
111212324|NCT02242396|Natriuretic Agents|natriuretic agents|mesh-ancestor
111212325|NCT02242396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111212326|NCT02242396|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
111212327|NCT02242396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111212328|NCT02242396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111212329|NCT02242396|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111212330|NCT02242396|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111212331|NCT02242474|Adalimumab|adalimumab|mesh-list
111212332|NCT02242474|Infliximab|infliximab|mesh-list
111212333|NCT02242474|Golimumab|golimumab|mesh-list
111212334|NCT02242474|Certolizumab Pegol|certolizumab pegol|mesh-list
111212335|NCT02242474|Etanercept|etanercept|mesh-list
111212336|NCT02242474|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111212337|NCT02242474|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111212338|NCT02242474|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111212339|NCT02242474|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111212340|NCT02242474|Dermatologic Agents|dermatologic agents|mesh-ancestor
111212341|NCT02242474|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111212342|NCT02242474|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111212343|NCT02242474|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111212344|NCT02242474|Analgesics|analgesics|mesh-ancestor
111212345|NCT02242474|Sensory System Agents|sensory system agents|mesh-ancestor
111212346|NCT02242474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111212347|NCT02242474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111212348|NCT02242474|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111212349|NCT02242474|Immunologic Factors|immunologic factors|mesh-ancestor
111212350|NCT01709864|Glycopyrrolate|glycopyrrolate|mesh-list
111212351|NCT01709864|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111212352|NCT01709864|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111212353|NCT01709864|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111212354|NCT01709864|Cholinergic Agents|cholinergic agents|mesh-ancestor
111212355|NCT01709864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111212356|NCT01709864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111212357|NCT01709864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111212358|NCT04878315|Captopril|captopril|mesh-list
111212359|NCT04878315|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
111212360|NCT04878315|Protease Inhibitors|protease inhibitors|mesh-ancestor
111212361|NCT04878315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111212362|NCT04878315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111212363|NCT04878315|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111212364|NCT04374604|Mitogens|mitogens|mesh-list
111212365|NCT04374604|Mitosis Modulators|mitosis modulators|mesh-ancestor
111212366|NCT04374604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111212367|NCT02242864|Telmisartan|telmisartan|mesh-list
111212368|NCT02242864|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
111212369|NCT02242864|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111212370|NCT02242864|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111212371|NCT02242864|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111212372|NCT02242864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111212373|NCT02242864|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
111212374|NCT02242864|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111212375|NCT02242864|Diuretics|diuretics|mesh-ancestor
111212376|NCT02242864|Natriuretic Agents|natriuretic agents|mesh-ancestor
111212377|NCT02242864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111212378|NCT01709708|Bupivacaine|bupivacaine|mesh-list
111212379|NCT01709708|Anesthetics, Local|anesthetics, local|mesh-ancestor
111212380|NCT01709708|Anesthetics|anesthetics|mesh-ancestor
111212381|NCT01709708|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111212382|NCT01709708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111212383|NCT01709708|Sensory System Agents|sensory system agents|mesh-ancestor
111212384|NCT01709708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111212385|NCT02243098|Digoxin|digoxin|mesh-list
111212386|NCT02243098|Atorvastatin|atorvastatin|mesh-list
111212387|NCT02243098|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111212388|NCT02243098|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111212389|NCT02243098|Antimetabolites|antimetabolites|mesh-ancestor
110980537|NCT03230786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111212390|NCT02243098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111212391|NCT02243098|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111212392|NCT02243098|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111212393|NCT02243098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111212394|NCT02243098|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111212395|NCT02243098|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111212396|NCT02243098|Protective Agents|protective agents|mesh-ancestor
111212397|NCT02243098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111212398|NCT02845323|Nivolumab|nivolumab|mesh-list
111212399|NCT02845323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111212400|NCT02845323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111212401|NCT02845323|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111212402|NCT02845323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111212403|NCT05289063|Atorvastatin|atorvastatin|mesh-list
111212404|NCT05289063|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111212405|NCT05289063|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111212406|NCT05289063|Antimetabolites|antimetabolites|mesh-ancestor
111212407|NCT05289063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111212408|NCT05289063|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111212409|NCT05289063|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111212410|NCT05289063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111212411|NCT01709318|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
111212412|NCT01709318|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
111212413|NCT01709318|Ethinyl Estradiol|ethinyl estradiol|mesh-list
111212414|NCT01709318|Etonogestrel|etonogestrel|mesh-list
111212415|NCT01709318|Estradiol|estradiol|mesh-list
111212416|NCT01709318|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
111212417|NCT01709318|Estrogens|estrogens|mesh-ancestor
111212418|NCT01709318|Hormones|hormones|mesh-ancestor
111212419|NCT01709318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111212420|NCT01709318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111212421|NCT01709318|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111212422|NCT01709318|Contraceptive Agents|contraceptive agents|mesh-ancestor
111212423|NCT01709318|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111212424|NCT01709318|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111212425|NCT01709318|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111212426|NCT01709318|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111212427|NCT02243254|Ibuprofen|ibuprofen|mesh-list
111212428|NCT02243254|Remifentanil|remifentanil|mesh-list
111212429|NCT02243254|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111212430|NCT02243254|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111212431|NCT02243254|Analgesics|analgesics|mesh-ancestor
111212432|NCT02243254|Sensory System Agents|sensory system agents|mesh-ancestor
111212433|NCT02243254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111212434|NCT02243254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111212435|NCT02243254|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111212436|NCT02243254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111212437|NCT02243254|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111212438|NCT02243254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111212439|NCT02243254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111212440|NCT02243254|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111212441|NCT02243254|Narcotics|narcotics|mesh-ancestor
111212442|NCT02243254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111212443|NCT03402880|Pembrolizumab|pembrolizumab|mesh-list
111212444|NCT03402880|Immunoglobulins|immunoglobulins|mesh-list
111212445|NCT03402880|Immunoglobulin G|immunoglobulin g|mesh-list
111212446|NCT03402880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111212447|NCT03402880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111212448|NCT03402880|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111212449|NCT03402880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111212450|NCT03402880|Immunologic Factors|immunologic factors|mesh-ancestor
111212451|NCT03402880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111212452|NCT01673997|Metoprolol|metoprolol|mesh-list
111212453|NCT01673997|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111212454|NCT01673997|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111212455|NCT01673997|Sympatholytics|sympatholytics|mesh-ancestor
111212456|NCT01673997|Autonomic Agents|autonomic agents|mesh-ancestor
111212457|NCT01673997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111212458|NCT01673997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111212459|NCT01673997|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
111212460|NCT01673997|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111212461|NCT01673997|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111212462|NCT01673997|Adrenergic Agents|adrenergic agents|mesh-ancestor
111212463|NCT01673997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111212464|NCT01673997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111212465|NCT04373824|Ivermectin|ivermectin|mesh-list
111212466|NCT04373824|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111212467|NCT04373824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111212468|NCT01676571|Vortioxetine|vortioxetine|mesh-list
111212469|NCT01676571|Antidepressive Agents|antidepressive agents|mesh-ancestor
111212470|NCT01676571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111212471|NCT01676571|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111212472|NCT01676571|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111212473|NCT01676571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111212474|NCT01676571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111212475|NCT01676571|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111212476|NCT01676571|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111212477|NCT01676571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111212478|NCT01676571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111212479|NCT01676571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111212480|NCT01676571|Serotonin Agents|serotonin agents|mesh-ancestor
111212481|NCT01676571|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111212482|NCT01676571|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111212483|NCT01676571|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111212484|NCT01676571|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111212485|NCT01699178|Methyltestosterone|methyltestosterone|mesh-list
111212486|NCT01699178|Testosterone|testosterone|mesh-list
111212487|NCT01699178|Testosterone undecanoate|testosterone undecanoate|mesh-list
111212488|NCT01699178|Testosterone enanthate|testosterone enanthate|mesh-list
111212489|NCT01699178|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
111212490|NCT01699178|Androgens|androgens|mesh-ancestor
111212491|NCT01699178|Hormones|hormones|mesh-ancestor
111212492|NCT01699178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111212493|NCT01699178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111212494|NCT01699178|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111212495|NCT01699178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111212496|NCT01699178|Anabolic Agents|anabolic agents|mesh-ancestor
111212497|NCT02077959|Lenalidomide|lenalidomide|mesh-list
111212498|NCT02077959|Pidilizumab|pidilizumab|mesh-list
111212499|NCT02077959|Immunologic Factors|immunologic factors|mesh-ancestor
111212500|NCT02077959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111212501|NCT02077959|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111212502|NCT02077959|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111212503|NCT02077959|Growth Substances|growth substances|mesh-ancestor
111212504|NCT02077959|Growth Inhibitors|growth inhibitors|mesh-ancestor
111212505|NCT02077959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111212506|NCT02077959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111212507|NCT04548518|Vaccines|vaccines|mesh-list
111212508|NCT04548518|Immunologic Factors|immunologic factors|mesh-ancestor
111212509|NCT04548518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111212510|NCT01699022|CycloProvera|cycloprovera|mesh-list
111212511|NCT01699022|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
111212512|NCT01699022|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111212513|NCT01699022|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111212514|NCT01699022|Contraceptive Agents|contraceptive agents|mesh-ancestor
111212515|NCT01699022|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111212516|NCT01699022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111212517|NCT01699022|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111212518|NCT01699022|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111212519|NCT01670175|Sirolimus|sirolimus|mesh-list
111212520|NCT01670175|Cyclophosphamide|cyclophosphamide|mesh-list
111212521|NCT01670175|Topotecan|topotecan|mesh-list
111212522|NCT01670175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111212523|NCT01670175|Immunologic Factors|immunologic factors|mesh-ancestor
111212524|NCT01670175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111212525|NCT01670175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111212526|NCT01670175|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111212527|NCT01670175|Alkylating Agents|alkylating agents|mesh-ancestor
111212528|NCT01670175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111212529|NCT01670175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111212530|NCT01670175|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111212531|NCT01670175|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111212532|NCT01670175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111212533|NCT01670175|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111212534|NCT01670175|Antifungal Agents|antifungal agents|mesh-ancestor
111212535|NCT01670175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111212536|NCT01670175|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111212537|NCT01670175|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111212538|NCT02243566|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
111212539|NCT02243566|Telmisartan|telmisartan|mesh-list
111212540|NCT02243566|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
111212541|NCT02243566|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111212543|NCT02243566|Natriuretic Agents|natriuretic agents|mesh-ancestor
111212544|NCT02243566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111212545|NCT02243566|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
111212546|NCT02243566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111212547|NCT02243566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111212548|NCT02243566|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111212549|NCT02243566|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111212550|NCT02243644|Albendazole|albendazole|mesh-list
111212551|NCT02243644|Anthelmintics|anthelmintics|mesh-ancestor
111212552|NCT02243644|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111212553|NCT02243644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111212554|NCT02243644|Anticestodal Agents|anticestodal agents|mesh-ancestor
111212555|NCT02243644|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
111212556|NCT02243644|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111212557|NCT02243644|Tubulin Modulators|tubulin modulators|mesh-ancestor
111212558|NCT02243644|Antimitotic Agents|antimitotic agents|mesh-ancestor
111212559|NCT02243644|Mitosis Modulators|mitosis modulators|mesh-ancestor
111212560|NCT02243644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111212561|NCT02243644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111212562|NCT01988883|Propranolol|propranolol|mesh-list
111212563|NCT01988883|Modafinil|modafinil|mesh-list
111212564|NCT01988883|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111212565|NCT01988883|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111212566|NCT01988883|Adrenergic Agents|adrenergic agents|mesh-ancestor
111212567|NCT01988883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111212568|NCT01988883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111212569|NCT01988883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111212570|NCT01988883|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111212571|NCT01988883|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111212572|NCT01988883|Vasodilator Agents|vasodilator agents|mesh-ancestor
111212573|NCT01988883|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111212574|NCT01988883|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
111212575|NCT01988883|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111212576|NCT01988883|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111212577|NCT04373356|Listerine|listerine|mesh-list
111212578|NCT04373356|Fluorides|fluorides|mesh-list
111212579|NCT04373356|Sodium Fluoride|sodium fluoride|mesh-list
111212580|NCT04373356|Fluorides, Topical|fluorides, topical|mesh-list
111212581|NCT04373356|Cariostatic Agents|cariostatic agents|mesh-ancestor
111212582|NCT04373356|Protective Agents|protective agents|mesh-ancestor
111212583|NCT04373356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111212584|NCT04373356|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111212585|NCT04373356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111212586|NCT01745757|Paclitaxel|paclitaxel|mesh-list
111212587|NCT01745757|Bevacizumab|bevacizumab|mesh-list
111212588|NCT01745757|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111212589|NCT01745757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111212590|NCT01745757|Tubulin Modulators|tubulin modulators|mesh-ancestor
111212591|NCT01745757|Antimitotic Agents|antimitotic agents|mesh-ancestor
111212592|NCT01745757|Mitosis Modulators|mitosis modulators|mesh-ancestor
111212593|NCT01745757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111212594|NCT01745757|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111212595|NCT01745757|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111212596|NCT01745757|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111212597|NCT01745757|Growth Substances|growth substances|mesh-ancestor
111212598|NCT01745757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111212599|NCT01745757|Growth Inhibitors|growth inhibitors|mesh-ancestor
111212600|NCT01709162|Ipilimumab|ipilimumab|mesh-list
111212601|NCT01709162|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111212602|NCT01709162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111212603|NCT01709162|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111212604|NCT01709162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111212605|NCT02243800|Cholecalciferol|cholecalciferol|mesh-list
111212606|NCT02243800|Vitamin D|vitamin d|mesh-list
111212607|NCT02243800|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111212608|NCT02243800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111212609|NCT02243800|Vitamins|vitamins|mesh-ancestor
111212610|NCT02243800|Micronutrients|micronutrients|mesh-ancestor
111212611|NCT02243800|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111212612|NCT03402100|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111212613|NCT03402100|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111212614|NCT04764045|Ropivacaine|ropivacaine|mesh-list
111212615|NCT04764045|Anesthetics, Local|anesthetics, local|mesh-ancestor
111212616|NCT04764045|Anesthetics|anesthetics|mesh-ancestor
111212617|NCT04764045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111212618|NCT04764045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111212619|NCT04764045|Sensory System Agents|sensory system agents|mesh-ancestor
111212620|NCT04764045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111212621|NCT01698554|Bimatoprost|bimatoprost|mesh-list
111212622|NCT01698554|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111212623|NCT01698554|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111212624|NCT04404855|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111212625|NCT04404855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111212626|NCT00895791|Umirolimus|umirolimus|mesh-list
111212627|NCT00895791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111212628|NCT00895791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111212629|NCT00895791|Immunologic Factors|immunologic factors|mesh-ancestor
111212630|NCT00895791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111212631|NCT01698320|Albuterol|albuterol|mesh-list
111212632|NCT01698320|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111212633|NCT01698320|Autonomic Agents|autonomic agents|mesh-ancestor
111212634|NCT01698320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111212635|NCT01698320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111212636|NCT01698320|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111212637|NCT01698320|Respiratory System Agents|respiratory system agents|mesh-ancestor
111212638|NCT01698320|Tocolytic Agents|tocolytic agents|mesh-ancestor
111212639|NCT01698320|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111212640|NCT01698320|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111212641|NCT01698320|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111212642|NCT01698320|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111212643|NCT01698320|Adrenergic Agents|adrenergic agents|mesh-ancestor
111212644|NCT01698320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111212645|NCT01698320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111212646|NCT03401476|Morphine|morphine|mesh-list
111212647|NCT03401476|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111212648|NCT03401476|Narcotics|narcotics|mesh-ancestor
111212649|NCT03401476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111212650|NCT03401476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111212651|NCT03401476|Analgesics|analgesics|mesh-ancestor
111212652|NCT03401476|Sensory System Agents|sensory system agents|mesh-ancestor
111212653|NCT03401476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111212654|NCT01674777|Ipragliflozin|ipragliflozin|mesh-list
111212655|NCT01674777|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111212656|NCT01674777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111212657|NCT01674777|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111212658|NCT01674777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111212659|NCT03876717|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
111212660|NCT03876717|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111212661|NCT03876717|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111212662|NCT03876717|Antimetabolites|antimetabolites|mesh-ancestor
111212663|NCT03876717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111212664|NCT03876717|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111212665|NCT01674855|Lenograstim|lenograstim|mesh-list
111212666|NCT01674855|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111212667|NCT01674855|Immunologic Factors|immunologic factors|mesh-ancestor
111212668|NCT01674855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111212669|NCT03854799|Capecitabine|capecitabine|mesh-list
111212670|NCT03854799|Avelumab|avelumab|mesh-list
111212671|NCT03854799|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111212672|NCT03854799|Antimetabolites|antimetabolites|mesh-ancestor
111212673|NCT03854799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111212674|NCT03854799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111212675|NCT03854799|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111212676|NCT00924352|Dasatinib|dasatinib|mesh-list
111212677|NCT00924352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111212678|NCT00924352|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111212679|NCT00924352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111212680|NCT00924352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111212681|NCT01674933|Listerine|listerine|mesh-list
111212682|NCT01674933|Fluorides|fluorides|mesh-list
111212683|NCT01674933|Fluorides, Topical|fluorides, topical|mesh-list
111212684|NCT01674933|Sodium fluoride topical preparation|sodium fluoride topical preparation|mesh-list
111212685|NCT01674933|Sodium Fluoride|sodium fluoride|mesh-list
111212686|NCT01674933|Cariostatic Agents|cariostatic agents|mesh-ancestor
111212687|NCT01674933|Protective Agents|protective agents|mesh-ancestor
111212688|NCT01674933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111212689|NCT01674933|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111212690|NCT01674933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111212691|NCT04373044|Hydroxychloroquine|hydroxychloroquine|mesh-list
111212692|NCT04373044|Antimalarials|antimalarials|mesh-ancestor
111212693|NCT04373044|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111212694|NCT04373044|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111212695|NCT04373044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111212696|NCT04373044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111212697|NCT04373044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111212698|NCT04373044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111212699|NCT01675089|Zoledronic Acid|zoledronic acid|mesh-list
111212700|NCT01675089|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111212701|NCT01675089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111212702|NCT01697696|Glycopyrrolate|glycopyrrolate|mesh-list
111212703|NCT01697696|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111212704|NCT01697696|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111212705|NCT01697696|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111212706|NCT01697696|Cholinergic Agents|cholinergic agents|mesh-ancestor
111212707|NCT01697696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111212708|NCT01697696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111212709|NCT01697696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111212710|NCT01569152|Methotrexate|methotrexate|mesh-list
111212711|NCT01569152|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111212712|NCT01569152|Abortifacient Agents|abortifacient agents|mesh-ancestor
111212713|NCT01569152|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111212714|NCT01569152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111212715|NCT01569152|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111212716|NCT01569152|Antimetabolites|antimetabolites|mesh-ancestor
111212717|NCT01569152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111212718|NCT01569152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111212719|NCT01569152|Dermatologic Agents|dermatologic agents|mesh-ancestor
111212720|NCT01569152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111212721|NCT01569152|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111212722|NCT01569152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111212723|NCT01569152|Immunologic Factors|immunologic factors|mesh-ancestor
111212724|NCT01569152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111212725|NCT01569152|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111212726|NCT01675557|Vitamin D|vitamin d|mesh-list
111212727|NCT01675557|Ergocalciferols|ergocalciferols|mesh-list
111212728|NCT01675557|Cholecalciferol|cholecalciferol|mesh-list
111212729|NCT01675557|Vitamins|vitamins|mesh-list
111212730|NCT01675557|Micronutrients|micronutrients|mesh-ancestor
111212731|NCT01675557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111212732|NCT01675557|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111212733|NCT01675557|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111212734|NCT01675947|Sirolimus|sirolimus|mesh-list
111212735|NCT01675947|Lidocaine|lidocaine|mesh-list
111212736|NCT01675947|Anesthetics, Local|anesthetics, local|mesh-ancestor
111212737|NCT01675947|Anesthetics|anesthetics|mesh-ancestor
111212738|NCT01675947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111212739|NCT01675947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111212740|NCT01675947|Sensory System Agents|sensory system agents|mesh-ancestor
111212741|NCT01675947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111212742|NCT01675947|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111212743|NCT01675947|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111212744|NCT01675947|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111212745|NCT01675947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111212746|NCT01675947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111212747|NCT01675947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111212748|NCT01675947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111212749|NCT01675947|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111212750|NCT01675947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111212751|NCT01675947|Antifungal Agents|antifungal agents|mesh-ancestor
111212752|NCT01675947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111212753|NCT01675947|Immunologic Factors|immunologic factors|mesh-ancestor
111212754|NCT03748953|Ixazomib|ixazomib|mesh-list
111212755|NCT03748953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111212756|NCT03748953|Protease Inhibitors|protease inhibitors|mesh-ancestor
111212757|NCT03748953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111212758|NCT03748953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111212759|NCT01567826|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111212760|NCT01567826|Atorvastatin|atorvastatin|mesh-list
111212761|NCT01567826|Simvastatin|simvastatin|mesh-list
111212762|NCT01567826|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111212763|NCT01567826|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111212764|NCT01567826|Antimetabolites|antimetabolites|mesh-ancestor
111212765|NCT01567826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111212767|NCT01567826|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111212768|NCT01567826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111212769|NCT03743025|Dulaglutide|dulaglutide|mesh-list
111212770|NCT03743025|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111212771|NCT03743025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111212772|NCT02083107|Misoprostol|misoprostol|mesh-list
111212773|NCT02083107|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111212774|NCT02083107|Abortifacient Agents|abortifacient agents|mesh-ancestor
111212775|NCT02083107|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111212776|NCT02083107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111212777|NCT02083107|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111212778|NCT02083107|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111212779|NCT02083107|Oxytocics|oxytocics|mesh-ancestor
111212780|NCT02335905|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
111212781|NCT02335905|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111212782|NCT02335905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111212783|NCT00925756|Maraviroc|maraviroc|mesh-list
111212784|NCT00925756|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
111212785|NCT00925756|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
111212786|NCT00925756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111212787|NCT00925756|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111212788|NCT00925756|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111212789|NCT00925756|Antiviral Agents|antiviral agents|mesh-ancestor
111212790|NCT00925756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111212791|NCT00925756|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
111212792|NCT04372732|Autoantibodies|autoantibodies|mesh-list
111212793|NCT04372732|Immunologic Factors|immunologic factors|mesh-ancestor
111212794|NCT04372732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111212795|NCT02245126|Lidocaine|lidocaine|mesh-list
111212796|NCT02245126|Bupivacaine|bupivacaine|mesh-list
111212797|NCT02245126|Anesthetics, Local|anesthetics, local|mesh-ancestor
111212798|NCT02245126|Anesthetics|anesthetics|mesh-ancestor
111212799|NCT02245126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111212800|NCT02245126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111212801|NCT02245126|Sensory System Agents|sensory system agents|mesh-ancestor
111212802|NCT02245126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111212803|NCT02245126|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111212804|NCT02245126|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111212805|NCT02245126|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111212806|NCT02245126|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111212807|NCT02245126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111212808|NCT04372342|Remifentanil|remifentanil|mesh-list
111212809|NCT04372342|Nalbuphine|nalbuphine|mesh-list
111212810|NCT04372342|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111212811|NCT04372342|Narcotics|narcotics|mesh-ancestor
111212812|NCT04372342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111212813|NCT04372342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111212814|NCT04372342|Analgesics|analgesics|mesh-ancestor
111212815|NCT04372342|Sensory System Agents|sensory system agents|mesh-ancestor
111212816|NCT04372342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111212817|NCT04372264|Acetaminophen|acetaminophen|mesh-list
111212818|NCT04372264|Ibuprofen|ibuprofen|mesh-list
111212819|NCT04372264|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
111212820|NCT04372264|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111212821|NCT04372264|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111212822|NCT04372264|Analgesics|analgesics|mesh-ancestor
111212823|NCT04372264|Sensory System Agents|sensory system agents|mesh-ancestor
111212824|NCT04372264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111212825|NCT04372264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111212826|NCT04372264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111212827|NCT04372264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111212828|NCT04372264|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111212829|NCT04372264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111212830|NCT04372264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111212831|NCT04372264|Antipyretics|antipyretics|mesh-ancestor
111212832|NCT02083809|Oxytocin|oxytocin|mesh-list
111212833|NCT02083809|Oxytocics|oxytocics|mesh-ancestor
111212834|NCT02083809|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111212835|NCT02083809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111212836|NCT02244112|Midazolam|midazolam|mesh-list
111212837|NCT02244112|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111212838|NCT02244112|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110665749|NCT00808145|Cisplatin|cisplatin|mesh-list
111212839|NCT02244112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111212840|NCT02244112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111212841|NCT02244112|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111212842|NCT02244112|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111212843|NCT02244112|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111212844|NCT02244112|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111212845|NCT02244112|Anesthetics, General|anesthetics, general|mesh-ancestor
111212846|NCT02244112|Anesthetics|anesthetics|mesh-ancestor
111212847|NCT02244112|GABA Modulators|gaba modulators|mesh-ancestor
111212848|NCT02244112|GABA Agents|gaba agents|mesh-ancestor
111212849|NCT02244112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111212850|NCT02244112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111212851|NCT02244190|Ritonavir|ritonavir|mesh-list
111212852|NCT02244190|Tipranavir|tipranavir|mesh-list
111212853|NCT02244190|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111212854|NCT02244190|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111212855|NCT02244190|Protease Inhibitors|protease inhibitors|mesh-ancestor
111212856|NCT02244190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111212857|NCT02244190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111212858|NCT02244190|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111212859|NCT02244190|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111212860|NCT02244190|Antiviral Agents|antiviral agents|mesh-ancestor
111212861|NCT02244190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111212862|NCT02244190|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111212863|NCT02244190|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111212864|NCT00926380|Denosumab|denosumab|mesh-list
111212865|NCT00926380|Teriparatide|teriparatide|mesh-list
111212866|NCT00926380|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111212867|NCT00926380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111212868|NCT00926380|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111212869|NCT02244268|Tamsulosin|tamsulosin|mesh-list
111212870|NCT02244268|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111212871|NCT02244268|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111212872|NCT02244268|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111212873|NCT02244268|Adrenergic Agents|adrenergic agents|mesh-ancestor
111212874|NCT02244268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111212875|NCT02244268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111212876|NCT02244268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111212877|NCT02244268|Urological Agents|urological agents|mesh-ancestor
111212878|NCT03630315|Bevacizumab|bevacizumab|mesh-list
111212879|NCT03630315|Ranibizumab|ranibizumab|mesh-list
111212880|NCT03630315|Aflibercept|aflibercept|mesh-list
111212881|NCT03630315|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111212882|NCT03630315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111212883|NCT03630315|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111212884|NCT03630315|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111212885|NCT03630315|Growth Substances|growth substances|mesh-ancestor
111212886|NCT03630315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111212887|NCT03630315|Growth Inhibitors|growth inhibitors|mesh-ancestor
111212888|NCT00929344|Pregabalin|pregabalin|mesh-list
111212889|NCT00929344|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
111212890|NCT00929344|Analgesics|analgesics|mesh-ancestor
111212891|NCT00929344|Sensory System Agents|sensory system agents|mesh-ancestor
111212892|NCT00929344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111212893|NCT00929344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111212894|NCT00929344|Anticonvulsants|anticonvulsants|mesh-ancestor
111212895|NCT00929344|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111212896|NCT00929344|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111212897|NCT00929344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111212898|NCT00929344|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111212899|NCT00929344|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111212900|NCT00929344|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111212901|NCT00929344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111212902|NCT00929344|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111212903|NCT00929344|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111212904|NCT00929344|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111212905|NCT00929344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111212906|NCT00929344|Antidepressive Agents|antidepressive agents|mesh-ancestor
111212907|NCT00929344|Dopamine Agents|dopamine agents|mesh-ancestor
111212908|NCT03630159|Pembrolizumab|pembrolizumab|mesh-list
111212909|NCT03630159|Tisagenlecleucel|tisagenlecleucel|mesh-list
111212910|NCT03630159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111212911|NCT03630159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111212912|NCT03630159|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111212913|NCT03630159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111212915|NCT04371874|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
111212916|NCT04371874|Captopril|captopril|mesh-list
111212917|NCT04371874|Nitrendipine|nitrendipine|mesh-list
111212918|NCT04371874|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111212919|NCT04371874|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111212920|NCT04371874|Analgesics|analgesics|mesh-ancestor
111212921|NCT04371874|Sensory System Agents|sensory system agents|mesh-ancestor
111212922|NCT04371874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111212923|NCT04371874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111212924|NCT04371874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111212925|NCT04371874|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111212926|NCT04371874|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111212927|NCT04371874|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111212928|NCT04371874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111212929|NCT04371874|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111212930|NCT04371874|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111212931|NCT04371874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111212932|NCT04371874|Antipyretics|antipyretics|mesh-ancestor
111212933|NCT04371874|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111212934|NCT04371874|Diuretics|diuretics|mesh-ancestor
111212935|NCT04371874|Natriuretic Agents|natriuretic agents|mesh-ancestor
111212936|NCT04371874|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
111212937|NCT04371874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111212938|NCT04371874|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
111212939|NCT04371874|Protease Inhibitors|protease inhibitors|mesh-ancestor
111212940|NCT04371874|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111212941|NCT04371874|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111212942|NCT04371874|Vasodilator Agents|vasodilator agents|mesh-ancestor
111212943|NCT03629223|Tepotinib|tepotinib|mesh-list
111212944|NCT03629223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111212945|NCT04376554|Amoxicillin|amoxicillin|mesh-list
111212946|NCT04376554|Clavulanic Acid|clavulanic acid|mesh-list
111212947|NCT04376554|Clavulanic Acids|clavulanic acids|mesh-list
111212948|NCT04376554|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
111212949|NCT04376554|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111212950|NCT04376554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111212951|NCT04376554|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
111212952|NCT04376554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111212953|NCT04376554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111212954|NCT03627741|Triamcinolone|triamcinolone|mesh-list
111212955|NCT03627741|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
111212956|NCT03627741|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
111212957|NCT03627741|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
111212958|NCT03627741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111212959|NCT03627741|Glucocorticoids|glucocorticoids|mesh-ancestor
111212960|NCT03627741|Hormones|hormones|mesh-ancestor
111212961|NCT03627741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111212962|NCT03627741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111212963|NCT03627741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111212964|NCT03627741|Immunologic Factors|immunologic factors|mesh-ancestor
111212965|NCT03627741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111212966|NCT03627741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111212967|NCT03626337|Thiamine|thiamine|mesh-list
111212968|NCT03626337|Vitamin B Complex|vitamin b complex|mesh-ancestor
111212969|NCT03626337|Vitamins|vitamins|mesh-ancestor
111212970|NCT03626337|Micronutrients|micronutrients|mesh-ancestor
111212971|NCT03626337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111212972|NCT00929578|Fluphenazine|fluphenazine|mesh-list
111212973|NCT00929578|Fluphenazine depot|fluphenazine depot|mesh-list
111212974|NCT00929578|Fluphenazine enanthate|fluphenazine enanthate|mesh-list
111212975|NCT00929578|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111212976|NCT00929578|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111212977|NCT00929578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111212978|NCT00929578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111212979|NCT00929578|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111212980|NCT00929578|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111212981|NCT00929578|Dopamine Agents|dopamine agents|mesh-ancestor
110792354|NCT01276431|Buprenorphine|buprenorphine|mesh-list
111212982|NCT00929578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111212983|NCT00929578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111212984|NCT04371406|Azithromycin|azithromycin|mesh-list
111212985|NCT04371406|Hydroxychloroquine|hydroxychloroquine|mesh-list
111212986|NCT04371406|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111212987|NCT04371406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111212989|NCT04371406|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111212990|NCT04371406|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111212991|NCT04371406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111212992|NCT04371406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111212993|NCT04371406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111212994|NCT03716739|Methyltestosterone|methyltestosterone|mesh-list
111212995|NCT03716739|Testosterone|testosterone|mesh-list
111212996|NCT03716739|Testosterone undecanoate|testosterone undecanoate|mesh-list
111212997|NCT03716739|Testosterone enanthate|testosterone enanthate|mesh-list
111212998|NCT03716739|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
111212999|NCT03716739|Androgens|androgens|mesh-ancestor
111213000|NCT03716739|Hormones|hormones|mesh-ancestor
111213001|NCT03716739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111213002|NCT03716739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111213003|NCT03716739|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111213004|NCT03716739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111213005|NCT03716739|Anabolic Agents|anabolic agents|mesh-ancestor
111213006|NCT04763265|Botulinum Toxins|botulinum toxins|mesh-list
111213007|NCT04763265|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111213008|NCT04763265|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111213009|NCT04763265|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111213010|NCT04763265|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111213011|NCT04763265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111213012|NCT04763265|Cholinergic Agents|cholinergic agents|mesh-ancestor
111213013|NCT04763265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111213014|NCT04763265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111213015|NCT04763265|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111213016|NCT04763265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111213017|NCT00004143|Alemtuzumab|alemtuzumab|mesh-list
111213018|NCT00004143|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111213019|NCT00004143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111213020|NCT03705429|Paclitaxel|paclitaxel|mesh-list
111213021|NCT03705429|Docetaxel|docetaxel|mesh-list
111213022|NCT03705429|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111213023|NCT03705429|Cyclophosphamide|cyclophosphamide|mesh-list
111213024|NCT03705429|Trastuzumab|trastuzumab|mesh-list
111213025|NCT03705429|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111213026|NCT03705429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111213027|NCT03705429|Tubulin Modulators|tubulin modulators|mesh-ancestor
111213028|NCT03705429|Antimitotic Agents|antimitotic agents|mesh-ancestor
111213029|NCT03705429|Mitosis Modulators|mitosis modulators|mesh-ancestor
111213030|NCT03705429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111213031|NCT03705429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111213032|NCT03705429|Immunologic Factors|immunologic factors|mesh-ancestor
111213033|NCT03705429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111213034|NCT03705429|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111213035|NCT03705429|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111213036|NCT03705429|Alkylating Agents|alkylating agents|mesh-ancestor
111213037|NCT03705429|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111213038|NCT03705429|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111213039|NCT04370782|Azithromycin|azithromycin|mesh-list
111213040|NCT04370782|Doxycycline|doxycycline|mesh-list
111213041|NCT04370782|Hydroxychloroquine|hydroxychloroquine|mesh-list
111213042|NCT04370782|Zinc Sulfate|zinc sulfate|mesh-list
111213043|NCT04370782|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111213044|NCT04370782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111213045|NCT04370782|Antimalarials|antimalarials|mesh-ancestor
111213046|NCT04370782|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111213047|NCT04370782|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111213048|NCT04370782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111213049|NCT04370782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111213050|NCT04370782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111213051|NCT04370782|Astringents|astringents|mesh-ancestor
111213052|NCT04370782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111213053|NCT04370782|Dermatologic Agents|dermatologic agents|mesh-ancestor
111213054|NCT03604653|Cisplatin|cisplatin|mesh-list
111213055|NCT03604653|Doxorubicin|doxorubicin|mesh-list
111213056|NCT03604653|Mitomycins|mitomycins|mesh-list
111213057|NCT03604653|Mitomycin|mitomycin|mesh-list
111213058|NCT03604653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111213059|NCT03604653|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111213060|NCT03604653|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111213061|NCT03604653|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111213062|NCT03604653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111213063|NCT03604653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111213064|NCT03604653|Alkylating Agents|alkylating agents|mesh-ancestor
111213065|NCT03604653|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111213066|NCT04376086|Anesthetics|anesthetics|mesh-list
111213067|NCT04376086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111213068|NCT04376086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111213069|NCT04375852|Autoantibodies|autoantibodies|mesh-list
111213070|NCT04375852|Immunologic Factors|immunologic factors|mesh-ancestor
111213071|NCT04375852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111213073|NCT04364464|Enzyme Activators|enzyme activators|mesh-ancestor
111213074|NCT04364464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111213075|NCT03600441|Abexinostat|abexinostat|mesh-list
111213076|NCT03600441|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111213077|NCT03600441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111213078|NCT03600441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111213079|NCT01592240|Bococizumab|bococizumab|mesh-list
111213080|NCT01592240|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111213081|NCT01592240|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111213082|NCT01592240|Antimetabolites|antimetabolites|mesh-ancestor
111213083|NCT01592240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111213084|NCT01592240|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111213085|NCT05620654|Paclitaxel|paclitaxel|mesh-list
111213086|NCT05620654|Cisplatin|cisplatin|mesh-list
111213087|NCT05620654|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111213088|NCT05620654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111213089|NCT05620654|Tubulin Modulators|tubulin modulators|mesh-ancestor
111213090|NCT05620654|Antimitotic Agents|antimitotic agents|mesh-ancestor
111213091|NCT05620654|Mitosis Modulators|mitosis modulators|mesh-ancestor
111213092|NCT05620654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111213093|NCT03692325|Nivolumab|nivolumab|mesh-list
111213094|NCT03692325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111213095|NCT03692325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111213096|NCT03692325|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111213097|NCT03692325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111213098|NCT04357522|Vaccines|vaccines|mesh-list
111213099|NCT04357522|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
111213100|NCT04357522|Immunologic Factors|immunologic factors|mesh-ancestor
111213101|NCT04357522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111213102|NCT00005901|Pamidronate|pamidronate|mesh-list
111213103|NCT00005901|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111213104|NCT00005901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111213105|NCT04369534|Clopidogrel|clopidogrel|mesh-list
111213106|NCT04369534|Ticagrelor|ticagrelor|mesh-list
111213107|NCT04369534|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111213108|NCT04369534|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111213109|NCT04369534|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111213110|NCT04369534|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111213111|NCT04369534|Purinergic Agents|purinergic agents|mesh-ancestor
111213112|NCT04369534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111213113|NCT04369534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111213114|NCT04369534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111213115|NCT04363762|Salicylic Acid|salicylic acid|mesh-list
111213116|NCT04363762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111213117|NCT04363762|Antifungal Agents|antifungal agents|mesh-ancestor
111213118|NCT04363762|Keratolytic Agents|keratolytic agents|mesh-ancestor
111213119|NCT04363762|Dermatologic Agents|dermatologic agents|mesh-ancestor
111213120|NCT04363450|Hydroxychloroquine|hydroxychloroquine|mesh-list
111213121|NCT04363450|Antimalarials|antimalarials|mesh-ancestor
111213122|NCT04363450|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111213123|NCT04363450|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111213124|NCT04363450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111213125|NCT04363450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111213126|NCT04363450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111213127|NCT04363450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111213128|NCT03685149|Flecainide|flecainide|mesh-list
111213129|NCT03685149|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111213130|NCT03685149|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111213131|NCT03685149|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111213132|NCT03685149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111213133|NCT03685149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111213134|NCT04370080|Fluorides|fluorides|mesh-list
111213135|NCT04370080|Cariostatic Agents|cariostatic agents|mesh-ancestor
111213136|NCT04370080|Protective Agents|protective agents|mesh-ancestor
110666033|NCT00061945|Hormones|hormones|mesh-ancestor
111213137|NCT04370080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111213138|NCT01591616|Lidocaine|lidocaine|mesh-list
111213139|NCT01591616|Prilocaine|prilocaine|mesh-list
111213140|NCT01591616|Anesthetics, Local|anesthetics, local|mesh-ancestor
111213141|NCT01591616|Anesthetics|anesthetics|mesh-ancestor
111213142|NCT01591616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111213143|NCT01591616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111213144|NCT01591616|Sensory System Agents|sensory system agents|mesh-ancestor
111213145|NCT01591616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111213146|NCT01591616|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111213147|NCT01591616|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111213148|NCT01591616|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111213149|NCT01591616|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111213150|NCT01591616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111213151|NCT00938314|Epoetin Alfa|epoetin alfa|mesh-list
111213152|NCT00938314|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
111213153|NCT00938314|Hematinics|hematinics|mesh-ancestor
111213154|NCT00938314|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111213155|NCT00938314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111213156|NCT04370392|Anesthetics|anesthetics|mesh-list
111213157|NCT04370392|Anesthetics, Local|anesthetics, local|mesh-list
111213158|NCT04370392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111213159|NCT04370392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111213160|NCT04370392|Sensory System Agents|sensory system agents|mesh-ancestor
111213161|NCT04370392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111213162|NCT04369222|Acetaminophen|acetaminophen|mesh-list
111213163|NCT04369222|Aspirin|aspirin|mesh-list
111213164|NCT04369222|Salicylic Acid|salicylic acid|mesh-list
111213165|NCT04369222|Salicylates|salicylates|mesh-list
111213166|NCT04369222|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
111213167|NCT04369222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
111213168|NCT04369222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111213169|NCT04369222|Analgesics|analgesics|mesh-ancestor
111213170|NCT04369222|Sensory System Agents|sensory system agents|mesh-ancestor
111213171|NCT04369222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111213172|NCT04369222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111213173|NCT04369222|Antipyretics|antipyretics|mesh-ancestor
111213174|NCT04369222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111213175|NCT04369222|Antifungal Agents|antifungal agents|mesh-ancestor
111213176|NCT04369222|Keratolytic Agents|keratolytic agents|mesh-ancestor
111213177|NCT04369222|Dermatologic Agents|dermatologic agents|mesh-ancestor
111213178|NCT04369222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111213179|NCT04369222|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111213180|NCT04369222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111213181|NCT04369222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111213182|NCT04369222|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111213183|NCT04369222|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111213184|NCT04369222|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111213185|NCT03584373|Acetaminophen|acetaminophen|mesh-list
111213186|NCT03584373|Ketorolac|ketorolac|mesh-list
111213187|NCT03584373|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
111213188|NCT03584373|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
111213189|NCT03584373|Oxycodone|oxycodone|mesh-list
111213190|NCT03584373|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111213191|NCT03584373|Analgesics|analgesics|mesh-ancestor
111213192|NCT03584373|Sensory System Agents|sensory system agents|mesh-ancestor
111213193|NCT03584373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111213194|NCT03584373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111213195|NCT03584373|Antipyretics|antipyretics|mesh-ancestor
111213196|NCT03584373|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111213197|NCT03584373|Narcotics|narcotics|mesh-ancestor
111213198|NCT03584373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111213199|NCT03584373|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111213200|NCT03584373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111213201|NCT03584373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111213202|NCT03584373|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111213203|NCT03584373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111213204|NCT03584373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111213205|NCT01591460|Ribavirin|ribavirin|mesh-list
111213206|NCT01591460|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
111213207|NCT01591460|Interferon-alpha|interferon-alpha|mesh-list
111213208|NCT01591460|Antimetabolites|antimetabolites|mesh-ancestor
111213209|NCT01591460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111213210|NCT01591460|Antiviral Agents|antiviral agents|mesh-ancestor
111213211|NCT01591460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111213212|NCT01591460|Immunologic Factors|immunologic factors|mesh-ancestor
111213213|NCT01591460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111213214|NCT04363216|Ascorbic Acid|ascorbic acid|mesh-list
111213216|NCT04363216|Micronutrients|micronutrients|mesh-ancestor
111213217|NCT04363216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111213218|NCT04363216|Antioxidants|antioxidants|mesh-ancestor
111213219|NCT04363216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111213220|NCT04363216|Protective Agents|protective agents|mesh-ancestor
111213221|NCT03678675|Ketorolac|ketorolac|mesh-list
111213222|NCT03678675|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111213223|NCT03678675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111213224|NCT03678675|Analgesics|analgesics|mesh-ancestor
111213225|NCT03678675|Sensory System Agents|sensory system agents|mesh-ancestor
111213226|NCT03678675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111213227|NCT03678675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111213228|NCT03678675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111213229|NCT03678675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111213230|NCT03678675|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111213231|NCT03678675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111213232|NCT03678675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111213233|NCT04363060|Amoxicillin|amoxicillin|mesh-list
111213234|NCT04363060|Azithromycin|azithromycin|mesh-list
111213235|NCT04363060|Clavulanic Acid|clavulanic acid|mesh-list
111213236|NCT04363060|Clavulanic Acids|clavulanic acids|mesh-list
111213237|NCT04363060|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
111213238|NCT04363060|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111213239|NCT04363060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111213240|NCT04363060|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
111213241|NCT04363060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111213242|NCT04363060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111213243|NCT01591382|Ketamine|ketamine|mesh-list
111213244|NCT01591382|Hydromorphone|hydromorphone|mesh-list
111213245|NCT01591382|Analgesics|analgesics|mesh-ancestor
111213246|NCT01591382|Sensory System Agents|sensory system agents|mesh-ancestor
111213247|NCT01591382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111213248|NCT01591382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111213249|NCT01591382|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111213250|NCT01591382|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111213251|NCT01591382|Anesthetics, General|anesthetics, general|mesh-ancestor
111213252|NCT01591382|Anesthetics|anesthetics|mesh-ancestor
111213253|NCT01591382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111213254|NCT01591382|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111213255|NCT01591382|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111213256|NCT01591382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111213257|NCT01591382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111213258|NCT01591382|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111213259|NCT01591382|Narcotics|narcotics|mesh-ancestor
111213260|NCT03677817|Lidocaine|lidocaine|mesh-list
111213261|NCT03677817|Anesthetics, Local|anesthetics, local|mesh-ancestor
111213262|NCT03677817|Anesthetics|anesthetics|mesh-ancestor
111213263|NCT03677817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111213264|NCT03677817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111213265|NCT03677817|Sensory System Agents|sensory system agents|mesh-ancestor
111213266|NCT03677817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111213267|NCT03677817|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111213268|NCT03677817|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111213269|NCT03677817|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111213270|NCT03677817|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111213271|NCT03677817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111213272|NCT00931996|Antipsychotic Agents|antipsychotic agents|mesh-list
111213273|NCT00931996|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111213274|NCT00931996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111213275|NCT00931996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111213276|NCT00931996|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111213277|NCT04348305|Hydrocortisone|hydrocortisone|mesh-list
111213278|NCT04348305|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
111213279|NCT04348305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111213280|NCT00928174|Fluorides|fluorides|mesh-list
111213281|NCT00928174|Cariostatic Agents|cariostatic agents|mesh-ancestor
111213282|NCT00928174|Protective Agents|protective agents|mesh-ancestor
111213283|NCT00928174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111213284|NCT01696214|Fluticasone|fluticasone|mesh-list
111213285|NCT01696214|Xhance|xhance|mesh-list
111213286|NCT01696214|Theophylline|theophylline|mesh-list
111213287|NCT01696214|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
111213288|NCT01696214|Ipratropium|ipratropium|mesh-list
111213289|NCT01696214|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
111213290|NCT01696214|Montelukast|montelukast|mesh-list
111213291|NCT01696214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111213292|NCT01696214|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111213293|NCT01696214|Autonomic Agents|autonomic agents|mesh-ancestor
111213294|NCT01696214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111213295|NCT01696214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111213296|NCT01696214|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111213297|NCT01696214|Respiratory System Agents|respiratory system agents|mesh-ancestor
111213298|NCT01696214|Dermatologic Agents|dermatologic agents|mesh-ancestor
111213299|NCT01696214|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111213300|NCT01696214|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111213301|NCT01696214|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111213302|NCT01696214|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111213303|NCT01696214|Adrenergic Agents|adrenergic agents|mesh-ancestor
111213304|NCT01696214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111213305|NCT01696214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111213306|NCT01696214|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
111213307|NCT01696214|Hormone Antagonists|hormone antagonists|mesh-ancestor
111213308|NCT01696214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111213309|NCT01696214|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
111213310|NCT01696214|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111213311|NCT01696214|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111213312|NCT01696214|Cholinergic Agents|cholinergic agents|mesh-ancestor
111213313|NCT01696214|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111213314|NCT01696214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111213315|NCT01696214|Vasodilator Agents|vasodilator agents|mesh-ancestor
111213316|NCT01696214|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
111213317|NCT01696214|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111213318|NCT01696214|Purinergic Agents|purinergic agents|mesh-ancestor
111213319|NCT01696214|Glucocorticoids|glucocorticoids|mesh-ancestor
111213321|NCT01696214|Sympathomimetics|sympathomimetics|mesh-ancestor
111213322|NCT03794037|Montelukast|montelukast|mesh-list
111213323|NCT03794037|Progesterone|progesterone|mesh-list
111213324|NCT03794037|Progestins|progestins|mesh-ancestor
111213325|NCT03794037|Hormones|hormones|mesh-ancestor
111213326|NCT03794037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111213327|NCT03794037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111213328|NCT03794037|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111213329|NCT03794037|Respiratory System Agents|respiratory system agents|mesh-ancestor
111213330|NCT03794037|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
111213331|NCT03794037|Hormone Antagonists|hormone antagonists|mesh-ancestor
111213332|NCT03794037|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
111213333|NCT03794037|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111213334|NCT03794037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111213335|NCT04356508|Nivolumab|nivolumab|mesh-list
111213336|NCT04356508|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111213337|NCT04356508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111213338|NCT04356508|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111213339|NCT04356508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111213340|NCT04368598|Acetylcysteine|acetylcysteine|mesh-list
111213341|NCT04368598|Dexamethasone|dexamethasone|mesh-list
111213342|NCT04368598|Dexamethasone acetate|dexamethasone acetate|mesh-list
111213343|NCT04368598|BB 1101|bb 1101|mesh-list
111213344|NCT04368598|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111213345|NCT04368598|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111213346|NCT04368598|Antiemetics|antiemetics|mesh-ancestor
111213347|NCT04368598|Autonomic Agents|autonomic agents|mesh-ancestor
111213348|NCT04368598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111213349|NCT04368598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111213350|NCT04368598|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111213351|NCT04368598|Glucocorticoids|glucocorticoids|mesh-ancestor
111213352|NCT04368598|Hormones|hormones|mesh-ancestor
111213353|NCT04368598|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111213354|NCT04368598|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111213355|NCT04368598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111213356|NCT04368598|Protease Inhibitors|protease inhibitors|mesh-ancestor
111213357|NCT04368598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111213358|NCT04368598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111213359|NCT04368598|Antiviral Agents|antiviral agents|mesh-ancestor
111213360|NCT04368598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111213361|NCT04368598|Expectorants|expectorants|mesh-ancestor
111213362|NCT04368598|Respiratory System Agents|respiratory system agents|mesh-ancestor
111213363|NCT04368598|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111213364|NCT04368598|Antioxidants|antioxidants|mesh-ancestor
111213365|NCT04368598|Protective Agents|protective agents|mesh-ancestor
111213366|NCT04368598|Antidotes|antidotes|mesh-ancestor
111213367|NCT05347641|Cytarabine|cytarabine|mesh-list
111213368|NCT05347641|Methotrexate|methotrexate|mesh-list
111213369|NCT05347641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111213370|NCT05347641|Immunologic Factors|immunologic factors|mesh-ancestor
111213371|NCT05347641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111213372|NCT05347641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111213373|NCT05347641|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111213374|NCT05347641|Abortifacient Agents|abortifacient agents|mesh-ancestor
111213375|NCT05347641|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111213376|NCT05347641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111213377|NCT05347641|Antimetabolites|antimetabolites|mesh-ancestor
111213378|NCT05347641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111213379|NCT05347641|Dermatologic Agents|dermatologic agents|mesh-ancestor
111213380|NCT05347641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111213381|NCT05347641|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111213382|NCT05347641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111213383|NCT05347641|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111213384|NCT05347641|Antiviral Agents|antiviral agents|mesh-ancestor
111213385|NCT05347641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111213386|NCT01696058|Tiotropium Bromide|tiotropium bromide|mesh-list
111213387|NCT01696058|Olodaterol|olodaterol|mesh-list
111213388|NCT01696058|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111213389|NCT01696058|Autonomic Agents|autonomic agents|mesh-ancestor
111213390|NCT01696058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111213391|NCT01696058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111213392|NCT01696058|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111213393|NCT01696058|Respiratory System Agents|respiratory system agents|mesh-ancestor
111213394|NCT01696058|Parasympatholytics|parasympatholytics|mesh-ancestor
111213395|NCT01696058|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111213396|NCT01696058|Cholinergic Agents|cholinergic agents|mesh-ancestor
111213397|NCT01696058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111213398|NCT01696058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111213399|NCT04368520|Vitamin D|vitamin d|mesh-list
111213400|NCT04368520|Ergocalciferols|ergocalciferols|mesh-list
111213401|NCT04368520|Cholecalciferol|cholecalciferol|mesh-list
111213402|NCT04368520|Vitamins|vitamins|mesh-list
111213403|NCT04368520|Micronutrients|micronutrients|mesh-ancestor
111213404|NCT04368520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111213405|NCT04368520|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111213406|NCT04368520|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111213407|NCT03790137|Fenfluramine|fenfluramine|mesh-list
111213408|NCT03790137|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111213409|NCT03790137|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111213410|NCT03790137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111213411|NCT03790137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111213412|NCT03790137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111213413|NCT03790137|Serotonin Agents|serotonin agents|mesh-ancestor
111213414|NCT03790137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111213415|NCT01694420|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
111213416|NCT01694420|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111213417|NCT01694420|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111213418|NCT01694420|Antiviral Agents|antiviral agents|mesh-ancestor
111213419|NCT01694420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111213420|NCT03580317|Carbamazepine|carbamazepine|mesh-list
111213421|NCT03580317|Anticonvulsants|anticonvulsants|mesh-ancestor
111213422|NCT03580317|Antimanic Agents|antimanic agents|mesh-ancestor
111213423|NCT03580317|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111213424|NCT03580317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111213425|NCT03580317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111213426|NCT03580317|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111213427|NCT03580317|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111213428|NCT03580317|Analgesics|analgesics|mesh-ancestor
111213429|NCT03580317|Sensory System Agents|sensory system agents|mesh-ancestor
111213430|NCT03580317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111213431|NCT03580317|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111213432|NCT03580317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111213433|NCT03580317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111213434|NCT03580317|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111213435|NCT03580317|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111213437|NCT04362124|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111213438|NCT04362124|Immunologic Factors|immunologic factors|mesh-ancestor
111213439|NCT04362124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111213440|NCT04356118|Methotrexate|methotrexate|mesh-list
111213441|NCT04356118|Endostatins|endostatins|mesh-list
111213442|NCT04356118|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111213443|NCT04356118|Abortifacient Agents|abortifacient agents|mesh-ancestor
111213444|NCT04356118|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111213445|NCT04356118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111213446|NCT04356118|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111213447|NCT04356118|Antimetabolites|antimetabolites|mesh-ancestor
111213448|NCT04356118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111213449|NCT04356118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111213450|NCT04356118|Dermatologic Agents|dermatologic agents|mesh-ancestor
111213451|NCT04356118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111213452|NCT04356118|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111213453|NCT04356118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111213454|NCT04356118|Immunologic Factors|immunologic factors|mesh-ancestor
111213455|NCT04356118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111213456|NCT04356118|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111213457|NCT04356118|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111213458|NCT04356118|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111213459|NCT04356118|Growth Substances|growth substances|mesh-ancestor
111213460|NCT04356118|Growth Inhibitors|growth inhibitors|mesh-ancestor
111213461|NCT04361734|Nitroglycerin|nitroglycerin|mesh-list
111213462|NCT04361734|Vasodilator Agents|vasodilator agents|mesh-ancestor
111213463|NCT04361812|Omalizumab|omalizumab|mesh-list
111213464|NCT04361812|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111213465|NCT04361812|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111213466|NCT04361812|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111213467|NCT04361812|Respiratory System Agents|respiratory system agents|mesh-ancestor
111213468|NCT04361812|Immunologic Factors|immunologic factors|mesh-ancestor
111213469|NCT04361812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111213470|NCT04355962|Sevoflurane|sevoflurane|mesh-list
111213471|NCT04355962|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111213472|NCT04355962|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111213473|NCT04355962|Anesthetics, General|anesthetics, general|mesh-ancestor
111213474|NCT04355962|Anesthetics|anesthetics|mesh-ancestor
111213475|NCT04355962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111213476|NCT04355962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111213477|NCT00705081|Ezetimibe|ezetimibe|mesh-list
111213478|NCT00705081|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111213479|NCT00705081|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111213480|NCT00705081|Antimetabolites|antimetabolites|mesh-ancestor
111213481|NCT00705081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111213482|NCT00705081|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111213483|NCT00704769|Desloratadine|desloratadine|mesh-list
111213484|NCT00704769|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111213485|NCT00704769|Cholinergic Agents|cholinergic agents|mesh-ancestor
111213486|NCT00704769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111213487|NCT00704769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111213488|NCT00704769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111213489|NCT00704769|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
111213490|NCT00704769|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111213491|NCT00704769|Histamine Antagonists|histamine antagonists|mesh-ancestor
111213492|NCT00704769|Histamine Agents|histamine agents|mesh-ancestor
111213493|NCT00938548|Pregabalin|pregabalin|mesh-list
111213494|NCT00938548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111213495|NCT00938548|Analgesics|analgesics|mesh-ancestor
111213496|NCT00938548|Sensory System Agents|sensory system agents|mesh-ancestor
111213497|NCT00938548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111213498|NCT00938548|Anticonvulsants|anticonvulsants|mesh-ancestor
111213499|NCT00938548|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111213500|NCT00938548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111213501|NCT00938548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111213502|NCT00938548|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111213503|NCT00938548|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111213504|NCT00938548|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111213505|NCT00938548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111213506|NCT00938548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111213507|NCT00932620|Simvastatin|simvastatin|mesh-list
111213508|NCT00932620|Ezetimibe|ezetimibe|mesh-list
111213509|NCT00932620|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111213510|NCT00932620|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111213511|NCT00932620|Antimetabolites|antimetabolites|mesh-ancestor
111213512|NCT00932620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111213513|NCT00932620|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111213514|NCT00932620|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111213515|NCT00932620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111213517|NCT04361188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111213518|NCT04361188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111213519|NCT04367818|Anesthetics|anesthetics|mesh-list
111213520|NCT04367818|Anesthetics, Local|anesthetics, local|mesh-list
111213521|NCT04367818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111213522|NCT04367818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111213523|NCT04367818|Sensory System Agents|sensory system agents|mesh-ancestor
111213524|NCT04367818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111213525|NCT01677273|Caseins|caseins|mesh-list
111213526|NCT01677273|Chelating Agents|chelating agents|mesh-ancestor
111213527|NCT01677273|Sequestering Agents|sequestering agents|mesh-ancestor
111213528|NCT01677273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111213529|NCT04355806|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111213530|NCT04355806|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
111213531|NCT04355806|Vaccines|vaccines|mesh-list
111213532|NCT04355806|Antibodies|antibodies|mesh-list
111213533|NCT04355806|Immunoglobulins|immunoglobulins|mesh-list
111213534|NCT04355806|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111213535|NCT04355806|Immunologic Factors|immunologic factors|mesh-ancestor
111213536|NCT04355806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111213537|NCT04355806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111213538|NCT04355806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111213539|NCT01677351|Clonidine|clonidine|mesh-list
111213540|NCT01677351|Analgesics|analgesics|mesh-ancestor
111213541|NCT01677351|Sensory System Agents|sensory system agents|mesh-ancestor
111213542|NCT01677351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111213543|NCT01677351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111213544|NCT01677351|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111213545|NCT01677351|Sympatholytics|sympatholytics|mesh-ancestor
111213546|NCT01677351|Autonomic Agents|autonomic agents|mesh-ancestor
111213547|NCT01677351|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111213548|NCT01677351|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111213549|NCT01677351|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111213550|NCT01677351|Adrenergic Agents|adrenergic agents|mesh-ancestor
111213551|NCT01677351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111213552|NCT01677351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111213553|NCT00938704|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
111213554|NCT00938704|Hyaluronic Acid|hyaluronic acid|mesh-list
111213555|NCT00938704|Glycerol|glycerol|mesh-list
111213556|NCT00938704|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111213557|NCT00938704|Immunologic Factors|immunologic factors|mesh-ancestor
111213558|NCT00938704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111213559|NCT00938704|Viscosupplements|viscosupplements|mesh-ancestor
111213560|NCT00938704|Protective Agents|protective agents|mesh-ancestor
111213561|NCT00938704|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
111213562|NCT00938704|Laxatives|laxatives|mesh-ancestor
111213563|NCT00938704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111213564|NCT03666351|Losartan|losartan|mesh-list
111213565|NCT03666351|Amlodipine|amlodipine|mesh-list
111213566|NCT03666351|Chlorthalidone|chlorthalidone|mesh-list
111213567|NCT03666351|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111213568|NCT03666351|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111213569|NCT03666351|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111213570|NCT03666351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111213571|NCT03666351|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111213572|NCT03666351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111213573|NCT03666351|Vasodilator Agents|vasodilator agents|mesh-ancestor
111213574|NCT03666351|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111213575|NCT03666351|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111213576|NCT03666351|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111213577|NCT03666351|Diuretics|diuretics|mesh-ancestor
111213578|NCT03666351|Natriuretic Agents|natriuretic agents|mesh-ancestor
111213579|NCT03666351|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
111213580|NCT00928642|Gemcitabine|gemcitabine|mesh-list
111213581|NCT00928642|Imatinib Mesylate|imatinib mesylate|mesh-list
111213582|NCT00928642|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111213583|NCT00928642|Antimetabolites|antimetabolites|mesh-ancestor
111213584|NCT00928642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111213585|NCT00928642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111213586|NCT00928642|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111213587|NCT00928642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111213589|NCT04361422|Dermatologic Agents|dermatologic agents|mesh-ancestor
111213590|NCT03579615|Insulin|insulin|mesh-list
111213591|NCT03579615|Insulin Aspart|insulin aspart|mesh-list
111213592|NCT03579615|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111213593|NCT03579615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111213594|NCT04355416|Curcumin|curcumin|mesh-list
111213595|NCT04355416|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111213596|NCT04355416|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111213597|NCT04355416|Analgesics|analgesics|mesh-ancestor
111213598|NCT04355416|Sensory System Agents|sensory system agents|mesh-ancestor
111213599|NCT04355416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111213600|NCT04355416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111213601|NCT04355416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111213602|NCT04355416|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111213603|NCT04355416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111213604|NCT04355416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111213605|NCT04355416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111213606|NCT04355494|Eculizumab|eculizumab|mesh-list
111213607|NCT04355494|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
111213608|NCT04355494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111213609|NCT04355494|Immunologic Factors|immunologic factors|mesh-ancestor
111213610|NCT04355494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111213611|NCT00934024|Varenicline|varenicline|mesh-list
111213612|NCT00934024|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111213613|NCT00934024|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111213614|NCT00934024|Cholinergic Agents|cholinergic agents|mesh-ancestor
111213615|NCT00934024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111213616|NCT00934024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111213617|NCT00934024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111213618|NCT04361032|Deferoxamine|deferoxamine|mesh-list
111213619|NCT04361032|Siderophores|siderophores|mesh-ancestor
111213620|NCT04361032|Iron Chelating Agents|iron chelating agents|mesh-ancestor
111213621|NCT04361032|Chelating Agents|chelating agents|mesh-ancestor
111213622|NCT04361032|Sequestering Agents|sequestering agents|mesh-ancestor
111213623|NCT04361032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111213624|NCT00928954|Gabapentin|gabapentin|mesh-list
111213625|NCT00928954|Memantine|memantine|mesh-list
111213626|NCT00928954|Analgesics|analgesics|mesh-ancestor
111213627|NCT00928954|Sensory System Agents|sensory system agents|mesh-ancestor
111213628|NCT00928954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111213629|NCT00928954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111213630|NCT00928954|Anticonvulsants|anticonvulsants|mesh-ancestor
111213631|NCT00928954|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111213632|NCT00928954|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111213633|NCT00928954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111213634|NCT00928954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111213635|NCT00928954|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111213636|NCT00928954|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111213637|NCT00928954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111213638|NCT00928954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111213639|NCT00928954|Antimanic Agents|antimanic agents|mesh-ancestor
111213640|NCT00928954|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111213641|NCT00928954|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111213642|NCT00928954|Dopamine Agents|dopamine agents|mesh-ancestor
111213643|NCT04355026|Hydroxychloroquine|hydroxychloroquine|mesh-list
111213644|NCT04355026|Bromhexine|bromhexine|mesh-list
111213645|NCT04355026|Antimalarials|antimalarials|mesh-ancestor
111213646|NCT04355026|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111213647|NCT04355026|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111213648|NCT04355026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111213649|NCT04355026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111213650|NCT04355026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111213651|NCT04355026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111213652|NCT04355026|Expectorants|expectorants|mesh-ancestor
111213653|NCT04355026|Respiratory System Agents|respiratory system agents|mesh-ancestor
111213654|NCT03548571|Temozolomide|temozolomide|mesh-list
111213655|NCT03548571|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111213656|NCT03548571|Alkylating Agents|alkylating agents|mesh-ancestor
111213657|NCT03548571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111213658|NCT03548571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111213659|NCT00939562|Doxycycline|doxycycline|mesh-list
111213660|NCT00939562|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111213661|NCT00939562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111213662|NCT00939562|Antimalarials|antimalarials|mesh-ancestor
111213663|NCT00939562|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111213664|NCT00939562|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111213666|NCT04359862|Sevoflurane|sevoflurane|mesh-list
111213667|NCT04359862|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111213668|NCT04359862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111213669|NCT04359862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111213670|NCT04359862|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111213671|NCT04359862|Anesthetics, General|anesthetics, general|mesh-ancestor
111213672|NCT04359862|Anesthetics|anesthetics|mesh-ancestor
111213673|NCT04359862|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111213674|NCT04359862|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111213675|NCT04366726|Abaloparatide|abaloparatide|mesh-list
111213676|NCT04366726|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111213677|NCT04366726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111213678|NCT04366960|Enoxaparin|enoxaparin|mesh-list
111213679|NCT04366960|Anticoagulants|anticoagulants|mesh-ancestor
111213680|NCT04366960|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111213681|NCT04366960|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111213682|NCT04366960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111213683|NCT03539445|3-n-butylphthalide|3-n-butylphthalide|mesh-list
111213684|NCT03539445|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111213685|NCT03539445|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111213686|NCT03539445|Protective Agents|protective agents|mesh-ancestor
111213687|NCT03539445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111213688|NCT04360876|Dexamethasone|dexamethasone|mesh-list
111213689|NCT04360876|Dexamethasone acetate|dexamethasone acetate|mesh-list
111213690|NCT04360876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111213691|NCT04360876|Antiemetics|antiemetics|mesh-ancestor
111213692|NCT04360876|Autonomic Agents|autonomic agents|mesh-ancestor
111213693|NCT04360876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111213694|NCT04360876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111213695|NCT04360876|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111213696|NCT04360876|Glucocorticoids|glucocorticoids|mesh-ancestor
111213697|NCT04360876|Hormones|hormones|mesh-ancestor
111213698|NCT04360876|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111213699|NCT04360876|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111213700|NCT04360876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111213701|NCT04359550|Antibodies|antibodies|mesh-list
111213702|NCT04359550|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111213703|NCT04359550|Immunologic Factors|immunologic factors|mesh-ancestor
111213704|NCT04359550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111213705|NCT02084511|Celecoxib|celecoxib|mesh-list
111213706|NCT02084511|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111213707|NCT02084511|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111213708|NCT02084511|Analgesics|analgesics|mesh-ancestor
111213709|NCT02084511|Sensory System Agents|sensory system agents|mesh-ancestor
111213710|NCT02084511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111213711|NCT02084511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111213712|NCT02084511|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111213713|NCT02084511|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111213714|NCT02084511|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111213715|NCT02084511|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111213716|NCT02084511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111213717|NCT02084511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111213718|NCT00942448|Diclofenac|diclofenac|mesh-list
111213719|NCT00942448|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111213720|NCT00942448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111213721|NCT00942448|Analgesics|analgesics|mesh-ancestor
111213722|NCT00942448|Sensory System Agents|sensory system agents|mesh-ancestor
111213723|NCT00942448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111213724|NCT00942448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111213725|NCT00942448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111213726|NCT00942448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111213727|NCT00942448|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111213728|NCT00942448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111213729|NCT00942448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111213730|NCT03532581|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111213731|NCT02982148|Methylene Blue|methylene blue|mesh-list
111213732|NCT02982148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111213733|NCT02982148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111213734|NCT04359316|Azithromycin|azithromycin|mesh-list
110666635|NCT01049854|Vidarabine|vidarabine|mesh-list
111213735|NCT04359316|Hydroxychloroquine|hydroxychloroquine|mesh-list
111213736|NCT04359316|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111213737|NCT04359316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111213738|NCT04359316|Antimalarials|antimalarials|mesh-ancestor
111213739|NCT04359316|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111213740|NCT04359316|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111213741|NCT04359316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111213742|NCT04359316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111213743|NCT04359316|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111213744|NCT00939874|Raltegravir Potassium|raltegravir potassium|mesh-list
111213745|NCT00939874|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111213746|NCT00939874|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111213747|NCT00939874|Antiviral Agents|antiviral agents|mesh-ancestor
111213748|NCT00939874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111213749|NCT00939874|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111213750|NCT00939874|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111213751|NCT00939874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111213752|NCT00939874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111213753|NCT03557385|Adenosine|adenosine|mesh-list
111213754|NCT03557385|Analgesics|analgesics|mesh-ancestor
111213755|NCT03557385|Sensory System Agents|sensory system agents|mesh-ancestor
111213756|NCT03557385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111213757|NCT03557385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111213758|NCT03557385|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111213759|NCT03557385|Vasodilator Agents|vasodilator agents|mesh-ancestor
111213760|NCT03557385|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
111213761|NCT03557385|Purinergic Agonists|purinergic agonists|mesh-ancestor
111213762|NCT03557385|Purinergic Agents|purinergic agents|mesh-ancestor
111213763|NCT03557385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111213764|NCT03557385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111213765|NCT04601350|Midazolam|midazolam|mesh-list
111213766|NCT04601350|Anesthetics|anesthetics|mesh-list
111213767|NCT04601350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111213768|NCT04601350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111213769|NCT04601350|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111213770|NCT04601350|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111213771|NCT04601350|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111213772|NCT04601350|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111213773|NCT04601350|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111213774|NCT04601350|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111213775|NCT04601350|Anesthetics, General|anesthetics, general|mesh-ancestor
111213776|NCT04601350|GABA Modulators|gaba modulators|mesh-ancestor
111213777|NCT04601350|GABA Agents|gaba agents|mesh-ancestor
111213778|NCT04601350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111213779|NCT04601350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111213780|NCT05346861|Trastuzumab|trastuzumab|mesh-list
111213781|NCT05346861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111213782|NCT05346861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111213783|NCT04358614|Ritonavir|ritonavir|mesh-list
111213784|NCT04358614|Lopinavir|lopinavir|mesh-list
111213785|NCT04358614|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111213786|NCT04358614|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111213787|NCT04358614|Protease Inhibitors|protease inhibitors|mesh-ancestor
111213788|NCT04358614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111213789|NCT04358614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111213790|NCT04358614|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111213791|NCT04358614|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111213792|NCT04358614|Antiviral Agents|antiviral agents|mesh-ancestor
111213793|NCT04358614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111213794|NCT04358614|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111213795|NCT04358614|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111213796|NCT01670409|Cisplatin|cisplatin|mesh-list
111213797|NCT01670409|Fluorouracil|fluorouracil|mesh-list
111213798|NCT01670409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111213799|NCT01670409|Antimetabolites|antimetabolites|mesh-ancestor
111213800|NCT01670409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111213801|NCT01670409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111213802|NCT01670409|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111213803|NCT01670409|Immunologic Factors|immunologic factors|mesh-ancestor
111213804|NCT01670409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111213805|NCT04761705|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111213806|NCT04761705|Latanoprost|latanoprost|mesh-list
111213807|NCT04761705|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111213808|NCT04358770|Clocortolone|clocortolone|mesh-list
111213809|NCT04358770|Fluocortolone|fluocortolone|mesh-list
111213810|NCT04358770|Clocortolone pivalate|clocortolone pivalate|mesh-list
110666715|NCT00461253|Copper|copper|mesh-list
111213811|NCT04358770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111213812|NCT04358770|Glucocorticoids|glucocorticoids|mesh-ancestor
111213813|NCT04358770|Hormones|hormones|mesh-ancestor
111213814|NCT04358770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111213815|NCT04358770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111213816|NCT03516981|Pembrolizumab|pembrolizumab|mesh-list
111213817|NCT03516981|Lenvatinib|lenvatinib|mesh-list
111213818|NCT03516981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111213819|NCT03516981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111213820|NCT03516981|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111213821|NCT03516981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111213822|NCT03516981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111213823|NCT03516981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111213824|NCT05618470|Botulinum Toxins|botulinum toxins|mesh-list
111213825|NCT05618470|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111213826|NCT05618470|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111213827|NCT05618470|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111213828|NCT05618470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111213829|NCT05618470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111213830|NCT05618470|Cholinergic Agents|cholinergic agents|mesh-ancestor
111213831|NCT05618470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111213832|NCT05618470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111213833|NCT05618470|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111213834|NCT05618470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111213835|NCT04358146|Locust bean gum|locust bean gum|mesh-list
111213836|NCT04358146|Antidiarrheals|antidiarrheals|mesh-ancestor
111213837|NCT04358146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111213838|NCT05620498|Lenvatinib|lenvatinib|mesh-list
111213839|NCT05620498|Tislelizumab|tislelizumab|mesh-list
111213840|NCT05620498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111213841|NCT05620498|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111213842|NCT05620498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111213843|NCT05620498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111213844|NCT05620498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111213845|NCT01670565|Mycophenolic Acid|mycophenolic acid|mesh-list
111213846|NCT01670565|Belimumab|belimumab|mesh-list
111213847|NCT01670565|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111213848|NCT01670565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111213849|NCT01670565|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111213850|NCT01670565|Antitubercular Agents|antitubercular agents|mesh-ancestor
111213851|NCT01670565|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111213852|NCT01670565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111213853|NCT01670565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111213854|NCT01670565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111213855|NCT01670565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111213856|NCT01670565|Immunologic Factors|immunologic factors|mesh-ancestor
111213857|NCT01670565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111213858|NCT01670799|Ketorolac|ketorolac|mesh-list
111213859|NCT01670799|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
111213860|NCT01670799|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111213861|NCT01670799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111213862|NCT01670799|Analgesics|analgesics|mesh-ancestor
111213863|NCT01670799|Sensory System Agents|sensory system agents|mesh-ancestor
111213864|NCT01670799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111213865|NCT01670799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111213866|NCT01670799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111213867|NCT01670799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111213868|NCT01670799|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111213869|NCT01670799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111213870|NCT01670799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111213871|NCT02404935|Cetuximab|cetuximab|mesh-list
111213872|NCT02404935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111213873|NCT02404935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111213874|NCT04320940|Phenobarbital|phenobarbital|mesh-list
111213875|NCT04320940|Anticonvulsants|anticonvulsants|mesh-ancestor
111213876|NCT04320940|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110980548|NCT00546273|Immunologic Factors|immunologic factors|mesh-ancestor
111213877|NCT04320940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111213878|NCT04320940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111213879|NCT04320940|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111213880|NCT04320940|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111213881|NCT04320940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111213882|NCT04320940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110666786|NCT00640835|Buprenorphine|buprenorphine|mesh-list
111213883|NCT04320940|GABA Modulators|gaba modulators|mesh-ancestor
111213884|NCT04320940|GABA Agents|gaba agents|mesh-ancestor
111213885|NCT04320940|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111213886|NCT04320940|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111213887|NCT04320940|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111213888|NCT03422523|Rituximab|rituximab|mesh-list
111213889|NCT03422523|Atezolizumab|atezolizumab|mesh-list
111213890|NCT03422523|Gemcitabine|gemcitabine|mesh-list
111213891|NCT03422523|Oxaliplatin|oxaliplatin|mesh-list
111213892|NCT03422523|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111213893|NCT03422523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111213894|NCT03422523|Immunologic Factors|immunologic factors|mesh-ancestor
111213895|NCT03422523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111213896|NCT03422523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111213897|NCT03422523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111213898|NCT03422523|Antimetabolites|antimetabolites|mesh-ancestor
111213899|NCT03422523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111213900|NCT03422523|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111213901|NCT03032536|Tenofovir|tenofovir|mesh-list
111213902|NCT03032536|Entecavir|entecavir|mesh-list
111213903|NCT03032536|Antiviral Agents|antiviral agents|mesh-ancestor
111213904|NCT03032536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111213905|NCT03032536|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111213906|NCT03032536|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111213907|NCT03032536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111213908|NCT03032536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111213909|NCT03032536|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111213910|NCT03032536|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111213911|NCT03032614|Carboplatin|carboplatin|mesh-list
111213912|NCT03032614|Veliparib|veliparib|mesh-list
111213913|NCT03032614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111213914|NCT03032614|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111213915|NCT03032614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111213916|NCT03032614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111213917|NCT03032458|Ketorolac|ketorolac|mesh-list
111213918|NCT03032458|Lidocaine|lidocaine|mesh-list
111213919|NCT03032458|Meperidine|meperidine|mesh-list
111213920|NCT03032458|Anesthetics, Local|anesthetics, local|mesh-ancestor
111213921|NCT03032458|Anesthetics|anesthetics|mesh-ancestor
111213922|NCT03032458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111213923|NCT03032458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111213924|NCT03032458|Sensory System Agents|sensory system agents|mesh-ancestor
111213925|NCT03032458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111213926|NCT03032458|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111213927|NCT03032458|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111213928|NCT03032458|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111213929|NCT03032458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111213930|NCT03032458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111213931|NCT03032458|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111213932|NCT03032458|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111213933|NCT03032458|Analgesics|analgesics|mesh-ancestor
111213934|NCT03032458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111213935|NCT03032458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111213936|NCT03032458|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111213937|NCT03032458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111213938|NCT03032458|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111213939|NCT03032458|Narcotics|narcotics|mesh-ancestor
111213940|NCT03032458|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111213941|NCT02245438|Ritonavir|ritonavir|mesh-list
111213942|NCT02245438|Tipranavir|tipranavir|mesh-list
111213943|NCT02245438|Ethinyl Estradiol|ethinyl estradiol|mesh-list
111213944|NCT02245438|Norethindrone|norethindrone|mesh-list
111213945|NCT02245438|Norethindrone Acetate|norethindrone acetate|mesh-list
111213946|NCT02245438|Norinyl|norinyl|mesh-list
111213947|NCT02245438|Estradiol|estradiol|mesh-list
111213948|NCT02245438|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111213949|NCT02245438|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111213950|NCT02245438|Protease Inhibitors|protease inhibitors|mesh-ancestor
110793318|NCT02036164|Cisplatin|cisplatin|mesh-list
111213951|NCT02245438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111213952|NCT02245438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111213953|NCT02245438|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111213954|NCT02245438|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111213955|NCT02245438|Antiviral Agents|antiviral agents|mesh-ancestor
111213956|NCT02245438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111213957|NCT02245438|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111213958|NCT02245438|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111213959|NCT02245438|Estrogens|estrogens|mesh-ancestor
111213960|NCT02245438|Hormones|hormones|mesh-ancestor
111213961|NCT02245438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111213962|NCT02245438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111213963|NCT02245438|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111213964|NCT02245438|Contraceptive Agents|contraceptive agents|mesh-ancestor
111213965|NCT02245438|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111213966|NCT02245438|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111213967|NCT02245438|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111213968|NCT02245438|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111213969|NCT02245438|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111213970|NCT02245438|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
111213971|NCT03087669|Norepinephrine|norepinephrine|mesh-list
111213972|NCT03087669|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111213973|NCT03087669|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111213974|NCT03087669|Adrenergic Agents|adrenergic agents|mesh-ancestor
111213975|NCT03087669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111213976|NCT03087669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111213977|NCT03087669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111213978|NCT03087669|Sympathomimetics|sympathomimetics|mesh-ancestor
111213979|NCT03087669|Autonomic Agents|autonomic agents|mesh-ancestor
111213980|NCT03087669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111213981|NCT03087669|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111213982|NCT00939952|Ertapenem|ertapenem|mesh-list
111213983|NCT00939952|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111213984|NCT00939952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111213985|NCT02401815|Sunitinib|sunitinib|mesh-list
111213986|NCT02401815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111213987|NCT02401815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111213988|NCT02401815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111213989|NCT02401815|Growth Substances|growth substances|mesh-ancestor
111213990|NCT02401815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111213991|NCT02401815|Growth Inhibitors|growth inhibitors|mesh-ancestor
111213992|NCT02401815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111213993|NCT02401815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111213994|NCT02401815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111213995|NCT00947752|Glatiramer Acetate|glatiramer acetate|mesh-list
111213996|NCT00947752|(T,G)-A-L|(t,g)-a-l|mesh-list
111213997|NCT00947752|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111213998|NCT00947752|Immunologic Factors|immunologic factors|mesh-ancestor
111213999|NCT00947752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111214000|NCT00947752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111214001|NCT00947752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111214002|NCT03456687|Exenatide|exenatide|mesh-list
111214003|NCT03456687|Glucagon|glucagon|mesh-list
111214004|NCT03456687|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
111214005|NCT03456687|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111214006|NCT03456687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111214007|NCT03456687|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111214008|NCT03456687|Incretins|incretins|mesh-ancestor
111214009|NCT03456687|Hormones|hormones|mesh-ancestor
111214010|NCT03456687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111214011|NCT03456687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111214012|NCT00948298|Vitamin D|vitamin d|mesh-list
111214013|NCT00948298|Vitamins|vitamins|mesh-ancestor
111214014|NCT00948298|Micronutrients|micronutrients|mesh-ancestor
111214015|NCT00948298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111214016|NCT00948298|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111214017|NCT00948610|Infliximab|infliximab|mesh-list
111214018|NCT00948610|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111214019|NCT00948610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111214020|NCT00948610|Dermatologic Agents|dermatologic agents|mesh-ancestor
111214021|NCT00948610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111214022|NCT00948610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111214023|NCT03031834|Quinapril|quinapril|mesh-list
111214024|NCT03031834|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
111214025|NCT03031834|Protease Inhibitors|protease inhibitors|mesh-ancestor
111214026|NCT03031834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111214027|NCT03031834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111214028|NCT03031834|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111214029|NCT00944554|Varenicline|varenicline|mesh-list
111214030|NCT00944554|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111214031|NCT00944554|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111214032|NCT00944554|Cholinergic Agents|cholinergic agents|mesh-ancestor
111214033|NCT00944554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111214034|NCT00944554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110666943|NCT00568451|Paclitaxel|paclitaxel|mesh-list
111214035|NCT00944554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111214036|NCT03031756|Glycine|glycine|mesh-list
111214037|NCT03031756|Glycine Agents|glycine agents|mesh-ancestor
111214038|NCT03031756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111214039|NCT03031756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111214040|NCT03031756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111214041|NCT00944710|Atropine|atropine|mesh-list
111214042|NCT00944710|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111214043|NCT00944710|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111214044|NCT00944710|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111214045|NCT00944710|Autonomic Agents|autonomic agents|mesh-ancestor
111214046|NCT00944710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111214047|NCT00944710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111214048|NCT00944710|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111214049|NCT00944710|Respiratory System Agents|respiratory system agents|mesh-ancestor
111214050|NCT00944710|Mydriatics|mydriatics|mesh-ancestor
111214051|NCT00944710|Parasympatholytics|parasympatholytics|mesh-ancestor
111214052|NCT00944710|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111214053|NCT00944710|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111214054|NCT00944710|Cholinergic Agents|cholinergic agents|mesh-ancestor
111214055|NCT00944710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111214056|NCT00944710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111214057|NCT00949078|Omalizumab|omalizumab|mesh-list
111214058|NCT00949078|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111214059|NCT00949078|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111214060|NCT00949078|Respiratory System Agents|respiratory system agents|mesh-ancestor
111214061|NCT00945256|Nitroprusside|nitroprusside|mesh-list
111214062|NCT00945256|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111214063|NCT00945256|Vasodilator Agents|vasodilator agents|mesh-ancestor
111214064|NCT00945256|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
111214065|NCT00945256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111214066|NCT03854032|Nivolumab|nivolumab|mesh-list
111214067|NCT03854032|Linrodostat|linrodostat|mesh-list
111214068|NCT03854032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111214069|NCT03854032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111214070|NCT03854032|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111214071|NCT03854032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111214072|NCT03854032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111214073|NCT03031444|Leucovorin|leucovorin|mesh-list
111214074|NCT03031444|Cetuximab|cetuximab|mesh-list
111214075|NCT03031444|Fluorouracil|fluorouracil|mesh-list
111214076|NCT03031444|Oxaliplatin|oxaliplatin|mesh-list
111214077|NCT03031444|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111214078|NCT03031444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111214079|NCT03031444|Antimetabolites|antimetabolites|mesh-ancestor
111214080|NCT03031444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111214081|NCT03031444|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111214082|NCT03031444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111214083|NCT03031444|Immunologic Factors|immunologic factors|mesh-ancestor
111214084|NCT03031444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111214085|NCT03031444|Antidotes|antidotes|mesh-ancestor
111214086|NCT03031444|Protective Agents|protective agents|mesh-ancestor
111214087|NCT03031444|Vitamin B Complex|vitamin b complex|mesh-ancestor
111214088|NCT03031444|Vitamins|vitamins|mesh-ancestor
111214089|NCT03031444|Micronutrients|micronutrients|mesh-ancestor
111214090|NCT03031054|Hyaluronic Acid|hyaluronic acid|mesh-list
111214091|NCT03031054|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111214092|NCT03031054|Immunologic Factors|immunologic factors|mesh-ancestor
111214093|NCT03031054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111214094|NCT03031054|Viscosupplements|viscosupplements|mesh-ancestor
111214095|NCT03031054|Protective Agents|protective agents|mesh-ancestor
111214096|NCT00945334|Rifaximin|rifaximin|mesh-list
111214097|NCT00945334|Neomycin|neomycin|mesh-list
111214098|NCT00945334|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111214099|NCT00945334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111214100|NCT00945334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111214101|NCT00945334|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111214102|NCT00945334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111214103|NCT00945334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111214104|NCT03559114|Dalteparin|dalteparin|mesh-list
111214105|NCT03559114|Tinzaparin|tinzaparin|mesh-list
111214106|NCT03559114|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
111214107|NCT03559114|Anticoagulants|anticoagulants|mesh-ancestor
111214108|NCT03559114|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111214109|NCT03559114|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111214110|NCT03559114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111214111|NCT05153590|Liraglutide|liraglutide|mesh-list
111214112|NCT05153590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111214113|NCT05153590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111214114|NCT05153590|Incretins|incretins|mesh-ancestor
111214116|NCT05153590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111214117|NCT03490864|Melatonin|melatonin|mesh-list
111214118|NCT03490864|Antioxidants|antioxidants|mesh-ancestor
111214119|NCT03490864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111214120|NCT03490864|Protective Agents|protective agents|mesh-ancestor
111214121|NCT03490864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111214122|NCT03490864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111214123|NCT04402203|Favipiravir|favipiravir|mesh-list
111214124|NCT04402203|Antiviral Agents|antiviral agents|mesh-ancestor
111214125|NCT04402203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111214126|NCT03030976|Cyclophosphamide|cyclophosphamide|mesh-list
111214127|NCT03030976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111214128|NCT03030976|Immunologic Factors|immunologic factors|mesh-ancestor
111214129|NCT03030976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111214130|NCT03030976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111214131|NCT03030976|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111214132|NCT03030976|Alkylating Agents|alkylating agents|mesh-ancestor
111214133|NCT03030976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111214134|NCT03030976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111214135|NCT03030976|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111214136|NCT00949234|Ritonavir|ritonavir|mesh-list
111214137|NCT00949234|Lopinavir|lopinavir|mesh-list
111214138|NCT00949234|Tenofovir|tenofovir|mesh-list
111214139|NCT00949234|Emtricitabine|emtricitabine|mesh-list
111214140|NCT00949234|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111214141|NCT00949234|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111214142|NCT00949234|Protease Inhibitors|protease inhibitors|mesh-ancestor
111214143|NCT00949234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111214144|NCT00949234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111214145|NCT00949234|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111214146|NCT00949234|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111214147|NCT00949234|Antiviral Agents|antiviral agents|mesh-ancestor
111214148|NCT00949234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111214149|NCT00949234|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111214150|NCT00949234|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111214151|NCT00949234|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110793543|NCT06008106|Cisplatin|cisplatin|mesh-list
111214152|NCT00949234|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111214153|NCT03090880|Tinzaparin|tinzaparin|mesh-list
111214154|NCT03090880|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
111214155|NCT03090880|Dalteparin|dalteparin|mesh-list
111214156|NCT03090880|Anticoagulants|anticoagulants|mesh-ancestor
111214157|NCT03090880|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111214158|NCT03090880|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111214159|NCT03090880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111214160|NCT05097976|Methylprednisolone|methylprednisolone|mesh-list
111214161|NCT05097976|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111214162|NCT05097976|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111214163|NCT05097976|Prednisolone|prednisolone|mesh-list
111214164|NCT05097976|Prednisolone acetate|prednisolone acetate|mesh-list
111214165|NCT05097976|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111214166|NCT05097976|Prednisolone phosphate|prednisolone phosphate|mesh-list
111214167|NCT05097976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111214168|NCT05097976|Antiemetics|antiemetics|mesh-ancestor
111214169|NCT05097976|Autonomic Agents|autonomic agents|mesh-ancestor
111214170|NCT05097976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111214171|NCT05097976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111214172|NCT05097976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111214173|NCT05097976|Glucocorticoids|glucocorticoids|mesh-ancestor
111214174|NCT05097976|Hormones|hormones|mesh-ancestor
111214175|NCT05097976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111214176|NCT05097976|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111214177|NCT05097976|Protective Agents|protective agents|mesh-ancestor
111214178|NCT05097976|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111214179|NCT05097976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111214180|NCT03030430|Bevacizumab|bevacizumab|mesh-list
111214181|NCT03030430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111214182|NCT03030430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111214183|NCT03030430|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111214184|NCT03030430|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111214185|NCT03030430|Growth Substances|growth substances|mesh-ancestor
111214186|NCT03030430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111214187|NCT03030430|Growth Inhibitors|growth inhibitors|mesh-ancestor
111214188|NCT00089661|Denosumab|denosumab|mesh-list
111214189|NCT00089661|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111214190|NCT00089661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111214191|NCT00941668|Triclosan|triclosan|mesh-list
111214192|NCT00941668|Fluorides|fluorides|mesh-list
111214193|NCT00941668|Fluorophosphate|fluorophosphate|mesh-list
111214194|NCT00941668|Cariostatic Agents|cariostatic agents|mesh-ancestor
111214195|NCT00941668|Protective Agents|protective agents|mesh-ancestor
111214196|NCT00941668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111214197|NCT00941668|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111214198|NCT00941668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111214199|NCT00941668|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
111214200|NCT00941668|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111214201|NCT00941668|Antimetabolites|antimetabolites|mesh-ancestor
111214202|NCT00941668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111214203|NCT00941668|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111214204|NCT01597414|Trastuzumab|trastuzumab|mesh-list
111214205|NCT01597414|Pertuzumab|pertuzumab|mesh-list
111214206|NCT01597414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111214207|NCT01597414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111214208|NCT04984330|Dexamethasone|dexamethasone|mesh-list
111214209|NCT04984330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111214210|NCT04984330|Antiemetics|antiemetics|mesh-ancestor
111214211|NCT04984330|Autonomic Agents|autonomic agents|mesh-ancestor
111214212|NCT04984330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111214213|NCT04984330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111214214|NCT04984330|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111214215|NCT04984330|Glucocorticoids|glucocorticoids|mesh-ancestor
111214216|NCT04984330|Hormones|hormones|mesh-ancestor
111214217|NCT04984330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111214218|NCT04984330|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111214219|NCT04984330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111214220|NCT03030196|Denosumab|denosumab|mesh-list
111214221|NCT03030196|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111214222|NCT03030196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111214223|NCT03035578|Morphine|morphine|mesh-list
111214224|NCT03035578|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111214225|NCT03035578|Narcotics|narcotics|mesh-ancestor
111214226|NCT03035578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111214227|NCT03035578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111214228|NCT03035578|Analgesics|analgesics|mesh-ancestor
111214229|NCT03035578|Sensory System Agents|sensory system agents|mesh-ancestor
111214230|NCT03035578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111214231|NCT04933942|Lomustine|lomustine|mesh-list
111214232|NCT04933942|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111214233|NCT04933942|Alkylating Agents|alkylating agents|mesh-ancestor
111214234|NCT04933942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111214235|NCT04933942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111214236|NCT00089583|Ritonavir|ritonavir|mesh-list
111214237|NCT00089583|Fosamprenavir|fosamprenavir|mesh-list
111214238|NCT00089583|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111214239|NCT00089583|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111214240|NCT00089583|Protease Inhibitors|protease inhibitors|mesh-ancestor
111214241|NCT00089583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111214242|NCT00089583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111214243|NCT00089583|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111214244|NCT00089583|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111214245|NCT00089583|Antiviral Agents|antiviral agents|mesh-ancestor
111214246|NCT00089583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111214247|NCT00089583|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111214248|NCT00089583|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111214249|NCT03029494|Ascorbic Acid|ascorbic acid|mesh-list
111214250|NCT03029494|Vitamins|vitamins|mesh-ancestor
111214251|NCT03029494|Micronutrients|micronutrients|mesh-ancestor
111214252|NCT03029494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111214253|NCT03029494|Antioxidants|antioxidants|mesh-ancestor
111214254|NCT03029494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111214255|NCT03029494|Protective Agents|protective agents|mesh-ancestor
111214256|NCT04402047|Diclofenac|diclofenac|mesh-list
111214257|NCT04402047|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111214258|NCT04402047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111214259|NCT04402047|Analgesics|analgesics|mesh-ancestor
111214260|NCT04402047|Sensory System Agents|sensory system agents|mesh-ancestor
111214261|NCT04402047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111214262|NCT04402047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111214263|NCT04402047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111214264|NCT04402047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111214265|NCT04402047|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111214266|NCT04402047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111214267|NCT04402047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111214268|NCT03017248|Ketamine|ketamine|mesh-list
111214269|NCT03017248|Morphine|morphine|mesh-list
111214270|NCT03017248|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111214271|NCT03017248|Analgesics|analgesics|mesh-ancestor
111214272|NCT03017248|Sensory System Agents|sensory system agents|mesh-ancestor
111214273|NCT03017248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111214274|NCT03017248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111214275|NCT03017248|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111214276|NCT03017248|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111214277|NCT03017248|Anesthetics, General|anesthetics, general|mesh-ancestor
111214278|NCT03017248|Anesthetics|anesthetics|mesh-ancestor
111214279|NCT03017248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111214280|NCT03017248|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111214281|NCT03017248|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111214282|NCT03017248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111214283|NCT03017248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111214284|NCT03017248|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111214285|NCT03017248|Narcotics|narcotics|mesh-ancestor
111214286|NCT00088881|Prednisone|prednisone|mesh-list
111214287|NCT00088881|Cyclophosphamide|cyclophosphamide|mesh-list
111214288|NCT00088881|Rituximab|rituximab|mesh-list
111214289|NCT00088881|Doxorubicin|doxorubicin|mesh-list
111214290|NCT00088881|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111214291|NCT00088881|Vincristine|vincristine|mesh-list
111214292|NCT00088881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111214293|NCT00088881|Immunologic Factors|immunologic factors|mesh-ancestor
111214294|NCT00088881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111214295|NCT00088881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111214296|NCT00088881|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111214297|NCT00088881|Alkylating Agents|alkylating agents|mesh-ancestor
111214298|NCT00088881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111214299|NCT00088881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111214300|NCT00088881|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111214301|NCT00088881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111214302|NCT00088881|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111214303|NCT00088881|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111214304|NCT00088881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111214305|NCT00088881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111214306|NCT00088881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111214307|NCT00088881|Glucocorticoids|glucocorticoids|mesh-ancestor
111214308|NCT00088881|Hormones|hormones|mesh-ancestor
111214309|NCT00088881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111214310|NCT00088881|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111214311|NCT00088881|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111214312|NCT00088881|Tubulin Modulators|tubulin modulators|mesh-ancestor
111214313|NCT00088881|Antimitotic Agents|antimitotic agents|mesh-ancestor
111214314|NCT00088881|Mitosis Modulators|mitosis modulators|mesh-ancestor
111214315|NCT02981914|Pembrolizumab|pembrolizumab|mesh-list
111214316|NCT02981914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111214317|NCT02981914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111214318|NCT02981914|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111214319|NCT02981914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111214320|NCT03025750|Vaccines|vaccines|mesh-list
111214321|NCT03025750|Immunologic Factors|immunologic factors|mesh-ancestor
111214322|NCT03025750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111214323|NCT03017404|Cyclophosphamide|cyclophosphamide|mesh-list
111214324|NCT03017404|Docetaxel|docetaxel|mesh-list
111214325|NCT03017404|Doxorubicin|doxorubicin|mesh-list
111214326|NCT03017404|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111214327|NCT03017404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111214328|NCT03017404|Immunologic Factors|immunologic factors|mesh-ancestor
111214329|NCT03017404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111214330|NCT03017404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111214331|NCT03017404|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111214332|NCT03017404|Alkylating Agents|alkylating agents|mesh-ancestor
111214333|NCT03017404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111214334|NCT03017404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111214335|NCT03017404|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111214336|NCT03017404|Tubulin Modulators|tubulin modulators|mesh-ancestor
111214337|NCT03017404|Antimitotic Agents|antimitotic agents|mesh-ancestor
111214338|NCT03017404|Mitosis Modulators|mitosis modulators|mesh-ancestor
111214339|NCT03017404|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111214340|NCT03017404|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111214341|NCT03017404|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111214342|NCT03017404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111214343|NCT00953212|Ascorbic Acid|ascorbic acid|mesh-list
111214344|NCT00953212|Amiodarone|amiodarone|mesh-list
111214345|NCT00953212|Metoprolol|metoprolol|mesh-list
111214346|NCT00953212|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
111214347|NCT00953212|Vitamins|vitamins|mesh-ancestor
111214348|NCT00953212|Micronutrients|micronutrients|mesh-ancestor
111214349|NCT00953212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111214350|NCT00953212|Antioxidants|antioxidants|mesh-ancestor
111214351|NCT00953212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111214352|NCT00953212|Protective Agents|protective agents|mesh-ancestor
111214353|NCT00953212|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111214354|NCT00953212|Adrenergic Agents|adrenergic agents|mesh-ancestor
111214355|NCT00953212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111214356|NCT00953212|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111214357|NCT00953212|Vasodilator Agents|vasodilator agents|mesh-ancestor
111214358|NCT00953212|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
111214359|NCT00953212|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111214360|NCT00953212|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111214361|NCT00953212|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111214362|NCT00953212|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111214363|NCT00953212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111214364|NCT00953212|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111214365|NCT00953212|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111214366|NCT00953212|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111214367|NCT00953212|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111214368|NCT00953212|Sympatholytics|sympatholytics|mesh-ancestor
111214369|NCT00953212|Autonomic Agents|autonomic agents|mesh-ancestor
111214370|NCT00953212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111214371|NCT00953212|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
111214372|NCT03034408|Mannitol|mannitol|mesh-list
111214373|NCT03034408|Baclofen|baclofen|mesh-list
111214374|NCT03034408|Nalmefene|nalmefene|mesh-list
111214375|NCT03034408|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
111214376|NCT03034408|Diuretics|diuretics|mesh-ancestor
111214377|NCT03034408|Natriuretic Agents|natriuretic agents|mesh-ancestor
111214378|NCT03034408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111214379|NCT03034408|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
111214380|NCT03034408|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111214381|NCT03034408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111214382|NCT03034408|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
111214383|NCT03034408|GABA Agonists|gaba agonists|mesh-ancestor
111214384|NCT03034408|GABA Agents|gaba agents|mesh-ancestor
111214385|NCT03034408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111214386|NCT03034408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111214387|NCT03034408|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111214388|NCT03034408|Sensory System Agents|sensory system agents|mesh-ancestor
111214389|NCT03023020|Aspirin|aspirin|mesh-list
111214390|NCT03023020|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
111214391|NCT03023020|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111214392|NCT03023020|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111214393|NCT03023020|Analgesics|analgesics|mesh-ancestor
111214394|NCT03023020|Sensory System Agents|sensory system agents|mesh-ancestor
111214395|NCT03023020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111214396|NCT03023020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111214397|NCT03023020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111214398|NCT03023020|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111214399|NCT03023020|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111214400|NCT03023020|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111214401|NCT03023020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111214402|NCT03023020|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111214403|NCT03023020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111214404|NCT03023020|Antipyretics|antipyretics|mesh-ancestor
111214405|NCT00087555|Sodium Oxybate|sodium oxybate|mesh-list
111214406|NCT00087555|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111214407|NCT00087555|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111214408|NCT00087555|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111214409|NCT00087555|Anesthetics, General|anesthetics, general|mesh-ancestor
111214410|NCT00087555|Anesthetics|anesthetics|mesh-ancestor
111214411|NCT00087555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110667313|NCT00815945|Doxorubicin|doxorubicin|mesh-list
111214412|NCT00087555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111214413|NCT03022318|Levodopa|levodopa|mesh-list
111214414|NCT03022318|Carbidopa|carbidopa|mesh-list
111214415|NCT03022318|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
111214416|NCT03022318|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111214417|NCT03022318|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111214418|NCT03022318|Dopamine Agents|dopamine agents|mesh-ancestor
111214419|NCT03022318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111214420|NCT03022318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111214421|NCT03022318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111214422|NCT03022318|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
111214423|NCT03022318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111214424|NCT03022318|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111214425|NCT03022318|Immunologic Factors|immunologic factors|mesh-ancestor
111214426|NCT03022318|Dopamine Agonists|dopamine agonists|mesh-ancestor
111214427|NCT01677897|Metformin|metformin|mesh-list
111214428|NCT01677897|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111214429|NCT01677897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111214430|NCT03483363|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111214431|NCT03483363|Bacitracin|bacitracin|mesh-list
111214432|NCT03483363|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
111214433|NCT03483363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111214434|NCT03483363|Antitubercular Agents|antitubercular agents|mesh-ancestor
111214435|NCT03483363|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111214436|NCT03086733|Metformin|metformin|mesh-list
111214437|NCT03086733|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111214438|NCT03086733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111214439|NCT00086619|Parathyroid Hormone|parathyroid hormone|mesh-list
111214440|NCT00086619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111214441|NCT00086619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111214442|NCT00085917|Interferons|interferons|mesh-list
111214443|NCT00085917|Ribavirin|ribavirin|mesh-list
111214444|NCT00085917|Interferon-alpha|interferon-alpha|mesh-list
111214445|NCT00085917|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
111214446|NCT00085917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111214447|NCT00085917|Antiviral Agents|antiviral agents|mesh-ancestor
111214448|NCT00085917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111214449|NCT00085917|Antimetabolites|antimetabolites|mesh-ancestor
111214450|NCT00085917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111214451|NCT00085917|Immunologic Factors|immunologic factors|mesh-ancestor
111214452|NCT00085917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111214453|NCT00084747|Bortezomib|bortezomib|mesh-list
111214454|NCT00084747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111214455|NCT04402671|Glutaral|glutaral|mesh-list
111214456|NCT04402671|Disinfectants|disinfectants|mesh-ancestor
111214457|NCT04402671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111214458|NCT01678287|Ipragliflozin|ipragliflozin|mesh-list
111214459|NCT01678287|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111214460|NCT01678287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111214461|NCT01678287|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111214462|NCT01678287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111214463|NCT01678365|Metronidazole|metronidazole|mesh-list
111214464|NCT01678365|Gentamicins|gentamicins|mesh-list
111214465|NCT01678365|Ceftriaxone|ceftriaxone|mesh-list
111214466|NCT01678365|Ampicillin|ampicillin|mesh-list
111214467|NCT01678365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111214468|NCT01678365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111214469|NCT01678365|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111214470|NCT01678365|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111214471|NCT01678365|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111214472|NCT01678365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111214473|NCT01678365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111214474|NCT00946270|Thalidomide|thalidomide|mesh-list
111214475|NCT00946270|Prednisone|prednisone|mesh-list
111214476|NCT00946270|Pomalidomide|pomalidomide|mesh-list
111214477|NCT00946270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111214478|NCT00946270|Glucocorticoids|glucocorticoids|mesh-ancestor
111214479|NCT00946270|Hormones|hormones|mesh-ancestor
111214480|NCT00946270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111214481|NCT00946270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111214482|NCT00946270|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111214483|NCT00946270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111214484|NCT00946270|Immunologic Factors|immunologic factors|mesh-ancestor
111214485|NCT00946270|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111214486|NCT00946270|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111214487|NCT00946270|Growth Substances|growth substances|mesh-ancestor
111214488|NCT00946270|Growth Inhibitors|growth inhibitors|mesh-ancestor
111214489|NCT00946270|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111214491|NCT00946270|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111214492|NCT00946270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111214493|NCT03021616|Moxifloxacin|moxifloxacin|mesh-list
111214494|NCT03021616|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111214495|NCT03021616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111214496|NCT03021616|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111214497|NCT03021616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111214498|NCT03021616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111214499|NCT03021616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111214500|NCT03021616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111214501|NCT03021694|Caseins|caseins|mesh-list
111214502|NCT03021694|Chelating Agents|chelating agents|mesh-ancestor
111214503|NCT03021694|Sequestering Agents|sequestering agents|mesh-ancestor
111214504|NCT03021694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111214505|NCT00956254|Fentanyl|fentanyl|mesh-list
111214506|NCT00956254|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111214507|NCT00956254|Narcotics|narcotics|mesh-ancestor
111214508|NCT00956254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111214509|NCT00956254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111214510|NCT00956254|Analgesics|analgesics|mesh-ancestor
111214511|NCT00956254|Sensory System Agents|sensory system agents|mesh-ancestor
111214512|NCT00956254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111214513|NCT00956254|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111214514|NCT00956254|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111214515|NCT00956254|Anesthetics, General|anesthetics, general|mesh-ancestor
111214516|NCT00956254|Anesthetics|anesthetics|mesh-ancestor
111214517|NCT03020680|Ubiquinone|ubiquinone|mesh-list
111214518|NCT03020680|Coenzyme Q10|coenzyme q10|mesh-list
111214519|NCT03020680|Micronutrients|micronutrients|mesh-ancestor
111214520|NCT03020680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111214521|NCT03020680|Vitamins|vitamins|mesh-ancestor
111214522|NCT01678599|Benzonidazole|benzonidazole|mesh-list
111214523|NCT01678599|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111214524|NCT01678599|Immunologic Factors|immunologic factors|mesh-ancestor
111214525|NCT01678599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111214526|NCT01678599|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
111214527|NCT01678599|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111214528|NCT01678599|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111214529|NCT01678599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111214530|NCT03019822|Amphetamine|amphetamine|mesh-list
111214531|NCT03019822|Dextroamphetamine|dextroamphetamine|mesh-list
111214532|NCT03019822|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
111214533|NCT03019822|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
111214534|NCT03019822|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111214535|NCT03019822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111214536|NCT03019822|Sympathomimetics|sympathomimetics|mesh-ancestor
111214537|NCT03019822|Autonomic Agents|autonomic agents|mesh-ancestor
111214538|NCT03019822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111214539|NCT03019822|Dopamine Agents|dopamine agents|mesh-ancestor
111214540|NCT03019822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111214541|NCT03019822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111214542|NCT03019822|Adrenergic Agents|adrenergic agents|mesh-ancestor
111214543|NCT03019822|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111214544|NCT03019822|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111214545|NCT03019822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111214546|NCT03019822|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111214547|NCT03019822|Hallucinogens|hallucinogens|mesh-ancestor
111214548|NCT03019822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111214549|NCT03019822|Serotonin Agents|serotonin agents|mesh-ancestor
111214550|NCT03019822|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111214551|NCT03019822|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111214552|NCT01678677|Vaccines|vaccines|mesh-list
111214553|NCT01678677|Immunologic Factors|immunologic factors|mesh-ancestor
111214554|NCT01678677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111214555|NCT00946348|Dronabinol|dronabinol|mesh-list
111214556|NCT00946348|Hallucinogens|hallucinogens|mesh-ancestor
111214557|NCT00946348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111214558|NCT00946348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111214559|NCT00946348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111214560|NCT00946348|Analgesics|analgesics|mesh-ancestor
111214561|NCT00946348|Sensory System Agents|sensory system agents|mesh-ancestor
111214562|NCT00946348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111214563|NCT00946348|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
111214564|NCT00946348|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
111214565|NCT00946348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111214566|NCT00946348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111214567|NCT00946348|Hormones|hormones|mesh-ancestor
111214568|NCT00946348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111214569|NCT00081159|Zoledronic Acid|zoledronic acid|mesh-list
111214570|NCT00081159|Doxorubicin|doxorubicin|mesh-list
111214571|NCT00081159|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111214572|NCT00081159|Leuprolide|leuprolide|mesh-list
111214573|NCT00081159|Goserelin|goserelin|mesh-list
111214574|NCT00081159|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111214575|NCT00081159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111214576|NCT00081159|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111214577|NCT00081159|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111214578|NCT00081159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111214579|NCT00081159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111214580|NCT00081159|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111214581|NCT00081159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111214582|NCT00081159|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111214583|NCT00081159|Fertility Agents|fertility agents|mesh-ancestor
111214584|NCT00081159|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111214585|NCT00081159|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111214586|NCT03033472|Clindamycin|clindamycin|mesh-list
111214587|NCT03033472|Clindamycin palmitate|clindamycin palmitate|mesh-list
111214588|NCT03033472|Clindamycin phosphate|clindamycin phosphate|mesh-list
111214589|NCT03033472|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111214590|NCT03033472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111214591|NCT03033472|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111214592|NCT03033472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111214593|NCT03033472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111214594|NCT02981836|Vaccines|vaccines|mesh-list
111214595|NCT02981836|Immunologic Factors|immunologic factors|mesh-ancestor
111214596|NCT02981836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111214597|NCT03033160|Estradiol|estradiol|mesh-list
111214598|NCT03033160|Estrogens|estrogens|mesh-ancestor
111214599|NCT03033160|Hormones|hormones|mesh-ancestor
111214600|NCT03033160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111214601|NCT03033160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111214602|NCT00958282|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
111214603|NCT00958282|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111214604|NCT00958282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111214605|NCT00958282|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111214606|NCT00958282|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111214607|NCT00958282|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111214608|NCT00958282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111214609|NCT00958282|Dopamine Agents|dopamine agents|mesh-ancestor
111214610|NCT00958282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111214611|NCT03033316|Dexamethasone|dexamethasone|mesh-list
111214612|NCT03033316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111214613|NCT03033316|Antiemetics|antiemetics|mesh-ancestor
111214614|NCT03033316|Autonomic Agents|autonomic agents|mesh-ancestor
111214615|NCT03033316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111214616|NCT03033316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111214617|NCT03033316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111214618|NCT03033316|Glucocorticoids|glucocorticoids|mesh-ancestor
111214619|NCT03033316|Hormones|hormones|mesh-ancestor
111214620|NCT03033316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111214621|NCT03033316|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111214622|NCT03033316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111214623|NCT03032848|Estrogens|estrogens|mesh-list
111214624|NCT03032848|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
111214625|NCT03032848|Hormones|hormones|mesh-ancestor
111214626|NCT03032848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111214627|NCT03032848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111214628|NCT00080223|Pirfenidone|pirfenidone|mesh-list
111214629|NCT00080223|Analgesics|analgesics|mesh-ancestor
111214630|NCT00080223|Sensory System Agents|sensory system agents|mesh-ancestor
111214631|NCT00080223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111214632|NCT00080223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111214633|NCT00080223|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111214634|NCT00080223|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111214635|NCT00080223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111214636|NCT00080223|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111214637|NCT00080223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111214638|NCT04402359|Meropenem|meropenem|mesh-list
111214639|NCT04402359|Ceftazidime|ceftazidime|mesh-list
111214640|NCT04402359|Avibactam|avibactam|mesh-list
111214641|NCT04402359|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111214642|NCT04402359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111214643|NCT04402359|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
111214644|NCT04402359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111214645|NCT04402359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111214646|NCT00959764|Calcitonin|calcitonin|mesh-list
111214647|NCT00959764|Salmon calcitonin|salmon calcitonin|mesh-list
111214648|NCT00959764|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
111214649|NCT00959764|Katacalcin|katacalcin|mesh-list
111214650|NCT00959764|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111214651|NCT00959764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111214652|NCT00959764|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111214653|NCT00959764|Vasodilator Agents|vasodilator agents|mesh-ancestor
111214654|NCT01005706|Mycophenolic Acid|mycophenolic acid|mesh-list
111214655|NCT01005706|Sirolimus|sirolimus|mesh-list
111214656|NCT01005706|Temsirolimus|temsirolimus|mesh-list
111214657|NCT01005706|MTOR Inhibitors|mtor inhibitors|mesh-list
111214658|NCT01005706|Tacrolimus|tacrolimus|mesh-list
111214659|NCT01005706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111214660|NCT01005706|Immunologic Factors|immunologic factors|mesh-ancestor
111214661|NCT01005706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111214662|NCT01005706|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111214663|NCT01005706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111214664|NCT01005706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111214665|NCT01005706|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111214666|NCT01005706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111214667|NCT01005706|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111214668|NCT01005706|Antitubercular Agents|antitubercular agents|mesh-ancestor
111214669|NCT01005706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111214670|NCT01005706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111214671|NCT01005706|Antifungal Agents|antifungal agents|mesh-ancestor
111214672|NCT01005706|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111214673|NCT03085485|Ivacaftor|ivacaftor|mesh-list
111214674|NCT03085485|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
111214675|NCT03085485|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111214676|NCT03085485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111214677|NCT01679691|Anesthetics|anesthetics|mesh-list
111214678|NCT01679691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111214679|NCT01679691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111214680|NCT03470805|Olaparib|olaparib|mesh-list
111214681|NCT03470805|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111214682|NCT03470805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111214683|NCT03470805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111214684|NCT03470805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111214685|NCT03088059|Durvalumab|durvalumab|mesh-list
111214686|NCT03088059|Palbociclib|palbociclib|mesh-list
111214687|NCT03088059|Niraparib|niraparib|mesh-list
111214688|NCT03088059|Afatinib|afatinib|mesh-list
111214689|NCT03088059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111214690|NCT03088059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111214691|NCT03088059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111214692|NCT03088059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111214693|NCT03088059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111214694|NCT03088059|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111214695|NCT03084549|Ropivacaine|ropivacaine|mesh-list
111214696|NCT03084549|Anesthetics, Local|anesthetics, local|mesh-ancestor
111214697|NCT03084549|Anesthetics|anesthetics|mesh-ancestor
111214698|NCT03084549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111214699|NCT03084549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111214700|NCT03084549|Sensory System Agents|sensory system agents|mesh-ancestor
111214701|NCT03084549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111214702|NCT03082521|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111214703|NCT03082521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111214704|NCT03085719|Pembrolizumab|pembrolizumab|mesh-list
111214705|NCT03085719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111214706|NCT03085719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111214707|NCT03085719|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111214708|NCT03085719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111214709|NCT03080259|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
111214710|NCT03080259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111214711|NCT03084861|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111214712|NCT03084861|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111214713|NCT01006252|Paclitaxel|paclitaxel|mesh-list
110678542|NCT03656666|Apremilast|apremilast|mesh-list
111214714|NCT01006252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111214715|NCT01006252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111214716|NCT01006252|Tubulin Modulators|tubulin modulators|mesh-ancestor
111214717|NCT01006252|Antimitotic Agents|antimitotic agents|mesh-ancestor
111214718|NCT01006252|Mitosis Modulators|mitosis modulators|mesh-ancestor
111214719|NCT01006252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111214720|NCT03080805|Capecitabine|capecitabine|mesh-list
111214721|NCT03080805|Lapatinib|lapatinib|mesh-list
111214722|NCT03080805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111214723|NCT03080805|Antimetabolites|antimetabolites|mesh-ancestor
111214724|NCT03080805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111214725|NCT03080805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111214726|NCT03080805|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111214727|NCT03080805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111214728|NCT03019120|Vitamin D|vitamin d|mesh-list
111214729|NCT03019120|Vitamins|vitamins|mesh-ancestor
111214730|NCT03019120|Micronutrients|micronutrients|mesh-ancestor
111214731|NCT03019120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111214732|NCT03019120|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111214733|NCT00960622|Tenofovir|tenofovir|mesh-list
111214734|NCT00960622|Lamivudine|lamivudine|mesh-list
111214735|NCT00960622|Emtricitabine|emtricitabine|mesh-list
111214736|NCT00960622|Zidovudine|zidovudine|mesh-list
111214737|NCT00960622|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
111214738|NCT00960622|Abacavir|abacavir|mesh-list
111214739|NCT00960622|Dideoxynucleosides|dideoxynucleosides|mesh-list
111214740|NCT00960622|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
111214741|NCT00960622|Antiviral Agents|antiviral agents|mesh-ancestor
111214742|NCT00960622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111214743|NCT00960622|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111214744|NCT00960622|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111214745|NCT00960622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111214746|NCT00960622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111214747|NCT00960622|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111214748|NCT00960622|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111214749|NCT00960622|Antimetabolites|antimetabolites|mesh-ancestor
111214750|NCT03430947|Vemurafenib|vemurafenib|mesh-list
111214751|NCT03430947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111214752|NCT03430947|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111214753|NCT03430947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111214754|NCT03430947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111214755|NCT00960778|Nicotine|nicotine|mesh-list
111214756|NCT00960778|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111214757|NCT00960778|Autonomic Agents|autonomic agents|mesh-ancestor
111214758|NCT00960778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111214759|NCT00960778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111214760|NCT00960778|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111214761|NCT00960778|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111214762|NCT00960778|Cholinergic Agents|cholinergic agents|mesh-ancestor
111214763|NCT00960778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111214764|NCT00960778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111214765|NCT03080181|Pasireotide|pasireotide|mesh-list
111214766|NCT03080181|Hormones|hormones|mesh-ancestor
111214767|NCT03080181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111214768|NCT03080181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111214769|NCT03088293|Infliximab|infliximab|mesh-list
111214770|NCT03088293|Cyclophosphamide|cyclophosphamide|mesh-list
111214771|NCT03088293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111214772|NCT03088293|Immunologic Factors|immunologic factors|mesh-ancestor
111214773|NCT03088293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111214774|NCT03088293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111214775|NCT03088293|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111214776|NCT03088293|Alkylating Agents|alkylating agents|mesh-ancestor
111214777|NCT03088293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111214778|NCT03088293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111214779|NCT03088293|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111214780|NCT03088293|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111214781|NCT03088293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111214782|NCT03088293|Dermatologic Agents|dermatologic agents|mesh-ancestor
111214783|NCT03088293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111214784|NCT01008280|Baclofen|baclofen|mesh-list
111214785|NCT01008280|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
111214786|NCT01008280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111214787|NCT01008280|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111214788|NCT01008280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111214789|NCT01008280|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
111214790|NCT01008280|GABA Agonists|gaba agonists|mesh-ancestor
111214791|NCT01008280|GABA Agents|gaba agents|mesh-ancestor
111214792|NCT01008280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111214793|NCT01008280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111214794|NCT03089073|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
111214795|NCT03089073|Hemostatics|hemostatics|mesh-ancestor
111214796|NCT03089073|Coagulants|coagulants|mesh-ancestor
111214797|NCT03089073|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
111214798|NCT03089073|Natriuretic Agents|natriuretic agents|mesh-ancestor
111214799|NCT03089073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111214800|NCT05688813|Anesthetics|anesthetics|mesh-list
111214801|NCT05688813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111214802|NCT05688813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111214803|NCT01009918|Carvedilol|carvedilol|mesh-list
111214804|NCT01009918|Lisinopril|lisinopril|mesh-list
111214805|NCT01009918|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111214806|NCT01009918|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111214807|NCT01009918|Adrenergic Agents|adrenergic agents|mesh-ancestor
111214808|NCT01009918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111214809|NCT01009918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111214810|NCT01009918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111214811|NCT01009918|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111214812|NCT01009918|Antioxidants|antioxidants|mesh-ancestor
111214813|NCT01009918|Protective Agents|protective agents|mesh-ancestor
111214814|NCT01009918|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111214815|NCT01009918|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111214816|NCT01009918|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111214817|NCT01009918|Vasodilator Agents|vasodilator agents|mesh-ancestor
111214818|NCT01009918|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111214819|NCT01009918|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111214820|NCT01009918|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
111214821|NCT01009918|Protease Inhibitors|protease inhibitors|mesh-ancestor
111214822|NCT01009918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111214823|NCT01009918|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111214824|NCT04401657|Adenosine|adenosine|mesh-list
111214825|NCT04401657|Analgesics|analgesics|mesh-ancestor
111214826|NCT04401657|Sensory System Agents|sensory system agents|mesh-ancestor
111214827|NCT04401657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111214828|NCT04401657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111214829|NCT04401657|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111214830|NCT04401657|Vasodilator Agents|vasodilator agents|mesh-ancestor
111214831|NCT04401657|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
111214832|NCT04401657|Purinergic Agonists|purinergic agonists|mesh-ancestor
111214833|NCT04401657|Purinergic Agents|purinergic agents|mesh-ancestor
111214834|NCT04401657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111214835|NCT04401657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111214836|NCT03019198|Tranexamic Acid|tranexamic acid|mesh-list
111214837|NCT03019198|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111214838|NCT03019198|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111214839|NCT03019198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111214840|NCT03019198|Hemostatics|hemostatics|mesh-ancestor
111214841|NCT03019198|Coagulants|coagulants|mesh-ancestor
111214842|NCT03083613|Paclitaxel|paclitaxel|mesh-list
111214843|NCT03083613|Raltitrexed|raltitrexed|mesh-list
111214844|NCT03083613|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111214845|NCT03083613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111214846|NCT03083613|Tubulin Modulators|tubulin modulators|mesh-ancestor
111214847|NCT03083613|Antimitotic Agents|antimitotic agents|mesh-ancestor
111214848|NCT03083613|Mitosis Modulators|mitosis modulators|mesh-ancestor
111214849|NCT03083613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111214850|NCT03083613|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111214851|NCT03083613|Antimetabolites|antimetabolites|mesh-ancestor
111214852|NCT03083613|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111214853|NCT03083613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111214854|NCT00963508|Permethrin|permethrin|mesh-list
111214855|NCT00963508|Malathion|malathion|mesh-list
111214856|NCT00963508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111214857|NCT00963508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111214858|NCT00963508|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111214859|NCT00963508|Cholinergic Agents|cholinergic agents|mesh-ancestor
111214860|NCT00963508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111214861|NCT00963508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111214862|NCT03088371|Lidocaine|lidocaine|mesh-list
111214863|NCT03088371|Bupivacaine|bupivacaine|mesh-list
110678695|NCT06050252|Cisplatin|cisplatin|mesh-list
111214864|NCT03088371|Anesthetics, Local|anesthetics, local|mesh-ancestor
111214865|NCT03088371|Anesthetics|anesthetics|mesh-ancestor
111214866|NCT03088371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111214867|NCT03088371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111214868|NCT03088371|Sensory System Agents|sensory system agents|mesh-ancestor
111214869|NCT03088371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111214870|NCT03088371|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111214871|NCT03088371|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111214872|NCT03088371|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111214873|NCT03088371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111214874|NCT03088371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111214875|NCT03083691|Nivolumab|nivolumab|mesh-list
111214876|NCT03083691|Ipilimumab|ipilimumab|mesh-list
111214877|NCT03083691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111214878|NCT03083691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111214879|NCT03083691|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111214880|NCT03083691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111214881|NCT05685537|Simendan|simendan|mesh-list
111214882|NCT05685537|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111214883|NCT05685537|Vasodilator Agents|vasodilator agents|mesh-ancestor
111214884|NCT05685537|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
111214885|NCT05685537|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111214886|NCT05685537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111214887|NCT05685537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111214888|NCT05685537|Protective Agents|protective agents|mesh-ancestor
111214889|NCT05685537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111214890|NCT04400721|Ropivacaine|ropivacaine|mesh-list
111214891|NCT04400721|Anesthetics, Local|anesthetics, local|mesh-ancestor
111214892|NCT04400721|Anesthetics|anesthetics|mesh-ancestor
111214893|NCT04400721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111214894|NCT04400721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111214895|NCT04400721|Sensory System Agents|sensory system agents|mesh-ancestor
111214896|NCT04400721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111214897|NCT01010932|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
111214898|NCT01010932|Chelating Agents|chelating agents|mesh-ancestor
111214899|NCT01010932|Sequestering Agents|sequestering agents|mesh-ancestor
111214900|NCT01010932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111214901|NCT03018652|Immunoglobulins|immunoglobulins|mesh-list
111214902|NCT03018652|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111214903|NCT03018652|Antibodies|antibodies|mesh-list
111214904|NCT03018652|gamma-Globulins|gamma-globulins|mesh-list
111214905|NCT03018652|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
111214906|NCT03018652|Immunologic Factors|immunologic factors|mesh-ancestor
111214907|NCT03018652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111214908|NCT01012336|Dexamethasone|dexamethasone|mesh-list
111214909|NCT01012336|Aprepitant|aprepitant|mesh-list
111214910|NCT01012336|Ramosetron|ramosetron|mesh-list
111214911|NCT01012336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111214912|NCT01012336|Antiemetics|antiemetics|mesh-ancestor
111214913|NCT01012336|Autonomic Agents|autonomic agents|mesh-ancestor
111214914|NCT01012336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111214915|NCT01012336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111214916|NCT01012336|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111214917|NCT01012336|Glucocorticoids|glucocorticoids|mesh-ancestor
111214918|NCT01012336|Hormones|hormones|mesh-ancestor
111214919|NCT01012336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111214920|NCT01012336|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111214921|NCT01012336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111214922|NCT01012336|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
111214923|NCT01012336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111214924|NCT01012336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111214925|NCT01012336|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111214926|NCT01012336|Serotonin Agents|serotonin agents|mesh-ancestor
111214927|NCT03387501|Mitogens|mitogens|mesh-list
111214928|NCT03387501|Mitosis Modulators|mitosis modulators|mesh-ancestor
111214929|NCT03387501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111214930|NCT01012492|Abatacept|abatacept|mesh-list
111214931|NCT01012492|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111214932|NCT01012492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111214933|NCT01012492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111214934|NCT01012492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111214935|NCT01012492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111214936|NCT01012492|Immunologic Factors|immunologic factors|mesh-ancestor
111214937|NCT01012492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111214938|NCT01012492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111214939|NCT05688345|Dexmedetomidine|dexmedetomidine|mesh-list
111214940|NCT05688345|Propofol|propofol|mesh-list
111214941|NCT05688345|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111214942|NCT05688345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111214943|NCT05688345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111214944|NCT05688345|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111214945|NCT05688345|Analgesics|analgesics|mesh-ancestor
111214946|NCT05688345|Sensory System Agents|sensory system agents|mesh-ancestor
111214947|NCT05688345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111214948|NCT05688345|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111214949|NCT05688345|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111214950|NCT05688345|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111214951|NCT05688345|Adrenergic Agents|adrenergic agents|mesh-ancestor
111214952|NCT05688345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111214953|NCT05688345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111214954|NCT05688345|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111214955|NCT05688345|Anesthetics, General|anesthetics, general|mesh-ancestor
111214956|NCT05688345|Anesthetics|anesthetics|mesh-ancestor
111214957|NCT03083457|Anesthetics|anesthetics|mesh-list
111214958|NCT03083457|Anesthetics, General|anesthetics, general|mesh-list
111214959|NCT03083457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111214960|NCT03083457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111214961|NCT04401345|Glycopyrrolate|glycopyrrolate|mesh-list
111214962|NCT04401345|Bromides|bromides|mesh-list
111214963|NCT04401345|Anticonvulsants|anticonvulsants|mesh-ancestor
111214964|NCT04401345|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111214965|NCT04401345|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111214966|NCT04401345|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111214967|NCT04401345|Cholinergic Agents|cholinergic agents|mesh-ancestor
111214968|NCT04401345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111214969|NCT04401345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111214970|NCT04401345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111214971|NCT01015534|Temozolomide|temozolomide|mesh-list
111214972|NCT01015534|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111214973|NCT01015534|Alkylating Agents|alkylating agents|mesh-ancestor
111214974|NCT01015534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111214975|NCT01015534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111214976|NCT00968890|Vaccines|vaccines|mesh-list
111214977|NCT00968890|Immunologic Factors|immunologic factors|mesh-ancestor
111214978|NCT00968890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111214979|NCT00970216|Telbivudine|telbivudine|mesh-list
111214980|NCT00970216|Antiviral Agents|antiviral agents|mesh-ancestor
111214981|NCT00970216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111214982|NCT00970216|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111214983|NCT00970216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111214984|NCT00970216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111214985|NCT00971620|Botulinum Toxins|botulinum toxins|mesh-list
111214986|NCT00971620|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111214987|NCT00971620|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111214988|NCT00971620|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111214989|NCT00971620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111214990|NCT00971620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111214991|NCT00971620|Cholinergic Agents|cholinergic agents|mesh-ancestor
111214992|NCT00971620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111214993|NCT00971620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111214994|NCT00971620|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111214995|NCT00971620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111214996|NCT01884922|Vinblastine|vinblastine|mesh-list
111214997|NCT01884922|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111214998|NCT01884922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111214999|NCT01884922|Tubulin Modulators|tubulin modulators|mesh-ancestor
111215000|NCT01884922|Antimitotic Agents|antimitotic agents|mesh-ancestor
111215001|NCT01884922|Mitosis Modulators|mitosis modulators|mesh-ancestor
111215002|NCT01884922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111215003|NCT05687409|Entecavir|entecavir|mesh-list
111215004|NCT05687409|Lactulose|lactulose|mesh-list
111215005|NCT05687409|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111215006|NCT05687409|Antiviral Agents|antiviral agents|mesh-ancestor
111215007|NCT05687409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111215008|NCT05687409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111215009|NCT02162680|Lidocaine|lidocaine|mesh-list
111215010|NCT02162680|Anesthetics, Local|anesthetics, local|mesh-ancestor
111215011|NCT02162680|Anesthetics|anesthetics|mesh-ancestor
111215012|NCT02162680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111215013|NCT02162680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111215014|NCT02162680|Sensory System Agents|sensory system agents|mesh-ancestor
111215015|NCT02162680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111215016|NCT02162680|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111215017|NCT02162680|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111215018|NCT02162680|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111215019|NCT02162680|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111215020|NCT02162680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111215021|NCT01017250|Bevacizumab|bevacizumab|mesh-list
111215022|NCT01017250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111215023|NCT01017250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111215024|NCT01017250|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111215025|NCT01017250|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111215026|NCT01017250|Growth Substances|growth substances|mesh-ancestor
111215027|NCT01017250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111215028|NCT01017250|Growth Inhibitors|growth inhibitors|mesh-ancestor
111215030|NCT00812032|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111215031|NCT00812032|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111215032|NCT00812032|Analgesics|analgesics|mesh-ancestor
111215033|NCT00812032|Sensory System Agents|sensory system agents|mesh-ancestor
111215034|NCT00812032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111215035|NCT00812032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111215036|NCT00812032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111215037|NCT00812032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111215038|NCT00812032|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111215039|NCT00812032|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111215040|NCT00812032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111215041|NCT00812032|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111215042|NCT00812032|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111215043|NCT00812032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111215044|NCT00812032|Antipyretics|antipyretics|mesh-ancestor
111215045|NCT02159872|Homoharringtonine|homoharringtonine|mesh-list
111215046|NCT02159872|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111215047|NCT02159872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111215048|NCT02159872|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111215049|NCT02159872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111215050|NCT02159872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111215051|NCT00417664|Midazolam|midazolam|mesh-list
111215052|NCT00417664|Dexmedetomidine|dexmedetomidine|mesh-list
111215053|NCT00417664|Propofol|propofol|mesh-list
111215054|NCT00417664|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111215055|NCT00417664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111215056|NCT00417664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111215057|NCT00417664|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111215058|NCT00417664|Analgesics|analgesics|mesh-ancestor
111215059|NCT00417664|Sensory System Agents|sensory system agents|mesh-ancestor
111215060|NCT00417664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111215061|NCT00417664|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111215062|NCT00417664|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111215063|NCT00417664|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111215064|NCT00417664|Adrenergic Agents|adrenergic agents|mesh-ancestor
111215065|NCT00417664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111215066|NCT00417664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111215067|NCT00417664|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111215068|NCT00417664|Anesthetics, General|anesthetics, general|mesh-ancestor
111215069|NCT00417664|Anesthetics|anesthetics|mesh-ancestor
111215070|NCT00417664|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111215071|NCT00417664|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111215072|NCT00417664|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111215073|NCT00417664|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111215074|NCT00417664|GABA Modulators|gaba modulators|mesh-ancestor
111215075|NCT00417664|GABA Agents|gaba agents|mesh-ancestor
111215076|NCT01021618|Dipyridamole|dipyridamole|mesh-list
111215077|NCT01021618|Regadenoson|regadenoson|mesh-list
111215078|NCT01021618|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
111215079|NCT01021618|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
111215080|NCT01021618|Purinergic Agonists|purinergic agonists|mesh-ancestor
111215081|NCT01021618|Purinergic Agents|purinergic agents|mesh-ancestor
111215082|NCT01021618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111215083|NCT01021618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111215084|NCT01021618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111215085|NCT01021618|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111215086|NCT01021618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111215087|NCT01021618|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111215088|NCT01021618|Vasodilator Agents|vasodilator agents|mesh-ancestor
111215089|NCT03082053|Capecitabine|capecitabine|mesh-list
111215090|NCT03082053|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111215091|NCT03082053|Antimetabolites|antimetabolites|mesh-ancestor
111215092|NCT03082053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111215093|NCT03082053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111215094|NCT03358563|Docetaxel|docetaxel|mesh-list
111215095|NCT03358563|Bicalutamide|bicalutamide|mesh-list
111215096|NCT03358563|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
111215097|NCT03358563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111215098|NCT03358563|Tubulin Modulators|tubulin modulators|mesh-ancestor
111215099|NCT03358563|Antimitotic Agents|antimitotic agents|mesh-ancestor
111215100|NCT03358563|Mitosis Modulators|mitosis modulators|mesh-ancestor
111215101|NCT03358563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111215102|NCT03358563|Androgen Antagonists|androgen antagonists|mesh-ancestor
111215103|NCT03358563|Hormone Antagonists|hormone antagonists|mesh-ancestor
111215104|NCT03358563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111215105|NCT03358563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111215106|NCT03358563|Hematinics|hematinics|mesh-ancestor
111215107|NCT03358563|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
111215108|NCT03358563|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111215109|NCT01018420|Moxifloxacin|moxifloxacin|mesh-list
111215110|NCT01018420|Colchicine|colchicine|mesh-list
111215111|NCT01018420|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111215112|NCT01018420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111215113|NCT01018420|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111215114|NCT01018420|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111215115|NCT01018420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111215116|NCT01018420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111215117|NCT01018420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111215118|NCT01018420|Gout Suppressants|gout suppressants|mesh-ancestor
111215119|NCT01018420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111215120|NCT01018420|Tubulin Modulators|tubulin modulators|mesh-ancestor
111215121|NCT01018420|Antimitotic Agents|antimitotic agents|mesh-ancestor
111215122|NCT01018420|Mitosis Modulators|mitosis modulators|mesh-ancestor
111215123|NCT00974350|Bupivacaine|bupivacaine|mesh-list
111215124|NCT00974350|Anesthetics, Local|anesthetics, local|mesh-ancestor
111215125|NCT00974350|Anesthetics|anesthetics|mesh-ancestor
111215126|NCT00974350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111215127|NCT00974350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111215128|NCT00974350|Sensory System Agents|sensory system agents|mesh-ancestor
111215129|NCT00974350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111215130|NCT05395702|Interferons|interferons|mesh-list
111215131|NCT05395702|Interferon-gamma|interferon-gamma|mesh-list
111215132|NCT05395702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111215133|NCT05395702|Antiviral Agents|antiviral agents|mesh-ancestor
111215134|NCT05395702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111215135|NCT01023178|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
111215136|NCT01023178|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
111215137|NCT01023178|Estradiol|estradiol|mesh-list
111215138|NCT01023178|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
111215139|NCT01023178|Estrogens|estrogens|mesh-list
111215140|NCT01023178|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
111215141|NCT01023178|Progesterone|progesterone|mesh-list
111215142|NCT01023178|Hormones|hormones|mesh-ancestor
111215143|NCT01023178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111215144|NCT01023178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111215145|NCT01023178|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111215146|NCT01023178|Contraceptive Agents|contraceptive agents|mesh-ancestor
111215147|NCT01023178|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111215148|NCT01023178|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111215149|NCT01023178|Progestins|progestins|mesh-ancestor
111215150|NCT03373851|Sufentanil|sufentanil|mesh-list
111215151|NCT03373851|Dsuvia|dsuvia|mesh-list
111215152|NCT03373851|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111215153|NCT03373851|Narcotics|narcotics|mesh-ancestor
111215154|NCT03373851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111215155|NCT03373851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111215156|NCT03373851|Analgesics|analgesics|mesh-ancestor
111215157|NCT03373851|Sensory System Agents|sensory system agents|mesh-ancestor
111215158|NCT03373851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111215159|NCT03373851|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111215160|NCT03373851|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111215161|NCT03373851|Anesthetics, General|anesthetics, general|mesh-ancestor
111215162|NCT03373851|Anesthetics|anesthetics|mesh-ancestor
111215163|NCT05623995|Evolocumab|evolocumab|mesh-list
111215164|NCT05623995|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-list
111215165|NCT05623995|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
111215166|NCT05623995|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111215167|NCT05623995|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111215168|NCT05623995|Antimetabolites|antimetabolites|mesh-ancestor
111215169|NCT05623995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111215170|NCT05623995|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111215171|NCT05623995|Protease Inhibitors|protease inhibitors|mesh-ancestor
111215172|NCT05623995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111215173|NCT05623995|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111215174|NCT01023724|Ketorolac|ketorolac|mesh-list
111215175|NCT01023724|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
111215176|NCT01023724|Bromfenac|bromfenac|mesh-list
111215177|NCT01023724|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111215178|NCT01023724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111215179|NCT01023724|Analgesics|analgesics|mesh-ancestor
111215180|NCT01023724|Sensory System Agents|sensory system agents|mesh-ancestor
111215181|NCT01023724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111215182|NCT01023724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111215183|NCT01023724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111215184|NCT01023724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111215185|NCT01023724|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111215186|NCT01023724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111215187|NCT01023724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111215188|NCT00974818|Mitomycins|mitomycins|mesh-list
111215189|NCT00974818|Mitomycin|mitomycin|mesh-list
111215190|NCT00974818|BCG Vaccine|bcg vaccine|mesh-list
111215191|NCT00974818|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111215192|NCT00974818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111215193|NCT00974818|Alkylating Agents|alkylating agents|mesh-ancestor
111215194|NCT00974818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111215195|NCT00974818|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111215196|NCT00974818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111215197|NCT00974818|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111215198|NCT00974818|Immunologic Factors|immunologic factors|mesh-ancestor
111215199|NCT00974818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111215200|NCT03371667|Methotrexate|methotrexate|mesh-list
111215201|NCT03371667|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111215202|NCT03371667|Abortifacient Agents|abortifacient agents|mesh-ancestor
111215203|NCT03371667|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111215204|NCT03371667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111215205|NCT03371667|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111215206|NCT03371667|Antimetabolites|antimetabolites|mesh-ancestor
111215207|NCT03371667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111215208|NCT03371667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111215209|NCT03371667|Dermatologic Agents|dermatologic agents|mesh-ancestor
111215210|NCT03371667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111215211|NCT03371667|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111215212|NCT03371667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111215213|NCT03371667|Immunologic Factors|immunologic factors|mesh-ancestor
111215214|NCT03371667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111215215|NCT03371667|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111215216|NCT01024738|Chlorhexidine|chlorhexidine|mesh-list
111215217|NCT01024738|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
111215218|NCT01024738|Triclosan|triclosan|mesh-list
111215219|NCT01024738|Fluorides|fluorides|mesh-list
111215220|NCT01024738|Cariostatic Agents|cariostatic agents|mesh-ancestor
111215221|NCT01024738|Protective Agents|protective agents|mesh-ancestor
111215222|NCT01024738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111215223|NCT01024738|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111215224|NCT01024738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111215225|NCT01024738|Disinfectants|disinfectants|mesh-ancestor
111215226|NCT01024738|Dermatologic Agents|dermatologic agents|mesh-ancestor
111215227|NCT01024738|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
111215228|NCT01024738|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111215229|NCT01024738|Antimetabolites|antimetabolites|mesh-ancestor
111215230|NCT01024738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111215231|NCT01024738|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111215232|NCT05613153|Peppermint oil|peppermint oil|mesh-list
111215233|NCT05613153|Antiemetics|antiemetics|mesh-ancestor
111215234|NCT05613153|Autonomic Agents|autonomic agents|mesh-ancestor
111215235|NCT05613153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111215236|NCT05613153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111215237|NCT05613153|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111215239|NCT01024972|Mannitol|mannitol|mesh-list
111215240|NCT01024972|Dantrolene|dantrolene|mesh-list
111215241|NCT01024972|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
111215242|NCT01024972|Diuretics|diuretics|mesh-ancestor
111215243|NCT01024972|Natriuretic Agents|natriuretic agents|mesh-ancestor
111215244|NCT01024972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111215245|NCT01024972|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
111215246|NCT01024972|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111215247|NCT01024972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111215248|NCT05686395|Bupivacaine|bupivacaine|mesh-list
111215249|NCT05686395|Anesthetics, Local|anesthetics, local|mesh-ancestor
111215250|NCT05686395|Anesthetics|anesthetics|mesh-ancestor
111215251|NCT05686395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111215252|NCT05686395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111215253|NCT05686395|Sensory System Agents|sensory system agents|mesh-ancestor
111215254|NCT05686395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111215255|NCT01025830|Lamivudine|lamivudine|mesh-list
111215256|NCT01025830|Nevirapine|nevirapine|mesh-list
111215257|NCT01025830|Stavudine|stavudine|mesh-list
111215258|NCT01025830|Stavudine, lamivudine, nevirapine drug combination|stavudine, lamivudine, nevirapine drug combination|mesh-list
111215259|NCT01025830|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111215260|NCT01025830|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111215261|NCT01025830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111215262|NCT01025830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111215263|NCT01025830|Antiviral Agents|antiviral agents|mesh-ancestor
111215264|NCT01025830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111215265|NCT01025830|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111215266|NCT01025830|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111215267|NCT01025830|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111215268|NCT01025830|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111215269|NCT01025830|Antimetabolites|antimetabolites|mesh-ancestor
111215270|NCT03081039|Carboplatin|carboplatin|mesh-list
111215271|NCT03081039|Gemcitabine|gemcitabine|mesh-list
111215272|NCT03081039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111215273|NCT03081039|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111215274|NCT03081039|Antimetabolites|antimetabolites|mesh-ancestor
111215275|NCT03081039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111215276|NCT01026844|Hydroxychloroquine|hydroxychloroquine|mesh-list
111215277|NCT01026844|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111215278|NCT01026844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111215279|NCT01026844|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111215280|NCT01026844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111215281|NCT01026844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111215282|NCT01026844|Antimalarials|antimalarials|mesh-ancestor
111215283|NCT01026844|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111215284|NCT01026844|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111215285|NCT01026844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111215286|NCT01026844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111215287|NCT00979732|Grape Seed Extract|grape seed extract|mesh-list
111215288|NCT00979732|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111215289|NCT00979732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111215290|NCT00979732|Antioxidants|antioxidants|mesh-ancestor
111215291|NCT00979732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111215292|NCT00979732|Protective Agents|protective agents|mesh-ancestor
111215293|NCT00979732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111215294|NCT03321981|Trastuzumab|trastuzumab|mesh-list
111215295|NCT03321981|Letrozole|letrozole|mesh-list
111215296|NCT03321981|Vinorelbine|vinorelbine|mesh-list
111215297|NCT03321981|Fulvestrant|fulvestrant|mesh-list
111215298|NCT03321981|Exemestane|exemestane|mesh-list
111215299|NCT03321981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111215300|NCT03321981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111215301|NCT03321981|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111215302|NCT03321981|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111215303|NCT03321981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111215304|NCT03321981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111215305|NCT03321981|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111215306|NCT03321981|Hormone Antagonists|hormone antagonists|mesh-ancestor
111215307|NCT03321981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111215308|NCT03321981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111215309|NCT03321981|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111215310|NCT03321981|Tubulin Modulators|tubulin modulators|mesh-ancestor
111215311|NCT03321981|Antimitotic Agents|antimitotic agents|mesh-ancestor
111215312|NCT03321981|Mitosis Modulators|mitosis modulators|mesh-ancestor
111215313|NCT03321981|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111215314|NCT03321981|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
111215316|NCT01027468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111215317|NCT01027468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111215318|NCT01027468|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111215319|NCT01027468|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110794743|NCT03012529|Riboflavin|riboflavin|mesh-list
111215320|NCT01027468|Growth Substances|growth substances|mesh-ancestor
111215321|NCT01027468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111215322|NCT01027468|Growth Inhibitors|growth inhibitors|mesh-ancestor
111215323|NCT05237349|Oxaliplatin|oxaliplatin|mesh-list
111215324|NCT05237349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111215325|NCT04278807|Anesthetics|anesthetics|mesh-list
111215326|NCT04278807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111215327|NCT04278807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111215328|NCT03344211|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
111215329|NCT03344211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111215330|NCT03274401|Anticoagulants|anticoagulants|mesh-list
111215331|NCT05086107|Rifabutin|rifabutin|mesh-list
111215332|NCT05086107|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111215333|NCT05086107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111215334|NCT05086107|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111215335|NCT05086107|Antitubercular Agents|antitubercular agents|mesh-ancestor
111215336|NCT01029730|Rituximab|rituximab|mesh-list
111215337|NCT01029730|Bortezomib|bortezomib|mesh-list
111215338|NCT01029730|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
111215339|NCT01029730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111215340|NCT01029730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111215341|NCT01029730|Immunologic Factors|immunologic factors|mesh-ancestor
111215342|NCT01029730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111215343|NCT01029730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111215344|NCT01029730|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111215345|NCT01029730|Alkylating Agents|alkylating agents|mesh-ancestor
111215346|NCT01029730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111215347|NCT05066997|Dexamethasone|dexamethasone|mesh-list
111215348|NCT05066997|Dexamethasone acetate|dexamethasone acetate|mesh-list
111215349|NCT05066997|BB 1101|bb 1101|mesh-list
111215350|NCT05066997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111215351|NCT05066997|Antiemetics|antiemetics|mesh-ancestor
111215352|NCT05066997|Autonomic Agents|autonomic agents|mesh-ancestor
111215353|NCT05066997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111215354|NCT05066997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111215355|NCT05066997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111215356|NCT05066997|Glucocorticoids|glucocorticoids|mesh-ancestor
111215357|NCT05066997|Hormones|hormones|mesh-ancestor
111215358|NCT05066997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111215359|NCT05066997|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111215360|NCT05066997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111215361|NCT05066997|Protease Inhibitors|protease inhibitors|mesh-ancestor
111215362|NCT05066997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111215363|NCT05066997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111215364|NCT05025033|Paclitaxel|paclitaxel|mesh-list
111215365|NCT05025033|Irinotecan|irinotecan|mesh-list
111215366|NCT05025033|Apatinib|apatinib|mesh-list
111215367|NCT05025033|Antibodies|antibodies|mesh-list
111215368|NCT05025033|Immunoglobulins|immunoglobulins|mesh-list
111215369|NCT05025033|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111215370|NCT05025033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111215371|NCT05025033|Tubulin Modulators|tubulin modulators|mesh-ancestor
111215372|NCT05025033|Antimitotic Agents|antimitotic agents|mesh-ancestor
111215373|NCT05025033|Mitosis Modulators|mitosis modulators|mesh-ancestor
111215374|NCT05025033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111215375|NCT05025033|Immunologic Factors|immunologic factors|mesh-ancestor
111215376|NCT05025033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111215377|NCT05025033|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111215378|NCT05025033|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111215379|NCT05025033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111215380|NCT05025033|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111215381|NCT00980746|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
111215382|NCT00980746|Anticonvulsants|anticonvulsants|mesh-ancestor
111215383|NCT00980746|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111215384|NCT00980746|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111215385|NCT00980746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111215386|NCT00980746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111215387|NCT00981214|Pancrelipase|pancrelipase|mesh-list
111215388|NCT00981214|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111215389|NCT05415657|Denosumab|denosumab|mesh-list
111215390|NCT05415657|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111215391|NCT05415657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111215392|NCT03016234|Propofol|propofol|mesh-list
111215393|NCT03016234|Desflurane|desflurane|mesh-list
111215394|NCT03016234|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110794810|NCT02537613|Obinutuzumab|obinutuzumab|mesh-list
111215395|NCT03016234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111215396|NCT03016234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111215397|NCT03016234|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111215398|NCT03016234|Anesthetics, General|anesthetics, general|mesh-ancestor
111215399|NCT03016234|Anesthetics|anesthetics|mesh-ancestor
111215400|NCT03016234|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111215401|NCT02167204|Alovudine|alovudine|mesh-list
111215402|NCT02167204|Antiviral Agents|antiviral agents|mesh-ancestor
111215403|NCT02167204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111215404|NCT00982072|Prednisolone|prednisolone|mesh-list
111215405|NCT00982072|Tacrolimus|tacrolimus|mesh-list
111215406|NCT00982072|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111215407|NCT00982072|Immunologic Factors|immunologic factors|mesh-ancestor
111215408|NCT00982072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111215409|NCT00982072|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111215410|NCT00982072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111215411|NCT00982072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111215412|NCT00982072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111215413|NCT00982072|Glucocorticoids|glucocorticoids|mesh-ancestor
111215414|NCT00982072|Hormones|hormones|mesh-ancestor
111215415|NCT00982072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111215416|NCT00982072|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111215417|NCT00982072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111215418|NCT01899053|Serabelisib|serabelisib|mesh-list
111215419|NCT01899053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111215420|NCT01899053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111215421|NCT01032694|Azithromycin|azithromycin|mesh-list
111215422|NCT01032694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111215423|NCT01032694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111215424|NCT04957095|Levodopa|levodopa|mesh-list
111215425|NCT04957095|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111215426|NCT04957095|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111215427|NCT04957095|Dopamine Agents|dopamine agents|mesh-ancestor
111215428|NCT04957095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111215429|NCT04957095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111215430|NCT04957095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111215431|NCT01032850|Capecitabine|capecitabine|mesh-list
111215432|NCT01032850|Sorafenib|sorafenib|mesh-list
111215433|NCT01032850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111215434|NCT01032850|Antimetabolites|antimetabolites|mesh-ancestor
111215435|NCT01032850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111215436|NCT01032850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111215437|NCT01032850|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111215438|NCT01032850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111215439|NCT00983242|Colchicine|colchicine|mesh-list
111215440|NCT00983242|Verapamil|verapamil|mesh-list
111215441|NCT00983242|Gout Suppressants|gout suppressants|mesh-ancestor
111215442|NCT00983242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111215443|NCT00983242|Tubulin Modulators|tubulin modulators|mesh-ancestor
111215444|NCT00983242|Antimitotic Agents|antimitotic agents|mesh-ancestor
111215445|NCT00983242|Mitosis Modulators|mitosis modulators|mesh-ancestor
111215446|NCT00983242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111215447|NCT00983242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111215448|NCT00983242|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111215449|NCT00983242|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111215450|NCT00983242|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111215451|NCT00983242|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111215452|NCT00983242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111215453|NCT00983242|Vasodilator Agents|vasodilator agents|mesh-ancestor
111215454|NCT00984334|Naloxone|naloxone|mesh-list
111215455|NCT00984334|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111215456|NCT00984334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111215457|NCT00984334|Sensory System Agents|sensory system agents|mesh-ancestor
111215458|NCT00984334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111215459|NCT02168062|Leuprolide|leuprolide|mesh-list
111215460|NCT02168062|Goserelin|goserelin|mesh-list
111215461|NCT02168062|Triptorelin Pamoate|triptorelin pamoate|mesh-list
111215462|NCT02168062|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111215463|NCT02168062|Fertility Agents|fertility agents|mesh-ancestor
111215464|NCT02168062|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111215465|NCT02168062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111215466|NCT02168062|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111215467|NCT02168062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111215468|NCT02168062|Luteolytic Agents|luteolytic agents|mesh-ancestor
111215469|NCT02168062|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111215470|NCT02168062|Contraceptive Agents|contraceptive agents|mesh-ancestor
111215471|NCT02168062|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111215472|NCT01888367|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111215473|NCT01888367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111215474|NCT05343117|Palbociclib|palbociclib|mesh-list
111215475|NCT05343117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111215476|NCT05343117|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111215477|NCT05343117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111215478|NCT05343117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111215479|NCT01898195|Varenicline|varenicline|mesh-list
111215480|NCT01898195|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111215481|NCT01898195|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111215482|NCT01898195|Cholinergic Agents|cholinergic agents|mesh-ancestor
111215483|NCT01898195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111215484|NCT01898195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111215485|NCT01898195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111215486|NCT01897727|Spironolactone|spironolactone|mesh-list
111215487|NCT01897727|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
111215488|NCT01897727|Hormone Antagonists|hormone antagonists|mesh-ancestor
111215489|NCT01897727|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111215490|NCT01897727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111215491|NCT01897727|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
111215492|NCT01897727|Diuretics|diuretics|mesh-ancestor
111215493|NCT01897727|Natriuretic Agents|natriuretic agents|mesh-ancestor
111215494|NCT01897493|Digoxin|digoxin|mesh-list
111215495|NCT01897493|Evacetrapib|evacetrapib|mesh-list
111215496|NCT01897493|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111215497|NCT01897493|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111215498|NCT01897493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111215499|NCT01897493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111215500|NCT01897493|Protective Agents|protective agents|mesh-ancestor
111215501|NCT01897493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111215502|NCT01897493|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111215503|NCT01897493|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111215504|NCT01897493|Antimetabolites|antimetabolites|mesh-ancestor
111215505|NCT01897493|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111215506|NCT01887353|Ranolazine|ranolazine|mesh-list
111215507|NCT01887353|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111215508|NCT01887353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111215509|NCT01887353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111215510|NCT00988156|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
111215511|NCT00988156|Anticonvulsants|anticonvulsants|mesh-ancestor
111215512|NCT00988156|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111215513|NCT00988156|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111215514|NCT00988156|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111215515|NCT00988156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111215516|NCT02160730|Roscovitine|roscovitine|mesh-list
111215517|NCT02160730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111215518|NCT02160730|Antiviral Agents|antiviral agents|mesh-ancestor
111215519|NCT02160730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111215520|NCT02160730|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111215521|NCT02160730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111215522|NCT02160730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111215523|NCT03329313|Dialysis Solutions|dialysis solutions|mesh-list
111215524|NCT03329313|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111215525|NCT01896869|Ipilimumab|ipilimumab|mesh-list
111215526|NCT01896869|Folfirinox|folfirinox|mesh-list
111215527|NCT01896869|Vaccines|vaccines|mesh-list
111215528|NCT01896869|Immunologic Factors|immunologic factors|mesh-ancestor
111215529|NCT01896869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111215530|NCT01896869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111215531|NCT01896869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111215532|NCT01896869|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111215533|NCT01896869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111215534|NCT03329001|Niraparib|niraparib|mesh-list
111215535|NCT03329001|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111215536|NCT03329001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111215537|NCT03329001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111215539|NCT01896557|Omeprazole|omeprazole|mesh-list
111215540|NCT01896557|Ranitidine|ranitidine|mesh-list
111215541|NCT01896557|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
111215542|NCT01896557|Clopidogrel|clopidogrel|mesh-list
111215543|NCT01896557|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-list
111215544|NCT01896557|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111215545|NCT01896557|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111215546|NCT01896557|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111215547|NCT01896557|Purinergic Agents|purinergic agents|mesh-ancestor
111215548|NCT01896557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111215549|NCT01896557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111215550|NCT01896557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111215551|NCT01896557|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111215552|NCT01896557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111215553|NCT01896557|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111215554|NCT01896557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111215555|NCT01896557|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
111215556|NCT01896557|Histamine Antagonists|histamine antagonists|mesh-ancestor
111215557|NCT01896557|Histamine Agents|histamine agents|mesh-ancestor
111215558|NCT02160808|Secretin|secretin|mesh-list
111215559|NCT02160808|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111215560|NCT02160808|Hormones|hormones|mesh-ancestor
111215561|NCT02160808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111215562|NCT02160808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111215563|NCT01886105|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
111215564|NCT01886105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111215565|NCT01886105|Analgesics|analgesics|mesh-ancestor
111215566|NCT01886105|Sensory System Agents|sensory system agents|mesh-ancestor
111215567|NCT01886105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111215568|NCT01886105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111215569|NCT03262779|Nivolumab|nivolumab|mesh-list
111215570|NCT03262779|Ipilimumab|ipilimumab|mesh-list
111215571|NCT03262779|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111215572|NCT03262779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111215573|NCT03262779|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111215574|NCT03262779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111215575|NCT05022394|Nivolumab|nivolumab|mesh-list
111215576|NCT05022394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111215577|NCT05022394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111215578|NCT05022394|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111215579|NCT05022394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111215580|NCT01895777|Dabigatran|dabigatran|mesh-list
111215581|NCT01895777|Antithrombins|antithrombins|mesh-ancestor
111215582|NCT01895777|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111215583|NCT01895777|Protease Inhibitors|protease inhibitors|mesh-ancestor
111215584|NCT01895777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111215585|NCT01895777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111215586|NCT01895777|Anticoagulants|anticoagulants|mesh-ancestor
111215587|NCT00992602|Cytarabine|cytarabine|mesh-list
111215588|NCT00992602|Methotrexate|methotrexate|mesh-list
111215589|NCT00992602|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111215590|NCT00992602|Abortifacient Agents|abortifacient agents|mesh-ancestor
111215591|NCT00992602|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111215592|NCT00992602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111215593|NCT00992602|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111215594|NCT00992602|Antimetabolites|antimetabolites|mesh-ancestor
111215595|NCT00992602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111215596|NCT00992602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111215597|NCT00992602|Dermatologic Agents|dermatologic agents|mesh-ancestor
111215598|NCT00992602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111215599|NCT00992602|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111215600|NCT00992602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111215601|NCT00992602|Immunologic Factors|immunologic factors|mesh-ancestor
111215602|NCT00992602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111215603|NCT00992602|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111215604|NCT00992602|Antiviral Agents|antiviral agents|mesh-ancestor
111215605|NCT00992602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111215606|NCT00993226|Bupivacaine|bupivacaine|mesh-list
111215607|NCT00993226|Anesthetics, Local|anesthetics, local|mesh-ancestor
111215608|NCT00993226|Anesthetics|anesthetics|mesh-ancestor
111215609|NCT00993226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111215610|NCT00993226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111215611|NCT00993226|Sensory System Agents|sensory system agents|mesh-ancestor
111215612|NCT00993226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111215613|NCT01885559|Telmisartan|telmisartan|mesh-list
111215614|NCT01885559|Lisinopril|lisinopril|mesh-list
111215615|NCT01885559|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
111215616|NCT01885559|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111215617|NCT01885559|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111215618|NCT01885559|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111215619|NCT01885559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111215620|NCT01885559|Protease Inhibitors|protease inhibitors|mesh-ancestor
111215621|NCT01885559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111215622|NCT01885559|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111215623|NCT01885559|Protective Agents|protective agents|mesh-ancestor
111215624|NCT01885559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111215625|NCT00994318|Ferric Compounds|ferric compounds|mesh-list
111215626|NCT00994318|Hematinics|hematinics|mesh-ancestor
111215627|NCT00995722|Prednisone|prednisone|mesh-list
111215628|NCT00995722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111215629|NCT00995722|Glucocorticoids|glucocorticoids|mesh-ancestor
111215630|NCT00995722|Hormones|hormones|mesh-ancestor
111215631|NCT00995722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111215632|NCT00995722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111215633|NCT00995722|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111215634|NCT00995722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111215635|NCT00996346|Sirolimus|sirolimus|mesh-list
111215636|NCT00996346|Irinotecan|irinotecan|mesh-list
111215637|NCT00996346|Temsirolimus|temsirolimus|mesh-list
111215638|NCT00996346|MTOR Inhibitors|mtor inhibitors|mesh-list
111215639|NCT00996346|Complement Factor H|complement factor h|mesh-list
111215640|NCT00996346|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111215641|NCT00996346|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111215642|NCT00996346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111215643|NCT00996346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111215644|NCT00996346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111215645|NCT00996346|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111215646|NCT00996346|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111215647|NCT00996346|Immunologic Factors|immunologic factors|mesh-ancestor
111215648|NCT00996346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111215649|NCT00996346|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111215650|NCT00996346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111215651|NCT00996346|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111215652|NCT00996346|Antifungal Agents|antifungal agents|mesh-ancestor
111215653|NCT00996346|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
111215654|NCT03016468|Treprostinil|treprostinil|mesh-list
111215655|NCT03016468|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111215656|NCT00997204|Icatibant|icatibant|mesh-list
111215657|NCT00997204|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111215658|NCT00997204|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111215659|NCT00997204|Analgesics|analgesics|mesh-ancestor
111215660|NCT00997204|Sensory System Agents|sensory system agents|mesh-ancestor
111215661|NCT00997204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111215662|NCT00997204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111215663|NCT00997204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111215664|NCT00997204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111215665|NCT00997204|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
111215666|NCT00997204|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
111215667|NCT00997204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111215668|NCT00997204|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
111215669|NCT00997204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111215670|NCT00997204|Immunologic Factors|immunologic factors|mesh-ancestor
111215671|NCT04263610|Dimethyl Fumarate|dimethyl fumarate|mesh-list
111215672|NCT04263610|Dermatologic Agents|dermatologic agents|mesh-ancestor
111215673|NCT04263610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111215674|NCT04263610|Immunologic Factors|immunologic factors|mesh-ancestor
111215675|NCT04263610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111215676|NCT04225390|Dacarbazine|dacarbazine|mesh-list
111215677|NCT04225390|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111215678|NCT04225390|Alkylating Agents|alkylating agents|mesh-ancestor
111215679|NCT04225390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111215680|NCT04225390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111215681|NCT00997672|Lithium Carbonate|lithium carbonate|mesh-list
111215682|NCT00997672|Antidepressive Agents|antidepressive agents|mesh-ancestor
111215683|NCT00997672|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111215684|NCT00997672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111215685|NCT00997672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111215686|NCT00997672|Antimanic Agents|antimanic agents|mesh-ancestor
111215687|NCT00997672|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111215688|NCT00997672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111215689|NCT00997672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111215691|NCT04606797|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111215692|NCT04606797|Autonomic Agents|autonomic agents|mesh-ancestor
111215693|NCT04606797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111215694|NCT04606797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111215695|NCT04606797|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111215696|NCT04606797|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111215697|NCT04606797|Cholinergic Agents|cholinergic agents|mesh-ancestor
111215698|NCT04606797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111215699|NCT04606797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111215700|NCT02164240|Sunitinib|sunitinib|mesh-list
111215701|NCT02164240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111215702|NCT02164240|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111215703|NCT02164240|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111215704|NCT02164240|Growth Substances|growth substances|mesh-ancestor
111215705|NCT02164240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111215706|NCT02164240|Growth Inhibitors|growth inhibitors|mesh-ancestor
111215707|NCT02164240|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111215708|NCT02164240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111215709|NCT02164240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111215710|NCT02169466|Opicapone|opicapone|mesh-list
111215711|NCT02169466|Benserazide, levodopa drug combination|benserazide, levodopa drug combination|mesh-list
111215712|NCT02169466|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
111215713|NCT02169466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111215714|NCT02169466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111215715|NCT02169466|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111215716|NCT02169466|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111215717|NCT02169466|Dopamine Agents|dopamine agents|mesh-ancestor
111215718|NCT02169466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111215719|NCT02169466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111215720|NCT01001806|Ketorolac|ketorolac|mesh-list
111215721|NCT01001806|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
111215722|NCT01001806|Nepafenac|nepafenac|mesh-list
111215723|NCT01001806|Bromfenac|bromfenac|mesh-list
111215724|NCT01001806|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111215725|NCT01001806|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111215726|NCT01001806|Analgesics|analgesics|mesh-ancestor
111215727|NCT01001806|Sensory System Agents|sensory system agents|mesh-ancestor
111215728|NCT01001806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111215729|NCT01001806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111215730|NCT01001806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111215731|NCT01001806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111215732|NCT01001806|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111215733|NCT01001806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111215734|NCT01001806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111215735|NCT04021264|Sufentanil|sufentanil|mesh-list
111215736|NCT04021264|Ropivacaine|ropivacaine|mesh-list
111215737|NCT04021264|Anesthetics, Local|anesthetics, local|mesh-ancestor
111215738|NCT04021264|Anesthetics|anesthetics|mesh-ancestor
111215739|NCT04021264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111215740|NCT04021264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111215741|NCT04021264|Sensory System Agents|sensory system agents|mesh-ancestor
111215742|NCT04021264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111215743|NCT04021264|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111215744|NCT04021264|Narcotics|narcotics|mesh-ancestor
111215745|NCT04021264|Analgesics|analgesics|mesh-ancestor
111215746|NCT04021264|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111215747|NCT04021264|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111215748|NCT04021264|Anesthetics, General|anesthetics, general|mesh-ancestor
111215749|NCT04757571|Paroxetine|paroxetine|mesh-list
111215750|NCT04757571|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111215751|NCT04757571|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111215752|NCT04757571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111215753|NCT04757571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111215754|NCT04757571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111215755|NCT04757571|Serotonin Agents|serotonin agents|mesh-ancestor
111215756|NCT04757571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111215757|NCT04757571|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111215758|NCT04757571|Antidepressive Agents|antidepressive agents|mesh-ancestor
110679616|NCT05267600|Prednisone|prednisone|mesh-list
111215760|NCT04757571|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111215761|NCT04757571|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111215762|NCT04757571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111215763|NCT03232593|Atezolizumab|atezolizumab|mesh-list
111215764|NCT03232593|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111215765|NCT03232593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111215766|NCT03232593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111215767|NCT03232593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111215768|NCT04746183|Ritonavir|ritonavir|mesh-list
111215769|NCT04746183|Nitazoxanide|nitazoxanide|mesh-list
111215770|NCT04746183|Favipiravir|favipiravir|mesh-list
111215771|NCT04746183|Nirmatrelvir|nirmatrelvir|mesh-list
111215772|NCT04746183|Sotrovimab|sotrovimab|mesh-list
111215773|NCT04746183|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
111215774|NCT04746183|Molnupiravir|molnupiravir|mesh-list
111215775|NCT04746183|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111215776|NCT04746183|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111215777|NCT04746183|Protease Inhibitors|protease inhibitors|mesh-ancestor
111215778|NCT04746183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111215779|NCT04746183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111215780|NCT04746183|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111215781|NCT04746183|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111215782|NCT04746183|Antiviral Agents|antiviral agents|mesh-ancestor
111215783|NCT04746183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111215784|NCT04746183|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111215785|NCT04746183|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111215786|NCT04746183|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111215787|NCT01895309|Etanercept|etanercept|mesh-list
111215788|NCT01895309|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111215789|NCT01895309|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111215790|NCT01895309|Analgesics|analgesics|mesh-ancestor
111215791|NCT01895309|Sensory System Agents|sensory system agents|mesh-ancestor
111215792|NCT01895309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111215793|NCT01895309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111215794|NCT01895309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111215795|NCT01895309|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111215796|NCT01895309|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111215797|NCT01895309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111215798|NCT01895309|Immunologic Factors|immunologic factors|mesh-ancestor
111215799|NCT04614311|Triamcinolone|triamcinolone|mesh-list
111215800|NCT04614311|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
111215801|NCT04614311|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
111215802|NCT04614311|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
111215803|NCT04614311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111215804|NCT04614311|Glucocorticoids|glucocorticoids|mesh-ancestor
111215805|NCT04614311|Hormones|hormones|mesh-ancestor
111215806|NCT04614311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111215807|NCT04614311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111215808|NCT04614311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111215809|NCT04614311|Immunologic Factors|immunologic factors|mesh-ancestor
111215810|NCT04614311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111215811|NCT04614311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111215812|NCT05066698|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111215813|NCT05066698|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111215814|NCT04323748|Rituximab|rituximab|mesh-list
111215815|NCT04323748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111215816|NCT04323748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111215817|NCT04323748|Immunologic Factors|immunologic factors|mesh-ancestor
111215818|NCT04323748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111215819|NCT04323748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111215820|NCT04197310|Nivolumab|nivolumab|mesh-list
111215821|NCT04197310|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111215822|NCT04197310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111215823|NCT04197310|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111215824|NCT04197310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111215825|NCT02808364|Vaccines|vaccines|mesh-list
111215826|NCT02808364|Immunologic Factors|immunologic factors|mesh-ancestor
111215827|NCT02808364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111215828|NCT02709616|Vaccines|vaccines|mesh-list
111215829|NCT02709616|Immunologic Factors|immunologic factors|mesh-ancestor
111215830|NCT02709616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111215831|NCT04534881|Progesterone|progesterone|mesh-list
111215832|NCT04534881|Progestins|progestins|mesh-ancestor
111215833|NCT04534881|Hormones|hormones|mesh-ancestor
111215834|NCT04534881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111215835|NCT04534881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111215837|NCT04817956|Atezolizumab|atezolizumab|mesh-list
111215838|NCT04817956|Pertuzumab|pertuzumab|mesh-list
111215839|NCT04817956|Vemurafenib|vemurafenib|mesh-list
111215840|NCT04817956|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111215841|NCT04817956|Entrectinib|entrectinib|mesh-list
111215842|NCT04817956|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111215843|NCT04817956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111215844|NCT04817956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111215845|NCT04817956|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111215846|NCT04817956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111215847|NCT04817956|Immunologic Factors|immunologic factors|mesh-ancestor
111215848|NCT04817956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111215849|NCT04817956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111215850|NCT01894919|Vaccines|vaccines|mesh-list
111215851|NCT01894919|Immunologic Factors|immunologic factors|mesh-ancestor
111215852|NCT01894919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111215853|NCT04130698|Nicotine|nicotine|mesh-list
111215854|NCT04130698|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111215855|NCT04130698|Autonomic Agents|autonomic agents|mesh-ancestor
111215856|NCT04130698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111215857|NCT04130698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111215858|NCT04130698|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111215859|NCT04130698|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111215860|NCT04130698|Cholinergic Agents|cholinergic agents|mesh-ancestor
111215861|NCT04130698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111215862|NCT04130698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111215863|NCT05306223|Levofloxacin|levofloxacin|mesh-list
111215864|NCT05306223|Cycloserine|cycloserine|mesh-list
111215865|NCT05306223|Linezolid|linezolid|mesh-list
111215866|NCT05306223|Pyrazinamide|pyrazinamide|mesh-list
111215867|NCT05306223|Bedaquiline|bedaquiline|mesh-list
111215868|NCT05306223|Clofazimine|clofazimine|mesh-list
111215869|NCT05306223|Prothionamide|prothionamide|mesh-list
111215870|NCT05306223|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111215871|NCT05306223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111215872|NCT05306223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111215873|NCT05306223|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111215874|NCT05306223|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111215875|NCT05306223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111215876|NCT05306223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111215877|NCT05306223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111215878|NCT05306223|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111215879|NCT05306223|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111215880|NCT05306223|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111215881|NCT05306223|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111215882|NCT05306223|Antitubercular Agents|antitubercular agents|mesh-ancestor
111215883|NCT05306223|Antimetabolites|antimetabolites|mesh-ancestor
111215884|NCT05306223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111215885|NCT05306223|Leprostatic Agents|leprostatic agents|mesh-ancestor
111215886|NCT03016000|Thalidomide|thalidomide|mesh-list
111215887|NCT03016000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111215888|NCT03016000|Immunologic Factors|immunologic factors|mesh-ancestor
111215889|NCT03016000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111215890|NCT03016000|Leprostatic Agents|leprostatic agents|mesh-ancestor
111215891|NCT03016000|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111215892|NCT03016000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111215893|NCT03016000|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111215894|NCT03016000|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111215895|NCT03016000|Growth Substances|growth substances|mesh-ancestor
111215896|NCT03016000|Growth Inhibitors|growth inhibitors|mesh-ancestor
111215897|NCT03016000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111215898|NCT04130152|Letrozole|letrozole|mesh-list
111215899|NCT04130152|Palbociclib|palbociclib|mesh-list
111215900|NCT04130152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111215901|NCT04130152|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111215902|NCT04130152|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111215903|NCT04130152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111215904|NCT04130152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111215905|NCT04130152|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111215906|NCT04130152|Hormone Antagonists|hormone antagonists|mesh-ancestor
111215907|NCT04130152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111215908|NCT04130152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111215909|NCT04130152|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111215910|NCT03254589|Sulfasalazine|sulfasalazine|mesh-list
111215911|NCT03254589|Methotrexate|methotrexate|mesh-list
111215912|NCT03254589|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111215913|NCT03254589|Abortifacient Agents|abortifacient agents|mesh-ancestor
111215914|NCT03254589|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111215915|NCT03254589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111215916|NCT03254589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111215917|NCT03254589|Antimetabolites|antimetabolites|mesh-ancestor
111215918|NCT03254589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111215919|NCT03254589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111215920|NCT03254589|Dermatologic Agents|dermatologic agents|mesh-ancestor
111215921|NCT03254589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111215922|NCT03254589|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111215923|NCT03254589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111215924|NCT03254589|Immunologic Factors|immunologic factors|mesh-ancestor
111215925|NCT03254589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111215926|NCT03254589|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111215927|NCT03254589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111215928|NCT03254589|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111215929|NCT03254589|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111215930|NCT03254589|Analgesics|analgesics|mesh-ancestor
111215931|NCT03254589|Sensory System Agents|sensory system agents|mesh-ancestor
111215932|NCT03254589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111215933|NCT03254589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111215934|NCT03254589|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111215935|NCT04399395|Naltrexone|naltrexone|mesh-list
111215936|NCT04399395|Bupropion|bupropion|mesh-list
111215937|NCT04399395|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111215938|NCT04399395|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111215939|NCT04399395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111215940|NCT04399395|Sensory System Agents|sensory system agents|mesh-ancestor
111215941|NCT04399395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111215942|NCT04399395|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111215943|NCT04399395|Antidepressive Agents|antidepressive agents|mesh-ancestor
111215944|NCT04399395|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111215945|NCT04399395|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111215946|NCT04399395|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111215947|NCT04399395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111215948|NCT04399395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111215949|NCT04399395|Dopamine Agents|dopamine agents|mesh-ancestor
111215950|NCT04399395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111215951|NCT04399395|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111215952|NCT04399395|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111215953|NCT04399395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111215954|NCT02000596|Trastuzumab|trastuzumab|mesh-list
111215955|NCT02000596|Pertuzumab|pertuzumab|mesh-list
111215956|NCT02000596|Fulvestrant|fulvestrant|mesh-list
111215957|NCT02000596|Anastrozole|anastrozole|mesh-list
111215958|NCT02000596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111215959|NCT02000596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111215960|NCT02000596|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111215961|NCT02000596|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
111215962|NCT02000596|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111215963|NCT02000596|Hormone Antagonists|hormone antagonists|mesh-ancestor
111215964|NCT02000596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111215965|NCT02000596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111215966|NCT02000596|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111215967|NCT02000596|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111215968|NCT02000596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111215969|NCT02000596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111215970|NCT03223779|Trifluridine|trifluridine|mesh-list
111215971|NCT03223779|Antimetabolites|antimetabolites|mesh-ancestor
111215972|NCT03223779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111215973|NCT03223779|Antiviral Agents|antiviral agents|mesh-ancestor
111215974|NCT03223779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111215975|NCT05168865|Letrozole|letrozole|mesh-list
111215976|NCT05168865|Estradiol|estradiol|mesh-list
111215977|NCT05168865|Progesterone|progesterone|mesh-list
111215978|NCT05168865|Estrogens|estrogens|mesh-ancestor
111215979|NCT05168865|Hormones|hormones|mesh-ancestor
111215980|NCT05168865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111215981|NCT05168865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110679813|NCT05014412|Hormones|hormones|mesh-ancestor
111215982|NCT05168865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111215983|NCT05168865|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111215984|NCT05168865|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111215985|NCT05168865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111215986|NCT05168865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111215987|NCT05168865|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111215988|NCT05168865|Hormone Antagonists|hormone antagonists|mesh-ancestor
111215989|NCT05168865|Progestins|progestins|mesh-ancestor
111215990|NCT01882985|Lycopene|lycopene|mesh-list
111215991|NCT01882985|Docetaxel|docetaxel|mesh-list
111215992|NCT01882985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111215993|NCT01882985|Tubulin Modulators|tubulin modulators|mesh-ancestor
111215994|NCT01882985|Antimitotic Agents|antimitotic agents|mesh-ancestor
111215995|NCT01882985|Mitosis Modulators|mitosis modulators|mesh-ancestor
111215996|NCT01882985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111215997|NCT01882985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111215998|NCT01882985|Antioxidants|antioxidants|mesh-ancestor
111215999|NCT01882985|Protective Agents|protective agents|mesh-ancestor
111216000|NCT01882985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111216001|NCT01882985|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111216002|NCT01882985|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
111216003|NCT02166346|4-Aminopyridine|4-aminopyridine|mesh-list
111216004|NCT02166346|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
111216005|NCT02166346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111216006|NCT02166346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111216007|NCT04460235|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
111216008|NCT04460235|Immunologic Factors|immunologic factors|mesh-ancestor
111216009|NCT04460235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111216010|NCT03015922|Lenalidomide|lenalidomide|mesh-list
111216011|NCT03015922|Pomalidomide|pomalidomide|mesh-list
111216012|NCT03015922|Immunologic Factors|immunologic factors|mesh-ancestor
111216013|NCT03015922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111216014|NCT03015922|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111216015|NCT03015922|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111216016|NCT03015922|Growth Substances|growth substances|mesh-ancestor
111216017|NCT03015922|Growth Inhibitors|growth inhibitors|mesh-ancestor
111216018|NCT03015922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111216019|NCT01893827|Naltrexone|naltrexone|mesh-list
111216020|NCT01893827|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111216021|NCT01893827|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111216022|NCT01893827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111216023|NCT01893827|Sensory System Agents|sensory system agents|mesh-ancestor
111216024|NCT01893827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111216025|NCT01882907|Pioglitazone|pioglitazone|mesh-list
111216026|NCT01882907|Vildagliptin|vildagliptin|mesh-list
111216027|NCT01882907|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111216028|NCT01882907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111216029|NCT01882907|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111216030|NCT01882907|Protease Inhibitors|protease inhibitors|mesh-ancestor
111216031|NCT01882907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111216032|NCT01882907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111216033|NCT01051570|Prednisone|prednisone|mesh-list
111216034|NCT01051570|Carboplatin|carboplatin|mesh-list
111216035|NCT01051570|Everolimus|everolimus|mesh-list
111216036|NCT01051570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111216037|NCT01051570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111216038|NCT01051570|Glucocorticoids|glucocorticoids|mesh-ancestor
111216039|NCT01051570|Hormones|hormones|mesh-ancestor
111216040|NCT01051570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111216041|NCT01051570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111216042|NCT01051570|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111216043|NCT01051570|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111216044|NCT01051570|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111216045|NCT01051570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111216046|NCT01051570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111216047|NCT01051570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111216048|NCT01051570|Immunologic Factors|immunologic factors|mesh-ancestor
111216049|NCT01893281|Methyltestosterone|methyltestosterone|mesh-list
111216050|NCT01893281|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111216051|NCT01893281|Testosterone|testosterone|mesh-list
111216052|NCT01893281|Testosterone undecanoate|testosterone undecanoate|mesh-list
111216053|NCT01893281|Testosterone enanthate|testosterone enanthate|mesh-list
111216054|NCT01893281|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
111216055|NCT01893281|Androgens|androgens|mesh-ancestor
111216056|NCT01893281|Hormones|hormones|mesh-ancestor
111216057|NCT01893281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111216058|NCT01893281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111216059|NCT01893281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111216060|NCT01893281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111216061|NCT01893281|Anabolic Agents|anabolic agents|mesh-ancestor
111216062|NCT02981446|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111216063|NCT02981446|Latanoprost|latanoprost|mesh-list
111216064|NCT02981446|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111216065|NCT01893203|Aminolevulinic Acid|aminolevulinic acid|mesh-list
111216066|NCT01893203|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111216067|NCT01893203|Dermatologic Agents|dermatologic agents|mesh-ancestor
111216068|NCT05263947|Bevacizumab|bevacizumab|mesh-list
111216069|NCT05263947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111216070|NCT05263947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111216071|NCT05263947|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111216072|NCT05263947|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111216073|NCT05263947|Growth Substances|growth substances|mesh-ancestor
111216074|NCT05263947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111216075|NCT05263947|Growth Inhibitors|growth inhibitors|mesh-ancestor
111216076|NCT04415567|Lenvatinib|lenvatinib|mesh-list
111216077|NCT04415567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111216078|NCT04415567|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111216079|NCT04415567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111216080|NCT04415567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111216081|NCT03280251|Methylphenidate|methylphenidate|mesh-list
111216082|NCT03280251|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111216083|NCT03280251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111216084|NCT03280251|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111216085|NCT03280251|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111216086|NCT03280251|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111216087|NCT03280251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111216088|NCT03280251|Dopamine Agents|dopamine agents|mesh-ancestor
111216089|NCT03280251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111216090|NCT01882829|Quinidine|quinidine|mesh-list
111216091|NCT01882829|Dextromethorphan|dextromethorphan|mesh-list
111216092|NCT01882829|Antitussive Agents|antitussive agents|mesh-ancestor
111216093|NCT01882829|Respiratory System Agents|respiratory system agents|mesh-ancestor
111216094|NCT01882829|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111216095|NCT01882829|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111216096|NCT01882829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111216097|NCT01882829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111216098|NCT01882829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111216099|NCT01882829|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111216100|NCT01882829|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111216101|NCT01882829|Adrenergic Agents|adrenergic agents|mesh-ancestor
111216102|NCT01882829|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111216103|NCT01882829|Antimalarials|antimalarials|mesh-ancestor
111216104|NCT01882829|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111216105|NCT01882829|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111216106|NCT01882829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111216107|NCT01882829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111216108|NCT01882829|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111216109|NCT01882829|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111216110|NCT01882829|Cholinergic Agents|cholinergic agents|mesh-ancestor
111216111|NCT01882829|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111216112|NCT01882829|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111216113|NCT01882829|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111216114|NCT01882829|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111216115|NCT01882829|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111216116|NCT04760301|Tranexamic Acid|tranexamic acid|mesh-list
111216117|NCT04760301|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111216118|NCT04760301|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111216119|NCT04760301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111216120|NCT04760301|Hemostatics|hemostatics|mesh-ancestor
111216121|NCT04760301|Coagulants|coagulants|mesh-ancestor
111216122|NCT01054768|Thioctic Acid|thioctic acid|mesh-list
111216123|NCT01054768|Acetylcarnitine|acetylcarnitine|mesh-list
111216124|NCT01054768|Antioxidants|antioxidants|mesh-ancestor
111216125|NCT01054768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111216126|NCT01054768|Protective Agents|protective agents|mesh-ancestor
111216127|NCT01054768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111216128|NCT01054768|Vitamin B Complex|vitamin b complex|mesh-ancestor
111216129|NCT01054768|Vitamins|vitamins|mesh-ancestor
110669040|NCT01050478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111216130|NCT01054768|Micronutrients|micronutrients|mesh-ancestor
111216131|NCT01054768|Nootropic Agents|nootropic agents|mesh-ancestor
111216132|NCT04387617|Cannabidiol|cannabidiol|mesh-list
111216133|NCT04387617|Anticonvulsants|anticonvulsants|mesh-ancestor
111216134|NCT03014830|Alirocumab|alirocumab|mesh-list
111216135|NCT03014830|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
110795560|NCT01294761|Darunavir|darunavir|mesh-list
111216136|NCT03014830|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111216137|NCT03014830|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111216138|NCT03014830|Antimetabolites|antimetabolites|mesh-ancestor
111216139|NCT03014830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111216140|NCT03014830|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111216141|NCT03014830|Protease Inhibitors|protease inhibitors|mesh-ancestor
111216142|NCT03014830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111216143|NCT03014830|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111216144|NCT01055704|Naltrexone|naltrexone|mesh-list
111216145|NCT01055704|Codeine|codeine|mesh-list
111216146|NCT01055704|Methylnaltrexone|methylnaltrexone|mesh-list
111216147|NCT01055704|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111216148|NCT01055704|Narcotics|narcotics|mesh-ancestor
111216149|NCT01055704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111216150|NCT01055704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111216151|NCT01055704|Analgesics|analgesics|mesh-ancestor
111216152|NCT01055704|Sensory System Agents|sensory system agents|mesh-ancestor
111216153|NCT01055704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111216154|NCT01055704|Antitussive Agents|antitussive agents|mesh-ancestor
111216155|NCT01055704|Respiratory System Agents|respiratory system agents|mesh-ancestor
111216156|NCT01055704|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111216157|NCT01055704|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111216158|NCT03280017|Ketamine|ketamine|mesh-list
111216159|NCT03280017|Analgesics|analgesics|mesh-ancestor
111216160|NCT03280017|Sensory System Agents|sensory system agents|mesh-ancestor
111216161|NCT03280017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111216162|NCT03280017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111216163|NCT03280017|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111216164|NCT03280017|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111216165|NCT03280017|Anesthetics, General|anesthetics, general|mesh-ancestor
111216166|NCT03280017|Anesthetics|anesthetics|mesh-ancestor
111216167|NCT03280017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111216168|NCT03280017|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111216169|NCT03280017|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111216170|NCT03280017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111216171|NCT03280017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111216172|NCT01882439|Tofacitinib|tofacitinib|mesh-list
111216173|NCT01882439|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
111216174|NCT01882439|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111216175|NCT01882439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111216176|NCT01882439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111216177|NCT04400019|Hydroxychloroquine|hydroxychloroquine|mesh-list
111216178|NCT04400019|Antimalarials|antimalarials|mesh-ancestor
111216179|NCT04400019|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111216180|NCT04400019|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111216181|NCT04400019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111216182|NCT04400019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111216183|NCT04400019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111216184|NCT04400019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111216185|NCT05225805|Lefamulin|lefamulin|mesh-list
111216186|NCT05225805|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111216187|NCT05225805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111216188|NCT03915405|Avelumab|avelumab|mesh-list
111216189|NCT03915405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111216190|NCT03915405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111216191|NCT04351581|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
111216192|NCT04351581|Protease Inhibitors|protease inhibitors|mesh-ancestor
111216193|NCT04351581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111216194|NCT04351581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111216195|NCT01109056|Cyclosporine|cyclosporine|mesh-list
111216196|NCT01109056|Cyclosporins|cyclosporins|mesh-list
111216197|NCT01109056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111216198|NCT01109056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111216199|NCT01109056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111216200|NCT01109056|Immunologic Factors|immunologic factors|mesh-ancestor
111216201|NCT01109056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111216202|NCT01109056|Antifungal Agents|antifungal agents|mesh-ancestor
111216203|NCT01109056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111216204|NCT01109056|Dermatologic Agents|dermatologic agents|mesh-ancestor
111216205|NCT01109056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111216206|NCT01109056|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111216207|NCT03870399|Tamoxifen|tamoxifen|mesh-list
111216208|NCT03870399|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111216209|NCT03870399|Hormone Antagonists|hormone antagonists|mesh-ancestor
111216210|NCT03870399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111216211|NCT03870399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111216212|NCT03870399|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111216213|NCT03870399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111216214|NCT03870399|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111216215|NCT03870399|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111216216|NCT03870399|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111216217|NCT04333407|Aspirin|aspirin|mesh-list
111216218|NCT04333407|Omeprazole|omeprazole|mesh-list
111216219|NCT04333407|Rivaroxaban|rivaroxaban|mesh-list
111216220|NCT04333407|Clopidogrel|clopidogrel|mesh-list
111216221|NCT04333407|Atorvastatin|atorvastatin|mesh-list
111216222|NCT04333407|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111216223|NCT04333407|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111216224|NCT04333407|Analgesics|analgesics|mesh-ancestor
111216225|NCT04333407|Sensory System Agents|sensory system agents|mesh-ancestor
111216226|NCT04333407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111216227|NCT04333407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111216228|NCT04333407|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111216229|NCT04333407|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111216230|NCT04333407|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111216231|NCT04333407|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111216232|NCT04333407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111216233|NCT04333407|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111216234|NCT04333407|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111216235|NCT04333407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111216236|NCT04333407|Antipyretics|antipyretics|mesh-ancestor
111216237|NCT04333407|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111216238|NCT04333407|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111216239|NCT04333407|Antimetabolites|antimetabolites|mesh-ancestor
111216240|NCT04333407|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111216241|NCT04333407|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111216242|NCT04333407|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111216243|NCT04333407|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111216244|NCT04333407|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111216245|NCT04333407|Purinergic Agents|purinergic agents|mesh-ancestor
111216246|NCT04333407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111216247|NCT04333407|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111216248|NCT04333407|Antithrombins|antithrombins|mesh-ancestor
111216249|NCT04333407|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111216250|NCT04333407|Protease Inhibitors|protease inhibitors|mesh-ancestor
111216251|NCT04333407|Anticoagulants|anticoagulants|mesh-ancestor
111216252|NCT04333407|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111216253|NCT04333407|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111216254|NCT04333407|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111216255|NCT04398927|Folfirinox|folfirinox|mesh-list
111216256|NCT04398927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111216257|NCT01059682|Dalcetrapib|dalcetrapib|mesh-list
111216258|NCT01059682|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111216259|NCT01059682|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111216260|NCT01059682|Antimetabolites|antimetabolites|mesh-ancestor
111216261|NCT01059682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111216262|NCT01059682|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111216263|NCT04399083|Caffeine|caffeine|mesh-list
111216264|NCT04399083|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111216265|NCT04399083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111216266|NCT04399083|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111216267|NCT04399083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111216268|NCT04399083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111216269|NCT04399083|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
111216270|NCT04399083|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111216271|NCT04399083|Purinergic Agents|purinergic agents|mesh-ancestor
111216272|NCT04399083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111216273|NCT01892345|Eculizumab|eculizumab|mesh-list
111216274|NCT01892345|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
111216275|NCT01892345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111216276|NCT01892345|Immunologic Factors|immunologic factors|mesh-ancestor
111216277|NCT01892345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111216278|NCT01059994|Sildenafil Citrate|sildenafil citrate|mesh-list
111216279|NCT01059994|Vasodilator Agents|vasodilator agents|mesh-ancestor
111216280|NCT01059994|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111216281|NCT01059994|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111216282|NCT01059994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111216283|NCT01059994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111216284|NCT01059994|Urological Agents|urological agents|mesh-ancestor
111216285|NCT01111318|Empagliflozin|empagliflozin|mesh-list
111216286|NCT01111318|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111216287|NCT01111318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111216288|NCT01111318|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111216289|NCT01111318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111216291|NCT01892189|Analgesics|analgesics|mesh-ancestor
111216292|NCT01892189|Sensory System Agents|sensory system agents|mesh-ancestor
111216293|NCT01892189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111216294|NCT01892189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111216295|NCT01892189|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111216296|NCT01892189|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111216297|NCT01892189|Anesthetics, General|anesthetics, general|mesh-ancestor
111216298|NCT01892189|Anesthetics|anesthetics|mesh-ancestor
111216299|NCT01892189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111216300|NCT01892189|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111216301|NCT01892189|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111216302|NCT01892189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111216303|NCT01892189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111216304|NCT01062568|Dexamethasone|dexamethasone|mesh-list
111216305|NCT01062568|Cosyntropin|cosyntropin|mesh-list
111216306|NCT01062568|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
111216307|NCT01062568|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
111216308|NCT01062568|beta-Endorphin|beta-endorphin|mesh-list
111216309|NCT01062568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111216310|NCT01062568|Antiemetics|antiemetics|mesh-ancestor
111216311|NCT01062568|Autonomic Agents|autonomic agents|mesh-ancestor
111216312|NCT01062568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111216313|NCT01062568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111216314|NCT01062568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111216315|NCT01062568|Glucocorticoids|glucocorticoids|mesh-ancestor
111216316|NCT01062568|Hormones|hormones|mesh-ancestor
111216317|NCT01062568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111216318|NCT01062568|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111216319|NCT01062568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111216320|NCT01062568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111216321|NCT01062568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111216322|NCT05155137|Amlodipine|amlodipine|mesh-list
111216323|NCT05155137|Valsartan|valsartan|mesh-list
111216324|NCT05155137|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111216325|NCT05155137|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111216326|NCT05155137|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111216327|NCT05155137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111216328|NCT05155137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111216329|NCT05155137|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111216330|NCT05155137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111216331|NCT05155137|Vasodilator Agents|vasodilator agents|mesh-ancestor
111216332|NCT05155137|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111216333|NCT05155137|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111216334|NCT05155137|Antimetabolites|antimetabolites|mesh-ancestor
111216335|NCT05155137|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111216336|NCT05155137|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111216337|NCT05155137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111216338|NCT05155137|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111216339|NCT05155137|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111216340|NCT01064284|Factor VIII|factor viii|mesh-list
111216341|NCT01064284|Coagulants|coagulants|mesh-ancestor
111216342|NCT01064362|Heparin|heparin|mesh-list
111216343|NCT01064362|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
111216344|NCT01064362|Tinzaparin|tinzaparin|mesh-list
111216345|NCT01064362|Dalteparin|dalteparin|mesh-list
111216346|NCT01064362|PENTA|penta|mesh-list
111216347|NCT01064362|Fondaparinux|fondaparinux|mesh-list
111216348|NCT01064362|Anticoagulants|anticoagulants|mesh-ancestor
111216349|NCT01064362|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111216350|NCT01064362|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111216351|NCT01064362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111216352|NCT01064362|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111216353|NCT01064362|Antithrombins|antithrombins|mesh-ancestor
111216354|NCT01064362|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110669266|NCT03880266|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111216355|NCT01064362|Protease Inhibitors|protease inhibitors|mesh-ancestor
111216356|NCT01064362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111216357|NCT03646461|Nivolumab|nivolumab|mesh-list
111216358|NCT03646461|Cetuximab|cetuximab|mesh-list
110795777|NCT01193595|Bevacizumab|bevacizumab|mesh-list
111216359|NCT03646461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111216360|NCT03646461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111216361|NCT03646461|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111216362|NCT03646461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111216363|NCT01880957|Lamotrigine|lamotrigine|mesh-list
111216364|NCT01880957|Lithium Carbonate|lithium carbonate|mesh-list
111216365|NCT01880957|Antidepressive Agents|antidepressive agents|mesh-ancestor
111216366|NCT01880957|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111216367|NCT01880957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111216368|NCT01880957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111216369|NCT01880957|Antimanic Agents|antimanic agents|mesh-ancestor
111216370|NCT01880957|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111216371|NCT01880957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111216372|NCT01880957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111216373|NCT01880957|Anticonvulsants|anticonvulsants|mesh-ancestor
111216374|NCT01880957|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111216375|NCT01880957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111216376|NCT01880957|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111216377|NCT01880957|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111216378|NCT01880957|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111216379|NCT01064830|Cyclosporine|cyclosporine|mesh-list
111216380|NCT01064830|Cyclosporins|cyclosporins|mesh-list
111216381|NCT01064830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111216382|NCT01064830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111216383|NCT01064830|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111216384|NCT01064830|Immunologic Factors|immunologic factors|mesh-ancestor
111216385|NCT01064830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111216386|NCT01064830|Antifungal Agents|antifungal agents|mesh-ancestor
111216387|NCT01064830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111216388|NCT01064830|Dermatologic Agents|dermatologic agents|mesh-ancestor
111216389|NCT01064830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111216390|NCT01064830|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111216391|NCT01890785|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
111216392|NCT01890785|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111216393|NCT01890785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111216394|NCT01890785|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111216395|NCT01890785|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111216396|NCT01890785|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111216397|NCT01890785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111216398|NCT01890785|Dopamine Agents|dopamine agents|mesh-ancestor
111216399|NCT01890785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111216400|NCT01066624|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111216401|NCT01066624|Calcium|calcium|mesh-list
111216402|NCT01066624|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111216403|NCT01066624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111216404|NCT04398771|Valsartan|valsartan|mesh-list
111216405|NCT04398771|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111216406|NCT04398771|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111216407|NCT04398771|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111216408|NCT04398771|Antimetabolites|antimetabolites|mesh-ancestor
111216409|NCT04398771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111216410|NCT04398771|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111216411|NCT04398771|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111216412|NCT04398771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111216413|NCT04398771|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111216414|NCT04398771|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111216415|NCT04398771|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111216416|NCT01863953|Brimonidine Tartrate|brimonidine tartrate|mesh-list
111216417|NCT01863953|Bimatoprost|bimatoprost|mesh-list
111216418|NCT01863953|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111216419|NCT01863953|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111216420|NCT01863953|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111216421|NCT01863953|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111216422|NCT01863953|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111216423|NCT01863953|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111216424|NCT01863953|Adrenergic Agents|adrenergic agents|mesh-ancestor
111216425|NCT01863953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111216426|NCT01863953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111216427|NCT01863953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111216428|NCT01068964|Timolol|timolol|mesh-list
111216429|NCT01068964|Bimatoprost|bimatoprost|mesh-list
111216430|NCT01068964|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111216431|NCT01068964|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111216432|NCT01068964|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111216433|NCT01068964|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111216434|NCT01068964|Adrenergic Agents|adrenergic agents|mesh-ancestor
111216435|NCT01068964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111216436|NCT01068964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111216437|NCT01068964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111216438|NCT01068964|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111216439|NCT01068964|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111216440|NCT03217162|Pulmonary Surfactants|pulmonary surfactants|mesh-list
111216441|NCT03217162|Respiratory System Agents|respiratory system agents|mesh-ancestor
111216442|NCT02984475|Metformin|metformin|mesh-list
111216443|NCT02984475|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111216444|NCT02984475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111216445|NCT01069354|Lidocaine|lidocaine|mesh-list
111216446|NCT01069354|Anesthetics, Local|anesthetics, local|mesh-ancestor
111216447|NCT01069354|Anesthetics|anesthetics|mesh-ancestor
111216448|NCT01069354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111216449|NCT01069354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111216450|NCT01069354|Sensory System Agents|sensory system agents|mesh-ancestor
111216451|NCT01069354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111216452|NCT01069354|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111216453|NCT01069354|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111216454|NCT01069354|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111216455|NCT01069354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111216456|NCT01069354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111216457|NCT03080974|Nivolumab|nivolumab|mesh-list
111216458|NCT03080974|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111216459|NCT03080974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111216460|NCT03080974|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111216461|NCT03080974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111216462|NCT01069510|Spironolactone|spironolactone|mesh-list
111216463|NCT01069510|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
111216464|NCT01069510|Hormone Antagonists|hormone antagonists|mesh-ancestor
111216465|NCT01069510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111216466|NCT01069510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111216467|NCT01069510|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
111216468|NCT01069510|Diuretics|diuretics|mesh-ancestor
111216469|NCT01069510|Natriuretic Agents|natriuretic agents|mesh-ancestor
111216470|NCT04278495|Losartan|losartan|mesh-list
111216471|NCT04278495|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111216472|NCT04278495|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111216473|NCT04278495|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111216474|NCT04278495|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111216475|NCT04278495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111216476|NCT04276545|Midazolam|midazolam|mesh-list
111216477|NCT04276545|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111216478|NCT04276545|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111216479|NCT04276545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111216480|NCT04276545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111216481|NCT04276545|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111216482|NCT04276545|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111216483|NCT04276545|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111216484|NCT04276545|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111216485|NCT04276545|Anesthetics, General|anesthetics, general|mesh-ancestor
111216486|NCT04276545|Anesthetics|anesthetics|mesh-ancestor
111216487|NCT04276545|GABA Modulators|gaba modulators|mesh-ancestor
111216488|NCT04276545|GABA Agents|gaba agents|mesh-ancestor
111216489|NCT04276545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111216490|NCT04276545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111216491|NCT01117948|Lornoxicam|lornoxicam|mesh-list
111216492|NCT01117948|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111216493|NCT01117948|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111216494|NCT01117948|Analgesics|analgesics|mesh-ancestor
111216495|NCT01117948|Sensory System Agents|sensory system agents|mesh-ancestor
111216496|NCT01117948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111216497|NCT01117948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111216498|NCT01117948|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111216499|NCT01117948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111216500|NCT03014440|Cannabidiol|cannabidiol|mesh-list
111216501|NCT03014440|Anticonvulsants|anticonvulsants|mesh-ancestor
111216503|NCT03013036|Midazolam|midazolam|mesh-list
111216504|NCT03013036|Propofol|propofol|mesh-list
111216505|NCT03013036|Sevoflurane|sevoflurane|mesh-list
111216506|NCT03013036|Rocuronium|rocuronium|mesh-list
111216507|NCT03013036|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111216508|NCT03013036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111216509|NCT03013036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111216510|NCT03013036|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111216511|NCT03013036|Anesthetics, General|anesthetics, general|mesh-ancestor
111216512|NCT03013036|Anesthetics|anesthetics|mesh-ancestor
111216513|NCT03013036|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111216514|NCT03013036|Narcotics|narcotics|mesh-ancestor
111216515|NCT03013036|Analgesics|analgesics|mesh-ancestor
111216516|NCT03013036|Sensory System Agents|sensory system agents|mesh-ancestor
111216517|NCT03013036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111216518|NCT03013036|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111216519|NCT03013036|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111216520|NCT03013036|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111216521|NCT03013036|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111216522|NCT03013036|GABA Modulators|gaba modulators|mesh-ancestor
111216523|NCT03013036|GABA Agents|gaba agents|mesh-ancestor
111216524|NCT03013036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111216525|NCT03013036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111216526|NCT03013036|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111216527|NCT03013036|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111216528|NCT03013036|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
111216529|NCT03013036|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
111216530|NCT03013036|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111216531|NCT01071538|Buprenorphine|buprenorphine|mesh-list
111216532|NCT01071538|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111216533|NCT01071538|Narcotics|narcotics|mesh-ancestor
111216534|NCT01071538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111216535|NCT01071538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111216536|NCT01071538|Analgesics|analgesics|mesh-ancestor
111216537|NCT01071538|Sensory System Agents|sensory system agents|mesh-ancestor
111216538|NCT01071538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111216539|NCT01071538|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111216540|NCT04352686|Buspirone|buspirone|mesh-list
111216541|NCT04352686|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111216542|NCT04352686|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111216543|NCT04352686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111216544|NCT04352686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111216545|NCT04352686|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111216546|NCT04352686|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111216547|NCT04352686|Serotonin Agents|serotonin agents|mesh-ancestor
111216548|NCT04352686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111216549|NCT04352686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111216550|NCT03146091|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111216551|NCT03146091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111216552|NCT02287311|Cyclophosphamide|cyclophosphamide|mesh-list
111216553|NCT02287311|Fludarabine|fludarabine|mesh-list
111216554|NCT02287311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111216555|NCT02287311|Immunologic Factors|immunologic factors|mesh-ancestor
111216556|NCT02287311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111216557|NCT02287311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111216558|NCT02287311|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111216559|NCT02287311|Alkylating Agents|alkylating agents|mesh-ancestor
111216560|NCT02287311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111216561|NCT02287311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111216562|NCT02287311|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111216563|NCT02172742|Digoxin|digoxin|mesh-list
111216564|NCT02172742|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
111216565|NCT02172742|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111216566|NCT02172742|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111216567|NCT02172742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111216568|NCT02172742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111216569|NCT02172742|Protective Agents|protective agents|mesh-ancestor
111216570|NCT02172742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111216571|NCT02172742|Anticonvulsants|anticonvulsants|mesh-ancestor
111216572|NCT02172742|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111216573|NCT02172742|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111216574|NCT02172742|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111216575|NCT01075204|Clarithromycin|clarithromycin|mesh-list
111216576|NCT01075204|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110796009|NCT04491968|Methadone|methadone|mesh-list
111216577|NCT01075204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111216578|NCT01075204|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111216579|NCT01075204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111216580|NCT01075204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111216581|NCT01075204|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111216582|NCT01075204|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111216583|NCT01120834|Azacitidine|azacitidine|mesh-list
111216584|NCT01120834|Vorinostat|vorinostat|mesh-list
111216585|NCT01120834|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111216586|NCT01120834|Antimetabolites|antimetabolites|mesh-ancestor
111216587|NCT01120834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111216588|NCT01120834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111216589|NCT01120834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111216590|NCT01120834|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111216591|NCT01122160|Omeprazole|omeprazole|mesh-list
111216592|NCT01122160|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111216593|NCT01122160|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111216594|NCT01122160|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111216595|NCT01122160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111216596|NCT01122160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111216597|NCT02623816|Omeprazole|omeprazole|mesh-list
111216598|NCT02623816|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111216599|NCT02623816|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111216600|NCT02623816|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111216601|NCT02623816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111216602|NCT02623816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111216603|NCT01122238|Nicotine|nicotine|mesh-list
111216604|NCT01122238|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111216605|NCT01122238|Autonomic Agents|autonomic agents|mesh-ancestor
111216606|NCT01122238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111216607|NCT01122238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111216608|NCT01122238|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111216609|NCT01122238|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111216610|NCT01122238|Cholinergic Agents|cholinergic agents|mesh-ancestor
111216611|NCT01122238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111216612|NCT01122238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111216613|NCT01122316|Metformin|metformin|mesh-list
111216614|NCT01122316|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111216615|NCT01122316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111216616|NCT03049449|Cyclophosphamide|cyclophosphamide|mesh-list
111216617|NCT03049449|Fludarabine|fludarabine|mesh-list
111216618|NCT03049449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111216619|NCT03049449|Immunologic Factors|immunologic factors|mesh-ancestor
111216620|NCT03049449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111216621|NCT03049449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111216622|NCT03049449|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111216623|NCT03049449|Alkylating Agents|alkylating agents|mesh-ancestor
111216624|NCT03049449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111216625|NCT03049449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111216626|NCT03049449|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111216627|NCT03186729|Fibrinolytic Agents|fibrinolytic agents|mesh-list
111216628|NCT03186729|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111216629|NCT03186729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111216630|NCT02399943|Panitumumab|panitumumab|mesh-list
111216631|NCT02399943|Trametinib|trametinib|mesh-list
111216632|NCT02399943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111216633|NCT02399943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111216634|NCT02399943|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111216635|NCT02399943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111216636|NCT02399943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111216637|NCT03186027|Coenzyme Q10|coenzyme q10|mesh-list
111216638|NCT03186027|Ubiquinone|ubiquinone|mesh-list
111216639|NCT03186027|Vitamins|vitamins|mesh-ancestor
111216640|NCT03186027|Micronutrients|micronutrients|mesh-ancestor
111216641|NCT03186027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111216642|NCT04397913|Acetaminophen|acetaminophen|mesh-list
111216643|NCT04397913|Ibuprofen|ibuprofen|mesh-list
111216644|NCT04397913|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111216645|NCT04397913|Analgesics|analgesics|mesh-ancestor
111216646|NCT04397913|Sensory System Agents|sensory system agents|mesh-ancestor
111216647|NCT04397913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111216648|NCT04397913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111216649|NCT04397913|Antipyretics|antipyretics|mesh-ancestor
111216650|NCT04397913|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111216651|NCT04397913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111216652|NCT04397913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111216653|NCT04397913|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111216654|NCT04397913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111216655|NCT04397913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111216656|NCT02176486|Ixazomib|ixazomib|mesh-list
111216657|NCT02176486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111216658|NCT02176486|Protease Inhibitors|protease inhibitors|mesh-ancestor
111216659|NCT02176486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111216660|NCT02176486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111216661|NCT01124188|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
111216662|NCT01124188|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111216663|NCT01124188|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111216664|NCT01124188|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111216665|NCT01124188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111216666|NCT01124188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111216667|NCT01124188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111216668|NCT01124188|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111216669|NCT01124188|Antidepressive Agents|antidepressive agents|mesh-ancestor
111216670|NCT01124188|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111216671|NCT03013114|Bortezomib|bortezomib|mesh-list
111216672|NCT03013114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111216673|NCT01077310|Naltrexone|naltrexone|mesh-list
111216674|NCT01077310|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111216675|NCT01077310|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111216676|NCT01077310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111216677|NCT01077310|Sensory System Agents|sensory system agents|mesh-ancestor
111216678|NCT01077310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111216679|NCT02989857|Ivosidenib|ivosidenib|mesh-list
111216680|NCT02989857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111216681|NCT02989857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111216682|NCT02989857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111216683|NCT02393937|Metronidazole|metronidazole|mesh-list
111216684|NCT02393937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111216685|NCT02393937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111216686|NCT02393937|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111216687|NCT02393937|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111216688|NCT01877915|Rivaroxaban|rivaroxaban|mesh-list
111216689|NCT01877915|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111216690|NCT01877915|Antithrombins|antithrombins|mesh-ancestor
111216691|NCT01877915|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111216692|NCT01877915|Protease Inhibitors|protease inhibitors|mesh-ancestor
111216693|NCT01877915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111216694|NCT01877915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111216695|NCT01877915|Anticoagulants|anticoagulants|mesh-ancestor
111216696|NCT04397601|Bevacizumab|bevacizumab|mesh-list
111216697|NCT04397601|Aflibercept|aflibercept|mesh-list
111216698|NCT04397601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111216699|NCT04397601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111216700|NCT04397601|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111216701|NCT04397601|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111216702|NCT04397601|Growth Substances|growth substances|mesh-ancestor
111216703|NCT04397601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111216704|NCT04397601|Growth Inhibitors|growth inhibitors|mesh-ancestor
111216705|NCT02870829|Vitamin K 2|vitamin k 2|mesh-list
111216706|NCT02870829|Vitamin K|vitamin k|mesh-list
111216707|NCT02870829|Menaquinone 7|menaquinone 7|mesh-list
111216708|NCT02870829|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111216709|NCT02870829|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111216710|NCT02870829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111216711|NCT02870829|Hemostatics|hemostatics|mesh-ancestor
111216712|NCT02870829|Coagulants|coagulants|mesh-ancestor
111216713|NCT02870829|Vitamins|vitamins|mesh-ancestor
111216714|NCT02870829|Micronutrients|micronutrients|mesh-ancestor
111216715|NCT02870829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111216716|NCT01876823|Memantine|memantine|mesh-list
111216717|NCT01876823|Citalopram|citalopram|mesh-list
111216718|NCT01876823|Escitalopram|escitalopram|mesh-list
111216719|NCT01876823|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111216720|NCT01876823|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111216721|NCT01876823|Dopamine Agents|dopamine agents|mesh-ancestor
111216722|NCT01876823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111216723|NCT01876823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111216724|NCT01876823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111216725|NCT01876823|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111216726|NCT01876823|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111216727|NCT01876823|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111216728|NCT01876823|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111216729|NCT01876823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111216730|NCT01876823|Serotonin Agents|serotonin agents|mesh-ancestor
111216731|NCT01876823|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111216732|NCT01876823|Antidepressive Agents|antidepressive agents|mesh-ancestor
111216733|NCT01876823|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111216734|NCT01876511|Pembrolizumab|pembrolizumab|mesh-list
111216735|NCT01876511|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111216736|NCT01876511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111216737|NCT01876511|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111216738|NCT01876511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111216740|NCT01993719|Aldesleukin|aldesleukin|mesh-list
111216741|NCT01993719|Cyclophosphamide|cyclophosphamide|mesh-list
111216742|NCT01993719|Pembrolizumab|pembrolizumab|mesh-list
111216743|NCT01993719|Fludarabine|fludarabine|mesh-list
111216744|NCT01993719|Fludarabine phosphate|fludarabine phosphate|mesh-list
111216745|NCT01993719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111216746|NCT01993719|Immunologic Factors|immunologic factors|mesh-ancestor
111216747|NCT01993719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111216748|NCT01993719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111216749|NCT01993719|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111216750|NCT01993719|Alkylating Agents|alkylating agents|mesh-ancestor
111216751|NCT01993719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111216752|NCT01993719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111216753|NCT01993719|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111216754|NCT01993719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111216755|NCT01993719|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111216756|NCT01993719|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111216757|NCT01993719|Antimetabolites|antimetabolites|mesh-ancestor
111216758|NCT01993719|Antiviral Agents|antiviral agents|mesh-ancestor
111216759|NCT01993719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111216760|NCT01993719|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111216761|NCT01993719|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111216762|NCT02758665|Venetoclax|venetoclax|mesh-list
111216763|NCT02758665|Obinutuzumab|obinutuzumab|mesh-list
111216764|NCT02758665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111216765|NCT02758665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111216766|NCT03182673|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
111216767|NCT03182673|Fluzoparib|fluzoparib|mesh-list
111216768|NCT03182673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111216769|NCT03182673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111216770|NCT03182673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111216771|NCT00638157|Gentamicins|gentamicins|mesh-list
111216772|NCT00638157|Daptomycin|daptomycin|mesh-list
111216773|NCT00638157|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111216774|NCT00638157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111216775|NCT00638157|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111216776|NCT00638157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111216777|NCT00638157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111216778|NCT00637377|Ranibizumab|ranibizumab|mesh-list
111216779|NCT00637377|Aflibercept|aflibercept|mesh-list
111216780|NCT00637377|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111216781|NCT00637377|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111216782|NCT00637377|Growth Substances|growth substances|mesh-ancestor
111216783|NCT00637377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111216784|NCT00637377|Growth Inhibitors|growth inhibitors|mesh-ancestor
111216785|NCT00637377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111216786|NCT01475110|Imatinib Mesylate|imatinib mesylate|mesh-list
111216787|NCT01475110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110796232|NCT03842631|Timolol|timolol|mesh-list
111216788|NCT01475110|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111216789|NCT01475110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111216790|NCT01475110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111216791|NCT05307718|Anticoagulants|anticoagulants|mesh-list
111216792|NCT05307718|Factor Xa Inhibitors|factor xa inhibitors|mesh-list
111216793|NCT05307718|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
111216794|NCT05307718|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
111216795|NCT05307718|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-list
111216796|NCT05307718|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111216797|NCT05307718|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111216798|NCT05307718|Antimetabolites|antimetabolites|mesh-ancestor
111216799|NCT05307718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111216800|NCT05307718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111216801|NCT05307718|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111216802|NCT05307718|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111216803|NCT05307718|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111216804|NCT05307718|Purinergic Agents|purinergic agents|mesh-ancestor
111216805|NCT05307718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111216806|NCT05307718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111216807|NCT05307718|Antithrombins|antithrombins|mesh-ancestor
111216808|NCT05307718|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111216809|NCT05307718|Protease Inhibitors|protease inhibitors|mesh-ancestor
111216810|NCT01033864|Mycophenolic Acid|mycophenolic acid|mesh-list
111216811|NCT01033864|Prednisone|prednisone|mesh-list
111216812|NCT01033864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111216813|NCT01033864|Glucocorticoids|glucocorticoids|mesh-ancestor
111216814|NCT01033864|Hormones|hormones|mesh-ancestor
111216815|NCT01033864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111216816|NCT01033864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111216817|NCT01033864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111216818|NCT01033864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111216819|NCT01033864|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111216820|NCT01033864|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111216821|NCT01033864|Antitubercular Agents|antitubercular agents|mesh-ancestor
111216822|NCT01033864|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111216823|NCT01033864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111216824|NCT01033864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111216825|NCT01033864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111216826|NCT01082380|Crizotinib|crizotinib|mesh-list
111216827|NCT01082380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111216828|NCT01082380|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111216829|NCT01082380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111216830|NCT01082380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111216831|NCT01083706|Azacitidine|azacitidine|mesh-list
111216832|NCT01083706|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111216833|NCT01083706|Antimetabolites|antimetabolites|mesh-ancestor
111216834|NCT01083706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111216835|NCT01083706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111216836|NCT01083706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111216837|NCT01035346|Ibuprofen|ibuprofen|mesh-list
111216838|NCT01035346|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111216839|NCT01035346|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111216840|NCT01035346|Analgesics|analgesics|mesh-ancestor
111216841|NCT01035346|Sensory System Agents|sensory system agents|mesh-ancestor
111216842|NCT01035346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111216843|NCT01035346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111216844|NCT01035346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111216845|NCT01035346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111216846|NCT01035346|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111216847|NCT01035346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111216848|NCT01035346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111216849|NCT01085344|Factor VIII|factor viii|mesh-list
111216850|NCT01085344|Coagulants|coagulants|mesh-ancestor
111216851|NCT01035658|Doxorubicin|doxorubicin|mesh-list
111216852|NCT01035658|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111216853|NCT01035658|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111216854|NCT01035658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111216855|NCT01035658|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111216856|NCT01035658|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111216857|NCT01035658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111216858|NCT01035658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111216859|NCT01037452|Calcium, Dietary|calcium, dietary|mesh-list
111216860|NCT01037452|Lansoprazole|lansoprazole|mesh-list
111216861|NCT01037452|Dexlansoprazole|dexlansoprazole|mesh-list
111216862|NCT01037452|Calcium Carbonate|calcium carbonate|mesh-list
111216863|NCT01037452|Magnesium Hydroxide|magnesium hydroxide|mesh-list
111216864|NCT01037452|Calcium|calcium|mesh-list
111216865|NCT01037452|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111216866|NCT01037452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111216867|NCT01037452|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111216868|NCT01037452|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111216869|NCT01037452|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111216870|NCT01037452|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111216871|NCT01037452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111216872|NCT01037452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111216873|NCT01037452|Antacids|antacids|mesh-ancestor
111216874|NCT03012646|Treprostinil|treprostinil|mesh-list
111216875|NCT03012646|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111216876|NCT05289856|Avelumab|avelumab|mesh-list
111216877|NCT05289856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111216878|NCT05289856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111216879|NCT00636441|Cyclophosphamide|cyclophosphamide|mesh-list
111216880|NCT00636441|Docetaxel|docetaxel|mesh-list
111216881|NCT00636441|Doxorubicin|doxorubicin|mesh-list
111216882|NCT00636441|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111216883|NCT00636441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111216884|NCT00636441|Immunologic Factors|immunologic factors|mesh-ancestor
111216885|NCT00636441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111216886|NCT00636441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111216887|NCT00636441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111216888|NCT00636441|Alkylating Agents|alkylating agents|mesh-ancestor
111216889|NCT00636441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111216890|NCT00636441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111216891|NCT00636441|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111216892|NCT00636441|Tubulin Modulators|tubulin modulators|mesh-ancestor
111216893|NCT00636441|Antimitotic Agents|antimitotic agents|mesh-ancestor
111216894|NCT00636441|Mitosis Modulators|mitosis modulators|mesh-ancestor
111216895|NCT00636441|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111216896|NCT00636441|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111216897|NCT00636441|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111216898|NCT00636441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111216899|NCT00636363|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111216900|NCT02984397|Ketotifen|ketotifen|mesh-list
111216901|NCT02984397|Antipruritics|antipruritics|mesh-ancestor
111216902|NCT02984397|Dermatologic Agents|dermatologic agents|mesh-ancestor
111216903|NCT02984397|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111216904|NCT02984397|Histamine Antagonists|histamine antagonists|mesh-ancestor
111216905|NCT02984397|Histamine Agents|histamine agents|mesh-ancestor
111216906|NCT02984397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111216907|NCT02984397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111216908|NCT02984397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111216909|NCT02984397|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111216910|NCT01922427|RNS60|rns60|mesh-list
111216911|NCT01922427|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111216912|NCT01922427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111216913|NCT01922427|Analgesics|analgesics|mesh-ancestor
111216914|NCT01922427|Sensory System Agents|sensory system agents|mesh-ancestor
111216915|NCT01922427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111216916|NCT01922427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111216917|NCT01922427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111216918|NCT01922427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111216919|NCT01922427|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111216920|NCT01088464|Necitumumab|necitumumab|mesh-list
111216921|NCT01088464|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111216922|NCT01088464|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111216923|NCT01088464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111216924|NCT01088464|Immunologic Factors|immunologic factors|mesh-ancestor
111216925|NCT01088464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111216926|NCT01090180|Dexamethasone|dexamethasone|mesh-list
111216927|NCT01090180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111216928|NCT01090180|Antiemetics|antiemetics|mesh-ancestor
111216929|NCT01090180|Autonomic Agents|autonomic agents|mesh-ancestor
111216930|NCT01090180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111216931|NCT01090180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111216932|NCT01090180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111216933|NCT01090180|Glucocorticoids|glucocorticoids|mesh-ancestor
111216934|NCT01090180|Hormones|hormones|mesh-ancestor
111216935|NCT01090180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111216936|NCT01090180|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111216937|NCT01090180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111216938|NCT00636207|Montelukast|montelukast|mesh-list
111216939|NCT00636207|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111216940|NCT00636207|Respiratory System Agents|respiratory system agents|mesh-ancestor
111216941|NCT00636207|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
111216942|NCT00636207|Hormone Antagonists|hormone antagonists|mesh-ancestor
111216943|NCT00636207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111216944|NCT00636207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111216945|NCT00636207|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
111216946|NCT00636207|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111216947|NCT00636207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111216948|NCT01091116|(4-amino-5-(4-(4-(2,4-dichloro-3-(2,4-dimethyl-8-quinolyloxymethyl)phenylsulfonamido)tetrahydro-2H-4-pyranoylcarbonyl)piperazino)-5-oxopentyl)(trimethyl)ammonium|(4-amino-5-(4-(4-(2,4-dichloro-3-(2,4-dimethyl-8-quinolyloxymethyl)phenylsulfonamido)tetrahydro-2h-4-pyranoylcarbonyl)piperazino)-5-oxopentyl)(trimethyl)ammonium|mesh-list
111216949|NCT01091116|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
111216950|NCT01091116|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
111216951|NCT01091116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111216952|NCT01091116|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
111216953|NCT01091116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111216954|NCT01091116|Immunologic Factors|immunologic factors|mesh-ancestor
111216955|NCT01091116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111216956|NCT03169881|Darbepoetin alfa|darbepoetin alfa|mesh-list
111216957|NCT03169881|Hematinics|hematinics|mesh-ancestor
111216958|NCT01092676|Ibuprofen|ibuprofen|mesh-list
111216959|NCT01092676|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111216960|NCT01092676|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111216961|NCT01092676|Analgesics|analgesics|mesh-ancestor
111216962|NCT01092676|Sensory System Agents|sensory system agents|mesh-ancestor
111216963|NCT01092676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111216964|NCT01092676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111216965|NCT01092676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111216966|NCT01092676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111216967|NCT01092676|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111216968|NCT01092676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111216969|NCT01092676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111216970|NCT05273320|Dronabinol|dronabinol|mesh-list
111216971|NCT05273320|Nabilone|nabilone|mesh-list
111216972|NCT05273320|Antiemetics|antiemetics|mesh-ancestor
111216973|NCT05273320|Autonomic Agents|autonomic agents|mesh-ancestor
111216974|NCT05273320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111216975|NCT05273320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111216976|NCT05273320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111216977|NCT05273320|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111216978|NCT05273320|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111216979|NCT05273320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111216980|NCT05273320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111216981|NCT05273320|Hallucinogens|hallucinogens|mesh-ancestor
111216982|NCT05273320|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111216983|NCT05273320|Analgesics|analgesics|mesh-ancestor
111216984|NCT05273320|Sensory System Agents|sensory system agents|mesh-ancestor
111216985|NCT05273320|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
111216986|NCT05273320|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
111216987|NCT05273320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111216988|NCT05273320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111216989|NCT05273320|Hormones|hormones|mesh-ancestor
111216990|NCT05273320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111216991|NCT01039792|Vitamin B 12|vitamin b 12|mesh-list
111216992|NCT01039792|Vitamins|vitamins|mesh-ancestor
111216993|NCT01039792|Micronutrients|micronutrients|mesh-ancestor
111216994|NCT01039792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111216995|NCT01039792|Vitamin B Complex|vitamin b complex|mesh-ancestor
111216996|NCT01041274|Citalopram|citalopram|mesh-list
111216997|NCT01041274|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111216998|NCT01041274|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111216999|NCT01041274|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111217000|NCT01041274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111217001|NCT01041274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111217002|NCT01041274|Serotonin Agents|serotonin agents|mesh-ancestor
111217003|NCT01041274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111217004|NCT01041274|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111217005|NCT01041274|Antidepressive Agents|antidepressive agents|mesh-ancestor
111217006|NCT01041274|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111217007|NCT00635349|Acetaminophen|acetaminophen|mesh-list
111217008|NCT00635349|Meloxicam|meloxicam|mesh-list
111217009|NCT00635349|Aceclofenac|aceclofenac|mesh-list
111217010|NCT00635349|Tramadol|tramadol|mesh-list
111217011|NCT00635349|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111217012|NCT00635349|Analgesics|analgesics|mesh-ancestor
111217013|NCT00635349|Sensory System Agents|sensory system agents|mesh-ancestor
111217014|NCT00635349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111217015|NCT00635349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111217016|NCT00635349|Antipyretics|antipyretics|mesh-ancestor
111217017|NCT00635349|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111217018|NCT00635349|Narcotics|narcotics|mesh-ancestor
111217019|NCT00635349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111217020|NCT00635349|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111217021|NCT00635349|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111217022|NCT00635349|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110669950|NCT04468776|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111217023|NCT00635349|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111217024|NCT00635349|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111217025|NCT00635349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111217026|NCT00635349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111217027|NCT00634803|Buprenorphine|buprenorphine|mesh-list
111217028|NCT00634803|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111217029|NCT00634803|Narcotics|narcotics|mesh-ancestor
111217030|NCT00634803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111217031|NCT00634803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111217032|NCT00634803|Analgesics|analgesics|mesh-ancestor
111217033|NCT00634803|Sensory System Agents|sensory system agents|mesh-ancestor
111217034|NCT00634803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111217035|NCT00634803|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111217036|NCT01042288|Carboplatin|carboplatin|mesh-list
111217037|NCT01042288|Pemetrexed|pemetrexed|mesh-list
111217038|NCT01042288|Panitumumab|panitumumab|mesh-list
111217039|NCT01042288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111217040|NCT01042288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111217041|NCT01042288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111217042|NCT01042288|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111217043|NCT01042288|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111217044|NCT01042288|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111217045|NCT01043926|Suvorexant|suvorexant|mesh-list
111217046|NCT01043926|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111217047|NCT01043926|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111217048|NCT01043926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111217049|NCT01043926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111217050|NCT01043926|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
111217051|NCT01043926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111217052|NCT01043926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111217053|NCT01044706|Bicalutamide|bicalutamide|mesh-list
111217054|NCT01044706|Androgen Antagonists|androgen antagonists|mesh-ancestor
111217055|NCT01044706|Hormone Antagonists|hormone antagonists|mesh-ancestor
111217056|NCT01044706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111217057|NCT01044706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111217058|NCT01044706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111217059|NCT04447534|Hydroxychloroquine|hydroxychloroquine|mesh-list
111217060|NCT04447534|Chloroquine|chloroquine|mesh-list
111217061|NCT04447534|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
111217062|NCT04447534|Antimalarials|antimalarials|mesh-ancestor
111217063|NCT04447534|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111217064|NCT04447534|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111217065|NCT04447534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111217066|NCT04447534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111217067|NCT04447534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111217068|NCT04447534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111217069|NCT04447534|Amebicides|amebicides|mesh-ancestor
111217070|NCT04447534|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111217071|NCT04447534|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111217072|NCT04447534|Analgesics|analgesics|mesh-ancestor
111217073|NCT04447534|Sensory System Agents|sensory system agents|mesh-ancestor
111217074|NCT04447534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111217075|NCT04447534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111217076|NCT04447534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111217077|NCT04447534|Filaricides|filaricides|mesh-ancestor
111217078|NCT04447534|Antinematodal Agents|antinematodal agents|mesh-ancestor
111217079|NCT04447534|Anthelmintics|anthelmintics|mesh-ancestor
111217080|NCT01044862|Letrozole|letrozole|mesh-list
111217081|NCT01044862|Clomiphene|clomiphene|mesh-list
111217082|NCT01044862|Enclomiphene|enclomiphene|mesh-list
111217083|NCT01044862|Zuclomiphene|zuclomiphene|mesh-list
111217084|NCT01044862|Hormones|hormones|mesh-list
111217085|NCT01044862|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
111217086|NCT01044862|Aromatase Inhibitors|aromatase inhibitors|mesh-list
111217087|NCT01044862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111217088|NCT01044862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111217089|NCT01044862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111217090|NCT01044862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111217091|NCT01044862|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111217092|NCT01044862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111217093|NCT01044862|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111217094|NCT01044862|Hormone Antagonists|hormone antagonists|mesh-ancestor
111217095|NCT01044862|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111217096|NCT01044862|Fertility Agents|fertility agents|mesh-ancestor
111217097|NCT01044862|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111217098|NCT01044862|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111217099|NCT01044862|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111217100|NCT04361656|Lubiprostone|lubiprostone|mesh-list
111217101|NCT04361656|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
111217102|NCT04361656|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111217103|NCT04361656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111217104|NCT01047358|Exemestane|exemestane|mesh-list
111217105|NCT01047358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111217106|NCT01047358|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111217107|NCT01047358|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111217108|NCT01047358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111217109|NCT01047358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111217110|NCT01047358|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111217111|NCT01047358|Hormone Antagonists|hormone antagonists|mesh-ancestor
111217112|NCT01047358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111217113|NCT01047358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111217114|NCT01048606|Phytoestrogens|phytoestrogens|mesh-list
111217115|NCT01048606|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
111217116|NCT01048606|Estrogens|estrogens|mesh-ancestor
111217117|NCT01048606|Hormones|hormones|mesh-ancestor
111217118|NCT01048606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111217119|NCT01048606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111217120|NCT04224766|Bupivacaine|bupivacaine|mesh-list
111217121|NCT04224766|Anesthetics, Local|anesthetics, local|mesh-ancestor
111217122|NCT04224766|Anesthetics|anesthetics|mesh-ancestor
111217123|NCT04224766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110796593|NCT03310970|Anesthetics|anesthetics|mesh-ancestor
111217124|NCT04224766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111217125|NCT04224766|Sensory System Agents|sensory system agents|mesh-ancestor
111217126|NCT04224766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111217127|NCT01772004|Avelumab|avelumab|mesh-list
111217128|NCT01772004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111217129|NCT01772004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111217130|NCT02930044|Insulin|insulin|mesh-list
111217131|NCT02930044|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111217132|NCT02930044|Insulin Glargine|insulin glargine|mesh-list
111217133|NCT02930044|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111217134|NCT02930044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111217135|NCT03683524|Dolutegravir|dolutegravir|mesh-list
111217136|NCT03683524|Darunavir|darunavir|mesh-list
111217137|NCT03683524|Cobicistat|cobicistat|mesh-list
111217138|NCT03683524|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
111217139|NCT03683524|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111217140|NCT03683524|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111217141|NCT03683524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111217142|NCT03683524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111217143|NCT03683524|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111217144|NCT03683524|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111217145|NCT03683524|Antiviral Agents|antiviral agents|mesh-ancestor
111217146|NCT03683524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111217147|NCT03683524|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111217148|NCT03683524|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111217149|NCT03683524|Protease Inhibitors|protease inhibitors|mesh-ancestor
111217150|NCT03683524|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111217151|NCT03683524|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111217152|NCT02246842|Immunoglobulins|immunoglobulins|mesh-list
111217153|NCT02246842|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111217154|NCT02246842|Antibodies|antibodies|mesh-list
111217155|NCT02246842|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
111217156|NCT02246842|gamma-Globulins|gamma-globulins|mesh-list
111217157|NCT02246842|Immunologic Factors|immunologic factors|mesh-ancestor
111217158|NCT02246842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111217159|NCT02182492|Clarithromycin|clarithromycin|mesh-list
111217160|NCT02182492|Glucocorticoids|glucocorticoids|mesh-list
111217161|NCT02182492|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111217162|NCT02182492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111217163|NCT02182492|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111217164|NCT02182492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111217165|NCT02182492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111217166|NCT02182492|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111217167|NCT02182492|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111217168|NCT02182492|Hormones|hormones|mesh-ancestor
111217169|NCT02182492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111217170|NCT02182492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110670108|NCT04118387|GABA Agonists|gaba agonists|mesh-ancestor
111217172|NCT01163656|Trace Elements|trace elements|mesh-ancestor
111217173|NCT01163656|Micronutrients|micronutrients|mesh-ancestor
111217174|NCT01163656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111217175|NCT01165840|Dapsone|dapsone|mesh-list
111217176|NCT01165840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111217177|NCT01165840|Antimalarials|antimalarials|mesh-ancestor
111217178|NCT01165840|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111217179|NCT01165840|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111217180|NCT01165840|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111217181|NCT01165840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111217182|NCT01165840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111217183|NCT01165840|Leprostatic Agents|leprostatic agents|mesh-ancestor
111217184|NCT01165840|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111217185|NCT00952692|Lapatinib|lapatinib|mesh-list
111217186|NCT00952692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111217187|NCT00952692|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111217188|NCT00952692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111217189|NCT00952692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111217190|NCT03535506|Palbociclib|palbociclib|mesh-list
111217191|NCT03535506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111217192|NCT03535506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111217193|NCT03535506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111217194|NCT03535506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111217195|NCT01170754|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
111217196|NCT01170754|Laxatives|laxatives|mesh-ancestor
111217197|NCT01170754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111217198|NCT01378104|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
111217199|NCT01378104|Interferon-alpha|interferon-alpha|mesh-list
111217200|NCT01378104|Antiviral Agents|antiviral agents|mesh-ancestor
111217201|NCT01378104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111217202|NCT01378104|Immunologic Factors|immunologic factors|mesh-ancestor
111217203|NCT01378104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111217204|NCT01131052|Insulin|insulin|mesh-list
111217205|NCT01131052|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111217206|NCT01131052|Insulin Glargine|insulin glargine|mesh-list
111217207|NCT01131052|Insulin glulisine|insulin glulisine|mesh-list
111217208|NCT01131052|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111217209|NCT01131052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111217210|NCT01379274|Lenalidomide|lenalidomide|mesh-list
111217211|NCT01379274|Azacitidine|azacitidine|mesh-list
111217212|NCT01379274|Immunologic Factors|immunologic factors|mesh-ancestor
111217213|NCT01379274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111217214|NCT01379274|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111217215|NCT01379274|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111217216|NCT01379274|Growth Substances|growth substances|mesh-ancestor
111217217|NCT01379274|Growth Inhibitors|growth inhibitors|mesh-ancestor
111217218|NCT01379274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111217219|NCT01379274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111217220|NCT01379274|Antimetabolites|antimetabolites|mesh-ancestor
111217221|NCT01379274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111217222|NCT01379274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111217223|NCT01171690|Teriparatide|teriparatide|mesh-list
111217224|NCT01171690|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111217225|NCT01171690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111217226|NCT01171690|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111217227|NCT05396742|Ravulizumab|ravulizumab|mesh-list
111217228|NCT05396742|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
111217229|NCT05396742|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111217230|NCT05396742|Immunologic Factors|immunologic factors|mesh-ancestor
111217231|NCT05396742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111217232|NCT05389176|Esmolol|esmolol|mesh-list
111217233|NCT05389176|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
111217234|NCT05389176|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111217235|NCT05389176|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111217236|NCT05389176|Adrenergic Agents|adrenergic agents|mesh-ancestor
111217237|NCT05389176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111217238|NCT05389176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111217239|NCT05389176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111217240|NCT01132846|Dopamine|dopamine|mesh-list
111217241|NCT01132846|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
111217242|NCT01132846|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111217243|NCT01132846|Sympathomimetics|sympathomimetics|mesh-ancestor
111217244|NCT01132846|Autonomic Agents|autonomic agents|mesh-ancestor
111217245|NCT01132846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110670244|NCT03685773|Niacin|niacin|mesh-list
111217246|NCT01132846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111217247|NCT01132846|Dopamine Agents|dopamine agents|mesh-ancestor
111217248|NCT01132846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111217249|NCT01132846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111217250|NCT01132846|Protective Agents|protective agents|mesh-ancestor
111217251|NCT01132846|Natriuretic Agents|natriuretic agents|mesh-ancestor
111217253|NCT01133158|Rituximab|rituximab|mesh-list
111217254|NCT01133158|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
111217255|NCT01133158|Mitoxantrone|mitoxantrone|mesh-list
111217256|NCT01133158|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111217257|NCT01133158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111217258|NCT01133158|Immunologic Factors|immunologic factors|mesh-ancestor
111217259|NCT01133158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111217260|NCT01133158|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111217261|NCT01133158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111217262|NCT01133158|Antiemetics|antiemetics|mesh-ancestor
111217263|NCT01133158|Autonomic Agents|autonomic agents|mesh-ancestor
111217264|NCT01133158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111217265|NCT01133158|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111217266|NCT01133158|Glucocorticoids|glucocorticoids|mesh-ancestor
111217267|NCT01133158|Hormones|hormones|mesh-ancestor
111217268|NCT01133158|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111217269|NCT01133158|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111217270|NCT01133158|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111217271|NCT01133158|Alkylating Agents|alkylating agents|mesh-ancestor
111217272|NCT01133158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111217273|NCT01133158|Analgesics|analgesics|mesh-ancestor
111217274|NCT01133158|Sensory System Agents|sensory system agents|mesh-ancestor
111217275|NCT01133158|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111217276|NCT01133158|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111217277|NCT01133158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111217278|NCT05396118|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
111217279|NCT05396118|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111217280|NCT05396118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111217281|NCT04092894|Suvorexant|suvorexant|mesh-list
111217282|NCT04092894|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111217283|NCT04092894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111217284|NCT04092894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111217285|NCT04092894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111217286|NCT04092894|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
111217287|NCT04092894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111217288|NCT04092894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111217289|NCT01134952|Mycophenolic Acid|mycophenolic acid|mesh-list
111217290|NCT01134952|Sirolimus|sirolimus|mesh-list
111217291|NCT01134952|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111217292|NCT01134952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111217293|NCT01134952|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111217294|NCT01134952|Antitubercular Agents|antitubercular agents|mesh-ancestor
111217295|NCT01134952|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111217296|NCT01134952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111217297|NCT01134952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111217298|NCT01134952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111217299|NCT01134952|Antifungal Agents|antifungal agents|mesh-ancestor
111217300|NCT01134952|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111217301|NCT01134952|Immunologic Factors|immunologic factors|mesh-ancestor
111217302|NCT01134952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111217303|NCT01175902|Timolol|timolol|mesh-list
111217304|NCT01175902|Dorzolamide|dorzolamide|mesh-list
111217305|NCT01175902|Latanoprost|latanoprost|mesh-list
111217306|NCT01175902|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111217307|NCT01175902|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111217308|NCT01175902|Adrenergic Agents|adrenergic agents|mesh-ancestor
111217309|NCT01175902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111217310|NCT01175902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111217311|NCT01175902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111217312|NCT01175902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111217313|NCT01175902|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111217314|NCT01175902|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
111217315|NCT01175902|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111217316|NCT01175902|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
111217317|NCT01175902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111217318|NCT01135186|Verapamil|verapamil|mesh-list
111217319|NCT01135186|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111217320|NCT01135186|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111217321|NCT01135186|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111217322|NCT01135186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111217323|NCT01135186|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111217324|NCT01135186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111217325|NCT01135186|Vasodilator Agents|vasodilator agents|mesh-ancestor
111217326|NCT05376228|Vancomycin|vancomycin|mesh-list
111217327|NCT05376228|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111217328|NCT05376228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111217329|NCT05164848|Afatinib|afatinib|mesh-list
111217330|NCT05164848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111217331|NCT05164848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111217332|NCT05164848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111217333|NCT05164848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111217334|NCT05164770|Prednisone|prednisone|mesh-list
111217335|NCT05164770|Zanubrutinib|zanubrutinib|mesh-list
111217336|NCT05164770|Cyclophosphamide|cyclophosphamide|mesh-list
111217337|NCT05164770|Vincristine|vincristine|mesh-list
111217338|NCT05164770|Rituximab|rituximab|mesh-list
111217339|NCT05164770|Doxorubicin|doxorubicin|mesh-list
111217340|NCT05164770|Etoposide|etoposide|mesh-list
111217341|NCT05164770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111217342|NCT05164770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111217343|NCT05164770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111217344|NCT05164770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111217345|NCT05164770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111217346|NCT05164770|Immunologic Factors|immunologic factors|mesh-ancestor
111217347|NCT05164770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111217348|NCT05164770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111217349|NCT05164770|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111217350|NCT05164770|Alkylating Agents|alkylating agents|mesh-ancestor
111217351|NCT05164770|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111217352|NCT05164770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111217353|NCT05164770|Glucocorticoids|glucocorticoids|mesh-ancestor
111217354|NCT05164770|Hormones|hormones|mesh-ancestor
111217355|NCT05164770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111217356|NCT05164770|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111217357|NCT05164770|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111217358|NCT05164770|Tubulin Modulators|tubulin modulators|mesh-ancestor
111217359|NCT05164770|Antimitotic Agents|antimitotic agents|mesh-ancestor
111217360|NCT05164770|Mitosis Modulators|mitosis modulators|mesh-ancestor
111217361|NCT05164770|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111217362|NCT05164770|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111217363|NCT05164770|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111217364|NCT05164770|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111217365|NCT00634569|gamma-Globulins|gamma-globulins|mesh-list
111217366|NCT00634569|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111217367|NCT00634569|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
111217368|NCT00634569|Immunologic Factors|immunologic factors|mesh-ancestor
111217369|NCT00634569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111217370|NCT01175980|Vorinostat|vorinostat|mesh-list
111217371|NCT01175980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111217372|NCT01175980|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111217373|NCT01175980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111217374|NCT01175980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111217375|NCT04246554|Acetaminophen|acetaminophen|mesh-list
111217376|NCT04246554|Ketorolac|ketorolac|mesh-list
111217377|NCT04246554|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
111217378|NCT04246554|Oxycodone|oxycodone|mesh-list
111217379|NCT04246554|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111217380|NCT04246554|Analgesics|analgesics|mesh-ancestor
111217381|NCT04246554|Sensory System Agents|sensory system agents|mesh-ancestor
111217382|NCT04246554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111217383|NCT04246554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111217384|NCT04246554|Antipyretics|antipyretics|mesh-ancestor
111217385|NCT04246554|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111217386|NCT04246554|Narcotics|narcotics|mesh-ancestor
111217387|NCT04246554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111217388|NCT04246554|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111217389|NCT04246554|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111217390|NCT04246554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111217391|NCT04246554|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111217392|NCT04246554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111217393|NCT04246554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110670380|NCT03039413|Copper|copper|mesh-list
111217394|NCT01922817|Saxagliptin|saxagliptin|mesh-list
111217395|NCT01922817|Incretins|incretins|mesh-ancestor
111217396|NCT01922817|Hormones|hormones|mesh-ancestor
111217397|NCT01922817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111217398|NCT01922817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111217399|NCT01922817|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111217400|NCT01922817|Protease Inhibitors|protease inhibitors|mesh-ancestor
111217401|NCT01922817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111217402|NCT01922817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111217403|NCT01922817|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111217404|NCT04397289|Heparin|heparin|mesh-list
111217405|NCT04397289|Rivaroxaban|rivaroxaban|mesh-list
111217406|NCT04397289|Anticoagulants|anticoagulants|mesh-ancestor
111217407|NCT04397289|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111217408|NCT04397289|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111217409|NCT04397289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111217410|NCT04397289|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111217411|NCT04397289|Antithrombins|antithrombins|mesh-ancestor
111217412|NCT04397289|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111217413|NCT04397289|Protease Inhibitors|protease inhibitors|mesh-ancestor
111217414|NCT04397289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111217415|NCT00634179|Prednisone|prednisone|mesh-list
111217416|NCT00634179|Cyclophosphamide|cyclophosphamide|mesh-list
111217417|NCT00634179|Rituximab|rituximab|mesh-list
111217418|NCT00634179|Doxorubicin|doxorubicin|mesh-list
111217419|NCT00634179|Vincristine|vincristine|mesh-list
111217420|NCT00634179|Bortezomib|bortezomib|mesh-list
111217421|NCT00634179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111217422|NCT00634179|Immunologic Factors|immunologic factors|mesh-ancestor
111217423|NCT00634179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111217424|NCT00634179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111217425|NCT00634179|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111217426|NCT00634179|Alkylating Agents|alkylating agents|mesh-ancestor
111217427|NCT00634179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111217428|NCT00634179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111217429|NCT00634179|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111217430|NCT00634179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111217431|NCT00634179|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111217432|NCT00634179|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111217433|NCT00634179|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111217434|NCT00634179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111217435|NCT00634179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111217436|NCT00634179|Glucocorticoids|glucocorticoids|mesh-ancestor
111217437|NCT00634179|Hormones|hormones|mesh-ancestor
111217438|NCT00634179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111217439|NCT00634179|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111217440|NCT00634179|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111217441|NCT00634179|Tubulin Modulators|tubulin modulators|mesh-ancestor
111217442|NCT00634179|Antimitotic Agents|antimitotic agents|mesh-ancestor
111217443|NCT00634179|Mitosis Modulators|mitosis modulators|mesh-ancestor
111217444|NCT01178944|Oxaliplatin|oxaliplatin|mesh-list
111217445|NCT01178944|10-deazaaminopterin|10-deazaaminopterin|mesh-list
111217446|NCT01178944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111217447|NCT01178944|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111217448|NCT01178944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111217449|NCT01178944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111217450|NCT01179490|Prednisolone|prednisolone|mesh-list
111217451|NCT01179490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111217452|NCT01179490|Glucocorticoids|glucocorticoids|mesh-ancestor
111217453|NCT01179490|Hormones|hormones|mesh-ancestor
111217454|NCT01179490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111217455|NCT01179490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111217456|NCT01179490|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111217457|NCT01179490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111217458|NCT01179568|Citalopram|citalopram|mesh-list
111217459|NCT01179568|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111217460|NCT01179568|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111217461|NCT01179568|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111217462|NCT01179568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111217463|NCT01179568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111217464|NCT01179568|Serotonin Agents|serotonin agents|mesh-ancestor
111217465|NCT01179568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111217466|NCT01179568|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111217467|NCT01179568|Antidepressive Agents|antidepressive agents|mesh-ancestor
111217468|NCT01179568|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111217469|NCT01180036|Cyclosporine|cyclosporine|mesh-list
111217471|NCT01180036|Cyclosporins|cyclosporins|mesh-list
111217472|NCT01180036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111217473|NCT01180036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111217474|NCT01180036|Immunologic Factors|immunologic factors|mesh-ancestor
111217475|NCT01180036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111217476|NCT01180036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111217477|NCT01180036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111217478|NCT01180036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111217479|NCT01180036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111217480|NCT01180036|Antifungal Agents|antifungal agents|mesh-ancestor
111217481|NCT01180036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111217482|NCT01180036|Dermatologic Agents|dermatologic agents|mesh-ancestor
111217483|NCT01180036|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111217484|NCT01180894|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
111217485|NCT01180894|Hematinics|hematinics|mesh-ancestor
111217486|NCT01181674|Insulin|insulin|mesh-list
111217487|NCT01181674|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111217488|NCT01181674|Metformin|metformin|mesh-list
111217489|NCT01181674|Insulin Glargine|insulin glargine|mesh-list
111217490|NCT01181674|Acarbose|acarbose|mesh-list
111217491|NCT01181674|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111217492|NCT01181674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111217493|NCT01181674|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
111217494|NCT01181674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111217495|NCT01181674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111217496|NCT01182376|Dronedarone|dronedarone|mesh-list
111217497|NCT01182376|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111217498|NCT01183312|Flumazenil|flumazenil|mesh-list
111217499|NCT01183312|Antidotes|antidotes|mesh-ancestor
111217500|NCT01183312|Protective Agents|protective agents|mesh-ancestor
111217501|NCT01183312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111217502|NCT01183312|GABA Modulators|gaba modulators|mesh-ancestor
111217503|NCT01183312|GABA Agents|gaba agents|mesh-ancestor
111217504|NCT01183312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111217505|NCT01183312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111217506|NCT03188172|Dexamethasone|dexamethasone|mesh-list
111217507|NCT03188172|Cyclophosphamide|cyclophosphamide|mesh-list
111217508|NCT03188172|Melphalan|melphalan|mesh-list
111217509|NCT03188172|Lenalidomide|lenalidomide|mesh-list
111217510|NCT03188172|Bortezomib|bortezomib|mesh-list
111217511|NCT03188172|Daratumumab|daratumumab|mesh-list
111217512|NCT03188172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111217513|NCT03188172|Immunologic Factors|immunologic factors|mesh-ancestor
111217514|NCT03188172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111217515|NCT03188172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111217516|NCT03188172|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111217517|NCT03188172|Alkylating Agents|alkylating agents|mesh-ancestor
111217518|NCT03188172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111217519|NCT03188172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111217520|NCT03188172|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111217521|NCT03188172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111217522|NCT03188172|Antiemetics|antiemetics|mesh-ancestor
111217523|NCT03188172|Autonomic Agents|autonomic agents|mesh-ancestor
111217524|NCT03188172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111217525|NCT03188172|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111217526|NCT03188172|Glucocorticoids|glucocorticoids|mesh-ancestor
111217527|NCT03188172|Hormones|hormones|mesh-ancestor
111217528|NCT03188172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111217529|NCT03188172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111217530|NCT03188172|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111217531|NCT03188172|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111217532|NCT03188172|Growth Substances|growth substances|mesh-ancestor
111217533|NCT03188172|Growth Inhibitors|growth inhibitors|mesh-ancestor
111217534|NCT01184014|Insulin|insulin|mesh-list
111217535|NCT01184014|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111217536|NCT01184014|Insulin Glargine|insulin glargine|mesh-list
111217537|NCT01184014|Insulin Lispro|insulin lispro|mesh-list
111217538|NCT01184014|Insulin, Isophane|insulin, isophane|mesh-list
111217539|NCT01184014|Isophane Insulin, Human|isophane insulin, human|mesh-list
111217540|NCT01184014|Isophane insulin, beef|isophane insulin, beef|mesh-list
111217541|NCT01184014|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111217542|NCT01184014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111217543|NCT01185028|Interferons|interferons|mesh-list
111217544|NCT01185028|Ribavirin|ribavirin|mesh-list
111217545|NCT01185028|Nitazoxanide|nitazoxanide|mesh-list
111217546|NCT01185028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111217547|NCT01185028|Antiviral Agents|antiviral agents|mesh-ancestor
111217548|NCT01185028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111217549|NCT01185028|Antimetabolites|antimetabolites|mesh-ancestor
111217550|NCT01185028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111217551|NCT01185028|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111217552|NCT02187016|Listerine|listerine|mesh-list
111217553|NCT02187016|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111217554|NCT02187016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111217555|NCT05439798|Dexamethasone|dexamethasone|mesh-list
111217556|NCT05439798|Dexamethasone acetate|dexamethasone acetate|mesh-list
111217557|NCT05439798|Ondansetron|ondansetron|mesh-list
111217558|NCT05439798|Palonosetron|palonosetron|mesh-list
111217559|NCT05439798|BB 1101|bb 1101|mesh-list
111217560|NCT05439798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111217561|NCT05439798|Antiemetics|antiemetics|mesh-ancestor
111217562|NCT05439798|Autonomic Agents|autonomic agents|mesh-ancestor
111217563|NCT05439798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111217564|NCT05439798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111217565|NCT05439798|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111217566|NCT05439798|Glucocorticoids|glucocorticoids|mesh-ancestor
111217567|NCT05439798|Hormones|hormones|mesh-ancestor
111217568|NCT05439798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111217569|NCT05439798|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111217570|NCT05439798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111217571|NCT05439798|Protease Inhibitors|protease inhibitors|mesh-ancestor
111217572|NCT05439798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111217573|NCT05439798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111217574|NCT05439798|Antipruritics|antipruritics|mesh-ancestor
111217575|NCT05439798|Dermatologic Agents|dermatologic agents|mesh-ancestor
111217576|NCT05439798|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111217577|NCT05439798|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111217578|NCT05439798|Serotonin Agents|serotonin agents|mesh-ancestor
111217579|NCT05439798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111217580|NCT02188576|Tranexamic Acid|tranexamic acid|mesh-list
111217581|NCT02188576|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111217582|NCT02188576|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111217583|NCT02188576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111217584|NCT02188576|Hemostatics|hemostatics|mesh-ancestor
111217585|NCT02188576|Coagulants|coagulants|mesh-ancestor
111217586|NCT02189122|Aspirin|aspirin|mesh-list
111217587|NCT02189122|Bradykinin|bradykinin|mesh-list
111217588|NCT02189122|Kininogens|kininogens|mesh-list
111217589|NCT02189122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111217590|NCT02189122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111217591|NCT02189122|Analgesics|analgesics|mesh-ancestor
111217592|NCT02189122|Sensory System Agents|sensory system agents|mesh-ancestor
111217593|NCT02189122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111217594|NCT02189122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111217595|NCT02189122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111217596|NCT02189122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111217597|NCT02189122|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111217598|NCT02189122|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111217599|NCT02189122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111217600|NCT02189122|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111217601|NCT02189122|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111217602|NCT02189122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111217603|NCT02189122|Antipyretics|antipyretics|mesh-ancestor
111217604|NCT02189122|Vasodilator Agents|vasodilator agents|mesh-ancestor
111217605|NCT02189122|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
111217606|NCT02189122|Protease Inhibitors|protease inhibitors|mesh-ancestor
111217607|NCT05309460|Labetalol|labetalol|mesh-list
111217608|NCT05309460|Nifedipine|nifedipine|mesh-list
111217609|NCT05309460|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111217610|NCT05309460|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111217611|NCT05309460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111217612|NCT05309460|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111217613|NCT05309460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111217614|NCT05309460|Vasodilator Agents|vasodilator agents|mesh-ancestor
111217615|NCT05309460|Tocolytic Agents|tocolytic agents|mesh-ancestor
111217616|NCT05309460|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111217617|NCT05309460|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111217618|NCT05309460|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111217619|NCT05309460|Adrenergic Agents|adrenergic agents|mesh-ancestor
111217620|NCT05309460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110681508|NCT01057498|RNS60|rns60|mesh-list
111217621|NCT05309460|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111217622|NCT05309460|Sympathomimetics|sympathomimetics|mesh-ancestor
111217623|NCT05309460|Autonomic Agents|autonomic agents|mesh-ancestor
111217624|NCT05309460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111217625|NCT05309460|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111217626|NCT05309460|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111217627|NCT01093690|Metoclopramide|metoclopramide|mesh-list
111217628|NCT01093690|Antiemetics|antiemetics|mesh-ancestor
111217629|NCT01093690|Autonomic Agents|autonomic agents|mesh-ancestor
111217630|NCT01093690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111217631|NCT01093690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111217632|NCT01093690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111217633|NCT01093690|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111217634|NCT01093690|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111217635|NCT01093690|Dopamine Agents|dopamine agents|mesh-ancestor
111217636|NCT01093690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111217637|NCT01093690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111217638|NCT01143688|Albuterol|albuterol|mesh-list
111217639|NCT01143688|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111217640|NCT01143688|Autonomic Agents|autonomic agents|mesh-ancestor
111217641|NCT01143688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111217642|NCT01143688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111217643|NCT01143688|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111217644|NCT01143688|Respiratory System Agents|respiratory system agents|mesh-ancestor
111217645|NCT01143688|Tocolytic Agents|tocolytic agents|mesh-ancestor
111217646|NCT01143688|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111217647|NCT01143688|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111217648|NCT01143688|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111217649|NCT01143688|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111217650|NCT01143688|Adrenergic Agents|adrenergic agents|mesh-ancestor
111217651|NCT01143688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111217652|NCT01143688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111217653|NCT04455594|Carboplatin|carboplatin|mesh-list
111217654|NCT04455594|Pemetrexed|pemetrexed|mesh-list
111217655|NCT04455594|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111217656|NCT04455594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111217657|NCT04455594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111217658|NCT04455594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111217659|NCT04455594|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111217660|NCT04455594|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111217661|NCT04455594|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111217662|NCT05439408|Dasatinib|dasatinib|mesh-list
111217663|NCT05439408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111217664|NCT05439408|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111217665|NCT05439408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111217666|NCT05439408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111217667|NCT03011476|Donepezil|donepezil|mesh-list
111217668|NCT03011476|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111217669|NCT03011476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111217670|NCT03011476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111217671|NCT03011476|Cholinergic Agents|cholinergic agents|mesh-ancestor
111217672|NCT03011476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111217673|NCT03011476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111217674|NCT03011476|Nootropic Agents|nootropic agents|mesh-ancestor
111217675|NCT02522754|Vaccines|vaccines|mesh-list
111217676|NCT02522754|Immunologic Factors|immunologic factors|mesh-ancestor
111217677|NCT02522754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111217678|NCT01188694|Methylene Blue|methylene blue|mesh-list
111217679|NCT01188694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111217680|NCT01188694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111217681|NCT01188928|Betamethasone|betamethasone|mesh-list
111217682|NCT01188928|Betamethasone Valerate|betamethasone valerate|mesh-list
111217683|NCT01188928|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
111217684|NCT01188928|Betamethasone benzoate|betamethasone benzoate|mesh-list
111217685|NCT01188928|Calcipotriene|calcipotriene|mesh-list
111217686|NCT01188928|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
111217687|NCT01188928|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111217688|NCT01188928|Glucocorticoids|glucocorticoids|mesh-ancestor
111217689|NCT01188928|Hormones|hormones|mesh-ancestor
111217690|NCT01188928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111217691|NCT01188928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111217692|NCT01188928|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111217693|NCT01188928|Respiratory System Agents|respiratory system agents|mesh-ancestor
111217694|NCT01188928|Dermatologic Agents|dermatologic agents|mesh-ancestor
111217695|NCT05438706|Carboplatin|carboplatin|mesh-list
111217696|NCT05438706|Capecitabine|capecitabine|mesh-list
110681553|NCT00354172|Cyclosporine|cyclosporine|mesh-list
111217697|NCT05438706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111217698|NCT05438706|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111217699|NCT05438706|Antimetabolites|antimetabolites|mesh-ancestor
111217700|NCT05438706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111217701|NCT01189240|Bevacizumab|bevacizumab|mesh-list
111217702|NCT01189240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111217703|NCT01189240|Antibodies|antibodies|mesh-list
111217704|NCT01189240|Immunoglobulins|immunoglobulins|mesh-list
111217705|NCT01189240|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111217706|NCT01189240|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
111217707|NCT01189240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111217708|NCT01189240|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111217709|NCT01189240|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111217710|NCT01189240|Growth Substances|growth substances|mesh-ancestor
111217711|NCT01189240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111217712|NCT01189240|Growth Inhibitors|growth inhibitors|mesh-ancestor
111217713|NCT01189240|Immunologic Factors|immunologic factors|mesh-ancestor
111217714|NCT01189240|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
111217715|NCT01189240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111217716|NCT01189240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111217717|NCT03467334|Simethicone|simethicone|mesh-list
111217718|NCT03467334|Antifoaming Agents|antifoaming agents|mesh-ancestor
111217719|NCT03467334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111217720|NCT03467334|Emollients|emollients|mesh-ancestor
111217721|NCT03467334|Dermatologic Agents|dermatologic agents|mesh-ancestor
111217722|NCT02874144|Mometasone Furoate|mometasone furoate|mesh-list
111217723|NCT02874144|Fluticasone|fluticasone|mesh-list
111217724|NCT02874144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111217725|NCT02874144|Dermatologic Agents|dermatologic agents|mesh-ancestor
111217726|NCT02874144|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111217727|NCT02874144|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111217728|NCT02874144|Autonomic Agents|autonomic agents|mesh-ancestor
111217729|NCT02874144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111217730|NCT02874144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111217731|NCT02874144|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111217732|NCT02874144|Respiratory System Agents|respiratory system agents|mesh-ancestor
111217733|NCT03467178|Paclitaxel|paclitaxel|mesh-list
111217734|NCT03467178|Carboplatin|carboplatin|mesh-list
111217735|NCT03467178|Gemcitabine|gemcitabine|mesh-list
111217736|NCT03467178|Doxorubicin|doxorubicin|mesh-list
111217737|NCT03467178|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111217738|NCT03467178|Decitabine|decitabine|mesh-list
111217739|NCT03467178|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111217740|NCT03467178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111217741|NCT03467178|Tubulin Modulators|tubulin modulators|mesh-ancestor
111217742|NCT03467178|Antimitotic Agents|antimitotic agents|mesh-ancestor
111217743|NCT03467178|Mitosis Modulators|mitosis modulators|mesh-ancestor
111217744|NCT03467178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111217745|NCT03467178|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111217746|NCT03467178|Antimetabolites|antimetabolites|mesh-ancestor
111217747|NCT03467178|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111217748|NCT03467178|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111217749|NCT03467178|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111217750|NCT03467178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111217751|NCT02835534|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
111217752|NCT02835534|Plasminogen|plasminogen|mesh-list
111217753|NCT02835534|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111217754|NCT02835534|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111217755|NCT02835534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111217756|NCT02722200|Hydrocortisone|hydrocortisone|mesh-list
111217757|NCT02722200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111217758|NCT01094548|Cyclophosphamide|cyclophosphamide|mesh-list
111217759|NCT01094548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111217760|NCT01094548|Immunologic Factors|immunologic factors|mesh-ancestor
111217761|NCT01094548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111217762|NCT01094548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111217763|NCT01094548|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111217764|NCT01094548|Alkylating Agents|alkylating agents|mesh-ancestor
111217765|NCT01094548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111217766|NCT01094548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111217767|NCT01094548|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111217768|NCT02611830|Vedolizumab|vedolizumab|mesh-list
111217769|NCT02611830|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111217770|NCT03461718|Fentanyl|fentanyl|mesh-list
111217771|NCT03461718|Midazolam|midazolam|mesh-list
111217772|NCT03461718|Ketamine|ketamine|mesh-list
111217773|NCT03461718|Analgesics|analgesics|mesh-ancestor
111217774|NCT03461718|Sensory System Agents|sensory system agents|mesh-ancestor
111217775|NCT03461718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111217776|NCT03461718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111217777|NCT03461718|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111217778|NCT03461718|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111217779|NCT03461718|Anesthetics, General|anesthetics, general|mesh-ancestor
111217780|NCT03461718|Anesthetics|anesthetics|mesh-ancestor
111217781|NCT03461718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111217782|NCT03461718|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111217783|NCT03461718|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111217784|NCT03461718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111217785|NCT03461718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111217786|NCT03461718|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111217787|NCT03461718|Narcotics|narcotics|mesh-ancestor
111217788|NCT03461718|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111217789|NCT03461718|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111217790|NCT03461718|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111217791|NCT03461718|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111217792|NCT03461718|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111217793|NCT03461718|GABA Modulators|gaba modulators|mesh-ancestor
111217794|NCT03461718|GABA Agents|gaba agents|mesh-ancestor
111217795|NCT03467022|Ascorbic Acid|ascorbic acid|mesh-list
111217796|NCT03467022|Vitamins|vitamins|mesh-ancestor
111217797|NCT03467022|Micronutrients|micronutrients|mesh-ancestor
111217798|NCT03467022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111217799|NCT03467022|Antioxidants|antioxidants|mesh-ancestor
111217800|NCT03467022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111217801|NCT03467022|Protective Agents|protective agents|mesh-ancestor
111217802|NCT03129594|Glucagon|glucagon|mesh-list
111217803|NCT03129594|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
111217804|NCT03129594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111217805|NCT03129594|Hormones|hormones|mesh-ancestor
111217806|NCT03129594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111217807|NCT03129594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111217808|NCT03129594|Incretins|incretins|mesh-ancestor
111217809|NCT03466632|Dexmedetomidine|dexmedetomidine|mesh-list
111217810|NCT03466632|Propofol|propofol|mesh-list
111217811|NCT03466632|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111217812|NCT03466632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111217813|NCT03466632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111217814|NCT03466632|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111217815|NCT03466632|Analgesics|analgesics|mesh-ancestor
111217816|NCT03466632|Sensory System Agents|sensory system agents|mesh-ancestor
111217817|NCT03466632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111217818|NCT03466632|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111217819|NCT03466632|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111217820|NCT03466632|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111217821|NCT03466632|Adrenergic Agents|adrenergic agents|mesh-ancestor
111217822|NCT03466632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111217823|NCT03466632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111217824|NCT03466632|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111217825|NCT03466632|Anesthetics, General|anesthetics, general|mesh-ancestor
111217826|NCT03466632|Anesthetics|anesthetics|mesh-ancestor
111217827|NCT05339334|Ritonavir|ritonavir|mesh-list
111217828|NCT05339334|Nirmatrelvir|nirmatrelvir|mesh-list
111217829|NCT05339334|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111217830|NCT05339334|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111217831|NCT05339334|Protease Inhibitors|protease inhibitors|mesh-ancestor
111217832|NCT05339334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111217833|NCT05339334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111217834|NCT05339334|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111217835|NCT05339334|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111217836|NCT05339334|Antiviral Agents|antiviral agents|mesh-ancestor
111217837|NCT05339334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111217838|NCT05339334|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111217839|NCT05339334|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111217840|NCT03461328|Magnesium Sulfate|magnesium sulfate|mesh-list
111217841|NCT03461328|Analgesics|analgesics|mesh-ancestor
111217842|NCT03461328|Sensory System Agents|sensory system agents|mesh-ancestor
111217843|NCT03461328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111217844|NCT03461328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111217845|NCT03461328|Anesthetics|anesthetics|mesh-ancestor
111217846|NCT03461328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111217847|NCT03461328|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111217848|NCT03461328|Anticonvulsants|anticonvulsants|mesh-ancestor
111217849|NCT03461328|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111217850|NCT03461328|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111217851|NCT03461328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111217852|NCT03461328|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111217853|NCT03461328|Tocolytic Agents|tocolytic agents|mesh-ancestor
111217854|NCT03461328|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111217855|NCT01145638|Iron|iron|mesh-list
111217856|NCT01145638|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
111217857|NCT01145638|Trace Elements|trace elements|mesh-ancestor
111217858|NCT01145638|Micronutrients|micronutrients|mesh-ancestor
111217859|NCT01145638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111217860|NCT01145638|Hematinics|hematinics|mesh-ancestor
111217861|NCT03466320|Cyclophosphamide|cyclophosphamide|mesh-list
111217862|NCT03466320|Fludarabine|fludarabine|mesh-list
111217863|NCT03466320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111217864|NCT03466320|Immunologic Factors|immunologic factors|mesh-ancestor
111217865|NCT03466320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111217866|NCT03466320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111217867|NCT03466320|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111217868|NCT03466320|Alkylating Agents|alkylating agents|mesh-ancestor
111217869|NCT03466320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111217870|NCT03466320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111217871|NCT03466320|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111217872|NCT03466242|Dexmedetomidine|dexmedetomidine|mesh-list
111217873|NCT03466242|Ketamine|ketamine|mesh-list
111217874|NCT03466242|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111217875|NCT03466242|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111217876|NCT03466242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111217877|NCT03466242|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111217878|NCT03466242|Analgesics|analgesics|mesh-ancestor
111217879|NCT03466242|Sensory System Agents|sensory system agents|mesh-ancestor
111217880|NCT03466242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111217881|NCT03466242|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111217882|NCT03466242|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111217883|NCT03466242|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111217884|NCT03466242|Adrenergic Agents|adrenergic agents|mesh-ancestor
111217885|NCT03466242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111217886|NCT03466242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111217887|NCT03466242|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111217888|NCT03466242|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111217889|NCT03466242|Anesthetics, General|anesthetics, general|mesh-ancestor
111217890|NCT03466242|Anesthetics|anesthetics|mesh-ancestor
111217891|NCT03466242|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111217892|NCT03466242|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111217893|NCT01190878|Bromfenac|bromfenac|mesh-list
111217894|NCT01190878|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111217895|NCT01190878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111217896|NCT01190878|Analgesics|analgesics|mesh-ancestor
111217897|NCT01190878|Sensory System Agents|sensory system agents|mesh-ancestor
111217898|NCT01190878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111217899|NCT01190878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111217900|NCT01190878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111217901|NCT01190878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111217902|NCT01146808|Adefovir|adefovir|mesh-list
111217903|NCT01146808|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
111217904|NCT01146808|Antiviral Agents|antiviral agents|mesh-ancestor
111217905|NCT01146808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111217906|NCT01146808|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111217907|NCT01146808|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111217908|NCT01146808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111217909|NCT01146808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111217910|NCT02522130|Naproxen|naproxen|mesh-list
111217911|NCT02522130|Lidocaine|lidocaine|mesh-list
111217912|NCT02522130|Misoprostol|misoprostol|mesh-list
111217913|NCT02522130|Anesthetics, Local|anesthetics, local|mesh-ancestor
111217914|NCT02522130|Anesthetics|anesthetics|mesh-ancestor
111217915|NCT02522130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111217916|NCT02522130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111217917|NCT02522130|Sensory System Agents|sensory system agents|mesh-ancestor
111217918|NCT02522130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111217919|NCT02522130|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111217920|NCT02522130|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111217921|NCT02522130|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111217922|NCT02522130|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111217923|NCT02522130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111217924|NCT02522130|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111217925|NCT02522130|Abortifacient Agents|abortifacient agents|mesh-ancestor
111217926|NCT02522130|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111217927|NCT02522130|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111217928|NCT02522130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111217929|NCT02522130|Oxytocics|oxytocics|mesh-ancestor
111217930|NCT02522130|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111217931|NCT02522130|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111217932|NCT02522130|Analgesics|analgesics|mesh-ancestor
111217933|NCT02522130|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111217934|NCT02522130|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111217935|NCT02522130|Gout Suppressants|gout suppressants|mesh-ancestor
111217936|NCT02522130|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111217937|NCT02522130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111217938|NCT01148524|Vaccines|vaccines|mesh-list
111217939|NCT01148524|Immunologic Factors|immunologic factors|mesh-ancestor
111217940|NCT01148524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111217941|NCT03460860|Tocopherols|tocopherols|mesh-list
111217942|NCT03460860|Vitamin E|vitamin e|mesh-list
111217943|NCT03460860|Tocotrienols|tocotrienols|mesh-list
111217944|NCT03460860|alpha-Tocopherol|alpha-tocopherol|mesh-list
111217945|NCT03460860|Lycopene|lycopene|mesh-list
111217946|NCT03460860|Antioxidants|antioxidants|mesh-ancestor
111217947|NCT03460860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111217948|NCT03460860|Protective Agents|protective agents|mesh-ancestor
111217949|NCT03460860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111217950|NCT03460860|Vitamins|vitamins|mesh-ancestor
111217951|NCT03460860|Micronutrients|micronutrients|mesh-ancestor
111217952|NCT03460860|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111217953|NCT03460860|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111217954|NCT03460860|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
111217955|NCT03460860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111217956|NCT03460782|Ipilimumab|ipilimumab|mesh-list
111217957|NCT03460782|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111217958|NCT03460782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111217959|NCT03460782|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111217960|NCT03460782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111217961|NCT01099618|Metformin|metformin|mesh-list
111217962|NCT01099618|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111217963|NCT01099618|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111217964|NCT01099618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111217965|NCT01099618|Incretins|incretins|mesh-ancestor
111217966|NCT01099618|Hormones|hormones|mesh-ancestor
111217967|NCT01099618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111217968|NCT01099618|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111217969|NCT01099618|Protease Inhibitors|protease inhibitors|mesh-ancestor
111217970|NCT01099618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111217971|NCT01099618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111217972|NCT01099774|Bimatoprost|bimatoprost|mesh-list
111217973|NCT01099774|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111217974|NCT01099774|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111217975|NCT01099774|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111217976|NCT01100242|Bortezomib|bortezomib|mesh-list
111217977|NCT01100242|Sorafenib|sorafenib|mesh-list
111217978|NCT01100242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111217979|NCT01100242|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111217980|NCT01100242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111217981|NCT01100242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111217982|NCT01148836|Ubiquinone|ubiquinone|mesh-list
111217983|NCT01148836|Coenzyme Q10|coenzyme q10|mesh-list
111217984|NCT01148836|Micronutrients|micronutrients|mesh-ancestor
111217985|NCT01148836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111217986|NCT01148836|Vitamins|vitamins|mesh-ancestor
111217987|NCT01149616|Dexamethasone|dexamethasone|mesh-list
111217988|NCT01149616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111217989|NCT01149616|Antiemetics|antiemetics|mesh-ancestor
111217990|NCT01149616|Autonomic Agents|autonomic agents|mesh-ancestor
111217991|NCT01149616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111217992|NCT01149616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111217993|NCT01149616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111217994|NCT01149616|Glucocorticoids|glucocorticoids|mesh-ancestor
111217995|NCT01149616|Hormones|hormones|mesh-ancestor
111217996|NCT01149616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110670955|NCT00423189|Ranibizumab|ranibizumab|mesh-list
111217997|NCT01149616|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111217998|NCT01149616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111218000|NCT03460470|Vasodilator Agents|vasodilator agents|mesh-ancestor
111218001|NCT03460470|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111218002|NCT03460470|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111218003|NCT03460470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111218004|NCT03460470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111218005|NCT03460470|Urological Agents|urological agents|mesh-ancestor
111218006|NCT01101100|Brodalumab|brodalumab|mesh-list
111218007|NCT01101100|Dermatologic Agents|dermatologic agents|mesh-ancestor
111218008|NCT03460392|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111218009|NCT03460392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111218010|NCT01101880|Cytarabine|cytarabine|mesh-list
111218011|NCT01101880|Clofarabine|clofarabine|mesh-list
111218012|NCT01101880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111218013|NCT01101880|Antimetabolites|antimetabolites|mesh-ancestor
111218014|NCT01101880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111218015|NCT01101880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111218016|NCT01101880|Antiviral Agents|antiviral agents|mesh-ancestor
111218017|NCT01101880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111218018|NCT01101880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111218019|NCT01101880|Immunologic Factors|immunologic factors|mesh-ancestor
111218020|NCT01101880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111218021|NCT04978038|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
111218022|NCT04978038|Immunologic Factors|immunologic factors|mesh-ancestor
111218023|NCT04978038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111218024|NCT03011632|Mometasone Furoate|mometasone furoate|mesh-list
111218025|NCT03011632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111218026|NCT03011632|Dermatologic Agents|dermatologic agents|mesh-ancestor
111218027|NCT03011632|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111218028|NCT01102270|Eszopiclone|eszopiclone|mesh-list
111218029|NCT01102270|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111218030|NCT01102270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111218031|NCT01102270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111218032|NCT01103440|polysaccharide-K|polysaccharide-k|mesh-list
111218033|NCT01103440|Tirofiban|tirofiban|mesh-list
111218034|NCT01103440|Ticlopidine|ticlopidine|mesh-list
111218035|NCT01103440|Abciximab|abciximab|mesh-list
111218036|NCT01103440|Clopidogrel|clopidogrel|mesh-list
111218037|NCT01103440|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
111218038|NCT01103440|Cangrelor|cangrelor|mesh-list
111218039|NCT01103440|Eptifibatide|eptifibatide|mesh-list
111218040|NCT01103440|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111218041|NCT01103440|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111218042|NCT01103440|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111218043|NCT01103440|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111218044|NCT01103440|Purinergic Agents|purinergic agents|mesh-ancestor
111218045|NCT01103440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111218046|NCT01103440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111218047|NCT01103440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111218048|NCT01103440|Anticoagulants|anticoagulants|mesh-ancestor
111218049|NCT01103440|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111218050|NCT01103440|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111218051|NCT01103440|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111218052|NCT01103440|Immunologic Factors|immunologic factors|mesh-ancestor
111218053|NCT01103440|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111218054|NCT01103440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111218055|NCT01103440|Antiviral Agents|antiviral agents|mesh-ancestor
111218056|NCT01103440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111218057|NCT01103440|Interferon Inducers|interferon inducers|mesh-ancestor
111218058|NCT01103440|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111218059|NCT01103440|Protective Agents|protective agents|mesh-ancestor
111218060|NCT01103440|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111218061|NCT01103440|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111218062|NCT01103440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111218063|NCT01105312|Letrozole|letrozole|mesh-list
111218064|NCT01105312|Panobinostat|panobinostat|mesh-list
111218065|NCT01105312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111218066|NCT01105312|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111218067|NCT01105312|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111218068|NCT01105312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111218069|NCT01105312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111218070|NCT01105312|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111218071|NCT01105312|Hormone Antagonists|hormone antagonists|mesh-ancestor
110681927|NCT00514514|Antitubercular Agents|antitubercular agents|mesh-ancestor
111218072|NCT01105312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111218073|NCT01105312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111218074|NCT01105312|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111218076|NCT04488978|Irbesartan|irbesartan|mesh-list
111218077|NCT04488978|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111218078|NCT04488978|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111218079|NCT04488978|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111218080|NCT04488978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111218081|NCT04488978|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111218082|NCT04488978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111218083|NCT04488978|Vasodilator Agents|vasodilator agents|mesh-ancestor
111218084|NCT04488978|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111218085|NCT04488978|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111218086|NCT03460002|Vaccines|vaccines|mesh-list
111218087|NCT03460002|Immunologic Factors|immunologic factors|mesh-ancestor
111218088|NCT03460002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111218089|NCT01105702|Bevacizumab|bevacizumab|mesh-list
111218090|NCT01105702|Temozolomide|temozolomide|mesh-list
111218091|NCT01105702|Lithium Carbonate|lithium carbonate|mesh-list
111218092|NCT01105702|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111218093|NCT01105702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111218094|NCT01105702|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111218095|NCT01105702|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111218096|NCT01105702|Growth Substances|growth substances|mesh-ancestor
111218097|NCT01105702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111218098|NCT01105702|Growth Inhibitors|growth inhibitors|mesh-ancestor
111218099|NCT01105702|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111218100|NCT01105702|Alkylating Agents|alkylating agents|mesh-ancestor
111218101|NCT01105702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111218102|NCT01105702|Antidepressive Agents|antidepressive agents|mesh-ancestor
111218103|NCT01105702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111218104|NCT01105702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111218105|NCT01105702|Antimanic Agents|antimanic agents|mesh-ancestor
111218106|NCT01105702|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111218107|NCT01105702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111218108|NCT04453332|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
111218109|NCT04453332|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
111218110|NCT04453332|Hormones|hormones|mesh-list
111218111|NCT04453332|Estradiol|estradiol|mesh-list
111218112|NCT04453332|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
111218113|NCT04453332|Progesterone|progesterone|mesh-list
111218114|NCT04453332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111218115|NCT04453332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111218116|NCT04453332|Estrogens|estrogens|mesh-ancestor
111218117|NCT04453332|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111218118|NCT04453332|Contraceptive Agents|contraceptive agents|mesh-ancestor
111218119|NCT04453332|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111218120|NCT04453332|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111218121|NCT04453332|Progestins|progestins|mesh-ancestor
111218122|NCT03456570|Dydrogesterone|dydrogesterone|mesh-list
111218123|NCT03456570|Progestins|progestins|mesh-ancestor
111218124|NCT03456570|Hormones|hormones|mesh-ancestor
111218125|NCT03456570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111218126|NCT03456570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111218127|NCT03468348|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
111218128|NCT03468348|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111218129|NCT03468348|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111218130|NCT03468348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111218131|NCT03468348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111218132|NCT03468348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111218133|NCT03468348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111218134|NCT03468348|Analgesics|analgesics|mesh-ancestor
111218135|NCT03468348|Sensory System Agents|sensory system agents|mesh-ancestor
111218136|NCT03468348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111218137|NCT03468348|Antidepressive Agents|antidepressive agents|mesh-ancestor
111218138|NCT03468348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111218139|NCT03468348|Dopamine Agents|dopamine agents|mesh-ancestor
111218140|NCT03464682|Atorvastatin|atorvastatin|mesh-list
111218141|NCT03464682|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111218142|NCT03464682|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111218143|NCT03464682|Antimetabolites|antimetabolites|mesh-ancestor
111218144|NCT03464682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111218145|NCT03464682|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111218146|NCT03464682|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111218147|NCT03464682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111218148|NCT03464058|Rabeprazole|rabeprazole|mesh-list
111218149|NCT03464058|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111218150|NCT03464058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111218151|NCT03464058|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111218152|NCT03464058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111218153|NCT03464058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111218154|NCT03451734|Metformin|metformin|mesh-list
111218155|NCT03451734|Antipsychotic Agents|antipsychotic agents|mesh-list
111218156|NCT03451734|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111218157|NCT03451734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111218158|NCT03451734|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111218159|NCT03451734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111218160|NCT03451734|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111218161|NCT03130218|Peppermint oil|peppermint oil|mesh-list
111218162|NCT03130218|Antiemetics|antiemetics|mesh-ancestor
111218163|NCT03130218|Autonomic Agents|autonomic agents|mesh-ancestor
111218164|NCT03130218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111218165|NCT03130218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111218166|NCT03130218|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111218167|NCT03130218|Parasympatholytics|parasympatholytics|mesh-ancestor
111218168|NCT01199146|Abiraterone Acetate|abiraterone acetate|mesh-list
111218169|NCT01199146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111218170|NCT01199146|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111218171|NCT01199146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111218172|NCT01199146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111218173|NCT01199146|Hormone Antagonists|hormone antagonists|mesh-ancestor
111218174|NCT01199146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111218175|NCT01199146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111218176|NCT01199146|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111218177|NCT01199926|Vitamin D|vitamin d|mesh-list
111218178|NCT01199926|Cholecalciferol|cholecalciferol|mesh-list
111218179|NCT01199926|Vitamins|vitamins|mesh-ancestor
111218180|NCT01199926|Micronutrients|micronutrients|mesh-ancestor
111218181|NCT01199926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111218182|NCT01199926|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111218183|NCT01199926|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111218184|NCT01106950|Cyclophosphamide|cyclophosphamide|mesh-list
111218185|NCT01106950|Fludarabine|fludarabine|mesh-list
111218186|NCT01106950|Interleukin-2|interleukin-2|mesh-list
111218187|NCT01106950|Denileukin diftitox|denileukin diftitox|mesh-list
111218188|NCT01106950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111218189|NCT01106950|Immunologic Factors|immunologic factors|mesh-ancestor
111218190|NCT01106950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111218191|NCT01106950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111218192|NCT01106950|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111218193|NCT01106950|Alkylating Agents|alkylating agents|mesh-ancestor
111218194|NCT01106950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111218195|NCT01106950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111218196|NCT01106950|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111218197|NCT01106950|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111218198|NCT01106950|Analgesics|analgesics|mesh-ancestor
111218199|NCT01106950|Sensory System Agents|sensory system agents|mesh-ancestor
111218200|NCT01106950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111218201|NCT03463044|Nangibotide|nangibotide|mesh-list
111218202|NCT03463044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111218203|NCT02522208|Hydralazine|hydralazine|mesh-list
111218204|NCT02522208|Isosorbide|isosorbide|mesh-list
111218205|NCT02522208|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
111218206|NCT02522208|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
111218207|NCT02522208|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
111218208|NCT02522208|Diuretics|diuretics|mesh-ancestor
111218209|NCT02522208|Natriuretic Agents|natriuretic agents|mesh-ancestor
111218210|NCT02522208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111218211|NCT02522208|Vasodilator Agents|vasodilator agents|mesh-ancestor
111218212|NCT02522208|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
111218213|NCT02522208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111218214|NCT02522208|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111218215|NCT05684172|Tenecteplase|tenecteplase|mesh-list
111218216|NCT05684172|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111218217|NCT05684172|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111218218|NCT05684172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111218219|NCT01200160|Niacin|niacin|mesh-list
111218220|NCT01200160|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111218221|NCT01200160|Antimetabolites|antimetabolites|mesh-ancestor
111218222|NCT01200160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111218223|NCT01200160|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111218224|NCT01200160|Vasodilator Agents|vasodilator agents|mesh-ancestor
111218225|NCT01200160|Vitamin B Complex|vitamin b complex|mesh-ancestor
111218226|NCT01200160|Vitamins|vitamins|mesh-ancestor
111218227|NCT01200160|Micronutrients|micronutrients|mesh-ancestor
111218228|NCT01200160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111218229|NCT04908228|Obinutuzumab|obinutuzumab|mesh-list
111218230|NCT04908228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111218231|NCT04908228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111218232|NCT01153672|Letrozole|letrozole|mesh-list
111218233|NCT01153672|Anastrozole|anastrozole|mesh-list
111218234|NCT01153672|Vorinostat|vorinostat|mesh-list
111218235|NCT01153672|Exemestane|exemestane|mesh-list
111218236|NCT01153672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111218237|NCT01153672|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111218238|NCT01153672|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111218239|NCT01153672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111218240|NCT01153672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111218241|NCT01153672|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111218242|NCT01153672|Hormone Antagonists|hormone antagonists|mesh-ancestor
111218243|NCT01153672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111218244|NCT01153672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111218245|NCT01153672|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111218246|NCT01153672|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111218247|NCT03010072|Ferric Compounds|ferric compounds|mesh-list
111218248|NCT03010072|Hematinics|hematinics|mesh-ancestor
111218249|NCT03462810|Cabotegravir|cabotegravir|mesh-list
111218250|NCT03462810|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111218251|NCT03462810|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111218252|NCT03462810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111218253|NCT03462810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111218254|NCT03462810|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111218255|NCT03462810|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111218256|NCT03462810|Antiviral Agents|antiviral agents|mesh-ancestor
111218257|NCT03462810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111218258|NCT01219738|Budesonide|budesonide|mesh-list
111218259|NCT01219738|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111218260|NCT01219738|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111218261|NCT01219738|Autonomic Agents|autonomic agents|mesh-ancestor
111218262|NCT01219738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111218263|NCT01219738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111218264|NCT01219738|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111218265|NCT01219738|Respiratory System Agents|respiratory system agents|mesh-ancestor
111218266|NCT01219738|Glucocorticoids|glucocorticoids|mesh-ancestor
111218267|NCT01219738|Hormones|hormones|mesh-ancestor
111218268|NCT01219738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111218269|NCT03848754|Gemtuzumab|gemtuzumab|mesh-list
111218270|NCT03848754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111218271|NCT03848754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111218272|NCT03848754|Immunotoxins|immunotoxins|mesh-ancestor
111218273|NCT03848754|Immunoconjugates|immunoconjugates|mesh-ancestor
111218274|NCT03848754|Immunologic Factors|immunologic factors|mesh-ancestor
111218275|NCT03848754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111218276|NCT01155154|Clindamycin|clindamycin|mesh-list
111218277|NCT01155154|Clindamycin palmitate|clindamycin palmitate|mesh-list
111218278|NCT01155154|Clindamycin phosphate|clindamycin phosphate|mesh-list
111218279|NCT01155154|Cephalexin|cephalexin|mesh-list
111218280|NCT01155154|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111218281|NCT01155154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111218282|NCT01155154|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111218283|NCT01155154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111218284|NCT01155154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111218285|NCT04614714|Niacinamide|niacinamide|mesh-list
111218286|NCT04614714|Niacin|niacin|mesh-list
111218287|NCT04614714|Nicotinic Acids|nicotinic acids|mesh-list
111218288|NCT04614714|Vitamin B Complex|vitamin b complex|mesh-ancestor
111218289|NCT04614714|Vitamins|vitamins|mesh-ancestor
111218290|NCT04614714|Micronutrients|micronutrients|mesh-ancestor
111218291|NCT04614714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111218292|NCT04614714|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111218293|NCT04614714|Antimetabolites|antimetabolites|mesh-ancestor
111218294|NCT04614714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111218295|NCT04614714|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111218296|NCT04614714|Vasodilator Agents|vasodilator agents|mesh-ancestor
111218297|NCT01221298|Ritonavir|ritonavir|mesh-list
111218298|NCT01221298|Ribavirin|ribavirin|mesh-list
111218299|NCT01221298|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111218300|NCT01221298|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111218301|NCT01221298|Protease Inhibitors|protease inhibitors|mesh-ancestor
111218302|NCT01221298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111218303|NCT01221298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111218304|NCT01221298|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111218305|NCT01221298|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111218306|NCT01221298|Antiviral Agents|antiviral agents|mesh-ancestor
111218307|NCT01221298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111218308|NCT01221298|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111218309|NCT01221298|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111218310|NCT01221298|Antimetabolites|antimetabolites|mesh-ancestor
111218311|NCT01222234|Vitamin D|vitamin d|mesh-list
111218312|NCT01222234|Ergocalciferols|ergocalciferols|mesh-list
111218313|NCT01222234|Cholecalciferol|cholecalciferol|mesh-list
111218314|NCT01222234|Calcitriol|calcitriol|mesh-list
111218315|NCT01222234|Vitamins|vitamins|mesh-list
111218316|NCT01222234|Micronutrients|micronutrients|mesh-ancestor
111218317|NCT01222234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111218318|NCT01222234|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111218319|NCT01222234|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111218320|NCT01222234|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
111218321|NCT01222234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111218322|NCT01222234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111218323|NCT01222234|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111218324|NCT01203046|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111218325|NCT01203046|Ertapenem|ertapenem|mesh-list
111218326|NCT01203046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111218327|NCT02460588|Prednisolone|prednisolone|mesh-list
111218328|NCT02460588|Cyclophosphamide|cyclophosphamide|mesh-list
111218329|NCT02460588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111218330|NCT02460588|Immunologic Factors|immunologic factors|mesh-ancestor
111218331|NCT02460588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111218332|NCT02460588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111218333|NCT02460588|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111218334|NCT02460588|Alkylating Agents|alkylating agents|mesh-ancestor
111218335|NCT02460588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111218336|NCT02460588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111218337|NCT02460588|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111218338|NCT02460588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111218339|NCT02460588|Glucocorticoids|glucocorticoids|mesh-ancestor
111218340|NCT02460588|Hormones|hormones|mesh-ancestor
111218341|NCT02460588|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111218342|NCT02460588|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111218343|NCT03449082|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
111218344|NCT03449082|Hemostatics|hemostatics|mesh-ancestor
111218345|NCT03449082|Coagulants|coagulants|mesh-ancestor
111218346|NCT03413202|3-n-butylphthalide|3-n-butylphthalide|mesh-list
111218347|NCT03413202|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111218348|NCT03413202|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111218349|NCT03413202|Protective Agents|protective agents|mesh-ancestor
111218350|NCT03413202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111218351|NCT04169100|Prednisone|prednisone|mesh-list
111218352|NCT04169100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111218353|NCT04169100|Glucocorticoids|glucocorticoids|mesh-ancestor
111218354|NCT04169100|Hormones|hormones|mesh-ancestor
111218355|NCT04169100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111218356|NCT04169100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111218357|NCT04169100|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111218358|NCT04169100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111218359|NCT04155840|Rituximab|rituximab|mesh-list
111218360|NCT04155840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111218361|NCT04155840|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
111218362|NCT04155840|Antibodies|antibodies|mesh-list
111218363|NCT04155840|Immunoglobulins|immunoglobulins|mesh-list
111218364|NCT04155840|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111218365|NCT04155840|Immunologic Factors|immunologic factors|mesh-ancestor
111218366|NCT04155840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111218367|NCT04155840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111218368|NCT04155840|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111218369|NCT04155840|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111218370|NCT04155840|Alkylating Agents|alkylating agents|mesh-ancestor
111218371|NCT04155840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111218372|NCT03448770|Lactulose|lactulose|mesh-list
111218373|NCT03448770|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111218374|NCT03443778|Dexamethasone|dexamethasone|mesh-list
110682232|NCT01058902|Aspirin|aspirin|mesh-list
111218375|NCT03443778|Bupivacaine|bupivacaine|mesh-list
111218376|NCT03443778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111218377|NCT03443778|Antiemetics|antiemetics|mesh-ancestor
111218378|NCT03443778|Autonomic Agents|autonomic agents|mesh-ancestor
111218379|NCT03443778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111218380|NCT03443778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111218381|NCT03443778|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111218382|NCT03443778|Glucocorticoids|glucocorticoids|mesh-ancestor
111218383|NCT03443778|Hormones|hormones|mesh-ancestor
111218384|NCT03443778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111218385|NCT03443778|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111218386|NCT03443778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111218387|NCT03443778|Anesthetics, Local|anesthetics, local|mesh-ancestor
111218388|NCT03443778|Anesthetics|anesthetics|mesh-ancestor
111218389|NCT03443778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111218390|NCT03443778|Sensory System Agents|sensory system agents|mesh-ancestor
111218391|NCT03011008|Liraglutide|liraglutide|mesh-list
111218392|NCT03011008|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111218393|NCT03011008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111218394|NCT03011008|Incretins|incretins|mesh-ancestor
111218395|NCT03011008|Hormones|hormones|mesh-ancestor
111218396|NCT03011008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111218397|NCT01157416|Cycloserine|cycloserine|mesh-list
111218398|NCT01157416|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111218399|NCT01157416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111218400|NCT01157416|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111218401|NCT01157416|Antitubercular Agents|antitubercular agents|mesh-ancestor
111218402|NCT01157416|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111218403|NCT01157416|Antimetabolites|antimetabolites|mesh-ancestor
111218404|NCT01157416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111218405|NCT01206478|Megestrol|megestrol|mesh-list
111218406|NCT01206478|Amitriptyline|amitriptyline|mesh-list
111218407|NCT01206478|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
111218408|NCT01206478|Antidepressive Agents|antidepressive agents|mesh-ancestor
111218409|NCT01206478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111218410|NCT01206478|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111218411|NCT01206478|Analgesics|analgesics|mesh-ancestor
111218412|NCT01206478|Sensory System Agents|sensory system agents|mesh-ancestor
111218413|NCT01206478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111218414|NCT01206478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111218415|NCT01206478|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111218416|NCT01206478|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111218417|NCT01206478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111218418|NCT01206478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111218419|NCT01206478|Adrenergic Agents|adrenergic agents|mesh-ancestor
111218420|NCT01206478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111218421|NCT01206478|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111218422|NCT01206478|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111218423|NCT01206478|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111218424|NCT01206478|Contraceptive Agents|contraceptive agents|mesh-ancestor
111218425|NCT01206478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111218426|NCT01206478|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111218427|NCT01206478|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111218428|NCT01206478|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111218429|NCT01206478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111218430|NCT04963530|Lithium Carbonate|lithium carbonate|mesh-list
111218431|NCT04963530|Antidepressive Agents|antidepressive agents|mesh-ancestor
111218432|NCT04963530|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111218433|NCT04963530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111218434|NCT04963530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111218435|NCT04963530|Antimanic Agents|antimanic agents|mesh-ancestor
111218436|NCT04963530|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111218437|NCT04963530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111218438|NCT04963530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111218439|NCT01158820|Diphenhydramine|diphenhydramine|mesh-list
111218440|NCT01158820|Fentanyl|fentanyl|mesh-list
111218441|NCT01158820|Midazolam|midazolam|mesh-list
111218442|NCT01158820|Dexmedetomidine|dexmedetomidine|mesh-list
111218443|NCT01158820|Ketamine|ketamine|mesh-list
111218444|NCT01158820|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111218445|NCT01158820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111218446|NCT01158820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111218447|NCT01158820|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111218448|NCT01158820|Analgesics|analgesics|mesh-ancestor
111218449|NCT01158820|Sensory System Agents|sensory system agents|mesh-ancestor
111218450|NCT01158820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111218451|NCT01158820|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111218452|NCT01158820|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111218453|NCT01158820|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111218454|NCT01158820|Adrenergic Agents|adrenergic agents|mesh-ancestor
111218455|NCT01158820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111218456|NCT01158820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111218457|NCT01158820|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111218458|NCT01158820|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111218459|NCT01158820|Anesthetics, General|anesthetics, general|mesh-ancestor
111218460|NCT01158820|Anesthetics|anesthetics|mesh-ancestor
111218461|NCT01158820|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111218462|NCT01158820|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111218463|NCT01158820|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111218464|NCT01158820|Narcotics|narcotics|mesh-ancestor
111218465|NCT01158820|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111218466|NCT01158820|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111218467|NCT01158820|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111218468|NCT01158820|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111218469|NCT01158820|GABA Modulators|gaba modulators|mesh-ancestor
111218470|NCT01158820|GABA Agents|gaba agents|mesh-ancestor
111218471|NCT01158820|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111218472|NCT01158820|Anesthetics, Local|anesthetics, local|mesh-ancestor
111218473|NCT01158820|Antiemetics|antiemetics|mesh-ancestor
111218474|NCT01158820|Autonomic Agents|autonomic agents|mesh-ancestor
111218475|NCT01158820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111218476|NCT01158820|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111218477|NCT01158820|Histamine Antagonists|histamine antagonists|mesh-ancestor
111218478|NCT01158820|Histamine Agents|histamine agents|mesh-ancestor
111218479|NCT01158820|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111218480|NCT03707028|Paclitaxel|paclitaxel|mesh-list
111218481|NCT03707028|Apatinib|apatinib|mesh-list
111218482|NCT03707028|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111218483|NCT03707028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111218484|NCT03707028|Tubulin Modulators|tubulin modulators|mesh-ancestor
111218485|NCT03707028|Antimitotic Agents|antimitotic agents|mesh-ancestor
111218486|NCT03707028|Mitosis Modulators|mitosis modulators|mesh-ancestor
111218487|NCT03707028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111218488|NCT03707028|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111218489|NCT03707028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111218490|NCT03447678|Pembrolizumab|pembrolizumab|mesh-list
111218491|NCT03447678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111218492|NCT03447678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111218493|NCT03447678|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111218494|NCT03447678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111218495|NCT01225354|Calcium|calcium|mesh-list
111218496|NCT01225354|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111218497|NCT01225354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111218498|NCT02521662|Nicotine|nicotine|mesh-list
111218499|NCT02521662|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111218500|NCT02521662|Autonomic Agents|autonomic agents|mesh-ancestor
111218501|NCT02521662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111218502|NCT02521662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111218503|NCT02521662|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111218504|NCT02521662|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111218505|NCT02521662|Cholinergic Agents|cholinergic agents|mesh-ancestor
111218506|NCT02521662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111218507|NCT02521662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111218508|NCT05183880|Vitamins|vitamins|mesh-list
111218509|NCT05183880|Ascorbic Acid|ascorbic acid|mesh-list
111218510|NCT05183880|Micronutrients|micronutrients|mesh-ancestor
111218511|NCT05183880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111218512|NCT05183880|Antioxidants|antioxidants|mesh-ancestor
111218513|NCT05183880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111218514|NCT05183880|Protective Agents|protective agents|mesh-ancestor
111218515|NCT01159054|Nicotinic Acids|nicotinic acids|mesh-list
111218516|NCT01159054|Niacin|niacin|mesh-list
111218517|NCT01159054|Niacinamide|niacinamide|mesh-list
111218518|NCT01159054|Vitamin B Complex|vitamin b complex|mesh-ancestor
111218519|NCT01159054|Vitamins|vitamins|mesh-ancestor
111218520|NCT01159054|Micronutrients|micronutrients|mesh-ancestor
111218521|NCT01159054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111218522|NCT01159054|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111218523|NCT01159054|Antimetabolites|antimetabolites|mesh-ancestor
111218524|NCT01159054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111218525|NCT01159054|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111218526|NCT01159054|Vasodilator Agents|vasodilator agents|mesh-ancestor
111218528|NCT01209442|Temozolomide|temozolomide|mesh-list
111218529|NCT01209442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111218530|NCT01209442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111218531|NCT01209442|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111218532|NCT01209442|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111218533|NCT01209442|Growth Substances|growth substances|mesh-ancestor
111218534|NCT01209442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111218535|NCT01209442|Growth Inhibitors|growth inhibitors|mesh-ancestor
111218536|NCT01209442|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111218537|NCT01209442|Alkylating Agents|alkylating agents|mesh-ancestor
111218538|NCT01209442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111218539|NCT01160380|Modafinil|modafinil|mesh-list
111218540|NCT01160380|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111218541|NCT01160380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111218542|NCT01160380|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
111218543|NCT01160380|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111218544|NCT01160380|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111218545|NCT01160380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111218546|NCT04956042|Cytarabine|cytarabine|mesh-list
111218547|NCT04956042|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111218548|NCT04956042|Antimetabolites|antimetabolites|mesh-ancestor
111218549|NCT04956042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111218550|NCT04956042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111218551|NCT04956042|Antiviral Agents|antiviral agents|mesh-ancestor
111218552|NCT04956042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111218553|NCT04956042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111218554|NCT04956042|Immunologic Factors|immunologic factors|mesh-ancestor
111218555|NCT04956042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111218556|NCT01228084|Sulforaphane|sulforaphane|mesh-list
111218557|NCT01228084|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
111218558|NCT01228084|Protective Agents|protective agents|mesh-ancestor
111218559|NCT01228084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111218560|NCT01228084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111218561|NCT01229410|Brimonidine Tartrate|brimonidine tartrate|mesh-list
111218562|NCT01229410|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111218563|NCT01229410|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111218564|NCT01229410|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111218565|NCT01229410|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111218566|NCT01229410|Adrenergic Agents|adrenergic agents|mesh-ancestor
111218567|NCT01229410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111218568|NCT01229410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111218569|NCT01229410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111218570|NCT01212484|Carbidopa|carbidopa|mesh-list
111218571|NCT01212484|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111218572|NCT01212484|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111218573|NCT01212484|Dopamine Agents|dopamine agents|mesh-ancestor
111218574|NCT01212484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111218575|NCT01212484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111218576|NCT01212484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111218577|NCT01212484|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
111218578|NCT01212484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111218579|NCT03446976|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111218580|NCT03446976|Immunologic Factors|immunologic factors|mesh-ancestor
111218581|NCT03446976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111218582|NCT01212874|Nitroglycerin|nitroglycerin|mesh-list
111218583|NCT01212874|Esmolol|esmolol|mesh-list
111218584|NCT01212874|Vasodilator Agents|vasodilator agents|mesh-ancestor
111218585|NCT01212874|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
111218586|NCT01212874|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111218587|NCT01212874|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111218588|NCT01212874|Adrenergic Agents|adrenergic agents|mesh-ancestor
111218589|NCT01212874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111218590|NCT01212874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111218591|NCT01212874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111218592|NCT01859741|Carboplatin|carboplatin|mesh-list
111218593|NCT01859741|Etoposide|etoposide|mesh-list
111218594|NCT01859741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111218595|NCT01859741|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111218596|NCT01859741|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111218597|NCT01859741|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111218598|NCT01859741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111218599|NCT01859741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111218600|NCT01212952|Dexamethasone|dexamethasone|mesh-list
111218601|NCT01212952|Bortezomib|bortezomib|mesh-list
111218602|NCT01212952|Pomalidomide|pomalidomide|mesh-list
111218603|NCT01212952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111218604|NCT01212952|Antiemetics|antiemetics|mesh-ancestor
111218605|NCT01212952|Autonomic Agents|autonomic agents|mesh-ancestor
111218606|NCT01212952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111218607|NCT01212952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111218608|NCT01212952|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111218609|NCT01212952|Glucocorticoids|glucocorticoids|mesh-ancestor
111218610|NCT01212952|Hormones|hormones|mesh-ancestor
111218611|NCT01212952|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111218612|NCT01212952|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111218613|NCT01212952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111218614|NCT01212952|Immunologic Factors|immunologic factors|mesh-ancestor
111218615|NCT01212952|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111218616|NCT01212952|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111218617|NCT01212952|Growth Substances|growth substances|mesh-ancestor
111218618|NCT01212952|Growth Inhibitors|growth inhibitors|mesh-ancestor
111218619|NCT04609865|Lidocaine|lidocaine|mesh-list
111218620|NCT04609865|Anesthetics, Local|anesthetics, local|mesh-ancestor
111218621|NCT04609865|Anesthetics|anesthetics|mesh-ancestor
111218622|NCT04609865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111218623|NCT04609865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111218624|NCT04609865|Sensory System Agents|sensory system agents|mesh-ancestor
111218625|NCT04609865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111218626|NCT04609865|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111218627|NCT04609865|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111218628|NCT04609865|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111218629|NCT04609865|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111218630|NCT04609865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111218631|NCT01873859|Metformin|metformin|mesh-list
111218632|NCT01873859|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111218633|NCT01873859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111218634|NCT00493896|Enoxaparin|enoxaparin|mesh-list
111218635|NCT00493896|PENTA|penta|mesh-list
111218636|NCT00493896|Fondaparinux|fondaparinux|mesh-list
111218637|NCT00493896|Anticoagulants|anticoagulants|mesh-ancestor
111218638|NCT00493896|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111218639|NCT00493896|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111218640|NCT00493896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111218641|NCT00493896|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111218642|NCT00493896|Antithrombins|antithrombins|mesh-ancestor
111218643|NCT00493896|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111218644|NCT00493896|Protease Inhibitors|protease inhibitors|mesh-ancestor
111218645|NCT00493896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111218646|NCT03449940|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111218647|NCT03449940|Ceftriaxone|ceftriaxone|mesh-list
111218648|NCT03449940|Diclofenac|diclofenac|mesh-list
111218649|NCT03449940|Lidocaine|lidocaine|mesh-list
111218650|NCT03449940|Analgesics|analgesics|mesh-list
111218651|NCT03449940|Anesthetics, Local|anesthetics, local|mesh-ancestor
111218652|NCT03449940|Anesthetics|anesthetics|mesh-ancestor
111218653|NCT03449940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111218654|NCT03449940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111218655|NCT03449940|Sensory System Agents|sensory system agents|mesh-ancestor
111218656|NCT03449940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111218657|NCT03449940|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111218658|NCT03449940|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111218659|NCT03449940|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111218660|NCT03449940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111218661|NCT03449940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111218662|NCT03449940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111218663|NCT03449940|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111218664|NCT03449940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111218665|NCT03449940|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111218666|NCT03449940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111218667|NCT03449940|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111218668|NCT03449940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111218669|NCT01230424|Triamcinolone|triamcinolone|mesh-list
111218670|NCT01230424|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
111218671|NCT01230424|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
111218672|NCT01230424|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
111218673|NCT01230424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111218674|NCT01230424|Glucocorticoids|glucocorticoids|mesh-ancestor
111218675|NCT01230424|Hormones|hormones|mesh-ancestor
111218676|NCT01230424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111218677|NCT01230424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111218678|NCT01230424|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111218679|NCT01230424|Immunologic Factors|immunologic factors|mesh-ancestor
111218680|NCT01230424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111218681|NCT01230424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111218682|NCT01230502|Mycophenolic Acid|mycophenolic acid|mesh-list
111218683|NCT01230502|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111218684|NCT01230502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111218685|NCT01230502|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111218686|NCT01230502|Antitubercular Agents|antitubercular agents|mesh-ancestor
110798167|NCT01308255|Infliximab|infliximab|mesh-list
111218687|NCT01230502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111218688|NCT01230502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111218689|NCT01230502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111218690|NCT01230502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111218691|NCT03438240|Fentanyl|fentanyl|mesh-list
111218692|NCT03438240|Dexmedetomidine|dexmedetomidine|mesh-list
111218693|NCT03438240|Bupivacaine|bupivacaine|mesh-list
111218694|NCT03438240|Anesthetics, Local|anesthetics, local|mesh-list
111218695|NCT03438240|Anesthetics|anesthetics|mesh-list
111218696|NCT03438240|Sympathomimetics|sympathomimetics|mesh-list
111218697|NCT03438240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111218698|NCT03438240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111218699|NCT03438240|Sensory System Agents|sensory system agents|mesh-ancestor
111218700|NCT03438240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111218701|NCT03438240|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111218702|NCT03438240|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111218703|NCT03438240|Analgesics|analgesics|mesh-ancestor
111218704|NCT03438240|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111218705|NCT03438240|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111218706|NCT03438240|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111218707|NCT03438240|Adrenergic Agents|adrenergic agents|mesh-ancestor
111218708|NCT03438240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111218709|NCT03438240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111218710|NCT03438240|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111218711|NCT03438240|Narcotics|narcotics|mesh-ancestor
111218712|NCT03438240|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111218713|NCT03438240|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111218714|NCT03438240|Anesthetics, General|anesthetics, general|mesh-ancestor
111218715|NCT03438240|Autonomic Agents|autonomic agents|mesh-ancestor
111218716|NCT01160848|Ethanol|ethanol|mesh-list
111218717|NCT01160848|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111218718|NCT01160848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111218719|NCT01160848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111218720|NCT01160848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111218721|NCT01213576|Ivermectin|ivermectin|mesh-list
111218722|NCT01213576|Albendazole|albendazole|mesh-list
111218723|NCT01213576|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111218724|NCT01213576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111218725|NCT01213576|Anthelmintics|anthelmintics|mesh-ancestor
111218726|NCT01213576|Anticestodal Agents|anticestodal agents|mesh-ancestor
111218727|NCT01213576|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
111218728|NCT01213576|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111218729|NCT01213576|Tubulin Modulators|tubulin modulators|mesh-ancestor
111218730|NCT01213576|Antimitotic Agents|antimitotic agents|mesh-ancestor
111218731|NCT01213576|Mitosis Modulators|mitosis modulators|mesh-ancestor
111218732|NCT01213576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111218733|NCT01213576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111218734|NCT04452318|Casirivimab and imdevimab drug combination|casirivimab and imdevimab drug combination|mesh-list
111218735|NCT04452318|Antiviral Agents|antiviral agents|mesh-ancestor
111218736|NCT04452318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111218737|NCT01161862|Glucagon|glucagon|mesh-list
111218738|NCT01161862|Pancrelipase|pancrelipase|mesh-list
111218739|NCT01161862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111218740|NCT01161862|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111218741|NCT01161862|Hormones|hormones|mesh-ancestor
111218742|NCT01161862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111218743|NCT01214356|Vitamin D|vitamin d|mesh-list
111218744|NCT01214356|Ergocalciferols|ergocalciferols|mesh-list
111218745|NCT01214356|Cholecalciferol|cholecalciferol|mesh-list
111218746|NCT01214356|Vitamins|vitamins|mesh-list
111218747|NCT01214356|Micronutrients|micronutrients|mesh-ancestor
111218748|NCT01214356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111218749|NCT01214356|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111218750|NCT01214356|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111218751|NCT01232920|Mycophenolic Acid|mycophenolic acid|mesh-list
111218753|NCT01232920|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111218754|NCT01232920|Abortifacient Agents|abortifacient agents|mesh-ancestor
111218755|NCT01232920|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111218756|NCT01232920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111218757|NCT01232920|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111218758|NCT01232920|Antimetabolites|antimetabolites|mesh-ancestor
111218759|NCT01232920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111218760|NCT01232920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111218761|NCT01232920|Dermatologic Agents|dermatologic agents|mesh-ancestor
111218762|NCT01232920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111218763|NCT01232920|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111218764|NCT01232920|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111218765|NCT01232920|Immunologic Factors|immunologic factors|mesh-ancestor
111218766|NCT01232920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111218767|NCT01232920|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111218768|NCT01232920|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111218769|NCT01232920|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111218770|NCT01232920|Antitubercular Agents|antitubercular agents|mesh-ancestor
111218771|NCT01232920|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111218772|NCT01232920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111218773|NCT03445182|Anesthetics|anesthetics|mesh-list
111218774|NCT03445182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111218775|NCT03445182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111218776|NCT03010540|Fentanyl|fentanyl|mesh-list
111218777|NCT03010540|Morphine|morphine|mesh-list
111218778|NCT03010540|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111218779|NCT03010540|Narcotics|narcotics|mesh-ancestor
111218780|NCT03010540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111218781|NCT03010540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111218782|NCT03010540|Analgesics|analgesics|mesh-ancestor
111218783|NCT03010540|Sensory System Agents|sensory system agents|mesh-ancestor
111218784|NCT03010540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111218785|NCT03010540|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111218786|NCT03010540|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111218787|NCT03010540|Anesthetics, General|anesthetics, general|mesh-ancestor
111218788|NCT03010540|Anesthetics|anesthetics|mesh-ancestor
111218789|NCT03445104|Huperzine A|huperzine a|mesh-list
111218790|NCT03445104|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111218791|NCT03445104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111218792|NCT03445104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111218793|NCT03445104|Cholinergic Agents|cholinergic agents|mesh-ancestor
111218794|NCT03445104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111218795|NCT03445104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111218796|NCT03445104|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111218797|NCT03445104|Protective Agents|protective agents|mesh-ancestor
111218798|NCT01234714|Liver Extracts|liver extracts|mesh-list
111218799|NCT01234714|Hematinics|hematinics|mesh-ancestor
111218800|NCT03440502|Anesthetics|anesthetics|mesh-list
111218801|NCT03440502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111218802|NCT03440502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111218803|NCT01234870|Adenosine|adenosine|mesh-list
111218804|NCT01234870|Analgesics|analgesics|mesh-ancestor
111218805|NCT01234870|Sensory System Agents|sensory system agents|mesh-ancestor
111218806|NCT01234870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111218807|NCT01234870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111218808|NCT01234870|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111218809|NCT01234870|Vasodilator Agents|vasodilator agents|mesh-ancestor
111218810|NCT01234870|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
111218811|NCT01234870|Purinergic Agonists|purinergic agonists|mesh-ancestor
111218812|NCT01234870|Purinergic Agents|purinergic agents|mesh-ancestor
111218813|NCT01234870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111218814|NCT01234870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111218815|NCT03437460|Ibuprofen|ibuprofen|mesh-list
111218816|NCT03437460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111218817|NCT03437460|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111218818|NCT03437460|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111218819|NCT03437460|Analgesics|analgesics|mesh-ancestor
111218820|NCT03437460|Sensory System Agents|sensory system agents|mesh-ancestor
111218821|NCT03437460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111218822|NCT03437460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111218823|NCT03437460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111218824|NCT03437460|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111218825|NCT03437460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111218826|NCT03437460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111218827|NCT03444636|Fentanyl|fentanyl|mesh-list
111218828|NCT03444636|Bupivacaine|bupivacaine|mesh-list
111218829|NCT03444636|Ropivacaine|ropivacaine|mesh-list
111218830|NCT03444636|Anesthetics, Local|anesthetics, local|mesh-ancestor
111218831|NCT03444636|Anesthetics|anesthetics|mesh-ancestor
111218832|NCT03444636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111218833|NCT03444636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111218834|NCT03444636|Sensory System Agents|sensory system agents|mesh-ancestor
111218835|NCT03444636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111218836|NCT03444636|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111218837|NCT03444636|Narcotics|narcotics|mesh-ancestor
111218838|NCT03444636|Analgesics|analgesics|mesh-ancestor
111218839|NCT03444636|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111218840|NCT03444636|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111218841|NCT03444636|Anesthetics, General|anesthetics, general|mesh-ancestor
111218842|NCT01215292|Ketoconazole|ketoconazole|mesh-list
111218843|NCT01215292|Anastrozole|anastrozole|mesh-list
111218844|NCT01215292|Testosterone|testosterone|mesh-list
111218845|NCT01215292|Dutasteride|dutasteride|mesh-list
111218846|NCT01215292|Acyline|acyline|mesh-list
111218847|NCT01215292|Androgens|androgens|mesh-ancestor
111218848|NCT01215292|Hormones|hormones|mesh-ancestor
111218849|NCT01215292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111218850|NCT01215292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111218851|NCT01215292|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111218852|NCT01215292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111218853|NCT01215292|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111218854|NCT01215292|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111218855|NCT01215292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111218856|NCT01215292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111218857|NCT01215292|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111218858|NCT01215292|Hormone Antagonists|hormone antagonists|mesh-ancestor
111218859|NCT01215292|Antifungal Agents|antifungal agents|mesh-ancestor
111218860|NCT01215292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111218861|NCT01215292|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111218862|NCT01215292|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111218863|NCT01215292|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111218864|NCT01215292|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
111218865|NCT04796454|Gemcitabine|gemcitabine|mesh-list
111218866|NCT04796454|Oxaliplatin|oxaliplatin|mesh-list
111218867|NCT04796454|Temozolomide|temozolomide|mesh-list
111218868|NCT04796454|Pamiparib|pamiparib|mesh-list
111218869|NCT04796454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111218870|NCT04796454|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111218871|NCT04796454|Antimetabolites|antimetabolites|mesh-ancestor
111218872|NCT04796454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111218873|NCT04796454|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111218874|NCT04796454|Alkylating Agents|alkylating agents|mesh-ancestor
111218875|NCT04796454|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111218876|NCT04796454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111218877|NCT02189668|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111218878|NCT02189668|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
111218879|NCT02189668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111218880|NCT02189668|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
111218881|NCT02189668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111218882|NCT02189668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111218883|NCT02981290|Mycophenolic Acid|mycophenolic acid|mesh-list
111218884|NCT02981290|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111218885|NCT02981290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111218886|NCT02981290|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111218887|NCT02981290|Antitubercular Agents|antitubercular agents|mesh-ancestor
111218888|NCT02981290|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111218889|NCT02981290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111218890|NCT02981290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111218891|NCT02981290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111218892|NCT03437226|Simendan|simendan|mesh-list
111218893|NCT03437226|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111218894|NCT03437226|Vasodilator Agents|vasodilator agents|mesh-ancestor
111218895|NCT03437226|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
111218896|NCT03437226|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111218897|NCT03437226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111218898|NCT03437226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111218899|NCT03437226|Protective Agents|protective agents|mesh-ancestor
110671841|NCT00841919|Insulin|insulin|mesh-list
111218900|NCT03437226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111218901|NCT04788420|Sorafenib|sorafenib|mesh-list
111218902|NCT04788420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111218903|NCT04788420|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111218904|NCT04788420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111218905|NCT04788420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111218906|NCT01282138|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
111218907|NCT01282138|Dextrans|dextrans|mesh-list
111218908|NCT01282138|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111218909|NCT01282138|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111218910|NCT01282138|Anticoagulants|anticoagulants|mesh-ancestor
111218911|NCT01282138|Plasma Substitutes|plasma substitutes|mesh-ancestor
111218912|NCT01282138|Blood Substitutes|blood substitutes|mesh-ancestor
111218913|NCT01282138|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111218914|NCT01282138|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111218915|NCT01282138|Analgesics|analgesics|mesh-ancestor
111218916|NCT01282138|Sensory System Agents|sensory system agents|mesh-ancestor
111218917|NCT01282138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111218918|NCT01282138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111218919|NCT01282138|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111218920|NCT01282138|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111218921|NCT01282138|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111218922|NCT01282138|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
111218923|NCT01282138|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111218924|NCT01282138|Histamine Antagonists|histamine antagonists|mesh-ancestor
111218925|NCT01282138|Histamine Agents|histamine agents|mesh-ancestor
111218926|NCT01282138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111218927|NCT01282138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111218928|NCT03444402|Esomeprazole|esomeprazole|mesh-list
111218929|NCT03444402|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111218930|NCT03444402|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111218931|NCT03444402|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111218932|NCT03444402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111218933|NCT03444402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111218934|NCT01238536|Dexamethasone|dexamethasone|mesh-list
111218935|NCT01238536|Betamethasone|betamethasone|mesh-list
111218936|NCT01238536|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111218937|NCT01238536|Lidocaine|lidocaine|mesh-list
111218938|NCT01238536|Anesthetics, Local|anesthetics, local|mesh-list
111218939|NCT01238536|Anesthetics|anesthetics|mesh-list
111218940|NCT01238536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111218941|NCT01238536|Antiemetics|antiemetics|mesh-ancestor
111218942|NCT01238536|Autonomic Agents|autonomic agents|mesh-ancestor
111218943|NCT01238536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111218944|NCT01238536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111218945|NCT01238536|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111218946|NCT01238536|Glucocorticoids|glucocorticoids|mesh-ancestor
111218947|NCT01238536|Hormones|hormones|mesh-ancestor
111218948|NCT01238536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111218949|NCT01238536|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111218950|NCT01238536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111218951|NCT01238536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111218952|NCT01238536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111218953|NCT01238536|Sensory System Agents|sensory system agents|mesh-ancestor
111218954|NCT01238536|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111218955|NCT01238536|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111218956|NCT01238536|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111218957|NCT01238536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111218958|NCT01238536|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111218959|NCT01238536|Respiratory System Agents|respiratory system agents|mesh-ancestor
111218960|NCT03437070|Doxorubicin|doxorubicin|mesh-list
111218961|NCT03437070|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111218962|NCT03437070|Trabectedin|trabectedin|mesh-list
111218963|NCT03437070|Olaratumab|olaratumab|mesh-list
111218964|NCT03437070|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111218965|NCT03437070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111218966|NCT03437070|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111218967|NCT03437070|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111218968|NCT03437070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111218969|NCT03437070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111218970|NCT03437070|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111218971|NCT03437070|Alkylating Agents|alkylating agents|mesh-ancestor
111218972|NCT03128736|Esomeprazole|esomeprazole|mesh-list
111218973|NCT03128736|Dexlansoprazole|dexlansoprazole|mesh-list
110682830|NCT00902915|Antiemetics|antiemetics|mesh-ancestor
111218974|NCT03128736|Lansoprazole|lansoprazole|mesh-list
111218975|NCT03128736|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111218976|NCT03128736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111218977|NCT03128736|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111218978|NCT03128736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111218979|NCT03128736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111218980|NCT01218958|Naltrexone|naltrexone|mesh-list
111218981|NCT01218958|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111218982|NCT01218958|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111218983|NCT01218958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111218984|NCT01218958|Sensory System Agents|sensory system agents|mesh-ancestor
111218985|NCT01218958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111218986|NCT03440268|Acetylcysteine|acetylcysteine|mesh-list
111218987|NCT03440268|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111218988|NCT03440268|Antiviral Agents|antiviral agents|mesh-ancestor
111218989|NCT03440268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111218990|NCT03440268|Expectorants|expectorants|mesh-ancestor
111218991|NCT03440268|Respiratory System Agents|respiratory system agents|mesh-ancestor
111218992|NCT03440268|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111218993|NCT03440268|Antioxidants|antioxidants|mesh-ancestor
111218994|NCT03440268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111218995|NCT03440268|Protective Agents|protective agents|mesh-ancestor
111218996|NCT03440268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111218997|NCT03440268|Antidotes|antidotes|mesh-ancestor
111218998|NCT03444246|Iodine|iodine|mesh-list
111218999|NCT03444246|Cadexomer iodine|cadexomer iodine|mesh-list
111219000|NCT03444246|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111219001|NCT03444246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111219002|NCT03444246|Trace Elements|trace elements|mesh-ancestor
111219003|NCT03444246|Micronutrients|micronutrients|mesh-ancestor
111219004|NCT03444246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111219005|NCT04369014|Anesthetics|anesthetics|mesh-list
111219006|NCT04369014|Propofol|propofol|mesh-list
111219007|NCT04369014|Etomidate|etomidate|mesh-list
111219008|NCT04369014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111219009|NCT04369014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111219010|NCT04369014|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111219011|NCT04369014|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111219012|NCT04369014|Anesthetics, General|anesthetics, general|mesh-ancestor
111219013|NCT03436836|Lidocaine|lidocaine|mesh-list
111219014|NCT03436836|Nalbuphine|nalbuphine|mesh-list
111219015|NCT03436836|Bupivacaine|bupivacaine|mesh-list
111219016|NCT03436836|Anesthetics, Local|anesthetics, local|mesh-ancestor
111219017|NCT03436836|Anesthetics|anesthetics|mesh-ancestor
111219018|NCT03436836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111219019|NCT03436836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111219020|NCT03436836|Sensory System Agents|sensory system agents|mesh-ancestor
111219021|NCT03436836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111219022|NCT03436836|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111219023|NCT03436836|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111219024|NCT03436836|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111219025|NCT03436836|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111219026|NCT03436836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111219027|NCT03436836|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111219028|NCT03436836|Narcotics|narcotics|mesh-ancestor
111219029|NCT03436836|Analgesics|analgesics|mesh-ancestor
111219030|NCT03444012|Ticagrelor|ticagrelor|mesh-list
111219031|NCT03444012|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111219032|NCT03444012|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111219033|NCT03444012|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111219034|NCT03444012|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111219035|NCT03444012|Purinergic Agents|purinergic agents|mesh-ancestor
111219036|NCT03444012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111219037|NCT03444012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111219038|NCT03444012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111219039|NCT03440034|Pioglitazone|pioglitazone|mesh-list
111219040|NCT03440034|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111219041|NCT03440034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111219042|NCT03433326|Grazoprevir|grazoprevir|mesh-list
111219043|NCT03433326|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
111219044|NCT03433326|Antiviral Agents|antiviral agents|mesh-ancestor
111219045|NCT03433326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111219046|NCT00244101|Pulmonary Surfactants|pulmonary surfactants|mesh-list
111219047|NCT00244101|Respiratory System Agents|respiratory system agents|mesh-ancestor
111219048|NCT04451382|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111219049|NCT04451382|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111219050|NCT04451382|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111119135|NCT05342844|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111219051|NCT04451382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111219052|NCT04451382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111219053|NCT04451382|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111219054|NCT04451382|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111219055|NCT04451382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111219056|NCT04451382|Cholinergic Agents|cholinergic agents|mesh-ancestor
111219057|NCT04451382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111219058|NCT04276389|Paclitaxel|paclitaxel|mesh-list
111219059|NCT04276389|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111219060|NCT04276389|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111219061|NCT04276389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111219062|NCT04276389|Tubulin Modulators|tubulin modulators|mesh-ancestor
111219063|NCT04276389|Antimitotic Agents|antimitotic agents|mesh-ancestor
111219064|NCT04276389|Mitosis Modulators|mitosis modulators|mesh-ancestor
111219065|NCT04276389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111219066|NCT03128619|Letrozole|letrozole|mesh-list
111219067|NCT03128619|Palbociclib|palbociclib|mesh-list
111219068|NCT03128619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111219069|NCT03128619|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111219070|NCT03128619|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111219071|NCT03128619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111219072|NCT03128619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111219073|NCT03128619|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111219074|NCT03128619|Hormone Antagonists|hormone antagonists|mesh-ancestor
111219075|NCT03128619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111219076|NCT03128619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111219077|NCT03128619|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111219078|NCT03433092|Carotenoids|carotenoids|mesh-list
111219079|NCT03433092|Antioxidants|antioxidants|mesh-ancestor
111219080|NCT03433092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111219081|NCT03433092|Protective Agents|protective agents|mesh-ancestor
111219082|NCT03433092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111219083|NCT03433014|Levobupivacaine|levobupivacaine|mesh-list
111219084|NCT03433014|Anesthetics, Local|anesthetics, local|mesh-ancestor
111219085|NCT03433014|Anesthetics|anesthetics|mesh-ancestor
111219086|NCT03433014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111219087|NCT03433014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111219088|NCT03433014|Sensory System Agents|sensory system agents|mesh-ancestor
111219089|NCT03433014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111219090|NCT01872689|Pirfenidone|pirfenidone|mesh-list
111219091|NCT01872689|Analgesics|analgesics|mesh-ancestor
111219092|NCT01872689|Sensory System Agents|sensory system agents|mesh-ancestor
111219093|NCT01872689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111219094|NCT01872689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111219095|NCT01872689|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111219096|NCT01872689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111219097|NCT01872689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111219098|NCT01872689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111219099|NCT01872689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111219100|NCT03435900|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111219101|NCT03435900|Metronidazole|metronidazole|mesh-list
111219102|NCT03435900|Fosfomycin|fosfomycin|mesh-list
111219103|NCT03435900|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
111219104|NCT03435900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111219105|NCT03435900|Antitubercular Agents|antitubercular agents|mesh-ancestor
111219106|NCT03435900|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111219107|NCT03435900|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111219108|NCT00632931|Vorinostat|vorinostat|mesh-list
111219109|NCT00632931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111219110|NCT00632931|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111219111|NCT00632931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111219112|NCT00632931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111219113|NCT01857323|Albuterol|albuterol|mesh-list
111219114|NCT01857323|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111219115|NCT01857323|Autonomic Agents|autonomic agents|mesh-ancestor
111219116|NCT01857323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111219117|NCT01857323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111219118|NCT01857323|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111219119|NCT01857323|Respiratory System Agents|respiratory system agents|mesh-ancestor
111219120|NCT01857323|Tocolytic Agents|tocolytic agents|mesh-ancestor
111219121|NCT01857323|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111219122|NCT01857323|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111219123|NCT01857323|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111219124|NCT01857323|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111219125|NCT01857323|Adrenergic Agents|adrenergic agents|mesh-ancestor
111219126|NCT01857323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111219127|NCT01857323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111219128|NCT03104439|Nivolumab|nivolumab|mesh-list
111219129|NCT03104439|Ipilimumab|ipilimumab|mesh-list
111219130|NCT03104439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111219131|NCT03104439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111219132|NCT03104439|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111219133|NCT03104439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111219134|NCT03432780|Docetaxel|docetaxel|mesh-list
111219135|NCT03432780|Hormones|hormones|mesh-list
111219136|NCT03432780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111219137|NCT03432780|Tubulin Modulators|tubulin modulators|mesh-ancestor
111219138|NCT03432780|Antimitotic Agents|antimitotic agents|mesh-ancestor
111219139|NCT03432780|Mitosis Modulators|mitosis modulators|mesh-ancestor
111219140|NCT03432780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111219141|NCT03432780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111219142|NCT03432780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111219143|NCT00055731|Aspirin|aspirin|mesh-list
111219144|NCT00055731|Docetaxel|docetaxel|mesh-list
111219145|NCT00055731|Goserelin|goserelin|mesh-list
111219146|NCT00055731|Bicalutamide|bicalutamide|mesh-list
111219147|NCT00055731|Estramustine|estramustine|mesh-list
111219148|NCT00055731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111219149|NCT00055731|Tubulin Modulators|tubulin modulators|mesh-ancestor
111219150|NCT00055731|Antimitotic Agents|antimitotic agents|mesh-ancestor
111219151|NCT00055731|Mitosis Modulators|mitosis modulators|mesh-ancestor
111219152|NCT00055731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111219153|NCT00055731|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111219154|NCT00055731|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111219155|NCT00055731|Analgesics|analgesics|mesh-ancestor
111219156|NCT00055731|Sensory System Agents|sensory system agents|mesh-ancestor
111219157|NCT00055731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111219158|NCT00055731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111219159|NCT00055731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111219160|NCT00055731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111219161|NCT00055731|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111219162|NCT00055731|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111219163|NCT00055731|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111219164|NCT00055731|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111219165|NCT00055731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111219166|NCT00055731|Antipyretics|antipyretics|mesh-ancestor
111219167|NCT00055731|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111219168|NCT00055731|Androgen Antagonists|androgen antagonists|mesh-ancestor
111219169|NCT00055731|Hormone Antagonists|hormone antagonists|mesh-ancestor
111219170|NCT00055731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111219171|NCT00055731|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111219172|NCT00055731|Alkylating Agents|alkylating agents|mesh-ancestor
111219173|NCT03435744|Simvastatin|simvastatin|mesh-list
111219174|NCT03435744|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111219175|NCT03435744|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111219176|NCT03435744|Antimetabolites|antimetabolites|mesh-ancestor
111219177|NCT03435744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111219178|NCT03435744|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111219179|NCT03435744|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111219180|NCT03435744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111219181|NCT03435666|Capecitabine|capecitabine|mesh-list
111219182|NCT03435666|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111219183|NCT03435666|Antimetabolites|antimetabolites|mesh-ancestor
111219184|NCT03435666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111219185|NCT03435666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111219186|NCT00632541|Bevacizumab|bevacizumab|mesh-list
111219187|NCT00632541|Sorafenib|sorafenib|mesh-list
111219188|NCT00632541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111219189|NCT00632541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111219190|NCT00632541|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111219191|NCT00632541|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111219192|NCT00632541|Growth Substances|growth substances|mesh-ancestor
111219193|NCT00632541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111219194|NCT00632541|Growth Inhibitors|growth inhibitors|mesh-ancestor
111219195|NCT00632541|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111219196|NCT00632541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111219197|NCT00632541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111219198|NCT01872611|Prednisolone|prednisolone|mesh-list
111219199|NCT01872611|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111219200|NCT01872611|Methylprednisolone|methylprednisolone|mesh-list
111219201|NCT01872611|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111219202|NCT01872611|Prednisolone acetate|prednisolone acetate|mesh-list
111219203|NCT01872611|Nepafenac|nepafenac|mesh-list
111219204|NCT01872611|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111219205|NCT01872611|Prednisolone phosphate|prednisolone phosphate|mesh-list
111219206|NCT01872611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111219207|NCT01872611|Glucocorticoids|glucocorticoids|mesh-ancestor
111219208|NCT01872611|Hormones|hormones|mesh-ancestor
111219209|NCT01872611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111219210|NCT01872611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111219211|NCT01872611|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111219212|NCT01872611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111219213|NCT01872611|Antiemetics|antiemetics|mesh-ancestor
111219214|NCT01872611|Autonomic Agents|autonomic agents|mesh-ancestor
111219215|NCT01872611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111219216|NCT01872611|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111219217|NCT01872611|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111219218|NCT01872611|Protective Agents|protective agents|mesh-ancestor
111219219|NCT01872611|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111219220|NCT01872611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111219221|NCT01872611|Analgesics|analgesics|mesh-ancestor
111219222|NCT01872611|Sensory System Agents|sensory system agents|mesh-ancestor
111219223|NCT01872611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111219224|NCT03432468|Valsartan|valsartan|mesh-list
111219225|NCT03432468|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111219226|NCT03432468|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111219227|NCT03432468|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111219228|NCT03432468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111219229|NCT01856543|Mometasone Furoate|mometasone furoate|mesh-list
111219230|NCT01856543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111219231|NCT01856543|Dermatologic Agents|dermatologic agents|mesh-ancestor
111219232|NCT01856543|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111219233|NCT03432312|Nicotine|nicotine|mesh-list
111219234|NCT03432312|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111219235|NCT03432312|Autonomic Agents|autonomic agents|mesh-ancestor
111219236|NCT03432312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111219237|NCT03432312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111219238|NCT03432312|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111219239|NCT03432312|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111219240|NCT03432312|Cholinergic Agents|cholinergic agents|mesh-ancestor
111219241|NCT03432312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111219242|NCT03432312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111219243|NCT03438942|Folic Acid|folic acid|mesh-list
111219244|NCT03438942|Hematinics|hematinics|mesh-ancestor
111219245|NCT03438942|Vitamin B Complex|vitamin b complex|mesh-ancestor
111219246|NCT03438942|Vitamins|vitamins|mesh-ancestor
111219247|NCT03438942|Micronutrients|micronutrients|mesh-ancestor
111219248|NCT03438942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111219249|NCT03432156|Immunomodulating Agents|immunomodulating agents|mesh-list
111219250|NCT03432156|Immunologic Factors|immunologic factors|mesh-ancestor
111219251|NCT03432156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111219252|NCT04450680|Lactams|lactams|mesh-list
111219253|NCT04450680|beta-Lactams|beta-lactams|mesh-list
111219254|NCT04450680|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111219255|NCT04450680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111219256|NCT03438708|Axitinib|axitinib|mesh-list
111219257|NCT03438708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111219258|NCT03438708|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111219259|NCT03438708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111219260|NCT03438708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111219261|NCT01923597|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
111219262|NCT01923597|Antioxidants|antioxidants|mesh-ancestor
111219263|NCT01923597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111219264|NCT01923597|Protective Agents|protective agents|mesh-ancestor
111219265|NCT01923597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111219266|NCT01923597|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
111219267|NCT01923597|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
111219268|NCT01923597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111219269|NCT01923597|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111219270|NCT00632229|Paliperidone Palmitate|paliperidone palmitate|mesh-list
111219271|NCT00632229|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111219272|NCT00632229|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111219273|NCT00632229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111219274|NCT00632229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111219275|NCT00632229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111219276|NCT00632229|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111219277|NCT00632229|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111219278|NCT00632229|Serotonin Agents|serotonin agents|mesh-ancestor
111219279|NCT00632229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111219280|NCT00632229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111219281|NCT00632229|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111219282|NCT00632229|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111219283|NCT00632229|Dopamine Agents|dopamine agents|mesh-ancestor
111219284|NCT00631137|Testosterone|testosterone|mesh-list
111219285|NCT00631137|Androgens|androgens|mesh-ancestor
111219286|NCT00631137|Hormones|hormones|mesh-ancestor
111219287|NCT00631137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111219288|NCT00631137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111219289|NCT03428880|Morphine|morphine|mesh-list
111219290|NCT03428880|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111219291|NCT03428880|Narcotics|narcotics|mesh-ancestor
111219292|NCT03428880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111219293|NCT03428880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111219294|NCT03428880|Analgesics|analgesics|mesh-ancestor
111219295|NCT03428880|Sensory System Agents|sensory system agents|mesh-ancestor
111219296|NCT03428880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111219297|NCT01923831|Dexamethasone|dexamethasone|mesh-list
111219298|NCT01923831|Magnesium Sulfate|magnesium sulfate|mesh-list
111219299|NCT01923831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111219300|NCT01923831|Antiemetics|antiemetics|mesh-ancestor
111219301|NCT01923831|Autonomic Agents|autonomic agents|mesh-ancestor
111219302|NCT01923831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111219303|NCT01923831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111219304|NCT01923831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111219305|NCT01923831|Glucocorticoids|glucocorticoids|mesh-ancestor
111219306|NCT01923831|Hormones|hormones|mesh-ancestor
111219307|NCT01923831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111219308|NCT01923831|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111219309|NCT01923831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111219310|NCT01923831|Analgesics|analgesics|mesh-ancestor
111219311|NCT01923831|Sensory System Agents|sensory system agents|mesh-ancestor
111219312|NCT01923831|Anesthetics|anesthetics|mesh-ancestor
111219313|NCT01923831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111219314|NCT01923831|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111219315|NCT01923831|Anticonvulsants|anticonvulsants|mesh-ancestor
111219316|NCT01923831|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111219317|NCT01923831|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111219318|NCT01923831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111219319|NCT01923831|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111219320|NCT01923831|Tocolytic Agents|tocolytic agents|mesh-ancestor
111219321|NCT01923831|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111219322|NCT01923909|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111219323|NCT01923909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111219324|NCT04892940|Analgesics|analgesics|mesh-list
111219325|NCT04892940|Sensory System Agents|sensory system agents|mesh-ancestor
111219326|NCT04892940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111219327|NCT04892940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111219328|NCT03085563|Midazolam|midazolam|mesh-list
111219329|NCT03085563|Nitrous Oxide|nitrous oxide|mesh-list
111219330|NCT03085563|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111219331|NCT03085563|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111219332|NCT03085563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111219333|NCT03085563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111219334|NCT03085563|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111219335|NCT03085563|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111219336|NCT03085563|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111219337|NCT03085563|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111219338|NCT03085563|Anesthetics, General|anesthetics, general|mesh-ancestor
111219339|NCT03085563|Anesthetics|anesthetics|mesh-ancestor
111219340|NCT03085563|GABA Modulators|gaba modulators|mesh-ancestor
111219341|NCT03085563|GABA Agents|gaba agents|mesh-ancestor
111219342|NCT03085563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111219343|NCT03085563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111219344|NCT03085563|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111219345|NCT03085563|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111219346|NCT03085563|Analgesics|analgesics|mesh-ancestor
111219347|NCT03085563|Sensory System Agents|sensory system agents|mesh-ancestor
111219348|NCT03085563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111219349|NCT03431766|Chlorhexidine|chlorhexidine|mesh-list
111219350|NCT03431766|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111219351|NCT03431766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111219352|NCT03431766|Disinfectants|disinfectants|mesh-ancestor
111219353|NCT04450446|Heparin|heparin|mesh-list
111219354|NCT04450446|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
111219355|NCT04450446|Tinzaparin|tinzaparin|mesh-list
111219356|NCT04450446|Dalteparin|dalteparin|mesh-list
111219357|NCT04450446|Anticoagulants|anticoagulants|mesh-ancestor
111219358|NCT04450446|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111219359|NCT04450446|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111219360|NCT04450446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111219361|NCT03274752|Paroxetine|paroxetine|mesh-list
111219362|NCT03274752|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111219363|NCT03274752|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111219364|NCT03274752|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111219365|NCT03274752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111219366|NCT03274752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111219367|NCT03274752|Serotonin Agents|serotonin agents|mesh-ancestor
111219368|NCT03274752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111219369|NCT03274752|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111219370|NCT03274752|Antidepressive Agents|antidepressive agents|mesh-ancestor
111219371|NCT03274752|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111219372|NCT03274752|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111219373|NCT03274752|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111219374|NCT03274752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111219375|NCT03242382|Palbociclib|palbociclib|mesh-list
111219376|NCT03242382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111219377|NCT03242382|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111219378|NCT03242382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111219379|NCT03242382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111219380|NCT03902418|Tenofovir|tenofovir|mesh-list
111219381|NCT03902418|Emtricitabine|emtricitabine|mesh-list
111219382|NCT03902418|Antiviral Agents|antiviral agents|mesh-ancestor
111219383|NCT03902418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111219384|NCT03902418|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111219385|NCT03902418|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111219386|NCT03902418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111219387|NCT03902418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111219388|NCT03902418|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111219389|NCT03902418|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111219390|NCT03428568|Clarithromycin|clarithromycin|mesh-list
111219391|NCT03428568|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111219392|NCT03428568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111219393|NCT03428568|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111219394|NCT03428568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111219395|NCT03428568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111219396|NCT03428568|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111219397|NCT03428568|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111219398|NCT00630825|Dulaglutide|dulaglutide|mesh-list
111219399|NCT00630825|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111219400|NCT00630825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111219401|NCT03434340|Dexamethasone|dexamethasone|mesh-list
111219402|NCT03434340|Granisetron|granisetron|mesh-list
111219403|NCT03434340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111219404|NCT03434340|Antiemetics|antiemetics|mesh-ancestor
111219405|NCT03434340|Autonomic Agents|autonomic agents|mesh-ancestor
111219406|NCT03434340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111219407|NCT03434340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111219408|NCT03434340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111219409|NCT03434340|Glucocorticoids|glucocorticoids|mesh-ancestor
111219410|NCT03434340|Hormones|hormones|mesh-ancestor
111219411|NCT03434340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111219412|NCT03434340|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111219413|NCT03434340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111219414|NCT03434340|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111219415|NCT03434340|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111219416|NCT03434340|Serotonin Agents|serotonin agents|mesh-ancestor
111219417|NCT03434340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111219418|NCT03434340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111219419|NCT03088605|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111219420|NCT03088605|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111219421|NCT01923987|Cetuximab|cetuximab|mesh-list
111219422|NCT01923987|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111219423|NCT01923987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110683274|NCT00338962|Adrenergic Agents|adrenergic agents|mesh-ancestor
111219424|NCT03101163|Hyaluronic Acid|hyaluronic acid|mesh-list
111219425|NCT03101163|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111219426|NCT03101163|Immunologic Factors|immunologic factors|mesh-ancestor
111219427|NCT03101163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111219428|NCT03101163|Viscosupplements|viscosupplements|mesh-ancestor
111219429|NCT03101163|Protective Agents|protective agents|mesh-ancestor
111219430|NCT01924065|Anticoagulants|anticoagulants|mesh-list
111219431|NCT03434106|Dextrans|dextrans|mesh-list
111219432|NCT03434106|Anticoagulants|anticoagulants|mesh-ancestor
111219433|NCT03434106|Plasma Substitutes|plasma substitutes|mesh-ancestor
111219434|NCT03434106|Blood Substitutes|blood substitutes|mesh-ancestor
111219435|NCT01241344|Brincidofovir|brincidofovir|mesh-list
111219436|NCT01241344|Antiviral Agents|antiviral agents|mesh-ancestor
111219437|NCT01241344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111219438|NCT01925001|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111219439|NCT03009682|Olaparib|olaparib|mesh-list
111219440|NCT03009682|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111219441|NCT03009682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111219442|NCT03009682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111219443|NCT03009682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111219444|NCT03431142|Aspirin|aspirin|mesh-list
111219445|NCT03431142|Clopidogrel|clopidogrel|mesh-list
111219446|NCT03431142|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111219447|NCT03431142|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111219448|NCT03431142|Analgesics|analgesics|mesh-ancestor
111219449|NCT03431142|Sensory System Agents|sensory system agents|mesh-ancestor
111219450|NCT03431142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111219451|NCT03431142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111219452|NCT03431142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111219453|NCT03431142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111219454|NCT03431142|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111219455|NCT03431142|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111219456|NCT03431142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111219457|NCT03431142|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111219458|NCT03431142|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111219459|NCT03431142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111219460|NCT03431142|Antipyretics|antipyretics|mesh-ancestor
111219461|NCT03431142|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111219462|NCT03431142|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111219463|NCT03431142|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111219464|NCT03431142|Purinergic Agents|purinergic agents|mesh-ancestor
111219465|NCT03431142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111219466|NCT03831321|Diclofenac|diclofenac|mesh-list
111219467|NCT03831321|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111219468|NCT03831321|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111219469|NCT03831321|Analgesics|analgesics|mesh-ancestor
111219470|NCT03831321|Sensory System Agents|sensory system agents|mesh-ancestor
111219471|NCT03831321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111219472|NCT03831321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111219473|NCT03831321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111219474|NCT03831321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111219475|NCT03831321|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111219476|NCT03831321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111219477|NCT03831321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111219478|NCT04450134|Fexofenadine|fexofenadine|mesh-list
111219479|NCT04450134|Famotidine|famotidine|mesh-list
111219480|NCT04450134|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111219481|NCT04450134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111219482|NCT04450134|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
111219483|NCT04450134|Histamine Antagonists|histamine antagonists|mesh-ancestor
111219484|NCT04450134|Histamine Agents|histamine agents|mesh-ancestor
111219485|NCT04450134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111219486|NCT04450134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111219487|NCT04450134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111219488|NCT04450134|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111219489|NCT04450134|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
111219490|NCT04450134|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111219491|NCT01286818|Leucovorin|leucovorin|mesh-list
111219492|NCT01286818|Fluorouracil|fluorouracil|mesh-list
111219493|NCT01286818|Irinotecan|irinotecan|mesh-list
111219494|NCT01286818|Ramucirumab|ramucirumab|mesh-list
111219495|NCT01286818|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111219496|NCT01286818|Levoleucovorin|levoleucovorin|mesh-list
111219497|NCT01286818|Antimetabolites|antimetabolites|mesh-ancestor
111219498|NCT01286818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111219499|NCT01286818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111219500|NCT01286818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111219501|NCT01286818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111219502|NCT01286818|Immunologic Factors|immunologic factors|mesh-ancestor
111219503|NCT01286818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111219504|NCT01286818|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111219505|NCT01286818|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111219506|NCT01286818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111219507|NCT01286818|Antidotes|antidotes|mesh-ancestor
111219508|NCT01286818|Protective Agents|protective agents|mesh-ancestor
111219509|NCT01286818|Vitamin B Complex|vitamin b complex|mesh-ancestor
111219510|NCT01286818|Vitamins|vitamins|mesh-ancestor
111219511|NCT01286818|Micronutrients|micronutrients|mesh-ancestor
111219512|NCT03428256|Anesthetics|anesthetics|mesh-list
111219513|NCT03428256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111219514|NCT03428256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111219515|NCT00635505|Albuterol|albuterol|mesh-list
111219516|NCT00635505|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111219517|NCT00635505|Autonomic Agents|autonomic agents|mesh-ancestor
111219518|NCT00635505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111219519|NCT00635505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111219520|NCT00635505|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111219521|NCT00635505|Respiratory System Agents|respiratory system agents|mesh-ancestor
111219522|NCT00635505|Tocolytic Agents|tocolytic agents|mesh-ancestor
111219523|NCT00635505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111219524|NCT00635505|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111219525|NCT00635505|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111219526|NCT00635505|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111219527|NCT00635505|Adrenergic Agents|adrenergic agents|mesh-ancestor
111219528|NCT00635505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111219529|NCT00635505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111219530|NCT01243450|Tretinoin|tretinoin|mesh-list
111219531|NCT01243450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111219532|NCT01243450|Keratolytic Agents|keratolytic agents|mesh-ancestor
111219533|NCT01243450|Dermatologic Agents|dermatologic agents|mesh-ancestor
111219534|NCT05249751|Arginine Vasopressin|arginine vasopressin|mesh-list
111219535|NCT05249751|Hemostatics|hemostatics|mesh-ancestor
111219536|NCT05249751|Coagulants|coagulants|mesh-ancestor
111219537|NCT05249751|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111219538|NCT05249751|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
111219539|NCT05249751|Natriuretic Agents|natriuretic agents|mesh-ancestor
111219540|NCT05249751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111219541|NCT00635193|Doxorubicin|doxorubicin|mesh-list
111219542|NCT00635193|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111219543|NCT00635193|Volociximab|volociximab|mesh-list
111219544|NCT00635193|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111219545|NCT00635193|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111219546|NCT00635193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111219547|NCT00635193|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111219548|NCT00635193|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111219549|NCT00635193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111219550|NCT00635193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111219551|NCT00635193|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111219552|NCT00635193|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111219553|NCT00635193|Growth Substances|growth substances|mesh-ancestor
111219554|NCT00635193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111219555|NCT00635193|Growth Inhibitors|growth inhibitors|mesh-ancestor
111219556|NCT00635193|Immunologic Factors|immunologic factors|mesh-ancestor
111219557|NCT00630201|Buprenorphine|buprenorphine|mesh-list
111219558|NCT00630201|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111219559|NCT00630201|Narcotics|narcotics|mesh-ancestor
111219560|NCT00630201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111219561|NCT00630201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111219562|NCT00630201|Analgesics|analgesics|mesh-ancestor
111219563|NCT00630201|Sensory System Agents|sensory system agents|mesh-ancestor
111219564|NCT00630201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111219565|NCT00630201|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111219566|NCT01925547|Curcumin|curcumin|mesh-list
111219567|NCT01925547|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111219568|NCT01925547|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111219569|NCT01925547|Analgesics|analgesics|mesh-ancestor
111219570|NCT01925547|Sensory System Agents|sensory system agents|mesh-ancestor
111219571|NCT01925547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111219572|NCT01925547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111219573|NCT01925547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111219574|NCT01925547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111219575|NCT01925547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111219576|NCT01925547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111219577|NCT01925547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111219578|NCT03122301|Bupivacaine|bupivacaine|mesh-list
111219579|NCT03122301|Anesthetics, Local|anesthetics, local|mesh-ancestor
111219580|NCT03122301|Anesthetics|anesthetics|mesh-ancestor
111219581|NCT03122301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111219582|NCT03122301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111219583|NCT03122301|Sensory System Agents|sensory system agents|mesh-ancestor
111219584|NCT03122301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111219585|NCT01925859|Dexamethasone|dexamethasone|mesh-list
111219586|NCT01925859|Dexamethasone acetate|dexamethasone acetate|mesh-list
111219587|NCT01925859|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
111219588|NCT01925859|BB 1101|bb 1101|mesh-list
111219589|NCT01925859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111219590|NCT01925859|Antiemetics|antiemetics|mesh-ancestor
111219591|NCT01925859|Autonomic Agents|autonomic agents|mesh-ancestor
111219592|NCT01925859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111219593|NCT01925859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111219594|NCT01925859|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111219595|NCT01925859|Glucocorticoids|glucocorticoids|mesh-ancestor
111219596|NCT01925859|Hormones|hormones|mesh-ancestor
111219597|NCT01925859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111219598|NCT01925859|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111219599|NCT01925859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111219600|NCT01925859|Protease Inhibitors|protease inhibitors|mesh-ancestor
111219601|NCT01925859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111219602|NCT01925859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111219603|NCT01920945|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111219604|NCT01920945|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111219605|NCT01920945|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111219606|NCT01920945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111219607|NCT01920945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111219608|NCT01920945|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111219609|NCT01920945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111219610|NCT01920945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111219611|NCT01920945|Cholinergic Agents|cholinergic agents|mesh-ancestor
111219612|NCT01920945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111219613|NCT01926639|Rituximab|rituximab|mesh-list
111219614|NCT01926639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111219615|NCT01926639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111219616|NCT01926639|Immunologic Factors|immunologic factors|mesh-ancestor
111219617|NCT01926639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111219618|NCT01926639|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111219619|NCT02199496|Ustekinumab|ustekinumab|mesh-list
111219620|NCT02199496|Dermatologic Agents|dermatologic agents|mesh-ancestor
111219621|NCT04395417|Hyaluronic Acid|hyaluronic acid|mesh-list
111219622|NCT04395417|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111219623|NCT04395417|Immunologic Factors|immunologic factors|mesh-ancestor
111219624|NCT04395417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111219625|NCT04395417|Viscosupplements|viscosupplements|mesh-ancestor
111219626|NCT04395417|Protective Agents|protective agents|mesh-ancestor
111219627|NCT02199574|Bupivacaine|bupivacaine|mesh-list
111219628|NCT02199574|Anesthetics, Local|anesthetics, local|mesh-ancestor
111219629|NCT02199574|Anesthetics|anesthetics|mesh-ancestor
111219630|NCT02199574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111219631|NCT02199574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111219632|NCT02199574|Sensory System Agents|sensory system agents|mesh-ancestor
111219633|NCT02199574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111219634|NCT02199652|Prazosin|prazosin|mesh-list
111219635|NCT02199652|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111219636|NCT02199652|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111219637|NCT02199652|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111219638|NCT02199652|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111219639|NCT02199652|Adrenergic Agents|adrenergic agents|mesh-ancestor
111219640|NCT02199652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111219641|NCT02199652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111219642|NCT02199652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111219643|NCT03009916|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
111219644|NCT03009916|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111219645|NCT03009916|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111219646|NCT03009916|Antimetabolites|antimetabolites|mesh-ancestor
111219647|NCT03009916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111219648|NCT03009916|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111219649|NCT01927029|Progesterone|progesterone|mesh-list
111219650|NCT01927029|Progestins|progestins|mesh-ancestor
111219651|NCT01927029|Hormones|hormones|mesh-ancestor
111219652|NCT01927029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111219653|NCT01927029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111219654|NCT01921647|Amoxicillin|amoxicillin|mesh-list
111219655|NCT01921647|Clarithromycin|clarithromycin|mesh-list
111219656|NCT01921647|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111219657|NCT01921647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111219658|NCT01921647|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111219659|NCT01921647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111219660|NCT01921647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111219661|NCT01921647|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111219662|NCT01921647|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111219663|NCT01339858|Acetylcysteine|acetylcysteine|mesh-list
111219664|NCT01339858|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111219665|NCT01339858|Antiviral Agents|antiviral agents|mesh-ancestor
111219666|NCT01339858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111219667|NCT01339858|Expectorants|expectorants|mesh-ancestor
111219668|NCT01339858|Respiratory System Agents|respiratory system agents|mesh-ancestor
111219669|NCT01339858|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111219670|NCT01339858|Antioxidants|antioxidants|mesh-ancestor
111219671|NCT01339858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111219672|NCT01339858|Protective Agents|protective agents|mesh-ancestor
111219673|NCT01339858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111219674|NCT01339858|Antidotes|antidotes|mesh-ancestor
111219675|NCT01339936|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
111219676|NCT01339936|Glycerol|glycerol|mesh-list
111219677|NCT01339936|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
111219678|NCT01339936|Protective Agents|protective agents|mesh-ancestor
111219679|NCT01339936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111219680|NCT01339936|Laxatives|laxatives|mesh-ancestor
111219681|NCT01339936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111219682|NCT05246865|Androgens|androgens|mesh-list
111219683|NCT05246865|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
111219684|NCT05246865|Hormones|hormones|mesh-ancestor
111219685|NCT05246865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111219686|NCT05246865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111219687|NCT05246865|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111219688|NCT05246865|Immunologic Factors|immunologic factors|mesh-ancestor
111219689|NCT03111537|Nicotine|nicotine|mesh-list
111219690|NCT03111537|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111219691|NCT03111537|Autonomic Agents|autonomic agents|mesh-ancestor
111219692|NCT03111537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111219693|NCT03111537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111219694|NCT03111537|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111219695|NCT03111537|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111219696|NCT03111537|Cholinergic Agents|cholinergic agents|mesh-ancestor
111219697|NCT03111537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111219698|NCT03111537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111219699|NCT05244525|Epinephrine|epinephrine|mesh-list
111219700|NCT05244525|Bupivacaine|bupivacaine|mesh-list
111219701|NCT05244525|Anesthetics, Local|anesthetics, local|mesh-ancestor
111219702|NCT05244525|Anesthetics|anesthetics|mesh-ancestor
111219703|NCT05244525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111219704|NCT05244525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111219705|NCT05244525|Sensory System Agents|sensory system agents|mesh-ancestor
111219706|NCT05244525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111219707|NCT05244525|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111219708|NCT05244525|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111219709|NCT05244525|Adrenergic Agents|adrenergic agents|mesh-ancestor
111219710|NCT05244525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111219711|NCT05244525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111219712|NCT05244525|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111219713|NCT05244525|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111219714|NCT05244525|Autonomic Agents|autonomic agents|mesh-ancestor
111219715|NCT05244525|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111219716|NCT05244525|Respiratory System Agents|respiratory system agents|mesh-ancestor
111219717|NCT05244525|Mydriatics|mydriatics|mesh-ancestor
111219718|NCT05244525|Sympathomimetics|sympathomimetics|mesh-ancestor
111219719|NCT05244525|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111219720|NCT01927263|Infliximab|infliximab|mesh-list
111219721|NCT01927263|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111219722|NCT01927263|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111219723|NCT01927263|Dermatologic Agents|dermatologic agents|mesh-ancestor
110672672|NCT00573755|Sorafenib|sorafenib|mesh-list
111219724|NCT01927263|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111219725|NCT01927263|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111219726|NCT01341730|Pioglitazone|pioglitazone|mesh-list
111219727|NCT01341730|Atorvastatin|atorvastatin|mesh-list
111219728|NCT01341730|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111219729|NCT01341730|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111219730|NCT01341730|Antimetabolites|antimetabolites|mesh-ancestor
111219731|NCT01341730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111219732|NCT01341730|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111219733|NCT01341730|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111219734|NCT01341730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111219735|NCT01341730|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111219736|NCT01341730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111219737|NCT01247272|Fluoxetine|fluoxetine|mesh-list
111219738|NCT01247272|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111219739|NCT01247272|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111219740|NCT01247272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111219741|NCT01247272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111219742|NCT01247272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111219743|NCT01247272|Serotonin Agents|serotonin agents|mesh-ancestor
111219744|NCT01247272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111219745|NCT01247272|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111219746|NCT01247272|Antidepressive Agents|antidepressive agents|mesh-ancestor
111219747|NCT01247272|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111219748|NCT01247272|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111219749|NCT01247272|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111219750|NCT01247272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111219751|NCT01290484|Sildenafil Citrate|sildenafil citrate|mesh-list
111219752|NCT01290484|Vasodilator Agents|vasodilator agents|mesh-ancestor
111219753|NCT01290484|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111219754|NCT01290484|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111219755|NCT01290484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111219756|NCT01290484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111219757|NCT01290484|Urological Agents|urological agents|mesh-ancestor
111219758|NCT04396743|Clotrimazole|clotrimazole|mesh-list
111219759|NCT04396743|Miconazole|miconazole|mesh-list
111219760|NCT04396743|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111219761|NCT04396743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111219762|NCT04396743|Antifungal Agents|antifungal agents|mesh-ancestor
111219763|NCT04396743|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111219764|NCT04396743|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111219765|NCT04396743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111219766|NCT04396743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111219767|NCT04396743|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111219768|NCT04396743|Hormone Antagonists|hormone antagonists|mesh-ancestor
111219769|NCT04396743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111219770|NCT04396743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111219771|NCT04396743|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111219772|NCT04396743|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111219773|NCT01928043|Curcumin|curcumin|mesh-list
111219774|NCT01928043|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111219775|NCT01928043|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111219776|NCT01928043|Analgesics|analgesics|mesh-ancestor
111219777|NCT01928043|Sensory System Agents|sensory system agents|mesh-ancestor
111219778|NCT01928043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111219779|NCT01928043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111219780|NCT01928043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111219781|NCT01928043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111219782|NCT01928043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111219783|NCT01928043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111219784|NCT01928043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111219785|NCT02979886|Triptorelin Pamoate|triptorelin pamoate|mesh-list
111219786|NCT02979886|Menotropins|menotropins|mesh-list
111219787|NCT02979886|Luteolytic Agents|luteolytic agents|mesh-ancestor
111219788|NCT02979886|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111219789|NCT02979886|Contraceptive Agents|contraceptive agents|mesh-ancestor
111219790|NCT02979886|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111219791|NCT02979886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111219792|NCT02979886|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111219793|NCT02979886|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111219794|NCT02979886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111219795|NCT02979886|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111219796|NCT02979886|Fertility Agents|fertility agents|mesh-ancestor
111219797|NCT01928511|Interferons|interferons|mesh-list
111219798|NCT01928511|Tenofovir|tenofovir|mesh-list
111219799|NCT01928511|Interferon-alpha|interferon-alpha|mesh-list
111219801|NCT01928511|Interferon alpha-2|interferon alpha-2|mesh-list
111219802|NCT01928511|Entecavir|entecavir|mesh-list
111219803|NCT01928511|Adefovir|adefovir|mesh-list
111219804|NCT01928511|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
111219805|NCT01928511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111219806|NCT01928511|Antiviral Agents|antiviral agents|mesh-ancestor
111219807|NCT01928511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111219808|NCT01928511|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111219809|NCT01928511|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111219810|NCT01928511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111219811|NCT01928511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111219812|NCT01928511|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111219813|NCT01928511|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111219814|NCT01928511|Immunologic Factors|immunologic factors|mesh-ancestor
111219815|NCT01928511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111219816|NCT05241249|Paclitaxel|paclitaxel|mesh-list
111219817|NCT05241249|Gemcitabine|gemcitabine|mesh-list
111219818|NCT05241249|Bethanechol|bethanechol|mesh-list
111219819|NCT05241249|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111219820|NCT05241249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111219821|NCT05241249|Tubulin Modulators|tubulin modulators|mesh-ancestor
111219822|NCT05241249|Antimitotic Agents|antimitotic agents|mesh-ancestor
111219823|NCT05241249|Mitosis Modulators|mitosis modulators|mesh-ancestor
111219824|NCT05241249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111219825|NCT05241249|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111219826|NCT05241249|Antimetabolites|antimetabolites|mesh-ancestor
111219827|NCT05241249|Parasympathomimetics|parasympathomimetics|mesh-ancestor
111219828|NCT05241249|Autonomic Agents|autonomic agents|mesh-ancestor
111219829|NCT05241249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111219830|NCT05241249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111219831|NCT05241249|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
111219832|NCT05241249|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111219833|NCT05241249|Cholinergic Agents|cholinergic agents|mesh-ancestor
111219834|NCT05241249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111219835|NCT01928823|Cycloserine|cycloserine|mesh-list
111219836|NCT01928823|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111219837|NCT01928823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111219838|NCT01928823|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111219839|NCT01928823|Antitubercular Agents|antitubercular agents|mesh-ancestor
111219840|NCT01928823|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111219841|NCT01928823|Antimetabolites|antimetabolites|mesh-ancestor
111219842|NCT01928823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111219843|NCT01290874|Formoterol Fumarate|formoterol fumarate|mesh-list
111219844|NCT01290874|Tiotropium Bromide|tiotropium bromide|mesh-list
111219845|NCT01290874|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
111219846|NCT01290874|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111219847|NCT01290874|Autonomic Agents|autonomic agents|mesh-ancestor
111219848|NCT01290874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111219849|NCT01290874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111219850|NCT01290874|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111219851|NCT01290874|Respiratory System Agents|respiratory system agents|mesh-ancestor
111219852|NCT01290874|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111219853|NCT01290874|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111219854|NCT01290874|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111219855|NCT01290874|Adrenergic Agents|adrenergic agents|mesh-ancestor
111219856|NCT01290874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111219857|NCT01290874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111219858|NCT01290874|Parasympatholytics|parasympatholytics|mesh-ancestor
111219859|NCT01290874|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111219860|NCT01290874|Cholinergic Agents|cholinergic agents|mesh-ancestor
111219861|NCT02977494|Dexamethasone|dexamethasone|mesh-list
111219862|NCT02977494|Dexamethasone acetate|dexamethasone acetate|mesh-list
111219863|NCT02977494|Bortezomib|bortezomib|mesh-list
111219864|NCT02977494|Daratumumab|daratumumab|mesh-list
111219865|NCT02977494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111219866|NCT02977494|Antiemetics|antiemetics|mesh-ancestor
111219867|NCT02977494|Autonomic Agents|autonomic agents|mesh-ancestor
111219868|NCT02977494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111219869|NCT02977494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111219870|NCT02977494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111219871|NCT02977494|Glucocorticoids|glucocorticoids|mesh-ancestor
111219872|NCT02977494|Hormones|hormones|mesh-ancestor
111219873|NCT02977494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111219874|NCT02977494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111219875|NCT02977494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111219876|NCT01929603|Rifampin|rifampin|mesh-list
111219877|NCT01929603|Olaparib|olaparib|mesh-list
111219878|NCT01929603|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111219879|NCT01929603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111219880|NCT01929603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111219881|NCT01929603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111219882|NCT01929603|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111219883|NCT01929603|Antitubercular Agents|antitubercular agents|mesh-ancestor
111219884|NCT01929603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111219885|NCT01929603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111219886|NCT01929603|Leprostatic Agents|leprostatic agents|mesh-ancestor
111219887|NCT01929603|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111219888|NCT01929603|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111219889|NCT01929603|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111219890|NCT01929603|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
111219891|NCT01929603|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
111219892|NCT01929603|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
111219893|NCT01929603|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111219894|NCT04178460|Niraparib|niraparib|mesh-list
111219895|NCT04178460|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111219896|NCT04178460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111219897|NCT04178460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111219898|NCT04178460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111219899|NCT01928901|Thymol|thymol|mesh-list
111219900|NCT01928901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111219901|NCT01928901|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111219902|NCT01928901|Antifungal Agents|antifungal agents|mesh-ancestor
111219903|NCT04395105|Dexamethasone|dexamethasone|mesh-list
111219904|NCT04395105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111219905|NCT04395105|Antiemetics|antiemetics|mesh-ancestor
111219906|NCT04395105|Autonomic Agents|autonomic agents|mesh-ancestor
111219907|NCT04395105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111219908|NCT04395105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111219909|NCT04395105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111219910|NCT04395105|Glucocorticoids|glucocorticoids|mesh-ancestor
111219911|NCT04395105|Hormones|hormones|mesh-ancestor
111219912|NCT04395105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111219913|NCT04395105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111219914|NCT04395105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111219915|NCT04072770|Caseins|caseins|mesh-list
111219916|NCT04072770|Chelating Agents|chelating agents|mesh-ancestor
111219917|NCT04072770|Sequestering Agents|sequestering agents|mesh-ancestor
111219918|NCT04072770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111219919|NCT01291108|Bimatoprost|bimatoprost|mesh-list
111219920|NCT01291108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111219921|NCT01929213|Bosentan|bosentan|mesh-list
111219922|NCT01929213|Udenafil|udenafil|mesh-list
111219923|NCT01929213|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111219924|NCT01929213|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
111219925|NCT01929213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111219926|NCT01929213|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111219927|NCT01929213|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111219928|NCT01929213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111219929|NCT03430518|Durvalumab|durvalumab|mesh-list
111219930|NCT03430518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111219931|NCT03430518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111219932|NCT05240157|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111219933|NCT05240157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111219934|NCT01925937|Ubiquinone|ubiquinone|mesh-list
111219935|NCT01925937|Coenzyme Q10|coenzyme q10|mesh-list
111219936|NCT01925937|Atorvastatin|atorvastatin|mesh-list
111219937|NCT01925937|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111219938|NCT01925937|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111219939|NCT01925937|Antimetabolites|antimetabolites|mesh-ancestor
111219940|NCT01925937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111219941|NCT01925937|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111219942|NCT01925937|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111219943|NCT01925937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111219944|NCT01925937|Micronutrients|micronutrients|mesh-ancestor
111219945|NCT01925937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111219946|NCT01925937|Vitamins|vitamins|mesh-ancestor
111219947|NCT03430362|Scopolamine|scopolamine|mesh-list
111219948|NCT03430362|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
111219949|NCT03430362|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111219950|NCT03430362|Antiemetics|antiemetics|mesh-ancestor
111219951|NCT03430362|Autonomic Agents|autonomic agents|mesh-ancestor
111219952|NCT03430362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111219953|NCT03430362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111219954|NCT03430362|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111219955|NCT03430362|Mydriatics|mydriatics|mesh-ancestor
111219956|NCT03430362|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111219957|NCT03430362|Cholinergic Agents|cholinergic agents|mesh-ancestor
111219958|NCT03430362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111219959|NCT03430362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111219960|NCT03430362|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111219961|NCT03430362|Parasympatholytics|parasympatholytics|mesh-ancestor
111219962|NCT03428022|Apatinib|apatinib|mesh-list
111219963|NCT03428022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111219964|NCT03428022|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111219965|NCT03428022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111219966|NCT03428022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111219967|NCT00989781|Dexamethasone|dexamethasone|mesh-list
111219968|NCT00989781|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
111219969|NCT00989781|Hormones|hormones|mesh-list
111219970|NCT00989781|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
111219971|NCT00989781|Cosyntropin|cosyntropin|mesh-list
111219972|NCT00989781|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
111219973|NCT00989781|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
111219974|NCT00989781|beta-Endorphin|beta-endorphin|mesh-list
111219975|NCT00989781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111219976|NCT00989781|Antiemetics|antiemetics|mesh-ancestor
111219977|NCT00989781|Autonomic Agents|autonomic agents|mesh-ancestor
111219978|NCT00989781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111219979|NCT00989781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111219980|NCT00989781|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111219981|NCT00989781|Glucocorticoids|glucocorticoids|mesh-ancestor
111219982|NCT00989781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111219983|NCT00989781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111219984|NCT00989781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111219985|NCT00989781|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111219986|NCT00989781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111219987|NCT00989781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111219988|NCT03430128|Immunomodulating Agents|immunomodulating agents|mesh-list
111219989|NCT03430128|Immunologic Factors|immunologic factors|mesh-ancestor
111219990|NCT03430128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111219991|NCT03427944|Calcium Dobesilate|calcium dobesilate|mesh-list
111219992|NCT03427944|Calcium|calcium|mesh-list
111219993|NCT03427944|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111219994|NCT03427944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111219995|NCT03427944|Hemostatics|hemostatics|mesh-ancestor
111219996|NCT03427944|Coagulants|coagulants|mesh-ancestor
111219997|NCT01922193|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
111219998|NCT01922193|Hormones|hormones|mesh-ancestor
111219999|NCT01922193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111220000|NCT01922193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111220001|NCT03429972|Paclitaxel|paclitaxel|mesh-list
111220002|NCT03429972|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111220003|NCT03429972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111220004|NCT03429972|Tubulin Modulators|tubulin modulators|mesh-ancestor
111220005|NCT03429972|Antimitotic Agents|antimitotic agents|mesh-ancestor
111220006|NCT03429972|Mitosis Modulators|mitosis modulators|mesh-ancestor
111220007|NCT03429972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111220008|NCT05601999|Tenecteplase|tenecteplase|mesh-list
111220009|NCT05601999|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111220010|NCT05601999|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111220011|NCT05601999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111220012|NCT01347034|Immunomodulating Agents|immunomodulating agents|mesh-list
111220013|NCT01347034|Immunologic Factors|immunologic factors|mesh-ancestor
111220014|NCT01347034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111220015|NCT03079167|Epoetin Alfa|epoetin alfa|mesh-list
111220016|NCT03079167|Hematinics|hematinics|mesh-ancestor
111220017|NCT03427632|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
111220018|NCT03427632|Vasodilator Agents|vasodilator agents|mesh-ancestor
111220019|NCT03427632|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
111220020|NCT03427632|Protective Agents|protective agents|mesh-ancestor
111220021|NCT03427632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111220022|NCT03427554|Tretinoin|tretinoin|mesh-list
111220023|NCT03427554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111220024|NCT03427554|Keratolytic Agents|keratolytic agents|mesh-ancestor
111220026|NCT01349920|Infliximab|infliximab|mesh-list
111220027|NCT01349920|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111220028|NCT01349920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111220029|NCT01349920|Dermatologic Agents|dermatologic agents|mesh-ancestor
111220030|NCT01349920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111220031|NCT01349920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111220032|NCT03128346|Aspirin|aspirin|mesh-list
111220033|NCT03128346|Acetaminophen|acetaminophen|mesh-list
111220034|NCT03128346|Fentanyl|fentanyl|mesh-list
111220035|NCT03128346|Hydromorphone|hydromorphone|mesh-list
111220036|NCT03128346|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111220037|NCT03128346|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111220038|NCT03128346|Analgesics|analgesics|mesh-ancestor
111220039|NCT03128346|Sensory System Agents|sensory system agents|mesh-ancestor
111220040|NCT03128346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111220041|NCT03128346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111220042|NCT03128346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111220043|NCT03128346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111220044|NCT03128346|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111220045|NCT03128346|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111220046|NCT03128346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111220047|NCT03128346|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111220048|NCT03128346|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111220049|NCT03128346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111220050|NCT03128346|Antipyretics|antipyretics|mesh-ancestor
111220051|NCT03128346|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111220052|NCT03128346|Narcotics|narcotics|mesh-ancestor
111220053|NCT03128346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111220054|NCT03128346|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111220055|NCT03128346|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111220056|NCT03128346|Anesthetics, General|anesthetics, general|mesh-ancestor
111220057|NCT03128346|Anesthetics|anesthetics|mesh-ancestor
111220058|NCT03423030|Macozinone|macozinone|mesh-list
111220059|NCT03423030|Antitubercular Agents|antitubercular agents|mesh-ancestor
111220060|NCT03423030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111220061|NCT03423030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111220062|NCT03427242|Apatinib|apatinib|mesh-list
111220063|NCT03427242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111220064|NCT03427242|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111220065|NCT03427242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111220066|NCT03427242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111220067|NCT01252732|Vancomycin|vancomycin|mesh-list
111220068|NCT01252732|Oritavancin|oritavancin|mesh-list
111220069|NCT01252732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111220070|NCT01252732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111220071|NCT00989235|Abatacept|abatacept|mesh-list
111220072|NCT00989235|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111220073|NCT00989235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111220074|NCT00989235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111220075|NCT00989235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111220076|NCT00989235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111220077|NCT00989235|Immunologic Factors|immunologic factors|mesh-ancestor
111220078|NCT00989235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111220079|NCT00989235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111220080|NCT03422874|Nelfinavir|nelfinavir|mesh-list
111220081|NCT03422874|Ixazomib|ixazomib|mesh-list
111220082|NCT03422874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111220083|NCT03422874|Protease Inhibitors|protease inhibitors|mesh-ancestor
111220084|NCT03422874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111220085|NCT03422874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111220086|NCT03422874|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111220087|NCT03422874|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111220088|NCT03422874|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111220089|NCT03422874|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111220090|NCT03422874|Antiviral Agents|antiviral agents|mesh-ancestor
111220091|NCT03422874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111220092|NCT01253824|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
111220093|NCT01253824|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
111220094|NCT01253824|Ethinyl Estradiol|ethinyl estradiol|mesh-list
111220095|NCT01253824|Norethindrone|norethindrone|mesh-list
111220096|NCT01253824|Norethindrone Acetate|norethindrone acetate|mesh-list
111220097|NCT01253824|Norinyl|norinyl|mesh-list
111220098|NCT01253824|Mestranol|mestranol|mesh-list
111220099|NCT01253824|Estradiol|estradiol|mesh-list
111220100|NCT01253824|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
111220101|NCT01253824|Estrogens|estrogens|mesh-ancestor
111220102|NCT01253824|Hormones|hormones|mesh-ancestor
111220103|NCT01253824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111220104|NCT01253824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111220105|NCT01253824|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111220106|NCT01253824|Contraceptive Agents|contraceptive agents|mesh-ancestor
111220107|NCT01253824|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111220108|NCT01253824|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111220109|NCT01253824|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111220110|NCT01253824|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111220111|NCT01253824|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111220112|NCT01253824|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
111220113|NCT03422796|Cilostazol|cilostazol|mesh-list
111220114|NCT03422796|Sumatriptan|sumatriptan|mesh-list
111220115|NCT03422796|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111220116|NCT03422796|Autonomic Agents|autonomic agents|mesh-ancestor
111220117|NCT03422796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111220118|NCT03422796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111220119|NCT03422796|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111220120|NCT03422796|Respiratory System Agents|respiratory system agents|mesh-ancestor
111220121|NCT03422796|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111220122|NCT03422796|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111220123|NCT03422796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111220124|NCT03422796|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111220125|NCT03422796|Vasodilator Agents|vasodilator agents|mesh-ancestor
111220126|NCT03422796|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111220127|NCT03422796|Protective Agents|protective agents|mesh-ancestor
111220128|NCT03422796|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
111220129|NCT03422796|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111220130|NCT03422796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111220131|NCT03422796|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111220132|NCT03422796|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111220133|NCT03422796|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111220134|NCT03422796|Serotonin Agents|serotonin agents|mesh-ancestor
111220135|NCT03422796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111220136|NCT04396977|Histamine|histamine|mesh-list
111220137|NCT04396977|Histamine Agonists|histamine agonists|mesh-ancestor
111220138|NCT04396977|Histamine Agents|histamine agents|mesh-ancestor
111220139|NCT04396977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111220140|NCT04396977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111220141|NCT04396977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111220142|NCT03429738|Ibuprofen|ibuprofen|mesh-list
111220143|NCT03429738|Pseudoephedrine|pseudoephedrine|mesh-list
111220144|NCT03429738|Ephedrine|ephedrine|mesh-list
111220145|NCT03429738|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111220146|NCT03429738|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111220147|NCT03429738|Analgesics|analgesics|mesh-ancestor
111220148|NCT03429738|Sensory System Agents|sensory system agents|mesh-ancestor
111220149|NCT03429738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111220150|NCT03429738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111220151|NCT03429738|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111220152|NCT03429738|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111220153|NCT03429738|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111220154|NCT03429738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111220155|NCT03429738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111220156|NCT03429738|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111220157|NCT03429738|Autonomic Agents|autonomic agents|mesh-ancestor
111220158|NCT03429738|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111220159|NCT03429738|Respiratory System Agents|respiratory system agents|mesh-ancestor
111220160|NCT03429738|Nasal Decongestants|nasal decongestants|mesh-ancestor
111220161|NCT03429738|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111220162|NCT03429738|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111220163|NCT03429738|Sympathomimetics|sympathomimetics|mesh-ancestor
111220164|NCT03429738|Adrenergic Agents|adrenergic agents|mesh-ancestor
111220165|NCT03429738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111220166|NCT01253902|Bimatoprost|bimatoprost|mesh-list
111220167|NCT01253902|Travoprost|travoprost|mesh-list
111220168|NCT01253902|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111220169|NCT01253902|Latanoprost|latanoprost|mesh-list
111220170|NCT01253902|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111220171|NCT01253902|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111220172|NCT01253980|Amoxicillin|amoxicillin|mesh-list
111220173|NCT01253980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111220174|NCT01253980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111220175|NCT00988533|Ivermectin|ivermectin|mesh-list
111220176|NCT00988533|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111220177|NCT00988533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111220179|NCT01350388|Gout Suppressants|gout suppressants|mesh-ancestor
111220180|NCT01350388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111220181|NCT03154749|Cyclophosphamide|cyclophosphamide|mesh-list
111220182|NCT03154749|Carboplatin|carboplatin|mesh-list
111220183|NCT03154749|Docetaxel|docetaxel|mesh-list
111220184|NCT03154749|Epirubicin|epirubicin|mesh-list
111220185|NCT03154749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111220186|NCT03154749|Immunologic Factors|immunologic factors|mesh-ancestor
111220187|NCT03154749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111220188|NCT03154749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111220189|NCT03154749|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111220190|NCT03154749|Alkylating Agents|alkylating agents|mesh-ancestor
111220191|NCT03154749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111220192|NCT03154749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111220193|NCT03154749|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111220194|NCT03154749|Tubulin Modulators|tubulin modulators|mesh-ancestor
111220195|NCT03154749|Antimitotic Agents|antimitotic agents|mesh-ancestor
111220196|NCT03154749|Mitosis Modulators|mitosis modulators|mesh-ancestor
111220197|NCT03154749|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111220198|NCT03154749|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111220199|NCT03154749|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111220200|NCT03154749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111220201|NCT03422640|Apremilast|apremilast|mesh-list
111220202|NCT03422640|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111220203|NCT03422640|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111220204|NCT03422640|Analgesics|analgesics|mesh-ancestor
111220205|NCT03422640|Sensory System Agents|sensory system agents|mesh-ancestor
111220206|NCT03422640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111220207|NCT03422640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111220208|NCT03422640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111220209|NCT03422640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111220210|NCT03422640|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
111220211|NCT03422640|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111220212|NCT03422640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111220213|NCT03422640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111220214|NCT01351090|Ketorolac|ketorolac|mesh-list
111220215|NCT01351090|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
111220216|NCT01351090|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111220217|NCT01351090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111220218|NCT01351090|Analgesics|analgesics|mesh-ancestor
111220219|NCT01351090|Sensory System Agents|sensory system agents|mesh-ancestor
111220220|NCT01351090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111220221|NCT01351090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111220222|NCT01351090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111220223|NCT01351090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111220224|NCT01351090|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111220225|NCT01351090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111220226|NCT01351090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111220227|NCT01918644|Capecitabine|capecitabine|mesh-list
111220228|NCT01918644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111220229|NCT01918644|Antimetabolites|antimetabolites|mesh-ancestor
111220230|NCT01918644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111220231|NCT01918644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111220232|NCT00987831|Methylprednisolone|methylprednisolone|mesh-list
111220233|NCT00987831|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111220234|NCT00987831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111220235|NCT00987831|Antiemetics|antiemetics|mesh-ancestor
111220236|NCT00987831|Autonomic Agents|autonomic agents|mesh-ancestor
111220237|NCT00987831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111220238|NCT00987831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111220239|NCT00987831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111220240|NCT00987831|Glucocorticoids|glucocorticoids|mesh-ancestor
111220241|NCT00987831|Hormones|hormones|mesh-ancestor
111220242|NCT00987831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111220243|NCT00987831|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111220244|NCT00987831|Protective Agents|protective agents|mesh-ancestor
111220245|NCT03608358|Metformin|metformin|mesh-list
111220246|NCT03608358|Dapagliflozin|dapagliflozin|mesh-list
111220247|NCT03608358|Saxagliptin|saxagliptin|mesh-list
111220248|NCT03608358|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111220249|NCT03608358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111220250|NCT03608358|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111220251|NCT03608358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110673190|NCT00872417|Lamivudine|lamivudine|mesh-list
111220252|NCT03608358|Incretins|incretins|mesh-ancestor
111220253|NCT03608358|Hormones|hormones|mesh-ancestor
111220254|NCT03608358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111220255|NCT03608358|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111220256|NCT03608358|Protease Inhibitors|protease inhibitors|mesh-ancestor
111220257|NCT03608358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111220258|NCT04274907|Pembrolizumab|pembrolizumab|mesh-list
111220259|NCT04274907|Venetoclax|venetoclax|mesh-list
111220260|NCT04274907|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111220261|NCT04274907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111220262|NCT04274907|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111220263|NCT04274907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111220264|NCT01256164|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
111220265|NCT01256164|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
111220266|NCT01256164|Hemostatics|hemostatics|mesh-ancestor
111220267|NCT01256164|Coagulants|coagulants|mesh-ancestor
111220268|NCT03427086|Biotin|biotin|mesh-list
111220269|NCT03427086|Vitamins|vitamins|mesh-ancestor
111220270|NCT03427086|Micronutrients|micronutrients|mesh-ancestor
111220271|NCT03427086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111220272|NCT03427086|Vitamin B Complex|vitamin b complex|mesh-ancestor
111220273|NCT01887522|Vinblastine|vinblastine|mesh-list
111220274|NCT01887522|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111220275|NCT01887522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111220276|NCT01887522|Tubulin Modulators|tubulin modulators|mesh-ancestor
111220277|NCT01887522|Antimitotic Agents|antimitotic agents|mesh-ancestor
111220278|NCT01887522|Mitosis Modulators|mitosis modulators|mesh-ancestor
111220279|NCT01887522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111220280|NCT03422406|Iodine|iodine|mesh-list
111220281|NCT03422406|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111220282|NCT03422406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111220283|NCT03422406|Trace Elements|trace elements|mesh-ancestor
111220284|NCT03422406|Micronutrients|micronutrients|mesh-ancestor
111220285|NCT03422406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111220286|NCT00986427|Cyclosporine|cyclosporine|mesh-list
111220287|NCT00986427|Cyclosporins|cyclosporins|mesh-list
111220288|NCT00986427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111220289|NCT00986427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111220290|NCT00986427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111220291|NCT00986427|Immunologic Factors|immunologic factors|mesh-ancestor
111220292|NCT00986427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111220293|NCT00986427|Antifungal Agents|antifungal agents|mesh-ancestor
111220294|NCT00986427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111220295|NCT00986427|Dermatologic Agents|dermatologic agents|mesh-ancestor
111220296|NCT00986427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111220297|NCT00986427|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111220298|NCT03426462|Propofol|propofol|mesh-list
111220299|NCT03426462|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111220300|NCT03426462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111220301|NCT03426462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111220302|NCT03426462|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111220303|NCT03426462|Anesthetics, General|anesthetics, general|mesh-ancestor
111220304|NCT03426462|Anesthetics|anesthetics|mesh-ancestor
111220305|NCT03421860|Phenylephrine|phenylephrine|mesh-list
111220306|NCT03421860|Epinephrine|epinephrine|mesh-list
111220307|NCT03421860|Oxymetazoline|oxymetazoline|mesh-list
111220308|NCT03421860|Ephedrine|ephedrine|mesh-list
111220309|NCT03421860|Norepinephrine|norepinephrine|mesh-list
111220310|NCT03421860|Ondansetron|ondansetron|mesh-list
111220311|NCT03421860|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111220312|NCT03421860|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111220313|NCT03421860|Adrenergic Agents|adrenergic agents|mesh-ancestor
111220314|NCT03421860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111220315|NCT03421860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111220316|NCT03421860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111220317|NCT03421860|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111220318|NCT03421860|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111220319|NCT03421860|Autonomic Agents|autonomic agents|mesh-ancestor
111220320|NCT03421860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111220321|NCT03421860|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111220322|NCT03421860|Respiratory System Agents|respiratory system agents|mesh-ancestor
111220323|NCT03421860|Mydriatics|mydriatics|mesh-ancestor
111220324|NCT03421860|Sympathomimetics|sympathomimetics|mesh-ancestor
111220325|NCT03421860|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111220326|NCT03421860|Antiemetics|antiemetics|mesh-ancestor
110673259|NCT00873353|Capecitabine|capecitabine|mesh-list
111220327|NCT03421860|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111220328|NCT03421860|Antipruritics|antipruritics|mesh-ancestor
111220329|NCT03421860|Dermatologic Agents|dermatologic agents|mesh-ancestor
111220330|NCT03421860|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111220331|NCT03421860|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111220332|NCT03421860|Serotonin Agents|serotonin agents|mesh-ancestor
111220333|NCT03421860|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111220334|NCT03421860|Nasal Decongestants|nasal decongestants|mesh-ancestor
111220335|NCT03421860|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111220336|NCT03421860|Protective Agents|protective agents|mesh-ancestor
111220337|NCT03421860|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111220338|NCT03421314|Selenium|selenium|mesh-list
111220339|NCT03421314|Antioxidants|antioxidants|mesh-ancestor
111220340|NCT03421314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111220341|NCT03421314|Protective Agents|protective agents|mesh-ancestor
111220342|NCT03421314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111220343|NCT03421314|Trace Elements|trace elements|mesh-ancestor
111220344|NCT03421314|Micronutrients|micronutrients|mesh-ancestor
111220345|NCT03425994|Emtricitabine|emtricitabine|mesh-list
111220346|NCT03425994|Cobicistat|cobicistat|mesh-list
111220347|NCT03425994|Elvitegravir|elvitegravir|mesh-list
111220348|NCT03425994|Antiviral Agents|antiviral agents|mesh-ancestor
111220349|NCT03425994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111220350|NCT03425994|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111220351|NCT03425994|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111220352|NCT03425994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111220353|NCT03425994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111220354|NCT03425994|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111220355|NCT03425994|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111220356|NCT03425994|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111220357|NCT03425994|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111220358|NCT03425994|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111220359|NCT03421002|Micafungin|micafungin|mesh-list
111220360|NCT03421002|Antifungal Agents|antifungal agents|mesh-ancestor
111220361|NCT03421002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111220362|NCT00754260|Caffeine|caffeine|mesh-list
111220363|NCT00754260|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111220364|NCT00754260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111220365|NCT00754260|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111220366|NCT00754260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111220367|NCT00754260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111220368|NCT00754260|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
111220369|NCT00754260|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111220370|NCT00754260|Purinergic Agents|purinergic agents|mesh-ancestor
111220371|NCT00754260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111220372|NCT02546232|Paclitaxel|paclitaxel|mesh-list
111220373|NCT02546232|Carboplatin|carboplatin|mesh-list
111220374|NCT02546232|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111220375|NCT02546232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111220376|NCT02546232|Tubulin Modulators|tubulin modulators|mesh-ancestor
111220377|NCT02546232|Antimitotic Agents|antimitotic agents|mesh-ancestor
111220378|NCT02546232|Mitosis Modulators|mitosis modulators|mesh-ancestor
111220379|NCT02546232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111220380|NCT02521038|Ticagrelor|ticagrelor|mesh-list
111220381|NCT02521038|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111220382|NCT02521038|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111220383|NCT02521038|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111220384|NCT02521038|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111220385|NCT02521038|Purinergic Agents|purinergic agents|mesh-ancestor
111220386|NCT02521038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111220387|NCT02521038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111220388|NCT02521038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111220389|NCT00985959|Prednisolone|prednisolone|mesh-list
111220390|NCT00985959|Bortezomib|bortezomib|mesh-list
111220391|NCT00985959|Melphalan|melphalan|mesh-list
111220392|NCT00985959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111220393|NCT00985959|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111220394|NCT00985959|Alkylating Agents|alkylating agents|mesh-ancestor
111220395|NCT00985959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111220396|NCT00985959|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111220397|NCT00985959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111220398|NCT00985959|Immunologic Factors|immunologic factors|mesh-ancestor
111220399|NCT00985959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111220400|NCT00985959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111220401|NCT00985959|Glucocorticoids|glucocorticoids|mesh-ancestor
111220402|NCT00985959|Hormones|hormones|mesh-ancestor
111220403|NCT00985959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111220404|NCT00985959|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111220405|NCT00985725|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
111220406|NCT00985725|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111220407|NCT00985725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111220408|NCT00985725|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111220409|NCT00985725|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111220410|NCT00985725|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111220411|NCT00985725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111220412|NCT00985725|Dopamine Agents|dopamine agents|mesh-ancestor
111220413|NCT00985725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111220414|NCT01294306|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111220415|NCT01294306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111220416|NCT01294306|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111220417|NCT01294306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111220418|NCT01294306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111220419|NCT01351480|Abatacept|abatacept|mesh-list
111220420|NCT01351480|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111220421|NCT01351480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111220422|NCT01351480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111220423|NCT01351480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111220424|NCT01351480|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111220425|NCT01351480|Immunologic Factors|immunologic factors|mesh-ancestor
111220426|NCT01351480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111220427|NCT01351480|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111220428|NCT01352182|Pioglitazone|pioglitazone|mesh-list
111220429|NCT01352182|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111220430|NCT01352182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111220431|NCT00984867|Dapagliflozin|dapagliflozin|mesh-list
111220432|NCT00984867|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111220433|NCT00984867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111220434|NCT00984867|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111220435|NCT00984867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111220436|NCT01294384|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
111220437|NCT01294384|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111220438|NCT01294384|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111220439|NCT01294384|Laxatives|laxatives|mesh-ancestor
111220440|NCT01294384|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111220441|NCT01257802|Leuprolide|leuprolide|mesh-list
111220442|NCT01257802|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111220443|NCT01257802|Fertility Agents|fertility agents|mesh-ancestor
111220444|NCT01257802|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111220445|NCT01257802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111220446|NCT01257802|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111220447|NCT01257802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111220448|NCT05607303|Estrogens|estrogens|mesh-list
111220449|NCT05607303|Hormones|hormones|mesh-ancestor
111220450|NCT05607303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111220451|NCT05607303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111220452|NCT00984009|Colchicine|colchicine|mesh-list
111220453|NCT00984009|Gout Suppressants|gout suppressants|mesh-ancestor
111220454|NCT00984009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111220455|NCT00984009|Tubulin Modulators|tubulin modulators|mesh-ancestor
111220456|NCT00984009|Antimitotic Agents|antimitotic agents|mesh-ancestor
111220457|NCT00984009|Mitosis Modulators|mitosis modulators|mesh-ancestor
111220458|NCT00984009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111220459|NCT00984009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111220460|NCT05606913|Dulaglutide|dulaglutide|mesh-list
111220461|NCT05606913|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111220462|NCT05606913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111220463|NCT00983931|Cyclosporine|cyclosporine|mesh-list
111220464|NCT00983931|Colchicine|colchicine|mesh-list
111220465|NCT00983931|Cyclosporins|cyclosporins|mesh-list
111220466|NCT00983931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111220467|NCT00983931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111220468|NCT00983931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111220469|NCT00983931|Immunologic Factors|immunologic factors|mesh-ancestor
111220470|NCT00983931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111220471|NCT00983931|Antifungal Agents|antifungal agents|mesh-ancestor
111220472|NCT00983931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111220473|NCT00983931|Dermatologic Agents|dermatologic agents|mesh-ancestor
111220474|NCT00983931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111220475|NCT00983931|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111220476|NCT00983931|Gout Suppressants|gout suppressants|mesh-ancestor
110684316|NCT02877134|Ustekinumab|ustekinumab|mesh-list
111220477|NCT00983931|Tubulin Modulators|tubulin modulators|mesh-ancestor
111220478|NCT00983931|Antimitotic Agents|antimitotic agents|mesh-ancestor
111220479|NCT00983931|Mitosis Modulators|mitosis modulators|mesh-ancestor
111220480|NCT00983931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111220481|NCT00983853|Ribavirin|ribavirin|mesh-list
111220482|NCT00983853|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
111220483|NCT00983853|Antimetabolites|antimetabolites|mesh-ancestor
111220484|NCT00983853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111220485|NCT00983853|Antiviral Agents|antiviral agents|mesh-ancestor
111220486|NCT00983853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111220487|NCT05604261|Rabeprazole|rabeprazole|mesh-list
111220488|NCT05604261|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111220489|NCT05604261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111220490|NCT05604261|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111220491|NCT05604261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111220492|NCT05604261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111220493|NCT03032601|Acetylcysteine|acetylcysteine|mesh-list
111220494|NCT03032601|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111220495|NCT03032601|Antiviral Agents|antiviral agents|mesh-ancestor
111220496|NCT03032601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111220497|NCT03032601|Expectorants|expectorants|mesh-ancestor
111220498|NCT03032601|Respiratory System Agents|respiratory system agents|mesh-ancestor
111220499|NCT03032601|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111220500|NCT03032601|Antioxidants|antioxidants|mesh-ancestor
111220501|NCT03032601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111220502|NCT03032601|Protective Agents|protective agents|mesh-ancestor
111220503|NCT03032601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111220504|NCT03032601|Antidotes|antidotes|mesh-ancestor
111220505|NCT05603013|Vinorelbine|vinorelbine|mesh-list
111220506|NCT05603013|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
111220507|NCT05603013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111220508|NCT05603013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111220509|NCT05603013|Tubulin Modulators|tubulin modulators|mesh-ancestor
111220510|NCT05603013|Antimitotic Agents|antimitotic agents|mesh-ancestor
111220511|NCT05603013|Mitosis Modulators|mitosis modulators|mesh-ancestor
111220512|NCT05603013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111220513|NCT05603013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111220514|NCT00983073|Tapentadol|tapentadol|mesh-list
111220515|NCT00983073|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111220516|NCT00983073|Narcotics|narcotics|mesh-ancestor
111220517|NCT00983073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111220518|NCT00983073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111220519|NCT00983073|Analgesics|analgesics|mesh-ancestor
111220520|NCT00983073|Sensory System Agents|sensory system agents|mesh-ancestor
111220521|NCT00983073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111220522|NCT00983073|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111220523|NCT00983073|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111220524|NCT00983073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111220525|NCT00983073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111220526|NCT00983073|Adrenergic Agents|adrenergic agents|mesh-ancestor
111220527|NCT00983073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111220528|NCT05603715|Bromides|bromides|mesh-list
111220529|NCT05603715|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
111220530|NCT05603715|Anticonvulsants|anticonvulsants|mesh-ancestor
111220531|NCT05603715|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111220532|NCT05603715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111220533|NCT05603715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111220534|NCT05603715|Cholinergic Agents|cholinergic agents|mesh-ancestor
111220535|NCT05603715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111220536|NCT05603715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111220537|NCT00981747|Losartan|losartan|mesh-list
111220538|NCT00981747|Sildenafil Citrate|sildenafil citrate|mesh-list
111220539|NCT00981747|Vasodilator Agents|vasodilator agents|mesh-ancestor
111220540|NCT00981747|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111220541|NCT00981747|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111220542|NCT00981747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111220543|NCT00981747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111220544|NCT00981747|Urological Agents|urological agents|mesh-ancestor
111220545|NCT00981747|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111220546|NCT00981747|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111220547|NCT00981747|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111220548|NCT00981747|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111220549|NCT03046251|Natalizumab|natalizumab|mesh-list
111220550|NCT03046251|Immunologic Factors|immunologic factors|mesh-ancestor
111220551|NCT03046251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111220553|NCT03029169|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
111220554|NCT03029169|Propafenone|propafenone|mesh-list
111220555|NCT03029169|Vasodilator Agents|vasodilator agents|mesh-ancestor
111220556|NCT03029169|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
111220557|NCT03029169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111220558|NCT03029169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111220559|NCT03029169|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111220560|NCT03029169|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111220561|NCT03029169|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111220562|NCT03029169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111220563|NCT03029169|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111220564|NCT03029169|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111220565|NCT03029169|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111220566|NCT03029169|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111220567|NCT01295710|Immunoglobulins|immunoglobulins|mesh-list
111220568|NCT01295710|Antilymphocyte Serum|antilymphocyte serum|mesh-list
111220569|NCT01295710|Immunologic Factors|immunologic factors|mesh-ancestor
111220570|NCT01295710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111220571|NCT01295710|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111220572|NCT01353976|Econazole|econazole|mesh-list
111220573|NCT01353976|Antifungal Agents|antifungal agents|mesh-ancestor
111220574|NCT01353976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111220575|NCT01353976|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111220576|NCT01353976|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111220577|NCT01353976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111220578|NCT01353976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111220579|NCT01353976|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111220580|NCT01353976|Hormone Antagonists|hormone antagonists|mesh-ancestor
111220581|NCT01353976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111220582|NCT01353976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111220583|NCT01354444|Carvedilol|carvedilol|mesh-list
111220584|NCT01354444|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111220585|NCT01354444|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111220586|NCT01354444|Adrenergic Agents|adrenergic agents|mesh-ancestor
111220587|NCT01354444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111220588|NCT01354444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111220589|NCT01354444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111220590|NCT01354444|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111220591|NCT01354444|Antioxidants|antioxidants|mesh-ancestor
111220592|NCT01354444|Protective Agents|protective agents|mesh-ancestor
111220593|NCT01354444|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111220594|NCT01354444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111220595|NCT01354444|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111220596|NCT01354444|Vasodilator Agents|vasodilator agents|mesh-ancestor
111220597|NCT01354444|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111220598|NCT01354444|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111220599|NCT03009526|Pyrimethamine|pyrimethamine|mesh-list
111220600|NCT03009526|Piperaquine|piperaquine|mesh-list
111220601|NCT03009526|Sulfadoxine|sulfadoxine|mesh-list
111220602|NCT03009526|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
111220603|NCT03009526|Artenimol|artenimol|mesh-list
111220604|NCT03009526|Antimalarials|antimalarials|mesh-ancestor
111220605|NCT03009526|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111220606|NCT03009526|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111220607|NCT03009526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111220608|NCT03009526|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111220609|NCT03009526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111220610|NCT03009526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111220611|NCT03009526|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111220612|NCT01354990|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111220613|NCT01354990|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111220614|NCT01354990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111220615|NCT01354990|Incretins|incretins|mesh-ancestor
111220616|NCT01354990|Hormones|hormones|mesh-ancestor
111220617|NCT01354990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111220618|NCT01354990|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111220619|NCT01354990|Protease Inhibitors|protease inhibitors|mesh-ancestor
111220620|NCT01354990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111220621|NCT01354990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111220622|NCT01260454|Capsaicin|capsaicin|mesh-list
111220623|NCT01260454|Antipruritics|antipruritics|mesh-ancestor
111220624|NCT01260454|Dermatologic Agents|dermatologic agents|mesh-ancestor
111220625|NCT01260454|Sensory System Agents|sensory system agents|mesh-ancestor
111220626|NCT01260454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111220627|NCT01260454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111220628|NCT01296646|Naltrexone|naltrexone|mesh-list
111220629|NCT01296646|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111220630|NCT01296646|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111220631|NCT01296646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111220632|NCT01296646|Sensory System Agents|sensory system agents|mesh-ancestor
111220633|NCT01296646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111220634|NCT01297348|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
111220635|NCT01297348|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
111220636|NCT01297348|Levonorgestrel|levonorgestrel|mesh-list
111220637|NCT01297348|Ethinyl Estradiol|ethinyl estradiol|mesh-list
111220638|NCT01297348|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
111220639|NCT01297348|Norinyl|norinyl|mesh-list
111220640|NCT01297348|Contraceptive Agents|contraceptive agents|mesh-list
111220641|NCT01297348|Contraceptives, Oral|contraceptives, oral|mesh-list
111220642|NCT01297348|Estradiol|estradiol|mesh-list
111220643|NCT01297348|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
111220644|NCT01297348|Estrogens|estrogens|mesh-ancestor
111220645|NCT01297348|Hormones|hormones|mesh-ancestor
111220646|NCT01297348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111220647|NCT01297348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111220648|NCT01297348|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111220649|NCT01297348|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111220650|NCT01297348|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111220651|NCT01297348|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111220652|NCT01297348|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111220653|NCT01297348|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
111220654|NCT01297348|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
111220655|NCT01856309|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111220656|NCT01856309|Immunologic Factors|immunologic factors|mesh-ancestor
111220657|NCT01856309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111220658|NCT01260688|Dasatinib|dasatinib|mesh-list
111220659|NCT01260688|Cediranib|cediranib|mesh-list
111220660|NCT01260688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111220661|NCT01260688|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111220662|NCT01260688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111220663|NCT01260688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111220664|NCT01298128|NuvaRing|nuvaring|mesh-list
111220665|NCT01298128|Desogestrel|desogestrel|mesh-list
111220666|NCT01298128|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111220667|NCT01298128|Contraceptive Agents|contraceptive agents|mesh-ancestor
111220668|NCT01298128|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111220669|NCT01298128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111220670|NCT01298128|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111220671|NCT01298128|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111220672|NCT01298128|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111220673|NCT01298128|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111220674|NCT01298128|Progestins|progestins|mesh-ancestor
111220675|NCT01298128|Hormones|hormones|mesh-ancestor
111220676|NCT01298128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111220677|NCT02199964|Cyclosporine|cyclosporine|mesh-list
111220678|NCT02199964|Lubricant Eye Drops|lubricant eye drops|mesh-list
111220679|NCT02199964|Cyclosporins|cyclosporins|mesh-list
111220680|NCT02199964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111220681|NCT02199964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111220682|NCT02199964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111220683|NCT02199964|Immunologic Factors|immunologic factors|mesh-ancestor
111220684|NCT02199964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111220685|NCT02199964|Antifungal Agents|antifungal agents|mesh-ancestor
111220686|NCT02199964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111220687|NCT02199964|Dermatologic Agents|dermatologic agents|mesh-ancestor
111220688|NCT02199964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111220689|NCT02199964|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111220690|NCT02199964|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
111220691|NCT02199964|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111220692|NCT02323048|Methamphetamine|methamphetamine|mesh-list
111220693|NCT02323048|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111220694|NCT02323048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111220695|NCT02323048|Sympathomimetics|sympathomimetics|mesh-ancestor
111220696|NCT02323048|Autonomic Agents|autonomic agents|mesh-ancestor
111220697|NCT02323048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110673633|NCT00875537|Capsaicin|capsaicin|mesh-list
111220698|NCT02323048|Dopamine Agents|dopamine agents|mesh-ancestor
111220699|NCT02323048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111220700|NCT02323048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111220701|NCT02323048|Adrenergic Agents|adrenergic agents|mesh-ancestor
111220702|NCT02323048|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111220703|NCT02323048|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111220704|NCT02323048|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111220705|NCT02323048|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111220707|NCT01265446|Anesthetics, Local|anesthetics, local|mesh-ancestor
111220708|NCT01265446|Anesthetics|anesthetics|mesh-ancestor
111220709|NCT01265446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111220710|NCT01265446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111220711|NCT01265446|Sensory System Agents|sensory system agents|mesh-ancestor
111220712|NCT01265446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111220713|NCT01265446|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111220714|NCT01265446|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111220715|NCT01265446|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111220716|NCT01265446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111220717|NCT01265446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111220718|NCT04352062|Amoxicillin|amoxicillin|mesh-list
111220719|NCT04352062|Levofloxacin|levofloxacin|mesh-list
111220720|NCT04352062|Ofloxacin|ofloxacin|mesh-list
111220721|NCT04352062|Melatonin|melatonin|mesh-list
111220722|NCT04352062|Pantoprazole|pantoprazole|mesh-list
111220723|NCT04352062|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111220724|NCT04352062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111220725|NCT04352062|Antioxidants|antioxidants|mesh-ancestor
111220726|NCT04352062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111220727|NCT04352062|Protective Agents|protective agents|mesh-ancestor
111220728|NCT04352062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111220729|NCT04352062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111220730|NCT04352062|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111220731|NCT04352062|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111220732|NCT04352062|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111220733|NCT04352062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111220734|NCT04352062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111220735|NCT04352062|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111220736|NCT04352062|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111220737|NCT04352062|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111220738|NCT04352062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111220739|NCT04352062|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111220740|NCT01302808|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111220741|NCT01302808|Romidepsin|romidepsin|mesh-list
111220742|NCT01302808|Antiemetics|antiemetics|mesh-list
111220743|NCT01302808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111220744|NCT01302808|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111220745|NCT01302808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111220746|NCT01302808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111220747|NCT01302808|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111220748|NCT01302808|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111220749|NCT01302808|Autonomic Agents|autonomic agents|mesh-ancestor
111220750|NCT01302808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111220751|NCT01302808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111220752|NCT01302808|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111220753|NCT01267240|Capecitabine|capecitabine|mesh-list
111220754|NCT01267240|Vorinostat|vorinostat|mesh-list
111220755|NCT01267240|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111220756|NCT01267240|Antimetabolites|antimetabolites|mesh-ancestor
111220757|NCT01267240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111220758|NCT01267240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111220759|NCT01267240|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111220760|NCT01267240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111220761|NCT01855919|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
111220762|NCT01855919|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111220763|NCT01855919|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111220764|NCT01855919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111220765|NCT01855919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111220766|NCT01855919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111220767|NCT01855919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111220768|NCT01855919|Analgesics|analgesics|mesh-ancestor
110684619|NCT01014234|Cyclosporine|cyclosporine|mesh-list
111220769|NCT01855919|Sensory System Agents|sensory system agents|mesh-ancestor
111220770|NCT01855919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111220771|NCT01855919|Antidepressive Agents|antidepressive agents|mesh-ancestor
111220772|NCT01855919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111220773|NCT01855919|Dopamine Agents|dopamine agents|mesh-ancestor
111220774|NCT01871285|Morphine|morphine|mesh-list
111220775|NCT01871285|Oxycodone|oxycodone|mesh-list
111220776|NCT01871285|Buprenorphine|buprenorphine|mesh-list
111220777|NCT01871285|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111220778|NCT01871285|Narcotics|narcotics|mesh-ancestor
111220779|NCT01871285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111220780|NCT01871285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111220781|NCT01871285|Analgesics|analgesics|mesh-ancestor
111220782|NCT01871285|Sensory System Agents|sensory system agents|mesh-ancestor
111220783|NCT01871285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111220784|NCT01871285|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111220785|NCT01358266|Sirolimus|sirolimus|mesh-list
111220786|NCT01358266|Temsirolimus|temsirolimus|mesh-list
111220787|NCT01358266|MTOR Inhibitors|mtor inhibitors|mesh-list
111220788|NCT01358266|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111220789|NCT01358266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111220790|NCT01358266|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111220791|NCT01358266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111220792|NCT01358266|Antifungal Agents|antifungal agents|mesh-ancestor
111220793|NCT01358266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111220794|NCT01358266|Immunologic Factors|immunologic factors|mesh-ancestor
111220795|NCT01358266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111220796|NCT01358266|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111220797|NCT01358266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111220798|NCT01358266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111220799|NCT01870973|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111220800|NCT01870973|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
111220801|NCT01870973|Analgesics|analgesics|mesh-list
111220802|NCT01870973|Anesthetics|anesthetics|mesh-list
111220803|NCT01870973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111220804|NCT01870973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111220805|NCT01870973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111220806|NCT01870973|Antitubercular Agents|antitubercular agents|mesh-ancestor
111220807|NCT01870973|Sensory System Agents|sensory system agents|mesh-ancestor
111220808|NCT01870973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111220809|NCT01267864|Ketorolac|ketorolac|mesh-list
111220810|NCT01267864|Valproic Acid|valproic acid|mesh-list
111220811|NCT01267864|Metoclopramide|metoclopramide|mesh-list
111220812|NCT01267864|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111220813|NCT01267864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111220814|NCT01267864|Analgesics|analgesics|mesh-ancestor
111220815|NCT01267864|Sensory System Agents|sensory system agents|mesh-ancestor
111220816|NCT01267864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111220817|NCT01267864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111220818|NCT01267864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111220819|NCT01267864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111220820|NCT01267864|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111220821|NCT01267864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111220822|NCT01267864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111220823|NCT01267864|Anticonvulsants|anticonvulsants|mesh-ancestor
111220824|NCT01267864|GABA Agents|gaba agents|mesh-ancestor
111220825|NCT01267864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111220826|NCT01267864|Antimanic Agents|antimanic agents|mesh-ancestor
111220827|NCT01267864|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111220828|NCT01267864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111220829|NCT01267864|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111220830|NCT01267864|Antiemetics|antiemetics|mesh-ancestor
111220831|NCT01267864|Autonomic Agents|autonomic agents|mesh-ancestor
111220832|NCT01267864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111220833|NCT01267864|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111220834|NCT01267864|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111220835|NCT01267864|Dopamine Agents|dopamine agents|mesh-ancestor
111220836|NCT01854827|Immunoglobulins|immunoglobulins|mesh-list
111220837|NCT01854827|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111220838|NCT01854827|Antibodies|antibodies|mesh-list
111220839|NCT01854827|gamma-Globulins|gamma-globulins|mesh-list
111220840|NCT01854827|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
111220841|NCT01854827|Immunologic Factors|immunologic factors|mesh-ancestor
111220842|NCT01854827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111220843|NCT01360450|Clonidine|clonidine|mesh-list
111220844|NCT01360450|Analgesics|analgesics|mesh-ancestor
111220845|NCT01360450|Sensory System Agents|sensory system agents|mesh-ancestor
111220846|NCT01360450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111220847|NCT01360450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111220848|NCT01360450|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111220849|NCT01360450|Sympatholytics|sympatholytics|mesh-ancestor
111220850|NCT01360450|Autonomic Agents|autonomic agents|mesh-ancestor
111220851|NCT01360450|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111220852|NCT01360450|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111220853|NCT01360450|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111220854|NCT01360450|Adrenergic Agents|adrenergic agents|mesh-ancestor
111220855|NCT01360450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111220856|NCT01360450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111220857|NCT01303744|1-(3',4'-dichloro-2-fluoro(1,1'-biphenyl)-4-yl)cyclopropanecarboxylic acid|1-(3',4'-dichloro-2-fluoro(1,1'-biphenyl)-4-yl)cyclopropanecarboxylic acid|mesh-list
111220858|NCT01303744|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
111220859|NCT01303744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111220860|NCT01303744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111220861|NCT01361620|Aspirin|aspirin|mesh-list
111220862|NCT01361620|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111220863|NCT01361620|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111220864|NCT01361620|Analgesics|analgesics|mesh-ancestor
111220865|NCT01361620|Sensory System Agents|sensory system agents|mesh-ancestor
111220866|NCT01361620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111220867|NCT01361620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111220868|NCT01361620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111220869|NCT01361620|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111220870|NCT01361620|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111220871|NCT01361620|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111220872|NCT01361620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111220873|NCT01361620|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111220874|NCT01361620|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111220875|NCT01361620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111220876|NCT01361620|Antipyretics|antipyretics|mesh-ancestor
111220877|NCT01305772|Panitumumab|panitumumab|mesh-list
111220878|NCT01305772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111220879|NCT01305772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111220880|NCT01271452|Botulinum Toxins|botulinum toxins|mesh-list
111220881|NCT01271452|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111220882|NCT01271452|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111220883|NCT01271452|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111220884|NCT01271452|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111220885|NCT01271452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111220886|NCT01271452|Cholinergic Agents|cholinergic agents|mesh-ancestor
111220887|NCT01271452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111220888|NCT01271452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111220889|NCT01271452|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111220890|NCT01271452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111220891|NCT01271686|Bimatoprost|bimatoprost|mesh-list
111220892|NCT01271686|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111220893|NCT01854047|Albuterol|albuterol|mesh-list
111220894|NCT01854047|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111220895|NCT01854047|Autonomic Agents|autonomic agents|mesh-ancestor
111220896|NCT01854047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111220897|NCT01854047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111220898|NCT01854047|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111220899|NCT01854047|Respiratory System Agents|respiratory system agents|mesh-ancestor
111220900|NCT01854047|Tocolytic Agents|tocolytic agents|mesh-ancestor
111220901|NCT01854047|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111220902|NCT01854047|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111220903|NCT01854047|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111220904|NCT01854047|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111220905|NCT01854047|Adrenergic Agents|adrenergic agents|mesh-ancestor
111220906|NCT01854047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111220907|NCT01854047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111220908|NCT01870739|Amlodipine|amlodipine|mesh-list
111220909|NCT01870739|Valsartan|valsartan|mesh-list
111220910|NCT01870739|Olmesartan|olmesartan|mesh-list
111220911|NCT01870739|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
111220912|NCT01870739|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
111220913|NCT01870739|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111220914|NCT01870739|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111220915|NCT01870739|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111220916|NCT01870739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111220917|NCT01870739|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110684777|NCT00307294|Thalidomide|thalidomide|mesh-list
111220918|NCT01870739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111220919|NCT01870739|Vasodilator Agents|vasodilator agents|mesh-ancestor
111220920|NCT01870739|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111220921|NCT01870739|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111220922|NCT01272388|Tadalafil|tadalafil|mesh-list
111220923|NCT01272388|Vasodilator Agents|vasodilator agents|mesh-ancestor
111220924|NCT01272388|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111220925|NCT01272388|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111220926|NCT01272388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111220927|NCT01272388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111220928|NCT01272388|Urological Agents|urological agents|mesh-ancestor
111220929|NCT01870583|Iodine|iodine|mesh-list
111220930|NCT01870583|Chlorhexidine|chlorhexidine|mesh-list
111220931|NCT01870583|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
111220932|NCT01870583|Cadexomer iodine|cadexomer iodine|mesh-list
111220933|NCT01870583|Povidone|povidone|mesh-list
111220934|NCT01870583|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111220935|NCT01870583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111220936|NCT01870583|Disinfectants|disinfectants|mesh-ancestor
111220937|NCT01870583|Dermatologic Agents|dermatologic agents|mesh-ancestor
111220938|NCT01870583|Trace Elements|trace elements|mesh-ancestor
111220939|NCT01870583|Micronutrients|micronutrients|mesh-ancestor
111220940|NCT01870583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111220941|NCT01870583|Plasma Substitutes|plasma substitutes|mesh-ancestor
111220942|NCT01870583|Blood Substitutes|blood substitutes|mesh-ancestor
111220943|NCT04351594|Menthol|menthol|mesh-list
111220944|NCT04351594|Antipruritics|antipruritics|mesh-ancestor
111220945|NCT04351594|Dermatologic Agents|dermatologic agents|mesh-ancestor
111220946|NCT01308814|Estradiol|estradiol|mesh-list
111220947|NCT01308814|Estrogens|estrogens|mesh-ancestor
111220948|NCT01308814|Hormones|hormones|mesh-ancestor
111220949|NCT01308814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111220950|NCT01308814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111220951|NCT03009604|Simethicone|simethicone|mesh-list
111220952|NCT03009604|Antifoaming Agents|antifoaming agents|mesh-ancestor
111220953|NCT03009604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111220954|NCT03009604|Emollients|emollients|mesh-ancestor
111220955|NCT03009604|Dermatologic Agents|dermatologic agents|mesh-ancestor
111220956|NCT01275664|Dexamethasone|dexamethasone|mesh-list
111220957|NCT01275664|Dexamethasone acetate|dexamethasone acetate|mesh-list
111220958|NCT01275664|Cisplatin|cisplatin|mesh-list
111220959|NCT01275664|Carboplatin|carboplatin|mesh-list
111220960|NCT01275664|Aprepitant|aprepitant|mesh-list
111220961|NCT01275664|Granisetron|granisetron|mesh-list
111220962|NCT01275664|Ichthammol|ichthammol|mesh-list
111220963|NCT01275664|BB 1101|bb 1101|mesh-list
111220964|NCT01275664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111220965|NCT01275664|Antiemetics|antiemetics|mesh-ancestor
111220966|NCT01275664|Autonomic Agents|autonomic agents|mesh-ancestor
111220967|NCT01275664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111220968|NCT01275664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111220969|NCT01275664|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111220970|NCT01275664|Glucocorticoids|glucocorticoids|mesh-ancestor
111220971|NCT01275664|Hormones|hormones|mesh-ancestor
111220972|NCT01275664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111220973|NCT01275664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111220974|NCT01275664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111220975|NCT01275664|Protease Inhibitors|protease inhibitors|mesh-ancestor
111220976|NCT01275664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111220977|NCT01275664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111220978|NCT01275664|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
111220979|NCT01275664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111220980|NCT01275664|Dermatologic Agents|dermatologic agents|mesh-ancestor
111220981|NCT01275664|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111220982|NCT01275664|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111220983|NCT01275664|Serotonin Agents|serotonin agents|mesh-ancestor
111220984|NCT01613027|Rituximab|rituximab|mesh-list
111220985|NCT01613027|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111220986|NCT01613027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111220987|NCT01613027|Immunologic Factors|immunologic factors|mesh-ancestor
111220988|NCT01613027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111220989|NCT01613027|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111220990|NCT04595045|Botulinum Toxins|botulinum toxins|mesh-list
111220991|NCT04595045|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111220992|NCT04595045|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111220993|NCT04595045|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111220994|NCT04595045|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111220995|NCT04595045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111220997|NCT04595045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111220998|NCT04595045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111220999|NCT04595045|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111221000|NCT04595045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111221001|NCT01369732|Epoetin Alfa|epoetin alfa|mesh-list
111221002|NCT01369732|Hematinics|hematinics|mesh-ancestor
111221003|NCT01869725|Octreotide|octreotide|mesh-list
111221004|NCT01869725|Edotreotide|edotreotide|mesh-list
111221005|NCT01869725|Indium-111-octreotide|indium-111-octreotide|mesh-list
111221006|NCT01869725|Somatostatin|somatostatin|mesh-list
111221007|NCT01869725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111221008|NCT01869725|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111221009|NCT01869725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111221010|NCT01869725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111221011|NCT01869725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111221012|NCT01869725|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111221013|NCT01869725|Hormones|hormones|mesh-ancestor
111221014|NCT01869725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111221015|NCT01309360|Midazolam|midazolam|mesh-list
111221016|NCT01309360|Prilocaine|prilocaine|mesh-list
111221017|NCT01309360|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111221018|NCT01309360|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111221019|NCT01309360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111221020|NCT01309360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111221021|NCT01309360|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111221022|NCT01309360|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111221023|NCT01309360|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111221024|NCT01309360|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111221025|NCT01309360|Anesthetics, General|anesthetics, general|mesh-ancestor
111221026|NCT01309360|Anesthetics|anesthetics|mesh-ancestor
111221027|NCT01309360|GABA Modulators|gaba modulators|mesh-ancestor
111221028|NCT01309360|GABA Agents|gaba agents|mesh-ancestor
111221029|NCT01309360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111221030|NCT01309360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111221031|NCT01309360|Anesthetics, Local|anesthetics, local|mesh-ancestor
111221032|NCT01309360|Sensory System Agents|sensory system agents|mesh-ancestor
111221033|NCT01309360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111221034|NCT01851863|Flupenthixol|flupenthixol|mesh-list
111221035|NCT01851863|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
111221036|NCT01851863|Omeprazole|omeprazole|mesh-list
111221037|NCT01851863|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111221038|NCT01851863|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111221039|NCT01851863|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111221040|NCT01851863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111221041|NCT01851863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111221042|NCT01851863|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111221043|NCT01851863|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111221044|NCT01851863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111221045|NCT01851863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111221046|NCT01851863|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111221047|NCT01851863|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111221048|NCT01851863|Dopamine Agents|dopamine agents|mesh-ancestor
111221049|NCT01851863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111221050|NCT01369888|Cyclophosphamide|cyclophosphamide|mesh-list
111221051|NCT01369888|Fludarabine|fludarabine|mesh-list
111221052|NCT01369888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111221053|NCT01369888|Immunologic Factors|immunologic factors|mesh-ancestor
111221054|NCT01369888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111221055|NCT01369888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111221056|NCT01369888|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111221057|NCT01369888|Alkylating Agents|alkylating agents|mesh-ancestor
111221058|NCT01369888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111221059|NCT01369888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111221060|NCT01369888|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111221061|NCT01850615|Insulin|insulin|mesh-list
111221062|NCT01850615|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111221063|NCT01850615|Insulin Aspart|insulin aspart|mesh-list
111221064|NCT01850615|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111221065|NCT01850615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111221066|NCT04602221|Lamotrigine|lamotrigine|mesh-list
111221067|NCT04602221|BI 425809|bi 425809|mesh-list
111221068|NCT04602221|BI 409306|bi 409306|mesh-list
111221069|NCT04602221|Anticonvulsants|anticonvulsants|mesh-ancestor
110674031|NCT05882864|Hormones|hormones|mesh-ancestor
111221070|NCT04602221|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111221071|NCT04602221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111221072|NCT04602221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111221073|NCT04602221|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111221074|NCT04602221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111221075|NCT04602221|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111221076|NCT04602221|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111221077|NCT04602221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111221078|NCT04602221|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111221079|NCT04602221|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111221080|NCT04602221|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111221081|NCT04602221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111221082|NCT04602221|Nootropic Agents|nootropic agents|mesh-ancestor
111221083|NCT01280110|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
111221084|NCT01280110|Laxatives|laxatives|mesh-ancestor
111221085|NCT01280110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111221086|NCT01374802|Ritonavir|ritonavir|mesh-list
111221087|NCT01374802|Darunavir|darunavir|mesh-list
111221088|NCT01374802|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111221089|NCT01374802|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111221090|NCT01374802|Protease Inhibitors|protease inhibitors|mesh-ancestor
111221091|NCT01374802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111221092|NCT01374802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111221093|NCT01374802|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111221094|NCT01374802|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111221095|NCT01374802|Antiviral Agents|antiviral agents|mesh-ancestor
111221096|NCT01374802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111221097|NCT01374802|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111221098|NCT01374802|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111221099|NCT01375660|Vitamin D|vitamin d|mesh-list
111221100|NCT01375660|Ergocalciferols|ergocalciferols|mesh-list
111221101|NCT01375660|Vitamins|vitamins|mesh-ancestor
111221102|NCT01375660|Micronutrients|micronutrients|mesh-ancestor
111221103|NCT01375660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111221104|NCT01375660|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111221105|NCT01375660|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111221106|NCT01868477|Epoetin Alfa|epoetin alfa|mesh-list
111221107|NCT01868477|Deferasirox|deferasirox|mesh-list
111221108|NCT01868477|Hematinics|hematinics|mesh-ancestor
111221109|NCT01868477|Iron Chelating Agents|iron chelating agents|mesh-ancestor
111221110|NCT01868477|Chelating Agents|chelating agents|mesh-ancestor
111221111|NCT01868477|Sequestering Agents|sequestering agents|mesh-ancestor
111221112|NCT01868477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111221113|NCT01849289|Insulin|insulin|mesh-list
111221114|NCT01849289|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111221115|NCT01849289|Insulin Glargine|insulin glargine|mesh-list
111221116|NCT01849289|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111221117|NCT01849289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111221118|NCT01868243|Warfarin|warfarin|mesh-list
111221119|NCT01868243|Dabigatran|dabigatran|mesh-list
111221120|NCT01868243|Anticoagulants|anticoagulants|mesh-ancestor
111221121|NCT01868243|Antithrombins|antithrombins|mesh-ancestor
111221122|NCT01868243|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111221123|NCT01868243|Protease Inhibitors|protease inhibitors|mesh-ancestor
111221124|NCT01868243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111221125|NCT01868243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111221126|NCT01611935|Vasopressins|vasopressins|mesh-list
111221127|NCT01611935|Arginine Vasopressin|arginine vasopressin|mesh-list
111221128|NCT01611935|Hemostatics|hemostatics|mesh-ancestor
111221129|NCT01611935|Coagulants|coagulants|mesh-ancestor
111221130|NCT01611935|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111221131|NCT01611935|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
111221132|NCT01611935|Natriuretic Agents|natriuretic agents|mesh-ancestor
111221133|NCT01611935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111221134|NCT02201212|Everolimus|everolimus|mesh-list
111221135|NCT02201212|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111221136|NCT02201212|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111221137|NCT02201212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111221138|NCT02201212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111221139|NCT02201212|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111221140|NCT02201212|Immunologic Factors|immunologic factors|mesh-ancestor
111221141|NCT02201212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111221142|NCT02201212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111221143|NCT01376362|Interferons|interferons|mesh-list
111221144|NCT01376362|Interferon-gamma|interferon-gamma|mesh-list
110674084|NCT05881187|Riboflavin|riboflavin|mesh-list
111221145|NCT01376362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111221146|NCT01376362|Antiviral Agents|antiviral agents|mesh-ancestor
111221147|NCT01376362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111221148|NCT03009292|Lenvatinib|lenvatinib|mesh-list
111221149|NCT03009292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111221150|NCT03009292|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111221151|NCT03009292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111221152|NCT03009292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111221153|NCT01962792|Dexamethasone|dexamethasone|mesh-list
111221154|NCT01962792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111221155|NCT01962792|Antiemetics|antiemetics|mesh-ancestor
111221156|NCT01962792|Autonomic Agents|autonomic agents|mesh-ancestor
111221157|NCT01962792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111221158|NCT01962792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111221159|NCT01962792|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111221160|NCT01962792|Glucocorticoids|glucocorticoids|mesh-ancestor
111221161|NCT01962792|Hormones|hormones|mesh-ancestor
111221162|NCT01962792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111221163|NCT01962792|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111221164|NCT01962792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111221165|NCT01849055|Celecoxib|celecoxib|mesh-list
111221166|NCT01849055|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111221167|NCT01849055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111221168|NCT01849055|Analgesics|analgesics|mesh-ancestor
111221169|NCT01849055|Sensory System Agents|sensory system agents|mesh-ancestor
111221170|NCT01849055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111221171|NCT01849055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111221172|NCT01849055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111221173|NCT01849055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111221174|NCT01849055|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111221175|NCT01849055|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111221176|NCT01849055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111221177|NCT01849055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111221178|NCT01404832|Lansoprazole|lansoprazole|mesh-list
111221179|NCT01404832|Dexlansoprazole|dexlansoprazole|mesh-list
111221180|NCT01404832|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111221181|NCT01404832|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111221182|NCT01404832|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111221183|NCT01404832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111221184|NCT01404832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111221185|NCT03420534|Iloperidone|iloperidone|mesh-list
111221186|NCT03420534|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111221187|NCT03420534|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111221188|NCT03420534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111221189|NCT03420534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111221190|NCT03420534|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111221191|NCT01313494|Albuterol|albuterol|mesh-list
111221192|NCT01313494|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111221193|NCT01313494|Autonomic Agents|autonomic agents|mesh-ancestor
111221194|NCT01313494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111221195|NCT01313494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111221196|NCT01313494|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111221197|NCT01313494|Respiratory System Agents|respiratory system agents|mesh-ancestor
111221198|NCT01313494|Tocolytic Agents|tocolytic agents|mesh-ancestor
111221199|NCT01313494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111221200|NCT01313494|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111221201|NCT01313494|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111221202|NCT01313494|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111221203|NCT01313494|Adrenergic Agents|adrenergic agents|mesh-ancestor
111221204|NCT01313494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111221205|NCT01313494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111221206|NCT01407094|Sertraline|sertraline|mesh-list
111221207|NCT01407094|Antidepressive Agents|antidepressive agents|mesh-ancestor
111221208|NCT01407094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111221209|NCT01407094|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111221210|NCT01407094|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111221211|NCT01407094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111221212|NCT01407094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111221213|NCT01407094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111221214|NCT01407094|Serotonin Agents|serotonin agents|mesh-ancestor
111221215|NCT01407094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111221216|NCT01867307|Empagliflozin|empagliflozin|mesh-list
111221217|NCT01867307|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111221218|NCT01867307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111221219|NCT01867307|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111221220|NCT01867307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110674155|NCT05880342|Reboxetine|reboxetine|mesh-list
111221221|NCT01845077|Metformin|metformin|mesh-list
111221222|NCT01845077|Linagliptin|linagliptin|mesh-list
111221223|NCT01845077|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111221224|NCT01845077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111221225|NCT01845077|Incretins|incretins|mesh-ancestor
111221226|NCT01845077|Hormones|hormones|mesh-ancestor
111221227|NCT01845077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111221228|NCT01845077|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111221229|NCT01845077|Protease Inhibitors|protease inhibitors|mesh-ancestor
111221230|NCT01845077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111221231|NCT01845077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111221232|NCT01866917|Ropivacaine|ropivacaine|mesh-list
111221233|NCT01866917|Anesthetics, Local|anesthetics, local|mesh-ancestor
111221234|NCT01866917|Anesthetics|anesthetics|mesh-ancestor
111221235|NCT01866917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111221236|NCT01866917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111221237|NCT01866917|Sensory System Agents|sensory system agents|mesh-ancestor
111221238|NCT01866917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111221239|NCT01316302|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
111221240|NCT01316302|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111221241|NCT01316302|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111221242|NCT01316302|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111221243|NCT01316302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111221244|NCT01316302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111221245|NCT01316302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111221246|NCT01316302|Antidepressive Agents|antidepressive agents|mesh-ancestor
111221247|NCT01316302|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111221248|NCT01410058|Efavirenz|efavirenz|mesh-list
111221249|NCT01410058|Nevirapine|nevirapine|mesh-list
111221250|NCT01410058|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111221251|NCT01410058|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111221252|NCT01410058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111221253|NCT01410058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111221254|NCT01410058|Antiviral Agents|antiviral agents|mesh-ancestor
111221255|NCT01410058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111221256|NCT01410058|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111221257|NCT01410058|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111221258|NCT01410058|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111221259|NCT01410058|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111221260|NCT01410058|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111221261|NCT01410058|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111221262|NCT01410058|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111221263|NCT01410058|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111221264|NCT01380106|Lenalidomide|lenalidomide|mesh-list
111221265|NCT01380106|Immunologic Factors|immunologic factors|mesh-ancestor
111221266|NCT01380106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110980639|NCT03213548|Growth Substances|growth substances|mesh-ancestor
111221267|NCT01380106|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111221268|NCT01380106|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111221269|NCT01380106|Growth Substances|growth substances|mesh-ancestor
111221270|NCT01380106|Growth Inhibitors|growth inhibitors|mesh-ancestor
111221271|NCT01380106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111221272|NCT01381120|Acetaminophen|acetaminophen|mesh-list
111221273|NCT01381120|Oxycodone|oxycodone|mesh-list
111221274|NCT01381120|Solifenacin Succinate|solifenacin succinate|mesh-list
111221275|NCT01381120|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111221276|NCT01381120|Analgesics|analgesics|mesh-ancestor
111221277|NCT01381120|Sensory System Agents|sensory system agents|mesh-ancestor
111221278|NCT01381120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111221279|NCT01381120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111221280|NCT01381120|Antipyretics|antipyretics|mesh-ancestor
111221281|NCT01381120|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111221282|NCT01381120|Narcotics|narcotics|mesh-ancestor
111221283|NCT01381120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111221284|NCT01381120|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111221285|NCT01381120|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111221286|NCT01381120|Cholinergic Agents|cholinergic agents|mesh-ancestor
111221287|NCT01381120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111221288|NCT01381120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111221289|NCT01381120|Urological Agents|urological agents|mesh-ancestor
111221290|NCT01316770|Dexamethasone|dexamethasone|mesh-list
111221291|NCT01316770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111221292|NCT01316770|Antiemetics|antiemetics|mesh-ancestor
111221293|NCT01316770|Autonomic Agents|autonomic agents|mesh-ancestor
111221294|NCT01316770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111221295|NCT01316770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111221296|NCT01316770|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111221297|NCT01316770|Glucocorticoids|glucocorticoids|mesh-ancestor
111221299|NCT01316770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111221300|NCT01316770|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111221301|NCT01316770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111221302|NCT01318408|Levetiracetam|levetiracetam|mesh-list
111221303|NCT01318408|Anticonvulsants|anticonvulsants|mesh-ancestor
111221304|NCT01318408|Nootropic Agents|nootropic agents|mesh-ancestor
111221305|NCT01319110|Ubiquinone|ubiquinone|mesh-list
111221306|NCT01319110|Coenzyme Q10|coenzyme q10|mesh-list
111221307|NCT01319110|Micronutrients|micronutrients|mesh-ancestor
111221308|NCT01319110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111221309|NCT01319110|Vitamins|vitamins|mesh-ancestor
111221310|NCT03008512|Paclitaxel|paclitaxel|mesh-list
111221311|NCT03008512|genexol-PM|genexol-pm|mesh-list
111221312|NCT03008512|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111221313|NCT03008512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111221314|NCT03008512|Tubulin Modulators|tubulin modulators|mesh-ancestor
111221315|NCT03008512|Antimitotic Agents|antimitotic agents|mesh-ancestor
111221316|NCT03008512|Mitosis Modulators|mitosis modulators|mesh-ancestor
111221317|NCT03008512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111221318|NCT04351516|Hydroxychloroquine|hydroxychloroquine|mesh-list
111221319|NCT04351516|Antimalarials|antimalarials|mesh-ancestor
111221320|NCT04351516|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111221321|NCT04351516|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111221322|NCT04351516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111221323|NCT04351516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111221324|NCT04351516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111221325|NCT04351516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111221326|NCT01411696|Dexamethasone|dexamethasone|mesh-list
111221327|NCT01411696|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111221328|NCT01411696|Antiemetics|antiemetics|mesh-ancestor
111221329|NCT01411696|Autonomic Agents|autonomic agents|mesh-ancestor
111221330|NCT01411696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111221331|NCT01411696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111221332|NCT01411696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111221333|NCT01411696|Glucocorticoids|glucocorticoids|mesh-ancestor
111221334|NCT01411696|Hormones|hormones|mesh-ancestor
111221335|NCT01411696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111221336|NCT01411696|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111221337|NCT01411696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111221338|NCT01412164|Sirolimus|sirolimus|mesh-list
111221339|NCT01412164|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111221340|NCT01412164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111221341|NCT01412164|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111221342|NCT01412164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111221343|NCT01412164|Antifungal Agents|antifungal agents|mesh-ancestor
111221344|NCT01412164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111221345|NCT01412164|Immunologic Factors|immunologic factors|mesh-ancestor
111221346|NCT01412164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111221347|NCT01844687|Cannabidiol|cannabidiol|mesh-list
111221348|NCT01844687|Anticonvulsants|anticonvulsants|mesh-ancestor
111221349|NCT01844531|Metformin|metformin|mesh-list
111221350|NCT01844531|Empagliflozin|empagliflozin|mesh-list
111221351|NCT01844531|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111221352|NCT01844531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111221353|NCT01844531|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111221354|NCT01844531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111221355|NCT02367456|Azacitidine|azacitidine|mesh-list
111221356|NCT02367456|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111221357|NCT02367456|Antimetabolites|antimetabolites|mesh-ancestor
111221358|NCT02367456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111221359|NCT02367456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111221360|NCT02367456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111221361|NCT03420378|Vitamin D|vitamin d|mesh-list
111221362|NCT03420378|Vitamins|vitamins|mesh-ancestor
111221363|NCT03420378|Micronutrients|micronutrients|mesh-ancestor
111221364|NCT03420378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111221365|NCT03420378|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111221366|NCT03425448|Heparin|heparin|mesh-list
111221367|NCT03425448|Anticoagulants|anticoagulants|mesh-ancestor
111221368|NCT03425448|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111221369|NCT03425448|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111221370|NCT03425448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110674303|NCT05875506|Chitosan|chitosan|mesh-list
111221371|NCT03419910|Cyclosporine|cyclosporine|mesh-list
111221372|NCT03419910|Deucravacitinib|deucravacitinib|mesh-list
111221373|NCT03419910|Cyclosporins|cyclosporins|mesh-list
111221374|NCT03419910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111221375|NCT03419910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111221376|NCT03419910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111221377|NCT03419910|Immunologic Factors|immunologic factors|mesh-ancestor
111221378|NCT03419910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111221379|NCT03419910|Antifungal Agents|antifungal agents|mesh-ancestor
111221380|NCT03419910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111221381|NCT03419910|Dermatologic Agents|dermatologic agents|mesh-ancestor
111221382|NCT03419910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111221383|NCT03419910|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111221384|NCT03419910|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111221385|NCT03415386|Anticoagulants|anticoagulants|mesh-list
111221386|NCT03415386|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
111221387|NCT01865747|Everolimus|everolimus|mesh-list
111221388|NCT01865747|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111221389|NCT01865747|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111221390|NCT01865747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111221391|NCT01865747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111221392|NCT01865747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111221393|NCT01865747|Immunologic Factors|immunologic factors|mesh-ancestor
111221394|NCT01865747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111221395|NCT01865747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111221396|NCT03424980|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
111221397|NCT03424980|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111221398|NCT03424980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111221399|NCT03424980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111221400|NCT03424746|Edetic Acid|edetic acid|mesh-list
111221401|NCT03424746|Pentetic Acid|pentetic acid|mesh-list
111221402|NCT03424746|Anticoagulants|anticoagulants|mesh-ancestor
111221403|NCT03424746|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
111221404|NCT03424746|Chelating Agents|chelating agents|mesh-ancestor
111221405|NCT03424746|Sequestering Agents|sequestering agents|mesh-ancestor
111221406|NCT03424746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111221407|NCT03424746|Antidotes|antidotes|mesh-ancestor
111221408|NCT03424746|Protective Agents|protective agents|mesh-ancestor
111221409|NCT03424746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111221410|NCT03424746|Iron Chelating Agents|iron chelating agents|mesh-ancestor
111221411|NCT03414918|Clarithromycin|clarithromycin|mesh-list
111221412|NCT03414918|Roxithromycin|roxithromycin|mesh-list
111221413|NCT03414918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111221414|NCT03414918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111221415|NCT03414918|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111221416|NCT03414918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111221417|NCT03414918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111221418|NCT03414918|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111221419|NCT03414918|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111221420|NCT04448496|Dexamethasone|dexamethasone|mesh-list
111221421|NCT04448496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111221422|NCT04448496|Antiemetics|antiemetics|mesh-ancestor
111221423|NCT04448496|Autonomic Agents|autonomic agents|mesh-ancestor
111221424|NCT04448496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111221425|NCT04448496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111221426|NCT04448496|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111221427|NCT04448496|Glucocorticoids|glucocorticoids|mesh-ancestor
111221428|NCT04448496|Hormones|hormones|mesh-ancestor
111221429|NCT04448496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111221430|NCT04448496|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111221431|NCT04448496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111221432|NCT01387672|Nitroglycerin|nitroglycerin|mesh-list
111221433|NCT01387672|Vasodilator Agents|vasodilator agents|mesh-ancestor
111221434|NCT03419442|Docetaxel|docetaxel|mesh-list
111221435|NCT03419442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111221436|NCT03419442|Tubulin Modulators|tubulin modulators|mesh-ancestor
111221437|NCT03419442|Antimitotic Agents|antimitotic agents|mesh-ancestor
111221438|NCT03419442|Mitosis Modulators|mitosis modulators|mesh-ancestor
111221439|NCT03419442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111221440|NCT01412710|Vitamin D|vitamin d|mesh-list
111221441|NCT01412710|Cholecalciferol|cholecalciferol|mesh-list
111221442|NCT01412710|Vitamins|vitamins|mesh-ancestor
111221443|NCT01412710|Micronutrients|micronutrients|mesh-ancestor
111221444|NCT01412710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111221445|NCT01412710|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111221446|NCT01412710|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111221448|NCT01843205|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111221449|NCT01843205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111221450|NCT01843205|Sympathomimetics|sympathomimetics|mesh-ancestor
111221451|NCT01843205|Autonomic Agents|autonomic agents|mesh-ancestor
111221452|NCT01843205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111221453|NCT01843205|Dopamine Agents|dopamine agents|mesh-ancestor
111221454|NCT01843205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111221455|NCT01843205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111221456|NCT01843205|Adrenergic Agents|adrenergic agents|mesh-ancestor
111221457|NCT01843205|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111221458|NCT01843205|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111221459|NCT01843205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111221460|NCT01843205|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111221461|NCT03419130|Pembrolizumab|pembrolizumab|mesh-list
111221462|NCT03419130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111221463|NCT03419130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111221464|NCT03419130|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111221465|NCT03419130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111221466|NCT03414840|Atorvastatin|atorvastatin|mesh-list
111221467|NCT03414840|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111221468|NCT03414840|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111221469|NCT03414840|Antimetabolites|antimetabolites|mesh-ancestor
111221470|NCT03414840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111221471|NCT03414840|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111221472|NCT03414840|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111221473|NCT03414840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111221474|NCT03418974|Atorvastatin|atorvastatin|mesh-list
111221475|NCT03418974|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111221476|NCT03418974|Pitavastatin|pitavastatin|mesh-list
111221477|NCT03418974|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111221478|NCT03418974|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111221479|NCT03418974|Antimetabolites|antimetabolites|mesh-ancestor
111221480|NCT03418974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111221481|NCT03418974|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111221482|NCT03418974|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111221483|NCT03418974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111221484|NCT03424356|Fentanyl|fentanyl|mesh-list
111221485|NCT03424356|Narcotics|narcotics|mesh-list
111221486|NCT03424356|Analgesics|analgesics|mesh-list
111221487|NCT03424356|Bromides|bromides|mesh-list
111221488|NCT03424356|Propofol|propofol|mesh-list
111221489|NCT03424356|Rocuronium|rocuronium|mesh-list
111221490|NCT03424356|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111221491|NCT03424356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111221492|NCT03424356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111221493|NCT03424356|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111221494|NCT03424356|Anesthetics, General|anesthetics, general|mesh-ancestor
111221495|NCT03424356|Anesthetics|anesthetics|mesh-ancestor
111221496|NCT03424356|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111221497|NCT03424356|Sensory System Agents|sensory system agents|mesh-ancestor
111221498|NCT03424356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111221499|NCT03424356|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111221500|NCT03424356|Anticonvulsants|anticonvulsants|mesh-ancestor
111221501|NCT03424356|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
111221502|NCT03424356|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
111221503|NCT03424356|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111221504|NCT03414450|Dasatinib|dasatinib|mesh-list
111221505|NCT03414450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111221506|NCT03414450|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111221507|NCT03414450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111221508|NCT03414450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111221509|NCT01389076|Methotrexate|methotrexate|mesh-list
111221510|NCT01389076|Tositumomab I-131|tositumomab i-131|mesh-list
111221511|NCT01389076|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111221512|NCT01389076|Abortifacient Agents|abortifacient agents|mesh-ancestor
111221513|NCT01389076|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111221514|NCT01389076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111221515|NCT01389076|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111221516|NCT01389076|Antimetabolites|antimetabolites|mesh-ancestor
111221517|NCT01389076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111221518|NCT01389076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111221519|NCT01389076|Dermatologic Agents|dermatologic agents|mesh-ancestor
111221520|NCT01389076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111221521|NCT01389076|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111221522|NCT01389076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111221523|NCT01389076|Immunologic Factors|immunologic factors|mesh-ancestor
111221524|NCT01389076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111221525|NCT01389076|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111221526|NCT03127800|Morphine|morphine|mesh-list
111221527|NCT03127800|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111221528|NCT03127800|Narcotics|narcotics|mesh-ancestor
111221529|NCT03127800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111221530|NCT03127800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111221531|NCT03127800|Analgesics|analgesics|mesh-ancestor
111221532|NCT03127800|Sensory System Agents|sensory system agents|mesh-ancestor
111221533|NCT03127800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111221534|NCT01389856|Bosentan|bosentan|mesh-list
111221535|NCT01389856|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111221536|NCT01389856|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
111221537|NCT01389856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111221538|NCT03418896|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
111221539|NCT03418896|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111221540|NCT03418896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111221541|NCT01323010|Albuterol|albuterol|mesh-list
111221542|NCT01323010|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111221543|NCT01323010|Autonomic Agents|autonomic agents|mesh-ancestor
111221544|NCT01323010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111221545|NCT01323010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111221546|NCT01323010|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111221547|NCT01323010|Respiratory System Agents|respiratory system agents|mesh-ancestor
111221548|NCT01323010|Tocolytic Agents|tocolytic agents|mesh-ancestor
111221549|NCT01323010|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111221550|NCT01323010|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111221551|NCT01323010|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111221552|NCT01323010|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111221553|NCT01323010|Adrenergic Agents|adrenergic agents|mesh-ancestor
111221554|NCT01323010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111221555|NCT01323010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111221556|NCT03423810|Hydralazine|hydralazine|mesh-list
111221557|NCT03423810|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111221558|NCT03423810|Vasodilator Agents|vasodilator agents|mesh-ancestor
111221559|NCT01390246|Bupropion|bupropion|mesh-list
111221560|NCT01390246|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111221561|NCT01390246|Antidepressive Agents|antidepressive agents|mesh-ancestor
111221562|NCT01390246|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111221563|NCT01390246|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111221564|NCT01390246|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111221565|NCT01390246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111221566|NCT01390246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111221567|NCT01390246|Dopamine Agents|dopamine agents|mesh-ancestor
111221568|NCT01390246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111221569|NCT01390246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111221570|NCT01390246|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111221571|NCT01390246|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111221572|NCT01390246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111221573|NCT01390870|Alfuzosin|alfuzosin|mesh-list
111221574|NCT01390870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111221575|NCT01390870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111221576|NCT01390870|Urological Agents|urological agents|mesh-ancestor
111221577|NCT01390870|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111221578|NCT01390870|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111221579|NCT01390870|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111221580|NCT01390870|Adrenergic Agents|adrenergic agents|mesh-ancestor
111221581|NCT01390870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111221582|NCT03418506|Lobeline|lobeline|mesh-list
111221583|NCT03418506|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111221584|NCT03418506|Autonomic Agents|autonomic agents|mesh-ancestor
111221585|NCT03418506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111221586|NCT03418506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111221587|NCT03418506|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111221588|NCT03418506|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111221589|NCT03418506|Cholinergic Agents|cholinergic agents|mesh-ancestor
111221590|NCT03418506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111221591|NCT03418506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111221592|NCT03418506|Respiratory System Agents|respiratory system agents|mesh-ancestor
111221593|NCT01842581|Rifaximin|rifaximin|mesh-list
111221594|NCT01842581|Lactulose|lactulose|mesh-list
111221595|NCT01842581|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111221596|NCT01842581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111221597|NCT01842581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111221598|NCT04448028|Esomeprazole|esomeprazole|mesh-list
111221599|NCT04448028|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
111221600|NCT04448028|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111221601|NCT04448028|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111221602|NCT04448028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111221603|NCT04448028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111221604|NCT01833533|Ribavirin|ribavirin|mesh-list
111221605|NCT01833533|Antimetabolites|antimetabolites|mesh-ancestor
111221606|NCT01833533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111221607|NCT01833533|Antiviral Agents|antiviral agents|mesh-ancestor
111221608|NCT01833533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111221609|NCT03413436|Cisplatin|cisplatin|mesh-list
111221610|NCT03413436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111221611|NCT01833455|Flecainide|flecainide|mesh-list
111221612|NCT01833455|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111221613|NCT01833455|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111221614|NCT01833455|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111221615|NCT01833455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111221616|NCT01833455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111221617|NCT03413358|Carboplatin|carboplatin|mesh-list
111221618|NCT03413358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111221619|NCT01833143|Acyclovir|acyclovir|mesh-list
111221620|NCT01833143|Bortezomib|bortezomib|mesh-list
111221621|NCT01833143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111221622|NCT01833143|Antiviral Agents|antiviral agents|mesh-ancestor
111221623|NCT01833143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111221624|NCT03411096|Ropivacaine|ropivacaine|mesh-list
111221625|NCT03411096|Anesthetics, Local|anesthetics, local|mesh-ancestor
111221626|NCT03411096|Anesthetics|anesthetics|mesh-ancestor
111221627|NCT03411096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111221628|NCT03411096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111221629|NCT03411096|Sensory System Agents|sensory system agents|mesh-ancestor
111221630|NCT03411096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111221631|NCT03417648|Vitamin E|vitamin e|mesh-list
111221632|NCT03417648|Vitamins|vitamins|mesh-ancestor
111221633|NCT03417648|Micronutrients|micronutrients|mesh-ancestor
111221634|NCT03417648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111221635|NCT03417648|Antioxidants|antioxidants|mesh-ancestor
111221636|NCT03417648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111221637|NCT03417648|Protective Agents|protective agents|mesh-ancestor
111221638|NCT01831817|Calcium, Dietary|calcium, dietary|mesh-list
111221639|NCT01831817|Listerine|listerine|mesh-list
111221640|NCT01831817|Calcium|calcium|mesh-list
111221641|NCT01831817|Fluorides|fluorides|mesh-list
111221642|NCT01831817|Sodium Fluoride|sodium fluoride|mesh-list
111221643|NCT01831817|Fluorophosphate|fluorophosphate|mesh-list
111221644|NCT01831817|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111221645|NCT01831817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111221646|NCT01831817|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111221647|NCT01831817|Cariostatic Agents|cariostatic agents|mesh-ancestor
111221648|NCT01831817|Protective Agents|protective agents|mesh-ancestor
111221649|NCT01831817|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111221650|NCT01831817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111221651|NCT03412500|Vancomycin|vancomycin|mesh-list
111221652|NCT03412500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111221653|NCT03412500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111221654|NCT01840943|Topotecan|topotecan|mesh-list
111221655|NCT01840943|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111221656|NCT01840943|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111221657|NCT01840943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111221658|NCT01840943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111221659|NCT01840943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111221660|NCT05171400|Insulin|insulin|mesh-list
111221661|NCT05171400|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111221662|NCT05171400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111221663|NCT02203630|Phenylephrine|phenylephrine|mesh-list
111221664|NCT02203630|Oxymetazoline|oxymetazoline|mesh-list
111221665|NCT02203630|Norepinephrine|norepinephrine|mesh-list
111221666|NCT02203630|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111221667|NCT02203630|Mydriatics|mydriatics|mesh-ancestor
111221668|NCT02203630|Autonomic Agents|autonomic agents|mesh-ancestor
111221669|NCT02203630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111221670|NCT02203630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111221671|NCT02203630|Sympathomimetics|sympathomimetics|mesh-ancestor
111221672|NCT02203630|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111221673|NCT02203630|Nasal Decongestants|nasal decongestants|mesh-ancestor
111221674|NCT02203630|Respiratory System Agents|respiratory system agents|mesh-ancestor
111221675|NCT02203630|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111221676|NCT02203630|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111221677|NCT02203630|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111221678|NCT02203630|Adrenergic Agents|adrenergic agents|mesh-ancestor
111221679|NCT02203630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111221680|NCT02203630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111221681|NCT02203630|Protective Agents|protective agents|mesh-ancestor
111221682|NCT03397446|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
111221683|NCT03397446|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111221684|NCT03397446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111221685|NCT03397446|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111221686|NCT03397446|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111221687|NCT03397446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111221688|NCT03397446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111221689|NCT03397446|Dopamine Agents|dopamine agents|mesh-ancestor
111221690|NCT03397446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111221691|NCT01393132|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111221692|NCT01393132|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111221693|NCT02520570|Urinastatin|urinastatin|mesh-list
111221694|NCT02520570|Trypsin Inhibitors|trypsin inhibitors|mesh-list
111221695|NCT02520570|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111221696|NCT02520570|Protease Inhibitors|protease inhibitors|mesh-ancestor
111221697|NCT02520570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111221698|NCT02520570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111221699|NCT03411798|Hydroxychloroquine|hydroxychloroquine|mesh-list
111221700|NCT03411798|Sulfasalazine|sulfasalazine|mesh-list
111221701|NCT03411798|Methotrexate|methotrexate|mesh-list
111221702|NCT03411798|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111221703|NCT03411798|Abortifacient Agents|abortifacient agents|mesh-ancestor
111221704|NCT03411798|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111221705|NCT03411798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111221706|NCT03411798|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111221707|NCT03411798|Antimetabolites|antimetabolites|mesh-ancestor
111221708|NCT03411798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111221709|NCT03411798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111221710|NCT03411798|Dermatologic Agents|dermatologic agents|mesh-ancestor
111221711|NCT03411798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111221712|NCT03411798|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111221713|NCT03411798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111221714|NCT03411798|Immunologic Factors|immunologic factors|mesh-ancestor
111221715|NCT03411798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111221716|NCT03411798|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111221717|NCT03411798|Antimalarials|antimalarials|mesh-ancestor
111221718|NCT03411798|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111221719|NCT03411798|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111221720|NCT03411798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111221721|NCT03411798|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111221722|NCT03411798|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111221723|NCT03411798|Analgesics|analgesics|mesh-ancestor
111221724|NCT03411798|Sensory System Agents|sensory system agents|mesh-ancestor
111221725|NCT03411798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111221726|NCT03411798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111221727|NCT03411798|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111221728|NCT03408756|Methotrexate|methotrexate|mesh-list
111221729|NCT03408756|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111221730|NCT03408756|Abortifacient Agents|abortifacient agents|mesh-ancestor
111221731|NCT03408756|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111221732|NCT03408756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111221733|NCT03408756|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111221734|NCT03408756|Antimetabolites|antimetabolites|mesh-ancestor
111221735|NCT03408756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111221736|NCT03408756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111221737|NCT03408756|Dermatologic Agents|dermatologic agents|mesh-ancestor
111221738|NCT03408756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111221739|NCT03408756|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111221740|NCT03408756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111221741|NCT03408756|Immunologic Factors|immunologic factors|mesh-ancestor
111221742|NCT03408756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111221743|NCT03408756|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111221744|NCT01394614|Vaccines|vaccines|mesh-list
111221745|NCT01394614|Immunologic Factors|immunologic factors|mesh-ancestor
111221746|NCT01394614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111221747|NCT04588818|Adalimumab|adalimumab|mesh-list
111221748|NCT04588818|Methotrexate|methotrexate|mesh-list
111221749|NCT04588818|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111221750|NCT04588818|Abortifacient Agents|abortifacient agents|mesh-ancestor
111221751|NCT04588818|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111221752|NCT04588818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111221753|NCT04588818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111221754|NCT04588818|Antimetabolites|antimetabolites|mesh-ancestor
111221755|NCT04588818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111221756|NCT04588818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111221757|NCT04588818|Dermatologic Agents|dermatologic agents|mesh-ancestor
111221758|NCT04588818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111221759|NCT04588818|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111221760|NCT04588818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111221761|NCT04588818|Immunologic Factors|immunologic factors|mesh-ancestor
111221762|NCT04588818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111221763|NCT04588818|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111221764|NCT04588818|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111221765|NCT04588818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111221766|NCT01422226|Alprostadil|alprostadil|mesh-list
111221767|NCT01422226|Misoprostol|misoprostol|mesh-list
111221768|NCT01422226|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111221769|NCT01422226|Abortifacient Agents|abortifacient agents|mesh-ancestor
111221770|NCT01422226|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111221771|NCT01422226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111221772|NCT01422226|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111221773|NCT01422226|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111221774|NCT01422226|Oxytocics|oxytocics|mesh-ancestor
111221775|NCT01422226|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111221776|NCT01422226|Vasodilator Agents|vasodilator agents|mesh-ancestor
111221777|NCT01422226|Urological Agents|urological agents|mesh-ancestor
111221778|NCT01423162|Ascorbic Acid|ascorbic acid|mesh-list
111221779|NCT01423162|Antioxidants|antioxidants|mesh-ancestor
111221780|NCT01423162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111221781|NCT01423162|Protective Agents|protective agents|mesh-ancestor
111221782|NCT01423162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111221783|NCT01423162|Vitamins|vitamins|mesh-ancestor
111221784|NCT01423162|Micronutrients|micronutrients|mesh-ancestor
111221785|NCT01328782|Acetaminophen|acetaminophen|mesh-list
111221786|NCT01328782|Oxycodone|oxycodone|mesh-list
111221787|NCT01328782|Bupivacaine|bupivacaine|mesh-list
111221788|NCT01328782|Ropivacaine|ropivacaine|mesh-list
111221789|NCT01328782|Anesthetics, Local|anesthetics, local|mesh-ancestor
111221790|NCT01328782|Anesthetics|anesthetics|mesh-ancestor
111221791|NCT01328782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111221792|NCT01328782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111221793|NCT01328782|Sensory System Agents|sensory system agents|mesh-ancestor
111221794|NCT01328782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111221795|NCT01328782|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111221796|NCT01328782|Analgesics|analgesics|mesh-ancestor
111221797|NCT01328782|Antipyretics|antipyretics|mesh-ancestor
111221798|NCT01328782|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111221799|NCT01328782|Narcotics|narcotics|mesh-ancestor
111221800|NCT04447326|Endostar protein|endostar protein|mesh-list
111221801|NCT04447326|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111221802|NCT04447326|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111221803|NCT04447326|Growth Substances|growth substances|mesh-ancestor
111221804|NCT04447326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111221805|NCT04447326|Growth Inhibitors|growth inhibitors|mesh-ancestor
111221806|NCT04447326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111221807|NCT03411330|Lidocaine|lidocaine|mesh-list
111221808|NCT03411330|Bupivacaine|bupivacaine|mesh-list
111221809|NCT03411330|Anesthetics, Local|anesthetics, local|mesh-ancestor
111221810|NCT03411330|Anesthetics|anesthetics|mesh-ancestor
111221811|NCT03411330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111221812|NCT03411330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111221813|NCT03411330|Sensory System Agents|sensory system agents|mesh-ancestor
111221814|NCT03411330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111221815|NCT03411330|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111221816|NCT03411330|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111221817|NCT03411330|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111221818|NCT03411330|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111221819|NCT03411330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111221820|NCT03411252|Mirabegron|mirabegron|mesh-list
111221821|NCT03411252|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
111221822|NCT03411252|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111221823|NCT03411252|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111221824|NCT03411252|Adrenergic Agents|adrenergic agents|mesh-ancestor
111221825|NCT03411252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111221826|NCT03411252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111221827|NCT03411252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111221828|NCT03411252|Urological Agents|urological agents|mesh-ancestor
111221829|NCT01831427|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111221830|NCT01831427|Immunologic Factors|immunologic factors|mesh-ancestor
111221831|NCT01831427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111221832|NCT01830881|Ibuprofen|ibuprofen|mesh-list
111221833|NCT01830881|Lidocaine|lidocaine|mesh-list
111221834|NCT01830881|Midazolam|midazolam|mesh-list
111221835|NCT01830881|Anesthetics, Local|anesthetics, local|mesh-ancestor
111221836|NCT01830881|Anesthetics|anesthetics|mesh-ancestor
111221837|NCT01830881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111221838|NCT01830881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111221839|NCT01830881|Sensory System Agents|sensory system agents|mesh-ancestor
111221840|NCT01830881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111221841|NCT01830881|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111221842|NCT01830881|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111221843|NCT01830881|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111221844|NCT01830881|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111221845|NCT01830881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111221846|NCT01830881|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111221847|NCT01830881|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111221848|NCT01830881|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111221849|NCT01830881|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111221850|NCT01830881|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111221851|NCT01830881|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111221852|NCT01830881|Anesthetics, General|anesthetics, general|mesh-ancestor
111221853|NCT01830881|GABA Modulators|gaba modulators|mesh-ancestor
111221854|NCT01830881|GABA Agents|gaba agents|mesh-ancestor
111221855|NCT01830881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111221856|NCT01830881|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111221857|NCT01830881|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111221858|NCT01830881|Analgesics|analgesics|mesh-ancestor
111221859|NCT01830881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111221860|NCT01830881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111221861|NCT01830881|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111221862|NCT01830881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111221863|NCT01396486|Inositol|inositol|mesh-list
111221864|NCT01396486|Vitamin B Complex|vitamin b complex|mesh-ancestor
111221865|NCT01396486|Vitamins|vitamins|mesh-ancestor
111221866|NCT01396486|Micronutrients|micronutrients|mesh-ancestor
111221867|NCT01396486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111221868|NCT01838681|Brexpiprazole|brexpiprazole|mesh-list
111221869|NCT01838681|Serotonin Agents|serotonin agents|mesh-ancestor
111221870|NCT01838681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110980641|NCT00534027|Conatumumab|conatumumab|mesh-list
111221871|NCT01838681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111221872|NCT01838681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111221873|NCT01838681|Dopamine Agonists|dopamine agonists|mesh-ancestor
111221874|NCT01838681|Dopamine Agents|dopamine agents|mesh-ancestor
111221875|NCT03404544|Carbetocin|carbetocin|mesh-list
111221876|NCT03404544|Oxytocin|oxytocin|mesh-list
111221877|NCT03404544|Oxytocics|oxytocics|mesh-ancestor
111221878|NCT03404544|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111221879|NCT03404544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111221880|NCT01398280|Aminocaproic Acid|aminocaproic acid|mesh-list
111221881|NCT01398280|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111221882|NCT01398280|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111221883|NCT01398280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111221884|NCT01398280|Hemostatics|hemostatics|mesh-ancestor
111221885|NCT01398280|Coagulants|coagulants|mesh-ancestor
111221886|NCT03403842|Sufentanil|sufentanil|mesh-list
111221887|NCT03403842|Morphine|morphine|mesh-list
111221888|NCT03403842|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111221889|NCT03403842|Narcotics|narcotics|mesh-ancestor
111221890|NCT03403842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111221891|NCT03403842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111221892|NCT03403842|Analgesics|analgesics|mesh-ancestor
111221893|NCT03403842|Sensory System Agents|sensory system agents|mesh-ancestor
111221894|NCT03403842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111221895|NCT03403842|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111221896|NCT03403842|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111221897|NCT03403842|Anesthetics, General|anesthetics, general|mesh-ancestor
111221898|NCT03403842|Anesthetics|anesthetics|mesh-ancestor
110682997|NCT00908921|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111221899|NCT01398982|Bupivacaine|bupivacaine|mesh-list
111221900|NCT01398982|Anesthetics, Local|anesthetics, local|mesh-ancestor
111221901|NCT01398982|Anesthetics|anesthetics|mesh-ancestor
111221902|NCT01398982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111221903|NCT01398982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111221904|NCT01398982|Sensory System Agents|sensory system agents|mesh-ancestor
111221905|NCT01398982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111221906|NCT04447560|Bupivacaine|bupivacaine|mesh-list
111221907|NCT04447560|Anesthetics, Local|anesthetics, local|mesh-ancestor
111221908|NCT04447560|Anesthetics|anesthetics|mesh-ancestor
111221909|NCT04447560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111221910|NCT04447560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111221911|NCT04447560|Sensory System Agents|sensory system agents|mesh-ancestor
111221912|NCT04447560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111221913|NCT03401736|Midazolam|midazolam|mesh-list
111221914|NCT03401736|Dexmedetomidine|dexmedetomidine|mesh-list
111221915|NCT03401736|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111221916|NCT03401736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111221917|NCT03401736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111221918|NCT03401736|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111221919|NCT03401736|Analgesics|analgesics|mesh-ancestor
111221920|NCT03401736|Sensory System Agents|sensory system agents|mesh-ancestor
111221921|NCT03401736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111221922|NCT03401736|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111221923|NCT03401736|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111221924|NCT03401736|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111221925|NCT03401736|Adrenergic Agents|adrenergic agents|mesh-ancestor
111221926|NCT03401736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111221927|NCT03401736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111221928|NCT03401736|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111221929|NCT03401736|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111221930|NCT03401736|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111221931|NCT03401736|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111221932|NCT03401736|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111221933|NCT03401736|Anesthetics, General|anesthetics, general|mesh-ancestor
111221934|NCT03401736|Anesthetics|anesthetics|mesh-ancestor
111221935|NCT03401736|GABA Modulators|gaba modulators|mesh-ancestor
111221936|NCT03401736|GABA Agents|gaba agents|mesh-ancestor
111221937|NCT02203786|Haloperidol|haloperidol|mesh-list
111221938|NCT02203786|Haloperidol decanoate|haloperidol decanoate|mesh-list
111221939|NCT02203786|Fluphenazine|fluphenazine|mesh-list
111221940|NCT02203786|Fluphenazine depot|fluphenazine depot|mesh-list
111221941|NCT02203786|Fluphenazine enanthate|fluphenazine enanthate|mesh-list
111221942|NCT02203786|Amphetamine|amphetamine|mesh-list
111221943|NCT02203786|Dextroamphetamine|dextroamphetamine|mesh-list
111221944|NCT02203786|Antiemetics|antiemetics|mesh-ancestor
111221945|NCT02203786|Autonomic Agents|autonomic agents|mesh-ancestor
111221946|NCT02203786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110801456|NCT02100202|Antioxidants|antioxidants|mesh-ancestor
111221947|NCT02203786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111221948|NCT02203786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111221949|NCT02203786|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111221950|NCT02203786|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111221951|NCT02203786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111221952|NCT02203786|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111221953|NCT02203786|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111221954|NCT02203786|Dopamine Agents|dopamine agents|mesh-ancestor
111221955|NCT02203786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111221956|NCT02203786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111221957|NCT02203786|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111221958|NCT02203786|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111221959|NCT02203786|Sympathomimetics|sympathomimetics|mesh-ancestor
111221960|NCT02203786|Adrenergic Agents|adrenergic agents|mesh-ancestor
111221961|NCT02203786|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111221962|NCT02203786|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111221963|NCT02203786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111221964|NCT02203786|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111221965|NCT03009058|Leucovorin|leucovorin|mesh-list
111221966|NCT03009058|Folic Acid|folic acid|mesh-list
111221967|NCT03009058|Cyclophosphamide|cyclophosphamide|mesh-list
111221968|NCT03009058|Gemcitabine|gemcitabine|mesh-list
111221969|NCT03009058|Pembrolizumab|pembrolizumab|mesh-list
111221970|NCT03009058|Fluorouracil|fluorouracil|mesh-list
111221971|NCT03009058|Capecitabine|capecitabine|mesh-list
111221972|NCT03009058|Oxaliplatin|oxaliplatin|mesh-list
111221973|NCT03009058|Nivolumab|nivolumab|mesh-list
111221974|NCT03009058|Irinotecan|irinotecan|mesh-list
111221975|NCT03009058|Cetuximab|cetuximab|mesh-list
111221976|NCT03009058|Ipilimumab|ipilimumab|mesh-list
111221977|NCT03009058|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111221978|NCT03009058|Levoleucovorin|levoleucovorin|mesh-list
111221979|NCT03009058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111221980|NCT03009058|Immunologic Factors|immunologic factors|mesh-ancestor
111221981|NCT03009058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111221982|NCT03009058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111221983|NCT03009058|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111221984|NCT03009058|Alkylating Agents|alkylating agents|mesh-ancestor
111221985|NCT03009058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111221986|NCT03009058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111221987|NCT03009058|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111221988|NCT03009058|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111221989|NCT03009058|Antimetabolites|antimetabolites|mesh-ancestor
111221990|NCT03009058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111221991|NCT03009058|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111221992|NCT03009058|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111221993|NCT03009058|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111221994|NCT03009058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111221995|NCT03009058|Antidotes|antidotes|mesh-ancestor
111221996|NCT03009058|Protective Agents|protective agents|mesh-ancestor
111221997|NCT03009058|Vitamin B Complex|vitamin b complex|mesh-ancestor
111221998|NCT03009058|Vitamins|vitamins|mesh-ancestor
111221999|NCT03009058|Micronutrients|micronutrients|mesh-ancestor
111222000|NCT03009058|Hematinics|hematinics|mesh-ancestor
111222001|NCT01611857|Leucovorin|leucovorin|mesh-list
111222002|NCT01611857|Fluorouracil|fluorouracil|mesh-list
111222003|NCT01611857|Oxaliplatin|oxaliplatin|mesh-list
111222004|NCT01611857|Levoleucovorin|levoleucovorin|mesh-list
111222005|NCT01611857|Antimetabolites|antimetabolites|mesh-ancestor
111222006|NCT01611857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111222007|NCT01611857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111222008|NCT01611857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111222009|NCT01611857|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111222010|NCT01611857|Immunologic Factors|immunologic factors|mesh-ancestor
111222011|NCT01611857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111222012|NCT01611857|Antidotes|antidotes|mesh-ancestor
111222013|NCT01611857|Protective Agents|protective agents|mesh-ancestor
111222014|NCT01611857|Vitamin B Complex|vitamin b complex|mesh-ancestor
111222015|NCT01611857|Vitamins|vitamins|mesh-ancestor
111222016|NCT01611857|Micronutrients|micronutrients|mesh-ancestor
111222017|NCT03393858|Antibodies|antibodies|mesh-list
111222018|NCT03393858|Immunologic Factors|immunologic factors|mesh-ancestor
111222019|NCT03393858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111222020|NCT03393702|Gabapentin|gabapentin|mesh-list
111222021|NCT03393702|Analgesics|analgesics|mesh-ancestor
111222022|NCT03393702|Sensory System Agents|sensory system agents|mesh-ancestor
111222023|NCT03393702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111222024|NCT03393702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111222025|NCT03393702|Anticonvulsants|anticonvulsants|mesh-ancestor
111222026|NCT03393702|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111222027|NCT03393702|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111222028|NCT03393702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111222029|NCT03393702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111222030|NCT03393702|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111222031|NCT03393702|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111222032|NCT03393702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111222033|NCT03393702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111222034|NCT03393702|Antimanic Agents|antimanic agents|mesh-ancestor
111222035|NCT01829477|Glimepiride|glimepiride|mesh-list
111222036|NCT01829477|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111222037|NCT01829477|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111222038|NCT01829477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111222039|NCT01829477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111222040|NCT01829477|Immunologic Factors|immunologic factors|mesh-ancestor
111222041|NCT03126864|Cyclophosphamide|cyclophosphamide|mesh-list
111222042|NCT03126864|Fludarabine|fludarabine|mesh-list
111222043|NCT03126864|Fludarabine phosphate|fludarabine phosphate|mesh-list
111222044|NCT03126864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111222045|NCT03126864|Immunologic Factors|immunologic factors|mesh-ancestor
111222046|NCT03126864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111222047|NCT03126864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111222048|NCT03126864|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111222049|NCT03126864|Alkylating Agents|alkylating agents|mesh-ancestor
111222050|NCT03126864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111222051|NCT03126864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111222052|NCT03126864|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111222053|NCT03126864|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111222054|NCT03126864|Antimetabolites|antimetabolites|mesh-ancestor
111222055|NCT03399708|Apremilast|apremilast|mesh-list
111222056|NCT03399708|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111222057|NCT03399708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111222059|NCT03399708|Sensory System Agents|sensory system agents|mesh-ancestor
111222060|NCT03399708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111222061|NCT03399708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111222062|NCT03399708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111222063|NCT03399708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111222064|NCT03399708|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
111222065|NCT03399708|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111222066|NCT03399708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111222067|NCT03399708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111222068|NCT03395730|Oxytocin|oxytocin|mesh-list
111222069|NCT03395730|Oxytocics|oxytocics|mesh-ancestor
111222070|NCT03395730|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111222071|NCT03395730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111222072|NCT01334086|Aprepitant|aprepitant|mesh-list
111222073|NCT01334086|Antiemetics|antiemetics|mesh-ancestor
111222074|NCT01334086|Autonomic Agents|autonomic agents|mesh-ancestor
111222075|NCT01334086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111222076|NCT01334086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111222077|NCT01334086|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111222078|NCT01334086|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
111222079|NCT01334086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111222080|NCT01334086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111222081|NCT03399474|Lidocaine|lidocaine|mesh-list
111222082|NCT03399474|Dexmedetomidine|dexmedetomidine|mesh-list
111222083|NCT03399474|Anesthetics, Local|anesthetics, local|mesh-ancestor
111222084|NCT03399474|Anesthetics|anesthetics|mesh-ancestor
111222085|NCT03399474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111222086|NCT03399474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111222087|NCT03399474|Sensory System Agents|sensory system agents|mesh-ancestor
111222088|NCT03399474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111222089|NCT03399474|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111222090|NCT03399474|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111222091|NCT03399474|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111222092|NCT03399474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111222093|NCT03399474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111222094|NCT03399474|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111222095|NCT03399474|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111222096|NCT03399474|Analgesics|analgesics|mesh-ancestor
111222097|NCT03399474|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111222098|NCT03399474|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111222099|NCT03399474|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111222100|NCT03399474|Adrenergic Agents|adrenergic agents|mesh-ancestor
111222101|NCT03399474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111222102|NCT01611155|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
111222103|NCT01611155|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111222104|NCT01611155|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111222105|NCT01611155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111222106|NCT01611155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111222107|NCT01611155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111222108|NCT01611155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111222109|NCT01611155|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111222110|NCT01611155|Antidepressive Agents|antidepressive agents|mesh-ancestor
111222111|NCT01611155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111222112|NCT01430182|Morphine|morphine|mesh-list
111222113|NCT01430182|Methadone|methadone|mesh-list
111222114|NCT01430182|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111222115|NCT01430182|Narcotics|narcotics|mesh-ancestor
111222116|NCT01430182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111222117|NCT01430182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111222118|NCT01430182|Analgesics|analgesics|mesh-ancestor
111222119|NCT01430182|Sensory System Agents|sensory system agents|mesh-ancestor
111222120|NCT01430182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111222121|NCT01430182|Antitussive Agents|antitussive agents|mesh-ancestor
111222122|NCT01430182|Respiratory System Agents|respiratory system agents|mesh-ancestor
111222123|NCT05097768|Dexamethasone|dexamethasone|mesh-list
111222124|NCT05097768|Ibuprofen|ibuprofen|mesh-list
111222125|NCT05097768|Ketorolac|ketorolac|mesh-list
111222126|NCT05097768|Meloxicam|meloxicam|mesh-list
111222127|NCT05097768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111222128|NCT05097768|Antiemetics|antiemetics|mesh-ancestor
111222129|NCT05097768|Autonomic Agents|autonomic agents|mesh-ancestor
110675072|NCT05997004|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111222130|NCT05097768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111222131|NCT05097768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111222132|NCT05097768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111222133|NCT05097768|Glucocorticoids|glucocorticoids|mesh-ancestor
111222134|NCT05097768|Hormones|hormones|mesh-ancestor
111222135|NCT05097768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111222136|NCT05097768|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111222137|NCT05097768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111222138|NCT05097768|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111222139|NCT05097768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111222140|NCT05097768|Analgesics|analgesics|mesh-ancestor
111222141|NCT05097768|Sensory System Agents|sensory system agents|mesh-ancestor
111222142|NCT05097768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111222143|NCT05097768|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111222144|NCT05097768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111222145|NCT05097768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111222146|NCT05097768|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111222147|NCT01829243|Milnacipran|milnacipran|mesh-list
111222148|NCT01829243|Levomilnacipran|levomilnacipran|mesh-list
111222149|NCT01829243|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111222150|NCT01829243|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111222151|NCT01829243|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111222152|NCT01829243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111222153|NCT01829243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111222154|NCT01829243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111222155|NCT01829243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111222156|NCT01829243|Analgesics|analgesics|mesh-ancestor
111222157|NCT01829243|Sensory System Agents|sensory system agents|mesh-ancestor
111222158|NCT01829243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111222159|NCT01829243|Antidepressive Agents|antidepressive agents|mesh-ancestor
111222160|NCT01829243|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111222161|NCT01838447|Vitamin D|vitamin d|mesh-list
111222162|NCT01838447|Cholecalciferol|cholecalciferol|mesh-list
111222163|NCT01838447|Vitamins|vitamins|mesh-ancestor
111222164|NCT01838447|Micronutrients|micronutrients|mesh-ancestor
111222165|NCT01838447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111222166|NCT01838447|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111222167|NCT01838447|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111222168|NCT03395574|Terlipressin|terlipressin|mesh-list
111222169|NCT03395574|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111222170|NCT03395574|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111222171|NCT04982172|Infliximab|infliximab|mesh-list
111222172|NCT04982172|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111222173|NCT04982172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111222174|NCT04982172|Dermatologic Agents|dermatologic agents|mesh-ancestor
111222175|NCT04982172|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111222176|NCT04982172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111222177|NCT01837823|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111222178|NCT01837823|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111222179|NCT01837823|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111222180|NCT01837823|Antimetabolites|antimetabolites|mesh-ancestor
111222181|NCT01837823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111222182|NCT01837823|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111222183|NCT01837823|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111222184|NCT01837823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111222185|NCT03395262|Caffeine|caffeine|mesh-list
111222186|NCT03395262|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111222187|NCT03395262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111222188|NCT03395262|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111222189|NCT03395262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111222190|NCT03395262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111222191|NCT03395262|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
111222192|NCT03395262|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111222193|NCT03395262|Purinergic Agents|purinergic agents|mesh-ancestor
111222194|NCT03395262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111222195|NCT03852888|Methotrexate|methotrexate|mesh-list
111222196|NCT03852888|7-hydroxymethotrexate|7-hydroxymethotrexate|mesh-list
111222197|NCT03852888|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111222198|NCT03852888|Abortifacient Agents|abortifacient agents|mesh-ancestor
111222199|NCT03852888|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111222200|NCT03852888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111222201|NCT03852888|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110675199|NCT05631899|Ipilimumab|ipilimumab|mesh-list
111222202|NCT03852888|Antimetabolites|antimetabolites|mesh-ancestor
111222203|NCT03852888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111222204|NCT03852888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111222205|NCT03852888|Dermatologic Agents|dermatologic agents|mesh-ancestor
111222206|NCT03852888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111222207|NCT03852888|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111222208|NCT03852888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111222209|NCT03852888|Immunologic Factors|immunologic factors|mesh-ancestor
111222210|NCT03852888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111222211|NCT03852888|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111222212|NCT04755972|Acetylcysteine|acetylcysteine|mesh-list
111222213|NCT04755972|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111222214|NCT04755972|Antiviral Agents|antiviral agents|mesh-ancestor
111222215|NCT04755972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111222216|NCT04755972|Expectorants|expectorants|mesh-ancestor
111222217|NCT04755972|Respiratory System Agents|respiratory system agents|mesh-ancestor
111222218|NCT04755972|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111222219|NCT04755972|Antioxidants|antioxidants|mesh-ancestor
111222220|NCT04755972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111222221|NCT04755972|Protective Agents|protective agents|mesh-ancestor
111222222|NCT04755972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111222223|NCT04755972|Antidotes|antidotes|mesh-ancestor
111222224|NCT01828073|Raltegravir Potassium|raltegravir potassium|mesh-list
111222225|NCT01828073|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111222226|NCT01828073|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111222227|NCT01828073|Antiviral Agents|antiviral agents|mesh-ancestor
111222228|NCT01828073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111222229|NCT01828073|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111222230|NCT01828073|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111222231|NCT01828073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111222232|NCT01828073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111222233|NCT04697693|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
111222234|NCT04697693|Escitalopram|escitalopram|mesh-list
111222235|NCT04697693|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111222236|NCT04697693|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111222237|NCT04697693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111222238|NCT04697693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111222239|NCT04697693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111222240|NCT04697693|Serotonin Agents|serotonin agents|mesh-ancestor
111222241|NCT04697693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111222242|NCT04697693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111222243|NCT04697693|Antidepressive Agents|antidepressive agents|mesh-ancestor
111222244|NCT04697693|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111222245|NCT04697693|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111222246|NCT04697693|Analgesics|analgesics|mesh-ancestor
111222247|NCT04697693|Sensory System Agents|sensory system agents|mesh-ancestor
111222248|NCT04697693|Dopamine Agents|dopamine agents|mesh-ancestor
111222249|NCT03819114|Levonorgestrel|levonorgestrel|mesh-list
111222250|NCT03819114|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111222251|NCT03819114|Contraceptive Agents|contraceptive agents|mesh-ancestor
111222252|NCT03819114|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111222253|NCT03819114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111222254|NCT03819114|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111222255|NCT03819114|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111222256|NCT03819114|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111222257|NCT01827839|Vaccines|vaccines|mesh-list
111222258|NCT01827839|Immunologic Factors|immunologic factors|mesh-ancestor
111222259|NCT01827839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111222260|NCT04709250|Bupivacaine|bupivacaine|mesh-list
111222261|NCT04709250|Anesthetics, Local|anesthetics, local|mesh-ancestor
111222262|NCT04709250|Anesthetics|anesthetics|mesh-ancestor
111222263|NCT04709250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111222264|NCT04709250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111222265|NCT04709250|Sensory System Agents|sensory system agents|mesh-ancestor
111222266|NCT04709250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111222267|NCT01401166|Trastuzumab|trastuzumab|mesh-list
111222268|NCT01401166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111222269|NCT01401166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111222270|NCT03395028|Lenograstim|lenograstim|mesh-list
111222271|NCT03395028|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111222272|NCT03395028|Immunologic Factors|immunologic factors|mesh-ancestor
111222273|NCT03395028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111222274|NCT03394950|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
111222275|NCT03394950|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111222276|NCT03394950|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111222277|NCT03394950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111222278|NCT04567992|Bupivacaine|bupivacaine|mesh-list
111222279|NCT04567992|Anesthetics, Local|anesthetics, local|mesh-ancestor
111222280|NCT04567992|Anesthetics|anesthetics|mesh-ancestor
111222281|NCT04567992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111222282|NCT04567992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111222283|NCT04567992|Sensory System Agents|sensory system agents|mesh-ancestor
111222284|NCT04567992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111222285|NCT01335724|Diclofenac|diclofenac|mesh-list
111222286|NCT01335724|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111222287|NCT01335724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111222288|NCT01335724|Analgesics|analgesics|mesh-ancestor
111222289|NCT01335724|Sensory System Agents|sensory system agents|mesh-ancestor
111222290|NCT01335724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111222291|NCT01335724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111222292|NCT01335724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111222293|NCT01335724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111222294|NCT01335724|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111222295|NCT01335724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111222296|NCT01335724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111222297|NCT01476202|Nicotine|nicotine|mesh-list
111222298|NCT01476202|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111222299|NCT01476202|Autonomic Agents|autonomic agents|mesh-ancestor
111222300|NCT01476202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111222301|NCT01476202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111222302|NCT01476202|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111222303|NCT01476202|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111222304|NCT01476202|Cholinergic Agents|cholinergic agents|mesh-ancestor
111222305|NCT01476202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111222306|NCT01476202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111222307|NCT01477762|Dexamethasone|dexamethasone|mesh-list
111222308|NCT01477762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111222309|NCT01477762|Antiemetics|antiemetics|mesh-ancestor
111222310|NCT01477762|Autonomic Agents|autonomic agents|mesh-ancestor
111222311|NCT01477762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111222312|NCT01477762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111222313|NCT01477762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111222314|NCT01477762|Glucocorticoids|glucocorticoids|mesh-ancestor
111222315|NCT01477762|Hormones|hormones|mesh-ancestor
111222316|NCT01477762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111222317|NCT01477762|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110801827|NCT02937740|Androgens|androgens|mesh-ancestor
111222318|NCT01477762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111222319|NCT01434472|Vidarabine|vidarabine|mesh-list
111222320|NCT01434472|Cyclosporine|cyclosporine|mesh-list
111222321|NCT01434472|Mycophenolic Acid|mycophenolic acid|mesh-list
111222322|NCT01434472|Rituximab|rituximab|mesh-list
111222323|NCT01434472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111222324|NCT01434472|Fludarabine|fludarabine|mesh-list
111222325|NCT01434472|Fludarabine phosphate|fludarabine phosphate|mesh-list
111222326|NCT01434472|Antibodies|antibodies|mesh-list
111222327|NCT01434472|Immunoglobulins|immunoglobulins|mesh-list
111222328|NCT01434472|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111222329|NCT01434472|Cyclosporins|cyclosporins|mesh-list
111222330|NCT01434472|Immunologic Factors|immunologic factors|mesh-ancestor
111222331|NCT01434472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111222332|NCT01434472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111222333|NCT01434472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111222334|NCT01434472|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111222335|NCT01434472|Antimetabolites|antimetabolites|mesh-ancestor
111222336|NCT01434472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111222337|NCT01434472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111222338|NCT01434472|Antiviral Agents|antiviral agents|mesh-ancestor
111222339|NCT01434472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111222340|NCT01434472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111222341|NCT01434472|Antifungal Agents|antifungal agents|mesh-ancestor
111222342|NCT01434472|Dermatologic Agents|dermatologic agents|mesh-ancestor
111222343|NCT01434472|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111222344|NCT01434472|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111222345|NCT01434472|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111222346|NCT01434472|Antitubercular Agents|antitubercular agents|mesh-ancestor
111222347|NCT01434472|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111222348|NCT01435174|Ranolazine|ranolazine|mesh-list
111222349|NCT01435174|Dialysis Solutions|dialysis solutions|mesh-list
111222350|NCT01435174|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111222351|NCT01435174|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111222352|NCT01435174|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111222353|NCT01435174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111222355|NCT01436266|Misoprostol|misoprostol|mesh-list
111222356|NCT01436266|Vitamins|vitamins|mesh-ancestor
111222357|NCT01436266|Micronutrients|micronutrients|mesh-ancestor
111222358|NCT01436266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111222359|NCT01436266|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111222360|NCT01436266|Abortifacient Agents|abortifacient agents|mesh-ancestor
111222361|NCT01436266|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111222362|NCT01436266|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111222363|NCT01436266|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111222364|NCT01436266|Oxytocics|oxytocics|mesh-ancestor
111222365|NCT01436266|Hematinics|hematinics|mesh-ancestor
111222366|NCT01436266|Vitamin B Complex|vitamin b complex|mesh-ancestor
111222367|NCT01542502|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
111222368|NCT01542502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111222369|NCT01439854|Dapagliflozin|dapagliflozin|mesh-list
111222370|NCT01439854|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111222371|NCT01439854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111222372|NCT01439854|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111222373|NCT01439854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111222374|NCT04409262|Remdesivir|remdesivir|mesh-list
111222375|NCT04409262|Antimetabolites|antimetabolites|mesh-ancestor
111222376|NCT04409262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111222377|NCT04409262|Antiviral Agents|antiviral agents|mesh-ancestor
111222378|NCT04409262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111222379|NCT01481740|Phenylephrine|phenylephrine|mesh-list
111222380|NCT01481740|Oxymetazoline|oxymetazoline|mesh-list
111222381|NCT01481740|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111222382|NCT01481740|Mydriatics|mydriatics|mesh-ancestor
111222383|NCT01481740|Autonomic Agents|autonomic agents|mesh-ancestor
111222384|NCT01481740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111222385|NCT01481740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111222386|NCT01481740|Sympathomimetics|sympathomimetics|mesh-ancestor
111222387|NCT01481740|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111222388|NCT01481740|Nasal Decongestants|nasal decongestants|mesh-ancestor
111222389|NCT01481740|Respiratory System Agents|respiratory system agents|mesh-ancestor
111222390|NCT01481740|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111222391|NCT01481740|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111222392|NCT01481740|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111222393|NCT01481740|Adrenergic Agents|adrenergic agents|mesh-ancestor
111222394|NCT01481740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111222395|NCT01481740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111222396|NCT01481740|Protective Agents|protective agents|mesh-ancestor
111222397|NCT01544062|Acetaminophen|acetaminophen|mesh-list
111222398|NCT01544062|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111222399|NCT01544062|Analgesics|analgesics|mesh-ancestor
111222400|NCT01544062|Sensory System Agents|sensory system agents|mesh-ancestor
111222401|NCT01544062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111222402|NCT01544062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111222403|NCT01544062|Antipyretics|antipyretics|mesh-ancestor
111222404|NCT03126084|Acetaminophen|acetaminophen|mesh-list
111222405|NCT03126084|Tramadol|tramadol|mesh-list
111222406|NCT03126084|Bupivacaine|bupivacaine|mesh-list
111222407|NCT03126084|Anesthetics, Local|anesthetics, local|mesh-ancestor
111222408|NCT03126084|Anesthetics|anesthetics|mesh-ancestor
111222409|NCT03126084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111222410|NCT03126084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111222411|NCT03126084|Sensory System Agents|sensory system agents|mesh-ancestor
111222412|NCT03126084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111222413|NCT03126084|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111222414|NCT03126084|Analgesics|analgesics|mesh-ancestor
111222415|NCT03126084|Antipyretics|antipyretics|mesh-ancestor
111222416|NCT03126084|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111222417|NCT03126084|Narcotics|narcotics|mesh-ancestor
111222418|NCT01544998|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
111222419|NCT01544998|Tadalafil|tadalafil|mesh-list
111222420|NCT01544998|Vasodilator Agents|vasodilator agents|mesh-ancestor
111222421|NCT01544998|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111222422|NCT01544998|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111222423|NCT01544998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111222424|NCT01544998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111222425|NCT01544998|Urological Agents|urological agents|mesh-ancestor
111222426|NCT01544998|Natriuretic Agents|natriuretic agents|mesh-ancestor
111222427|NCT01544998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111222428|NCT03391830|Ascorbic Acid|ascorbic acid|mesh-list
111222429|NCT03391830|Atorvastatin|atorvastatin|mesh-list
111222430|NCT03391830|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111222431|NCT03391830|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111222432|NCT03391830|Antimetabolites|antimetabolites|mesh-ancestor
111222433|NCT03391830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111222434|NCT03391830|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111222435|NCT03391830|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111222436|NCT03391830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111222437|NCT03391830|Antioxidants|antioxidants|mesh-ancestor
111222438|NCT03391830|Protective Agents|protective agents|mesh-ancestor
111222439|NCT03391830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111222440|NCT03391830|Vitamins|vitamins|mesh-ancestor
111222441|NCT03391830|Micronutrients|micronutrients|mesh-ancestor
111222442|NCT01441570|Metoprolol|metoprolol|mesh-list
111222443|NCT01441570|Nebivolol|nebivolol|mesh-list
111222444|NCT01441570|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111222445|NCT01441570|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111222446|NCT01441570|Sympatholytics|sympatholytics|mesh-ancestor
111222447|NCT01441570|Autonomic Agents|autonomic agents|mesh-ancestor
111222448|NCT01441570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111222449|NCT01441570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111222450|NCT01441570|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
111222451|NCT01441570|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111222452|NCT01441570|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111222453|NCT01441570|Adrenergic Agents|adrenergic agents|mesh-ancestor
111222454|NCT01441570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111222455|NCT01441570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111222456|NCT01441570|Vasodilator Agents|vasodilator agents|mesh-ancestor
111222457|NCT01441570|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
111222458|NCT01441570|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111222459|NCT01441570|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111222460|NCT05238012|Atorvastatin|atorvastatin|mesh-list
111222461|NCT05238012|Calcium|calcium|mesh-list
111222462|NCT05238012|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111222463|NCT05238012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111222464|NCT05238012|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111222465|NCT05238012|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111222466|NCT05238012|Antimetabolites|antimetabolites|mesh-ancestor
111222467|NCT05238012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111222468|NCT05238012|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110980643|NCT00534027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111222469|NCT05238012|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111222470|NCT05238012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111222471|NCT01441882|Dasatinib|dasatinib|mesh-list
111222472|NCT01441882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111222473|NCT01441882|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111222474|NCT01441882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111222475|NCT01441882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111222476|NCT01484626|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
111222477|NCT01484626|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111222478|NCT01484626|Alkylating Agents|alkylating agents|mesh-ancestor
111222479|NCT01484626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111222480|NCT01484626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111222481|NCT01545700|Dexamethasone|dexamethasone|mesh-list
111222482|NCT01545700|Dexamethasone acetate|dexamethasone acetate|mesh-list
111222483|NCT01545700|BB 1101|bb 1101|mesh-list
111222484|NCT01545700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111222485|NCT01545700|Antiemetics|antiemetics|mesh-ancestor
111222486|NCT01545700|Autonomic Agents|autonomic agents|mesh-ancestor
111222487|NCT01545700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111222488|NCT01545700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111222489|NCT01545700|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111222490|NCT01545700|Glucocorticoids|glucocorticoids|mesh-ancestor
111222491|NCT01545700|Hormones|hormones|mesh-ancestor
111222492|NCT01545700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111222493|NCT01545700|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111222494|NCT01545700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111222495|NCT01545700|Protease Inhibitors|protease inhibitors|mesh-ancestor
111222496|NCT01545700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111222497|NCT01545700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111222498|NCT01486810|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
111222499|NCT01486810|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111222500|NCT01486810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111222501|NCT01486810|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111222502|NCT01486810|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111222503|NCT01486810|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111222504|NCT01486810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111222505|NCT01486810|Dopamine Agents|dopamine agents|mesh-ancestor
111222506|NCT01486810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111222507|NCT01443442|Loteprednol Etabonate|loteprednol etabonate|mesh-list
111222508|NCT01443442|Bepotastine besilate|bepotastine besilate|mesh-list
111222509|NCT01443442|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111222510|NCT01444924|Bupivacaine|bupivacaine|mesh-list
111222511|NCT01444924|Anesthetics, Local|anesthetics, local|mesh-ancestor
111222512|NCT01444924|Anesthetics|anesthetics|mesh-ancestor
111222513|NCT01444924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111222514|NCT01444924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111222515|NCT01444924|Sensory System Agents|sensory system agents|mesh-ancestor
111222516|NCT01444924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111222517|NCT01546402|Dexamethasone|dexamethasone|mesh-list
111222518|NCT01546402|Dexamethasone acetate|dexamethasone acetate|mesh-list
111222519|NCT01546402|BB 1101|bb 1101|mesh-list
111222520|NCT01546402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111222521|NCT01546402|Antiemetics|antiemetics|mesh-ancestor
111222522|NCT01546402|Autonomic Agents|autonomic agents|mesh-ancestor
111222523|NCT01546402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111222524|NCT01546402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111222525|NCT01546402|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111222526|NCT01546402|Glucocorticoids|glucocorticoids|mesh-ancestor
111222527|NCT01546402|Hormones|hormones|mesh-ancestor
111222528|NCT01546402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111222529|NCT01546402|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111222530|NCT01546402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111222531|NCT01546402|Protease Inhibitors|protease inhibitors|mesh-ancestor
111222532|NCT01546402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111222533|NCT01546402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111222534|NCT03389490|Insulin|insulin|mesh-list
111222535|NCT03389490|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111222536|NCT03389490|Insulin Glargine|insulin glargine|mesh-list
111222537|NCT03389490|Insulin, Isophane|insulin, isophane|mesh-list
111222538|NCT03389490|Isophane Insulin, Human|isophane insulin, human|mesh-list
111222539|NCT03389490|Isophane insulin, beef|isophane insulin, beef|mesh-list
111222540|NCT03389490|Protamines|protamines|mesh-list
111222541|NCT03389490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110802048|NCT02119234|Hormones|hormones|mesh-ancestor
111222542|NCT03389490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111222543|NCT03389490|Heparin Antagonists|heparin antagonists|mesh-ancestor
111222544|NCT03389490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111222545|NCT03389490|Coagulants|coagulants|mesh-ancestor
111222546|NCT01547806|Plerixafor|plerixafor|mesh-list
111222547|NCT01547806|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111222548|NCT01547806|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111222549|NCT01547806|Antiviral Agents|antiviral agents|mesh-ancestor
111222550|NCT01547806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111222551|NCT01445626|Dexamethasone|dexamethasone|mesh-list
111222552|NCT01445626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111222553|NCT01445626|Antiemetics|antiemetics|mesh-ancestor
111222554|NCT01445626|Autonomic Agents|autonomic agents|mesh-ancestor
111222555|NCT01445626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111222556|NCT01445626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111222557|NCT01445626|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111222558|NCT01445626|Glucocorticoids|glucocorticoids|mesh-ancestor
111222559|NCT01445626|Hormones|hormones|mesh-ancestor
111222560|NCT01445626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111222561|NCT01445626|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111222562|NCT01445626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111222563|NCT02744742|Cyclophosphamide|cyclophosphamide|mesh-list
111222564|NCT02744742|Busulfan|busulfan|mesh-list
111222565|NCT02744742|Decitabine|decitabine|mesh-list
111222566|NCT02744742|Lenograstim|lenograstim|mesh-list
111222567|NCT02744742|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111222568|NCT02744742|Immunologic Factors|immunologic factors|mesh-ancestor
111222569|NCT02744742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111222570|NCT02744742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111222571|NCT02744742|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111222572|NCT02744742|Alkylating Agents|alkylating agents|mesh-ancestor
111222573|NCT02744742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111222574|NCT02744742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111222575|NCT02744742|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111222576|NCT02744742|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111222577|NCT02744742|Antimetabolites|antimetabolites|mesh-ancestor
111222578|NCT02744742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110675628|NCT03986034|Venetoclax|venetoclax|mesh-list
111222579|NCT02744742|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111222580|NCT03125772|Paclitaxel|paclitaxel|mesh-list
111222581|NCT03125772|Everolimus|everolimus|mesh-list
111222582|NCT03125772|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111222583|NCT03125772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111222584|NCT03125772|Tubulin Modulators|tubulin modulators|mesh-ancestor
111222585|NCT03125772|Antimitotic Agents|antimitotic agents|mesh-ancestor
111222586|NCT03125772|Mitosis Modulators|mitosis modulators|mesh-ancestor
111222587|NCT03125772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111222588|NCT03125772|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111222589|NCT03125772|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111222590|NCT03125772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111222591|NCT03125772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111222592|NCT03125772|Immunologic Factors|immunologic factors|mesh-ancestor
111222593|NCT03125772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111222594|NCT01447888|Morphine|morphine|mesh-list
111222595|NCT01447888|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111222596|NCT01447888|Narcotics|narcotics|mesh-ancestor
111222597|NCT01447888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111222598|NCT01447888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111222599|NCT01447888|Analgesics|analgesics|mesh-ancestor
111222600|NCT01447888|Sensory System Agents|sensory system agents|mesh-ancestor
111222601|NCT01447888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111222602|NCT03389256|Apatinib|apatinib|mesh-list
111222603|NCT03389256|Gefitinib|gefitinib|mesh-list
111222604|NCT03389256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111222605|NCT03389256|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111222606|NCT03389256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111222607|NCT03389256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111222608|NCT01490788|Amitriptyline|amitriptyline|mesh-list
111222609|NCT01490788|Cyclobenzaprine|cyclobenzaprine|mesh-list
111222610|NCT01490788|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
111222611|NCT01490788|Antidepressive Agents|antidepressive agents|mesh-ancestor
111222612|NCT01490788|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111222613|NCT01490788|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
111222614|NCT01490788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111222615|NCT01490788|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111222616|NCT01490788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111222617|NCT01490788|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111222618|NCT01490788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111222619|NCT01490788|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111222620|NCT01490788|Analgesics|analgesics|mesh-ancestor
111222621|NCT01490788|Sensory System Agents|sensory system agents|mesh-ancestor
111222622|NCT01490788|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111222623|NCT01490788|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111222624|NCT01490788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111222625|NCT01490788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111222626|NCT01490788|Adrenergic Agents|adrenergic agents|mesh-ancestor
111222627|NCT01490788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111222628|NCT02520180|Everolimus|everolimus|mesh-list
111222629|NCT02520180|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111222630|NCT02520180|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111222631|NCT02520180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111222632|NCT02520180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111222633|NCT02520180|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111222634|NCT02520180|Immunologic Factors|immunologic factors|mesh-ancestor
111222635|NCT02520180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111222636|NCT02520180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111222637|NCT03391050|Dabrafenib|dabrafenib|mesh-list
111222638|NCT03391050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111222639|NCT03391050|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111222640|NCT03391050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111222641|NCT03391050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111222642|NCT03397992|Dialysis Solutions|dialysis solutions|mesh-list
111222643|NCT03397992|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111222644|NCT03390972|Dexmedetomidine|dexmedetomidine|mesh-list
111222645|NCT03390972|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111222646|NCT03390972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111222647|NCT03390972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111222648|NCT03390972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111222649|NCT03390972|Analgesics|analgesics|mesh-ancestor
111222650|NCT03390972|Sensory System Agents|sensory system agents|mesh-ancestor
111222651|NCT03390972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111222652|NCT03390972|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111222653|NCT03390972|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111222655|NCT03390972|Adrenergic Agents|adrenergic agents|mesh-ancestor
111222656|NCT03390972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111222657|NCT03390972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111222658|NCT01550224|Temozolomide|temozolomide|mesh-list
111222659|NCT01550224|Vorinostat|vorinostat|mesh-list
111222660|NCT01550224|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111222661|NCT01550224|Alkylating Agents|alkylating agents|mesh-ancestor
111222662|NCT01550224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111222663|NCT01550224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111222664|NCT01550224|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111222665|NCT01550224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111222666|NCT01491022|4-Aminopyridine|4-aminopyridine|mesh-list
111222667|NCT01491022|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
111222668|NCT01491022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111222669|NCT01491022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111222670|NCT00782184|Atorvastatin|atorvastatin|mesh-list
111222671|NCT00782184|Simvastatin|simvastatin|mesh-list
111222672|NCT00782184|Ezetimibe|ezetimibe|mesh-list
111222673|NCT00782184|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
111222674|NCT00782184|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111222675|NCT00782184|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111222676|NCT00782184|Antimetabolites|antimetabolites|mesh-ancestor
111222677|NCT00782184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111222678|NCT00782184|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111222679|NCT00782184|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111222680|NCT00782184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111222681|NCT03397914|Colistin|colistin|mesh-list
111222682|NCT03397914|Polymyxins|polymyxins|mesh-list
111222683|NCT03397914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111222684|NCT03397914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111222685|NCT01450306|Cycloserine|cycloserine|mesh-list
111222686|NCT01450306|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111222687|NCT01450306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111222688|NCT01450306|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111222689|NCT01450306|Antitubercular Agents|antitubercular agents|mesh-ancestor
111222690|NCT01450306|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111222691|NCT01450306|Antimetabolites|antimetabolites|mesh-ancestor
111222692|NCT01450306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111222693|NCT03126708|Paclitaxel|paclitaxel|mesh-list
111222694|NCT03126708|Cetuximab|cetuximab|mesh-list
111222695|NCT03126708|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111222696|NCT03126708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111222697|NCT03126708|Tubulin Modulators|tubulin modulators|mesh-ancestor
111222698|NCT03126708|Antimitotic Agents|antimitotic agents|mesh-ancestor
111222699|NCT03126708|Mitosis Modulators|mitosis modulators|mesh-ancestor
111222700|NCT03126708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111222701|NCT03126708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111222702|NCT03390738|Nivolumab|nivolumab|mesh-list
111222703|NCT03390738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111222704|NCT03390738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111222705|NCT03390738|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111222706|NCT03390738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111222707|NCT03390582|Methimazole|methimazole|mesh-list
111222708|NCT03390582|Antithyroid Agents|antithyroid agents|mesh-ancestor
111222709|NCT03390582|Hormone Antagonists|hormone antagonists|mesh-ancestor
111222710|NCT03390582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111222711|NCT03390582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111222712|NCT03385356|Vitamin D|vitamin d|mesh-list
111222713|NCT03385356|Vitamins|vitamins|mesh-ancestor
111222714|NCT03385356|Micronutrients|micronutrients|mesh-ancestor
111222715|NCT03385356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111222716|NCT03385356|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111222717|NCT03388866|Immunomodulating Agents|immunomodulating agents|mesh-list
111222718|NCT03388866|Immunologic Factors|immunologic factors|mesh-list
111222719|NCT03388866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111222720|NCT01873170|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
111222721|NCT01873170|Contraceptive Agents|contraceptive agents|mesh-list
111222722|NCT01873170|Levonorgestrel|levonorgestrel|mesh-list
111222723|NCT01873170|Etonogestrel|etonogestrel|mesh-list
111222724|NCT01873170|Desogestrel|desogestrel|mesh-list
111222725|NCT01873170|Contraceptives, Oral|contraceptives, oral|mesh-list
111222726|NCT01873170|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
110675767|NCT03160040|Minocycline|minocycline|mesh-list
111222727|NCT01873170|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111222728|NCT01873170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111222729|NCT01873170|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111222730|NCT01873170|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111222731|NCT01873170|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111222732|NCT01873170|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
111222733|NCT01873170|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111222734|NCT01873170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111222735|NCT01873170|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111222736|NCT01873170|Progestins|progestins|mesh-ancestor
111222737|NCT01873170|Hormones|hormones|mesh-ancestor
111222738|NCT01873170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111222739|NCT03125694|Pioglitazone|pioglitazone|mesh-list
111222740|NCT03125694|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111222741|NCT03125694|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111222742|NCT03125694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111222743|NCT03125694|Incretins|incretins|mesh-ancestor
111222744|NCT03125694|Hormones|hormones|mesh-ancestor
111222745|NCT03125694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111222746|NCT03125694|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111222747|NCT03125694|Protease Inhibitors|protease inhibitors|mesh-ancestor
111222748|NCT03125694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111222749|NCT03125694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111222750|NCT02731638|Voriconazole|voriconazole|mesh-list
111222751|NCT02731638|Natamycin|natamycin|mesh-list
111222752|NCT02731638|Antifungal Agents|antifungal agents|mesh-ancestor
111222753|NCT02731638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111222754|NCT02731638|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111222755|NCT02731638|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111222756|NCT02731638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111222757|NCT02731638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111222758|NCT02731638|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111222759|NCT02731638|Hormone Antagonists|hormone antagonists|mesh-ancestor
111222760|NCT02731638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111222761|NCT02731638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111222762|NCT02731638|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111222763|NCT02731638|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111222764|NCT02731638|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111222765|NCT01451632|Irinotecan|irinotecan|mesh-list
111222766|NCT01451632|Cetuximab|cetuximab|mesh-list
111222767|NCT01451632|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111222768|NCT01451632|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111222769|NCT01451632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111222770|NCT01451632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111222771|NCT01451632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111222772|NCT01451632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111222773|NCT01491958|Methotrexate|methotrexate|mesh-list
111222774|NCT01491958|Atorvastatin|atorvastatin|mesh-list
111222775|NCT01491958|Tacrolimus|tacrolimus|mesh-list
111222776|NCT01491958|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111222777|NCT01491958|Abortifacient Agents|abortifacient agents|mesh-ancestor
111222778|NCT01491958|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111222779|NCT01491958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111222780|NCT01491958|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111222781|NCT01491958|Antimetabolites|antimetabolites|mesh-ancestor
111222782|NCT01491958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111222783|NCT01491958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111222784|NCT01491958|Dermatologic Agents|dermatologic agents|mesh-ancestor
111222785|NCT01491958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111222786|NCT01491958|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111222787|NCT01491958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111222788|NCT01491958|Immunologic Factors|immunologic factors|mesh-ancestor
111222789|NCT01491958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111222790|NCT01491958|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111222791|NCT01491958|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111222792|NCT01491958|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111222793|NCT01491958|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111222794|NCT01491958|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111222795|NCT01491958|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111222796|NCT01492582|Vaccines|vaccines|mesh-list
111222797|NCT01492582|Immunologic Factors|immunologic factors|mesh-ancestor
111222798|NCT01492582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111222799|NCT02214628|Becaplermin|becaplermin|mesh-list
111222800|NCT02214628|Anticoagulants|anticoagulants|mesh-ancestor
111222801|NCT02214628|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
111222802|NCT02214628|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111222803|NCT02214628|Growth Substances|growth substances|mesh-ancestor
111222804|NCT02214628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111222805|NCT01495858|Naproxen|naproxen|mesh-list
111222806|NCT01495858|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111222807|NCT01495858|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111222808|NCT01495858|Analgesics|analgesics|mesh-ancestor
111222809|NCT01495858|Sensory System Agents|sensory system agents|mesh-ancestor
111222810|NCT01495858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111222811|NCT01495858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111222812|NCT01495858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111222813|NCT01495858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111222814|NCT01495858|Gout Suppressants|gout suppressants|mesh-ancestor
111222815|NCT01495858|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111222816|NCT01495858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111222817|NCT01495858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111222818|NCT01497496|Methylprednisolone|methylprednisolone|mesh-list
111222819|NCT01497496|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111222820|NCT01497496|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111222821|NCT01497496|Prednisolone|prednisolone|mesh-list
111222822|NCT01497496|Prednisolone acetate|prednisolone acetate|mesh-list
111222823|NCT01497496|Lenalidomide|lenalidomide|mesh-list
111222824|NCT01497496|Ofatumumab|ofatumumab|mesh-list
111222825|NCT01497496|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111222826|NCT01497496|Prednisolone phosphate|prednisolone phosphate|mesh-list
111222827|NCT01497496|Immunologic Factors|immunologic factors|mesh-ancestor
111222828|NCT01497496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111222829|NCT01497496|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111222830|NCT01497496|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111222831|NCT01497496|Growth Substances|growth substances|mesh-ancestor
111222832|NCT01497496|Growth Inhibitors|growth inhibitors|mesh-ancestor
111222833|NCT01497496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111222834|NCT01497496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111222835|NCT01497496|Antiemetics|antiemetics|mesh-ancestor
111222836|NCT01497496|Autonomic Agents|autonomic agents|mesh-ancestor
111222837|NCT01497496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111222838|NCT01497496|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111222839|NCT01497496|Glucocorticoids|glucocorticoids|mesh-ancestor
111222840|NCT01497496|Hormones|hormones|mesh-ancestor
111222841|NCT01497496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111222842|NCT01497496|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111222843|NCT01497496|Protective Agents|protective agents|mesh-ancestor
111222844|NCT01497496|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111222845|NCT02208310|Vitamin D|vitamin d|mesh-list
111222846|NCT02208310|Ergocalciferols|ergocalciferols|mesh-list
111222847|NCT02208310|Cholecalciferol|cholecalciferol|mesh-list
111222848|NCT02208310|Vitamins|vitamins|mesh-list
111222849|NCT02208310|Micronutrients|micronutrients|mesh-ancestor
111222850|NCT02208310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111222851|NCT02208310|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111222852|NCT02208310|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111222853|NCT01454362|Nicotine|nicotine|mesh-list
111222854|NCT01454362|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111222855|NCT01454362|Autonomic Agents|autonomic agents|mesh-ancestor
111222856|NCT01454362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111222857|NCT01454362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111222858|NCT01454362|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111222859|NCT01454362|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111222860|NCT01454362|Cholinergic Agents|cholinergic agents|mesh-ancestor
111222861|NCT01454362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111222862|NCT01454362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111222863|NCT01497808|Ipilimumab|ipilimumab|mesh-list
111222864|NCT01497808|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111222865|NCT01497808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111222866|NCT01497808|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111222867|NCT01497808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111222868|NCT01498588|Cyclophosphamide|cyclophosphamide|mesh-list
111222869|NCT01498588|Doxorubicin|doxorubicin|mesh-list
111222870|NCT01498588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111222871|NCT01498588|Immunologic Factors|immunologic factors|mesh-ancestor
111222872|NCT01498588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111222873|NCT01498588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111222874|NCT01498588|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110675920|NCT02597062|Hormones|hormones|mesh-ancestor
111222875|NCT01498588|Alkylating Agents|alkylating agents|mesh-ancestor
111222876|NCT01498588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111222877|NCT01498588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111222878|NCT01498588|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111222879|NCT01498588|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111222880|NCT01498588|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111222881|NCT01498588|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111222882|NCT01498588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111222883|NCT01498744|Clindamycin|clindamycin|mesh-list
111222884|NCT01498744|Clindamycin palmitate|clindamycin palmitate|mesh-list
111222885|NCT01498744|Clindamycin phosphate|clindamycin phosphate|mesh-list
111222886|NCT01498744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111222887|NCT01498744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111222888|NCT01498744|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111222889|NCT01498744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111222890|NCT01498744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111222891|NCT01498978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111222892|NCT01498978|Ipilimumab|ipilimumab|mesh-list
111222893|NCT01498978|Antibodies|antibodies|mesh-list
111222894|NCT01498978|Immunoglobulins|immunoglobulins|mesh-list
111222895|NCT01498978|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111222896|NCT01498978|Immunologic Factors|immunologic factors|mesh-ancestor
111222897|NCT01498978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111222898|NCT01498978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111222899|NCT01498978|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111222900|NCT01498978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111222901|NCT01458418|Montelukast|montelukast|mesh-list
111222902|NCT01458418|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111222903|NCT01458418|Respiratory System Agents|respiratory system agents|mesh-ancestor
111222904|NCT01458418|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
111222905|NCT01458418|Hormone Antagonists|hormone antagonists|mesh-ancestor
111222906|NCT01458418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111222907|NCT01458418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111222908|NCT01458418|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
111222909|NCT01458418|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111222910|NCT01458418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111222911|NCT01557322|Etanercept|etanercept|mesh-list
111222912|NCT01557322|Methotrexate|methotrexate|mesh-list
111222913|NCT01557322|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111222914|NCT01557322|Abortifacient Agents|abortifacient agents|mesh-ancestor
111222915|NCT01557322|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111222916|NCT01557322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111222917|NCT01557322|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111222918|NCT01557322|Antimetabolites|antimetabolites|mesh-ancestor
111222919|NCT01557322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111222920|NCT01557322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111222921|NCT01557322|Dermatologic Agents|dermatologic agents|mesh-ancestor
111222922|NCT01557322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111222923|NCT01557322|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111222924|NCT01557322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111222925|NCT01557322|Immunologic Factors|immunologic factors|mesh-ancestor
111222926|NCT01557322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111222927|NCT01557322|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111222928|NCT01557322|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111222929|NCT01557322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111222930|NCT01557322|Analgesics|analgesics|mesh-ancestor
111222931|NCT01557322|Sensory System Agents|sensory system agents|mesh-ancestor
111222932|NCT01557322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111222933|NCT01557322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111222934|NCT01557322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111222935|NCT01459588|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
111222936|NCT01459588|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111222937|NCT01459588|Lubricant Eye Drops|lubricant eye drops|mesh-list
111222938|NCT01459588|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111222939|NCT01459588|Laxatives|laxatives|mesh-ancestor
111222940|NCT01459588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111222941|NCT01501162|Ethanol|ethanol|mesh-list
111222942|NCT01501162|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111222943|NCT01501162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111222944|NCT01501162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111222945|NCT01501162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111222946|NCT01557868|Hyaluronic Acid|hyaluronic acid|mesh-list
111222947|NCT01557868|Hylan|hylan|mesh-list
110676006|NCT05316467|Megestrol|megestrol|mesh-list
111222948|NCT01557868|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111222949|NCT01557868|Immunologic Factors|immunologic factors|mesh-ancestor
111222950|NCT01557868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111222951|NCT01557868|Viscosupplements|viscosupplements|mesh-ancestor
111222952|NCT01557868|Protective Agents|protective agents|mesh-ancestor
111222953|NCT02208466|Fluoxetine|fluoxetine|mesh-list
111222954|NCT02208466|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111222955|NCT02208466|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111222956|NCT02208466|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111222957|NCT02208466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111222958|NCT02208466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111222959|NCT02208466|Serotonin Agents|serotonin agents|mesh-ancestor
111222960|NCT02208466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111222961|NCT02208466|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111222962|NCT02208466|Antidepressive Agents|antidepressive agents|mesh-ancestor
111222963|NCT02208466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111222964|NCT02208466|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111222965|NCT02208466|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111222966|NCT02208466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111222967|NCT02209948|Temozolomide|temozolomide|mesh-list
111222968|NCT02209948|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111222969|NCT02209948|Alkylating Agents|alkylating agents|mesh-ancestor
111222970|NCT02209948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111222971|NCT02209948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111222972|NCT02981212|Mycophenolic Acid|mycophenolic acid|mesh-list
111222973|NCT02981212|Prednisolone|prednisolone|mesh-list
111222974|NCT02981212|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
111222975|NCT02981212|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111222976|NCT02981212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111222977|NCT02981212|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111222978|NCT02981212|Antitubercular Agents|antitubercular agents|mesh-ancestor
111222979|NCT02981212|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111222980|NCT02981212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111222981|NCT02981212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111222982|NCT02981212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111222983|NCT02981212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111222984|NCT02981212|Glucocorticoids|glucocorticoids|mesh-ancestor
111222985|NCT02981212|Hormones|hormones|mesh-ancestor
111222986|NCT02981212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111222987|NCT02981212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111222988|NCT02981212|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111222989|NCT02981212|Protease Inhibitors|protease inhibitors|mesh-ancestor
111222990|NCT01464190|Sevelamer|sevelamer|mesh-list
111222991|NCT01464190|Chelating Agents|chelating agents|mesh-ancestor
111222992|NCT01464190|Sequestering Agents|sequestering agents|mesh-ancestor
111222993|NCT01464190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111222994|NCT01466764|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
111222995|NCT01466764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111222996|NCT01563406|Ethanol|ethanol|mesh-list
111222997|NCT01563406|Chlorhexidine|chlorhexidine|mesh-list
111222998|NCT01563406|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111222999|NCT01563406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111223000|NCT01563406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111223001|NCT01563406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111223002|NCT01563406|Disinfectants|disinfectants|mesh-ancestor
111223003|NCT01468012|Levodopa|levodopa|mesh-list
111223004|NCT01468012|Carbidopa|carbidopa|mesh-list
111223005|NCT01468012|Entacapone|entacapone|mesh-list
111223006|NCT01468012|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
111223007|NCT01468012|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111223008|NCT01468012|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111223009|NCT01468012|Dopamine Agents|dopamine agents|mesh-ancestor
111223010|NCT01468012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111223011|NCT01468012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111223012|NCT01468012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111223013|NCT01468012|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
111223014|NCT01468012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111223015|NCT01468012|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
111223016|NCT01468012|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111223017|NCT01468012|Immunologic Factors|immunologic factors|mesh-ancestor
111223018|NCT01468012|Dopamine Agonists|dopamine agonists|mesh-ancestor
111223019|NCT01468558|Ketoconazole|ketoconazole|mesh-list
111223020|NCT01468558|Antifungal Agents|antifungal agents|mesh-ancestor
111223021|NCT01468558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111223022|NCT01468558|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111223023|NCT01468558|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111223024|NCT01468558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111223025|NCT01468558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111223026|NCT01468558|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111223027|NCT01468558|Hormone Antagonists|hormone antagonists|mesh-ancestor
111223028|NCT01468558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111223029|NCT01468558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111223030|NCT01468558|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111223031|NCT03730662|Insulin Glargine|insulin glargine|mesh-list
111223032|NCT03730662|Tirzepatide|tirzepatide|mesh-list
111223033|NCT03730662|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111223034|NCT03730662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111223035|NCT03730662|Incretins|incretins|mesh-ancestor
111223036|NCT03730662|Hormones|hormones|mesh-ancestor
111223037|NCT03730662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111223038|NCT01470118|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
111223039|NCT01470118|Dextrans|dextrans|mesh-list
111223040|NCT01470118|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111223041|NCT01470118|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111223042|NCT01470118|Lubricant Eye Drops|lubricant eye drops|mesh-list
111223043|NCT01470118|Alcaftadine|alcaftadine|mesh-list
111223044|NCT01470118|Anticoagulants|anticoagulants|mesh-ancestor
111223045|NCT01470118|Plasma Substitutes|plasma substitutes|mesh-ancestor
111223046|NCT01470118|Blood Substitutes|blood substitutes|mesh-ancestor
111223047|NCT01470118|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111223048|NCT01470118|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111223049|NCT01470118|Analgesics|analgesics|mesh-ancestor
111223050|NCT01470118|Sensory System Agents|sensory system agents|mesh-ancestor
111223051|NCT01470118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111223052|NCT01470118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111223053|NCT01470118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111223054|NCT01470118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111223055|NCT01470118|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111223056|NCT01470118|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
111223057|NCT01470118|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111223058|NCT01470118|Histamine Antagonists|histamine antagonists|mesh-ancestor
111223059|NCT01470118|Histamine Agents|histamine agents|mesh-ancestor
111223060|NCT01470118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111223061|NCT01470118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111223062|NCT01470196|Dexamethasone|dexamethasone|mesh-list
111223063|NCT01470196|Rituximab|rituximab|mesh-list
111223064|NCT01470196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111223065|NCT01470196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111223066|NCT01470196|Immunologic Factors|immunologic factors|mesh-ancestor
111223067|NCT01470196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111223068|NCT01470196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111223069|NCT01470196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111223070|NCT01470196|Antiemetics|antiemetics|mesh-ancestor
111223071|NCT01470196|Autonomic Agents|autonomic agents|mesh-ancestor
111223072|NCT01470196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111223073|NCT01470196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111223074|NCT01470196|Glucocorticoids|glucocorticoids|mesh-ancestor
111223075|NCT01470196|Hormones|hormones|mesh-ancestor
111223076|NCT01470196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111223077|NCT01470196|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111223078|NCT03389958|Copper|copper|mesh-list
111223079|NCT03389958|Trace Elements|trace elements|mesh-ancestor
111223080|NCT03389958|Micronutrients|micronutrients|mesh-ancestor
111223081|NCT03389958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111223082|NCT04446234|Risperidone|risperidone|mesh-list
111223083|NCT04446234|Aripiprazole|aripiprazole|mesh-list
111223084|NCT04446234|Quetiapine Fumarate|quetiapine fumarate|mesh-list
111223085|NCT04446234|Ziprasidone|ziprasidone|mesh-list
111223086|NCT04446234|Amisulpride|amisulpride|mesh-list
111223087|NCT04446234|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111223088|NCT04446234|Serotonin Agents|serotonin agents|mesh-ancestor
110686950|NCT00410163|Fludarabine|fludarabine|mesh-list
110676152|NCT05099107|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110676153|NCT05099107|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110676154|NCT05099107|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110676155|NCT05099107|Adrenergic Agents|adrenergic agents|mesh-ancestor
110676156|NCT05099107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110676157|NCT05099107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111223089|NCT04446234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111223090|NCT04446234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111223091|NCT04446234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111223092|NCT04446234|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111223093|NCT04446234|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111223094|NCT04446234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111223095|NCT04446234|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111223096|NCT04446234|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111223097|NCT04446234|Dopamine Agents|dopamine agents|mesh-ancestor
111223098|NCT04446234|Antidepressive Agents|antidepressive agents|mesh-ancestor
111223099|NCT04446234|Dopamine Agonists|dopamine agonists|mesh-ancestor
111223100|NCT04446234|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111223101|NCT04446234|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111223102|NCT04446234|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111223103|NCT04446234|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111223104|NCT04446234|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111223106|NCT03613506|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
111223107|NCT03613506|Protease Inhibitors|protease inhibitors|mesh-ancestor
111223108|NCT03613506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111223109|NCT03613506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111223110|NCT03613506|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111223111|NCT01565902|Siponimod|siponimod|mesh-list
111223112|NCT01565902|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
111223113|NCT01565902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111223114|NCT01565902|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111223115|NCT01565902|Immunologic Factors|immunologic factors|mesh-ancestor
111223116|NCT01565902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111223117|NCT01566448|Ketamine|ketamine|mesh-list
111223118|NCT01566448|Analgesics|analgesics|mesh-ancestor
111223119|NCT01566448|Sensory System Agents|sensory system agents|mesh-ancestor
111223120|NCT01566448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111223121|NCT01566448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111223122|NCT01566448|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111223123|NCT01566448|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111223124|NCT01566448|Anesthetics, General|anesthetics, general|mesh-ancestor
111223125|NCT01566448|Anesthetics|anesthetics|mesh-ancestor
111223126|NCT01566448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111223127|NCT01566448|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111223128|NCT01566448|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111223129|NCT01566448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111223130|NCT01566448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111223131|NCT05565976|Aspirin|aspirin|mesh-list
111223132|NCT05565976|Insulin|insulin|mesh-list
111223133|NCT05565976|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111223134|NCT05565976|Insulin Glargine|insulin glargine|mesh-list
111223135|NCT05565976|Dapagliflozin|dapagliflozin|mesh-list
111223136|NCT05565976|Insulin Lispro|insulin lispro|mesh-list
111223137|NCT05565976|Biguanides|biguanides|mesh-list
111223138|NCT05565976|Hypoglycemic Agents|hypoglycemic agents|mesh-list
111223139|NCT05565976|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
111223140|NCT05565976|Meglitinide|meglitinide|mesh-list
111223141|NCT05565976|Clopidogrel|clopidogrel|mesh-list
111223142|NCT05565976|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
111223143|NCT05565976|Atorvastatin|atorvastatin|mesh-list
111223144|NCT05565976|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111223145|NCT05565976|Pravastatin|pravastatin|mesh-list
111223146|NCT05565976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111223147|NCT05565976|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111223148|NCT05565976|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111223149|NCT05565976|Antimetabolites|antimetabolites|mesh-ancestor
111223150|NCT05565976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110802756|NCT02932904|Vortioxetine|vortioxetine|mesh-list
111223151|NCT05565976|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111223152|NCT05565976|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111223153|NCT05565976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111223154|NCT05565976|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111223155|NCT05565976|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111223156|NCT05565976|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111223157|NCT05565976|Purinergic Agents|purinergic agents|mesh-ancestor
111223158|NCT05565976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111223159|NCT05565976|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111223160|NCT05565976|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110687026|NCT00316264|Palivizumab|palivizumab|mesh-list
111223161|NCT05565976|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111223162|NCT05565976|Analgesics|analgesics|mesh-ancestor
111223163|NCT05565976|Sensory System Agents|sensory system agents|mesh-ancestor
111223164|NCT05565976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111223165|NCT05565976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111223166|NCT05565976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111223167|NCT05565976|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111223168|NCT05565976|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111223169|NCT05565976|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111223170|NCT05565976|Antipyretics|antipyretics|mesh-ancestor
111223171|NCT01566526|Dexamethasone|dexamethasone|mesh-list
111223172|NCT01566526|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111223173|NCT01566526|Antiemetics|antiemetics|mesh-ancestor
111223174|NCT01566526|Autonomic Agents|autonomic agents|mesh-ancestor
111223175|NCT01566526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111223176|NCT01566526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111223177|NCT01566526|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111223178|NCT01566526|Glucocorticoids|glucocorticoids|mesh-ancestor
111223179|NCT01566526|Hormones|hormones|mesh-ancestor
111223180|NCT01566526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111223181|NCT01566526|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111223182|NCT01566526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111223183|NCT01566838|Bupivacaine|bupivacaine|mesh-list
111223184|NCT01566838|Anesthetics, Local|anesthetics, local|mesh-ancestor
111223185|NCT01566838|Anesthetics|anesthetics|mesh-ancestor
111223186|NCT01566838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111223187|NCT01566838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111223188|NCT01566838|Sensory System Agents|sensory system agents|mesh-ancestor
111223189|NCT01566838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111223190|NCT05565664|Magnesium Sulfate|magnesium sulfate|mesh-list
111223191|NCT05565664|Ketamine|ketamine|mesh-list
111223192|NCT05565664|Analgesics|analgesics|mesh-ancestor
111223193|NCT05565664|Sensory System Agents|sensory system agents|mesh-ancestor
111223194|NCT05565664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111223195|NCT05565664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111223196|NCT05565664|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111223197|NCT05565664|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111223198|NCT05565664|Anesthetics, General|anesthetics, general|mesh-ancestor
111223199|NCT05565664|Anesthetics|anesthetics|mesh-ancestor
111223200|NCT05565664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111223201|NCT05565664|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111223202|NCT05565664|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111223203|NCT05565664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111223204|NCT05565664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111223205|NCT05565664|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111223206|NCT05565664|Anticonvulsants|anticonvulsants|mesh-ancestor
111223207|NCT05565664|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111223208|NCT05565664|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111223209|NCT05565664|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111223210|NCT05565664|Tocolytic Agents|tocolytic agents|mesh-ancestor
111223211|NCT05565664|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111223212|NCT03125616|Vaccines|vaccines|mesh-list
111223213|NCT03125616|Immunologic Factors|immunologic factors|mesh-ancestor
111223214|NCT03125616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111223215|NCT01568008|Bimatoprost|bimatoprost|mesh-list
111223216|NCT01568008|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111223217|NCT01568008|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111223218|NCT01568008|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111223219|NCT05658120|Epinephrine|epinephrine|mesh-list
111223220|NCT05658120|Racepinephrine|racepinephrine|mesh-list
111223221|NCT05658120|Norepinephrine|norepinephrine|mesh-list
111223222|NCT05658120|Epinephryl borate|epinephryl borate|mesh-list
111223223|NCT05658120|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111223224|NCT05658120|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111223225|NCT05658120|Adrenergic Agents|adrenergic agents|mesh-ancestor
111223226|NCT05658120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111223227|NCT05658120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111223228|NCT05658120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111223229|NCT05658120|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111223230|NCT05658120|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111223231|NCT05658120|Autonomic Agents|autonomic agents|mesh-ancestor
111223232|NCT05658120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111223233|NCT05658120|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111223234|NCT05658120|Respiratory System Agents|respiratory system agents|mesh-ancestor
111223235|NCT05658120|Mydriatics|mydriatics|mesh-ancestor
111223236|NCT05658120|Sympathomimetics|sympathomimetics|mesh-ancestor
111223237|NCT05658120|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111223239|NCT01514734|Brinzolamide|brinzolamide|mesh-list
111223240|NCT01514734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111223241|NCT01514734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111223242|NCT01514734|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111223243|NCT01514734|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111223244|NCT01514734|Adrenergic Agents|adrenergic agents|mesh-ancestor
111223245|NCT01514734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111223246|NCT01514734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111223247|NCT01514734|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111223248|NCT01514734|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111223249|NCT01514734|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
111223250|NCT01515046|Ascorbic Acid|ascorbic acid|mesh-list
111223251|NCT01515046|Gemcitabine|gemcitabine|mesh-list
111223252|NCT01515046|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111223253|NCT01515046|Antimetabolites|antimetabolites|mesh-ancestor
111223254|NCT01515046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111223255|NCT01515046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111223256|NCT01515046|Antioxidants|antioxidants|mesh-ancestor
111223257|NCT01515046|Protective Agents|protective agents|mesh-ancestor
111223258|NCT01515046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111223259|NCT01515046|Vitamins|vitamins|mesh-ancestor
111223260|NCT01515046|Micronutrients|micronutrients|mesh-ancestor
111223261|NCT01568944|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111223262|NCT01568944|Lansoprazole|lansoprazole|mesh-list
111223263|NCT01568944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111223264|NCT01568944|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111223265|NCT01568944|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111223266|NCT01568944|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111223267|NCT01568944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111223268|NCT01568944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111223269|NCT05565274|Pentazocine|pentazocine|mesh-list
111223270|NCT05565274|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111223271|NCT05565274|Narcotics|narcotics|mesh-ancestor
111223272|NCT05565274|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111223273|NCT05565274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111223274|NCT05565274|Analgesics|analgesics|mesh-ancestor
111223275|NCT05565274|Sensory System Agents|sensory system agents|mesh-ancestor
111223276|NCT05565274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111223277|NCT05565274|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111223278|NCT05565274|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111223279|NCT05173584|Albuterol|albuterol|mesh-list
111223280|NCT05173584|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111223281|NCT05173584|Autonomic Agents|autonomic agents|mesh-ancestor
111223282|NCT05173584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111223283|NCT05173584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111223284|NCT05173584|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111223285|NCT05173584|Respiratory System Agents|respiratory system agents|mesh-ancestor
111223286|NCT05173584|Tocolytic Agents|tocolytic agents|mesh-ancestor
111223287|NCT05173584|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111223288|NCT05173584|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111223289|NCT05173584|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111223290|NCT05173584|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111223291|NCT05173584|Adrenergic Agents|adrenergic agents|mesh-ancestor
111223292|NCT05173584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111223293|NCT05173584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111223294|NCT04671030|Glycopyrrolate|glycopyrrolate|mesh-list
111223295|NCT04671030|Neostigmine|neostigmine|mesh-list
111223296|NCT04671030|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111223297|NCT04671030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111223298|NCT04671030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111223299|NCT04671030|Cholinergic Agents|cholinergic agents|mesh-ancestor
111223300|NCT04671030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111223301|NCT04671030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111223302|NCT04671030|Parasympathomimetics|parasympathomimetics|mesh-ancestor
111223303|NCT04671030|Autonomic Agents|autonomic agents|mesh-ancestor
111223304|NCT04671030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111223305|NCT04671030|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111223306|NCT04671030|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111223307|NCT04671030|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111223308|NCT04660890|Moxifloxacin|moxifloxacin|mesh-list
111223309|NCT04660890|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
111223310|NCT04660890|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111223311|NCT04660890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111223312|NCT04660890|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111223313|NCT04660890|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111223314|NCT04660890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111223315|NCT04660890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111223316|NCT04660890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111223317|NCT04660890|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111223318|NCT04660890|Contraceptive Agents|contraceptive agents|mesh-ancestor
111223319|NCT04660890|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111223320|NCT04660890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111223321|NCT04660890|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
111223322|NCT04660890|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111223323|NCT04660890|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111223324|NCT04632264|Oxytocin|oxytocin|mesh-list
111223325|NCT04632264|Oxytocics|oxytocics|mesh-ancestor
111223326|NCT04632264|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111223327|NCT04632264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111223328|NCT04607928|Pirfenidone|pirfenidone|mesh-list
111223329|NCT04607928|Analgesics|analgesics|mesh-ancestor
111223330|NCT04607928|Sensory System Agents|sensory system agents|mesh-ancestor
111223331|NCT04607928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111223332|NCT04607928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111223333|NCT04607928|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111223334|NCT04607928|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111223335|NCT04607928|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111223336|NCT04607928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111223337|NCT04607928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111223338|NCT03380442|Ketamine|ketamine|mesh-list
111223339|NCT03380442|Psilocybin|psilocybin|mesh-list
111223340|NCT03380442|Analgesics|analgesics|mesh-ancestor
111223341|NCT03380442|Sensory System Agents|sensory system agents|mesh-ancestor
111223342|NCT03380442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111223343|NCT03380442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111223344|NCT03380442|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111223345|NCT03380442|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111223346|NCT03380442|Anesthetics, General|anesthetics, general|mesh-ancestor
111223347|NCT03380442|Anesthetics|anesthetics|mesh-ancestor
111223348|NCT03380442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111223349|NCT03380442|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111223350|NCT03380442|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111223351|NCT03380442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111223352|NCT03380442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111223353|NCT03380442|Hallucinogens|hallucinogens|mesh-ancestor
111223354|NCT03380442|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111223355|NCT05172570|Gabapentin|gabapentin|mesh-list
111223356|NCT05172570|Analgesics|analgesics|mesh-ancestor
111223357|NCT05172570|Sensory System Agents|sensory system agents|mesh-ancestor
111223358|NCT05172570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111223359|NCT05172570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111223360|NCT05172570|Anticonvulsants|anticonvulsants|mesh-ancestor
111223361|NCT05172570|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111223362|NCT05172570|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111223363|NCT05172570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111223364|NCT05172570|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111223365|NCT05172570|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111223366|NCT05172570|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111223367|NCT05172570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111223368|NCT05172570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111223369|NCT05172570|Antimanic Agents|antimanic agents|mesh-ancestor
111223370|NCT03380130|Nivolumab|nivolumab|mesh-list
111223371|NCT03380130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111223372|NCT03380130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111223373|NCT03380130|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111223374|NCT03380130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111223375|NCT03386838|Carboplatin|carboplatin|mesh-list
111223376|NCT03386838|Fluorouracil|fluorouracil|mesh-list
111223377|NCT03386838|Nivolumab|nivolumab|mesh-list
111223378|NCT03386838|Cetuximab|cetuximab|mesh-list
111223379|NCT03386838|Linrodostat|linrodostat|mesh-list
111223380|NCT03386838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111223381|NCT03386838|Antimetabolites|antimetabolites|mesh-ancestor
111223382|NCT03386838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111223383|NCT03386838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111223384|NCT03386838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111223385|NCT03386838|Immunologic Factors|immunologic factors|mesh-ancestor
111223386|NCT03386838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111223387|NCT03386838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111223388|NCT03386838|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111223389|NCT03386838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111223390|NCT03379974|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
111223391|NCT03379974|Hemostatics|hemostatics|mesh-ancestor
111223392|NCT03379974|Coagulants|coagulants|mesh-ancestor
111223393|NCT03379974|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
111223394|NCT03379974|Natriuretic Agents|natriuretic agents|mesh-ancestor
111223395|NCT03379974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111223396|NCT01570036|Trastuzumab|trastuzumab|mesh-list
111223397|NCT01570036|Molgramostim|molgramostim|mesh-list
111223398|NCT01570036|Sargramostim|sargramostim|mesh-list
111223399|NCT01570036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111223400|NCT01570036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111223401|NCT01570036|Immunologic Factors|immunologic factors|mesh-ancestor
111223402|NCT01570036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111223403|NCT01516684|Lidocaine|lidocaine|mesh-list
111223404|NCT01516684|Fentanyl|fentanyl|mesh-list
111223405|NCT01516684|Anesthetics, Local|anesthetics, local|mesh-list
111223406|NCT01516684|Prilocaine|prilocaine|mesh-list
111223407|NCT01516684|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
111223408|NCT01516684|Propofol|propofol|mesh-list
111223409|NCT01516684|Anesthetics|anesthetics|mesh-list
111223410|NCT01516684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111223411|NCT01516684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111223412|NCT01516684|Sensory System Agents|sensory system agents|mesh-ancestor
111223413|NCT01516684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111223414|NCT01516684|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111223415|NCT01516684|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111223416|NCT01516684|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111223417|NCT01516684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111223418|NCT01516684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111223419|NCT01516684|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111223420|NCT01516684|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111223421|NCT01516684|Anesthetics, General|anesthetics, general|mesh-ancestor
111223422|NCT01516684|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111223423|NCT01516684|Narcotics|narcotics|mesh-ancestor
111223424|NCT01516684|Analgesics|analgesics|mesh-ancestor
111223425|NCT01516684|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111223426|NCT01516684|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
111223427|NCT01517074|Sirolimus|sirolimus|mesh-list
111223428|NCT01517074|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111223429|NCT01517074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111223430|NCT01517074|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111223431|NCT01517074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111223432|NCT01517074|Antifungal Agents|antifungal agents|mesh-ancestor
111223433|NCT01517074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111223434|NCT01517074|Immunologic Factors|immunologic factors|mesh-ancestor
111223435|NCT01517074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111223436|NCT01570348|Mycophenolic Acid|mycophenolic acid|mesh-list
111223437|NCT01570348|Cyclophosphamide|cyclophosphamide|mesh-list
111223438|NCT01570348|Fludarabine|fludarabine|mesh-list
111223439|NCT01570348|Fludarabine phosphate|fludarabine phosphate|mesh-list
111223440|NCT01570348|Tacrolimus|tacrolimus|mesh-list
111223441|NCT01570348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111223442|NCT01570348|Immunologic Factors|immunologic factors|mesh-ancestor
111223443|NCT01570348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111223444|NCT01570348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111223445|NCT01570348|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111223446|NCT01570348|Alkylating Agents|alkylating agents|mesh-ancestor
111223447|NCT01570348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111223448|NCT01570348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111223449|NCT01570348|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111223450|NCT01570348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111223451|NCT01570348|Antimetabolites|antimetabolites|mesh-ancestor
111223452|NCT01570348|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111223453|NCT01570348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111223454|NCT01570348|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111223455|NCT01570348|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111223456|NCT01570348|Antitubercular Agents|antitubercular agents|mesh-ancestor
111223457|NCT01570348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111223458|NCT01570348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111223459|NCT03383406|Cytarabine|cytarabine|mesh-list
110676533|NCT04542824|Mitosis Modulators|mitosis modulators|mesh-ancestor
111223460|NCT03383406|Methotrexate|methotrexate|mesh-list
111223461|NCT03383406|Etoposide|etoposide|mesh-list
111223462|NCT03383406|Ifosfamide|ifosfamide|mesh-list
111223463|NCT03383406|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111223465|NCT03383406|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111223466|NCT03383406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111223467|NCT03383406|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111223468|NCT03383406|Antimetabolites|antimetabolites|mesh-ancestor
111223469|NCT03383406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111223470|NCT03383406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111223471|NCT03383406|Dermatologic Agents|dermatologic agents|mesh-ancestor
111223472|NCT03383406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111223473|NCT03383406|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111223474|NCT03383406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111223475|NCT03383406|Immunologic Factors|immunologic factors|mesh-ancestor
111223476|NCT03383406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111223477|NCT03383406|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111223478|NCT03383406|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111223479|NCT03383406|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111223480|NCT03383406|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111223481|NCT03383406|Antiviral Agents|antiviral agents|mesh-ancestor
111223482|NCT03383406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111223483|NCT03383406|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111223484|NCT03383406|Alkylating Agents|alkylating agents|mesh-ancestor
111223485|NCT04445922|Anastrozole|anastrozole|mesh-list
111223486|NCT04445922|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111223487|NCT04445922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111223488|NCT04445922|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111223489|NCT04445922|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111223490|NCT04445922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111223491|NCT04445922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111223492|NCT04445922|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111223493|NCT04445922|Hormone Antagonists|hormone antagonists|mesh-ancestor
111223494|NCT04445922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111223495|NCT04445922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111223496|NCT03383328|Prednisolone|prednisolone|mesh-list
111223497|NCT03383328|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111223498|NCT03383328|Methylprednisolone|methylprednisolone|mesh-list
111223499|NCT03383328|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111223500|NCT03383328|Prednisolone acetate|prednisolone acetate|mesh-list
111223501|NCT03383328|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
111223502|NCT03383328|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111223503|NCT03383328|Prednisolone phosphate|prednisolone phosphate|mesh-list
111223504|NCT03383328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111223505|NCT03383328|Glucocorticoids|glucocorticoids|mesh-ancestor
111223506|NCT03383328|Hormones|hormones|mesh-ancestor
111223507|NCT03383328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111223508|NCT03383328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111223509|NCT03383328|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111223510|NCT03383328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111223511|NCT03383328|Antiemetics|antiemetics|mesh-ancestor
111223512|NCT03383328|Autonomic Agents|autonomic agents|mesh-ancestor
111223513|NCT03383328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111223514|NCT03383328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111223515|NCT03383328|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111223516|NCT03383328|Protective Agents|protective agents|mesh-ancestor
111223517|NCT03383328|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111223518|NCT03383328|Analgesics|analgesics|mesh-ancestor
111223519|NCT03383328|Sensory System Agents|sensory system agents|mesh-ancestor
111223520|NCT03383328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111223521|NCT01573702|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111223522|NCT01573702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111223523|NCT01573702|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111223524|NCT01573702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111223525|NCT01573702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111223526|NCT03093246|Aspirin|aspirin|mesh-list
111223527|NCT03093246|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111223528|NCT03093246|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111223529|NCT03093246|Analgesics|analgesics|mesh-ancestor
111223530|NCT03093246|Sensory System Agents|sensory system agents|mesh-ancestor
111223531|NCT03093246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111223532|NCT03093246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110676603|NCT04305496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110676604|NCT04305496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110676605|NCT04301934|Estradiol|estradiol|mesh-list
111223533|NCT03093246|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111223534|NCT03093246|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111223535|NCT03093246|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111223536|NCT03093246|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111223537|NCT03093246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111223538|NCT03093246|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111223539|NCT03093246|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111223540|NCT03093246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111223541|NCT03093246|Antipyretics|antipyretics|mesh-ancestor
111223542|NCT02969928|Amoxicillin|amoxicillin|mesh-list
111223543|NCT02969928|Metronidazole|metronidazole|mesh-list
111223544|NCT02969928|Clarithromycin|clarithromycin|mesh-list
111223545|NCT02969928|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111223546|NCT02969928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111223547|NCT02969928|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111223548|NCT02969928|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111223549|NCT02969928|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111223550|NCT02969928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111223551|NCT02969928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111223552|NCT02969928|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111223553|NCT02969928|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111223554|NCT02968446|Vitamin D|vitamin d|mesh-list
111223555|NCT02968446|Cholecalciferol|cholecalciferol|mesh-list
111223556|NCT02968446|Mechlorethamine|mechlorethamine|mesh-list
111223557|NCT02968446|Vitamins|vitamins|mesh-ancestor
111223558|NCT02968446|Micronutrients|micronutrients|mesh-ancestor
111223559|NCT02968446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111223560|NCT02968446|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111223561|NCT02968446|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111223562|NCT02968446|Alkylating Agents|alkylating agents|mesh-ancestor
111223563|NCT02968446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111223564|NCT02968446|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111223565|NCT02968446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111223566|NCT03378960|Omeprazole|omeprazole|mesh-list
111223567|NCT03378960|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111223568|NCT03378960|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111223569|NCT03378960|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111223570|NCT03378960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111223571|NCT03378960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111223572|NCT02907996|Sofosbuvir|sofosbuvir|mesh-list
111223573|NCT02907996|Antiviral Agents|antiviral agents|mesh-ancestor
111223574|NCT02907996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111223575|NCT03378726|Micronutrients|micronutrients|mesh-list
111223576|NCT03378726|Trace Elements|trace elements|mesh-list
111223577|NCT03378726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111223578|NCT03378648|Bromides|bromides|mesh-list
111223579|NCT03378648|Anticonvulsants|anticonvulsants|mesh-ancestor
111223580|NCT01519882|Rotigotine|rotigotine|mesh-list
111223581|NCT01519882|Dopamine Agonists|dopamine agonists|mesh-ancestor
111223582|NCT01519882|Dopamine Agents|dopamine agents|mesh-ancestor
111223583|NCT01519882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111223584|NCT01519882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111223585|NCT01519882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111223586|NCT01576276|Ketorolac|ketorolac|mesh-list
111223587|NCT01576276|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111223588|NCT01576276|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111223589|NCT01576276|Analgesics|analgesics|mesh-ancestor
111223590|NCT01576276|Sensory System Agents|sensory system agents|mesh-ancestor
111223591|NCT01576276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111223592|NCT01576276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111223593|NCT01576276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111223594|NCT01576276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111223595|NCT01576276|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111223596|NCT01576276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111223597|NCT01576276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111223598|NCT01576588|Rituximab|rituximab|mesh-list
111223599|NCT01576588|Glucocorticoids|glucocorticoids|mesh-list
111223600|NCT01576588|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111223601|NCT01576588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111223602|NCT01576588|Immunologic Factors|immunologic factors|mesh-ancestor
111223603|NCT01576588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111223604|NCT01576588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111223605|NCT01576588|Hormones|hormones|mesh-ancestor
111223606|NCT01576588|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111223607|NCT01826981|Sofosbuvir|sofosbuvir|mesh-list
111223608|NCT01826981|Antiviral Agents|antiviral agents|mesh-ancestor
111223609|NCT01826981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111223610|NCT02247154|Immunoglobulins|immunoglobulins|mesh-list
111223611|NCT02247154|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111223612|NCT02247154|Antibodies|antibodies|mesh-list
111223613|NCT02247154|Immunologic Factors|immunologic factors|mesh-ancestor
111223614|NCT02247154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111223615|NCT02728752|gamma-Globulins|gamma-globulins|mesh-list
111223616|NCT02728752|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111223617|NCT02728752|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
111223618|NCT02728752|Immunologic Factors|immunologic factors|mesh-ancestor
111223619|NCT02728752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111223620|NCT03007810|Hemay005|hemay005|mesh-list
111223621|NCT03007810|Dermatologic Agents|dermatologic agents|mesh-ancestor
111223622|NCT03007810|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
111223623|NCT03007810|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111223624|NCT03007810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111223625|NCT03007810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111223626|NCT01578772|Telmisartan|telmisartan|mesh-list
111223627|NCT01578772|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111223628|NCT01578772|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111223629|NCT01578772|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111223630|NCT01578772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111223631|NCT01804049|Metformin|metformin|mesh-list
111223632|NCT01804049|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111223633|NCT01804049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111223634|NCT02383992|Hydrogen Peroxide|hydrogen peroxide|mesh-list
111223635|NCT02383992|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111223636|NCT02383992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111223637|NCT02346630|Levodopa|levodopa|mesh-list
111223638|NCT02346630|Carbidopa|carbidopa|mesh-list
111223639|NCT02346630|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111223640|NCT02346630|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111223641|NCT02346630|Dopamine Agents|dopamine agents|mesh-ancestor
111223642|NCT02346630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111223643|NCT02346630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111223644|NCT02346630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111223645|NCT02346630|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
111223646|NCT02346630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111223647|NCT03385668|Pirfenidone|pirfenidone|mesh-list
111223648|NCT03385668|Analgesics|analgesics|mesh-ancestor
111223649|NCT03385668|Sensory System Agents|sensory system agents|mesh-ancestor
111223650|NCT03385668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111223651|NCT03385668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111223652|NCT03385668|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111223653|NCT03385668|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111223654|NCT03385668|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111223655|NCT03385668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111223656|NCT03385668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111223657|NCT04947072|Anesthetics|anesthetics|mesh-list
111223658|NCT04947072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111223659|NCT04947072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111223660|NCT04942158|Eugenol|eugenol|mesh-list
111223661|NCT04942158|Zinc Oxide|zinc oxide|mesh-list
111223662|NCT04942158|Dermatologic Agents|dermatologic agents|mesh-ancestor
111223663|NCT04942158|Sunscreening Agents|sunscreening agents|mesh-ancestor
111223664|NCT04942158|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111223665|NCT04942158|Protective Agents|protective agents|mesh-ancestor
111223666|NCT04942158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110980653|NCT00532311|Dihydromevinolin|dihydromevinolin|mesh-list
111223667|NCT04942158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111223668|NCT03382470|Anti-Infective Agents|anti-infective agents|mesh-list
111223669|NCT03382470|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111223670|NCT03387774|Urinastatin|urinastatin|mesh-list
111223671|NCT03387774|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
111223672|NCT03387774|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111223673|NCT03387774|Protease Inhibitors|protease inhibitors|mesh-ancestor
111223674|NCT03387774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111223675|NCT03387774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111223676|NCT03382314|Cholecalciferol|cholecalciferol|mesh-list
111223677|NCT03382314|Vitamin D|vitamin d|mesh-list
111223678|NCT03382314|Bazedoxifene|bazedoxifene|mesh-list
111223679|NCT03382314|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111223680|NCT03382314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111223681|NCT03382314|Vitamins|vitamins|mesh-ancestor
111223682|NCT03382314|Micronutrients|micronutrients|mesh-ancestor
111223683|NCT03382314|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110687543|NCT00375219|Homoharringtonine|homoharringtonine|mesh-list
111223684|NCT03382314|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111223685|NCT03382314|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111223686|NCT03382314|Hormone Antagonists|hormone antagonists|mesh-ancestor
111223687|NCT03382314|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111223688|NCT03124524|Dienogest|dienogest|mesh-list
111223689|NCT03124524|Drospirenone|drospirenone|mesh-list
111223690|NCT03124524|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
111223691|NCT03124524|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
111223692|NCT03124524|Ethinyl Estradiol|ethinyl estradiol|mesh-list
111223693|NCT03124524|Estradiol|estradiol|mesh-list
111223694|NCT03124524|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
111223695|NCT03124524|Estrogens|estrogens|mesh-ancestor
111223696|NCT03124524|Hormones|hormones|mesh-ancestor
111223697|NCT03124524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111223698|NCT03124524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111223699|NCT03124524|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111223700|NCT03124524|Contraceptive Agents|contraceptive agents|mesh-ancestor
111223701|NCT03124524|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111223702|NCT03124524|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111223703|NCT03124524|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111223704|NCT03124524|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111223705|NCT03124524|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
111223706|NCT03124524|Hormone Antagonists|hormone antagonists|mesh-ancestor
111223707|NCT03124524|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
111223708|NCT03124524|Diuretics|diuretics|mesh-ancestor
111223709|NCT03124524|Natriuretic Agents|natriuretic agents|mesh-ancestor
111223710|NCT03124524|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
111223711|NCT03124524|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111223712|NCT03124524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111223713|NCT03377400|Cisplatin|cisplatin|mesh-list
111223714|NCT03377400|Durvalumab|durvalumab|mesh-list
111223715|NCT03377400|Tremelimumab|tremelimumab|mesh-list
111223716|NCT03377400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111223717|NCT03377400|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111223718|NCT01803269|Topotecan|topotecan|mesh-list
111223719|NCT01803269|Camptothecin|camptothecin|mesh-list
111223720|NCT01803269|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111223721|NCT01803269|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111223722|NCT01803269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111223723|NCT01803269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111223724|NCT01803269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111223725|NCT01803269|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111223726|NCT01802879|Panobinostat|panobinostat|mesh-list
111223727|NCT01802879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111223728|NCT01802879|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111223729|NCT01802879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111223730|NCT01802879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111223731|NCT01825577|Methylphenidate|methylphenidate|mesh-list
111223732|NCT01825577|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111223733|NCT01825577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111223734|NCT01825577|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111223735|NCT01825577|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111223736|NCT01825577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111223737|NCT01825577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111223738|NCT01825577|Dopamine Agents|dopamine agents|mesh-ancestor
111223739|NCT01825577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111223740|NCT03375138|Abatacept|abatacept|mesh-list
111223741|NCT03375138|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111223742|NCT03375138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111223743|NCT03375138|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111223744|NCT03375138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111223745|NCT03375138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111223746|NCT03375138|Immunologic Factors|immunologic factors|mesh-ancestor
111223747|NCT03375138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111223748|NCT03375138|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111223749|NCT03124680|Analgesics, Opioid|analgesics, opioid|mesh-list
111223750|NCT03124680|Narcotics|narcotics|mesh-ancestor
111223751|NCT03124680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111223752|NCT03124680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111223753|NCT03124680|Analgesics|analgesics|mesh-ancestor
111223754|NCT03124680|Sensory System Agents|sensory system agents|mesh-ancestor
111223755|NCT03124680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111223756|NCT03374670|Aflibercept|aflibercept|mesh-list
111223757|NCT03374670|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111223758|NCT03374670|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111223759|NCT03374670|Growth Substances|growth substances|mesh-ancestor
111223760|NCT03374670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111223761|NCT03374670|Growth Inhibitors|growth inhibitors|mesh-ancestor
111223762|NCT03374670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111223763|NCT02963610|Pembrolizumab|pembrolizumab|mesh-list
111223764|NCT02963610|Lenalidomide|lenalidomide|mesh-list
111223765|NCT02963610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111223766|NCT02963610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111223767|NCT02963610|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111223768|NCT02963610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111223769|NCT02963610|Immunologic Factors|immunologic factors|mesh-ancestor
111223770|NCT02963610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111223771|NCT02963610|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111223772|NCT02963610|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111223773|NCT02963610|Growth Substances|growth substances|mesh-ancestor
111223774|NCT02963610|Growth Inhibitors|growth inhibitors|mesh-ancestor
111223775|NCT03376932|Albuterol|albuterol|mesh-list
111223776|NCT03376932|Tiotropium Bromide|tiotropium bromide|mesh-list
111223777|NCT03376932|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111223778|NCT03376932|Autonomic Agents|autonomic agents|mesh-ancestor
111223779|NCT03376932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111223780|NCT03376932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111223781|NCT03376932|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111223782|NCT03376932|Respiratory System Agents|respiratory system agents|mesh-ancestor
111223783|NCT03376932|Parasympatholytics|parasympatholytics|mesh-ancestor
111223784|NCT03376932|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111223785|NCT03376932|Cholinergic Agents|cholinergic agents|mesh-ancestor
111223786|NCT03376932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111223787|NCT03376932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111223788|NCT03376932|Tocolytic Agents|tocolytic agents|mesh-ancestor
111223789|NCT03376932|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111223790|NCT03376932|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111223791|NCT03376932|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111223792|NCT03376932|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111223793|NCT03376932|Adrenergic Agents|adrenergic agents|mesh-ancestor
111223794|NCT03007342|Amoxicillin|amoxicillin|mesh-list
111223795|NCT03007342|Clavulanic Acid|clavulanic acid|mesh-list
111223796|NCT03007342|Clavulanic Acids|clavulanic acids|mesh-list
111223797|NCT03007342|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
111223798|NCT03007342|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111223799|NCT03007342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111223800|NCT03007342|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
111223801|NCT03007342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111223802|NCT03007342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111223803|NCT03376854|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
111223804|NCT03376854|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111223805|NCT03376854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111223806|NCT03376854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111223807|NCT01579162|Cholic Acids|cholic acids|mesh-list
111223808|NCT01579162|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111223809|NCT03007654|Chitosan|chitosan|mesh-list
111223810|NCT03007654|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111223811|NCT03007654|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111223812|NCT03007654|Antimetabolites|antimetabolites|mesh-ancestor
111223813|NCT03007654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111223814|NCT03007654|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111223815|NCT03007654|Chelating Agents|chelating agents|mesh-ancestor
111223816|NCT03007654|Sequestering Agents|sequestering agents|mesh-ancestor
111223817|NCT03007654|Hemostatics|hemostatics|mesh-ancestor
111223818|NCT03007654|Coagulants|coagulants|mesh-ancestor
111223819|NCT03374514|Dexamethasone|dexamethasone|mesh-list
111223820|NCT03374514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111223821|NCT03374514|Antiemetics|antiemetics|mesh-ancestor
111223822|NCT03374514|Autonomic Agents|autonomic agents|mesh-ancestor
111223823|NCT03374514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111223824|NCT03374514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111223825|NCT03374514|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111223826|NCT03374514|Glucocorticoids|glucocorticoids|mesh-ancestor
111223827|NCT03374514|Hormones|hormones|mesh-ancestor
111223828|NCT03374514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111223829|NCT03374514|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111223830|NCT03374514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111223831|NCT01526356|Sirolimus|sirolimus|mesh-list
111223832|NCT01526356|Temsirolimus|temsirolimus|mesh-list
110948267|NCT03039478|Erythritol|erythritol|mesh-list
111223833|NCT01526356|MTOR Inhibitors|mtor inhibitors|mesh-list
111223834|NCT01526356|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111223835|NCT01526356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111223836|NCT01526356|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111223837|NCT01526356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111223838|NCT01526356|Antifungal Agents|antifungal agents|mesh-ancestor
111223839|NCT01526356|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111223840|NCT01526356|Immunologic Factors|immunologic factors|mesh-ancestor
111223841|NCT01526356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111223842|NCT01526356|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111223843|NCT01526356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111223844|NCT01526356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111223845|NCT02903160|Prednisone|prednisone|mesh-list
111223846|NCT02903160|Carboplatin|carboplatin|mesh-list
111223847|NCT02903160|Abiraterone Acetate|abiraterone acetate|mesh-list
111223848|NCT02903160|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
111223849|NCT02903160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111223850|NCT02903160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111223851|NCT02903160|Glucocorticoids|glucocorticoids|mesh-ancestor
111223852|NCT02903160|Hormones|hormones|mesh-ancestor
111223853|NCT02903160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111223854|NCT02903160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111223855|NCT02903160|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111223856|NCT02903160|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111223857|NCT02903160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111223858|NCT02903160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111223859|NCT02903160|Hormone Antagonists|hormone antagonists|mesh-ancestor
111223860|NCT02903160|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111223861|NCT03376464|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
111223862|NCT03376464|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111223863|NCT03376464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111223864|NCT03376464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111223865|NCT03376464|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111223866|NCT03376464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111223867|NCT03376464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111223868|NCT03376464|Cholinergic Agents|cholinergic agents|mesh-ancestor
111223869|NCT03376464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111223870|NCT03374280|Cisplatin|cisplatin|mesh-list
111223871|NCT03374280|Pemetrexed|pemetrexed|mesh-list
111223872|NCT03374280|Gefitinib|gefitinib|mesh-list
111223873|NCT03374280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111223874|NCT03374280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111223875|NCT03374280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111223876|NCT03374280|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111223877|NCT03374280|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111223878|NCT03374280|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111223879|NCT03381066|Cisplatin|cisplatin|mesh-list
111223880|NCT03381066|Pemetrexed|pemetrexed|mesh-list
111223881|NCT03381066|Vinorelbine|vinorelbine|mesh-list
111223882|NCT03381066|Gefitinib|gefitinib|mesh-list
111223883|NCT03381066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111223884|NCT03381066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111223885|NCT03381066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111223886|NCT03381066|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111223887|NCT03381066|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111223888|NCT03381066|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111223889|NCT03381066|Tubulin Modulators|tubulin modulators|mesh-ancestor
111223890|NCT03381066|Antimitotic Agents|antimitotic agents|mesh-ancestor
111223891|NCT03381066|Mitosis Modulators|mitosis modulators|mesh-ancestor
111223892|NCT03381066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111223893|NCT03375996|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111223894|NCT03375996|Cyclopentolate|cyclopentolate|mesh-list
111223895|NCT03375996|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111223896|NCT03375996|Mydriatics|mydriatics|mesh-ancestor
111223897|NCT03375996|Autonomic Agents|autonomic agents|mesh-ancestor
111223898|NCT03375996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111223899|NCT03375996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111223900|NCT03375996|Parasympatholytics|parasympatholytics|mesh-ancestor
111223901|NCT03375996|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111223902|NCT03375996|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111223903|NCT03375996|Cholinergic Agents|cholinergic agents|mesh-ancestor
111223904|NCT03375996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111223905|NCT03375996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111223906|NCT01580410|Oxaliplatin|oxaliplatin|mesh-list
111223907|NCT01580410|Mitomycins|mitomycins|mesh-list
111223909|NCT01580410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111223910|NCT01580410|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111223911|NCT01580410|Alkylating Agents|alkylating agents|mesh-ancestor
111223912|NCT01580410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111223913|NCT01580410|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111223914|NCT01580410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111223915|NCT02606136|Mitogens|mitogens|mesh-list
111223916|NCT02606136|Mitosis Modulators|mitosis modulators|mesh-ancestor
111223917|NCT02606136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111223918|NCT01581658|Empagliflozin|empagliflozin|mesh-list
111223919|NCT01581658|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111223920|NCT01581658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111223921|NCT01581658|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111223922|NCT01581658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111223923|NCT01530178|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111223924|NCT01530178|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111223925|NCT01530178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111223926|NCT01530178|Incretins|incretins|mesh-ancestor
111223927|NCT01530178|Hormones|hormones|mesh-ancestor
111223928|NCT01530178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111223929|NCT01530178|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111223930|NCT01530178|Protease Inhibitors|protease inhibitors|mesh-ancestor
111223931|NCT01530178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111223932|NCT01530178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111223933|NCT03369990|Botulinum Toxins|botulinum toxins|mesh-list
111223934|NCT03369990|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111223935|NCT03369990|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111223936|NCT03369990|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111223937|NCT03369990|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111223938|NCT03369990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111223939|NCT03369990|Cholinergic Agents|cholinergic agents|mesh-ancestor
111223940|NCT03369990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111223941|NCT03369990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111223942|NCT03369990|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111223943|NCT03369990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111223944|NCT03006874|Esomeprazole|esomeprazole|mesh-list
111223945|NCT03006874|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111223946|NCT03006874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111223947|NCT03006874|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111223948|NCT03006874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111223949|NCT03006874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111223950|NCT01581970|Cyclophosphamide|cyclophosphamide|mesh-list
111223951|NCT01581970|Cetuximab|cetuximab|mesh-list
111223952|NCT01581970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111223953|NCT01581970|Immunologic Factors|immunologic factors|mesh-ancestor
111223954|NCT01581970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111223955|NCT01581970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111223956|NCT01581970|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111223957|NCT01581970|Alkylating Agents|alkylating agents|mesh-ancestor
111223958|NCT01581970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111223959|NCT01581970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111223960|NCT01581970|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111223961|NCT01581970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111223962|NCT01583686|Aldesleukin|aldesleukin|mesh-list
111223963|NCT01583686|Cyclophosphamide|cyclophosphamide|mesh-list
111223964|NCT01583686|Fludarabine|fludarabine|mesh-list
111223965|NCT01583686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111223966|NCT01583686|Immunologic Factors|immunologic factors|mesh-ancestor
111223967|NCT01583686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111223968|NCT01583686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111223969|NCT01583686|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111223970|NCT01583686|Alkylating Agents|alkylating agents|mesh-ancestor
111223971|NCT01583686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111223972|NCT01583686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111223973|NCT01583686|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111223974|NCT01583686|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111223975|NCT01583686|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111223976|NCT01583686|Antiviral Agents|antiviral agents|mesh-ancestor
111223977|NCT01583686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111223978|NCT01532128|Opicapone|opicapone|mesh-list
111223979|NCT01532128|Rasagiline|rasagiline|mesh-list
111223980|NCT01532128|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
111223981|NCT01532128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111223982|NCT01532128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111223983|NCT01532128|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111223984|NCT01532128|Protective Agents|protective agents|mesh-ancestor
111223985|NCT01532128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111223986|NCT01532128|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
111223987|NCT01532128|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111223988|NCT01532128|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111223989|NCT01584388|Rituximab|rituximab|mesh-list
111223990|NCT01584388|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111223991|NCT01584388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111223992|NCT01584388|Immunologic Factors|immunologic factors|mesh-ancestor
111223993|NCT01584388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111223994|NCT01584388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111223995|NCT01584544|Capecitabine|capecitabine|mesh-list
111223996|NCT01584544|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111223997|NCT01584544|Antimetabolites|antimetabolites|mesh-ancestor
111223998|NCT01584544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111223999|NCT01584544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111224000|NCT03006952|Losartan|losartan|mesh-list
111224001|NCT03006952|Pentoxifylline|pentoxifylline|mesh-list
111224002|NCT03006952|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111224003|NCT03006952|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111224004|NCT03006952|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111224005|NCT03006952|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111224006|NCT03006952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111224007|NCT03006952|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111224008|NCT03006952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111224009|NCT03006952|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111224010|NCT03006952|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111224011|NCT03006952|Protective Agents|protective agents|mesh-ancestor
111224012|NCT03006952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111224013|NCT03006952|Vasodilator Agents|vasodilator agents|mesh-ancestor
111224014|NCT03006952|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111224015|NCT03006952|Antioxidants|antioxidants|mesh-ancestor
111224016|NCT01802333|Cytarabine|cytarabine|mesh-list
111224017|NCT01802333|Daunorubicin|daunorubicin|mesh-list
111224018|NCT01802333|Vorinostat|vorinostat|mesh-list
111224019|NCT01802333|Idarubicin|idarubicin|mesh-list
111224020|NCT01802333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111224021|NCT01802333|Antimetabolites|antimetabolites|mesh-ancestor
111224022|NCT01802333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111224023|NCT01802333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111224024|NCT01802333|Antiviral Agents|antiviral agents|mesh-ancestor
111224025|NCT01802333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111224026|NCT01802333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111224027|NCT01802333|Immunologic Factors|immunologic factors|mesh-ancestor
111224028|NCT01802333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111224029|NCT01802333|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111224030|NCT01802333|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111224031|NCT01802333|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111224032|NCT01802333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111224033|NCT01802333|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111224034|NCT01585324|Ribavirin|ribavirin|mesh-list
111224035|NCT01585324|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
111224036|NCT01585324|Antimetabolites|antimetabolites|mesh-ancestor
111224037|NCT01585324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111224038|NCT01585324|Antiviral Agents|antiviral agents|mesh-ancestor
111224039|NCT01585324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111224040|NCT01586962|Acetaminophen|acetaminophen|mesh-list
111224041|NCT01586962|Pseudoephedrine|pseudoephedrine|mesh-list
111224042|NCT01586962|Ephedrine|ephedrine|mesh-list
111224043|NCT01586962|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111224044|NCT01586962|Analgesics|analgesics|mesh-ancestor
111224045|NCT01586962|Sensory System Agents|sensory system agents|mesh-ancestor
111224046|NCT01586962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111224047|NCT01586962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111224048|NCT01586962|Antipyretics|antipyretics|mesh-ancestor
111224049|NCT01586962|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111224050|NCT01586962|Autonomic Agents|autonomic agents|mesh-ancestor
111224051|NCT01586962|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111224052|NCT01586962|Respiratory System Agents|respiratory system agents|mesh-ancestor
111224053|NCT01586962|Nasal Decongestants|nasal decongestants|mesh-ancestor
111224054|NCT01586962|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111224055|NCT01586962|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111224056|NCT01586962|Sympathomimetics|sympathomimetics|mesh-ancestor
111224058|NCT01586962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111224059|NCT01586962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111224060|NCT03006250|Sevoflurane|sevoflurane|mesh-list
111224061|NCT03006250|Desflurane|desflurane|mesh-list
111224062|NCT03006250|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111224063|NCT03006250|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111224064|NCT03006250|Anesthetics, General|anesthetics, general|mesh-ancestor
111224065|NCT03006250|Anesthetics|anesthetics|mesh-ancestor
111224066|NCT03006250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111224067|NCT03006250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111224068|NCT04129437|Ibuprofen|ibuprofen|mesh-list
111224069|NCT04129437|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111224070|NCT04129437|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111224071|NCT04129437|Analgesics|analgesics|mesh-ancestor
111224072|NCT04129437|Sensory System Agents|sensory system agents|mesh-ancestor
111224073|NCT04129437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111224074|NCT04129437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111224075|NCT04129437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111224076|NCT04129437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111224077|NCT04129437|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111224078|NCT04129437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111224079|NCT04129437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111224080|NCT04588259|Insulin|insulin|mesh-list
111224081|NCT04588259|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111224082|NCT04588259|Insulin Aspart|insulin aspart|mesh-list
111224083|NCT04588259|Insulin, Long-Acting|insulin, long-acting|mesh-list
111224084|NCT04588259|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
111224085|NCT04588259|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111224086|NCT04588259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111224087|NCT01801475|Ondansetron|ondansetron|mesh-list
111224088|NCT01801475|Antiemetics|antiemetics|mesh-ancestor
111224089|NCT01801475|Autonomic Agents|autonomic agents|mesh-ancestor
111224090|NCT01801475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111224091|NCT01801475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111224092|NCT01801475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111224093|NCT01801475|Antipruritics|antipruritics|mesh-ancestor
111224094|NCT01801475|Dermatologic Agents|dermatologic agents|mesh-ancestor
111224095|NCT01801475|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111224096|NCT01801475|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111224097|NCT01801475|Serotonin Agents|serotonin agents|mesh-ancestor
111224098|NCT01801475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111224099|NCT01801475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111224100|NCT03063021|Acetylcysteine|acetylcysteine|mesh-list
111224101|NCT03063021|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111224102|NCT03063021|Antiviral Agents|antiviral agents|mesh-ancestor
111224103|NCT03063021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111224104|NCT03063021|Expectorants|expectorants|mesh-ancestor
111224105|NCT03063021|Respiratory System Agents|respiratory system agents|mesh-ancestor
111224106|NCT03063021|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111224107|NCT03063021|Antioxidants|antioxidants|mesh-ancestor
111224108|NCT03063021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111224109|NCT03063021|Protective Agents|protective agents|mesh-ancestor
111224110|NCT03063021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111224111|NCT03063021|Antidotes|antidotes|mesh-ancestor
111224112|NCT02337933|Ursolic acid|ursolic acid|mesh-list
111224113|NCT02337933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111224114|NCT02337933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111224115|NCT02337933|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111224116|NCT02337933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111224117|NCT02337933|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111224118|NCT02337933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111224119|NCT02337933|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111224120|NCT02337933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111224121|NCT02337933|Analgesics|analgesics|mesh-ancestor
111224122|NCT02337933|Sensory System Agents|sensory system agents|mesh-ancestor
111224123|NCT02337933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111224124|NCT02337933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111224125|NCT02337933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111224126|NCT02337933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111224127|NCT03062943|Nintedanib|nintedanib|mesh-list
111224128|NCT03062943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111224129|NCT03062943|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111224130|NCT03062943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111224131|NCT03062943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111224132|NCT01536886|Betamethasone|betamethasone|mesh-list
111224133|NCT01536886|Calcipotriene|calcipotriene|mesh-list
111224134|NCT01536886|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111224135|NCT01536886|Glucocorticoids|glucocorticoids|mesh-ancestor
111224136|NCT01536886|Hormones|hormones|mesh-ancestor
111224137|NCT01536886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111224138|NCT01536886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111224139|NCT01536886|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111224140|NCT01536886|Respiratory System Agents|respiratory system agents|mesh-ancestor
111224141|NCT01536886|Dermatologic Agents|dermatologic agents|mesh-ancestor
111224142|NCT02247310|Interferons|interferons|mesh-list
111224143|NCT02247310|Interferon-beta|interferon-beta|mesh-list
111224144|NCT02247310|Interferon beta-1b|interferon beta-1b|mesh-list
111224145|NCT02247310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111224146|NCT02247310|Antiviral Agents|antiviral agents|mesh-ancestor
111224147|NCT02247310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111224148|NCT02247310|Immunologic Factors|immunologic factors|mesh-ancestor
111224149|NCT02247310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111224150|NCT02247310|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111224151|NCT03061539|Nivolumab|nivolumab|mesh-list
111224152|NCT03061539|Ipilimumab|ipilimumab|mesh-list
111224153|NCT03061539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111224154|NCT03061539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111224155|NCT03061539|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111224156|NCT03061539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111224157|NCT01590550|Dialysis Solutions|dialysis solutions|mesh-list
111224158|NCT01590550|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111224159|NCT05609253|Itraconazole|itraconazole|mesh-list
111224160|NCT05609253|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
111224161|NCT05609253|Antifungal Agents|antifungal agents|mesh-ancestor
111224162|NCT05609253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111224163|NCT05609253|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111224164|NCT05609253|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111224165|NCT05609253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111224166|NCT05609253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111224167|NCT05609253|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111224168|NCT05609253|Hormone Antagonists|hormone antagonists|mesh-ancestor
111224169|NCT05609253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111224170|NCT05609253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111224171|NCT05609253|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111224172|NCT01822535|Midodrine|midodrine|mesh-list
111224173|NCT01822535|Sympathomimetics|sympathomimetics|mesh-ancestor
111224174|NCT01822535|Autonomic Agents|autonomic agents|mesh-ancestor
111224175|NCT01822535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111224176|NCT01822535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111224177|NCT01822535|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111224178|NCT01822535|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111224179|NCT01822535|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111224180|NCT01822535|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111224181|NCT01822535|Adrenergic Agents|adrenergic agents|mesh-ancestor
111224182|NCT01822535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111224183|NCT01822535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111224184|NCT01537666|Vancomycin|vancomycin|mesh-list
111224185|NCT01537666|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111224186|NCT01537666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111224187|NCT01537900|Grazoprevir|grazoprevir|mesh-list
111224188|NCT01537900|Antiviral Agents|antiviral agents|mesh-ancestor
111224189|NCT01537900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111224190|NCT01799993|Amikacin|amikacin|mesh-list
111224191|NCT01799993|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111224192|NCT01799993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111224193|NCT03005860|Fentanyl|fentanyl|mesh-list
111224194|NCT03005860|Propofol|propofol|mesh-list
111224195|NCT03005860|Sevoflurane|sevoflurane|mesh-list
111224196|NCT03005860|Atracurium|atracurium|mesh-list
111224197|NCT03005860|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111224198|NCT03005860|Narcotics|narcotics|mesh-ancestor
111224199|NCT03005860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111224200|NCT03005860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111224201|NCT03005860|Analgesics|analgesics|mesh-ancestor
111224202|NCT03005860|Sensory System Agents|sensory system agents|mesh-ancestor
111224203|NCT03005860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111224204|NCT03005860|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111224205|NCT03005860|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111224206|NCT03005860|Anesthetics, General|anesthetics, general|mesh-ancestor
111224207|NCT03005860|Anesthetics|anesthetics|mesh-ancestor
111224208|NCT03005860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111224209|NCT03005860|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111224210|NCT03005860|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111224211|NCT03005860|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
111224212|NCT03005860|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
111224213|NCT03005860|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111224214|NCT03005860|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
111224215|NCT03005860|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111224216|NCT03005860|Cholinergic Agents|cholinergic agents|mesh-ancestor
111224217|NCT03005860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111224218|NCT03005860|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111224219|NCT01593592|Amoxicillin|amoxicillin|mesh-list
111224220|NCT01593592|Clarithromycin|clarithromycin|mesh-list
111224221|NCT01593592|Omeprazole|omeprazole|mesh-list
111224222|NCT01593592|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111224223|NCT01593592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111224224|NCT01593592|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111224225|NCT01593592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111224226|NCT01593592|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111224227|NCT01593592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111224228|NCT01593592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111224229|NCT01593592|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111224230|NCT01593592|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111224231|NCT01593592|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111224232|NCT03001960|Clopidogrel|clopidogrel|mesh-list
111224233|NCT03001960|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111224234|NCT03001960|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111224235|NCT03001960|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111224236|NCT03001960|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111224237|NCT03001960|Purinergic Agents|purinergic agents|mesh-ancestor
111224238|NCT03001960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111224239|NCT03001960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111224240|NCT03001960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111224241|NCT01593670|Decitabine|decitabine|mesh-list
111224242|NCT01593670|Interleukin-2|interleukin-2|mesh-list
111224243|NCT01593670|Vorinostat|vorinostat|mesh-list
111224244|NCT01593670|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111224245|NCT01593670|Antimetabolites|antimetabolites|mesh-ancestor
111224246|NCT01593670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111224247|NCT01593670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111224248|NCT01593670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111224249|NCT01593670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111224250|NCT01593670|Analgesics|analgesics|mesh-ancestor
111224251|NCT01593670|Sensory System Agents|sensory system agents|mesh-ancestor
111224252|NCT01593670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111224253|NCT01593670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111224254|NCT01593670|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111224255|NCT01593748|Gemcitabine|gemcitabine|mesh-list
111224256|NCT01593748|Docetaxel|docetaxel|mesh-list
111224257|NCT01593748|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111224258|NCT01593748|Antimetabolites|antimetabolites|mesh-ancestor
111224259|NCT01593748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111224260|NCT01593748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111224261|NCT01593748|Tubulin Modulators|tubulin modulators|mesh-ancestor
111224262|NCT01593748|Antimitotic Agents|antimitotic agents|mesh-ancestor
111224263|NCT01593748|Mitosis Modulators|mitosis modulators|mesh-ancestor
111224264|NCT01594294|Contact Lens Solutions|contact lens solutions|mesh-list
111224265|NCT01594294|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111224266|NCT01594294|Disinfectants|disinfectants|mesh-ancestor
111224267|NCT01594294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111224268|NCT03005704|Aspirin|aspirin|mesh-list
111224269|NCT03005704|Ticagrelor|ticagrelor|mesh-list
111224270|NCT03005704|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111224271|NCT03005704|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111224272|NCT03005704|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111224273|NCT03005704|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111224274|NCT03005704|Purinergic Agents|purinergic agents|mesh-ancestor
111224275|NCT03005704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111224276|NCT03005704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111224277|NCT03005704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111224278|NCT03005704|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111224279|NCT03005704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111224280|NCT03005704|Analgesics|analgesics|mesh-ancestor
111224281|NCT03005704|Sensory System Agents|sensory system agents|mesh-ancestor
111224282|NCT03005704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111224283|NCT03005704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111224284|NCT03005704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111224285|NCT03005704|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111224286|NCT03005704|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111224287|NCT03005704|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111224288|NCT03005704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111224289|NCT03005704|Antipyretics|antipyretics|mesh-ancestor
111224290|NCT01595386|Hydrocortisone|hydrocortisone|mesh-list
111224291|NCT01595386|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
111224292|NCT01595386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111224294|NCT01595854|Ticagrelor|ticagrelor|mesh-list
111224295|NCT01595854|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111224296|NCT01595854|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111224297|NCT01595854|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111224298|NCT01595854|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111224299|NCT01595854|Purinergic Agents|purinergic agents|mesh-ancestor
111224300|NCT01595854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111224301|NCT01595854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111224302|NCT01595854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111224303|NCT01595854|Antithrombins|antithrombins|mesh-ancestor
111224304|NCT01595854|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111224305|NCT01595854|Protease Inhibitors|protease inhibitors|mesh-ancestor
111224306|NCT01595854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111224307|NCT01595854|Anticoagulants|anticoagulants|mesh-ancestor
111224308|NCT01596088|Dexrazoxane|dexrazoxane|mesh-list
111224309|NCT01596088|Razoxane|razoxane|mesh-list
111224310|NCT01596088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111224311|NCT01596088|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111224312|NCT01596088|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111224313|NCT01596088|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111224314|NCT01596088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111224315|NCT01596088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111224316|NCT01596088|Protective Agents|protective agents|mesh-ancestor
111224317|NCT01596088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111224318|NCT01596088|Antimitotic Agents|antimitotic agents|mesh-ancestor
111224319|NCT01596088|Mitosis Modulators|mitosis modulators|mesh-ancestor
111224320|NCT02216422|Ritonavir|ritonavir|mesh-list
111224321|NCT02216422|Ribavirin|ribavirin|mesh-list
111224322|NCT02216422|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111224323|NCT02216422|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111224324|NCT02216422|Protease Inhibitors|protease inhibitors|mesh-ancestor
111224325|NCT02216422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111224326|NCT02216422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111224327|NCT02216422|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111224328|NCT02216422|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111224329|NCT02216422|Antiviral Agents|antiviral agents|mesh-ancestor
111224330|NCT02216422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111224331|NCT02216422|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111224332|NCT02216422|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111224333|NCT02216422|Antimetabolites|antimetabolites|mesh-ancestor
111224334|NCT03001570|Cetuximab|cetuximab|mesh-list
111224335|NCT03001570|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111224336|NCT03001570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111224337|NCT03005548|Morphine|morphine|mesh-list
111224338|NCT03005548|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111224339|NCT03005548|Narcotics|narcotics|mesh-ancestor
111224340|NCT03005548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111224341|NCT03005548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111224342|NCT03005548|Analgesics|analgesics|mesh-ancestor
111224343|NCT03005548|Sensory System Agents|sensory system agents|mesh-ancestor
111224344|NCT03005548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111224345|NCT03373266|Anesthetics|anesthetics|mesh-list
111224346|NCT03373266|Sevoflurane|sevoflurane|mesh-list
111224347|NCT03373266|Isoflurane|isoflurane|mesh-list
111224348|NCT03373266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111224349|NCT03373266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111224350|NCT03373266|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111224351|NCT03373266|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111224352|NCT03373266|Anesthetics, General|anesthetics, general|mesh-ancestor
111224353|NCT02217904|Islatravir|islatravir|mesh-list
111224354|NCT02217904|Antiviral Agents|antiviral agents|mesh-ancestor
111224355|NCT02217904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110948795|NCT02261844|Resveratrol|resveratrol|mesh-list
111224356|NCT02217904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111224357|NCT02217904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111224358|NCT02217904|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111224359|NCT02217904|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111224360|NCT02217904|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111224361|NCT05566834|14-O-phosphonooxymethyltriptolide disodium salt|14-o-phosphonooxymethyltriptolide disodium salt|mesh-list
111224362|NCT05566834|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111224363|NCT05566834|Alkylating Agents|alkylating agents|mesh-ancestor
111224364|NCT05566834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111224365|NCT05566834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111224366|NCT01900002|Sorafenib|sorafenib|mesh-list
111224367|NCT01900002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111224368|NCT01900002|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111224369|NCT01900002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111224370|NCT01900002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111224371|NCT03005002|Durvalumab|durvalumab|mesh-list
111224372|NCT03005002|Ipilimumab|ipilimumab|mesh-list
111224373|NCT03005002|Tremelimumab|tremelimumab|mesh-list
111224374|NCT03005002|Immunoglobulins|immunoglobulins|mesh-list
111224375|NCT03005002|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111224376|NCT03005002|Immunoglobulin G|immunoglobulin g|mesh-list
111224377|NCT03005002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111224378|NCT03005002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111224379|NCT03005002|Immunologic Factors|immunologic factors|mesh-ancestor
111224380|NCT03005002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111224381|NCT03005002|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111224382|NCT03005002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111224383|NCT03001102|Chlorhexidine|chlorhexidine|mesh-list
111224384|NCT03001102|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
111224385|NCT03001102|Povidone-Iodine|povidone-iodine|mesh-list
111224386|NCT03001102|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
111224387|NCT03001102|Povidone|povidone|mesh-list
111224388|NCT03001102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111224389|NCT03001102|Disinfectants|disinfectants|mesh-ancestor
111224390|NCT03001102|Dermatologic Agents|dermatologic agents|mesh-ancestor
111224391|NCT03001102|Plasma Substitutes|plasma substitutes|mesh-ancestor
111224392|NCT03001102|Blood Substitutes|blood substitutes|mesh-ancestor
111224393|NCT03000946|Octreotide|octreotide|mesh-list
111224394|NCT03000946|Somatostatin|somatostatin|mesh-list
111224395|NCT03000946|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111224396|NCT03000946|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111224397|NCT03000946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111224398|NCT03000946|Hormones|hormones|mesh-ancestor
111224399|NCT03000946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111224400|NCT03000946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111224401|NCT03004768|Deucravacitinib|deucravacitinib|mesh-list
111224402|NCT03004768|Dermatologic Agents|dermatologic agents|mesh-ancestor
111224403|NCT03004768|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111224404|NCT03004768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111224405|NCT03004768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111224406|NCT03005236|Tacrolimus|tacrolimus|mesh-list
111224407|NCT03005236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111224408|NCT03005236|Immunologic Factors|immunologic factors|mesh-ancestor
111224409|NCT03005236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111224410|NCT03005236|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111224411|NCT03005236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111224412|NCT03005236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111224413|NCT03363204|Salicylic Acid|salicylic acid|mesh-list
111224414|NCT03363204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111224415|NCT03363204|Antifungal Agents|antifungal agents|mesh-ancestor
111224416|NCT03363204|Keratolytic Agents|keratolytic agents|mesh-ancestor
111224417|NCT03363204|Dermatologic Agents|dermatologic agents|mesh-ancestor
111224418|NCT02519010|Amlodipine|amlodipine|mesh-list
111224419|NCT02519010|Valsartan|valsartan|mesh-list
111224420|NCT02519010|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
111224421|NCT02519010|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111224422|NCT02519010|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111224423|NCT02519010|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111224424|NCT02519010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111224425|NCT02519010|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111224426|NCT02519010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111224427|NCT02519010|Vasodilator Agents|vasodilator agents|mesh-ancestor
111224428|NCT02519010|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111224429|NCT02519010|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111224430|NCT03004612|Metformin|metformin|mesh-list
111224431|NCT03004612|Linagliptin|linagliptin|mesh-list
111224432|NCT03004612|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111224433|NCT03004612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111224434|NCT03004612|Incretins|incretins|mesh-ancestor
111224435|NCT03004612|Hormones|hormones|mesh-ancestor
111224436|NCT03004612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111224437|NCT03004612|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111224438|NCT03004612|Protease Inhibitors|protease inhibitors|mesh-ancestor
111224439|NCT03004612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111224440|NCT03004612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111224441|NCT04527042|Rivaroxaban|rivaroxaban|mesh-list
111224442|NCT04527042|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111224443|NCT04527042|Antithrombins|antithrombins|mesh-ancestor
111224444|NCT04527042|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111224445|NCT04527042|Protease Inhibitors|protease inhibitors|mesh-ancestor
111224446|NCT04527042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111224447|NCT04527042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111224448|NCT04527042|Anticoagulants|anticoagulants|mesh-ancestor
111224449|NCT03372486|Bupivacaine|bupivacaine|mesh-list
111224450|NCT03372486|Naloxone|naloxone|mesh-list
111224451|NCT03372486|Anesthetics, Local|anesthetics, local|mesh-ancestor
111224452|NCT03372486|Anesthetics|anesthetics|mesh-ancestor
111224453|NCT03372486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111224454|NCT03372486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111224455|NCT03372486|Sensory System Agents|sensory system agents|mesh-ancestor
111224456|NCT03372486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111224457|NCT03372486|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111224458|NCT05035888|Phenylephrine|phenylephrine|mesh-list
111224459|NCT05035888|Oxymetazoline|oxymetazoline|mesh-list
111224460|NCT05035888|Norepinephrine|norepinephrine|mesh-list
111224461|NCT05035888|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
111224462|NCT05035888|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111224463|NCT05035888|Mydriatics|mydriatics|mesh-ancestor
111224464|NCT05035888|Autonomic Agents|autonomic agents|mesh-ancestor
111224465|NCT05035888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111224466|NCT05035888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111224467|NCT05035888|Sympathomimetics|sympathomimetics|mesh-ancestor
111224468|NCT05035888|Nasal Decongestants|nasal decongestants|mesh-ancestor
111224469|NCT05035888|Respiratory System Agents|respiratory system agents|mesh-ancestor
111224470|NCT05035888|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111224471|NCT05035888|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111224472|NCT05035888|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111224473|NCT05035888|Adrenergic Agents|adrenergic agents|mesh-ancestor
111224474|NCT05035888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111224475|NCT05035888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111224476|NCT05035888|Protective Agents|protective agents|mesh-ancestor
111224477|NCT03362814|Ritonavir|ritonavir|mesh-list
111224478|NCT03362814|Ribavirin|ribavirin|mesh-list
111224479|NCT03362814|Lactams|lactams|mesh-list
111224480|NCT03362814|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111224481|NCT03362814|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111224482|NCT03362814|Protease Inhibitors|protease inhibitors|mesh-ancestor
111224483|NCT03362814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111224484|NCT03362814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111224485|NCT03362814|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111224486|NCT03362814|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111224487|NCT03362814|Antiviral Agents|antiviral agents|mesh-ancestor
111224488|NCT03362814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111224489|NCT03362814|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111224490|NCT03362814|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111224491|NCT03362814|Antimetabolites|antimetabolites|mesh-ancestor
111224492|NCT03362814|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111224493|NCT03004066|Daptomycin|daptomycin|mesh-list
111224494|NCT03004066|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111224495|NCT03004066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111224496|NCT03362736|Ustekinumab|ustekinumab|mesh-list
111224497|NCT03362736|Dermatologic Agents|dermatologic agents|mesh-ancestor
111224498|NCT03004222|Bupivacaine|bupivacaine|mesh-list
111224499|NCT03004222|Anesthetics, Local|anesthetics, local|mesh-ancestor
111224500|NCT03004222|Anesthetics|anesthetics|mesh-ancestor
111224501|NCT03004222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111224502|NCT03004222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111224503|NCT03004222|Sensory System Agents|sensory system agents|mesh-ancestor
111224504|NCT03004222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111224505|NCT03000634|Dexamethasone|dexamethasone|mesh-list
111224506|NCT03000634|Lenalidomide|lenalidomide|mesh-list
111224507|NCT03000634|Bortezomib|bortezomib|mesh-list
111224508|NCT03000634|Elotuzumab|elotuzumab|mesh-list
111224509|NCT03000634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111224510|NCT03000634|Antiemetics|antiemetics|mesh-ancestor
111224511|NCT03000634|Autonomic Agents|autonomic agents|mesh-ancestor
111224512|NCT03000634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111224513|NCT03000634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111224514|NCT03000634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111224515|NCT03000634|Glucocorticoids|glucocorticoids|mesh-ancestor
111224516|NCT03000634|Hormones|hormones|mesh-ancestor
111224517|NCT03000634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111224518|NCT03000634|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111224519|NCT03000634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111224520|NCT03000634|Immunologic Factors|immunologic factors|mesh-ancestor
111224521|NCT03000634|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111224522|NCT03000634|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111224523|NCT03000634|Growth Substances|growth substances|mesh-ancestor
111224524|NCT03000634|Growth Inhibitors|growth inhibitors|mesh-ancestor
111224525|NCT02520102|Sargramostim|sargramostim|mesh-list
111224526|NCT02520102|Immunologic Factors|immunologic factors|mesh-ancestor
111224527|NCT02520102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111224528|NCT03000556|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111224529|NCT03000556|Hyaluronic Acid|hyaluronic acid|mesh-list
111224530|NCT03000556|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111224531|NCT03000556|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111224532|NCT03000556|Immunologic Factors|immunologic factors|mesh-ancestor
111224533|NCT03000556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111224534|NCT03000556|Viscosupplements|viscosupplements|mesh-ancestor
111224535|NCT03000556|Protective Agents|protective agents|mesh-ancestor
111224536|NCT03371862|Liraglutide|liraglutide|mesh-list
111224537|NCT03371862|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111224538|NCT03371862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111224539|NCT03371862|Incretins|incretins|mesh-ancestor
111224540|NCT03371862|Hormones|hormones|mesh-ancestor
111224541|NCT03371862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111224542|NCT03368430|Melatonin|melatonin|mesh-list
111224543|NCT03368430|Antioxidants|antioxidants|mesh-ancestor
111224544|NCT03368430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111224545|NCT03368430|Protective Agents|protective agents|mesh-ancestor
111224546|NCT03368430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111224547|NCT03368430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111224548|NCT03371784|Hydrocortisone|hydrocortisone|mesh-list
111224549|NCT03371784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111224550|NCT03003832|Analgesics, Opioid|analgesics, opioid|mesh-list
111224551|NCT03003832|Analgesics|analgesics|mesh-list
111224552|NCT03003832|Narcotics|narcotics|mesh-ancestor
111224553|NCT03003832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111224554|NCT03003832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111224555|NCT03003832|Sensory System Agents|sensory system agents|mesh-ancestor
111224556|NCT03003832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111224557|NCT03368352|Melatonin|melatonin|mesh-list
111224558|NCT03368352|Antioxidants|antioxidants|mesh-ancestor
111224559|NCT03368352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111224560|NCT03368352|Protective Agents|protective agents|mesh-ancestor
111224561|NCT03368352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111224562|NCT03368352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111224563|NCT02248012|Everolimus|everolimus|mesh-list
111224564|NCT02248012|Temozolomide|temozolomide|mesh-list
111224565|NCT02248012|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111224566|NCT02248012|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111224567|NCT02248012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111224568|NCT02248012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111224569|NCT02248012|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111224570|NCT02248012|Immunologic Factors|immunologic factors|mesh-ancestor
111224571|NCT02248012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111224572|NCT02248012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111224573|NCT02248012|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111224574|NCT02248012|Alkylating Agents|alkylating agents|mesh-ancestor
111224575|NCT03362268|Omeprazole|omeprazole|mesh-list
111224576|NCT03362268|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111224577|NCT03362268|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111224578|NCT03362268|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111224579|NCT03362268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111224580|NCT03362268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111224581|NCT04523844|Brimonidine Tartrate|brimonidine tartrate|mesh-list
111224582|NCT04523844|Brinzolamide|brinzolamide|mesh-list
111224583|NCT04523844|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111224584|NCT04523844|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111224585|NCT04523844|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111224586|NCT04523844|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111224587|NCT04523844|Adrenergic Agents|adrenergic agents|mesh-ancestor
111224588|NCT04523844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111224589|NCT04523844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111224590|NCT04523844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111224591|NCT04523844|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
111224592|NCT04523844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111224593|NCT03361878|Metformin|metformin|mesh-list
111224594|NCT03361878|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111224595|NCT03361878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111224596|NCT03361800|Entinostat|entinostat|mesh-list
111224597|NCT03361800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111224598|NCT03361800|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111224599|NCT03361800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111224600|NCT03361800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111224601|NCT02998918|Curcumin|curcumin|mesh-list
111224602|NCT02998918|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111224603|NCT02998918|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111224604|NCT02998918|Analgesics|analgesics|mesh-ancestor
111224605|NCT02998918|Sensory System Agents|sensory system agents|mesh-ancestor
111224606|NCT02998918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111224607|NCT02998918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111224608|NCT02998918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111224609|NCT02998918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111224610|NCT02998918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111224611|NCT02998918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111224612|NCT02998918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111224613|NCT02995642|Arginyl-glycyl-aspartic acid|arginyl-glycyl-aspartic acid|mesh-list
111224614|NCT02995642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111224615|NCT02998606|Naloxegol|naloxegol|mesh-list
111224616|NCT02998606|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111224617|NCT02998606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111224618|NCT02998606|Sensory System Agents|sensory system agents|mesh-ancestor
111224619|NCT02998606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111224620|NCT05365438|Atorvastatin|atorvastatin|mesh-list
111224621|NCT05365438|Ezetimibe|ezetimibe|mesh-list
111224622|NCT05365438|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111224623|NCT05365438|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111224624|NCT05365438|Antimetabolites|antimetabolites|mesh-ancestor
111224625|NCT05365438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111224626|NCT05365438|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111224627|NCT05365438|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111224628|NCT05365438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111224629|NCT05264506|Estradiol|estradiol|mesh-list
111224630|NCT05264506|Estrogens|estrogens|mesh-ancestor
111224631|NCT05264506|Hormones|hormones|mesh-ancestor
110804210|NCT03058354|Propofol|propofol|mesh-list
111224632|NCT05264506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111224633|NCT05264506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111224634|NCT02248168|Pramipexole|pramipexole|mesh-list
111224635|NCT02248168|Antioxidants|antioxidants|mesh-ancestor
111224636|NCT02248168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111224637|NCT02248168|Protective Agents|protective agents|mesh-ancestor
111224638|NCT02248168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111224639|NCT02248168|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111224640|NCT02248168|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111224641|NCT02248168|Dopamine Agonists|dopamine agonists|mesh-ancestor
111224642|NCT02248168|Dopamine Agents|dopamine agents|mesh-ancestor
111224643|NCT02248168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111224644|NCT05672680|Bupivacaine|bupivacaine|mesh-list
111224645|NCT05672680|Anesthetics, Local|anesthetics, local|mesh-ancestor
111224646|NCT05672680|Anesthetics|anesthetics|mesh-ancestor
111224647|NCT05672680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111224648|NCT05672680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111224649|NCT05672680|Sensory System Agents|sensory system agents|mesh-ancestor
111224650|NCT05672680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111224651|NCT03002428|Teriparatide|teriparatide|mesh-list
111224652|NCT03002428|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111224653|NCT03002428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111224654|NCT03002428|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111224655|NCT03371550|Docetaxel|docetaxel|mesh-list
111224656|NCT03371550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111224657|NCT03371550|Tubulin Modulators|tubulin modulators|mesh-ancestor
111224658|NCT03371550|Antimitotic Agents|antimitotic agents|mesh-ancestor
111224659|NCT03371550|Mitosis Modulators|mitosis modulators|mesh-ancestor
111224660|NCT03371550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111224661|NCT05670028|Antihypertensive Agents|antihypertensive agents|mesh-list
111224662|NCT05669872|Ferric Compounds|ferric compounds|mesh-list
111224663|NCT05669872|Hematinics|hematinics|mesh-ancestor
111224664|NCT04861948|Bevacizumab|bevacizumab|mesh-list
111224665|NCT04861948|Carboplatin|carboplatin|mesh-list
111224666|NCT04861948|Pemetrexed|pemetrexed|mesh-list
111224667|NCT04861948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111224668|NCT04861948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111224669|NCT04861948|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111224670|NCT04861948|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111224671|NCT04861948|Growth Substances|growth substances|mesh-ancestor
111224672|NCT04861948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111224673|NCT04861948|Growth Inhibitors|growth inhibitors|mesh-ancestor
111224674|NCT04861948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111224675|NCT04861948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111224676|NCT04861948|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111224677|NCT04861948|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111224678|NCT04526028|Fulvestrant|fulvestrant|mesh-list
111224679|NCT04526028|Palbociclib|palbociclib|mesh-list
111224680|NCT04526028|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111224681|NCT04526028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111224682|NCT04526028|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
111224683|NCT04526028|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111224684|NCT04526028|Hormone Antagonists|hormone antagonists|mesh-ancestor
111224685|NCT04526028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111224686|NCT04526028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111224687|NCT04526028|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111224688|NCT04526028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111224689|NCT04526028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111224690|NCT02518698|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
111224691|NCT02518698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111224692|NCT03368274|Betamethasone dipropionate, betamethasone sodium phosphate drug combination|betamethasone dipropionate, betamethasone sodium phosphate drug combination|mesh-list
111224693|NCT03368274|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111224694|NCT03368274|Glucocorticoids|glucocorticoids|mesh-ancestor
111224695|NCT03368274|Hormones|hormones|mesh-ancestor
111224696|NCT03368274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111224697|NCT03368274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111224698|NCT02247544|Trabectedin|trabectedin|mesh-list
111224699|NCT02247544|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111224700|NCT02247544|Alkylating Agents|alkylating agents|mesh-ancestor
111224701|NCT02247544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111224702|NCT02247544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111224703|NCT03370848|Aspirin|aspirin|mesh-list
111224704|NCT03370848|Psyllium|psyllium|mesh-list
111224705|NCT03370848|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111224706|NCT03370848|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111224707|NCT03370848|Analgesics|analgesics|mesh-ancestor
111224708|NCT03370848|Sensory System Agents|sensory system agents|mesh-ancestor
111224709|NCT03370848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111224710|NCT03370848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111224711|NCT03370848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111224712|NCT03370848|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111224713|NCT03370848|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111224714|NCT03370848|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111224715|NCT03370848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111224716|NCT03370848|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111224717|NCT03370848|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111224718|NCT03370848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111224719|NCT03370848|Antipyretics|antipyretics|mesh-ancestor
111224720|NCT03370848|Cathartics|cathartics|mesh-ancestor
111224721|NCT03370848|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111224722|NCT02248792|Methotrexate|methotrexate|mesh-list
111224723|NCT02248792|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111224724|NCT02248792|Abortifacient Agents|abortifacient agents|mesh-ancestor
111224725|NCT02248792|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111224726|NCT02248792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111224727|NCT02248792|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111224728|NCT02248792|Antimetabolites|antimetabolites|mesh-ancestor
111224729|NCT02248792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111224730|NCT02248792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111224731|NCT02248792|Dermatologic Agents|dermatologic agents|mesh-ancestor
111224732|NCT02248792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111224733|NCT02248792|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111224734|NCT02248792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111224735|NCT02248792|Immunologic Factors|immunologic factors|mesh-ancestor
111224736|NCT02248792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111224737|NCT02248792|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111224738|NCT03367728|Ropivacaine|ropivacaine|mesh-list
111224739|NCT03367728|Anesthetics, Local|anesthetics, local|mesh-ancestor
111224740|NCT03367728|Anesthetics|anesthetics|mesh-ancestor
111224741|NCT03367728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111224742|NCT03367728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111224743|NCT03367728|Sensory System Agents|sensory system agents|mesh-ancestor
111224744|NCT03367728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111224745|NCT02248870|Dexamethasone|dexamethasone|mesh-list
111224746|NCT02248870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111224747|NCT02248870|Antiemetics|antiemetics|mesh-ancestor
111224748|NCT02248870|Autonomic Agents|autonomic agents|mesh-ancestor
111224749|NCT02248870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111224750|NCT02248870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111224751|NCT02248870|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111224752|NCT02248870|Glucocorticoids|glucocorticoids|mesh-ancestor
111224753|NCT02248870|Hormones|hormones|mesh-ancestor
111224754|NCT02248870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111224755|NCT02248870|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111224756|NCT02248870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111224757|NCT04073056|Bupivacaine|bupivacaine|mesh-list
111224758|NCT04073056|Anesthetics, Local|anesthetics, local|mesh-ancestor
111224759|NCT04073056|Anesthetics|anesthetics|mesh-ancestor
111224760|NCT04073056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111224761|NCT04073056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111224762|NCT04073056|Sensory System Agents|sensory system agents|mesh-ancestor
111224763|NCT04073056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111224764|NCT03361098|Dapagliflozin|dapagliflozin|mesh-list
111224765|NCT03361098|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
111224766|NCT03361098|Exenatide|exenatide|mesh-list
111224767|NCT03361098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111224768|NCT03361098|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111224769|NCT03361098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111224770|NCT03361098|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111224771|NCT03361098|Incretins|incretins|mesh-ancestor
111224772|NCT03361098|Hormones|hormones|mesh-ancestor
111224773|NCT03361098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111224774|NCT03367494|Bromides|bromides|mesh-list
111224775|NCT03367494|Anticonvulsants|anticonvulsants|mesh-ancestor
111224776|NCT05594290|Etoposide|etoposide|mesh-list
111224777|NCT05594290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111224778|NCT05594290|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111224779|NCT05594290|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111224780|NCT05594290|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111224781|NCT05594290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111224782|NCT05594290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111224783|NCT03370380|Aflibercept|aflibercept|mesh-list
111224784|NCT03370380|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111224785|NCT03370380|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111224786|NCT03370380|Growth Substances|growth substances|mesh-ancestor
111224787|NCT03370380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111224788|NCT03370380|Growth Inhibitors|growth inhibitors|mesh-ancestor
111224789|NCT03370380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111224790|NCT04414540|Metformin|metformin|mesh-list
111224791|NCT04414540|Pembrolizumab|pembrolizumab|mesh-list
111224792|NCT04414540|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111224793|NCT04414540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111224794|NCT04414540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111224795|NCT04414540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111224796|NCT04414540|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111224797|NCT04414540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111224798|NCT03367182|Paclitaxel|paclitaxel|mesh-list
111224799|NCT03367182|Bevacizumab|bevacizumab|mesh-list
111224800|NCT03367182|Doxorubicin|doxorubicin|mesh-list
111224801|NCT03367182|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111224802|NCT03367182|Topotecan|topotecan|mesh-list
111224803|NCT03367182|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111224804|NCT03367182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111224805|NCT03367182|Tubulin Modulators|tubulin modulators|mesh-ancestor
111224806|NCT03367182|Antimitotic Agents|antimitotic agents|mesh-ancestor
111224807|NCT03367182|Mitosis Modulators|mitosis modulators|mesh-ancestor
111224808|NCT03367182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111224809|NCT03367182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111224810|NCT03367182|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111224811|NCT03367182|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111224812|NCT03367182|Growth Substances|growth substances|mesh-ancestor
111224813|NCT03367182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111224814|NCT03367182|Growth Inhibitors|growth inhibitors|mesh-ancestor
111224815|NCT03367182|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111224816|NCT03367182|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111224817|NCT03367182|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111224818|NCT03367182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111224819|NCT03367182|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111224820|NCT05561764|Imipenem|imipenem|mesh-list
111224821|NCT05561764|Relebactam|relebactam|mesh-list
111224822|NCT05561764|Cilastatin|cilastatin|mesh-list
111224823|NCT05561764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111224824|NCT05561764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111224825|NCT05561764|Protease Inhibitors|protease inhibitors|mesh-ancestor
111224826|NCT05561764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111224827|NCT05561764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111224828|NCT05561764|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
111224829|NCT04119180|Midazolam|midazolam|mesh-list
111224830|NCT04119180|Ketamine|ketamine|mesh-list
111224831|NCT04119180|Analgesics|analgesics|mesh-ancestor
111224832|NCT04119180|Sensory System Agents|sensory system agents|mesh-ancestor
111224833|NCT04119180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111224834|NCT04119180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111224835|NCT04119180|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111224836|NCT04119180|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111224837|NCT04119180|Anesthetics, General|anesthetics, general|mesh-ancestor
111224838|NCT04119180|Anesthetics|anesthetics|mesh-ancestor
111224839|NCT04119180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111224840|NCT04119180|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111224841|NCT04119180|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111224842|NCT04119180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111224843|NCT04119180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111224844|NCT04119180|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111224845|NCT04119180|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111224846|NCT04119180|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111224847|NCT04119180|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111224848|NCT04119180|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111224849|NCT04119180|GABA Modulators|gaba modulators|mesh-ancestor
111224850|NCT04119180|GABA Agents|gaba agents|mesh-ancestor
111224851|NCT03358212|Denosumab|denosumab|mesh-list
111224852|NCT03358212|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111224853|NCT03358212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111224854|NCT03109392|Lidocaine|lidocaine|mesh-list
111224855|NCT03109392|Anesthetics, Local|anesthetics, local|mesh-ancestor
111224856|NCT03109392|Anesthetics|anesthetics|mesh-ancestor
111224857|NCT03109392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111224858|NCT03109392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111224859|NCT03109392|Sensory System Agents|sensory system agents|mesh-ancestor
111224860|NCT03109392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111224861|NCT03109392|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111224862|NCT03109392|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111224863|NCT03109392|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111224864|NCT03109392|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111224865|NCT03109392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111224866|NCT03357900|Remifentanil|remifentanil|mesh-list
111224867|NCT03357900|Propofol|propofol|mesh-list
111224868|NCT03357900|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111224869|NCT03357900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111224870|NCT03357900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111224871|NCT03357900|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111224872|NCT03357900|Anesthetics, General|anesthetics, general|mesh-ancestor
111224873|NCT03357900|Anesthetics|anesthetics|mesh-ancestor
111224874|NCT03357900|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111224875|NCT03357900|Narcotics|narcotics|mesh-ancestor
111224876|NCT03357900|Analgesics|analgesics|mesh-ancestor
111224877|NCT03357900|Sensory System Agents|sensory system agents|mesh-ancestor
111224878|NCT03357900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111224879|NCT04525326|Bevacizumab|bevacizumab|mesh-list
111224880|NCT04525326|Cetuximab|cetuximab|mesh-list
111224881|NCT04525326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111224882|NCT04525326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110949323|NCT01023204|Paclitaxel|paclitaxel|mesh-list
111224883|NCT04525326|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111224884|NCT04525326|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111224885|NCT04525326|Growth Substances|growth substances|mesh-ancestor
111224886|NCT04525326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111224887|NCT04525326|Growth Inhibitors|growth inhibitors|mesh-ancestor
111224888|NCT03357822|Interferons|interferons|mesh-list
111224889|NCT03357822|Tenofovir|tenofovir|mesh-list
111224890|NCT03357822|Entecavir|entecavir|mesh-list
111224891|NCT03357822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111224892|NCT03357822|Antiviral Agents|antiviral agents|mesh-ancestor
111224893|NCT03357822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111224894|NCT03357822|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111224895|NCT03357822|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111224896|NCT03357822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111224897|NCT03357822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111224898|NCT03357822|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111224899|NCT03357822|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111224900|NCT03359694|Docetaxel|docetaxel|mesh-list
111224901|NCT03359694|Doxorubicin|doxorubicin|mesh-list
111224902|NCT03359694|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111224903|NCT03359694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111224904|NCT03359694|Tubulin Modulators|tubulin modulators|mesh-ancestor
111224905|NCT03359694|Antimitotic Agents|antimitotic agents|mesh-ancestor
111224906|NCT03359694|Mitosis Modulators|mitosis modulators|mesh-ancestor
111224907|NCT03359694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111224908|NCT03359694|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111224909|NCT03359694|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111224910|NCT03359694|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111224911|NCT03359694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111224912|NCT03123276|Gemcitabine|gemcitabine|mesh-list
111224913|NCT03123276|Pembrolizumab|pembrolizumab|mesh-list
111224914|NCT03123276|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111224915|NCT03123276|Antimetabolites|antimetabolites|mesh-ancestor
111224916|NCT03123276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111224917|NCT03123276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111224918|NCT03123276|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111224919|NCT03123276|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111224920|NCT03357276|Immunomodulating Agents|immunomodulating agents|mesh-list
111224921|NCT03357276|Immunologic Factors|immunologic factors|mesh-ancestor
111224922|NCT03357276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111224923|NCT02249026|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
111224924|NCT02249026|Buprenorphine|buprenorphine|mesh-list
111224925|NCT02249026|Opiate Alkaloids|opiate alkaloids|mesh-list
111224926|NCT02249026|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111224927|NCT02249026|Narcotics|narcotics|mesh-ancestor
111224928|NCT02249026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111224929|NCT02249026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111224930|NCT02249026|Analgesics|analgesics|mesh-ancestor
111224931|NCT02249026|Sensory System Agents|sensory system agents|mesh-ancestor
111224932|NCT02249026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111224933|NCT02249026|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111224934|NCT04521192|Fluzoparib|fluzoparib|mesh-list
111224935|NCT04521192|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111224936|NCT04521192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111224937|NCT04521192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111224938|NCT04521192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111224939|NCT03359070|Miconazole|miconazole|mesh-list
111224940|NCT03359070|Clotrimazole|clotrimazole|mesh-list
111224941|NCT03359070|Antifungal Agents|antifungal agents|mesh-ancestor
111224942|NCT03359070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111224943|NCT03359070|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111224944|NCT03359070|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111224945|NCT03359070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111224946|NCT03359070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111224947|NCT03359070|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111224948|NCT03359070|Hormone Antagonists|hormone antagonists|mesh-ancestor
111224949|NCT03359070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111224950|NCT03359070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111224951|NCT03359070|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111224952|NCT03359070|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111224953|NCT03359070|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111224954|NCT03366246|Lidocaine|lidocaine|mesh-list
111224955|NCT03366246|Prilocaine|prilocaine|mesh-list
111224956|NCT03366246|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
111224957|NCT03366246|Anesthetics, Local|anesthetics, local|mesh-ancestor
111224958|NCT03366246|Anesthetics|anesthetics|mesh-ancestor
111224959|NCT03366246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111224960|NCT03366246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111224961|NCT03366246|Sensory System Agents|sensory system agents|mesh-ancestor
111224962|NCT03366246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111224963|NCT03366246|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111224964|NCT03366246|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111224965|NCT03366246|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111224966|NCT03366246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111224967|NCT03366246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111224968|NCT03366246|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
111224969|NCT01623466|Contraceptive Agents|contraceptive agents|mesh-list
111224970|NCT01623466|Levonorgestrel|levonorgestrel|mesh-list
111224971|NCT01623466|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111224972|NCT01623466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111224973|NCT01623466|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111224974|NCT01623466|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111224975|NCT01623466|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111224976|NCT01623466|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111224977|NCT04520646|Empagliflozin|empagliflozin|mesh-list
111224978|NCT04520646|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111224979|NCT04520646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111224980|NCT04520646|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111224981|NCT04520646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111224982|NCT01624948|Mycophenolic Acid|mycophenolic acid|mesh-list
111224983|NCT01624948|Everolimus|everolimus|mesh-list
111224984|NCT01624948|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111224985|NCT01624948|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111224986|NCT01624948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111224987|NCT01624948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111224988|NCT01624948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111224989|NCT01624948|Immunologic Factors|immunologic factors|mesh-ancestor
111224990|NCT01624948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111224991|NCT01624948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111224992|NCT01624948|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111224993|NCT01624948|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111224994|NCT01624948|Antitubercular Agents|antitubercular agents|mesh-ancestor
111224995|NCT01624948|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111224996|NCT01624948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111224997|NCT04523064|Empagliflozin|empagliflozin|mesh-list
111224998|NCT04523064|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111224999|NCT04523064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111225000|NCT04523064|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111225001|NCT04523064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111225002|NCT04520880|Antibodies|antibodies|mesh-list
111225003|NCT04520880|Immunoglobulins|immunoglobulins|mesh-list
111225004|NCT04520880|Antibodies, Blocking|antibodies, blocking|mesh-list
111225005|NCT04520880|Immunologic Factors|immunologic factors|mesh-ancestor
111225006|NCT04520880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111225007|NCT03365466|Aspirin|aspirin|mesh-list
111225008|NCT03365466|Heparin|heparin|mesh-list
111225009|NCT03365466|Calcium heparin|calcium heparin|mesh-list
111225010|NCT03365466|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
111225011|NCT03365466|Tinzaparin|tinzaparin|mesh-list
111225012|NCT03365466|Dalteparin|dalteparin|mesh-list
111225013|NCT03365466|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111225014|NCT03365466|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111225015|NCT03365466|Analgesics|analgesics|mesh-ancestor
111225016|NCT03365466|Sensory System Agents|sensory system agents|mesh-ancestor
111225017|NCT03365466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111225018|NCT03365466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111225019|NCT03365466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111225020|NCT03365466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111225021|NCT03365466|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111225022|NCT03365466|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111225023|NCT03365466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111225024|NCT03365466|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111225025|NCT03365466|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111225026|NCT03365466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111225027|NCT03365466|Antipyretics|antipyretics|mesh-ancestor
111225028|NCT03365466|Anticoagulants|anticoagulants|mesh-ancestor
111225029|NCT03356964|Hormones|hormones|mesh-list
111225030|NCT03356964|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
111225031|NCT03356964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111225032|NCT03356964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111225033|NCT03346252|Botulinum Toxins|botulinum toxins|mesh-list
111225034|NCT03346252|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111225035|NCT03346252|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111225036|NCT03346252|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111225037|NCT03346252|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111225038|NCT03346252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111225039|NCT03346252|Cholinergic Agents|cholinergic agents|mesh-ancestor
111225040|NCT03346252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111225041|NCT03346252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111225042|NCT03346252|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111225043|NCT03346252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111225044|NCT03365388|Hyaluronic Acid|hyaluronic acid|mesh-list
111225045|NCT03365388|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111225046|NCT03365388|Immunologic Factors|immunologic factors|mesh-ancestor
111225047|NCT03365388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111225048|NCT03365388|Viscosupplements|viscosupplements|mesh-ancestor
111225049|NCT03365388|Protective Agents|protective agents|mesh-ancestor
111225050|NCT03123744|Palbociclib|palbociclib|mesh-list
111225051|NCT03123744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111225052|NCT03123744|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111225053|NCT03123744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111225054|NCT03123744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111225055|NCT03358524|Vitamins|vitamins|mesh-list
111225056|NCT03358524|Vitamin E|vitamin e|mesh-list
111225057|NCT03358524|Tocopherols|tocopherols|mesh-list
111225058|NCT03358524|Tocotrienols|tocotrienols|mesh-list
111225059|NCT03358524|alpha-Tocopherol|alpha-tocopherol|mesh-list
111225060|NCT03358524|Micronutrients|micronutrients|mesh-ancestor
111225061|NCT03358524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111225062|NCT03358524|Antioxidants|antioxidants|mesh-ancestor
111225063|NCT03358524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111225064|NCT03358524|Protective Agents|protective agents|mesh-ancestor
111225065|NCT04444986|Favipiravir|favipiravir|mesh-list
111225066|NCT04444986|Antiviral Agents|antiviral agents|mesh-ancestor
111225067|NCT04444986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111225068|NCT03356730|Vitamin D|vitamin d|mesh-list
111225069|NCT03356730|Vitamins|vitamins|mesh-ancestor
111225070|NCT03356730|Micronutrients|micronutrients|mesh-ancestor
111225071|NCT03356730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111225072|NCT03356730|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111225073|NCT03364998|Factor VIII|factor viii|mesh-list
111225074|NCT03364998|Coagulants|coagulants|mesh-ancestor
111225075|NCT04509102|Adderall|adderall|mesh-list
111225076|NCT04509102|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111225077|NCT04509102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111225078|NCT04508946|Thiamine|thiamine|mesh-list
111225079|NCT04508946|Hydrocortisone|hydrocortisone|mesh-list
111225080|NCT04508946|Vitamins|vitamins|mesh-ancestor
111225081|NCT04508946|Micronutrients|micronutrients|mesh-ancestor
111225082|NCT04508946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111225083|NCT04508946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111225084|NCT04508946|Vitamin B Complex|vitamin b complex|mesh-ancestor
111225085|NCT03364842|Furosemide|furosemide|mesh-list
111225086|NCT03364842|Diuretics|diuretics|mesh-ancestor
111225087|NCT03364842|Natriuretic Agents|natriuretic agents|mesh-ancestor
111225088|NCT03364842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111225089|NCT03364842|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
111225090|NCT03364842|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111225091|NCT03364842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111225092|NCT03364764|Sirolimus|sirolimus|mesh-list
111225093|NCT03364764|Temsirolimus|temsirolimus|mesh-list
111225094|NCT03364764|MTOR Inhibitors|mtor inhibitors|mesh-list
111225095|NCT03364764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111225096|NCT03364764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111225097|NCT03364764|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111225098|NCT03364764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111225099|NCT03364764|Antifungal Agents|antifungal agents|mesh-ancestor
111225100|NCT03364764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111225101|NCT03364764|Immunologic Factors|immunologic factors|mesh-ancestor
111225102|NCT03364764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111225103|NCT03364764|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111225104|NCT03364764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110661559|NCT00539864|Hemagglutinins|hemagglutinins|mesh-list
111225105|NCT03364764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111225106|NCT02519400|Amitriptyline|amitriptyline|mesh-list
111225108|NCT02519400|Antidepressive Agents|antidepressive agents|mesh-ancestor
111225109|NCT02519400|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111225110|NCT02519400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111225111|NCT02519400|Analgesics|analgesics|mesh-ancestor
111225112|NCT02519400|Sensory System Agents|sensory system agents|mesh-ancestor
111225113|NCT02519400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111225114|NCT02519400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111225115|NCT02519400|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111225116|NCT02519400|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111225117|NCT02519400|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111225118|NCT02519400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111225119|NCT02519400|Adrenergic Agents|adrenergic agents|mesh-ancestor
111225120|NCT02519400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111225121|NCT04509258|Acetylcarnitine|acetylcarnitine|mesh-list
111225122|NCT04509258|Acetylcysteine|acetylcysteine|mesh-list
111225123|NCT04509258|Ondansetron|ondansetron|mesh-list
111225124|NCT04509258|Mineral Oil|mineral oil|mesh-list
111225125|NCT04509258|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111225126|NCT04509258|Antiemetics|antiemetics|mesh-ancestor
111225127|NCT04509258|Autonomic Agents|autonomic agents|mesh-ancestor
111225128|NCT04509258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111225129|NCT04509258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111225130|NCT04509258|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111225131|NCT04509258|Antipruritics|antipruritics|mesh-ancestor
111225132|NCT04509258|Dermatologic Agents|dermatologic agents|mesh-ancestor
111225133|NCT04509258|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111225134|NCT04509258|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111225135|NCT04509258|Serotonin Agents|serotonin agents|mesh-ancestor
111225136|NCT04509258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111225137|NCT04509258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111225138|NCT04509258|Antiviral Agents|antiviral agents|mesh-ancestor
111225139|NCT04509258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111225140|NCT04509258|Expectorants|expectorants|mesh-ancestor
111225141|NCT04509258|Respiratory System Agents|respiratory system agents|mesh-ancestor
111225142|NCT04509258|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111225143|NCT04509258|Antioxidants|antioxidants|mesh-ancestor
111225144|NCT04509258|Protective Agents|protective agents|mesh-ancestor
111225145|NCT04509258|Antidotes|antidotes|mesh-ancestor
111225146|NCT04509258|Vitamin B Complex|vitamin b complex|mesh-ancestor
111225147|NCT04509258|Vitamins|vitamins|mesh-ancestor
111225148|NCT04509258|Micronutrients|micronutrients|mesh-ancestor
111225149|NCT04509258|Nootropic Agents|nootropic agents|mesh-ancestor
111225150|NCT04509258|Emollients|emollients|mesh-ancestor
111225151|NCT03354624|Mitogens|mitogens|mesh-list
111225152|NCT03354624|Mitosis Modulators|mitosis modulators|mesh-ancestor
111225153|NCT03354624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111225154|NCT03364218|Acetylcysteine|acetylcysteine|mesh-list
111225155|NCT03364218|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111225156|NCT03364218|Antiviral Agents|antiviral agents|mesh-ancestor
111225157|NCT03364218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111225158|NCT03364218|Expectorants|expectorants|mesh-ancestor
111225159|NCT03364218|Respiratory System Agents|respiratory system agents|mesh-ancestor
111225160|NCT03364218|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111225161|NCT03364218|Antioxidants|antioxidants|mesh-ancestor
111225162|NCT03364218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111225163|NCT03364218|Protective Agents|protective agents|mesh-ancestor
111225164|NCT03364218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111225165|NCT03364218|Antidotes|antidotes|mesh-ancestor
111225166|NCT04444284|Vaccines|vaccines|mesh-list
111225167|NCT04444284|Immunologic Factors|immunologic factors|mesh-ancestor
111225168|NCT04444284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111225169|NCT03354312|Lidocaine|lidocaine|mesh-list
111225170|NCT03354312|Epinephrine|epinephrine|mesh-list
111225171|NCT03354312|Racepinephrine|racepinephrine|mesh-list
111225172|NCT03354312|Carticaine|carticaine|mesh-list
111225173|NCT03354312|Epinephryl borate|epinephryl borate|mesh-list
111225174|NCT03354312|Anesthetics, Local|anesthetics, local|mesh-ancestor
111225175|NCT03354312|Anesthetics|anesthetics|mesh-ancestor
111225176|NCT03354312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111225177|NCT03354312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111225178|NCT03354312|Sensory System Agents|sensory system agents|mesh-ancestor
111225179|NCT03354312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111225180|NCT03354312|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111225181|NCT03354312|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111225182|NCT03354312|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111225183|NCT03354312|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111225184|NCT03354312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111225185|NCT03354312|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111225186|NCT03354312|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111225187|NCT03354312|Adrenergic Agents|adrenergic agents|mesh-ancestor
111225188|NCT03354312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111225189|NCT03354312|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111225190|NCT03354312|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111225191|NCT03354312|Autonomic Agents|autonomic agents|mesh-ancestor
111225192|NCT03354312|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111225193|NCT03354312|Respiratory System Agents|respiratory system agents|mesh-ancestor
111225194|NCT03354312|Mydriatics|mydriatics|mesh-ancestor
111225195|NCT03354312|Sympathomimetics|sympathomimetics|mesh-ancestor
111225196|NCT03354312|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111225198|NCT03363984|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111225199|NCT03363984|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111225200|NCT03363984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111225201|NCT03363984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111225202|NCT03363984|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111225203|NCT03363984|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111225204|NCT03363984|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111225205|NCT03363984|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111225206|NCT03363984|Anesthetics, General|anesthetics, general|mesh-ancestor
111225207|NCT03363984|Anesthetics|anesthetics|mesh-ancestor
111225208|NCT03363984|GABA Modulators|gaba modulators|mesh-ancestor
111225209|NCT03363984|GABA Agents|gaba agents|mesh-ancestor
111225210|NCT03363984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111225211|NCT03363984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111225212|NCT03355716|Fentanyl|fentanyl|mesh-list
111225213|NCT03355716|Ketamine|ketamine|mesh-list
111225214|NCT03355716|Morphine|morphine|mesh-list
111225215|NCT03355716|Bupivacaine|bupivacaine|mesh-list
111225216|NCT03355716|Anesthetics, Local|anesthetics, local|mesh-ancestor
111225217|NCT03355716|Anesthetics|anesthetics|mesh-ancestor
111225218|NCT03355716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111225219|NCT03355716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111225220|NCT03355716|Sensory System Agents|sensory system agents|mesh-ancestor
111225221|NCT03355716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111225222|NCT03355716|Analgesics|analgesics|mesh-ancestor
111225223|NCT03355716|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111225224|NCT03355716|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111225225|NCT03355716|Anesthetics, General|anesthetics, general|mesh-ancestor
111225226|NCT03355716|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111225227|NCT03355716|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111225228|NCT03355716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111225229|NCT03355716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111225230|NCT03355716|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111225231|NCT03355716|Narcotics|narcotics|mesh-ancestor
111225232|NCT03355716|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111225233|NCT04508400|Dexamethasone|dexamethasone|mesh-list
111225234|NCT04508400|Dexamethasone acetate|dexamethasone acetate|mesh-list
111225235|NCT04508400|Ondansetron|ondansetron|mesh-list
111225236|NCT04508400|Fosaprepitant|fosaprepitant|mesh-list
111225237|NCT04508400|Aprepitant|aprepitant|mesh-list
111225238|NCT04508400|BB 1101|bb 1101|mesh-list
111225239|NCT04508400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111225240|NCT04508400|Antiemetics|antiemetics|mesh-ancestor
111225241|NCT04508400|Autonomic Agents|autonomic agents|mesh-ancestor
111225242|NCT04508400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111225243|NCT04508400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111225244|NCT04508400|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111225245|NCT04508400|Glucocorticoids|glucocorticoids|mesh-ancestor
111225246|NCT04508400|Hormones|hormones|mesh-ancestor
111225247|NCT04508400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111225248|NCT04508400|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111225249|NCT04508400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111225250|NCT04508400|Protease Inhibitors|protease inhibitors|mesh-ancestor
111225251|NCT04508400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111225252|NCT04508400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111225253|NCT04508400|Antipruritics|antipruritics|mesh-ancestor
111225254|NCT04508400|Dermatologic Agents|dermatologic agents|mesh-ancestor
111225255|NCT04508400|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111225256|NCT04508400|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111225257|NCT04508400|Serotonin Agents|serotonin agents|mesh-ancestor
111225258|NCT04508400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111225259|NCT04508400|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
111225260|NCT03355638|Pyranoprofen|pyranoprofen|mesh-list
111225262|NCT03355638|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111225263|NCT03355638|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111225264|NCT03355638|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111225265|NCT03355638|Growth Substances|growth substances|mesh-ancestor
111225266|NCT03355638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111225267|NCT03355638|Growth Inhibitors|growth inhibitors|mesh-ancestor
111225268|NCT03355638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111225269|NCT03355638|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111225270|NCT03355638|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111225271|NCT03355638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111225272|NCT03355638|Analgesics|analgesics|mesh-ancestor
111225273|NCT03355638|Sensory System Agents|sensory system agents|mesh-ancestor
111225274|NCT03355638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111225275|NCT03355638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111225276|NCT03355638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111225277|NCT03355638|Gout Suppressants|gout suppressants|mesh-ancestor
111225278|NCT01626664|Gemcitabine|gemcitabine|mesh-list
111225279|NCT01626664|Oxaliplatin|oxaliplatin|mesh-list
111225280|NCT01626664|Mogamulizumab|mogamulizumab|mesh-list
111225281|NCT01626664|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111225282|NCT01626664|Antimetabolites|antimetabolites|mesh-ancestor
111225283|NCT01626664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111225284|NCT01626664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111225285|NCT04515966|Methylprednisolone|methylprednisolone|mesh-list
111225286|NCT04515966|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111225287|NCT04515966|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111225288|NCT04515966|Prednisolone|prednisolone|mesh-list
111225289|NCT04515966|Prednisolone acetate|prednisolone acetate|mesh-list
111225290|NCT04515966|Lidocaine|lidocaine|mesh-list
111225291|NCT04515966|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111225292|NCT04515966|Prednisolone phosphate|prednisolone phosphate|mesh-list
111225293|NCT04515966|Anesthetics, Local|anesthetics, local|mesh-ancestor
111225294|NCT04515966|Anesthetics|anesthetics|mesh-ancestor
111225295|NCT04515966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111225296|NCT04515966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111225297|NCT04515966|Sensory System Agents|sensory system agents|mesh-ancestor
111225298|NCT04515966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111225299|NCT04515966|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111225300|NCT04515966|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111225301|NCT04515966|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111225302|NCT04515966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111225303|NCT04515966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111225304|NCT04515966|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111225305|NCT04515966|Antiemetics|antiemetics|mesh-ancestor
111225306|NCT04515966|Autonomic Agents|autonomic agents|mesh-ancestor
111225307|NCT04515966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111225308|NCT04515966|Glucocorticoids|glucocorticoids|mesh-ancestor
111225309|NCT04515966|Hormones|hormones|mesh-ancestor
111225310|NCT04515966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111225311|NCT04515966|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111225312|NCT04515966|Protective Agents|protective agents|mesh-ancestor
111225313|NCT04515966|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111225314|NCT04515966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111225315|NCT04504110|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
111225316|NCT04504110|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111225317|NCT04504110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111225318|NCT03355248|Acetaminophen|acetaminophen|mesh-list
111225319|NCT03355248|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
111225320|NCT03355248|Oxycodone|oxycodone|mesh-list
111225321|NCT03355248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111225322|NCT03355248|Analgesics|analgesics|mesh-ancestor
111225323|NCT03355248|Sensory System Agents|sensory system agents|mesh-ancestor
111225324|NCT03355248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111225325|NCT03355248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111225326|NCT03355248|Antipyretics|antipyretics|mesh-ancestor
111225327|NCT03355248|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111225328|NCT03355248|Narcotics|narcotics|mesh-ancestor
111225329|NCT03355248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111225330|NCT03355248|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111225331|NCT03355248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111225332|NCT03355248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111225333|NCT03350334|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
111225334|NCT03350334|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111225335|NCT03350334|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111225336|NCT03350334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111225337|NCT03350334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111225338|NCT03350334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111225339|NCT03350334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111225340|NCT03350334|Analgesics|analgesics|mesh-ancestor
111225341|NCT03350334|Sensory System Agents|sensory system agents|mesh-ancestor
111225342|NCT03350334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111225343|NCT03350334|Antidepressive Agents|antidepressive agents|mesh-ancestor
111225344|NCT03350334|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111225345|NCT03350334|Dopamine Agents|dopamine agents|mesh-ancestor
111225346|NCT02230696|Fluticasone|fluticasone|mesh-list
111225347|NCT02230696|Xhance|xhance|mesh-list
111225348|NCT02230696|Azelastine|azelastine|mesh-list
111225349|NCT02230696|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111225350|NCT02230696|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111225351|NCT02230696|Autonomic Agents|autonomic agents|mesh-ancestor
111225352|NCT02230696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111225353|NCT02230696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111225354|NCT02230696|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111225355|NCT02230696|Respiratory System Agents|respiratory system agents|mesh-ancestor
111225356|NCT02230696|Dermatologic Agents|dermatologic agents|mesh-ancestor
111225357|NCT02230696|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111225358|NCT02230696|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
111225359|NCT02230696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111225360|NCT02230696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111225361|NCT02230696|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
111225362|NCT02230696|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111225363|NCT02230696|Histamine Antagonists|histamine antagonists|mesh-ancestor
111225364|NCT02230696|Histamine Agents|histamine agents|mesh-ancestor
111225365|NCT02230696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111225366|NCT03355014|Metformin|metformin|mesh-list
111225367|NCT03355014|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111225368|NCT03355014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111225369|NCT02231086|Leucovorin|leucovorin|mesh-list
111225370|NCT02231086|Fluorouracil|fluorouracil|mesh-list
111225371|NCT02231086|Capecitabine|capecitabine|mesh-list
111225372|NCT02231086|Oxaliplatin|oxaliplatin|mesh-list
111225373|NCT02231086|Antimetabolites|antimetabolites|mesh-ancestor
111225374|NCT02231086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111225375|NCT02231086|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111225376|NCT02231086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111225377|NCT02231086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111225378|NCT02231086|Immunologic Factors|immunologic factors|mesh-ancestor
111225379|NCT02231086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111225380|NCT02231086|Antidotes|antidotes|mesh-ancestor
111225381|NCT02231086|Protective Agents|protective agents|mesh-ancestor
111225382|NCT02231086|Vitamin B Complex|vitamin b complex|mesh-ancestor
111225383|NCT02231086|Vitamins|vitamins|mesh-ancestor
111225384|NCT02231086|Micronutrients|micronutrients|mesh-ancestor
111225385|NCT03353298|Allopurinol|allopurinol|mesh-list
111225386|NCT03353298|Antimetabolites|antimetabolites|mesh-ancestor
111225387|NCT03353298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111225388|NCT03353298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111225389|NCT03353298|Gout Suppressants|gout suppressants|mesh-ancestor
111225390|NCT03353298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111225391|NCT03353298|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111225392|NCT03353298|Antioxidants|antioxidants|mesh-ancestor
111225393|NCT03353298|Protective Agents|protective agents|mesh-ancestor
111225394|NCT03353298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111225395|NCT02509546|Adenosine|adenosine|mesh-list
111225396|NCT02509546|Analgesics|analgesics|mesh-ancestor
111225397|NCT02509546|Sensory System Agents|sensory system agents|mesh-ancestor
111225398|NCT02509546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111225399|NCT02509546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111225400|NCT02509546|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111225401|NCT02509546|Vasodilator Agents|vasodilator agents|mesh-ancestor
111225402|NCT02509546|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
111225403|NCT02509546|Purinergic Agonists|purinergic agonists|mesh-ancestor
111225404|NCT02509546|Purinergic Agents|purinergic agents|mesh-ancestor
111225405|NCT02509546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111225406|NCT02509546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111225407|NCT03187210|Brentuximab Vedotin|brentuximab vedotin|mesh-list
111225408|NCT03187210|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111225409|NCT03187210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111225410|NCT03187210|Immunotoxins|immunotoxins|mesh-ancestor
111225411|NCT03187210|Immunoconjugates|immunoconjugates|mesh-ancestor
111225413|NCT03187210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111225414|NCT03349866|Capecitabine|capecitabine|mesh-list
111225415|NCT03349866|Oxaliplatin|oxaliplatin|mesh-list
111225416|NCT03349866|Apatinib|apatinib|mesh-list
111225417|NCT03349866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111225418|NCT03349866|Antimetabolites|antimetabolites|mesh-ancestor
111225419|NCT03349866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111225420|NCT03349866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111225421|NCT03349866|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111225422|NCT03349866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111225423|NCT01631110|Vaccines|vaccines|mesh-list
111225424|NCT01631110|Immunologic Factors|immunologic factors|mesh-ancestor
111225425|NCT01631110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111225426|NCT01631656|Azelaic acid|azelaic acid|mesh-list
111225427|NCT01631656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111225428|NCT01631656|Dermatologic Agents|dermatologic agents|mesh-ancestor
111225429|NCT02985190|Azacitidine|azacitidine|mesh-list
111225430|NCT02985190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111225431|NCT02985190|Antimetabolites|antimetabolites|mesh-ancestor
111225432|NCT02985190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111225433|NCT02985190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111225434|NCT02985190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111225435|NCT01376310|Paclitaxel|paclitaxel|mesh-list
111225436|NCT01376310|Docetaxel|docetaxel|mesh-list
111225437|NCT01376310|Carboplatin|carboplatin|mesh-list
111225438|NCT01376310|Gemcitabine|gemcitabine|mesh-list
111225439|NCT01376310|Pemetrexed|pemetrexed|mesh-list
111225440|NCT01376310|Everolimus|everolimus|mesh-list
111225441|NCT01376310|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111225442|NCT01376310|Trametinib|trametinib|mesh-list
111225443|NCT01376310|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111225444|NCT01376310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111225445|NCT01376310|Tubulin Modulators|tubulin modulators|mesh-ancestor
111225446|NCT01376310|Antimitotic Agents|antimitotic agents|mesh-ancestor
111225447|NCT01376310|Mitosis Modulators|mitosis modulators|mesh-ancestor
111225448|NCT01376310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111225449|NCT01376310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111225450|NCT01376310|Antimetabolites|antimetabolites|mesh-ancestor
111225451|NCT01376310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111225452|NCT01376310|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111225453|NCT01376310|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111225454|NCT01376310|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111225455|NCT01376310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111225456|NCT01376310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111225457|NCT01376310|Immunologic Factors|immunologic factors|mesh-ancestor
111225458|NCT01376310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111225459|NCT01585402|Etidronic Acid|etidronic acid|mesh-list
111225460|NCT01585402|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111225461|NCT01585402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111225462|NCT01638052|Clonidine|clonidine|mesh-list
111225463|NCT01638052|Bupivacaine|bupivacaine|mesh-list
111225464|NCT01638052|Anesthetics, Local|anesthetics, local|mesh-ancestor
111225465|NCT01638052|Anesthetics|anesthetics|mesh-ancestor
111225466|NCT01638052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111225467|NCT01638052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111225468|NCT01638052|Sensory System Agents|sensory system agents|mesh-ancestor
111225469|NCT01638052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111225470|NCT01638052|Analgesics|analgesics|mesh-ancestor
111225471|NCT01638052|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111225472|NCT01638052|Sympatholytics|sympatholytics|mesh-ancestor
111225473|NCT01638052|Autonomic Agents|autonomic agents|mesh-ancestor
111225474|NCT01638052|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111225475|NCT01638052|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111225476|NCT01638052|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111225477|NCT01638052|Adrenergic Agents|adrenergic agents|mesh-ancestor
111225478|NCT01638052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111225479|NCT01638052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111225480|NCT02518152|Alendronate|alendronate|mesh-list
111225481|NCT02518152|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111225482|NCT02518152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111225483|NCT01229878|Vitamin D|vitamin d|mesh-list
111225484|NCT01229878|Cholecalciferol|cholecalciferol|mesh-list
111225485|NCT01229878|Vitamins|vitamins|mesh-ancestor
111225486|NCT01229878|Micronutrients|micronutrients|mesh-ancestor
111225487|NCT01229878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111225488|NCT01229878|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111225489|NCT01229878|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111225490|NCT03352674|Insulin|insulin|mesh-list
111225491|NCT03352674|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111225492|NCT03352674|Insulin Glargine|insulin glargine|mesh-list
111225493|NCT03352674|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111225494|NCT03352674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111225495|NCT01639222|Calcium, Dietary|calcium, dietary|mesh-list
111225496|NCT01639222|Vitamin D|vitamin d|mesh-list
111225497|NCT01639222|Cholecalciferol|cholecalciferol|mesh-list
111225498|NCT01639222|Calcium|calcium|mesh-list
111225499|NCT01639222|Vitamins|vitamins|mesh-ancestor
111225500|NCT01639222|Micronutrients|micronutrients|mesh-ancestor
111225501|NCT01639222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111225502|NCT01639222|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111225503|NCT01639222|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111225504|NCT04443270|Chloroquine|chloroquine|mesh-list
111225505|NCT04443270|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
111225506|NCT04443270|Amebicides|amebicides|mesh-ancestor
111225507|NCT04443270|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111225508|NCT04443270|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111225509|NCT04443270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111225510|NCT04443270|Antimalarials|antimalarials|mesh-ancestor
111225511|NCT04443270|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111225512|NCT04443270|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111225513|NCT04443270|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111225514|NCT04443270|Analgesics|analgesics|mesh-ancestor
111225515|NCT04443270|Sensory System Agents|sensory system agents|mesh-ancestor
111225516|NCT04443270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111225517|NCT04443270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111225518|NCT04443270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111225519|NCT04443270|Filaricides|filaricides|mesh-ancestor
111225520|NCT04443270|Antinematodal Agents|antinematodal agents|mesh-ancestor
111225521|NCT04443270|Anthelmintics|anthelmintics|mesh-ancestor
111225522|NCT03349008|Entecavir|entecavir|mesh-list
111225523|NCT03349008|Glycyrrhizic Acid|glycyrrhizic acid|mesh-list
111225524|NCT03349008|Antiviral Agents|antiviral agents|mesh-ancestor
111225525|NCT03349008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111225526|NCT03349008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111225527|NCT03352362|Acetaminophen|acetaminophen|mesh-list
111225528|NCT03352362|Ibuprofen|ibuprofen|mesh-list
111225529|NCT03352362|Propacetamol|propacetamol|mesh-list
111225530|NCT03352362|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111225531|NCT03352362|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111225532|NCT03352362|Analgesics|analgesics|mesh-ancestor
111225533|NCT03352362|Sensory System Agents|sensory system agents|mesh-ancestor
111225534|NCT03352362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111225535|NCT03352362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111225536|NCT03352362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111225537|NCT03352362|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111225538|NCT03352362|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111225539|NCT03352362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111225540|NCT03352362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111225541|NCT03352362|Antipyretics|antipyretics|mesh-ancestor
111225542|NCT01598740|Spironolactone|spironolactone|mesh-list
111225543|NCT01598740|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
111225544|NCT01598740|Hormone Antagonists|hormone antagonists|mesh-ancestor
111225545|NCT01598740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111225546|NCT01598740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111225547|NCT01598740|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
111225548|NCT01598740|Diuretics|diuretics|mesh-ancestor
111225549|NCT01598740|Natriuretic Agents|natriuretic agents|mesh-ancestor
111225550|NCT00709098|Iloprost|iloprost|mesh-list
111225551|NCT00709098|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111225552|NCT00709098|Vasodilator Agents|vasodilator agents|mesh-ancestor
111225553|NCT03348696|Dexamethasone|dexamethasone|mesh-list
111225554|NCT03348696|Dexamethasone acetate|dexamethasone acetate|mesh-list
111225555|NCT03348696|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
111225556|NCT03348696|BB 1101|bb 1101|mesh-list
111225557|NCT03348696|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111225558|NCT03348696|Antiemetics|antiemetics|mesh-ancestor
111225559|NCT03348696|Autonomic Agents|autonomic agents|mesh-ancestor
111225560|NCT03348696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111225561|NCT03348696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111225562|NCT03348696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111225563|NCT03348696|Glucocorticoids|glucocorticoids|mesh-ancestor
110949982|NCT03595982|Vasodilator Agents|vasodilator agents|mesh-ancestor
111225564|NCT03348696|Hormones|hormones|mesh-ancestor
111225565|NCT03348696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111225566|NCT03348696|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111225567|NCT03348696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111225568|NCT03348696|Protease Inhibitors|protease inhibitors|mesh-ancestor
111225569|NCT03348696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111225570|NCT03348696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111225571|NCT04506450|Anesthetics|anesthetics|mesh-list
111225572|NCT04506450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111225573|NCT04506450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111225574|NCT03352128|Calcium|calcium|mesh-list
111225575|NCT03352128|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111225576|NCT03352128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111225577|NCT03122730|Epoprostenol|epoprostenol|mesh-list
111225578|NCT03122730|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111225579|NCT03122730|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111225580|NCT04505904|Oxytocin|oxytocin|mesh-list
111225581|NCT04505904|Oxytocics|oxytocics|mesh-ancestor
111225582|NCT04505904|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111225583|NCT04505904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111225584|NCT03348462|Anthralin|anthralin|mesh-list
111225585|NCT03348462|Dermatologic Agents|dermatologic agents|mesh-ancestor
111225586|NCT04505514|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
111225587|NCT04505514|Hematinics|hematinics|mesh-ancestor
111225588|NCT04505202|Chlorhexidine|chlorhexidine|mesh-list
111225589|NCT04505202|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
111225590|NCT04505202|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111225591|NCT04505202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111225592|NCT04505202|Disinfectants|disinfectants|mesh-ancestor
111225593|NCT04505202|Dermatologic Agents|dermatologic agents|mesh-ancestor
111225594|NCT05585346|Prednisolone|prednisolone|mesh-list
111225595|NCT05585346|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111225596|NCT05585346|Methylprednisolone|methylprednisolone|mesh-list
111225597|NCT05585346|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111225598|NCT05585346|Prednisolone acetate|prednisolone acetate|mesh-list
111225599|NCT05585346|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111225600|NCT05585346|Prednisolone phosphate|prednisolone phosphate|mesh-list
111225601|NCT05585346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111225602|NCT05585346|Glucocorticoids|glucocorticoids|mesh-ancestor
111225603|NCT05585346|Hormones|hormones|mesh-ancestor
111225604|NCT05585346|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111225605|NCT05585346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111225606|NCT05585346|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111225607|NCT05585346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111225608|NCT05585346|Antiemetics|antiemetics|mesh-ancestor
111225609|NCT05585346|Autonomic Agents|autonomic agents|mesh-ancestor
111225610|NCT05585346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111225611|NCT05585346|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111225612|NCT05585346|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111225613|NCT05585346|Protective Agents|protective agents|mesh-ancestor
111225614|NCT05098704|Clopidogrel|clopidogrel|mesh-list
111225615|NCT05098704|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111225616|NCT05098704|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111225617|NCT05098704|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111225618|NCT05098704|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111225619|NCT05098704|Purinergic Agents|purinergic agents|mesh-ancestor
111225620|NCT05098704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111225621|NCT05098704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111225622|NCT05098704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111225623|NCT05584956|Sildenafil Citrate|sildenafil citrate|mesh-list
111225624|NCT05584956|Vasodilator Agents|vasodilator agents|mesh-ancestor
111225625|NCT05584956|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111225626|NCT05584956|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111225627|NCT05584956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111225628|NCT05584956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111225629|NCT05584956|Urological Agents|urological agents|mesh-ancestor
111225630|NCT01376700|Factor VIII|factor viii|mesh-list
111225631|NCT01376700|Coagulants|coagulants|mesh-ancestor
111225632|NCT01797965|Daclizumab|daclizumab|mesh-list
111225633|NCT01797965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111225634|NCT01797965|Immunologic Factors|immunologic factors|mesh-ancestor
111225635|NCT01797965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111225636|NCT01601236|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
111225637|NCT01601236|Hormones|hormones|mesh-ancestor
111225638|NCT01601236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111225639|NCT01601236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111225640|NCT05584878|Chitosan|chitosan|mesh-list
110950059|NCT00938652|Iniparib|iniparib|mesh-list
111225642|NCT05584878|Caseins|caseins|mesh-list
111225643|NCT05584878|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111225644|NCT05584878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111225645|NCT05584878|Chelating Agents|chelating agents|mesh-ancestor
111225646|NCT05584878|Sequestering Agents|sequestering agents|mesh-ancestor
111225647|NCT05584878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111225648|NCT05584878|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111225649|NCT05584878|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111225650|NCT05584878|Antimetabolites|antimetabolites|mesh-ancestor
111225651|NCT05584878|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111225652|NCT05584878|Hemostatics|hemostatics|mesh-ancestor
111225653|NCT05584878|Coagulants|coagulants|mesh-ancestor
111225654|NCT01643902|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
111225655|NCT01643902|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111225656|NCT01643902|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111225657|NCT01643902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111225658|NCT03347994|14-O-phosphonooxymethyltriptolide disodium salt|14-o-phosphonooxymethyltriptolide disodium salt|mesh-list
111225659|NCT03347994|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111225660|NCT03347994|Alkylating Agents|alkylating agents|mesh-ancestor
111225661|NCT03347994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111225662|NCT03347994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111225663|NCT04966338|Ocrelizumab|ocrelizumab|mesh-list
111225664|NCT04966338|Immunologic Factors|immunologic factors|mesh-ancestor
111225665|NCT04966338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111225666|NCT03347916|Gabapentin|gabapentin|mesh-list
111225667|NCT03347916|Analgesics|analgesics|mesh-ancestor
111225668|NCT03347916|Sensory System Agents|sensory system agents|mesh-ancestor
111225669|NCT03347916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111225670|NCT03347916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111225671|NCT03347916|Anticonvulsants|anticonvulsants|mesh-ancestor
111225672|NCT03347916|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111225673|NCT03347916|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111225674|NCT03347916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111225675|NCT03347916|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111225676|NCT03347916|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111225677|NCT03347916|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111225678|NCT03347916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111225679|NCT03347916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111225680|NCT03347916|Antimanic Agents|antimanic agents|mesh-ancestor
111225681|NCT05584644|Palbociclib|palbociclib|mesh-list
111225682|NCT05584644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111225683|NCT05584644|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111225684|NCT05584644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111225685|NCT05584644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111225686|NCT01821677|Danazol|danazol|mesh-list
111225687|NCT01821677|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111225688|NCT01821677|Hormone Antagonists|hormone antagonists|mesh-ancestor
111225689|NCT01821677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111225690|NCT01821677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111225691|NCT03347760|Octreotide|octreotide|mesh-list
111225692|NCT03347760|Edotreotide|edotreotide|mesh-list
111225693|NCT03347760|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111225694|NCT03347760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111225695|NCT03347760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111225696|NCT03347760|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111225697|NCT03347760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111225698|NCT03062280|Hydrocortisone|hydrocortisone|mesh-list
111225699|NCT03062280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111225700|NCT00709722|Gusperimus|gusperimus|mesh-list
111225701|NCT00709722|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111225702|NCT00709722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111225703|NCT00709722|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111225704|NCT00709722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111225705|NCT00709722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111225706|NCT00709722|Immunologic Factors|immunologic factors|mesh-ancestor
111225707|NCT00709722|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111225708|NCT00709722|Protective Agents|protective agents|mesh-ancestor
111225709|NCT01820585|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
111225710|NCT01820585|Anticonvulsants|anticonvulsants|mesh-ancestor
111225711|NCT01820585|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111225712|NCT01820585|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111225713|NCT01820585|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111225714|NCT01820585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111225715|NCT02378298|Methylprednisolone|methylprednisolone|mesh-list
111225716|NCT02378298|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111225717|NCT02378298|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111225718|NCT02378298|Prednisolone|prednisolone|mesh-list
111225719|NCT02378298|Prednisolone acetate|prednisolone acetate|mesh-list
111225720|NCT02378298|Rituximab|rituximab|mesh-list
111225721|NCT02378298|Methotrexate|methotrexate|mesh-list
111225722|NCT02378298|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111225723|NCT02378298|Prednisolone phosphate|prednisolone phosphate|mesh-list
111225724|NCT02378298|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111225725|NCT02378298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111225726|NCT02378298|Immunologic Factors|immunologic factors|mesh-ancestor
111225727|NCT02378298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111225728|NCT02378298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111225729|NCT02378298|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111225730|NCT02378298|Abortifacient Agents|abortifacient agents|mesh-ancestor
111225731|NCT02378298|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111225732|NCT02378298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111225733|NCT02378298|Antimetabolites|antimetabolites|mesh-ancestor
111225734|NCT02378298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111225735|NCT02378298|Dermatologic Agents|dermatologic agents|mesh-ancestor
111225736|NCT02378298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111225737|NCT02378298|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111225738|NCT02378298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111225739|NCT02378298|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111225740|NCT02378298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111225741|NCT02378298|Antiemetics|antiemetics|mesh-ancestor
111225742|NCT02378298|Autonomic Agents|autonomic agents|mesh-ancestor
111225743|NCT02378298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111225744|NCT02378298|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111225745|NCT02378298|Glucocorticoids|glucocorticoids|mesh-ancestor
111225746|NCT02378298|Hormones|hormones|mesh-ancestor
111225747|NCT02378298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111225748|NCT02378298|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111225749|NCT02378298|Protective Agents|protective agents|mesh-ancestor
111225750|NCT02378298|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111225751|NCT02253108|Everolimus|everolimus|mesh-list
111225752|NCT02253108|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111225753|NCT02253108|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111225754|NCT02253108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111225755|NCT02253108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111225756|NCT02253108|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111225757|NCT02253108|Immunologic Factors|immunologic factors|mesh-ancestor
111225758|NCT02253108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111225759|NCT02253108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111225760|NCT01603420|Ascorbic Acid|ascorbic acid|mesh-list
111225761|NCT01603420|Docetaxel|docetaxel|mesh-list
111225762|NCT01603420|Methyltestosterone|methyltestosterone|mesh-list
111225763|NCT01603420|Hormones|hormones|mesh-list
111225764|NCT01603420|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
111225765|NCT01603420|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
111225766|NCT01603420|Androgens|androgens|mesh-list
111225767|NCT01603420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111225768|NCT01603420|Tubulin Modulators|tubulin modulators|mesh-ancestor
111225769|NCT01603420|Antimitotic Agents|antimitotic agents|mesh-ancestor
111225770|NCT01603420|Mitosis Modulators|mitosis modulators|mesh-ancestor
111225771|NCT01603420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111225772|NCT01603420|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111225773|NCT01603420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111225774|NCT01603420|Antioxidants|antioxidants|mesh-ancestor
111225775|NCT01603420|Protective Agents|protective agents|mesh-ancestor
111225776|NCT01603420|Vitamins|vitamins|mesh-ancestor
111225777|NCT01603420|Micronutrients|micronutrients|mesh-ancestor
111225778|NCT01603420|Estrogens|estrogens|mesh-ancestor
111225779|NCT01603420|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111225780|NCT01603420|Anabolic Agents|anabolic agents|mesh-ancestor
111225781|NCT02064036|Leuprolide|leuprolide|mesh-list
111225782|NCT02064036|Goserelin|goserelin|mesh-list
111225783|NCT02064036|Bicalutamide|bicalutamide|mesh-list
111225784|NCT02064036|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111225785|NCT02064036|Fertility Agents|fertility agents|mesh-ancestor
111225786|NCT02064036|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111225787|NCT02064036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111225788|NCT02064036|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111225789|NCT02064036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111225790|NCT02064036|Androgen Antagonists|androgen antagonists|mesh-ancestor
111225791|NCT02064036|Hormone Antagonists|hormone antagonists|mesh-ancestor
111225792|NCT02064036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111225793|NCT05645484|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
111225794|NCT05645484|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111225795|NCT05645484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111225796|NCT04551300|Sevelamer|sevelamer|mesh-list
111225797|NCT04551300|Chelating Agents|chelating agents|mesh-ancestor
111225798|NCT04551300|Sequestering Agents|sequestering agents|mesh-ancestor
111225799|NCT04551300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111225800|NCT04974580|Nicotine|nicotine|mesh-list
111225801|NCT04974580|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111225802|NCT04974580|Autonomic Agents|autonomic agents|mesh-ancestor
111225803|NCT04974580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111225804|NCT04974580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111225805|NCT04974580|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111225806|NCT04974580|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111225807|NCT04974580|Cholinergic Agents|cholinergic agents|mesh-ancestor
111225808|NCT04974580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111225809|NCT04974580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111225810|NCT01691326|Vaccines|vaccines|mesh-list
111225811|NCT01691326|Immunologic Factors|immunologic factors|mesh-ancestor
111225812|NCT01691326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111225813|NCT01606852|Dexmedetomidine|dexmedetomidine|mesh-list
111225814|NCT01606852|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111225815|NCT01606852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111225816|NCT01606852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111225817|NCT01606852|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111225818|NCT01606852|Analgesics|analgesics|mesh-ancestor
111225819|NCT01606852|Sensory System Agents|sensory system agents|mesh-ancestor
111225820|NCT01606852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111225821|NCT01606852|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111225822|NCT01606852|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111225823|NCT01606852|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111225824|NCT01606852|Adrenergic Agents|adrenergic agents|mesh-ancestor
111225825|NCT01606852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111225826|NCT01606852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111225827|NCT01691560|Calcium, Dietary|calcium, dietary|mesh-list
111225828|NCT01691560|Listerine|listerine|mesh-list
111225829|NCT01691560|Calcium|calcium|mesh-list
111225830|NCT01691560|Fluorides|fluorides|mesh-list
111225831|NCT01691560|Sodium Fluoride|sodium fluoride|mesh-list
111225832|NCT01691560|Fluorophosphate|fluorophosphate|mesh-list
111225833|NCT01691560|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111225834|NCT01691560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111225835|NCT01691560|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111225836|NCT01691560|Cariostatic Agents|cariostatic agents|mesh-ancestor
111225837|NCT01691560|Protective Agents|protective agents|mesh-ancestor
111225838|NCT01691560|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111225839|NCT01691560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111225840|NCT03346200|Tamoxifen|tamoxifen|mesh-list
111225841|NCT03346200|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111225842|NCT03346200|Hormone Antagonists|hormone antagonists|mesh-ancestor
111225843|NCT03346200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111225844|NCT03346200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111225845|NCT03346200|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111225846|NCT03346200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111225847|NCT03346200|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111225848|NCT03346200|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111225849|NCT03346200|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111225850|NCT01692340|Lycopene|lycopene|mesh-list
111225851|NCT01692340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111225852|NCT01692340|Antioxidants|antioxidants|mesh-ancestor
111225853|NCT01692340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111225854|NCT01692340|Protective Agents|protective agents|mesh-ancestor
111225855|NCT01692340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111225856|NCT01692340|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111225857|NCT01692340|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
111225858|NCT01692340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111225859|NCT02517372|Pemirolast|pemirolast|mesh-list
111225860|NCT02517372|Histamine Antagonists|histamine antagonists|mesh-ancestor
111225861|NCT02517372|Histamine Agents|histamine agents|mesh-ancestor
111225862|NCT02517372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111225863|NCT02517372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111225864|NCT02517372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111225865|NCT02516826|Olmesartan|olmesartan|mesh-list
111225866|NCT02516826|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
111225867|NCT02516826|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111225868|NCT02516826|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111225869|NCT02516826|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111225870|NCT02516826|Antimetabolites|antimetabolites|mesh-ancestor
111225871|NCT02516826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111225872|NCT02516826|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111225873|NCT02516826|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111225874|NCT02516826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111225875|NCT02516826|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111225876|NCT02516826|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111225877|NCT02516826|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111225878|NCT01650298|Factor Xa Inhibitors|factor xa inhibitors|mesh-list
111225879|NCT01650298|Thrombin|thrombin|mesh-list
111225880|NCT01650298|Hemostatics|hemostatics|mesh-ancestor
111225881|NCT01650298|Coagulants|coagulants|mesh-ancestor
111225882|NCT01650298|Antithrombins|antithrombins|mesh-ancestor
111225883|NCT01650298|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111225884|NCT01650298|Protease Inhibitors|protease inhibitors|mesh-ancestor
111225885|NCT01650298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111225886|NCT01650298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111225887|NCT01650298|Anticoagulants|anticoagulants|mesh-ancestor
111225888|NCT05583006|Tenofovir|tenofovir|mesh-list
111225889|NCT05583006|Antiviral Agents|antiviral agents|mesh-ancestor
111225890|NCT05583006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111225891|NCT05583006|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111225892|NCT05583006|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111225893|NCT05583006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111225894|NCT05583006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111225895|NCT05583006|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111225896|NCT05583006|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111225897|NCT01795937|Itraconazole|itraconazole|mesh-list
111225898|NCT01795937|Atorvastatin|atorvastatin|mesh-list
111225899|NCT01795937|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111225900|NCT01795937|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111225901|NCT01795937|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111225902|NCT01795937|Antimetabolites|antimetabolites|mesh-ancestor
111225903|NCT01795937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111225904|NCT01795937|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111225905|NCT01795937|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111225906|NCT01795937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111225907|NCT01795937|Antifungal Agents|antifungal agents|mesh-ancestor
111225908|NCT01795937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111225909|NCT01795937|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111225910|NCT01795937|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111225911|NCT01795937|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111225912|NCT01795937|Hormone Antagonists|hormone antagonists|mesh-ancestor
111225913|NCT01795937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111225914|NCT01795937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111225915|NCT01795937|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111225916|NCT04501224|Tenofovir|tenofovir|mesh-list
111225917|NCT04501224|Entecavir|entecavir|mesh-list
111225918|NCT04501224|Antiviral Agents|antiviral agents|mesh-ancestor
111225919|NCT04501224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111225920|NCT04501224|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111225921|NCT04501224|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111225922|NCT04501224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111225923|NCT04501224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111225924|NCT04501224|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111225925|NCT04501224|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111225926|NCT01817777|Metformin|metformin|mesh-list
111225927|NCT01817777|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111225928|NCT01817777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111225929|NCT01795547|Aripiprazole|aripiprazole|mesh-list
111225930|NCT01795547|Paliperidone Palmitate|paliperidone palmitate|mesh-list
111225931|NCT01795547|Antidepressive Agents|antidepressive agents|mesh-ancestor
111225932|NCT01795547|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111225933|NCT01795547|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111225934|NCT01795547|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111225935|NCT01795547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111225936|NCT01795547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110950351|NCT03448094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111225938|NCT01795547|Dopamine Agents|dopamine agents|mesh-ancestor
111225939|NCT01795547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111225940|NCT01795547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111225941|NCT01795547|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111225942|NCT01795547|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111225943|NCT01795547|Serotonin Agents|serotonin agents|mesh-ancestor
111225944|NCT01795547|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111225945|NCT01795547|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111225946|NCT01795547|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111225947|NCT01795547|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111225948|NCT02516904|Rezafungin|rezafungin|mesh-list
111225949|NCT02516904|Antifungal Agents|antifungal agents|mesh-ancestor
111225950|NCT02516904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111225951|NCT01794845|Docetaxel|docetaxel|mesh-list
111225952|NCT01794845|Cetuximab|cetuximab|mesh-list
111225953|NCT01794845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111225954|NCT01794845|Tubulin Modulators|tubulin modulators|mesh-ancestor
111225955|NCT01794845|Antimitotic Agents|antimitotic agents|mesh-ancestor
111225956|NCT01794845|Mitosis Modulators|mitosis modulators|mesh-ancestor
111225957|NCT01794845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111225958|NCT01794845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111225959|NCT01794689|Morphine|morphine|mesh-list
111225960|NCT01794689|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111225961|NCT01794689|Narcotics|narcotics|mesh-ancestor
111225962|NCT01794689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111225963|NCT01794689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111225964|NCT01794689|Analgesics|analgesics|mesh-ancestor
111225965|NCT01794689|Sensory System Agents|sensory system agents|mesh-ancestor
111225966|NCT01794689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111225967|NCT01817075|Chlorhexidine|chlorhexidine|mesh-list
111225968|NCT01817075|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
111225969|NCT01817075|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111225970|NCT01817075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111225971|NCT01817075|Disinfectants|disinfectants|mesh-ancestor
111225972|NCT01817075|Dermatologic Agents|dermatologic agents|mesh-ancestor
111225973|NCT00708552|Donepezil|donepezil|mesh-list
111225974|NCT00708552|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111225975|NCT00708552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111225976|NCT00708552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111225977|NCT00708552|Cholinergic Agents|cholinergic agents|mesh-ancestor
111225978|NCT00708552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111225979|NCT00708552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111225980|NCT00708552|Nootropic Agents|nootropic agents|mesh-ancestor
111225981|NCT02516436|Buprenorphine|buprenorphine|mesh-list
111225982|NCT02516436|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111225983|NCT02516436|Narcotics|narcotics|mesh-ancestor
111225984|NCT02516436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111225985|NCT02516436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111225986|NCT02516436|Analgesics|analgesics|mesh-ancestor
111225987|NCT02516436|Sensory System Agents|sensory system agents|mesh-ancestor
111225988|NCT02516436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111225989|NCT02516436|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111225990|NCT03347526|Vigabatrin|vigabatrin|mesh-list
111225991|NCT03347526|Cosyntropin|cosyntropin|mesh-list
111225992|NCT03347526|Anticonvulsants|anticonvulsants|mesh-ancestor
111225993|NCT03347526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111225994|NCT03347526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111225995|NCT03347526|GABA Agents|gaba agents|mesh-ancestor
111225996|NCT03347526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111225997|NCT03347526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111225998|NCT03347526|Hormones|hormones|mesh-ancestor
111225999|NCT03347526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111226000|NCT03347370|Interferons|interferons|mesh-list
111226001|NCT03347370|Interferon-beta|interferon-beta|mesh-list
111226002|NCT03347370|Interferon beta-1a|interferon beta-1a|mesh-list
111226003|NCT03347370|Interferon beta-1b|interferon beta-1b|mesh-list
111226004|NCT03347370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111226005|NCT03347370|Antiviral Agents|antiviral agents|mesh-ancestor
111226006|NCT03347370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111226007|NCT03347370|Immunologic Factors|immunologic factors|mesh-ancestor
111226008|NCT03347370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111226009|NCT03347370|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111226010|NCT02515968|Propofol|propofol|mesh-list
111226011|NCT02515968|Desflurane|desflurane|mesh-list
110950429|NCT04818736|Vaccines|vaccines|mesh-list
111226012|NCT02515968|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111226013|NCT02515968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111226014|NCT02515968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111226015|NCT02515968|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111226016|NCT02515968|Anesthetics, General|anesthetics, general|mesh-ancestor
111226017|NCT02515968|Anesthetics|anesthetics|mesh-ancestor
111226018|NCT02515968|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111226019|NCT03345966|Antibodies|antibodies|mesh-list
111226020|NCT03345966|Immunologic Factors|immunologic factors|mesh-ancestor
111226021|NCT03345966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111226022|NCT02507700|Bupivacaine|bupivacaine|mesh-list
111226023|NCT02507700|Sevoflurane|sevoflurane|mesh-list
111226024|NCT02507700|Anesthetics, Local|anesthetics, local|mesh-ancestor
111226025|NCT02507700|Anesthetics|anesthetics|mesh-ancestor
111226026|NCT02507700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111226027|NCT02507700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111226028|NCT02507700|Sensory System Agents|sensory system agents|mesh-ancestor
111226029|NCT02507700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111226030|NCT02507700|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111226031|NCT02507700|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111226032|NCT02507700|Anesthetics, General|anesthetics, general|mesh-ancestor
111226033|NCT02513004|Clopidogrel|clopidogrel|mesh-list
111226034|NCT02513004|Ticagrelor|ticagrelor|mesh-list
111226035|NCT02513004|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111226036|NCT02513004|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111226037|NCT02513004|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111226038|NCT02513004|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111226039|NCT02513004|Purinergic Agents|purinergic agents|mesh-ancestor
111226040|NCT02513004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111226041|NCT02513004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111226042|NCT02513004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111226043|NCT04500522|Isoniazid|isoniazid|mesh-list
111226044|NCT04500522|Antitubercular Agents|antitubercular agents|mesh-ancestor
111226045|NCT04500522|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111226046|NCT04500522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111226047|NCT04500522|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
111226048|NCT04500522|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111226049|NCT04500522|Antimetabolites|antimetabolites|mesh-ancestor
111226050|NCT04500522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111226051|NCT04500522|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111226052|NCT02507232|Temozolomide|temozolomide|mesh-list
111226053|NCT02507232|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111226054|NCT02507232|Alkylating Agents|alkylating agents|mesh-ancestor
111226055|NCT02507232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111226056|NCT02507232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111226057|NCT02506998|Histamine|histamine|mesh-list
111226058|NCT02506998|Histamine Antagonists|histamine antagonists|mesh-list
111226059|NCT02506998|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
111226060|NCT02506998|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-list
111226061|NCT02506998|Histamine Agonists|histamine agonists|mesh-ancestor
111226062|NCT02506998|Histamine Agents|histamine agents|mesh-ancestor
111226063|NCT02506998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111226064|NCT02506998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111226065|NCT02506998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111226066|NCT02507076|Melphalan|melphalan|mesh-list
111226067|NCT02507076|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111226068|NCT02507076|Alkylating Agents|alkylating agents|mesh-ancestor
111226069|NCT02507076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111226070|NCT02507076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111226071|NCT02507076|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111226072|NCT02507076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111226073|NCT02507076|Immunologic Factors|immunologic factors|mesh-ancestor
111226074|NCT02507076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111226075|NCT01609348|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
111226076|NCT01609348|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111226077|NCT01609348|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111226078|NCT01609348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111226079|NCT01609348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111226080|NCT01609348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111226081|NCT01609348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111226082|NCT01609348|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111226083|NCT01609348|Antidepressive Agents|antidepressive agents|mesh-ancestor
111226084|NCT01609348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111226086|NCT04500678|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111226087|NCT04500678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111226088|NCT02507154|Cetuximab|cetuximab|mesh-list
111226089|NCT02507154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111226090|NCT02507154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111226091|NCT02515734|Leucovorin|leucovorin|mesh-list
111226092|NCT02515734|Bevacizumab|bevacizumab|mesh-list
111226093|NCT02515734|Cetuximab|cetuximab|mesh-list
111226094|NCT02515734|Fluorouracil|fluorouracil|mesh-list
111226095|NCT02515734|Oxaliplatin|oxaliplatin|mesh-list
111226096|NCT02515734|Irinotecan|irinotecan|mesh-list
111226097|NCT02515734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111226098|NCT02515734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111226099|NCT02515734|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111226100|NCT02515734|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111226101|NCT02515734|Growth Substances|growth substances|mesh-ancestor
111226102|NCT02515734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111226103|NCT02515734|Growth Inhibitors|growth inhibitors|mesh-ancestor
111226104|NCT02515734|Antimetabolites|antimetabolites|mesh-ancestor
111226105|NCT02515734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111226106|NCT02515734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111226107|NCT02515734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111226108|NCT02515734|Immunologic Factors|immunologic factors|mesh-ancestor
111226109|NCT02515734|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111226110|NCT02515734|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111226111|NCT02515734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111226112|NCT02515734|Antidotes|antidotes|mesh-ancestor
111226113|NCT02515734|Protective Agents|protective agents|mesh-ancestor
111226114|NCT02515734|Vitamin B Complex|vitamin b complex|mesh-ancestor
111226115|NCT02515734|Vitamins|vitamins|mesh-ancestor
111226116|NCT02515734|Micronutrients|micronutrients|mesh-ancestor
111226117|NCT02512536|Botulinum Toxins|botulinum toxins|mesh-list
111226118|NCT02512536|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111226119|NCT02512536|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111226120|NCT02512536|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111226121|NCT02512536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111226122|NCT02512536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111226123|NCT02512536|Cholinergic Agents|cholinergic agents|mesh-ancestor
111226124|NCT02512536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111226125|NCT02512536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111226126|NCT02512536|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111226127|NCT02512536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111226128|NCT02506842|Leucovorin|leucovorin|mesh-list
111226129|NCT02506842|Folic Acid|folic acid|mesh-list
111226130|NCT02506842|Gemcitabine|gemcitabine|mesh-list
111226131|NCT02506842|Fluorouracil|fluorouracil|mesh-list
111226132|NCT02506842|Oxaliplatin|oxaliplatin|mesh-list
111226133|NCT02506842|Levoleucovorin|levoleucovorin|mesh-list
111226134|NCT02506842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111226135|NCT02506842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111226136|NCT02506842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111226137|NCT02506842|Antimetabolites|antimetabolites|mesh-ancestor
111226138|NCT02506842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111226139|NCT02506842|Immunologic Factors|immunologic factors|mesh-ancestor
111226140|NCT02506842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111226141|NCT02506842|Antidotes|antidotes|mesh-ancestor
111226142|NCT02506842|Protective Agents|protective agents|mesh-ancestor
111226143|NCT02506842|Vitamin B Complex|vitamin b complex|mesh-ancestor
111226144|NCT02506842|Vitamins|vitamins|mesh-ancestor
111226145|NCT02506842|Micronutrients|micronutrients|mesh-ancestor
111226146|NCT02506842|Hematinics|hematinics|mesh-ancestor
111226147|NCT02512614|Anti-Infective Agents|anti-infective agents|mesh-list
111226148|NCT02512614|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111226149|NCT03345498|Entecavir|entecavir|mesh-list
111226150|NCT03345498|Antiviral Agents|antiviral agents|mesh-ancestor
111226151|NCT03345498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111226152|NCT02506686|Meropenem|meropenem|mesh-list
111226153|NCT02506686|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111226154|NCT02506686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111226155|NCT04499742|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
111226156|NCT04499742|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111226157|NCT04499742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111226158|NCT02512380|Docetaxel|docetaxel|mesh-list
111226159|NCT02512380|Oxaliplatin|oxaliplatin|mesh-list
111226160|NCT02512380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111226161|NCT02512380|Tubulin Modulators|tubulin modulators|mesh-ancestor
111226162|NCT02512380|Antimitotic Agents|antimitotic agents|mesh-ancestor
111226163|NCT02512380|Mitosis Modulators|mitosis modulators|mesh-ancestor
111226164|NCT02512380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111226165|NCT04497792|Metformin|metformin|mesh-list
111226166|NCT04497792|Empagliflozin|empagliflozin|mesh-list
111226167|NCT04497792|Hypoglycemic Agents|hypoglycemic agents|mesh-list
111226168|NCT04497792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111226169|NCT04497792|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111226170|NCT04497792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111226171|NCT03344952|Botulinum Toxins|botulinum toxins|mesh-list
111226172|NCT03344952|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111226173|NCT03344952|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111226174|NCT03344952|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111226175|NCT03344952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111226176|NCT03344952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111226177|NCT03344952|Cholinergic Agents|cholinergic agents|mesh-ancestor
111226178|NCT03344952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111226179|NCT03344952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111226180|NCT03344952|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111226181|NCT03344952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111226182|NCT02515422|Ketamine|ketamine|mesh-list
111226183|NCT02515422|Bupivacaine|bupivacaine|mesh-list
111226184|NCT02515422|Anesthetics, Local|anesthetics, local|mesh-ancestor
111226185|NCT02515422|Anesthetics|anesthetics|mesh-ancestor
111226186|NCT02515422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111226187|NCT02515422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111226188|NCT02515422|Sensory System Agents|sensory system agents|mesh-ancestor
111226189|NCT02515422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111226190|NCT02515422|Analgesics|analgesics|mesh-ancestor
111226191|NCT02515422|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111226192|NCT02515422|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111226193|NCT02515422|Anesthetics, General|anesthetics, general|mesh-ancestor
111226194|NCT02515422|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111226195|NCT02515422|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111226196|NCT02515422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111226197|NCT02515422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111226198|NCT02506296|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
111226199|NCT02506296|Protease Inhibitors|protease inhibitors|mesh-ancestor
111226200|NCT02506296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111226201|NCT02506296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111226202|NCT02506296|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111226203|NCT02506296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111226204|NCT02506140|Aspirin|aspirin|mesh-list
111226205|NCT02506140|Clopidogrel|clopidogrel|mesh-list
111226206|NCT02506140|Ticagrelor|ticagrelor|mesh-list
111226207|NCT02506140|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111226208|NCT02506140|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111226209|NCT02506140|Analgesics|analgesics|mesh-ancestor
111226210|NCT02506140|Sensory System Agents|sensory system agents|mesh-ancestor
111226211|NCT02506140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111226212|NCT02506140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111226213|NCT02506140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111226214|NCT02506140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111226215|NCT02506140|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111226216|NCT02506140|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111226217|NCT02506140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111226218|NCT02506140|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111226219|NCT02506140|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111226220|NCT02506140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111226221|NCT02506140|Antipyretics|antipyretics|mesh-ancestor
111226222|NCT02506140|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111226223|NCT02506140|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111226224|NCT02506140|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111226225|NCT02506140|Purinergic Agents|purinergic agents|mesh-ancestor
111226226|NCT02506140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111226227|NCT02515188|Acetaminophen|acetaminophen|mesh-list
111226228|NCT02515188|Propacetamol|propacetamol|mesh-list
111226229|NCT02515188|Analgesics|analgesics|mesh-ancestor
111226230|NCT02515188|Sensory System Agents|sensory system agents|mesh-ancestor
111226231|NCT02515188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111226232|NCT02515188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111226233|NCT02515188|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111226234|NCT02515188|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111226235|NCT02515188|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111226236|NCT02515188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111226237|NCT02515188|Antipyretics|antipyretics|mesh-ancestor
111226238|NCT01696084|Cytarabine|cytarabine|mesh-list
111226239|NCT01696084|Daunorubicin|daunorubicin|mesh-list
111226240|NCT01696084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111226241|NCT01696084|Antimetabolites|antimetabolites|mesh-ancestor
111226242|NCT01696084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111226243|NCT01696084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111226244|NCT01696084|Antiviral Agents|antiviral agents|mesh-ancestor
111226245|NCT01696084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111226246|NCT01696084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111226247|NCT01696084|Immunologic Factors|immunologic factors|mesh-ancestor
111226248|NCT01696084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111226249|NCT01696084|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111226250|NCT01696084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111226251|NCT01696084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111226252|NCT01696084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111226253|NCT02228824|Nicotine|nicotine|mesh-list
111226254|NCT02228824|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111226255|NCT02228824|Autonomic Agents|autonomic agents|mesh-ancestor
111226256|NCT02228824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111226257|NCT02228824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111226258|NCT02228824|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111226259|NCT02228824|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111226260|NCT02228824|Cholinergic Agents|cholinergic agents|mesh-ancestor
111226261|NCT02228824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111226262|NCT02228824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111226263|NCT02511366|Caseins|caseins|mesh-list
111226264|NCT02511366|Chelating Agents|chelating agents|mesh-ancestor
111226265|NCT02511366|Sequestering Agents|sequestering agents|mesh-ancestor
111226266|NCT02511366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111226267|NCT02514954|Insulin Lispro|insulin lispro|mesh-list
111226268|NCT02514954|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111226269|NCT02514954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111226270|NCT04443036|Paclitaxel|paclitaxel|mesh-list
111226271|NCT04443036|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111226272|NCT04443036|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111226273|NCT04443036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110805841|NCT03557931|Ziprasidone|ziprasidone|mesh-list
111226274|NCT04443036|Tubulin Modulators|tubulin modulators|mesh-ancestor
111226275|NCT04443036|Antimitotic Agents|antimitotic agents|mesh-ancestor
111226276|NCT04443036|Mitosis Modulators|mitosis modulators|mesh-ancestor
111226277|NCT04443036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111226278|NCT01653418|Cytarabine|cytarabine|mesh-list
111226279|NCT01653418|Etoposide|etoposide|mesh-list
111226280|NCT01653418|Bortezomib|bortezomib|mesh-list
111226281|NCT01653418|Melphalan|melphalan|mesh-list
111226282|NCT01653418|Carmustine|carmustine|mesh-list
111226283|NCT01653418|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111226284|NCT01653418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111226285|NCT01653418|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111226286|NCT01653418|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111226287|NCT01653418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111226288|NCT01653418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111226289|NCT01653418|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111226290|NCT01653418|Antimetabolites|antimetabolites|mesh-ancestor
111226291|NCT01653418|Antiviral Agents|antiviral agents|mesh-ancestor
111226292|NCT01653418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111226293|NCT01653418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111226294|NCT01653418|Immunologic Factors|immunologic factors|mesh-ancestor
111226295|NCT01653418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111226296|NCT01653418|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111226297|NCT01653418|Alkylating Agents|alkylating agents|mesh-ancestor
111226298|NCT01653418|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111226299|NCT02514642|Clopidogrel|clopidogrel|mesh-list
111226300|NCT02514642|Ticagrelor|ticagrelor|mesh-list
111226301|NCT02514642|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111226302|NCT02514642|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111226303|NCT02514642|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111226304|NCT02514642|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111226305|NCT02514642|Purinergic Agents|purinergic agents|mesh-ancestor
111226306|NCT02514642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111226307|NCT02514642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111226308|NCT02514642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111226309|NCT02511210|Anesthetics|anesthetics|mesh-list
111226310|NCT02511210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111226311|NCT02511210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111226312|NCT02237950|Metronidazole|metronidazole|mesh-list
111226314|NCT02237950|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111226315|NCT02237950|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111226316|NCT02237950|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111226317|NCT02511054|Chloroquine|chloroquine|mesh-list
111226318|NCT02511054|Pyrimethamine|pyrimethamine|mesh-list
111226319|NCT02511054|Amebicides|amebicides|mesh-ancestor
111226320|NCT02511054|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111226321|NCT02511054|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111226322|NCT02511054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111226323|NCT02511054|Antimalarials|antimalarials|mesh-ancestor
111226324|NCT02511054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111226325|NCT02511054|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111226326|NCT02511054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111226327|NCT02511054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111226328|NCT04499118|Paclitaxel|paclitaxel|mesh-list
111226329|NCT04499118|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111226330|NCT04499118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111226331|NCT04499118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111226332|NCT04499118|Tubulin Modulators|tubulin modulators|mesh-ancestor
111226333|NCT04499118|Antimitotic Agents|antimitotic agents|mesh-ancestor
111226334|NCT04499118|Mitosis Modulators|mitosis modulators|mesh-ancestor
111226335|NCT04499118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111226336|NCT01612546|Camptothecin|camptothecin|mesh-list
111226337|NCT01612546|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111226338|NCT01612546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111226339|NCT01612546|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111226340|NCT01612546|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111226341|NCT01612546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111226342|NCT01612546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111226343|NCT04499898|Carvedilol|carvedilol|mesh-list
111226344|NCT04499898|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111226345|NCT04499898|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111226346|NCT04499898|Adrenergic Agents|adrenergic agents|mesh-ancestor
111226347|NCT04499898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111226348|NCT04499898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111226349|NCT04499898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111226350|NCT04499898|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111226351|NCT04499898|Antioxidants|antioxidants|mesh-ancestor
111226352|NCT04499898|Protective Agents|protective agents|mesh-ancestor
111226353|NCT04499898|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111226354|NCT04499898|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111226355|NCT04499898|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111226356|NCT04499898|Vasodilator Agents|vasodilator agents|mesh-ancestor
111226357|NCT04499898|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111226358|NCT04499898|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111226359|NCT02514330|Dihydrotachysterol|dihydrotachysterol|mesh-list
111226360|NCT02514330|Vitamins|vitamins|mesh-ancestor
111226361|NCT02514330|Micronutrients|micronutrients|mesh-ancestor
111226362|NCT02514330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111226363|NCT02514330|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111226364|NCT02510976|Prucalopride|prucalopride|mesh-list
111226365|NCT02510976|Laxatives|laxatives|mesh-ancestor
111226366|NCT02510976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111226367|NCT02510976|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
111226368|NCT02510976|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111226369|NCT02510976|Serotonin Agents|serotonin agents|mesh-ancestor
111226370|NCT02510976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111226371|NCT02510976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111226372|NCT02510976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111226373|NCT02505516|Metformin|metformin|mesh-list
111226374|NCT02505516|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111226375|NCT02505516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111226376|NCT02505360|Hyaluronic Acid|hyaluronic acid|mesh-list
111226377|NCT02505360|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111226378|NCT02505360|Immunologic Factors|immunologic factors|mesh-ancestor
111226379|NCT02505360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111226380|NCT02505360|Viscosupplements|viscosupplements|mesh-ancestor
111226381|NCT02505360|Protective Agents|protective agents|mesh-ancestor
111226382|NCT04499586|Irinotecan|irinotecan|mesh-list
111226383|NCT04499586|Raltitrexed|raltitrexed|mesh-list
111226384|NCT04499586|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111226385|NCT04499586|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110950800|NCT00747318|Fluticasone|fluticasone|mesh-list
111226386|NCT04499586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111226387|NCT04499586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111226388|NCT04499586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111226389|NCT04499586|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111226390|NCT04499586|Antimetabolites|antimetabolites|mesh-ancestor
111226391|NCT04499586|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111226392|NCT02505282|Vitamin K|vitamin k|mesh-list
111226393|NCT02505282|Vitamins|vitamins|mesh-ancestor
111226394|NCT02505282|Micronutrients|micronutrients|mesh-ancestor
111226395|NCT02505282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111226396|NCT02505282|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111226397|NCT02505282|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111226398|NCT02505282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111226399|NCT02505282|Hemostatics|hemostatics|mesh-ancestor
111226400|NCT02505282|Coagulants|coagulants|mesh-ancestor
111226401|NCT01816295|Methyltestosterone|methyltestosterone|mesh-list
111226402|NCT01816295|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111226403|NCT01816295|Testosterone|testosterone|mesh-list
111226404|NCT01816295|Testosterone undecanoate|testosterone undecanoate|mesh-list
111226405|NCT01816295|Testosterone enanthate|testosterone enanthate|mesh-list
111226406|NCT01816295|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
111226407|NCT01816295|Androgens|androgens|mesh-ancestor
111226408|NCT01816295|Hormones|hormones|mesh-ancestor
111226409|NCT01816295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111226410|NCT01816295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111226411|NCT01816295|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111226412|NCT01816295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111226413|NCT01816295|Anabolic Agents|anabolic agents|mesh-ancestor
111226414|NCT02514018|Vaccines|vaccines|mesh-list
111226415|NCT02514018|Immunologic Factors|immunologic factors|mesh-ancestor
111226416|NCT02514018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111226417|NCT02513862|Heparin|heparin|mesh-list
111226418|NCT02513862|Protamines|protamines|mesh-list
111226419|NCT02513862|Anticoagulants|anticoagulants|mesh-ancestor
111226420|NCT02513862|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111226421|NCT02513862|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111226422|NCT02513862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111226423|NCT02513862|Heparin Antagonists|heparin antagonists|mesh-ancestor
111226424|NCT02513862|Coagulants|coagulants|mesh-ancestor
111226425|NCT02510586|Sevoflurane|sevoflurane|mesh-list
111226426|NCT02510586|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111226427|NCT02510586|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111226428|NCT02510586|Anesthetics, General|anesthetics, general|mesh-ancestor
111226429|NCT02510586|Anesthetics|anesthetics|mesh-ancestor
111226430|NCT02510586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111226431|NCT02510586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111226432|NCT01610297|Deferasirox|deferasirox|mesh-list
111226433|NCT01610297|Iron Chelating Agents|iron chelating agents|mesh-ancestor
111226434|NCT01610297|Chelating Agents|chelating agents|mesh-ancestor
111226435|NCT01610297|Sequestering Agents|sequestering agents|mesh-ancestor
111226436|NCT01610297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111226437|NCT01660672|Levetiracetam|levetiracetam|mesh-list
111226438|NCT01660672|Anticonvulsants|anticonvulsants|mesh-ancestor
111226439|NCT01660672|Nootropic Agents|nootropic agents|mesh-ancestor
111226440|NCT02505048|Rucaparib|rucaparib|mesh-list
111226441|NCT02505048|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111226442|NCT02505048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111226443|NCT02505048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111226444|NCT02505048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111226445|NCT01793051|Minocycline|minocycline|mesh-list
111226446|NCT01793051|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111226447|NCT01793051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111226448|NCT01792115|Vitamins|vitamins|mesh-list
111226449|NCT01792115|Vitamin E|vitamin e|mesh-list
111226450|NCT01792115|Tocopherols|tocopherols|mesh-list
111226451|NCT01792115|Tocotrienols|tocotrienols|mesh-list
111226452|NCT01792115|alpha-Tocopherol|alpha-tocopherol|mesh-list
111226453|NCT01792115|Micronutrients|micronutrients|mesh-ancestor
111226454|NCT01792115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111226455|NCT01792115|Antioxidants|antioxidants|mesh-ancestor
111226456|NCT01792115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111226457|NCT01792115|Protective Agents|protective agents|mesh-ancestor
111226458|NCT01791803|Nicotine|nicotine|mesh-list
111226459|NCT01791803|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110950873|NCT01370499|Serotonin Agents|serotonin agents|mesh-ancestor
111226460|NCT01791803|Autonomic Agents|autonomic agents|mesh-ancestor
111226461|NCT01791803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111226462|NCT01791803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111226463|NCT01791803|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111226464|NCT01791803|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111226465|NCT01791803|Cholinergic Agents|cholinergic agents|mesh-ancestor
111226466|NCT01791803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111226467|NCT01791803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111226468|NCT01662856|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
111226469|NCT01662856|Hemostatics|hemostatics|mesh-ancestor
111226470|NCT01662856|Coagulants|coagulants|mesh-ancestor
111226471|NCT04499976|Misoprostol|misoprostol|mesh-list
111226472|NCT04499976|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111226473|NCT04499976|Abortifacient Agents|abortifacient agents|mesh-ancestor
111226474|NCT04499976|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111226475|NCT04499976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111226476|NCT04499976|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111226477|NCT04499976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111226478|NCT04499976|Oxytocics|oxytocics|mesh-ancestor
111226479|NCT01791413|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
111226480|NCT01791413|Medroxyprogesterone|medroxyprogesterone|mesh-list
111226481|NCT01791413|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111226482|NCT01791413|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111226483|NCT01791413|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111226484|NCT01791413|Contraceptive Agents|contraceptive agents|mesh-ancestor
111226485|NCT01791413|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111226486|NCT01791413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111226487|NCT01791413|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111226488|NCT01791413|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111226489|NCT01791413|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
111226490|NCT01791413|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111226491|NCT01791413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111226492|NCT02509806|Apatinib|apatinib|mesh-list
111226493|NCT02509806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111226494|NCT02509806|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111226495|NCT02509806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111226496|NCT02509806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111226497|NCT02509728|Choline|choline|mesh-list
111226498|NCT02509728|Lipotropic Agents|lipotropic agents|mesh-ancestor
111226499|NCT02509728|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111226500|NCT02509728|Antimetabolites|antimetabolites|mesh-ancestor
111226501|NCT02509728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111226502|NCT02509728|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111226503|NCT02509728|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111226504|NCT02509728|Nootropic Agents|nootropic agents|mesh-ancestor
111226505|NCT02501616|Metformin|metformin|mesh-list
111226506|NCT02501616|Dapagliflozin|dapagliflozin|mesh-list
111226507|NCT02501616|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111226508|NCT02501616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111226509|NCT02501616|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111226510|NCT02501616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111226511|NCT01788215|Doxycycline|doxycycline|mesh-list
111226512|NCT01788215|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111226513|NCT01788215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111226514|NCT01788215|Antimalarials|antimalarials|mesh-ancestor
111226515|NCT01788215|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111226516|NCT01788215|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111226517|NCT01812707|Atorvastatin|atorvastatin|mesh-list
111226518|NCT01812707|Alirocumab|alirocumab|mesh-list
111226519|NCT01812707|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111226520|NCT01812707|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111226521|NCT01812707|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111226522|NCT01812707|Antimetabolites|antimetabolites|mesh-ancestor
111226523|NCT01812707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111226524|NCT01812707|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111226525|NCT01812707|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111226526|NCT01812707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111226527|NCT01812707|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
111226528|NCT01812707|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111226529|NCT01812707|Protease Inhibitors|protease inhibitors|mesh-ancestor
111226530|NCT01812707|Immunologic Factors|immunologic factors|mesh-ancestor
111226531|NCT01812707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111226532|NCT01787279|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
111226533|NCT01787279|Antiviral Agents|antiviral agents|mesh-ancestor
111226534|NCT01787279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111226535|NCT02728206|Sofosbuvir|sofosbuvir|mesh-list
111226536|NCT02728206|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
110950949|NCT00687882|Anticoagulants|anticoagulants|mesh-list
111226537|NCT02728206|Velpatasvir|velpatasvir|mesh-list
111226538|NCT02728206|Antiviral Agents|antiviral agents|mesh-ancestor
111226539|NCT02728206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111226540|NCT01811225|Progesterone|progesterone|mesh-list
111226541|NCT01811225|Progestins|progestins|mesh-ancestor
111226542|NCT01811225|Hormones|hormones|mesh-ancestor
111226543|NCT01811225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111226544|NCT01811225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111226545|NCT01809197|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111226546|NCT02508870|Azacitidine|azacitidine|mesh-list
111226547|NCT02508870|Atezolizumab|atezolizumab|mesh-list
111226548|NCT02508870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111226549|NCT02508870|Antimetabolites|antimetabolites|mesh-ancestor
111226550|NCT02508870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111226551|NCT02508870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111226552|NCT02508870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111226553|NCT02508870|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111226554|NCT02508870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111226555|NCT01786109|Dronabinol|dronabinol|mesh-list
111226556|NCT01786109|Hallucinogens|hallucinogens|mesh-ancestor
111226557|NCT01786109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111226558|NCT01786109|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111226559|NCT01786109|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111226560|NCT01786109|Analgesics|analgesics|mesh-ancestor
111226561|NCT01786109|Sensory System Agents|sensory system agents|mesh-ancestor
111226562|NCT01786109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111226563|NCT01786109|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
111226564|NCT01786109|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
111226565|NCT01786109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111226566|NCT01786109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111226567|NCT01786109|Hormones|hormones|mesh-ancestor
111226568|NCT01786109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111226569|NCT02509104|Tamsulosin|tamsulosin|mesh-list
111226570|NCT02509104|Dutasteride|dutasteride|mesh-list
111226571|NCT02509104|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111226572|NCT02509104|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111226573|NCT02509104|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111226574|NCT02509104|Adrenergic Agents|adrenergic agents|mesh-ancestor
111226575|NCT02509104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111226576|NCT02509104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111226577|NCT02509104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111226578|NCT02509104|Urological Agents|urological agents|mesh-ancestor
111226579|NCT02509104|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
111226580|NCT02509104|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111226581|NCT02509104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111226582|NCT02509104|Hormone Antagonists|hormone antagonists|mesh-ancestor
111226583|NCT02509104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111226584|NCT02500680|Vaccines|vaccines|mesh-list
111226585|NCT02500680|Immunologic Factors|immunologic factors|mesh-ancestor
111226586|NCT02500680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111226587|NCT02500446|Dolutegravir|dolutegravir|mesh-list
111226588|NCT02500446|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111226589|NCT02500446|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111226590|NCT02500446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111226591|NCT02500446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111226592|NCT02500446|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111226593|NCT02500446|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111226594|NCT02500446|Antiviral Agents|antiviral agents|mesh-ancestor
111226595|NCT02500446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111226596|NCT02500524|Permethrin|permethrin|mesh-list
111226597|NCT02500524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111226598|NCT02500524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111226599|NCT02508402|Dexamethasone|dexamethasone|mesh-list
111226600|NCT02508402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111226601|NCT02508402|Antiemetics|antiemetics|mesh-ancestor
111226602|NCT02508402|Autonomic Agents|autonomic agents|mesh-ancestor
111226603|NCT02508402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111226604|NCT02508402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111226605|NCT02508402|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111226606|NCT02508402|Glucocorticoids|glucocorticoids|mesh-ancestor
111226607|NCT02508402|Hormones|hormones|mesh-ancestor
111226608|NCT02508402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111226609|NCT02508402|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111226610|NCT02508402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111226611|NCT02500212|Tacrolimus|tacrolimus|mesh-list
110951026|NCT02280876|Antiviral Agents|antiviral agents|mesh-ancestor
111226612|NCT02500212|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111226613|NCT02500212|Immunologic Factors|immunologic factors|mesh-ancestor
111226614|NCT02500212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111226615|NCT02500212|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111226616|NCT02500212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111226617|NCT02500212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111226618|NCT02508168|Metformin|metformin|mesh-list
111226619|NCT02508168|Alogliptin|alogliptin|mesh-list
111226620|NCT02508168|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111226621|NCT02508168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111226622|NCT02508168|Incretins|incretins|mesh-ancestor
111226623|NCT02508168|Hormones|hormones|mesh-ancestor
111226624|NCT02508168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111226625|NCT02508168|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111226626|NCT02508168|Protease Inhibitors|protease inhibitors|mesh-ancestor
111226627|NCT02508168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111226628|NCT02508168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111226629|NCT02503176|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111226630|NCT02503176|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111226631|NCT02508246|Cisplatin|cisplatin|mesh-list
111226632|NCT02508246|Docetaxel|docetaxel|mesh-list
111226633|NCT02508246|Adavosertib|adavosertib|mesh-list
111226634|NCT02508246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111226635|NCT02508246|Tubulin Modulators|tubulin modulators|mesh-ancestor
111226636|NCT02508246|Antimitotic Agents|antimitotic agents|mesh-ancestor
111226637|NCT02508246|Mitosis Modulators|mitosis modulators|mesh-ancestor
111226638|NCT02508246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111226639|NCT02508246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111226640|NCT01617148|Aflibercept|aflibercept|mesh-list
111226641|NCT01617148|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111226642|NCT01617148|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111226643|NCT01617148|Growth Substances|growth substances|mesh-ancestor
111226644|NCT01617148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111226645|NCT01617148|Growth Inhibitors|growth inhibitors|mesh-ancestor
111226646|NCT01617148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111226647|NCT02499978|Dolutegravir|dolutegravir|mesh-list
111226648|NCT02499978|Darunavir|darunavir|mesh-list
111226649|NCT02499978|Cobicistat|cobicistat|mesh-list
111226650|NCT02499978|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
111226651|NCT02499978|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111226652|NCT02499978|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111226653|NCT02499978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111226654|NCT02499978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111226655|NCT02499978|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111226656|NCT02499978|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111226657|NCT02499978|Antiviral Agents|antiviral agents|mesh-ancestor
111226658|NCT02499978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111226659|NCT02499978|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111226660|NCT02499978|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111226661|NCT02499978|Protease Inhibitors|protease inhibitors|mesh-ancestor
111226662|NCT02499978|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111226663|NCT02499978|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111226664|NCT01620190|Paclitaxel|paclitaxel|mesh-list
111226665|NCT01620190|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111226666|NCT01620190|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111226667|NCT01620190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111226668|NCT01620190|Tubulin Modulators|tubulin modulators|mesh-ancestor
111226669|NCT01620190|Antimitotic Agents|antimitotic agents|mesh-ancestor
111226670|NCT01620190|Mitosis Modulators|mitosis modulators|mesh-ancestor
111226671|NCT01620190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111226672|NCT04498884|Insulin|insulin|mesh-list
111226673|NCT04498884|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111226674|NCT04498884|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111226675|NCT04498884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111226676|NCT01621672|Lenalidomide|lenalidomide|mesh-list
111226677|NCT01621672|Immunologic Factors|immunologic factors|mesh-ancestor
111226678|NCT01621672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111226679|NCT01621672|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111226680|NCT01621672|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111226681|NCT01621672|Growth Substances|growth substances|mesh-ancestor
111226682|NCT01621672|Growth Inhibitors|growth inhibitors|mesh-ancestor
111226683|NCT01621672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111226684|NCT03344328|Bortezomib|bortezomib|mesh-list
111226685|NCT03344328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111226686|NCT02499822|Ramipril|ramipril|mesh-list
111226687|NCT02499822|Nifedipine|nifedipine|mesh-list
111226688|NCT02499822|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
111226689|NCT02499822|Protease Inhibitors|protease inhibitors|mesh-ancestor
111226690|NCT02499822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111226691|NCT02499822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111226692|NCT02499822|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111226693|NCT02499822|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111226694|NCT02499822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111226695|NCT02499822|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111226696|NCT02499822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111226697|NCT02499822|Vasodilator Agents|vasodilator agents|mesh-ancestor
111226698|NCT02499822|Tocolytic Agents|tocolytic agents|mesh-ancestor
111226699|NCT02499822|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111226700|NCT01663012|Etirinotecan pegol|etirinotecan pegol|mesh-list
111226701|NCT01663012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111226702|NCT01663012|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111226703|NCT01663012|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111226704|NCT01663012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111226705|NCT01663012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111226706|NCT03343548|Magnesium Sulfate|magnesium sulfate|mesh-list
111226707|NCT03343548|Analgesics|analgesics|mesh-ancestor
111226708|NCT03343548|Sensory System Agents|sensory system agents|mesh-ancestor
111226709|NCT03343548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111226710|NCT03343548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111226711|NCT03343548|Anesthetics|anesthetics|mesh-ancestor
111226712|NCT03343548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111226713|NCT03343548|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111226714|NCT03343548|Anticonvulsants|anticonvulsants|mesh-ancestor
111226715|NCT03343548|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111226716|NCT03343548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111226717|NCT03343548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111226718|NCT03343548|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111226719|NCT03343548|Tocolytic Agents|tocolytic agents|mesh-ancestor
111226720|NCT03343548|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111226721|NCT02507934|Hyaluronic Acid|hyaluronic acid|mesh-list
111226722|NCT02507934|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111226723|NCT02507934|Immunologic Factors|immunologic factors|mesh-ancestor
111226724|NCT02507934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111226725|NCT02507934|Viscosupplements|viscosupplements|mesh-ancestor
111226726|NCT02507934|Protective Agents|protective agents|mesh-ancestor
111226727|NCT01622296|Lidocaine|lidocaine|mesh-list
111226728|NCT01622296|Epinephrine|epinephrine|mesh-list
111226729|NCT01622296|Anesthetics, Local|anesthetics, local|mesh-list
111226730|NCT01622296|Anesthetics|anesthetics|mesh-list
111226731|NCT01622296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111226732|NCT01622296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111226733|NCT01622296|Sensory System Agents|sensory system agents|mesh-ancestor
111226734|NCT01622296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111226735|NCT01622296|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111226736|NCT01622296|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111226737|NCT01622296|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111226738|NCT01622296|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111226739|NCT01622296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111226740|NCT01622296|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111226741|NCT01622296|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111226742|NCT01622296|Adrenergic Agents|adrenergic agents|mesh-ancestor
111226743|NCT01622296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111226744|NCT01622296|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111226745|NCT01622296|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111226746|NCT01622296|Autonomic Agents|autonomic agents|mesh-ancestor
111226747|NCT01622296|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111226748|NCT01622296|Respiratory System Agents|respiratory system agents|mesh-ancestor
111226749|NCT01622296|Mydriatics|mydriatics|mesh-ancestor
111226750|NCT01622296|Sympathomimetics|sympathomimetics|mesh-ancestor
111226751|NCT01622296|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111226752|NCT02728830|Pembrolizumab|pembrolizumab|mesh-list
111226753|NCT02728830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111226754|NCT02728830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111226755|NCT02728830|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111226756|NCT02728830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111226757|NCT01705288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
111226758|NCT01705288|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
111226759|NCT01705288|Morphine|morphine|mesh-list
111226760|NCT01705288|Narcotics|narcotics|mesh-list
111226761|NCT01705288|Anesthetics|anesthetics|mesh-list
111226762|NCT01705288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111226763|NCT01705288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111226764|NCT01705288|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111226765|NCT01705288|Analgesics|analgesics|mesh-ancestor
111226766|NCT01705288|Sensory System Agents|sensory system agents|mesh-ancestor
111226767|NCT01705288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111226768|NCT01705288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111226769|NCT01705288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111226770|NCT03343002|Fentanyl|fentanyl|mesh-list
111226771|NCT03343002|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111226772|NCT03343002|Narcotics|narcotics|mesh-ancestor
111226773|NCT03343002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111226774|NCT03343002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111226775|NCT03343002|Analgesics|analgesics|mesh-ancestor
111226776|NCT03343002|Sensory System Agents|sensory system agents|mesh-ancestor
111226777|NCT03343002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111226778|NCT03343002|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111226779|NCT03343002|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111226780|NCT03343002|Anesthetics, General|anesthetics, general|mesh-ancestor
111226781|NCT03343002|Anesthetics|anesthetics|mesh-ancestor
111226782|NCT03120936|Tenofovir|tenofovir|mesh-list
111226783|NCT03120936|Emtricitabine|emtricitabine|mesh-list
111226784|NCT03120936|Antiviral Agents|antiviral agents|mesh-ancestor
111226785|NCT03120936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111226786|NCT03120936|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111226787|NCT03120936|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111226788|NCT03120936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111226789|NCT03120936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111226790|NCT03120936|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111226791|NCT03120936|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111226792|NCT02234752|Memantine|memantine|mesh-list
111226793|NCT02234752|Galantamine|galantamine|mesh-list
111226794|NCT02234752|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111226795|NCT02234752|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111226796|NCT02234752|Dopamine Agents|dopamine agents|mesh-ancestor
111226797|NCT02234752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110806370|NCT02172352|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111226798|NCT02234752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111226799|NCT02234752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111226800|NCT02234752|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111226801|NCT02234752|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111226802|NCT02234752|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111226803|NCT02234752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111226804|NCT02234752|Cholinergic Agents|cholinergic agents|mesh-ancestor
111226805|NCT02234752|Parasympathomimetics|parasympathomimetics|mesh-ancestor
111226806|NCT02234752|Autonomic Agents|autonomic agents|mesh-ancestor
111226807|NCT02234752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111226808|NCT02234752|Nootropic Agents|nootropic agents|mesh-ancestor
111226809|NCT01665508|Nebivolol|nebivolol|mesh-list
111226810|NCT01665508|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111226811|NCT01665508|Vasodilator Agents|vasodilator agents|mesh-ancestor
111226812|NCT01665508|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
111226813|NCT01665508|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111226814|NCT01665508|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111226815|NCT01665508|Adrenergic Agents|adrenergic agents|mesh-ancestor
111226816|NCT01665508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111226817|NCT01665508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111226818|NCT01665508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111226819|NCT03344094|Interferons|interferons|mesh-list
111226820|NCT03344094|Interferon-beta|interferon-beta|mesh-list
111226821|NCT03344094|Ocrelizumab|ocrelizumab|mesh-list
111226822|NCT03344094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111226823|NCT03344094|Antiviral Agents|antiviral agents|mesh-ancestor
111226824|NCT03344094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111226825|NCT03344094|Immunologic Factors|immunologic factors|mesh-ancestor
111226826|NCT03344094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111226827|NCT02498496|Magnesium Sulfate|magnesium sulfate|mesh-list
111226828|NCT02498496|Analgesics|analgesics|mesh-ancestor
111226829|NCT02498496|Sensory System Agents|sensory system agents|mesh-ancestor
111226830|NCT02498496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111226831|NCT02498496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111226832|NCT02498496|Anesthetics|anesthetics|mesh-ancestor
111226833|NCT02498496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111226834|NCT02498496|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111226835|NCT02498496|Anticonvulsants|anticonvulsants|mesh-ancestor
111226836|NCT02498496|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111226837|NCT02498496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111226838|NCT02498496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111226839|NCT02498496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111226840|NCT02498496|Tocolytic Agents|tocolytic agents|mesh-ancestor
111226841|NCT02498496|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111226842|NCT02502708|Cyclophosphamide|cyclophosphamide|mesh-list
111226843|NCT02502708|Temozolomide|temozolomide|mesh-list
111226844|NCT02502708|Etoposide|etoposide|mesh-list
111226845|NCT02502708|Tryptophan|tryptophan|mesh-list
111226846|NCT02502708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111226847|NCT02502708|Immunologic Factors|immunologic factors|mesh-ancestor
111226848|NCT02502708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111226849|NCT02502708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111226850|NCT02502708|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111226851|NCT02502708|Alkylating Agents|alkylating agents|mesh-ancestor
111226852|NCT02502708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111226853|NCT02502708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111226854|NCT02502708|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111226855|NCT02502708|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111226856|NCT02502708|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111226857|NCT02502708|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111226858|NCT02502708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111226859|NCT02502708|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111226860|NCT02502708|Antidepressive Agents|antidepressive agents|mesh-ancestor
111226861|NCT02502708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111226862|NCT01666210|Dexamethasone|dexamethasone|mesh-list
111226863|NCT01666210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111226864|NCT01666210|Antiemetics|antiemetics|mesh-ancestor
111226865|NCT01666210|Autonomic Agents|autonomic agents|mesh-ancestor
111226866|NCT01666210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111226867|NCT01666210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111226868|NCT01666210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111226869|NCT01666210|Glucocorticoids|glucocorticoids|mesh-ancestor
111226870|NCT01666210|Hormones|hormones|mesh-ancestor
111320771|NCT02285283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111226871|NCT01666210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111226872|NCT01666210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111226873|NCT01666210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111226874|NCT01666912|Contraceptive Agents|contraceptive agents|mesh-list
111226875|NCT01666912|Etonogestrel|etonogestrel|mesh-list
111226876|NCT01666912|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111226877|NCT01666912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111226878|NCT01666912|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111226879|NCT01666912|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111226880|NCT03341988|Ritonavir|ritonavir|mesh-list
111226881|NCT03341988|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111226882|NCT03341988|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111226883|NCT03341988|Protease Inhibitors|protease inhibitors|mesh-ancestor
111226884|NCT03341988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111226885|NCT03341988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111226886|NCT03341988|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111226887|NCT03341988|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111226888|NCT03341988|Antiviral Agents|antiviral agents|mesh-ancestor
111226889|NCT03341988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111226890|NCT03341988|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111226891|NCT03341988|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111226892|NCT02501850|Metformin|metformin|mesh-list
111226893|NCT02501850|Liraglutide|liraglutide|mesh-list
111226894|NCT02501850|Exenatide|exenatide|mesh-list
111226895|NCT02501850|Lixisenatide|lixisenatide|mesh-list
111226896|NCT02501850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111226897|NCT02501850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111226898|NCT02501850|Incretins|incretins|mesh-ancestor
111226899|NCT02501850|Hormones|hormones|mesh-ancestor
111226900|NCT02501850|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111226901|NCT02501850|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111226902|NCT01709032|Deferasirox|deferasirox|mesh-list
111226903|NCT01709032|Deferiprone|deferiprone|mesh-list
111226904|NCT01709032|Iron Chelating Agents|iron chelating agents|mesh-ancestor
111226905|NCT01709032|Chelating Agents|chelating agents|mesh-ancestor
111226906|NCT01709032|Sequestering Agents|sequestering agents|mesh-ancestor
111226907|NCT01709032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111226908|NCT02496078|Asunaprevir|asunaprevir|mesh-list
111226909|NCT02496078|Protease Inhibitors|protease inhibitors|mesh-ancestor
111226910|NCT02496078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111226911|NCT02496078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111226912|NCT02495922|Dexamethasone|dexamethasone|mesh-list
111226913|NCT02495922|Lenalidomide|lenalidomide|mesh-list
111226914|NCT02495922|Bortezomib|bortezomib|mesh-list
111226915|NCT02495922|Elotuzumab|elotuzumab|mesh-list
111226916|NCT02495922|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111226917|NCT02495922|Antiemetics|antiemetics|mesh-ancestor
111226918|NCT02495922|Autonomic Agents|autonomic agents|mesh-ancestor
111226919|NCT02495922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111226920|NCT02495922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111226921|NCT02495922|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111226922|NCT02495922|Glucocorticoids|glucocorticoids|mesh-ancestor
111226923|NCT02495922|Hormones|hormones|mesh-ancestor
111226924|NCT02495922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111226925|NCT02495922|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111226926|NCT02495922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111226927|NCT02495922|Immunologic Factors|immunologic factors|mesh-ancestor
111226928|NCT02495922|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111226929|NCT02495922|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111226930|NCT02495922|Growth Substances|growth substances|mesh-ancestor
111226931|NCT02495922|Growth Inhibitors|growth inhibitors|mesh-ancestor
111226932|NCT01709422|Midazolam|midazolam|mesh-list
111226933|NCT01709422|Meperidine|meperidine|mesh-list
111226934|NCT01709422|Propofol|propofol|mesh-list
111226935|NCT01709422|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111226936|NCT01709422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111226937|NCT01709422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111226938|NCT01709422|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111226939|NCT01709422|Anesthetics, General|anesthetics, general|mesh-ancestor
111226940|NCT01709422|Anesthetics|anesthetics|mesh-ancestor
111226941|NCT01709422|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111226942|NCT01709422|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111226943|NCT01709422|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111226944|NCT01709422|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111226945|NCT01709422|GABA Modulators|gaba modulators|mesh-ancestor
111226946|NCT01709422|GABA Agents|gaba agents|mesh-ancestor
111226947|NCT01709422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111226948|NCT01709422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111226949|NCT01709422|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111226950|NCT01709422|Narcotics|narcotics|mesh-ancestor
111226951|NCT01709422|Analgesics|analgesics|mesh-ancestor
111226952|NCT01709422|Sensory System Agents|sensory system agents|mesh-ancestor
111226953|NCT01709422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111226954|NCT01669642|Ketamine|ketamine|mesh-list
111226955|NCT01669642|Analgesics|analgesics|mesh-ancestor
111226956|NCT01669642|Sensory System Agents|sensory system agents|mesh-ancestor
111226957|NCT01669642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111226958|NCT01669642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111226959|NCT01669642|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111226960|NCT01669642|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111226961|NCT01669642|Anesthetics, General|anesthetics, general|mesh-ancestor
111226962|NCT01669642|Anesthetics|anesthetics|mesh-ancestor
111226963|NCT01669642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111226964|NCT01669642|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111226965|NCT01669642|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111226966|NCT01669642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111226967|NCT01669642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111226968|NCT01669720|Aflibercept|aflibercept|mesh-list
111226969|NCT01669720|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111226970|NCT01669720|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111226971|NCT01669720|Growth Substances|growth substances|mesh-ancestor
111226972|NCT01669720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111226973|NCT01669720|Growth Inhibitors|growth inhibitors|mesh-ancestor
111226974|NCT01669720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111226975|NCT01670110|Pasireotide|pasireotide|mesh-list
111226976|NCT01670110|Hormones|hormones|mesh-ancestor
111226977|NCT01670110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111226978|NCT01670110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111226979|NCT02245516|Loteprednol Etabonate|loteprednol etabonate|mesh-list
111226980|NCT02245516|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111226981|NCT01677286|Doxycycline|doxycycline|mesh-list
111226982|NCT01677286|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111226983|NCT01677286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111226984|NCT01677286|Antimalarials|antimalarials|mesh-ancestor
111226985|NCT01677286|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111226986|NCT01677286|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111226987|NCT04498260|Triamcinolone|triamcinolone|mesh-list
111226988|NCT04498260|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
111226989|NCT04498260|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
111226990|NCT04498260|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
111226991|NCT04498260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110951395|NCT02783508|Meperidine|meperidine|mesh-list
111226992|NCT04498260|Glucocorticoids|glucocorticoids|mesh-ancestor
111226993|NCT04498260|Hormones|hormones|mesh-ancestor
111226994|NCT04498260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111226995|NCT04498260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111226996|NCT04498260|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111226997|NCT04498260|Immunologic Factors|immunologic factors|mesh-ancestor
111226998|NCT04498260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111226999|NCT04498260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111227000|NCT01680172|Ketamine|ketamine|mesh-list
111227001|NCT01680172|Analgesics|analgesics|mesh-ancestor
111227002|NCT01680172|Sensory System Agents|sensory system agents|mesh-ancestor
111227003|NCT01680172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111227004|NCT01680172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111227005|NCT01680172|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111227006|NCT01680172|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111227007|NCT01680172|Anesthetics, General|anesthetics, general|mesh-ancestor
111227008|NCT01680172|Anesthetics|anesthetics|mesh-ancestor
111227009|NCT01680172|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111227010|NCT01680172|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111227011|NCT01680172|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111227012|NCT01680172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111227013|NCT01680172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111227014|NCT02235064|Sertraline|sertraline|mesh-list
111227015|NCT02235064|Antidepressive Agents|antidepressive agents|mesh-ancestor
111227016|NCT02235064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111227017|NCT02235064|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111227018|NCT02235064|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111227019|NCT02235064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111227020|NCT02235064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111227021|NCT02235064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111227022|NCT02235064|Serotonin Agents|serotonin agents|mesh-ancestor
111227023|NCT02235064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111227024|NCT05118490|Isoniazid|isoniazid|mesh-list
111227025|NCT05118490|Rifapentine|rifapentine|mesh-list
111227026|NCT05118490|Rifampin|rifampin|mesh-list
111227027|NCT05118490|Antitubercular Agents|antitubercular agents|mesh-ancestor
111227028|NCT05118490|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111227029|NCT05118490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111227030|NCT05118490|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
111227031|NCT05118490|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111227032|NCT05118490|Antimetabolites|antimetabolites|mesh-ancestor
111227033|NCT05118490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111227034|NCT05118490|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111227035|NCT05118490|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111227036|NCT05118490|Leprostatic Agents|leprostatic agents|mesh-ancestor
111227037|NCT05118490|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111227038|NCT05118490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111227039|NCT05118490|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111227040|NCT05118490|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111227041|NCT05118490|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
111227042|NCT05118490|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
111227043|NCT05118490|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
111227044|NCT05118490|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111227045|NCT01681030|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
111227046|NCT01681030|Hemostatics|hemostatics|mesh-ancestor
111227047|NCT01681030|Coagulants|coagulants|mesh-ancestor
111227048|NCT02249416|Ritonavir|ritonavir|mesh-list
111227049|NCT02249416|Zidovudine|zidovudine|mesh-list
111227050|NCT02249416|Tipranavir|tipranavir|mesh-list
111227051|NCT02249416|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111227052|NCT02249416|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111227053|NCT02249416|Protease Inhibitors|protease inhibitors|mesh-ancestor
111227054|NCT02249416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111227055|NCT02249416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111227056|NCT02249416|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111227057|NCT02249416|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111227058|NCT02249416|Antiviral Agents|antiviral agents|mesh-ancestor
111227059|NCT02249416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111227060|NCT02249416|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111227061|NCT02249416|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111227062|NCT02249416|Antimetabolites|antimetabolites|mesh-ancestor
111227063|NCT02249416|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111227064|NCT02249416|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111227065|NCT01685242|Cetirizine|cetirizine|mesh-list
111227066|NCT01685242|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111227067|NCT01685242|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
111227068|NCT01685242|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111227069|NCT01685242|Histamine Antagonists|histamine antagonists|mesh-ancestor
111227070|NCT01685242|Histamine Agents|histamine agents|mesh-ancestor
111227071|NCT01685242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111227072|NCT01685242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111227073|NCT01685242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111227074|NCT00708162|Raltegravir Potassium|raltegravir potassium|mesh-list
111227075|NCT00708162|Elvitegravir|elvitegravir|mesh-list
111227076|NCT00708162|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111227077|NCT00708162|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111227078|NCT00708162|Antiviral Agents|antiviral agents|mesh-ancestor
111227079|NCT00708162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111227080|NCT00708162|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111227081|NCT00708162|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111227082|NCT00708162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111227083|NCT00708162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111227084|NCT04930042|Ustekinumab|ustekinumab|mesh-list
111227085|NCT04930042|Dermatologic Agents|dermatologic agents|mesh-ancestor
111227086|NCT04898920|Dexamethasone|dexamethasone|mesh-list
111227087|NCT04898920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111227088|NCT04898920|Antiemetics|antiemetics|mesh-ancestor
111227089|NCT04898920|Autonomic Agents|autonomic agents|mesh-ancestor
111227090|NCT04898920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111227091|NCT04898920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111227092|NCT04898920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111227093|NCT04898920|Glucocorticoids|glucocorticoids|mesh-ancestor
111227094|NCT04898920|Hormones|hormones|mesh-ancestor
111227095|NCT04898920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111227096|NCT04898920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111227097|NCT04898920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111227098|NCT02249884|Carbamide Peroxide|carbamide peroxide|mesh-list
111227099|NCT02249884|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111227100|NCT02249884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111227101|NCT01686646|Acetaminophen|acetaminophen|mesh-list
111227102|NCT01686646|Caffeine|caffeine|mesh-list
111227103|NCT01686646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111227104|NCT01686646|Analgesics|analgesics|mesh-ancestor
111227105|NCT01686646|Sensory System Agents|sensory system agents|mesh-ancestor
111227106|NCT01686646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111227107|NCT01686646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111227108|NCT01686646|Antipyretics|antipyretics|mesh-ancestor
111227109|NCT01686646|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111227110|NCT01686646|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111227111|NCT01686646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111227112|NCT01686646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111227113|NCT01686646|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
111227114|NCT01686646|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111227115|NCT01686646|Purinergic Agents|purinergic agents|mesh-ancestor
111227116|NCT01686646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111227117|NCT02495688|Anesthetics|anesthetics|mesh-list
111227118|NCT02495688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111227119|NCT02495688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111227120|NCT01688596|Bupivacaine|bupivacaine|mesh-list
111227121|NCT01688596|Anesthetics, Local|anesthetics, local|mesh-ancestor
111227122|NCT01688596|Anesthetics|anesthetics|mesh-ancestor
111227123|NCT01688596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111227124|NCT01688596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111227125|NCT01688596|Sensory System Agents|sensory system agents|mesh-ancestor
111227126|NCT01688596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111227127|NCT02495532|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111227128|NCT04869592|Vaccines|vaccines|mesh-list
111227129|NCT04869592|Immunologic Factors|immunologic factors|mesh-ancestor
111227130|NCT04869592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111227131|NCT05709652|Ivermectin|ivermectin|mesh-list
111227132|NCT05709652|Selamectin|selamectin|mesh-list
111227133|NCT05709652|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111227134|NCT05709652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111227135|NCT01690000|Melatonin|melatonin|mesh-list
111227136|NCT01690000|Antioxidants|antioxidants|mesh-ancestor
111227137|NCT01690000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111227138|NCT01690000|Protective Agents|protective agents|mesh-ancestor
111227139|NCT01690000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111227140|NCT01690000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111227141|NCT02495220|Dexmedetomidine|dexmedetomidine|mesh-list
111227142|NCT02495220|Bupivacaine|bupivacaine|mesh-list
111227143|NCT02495220|Anesthetics, Local|anesthetics, local|mesh-ancestor
111227144|NCT02495220|Anesthetics|anesthetics|mesh-ancestor
111227145|NCT02495220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111227146|NCT02495220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111227147|NCT02495220|Sensory System Agents|sensory system agents|mesh-ancestor
111227148|NCT02495220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111227149|NCT02495220|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111227150|NCT02495220|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111227151|NCT02495220|Analgesics|analgesics|mesh-ancestor
111227152|NCT02495220|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111227153|NCT02495220|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111227154|NCT02495220|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111227155|NCT02495220|Adrenergic Agents|adrenergic agents|mesh-ancestor
111227156|NCT02495220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111227157|NCT02495220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111227158|NCT01690546|Naltrexone|naltrexone|mesh-list
111227159|NCT01690546|Buprenorphine|buprenorphine|mesh-list
111227160|NCT01690546|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
111227161|NCT01690546|Naloxone|naloxone|mesh-list
111227162|NCT01690546|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111227163|NCT01690546|Narcotics|narcotics|mesh-ancestor
111227164|NCT01690546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111227165|NCT01690546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111227166|NCT01690546|Analgesics|analgesics|mesh-ancestor
111227167|NCT01690546|Sensory System Agents|sensory system agents|mesh-ancestor
111227168|NCT01690546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111227169|NCT01690546|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111227170|NCT01690546|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111227171|NCT03336918|Lithium Carbonate|lithium carbonate|mesh-list
111227172|NCT03336918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111227173|NCT03336918|Antidepressive Agents|antidepressive agents|mesh-ancestor
111227174|NCT03336918|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111227175|NCT03336918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111227176|NCT03336918|Antimanic Agents|antimanic agents|mesh-ancestor
111227177|NCT03336918|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111227178|NCT03336918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111227179|NCT03336918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111227180|NCT02494830|Ketamine|ketamine|mesh-list
111227181|NCT02494830|Analgesics|analgesics|mesh-ancestor
111227182|NCT02494830|Sensory System Agents|sensory system agents|mesh-ancestor
111227183|NCT02494830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111227184|NCT02494830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111227185|NCT02494830|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111227186|NCT02494830|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111227187|NCT02494830|Anesthetics, General|anesthetics, general|mesh-ancestor
111227188|NCT02494830|Anesthetics|anesthetics|mesh-ancestor
111227189|NCT02494830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111227190|NCT02494830|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111227191|NCT02494830|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111227192|NCT02494830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111227193|NCT02494830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111227194|NCT03336840|Metformin|metformin|mesh-list
111227195|NCT03336840|Promethazine|promethazine|mesh-list
111227196|NCT03336840|Diphenhydramine|diphenhydramine|mesh-list
111227197|NCT03336840|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111227198|NCT03336840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111227199|NCT03336840|Antipruritics|antipruritics|mesh-ancestor
111227200|NCT03336840|Dermatologic Agents|dermatologic agents|mesh-ancestor
111227201|NCT03336840|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111227202|NCT03336840|Histamine Antagonists|histamine antagonists|mesh-ancestor
111227203|NCT03336840|Histamine Agents|histamine agents|mesh-ancestor
111227204|NCT03336840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111227205|NCT03336840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111227206|NCT03336840|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111227207|NCT03336840|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111227208|NCT03336840|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111227209|NCT03336840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111227210|NCT03336840|Anesthetics, Local|anesthetics, local|mesh-ancestor
111227211|NCT03336840|Anesthetics|anesthetics|mesh-ancestor
111227212|NCT03336840|Sensory System Agents|sensory system agents|mesh-ancestor
111227213|NCT03336840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111227214|NCT03336840|Antiemetics|antiemetics|mesh-ancestor
111227215|NCT03336840|Autonomic Agents|autonomic agents|mesh-ancestor
111227216|NCT03336840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111227217|NCT02497638|Metformin|metformin|mesh-list
111227219|NCT02497638|Atorvastatin|atorvastatin|mesh-list
111227220|NCT02497638|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111227221|NCT02497638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111227222|NCT02497638|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111227223|NCT02497638|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111227224|NCT02497638|Antimetabolites|antimetabolites|mesh-ancestor
111227225|NCT02497638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111227226|NCT02497638|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111227227|NCT02497638|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111227228|NCT02497638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111227229|NCT02495064|Mometasone Furoate|mometasone furoate|mesh-list
111227230|NCT02495064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111227231|NCT02495064|Dermatologic Agents|dermatologic agents|mesh-ancestor
111227232|NCT02495064|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111227233|NCT02493192|Meperidine|meperidine|mesh-list
111227234|NCT02493192|Haloperidol|haloperidol|mesh-list
111227235|NCT02493192|Haloperidol decanoate|haloperidol decanoate|mesh-list
111227236|NCT02493192|Antiemetics|antiemetics|mesh-ancestor
111227237|NCT02493192|Autonomic Agents|autonomic agents|mesh-ancestor
111227238|NCT02493192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111227239|NCT02493192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111227240|NCT02493192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111227241|NCT02493192|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111227242|NCT02493192|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111227243|NCT02493192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111227244|NCT02493192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111227245|NCT02493192|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111227246|NCT02493192|Dopamine Agents|dopamine agents|mesh-ancestor
111227247|NCT02493192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111227248|NCT02493192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111227249|NCT02493192|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111227250|NCT02493192|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111227251|NCT02493192|Narcotics|narcotics|mesh-ancestor
111227252|NCT02493192|Analgesics|analgesics|mesh-ancestor
111227253|NCT02493192|Sensory System Agents|sensory system agents|mesh-ancestor
111227254|NCT02493192|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111227255|NCT02497716|Rivaroxaban|rivaroxaban|mesh-list
111227256|NCT02497716|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111227257|NCT02497716|Antithrombins|antithrombins|mesh-ancestor
111227258|NCT02497716|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111227259|NCT02497716|Protease Inhibitors|protease inhibitors|mesh-ancestor
111227260|NCT02497716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111227261|NCT02497716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111227262|NCT02497716|Anticoagulants|anticoagulants|mesh-ancestor
111227263|NCT02238808|Estradiol|estradiol|mesh-list
111227264|NCT02238808|Estrogens|estrogens|mesh-list
111227265|NCT02238808|Hormones|hormones|mesh-ancestor
111227266|NCT02238808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111227267|NCT02238808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111227268|NCT02497326|Heparin|heparin|mesh-list
111227269|NCT02497326|Tramadol|tramadol|mesh-list
111227270|NCT02497326|Anticoagulants|anticoagulants|mesh-ancestor
111227271|NCT02497326|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111227272|NCT02497326|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111227273|NCT02497326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111227274|NCT02497326|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111227275|NCT02497326|Narcotics|narcotics|mesh-ancestor
111227276|NCT02497326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111227277|NCT02497326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111227278|NCT02497326|Analgesics|analgesics|mesh-ancestor
111227279|NCT02497326|Sensory System Agents|sensory system agents|mesh-ancestor
111227280|NCT02497326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111227281|NCT02245672|Fluticasone|fluticasone|mesh-list
111227282|NCT02245672|Xhance|xhance|mesh-list
111227283|NCT02245672|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
111227284|NCT02245672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111227285|NCT02245672|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111227286|NCT02245672|Autonomic Agents|autonomic agents|mesh-ancestor
111227287|NCT02245672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111227288|NCT02245672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111227289|NCT02245672|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111227290|NCT02245672|Respiratory System Agents|respiratory system agents|mesh-ancestor
111227291|NCT02245672|Dermatologic Agents|dermatologic agents|mesh-ancestor
111227292|NCT02245672|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111227293|NCT02245672|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111227294|NCT02245672|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111227296|NCT02245672|Adrenergic Agents|adrenergic agents|mesh-ancestor
111227297|NCT02245672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111227298|NCT02245672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111227299|NCT04461418|Glucocorticoids|glucocorticoids|mesh-list
111227300|NCT04461418|Hormones|hormones|mesh-ancestor
111227301|NCT04461418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111227302|NCT04461418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111227303|NCT03335904|Losartan|losartan|mesh-list
111227304|NCT03335904|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111227305|NCT03335904|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111227306|NCT03335904|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111227307|NCT03335904|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111227308|NCT03335904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111227309|NCT03335826|Anesthetics|anesthetics|mesh-list
111227310|NCT03335826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111227311|NCT03335826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111227312|NCT03340740|Cetirizine|cetirizine|mesh-list
111227313|NCT03340740|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111227314|NCT03340740|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
111227315|NCT03340740|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111227316|NCT03340740|Histamine Antagonists|histamine antagonists|mesh-ancestor
111227317|NCT03340740|Histamine Agents|histamine agents|mesh-ancestor
111227318|NCT03340740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111227319|NCT03340740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111227320|NCT03340740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111227321|NCT03340662|Itraconazole|itraconazole|mesh-list
111227322|NCT03340662|Rifampin|rifampin|mesh-list
111227323|NCT03340662|Fluvoxamine|fluvoxamine|mesh-list
111227324|NCT03340662|Antifungal Agents|antifungal agents|mesh-ancestor
111227325|NCT03340662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111227326|NCT03340662|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111227327|NCT03340662|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111227328|NCT03340662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111227329|NCT03340662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111227330|NCT03340662|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111227331|NCT03340662|Hormone Antagonists|hormone antagonists|mesh-ancestor
111227332|NCT03340662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111227333|NCT03340662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111227334|NCT03340662|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111227335|NCT03340662|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111227336|NCT03340662|Antitubercular Agents|antitubercular agents|mesh-ancestor
111227337|NCT03340662|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111227338|NCT03340662|Leprostatic Agents|leprostatic agents|mesh-ancestor
111227339|NCT03340662|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111227340|NCT03340662|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111227341|NCT03340662|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111227342|NCT03340662|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
111227343|NCT03340662|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
111227344|NCT03340662|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
111227345|NCT03340662|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111227346|NCT03340662|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111227347|NCT03340662|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111227348|NCT03340662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111227349|NCT03340662|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111227350|NCT03340662|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111227351|NCT03340662|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111227352|NCT03340662|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111227353|NCT03340662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111227354|NCT03340662|Serotonin Agents|serotonin agents|mesh-ancestor
111227355|NCT03340662|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111227356|NCT03340662|Antidepressive Agents|antidepressive agents|mesh-ancestor
111227357|NCT03340662|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111227358|NCT03340662|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111227359|NCT03342300|Doxorubicin|doxorubicin|mesh-list
111227360|NCT03342300|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111227361|NCT03342300|Pirarubicin|pirarubicin|mesh-list
111227362|NCT03342300|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111227363|NCT03342300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111227364|NCT03342300|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111227365|NCT03342300|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111227366|NCT03342300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111227367|NCT03342300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111227368|NCT01711918|Domperidone|domperidone|mesh-list
111227369|NCT01711918|Antiemetics|antiemetics|mesh-ancestor
111227370|NCT01711918|Autonomic Agents|autonomic agents|mesh-ancestor
111227371|NCT01711918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111227372|NCT01711918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111227373|NCT01711918|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111227374|NCT01711918|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111227375|NCT01711918|Dopamine Agents|dopamine agents|mesh-ancestor
111227376|NCT01711918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111227377|NCT01711918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111227378|NCT03120468|Topiramate|topiramate|mesh-list
111227379|NCT03120468|Acetylcysteine|acetylcysteine|mesh-list
111227380|NCT03120468|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111227381|NCT03120468|Anticonvulsants|anticonvulsants|mesh-ancestor
111227382|NCT03120468|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111227383|NCT03120468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111227384|NCT03120468|Antiviral Agents|antiviral agents|mesh-ancestor
111227385|NCT03120468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111227386|NCT03120468|Expectorants|expectorants|mesh-ancestor
111227387|NCT03120468|Respiratory System Agents|respiratory system agents|mesh-ancestor
111227388|NCT03120468|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111227389|NCT03120468|Antioxidants|antioxidants|mesh-ancestor
111227390|NCT03120468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111227391|NCT03120468|Protective Agents|protective agents|mesh-ancestor
111227392|NCT03120468|Antidotes|antidotes|mesh-ancestor
111227393|NCT01712230|Leuprolide|leuprolide|mesh-list
111227394|NCT01712230|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111227395|NCT01712230|Fertility Agents|fertility agents|mesh-ancestor
111227396|NCT01712230|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111227397|NCT01712230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111227398|NCT01712230|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111227399|NCT01712230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111227400|NCT03335436|Gabapentin|gabapentin|mesh-list
111227401|NCT03335436|Analgesics|analgesics|mesh-ancestor
111227402|NCT03335436|Sensory System Agents|sensory system agents|mesh-ancestor
111227403|NCT03335436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111227404|NCT03335436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111227405|NCT03335436|Anticonvulsants|anticonvulsants|mesh-ancestor
111227406|NCT03335436|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111227407|NCT03335436|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111227408|NCT03335436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111227409|NCT03335436|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111227410|NCT03335436|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111227411|NCT03335436|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111227412|NCT03335436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111227413|NCT03335436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111227414|NCT03335436|Antimanic Agents|antimanic agents|mesh-ancestor
111227415|NCT02494284|Aspirin|aspirin|mesh-list
111227416|NCT02494284|Clopidogrel|clopidogrel|mesh-list
111227417|NCT02494284|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111227418|NCT02494284|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111227419|NCT02494284|Analgesics|analgesics|mesh-ancestor
111227420|NCT02494284|Sensory System Agents|sensory system agents|mesh-ancestor
111227421|NCT02494284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111227422|NCT02494284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111227423|NCT02494284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111227424|NCT02494284|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111227425|NCT02494284|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111227426|NCT02494284|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111227427|NCT02494284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111227428|NCT02494284|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111227429|NCT02494284|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111227430|NCT02494284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111227431|NCT02494284|Antipyretics|antipyretics|mesh-ancestor
111227432|NCT02494284|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111227433|NCT02494284|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111227434|NCT02494284|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111227435|NCT02494284|Purinergic Agents|purinergic agents|mesh-ancestor
111227436|NCT02494284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111227437|NCT01713400|Sirolimus|sirolimus|mesh-list
111227438|NCT01713400|Ustekinumab|ustekinumab|mesh-list
111227439|NCT01713400|Tacrolimus|tacrolimus|mesh-list
111227440|NCT01713400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111227441|NCT01713400|Immunologic Factors|immunologic factors|mesh-ancestor
111227442|NCT01713400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111227443|NCT01713400|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111227444|NCT01713400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111227445|NCT01713400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111227446|NCT01713400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111227447|NCT01713400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111227448|NCT01713400|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111227449|NCT01713400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111227450|NCT01713400|Antifungal Agents|antifungal agents|mesh-ancestor
111227451|NCT01713400|Dermatologic Agents|dermatologic agents|mesh-ancestor
111227452|NCT04494828|Dexmedetomidine|dexmedetomidine|mesh-list
111227453|NCT04494828|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111227454|NCT04494828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111227455|NCT04494828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111227456|NCT04494828|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111227457|NCT04494828|Analgesics|analgesics|mesh-ancestor
111227458|NCT04494828|Sensory System Agents|sensory system agents|mesh-ancestor
111227459|NCT04494828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111227460|NCT04494828|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111227461|NCT04494828|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111227462|NCT04494828|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111227463|NCT04494828|Adrenergic Agents|adrenergic agents|mesh-ancestor
111227464|NCT04494828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111227465|NCT04494828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111227466|NCT01714336|Tranexamic Acid|tranexamic acid|mesh-list
111227467|NCT01714336|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110807086|NCT00108485|Niacin|niacin|mesh-list
111227468|NCT01714336|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111227469|NCT01714336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111227470|NCT01714336|Hemostatics|hemostatics|mesh-ancestor
111227471|NCT01714336|Coagulants|coagulants|mesh-ancestor
111227472|NCT01716208|Ofatumumab|ofatumumab|mesh-list
111227473|NCT01716208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111227474|NCT00706992|Aldesleukin|aldesleukin|mesh-list
111227475|NCT00706992|Vaccines|vaccines|mesh-list
111227476|NCT00706992|Freund's Adjuvant|freund's adjuvant|mesh-list
111227477|NCT00706992|Immunologic Factors|immunologic factors|mesh-ancestor
111227478|NCT00706992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111227479|NCT00706992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111227480|NCT00706992|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111227481|NCT00706992|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111227482|NCT00706992|Antiviral Agents|antiviral agents|mesh-ancestor
111227483|NCT00706992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111227484|NCT00706992|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111227485|NCT03335124|Vitamins|vitamins|mesh-list
111227486|NCT03335124|Ascorbic Acid|ascorbic acid|mesh-list
111227487|NCT03335124|Thiamine|thiamine|mesh-list
111227488|NCT03335124|Hydrocortisone|hydrocortisone|mesh-list
111227489|NCT03335124|Micronutrients|micronutrients|mesh-ancestor
111227490|NCT03335124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111227491|NCT03335124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111227492|NCT03335124|Antioxidants|antioxidants|mesh-ancestor
111227493|NCT03335124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111227494|NCT03335124|Protective Agents|protective agents|mesh-ancestor
111227495|NCT03335124|Vitamin B Complex|vitamin b complex|mesh-ancestor
111227496|NCT03339804|Cyclophosphamide|cyclophosphamide|mesh-list
111227497|NCT03339804|Doxorubicin|doxorubicin|mesh-list
111227498|NCT03339804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111227499|NCT03339804|Immunologic Factors|immunologic factors|mesh-ancestor
111227500|NCT03339804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111227501|NCT03339804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111227502|NCT03339804|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111227503|NCT03339804|Alkylating Agents|alkylating agents|mesh-ancestor
111227504|NCT03339804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111227505|NCT03339804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111227506|NCT03339804|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111227507|NCT03339804|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111227508|NCT03339804|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111227509|NCT03339804|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111227510|NCT03339804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111227511|NCT02248636|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
111227512|NCT02248636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111227513|NCT02248636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111227514|NCT02248636|Cholinergic Agents|cholinergic agents|mesh-ancestor
111227515|NCT02248636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111227516|NCT02248636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111227517|NCT02491320|Letrozole|letrozole|mesh-list
111227518|NCT02491320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111227519|NCT02491320|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111227520|NCT02491320|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111227521|NCT02491320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111227522|NCT02491320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111227523|NCT02491320|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111227524|NCT02491320|Hormone Antagonists|hormone antagonists|mesh-ancestor
111227525|NCT02491320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111227526|NCT02491320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111227527|NCT02491242|Dolutegravir|dolutegravir|mesh-list
111227528|NCT02491242|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111227529|NCT02491242|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111227530|NCT02491242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111227531|NCT02491242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111227532|NCT02491242|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111227533|NCT02491242|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111227534|NCT02491242|Antiviral Agents|antiviral agents|mesh-ancestor
111227535|NCT02491242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111227536|NCT03330990|Midazolam|midazolam|mesh-list
111227537|NCT03330990|Entrectinib|entrectinib|mesh-list
111227538|NCT03330990|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111227539|NCT03330990|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111227540|NCT03330990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111227541|NCT03330990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111227542|NCT03330990|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111227543|NCT03330990|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111227544|NCT03330990|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111227545|NCT03330990|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111227546|NCT03330990|Anesthetics, General|anesthetics, general|mesh-ancestor
111227547|NCT03330990|Anesthetics|anesthetics|mesh-ancestor
111227548|NCT03330990|GABA Modulators|gaba modulators|mesh-ancestor
111227549|NCT03330990|GABA Agents|gaba agents|mesh-ancestor
111227550|NCT03330990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111227551|NCT03330990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111227552|NCT03330990|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111227553|NCT03330990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111227554|NCT03339024|Oxytocin|oxytocin|mesh-list
111227555|NCT03339024|Oxytocics|oxytocics|mesh-ancestor
111227556|NCT03339024|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111227557|NCT03339024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111227558|NCT06038526|Carbon Monoxide|carbon monoxide|mesh-list
111227559|NCT06038526|Antimetabolites|antimetabolites|mesh-ancestor
111227560|NCT06038526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111227561|NCT06038526|Gasotransmitters|gasotransmitters|mesh-ancestor
111227562|NCT06038526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111227563|NCT06038526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111227564|NCT06038461|Temozolomide|temozolomide|mesh-list
111227565|NCT06038461|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111227566|NCT06038461|Alkylating Agents|alkylating agents|mesh-ancestor
111227567|NCT06038461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111227568|NCT06038461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111227569|NCT06038409|Ketamine|ketamine|mesh-list
111227570|NCT06038409|Analgesics|analgesics|mesh-ancestor
111227571|NCT06038409|Sensory System Agents|sensory system agents|mesh-ancestor
111227572|NCT06038409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111227573|NCT06038409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111227574|NCT06038409|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111227575|NCT06038409|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111227576|NCT06038409|Anesthetics, General|anesthetics, general|mesh-ancestor
111227577|NCT06038409|Anesthetics|anesthetics|mesh-ancestor
111227578|NCT06038409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111227579|NCT06038409|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111227580|NCT06038409|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111227581|NCT06038409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111227582|NCT06038409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111227583|NCT06037876|Ivermectin|ivermectin|mesh-list
111227584|NCT06037876|Albendazole|albendazole|mesh-list
111227585|NCT06037876|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111227586|NCT06037876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111227587|NCT06037876|Anthelmintics|anthelmintics|mesh-ancestor
111227588|NCT06037876|Anticestodal Agents|anticestodal agents|mesh-ancestor
111227589|NCT06037876|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
111227590|NCT06037876|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111227591|NCT06037876|Tubulin Modulators|tubulin modulators|mesh-ancestor
111227592|NCT06037876|Antimitotic Agents|antimitotic agents|mesh-ancestor
111227593|NCT06037876|Mitosis Modulators|mitosis modulators|mesh-ancestor
111227594|NCT06037876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111227595|NCT06037876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111227596|NCT06037577|Streptococcal polysaccharide type III group B|streptococcal polysaccharide type iii group b|mesh-list
111227597|NCT06037577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111227598|NCT06037564|Lamivudine|lamivudine|mesh-list
111227599|NCT06037564|Dolutegravir|dolutegravir|mesh-list
111227600|NCT06037564|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111227601|NCT06037564|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111227602|NCT06037564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111227603|NCT06037564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111227604|NCT06037564|Antiviral Agents|antiviral agents|mesh-ancestor
111227605|NCT06037564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111227606|NCT06037564|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111227607|NCT06037564|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111227608|NCT06037564|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111227609|NCT06037564|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111227610|NCT06037473|Hormones|hormones|mesh-list
111227611|NCT06037473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111227612|NCT06037473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111227613|NCT06037460|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
111227614|NCT06037460|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111227615|NCT06037460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111227616|NCT06037395|Denosumab|denosumab|mesh-list
111227617|NCT06037395|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111227618|NCT06037395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111227619|NCT06037330|Sufentanil|sufentanil|mesh-list
111227620|NCT06037330|Dsuvia|dsuvia|mesh-list
111227621|NCT06037330|Nalbuphine|nalbuphine|mesh-list
111227622|NCT06037330|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111227623|NCT06037330|Narcotics|narcotics|mesh-ancestor
111227624|NCT06037330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111227625|NCT06037330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111227626|NCT06037330|Analgesics|analgesics|mesh-ancestor
111227627|NCT06037330|Sensory System Agents|sensory system agents|mesh-ancestor
111227628|NCT06037330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111227629|NCT06037330|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111227630|NCT06037330|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111227631|NCT06037330|Anesthetics, General|anesthetics, general|mesh-ancestor
111227632|NCT06037330|Anesthetics|anesthetics|mesh-ancestor
111227633|NCT06037252|Tirzepatide|tirzepatide|mesh-list
111227634|NCT06037252|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111227635|NCT06037252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111227636|NCT06037252|Incretins|incretins|mesh-ancestor
111227637|NCT06037252|Hormones|hormones|mesh-ancestor
111227638|NCT06037252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111227639|NCT06037135|Dexmedetomidine|dexmedetomidine|mesh-list
111227640|NCT06037135|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111227641|NCT06037135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111227642|NCT06037135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111227643|NCT06037135|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111227644|NCT06037135|Analgesics|analgesics|mesh-ancestor
111227645|NCT06037135|Sensory System Agents|sensory system agents|mesh-ancestor
111227646|NCT06037135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111227647|NCT06037135|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111227648|NCT06037135|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111227649|NCT06037135|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111227650|NCT06037135|Adrenergic Agents|adrenergic agents|mesh-ancestor
111227651|NCT06037135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111227652|NCT06037135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111227653|NCT06036914|Furosemide|furosemide|mesh-list
111227654|NCT06036914|Bumetanide|bumetanide|mesh-list
111227655|NCT06036914|Diuretics|diuretics|mesh-list
111227656|NCT06036914|Natriuretic Agents|natriuretic agents|mesh-ancestor
111227657|NCT06036914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111227658|NCT06036914|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
111227659|NCT06036914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111227660|NCT06036914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111227661|NCT06036836|Pembrolizumab|pembrolizumab|mesh-list
111227662|NCT06036836|Lenvatinib|lenvatinib|mesh-list
111227663|NCT06036836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111227664|NCT06036836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111227665|NCT06036836|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111227666|NCT06036836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111227667|NCT06036836|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111227668|NCT06036836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111227669|NCT06036797|Sufentanil|sufentanil|mesh-list
111227670|NCT06036797|Hydromorphone|hydromorphone|mesh-list
111227671|NCT06036797|Ropivacaine|ropivacaine|mesh-list
111227672|NCT06036797|Anesthetics, Local|anesthetics, local|mesh-ancestor
111227673|NCT06036797|Anesthetics|anesthetics|mesh-ancestor
111227674|NCT06036797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111227675|NCT06036797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111227676|NCT06036797|Sensory System Agents|sensory system agents|mesh-ancestor
111227677|NCT06036797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111227678|NCT06036797|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111227679|NCT06036797|Narcotics|narcotics|mesh-ancestor
111227680|NCT06036797|Analgesics|analgesics|mesh-ancestor
111227681|NCT06036797|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111227682|NCT06036797|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111227683|NCT06036797|Anesthetics, General|anesthetics, general|mesh-ancestor
111227684|NCT06036745|Pembrolizumab|pembrolizumab|mesh-list
111227685|NCT06036745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111227686|NCT06036745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111227687|NCT06036745|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111227688|NCT06036745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111227689|NCT06036472|Anesthetics|anesthetics|mesh-list
111227690|NCT06036472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111227691|NCT06036472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111227692|NCT06036446|Progesterone|progesterone|mesh-list
111227693|NCT06036446|Progestins|progestins|mesh-ancestor
111227694|NCT06036446|Hormones|hormones|mesh-ancestor
111227695|NCT06036446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111227696|NCT06036446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111227697|NCT06035744|Pembrolizumab|pembrolizumab|mesh-list
111227698|NCT06035744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111227699|NCT06035744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111227700|NCT06035744|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111227701|NCT06035744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111227702|NCT06034314|Dronabinol|dronabinol|mesh-list
111227703|NCT06034314|Hallucinogens|hallucinogens|mesh-ancestor
111227704|NCT06034314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111227705|NCT06034314|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111227706|NCT06034314|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111227707|NCT06034314|Analgesics|analgesics|mesh-ancestor
111227708|NCT06034314|Sensory System Agents|sensory system agents|mesh-ancestor
111227709|NCT06034314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111227710|NCT06034314|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
111227711|NCT06034314|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
111227712|NCT06034314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111227713|NCT06034314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111227714|NCT06034314|Hormones|hormones|mesh-ancestor
111227715|NCT06034314|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111227716|NCT06034288|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111227717|NCT06034288|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
111227718|NCT06034288|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111227719|NCT06034288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111227720|NCT06034288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111227721|NCT06034288|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111227722|NCT06034288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111227723|NCT06034288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111227724|NCT06034288|Cholinergic Agents|cholinergic agents|mesh-ancestor
111227725|NCT06034288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111227726|NCT06033989|Hyaluronic Acid|hyaluronic acid|mesh-list
111227727|NCT06033989|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111227728|NCT06033989|Immunologic Factors|immunologic factors|mesh-ancestor
111227729|NCT06033989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111227730|NCT06033989|Viscosupplements|viscosupplements|mesh-ancestor
111227731|NCT06033989|Protective Agents|protective agents|mesh-ancestor
111227732|NCT06033846|Minocycline|minocycline|mesh-list
111227733|NCT06033846|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111227734|NCT06033846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111227735|NCT06033729|Fentanyl|fentanyl|mesh-list
111227736|NCT06033729|Midazolam|midazolam|mesh-list
111227737|NCT06033729|Remifentanil|remifentanil|mesh-list
111227738|NCT06033729|Propofol|propofol|mesh-list
111227739|NCT06033729|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111227740|NCT06033729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111227741|NCT06033729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111227743|NCT06033729|Anesthetics, General|anesthetics, general|mesh-ancestor
111227744|NCT06033729|Anesthetics|anesthetics|mesh-ancestor
111227745|NCT06033729|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111227746|NCT06033729|Narcotics|narcotics|mesh-ancestor
111227747|NCT06033729|Analgesics|analgesics|mesh-ancestor
111227748|NCT06033729|Sensory System Agents|sensory system agents|mesh-ancestor
111227749|NCT06033729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111227750|NCT06033729|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111227751|NCT06033729|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111227752|NCT06033729|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111227753|NCT06033729|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111227754|NCT06033729|GABA Modulators|gaba modulators|mesh-ancestor
111227755|NCT06033729|GABA Agents|gaba agents|mesh-ancestor
111227756|NCT06033729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111227757|NCT06033729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111227758|NCT06033612|Midazolam|midazolam|mesh-list
111227759|NCT06033612|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111227760|NCT06033612|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111227761|NCT06033612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111227762|NCT06033612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111227763|NCT06033612|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111227764|NCT06033612|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111227765|NCT06033612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111227766|NCT06033612|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111227767|NCT06033612|Anesthetics, General|anesthetics, general|mesh-ancestor
111227768|NCT06033612|Anesthetics|anesthetics|mesh-ancestor
111227769|NCT06033612|GABA Modulators|gaba modulators|mesh-ancestor
111227770|NCT06033612|GABA Agents|gaba agents|mesh-ancestor
111227771|NCT06033612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111227772|NCT06033612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111227773|NCT06033547|Cabotegravir|cabotegravir|mesh-list
111227774|NCT06033547|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111227775|NCT06033547|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111227776|NCT06033547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111227777|NCT06033547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111227778|NCT06033547|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111227779|NCT06033547|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111227780|NCT06033547|Antiviral Agents|antiviral agents|mesh-ancestor
111227781|NCT06033547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111227782|NCT06033521|Hormones|hormones|mesh-list
111227783|NCT06033521|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111227784|NCT06033521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111227785|NCT06033469|Adalimumab|adalimumab|mesh-list
111227786|NCT06033469|Infliximab|infliximab|mesh-list
111227787|NCT06033469|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111227788|NCT06033469|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111227789|NCT06033469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111227790|NCT06033469|Dermatologic Agents|dermatologic agents|mesh-ancestor
111227791|NCT06033469|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111227792|NCT06033352|Ivermectin|ivermectin|mesh-list
111227793|NCT06033352|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111227794|NCT06033352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111227795|NCT06033131|Metformin|metformin|mesh-list
111227796|NCT06033131|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111227797|NCT06033131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111227798|NCT06033118|Gemcitabine|gemcitabine|mesh-list
111227799|NCT06033118|Oxaliplatin|oxaliplatin|mesh-list
111227800|NCT06033118|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111227801|NCT06033118|Antimetabolites|antimetabolites|mesh-ancestor
111227802|NCT06033118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111227803|NCT06033118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111227804|NCT06033092|Tamoxifen|tamoxifen|mesh-list
111227805|NCT06033092|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111227806|NCT06033092|Hormone Antagonists|hormone antagonists|mesh-ancestor
111227807|NCT06033092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111227808|NCT06033092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111227809|NCT06033092|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111227810|NCT06033092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111227811|NCT06033092|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111227812|NCT06033092|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111227813|NCT06033092|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111227814|NCT06032936|Osimertinib|osimertinib|mesh-list
111227815|NCT06032936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111227816|NCT06032936|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111227817|NCT06032936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111227818|NCT06032936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111227820|NCT06032858|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111227821|NCT06032858|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111227822|NCT06032858|Analgesics|analgesics|mesh-ancestor
111227823|NCT06032858|Sensory System Agents|sensory system agents|mesh-ancestor
111227824|NCT06032858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111227825|NCT06032858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111227826|NCT06032858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111227827|NCT06032858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111227828|NCT06032858|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
111227829|NCT06032858|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111227830|NCT06032858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111227831|NCT06032858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111227832|NCT06032845|Lenvatinib|lenvatinib|mesh-list
111227833|NCT06032845|Tislelizumab|tislelizumab|mesh-list
111227834|NCT06032845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111227835|NCT06032845|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111227836|NCT06032845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111227837|NCT06032845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111227838|NCT06032845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111227839|NCT06032728|Sunitinib|sunitinib|mesh-list
111227840|NCT06032728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111227841|NCT06032728|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111227842|NCT06032728|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111227843|NCT06032728|Growth Substances|growth substances|mesh-ancestor
111227844|NCT06032728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111227845|NCT06032728|Growth Inhibitors|growth inhibitors|mesh-ancestor
111227846|NCT06032728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111227847|NCT06032728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111227848|NCT06032728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111227849|NCT06031597|Cisplatin|cisplatin|mesh-list
111227850|NCT06031597|Pembrolizumab|pembrolizumab|mesh-list
111227851|NCT06031597|Nivolumab|nivolumab|mesh-list
111227852|NCT06031597|Atezolizumab|atezolizumab|mesh-list
111227853|NCT06031597|Durvalumab|durvalumab|mesh-list
111227854|NCT06031597|Tislelizumab|tislelizumab|mesh-list
111227855|NCT06031597|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111227856|NCT06031597|Immunomodulating Agents|immunomodulating agents|mesh-list
111227857|NCT06031597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111227858|NCT06031597|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111227859|NCT06031597|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111227860|NCT06031597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111227861|NCT06031597|Immunologic Factors|immunologic factors|mesh-ancestor
111227862|NCT06031597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111227863|NCT06030843|Empagliflozin|empagliflozin|mesh-list
111227864|NCT06030843|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111227865|NCT06030843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111227866|NCT06030843|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111227867|NCT06030843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111227868|NCT06020118|Vaccines|vaccines|mesh-list
111227869|NCT06020118|Immunologic Factors|immunologic factors|mesh-ancestor
111227870|NCT06020118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111227871|NCT06016205|Morphine|morphine|mesh-list
111227872|NCT06016205|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111227873|NCT06016205|Narcotics|narcotics|mesh-ancestor
111227874|NCT06016205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111227875|NCT06016205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111227876|NCT06016205|Analgesics|analgesics|mesh-ancestor
111227877|NCT06016205|Sensory System Agents|sensory system agents|mesh-ancestor
111227878|NCT06016205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111227879|NCT06015308|Vaccines|vaccines|mesh-list
111227880|NCT06015308|Immunologic Factors|immunologic factors|mesh-ancestor
111227881|NCT06015308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111227882|NCT06014983|Ferrous fumarate|ferrous fumarate|mesh-list
111227883|NCT06014983|Trace Elements|trace elements|mesh-ancestor
111227884|NCT06014983|Micronutrients|micronutrients|mesh-ancestor
111227885|NCT06014983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111227886|NCT06010758|Listerine|listerine|mesh-list
111227887|NCT06010758|Sodium Fluoride|sodium fluoride|mesh-list
111227888|NCT06010758|Cariostatic Agents|cariostatic agents|mesh-ancestor
111227889|NCT06010758|Protective Agents|protective agents|mesh-ancestor
111227890|NCT06010758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111227891|NCT06010758|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110952285|NCT00543582|Mocetinostat|mocetinostat|mesh-list
111227892|NCT06010758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111227893|NCT06007586|Aprepitant|aprepitant|mesh-list
111227894|NCT06007586|Antiemetics|antiemetics|mesh-ancestor
111227895|NCT06007586|Autonomic Agents|autonomic agents|mesh-ancestor
111227896|NCT06007586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111227897|NCT06007586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111227898|NCT06007586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111227899|NCT06007586|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
111227900|NCT06007586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111227901|NCT06007586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111227902|NCT06003829|Denatonium|denatonium|mesh-list
111227903|NCT06003829|Aversive Agents|aversive agents|mesh-ancestor
111227904|NCT06003829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111227905|NCT06003829|Abuse-Deterrent Formulations|abuse-deterrent formulations|mesh-ancestor
111227906|NCT06003829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111227907|NCT06003829|Sensory System Agents|sensory system agents|mesh-ancestor
111227908|NCT06003829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111227909|NCT06003114|Palbociclib|palbociclib|mesh-list
111227910|NCT06003114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111227911|NCT06003114|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111227912|NCT06003114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111227913|NCT06003114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111227914|NCT06000462|Metformin|metformin|mesh-list
111227915|NCT06000462|Dapagliflozin|dapagliflozin|mesh-list
111227916|NCT06000462|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111227917|NCT06000462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111227918|NCT06000462|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111227919|NCT06000462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111227920|NCT05994183|Dexamethasone|dexamethasone|mesh-list
111227921|NCT05994183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111227922|NCT05994183|Antiemetics|antiemetics|mesh-ancestor
111227923|NCT05994183|Autonomic Agents|autonomic agents|mesh-ancestor
111227924|NCT05994183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111227925|NCT05994183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111227926|NCT05994183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111227927|NCT05994183|Glucocorticoids|glucocorticoids|mesh-ancestor
111227928|NCT05994183|Hormones|hormones|mesh-ancestor
111227929|NCT05994183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111227930|NCT05994183|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111227931|NCT05994183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111227932|NCT05992584|Lenvatinib|lenvatinib|mesh-list
111227933|NCT05992584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111227934|NCT05992584|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111227935|NCT05992584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111227936|NCT05992584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111227937|NCT05986240|Venetoclax|venetoclax|mesh-list
111227938|NCT05986240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111227939|NCT05985954|Cetuximab|cetuximab|mesh-list
111227940|NCT05985954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111227941|NCT05985954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111227942|NCT05981365|Metformin|metformin|mesh-list
111227943|NCT05981365|Repaglinide|repaglinide|mesh-list
111227944|NCT05981365|Flurbiprofen|flurbiprofen|mesh-list
111227945|NCT05981365|Furosemide|furosemide|mesh-list
111227946|NCT05981365|Midazolam|midazolam|mesh-list
111227947|NCT05981365|Bupropion|bupropion|mesh-list
111227948|NCT05981365|Omeprazole|omeprazole|mesh-list
111227949|NCT05981365|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111227950|NCT05981365|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111227951|NCT05981365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111227952|NCT05981365|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111227953|NCT05981365|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111227954|NCT05981365|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111227955|NCT05981365|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111227956|NCT05981365|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111227957|NCT05981365|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111227958|NCT05981365|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111227959|NCT05981365|Anesthetics, General|anesthetics, general|mesh-ancestor
111227960|NCT05981365|Anesthetics|anesthetics|mesh-ancestor
111227961|NCT05981365|GABA Modulators|gaba modulators|mesh-ancestor
111227962|NCT05981365|GABA Agents|gaba agents|mesh-ancestor
110952359|NCT00401388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110952361|NCT00401388|Antioxidants|antioxidants|mesh-ancestor
111227963|NCT05981365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111227964|NCT05981365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111227965|NCT05981365|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111227966|NCT05981365|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111227967|NCT05981365|Antimetabolites|antimetabolites|mesh-ancestor
111227968|NCT05981365|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111227969|NCT05981365|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111227970|NCT05981365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111227971|NCT05981365|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111227972|NCT05981365|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111227973|NCT05981365|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111227974|NCT05981365|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111227975|NCT05981365|Antidepressive Agents|antidepressive agents|mesh-ancestor
111227976|NCT05981365|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111227977|NCT05981365|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111227978|NCT05981365|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111227979|NCT05981365|Dopamine Agents|dopamine agents|mesh-ancestor
111227980|NCT05981365|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111227981|NCT05981365|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111227982|NCT05981365|Diuretics|diuretics|mesh-ancestor
111227983|NCT05981365|Natriuretic Agents|natriuretic agents|mesh-ancestor
111227984|NCT05981365|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
111227985|NCT05981365|Analgesics|analgesics|mesh-ancestor
111227986|NCT05981365|Sensory System Agents|sensory system agents|mesh-ancestor
111227987|NCT05981365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111227988|NCT05981365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111227989|NCT05981365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111227990|NCT05981365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111227991|NCT05981365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111227992|NCT05981365|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111227993|NCT05979948|Rituximab|rituximab|mesh-list
111227994|NCT05979948|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
111227995|NCT05979948|Zanubrutinib|zanubrutinib|mesh-list
111227996|NCT05979948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111227997|NCT05979948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111227998|NCT05979948|Immunologic Factors|immunologic factors|mesh-ancestor
111227999|NCT05979948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111228000|NCT05979948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111228001|NCT05979948|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111228002|NCT05979948|Alkylating Agents|alkylating agents|mesh-ancestor
111228003|NCT05979948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111228004|NCT05979948|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111228005|NCT05979948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111228006|NCT05979415|Apomorphine|apomorphine|mesh-list
111228007|NCT05979415|Emetics|emetics|mesh-ancestor
111228008|NCT05979415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111228009|NCT05979415|Autonomic Agents|autonomic agents|mesh-ancestor
111228010|NCT05979415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111228011|NCT05979415|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111228012|NCT05979415|Dopamine Agonists|dopamine agonists|mesh-ancestor
111228013|NCT05979415|Dopamine Agents|dopamine agents|mesh-ancestor
111228014|NCT05979415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111228015|NCT05979415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111228016|NCT05977998|Diphenhydramine|diphenhydramine|mesh-list
111228017|NCT05977998|Promethazine|promethazine|mesh-list
111228018|NCT05977998|Dexamethasone|dexamethasone|mesh-list
111228019|NCT05977998|Paclitaxel|paclitaxel|mesh-list
111228020|NCT05977998|Famotidine|famotidine|mesh-list
111228021|NCT05977998|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111228022|NCT05977998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111228023|NCT05977998|Tubulin Modulators|tubulin modulators|mesh-ancestor
111228024|NCT05977998|Antimitotic Agents|antimitotic agents|mesh-ancestor
111228025|NCT05977998|Mitosis Modulators|mitosis modulators|mesh-ancestor
111228026|NCT05977998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111228027|NCT05977998|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111228028|NCT05977998|Antiemetics|antiemetics|mesh-ancestor
111228029|NCT05977998|Autonomic Agents|autonomic agents|mesh-ancestor
111228030|NCT05977998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111228031|NCT05977998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111228032|NCT05977998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111228033|NCT05977998|Glucocorticoids|glucocorticoids|mesh-ancestor
111228034|NCT05977998|Hormones|hormones|mesh-ancestor
111228035|NCT05977998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111228036|NCT05977998|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111228037|NCT05977998|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111228038|NCT05977998|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111228039|NCT05977998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111228040|NCT05977998|Anesthetics, Local|anesthetics, local|mesh-ancestor
111228041|NCT05977998|Anesthetics|anesthetics|mesh-ancestor
111228042|NCT05977998|Sensory System Agents|sensory system agents|mesh-ancestor
111228043|NCT05977998|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111228044|NCT05977998|Histamine Antagonists|histamine antagonists|mesh-ancestor
111228045|NCT05977998|Histamine Agents|histamine agents|mesh-ancestor
111228046|NCT05977998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111228047|NCT05977998|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111228048|NCT05977998|Antipruritics|antipruritics|mesh-ancestor
111228049|NCT05977998|Dermatologic Agents|dermatologic agents|mesh-ancestor
111228050|NCT05977998|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111228051|NCT05977998|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
111228053|NCT05976763|Zanubrutinib|zanubrutinib|mesh-list
111228054|NCT05976763|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
111228055|NCT05976763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111228056|NCT05976763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111228057|NCT05976763|Immunologic Factors|immunologic factors|mesh-ancestor
111228058|NCT05976763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111228059|NCT05976763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111228060|NCT05976763|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111228061|NCT05976763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111228062|NCT05976763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111228063|NCT05976763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111228064|NCT05975671|Vancomycin|vancomycin|mesh-list
111228065|NCT05975671|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111228066|NCT05975671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111228067|NCT05975268|Antibodies|antibodies|mesh-list
111228068|NCT05975268|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111228069|NCT05975268|Immunologic Factors|immunologic factors|mesh-ancestor
111228070|NCT05975268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111228071|NCT05974462|Methylprednisolone|methylprednisolone|mesh-list
111228072|NCT05974462|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111228073|NCT05974462|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111228074|NCT05974462|Prednisolone|prednisolone|mesh-list
111228075|NCT05974462|Prednisolone acetate|prednisolone acetate|mesh-list
111228076|NCT05974462|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111228077|NCT05974462|Prednisolone phosphate|prednisolone phosphate|mesh-list
111228078|NCT05974462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111228079|NCT05974462|Antiemetics|antiemetics|mesh-ancestor
111228080|NCT05974462|Autonomic Agents|autonomic agents|mesh-ancestor
111228081|NCT05974462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111228082|NCT05974462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111228083|NCT05974462|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111228084|NCT05974462|Glucocorticoids|glucocorticoids|mesh-ancestor
111228085|NCT05974462|Hormones|hormones|mesh-ancestor
111228086|NCT05974462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111228087|NCT05974462|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111228088|NCT05974462|Protective Agents|protective agents|mesh-ancestor
111228089|NCT05974462|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111228090|NCT05974462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111228091|NCT05968326|Atezolizumab|atezolizumab|mesh-list
111228092|NCT05968326|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111228093|NCT05968326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111228094|NCT05968326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111228095|NCT05968326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111228096|NCT05967741|Erythritol|erythritol|mesh-list
111228097|NCT05967741|Vasodilator Agents|vasodilator agents|mesh-ancestor
111228098|NCT05965219|Metformin|metformin|mesh-list
111228099|NCT05965219|Itraconazole|itraconazole|mesh-list
111228100|NCT05965219|Carbamazepine|carbamazepine|mesh-list
111228101|NCT05965219|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111228102|NCT05965219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111228103|NCT05965219|Antifungal Agents|antifungal agents|mesh-ancestor
111228104|NCT05965219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111228105|NCT05965219|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111228106|NCT05965219|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111228107|NCT05965219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111228108|NCT05965219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111228109|NCT05965219|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111228110|NCT05965219|Hormone Antagonists|hormone antagonists|mesh-ancestor
111228111|NCT05965219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111228112|NCT05965219|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110952504|NCT02605174|Serotonin Agents|serotonin agents|mesh-ancestor
111228113|NCT05965219|Anticonvulsants|anticonvulsants|mesh-ancestor
111228114|NCT05965219|Antimanic Agents|antimanic agents|mesh-ancestor
111228115|NCT05965219|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111228116|NCT05965219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111228117|NCT05965219|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111228118|NCT05965219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111228120|NCT05965219|Sensory System Agents|sensory system agents|mesh-ancestor
111228121|NCT05965219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111228122|NCT05965219|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111228123|NCT05965219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111228124|NCT05965219|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111228125|NCT05965219|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111228126|NCT05963074|Venetoclax|venetoclax|mesh-list
111228127|NCT05963074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111228128|NCT05954910|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
111228129|NCT05954910|Immunoconjugates|immunoconjugates|mesh-ancestor
111228130|NCT05954910|Immunologic Factors|immunologic factors|mesh-ancestor
111228131|NCT05954910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111228132|NCT05952089|Midazolam|midazolam|mesh-list
111228133|NCT05952089|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111228134|NCT05952089|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111228135|NCT05952089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111228136|NCT05952089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111228137|NCT05952089|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111228138|NCT05952089|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111228139|NCT05952089|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111228140|NCT05952089|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111228141|NCT05952089|Anesthetics, General|anesthetics, general|mesh-ancestor
111228142|NCT05952089|Anesthetics|anesthetics|mesh-ancestor
111228143|NCT05952089|GABA Modulators|gaba modulators|mesh-ancestor
111228144|NCT05952089|GABA Agents|gaba agents|mesh-ancestor
111228145|NCT05952089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111228146|NCT05952089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111228147|NCT05946798|Insulin Aspart|insulin aspart|mesh-list
111228148|NCT05946798|Acetylcholine|acetylcholine|mesh-list
111228149|NCT05946798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111228150|NCT05946798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111228151|NCT05946798|Vasodilator Agents|vasodilator agents|mesh-ancestor
111228152|NCT05946798|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111228153|NCT05946798|Cholinergic Agents|cholinergic agents|mesh-ancestor
111228154|NCT05946798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111228155|NCT05946798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111228156|NCT05946785|Insulin Aspart|insulin aspart|mesh-list
111228157|NCT05946785|Acetylcholine|acetylcholine|mesh-list
111228158|NCT05946785|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111228159|NCT05946785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111228160|NCT05946785|Vasodilator Agents|vasodilator agents|mesh-ancestor
111228161|NCT05946785|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111228162|NCT05946785|Cholinergic Agents|cholinergic agents|mesh-ancestor
111228163|NCT05946785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111228164|NCT05946785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111228165|NCT05945875|Panitumumab|panitumumab|mesh-list
111228166|NCT05945875|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111228167|NCT05945875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111228168|NCT05940961|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
111228169|NCT05940961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111228170|NCT05940961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111228171|NCT05940961|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111228172|NCT05940961|Immunotoxins|immunotoxins|mesh-ancestor
111228173|NCT05940961|Immunoconjugates|immunoconjugates|mesh-ancestor
111228174|NCT05940961|Immunologic Factors|immunologic factors|mesh-ancestor
111228175|NCT05940961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111228176|NCT05939518|Anesthetics|anesthetics|mesh-list
111228177|NCT05939518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111228178|NCT05939518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111228179|NCT05935748|Palbociclib|palbociclib|mesh-list
111228180|NCT05935748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111228181|NCT05935748|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111228182|NCT05935748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111228183|NCT05935748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111228184|NCT05934500|Cannabidiol|cannabidiol|mesh-list
111228185|NCT05934500|Anticonvulsants|anticonvulsants|mesh-ancestor
111228186|NCT05926960|Pembrolizumab|pembrolizumab|mesh-list
111228187|NCT05926960|Nivolumab|nivolumab|mesh-list
111228188|NCT05926960|Ipilimumab|ipilimumab|mesh-list
111228189|NCT05926960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111228190|NCT05926960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111228191|NCT05926960|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111228192|NCT05926960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111228193|NCT05924672|Diphosphonates|diphosphonates|mesh-list
111228194|NCT05924672|Methylene diphosphonate|methylene diphosphonate|mesh-list
111228195|NCT05924672|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
111228196|NCT05924672|Technetium Tc 99m Medronate|technetium tc 99m medronate|mesh-list
111228197|NCT05924672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111228198|NCT05924672|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111228199|NCT05924672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111228200|NCT05924672|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111228201|NCT05924672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111228202|NCT05920863|Lenvatinib|lenvatinib|mesh-list
111228203|NCT05920863|Tislelizumab|tislelizumab|mesh-list
111228204|NCT05920863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111228205|NCT05920863|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111228206|NCT05920863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111228207|NCT05920863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111228208|NCT05920863|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111228209|NCT05920122|Chlorhexidine|chlorhexidine|mesh-list
111228210|NCT05920122|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
111228211|NCT05920122|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111228212|NCT05920122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111228213|NCT05920122|Disinfectants|disinfectants|mesh-ancestor
111228214|NCT05920122|Dermatologic Agents|dermatologic agents|mesh-ancestor
111228215|NCT05917587|Metformin|metformin|mesh-list
111228216|NCT05917587|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111228217|NCT05917587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111228218|NCT05908799|Pembrolizumab|pembrolizumab|mesh-list
111228219|NCT05908799|Pemetrexed|pemetrexed|mesh-list
111228220|NCT05908799|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111228221|NCT05908799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111228222|NCT05908799|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111228223|NCT05908799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111228224|NCT05908799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111228225|NCT05908799|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111228226|NCT05908799|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111228227|NCT05907122|Nivolumab|nivolumab|mesh-list
111228228|NCT05907122|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111228229|NCT05907122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111228230|NCT05907122|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111228231|NCT05907122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111228232|NCT05906303|Sodium Benzoate|sodium benzoate|mesh-list
111228233|NCT05906303|Caffeine, sodium benzoate drug combination|caffeine, sodium benzoate drug combination|mesh-list
111228234|NCT05906303|Caffeine|caffeine|mesh-list
111228235|NCT05906303|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111228236|NCT05906303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111228237|NCT05906303|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111228238|NCT05906303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111228239|NCT05906303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111228240|NCT05906303|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
111228241|NCT05906303|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111228242|NCT05906303|Purinergic Agents|purinergic agents|mesh-ancestor
111228243|NCT05906303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111228244|NCT05906303|Antifungal Agents|antifungal agents|mesh-ancestor
111228245|NCT05906303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111228246|NCT05906303|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
111228247|NCT05906303|Protective Agents|protective agents|mesh-ancestor
111228248|NCT05906303|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111228249|NCT05906303|Analgesics|analgesics|mesh-ancestor
111228250|NCT05906303|Sensory System Agents|sensory system agents|mesh-ancestor
111228251|NCT05906303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111228252|NCT05904886|Bevacizumab|bevacizumab|mesh-list
111228253|NCT05904886|Atezolizumab|atezolizumab|mesh-list
111228254|NCT05904886|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111228255|NCT05904886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111228256|NCT05904886|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111228257|NCT05904886|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111228258|NCT05904886|Growth Substances|growth substances|mesh-ancestor
111228259|NCT05904886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111228260|NCT05904886|Growth Inhibitors|growth inhibitors|mesh-ancestor
111228261|NCT05904886|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111228262|NCT05904886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111228263|NCT05900427|Bupivacaine|bupivacaine|mesh-list
111228264|NCT05900427|Anesthetics, Local|anesthetics, local|mesh-ancestor
111228265|NCT05900427|Anesthetics|anesthetics|mesh-ancestor
111228266|NCT05900427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111228267|NCT05900427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111228268|NCT05900427|Sensory System Agents|sensory system agents|mesh-ancestor
111228269|NCT05900427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111228270|NCT05898724|Zinc Oxide|zinc oxide|mesh-list
111228271|NCT05898724|Dermatologic Agents|dermatologic agents|mesh-ancestor
111228272|NCT05898724|Sunscreening Agents|sunscreening agents|mesh-ancestor
111228273|NCT05898724|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111228274|NCT05898724|Protective Agents|protective agents|mesh-ancestor
111228275|NCT05898724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111228276|NCT05897307|Ropivacaine|ropivacaine|mesh-list
111228277|NCT05897307|Anesthetics, Local|anesthetics, local|mesh-ancestor
111228278|NCT05897307|Anesthetics|anesthetics|mesh-ancestor
111228279|NCT05897307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111228280|NCT05897307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111228281|NCT05897307|Sensory System Agents|sensory system agents|mesh-ancestor
111228282|NCT05897307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111228283|NCT05897086|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
111228284|NCT05897086|Laxatives|laxatives|mesh-ancestor
111228285|NCT05897086|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111228286|NCT05896683|Lazertinib|lazertinib|mesh-list
111228287|NCT05896683|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111228288|NCT05896683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111228289|NCT05896683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111228290|NCT05893797|Insulin Lispro|insulin lispro|mesh-list
111228291|NCT05893797|TEMPO|tempo|mesh-list
111228292|NCT05893797|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111228293|NCT05893797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111228294|NCT05893797|Antioxidants|antioxidants|mesh-ancestor
111228295|NCT05893797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111228296|NCT05893797|Protective Agents|protective agents|mesh-ancestor
111228297|NCT05882877|KHK4083|khk4083|mesh-list
111228298|NCT05882877|Dermatologic Agents|dermatologic agents|mesh-ancestor
111228299|NCT05877807|Baclofen|baclofen|mesh-list
111228300|NCT05877807|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
111228301|NCT05877807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111228302|NCT05877807|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111228303|NCT05877807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111228304|NCT05877807|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
111228305|NCT05877807|GABA Agonists|gaba agonists|mesh-ancestor
111228306|NCT05877807|GABA Agents|gaba agents|mesh-ancestor
111228307|NCT05877807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111228308|NCT05877807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111228309|NCT05876377|Vaccines|vaccines|mesh-list
111228310|NCT05876377|Immunologic Factors|immunologic factors|mesh-ancestor
111228311|NCT05876377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111228312|NCT05875727|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
111228313|NCT05875727|Immunologic Factors|immunologic factors|mesh-ancestor
111228314|NCT05875727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111228315|NCT05875025|Norflurane|norflurane|mesh-list
111228316|NCT05875025|Anesthetics|anesthetics|mesh-ancestor
111228317|NCT05875025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111228318|NCT05875025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111228319|NCT05869760|Carotenoids|carotenoids|mesh-list
111228320|NCT05869760|Antioxidants|antioxidants|mesh-ancestor
111228321|NCT05869760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111228322|NCT05869760|Protective Agents|protective agents|mesh-ancestor
111228323|NCT05869760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111228324|NCT05864144|Cemiplimab|cemiplimab|mesh-list
111228325|NCT05864144|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111228326|NCT05864144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111228327|NCT05860296|Pembrolizumab|pembrolizumab|mesh-list
111228328|NCT05860296|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111228329|NCT05860296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111228330|NCT05860296|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111228331|NCT05860296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111228332|NCT05859269|Methylprednisolone|methylprednisolone|mesh-list
111228333|NCT05859269|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111228334|NCT05859269|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111228335|NCT05859269|Prednisolone|prednisolone|mesh-list
111228336|NCT05859269|Prednisolone acetate|prednisolone acetate|mesh-list
111228337|NCT05859269|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111228338|NCT05859269|Prednisolone phosphate|prednisolone phosphate|mesh-list
111228339|NCT05859269|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111228340|NCT05859269|Antiemetics|antiemetics|mesh-ancestor
111228341|NCT05859269|Autonomic Agents|autonomic agents|mesh-ancestor
111228342|NCT05859269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111228343|NCT05859269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111228344|NCT05859269|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111228345|NCT05859269|Glucocorticoids|glucocorticoids|mesh-ancestor
111228346|NCT05859269|Hormones|hormones|mesh-ancestor
111228347|NCT05859269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111228348|NCT05859269|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111228349|NCT05859269|Protective Agents|protective agents|mesh-ancestor
111228350|NCT05859269|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111228351|NCT05859269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111228352|NCT05856227|Ceftobiprole|ceftobiprole|mesh-list
111228353|NCT05856227|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
111228354|NCT05856227|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111228355|NCT05856227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111228356|NCT05845008|Acetaminophen|acetaminophen|mesh-list
111228357|NCT05845008|Naproxen|naproxen|mesh-list
111228358|NCT05845008|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111228359|NCT05845008|Analgesics|analgesics|mesh-ancestor
111228360|NCT05845008|Sensory System Agents|sensory system agents|mesh-ancestor
111228361|NCT05845008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111228362|NCT05845008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111228363|NCT05845008|Antipyretics|antipyretics|mesh-ancestor
111228364|NCT05845008|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111228365|NCT05845008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111228366|NCT05845008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111228367|NCT05845008|Gout Suppressants|gout suppressants|mesh-ancestor
111228368|NCT05845008|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111228369|NCT05845008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111228370|NCT05845008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111228371|NCT05844332|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
111228372|NCT05844332|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111228373|NCT05844332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111228374|NCT05843786|Interferons|interferons|mesh-list
111228375|NCT05843786|Interferon-gamma|interferon-gamma|mesh-list
111228376|NCT05843786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111228377|NCT05843786|Antiviral Agents|antiviral agents|mesh-ancestor
111228378|NCT05843786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111228379|NCT05826119|Magnesium Sulfate|magnesium sulfate|mesh-list
111228380|NCT05826119|Analgesics|analgesics|mesh-ancestor
111228381|NCT05826119|Sensory System Agents|sensory system agents|mesh-ancestor
111228382|NCT05826119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111228383|NCT05826119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111228384|NCT05826119|Anesthetics|anesthetics|mesh-ancestor
111228385|NCT05826119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111228386|NCT05826119|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111228387|NCT05826119|Anticonvulsants|anticonvulsants|mesh-ancestor
111228388|NCT05826119|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111228389|NCT05826119|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111228390|NCT05826119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111228391|NCT05826119|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111228392|NCT05826119|Tocolytic Agents|tocolytic agents|mesh-ancestor
111228393|NCT05826119|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111228394|NCT05824728|Levetiracetam|levetiracetam|mesh-list
111228395|NCT05824728|Anticonvulsants|anticonvulsants|mesh-ancestor
111228396|NCT05824728|Nootropic Agents|nootropic agents|mesh-ancestor
111228397|NCT05823623|Vinorelbine|vinorelbine|mesh-list
111228398|NCT05823623|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111228399|NCT05823623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111228400|NCT05823623|Tubulin Modulators|tubulin modulators|mesh-ancestor
111228401|NCT05823623|Antimitotic Agents|antimitotic agents|mesh-ancestor
111228402|NCT05823623|Mitosis Modulators|mitosis modulators|mesh-ancestor
111228403|NCT05823623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111228404|NCT05808764|Risdiplam|risdiplam|mesh-list
111228405|NCT05808764|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111228406|NCT05808764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111228407|NCT05808764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111228408|NCT05806346|Tranexamic Acid|tranexamic acid|mesh-list
111228409|NCT05806346|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111228410|NCT05806346|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111228411|NCT05806346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111228412|NCT05806346|Hemostatics|hemostatics|mesh-ancestor
111228413|NCT05806346|Coagulants|coagulants|mesh-ancestor
111228414|NCT05800366|Prednisone|prednisone|mesh-list
111228415|NCT05800366|Methylprednisolone|methylprednisolone|mesh-list
111228416|NCT05800366|Prednisolone|prednisolone|mesh-list
111228417|NCT05800366|Cyclophosphamide|cyclophosphamide|mesh-list
111228418|NCT05800366|Rituximab|rituximab|mesh-list
111228419|NCT05800366|Doxorubicin|doxorubicin|mesh-list
111228420|NCT05800366|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111228421|NCT05800366|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
111228422|NCT05800366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111228423|NCT05800366|Immunologic Factors|immunologic factors|mesh-ancestor
111228424|NCT05800366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111228425|NCT05800366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111228426|NCT05800366|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111228427|NCT05800366|Alkylating Agents|alkylating agents|mesh-ancestor
111228428|NCT05800366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111228429|NCT05800366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111228430|NCT05800366|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111228431|NCT05800366|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111228432|NCT05800366|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111228433|NCT05800366|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111228434|NCT05800366|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111228435|NCT05800366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111228436|NCT05800366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111228437|NCT05800366|Glucocorticoids|glucocorticoids|mesh-ancestor
111228438|NCT05800366|Hormones|hormones|mesh-ancestor
111228439|NCT05800366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111228440|NCT05800366|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111228441|NCT05800366|Antiemetics|antiemetics|mesh-ancestor
111228442|NCT05800366|Autonomic Agents|autonomic agents|mesh-ancestor
111228443|NCT05800366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111228444|NCT05800366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111228445|NCT05800366|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111228446|NCT05800366|Protective Agents|protective agents|mesh-ancestor
111228447|NCT05800366|Immunoconjugates|immunoconjugates|mesh-ancestor
111228448|NCT05795309|Insulin|insulin|mesh-list
111228449|NCT05795309|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111228450|NCT05795309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111228451|NCT05790486|Nicotine|nicotine|mesh-list
111228452|NCT05790486|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111228453|NCT05790486|Autonomic Agents|autonomic agents|mesh-ancestor
111228454|NCT05790486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111228455|NCT05790486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111228456|NCT05790486|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111228457|NCT05790486|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111228458|NCT05790486|Cholinergic Agents|cholinergic agents|mesh-ancestor
111228459|NCT05790486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111228460|NCT05790486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111228461|NCT05788328|Dabigatran|dabigatran|mesh-list
111228462|NCT05788328|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111228463|NCT05788328|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111228464|NCT05788328|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111228465|NCT05788328|Antimetabolites|antimetabolites|mesh-ancestor
111228466|NCT05788328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111228467|NCT05788328|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111228468|NCT05788328|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111228469|NCT05788328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111228470|NCT05788328|Antithrombins|antithrombins|mesh-ancestor
111228471|NCT05788328|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111228472|NCT05788328|Protease Inhibitors|protease inhibitors|mesh-ancestor
111228473|NCT05788328|Anticoagulants|anticoagulants|mesh-ancestor
111228474|NCT05775471|Pembrolizumab|pembrolizumab|mesh-list
111228475|NCT05775471|Immunoconjugates|immunoconjugates|mesh-list
111228476|NCT05775471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111228477|NCT05775471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111228478|NCT05775471|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111228479|NCT05775471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111228480|NCT05775471|Immunologic Factors|immunologic factors|mesh-ancestor
111228481|NCT05775471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111228482|NCT05771480|Paclitaxel|paclitaxel|mesh-list
111228483|NCT05771480|Cisplatin|cisplatin|mesh-list
111228484|NCT05771480|Carboplatin|carboplatin|mesh-list
111228485|NCT05771480|Gemcitabine|gemcitabine|mesh-list
111228486|NCT05771480|Oxaliplatin|oxaliplatin|mesh-list
111228487|NCT05771480|Durvalumab|durvalumab|mesh-list
111228488|NCT05771480|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111228489|NCT05771480|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111228490|NCT05771480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111228491|NCT05771480|Tubulin Modulators|tubulin modulators|mesh-ancestor
111228492|NCT05771480|Antimitotic Agents|antimitotic agents|mesh-ancestor
111228493|NCT05771480|Mitosis Modulators|mitosis modulators|mesh-ancestor
111228494|NCT05771480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111228495|NCT05771480|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111228496|NCT05771480|Antimetabolites|antimetabolites|mesh-ancestor
111228497|NCT05771480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111228498|NCT05767021|Mirikizumab|mirikizumab|mesh-list
111228499|NCT05767021|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111228500|NCT05767021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111228501|NCT05767021|Analgesics|analgesics|mesh-ancestor
111228502|NCT05767021|Sensory System Agents|sensory system agents|mesh-ancestor
111228503|NCT05767021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111228504|NCT05767021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111228505|NCT05767021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111228506|NCT05767021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111228507|NCT05767021|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111228508|NCT05767021|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111228509|NCT05763823|Letermovir|letermovir|mesh-list
111228510|NCT05763823|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111228511|NCT05763823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111228512|NCT05763823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111228513|NCT05763823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111228514|NCT05763823|Antiviral Agents|antiviral agents|mesh-ancestor
111228515|NCT05763823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111228516|NCT05761574|Acetaminophen|acetaminophen|mesh-list
111228517|NCT05761574|Naproxen|naproxen|mesh-list
111228518|NCT05761574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111228519|NCT05761574|Analgesics|analgesics|mesh-ancestor
111228520|NCT05761574|Sensory System Agents|sensory system agents|mesh-ancestor
111228521|NCT05761574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111228522|NCT05761574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111228523|NCT05761574|Antipyretics|antipyretics|mesh-ancestor
111228524|NCT05761574|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111228525|NCT05761574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111228526|NCT05761574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111228527|NCT05761574|Gout Suppressants|gout suppressants|mesh-ancestor
111228528|NCT05761574|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111228529|NCT05761574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111228530|NCT05761574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111228531|NCT05756673|Listerine|listerine|mesh-list
111228532|NCT05756673|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
111228533|NCT05756673|Sodium Fluoride|sodium fluoride|mesh-list
111228534|NCT05756673|Cariostatic Agents|cariostatic agents|mesh-ancestor
111228535|NCT05756673|Protective Agents|protective agents|mesh-ancestor
111228536|NCT05756673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111228537|NCT05756673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111228538|NCT05750030|Bevacizumab|bevacizumab|mesh-list
111228539|NCT05750030|Atezolizumab|atezolizumab|mesh-list
111228540|NCT05750030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111228541|NCT05750030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111228542|NCT05750030|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111228543|NCT05750030|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111228544|NCT05750030|Growth Substances|growth substances|mesh-ancestor
111228545|NCT05750030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111228546|NCT05750030|Growth Inhibitors|growth inhibitors|mesh-ancestor
111228547|NCT05750030|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111228548|NCT05750030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111228549|NCT05742958|Morphine|morphine|mesh-list
111228550|NCT05742958|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111228551|NCT05742958|Narcotics|narcotics|mesh-ancestor
111228552|NCT05742958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111228553|NCT05742958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111228554|NCT05742958|Analgesics|analgesics|mesh-ancestor
111228555|NCT05742958|Sensory System Agents|sensory system agents|mesh-ancestor
111228556|NCT05742958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111228557|NCT05742841|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111228558|NCT05742841|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111228559|NCT05742841|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111228560|NCT05742841|Antimetabolites|antimetabolites|mesh-ancestor
111228561|NCT05742841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111228562|NCT05742841|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111228563|NCT05742841|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111228564|NCT05742841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111228565|NCT05735535|Antiviral Agents|antiviral agents|mesh-list
111228566|NCT05735535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110952954|NCT04801888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111228567|NCT05722418|Cyclophosphamide|cyclophosphamide|mesh-list
111228568|NCT05722418|Fludarabine|fludarabine|mesh-list
111228569|NCT05722418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111228570|NCT05722418|Immunologic Factors|immunologic factors|mesh-ancestor
111228571|NCT05722418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111228572|NCT05722418|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111228573|NCT05722418|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111228574|NCT05722418|Alkylating Agents|alkylating agents|mesh-ancestor
111228575|NCT05722418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111228576|NCT05722418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111228577|NCT05722418|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111228578|NCT05720715|Cyclosporine|cyclosporine|mesh-list
111228579|NCT05720715|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111228580|NCT05720715|Cyclosporins|cyclosporins|mesh-list
111228581|NCT05720715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111228582|NCT05720715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111228583|NCT05720715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111228584|NCT05720715|Immunologic Factors|immunologic factors|mesh-ancestor
111228585|NCT05720715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111228586|NCT05720715|Antifungal Agents|antifungal agents|mesh-ancestor
111228587|NCT05720715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111228588|NCT05720715|Dermatologic Agents|dermatologic agents|mesh-ancestor
111228589|NCT05720715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111228590|NCT05720715|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111228591|NCT05720715|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111228592|NCT05711940|Psilocybin|psilocybin|mesh-list
111228593|NCT05711940|Hallucinogens|hallucinogens|mesh-ancestor
111228594|NCT05711940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111228595|NCT05711940|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111228596|NCT05694013|Atezolizumab|atezolizumab|mesh-list
111228597|NCT05694013|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111228598|NCT05694013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111228599|NCT05694013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111228600|NCT05694013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111228601|NCT05689710|Inositol|inositol|mesh-list
111228602|NCT05689710|Vitamin B Complex|vitamin b complex|mesh-ancestor
111228603|NCT05689710|Vitamins|vitamins|mesh-ancestor
111228604|NCT05689710|Micronutrients|micronutrients|mesh-ancestor
111228605|NCT05689710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111228606|NCT05680792|Ritonavir|ritonavir|mesh-list
111228607|NCT05680792|Atazanavir Sulfate|atazanavir sulfate|mesh-list
111228608|NCT05680792|Nitazoxanide|nitazoxanide|mesh-list
111228609|NCT05680792|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111228610|NCT05680792|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111228611|NCT05680792|Protease Inhibitors|protease inhibitors|mesh-ancestor
111228612|NCT05680792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111228613|NCT05680792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111228614|NCT05680792|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111228615|NCT05680792|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111228616|NCT05680792|Antiviral Agents|antiviral agents|mesh-ancestor
111228617|NCT05680792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111228618|NCT05680792|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111228619|NCT05680792|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111228620|NCT05680792|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111228621|NCT05667662|Itraconazole|itraconazole|mesh-list
111228622|NCT05667662|Antifungal Agents|antifungal agents|mesh-ancestor
111228623|NCT05667662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111228624|NCT05667662|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111228625|NCT05667662|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111228626|NCT05667662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111228627|NCT05667662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111228628|NCT05667662|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111228629|NCT05667662|Hormone Antagonists|hormone antagonists|mesh-ancestor
111228630|NCT05667662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111228631|NCT05667662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111228632|NCT05667662|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111228633|NCT05663580|Rilpivirine|rilpivirine|mesh-list
111228634|NCT05663580|Cabotegravir|cabotegravir|mesh-list
111228635|NCT05663580|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111228636|NCT05663580|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111228637|NCT05663580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111228638|NCT05663580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111228639|NCT05663580|Antiviral Agents|antiviral agents|mesh-ancestor
111228640|NCT05663580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111228641|NCT05663580|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111228642|NCT05663580|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111228643|NCT05663580|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111228644|NCT05663580|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111228646|NCT05661578|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111228647|NCT05661578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111228648|NCT05661578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111228649|NCT05661578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111228650|NCT05655598|Palbociclib|palbociclib|mesh-list
111228651|NCT05655598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111228652|NCT05655598|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111228653|NCT05655598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111228654|NCT05655598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111228655|NCT05646303|Psilocybin|psilocybin|mesh-list
111228656|NCT05646303|Hallucinogens|hallucinogens|mesh-ancestor
111228657|NCT05646303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111228658|NCT05646303|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111228659|NCT05645692|Atezolizumab|atezolizumab|mesh-list
111228660|NCT05645692|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111228661|NCT05645692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111228662|NCT05645692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111228663|NCT05645692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111228664|NCT05645536|Tamoxifen|tamoxifen|mesh-list
111228665|NCT05645536|Letrozole|letrozole|mesh-list
111228666|NCT05645536|Anastrozole|anastrozole|mesh-list
111228667|NCT05645536|Exemestane|exemestane|mesh-list
111228668|NCT05645536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111228669|NCT05645536|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111228670|NCT05645536|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111228671|NCT05645536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111228672|NCT05645536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111228673|NCT05645536|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111228674|NCT05645536|Hormone Antagonists|hormone antagonists|mesh-ancestor
111228675|NCT05645536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111228676|NCT05645536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111228677|NCT05645536|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111228678|NCT05645536|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111228679|NCT05645536|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111228680|NCT05645536|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111228681|NCT05643560|Factor VIII|factor viii|mesh-list
111228682|NCT05643560|Coagulants|coagulants|mesh-ancestor
111228683|NCT05641246|Diclofenac|diclofenac|mesh-list
111228684|NCT05641246|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111228685|NCT05641246|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111228686|NCT05641246|Analgesics|analgesics|mesh-ancestor
111228687|NCT05641246|Sensory System Agents|sensory system agents|mesh-ancestor
111228688|NCT05641246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111228689|NCT05641246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111228690|NCT05641246|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111228691|NCT05641246|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111228692|NCT05641246|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111228693|NCT05641246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111228694|NCT05641246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111228695|NCT05640180|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
111228696|NCT05640180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111228697|NCT05640180|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111228698|NCT05640180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111228699|NCT05639647|Aztreonam|aztreonam|mesh-list
111228700|NCT05639647|Avibactam|avibactam|mesh-list
111228701|NCT05639647|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111228702|NCT05639647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111228703|NCT05639647|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
111228704|NCT05639647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111228705|NCT05639647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111228706|NCT05633602|Pembrolizumab|pembrolizumab|mesh-list
111228707|NCT05633602|Ramucirumab|ramucirumab|mesh-list
111228708|NCT05633602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111228709|NCT05633602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111228710|NCT05633602|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111228711|NCT05633602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111228712|NCT05619627|Dexmedetomidine|dexmedetomidine|mesh-list
111228713|NCT05619627|Anesthetics|anesthetics|mesh-list
111228714|NCT05619627|Anesthetics, General|anesthetics, general|mesh-list
111228715|NCT05619627|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111228716|NCT05619627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111228717|NCT05619627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111228718|NCT05619627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111228719|NCT05619627|Analgesics|analgesics|mesh-ancestor
111228720|NCT05619627|Sensory System Agents|sensory system agents|mesh-ancestor
111228721|NCT05619627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111228722|NCT05619627|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111228723|NCT05619627|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111228724|NCT05619627|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111228725|NCT05619627|Adrenergic Agents|adrenergic agents|mesh-ancestor
111228726|NCT05619627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111228727|NCT05619627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111228728|NCT05617742|FAPI-46|fapi-46|mesh-list
111228729|NCT05617742|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111228730|NCT05617742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111228731|NCT05601440|Gemcitabine|gemcitabine|mesh-list
111228732|NCT05601440|Fulvestrant|fulvestrant|mesh-list
111228733|NCT05601440|Niraparib|niraparib|mesh-list
111228734|NCT05601440|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111228735|NCT05601440|Antimetabolites|antimetabolites|mesh-ancestor
111228736|NCT05601440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111228737|NCT05601440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111228738|NCT05601440|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111228739|NCT05601440|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
111228740|NCT05601440|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111228741|NCT05601440|Hormone Antagonists|hormone antagonists|mesh-ancestor
111228742|NCT05601440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111228743|NCT05601440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111228744|NCT05601440|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111228745|NCT05601440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111228746|NCT05600062|Racecadotril|racecadotril|mesh-list
111228747|NCT05600062|Antidiarrheals|antidiarrheals|mesh-ancestor
111228748|NCT05600062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111228749|NCT05600062|Protease Inhibitors|protease inhibitors|mesh-ancestor
111228750|NCT05600062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111228751|NCT05600062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111228752|NCT05599295|Oritavancin|oritavancin|mesh-list
111228753|NCT05599295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111228754|NCT05599295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111228755|NCT05598580|Lenalidomide|lenalidomide|mesh-list
111228756|NCT05598580|Immunologic Factors|immunologic factors|mesh-ancestor
111228757|NCT05598580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111228758|NCT05598580|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111228759|NCT05598580|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111228760|NCT05598580|Growth Substances|growth substances|mesh-ancestor
111228761|NCT05598580|Growth Inhibitors|growth inhibitors|mesh-ancestor
111228762|NCT05598580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111228763|NCT05597280|Rifampin|rifampin|mesh-list
111228764|NCT05597280|Bedaquiline|bedaquiline|mesh-list
111228765|NCT05597280|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111228766|NCT05597280|Antitubercular Agents|antitubercular agents|mesh-ancestor
111228767|NCT05597280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111228768|NCT05597280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111228769|NCT05597280|Leprostatic Agents|leprostatic agents|mesh-ancestor
111228770|NCT05597280|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111228771|NCT05597280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111228772|NCT05597280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111228773|NCT05597280|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111228774|NCT05597280|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111228775|NCT05597280|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
111228776|NCT05597280|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
111228777|NCT05597280|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
111228778|NCT05597280|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111228779|NCT05595369|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
111228780|NCT05595369|Antiviral Agents|antiviral agents|mesh-ancestor
111228781|NCT05595369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111228782|NCT05593757|Quinidine|quinidine|mesh-list
111228783|NCT05593757|Verapamil|verapamil|mesh-list
111228784|NCT05593757|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111228785|NCT05593757|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111228786|NCT05593757|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111228787|NCT05593757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111228788|NCT05593757|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111228789|NCT05593757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111228790|NCT05593757|Vasodilator Agents|vasodilator agents|mesh-ancestor
111228791|NCT05593757|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111228792|NCT05593757|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111228793|NCT05593757|Adrenergic Agents|adrenergic agents|mesh-ancestor
111228794|NCT05593757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111228796|NCT05593757|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111228797|NCT05593757|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111228798|NCT05593757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111228799|NCT05593757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111228800|NCT05593757|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111228801|NCT05593757|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111228802|NCT05593757|Cholinergic Agents|cholinergic agents|mesh-ancestor
111228803|NCT05593757|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111228804|NCT05593757|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111228805|NCT05593757|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111228806|NCT05593757|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111228807|NCT05567952|Ritonavir|ritonavir|mesh-list
111228808|NCT05567952|Nirmatrelvir|nirmatrelvir|mesh-list
111228809|NCT05567952|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111228810|NCT05567952|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111228811|NCT05567952|Protease Inhibitors|protease inhibitors|mesh-ancestor
111228812|NCT05567952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111228813|NCT05567952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111228814|NCT05567952|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111228815|NCT05567952|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111228816|NCT05567952|Antiviral Agents|antiviral agents|mesh-ancestor
111228817|NCT05567952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111228818|NCT05567952|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111228819|NCT05567952|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111228820|NCT05564403|Calcium, Dietary|calcium, dietary|mesh-list
111228821|NCT05564403|Leucovorin|leucovorin|mesh-list
111228822|NCT05564403|Folic Acid|folic acid|mesh-list
111228823|NCT05564403|Fluorouracil|fluorouracil|mesh-list
111228824|NCT05564403|Oxaliplatin|oxaliplatin|mesh-list
111228825|NCT05564403|Calcium|calcium|mesh-list
111228826|NCT05564403|Levoleucovorin|levoleucovorin|mesh-list
111228827|NCT05564403|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111228828|NCT05564403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111228829|NCT05564403|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111228830|NCT05564403|Antimetabolites|antimetabolites|mesh-ancestor
111228831|NCT05564403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111228832|NCT05564403|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111228833|NCT05564403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111228834|NCT05564403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111228835|NCT05564403|Immunologic Factors|immunologic factors|mesh-ancestor
111228836|NCT05564403|Antidotes|antidotes|mesh-ancestor
111228837|NCT05564403|Protective Agents|protective agents|mesh-ancestor
111228838|NCT05564403|Vitamin B Complex|vitamin b complex|mesh-ancestor
111228839|NCT05564403|Vitamins|vitamins|mesh-ancestor
111228840|NCT05564403|Micronutrients|micronutrients|mesh-ancestor
111228841|NCT05564403|Hematinics|hematinics|mesh-ancestor
111228842|NCT05562713|Denatonium|denatonium|mesh-list
111228843|NCT05562713|Aversive Agents|aversive agents|mesh-ancestor
111228844|NCT05562713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111228845|NCT05562713|Abuse-Deterrent Formulations|abuse-deterrent formulations|mesh-ancestor
111228846|NCT05562713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111228847|NCT05562713|Sensory System Agents|sensory system agents|mesh-ancestor
111228848|NCT05562713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111228849|NCT05552222|Dexamethasone|dexamethasone|mesh-list
111228850|NCT05552222|Lenalidomide|lenalidomide|mesh-list
111228851|NCT05552222|Daratumumab|daratumumab|mesh-list
111228852|NCT05552222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111228853|NCT05552222|Antiemetics|antiemetics|mesh-ancestor
111228854|NCT05552222|Autonomic Agents|autonomic agents|mesh-ancestor
111228855|NCT05552222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111228856|NCT05552222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111228857|NCT05552222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111228858|NCT05552222|Glucocorticoids|glucocorticoids|mesh-ancestor
111228859|NCT05552222|Hormones|hormones|mesh-ancestor
111228860|NCT05552222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111228861|NCT05552222|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111228862|NCT05552222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111228863|NCT05552222|Immunologic Factors|immunologic factors|mesh-ancestor
111228864|NCT05552222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111228865|NCT05552222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111228866|NCT05552222|Growth Substances|growth substances|mesh-ancestor
111228867|NCT05552222|Growth Inhibitors|growth inhibitors|mesh-ancestor
111228868|NCT05548283|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111228870|NCT05548283|beta-Lactams|beta-lactams|mesh-list
111228871|NCT05548283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111228872|NCT05537220|Acetylcysteine|acetylcysteine|mesh-list
111228873|NCT05537220|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111228874|NCT05537220|Antiviral Agents|antiviral agents|mesh-ancestor
111228875|NCT05537220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111228876|NCT05537220|Expectorants|expectorants|mesh-ancestor
111228877|NCT05537220|Respiratory System Agents|respiratory system agents|mesh-ancestor
111228878|NCT05537220|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111228879|NCT05537220|Antioxidants|antioxidants|mesh-ancestor
111228880|NCT05537220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111228881|NCT05537220|Protective Agents|protective agents|mesh-ancestor
111228882|NCT05537220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111228883|NCT05537220|Antidotes|antidotes|mesh-ancestor
111228884|NCT05532618|Levobupivacaine|levobupivacaine|mesh-list
111228885|NCT05532618|Anesthetics, Local|anesthetics, local|mesh-ancestor
111228886|NCT05532618|Anesthetics|anesthetics|mesh-ancestor
111228887|NCT05532618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111228888|NCT05532618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111228889|NCT05532618|Sensory System Agents|sensory system agents|mesh-ancestor
111228890|NCT05532618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111228891|NCT05529069|Venetoclax|venetoclax|mesh-list
111228892|NCT05529069|Pirtobrutinib|pirtobrutinib|mesh-list
111228893|NCT05529069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111228894|NCT05529069|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111228895|NCT05529069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111228896|NCT05529069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111228897|NCT05527704|Albuterol|albuterol|mesh-list
111228898|NCT05527704|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111228899|NCT05527704|Autonomic Agents|autonomic agents|mesh-ancestor
111228900|NCT05527704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111228901|NCT05527704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111228902|NCT05527704|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111228903|NCT05527704|Respiratory System Agents|respiratory system agents|mesh-ancestor
111228904|NCT05527704|Tocolytic Agents|tocolytic agents|mesh-ancestor
111228905|NCT05527704|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111228906|NCT05527704|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111228907|NCT05527704|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111228908|NCT05527704|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111228909|NCT05527704|Adrenergic Agents|adrenergic agents|mesh-ancestor
111228910|NCT05527704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111228911|NCT05527704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111228912|NCT05516498|Dapagliflozin|dapagliflozin|mesh-list
111228913|NCT05516498|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111228914|NCT05516498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111228915|NCT05516498|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111228916|NCT05516498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111228917|NCT05501054|Nivolumab|nivolumab|mesh-list
111228918|NCT05501054|Ipilimumab|ipilimumab|mesh-list
111228919|NCT05501054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111228920|NCT05501054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111228921|NCT05501054|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111228922|NCT05501054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111228923|NCT05476926|Ranibizumab|ranibizumab|mesh-list
111228924|NCT05476926|Faricimab|faricimab|mesh-list
111228925|NCT05476926|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111228926|NCT05476926|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111228927|NCT05476926|Growth Substances|growth substances|mesh-ancestor
111228928|NCT05476926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111228929|NCT05476926|Growth Inhibitors|growth inhibitors|mesh-ancestor
111228930|NCT05476926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111228931|NCT05465954|Pembrolizumab|pembrolizumab|mesh-list
111228932|NCT05465954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111228933|NCT05465954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111228934|NCT05465954|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111228935|NCT05465954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111228936|NCT05464615|Amoxicillin|amoxicillin|mesh-list
111228937|NCT05464615|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110953331|NCT00389870|Cyclosporine|cyclosporine|mesh-list
111228938|NCT05464615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111228939|NCT05462756|Insulin|insulin|mesh-list
111228940|NCT05462756|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111228941|NCT05462756|Insulin Glargine|insulin glargine|mesh-list
111228942|NCT05462756|Insulin Lispro|insulin lispro|mesh-list
111228943|NCT05462756|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111228944|NCT05462756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111228945|NCT05459129|Paclitaxel|paclitaxel|mesh-list
111228946|NCT05459129|Carboplatin|carboplatin|mesh-list
111228947|NCT05459129|Atezolizumab|atezolizumab|mesh-list
111228948|NCT05459129|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111228949|NCT05459129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111228950|NCT05459129|Tubulin Modulators|tubulin modulators|mesh-ancestor
111228951|NCT05459129|Antimitotic Agents|antimitotic agents|mesh-ancestor
111228952|NCT05459129|Mitosis Modulators|mitosis modulators|mesh-ancestor
111228953|NCT05459129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111228954|NCT05459129|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111228955|NCT05459129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111228956|NCT05454358|Letrozole|letrozole|mesh-list
111228957|NCT05454358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111228958|NCT05454358|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111228959|NCT05454358|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111228960|NCT05454358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111228961|NCT05454358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111228962|NCT05454358|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111228963|NCT05454358|Hormone Antagonists|hormone antagonists|mesh-ancestor
111228964|NCT05454358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111228965|NCT05454358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111228966|NCT05433584|Tirzepatide|tirzepatide|mesh-list
111228967|NCT05433584|Hypoglycemic Agents|hypoglycemic agents|mesh-list
111228968|NCT05433584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111228969|NCT05433584|Incretins|incretins|mesh-ancestor
111228970|NCT05433584|Hormones|hormones|mesh-ancestor
111228971|NCT05433584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111228972|NCT05408429|Vaccines|vaccines|mesh-list
111228973|NCT05408429|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
111228974|NCT05408429|Immunologic Factors|immunologic factors|mesh-ancestor
111228975|NCT05408429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111228976|NCT05382091|Naltrexone|naltrexone|mesh-list
111228977|NCT05382091|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111228978|NCT05382091|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111228979|NCT05382091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111228980|NCT05382091|Sensory System Agents|sensory system agents|mesh-ancestor
111228981|NCT05382091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111228982|NCT05380453|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111228983|NCT05380453|Immunologic Factors|immunologic factors|mesh-ancestor
111228984|NCT05380453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111228985|NCT05367440|Abiraterone Acetate|abiraterone acetate|mesh-list
111228986|NCT05367440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111228987|NCT05367440|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111228988|NCT05367440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111228989|NCT05367440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111228990|NCT05367440|Hormone Antagonists|hormone antagonists|mesh-ancestor
111228991|NCT05367440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111228992|NCT05367440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111228993|NCT05367440|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111228994|NCT05364190|Empagliflozin|empagliflozin|mesh-list
111228995|NCT05364190|Canagliflozin|canagliflozin|mesh-list
111228996|NCT05364190|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111228997|NCT05364190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111228998|NCT05364190|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111228999|NCT05364190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111229000|NCT05355272|Hormones|hormones|mesh-list
111229001|NCT05355272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111229002|NCT05355272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111229003|NCT05352672|Pembrolizumab|pembrolizumab|mesh-list
111229004|NCT05352672|Cemiplimab|cemiplimab|mesh-list
111229005|NCT05352672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111229006|NCT05352672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111229007|NCT05352672|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111229008|NCT05352672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111229009|NCT05325866|Bemarituzumab|bemarituzumab|mesh-list
111229010|NCT05325866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111229011|NCT05325866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111229013|NCT05315479|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111229014|NCT05315479|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111229015|NCT05315479|Analgesics|analgesics|mesh-ancestor
111229016|NCT05315479|Sensory System Agents|sensory system agents|mesh-ancestor
111229017|NCT05315479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111229018|NCT05315479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111229019|NCT05315479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111229020|NCT05315479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111229021|NCT05315479|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111229022|NCT05315479|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111229023|NCT05315479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111229024|NCT05315479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111229025|NCT05315206|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
111229026|NCT05315206|Nootropic Agents|nootropic agents|mesh-ancestor
111229027|NCT05311254|Fosfomycin|fosfomycin|mesh-list
111229028|NCT05311254|Calcium|calcium|mesh-list
111229029|NCT05311254|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111229030|NCT05311254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111229031|NCT05311254|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111229032|NCT05311254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111229033|NCT05299580|Trametinib|trametinib|mesh-list
111229034|NCT05299580|Dabrafenib|dabrafenib|mesh-list
111229035|NCT05299580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111229036|NCT05299580|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111229037|NCT05299580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111229038|NCT05299580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111229039|NCT05296603|Lenvatinib|lenvatinib|mesh-list
111229040|NCT05296603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111229041|NCT05296603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111229042|NCT05296603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111229043|NCT05296603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111229044|NCT05296278|Bevacizumab|bevacizumab|mesh-list
111229045|NCT05296278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111229046|NCT05296278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111229047|NCT05296278|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111229048|NCT05296278|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111229049|NCT05296278|Growth Substances|growth substances|mesh-ancestor
111229050|NCT05296278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111229051|NCT05296278|Growth Inhibitors|growth inhibitors|mesh-ancestor
111229052|NCT05284747|Evolocumab|evolocumab|mesh-list
111229053|NCT05284747|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
111229054|NCT05284747|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111229055|NCT05284747|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111229056|NCT05284747|Antimetabolites|antimetabolites|mesh-ancestor
111229057|NCT05284747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111229058|NCT05284747|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111229059|NCT05284747|Protease Inhibitors|protease inhibitors|mesh-ancestor
111229060|NCT05284747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111229061|NCT05284747|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111229062|NCT05278676|Dotinurad|dotinurad|mesh-list
111229063|NCT05278676|Uricosuric Agents|uricosuric agents|mesh-ancestor
111229064|NCT05278676|Gout Suppressants|gout suppressants|mesh-ancestor
111229065|NCT05278676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111229066|NCT05266846|Bevacizumab|bevacizumab|mesh-list
111229067|NCT05266846|Pembrolizumab|pembrolizumab|mesh-list
111229068|NCT05266846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111229069|NCT05266846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111229070|NCT05266846|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111229071|NCT05266846|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111229072|NCT05266846|Growth Substances|growth substances|mesh-ancestor
111229073|NCT05266846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111229074|NCT05266846|Growth Inhibitors|growth inhibitors|mesh-ancestor
111229075|NCT05266846|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111229076|NCT05266846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111229077|NCT05262400|Letrozole|letrozole|mesh-list
111229078|NCT05262400|Fulvestrant|fulvestrant|mesh-list
111229079|NCT05262400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111229080|NCT05262400|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111229081|NCT05262400|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111229082|NCT05262400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111229083|NCT05262400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111229084|NCT05262400|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111229085|NCT05262400|Hormone Antagonists|hormone antagonists|mesh-ancestor
111229086|NCT05262400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111229087|NCT05262400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111229088|NCT05262400|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111229089|NCT05262400|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
111229090|NCT05256290|Temozolomide|temozolomide|mesh-list
111229091|NCT05256290|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111229092|NCT05256290|Alkylating Agents|alkylating agents|mesh-ancestor
111229093|NCT05256290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111229094|NCT05256290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111229095|NCT05253651|Leucovorin|leucovorin|mesh-list
111229096|NCT05253651|Bevacizumab|bevacizumab|mesh-list
111229097|NCT05253651|Trastuzumab|trastuzumab|mesh-list
111229098|NCT05253651|Cetuximab|cetuximab|mesh-list
111229099|NCT05253651|Fluorouracil|fluorouracil|mesh-list
111229100|NCT05253651|Oxaliplatin|oxaliplatin|mesh-list
111229101|NCT05253651|Tucatinib|tucatinib|mesh-list
111229102|NCT05253651|Levoleucovorin|levoleucovorin|mesh-list
111229103|NCT05253651|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111229104|NCT05253651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111229105|NCT05253651|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111229106|NCT05253651|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111229107|NCT05253651|Growth Substances|growth substances|mesh-ancestor
111229108|NCT05253651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111229109|NCT05253651|Growth Inhibitors|growth inhibitors|mesh-ancestor
111229110|NCT05253651|Antimetabolites|antimetabolites|mesh-ancestor
111229111|NCT05253651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111229112|NCT05253651|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111229113|NCT05253651|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111229114|NCT05253651|Immunologic Factors|immunologic factors|mesh-ancestor
111229115|NCT05253651|Antidotes|antidotes|mesh-ancestor
111229116|NCT05253651|Protective Agents|protective agents|mesh-ancestor
111229117|NCT05253651|Vitamin B Complex|vitamin b complex|mesh-ancestor
111229118|NCT05253651|Vitamins|vitamins|mesh-ancestor
111229119|NCT05253651|Micronutrients|micronutrients|mesh-ancestor
111229120|NCT05253651|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111229121|NCT05253651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111229122|NCT05238142|Insulin|insulin|mesh-list
111229123|NCT05238142|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111229124|NCT05238142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111229125|NCT05232929|Risdiplam|risdiplam|mesh-list
111229126|NCT05232929|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111229127|NCT05232929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111229128|NCT05232929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111229129|NCT05222438|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
111229130|NCT05222438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111229131|NCT05222438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111229132|NCT05221840|Durvalumab|durvalumab|mesh-list
111229133|NCT05221840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111229134|NCT05221840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111229135|NCT05219487|Risdiplam|risdiplam|mesh-list
111229136|NCT05219487|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111229137|NCT05219487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111229138|NCT05219487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111229139|NCT05217446|Pembrolizumab|pembrolizumab|mesh-list
111229140|NCT05217446|Cetuximab|cetuximab|mesh-list
111229141|NCT05217446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111229142|NCT05217446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111229143|NCT05217446|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111229144|NCT05217446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111229145|NCT05215340|Pembrolizumab|pembrolizumab|mesh-list
111229146|NCT05215340|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111229147|NCT05215340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111229148|NCT05215340|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111229149|NCT05215340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111229150|NCT05203172|Cetuximab|cetuximab|mesh-list
111229151|NCT05203172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111229152|NCT05203172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111229153|NCT05197075|Darunavir|darunavir|mesh-list
111229154|NCT05197075|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111229155|NCT05197075|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111229156|NCT05197075|Protease Inhibitors|protease inhibitors|mesh-ancestor
111229157|NCT05197075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111229158|NCT05197075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111229159|NCT05197075|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111229160|NCT05197075|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111229161|NCT05197075|Antiviral Agents|antiviral agents|mesh-ancestor
111229162|NCT05197075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111229164|NCT05180097|Gemcitabine|gemcitabine|mesh-list
111229165|NCT05180097|Pembrolizumab|pembrolizumab|mesh-list
111229166|NCT05180097|Brentuximab Vedotin|brentuximab vedotin|mesh-list
111229167|NCT05180097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111229168|NCT05180097|Antiemetics|antiemetics|mesh-ancestor
111229169|NCT05180097|Autonomic Agents|autonomic agents|mesh-ancestor
111229170|NCT05180097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111229171|NCT05180097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111229172|NCT05180097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111229173|NCT05180097|Glucocorticoids|glucocorticoids|mesh-ancestor
111229174|NCT05180097|Hormones|hormones|mesh-ancestor
111229175|NCT05180097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111229176|NCT05180097|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111229177|NCT05180097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111229178|NCT05180097|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111229179|NCT05180097|Antimetabolites|antimetabolites|mesh-ancestor
111229180|NCT05180097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111229181|NCT05180097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111229182|NCT05180097|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111229183|NCT05180097|Immunotoxins|immunotoxins|mesh-ancestor
111229184|NCT05180097|Immunoconjugates|immunoconjugates|mesh-ancestor
111229185|NCT05180097|Immunologic Factors|immunologic factors|mesh-ancestor
111229186|NCT05171647|Rituximab|rituximab|mesh-list
111229187|NCT05171647|Gemcitabine|gemcitabine|mesh-list
111229188|NCT05171647|Oxaliplatin|oxaliplatin|mesh-list
111229189|NCT05171647|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
111229190|NCT05171647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111229191|NCT05171647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111229192|NCT05171647|Immunologic Factors|immunologic factors|mesh-ancestor
111229193|NCT05171647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111229194|NCT05171647|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111229195|NCT05171647|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111229196|NCT05171647|Antimetabolites|antimetabolites|mesh-ancestor
111229197|NCT05171647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111229198|NCT05171647|Immunoconjugates|immunoconjugates|mesh-ancestor
111229199|NCT05168735|Ketamine|ketamine|mesh-list
111229200|NCT05168735|Analgesics|analgesics|mesh-ancestor
111229201|NCT05168735|Sensory System Agents|sensory system agents|mesh-ancestor
111229202|NCT05168735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111229203|NCT05168735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111229204|NCT05168735|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111229205|NCT05168735|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111229206|NCT05168735|Anesthetics, General|anesthetics, general|mesh-ancestor
111229207|NCT05168735|Anesthetics|anesthetics|mesh-ancestor
111229208|NCT05168735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111229209|NCT05168735|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111229210|NCT05168735|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111229211|NCT05168735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111229212|NCT05168735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111229213|NCT05155254|Pembrolizumab|pembrolizumab|mesh-list
111229214|NCT05155254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111229215|NCT05155254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111229216|NCT05155254|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111229217|NCT05155254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111229218|NCT05151731|Ranibizumab|ranibizumab|mesh-list
111229219|NCT05151731|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111229220|NCT05151731|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111229221|NCT05151731|Growth Substances|growth substances|mesh-ancestor
111229222|NCT05151731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111229223|NCT05151731|Growth Inhibitors|growth inhibitors|mesh-ancestor
111229224|NCT05151731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111229225|NCT05148078|Anesthetics|anesthetics|mesh-list
111229226|NCT05148078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111229227|NCT05148078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111229228|NCT05139316|Prednisolone|prednisolone|mesh-list
111229229|NCT05139316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111229230|NCT05139316|Glucocorticoids|glucocorticoids|mesh-ancestor
111229231|NCT05139316|Hormones|hormones|mesh-ancestor
111229232|NCT05139316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111229233|NCT05139316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110953635|NCT05817019|Autonomic Agents|autonomic agents|mesh-ancestor
111229234|NCT05139316|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111229235|NCT05139316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111229236|NCT05128162|Psilocybin|psilocybin|mesh-list
111229237|NCT05128162|Hallucinogens|hallucinogens|mesh-ancestor
111229238|NCT05128162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111229239|NCT05128162|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111229240|NCT05120960|Osimertinib|osimertinib|mesh-list
111229241|NCT05120960|Tepotinib|tepotinib|mesh-list
111229242|NCT05120960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111229243|NCT05120960|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111229244|NCT05120960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111229245|NCT05120960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111229246|NCT05116202|Nivolumab|nivolumab|mesh-list
111229247|NCT05116202|Ipilimumab|ipilimumab|mesh-list
111229248|NCT05116202|Atezolizumab|atezolizumab|mesh-list
111229249|NCT05116202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111229250|NCT05116202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111229251|NCT05116202|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111229252|NCT05116202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111229253|NCT05115838|Islatravir|islatravir|mesh-list
111229254|NCT05115838|Antiviral Agents|antiviral agents|mesh-ancestor
111229255|NCT05115838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111229256|NCT05115838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111229257|NCT05115838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111229258|NCT05115838|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111229259|NCT05115838|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111229260|NCT05115838|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111229261|NCT05115630|Mycophenolic Acid|mycophenolic acid|mesh-list
111229262|NCT05115630|Cyclophosphamide|cyclophosphamide|mesh-list
111229263|NCT05115630|Melphalan|melphalan|mesh-list
111229264|NCT05115630|Fludarabine|fludarabine|mesh-list
111229265|NCT05115630|Fludarabine phosphate|fludarabine phosphate|mesh-list
111229266|NCT05115630|Tacrolimus|tacrolimus|mesh-list
111229267|NCT05115630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111229268|NCT05115630|Immunologic Factors|immunologic factors|mesh-ancestor
111229269|NCT05115630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111229270|NCT05115630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111229271|NCT05115630|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111229272|NCT05115630|Alkylating Agents|alkylating agents|mesh-ancestor
111229273|NCT05115630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111229274|NCT05115630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111229275|NCT05115630|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111229276|NCT05115630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111229277|NCT05115630|Antimetabolites|antimetabolites|mesh-ancestor
111229278|NCT05115630|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111229279|NCT05115630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111229280|NCT05115630|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111229281|NCT05115630|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111229282|NCT05115630|Antitubercular Agents|antitubercular agents|mesh-ancestor
111229283|NCT05115630|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111229284|NCT05115630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111229285|NCT05091567|Carboplatin|carboplatin|mesh-list
111229286|NCT05091567|Etoposide|etoposide|mesh-list
111229287|NCT05091567|Atezolizumab|atezolizumab|mesh-list
111229288|NCT05091567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111229289|NCT05091567|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111229290|NCT05091567|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111229291|NCT05091567|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111229292|NCT05091567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111229293|NCT05091567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111229294|NCT05091567|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111229295|NCT05091567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111229296|NCT05071313|Vaccines|vaccines|mesh-list
111229297|NCT05071313|Immunologic Factors|immunologic factors|mesh-ancestor
111229298|NCT05071313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111229299|NCT05070104|Bevacizumab|bevacizumab|mesh-list
111229300|NCT05070104|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111229301|NCT05070104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111229302|NCT05070104|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111229303|NCT05070104|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111229304|NCT05070104|Growth Substances|growth substances|mesh-ancestor
111229305|NCT05070104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111229306|NCT05070104|Growth Inhibitors|growth inhibitors|mesh-ancestor
111229307|NCT05063513|Mycophenolic Acid|mycophenolic acid|mesh-list
111229308|NCT05063513|Rituximab|rituximab|mesh-list
111229309|NCT05063513|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111229310|NCT05063513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111229311|NCT05063513|Immunologic Factors|immunologic factors|mesh-ancestor
111229312|NCT05063513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111229313|NCT05063513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111229314|NCT05063513|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111229315|NCT05063513|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111229316|NCT05063513|Antitubercular Agents|antitubercular agents|mesh-ancestor
111229317|NCT05063513|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111229318|NCT05063513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111229319|NCT05063513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111229320|NCT05063513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111229321|NCT05053867|Tranexamic Acid|tranexamic acid|mesh-list
111229322|NCT05053867|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111229323|NCT05053867|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111229324|NCT05053867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111229326|NCT05053867|Coagulants|coagulants|mesh-ancestor
111229327|NCT05048342|Remibrutinib|remibrutinib|mesh-list
111229328|NCT05048342|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111229329|NCT05048342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111229330|NCT05048342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111229331|NCT05047250|Atezolizumab|atezolizumab|mesh-list
111229332|NCT05047250|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111229333|NCT05047250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111229334|NCT05047250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111229335|NCT05047250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111229336|NCT05040568|Cyclophosphamide|cyclophosphamide|mesh-list
111229337|NCT05040568|Fludarabine|fludarabine|mesh-list
111229338|NCT05040568|Fludarabine phosphate|fludarabine phosphate|mesh-list
111229339|NCT05040568|Cetuximab|cetuximab|mesh-list
111229340|NCT05040568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111229341|NCT05040568|Immunologic Factors|immunologic factors|mesh-ancestor
111229342|NCT05040568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111229343|NCT05040568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111229344|NCT05040568|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111229345|NCT05040568|Alkylating Agents|alkylating agents|mesh-ancestor
111229346|NCT05040568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111229347|NCT05040568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111229348|NCT05040568|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111229349|NCT05040568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111229350|NCT05040568|Antimetabolites|antimetabolites|mesh-ancestor
111229351|NCT05040568|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111229352|NCT05029921|Ustekinumab|ustekinumab|mesh-list
111229353|NCT05029921|Dermatologic Agents|dermatologic agents|mesh-ancestor
111229354|NCT04989803|Cyclophosphamide|cyclophosphamide|mesh-list
111229355|NCT04989803|Fludarabine|fludarabine|mesh-list
111229356|NCT04989803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111229357|NCT04989803|Immunologic Factors|immunologic factors|mesh-ancestor
111229358|NCT04989803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111229359|NCT04989803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111229360|NCT04989803|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111229361|NCT04989803|Alkylating Agents|alkylating agents|mesh-ancestor
111229362|NCT04989803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111229363|NCT04989803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111229364|NCT04989803|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111229365|NCT04980222|Prednisone|prednisone|mesh-list
111229366|NCT04980222|Cyclophosphamide|cyclophosphamide|mesh-list
111229367|NCT04980222|Rituximab|rituximab|mesh-list
111229368|NCT04980222|Doxorubicin|doxorubicin|mesh-list
111229369|NCT04980222|Vincristine|vincristine|mesh-list
111229370|NCT04980222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111229371|NCT04980222|Immunologic Factors|immunologic factors|mesh-ancestor
111229372|NCT04980222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111229373|NCT04980222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111229374|NCT04980222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111229375|NCT04980222|Alkylating Agents|alkylating agents|mesh-ancestor
111229376|NCT04980222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111229377|NCT04980222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111229378|NCT04980222|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111229379|NCT04980222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111229380|NCT04980222|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111229381|NCT04980222|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111229382|NCT04980222|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111229383|NCT04980222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111229384|NCT04980222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111229386|NCT04980222|Hormones|hormones|mesh-ancestor
111229387|NCT04980222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111229388|NCT04980222|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111229389|NCT04980222|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111229390|NCT04980222|Tubulin Modulators|tubulin modulators|mesh-ancestor
111229391|NCT04980222|Antimitotic Agents|antimitotic agents|mesh-ancestor
111229392|NCT04980222|Mitosis Modulators|mitosis modulators|mesh-ancestor
111229393|NCT04965597|Methotrexate|methotrexate|mesh-list
111229394|NCT04965597|Fludarabine phosphate|fludarabine phosphate|mesh-list
111229395|NCT04965597|Fludarabine|fludarabine|mesh-list
111229396|NCT04965597|Treosulfan|treosulfan|mesh-list
111229397|NCT04965597|Busulfan|busulfan|mesh-list
111229398|NCT04965597|Tacrolimus|tacrolimus|mesh-list
111229399|NCT04965597|Thymoglobulin|thymoglobulin|mesh-list
111229400|NCT04965597|Antilymphocyte Serum|antilymphocyte serum|mesh-list
111229401|NCT04965597|Immunoglobulins|immunoglobulins|mesh-list
111229402|NCT04965597|Antibodies|antibodies|mesh-list
111229403|NCT04965597|gamma-Globulins|gamma-globulins|mesh-list
111229404|NCT04965597|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111229405|NCT04965597|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
111229406|NCT04965597|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111229407|NCT04965597|Abortifacient Agents|abortifacient agents|mesh-ancestor
111229408|NCT04965597|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111229409|NCT04965597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111229410|NCT04965597|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111229411|NCT04965597|Antimetabolites|antimetabolites|mesh-ancestor
111229412|NCT04965597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111229413|NCT04965597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111229414|NCT04965597|Dermatologic Agents|dermatologic agents|mesh-ancestor
111229415|NCT04965597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111229416|NCT04965597|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111229417|NCT04965597|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111229418|NCT04965597|Immunologic Factors|immunologic factors|mesh-ancestor
111229419|NCT04965597|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111229420|NCT04965597|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111229421|NCT04965597|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111229422|NCT04965597|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111229423|NCT04965597|Alkylating Agents|alkylating agents|mesh-ancestor
111229424|NCT04965597|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111229425|NCT04965493|Rituximab|rituximab|mesh-list
111229426|NCT04965493|Venetoclax|venetoclax|mesh-list
111229427|NCT04965493|Pirtobrutinib|pirtobrutinib|mesh-list
111229428|NCT04965493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111229429|NCT04965493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111229430|NCT04965493|Immunologic Factors|immunologic factors|mesh-ancestor
111229431|NCT04965493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111229432|NCT04965493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111229433|NCT04965493|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111229434|NCT04965493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111229435|NCT04965493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111229436|NCT04963673|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
111229437|NCT04963673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111229438|NCT04963673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111229439|NCT04963153|Immunoconjugates|immunoconjugates|mesh-list
111229440|NCT04963153|Immunologic Factors|immunologic factors|mesh-ancestor
111229441|NCT04963153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111229442|NCT04962009|Travoprost|travoprost|mesh-list
111229443|NCT04962009|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111229444|NCT04954599|Carboplatin|carboplatin|mesh-list
111229445|NCT04954599|Pembrolizumab|pembrolizumab|mesh-list
111229446|NCT04954599|Nivolumab|nivolumab|mesh-list
111229447|NCT04954599|Ipilimumab|ipilimumab|mesh-list
111229448|NCT04954599|Atezolizumab|atezolizumab|mesh-list
111229449|NCT04954599|Durvalumab|durvalumab|mesh-list
111229450|NCT04954599|Avelumab|avelumab|mesh-list
111229451|NCT04954599|Cemiplimab|cemiplimab|mesh-list
111229452|NCT04954599|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
111229453|NCT04954599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111229454|NCT04954599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111229455|NCT04954599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111229456|NCT04948697|Tislelizumab|tislelizumab|mesh-list
111229457|NCT04948697|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111229458|NCT04948697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111229459|NCT04941287|Atezolizumab|atezolizumab|mesh-list
111229460|NCT04941287|Immunoglobulins|immunoglobulins|mesh-list
111229461|NCT04941287|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111229462|NCT04941287|Immunoglobulin G|immunoglobulin g|mesh-list
111229463|NCT04941287|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111229464|NCT04941287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111229465|NCT04941287|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111229466|NCT04941287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111229467|NCT04941287|Immunologic Factors|immunologic factors|mesh-ancestor
111229468|NCT04941287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111229469|NCT04931342|Maytansine|maytansine|mesh-list
111229470|NCT04931342|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
111229471|NCT04931342|Cyclophosphamide|cyclophosphamide|mesh-list
111229472|NCT04931342|Bevacizumab|bevacizumab|mesh-list
111229473|NCT04931342|Trastuzumab|trastuzumab|mesh-list
111229474|NCT04931342|Atezolizumab|atezolizumab|mesh-list
111229475|NCT04931342|Letrozole|letrozole|mesh-list
111229476|NCT04931342|Olaparib|olaparib|mesh-list
111229477|NCT04931342|Palbociclib|palbociclib|mesh-list
111229478|NCT04931342|Ipatasertib|ipatasertib|mesh-list
111229479|NCT04931342|Hormones|hormones|mesh-list
111229480|NCT04931342|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
111229481|NCT04931342|Inavolisib|inavolisib|mesh-list
110809070|NCT05563480|Cisplatin|cisplatin|mesh-list
111229482|NCT04931342|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111229483|NCT04931342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111229484|NCT04931342|Tubulin Modulators|tubulin modulators|mesh-ancestor
111229485|NCT04931342|Antimitotic Agents|antimitotic agents|mesh-ancestor
111229486|NCT04931342|Mitosis Modulators|mitosis modulators|mesh-ancestor
111229487|NCT04931342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111229488|NCT04931342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111229489|NCT04931342|Immunologic Factors|immunologic factors|mesh-ancestor
111229490|NCT04931342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111229491|NCT04931342|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111229492|NCT04931342|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111229493|NCT04931342|Alkylating Agents|alkylating agents|mesh-ancestor
111229494|NCT04931342|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111229495|NCT04931342|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111229496|NCT04931342|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111229497|NCT04931342|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111229498|NCT04931342|Growth Substances|growth substances|mesh-ancestor
111229499|NCT04931342|Growth Inhibitors|growth inhibitors|mesh-ancestor
111229500|NCT04931342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111229501|NCT04931342|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111229502|NCT04931342|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111229503|NCT04931342|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111229504|NCT04931342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111229505|NCT04931342|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111229506|NCT04931342|Hormone Antagonists|hormone antagonists|mesh-ancestor
111229507|NCT04931342|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111229508|NCT04931342|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111229509|NCT04931342|Immunotoxins|immunotoxins|mesh-ancestor
111229510|NCT04931342|Immunoconjugates|immunoconjugates|mesh-ancestor
111229511|NCT04931342|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
111229512|NCT04926545|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
111229513|NCT04926545|Fluorouracil|fluorouracil|mesh-list
111229514|NCT04926545|Irinotecan|irinotecan|mesh-list
111229515|NCT04926545|Antimetabolites|antimetabolites|mesh-ancestor
111229516|NCT04926545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111229517|NCT04926545|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111229518|NCT04926545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111229519|NCT04926545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111229520|NCT04926545|Immunologic Factors|immunologic factors|mesh-ancestor
111229521|NCT04926545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111229522|NCT04926545|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111229523|NCT04926545|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111229524|NCT04926545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111229525|NCT04926545|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111229526|NCT04926545|Hormone Antagonists|hormone antagonists|mesh-ancestor
111229527|NCT04926545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111229528|NCT04926545|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111229529|NCT04926545|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111229530|NCT04926545|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111229531|NCT04916548|Ketamine|ketamine|mesh-list
111229532|NCT04916548|Analgesics|analgesics|mesh-ancestor
111229533|NCT04916548|Sensory System Agents|sensory system agents|mesh-ancestor
111229534|NCT04916548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111229535|NCT04916548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111229536|NCT04916548|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111229537|NCT04916548|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111229539|NCT04916548|Anesthetics|anesthetics|mesh-ancestor
111229540|NCT04916548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111229541|NCT04916548|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111229542|NCT04916548|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111229543|NCT04916548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111229544|NCT04916548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111229545|NCT04887831|Carboplatin|carboplatin|mesh-list
111229546|NCT04887831|Gemcitabine|gemcitabine|mesh-list
111229547|NCT04887831|Avelumab|avelumab|mesh-list
111229548|NCT04887831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111229549|NCT04887831|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111229550|NCT04887831|Antimetabolites|antimetabolites|mesh-ancestor
111229551|NCT04887831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111229552|NCT04887831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111229553|NCT04884360|Olaparib|olaparib|mesh-list
111229554|NCT04884360|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111229555|NCT04884360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111229556|NCT04884360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111229557|NCT04884360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111229558|NCT04883749|Acalabrutinib|acalabrutinib|mesh-list
111229559|NCT04883749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111229560|NCT04874480|Decitabine|decitabine|mesh-list
111229561|NCT04874480|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111229562|NCT04874480|Antimetabolites|antimetabolites|mesh-ancestor
111229563|NCT04874480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111229564|NCT04874480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111229565|NCT04874480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111229566|NCT04873583|Methylprednisolone|methylprednisolone|mesh-list
111229567|NCT04873583|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111229568|NCT04873583|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111229569|NCT04873583|Prednisolone|prednisolone|mesh-list
111229570|NCT04873583|Prednisolone acetate|prednisolone acetate|mesh-list
111229571|NCT04873583|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111229572|NCT04873583|Prednisolone phosphate|prednisolone phosphate|mesh-list
111229573|NCT04873583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111229574|NCT04873583|Antiemetics|antiemetics|mesh-ancestor
111229575|NCT04873583|Autonomic Agents|autonomic agents|mesh-ancestor
111229576|NCT04873583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111229577|NCT04873583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111229578|NCT04873583|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111229579|NCT04873583|Glucocorticoids|glucocorticoids|mesh-ancestor
111229580|NCT04873583|Hormones|hormones|mesh-ancestor
111229581|NCT04873583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111229582|NCT04873583|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111229583|NCT04873583|Protective Agents|protective agents|mesh-ancestor
111229584|NCT04873583|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111229585|NCT04873583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111229586|NCT04872543|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
111229587|NCT04872543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111229588|NCT04872543|Antimetabolites|antimetabolites|mesh-ancestor
111229589|NCT04872543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111229590|NCT04872543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111229591|NCT04857138|Atezolizumab|atezolizumab|mesh-list
111229592|NCT04857138|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111229593|NCT04857138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111229594|NCT04857138|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111229595|NCT04857138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111229596|NCT04848480|Insulin|insulin|mesh-list
111229597|NCT04848480|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111229598|NCT04848480|Insulin Aspart|insulin aspart|mesh-list
111229599|NCT04848480|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111229600|NCT04848480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111229601|NCT04841018|Dexamethasone|dexamethasone|mesh-list
111229602|NCT04841018|Dexamethasone acetate|dexamethasone acetate|mesh-list
111229603|NCT04841018|BB 1101|bb 1101|mesh-list
111229604|NCT04841018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111229605|NCT04841018|Antiemetics|antiemetics|mesh-ancestor
111229606|NCT04841018|Autonomic Agents|autonomic agents|mesh-ancestor
111229607|NCT04841018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111229608|NCT04841018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111229609|NCT04841018|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111229610|NCT04841018|Glucocorticoids|glucocorticoids|mesh-ancestor
111229611|NCT04841018|Hormones|hormones|mesh-ancestor
111229612|NCT04841018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111229613|NCT04841018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111229614|NCT04841018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111229615|NCT04841018|Protease Inhibitors|protease inhibitors|mesh-ancestor
111229616|NCT04841018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111229617|NCT04841018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111229618|NCT04840264|Docetaxel|docetaxel|mesh-list
111229619|NCT04840264|Fluorouracil|fluorouracil|mesh-list
111229620|NCT04840264|Oxaliplatin|oxaliplatin|mesh-list
111229621|NCT04840264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111229622|NCT04840264|Tubulin Modulators|tubulin modulators|mesh-ancestor
111229623|NCT04840264|Antimitotic Agents|antimitotic agents|mesh-ancestor
111229624|NCT04840264|Mitosis Modulators|mitosis modulators|mesh-ancestor
111229625|NCT04840264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111229626|NCT04840264|Antimetabolites|antimetabolites|mesh-ancestor
111229627|NCT04840264|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111229628|NCT04840264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111229629|NCT04840264|Immunologic Factors|immunologic factors|mesh-ancestor
111229630|NCT04840264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111229631|NCT04838613|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
111229632|NCT04838613|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111229633|NCT04838613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111229634|NCT04837859|Tislelizumab|tislelizumab|mesh-list
111229635|NCT04837859|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111229636|NCT04837859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111229637|NCT04837066|Imidacloprid|imidacloprid|mesh-list
111229638|NCT04837066|Cholinergic Agents|cholinergic agents|mesh-ancestor
111229639|NCT04837066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111229640|NCT04837066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111229641|NCT04837066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111229642|NCT04833855|Omalizumab|omalizumab|mesh-list
111229643|NCT04833855|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111229644|NCT04833855|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111229645|NCT04833855|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111229646|NCT04833855|Respiratory System Agents|respiratory system agents|mesh-ancestor
111229647|NCT04833855|Immunologic Factors|immunologic factors|mesh-ancestor
111229648|NCT04833855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111229649|NCT04832854|Paclitaxel|paclitaxel|mesh-list
111229650|NCT04832854|Carboplatin|carboplatin|mesh-list
111229651|NCT04832854|Gemcitabine|gemcitabine|mesh-list
111229652|NCT04832854|Pemetrexed|pemetrexed|mesh-list
111229653|NCT04832854|Atezolizumab|atezolizumab|mesh-list
111229654|NCT04832854|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111229655|NCT04832854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111229656|NCT04832854|Tubulin Modulators|tubulin modulators|mesh-ancestor
111229657|NCT04832854|Antimitotic Agents|antimitotic agents|mesh-ancestor
111229658|NCT04832854|Mitosis Modulators|mitosis modulators|mesh-ancestor
111229659|NCT04832854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111229660|NCT04832854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111229661|NCT04832854|Antimetabolites|antimetabolites|mesh-ancestor
111229662|NCT04832854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111229663|NCT04832854|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111229664|NCT04832854|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111229665|NCT04832854|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111229666|NCT04832854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111229667|NCT04827745|Blinatumomab|blinatumomab|mesh-list
111229668|NCT04827745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111229669|NCT04816643|Vaccines|vaccines|mesh-list
111229670|NCT04816643|Immunologic Factors|immunologic factors|mesh-ancestor
111229671|NCT04816643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111229672|NCT04802759|Trastuzumab|trastuzumab|mesh-list
111229673|NCT04802759|Atezolizumab|atezolizumab|mesh-list
111229674|NCT04802759|Pertuzumab|pertuzumab|mesh-list
111229675|NCT04802759|Everolimus|everolimus|mesh-list
111229676|NCT04802759|Palbociclib|palbociclib|mesh-list
111229677|NCT04802759|Ipatasertib|ipatasertib|mesh-list
111229678|NCT04802759|Inavolisib|inavolisib|mesh-list
111229679|NCT04802759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111229680|NCT04802759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111229681|NCT04802759|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111229682|NCT04802759|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111229683|NCT04802759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110954083|NCT04846478|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111229684|NCT04802759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111229685|NCT04802759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111229686|NCT04802759|Immunologic Factors|immunologic factors|mesh-ancestor
111229687|NCT04802759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111229688|NCT04802759|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111229689|NCT04802759|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
111229690|NCT04788823|Prednisone|prednisone|mesh-list
111229691|NCT04788823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111229692|NCT04788823|Glucocorticoids|glucocorticoids|mesh-ancestor
111229693|NCT04788823|Hormones|hormones|mesh-ancestor
111229694|NCT04788823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111229695|NCT04788823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111229696|NCT04788823|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111229697|NCT04788823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111229698|NCT04770896|Sorafenib|sorafenib|mesh-list
111229699|NCT04770896|Atezolizumab|atezolizumab|mesh-list
111229700|NCT04770896|Lenvatinib|lenvatinib|mesh-list
111229701|NCT04770896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111229702|NCT04770896|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111229703|NCT04770896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111229704|NCT04770896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111229705|NCT04770896|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111229706|NCT04770896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111229707|NCT04747496|Edoxaban|edoxaban|mesh-list
111229708|NCT04747496|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111229709|NCT04747496|Antithrombins|antithrombins|mesh-ancestor
111229710|NCT04747496|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111229711|NCT04747496|Protease Inhibitors|protease inhibitors|mesh-ancestor
111229712|NCT04747496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111229713|NCT04747496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111229714|NCT04747496|Anticoagulants|anticoagulants|mesh-ancestor
111229715|NCT04747145|Temozolomide|temozolomide|mesh-list
111229716|NCT04747145|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111229717|NCT04747145|Alkylating Agents|alkylating agents|mesh-ancestor
111229718|NCT04747145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111229719|NCT04747145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111229720|NCT04744831|Camptothecin|camptothecin|mesh-list
111229721|NCT04744831|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
111229722|NCT04744831|Immunoconjugates|immunoconjugates|mesh-list
111229723|NCT04744831|Immunologic Factors|immunologic factors|mesh-ancestor
111229724|NCT04744831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111229725|NCT04744831|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111229726|NCT04744831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111229727|NCT04744831|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111229728|NCT04744831|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111229729|NCT04744831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111229730|NCT04744831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111229731|NCT04734535|Thrombin|thrombin|mesh-list
111229732|NCT04734535|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
111229733|NCT04734535|Hemostatics|hemostatics|mesh-ancestor
111229734|NCT04734535|Coagulants|coagulants|mesh-ancestor
111229735|NCT04729959|Atezolizumab|atezolizumab|mesh-list
111229736|NCT04729959|Immunoglobulins|immunoglobulins|mesh-list
111229737|NCT04729959|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111229738|NCT04729959|Immunoglobulin G|immunoglobulin g|mesh-list
111229739|NCT04729959|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111229740|NCT04729959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111229741|NCT04729959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111229742|NCT04729959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111229743|NCT04729959|Immunologic Factors|immunologic factors|mesh-ancestor
111229744|NCT04729959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111229745|NCT04729205|Mitomycins|mitomycins|mesh-list
111229746|NCT04729205|Mitomycin|mitomycin|mesh-list
111229747|NCT04729205|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111229748|NCT04729205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111229749|NCT04729205|Alkylating Agents|alkylating agents|mesh-ancestor
111229750|NCT04729205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111229751|NCT04729205|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111229752|NCT04729205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111229753|NCT04727151|Pembrolizumab|pembrolizumab|mesh-list
111229754|NCT04727151|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111229755|NCT04727151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111229756|NCT04727151|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111229757|NCT04727151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111229758|NCT04723446|Chlorhexidine|chlorhexidine|mesh-list
111229759|NCT04723446|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
111229760|NCT04723446|Hydrogen Peroxide|hydrogen peroxide|mesh-list
111229761|NCT04723446|Cetylpyridinium|cetylpyridinium|mesh-list
111229762|NCT04723446|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111229763|NCT04723446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111229764|NCT04723446|Disinfectants|disinfectants|mesh-ancestor
111229765|NCT04723446|Dermatologic Agents|dermatologic agents|mesh-ancestor
111229766|NCT04689828|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
111229768|NCT04689828|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111229769|NCT04689828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111229770|NCT04686305|Carboplatin|carboplatin|mesh-list
111229771|NCT04686305|Trastuzumab|trastuzumab|mesh-list
111229772|NCT04686305|Pemetrexed|pemetrexed|mesh-list
111229773|NCT04686305|Durvalumab|durvalumab|mesh-list
111229774|NCT04686305|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
111229775|NCT04686305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111229776|NCT04686305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111229777|NCT04686305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110809352|NCT03956303|Anesthetics|anesthetics|mesh-ancestor
111229778|NCT04686305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111229779|NCT04686305|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111229780|NCT04686305|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111229781|NCT04686305|Immunoconjugates|immunoconjugates|mesh-ancestor
111229782|NCT04686305|Immunologic Factors|immunologic factors|mesh-ancestor
111229783|NCT04686305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111229784|NCT04676646|Spironolactone|spironolactone|mesh-list
111229785|NCT04676646|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
111229786|NCT04676646|Hormone Antagonists|hormone antagonists|mesh-ancestor
111229787|NCT04676646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111229788|NCT04676646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111229789|NCT04676646|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
111229790|NCT04676646|Diuretics|diuretics|mesh-ancestor
111229791|NCT04676646|Natriuretic Agents|natriuretic agents|mesh-ancestor
111229792|NCT04670432|Troxerutin|troxerutin|mesh-list
111229793|NCT04670432|Anticoagulants|anticoagulants|mesh-ancestor
111229794|NCT04665648|Nicorandil|nicorandil|mesh-list
111229795|NCT04665648|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111229796|NCT04665648|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111229797|NCT04665648|Vasodilator Agents|vasodilator agents|mesh-ancestor
111229798|NCT04665648|Vitamin B Complex|vitamin b complex|mesh-ancestor
111229799|NCT04665648|Vitamins|vitamins|mesh-ancestor
111229800|NCT04665648|Micronutrients|micronutrients|mesh-ancestor
111229801|NCT04665648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111229802|NCT04663997|Docetaxel|docetaxel|mesh-list
111229803|NCT04663997|177Lu-PSMA-617|177lu-psma-617|mesh-list
111229804|NCT04663997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111229805|NCT04663997|Tubulin Modulators|tubulin modulators|mesh-ancestor
111229806|NCT04663997|Antimitotic Agents|antimitotic agents|mesh-ancestor
111229807|NCT04663997|Mitosis Modulators|mitosis modulators|mesh-ancestor
111229808|NCT04663997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111229809|NCT04663997|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111229810|NCT04657991|Pembrolizumab|pembrolizumab|mesh-list
111229811|NCT04657991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111229812|NCT04657991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111229813|NCT04657991|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111229814|NCT04657991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111229815|NCT04637763|Cyclophosphamide|cyclophosphamide|mesh-list
111229816|NCT04637763|Fludarabine|fludarabine|mesh-list
111229817|NCT04637763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111229818|NCT04637763|Immunologic Factors|immunologic factors|mesh-ancestor
111229819|NCT04637763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111229820|NCT04637763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111229821|NCT04637763|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111229822|NCT04637763|Alkylating Agents|alkylating agents|mesh-ancestor
111229823|NCT04637763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111229824|NCT04637763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111229825|NCT04637763|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111229826|NCT04637594|Pembrolizumab|pembrolizumab|mesh-list
111229827|NCT04637594|Nivolumab|nivolumab|mesh-list
111229828|NCT04637594|Atezolizumab|atezolizumab|mesh-list
111229829|NCT04637594|Durvalumab|durvalumab|mesh-list
111229830|NCT04637594|Avelumab|avelumab|mesh-list
111229831|NCT04637594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111229832|NCT04637594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111229833|NCT04637594|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111229834|NCT04637594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110954234|NCT04549311|Amoxicillin|amoxicillin|mesh-list
111229835|NCT04625283|Ketamine|ketamine|mesh-list
111229836|NCT04625283|Analgesics|analgesics|mesh-ancestor
111229837|NCT04625283|Sensory System Agents|sensory system agents|mesh-ancestor
111229838|NCT04625283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111229839|NCT04625283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111229840|NCT04625283|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111229841|NCT04625283|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111229842|NCT04625283|Anesthetics, General|anesthetics, general|mesh-ancestor
111229844|NCT04625283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111229845|NCT04625283|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111229846|NCT04625283|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111229847|NCT04625283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111229848|NCT04625283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111229849|NCT04623099|Escitalopram|escitalopram|mesh-list
111229850|NCT04623099|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111229851|NCT04623099|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111229852|NCT04623099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111229853|NCT04623099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111229854|NCT04623099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111229855|NCT04623099|Serotonin Agents|serotonin agents|mesh-ancestor
111229856|NCT04623099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111229857|NCT04619797|Carboplatin|carboplatin|mesh-list
111229858|NCT04619797|Pembrolizumab|pembrolizumab|mesh-list
111229859|NCT04619797|Pemetrexed|pemetrexed|mesh-list
111229860|NCT04619797|Atezolizumab|atezolizumab|mesh-list
111229861|NCT04619797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111229862|NCT04619797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111229863|NCT04619797|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111229864|NCT04619797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111229865|NCT04619797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111229866|NCT04619797|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111229867|NCT04619797|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111229868|NCT04619680|Nintedanib|nintedanib|mesh-list
111229869|NCT04619680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111229870|NCT04619680|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111229871|NCT04619680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111229872|NCT04619680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111229873|NCT04616183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111229874|NCT04616183|Cetuximab|cetuximab|mesh-list
111229875|NCT04616183|Antibodies|antibodies|mesh-list
111229876|NCT04616183|Immunoglobulins|immunoglobulins|mesh-list
111229877|NCT04616183|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111229878|NCT04616183|Immunologic Factors|immunologic factors|mesh-ancestor
111229879|NCT04616183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111229880|NCT04616183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111229881|NCT04609579|Pembrolizumab|pembrolizumab|mesh-list
111229882|NCT04609579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111229883|NCT04609579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111229884|NCT04609579|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111229885|NCT04609579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111229886|NCT04599140|Nivolumab|nivolumab|mesh-list
111229887|NCT04599140|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111229888|NCT04599140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111229889|NCT04599140|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111229890|NCT04599140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111229891|NCT04586010|Teriflunomide|teriflunomide|mesh-list
111229892|NCT04586010|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111229893|NCT04586010|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111229894|NCT04586010|Analgesics|analgesics|mesh-ancestor
111229895|NCT04586010|Sensory System Agents|sensory system agents|mesh-ancestor
111229896|NCT04586010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111229897|NCT04586010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111229898|NCT04586010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111229899|NCT04586010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111229900|NCT04586010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111229901|NCT04586010|Immunologic Factors|immunologic factors|mesh-ancestor
111229902|NCT04579367|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
111229903|NCT04579367|Ezetimibe|ezetimibe|mesh-list
111229904|NCT04579367|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111229905|NCT04579367|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111229906|NCT04579367|Antimetabolites|antimetabolites|mesh-ancestor
111229907|NCT04579367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111229908|NCT04579367|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111229909|NCT04579367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111229910|NCT04579367|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111229911|NCT04579367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111229912|NCT04572256|Montelukast|montelukast|mesh-list
111229913|NCT04572256|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111229914|NCT04572256|Respiratory System Agents|respiratory system agents|mesh-ancestor
111229915|NCT04572256|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
111229916|NCT04572256|Hormone Antagonists|hormone antagonists|mesh-ancestor
111229917|NCT04572256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111229918|NCT04572256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111229919|NCT04572256|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
111229920|NCT04572256|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111229921|NCT04572256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111229922|NCT04571580|Reteplase|reteplase|mesh-list
111229923|NCT04571580|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
111229924|NCT04571580|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111229925|NCT04571580|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111229926|NCT04571580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111229927|NCT04567108|Benzocaine|benzocaine|mesh-list
111229928|NCT04567108|Anesthetics, Local|anesthetics, local|mesh-ancestor
111229929|NCT04567108|Anesthetics|anesthetics|mesh-ancestor
111229930|NCT04567108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111229931|NCT04567108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111229932|NCT04567108|Sensory System Agents|sensory system agents|mesh-ancestor
111229933|NCT04567108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111229934|NCT04544449|Ocrelizumab|ocrelizumab|mesh-list
111229935|NCT04544449|Immunologic Factors|immunologic factors|mesh-ancestor
111229936|NCT04544449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111229937|NCT04542070|Rilpivirine|rilpivirine|mesh-list
111229938|NCT04542070|Cabotegravir|cabotegravir|mesh-list
111229939|NCT04542070|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111229940|NCT04542070|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111229941|NCT04542070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111229942|NCT04542070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111229943|NCT04542070|Antiviral Agents|antiviral agents|mesh-ancestor
111229944|NCT04542070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111229945|NCT04542070|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111229946|NCT04542070|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111229947|NCT04542070|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111229948|NCT04542070|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111229949|NCT04538950|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
111229950|NCT04538950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111229951|NCT04530305|Upadacitinib|upadacitinib|mesh-list
111229952|NCT04530305|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
111229953|NCT04530305|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111229954|NCT04530305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111229955|NCT04530305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111229956|NCT04530305|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111229957|NCT04529772|Prednisone|prednisone|mesh-list
111229958|NCT04529772|Cyclophosphamide|cyclophosphamide|mesh-list
111229959|NCT04529772|Rituximab|rituximab|mesh-list
111229960|NCT04529772|Doxorubicin|doxorubicin|mesh-list
111229961|NCT04529772|Vincristine|vincristine|mesh-list
111229962|NCT04529772|Acalabrutinib|acalabrutinib|mesh-list
111229963|NCT04529772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111229964|NCT04529772|Immunologic Factors|immunologic factors|mesh-ancestor
111229965|NCT04529772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111229966|NCT04529772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111229967|NCT04529772|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111229968|NCT04529772|Alkylating Agents|alkylating agents|mesh-ancestor
111229969|NCT04529772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111229970|NCT04529772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111229971|NCT04529772|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111229972|NCT04529772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111229973|NCT04529772|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111229974|NCT04529772|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111229975|NCT04529772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111229976|NCT04529772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111229977|NCT04529772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111229978|NCT04529772|Glucocorticoids|glucocorticoids|mesh-ancestor
111229979|NCT04529772|Hormones|hormones|mesh-ancestor
111229980|NCT04529772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111229981|NCT04529772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111229982|NCT04529772|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110954378|NCT04170738|Amphetamine|amphetamine|mesh-list
111229983|NCT04529772|Tubulin Modulators|tubulin modulators|mesh-ancestor
111229984|NCT04529772|Antimitotic Agents|antimitotic agents|mesh-ancestor
111229985|NCT04529772|Mitosis Modulators|mitosis modulators|mesh-ancestor
111229986|NCT04526795|Cytarabine|cytarabine|mesh-list
111229987|NCT04526795|Fludarabine|fludarabine|mesh-list
111229988|NCT04526795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111229989|NCT04526795|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111229990|NCT04526795|Antimetabolites|antimetabolites|mesh-ancestor
111229991|NCT04526795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111229992|NCT04526795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111229993|NCT04526795|Immunologic Factors|immunologic factors|mesh-ancestor
111229994|NCT04526795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111229995|NCT04526795|Antiviral Agents|antiviral agents|mesh-ancestor
111229996|NCT04526795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111229997|NCT04513951|Leucovorin|leucovorin|mesh-list
111229998|NCT04513951|Fluorouracil|fluorouracil|mesh-list
111229999|NCT04513951|Oxaliplatin|oxaliplatin|mesh-list
111230000|NCT04513951|Irinotecan|irinotecan|mesh-list
111230001|NCT04513951|Cetuximab|cetuximab|mesh-list
111230002|NCT04513951|Avelumab|avelumab|mesh-list
111230003|NCT04513951|Levoleucovorin|levoleucovorin|mesh-list
111230004|NCT04513951|Antimetabolites|antimetabolites|mesh-ancestor
111230005|NCT04513951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111230006|NCT04513951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111230007|NCT04513951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111230008|NCT04513951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111230009|NCT04513951|Immunologic Factors|immunologic factors|mesh-ancestor
111230010|NCT04513951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111230011|NCT04513951|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111230012|NCT04513951|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111230013|NCT04513951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111230014|NCT04513951|Antidotes|antidotes|mesh-ancestor
111230015|NCT04513951|Protective Agents|protective agents|mesh-ancestor
111230016|NCT04513951|Vitamin B Complex|vitamin b complex|mesh-ancestor
111230017|NCT04513951|Vitamins|vitamins|mesh-ancestor
111230018|NCT04513951|Micronutrients|micronutrients|mesh-ancestor
111230019|NCT04513951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111230020|NCT04513522|Nivolumab|nivolumab|mesh-list
111230021|NCT04513522|Ipilimumab|ipilimumab|mesh-list
111230022|NCT04513522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111230023|NCT04513522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111230024|NCT04513522|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111230025|NCT04513522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111230026|NCT04509596|Capecitabine|capecitabine|mesh-list
111230027|NCT04509596|Trastuzumab|trastuzumab|mesh-list
111230028|NCT04509596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111230029|NCT04509596|Antimetabolites|antimetabolites|mesh-ancestor
111230030|NCT04509596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111230031|NCT04509596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111230032|NCT04509596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111230033|NCT04499235|Mometasone Furoate|mometasone furoate|mesh-list
111230034|NCT04499235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111230035|NCT04499235|Dermatologic Agents|dermatologic agents|mesh-ancestor
111230036|NCT04499235|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111230037|NCT04476446|Esketamine|esketamine|mesh-list
111230038|NCT04476446|Antidepressive Agents|antidepressive agents|mesh-ancestor
111230039|NCT04476446|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111230040|NCT04465071|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111230041|NCT04465071|Lubricant Eye Drops|lubricant eye drops|mesh-list
111230042|NCT04465071|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111230043|NCT04445688|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
111230044|NCT04445688|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111230045|NCT04445688|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111230046|NCT04445688|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111230047|NCT04445688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111230048|NCT04445688|Adrenergic Agents|adrenergic agents|mesh-ancestor
111230049|NCT04445688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111230050|NCT04445688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111230051|NCT04436250|Ketamine|ketamine|mesh-list
111230052|NCT04436250|Esketamine|esketamine|mesh-list
111230053|NCT04436250|Analgesics|analgesics|mesh-ancestor
111230054|NCT04436250|Sensory System Agents|sensory system agents|mesh-ancestor
111230055|NCT04436250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111230056|NCT04436250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111230057|NCT04436250|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111230058|NCT04436250|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111230059|NCT04436250|Anesthetics, General|anesthetics, general|mesh-ancestor
111230060|NCT04436250|Anesthetics|anesthetics|mesh-ancestor
111230061|NCT04436250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111230062|NCT04436250|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111230063|NCT04436250|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111230064|NCT04436250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111230065|NCT04436250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111230066|NCT04436250|Antidepressive Agents|antidepressive agents|mesh-ancestor
111230067|NCT04436250|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111230068|NCT04396574|Lasmiditan|lasmiditan|mesh-list
111230069|NCT04396574|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111230070|NCT04396574|Serotonin Agents|serotonin agents|mesh-ancestor
111230071|NCT04396574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111230072|NCT04396574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111230073|NCT04396574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111230074|NCT04396236|Lasmiditan|lasmiditan|mesh-list
111230075|NCT04396236|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111230076|NCT04396236|Serotonin Agents|serotonin agents|mesh-ancestor
111230077|NCT04396236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111230078|NCT04396236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111230079|NCT04396236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111230080|NCT04355832|Glucagon|glucagon|mesh-list
111230081|NCT04355832|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
111230082|NCT04355832|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111230083|NCT04355832|Hormones|hormones|mesh-ancestor
111230084|NCT04355832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111230085|NCT04355832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111230086|NCT04355832|Incretins|incretins|mesh-ancestor
111230087|NCT04330820|Venetoclax|venetoclax|mesh-list
111230088|NCT04330820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111230089|NCT04330664|Adagrasib|adagrasib|mesh-list
111230090|NCT04330664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111230091|NCT04329494|Leucovorin|leucovorin|mesh-list
111230092|NCT04329494|Cisplatin|cisplatin|mesh-list
111230093|NCT04329494|Doxorubicin|doxorubicin|mesh-list
111230094|NCT04329494|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111230095|NCT04329494|Fluorouracil|fluorouracil|mesh-list
111230096|NCT04329494|Oxaliplatin|oxaliplatin|mesh-list
111230097|NCT04329494|Irinotecan|irinotecan|mesh-list
111230098|NCT04329494|Daunorubicin|daunorubicin|mesh-list
111230099|NCT04329494|Mitomycins|mitomycins|mesh-list
111230100|NCT04329494|Mitomycin|mitomycin|mesh-list
111230101|NCT04329494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111230102|NCT04329494|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111230103|NCT04329494|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111230104|NCT04329494|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111230105|NCT04329494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111230106|NCT04329494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111230107|NCT04329494|Antimetabolites|antimetabolites|mesh-ancestor
111230108|NCT04329494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111230109|NCT04329494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111230110|NCT04329494|Immunologic Factors|immunologic factors|mesh-ancestor
111230111|NCT04329494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111230112|NCT04329494|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111230113|NCT04329494|Antidotes|antidotes|mesh-ancestor
111230114|NCT04329494|Protective Agents|protective agents|mesh-ancestor
111230115|NCT04329494|Vitamin B Complex|vitamin b complex|mesh-ancestor
111230116|NCT04329494|Vitamins|vitamins|mesh-ancestor
111230117|NCT04329494|Micronutrients|micronutrients|mesh-ancestor
111230118|NCT04329494|Alkylating Agents|alkylating agents|mesh-ancestor
111230119|NCT04329494|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111230120|NCT04305327|Ustekinumab|ustekinumab|mesh-list
111230121|NCT04305327|Brodalumab|brodalumab|mesh-list
111230122|NCT04305327|Dermatologic Agents|dermatologic agents|mesh-ancestor
111230123|NCT04294810|Atezolizumab|atezolizumab|mesh-list
111230124|NCT04294810|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111230125|NCT04294810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111230126|NCT04294810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111230127|NCT04294810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111230128|NCT04278768|Venetoclax|venetoclax|mesh-list
111230129|NCT04278768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111230130|NCT04278144|Nivolumab|nivolumab|mesh-list
111230131|NCT04278144|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111230132|NCT04278144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111230133|NCT04278144|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110954522|NCT03693300|Durvalumab|durvalumab|mesh-list
111230134|NCT04278144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111230135|NCT04274426|Paclitaxel|paclitaxel|mesh-list
111230136|NCT04274426|Maytansine|maytansine|mesh-list
111230137|NCT04274426|Carboplatin|carboplatin|mesh-list
111230139|NCT04274426|Doxorubicin|doxorubicin|mesh-list
111230140|NCT04274426|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111230141|NCT04274426|Mirvetuximab soravtansine|mirvetuximab soravtansine|mesh-list
111230142|NCT04274426|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111230143|NCT04274426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111230144|NCT04274426|Tubulin Modulators|tubulin modulators|mesh-ancestor
111230145|NCT04274426|Antimitotic Agents|antimitotic agents|mesh-ancestor
111230146|NCT04274426|Mitosis Modulators|mitosis modulators|mesh-ancestor
111230147|NCT04274426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111230148|NCT04274426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111230149|NCT04274426|Antimetabolites|antimetabolites|mesh-ancestor
111230150|NCT04274426|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111230151|NCT04274426|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111230152|NCT04274426|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111230153|NCT04274426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111230154|NCT04274426|Immunoconjugates|immunoconjugates|mesh-ancestor
111230155|NCT04274426|Immunologic Factors|immunologic factors|mesh-ancestor
111230156|NCT04274426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111230157|NCT04254107|Brentuximab Vedotin|brentuximab vedotin|mesh-list
111230158|NCT04254107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111230159|NCT04254107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111230160|NCT04254107|Immunotoxins|immunotoxins|mesh-ancestor
111230161|NCT04254107|Immunoconjugates|immunoconjugates|mesh-ancestor
111230162|NCT04254107|Immunologic Factors|immunologic factors|mesh-ancestor
111230163|NCT04254107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111230164|NCT04250116|Apixaban|apixaban|mesh-list
111230165|NCT04250116|Clopidogrel|clopidogrel|mesh-list
111230166|NCT04250116|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111230167|NCT04250116|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111230168|NCT04250116|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111230169|NCT04250116|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111230170|NCT04250116|Purinergic Agents|purinergic agents|mesh-ancestor
111230171|NCT04250116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111230172|NCT04250116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111230173|NCT04250116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111230174|NCT04250116|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111230175|NCT04250116|Antithrombins|antithrombins|mesh-ancestor
111230176|NCT04250116|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111230177|NCT04250116|Protease Inhibitors|protease inhibitors|mesh-ancestor
111230178|NCT04250116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111230179|NCT04250116|Anticoagulants|anticoagulants|mesh-ancestor
111230180|NCT04249882|Naltrexone|naltrexone|mesh-list
111230181|NCT04249882|Varenicline|varenicline|mesh-list
111230182|NCT04249882|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111230183|NCT04249882|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111230184|NCT04249882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111230185|NCT04249882|Sensory System Agents|sensory system agents|mesh-ancestor
111230186|NCT04249882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111230187|NCT04249882|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111230188|NCT04249882|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111230189|NCT04249882|Cholinergic Agents|cholinergic agents|mesh-ancestor
111230190|NCT04249882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111230191|NCT04249882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111230192|NCT04249401|Warfarin|warfarin|mesh-list
111230193|NCT04249401|Rivaroxaban|rivaroxaban|mesh-list
111230194|NCT04249401|Dabigatran|dabigatran|mesh-list
111230195|NCT04249401|Apixaban|apixaban|mesh-list
111230196|NCT04249401|Anticoagulants|anticoagulants|mesh-ancestor
111230197|NCT04249401|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111230198|NCT04249401|Antithrombins|antithrombins|mesh-ancestor
111230199|NCT04249401|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111230200|NCT04249401|Protease Inhibitors|protease inhibitors|mesh-ancestor
111230201|NCT04249401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111230202|NCT04249401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111230203|NCT04245748|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
111230204|NCT04245748|Escitalopram|escitalopram|mesh-list
111230205|NCT04245748|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111230206|NCT04245748|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111230207|NCT04245748|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111230208|NCT04245748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111230209|NCT04245748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111230210|NCT04245748|Serotonin Agents|serotonin agents|mesh-ancestor
111230211|NCT04245748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111230212|NCT04245748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111230213|NCT04245748|Antidepressive Agents|antidepressive agents|mesh-ancestor
111230215|NCT04245748|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111230216|NCT04245748|Analgesics|analgesics|mesh-ancestor
111230217|NCT04245748|Sensory System Agents|sensory system agents|mesh-ancestor
111230218|NCT04245748|Dopamine Agents|dopamine agents|mesh-ancestor
111230219|NCT04245436|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
111230220|NCT04245436|Escitalopram|escitalopram|mesh-list
111230221|NCT04245436|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111230222|NCT04245436|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111230223|NCT04245436|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111230224|NCT04245436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111230225|NCT04245436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111230226|NCT04245436|Serotonin Agents|serotonin agents|mesh-ancestor
111230227|NCT04245436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111230228|NCT04245436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111230229|NCT04245436|Antidepressive Agents|antidepressive agents|mesh-ancestor
111230230|NCT04245436|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111230231|NCT04245436|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111230232|NCT04245436|Analgesics|analgesics|mesh-ancestor
111230233|NCT04245436|Sensory System Agents|sensory system agents|mesh-ancestor
111230234|NCT04245436|Dopamine Agents|dopamine agents|mesh-ancestor
111230235|NCT04232553|Mirikizumab|mirikizumab|mesh-list
111230236|NCT04232553|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111230237|NCT04232553|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111230238|NCT04232553|Analgesics|analgesics|mesh-ancestor
111230239|NCT04232553|Sensory System Agents|sensory system agents|mesh-ancestor
111230240|NCT04232553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111230241|NCT04232553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111230242|NCT04232553|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111230243|NCT04232553|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111230244|NCT04232553|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111230245|NCT04232553|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111230246|NCT04222972|Paclitaxel|paclitaxel|mesh-list
111230247|NCT04222972|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111230248|NCT04222972|Carboplatin|carboplatin|mesh-list
111230249|NCT04222972|Gemcitabine|gemcitabine|mesh-list
111230250|NCT04222972|Pembrolizumab|pembrolizumab|mesh-list
111230251|NCT04222972|Pemetrexed|pemetrexed|mesh-list
111230252|NCT04222972|Pralsetinib|pralsetinib|mesh-list
111230253|NCT04222972|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111230254|NCT04222972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111230255|NCT04222972|Tubulin Modulators|tubulin modulators|mesh-ancestor
111230256|NCT04222972|Antimitotic Agents|antimitotic agents|mesh-ancestor
111230257|NCT04222972|Mitosis Modulators|mitosis modulators|mesh-ancestor
111230258|NCT04222972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111230259|NCT04222972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111230260|NCT04222972|Antimetabolites|antimetabolites|mesh-ancestor
111230261|NCT04222972|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111230262|NCT04222972|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111230263|NCT04222972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111230264|NCT04222972|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111230265|NCT04222972|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111230266|NCT04221997|Sertraline|sertraline|mesh-list
111230267|NCT04221997|Antidepressive Agents|antidepressive agents|mesh-ancestor
111230268|NCT04221997|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111230269|NCT04221997|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111230270|NCT04221997|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111230271|NCT04221997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111230272|NCT04221997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111230273|NCT04221997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111230274|NCT04221997|Serotonin Agents|serotonin agents|mesh-ancestor
111230275|NCT04221997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111230276|NCT04218539|Psilocybin|psilocybin|mesh-list
111230277|NCT04218539|Hallucinogens|hallucinogens|mesh-ancestor
111230278|NCT04218539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111230279|NCT04218539|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111230280|NCT04208516|Dexamethasone|dexamethasone|mesh-list
111230281|NCT04208516|Lidocaine|lidocaine|mesh-list
111230282|NCT04208516|Dexmedetomidine|dexmedetomidine|mesh-list
111230283|NCT04208516|Ropivacaine|ropivacaine|mesh-list
111230284|NCT04208516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111230285|NCT04208516|Antiemetics|antiemetics|mesh-ancestor
111230286|NCT04208516|Autonomic Agents|autonomic agents|mesh-ancestor
111230287|NCT04208516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111230288|NCT04208516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111230289|NCT04208516|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111230290|NCT04208516|Glucocorticoids|glucocorticoids|mesh-ancestor
111230292|NCT04208516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111230293|NCT04208516|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111230294|NCT04208516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111230295|NCT04208516|Anesthetics, Local|anesthetics, local|mesh-ancestor
111230296|NCT04208516|Anesthetics|anesthetics|mesh-ancestor
111230297|NCT04208516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111230298|NCT04208516|Sensory System Agents|sensory system agents|mesh-ancestor
111230299|NCT04208516|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111230300|NCT04208516|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111230301|NCT04208516|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111230302|NCT04208516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111230303|NCT04208516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111230304|NCT04208516|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111230305|NCT04208516|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111230306|NCT04208516|Analgesics|analgesics|mesh-ancestor
111230307|NCT04208516|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111230308|NCT04208516|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111230309|NCT04208516|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111230310|NCT04208516|Adrenergic Agents|adrenergic agents|mesh-ancestor
111230311|NCT04208516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111230312|NCT04194554|Leuprolide|leuprolide|mesh-list
111230313|NCT04194554|Abiraterone Acetate|abiraterone acetate|mesh-list
111230314|NCT04194554|Niraparib|niraparib|mesh-list
111230315|NCT04194554|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111230316|NCT04194554|Fertility Agents|fertility agents|mesh-ancestor
111230317|NCT04194554|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111230318|NCT04194554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111230319|NCT04194554|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111230320|NCT04194554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111230321|NCT04194554|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111230322|NCT04194554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111230323|NCT04194554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111230324|NCT04194554|Hormone Antagonists|hormone antagonists|mesh-ancestor
111230325|NCT04194554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111230326|NCT04194554|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111230327|NCT04194554|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111230328|NCT04191889|Apatinib|apatinib|mesh-list
111230329|NCT04191889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111230330|NCT04191889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111230331|NCT04191889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111230332|NCT04191889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111230333|NCT04189783|Bupivacaine|bupivacaine|mesh-list
111230334|NCT04189783|Anesthetics, Local|anesthetics, local|mesh-ancestor
111230335|NCT04189783|Anesthetics|anesthetics|mesh-ancestor
111230336|NCT04189783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111230337|NCT04189783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111230338|NCT04189783|Sensory System Agents|sensory system agents|mesh-ancestor
111230339|NCT04189783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111230340|NCT04185883|Docetaxel|docetaxel|mesh-list
111230341|NCT04185883|Bevacizumab|bevacizumab|mesh-list
111230342|NCT04185883|Carboplatin|carboplatin|mesh-list
111230343|NCT04185883|Pembrolizumab|pembrolizumab|mesh-list
111230344|NCT04185883|Pemetrexed|pemetrexed|mesh-list
111230345|NCT04185883|Everolimus|everolimus|mesh-list
111230346|NCT04185883|Atezolizumab|atezolizumab|mesh-list
111230347|NCT04185883|Palbociclib|palbociclib|mesh-list
111230348|NCT04185883|Panitumumab|panitumumab|mesh-list
111230349|NCT04185883|Trametinib|trametinib|mesh-list
111230350|NCT04185883|Afatinib|afatinib|mesh-list
111230351|NCT04185883|Sotorasib|sotorasib|mesh-list
111230352|NCT04185883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111230353|NCT04185883|Tubulin Modulators|tubulin modulators|mesh-ancestor
111230354|NCT04185883|Antimitotic Agents|antimitotic agents|mesh-ancestor
111230355|NCT04185883|Mitosis Modulators|mitosis modulators|mesh-ancestor
111230356|NCT04185883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111230357|NCT04185883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111230358|NCT04185883|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111230359|NCT04185883|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111230360|NCT04185883|Growth Substances|growth substances|mesh-ancestor
111230361|NCT04185883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111230362|NCT04185883|Growth Inhibitors|growth inhibitors|mesh-ancestor
111230363|NCT04185883|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111230364|NCT04185883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111230365|NCT04185883|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111230366|NCT04185883|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111230367|NCT04185883|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111230368|NCT04185883|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111230369|NCT04185883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111230370|NCT04185883|Immunologic Factors|immunologic factors|mesh-ancestor
111230371|NCT04181255|Poractant alfa|poractant alfa|mesh-list
111230372|NCT04181255|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
111230373|NCT04181255|Respiratory System Agents|respiratory system agents|mesh-ancestor
111230374|NCT04171219|Pembrolizumab|pembrolizumab|mesh-list
111230375|NCT04171219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111230376|NCT04171219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111230377|NCT04171219|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111230378|NCT04171219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111230379|NCT04169737|Venetoclax|venetoclax|mesh-list
111230380|NCT04169737|Obinutuzumab|obinutuzumab|mesh-list
111230381|NCT04169737|Acalabrutinib|acalabrutinib|mesh-list
111230382|NCT04169737|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
111230383|NCT04169737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111230384|NCT04169737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111230385|NCT04169737|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111230386|NCT04169737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111230387|NCT04169737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111230388|NCT04153760|Aspirin|aspirin|mesh-list
111230389|NCT04153760|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111230390|NCT04153760|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111230391|NCT04153760|Analgesics|analgesics|mesh-ancestor
111230392|NCT04153760|Sensory System Agents|sensory system agents|mesh-ancestor
111230393|NCT04153760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111230394|NCT04153760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111230395|NCT04153760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111230396|NCT04153760|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111230397|NCT04153760|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111230398|NCT04153760|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111230399|NCT04153760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111230400|NCT04153760|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111230401|NCT04153760|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111230402|NCT04153760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111230403|NCT04153760|Antipyretics|antipyretics|mesh-ancestor
111230404|NCT04125862|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
111230405|NCT04125862|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111230406|NCT04125862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111230407|NCT04094688|Vitamin D|vitamin d|mesh-list
111230408|NCT04094688|Cholecalciferol|cholecalciferol|mesh-list
111230409|NCT04094688|Leucovorin|leucovorin|mesh-list
111230410|NCT04094688|Bevacizumab|bevacizumab|mesh-list
111230411|NCT04094688|Fluorouracil|fluorouracil|mesh-list
111230412|NCT04094688|Oxaliplatin|oxaliplatin|mesh-list
111230413|NCT04094688|Irinotecan|irinotecan|mesh-list
111230414|NCT04094688|Levoleucovorin|levoleucovorin|mesh-list
111230415|NCT04094688|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111230416|NCT04094688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111230417|NCT04094688|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111230418|NCT04094688|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111230419|NCT04094688|Growth Substances|growth substances|mesh-ancestor
111230420|NCT04094688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111230421|NCT04094688|Growth Inhibitors|growth inhibitors|mesh-ancestor
111230422|NCT04094688|Vitamins|vitamins|mesh-ancestor
111230423|NCT04094688|Micronutrients|micronutrients|mesh-ancestor
111230424|NCT04094688|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111230425|NCT04094688|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111230426|NCT04094688|Antimetabolites|antimetabolites|mesh-ancestor
111230427|NCT04094688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111230428|NCT04094688|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111230429|NCT04094688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111230430|NCT04094688|Immunologic Factors|immunologic factors|mesh-ancestor
111230431|NCT04094688|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111230432|NCT04094688|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111230433|NCT04094688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111230434|NCT04094688|Antidotes|antidotes|mesh-ancestor
111230435|NCT04094688|Protective Agents|protective agents|mesh-ancestor
111230436|NCT04094688|Vitamin B Complex|vitamin b complex|mesh-ancestor
111230437|NCT04085094|Pilocarpine|pilocarpine|mesh-list
111230438|NCT04085094|Miotics|miotics|mesh-ancestor
111230439|NCT04085094|Autonomic Agents|autonomic agents|mesh-ancestor
111230440|NCT04085094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111230441|NCT04085094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111230442|NCT04085094|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
111230443|NCT04085094|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111230444|NCT04085094|Cholinergic Agents|cholinergic agents|mesh-ancestor
111230445|NCT04085094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111230446|NCT04085094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111230447|NCT04081805|Estradiol|estradiol|mesh-list
111230448|NCT04081805|Estrogens|estrogens|mesh-ancestor
111230449|NCT04081805|Hormones|hormones|mesh-ancestor
110810026|NCT01373086|Eplerenone|eplerenone|mesh-list
111230450|NCT04081805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111230451|NCT04081805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111230452|NCT04077723|Obinutuzumab|obinutuzumab|mesh-list
111230453|NCT04077723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111230454|NCT04077723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111230455|NCT04069273|Paclitaxel|paclitaxel|mesh-list
111230456|NCT04069273|Pembrolizumab|pembrolizumab|mesh-list
111230457|NCT04069273|Ramucirumab|ramucirumab|mesh-list
111230458|NCT04069273|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111230459|NCT04069273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111230460|NCT04069273|Tubulin Modulators|tubulin modulators|mesh-ancestor
111230461|NCT04069273|Antimitotic Agents|antimitotic agents|mesh-ancestor
111230462|NCT04069273|Mitosis Modulators|mitosis modulators|mesh-ancestor
111230463|NCT04069273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111230464|NCT04069273|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111230465|NCT04069273|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111230466|NCT04066114|Mycophenolic Acid|mycophenolic acid|mesh-list
111230467|NCT04066114|Prednisone|prednisone|mesh-list
111230468|NCT04066114|Methylprednisolone|methylprednisolone|mesh-list
111230469|NCT04066114|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111230470|NCT04066114|Everolimus|everolimus|mesh-list
111230471|NCT04066114|Abatacept|abatacept|mesh-list
111230472|NCT04066114|Thymoglobulin|thymoglobulin|mesh-list
111230473|NCT04066114|Antilymphocyte Serum|antilymphocyte serum|mesh-list
111230474|NCT04066114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111230475|NCT04066114|Glucocorticoids|glucocorticoids|mesh-ancestor
111230476|NCT04066114|Hormones|hormones|mesh-ancestor
111230477|NCT04066114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111230478|NCT04066114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111230479|NCT04066114|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111230480|NCT04066114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111230481|NCT04066114|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111230482|NCT04066114|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111230483|NCT04066114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111230484|NCT04066114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111230485|NCT04066114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111230486|NCT04066114|Immunologic Factors|immunologic factors|mesh-ancestor
111230487|NCT04066114|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111230488|NCT04066114|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111230489|NCT04066114|Antitubercular Agents|antitubercular agents|mesh-ancestor
111230490|NCT04066114|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111230491|NCT04066114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111230492|NCT04066114|Antiemetics|antiemetics|mesh-ancestor
111230493|NCT04066114|Autonomic Agents|autonomic agents|mesh-ancestor
111230494|NCT04066114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111230495|NCT04066114|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111230496|NCT04066114|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111230497|NCT04066114|Protective Agents|protective agents|mesh-ancestor
111230498|NCT04066114|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111230499|NCT04066114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111230500|NCT04066114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111230501|NCT04029688|Cytarabine|cytarabine|mesh-list
111230502|NCT04029688|Cyclophosphamide|cyclophosphamide|mesh-list
111230503|NCT04029688|Fludarabine|fludarabine|mesh-list
111230504|NCT04029688|Venetoclax|venetoclax|mesh-list
111230505|NCT04029688|Topotecan|topotecan|mesh-list
111230506|NCT04029688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111230507|NCT04029688|Immunologic Factors|immunologic factors|mesh-ancestor
111230508|NCT04029688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111230509|NCT04029688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111230510|NCT04029688|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111230511|NCT04029688|Alkylating Agents|alkylating agents|mesh-ancestor
111230512|NCT04029688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111230513|NCT04029688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111230514|NCT04029688|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111230515|NCT04029688|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111230516|NCT04029688|Antimetabolites|antimetabolites|mesh-ancestor
111230517|NCT04029688|Antiviral Agents|antiviral agents|mesh-ancestor
111230518|NCT04029688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111230519|NCT04029688|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111230520|NCT04029688|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111230521|NCT04029688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111230522|NCT04013854|Nivolumab|nivolumab|mesh-list
111230523|NCT04013854|Ipilimumab|ipilimumab|mesh-list
111230524|NCT04013854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111230525|NCT04013854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111230526|NCT04013854|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111230527|NCT04013854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111230528|NCT04002947|Rituximab|rituximab|mesh-list
111230529|NCT04002947|Acalabrutinib|acalabrutinib|mesh-list
111230530|NCT04002947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111230531|NCT04002947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111230532|NCT04002947|Immunologic Factors|immunologic factors|mesh-ancestor
111230533|NCT04002947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111230534|NCT04002947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111230535|NCT04002115|Mycophenolic Acid|mycophenolic acid|mesh-list
111230536|NCT04002115|Cyclophosphamide|cyclophosphamide|mesh-list
111230537|NCT04002115|Busulfan|busulfan|mesh-list
111230538|NCT04002115|Fludarabine|fludarabine|mesh-list
111230539|NCT04002115|Clofarabine|clofarabine|mesh-list
111230540|NCT04002115|Tacrolimus|tacrolimus|mesh-list
111230541|NCT04002115|Lenograstim|lenograstim|mesh-list
111230542|NCT04002115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111230543|NCT04002115|Immunologic Factors|immunologic factors|mesh-ancestor
111230544|NCT04002115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111230545|NCT04002115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111230546|NCT04002115|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111230547|NCT04002115|Alkylating Agents|alkylating agents|mesh-ancestor
111230548|NCT04002115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111230549|NCT04002115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111230550|NCT04002115|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111230551|NCT04002115|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111230552|NCT04002115|Antimetabolites|antimetabolites|mesh-ancestor
111230553|NCT04002115|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111230554|NCT04002115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111230555|NCT04002115|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111230556|NCT04002115|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111230557|NCT04002115|Antitubercular Agents|antitubercular agents|mesh-ancestor
111230558|NCT04002115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111230559|NCT04002115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111230560|NCT04002115|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111230561|NCT03976544|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
111230562|NCT03976544|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
111230563|NCT03976544|Estradiol|estradiol|mesh-list
111230564|NCT03976544|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
111230565|NCT03976544|Progesterone|progesterone|mesh-list
111230566|NCT03976544|Estrogens|estrogens|mesh-ancestor
111230567|NCT03976544|Hormones|hormones|mesh-ancestor
111230568|NCT03976544|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111230569|NCT03976544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111230570|NCT03976544|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111230571|NCT03976544|Contraceptive Agents|contraceptive agents|mesh-ancestor
111230572|NCT03976544|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111230573|NCT03976544|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111230574|NCT03976544|Progestins|progestins|mesh-ancestor
111230575|NCT03969212|Baloxavir|baloxavir|mesh-list
111230576|NCT03969212|Antiviral Agents|antiviral agents|mesh-ancestor
111230577|NCT03969212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111230578|NCT03969212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111230579|NCT03969212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111230580|NCT03960866|Phentolamine|phentolamine|mesh-list
111230581|NCT03960866|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111230582|NCT03960866|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111230583|NCT03960866|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111230584|NCT03960866|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111230585|NCT03960866|Adrenergic Agents|adrenergic agents|mesh-ancestor
111230586|NCT03960866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111230587|NCT03960866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111230588|NCT03960866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111230589|NCT03960866|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111230590|NCT03959085|Calcium, Dietary|calcium, dietary|mesh-list
111230591|NCT03959085|Leucovorin|leucovorin|mesh-list
111230592|NCT03959085|Folic Acid|folic acid|mesh-list
111230593|NCT03959085|Cytarabine|cytarabine|mesh-list
111230594|NCT03959085|Dexamethasone|dexamethasone|mesh-list
111230595|NCT03959085|Dexamethasone acetate|dexamethasone acetate|mesh-list
111230596|NCT03959085|Prednisolone|prednisolone|mesh-list
111230597|NCT03959085|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111230598|NCT03959085|Methylprednisolone|methylprednisolone|mesh-list
111230599|NCT03959085|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111230600|NCT03959085|Prednisolone acetate|prednisolone acetate|mesh-list
111230601|NCT03959085|Hydrocortisone|hydrocortisone|mesh-list
111230602|NCT03959085|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
111230603|NCT03959085|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
111230604|NCT03959085|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
111230605|NCT03959085|Cyclophosphamide|cyclophosphamide|mesh-list
111230606|NCT03959085|Doxorubicin|doxorubicin|mesh-list
111230607|NCT03959085|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111230608|NCT03959085|Methotrexate|methotrexate|mesh-list
111230609|NCT03959085|Vincristine|vincristine|mesh-list
111230610|NCT03959085|Daunorubicin|daunorubicin|mesh-list
111230611|NCT03959085|Asparaginase|asparaginase|mesh-list
111230612|NCT03959085|Mercaptopurine|mercaptopurine|mesh-list
111230613|NCT03959085|Pegaspargase|pegaspargase|mesh-list
111230614|NCT03959085|Thioguanine|thioguanine|mesh-list
111230615|NCT03959085|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
111230616|NCT03959085|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111230617|NCT03959085|Prednisolone phosphate|prednisolone phosphate|mesh-list
111230618|NCT03959085|BB 1101|bb 1101|mesh-list
111230619|NCT03959085|Calcium|calcium|mesh-list
111230620|NCT03959085|2-Aminopurine|2-aminopurine|mesh-list
111230621|NCT03959085|Levoleucovorin|levoleucovorin|mesh-list
111230622|NCT03959085|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111230623|NCT03959085|Immunologic Factors|immunologic factors|mesh-ancestor
111230624|NCT03959085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111230625|NCT03959085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111230626|NCT03959085|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111230627|NCT03959085|Alkylating Agents|alkylating agents|mesh-ancestor
111230628|NCT03959085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111230629|NCT03959085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111230630|NCT03959085|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111230631|NCT03959085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111230632|NCT03959085|Antiemetics|antiemetics|mesh-ancestor
111230633|NCT03959085|Autonomic Agents|autonomic agents|mesh-ancestor
111230634|NCT03959085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111230635|NCT03959085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111230636|NCT03959085|Glucocorticoids|glucocorticoids|mesh-ancestor
111230637|NCT03959085|Hormones|hormones|mesh-ancestor
111230638|NCT03959085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111230639|NCT03959085|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111230640|NCT03959085|Protease Inhibitors|protease inhibitors|mesh-ancestor
111230641|NCT03959085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111230642|NCT03959085|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111230643|NCT03959085|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111230644|NCT03959085|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111230645|NCT03959085|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111230646|NCT03959085|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111230647|NCT03959085|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111230648|NCT03959085|Abortifacient Agents|abortifacient agents|mesh-ancestor
111230649|NCT03959085|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111230650|NCT03959085|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111230651|NCT03959085|Antimetabolites|antimetabolites|mesh-ancestor
111230652|NCT03959085|Dermatologic Agents|dermatologic agents|mesh-ancestor
111230653|NCT03959085|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111230654|NCT03959085|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111230655|NCT03959085|Antiviral Agents|antiviral agents|mesh-ancestor
111230656|NCT03959085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111230657|NCT03959085|Antidotes|antidotes|mesh-ancestor
111230658|NCT03959085|Protective Agents|protective agents|mesh-ancestor
111230659|NCT03959085|Vitamin B Complex|vitamin b complex|mesh-ancestor
111230660|NCT03959085|Vitamins|vitamins|mesh-ancestor
111230661|NCT03959085|Micronutrients|micronutrients|mesh-ancestor
111230662|NCT03959085|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111230663|NCT03959085|Tubulin Modulators|tubulin modulators|mesh-ancestor
111230664|NCT03959085|Antimitotic Agents|antimitotic agents|mesh-ancestor
111230665|NCT03959085|Mitosis Modulators|mitosis modulators|mesh-ancestor
111230666|NCT03959085|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111230667|NCT03959085|Hematinics|hematinics|mesh-ancestor
111230668|NCT03959085|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111230669|NCT03959085|Immunotoxins|immunotoxins|mesh-ancestor
111230670|NCT03959085|Immunoconjugates|immunoconjugates|mesh-ancestor
111230671|NCT03953833|Antibodies|antibodies|mesh-list
111230672|NCT03953833|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111230673|NCT03953833|Immunologic Factors|immunologic factors|mesh-ancestor
111230674|NCT03953833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111230675|NCT03953300|Benralizumab|benralizumab|mesh-list
111230676|NCT03953300|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111230677|NCT03953300|Respiratory System Agents|respiratory system agents|mesh-ancestor
111230678|NCT03944512|Pravastatin|pravastatin|mesh-list
111230679|NCT03944512|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111230680|NCT03944512|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111230681|NCT03944512|Antimetabolites|antimetabolites|mesh-ancestor
111230682|NCT03944512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111230683|NCT03944512|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111230684|NCT03944512|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111230685|NCT03944512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111230686|NCT03933202|Cladribine|cladribine|mesh-list
111230687|NCT03933202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111230688|NCT03933202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111230689|NCT03933202|Immunologic Factors|immunologic factors|mesh-ancestor
111230690|NCT03933202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111230691|NCT03918915|Atropine|atropine|mesh-list
111230692|NCT03918915|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111230693|NCT03918915|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111230694|NCT03918915|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111230695|NCT03918915|Autonomic Agents|autonomic agents|mesh-ancestor
111230696|NCT03918915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111230697|NCT03918915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111230698|NCT03918915|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111230699|NCT03918915|Respiratory System Agents|respiratory system agents|mesh-ancestor
111230700|NCT03918915|Mydriatics|mydriatics|mesh-ancestor
111230701|NCT03918915|Parasympatholytics|parasympatholytics|mesh-ancestor
111230702|NCT03918915|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111230703|NCT03918915|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111230704|NCT03918915|Cholinergic Agents|cholinergic agents|mesh-ancestor
111230705|NCT03918915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111230706|NCT03918915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111230707|NCT03907046|Aspirin|aspirin|mesh-list
111230708|NCT03907046|Apixaban|apixaban|mesh-list
111230709|NCT03907046|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111230710|NCT03907046|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111230711|NCT03907046|Analgesics|analgesics|mesh-ancestor
111230712|NCT03907046|Sensory System Agents|sensory system agents|mesh-ancestor
111230713|NCT03907046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111230714|NCT03907046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111230715|NCT03907046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111230716|NCT03907046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111230717|NCT03907046|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111230718|NCT03907046|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111230719|NCT03907046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111230720|NCT03907046|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111230721|NCT03907046|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111230722|NCT03907046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111230723|NCT03907046|Antipyretics|antipyretics|mesh-ancestor
111230724|NCT03907046|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111230725|NCT03907046|Antithrombins|antithrombins|mesh-ancestor
111230726|NCT03907046|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111230727|NCT03907046|Protease Inhibitors|protease inhibitors|mesh-ancestor
111230728|NCT03907046|Anticoagulants|anticoagulants|mesh-ancestor
111230729|NCT03904693|Tadalafil|tadalafil|mesh-list
111230730|NCT03904693|Macitentan|macitentan|mesh-list
111230731|NCT03904693|Vasodilator Agents|vasodilator agents|mesh-ancestor
111230732|NCT03904693|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111230733|NCT03904693|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111230734|NCT03904693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111230735|NCT03904693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111230736|NCT03904693|Urological Agents|urological agents|mesh-ancestor
111230737|NCT03904693|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
111230738|NCT03904693|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
111230739|NCT03904693|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
111230740|NCT03896503|Topotecan|topotecan|mesh-list
111230741|NCT03896503|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111230742|NCT03896503|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111230743|NCT03896503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111230744|NCT03896503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111230745|NCT03896503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111230746|NCT03872388|Capecitabine|capecitabine|mesh-list
111230747|NCT03872388|Atorvastatin|atorvastatin|mesh-list
111230748|NCT03872388|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111230749|NCT03872388|Antimetabolites|antimetabolites|mesh-ancestor
111230750|NCT03872388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111230751|NCT03872388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110810336|NCT00154102|Vitamins|vitamins|mesh-ancestor
111230752|NCT03872388|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111230753|NCT03872388|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111230754|NCT03872388|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111230755|NCT03872388|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111230756|NCT03872388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111230757|NCT03869190|Gemcitabine|gemcitabine|mesh-list
111230758|NCT03869190|Atezolizumab|atezolizumab|mesh-list
111230760|NCT03869190|Magrolimab|magrolimab|mesh-list
111230761|NCT03869190|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
111230762|NCT03869190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111230763|NCT03869190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111230764|NCT03869190|Antimetabolites|antimetabolites|mesh-ancestor
111230765|NCT03869190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111230766|NCT03869190|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111230767|NCT03869190|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111230768|NCT03869190|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111230769|NCT03869190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111230770|NCT03869190|Immunoconjugates|immunoconjugates|mesh-ancestor
111230771|NCT03869190|Immunologic Factors|immunologic factors|mesh-ancestor
111230772|NCT03869190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111230773|NCT03861793|Pembrolizumab|pembrolizumab|mesh-list
111230774|NCT03861793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111230775|NCT03861793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111230776|NCT03861793|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111230777|NCT03861793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111230778|NCT03860207|Antibodies|antibodies|mesh-list
111230779|NCT03860207|Immunoglobulins|immunoglobulins|mesh-list
111230780|NCT03860207|Antibodies, Bispecific|antibodies, bispecific|mesh-list
111230781|NCT03860207|Immunologic Factors|immunologic factors|mesh-ancestor
111230782|NCT03860207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111230783|NCT03860038|Dexamethasone|dexamethasone|mesh-list
111230784|NCT03860038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111230785|NCT03860038|Antiemetics|antiemetics|mesh-ancestor
111230786|NCT03860038|Autonomic Agents|autonomic agents|mesh-ancestor
111230787|NCT03860038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111230788|NCT03860038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111230789|NCT03860038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111230790|NCT03860038|Glucocorticoids|glucocorticoids|mesh-ancestor
111230791|NCT03860038|Hormones|hormones|mesh-ancestor
111230792|NCT03860038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111230793|NCT03860038|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111230794|NCT03860038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111230795|NCT03844061|Mycophenolic Acid|mycophenolic acid|mesh-list
111230796|NCT03844061|Rituximab|rituximab|mesh-list
111230797|NCT03844061|Belimumab|belimumab|mesh-list
111230798|NCT03844061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111230799|NCT03844061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111230800|NCT03844061|Immunologic Factors|immunologic factors|mesh-ancestor
111230801|NCT03844061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111230802|NCT03844061|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111230803|NCT03844061|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111230804|NCT03844061|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111230805|NCT03844061|Antitubercular Agents|antitubercular agents|mesh-ancestor
111230806|NCT03844061|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111230807|NCT03844061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111230808|NCT03844061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111230809|NCT03844061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111230810|NCT03844061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111230811|NCT03836040|Erenumab|erenumab|mesh-list
111230812|NCT03836040|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111230813|NCT03836040|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
111230814|NCT03836040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111230815|NCT03836040|Analgesics|analgesics|mesh-ancestor
111230816|NCT03836040|Sensory System Agents|sensory system agents|mesh-ancestor
111230817|NCT03836040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111230818|NCT03836040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111230819|NCT03836040|Immunologic Factors|immunologic factors|mesh-ancestor
110955203|NCT02100267|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
111230821|NCT03829254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111230822|NCT03829254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111230823|NCT03829254|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111230824|NCT03829254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111230825|NCT03819049|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
111230826|NCT03819049|Immunologic Factors|immunologic factors|mesh-ancestor
111230827|NCT03819049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111230828|NCT03817398|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
111230829|NCT03817398|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111230830|NCT03817398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111230831|NCT03817398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111230832|NCT03807479|Ponatinib|ponatinib|mesh-list
111230833|NCT03807479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111230834|NCT03807479|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111230835|NCT03807479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111230836|NCT03807479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111230837|NCT03782415|Temozolomide|temozolomide|mesh-list
111230838|NCT03782415|Ibudilast|ibudilast|mesh-list
111230839|NCT03782415|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111230840|NCT03782415|Alkylating Agents|alkylating agents|mesh-ancestor
111230841|NCT03782415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111230842|NCT03782415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111230843|NCT03782415|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111230844|NCT03782415|Autonomic Agents|autonomic agents|mesh-ancestor
111230845|NCT03782415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111230846|NCT03782415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111230847|NCT03782415|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111230848|NCT03782415|Respiratory System Agents|respiratory system agents|mesh-ancestor
111230849|NCT03782415|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111230850|NCT03782415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111230851|NCT03782415|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111230852|NCT03782415|Vasodilator Agents|vasodilator agents|mesh-ancestor
111230853|NCT03782376|Ustekinumab|ustekinumab|mesh-list
111230854|NCT03782376|Dermatologic Agents|dermatologic agents|mesh-ancestor
111230855|NCT03757130|Liraglutide|liraglutide|mesh-list
111230856|NCT03757130|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111230857|NCT03757130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111230858|NCT03757130|Incretins|incretins|mesh-ancestor
111230859|NCT03757130|Hormones|hormones|mesh-ancestor
111230860|NCT03757130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111230861|NCT03712202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111230862|NCT03712202|Nivolumab|nivolumab|mesh-list
111230863|NCT03712202|Brentuximab Vedotin|brentuximab vedotin|mesh-list
111230864|NCT03712202|Doxorubicin|doxorubicin|mesh-list
111230865|NCT03712202|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111230866|NCT03712202|Daunorubicin|daunorubicin|mesh-list
111230867|NCT03712202|Bleomycin|bleomycin|mesh-list
111230868|NCT03712202|Dacarbazine|dacarbazine|mesh-list
111230869|NCT03712202|Vinblastine|vinblastine|mesh-list
111230870|NCT03712202|Antibodies|antibodies|mesh-list
111230871|NCT03712202|Immunoglobulins|immunoglobulins|mesh-list
111230872|NCT03712202|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111230873|NCT03712202|Imidazole|imidazole|mesh-list
111230874|NCT03712202|Immunoconjugates|immunoconjugates|mesh-list
111230875|NCT03712202|Immunologic Factors|immunologic factors|mesh-ancestor
111230876|NCT03712202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111230877|NCT03712202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111230878|NCT03712202|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111230879|NCT03712202|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111230880|NCT03712202|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111230881|NCT03712202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111230882|NCT03712202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111230883|NCT03712202|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111230884|NCT03712202|Immunotoxins|immunotoxins|mesh-ancestor
111230885|NCT03712202|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111230886|NCT03712202|Alkylating Agents|alkylating agents|mesh-ancestor
111230887|NCT03712202|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111230888|NCT03712202|Tubulin Modulators|tubulin modulators|mesh-ancestor
111230889|NCT03712202|Antimitotic Agents|antimitotic agents|mesh-ancestor
111230890|NCT03712202|Mitosis Modulators|mitosis modulators|mesh-ancestor
111230891|NCT03708341|Melatonin|melatonin|mesh-list
111230892|NCT03708341|Antioxidants|antioxidants|mesh-ancestor
111230893|NCT03708341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111230894|NCT03708341|Protective Agents|protective agents|mesh-ancestor
111230896|NCT03708341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111230897|NCT03692065|Apixaban|apixaban|mesh-list
111230898|NCT03692065|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111230899|NCT03692065|Antithrombins|antithrombins|mesh-ancestor
111230900|NCT03692065|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111230901|NCT03692065|Protease Inhibitors|protease inhibitors|mesh-ancestor
111230902|NCT03692065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111230903|NCT03692065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111230904|NCT03692065|Anticoagulants|anticoagulants|mesh-ancestor
111230905|NCT03682068|Carboplatin|carboplatin|mesh-list
111230906|NCT03682068|Gemcitabine|gemcitabine|mesh-list
111230907|NCT03682068|Durvalumab|durvalumab|mesh-list
111230908|NCT03682068|Tremelimumab|tremelimumab|mesh-list
111230909|NCT03682068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111230910|NCT03682068|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111230911|NCT03682068|Antimetabolites|antimetabolites|mesh-ancestor
111230912|NCT03682068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111230913|NCT03682068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111230914|NCT03660046|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
111230915|NCT03660046|Levonorgestrel|levonorgestrel|mesh-list
111230916|NCT03660046|Medroxyprogesterone|medroxyprogesterone|mesh-list
111230917|NCT03660046|Etonogestrel|etonogestrel|mesh-list
111230918|NCT03660046|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111230919|NCT03660046|Contraceptive Agents|contraceptive agents|mesh-ancestor
111230920|NCT03660046|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111230921|NCT03660046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111230922|NCT03660046|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111230923|NCT03660046|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111230924|NCT03660046|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111230925|NCT03660046|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111230926|NCT03660046|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
111230927|NCT03660046|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111230928|NCT03660046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111230929|NCT03643198|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111230930|NCT03643198|Metronidazole|metronidazole|mesh-list
111230931|NCT03643198|Ciprofloxacin|ciprofloxacin|mesh-list
111230932|NCT03643198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111230933|NCT03643198|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111230934|NCT03643198|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111230935|NCT03643198|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111230936|NCT03643198|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111230937|NCT03643198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111230938|NCT03643198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111230939|NCT03643198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111230940|NCT03643198|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111230941|NCT03643198|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111230942|NCT03598842|Metronidazole|metronidazole|mesh-list
111230943|NCT03598842|Ivermectin|ivermectin|mesh-list
111230944|NCT03598842|Albendazole|albendazole|mesh-list
111230945|NCT03598842|Antiparasitic Agents|antiparasitic agents|mesh-list
111230946|NCT03598842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111230947|NCT03598842|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111230948|NCT03598842|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111230949|NCT03598842|Anthelmintics|anthelmintics|mesh-ancestor
111230950|NCT03598842|Anticestodal Agents|anticestodal agents|mesh-ancestor
111230951|NCT03598842|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
111230952|NCT03598842|Tubulin Modulators|tubulin modulators|mesh-ancestor
111230953|NCT03598842|Antimitotic Agents|antimitotic agents|mesh-ancestor
111230954|NCT03598842|Mitosis Modulators|mitosis modulators|mesh-ancestor
111230955|NCT03598842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111230956|NCT03598842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111230957|NCT03598608|Pembrolizumab|pembrolizumab|mesh-list
111230958|NCT03598608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111230959|NCT03598608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111230960|NCT03598608|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111230961|NCT03598608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111230962|NCT03587701|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
111230963|NCT03587701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111230964|NCT03555565|Metformin|metformin|mesh-list
111230965|NCT03555565|Alogliptin|alogliptin|mesh-list
111230966|NCT03555565|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111230967|NCT03555565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111230968|NCT03555565|Incretins|incretins|mesh-ancestor
111230969|NCT03555565|Hormones|hormones|mesh-ancestor
111230970|NCT03555565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111230971|NCT03555565|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111230972|NCT03555565|Protease Inhibitors|protease inhibitors|mesh-ancestor
111230973|NCT03555565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111230974|NCT03555565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111230975|NCT03553836|Pembrolizumab|pembrolizumab|mesh-list
111230976|NCT03553836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111230977|NCT03553836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111230978|NCT03553836|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111230979|NCT03553836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111230980|NCT03547973|Carboplatin|carboplatin|mesh-list
111230981|NCT03547973|Gemcitabine|gemcitabine|mesh-list
111230982|NCT03547973|Pembrolizumab|pembrolizumab|mesh-list
111230983|NCT03547973|Avelumab|avelumab|mesh-list
111230984|NCT03547973|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
111230985|NCT03547973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111230986|NCT03547973|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111230987|NCT03547973|Antimetabolites|antimetabolites|mesh-ancestor
111230988|NCT03547973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111230989|NCT03547973|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111230990|NCT03547973|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111230991|NCT03547973|Immunoconjugates|immunoconjugates|mesh-ancestor
111230992|NCT03547973|Immunologic Factors|immunologic factors|mesh-ancestor
111230993|NCT03547973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111230994|NCT03529422|Durvalumab|durvalumab|mesh-list
111230995|NCT03529422|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111230996|NCT03529422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111230997|NCT03519945|Mirikizumab|mirikizumab|mesh-list
111230998|NCT03519945|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111230999|NCT03519945|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111231000|NCT03519945|Analgesics|analgesics|mesh-ancestor
111231001|NCT03519945|Sensory System Agents|sensory system agents|mesh-ancestor
111231002|NCT03519945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111231003|NCT03519945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111231004|NCT03519945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111231005|NCT03519945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111231006|NCT03519945|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111231007|NCT03519945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111231008|NCT03519386|Travoprost|travoprost|mesh-list
111231009|NCT03519386|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111231010|NCT03519386|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111231011|NCT03519386|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111231012|NCT03492177|Selexipag|selexipag|mesh-list
111231013|NCT03492177|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111231014|NCT03467373|Prednisone|prednisone|mesh-list
111231015|NCT03467373|Cyclophosphamide|cyclophosphamide|mesh-list
111231016|NCT03467373|Rituximab|rituximab|mesh-list
111231017|NCT03467373|Doxorubicin|doxorubicin|mesh-list
111231018|NCT03467373|Vincristine|vincristine|mesh-list
111231019|NCT03467373|Obinutuzumab|obinutuzumab|mesh-list
111231020|NCT03467373|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
111231021|NCT03467373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111231022|NCT03467373|Immunologic Factors|immunologic factors|mesh-ancestor
111231023|NCT03467373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111231024|NCT03467373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111231025|NCT03467373|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111231026|NCT03467373|Alkylating Agents|alkylating agents|mesh-ancestor
111231027|NCT03467373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111231028|NCT03467373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111231029|NCT03467373|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111231030|NCT03467373|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111231031|NCT03467373|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111231032|NCT03467373|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111231033|NCT03467373|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111231034|NCT03467373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111231035|NCT03467373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111231036|NCT03467373|Glucocorticoids|glucocorticoids|mesh-ancestor
111231037|NCT03467373|Hormones|hormones|mesh-ancestor
111231038|NCT03467373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111231039|NCT03467373|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111231040|NCT03467373|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111231041|NCT03467373|Tubulin Modulators|tubulin modulators|mesh-ancestor
111231042|NCT03467373|Antimitotic Agents|antimitotic agents|mesh-ancestor
111231043|NCT03467373|Mitosis Modulators|mitosis modulators|mesh-ancestor
111231044|NCT03467373|Immunoconjugates|immunoconjugates|mesh-ancestor
111231046|NCT03452332|Ipilimumab|ipilimumab|mesh-list
111231047|NCT03452332|Tremelimumab|tremelimumab|mesh-list
111231048|NCT03452332|Immunoglobulins|immunoglobulins|mesh-list
111231049|NCT03452332|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111231050|NCT03452332|Immunoglobulin G|immunoglobulin g|mesh-list
111231051|NCT03452332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111231052|NCT03452332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111231053|NCT03452332|Immunologic Factors|immunologic factors|mesh-ancestor
111231054|NCT03452332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111231055|NCT03452332|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111231056|NCT03452332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111231057|NCT03425201|Niraparib|niraparib|mesh-list
111231058|NCT03425201|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111231059|NCT03425201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111231060|NCT03425201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111231061|NCT03425201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111231062|NCT03422328|Macitentan|macitentan|mesh-list
111231063|NCT03422328|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
111231064|NCT03422328|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
111231065|NCT03422328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111231066|NCT03422328|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
111231067|NCT03414502|Hydroxychloroquine|hydroxychloroquine|mesh-list
111231068|NCT03414502|Minocycline|minocycline|mesh-list
111231069|NCT03414502|Sulfasalazine|sulfasalazine|mesh-list
111231070|NCT03414502|Adalimumab|adalimumab|mesh-list
111231071|NCT03414502|Infliximab|infliximab|mesh-list
111231072|NCT03414502|Golimumab|golimumab|mesh-list
111231073|NCT03414502|Certolizumab Pegol|certolizumab pegol|mesh-list
111231074|NCT03414502|Etanercept|etanercept|mesh-list
111231075|NCT03414502|Rituximab|rituximab|mesh-list
111231076|NCT03414502|Abatacept|abatacept|mesh-list
111231077|NCT03414502|Methotrexate|methotrexate|mesh-list
111231078|NCT03414502|Azathioprine|azathioprine|mesh-list
111231079|NCT03414502|Leflunomide|leflunomide|mesh-list
111231080|NCT03414502|Tofacitinib|tofacitinib|mesh-list
111231081|NCT03414502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111231082|NCT03414502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111231083|NCT03414502|Immunologic Factors|immunologic factors|mesh-ancestor
111231084|NCT03414502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111231085|NCT03414502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111231086|NCT03414502|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111231087|NCT03414502|Abortifacient Agents|abortifacient agents|mesh-ancestor
111231088|NCT03414502|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111231089|NCT03414502|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111231090|NCT03414502|Antimetabolites|antimetabolites|mesh-ancestor
111231091|NCT03414502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111231092|NCT03414502|Dermatologic Agents|dermatologic agents|mesh-ancestor
111231093|NCT03414502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111231094|NCT03414502|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111231095|NCT03414502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111231096|NCT03414502|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111231097|NCT03414502|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111231098|NCT03414502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111231099|NCT03414502|Antimalarials|antimalarials|mesh-ancestor
111231100|NCT03414502|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111231101|NCT03414502|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111231102|NCT03414502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111231103|NCT03414502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111231104|NCT03414502|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111231105|NCT03414502|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111231106|NCT03414502|Analgesics|analgesics|mesh-ancestor
111231107|NCT03414502|Sensory System Agents|sensory system agents|mesh-ancestor
111231108|NCT03414502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111231109|NCT03414502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111231110|NCT03414502|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111231111|NCT03414502|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
111231112|NCT03414502|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111231113|NCT03412565|Dexamethasone|dexamethasone|mesh-list
111231114|NCT03412565|Prednisone|prednisone|mesh-list
111231115|NCT03412565|Lenalidomide|lenalidomide|mesh-list
111231116|NCT03412565|Bortezomib|bortezomib|mesh-list
111231117|NCT03412565|Melphalan|melphalan|mesh-list
111231118|NCT03412565|Daratumumab|daratumumab|mesh-list
111231119|NCT03412565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111231120|NCT03412565|Antiemetics|antiemetics|mesh-ancestor
111231121|NCT03412565|Autonomic Agents|autonomic agents|mesh-ancestor
111231122|NCT03412565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111231123|NCT03412565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111231124|NCT03412565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111231125|NCT03412565|Glucocorticoids|glucocorticoids|mesh-ancestor
111231127|NCT03412565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111231128|NCT03412565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111231129|NCT03412565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111231130|NCT03412565|Immunologic Factors|immunologic factors|mesh-ancestor
111231131|NCT03412565|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111231132|NCT03412565|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111231133|NCT03412565|Growth Substances|growth substances|mesh-ancestor
111231134|NCT03412565|Growth Inhibitors|growth inhibitors|mesh-ancestor
111231135|NCT03412565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111231136|NCT03412565|Alkylating Agents|alkylating agents|mesh-ancestor
111231137|NCT03412565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111231138|NCT03412565|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111231139|NCT03412565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111231140|NCT03405792|Pembrolizumab|pembrolizumab|mesh-list
111231141|NCT03405792|Temozolomide|temozolomide|mesh-list
111231142|NCT03405792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111231143|NCT03405792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111231144|NCT03405792|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111231145|NCT03405792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111231146|NCT03405792|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111231147|NCT03405792|Alkylating Agents|alkylating agents|mesh-ancestor
111231148|NCT03403621|Pentamidine|pentamidine|mesh-list
111231149|NCT03403621|Antifungal Agents|antifungal agents|mesh-ancestor
111231150|NCT03403621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111231151|NCT03403621|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111231152|NCT03403621|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111231153|NCT03403621|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
111231154|NCT03391973|Pembrolizumab|pembrolizumab|mesh-list
111231155|NCT03391973|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111231156|NCT03391973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111231157|NCT03391973|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111231158|NCT03391973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111231159|NCT03385655|Carboplatin|carboplatin|mesh-list
111231160|NCT03385655|Durvalumab|durvalumab|mesh-list
111231161|NCT03385655|Tremelimumab|tremelimumab|mesh-list
111231162|NCT03385655|Ipatasertib|ipatasertib|mesh-list
111231163|NCT03385655|Adavosertib|adavosertib|mesh-list
111231164|NCT03385655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111231165|NCT03385655|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111231166|NCT03385655|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111231167|NCT03385655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111231168|NCT03385655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111231169|NCT03383575|Azacitidine|azacitidine|mesh-list
111231170|NCT03383575|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111231171|NCT03383575|Antimetabolites|antimetabolites|mesh-ancestor
111231172|NCT03383575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111231173|NCT03383575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111231174|NCT03383575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111231175|NCT03382561|Cisplatin|cisplatin|mesh-list
111231176|NCT03382561|Carboplatin|carboplatin|mesh-list
111231177|NCT03382561|Nivolumab|nivolumab|mesh-list
111231178|NCT03382561|Etoposide|etoposide|mesh-list
111231179|NCT03382561|Etoposide phosphate|etoposide phosphate|mesh-list
111231180|NCT03382561|Podophyllotoxin|podophyllotoxin|mesh-list
111231181|NCT03382561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111231182|NCT03382561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111231183|NCT03382561|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111231184|NCT03382561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111231185|NCT03382561|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111231186|NCT03382561|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111231187|NCT03382561|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111231188|NCT03382561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111231189|NCT03382561|Keratolytic Agents|keratolytic agents|mesh-ancestor
111231190|NCT03382561|Dermatologic Agents|dermatologic agents|mesh-ancestor
111231191|NCT03382561|Tubulin Modulators|tubulin modulators|mesh-ancestor
111231192|NCT03382561|Antimitotic Agents|antimitotic agents|mesh-ancestor
111231193|NCT03382561|Mitosis Modulators|mitosis modulators|mesh-ancestor
111231194|NCT03369665|Cladribine|cladribine|mesh-list
111231195|NCT03369665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111231196|NCT03369665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111231197|NCT03369665|Immunologic Factors|immunologic factors|mesh-ancestor
111231198|NCT03369665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111231199|NCT03361436|Halichondrin B|halichondrin b|mesh-list
111231200|NCT03361436|Tubulin Modulators|tubulin modulators|mesh-ancestor
111231201|NCT03361436|Antimitotic Agents|antimitotic agents|mesh-ancestor
111231202|NCT03361436|Mitosis Modulators|mitosis modulators|mesh-ancestor
111231203|NCT03361436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111231204|NCT03361436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111231205|NCT03345784|Cisplatin|cisplatin|mesh-list
111231206|NCT03345784|Adavosertib|adavosertib|mesh-list
111231207|NCT03345784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111231208|NCT03345784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111231209|NCT03345784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111231210|NCT03337698|Linagliptin|linagliptin|mesh-list
111231211|NCT03337698|Bevacizumab|bevacizumab|mesh-list
111231212|NCT03337698|Atezolizumab|atezolizumab|mesh-list
111231213|NCT03337698|Carboplatin|carboplatin|mesh-list
111231214|NCT03337698|Gemcitabine|gemcitabine|mesh-list
111231215|NCT03337698|Docetaxel|docetaxel|mesh-list
111231216|NCT03337698|Pemetrexed|pemetrexed|mesh-list
111231217|NCT03337698|Ipatasertib|ipatasertib|mesh-list
111231218|NCT03337698|Evolocumab|evolocumab|mesh-list
111231219|NCT03337698|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
111231220|NCT03337698|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111231221|NCT03337698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111231222|NCT03337698|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111231223|NCT03337698|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111231224|NCT03337698|Growth Substances|growth substances|mesh-ancestor
111231225|NCT03337698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111231226|NCT03337698|Growth Inhibitors|growth inhibitors|mesh-ancestor
111231227|NCT03337698|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111231228|NCT03337698|Antimetabolites|antimetabolites|mesh-ancestor
111231229|NCT03337698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111231230|NCT03337698|Tubulin Modulators|tubulin modulators|mesh-ancestor
111231231|NCT03337698|Antimitotic Agents|antimitotic agents|mesh-ancestor
111231232|NCT03337698|Mitosis Modulators|mitosis modulators|mesh-ancestor
111231233|NCT03337698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111231234|NCT03337698|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111231235|NCT03337698|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111231236|NCT03337698|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111231237|NCT03337698|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111231238|NCT03337698|Incretins|incretins|mesh-ancestor
111231239|NCT03337698|Hormones|hormones|mesh-ancestor
111231240|NCT03337698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111231241|NCT03337698|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111231242|NCT03337698|Protease Inhibitors|protease inhibitors|mesh-ancestor
111231243|NCT03337698|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
111231244|NCT03337698|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111231245|NCT03337698|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111231246|NCT03337698|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111231247|NCT03337698|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111231248|NCT03337698|Immunoconjugates|immunoconjugates|mesh-ancestor
111231249|NCT03337698|Immunologic Factors|immunologic factors|mesh-ancestor
111231250|NCT03337698|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111231251|NCT03317405|Tamoxifen|tamoxifen|mesh-list
111231252|NCT03317405|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111231253|NCT03317405|Hormone Antagonists|hormone antagonists|mesh-ancestor
111231254|NCT03317405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111231255|NCT03317405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111231256|NCT03317405|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111231257|NCT03317405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111231258|NCT03317405|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111231259|NCT03317405|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111231260|NCT03317405|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111231261|NCT03307616|Nivolumab|nivolumab|mesh-list
111231262|NCT03307616|Ipilimumab|ipilimumab|mesh-list
111231263|NCT03307616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111231264|NCT03307616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111231265|NCT03307616|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111231266|NCT03307616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111231267|NCT03271372|Avelumab|avelumab|mesh-list
111231268|NCT03271372|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111231269|NCT03271372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111231270|NCT03271372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111231271|NCT03271372|Immunologic Factors|immunologic factors|mesh-ancestor
111231272|NCT03271372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111231273|NCT03255174|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
111231275|NCT03255174|Coagulants|coagulants|mesh-ancestor
111231276|NCT03243058|Aldesleukin|aldesleukin|mesh-list
111231277|NCT03243058|Interleukin-2|interleukin-2|mesh-list
111231278|NCT03243058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111231279|NCT03243058|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111231280|NCT03243058|Analgesics|analgesics|mesh-ancestor
111231281|NCT03243058|Sensory System Agents|sensory system agents|mesh-ancestor
111231282|NCT03243058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111231283|NCT03243058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111231284|NCT03243058|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111231285|NCT03243058|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111231286|NCT03243058|Antiviral Agents|antiviral agents|mesh-ancestor
111231287|NCT03243058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111231288|NCT03232073|Ponesimod|ponesimod|mesh-list
111231289|NCT03232073|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
111231290|NCT03232073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111231291|NCT03232073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111231292|NCT03232073|Immunologic Factors|immunologic factors|mesh-ancestor
111231293|NCT03232073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111231294|NCT03226522|Bupropion|bupropion|mesh-list
111231295|NCT03226522|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111231296|NCT03226522|Antidepressive Agents|antidepressive agents|mesh-ancestor
111231297|NCT03226522|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111231298|NCT03226522|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111231299|NCT03226522|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111231300|NCT03226522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111231301|NCT03226522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111231302|NCT03226522|Dopamine Agents|dopamine agents|mesh-ancestor
111231303|NCT03226522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111231304|NCT03226522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111231305|NCT03226522|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111231306|NCT03226522|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111231307|NCT03226522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111231308|NCT03206203|Carboplatin|carboplatin|mesh-list
111231309|NCT03206203|Atezolizumab|atezolizumab|mesh-list
111231310|NCT03206203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111231311|NCT03206203|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111231312|NCT03206203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111231313|NCT03206203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111231314|NCT03201965|Dexamethasone|dexamethasone|mesh-list
111231315|NCT03201965|Cyclophosphamide|cyclophosphamide|mesh-list
111231316|NCT03201965|Bortezomib|bortezomib|mesh-list
111231317|NCT03201965|Daratumumab|daratumumab|mesh-list
111231318|NCT03201965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111231319|NCT03201965|Immunologic Factors|immunologic factors|mesh-ancestor
111231320|NCT03201965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111231321|NCT03201965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111231322|NCT03201965|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111231323|NCT03201965|Alkylating Agents|alkylating agents|mesh-ancestor
111231324|NCT03201965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111231325|NCT03201965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111231326|NCT03201965|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111231327|NCT03201965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111231328|NCT03201965|Antiemetics|antiemetics|mesh-ancestor
111231329|NCT03201965|Autonomic Agents|autonomic agents|mesh-ancestor
111231330|NCT03201965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111231331|NCT03201965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111231332|NCT03201965|Glucocorticoids|glucocorticoids|mesh-ancestor
111231333|NCT03201965|Hormones|hormones|mesh-ancestor
111231334|NCT03201965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111231335|NCT03201965|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111231336|NCT03201458|Atezolizumab|atezolizumab|mesh-list
111231337|NCT03201458|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111231338|NCT03201458|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111231339|NCT03201458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111231340|NCT03201458|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111231341|NCT03201458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111231342|NCT03201458|Immunologic Factors|immunologic factors|mesh-ancestor
111231343|NCT03201458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111231344|NCT03189706|Irinotecan|irinotecan|mesh-list
111231345|NCT03189706|Temozolomide|temozolomide|mesh-list
111231346|NCT03189706|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111231347|NCT03189706|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111231348|NCT03189706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111231349|NCT03189706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111231350|NCT03189706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111231351|NCT03189706|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111231352|NCT03189706|Alkylating Agents|alkylating agents|mesh-ancestor
111231354|NCT03159897|Bleomycin|bleomycin|mesh-list
111231355|NCT03159897|Dacarbazine|dacarbazine|mesh-list
111231356|NCT03159897|Vinblastine|vinblastine|mesh-list
111231357|NCT03159897|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111231358|NCT03159897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111231359|NCT03159897|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111231360|NCT03159897|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111231361|NCT03159897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111231362|NCT03159897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111231363|NCT03159897|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111231364|NCT03159897|Alkylating Agents|alkylating agents|mesh-ancestor
111231365|NCT03159897|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111231366|NCT03159897|Tubulin Modulators|tubulin modulators|mesh-ancestor
111231367|NCT03159897|Antimitotic Agents|antimitotic agents|mesh-ancestor
111231368|NCT03159897|Mitosis Modulators|mitosis modulators|mesh-ancestor
111231369|NCT03157804|Plerixafor|plerixafor|mesh-list
111231370|NCT03157804|Lenograstim|lenograstim|mesh-list
111231371|NCT03157804|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111231372|NCT03157804|Immunologic Factors|immunologic factors|mesh-ancestor
111231373|NCT03157804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111231374|NCT03157804|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111231375|NCT03157804|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111231376|NCT03157804|Antiviral Agents|antiviral agents|mesh-ancestor
111231377|NCT03157804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111231378|NCT03128879|Venetoclax|venetoclax|mesh-list
111231379|NCT03128879|Acalabrutinib|acalabrutinib|mesh-list
111231380|NCT03128879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111231381|NCT03077243|Cisplatin|cisplatin|mesh-list
111231382|NCT03077243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111231383|NCT03073967|Foscarnet|foscarnet|mesh-list
111231384|NCT03073967|Pritelivir|pritelivir|mesh-list
111231385|NCT03073967|Antiviral Agents|antiviral agents|mesh-ancestor
111231386|NCT03073967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111231387|NCT03073967|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111231388|NCT03073967|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111231389|NCT03073967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111231390|NCT03073967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111231391|NCT03072238|Prednisone|prednisone|mesh-list
111231392|NCT03072238|Prednisolone|prednisolone|mesh-list
111231393|NCT03072238|Ipatasertib|ipatasertib|mesh-list
111231394|NCT03072238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111231395|NCT03072238|Glucocorticoids|glucocorticoids|mesh-ancestor
111231396|NCT03072238|Hormones|hormones|mesh-ancestor
111231397|NCT03072238|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111231398|NCT03072238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111231399|NCT03072238|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111231400|NCT03072238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111231401|NCT03072238|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111231402|NCT03072238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111231403|NCT03072238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111231404|NCT03064035|Thrombin|thrombin|mesh-list
111231405|NCT03064035|Hemostatics|hemostatics|mesh-ancestor
111231406|NCT03064035|Coagulants|coagulants|mesh-ancestor
111231407|NCT03054181|Immunoglobulins|immunoglobulins|mesh-list
111231408|NCT03054181|Immunologic Factors|immunologic factors|mesh-ancestor
111231409|NCT03054181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111231410|NCT03028311|Technetium Tc 99m Aggregated Albumin|technetium tc 99m aggregated albumin|mesh-list
111231411|NCT03028311|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111231412|NCT03028311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111231413|NCT03016377|Cyclophosphamide|cyclophosphamide|mesh-list
111231414|NCT03016377|Fludarabine|fludarabine|mesh-list
111231415|NCT03016377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111231416|NCT03016377|Immunologic Factors|immunologic factors|mesh-ancestor
111231417|NCT03016377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111231418|NCT03016377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111231419|NCT03016377|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111231420|NCT03016377|Alkylating Agents|alkylating agents|mesh-ancestor
111231421|NCT03016377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111231422|NCT03016377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111231423|NCT03016377|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111231424|NCT02981628|Calcium, Dietary|calcium, dietary|mesh-list
111231425|NCT02981628|Leucovorin|leucovorin|mesh-list
111231426|NCT02981628|Folic Acid|folic acid|mesh-list
111231427|NCT02981628|Cytarabine|cytarabine|mesh-list
111231428|NCT02981628|Cyclophosphamide|cyclophosphamide|mesh-list
111231429|NCT02981628|Methotrexate|methotrexate|mesh-list
111231430|NCT02981628|Vincristine|vincristine|mesh-list
111231431|NCT02981628|Asparaginase|asparaginase|mesh-list
111231432|NCT02981628|Pegaspargase|pegaspargase|mesh-list
111231433|NCT02981628|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
111231434|NCT02981628|Calcium|calcium|mesh-list
111231435|NCT02981628|Levoleucovorin|levoleucovorin|mesh-list
111231436|NCT02981628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111231437|NCT02981628|Immunologic Factors|immunologic factors|mesh-ancestor
111231438|NCT02981628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111231439|NCT02981628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111231440|NCT02981628|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111231441|NCT02981628|Alkylating Agents|alkylating agents|mesh-ancestor
111231442|NCT02981628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111231443|NCT02981628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111231444|NCT02981628|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111231445|NCT02981628|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111231446|NCT02981628|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111231447|NCT02981628|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111231448|NCT02981628|Abortifacient Agents|abortifacient agents|mesh-ancestor
111231449|NCT02981628|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111231450|NCT02981628|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111231451|NCT02981628|Antimetabolites|antimetabolites|mesh-ancestor
111231452|NCT02981628|Dermatologic Agents|dermatologic agents|mesh-ancestor
111231453|NCT02981628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111231454|NCT02981628|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111231455|NCT02981628|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111231456|NCT02981628|Antiviral Agents|antiviral agents|mesh-ancestor
111231457|NCT02981628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111231458|NCT02981628|Antidotes|antidotes|mesh-ancestor
111231459|NCT02981628|Protective Agents|protective agents|mesh-ancestor
111231460|NCT02981628|Vitamin B Complex|vitamin b complex|mesh-ancestor
111231461|NCT02981628|Vitamins|vitamins|mesh-ancestor
111231462|NCT02981628|Micronutrients|micronutrients|mesh-ancestor
111231463|NCT02981628|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111231464|NCT02981628|Tubulin Modulators|tubulin modulators|mesh-ancestor
111231465|NCT02981628|Antimitotic Agents|antimitotic agents|mesh-ancestor
111231466|NCT02981628|Mitosis Modulators|mitosis modulators|mesh-ancestor
111231467|NCT02981628|Hematinics|hematinics|mesh-ancestor
111231468|NCT02981628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111231469|NCT02981628|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111231470|NCT02981628|Immunotoxins|immunotoxins|mesh-ancestor
111231471|NCT02981628|Immunoconjugates|immunoconjugates|mesh-ancestor
111231472|NCT02971891|Furosemide|furosemide|mesh-list
111231473|NCT02971891|Diuretics|diuretics|mesh-ancestor
111231474|NCT02971891|Natriuretic Agents|natriuretic agents|mesh-ancestor
111231475|NCT02971891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111231476|NCT02971891|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
111231477|NCT02971891|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111231478|NCT02971891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111231479|NCT02940301|Nivolumab|nivolumab|mesh-list
111231480|NCT02940301|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111231481|NCT02940301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111231482|NCT02940301|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111231483|NCT02940301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111231484|NCT02932410|Macitentan|macitentan|mesh-list
111231485|NCT02932410|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
111231486|NCT02932410|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
111231487|NCT02932410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111231488|NCT02932410|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
111231489|NCT02921256|Leucovorin|leucovorin|mesh-list
111231490|NCT02921256|Pembrolizumab|pembrolizumab|mesh-list
111231491|NCT02921256|Fluorouracil|fluorouracil|mesh-list
111231492|NCT02921256|Capecitabine|capecitabine|mesh-list
111231493|NCT02921256|Oxaliplatin|oxaliplatin|mesh-list
111231494|NCT02921256|Veliparib|veliparib|mesh-list
111231495|NCT02921256|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111231496|NCT02921256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111231497|NCT02921256|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111231498|NCT02921256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111231499|NCT02921256|Antimetabolites|antimetabolites|mesh-ancestor
111231500|NCT02921256|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111231501|NCT02921256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111231502|NCT02921256|Immunologic Factors|immunologic factors|mesh-ancestor
111231503|NCT02921256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111231504|NCT02921256|Antidotes|antidotes|mesh-ancestor
111231505|NCT02921256|Protective Agents|protective agents|mesh-ancestor
111231506|NCT02921256|Vitamin B Complex|vitamin b complex|mesh-ancestor
111231507|NCT02921256|Vitamins|vitamins|mesh-ancestor
111231508|NCT02921256|Micronutrients|micronutrients|mesh-ancestor
111231509|NCT02921256|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111231510|NCT02921256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111231511|NCT02890355|Calcium, Dietary|calcium, dietary|mesh-list
111231512|NCT02890355|Leucovorin|leucovorin|mesh-list
111231513|NCT02890355|Folic Acid|folic acid|mesh-list
111231514|NCT02890355|Fluorouracil|fluorouracil|mesh-list
111231515|NCT02890355|Irinotecan|irinotecan|mesh-list
111231516|NCT02890355|Veliparib|veliparib|mesh-list
111231517|NCT02890355|Camptothecin|camptothecin|mesh-list
111231518|NCT02890355|Calcium|calcium|mesh-list
111231519|NCT02890355|Levoleucovorin|levoleucovorin|mesh-list
111231520|NCT02890355|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111231521|NCT02890355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111231522|NCT02890355|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111231523|NCT02890355|Antimetabolites|antimetabolites|mesh-ancestor
111231524|NCT02890355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111231525|NCT02890355|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111231526|NCT02890355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111231527|NCT02890355|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111231528|NCT02890355|Immunologic Factors|immunologic factors|mesh-ancestor
111231529|NCT02890355|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111231530|NCT02890355|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111231531|NCT02890355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111231532|NCT02890355|Antidotes|antidotes|mesh-ancestor
111231533|NCT02890355|Protective Agents|protective agents|mesh-ancestor
111231534|NCT02890355|Vitamin B Complex|vitamin b complex|mesh-ancestor
111231535|NCT02890355|Vitamins|vitamins|mesh-ancestor
111231536|NCT02890355|Micronutrients|micronutrients|mesh-ancestor
111231537|NCT02890355|Hematinics|hematinics|mesh-ancestor
111231538|NCT02890355|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111231539|NCT02890355|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111231540|NCT02872025|Pembrolizumab|pembrolizumab|mesh-list
111231541|NCT02872025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111231542|NCT02872025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111231543|NCT02872025|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111231544|NCT02872025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111231545|NCT02859337|Ulipristal acetate|ulipristal acetate|mesh-list
111231546|NCT02859337|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111231547|NCT02859337|Contraceptive Agents|contraceptive agents|mesh-ancestor
111231548|NCT02859337|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111231549|NCT02859337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111231550|NCT02859337|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111231551|NCT02854436|Niraparib|niraparib|mesh-list
111231552|NCT02854436|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111231553|NCT02854436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111231554|NCT02854436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111231555|NCT02854436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111231556|NCT02822573|Donepezil|donepezil|mesh-list
111231557|NCT02822573|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111231558|NCT02822573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111231559|NCT02822573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111231560|NCT02822573|Cholinergic Agents|cholinergic agents|mesh-ancestor
111231561|NCT02822573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111231562|NCT02822573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111231563|NCT02822573|Nootropic Agents|nootropic agents|mesh-ancestor
111231564|NCT02794571|Paclitaxel|paclitaxel|mesh-list
111231565|NCT02794571|Etoposide|etoposide|mesh-list
111231566|NCT02794571|Bevacizumab|bevacizumab|mesh-list
111231567|NCT02794571|Carboplatin|carboplatin|mesh-list
111231568|NCT02794571|Pembrolizumab|pembrolizumab|mesh-list
111231569|NCT02794571|Capecitabine|capecitabine|mesh-list
111231570|NCT02794571|Pemetrexed|pemetrexed|mesh-list
111231571|NCT02794571|Atezolizumab|atezolizumab|mesh-list
111231572|NCT02794571|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111231573|NCT02794571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111231574|NCT02794571|Tubulin Modulators|tubulin modulators|mesh-ancestor
111231575|NCT02794571|Antimitotic Agents|antimitotic agents|mesh-ancestor
111231576|NCT02794571|Mitosis Modulators|mitosis modulators|mesh-ancestor
111231577|NCT02794571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110955950|NCT02479646|Lenograstim|lenograstim|mesh-list
111231578|NCT02794571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111231579|NCT02794571|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111231580|NCT02794571|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111231581|NCT02794571|Growth Substances|growth substances|mesh-ancestor
110980703|NCT05459194|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111231582|NCT02794571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111231583|NCT02794571|Growth Inhibitors|growth inhibitors|mesh-ancestor
111231584|NCT02794571|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111231585|NCT02794571|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111231586|NCT02794571|Antimetabolites|antimetabolites|mesh-ancestor
111231587|NCT02794571|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111231588|NCT02794571|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111231589|NCT02794571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111231590|NCT02794571|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111231591|NCT02794571|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111231592|NCT02784535|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
111231593|NCT02784535|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111231594|NCT02784535|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111231595|NCT02784535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111231596|NCT02784535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111231597|NCT02784535|Adrenergic Agents|adrenergic agents|mesh-ancestor
111231598|NCT02784535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111231599|NCT02784535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111231600|NCT02711826|Acetaminophen|acetaminophen|mesh-list
111231601|NCT02711826|Diphenhydramine|diphenhydramine|mesh-list
111231602|NCT02711826|Promethazine|promethazine|mesh-list
111231603|NCT02711826|Mycophenolic Acid|mycophenolic acid|mesh-list
111231604|NCT02711826|Everolimus|everolimus|mesh-list
111231605|NCT02711826|Tacrolimus|tacrolimus|mesh-list
111231606|NCT02711826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111231607|NCT02711826|Immunologic Factors|immunologic factors|mesh-ancestor
111231608|NCT02711826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111231609|NCT02711826|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111231610|NCT02711826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111231611|NCT02711826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111231612|NCT02711826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111231613|NCT02711826|Analgesics|analgesics|mesh-ancestor
111231614|NCT02711826|Sensory System Agents|sensory system agents|mesh-ancestor
111231615|NCT02711826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111231616|NCT02711826|Antipyretics|antipyretics|mesh-ancestor
111231617|NCT02711826|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111231618|NCT02711826|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111231619|NCT02711826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111231620|NCT02711826|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111231621|NCT02711826|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111231622|NCT02711826|Antitubercular Agents|antitubercular agents|mesh-ancestor
111231623|NCT02711826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111231624|NCT02711826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111231625|NCT02711826|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111231626|NCT02711826|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111231627|NCT02711826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111231628|NCT02711826|Anesthetics, Local|anesthetics, local|mesh-ancestor
111231629|NCT02711826|Anesthetics|anesthetics|mesh-ancestor
111231630|NCT02711826|Antiemetics|antiemetics|mesh-ancestor
111231631|NCT02711826|Autonomic Agents|autonomic agents|mesh-ancestor
111231632|NCT02711826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111231633|NCT02711826|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111231634|NCT02711826|Histamine Antagonists|histamine antagonists|mesh-ancestor
111231635|NCT02711826|Histamine Agents|histamine agents|mesh-ancestor
111231636|NCT02711826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111231637|NCT02711826|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111231638|NCT02711826|Antipruritics|antipruritics|mesh-ancestor
111231639|NCT02711826|Dermatologic Agents|dermatologic agents|mesh-ancestor
111231640|NCT02708836|Anesthetics|anesthetics|mesh-list
111231641|NCT02708836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111231642|NCT02708836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111231643|NCT02684162|Guadecitabine|guadecitabine|mesh-list
111231644|NCT02684162|Azacitidine|azacitidine|mesh-list
111231645|NCT02684162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111231646|NCT02684162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111231647|NCT02684162|Antimetabolites|antimetabolites|mesh-ancestor
111231648|NCT02684162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111231649|NCT02684162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111231650|NCT02639026|Durvalumab|durvalumab|mesh-list
111231651|NCT02639026|Tremelimumab|tremelimumab|mesh-list
111231652|NCT02639026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111231653|NCT02639026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111231655|NCT02632448|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111231656|NCT02632448|Antimetabolites|antimetabolites|mesh-ancestor
111320772|NCT02285283|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111231657|NCT02632448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111231658|NCT02632448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111231659|NCT02629120|Sirolimus|sirolimus|mesh-list
111231660|NCT02629120|Cyclophosphamide|cyclophosphamide|mesh-list
111231661|NCT02629120|Busulfan|busulfan|mesh-list
111231662|NCT02629120|Alemtuzumab|alemtuzumab|mesh-list
111231663|NCT02629120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111231664|NCT02629120|Immunologic Factors|immunologic factors|mesh-ancestor
111231665|NCT02629120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111231666|NCT02629120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111231667|NCT02629120|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111231668|NCT02629120|Alkylating Agents|alkylating agents|mesh-ancestor
111231669|NCT02629120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111231670|NCT02629120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111231671|NCT02629120|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111231672|NCT02629120|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111231673|NCT02629120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111231674|NCT02629120|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111231675|NCT02629120|Antifungal Agents|antifungal agents|mesh-ancestor
111231676|NCT02629120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111231677|NCT02521285|Aspirin|aspirin|mesh-list
111231678|NCT02521285|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111231679|NCT02521285|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111231680|NCT02521285|Analgesics|analgesics|mesh-ancestor
111231681|NCT02521285|Sensory System Agents|sensory system agents|mesh-ancestor
111231682|NCT02521285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111231683|NCT02521285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111231684|NCT02521285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111231685|NCT02521285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111231686|NCT02521285|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111231687|NCT02521285|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111231688|NCT02521285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111231689|NCT02521285|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111231690|NCT02521285|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111231691|NCT02521285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111231692|NCT02521285|Antipyretics|antipyretics|mesh-ancestor
111231693|NCT02516241|Carboplatin|carboplatin|mesh-list
111231694|NCT02516241|Gemcitabine|gemcitabine|mesh-list
111231695|NCT02516241|Durvalumab|durvalumab|mesh-list
111231696|NCT02516241|Tremelimumab|tremelimumab|mesh-list
111231697|NCT02516241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111231698|NCT02516241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111231699|NCT02516241|Antimetabolites|antimetabolites|mesh-ancestor
111231700|NCT02516241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111231701|NCT02516241|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111231702|NCT02512926|Cyclophosphamide|cyclophosphamide|mesh-list
111231703|NCT02512926|Etoposide|etoposide|mesh-list
111231704|NCT02512926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111231705|NCT02512926|Immunologic Factors|immunologic factors|mesh-ancestor
111231706|NCT02512926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111231707|NCT02512926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111231708|NCT02512926|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111231709|NCT02512926|Alkylating Agents|alkylating agents|mesh-ancestor
111231710|NCT02512926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111231711|NCT02512926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111231712|NCT02512926|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111231713|NCT02512926|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111231714|NCT02512926|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111231715|NCT02512926|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111231716|NCT02512926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111231717|NCT02506153|Interferons|interferons|mesh-list
111231718|NCT02506153|Interferon-alpha|interferon-alpha|mesh-list
111231719|NCT02506153|Interferon alpha-2|interferon alpha-2|mesh-list
111231720|NCT02506153|Pembrolizumab|pembrolizumab|mesh-list
111231721|NCT02506153|Ipilimumab|ipilimumab|mesh-list
111231722|NCT02506153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111231723|NCT02506153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111231724|NCT02506153|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111231725|NCT02506153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111231726|NCT02506153|Antiviral Agents|antiviral agents|mesh-ancestor
111231727|NCT02506153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110956105|NCT02105103|Insulin|insulin|mesh-list
111231728|NCT02506153|Immunologic Factors|immunologic factors|mesh-ancestor
111231729|NCT02506153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111231730|NCT02494986|Rilpivirine|rilpivirine|mesh-list
111231731|NCT02494986|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111231732|NCT02494986|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111231733|NCT02494986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111231734|NCT02494986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111231735|NCT02494986|Antiviral Agents|antiviral agents|mesh-ancestor
111231736|NCT02494986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111231737|NCT02494986|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111231738|NCT02494986|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111231739|NCT02489604|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
111231740|NCT02489604|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111231741|NCT02489604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111231742|NCT02489318|Androgens|androgens|mesh-list
111231743|NCT02489318|Hormones|hormones|mesh-ancestor
111231744|NCT02489318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111231745|NCT02489318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111231746|NCT02477826|Paclitaxel|paclitaxel|mesh-list
111231747|NCT02477826|Carboplatin|carboplatin|mesh-list
111231748|NCT02477826|Gemcitabine|gemcitabine|mesh-list
111231749|NCT02477826|Nivolumab|nivolumab|mesh-list
111231750|NCT02477826|Pemetrexed|pemetrexed|mesh-list
111231751|NCT02477826|Ipilimumab|ipilimumab|mesh-list
111231752|NCT02477826|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111231753|NCT02477826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111231754|NCT02477826|Tubulin Modulators|tubulin modulators|mesh-ancestor
111231755|NCT02477826|Antimitotic Agents|antimitotic agents|mesh-ancestor
111231756|NCT02477826|Mitosis Modulators|mitosis modulators|mesh-ancestor
111231757|NCT02477826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111231758|NCT02477826|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111231759|NCT02477826|Antimetabolites|antimetabolites|mesh-ancestor
111231760|NCT02477826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111231761|NCT02477826|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111231762|NCT02477826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111231763|NCT02477826|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111231764|NCT02477826|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111231765|NCT02473276|Morphine|morphine|mesh-list
111231766|NCT02473276|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111231767|NCT02473276|Narcotics|narcotics|mesh-ancestor
111231768|NCT02473276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111231769|NCT02473276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111231770|NCT02473276|Analgesics|analgesics|mesh-ancestor
111231771|NCT02473276|Sensory System Agents|sensory system agents|mesh-ancestor
111231772|NCT02473276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111231773|NCT02451423|Atezolizumab|atezolizumab|mesh-list
111231774|NCT02451423|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111231775|NCT02451423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111231776|NCT02451423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111231777|NCT02451423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111231778|NCT02378428|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
111231779|NCT02378428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111231780|NCT02378428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111231781|NCT02378428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111231782|NCT02378428|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111231783|NCT02277444|Golimumab|golimumab|mesh-list
111231784|NCT02277444|Methotrexate|methotrexate|mesh-list
111231785|NCT02277444|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111231786|NCT02277444|Abortifacient Agents|abortifacient agents|mesh-ancestor
111231787|NCT02277444|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111231788|NCT02277444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111231789|NCT02277444|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111231790|NCT02277444|Antimetabolites|antimetabolites|mesh-ancestor
111231791|NCT02277444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111231792|NCT02277444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111231793|NCT02277444|Dermatologic Agents|dermatologic agents|mesh-ancestor
111231794|NCT02277444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111231795|NCT02277444|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111231796|NCT02277444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111231797|NCT02277444|Immunologic Factors|immunologic factors|mesh-ancestor
111231798|NCT02277444|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111231799|NCT02277444|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111231800|NCT02277444|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111231801|NCT02277444|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111231802|NCT02225405|Cisplatin|cisplatin|mesh-list
111231803|NCT02225405|Docetaxel|docetaxel|mesh-list
111231804|NCT02225405|Nintedanib|nintedanib|mesh-list
111231805|NCT02225405|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
111231806|NCT02225405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111231807|NCT02225405|Tubulin Modulators|tubulin modulators|mesh-ancestor
111231808|NCT02225405|Antimitotic Agents|antimitotic agents|mesh-ancestor
111231809|NCT02225405|Mitosis Modulators|mitosis modulators|mesh-ancestor
111231810|NCT02225405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111231811|NCT02225405|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111231812|NCT02225405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111231813|NCT02195479|Dexamethasone|dexamethasone|mesh-list
111231814|NCT02195479|Prednisone|prednisone|mesh-list
111231815|NCT02195479|Melphalan|melphalan|mesh-list
111231816|NCT02195479|Bortezomib|bortezomib|mesh-list
111231817|NCT02195479|Daratumumab|daratumumab|mesh-list
111231818|NCT02195479|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111231819|NCT02195479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111231820|NCT02195479|Antiemetics|antiemetics|mesh-ancestor
111231821|NCT02195479|Autonomic Agents|autonomic agents|mesh-ancestor
111231822|NCT02195479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111231823|NCT02195479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111231824|NCT02195479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111231825|NCT02195479|Glucocorticoids|glucocorticoids|mesh-ancestor
111231826|NCT02195479|Hormones|hormones|mesh-ancestor
111231827|NCT02195479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111231828|NCT02195479|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111231829|NCT02195479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111231830|NCT02195479|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111231831|NCT02195479|Alkylating Agents|alkylating agents|mesh-ancestor
111231832|NCT02195479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111231833|NCT02195479|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111231834|NCT02195479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111231835|NCT02195479|Immunologic Factors|immunologic factors|mesh-ancestor
111231836|NCT02189720|Amifampridine|amifampridine|mesh-list
111231837|NCT02189720|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111231838|NCT02189720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111231839|NCT02189720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111231840|NCT02189720|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
111231841|NCT02189720|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111231842|NCT02189720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111231843|NCT02184195|Olaparib|olaparib|mesh-list
111231844|NCT02184195|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111231845|NCT02184195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111231846|NCT02184195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111231847|NCT02184195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111231848|NCT02181413|Ixazomib|ixazomib|mesh-list
111231849|NCT02181413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111231850|NCT02181413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111231851|NCT02181413|Protease Inhibitors|protease inhibitors|mesh-ancestor
111231852|NCT02181413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111231853|NCT02180867|Doxorubicin|doxorubicin|mesh-list
111231854|NCT02180867|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111231855|NCT02180867|Daunorubicin|daunorubicin|mesh-list
111231856|NCT02180867|Ifosfamide|ifosfamide|mesh-list
111231857|NCT02180867|Isophosphamide mustard|isophosphamide mustard|mesh-list
111231858|NCT02180867|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111231859|NCT02180867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111231860|NCT02180867|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111231861|NCT02180867|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111231862|NCT02180867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111231863|NCT02180867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111231864|NCT02180867|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111231865|NCT02180867|Alkylating Agents|alkylating agents|mesh-ancestor
111231866|NCT02152982|Temozolomide|temozolomide|mesh-list
111231867|NCT02152982|Veliparib|veliparib|mesh-list
111231868|NCT02152982|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111231869|NCT02152982|Alkylating Agents|alkylating agents|mesh-ancestor
111231870|NCT02152982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111231871|NCT02152982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111231872|NCT02152982|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111231873|NCT02152982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111231874|NCT02152631|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110956251|NCT02114463|Analgesics|analgesics|mesh-list
111231875|NCT02152631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111231876|NCT02152631|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110980706|NCT05459194|Hormones|hormones|mesh-ancestor
111231877|NCT02152631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111231878|NCT02152631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111231879|NCT02151981|Osimertinib|osimertinib|mesh-list
111231880|NCT02151981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111231881|NCT02151981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111231882|NCT02151981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111231883|NCT02151981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111231884|NCT02143466|Durvalumab|durvalumab|mesh-list
111231885|NCT02143466|Osimertinib|osimertinib|mesh-list
111231886|NCT02143466|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111231887|NCT02143466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111231888|NCT02143466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111231889|NCT02143466|Immunologic Factors|immunologic factors|mesh-ancestor
111231890|NCT02143466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111231891|NCT02143466|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111231892|NCT02143466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111231893|NCT02143466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111231894|NCT02143401|Sorafenib|sorafenib|mesh-list
111231895|NCT02143401|Navitoclax|navitoclax|mesh-list
111231896|NCT02143401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111231897|NCT02143401|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111231898|NCT02143401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111231899|NCT02143401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111231900|NCT02138617|Leucovorin|leucovorin|mesh-list
111231901|NCT02138617|Bevacizumab|bevacizumab|mesh-list
111231902|NCT02138617|Fluorouracil|fluorouracil|mesh-list
111231903|NCT02138617|Irinotecan|irinotecan|mesh-list
111231904|NCT02138617|Levoleucovorin|levoleucovorin|mesh-list
111231905|NCT02138617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111231906|NCT02138617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111231907|NCT02138617|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111231908|NCT02138617|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111231909|NCT02138617|Growth Substances|growth substances|mesh-ancestor
111231910|NCT02138617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111231911|NCT02138617|Growth Inhibitors|growth inhibitors|mesh-ancestor
111231912|NCT02138617|Antimetabolites|antimetabolites|mesh-ancestor
111231913|NCT02138617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111231914|NCT02138617|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111231915|NCT02138617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111231916|NCT02138617|Immunologic Factors|immunologic factors|mesh-ancestor
111231917|NCT02138617|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111231918|NCT02138617|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111231919|NCT02138617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111231920|NCT02138617|Antidotes|antidotes|mesh-ancestor
111231921|NCT02138617|Protective Agents|protective agents|mesh-ancestor
111231922|NCT02138617|Vitamin B Complex|vitamin b complex|mesh-ancestor
111231923|NCT02138617|Vitamins|vitamins|mesh-ancestor
111231924|NCT02138617|Micronutrients|micronutrients|mesh-ancestor
111231925|NCT02136134|Dexamethasone|dexamethasone|mesh-list
111231926|NCT02136134|Bortezomib|bortezomib|mesh-list
111231927|NCT02136134|Daratumumab|daratumumab|mesh-list
111231928|NCT02136134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111231929|NCT02136134|Antiemetics|antiemetics|mesh-ancestor
111231930|NCT02136134|Autonomic Agents|autonomic agents|mesh-ancestor
111231931|NCT02136134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111231932|NCT02136134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111231933|NCT02136134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111231934|NCT02136134|Glucocorticoids|glucocorticoids|mesh-ancestor
111231935|NCT02136134|Hormones|hormones|mesh-ancestor
111231936|NCT02136134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111231937|NCT02136134|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111231938|NCT02136134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111231939|NCT02118584|Etrolizumab|etrolizumab|mesh-list
111231940|NCT02118584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111231941|NCT02118584|Immunologic Factors|immunologic factors|mesh-ancestor
111231942|NCT02118584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111231943|NCT02106988|Dexamethasone|dexamethasone|mesh-list
111231944|NCT02106988|Carboplatin|carboplatin|mesh-list
111231945|NCT02106988|Etoposide|etoposide|mesh-list
111231946|NCT02106988|Ifosfamide|ifosfamide|mesh-list
111231947|NCT02106988|Etoposide phosphate|etoposide phosphate|mesh-list
111231948|NCT02106988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111231949|NCT02106988|Antiemetics|antiemetics|mesh-ancestor
111231950|NCT02106988|Autonomic Agents|autonomic agents|mesh-ancestor
111231951|NCT02106988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111231952|NCT02106988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111231953|NCT02106988|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111231954|NCT02106988|Glucocorticoids|glucocorticoids|mesh-ancestor
111231955|NCT02106988|Hormones|hormones|mesh-ancestor
111231956|NCT02106988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111231957|NCT02106988|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111231958|NCT02106988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111231959|NCT02106988|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111231960|NCT02106988|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111231961|NCT02106988|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111231962|NCT02106988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111231963|NCT02106988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111231964|NCT02106988|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111231965|NCT02106988|Alkylating Agents|alkylating agents|mesh-ancestor
111231966|NCT02076009|Dexamethasone|dexamethasone|mesh-list
111231967|NCT02076009|Lenalidomide|lenalidomide|mesh-list
111231968|NCT02076009|Daratumumab|daratumumab|mesh-list
111231969|NCT02076009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111231970|NCT02076009|Antiemetics|antiemetics|mesh-ancestor
111231971|NCT02076009|Autonomic Agents|autonomic agents|mesh-ancestor
111231972|NCT02076009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111231973|NCT02076009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111231974|NCT02076009|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111231975|NCT02076009|Glucocorticoids|glucocorticoids|mesh-ancestor
111231976|NCT02076009|Hormones|hormones|mesh-ancestor
111231977|NCT02076009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111231978|NCT02076009|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111231979|NCT02076009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111231980|NCT02076009|Immunologic Factors|immunologic factors|mesh-ancestor
111231981|NCT02076009|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111231982|NCT02076009|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111231983|NCT02076009|Growth Substances|growth substances|mesh-ancestor
111231984|NCT02076009|Growth Inhibitors|growth inhibitors|mesh-ancestor
111231985|NCT02060188|Nivolumab|nivolumab|mesh-list
111231986|NCT02060188|Ipilimumab|ipilimumab|mesh-list
111231987|NCT02060188|Relatlimab|relatlimab|mesh-list
111231988|NCT02060188|Daratumumab|daratumumab|mesh-list
111231989|NCT02060188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111231990|NCT02060188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111231991|NCT02060188|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111231992|NCT02060188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111231993|NCT02035787|Metformin|metformin|mesh-list
111231994|NCT02035787|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111231995|NCT02035787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111231996|NCT02003209|Carboplatin|carboplatin|mesh-list
111231997|NCT02003209|Docetaxel|docetaxel|mesh-list
111231998|NCT02003209|Trastuzumab|trastuzumab|mesh-list
111231999|NCT02003209|Pertuzumab|pertuzumab|mesh-list
111232000|NCT02003209|Goserelin|goserelin|mesh-list
111232001|NCT02003209|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
111232002|NCT02003209|Antibodies|antibodies|mesh-list
111232003|NCT02003209|Immunoglobulins|immunoglobulins|mesh-list
111232004|NCT02003209|Aromatase Inhibitors|aromatase inhibitors|mesh-list
111232005|NCT02003209|Immunologic Factors|immunologic factors|mesh-ancestor
111232006|NCT02003209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111232007|NCT02003209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111232008|NCT02003209|Tubulin Modulators|tubulin modulators|mesh-ancestor
111232009|NCT02003209|Antimitotic Agents|antimitotic agents|mesh-ancestor
111232010|NCT02003209|Mitosis Modulators|mitosis modulators|mesh-ancestor
111232011|NCT02003209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111232012|NCT02003209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111232013|NCT02003209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111232014|NCT02003209|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111232015|NCT02003209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111232016|NCT02003209|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111232017|NCT02003209|Hormone Antagonists|hormone antagonists|mesh-ancestor
111232018|NCT02003209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111232019|NCT01996605|Oxytocin|oxytocin|mesh-list
111232020|NCT01996605|Oxytocics|oxytocics|mesh-ancestor
111232021|NCT01996605|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111232022|NCT01996605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111232023|NCT01976182|Cyclophosphamide|cyclophosphamide|mesh-list
111232024|NCT01976182|Methotrexate|methotrexate|mesh-list
111232025|NCT01976182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111232026|NCT01976182|Immunologic Factors|immunologic factors|mesh-ancestor
111232027|NCT01976182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111232028|NCT01976182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111232029|NCT01976182|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111232030|NCT01976182|Alkylating Agents|alkylating agents|mesh-ancestor
111232031|NCT01976182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111232032|NCT01976182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111232033|NCT01976182|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111232034|NCT01976182|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111232035|NCT01976182|Abortifacient Agents|abortifacient agents|mesh-ancestor
111232036|NCT01976182|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111232037|NCT01976182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111232038|NCT01976182|Antimetabolites|antimetabolites|mesh-ancestor
111232039|NCT01976182|Dermatologic Agents|dermatologic agents|mesh-ancestor
111232040|NCT01976182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111232041|NCT01976182|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111232042|NCT01976182|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111232043|NCT01974440|Prednisone|prednisone|mesh-list
111232044|NCT01974440|Cyclophosphamide|cyclophosphamide|mesh-list
111232045|NCT01974440|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
111232046|NCT01974440|Rituximab|rituximab|mesh-list
111232047|NCT01974440|Doxorubicin|doxorubicin|mesh-list
111232048|NCT01974440|Vincristine|vincristine|mesh-list
111232049|NCT01974440|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111232050|NCT01974440|Immunologic Factors|immunologic factors|mesh-ancestor
111232051|NCT01974440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111232052|NCT01974440|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111232053|NCT01974440|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111232054|NCT01974440|Alkylating Agents|alkylating agents|mesh-ancestor
111232055|NCT01974440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111232056|NCT01974440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111232057|NCT01974440|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111232058|NCT01974440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111232059|NCT01974440|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111232060|NCT01974440|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111232061|NCT01974440|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111232062|NCT01974440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111232063|NCT01974440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111232064|NCT01974440|Glucocorticoids|glucocorticoids|mesh-ancestor
111232065|NCT01974440|Hormones|hormones|mesh-ancestor
111232066|NCT01974440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111232067|NCT01974440|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111232068|NCT01974440|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111232069|NCT01974440|Tubulin Modulators|tubulin modulators|mesh-ancestor
111232070|NCT01974440|Antimitotic Agents|antimitotic agents|mesh-ancestor
111232071|NCT01974440|Mitosis Modulators|mitosis modulators|mesh-ancestor
111232072|NCT01932125|Bevacizumab|bevacizumab|mesh-list
111232073|NCT01932125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111232074|NCT01932125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111232075|NCT01932125|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111232076|NCT01932125|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111232077|NCT01932125|Growth Substances|growth substances|mesh-ancestor
111232078|NCT01932125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111232079|NCT01932125|Growth Inhibitors|growth inhibitors|mesh-ancestor
111232080|NCT01921166|Leuprolide|leuprolide|mesh-list
111232081|NCT01921166|Clomiphene|clomiphene|mesh-list
111232082|NCT01921166|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111232083|NCT01921166|Fertility Agents|fertility agents|mesh-ancestor
111232084|NCT01921166|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111232085|NCT01921166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111232086|NCT01921166|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111232087|NCT01921166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111232088|NCT01921166|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111232089|NCT01921166|Hormone Antagonists|hormone antagonists|mesh-ancestor
111232090|NCT01921166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111232091|NCT01921166|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111232092|NCT01921166|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111232093|NCT01902173|Trametinib|trametinib|mesh-list
111232094|NCT01902173|Dabrafenib|dabrafenib|mesh-list
111232095|NCT01902173|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
111232096|NCT01902173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111232097|NCT01902173|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111232098|NCT01902173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111232099|NCT01902173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111232100|NCT01902173|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
111232101|NCT01902173|Protective Agents|protective agents|mesh-ancestor
111232102|NCT01902173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111232103|NCT01902173|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110956474|NCT01330017|Loratadine|loratadine|mesh-list
111232105|NCT01825603|Cisplatin|cisplatin|mesh-list
111232106|NCT01825603|Gemcitabine|gemcitabine|mesh-list
111232107|NCT01825603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111232108|NCT01825603|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111232109|NCT01825603|Antimetabolites|antimetabolites|mesh-ancestor
111232110|NCT01825603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111232111|NCT01776840|Rituximab|rituximab|mesh-list
111232112|NCT01776840|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
111232113|NCT01776840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111232114|NCT01776840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111232115|NCT01776840|Immunologic Factors|immunologic factors|mesh-ancestor
111232116|NCT01776840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111232117|NCT01776840|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111232118|NCT01776840|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111232119|NCT01776840|Alkylating Agents|alkylating agents|mesh-ancestor
111232120|NCT01776840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111232121|NCT01696461|Plerixafor|plerixafor|mesh-list
111232122|NCT01696461|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111232123|NCT01696461|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111232124|NCT01696461|Antiviral Agents|antiviral agents|mesh-ancestor
111232125|NCT01696461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111232126|NCT01688492|Ipilimumab|ipilimumab|mesh-list
111232127|NCT01688492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111232128|NCT01688492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111232129|NCT01688492|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111232130|NCT01688492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111232131|NCT01615029|Dexamethasone|dexamethasone|mesh-list
111232132|NCT01615029|Lenalidomide|lenalidomide|mesh-list
111232133|NCT01615029|Daratumumab|daratumumab|mesh-list
111232134|NCT01615029|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111232135|NCT01615029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111232136|NCT01615029|Antiemetics|antiemetics|mesh-ancestor
111232137|NCT01615029|Autonomic Agents|autonomic agents|mesh-ancestor
111232138|NCT01615029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111232139|NCT01615029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111232140|NCT01615029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111232141|NCT01615029|Glucocorticoids|glucocorticoids|mesh-ancestor
111232142|NCT01615029|Hormones|hormones|mesh-ancestor
111232143|NCT01615029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111232144|NCT01615029|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111232145|NCT01615029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111232146|NCT01615029|Immunologic Factors|immunologic factors|mesh-ancestor
111232147|NCT01615029|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111232148|NCT01615029|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111232149|NCT01615029|Growth Substances|growth substances|mesh-ancestor
111232150|NCT01615029|Growth Inhibitors|growth inhibitors|mesh-ancestor
111232151|NCT01606098|Bevacizumab|bevacizumab|mesh-list
111232152|NCT01606098|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111232153|NCT01606098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111232154|NCT01606098|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111232155|NCT01606098|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111232156|NCT01606098|Growth Substances|growth substances|mesh-ancestor
111232157|NCT01606098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111232158|NCT01606098|Growth Inhibitors|growth inhibitors|mesh-ancestor
111232159|NCT01568307|Antidepressive Agents|antidepressive agents|mesh-list
111232160|NCT01568307|Serotonin|serotonin|mesh-list
111232161|NCT01568307|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
111232162|NCT01568307|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111232163|NCT01568307|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111232164|NCT01568307|Serotonin Agents|serotonin agents|mesh-ancestor
111232165|NCT01568307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111232166|NCT01568307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111232167|NCT01568307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111232168|NCT01568307|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111232169|NCT01568307|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111232170|NCT01522976|Lenalidomide|lenalidomide|mesh-list
111232171|NCT01522976|Azacitidine|azacitidine|mesh-list
111232172|NCT01522976|Vorinostat|vorinostat|mesh-list
111232173|NCT01522976|Immunologic Factors|immunologic factors|mesh-ancestor
111232174|NCT01522976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111232175|NCT01522976|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111232176|NCT01522976|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111232177|NCT01522976|Growth Substances|growth substances|mesh-ancestor
111232178|NCT01522976|Growth Inhibitors|growth inhibitors|mesh-ancestor
111232179|NCT01522976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111232180|NCT01522976|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111232181|NCT01522976|Antimetabolites|antimetabolites|mesh-ancestor
111232182|NCT01522976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111232183|NCT01522976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111232184|NCT01522976|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111232185|NCT01508221|Vitamin E|vitamin e|mesh-list
111232186|NCT01508221|Pentoxifylline|pentoxifylline|mesh-list
111232187|NCT01508221|Vitamins|vitamins|mesh-ancestor
111232188|NCT01508221|Micronutrients|micronutrients|mesh-ancestor
111232189|NCT01508221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111232190|NCT01508221|Antioxidants|antioxidants|mesh-ancestor
111232191|NCT01508221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111232192|NCT01508221|Protective Agents|protective agents|mesh-ancestor
111232193|NCT01508221|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111232194|NCT01508221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111232195|NCT01508221|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111232196|NCT01508221|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111232197|NCT01508221|Vasodilator Agents|vasodilator agents|mesh-ancestor
111232198|NCT01508221|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111232199|NCT01485861|Prednisone|prednisone|mesh-list
111232200|NCT01485861|Prednisolone|prednisolone|mesh-list
111232201|NCT01485861|Ipatasertib|ipatasertib|mesh-list
111232202|NCT01485861|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111232203|NCT01485861|Glucocorticoids|glucocorticoids|mesh-ancestor
111232204|NCT01485861|Hormones|hormones|mesh-ancestor
111232205|NCT01485861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111232206|NCT01485861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111232207|NCT01485861|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111232208|NCT01485861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111232209|NCT01485861|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111232210|NCT01485861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111232211|NCT01485861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111232212|NCT01386385|Paclitaxel|paclitaxel|mesh-list
111232213|NCT01386385|Carboplatin|carboplatin|mesh-list
111232214|NCT01386385|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111232215|NCT01386385|Veliparib|veliparib|mesh-list
111232216|NCT01386385|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111232217|NCT01386385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111232218|NCT01386385|Tubulin Modulators|tubulin modulators|mesh-ancestor
111232219|NCT01386385|Antimitotic Agents|antimitotic agents|mesh-ancestor
111232220|NCT01386385|Mitosis Modulators|mitosis modulators|mesh-ancestor
111232221|NCT01386385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111232222|NCT01386385|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111232223|NCT01386385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111232224|NCT01374984|Immunoglobulins|immunoglobulins|mesh-list
111232225|NCT01374984|gamma-Globulins|gamma-globulins|mesh-list
111232226|NCT01374984|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111232227|NCT01374984|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
111232228|NCT01374984|Immunologic Factors|immunologic factors|mesh-ancestor
111232229|NCT01374984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111232230|NCT01314118|Prednisone|prednisone|mesh-list
111232231|NCT01314118|Abiraterone Acetate|abiraterone acetate|mesh-list
111232232|NCT01314118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111232233|NCT01314118|Glucocorticoids|glucocorticoids|mesh-ancestor
111232234|NCT01314118|Hormones|hormones|mesh-ancestor
111232235|NCT01314118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111232236|NCT01314118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111232237|NCT01314118|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111232238|NCT01314118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111232239|NCT01314118|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111232240|NCT01314118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111232241|NCT01314118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111232242|NCT01314118|Hormone Antagonists|hormone antagonists|mesh-ancestor
111232243|NCT01314118|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111232244|NCT01275677|Paclitaxel|paclitaxel|mesh-list
111232245|NCT01275677|Docetaxel|docetaxel|mesh-list
111232246|NCT01275677|Cyclophosphamide|cyclophosphamide|mesh-list
111232247|NCT01275677|Doxorubicin|doxorubicin|mesh-list
111232248|NCT01275677|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111232249|NCT01275677|Trastuzumab|trastuzumab|mesh-list
111232250|NCT01275677|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111232251|NCT01275677|Daunorubicin|daunorubicin|mesh-list
111232252|NCT01275677|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
111232253|NCT01275677|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111232254|NCT01275677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111232255|NCT01275677|Tubulin Modulators|tubulin modulators|mesh-ancestor
111232256|NCT01275677|Antimitotic Agents|antimitotic agents|mesh-ancestor
111232257|NCT01275677|Mitosis Modulators|mitosis modulators|mesh-ancestor
111232258|NCT01275677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111232259|NCT01275677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111232260|NCT01275677|Immunologic Factors|immunologic factors|mesh-ancestor
111232261|NCT01275677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111232262|NCT01275677|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111232263|NCT01275677|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111232264|NCT01275677|Alkylating Agents|alkylating agents|mesh-ancestor
111232265|NCT01275677|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111232266|NCT01275677|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111232267|NCT01275677|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111232268|NCT01275677|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111232269|NCT01275677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111232270|NCT01275677|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111232271|NCT01274338|Interferons|interferons|mesh-list
111232272|NCT01274338|Interferon-alpha|interferon-alpha|mesh-list
111232273|NCT01274338|Interferon alpha-2|interferon alpha-2|mesh-list
111232274|NCT01274338|Ipilimumab|ipilimumab|mesh-list
111232275|NCT01274338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111232276|NCT01274338|Antiviral Agents|antiviral agents|mesh-ancestor
111232277|NCT01274338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111232278|NCT01274338|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111232279|NCT01274338|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111232280|NCT01274338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111232281|NCT01274338|Immunologic Factors|immunologic factors|mesh-ancestor
111232282|NCT01274338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111232283|NCT01241734|Lenalidomide|lenalidomide|mesh-list
111232284|NCT01241734|Immunologic Factors|immunologic factors|mesh-ancestor
111232285|NCT01241734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111232286|NCT01241734|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111232287|NCT01241734|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111232288|NCT01241734|Growth Substances|growth substances|mesh-ancestor
111232289|NCT01241734|Growth Inhibitors|growth inhibitors|mesh-ancestor
111232290|NCT01241734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111232291|NCT01169337|Lenalidomide|lenalidomide|mesh-list
111232292|NCT01169337|Immunologic Factors|immunologic factors|mesh-ancestor
111232293|NCT01169337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111232294|NCT01169337|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111232295|NCT01169337|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111232296|NCT01169337|Growth Substances|growth substances|mesh-ancestor
111232297|NCT01169337|Growth Inhibitors|growth inhibitors|mesh-ancestor
111232298|NCT01169337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111232299|NCT01167712|Paclitaxel|paclitaxel|mesh-list
111232300|NCT01167712|Bevacizumab|bevacizumab|mesh-list
111232301|NCT01167712|Carboplatin|carboplatin|mesh-list
111232302|NCT01167712|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111232303|NCT01167712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111232304|NCT01167712|Endothelial Growth Factors|endothelial growth factors|mesh-list
111232305|NCT01167712|Antibodies|antibodies|mesh-list
111232306|NCT01167712|Immunoglobulins|immunoglobulins|mesh-list
111232307|NCT01167712|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111232308|NCT01167712|Immunoglobulin G|immunoglobulin g|mesh-list
111232309|NCT01167712|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111232310|NCT01167712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111232311|NCT01167712|Tubulin Modulators|tubulin modulators|mesh-ancestor
111232312|NCT01167712|Antimitotic Agents|antimitotic agents|mesh-ancestor
111232313|NCT01167712|Mitosis Modulators|mitosis modulators|mesh-ancestor
111232314|NCT01167712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111232315|NCT01167712|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111232316|NCT01167712|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111232317|NCT01167712|Growth Substances|growth substances|mesh-ancestor
111232318|NCT01167712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111232319|NCT01167712|Growth Inhibitors|growth inhibitors|mesh-ancestor
111232320|NCT01167712|Immunologic Factors|immunologic factors|mesh-ancestor
111232321|NCT01101438|Metformin|metformin|mesh-list
111232322|NCT01101438|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111232323|NCT01101438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111232324|NCT01094769|Moxonidine|moxonidine|mesh-list
111232325|NCT01094769|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111232326|NCT01093326|Ponesimod|ponesimod|mesh-list
111232327|NCT01093326|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
111232328|NCT01093326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111232329|NCT01093326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111232330|NCT01093326|Immunologic Factors|immunologic factors|mesh-ancestor
111232331|NCT01093326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111232333|NCT01081262|Bevacizumab|bevacizumab|mesh-list
111232334|NCT01081262|Carboplatin|carboplatin|mesh-list
111232335|NCT01081262|Capecitabine|capecitabine|mesh-list
111232336|NCT01081262|Oxaliplatin|oxaliplatin|mesh-list
111232337|NCT01081262|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111232338|NCT01081262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111232339|NCT01081262|Endothelial Growth Factors|endothelial growth factors|mesh-list
111232340|NCT01081262|Antibodies|antibodies|mesh-list
111232341|NCT01081262|Immunoglobulins|immunoglobulins|mesh-list
111232342|NCT01081262|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111232343|NCT01081262|Immunoglobulin G|immunoglobulin g|mesh-list
111232344|NCT01081262|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111232345|NCT01081262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111232346|NCT01081262|Tubulin Modulators|tubulin modulators|mesh-ancestor
111232347|NCT01081262|Antimitotic Agents|antimitotic agents|mesh-ancestor
111232348|NCT01081262|Mitosis Modulators|mitosis modulators|mesh-ancestor
111232349|NCT01081262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111232350|NCT01081262|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111232351|NCT01081262|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111232352|NCT01081262|Growth Substances|growth substances|mesh-ancestor
111232353|NCT01081262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111232354|NCT01081262|Growth Inhibitors|growth inhibitors|mesh-ancestor
111232355|NCT01081262|Immunologic Factors|immunologic factors|mesh-ancestor
111232356|NCT01081262|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111232357|NCT01081262|Antimetabolites|antimetabolites|mesh-ancestor
111232358|NCT01046825|Leucovorin|leucovorin|mesh-list
111232359|NCT01046825|Folic Acid|folic acid|mesh-list
111232360|NCT01046825|Cytarabine|cytarabine|mesh-list
111232361|NCT01046825|Prednisone|prednisone|mesh-list
111232362|NCT01046825|Cyclophosphamide|cyclophosphamide|mesh-list
111232363|NCT01046825|Doxorubicin|doxorubicin|mesh-list
111232364|NCT01046825|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111232365|NCT01046825|Rituximab|rituximab|mesh-list
111232366|NCT01046825|Rasburicase|rasburicase|mesh-list
111232367|NCT01046825|Lenograstim|lenograstim|mesh-list
111232368|NCT01046825|Levoleucovorin|levoleucovorin|mesh-list
111232369|NCT01046825|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111232370|NCT01046825|Glucocorticoids|glucocorticoids|mesh-ancestor
111232371|NCT01046825|Hormones|hormones|mesh-ancestor
111232372|NCT01046825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111232373|NCT01046825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111232374|NCT01046825|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111232375|NCT01046825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111232376|NCT01046825|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111232377|NCT01046825|Immunologic Factors|immunologic factors|mesh-ancestor
111232378|NCT01046825|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111232379|NCT01046825|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111232380|NCT01046825|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111232381|NCT01046825|Alkylating Agents|alkylating agents|mesh-ancestor
111232382|NCT01046825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111232383|NCT01046825|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111232384|NCT01046825|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111232385|NCT01046825|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111232386|NCT01046825|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111232387|NCT01046825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111232388|NCT01046825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111232389|NCT01046825|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111232390|NCT01046825|Antimetabolites|antimetabolites|mesh-ancestor
111232391|NCT01046825|Antiviral Agents|antiviral agents|mesh-ancestor
111232392|NCT01046825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111232393|NCT01046825|Antidotes|antidotes|mesh-ancestor
111232394|NCT01046825|Protective Agents|protective agents|mesh-ancestor
111232395|NCT01046825|Vitamin B Complex|vitamin b complex|mesh-ancestor
111232396|NCT01046825|Vitamins|vitamins|mesh-ancestor
111232397|NCT01046825|Micronutrients|micronutrients|mesh-ancestor
111232398|NCT01046825|Hematinics|hematinics|mesh-ancestor
111232399|NCT01046825|Gout Suppressants|gout suppressants|mesh-ancestor
111232400|NCT01007773|Fentanyl|fentanyl|mesh-list
111232401|NCT01007773|Dexmedetomidine|dexmedetomidine|mesh-list
111232402|NCT01007773|Propofol|propofol|mesh-list
110956775|NCT00079482|Mitoxantrone|mitoxantrone|mesh-list
111232403|NCT01007773|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111232404|NCT01007773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111232405|NCT01007773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111232406|NCT01007773|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111232407|NCT01007773|Analgesics|analgesics|mesh-ancestor
111232408|NCT01007773|Sensory System Agents|sensory system agents|mesh-ancestor
111232409|NCT01007773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111232410|NCT01007773|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111232411|NCT01007773|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111232412|NCT01007773|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111232413|NCT01007773|Adrenergic Agents|adrenergic agents|mesh-ancestor
111232414|NCT01007773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111232415|NCT01007773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111232416|NCT01007773|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111232417|NCT01007773|Anesthetics, General|anesthetics, general|mesh-ancestor
111232418|NCT01007773|Anesthetics|anesthetics|mesh-ancestor
111232419|NCT01007773|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111232420|NCT01007773|Narcotics|narcotics|mesh-ancestor
111232421|NCT01007773|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111232422|NCT00980538|Etravirine|etravirine|mesh-list
111232423|NCT00980538|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111232424|NCT00980538|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111232425|NCT00980538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111232426|NCT00980538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111232427|NCT00980538|Antiviral Agents|antiviral agents|mesh-ancestor
111232428|NCT00980538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111232429|NCT00977574|Sirolimus|sirolimus|mesh-list
111232430|NCT00977574|Paclitaxel|paclitaxel|mesh-list
111232431|NCT00977574|Epothilones|epothilones|mesh-list
111232432|NCT00977574|Epothilone B|epothilone b|mesh-list
111232433|NCT00977574|Bevacizumab|bevacizumab|mesh-list
111232434|NCT00977574|Carboplatin|carboplatin|mesh-list
111232435|NCT00977574|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111232436|NCT00977574|Temsirolimus|temsirolimus|mesh-list
111232437|NCT00977574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111232438|NCT00977574|MTOR Inhibitors|mtor inhibitors|mesh-list
111232439|NCT00977574|Endothelial Growth Factors|endothelial growth factors|mesh-list
111232440|NCT00977574|Antibodies|antibodies|mesh-list
111232441|NCT00977574|Immunoglobulins|immunoglobulins|mesh-list
111232442|NCT00977574|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111232443|NCT00977574|Immunoglobulin G|immunoglobulin g|mesh-list
111232444|NCT00977574|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111232445|NCT00977574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111232446|NCT00977574|Tubulin Modulators|tubulin modulators|mesh-ancestor
111232447|NCT00977574|Antimitotic Agents|antimitotic agents|mesh-ancestor
111232448|NCT00977574|Mitosis Modulators|mitosis modulators|mesh-ancestor
111232449|NCT00977574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111232450|NCT00977574|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111232451|NCT00977574|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111232452|NCT00977574|Growth Substances|growth substances|mesh-ancestor
111232453|NCT00977574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111232454|NCT00977574|Growth Inhibitors|growth inhibitors|mesh-ancestor
111232455|NCT00977574|Immunologic Factors|immunologic factors|mesh-ancestor
111232456|NCT00977574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111232457|NCT00977574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111232458|NCT00977574|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111232459|NCT00977574|Antifungal Agents|antifungal agents|mesh-ancestor
111232460|NCT00977574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111232461|NCT00977574|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111232462|NCT00977574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111232463|NCT00936663|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111232464|NCT00936663|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111232465|NCT00936663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111232466|NCT00936663|Incretins|incretins|mesh-ancestor
111232467|NCT00936663|Hormones|hormones|mesh-ancestor
111232468|NCT00936663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111232469|NCT00936663|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111232470|NCT00936663|Protease Inhibitors|protease inhibitors|mesh-ancestor
111232471|NCT00936663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111232472|NCT00936663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111232473|NCT00769379|Trastuzumab|trastuzumab|mesh-list
111232474|NCT00769379|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
111232475|NCT00769379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111232476|NCT00769379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111232477|NCT00681343|Alemtuzumab|alemtuzumab|mesh-list
111232478|NCT00681343|Thymoglobulin|thymoglobulin|mesh-list
111232479|NCT00681343|Daclizumab|daclizumab|mesh-list
111232480|NCT00681343|Immunologic Factors|immunologic factors|mesh-ancestor
111232481|NCT00681343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111232482|NCT00681343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111320773|NCT02285283|Hormone Antagonists|hormone antagonists|mesh-ancestor
111232483|NCT00681343|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111232484|NCT00681343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111232485|NCT00665457|Celecoxib|celecoxib|mesh-list
111232486|NCT00665457|Cyclophosphamide|cyclophosphamide|mesh-list
111232487|NCT00665457|Docetaxel|docetaxel|mesh-list
111232488|NCT00665457|Doxorubicin|doxorubicin|mesh-list
111232489|NCT00665457|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111232490|NCT00665457|Capecitabine|capecitabine|mesh-list
111232491|NCT00665457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111232492|NCT00665457|Immunologic Factors|immunologic factors|mesh-ancestor
111232493|NCT00665457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111232494|NCT00665457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111232495|NCT00665457|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111232496|NCT00665457|Alkylating Agents|alkylating agents|mesh-ancestor
111232497|NCT00665457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111232498|NCT00665457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111232499|NCT00665457|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111232500|NCT00665457|Tubulin Modulators|tubulin modulators|mesh-ancestor
111232501|NCT00665457|Antimitotic Agents|antimitotic agents|mesh-ancestor
111232502|NCT00665457|Mitosis Modulators|mitosis modulators|mesh-ancestor
111232503|NCT00665457|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111232504|NCT00665457|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111232505|NCT00665457|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111232506|NCT00665457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111232507|NCT00665457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111232508|NCT00665457|Antimetabolites|antimetabolites|mesh-ancestor
111232509|NCT00665457|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111232510|NCT00665457|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111232511|NCT00665457|Analgesics|analgesics|mesh-ancestor
111232512|NCT00665457|Sensory System Agents|sensory system agents|mesh-ancestor
111232513|NCT00665457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111232514|NCT00665457|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111232515|NCT00665457|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111232516|NCT00665457|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111232517|NCT00644228|Dexamethasone|dexamethasone|mesh-list
111232518|NCT00644228|Dexamethasone acetate|dexamethasone acetate|mesh-list
111232519|NCT00644228|Lenalidomide|lenalidomide|mesh-list
111232520|NCT00644228|Bortezomib|bortezomib|mesh-list
111232521|NCT00644228|Ichthammol|ichthammol|mesh-list
111232522|NCT00644228|BB 1101|bb 1101|mesh-list
111232523|NCT00644228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111232524|NCT00644228|Antiemetics|antiemetics|mesh-ancestor
111232525|NCT00644228|Autonomic Agents|autonomic agents|mesh-ancestor
111232526|NCT00644228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111232527|NCT00644228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111232528|NCT00644228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111232529|NCT00644228|Glucocorticoids|glucocorticoids|mesh-ancestor
111232530|NCT00644228|Hormones|hormones|mesh-ancestor
111232531|NCT00644228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111232532|NCT00644228|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111232533|NCT00644228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111232534|NCT00644228|Protease Inhibitors|protease inhibitors|mesh-ancestor
111232535|NCT00644228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111232536|NCT00644228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111232537|NCT00644228|Immunologic Factors|immunologic factors|mesh-ancestor
111232538|NCT00644228|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111232539|NCT00644228|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111232540|NCT00644228|Growth Substances|growth substances|mesh-ancestor
111232541|NCT00644228|Growth Inhibitors|growth inhibitors|mesh-ancestor
111232542|NCT00644228|Dermatologic Agents|dermatologic agents|mesh-ancestor
111232543|NCT00606346|Infliximab|infliximab|mesh-list
111232544|NCT00606346|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111232545|NCT00606346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111232546|NCT00606346|Dermatologic Agents|dermatologic agents|mesh-ancestor
111232547|NCT00606346|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111232548|NCT00606346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111232549|NCT00574730|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
111232550|NCT00574730|Rituximab|rituximab|mesh-list
111232551|NCT00574730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111232552|NCT00574730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111232553|NCT00574730|Immunologic Factors|immunologic factors|mesh-ancestor
111232554|NCT00574730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111232555|NCT00574730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111232556|NCT00574730|Antiviral Agents|antiviral agents|mesh-ancestor
111232557|NCT00574730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111232558|NCT00569127|Interferons|interferons|mesh-list
111232559|NCT00569127|Interferon-alpha|interferon-alpha|mesh-list
111232560|NCT00569127|Interferon alpha-2|interferon alpha-2|mesh-list
111232561|NCT00569127|Bevacizumab|bevacizumab|mesh-list
110668998|NCT01052896|Analgesics|analgesics|mesh-ancestor
111232562|NCT00569127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111232563|NCT00569127|Octreotide|octreotide|mesh-list
111232564|NCT00569127|Endothelial Growth Factors|endothelial growth factors|mesh-list
111232565|NCT00569127|Antibodies|antibodies|mesh-list
111232566|NCT00569127|Immunoglobulins|immunoglobulins|mesh-list
111232567|NCT00569127|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111232568|NCT00569127|Immunoglobulin G|immunoglobulin g|mesh-list
111232569|NCT00569127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111232570|NCT00569127|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111232571|NCT00569127|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111232572|NCT00569127|Growth Substances|growth substances|mesh-ancestor
111232573|NCT00569127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111232574|NCT00569127|Growth Inhibitors|growth inhibitors|mesh-ancestor
111232575|NCT00569127|Immunologic Factors|immunologic factors|mesh-ancestor
111232576|NCT00569127|Antiviral Agents|antiviral agents|mesh-ancestor
111232577|NCT00569127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111232578|NCT00569127|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111232579|NCT00569127|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111232580|NCT00496756|Sorafenib|sorafenib|mesh-list
111232581|NCT00496756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111232582|NCT00496756|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111232583|NCT00496756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111232584|NCT00496756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111232585|NCT00483561|Etoposide|etoposide|mesh-list
111232586|NCT00483561|Gefitinib|gefitinib|mesh-list
111232587|NCT00483561|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111232588|NCT00483561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111232589|NCT00483561|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111232590|NCT00483561|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111232591|NCT00483561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111232592|NCT00483561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111232593|NCT00483561|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111232594|NCT00483366|Gemcitabine|gemcitabine|mesh-list
111232595|NCT00483366|Capecitabine|capecitabine|mesh-list
111232596|NCT00483366|Imatinib Mesylate|imatinib mesylate|mesh-list
111232597|NCT00483366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111232598|NCT00483366|Antimetabolites|antimetabolites|mesh-ancestor
111232599|NCT00483366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111232600|NCT00483366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111232601|NCT00483366|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111232602|NCT00483366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111232603|NCT00324805|Bevacizumab|bevacizumab|mesh-list
111232604|NCT00324805|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111232605|NCT00324805|Cisplatin|cisplatin|mesh-list
111232606|NCT00324805|Gemcitabine|gemcitabine|mesh-list
111232607|NCT00324805|Docetaxel|docetaxel|mesh-list
111232608|NCT00324805|Pemetrexed|pemetrexed|mesh-list
111232609|NCT00324805|Vinorelbine|vinorelbine|mesh-list
111232610|NCT00324805|Endothelial Growth Factors|endothelial growth factors|mesh-list
111232611|NCT00324805|Antibodies|antibodies|mesh-list
111232612|NCT00324805|Immunoglobulins|immunoglobulins|mesh-list
111232613|NCT00324805|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111232614|NCT00324805|Immunoglobulin G|immunoglobulin g|mesh-list
111232615|NCT00324805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111232616|NCT00324805|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111232617|NCT00324805|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111232618|NCT00324805|Growth Substances|growth substances|mesh-ancestor
111232619|NCT00324805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111232620|NCT00324805|Growth Inhibitors|growth inhibitors|mesh-ancestor
111232621|NCT00324805|Immunologic Factors|immunologic factors|mesh-ancestor
111232622|NCT00324805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111232623|NCT00324805|Antimetabolites|antimetabolites|mesh-ancestor
111232624|NCT00324805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111232625|NCT00324805|Tubulin Modulators|tubulin modulators|mesh-ancestor
111232626|NCT00324805|Antimitotic Agents|antimitotic agents|mesh-ancestor
111232627|NCT00324805|Mitosis Modulators|mitosis modulators|mesh-ancestor
111232628|NCT00324805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111232629|NCT00324805|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111232630|NCT00324805|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111232631|NCT00324805|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111232632|NCT00310180|Tamoxifen|tamoxifen|mesh-list
111232633|NCT00310180|Letrozole|letrozole|mesh-list
111232634|NCT00310180|Anastrozole|anastrozole|mesh-list
111232635|NCT00310180|Exemestane|exemestane|mesh-list
111232636|NCT00310180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111232637|NCT00310180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111232638|NCT00310180|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111232639|NCT00310180|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111232640|NCT00310180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111232641|NCT00310180|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111232642|NCT00310180|Hormone Antagonists|hormone antagonists|mesh-ancestor
111232643|NCT00310180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111232644|NCT00310180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111232645|NCT00310180|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111232646|NCT00310180|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111232647|NCT00310180|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111232648|NCT00310180|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111232649|NCT00278083|Nitric Oxide|nitric oxide|mesh-list
111232650|NCT00278083|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111232651|NCT00278083|Autonomic Agents|autonomic agents|mesh-ancestor
111232652|NCT00278083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111232653|NCT00278083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111232654|NCT00278083|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111232655|NCT00278083|Respiratory System Agents|respiratory system agents|mesh-ancestor
111232656|NCT00278083|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111232657|NCT00278083|Antioxidants|antioxidants|mesh-ancestor
111232658|NCT00278083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111232659|NCT00278083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111232660|NCT00278083|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
111232661|NCT00278083|Vasodilator Agents|vasodilator agents|mesh-ancestor
111232662|NCT00278083|Gasotransmitters|gasotransmitters|mesh-ancestor
111232663|NCT00278083|Protective Agents|protective agents|mesh-ancestor
111232664|NCT03330132|Hemagglutinins|hemagglutinins|mesh-list
111232666|NCT03330132|Immunologic Factors|immunologic factors|mesh-ancestor
111232667|NCT03330132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111232668|NCT03330132|Agglutinins|agglutinins|mesh-ancestor
111232669|NCT03330132|Coagulants|coagulants|mesh-ancestor
111232670|NCT02492412|Cyclosporine|cyclosporine|mesh-list
111232671|NCT02492412|Cyclosporins|cyclosporins|mesh-list
111232672|NCT02492412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111232673|NCT02492412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111232674|NCT02492412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111232675|NCT02492412|Immunologic Factors|immunologic factors|mesh-ancestor
111232676|NCT02492412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111232677|NCT02492412|Antifungal Agents|antifungal agents|mesh-ancestor
111232678|NCT02492412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111232679|NCT02492412|Dermatologic Agents|dermatologic agents|mesh-ancestor
111232680|NCT02492412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111232681|NCT02492412|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111232682|NCT03329898|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
111232683|NCT03329898|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
111232684|NCT03329898|Estradiol|estradiol|mesh-list
111232685|NCT03329898|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
111232686|NCT03329898|Dydrogesterone|dydrogesterone|mesh-list
111232687|NCT03329898|Estrogens|estrogens|mesh-ancestor
111232688|NCT03329898|Hormones|hormones|mesh-ancestor
111232689|NCT03329898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111232690|NCT03329898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111232691|NCT03329898|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111232692|NCT03329898|Contraceptive Agents|contraceptive agents|mesh-ancestor
111232693|NCT03329898|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111232694|NCT03329898|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111232695|NCT03329898|Progestins|progestins|mesh-ancestor
111232696|NCT02492568|Pembrolizumab|pembrolizumab|mesh-list
111232697|NCT02492568|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111232698|NCT02492568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111232699|NCT02492568|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111232700|NCT02492568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111232701|NCT01722292|Carboplatin|carboplatin|mesh-list
111232702|NCT01722292|Etoposide|etoposide|mesh-list
111232703|NCT01722292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111232704|NCT01722292|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111232705|NCT01722292|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111232706|NCT01722292|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111232707|NCT01722292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111232708|NCT01722292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111232709|NCT02493894|Cefazolin|cefazolin|mesh-list
111232710|NCT02493894|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111232711|NCT02493894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111232712|NCT02493738|Itraconazole|itraconazole|mesh-list
111232713|NCT02493738|Antifungal Agents|antifungal agents|mesh-ancestor
111232714|NCT02493738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110957080|NCT02128425|Leucovorin|leucovorin|mesh-list
111232715|NCT02493738|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111232716|NCT02493738|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111232717|NCT02493738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111232718|NCT02493738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111232719|NCT02493738|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111232720|NCT02493738|Hormone Antagonists|hormone antagonists|mesh-ancestor
111232721|NCT02493738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111232722|NCT02493738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111232723|NCT02493738|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111232724|NCT03875638|Levetiracetam|levetiracetam|mesh-list
111232725|NCT03875638|Anticonvulsants|anticonvulsants|mesh-ancestor
111232726|NCT03875638|Nootropic Agents|nootropic agents|mesh-ancestor
111232727|NCT02493582|Apatinib|apatinib|mesh-list
111232728|NCT02493582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111232729|NCT02493582|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111232730|NCT02493582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111232731|NCT02493582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111232732|NCT05560360|Efavirenz|efavirenz|mesh-list
111232733|NCT05560360|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111232734|NCT05560360|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111232735|NCT05560360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111232736|NCT05560360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111232737|NCT05560360|Antiviral Agents|antiviral agents|mesh-ancestor
111232738|NCT05560360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111232739|NCT05560360|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111232740|NCT05560360|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111232741|NCT05560360|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111232742|NCT05560360|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111232743|NCT05560360|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111232744|NCT05560360|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111232745|NCT03329118|Simvastatin|simvastatin|mesh-list
111232746|NCT03329118|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111232747|NCT03329118|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111232748|NCT03329118|Antimetabolites|antimetabolites|mesh-ancestor
111232749|NCT03329118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111232750|NCT03329118|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111232751|NCT03329118|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111232752|NCT03329118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111232753|NCT01723384|Naltrexone|naltrexone|mesh-list
111232754|NCT01723384|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111232755|NCT01723384|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111232756|NCT01723384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111232757|NCT01723384|Sensory System Agents|sensory system agents|mesh-ancestor
111232758|NCT01723384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111232759|NCT02492490|Basiliximab|basiliximab|mesh-list
111232760|NCT02492490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111232761|NCT02492490|Immunologic Factors|immunologic factors|mesh-ancestor
111232762|NCT02492490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111232763|NCT03337932|Doxycycline|doxycycline|mesh-list
111232764|NCT03337932|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111232765|NCT03337932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111232766|NCT03337932|Antimalarials|antimalarials|mesh-ancestor
111232767|NCT03337932|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111232768|NCT03337932|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111232769|NCT02493504|Heparin|heparin|mesh-list
111232770|NCT02493504|Anticoagulants|anticoagulants|mesh-ancestor
111232771|NCT02493504|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111232772|NCT02493504|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111232773|NCT02493504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111232774|NCT00706914|Formoterol Fumarate|formoterol fumarate|mesh-list
111232775|NCT00706914|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111232776|NCT00706914|Autonomic Agents|autonomic agents|mesh-ancestor
111232777|NCT00706914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111232778|NCT00706914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111232779|NCT00706914|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111232780|NCT00706914|Respiratory System Agents|respiratory system agents|mesh-ancestor
111232781|NCT00706914|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111232782|NCT00706914|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111232783|NCT00706914|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111232784|NCT00706914|Adrenergic Agents|adrenergic agents|mesh-ancestor
111232785|NCT00706914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111232786|NCT00706914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111232787|NCT03328728|Hylan|hylan|mesh-list
111232788|NCT03328728|Viscosupplements|viscosupplements|mesh-ancestor
111232789|NCT03328728|Protective Agents|protective agents|mesh-ancestor
111232790|NCT03328728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111232791|NCT03328494|Paclitaxel|paclitaxel|mesh-list
111232792|NCT03328494|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111232793|NCT03328494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111232794|NCT03328494|Tubulin Modulators|tubulin modulators|mesh-ancestor
111232795|NCT03328494|Antimitotic Agents|antimitotic agents|mesh-ancestor
111232796|NCT03328494|Mitosis Modulators|mitosis modulators|mesh-ancestor
111232797|NCT03328494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111232798|NCT02491398|Rituximab|rituximab|mesh-list
111232799|NCT02491398|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
111232800|NCT02491398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111232801|NCT02491398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111232802|NCT02491398|Immunologic Factors|immunologic factors|mesh-ancestor
111232803|NCT02491398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111232804|NCT02491398|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111232805|NCT02491398|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111232806|NCT02491398|Alkylating Agents|alkylating agents|mesh-ancestor
111232807|NCT02491398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111232808|NCT03333018|Bromides|bromides|mesh-list
111232809|NCT03333018|Formoterol Fumarate|formoterol fumarate|mesh-list
111232810|NCT03333018|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111232811|NCT03333018|Autonomic Agents|autonomic agents|mesh-ancestor
111232812|NCT03333018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111232813|NCT03333018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111232814|NCT03333018|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111232815|NCT03333018|Respiratory System Agents|respiratory system agents|mesh-ancestor
111232816|NCT03333018|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111232817|NCT03333018|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111232818|NCT03333018|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111232819|NCT03333018|Adrenergic Agents|adrenergic agents|mesh-ancestor
111232820|NCT03333018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111232821|NCT03333018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111232822|NCT03333018|Anticonvulsants|anticonvulsants|mesh-ancestor
111232823|NCT03332940|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
111232824|NCT03332940|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111232825|NCT03332940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111232826|NCT01723696|Vitamins|vitamins|mesh-list
111232827|NCT01723696|Ascorbic Acid|ascorbic acid|mesh-list
111232828|NCT01723696|Micronutrients|micronutrients|mesh-ancestor
111232829|NCT01723696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111232830|NCT01723696|Antioxidants|antioxidants|mesh-ancestor
111232831|NCT01723696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111232832|NCT01723696|Protective Agents|protective agents|mesh-ancestor
111232833|NCT03327558|Mesalamine|mesalamine|mesh-list
111232834|NCT03327558|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111232835|NCT03327558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111232836|NCT03327558|Analgesics|analgesics|mesh-ancestor
111232837|NCT03327558|Sensory System Agents|sensory system agents|mesh-ancestor
111232838|NCT03327558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111232839|NCT03327558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111232840|NCT03327558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111232841|NCT03327558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111232842|NCT02242630|Methylprednisolone|methylprednisolone|mesh-list
111232843|NCT02242630|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111232844|NCT02242630|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111232845|NCT02242630|Prednisolone|prednisolone|mesh-list
111232846|NCT02242630|Prednisolone acetate|prednisolone acetate|mesh-list
111232847|NCT02242630|Triamcinolone|triamcinolone|mesh-list
111232848|NCT02242630|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
111232849|NCT02242630|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
111232850|NCT02242630|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111232851|NCT02242630|Prednisolone phosphate|prednisolone phosphate|mesh-list
111232852|NCT02242630|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
111232853|NCT02242630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111232854|NCT02242630|Antiemetics|antiemetics|mesh-ancestor
111232855|NCT02242630|Autonomic Agents|autonomic agents|mesh-ancestor
111232856|NCT02242630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111232857|NCT02242630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111232858|NCT02242630|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111232859|NCT02242630|Glucocorticoids|glucocorticoids|mesh-ancestor
111232860|NCT02242630|Hormones|hormones|mesh-ancestor
111232861|NCT02242630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110957226|NCT02251977|Micronutrients|micronutrients|mesh-ancestor
111232862|NCT02242630|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111232863|NCT02242630|Protective Agents|protective agents|mesh-ancestor
111232864|NCT02242630|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111232865|NCT02242630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111232866|NCT02242630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111232867|NCT02242630|Immunologic Factors|immunologic factors|mesh-ancestor
111232868|NCT02242630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111232869|NCT02242630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111232870|NCT03109080|Olaparib|olaparib|mesh-list
111232871|NCT03109080|Adenosine|adenosine|mesh-list
111232872|NCT03109080|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111232873|NCT03109080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111232874|NCT03109080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111232875|NCT03109080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111232876|NCT03109080|Analgesics|analgesics|mesh-ancestor
111232877|NCT03109080|Sensory System Agents|sensory system agents|mesh-ancestor
111232878|NCT03109080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111232879|NCT03109080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111232880|NCT03109080|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111232881|NCT03109080|Vasodilator Agents|vasodilator agents|mesh-ancestor
111232882|NCT03109080|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
111232883|NCT03109080|Purinergic Agonists|purinergic agonists|mesh-ancestor
111232884|NCT03109080|Purinergic Agents|purinergic agents|mesh-ancestor
111232885|NCT03109080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111232886|NCT03109158|Cetuximab|cetuximab|mesh-list
111232887|NCT03109158|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111232888|NCT03109158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111232889|NCT03324828|Hydroxyzine|hydroxyzine|mesh-list
111232890|NCT03324828|Antipruritics|antipruritics|mesh-ancestor
111232891|NCT03324828|Dermatologic Agents|dermatologic agents|mesh-ancestor
111232892|NCT03324828|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111232893|NCT03324828|Histamine Antagonists|histamine antagonists|mesh-ancestor
111232894|NCT03324828|Histamine Agents|histamine agents|mesh-ancestor
111232895|NCT03324828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111232896|NCT03324828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111232897|NCT03324828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111232898|NCT03332316|Dexamethasone|dexamethasone|mesh-list
111232899|NCT03332316|Dexamethasone acetate|dexamethasone acetate|mesh-list
111232900|NCT03332316|Ropivacaine|ropivacaine|mesh-list
111232901|NCT03332316|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
111232902|NCT03332316|BB 1101|bb 1101|mesh-list
111232903|NCT03332316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111232904|NCT03332316|Antiemetics|antiemetics|mesh-ancestor
111232905|NCT03332316|Autonomic Agents|autonomic agents|mesh-ancestor
111232906|NCT03332316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111232907|NCT03332316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111232908|NCT03332316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111232909|NCT03332316|Glucocorticoids|glucocorticoids|mesh-ancestor
111232910|NCT03332316|Hormones|hormones|mesh-ancestor
111232911|NCT03332316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111232912|NCT03332316|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111232913|NCT03332316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111232914|NCT03332316|Anesthetics, Local|anesthetics, local|mesh-ancestor
111232915|NCT03332316|Anesthetics|anesthetics|mesh-ancestor
111232916|NCT03332316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111232917|NCT03332316|Sensory System Agents|sensory system agents|mesh-ancestor
111232918|NCT03332316|Protease Inhibitors|protease inhibitors|mesh-ancestor
111232919|NCT03332316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111232920|NCT03332316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111232921|NCT03327168|Adenosine|adenosine|mesh-list
111232922|NCT03327168|Analgesics|analgesics|mesh-ancestor
111232923|NCT03327168|Sensory System Agents|sensory system agents|mesh-ancestor
111232924|NCT03327168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111232925|NCT03327168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111232926|NCT03327168|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111232927|NCT03327168|Vasodilator Agents|vasodilator agents|mesh-ancestor
111232928|NCT03327168|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
111232929|NCT03327168|Purinergic Agonists|purinergic agonists|mesh-ancestor
111232930|NCT03327168|Purinergic Agents|purinergic agents|mesh-ancestor
111232931|NCT03327168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111232932|NCT03327168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111232933|NCT01726738|Trametinib|trametinib|mesh-list
111232934|NCT01726738|Dabrafenib|dabrafenib|mesh-list
111232935|NCT01726738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111232936|NCT01726738|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111232937|NCT01726738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111232938|NCT01726738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111232939|NCT02492178|Artesunate|artesunate|mesh-list
111232940|NCT02492178|Quinine|quinine|mesh-list
111232941|NCT02492178|Antimalarials|antimalarials|mesh-ancestor
111232942|NCT02492178|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111232943|NCT02492178|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111232944|NCT02492178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111232945|NCT02492178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111232946|NCT02492178|Antiviral Agents|antiviral agents|mesh-ancestor
111232947|NCT02492178|Schistosomicides|schistosomicides|mesh-ancestor
111232948|NCT02492178|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
111232949|NCT02492178|Anthelmintics|anthelmintics|mesh-ancestor
111232950|NCT02492178|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
111232951|NCT02492178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111232952|NCT02492178|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111232953|NCT02492178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111232954|NCT02492178|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111232955|NCT02492178|Analgesics|analgesics|mesh-ancestor
111232956|NCT02492178|Sensory System Agents|sensory system agents|mesh-ancestor
111232957|NCT03679624|Daratumumab|daratumumab|mesh-list
111232958|NCT03679624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111232959|NCT04494126|Tranexamic Acid|tranexamic acid|mesh-list
111232960|NCT04494126|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111232961|NCT04494126|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111232962|NCT04494126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111232963|NCT04494126|Hemostatics|hemostatics|mesh-ancestor
111232964|NCT04494126|Coagulants|coagulants|mesh-ancestor
111232965|NCT01730872|Prednisolone|prednisolone|mesh-list
111232966|NCT01730872|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111232967|NCT01730872|Methylprednisolone|methylprednisolone|mesh-list
111232968|NCT01730872|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111232969|NCT01730872|Prednisolone acetate|prednisolone acetate|mesh-list
111232970|NCT01730872|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111232971|NCT01730872|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111232972|NCT01730872|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111232973|NCT01730872|Prednisolone phosphate|prednisolone phosphate|mesh-list
111232974|NCT01730872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111232975|NCT01730872|Glucocorticoids|glucocorticoids|mesh-ancestor
111232976|NCT01730872|Hormones|hormones|mesh-ancestor
111232977|NCT01730872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111232978|NCT01730872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111232979|NCT01730872|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111232980|NCT01730872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111232981|NCT01730872|Antiemetics|antiemetics|mesh-ancestor
111232982|NCT01730872|Autonomic Agents|autonomic agents|mesh-ancestor
111232983|NCT01730872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111232984|NCT01730872|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111232985|NCT01730872|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111232986|NCT01730872|Protective Agents|protective agents|mesh-ancestor
111232987|NCT02491086|Nicotine|nicotine|mesh-list
111232988|NCT02491086|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111232989|NCT02491086|Autonomic Agents|autonomic agents|mesh-ancestor
111232990|NCT02491086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111232991|NCT02491086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111232992|NCT02491086|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111232993|NCT02491086|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111232994|NCT02491086|Cholinergic Agents|cholinergic agents|mesh-ancestor
111232995|NCT02491086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111232996|NCT02491086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111232997|NCT03469492|Insulin|insulin|mesh-list
111232998|NCT03469492|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111232999|NCT03469492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111233000|NCT03331770|Latanoprost|latanoprost|mesh-list
111233001|NCT03331770|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
111233002|NCT03331770|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111233003|NCT03331692|Anesthetics|anesthetics|mesh-list
111233004|NCT03331692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111233005|NCT03331692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111233006|NCT04826692|Metformin|metformin|mesh-list
111233007|NCT04826692|Biguanides|biguanides|mesh-list
111233008|NCT04826692|Hypoglycemic Agents|hypoglycemic agents|mesh-list
111233009|NCT04826692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111233010|NCT02490930|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
110957375|NCT05553496|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111233011|NCT02490930|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
111233012|NCT02490930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111233013|NCT02490930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111233014|NCT02490930|Immunologic Factors|immunologic factors|mesh-ancestor
111233015|NCT02490930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111233016|NCT04825990|Pembrolizumab|pembrolizumab|mesh-list
111233017|NCT04825990|Olaparib|olaparib|mesh-list
111233018|NCT04825990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111233019|NCT04825990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111233020|NCT04825990|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111233021|NCT04825990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111233022|NCT04825990|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111233023|NCT04825990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111233024|NCT03331302|Xenon|xenon|mesh-list
111233025|NCT03331302|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111233026|NCT03331302|Anesthetics, General|anesthetics, general|mesh-ancestor
111233027|NCT03331302|Anesthetics|anesthetics|mesh-ancestor
111233028|NCT03331302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111233029|NCT03331302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111233030|NCT01738672|Nitrous Oxide|nitrous oxide|mesh-list
111233031|NCT01738672|Entonox|entonox|mesh-list
111233032|NCT01738672|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111233033|NCT01738672|Anesthetics, General|anesthetics, general|mesh-ancestor
111233034|NCT01738672|Anesthetics|anesthetics|mesh-ancestor
111233035|NCT01738672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111233036|NCT01738672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111233037|NCT01738672|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111233038|NCT01738672|Analgesics|analgesics|mesh-ancestor
111233039|NCT01738672|Sensory System Agents|sensory system agents|mesh-ancestor
111233040|NCT01738672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111233041|NCT01738672|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
111233042|NCT02488512|Edotreotide|edotreotide|mesh-list
111233043|NCT02488512|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111233044|NCT02488512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111233045|NCT01808651|Fluoxetine|fluoxetine|mesh-list
111233046|NCT01808651|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111233047|NCT01808651|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111233048|NCT01808651|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111233049|NCT01808651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111233050|NCT01808651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111233051|NCT01808651|Serotonin Agents|serotonin agents|mesh-ancestor
111233052|NCT01808651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111233053|NCT01808651|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111233054|NCT01808651|Antidepressive Agents|antidepressive agents|mesh-ancestor
111233055|NCT01808651|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111233056|NCT01808651|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111233057|NCT01808651|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111233058|NCT01808651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111233059|NCT02488590|Bronchodilator Agents|bronchodilator agents|mesh-list
111233060|NCT02488590|Autonomic Agents|autonomic agents|mesh-ancestor
111233061|NCT02488590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111233062|NCT02488590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111233063|NCT02488590|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111233064|NCT02488590|Respiratory System Agents|respiratory system agents|mesh-ancestor
111233065|NCT05316376|Paclitaxel|paclitaxel|mesh-list
111233066|NCT05316376|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111233067|NCT05316376|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111233068|NCT05316376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111233069|NCT05316376|Tubulin Modulators|tubulin modulators|mesh-ancestor
111233070|NCT05316376|Antimitotic Agents|antimitotic agents|mesh-ancestor
111233071|NCT05316376|Mitosis Modulators|mitosis modulators|mesh-ancestor
111233072|NCT05316376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111233073|NCT01743976|Donepezil|donepezil|mesh-list
111233074|NCT01743976|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111233075|NCT01743976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110980716|NCT02279589|Immunologic Factors|immunologic factors|mesh-ancestor
111233076|NCT01743976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111233077|NCT01743976|Cholinergic Agents|cholinergic agents|mesh-ancestor
111233078|NCT01743976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111233079|NCT01743976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111233080|NCT01743976|Nootropic Agents|nootropic agents|mesh-ancestor
111233081|NCT05315830|Vaccines|vaccines|mesh-list
111233082|NCT05315830|Immunologic Factors|immunologic factors|mesh-ancestor
111233083|NCT05315830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111233084|NCT05463822|Botulinum Toxins|botulinum toxins|mesh-list
111233085|NCT05463822|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111233086|NCT05463822|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111233087|NCT05463822|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111233088|NCT05463822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111233089|NCT05463822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111233091|NCT05463822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111233092|NCT05463822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111233093|NCT05463822|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111233094|NCT05463822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111233095|NCT04639960|Risperidone|risperidone|mesh-list
111233096|NCT04639960|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111233097|NCT04639960|Serotonin Agents|serotonin agents|mesh-ancestor
111233098|NCT04639960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111233099|NCT04639960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111233100|NCT04639960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111233101|NCT04639960|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111233102|NCT04639960|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111233103|NCT04639960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111233104|NCT04639960|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111233105|NCT04639960|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111233106|NCT04639960|Dopamine Agents|dopamine agents|mesh-ancestor
111233107|NCT03109314|Donepezil|donepezil|mesh-list
111233108|NCT03109314|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111233109|NCT03109314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111233110|NCT03109314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111233111|NCT03109314|Cholinergic Agents|cholinergic agents|mesh-ancestor
111233112|NCT03109314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111233113|NCT03109314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111233114|NCT03109314|Nootropic Agents|nootropic agents|mesh-ancestor
111233115|NCT04566016|Anesthetics|anesthetics|mesh-list
111233116|NCT04566016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111233117|NCT04566016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111233118|NCT03320538|Rabeprazole|rabeprazole|mesh-list
111233119|NCT03320538|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111233120|NCT03320538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111233121|NCT03320538|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111233122|NCT03320538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111233123|NCT03320538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111233124|NCT03322878|Magnesium Sulfate|magnesium sulfate|mesh-list
111233125|NCT03322878|Analgesics|analgesics|mesh-ancestor
111233126|NCT03322878|Sensory System Agents|sensory system agents|mesh-ancestor
111233127|NCT03322878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111233128|NCT03322878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111233129|NCT03322878|Anesthetics|anesthetics|mesh-ancestor
111233130|NCT03322878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111233131|NCT03322878|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111233132|NCT03322878|Anticonvulsants|anticonvulsants|mesh-ancestor
111233133|NCT03322878|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111233134|NCT03322878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111233135|NCT03322878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111233136|NCT03322878|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111233137|NCT03322878|Tocolytic Agents|tocolytic agents|mesh-ancestor
111233138|NCT03322878|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111233139|NCT03322800|Ziresovir|ziresovir|mesh-list
111233140|NCT03322800|Antiviral Agents|antiviral agents|mesh-ancestor
111233141|NCT03322800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111233142|NCT03320460|Clobetasol|clobetasol|mesh-list
111233143|NCT03320460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111233144|NCT03320460|Glucocorticoids|glucocorticoids|mesh-ancestor
111233145|NCT03320460|Hormones|hormones|mesh-ancestor
111233146|NCT03320460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111233147|NCT03320460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111233148|NCT04471714|Baclofen|baclofen|mesh-list
111233149|NCT04471714|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
111233150|NCT04471714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111233151|NCT04471714|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111233152|NCT04471714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111233153|NCT04471714|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
111233154|NCT04471714|GABA Agonists|gaba agonists|mesh-ancestor
111233155|NCT04471714|GABA Agents|gaba agents|mesh-ancestor
111233156|NCT04471714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111233157|NCT04471714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111233158|NCT03325686|Vitamin D|vitamin d|mesh-list
111233159|NCT03325686|Vitamins|vitamins|mesh-ancestor
111233160|NCT03325686|Micronutrients|micronutrients|mesh-ancestor
111233161|NCT03325686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111233162|NCT03325686|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111233163|NCT05315128|Methotrexate|methotrexate|mesh-list
111233164|NCT05315128|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111233165|NCT05315128|Abortifacient Agents|abortifacient agents|mesh-ancestor
111233166|NCT05315128|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111233167|NCT05315128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111233168|NCT05315128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111233169|NCT05315128|Antimetabolites|antimetabolites|mesh-ancestor
111233170|NCT05315128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111233171|NCT05315128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111233172|NCT05315128|Dermatologic Agents|dermatologic agents|mesh-ancestor
111233173|NCT05315128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111233174|NCT05315128|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111233175|NCT05315128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111233176|NCT05315128|Immunologic Factors|immunologic factors|mesh-ancestor
111233177|NCT05315128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111233178|NCT05315128|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111233179|NCT03322488|Metronidazole|metronidazole|mesh-list
111233180|NCT03322488|Doxycycline|doxycycline|mesh-list
111233181|NCT03322488|Ciprofloxacin|ciprofloxacin|mesh-list
111233182|NCT03322488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111233183|NCT03322488|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111233184|NCT03322488|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111233185|NCT03322488|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111233186|NCT03322488|Antimalarials|antimalarials|mesh-ancestor
111233187|NCT03322488|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111233188|NCT03322488|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111233189|NCT03322488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111233190|NCT03322488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111233191|NCT03322488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111233192|NCT03322488|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111233193|NCT03322488|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111233194|NCT01808573|Capecitabine|capecitabine|mesh-list
111233195|NCT01808573|Lapatinib|lapatinib|mesh-list
111233196|NCT01808573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111233197|NCT01808573|Antimetabolites|antimetabolites|mesh-ancestor
111233198|NCT01808573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111233199|NCT01808573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111233200|NCT01808573|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111233201|NCT01808573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111233202|NCT01746940|Cocaine|cocaine|mesh-list
111233203|NCT01746940|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111233204|NCT01746940|Anesthetics, Local|anesthetics, local|mesh-ancestor
111233205|NCT01746940|Anesthetics|anesthetics|mesh-ancestor
111233206|NCT01746940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111233207|NCT01746940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111233208|NCT01746940|Sensory System Agents|sensory system agents|mesh-ancestor
111233209|NCT01746940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111233210|NCT01746940|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111233211|NCT01746940|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111233212|NCT01746940|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111233213|NCT01746940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111233214|NCT01746940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111233215|NCT01746940|Dopamine Agents|dopamine agents|mesh-ancestor
111233216|NCT01746940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111233217|NCT01747330|Pancreatin|pancreatin|mesh-list
111233218|NCT01747330|Pancrelipase|pancrelipase|mesh-list
111233219|NCT01747330|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111233220|NCT02990962|Triamcinolone|triamcinolone|mesh-list
111233221|NCT02990962|Lidocaine|lidocaine|mesh-list
111233222|NCT02990962|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111233223|NCT02990962|Glucocorticoids|glucocorticoids|mesh-ancestor
111233224|NCT02990962|Hormones|hormones|mesh-ancestor
111233225|NCT02990962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111233226|NCT02990962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111233227|NCT02990962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111233228|NCT02990962|Anesthetics, Local|anesthetics, local|mesh-ancestor
111233229|NCT02990962|Anesthetics|anesthetics|mesh-ancestor
111233230|NCT02990962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111233231|NCT02990962|Sensory System Agents|sensory system agents|mesh-ancestor
111233232|NCT02990962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111233233|NCT02990962|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111233234|NCT02990962|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111233235|NCT02990962|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111233237|NCT03322098|Atropine|atropine|mesh-list
111233238|NCT03322098|Glycopyrrolate|glycopyrrolate|mesh-list
111233239|NCT03322098|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111233240|NCT03322098|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111233241|NCT03322098|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111233242|NCT03322098|Autonomic Agents|autonomic agents|mesh-ancestor
111233243|NCT03322098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111233244|NCT03322098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111233245|NCT03322098|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111233246|NCT03322098|Respiratory System Agents|respiratory system agents|mesh-ancestor
111233247|NCT03322098|Mydriatics|mydriatics|mesh-ancestor
111233248|NCT03322098|Parasympatholytics|parasympatholytics|mesh-ancestor
111233249|NCT03322098|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111233250|NCT03322098|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111233251|NCT03322098|Cholinergic Agents|cholinergic agents|mesh-ancestor
111233252|NCT03322098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111233253|NCT03322098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111233254|NCT03319680|Dialysis Solutions|dialysis solutions|mesh-list
111233255|NCT03319680|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111233256|NCT01808339|Fluticasone|fluticasone|mesh-list
111233257|NCT01808339|Xhance|xhance|mesh-list
111233258|NCT01808339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111233259|NCT01808339|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111233260|NCT01808339|Autonomic Agents|autonomic agents|mesh-ancestor
111233261|NCT01808339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111233262|NCT01808339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111233263|NCT01808339|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111233264|NCT01808339|Respiratory System Agents|respiratory system agents|mesh-ancestor
111233265|NCT01808339|Dermatologic Agents|dermatologic agents|mesh-ancestor
111233266|NCT01808339|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111233267|NCT01749904|Timolol|timolol|mesh-list
111233268|NCT01749904|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111233269|NCT01749904|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111233270|NCT01749904|Adrenergic Agents|adrenergic agents|mesh-ancestor
111233271|NCT01749904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111233272|NCT01749904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111233273|NCT01749904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111233274|NCT01749904|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111233275|NCT01749904|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111233276|NCT02484768|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
111233277|NCT02484768|Hematinics|hematinics|mesh-ancestor
111233278|NCT03316326|Oxaliplatin|oxaliplatin|mesh-list
111233279|NCT03316326|Irinotecan|irinotecan|mesh-list
111233280|NCT03316326|Tegafur|tegafur|mesh-list
111233281|NCT03316326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111233282|NCT03316326|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111233283|NCT03316326|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111233284|NCT03316326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111233285|NCT03316326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111233286|NCT03316326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111233287|NCT03316326|Antimetabolites|antimetabolites|mesh-ancestor
111233288|NCT02487732|Ticagrelor|ticagrelor|mesh-list
111233289|NCT02487732|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
111233290|NCT02487732|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111233291|NCT02487732|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111233292|NCT02487732|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111233293|NCT02487732|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111233294|NCT02487732|Purinergic Agents|purinergic agents|mesh-ancestor
111233295|NCT02487732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111233296|NCT02487732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111233297|NCT02487732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111233298|NCT03833362|Interferons|interferons|mesh-list
111233299|NCT03833362|Ritonavir|ritonavir|mesh-list
111233300|NCT03833362|Ribavirin|ribavirin|mesh-list
111233301|NCT03833362|Interferon-alpha|interferon-alpha|mesh-list
111233302|NCT03833362|Interferon alpha-2|interferon alpha-2|mesh-list
111233303|NCT03833362|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
111233304|NCT03833362|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
111233305|NCT03833362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111233306|NCT03833362|Antiviral Agents|antiviral agents|mesh-ancestor
111233307|NCT03833362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111233308|NCT03833362|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111233309|NCT03833362|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111233310|NCT03833362|Protease Inhibitors|protease inhibitors|mesh-ancestor
111233311|NCT03833362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111233312|NCT03833362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111233313|NCT03833362|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111233314|NCT03833362|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111233315|NCT03833362|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111233316|NCT03833362|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111233317|NCT03833362|Antimetabolites|antimetabolites|mesh-ancestor
111233318|NCT03833362|Immunologic Factors|immunologic factors|mesh-ancestor
111233319|NCT03833362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111233320|NCT05463588|Methamphetamine|methamphetamine|mesh-list
111233321|NCT05463588|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111233322|NCT05463588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111233323|NCT05463588|Sympathomimetics|sympathomimetics|mesh-ancestor
111233324|NCT05463588|Autonomic Agents|autonomic agents|mesh-ancestor
111233325|NCT05463588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111233326|NCT05463588|Dopamine Agents|dopamine agents|mesh-ancestor
111233327|NCT05463588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111233328|NCT05463588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111233329|NCT05463588|Adrenergic Agents|adrenergic agents|mesh-ancestor
111233330|NCT05463588|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111233331|NCT05463588|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111233332|NCT05463588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111233333|NCT05463588|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111233334|NCT02490774|Levonorgestrel|levonorgestrel|mesh-list
111233335|NCT02490774|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111233336|NCT02490774|Contraceptive Agents|contraceptive agents|mesh-ancestor
111233337|NCT02490774|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111233338|NCT02490774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111233339|NCT02490774|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111233340|NCT02490774|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111233341|NCT02490774|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111233342|NCT02490540|Sufentanil|sufentanil|mesh-list
111233343|NCT02490540|Dsuvia|dsuvia|mesh-list
111233344|NCT02490540|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111233345|NCT02490540|Narcotics|narcotics|mesh-ancestor
111233346|NCT02490540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111233347|NCT02490540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111233348|NCT02490540|Analgesics|analgesics|mesh-ancestor
111233349|NCT02490540|Sensory System Agents|sensory system agents|mesh-ancestor
111233350|NCT02490540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111233351|NCT02490540|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111233352|NCT02490540|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111233353|NCT02490540|Anesthetics, General|anesthetics, general|mesh-ancestor
111233354|NCT02490540|Anesthetics|anesthetics|mesh-ancestor
111233355|NCT02484300|Melatonin|melatonin|mesh-list
111233356|NCT02484300|Antioxidants|antioxidants|mesh-ancestor
111233357|NCT02484300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111233358|NCT02484300|Protective Agents|protective agents|mesh-ancestor
111233359|NCT02484300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111233360|NCT02484300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111233361|NCT02727660|Budesonide|budesonide|mesh-list
111233362|NCT02727660|Formoterol Fumarate|formoterol fumarate|mesh-list
111233363|NCT02727660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111233364|NCT02727660|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111233365|NCT02727660|Autonomic Agents|autonomic agents|mesh-ancestor
111233366|NCT02727660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111233367|NCT02727660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111233368|NCT02727660|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111233369|NCT02727660|Respiratory System Agents|respiratory system agents|mesh-ancestor
111233370|NCT02727660|Glucocorticoids|glucocorticoids|mesh-ancestor
111233371|NCT02727660|Hormones|hormones|mesh-ancestor
111233372|NCT02727660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111233373|NCT02727660|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111233374|NCT02727660|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111233375|NCT02727660|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111233376|NCT02727660|Adrenergic Agents|adrenergic agents|mesh-ancestor
111233377|NCT02727660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111233378|NCT02727660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111233379|NCT02490072|Dexmedetomidine|dexmedetomidine|mesh-list
111233380|NCT02490072|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111233381|NCT02490072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111233382|NCT02490072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111233383|NCT02490072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111233384|NCT02490072|Analgesics|analgesics|mesh-ancestor
110957756|NCT02137161|Tobramycin|tobramycin|mesh-list
111233385|NCT02490072|Sensory System Agents|sensory system agents|mesh-ancestor
111233386|NCT02490072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111233387|NCT02490072|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111233388|NCT02490072|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111233389|NCT02490072|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111233390|NCT02490072|Adrenergic Agents|adrenergic agents|mesh-ancestor
111233391|NCT02490072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111233392|NCT02490072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111233393|NCT02483598|Buspirone|buspirone|mesh-list
111233394|NCT02483598|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111233395|NCT02483598|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111233396|NCT02483598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111233397|NCT02483598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111233398|NCT02483598|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111233399|NCT02483598|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111233400|NCT02483598|Serotonin Agents|serotonin agents|mesh-ancestor
111233401|NCT02483598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111233402|NCT02483598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111233403|NCT03321318|Cholecalciferol|cholecalciferol|mesh-list
111233404|NCT03321318|Vitamin D|vitamin d|mesh-list
111233405|NCT03321318|Bazedoxifene|bazedoxifene|mesh-list
111233406|NCT03321318|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111233407|NCT03321318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111233408|NCT03321318|Vitamins|vitamins|mesh-ancestor
111233409|NCT03321318|Micronutrients|micronutrients|mesh-ancestor
111233410|NCT03321318|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111233411|NCT03321318|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111233412|NCT03321318|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111233413|NCT03321318|Hormone Antagonists|hormone antagonists|mesh-ancestor
111233414|NCT03321318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111233415|NCT01784861|Everolimus|everolimus|mesh-list
111233416|NCT01784861|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111233417|NCT01784861|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111233418|NCT01784861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111233419|NCT01784861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111233420|NCT01784861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111233421|NCT01784861|Immunologic Factors|immunologic factors|mesh-ancestor
111233422|NCT01784861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111233423|NCT01784861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111233424|NCT03318744|Aspirin|aspirin|mesh-list
111233425|NCT03318744|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111233426|NCT03318744|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111233427|NCT03318744|Analgesics|analgesics|mesh-ancestor
111233428|NCT03318744|Sensory System Agents|sensory system agents|mesh-ancestor
111233429|NCT03318744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111233430|NCT03318744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111233431|NCT03318744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111233432|NCT03318744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111233433|NCT03318744|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111233434|NCT03318744|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111233435|NCT03318744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111233436|NCT03318744|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111233437|NCT03318744|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111233438|NCT03318744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111233439|NCT03318744|Antipyretics|antipyretics|mesh-ancestor
111233440|NCT01751386|Baclofen|baclofen|mesh-list
111233441|NCT01751386|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
111233442|NCT01751386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111233443|NCT01751386|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111233444|NCT01751386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111233445|NCT01751386|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
111233446|NCT01751386|GABA Agonists|gaba agonists|mesh-ancestor
111233447|NCT01751386|GABA Agents|gaba agents|mesh-ancestor
111233448|NCT01751386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111233449|NCT01751386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111233450|NCT02489760|Adalimumab|adalimumab|mesh-list
111233451|NCT02489760|Etanercept|etanercept|mesh-list
111233452|NCT02489760|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111233453|NCT02489760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111233454|NCT02489760|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111233455|NCT02489760|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111233456|NCT02489760|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111233457|NCT02489760|Analgesics|analgesics|mesh-ancestor
111233458|NCT02489760|Sensory System Agents|sensory system agents|mesh-ancestor
111233459|NCT02489760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111233460|NCT02489760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111233461|NCT02489760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111233462|NCT02489760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111233463|NCT02489760|Immunologic Factors|immunologic factors|mesh-ancestor
111233465|NCT01752712|Oxytocics|oxytocics|mesh-ancestor
111233466|NCT01752712|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111233467|NCT01752712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111233468|NCT05127928|Vitamins|vitamins|mesh-list
111233469|NCT05127928|Ascorbic Acid|ascorbic acid|mesh-list
111233470|NCT05127928|Vitamin E|vitamin e|mesh-list
111233471|NCT05127928|Tocopherols|tocopherols|mesh-list
111233472|NCT05127928|Micronutrients|micronutrients|mesh-ancestor
111233473|NCT05127928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111233474|NCT05127928|Antioxidants|antioxidants|mesh-ancestor
111233475|NCT05127928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111233476|NCT05127928|Protective Agents|protective agents|mesh-ancestor
111233477|NCT02483130|Acetylcysteine|acetylcysteine|mesh-list
111233478|NCT02483130|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111233479|NCT02483130|Antiviral Agents|antiviral agents|mesh-ancestor
111233480|NCT02483130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111233481|NCT02483130|Expectorants|expectorants|mesh-ancestor
111233482|NCT02483130|Respiratory System Agents|respiratory system agents|mesh-ancestor
111233483|NCT02483130|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111233484|NCT02483130|Antioxidants|antioxidants|mesh-ancestor
111233485|NCT02483130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111233486|NCT02483130|Protective Agents|protective agents|mesh-ancestor
111233487|NCT02483130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111233488|NCT02483130|Antidotes|antidotes|mesh-ancestor
111233489|NCT03318354|Olmesartan|olmesartan|mesh-list
111233490|NCT03318354|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
111233491|NCT03318354|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111233492|NCT03318354|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111233493|NCT03318354|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111233494|NCT03318354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111233495|NCT05093140|Prednisone|prednisone|mesh-list
111233496|NCT05093140|Cyclophosphamide|cyclophosphamide|mesh-list
111233497|NCT05093140|Vincristine|vincristine|mesh-list
111233498|NCT05093140|Doxorubicin|doxorubicin|mesh-list
111233499|NCT05093140|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111233500|NCT05093140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111233501|NCT05093140|Immunologic Factors|immunologic factors|mesh-ancestor
111233502|NCT05093140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111233503|NCT05093140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111233504|NCT05093140|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111233505|NCT05093140|Alkylating Agents|alkylating agents|mesh-ancestor
111233506|NCT05093140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111233507|NCT05093140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111233508|NCT05093140|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111233509|NCT05093140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111233510|NCT05093140|Glucocorticoids|glucocorticoids|mesh-ancestor
111233511|NCT05093140|Hormones|hormones|mesh-ancestor
111233512|NCT05093140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111233513|NCT05093140|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111233514|NCT05093140|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111233515|NCT05093140|Tubulin Modulators|tubulin modulators|mesh-ancestor
111233516|NCT05093140|Antimitotic Agents|antimitotic agents|mesh-ancestor
111233517|NCT05093140|Mitosis Modulators|mitosis modulators|mesh-ancestor
111233518|NCT05093140|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111233519|NCT05093140|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111233520|NCT05093140|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111233521|NCT05093140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111233522|NCT03315312|Fluorides|fluorides|mesh-list
111233523|NCT03315312|Fluorides, Topical|fluorides, topical|mesh-list
111233524|NCT03315312|Cariostatic Agents|cariostatic agents|mesh-ancestor
111233525|NCT03315312|Protective Agents|protective agents|mesh-ancestor
111233526|NCT03315312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111233527|NCT00705666|Ribavirin|ribavirin|mesh-list
111233528|NCT00705666|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
111233529|NCT00705666|Antimetabolites|antimetabolites|mesh-ancestor
111233530|NCT00705666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111233531|NCT00705666|Antiviral Agents|antiviral agents|mesh-ancestor
111233532|NCT00705666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111233533|NCT04955236|Fentanyl|fentanyl|mesh-list
111233534|NCT04955236|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111233535|NCT04955236|Narcotics|narcotics|mesh-ancestor
111233536|NCT04955236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111233537|NCT04955236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111233538|NCT04955236|Analgesics|analgesics|mesh-ancestor
111233539|NCT04955236|Sensory System Agents|sensory system agents|mesh-ancestor
111233540|NCT04955236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111233541|NCT04955236|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111233542|NCT04955236|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111233543|NCT04955236|Anesthetics, General|anesthetics, general|mesh-ancestor
111233544|NCT04955236|Anesthetics|anesthetics|mesh-ancestor
111233545|NCT03957304|Dexmedetomidine|dexmedetomidine|mesh-list
111233546|NCT03957304|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111233547|NCT03957304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111233548|NCT03957304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111233549|NCT03957304|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111233550|NCT03957304|Analgesics|analgesics|mesh-ancestor
111233551|NCT03957304|Sensory System Agents|sensory system agents|mesh-ancestor
111233552|NCT03957304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111233553|NCT03957304|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111233554|NCT03957304|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111233555|NCT03957304|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111233556|NCT03957304|Adrenergic Agents|adrenergic agents|mesh-ancestor
111233557|NCT03957304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111233558|NCT03957304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111233559|NCT03320928|Methotrexate|methotrexate|mesh-list
111233560|NCT03320928|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111233561|NCT03320928|Abortifacient Agents|abortifacient agents|mesh-ancestor
111233562|NCT03320928|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111233563|NCT03320928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111233564|NCT03320928|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111233565|NCT03320928|Antimetabolites|antimetabolites|mesh-ancestor
111233566|NCT03320928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111233567|NCT03320928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111233568|NCT03320928|Dermatologic Agents|dermatologic agents|mesh-ancestor
111233569|NCT03320928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111233570|NCT03320928|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111233571|NCT03320928|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111233572|NCT03320928|Immunologic Factors|immunologic factors|mesh-ancestor
111233573|NCT03320928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111233574|NCT03320928|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111233575|NCT02488902|Mefloquine|mefloquine|mesh-list
111233576|NCT02488902|Tafenoquine|tafenoquine|mesh-list
111233577|NCT02488902|Antimalarials|antimalarials|mesh-ancestor
111233578|NCT02488902|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111233579|NCT02488902|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111233580|NCT02488902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111233581|NCT02253160|Lenograstim|lenograstim|mesh-list
111233582|NCT02253160|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111233583|NCT02253160|Immunologic Factors|immunologic factors|mesh-ancestor
111233584|NCT02253160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111233585|NCT02254252|Nicorandil|nicorandil|mesh-list
111233586|NCT02254252|Nitroglycerin|nitroglycerin|mesh-list
111233587|NCT02254252|Vasodilator Agents|vasodilator agents|mesh-ancestor
111233588|NCT02254252|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111233589|NCT02254252|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111233590|NCT02254252|Vitamin B Complex|vitamin b complex|mesh-ancestor
111233591|NCT02254252|Vitamins|vitamins|mesh-ancestor
111233592|NCT02254252|Micronutrients|micronutrients|mesh-ancestor
111233593|NCT02254252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111233594|NCT03315078|Busulfan|busulfan|mesh-list
111233595|NCT03315078|Alkylating Agents|alkylating agents|mesh-ancestor
111233596|NCT03315078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111233597|NCT03315078|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111233598|NCT03315078|Immunologic Factors|immunologic factors|mesh-ancestor
111233599|NCT03315078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110980719|NCT02282709|Protease Inhibitors|protease inhibitors|mesh-ancestor
111233600|NCT03315078|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111233601|NCT03315078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111233602|NCT03315078|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111233603|NCT02255110|Doxorubicin|doxorubicin|mesh-list
111233604|NCT02255110|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111233605|NCT02255110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111233606|NCT02255110|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111233607|NCT02255110|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111233608|NCT02255110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111233609|NCT02255110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111233610|NCT03320694|Insulin|insulin|mesh-list
111233611|NCT03320694|Metformin|metformin|mesh-list
111233612|NCT03320694|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111233613|NCT03320694|Isophane Insulin, Human|isophane insulin, human|mesh-list
111233614|NCT03320694|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111233615|NCT03320694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111233616|NCT02482740|Tamoxifen|tamoxifen|mesh-list
111233617|NCT02482740|Letrozole|letrozole|mesh-list
111233618|NCT02482740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111233619|NCT02482740|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111233620|NCT02482740|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111233621|NCT02482740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111233622|NCT02482740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111233623|NCT02482740|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111233624|NCT02482740|Hormone Antagonists|hormone antagonists|mesh-ancestor
111233625|NCT02482740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111233626|NCT02482740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111233627|NCT02482740|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111233628|NCT02482740|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111233629|NCT02482740|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111233630|NCT02482740|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111233631|NCT03315000|Fluticasone|fluticasone|mesh-list
111233632|NCT03315000|Xhance|xhance|mesh-list
111233633|NCT03315000|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111233634|NCT03315000|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111233635|NCT03315000|Autonomic Agents|autonomic agents|mesh-ancestor
111233636|NCT03315000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111233637|NCT03315000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111233638|NCT03315000|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111233639|NCT03315000|Respiratory System Agents|respiratory system agents|mesh-ancestor
111233640|NCT03315000|Dermatologic Agents|dermatologic agents|mesh-ancestor
111233641|NCT03315000|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111233642|NCT02482818|Pregabalin|pregabalin|mesh-list
111233643|NCT02482818|Analgesics|analgesics|mesh-ancestor
111233644|NCT02482818|Sensory System Agents|sensory system agents|mesh-ancestor
111233645|NCT02482818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111233646|NCT02482818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111233647|NCT02482818|Anticonvulsants|anticonvulsants|mesh-ancestor
111233648|NCT02482818|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111233649|NCT02482818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111233650|NCT02482818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111233651|NCT02482818|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111233652|NCT02482818|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111233653|NCT02482818|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111233654|NCT02482818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111233655|NCT02482818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111233656|NCT02989870|Sorafenib|sorafenib|mesh-list
111233657|NCT02989870|Bavituximab|bavituximab|mesh-list
111233658|NCT02989870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111233659|NCT02989870|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111233660|NCT02989870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111233661|NCT02989870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111233662|NCT02989870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111233663|NCT02480088|Palonosetron|palonosetron|mesh-list
111233664|NCT02480088|Ramosetron|ramosetron|mesh-list
111233665|NCT02480088|Antiemetics|antiemetics|mesh-ancestor
111233666|NCT02480088|Autonomic Agents|autonomic agents|mesh-ancestor
111233667|NCT02480088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111233668|NCT02480088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111233669|NCT02480088|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111233670|NCT02480088|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111233671|NCT02480088|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111233672|NCT02480088|Serotonin Agents|serotonin agents|mesh-ancestor
111233673|NCT02480088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111233674|NCT02480088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111233675|NCT01807624|Phenylephrine|phenylephrine|mesh-list
111233676|NCT01807624|Oxymetazoline|oxymetazoline|mesh-list
111233677|NCT01807624|Tetracaine|tetracaine|mesh-list
111233678|NCT01807624|Anesthetics, Local|anesthetics, local|mesh-ancestor
111233679|NCT01807624|Anesthetics|anesthetics|mesh-ancestor
111233680|NCT01807624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111233681|NCT01807624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111233682|NCT01807624|Sensory System Agents|sensory system agents|mesh-ancestor
111233683|NCT01807624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111233684|NCT01807624|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111233685|NCT01807624|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111233686|NCT01807624|Adrenergic Agents|adrenergic agents|mesh-ancestor
111233687|NCT01807624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111233688|NCT01807624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111233689|NCT01807624|Sympathomimetics|sympathomimetics|mesh-ancestor
111233690|NCT01807624|Autonomic Agents|autonomic agents|mesh-ancestor
111233691|NCT01807624|Nasal Decongestants|nasal decongestants|mesh-ancestor
111233692|NCT01807624|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111233693|NCT01807624|Respiratory System Agents|respiratory system agents|mesh-ancestor
111233694|NCT01807624|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111233695|NCT01807624|Mydriatics|mydriatics|mesh-ancestor
111233696|NCT01807624|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111233697|NCT01807624|Protective Agents|protective agents|mesh-ancestor
111233698|NCT01808326|Chlorambucil|chlorambucil|mesh-list
111233699|NCT01808326|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111233700|NCT01808326|Alkylating Agents|alkylating agents|mesh-ancestor
111233701|NCT01808326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111233702|NCT01808326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111233703|NCT03317730|Oxycodone|oxycodone|mesh-list
111233704|NCT03317730|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111233705|NCT03317730|Narcotics|narcotics|mesh-ancestor
111233706|NCT03317730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111233707|NCT03317730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111233708|NCT03317730|Analgesics|analgesics|mesh-ancestor
111233709|NCT03317730|Sensory System Agents|sensory system agents|mesh-ancestor
111233710|NCT03317730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111233711|NCT02486484|Aflibercept|aflibercept|mesh-list
111233712|NCT02486484|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111233713|NCT02486484|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111233714|NCT02486484|Growth Substances|growth substances|mesh-ancestor
111233715|NCT02486484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111233716|NCT02486484|Growth Inhibitors|growth inhibitors|mesh-ancestor
111233717|NCT02486484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111233718|NCT03317652|Nitroprusside|nitroprusside|mesh-list
111233719|NCT03317652|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111233720|NCT03317652|Vasodilator Agents|vasodilator agents|mesh-ancestor
111233721|NCT03317652|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
111233722|NCT03317652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111233723|NCT02479854|Montelukast|montelukast|mesh-list
111233724|NCT02479854|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111233725|NCT02479854|Respiratory System Agents|respiratory system agents|mesh-ancestor
111233726|NCT02479854|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
111233727|NCT02479854|Hormone Antagonists|hormone antagonists|mesh-ancestor
111233728|NCT02479854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111233729|NCT02479854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111233730|NCT02479854|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
111233731|NCT02479854|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111233732|NCT02479854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111233733|NCT01809106|Fentanyl|fentanyl|mesh-list
111233734|NCT01809106|Morphine|morphine|mesh-list
111233735|NCT01809106|Oxycodone|oxycodone|mesh-list
111233736|NCT01809106|Buprenorphine|buprenorphine|mesh-list
111233737|NCT01809106|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111233738|NCT01809106|Narcotics|narcotics|mesh-ancestor
111233739|NCT01809106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111233740|NCT01809106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111233741|NCT01809106|Analgesics|analgesics|mesh-ancestor
111233742|NCT01809106|Sensory System Agents|sensory system agents|mesh-ancestor
111233743|NCT01809106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111233744|NCT01809106|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111233745|NCT01809106|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111233746|NCT01809106|Anesthetics, General|anesthetics, general|mesh-ancestor
111233747|NCT01809106|Anesthetics|anesthetics|mesh-ancestor
111233748|NCT01809106|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111233749|NCT03804580|Osimertinib|osimertinib|mesh-list
111233750|NCT03804580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111233751|NCT03804580|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111233752|NCT03804580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111233753|NCT03804580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111233754|NCT03317574|Botulinum Toxins|botulinum toxins|mesh-list
111233755|NCT03317574|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111233756|NCT03317574|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111233757|NCT03317574|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111233758|NCT03317574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111233759|NCT03317574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111233760|NCT03317574|Cholinergic Agents|cholinergic agents|mesh-ancestor
111233761|NCT03317574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111233762|NCT03317574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111233763|NCT03317574|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111233764|NCT03317574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111233765|NCT01810666|Factor VIII|factor viii|mesh-list
111233766|NCT01810666|Coagulants|coagulants|mesh-ancestor
111233767|NCT02482272|Lamivudine|lamivudine|mesh-list
111233768|NCT02482272|Adefovir|adefovir|mesh-list
111233769|NCT02482272|Entecavir|entecavir|mesh-list
111233770|NCT02482272|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111233771|NCT02482272|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111233772|NCT02482272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111233773|NCT02482272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111233774|NCT02482272|Antiviral Agents|antiviral agents|mesh-ancestor
111233775|NCT02482272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111233776|NCT02482272|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111233777|NCT02482272|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111233778|NCT01766440|Calcitriol|calcitriol|mesh-list
111233779|NCT01766440|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111233780|NCT01766440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111233781|NCT01766440|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
111233782|NCT01766440|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111233783|NCT01766440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111233784|NCT01766440|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111233785|NCT01766440|Vitamins|vitamins|mesh-ancestor
111233786|NCT01766440|Micronutrients|micronutrients|mesh-ancestor
111233787|NCT01766440|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111233788|NCT02479620|Dexamethasone|dexamethasone|mesh-list
111233789|NCT02479620|Dexamethasone acetate|dexamethasone acetate|mesh-list
111233790|NCT02479620|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
111233791|NCT02479620|BB 1101|bb 1101|mesh-list
111233792|NCT02479620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111233793|NCT02479620|Antiemetics|antiemetics|mesh-ancestor
111233794|NCT02479620|Autonomic Agents|autonomic agents|mesh-ancestor
111233795|NCT02479620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111233796|NCT02479620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111233797|NCT02479620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111233798|NCT02479620|Glucocorticoids|glucocorticoids|mesh-ancestor
111233799|NCT02479620|Hormones|hormones|mesh-ancestor
111233800|NCT02479620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111233801|NCT02479620|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111233802|NCT02479620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111233803|NCT02479620|Protease Inhibitors|protease inhibitors|mesh-ancestor
111233804|NCT02479620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111233805|NCT02479620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111233806|NCT02481960|Irinotecan|irinotecan|mesh-list
111233807|NCT02481960|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111233808|NCT02481960|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111233809|NCT02481960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111233810|NCT02481960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111233811|NCT02481960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111233812|NCT02725866|Ritonavir|ritonavir|mesh-list
111233813|NCT02725866|Ribavirin|ribavirin|mesh-list
111233814|NCT02725866|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111233815|NCT02725866|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111233816|NCT02725866|Protease Inhibitors|protease inhibitors|mesh-ancestor
111233817|NCT02725866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111233818|NCT02725866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111233819|NCT02725866|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111233820|NCT02725866|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111233821|NCT02725866|Antiviral Agents|antiviral agents|mesh-ancestor
110813372|NCT00092690|Simvastatin|simvastatin|mesh-list
111233822|NCT02725866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111233823|NCT02725866|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111233824|NCT02725866|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111233825|NCT02725866|Antimetabolites|antimetabolites|mesh-ancestor
111233826|NCT02481726|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
111233827|NCT02481726|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111233828|NCT02481726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111233829|NCT03314298|Methyltestosterone|methyltestosterone|mesh-list
111233830|NCT03314298|Anastrozole|anastrozole|mesh-list
111233831|NCT03314298|Testosterone|testosterone|mesh-list
111233832|NCT03314298|Testosterone undecanoate|testosterone undecanoate|mesh-list
111233833|NCT03314298|Testosterone enanthate|testosterone enanthate|mesh-list
111233834|NCT03314298|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
111233835|NCT03314298|Androgens|androgens|mesh-ancestor
111233836|NCT03314298|Hormones|hormones|mesh-ancestor
111233837|NCT03314298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111233838|NCT03314298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111233839|NCT03314298|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111233840|NCT03314298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111233841|NCT03314298|Anabolic Agents|anabolic agents|mesh-ancestor
111233842|NCT03314298|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111233843|NCT03314298|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111233844|NCT03314298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111233845|NCT03314298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111233846|NCT03314298|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111233847|NCT03314298|Hormone Antagonists|hormone antagonists|mesh-ancestor
111233848|NCT02479308|Moxifloxacin|moxifloxacin|mesh-list
111233849|NCT02479308|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111233850|NCT02479308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111233851|NCT02479308|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111233852|NCT02479308|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111233853|NCT02479308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111233854|NCT02479308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111233855|NCT02479308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111233856|NCT05461560|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111233857|NCT05713578|Docetaxel|docetaxel|mesh-list
111233858|NCT05713578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111233859|NCT05713578|Tubulin Modulators|tubulin modulators|mesh-ancestor
111233860|NCT05713578|Antimitotic Agents|antimitotic agents|mesh-ancestor
111233861|NCT05713578|Mitosis Modulators|mitosis modulators|mesh-ancestor
111233862|NCT05713578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111233863|NCT02485548|Fluorouracil|fluorouracil|mesh-list
111233864|NCT02485548|Raltitrexed|raltitrexed|mesh-list
111233865|NCT02485548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111233866|NCT02485548|Antimetabolites|antimetabolites|mesh-ancestor
111233867|NCT02485548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111233868|NCT02485548|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111233869|NCT02485548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111233870|NCT02485548|Immunologic Factors|immunologic factors|mesh-ancestor
111233871|NCT02485548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111233872|NCT02485548|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111233873|NCT02485548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111233874|NCT02479074|Prednisolone|prednisolone|mesh-list
111233875|NCT02479074|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111233876|NCT02479074|Methylprednisolone|methylprednisolone|mesh-list
111233877|NCT02479074|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111233878|NCT02479074|Prednisolone acetate|prednisolone acetate|mesh-list
111233879|NCT02479074|Montelukast|montelukast|mesh-list
111233880|NCT02479074|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111233881|NCT02479074|Prednisolone phosphate|prednisolone phosphate|mesh-list
111233882|NCT02479074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111233883|NCT02479074|Glucocorticoids|glucocorticoids|mesh-ancestor
111233884|NCT02479074|Hormones|hormones|mesh-ancestor
111233885|NCT02479074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111233886|NCT02479074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111233887|NCT02479074|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111233888|NCT02479074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111233889|NCT02479074|Antiemetics|antiemetics|mesh-ancestor
111233890|NCT02479074|Autonomic Agents|autonomic agents|mesh-ancestor
111233891|NCT02479074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111233892|NCT02479074|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111233893|NCT02479074|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111233894|NCT02479074|Protective Agents|protective agents|mesh-ancestor
111233895|NCT02479074|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111233896|NCT02479074|Respiratory System Agents|respiratory system agents|mesh-ancestor
111233897|NCT02479074|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
111233898|NCT02479074|Hormone Antagonists|hormone antagonists|mesh-ancestor
111233899|NCT02479074|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
111233900|NCT02479074|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111233901|NCT02479074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111233902|NCT02481180|T0001|t0001|mesh-list
111233903|NCT02481180|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
111233904|NCT02481180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111233905|NCT02481180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111233906|NCT02481180|Immunologic Factors|immunologic factors|mesh-ancestor
111233907|NCT02480946|Methotrexate|methotrexate|mesh-list
111233908|NCT02480946|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111233909|NCT02480946|Abortifacient Agents|abortifacient agents|mesh-ancestor
111233910|NCT02480946|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111233911|NCT02480946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110958264|NCT02135055|Narcotics|narcotics|mesh-ancestor
111233912|NCT02480946|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111233913|NCT02480946|Antimetabolites|antimetabolites|mesh-ancestor
111233914|NCT02480946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111233915|NCT02480946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111233916|NCT02480946|Dermatologic Agents|dermatologic agents|mesh-ancestor
111233917|NCT02480946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111233918|NCT02480946|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111233919|NCT02480946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111233920|NCT02480946|Immunologic Factors|immunologic factors|mesh-ancestor
111233921|NCT02480946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111233922|NCT02480946|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111233923|NCT01769170|Cidofovir|cidofovir|mesh-list
111233924|NCT01769170|Brincidofovir|brincidofovir|mesh-list
111233925|NCT01769170|Antiviral Agents|antiviral agents|mesh-ancestor
111233926|NCT01769170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111233927|NCT01769170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111233928|NCT01769170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111233929|NCT02480634|Zoledronic Acid|zoledronic acid|mesh-list
111233930|NCT02480634|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111233931|NCT02480634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111233932|NCT03399292|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111233933|NCT03399292|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111233934|NCT02726022|Ribavirin|ribavirin|mesh-list
111233935|NCT02726022|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
111233936|NCT02726022|Antimetabolites|antimetabolites|mesh-ancestor
111233937|NCT02726022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111233938|NCT02726022|Antiviral Agents|antiviral agents|mesh-ancestor
111233939|NCT02726022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111233940|NCT02478294|Warfarin|warfarin|mesh-list
111233941|NCT02478294|Anticoagulants|anticoagulants|mesh-list
111233942|NCT01770652|Deferiprone|deferiprone|mesh-list
111233943|NCT01770652|Iron Chelating Agents|iron chelating agents|mesh-ancestor
111233944|NCT01770652|Chelating Agents|chelating agents|mesh-ancestor
111233945|NCT01770652|Sequestering Agents|sequestering agents|mesh-ancestor
111233946|NCT01770652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111233947|NCT03316482|Leuprolide|leuprolide|mesh-list
111233948|NCT03316482|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111233949|NCT03316482|Fertility Agents|fertility agents|mesh-ancestor
111233950|NCT03316482|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111233951|NCT03316482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111233952|NCT03316482|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111233953|NCT03316482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111233954|NCT01771666|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
111233955|NCT01771666|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111233956|NCT01771666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111233957|NCT01772758|Antioxidants|antioxidants|mesh-list
111233958|NCT01772758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111233959|NCT01772758|Protective Agents|protective agents|mesh-ancestor
111233960|NCT01772758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111233961|NCT02485080|Sofosbuvir|sofosbuvir|mesh-list
111233962|NCT02485080|Simeprevir|simeprevir|mesh-list
111233963|NCT02485080|Antiviral Agents|antiviral agents|mesh-ancestor
111233964|NCT02485080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111233965|NCT02485080|Protease Inhibitors|protease inhibitors|mesh-ancestor
111233966|NCT02485080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111233967|NCT02485080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111233968|NCT02480400|Dexetimide|dexetimide|mesh-list
111233969|NCT02480400|Citalopram|citalopram|mesh-list
111233970|NCT02480400|Escitalopram|escitalopram|mesh-list
111233971|NCT02480400|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111233972|NCT02480400|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111233973|NCT02480400|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111233974|NCT02480400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111233975|NCT02480400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111233976|NCT02480400|Serotonin Agents|serotonin agents|mesh-ancestor
111233977|NCT02480400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111233978|NCT02480400|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111233979|NCT02480400|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111233980|NCT02480400|Parasympatholytics|parasympatholytics|mesh-ancestor
111233981|NCT02480400|Autonomic Agents|autonomic agents|mesh-ancestor
111233982|NCT02480400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111233983|NCT02480400|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111233984|NCT02480400|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111233985|NCT02480400|Cholinergic Agents|cholinergic agents|mesh-ancestor
111233986|NCT02480400|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111233987|NCT02480400|Antidepressive Agents|antidepressive agents|mesh-ancestor
111233988|NCT02480400|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111233990|NCT02725710|Analgesics|analgesics|mesh-ancestor
111233991|NCT02725710|Sensory System Agents|sensory system agents|mesh-ancestor
111233992|NCT02725710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111233993|NCT02725710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111233994|NCT02725710|Anticonvulsants|anticonvulsants|mesh-ancestor
111233995|NCT02725710|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111233996|NCT02725710|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111233997|NCT02725710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111233998|NCT02725710|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111233999|NCT02725710|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111234000|NCT02725710|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111234001|NCT02725710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111234002|NCT02725710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111234003|NCT02725710|Antimanic Agents|antimanic agents|mesh-ancestor
111234004|NCT02256358|Midazolam|midazolam|mesh-list
111234005|NCT02256358|Ketamine|ketamine|mesh-list
111234006|NCT02256358|Analgesics|analgesics|mesh-ancestor
111234007|NCT02256358|Sensory System Agents|sensory system agents|mesh-ancestor
111234008|NCT02256358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111234009|NCT02256358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111234010|NCT02256358|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111234011|NCT02256358|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111234012|NCT02256358|Anesthetics, General|anesthetics, general|mesh-ancestor
111234013|NCT02256358|Anesthetics|anesthetics|mesh-ancestor
111234014|NCT02256358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111234015|NCT02256358|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111234016|NCT02256358|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111234017|NCT02256358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111234018|NCT02256358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111234019|NCT02256358|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111234020|NCT02256358|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111234021|NCT02256358|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111234022|NCT02256358|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111234023|NCT02256358|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111234024|NCT02256358|GABA Modulators|gaba modulators|mesh-ancestor
111234025|NCT02256358|GABA Agents|gaba agents|mesh-ancestor
111234026|NCT01825408|Azithromycin|azithromycin|mesh-list
111234027|NCT01825408|Doxycycline|doxycycline|mesh-list
111234028|NCT01825408|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
111234029|NCT01825408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111234030|NCT01825408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111234031|NCT01825408|Antimalarials|antimalarials|mesh-ancestor
111234032|NCT01825408|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111234033|NCT01825408|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111234034|NCT01825408|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
111234035|NCT01825408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111234036|NCT01825408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111234037|NCT04945824|Dexamethasone|dexamethasone|mesh-list
111234038|NCT04945824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111234039|NCT04945824|Antiemetics|antiemetics|mesh-ancestor
111234040|NCT04945824|Autonomic Agents|autonomic agents|mesh-ancestor
111234041|NCT04945824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111234042|NCT04945824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111234043|NCT04945824|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111234044|NCT04945824|Glucocorticoids|glucocorticoids|mesh-ancestor
111234045|NCT04945824|Hormones|hormones|mesh-ancestor
111234046|NCT04945824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111234047|NCT04945824|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111234048|NCT04945824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111234049|NCT04937634|Melphalan|melphalan|mesh-list
111234050|NCT04937634|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111234051|NCT04937634|Alkylating Agents|alkylating agents|mesh-ancestor
111234052|NCT04937634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111234053|NCT04937634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111234054|NCT04937634|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111234055|NCT04937634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111234056|NCT04937634|Immunologic Factors|immunologic factors|mesh-ancestor
111234057|NCT04937634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111234058|NCT02262130|Omalizumab|omalizumab|mesh-list
111234059|NCT02262130|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111234060|NCT02262130|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110958415|NCT02140125|Immunologic Factors|immunologic factors|mesh-ancestor
111234061|NCT02262130|Respiratory System Agents|respiratory system agents|mesh-ancestor
111234062|NCT04887870|Pembrolizumab|pembrolizumab|mesh-list
111234063|NCT04887870|Nivolumab|nivolumab|mesh-list
111234064|NCT04887870|Ipilimumab|ipilimumab|mesh-list
111234065|NCT04887870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111234066|NCT04887870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111234067|NCT04887870|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111234068|NCT04887870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111234069|NCT01827358|Calcium, Dietary|calcium, dietary|mesh-list
111234070|NCT01827358|Mupirocin|mupirocin|mesh-list
111234071|NCT01827358|Calcium|calcium|mesh-list
111234072|NCT01827358|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111234073|NCT01827358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111234074|NCT01827358|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111234075|NCT01827358|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111234076|NCT01827358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111234077|NCT01827358|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111234078|NCT01827358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111234079|NCT01827358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111234080|NCT01780324|Lidocaine|lidocaine|mesh-list
111234081|NCT01780324|Anesthetics, Local|anesthetics, local|mesh-ancestor
111234082|NCT01780324|Anesthetics|anesthetics|mesh-ancestor
111234083|NCT01780324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111234084|NCT01780324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111234085|NCT01780324|Sensory System Agents|sensory system agents|mesh-ancestor
111234086|NCT01780324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111234087|NCT01780324|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111234088|NCT01780324|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111234089|NCT01780324|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111234090|NCT01780324|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111234091|NCT01780324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111234092|NCT02472600|Colistin|colistin|mesh-list
111234093|NCT02472600|Polymyxins|polymyxins|mesh-list
111234094|NCT02472600|Neomycin|neomycin|mesh-list
111234095|NCT02472600|Omeprazole|omeprazole|mesh-list
111234096|NCT02472600|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111234097|NCT02472600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111234098|NCT02472600|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111234099|NCT02472600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111234100|NCT02472600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111234101|NCT02472600|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111234102|NCT02472600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111234103|NCT02472600|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111234104|NCT04858776|Dexamethasone|dexamethasone|mesh-list
111234105|NCT04858776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111234106|NCT04858776|Antiemetics|antiemetics|mesh-ancestor
111234107|NCT04858776|Autonomic Agents|autonomic agents|mesh-ancestor
111234108|NCT04858776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111234109|NCT04858776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111234110|NCT04858776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111234111|NCT04858776|Glucocorticoids|glucocorticoids|mesh-ancestor
111234112|NCT04858776|Hormones|hormones|mesh-ancestor
111234113|NCT04858776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111234114|NCT04858776|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111234115|NCT04858776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111234116|NCT01781806|Tenofovir|tenofovir|mesh-list
111234117|NCT01781806|Emtricitabine|emtricitabine|mesh-list
111234118|NCT01781806|Antiviral Agents|antiviral agents|mesh-ancestor
111234119|NCT01781806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111234120|NCT01781806|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111234121|NCT01781806|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111234122|NCT01781806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111234123|NCT01781806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111234124|NCT01781806|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111234125|NCT01781806|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111234126|NCT02477514|Tedizolid|tedizolid|mesh-list
111234127|NCT02477514|Tedizolid phosphate|tedizolid phosphate|mesh-list
111234128|NCT02477514|Midazolam|midazolam|mesh-list
111234129|NCT02477514|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111234130|NCT02477514|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111234131|NCT02477514|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111234132|NCT02477514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111234133|NCT02477514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111234134|NCT02477514|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111234135|NCT02477514|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111234136|NCT02477514|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111234137|NCT02477514|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111234138|NCT02477514|Anesthetics, General|anesthetics, general|mesh-ancestor
111234139|NCT02477514|Anesthetics|anesthetics|mesh-ancestor
111234140|NCT02477514|GABA Modulators|gaba modulators|mesh-ancestor
111234141|NCT02477514|GABA Agents|gaba agents|mesh-ancestor
111234142|NCT02477514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111234143|NCT02477514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111234144|NCT02477514|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111234145|NCT02477514|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111234146|NCT02477514|Antimetabolites|antimetabolites|mesh-ancestor
111234147|NCT02477514|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111234148|NCT02477514|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111234149|NCT02477514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111234150|NCT02477514|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111234151|NCT02477514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111234152|NCT01746238|Bevacizumab|bevacizumab|mesh-list
111234153|NCT01746238|Doxorubicin|doxorubicin|mesh-list
111234154|NCT01746238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111234155|NCT01746238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111234156|NCT01746238|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111234157|NCT01746238|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111234158|NCT01746238|Growth Substances|growth substances|mesh-ancestor
111234159|NCT01746238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111234160|NCT01746238|Growth Inhibitors|growth inhibitors|mesh-ancestor
111234161|NCT01746238|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111234162|NCT01746238|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111234163|NCT01746238|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111234164|NCT01746238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111234165|NCT01746238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111234166|NCT02472054|Cyclosporine|cyclosporine|mesh-list
111234167|NCT02472054|Prednisolone|prednisolone|mesh-list
111234168|NCT02472054|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111234169|NCT02472054|Methylprednisolone|methylprednisolone|mesh-list
111234170|NCT02472054|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111234171|NCT02472054|Prednisolone acetate|prednisolone acetate|mesh-list
111234172|NCT02472054|Alemtuzumab|alemtuzumab|mesh-list
111234173|NCT02472054|Cyclosporins|cyclosporins|mesh-list
111234174|NCT02472054|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111234175|NCT02472054|Prednisolone phosphate|prednisolone phosphate|mesh-list
111234176|NCT02472054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111234177|NCT02472054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111234178|NCT02472054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111234179|NCT02472054|Immunologic Factors|immunologic factors|mesh-ancestor
111234180|NCT02472054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111234181|NCT02472054|Antifungal Agents|antifungal agents|mesh-ancestor
111234182|NCT02472054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111234183|NCT02472054|Dermatologic Agents|dermatologic agents|mesh-ancestor
111234184|NCT02472054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111234185|NCT02472054|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111234186|NCT02472054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111234187|NCT02472054|Glucocorticoids|glucocorticoids|mesh-ancestor
111234188|NCT02472054|Hormones|hormones|mesh-ancestor
111234189|NCT02472054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111234190|NCT02472054|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111234191|NCT02472054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111234192|NCT02472054|Antiemetics|antiemetics|mesh-ancestor
111234193|NCT02472054|Autonomic Agents|autonomic agents|mesh-ancestor
111234194|NCT02472054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111234195|NCT02472054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111234196|NCT02472054|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111234197|NCT02472054|Protective Agents|protective agents|mesh-ancestor
111234198|NCT02472054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111234199|NCT01782898|Esmolol|esmolol|mesh-list
111234200|NCT01782898|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
111234201|NCT01782898|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111234202|NCT01782898|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111234203|NCT01782898|Adrenergic Agents|adrenergic agents|mesh-ancestor
111234204|NCT01782898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111234205|NCT01782898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111234206|NCT01782898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111234207|NCT02475876|Clindamycin|clindamycin|mesh-list
111234208|NCT02475876|Clindamycin palmitate|clindamycin palmitate|mesh-list
111234209|NCT02475876|Clindamycin phosphate|clindamycin phosphate|mesh-list
111234210|NCT02475876|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
111234211|NCT02475876|Trimethoprim|trimethoprim|mesh-list
111234212|NCT02475876|Sulfamethoxazole|sulfamethoxazole|mesh-list
111234213|NCT02475876|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111234214|NCT02475876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111234215|NCT02475876|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111234216|NCT02475876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111234217|NCT02475876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111234218|NCT02475876|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111234219|NCT02475876|Antimalarials|antimalarials|mesh-ancestor
111234220|NCT02475876|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111234221|NCT02475876|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111234222|NCT02475876|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111234223|NCT02475876|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111234224|NCT02475876|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
111234225|NCT02475876|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111234226|NCT02472210|Botulinum Toxins|botulinum toxins|mesh-list
111234227|NCT02472210|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111234228|NCT02472210|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111234229|NCT02472210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111234230|NCT02472210|Cholinergic Agents|cholinergic agents|mesh-ancestor
111234231|NCT02472210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111234232|NCT02472210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111234233|NCT01783054|Gemcitabine|gemcitabine|mesh-list
111234234|NCT01783054|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111234235|NCT01783054|Antimetabolites|antimetabolites|mesh-ancestor
111234236|NCT01783054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111234237|NCT01783054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111234238|NCT05397600|Bimatoprost|bimatoprost|mesh-list
111234239|NCT05397600|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111234240|NCT02725008|Dexamethasone|dexamethasone|mesh-list
111234241|NCT02725008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111234242|NCT02725008|Antiemetics|antiemetics|mesh-ancestor
111234243|NCT02725008|Autonomic Agents|autonomic agents|mesh-ancestor
111234244|NCT02725008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111234245|NCT02725008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111234246|NCT02725008|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111234247|NCT02725008|Glucocorticoids|glucocorticoids|mesh-ancestor
111234248|NCT02725008|Hormones|hormones|mesh-ancestor
111234249|NCT02725008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111234250|NCT02725008|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111234251|NCT02725008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111234252|NCT02477436|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
111234253|NCT02477436|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111234254|NCT02477436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111234255|NCT02477436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111234256|NCT02471820|Dexamethasone|dexamethasone|mesh-list
111234257|NCT02471820|Dexamethasone acetate|dexamethasone acetate|mesh-list
111234258|NCT02471820|Lenalidomide|lenalidomide|mesh-list
111234259|NCT02471820|Doxorubicin|doxorubicin|mesh-list
111234260|NCT02471820|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111234261|NCT02471820|BB 1101|bb 1101|mesh-list
111234262|NCT02471820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111234263|NCT02471820|Antiemetics|antiemetics|mesh-ancestor
111234264|NCT02471820|Autonomic Agents|autonomic agents|mesh-ancestor
111234265|NCT02471820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111234266|NCT02471820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111234267|NCT02471820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111234268|NCT02471820|Glucocorticoids|glucocorticoids|mesh-ancestor
111234269|NCT02471820|Hormones|hormones|mesh-ancestor
111234270|NCT02471820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111234271|NCT02471820|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111234272|NCT02471820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111234273|NCT02471820|Protease Inhibitors|protease inhibitors|mesh-ancestor
111234274|NCT02471820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111234275|NCT02471820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111234276|NCT02471820|Immunologic Factors|immunologic factors|mesh-ancestor
111234277|NCT02471820|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111234278|NCT02471820|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111234279|NCT02471820|Growth Substances|growth substances|mesh-ancestor
111234280|NCT02471820|Growth Inhibitors|growth inhibitors|mesh-ancestor
111234281|NCT02471820|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111234282|NCT02471820|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111234283|NCT02471820|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111234284|NCT01833130|Botulinum Toxins|botulinum toxins|mesh-list
111234285|NCT01833130|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111234286|NCT01833130|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111234287|NCT01833130|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111234288|NCT01833130|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111234289|NCT01833130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111234290|NCT01833130|Cholinergic Agents|cholinergic agents|mesh-ancestor
111234291|NCT01833130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111234292|NCT01833130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111234293|NCT01833130|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111234294|NCT01833130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111234295|NCT01783912|Nicotine|nicotine|mesh-list
111234296|NCT01783912|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111234297|NCT01783912|Autonomic Agents|autonomic agents|mesh-ancestor
111234298|NCT01783912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111234299|NCT01783912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111234300|NCT01783912|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111234301|NCT01783912|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111234302|NCT01783912|Cholinergic Agents|cholinergic agents|mesh-ancestor
111234303|NCT01783912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111234304|NCT01783912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111234305|NCT01783990|Hydroxyurea|hydroxyurea|mesh-list
111234306|NCT01783990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111234307|NCT01783990|Antisickling Agents|antisickling agents|mesh-ancestor
111234308|NCT01783990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111234309|NCT01783990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111234310|NCT01783990|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111234311|NCT01833988|Pancrelipase|pancrelipase|mesh-list
111234312|NCT01833988|Pancreatin|pancreatin|mesh-list
111234313|NCT01833988|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111234314|NCT05363436|Oxycodone|oxycodone|mesh-list
111234315|NCT05363436|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111234316|NCT05363436|Narcotics|narcotics|mesh-ancestor
111234317|NCT05363436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111234318|NCT05363436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111234319|NCT05363436|Analgesics|analgesics|mesh-ancestor
111234320|NCT05363436|Sensory System Agents|sensory system agents|mesh-ancestor
111234321|NCT05363436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111234322|NCT01784614|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111234323|NCT02474706|Imipenem|imipenem|mesh-list
111234324|NCT02474706|Cefoxitin|cefoxitin|mesh-list
111234325|NCT02474706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111234326|NCT02474706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111234327|NCT01784770|Azithromycin|azithromycin|mesh-list
111234328|NCT01784770|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111234329|NCT01784770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111234330|NCT02471274|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
111234331|NCT02471274|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111234332|NCT02471274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111234333|NCT02471274|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111234334|NCT02471274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111234335|NCT04491786|Gabapentin|gabapentin|mesh-list
111234336|NCT04491786|Nefopam|nefopam|mesh-list
111234337|NCT04491786|Analgesics|analgesics|mesh-ancestor
111234338|NCT04491786|Sensory System Agents|sensory system agents|mesh-ancestor
111234339|NCT04491786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111234340|NCT04491786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111234341|NCT04491786|Anticonvulsants|anticonvulsants|mesh-ancestor
111234342|NCT04491786|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111234343|NCT04491786|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111234344|NCT04491786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111234345|NCT04491786|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111234346|NCT04491786|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111234347|NCT04491786|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111234348|NCT04491786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111234349|NCT04491786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111234350|NCT04491786|Antimanic Agents|antimanic agents|mesh-ancestor
111234351|NCT04491786|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111234352|NCT01786252|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
111234353|NCT01786252|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111234354|NCT01786252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111234355|NCT02470026|Yohimbine|yohimbine|mesh-list
111234356|NCT02470026|Mydriatics|mydriatics|mesh-ancestor
111234357|NCT02470026|Autonomic Agents|autonomic agents|mesh-ancestor
111234358|NCT02470026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111234359|NCT02470026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111234360|NCT02470026|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
111234361|NCT02470026|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111234362|NCT02470026|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111234363|NCT02470026|Adrenergic Agents|adrenergic agents|mesh-ancestor
111234364|NCT02470026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111234365|NCT02470026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111234366|NCT02470026|Urological Agents|urological agents|mesh-ancestor
111234367|NCT01840072|Antihypertensive Agents|antihypertensive agents|mesh-list
111234368|NCT01807949|Ivacaftor|ivacaftor|mesh-list
111234369|NCT01807949|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
111234370|NCT01807949|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111234371|NCT01807949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111234372|NCT02989558|Aspirin|aspirin|mesh-list
111234373|NCT02989558|Clopidogrel|clopidogrel|mesh-list
111234374|NCT02989558|Ticagrelor|ticagrelor|mesh-list
111234375|NCT02989558|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111234376|NCT02989558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111234377|NCT02989558|Analgesics|analgesics|mesh-ancestor
111234378|NCT02989558|Sensory System Agents|sensory system agents|mesh-ancestor
111234379|NCT02989558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111234380|NCT02989558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111234381|NCT02989558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111234382|NCT02989558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111234383|NCT02989558|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111234384|NCT02989558|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111234385|NCT02989558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111234386|NCT02989558|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111234387|NCT02989558|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111234388|NCT02989558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111234389|NCT02989558|Antipyretics|antipyretics|mesh-ancestor
111234390|NCT02989558|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111234391|NCT02989558|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111234392|NCT02989558|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111234393|NCT02989558|Purinergic Agents|purinergic agents|mesh-ancestor
111234394|NCT02989558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111234395|NCT01806779|Bupropion|bupropion|mesh-list
111234396|NCT01806779|Nicotine|nicotine|mesh-list
111234397|NCT01806779|Varenicline|varenicline|mesh-list
111234398|NCT01806779|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111234399|NCT01806779|Autonomic Agents|autonomic agents|mesh-ancestor
111234400|NCT01806779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111234401|NCT01806779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111234402|NCT01806779|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111234403|NCT01806779|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111234404|NCT01806779|Cholinergic Agents|cholinergic agents|mesh-ancestor
111234405|NCT01806779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111234406|NCT01806779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111234407|NCT01806779|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111234408|NCT01806779|Antidepressive Agents|antidepressive agents|mesh-ancestor
111234409|NCT01806779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111234410|NCT01806779|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111234411|NCT01806779|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111234412|NCT01806779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111234413|NCT01806779|Dopamine Agents|dopamine agents|mesh-ancestor
111234414|NCT01806779|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111234415|NCT01806779|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111234416|NCT01806779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111234417|NCT01878526|Domperidone|domperidone|mesh-list
111234418|NCT01878526|Antiemetics|antiemetics|mesh-ancestor
111234419|NCT01878526|Autonomic Agents|autonomic agents|mesh-ancestor
111234420|NCT01878526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111234421|NCT01878526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111234422|NCT01878526|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111234423|NCT01878526|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111234424|NCT01878526|Dopamine Agents|dopamine agents|mesh-ancestor
111234425|NCT01878526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111234426|NCT01878526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111234427|NCT01878604|Hypolipidemic Agents|hypolipidemic agents|mesh-list
111234428|NCT01878604|Antimetabolites|antimetabolites|mesh-ancestor
111234429|NCT01878604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111234430|NCT01878604|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111234431|NCT02266810|Mometasone Furoate|mometasone furoate|mesh-list
111234432|NCT02266810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110958789|NCT05007262|Calcium|calcium|mesh-list
111234434|NCT02266810|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111234435|NCT01806623|Fluconazole|fluconazole|mesh-list
111234436|NCT01806623|Antifungal Agents|antifungal agents|mesh-ancestor
111234437|NCT01806623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111234438|NCT01806623|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111234439|NCT01806623|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111234440|NCT01806623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111234441|NCT01806623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111234442|NCT01806623|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111234443|NCT01806623|Hormone Antagonists|hormone antagonists|mesh-ancestor
111234444|NCT01806623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111234445|NCT01806623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111234446|NCT01806623|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111234447|NCT01806623|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111234448|NCT01806545|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
111234449|NCT01806545|Hemostatics|hemostatics|mesh-ancestor
111234450|NCT01806545|Coagulants|coagulants|mesh-ancestor
111234451|NCT01847014|Macitentan|macitentan|mesh-list
111234452|NCT01847014|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
111234453|NCT01847014|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
111234454|NCT01847014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111234455|NCT01847014|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
111234456|NCT01847638|Nepafenac|nepafenac|mesh-list
111234457|NCT01847638|Bromfenac|bromfenac|mesh-list
111234458|NCT01847638|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111234459|NCT01847638|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111234460|NCT01847638|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111234461|NCT01847638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111234462|NCT01847638|Analgesics|analgesics|mesh-ancestor
111234463|NCT01847638|Sensory System Agents|sensory system agents|mesh-ancestor
111234464|NCT01847638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111234465|NCT01847638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111234466|NCT01847638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111234467|NCT01847638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111234468|NCT02474628|Calcium Carbonate|calcium carbonate|mesh-list
111234469|NCT02474628|Calcium|calcium|mesh-list
111234470|NCT02474628|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111234471|NCT02474628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111234472|NCT02474628|Antacids|antacids|mesh-ancestor
111234473|NCT02474628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111234474|NCT02474628|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111234475|NCT05211570|Azacitidine|azacitidine|mesh-list
111234476|NCT05211570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111234477|NCT05211570|Antimetabolites|antimetabolites|mesh-ancestor
111234478|NCT05211570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111234479|NCT05211570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111234480|NCT05211570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111234481|NCT03099564|Pembrolizumab|pembrolizumab|mesh-list
111234482|NCT03099564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111234483|NCT03099564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111234484|NCT03099564|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111234485|NCT03099564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111234486|NCT02469948|Botulinum Toxins|botulinum toxins|mesh-list
111234487|NCT02469948|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111234488|NCT02469948|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111234489|NCT02469948|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111234490|NCT02469948|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111234491|NCT02469948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111234492|NCT02469948|Cholinergic Agents|cholinergic agents|mesh-ancestor
111234493|NCT02469948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111234494|NCT02469948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111234495|NCT02469948|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111234496|NCT02469948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111234497|NCT05328310|Nebivolol|nebivolol|mesh-list
111234498|NCT05328310|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111234499|NCT05328310|Vasodilator Agents|vasodilator agents|mesh-ancestor
111234500|NCT05328310|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
111234501|NCT05328310|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111234502|NCT05328310|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111234503|NCT05328310|Adrenergic Agents|adrenergic agents|mesh-ancestor
111234504|NCT05328310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111234505|NCT05328310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111234506|NCT05328310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111234507|NCT01797484|Ranolazine|ranolazine|mesh-list
111234508|NCT01797484|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111234509|NCT01797484|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111234510|NCT01797484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111234511|NCT01798264|Exenatide|exenatide|mesh-list
111234512|NCT01798264|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111234513|NCT01798264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111234514|NCT01798264|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111234515|NCT01798264|Incretins|incretins|mesh-ancestor
111234516|NCT01798264|Hormones|hormones|mesh-ancestor
111234517|NCT01798264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111234518|NCT05326984|Metformin|metformin|mesh-list
111234519|NCT05326984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111234520|NCT05326984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111234521|NCT01800838|Silicon|silicon|mesh-list
111234522|NCT01800838|Silicon phthalocyanine|silicon phthalocyanine|mesh-list
111234523|NCT01800838|Trace Elements|trace elements|mesh-ancestor
111234524|NCT01800838|Micronutrients|micronutrients|mesh-ancestor
111234525|NCT01800838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111234526|NCT01800838|Antimalarials|antimalarials|mesh-ancestor
111234527|NCT01800838|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111234528|NCT01800838|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111234529|NCT01800838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111234530|NCT01800838|Antiviral Agents|antiviral agents|mesh-ancestor
111234531|NCT01800838|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111234532|NCT01800838|Dermatologic Agents|dermatologic agents|mesh-ancestor
111234533|NCT01782131|Voriconazole|voriconazole|mesh-list
111234534|NCT01782131|Posaconazole|posaconazole|mesh-list
111234535|NCT01782131|Antifungal Agents|antifungal agents|mesh-ancestor
111234536|NCT01782131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111234537|NCT01782131|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111234538|NCT01782131|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111234539|NCT01782131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111234540|NCT01782131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111234541|NCT01782131|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111234542|NCT01782131|Hormone Antagonists|hormone antagonists|mesh-ancestor
111234543|NCT01782131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111234544|NCT01782131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111234545|NCT01782131|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111234546|NCT01782131|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
111234547|NCT01782131|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111234548|NCT01782131|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111234549|NCT01781975|Imatinib Mesylate|imatinib mesylate|mesh-list
111234550|NCT01781975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111234551|NCT01781975|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111234552|NCT01781975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111234553|NCT01781975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111234554|NCT01855360|Doxycycline|doxycycline|mesh-list
111234555|NCT01855360|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
111234556|NCT01855360|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111234557|NCT01855360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111234558|NCT01855360|Antimalarials|antimalarials|mesh-ancestor
111234559|NCT01855360|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111234560|NCT01855360|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111234561|NCT01855360|Antiviral Agents|antiviral agents|mesh-ancestor
111234562|NCT01855360|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
111234563|NCT01855360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111234564|NCT04351126|Fludrocortisone|fludrocortisone|mesh-list
111234565|NCT04351126|Bromocriptine|bromocriptine|mesh-list
111234566|NCT04351126|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111234567|NCT04351126|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111234568|NCT04351126|Hormone Antagonists|hormone antagonists|mesh-ancestor
111234569|NCT04351126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111234570|NCT04351126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111234571|NCT04351126|Dopamine Agonists|dopamine agonists|mesh-ancestor
111234572|NCT04351126|Dopamine Agents|dopamine agents|mesh-ancestor
111234573|NCT04351126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111234574|NCT04351126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111234575|NCT04351126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111234576|NCT01804673|Fentanyl|fentanyl|mesh-list
111234577|NCT01804673|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111234578|NCT01804673|Narcotics|narcotics|mesh-ancestor
111234579|NCT01804673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111234580|NCT01804673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111234581|NCT01804673|Analgesics|analgesics|mesh-ancestor
111234582|NCT01804673|Sensory System Agents|sensory system agents|mesh-ancestor
111234583|NCT01804673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111234584|NCT01804673|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111234585|NCT01804673|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111234586|NCT01804673|Anesthetics, General|anesthetics, general|mesh-ancestor
111234587|NCT01804673|Anesthetics|anesthetics|mesh-ancestor
111234588|NCT01856530|Oxytocin|oxytocin|mesh-list
111234589|NCT01856530|Oxytocics|oxytocics|mesh-ancestor
111234590|NCT01856530|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111234591|NCT01856530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111234592|NCT05302336|Cyclophosphamide|cyclophosphamide|mesh-list
111234593|NCT05302336|Docetaxel|docetaxel|mesh-list
111234594|NCT05302336|Doxorubicin|doxorubicin|mesh-list
111234595|NCT05302336|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111234596|NCT05302336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111234597|NCT05302336|Immunologic Factors|immunologic factors|mesh-ancestor
111234598|NCT05302336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111234599|NCT05302336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111234600|NCT05302336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111234601|NCT05302336|Alkylating Agents|alkylating agents|mesh-ancestor
111234602|NCT05302336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111234603|NCT05302336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111234604|NCT05302336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111234605|NCT05302336|Tubulin Modulators|tubulin modulators|mesh-ancestor
111234606|NCT05302336|Antimitotic Agents|antimitotic agents|mesh-ancestor
111234607|NCT05302336|Mitosis Modulators|mitosis modulators|mesh-ancestor
111234608|NCT05302336|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111234609|NCT05302336|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111234610|NCT05302336|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111234611|NCT05302336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111234612|NCT01804036|Zolpidem|zolpidem|mesh-list
111234613|NCT01804036|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111234614|NCT01804036|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111234615|NCT01804036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111234616|NCT01804036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111234617|NCT01804036|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
111234618|NCT01804036|GABA Agonists|gaba agonists|mesh-ancestor
111234619|NCT01804036|GABA Agents|gaba agents|mesh-ancestor
111234620|NCT01804036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111234621|NCT01804036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111234622|NCT01857232|Dexamethasone|dexamethasone|mesh-list
111234623|NCT01857232|Ondansetron|ondansetron|mesh-list
111234624|NCT01857232|Fosaprepitant|fosaprepitant|mesh-list
111234625|NCT01857232|Aprepitant|aprepitant|mesh-list
111234626|NCT01857232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111234627|NCT01857232|Antiemetics|antiemetics|mesh-ancestor
111234628|NCT01857232|Autonomic Agents|autonomic agents|mesh-ancestor
111234629|NCT01857232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111234630|NCT01857232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111234631|NCT01857232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111234632|NCT01857232|Glucocorticoids|glucocorticoids|mesh-ancestor
111234633|NCT01857232|Hormones|hormones|mesh-ancestor
111234634|NCT01857232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111234635|NCT01857232|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111234636|NCT01857232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111234637|NCT01857232|Antipruritics|antipruritics|mesh-ancestor
111234638|NCT01857232|Dermatologic Agents|dermatologic agents|mesh-ancestor
111234639|NCT01857232|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111234640|NCT01857232|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111234641|NCT01857232|Serotonin Agents|serotonin agents|mesh-ancestor
111234642|NCT01857232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111234643|NCT01857232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111234644|NCT01857232|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
111234645|NCT01766128|Zonisamide|zonisamide|mesh-list
111234646|NCT01766128|Anticonvulsants|anticonvulsants|mesh-ancestor
111234647|NCT01766128|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111234648|NCT01766128|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111234649|NCT01766128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111234650|NCT01766128|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111234651|NCT01766128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111234652|NCT02859558|Tenofovir|tenofovir|mesh-list
111234653|NCT02859558|Emtricitabine|emtricitabine|mesh-list
111234654|NCT02859558|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
111234655|NCT02859558|Cobicistat|cobicistat|mesh-list
111234656|NCT02859558|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
111234657|NCT02859558|Elvitegravir|elvitegravir|mesh-list
111234658|NCT02859558|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
111234659|NCT02859558|Antiviral Agents|antiviral agents|mesh-ancestor
111234660|NCT02859558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111234661|NCT02859558|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111234662|NCT02859558|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111234663|NCT02859558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111234664|NCT02859558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111234665|NCT02859558|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111234666|NCT02859558|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111234667|NCT02859558|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111234668|NCT02859558|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111234669|NCT01860586|Bevacizumab|bevacizumab|mesh-list
111234670|NCT01860586|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111234671|NCT01860586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111234672|NCT01860586|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111234673|NCT01860586|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111234674|NCT01860586|Growth Substances|growth substances|mesh-ancestor
111234675|NCT01860586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111234676|NCT01860586|Growth Inhibitors|growth inhibitors|mesh-ancestor
111234677|NCT00705432|Ribavirin|ribavirin|mesh-list
111234678|NCT00705432|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
111234679|NCT00705432|Antimetabolites|antimetabolites|mesh-ancestor
111234680|NCT00705432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111234681|NCT00705432|Antiviral Agents|antiviral agents|mesh-ancestor
111234682|NCT00705432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111234683|NCT00704964|Ribavirin|ribavirin|mesh-list
111234684|NCT00704964|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
111234685|NCT00704964|Interferon-alpha|interferon-alpha|mesh-list
111234686|NCT00704964|Antimetabolites|antimetabolites|mesh-ancestor
111234687|NCT00704964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111234688|NCT00704964|Antiviral Agents|antiviral agents|mesh-ancestor
111234689|NCT00704964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111234690|NCT00704964|Immunologic Factors|immunologic factors|mesh-ancestor
111234691|NCT00704964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111234692|NCT00704808|Temozolomide|temozolomide|mesh-list
111234693|NCT00704808|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111234694|NCT00704808|Alkylating Agents|alkylating agents|mesh-ancestor
111234695|NCT00704808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111234696|NCT00704808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111234697|NCT05305794|Insulin|insulin|mesh-list
111234698|NCT05305794|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111234699|NCT05305794|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111234700|NCT05305794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111234701|NCT02474316|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
111234702|NCT02474316|Antiviral Agents|antiviral agents|mesh-ancestor
111234703|NCT02474316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111234704|NCT01862536|Tadalafil|tadalafil|mesh-list
111234705|NCT01862536|Vasodilator Agents|vasodilator agents|mesh-ancestor
111234706|NCT01862536|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111234707|NCT01862536|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111234708|NCT01862536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111234709|NCT01862536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111234710|NCT01862536|Urological Agents|urological agents|mesh-ancestor
111234711|NCT01862614|Epinephrine|epinephrine|mesh-list
111234712|NCT01862614|Racepinephrine|racepinephrine|mesh-list
111234713|NCT01862614|Carticaine|carticaine|mesh-list
111234714|NCT01862614|Epinephryl borate|epinephryl borate|mesh-list
111234715|NCT01862614|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111234716|NCT01862614|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111234717|NCT01862614|Adrenergic Agents|adrenergic agents|mesh-ancestor
111234718|NCT01862614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111234719|NCT01862614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111234720|NCT01862614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111234721|NCT01862614|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111234722|NCT01862614|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111234723|NCT01862614|Autonomic Agents|autonomic agents|mesh-ancestor
111234724|NCT01862614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111234725|NCT01862614|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111234726|NCT01862614|Respiratory System Agents|respiratory system agents|mesh-ancestor
111234727|NCT01862614|Mydriatics|mydriatics|mesh-ancestor
111234728|NCT01862614|Sympathomimetics|sympathomimetics|mesh-ancestor
111234729|NCT01862614|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111234730|NCT01862614|Anesthetics, Local|anesthetics, local|mesh-ancestor
110959101|NCT04315558|Bromides|bromides|mesh-list
111234731|NCT01862614|Anesthetics|anesthetics|mesh-ancestor
111234732|NCT01862614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111234733|NCT01862614|Sensory System Agents|sensory system agents|mesh-ancestor
111234734|NCT05166876|Brequinar|brequinar|mesh-list
111234735|NCT05166876|Dipyridamole|dipyridamole|mesh-list
111234736|NCT05166876|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111234737|NCT05166876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111234738|NCT05166876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111234739|NCT05166876|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111234740|NCT05166876|Vasodilator Agents|vasodilator agents|mesh-ancestor
111234741|NCT05166876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111234742|NCT05166876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111234743|NCT05166876|Immunologic Factors|immunologic factors|mesh-ancestor
111234744|NCT05166876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111234745|NCT02470650|Ritonavir|ritonavir|mesh-list
111234746|NCT02470650|Darunavir|darunavir|mesh-list
111234747|NCT02470650|Tenofovir|tenofovir|mesh-list
111234748|NCT02470650|Lamivudine|lamivudine|mesh-list
111234749|NCT02470650|Emtricitabine|emtricitabine|mesh-list
111234750|NCT02470650|Abacavir|abacavir|mesh-list
111234751|NCT02470650|Cobicistat|cobicistat|mesh-list
111234752|NCT02470650|Rilpivirine|rilpivirine|mesh-list
111234753|NCT02470650|Elvitegravir|elvitegravir|mesh-list
111234754|NCT02470650|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111234755|NCT02470650|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111234756|NCT02470650|Protease Inhibitors|protease inhibitors|mesh-ancestor
111234757|NCT02470650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111234758|NCT02470650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111234759|NCT02470650|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111234760|NCT02470650|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111234761|NCT02470650|Antiviral Agents|antiviral agents|mesh-ancestor
111234762|NCT02470650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111234763|NCT02470650|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111234764|NCT02470650|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111234765|NCT02470650|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111234766|NCT02470650|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111234767|NCT02470650|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111234768|NCT01866592|Adalimumab|adalimumab|mesh-list
111234769|NCT01866592|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111234770|NCT01866592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111234771|NCT01866592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111234772|NCT01375608|Decitabine|decitabine|mesh-list
111234773|NCT01375608|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111234774|NCT01375608|Antimetabolites|antimetabolites|mesh-ancestor
111234775|NCT01375608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111234776|NCT01375608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111234777|NCT01375608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111234778|NCT01868776|Lidocaine|lidocaine|mesh-list
111234779|NCT01868776|Anesthetics, Local|anesthetics, local|mesh-ancestor
111234780|NCT01868776|Anesthetics|anesthetics|mesh-ancestor
111234781|NCT01868776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111234782|NCT01868776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111234783|NCT01868776|Sensory System Agents|sensory system agents|mesh-ancestor
111234784|NCT01868776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111234785|NCT01868776|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111234786|NCT01868776|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111234787|NCT01868776|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111234788|NCT01868776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111234789|NCT01868776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111234790|NCT00704418|Bromfenac|bromfenac|mesh-list
111234791|NCT00704418|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111234792|NCT00704418|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111234793|NCT00704418|Analgesics|analgesics|mesh-ancestor
111234794|NCT00704418|Sensory System Agents|sensory system agents|mesh-ancestor
111234795|NCT00704418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111234796|NCT00704418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111234797|NCT00704418|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111234798|NCT00704418|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111234799|NCT01869634|Ritonavir|ritonavir|mesh-list
111234800|NCT01869634|Darunavir|darunavir|mesh-list
111234801|NCT01869634|Emtricitabine|emtricitabine|mesh-list
111234802|NCT01869634|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111234803|NCT01869634|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111234804|NCT01869634|Protease Inhibitors|protease inhibitors|mesh-ancestor
111234805|NCT01869634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111234806|NCT01869634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111234807|NCT01869634|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111234808|NCT01869634|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111234810|NCT01869634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111234811|NCT01869634|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111234812|NCT01869634|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111234813|NCT01869634|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111234814|NCT01869634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111234815|NCT02047578|Busulfan|busulfan|mesh-list
111234816|NCT02047578|Alkylating Agents|alkylating agents|mesh-ancestor
111234817|NCT02047578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111234818|NCT02047578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111234819|NCT02047578|Immunologic Factors|immunologic factors|mesh-ancestor
111234820|NCT02047578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111234821|NCT02047578|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111234822|NCT02047578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111234823|NCT02047578|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111234824|NCT04807894|Testosterone|testosterone|mesh-list
111234825|NCT04807894|Androgens|androgens|mesh-ancestor
111234826|NCT04807894|Hormones|hormones|mesh-ancestor
111234827|NCT04807894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111234828|NCT04807894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111234829|NCT01874392|Insulin|insulin|mesh-list
111234830|NCT01874392|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111234831|NCT01874392|Pancrelipase|pancrelipase|mesh-list
111234832|NCT01874392|Pancreatin|pancreatin|mesh-list
111234833|NCT01874392|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111234834|NCT01874392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111234835|NCT01874392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111234836|NCT00576654|Irinotecan|irinotecan|mesh-list
111234837|NCT00576654|Camptothecin|camptothecin|mesh-list
111234838|NCT00576654|Veliparib|veliparib|mesh-list
111234839|NCT00576654|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111234840|NCT00576654|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111234841|NCT00576654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111234842|NCT00576654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111234843|NCT00576654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111234844|NCT00576654|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111234845|NCT00576654|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111234846|NCT03314064|Dolutegravir|dolutegravir|mesh-list
111234847|NCT03314064|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111234848|NCT03314064|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111234849|NCT03314064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111234850|NCT03314064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111234851|NCT03314064|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111234852|NCT03314064|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111234853|NCT03314064|Antiviral Agents|antiviral agents|mesh-ancestor
111234854|NCT03314064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111234855|NCT00552058|Certolizumab Pegol|certolizumab pegol|mesh-list
111234856|NCT00552058|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111234857|NCT00552058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111234858|NCT00552058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111234859|NCT00552058|Immunologic Factors|immunologic factors|mesh-ancestor
111234860|NCT00552058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111234861|NCT00552058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111234862|NCT02473302|Tocopherols|tocopherols|mesh-list
111234863|NCT02473302|Vitamin E|vitamin e|mesh-list
111234864|NCT02473302|Tocotrienols|tocotrienols|mesh-list
111234865|NCT02473302|alpha-Tocopherol|alpha-tocopherol|mesh-list
111234866|NCT02473302|Antioxidants|antioxidants|mesh-ancestor
111234867|NCT02473302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111234868|NCT02473302|Protective Agents|protective agents|mesh-ancestor
111234869|NCT02473302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111234870|NCT02473302|Vitamins|vitamins|mesh-ancestor
111234871|NCT02473302|Micronutrients|micronutrients|mesh-ancestor
111234872|NCT05747326|Capecitabine|capecitabine|mesh-list
111234873|NCT05747326|Vinorelbine|vinorelbine|mesh-list
111234874|NCT05747326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111234875|NCT05747326|Antimetabolites|antimetabolites|mesh-ancestor
111234876|NCT05747326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111234877|NCT05747326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110959233|NCT03523572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110959234|NCT00972309|Vaccines|vaccines|mesh-list
110959235|NCT00972309|Immunologic Factors|immunologic factors|mesh-ancestor
110959236|NCT00972309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110959237|NCT03526224|Teriflunomide|teriflunomide|mesh-list
110959250|NCT03639246|Paclitaxel|paclitaxel|mesh-list
111234878|NCT05747326|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111234879|NCT05747326|Tubulin Modulators|tubulin modulators|mesh-ancestor
111234880|NCT05747326|Antimitotic Agents|antimitotic agents|mesh-ancestor
111234881|NCT05747326|Mitosis Modulators|mitosis modulators|mesh-ancestor
111234882|NCT03108300|Doxorubicin|doxorubicin|mesh-list
111234883|NCT03108300|Propranolol|propranolol|mesh-list
111234884|NCT03108300|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111234885|NCT03108300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111234886|NCT03108300|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111234887|NCT03108300|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111234888|NCT03108300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111234889|NCT03108300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111234890|NCT03108300|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111234891|NCT03108300|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111234892|NCT03108300|Adrenergic Agents|adrenergic agents|mesh-ancestor
111234893|NCT03108300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111234894|NCT03108300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111234895|NCT03108300|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111234896|NCT03108300|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111234897|NCT03108300|Vasodilator Agents|vasodilator agents|mesh-ancestor
111234898|NCT03313752|Dapagliflozin|dapagliflozin|mesh-list
111234899|NCT03313752|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111234900|NCT03313752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111234901|NCT03313752|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111234902|NCT03313752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111234903|NCT02473146|Gemtuzumab|gemtuzumab|mesh-list
111234904|NCT02473146|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111234905|NCT02473146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111234906|NCT02473146|Immunotoxins|immunotoxins|mesh-ancestor
111234907|NCT02473146|Immunoconjugates|immunoconjugates|mesh-ancestor
111234908|NCT02473146|Immunologic Factors|immunologic factors|mesh-ancestor
111234909|NCT02473146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111234910|NCT02989012|Oseltamivir|oseltamivir|mesh-list
111234911|NCT02989012|Antiviral Agents|antiviral agents|mesh-ancestor
111234912|NCT02989012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111234913|NCT02989012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111234914|NCT02989012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111234915|NCT03832894|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
111234916|NCT03832894|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
111234917|NCT03832894|Estradiol|estradiol|mesh-list
111234918|NCT03832894|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
111234919|NCT03832894|Progesterone|progesterone|mesh-list
111234920|NCT03832894|Estrogens|estrogens|mesh-ancestor
111234921|NCT03832894|Hormones|hormones|mesh-ancestor
111234922|NCT03832894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111234923|NCT03832894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111234924|NCT03832894|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111234925|NCT03832894|Contraceptive Agents|contraceptive agents|mesh-ancestor
111234926|NCT03832894|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111234927|NCT03832894|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111234928|NCT03832894|Progestins|progestins|mesh-ancestor
111234929|NCT02989324|Misoprostol|misoprostol|mesh-list
111234930|NCT02989324|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111234931|NCT02989324|Abortifacient Agents|abortifacient agents|mesh-ancestor
111234932|NCT02989324|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111234933|NCT02989324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111234934|NCT02989324|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111234935|NCT02989324|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111234936|NCT02989324|Oxytocics|oxytocics|mesh-ancestor
111234937|NCT00550732|Posaconazole|posaconazole|mesh-list
111234938|NCT00550732|Antifungal Agents|antifungal agents|mesh-ancestor
111234939|NCT00550732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111234940|NCT00550732|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
111234941|NCT00550732|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111234942|NCT00550732|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111234943|NCT00550732|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111234944|NCT00550732|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111234945|NCT00550732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111234946|NCT00550732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111234947|NCT00550732|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111234948|NCT00550732|Hormone Antagonists|hormone antagonists|mesh-ancestor
111234949|NCT00550732|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111234950|NCT00550732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111234951|NCT03311022|Nefopam|nefopam|mesh-list
111234952|NCT03311022|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111234953|NCT03311022|Analgesics|analgesics|mesh-ancestor
111234954|NCT03311022|Sensory System Agents|sensory system agents|mesh-ancestor
111234955|NCT03311022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111234956|NCT03311022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111234957|NCT00550420|Rosiglitazone|rosiglitazone|mesh-list
111234958|NCT00550420|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111234959|NCT00550420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111234960|NCT00559936|Bevacizumab|bevacizumab|mesh-list
111234961|NCT00559936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111234962|NCT00559936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111234963|NCT00559936|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111234964|NCT00559936|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111234965|NCT00559936|Growth Substances|growth substances|mesh-ancestor
111234966|NCT00559936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111234967|NCT00559936|Growth Inhibitors|growth inhibitors|mesh-ancestor
111234968|NCT05353192|Hormones|hormones|mesh-list
111234969|NCT05353192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111234970|NCT05353192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111234971|NCT03310242|Vitamin D|vitamin d|mesh-list
111234972|NCT03310242|Vitamins|vitamins|mesh-ancestor
111234973|NCT03310242|Micronutrients|micronutrients|mesh-ancestor
111234974|NCT03310242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111234975|NCT03310242|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111234976|NCT00557128|Lisinopril|lisinopril|mesh-list
111234977|NCT00557128|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
111234978|NCT00557128|Protease Inhibitors|protease inhibitors|mesh-ancestor
111234979|NCT00557128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111234980|NCT00557128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111234981|NCT00557128|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111234982|NCT00557128|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111234983|NCT00557128|Protective Agents|protective agents|mesh-ancestor
111234984|NCT00557128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111234985|NCT03312582|Metformin|metformin|mesh-list
111234986|NCT03312582|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111234987|NCT03312582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111234988|NCT04350580|Immunoglobulins|immunoglobulins|mesh-list
111234989|NCT04350580|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111234990|NCT04350580|Antibodies|antibodies|mesh-list
111234991|NCT04350580|Immunologic Factors|immunologic factors|mesh-ancestor
111234992|NCT04350580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111234993|NCT00558064|Amlodipine|amlodipine|mesh-list
111234994|NCT00558064|Telmisartan|telmisartan|mesh-list
111234995|NCT00558064|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
111234996|NCT00558064|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111234997|NCT00558064|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111234998|NCT00558064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111234999|NCT00558064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111235000|NCT00558064|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111235001|NCT00558064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111235002|NCT00558064|Vasodilator Agents|vasodilator agents|mesh-ancestor
111235003|NCT00558064|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111235004|NCT00558064|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111235005|NCT03312426|Linrodostat|linrodostat|mesh-list
111235006|NCT03312426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111235007|NCT03312426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111235008|NCT03309618|Valsartan|valsartan|mesh-list
111235009|NCT03309618|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111235010|NCT03309618|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111235011|NCT03309618|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111235012|NCT03309618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111235013|NCT03303924|Sulbactam|sulbactam|mesh-list
111235014|NCT03303924|Durlobactam|durlobactam|mesh-list
111235015|NCT03303924|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111235016|NCT03303924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111235017|NCT03303924|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
111235018|NCT03303924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111235019|NCT03303924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111235020|NCT00557830|Sorafenib|sorafenib|mesh-list
111235021|NCT00557830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111235022|NCT00557830|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111235023|NCT00557830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111235024|NCT00557830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111235025|NCT00557440|Fluticasone|fluticasone|mesh-list
111235026|NCT00557440|Xhance|xhance|mesh-list
111235028|NCT00557440|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
111235029|NCT00557440|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
111235030|NCT00557440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111235031|NCT00557440|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111235032|NCT00557440|Autonomic Agents|autonomic agents|mesh-ancestor
111235033|NCT00557440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111235034|NCT00557440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111235035|NCT00557440|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111235036|NCT00557440|Respiratory System Agents|respiratory system agents|mesh-ancestor
111235037|NCT00557440|Dermatologic Agents|dermatologic agents|mesh-ancestor
111235038|NCT00557440|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111235039|NCT00557440|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111235040|NCT00557440|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111235041|NCT00557440|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111235042|NCT00557440|Adrenergic Agents|adrenergic agents|mesh-ancestor
111235043|NCT00557440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111235044|NCT00557440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111235045|NCT00557440|Glucocorticoids|glucocorticoids|mesh-ancestor
111235046|NCT00557440|Hormones|hormones|mesh-ancestor
111235047|NCT00557440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111235048|NCT00557440|Sympathomimetics|sympathomimetics|mesh-ancestor
111235049|NCT03311178|Dobutamine|dobutamine|mesh-list
111235050|NCT03311178|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111235051|NCT03311178|Sympathomimetics|sympathomimetics|mesh-ancestor
111235052|NCT03311178|Autonomic Agents|autonomic agents|mesh-ancestor
111235053|NCT03311178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111235054|NCT03311178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111235055|NCT03311178|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
111235056|NCT03311178|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111235057|NCT03311178|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111235058|NCT03311178|Adrenergic Agents|adrenergic agents|mesh-ancestor
111235059|NCT03311178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111235060|NCT03311178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111235061|NCT03311178|Protective Agents|protective agents|mesh-ancestor
111235062|NCT02469012|Ribavirin|ribavirin|mesh-list
111235063|NCT02469012|Sofosbuvir|sofosbuvir|mesh-list
111235064|NCT02469012|Ledipasvir|ledipasvir|mesh-list
111235065|NCT02469012|Antimetabolites|antimetabolites|mesh-ancestor
111235066|NCT02469012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111235067|NCT02469012|Antiviral Agents|antiviral agents|mesh-ancestor
111235068|NCT02469012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111235069|NCT02468856|Modafinil|modafinil|mesh-list
111235070|NCT02468856|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110814648|NCT05116293|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111235071|NCT02468856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111235072|NCT02468856|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
111235073|NCT02468856|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111235074|NCT02468856|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111235075|NCT02468856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111235076|NCT05224336|Niacin|niacin|mesh-list
111235077|NCT05224336|Psilocybin|psilocybin|mesh-list
111235078|NCT05224336|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111235079|NCT05224336|Antimetabolites|antimetabolites|mesh-ancestor
111235080|NCT05224336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111235081|NCT05224336|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111235082|NCT05224336|Vasodilator Agents|vasodilator agents|mesh-ancestor
111235083|NCT05224336|Vitamin B Complex|vitamin b complex|mesh-ancestor
111235084|NCT05224336|Vitamins|vitamins|mesh-ancestor
111235085|NCT05224336|Micronutrients|micronutrients|mesh-ancestor
111235086|NCT05224336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111235087|NCT05224336|Hallucinogens|hallucinogens|mesh-ancestor
111235088|NCT05224336|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111235089|NCT03303378|Melatonin|melatonin|mesh-list
111235090|NCT03303378|Antioxidants|antioxidants|mesh-ancestor
111235091|NCT03303378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111235092|NCT03303378|Protective Agents|protective agents|mesh-ancestor
111235093|NCT03303378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111235094|NCT03303378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111235095|NCT04491474|Lidocaine|lidocaine|mesh-list
111235096|NCT04491474|Anesthetics, Local|anesthetics, local|mesh-ancestor
111235097|NCT04491474|Anesthetics|anesthetics|mesh-ancestor
111235098|NCT04491474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110959458|NCT02140983|Hormones|hormones|mesh-ancestor
111235099|NCT04491474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111235100|NCT04491474|Sensory System Agents|sensory system agents|mesh-ancestor
111235102|NCT04491474|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111235103|NCT04491474|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111235104|NCT04491474|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111235105|NCT04491474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111235106|NCT04491474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111235107|NCT03308682|(177)Lu-DOTA-EB-TATE|(177)lu-dota-eb-tate|mesh-list
111235108|NCT03308682|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111235109|NCT03308682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111235110|NCT03308604|Cisplatin|cisplatin|mesh-list
111235111|NCT03308604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111235112|NCT00553306|Aldesleukin|aldesleukin|mesh-list
111235113|NCT00553306|Cyclophosphamide|cyclophosphamide|mesh-list
111235114|NCT00553306|Interleukin-2|interleukin-2|mesh-list
111235115|NCT00553306|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111235116|NCT00553306|Immunologic Factors|immunologic factors|mesh-ancestor
111235117|NCT00553306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111235118|NCT00553306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111235119|NCT00553306|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111235120|NCT00553306|Alkylating Agents|alkylating agents|mesh-ancestor
111235121|NCT00553306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111235122|NCT00553306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111235123|NCT00553306|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111235124|NCT00553306|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111235125|NCT00553306|Analgesics|analgesics|mesh-ancestor
111235126|NCT00553306|Sensory System Agents|sensory system agents|mesh-ancestor
111235127|NCT00553306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111235128|NCT00553306|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111235129|NCT00553306|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111235130|NCT00553306|Antiviral Agents|antiviral agents|mesh-ancestor
111235131|NCT00553306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111235132|NCT02722044|Adalimumab|adalimumab|mesh-list
111235133|NCT02722044|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111235134|NCT02722044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111235135|NCT02722044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111235136|NCT05728008|Ustekinumab|ustekinumab|mesh-list
111235137|NCT05728008|Tofacitinib|tofacitinib|mesh-list
111235138|NCT05728008|Dermatologic Agents|dermatologic agents|mesh-ancestor
111235139|NCT05728008|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
111235140|NCT05728008|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111235141|NCT05728008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111235142|NCT05728008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111235143|NCT02988700|Bupivacaine|bupivacaine|mesh-list
111235144|NCT02988700|Anesthetics, Local|anesthetics, local|mesh-ancestor
111235145|NCT02988700|Anesthetics|anesthetics|mesh-ancestor
111235146|NCT02988700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111235147|NCT02988700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111235148|NCT02988700|Sensory System Agents|sensory system agents|mesh-ancestor
111235149|NCT02988700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111235150|NCT03308214|Imipenem|imipenem|mesh-list
111235151|NCT03308214|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111235152|NCT03308214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111235153|NCT03308136|Lidocaine|lidocaine|mesh-list
111235154|NCT03308136|Anesthetics, Local|anesthetics, local|mesh-list
111235155|NCT03308136|Anesthetics|anesthetics|mesh-list
111235156|NCT03308136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111235157|NCT03308136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111235158|NCT03308136|Sensory System Agents|sensory system agents|mesh-ancestor
111235159|NCT03308136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111235160|NCT03308136|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111235161|NCT03308136|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111235162|NCT03308136|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111235163|NCT03308136|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111235164|NCT03308136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111235165|NCT02466984|Metoclopramide|metoclopramide|mesh-list
111235166|NCT02466984|Antiemetics|antiemetics|mesh-ancestor
111235167|NCT02466984|Autonomic Agents|autonomic agents|mesh-ancestor
111235168|NCT02466984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111235169|NCT02466984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111235170|NCT02466984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111235171|NCT02466984|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111235172|NCT02466984|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111235173|NCT02466984|Dopamine Agents|dopamine agents|mesh-ancestor
111235174|NCT02466984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111235175|NCT02466984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111235176|NCT03302754|Alemtuzumab|alemtuzumab|mesh-list
111235177|NCT03302754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111235178|NCT03302754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111235179|NCT03307902|Imiquimod|imiquimod|mesh-list
111235180|NCT03307902|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111235181|NCT03307902|Immunologic Factors|immunologic factors|mesh-ancestor
111235182|NCT03307902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111235183|NCT03307902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111235184|NCT03307902|Interferon Inducers|interferon inducers|mesh-ancestor
111235185|NCT03302364|Risperidone|risperidone|mesh-list
111235186|NCT03302364|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111235187|NCT03302364|Serotonin Agents|serotonin agents|mesh-ancestor
111235188|NCT03302364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111235189|NCT03302364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111235190|NCT03302364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111235191|NCT03302364|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111235192|NCT03302364|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111235193|NCT03302364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111235194|NCT03302364|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111235195|NCT03302364|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111235196|NCT03302364|Dopamine Agents|dopamine agents|mesh-ancestor
111235197|NCT02467920|Exenatide|exenatide|mesh-list
111235198|NCT02467920|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111235199|NCT02467920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111235200|NCT02467920|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111235201|NCT02467920|Incretins|incretins|mesh-ancestor
111235202|NCT02467920|Hormones|hormones|mesh-ancestor
111235203|NCT02467920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111235204|NCT04927312|Metronidazole|metronidazole|mesh-list
111235205|NCT04927312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111235206|NCT04927312|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111235207|NCT04927312|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111235208|NCT04927312|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111235209|NCT03307590|Dexmedetomidine|dexmedetomidine|mesh-list
111235210|NCT03307590|Bupivacaine|bupivacaine|mesh-list
111235211|NCT03307590|Anesthetics, Local|anesthetics, local|mesh-ancestor
111235212|NCT03307590|Anesthetics|anesthetics|mesh-ancestor
111235213|NCT03307590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111235214|NCT03307590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111235215|NCT03307590|Sensory System Agents|sensory system agents|mesh-ancestor
111235216|NCT03307590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111235217|NCT03307590|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111235218|NCT03307590|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111235219|NCT03307590|Analgesics|analgesics|mesh-ancestor
111235220|NCT03307590|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111235221|NCT03307590|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111235222|NCT03307590|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111235223|NCT03307590|Adrenergic Agents|adrenergic agents|mesh-ancestor
111235224|NCT03307590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111235225|NCT03307590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111235226|NCT03302208|Pregabalin|pregabalin|mesh-list
111235227|NCT03302208|Analgesics|analgesics|mesh-ancestor
111235228|NCT03302208|Sensory System Agents|sensory system agents|mesh-ancestor
111235229|NCT03302208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111235230|NCT03302208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111235231|NCT03302208|Anticonvulsants|anticonvulsants|mesh-ancestor
111235232|NCT03302208|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111235233|NCT03302208|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111235234|NCT03302208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111235235|NCT03302208|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111235236|NCT03302208|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111235237|NCT03302208|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111235238|NCT03302208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111235239|NCT03302208|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111235240|NCT03307512|Insulin|insulin|mesh-list
111235241|NCT03307512|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111235242|NCT03307512|Insulin Lispro|insulin lispro|mesh-list
111235243|NCT03307512|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111235244|NCT03307512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111235245|NCT02466828|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
111235246|NCT02466828|Hematinics|hematinics|mesh-ancestor
111235247|NCT02466828|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
111235248|NCT02466828|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111235249|NCT02721966|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111235250|NCT02721966|Immunologic Factors|immunologic factors|mesh-ancestor
111235251|NCT02721966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111235253|NCT00553462|Carboplatin|carboplatin|mesh-list
111235254|NCT00553462|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111235255|NCT00553462|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111235256|NCT00553462|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111235257|NCT00553462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111235258|NCT00553462|Tubulin Modulators|tubulin modulators|mesh-ancestor
111235259|NCT00553462|Antimitotic Agents|antimitotic agents|mesh-ancestor
111235260|NCT00553462|Mitosis Modulators|mitosis modulators|mesh-ancestor
111235261|NCT00553462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111235262|NCT00553462|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111235263|NCT00553462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111235264|NCT04874038|Lidocaine|lidocaine|mesh-list
111235265|NCT04874038|Anesthetics, Local|anesthetics, local|mesh-ancestor
111235266|NCT04874038|Anesthetics|anesthetics|mesh-ancestor
111235267|NCT04874038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111235268|NCT04874038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111235269|NCT04874038|Sensory System Agents|sensory system agents|mesh-ancestor
111235270|NCT04874038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111235271|NCT04874038|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111235272|NCT04874038|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111235273|NCT04874038|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111235274|NCT04874038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111235275|NCT04874038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111235276|NCT03301974|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
111235277|NCT03301974|Hemostatics|hemostatics|mesh-ancestor
111235278|NCT03301974|Coagulants|coagulants|mesh-ancestor
111235279|NCT03306732|Thiamine|thiamine|mesh-list
111235280|NCT03306732|Vitamin B Complex|vitamin b complex|mesh-ancestor
111235281|NCT03306732|Vitamins|vitamins|mesh-ancestor
111235282|NCT03306732|Micronutrients|micronutrients|mesh-ancestor
111235283|NCT03306732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111235284|NCT00553150|Everolimus|everolimus|mesh-list
111235285|NCT00553150|Temozolomide|temozolomide|mesh-list
111235286|NCT00553150|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111235287|NCT00553150|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111235288|NCT00553150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111235289|NCT00553150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111235290|NCT00553150|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111235291|NCT00553150|Immunologic Factors|immunologic factors|mesh-ancestor
111235292|NCT00553150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111235293|NCT00553150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111235294|NCT00553150|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111235295|NCT00553150|Alkylating Agents|alkylating agents|mesh-ancestor
111235296|NCT02468232|Enalapril|enalapril|mesh-list
111235297|NCT02468232|Enalaprilat|enalaprilat|mesh-list
111235298|NCT02468232|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
111235299|NCT02468232|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
111235300|NCT02468232|Protease Inhibitors|protease inhibitors|mesh-ancestor
111235301|NCT02468232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111235302|NCT02468232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111235303|NCT02468232|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111235304|NCT02468232|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111235305|NCT04630834|Acetaminophen|acetaminophen|mesh-list
111235306|NCT04630834|Ibuprofen|ibuprofen|mesh-list
111235307|NCT04630834|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111235308|NCT04630834|Analgesics|analgesics|mesh-ancestor
111235309|NCT04630834|Sensory System Agents|sensory system agents|mesh-ancestor
111235310|NCT04630834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111235311|NCT04630834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111235312|NCT04630834|Antipyretics|antipyretics|mesh-ancestor
111235313|NCT04630834|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111235314|NCT04630834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111235315|NCT04630834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111235316|NCT04630834|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111235317|NCT04630834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111235318|NCT04630834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111235319|NCT03301350|Paclitaxel|paclitaxel|mesh-list
111235320|NCT03301350|Cyclophosphamide|cyclophosphamide|mesh-list
111235321|NCT03301350|Carboplatin|carboplatin|mesh-list
111235322|NCT03301350|Doxorubicin|doxorubicin|mesh-list
111235323|NCT03301350|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111235324|NCT03301350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111235325|NCT03301350|Tubulin Modulators|tubulin modulators|mesh-ancestor
111235326|NCT03301350|Antimitotic Agents|antimitotic agents|mesh-ancestor
111235327|NCT03301350|Mitosis Modulators|mitosis modulators|mesh-ancestor
111235328|NCT03301350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111235329|NCT03301350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111235330|NCT03301350|Immunologic Factors|immunologic factors|mesh-ancestor
111235331|NCT03301350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111235332|NCT03301350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111235333|NCT03301350|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111235334|NCT03301350|Alkylating Agents|alkylating agents|mesh-ancestor
111235335|NCT03301350|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111235336|NCT03301350|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111235337|NCT03301350|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111235338|NCT03301350|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111235339|NCT03301350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111235340|NCT02722278|Methyltestosterone|methyltestosterone|mesh-list
111235341|NCT02722278|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111235342|NCT02722278|Testosterone|testosterone|mesh-list
111235343|NCT02722278|Testosterone undecanoate|testosterone undecanoate|mesh-list
111235344|NCT02722278|Testosterone enanthate|testosterone enanthate|mesh-list
111235345|NCT02722278|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
111235346|NCT02722278|Androgens|androgens|mesh-ancestor
111235347|NCT02722278|Hormones|hormones|mesh-ancestor
111235348|NCT02722278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111235349|NCT02722278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111235350|NCT02722278|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111235351|NCT02722278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111235352|NCT02722278|Anabolic Agents|anabolic agents|mesh-ancestor
111235353|NCT03300960|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
111235354|NCT03300960|Ganirelix|ganirelix|mesh-list
111235355|NCT03300960|Hormone Antagonists|hormone antagonists|mesh-ancestor
111235356|NCT03300960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111235357|NCT03300960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111235358|NCT03300960|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111235359|NCT03300960|Contraceptive Agents|contraceptive agents|mesh-ancestor
111235360|NCT03300960|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111235361|NCT03300960|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111235362|NCT03300960|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
111235363|NCT03300960|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111235364|NCT03300960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111235365|NCT02993146|Ropidoxuridine|ropidoxuridine|mesh-list
111235366|NCT02993146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111235367|NCT02485444|Oxytocin|oxytocin|mesh-list
111235368|NCT02485444|Oxytocics|oxytocics|mesh-ancestor
111235369|NCT02485444|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111235370|NCT02485444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111235371|NCT04443010|Temozolomide|temozolomide|mesh-list
111235372|NCT04443010|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111235373|NCT04443010|Alkylating Agents|alkylating agents|mesh-ancestor
111235374|NCT04443010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111235375|NCT04443010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111235376|NCT04490694|Lenvatinib|lenvatinib|mesh-list
111235377|NCT04490694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111235378|NCT04490694|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111235379|NCT04490694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111235380|NCT04490694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111235381|NCT04601584|Antibodies|antibodies|mesh-list
111235382|NCT04601584|Immunoglobulins|immunoglobulins|mesh-list
111235383|NCT04601584|Immunologic Factors|immunologic factors|mesh-ancestor
111235384|NCT04601584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111235385|NCT02359474|Trabectedin|trabectedin|mesh-list
111235386|NCT02359474|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111235387|NCT02359474|Alkylating Agents|alkylating agents|mesh-ancestor
111235388|NCT02359474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111235389|NCT02359474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111235390|NCT02467686|Tamoxifen|tamoxifen|mesh-list
111235391|NCT02467686|Exemestane|exemestane|mesh-list
111235392|NCT02467686|Aromatase Inhibitors|aromatase inhibitors|mesh-list
111235393|NCT02467686|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111235394|NCT02467686|Hormone Antagonists|hormone antagonists|mesh-ancestor
111235395|NCT02467686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111235396|NCT02467686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111235397|NCT02467686|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111235398|NCT02467686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110959772|NCT05172518|Taxane|taxane|mesh-list
111235399|NCT02467686|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111235400|NCT02467686|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111235401|NCT02467686|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111235402|NCT02467686|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111235403|NCT02467686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111235404|NCT02467686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111235405|NCT05707962|Magnesium Sulfate|magnesium sulfate|mesh-list
111235406|NCT05707962|Neuroprotective Agents|neuroprotective agents|mesh-list
111235407|NCT05707962|Analgesics|analgesics|mesh-ancestor
111235408|NCT05707962|Sensory System Agents|sensory system agents|mesh-ancestor
111235409|NCT05707962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111235410|NCT05707962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111235411|NCT05707962|Anesthetics|anesthetics|mesh-ancestor
111235412|NCT05707962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111235413|NCT05707962|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111235414|NCT05707962|Anticonvulsants|anticonvulsants|mesh-ancestor
111235415|NCT05707962|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111235416|NCT05707962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111235417|NCT05707962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111235418|NCT05707962|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111235419|NCT05707962|Tocolytic Agents|tocolytic agents|mesh-ancestor
111235420|NCT05707962|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111235421|NCT05707962|Protective Agents|protective agents|mesh-ancestor
111235422|NCT01993810|Paclitaxel|paclitaxel|mesh-list
111235423|NCT01993810|Etoposide|etoposide|mesh-list
111235424|NCT01993810|Podophyllotoxin|podophyllotoxin|mesh-list
111235425|NCT01993810|Cisplatin|cisplatin|mesh-list
111235426|NCT01993810|Carboplatin|carboplatin|mesh-list
111235427|NCT01993810|Pemetrexed|pemetrexed|mesh-list
111235428|NCT01993810|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111235429|NCT01993810|Etoposide phosphate|etoposide phosphate|mesh-list
111235430|NCT01993810|Durvalumab|durvalumab|mesh-list
111235431|NCT01993810|Immunoglobulins|immunoglobulins|mesh-list
111235432|NCT01993810|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111235433|NCT01993810|Immunoglobulin G|immunoglobulin g|mesh-list
111235434|NCT01993810|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111235435|NCT01993810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111235436|NCT01993810|Tubulin Modulators|tubulin modulators|mesh-ancestor
111235437|NCT01993810|Antimitotic Agents|antimitotic agents|mesh-ancestor
111235438|NCT01993810|Mitosis Modulators|mitosis modulators|mesh-ancestor
111235439|NCT01993810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111235440|NCT01993810|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111235441|NCT01993810|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111235442|NCT01993810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111235443|NCT01993810|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111235444|NCT01993810|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111235445|NCT01993810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111235446|NCT01993810|Immunologic Factors|immunologic factors|mesh-ancestor
111235447|NCT01993810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111235448|NCT01993810|Keratolytic Agents|keratolytic agents|mesh-ancestor
111235449|NCT01993810|Dermatologic Agents|dermatologic agents|mesh-ancestor
111235450|NCT05698680|Prednisolone|prednisolone|mesh-list
111235451|NCT05698680|Colchicine|colchicine|mesh-list
111235452|NCT05698680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111235453|NCT05698680|Glucocorticoids|glucocorticoids|mesh-ancestor
111235454|NCT05698680|Hormones|hormones|mesh-ancestor
111235455|NCT05698680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111235456|NCT05698680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111235457|NCT05698680|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111235458|NCT05698680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111235459|NCT05698680|Gout Suppressants|gout suppressants|mesh-ancestor
111235460|NCT05698680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111235461|NCT05698680|Tubulin Modulators|tubulin modulators|mesh-ancestor
111235462|NCT05698680|Antimitotic Agents|antimitotic agents|mesh-ancestor
111235463|NCT05698680|Mitosis Modulators|mitosis modulators|mesh-ancestor
111235464|NCT05698680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111235465|NCT04058470|Prednisone|prednisone|mesh-list
111235466|NCT04058470|Cyclophosphamide|cyclophosphamide|mesh-list
111235467|NCT04058470|Rituximab|rituximab|mesh-list
111235468|NCT04058470|Doxorubicin|doxorubicin|mesh-list
111235469|NCT04058470|Vincristine|vincristine|mesh-list
111235470|NCT04058470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111235471|NCT04058470|Immunologic Factors|immunologic factors|mesh-ancestor
111235472|NCT04058470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111235473|NCT04058470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111235474|NCT04058470|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111235476|NCT04058470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111235477|NCT04058470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111235478|NCT04058470|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111235479|NCT04058470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111235480|NCT04058470|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111235481|NCT04058470|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111235482|NCT04058470|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111235483|NCT04058470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111235484|NCT04058470|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111235485|NCT04058470|Glucocorticoids|glucocorticoids|mesh-ancestor
111235486|NCT04058470|Hormones|hormones|mesh-ancestor
111235487|NCT04058470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111235488|NCT04058470|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111235489|NCT04058470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111235490|NCT04058470|Tubulin Modulators|tubulin modulators|mesh-ancestor
111235491|NCT04058470|Antimitotic Agents|antimitotic agents|mesh-ancestor
111235492|NCT04058470|Mitosis Modulators|mitosis modulators|mesh-ancestor
111235493|NCT02720484|Nivolumab|nivolumab|mesh-list
111235494|NCT02720484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111235495|NCT02720484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111235496|NCT02720484|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111235497|NCT02720484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111235498|NCT05447520|Montelukast|montelukast|mesh-list
111235499|NCT05447520|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111235500|NCT05447520|Respiratory System Agents|respiratory system agents|mesh-ancestor
111235501|NCT05447520|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
111235502|NCT05447520|Hormone Antagonists|hormone antagonists|mesh-ancestor
111235503|NCT05447520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111235504|NCT05447520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111235505|NCT05447520|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
111235506|NCT05447520|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111235507|NCT05447520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111235508|NCT05438550|Amoxicillin|amoxicillin|mesh-list
111235509|NCT05438550|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111235510|NCT05438550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111235511|NCT05639946|Brivaracetam|brivaracetam|mesh-list
111235512|NCT05639946|Anticonvulsants|anticonvulsants|mesh-ancestor
111235513|NCT03299712|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
111235514|NCT03299712|Vasodilator Agents|vasodilator agents|mesh-ancestor
111235515|NCT03299712|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
111235516|NCT03299712|Protective Agents|protective agents|mesh-ancestor
111235517|NCT03299712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111235518|NCT05327556|Epinephrine|epinephrine|mesh-list
111235519|NCT05327556|Racepinephrine|racepinephrine|mesh-list
111235520|NCT05327556|Epinephryl borate|epinephryl borate|mesh-list
111235521|NCT05327556|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111235522|NCT05327556|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111235523|NCT05327556|Adrenergic Agents|adrenergic agents|mesh-ancestor
111235524|NCT05327556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111235525|NCT05327556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111235526|NCT05327556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111235527|NCT05327556|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111235528|NCT05327556|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111235529|NCT05327556|Autonomic Agents|autonomic agents|mesh-ancestor
111235530|NCT05327556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111235531|NCT05327556|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111235532|NCT05327556|Respiratory System Agents|respiratory system agents|mesh-ancestor
111235533|NCT05327556|Mydriatics|mydriatics|mesh-ancestor
111235534|NCT05327556|Sympathomimetics|sympathomimetics|mesh-ancestor
111235535|NCT05327556|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111235536|NCT02466438|Tazobactam|tazobactam|mesh-list
111235537|NCT02466438|Piperacillin|piperacillin|mesh-list
111235538|NCT02466438|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
111235539|NCT02466438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111235540|NCT02466438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111235541|NCT02466438|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
111235542|NCT02466438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111235543|NCT02466438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111235544|NCT05587062|Aflibercept|aflibercept|mesh-list
111235545|NCT05587062|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111235546|NCT05587062|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111235547|NCT05587062|Growth Substances|growth substances|mesh-ancestor
111235548|NCT05587062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111235549|NCT05587062|Growth Inhibitors|growth inhibitors|mesh-ancestor
111235550|NCT05587062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111235551|NCT02463006|Methamphetamine|methamphetamine|mesh-list
111235552|NCT02463006|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111235553|NCT02463006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111235554|NCT02463006|Sympathomimetics|sympathomimetics|mesh-ancestor
111235555|NCT02463006|Autonomic Agents|autonomic agents|mesh-ancestor
111235556|NCT02463006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111235557|NCT02463006|Dopamine Agents|dopamine agents|mesh-ancestor
111235558|NCT02463006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111235559|NCT02463006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111235560|NCT02463006|Adrenergic Agents|adrenergic agents|mesh-ancestor
111235561|NCT02463006|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111235562|NCT02463006|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111235563|NCT02463006|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111235564|NCT02463006|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111235565|NCT04779216|Alendronate|alendronate|mesh-list
111235566|NCT04779216|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111235567|NCT04779216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111235568|NCT02466204|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
111235569|NCT02466204|Hormones|hormones|mesh-ancestor
111235570|NCT02466204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111235571|NCT02466204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111235572|NCT02715804|Paclitaxel|paclitaxel|mesh-list
111235573|NCT02715804|Gemcitabine|gemcitabine|mesh-list
111235574|NCT02715804|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111235575|NCT02715804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111235576|NCT02715804|Tubulin Modulators|tubulin modulators|mesh-ancestor
111235577|NCT02715804|Antimitotic Agents|antimitotic agents|mesh-ancestor
111235578|NCT02715804|Mitosis Modulators|mitosis modulators|mesh-ancestor
111235579|NCT02715804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111235580|NCT02715804|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111235581|NCT02715804|Antimetabolites|antimetabolites|mesh-ancestor
111235582|NCT04745130|Cetuximab|cetuximab|mesh-list
111235583|NCT04745130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111235584|NCT04745130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111235585|NCT02462304|Bevacizumab|bevacizumab|mesh-list
111235586|NCT02462304|Ranibizumab|ranibizumab|mesh-list
111235587|NCT02462304|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111235588|NCT02462304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111235589|NCT02462304|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111235590|NCT02462304|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111235591|NCT02462304|Growth Substances|growth substances|mesh-ancestor
110815174|NCT03904251|Gemtuzumab|gemtuzumab|mesh-list
111235592|NCT02462304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111235593|NCT02462304|Growth Inhibitors|growth inhibitors|mesh-ancestor
111235594|NCT03501576|Vaccines|vaccines|mesh-list
111235595|NCT03501576|Immunologic Factors|immunologic factors|mesh-ancestor
111235596|NCT03501576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111235597|NCT02465814|Ulipristal acetate|ulipristal acetate|mesh-list
111235598|NCT02465814|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111235599|NCT02465814|Contraceptive Agents|contraceptive agents|mesh-ancestor
111235600|NCT02465814|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111235601|NCT02465814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111235602|NCT02465814|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111235603|NCT04645212|Aflibercept|aflibercept|mesh-list
111235604|NCT04645212|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111235605|NCT04645212|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111235606|NCT04645212|Growth Substances|growth substances|mesh-ancestor
111235607|NCT04645212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111235608|NCT04645212|Growth Inhibitors|growth inhibitors|mesh-ancestor
111235609|NCT04645212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111235610|NCT04489446|Sildenafil Citrate|sildenafil citrate|mesh-list
111235611|NCT04489446|Vasodilator Agents|vasodilator agents|mesh-ancestor
111235612|NCT04489446|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111235613|NCT04489446|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111235614|NCT04489446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111235615|NCT04489446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111235616|NCT04489446|Urological Agents|urological agents|mesh-ancestor
111235617|NCT02717754|Oseltamivir|oseltamivir|mesh-list
111235618|NCT02717754|Antiviral Agents|antiviral agents|mesh-ancestor
111235619|NCT02717754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111235620|NCT02717754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111235621|NCT02717754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111235622|NCT04497168|Citalopram|citalopram|mesh-list
111235623|NCT04497168|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111235624|NCT04497168|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111235625|NCT04497168|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111235626|NCT04497168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111235627|NCT04497168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111235628|NCT04497168|Serotonin Agents|serotonin agents|mesh-ancestor
111235629|NCT04497168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111235630|NCT04497168|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111235631|NCT04497168|Antidepressive Agents|antidepressive agents|mesh-ancestor
111235632|NCT04497168|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111235633|NCT02717130|Aripiprazole|aripiprazole|mesh-list
111235634|NCT02717130|Antidepressive Agents|antidepressive agents|mesh-ancestor
111235635|NCT02717130|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111235636|NCT02717130|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111235637|NCT02717130|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111235638|NCT02717130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111235639|NCT02717130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111235640|NCT02717130|Dopamine Agonists|dopamine agonists|mesh-ancestor
111235641|NCT02717130|Dopamine Agents|dopamine agents|mesh-ancestor
111235642|NCT02717130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111235643|NCT02717130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111235644|NCT02717130|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111235645|NCT02717130|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111235646|NCT02717130|Serotonin Agents|serotonin agents|mesh-ancestor
111235647|NCT02717130|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111235648|NCT02717130|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111235649|NCT02717130|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111235650|NCT02717130|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111235651|NCT02256696|Rifampin|rifampin|mesh-list
111235652|NCT02256696|Rifabutin|rifabutin|mesh-list
111235653|NCT02256696|Isoniazid|isoniazid|mesh-list
111235654|NCT02256696|Pyrazinamide|pyrazinamide|mesh-list
111235655|NCT02256696|Ethambutol|ethambutol|mesh-list
111235656|NCT02256696|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111235657|NCT02256696|Antitubercular Agents|antitubercular agents|mesh-ancestor
111235658|NCT02256696|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111235659|NCT02256696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111235660|NCT02256696|Leprostatic Agents|leprostatic agents|mesh-ancestor
111235661|NCT02256696|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111235662|NCT02256696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111235663|NCT02256696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111235664|NCT02256696|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111235665|NCT02256696|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111235666|NCT02256696|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
111235667|NCT02256696|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
111235668|NCT02256696|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
111235669|NCT02256696|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111235670|NCT02256696|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
111235671|NCT02256696|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111235672|NCT02256696|Antimetabolites|antimetabolites|mesh-ancestor
111235673|NCT02256696|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111235674|NCT01773473|Insulin|insulin|mesh-list
111235675|NCT01773473|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111235676|NCT01773473|Insulin Lispro|insulin lispro|mesh-list
111235677|NCT01773473|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111235678|NCT01773473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111235679|NCT01779869|Regadenoson|regadenoson|mesh-list
111235680|NCT01779869|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
111235681|NCT01779869|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
111235682|NCT01779869|Purinergic Agonists|purinergic agonists|mesh-ancestor
111235683|NCT01779869|Purinergic Agents|purinergic agents|mesh-ancestor
111235684|NCT01779869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111235685|NCT01779869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111235686|NCT01779869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111235687|NCT01772537|Propofol|propofol|mesh-list
111235688|NCT01772537|Isoflurane|isoflurane|mesh-list
111235689|NCT01772537|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111235690|NCT01772537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111235691|NCT01772537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111235692|NCT01772537|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111235693|NCT01772537|Anesthetics, General|anesthetics, general|mesh-ancestor
111235694|NCT01772537|Anesthetics|anesthetics|mesh-ancestor
111235695|NCT01772537|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111235696|NCT01772147|Fluticasone|fluticasone|mesh-list
111235698|NCT01772147|Bromides|bromides|mesh-list
111235699|NCT01772147|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
111235700|NCT01772147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111235701|NCT01772147|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111235702|NCT01772147|Autonomic Agents|autonomic agents|mesh-ancestor
111235703|NCT01772147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111235704|NCT01772147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111235705|NCT01772147|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111235706|NCT01772147|Respiratory System Agents|respiratory system agents|mesh-ancestor
111235707|NCT01772147|Dermatologic Agents|dermatologic agents|mesh-ancestor
111235708|NCT01772147|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111235709|NCT01772147|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111235710|NCT01772147|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111235711|NCT01772147|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111235712|NCT01772147|Adrenergic Agents|adrenergic agents|mesh-ancestor
111235713|NCT01772147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111235714|NCT01772147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111235715|NCT01772147|Anticonvulsants|anticonvulsants|mesh-ancestor
111235716|NCT01606787|Mannitol|mannitol|mesh-list
111235717|NCT01606787|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
111235718|NCT01606787|Diuretics|diuretics|mesh-ancestor
111235719|NCT01606787|Natriuretic Agents|natriuretic agents|mesh-ancestor
111235720|NCT01606787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111235721|NCT01777997|Tenofovir|tenofovir|mesh-list
111235722|NCT01777997|Emtricitabine|emtricitabine|mesh-list
111235723|NCT01777997|Rilpivirine|rilpivirine|mesh-list
111235724|NCT01777997|Antiviral Agents|antiviral agents|mesh-ancestor
111235725|NCT01777997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111235726|NCT01777997|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111235727|NCT01777997|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111235728|NCT01777997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111235729|NCT01777997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111235730|NCT01777997|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111235731|NCT01777997|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111235732|NCT01770353|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
111235733|NCT01770353|Hematinics|hematinics|mesh-ancestor
111235734|NCT01770353|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
111235735|NCT01770353|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111235736|NCT01777763|Posaconazole|posaconazole|mesh-list
111235737|NCT01777763|Antifungal Agents|antifungal agents|mesh-ancestor
111235738|NCT01777763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111235739|NCT01777763|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
111235740|NCT01777763|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111235741|NCT01777763|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111235742|NCT01777763|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111235743|NCT01777763|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111235744|NCT01777763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111235745|NCT01777763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111235746|NCT01777763|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111235747|NCT01777763|Hormone Antagonists|hormone antagonists|mesh-ancestor
111235748|NCT01777763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111235749|NCT01777763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111235750|NCT01769339|Miconazole|miconazole|mesh-list
111235751|NCT01769339|Hydrocortisone|hydrocortisone|mesh-list
111235752|NCT01769339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111235753|NCT01769339|Antifungal Agents|antifungal agents|mesh-ancestor
111235754|NCT01769339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111235755|NCT01769339|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111235756|NCT01769339|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111235757|NCT01769339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111235758|NCT01769339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111235759|NCT01769339|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111235760|NCT01769339|Hormone Antagonists|hormone antagonists|mesh-ancestor
111235761|NCT01769339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111235762|NCT01769339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111235763|NCT01769339|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111235764|NCT01769339|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111235765|NCT01777139|Ezogabine|ezogabine|mesh-list
111235766|NCT01777139|Anticonvulsants|anticonvulsants|mesh-ancestor
111235767|NCT01777139|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111235768|NCT01777139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110960132|NCT03544827|Cholinergic Agents|cholinergic agents|mesh-ancestor
111235769|NCT01768637|Aspirin|aspirin|mesh-list
111235770|NCT01768637|Clopidogrel|clopidogrel|mesh-list
111235771|NCT01768637|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111235772|NCT01768637|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111235773|NCT01768637|Analgesics|analgesics|mesh-ancestor
111235774|NCT01768637|Sensory System Agents|sensory system agents|mesh-ancestor
111235775|NCT01768637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111235776|NCT01768637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111235777|NCT01768637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111235778|NCT01768637|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111235779|NCT01768637|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111235780|NCT01768637|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111235781|NCT01768637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111235782|NCT01768637|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111235783|NCT01768637|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111235784|NCT01768637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111235785|NCT01768637|Antipyretics|antipyretics|mesh-ancestor
111235786|NCT01768637|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111235787|NCT01768637|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111235788|NCT01768637|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111235789|NCT01768637|Purinergic Agents|purinergic agents|mesh-ancestor
111235790|NCT01768637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111235791|NCT01768559|Insulin|insulin|mesh-list
111235792|NCT01768559|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111235793|NCT01768559|Metformin|metformin|mesh-list
111235794|NCT01768559|Insulin Glargine|insulin glargine|mesh-list
111235795|NCT01768559|Insulin glulisine|insulin glulisine|mesh-list
111235796|NCT01768559|Lixisenatide|lixisenatide|mesh-list
111235797|NCT01768559|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111235798|NCT01768559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111235799|NCT00983619|Rituximab|rituximab|mesh-list
111235800|NCT00983619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111235801|NCT00983619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111235802|NCT00983619|Immunologic Factors|immunologic factors|mesh-ancestor
111235803|NCT00983619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111235804|NCT00983619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111235805|NCT00653068|Calcium, Dietary|calcium, dietary|mesh-list
111235806|NCT00653068|Leucovorin|leucovorin|mesh-list
111235807|NCT00653068|Folic Acid|folic acid|mesh-list
111235808|NCT00653068|Cyclophosphamide|cyclophosphamide|mesh-list
111235809|NCT00653068|Thiotepa|thiotepa|mesh-list
111235810|NCT00653068|Cisplatin|cisplatin|mesh-list
111235811|NCT00653068|Carboplatin|carboplatin|mesh-list
111235812|NCT00653068|Methotrexate|methotrexate|mesh-list
111235813|NCT00653068|Etoposide|etoposide|mesh-list
111235814|NCT00653068|Vincristine|vincristine|mesh-list
111235815|NCT00653068|Etoposide phosphate|etoposide phosphate|mesh-list
111235816|NCT00653068|Podophyllotoxin|podophyllotoxin|mesh-list
111235817|NCT00653068|Lenograstim|lenograstim|mesh-list
111235818|NCT00653068|Calcium|calcium|mesh-list
111235819|NCT00653068|Levoleucovorin|levoleucovorin|mesh-list
111235820|NCT00653068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111235821|NCT00653068|Immunologic Factors|immunologic factors|mesh-ancestor
111235822|NCT00653068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111235823|NCT00653068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111235824|NCT00653068|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111235825|NCT00653068|Alkylating Agents|alkylating agents|mesh-ancestor
111235826|NCT00653068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111235827|NCT00653068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111235828|NCT00653068|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111235829|NCT00653068|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111235830|NCT00653068|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111235831|NCT00653068|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111235832|NCT00653068|Abortifacient Agents|abortifacient agents|mesh-ancestor
111235833|NCT00653068|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111235834|NCT00653068|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111235835|NCT00653068|Antimetabolites|antimetabolites|mesh-ancestor
111235836|NCT00653068|Dermatologic Agents|dermatologic agents|mesh-ancestor
111235837|NCT00653068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111235838|NCT00653068|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111235839|NCT00653068|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111235840|NCT00653068|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111235841|NCT00653068|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111235842|NCT00653068|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111235843|NCT00653068|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111235844|NCT00653068|Antidotes|antidotes|mesh-ancestor
111235845|NCT00653068|Protective Agents|protective agents|mesh-ancestor
111235846|NCT00653068|Vitamin B Complex|vitamin b complex|mesh-ancestor
111235847|NCT00653068|Vitamins|vitamins|mesh-ancestor
111235848|NCT00653068|Micronutrients|micronutrients|mesh-ancestor
111235849|NCT00653068|Tubulin Modulators|tubulin modulators|mesh-ancestor
111235850|NCT00653068|Antimitotic Agents|antimitotic agents|mesh-ancestor
111235851|NCT00653068|Mitosis Modulators|mitosis modulators|mesh-ancestor
111235852|NCT00653068|Hematinics|hematinics|mesh-ancestor
111235853|NCT00653068|Keratolytic Agents|keratolytic agents|mesh-ancestor
111235854|NCT05608785|Capecitabine|capecitabine|mesh-list
111235855|NCT05608785|Oxaliplatin|oxaliplatin|mesh-list
111235856|NCT05608785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111235857|NCT05608785|Antimetabolites|antimetabolites|mesh-ancestor
111235858|NCT05608785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111235859|NCT05608785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111235860|NCT01775501|Leucovorin|leucovorin|mesh-list
111235861|NCT01775501|Fluorouracil|fluorouracil|mesh-list
111235862|NCT01775501|Oxaliplatin|oxaliplatin|mesh-list
111235863|NCT01775501|Sorafenib|sorafenib|mesh-list
111235864|NCT01775501|Antimetabolites|antimetabolites|mesh-ancestor
111235865|NCT01775501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111235866|NCT01775501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111235867|NCT01775501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111235868|NCT01775501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111235869|NCT01775501|Immunologic Factors|immunologic factors|mesh-ancestor
111235870|NCT01775501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111235871|NCT01775501|Antidotes|antidotes|mesh-ancestor
111235872|NCT01775501|Protective Agents|protective agents|mesh-ancestor
111235873|NCT01775501|Vitamin B Complex|vitamin b complex|mesh-ancestor
111235874|NCT01775501|Vitamins|vitamins|mesh-ancestor
111235875|NCT01775501|Micronutrients|micronutrients|mesh-ancestor
111235876|NCT01775501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111235877|NCT01775501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111235878|NCT04346667|Hydroxychloroquine|hydroxychloroquine|mesh-list
111235879|NCT04346667|Chloroquine|chloroquine|mesh-list
111235880|NCT04346667|Antimalarials|antimalarials|mesh-ancestor
111235881|NCT04346667|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111235882|NCT04346667|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111235883|NCT04346667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111235884|NCT04346667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111235885|NCT04346667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111235886|NCT04346667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111235887|NCT04346667|Amebicides|amebicides|mesh-ancestor
111235888|NCT03024489|Cetuximab|cetuximab|mesh-list
111235889|NCT03024489|Palbociclib|palbociclib|mesh-list
111235890|NCT03024489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111235891|NCT03024489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111235892|NCT03024489|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111235893|NCT03024489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111235894|NCT03024489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111235895|NCT01775189|Naltrexone|naltrexone|mesh-list
111235896|NCT01775189|Oxycodone|oxycodone|mesh-list
111235897|NCT01775189|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111235898|NCT01775189|Narcotics|narcotics|mesh-ancestor
111235899|NCT01775189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111235900|NCT01775189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111235901|NCT01775189|Analgesics|analgesics|mesh-ancestor
111235902|NCT01775189|Sensory System Agents|sensory system agents|mesh-ancestor
111235903|NCT01775189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111235904|NCT01775189|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111235905|NCT01775189|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111235906|NCT04551963|Clarithromycin|clarithromycin|mesh-list
111235907|NCT04551963|Fluconazole|fluconazole|mesh-list
111235908|NCT04551963|Voriconazole|voriconazole|mesh-list
111235909|NCT04551963|Zanubrutinib|zanubrutinib|mesh-list
111235910|NCT04551963|Diltiazem|diltiazem|mesh-list
111235911|NCT04551963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111235912|NCT04551963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111235913|NCT04551963|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111235914|NCT04551963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111235915|NCT04551963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111235916|NCT04551963|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111235917|NCT04551963|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111235918|NCT04551963|Antifungal Agents|antifungal agents|mesh-ancestor
111235919|NCT04551963|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111235920|NCT04551963|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111235921|NCT04551963|Hormone Antagonists|hormone antagonists|mesh-ancestor
110672379|NCT00861731|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111235922|NCT04551963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111235923|NCT04551963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111235924|NCT04551963|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111235925|NCT04551963|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111235926|NCT04551963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111235927|NCT04551963|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111235928|NCT04551963|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111235929|NCT04551963|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111235930|NCT04551963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111235931|NCT04551963|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111235932|NCT04551963|Vasodilator Agents|vasodilator agents|mesh-ancestor
111235933|NCT01881412|Fluticasone|fluticasone|mesh-list
111235934|NCT01881412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111235935|NCT01881412|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111235936|NCT01881412|Autonomic Agents|autonomic agents|mesh-ancestor
111235937|NCT01881412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111235938|NCT01881412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111235939|NCT01881412|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111235940|NCT01881412|Respiratory System Agents|respiratory system agents|mesh-ancestor
111235941|NCT01881412|Dermatologic Agents|dermatologic agents|mesh-ancestor
111235942|NCT01881412|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111235943|NCT03832816|Dronabinol|dronabinol|mesh-list
111235944|NCT03832816|Hallucinogens|hallucinogens|mesh-ancestor
111235945|NCT03832816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111235946|NCT03832816|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111235947|NCT03832816|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111235948|NCT03832816|Analgesics|analgesics|mesh-ancestor
111235949|NCT03832816|Sensory System Agents|sensory system agents|mesh-ancestor
111235950|NCT03832816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111235951|NCT03832816|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
111235952|NCT03832816|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
111235953|NCT03832816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111235954|NCT03832816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111235955|NCT03832816|Hormones|hormones|mesh-ancestor
111235956|NCT03832816|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111235957|NCT04231084|Epoprostenol|epoprostenol|mesh-list
111235958|NCT04231084|Nitric Oxide|nitric oxide|mesh-list
111235959|NCT04231084|Vasodilator Agents|vasodilator agents|mesh-list
111235960|NCT04231084|Tezosentan|tezosentan|mesh-list
111235961|NCT04231084|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111235962|NCT04231084|Autonomic Agents|autonomic agents|mesh-ancestor
111235963|NCT04231084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111235964|NCT04231084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110815547|NCT01336322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111235965|NCT04231084|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111235966|NCT04231084|Respiratory System Agents|respiratory system agents|mesh-ancestor
111235967|NCT04231084|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111235968|NCT04231084|Antioxidants|antioxidants|mesh-ancestor
111235969|NCT04231084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111235970|NCT04231084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111235971|NCT04231084|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
111235972|NCT04231084|Gasotransmitters|gasotransmitters|mesh-ancestor
111235973|NCT04231084|Protective Agents|protective agents|mesh-ancestor
111235974|NCT04231084|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111235975|NCT04231084|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111235976|NCT01770743|Vaccines|vaccines|mesh-list
111235977|NCT01770743|Immunologic Factors|immunologic factors|mesh-ancestor
111235978|NCT01770743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111235979|NCT01884844|Vitamin D|vitamin d|mesh-list
111235980|NCT01884844|Cholecalciferol|cholecalciferol|mesh-list
111235981|NCT01884844|Vitamins|vitamins|mesh-ancestor
111235982|NCT01884844|Micronutrients|micronutrients|mesh-ancestor
111235983|NCT01884844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111235984|NCT01884844|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111235985|NCT01884844|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111235986|NCT04123587|Hypoglycemic Agents|hypoglycemic agents|mesh-list
111235987|NCT04123587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111235988|NCT04127721|Methotrexate|methotrexate|mesh-list
111235989|NCT04127721|Fludarabine|fludarabine|mesh-list
111235990|NCT04127721|Busulfan|busulfan|mesh-list
111235991|NCT04127721|Tacrolimus|tacrolimus|mesh-list
111235992|NCT04127721|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111235993|NCT04127721|Abortifacient Agents|abortifacient agents|mesh-ancestor
111235994|NCT04127721|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111235995|NCT04127721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111235996|NCT04127721|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111235997|NCT04127721|Antimetabolites|antimetabolites|mesh-ancestor
111235998|NCT04127721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111235999|NCT04127721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111236000|NCT04127721|Dermatologic Agents|dermatologic agents|mesh-ancestor
111236001|NCT04127721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111236002|NCT04127721|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111236003|NCT04127721|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111236004|NCT04127721|Immunologic Factors|immunologic factors|mesh-ancestor
111236005|NCT04127721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111236006|NCT04127721|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111236007|NCT04127721|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111236008|NCT04127721|Alkylating Agents|alkylating agents|mesh-ancestor
111236009|NCT04127721|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111236010|NCT04127721|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111236011|NCT04123743|Sunscreening Agents|sunscreening agents|mesh-list
111236012|NCT04123743|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111236013|NCT04123743|Protective Agents|protective agents|mesh-ancestor
111236014|NCT04123743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111236015|NCT04123743|Dermatologic Agents|dermatologic agents|mesh-ancestor
111236016|NCT02996721|Vitamin D|vitamin d|mesh-list
111236017|NCT02996721|Cholecalciferol|cholecalciferol|mesh-list
111236018|NCT02996721|Vitamins|vitamins|mesh-ancestor
111236019|NCT02996721|Micronutrients|micronutrients|mesh-ancestor
111236020|NCT02996721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111236021|NCT02996721|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111236022|NCT02996721|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111236023|NCT04122885|Oxaliplatin|oxaliplatin|mesh-list
111236024|NCT04122885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111236025|NCT03926338|Celecoxib|celecoxib|mesh-list
111236026|NCT03926338|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-list
111236027|NCT03926338|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
111236028|NCT03926338|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111236029|NCT03926338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111236030|NCT03926338|Analgesics|analgesics|mesh-ancestor
111236031|NCT03926338|Sensory System Agents|sensory system agents|mesh-ancestor
111236032|NCT03926338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111236033|NCT03926338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111236034|NCT03926338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111236035|NCT03926338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111236036|NCT03926338|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111236037|NCT03926338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111236038|NCT03926338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111236039|NCT03926338|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111236040|NCT03926338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111236041|NCT04126941|Calcium|calcium|mesh-list
111236042|NCT04126941|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111236043|NCT04126941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111236044|NCT02506192|Prednisone|prednisone|mesh-list
111236045|NCT02506192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111236046|NCT02506192|Glucocorticoids|glucocorticoids|mesh-ancestor
111236047|NCT02506192|Hormones|hormones|mesh-ancestor
111236048|NCT02506192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111236049|NCT02506192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111236050|NCT02506192|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111236051|NCT02506192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111236052|NCT04122105|Sildenafil Citrate|sildenafil citrate|mesh-list
111236053|NCT04122105|Vasodilator Agents|vasodilator agents|mesh-ancestor
111236054|NCT04122105|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111236055|NCT04122105|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111236056|NCT04122105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111236057|NCT04122105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111236058|NCT04122105|Urological Agents|urological agents|mesh-ancestor
111236059|NCT04127019|Paclitaxel|paclitaxel|mesh-list
111236060|NCT04127019|Docetaxel|docetaxel|mesh-list
111236061|NCT04127019|Cyclophosphamide|cyclophosphamide|mesh-list
111236062|NCT04127019|Fluorouracil|fluorouracil|mesh-list
111236063|NCT04127019|Epirubicin|epirubicin|mesh-list
111236064|NCT04127019|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111236065|NCT04127019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111236066|NCT04127019|Tubulin Modulators|tubulin modulators|mesh-ancestor
111236067|NCT04127019|Antimitotic Agents|antimitotic agents|mesh-ancestor
111236068|NCT04127019|Mitosis Modulators|mitosis modulators|mesh-ancestor
111236069|NCT04127019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111236070|NCT04127019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111236071|NCT04127019|Immunologic Factors|immunologic factors|mesh-ancestor
111236072|NCT04127019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111236073|NCT04127019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111236074|NCT04127019|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111236076|NCT04127019|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111236077|NCT04127019|Antimetabolites|antimetabolites|mesh-ancestor
111236078|NCT04127019|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111236079|NCT04127019|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111236080|NCT04127019|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111236081|NCT04127019|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111236082|NCT04127019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111236083|NCT02076646|Interleukin-2|interleukin-2|mesh-list
111236084|NCT02076646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111236085|NCT02076646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111236086|NCT02076646|Analgesics|analgesics|mesh-ancestor
111236087|NCT02076646|Sensory System Agents|sensory system agents|mesh-ancestor
111236088|NCT02076646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111236089|NCT02076646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111236090|NCT04121091|Pramipexole|pramipexole|mesh-list
111236091|NCT04121091|Antioxidants|antioxidants|mesh-ancestor
111236092|NCT04121091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111236093|NCT04121091|Protective Agents|protective agents|mesh-ancestor
111236094|NCT04121091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111236095|NCT04121091|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111236096|NCT04121091|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111236097|NCT04121091|Dopamine Agonists|dopamine agonists|mesh-ancestor
111236098|NCT04121091|Dopamine Agents|dopamine agents|mesh-ancestor
111236099|NCT04121091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111236100|NCT03283605|Durvalumab|durvalumab|mesh-list
111236101|NCT03283605|Tremelimumab|tremelimumab|mesh-list
111236102|NCT03283605|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111236103|NCT03283605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111236104|NCT01896544|Cholecalciferol|cholecalciferol|mesh-list
111236105|NCT01896544|Vitamin D|vitamin d|mesh-list
111236106|NCT01896544|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111236107|NCT01896544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111236108|NCT01896544|Vitamins|vitamins|mesh-ancestor
111236109|NCT01896544|Micronutrients|micronutrients|mesh-ancestor
111236110|NCT01896544|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111236111|NCT04120623|Dapagliflozin|dapagliflozin|mesh-list
111236112|NCT04120623|Insulin Aspart|insulin aspart|mesh-list
111236113|NCT04120623|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111236114|NCT04120623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111236115|NCT04120623|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111236116|NCT04120623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111236117|NCT01931878|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
111236118|NCT01931878|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111236119|NCT01931878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111236120|NCT01931878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111236121|NCT01931878|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111236122|NCT01931878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111236123|NCT01931878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111236124|NCT01931878|Cholinergic Agents|cholinergic agents|mesh-ancestor
111236125|NCT01931878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111236126|NCT01932112|Adenosine|adenosine|mesh-list
111236127|NCT01932112|Analgesics|analgesics|mesh-ancestor
111236128|NCT01932112|Sensory System Agents|sensory system agents|mesh-ancestor
111236129|NCT01932112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111236130|NCT01932112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111236131|NCT01932112|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111236132|NCT01932112|Vasodilator Agents|vasodilator agents|mesh-ancestor
111236133|NCT01932112|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
111236134|NCT01932112|Purinergic Agonists|purinergic agonists|mesh-ancestor
111236135|NCT01932112|Purinergic Agents|purinergic agents|mesh-ancestor
111236136|NCT01932112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111236137|NCT01932112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111236138|NCT04120311|Dexamethasone|dexamethasone|mesh-list
111236139|NCT04120311|Dexamethasone acetate|dexamethasone acetate|mesh-list
111236140|NCT04120311|BB 1101|bb 1101|mesh-list
111236141|NCT04120311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111236142|NCT04120311|Antiemetics|antiemetics|mesh-ancestor
111236143|NCT04120311|Autonomic Agents|autonomic agents|mesh-ancestor
111236144|NCT04120311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111236145|NCT04120311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111236146|NCT04120311|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111236147|NCT04120311|Glucocorticoids|glucocorticoids|mesh-ancestor
111236148|NCT04120311|Hormones|hormones|mesh-ancestor
111236149|NCT04120311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111236150|NCT04120311|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111236151|NCT04120311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111236152|NCT04120311|Protease Inhibitors|protease inhibitors|mesh-ancestor
111236153|NCT04120311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111236154|NCT04120311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111236155|NCT01897402|Vaccines|vaccines|mesh-list
111236156|NCT01897402|Immunologic Factors|immunologic factors|mesh-ancestor
111236157|NCT01897402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111236158|NCT01897792|Vitamins|vitamins|mesh-list
111236159|NCT01897792|Ascorbic Acid|ascorbic acid|mesh-list
111236160|NCT01897792|Vitamin E|vitamin e|mesh-list
111236161|NCT01897792|Tocopherols|tocopherols|mesh-list
111236162|NCT01897792|Tocotrienols|tocotrienols|mesh-list
111236163|NCT01897792|alpha-Tocopherol|alpha-tocopherol|mesh-list
111236164|NCT01897792|Micronutrients|micronutrients|mesh-ancestor
111236165|NCT01897792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111236166|NCT01897792|Antioxidants|antioxidants|mesh-ancestor
111236167|NCT01897792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111236168|NCT01897792|Protective Agents|protective agents|mesh-ancestor
111236169|NCT01933984|Fluticasone|fluticasone|mesh-list
111236170|NCT01933984|Fenoterol|fenoterol|mesh-list
111236171|NCT01933984|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
111236172|NCT01933984|Bronchodilator Agents|bronchodilator agents|mesh-list
111236173|NCT01933984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111236174|NCT01933984|Autonomic Agents|autonomic agents|mesh-ancestor
111236175|NCT01933984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111236176|NCT01933984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111236177|NCT01933984|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111236178|NCT01933984|Respiratory System Agents|respiratory system agents|mesh-ancestor
111236179|NCT01933984|Dermatologic Agents|dermatologic agents|mesh-ancestor
111236180|NCT01933984|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111236181|NCT01933984|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111236182|NCT01933984|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111236183|NCT01933984|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111236184|NCT01933984|Adrenergic Agents|adrenergic agents|mesh-ancestor
111236185|NCT01933984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111236186|NCT01933984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111236187|NCT01933984|Sympathomimetics|sympathomimetics|mesh-ancestor
111236188|NCT01933984|Tocolytic Agents|tocolytic agents|mesh-ancestor
111236189|NCT01933984|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111236190|NCT04126083|Lofexidine|lofexidine|mesh-list
111236191|NCT04126083|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111236192|NCT04126083|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111236193|NCT04126083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111236194|NCT04126083|Sensory System Agents|sensory system agents|mesh-ancestor
111236195|NCT04126083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111236196|NCT04126083|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111236197|NCT04126083|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111236198|NCT04126083|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111236199|NCT04126083|Adrenergic Agents|adrenergic agents|mesh-ancestor
111236200|NCT04126083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111236201|NCT04126083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111236202|NCT01935622|Doxycycline|doxycycline|mesh-list
111236203|NCT01935622|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111236204|NCT01935622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111236205|NCT01935622|Antimalarials|antimalarials|mesh-ancestor
111236206|NCT01935622|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111236207|NCT01935622|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111236208|NCT03010917|Ethanol|ethanol|mesh-list
111236209|NCT03010917|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111236210|NCT03010917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111236211|NCT03010917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111236212|NCT03010917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111236213|NCT02979561|Warfarin|warfarin|mesh-list
111236214|NCT02979561|Dabigatran|dabigatran|mesh-list
111236215|NCT02979561|Anticoagulants|anticoagulants|mesh-ancestor
111236216|NCT02979561|Antithrombins|antithrombins|mesh-ancestor
111236217|NCT02979561|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111236218|NCT02979561|Protease Inhibitors|protease inhibitors|mesh-ancestor
111236219|NCT02979561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111236220|NCT02979561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111236221|NCT01937026|Probenecid|probenecid|mesh-list
111236222|NCT01937026|Uricosuric Agents|uricosuric agents|mesh-ancestor
111236223|NCT01937026|Gout Suppressants|gout suppressants|mesh-ancestor
111236224|NCT01937026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110960579|NCT02152917|Hemostatics|hemostatics|mesh-ancestor
111236226|NCT01937260|Dermatologic Agents|dermatologic agents|mesh-ancestor
111236227|NCT01902004|Memantine|memantine|mesh-list
111236228|NCT01902004|Escitalopram|escitalopram|mesh-list
111236229|NCT01902004|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111236230|NCT01902004|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111236231|NCT01902004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111236232|NCT01902004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111236233|NCT01902004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111236234|NCT01902004|Serotonin Agents|serotonin agents|mesh-ancestor
111236235|NCT01902004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111236236|NCT01902004|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111236237|NCT01902004|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111236238|NCT01902004|Dopamine Agents|dopamine agents|mesh-ancestor
111236239|NCT01902004|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111236240|NCT01902004|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111236241|NCT01938040|Ibuprofen|ibuprofen|mesh-list
111236242|NCT01938040|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111236243|NCT01938040|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111236244|NCT01938040|Analgesics|analgesics|mesh-ancestor
111236245|NCT01938040|Sensory System Agents|sensory system agents|mesh-ancestor
111236246|NCT01938040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111236247|NCT01938040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111236248|NCT01938040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111236249|NCT01938040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111236250|NCT01938040|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111236251|NCT01938040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111236252|NCT01938040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111236253|NCT03829839|Lorazepam|lorazepam|mesh-list
111236254|NCT03829839|Oxytocin|oxytocin|mesh-list
111236255|NCT03829839|Oxytocics|oxytocics|mesh-ancestor
111236256|NCT03829839|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111236257|NCT03829839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111236258|NCT03829839|Anticonvulsants|anticonvulsants|mesh-ancestor
111236259|NCT03829839|Antiemetics|antiemetics|mesh-ancestor
111236260|NCT03829839|Autonomic Agents|autonomic agents|mesh-ancestor
111236261|NCT03829839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111236262|NCT03829839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111236263|NCT03829839|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111236264|NCT03829839|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111236265|NCT03829839|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111236266|NCT03829839|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111236267|NCT03829839|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111236268|NCT03829839|GABA Modulators|gaba modulators|mesh-ancestor
111236269|NCT03829839|GABA Agents|gaba agents|mesh-ancestor
111236270|NCT03829839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111236271|NCT03829839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111236272|NCT01938664|Candesartan|candesartan|mesh-list
111236273|NCT01938664|Candesartan cilexetil|candesartan cilexetil|mesh-list
111236274|NCT01938664|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111236275|NCT01938664|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111236276|NCT01938664|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111236277|NCT01938664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111236278|NCT03829917|Paromomycin|paromomycin|mesh-list
111236279|NCT03829917|Miltefosine|miltefosine|mesh-list
111236280|NCT03829917|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111236281|NCT03829917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111236282|NCT03829917|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111236283|NCT03829917|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111236284|NCT03829917|Antifungal Agents|antifungal agents|mesh-ancestor
111236285|NCT03829917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111236286|NCT02284126|Vancomycin|vancomycin|mesh-list
111236287|NCT02284126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111236288|NCT02284126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111236289|NCT01736579|Immunoglobulins|immunoglobulins|mesh-list
111236290|NCT01736579|Antibodies|antibodies|mesh-list
111236291|NCT01736579|gamma-Globulins|gamma-globulins|mesh-list
111236292|NCT01736579|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111236293|NCT01736579|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
111236294|NCT01736579|Immunologic Factors|immunologic factors|mesh-ancestor
111236295|NCT01736579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111236296|NCT04124913|Progesterone|progesterone|mesh-list
111236297|NCT04124913|Dydrogesterone|dydrogesterone|mesh-list
111236298|NCT04124913|Progestins|progestins|mesh-ancestor
111236299|NCT04124913|Hormones|hormones|mesh-ancestor
111236300|NCT04124913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111236301|NCT04124913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111236302|NCT03828279|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
111236303|NCT03828279|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
111236304|NCT03828279|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111236305|NCT03828279|Immunologic Factors|immunologic factors|mesh-ancestor
111236306|NCT03828279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111236307|NCT02987920|Acetaminophen|acetaminophen|mesh-list
111236308|NCT02987920|Celecoxib|celecoxib|mesh-list
111236309|NCT02987920|Ketorolac|ketorolac|mesh-list
111236310|NCT02987920|Oxycodone|oxycodone|mesh-list
111236311|NCT02987920|Gabapentin|gabapentin|mesh-list
111236312|NCT02987920|Hydromorphone|hydromorphone|mesh-list
111236313|NCT02987920|Dextromethorphan|dextromethorphan|mesh-list
111236314|NCT02987920|Pantoprazole|pantoprazole|mesh-list
111236315|NCT02987920|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111236316|NCT02987920|Analgesics|analgesics|mesh-ancestor
111236317|NCT02987920|Sensory System Agents|sensory system agents|mesh-ancestor
111236318|NCT02987920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111236319|NCT02987920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111236320|NCT02987920|Antipyretics|antipyretics|mesh-ancestor
111236321|NCT02987920|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111236322|NCT02987920|Narcotics|narcotics|mesh-ancestor
111236323|NCT02987920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111236324|NCT02987920|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111236325|NCT02987920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111236326|NCT02987920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111236327|NCT02987920|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111236328|NCT02987920|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111236329|NCT02987920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111236330|NCT02987920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111236331|NCT02987920|Anticonvulsants|anticonvulsants|mesh-ancestor
111236332|NCT02987920|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111236333|NCT02987920|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111236334|NCT02987920|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111236335|NCT02987920|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111236336|NCT02987920|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111236337|NCT02987920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111236338|NCT02987920|Antimanic Agents|antimanic agents|mesh-ancestor
111236339|NCT02987920|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111236340|NCT02987920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111236341|NCT02987920|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111236342|NCT02987920|Antitussive Agents|antitussive agents|mesh-ancestor
111236343|NCT02987920|Respiratory System Agents|respiratory system agents|mesh-ancestor
111236344|NCT02974257|Thiamine|thiamine|mesh-list
111236345|NCT02974257|Vitamins|vitamins|mesh-ancestor
111236346|NCT02974257|Micronutrients|micronutrients|mesh-ancestor
111236347|NCT02974257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111236348|NCT02974257|Vitamin B Complex|vitamin b complex|mesh-ancestor
111236349|NCT01736189|Adalimumab|adalimumab|mesh-list
111236350|NCT01736189|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111236351|NCT01736189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111236352|NCT01736189|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111236353|NCT02970981|Nivolumab|nivolumab|mesh-list
111236354|NCT02970981|Ipilimumab|ipilimumab|mesh-list
111236355|NCT02970981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111236356|NCT02970981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111236357|NCT02970981|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111236358|NCT02970981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111236359|NCT02983773|Dronabinol|dronabinol|mesh-list
111236360|NCT02983773|Hallucinogens|hallucinogens|mesh-ancestor
111236361|NCT02983773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111236362|NCT02983773|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111236363|NCT02983773|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111236364|NCT02983773|Analgesics|analgesics|mesh-ancestor
111236365|NCT02983773|Sensory System Agents|sensory system agents|mesh-ancestor
111236366|NCT02983773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111236367|NCT02983773|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
111236368|NCT02983773|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
111236369|NCT02983773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111236370|NCT02983773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111236371|NCT02983773|Hormones|hormones|mesh-ancestor
111236372|NCT02983773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111236373|NCT01941628|Rocuronium|rocuronium|mesh-list
111236374|NCT01941628|Succinylcholine|succinylcholine|mesh-list
111236375|NCT01941628|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
111236376|NCT01941628|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
111236377|NCT01941628|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111236378|NCT01941628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111236379|NCT01941628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111236380|NCT01941628|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
111236381|NCT02987218|Propofol|propofol|mesh-list
111236382|NCT02987218|Desflurane|desflurane|mesh-list
111236383|NCT02987218|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111236384|NCT02987218|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111236385|NCT02987218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111236386|NCT02987218|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111236387|NCT02987218|Anesthetics, General|anesthetics, general|mesh-ancestor
111236388|NCT02987218|Anesthetics|anesthetics|mesh-ancestor
111236389|NCT02987218|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111236390|NCT01762943|Leuprolide|leuprolide|mesh-list
111236391|NCT01762943|Estradiol|estradiol|mesh-list
111236392|NCT01762943|Progesterone|progesterone|mesh-list
111236393|NCT01762943|Estrogens|estrogens|mesh-ancestor
111236394|NCT01762943|Hormones|hormones|mesh-ancestor
111236395|NCT01762943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111236396|NCT01762943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111236397|NCT01762943|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111236398|NCT01762943|Progestins|progestins|mesh-ancestor
111236399|NCT01762943|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111236400|NCT01762943|Fertility Agents|fertility agents|mesh-ancestor
111236401|NCT01762943|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111236402|NCT01762943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111236403|NCT04392063|Melatonin|melatonin|mesh-list
111236404|NCT04392063|Antioxidants|antioxidants|mesh-ancestor
111236405|NCT04392063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111236406|NCT04392063|Protective Agents|protective agents|mesh-ancestor
111236407|NCT04392063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111236408|NCT04392063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111236409|NCT01903798|Mycophenolic Acid|mycophenolic acid|mesh-list
111236410|NCT01903798|Prednisolone|prednisolone|mesh-list
111236411|NCT01903798|Rilonacept|rilonacept|mesh-list
111236412|NCT01903798|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111236413|NCT01903798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111236414|NCT01903798|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111236415|NCT01903798|Antitubercular Agents|antitubercular agents|mesh-ancestor
111236416|NCT01903798|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111236417|NCT01903798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111236418|NCT01903798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111236419|NCT01903798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111236420|NCT01903798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111236421|NCT01903798|Glucocorticoids|glucocorticoids|mesh-ancestor
111236422|NCT01903798|Hormones|hormones|mesh-ancestor
111236423|NCT01903798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111236424|NCT01903798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111236425|NCT01903798|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111236426|NCT01945138|Insulin|insulin|mesh-list
111236427|NCT01945138|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111236428|NCT01945138|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111236429|NCT01945138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111236430|NCT01734785|Empagliflozin|empagliflozin|mesh-list
111236431|NCT01734785|Linagliptin|linagliptin|mesh-list
111236432|NCT01734785|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111236433|NCT01734785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111236434|NCT01734785|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111236435|NCT01734785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111236436|NCT01734785|Incretins|incretins|mesh-ancestor
111236437|NCT01734785|Hormones|hormones|mesh-ancestor
111236438|NCT01734785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111236439|NCT01734785|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111236440|NCT01734785|Protease Inhibitors|protease inhibitors|mesh-ancestor
111236441|NCT01734785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111236442|NCT03821415|Estradiol|estradiol|mesh-list
111236443|NCT03821415|Estrogens|estrogens|mesh-ancestor
111236444|NCT03821415|Hormones|hormones|mesh-ancestor
111236445|NCT03821415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111236446|NCT03821415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111236447|NCT01734395|Galantamine|galantamine|mesh-list
111236448|NCT01734395|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111236449|NCT01734395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111236450|NCT01734395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111236451|NCT01734395|Cholinergic Agents|cholinergic agents|mesh-ancestor
110960806|NCT03374228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111236452|NCT01734395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111236453|NCT01734395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111236455|NCT01734395|Autonomic Agents|autonomic agents|mesh-ancestor
111236456|NCT01734395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111236457|NCT01734395|Nootropic Agents|nootropic agents|mesh-ancestor
111236458|NCT01945294|Interferons|interferons|mesh-list
111236459|NCT01945294|Ribavirin|ribavirin|mesh-list
111236460|NCT01945294|Interferon-alpha|interferon-alpha|mesh-list
111236461|NCT01945294|Interferon alpha-2|interferon alpha-2|mesh-list
111236462|NCT01945294|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
111236463|NCT01945294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111236464|NCT01945294|Antiviral Agents|antiviral agents|mesh-ancestor
111236465|NCT01945294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111236466|NCT01945294|Antimetabolites|antimetabolites|mesh-ancestor
111236467|NCT01945294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111236468|NCT01945294|Immunologic Factors|immunologic factors|mesh-ancestor
111236469|NCT01945294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111236470|NCT04392297|Antibodies|antibodies|mesh-list
111236471|NCT04392297|Immunoglobulin G|immunoglobulin g|mesh-list
111236472|NCT04392297|Immunologic Factors|immunologic factors|mesh-ancestor
111236473|NCT04392297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111236474|NCT01947946|Benralizumab|benralizumab|mesh-list
111236475|NCT01947946|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111236476|NCT01947946|Respiratory System Agents|respiratory system agents|mesh-ancestor
111236477|NCT02954055|Paclitaxel|paclitaxel|mesh-list
111236478|NCT02954055|Vinorelbine|vinorelbine|mesh-list
111236479|NCT02954055|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111236480|NCT02954055|Cyclophosphamide|cyclophosphamide|mesh-list
111236481|NCT02954055|Capecitabine|capecitabine|mesh-list
111236482|NCT02954055|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111236483|NCT02954055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111236484|NCT02954055|Tubulin Modulators|tubulin modulators|mesh-ancestor
111236485|NCT02954055|Antimitotic Agents|antimitotic agents|mesh-ancestor
111236486|NCT02954055|Mitosis Modulators|mitosis modulators|mesh-ancestor
111236487|NCT02954055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111236488|NCT02954055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111236489|NCT02954055|Immunologic Factors|immunologic factors|mesh-ancestor
111236490|NCT02954055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111236491|NCT02954055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111236492|NCT02954055|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111236493|NCT02954055|Alkylating Agents|alkylating agents|mesh-ancestor
111236494|NCT02954055|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111236495|NCT02954055|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111236496|NCT02954055|Antimetabolites|antimetabolites|mesh-ancestor
111236497|NCT03313180|Nintedanib|nintedanib|mesh-list
111236498|NCT03313180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111236499|NCT03313180|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111236500|NCT03313180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111236501|NCT03313180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111236502|NCT03820245|Lycopene|lycopene|mesh-list
111236503|NCT03820245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111236504|NCT03820245|Antioxidants|antioxidants|mesh-ancestor
111236505|NCT03820245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111236506|NCT03820245|Protective Agents|protective agents|mesh-ancestor
111236507|NCT03820245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111236508|NCT03820245|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111236509|NCT03820245|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
111236510|NCT03820245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111236511|NCT01597505|Vancomycin|vancomycin|mesh-list
111236512|NCT01597505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111236513|NCT01597505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111236514|NCT03826485|Pranlukast|pranlukast|mesh-list
111236515|NCT03826485|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111236516|NCT03826485|Respiratory System Agents|respiratory system agents|mesh-ancestor
111236517|NCT03826485|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
111236518|NCT03826485|Hormone Antagonists|hormone antagonists|mesh-ancestor
111236519|NCT03826485|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111236520|NCT03826485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111236521|NCT03823989|Mitomycins|mitomycins|mesh-list
111236522|NCT03823989|Mitomycin|mitomycin|mesh-list
111236523|NCT03823989|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111236524|NCT03823989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110960881|NCT05467462|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111236525|NCT03823989|Alkylating Agents|alkylating agents|mesh-ancestor
111236526|NCT03823989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111236527|NCT03823989|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111236528|NCT03823989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111236530|NCT03826875|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111236531|NCT03826875|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111236532|NCT03826875|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111236533|NCT03826875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111236534|NCT03826875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111236535|NCT03826875|Serotonin Agents|serotonin agents|mesh-ancestor
111236536|NCT03826875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111236537|NCT03826875|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111236538|NCT03826875|Antidepressive Agents|antidepressive agents|mesh-ancestor
111236539|NCT03826875|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111236540|NCT03826875|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111236541|NCT03826875|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111236542|NCT03826875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111236543|NCT01951066|Dexamethasone|dexamethasone|mesh-list
111236544|NCT01951066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111236545|NCT01951066|Antiemetics|antiemetics|mesh-ancestor
111236546|NCT01951066|Autonomic Agents|autonomic agents|mesh-ancestor
111236547|NCT01951066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111236548|NCT01951066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111236549|NCT01951066|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111236550|NCT01951066|Glucocorticoids|glucocorticoids|mesh-ancestor
111236551|NCT01951066|Hormones|hormones|mesh-ancestor
111236552|NCT01951066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111236553|NCT01951066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111236554|NCT01951066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111236555|NCT05735626|Capsaicin|capsaicin|mesh-list
111236556|NCT05735626|Piperine|piperine|mesh-list
111236557|NCT05735626|Antipruritics|antipruritics|mesh-ancestor
111236558|NCT05735626|Dermatologic Agents|dermatologic agents|mesh-ancestor
111236559|NCT05735626|Sensory System Agents|sensory system agents|mesh-ancestor
111236560|NCT05735626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111236561|NCT05735626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111236562|NCT05735626|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111236563|NCT05735626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111236564|NCT05735626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111236565|NCT01951768|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111236566|NCT01951768|Gentamicins|gentamicins|mesh-list
111236567|NCT01951768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111236568|NCT01951768|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111236569|NCT01951768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111236570|NCT01951768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111236571|NCT05735470|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111236572|NCT05735470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111236573|NCT03825861|Folfirinox|folfirinox|mesh-list
111236574|NCT03825861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111236575|NCT01760447|Metformin|metformin|mesh-list
111236576|NCT01760447|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111236577|NCT01760447|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111236578|NCT01760447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111236579|NCT01760447|Incretins|incretins|mesh-ancestor
111236580|NCT01760447|Hormones|hormones|mesh-ancestor
111236581|NCT01760447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111236582|NCT01760447|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111236583|NCT01760447|Protease Inhibitors|protease inhibitors|mesh-ancestor
111236584|NCT01760447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111236585|NCT01760447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111236586|NCT01915108|Remifentanil|remifentanil|mesh-list
111236587|NCT01915108|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111236588|NCT01915108|Narcotics|narcotics|mesh-ancestor
111236589|NCT01915108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111236590|NCT01915108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111236591|NCT01915108|Analgesics|analgesics|mesh-ancestor
111236592|NCT01915108|Sensory System Agents|sensory system agents|mesh-ancestor
111236593|NCT01915108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111236594|NCT03825471|Analgesics, Opioid|analgesics, opioid|mesh-list
111236595|NCT03825471|Anesthetics|anesthetics|mesh-list
111236596|NCT03825471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111236597|NCT03825471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111236598|NCT03825471|Narcotics|narcotics|mesh-ancestor
111236599|NCT03825471|Analgesics|analgesics|mesh-ancestor
110960969|NCT03377348|Hormones|hormones|mesh-ancestor
111236600|NCT03825471|Sensory System Agents|sensory system agents|mesh-ancestor
111236601|NCT03825471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111236602|NCT01917136|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
111236603|NCT01917136|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111236604|NCT01917136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111236605|NCT01450215|Lenalidomide|lenalidomide|mesh-list
111236606|NCT01450215|Immunologic Factors|immunologic factors|mesh-ancestor
111236607|NCT01450215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111236608|NCT01450215|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111236609|NCT01450215|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111236610|NCT01450215|Growth Substances|growth substances|mesh-ancestor
111236611|NCT01450215|Growth Inhibitors|growth inhibitors|mesh-ancestor
111236612|NCT01450215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111236613|NCT02915523|Avelumab|avelumab|mesh-list
111236614|NCT02915523|Entinostat|entinostat|mesh-list
111236615|NCT02915523|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111236616|NCT02915523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111236617|NCT02915523|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111236618|NCT02915523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111236619|NCT02915523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111236620|NCT01917214|Sunitinib|sunitinib|mesh-list
111236621|NCT01917214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111236622|NCT01917214|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111236623|NCT01917214|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111236624|NCT01917214|Growth Substances|growth substances|mesh-ancestor
111236625|NCT01917214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111236626|NCT01917214|Growth Inhibitors|growth inhibitors|mesh-ancestor
111236627|NCT01917214|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111236628|NCT01917214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111236629|NCT01917214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111236630|NCT01955434|Cyclophosphamide|cyclophosphamide|mesh-list
111236631|NCT01955434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111236632|NCT01955434|Immunologic Factors|immunologic factors|mesh-ancestor
111236633|NCT01955434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111236634|NCT01955434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111236635|NCT01955434|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111236636|NCT01955434|Alkylating Agents|alkylating agents|mesh-ancestor
111236637|NCT01955434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111236638|NCT01955434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111236639|NCT01955434|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111236640|NCT01732913|Rituximab|rituximab|mesh-list
111236641|NCT01732913|Idelalisib|idelalisib|mesh-list
111236642|NCT01732913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111236643|NCT01732913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111236644|NCT01732913|Immunologic Factors|immunologic factors|mesh-ancestor
111236645|NCT01732913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111236646|NCT01732913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111236647|NCT01732913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111236648|NCT01732913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111236649|NCT03824925|Zinc|zinc|mesh-list
111236650|NCT03824925|Zinc Sulfate|zinc sulfate|mesh-list
111236651|NCT03824925|Trace Elements|trace elements|mesh-ancestor
111236652|NCT03824925|Micronutrients|micronutrients|mesh-ancestor
111236653|NCT03824925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111236654|NCT03824925|Astringents|astringents|mesh-ancestor
111236655|NCT03824925|Dermatologic Agents|dermatologic agents|mesh-ancestor
111236656|NCT03825081|Brimonidine Tartrate|brimonidine tartrate|mesh-list
111236657|NCT03825081|Pilocarpine|pilocarpine|mesh-list
111236658|NCT03825081|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111236659|NCT03825081|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111236660|NCT03825081|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111236661|NCT03825081|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111236662|NCT03825081|Adrenergic Agents|adrenergic agents|mesh-ancestor
111236663|NCT03825081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111236664|NCT03825081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111236665|NCT03825081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111236666|NCT03825081|Miotics|miotics|mesh-ancestor
111236667|NCT03825081|Autonomic Agents|autonomic agents|mesh-ancestor
111236668|NCT03825081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111236669|NCT03825081|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
111236670|NCT03825081|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111236671|NCT03825081|Cholinergic Agents|cholinergic agents|mesh-ancestor
111236672|NCT01920802|Olanzapine|olanzapine|mesh-list
111236673|NCT01920802|Iloperidone|iloperidone|mesh-list
111236674|NCT01920802|Antiemetics|antiemetics|mesh-ancestor
110961034|NCT02519816|Plasma-lyte 148|plasma-lyte 148|mesh-list
111236675|NCT01920802|Autonomic Agents|autonomic agents|mesh-ancestor
111236676|NCT01920802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111236677|NCT01920802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111236678|NCT01920802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111236679|NCT01920802|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111236680|NCT01920802|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111236681|NCT01920802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111236682|NCT01920802|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111236683|NCT01920802|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111236684|NCT01920802|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111236685|NCT01920802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111236686|NCT01920802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111236687|NCT01920802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111236688|NCT01920802|Serotonin Agents|serotonin agents|mesh-ancestor
111236689|NCT01451229|Higenamine|higenamine|mesh-list
111236690|NCT01451229|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111236691|NCT01451229|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111236692|NCT01451229|Adrenergic Agents|adrenergic agents|mesh-ancestor
111236693|NCT01451229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111236694|NCT01451229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111236695|NCT01451229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111236696|NCT01451229|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111236697|NCT01451229|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111236698|NCT01451229|Analgesics|analgesics|mesh-ancestor
111236699|NCT01451229|Sensory System Agents|sensory system agents|mesh-ancestor
111236700|NCT01451229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111236701|NCT01451229|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111236702|NCT01451229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111236703|NCT01451229|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111236704|NCT01451229|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111236705|NCT01451229|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111236706|NCT01451229|Protective Agents|protective agents|mesh-ancestor
111236707|NCT03054519|Metformin|metformin|mesh-list
111236708|NCT03054519|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111236709|NCT03054519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111236710|NCT01921894|Vitamin D|vitamin d|mesh-list
111236711|NCT01921894|Cholecalciferol|cholecalciferol|mesh-list
111236712|NCT01921894|Vitamins|vitamins|mesh-ancestor
111236713|NCT01921894|Micronutrients|micronutrients|mesh-ancestor
111236714|NCT01921894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111236715|NCT01921894|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111236716|NCT01921894|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111236717|NCT01452009|Travoprost|travoprost|mesh-list
111236718|NCT01452009|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111236719|NCT01452009|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111236720|NCT01452009|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111236721|NCT03824379|Hypoglycemic Agents|hypoglycemic agents|mesh-list
111236722|NCT03824379|Magnesium citrate|magnesium citrate|mesh-list
111236723|NCT03824379|Cathartics|cathartics|mesh-ancestor
111236724|NCT03824379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111236725|NCT03824379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111236726|NCT01957930|Insulin|insulin|mesh-list
111236727|NCT01957930|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111236728|NCT01957930|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111236729|NCT01957930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111236730|NCT01732757|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
111236731|NCT01732757|Dextrans|dextrans|mesh-list
111236732|NCT01732757|Alcaftadine|alcaftadine|mesh-list
111236733|NCT01732757|Anticoagulants|anticoagulants|mesh-ancestor
111236734|NCT01732757|Plasma Substitutes|plasma substitutes|mesh-ancestor
111236735|NCT01732757|Blood Substitutes|blood substitutes|mesh-ancestor
111236736|NCT01732757|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111236737|NCT01732757|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111236738|NCT01732757|Analgesics|analgesics|mesh-ancestor
111236739|NCT01732757|Sensory System Agents|sensory system agents|mesh-ancestor
111236740|NCT01732757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111236741|NCT01732757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111236742|NCT01732757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111236743|NCT01732757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111236744|NCT01732757|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111236745|NCT01732757|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
111236746|NCT01732757|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111236747|NCT01732757|Histamine Antagonists|histamine antagonists|mesh-ancestor
110961109|NCT02292966|Asunaprevir|asunaprevir|mesh-list
111236748|NCT01732757|Histamine Agents|histamine agents|mesh-ancestor
111236749|NCT01732757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111236750|NCT01732757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111236751|NCT01758731|Cetuximab|cetuximab|mesh-list
111236752|NCT01758731|Olaparib|olaparib|mesh-list
111236753|NCT01758731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111236754|NCT01758731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111236755|NCT01758731|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111236756|NCT01758731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111236757|NCT01758731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111236758|NCT01452477|Tanshinone|tanshinone|mesh-list
111236759|NCT01452477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111236760|NCT01452477|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111236761|NCT01452477|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111236762|NCT01452477|Analgesics|analgesics|mesh-ancestor
111236763|NCT01452477|Sensory System Agents|sensory system agents|mesh-ancestor
111236764|NCT01452477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111236765|NCT01452477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111236766|NCT01452477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111236767|NCT01452477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111236768|NCT01452477|Anticoagulants|anticoagulants|mesh-ancestor
111236769|NCT01452477|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111236770|NCT01452477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111236771|NCT01452477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111236772|NCT01452477|Immunologic Factors|immunologic factors|mesh-ancestor
111236773|NCT01452633|Bupivacaine|bupivacaine|mesh-list
111236774|NCT01452633|Anesthetics, Local|anesthetics, local|mesh-ancestor
111236775|NCT01452633|Anesthetics|anesthetics|mesh-ancestor
111236776|NCT01452633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111236777|NCT01452633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111236778|NCT01452633|Sensory System Agents|sensory system agents|mesh-ancestor
111236779|NCT01452633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111236780|NCT01606319|Acetaminophen|acetaminophen|mesh-list
111236781|NCT01606319|Ibuprofen|ibuprofen|mesh-list
111236782|NCT01606319|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
111236783|NCT01606319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
111236784|NCT01606319|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111236785|NCT01606319|Analgesics|analgesics|mesh-ancestor
111236786|NCT01606319|Sensory System Agents|sensory system agents|mesh-ancestor
111236787|NCT01606319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111236788|NCT01606319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111236789|NCT01606319|Antipyretics|antipyretics|mesh-ancestor
111236790|NCT01606319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111236791|NCT01606319|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111236792|NCT01606319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111236793|NCT01606319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111236794|NCT01452711|Lansoprazole|lansoprazole|mesh-list
111236795|NCT01452711|Dexlansoprazole|dexlansoprazole|mesh-list
111236796|NCT01452711|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111236797|NCT01452711|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111236798|NCT01452711|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111236799|NCT01452711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111236800|NCT01452711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111236801|NCT02630121|Phenylephrine|phenylephrine|mesh-list
111236802|NCT02630121|Oxymetazoline|oxymetazoline|mesh-list
111236803|NCT02630121|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111236804|NCT02630121|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111236805|NCT02630121|Adrenergic Agents|adrenergic agents|mesh-ancestor
111236806|NCT02630121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111236807|NCT02630121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111236808|NCT02630121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111236809|NCT02630121|Sympathomimetics|sympathomimetics|mesh-ancestor
111236810|NCT02630121|Autonomic Agents|autonomic agents|mesh-ancestor
111236811|NCT02630121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111236812|NCT02630121|Nasal Decongestants|nasal decongestants|mesh-ancestor
111236813|NCT02630121|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111236814|NCT02630121|Respiratory System Agents|respiratory system agents|mesh-ancestor
111236815|NCT02630121|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111236816|NCT02630121|Mydriatics|mydriatics|mesh-ancestor
111236817|NCT02630121|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111236818|NCT02630121|Protective Agents|protective agents|mesh-ancestor
111236819|NCT02956785|Dinoprostone|dinoprostone|mesh-list
111236820|NCT02956785|Oxytocics|oxytocics|mesh-ancestor
111236821|NCT02956785|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111236822|NCT02956785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111236823|NCT01452867|Chlorhexidine|chlorhexidine|mesh-list
111236824|NCT01452867|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111236825|NCT01452867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111236826|NCT01452867|Disinfectants|disinfectants|mesh-ancestor
111236827|NCT02910531|Thioctic Acid|thioctic acid|mesh-list
111236828|NCT02910531|Antioxidants|antioxidants|mesh-ancestor
111236829|NCT02910531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111236830|NCT02910531|Protective Agents|protective agents|mesh-ancestor
111236831|NCT02910531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111236832|NCT02910531|Vitamin B Complex|vitamin b complex|mesh-ancestor
111236833|NCT02910531|Vitamins|vitamins|mesh-ancestor
111236834|NCT02910531|Micronutrients|micronutrients|mesh-ancestor
111236835|NCT02947581|Albendazole|albendazole|mesh-list
111236836|NCT02947581|Praziquantel|praziquantel|mesh-list
111236837|NCT02947581|Anthelmintics|anthelmintics|mesh-ancestor
111236838|NCT02947581|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111236839|NCT02947581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111236840|NCT02947581|Anticestodal Agents|anticestodal agents|mesh-ancestor
111236841|NCT02947581|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
111236842|NCT02947581|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111236843|NCT02947581|Tubulin Modulators|tubulin modulators|mesh-ancestor
111236844|NCT02947581|Antimitotic Agents|antimitotic agents|mesh-ancestor
111236845|NCT02947581|Mitosis Modulators|mitosis modulators|mesh-ancestor
111236846|NCT02947581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111236847|NCT02947581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111236848|NCT05606757|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111236849|NCT05606757|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111236850|NCT05606757|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111236851|NCT05606757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111236852|NCT05606757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111236853|NCT05606757|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111236854|NCT05606757|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111236855|NCT05606757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111236856|NCT05606757|Cholinergic Agents|cholinergic agents|mesh-ancestor
111236857|NCT05606757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111236858|NCT01453881|Beclomethasone|beclomethasone|mesh-list
111236859|NCT01453881|Formoterol Fumarate|formoterol fumarate|mesh-list
111236860|NCT01453881|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111236861|NCT01453881|Autonomic Agents|autonomic agents|mesh-ancestor
111236862|NCT01453881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111236863|NCT01453881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111236864|NCT01453881|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111236865|NCT01453881|Respiratory System Agents|respiratory system agents|mesh-ancestor
111236866|NCT01453881|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111236867|NCT01453881|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111236868|NCT01453881|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111236869|NCT01453881|Adrenergic Agents|adrenergic agents|mesh-ancestor
111236870|NCT01453881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111236871|NCT01453881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111236872|NCT01453881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111236873|NCT01453881|Glucocorticoids|glucocorticoids|mesh-ancestor
111236874|NCT01453881|Hormones|hormones|mesh-ancestor
111236875|NCT01453881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111236876|NCT04391361|Atropine|atropine|mesh-list
111236877|NCT04391361|Scopolamine|scopolamine|mesh-list
111236878|NCT04391361|Dexmedetomidine|dexmedetomidine|mesh-list
111236879|NCT04391361|Edaravone|edaravone|mesh-list
111236880|NCT04391361|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
111236881|NCT04391361|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111236882|NCT04391361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111236883|NCT04391361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111236884|NCT04391361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111236885|NCT04391361|Analgesics|analgesics|mesh-ancestor
111236886|NCT04391361|Sensory System Agents|sensory system agents|mesh-ancestor
111236887|NCT04391361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111236888|NCT04391361|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111236889|NCT04391361|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111236890|NCT04391361|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111236891|NCT04391361|Adrenergic Agents|adrenergic agents|mesh-ancestor
111236892|NCT04391361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111236893|NCT04391361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111236894|NCT04391361|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111236895|NCT04391361|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111236896|NCT04391361|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111236897|NCT04391361|Autonomic Agents|autonomic agents|mesh-ancestor
111236898|NCT04391361|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111236899|NCT04391361|Respiratory System Agents|respiratory system agents|mesh-ancestor
111236900|NCT04391361|Mydriatics|mydriatics|mesh-ancestor
111236901|NCT04391361|Parasympatholytics|parasympatholytics|mesh-ancestor
111236902|NCT04391361|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111236903|NCT04391361|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111236904|NCT04391361|Cholinergic Agents|cholinergic agents|mesh-ancestor
111236905|NCT04391361|Antiemetics|antiemetics|mesh-ancestor
111236906|NCT04391361|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111236907|NCT04391361|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111236908|NCT04391361|Antioxidants|antioxidants|mesh-ancestor
111236909|NCT04391361|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111236910|NCT04391361|Protective Agents|protective agents|mesh-ancestor
111236911|NCT04273191|Brexanolone|brexanolone|mesh-list
111236912|NCT04273191|Neurosteroids|neurosteroids|mesh-ancestor
111236913|NCT04273191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111236914|NCT04273191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111236915|NCT04273191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111236916|NCT04273191|GABA Modulators|gaba modulators|mesh-ancestor
111236917|NCT04273191|GABA Agents|gaba agents|mesh-ancestor
111236918|NCT04391985|Sofosbuvir|sofosbuvir|mesh-list
111236919|NCT04391985|Antiviral Agents|antiviral agents|mesh-ancestor
111236920|NCT04391985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111236921|NCT01454115|BMS 708163|bms 708163|mesh-list
111236922|NCT01454115|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-list
111236923|NCT01454115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111236924|NCT01454115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111236925|NCT01455597|Estradiol|estradiol|mesh-list
111236926|NCT01455597|Estrogens|estrogens|mesh-ancestor
111236927|NCT01455597|Hormones|hormones|mesh-ancestor
111236928|NCT01455597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111236929|NCT01455597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111236930|NCT01453101|Fludarabine|fludarabine|mesh-list
111236931|NCT01453101|Fludarabine phosphate|fludarabine phosphate|mesh-list
111236932|NCT01453101|Bortezomib|bortezomib|mesh-list
111236933|NCT01453101|Melphalan|melphalan|mesh-list
111236934|NCT01453101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111236935|NCT01453101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111236936|NCT01453101|Antimetabolites|antimetabolites|mesh-ancestor
111236937|NCT01453101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111236938|NCT01453101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111236939|NCT01453101|Immunologic Factors|immunologic factors|mesh-ancestor
111236940|NCT01453101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111236941|NCT01453101|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111236942|NCT01453101|Alkylating Agents|alkylating agents|mesh-ancestor
111236943|NCT01453101|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111236944|NCT02085447|Haloperidol|haloperidol|mesh-list
111236945|NCT02085447|Paliperidone Palmitate|paliperidone palmitate|mesh-list
111236946|NCT02085447|Haloperidol decanoate|haloperidol decanoate|mesh-list
111236947|NCT02085447|Antipsychotic Agents|antipsychotic agents|mesh-list
111236948|NCT02085447|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111236949|NCT02085447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111236950|NCT02085447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111236951|NCT02085447|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111236952|NCT02085447|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111236953|NCT02085447|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111236954|NCT02085447|Serotonin Agents|serotonin agents|mesh-ancestor
111236955|NCT02085447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111236956|NCT02085447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111236957|NCT02085447|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111236958|NCT02085447|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111236959|NCT02085447|Dopamine Agents|dopamine agents|mesh-ancestor
111236960|NCT02085447|Antiemetics|antiemetics|mesh-ancestor
111236961|NCT02085447|Autonomic Agents|autonomic agents|mesh-ancestor
111236962|NCT02085447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111236963|NCT02085447|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111236964|NCT02085447|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111236965|NCT04847193|Xanthohumol|xanthohumol|mesh-list
111236966|NCT04847193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111236967|NCT04847193|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111236968|NCT04847193|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111236969|NCT04847193|Growth Substances|growth substances|mesh-ancestor
111236970|NCT04847193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111236971|NCT04847193|Growth Inhibitors|growth inhibitors|mesh-ancestor
111236972|NCT04273035|Midazolam|midazolam|mesh-list
111236973|NCT04273035|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111236974|NCT04273035|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111236975|NCT04273035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111236976|NCT04273035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111236977|NCT04273035|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111236978|NCT04273035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111236979|NCT04273035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111236980|NCT04273035|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111236981|NCT04273035|Anesthetics, General|anesthetics, general|mesh-ancestor
111236983|NCT04273035|GABA Modulators|gaba modulators|mesh-ancestor
111236984|NCT04273035|GABA Agents|gaba agents|mesh-ancestor
111236985|NCT04273035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111236986|NCT04273035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111236987|NCT02836899|Nitric Oxide|nitric oxide|mesh-list
111236988|NCT02836899|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111236989|NCT02836899|Autonomic Agents|autonomic agents|mesh-ancestor
111236990|NCT02836899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111236991|NCT02836899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111236992|NCT02836899|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111236993|NCT02836899|Respiratory System Agents|respiratory system agents|mesh-ancestor
111236994|NCT02836899|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111236995|NCT02836899|Antioxidants|antioxidants|mesh-ancestor
111236996|NCT02836899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111236997|NCT02836899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111236998|NCT02836899|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
111236999|NCT02836899|Vasodilator Agents|vasodilator agents|mesh-ancestor
111237000|NCT02836899|Gasotransmitters|gasotransmitters|mesh-ancestor
111237001|NCT02836899|Protective Agents|protective agents|mesh-ancestor
111237002|NCT02902029|Atezolizumab|atezolizumab|mesh-list
111237003|NCT02902029|Vemurafenib|vemurafenib|mesh-list
111237004|NCT02902029|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111237005|NCT02902029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111237006|NCT02902029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111237007|NCT02902029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111237008|NCT02902029|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110816616|NCT01121809|Etravirine|etravirine|mesh-list
111237009|NCT02902029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111237010|NCT02933697|Apixaban|apixaban|mesh-list
111237011|NCT02933697|Phenprocoumon|phenprocoumon|mesh-list
111237012|NCT02933697|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111237013|NCT02933697|Antithrombins|antithrombins|mesh-ancestor
111237014|NCT02933697|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111237015|NCT02933697|Protease Inhibitors|protease inhibitors|mesh-ancestor
111237016|NCT02933697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111237017|NCT02933697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111237018|NCT02933697|Anticoagulants|anticoagulants|mesh-ancestor
111237019|NCT01455129|Tiotropium Bromide|tiotropium bromide|mesh-list
111237020|NCT01455129|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111237021|NCT01455129|Autonomic Agents|autonomic agents|mesh-ancestor
111237022|NCT01455129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111237023|NCT01455129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111237024|NCT01455129|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111237025|NCT01455129|Respiratory System Agents|respiratory system agents|mesh-ancestor
111237026|NCT01455129|Parasympatholytics|parasympatholytics|mesh-ancestor
111237027|NCT01455129|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111237028|NCT01455129|Cholinergic Agents|cholinergic agents|mesh-ancestor
111237029|NCT01455129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111237030|NCT01455129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111237031|NCT01455441|Liraglutide|liraglutide|mesh-list
111237032|NCT01455441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111237033|NCT01455441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111237034|NCT01455441|Incretins|incretins|mesh-ancestor
111237035|NCT01455441|Hormones|hormones|mesh-ancestor
111237036|NCT01455441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111237037|NCT01455831|Tinzaparin|tinzaparin|mesh-list
111237038|NCT01455831|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
111237039|NCT01455831|Dalteparin|dalteparin|mesh-list
111237040|NCT01455831|Anticoagulants|anticoagulants|mesh-ancestor
111237041|NCT01455831|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111237042|NCT01455831|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111237043|NCT01455831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111237044|NCT04840641|Efavirenz|efavirenz|mesh-list
111237045|NCT04840641|Floxacillin|floxacillin|mesh-list
111237046|NCT04840641|Losartan|losartan|mesh-list
111237047|NCT04840641|Metoprolol|metoprolol|mesh-list
111237048|NCT04840641|Midazolam|midazolam|mesh-list
111237049|NCT04840641|Caffeine|caffeine|mesh-list
111237050|NCT04840641|Omeprazole|omeprazole|mesh-list
111237051|NCT04840641|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111237052|NCT04840641|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111237053|NCT04840641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111237054|NCT04840641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111237055|NCT04840641|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111237056|NCT04840641|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111237057|NCT04840641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111237058|NCT04840641|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111237059|NCT04840641|Anesthetics, General|anesthetics, general|mesh-ancestor
111237060|NCT04840641|Anesthetics|anesthetics|mesh-ancestor
111237061|NCT04840641|GABA Modulators|gaba modulators|mesh-ancestor
111237062|NCT04840641|GABA Agents|gaba agents|mesh-ancestor
111237063|NCT04840641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111237064|NCT04840641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111237065|NCT04840641|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111237066|NCT04840641|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111237067|NCT04840641|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111237068|NCT04840641|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111237069|NCT04840641|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111237070|NCT04840641|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111237071|NCT04840641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111237072|NCT04840641|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
111237073|NCT04840641|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111237074|NCT04840641|Purinergic Agents|purinergic agents|mesh-ancestor
111237075|NCT04840641|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111237076|NCT04840641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111237077|NCT04840641|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111237078|NCT04840641|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111237079|NCT04840641|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111237080|NCT04840641|Antiviral Agents|antiviral agents|mesh-ancestor
111237081|NCT04840641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111237082|NCT04840641|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111237083|NCT04840641|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111237084|NCT04840641|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111237085|NCT04840641|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111237086|NCT04840641|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111237087|NCT04840641|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111237088|NCT04840641|Sympatholytics|sympatholytics|mesh-ancestor
111237089|NCT04840641|Autonomic Agents|autonomic agents|mesh-ancestor
111237090|NCT04840641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111237091|NCT04840641|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
111237092|NCT04840641|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111237093|NCT04840641|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111237094|NCT04840641|Adrenergic Agents|adrenergic agents|mesh-ancestor
111237095|NCT04840641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111237096|NCT01455909|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111237097|NCT01455909|Exenatide|exenatide|mesh-list
111237098|NCT01455909|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111237099|NCT01455909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111237100|NCT01455909|Incretins|incretins|mesh-ancestor
111237101|NCT01455909|Hormones|hormones|mesh-ancestor
111237102|NCT01455909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111237103|NCT01455909|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111237104|NCT01455909|Protease Inhibitors|protease inhibitors|mesh-ancestor
111237105|NCT01455909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111237106|NCT01455909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111237107|NCT01455909|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111237108|NCT04844619|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111237109|NCT04844619|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111237110|NCT02555787|Tacrolimus|tacrolimus|mesh-list
111237111|NCT02555787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111237112|NCT02555787|Immunologic Factors|immunologic factors|mesh-ancestor
111237113|NCT02555787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111237114|NCT02555787|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111237115|NCT02555787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111237116|NCT02555787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111237117|NCT01730729|Cabergoline|cabergoline|mesh-list
111237118|NCT01730729|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111237119|NCT01730729|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111237120|NCT01730729|Dopamine Agonists|dopamine agonists|mesh-ancestor
111237121|NCT01730729|Dopamine Agents|dopamine agents|mesh-ancestor
111237122|NCT01730729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111237123|NCT01730729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111237124|NCT01730729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111237125|NCT01756157|Complement C1s|complement c1s|mesh-list
111237126|NCT01756157|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
111237127|NCT01756157|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
111237128|NCT01756157|Immunologic Factors|immunologic factors|mesh-ancestor
111237129|NCT01756157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111237130|NCT01756157|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
111237131|NCT01756157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111237133|NCT01756079|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
111237134|NCT01756079|Antimetabolites|antimetabolites|mesh-ancestor
111237135|NCT01756079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111237136|NCT01756079|Antiviral Agents|antiviral agents|mesh-ancestor
111237137|NCT01756079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111237138|NCT04272645|Atezolizumab|atezolizumab|mesh-list
111237139|NCT04272645|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111237140|NCT04272645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111237141|NCT04272645|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111237142|NCT04272645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111237143|NCT04390815|Insulin|insulin|mesh-list
111237144|NCT04390815|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111237145|NCT04390815|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111237146|NCT04390815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111237147|NCT01456611|Diclofenac|diclofenac|mesh-list
111237148|NCT01456611|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111237149|NCT01456611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111237150|NCT01456611|Analgesics|analgesics|mesh-ancestor
111237151|NCT01456611|Sensory System Agents|sensory system agents|mesh-ancestor
111237152|NCT01456611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111237153|NCT01456611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111237154|NCT01456611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111237155|NCT01456611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111237156|NCT01456611|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111237157|NCT01456611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111237158|NCT01456611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111237159|NCT01456689|Midazolam|midazolam|mesh-list
111237160|NCT01456689|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111237161|NCT01456689|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111237162|NCT01456689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111237163|NCT01456689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111237164|NCT01456689|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111237165|NCT01456689|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111237166|NCT01456689|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111237167|NCT01456689|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111237168|NCT01456689|Anesthetics, General|anesthetics, general|mesh-ancestor
111237169|NCT01456689|Anesthetics|anesthetics|mesh-ancestor
111237170|NCT01456689|GABA Modulators|gaba modulators|mesh-ancestor
111237171|NCT01456689|GABA Agents|gaba agents|mesh-ancestor
111237172|NCT01456689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111237173|NCT01456689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111237174|NCT05827081|Letrozole|letrozole|mesh-list
111237175|NCT05827081|Leuprolide|leuprolide|mesh-list
111237176|NCT05827081|Goserelin|goserelin|mesh-list
111237177|NCT05827081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111237178|NCT05827081|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111237179|NCT05827081|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111237180|NCT05827081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111237181|NCT05827081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111237182|NCT05827081|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111237183|NCT05827081|Hormone Antagonists|hormone antagonists|mesh-ancestor
111237184|NCT05827081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111237185|NCT05827081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111237186|NCT05827081|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111237187|NCT05827081|Fertility Agents|fertility agents|mesh-ancestor
111237188|NCT05827081|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111237189|NCT05827081|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111237190|NCT05826990|Cefepime|cefepime|mesh-list
111237191|NCT05826990|Enmetazobactam|enmetazobactam|mesh-list
111237192|NCT05826990|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111237193|NCT05826990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111237194|NCT05826990|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
111237195|NCT05826990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111237196|NCT05826990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111237197|NCT05826821|Pirfenidone|pirfenidone|mesh-list
111237198|NCT05826821|Analgesics|analgesics|mesh-ancestor
111237199|NCT05826821|Sensory System Agents|sensory system agents|mesh-ancestor
111237200|NCT05826821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110961552|NCT04524026|Letrozole|letrozole|mesh-list
111237201|NCT05826821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111237202|NCT05826821|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111237204|NCT05826821|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111237205|NCT05826821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111237206|NCT05826821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111237207|NCT05826444|Calcium|calcium|mesh-list
111237208|NCT05826444|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111237209|NCT05826444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111237210|NCT05826249|Ritonavir|ritonavir|mesh-list
111237211|NCT05826249|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111237212|NCT05826249|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111237213|NCT05826249|Protease Inhibitors|protease inhibitors|mesh-ancestor
111237214|NCT05826249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111237215|NCT05826249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111237216|NCT05826249|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111237217|NCT05826249|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111237218|NCT05826249|Antiviral Agents|antiviral agents|mesh-ancestor
111237219|NCT05826249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111237220|NCT05826249|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111237221|NCT05826249|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111237222|NCT05825963|Psyllium|psyllium|mesh-list
111237223|NCT05825963|Cathartics|cathartics|mesh-ancestor
111237224|NCT05825963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111237225|NCT05825872|Lidocaine|lidocaine|mesh-list
111237226|NCT05825872|Bupivacaine|bupivacaine|mesh-list
111237227|NCT05825872|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111237228|NCT05825872|Anesthetics, Local|anesthetics, local|mesh-ancestor
111237229|NCT05825872|Anesthetics|anesthetics|mesh-ancestor
111237230|NCT05825872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111237231|NCT05825872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111237232|NCT05825872|Sensory System Agents|sensory system agents|mesh-ancestor
111237233|NCT05825872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111237234|NCT05825872|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111237235|NCT05825872|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111237236|NCT05825872|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111237237|NCT05825872|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111237238|NCT05825872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111237239|NCT05825599|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111237240|NCT05825599|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111237241|NCT05825586|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111237242|NCT05825586|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111237243|NCT05825378|Dexamethasone|dexamethasone|mesh-list
111237244|NCT05825378|Ropivacaine|ropivacaine|mesh-list
111237245|NCT05825378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111237246|NCT05825378|Antiemetics|antiemetics|mesh-ancestor
111237247|NCT05825378|Autonomic Agents|autonomic agents|mesh-ancestor
111237248|NCT05825378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111237249|NCT05825378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111237250|NCT05825378|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111237251|NCT05825378|Glucocorticoids|glucocorticoids|mesh-ancestor
111237252|NCT05825378|Hormones|hormones|mesh-ancestor
111237253|NCT05825378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111237254|NCT05825378|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111237255|NCT05825378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111237256|NCT05825378|Anesthetics, Local|anesthetics, local|mesh-ancestor
111237257|NCT05825378|Anesthetics|anesthetics|mesh-ancestor
111237258|NCT05825378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111237259|NCT05825378|Sensory System Agents|sensory system agents|mesh-ancestor
111237260|NCT05825092|Methyltestosterone|methyltestosterone|mesh-list
111237261|NCT05825092|Testosterone|testosterone|mesh-list
111237262|NCT05825092|Testosterone undecanoate|testosterone undecanoate|mesh-list
111237263|NCT05825092|Testosterone enanthate|testosterone enanthate|mesh-list
111237264|NCT05825092|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
111237265|NCT05825092|Androgens|androgens|mesh-ancestor
111237266|NCT05825092|Hormones|hormones|mesh-ancestor
111237267|NCT05825092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111237268|NCT05825092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111237269|NCT05825092|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111237270|NCT05825092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111237271|NCT05825092|Anabolic Agents|anabolic agents|mesh-ancestor
111237272|NCT05824897|Vitamin D|vitamin d|mesh-list
111237273|NCT05824897|Vitamins|vitamins|mesh-ancestor
111237274|NCT05824897|Micronutrients|micronutrients|mesh-ancestor
111237275|NCT05824897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111237276|NCT05824897|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111237277|NCT05824871|Bedaquiline|bedaquiline|mesh-list
111237278|NCT05824871|Antitubercular Agents|antitubercular agents|mesh-ancestor
111237279|NCT05824871|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111237280|NCT05824871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111237281|NCT05824832|Dexamethasone|dexamethasone|mesh-list
111237282|NCT05824832|Dexamethasone acetate|dexamethasone acetate|mesh-list
111237283|NCT05824832|Clonidine|clonidine|mesh-list
111237284|NCT05824832|Buprenorphine|buprenorphine|mesh-list
111237285|NCT05824832|BB 1101|bb 1101|mesh-list
111237286|NCT05824832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111237287|NCT05824832|Antiemetics|antiemetics|mesh-ancestor
111237288|NCT05824832|Autonomic Agents|autonomic agents|mesh-ancestor
111237289|NCT05824832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111237290|NCT05824832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111237291|NCT05824832|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111237292|NCT05824832|Glucocorticoids|glucocorticoids|mesh-ancestor
111237293|NCT05824832|Hormones|hormones|mesh-ancestor
111237294|NCT05824832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111237295|NCT05824832|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111237296|NCT05824832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111237297|NCT05824832|Protease Inhibitors|protease inhibitors|mesh-ancestor
111237298|NCT05824832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111237299|NCT05824832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111237300|NCT05824832|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111237301|NCT05824832|Narcotics|narcotics|mesh-ancestor
111237302|NCT05824832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111237303|NCT05824832|Analgesics|analgesics|mesh-ancestor
111237304|NCT05824832|Sensory System Agents|sensory system agents|mesh-ancestor
111237305|NCT05824832|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111237306|NCT05824832|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111237307|NCT05824832|Sympatholytics|sympatholytics|mesh-ancestor
111237308|NCT05824832|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111237309|NCT05824832|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111237310|NCT05824832|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111237311|NCT05824832|Adrenergic Agents|adrenergic agents|mesh-ancestor
111237312|NCT05824832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111237313|NCT05824767|Angiotensin II|angiotensin ii|mesh-list
111237314|NCT05824767|Giapreza|giapreza|mesh-list
111237315|NCT05824767|Angiotensinogen|angiotensinogen|mesh-list
111237316|NCT05824767|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111237317|NCT05824767|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111237318|NCT05824767|Protease Inhibitors|protease inhibitors|mesh-ancestor
111237319|NCT05824767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111237320|NCT05824767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111237321|NCT05823844|Suvorexant|suvorexant|mesh-list
111237322|NCT05823844|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111237323|NCT05823844|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111237324|NCT05823844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111237325|NCT05823844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111237326|NCT05823844|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
111237327|NCT05823844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111237328|NCT05823844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111237329|NCT05823662|Silodosin|silodosin|mesh-list
111237330|NCT05823662|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111237331|NCT05823662|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111237332|NCT05823662|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111237333|NCT05823662|Adrenergic Agents|adrenergic agents|mesh-ancestor
111237334|NCT05823662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111237335|NCT05823662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111237336|NCT05823662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111237337|NCT05823662|Urological Agents|urological agents|mesh-ancestor
111237338|NCT05823363|Bupivacaine|bupivacaine|mesh-list
111237339|NCT05823363|Anesthetics, Local|anesthetics, local|mesh-ancestor
111237340|NCT05823363|Anesthetics|anesthetics|mesh-ancestor
111237341|NCT05823363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111237342|NCT05823363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111237343|NCT05823363|Sensory System Agents|sensory system agents|mesh-ancestor
111237344|NCT05823363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111237345|NCT05822076|Ropivacaine|ropivacaine|mesh-list
111237346|NCT05822076|Anesthetics, Local|anesthetics, local|mesh-ancestor
111237347|NCT05822076|Anesthetics|anesthetics|mesh-ancestor
111237348|NCT05822076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111237349|NCT05822076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110961705|NCT02307396|Antiemetics|antiemetics|mesh-ancestor
111237350|NCT05822076|Sensory System Agents|sensory system agents|mesh-ancestor
111237351|NCT05822076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111237352|NCT05821543|Metformin|metformin|mesh-list
111237353|NCT05821543|Sibutramine|sibutramine|mesh-list
111237354|NCT05821543|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111237355|NCT05821543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111237356|NCT05821543|Antidepressive Agents|antidepressive agents|mesh-ancestor
111237357|NCT05821543|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111237358|NCT05821543|Appetite Depressants|appetite depressants|mesh-ancestor
111237359|NCT05821543|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111237360|NCT05811949|Dimethyl Fumarate|dimethyl fumarate|mesh-list
111237361|NCT05811949|Dermatologic Agents|dermatologic agents|mesh-ancestor
111237362|NCT05811949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111237363|NCT05811949|Immunologic Factors|immunologic factors|mesh-ancestor
111237364|NCT05811949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111237365|NCT05801978|Vaccines|vaccines|mesh-list
111237366|NCT05801978|Immunologic Factors|immunologic factors|mesh-ancestor
111237367|NCT05801978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111237368|NCT05800639|Anesthetics|anesthetics|mesh-list
111237369|NCT05800639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111237370|NCT05800639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111237371|NCT05776108|Cabotegravir|cabotegravir|mesh-list
111237372|NCT05776108|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111237373|NCT05776108|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111237374|NCT05776108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111237375|NCT05776108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111237376|NCT05776108|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111237377|NCT05776108|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111237378|NCT05776108|Antiviral Agents|antiviral agents|mesh-ancestor
111237379|NCT05776108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111237380|NCT05753618|Lenograstim|lenograstim|mesh-list
111237381|NCT05753618|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111237382|NCT05753618|Immunologic Factors|immunologic factors|mesh-ancestor
111237383|NCT05753618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111237384|NCT05752461|Enoxaparin|enoxaparin|mesh-list
111237385|NCT05752461|Enoxaparin sodium|enoxaparin sodium|mesh-list
111237386|NCT05752461|Anticoagulants|anticoagulants|mesh-ancestor
111237387|NCT05752461|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111237388|NCT05752461|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111237389|NCT05752461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111237390|NCT05733546|Psilocybin|psilocybin|mesh-list
111237391|NCT05733546|Hallucinogens|hallucinogens|mesh-ancestor
111237392|NCT05733546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111237393|NCT05733546|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111237394|NCT05724550|Neostigmine|neostigmine|mesh-list
111237395|NCT05724550|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111237396|NCT05724550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111237397|NCT05724550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111237398|NCT05724550|Cholinergic Agents|cholinergic agents|mesh-ancestor
111237399|NCT05724550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111237400|NCT05724550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111237401|NCT05724550|Parasympathomimetics|parasympathomimetics|mesh-ancestor
111237402|NCT05724550|Autonomic Agents|autonomic agents|mesh-ancestor
111237403|NCT05724550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111237404|NCT05659329|Gentamicins|gentamicins|mesh-list
111237405|NCT05659329|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111237406|NCT05659329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111237407|NCT05659329|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111237408|NCT05659329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111237409|NCT05659329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111237410|NCT05632627|Cannabidiol|cannabidiol|mesh-list
111237411|NCT05632627|Anticonvulsants|anticonvulsants|mesh-ancestor
111237412|NCT05586802|Anastrozole|anastrozole|mesh-list
111237413|NCT05586802|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
111237414|NCT05586802|Testosterone|testosterone|mesh-list
111237415|NCT05586802|Androgens|androgens|mesh-ancestor
111237416|NCT05586802|Hormones|hormones|mesh-ancestor
111237417|NCT05586802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111237418|NCT05586802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111237419|NCT05586802|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111237420|NCT05586802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111237421|NCT05586802|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111237422|NCT05586802|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111237423|NCT05586802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111237424|NCT05586802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111237425|NCT05586802|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110961777|NCT03506802|Aldesleukin|aldesleukin|mesh-list
111237426|NCT05586802|Hormone Antagonists|hormone antagonists|mesh-ancestor
111237427|NCT05586802|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111237428|NCT05496036|Pembrolizumab|pembrolizumab|mesh-list
111237429|NCT05496036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111237430|NCT05496036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111237431|NCT05496036|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111237432|NCT05496036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111237433|NCT05487859|Acarbose|acarbose|mesh-list
111237434|NCT05487859|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
111237435|NCT05487859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111237436|NCT05487859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111237437|NCT05487859|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111237438|NCT05487859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111237439|NCT05320068|Vancomycin|vancomycin|mesh-list
111237440|NCT05320068|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111237441|NCT05320068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111237442|NCT05277402|Pembrolizumab|pembrolizumab|mesh-list
111237443|NCT05277402|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111237444|NCT05277402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111237445|NCT05277402|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111237446|NCT05277402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111237447|NCT05223647|Carboplatin|carboplatin|mesh-list
111237448|NCT05223647|Etoposide|etoposide|mesh-list
111237449|NCT05223647|Durvalumab|durvalumab|mesh-list
111237450|NCT05223647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111237451|NCT05223647|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111237452|NCT05223647|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111237453|NCT05223647|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111237454|NCT05223647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111237455|NCT05223647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111237456|NCT05223647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111237457|NCT05204160|Pembrolizumab|pembrolizumab|mesh-list
111237458|NCT05204160|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111237459|NCT05204160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111237460|NCT05204160|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111237461|NCT05204160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111237462|NCT05161637|Bupivacaine|bupivacaine|mesh-list
111237463|NCT05161637|Ropivacaine|ropivacaine|mesh-list
111237464|NCT05161637|Anesthetics, Local|anesthetics, local|mesh-ancestor
111237465|NCT05161637|Anesthetics|anesthetics|mesh-ancestor
111237466|NCT05161637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111237467|NCT05161637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111237468|NCT05161637|Sensory System Agents|sensory system agents|mesh-ancestor
111237469|NCT05161637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111237470|NCT05136677|Carboplatin|carboplatin|mesh-list
111237471|NCT05136677|Nivolumab|nivolumab|mesh-list
111237472|NCT05136677|Pemetrexed|pemetrexed|mesh-list
111237473|NCT05136677|Ipilimumab|ipilimumab|mesh-list
111237474|NCT05136677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111237475|NCT05136677|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111237476|NCT05136677|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111237477|NCT05136677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111237478|NCT05136677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111237479|NCT05136677|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111237480|NCT05136677|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111237481|NCT05015439|Cannabidiol|cannabidiol|mesh-list
111237482|NCT05015439|Anticonvulsants|anticonvulsants|mesh-ancestor
111237483|NCT04922333|Risedronic Acid|risedronic acid|mesh-list
111237484|NCT04922333|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111237485|NCT04922333|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111237486|NCT04922333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111237487|NCT04922333|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111237488|NCT04922333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111237489|NCT04922333|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111237490|NCT04911166|Atezolizumab|atezolizumab|mesh-list
111237491|NCT04911166|Interleukin-12|interleukin-12|mesh-list
111237492|NCT04911166|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111237493|NCT04911166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111237494|NCT04911166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111237495|NCT04911166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111237496|NCT04911166|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111237497|NCT04911166|Immunologic Factors|immunologic factors|mesh-ancestor
111237498|NCT04911166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111237499|NCT04911166|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111237500|NCT04911166|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111237502|NCT04911166|Growth Inhibitors|growth inhibitors|mesh-ancestor
111237503|NCT04903353|Risperidone|risperidone|mesh-list
111237504|NCT04903353|Aripiprazole|aripiprazole|mesh-list
111237505|NCT04903353|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111237506|NCT04903353|Serotonin Agents|serotonin agents|mesh-ancestor
111237507|NCT04903353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111237508|NCT04903353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111237509|NCT04903353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111237510|NCT04903353|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111237511|NCT04903353|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111237512|NCT04903353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111237513|NCT04903353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111237514|NCT04903353|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111237515|NCT04903353|Dopamine Agents|dopamine agents|mesh-ancestor
111237516|NCT04903353|Antidepressive Agents|antidepressive agents|mesh-ancestor
111237517|NCT04903353|Dopamine Agonists|dopamine agonists|mesh-ancestor
111237518|NCT04903353|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111237519|NCT04903353|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111237520|NCT04903353|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111237521|NCT04903353|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111237522|NCT04831047|Phenylephrine|phenylephrine|mesh-list
111237523|NCT04831047|Oxymetazoline|oxymetazoline|mesh-list
111237524|NCT04831047|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111237525|NCT04831047|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111237526|NCT04831047|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111237527|NCT04831047|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111237528|NCT04831047|Adrenergic Agents|adrenergic agents|mesh-ancestor
111237529|NCT04831047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111237530|NCT04831047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111237531|NCT04831047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111237532|NCT04831047|Sympathomimetics|sympathomimetics|mesh-ancestor
111237533|NCT04831047|Autonomic Agents|autonomic agents|mesh-ancestor
111237534|NCT04831047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111237535|NCT04831047|Nasal Decongestants|nasal decongestants|mesh-ancestor
111237536|NCT04831047|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111237537|NCT04831047|Respiratory System Agents|respiratory system agents|mesh-ancestor
111237538|NCT04831047|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111237539|NCT04831047|Mydriatics|mydriatics|mesh-ancestor
111237540|NCT04831047|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111237541|NCT04831047|Protective Agents|protective agents|mesh-ancestor
111237542|NCT04775680|Antibodies|antibodies|mesh-list
111237543|NCT04775680|Immunologic Factors|immunologic factors|mesh-ancestor
111237544|NCT04775680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111237545|NCT04747314|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
111237546|NCT04747314|Aripiprazole|aripiprazole|mesh-list
111237547|NCT04747314|Mirtazapine|mirtazapine|mesh-list
111237548|NCT04747314|Bupropion|bupropion|mesh-list
111237549|NCT04747314|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
111237550|NCT04747314|Sertraline|sertraline|mesh-list
111237551|NCT04747314|Antidepressive Agents|antidepressive agents|mesh-list
111237552|NCT04747314|Escitalopram|escitalopram|mesh-list
111237553|NCT04747314|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111237554|NCT04747314|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111237555|NCT04747314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111237556|NCT04747314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111237557|NCT04747314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111237558|NCT04747314|Serotonin Agents|serotonin agents|mesh-ancestor
111237559|NCT04747314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111237560|NCT04747314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111237561|NCT04747314|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111237562|NCT04747314|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111237563|NCT04747314|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111237564|NCT04747314|Dopamine Agents|dopamine agents|mesh-ancestor
111237565|NCT04747314|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111237566|NCT04747314|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111237567|NCT04747314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111237568|NCT04747314|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111237569|NCT04747314|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111237570|NCT04747314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111237571|NCT04747314|Dopamine Agonists|dopamine agonists|mesh-ancestor
111237572|NCT04747314|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111237573|NCT04747314|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111237574|NCT04747314|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111237575|NCT04747314|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111237576|NCT04747314|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111237577|NCT04747314|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111237578|NCT04747314|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111237579|NCT04747314|Analgesics|analgesics|mesh-ancestor
111237580|NCT04747314|Sensory System Agents|sensory system agents|mesh-ancestor
111237581|NCT04747314|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111237582|NCT04747314|Histamine Antagonists|histamine antagonists|mesh-ancestor
111237583|NCT04747314|Histamine Agents|histamine agents|mesh-ancestor
111237584|NCT04747314|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111237585|NCT04747314|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
111237586|NCT04747314|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111237587|NCT04747314|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111237588|NCT04747314|Adrenergic Agents|adrenergic agents|mesh-ancestor
111237589|NCT04747314|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111237590|NCT04700514|Dexmedetomidine|dexmedetomidine|mesh-list
111237591|NCT04700514|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111237592|NCT04700514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111237593|NCT04700514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111237594|NCT04700514|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111237595|NCT04700514|Analgesics|analgesics|mesh-ancestor
111237596|NCT04700514|Sensory System Agents|sensory system agents|mesh-ancestor
111237597|NCT04700514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111237598|NCT04700514|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111237599|NCT04700514|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111237600|NCT04700514|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111237601|NCT04700514|Adrenergic Agents|adrenergic agents|mesh-ancestor
111237602|NCT04700514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111237603|NCT04700514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111237604|NCT04669145|Ropivacaine|ropivacaine|mesh-list
111237605|NCT04669145|Anesthetics, Local|anesthetics, local|mesh-ancestor
111237606|NCT04669145|Anesthetics|anesthetics|mesh-ancestor
111237607|NCT04669145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111237608|NCT04669145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111237609|NCT04669145|Sensory System Agents|sensory system agents|mesh-ancestor
111237610|NCT04669145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111237611|NCT04650074|Lidocaine|lidocaine|mesh-list
111237612|NCT04650074|Ketamine|ketamine|mesh-list
111237613|NCT04650074|Anesthetics, Local|anesthetics, local|mesh-ancestor
111237614|NCT04650074|Anesthetics|anesthetics|mesh-ancestor
111237615|NCT04650074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111237616|NCT04650074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111237617|NCT04650074|Sensory System Agents|sensory system agents|mesh-ancestor
111237618|NCT04650074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111237619|NCT04650074|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111237620|NCT04650074|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111237621|NCT04650074|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111237622|NCT04650074|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111237623|NCT04650074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111237624|NCT04650074|Analgesics|analgesics|mesh-ancestor
111237625|NCT04650074|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111237626|NCT04650074|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111237627|NCT04650074|Anesthetics, General|anesthetics, general|mesh-ancestor
111237628|NCT04650074|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111237629|NCT04650074|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111237630|NCT04650074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111237631|NCT04620304|UB-421|ub-421|mesh-list
111237632|NCT04620304|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111237633|NCT04620304|Antiviral Agents|antiviral agents|mesh-ancestor
111237634|NCT04620304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111237635|NCT04579380|Trastuzumab|trastuzumab|mesh-list
111237636|NCT04579380|Fulvestrant|fulvestrant|mesh-list
111237637|NCT04579380|Tucatinib|tucatinib|mesh-list
111237638|NCT04579380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111237639|NCT04579380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111237640|NCT04579380|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111237641|NCT04579380|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
111237642|NCT04579380|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111237643|NCT04579380|Hormone Antagonists|hormone antagonists|mesh-ancestor
111237644|NCT04579380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111237645|NCT04579380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111237646|NCT04579380|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111237647|NCT04579380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111237648|NCT04579380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111237649|NCT04578886|Guanfacine|guanfacine|mesh-list
111237650|NCT04578886|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111237651|NCT04578886|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111237652|NCT04578886|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111237653|NCT04578886|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111237654|NCT04578886|Adrenergic Agents|adrenergic agents|mesh-ancestor
111237655|NCT04578886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111237656|NCT04578886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111237657|NCT04578886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111237658|NCT04550585|Insulin|insulin|mesh-list
111237659|NCT04550585|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111237660|NCT04550585|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111237661|NCT04550585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111237662|NCT04545515|Ivacaftor|ivacaftor|mesh-list
111237663|NCT04545515|Elexacaftor|elexacaftor|mesh-list
111237664|NCT04545515|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
111237665|NCT04545515|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111237666|NCT04545515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111237667|NCT04512066|Risperidone|risperidone|mesh-list
111237668|NCT04512066|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111237669|NCT04512066|Serotonin Agents|serotonin agents|mesh-ancestor
111237670|NCT04512066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111237671|NCT04512066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111237672|NCT04512066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111237673|NCT04512066|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111237674|NCT04512066|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111237675|NCT04512066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111237676|NCT04512066|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111237677|NCT04512066|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111237678|NCT04512066|Dopamine Agents|dopamine agents|mesh-ancestor
111237679|NCT04449549|Paclitaxel|paclitaxel|mesh-list
111237680|NCT04449549|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111237681|NCT04449549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111237682|NCT04449549|Tubulin Modulators|tubulin modulators|mesh-ancestor
111237683|NCT04449549|Antimitotic Agents|antimitotic agents|mesh-ancestor
111237684|NCT04449549|Mitosis Modulators|mitosis modulators|mesh-ancestor
111237685|NCT04449549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111237686|NCT04421092|Lidocaine|lidocaine|mesh-list
111237687|NCT04421092|Anesthetics, Local|anesthetics, local|mesh-ancestor
111237688|NCT04421092|Anesthetics|anesthetics|mesh-ancestor
111237689|NCT04421092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111237690|NCT04421092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111237691|NCT04421092|Sensory System Agents|sensory system agents|mesh-ancestor
111237692|NCT04421092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111237693|NCT04421092|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111237694|NCT04421092|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111237695|NCT04421092|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111237696|NCT04421092|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111237697|NCT04421092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111237698|NCT04406727|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
111237699|NCT04406727|UB-421|ub-421|mesh-list
111237700|NCT04406727|Antiviral Agents|antiviral agents|mesh-ancestor
111237701|NCT04406727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111237702|NCT04364945|Dexmedetomidine|dexmedetomidine|mesh-list
111237703|NCT04364945|Remifentanil|remifentanil|mesh-list
111237704|NCT04364945|Sevoflurane|sevoflurane|mesh-list
111237705|NCT04364945|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111237706|NCT04364945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111237707|NCT04364945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111237708|NCT04364945|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111237709|NCT04364945|Analgesics|analgesics|mesh-ancestor
111237710|NCT04364945|Sensory System Agents|sensory system agents|mesh-ancestor
111237711|NCT04364945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111237712|NCT04364945|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111237713|NCT04364945|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111237714|NCT04364945|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111237715|NCT04364945|Adrenergic Agents|adrenergic agents|mesh-ancestor
111237716|NCT04364945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111237717|NCT04364945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111237718|NCT04364945|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111237719|NCT04364945|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110962079|NCT03503604|Leucovorin|leucovorin|mesh-list
111237720|NCT04364945|Anesthetics, General|anesthetics, general|mesh-ancestor
111237721|NCT04364945|Anesthetics|anesthetics|mesh-ancestor
111237722|NCT04364945|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111237723|NCT04364945|Narcotics|narcotics|mesh-ancestor
111237724|NCT04235608|Propofol|propofol|mesh-list
111237725|NCT04235608|Sevoflurane|sevoflurane|mesh-list
111237726|NCT04235608|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111237727|NCT04235608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111237728|NCT04235608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111237729|NCT04235608|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111237730|NCT04235608|Anesthetics, General|anesthetics, general|mesh-ancestor
111237731|NCT04235608|Anesthetics|anesthetics|mesh-ancestor
111237732|NCT04235608|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111237733|NCT04235608|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111237734|NCT04232306|Bupivacaine|bupivacaine|mesh-list
111237735|NCT04232306|Anesthetics, Local|anesthetics, local|mesh-ancestor
111237736|NCT04232306|Anesthetics|anesthetics|mesh-ancestor
111237737|NCT04232306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111237738|NCT04232306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111237739|NCT04232306|Sensory System Agents|sensory system agents|mesh-ancestor
111237740|NCT04232306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111237741|NCT04161027|Pregabalin|pregabalin|mesh-list
111237742|NCT04161027|Analgesics|analgesics|mesh-ancestor
111237743|NCT04161027|Sensory System Agents|sensory system agents|mesh-ancestor
111237744|NCT04161027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111237745|NCT04161027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111237746|NCT04161027|Anticonvulsants|anticonvulsants|mesh-ancestor
111237747|NCT04161027|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111237748|NCT04161027|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111237749|NCT04161027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111237750|NCT04161027|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111237751|NCT04161027|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111237752|NCT04161027|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111237753|NCT04161027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111237754|NCT04161027|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111237755|NCT04019964|Nivolumab|nivolumab|mesh-list
111237756|NCT04019964|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111237757|NCT04019964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111237758|NCT04019964|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111237759|NCT04019964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111237760|NCT03927521|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
111237761|NCT03927521|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111237762|NCT03927521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111237763|NCT03889756|Midazolam|midazolam|mesh-list
111237764|NCT03889756|Ketamine|ketamine|mesh-list
111237765|NCT03889756|Analgesics|analgesics|mesh-ancestor
111237766|NCT03889756|Sensory System Agents|sensory system agents|mesh-ancestor
111237767|NCT03889756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111237768|NCT03889756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111237769|NCT03889756|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111237770|NCT03889756|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111237771|NCT03889756|Anesthetics, General|anesthetics, general|mesh-ancestor
111237772|NCT03889756|Anesthetics|anesthetics|mesh-ancestor
111237773|NCT03889756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111237774|NCT03889756|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111237775|NCT03889756|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111237776|NCT03889756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111237777|NCT03889756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111237778|NCT03889756|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111237779|NCT03889756|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111237780|NCT03889756|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111237781|NCT03889756|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111237782|NCT03889756|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111237783|NCT03889756|GABA Modulators|gaba modulators|mesh-ancestor
111237784|NCT03889756|GABA Agents|gaba agents|mesh-ancestor
111237785|NCT03882580|Antineoplastic Agents|antineoplastic agents|mesh-list
111237786|NCT03881696|Omalizumab|omalizumab|mesh-list
111237787|NCT03881696|Immunomodulating Agents|immunomodulating agents|mesh-list
111237788|NCT03881696|Immunologic Factors|immunologic factors|mesh-list
111237789|NCT03881696|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111237790|NCT03881696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111237791|NCT03881696|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111237792|NCT03881696|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111237793|NCT03881696|Respiratory System Agents|respiratory system agents|mesh-ancestor
111237794|NCT03864406|Darunavir|darunavir|mesh-list
111237795|NCT03864406|Cobicistat|cobicistat|mesh-list
111237796|NCT03864406|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
111237797|NCT03864406|Rivaroxaban|rivaroxaban|mesh-list
111237798|NCT03864406|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111237799|NCT03864406|Antithrombins|antithrombins|mesh-ancestor
111237800|NCT03864406|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111237801|NCT03864406|Protease Inhibitors|protease inhibitors|mesh-ancestor
111237802|NCT03864406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111237803|NCT03864406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111237804|NCT03864406|Anticoagulants|anticoagulants|mesh-ancestor
111237805|NCT03864406|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111237806|NCT03864406|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111237807|NCT03864406|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111237808|NCT03864406|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111237809|NCT03864406|Antiviral Agents|antiviral agents|mesh-ancestor
111237810|NCT03864406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111237811|NCT03864406|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111237812|NCT03864406|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111237813|NCT03845114|Insulin|insulin|mesh-list
111237814|NCT03845114|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111237815|NCT03845114|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111237816|NCT03845114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111237817|NCT03778502|Rivaroxaban|rivaroxaban|mesh-list
111237818|NCT03778502|Apixaban|apixaban|mesh-list
111237819|NCT03778502|Edoxaban|edoxaban|mesh-list
111237820|NCT03778502|Dabigatran|dabigatran|mesh-list
111237821|NCT03778502|Anticoagulants|anticoagulants|mesh-list
111237822|NCT03778502|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111237823|NCT03778502|Antithrombins|antithrombins|mesh-ancestor
111237824|NCT03778502|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111237825|NCT03778502|Protease Inhibitors|protease inhibitors|mesh-ancestor
111237826|NCT03778502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111237827|NCT03778502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111237828|NCT03775200|Psilocybin|psilocybin|mesh-list
111237829|NCT03775200|Hallucinogens|hallucinogens|mesh-ancestor
111237830|NCT03775200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111237831|NCT03775200|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111237832|NCT03689855|Atezolizumab|atezolizumab|mesh-list
111237833|NCT03689855|Ramucirumab|ramucirumab|mesh-list
111237834|NCT03689855|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111237835|NCT03689855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111237836|NCT03689855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111237837|NCT03689855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111237838|NCT03635996|Etripamil|etripamil|mesh-list
111237839|NCT03635996|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111237840|NCT03635996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111237841|NCT03635996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111237842|NCT03635996|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111237843|NCT03635996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111237844|NCT03613181|Paclitaxel|paclitaxel|mesh-list
111237845|NCT03613181|Capecitabine|capecitabine|mesh-list
111237846|NCT03613181|Methotrexate|methotrexate|mesh-list
111237847|NCT03613181|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111237848|NCT03613181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111237849|NCT03613181|Tubulin Modulators|tubulin modulators|mesh-ancestor
111237850|NCT03613181|Antimitotic Agents|antimitotic agents|mesh-ancestor
111237851|NCT03613181|Mitosis Modulators|mitosis modulators|mesh-ancestor
111237852|NCT03613181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111237853|NCT03613181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111237854|NCT03613181|Antimetabolites|antimetabolites|mesh-ancestor
111237855|NCT03613181|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111237856|NCT03613181|Abortifacient Agents|abortifacient agents|mesh-ancestor
111237857|NCT03613181|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111237858|NCT03613181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111237859|NCT03613181|Dermatologic Agents|dermatologic agents|mesh-ancestor
111237860|NCT03613181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111237861|NCT03613181|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111237862|NCT03613181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111237863|NCT03613181|Immunologic Factors|immunologic factors|mesh-ancestor
111237864|NCT03613181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111237865|NCT03613181|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111237866|NCT03468478|Mycophenolic Acid|mycophenolic acid|mesh-list
111237867|NCT03468478|Sirolimus|sirolimus|mesh-list
111237868|NCT03468478|Everolimus|everolimus|mesh-list
111237869|NCT03468478|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111237870|NCT03468478|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111237871|NCT03468478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110962244|NCT04128436|Hormones|hormones|mesh-ancestor
111237872|NCT03468478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111237873|NCT03468478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111237874|NCT03468478|Immunologic Factors|immunologic factors|mesh-ancestor
111237875|NCT03468478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111237876|NCT03468478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111237877|NCT03468478|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111237878|NCT03468478|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111237879|NCT03468478|Antitubercular Agents|antitubercular agents|mesh-ancestor
111237880|NCT03468478|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111237881|NCT03468478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111237882|NCT03468478|Antifungal Agents|antifungal agents|mesh-ancestor
111237884|NCT03409367|Petrolatum|petrolatum|mesh-list
111237885|NCT03409367|Dermatologic Agents|dermatologic agents|mesh-ancestor
111237886|NCT03168464|Nivolumab|nivolumab|mesh-list
111237887|NCT03168464|Ipilimumab|ipilimumab|mesh-list
111237888|NCT03168464|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111237889|NCT03168464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111237890|NCT03168464|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111237891|NCT03168464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111237892|NCT03164447|UB-421|ub-421|mesh-list
111237893|NCT03164447|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111237894|NCT03164447|Antiviral Agents|antiviral agents|mesh-ancestor
111237895|NCT03164447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111237896|NCT03054792|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
111237897|NCT03054792|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111237898|NCT03054792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111237899|NCT02875262|Deferoxamine|deferoxamine|mesh-list
111237900|NCT02875262|Siderophores|siderophores|mesh-ancestor
111237901|NCT02875262|Iron Chelating Agents|iron chelating agents|mesh-ancestor
111237902|NCT02875262|Chelating Agents|chelating agents|mesh-ancestor
111237903|NCT02875262|Sequestering Agents|sequestering agents|mesh-ancestor
111237904|NCT02875262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111237905|NCT02818920|Pembrolizumab|pembrolizumab|mesh-list
111237906|NCT02818920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111237907|NCT02818920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111237908|NCT02818920|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111237909|NCT02818920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111237910|NCT02811510|Dronabinol|dronabinol|mesh-list
111237911|NCT02811510|Hallucinogens|hallucinogens|mesh-ancestor
111237912|NCT02811510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111237913|NCT02811510|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111237914|NCT02811510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111237915|NCT02811510|Analgesics|analgesics|mesh-ancestor
111237916|NCT02811510|Sensory System Agents|sensory system agents|mesh-ancestor
111237917|NCT02811510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111237918|NCT02811510|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
111237919|NCT02811510|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
111237920|NCT02811510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111237921|NCT02811510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111237922|NCT02811510|Hormones|hormones|mesh-ancestor
111237923|NCT02811510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111237924|NCT02786264|Dexmedetomidine|dexmedetomidine|mesh-list
111237925|NCT02786264|Propofol|propofol|mesh-list
111237926|NCT02786264|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111237927|NCT02786264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111237928|NCT02786264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111237929|NCT02786264|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111237930|NCT02786264|Analgesics|analgesics|mesh-ancestor
111237931|NCT02786264|Sensory System Agents|sensory system agents|mesh-ancestor
111237932|NCT02786264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111237933|NCT02786264|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111237934|NCT02786264|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111237935|NCT02786264|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111237936|NCT02786264|Adrenergic Agents|adrenergic agents|mesh-ancestor
111237937|NCT02786264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111237938|NCT02786264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111237939|NCT02786264|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111237940|NCT02786264|Anesthetics, General|anesthetics, general|mesh-ancestor
111237941|NCT02786264|Anesthetics|anesthetics|mesh-ancestor
111237942|NCT02778971|Flutemetamol|flutemetamol|mesh-list
111237943|NCT02778971|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111237944|NCT02778971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111237945|NCT02444546|Sargramostim|sargramostim|mesh-list
111237946|NCT02444546|Immunologic Factors|immunologic factors|mesh-ancestor
111237947|NCT02444546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111237948|NCT01948505|Acetaminophen|acetaminophen|mesh-list
111237949|NCT01948505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111237950|NCT01948505|Analgesics|analgesics|mesh-ancestor
111237951|NCT01948505|Sensory System Agents|sensory system agents|mesh-ancestor
111237952|NCT01948505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111237953|NCT01948505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111237954|NCT01948505|Antipyretics|antipyretics|mesh-ancestor
111237955|NCT01916005|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
111237956|NCT01916005|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111237957|NCT01916005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111237958|NCT01160926|Cediranib|cediranib|mesh-list
111237959|NCT01160926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111237960|NCT01160926|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111237961|NCT01160926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111237962|NCT01160926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111237963|NCT01126957|Fentanyl|fentanyl|mesh-list
111237964|NCT01126957|Ketamine|ketamine|mesh-list
111237965|NCT01126957|Propofol|propofol|mesh-list
111237966|NCT01126957|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111237967|NCT01126957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111237968|NCT01126957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111237969|NCT01126957|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111237970|NCT01126957|Anesthetics, General|anesthetics, general|mesh-ancestor
111237971|NCT01126957|Anesthetics|anesthetics|mesh-ancestor
111237972|NCT01126957|Analgesics|analgesics|mesh-ancestor
111237973|NCT01126957|Sensory System Agents|sensory system agents|mesh-ancestor
111237974|NCT01126957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111237975|NCT01126957|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111237976|NCT01126957|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111237977|NCT01126957|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111237978|NCT01126957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111237979|NCT01126957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111237980|NCT01126957|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111237981|NCT01126957|Narcotics|narcotics|mesh-ancestor
111237982|NCT01126957|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111237983|NCT00811122|Corticosterone|corticosterone|mesh-list
111237984|NCT00811122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111237985|NCT00651885|Treprostinil|treprostinil|mesh-list
111237986|NCT00651885|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111237987|NCT01457001|Vitamin D|vitamin d|mesh-list
111237988|NCT01457001|Vitamins|vitamins|mesh-ancestor
111237989|NCT01457001|Micronutrients|micronutrients|mesh-ancestor
111237990|NCT01457001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111237991|NCT01457001|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111237992|NCT02846883|Plasma-lyte 148|plasma-lyte 148|mesh-list
111237993|NCT02846883|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
111237994|NCT02846883|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111237995|NCT01457469|Nicotine|nicotine|mesh-list
111237996|NCT01457469|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111237997|NCT01457469|Autonomic Agents|autonomic agents|mesh-ancestor
111237998|NCT01457469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111237999|NCT01457469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111238000|NCT01457469|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111238001|NCT01457469|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111238002|NCT01457469|Cholinergic Agents|cholinergic agents|mesh-ancestor
111238003|NCT01457469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111238004|NCT01457469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111238005|NCT01457547|Edetic Acid|edetic acid|mesh-list
111238006|NCT01457547|Vaccines|vaccines|mesh-list
111238007|NCT01457547|Pentetic Acid|pentetic acid|mesh-list
111238008|NCT01457547|Immunologic Factors|immunologic factors|mesh-ancestor
111238009|NCT01457547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111238010|NCT01457547|Antidotes|antidotes|mesh-ancestor
111238011|NCT01457547|Protective Agents|protective agents|mesh-ancestor
111238012|NCT01457547|Chelating Agents|chelating agents|mesh-ancestor
111238013|NCT01457547|Sequestering Agents|sequestering agents|mesh-ancestor
111238014|NCT01457547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111238015|NCT01457547|Iron Chelating Agents|iron chelating agents|mesh-ancestor
111238016|NCT01457547|Anticoagulants|anticoagulants|mesh-ancestor
111238017|NCT01457547|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
111238018|NCT01457859|Triclosan|triclosan|mesh-list
111238019|NCT01457859|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111238020|NCT01457859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111238021|NCT01457859|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
111238022|NCT01457859|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111238023|NCT01457859|Antimetabolites|antimetabolites|mesh-ancestor
111238024|NCT01457859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111238025|NCT01457859|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111238026|NCT01890993|Liraglutide|liraglutide|mesh-list
111238027|NCT01890993|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111238028|NCT01890993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111238029|NCT01890993|Incretins|incretins|mesh-ancestor
111238030|NCT01890993|Hormones|hormones|mesh-ancestor
111238031|NCT01890993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111238032|NCT01457937|Interferons|interferons|mesh-list
111238033|NCT01457937|Ribavirin|ribavirin|mesh-list
111238034|NCT01457937|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
111238035|NCT01457937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111238036|NCT01457937|Antiviral Agents|antiviral agents|mesh-ancestor
111238037|NCT01457937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111238038|NCT01457937|Antimetabolites|antimetabolites|mesh-ancestor
111238039|NCT01457937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111238040|NCT04272255|Scopolamine|scopolamine|mesh-list
111238041|NCT04272255|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
111238042|NCT04272255|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111238043|NCT04272255|Antiemetics|antiemetics|mesh-ancestor
111238044|NCT04272255|Autonomic Agents|autonomic agents|mesh-ancestor
111238045|NCT04272255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111238046|NCT04272255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111238047|NCT04272255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111238048|NCT04272255|Mydriatics|mydriatics|mesh-ancestor
111238049|NCT04272255|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111238050|NCT04272255|Cholinergic Agents|cholinergic agents|mesh-ancestor
111238051|NCT04272255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111238052|NCT04272255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111238053|NCT04272255|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111238054|NCT04272255|Parasympatholytics|parasympatholytics|mesh-ancestor
111238055|NCT01458015|Oxycodone|oxycodone|mesh-list
111238056|NCT01458015|Tapentadol|tapentadol|mesh-list
111238057|NCT01458015|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111238058|NCT01458015|Narcotics|narcotics|mesh-ancestor
111238059|NCT01458015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111238060|NCT01458015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111238061|NCT01458015|Analgesics|analgesics|mesh-ancestor
111238062|NCT01458015|Sensory System Agents|sensory system agents|mesh-ancestor
111238063|NCT01458015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111238064|NCT01458015|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111238065|NCT01458015|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111238066|NCT01458015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111238067|NCT01458015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111238068|NCT01458015|Adrenergic Agents|adrenergic agents|mesh-ancestor
111238069|NCT01458015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111238070|NCT05026125|Remifentanil|remifentanil|mesh-list
111238071|NCT05026125|Anesthetics|anesthetics|mesh-list
111238072|NCT05026125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111238073|NCT05026125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111238074|NCT05026125|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111238075|NCT05026125|Narcotics|narcotics|mesh-ancestor
111238076|NCT05026125|Analgesics|analgesics|mesh-ancestor
111238077|NCT05026125|Sensory System Agents|sensory system agents|mesh-ancestor
111238078|NCT05026125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111238079|NCT01891227|Capecitabine|capecitabine|mesh-list
111238080|NCT01891227|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
111238081|NCT01891227|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111238082|NCT01891227|Antimetabolites|antimetabolites|mesh-ancestor
111238083|NCT01891227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111238084|NCT01891227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111238085|NCT01891227|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111238086|NCT01891227|Alkylating Agents|alkylating agents|mesh-ancestor
111238087|NCT04391439|Methylprednisolone|methylprednisolone|mesh-list
111238088|NCT04391439|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111238089|NCT04391439|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111238090|NCT04391439|Prednisolone|prednisolone|mesh-list
111238091|NCT04391439|Prednisolone acetate|prednisolone acetate|mesh-list
111238092|NCT04391439|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111238093|NCT04391439|Prednisolone phosphate|prednisolone phosphate|mesh-list
111238094|NCT04391439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111238095|NCT04391439|Antiemetics|antiemetics|mesh-ancestor
111238096|NCT04391439|Autonomic Agents|autonomic agents|mesh-ancestor
111238097|NCT04391439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111238098|NCT04391439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111238099|NCT04391439|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111238100|NCT04391439|Glucocorticoids|glucocorticoids|mesh-ancestor
111238101|NCT04391439|Hormones|hormones|mesh-ancestor
111238102|NCT04391439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111238103|NCT04391439|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111238104|NCT04391439|Protective Agents|protective agents|mesh-ancestor
111238105|NCT04391439|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111238106|NCT04391439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111238107|NCT02884245|Estrogens|estrogens|mesh-list
111238108|NCT02884245|Hormones|hormones|mesh-ancestor
111238109|NCT02884245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111238110|NCT02884245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111238111|NCT01891461|Hemostatics|hemostatics|mesh-list
111238112|NCT01891461|Coagulants|coagulants|mesh-ancestor
111238113|NCT04272567|Norepinephrine|norepinephrine|mesh-list
111238114|NCT04272567|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111238115|NCT04272567|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111238116|NCT04272567|Adrenergic Agents|adrenergic agents|mesh-ancestor
111238117|NCT04272567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111238118|NCT04272567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111238119|NCT04272567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111238120|NCT04272567|Sympathomimetics|sympathomimetics|mesh-ancestor
111238121|NCT04272567|Autonomic Agents|autonomic agents|mesh-ancestor
111238122|NCT04272567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111238123|NCT04272567|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111238124|NCT01891851|Ritonavir|ritonavir|mesh-list
111238125|NCT01891851|Simeprevir|simeprevir|mesh-list
111238126|NCT01891851|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111238127|NCT01891851|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111238128|NCT01891851|Protease Inhibitors|protease inhibitors|mesh-ancestor
111238129|NCT01891851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111238130|NCT01891851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111238131|NCT01891851|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111238132|NCT01891851|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111238133|NCT01891851|Antiviral Agents|antiviral agents|mesh-ancestor
111238134|NCT01891851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111238135|NCT01891851|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111238136|NCT01891851|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111238137|NCT01459419|Antibodies|antibodies|mesh-list
111238138|NCT01459419|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111238139|NCT01459419|Immunologic Factors|immunologic factors|mesh-ancestor
111238140|NCT01459419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111238141|NCT01892241|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
111238142|NCT01892241|Entecavir|entecavir|mesh-list
111238143|NCT01892241|Antiviral Agents|antiviral agents|mesh-ancestor
111238144|NCT01892241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111238145|NCT04391127|Hydroxychloroquine|hydroxychloroquine|mesh-list
111238146|NCT04391127|Ivermectin|ivermectin|mesh-list
111238147|NCT04391127|Antimalarials|antimalarials|mesh-ancestor
111238148|NCT04391127|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111238149|NCT04391127|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111238150|NCT04391127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111238151|NCT04391127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111238152|NCT04391127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111238153|NCT04391127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111238154|NCT05024253|Tranexamic Acid|tranexamic acid|mesh-list
111238155|NCT05024253|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111238156|NCT05024253|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111238157|NCT05024253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111238158|NCT05024253|Hemostatics|hemostatics|mesh-ancestor
111238159|NCT05024253|Coagulants|coagulants|mesh-ancestor
111238160|NCT01459809|Metformin|metformin|mesh-list
111238161|NCT01459809|Glimepiride|glimepiride|mesh-list
111238162|NCT01459809|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111238163|NCT01459809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111238164|NCT01459809|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111238165|NCT01459809|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111238166|NCT01459809|Immunologic Factors|immunologic factors|mesh-ancestor
111238167|NCT01459887|Prednisone|prednisone|mesh-list
111238168|NCT01459887|Cyclophosphamide|cyclophosphamide|mesh-list
111238169|NCT01459887|Doxorubicin|doxorubicin|mesh-list
111238170|NCT01459887|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111238171|NCT01459887|Vincristine|vincristine|mesh-list
111238172|NCT01459887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111238173|NCT01459887|Immunologic Factors|immunologic factors|mesh-ancestor
111238174|NCT01459887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111238175|NCT01459887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110962534|NCT04462614|Heparin|heparin|mesh-list
111238176|NCT01459887|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111238177|NCT01459887|Alkylating Agents|alkylating agents|mesh-ancestor
111238178|NCT01459887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111238179|NCT01459887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111238180|NCT01459887|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111238181|NCT01459887|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111238182|NCT01459887|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111238183|NCT01459887|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111238184|NCT01459887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111238185|NCT01459887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111238186|NCT01459887|Glucocorticoids|glucocorticoids|mesh-ancestor
111238187|NCT01459887|Hormones|hormones|mesh-ancestor
111238188|NCT01459887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111238189|NCT01459887|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111238190|NCT01459887|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111238191|NCT01459887|Tubulin Modulators|tubulin modulators|mesh-ancestor
111238192|NCT01459887|Antimitotic Agents|antimitotic agents|mesh-ancestor
111238193|NCT01459887|Mitosis Modulators|mitosis modulators|mesh-ancestor
111238194|NCT02876211|Vitamin D|vitamin d|mesh-list
111238195|NCT02876211|Vitamins|vitamins|mesh-ancestor
111238196|NCT02876211|Micronutrients|micronutrients|mesh-ancestor
111238197|NCT02876211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111238198|NCT02876211|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111238199|NCT02682147|Sildenafil Citrate|sildenafil citrate|mesh-list
111238200|NCT02682147|Vasodilator Agents|vasodilator agents|mesh-ancestor
111238201|NCT02682147|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111238202|NCT02682147|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111238203|NCT02682147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111238204|NCT02682147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111238205|NCT02682147|Urological Agents|urological agents|mesh-ancestor
111238206|NCT01892787|Formoterol Fumarate|formoterol fumarate|mesh-list
111238207|NCT01892787|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
111238208|NCT01892787|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111238209|NCT01892787|Autonomic Agents|autonomic agents|mesh-ancestor
111238210|NCT01892787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111238211|NCT01892787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111238212|NCT01892787|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111238213|NCT01892787|Respiratory System Agents|respiratory system agents|mesh-ancestor
111238214|NCT01892787|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111238215|NCT01892787|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111238216|NCT01892787|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111238217|NCT01892787|Adrenergic Agents|adrenergic agents|mesh-ancestor
111238218|NCT01892787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111238219|NCT01892787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111238220|NCT01893723|Remifentanil|remifentanil|mesh-list
111238221|NCT01893723|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111238222|NCT01893723|Narcotics|narcotics|mesh-ancestor
111238223|NCT01893723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111238224|NCT01893723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111238225|NCT01893723|Analgesics|analgesics|mesh-ancestor
111238226|NCT01893723|Sensory System Agents|sensory system agents|mesh-ancestor
111238227|NCT01893723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111238228|NCT01453959|Fludrocortisone|fludrocortisone|mesh-list
111238229|NCT01453959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111238230|NCT02669901|Naloxone|naloxone|mesh-list
111238231|NCT02669901|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111238232|NCT02669901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111238233|NCT02669901|Sensory System Agents|sensory system agents|mesh-ancestor
111238234|NCT02669901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111238235|NCT01893099|Sorafenib|sorafenib|mesh-list
111238236|NCT01893099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111238237|NCT01893099|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111238238|NCT01893099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111238239|NCT01893099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111238240|NCT02327403|Abatacept|abatacept|mesh-list
111238241|NCT02327403|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111238242|NCT02327403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111238243|NCT02327403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111238244|NCT02327403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111238245|NCT02327403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111238246|NCT02327403|Immunologic Factors|immunologic factors|mesh-ancestor
111238247|NCT02327403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111238248|NCT02327403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111238249|NCT01893177|Vaccines|vaccines|mesh-list
111238250|NCT01893177|Immunologic Factors|immunologic factors|mesh-ancestor
111238251|NCT01893177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111238253|NCT05740150|Heparin|heparin|mesh-list
111238254|NCT05740150|Calcium heparin|calcium heparin|mesh-list
111238255|NCT05740150|Anticoagulants|anticoagulants|mesh-ancestor
111238256|NCT05740150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111238257|NCT05740150|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111238258|NCT05740150|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111238259|NCT05740150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111238260|NCT05740150|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111238261|NCT05740150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111238262|NCT05734612|Colchicine|colchicine|mesh-list
111238263|NCT05734612|Gout Suppressants|gout suppressants|mesh-ancestor
111238264|NCT05734612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111238265|NCT05734612|Tubulin Modulators|tubulin modulators|mesh-ancestor
111238266|NCT05734612|Antimitotic Agents|antimitotic agents|mesh-ancestor
111238267|NCT05734612|Mitosis Modulators|mitosis modulators|mesh-ancestor
110817842|NCT05789680|Parathyroid Hormone|parathyroid hormone|mesh-list
111238268|NCT05734612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111238269|NCT05734612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111238270|NCT02349867|Gemcitabine|gemcitabine|mesh-list
111238271|NCT02349867|Sorafenib|sorafenib|mesh-list
111238272|NCT02349867|Vorinostat|vorinostat|mesh-list
111238273|NCT02349867|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111238274|NCT02349867|Antimetabolites|antimetabolites|mesh-ancestor
111238275|NCT02349867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111238276|NCT02349867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111238277|NCT02349867|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111238278|NCT02349867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111238279|NCT02349867|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111238280|NCT02629419|Amphotericin B|amphotericin b|mesh-list
111238281|NCT02629419|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
111238282|NCT02629419|Amebicides|amebicides|mesh-ancestor
111238283|NCT02629419|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111238284|NCT02629419|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111238285|NCT02629419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111238286|NCT02629419|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111238287|NCT02629419|Antifungal Agents|antifungal agents|mesh-ancestor
111238288|NCT02334735|Vaccines|vaccines|mesh-list
111238289|NCT02334735|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
111238290|NCT02334735|Poly ICLC|poly iclc|mesh-list
111238291|NCT02334735|Immunologic Factors|immunologic factors|mesh-ancestor
111238292|NCT02334735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111238293|NCT02334735|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111238294|NCT02334735|Interferon Inducers|interferon inducers|mesh-ancestor
111238295|NCT02329600|Triamcinolone|triamcinolone|mesh-list
111238296|NCT02329600|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
111238297|NCT02329600|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
111238298|NCT02329600|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
111238299|NCT02329600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111238300|NCT02329600|Glucocorticoids|glucocorticoids|mesh-ancestor
111238301|NCT02329600|Hormones|hormones|mesh-ancestor
111238302|NCT02329600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111238303|NCT02329600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111238304|NCT02329600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111238305|NCT02329600|Immunologic Factors|immunologic factors|mesh-ancestor
111238306|NCT02329600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111238307|NCT02329600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111238308|NCT02620761|Fenoldopam|fenoldopam|mesh-list
111238309|NCT02620761|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111238310|NCT02620761|Vasodilator Agents|vasodilator agents|mesh-ancestor
111238311|NCT02620761|Dopamine Agonists|dopamine agonists|mesh-ancestor
111238312|NCT02620761|Dopamine Agents|dopamine agents|mesh-ancestor
111238313|NCT02620761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111238314|NCT02620761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111238315|NCT02620761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111238316|NCT04758273|Vaccines|vaccines|mesh-list
111238317|NCT04758273|Immunologic Factors|immunologic factors|mesh-ancestor
111238318|NCT04758273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111238319|NCT01729871|Vitamin K|vitamin k|mesh-list
111238320|NCT01729871|Rivaroxaban|rivaroxaban|mesh-list
111238321|NCT01729871|Vitamins|vitamins|mesh-ancestor
111238322|NCT01729871|Micronutrients|micronutrients|mesh-ancestor
111238323|NCT01729871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110962684|NCT04610476|Abatacept|abatacept|mesh-list
111238324|NCT01729871|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111238325|NCT01729871|Antithrombins|antithrombins|mesh-ancestor
111238326|NCT01729871|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111238327|NCT01729871|Protease Inhibitors|protease inhibitors|mesh-ancestor
111238328|NCT01729871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111238329|NCT01729871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111238330|NCT01729871|Anticoagulants|anticoagulants|mesh-ancestor
111238331|NCT01729871|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111238332|NCT01729871|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111238333|NCT01729871|Hemostatics|hemostatics|mesh-ancestor
111238334|NCT01729871|Coagulants|coagulants|mesh-ancestor
111238335|NCT02611323|Rituximab|rituximab|mesh-list
111238336|NCT02611323|Obinutuzumab|obinutuzumab|mesh-list
111238337|NCT02611323|Venetoclax|venetoclax|mesh-list
111238338|NCT02611323|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
111238339|NCT02611323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111238340|NCT02611323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111238341|NCT02611323|Immunologic Factors|immunologic factors|mesh-ancestor
111238342|NCT02611323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111238343|NCT02611323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111238344|NCT02611323|Immunoconjugates|immunoconjugates|mesh-ancestor
111238345|NCT02608359|Abiraterone Acetate|abiraterone acetate|mesh-list
111238346|NCT02608359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111238347|NCT02608359|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111238348|NCT02608359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111238349|NCT02608359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111238350|NCT02608359|Hormone Antagonists|hormone antagonists|mesh-ancestor
111238351|NCT02608359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111238352|NCT02608359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111238353|NCT02608359|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111238354|NCT01729559|Heparin|heparin|mesh-list
111238355|NCT01729559|Enoxaparin|enoxaparin|mesh-list
111238356|NCT01729559|Calcium heparin|calcium heparin|mesh-list
111238357|NCT01729559|Enoxaparin sodium|enoxaparin sodium|mesh-list
111238358|NCT01729559|Anticoagulants|anticoagulants|mesh-ancestor
111238359|NCT01729559|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111238360|NCT01729559|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111238361|NCT01729559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111238362|NCT01926496|Imiquimod|imiquimod|mesh-list
111238363|NCT01926496|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111238364|NCT01926496|Immunologic Factors|immunologic factors|mesh-ancestor
111238365|NCT01926496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111238366|NCT01926496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111238367|NCT01926496|Interferon Inducers|interferon inducers|mesh-ancestor
111238368|NCT01728779|Nelfinavir|nelfinavir|mesh-list
111238369|NCT01728779|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111238370|NCT01728779|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111238371|NCT01728779|Protease Inhibitors|protease inhibitors|mesh-ancestor
111238372|NCT01728779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111238373|NCT01728779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111238374|NCT01728779|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111238375|NCT01728779|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111238376|NCT01728779|Antiviral Agents|antiviral agents|mesh-ancestor
111238377|NCT01728779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111238378|NCT01927120|Sirolimus|sirolimus|mesh-list
111238379|NCT01927120|Aldesleukin|aldesleukin|mesh-list
111238380|NCT01927120|Tacrolimus|tacrolimus|mesh-list
111238381|NCT01927120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111238382|NCT01927120|Immunologic Factors|immunologic factors|mesh-ancestor
111238383|NCT01927120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111238384|NCT01927120|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111238385|NCT01927120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111238386|NCT01927120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111238387|NCT01927120|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111238388|NCT01927120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111238389|NCT01927120|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111238390|NCT01927120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111238391|NCT01927120|Antifungal Agents|antifungal agents|mesh-ancestor
111238392|NCT01927120|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111238393|NCT01927120|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111238394|NCT01927120|Antiviral Agents|antiviral agents|mesh-ancestor
111238395|NCT01728623|Lenvatinib|lenvatinib|mesh-list
111238396|NCT01728623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111238397|NCT01728623|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111238398|NCT01728623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111238399|NCT01728623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111238400|NCT02573337|Lidocaine|lidocaine|mesh-list
111238401|NCT02573337|Anesthetics, Local|anesthetics, local|mesh-ancestor
111238402|NCT02573337|Anesthetics|anesthetics|mesh-ancestor
111238403|NCT02573337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111238404|NCT02573337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111238405|NCT02573337|Sensory System Agents|sensory system agents|mesh-ancestor
111238406|NCT02573337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111238407|NCT02573337|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111238408|NCT02573337|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111238409|NCT02573337|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110817988|NCT05767086|Progestins|progestins|mesh-ancestor
111238410|NCT02573337|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111238411|NCT02573337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111238413|NCT01728077|Anticonvulsants|anticonvulsants|mesh-ancestor
111238414|NCT01606007|Metformin|metformin|mesh-list
111238415|NCT01606007|Dapagliflozin|dapagliflozin|mesh-list
111238416|NCT01606007|Saxagliptin|saxagliptin|mesh-list
111238417|NCT01606007|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111238418|NCT01606007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111238419|NCT01606007|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111238420|NCT01606007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111238421|NCT01606007|Incretins|incretins|mesh-ancestor
111238422|NCT01606007|Hormones|hormones|mesh-ancestor
111238423|NCT01606007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111238424|NCT01606007|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111238425|NCT01606007|Protease Inhibitors|protease inhibitors|mesh-ancestor
111238426|NCT01606007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111238427|NCT02304783|Acetaminophen|acetaminophen|mesh-list
111238428|NCT02304783|Piroxicam|piroxicam|mesh-list
111238429|NCT02304783|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111238430|NCT02304783|Analgesics|analgesics|mesh-ancestor
111238431|NCT02304783|Sensory System Agents|sensory system agents|mesh-ancestor
111238432|NCT02304783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111238433|NCT02304783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111238434|NCT02304783|Antipyretics|antipyretics|mesh-ancestor
111238435|NCT02304783|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111238436|NCT02304783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111238437|NCT02304783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111238438|NCT02304783|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111238439|NCT02304783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111238440|NCT02304783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111238441|NCT02553447|Vitamin D|vitamin d|mesh-list
111238442|NCT02553447|Cholecalciferol|cholecalciferol|mesh-list
111238443|NCT02553447|Vitamins|vitamins|mesh-ancestor
111238444|NCT02553447|Micronutrients|micronutrients|mesh-ancestor
111238445|NCT02553447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111238446|NCT02553447|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111238447|NCT02553447|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111238448|NCT01928290|Leucovorin|leucovorin|mesh-list
111238449|NCT01928290|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
111238450|NCT01928290|Tetrahydrofolates|tetrahydrofolates|mesh-list
111238451|NCT01928290|Fluorouracil|fluorouracil|mesh-list
111238452|NCT01928290|Oxaliplatin|oxaliplatin|mesh-list
111238453|NCT01928290|Trastuzumab|trastuzumab|mesh-list
111238454|NCT01928290|Irinotecan|irinotecan|mesh-list
111238455|NCT01928290|Levoleucovorin|levoleucovorin|mesh-list
111238456|NCT01928290|Antimetabolites|antimetabolites|mesh-ancestor
111238457|NCT01928290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111238458|NCT01928290|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111238459|NCT01928290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111238460|NCT01928290|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111238461|NCT01928290|Immunologic Factors|immunologic factors|mesh-ancestor
111238462|NCT01928290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111238463|NCT01928290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111238464|NCT01928290|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111238465|NCT01928290|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111238466|NCT01928290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111238467|NCT01928290|Antidotes|antidotes|mesh-ancestor
111238468|NCT01928290|Protective Agents|protective agents|mesh-ancestor
110980743|NCT03223844|Dopamine Agents|dopamine agents|mesh-ancestor
111238469|NCT01928290|Vitamin B Complex|vitamin b complex|mesh-ancestor
111238470|NCT01928290|Vitamins|vitamins|mesh-ancestor
111238471|NCT01928290|Micronutrients|micronutrients|mesh-ancestor
111238472|NCT02282319|Dexmedetomidine|dexmedetomidine|mesh-list
111238473|NCT02282319|Chloroprocaine|chloroprocaine|mesh-list
111238474|NCT02282319|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111238475|NCT02282319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111238476|NCT02282319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111238477|NCT02282319|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111238478|NCT02282319|Analgesics|analgesics|mesh-ancestor
111238479|NCT02282319|Sensory System Agents|sensory system agents|mesh-ancestor
111238480|NCT02282319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111238481|NCT02282319|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111238482|NCT02282319|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111238483|NCT02282319|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111238484|NCT02282319|Adrenergic Agents|adrenergic agents|mesh-ancestor
111238485|NCT02282319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111238486|NCT02282319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111238487|NCT02282319|Anesthetics, Local|anesthetics, local|mesh-ancestor
111238488|NCT02282319|Anesthetics|anesthetics|mesh-ancestor
111238489|NCT02772081|Poractant alfa|poractant alfa|mesh-list
111238490|NCT02772081|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
111238491|NCT02772081|Respiratory System Agents|respiratory system agents|mesh-ancestor
111238492|NCT02278965|Metformin|metformin|mesh-list
111238493|NCT02278965|Biguanides|biguanides|mesh-list
111238494|NCT02278965|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111238495|NCT02278965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111238496|NCT02757885|Cyclophosphamide|cyclophosphamide|mesh-list
111238497|NCT02757885|Thiotepa|thiotepa|mesh-list
111238498|NCT02757885|Fludarabine|fludarabine|mesh-list
111238499|NCT02757885|Fludarabine phosphate|fludarabine phosphate|mesh-list
111238500|NCT02757885|Hydroxyurea|hydroxyurea|mesh-list
111238501|NCT02757885|Antilymphocyte Serum|antilymphocyte serum|mesh-list
111238502|NCT02757885|Thymoglobulin|thymoglobulin|mesh-list
111238503|NCT02757885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111238504|NCT02757885|Immunologic Factors|immunologic factors|mesh-ancestor
111238505|NCT02757885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111238506|NCT02757885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111238507|NCT02757885|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111238508|NCT02757885|Alkylating Agents|alkylating agents|mesh-ancestor
111238509|NCT02757885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111238510|NCT02757885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111238511|NCT02757885|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111238512|NCT02757885|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111238513|NCT02757885|Antimetabolites|antimetabolites|mesh-ancestor
111238514|NCT02757885|Antisickling Agents|antisickling agents|mesh-ancestor
111238515|NCT02757885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111238516|NCT02757885|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111238517|NCT01928446|Lithium Carbonate|lithium carbonate|mesh-list
111238518|NCT01928446|Antidepressive Agents|antidepressive agents|mesh-ancestor
111238519|NCT01928446|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111238520|NCT01928446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111238521|NCT01928446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111238522|NCT01928446|Antimanic Agents|antimanic agents|mesh-ancestor
111238523|NCT01928446|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111238524|NCT01928446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111238525|NCT01928446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111238526|NCT02983383|Anesthetics|anesthetics|mesh-list
111238527|NCT02983383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111238528|NCT02983383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111238529|NCT02748369|Glucagon|glucagon|mesh-list
111238530|NCT02748369|Hormones|hormones|mesh-list
111238531|NCT02748369|Somatostatin|somatostatin|mesh-list
111238532|NCT02748369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111238533|NCT02748369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111238534|NCT02748369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111238535|NCT01928680|Capecitabine|capecitabine|mesh-list
111238536|NCT01928680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111238537|NCT01928680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111238538|NCT01928680|Antimetabolites|antimetabolites|mesh-ancestor
111238539|NCT01928680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111238540|NCT01929460|Ciprofloxacin|ciprofloxacin|mesh-list
111238541|NCT01929460|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111238542|NCT01929460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111238543|NCT01929460|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110818134|NCT05461456|Fexofenadine|fexofenadine|mesh-list
111238544|NCT01929460|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111238545|NCT01929460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111238546|NCT01929460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111238547|NCT01929460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111238548|NCT01929460|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111238549|NCT01929460|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111238550|NCT02283814|Topiramate|topiramate|mesh-list
111238551|NCT02283814|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
111238552|NCT02283814|Anticonvulsants|anticonvulsants|mesh-ancestor
111238553|NCT02283814|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111238554|NCT02283814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111238555|NCT02283814|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111238556|NCT02283814|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111238557|NCT02283814|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111238558|NCT02283814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111238559|NCT05739682|Anti-Infective Agents|anti-infective agents|mesh-list
111238560|NCT05739682|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111238561|NCT05739682|Epinephrine|epinephrine|mesh-list
111238562|NCT05739682|Anesthetics|anesthetics|mesh-list
111238563|NCT05739682|Carticaine|carticaine|mesh-list
111238564|NCT05739682|Anesthetics, Local|anesthetics, local|mesh-list
111238565|NCT05739682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111238566|NCT05739682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111238567|NCT05739682|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111238568|NCT05739682|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111238569|NCT05739682|Adrenergic Agents|adrenergic agents|mesh-ancestor
111238570|NCT05739682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111238571|NCT05739682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111238572|NCT05739682|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111238573|NCT05739682|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111238574|NCT05739682|Autonomic Agents|autonomic agents|mesh-ancestor
111238575|NCT05739682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111238576|NCT05739682|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111238577|NCT05739682|Respiratory System Agents|respiratory system agents|mesh-ancestor
111238578|NCT05739682|Mydriatics|mydriatics|mesh-ancestor
111238579|NCT05739682|Sympathomimetics|sympathomimetics|mesh-ancestor
111238580|NCT05739682|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111238581|NCT05739682|Sensory System Agents|sensory system agents|mesh-ancestor
111238582|NCT02462421|Canagliflozin|canagliflozin|mesh-list
111238583|NCT02462421|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111238584|NCT02462421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111238585|NCT02462421|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111238586|NCT02462421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111238587|NCT02727387|Cyclophosphamide|cyclophosphamide|mesh-list
111238588|NCT02727387|Temozolomide|temozolomide|mesh-list
111238589|NCT02727387|Melphalan|melphalan|mesh-list
111238590|NCT02727387|Busulfan|busulfan|mesh-list
111238591|NCT02727387|Ifosfamide|ifosfamide|mesh-list
111238592|NCT02727387|Irinotecan|irinotecan|mesh-list
111238593|NCT02727387|Etoposide|etoposide|mesh-list
111238594|NCT02727387|Vincristine|vincristine|mesh-list
111238595|NCT02727387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111238596|NCT02727387|Immunologic Factors|immunologic factors|mesh-ancestor
111238597|NCT02727387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111238598|NCT02727387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111238599|NCT02727387|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111238600|NCT02727387|Alkylating Agents|alkylating agents|mesh-ancestor
111238601|NCT02727387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111238602|NCT02727387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111238603|NCT02727387|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111238604|NCT02727387|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111238605|NCT02727387|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111238606|NCT02727387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111238607|NCT02727387|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111238608|NCT02727387|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111238609|NCT02727387|Tubulin Modulators|tubulin modulators|mesh-ancestor
111238610|NCT02727387|Antimitotic Agents|antimitotic agents|mesh-ancestor
111238611|NCT02727387|Mitosis Modulators|mitosis modulators|mesh-ancestor
111238612|NCT01753115|Ciprofloxacin|ciprofloxacin|mesh-list
111238613|NCT01753115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111238614|NCT01753115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111238615|NCT01753115|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111238616|NCT01753115|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111238617|NCT01753115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111238618|NCT01753115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111238619|NCT01753115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111238620|NCT01753115|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111238621|NCT01753115|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111238622|NCT02445651|Acetylcysteine|acetylcysteine|mesh-list
111238623|NCT02445651|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111238624|NCT02445651|Antiviral Agents|antiviral agents|mesh-ancestor
111238625|NCT02445651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111238626|NCT02445651|Expectorants|expectorants|mesh-ancestor
111238627|NCT02445651|Respiratory System Agents|respiratory system agents|mesh-ancestor
111238628|NCT02445651|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111238629|NCT02445651|Antioxidants|antioxidants|mesh-ancestor
111238630|NCT02445651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111238631|NCT02445651|Protective Agents|protective agents|mesh-ancestor
111238632|NCT02445651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111238633|NCT02445651|Antidotes|antidotes|mesh-ancestor
111238634|NCT05719714|Dapagliflozin|dapagliflozin|mesh-list
111238635|NCT05719714|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111238636|NCT05719714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111238637|NCT05719714|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111238638|NCT05719714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111238639|NCT02284516|Lifitegrast|lifitegrast|mesh-list
111238640|NCT02284516|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
111238641|NCT02284516|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111238642|NCT02721537|Niacinamide|niacinamide|mesh-list
111238643|NCT02721537|Niacin|niacin|mesh-list
111238644|NCT02721537|Nicotinic Acids|nicotinic acids|mesh-list
111238645|NCT02721537|Vitamin B Complex|vitamin b complex|mesh-ancestor
111238646|NCT02721537|Vitamins|vitamins|mesh-ancestor
111238647|NCT02721537|Micronutrients|micronutrients|mesh-ancestor
111238648|NCT02721537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111238649|NCT02721537|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111238650|NCT02721537|Antimetabolites|antimetabolites|mesh-ancestor
111238651|NCT02721537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111238652|NCT02721537|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111238653|NCT02721537|Vasodilator Agents|vasodilator agents|mesh-ancestor
111238654|NCT02185209|Amoxicillin|amoxicillin|mesh-list
111238655|NCT02185209|Metronidazole|metronidazole|mesh-list
111238656|NCT02185209|Penicillin V|penicillin v|mesh-list
111238657|NCT02185209|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111238658|NCT02185209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111238659|NCT02185209|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111238660|NCT02185209|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111238661|NCT01894035|Iloprost|iloprost|mesh-list
111238662|NCT01894035|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111238663|NCT01894035|Vasodilator Agents|vasodilator agents|mesh-ancestor
111238664|NCT01727141|Glycopyrrolate|glycopyrrolate|mesh-list
111238665|NCT01727141|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111238666|NCT01727141|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111238667|NCT01727141|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111238668|NCT01727141|Cholinergic Agents|cholinergic agents|mesh-ancestor
111238669|NCT01727141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111238670|NCT01727141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111238671|NCT01727141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111238672|NCT02716311|Cetuximab|cetuximab|mesh-list
111238673|NCT02716311|Afatinib|afatinib|mesh-list
111238674|NCT02716311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111238675|NCT02716311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111238676|NCT02716311|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111238677|NCT02716311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111238678|NCT02716311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111238679|NCT05439694|Tranexamic Acid|tranexamic acid|mesh-list
111238680|NCT05439694|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111238681|NCT05439694|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111238682|NCT05439694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111238683|NCT05439694|Hemostatics|hemostatics|mesh-ancestor
111238684|NCT05439694|Coagulants|coagulants|mesh-ancestor
111238685|NCT02290444|Hormones|hormones|mesh-list
111238686|NCT02290444|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
111238687|NCT02290444|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
111238688|NCT02290444|beta-Endorphin|beta-endorphin|mesh-list
111238689|NCT02290444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111238690|NCT02290444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111238691|NCT02290444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111238692|NCT02290444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111238693|NCT01726517|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
111238694|NCT01726517|Antiviral Agents|antiviral agents|mesh-ancestor
111238695|NCT01726517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111238696|NCT01752023|Itraconazole|itraconazole|mesh-list
111238697|NCT01752023|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
111238698|NCT01752023|Cisplatin|cisplatin|mesh-list
111238699|NCT01752023|Gemcitabine|gemcitabine|mesh-list
111238700|NCT01752023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111238701|NCT01752023|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111238702|NCT01752023|Antimetabolites|antimetabolites|mesh-ancestor
110963044|NCT05520658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111238703|NCT01752023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111238704|NCT01752023|Antifungal Agents|antifungal agents|mesh-ancestor
111238705|NCT01752023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111238706|NCT01752023|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111238707|NCT01752023|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111238708|NCT01752023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111238709|NCT01752023|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111238710|NCT01752023|Hormone Antagonists|hormone antagonists|mesh-ancestor
111238711|NCT01752023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111238712|NCT01752023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111238713|NCT01752023|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111238714|NCT02986906|Triamcinolone|triamcinolone|mesh-list
111238715|NCT02986906|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111238716|NCT02986906|Glucocorticoids|glucocorticoids|mesh-ancestor
111238717|NCT02986906|Hormones|hormones|mesh-ancestor
111238718|NCT02986906|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111238719|NCT02986906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111238720|NCT01726049|Sildenafil Citrate|sildenafil citrate|mesh-list
111238721|NCT01726049|Vasodilator Agents|vasodilator agents|mesh-ancestor
111238722|NCT01726049|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111238723|NCT01726049|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111238724|NCT01726049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111238725|NCT01726049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111238726|NCT01726049|Urological Agents|urological agents|mesh-ancestor
111238727|NCT02162667|Trastuzumab|trastuzumab|mesh-list
111238728|NCT02162667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111238729|NCT02162667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111238730|NCT01605617|Fesoterodine|fesoterodine|mesh-list
111238731|NCT01605617|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111238732|NCT01605617|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111238733|NCT01605617|Cholinergic Agents|cholinergic agents|mesh-ancestor
111238734|NCT01605617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111238735|NCT01605617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111238736|NCT01605617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111238737|NCT01605617|Urological Agents|urological agents|mesh-ancestor
111238738|NCT05402020|Tiotropium Bromide|tiotropium bromide|mesh-list
111238739|NCT05402020|Olodaterol|olodaterol|mesh-list
111238740|NCT05402020|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111238741|NCT05402020|Autonomic Agents|autonomic agents|mesh-ancestor
111238742|NCT05402020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111238743|NCT05402020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111238744|NCT05402020|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111238745|NCT05402020|Respiratory System Agents|respiratory system agents|mesh-ancestor
111238746|NCT05402020|Parasympatholytics|parasympatholytics|mesh-ancestor
111238747|NCT05402020|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111238748|NCT05402020|Cholinergic Agents|cholinergic agents|mesh-ancestor
111238749|NCT05402020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111238750|NCT05402020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111238751|NCT02284828|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
111238752|NCT02284828|Anticonvulsants|anticonvulsants|mesh-ancestor
111238753|NCT02284828|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111238754|NCT02284828|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111238755|NCT02284828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111238756|NCT02284828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111238757|NCT01751867|Decitabine|decitabine|mesh-list
111238758|NCT01751867|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111238759|NCT01751867|Antimetabolites|antimetabolites|mesh-ancestor
111238760|NCT01751867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111238761|NCT01751867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111238762|NCT01751867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111238763|NCT02418195|Ketamine|ketamine|mesh-list
111238764|NCT02418195|Analgesics|analgesics|mesh-ancestor
111238765|NCT02418195|Sensory System Agents|sensory system agents|mesh-ancestor
111238766|NCT02418195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111238767|NCT02418195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111238768|NCT02418195|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111238769|NCT02418195|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111238770|NCT02418195|Anesthetics, General|anesthetics, general|mesh-ancestor
111238771|NCT02418195|Anesthetics|anesthetics|mesh-ancestor
111238772|NCT02418195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111238773|NCT02418195|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111238774|NCT02418195|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111238775|NCT02418195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111238776|NCT02418195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111238777|NCT05633914|Paclitaxel|paclitaxel|mesh-list
111238778|NCT05633914|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111238779|NCT05633914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111238780|NCT05633914|Tubulin Modulators|tubulin modulators|mesh-ancestor
111238781|NCT05633914|Antimitotic Agents|antimitotic agents|mesh-ancestor
111238782|NCT05633914|Mitosis Modulators|mitosis modulators|mesh-ancestor
111238783|NCT05633914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111238784|NCT05383612|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111238785|NCT05383612|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111238787|NCT05382364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111238788|NCT05382364|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111238789|NCT05382364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111238790|NCT05382364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111238791|NCT02712801|Ritonavir|ritonavir|mesh-list
111238792|NCT02712801|Lopinavir|lopinavir|mesh-list
111238793|NCT02712801|Lamivudine|lamivudine|mesh-list
111238794|NCT02712801|Zidovudine|zidovudine|mesh-list
111238795|NCT02712801|Nevirapine|nevirapine|mesh-list
111238796|NCT02712801|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111238797|NCT02712801|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111238798|NCT02712801|Protease Inhibitors|protease inhibitors|mesh-ancestor
111238799|NCT02712801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111238800|NCT02712801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111238801|NCT02712801|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111238802|NCT02712801|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111238803|NCT02712801|Antiviral Agents|antiviral agents|mesh-ancestor
111238804|NCT02712801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111238805|NCT02712801|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111238806|NCT02712801|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111238807|NCT02712801|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111238808|NCT02712801|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111238809|NCT02712801|Antimetabolites|antimetabolites|mesh-ancestor
111238810|NCT02712801|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111238811|NCT02712801|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111238812|NCT02712723|Letrozole|letrozole|mesh-list
111238813|NCT02712723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111238814|NCT02712723|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111238815|NCT02712723|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111238816|NCT02712723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111238817|NCT02712723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111238818|NCT02712723|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111238819|NCT02712723|Hormone Antagonists|hormone antagonists|mesh-ancestor
111238820|NCT02712723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111238821|NCT02712723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111238822|NCT01751087|Vitamins|vitamins|mesh-list
111238823|NCT01751087|Vitamin B 12|vitamin b 12|mesh-list
111238824|NCT01751087|Misoprostol|misoprostol|mesh-list
111238825|NCT01751087|Mifepristone|mifepristone|mesh-list
111238826|NCT01751087|Micronutrients|micronutrients|mesh-ancestor
111238827|NCT01751087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111238828|NCT01751087|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111238829|NCT01751087|Abortifacient Agents|abortifacient agents|mesh-ancestor
111238830|NCT01751087|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111238831|NCT01751087|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111238832|NCT01751087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111238833|NCT01751087|Oxytocics|oxytocics|mesh-ancestor
111238834|NCT01751087|Vitamin B Complex|vitamin b complex|mesh-ancestor
111238835|NCT01751087|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
111238836|NCT01751087|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111238837|NCT01751087|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111238838|NCT01751087|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111238839|NCT01751087|Contraceptive Agents|contraceptive agents|mesh-ancestor
111238840|NCT01751087|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
111238841|NCT01751087|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
111238842|NCT01751087|Hormone Antagonists|hormone antagonists|mesh-ancestor
111238843|NCT01751087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111238844|NCT01751087|Luteolytic Agents|luteolytic agents|mesh-ancestor
111238845|NCT01751087|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111238846|NCT01751087|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
111238847|NCT02393157|Carboplatin|carboplatin|mesh-list
111238848|NCT02393157|Etoposide|etoposide|mesh-list
111238849|NCT02393157|Ifosfamide|ifosfamide|mesh-list
111238850|NCT02393157|Obinutuzumab|obinutuzumab|mesh-list
111238851|NCT02393157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111238852|NCT02393157|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111238853|NCT02393157|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111238854|NCT02393157|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111238855|NCT02393157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111238856|NCT02393157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111238857|NCT02393157|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111238858|NCT02393157|Alkylating Agents|alkylating agents|mesh-ancestor
111238859|NCT02393157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111238861|NCT01750697|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111238862|NCT01750697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111238863|NCT01750697|Immunologic Factors|immunologic factors|mesh-ancestor
111238864|NCT01750697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111238865|NCT01750697|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111238866|NCT02127723|Hyaluronic Acid|hyaluronic acid|mesh-list
111238867|NCT02127723|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111238868|NCT02127723|Immunologic Factors|immunologic factors|mesh-ancestor
111238869|NCT02127723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111238870|NCT02127723|Viscosupplements|viscosupplements|mesh-ancestor
111238871|NCT02127723|Protective Agents|protective agents|mesh-ancestor
111238872|NCT05586711|Estradiol|estradiol|mesh-list
111238873|NCT05586711|Estrogens|estrogens|mesh-ancestor
111238874|NCT05586711|Hormones|hormones|mesh-ancestor
111238875|NCT05586711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111238876|NCT05586711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111238877|NCT01724489|Hormones|hormones|mesh-list
111238878|NCT01724489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111238879|NCT01724489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111238880|NCT01996293|Lamotrigine|lamotrigine|mesh-list
111238881|NCT01996293|Anticonvulsants|anticonvulsants|mesh-ancestor
111238882|NCT01996293|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111238883|NCT01996293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111238884|NCT01996293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111238885|NCT01996293|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111238886|NCT01996293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111238887|NCT01996293|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111238888|NCT01996293|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111238889|NCT01996293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111238890|NCT01996293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111238891|NCT01996293|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111238892|NCT02986750|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111238893|NCT02986750|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111238894|NCT05304364|Naltrexone|naltrexone|mesh-list
111238895|NCT05304364|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111238896|NCT05304364|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111238897|NCT05304364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111238898|NCT05304364|Sensory System Agents|sensory system agents|mesh-ancestor
111238899|NCT05304364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111238900|NCT01724177|Lenalidomide|lenalidomide|mesh-list
111238901|NCT01724177|Immunologic Factors|immunologic factors|mesh-ancestor
111238902|NCT01724177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111238903|NCT01724177|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111238904|NCT01724177|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111238905|NCT01724177|Growth Substances|growth substances|mesh-ancestor
111238906|NCT01724177|Growth Inhibitors|growth inhibitors|mesh-ancestor
111238907|NCT01724177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111238908|NCT01991457|Fludarabine|fludarabine|mesh-list
111238909|NCT01991457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111238910|NCT02117817|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111238911|NCT02117817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111238912|NCT05529784|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111238913|NCT05529784|Immunologic Factors|immunologic factors|mesh-ancestor
111238914|NCT05529784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111238915|NCT05524246|Pravastatin|pravastatin|mesh-list
111238916|NCT05524246|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111238917|NCT05524246|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111238918|NCT05524246|Antimetabolites|antimetabolites|mesh-ancestor
111238919|NCT05524246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111238920|NCT05524246|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111238921|NCT05524246|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111238922|NCT05524246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111238923|NCT02685735|Gabapentin|gabapentin|mesh-list
111238924|NCT02685735|Analgesics|analgesics|mesh-ancestor
111238925|NCT02685735|Sensory System Agents|sensory system agents|mesh-ancestor
111238926|NCT02685735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110963254|NCT05042128|Gemcitabine|gemcitabine|mesh-list
111238927|NCT02685735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111238928|NCT02685735|Anticonvulsants|anticonvulsants|mesh-ancestor
111238929|NCT02685735|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111238930|NCT02685735|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111238931|NCT02685735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111238932|NCT02685735|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111238933|NCT02685735|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111238934|NCT02685735|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111238935|NCT02685735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111238936|NCT02685735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111238937|NCT02685735|Antimanic Agents|antimanic agents|mesh-ancestor
111238938|NCT01530009|Amoxicillin|amoxicillin|mesh-list
111238939|NCT01530009|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111238940|NCT01530009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111238941|NCT04915144|Edotreotide lutetium LU-177|edotreotide lutetium lu-177|mesh-list
111238942|NCT04915144|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111238943|NCT04915144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111238944|NCT01724021|Prednisone|prednisone|mesh-list
111238945|NCT01724021|Prednisolone|prednisolone|mesh-list
111238946|NCT01724021|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111238947|NCT01724021|Methylprednisolone|methylprednisolone|mesh-list
111238948|NCT01724021|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111238949|NCT01724021|Prednisolone acetate|prednisolone acetate|mesh-list
111238950|NCT01724021|Cyclophosphamide|cyclophosphamide|mesh-list
111238951|NCT01724021|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
111238952|NCT01724021|Rituximab|rituximab|mesh-list
111238953|NCT01724021|Vincristine|vincristine|mesh-list
111238954|NCT01724021|Doxorubicin|doxorubicin|mesh-list
111238955|NCT01724021|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111238956|NCT01724021|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111238957|NCT01724021|Prednisolone phosphate|prednisolone phosphate|mesh-list
111238958|NCT01724021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111238959|NCT01724021|Immunologic Factors|immunologic factors|mesh-ancestor
111238960|NCT01724021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111238961|NCT01724021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111238962|NCT01724021|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111238963|NCT01724021|Alkylating Agents|alkylating agents|mesh-ancestor
111238964|NCT01724021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111238965|NCT01724021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111238966|NCT01724021|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111238967|NCT01724021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111238968|NCT01724021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111238969|NCT01724021|Glucocorticoids|glucocorticoids|mesh-ancestor
111238970|NCT01724021|Hormones|hormones|mesh-ancestor
111238971|NCT01724021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111238972|NCT01724021|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111238973|NCT01724021|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111238974|NCT01724021|Tubulin Modulators|tubulin modulators|mesh-ancestor
111238975|NCT01724021|Antimitotic Agents|antimitotic agents|mesh-ancestor
111238976|NCT01724021|Mitosis Modulators|mitosis modulators|mesh-ancestor
111238977|NCT01724021|Antiemetics|antiemetics|mesh-ancestor
111238978|NCT01724021|Autonomic Agents|autonomic agents|mesh-ancestor
111238979|NCT01724021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111238980|NCT01724021|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111238981|NCT01724021|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111238982|NCT01724021|Protective Agents|protective agents|mesh-ancestor
111238983|NCT01724021|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111238984|NCT01724021|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111238985|NCT01724021|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111238986|NCT01724021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111238987|NCT05197504|Bevacizumab|bevacizumab|mesh-list
111238988|NCT05197504|Atezolizumab|atezolizumab|mesh-list
111238989|NCT05197504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111238990|NCT05197504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111238991|NCT05197504|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111238992|NCT05197504|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111238993|NCT05197504|Growth Substances|growth substances|mesh-ancestor
111238994|NCT05197504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111238995|NCT05197504|Growth Inhibitors|growth inhibitors|mesh-ancestor
111238996|NCT05197504|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111238997|NCT05197504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111238998|NCT02293096|Metoprolol|metoprolol|mesh-list
111238999|NCT02293096|Dextromethorphan|dextromethorphan|mesh-list
111239000|NCT02293096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111239001|NCT02293096|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111239002|NCT02293096|Sympatholytics|sympatholytics|mesh-ancestor
111239003|NCT02293096|Autonomic Agents|autonomic agents|mesh-ancestor
111239004|NCT02293096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111239005|NCT02293096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111239006|NCT02293096|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
111239007|NCT02293096|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111239008|NCT02293096|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111239009|NCT02293096|Adrenergic Agents|adrenergic agents|mesh-ancestor
111239010|NCT02293096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111239011|NCT02293096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111239012|NCT02293096|Antitussive Agents|antitussive agents|mesh-ancestor
111239013|NCT02293096|Respiratory System Agents|respiratory system agents|mesh-ancestor
111239014|NCT02293096|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111239015|NCT02293096|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111239016|NCT01722071|Oxytocin|oxytocin|mesh-list
111239017|NCT01722071|Oxytocics|oxytocics|mesh-ancestor
111239018|NCT01722071|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111239019|NCT01722071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111239020|NCT04187404|Nivolumab|nivolumab|mesh-list
111239021|NCT04187404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111239022|NCT04187404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111239023|NCT04187404|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111239024|NCT04187404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111239025|NCT04155580|Decitabine|decitabine|mesh-list
111239026|NCT04155580|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
111239027|NCT04155580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111239028|NCT04155580|Antimetabolites|antimetabolites|mesh-ancestor
111239029|NCT04155580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111239030|NCT04155580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111239031|NCT04155580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111239032|NCT01721759|Nivolumab|nivolumab|mesh-list
111239033|NCT01721759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111239034|NCT01721759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111239035|NCT01721759|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111239036|NCT01721759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111239037|NCT04776850|Mycophenolic Acid|mycophenolic acid|mesh-list
111239038|NCT04776850|Dexamethasone|dexamethasone|mesh-list
111239039|NCT04776850|Dexamethasone acetate|dexamethasone acetate|mesh-list
111239040|NCT04776850|Cyclophosphamide|cyclophosphamide|mesh-list
111239041|NCT04776850|Busulfan|busulfan|mesh-list
111239042|NCT04776850|Rituximab|rituximab|mesh-list
111239043|NCT04776850|Fludarabine|fludarabine|mesh-list
111239044|NCT04776850|Fludarabine phosphate|fludarabine phosphate|mesh-list
111239045|NCT04776850|Bortezomib|bortezomib|mesh-list
111239046|NCT04776850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111239047|NCT04776850|Tacrolimus|tacrolimus|mesh-list
111239048|NCT04776850|Thymoglobulin|thymoglobulin|mesh-list
111239049|NCT04776850|Antilymphocyte Serum|antilymphocyte serum|mesh-list
111239050|NCT04776850|Antibodies|antibodies|mesh-list
111239051|NCT04776850|Immunoglobulins|immunoglobulins|mesh-list
111239052|NCT04776850|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111239053|NCT04776850|gamma-Globulins|gamma-globulins|mesh-list
111239054|NCT04776850|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111239055|NCT04776850|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
111239056|NCT04776850|BB 1101|bb 1101|mesh-list
111239057|NCT04776850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111239058|NCT04776850|Immunologic Factors|immunologic factors|mesh-ancestor
111239059|NCT04776850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111239060|NCT04776850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111239061|NCT04776850|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111239062|NCT04776850|Alkylating Agents|alkylating agents|mesh-ancestor
111239063|NCT04776850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111239064|NCT04776850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111239065|NCT04776850|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111239066|NCT04776850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111239067|NCT04776850|Antiemetics|antiemetics|mesh-ancestor
111239068|NCT04776850|Autonomic Agents|autonomic agents|mesh-ancestor
111239069|NCT04776850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111239070|NCT04776850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111239071|NCT04776850|Glucocorticoids|glucocorticoids|mesh-ancestor
111239072|NCT04776850|Hormones|hormones|mesh-ancestor
111239073|NCT04776850|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111239074|NCT04776850|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111239075|NCT04776850|Protease Inhibitors|protease inhibitors|mesh-ancestor
111239076|NCT04776850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111239077|NCT04776850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111239078|NCT04776850|Antimetabolites|antimetabolites|mesh-ancestor
111239079|NCT04776850|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111239080|NCT04776850|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111239081|NCT04776850|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111239082|NCT04776850|Antitubercular Agents|antitubercular agents|mesh-ancestor
111239083|NCT04776850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111239084|NCT04776850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111239085|NCT04132648|Curcumin|curcumin|mesh-list
111239086|NCT04132648|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111239087|NCT04132648|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111239088|NCT04132648|Analgesics|analgesics|mesh-ancestor
111239089|NCT04132648|Sensory System Agents|sensory system agents|mesh-ancestor
111239090|NCT04132648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111239091|NCT04132648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111239092|NCT04132648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111239093|NCT04132648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111239094|NCT04132648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111239095|NCT04132648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111239096|NCT04132648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111239097|NCT02331940|Tiotropium Bromide|tiotropium bromide|mesh-list
111239098|NCT02331940|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111239099|NCT02331940|Autonomic Agents|autonomic agents|mesh-ancestor
111239100|NCT02331940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111239101|NCT02331940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111239102|NCT02331940|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111239103|NCT02331940|Respiratory System Agents|respiratory system agents|mesh-ancestor
111239104|NCT02331940|Parasympatholytics|parasympatholytics|mesh-ancestor
111239105|NCT02331940|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111239106|NCT02331940|Cholinergic Agents|cholinergic agents|mesh-ancestor
111239107|NCT02331940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111239108|NCT02331940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111239109|NCT04095208|Nivolumab|nivolumab|mesh-list
111239110|NCT04095208|Relatlimab|relatlimab|mesh-list
111239111|NCT04095208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111239112|NCT04095208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111239113|NCT04095208|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111239114|NCT04095208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111239115|NCT02292082|Cefazolin|cefazolin|mesh-list
111239116|NCT02292082|Dexamethasone|dexamethasone|mesh-list
111239117|NCT02292082|Methylprednisolone|methylprednisolone|mesh-list
111239118|NCT02292082|Midazolam|midazolam|mesh-list
111239119|NCT02292082|Morphine|morphine|mesh-list
111239120|NCT02292082|Bupivacaine|bupivacaine|mesh-list
111239121|NCT02292082|Propofol|propofol|mesh-list
111239122|NCT02292082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111239123|NCT02292082|Antiemetics|antiemetics|mesh-ancestor
111239124|NCT02292082|Autonomic Agents|autonomic agents|mesh-ancestor
111239125|NCT02292082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111239126|NCT02292082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111239127|NCT02292082|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111239128|NCT02292082|Glucocorticoids|glucocorticoids|mesh-ancestor
111239129|NCT02292082|Hormones|hormones|mesh-ancestor
111239130|NCT02292082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111239131|NCT02292082|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111239132|NCT02292082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111239133|NCT02292082|Anesthetics, Local|anesthetics, local|mesh-ancestor
111239134|NCT02292082|Anesthetics|anesthetics|mesh-ancestor
111239135|NCT02292082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111239136|NCT02292082|Sensory System Agents|sensory system agents|mesh-ancestor
111239137|NCT02292082|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111239138|NCT02292082|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111239139|NCT02292082|Anesthetics, General|anesthetics, general|mesh-ancestor
111239140|NCT02292082|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111239141|NCT02292082|Narcotics|narcotics|mesh-ancestor
111239142|NCT02292082|Analgesics|analgesics|mesh-ancestor
111239143|NCT02292082|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111239144|NCT02292082|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111239145|NCT02292082|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111239146|NCT02292082|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111239147|NCT02292082|GABA Modulators|gaba modulators|mesh-ancestor
111239148|NCT02292082|GABA Agents|gaba agents|mesh-ancestor
111239149|NCT02292082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111239150|NCT02292082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111239151|NCT02292082|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111239152|NCT02292082|Protective Agents|protective agents|mesh-ancestor
111239153|NCT02292082|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111239154|NCT02292082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111239156|NCT05072704|Dexmedetomidine|dexmedetomidine|mesh-list
111239157|NCT05072704|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111239158|NCT05072704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111239159|NCT05072704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111239160|NCT05072704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111239161|NCT05072704|Analgesics|analgesics|mesh-ancestor
111239162|NCT05072704|Sensory System Agents|sensory system agents|mesh-ancestor
111239163|NCT05072704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111239164|NCT05072704|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111239165|NCT05072704|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111239166|NCT05072704|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111239167|NCT05072704|Adrenergic Agents|adrenergic agents|mesh-ancestor
111239168|NCT05072704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111239169|NCT05072704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111239170|NCT05072704|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111239171|NCT05072704|Narcotics|narcotics|mesh-ancestor
111239172|NCT05072704|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111239173|NCT05072704|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111239174|NCT05072704|Anesthetics, General|anesthetics, general|mesh-ancestor
111239175|NCT05072704|Anesthetics|anesthetics|mesh-ancestor
111239176|NCT04678336|Cyclophosphamide|cyclophosphamide|mesh-list
111239177|NCT04678336|Fludarabine|fludarabine|mesh-list
111239178|NCT04678336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111239179|NCT04678336|Immunologic Factors|immunologic factors|mesh-ancestor
111239180|NCT04678336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111239181|NCT04678336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111239182|NCT04678336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111239183|NCT04678336|Alkylating Agents|alkylating agents|mesh-ancestor
111239184|NCT04678336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111239185|NCT04678336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111239186|NCT04678336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111239188|NCT03195478|Ipilimumab|ipilimumab|mesh-list
111239189|NCT03195478|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111239190|NCT03195478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111239191|NCT03195478|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111239192|NCT03195478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111239193|NCT04607122|Landiolol|landiolol|mesh-list
111239194|NCT04607122|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111239195|NCT04607122|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111239196|NCT04607122|Adrenergic Agents|adrenergic agents|mesh-ancestor
111239197|NCT04607122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111239198|NCT04607122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111239199|NCT04607122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111239200|NCT04607122|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111239201|NCT03099382|Docetaxel|docetaxel|mesh-list
111239202|NCT03099382|Irinotecan|irinotecan|mesh-list
111239203|NCT03099382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111239204|NCT03099382|Tubulin Modulators|tubulin modulators|mesh-ancestor
111239205|NCT03099382|Antimitotic Agents|antimitotic agents|mesh-ancestor
111239206|NCT03099382|Mitosis Modulators|mitosis modulators|mesh-ancestor
111239207|NCT03099382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111239208|NCT03099382|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111239209|NCT03099382|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111239210|NCT03099382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111239211|NCT04590664|Verteporfin|verteporfin|mesh-list
111239212|NCT04590664|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111239213|NCT04590664|Dermatologic Agents|dermatologic agents|mesh-ancestor
111239214|NCT04494412|Zanamivir|zanamivir|mesh-list
111239215|NCT04494412|Antiviral Agents|antiviral agents|mesh-ancestor
111239216|NCT04494412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111239217|NCT04494412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111239218|NCT04494412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111239219|NCT03583528|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
111239220|NCT03583528|Edotreotide|edotreotide|mesh-list
111239221|NCT03583528|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111239222|NCT03583528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111239223|NCT03578146|Rivaroxaban|rivaroxaban|mesh-list
111239224|NCT03578146|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111239225|NCT03578146|Antithrombins|antithrombins|mesh-ancestor
111239226|NCT03578146|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111239227|NCT03578146|Protease Inhibitors|protease inhibitors|mesh-ancestor
111239228|NCT03578146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110963535|NCT05512546|Antipyretics|antipyretics|mesh-ancestor
111239229|NCT03578146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111239231|NCT02518594|Progesterone|progesterone|mesh-list
111239232|NCT02518594|Progestins|progestins|mesh-ancestor
111239233|NCT02518594|Hormones|hormones|mesh-ancestor
111239234|NCT02518594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111239235|NCT02518594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111239236|NCT01516593|Cytarabine|cytarabine|mesh-list
111239237|NCT01516593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111239238|NCT01516593|Antimetabolites|antimetabolites|mesh-ancestor
111239239|NCT01516593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111239240|NCT01516593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111239241|NCT01516593|Antiviral Agents|antiviral agents|mesh-ancestor
111239242|NCT01516593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111239243|NCT01516593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111239244|NCT01516593|Immunologic Factors|immunologic factors|mesh-ancestor
111239245|NCT01516593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111239246|NCT02042391|Cytarabine|cytarabine|mesh-list
111239247|NCT02042391|Prednisone|prednisone|mesh-list
111239248|NCT02042391|Cyclophosphamide|cyclophosphamide|mesh-list
111239249|NCT02042391|Rituximab|rituximab|mesh-list
111239250|NCT02042391|Oxaliplatin|oxaliplatin|mesh-list
111239251|NCT02042391|Doxorubicin|doxorubicin|mesh-list
111239252|NCT02042391|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111239253|NCT02042391|Vincristine|vincristine|mesh-list
111239254|NCT02042391|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111239255|NCT02042391|Immunologic Factors|immunologic factors|mesh-ancestor
111239256|NCT02042391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111239257|NCT02042391|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111239258|NCT02042391|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111239259|NCT02042391|Alkylating Agents|alkylating agents|mesh-ancestor
111239260|NCT02042391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111239261|NCT02042391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111239262|NCT02042391|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111239263|NCT02042391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111239264|NCT02042391|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111239265|NCT02042391|Glucocorticoids|glucocorticoids|mesh-ancestor
111239266|NCT02042391|Hormones|hormones|mesh-ancestor
111239267|NCT02042391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111239268|NCT02042391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111239269|NCT02042391|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111239270|NCT02042391|Antimetabolites|antimetabolites|mesh-ancestor
111239271|NCT02042391|Antiviral Agents|antiviral agents|mesh-ancestor
111239272|NCT02042391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111239273|NCT02042391|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111239274|NCT02042391|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111239275|NCT02042391|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111239276|NCT02042391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111239277|NCT02042391|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111239278|NCT02042391|Tubulin Modulators|tubulin modulators|mesh-ancestor
111239279|NCT02042391|Antimitotic Agents|antimitotic agents|mesh-ancestor
110818882|NCT00496873|Rituximab|rituximab|mesh-list
111239280|NCT02042391|Mitosis Modulators|mitosis modulators|mesh-ancestor
111239281|NCT02461836|Gemcitabine|gemcitabine|mesh-list
111239282|NCT02461836|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111239283|NCT02461836|Antimetabolites|antimetabolites|mesh-ancestor
111239284|NCT02461836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111239285|NCT02461836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111239286|NCT02034981|Crizotinib|crizotinib|mesh-list
111239287|NCT02034981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111239288|NCT02034981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111239289|NCT02034981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111239290|NCT02034981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111239291|NCT01986946|Hydromorphone|hydromorphone|mesh-list
111239292|NCT01986946|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111239293|NCT01986946|Narcotics|narcotics|mesh-ancestor
111239294|NCT01986946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111239295|NCT01986946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111239296|NCT01986946|Analgesics|analgesics|mesh-ancestor
111239297|NCT01986946|Sensory System Agents|sensory system agents|mesh-ancestor
111239298|NCT01986946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111239299|NCT02427724|Lidocaine|lidocaine|mesh-list
111239300|NCT02427724|Tetracaine|tetracaine|mesh-list
111239301|NCT02427724|Prilocaine|prilocaine|mesh-list
111239302|NCT02427724|Anesthetics, Local|anesthetics, local|mesh-list
111239303|NCT02427724|Anesthetics|anesthetics|mesh-list
111239304|NCT02427724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111239305|NCT02427724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111239306|NCT02427724|Sensory System Agents|sensory system agents|mesh-ancestor
111239307|NCT02427724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111239308|NCT02427724|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111239309|NCT02427724|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111239310|NCT02427724|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111239311|NCT02427724|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111239312|NCT02427724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111239313|NCT03437200|Nivolumab|nivolumab|mesh-list
111239314|NCT03437200|Ipilimumab|ipilimumab|mesh-list
111239315|NCT03437200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111239316|NCT03437200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111239317|NCT03437200|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111239318|NCT03437200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111239319|NCT01903473|Sirolimus|sirolimus|mesh-list
111239320|NCT01903473|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111239321|NCT01903473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111239322|NCT01903473|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111239323|NCT01903473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111239324|NCT01903473|Antifungal Agents|antifungal agents|mesh-ancestor
111239325|NCT01903473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111239326|NCT01903473|Immunologic Factors|immunologic factors|mesh-ancestor
111239327|NCT01903473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111239328|NCT02715726|Atorvastatin|atorvastatin|mesh-list
111239329|NCT02715726|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111239330|NCT02715726|Simvastatin|simvastatin|mesh-list
111239331|NCT02715726|Ezetimibe|ezetimibe|mesh-list
111239332|NCT02715726|Alirocumab|alirocumab|mesh-list
111239333|NCT02715726|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111239334|NCT02715726|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111239335|NCT02715726|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111239336|NCT02715726|Antimetabolites|antimetabolites|mesh-ancestor
111239337|NCT02715726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111239338|NCT02715726|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111239339|NCT02715726|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111239340|NCT02715726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111239341|NCT02715726|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
111239342|NCT02715726|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111239343|NCT02715726|Protease Inhibitors|protease inhibitors|mesh-ancestor
111239344|NCT02715726|Immunologic Factors|immunologic factors|mesh-ancestor
111239345|NCT02715726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111239346|NCT01893567|Clobetasol|clobetasol|mesh-list
111239347|NCT01893567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111239348|NCT01893567|Glucocorticoids|glucocorticoids|mesh-ancestor
111239349|NCT01893567|Hormones|hormones|mesh-ancestor
111239350|NCT01893567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111239351|NCT01893567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111239352|NCT04249596|Tianeptine|tianeptine|mesh-list
111239353|NCT04249596|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
111239354|NCT04249596|Antidepressive Agents|antidepressive agents|mesh-ancestor
111239355|NCT04249596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111239356|NCT01476501|Vitamin D|vitamin d|mesh-list
111239357|NCT01476501|Cholecalciferol|cholecalciferol|mesh-list
111239358|NCT01476501|Vitamins|vitamins|mesh-ancestor
111239359|NCT01476501|Micronutrients|micronutrients|mesh-ancestor
111239360|NCT01476501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111239361|NCT01476501|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111239362|NCT01476501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111239363|NCT03426124|Fibrinolytic Agents|fibrinolytic agents|mesh-list
111239364|NCT03426124|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111239365|NCT03426124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111239366|NCT02464020|Vancomycin|vancomycin|mesh-list
111239367|NCT02464020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111239368|NCT02464020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111239369|NCT04756089|Oxytocin|oxytocin|mesh-list
111239370|NCT04756089|Oxytocics|oxytocics|mesh-ancestor
111239371|NCT04756089|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111239372|NCT04756089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111239373|NCT03397888|Betrixaban|betrixaban|mesh-list
111239374|NCT03397888|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111239375|NCT03397888|Antithrombins|antithrombins|mesh-ancestor
111239376|NCT03397888|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111239377|NCT03397888|Protease Inhibitors|protease inhibitors|mesh-ancestor
111239378|NCT03397888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110963695|NCT04500704|Pemetrexed|pemetrexed|mesh-list
111239379|NCT03397888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111239380|NCT03397888|Anticoagulants|anticoagulants|mesh-ancestor
111239381|NCT01886859|Lenalidomide|lenalidomide|mesh-list
111239382|NCT01886859|Immunologic Factors|immunologic factors|mesh-ancestor
111239383|NCT01886859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111239384|NCT01886859|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111239385|NCT01886859|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111239386|NCT01886859|Growth Substances|growth substances|mesh-ancestor
111239387|NCT01886859|Growth Inhibitors|growth inhibitors|mesh-ancestor
111239388|NCT01886859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111239389|NCT01989910|Efavirenz|efavirenz|mesh-list
111239390|NCT01989910|Raltegravir Potassium|raltegravir potassium|mesh-list
111239391|NCT01989910|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111239392|NCT01989910|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111239393|NCT01989910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111239394|NCT01989910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111239395|NCT01989910|Antiviral Agents|antiviral agents|mesh-ancestor
111239396|NCT01989910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111239397|NCT01989910|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111239398|NCT01989910|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111239399|NCT01989910|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111239400|NCT01989910|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111239401|NCT01989910|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111239402|NCT01989910|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111239403|NCT01989910|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111239404|NCT01989910|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111239405|NCT01989910|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111239406|NCT01989910|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111239407|NCT02464722|Epinephrine|epinephrine|mesh-list
111239408|NCT02464722|Dexmedetomidine|dexmedetomidine|mesh-list
111239409|NCT02464722|Remifentanil|remifentanil|mesh-list
111239410|NCT02464722|Propofol|propofol|mesh-list
111239411|NCT02464722|Rocuronium|rocuronium|mesh-list
111239412|NCT02464722|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111239413|NCT02464722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111239414|NCT02464722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111239415|NCT02464722|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111239416|NCT02464722|Analgesics|analgesics|mesh-ancestor
111239417|NCT02464722|Sensory System Agents|sensory system agents|mesh-ancestor
111239418|NCT02464722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111239419|NCT02464722|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111239420|NCT02464722|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111239421|NCT02464722|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111239422|NCT02464722|Adrenergic Agents|adrenergic agents|mesh-ancestor
111239423|NCT02464722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111239424|NCT02464722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111239425|NCT02464722|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111239426|NCT02464722|Anesthetics, General|anesthetics, general|mesh-ancestor
111239427|NCT02464722|Anesthetics|anesthetics|mesh-ancestor
111239428|NCT02464722|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111239429|NCT02464722|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111239430|NCT02464722|Autonomic Agents|autonomic agents|mesh-ancestor
111239431|NCT02464722|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111239432|NCT02464722|Respiratory System Agents|respiratory system agents|mesh-ancestor
111239433|NCT02464722|Mydriatics|mydriatics|mesh-ancestor
111239434|NCT02464722|Sympathomimetics|sympathomimetics|mesh-ancestor
111239435|NCT02464722|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111239436|NCT02464722|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111239437|NCT02464722|Narcotics|narcotics|mesh-ancestor
111239438|NCT02464722|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
111239439|NCT02464722|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
111239440|NCT02464722|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111239441|NCT01991548|Insulin|insulin|mesh-list
111239442|NCT01991548|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111239443|NCT01991548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111239444|NCT03298854|Technetium Tc 99m Medronate|technetium tc 99m medronate|mesh-list
111239445|NCT03298854|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111239446|NCT03298854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111239447|NCT02461914|Warfarin|warfarin|mesh-list
111239448|NCT02461914|Anticoagulants|anticoagulants|mesh-ancestor
111239449|NCT01991860|Amisulpride|amisulpride|mesh-list
111239450|NCT01991860|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111239451|NCT01991860|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111239452|NCT01991860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111239453|NCT01991860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111239454|NCT01991860|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110963763|NCT04500002|Antimetabolites|antimetabolites|mesh-ancestor
111239456|NCT01991860|Dopamine Agents|dopamine agents|mesh-ancestor
111239457|NCT01991860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111239458|NCT01991860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111239459|NCT01991860|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111239460|NCT01991860|Antidepressive Agents|antidepressive agents|mesh-ancestor
111239461|NCT01873131|Timolol|timolol|mesh-list
111239462|NCT01873131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111239463|NCT01873131|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111239464|NCT01873131|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111239465|NCT01873131|Adrenergic Agents|adrenergic agents|mesh-ancestor
111239466|NCT01873131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111239467|NCT01873131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111239468|NCT01873131|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111239469|NCT01873131|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111239470|NCT02463552|Naproxen|naproxen|mesh-list
111239471|NCT02463552|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111239472|NCT02463552|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111239473|NCT02463552|Analgesics|analgesics|mesh-ancestor
111239474|NCT02463552|Sensory System Agents|sensory system agents|mesh-ancestor
111239475|NCT02463552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111239476|NCT02463552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111239477|NCT02463552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111239478|NCT02463552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111239479|NCT02463552|Gout Suppressants|gout suppressants|mesh-ancestor
111239480|NCT02463552|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111239481|NCT02463552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111239482|NCT02463552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111239483|NCT01992016|Ranolazine|ranolazine|mesh-list
111239484|NCT01992016|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111239485|NCT01992016|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111239486|NCT01992016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111239487|NCT01871571|Leucovorin|leucovorin|mesh-list
111239488|NCT01871571|Bevacizumab|bevacizumab|mesh-list
111239489|NCT01871571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111239490|NCT01871571|Fluorouracil|fluorouracil|mesh-list
111239491|NCT01871571|Oxaliplatin|oxaliplatin|mesh-list
111239492|NCT01871571|Antibodies|antibodies|mesh-list
111239493|NCT01871571|Immunoglobulins|immunoglobulins|mesh-list
111239494|NCT01871571|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111239495|NCT01871571|Levoleucovorin|levoleucovorin|mesh-list
111239496|NCT01871571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111239497|NCT01871571|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111239498|NCT01871571|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111239499|NCT01871571|Growth Substances|growth substances|mesh-ancestor
111239500|NCT01871571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111239501|NCT01871571|Growth Inhibitors|growth inhibitors|mesh-ancestor
111239502|NCT01871571|Immunologic Factors|immunologic factors|mesh-ancestor
111239503|NCT01871571|Antimetabolites|antimetabolites|mesh-ancestor
110980771|NCT00658047|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111239504|NCT01871571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111239505|NCT01871571|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111239506|NCT01871571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111239507|NCT01871571|Antidotes|antidotes|mesh-ancestor
111239508|NCT01871571|Protective Agents|protective agents|mesh-ancestor
111239509|NCT01871571|Vitamin B Complex|vitamin b complex|mesh-ancestor
111239510|NCT01871571|Vitamins|vitamins|mesh-ancestor
111239511|NCT01871571|Micronutrients|micronutrients|mesh-ancestor
111239512|NCT01422759|Spironolactone|spironolactone|mesh-list
111239513|NCT01422759|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
111239514|NCT01422759|Hormone Antagonists|hormone antagonists|mesh-ancestor
111239515|NCT01422759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111239516|NCT01422759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111239517|NCT01422759|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
111239518|NCT01422759|Diuretics|diuretics|mesh-ancestor
111239519|NCT01422759|Natriuretic Agents|natriuretic agents|mesh-ancestor
111239520|NCT01992172|Sunscreening Agents|sunscreening agents|mesh-list
111239521|NCT01992172|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111239522|NCT01992172|Protective Agents|protective agents|mesh-ancestor
111239523|NCT01992172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111239524|NCT01992172|Dermatologic Agents|dermatologic agents|mesh-ancestor
111239525|NCT03296982|Enoxaparin|enoxaparin|mesh-list
111239526|NCT03296982|Edoxaban|edoxaban|mesh-list
111239527|NCT03296982|Anticoagulants|anticoagulants|mesh-ancestor
111239528|NCT03296982|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111239529|NCT03296982|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111239530|NCT03296982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111239532|NCT03296982|Antithrombins|antithrombins|mesh-ancestor
111239533|NCT03296982|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111239534|NCT03296982|Protease Inhibitors|protease inhibitors|mesh-ancestor
111239535|NCT03296982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111239536|NCT01895829|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
111239537|NCT01895829|Hematinics|hematinics|mesh-ancestor
111239538|NCT01895829|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
111239539|NCT01895829|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111239540|NCT03298698|Prednisone|prednisone|mesh-list
111239541|NCT03298698|Prednisolone|prednisolone|mesh-list
111239542|NCT03298698|Rituximab|rituximab|mesh-list
111239543|NCT03298698|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111239544|NCT03298698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111239545|NCT03298698|Immunologic Factors|immunologic factors|mesh-ancestor
111239546|NCT03298698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111239547|NCT03298698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111239548|NCT03298698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111239549|NCT03298698|Glucocorticoids|glucocorticoids|mesh-ancestor
111239550|NCT03298698|Hormones|hormones|mesh-ancestor
111239551|NCT03298698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111239552|NCT03298698|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111239553|NCT03389620|Dexamethasone|dexamethasone|mesh-list
111239554|NCT03389620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111239555|NCT03389620|Antiemetics|antiemetics|mesh-ancestor
111239556|NCT03389620|Autonomic Agents|autonomic agents|mesh-ancestor
111239557|NCT03389620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111239558|NCT03389620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111239559|NCT03389620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111239560|NCT03389620|Glucocorticoids|glucocorticoids|mesh-ancestor
111239561|NCT03389620|Hormones|hormones|mesh-ancestor
111239562|NCT03389620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111239563|NCT03389620|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111239564|NCT03389620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111239565|NCT02463942|Doxycycline|doxycycline|mesh-list
111239566|NCT02463942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111239567|NCT02463942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111239568|NCT02463942|Antimalarials|antimalarials|mesh-ancestor
111239569|NCT02463942|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111239570|NCT02463942|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111239571|NCT03298542|Golimumab|golimumab|mesh-list
111239572|NCT03298542|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111239573|NCT03298542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111239574|NCT03298542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111239575|NCT03298542|Immunologic Factors|immunologic factors|mesh-ancestor
111239576|NCT03298542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111239577|NCT03296670|Nitroglycerin|nitroglycerin|mesh-list
111239578|NCT03296670|Alprostadil|alprostadil|mesh-list
111239579|NCT03296670|Vasodilator Agents|vasodilator agents|mesh-ancestor
111239580|NCT03296670|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111239581|NCT03296670|Urological Agents|urological agents|mesh-ancestor
111239582|NCT03298464|Pioglitazone|pioglitazone|mesh-list
111239583|NCT03298464|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111239584|NCT03298464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111239585|NCT01852071|Busulfan|busulfan|mesh-list
111239586|NCT01852071|Alkylating Agents|alkylating agents|mesh-ancestor
111239587|NCT01852071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111239588|NCT01852071|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111239589|NCT01852071|Immunologic Factors|immunologic factors|mesh-ancestor
111239590|NCT01852071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111239591|NCT01852071|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111239592|NCT01852071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111239593|NCT01852071|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111239594|NCT04084548|Lidocaine|lidocaine|mesh-list
111239595|NCT04084548|Ketamine|ketamine|mesh-list
111239596|NCT04084548|Anesthetics, Local|anesthetics, local|mesh-ancestor
111239597|NCT04084548|Anesthetics|anesthetics|mesh-ancestor
111239598|NCT04084548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111239599|NCT04084548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111239600|NCT04084548|Sensory System Agents|sensory system agents|mesh-ancestor
111239601|NCT04084548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111239602|NCT04084548|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111239603|NCT04084548|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111239604|NCT04084548|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110963920|NCT02171013|Dabigatran|dabigatran|mesh-list
111239605|NCT04084548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111239606|NCT04084548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111239607|NCT04084548|Analgesics|analgesics|mesh-ancestor
111239608|NCT04084548|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111239609|NCT04084548|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111239610|NCT04084548|Anesthetics, General|anesthetics, general|mesh-ancestor
111239611|NCT04084548|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111239612|NCT04084548|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111239613|NCT04084548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111239615|NCT02059642|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111239616|NCT03296358|Dexamethasone|dexamethasone|mesh-list
111239617|NCT03296358|Prednisolone|prednisolone|mesh-list
111239618|NCT03296358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111239619|NCT03296358|Antiemetics|antiemetics|mesh-ancestor
111239620|NCT03296358|Autonomic Agents|autonomic agents|mesh-ancestor
111239621|NCT03296358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111239622|NCT03296358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111239623|NCT03296358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111239624|NCT03296358|Glucocorticoids|glucocorticoids|mesh-ancestor
111239625|NCT03296358|Hormones|hormones|mesh-ancestor
111239626|NCT03296358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111239627|NCT03296358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111239628|NCT03296358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111239629|NCT04756323|Vaccines|vaccines|mesh-list
111239630|NCT04756323|Immunologic Factors|immunologic factors|mesh-ancestor
111239631|NCT04756323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111239632|NCT00469755|Nicotinic Acids|nicotinic acids|mesh-list
111239633|NCT00469755|Adapalene|adapalene|mesh-list
111239634|NCT00469755|Tazarotene|tazarotene|mesh-list
111239635|NCT00469755|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111239636|NCT00469755|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111239637|NCT00469755|Analgesics|analgesics|mesh-ancestor
111239638|NCT00469755|Sensory System Agents|sensory system agents|mesh-ancestor
111239639|NCT00469755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111239640|NCT00469755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111239641|NCT00469755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111239642|NCT00469755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111239643|NCT00469755|Dermatologic Agents|dermatologic agents|mesh-ancestor
111239644|NCT00469755|Keratolytic Agents|keratolytic agents|mesh-ancestor
111239645|NCT00469755|Vitamin B Complex|vitamin b complex|mesh-ancestor
111239646|NCT00469755|Vitamins|vitamins|mesh-ancestor
111239647|NCT00469755|Micronutrients|micronutrients|mesh-ancestor
111239648|NCT00453531|Acetylcholine|acetylcholine|mesh-list
111239649|NCT00453531|Vasodilator Agents|vasodilator agents|mesh-ancestor
111239650|NCT00453531|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111239651|NCT00453531|Cholinergic Agents|cholinergic agents|mesh-ancestor
111239652|NCT00453531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111239653|NCT00453531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111239654|NCT00453531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111239655|NCT03295968|Ibuprofen|ibuprofen|mesh-list
111239656|NCT03295968|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111239657|NCT03295968|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111239658|NCT03295968|Analgesics|analgesics|mesh-ancestor
111239659|NCT03295968|Sensory System Agents|sensory system agents|mesh-ancestor
111239660|NCT03295968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111239661|NCT03295968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111239662|NCT03295968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111239663|NCT03295968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111239664|NCT03295968|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111239665|NCT03295968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111239666|NCT03295968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111239667|NCT03298074|Etoposide|etoposide|mesh-list
111239668|NCT03298074|Apatinib|apatinib|mesh-list
111239669|NCT03298074|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111239670|NCT03298074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111239671|NCT03298074|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111239672|NCT03298074|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111239673|NCT03298074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111239674|NCT03298074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111239675|NCT03298074|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111239676|NCT01992874|Niacinamide|niacinamide|mesh-list
111239677|NCT01992874|Vitamin B Complex|vitamin b complex|mesh-ancestor
111239678|NCT01992874|Vitamins|vitamins|mesh-ancestor
111239679|NCT01992874|Micronutrients|micronutrients|mesh-ancestor
111239680|NCT01992874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111239681|NCT04755543|Fluorouracil|fluorouracil|mesh-list
111239682|NCT04755543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111239683|NCT04755543|Antimetabolites|antimetabolites|mesh-ancestor
111239684|NCT04755543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111239685|NCT04755543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111239686|NCT04755543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111239687|NCT04755543|Immunologic Factors|immunologic factors|mesh-ancestor
111239688|NCT04755543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111239689|NCT01993108|Naltrexone|naltrexone|mesh-list
111239690|NCT01993108|Methylphenidate|methylphenidate|mesh-list
111239691|NCT01993108|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111239692|NCT01993108|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111239693|NCT01993108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111239694|NCT01993108|Sensory System Agents|sensory system agents|mesh-ancestor
111239695|NCT01993108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111239696|NCT01993108|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111239697|NCT01993108|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111239698|NCT01993108|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111239699|NCT01993108|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111239700|NCT01993108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111239701|NCT01993108|Dopamine Agents|dopamine agents|mesh-ancestor
111239702|NCT01993108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111239703|NCT02307526|Bromides|bromides|mesh-list
111239704|NCT02307526|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
111239705|NCT02307526|Anticonvulsants|anticonvulsants|mesh-ancestor
111239706|NCT02307526|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111239707|NCT02307526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111239708|NCT02307526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111239709|NCT02307526|Cholinergic Agents|cholinergic agents|mesh-ancestor
111239710|NCT02307526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111239711|NCT02307526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111239712|NCT01371201|Sunitinib|sunitinib|mesh-list
111239713|NCT01371201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111239714|NCT01371201|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111239715|NCT01371201|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111239716|NCT01371201|Growth Substances|growth substances|mesh-ancestor
111239717|NCT01371201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111239718|NCT01371201|Growth Inhibitors|growth inhibitors|mesh-ancestor
111239719|NCT01371201|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111239720|NCT01371201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111239721|NCT01371201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111239722|NCT00436527|Metronidazole|metronidazole|mesh-list
111239723|NCT00436527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111239724|NCT00436527|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111239725|NCT00436527|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111239726|NCT00436527|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111239727|NCT02307916|Mitogens|mitogens|mesh-list
111239728|NCT02307916|Mitosis Modulators|mitosis modulators|mesh-ancestor
111239729|NCT02307916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111239730|NCT00419367|Vorinostat|vorinostat|mesh-list
111239731|NCT00419367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111239732|NCT00419367|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111239733|NCT00419367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111239734|NCT00419367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111239735|NCT01994746|Glucagon|glucagon|mesh-list
111239736|NCT01994746|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
111239737|NCT01994746|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111239738|NCT01994746|Hormones|hormones|mesh-ancestor
111239739|NCT01994746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111239740|NCT01994746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111239741|NCT01994746|Incretins|incretins|mesh-ancestor
111239742|NCT00291525|Warfarin|warfarin|mesh-list
111239743|NCT00291525|Anticoagulants|anticoagulants|mesh-ancestor
111239744|NCT01337349|Pentoxifylline|pentoxifylline|mesh-list
111239745|NCT01337349|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111239746|NCT01337349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111239747|NCT01337349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111239748|NCT01337349|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111239749|NCT01337349|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111239750|NCT01337349|Protective Agents|protective agents|mesh-ancestor
111239751|NCT01337349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111239752|NCT01337349|Vasodilator Agents|vasodilator agents|mesh-ancestor
111239753|NCT01337349|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111239754|NCT01337349|Antioxidants|antioxidants|mesh-ancestor
111239755|NCT01999348|Timolol|timolol|mesh-list
111239756|NCT01999348|Bimatoprost|bimatoprost|mesh-list
111239757|NCT01999348|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111239758|NCT01999348|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111239759|NCT01999348|Adrenergic Agents|adrenergic agents|mesh-ancestor
111239760|NCT01999348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111239761|NCT01999348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111239762|NCT01999348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111239763|NCT01999348|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111239764|NCT01999348|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111239765|NCT00280761|Fluorouracil|fluorouracil|mesh-list
111239766|NCT00280761|Capecitabine|capecitabine|mesh-list
111239767|NCT00280761|Antimetabolites|antimetabolites|mesh-ancestor
111239768|NCT00280761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111239769|NCT00280761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111239770|NCT00280761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111239771|NCT00280761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111239772|NCT00280761|Immunologic Factors|immunologic factors|mesh-ancestor
111239773|NCT00280761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111239774|NCT02463318|Hydrogen Peroxide|hydrogen peroxide|mesh-list
111239775|NCT02463318|Melatonin|melatonin|mesh-list
111239776|NCT02463318|Antioxidants|antioxidants|mesh-ancestor
111239777|NCT02463318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111239778|NCT02463318|Protective Agents|protective agents|mesh-ancestor
111239779|NCT02463318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111239780|NCT02463318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111239781|NCT02463318|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111239782|NCT02463318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111239783|NCT01436968|Valacyclovir|valacyclovir|mesh-list
111239784|NCT01436968|Antiviral Agents|antiviral agents|mesh-ancestor
111239785|NCT01436968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111239786|NCT02462772|Cabotegravir|cabotegravir|mesh-list
111239787|NCT02462772|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
111239788|NCT02462772|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
111239789|NCT02462772|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
111239790|NCT02462772|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111239791|NCT02462772|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111239792|NCT02462772|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111239793|NCT02462772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111239794|NCT02462772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111239795|NCT02462772|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111239796|NCT02462772|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111239797|NCT02462772|Antiviral Agents|antiviral agents|mesh-ancestor
111239798|NCT02462772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111239799|NCT02716194|Factor VIII|factor viii|mesh-list
111239800|NCT02716194|Coagulants|coagulants|mesh-ancestor
111239801|NCT02461056|Ibuprofen|ibuprofen|mesh-list
111239802|NCT02461056|Hydromorphone|hydromorphone|mesh-list
111239803|NCT02461056|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111239804|NCT02461056|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111239805|NCT02461056|Analgesics|analgesics|mesh-ancestor
111239806|NCT02461056|Sensory System Agents|sensory system agents|mesh-ancestor
111239807|NCT02461056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111239808|NCT02461056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111239809|NCT02461056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111239810|NCT02461056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111239811|NCT02461056|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111239812|NCT02461056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111239813|NCT02461056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111239814|NCT02461056|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111239815|NCT02461056|Narcotics|narcotics|mesh-ancestor
111239816|NCT02461056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111239817|NCT01173172|Boron|boron|mesh-list
111239818|NCT01173172|Trace Elements|trace elements|mesh-ancestor
111239819|NCT01173172|Micronutrients|micronutrients|mesh-ancestor
111239820|NCT01173172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111239821|NCT00003270|Cyclosporine|cyclosporine|mesh-list
111239822|NCT00003270|Methylprednisolone|methylprednisolone|mesh-list
111239823|NCT00003270|Cyclophosphamide|cyclophosphamide|mesh-list
111239824|NCT00003270|Busulfan|busulfan|mesh-list
111239825|NCT00003270|Cyclosporins|cyclosporins|mesh-list
111239826|NCT00003270|Antilymphocyte Serum|antilymphocyte serum|mesh-list
111239827|NCT00003270|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111239828|NCT00003270|Immunologic Factors|immunologic factors|mesh-ancestor
111239829|NCT00003270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111239830|NCT00003270|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111239831|NCT00003270|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110964137|NCT02504138|Anesthetics|anesthetics|mesh-list
111239832|NCT00003270|Alkylating Agents|alkylating agents|mesh-ancestor
111239833|NCT00003270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111239834|NCT00003270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111239835|NCT00003270|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111239836|NCT00003270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111239837|NCT00003270|Antifungal Agents|antifungal agents|mesh-ancestor
111239838|NCT00003270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111239839|NCT00003270|Dermatologic Agents|dermatologic agents|mesh-ancestor
111239840|NCT00003270|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111239841|NCT00003270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111239842|NCT00003270|Antiemetics|antiemetics|mesh-ancestor
111239843|NCT00003270|Autonomic Agents|autonomic agents|mesh-ancestor
111239844|NCT00003270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111239845|NCT00003270|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111239846|NCT00003270|Glucocorticoids|glucocorticoids|mesh-ancestor
111239847|NCT00003270|Hormones|hormones|mesh-ancestor
111239848|NCT00003270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111239849|NCT00003270|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111239850|NCT00003270|Protective Agents|protective agents|mesh-ancestor
111239851|NCT02005354|Nitrous Oxide|nitrous oxide|mesh-list
111239852|NCT02005354|Anesthetics|anesthetics|mesh-list
111239853|NCT02005354|Anesthetics, Local|anesthetics, local|mesh-list
111239854|NCT02005354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111239855|NCT02005354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111239856|NCT02005354|Sensory System Agents|sensory system agents|mesh-ancestor
111239857|NCT02005354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111239858|NCT02005354|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111239859|NCT02005354|Anesthetics, General|anesthetics, general|mesh-ancestor
111239860|NCT02005354|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111239861|NCT02005354|Analgesics|analgesics|mesh-ancestor
111239862|NCT03290820|Aspirin|aspirin|mesh-list
111239863|NCT03290820|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111239864|NCT03290820|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111239865|NCT03290820|Analgesics|analgesics|mesh-ancestor
111239866|NCT03290820|Sensory System Agents|sensory system agents|mesh-ancestor
111239867|NCT03290820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111239868|NCT03290820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111239869|NCT03290820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111239870|NCT03290820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111239871|NCT03290820|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111239872|NCT03290820|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111239873|NCT03290820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111239874|NCT03290820|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111239875|NCT03290820|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110819500|NCT02295046|Amlodipine|amlodipine|mesh-list
111239876|NCT03290820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111239877|NCT03290820|Antipyretics|antipyretics|mesh-ancestor
111239878|NCT03295110|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111239879|NCT03773484|Analgesics, Opioid|analgesics, opioid|mesh-list
111239880|NCT03773484|Narcotics|narcotics|mesh-ancestor
111239881|NCT03773484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111239882|NCT03773484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111239883|NCT03773484|Analgesics|analgesics|mesh-ancestor
111239884|NCT03773484|Sensory System Agents|sensory system agents|mesh-ancestor
111239885|NCT03773484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111239886|NCT03283410|Propofol|propofol|mesh-list
111239887|NCT03283410|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111239888|NCT03283410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111239889|NCT03283410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111239890|NCT03283410|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111239891|NCT03283410|Anesthetics, General|anesthetics, general|mesh-ancestor
111239892|NCT03283410|Anesthetics|anesthetics|mesh-ancestor
111239893|NCT04318704|Ifenprodil|ifenprodil|mesh-list
111239894|NCT04318704|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111239895|NCT04318704|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111239896|NCT04318704|Adrenergic Agents|adrenergic agents|mesh-ancestor
111239897|NCT04318704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111239898|NCT04318704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111239899|NCT04318704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111239900|NCT04318704|Vasodilator Agents|vasodilator agents|mesh-ancestor
111239901|NCT04318704|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111239902|NCT04318704|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111239903|NCT03283176|Folic Acid|folic acid|mesh-list
111239904|NCT03283176|Vitamin B 12|vitamin b 12|mesh-list
111239905|NCT03283176|Hydroxocobalamin|hydroxocobalamin|mesh-list
111239906|NCT03283176|Vitamins|vitamins|mesh-ancestor
110964220|NCT02503904|Autonomic Agents|autonomic agents|mesh-ancestor
111239907|NCT03283176|Micronutrients|micronutrients|mesh-ancestor
111239908|NCT03283176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111239909|NCT03283176|Hematinics|hematinics|mesh-ancestor
111239910|NCT03283176|Vitamin B Complex|vitamin b complex|mesh-ancestor
111239911|NCT03290430|Nicotine|nicotine|mesh-list
111239912|NCT03290430|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111239913|NCT03290430|Autonomic Agents|autonomic agents|mesh-ancestor
111239914|NCT03290430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111239915|NCT03290430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111239916|NCT03290430|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111239917|NCT03290430|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111239918|NCT03290430|Cholinergic Agents|cholinergic agents|mesh-ancestor
111239919|NCT03290430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111239920|NCT03290430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111239921|NCT03294798|Interferons|interferons|mesh-list
111239922|NCT03294798|Interferon-alpha|interferon-alpha|mesh-list
111239923|NCT03294798|Interferon alpha-2|interferon alpha-2|mesh-list
111239924|NCT03294798|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
111239925|NCT03294798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111239926|NCT03294798|Antiviral Agents|antiviral agents|mesh-ancestor
111239927|NCT03294798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111239928|NCT03294798|Immunologic Factors|immunologic factors|mesh-ancestor
111239929|NCT03294798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111239930|NCT04488744|Nicotine|nicotine|mesh-list
111239931|NCT04488744|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111239932|NCT04488744|Autonomic Agents|autonomic agents|mesh-ancestor
111239933|NCT04488744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111239934|NCT04488744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111239935|NCT04488744|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111239936|NCT04488744|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111239937|NCT04488744|Cholinergic Agents|cholinergic agents|mesh-ancestor
111239938|NCT04488744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111239939|NCT04488744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111239940|NCT02005666|Clindamycin|clindamycin|mesh-list
111239941|NCT02005666|Clindamycin palmitate|clindamycin palmitate|mesh-list
111239942|NCT02005666|Clindamycin phosphate|clindamycin phosphate|mesh-list
111239943|NCT02005666|Benzoyl Peroxide|benzoyl peroxide|mesh-list
111239944|NCT02005666|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111239945|NCT02005666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111239946|NCT02005666|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111239947|NCT02005666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111239948|NCT02005666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111239949|NCT02005666|Dermatologic Agents|dermatologic agents|mesh-ancestor
111239950|NCT03283020|Naltrexone|naltrexone|mesh-list
111239951|NCT03283020|Remifentanil|remifentanil|mesh-list
111239952|NCT03283020|Methylnaltrexone|methylnaltrexone|mesh-list
111239953|NCT03283020|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111239954|NCT03283020|Narcotics|narcotics|mesh-ancestor
111239955|NCT03283020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111239956|NCT03283020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111239957|NCT03283020|Analgesics|analgesics|mesh-ancestor
111239958|NCT03283020|Sensory System Agents|sensory system agents|mesh-ancestor
111239959|NCT03283020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111239960|NCT03283020|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111239961|NCT03283020|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111239962|NCT00494182|Paclitaxel|paclitaxel|mesh-list
111239963|NCT00494182|Carboplatin|carboplatin|mesh-list
111239964|NCT00494182|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111239965|NCT00494182|Sorafenib|sorafenib|mesh-list
111239966|NCT00494182|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111239967|NCT00494182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111239968|NCT00494182|Tubulin Modulators|tubulin modulators|mesh-ancestor
111239969|NCT00494182|Antimitotic Agents|antimitotic agents|mesh-ancestor
111239970|NCT00494182|Mitosis Modulators|mitosis modulators|mesh-ancestor
111239971|NCT00494182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111239972|NCT00494182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111239973|NCT00494182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111239974|NCT02006056|Ondansetron|ondansetron|mesh-list
111239975|NCT02006056|Antiemetics|antiemetics|mesh-ancestor
111239976|NCT02006056|Autonomic Agents|autonomic agents|mesh-ancestor
111239977|NCT02006056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111239978|NCT02006056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111239979|NCT02006056|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111239980|NCT02006056|Antipruritics|antipruritics|mesh-ancestor
111239981|NCT02006056|Dermatologic Agents|dermatologic agents|mesh-ancestor
111239982|NCT02006056|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111239983|NCT02006056|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111239984|NCT02006056|Serotonin Agents|serotonin agents|mesh-ancestor
111239985|NCT02006056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111239986|NCT02006056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111239987|NCT03290196|Bupivacaine|bupivacaine|mesh-list
111239988|NCT03290196|Anesthetics, Local|anesthetics, local|mesh-ancestor
111239989|NCT03290196|Anesthetics|anesthetics|mesh-ancestor
111239990|NCT03290196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111239991|NCT03290196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111239992|NCT03290196|Sensory System Agents|sensory system agents|mesh-ancestor
111239993|NCT03290196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111239994|NCT02006836|Insulin|insulin|mesh-list
111239995|NCT02006836|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111239996|NCT02006836|Metformin|metformin|mesh-list
111239997|NCT02006836|Insulin Aspart|insulin aspart|mesh-list
111239998|NCT02006836|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111239999|NCT02006836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111240000|NCT02068846|Ciprofloxacin|ciprofloxacin|mesh-list
111240001|NCT02068846|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111240002|NCT02068846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111240003|NCT02068846|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111240004|NCT02068846|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111240005|NCT02068846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111240006|NCT02068846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111240007|NCT02068846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111240008|NCT02068846|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111240009|NCT02068846|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111240010|NCT03294486|Flucytosine|flucytosine|mesh-list
111240011|NCT03294486|Antifungal Agents|antifungal agents|mesh-ancestor
111240012|NCT03294486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111240013|NCT03294486|Antimetabolites|antimetabolites|mesh-ancestor
111240014|NCT03294486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111240015|NCT03294252|Leucovorin|leucovorin|mesh-list
111240016|NCT03294252|Folic Acid|folic acid|mesh-list
111240017|NCT03294252|Fluorouracil|fluorouracil|mesh-list
111240018|NCT03294252|Oxaliplatin|oxaliplatin|mesh-list
111240019|NCT03294252|Levoleucovorin|levoleucovorin|mesh-list
111240020|NCT03294252|Antimetabolites|antimetabolites|mesh-ancestor
111240021|NCT03294252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111240022|NCT03294252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111240023|NCT03294252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111240024|NCT03294252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111240025|NCT03294252|Immunologic Factors|immunologic factors|mesh-ancestor
111240026|NCT03294252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111240027|NCT03294252|Antidotes|antidotes|mesh-ancestor
111240028|NCT03294252|Protective Agents|protective agents|mesh-ancestor
111240029|NCT03294252|Vitamin B Complex|vitamin b complex|mesh-ancestor
111240030|NCT03294252|Vitamins|vitamins|mesh-ancestor
111240031|NCT03294252|Micronutrients|micronutrients|mesh-ancestor
111240032|NCT03294252|Hematinics|hematinics|mesh-ancestor
111240033|NCT03294174|Ropivacaine|ropivacaine|mesh-list
111240034|NCT03294174|Anesthetics, Local|anesthetics, local|mesh-ancestor
111240035|NCT03294174|Anesthetics|anesthetics|mesh-ancestor
111240036|NCT03294174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111240037|NCT03294174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111240038|NCT03294174|Sensory System Agents|sensory system agents|mesh-ancestor
111240039|NCT03294174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111240040|NCT03289338|Zoledronic Acid|zoledronic acid|mesh-list
111240041|NCT03289338|Methylprednisolone|methylprednisolone|mesh-list
111240042|NCT03289338|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111240043|NCT03289338|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111240044|NCT03289338|Prednisolone|prednisolone|mesh-list
111240045|NCT03289338|Prednisolone acetate|prednisolone acetate|mesh-list
111240046|NCT03289338|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111240047|NCT03289338|Prednisolone phosphate|prednisolone phosphate|mesh-list
111240048|NCT03289338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111240049|NCT03289338|Antiemetics|antiemetics|mesh-ancestor
111240050|NCT03289338|Autonomic Agents|autonomic agents|mesh-ancestor
111240051|NCT03289338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111240052|NCT03289338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111240053|NCT03289338|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111240054|NCT03289338|Glucocorticoids|glucocorticoids|mesh-ancestor
111240055|NCT03289338|Hormones|hormones|mesh-ancestor
111240056|NCT03289338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110964357|NCT02172417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111240057|NCT03289338|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111240058|NCT03289338|Protective Agents|protective agents|mesh-ancestor
111240059|NCT03289338|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111240060|NCT03289338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111240061|NCT03289338|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111240062|NCT02069704|Leucovorin|leucovorin|mesh-list
111240063|NCT02069704|Folic Acid|folic acid|mesh-list
111240064|NCT02069704|Bevacizumab|bevacizumab|mesh-list
111240065|NCT02069704|Fluorouracil|fluorouracil|mesh-list
111240066|NCT02069704|Oxaliplatin|oxaliplatin|mesh-list
111240067|NCT02069704|Irinotecan|irinotecan|mesh-list
111240068|NCT02069704|Levoleucovorin|levoleucovorin|mesh-list
111240069|NCT02069704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111240070|NCT02069704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111240071|NCT02069704|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111240072|NCT02069704|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111240073|NCT02069704|Growth Substances|growth substances|mesh-ancestor
111240074|NCT02069704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111240075|NCT02069704|Growth Inhibitors|growth inhibitors|mesh-ancestor
111240076|NCT02069704|Antimetabolites|antimetabolites|mesh-ancestor
111240077|NCT02069704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111240078|NCT02069704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111240079|NCT02069704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111240080|NCT02069704|Immunologic Factors|immunologic factors|mesh-ancestor
111240081|NCT02069704|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111240082|NCT02069704|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111240083|NCT02069704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111240084|NCT02069704|Antidotes|antidotes|mesh-ancestor
111240085|NCT02069704|Protective Agents|protective agents|mesh-ancestor
111240086|NCT02069704|Vitamin B Complex|vitamin b complex|mesh-ancestor
111240087|NCT02069704|Vitamins|vitamins|mesh-ancestor
111240088|NCT02069704|Micronutrients|micronutrients|mesh-ancestor
111240089|NCT02069704|Hematinics|hematinics|mesh-ancestor
111240090|NCT02314546|Lidocaine|lidocaine|mesh-list
111240091|NCT02314546|Midazolam|midazolam|mesh-list
111240092|NCT02314546|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111240093|NCT02314546|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111240094|NCT02314546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111240095|NCT02314546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111240096|NCT02314546|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111240097|NCT02314546|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111240098|NCT02314546|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111240099|NCT02314546|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111240100|NCT02314546|Anesthetics, General|anesthetics, general|mesh-ancestor
111240101|NCT02314546|Anesthetics|anesthetics|mesh-ancestor
111240102|NCT02314546|GABA Modulators|gaba modulators|mesh-ancestor
111240103|NCT02314546|GABA Agents|gaba agents|mesh-ancestor
111240104|NCT02314546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111240105|NCT02314546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111240106|NCT02314546|Anesthetics, Local|anesthetics, local|mesh-ancestor
111240107|NCT02314546|Sensory System Agents|sensory system agents|mesh-ancestor
111240108|NCT02314546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111240109|NCT02314546|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111240110|NCT02314546|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111240111|NCT02314546|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111240112|NCT02314546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111240113|NCT03289260|Imiquimod|imiquimod|mesh-list
111240114|NCT03289260|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111240115|NCT03289260|Immunologic Factors|immunologic factors|mesh-ancestor
111240116|NCT03289260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111240117|NCT03289260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111240118|NCT03289260|Interferon Inducers|interferon inducers|mesh-ancestor
111240119|NCT03289182|Rituximab|rituximab|mesh-list
111240120|NCT03289182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111240121|NCT03289182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111240122|NCT03289182|Immunologic Factors|immunologic factors|mesh-ancestor
111240123|NCT03289182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111240124|NCT03289182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111240125|NCT03289026|Aripiprazole|aripiprazole|mesh-list
111240126|NCT03289026|Antidepressive Agents|antidepressive agents|mesh-ancestor
111240127|NCT03289026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111240128|NCT03289026|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111240129|NCT03289026|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111240130|NCT03289026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111240131|NCT03289026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111240132|NCT03289026|Dopamine Agonists|dopamine agonists|mesh-ancestor
111240133|NCT03289026|Dopamine Agents|dopamine agents|mesh-ancestor
111240134|NCT03289026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111240135|NCT03289026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111240136|NCT03289026|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111240137|NCT03289026|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111240138|NCT03289026|Serotonin Agents|serotonin agents|mesh-ancestor
111240139|NCT03289026|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111240140|NCT03289026|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111240141|NCT03289026|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111240142|NCT03289026|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111240144|NCT02460510|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
111240145|NCT02460510|Diuretics|diuretics|mesh-ancestor
111240146|NCT02460510|Natriuretic Agents|natriuretic agents|mesh-ancestor
111240147|NCT02460510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111240148|NCT02334436|Botulinum Toxins|botulinum toxins|mesh-list
111240149|NCT02334436|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111240150|NCT02334436|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111240151|NCT02334436|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111240152|NCT02334436|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111240153|NCT02334436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111240154|NCT02334436|Cholinergic Agents|cholinergic agents|mesh-ancestor
111240155|NCT02334436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111240156|NCT02334436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111240157|NCT02334436|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111240158|NCT02334436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111240159|NCT03288870|Docetaxel|docetaxel|mesh-list
111240160|NCT03288870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111240161|NCT03288870|Tubulin Modulators|tubulin modulators|mesh-ancestor
111240162|NCT03288870|Antimitotic Agents|antimitotic agents|mesh-ancestor
111240163|NCT03288870|Mitosis Modulators|mitosis modulators|mesh-ancestor
111240164|NCT03288870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111240165|NCT03282474|Sofosbuvir|sofosbuvir|mesh-list
111240166|NCT03282474|Antiviral Agents|antiviral agents|mesh-ancestor
111240167|NCT03282474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111240168|NCT02460354|Metformin|metformin|mesh-list
111240169|NCT02460354|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111240170|NCT02460354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111240171|NCT02008942|Aspirin|aspirin|mesh-list
111240172|NCT02008942|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111240173|NCT02008942|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111240174|NCT02008942|Analgesics|analgesics|mesh-ancestor
111240175|NCT02008942|Sensory System Agents|sensory system agents|mesh-ancestor
111240176|NCT02008942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111240177|NCT02008942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111240178|NCT02008942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111240179|NCT02008942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111240180|NCT02008942|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111240181|NCT02008942|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111240182|NCT02008942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111240183|NCT02008942|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111240184|NCT02008942|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111240185|NCT02008942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111240186|NCT02008942|Antipyretics|antipyretics|mesh-ancestor
111240187|NCT03288636|Ritonavir|ritonavir|mesh-list
111240188|NCT03288636|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111240189|NCT03288636|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111240190|NCT03288636|Protease Inhibitors|protease inhibitors|mesh-ancestor
111240191|NCT03288636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111240192|NCT03288636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111240193|NCT03288636|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111240194|NCT03288636|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111240195|NCT03288636|Antiviral Agents|antiviral agents|mesh-ancestor
111240196|NCT03288636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111240197|NCT03288636|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111240198|NCT03288636|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111240199|NCT03293472|Bupivacaine|bupivacaine|mesh-list
111240200|NCT03293472|Ropivacaine|ropivacaine|mesh-list
111240201|NCT03293472|Anesthetics, Local|anesthetics, local|mesh-ancestor
111240202|NCT03293472|Anesthetics|anesthetics|mesh-ancestor
111240203|NCT03293472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111240204|NCT03293472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111240205|NCT03293472|Sensory System Agents|sensory system agents|mesh-ancestor
111240206|NCT03293472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111240207|NCT02071810|Opicapone|opicapone|mesh-list
111240208|NCT02071810|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
111240209|NCT02071810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111240210|NCT02071810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111240211|NCT02071810|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110964506|NCT03344042|Fentanyl|fentanyl|mesh-list
111240212|NCT02071810|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111240213|NCT02715258|Bexagliflozin|bexagliflozin|mesh-list
111240214|NCT02715258|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111240215|NCT02715258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111240216|NCT01959490|Paclitaxel|paclitaxel|mesh-list
111240217|NCT01959490|Docetaxel|docetaxel|mesh-list
111240218|NCT01959490|Cyclophosphamide|cyclophosphamide|mesh-list
111240219|NCT01959490|Bevacizumab|bevacizumab|mesh-list
111240220|NCT01959490|Carboplatin|carboplatin|mesh-list
111240221|NCT01959490|Doxorubicin|doxorubicin|mesh-list
111240222|NCT01959490|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111240223|NCT01959490|Trastuzumab|trastuzumab|mesh-list
111240224|NCT01959490|Pertuzumab|pertuzumab|mesh-list
111240225|NCT01959490|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111240226|NCT01959490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111240227|NCT01959490|Tubulin Modulators|tubulin modulators|mesh-ancestor
111240228|NCT01959490|Antimitotic Agents|antimitotic agents|mesh-ancestor
111240229|NCT01959490|Mitosis Modulators|mitosis modulators|mesh-ancestor
111240230|NCT01959490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111240231|NCT01959490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111240232|NCT01959490|Immunologic Factors|immunologic factors|mesh-ancestor
111240233|NCT01959490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111240234|NCT01959490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111240235|NCT01959490|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111240236|NCT01959490|Alkylating Agents|alkylating agents|mesh-ancestor
111240237|NCT01959490|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111240238|NCT01959490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111240239|NCT01959490|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111240240|NCT01959490|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111240241|NCT01959490|Growth Substances|growth substances|mesh-ancestor
111240242|NCT01959490|Growth Inhibitors|growth inhibitors|mesh-ancestor
111240243|NCT01959490|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111240244|NCT01959490|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111240245|NCT01959490|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111240246|NCT01959490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111240247|NCT03288402|Caffeine|caffeine|mesh-list
111240248|NCT03288402|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111240249|NCT03288402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111240250|NCT03288402|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111240251|NCT03288402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111240252|NCT03288402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110819842|NCT03647852|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111240253|NCT03288402|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
111240254|NCT03288402|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111240255|NCT03288402|Purinergic Agents|purinergic agents|mesh-ancestor
111240256|NCT03288402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111240257|NCT02011516|Baclofen|baclofen|mesh-list
111240258|NCT02011516|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
111240259|NCT02011516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111240260|NCT02011516|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111240261|NCT02011516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111240262|NCT02011516|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
111240263|NCT02011516|GABA Agonists|gaba agonists|mesh-ancestor
111240264|NCT02011516|GABA Agents|gaba agents|mesh-ancestor
111240265|NCT02011516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111240266|NCT02011516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111240267|NCT04349410|Interferons|interferons|mesh-list
111240268|NCT04349410|Interferon-alpha|interferon-alpha|mesh-list
111240269|NCT04349410|Interferon alpha-2|interferon alpha-2|mesh-list
111240270|NCT04349410|Remdesivir|remdesivir|mesh-list
111240271|NCT04349410|Azithromycin|azithromycin|mesh-list
111240272|NCT04349410|Hydroxychloroquine|hydroxychloroquine|mesh-list
111240273|NCT04349410|Doxycycline|doxycycline|mesh-list
111240274|NCT04349410|Clindamycin|clindamycin|mesh-list
111240275|NCT04349410|Clindamycin palmitate|clindamycin palmitate|mesh-list
111240276|NCT04349410|Clindamycin phosphate|clindamycin phosphate|mesh-list
111240277|NCT04349410|Primaquine|primaquine|mesh-list
111240278|NCT04349410|Methylprednisolone|methylprednisolone|mesh-list
111240279|NCT04349410|Losartan|losartan|mesh-list
111240280|NCT04349410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111240281|NCT04349410|Antiviral Agents|antiviral agents|mesh-ancestor
111240282|NCT04349410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111240283|NCT04349410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111240284|NCT04349410|Antiemetics|antiemetics|mesh-ancestor
111240285|NCT04349410|Autonomic Agents|autonomic agents|mesh-ancestor
111240286|NCT04349410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110964585|NCT02500940|Leucovorin|leucovorin|mesh-list
111240287|NCT04349410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111240288|NCT04349410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111240289|NCT04349410|Glucocorticoids|glucocorticoids|mesh-ancestor
111240290|NCT04349410|Hormones|hormones|mesh-ancestor
111240291|NCT04349410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111240292|NCT04349410|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111240293|NCT04349410|Protective Agents|protective agents|mesh-ancestor
111240294|NCT04349410|Immunologic Factors|immunologic factors|mesh-ancestor
111240295|NCT04349410|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111240296|NCT04349410|Antimalarials|antimalarials|mesh-ancestor
111240297|NCT04349410|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111240298|NCT04349410|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111240299|NCT04349410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111240300|NCT04349410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111240301|NCT04349410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111240302|NCT04349410|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111240303|NCT04349410|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111240304|NCT04349410|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111240305|NCT04349410|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111240306|NCT04349410|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111240307|NCT04349410|Antimetabolites|antimetabolites|mesh-ancestor
111240308|NCT03287388|Rocuronium|rocuronium|mesh-list
111240309|NCT03287388|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
111240310|NCT03287388|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
111240311|NCT03287388|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111240312|NCT03287388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111240313|NCT03287388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111240314|NCT03293004|Vitamins|vitamins|mesh-list
111240315|NCT03293004|Ascorbic Acid|ascorbic acid|mesh-list
111240316|NCT03293004|Micronutrients|micronutrients|mesh-ancestor
111240317|NCT03293004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111240318|NCT03293004|Antioxidants|antioxidants|mesh-ancestor
111240319|NCT03293004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111240320|NCT03293004|Protective Agents|protective agents|mesh-ancestor
111240321|NCT03292848|Brexpiprazole|brexpiprazole|mesh-list
111240322|NCT03292848|Serotonin Agents|serotonin agents|mesh-ancestor
111240323|NCT03292848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111240324|NCT03292848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111240325|NCT03292848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111240326|NCT03292848|Dopamine Agonists|dopamine agonists|mesh-ancestor
111240327|NCT03292848|Dopamine Agents|dopamine agents|mesh-ancestor
111240328|NCT03282162|Oxytocin|oxytocin|mesh-list
111240329|NCT03282162|Oxytocics|oxytocics|mesh-ancestor
111240330|NCT03282162|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111240331|NCT03282162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111240332|NCT03287076|Exenatide|exenatide|mesh-list
111240333|NCT03287076|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111240334|NCT03287076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111240335|NCT03287076|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111240336|NCT03287076|Incretins|incretins|mesh-ancestor
111240337|NCT03287076|Hormones|hormones|mesh-ancestor
111240338|NCT03287076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111240339|NCT02460276|Rituximab|rituximab|mesh-list
111240340|NCT02460276|Lenalidomide|lenalidomide|mesh-list
111240341|NCT02460276|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111240342|NCT02460276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111240343|NCT02460276|Immunologic Factors|immunologic factors|mesh-ancestor
111240344|NCT02460276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111240345|NCT02460276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111240346|NCT02460276|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111240347|NCT02460276|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111240348|NCT02460276|Growth Substances|growth substances|mesh-ancestor
111240349|NCT02460276|Growth Inhibitors|growth inhibitors|mesh-ancestor
111240350|NCT02460432|Paclitaxel|paclitaxel|mesh-list
111240351|NCT02460432|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111240352|NCT02460432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111240353|NCT02460432|Tubulin Modulators|tubulin modulators|mesh-ancestor
111240354|NCT02460432|Antimitotic Agents|antimitotic agents|mesh-ancestor
111240355|NCT02460432|Mitosis Modulators|mitosis modulators|mesh-ancestor
111240356|NCT02460432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111240357|NCT03282006|Amdinocillin Pivoxil|amdinocillin pivoxil|mesh-list
111240358|NCT03282006|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111240359|NCT03282006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111240360|NCT03282006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111240361|NCT03281928|Potassium Citrate|potassium citrate|mesh-list
111240362|NCT03281928|Diuretics|diuretics|mesh-ancestor
111240363|NCT03281928|Natriuretic Agents|natriuretic agents|mesh-ancestor
111240364|NCT03281928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111240365|NCT03281928|Expectorants|expectorants|mesh-ancestor
111240366|NCT03281928|Respiratory System Agents|respiratory system agents|mesh-ancestor
111240368|NCT03286764|Antiemetics|antiemetics|mesh-ancestor
111240369|NCT03286764|Autonomic Agents|autonomic agents|mesh-ancestor
111240370|NCT03286764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111240371|NCT03286764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111240372|NCT03286764|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111240373|NCT03286764|Parasympatholytics|parasympatholytics|mesh-ancestor
111240374|NCT03281694|Nicotine|nicotine|mesh-list
111240375|NCT03281694|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111240376|NCT03281694|Autonomic Agents|autonomic agents|mesh-ancestor
111240377|NCT03281694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111240378|NCT03281694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111240379|NCT03281694|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111240380|NCT03281694|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111240381|NCT03281694|Cholinergic Agents|cholinergic agents|mesh-ancestor
111240382|NCT03281694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111240383|NCT03281694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111240384|NCT03286452|Anti-Infective Agents|anti-infective agents|mesh-list
111240385|NCT03286452|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111240386|NCT03291054|Pembrolizumab|pembrolizumab|mesh-list
111240387|NCT03291054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111240388|NCT03291054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111240389|NCT03291054|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111240390|NCT03291054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111240391|NCT03286296|Antibodies|antibodies|mesh-list
111240392|NCT03286296|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111240393|NCT03286296|Immunologic Factors|immunologic factors|mesh-ancestor
111240394|NCT03286296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111240395|NCT03285906|Apatinib|apatinib|mesh-list
111240396|NCT03285906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111240397|NCT03285906|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111240398|NCT03285906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111240399|NCT03285906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111240400|NCT01895205|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
111240401|NCT01895205|Hematinics|hematinics|mesh-ancestor
111240402|NCT01748175|Triamcinolone|triamcinolone|mesh-list
111240403|NCT01748175|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
111240404|NCT01748175|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
111240405|NCT01748175|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
111240406|NCT01748175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111240407|NCT01748175|Glucocorticoids|glucocorticoids|mesh-ancestor
111240408|NCT01748175|Hormones|hormones|mesh-ancestor
111240409|NCT01748175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111240410|NCT01748175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111240411|NCT01748175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111240412|NCT01748175|Immunologic Factors|immunologic factors|mesh-ancestor
111240413|NCT01748175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111240414|NCT01748175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111240415|NCT04755387|Ticagrelor|ticagrelor|mesh-list
111240416|NCT04755387|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111240417|NCT04755387|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111240418|NCT04755387|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111240419|NCT04755387|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111240420|NCT04755387|Purinergic Agents|purinergic agents|mesh-ancestor
111240421|NCT04755387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111240422|NCT04755387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111240423|NCT04755387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111240424|NCT04046328|Cholestyramine Resin|cholestyramine resin|mesh-list
111240425|NCT04046328|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111240426|NCT04046328|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111240427|NCT04046328|Antimetabolites|antimetabolites|mesh-ancestor
111240428|NCT04046328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111240429|NCT04046328|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111240430|NCT03285360|Fluorides|fluorides|mesh-list
111240431|NCT03285360|Fluorides, Topical|fluorides, topical|mesh-list
111240432|NCT03285360|Cariostatic Agents|cariostatic agents|mesh-ancestor
111240433|NCT03285360|Protective Agents|protective agents|mesh-ancestor
111240434|NCT03285360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111240435|NCT00160173|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
111240436|NCT00160173|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
111240437|NCT00160173|Estradiol|estradiol|mesh-list
111240438|NCT00160173|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
111240439|NCT00160173|Estrogens|estrogens|mesh-ancestor
111240440|NCT00160173|Hormones|hormones|mesh-ancestor
111240441|NCT00160173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111240442|NCT00160173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111240443|NCT00160173|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111240444|NCT00160173|Contraceptive Agents|contraceptive agents|mesh-ancestor
111240445|NCT00160173|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111240446|NCT00160173|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111240447|NCT00136695|Anastrozole|anastrozole|mesh-list
111240448|NCT00136695|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111240449|NCT00136695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111240450|NCT00136695|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111240451|NCT00136695|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111240452|NCT00136695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111240453|NCT00136695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111240454|NCT00136695|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111240455|NCT00136695|Hormone Antagonists|hormone antagonists|mesh-ancestor
111240456|NCT00136695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111240457|NCT00136695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111240458|NCT04782375|Antiviral Agents|antiviral agents|mesh-list
111240459|NCT04782375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111240460|NCT02459574|Amiodarone|amiodarone|mesh-list
111240461|NCT02459574|Sotalol|sotalol|mesh-list
111240462|NCT02459574|Flecainide|flecainide|mesh-list
111240463|NCT02459574|Propafenone|propafenone|mesh-list
111240464|NCT02459574|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
111240465|NCT02459574|Calcium Channel Blockers|calcium channel blockers|mesh-list
111240466|NCT02459574|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111240467|NCT02459574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111240468|NCT02459574|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111240469|NCT02459574|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111240470|NCT02459574|Adrenergic Agents|adrenergic agents|mesh-ancestor
111240471|NCT02459574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111240472|NCT02459574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111240473|NCT02459574|Vasodilator Agents|vasodilator agents|mesh-ancestor
111240474|NCT02459574|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
111240475|NCT02459574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111240476|NCT02459574|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111240477|NCT02459574|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111240478|NCT02459574|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111240479|NCT02459574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111240480|NCT02459574|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111240481|NCT02459574|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111240482|NCT02459574|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111240483|NCT02459574|Sympatholytics|sympatholytics|mesh-ancestor
111240484|NCT02459574|Autonomic Agents|autonomic agents|mesh-ancestor
111240485|NCT02459574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111240486|NCT02459574|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111240487|NCT04168866|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111240488|NCT04168866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111240489|NCT03280212|Tranexamic Acid|tranexamic acid|mesh-list
111240490|NCT03280212|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111240491|NCT03280212|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111240492|NCT03280212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111240493|NCT03280212|Hemostatics|hemostatics|mesh-ancestor
111240494|NCT03280212|Coagulants|coagulants|mesh-ancestor
111240495|NCT03536520|Acetazolamide|acetazolamide|mesh-list
111240496|NCT03536520|Anticonvulsants|anticonvulsants|mesh-ancestor
111240497|NCT03536520|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
111240498|NCT03536520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111240499|NCT03536520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111240500|NCT03536520|Diuretics|diuretics|mesh-ancestor
111240501|NCT03536520|Natriuretic Agents|natriuretic agents|mesh-ancestor
111240502|NCT03536520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111240503|NCT01673217|Doxorubicin|doxorubicin|mesh-list
111240504|NCT01673217|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111240505|NCT01673217|Decitabine|decitabine|mesh-list
111240506|NCT01673217|Azacitidine|azacitidine|mesh-list
111240507|NCT01673217|Vaccines|vaccines|mesh-list
111240508|NCT01673217|Sargramostim|sargramostim|mesh-list
111240509|NCT01673217|Freund's Adjuvant|freund's adjuvant|mesh-list
111240510|NCT01673217|Immunologic Factors|immunologic factors|mesh-ancestor
111240511|NCT01673217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111240512|NCT01673217|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111240513|NCT01673217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110964814|NCT03120494|Tenofovir|tenofovir|mesh-list
111240514|NCT01673217|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111240515|NCT01673217|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111240516|NCT01673217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111240517|NCT01673217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111240518|NCT01673217|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111240519|NCT01673217|Antimetabolites|antimetabolites|mesh-ancestor
111240520|NCT01673217|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111240521|NCT03475134|Cyclophosphamide|cyclophosphamide|mesh-list
111240523|NCT03475134|Fludarabine|fludarabine|mesh-list
111240524|NCT03475134|Interleukin-2|interleukin-2|mesh-list
111240525|NCT03475134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111240526|NCT03475134|Immunologic Factors|immunologic factors|mesh-ancestor
111240527|NCT03475134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111240528|NCT03475134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111240529|NCT03475134|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111240530|NCT03475134|Alkylating Agents|alkylating agents|mesh-ancestor
111240531|NCT03475134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111240532|NCT03475134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111240533|NCT03475134|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111240534|NCT03475134|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111240535|NCT03475134|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111240536|NCT03475134|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111240537|NCT03475134|Analgesics|analgesics|mesh-ancestor
111240538|NCT03475134|Sensory System Agents|sensory system agents|mesh-ancestor
111240539|NCT03475134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111240540|NCT01668849|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
111240541|NCT01668849|Fentanyl|fentanyl|mesh-list
111240542|NCT01668849|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111240543|NCT01668849|Narcotics|narcotics|mesh-ancestor
111240544|NCT01668849|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111240545|NCT01668849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111240546|NCT01668849|Analgesics|analgesics|mesh-ancestor
111240547|NCT01668849|Sensory System Agents|sensory system agents|mesh-ancestor
111240548|NCT01668849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111240549|NCT01668849|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111240550|NCT01668849|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111240551|NCT01668849|Anesthetics, General|anesthetics, general|mesh-ancestor
111240552|NCT01668849|Anesthetics|anesthetics|mesh-ancestor
111240553|NCT01668849|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111240554|NCT01668849|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111240555|NCT01668849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111240556|NCT01668849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111240557|NCT01252719|Vancomycin|vancomycin|mesh-list
111240558|NCT01252719|Oritavancin|oritavancin|mesh-list
111240559|NCT01252719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111240560|NCT01252719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111240561|NCT01230411|Ibuprofen|ibuprofen|mesh-list
111240562|NCT01230411|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111240563|NCT01230411|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111240564|NCT01230411|Analgesics|analgesics|mesh-ancestor
111240565|NCT01230411|Sensory System Agents|sensory system agents|mesh-ancestor
111240566|NCT01230411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111240567|NCT01230411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111240568|NCT01230411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111240569|NCT01230411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111240570|NCT01230411|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111240571|NCT01230411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111240572|NCT01230411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111240573|NCT03283800|Copper|copper|mesh-list
111240574|NCT03283800|Trace Elements|trace elements|mesh-ancestor
111240575|NCT03283800|Micronutrients|micronutrients|mesh-ancestor
111240576|NCT03283800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111240577|NCT01962688|Diuretics|diuretics|mesh-list
111240578|NCT01962688|Natriuretic Agents|natriuretic agents|mesh-ancestor
111240579|NCT01962688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111240580|NCT03274596|Vitamin E|vitamin e|mesh-list
111240581|NCT03274596|Vitamins|vitamins|mesh-ancestor
111240582|NCT03274596|Micronutrients|micronutrients|mesh-ancestor
111240583|NCT03274596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111240584|NCT03274596|Antioxidants|antioxidants|mesh-ancestor
111240585|NCT03274596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111240586|NCT03274596|Protective Agents|protective agents|mesh-ancestor
111240587|NCT01963078|Oxytocin|oxytocin|mesh-list
110959162|NCT05681182|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111240588|NCT01963078|Oxytocics|oxytocics|mesh-ancestor
111240589|NCT01963078|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111240590|NCT01963078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111240591|NCT03269760|Zolpidem|zolpidem|mesh-list
111240592|NCT03269760|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111240593|NCT03269760|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111240594|NCT03269760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111240595|NCT03269760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111240596|NCT03269760|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
111240597|NCT03269760|GABA Agonists|gaba agonists|mesh-ancestor
111240598|NCT03269760|GABA Agents|gaba agents|mesh-ancestor
111240599|NCT03269760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111240600|NCT03269760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111240601|NCT03269916|Hormones|hormones|mesh-list
111240602|NCT03269916|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
111240603|NCT03269916|Estrogens|estrogens|mesh-list
111240604|NCT03269916|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111240605|NCT03269916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111240606|NCT02346916|Capsaicin|capsaicin|mesh-list
111240607|NCT02346916|Antipruritics|antipruritics|mesh-ancestor
111240608|NCT02346916|Dermatologic Agents|dermatologic agents|mesh-ancestor
111240609|NCT02346916|Sensory System Agents|sensory system agents|mesh-ancestor
111240610|NCT02346916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111240611|NCT02346916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111240612|NCT02458482|Albuterol|albuterol|mesh-list
111240613|NCT02458482|Ipratropium|ipratropium|mesh-list
111240614|NCT02458482|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111240615|NCT02458482|Autonomic Agents|autonomic agents|mesh-ancestor
111240616|NCT02458482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111240617|NCT02458482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111240618|NCT02458482|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111240619|NCT02458482|Respiratory System Agents|respiratory system agents|mesh-ancestor
111240620|NCT02458482|Tocolytic Agents|tocolytic agents|mesh-ancestor
111240621|NCT02458482|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111240622|NCT02458482|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111240623|NCT02458482|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111240624|NCT02458482|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111240625|NCT02458482|Adrenergic Agents|adrenergic agents|mesh-ancestor
111240626|NCT02458482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110820217|NCT01134523|Paclitaxel|paclitaxel|mesh-list
111240627|NCT02458482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111240628|NCT02458482|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111240629|NCT02458482|Cholinergic Agents|cholinergic agents|mesh-ancestor
111240630|NCT03273192|Adalimumab|adalimumab|mesh-list
111240631|NCT03273192|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111240632|NCT03273192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111240633|NCT03273192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111240634|NCT03269604|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111240635|NCT03269604|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
111240636|NCT03269604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111240637|NCT03269604|Antitubercular Agents|antitubercular agents|mesh-ancestor
111240638|NCT02349178|Cyclophosphamide|cyclophosphamide|mesh-list
111240639|NCT02349178|Etoposide|etoposide|mesh-list
111240640|NCT02349178|Clofarabine|clofarabine|mesh-list
111240641|NCT02349178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111240642|NCT02349178|Immunologic Factors|immunologic factors|mesh-ancestor
111240643|NCT02349178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111240644|NCT02349178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111240645|NCT02349178|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111240646|NCT02349178|Alkylating Agents|alkylating agents|mesh-ancestor
111240647|NCT02349178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111240648|NCT02349178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111240649|NCT02349178|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111240650|NCT02349178|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111240651|NCT02349178|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111240652|NCT02349178|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111240653|NCT02349178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111240654|NCT02349178|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111240655|NCT02349178|Antimetabolites|antimetabolites|mesh-ancestor
111240656|NCT03970356|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111240657|NCT03970356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111240658|NCT05075460|Azacitidine|azacitidine|mesh-list
111240659|NCT05075460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111240660|NCT05075460|Antimetabolites|antimetabolites|mesh-ancestor
111240661|NCT05075460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111240662|NCT05075460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111240663|NCT05075460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111240665|NCT01966978|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111240666|NCT01966978|Metformin|metformin|mesh-list
111240667|NCT01966978|Insulin Aspart|insulin aspart|mesh-list
111240668|NCT01966978|Insulin, Long-Acting|insulin, long-acting|mesh-list
111240669|NCT01966978|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
111240670|NCT01966978|Liraglutide|liraglutide|mesh-list
111240671|NCT01966978|Insulin Detemir|insulin detemir|mesh-list
111240672|NCT01966978|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111240673|NCT01966978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111240674|NCT01966978|Incretins|incretins|mesh-ancestor
111240675|NCT01966978|Hormones|hormones|mesh-ancestor
111240676|NCT01966978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111240677|NCT03269214|Phenytoin|phenytoin|mesh-list
111240678|NCT03269214|Anticonvulsants|anticonvulsants|mesh-ancestor
111240679|NCT03269214|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111240680|NCT03269214|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111240681|NCT03269214|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111240682|NCT03269214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111240683|NCT03269214|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
111240684|NCT03269214|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111240685|NCT03269058|Dapagliflozin|dapagliflozin|mesh-list
111240686|NCT03269058|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111240687|NCT03269058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111240688|NCT03269058|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111240689|NCT03269058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111240690|NCT05074602|Fluconazole|fluconazole|mesh-list
111240691|NCT05074602|Antifungal Agents|antifungal agents|mesh-ancestor
111240692|NCT05074602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111240693|NCT05074602|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111240694|NCT05074602|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111240695|NCT05074602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111240696|NCT05074602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111240697|NCT05074602|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111240698|NCT05074602|Hormone Antagonists|hormone antagonists|mesh-ancestor
110980780|NCT03230162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111240699|NCT05074602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111240700|NCT05074602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111240701|NCT05074602|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111240702|NCT05074602|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111240703|NCT02457312|Letrozole|letrozole|mesh-list
111240704|NCT02457312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111240705|NCT02457312|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111240706|NCT02457312|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111240707|NCT02457312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111240708|NCT02457312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111240709|NCT02457312|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111240710|NCT02457312|Hormone Antagonists|hormone antagonists|mesh-ancestor
111240711|NCT02457312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111240712|NCT02457312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111240713|NCT03268902|Niacinamide|niacinamide|mesh-list
111240714|NCT03268902|Niacin|niacin|mesh-list
111240715|NCT03268902|Nicotinic Acids|nicotinic acids|mesh-list
111240716|NCT03268902|Azithromycin|azithromycin|mesh-list
111240717|NCT03268902|Nitazoxanide|nitazoxanide|mesh-list
111240718|NCT03268902|Vitamins|vitamins|mesh-ancestor
111240719|NCT03268902|Micronutrients|micronutrients|mesh-ancestor
111240720|NCT03268902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111240721|NCT03268902|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111240722|NCT03268902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111240723|NCT03268902|Vitamin B Complex|vitamin b complex|mesh-ancestor
111240724|NCT03268902|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111240725|NCT03268902|Antimetabolites|antimetabolites|mesh-ancestor
111240726|NCT03268902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111240727|NCT03268902|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111240728|NCT03268902|Vasodilator Agents|vasodilator agents|mesh-ancestor
111240729|NCT03268902|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111240730|NCT02458716|Leuprolide|leuprolide|mesh-list
111240731|NCT02458716|Bicalutamide|bicalutamide|mesh-list
111240732|NCT02458716|Androgens|androgens|mesh-list
111240733|NCT02458716|Androgen Receptor Antagonists|androgen receptor antagonists|mesh-list
111240734|NCT02458716|Hormones|hormones|mesh-ancestor
111240735|NCT02458716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111240736|NCT02458716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110965055|NCT03339362|Hormones|hormones|mesh-ancestor
111240737|NCT02458716|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111240739|NCT02458716|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111240740|NCT02458716|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111240741|NCT02458716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111240742|NCT02458716|Androgen Antagonists|androgen antagonists|mesh-ancestor
111240743|NCT02458716|Hormone Antagonists|hormone antagonists|mesh-ancestor
111240744|NCT03268278|Lidocaine|lidocaine|mesh-list
111240745|NCT03268278|Epinephrine|epinephrine|mesh-list
111240746|NCT03268278|Buprenorphine|buprenorphine|mesh-list
111240747|NCT03268278|Anesthetics, Local|anesthetics, local|mesh-list
111240748|NCT03268278|Anesthetics|anesthetics|mesh-list
111240749|NCT03268278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111240750|NCT03268278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111240751|NCT03268278|Sensory System Agents|sensory system agents|mesh-ancestor
111240752|NCT03268278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111240753|NCT03268278|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111240754|NCT03268278|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111240755|NCT03268278|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111240756|NCT03268278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111240757|NCT03268278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111240758|NCT03268278|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111240759|NCT03268278|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111240760|NCT03268278|Adrenergic Agents|adrenergic agents|mesh-ancestor
111240761|NCT03268278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111240762|NCT03268278|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111240763|NCT03268278|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111240764|NCT03268278|Autonomic Agents|autonomic agents|mesh-ancestor
111240765|NCT03268278|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111240766|NCT03268278|Respiratory System Agents|respiratory system agents|mesh-ancestor
111240767|NCT03268278|Mydriatics|mydriatics|mesh-ancestor
111240768|NCT03268278|Sympathomimetics|sympathomimetics|mesh-ancestor
111240769|NCT03268278|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111240770|NCT03268278|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111240771|NCT03268278|Narcotics|narcotics|mesh-ancestor
111240772|NCT03268278|Analgesics|analgesics|mesh-ancestor
111240773|NCT03268278|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111240774|NCT05045586|Hyaluronic Acid|hyaluronic acid|mesh-list
111240775|NCT05045586|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111240776|NCT05045586|Immunologic Factors|immunologic factors|mesh-ancestor
111240777|NCT05045586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111240778|NCT05045586|Viscosupplements|viscosupplements|mesh-ancestor
111240779|NCT05045586|Protective Agents|protective agents|mesh-ancestor
111240780|NCT03263520|Nandrolone Decanoate|nandrolone decanoate|mesh-list
111240781|NCT03263520|Dexamethasone|dexamethasone|mesh-list
111240782|NCT03263520|Dexamethasone acetate|dexamethasone acetate|mesh-list
111240783|NCT03263520|Nandrolone|nandrolone|mesh-list
111240784|NCT03263520|Nandrolone phenpropionate|nandrolone phenpropionate|mesh-list
111240785|NCT03263520|BB 1101|bb 1101|mesh-list
111240786|NCT03263520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111240787|NCT03263520|Antiemetics|antiemetics|mesh-ancestor
111240788|NCT03263520|Autonomic Agents|autonomic agents|mesh-ancestor
111240789|NCT03263520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111240790|NCT03263520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111240791|NCT03263520|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111240792|NCT03263520|Glucocorticoids|glucocorticoids|mesh-ancestor
111240793|NCT03263520|Hormones|hormones|mesh-ancestor
111240794|NCT03263520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111240795|NCT03263520|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111240796|NCT03263520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111240797|NCT03263520|Protease Inhibitors|protease inhibitors|mesh-ancestor
111240798|NCT03263520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111240799|NCT03263520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111240800|NCT03263520|Androgens|androgens|mesh-ancestor
111240801|NCT03263520|Anabolic Agents|anabolic agents|mesh-ancestor
111240802|NCT03263520|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111240803|NCT02456844|Leucovorin|leucovorin|mesh-list
111240804|NCT02456844|Flurbiprofen|flurbiprofen|mesh-list
111240805|NCT02456844|Methotrexate|methotrexate|mesh-list
111240806|NCT02456844|Digoxin|digoxin|mesh-list
111240807|NCT02456844|Midazolam|midazolam|mesh-list
111240808|NCT02456844|Pravastatin|pravastatin|mesh-list
111240809|NCT02456844|Montelukast|montelukast|mesh-list
111240810|NCT02456844|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111240811|NCT02456844|Abortifacient Agents|abortifacient agents|mesh-ancestor
111240812|NCT02456844|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110965103|NCT02497118|Tubulin Modulators|tubulin modulators|mesh-ancestor
111240813|NCT02456844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111240814|NCT02456844|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111240815|NCT02456844|Antimetabolites|antimetabolites|mesh-ancestor
111240816|NCT02456844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111240817|NCT02456844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111240818|NCT02456844|Dermatologic Agents|dermatologic agents|mesh-ancestor
111240819|NCT02456844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111240820|NCT02456844|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111240821|NCT02456844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111240822|NCT02456844|Immunologic Factors|immunologic factors|mesh-ancestor
111240823|NCT02456844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111240824|NCT02456844|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111240825|NCT02456844|Antidotes|antidotes|mesh-ancestor
111240826|NCT02456844|Protective Agents|protective agents|mesh-ancestor
111240827|NCT02456844|Vitamin B Complex|vitamin b complex|mesh-ancestor
111240829|NCT02456844|Micronutrients|micronutrients|mesh-ancestor
111240830|NCT02456844|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111240831|NCT02456844|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111240832|NCT02456844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111240833|NCT02456844|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111240834|NCT02456844|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111240835|NCT02456844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111240836|NCT02456844|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111240837|NCT02456844|Anesthetics, General|anesthetics, general|mesh-ancestor
111240838|NCT02456844|Anesthetics|anesthetics|mesh-ancestor
111240839|NCT02456844|GABA Modulators|gaba modulators|mesh-ancestor
111240840|NCT02456844|GABA Agents|gaba agents|mesh-ancestor
111240841|NCT02456844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111240842|NCT02456844|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111240843|NCT02456844|Respiratory System Agents|respiratory system agents|mesh-ancestor
111240844|NCT02456844|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
111240845|NCT02456844|Hormone Antagonists|hormone antagonists|mesh-ancestor
111240846|NCT02456844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111240847|NCT02456844|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
111240848|NCT02456844|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111240849|NCT02456844|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111240850|NCT02456844|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111240851|NCT02456844|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111240852|NCT02456844|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111240853|NCT02456844|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111240854|NCT02456844|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111240855|NCT02456844|Analgesics|analgesics|mesh-ancestor
111240856|NCT02456844|Sensory System Agents|sensory system agents|mesh-ancestor
111240857|NCT02456844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111240858|NCT02456844|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111240859|NCT02456844|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111240860|NCT02456844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111240861|NCT02456844|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111240862|NCT03263208|Cyclophosphamide|cyclophosphamide|mesh-list
111240863|NCT03263208|Fludarabine|fludarabine|mesh-list
111240864|NCT03263208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111240865|NCT03263208|Immunologic Factors|immunologic factors|mesh-ancestor
111240866|NCT03263208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111240867|NCT03263208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111240868|NCT03263208|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111240869|NCT03263208|Alkylating Agents|alkylating agents|mesh-ancestor
111240870|NCT03263208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111240871|NCT03263208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111240872|NCT03263208|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111240873|NCT03259542|Itraconazole|itraconazole|mesh-list
111240874|NCT03259542|Mifepristone|mifepristone|mesh-list
111240875|NCT03259542|Antifungal Agents|antifungal agents|mesh-ancestor
111240876|NCT03259542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111240877|NCT03259542|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111240878|NCT03259542|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111240879|NCT03259542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111240880|NCT03259542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111240881|NCT03259542|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111240882|NCT03259542|Hormone Antagonists|hormone antagonists|mesh-ancestor
111240883|NCT03259542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111240884|NCT03259542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111240885|NCT03259542|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111240886|NCT03259542|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
111240887|NCT03259542|Abortifacient Agents|abortifacient agents|mesh-ancestor
111240888|NCT03259542|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111240889|NCT03259542|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111240890|NCT03259542|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111240891|NCT03259542|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111240892|NCT03259542|Contraceptive Agents|contraceptive agents|mesh-ancestor
111240893|NCT03259542|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
111240894|NCT03259542|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
111240895|NCT03259542|Luteolytic Agents|luteolytic agents|mesh-ancestor
111240896|NCT03259542|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111240897|NCT03259542|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
111240898|NCT03267654|Apatinib|apatinib|mesh-list
111240899|NCT03267654|Gefitinib|gefitinib|mesh-list
111240900|NCT03267654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111240901|NCT03267654|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111240902|NCT03267654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111240903|NCT03267654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111240904|NCT03263052|Tacrolimus|tacrolimus|mesh-list
111240905|NCT03263052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111240906|NCT03263052|Immunologic Factors|immunologic factors|mesh-ancestor
111240907|NCT03263052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111240908|NCT03263052|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111240909|NCT03263052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111240910|NCT03263052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111240911|NCT03267030|Eryaspase|eryaspase|mesh-list
111240912|NCT03267030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111240913|NCT03259152|Denosumab|denosumab|mesh-list
111240914|NCT03259152|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111240915|NCT03259152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111240916|NCT02456142|Morphine|morphine|mesh-list
111240917|NCT02456142|Bupivacaine|bupivacaine|mesh-list
111240918|NCT02456142|Anesthetics, Local|anesthetics, local|mesh-ancestor
111240919|NCT02456142|Anesthetics|anesthetics|mesh-ancestor
111240920|NCT02456142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111240921|NCT02456142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111240922|NCT02456142|Sensory System Agents|sensory system agents|mesh-ancestor
111240923|NCT02456142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111240924|NCT02456142|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111240925|NCT02456142|Narcotics|narcotics|mesh-ancestor
111240926|NCT02456142|Analgesics|analgesics|mesh-ancestor
111240927|NCT03262740|Ethinyl Estradiol|ethinyl estradiol|mesh-list
111240928|NCT03262740|Norethindrone|norethindrone|mesh-list
111240929|NCT03262740|Norethindrone Acetate|norethindrone acetate|mesh-list
111240930|NCT03262740|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
111240931|NCT03262740|Estradiol|estradiol|mesh-list
111240932|NCT03262740|Branebrutinib|branebrutinib|mesh-list
111240933|NCT03262740|Estrogens|estrogens|mesh-ancestor
111240934|NCT03262740|Hormones|hormones|mesh-ancestor
111240935|NCT03262740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111240936|NCT03262740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111240937|NCT03262740|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111240938|NCT03262740|Contraceptive Agents|contraceptive agents|mesh-ancestor
111240939|NCT03262740|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111240940|NCT03262740|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111240941|NCT03262740|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111240942|NCT03262740|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111240943|NCT03262740|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111240944|NCT03262740|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
111240945|NCT03262740|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
111240946|NCT03262740|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111240947|NCT03262740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111240948|NCT03262740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111240949|NCT03266562|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
111240950|NCT03266562|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111240951|NCT03266562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111240952|NCT03258684|Thiamine|thiamine|mesh-list
111240953|NCT03258684|Hydrocortisone|hydrocortisone|mesh-list
111240954|NCT03258684|Vitamins|vitamins|mesh-ancestor
111240955|NCT03258684|Micronutrients|micronutrients|mesh-ancestor
111240956|NCT03258684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111240957|NCT03258684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111240958|NCT03258684|Vitamin B Complex|vitamin b complex|mesh-ancestor
111240959|NCT03266250|Anesthetics|anesthetics|mesh-list
111240960|NCT03266250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111240961|NCT03266250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111240962|NCT03258372|Rifampin|rifampin|mesh-list
111240963|NCT03258372|Mifepristone|mifepristone|mesh-list
111240964|NCT03258372|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111240965|NCT03258372|Antitubercular Agents|antitubercular agents|mesh-ancestor
111240966|NCT03258372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111240967|NCT03258372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111240968|NCT03258372|Leprostatic Agents|leprostatic agents|mesh-ancestor
111240969|NCT03258372|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111240970|NCT03258372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111240971|NCT03258372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111240972|NCT03258372|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111240973|NCT03258372|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111240974|NCT03258372|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
111240975|NCT03258372|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
111240976|NCT03258372|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
111240977|NCT03258372|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111240978|NCT03258372|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
111240979|NCT03258372|Abortifacient Agents|abortifacient agents|mesh-ancestor
111240980|NCT03258372|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111240981|NCT03258372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111240982|NCT03258372|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111240983|NCT03258372|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111240984|NCT03258372|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111240985|NCT03258372|Contraceptive Agents|contraceptive agents|mesh-ancestor
111240986|NCT03258372|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
111240987|NCT03258372|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
111240988|NCT03258372|Hormone Antagonists|hormone antagonists|mesh-ancestor
111240989|NCT03258372|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111240990|NCT03258372|Luteolytic Agents|luteolytic agents|mesh-ancestor
111240991|NCT03258372|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111240992|NCT03258372|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
111240993|NCT02456454|Valproic Acid|valproic acid|mesh-list
111240994|NCT02456454|Risperidone|risperidone|mesh-list
111240995|NCT02456454|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111240996|NCT02456454|Serotonin Agents|serotonin agents|mesh-ancestor
111240997|NCT02456454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111240998|NCT02456454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111240999|NCT02456454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111241000|NCT02456454|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111241001|NCT02456454|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111241002|NCT02456454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111241003|NCT02456454|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111241004|NCT02456454|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111241005|NCT02456454|Dopamine Agents|dopamine agents|mesh-ancestor
111241006|NCT02456454|Anticonvulsants|anticonvulsants|mesh-ancestor
111241007|NCT02456454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111241008|NCT02456454|GABA Agents|gaba agents|mesh-ancestor
111241009|NCT02456454|Antimanic Agents|antimanic agents|mesh-ancestor
111241010|NCT03258294|Melatonin|melatonin|mesh-list
111241011|NCT03258294|Antioxidants|antioxidants|mesh-ancestor
111241012|NCT03258294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111241013|NCT03258294|Protective Agents|protective agents|mesh-ancestor
111241014|NCT03258294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111241015|NCT03258294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111241016|NCT03265782|Acetaminophen|acetaminophen|mesh-list
111241017|NCT03265782|Ibuprofen|ibuprofen|mesh-list
111241018|NCT03265782|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111241019|NCT03265782|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111241020|NCT03265782|Analgesics|analgesics|mesh-ancestor
111241021|NCT03265782|Sensory System Agents|sensory system agents|mesh-ancestor
111241022|NCT03265782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111241023|NCT03265782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111241024|NCT03265782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111241025|NCT03265782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111241026|NCT03265782|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111241027|NCT03265782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111241028|NCT03265782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111241029|NCT03265782|Antipyretics|antipyretics|mesh-ancestor
111241030|NCT03798054|Insulin|insulin|mesh-list
111241031|NCT03798054|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111241032|NCT03798054|Metformin|metformin|mesh-list
111241033|NCT03798054|Insulin Glargine|insulin glargine|mesh-list
111241034|NCT03798054|Lixisenatide|lixisenatide|mesh-list
111241035|NCT03798054|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
111241036|NCT03798054|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111241037|NCT03798054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111241038|NCT03798054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111241039|NCT03265470|Fentanyl|fentanyl|mesh-list
111241040|NCT03265470|Dexmedetomidine|dexmedetomidine|mesh-list
111241041|NCT03265470|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111241042|NCT03265470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111241043|NCT03265470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111241044|NCT03265470|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111241045|NCT03265470|Analgesics|analgesics|mesh-ancestor
111241046|NCT03265470|Sensory System Agents|sensory system agents|mesh-ancestor
111241047|NCT03265470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111241048|NCT03265470|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111241049|NCT03265470|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111241050|NCT03265470|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111241051|NCT03265470|Adrenergic Agents|adrenergic agents|mesh-ancestor
111241052|NCT03265470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111241053|NCT03265470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111241054|NCT03265470|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111241055|NCT03265470|Narcotics|narcotics|mesh-ancestor
111241056|NCT03265470|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111241057|NCT03265470|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111241058|NCT03265470|Anesthetics, General|anesthetics, general|mesh-ancestor
111241059|NCT03265470|Anesthetics|anesthetics|mesh-ancestor
111241060|NCT02019940|Riluzole|riluzole|mesh-list
111241061|NCT02019940|Anticonvulsants|anticonvulsants|mesh-ancestor
111241062|NCT02019940|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111241063|NCT02019940|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111241064|NCT02019940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111241065|NCT02019940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111241066|NCT02019940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111241067|NCT02019940|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111241068|NCT02019940|Protective Agents|protective agents|mesh-ancestor
111241069|NCT01229943|Bevacizumab|bevacizumab|mesh-list
111241070|NCT01229943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111241071|NCT01229943|Everolimus|everolimus|mesh-list
111241072|NCT01229943|Octreotide|octreotide|mesh-list
111241073|NCT01229943|Endothelial Growth Factors|endothelial growth factors|mesh-list
111241074|NCT01229943|Antibodies|antibodies|mesh-list
111241075|NCT01229943|Immunoglobulins|immunoglobulins|mesh-list
111241076|NCT01229943|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111241077|NCT01229943|Immunoglobulin G|immunoglobulin g|mesh-list
111241078|NCT01229943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111241079|NCT01229943|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111241080|NCT01229943|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111241081|NCT01229943|Growth Substances|growth substances|mesh-ancestor
111241082|NCT01229943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111241083|NCT01229943|Growth Inhibitors|growth inhibitors|mesh-ancestor
111241084|NCT01229943|Immunologic Factors|immunologic factors|mesh-ancestor
111241085|NCT01229943|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111241086|NCT01229943|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111241087|NCT01229943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111241088|NCT01229943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111241089|NCT01229943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111241090|NCT01229943|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111241091|NCT01229943|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111241092|NCT02020408|Raclopride|raclopride|mesh-list
111241093|NCT02020408|Amphetamine|amphetamine|mesh-list
111241094|NCT02020408|Dextroamphetamine|dextroamphetamine|mesh-list
111241095|NCT02020408|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111241096|NCT02020408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111241097|NCT02020408|Sympathomimetics|sympathomimetics|mesh-ancestor
111241098|NCT02020408|Autonomic Agents|autonomic agents|mesh-ancestor
111241099|NCT02020408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111241100|NCT02020408|Dopamine Agents|dopamine agents|mesh-ancestor
111241101|NCT02020408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111241102|NCT02020408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111241103|NCT02020408|Adrenergic Agents|adrenergic agents|mesh-ancestor
111241104|NCT02020408|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111241105|NCT02020408|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111241106|NCT02020408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111241107|NCT02020408|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111241108|NCT02020408|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111241109|NCT02020408|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111241110|NCT02020408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111241111|NCT02020408|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111241112|NCT02020408|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111241113|NCT01219257|Adalimumab|adalimumab|mesh-list
111241114|NCT01219257|Infliximab|infliximab|mesh-list
111241115|NCT01219257|Golimumab|golimumab|mesh-list
111241116|NCT01219257|Etanercept|etanercept|mesh-list
111241117|NCT01219257|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111241118|NCT01219257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111241119|NCT01219257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111241120|NCT01219257|Dermatologic Agents|dermatologic agents|mesh-ancestor
111241121|NCT01219257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111241122|NCT01219257|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111241123|NCT01219257|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111241124|NCT01219257|Analgesics|analgesics|mesh-ancestor
111241125|NCT01219257|Sensory System Agents|sensory system agents|mesh-ancestor
111241126|NCT01219257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111241127|NCT01219257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111241128|NCT01219257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111241129|NCT01219257|Immunologic Factors|immunologic factors|mesh-ancestor
111241130|NCT01615887|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
111241131|NCT01615887|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111241132|NCT01615887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111241133|NCT01615887|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111241134|NCT01615887|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111241135|NCT01615887|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111241136|NCT01615887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111241137|NCT01615887|Dopamine Agents|dopamine agents|mesh-ancestor
111241138|NCT01615887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111241139|NCT04389801|Deferoxamine|deferoxamine|mesh-list
111241140|NCT04389801|Siderophores|siderophores|mesh-ancestor
111241141|NCT04389801|Iron Chelating Agents|iron chelating agents|mesh-ancestor
111241142|NCT04389801|Chelating Agents|chelating agents|mesh-ancestor
111241143|NCT04389801|Sequestering Agents|sequestering agents|mesh-ancestor
111241144|NCT04389801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111241145|NCT01606995|Rivaroxaban|rivaroxaban|mesh-list
110820752|NCT03509662|Thiamine|thiamine|mesh-list
111241146|NCT01606995|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111241147|NCT01606995|Antithrombins|antithrombins|mesh-ancestor
111241148|NCT01606995|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111241149|NCT01606995|Protease Inhibitors|protease inhibitors|mesh-ancestor
111241150|NCT01606995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111241151|NCT01606995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111241152|NCT01606995|Anticoagulants|anticoagulants|mesh-ancestor
111241153|NCT03548220|Mitapivat|mitapivat|mesh-list
111241154|NCT03548220|Enzyme Activators|enzyme activators|mesh-ancestor
111241155|NCT03548220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111241156|NCT03257670|Lidocaine|lidocaine|mesh-list
111241157|NCT03257670|Anesthetics, Local|anesthetics, local|mesh-ancestor
111241158|NCT03257670|Anesthetics|anesthetics|mesh-ancestor
111241159|NCT03257670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111241160|NCT03257670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111241161|NCT03257670|Sensory System Agents|sensory system agents|mesh-ancestor
111241162|NCT03257670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111241163|NCT03257670|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111241164|NCT03257670|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111241165|NCT03257670|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111241166|NCT03257670|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111241167|NCT03257670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111241168|NCT03265002|Psyllium|psyllium|mesh-list
111241169|NCT03265002|Calcium polycarbophil|calcium polycarbophil|mesh-list
111241170|NCT03265002|Cathartics|cathartics|mesh-ancestor
111241171|NCT03265002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111241172|NCT03265002|Antidiarrheals|antidiarrheals|mesh-ancestor
111241173|NCT03257514|Thioctic Acid|thioctic acid|mesh-list
111241174|NCT03257514|Antioxidants|antioxidants|mesh-ancestor
111241175|NCT03257514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111241176|NCT03257514|Protective Agents|protective agents|mesh-ancestor
111241177|NCT03257514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111241178|NCT03257514|Vitamin B Complex|vitamin b complex|mesh-ancestor
111241179|NCT03257514|Vitamins|vitamins|mesh-ancestor
111241180|NCT03257514|Micronutrients|micronutrients|mesh-ancestor
111241181|NCT04781751|Insulin|insulin|mesh-list
111241182|NCT04781751|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111241183|NCT04781751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111241184|NCT04781439|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111241185|NCT04781439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111241186|NCT03261024|Nickel|nickel|mesh-list
111241187|NCT03261024|Trace Elements|trace elements|mesh-ancestor
111241188|NCT03261024|Micronutrients|micronutrients|mesh-ancestor
111241189|NCT03261024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111241190|NCT04777383|Atropine|atropine|mesh-list
111241191|NCT04777383|Phenylephrine|phenylephrine|mesh-list
111241192|NCT04777383|Oxymetazoline|oxymetazoline|mesh-list
111241193|NCT04777383|Norepinephrine|norepinephrine|mesh-list
111241194|NCT04777383|Acetylcholine|acetylcholine|mesh-list
111241195|NCT04777383|Neostigmine|neostigmine|mesh-list
111241196|NCT04777383|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111241197|NCT04777383|Mydriatics|mydriatics|mesh-ancestor
111241198|NCT04777383|Autonomic Agents|autonomic agents|mesh-ancestor
111241199|NCT04777383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111241200|NCT04777383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111241201|NCT04777383|Sympathomimetics|sympathomimetics|mesh-ancestor
111241202|NCT04777383|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111241203|NCT04777383|Nasal Decongestants|nasal decongestants|mesh-ancestor
111241204|NCT04777383|Respiratory System Agents|respiratory system agents|mesh-ancestor
111241205|NCT04777383|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111241206|NCT04777383|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111241207|NCT04777383|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111241208|NCT04777383|Adrenergic Agents|adrenergic agents|mesh-ancestor
111241209|NCT04777383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111241210|NCT04777383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111241211|NCT04777383|Protective Agents|protective agents|mesh-ancestor
111241212|NCT04777383|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111241213|NCT04777383|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111241214|NCT04777383|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111241215|NCT04777383|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111241216|NCT04777383|Parasympatholytics|parasympatholytics|mesh-ancestor
111241217|NCT04777383|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111241218|NCT04777383|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111241219|NCT04777383|Cholinergic Agents|cholinergic agents|mesh-ancestor
111241220|NCT04777383|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111241221|NCT04777383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111241222|NCT04777383|Parasympathomimetics|parasympathomimetics|mesh-ancestor
111241223|NCT04777383|Vasodilator Agents|vasodilator agents|mesh-ancestor
111241224|NCT04777383|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111241225|NCT03257124|Osimertinib|osimertinib|mesh-list
111241226|NCT03257124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111241227|NCT03257124|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111241228|NCT03257124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111241229|NCT03257124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111241230|NCT02089113|Dexamethasone|dexamethasone|mesh-list
111241231|NCT02089113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111241232|NCT02089113|Antiemetics|antiemetics|mesh-ancestor
111241233|NCT02089113|Autonomic Agents|autonomic agents|mesh-ancestor
111241234|NCT02089113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111241235|NCT02089113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111241236|NCT02089113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111241237|NCT02089113|Glucocorticoids|glucocorticoids|mesh-ancestor
111241238|NCT02089113|Hormones|hormones|mesh-ancestor
111241239|NCT02089113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111241240|NCT02089113|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111241241|NCT02089113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111241242|NCT03260634|Voriconazole|voriconazole|mesh-list
111241243|NCT03260634|Antifungal Agents|antifungal agents|mesh-ancestor
111241244|NCT03260634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111241245|NCT03260634|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111241246|NCT03260634|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111241247|NCT03260634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111241248|NCT03260634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111241249|NCT03260634|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111241250|NCT03260634|Hormone Antagonists|hormone antagonists|mesh-ancestor
111241251|NCT03260634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111241252|NCT03260634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111241253|NCT03260634|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111241254|NCT04777227|Lidocaine|lidocaine|mesh-list
111241255|NCT04777227|Anesthetics, Local|anesthetics, local|mesh-ancestor
111241256|NCT04777227|Anesthetics|anesthetics|mesh-ancestor
111241257|NCT04777227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111241258|NCT04777227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111241259|NCT04777227|Sensory System Agents|sensory system agents|mesh-ancestor
111241260|NCT04777227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111241261|NCT04777227|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111241262|NCT04777227|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111241263|NCT04777227|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111241264|NCT04777227|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111241265|NCT04777227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111241266|NCT03260556|Pirfenidone|pirfenidone|mesh-list
111241267|NCT03260556|Analgesics|analgesics|mesh-ancestor
111241268|NCT03260556|Sensory System Agents|sensory system agents|mesh-ancestor
111241269|NCT03260556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111241270|NCT03260556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111241271|NCT03260556|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111241272|NCT03260556|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111241273|NCT03260556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111241274|NCT03260556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111241275|NCT03260556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111241276|NCT02712996|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
111241277|NCT02712996|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111241278|NCT02712996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111241279|NCT02712996|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111241280|NCT02712996|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111241281|NCT02712996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111241282|NCT02712996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111241283|NCT02712996|Dopamine Agents|dopamine agents|mesh-ancestor
111241284|NCT02712996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111241285|NCT03252366|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
111241286|NCT03252366|Hemostatics|hemostatics|mesh-ancestor
111241287|NCT03252366|Coagulants|coagulants|mesh-ancestor
111241288|NCT04346277|Antibodies|antibodies|mesh-list
111241289|NCT04346277|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111241290|NCT04346277|Immunologic Factors|immunologic factors|mesh-ancestor
111241291|NCT04346277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111241292|NCT04780347|Paclitaxel|paclitaxel|mesh-list
111241293|NCT04780347|Capecitabine|capecitabine|mesh-list
111241294|NCT04780347|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111241295|NCT04780347|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111241296|NCT04780347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111241297|NCT04780347|Tubulin Modulators|tubulin modulators|mesh-ancestor
111241298|NCT04780347|Antimitotic Agents|antimitotic agents|mesh-ancestor
111241299|NCT04780347|Mitosis Modulators|mitosis modulators|mesh-ancestor
111241300|NCT04780347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111241301|NCT04780347|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111241302|NCT04780347|Antimetabolites|antimetabolites|mesh-ancestor
111241303|NCT02455596|Interferons|interferons|mesh-list
111241304|NCT02455596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111241305|NCT02455596|Antiviral Agents|antiviral agents|mesh-ancestor
111241306|NCT02455596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111241307|NCT02455440|Propofol|propofol|mesh-list
111241308|NCT02455440|Sevoflurane|sevoflurane|mesh-list
111241309|NCT02455440|Esmolol|esmolol|mesh-list
111241310|NCT02455440|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111241311|NCT02455440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111241312|NCT02455440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111241313|NCT02455440|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111241314|NCT02455440|Anesthetics, General|anesthetics, general|mesh-ancestor
111241315|NCT02455440|Anesthetics|anesthetics|mesh-ancestor
111241316|NCT02455440|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111241317|NCT02455440|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111241318|NCT02455440|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
111241319|NCT02455440|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111241320|NCT02455440|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111241321|NCT02455440|Adrenergic Agents|adrenergic agents|mesh-ancestor
111241322|NCT02455440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111241323|NCT02455440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111241324|NCT03260166|Niacinamide|niacinamide|mesh-list
111241325|NCT03260166|Niacin|niacin|mesh-list
111241326|NCT03260166|Nicotinic Acids|nicotinic acids|mesh-list
111241327|NCT03260166|Vitamin B Complex|vitamin b complex|mesh-ancestor
111241328|NCT03260166|Vitamins|vitamins|mesh-ancestor
111241329|NCT03260166|Micronutrients|micronutrients|mesh-ancestor
111241330|NCT03260166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111241331|NCT03260166|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111241332|NCT03260166|Antimetabolites|antimetabolites|mesh-ancestor
111241333|NCT03260166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111241334|NCT03260166|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111241335|NCT03260166|Vasodilator Agents|vasodilator agents|mesh-ancestor
111241336|NCT03260010|Fosfomycin|fosfomycin|mesh-list
111241337|NCT03260010|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111241338|NCT03260010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111241339|NCT03260088|Immunoglobulins|immunoglobulins|mesh-list
111241340|NCT03260088|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111241341|NCT03260088|Antibodies|antibodies|mesh-list
111241342|NCT03260088|Immunoglobulin G|immunoglobulin g|mesh-list
111241343|NCT03260088|Immunologic Factors|immunologic factors|mesh-ancestor
111241344|NCT03260088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111241345|NCT04776135|Edaravone|edaravone|mesh-list
111241346|NCT04776135|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111241347|NCT04776135|Antioxidants|antioxidants|mesh-ancestor
111241348|NCT04776135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111241349|NCT04776135|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111241350|NCT04776135|Protective Agents|protective agents|mesh-ancestor
111241351|NCT04776135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111241352|NCT03474276|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111241353|NCT03474276|Azithromycin|azithromycin|mesh-list
111241354|NCT03474276|Albendazole|albendazole|mesh-list
111241355|NCT03474276|Antiparasitic Agents|antiparasitic agents|mesh-list
111241356|NCT03474276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111241357|NCT03474276|Anthelmintics|anthelmintics|mesh-ancestor
111241358|NCT03474276|Anticestodal Agents|anticestodal agents|mesh-ancestor
111241359|NCT03474276|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
111241360|NCT03474276|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111241361|NCT03474276|Tubulin Modulators|tubulin modulators|mesh-ancestor
111241362|NCT03474276|Antimitotic Agents|antimitotic agents|mesh-ancestor
111241363|NCT03474276|Mitosis Modulators|mitosis modulators|mesh-ancestor
111241364|NCT03474276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111241365|NCT03474276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111241366|NCT04779255|Acetaminophen|acetaminophen|mesh-list
111241367|NCT04779255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111241368|NCT04779255|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111241369|NCT04779255|Analgesics|analgesics|mesh-ancestor
111241370|NCT04779255|Sensory System Agents|sensory system agents|mesh-ancestor
111241371|NCT04779255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111241372|NCT04779255|Antipyretics|antipyretics|mesh-ancestor
111241373|NCT04779567|Acetaminophen|acetaminophen|mesh-list
111241374|NCT04779567|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111241375|NCT04779567|Analgesics|analgesics|mesh-ancestor
111241376|NCT04779567|Sensory System Agents|sensory system agents|mesh-ancestor
111241377|NCT04779567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111241378|NCT04779567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111241379|NCT04779567|Antipyretics|antipyretics|mesh-ancestor
111241380|NCT02352844|Everolimus|everolimus|mesh-list
111241381|NCT02352844|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111241382|NCT02352844|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111241383|NCT02352844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111241384|NCT02352844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111241385|NCT02352844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111241386|NCT02352844|Immunologic Factors|immunologic factors|mesh-ancestor
111241387|NCT02352844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111241388|NCT02352844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111241389|NCT03255642|Clonazepam|clonazepam|mesh-list
111241390|NCT03255642|Melatonin|melatonin|mesh-list
111241391|NCT03255642|Antioxidants|antioxidants|mesh-ancestor
111241392|NCT03255642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111241393|NCT03255642|Protective Agents|protective agents|mesh-ancestor
111241394|NCT03255642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111241395|NCT03255642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111241396|NCT03255642|Anticonvulsants|anticonvulsants|mesh-ancestor
111241397|NCT03255642|GABA Modulators|gaba modulators|mesh-ancestor
111241398|NCT03255642|GABA Agents|gaba agents|mesh-ancestor
111241399|NCT03255642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111241400|NCT03562377|Vaccines|vaccines|mesh-list
111241401|NCT03562377|Immunologic Factors|immunologic factors|mesh-ancestor
111241402|NCT03562377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111241403|NCT02352922|Bupivacaine|bupivacaine|mesh-list
111241404|NCT02352922|Anesthetics, Local|anesthetics, local|mesh-ancestor
111241405|NCT02352922|Anesthetics|anesthetics|mesh-ancestor
111241406|NCT02352922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111241407|NCT02352922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111241408|NCT02352922|Sensory System Agents|sensory system agents|mesh-ancestor
111241409|NCT02352922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111241410|NCT03255330|Dipyrone|dipyrone|mesh-list
111241411|NCT03255330|Gabapentin|gabapentin|mesh-list
111241412|NCT03255330|Tramadol|tramadol|mesh-list
111241413|NCT03255330|Analgesics|analgesics|mesh-ancestor
111241414|NCT03255330|Sensory System Agents|sensory system agents|mesh-ancestor
111241415|NCT03255330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111241416|NCT03255330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111241417|NCT03255330|Anticonvulsants|anticonvulsants|mesh-ancestor
111241418|NCT03255330|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111241419|NCT03255330|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111241420|NCT03255330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111241421|NCT03255330|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111241422|NCT03255330|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111241423|NCT03255330|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111241424|NCT03255330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111241425|NCT03255330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111241426|NCT03255330|Antimanic Agents|antimanic agents|mesh-ancestor
111241427|NCT03255330|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111241428|NCT03255330|Narcotics|narcotics|mesh-ancestor
111241429|NCT03255330|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111241430|NCT03255330|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111241431|NCT03255330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111241432|NCT03255330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111241433|NCT03255330|Antipyretics|antipyretics|mesh-ancestor
111241434|NCT02353780|Etanercept|etanercept|mesh-list
111241435|NCT02353780|Infliximab|infliximab|mesh-list
111241436|NCT02353780|Certolizumab Pegol|certolizumab pegol|mesh-list
111241437|NCT02353780|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
111241438|NCT02353780|Abatacept|abatacept|mesh-list
111241439|NCT02353780|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111241440|NCT02353780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111241441|NCT02353780|Analgesics|analgesics|mesh-ancestor
111241442|NCT02353780|Sensory System Agents|sensory system agents|mesh-ancestor
111241443|NCT02353780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111241444|NCT02353780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111241445|NCT02353780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111241446|NCT02353780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111241447|NCT02353780|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111241448|NCT02353780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111241449|NCT02353780|Immunologic Factors|immunologic factors|mesh-ancestor
111241450|NCT02353780|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111241451|NCT02353780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111241452|NCT02353780|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111241453|NCT02353780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111241454|NCT02353780|Dermatologic Agents|dermatologic agents|mesh-ancestor
111241455|NCT03246360|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111241456|NCT03246360|Cloxacillin|cloxacillin|mesh-list
111241457|NCT03246360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111241458|NCT02354092|Anesthetics|anesthetics|mesh-list
111241459|NCT02354092|Anesthetics, Local|anesthetics, local|mesh-list
111241460|NCT02354092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111241461|NCT02354092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111241462|NCT02354092|Sensory System Agents|sensory system agents|mesh-ancestor
111241463|NCT02354092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111241464|NCT00907101|Adapalene|adapalene|mesh-list
111241465|NCT00907101|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
111241466|NCT00907101|Benzoyl Peroxide|benzoyl peroxide|mesh-list
111241467|NCT00907101|Dermatologic Agents|dermatologic agents|mesh-ancestor
111241468|NCT00907101|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111241469|NCT00907101|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111241470|NCT00907101|Analgesics|analgesics|mesh-ancestor
111241471|NCT00907101|Sensory System Agents|sensory system agents|mesh-ancestor
111241472|NCT00907101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111241473|NCT00907101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111241474|NCT00907101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111241475|NCT00907101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111241476|NCT03245970|Atenolol|atenolol|mesh-list
111241477|NCT03245970|Labetalol|labetalol|mesh-list
111241478|NCT03245970|Nifedipine|nifedipine|mesh-list
111241479|NCT03245970|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111241480|NCT03245970|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111241481|NCT03245970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111241482|NCT03245970|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111241483|NCT03245970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111241484|NCT03245970|Vasodilator Agents|vasodilator agents|mesh-ancestor
111241485|NCT03245970|Tocolytic Agents|tocolytic agents|mesh-ancestor
111241486|NCT03245970|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111241487|NCT03245970|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111241488|NCT03245970|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111241489|NCT03245970|Sympatholytics|sympatholytics|mesh-ancestor
111241490|NCT03245970|Autonomic Agents|autonomic agents|mesh-ancestor
111241491|NCT03245970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110965778|NCT05045170|Dexmedetomidine|dexmedetomidine|mesh-list
111241492|NCT03245970|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
111241493|NCT03245970|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111241494|NCT03245970|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111241495|NCT03245970|Adrenergic Agents|adrenergic agents|mesh-ancestor
111241496|NCT03245970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111241498|NCT03245970|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111241499|NCT03245970|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111241500|NCT02454348|Vasopressins|vasopressins|mesh-list
111241501|NCT02454348|Arginine Vasopressin|arginine vasopressin|mesh-list
111241502|NCT02454348|Norepinephrine|norepinephrine|mesh-list
111241503|NCT02454348|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111241504|NCT02454348|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111241505|NCT02454348|Adrenergic Agents|adrenergic agents|mesh-ancestor
111241506|NCT02454348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111241507|NCT02454348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111241508|NCT02454348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111241509|NCT02454348|Sympathomimetics|sympathomimetics|mesh-ancestor
111241510|NCT02454348|Autonomic Agents|autonomic agents|mesh-ancestor
111241511|NCT02454348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111241512|NCT02454348|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111241513|NCT02454348|Hemostatics|hemostatics|mesh-ancestor
111241514|NCT02454348|Coagulants|coagulants|mesh-ancestor
111241515|NCT02454348|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
111241516|NCT02454348|Natriuretic Agents|natriuretic agents|mesh-ancestor
111241517|NCT02455908|Aldesleukin|aldesleukin|mesh-list
111241518|NCT02455908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111241519|NCT02455908|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111241520|NCT02455908|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111241521|NCT02455908|Antiviral Agents|antiviral agents|mesh-ancestor
111241522|NCT02455908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111241523|NCT03245424|Ivosidenib|ivosidenib|mesh-list
111241524|NCT03245424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111241525|NCT03245424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111241526|NCT03245424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111241527|NCT03251040|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
111241528|NCT03251040|Hemostatics|hemostatics|mesh-ancestor
111241529|NCT03251040|Coagulants|coagulants|mesh-ancestor
111241530|NCT04754763|Propolis|propolis|mesh-list
111241531|NCT04754763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111241532|NCT02454894|Lidocaine|lidocaine|mesh-list
111241533|NCT02454894|Anesthetics, Local|anesthetics, local|mesh-ancestor
111241534|NCT02454894|Anesthetics|anesthetics|mesh-ancestor
111241535|NCT02454894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111241536|NCT02454894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111241537|NCT02454894|Sensory System Agents|sensory system agents|mesh-ancestor
111241538|NCT02454894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111241539|NCT02454894|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111241540|NCT02454894|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111241541|NCT02454894|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111241542|NCT02454894|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111241543|NCT02454894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111241544|NCT03250962|Decitabine|decitabine|mesh-list
111241545|NCT03250962|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111241546|NCT03250962|Antimetabolites|antimetabolites|mesh-ancestor
111241547|NCT03250962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111241548|NCT03250962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111241549|NCT03250962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111241550|NCT04774029|Lidocaine|lidocaine|mesh-list
111241551|NCT04774029|Anesthetics, Local|anesthetics, local|mesh-ancestor
111241552|NCT04774029|Anesthetics|anesthetics|mesh-ancestor
111241553|NCT04774029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111241554|NCT04774029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111241555|NCT04774029|Sensory System Agents|sensory system agents|mesh-ancestor
111241556|NCT04774029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111241557|NCT04774029|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111241558|NCT04774029|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111241559|NCT04774029|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111241560|NCT04774029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111241561|NCT04774029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111241562|NCT03245346|Anesthetics|anesthetics|mesh-list
111241563|NCT03245346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111241564|NCT03245346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111241565|NCT03244956|Trametinib|trametinib|mesh-list
111241566|NCT03244956|Dabrafenib|dabrafenib|mesh-list
111241567|NCT03244956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111241568|NCT03244956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111241569|NCT03244956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111241570|NCT03244956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111241571|NCT03244488|Mecamylamine|mecamylamine|mesh-list
111241572|NCT03244488|Scopolamine|scopolamine|mesh-list
111241573|NCT03244488|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
111241574|NCT03244488|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111241575|NCT03244488|Antiemetics|antiemetics|mesh-ancestor
111241576|NCT03244488|Autonomic Agents|autonomic agents|mesh-ancestor
111241577|NCT03244488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111241578|NCT03244488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111241579|NCT03244488|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111241580|NCT03244488|Mydriatics|mydriatics|mesh-ancestor
111241581|NCT03244488|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111241582|NCT03244488|Cholinergic Agents|cholinergic agents|mesh-ancestor
111241583|NCT03244488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111241584|NCT03244488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111241585|NCT03244488|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111241586|NCT03244488|Parasympatholytics|parasympatholytics|mesh-ancestor
111241587|NCT03244488|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111241588|NCT03244488|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
111241589|NCT03244488|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
111241590|NCT03254784|Deucravacitinib|deucravacitinib|mesh-list
111241591|NCT03254784|Dermatologic Agents|dermatologic agents|mesh-ancestor
111241592|NCT03254784|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111241593|NCT03254784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111241594|NCT03254784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111241595|NCT03245658|Nabiximols|nabiximols|mesh-list
111241596|NCT03245658|Analgesics|analgesics|mesh-ancestor
111241597|NCT03245658|Sensory System Agents|sensory system agents|mesh-ancestor
111241598|NCT03245658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111241599|NCT03245658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111241600|NCT03245190|Chiauranib|chiauranib|mesh-list
111241601|NCT03245190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111241602|NCT03245190|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111241603|NCT03245190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111241604|NCT03245190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111241605|NCT01969708|Bevacizumab|bevacizumab|mesh-list
111241606|NCT01969708|Aflibercept|aflibercept|mesh-list
111241607|NCT01969708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111241608|NCT01969708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111241609|NCT01969708|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111241610|NCT01969708|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111241611|NCT01969708|Growth Substances|growth substances|mesh-ancestor
111241612|NCT01969708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111241613|NCT01969708|Growth Inhibitors|growth inhibitors|mesh-ancestor
111241614|NCT03243864|Ceftazidime|ceftazidime|mesh-list
111241615|NCT03243864|Avibactam|avibactam|mesh-list
111241616|NCT03243864|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
111241617|NCT03243864|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111241618|NCT03243864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111241619|NCT03243864|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
111241620|NCT03243864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111241621|NCT03243864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111241622|NCT03250494|Dexamethasone|dexamethasone|mesh-list
111241623|NCT03250494|Dexamethasone acetate|dexamethasone acetate|mesh-list
111241624|NCT03250494|BB 1101|bb 1101|mesh-list
111241625|NCT03250494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111241626|NCT03250494|Antiemetics|antiemetics|mesh-ancestor
111241627|NCT03250494|Autonomic Agents|autonomic agents|mesh-ancestor
111241628|NCT03250494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111241629|NCT03250494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111241630|NCT03250494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111241631|NCT03250494|Glucocorticoids|glucocorticoids|mesh-ancestor
111241632|NCT03250494|Hormones|hormones|mesh-ancestor
111241633|NCT03250494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111241634|NCT03250494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111241635|NCT03250494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111241636|NCT03250494|Protease Inhibitors|protease inhibitors|mesh-ancestor
111241637|NCT03250494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111241638|NCT03250494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111241639|NCT03254628|Misoprostol|misoprostol|mesh-list
111241640|NCT03254628|Oxytocin|oxytocin|mesh-list
111241641|NCT03254628|Oxytocics|oxytocics|mesh-ancestor
111241642|NCT03254628|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111241643|NCT03254628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111241644|NCT03254628|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111241646|NCT03254628|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111241647|NCT03254628|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111241648|NCT01970176|Tadalafil|tadalafil|mesh-list
111241649|NCT01970176|Vasodilator Agents|vasodilator agents|mesh-ancestor
111241650|NCT01970176|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111241651|NCT01970176|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111241652|NCT01970176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111241653|NCT01970176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111241654|NCT01970176|Urological Agents|urological agents|mesh-ancestor
111241655|NCT02024386|Riociguat|riociguat|mesh-list
111241656|NCT02024386|Enzyme Activators|enzyme activators|mesh-ancestor
111241657|NCT02024386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111241658|NCT03250338|Cytarabine|cytarabine|mesh-list
111241659|NCT03250338|Fludarabine|fludarabine|mesh-list
111241660|NCT03250338|Mitoxantrone|mitoxantrone|mesh-list
111241661|NCT03250338|Idarubicin|idarubicin|mesh-list
111241662|NCT03250338|Crenolanib|crenolanib|mesh-list
111241663|NCT03250338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111241664|NCT03250338|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111241665|NCT03250338|Antimetabolites|antimetabolites|mesh-ancestor
111241666|NCT03250338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111241667|NCT03250338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111241668|NCT03250338|Immunologic Factors|immunologic factors|mesh-ancestor
111241669|NCT03250338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111241670|NCT03250338|Antiviral Agents|antiviral agents|mesh-ancestor
111241671|NCT03250338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111241672|NCT03250338|Analgesics|analgesics|mesh-ancestor
111241673|NCT03250338|Sensory System Agents|sensory system agents|mesh-ancestor
111241674|NCT03250338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111241675|NCT03250338|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111241676|NCT03250338|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111241677|NCT03250338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111241678|NCT03250338|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111241679|NCT01971580|Ambrisentan|ambrisentan|mesh-list
111241680|NCT01971580|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111241681|NCT00354562|Docetaxel|docetaxel|mesh-list
111241682|NCT00354562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111241683|NCT00354562|Tubulin Modulators|tubulin modulators|mesh-ancestor
111241684|NCT00354562|Antimitotic Agents|antimitotic agents|mesh-ancestor
111241685|NCT00354562|Mitosis Modulators|mitosis modulators|mesh-ancestor
111241686|NCT00354562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111241687|NCT03250104|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111241688|NCT03250104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111241689|NCT00838383|Sitaxsentan|sitaxsentan|mesh-list
111241690|NCT00838383|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
111241691|NCT00838383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111241692|NCT02355886|Gabapentin|gabapentin|mesh-list
111241693|NCT02355886|Analgesics|analgesics|mesh-ancestor
111241694|NCT02355886|Sensory System Agents|sensory system agents|mesh-ancestor
111241695|NCT02355886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111241696|NCT02355886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111241697|NCT02355886|Anticonvulsants|anticonvulsants|mesh-ancestor
111241698|NCT02355886|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111241699|NCT02355886|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111241700|NCT02355886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111241701|NCT02355886|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111241702|NCT02355886|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111241703|NCT02355886|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111241704|NCT02355886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111241705|NCT02355886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111241706|NCT02355886|Antimanic Agents|antimanic agents|mesh-ancestor
111241707|NCT03247413|Dexamethasone|dexamethasone|mesh-list
111241708|NCT03247413|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111241709|NCT03247413|Antiemetics|antiemetics|mesh-ancestor
111241710|NCT03247413|Autonomic Agents|autonomic agents|mesh-ancestor
111241711|NCT03247413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111241712|NCT03247413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111241713|NCT03247413|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111241714|NCT03247413|Glucocorticoids|glucocorticoids|mesh-ancestor
111241715|NCT03247413|Hormones|hormones|mesh-ancestor
111241716|NCT03247413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111241717|NCT03247413|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111241718|NCT03247413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111241719|NCT02356198|Hydromorphone|hydromorphone|mesh-list
111241720|NCT02356198|Bupivacaine|bupivacaine|mesh-list
111241721|NCT02356198|Anesthetics, Local|anesthetics, local|mesh-ancestor
111241722|NCT02356198|Anesthetics|anesthetics|mesh-ancestor
111241723|NCT02356198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111241724|NCT02356198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111241725|NCT02356198|Sensory System Agents|sensory system agents|mesh-ancestor
111241726|NCT02356198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111241727|NCT02356198|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111241728|NCT02356198|Narcotics|narcotics|mesh-ancestor
111241729|NCT02356198|Analgesics|analgesics|mesh-ancestor
111241730|NCT03254004|Pembrolizumab|pembrolizumab|mesh-list
111241731|NCT03254004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111241732|NCT03254004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111241733|NCT03254004|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111241734|NCT03254004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111241735|NCT04778865|Vitamin D|vitamin d|mesh-list
111241736|NCT04778865|Ergocalciferols|ergocalciferols|mesh-list
111241737|NCT04778865|Cholecalciferol|cholecalciferol|mesh-list
111241738|NCT04778865|Vitamins|vitamins|mesh-list
111241739|NCT04778865|Micronutrients|micronutrients|mesh-ancestor
111241740|NCT04778865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111241741|NCT04778865|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111241742|NCT04778865|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111241743|NCT02025634|Acetaminophen|acetaminophen|mesh-list
111241744|NCT02025634|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111241745|NCT02025634|Analgesics|analgesics|mesh-ancestor
111241746|NCT02025634|Sensory System Agents|sensory system agents|mesh-ancestor
111241747|NCT02025634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111241748|NCT02025634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111241749|NCT02025634|Antipyretics|antipyretics|mesh-ancestor
111241750|NCT04773951|Antibodies|antibodies|mesh-list
111241751|NCT04773951|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111241752|NCT04773951|Immunologic Factors|immunologic factors|mesh-ancestor
111241753|NCT04773951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111241754|NCT04773717|Ascorbic Acid|ascorbic acid|mesh-list
111241755|NCT04773717|Antioxidants|antioxidants|mesh-ancestor
111241756|NCT04773717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111241757|NCT04773717|Protective Agents|protective agents|mesh-ancestor
111241758|NCT04773717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111241759|NCT04773717|Vitamins|vitamins|mesh-ancestor
111241760|NCT04773717|Micronutrients|micronutrients|mesh-ancestor
111241761|NCT04444167|Lenvatinib|lenvatinib|mesh-list
111241762|NCT04444167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111241763|NCT04444167|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111241764|NCT04444167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111241765|NCT04444167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111241766|NCT03243006|Acetaminophen|acetaminophen|mesh-list
111241767|NCT03243006|Tramadol|tramadol|mesh-list
111241768|NCT03243006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111241769|NCT03243006|Analgesics|analgesics|mesh-ancestor
111241770|NCT03243006|Sensory System Agents|sensory system agents|mesh-ancestor
111241771|NCT03243006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111241772|NCT03243006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111241773|NCT03243006|Antipyretics|antipyretics|mesh-ancestor
111241774|NCT03243006|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111241775|NCT03243006|Narcotics|narcotics|mesh-ancestor
111241776|NCT03243006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111241777|NCT03249402|Levonorgestrel|levonorgestrel|mesh-list
111241778|NCT03249402|Ethinyl Estradiol|ethinyl estradiol|mesh-list
111241779|NCT03249402|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
111241780|NCT03249402|Estradiol|estradiol|mesh-list
111241781|NCT03249402|Estrogens|estrogens|mesh-ancestor
110966076|NCT06035055|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110966077|NCT06035055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110966078|NCT06035055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110966079|NCT06035055|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110966080|NCT06035016|Capecitabine|capecitabine|mesh-list
110966081|NCT06035016|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110966082|NCT06035016|Antimetabolites|antimetabolites|mesh-ancestor
110966083|NCT06035016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110966084|NCT06035016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110966085|NCT06034964|Tislelizumab|tislelizumab|mesh-list
110966086|NCT06034964|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110966087|NCT06034964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110966088|NCT06034938|Tenofovir|tenofovir|mesh-list
111241782|NCT03249402|Hormones|hormones|mesh-ancestor
111241783|NCT03249402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111241784|NCT03249402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111241785|NCT03249402|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111241786|NCT03249402|Contraceptive Agents|contraceptive agents|mesh-ancestor
111241787|NCT03249402|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111241788|NCT03249402|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111241789|NCT03249402|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111241790|NCT03249402|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111241791|NCT03249402|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111241792|NCT03249402|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
111241793|NCT03242460|Dexamethasone|dexamethasone|mesh-list
111241794|NCT03242460|Cyclophosphamide|cyclophosphamide|mesh-list
111241795|NCT03242460|Pomalidomide|pomalidomide|mesh-list
111241796|NCT03242460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111241797|NCT03242460|Immunologic Factors|immunologic factors|mesh-ancestor
111241798|NCT03242460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111241799|NCT03242460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111241800|NCT03242460|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111241801|NCT03242460|Alkylating Agents|alkylating agents|mesh-ancestor
111241802|NCT03242460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111241803|NCT03242460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111241804|NCT03242460|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111241805|NCT03242460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111241806|NCT03242460|Antiemetics|antiemetics|mesh-ancestor
111241807|NCT03242460|Autonomic Agents|autonomic agents|mesh-ancestor
111241808|NCT03242460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111241809|NCT03242460|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111241810|NCT03242460|Glucocorticoids|glucocorticoids|mesh-ancestor
111241811|NCT03242460|Hormones|hormones|mesh-ancestor
111241812|NCT03242460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111241813|NCT03242460|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111241814|NCT03242460|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111241815|NCT03242460|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111241816|NCT03242460|Growth Substances|growth substances|mesh-ancestor
111241817|NCT03242460|Growth Inhibitors|growth inhibitors|mesh-ancestor
111241818|NCT01972516|Tivozanib|tivozanib|mesh-list
111241819|NCT01972516|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111241820|NCT01972516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111241821|NCT01972516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111241822|NCT03242616|Pemetrexed|pemetrexed|mesh-list
111241823|NCT03242616|Vinorelbine|vinorelbine|mesh-list
111241824|NCT03242616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111241825|NCT03242616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111241826|NCT03242616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111241827|NCT03242616|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111241828|NCT03242616|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111241829|NCT03242616|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111241830|NCT03242616|Tubulin Modulators|tubulin modulators|mesh-ancestor
111241831|NCT03242616|Antimitotic Agents|antimitotic agents|mesh-ancestor
111241832|NCT03242616|Mitosis Modulators|mitosis modulators|mesh-ancestor
111241833|NCT01748825|Adavosertib|adavosertib|mesh-list
111241834|NCT01748825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111241835|NCT01748825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111241836|NCT03253224|Magnesium Sulfate|magnesium sulfate|mesh-list
111241837|NCT03253224|Analgesics|analgesics|mesh-ancestor
111241838|NCT03253224|Sensory System Agents|sensory system agents|mesh-ancestor
111241839|NCT03253224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111241840|NCT03253224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111241841|NCT03253224|Anesthetics|anesthetics|mesh-ancestor
111241842|NCT03253224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111241843|NCT03253224|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111241844|NCT03253224|Anticonvulsants|anticonvulsants|mesh-ancestor
111241845|NCT03253224|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111241846|NCT03253224|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111241847|NCT03253224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111241848|NCT03253224|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111241849|NCT03253224|Tocolytic Agents|tocolytic agents|mesh-ancestor
111241850|NCT03253224|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111241851|NCT00789399|PENTA|penta|mesh-list
111241852|NCT00789399|Fondaparinux|fondaparinux|mesh-list
111241853|NCT00789399|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111241854|NCT00789399|Antithrombins|antithrombins|mesh-ancestor
111241855|NCT00789399|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111241856|NCT00789399|Protease Inhibitors|protease inhibitors|mesh-ancestor
111241857|NCT00789399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111241858|NCT00789399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111241859|NCT00789399|Anticoagulants|anticoagulants|mesh-ancestor
111241860|NCT00789399|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111241861|NCT00789399|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111241862|NCT01720667|Levetiracetam|levetiracetam|mesh-list
111241863|NCT01720667|Phenobarbital|phenobarbital|mesh-list
111241864|NCT01720667|Anticonvulsants|anticonvulsants|mesh-ancestor
111241865|NCT01720667|Nootropic Agents|nootropic agents|mesh-ancestor
111241866|NCT01720667|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111241867|NCT01720667|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111241868|NCT01720667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111241869|NCT01720667|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111241870|NCT01720667|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111241871|NCT01720667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111241872|NCT01720667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111241873|NCT01720667|GABA Modulators|gaba modulators|mesh-ancestor
111241874|NCT01720667|GABA Agents|gaba agents|mesh-ancestor
111241875|NCT01720667|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111241876|NCT01720667|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111241877|NCT01720667|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111241878|NCT04773093|Lidocaine|lidocaine|mesh-list
111241879|NCT04773093|Anesthetics, Local|anesthetics, local|mesh-ancestor
111241880|NCT04773093|Anesthetics|anesthetics|mesh-ancestor
111241881|NCT04773093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111241882|NCT04773093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111241883|NCT04773093|Sensory System Agents|sensory system agents|mesh-ancestor
111241884|NCT04773093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111241885|NCT04773093|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111241886|NCT04773093|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111241887|NCT04773093|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111241888|NCT04773093|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111241889|NCT04773093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111241890|NCT01720043|Bortezomib|bortezomib|mesh-list
111241891|NCT01720043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111241892|NCT02455362|Morphine|morphine|mesh-list
111241893|NCT02455362|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111241894|NCT02455362|Narcotics|narcotics|mesh-ancestor
111241895|NCT02455362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111241896|NCT02455362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111241897|NCT02455362|Analgesics|analgesics|mesh-ancestor
111241898|NCT02455362|Sensory System Agents|sensory system agents|mesh-ancestor
111241899|NCT02455362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111241900|NCT03242304|Hydrocortisone|hydrocortisone|mesh-list
111241901|NCT03242304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111241902|NCT03253068|Pembrolizumab|pembrolizumab|mesh-list
111241903|NCT03253068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111241904|NCT03253068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111241905|NCT03253068|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111241906|NCT03253068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111241907|NCT01718483|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
111241908|NCT01718483|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111241909|NCT01718483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111241910|NCT01718483|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111241911|NCT01718483|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111241912|NCT01718483|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111241913|NCT01718483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111241914|NCT01718483|Dopamine Agents|dopamine agents|mesh-ancestor
111241915|NCT01718483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111241916|NCT03249168|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
111241917|NCT03249168|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111241918|NCT03249168|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111241919|NCT03249168|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111241920|NCT03249168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111241921|NCT03249168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111241922|NCT03249168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111241923|NCT03249168|Analgesics|analgesics|mesh-ancestor
111241924|NCT03249168|Sensory System Agents|sensory system agents|mesh-ancestor
111241925|NCT03249168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111241926|NCT03249168|Antidepressive Agents|antidepressive agents|mesh-ancestor
111241927|NCT03249168|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111241928|NCT03249168|Dopamine Agents|dopamine agents|mesh-ancestor
111241929|NCT03248856|Triamcinolone|triamcinolone|mesh-list
111241930|NCT03248856|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
111241931|NCT03248856|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
111241932|NCT03248856|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
111241933|NCT03248856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111241934|NCT03248856|Glucocorticoids|glucocorticoids|mesh-ancestor
111241935|NCT03248856|Hormones|hormones|mesh-ancestor
111241936|NCT03248856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111241937|NCT03248856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111241938|NCT03248856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111241939|NCT03248856|Immunologic Factors|immunologic factors|mesh-ancestor
111241940|NCT03248856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111241941|NCT03248856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111241942|NCT03241602|Lidocaine|lidocaine|mesh-list
111241943|NCT03241602|Anesthetics, Local|anesthetics, local|mesh-ancestor
111241944|NCT03241602|Anesthetics|anesthetics|mesh-ancestor
111241945|NCT03241602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111241946|NCT03241602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111241947|NCT03241602|Sensory System Agents|sensory system agents|mesh-ancestor
111241948|NCT03241602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111241949|NCT03241602|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111241950|NCT03241602|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111241951|NCT03241602|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111241952|NCT03241602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111241953|NCT03241602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111241954|NCT02357290|Acetylcysteine|acetylcysteine|mesh-list
111241955|NCT02357290|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111241956|NCT02357290|Antiviral Agents|antiviral agents|mesh-ancestor
111241957|NCT02357290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111241958|NCT02357290|Expectorants|expectorants|mesh-ancestor
111241959|NCT02357290|Respiratory System Agents|respiratory system agents|mesh-ancestor
111241960|NCT02357290|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111241961|NCT02357290|Antioxidants|antioxidants|mesh-ancestor
111241962|NCT02357290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111241963|NCT02357290|Protective Agents|protective agents|mesh-ancestor
111241964|NCT02357290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111241965|NCT02357290|Antidotes|antidotes|mesh-ancestor
111241966|NCT02477202|Levonorgestrel|levonorgestrel|mesh-list
111241967|NCT02477202|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111241968|NCT02477202|Contraceptive Agents|contraceptive agents|mesh-ancestor
111241969|NCT02477202|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111241970|NCT02477202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111241971|NCT02477202|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111241972|NCT02477202|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111241973|NCT02477202|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111241974|NCT00687765|Temozolomide|temozolomide|mesh-list
111241975|NCT00687765|Iniparib|iniparib|mesh-list
111241976|NCT00687765|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111241977|NCT00687765|Alkylating Agents|alkylating agents|mesh-ancestor
111241978|NCT00687765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111241979|NCT00687765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111241980|NCT00687765|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111241981|NCT00687765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111241982|NCT03248544|Vitamin D|vitamin d|mesh-list
111241983|NCT03248544|Cholecalciferol|cholecalciferol|mesh-list
111241984|NCT03248544|Vitamins|vitamins|mesh-ancestor
111241985|NCT03248544|Micronutrients|micronutrients|mesh-ancestor
111241986|NCT03248544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111241987|NCT03248544|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111241988|NCT03248544|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111241989|NCT00984399|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
111241990|NCT00984399|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
111241991|NCT00984399|Estradiol|estradiol|mesh-list
111241992|NCT00984399|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
111241993|NCT00984399|Estrogens|estrogens|mesh-ancestor
111241994|NCT00984399|Hormones|hormones|mesh-ancestor
111241995|NCT00984399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111241996|NCT00984399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111241997|NCT00984399|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111241998|NCT00984399|Contraceptive Agents|contraceptive agents|mesh-ancestor
111241999|NCT00984399|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111242000|NCT00984399|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110966304|NCT05994807|Analgesics|analgesics|mesh-ancestor
111242001|NCT03248700|Vitamins|vitamins|mesh-list
111242003|NCT03248700|Retinol palmitate|retinol palmitate|mesh-list
111242004|NCT03248700|Retinol acetate|retinol acetate|mesh-list
111242005|NCT03248700|Micronutrients|micronutrients|mesh-ancestor
111242006|NCT03248700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111242007|NCT03248700|Antioxidants|antioxidants|mesh-ancestor
111242008|NCT03248700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111242009|NCT03248700|Protective Agents|protective agents|mesh-ancestor
111242010|NCT03248700|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
111242011|NCT03248700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111242012|NCT03248700|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111242013|NCT03248700|Immunologic Factors|immunologic factors|mesh-ancestor
111242014|NCT03238482|Fluticasone|fluticasone|mesh-list
111242015|NCT03238482|Xhance|xhance|mesh-list
111242016|NCT03238482|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
111242017|NCT03238482|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
111242018|NCT03238482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111242019|NCT03238482|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111242020|NCT03238482|Autonomic Agents|autonomic agents|mesh-ancestor
111242021|NCT03238482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111242022|NCT03238482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111242023|NCT03238482|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111242024|NCT03238482|Respiratory System Agents|respiratory system agents|mesh-ancestor
111242025|NCT03238482|Dermatologic Agents|dermatologic agents|mesh-ancestor
111242026|NCT03238482|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111242027|NCT03238482|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111242028|NCT03238482|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111242029|NCT03238482|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111242030|NCT03238482|Adrenergic Agents|adrenergic agents|mesh-ancestor
111242031|NCT03238482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111242032|NCT03238482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111242033|NCT03238482|Glucocorticoids|glucocorticoids|mesh-ancestor
111242034|NCT03238482|Hormones|hormones|mesh-ancestor
111242035|NCT03238482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111242036|NCT03238482|Sympathomimetics|sympathomimetics|mesh-ancestor
111242037|NCT02454504|Neostigmine|neostigmine|mesh-list
111242038|NCT02454504|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111242039|NCT02454504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111242040|NCT02454504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111242041|NCT02454504|Cholinergic Agents|cholinergic agents|mesh-ancestor
111242042|NCT02454504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111242043|NCT02454504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111242044|NCT02454504|Parasympathomimetics|parasympathomimetics|mesh-ancestor
111242045|NCT02454504|Autonomic Agents|autonomic agents|mesh-ancestor
111242046|NCT02454504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111242047|NCT03240822|Antibodies|antibodies|mesh-list
111242048|NCT03240822|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111242049|NCT03240822|Tacrolimus|tacrolimus|mesh-list
111242050|NCT03240822|Immunologic Factors|immunologic factors|mesh-ancestor
111242051|NCT03240822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111242052|NCT03240822|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111242053|NCT03240822|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111242054|NCT03240822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111242055|NCT03240822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111242056|NCT03238560|Montelukast|montelukast|mesh-list
111242057|NCT03238560|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111242058|NCT03238560|Respiratory System Agents|respiratory system agents|mesh-ancestor
111242059|NCT03238560|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
111242060|NCT03238560|Hormone Antagonists|hormone antagonists|mesh-ancestor
111242061|NCT03238560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111242062|NCT03238560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111242063|NCT03238560|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
111242064|NCT03238560|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111242065|NCT03238560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111242066|NCT04486092|Valproic Acid|valproic acid|mesh-list
111242067|NCT04486092|Anticonvulsants|anticonvulsants|mesh-ancestor
111242068|NCT04486092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111242069|NCT04486092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111242070|NCT04486092|GABA Agents|gaba agents|mesh-ancestor
111242071|NCT04486092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111242072|NCT04486092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111242073|NCT04486092|Antimanic Agents|antimanic agents|mesh-ancestor
111242074|NCT04486092|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111242075|NCT04486092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111242076|NCT04486092|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111242077|NCT03238638|Pembrolizumab|pembrolizumab|mesh-list
111242078|NCT03238638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111242079|NCT03238638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111242080|NCT03238638|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111242081|NCT03238638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111242082|NCT00668655|Metronidazole|metronidazole|mesh-list
111242083|NCT00668655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111242084|NCT00668655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111242085|NCT00668655|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111242086|NCT00668655|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111242087|NCT02454426|Vortioxetine|vortioxetine|mesh-list
111242088|NCT02454426|Antidepressive Agents|antidepressive agents|mesh-ancestor
111242089|NCT02454426|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111242090|NCT02454426|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111242091|NCT02454426|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111242092|NCT02454426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111242093|NCT02454426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111242094|NCT02454426|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111242095|NCT02454426|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111242096|NCT02454426|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111242097|NCT02454426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111242098|NCT02454426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111242099|NCT02454426|Serotonin Agents|serotonin agents|mesh-ancestor
111242100|NCT02454426|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111242101|NCT02454426|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111242102|NCT02454426|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111242103|NCT02454426|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111242104|NCT03238092|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
111242105|NCT03238092|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
111242106|NCT03238092|Estradiol|estradiol|mesh-list
111242107|NCT03238092|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
111242108|NCT03238092|Testosterone|testosterone|mesh-list
111242109|NCT03238092|Estrogens|estrogens|mesh-ancestor
111242110|NCT03238092|Hormones|hormones|mesh-ancestor
111242111|NCT03238092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111242112|NCT03238092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111242113|NCT03238092|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111242114|NCT03238092|Contraceptive Agents|contraceptive agents|mesh-ancestor
111242115|NCT03238092|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111242116|NCT03238092|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111242117|NCT03238092|Androgens|androgens|mesh-ancestor
111242118|NCT03247998|Remifentanil|remifentanil|mesh-list
111242119|NCT03247998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111242120|NCT03247998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111242121|NCT03247998|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111242122|NCT03247998|Narcotics|narcotics|mesh-ancestor
111242123|NCT03247998|Analgesics|analgesics|mesh-ancestor
111242124|NCT03247998|Sensory System Agents|sensory system agents|mesh-ancestor
111242125|NCT03247998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111242126|NCT03248076|Fentanyl|fentanyl|mesh-list
111242127|NCT03248076|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111242128|NCT03248076|Narcotics|narcotics|mesh-ancestor
111242129|NCT03248076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111242130|NCT03248076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111242131|NCT03248076|Analgesics|analgesics|mesh-ancestor
111242132|NCT03248076|Sensory System Agents|sensory system agents|mesh-ancestor
111242133|NCT03248076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111242134|NCT03248076|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111242135|NCT03248076|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111242136|NCT03248076|Anesthetics, General|anesthetics, general|mesh-ancestor
111242137|NCT03248076|Anesthetics|anesthetics|mesh-ancestor
111242138|NCT03240120|Tinzaparin|tinzaparin|mesh-list
111242139|NCT03240120|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
111242140|NCT03240120|Dalteparin|dalteparin|mesh-list
111242141|NCT03240120|Dabigatran|dabigatran|mesh-list
111242142|NCT03240120|Antithrombins|antithrombins|mesh-ancestor
111242143|NCT03240120|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111242144|NCT03240120|Protease Inhibitors|protease inhibitors|mesh-ancestor
111242145|NCT03240120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111242146|NCT03240120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111242147|NCT03240120|Anticoagulants|anticoagulants|mesh-ancestor
111242148|NCT03240120|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111242149|NCT03240120|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111242150|NCT03237936|Cyclosporine|cyclosporine|mesh-list
110966457|NCT05868837|Rituximab|rituximab|mesh-list
111242152|NCT03237936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111242153|NCT03237936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111242154|NCT03237936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111242155|NCT03237936|Immunologic Factors|immunologic factors|mesh-ancestor
111242156|NCT03237936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111242157|NCT03237936|Antifungal Agents|antifungal agents|mesh-ancestor
111242158|NCT03237936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111242159|NCT03237936|Dermatologic Agents|dermatologic agents|mesh-ancestor
111242160|NCT03237936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111242161|NCT03237936|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111242162|NCT03247920|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111242163|NCT03247920|Amoxicillin|amoxicillin|mesh-list
111242164|NCT03247920|Clavulanic Acid|clavulanic acid|mesh-list
111242165|NCT03247920|Clavulanic Acids|clavulanic acids|mesh-list
111242166|NCT03247920|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
111242167|NCT03247920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111242168|NCT03247920|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
111242169|NCT03247920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111242170|NCT03247920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111242171|NCT03239964|Dexamethasone|dexamethasone|mesh-list
111242172|NCT03239964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111242173|NCT03239964|Antiemetics|antiemetics|mesh-ancestor
111242174|NCT03239964|Autonomic Agents|autonomic agents|mesh-ancestor
111242175|NCT03239964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111242176|NCT03239964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111242177|NCT03239964|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111242178|NCT03239964|Glucocorticoids|glucocorticoids|mesh-ancestor
111242179|NCT03239964|Hormones|hormones|mesh-ancestor
111242180|NCT03239964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111242181|NCT03239964|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111242182|NCT03239964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111242183|NCT03239886|Imatinib Mesylate|imatinib mesylate|mesh-list
111242184|NCT03239886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111242185|NCT03239886|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111242186|NCT03239886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111242187|NCT03239886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111242188|NCT03102723|Cangrelor|cangrelor|mesh-list
111242189|NCT03102723|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111242190|NCT03102723|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111242191|NCT03102723|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111242192|NCT03102723|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111242193|NCT03102723|Purinergic Agents|purinergic agents|mesh-ancestor
111242194|NCT03102723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111242195|NCT03102723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111242196|NCT03102723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111242197|NCT03237312|Hormones|hormones|mesh-list
111242198|NCT03237312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111242199|NCT03237312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111242200|NCT03241914|Megestrol|megestrol|mesh-list
111242201|NCT03241914|Megestrol Acetate|megestrol acetate|mesh-list
111242202|NCT03241914|Levonorgestrel|levonorgestrel|mesh-list
111242203|NCT03241914|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111242204|NCT03241914|Contraceptive Agents|contraceptive agents|mesh-ancestor
111242205|NCT03241914|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111242206|NCT03241914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111242207|NCT03241914|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111242208|NCT03241914|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111242209|NCT03241914|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111242210|NCT03241914|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111242211|NCT03241914|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111242212|NCT03241914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111242213|NCT03241914|Appetite Stimulants|appetite stimulants|mesh-ancestor
111242214|NCT03241914|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111242215|NCT00057681|Valproic Acid|valproic acid|mesh-list
111242216|NCT00057681|Risperidone|risperidone|mesh-list
111242217|NCT00057681|Lithium Carbonate|lithium carbonate|mesh-list
111242218|NCT00057681|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111242219|NCT00057681|Serotonin Agents|serotonin agents|mesh-ancestor
111242220|NCT00057681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111242221|NCT00057681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111242222|NCT00057681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111242223|NCT00057681|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111242224|NCT00057681|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111242225|NCT00057681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111242226|NCT00057681|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111242227|NCT00057681|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111242228|NCT00057681|Dopamine Agents|dopamine agents|mesh-ancestor
111242229|NCT00057681|Antidepressive Agents|antidepressive agents|mesh-ancestor
111242230|NCT00057681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111242231|NCT00057681|Antimanic Agents|antimanic agents|mesh-ancestor
111242232|NCT00057681|Anticonvulsants|anticonvulsants|mesh-ancestor
111242234|NCT03234816|Norepinephrine|norepinephrine|mesh-list
111242235|NCT03234816|Bupivacaine|bupivacaine|mesh-list
111242236|NCT03234816|Anesthetics, Local|anesthetics, local|mesh-ancestor
111242237|NCT03234816|Anesthetics|anesthetics|mesh-ancestor
111242238|NCT03234816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111242239|NCT03234816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111242240|NCT03234816|Sensory System Agents|sensory system agents|mesh-ancestor
111242241|NCT03234816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111242242|NCT03234816|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111242243|NCT03234816|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111242244|NCT03234816|Adrenergic Agents|adrenergic agents|mesh-ancestor
111242245|NCT03234816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111242246|NCT03234816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111242247|NCT03234816|Sympathomimetics|sympathomimetics|mesh-ancestor
111242248|NCT03234816|Autonomic Agents|autonomic agents|mesh-ancestor
111242249|NCT03234816|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111242250|NCT03247452|Ascorbic Acid|ascorbic acid|mesh-list
111242251|NCT03247452|Antioxidants|antioxidants|mesh-ancestor
111242252|NCT03247452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111242253|NCT03247452|Protective Agents|protective agents|mesh-ancestor
111242254|NCT03247452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111242255|NCT03247452|Vitamins|vitamins|mesh-ancestor
111242256|NCT03247452|Micronutrients|micronutrients|mesh-ancestor
111242257|NCT03247140|Amlodipine|amlodipine|mesh-list
111242258|NCT03247140|Telmisartan|telmisartan|mesh-list
111242259|NCT03247140|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
111242260|NCT03247140|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111242261|NCT03247140|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111242262|NCT03247140|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111242263|NCT03247140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111242264|NCT03247140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111242265|NCT03247140|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111242266|NCT03247140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111242267|NCT03247140|Vasodilator Agents|vasodilator agents|mesh-ancestor
111242268|NCT03247140|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111242269|NCT03247140|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111242270|NCT03247140|Antimetabolites|antimetabolites|mesh-ancestor
111242271|NCT03247140|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111242272|NCT03247140|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111242273|NCT03247140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111242274|NCT03247140|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111242275|NCT03247140|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111242276|NCT03237546|Anesthetics|anesthetics|mesh-list
111242277|NCT03237546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111242278|NCT03237546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111242279|NCT03247296|Ribavirin|ribavirin|mesh-list
111242280|NCT03247296|Sofosbuvir|sofosbuvir|mesh-list
111242281|NCT03247296|Antimetabolites|antimetabolites|mesh-ancestor
111242282|NCT03247296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111242283|NCT03247296|Antiviral Agents|antiviral agents|mesh-ancestor
111242284|NCT03247296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111242285|NCT03247218|Memantine|memantine|mesh-list
111242286|NCT03247218|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111242287|NCT03247218|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111242288|NCT03247218|Dopamine Agents|dopamine agents|mesh-ancestor
111242289|NCT03247218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111242290|NCT03247218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111242291|NCT03247218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111242292|NCT03247218|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111242293|NCT03247218|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111242294|NCT03237624|Chitosan|chitosan|mesh-list
111242295|NCT03237624|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111242296|NCT03237624|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111242297|NCT03237624|Antimetabolites|antimetabolites|mesh-ancestor
111242298|NCT03237624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111242300|NCT03237624|Chelating Agents|chelating agents|mesh-ancestor
111242301|NCT03237624|Sequestering Agents|sequestering agents|mesh-ancestor
111242302|NCT03237624|Hemostatics|hemostatics|mesh-ancestor
111242303|NCT03237624|Coagulants|coagulants|mesh-ancestor
111242304|NCT03234660|Dexmedetomidine|dexmedetomidine|mesh-list
111242305|NCT03234660|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111242306|NCT03234660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111242307|NCT03234660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111242308|NCT03234660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111242309|NCT03234660|Analgesics|analgesics|mesh-ancestor
111242310|NCT03234660|Sensory System Agents|sensory system agents|mesh-ancestor
111242311|NCT03234660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111242312|NCT03234660|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111242313|NCT03234660|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111242314|NCT03234660|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111242315|NCT03234660|Adrenergic Agents|adrenergic agents|mesh-ancestor
111242316|NCT03234660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111242317|NCT03234660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111242318|NCT04485780|Botulinum Toxins|botulinum toxins|mesh-list
111242319|NCT04485780|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111242320|NCT04485780|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111242321|NCT04485780|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111242322|NCT04485780|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111242323|NCT04485780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111242324|NCT04485780|Cholinergic Agents|cholinergic agents|mesh-ancestor
111242325|NCT04485780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111242326|NCT04485780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111242327|NCT04485780|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111242328|NCT04485780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111242329|NCT00059475|polysaccharide-K|polysaccharide-k|mesh-list
111242330|NCT00059475|Interleukin-2|interleukin-2|mesh-list
111242331|NCT00059475|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
111242332|NCT00059475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111242333|NCT00059475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111242334|NCT00059475|Analgesics|analgesics|mesh-ancestor
111242335|NCT00059475|Sensory System Agents|sensory system agents|mesh-ancestor
111242336|NCT00059475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111242337|NCT00059475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111242338|NCT00059475|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111242339|NCT00059475|Immunologic Factors|immunologic factors|mesh-ancestor
111242340|NCT00059475|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111242341|NCT00059475|Antiviral Agents|antiviral agents|mesh-ancestor
111242342|NCT00059475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111242343|NCT00059475|Interferon Inducers|interferon inducers|mesh-ancestor
111242344|NCT00059475|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111242345|NCT00059475|Protective Agents|protective agents|mesh-ancestor
111242346|NCT02453802|Tranylcypromine|tranylcypromine|mesh-list
111242347|NCT02453802|Rivaroxaban|rivaroxaban|mesh-list
111242348|NCT02453802|Tranexamic Acid|tranexamic acid|mesh-list
111242349|NCT02453802|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111242350|NCT02453802|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111242351|NCT02453802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111242352|NCT02453802|Hemostatics|hemostatics|mesh-ancestor
111242353|NCT02453802|Coagulants|coagulants|mesh-ancestor
111242354|NCT02453802|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111242355|NCT02453802|Antithrombins|antithrombins|mesh-ancestor
111242356|NCT02453802|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111242357|NCT02453802|Protease Inhibitors|protease inhibitors|mesh-ancestor
111242358|NCT02453802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111242359|NCT02453802|Anticoagulants|anticoagulants|mesh-ancestor
111242360|NCT02453802|Antidepressive Agents|antidepressive agents|mesh-ancestor
111242361|NCT02453802|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111242362|NCT02453802|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
111242363|NCT02453802|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111242364|NCT02453802|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111242365|NCT02453802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111242366|NCT02453802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111242367|NCT02028676|Lamivudine|lamivudine|mesh-list
111242368|NCT02028676|Zidovudine|zidovudine|mesh-list
111242369|NCT02028676|Efavirenz|efavirenz|mesh-list
111242370|NCT02028676|Nevirapine|nevirapine|mesh-list
111242371|NCT02028676|Abacavir|abacavir|mesh-list
111242372|NCT02028676|Dideoxynucleosides|dideoxynucleosides|mesh-list
111242373|NCT02028676|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
111242374|NCT02028676|Trimethoprim|trimethoprim|mesh-list
111242375|NCT02028676|Sulfamethoxazole|sulfamethoxazole|mesh-list
111242376|NCT02028676|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
111242377|NCT02028676|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111242378|NCT02028676|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111242379|NCT02028676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111242380|NCT02028676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111242381|NCT02028676|Antiviral Agents|antiviral agents|mesh-ancestor
111242382|NCT02028676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111242383|NCT02028676|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111242384|NCT02028676|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111242385|NCT02028676|Antimetabolites|antimetabolites|mesh-ancestor
111242386|NCT02028676|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111242387|NCT02028676|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111242388|NCT02028676|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111242389|NCT02028676|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111242390|NCT02028676|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111242391|NCT02028676|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111242392|NCT02028676|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111242393|NCT02028676|Antimalarials|antimalarials|mesh-ancestor
111242394|NCT02028676|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111242395|NCT02028676|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111242396|NCT02028676|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111242397|NCT02028676|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111242398|NCT02028676|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
111242399|NCT02028676|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111242400|NCT03233880|Azithromycin|azithromycin|mesh-list
111242401|NCT03233880|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111242402|NCT03233880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111242403|NCT00061893|Celecoxib|celecoxib|mesh-list
111242404|NCT00061893|Cyclophosphamide|cyclophosphamide|mesh-list
111242405|NCT00061893|Ifosfamide|ifosfamide|mesh-list
111242406|NCT00061893|Doxorubicin|doxorubicin|mesh-list
111242407|NCT00061893|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111242408|NCT00061893|Etoposide|etoposide|mesh-list
111242409|NCT00061893|Vincristine|vincristine|mesh-list
111242410|NCT00061893|Vinblastine|vinblastine|mesh-list
111242411|NCT00061893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111242412|NCT00061893|Immunologic Factors|immunologic factors|mesh-ancestor
111242413|NCT00061893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111242414|NCT00061893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111242415|NCT00061893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111242416|NCT00061893|Alkylating Agents|alkylating agents|mesh-ancestor
111242417|NCT00061893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111242418|NCT00061893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111242419|NCT00061893|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111242420|NCT00061893|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111242421|NCT00061893|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111242422|NCT00061893|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111242423|NCT00061893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111242424|NCT00061893|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111242425|NCT00061893|Tubulin Modulators|tubulin modulators|mesh-ancestor
111242426|NCT00061893|Antimitotic Agents|antimitotic agents|mesh-ancestor
111242427|NCT00061893|Mitosis Modulators|mitosis modulators|mesh-ancestor
111242428|NCT00061893|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111242429|NCT00061893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111242430|NCT00061893|Analgesics|analgesics|mesh-ancestor
111242431|NCT00061893|Sensory System Agents|sensory system agents|mesh-ancestor
111242432|NCT00061893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111242433|NCT00061893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111242434|NCT00061893|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111242435|NCT00061893|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111242436|NCT02957019|Rituximab|rituximab|mesh-list
111242437|NCT02957019|Interleukin-2|interleukin-2|mesh-list
111242438|NCT02957019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111242439|NCT02957019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111242440|NCT02957019|Immunologic Factors|immunologic factors|mesh-ancestor
111242441|NCT02957019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111242442|NCT02957019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111242443|NCT02957019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111242444|NCT02957019|Analgesics|analgesics|mesh-ancestor
111242445|NCT02957019|Sensory System Agents|sensory system agents|mesh-ancestor
111242446|NCT02957019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111242447|NCT02028754|Levofloxacin|levofloxacin|mesh-list
111242448|NCT02028754|Prednisolone|prednisolone|mesh-list
111242449|NCT02028754|Prednisolone acetate|prednisolone acetate|mesh-list
110966746|NCT05521087|Fludarabine|fludarabine|mesh-list
111242451|NCT02028754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111242452|NCT02028754|Glucocorticoids|glucocorticoids|mesh-ancestor
111242453|NCT02028754|Hormones|hormones|mesh-ancestor
111242454|NCT02028754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111242455|NCT02028754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111242456|NCT02028754|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111242457|NCT02028754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111242458|NCT02028754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111242459|NCT02028754|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111242460|NCT02028754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111242461|NCT02028754|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111242462|NCT02028754|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111242463|NCT02028754|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111242464|NCT02028754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111242465|NCT02028754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111242466|NCT02028754|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111242467|NCT02028754|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111242468|NCT02028754|Laxatives|laxatives|mesh-ancestor
111242469|NCT02453490|Fluorouracil|fluorouracil|mesh-list
111242470|NCT02453490|Raltitrexed|raltitrexed|mesh-list
111242471|NCT02453490|Antimetabolites|antimetabolites|mesh-ancestor
111242472|NCT02453490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111242473|NCT02453490|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111242474|NCT02453490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111242475|NCT02453490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111242476|NCT02453490|Immunologic Factors|immunologic factors|mesh-ancestor
111242477|NCT02453490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111242478|NCT02453490|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111242479|NCT02453490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111242480|NCT01974700|Levetiracetam|levetiracetam|mesh-list
111242481|NCT01974700|Anticonvulsants|anticonvulsants|mesh-ancestor
111242482|NCT01974700|Nootropic Agents|nootropic agents|mesh-ancestor
111242483|NCT04753203|Capecitabine|capecitabine|mesh-list
111242484|NCT04753203|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111242485|NCT04753203|Antimetabolites|antimetabolites|mesh-ancestor
111242486|NCT04753203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111242487|NCT04753203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111242488|NCT03236610|Tenofovir|tenofovir|mesh-list
111242489|NCT03236610|Entecavir|entecavir|mesh-list
111242490|NCT03236610|Antiviral Agents|antiviral agents|mesh-ancestor
111242491|NCT03236610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111242492|NCT03236610|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111242493|NCT03236610|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111242494|NCT03236610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111242495|NCT03236610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111242496|NCT03236610|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111242497|NCT03236610|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111242498|NCT05287893|Pyronaridine|pyronaridine|mesh-list
111242499|NCT05287893|Antimalarials|antimalarials|mesh-ancestor
111242500|NCT05287893|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111242501|NCT05287893|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111242502|NCT05287893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111242503|NCT02357758|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111242504|NCT02357758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111242505|NCT02357836|Itraconazole|itraconazole|mesh-list
111242506|NCT02357836|Antifungal Agents|antifungal agents|mesh-ancestor
111242507|NCT02357836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111242508|NCT02357836|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111242509|NCT02357836|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111242510|NCT02357836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111242511|NCT02357836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111242512|NCT02357836|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111242513|NCT02357836|Hormone Antagonists|hormone antagonists|mesh-ancestor
111242514|NCT02357836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111242515|NCT02357836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111242516|NCT02357836|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111242517|NCT02359006|Minocycline|minocycline|mesh-list
111242518|NCT02359006|Tetracycline|tetracycline|mesh-list
111242519|NCT02359006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111242520|NCT02359006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111242521|NCT02359006|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111242522|NCT02359006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111242523|NCT02359006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111242524|NCT04485702|Midazolam|midazolam|mesh-list
111242525|NCT04485702|Ketamine|ketamine|mesh-list
111242526|NCT04485702|Analgesics|analgesics|mesh-ancestor
111242527|NCT04485702|Sensory System Agents|sensory system agents|mesh-ancestor
111242528|NCT04485702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111242529|NCT04485702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111242530|NCT04485702|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111242531|NCT04485702|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111242532|NCT04485702|Anesthetics, General|anesthetics, general|mesh-ancestor
111242533|NCT04485702|Anesthetics|anesthetics|mesh-ancestor
111242534|NCT04485702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111242535|NCT04485702|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111242536|NCT04485702|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111242537|NCT04485702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111242538|NCT04485702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111242539|NCT04485702|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111242540|NCT04485702|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111242541|NCT04485702|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111242542|NCT04485702|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111242543|NCT04485702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111242544|NCT04485702|GABA Modulators|gaba modulators|mesh-ancestor
111242545|NCT04485702|GABA Agents|gaba agents|mesh-ancestor
111242546|NCT00068367|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111242547|NCT00068367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111242548|NCT00068367|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111242549|NCT00068367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111242550|NCT00068367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111242551|NCT03233412|Imiquimod|imiquimod|mesh-list
111242552|NCT03233412|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111242553|NCT03233412|Immunologic Factors|immunologic factors|mesh-ancestor
111242554|NCT03233412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111242555|NCT03233412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111242556|NCT03233412|Interferon Inducers|interferon inducers|mesh-ancestor
111242557|NCT01976416|Hydroxyurea|hydroxyurea|mesh-list
111242558|NCT01976416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111242559|NCT01976416|Antisickling Agents|antisickling agents|mesh-ancestor
111242560|NCT01976416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111242561|NCT01976416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111242562|NCT01976416|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111242563|NCT01976572|Candesartan|candesartan|mesh-list
111242564|NCT01976572|Candesartan cilexetil|candesartan cilexetil|mesh-list
111242565|NCT01976572|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111242566|NCT01976572|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111242567|NCT01976572|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111242568|NCT01976572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111242569|NCT01976650|Dexamethasone|dexamethasone|mesh-list
111242570|NCT01976650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111242571|NCT01976650|Antiemetics|antiemetics|mesh-ancestor
111242572|NCT01976650|Autonomic Agents|autonomic agents|mesh-ancestor
111242573|NCT01976650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111242574|NCT01976650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111242575|NCT01976650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111242576|NCT01976650|Glucocorticoids|glucocorticoids|mesh-ancestor
111242577|NCT01976650|Hormones|hormones|mesh-ancestor
111242578|NCT01976650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111242579|NCT01976650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111242580|NCT01976650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111242581|NCT01978600|Timolol|timolol|mesh-list
111242582|NCT01978600|Brimonidine Tartrate|brimonidine tartrate|mesh-list
111242583|NCT01978600|Brinzolamide|brinzolamide|mesh-list
111242584|NCT01978600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111242585|NCT01978600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111242586|NCT01978600|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111242587|NCT01978600|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111242588|NCT01978600|Adrenergic Agents|adrenergic agents|mesh-ancestor
111242589|NCT01978600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111242590|NCT01978600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111242591|NCT01978600|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111242592|NCT01978600|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111242593|NCT01978600|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111242594|NCT01978600|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111242595|NCT01978600|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111242596|NCT01978600|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
111242597|NCT03236220|Acetylcysteine|acetylcysteine|mesh-list
111242598|NCT03236220|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111242599|NCT03236220|Antiviral Agents|antiviral agents|mesh-ancestor
111242600|NCT03236220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111242601|NCT03236220|Expectorants|expectorants|mesh-ancestor
111242602|NCT03236220|Respiratory System Agents|respiratory system agents|mesh-ancestor
111242603|NCT03236220|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111242604|NCT03236220|Antioxidants|antioxidants|mesh-ancestor
111242605|NCT03236220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111242606|NCT03236220|Protective Agents|protective agents|mesh-ancestor
111242607|NCT03236220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111242608|NCT03236220|Antidotes|antidotes|mesh-ancestor
111242609|NCT03232632|Flutemetamol|flutemetamol|mesh-list
111242610|NCT03232632|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111242611|NCT03232632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111242612|NCT01747499|Azacitidine|azacitidine|mesh-list
111242613|NCT01747499|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111242614|NCT01747499|Antimetabolites|antimetabolites|mesh-ancestor
111242615|NCT01747499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111242616|NCT01747499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111242617|NCT01747499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111242618|NCT00071721|Valproic Acid|valproic acid|mesh-list
111242619|NCT00071721|Anticonvulsants|anticonvulsants|mesh-ancestor
111242620|NCT00071721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111242621|NCT00071721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111242622|NCT00071721|GABA Agents|gaba agents|mesh-ancestor
111242623|NCT00071721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111242624|NCT00071721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111242625|NCT00071721|Antimanic Agents|antimanic agents|mesh-ancestor
111242626|NCT00071721|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111242627|NCT00071721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111242628|NCT00071721|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111242629|NCT03107208|Insulin Glargine|insulin glargine|mesh-list
111242630|NCT03107208|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111242631|NCT03107208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111242633|NCT05606055|Emtricitabine|emtricitabine|mesh-list
111242634|NCT05606055|Antiviral Agents|antiviral agents|mesh-ancestor
111242635|NCT05606055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111242636|NCT05606055|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111242637|NCT05606055|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111242638|NCT05606055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111242639|NCT05606055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111242640|NCT05606055|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111242641|NCT05606055|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111242642|NCT01896609|Interferons|interferons|mesh-list
111242643|NCT01896609|Ribavirin|ribavirin|mesh-list
111242644|NCT01896609|Interferon-alpha|interferon-alpha|mesh-list
111242645|NCT01896609|Interferon alpha-2|interferon alpha-2|mesh-list
111242646|NCT01896609|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
111242647|NCT01896609|Nitazoxanide|nitazoxanide|mesh-list
111242648|NCT01896609|Complement Factor H|complement factor h|mesh-list
111242649|NCT01896609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111242650|NCT01896609|Antiviral Agents|antiviral agents|mesh-ancestor
111242651|NCT01896609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111242652|NCT01896609|Antimetabolites|antimetabolites|mesh-ancestor
111242653|NCT01896609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111242654|NCT01896609|Immunologic Factors|immunologic factors|mesh-ancestor
111242655|NCT01896609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111242656|NCT01896609|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
111242657|NCT01896609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111242658|NCT01896609|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111242659|NCT03232554|Iron|iron|mesh-list
111242660|NCT03232554|Trace Elements|trace elements|mesh-ancestor
111242661|NCT03232554|Micronutrients|micronutrients|mesh-ancestor
111242662|NCT03232554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111242663|NCT03232398|Warfarin|warfarin|mesh-list
111242664|NCT03232398|Apixaban|apixaban|mesh-list
111242665|NCT03232398|Anticoagulants|anticoagulants|mesh-ancestor
111242666|NCT03232398|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111242667|NCT03232398|Antithrombins|antithrombins|mesh-ancestor
111242668|NCT03232398|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111242669|NCT03232398|Protease Inhibitors|protease inhibitors|mesh-ancestor
110966977|NCT05389995|Autonomic Agents|autonomic agents|mesh-ancestor
111242670|NCT03232398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111242671|NCT03232398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111242672|NCT02362048|Pembrolizumab|pembrolizumab|mesh-list
111242673|NCT02362048|Acalabrutinib|acalabrutinib|mesh-list
111242674|NCT02362048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111242675|NCT02362048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111242676|NCT02362048|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111242677|NCT02362048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111242679|NCT00158223|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111242680|NCT00158223|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111242681|NCT00158223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111242682|NCT00158223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111242683|NCT00158223|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111242684|NCT00158223|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111242685|NCT00158223|Dopamine Agents|dopamine agents|mesh-ancestor
111242686|NCT00158223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111242687|NCT00158223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111242688|NCT00158223|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111242689|NCT03228576|Everolimus|everolimus|mesh-list
111242690|NCT03228576|Tacrolimus|tacrolimus|mesh-list
111242691|NCT03228576|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111242692|NCT03228576|Immunologic Factors|immunologic factors|mesh-ancestor
111242693|NCT03228576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111242694|NCT03228576|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111242695|NCT03228576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111242696|NCT03228576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111242697|NCT03228576|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111242698|NCT03228576|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111242699|NCT03228576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111242700|NCT00158379|Paclitaxel|paclitaxel|mesh-list
111242701|NCT00158379|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111242702|NCT00158379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111242703|NCT00158379|Tubulin Modulators|tubulin modulators|mesh-ancestor
111242704|NCT00158379|Antimitotic Agents|antimitotic agents|mesh-ancestor
111242705|NCT00158379|Mitosis Modulators|mitosis modulators|mesh-ancestor
111242706|NCT00158379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111242707|NCT03228498|Choline|choline|mesh-list
111242708|NCT03228498|Lipotropic Agents|lipotropic agents|mesh-ancestor
111242709|NCT03228498|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111242710|NCT03228498|Antimetabolites|antimetabolites|mesh-ancestor
111242711|NCT03228498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111242712|NCT03228498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111242713|NCT03228498|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111242714|NCT03228498|Nootropic Agents|nootropic agents|mesh-ancestor
111242715|NCT03232320|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111242716|NCT03232320|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111242717|NCT03232320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111242718|NCT03232320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111242719|NCT03232320|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111242720|NCT03232320|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111242721|NCT03232320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111242722|NCT03232320|Cholinergic Agents|cholinergic agents|mesh-ancestor
111242723|NCT03232320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111242724|NCT02364076|Pembrolizumab|pembrolizumab|mesh-list
111242725|NCT02364076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111242726|NCT02364076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111242727|NCT02364076|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111242728|NCT02364076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111242729|NCT02453022|Omeprazole|omeprazole|mesh-list
111242730|NCT02453022|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111242731|NCT02453022|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111242732|NCT02453022|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111242733|NCT02453022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111242734|NCT02453022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111242735|NCT00163293|Ciclesonide|ciclesonide|mesh-list
111242736|NCT00163293|Glucocorticoids|glucocorticoids|mesh-ancestor
111242737|NCT00163293|Hormones|hormones|mesh-ancestor
111242738|NCT00163293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111242739|NCT00163293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110967051|NCT05318794|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110967052|NCT05318794|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110967053|NCT05318794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110967054|NCT05318794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110967055|NCT05312593|Chlorhexidine|chlorhexidine|mesh-list
110967056|NCT05312593|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111242740|NCT00163293|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111242741|NCT02365870|Rotigotine|rotigotine|mesh-list
111242742|NCT02365870|Dopamine Agonists|dopamine agonists|mesh-ancestor
111242743|NCT02365870|Dopamine Agents|dopamine agents|mesh-ancestor
111242744|NCT02365870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111242745|NCT02365870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111242746|NCT02365870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111242747|NCT03228108|Amoxicillin|amoxicillin|mesh-list
111242748|NCT03228108|Ciprofloxacin|ciprofloxacin|mesh-list
111242749|NCT03228108|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
111242750|NCT03228108|Clavulanic Acids|clavulanic acids|mesh-list
111242751|NCT03228108|Clavulanic Acid|clavulanic acid|mesh-list
111242752|NCT03228108|Fosfomycin|fosfomycin|mesh-list
111242753|NCT03228108|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
111242754|NCT03228108|Amdinocillin Pivoxil|amdinocillin pivoxil|mesh-list
111242755|NCT03228108|Trimethoprim|trimethoprim|mesh-list
111242756|NCT03228108|Sulfamethoxazole|sulfamethoxazole|mesh-list
111242757|NCT03228108|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111242758|NCT03228108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111242759|NCT03228108|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111242760|NCT03228108|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111242761|NCT03228108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111242762|NCT03228108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111242763|NCT03228108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111242764|NCT03228108|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111242765|NCT03228108|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111242766|NCT03228108|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111242767|NCT03228108|Antimalarials|antimalarials|mesh-ancestor
111242768|NCT03228108|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111242769|NCT03228108|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111242770|NCT03228108|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111242771|NCT03228108|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111242772|NCT03228108|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
111242773|NCT03228108|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
111242774|NCT00078897|Selenium|selenium|mesh-list
111242775|NCT00078897|Antioxidants|antioxidants|mesh-ancestor
111242776|NCT00078897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111242777|NCT00078897|Protective Agents|protective agents|mesh-ancestor
111242778|NCT00078897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111242779|NCT00078897|Trace Elements|trace elements|mesh-ancestor
111242780|NCT00078897|Micronutrients|micronutrients|mesh-ancestor
111242781|NCT03228030|Thiamine|thiamine|mesh-list
111242782|NCT03228030|Vitamin B Complex|vitamin b complex|mesh-ancestor
111242783|NCT03228030|Vitamins|vitamins|mesh-ancestor
111242784|NCT03228030|Micronutrients|micronutrients|mesh-ancestor
111242785|NCT03228030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111242786|NCT01717313|Metformin|metformin|mesh-list
111242787|NCT01717313|Glimepiride|glimepiride|mesh-list
111242788|NCT01717313|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111242789|NCT01717313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111242790|NCT01717313|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111242791|NCT01717313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111242792|NCT01717313|Immunologic Factors|immunologic factors|mesh-ancestor
111242793|NCT00081861|Bevacizumab|bevacizumab|mesh-list
111242794|NCT00081861|Rituximab|rituximab|mesh-list
111242795|NCT00081861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111242796|NCT00081861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111242797|NCT00081861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111242798|NCT00081861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111242799|NCT00081861|Growth Substances|growth substances|mesh-ancestor
111242800|NCT00081861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111242801|NCT00081861|Growth Inhibitors|growth inhibitors|mesh-ancestor
111242802|NCT00081861|Immunologic Factors|immunologic factors|mesh-ancestor
111242803|NCT00081861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111242804|NCT03120234|Fentanyl|fentanyl|mesh-list
111242805|NCT03120234|Dexmedetomidine|dexmedetomidine|mesh-list
111242806|NCT03120234|Ketamine|ketamine|mesh-list
111242807|NCT03120234|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111242808|NCT03120234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111242809|NCT03120234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111242810|NCT03120234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111242811|NCT03120234|Analgesics|analgesics|mesh-ancestor
111242812|NCT03120234|Sensory System Agents|sensory system agents|mesh-ancestor
111242813|NCT03120234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111242814|NCT03120234|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111242815|NCT03120234|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111242816|NCT03120234|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111242817|NCT03120234|Adrenergic Agents|adrenergic agents|mesh-ancestor
111242818|NCT03120234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111242819|NCT03120234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111242820|NCT03120234|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111242821|NCT03120234|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111242822|NCT03120234|Anesthetics, General|anesthetics, general|mesh-ancestor
111242824|NCT03120234|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111242825|NCT03120234|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111242826|NCT03120234|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111242827|NCT03120234|Narcotics|narcotics|mesh-ancestor
111242828|NCT03120234|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111242829|NCT03230682|Antidepressive Agents|antidepressive agents|mesh-list
111242830|NCT03230682|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111242831|NCT03232710|Aripiprazole|aripiprazole|mesh-list
111242832|NCT03232710|Antidepressive Agents|antidepressive agents|mesh-ancestor
111242833|NCT03232710|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111242834|NCT03232710|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111242835|NCT03232710|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111242836|NCT03232710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111242837|NCT03232710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111242838|NCT03232710|Dopamine Agonists|dopamine agonists|mesh-ancestor
111242839|NCT03232710|Dopamine Agents|dopamine agents|mesh-ancestor
111242840|NCT03232710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111242841|NCT03232710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111242842|NCT03232710|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111242843|NCT03232710|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111242844|NCT03232710|Serotonin Agents|serotonin agents|mesh-ancestor
111242845|NCT03232710|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111242846|NCT03232710|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111242847|NCT03232710|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111242848|NCT03232710|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111242849|NCT03227484|Empagliflozin|empagliflozin|mesh-list
111242850|NCT03227484|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111242851|NCT03227484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111242852|NCT03227484|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111242853|NCT03227484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111242854|NCT02038894|Propofol|propofol|mesh-list
111242855|NCT02038894|Sevoflurane|sevoflurane|mesh-list
111242856|NCT02038894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111242857|NCT02038894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111242858|NCT02038894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111242859|NCT02038894|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111242860|NCT02038894|Anesthetics, General|anesthetics, general|mesh-ancestor
111242861|NCT02038894|Anesthetics|anesthetics|mesh-ancestor
111242862|NCT02038894|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111242863|NCT02038894|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111242864|NCT01375374|Lacosamide|lacosamide|mesh-list
111242865|NCT01375374|Levetiracetam|levetiracetam|mesh-list
111242866|NCT01375374|Anticonvulsants|anticonvulsants|mesh-ancestor
111242867|NCT01375374|Nootropic Agents|nootropic agents|mesh-ancestor
111242868|NCT01375374|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111242869|NCT01375374|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111242870|NCT01375374|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111242871|NCT01375374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111242872|NCT04348786|Amoxicillin|amoxicillin|mesh-list
111242873|NCT04348786|Doxycycline|doxycycline|mesh-list
111242874|NCT04348786|Levofloxacin|levofloxacin|mesh-list
111242875|NCT04348786|Esomeprazole|esomeprazole|mesh-list
111242876|NCT04348786|Bismuth|bismuth|mesh-list
111242877|NCT04348786|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
111242878|NCT04348786|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111242879|NCT04348786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111242880|NCT04348786|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111242881|NCT04348786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111242882|NCT04348786|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111242883|NCT04348786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111242884|NCT04348786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111242885|NCT04348786|Antimalarials|antimalarials|mesh-ancestor
111242886|NCT04348786|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111242887|NCT04348786|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111242888|NCT04348786|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111242889|NCT04348786|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111242890|NCT04348786|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110967201|NCT05211323|Antimetabolites|antimetabolites|mesh-ancestor
111242891|NCT04348786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111242892|NCT04348786|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111242893|NCT04348786|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111242894|NCT04348786|Antacids|antacids|mesh-ancestor
111242895|NCT04348786|Antidiarrheals|antidiarrheals|mesh-ancestor
111242896|NCT02369068|Triamcinolone|triamcinolone|mesh-list
111242897|NCT02369068|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
111242898|NCT02369068|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111242899|NCT02369068|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111242900|NCT02369068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111242901|NCT02369068|Glucocorticoids|glucocorticoids|mesh-ancestor
111242902|NCT02369068|Hormones|hormones|mesh-ancestor
111242903|NCT02369068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111242904|NCT02369068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111242905|NCT02369068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111242906|NCT02369068|Immunologic Factors|immunologic factors|mesh-ancestor
111242907|NCT02369068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111242908|NCT02369068|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111242909|NCT02369068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111242910|NCT02369068|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111242911|NCT02369068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111242912|NCT02369068|Cholinergic Agents|cholinergic agents|mesh-ancestor
111242913|NCT02369068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111242914|NCT02452632|Ipragliflozin|ipragliflozin|mesh-list
111242915|NCT02452632|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111242916|NCT02452632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111242917|NCT02452632|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111242918|NCT02452632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111242919|NCT02371252|Alendronate|alendronate|mesh-list
111242920|NCT02371252|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111242921|NCT02371252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111242922|NCT03221946|Diclofenac|diclofenac|mesh-list
111242923|NCT03221946|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111242924|NCT03221946|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111242925|NCT03221946|Analgesics|analgesics|mesh-ancestor
111242926|NCT03221946|Sensory System Agents|sensory system agents|mesh-ancestor
111242927|NCT03221946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111242928|NCT03221946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111242929|NCT03221946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111242930|NCT03221946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111242931|NCT03221946|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111242932|NCT03221946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111242933|NCT03221946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111242934|NCT03229746|Hydroxychloroquine|hydroxychloroquine|mesh-list
111242935|NCT03229746|Vincristine|vincristine|mesh-list
111242936|NCT03229746|Azathioprine|azathioprine|mesh-list
111242937|NCT03229746|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111242938|NCT03229746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111242939|NCT03229746|Tubulin Modulators|tubulin modulators|mesh-ancestor
111242940|NCT03229746|Antimitotic Agents|antimitotic agents|mesh-ancestor
111242941|NCT03229746|Mitosis Modulators|mitosis modulators|mesh-ancestor
111242942|NCT03229746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111242943|NCT03229746|Antimalarials|antimalarials|mesh-ancestor
111242944|NCT03229746|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111242945|NCT03229746|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111242946|NCT03229746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111242947|NCT03229746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111242948|NCT03229746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111242949|NCT03229746|Antimetabolites|antimetabolites|mesh-ancestor
111242950|NCT03229746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111242951|NCT03229746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111242952|NCT03229746|Immunologic Factors|immunologic factors|mesh-ancestor
111242953|NCT03229746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111242954|NCT02040298|Clemastine|clemastine|mesh-list
111242955|NCT02040298|Antipruritics|antipruritics|mesh-ancestor
111242956|NCT02040298|Dermatologic Agents|dermatologic agents|mesh-ancestor
111242957|NCT02040298|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111242958|NCT02040298|Histamine Antagonists|histamine antagonists|mesh-ancestor
111242959|NCT02040298|Histamine Agents|histamine agents|mesh-ancestor
111242960|NCT02040298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111242961|NCT02040298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111242962|NCT02040298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111242963|NCT02040298|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110967273|NCT05132504|Pembrolizumab|pembrolizumab|mesh-list
111242965|NCT03229668|Analgesics|analgesics|mesh-ancestor
111242966|NCT03229668|Sensory System Agents|sensory system agents|mesh-ancestor
111242967|NCT03229668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111242968|NCT03229668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111242969|NCT03229668|Anticonvulsants|anticonvulsants|mesh-ancestor
111242970|NCT03229668|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111242971|NCT03229668|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111242972|NCT03229668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111242973|NCT03229668|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111242974|NCT03229668|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111242975|NCT03229668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111242976|NCT03229668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111242977|NCT03229668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111242978|NCT03230058|Voriconazole|voriconazole|mesh-list
111242979|NCT03230058|Natamycin|natamycin|mesh-list
111242980|NCT03230058|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111242981|NCT03230058|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111242982|NCT03230058|Antifungal Agents|antifungal agents|mesh-ancestor
111242983|NCT03230058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111242984|NCT03230058|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111242985|NCT03230058|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111242986|NCT03230058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111242987|NCT03230058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111242988|NCT03230058|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111242989|NCT03230058|Hormone Antagonists|hormone antagonists|mesh-ancestor
111242990|NCT03230058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111242991|NCT03230058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111242992|NCT03230058|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111242993|NCT03230058|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111242994|NCT03230058|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111242995|NCT01985542|Immunomodulating Agents|immunomodulating agents|mesh-list
111242996|NCT01985542|Immunologic Factors|immunologic factors|mesh-ancestor
111242997|NCT01985542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111242998|NCT03229824|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
111242999|NCT03229824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111243000|NCT00081939|Thalidomide|thalidomide|mesh-list
111243001|NCT00081939|Bortezomib|bortezomib|mesh-list
111243002|NCT00081939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111243003|NCT00081939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111243004|NCT00081939|Immunologic Factors|immunologic factors|mesh-ancestor
111243005|NCT00081939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111243006|NCT00081939|Leprostatic Agents|leprostatic agents|mesh-ancestor
111243007|NCT00081939|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111243008|NCT00081939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111243009|NCT00081939|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111243010|NCT00081939|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111243011|NCT00081939|Growth Substances|growth substances|mesh-ancestor
111243012|NCT00081939|Growth Inhibitors|growth inhibitors|mesh-ancestor
111243013|NCT02373124|N-Methylaspartate|n-methylaspartate|mesh-list
111243014|NCT02373124|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
111243015|NCT02373124|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111243016|NCT02373124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111243017|NCT02373124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111243018|NCT02373124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111243019|NCT03221634|Pembrolizumab|pembrolizumab|mesh-list
111243020|NCT03221634|Daratumumab|daratumumab|mesh-list
111243021|NCT03221634|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111243022|NCT03221634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111243023|NCT03221634|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111243024|NCT03221634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111243025|NCT05003037|Carboplatin|carboplatin|mesh-list
111243026|NCT05003037|Pemetrexed|pemetrexed|mesh-list
111243027|NCT05003037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111243028|NCT05003037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111243029|NCT05003037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111243030|NCT05003037|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111243031|NCT05003037|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111243032|NCT02374060|Dexamethasone|dexamethasone|mesh-list
111243033|NCT02374060|Triamcinolone|triamcinolone|mesh-list
111243034|NCT02374060|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
111243035|NCT02374060|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110967334|NCT05071664|Golimumab|golimumab|mesh-list
111243036|NCT02374060|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
111243037|NCT02374060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111243038|NCT02374060|Antiemetics|antiemetics|mesh-ancestor
111243039|NCT02374060|Autonomic Agents|autonomic agents|mesh-ancestor
111243040|NCT02374060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111243041|NCT02374060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111243042|NCT02374060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111243043|NCT02374060|Glucocorticoids|glucocorticoids|mesh-ancestor
111243044|NCT02374060|Hormones|hormones|mesh-ancestor
111243045|NCT02374060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111243046|NCT02374060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111243047|NCT02374060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111243048|NCT02374060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111243049|NCT02374060|Immunologic Factors|immunologic factors|mesh-ancestor
111243050|NCT02374060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111243051|NCT02374060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111243052|NCT03221166|Thalidomide|thalidomide|mesh-list
111243053|NCT03221166|Infliximab|infliximab|mesh-list
111243054|NCT03221166|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111243055|NCT03221166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111243056|NCT03221166|Dermatologic Agents|dermatologic agents|mesh-ancestor
111243057|NCT03221166|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111243058|NCT03221166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111243059|NCT03221166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111243060|NCT03221166|Immunologic Factors|immunologic factors|mesh-ancestor
111243061|NCT03221166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111243062|NCT03221166|Leprostatic Agents|leprostatic agents|mesh-ancestor
111243063|NCT03221166|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111243064|NCT03221166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111243065|NCT03221166|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111243066|NCT03221166|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111243067|NCT03221166|Growth Substances|growth substances|mesh-ancestor
111243068|NCT03221166|Growth Inhibitors|growth inhibitors|mesh-ancestor
111243069|NCT03221166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111243070|NCT03220932|Bevacizumab|bevacizumab|mesh-list
111243071|NCT03220932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111243072|NCT03220932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111243073|NCT03220932|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111243074|NCT03220932|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111243075|NCT03220932|Growth Substances|growth substances|mesh-ancestor
111243076|NCT03220932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111243077|NCT03220932|Growth Inhibitors|growth inhibitors|mesh-ancestor
111243078|NCT02042872|Zoledronic Acid|zoledronic acid|mesh-list
111243079|NCT02042872|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111243080|NCT02042872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111243081|NCT04484688|Bisoprolol|bisoprolol|mesh-list
111243082|NCT04484688|Perindopril|perindopril|mesh-list
111243083|NCT04484688|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111243084|NCT04484688|Sympatholytics|sympatholytics|mesh-ancestor
111243085|NCT04484688|Autonomic Agents|autonomic agents|mesh-ancestor
111243086|NCT04484688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111243087|NCT04484688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111243088|NCT04484688|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
111243089|NCT04484688|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111243090|NCT04484688|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111243091|NCT04484688|Adrenergic Agents|adrenergic agents|mesh-ancestor
111243092|NCT04484688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111243093|NCT04484688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111243094|NCT04484688|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
111243095|NCT04484688|Protease Inhibitors|protease inhibitors|mesh-ancestor
111243096|NCT04484688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111243097|NCT00082017|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
111243098|NCT00082017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111243099|NCT00082017|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111243100|NCT00082017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111243101|NCT00082017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111243102|NCT00082329|Plerixafor|plerixafor|mesh-list
111243103|NCT00082329|Lenograstim|lenograstim|mesh-list
111243104|NCT00082329|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111243105|NCT00082329|Immunologic Factors|immunologic factors|mesh-ancestor
111243106|NCT00082329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111243107|NCT00082329|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111243108|NCT00082329|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111243109|NCT00082329|Antiviral Agents|antiviral agents|mesh-ancestor
111243110|NCT00082329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111243111|NCT02451462|Zoledronic Acid|zoledronic acid|mesh-list
111243112|NCT02451462|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111243113|NCT02451462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111243114|NCT03207204|Hydrogen Peroxide|hydrogen peroxide|mesh-list
111243115|NCT03207204|Carbamide Peroxide|carbamide peroxide|mesh-list
111243116|NCT03207204|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111243117|NCT03207204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111243118|NCT02451306|Quetiapine Fumarate|quetiapine fumarate|mesh-list
111243119|NCT02451306|Antidepressive Agents|antidepressive agents|mesh-ancestor
111243120|NCT02451306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111243121|NCT02451306|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111243122|NCT02451306|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111243123|NCT02451306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111243124|NCT02451306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111243125|NCT00167661|Alemtuzumab|alemtuzumab|mesh-list
111243126|NCT00167661|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111243127|NCT00167661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111243128|NCT03220542|Amoxicillin|amoxicillin|mesh-list
111243129|NCT03220542|Clarithromycin|clarithromycin|mesh-list
111243130|NCT03220542|Sulforaphane|sulforaphane|mesh-list
111243131|NCT03220542|Esomeprazole|esomeprazole|mesh-list
111243132|NCT03220542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111243133|NCT03220542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111243134|NCT03220542|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111243135|NCT03220542|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111243136|NCT03220542|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111243137|NCT03220542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111243138|NCT03220542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111243139|NCT03220542|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111243140|NCT03220542|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111243141|NCT03220542|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111243142|NCT03220542|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
111243143|NCT03220542|Protective Agents|protective agents|mesh-ancestor
111243144|NCT03220542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111243145|NCT03220542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111243146|NCT03220152|Tenofovir|tenofovir|mesh-list
111243147|NCT03220152|Emtricitabine|emtricitabine|mesh-list
111243148|NCT03220152|Antiviral Agents|antiviral agents|mesh-ancestor
111243149|NCT03220152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111243150|NCT03220152|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111243151|NCT03220152|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111243152|NCT03220152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111243153|NCT03220152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111243154|NCT03220152|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111243155|NCT03220152|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111243156|NCT03220464|Interferons|interferons|mesh-list
111243157|NCT03220464|Interferon-gamma|interferon-gamma|mesh-list
110967479|NCT04983901|Protease Inhibitors|protease inhibitors|mesh-ancestor
110967480|NCT04979377|Insulin|insulin|mesh-list
110967481|NCT04979377|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110967482|NCT04979377|Hormones|hormones|mesh-list
110967483|NCT04979377|Testosterone|testosterone|mesh-list
110967484|NCT04979377|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
110967485|NCT04979377|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110967486|NCT04979377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110967487|NCT04979377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110967488|NCT04979377|Androgens|androgens|mesh-ancestor
110967489|NCT04979377|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110967490|NCT04979377|Immunologic Factors|immunologic factors|mesh-ancestor
110967520|NCT04965181|Nicotine|nicotine|mesh-list
110967521|NCT04965181|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110967522|NCT04965181|Autonomic Agents|autonomic agents|mesh-ancestor
110967523|NCT04965181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110967524|NCT04965181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110967525|NCT04965181|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110967526|NCT04965181|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110967527|NCT04965181|Cholinergic Agents|cholinergic agents|mesh-ancestor
110967528|NCT04965181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110967529|NCT04965181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110967530|NCT04964128|Insulin|insulin|mesh-list
110967531|NCT04964128|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110967532|NCT04964128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110967533|NCT04943341|Triamcinolone|triamcinolone|mesh-list
110967534|NCT04943341|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110967535|NCT04943341|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110967536|NCT04943341|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
111243158|NCT03220464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111243159|NCT03220464|Antiviral Agents|antiviral agents|mesh-ancestor
111243160|NCT03220464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111243161|NCT03206658|Spironolactone|spironolactone|mesh-list
111243162|NCT03206658|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
111243163|NCT03206658|Hormone Antagonists|hormone antagonists|mesh-ancestor
111243164|NCT03206658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111243165|NCT03206658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111243166|NCT03206658|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
111243167|NCT03206658|Diuretics|diuretics|mesh-ancestor
111243168|NCT03206658|Natriuretic Agents|natriuretic agents|mesh-ancestor
111243169|NCT00170157|Ipilimumab|ipilimumab|mesh-list
111243170|NCT00170157|Leuprolide|leuprolide|mesh-list
111243171|NCT00170157|Goserelin|goserelin|mesh-list
111243172|NCT00170157|Bicalutamide|bicalutamide|mesh-list
111243173|NCT00170157|Flutamide|flutamide|mesh-list
111243174|NCT00170157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111243175|NCT00170157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111243176|NCT00170157|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111243177|NCT00170157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111243178|NCT00170157|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111243179|NCT00170157|Fertility Agents|fertility agents|mesh-ancestor
111243180|NCT00170157|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111243181|NCT00170157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111243182|NCT00170157|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111243183|NCT00170157|Androgen Antagonists|androgen antagonists|mesh-ancestor
111243184|NCT00170157|Hormone Antagonists|hormone antagonists|mesh-ancestor
111243185|NCT00170157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111243186|NCT03206346|Pentanedioic acid imidazolyl ethanamide|pentanedioic acid imidazolyl ethanamide|mesh-list
111243187|NCT03206346|Antiviral Agents|antiviral agents|mesh-ancestor
111243188|NCT03206346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111243189|NCT00170625|Topotecan|topotecan|mesh-list
111243190|NCT00170625|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111243191|NCT00170625|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111243192|NCT00170625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111243193|NCT00170625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111243194|NCT00170625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111243195|NCT02043652|Chloroquine|chloroquine|mesh-list
111243196|NCT02043652|Primaquine|primaquine|mesh-list
111243197|NCT02043652|Amebicides|amebicides|mesh-ancestor
111243198|NCT02043652|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111243199|NCT02043652|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111243200|NCT02043652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111243201|NCT02043652|Antimalarials|antimalarials|mesh-ancestor
111243202|NCT02043652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111243203|NCT01898169|Nicotine|nicotine|mesh-list
111243204|NCT01898169|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111243205|NCT01898169|Autonomic Agents|autonomic agents|mesh-ancestor
111243206|NCT01898169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111243207|NCT01898169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111243208|NCT01898169|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111243209|NCT01898169|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111243210|NCT01898169|Cholinergic Agents|cholinergic agents|mesh-ancestor
111243211|NCT01898169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111243212|NCT01898169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111243213|NCT03227016|Topotecan|topotecan|mesh-list
111243214|NCT03227016|Veliparib|veliparib|mesh-list
111243215|NCT03227016|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
111243216|NCT03227016|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111243217|NCT03227016|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111243218|NCT03227016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111243219|NCT03227016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111243220|NCT03227016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111243221|NCT04748991|Amiodarone|amiodarone|mesh-list
111243222|NCT04748991|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111243223|NCT04748991|Vasodilator Agents|vasodilator agents|mesh-ancestor
111243224|NCT04748991|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
111243225|NCT04748991|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111243226|NCT04748991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111243227|NCT04748991|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111243228|NCT04748991|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111243229|NCT04748991|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111243230|NCT04748991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110967556|NCT04940039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111243231|NCT04748991|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111243232|NCT04748991|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111243233|NCT04748991|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111243234|NCT03230136|Anesthetics|anesthetics|mesh-list
111243235|NCT03230136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111243236|NCT03230136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111243237|NCT00176865|Cyclosporine|cyclosporine|mesh-list
111243238|NCT00176865|Mycophenolic Acid|mycophenolic acid|mesh-list
111243239|NCT00176865|Fludarabine|fludarabine|mesh-list
111243240|NCT00176865|Melphalan|melphalan|mesh-list
111243241|NCT00176865|Alemtuzumab|alemtuzumab|mesh-list
111243242|NCT00176865|Cyclosporins|cyclosporins|mesh-list
111243243|NCT00176865|Antilymphocyte Serum|antilymphocyte serum|mesh-list
111243244|NCT00176865|Immunoglobulins|immunoglobulins|mesh-list
111243245|NCT00176865|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111243246|NCT00176865|gamma-Globulins|gamma-globulins|mesh-list
111243247|NCT00176865|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
111243248|NCT00176865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111243249|NCT00176865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111243250|NCT00176865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111243251|NCT00176865|Immunologic Factors|immunologic factors|mesh-ancestor
111243252|NCT00176865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111243253|NCT00176865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111243254|NCT00176865|Antifungal Agents|antifungal agents|mesh-ancestor
111243255|NCT00176865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111243256|NCT00176865|Dermatologic Agents|dermatologic agents|mesh-ancestor
111243257|NCT00176865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110981004|NCT00508989|Niacin|niacin|mesh-list
111243258|NCT00176865|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110981100|NCT05726019|Colchicine|colchicine|mesh-list
110981169|NCT00370383|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111243259|NCT00176865|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111243260|NCT00176865|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110981467|NCT03199976|Anticonvulsants|anticonvulsants|mesh-ancestor
110981541|NCT02303821|Hydrocortisone|hydrocortisone|mesh-list
110981692|NCT03204734|Antimetabolites|antimetabolites|mesh-ancestor
111243261|NCT00176865|Antitubercular Agents|antitubercular agents|mesh-ancestor
110982374|NCT05707169|Autonomic Agents|autonomic agents|mesh-ancestor
110982524|NCT03118076|Anesthetics, Local|anesthetics, local|mesh-ancestor
111243262|NCT00176865|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110982826|NCT02443142|Antipyretics|antipyretics|mesh-ancestor
110983047|NCT04465773|Narcotics|narcotics|mesh-ancestor
111243263|NCT00176865|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111243264|NCT00176865|Alkylating Agents|alkylating agents|mesh-ancestor
110983535|NCT02431286|Aprepitant|aprepitant|mesh-list
111243265|NCT00176865|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110983568|NCT02431208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111243266|NCT00176865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111243267|NCT02451072|Ketanserin|ketanserin|mesh-list
111243268|NCT02451072|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
110983999|NCT02419820|APD791|apd791|mesh-list
111243269|NCT02451072|Hallucinogens|hallucinogens|mesh-ancestor
111243270|NCT02451072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111243271|NCT02451072|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111243272|NCT02451072|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111243273|NCT02451072|Serotonin Agents|serotonin agents|mesh-ancestor
111243274|NCT02451072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110984721|NCT02405858|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110984796|NCT03172988|Antiemetics|antiemetics|mesh-ancestor
110984942|NCT02404844|Hormone Antagonists|hormone antagonists|mesh-ancestor
111243275|NCT02451072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110985103|NCT02404064|Metronidazole|metronidazole|mesh-list
110985165|NCT03521895|Growth Inhibitors|growth inhibitors|mesh-ancestor
110985242|NCT02396888|Insulin|insulin|mesh-list
111243276|NCT02451072|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111243277|NCT02451072|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111243278|NCT02451072|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111243279|NCT03226626|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111243280|NCT03226626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111243281|NCT02450994|Dexamethasone|dexamethasone|mesh-list
111243282|NCT02450994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111243283|NCT02450994|Antiemetics|antiemetics|mesh-ancestor
111243284|NCT02450994|Autonomic Agents|autonomic agents|mesh-ancestor
111243285|NCT02450994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111243286|NCT02450994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110985315|NCT03519633|Autonomic Agents|autonomic agents|mesh-ancestor
111243287|NCT02450994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111243288|NCT02450994|Glucocorticoids|glucocorticoids|mesh-ancestor
110985686|NCT02300649|Analgesics|analgesics|mesh-ancestor
110985753|NCT03511833|Narcotics|narcotics|mesh-ancestor
111243289|NCT02450994|Hormones|hormones|mesh-ancestor
110985976|NCT03505047|Trace Elements|trace elements|mesh-ancestor
110986052|NCT03507387|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110986128|NCT03106532|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110986201|NCT02307045|Nicotine|nicotine|mesh-list
110986328|NCT02392520|Cetrorelix|cetrorelix|mesh-list
110986348|NCT02696096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110986420|NCT02398136|GABA Agents|gaba agents|mesh-ancestor
110986421|NCT05745584|Mirabegron|mirabegron|mesh-list
110986661|NCT02957968|Paclitaxel|paclitaxel|mesh-list
110986730|NCT02942290|Azacitidine|azacitidine|mesh-list
110987034|NCT00647933|Estrogens|estrogens|mesh-ancestor
110987102|NCT01272037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110987246|NCT03673501|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110987264|NCT02309385|BB 1101|bb 1101|mesh-list
110987472|NCT04738097|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110987548|NCT03583307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110987674|NCT04912427|Hormones|hormones|mesh-ancestor
110987699|NCT03496389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110987922|NCT05426434|Sulfadoxine|sulfadoxine|mesh-list
111243290|NCT02450994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110988062|NCT01661140|Antimetabolites|antimetabolites|mesh-ancestor
110988132|NCT05436652|Prednisolone acetate|prednisolone acetate|mesh-list
111243291|NCT02450994|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111243292|NCT02450994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111243293|NCT00177255|Docetaxel|docetaxel|mesh-list
111243294|NCT00177255|Capecitabine|capecitabine|mesh-list
111243295|NCT00177255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110988587|NCT04308837|Hormones|hormones|mesh-ancestor
111243296|NCT00177255|Tubulin Modulators|tubulin modulators|mesh-ancestor
110989029|NCT03699215|Simendan|simendan|mesh-list
111243297|NCT00177255|Antimitotic Agents|antimitotic agents|mesh-ancestor
111243298|NCT00177255|Mitosis Modulators|mitosis modulators|mesh-ancestor
110989296|NCT03681197|Metformin|metformin|mesh-list
111243299|NCT00177255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111243300|NCT00177255|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110989633|NCT04460001|Triamcinolone|triamcinolone|mesh-list
111243301|NCT00177255|Antimetabolites|antimetabolites|mesh-ancestor
111243302|NCT02401048|Durvalumab|durvalumab|mesh-list
110989933|NCT04965220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110990007|NCT05132985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111243303|NCT02401048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110990158|NCT03480321|Vasodilator Agents|vasodilator agents|mesh-ancestor
110990235|NCT05311852|Hormones|hormones|mesh-ancestor
110990377|NCT05226754|Diacerein|diacerein|mesh-list
110990603|NCT03674411|Melphalan|melphalan|mesh-list
110990680|NCT03670043|Psyllium|psyllium|mesh-list
111243304|NCT02401048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111243305|NCT02046382|Acetaminophen|acetaminophen|mesh-list
111243306|NCT02046382|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110991067|NCT02665286|Autonomic Agents|autonomic agents|mesh-ancestor
111243307|NCT02046382|Analgesics|analgesics|mesh-ancestor
110991439|NCT05797077|Capecitabine|capecitabine|mesh-list
110991508|NCT05661591|Antifungal Agents|antifungal agents|mesh-ancestor
110991664|NCT05366621|Denosumab|denosumab|mesh-list
111243308|NCT02046382|Sensory System Agents|sensory system agents|mesh-ancestor
110991783|NCT05142904|Iodine|iodine|mesh-list
111243309|NCT02046382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111243310|NCT02046382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111243311|NCT02046382|Antipyretics|antipyretics|mesh-ancestor
111243312|NCT03205176|Olaparib|olaparib|mesh-list
111243313|NCT03205176|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111243314|NCT03205176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110992973|NCT05043766|Analgesics|analgesics|mesh-ancestor
110993122|NCT02381600|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110993198|NCT03105674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111243315|NCT03205176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110993351|NCT03661489|Propofol|propofol|mesh-list
110993436|NCT03666299|Lidocaine|lidocaine|mesh-list
111243316|NCT03205176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111243317|NCT02046772|Morphine|morphine|mesh-list
111243318|NCT02046772|Bupivacaine|bupivacaine|mesh-list
111243319|NCT02046772|Anesthetics, Local|anesthetics, local|mesh-ancestor
111243320|NCT02046772|Anesthetics|anesthetics|mesh-ancestor
110993949|NCT02359136|Epinephrine|epinephrine|mesh-list
111243321|NCT02046772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111243322|NCT02046772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110994161|NCT02519842|Serotonin Agents|serotonin agents|mesh-ancestor
110994315|NCT03658421|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111243323|NCT02046772|Sensory System Agents|sensory system agents|mesh-ancestor
111243324|NCT02046772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111243325|NCT02046772|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111243326|NCT02046772|Narcotics|narcotics|mesh-ancestor
111243327|NCT02046772|Analgesics|analgesics|mesh-ancestor
111243328|NCT00178503|Methylphenidate|methylphenidate|mesh-list
111243329|NCT00178503|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111243330|NCT00178503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111243331|NCT00178503|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111243332|NCT00178503|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111243333|NCT00178503|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111243334|NCT00178503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111243335|NCT00178503|Dopamine Agents|dopamine agents|mesh-ancestor
110994614|NCT00455403|Chloroquine|chloroquine|mesh-list
110994762|NCT03469167|Mydriatics|mydriatics|mesh-ancestor
110994902|NCT04454775|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110994981|NCT04054999|Micronutrients|micronutrients|mesh-ancestor
111243336|NCT00178503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111243337|NCT02376010|Warfarin|warfarin|mesh-list
110995434|NCT01909245|Gastrins|gastrins|mesh-list
110995504|NCT05424315|Dapagliflozin|dapagliflozin|mesh-list
111243338|NCT02376010|Rivaroxaban|rivaroxaban|mesh-list
111243339|NCT02376010|Anticoagulants|anticoagulants|mesh-ancestor
110995648|NCT05226897|Metformin|metformin|mesh-list
110996327|NCT03447093|Propylthiouracil|propylthiouracil|mesh-list
110996405|NCT03446937|Hormones|hormones|mesh-ancestor
111243340|NCT02376010|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111243341|NCT02376010|Antithrombins|antithrombins|mesh-ancestor
111243342|NCT02376010|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111243343|NCT02376010|Protease Inhibitors|protease inhibitors|mesh-ancestor
111243344|NCT02376010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111243345|NCT02376010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111243346|NCT00085293|Decitabine|decitabine|mesh-list
111243347|NCT00085293|Azacitidine|azacitidine|mesh-list
111243348|NCT00085293|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
111243349|NCT00085293|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111243350|NCT00085293|Antimetabolites|antimetabolites|mesh-ancestor
111243351|NCT00085293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111243352|NCT00085293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111243353|NCT00085293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111243354|NCT00085293|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111243355|NCT02402062|Sunitinib|sunitinib|mesh-list
111243356|NCT02402062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111243357|NCT02402062|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111243358|NCT02402062|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111243359|NCT02402062|Growth Substances|growth substances|mesh-ancestor
111243360|NCT02402062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111243361|NCT02402062|Growth Inhibitors|growth inhibitors|mesh-ancestor
111243362|NCT02402062|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111243363|NCT02402062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110996835|NCT05665647|Rifampin|rifampin|mesh-list
110997049|NCT03427437|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111243364|NCT02402062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110997221|NCT03421275|Fentanyl|fentanyl|mesh-list
110714352|NCT00073918|Iodine|iodine|mesh-list
110997357|NCT04448457|Sufentanil|sufentanil|mesh-list
111243365|NCT02450838|Aluminum Hydroxide|aluminum hydroxide|mesh-list
111243366|NCT02450838|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111243367|NCT02450838|Immunologic Factors|immunologic factors|mesh-ancestor
110997806|NCT03423849|Gemcitabine|gemcitabine|mesh-list
110998113|NCT02351024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111243368|NCT02450838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111243369|NCT02450838|Antacids|antacids|mesh-ancestor
110998332|NCT02032303|Ticagrelor|ticagrelor|mesh-list
110998557|NCT03612037|Micronutrients|micronutrients|mesh-ancestor
110998635|NCT02032927|Antipyretics|antipyretics|mesh-ancestor
111243370|NCT02450838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111243371|NCT02450838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111243372|NCT03214302|Tenofovir|tenofovir|mesh-list
110999236|NCT04935476|Dapsone|dapsone|mesh-list
111243373|NCT03214302|Antiviral Agents|antiviral agents|mesh-ancestor
110999310|NCT03145610|Cariostatic Agents|cariostatic agents|mesh-ancestor
111243374|NCT03214302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110999385|NCT03612947|Anticonvulsants|anticonvulsants|mesh-ancestor
111243375|NCT03214302|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110999982|NCT05383625|Vaccines|vaccines|mesh-list
111000057|NCT01336205|Naloxegol|naloxegol|mesh-list
111000144|NCT03385161|Ethanol|ethanol|mesh-list
111000204|NCT00725127|Analgesics|analgesics|mesh-ancestor
111243376|NCT03214302|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111243377|NCT03214302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111000494|NCT04822376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111000568|NCT03143738|Anesthetics|anesthetics|mesh-list
111000639|NCT02237209|Vaccines|vaccines|mesh-list
111000790|NCT02856113|Alogliptin|alogliptin|mesh-list
111001015|NCT04282239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111001090|NCT03607331|Citalopram|citalopram|mesh-list
111243378|NCT03214302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111001315|NCT05078372|Midazolam|midazolam|mesh-list
111243379|NCT03214302|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111243380|NCT03214302|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111001611|NCT02484716|Adrenergic Agents|adrenergic agents|mesh-ancestor
110967687|NCT04837014|Sensory System Agents|sensory system agents|mesh-ancestor
111243382|NCT00085839|Carboplatin|carboplatin|mesh-list
111243383|NCT00085839|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111001907|NCT06042010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111001982|NCT06041477|Antidotes|antidotes|mesh-ancestor
111243384|NCT00085839|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111243385|NCT00085839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111243386|NCT00085839|Tubulin Modulators|tubulin modulators|mesh-ancestor
111243387|NCT00085839|Antimitotic Agents|antimitotic agents|mesh-ancestor
111243388|NCT00085839|Mitosis Modulators|mitosis modulators|mesh-ancestor
111002524|NCT05607017|Losartan|losartan|mesh-list
111002664|NCT05382286|Tubulin Modulators|tubulin modulators|mesh-ancestor
111002837|NCT05160922|Crizotinib|crizotinib|mesh-list
111002959|NCT04893798|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111003095|NCT04737603|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111003259|NCT04580121|Dasatinib|dasatinib|mesh-list
111003412|NCT04321993|Antiviral Agents|antiviral agents|mesh-list
111243389|NCT00085839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111003635|NCT03816163|Paclitaxel|paclitaxel|mesh-list
111003710|NCT03666273|Pembrolizumab|pembrolizumab|mesh-list
111003952|NCT03007147|Antidotes|antidotes|mesh-ancestor
111004011|NCT02465268|Molgramostim|molgramostim|mesh-list
111243390|NCT00085839|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111004160|NCT01697566|Metformin|metformin|mesh-list
111243391|NCT00085839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111004389|NCT05849662|Cytarabine|cytarabine|mesh-list
111004478|NCT05827705|Ephedrine|ephedrine|mesh-list
111243392|NCT03204474|Lacosamide|lacosamide|mesh-list
111243393|NCT03204474|Anticonvulsants|anticonvulsants|mesh-ancestor
111243394|NCT03204474|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111243395|NCT03204474|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111004838|NCT05808010|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111004913|NCT05508009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111243396|NCT03204474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111005272|NCT04112043|Niacin|niacin|mesh-list
111243397|NCT03204474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111243398|NCT03204318|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
111243399|NCT03204318|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
111243400|NCT03204318|Norethindrone|norethindrone|mesh-list
111243401|NCT03204318|Norethindrone Acetate|norethindrone acetate|mesh-list
111243402|NCT03204318|Estradiol|estradiol|mesh-list
111243403|NCT03204318|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
111243404|NCT03204318|Relugolix|relugolix|mesh-list
111243405|NCT03204318|Estrogens|estrogens|mesh-ancestor
111243406|NCT03204318|Hormones|hormones|mesh-ancestor
111243407|NCT03204318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111243408|NCT03204318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111243409|NCT03204318|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111243410|NCT03204318|Contraceptive Agents|contraceptive agents|mesh-ancestor
111243411|NCT03204318|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111243412|NCT03204318|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111243413|NCT03204318|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111243414|NCT03204318|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111243415|NCT03204318|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111243416|NCT03204318|Androgen Antagonists|androgen antagonists|mesh-ancestor
111243417|NCT03204318|Hormone Antagonists|hormone antagonists|mesh-ancestor
111006821|NCT03827889|Fluorides|fluorides|mesh-list
111243418|NCT03204006|Dexmedetomidine|dexmedetomidine|mesh-list
111007428|NCT04524897|Hormones|hormones|mesh-ancestor
111243419|NCT03204006|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111243420|NCT03204006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111007729|NCT02518503|Lovastatin|lovastatin|mesh-list
111007804|NCT04509219|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111007888|NCT03601091|Anesthetics|anesthetics|mesh-ancestor
111243421|NCT03204006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111243422|NCT03204006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111243423|NCT03204006|Analgesics|analgesics|mesh-ancestor
111008330|NCT04505475|Coagulants|coagulants|mesh-ancestor
111008405|NCT03030261|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111243424|NCT03204006|Sensory System Agents|sensory system agents|mesh-ancestor
111008554|NCT04850144|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111008857|NCT02238145|Ipratropium|ipratropium|mesh-list
111243425|NCT03204006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111243426|NCT03204006|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111009088|NCT02511483|Morphine|morphine|mesh-list
111243427|NCT03204006|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111243428|NCT03204006|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111243429|NCT03204006|Adrenergic Agents|adrenergic agents|mesh-ancestor
111243430|NCT03204006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111009449|NCT03143985|Pomalidomide|pomalidomide|mesh-list
111243431|NCT03204006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111243432|NCT03226080|Rocuronium|rocuronium|mesh-list
111009673|NCT03592199|Sunitinib|sunitinib|mesh-list
111243433|NCT03226080|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
111243434|NCT03226080|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
111243435|NCT03226080|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111009977|NCT03569995|Antimetabolites|antimetabolites|mesh-ancestor
111010202|NCT03567655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111010281|NCT03567343|Melatonin|melatonin|mesh-list
111243436|NCT03226080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111243437|NCT03226080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111243438|NCT03225924|Prednisone|prednisone|mesh-list
111243439|NCT03225924|Cyclophosphamide|cyclophosphamide|mesh-list
111243440|NCT03225924|Rituximab|rituximab|mesh-list
111011110|NCT03323697|Escitalopram|escitalopram|mesh-list
111243441|NCT03225924|Doxorubicin|doxorubicin|mesh-list
111011409|NCT00748904|Rifaximin|rifaximin|mesh-list
111243442|NCT03225924|Vincristine|vincristine|mesh-list
111011709|NCT03318471|Magnesium Sulfate|magnesium sulfate|mesh-list
111011789|NCT02604446|Oxycodone|oxycodone|mesh-list
111243443|NCT03225924|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111243444|NCT03225924|Immunologic Factors|immunologic factors|mesh-ancestor
111243445|NCT03225924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111012538|NCT02824627|Oxytocin|oxytocin|mesh-list
111012617|NCT05870553|Laxatives|laxatives|mesh-ancestor
111243446|NCT03225924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111012918|NCT05245474|Tislelizumab|tislelizumab|mesh-list
111013218|NCT04166110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111013298|NCT03994211|Rifampin|rifampin|mesh-list
111243447|NCT03225924|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111243448|NCT03225924|Alkylating Agents|alkylating agents|mesh-ancestor
111243449|NCT03225924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111243450|NCT03225924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111243451|NCT03225924|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111243452|NCT03225924|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111243453|NCT03225924|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110967765|NCT04774393|Antimetabolites|antimetabolites|mesh-ancestor
111243454|NCT03225924|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111243455|NCT03225924|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111243456|NCT03225924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111243457|NCT03225924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111243458|NCT03225924|Glucocorticoids|glucocorticoids|mesh-ancestor
111243459|NCT03225924|Hormones|hormones|mesh-ancestor
111243460|NCT03225924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111243461|NCT03225924|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111243462|NCT03225924|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111243463|NCT03225924|Tubulin Modulators|tubulin modulators|mesh-ancestor
111243464|NCT03225924|Antimitotic Agents|antimitotic agents|mesh-ancestor
111243465|NCT03225924|Mitosis Modulators|mitosis modulators|mesh-ancestor
111243466|NCT03119532|Metronidazole|metronidazole|mesh-list
111243467|NCT03119532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111243468|NCT03119532|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111243469|NCT03119532|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111243470|NCT03119532|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111243471|NCT02404168|Lamotrigine|lamotrigine|mesh-list
111013800|NCT01338415|Bosentan|bosentan|mesh-list
111243472|NCT02404168|Anticonvulsants|anticonvulsants|mesh-list
111013943|NCT05134298|Meropenem|meropenem|mesh-list
111014019|NCT02817841|Diuretics|diuretics|mesh-ancestor
111243473|NCT02404168|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111014239|NCT02475057|Hormones|hormones|mesh-list
111014314|NCT04495088|Oxaliplatin|oxaliplatin|mesh-list
111014393|NCT02472249|Sympathomimetics|sympathomimetics|mesh-ancestor
111243474|NCT02404168|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111243475|NCT02404168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111014741|NCT02049073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111014812|NCT02049229|Everolimus|everolimus|mesh-list
111015036|NCT02056405|Mosapride|mosapride|mesh-list
111015192|NCT02058823|Amlodipine|amlodipine|mesh-list
111243476|NCT02404168|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111243477|NCT02404168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111243478|NCT02404168|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111243479|NCT02404168|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111243480|NCT02404168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111243481|NCT02404168|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111015262|NCT05291325|Linaclotide|linaclotide|mesh-list
111015407|NCT05302232|Anesthetics|anesthetics|mesh-ancestor
111015482|NCT04490967|Analgesics|analgesics|mesh-ancestor
111015573|NCT02714894|Clozapine|clozapine|mesh-list
111243482|NCT02404168|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111015872|NCT05391074|Vitamins|vitamins|mesh-list
111243483|NCT04733937|Caseins|caseins|mesh-list
111243484|NCT04733937|Chelating Agents|chelating agents|mesh-ancestor
111016141|NCT01673594|Naltrexone|naltrexone|mesh-list
111243485|NCT04733937|Sequestering Agents|sequestering agents|mesh-ancestor
111016417|NCT02471404|Incretins|incretins|mesh-ancestor
110733580|NCT05444543|Xhance|xhance|mesh-list
111016484|NCT02063269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111016563|NCT00651404|Ezetimibe|ezetimibe|mesh-list
111016633|NCT03493646|Antimetabolites|antimetabolites|mesh-ancestor
111016711|NCT03098810|Zinc Sulfate|zinc sulfate|mesh-list
111016781|NCT05059418|Anticonvulsants|anticonvulsants|mesh-ancestor
111017001|NCT02064049|Sofosbuvir|sofosbuvir|mesh-list
111017076|NCT02069197|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111017150|NCT02463825|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111243486|NCT04733937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111243487|NCT02051452|Methylphenidate|methylphenidate|mesh-list
111017465|NCT02077231|Vitamins|vitamins|mesh-list
111017526|NCT02074267|Gabapentin|gabapentin|mesh-list
111243488|NCT02051452|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111017607|NCT02078089|Morphine|morphine|mesh-list
111243489|NCT02051452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111243490|NCT02051452|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111243491|NCT02051452|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111243492|NCT02051452|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111243493|NCT02051452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111243494|NCT02051452|Dopamine Agents|dopamine agents|mesh-ancestor
111243495|NCT02051452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111243496|NCT00180687|Bupivacaine|bupivacaine|mesh-list
111243497|NCT00180687|Coal Tar|coal tar|mesh-list
111243498|NCT00180687|Anesthetics, Local|anesthetics, local|mesh-ancestor
111243499|NCT00180687|Anesthetics|anesthetics|mesh-ancestor
111243500|NCT00180687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111243501|NCT00180687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111243502|NCT00180687|Sensory System Agents|sensory system agents|mesh-ancestor
111017673|NCT02081287|Vitamins|vitamins|mesh-ancestor
111243503|NCT00180687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111243504|NCT00180687|Keratolytic Agents|keratolytic agents|mesh-ancestor
111243505|NCT00180687|Dermatologic Agents|dermatologic agents|mesh-ancestor
111243506|NCT00087633|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
111243507|NCT00087633|Antiviral Agents|antiviral agents|mesh-ancestor
111243508|NCT00087633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111243509|NCT02384044|Listerine|listerine|mesh-list
111243510|NCT02384044|Sodium Fluoride|sodium fluoride|mesh-list
111243511|NCT02384044|Cariostatic Agents|cariostatic agents|mesh-ancestor
111243512|NCT02384044|Protective Agents|protective agents|mesh-ancestor
111243513|NCT02384044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111243514|NCT02384044|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111243515|NCT02384044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111243516|NCT02384200|Vancomycin|vancomycin|mesh-list
111243517|NCT02384200|Gentamicins|gentamicins|mesh-list
111243518|NCT02384200|Ceftriaxone|ceftriaxone|mesh-list
111243519|NCT02384200|Ampicillin|ampicillin|mesh-list
111243520|NCT02384200|Nitrofurantoin|nitrofurantoin|mesh-list
111243521|NCT02384200|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111243522|NCT02384200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111243523|NCT02384200|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111243524|NCT02384200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111243525|NCT02384200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111243526|NCT02384200|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111243527|NCT02051686|Tranexamic Acid|tranexamic acid|mesh-list
110967862|NCT04685577|Nefopam|nefopam|mesh-list
111243528|NCT02051686|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111243530|NCT02051686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111243531|NCT02051686|Hemostatics|hemostatics|mesh-ancestor
111243532|NCT02051686|Coagulants|coagulants|mesh-ancestor
111243533|NCT00182793|Cyclophosphamide|cyclophosphamide|mesh-list
111243534|NCT00182793|Melphalan|melphalan|mesh-list
111243535|NCT00182793|Thiotepa|thiotepa|mesh-list
111243536|NCT00182793|Carboplatin|carboplatin|mesh-list
111243537|NCT00182793|Trastuzumab|trastuzumab|mesh-list
111243538|NCT00182793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111243539|NCT00182793|Immunologic Factors|immunologic factors|mesh-ancestor
111243540|NCT00182793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111243541|NCT00182793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111243542|NCT00182793|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111243543|NCT00182793|Alkylating Agents|alkylating agents|mesh-ancestor
111243544|NCT00182793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111243545|NCT00182793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111243546|NCT00182793|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111243547|NCT00182793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111243548|NCT00183339|Fluoxetine|fluoxetine|mesh-list
111243549|NCT00183339|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111243550|NCT00183339|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111243551|NCT00183339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111243552|NCT00183339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111243553|NCT00183339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111243554|NCT00183339|Serotonin Agents|serotonin agents|mesh-ancestor
111243555|NCT00183339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111243556|NCT00183339|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111243557|NCT00183339|Antidepressive Agents|antidepressive agents|mesh-ancestor
111243558|NCT00183339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111243559|NCT00183339|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111243560|NCT00183339|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111243561|NCT00183339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111243562|NCT00183729|Memantine|memantine|mesh-list
111243563|NCT00183729|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111243564|NCT00183729|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111243565|NCT00183729|Dopamine Agents|dopamine agents|mesh-ancestor
111243566|NCT00183729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111243567|NCT00183729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111243568|NCT00183729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111243569|NCT00183729|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111243570|NCT00183729|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111243571|NCT00186069|Magnesium Sulfate|magnesium sulfate|mesh-list
111243572|NCT00186069|Analgesics|analgesics|mesh-ancestor
111243573|NCT00186069|Sensory System Agents|sensory system agents|mesh-ancestor
111243574|NCT00186069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111243575|NCT00186069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111243576|NCT00186069|Anesthetics|anesthetics|mesh-ancestor
111243577|NCT00186069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111243578|NCT00186069|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111243579|NCT00186069|Anticonvulsants|anticonvulsants|mesh-ancestor
111243580|NCT00186069|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111243581|NCT00186069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111243582|NCT00186069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111243583|NCT00186069|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111243584|NCT00186069|Tocolytic Agents|tocolytic agents|mesh-ancestor
111243585|NCT00186069|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111243586|NCT01742897|Fentanyl|fentanyl|mesh-list
111243587|NCT01742897|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111243588|NCT01742897|Narcotics|narcotics|mesh-ancestor
111243589|NCT01742897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111243590|NCT01742897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111243591|NCT01742897|Analgesics|analgesics|mesh-ancestor
111243592|NCT01742897|Sensory System Agents|sensory system agents|mesh-ancestor
111243593|NCT01742897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111243594|NCT01742897|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111243595|NCT01742897|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111243596|NCT01742897|Anesthetics, General|anesthetics, general|mesh-ancestor
111243597|NCT01742897|Anesthetics|anesthetics|mesh-ancestor
111243598|NCT04554485|Blinatumomab|blinatumomab|mesh-list
111243599|NCT04554485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111243600|NCT01741259|Meperidine|meperidine|mesh-list
111243601|NCT01741259|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111243602|NCT01741259|Narcotics|narcotics|mesh-ancestor
111243603|NCT01741259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111243604|NCT01741259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111243605|NCT01741259|Analgesics|analgesics|mesh-ancestor
111243606|NCT01741259|Sensory System Agents|sensory system agents|mesh-ancestor
111243607|NCT01741259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111243608|NCT01741259|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111243609|NCT01715129|Triptorelin Pamoate|triptorelin pamoate|mesh-list
111243610|NCT01715129|Luteolytic Agents|luteolytic agents|mesh-ancestor
111243611|NCT01715129|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111243612|NCT01715129|Contraceptive Agents|contraceptive agents|mesh-ancestor
111243613|NCT01715129|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111243614|NCT01715129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111243615|NCT01715129|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111243616|NCT01715129|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111243617|NCT01715129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111243618|NCT02387554|Losartan|losartan|mesh-list
111243619|NCT02387554|Amlodipine|amlodipine|mesh-list
111243620|NCT02387554|Chlorthalidone|chlorthalidone|mesh-list
111243621|NCT02387554|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111243622|NCT02387554|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111243623|NCT02387554|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111243624|NCT02387554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111243625|NCT02387554|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111243626|NCT02387554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111243627|NCT02387554|Vasodilator Agents|vasodilator agents|mesh-ancestor
111243628|NCT02387554|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111243629|NCT02387554|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111243630|NCT02387554|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111243631|NCT02387554|Diuretics|diuretics|mesh-ancestor
111243632|NCT02387554|Natriuretic Agents|natriuretic agents|mesh-ancestor
111243633|NCT02387554|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
111243634|NCT02387710|Tiagabine|tiagabine|mesh-list
111243635|NCT02387710|Anticonvulsants|anticonvulsants|mesh-ancestor
111243636|NCT02387710|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
111243637|NCT02387710|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111243638|NCT02387710|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111243639|NCT02387710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111243640|NCT02387710|GABA Agents|gaba agents|mesh-ancestor
111243641|NCT02387710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111243642|NCT02387710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111243643|NCT01740791|Velpatasvir|velpatasvir|mesh-list
111243644|NCT01740791|Antiviral Agents|antiviral agents|mesh-ancestor
111243645|NCT01740791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111243646|NCT01740323|Curcumin|curcumin|mesh-list
111243647|NCT01740323|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111243648|NCT01740323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111243649|NCT01740323|Analgesics|analgesics|mesh-ancestor
111243650|NCT01740323|Sensory System Agents|sensory system agents|mesh-ancestor
111243651|NCT01740323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111243652|NCT01740323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111243653|NCT01740323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111243654|NCT01740323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111243655|NCT01740323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111243656|NCT01740323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111243657|NCT01740323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111243658|NCT00090051|Cyclophosphamide|cyclophosphamide|mesh-list
111243659|NCT00090051|Rituximab|rituximab|mesh-list
111243660|NCT00090051|Fludarabine|fludarabine|mesh-list
111243661|NCT00090051|Fludarabine phosphate|fludarabine phosphate|mesh-list
111243662|NCT00090051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111243663|NCT00090051|Immunologic Factors|immunologic factors|mesh-ancestor
111243664|NCT00090051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111243665|NCT00090051|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111243666|NCT00090051|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111243667|NCT00090051|Alkylating Agents|alkylating agents|mesh-ancestor
111243668|NCT00090051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111243669|NCT00090051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111243670|NCT00090051|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111243671|NCT00090051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111243672|NCT00090051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111243673|NCT00090051|Antimetabolites|antimetabolites|mesh-ancestor
111243674|NCT01740089|Ribavirin|ribavirin|mesh-list
111243675|NCT01740089|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110967979|NCT04615013|Docetaxel|docetaxel|mesh-list
111243677|NCT01740089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111243678|NCT01740089|Antiviral Agents|antiviral agents|mesh-ancestor
111243679|NCT01740089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111243680|NCT01739933|Dexmedetomidine|dexmedetomidine|mesh-list
111243681|NCT01739933|Propofol|propofol|mesh-list
111243682|NCT01739933|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111243683|NCT01739933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111243684|NCT01739933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111243685|NCT01739933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111243686|NCT01739933|Analgesics|analgesics|mesh-ancestor
111243687|NCT01739933|Sensory System Agents|sensory system agents|mesh-ancestor
111243688|NCT01739933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111243689|NCT01739933|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111243690|NCT01739933|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111243691|NCT01739933|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111243692|NCT01739933|Adrenergic Agents|adrenergic agents|mesh-ancestor
111243693|NCT01739933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111243694|NCT01739933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111243695|NCT01739933|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111243696|NCT01739933|Anesthetics, General|anesthetics, general|mesh-ancestor
111243697|NCT01739933|Anesthetics|anesthetics|mesh-ancestor
111243698|NCT00094497|Doxorubicin|doxorubicin|mesh-list
111243699|NCT00094497|Etoposide|etoposide|mesh-list
111243700|NCT00094497|Mitotane|mitotane|mesh-list
111243701|NCT00094497|Streptozocin|streptozocin|mesh-list
111243702|NCT00094497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111243703|NCT00094497|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111243704|NCT00094497|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111243705|NCT00094497|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111243706|NCT00094497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111243707|NCT00094497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111243708|NCT00094497|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111243709|NCT00094497|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111243710|NCT00094887|Nitric Oxide|nitric oxide|mesh-list
111243711|NCT00094887|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111243712|NCT00094887|Autonomic Agents|autonomic agents|mesh-ancestor
111243713|NCT00094887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111243714|NCT00094887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111243715|NCT00094887|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111243716|NCT00094887|Respiratory System Agents|respiratory system agents|mesh-ancestor
111243717|NCT00094887|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111243718|NCT00094887|Antioxidants|antioxidants|mesh-ancestor
111243719|NCT00094887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111243720|NCT00094887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111243721|NCT00094887|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
111243722|NCT00094887|Vasodilator Agents|vasodilator agents|mesh-ancestor
111243723|NCT00094887|Gasotransmitters|gasotransmitters|mesh-ancestor
111243724|NCT00094887|Protective Agents|protective agents|mesh-ancestor
111243725|NCT01712399|Mavrilimumab|mavrilimumab|mesh-list
111243726|NCT01712399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111243727|NCT00097695|Icatibant|icatibant|mesh-list
111243728|NCT00097695|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111243729|NCT00097695|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111243730|NCT00097695|Analgesics|analgesics|mesh-ancestor
111243731|NCT00097695|Sensory System Agents|sensory system agents|mesh-ancestor
111243732|NCT00097695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111243733|NCT00097695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111243734|NCT00097695|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111243735|NCT00097695|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111243736|NCT00097695|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
111243737|NCT00097695|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
111243738|NCT00097695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111243739|NCT00097695|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
111243740|NCT00097695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111243741|NCT00097695|Immunologic Factors|immunologic factors|mesh-ancestor
111243742|NCT02096679|Osimertinib|osimertinib|mesh-list
111243743|NCT02096679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111243744|NCT02096679|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111243745|NCT02096679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111243746|NCT02096679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111243747|NCT00195039|Antibodies|antibodies|mesh-list
111243748|NCT00195039|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111243749|NCT00195039|Immunologic Factors|immunologic factors|mesh-ancestor
111243750|NCT00195039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111243751|NCT04645719|Magnesium Sulfate|magnesium sulfate|mesh-list
111243753|NCT04645719|Sensory System Agents|sensory system agents|mesh-ancestor
111243754|NCT04645719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111243755|NCT04645719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111243756|NCT04645719|Anesthetics|anesthetics|mesh-ancestor
111243757|NCT04645719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111243758|NCT04645719|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111243759|NCT04645719|Anticonvulsants|anticonvulsants|mesh-ancestor
111243760|NCT04645719|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111243761|NCT04645719|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111243762|NCT04645719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111243763|NCT04645719|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111243764|NCT04645719|Tocolytic Agents|tocolytic agents|mesh-ancestor
111243765|NCT04645719|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111243766|NCT02054338|Paclitaxel|paclitaxel|mesh-list
111243767|NCT02054338|Gemcitabine|gemcitabine|mesh-list
111243768|NCT02054338|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111243769|NCT02054338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111243770|NCT02054338|Tubulin Modulators|tubulin modulators|mesh-ancestor
111243771|NCT02054338|Antimitotic Agents|antimitotic agents|mesh-ancestor
111243772|NCT02054338|Mitosis Modulators|mitosis modulators|mesh-ancestor
111243773|NCT02054338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111243774|NCT02054338|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111243775|NCT02054338|Antimetabolites|antimetabolites|mesh-ancestor
111243776|NCT00198081|Celecoxib|celecoxib|mesh-list
111243777|NCT00198081|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
111243778|NCT00198081|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111243779|NCT00198081|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111243780|NCT00198081|Analgesics|analgesics|mesh-ancestor
111243781|NCT00198081|Sensory System Agents|sensory system agents|mesh-ancestor
111243782|NCT00198081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111243783|NCT00198081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111243784|NCT00198081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111243785|NCT00198081|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111243786|NCT00198081|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111243787|NCT00198081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111243788|NCT00198081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111243789|NCT00100659|Interferons|interferons|mesh-list
111243790|NCT00100659|Ribavirin|ribavirin|mesh-list
111243791|NCT00100659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111243792|NCT00100659|Antiviral Agents|antiviral agents|mesh-ancestor
111243793|NCT00100659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111243794|NCT00100659|Antimetabolites|antimetabolites|mesh-ancestor
111243795|NCT00100659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111243796|NCT00101361|Oxandrolone|oxandrolone|mesh-list
111243797|NCT00101361|Androgens|androgens|mesh-ancestor
111243798|NCT00101361|Hormones|hormones|mesh-ancestor
111243799|NCT00101361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111243800|NCT00101361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111243801|NCT00101361|Anabolic Agents|anabolic agents|mesh-ancestor
111243802|NCT03225690|Morphine|morphine|mesh-list
111243803|NCT03225690|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111243804|NCT03225690|Narcotics|narcotics|mesh-ancestor
111243805|NCT03225690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111243806|NCT03225690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111243807|NCT03225690|Analgesics|analgesics|mesh-ancestor
111243808|NCT03225690|Sensory System Agents|sensory system agents|mesh-ancestor
111243809|NCT03225690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111243810|NCT02389738|Temozolomide|temozolomide|mesh-list
111243811|NCT02389738|Regadenoson|regadenoson|mesh-list
111243812|NCT02389738|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111243813|NCT02389738|Alkylating Agents|alkylating agents|mesh-ancestor
111243814|NCT02389738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111243815|NCT02389738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111243816|NCT02389738|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
111243817|NCT02389738|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
111243818|NCT02389738|Purinergic Agonists|purinergic agonists|mesh-ancestor
111243819|NCT02389738|Purinergic Agents|purinergic agents|mesh-ancestor
111243820|NCT02389738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111243821|NCT02389738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111243822|NCT00200343|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
111243823|NCT00200343|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
111243824|NCT00200343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111243825|NCT00201123|Interferons|interferons|mesh-list
111243826|NCT00201123|Interferon-gamma|interferon-gamma|mesh-list
111243827|NCT00201123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111243828|NCT00201123|Antiviral Agents|antiviral agents|mesh-ancestor
111243829|NCT00201123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111243830|NCT01712009|Loratadine|loratadine|mesh-list
111243831|NCT01712009|Naproxen|naproxen|mesh-list
111243832|NCT01712009|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111243833|NCT01712009|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111243834|NCT01712009|Analgesics|analgesics|mesh-ancestor
111243835|NCT01712009|Sensory System Agents|sensory system agents|mesh-ancestor
111243836|NCT01712009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111243837|NCT01712009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111243838|NCT01712009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111243839|NCT01712009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111243840|NCT01712009|Gout Suppressants|gout suppressants|mesh-ancestor
111243841|NCT01712009|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111243842|NCT01712009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111243843|NCT01712009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111243844|NCT01712009|Antipruritics|antipruritics|mesh-ancestor
111243845|NCT01712009|Dermatologic Agents|dermatologic agents|mesh-ancestor
111243846|NCT01712009|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111243847|NCT01712009|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
111243848|NCT01712009|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111243849|NCT01712009|Histamine Antagonists|histamine antagonists|mesh-ancestor
111243850|NCT01712009|Histamine Agents|histamine agents|mesh-ancestor
111243851|NCT01712009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111243852|NCT03212352|Misoprostol|misoprostol|mesh-list
111243853|NCT03212352|Mifepristone|mifepristone|mesh-list
111243854|NCT03212352|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111243855|NCT03212352|Abortifacient Agents|abortifacient agents|mesh-ancestor
111243856|NCT03212352|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111243857|NCT03212352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111243858|NCT03212352|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111243859|NCT03212352|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111243860|NCT03212352|Oxytocics|oxytocics|mesh-ancestor
111243861|NCT03212352|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
111243862|NCT03212352|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111243863|NCT03212352|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111243864|NCT03212352|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111243865|NCT03212352|Contraceptive Agents|contraceptive agents|mesh-ancestor
111243866|NCT03212352|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
111243867|NCT03212352|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
111243868|NCT03212352|Hormone Antagonists|hormone antagonists|mesh-ancestor
111243869|NCT03212352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111243870|NCT03212352|Luteolytic Agents|luteolytic agents|mesh-ancestor
111243871|NCT03212352|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111243872|NCT03212352|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
111243873|NCT00201825|Docetaxel|docetaxel|mesh-list
111243874|NCT00201825|Capecitabine|capecitabine|mesh-list
111243875|NCT00201825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111243876|NCT00201825|Tubulin Modulators|tubulin modulators|mesh-ancestor
111243877|NCT00201825|Antimitotic Agents|antimitotic agents|mesh-ancestor
111243878|NCT00201825|Mitosis Modulators|mitosis modulators|mesh-ancestor
111243879|NCT00201825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111243880|NCT00201825|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111243881|NCT00201825|Antimetabolites|antimetabolites|mesh-ancestor
111243882|NCT02390050|Bexagliflozin|bexagliflozin|mesh-list
111243883|NCT02390050|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111243884|NCT02390050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111243885|NCT01711853|Dabigatran|dabigatran|mesh-list
111243886|NCT01711853|Antithrombins|antithrombins|mesh-ancestor
111243887|NCT01711853|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111243888|NCT01711853|Protease Inhibitors|protease inhibitors|mesh-ancestor
111243889|NCT01711853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111243890|NCT01711853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111243891|NCT01711853|Anticoagulants|anticoagulants|mesh-ancestor
111243892|NCT00202449|Prazosin|prazosin|mesh-list
111243893|NCT00202449|Paroxetine|paroxetine|mesh-list
111243894|NCT00202449|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111243895|NCT00202449|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111243896|NCT00202449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111243897|NCT00202449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111243898|NCT00202449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111243899|NCT00202449|Serotonin Agents|serotonin agents|mesh-ancestor
111243900|NCT00202449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111243901|NCT00202449|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111243902|NCT00202449|Antidepressive Agents|antidepressive agents|mesh-ancestor
111243903|NCT00202449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111243904|NCT00202449|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111243905|NCT00202449|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111243906|NCT00202449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111243907|NCT00202449|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111243908|NCT00202449|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111243909|NCT00202449|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111243910|NCT00202449|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111243911|NCT00202449|Adrenergic Agents|adrenergic agents|mesh-ancestor
111243912|NCT03203304|Nivolumab|nivolumab|mesh-list
111243913|NCT03203304|Ipilimumab|ipilimumab|mesh-list
111243914|NCT03203304|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111243915|NCT03203304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111243916|NCT03203304|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111243917|NCT03203304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111243918|NCT03225456|Oxytocin|oxytocin|mesh-list
111243919|NCT03225456|Oxytocics|oxytocics|mesh-ancestor
111243920|NCT03225456|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111243921|NCT03225456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111243922|NCT00203229|Lamotrigine|lamotrigine|mesh-list
111243923|NCT00203229|Anticonvulsants|anticonvulsants|mesh-ancestor
111243924|NCT00203229|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111243925|NCT00203229|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111243926|NCT00203229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111243927|NCT00203229|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111243928|NCT00203229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111243929|NCT00203229|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111243930|NCT00203229|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111243931|NCT00203229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111243932|NCT00203229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111243933|NCT00203229|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111243934|NCT00203931|Pemetrexed|pemetrexed|mesh-list
111243935|NCT00203931|Cetuximab|cetuximab|mesh-list
111243936|NCT00203931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111243937|NCT00203931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111243938|NCT00203931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111243939|NCT00203931|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111243940|NCT00203931|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111243941|NCT00203931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111243942|NCT02412982|Enoxaparin|enoxaparin|mesh-list
111243943|NCT02412982|Enoxaparin sodium|enoxaparin sodium|mesh-list
111243944|NCT02412982|Anticoagulants|anticoagulants|mesh-ancestor
111243945|NCT02412982|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111243946|NCT02412982|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111243947|NCT02412982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111243948|NCT03203616|Trastuzumab|trastuzumab|mesh-list
111243949|NCT03203616|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
111243950|NCT03203616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111243951|NCT03203616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111243952|NCT03203616|Tubulin Modulators|tubulin modulators|mesh-ancestor
111243953|NCT03203616|Antimitotic Agents|antimitotic agents|mesh-ancestor
111243954|NCT03203616|Mitosis Modulators|mitosis modulators|mesh-ancestor
111243955|NCT03203616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111243956|NCT03203616|Immunotoxins|immunotoxins|mesh-ancestor
111243957|NCT03203616|Immunoconjugates|immunoconjugates|mesh-ancestor
111243958|NCT03203616|Immunologic Factors|immunologic factors|mesh-ancestor
111243959|NCT03203616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111243960|NCT02450214|Ketamine|ketamine|mesh-list
111243961|NCT02450214|Analgesics|analgesics|mesh-ancestor
111243962|NCT02450214|Sensory System Agents|sensory system agents|mesh-ancestor
111243963|NCT02450214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111243964|NCT02450214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111243965|NCT02450214|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111243966|NCT02450214|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111243967|NCT02450214|Anesthetics, General|anesthetics, general|mesh-ancestor
111243968|NCT02450214|Anesthetics|anesthetics|mesh-ancestor
111243969|NCT02450214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111243970|NCT02450214|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111243971|NCT02450214|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110968268|NCT04383119|Gemcitabine|gemcitabine|mesh-list
111243972|NCT02450214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111243973|NCT02450214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111243974|NCT02450682|Warfarin|warfarin|mesh-list
111243975|NCT02450682|Apixaban|apixaban|mesh-list
111243976|NCT02450682|Anticoagulants|anticoagulants|mesh-ancestor
111243977|NCT02450682|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111243978|NCT02450682|Antithrombins|antithrombins|mesh-ancestor
111243979|NCT02450682|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111243980|NCT02450682|Protease Inhibitors|protease inhibitors|mesh-ancestor
111243981|NCT02450682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111243982|NCT02450682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111243983|NCT01740401|Cyclophosphamide|cyclophosphamide|mesh-list
111243984|NCT01740401|Ipilimumab|ipilimumab|mesh-list
111243985|NCT01740401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111243986|NCT01740401|Immunologic Factors|immunologic factors|mesh-ancestor
111243987|NCT01740401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111243988|NCT01740401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111243989|NCT01740401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111243990|NCT01740401|Alkylating Agents|alkylating agents|mesh-ancestor
111243991|NCT01740401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111243992|NCT01740401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111243993|NCT01740401|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111243994|NCT01740401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111243995|NCT01740401|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111243996|NCT03202836|Tocolytic Agents|tocolytic agents|mesh-list
111243997|NCT03202836|Progesterone|progesterone|mesh-list
111243998|NCT03202836|Progestins|progestins|mesh-ancestor
111243999|NCT03202836|Hormones|hormones|mesh-ancestor
111244000|NCT03202836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111244001|NCT03202836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111244002|NCT03202836|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111244003|NCT03203070|Dipyrone|dipyrone|mesh-list
111244004|NCT03203070|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111244005|NCT03203070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111244006|NCT03203070|Analgesics|analgesics|mesh-ancestor
111244007|NCT03203070|Sensory System Agents|sensory system agents|mesh-ancestor
111244008|NCT03203070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111244009|NCT03203070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111244010|NCT03203070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111244011|NCT03203070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111244012|NCT03203070|Antipyretics|antipyretics|mesh-ancestor
111244013|NCT03209856|Vitamin D|vitamin d|mesh-list
111244014|NCT03209856|Calcitriol|calcitriol|mesh-list
111244015|NCT03209856|Vitamins|vitamins|mesh-ancestor
111244016|NCT03209856|Micronutrients|micronutrients|mesh-ancestor
111244017|NCT03209856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111244018|NCT03209856|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111244019|NCT03209856|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111244020|NCT03209856|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
111244021|NCT03209856|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111244022|NCT03209856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111244023|NCT03209856|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111244024|NCT02413918|Iloperidone|iloperidone|mesh-list
111244025|NCT02413918|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111244026|NCT02413918|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111244027|NCT02413918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111244028|NCT02413918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111244029|NCT02413918|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111244030|NCT03209622|Nicotine|nicotine|mesh-list
111244031|NCT03209622|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111244032|NCT03209622|Autonomic Agents|autonomic agents|mesh-ancestor
111244033|NCT03209622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111244034|NCT03209622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111244035|NCT03209622|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111244036|NCT03209622|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111244037|NCT03209622|Cholinergic Agents|cholinergic agents|mesh-ancestor
110968339|NCT04308785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110968340|NCT04305548|Trabectedin|trabectedin|mesh-list
110968341|NCT04305548|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110968342|NCT04305548|Alkylating Agents|alkylating agents|mesh-ancestor
110968343|NCT04305548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110968344|NCT04305548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110968345|NCT04294134|6-chloro-2-(1-piperazinyl)pyrazine|6-chloro-2-(1-piperazinyl)pyrazine|mesh-list
110968346|NCT04294134|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111244038|NCT03209622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111244039|NCT03209622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111244040|NCT00099021|Pioglitazone|pioglitazone|mesh-list
111244041|NCT00099021|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111244042|NCT00099021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111244043|NCT00354874|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
111244044|NCT00354874|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111244045|NCT00354874|Autonomic Agents|autonomic agents|mesh-ancestor
111244046|NCT00354874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111244047|NCT00354874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111244048|NCT00354874|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111244049|NCT00354874|Respiratory System Agents|respiratory system agents|mesh-ancestor
111244050|NCT00354874|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111244051|NCT00354874|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111244052|NCT00354874|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111244053|NCT00354874|Adrenergic Agents|adrenergic agents|mesh-ancestor
111244054|NCT00354874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111244055|NCT00354874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111244056|NCT03209466|Chlorhexidine|chlorhexidine|mesh-list
111244057|NCT03209466|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
111244058|NCT03209466|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111244059|NCT03209466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111244060|NCT03209466|Disinfectants|disinfectants|mesh-ancestor
111244061|NCT03209466|Dermatologic Agents|dermatologic agents|mesh-ancestor
111244063|NCT03834688|Venetoclax|venetoclax|mesh-list
111244064|NCT03834688|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
111244065|NCT03834688|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111244066|NCT03834688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111244067|NCT03834688|Immunologic Factors|immunologic factors|mesh-ancestor
111244068|NCT03834688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111244069|NCT03834688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111244070|NCT03834688|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111244071|NCT03834688|Alkylating Agents|alkylating agents|mesh-ancestor
111244072|NCT03834688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111244073|NCT01710527|Metformin|metformin|mesh-list
111244074|NCT01710527|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111244075|NCT01710527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111244076|NCT00354952|Azithromycin|azithromycin|mesh-list
111244077|NCT00354952|Clarithromycin|clarithromycin|mesh-list
111244078|NCT00354952|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111244079|NCT00354952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111244080|NCT00354952|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111244081|NCT00354952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111244082|NCT00354952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111244083|NCT00354952|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111244084|NCT00354952|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111244085|NCT01706939|Carboplatin|carboplatin|mesh-list
111244086|NCT01706939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111244087|NCT04938232|Nivolumab|nivolumab|mesh-list
111244088|NCT04938232|Ipilimumab|ipilimumab|mesh-list
111244089|NCT04938232|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111244090|NCT04938232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111244091|NCT04938232|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111244092|NCT04938232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111244093|NCT03209232|Infliximab|infliximab|mesh-list
111244094|NCT03209232|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111244095|NCT03209232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111244096|NCT03209232|Dermatologic Agents|dermatologic agents|mesh-ancestor
111244097|NCT03209232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111244098|NCT03209232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111244099|NCT04485312|Chlorhexidine|chlorhexidine|mesh-list
111244100|NCT04485312|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111244101|NCT04485312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111244102|NCT04485312|Disinfectants|disinfectants|mesh-ancestor
111244103|NCT01709903|Fluticasone|fluticasone|mesh-list
111244104|NCT01709903|Xhance|xhance|mesh-list
111244105|NCT01709903|Glycopyrrolate|glycopyrrolate|mesh-list
111244106|NCT01709903|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
111244107|NCT01709903|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
111244108|NCT01709903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111244109|NCT01709903|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111244110|NCT01709903|Autonomic Agents|autonomic agents|mesh-ancestor
111244111|NCT01709903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111244112|NCT01709903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111244113|NCT01709903|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111244114|NCT01709903|Respiratory System Agents|respiratory system agents|mesh-ancestor
111244115|NCT01709903|Dermatologic Agents|dermatologic agents|mesh-ancestor
111244116|NCT01709903|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111244117|NCT01709903|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111244118|NCT01709903|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111244119|NCT01709903|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111244120|NCT01709903|Adrenergic Agents|adrenergic agents|mesh-ancestor
111244121|NCT01709903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111244122|NCT01709903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111244123|NCT01709903|Glucocorticoids|glucocorticoids|mesh-ancestor
111244124|NCT01709903|Hormones|hormones|mesh-ancestor
111244125|NCT01709903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111244126|NCT01709903|Sympathomimetics|sympathomimetics|mesh-ancestor
111244127|NCT01709903|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111244128|NCT01709903|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111244129|NCT01709903|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111244130|NCT01709903|Cholinergic Agents|cholinergic agents|mesh-ancestor
111244131|NCT03202446|Cyclophosphamide|cyclophosphamide|mesh-list
111244132|NCT03202446|Chitosan|chitosan|mesh-list
111244133|NCT03202446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111244134|NCT03202446|Immunologic Factors|immunologic factors|mesh-ancestor
111244135|NCT03202446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111244136|NCT03202446|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111244137|NCT03202446|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111244138|NCT03202446|Alkylating Agents|alkylating agents|mesh-ancestor
111244139|NCT03202446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111244140|NCT03202446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111244141|NCT03202446|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111244142|NCT03202446|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111244143|NCT03202446|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111244144|NCT03202446|Antimetabolites|antimetabolites|mesh-ancestor
111244145|NCT03202446|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111244146|NCT03202446|Chelating Agents|chelating agents|mesh-ancestor
111244147|NCT03202446|Sequestering Agents|sequestering agents|mesh-ancestor
111244148|NCT03202446|Hemostatics|hemostatics|mesh-ancestor
111244149|NCT03202446|Coagulants|coagulants|mesh-ancestor
111244150|NCT05718934|Glycopyrrolate|glycopyrrolate|mesh-list
111244151|NCT05718934|Neostigmine|neostigmine|mesh-list
111244152|NCT05718934|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111244153|NCT05718934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111244154|NCT05718934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111244155|NCT05718934|Cholinergic Agents|cholinergic agents|mesh-ancestor
111244156|NCT05718934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111244157|NCT05718934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110823654|NCT01373684|Tenofovir|tenofovir|mesh-list
111244158|NCT05718934|Parasympathomimetics|parasympathomimetics|mesh-ancestor
111244159|NCT05718934|Autonomic Agents|autonomic agents|mesh-ancestor
111244160|NCT05718934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111244161|NCT05718934|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111244162|NCT05718934|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111244163|NCT05718934|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111244164|NCT03208764|Nitric Oxide|nitric oxide|mesh-list
111244165|NCT03208764|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111244166|NCT03208764|Autonomic Agents|autonomic agents|mesh-ancestor
111244167|NCT03208764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111244168|NCT03208764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111244169|NCT03208764|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111244170|NCT03208764|Respiratory System Agents|respiratory system agents|mesh-ancestor
111244171|NCT03208764|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111244172|NCT03208764|Antioxidants|antioxidants|mesh-ancestor
111244173|NCT03208764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111244174|NCT03208764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111244175|NCT03208764|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
111244176|NCT03208764|Vasodilator Agents|vasodilator agents|mesh-ancestor
111244177|NCT03208764|Gasotransmitters|gasotransmitters|mesh-ancestor
111244178|NCT03208764|Protective Agents|protective agents|mesh-ancestor
111244179|NCT03208998|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
111244180|NCT03208998|Antiviral Agents|antiviral agents|mesh-ancestor
111244181|NCT03208998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111244182|NCT05718310|Nitroglycerin|nitroglycerin|mesh-list
111244183|NCT05718310|Vasodilator Agents|vasodilator agents|mesh-ancestor
111244184|NCT03224208|Vemurafenib|vemurafenib|mesh-list
111244185|NCT03224208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111244186|NCT03224208|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111244187|NCT03224208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111244188|NCT03224208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111244189|NCT05718232|Lenvatinib|lenvatinib|mesh-list
111244190|NCT05718232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111244191|NCT05718232|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111244192|NCT05718232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111244193|NCT05718232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111244194|NCT00355966|Misoprostol|misoprostol|mesh-list
111244195|NCT00355966|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111244196|NCT00355966|Abortifacient Agents|abortifacient agents|mesh-ancestor
111244197|NCT00355966|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111244198|NCT00355966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111244199|NCT00355966|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111244200|NCT00355966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111244201|NCT00355966|Oxytocics|oxytocics|mesh-ancestor
111244202|NCT03208218|Lenalidomide|lenalidomide|mesh-list
111244203|NCT03208218|Immunologic Factors|immunologic factors|mesh-ancestor
111244204|NCT03208218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111244205|NCT03208218|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111244206|NCT03208218|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111244207|NCT03208218|Growth Substances|growth substances|mesh-ancestor
111244208|NCT03208218|Growth Inhibitors|growth inhibitors|mesh-ancestor
111244209|NCT03208218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111244210|NCT05372380|Atorvastatin|atorvastatin|mesh-list
111244211|NCT05372380|Ezetimibe|ezetimibe|mesh-list
111244212|NCT05372380|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111244213|NCT05372380|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111244214|NCT05372380|Antimetabolites|antimetabolites|mesh-ancestor
111244215|NCT05372380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111244216|NCT05372380|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111244217|NCT05372380|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111244218|NCT05372380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111244219|NCT02451774|Pentoxifylline|pentoxifylline|mesh-list
111244220|NCT02451774|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111244221|NCT02451774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111244222|NCT02451774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111244223|NCT02451774|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111244224|NCT02451774|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111244225|NCT02451774|Protective Agents|protective agents|mesh-ancestor
111244226|NCT02451774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111244227|NCT02451774|Vasodilator Agents|vasodilator agents|mesh-ancestor
111244228|NCT02451774|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111244229|NCT02451774|Antioxidants|antioxidants|mesh-ancestor
111244230|NCT00355576|Minocycline|minocycline|mesh-list
111244231|NCT00355576|Celecoxib|celecoxib|mesh-list
111244232|NCT00355576|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111244233|NCT00355576|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111244234|NCT00355576|Analgesics|analgesics|mesh-ancestor
111244235|NCT00355576|Sensory System Agents|sensory system agents|mesh-ancestor
111244236|NCT00355576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111244237|NCT00355576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111244238|NCT00355576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111244239|NCT00355576|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111244240|NCT00355576|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111244241|NCT00355576|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111244242|NCT00355576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111244243|NCT00355576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111244244|NCT00355576|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111244245|NCT00355576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111244246|NCT03195582|Chlorhexidine|chlorhexidine|mesh-list
111244247|NCT03195582|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
111244248|NCT03195582|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111244249|NCT03195582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111244250|NCT03195582|Disinfectants|disinfectants|mesh-ancestor
111244251|NCT03195582|Dermatologic Agents|dermatologic agents|mesh-ancestor
111244252|NCT02448264|Berotralstat|berotralstat|mesh-list
111244253|NCT02448264|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111244254|NCT02448264|Protease Inhibitors|protease inhibitors|mesh-ancestor
111244255|NCT02448264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111244256|NCT02448264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111244257|NCT02451852|Osimertinib|osimertinib|mesh-list
111244258|NCT02451852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111244259|NCT02451852|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111244260|NCT02451852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111244261|NCT02451852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111244262|NCT00421642|Adalimumab|adalimumab|mesh-list
111244263|NCT00421642|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111244264|NCT00421642|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111244265|NCT00421642|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111244267|NCT03200964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111244268|NCT03200964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111244269|NCT04484844|Listerine|listerine|mesh-list
111244270|NCT04484844|Fluorides|fluorides|mesh-list
111244271|NCT04484844|Sodium Fluoride|sodium fluoride|mesh-list
111244272|NCT04484844|Cariostatic Agents|cariostatic agents|mesh-ancestor
111244273|NCT04484844|Protective Agents|protective agents|mesh-ancestor
111244274|NCT04484844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111244275|NCT04484844|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111244276|NCT04484844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111244277|NCT03119454|Betamethasone|betamethasone|mesh-list
111244278|NCT03119454|Betamethasone dipropionate, betamethasone sodium phosphate drug combination|betamethasone dipropionate, betamethasone sodium phosphate drug combination|mesh-list
111244279|NCT03119454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111244280|NCT03119454|Glucocorticoids|glucocorticoids|mesh-ancestor
111244281|NCT03119454|Hormones|hormones|mesh-ancestor
111244282|NCT03119454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111244283|NCT03119454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111244284|NCT03119454|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111244285|NCT03119454|Respiratory System Agents|respiratory system agents|mesh-ancestor
111244286|NCT04485156|Rifampin|rifampin|mesh-list
111244287|NCT04485156|Isoniazid|isoniazid|mesh-list
111244288|NCT04485156|Pyrazinamide|pyrazinamide|mesh-list
111244289|NCT04485156|Ethambutol|ethambutol|mesh-list
111244290|NCT04485156|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111244291|NCT04485156|Antitubercular Agents|antitubercular agents|mesh-ancestor
111244292|NCT04485156|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111244293|NCT04485156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111244294|NCT04485156|Leprostatic Agents|leprostatic agents|mesh-ancestor
111244295|NCT04485156|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111244296|NCT04485156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111244297|NCT04485156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111244298|NCT04485156|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111244299|NCT04485156|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111244300|NCT04485156|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
111244301|NCT04485156|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
111244302|NCT04485156|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
111244303|NCT04485156|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111244304|NCT04485156|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
111244305|NCT04485156|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111244306|NCT04485156|Antimetabolites|antimetabolites|mesh-ancestor
111244307|NCT04485156|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111244308|NCT04637620|Sertraline|sertraline|mesh-list
111244309|NCT04637620|Antidepressive Agents|antidepressive agents|mesh-ancestor
111244310|NCT04637620|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111244311|NCT04637620|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111244312|NCT04637620|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110968613|NCT04008030|Bevacizumab|bevacizumab|mesh-list
110968614|NCT04008030|Nivolumab|nivolumab|mesh-list
110968615|NCT04008030|Cetuximab|cetuximab|mesh-list
110968616|NCT04008030|Ipilimumab|ipilimumab|mesh-list
110968617|NCT04008030|Fluorouracil|fluorouracil|mesh-list
110968618|NCT04008030|Oxaliplatin|oxaliplatin|mesh-list
110968619|NCT04008030|Irinotecan|irinotecan|mesh-list
110968620|NCT04008030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110968621|NCT04008030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110968622|NCT04008030|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110968623|NCT04008030|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110968624|NCT04008030|Growth Substances|growth substances|mesh-ancestor
110968625|NCT04008030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110968626|NCT04008030|Growth Inhibitors|growth inhibitors|mesh-ancestor
110968627|NCT04008030|Antimetabolites|antimetabolites|mesh-ancestor
110968628|NCT04008030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110968629|NCT04008030|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110968630|NCT04008030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110968631|NCT04008030|Immunologic Factors|immunologic factors|mesh-ancestor
110968632|NCT04008030|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110968633|NCT04008030|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110968634|NCT04008030|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110968635|NCT04008030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110968636|NCT04008030|Antidotes|antidotes|mesh-ancestor
110968637|NCT04008030|Protective Agents|protective agents|mesh-ancestor
111244313|NCT04637620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111244314|NCT04637620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111244315|NCT04637620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111244316|NCT04637620|Serotonin Agents|serotonin agents|mesh-ancestor
111244317|NCT04637620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111244318|NCT00355108|Tranexamic Acid|tranexamic acid|mesh-list
111244319|NCT00355108|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111244320|NCT00355108|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111244321|NCT00355108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111244322|NCT00355108|Hemostatics|hemostatics|mesh-ancestor
111244323|NCT00355108|Coagulants|coagulants|mesh-ancestor
111244324|NCT04614766|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
111244325|NCT04614766|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111244326|NCT04614766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111244327|NCT03200886|Triamcinolone|triamcinolone|mesh-list
111244328|NCT03200886|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
111244329|NCT03200886|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
111244330|NCT03200886|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
111244331|NCT03200886|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111244332|NCT03200886|Glucocorticoids|glucocorticoids|mesh-ancestor
111244333|NCT03200886|Hormones|hormones|mesh-ancestor
111244334|NCT03200886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111244335|NCT03200886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111244336|NCT03200886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111244337|NCT03200886|Immunologic Factors|immunologic factors|mesh-ancestor
111244338|NCT03200886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111244339|NCT03200886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111244340|NCT05717764|Capecitabine|capecitabine|mesh-list
111244341|NCT05717764|Mitoxantrone|mitoxantrone|mesh-list
111244342|NCT05717764|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111244343|NCT05717764|Antimetabolites|antimetabolites|mesh-ancestor
111244344|NCT05717764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111244345|NCT05717764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111244346|NCT05717764|Analgesics|analgesics|mesh-ancestor
111244347|NCT05717764|Sensory System Agents|sensory system agents|mesh-ancestor
111244348|NCT05717764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111244349|NCT05717764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111244350|NCT05717764|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111244351|NCT05717764|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111244352|NCT05717764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111244353|NCT03118830|Triptorelin Pamoate|triptorelin pamoate|mesh-list
111244354|NCT03118830|Cetrorelix|cetrorelix|mesh-list
111244355|NCT03118830|Hormones|hormones|mesh-list
111244356|NCT03118830|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
111244357|NCT03118830|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111244358|NCT03118830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111244359|NCT03118830|Luteolytic Agents|luteolytic agents|mesh-ancestor
111244360|NCT03118830|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111244361|NCT03118830|Contraceptive Agents|contraceptive agents|mesh-ancestor
111244362|NCT03118830|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111244363|NCT03118830|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111244364|NCT03118830|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111244365|NCT03118830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111244366|NCT03118830|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111244367|NCT03118830|Fertility Agents|fertility agents|mesh-ancestor
111244368|NCT03118830|Hormone Antagonists|hormone antagonists|mesh-ancestor
111244369|NCT03223506|Acetaminophen|acetaminophen|mesh-list
111244370|NCT03223506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111244371|NCT03223506|Analgesics|analgesics|mesh-ancestor
111244372|NCT03223506|Sensory System Agents|sensory system agents|mesh-ancestor
111244373|NCT03223506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111244374|NCT03223506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111244375|NCT03223506|Antipyretics|antipyretics|mesh-ancestor
111244376|NCT03223896|Naloxone|naloxone|mesh-list
111244377|NCT03223896|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111244378|NCT03223896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111244379|NCT03223896|Sensory System Agents|sensory system agents|mesh-ancestor
111244380|NCT03223896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111244381|NCT02447796|Dexmedetomidine|dexmedetomidine|mesh-list
111244382|NCT02447796|Propofol|propofol|mesh-list
111244383|NCT02447796|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111244384|NCT02447796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111244385|NCT02447796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111244386|NCT02447796|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111244387|NCT02447796|Analgesics|analgesics|mesh-ancestor
111244388|NCT02447796|Sensory System Agents|sensory system agents|mesh-ancestor
111244389|NCT02447796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111244390|NCT02447796|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111244391|NCT02447796|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111244392|NCT02447796|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111244393|NCT02447796|Adrenergic Agents|adrenergic agents|mesh-ancestor
111244394|NCT02447796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111244395|NCT02447796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111244396|NCT02447796|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111244397|NCT02447796|Anesthetics, General|anesthetics, general|mesh-ancestor
111244398|NCT02447796|Anesthetics|anesthetics|mesh-ancestor
111244399|NCT05225116|Lenvatinib|lenvatinib|mesh-list
111244400|NCT05225116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111244401|NCT05225116|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111244402|NCT05225116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111244403|NCT05225116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111244404|NCT03838042|Nivolumab|nivolumab|mesh-list
111244405|NCT03838042|Entinostat|entinostat|mesh-list
111244406|NCT03838042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111244407|NCT03838042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111244408|NCT03838042|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111244409|NCT03838042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111244410|NCT03838042|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111244411|NCT03838042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111244412|NCT03200184|Sofosbuvir|sofosbuvir|mesh-list
111244413|NCT03200184|Antiviral Agents|antiviral agents|mesh-ancestor
111244414|NCT03200184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111244415|NCT03222960|Propolis|propolis|mesh-list
111244416|NCT03222960|Fluorides|fluorides|mesh-list
111244417|NCT03222960|Cariostatic Agents|cariostatic agents|mesh-ancestor
111244418|NCT03222960|Protective Agents|protective agents|mesh-ancestor
111244419|NCT03222960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111244420|NCT03222960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111244421|NCT05681260|Cytarabine|cytarabine|mesh-list
111244422|NCT05681260|Dexamethasone|dexamethasone|mesh-list
111244423|NCT05681260|Dexamethasone acetate|dexamethasone acetate|mesh-list
111244424|NCT05681260|Prednisone|prednisone|mesh-list
111244425|NCT05681260|Cyclophosphamide|cyclophosphamide|mesh-list
111244426|NCT05681260|Ifosfamide|ifosfamide|mesh-list
111244427|NCT05681260|Doxorubicin|doxorubicin|mesh-list
111244428|NCT05681260|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111244429|NCT05681260|Methotrexate|methotrexate|mesh-list
111244430|NCT05681260|Etoposide|etoposide|mesh-list
111244431|NCT05681260|Vincristine|vincristine|mesh-list
111244432|NCT05681260|Bortezomib|bortezomib|mesh-list
111244433|NCT05681260|Daunorubicin|daunorubicin|mesh-list
111244434|NCT05681260|Asparaginase|asparaginase|mesh-list
111244435|NCT05681260|Mercaptopurine|mercaptopurine|mesh-list
111244436|NCT05681260|Vindesine|vindesine|mesh-list
111244437|NCT05681260|Pegaspargase|pegaspargase|mesh-list
111244438|NCT05681260|BB 1101|bb 1101|mesh-list
111244439|NCT05681260|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111244440|NCT05681260|Immunologic Factors|immunologic factors|mesh-ancestor
111244441|NCT05681260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111244442|NCT05681260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111244443|NCT05681260|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111244444|NCT05681260|Alkylating Agents|alkylating agents|mesh-ancestor
111244445|NCT05681260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111244446|NCT05681260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111244447|NCT05681260|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111244448|NCT05681260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111244449|NCT05681260|Antiemetics|antiemetics|mesh-ancestor
111244450|NCT05681260|Autonomic Agents|autonomic agents|mesh-ancestor
111244451|NCT05681260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111244452|NCT05681260|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111244453|NCT05681260|Glucocorticoids|glucocorticoids|mesh-ancestor
111244454|NCT05681260|Hormones|hormones|mesh-ancestor
111244455|NCT05681260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111244456|NCT05681260|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111244457|NCT05681260|Protease Inhibitors|protease inhibitors|mesh-ancestor
111244458|NCT05681260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111244459|NCT05681260|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111244460|NCT05681260|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111244461|NCT05681260|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111244462|NCT05681260|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111244463|NCT05681260|Abortifacient Agents|abortifacient agents|mesh-ancestor
111244464|NCT05681260|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111244465|NCT05681260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111244466|NCT05681260|Antimetabolites|antimetabolites|mesh-ancestor
111244467|NCT05681260|Dermatologic Agents|dermatologic agents|mesh-ancestor
111244468|NCT05681260|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111244469|NCT05681260|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111244470|NCT05681260|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111244471|NCT05681260|Antiviral Agents|antiviral agents|mesh-ancestor
111244472|NCT05681260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111244473|NCT05681260|Tubulin Modulators|tubulin modulators|mesh-ancestor
111244474|NCT05681260|Antimitotic Agents|antimitotic agents|mesh-ancestor
111244475|NCT05681260|Mitosis Modulators|mitosis modulators|mesh-ancestor
111244476|NCT03193086|Alemtuzumab|alemtuzumab|mesh-list
111244477|NCT03193086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111244478|NCT03193086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111244479|NCT03199950|Haloperidol|haloperidol|mesh-list
111244480|NCT03199950|Haloperidol decanoate|haloperidol decanoate|mesh-list
111244481|NCT03199950|Antiemetics|antiemetics|mesh-ancestor
111244482|NCT03199950|Autonomic Agents|autonomic agents|mesh-ancestor
111244483|NCT03199950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111244484|NCT03199950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111244485|NCT03199950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111244486|NCT03199950|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111244487|NCT03199950|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111244488|NCT03199950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111244489|NCT03199950|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111244490|NCT03199950|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111244491|NCT03199950|Dopamine Agents|dopamine agents|mesh-ancestor
111244492|NCT03199950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111244493|NCT03199950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111244494|NCT03199950|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111244495|NCT05156632|Aluminum Hydroxide|aluminum hydroxide|mesh-list
111244497|NCT05156632|Immunologic Factors|immunologic factors|mesh-ancestor
111244498|NCT05156632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111244499|NCT05156632|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111244500|NCT05156632|Antacids|antacids|mesh-ancestor
111244501|NCT05156632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111244502|NCT05156632|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111244503|NCT03118362|Plasma-lyte 148|plasma-lyte 148|mesh-list
111244504|NCT03118362|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
111244505|NCT03118362|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111244506|NCT02447016|Tenofovir|tenofovir|mesh-list
111244507|NCT02447016|Emtricitabine|emtricitabine|mesh-list
111244508|NCT02447016|Efavirenz|efavirenz|mesh-list
111244509|NCT02447016|Rilpivirine|rilpivirine|mesh-list
111244510|NCT02447016|Antiviral Agents|antiviral agents|mesh-ancestor
111244511|NCT02447016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111244512|NCT02447016|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111244513|NCT02447016|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111244514|NCT02447016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111244515|NCT02447016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111244516|NCT02447016|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111244517|NCT02447016|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111244518|NCT02447016|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111244519|NCT02447016|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111244520|NCT02447016|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111244521|NCT02447016|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111244522|NCT02447016|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111244523|NCT02447016|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111244524|NCT02447094|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
111244525|NCT02447094|Plasminogen|plasminogen|mesh-list
111244526|NCT02447094|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111244527|NCT02447094|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111244528|NCT02447094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111244529|NCT02446860|Nivolumab|nivolumab|mesh-list
111244530|NCT02446860|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111244531|NCT02446860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111244532|NCT02446860|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111244533|NCT02446860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111244534|NCT02449746|Immunoglobulins|immunoglobulins|mesh-list
111244535|NCT02449746|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111244536|NCT02449746|Antibodies|antibodies|mesh-list
111244537|NCT02449746|gamma-Globulins|gamma-globulins|mesh-list
111244538|NCT02449746|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
111244539|NCT02449746|Immunologic Factors|immunologic factors|mesh-ancestor
111244540|NCT02449746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111244541|NCT02446782|Clindamycin|clindamycin|mesh-list
111244542|NCT02446782|Cefazolin|cefazolin|mesh-list
111244543|NCT02446782|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111244544|NCT02446782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111244545|NCT02446782|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111244546|NCT02446782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111244547|NCT02446782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111244548|NCT04745260|Fentanyl|fentanyl|mesh-list
111244549|NCT04745260|Midazolam|midazolam|mesh-list
111244550|NCT04745260|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111244551|NCT04745260|Narcotics|narcotics|mesh-ancestor
111244552|NCT04745260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111244553|NCT04745260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111244554|NCT04745260|Analgesics|analgesics|mesh-ancestor
111244555|NCT04745260|Sensory System Agents|sensory system agents|mesh-ancestor
111244556|NCT04745260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111244557|NCT04745260|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111244558|NCT04745260|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111244559|NCT04745260|Anesthetics, General|anesthetics, general|mesh-ancestor
111244560|NCT04745260|Anesthetics|anesthetics|mesh-ancestor
111244561|NCT04745260|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111244562|NCT04745260|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111244563|NCT04745260|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111244564|NCT04745260|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111244565|NCT04745260|GABA Modulators|gaba modulators|mesh-ancestor
111244566|NCT04745260|GABA Agents|gaba agents|mesh-ancestor
111244567|NCT04745260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111244568|NCT04745260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111244569|NCT03199482|Dexamethasone|dexamethasone|mesh-list
111244570|NCT03199482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111244571|NCT03199482|Antiemetics|antiemetics|mesh-ancestor
111244572|NCT03199482|Autonomic Agents|autonomic agents|mesh-ancestor
111244573|NCT03199482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111244574|NCT03199482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111244575|NCT03199482|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111244576|NCT03199482|Glucocorticoids|glucocorticoids|mesh-ancestor
111244577|NCT03199482|Hormones|hormones|mesh-ancestor
111244578|NCT03199482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111244579|NCT03199482|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111244580|NCT03199482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111244581|NCT02446704|Temozolomide|temozolomide|mesh-list
111244582|NCT02446704|Olaparib|olaparib|mesh-list
111244583|NCT02446704|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111244584|NCT02446704|Alkylating Agents|alkylating agents|mesh-ancestor
111244585|NCT02446704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111244586|NCT02446704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111244587|NCT02446704|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111244588|NCT02446704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111244589|NCT01605227|Prednisone|prednisone|mesh-list
111244590|NCT01605227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111244591|NCT01605227|Glucocorticoids|glucocorticoids|mesh-ancestor
111244592|NCT01605227|Hormones|hormones|mesh-ancestor
111244593|NCT01605227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111244594|NCT01605227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111244595|NCT01605227|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111244596|NCT01605227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111244597|NCT02446548|Losartan|losartan|mesh-list
111244598|NCT02446548|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111244599|NCT02446548|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111244600|NCT02446548|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111244601|NCT02446548|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111244602|NCT02446548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111244603|NCT04291768|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111244604|NCT04291768|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
111244605|NCT04291768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111244606|NCT04291768|Antitubercular Agents|antitubercular agents|mesh-ancestor
111244607|NCT03199170|Morphine|morphine|mesh-list
111244608|NCT03199170|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111244609|NCT03199170|Narcotics|narcotics|mesh-ancestor
111244610|NCT03199170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111244611|NCT03199170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111244612|NCT03199170|Analgesics|analgesics|mesh-ancestor
111244613|NCT03199170|Sensory System Agents|sensory system agents|mesh-ancestor
111244614|NCT03199170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111244615|NCT03118128|Metformin|metformin|mesh-list
111244616|NCT03118128|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111244617|NCT03118128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111244618|NCT05100472|Androgens|androgens|mesh-list
111244619|NCT05100472|Hormones|hormones|mesh-ancestor
111244620|NCT05100472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111244621|NCT05100472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111244622|NCT05087914|Naproxen|naproxen|mesh-list
111244623|NCT05087914|Levodopa|levodopa|mesh-list
111244624|NCT05087914|Carbidopa|carbidopa|mesh-list
111244625|NCT05087914|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
111244626|NCT05087914|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111244627|NCT05087914|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111244628|NCT05087914|Analgesics|analgesics|mesh-ancestor
111244629|NCT05087914|Sensory System Agents|sensory system agents|mesh-ancestor
111244630|NCT05087914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111244631|NCT05087914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111244632|NCT05087914|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111244633|NCT05087914|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111244634|NCT05087914|Gout Suppressants|gout suppressants|mesh-ancestor
111244635|NCT05087914|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111244636|NCT05087914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111244637|NCT05087914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111244638|NCT05087914|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111244639|NCT05087914|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111244640|NCT05087914|Dopamine Agents|dopamine agents|mesh-ancestor
111244641|NCT05087914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111244642|NCT05087914|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
111244643|NCT05087914|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111244644|NCT05087914|Immunologic Factors|immunologic factors|mesh-ancestor
111244645|NCT05087914|Dopamine Agonists|dopamine agonists|mesh-ancestor
111244646|NCT03194724|Vitamin A|vitamin a|mesh-list
111244647|NCT03194724|Vitamins|vitamins|mesh-ancestor
111244648|NCT03194724|Micronutrients|micronutrients|mesh-ancestor
111244649|NCT03194724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111244650|NCT03198702|Botulinum Toxins|botulinum toxins|mesh-list
111244651|NCT03198702|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111244652|NCT03198702|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111244653|NCT03198702|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111244654|NCT03198702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111244655|NCT03198702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111244656|NCT03198702|Cholinergic Agents|cholinergic agents|mesh-ancestor
111244657|NCT03198702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111244658|NCT03198702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111244659|NCT03198702|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111244660|NCT03198702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111244661|NCT01709513|Atorvastatin|atorvastatin|mesh-list
111244662|NCT01709513|Ezetimibe|ezetimibe|mesh-list
111244663|NCT01709513|Alirocumab|alirocumab|mesh-list
111244664|NCT01709513|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111244665|NCT01709513|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111244666|NCT01709513|Antimetabolites|antimetabolites|mesh-ancestor
111244667|NCT01709513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111244668|NCT01709513|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111244669|NCT01709513|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111244670|NCT01709513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111244671|NCT01709513|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
111244672|NCT01709513|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111244673|NCT01709513|Protease Inhibitors|protease inhibitors|mesh-ancestor
111244674|NCT02446158|Chlorhexidine|chlorhexidine|mesh-list
111244675|NCT02446158|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
111244676|NCT02446158|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111244677|NCT02446158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111244678|NCT02446158|Disinfectants|disinfectants|mesh-ancestor
111244679|NCT02446158|Dermatologic Agents|dermatologic agents|mesh-ancestor
111244680|NCT02446002|Lofexidine|lofexidine|mesh-list
110968983|NCT03462342|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110968984|NCT03462342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110968985|NCT03462342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110968986|NCT03462342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110968987|NCT03451851|Etanercept|etanercept|mesh-list
110968988|NCT03451851|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110968989|NCT03451851|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110968990|NCT03451851|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110968991|NCT03451851|Analgesics|analgesics|mesh-ancestor
110968992|NCT03451851|Sensory System Agents|sensory system agents|mesh-ancestor
110968995|NCT03451851|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111244681|NCT02446002|Clonidine|clonidine|mesh-list
111244682|NCT02446002|Naltrexone|naltrexone|mesh-list
111244683|NCT02446002|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111244684|NCT02446002|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111244685|NCT02446002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111244686|NCT02446002|Sensory System Agents|sensory system agents|mesh-ancestor
111244687|NCT02446002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111244688|NCT02446002|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111244689|NCT02446002|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111244690|NCT02446002|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111244691|NCT02446002|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111244692|NCT02446002|Adrenergic Agents|adrenergic agents|mesh-ancestor
111244693|NCT02446002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111244694|NCT02446002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111244695|NCT02446002|Analgesics|analgesics|mesh-ancestor
111244696|NCT02446002|Sympatholytics|sympatholytics|mesh-ancestor
111244697|NCT02446002|Autonomic Agents|autonomic agents|mesh-ancestor
111244698|NCT01605071|Estradiol|estradiol|mesh-list
111244699|NCT01605071|Estrogens|estrogens|mesh-ancestor
111244700|NCT01605071|Hormones|hormones|mesh-ancestor
111244701|NCT01605071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111244702|NCT01605071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111244703|NCT04345198|Epinephrine|epinephrine|mesh-list
111244704|NCT04345198|Racepinephrine|racepinephrine|mesh-list
111244705|NCT04345198|Epinephryl borate|epinephryl borate|mesh-list
111244706|NCT04345198|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111244707|NCT04345198|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111244708|NCT04345198|Adrenergic Agents|adrenergic agents|mesh-ancestor
111244709|NCT04345198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111244710|NCT04345198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111244711|NCT04345198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111244712|NCT04345198|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111244713|NCT04345198|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111244714|NCT04345198|Autonomic Agents|autonomic agents|mesh-ancestor
111244715|NCT04345198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111244716|NCT04345198|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111244717|NCT04345198|Respiratory System Agents|respiratory system agents|mesh-ancestor
111244718|NCT04345198|Mydriatics|mydriatics|mesh-ancestor
111244719|NCT04345198|Sympathomimetics|sympathomimetics|mesh-ancestor
111244720|NCT04345198|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111244721|NCT03192618|Leucovorin|leucovorin|mesh-list
111244722|NCT03192618|Oxaliplatin|oxaliplatin|mesh-list
111244723|NCT03192618|Calcium|calcium|mesh-list
111244724|NCT03192618|Levoleucovorin|levoleucovorin|mesh-list
111244725|NCT03192618|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110824251|NCT03446456|Vasopressins|vasopressins|mesh-list
111244726|NCT03192618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111244727|NCT03192618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111244728|NCT03192618|Antidotes|antidotes|mesh-ancestor
111244729|NCT03192618|Protective Agents|protective agents|mesh-ancestor
111244730|NCT03192618|Vitamin B Complex|vitamin b complex|mesh-ancestor
111244731|NCT03192618|Vitamins|vitamins|mesh-ancestor
111244732|NCT03192618|Micronutrients|micronutrients|mesh-ancestor
111244733|NCT04113226|Rituximab|rituximab|mesh-list
111244734|NCT04113226|Lenalidomide|lenalidomide|mesh-list
111244735|NCT04113226|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111244736|NCT04113226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111244737|NCT04113226|Immunologic Factors|immunologic factors|mesh-ancestor
111244738|NCT04113226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111244739|NCT04113226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111244740|NCT04113226|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111244741|NCT04113226|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111244742|NCT04113226|Growth Substances|growth substances|mesh-ancestor
111244743|NCT04113226|Growth Inhibitors|growth inhibitors|mesh-ancestor
111244744|NCT02444364|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111244745|NCT02444364|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111244746|NCT02444364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111244747|NCT02444364|Incretins|incretins|mesh-ancestor
111244748|NCT02444364|Hormones|hormones|mesh-ancestor
110969060|NCT03390504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110969061|NCT03390504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111244749|NCT02444364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110969062|NCT03390504|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110969063|NCT03384641|Bedaquiline|bedaquiline|mesh-list
110969064|NCT03384641|Antitubercular Agents|antitubercular agents|mesh-ancestor
111244750|NCT02444364|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111244751|NCT02444364|Protease Inhibitors|protease inhibitors|mesh-ancestor
111244752|NCT02444364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111244753|NCT02444364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111244754|NCT05039476|Vitamin A|vitamin a|mesh-list
111244755|NCT05039476|Vitamins|vitamins|mesh-ancestor
111244756|NCT05039476|Micronutrients|micronutrients|mesh-ancestor
111244757|NCT05039476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111244758|NCT00356356|Etanercept|etanercept|mesh-list
111244759|NCT00356356|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111244760|NCT00356356|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111244761|NCT00356356|Analgesics|analgesics|mesh-ancestor
111244762|NCT00356356|Sensory System Agents|sensory system agents|mesh-ancestor
111244763|NCT00356356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111244764|NCT00356356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111244765|NCT00356356|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111244766|NCT00356356|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111244767|NCT00356356|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111244768|NCT00356356|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111244769|NCT00356356|Immunologic Factors|immunologic factors|mesh-ancestor
111244770|NCT02443818|Sirolimus|sirolimus|mesh-list
111244771|NCT02443818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111244772|NCT02443818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111244773|NCT02443818|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111244774|NCT02443818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111244775|NCT02443818|Antifungal Agents|antifungal agents|mesh-ancestor
111244776|NCT02443818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111244777|NCT02443818|Immunologic Factors|immunologic factors|mesh-ancestor
111244778|NCT02443818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111244779|NCT01705691|Paclitaxel|paclitaxel|mesh-list
111244780|NCT01705691|Cyclophosphamide|cyclophosphamide|mesh-list
111244781|NCT01705691|Doxorubicin|doxorubicin|mesh-list
111244782|NCT01705691|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111244783|NCT01705691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111244784|NCT01705691|Tubulin Modulators|tubulin modulators|mesh-ancestor
111244785|NCT01705691|Antimitotic Agents|antimitotic agents|mesh-ancestor
111244786|NCT01705691|Mitosis Modulators|mitosis modulators|mesh-ancestor
111244787|NCT01705691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111244788|NCT01705691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111244789|NCT01705691|Immunologic Factors|immunologic factors|mesh-ancestor
111244790|NCT01705691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111244791|NCT01705691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111244792|NCT01705691|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111244793|NCT01705691|Alkylating Agents|alkylating agents|mesh-ancestor
111244794|NCT01705691|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111244795|NCT01705691|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111244796|NCT01705691|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111244797|NCT01705691|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111244798|NCT01705691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111244799|NCT02450058|Paclitaxel|paclitaxel|mesh-list
111244800|NCT02450058|Cyclophosphamide|cyclophosphamide|mesh-list
111244801|NCT02450058|Fluorouracil|fluorouracil|mesh-list
111244802|NCT02450058|Epirubicin|epirubicin|mesh-list
111244803|NCT02450058|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111244804|NCT02450058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111244805|NCT02450058|Tubulin Modulators|tubulin modulators|mesh-ancestor
111244806|NCT02450058|Antimitotic Agents|antimitotic agents|mesh-ancestor
111244807|NCT02450058|Mitosis Modulators|mitosis modulators|mesh-ancestor
111244808|NCT02450058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111244809|NCT02450058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111244810|NCT02450058|Immunologic Factors|immunologic factors|mesh-ancestor
111244811|NCT02450058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111244812|NCT02450058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111244813|NCT02450058|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111244814|NCT02450058|Alkylating Agents|alkylating agents|mesh-ancestor
111244815|NCT02450058|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111244816|NCT02450058|Antimetabolites|antimetabolites|mesh-ancestor
111244817|NCT02450058|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111244818|NCT02450058|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111244819|NCT02450058|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111244820|NCT02450058|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111244821|NCT02450058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111244822|NCT02445300|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
111244823|NCT02445300|Laxatives|laxatives|mesh-ancestor
111244824|NCT02445300|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111244825|NCT02445066|Vitamin D|vitamin d|mesh-list
111244826|NCT02445066|Cholecalciferol|cholecalciferol|mesh-list
111244827|NCT02445066|Vitamins|vitamins|mesh-ancestor
111244828|NCT02445066|Micronutrients|micronutrients|mesh-ancestor
110969133|NCT03227419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111244829|NCT02445066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111244830|NCT02445066|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111244831|NCT02445066|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111244832|NCT03197298|Clopidogrel|clopidogrel|mesh-list
111244833|NCT03197298|Ticagrelor|ticagrelor|mesh-list
111244834|NCT03197298|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111244835|NCT03197298|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111244836|NCT03197298|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111244837|NCT03197298|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111244838|NCT03197298|Purinergic Agents|purinergic agents|mesh-ancestor
111244839|NCT03197298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111244840|NCT03197298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111244841|NCT03197298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111244842|NCT00357448|Interleukin-2|interleukin-2|mesh-list
111244843|NCT00357448|Denileukin diftitox|denileukin diftitox|mesh-list
111244844|NCT00357448|Immunotoxins|immunotoxins|mesh-list
111244845|NCT00357448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111244846|NCT00357448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111244847|NCT00357448|Analgesics|analgesics|mesh-ancestor
111244848|NCT00357448|Sensory System Agents|sensory system agents|mesh-ancestor
111244849|NCT00357448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111244850|NCT00357448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111244851|NCT00357448|Immunoconjugates|immunoconjugates|mesh-ancestor
111244852|NCT00357448|Immunologic Factors|immunologic factors|mesh-ancestor
111244853|NCT05715658|Dabigatran|dabigatran|mesh-list
111244854|NCT05715658|Antithrombins|antithrombins|mesh-ancestor
111244855|NCT05715658|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111244856|NCT05715658|Protease Inhibitors|protease inhibitors|mesh-ancestor
111244857|NCT05715658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111244858|NCT05715658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111244859|NCT05715658|Anticoagulants|anticoagulants|mesh-ancestor
111244860|NCT02443194|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
111244861|NCT02443194|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111244862|NCT02443194|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111244863|NCT02443194|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111244864|NCT02443194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111244865|NCT02443194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111244866|NCT02443194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111244867|NCT02443194|Analgesics|analgesics|mesh-ancestor
111244868|NCT02443194|Sensory System Agents|sensory system agents|mesh-ancestor
111244869|NCT02443194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111244870|NCT02443194|Antidepressive Agents|antidepressive agents|mesh-ancestor
111244871|NCT02443194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111244872|NCT02443194|Dopamine Agents|dopamine agents|mesh-ancestor
111244873|NCT03193944|Vitamin D|vitamin d|mesh-list
111244874|NCT03193944|Ergocalciferols|ergocalciferols|mesh-list
111244875|NCT03193944|Cholecalciferol|cholecalciferol|mesh-list
111244876|NCT03193944|Vitamins|vitamins|mesh-list
111244877|NCT03193944|Micronutrients|micronutrients|mesh-ancestor
111244878|NCT03193944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111244879|NCT03193944|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111244880|NCT03193944|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111244881|NCT00357604|Ritonavir|ritonavir|mesh-list
111244882|NCT00357604|Atazanavir Sulfate|atazanavir sulfate|mesh-list
111244883|NCT00357604|Moxifloxacin|moxifloxacin|mesh-list
111244884|NCT00357604|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
111244885|NCT00357604|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
111244886|NCT00357604|Ethinyl Estradiol|ethinyl estradiol|mesh-list
111244887|NCT00357604|Norgestimate|norgestimate|mesh-list
111244888|NCT00357604|Norgestrel|norgestrel|mesh-list
111244889|NCT00357604|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
111244890|NCT00357604|Estradiol|estradiol|mesh-list
111244891|NCT00357604|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
111244892|NCT00357604|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111244893|NCT00357604|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111244894|NCT00357604|Protease Inhibitors|protease inhibitors|mesh-ancestor
111244895|NCT00357604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111244896|NCT00357604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111244897|NCT00357604|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111244898|NCT00357604|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111244899|NCT00357604|Antiviral Agents|antiviral agents|mesh-ancestor
111244900|NCT00357604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111244901|NCT00357604|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111244902|NCT00357604|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111244903|NCT00357604|Estrogens|estrogens|mesh-ancestor
111244904|NCT00357604|Hormones|hormones|mesh-ancestor
111244905|NCT00357604|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111244906|NCT00357604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111244907|NCT00357604|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111244908|NCT00357604|Contraceptive Agents|contraceptive agents|mesh-ancestor
111244909|NCT00357604|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111244910|NCT00357604|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111244911|NCT00357604|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111244912|NCT00357604|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111244913|NCT00357604|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111244914|NCT00357604|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
111244915|NCT00357604|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111244916|NCT00357604|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111244917|NCT00357604|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111244918|NCT00357604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111244919|NCT03193788|Folic Acid|folic acid|mesh-list
111244920|NCT03193788|Vitamin B 12|vitamin b 12|mesh-list
111244921|NCT03193788|Dexamethasone|dexamethasone|mesh-list
111244922|NCT03193788|Pemetrexed|pemetrexed|mesh-list
111244923|NCT03193788|Vitamins|vitamins|mesh-ancestor
111244924|NCT03193788|Micronutrients|micronutrients|mesh-ancestor
111244925|NCT03193788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111244926|NCT03193788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111244927|NCT03193788|Antiemetics|antiemetics|mesh-ancestor
111244928|NCT03193788|Autonomic Agents|autonomic agents|mesh-ancestor
111244929|NCT03193788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111244930|NCT03193788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111244931|NCT03193788|Glucocorticoids|glucocorticoids|mesh-ancestor
111244932|NCT03193788|Hormones|hormones|mesh-ancestor
111244933|NCT03193788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111244934|NCT03193788|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111244935|NCT03193788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111244936|NCT03193788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111244937|NCT03193788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111244938|NCT03193788|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111244939|NCT03193788|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111244940|NCT03193788|Hematinics|hematinics|mesh-ancestor
111244941|NCT03193788|Vitamin B Complex|vitamin b complex|mesh-ancestor
111244942|NCT02442648|Rituximab|rituximab|mesh-list
111244943|NCT02442648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111244944|NCT02442648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111244945|NCT02442648|Immunologic Factors|immunologic factors|mesh-ancestor
111244946|NCT02442648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111244947|NCT02442648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111244948|NCT00356824|Artesunate|artesunate|mesh-list
111244949|NCT00356824|Amodiaquine|amodiaquine|mesh-list
111244950|NCT00356824|Antimalarials|antimalarials|mesh-ancestor
111244951|NCT00356824|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111244952|NCT00356824|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111244953|NCT00356824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111244954|NCT00356824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111244955|NCT00356824|Antiviral Agents|antiviral agents|mesh-ancestor
111244956|NCT00356824|Schistosomicides|schistosomicides|mesh-ancestor
111244957|NCT00356824|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
111244958|NCT00356824|Anthelmintics|anthelmintics|mesh-ancestor
111244959|NCT01705145|Ivacaftor|ivacaftor|mesh-list
111244960|NCT01705145|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
111244961|NCT01705145|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111244962|NCT01705145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111244963|NCT03716934|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
111244964|NCT04483830|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
111244965|NCT04483830|Anticoagulants|anticoagulants|mesh-ancestor
111244966|NCT04483830|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111244967|NCT04483830|Antimetabolites|antimetabolites|mesh-ancestor
111244968|NCT04483830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111244969|NCT04483830|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111244970|NCT04483830|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111244971|NCT04483830|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111244972|NCT04483830|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111244973|NCT04483830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111244974|NCT02442492|Sildenafil Citrate|sildenafil citrate|mesh-list
111244975|NCT02442492|Vasodilator Agents|vasodilator agents|mesh-ancestor
111244976|NCT02442492|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111244977|NCT02442492|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110969289|NCT02915263|Immunoglobulins|immunoglobulins|mesh-list
111244978|NCT02442492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111244979|NCT02442492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111244980|NCT02442492|Urological Agents|urological agents|mesh-ancestor
111244982|NCT01704755|Antimetabolites|antimetabolites|mesh-ancestor
111244983|NCT01704755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111244984|NCT01704755|Antiviral Agents|antiviral agents|mesh-ancestor
111244985|NCT01704755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111244986|NCT05165550|Elsulfavirine|elsulfavirine|mesh-list
111244987|NCT05165550|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111244988|NCT05165550|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111244989|NCT05165550|Antiviral Agents|antiviral agents|mesh-ancestor
111244990|NCT05165550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111244991|NCT04166669|Itraconazole|itraconazole|mesh-list
111244992|NCT04166669|Rifampin|rifampin|mesh-list
111244993|NCT04166669|Antifungal Agents|antifungal agents|mesh-ancestor
111244994|NCT04166669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111244995|NCT04166669|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111244996|NCT04166669|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111244997|NCT04166669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111244998|NCT04166669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111244999|NCT04166669|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111245000|NCT04166669|Hormone Antagonists|hormone antagonists|mesh-ancestor
111245001|NCT04166669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111245002|NCT04166669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111245003|NCT04166669|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111245004|NCT04166669|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111245005|NCT04166669|Antitubercular Agents|antitubercular agents|mesh-ancestor
111245006|NCT04166669|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111245007|NCT04166669|Leprostatic Agents|leprostatic agents|mesh-ancestor
111245008|NCT04166669|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111245009|NCT04166669|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111245010|NCT04166669|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111245011|NCT04166669|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
111245012|NCT04166669|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
111245013|NCT04166669|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
111245014|NCT04166669|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111245015|NCT03193710|Remifentanil|remifentanil|mesh-list
111245016|NCT03193710|Propofol|propofol|mesh-list
111245017|NCT03193710|Sevoflurane|sevoflurane|mesh-list
111245018|NCT03193710|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111245019|NCT03193710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111245020|NCT03193710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111245021|NCT03193710|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111245022|NCT03193710|Anesthetics, General|anesthetics, general|mesh-ancestor
111245023|NCT03193710|Anesthetics|anesthetics|mesh-ancestor
111245024|NCT03193710|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111245025|NCT03193710|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111245026|NCT03193710|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111245027|NCT03193710|Narcotics|narcotics|mesh-ancestor
111245028|NCT03193710|Analgesics|analgesics|mesh-ancestor
111245029|NCT03193710|Sensory System Agents|sensory system agents|mesh-ancestor
111245030|NCT03193710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111245031|NCT01704599|Vitamins|vitamins|mesh-list
111245032|NCT01704599|Folic Acid|folic acid|mesh-list
111245033|NCT01704599|Vitamin B 12|vitamin b 12|mesh-list
111245034|NCT01704599|Pyridoxine|pyridoxine|mesh-list
111245035|NCT01704599|Vitamin B 6|vitamin b 6|mesh-list
111245036|NCT01704599|Vitamin B Complex|vitamin b complex|mesh-list
111245037|NCT01704599|Adalimumab|adalimumab|mesh-list
111245038|NCT01704599|Micronutrients|micronutrients|mesh-ancestor
111245039|NCT01704599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111245040|NCT01704599|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111245041|NCT01704599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111245042|NCT01704599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111245043|NCT01704599|Hematinics|hematinics|mesh-ancestor
111245044|NCT03196362|Metformin|metformin|mesh-list
111245045|NCT03196362|Pioglitazone|pioglitazone|mesh-list
111245046|NCT03196362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111245047|NCT03196362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111245048|NCT02449278|Prednisone|prednisone|mesh-list
111245049|NCT02449278|Cyclophosphamide|cyclophosphamide|mesh-list
111245050|NCT02449278|Doxorubicin|doxorubicin|mesh-list
111245051|NCT02449278|Vincristine|vincristine|mesh-list
111245052|NCT02449278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111245053|NCT02449278|Immunologic Factors|immunologic factors|mesh-ancestor
111245054|NCT02449278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111245055|NCT02449278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111245056|NCT02449278|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111245057|NCT02449278|Alkylating Agents|alkylating agents|mesh-ancestor
111245058|NCT02449278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111245059|NCT02449278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111245060|NCT02449278|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111245061|NCT02449278|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111245062|NCT02449278|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111245063|NCT02449278|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111245064|NCT02449278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111245065|NCT02449278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111245066|NCT02449278|Glucocorticoids|glucocorticoids|mesh-ancestor
111245067|NCT02449278|Hormones|hormones|mesh-ancestor
111245068|NCT02449278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111245069|NCT02449278|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111245070|NCT02449278|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111245071|NCT02449278|Tubulin Modulators|tubulin modulators|mesh-ancestor
111245072|NCT02449278|Antimitotic Agents|antimitotic agents|mesh-ancestor
111245073|NCT02449278|Mitosis Modulators|mitosis modulators|mesh-ancestor
111245074|NCT03599518|Gefitinib|gefitinib|mesh-list
111245075|NCT03599518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111245076|NCT03599518|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111245077|NCT03599518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111245078|NCT03599518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111245079|NCT03099486|Leucovorin|leucovorin|mesh-list
111245080|NCT03099486|Antidotes|antidotes|mesh-ancestor
111245081|NCT03099486|Protective Agents|protective agents|mesh-ancestor
111245082|NCT03099486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111245083|NCT03099486|Vitamin B Complex|vitamin b complex|mesh-ancestor
111245084|NCT03099486|Vitamins|vitamins|mesh-ancestor
111245085|NCT03099486|Micronutrients|micronutrients|mesh-ancestor
111245086|NCT00358228|Rimonabant|rimonabant|mesh-list
111245087|NCT00358228|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111245088|NCT00358228|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
111245089|NCT00358228|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
111245090|NCT00358228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111245091|NCT00358228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111245092|NCT00358228|Hormones|hormones|mesh-ancestor
111245093|NCT00358228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111245094|NCT00358228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111245095|NCT05710198|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
111245096|NCT05710198|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111245097|NCT05710198|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111245098|NCT05710198|Nootropic Agents|nootropic agents|mesh-ancestor
111245099|NCT05709028|Fosfomycin|fosfomycin|mesh-list
111245100|NCT05709028|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111245101|NCT05709028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111245102|NCT01336530|Oxethazaine|oxethazaine|mesh-list
111245103|NCT01336530|Aluminum Hydroxide|aluminum hydroxide|mesh-list
111245104|NCT01336530|Antacids|antacids|mesh-list
111245105|NCT01336530|Magnesium Hydroxide|magnesium hydroxide|mesh-list
111245106|NCT01336530|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111245107|NCT01336530|Immunologic Factors|immunologic factors|mesh-ancestor
111245108|NCT01336530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111245109|NCT01336530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111245110|NCT01336530|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111245111|NCT01336530|Anesthetics, Local|anesthetics, local|mesh-ancestor
111245112|NCT01336530|Anesthetics|anesthetics|mesh-ancestor
111245113|NCT01336530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111245114|NCT01336530|Sensory System Agents|sensory system agents|mesh-ancestor
111245115|NCT01336530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111245116|NCT00777348|Reproterol|reproterol|mesh-list
111245117|NCT00777348|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111245118|NCT00777348|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111245119|NCT00777348|Adrenergic Agents|adrenergic agents|mesh-ancestor
111245120|NCT00777348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111245121|NCT00777348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111245122|NCT00777348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111245123|NCT00777348|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111245124|NCT00777348|Autonomic Agents|autonomic agents|mesh-ancestor
111245125|NCT00777348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111245126|NCT00777348|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111245127|NCT00777348|Respiratory System Agents|respiratory system agents|mesh-ancestor
111245128|NCT03836560|Nicotine|nicotine|mesh-list
111245129|NCT03836560|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111245130|NCT03836560|Autonomic Agents|autonomic agents|mesh-ancestor
111245131|NCT03836560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111245132|NCT03836560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111245133|NCT03836560|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111245134|NCT03836560|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111245135|NCT03836560|Cholinergic Agents|cholinergic agents|mesh-ancestor
111245136|NCT03836560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111245137|NCT03836560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111245138|NCT04483596|Melatonin|melatonin|mesh-list
111245139|NCT04483596|Antioxidants|antioxidants|mesh-ancestor
111245140|NCT04483596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111245141|NCT04483596|Protective Agents|protective agents|mesh-ancestor
111245142|NCT04483596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111245143|NCT04483596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111245144|NCT05721586|Listerine|listerine|mesh-list
111245145|NCT05721586|Fluorides|fluorides|mesh-list
111245146|NCT05721586|Fluorides, Topical|fluorides, topical|mesh-list
111245147|NCT05721586|Sodium Fluoride|sodium fluoride|mesh-list
111245148|NCT05721586|Cariostatic Agents|cariostatic agents|mesh-ancestor
111245149|NCT05721586|Protective Agents|protective agents|mesh-ancestor
111245150|NCT05721586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111245151|NCT05721586|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111245152|NCT05721586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111245153|NCT02978482|Durvalumab|durvalumab|mesh-list
111245154|NCT02978482|Tremelimumab|tremelimumab|mesh-list
111245155|NCT02978482|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111245156|NCT02978482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111245157|NCT02978482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111245158|NCT02978482|Immunologic Factors|immunologic factors|mesh-ancestor
111245159|NCT02978482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111245160|NCT00357682|Aspirin|aspirin|mesh-list
111245161|NCT00357682|Esomeprazole|esomeprazole|mesh-list
111245162|NCT00357682|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111245163|NCT00357682|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111245164|NCT00357682|Analgesics|analgesics|mesh-ancestor
111245165|NCT00357682|Sensory System Agents|sensory system agents|mesh-ancestor
111245166|NCT00357682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111245167|NCT00357682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111245168|NCT00357682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111245169|NCT00357682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111245170|NCT00357682|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111245171|NCT00357682|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111245172|NCT00357682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111245173|NCT00357682|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111245174|NCT00357682|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111245175|NCT00357682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111245176|NCT00357682|Antipyretics|antipyretics|mesh-ancestor
111245177|NCT00357682|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111245178|NCT00357682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111245179|NCT00357682|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111245180|NCT00105027|Triamcinolone|triamcinolone|mesh-list
111245181|NCT00105027|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
111245182|NCT00105027|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
111245183|NCT00105027|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
111245184|NCT00105027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111245185|NCT00105027|Glucocorticoids|glucocorticoids|mesh-ancestor
111245186|NCT00105027|Hormones|hormones|mesh-ancestor
111245187|NCT00105027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111245188|NCT00105027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111245189|NCT00105027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111245190|NCT00105027|Immunologic Factors|immunologic factors|mesh-ancestor
111245191|NCT00105027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111245192|NCT00105027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111245193|NCT03145012|Ranitidine|ranitidine|mesh-list
111245194|NCT03145012|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
111245195|NCT03145012|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111245196|NCT03145012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111245197|NCT03145012|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
111245198|NCT03145012|Histamine Antagonists|histamine antagonists|mesh-ancestor
111245199|NCT03145012|Histamine Agents|histamine agents|mesh-ancestor
111245200|NCT03145012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111245201|NCT03145012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111245202|NCT03145012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111245203|NCT03832660|Valsartan|valsartan|mesh-list
111245204|NCT03832660|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
110969509|NCT02123758|Prednisone|prednisone|mesh-list
111245205|NCT03832660|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111245206|NCT03832660|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111245207|NCT03832660|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111245208|NCT03832660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111245209|NCT00030147|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
111245211|NCT00030147|Estrogens|estrogens|mesh-ancestor
111245212|NCT00030147|Hormones|hormones|mesh-ancestor
111245213|NCT00030147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111245214|NCT00030147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111245215|NCT00030147|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111245216|NCT00030147|Hormone Antagonists|hormone antagonists|mesh-ancestor
111245217|NCT00030147|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111245218|NCT00030147|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111245219|NCT00030147|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111245220|NCT02709486|Tanezumab|tanezumab|mesh-list
111245221|NCT02709486|Analgesics|analgesics|mesh-ancestor
111245222|NCT02709486|Sensory System Agents|sensory system agents|mesh-ancestor
111245223|NCT02709486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111245224|NCT02709486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111245225|NCT00106431|Romidepsin|romidepsin|mesh-list
111245226|NCT00106431|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111245227|NCT00106431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111245228|NCT00106431|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111245229|NCT00106431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111245230|NCT00106431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111245231|NCT03107416|Bumetanide|bumetanide|mesh-list
111245232|NCT03107416|Diuretics|diuretics|mesh-ancestor
111245233|NCT03107416|Natriuretic Agents|natriuretic agents|mesh-ancestor
111245234|NCT03107416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111245235|NCT03107416|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
111245236|NCT03107416|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111245237|NCT03107416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111245238|NCT02439996|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111245239|NCT02439996|gamma-Globulins|gamma-globulins|mesh-list
111245240|NCT02439996|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
111245241|NCT02439996|Immunologic Factors|immunologic factors|mesh-ancestor
111245242|NCT02439996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111245243|NCT03833596|Prednisone|prednisone|mesh-list
111245244|NCT03833596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111245245|NCT03833596|Glucocorticoids|glucocorticoids|mesh-ancestor
111245246|NCT03833596|Hormones|hormones|mesh-ancestor
111245247|NCT03833596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111245248|NCT03833596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111245249|NCT03833596|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111245250|NCT03833596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111245251|NCT02831998|Ethanol|ethanol|mesh-list
111245252|NCT02831998|Chlorhexidine|chlorhexidine|mesh-list
111245253|NCT02831998|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
111245254|NCT02831998|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111245255|NCT02831998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111245256|NCT02831998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111245257|NCT02831998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111245258|NCT02831998|Disinfectants|disinfectants|mesh-ancestor
111245259|NCT02831998|Dermatologic Agents|dermatologic agents|mesh-ancestor
111245260|NCT02434614|Cisplatin|cisplatin|mesh-list
111245261|NCT02434614|Docetaxel|docetaxel|mesh-list
111245262|NCT02434614|Fluorouracil|fluorouracil|mesh-list
111245263|NCT02434614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111245264|NCT02434614|Tubulin Modulators|tubulin modulators|mesh-ancestor
111245265|NCT02434614|Antimitotic Agents|antimitotic agents|mesh-ancestor
111245266|NCT02434614|Mitosis Modulators|mitosis modulators|mesh-ancestor
111245267|NCT02434614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111245268|NCT02434614|Antimetabolites|antimetabolites|mesh-ancestor
111245269|NCT02434614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111245270|NCT02434614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111245271|NCT02434614|Immunologic Factors|immunologic factors|mesh-ancestor
111245272|NCT02434614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111245273|NCT05720260|Durvalumab|durvalumab|mesh-list
111245274|NCT05720260|Fulvestrant|fulvestrant|mesh-list
111245275|NCT05720260|Goserelin|goserelin|mesh-list
111245276|NCT05720260|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111245277|NCT05720260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111245278|NCT05720260|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111245279|NCT05720260|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
111245280|NCT05720260|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111245281|NCT05720260|Hormone Antagonists|hormone antagonists|mesh-ancestor
111245282|NCT05720260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111245283|NCT05720260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111245284|NCT05720026|Docetaxel|docetaxel|mesh-list
111245285|NCT05720026|Trastuzumab|trastuzumab|mesh-list
111245286|NCT05720026|Pertuzumab|pertuzumab|mesh-list
111245287|NCT05720026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111245288|NCT05720026|Tubulin Modulators|tubulin modulators|mesh-ancestor
111245289|NCT05720026|Antimitotic Agents|antimitotic agents|mesh-ancestor
111245290|NCT05720026|Mitosis Modulators|mitosis modulators|mesh-ancestor
111245291|NCT05720026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111245292|NCT05720026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111245293|NCT04483674|Tenofovir|tenofovir|mesh-list
111245294|NCT04483674|Emtricitabine|emtricitabine|mesh-list
111245295|NCT04483674|Antiviral Agents|antiviral agents|mesh-ancestor
111245296|NCT04483674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111245297|NCT04483674|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111245298|NCT04483674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111245299|NCT04483674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111245300|NCT04483674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111245301|NCT04483674|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111245302|NCT04483674|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111245303|NCT02438982|Rituximab|rituximab|mesh-list
111245304|NCT02438982|Tacrolimus|tacrolimus|mesh-list
111245305|NCT02438982|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
111245306|NCT02438982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111245307|NCT02438982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111245308|NCT02438982|Immunologic Factors|immunologic factors|mesh-ancestor
111245309|NCT02438982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111245310|NCT02438982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111245311|NCT02438982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111245312|NCT02438982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111245313|NCT02438982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111245314|NCT02425774|Prucalopride|prucalopride|mesh-list
111245315|NCT02425774|Laxatives|laxatives|mesh-ancestor
111245316|NCT02425774|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111245317|NCT02425774|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
111245318|NCT02425774|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111245319|NCT02425774|Serotonin Agents|serotonin agents|mesh-ancestor
111245320|NCT02425774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111245321|NCT02425774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111245322|NCT02425774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111245323|NCT02420002|Nitrous Oxide|nitrous oxide|mesh-list
111245324|NCT02420002|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111245325|NCT02420002|Anesthetics, General|anesthetics, general|mesh-ancestor
111245326|NCT02420002|Anesthetics|anesthetics|mesh-ancestor
111245327|NCT02420002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111245328|NCT02420002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111245329|NCT02420002|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111245330|NCT02420002|Analgesics|analgesics|mesh-ancestor
111245331|NCT02420002|Sensory System Agents|sensory system agents|mesh-ancestor
111245332|NCT02420002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111245333|NCT03187626|Botulinum Toxins|botulinum toxins|mesh-list
111245334|NCT03187626|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111245335|NCT03187626|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111245336|NCT03187626|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111245337|NCT03187626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111245338|NCT03187626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111245339|NCT03187626|Cholinergic Agents|cholinergic agents|mesh-ancestor
111245340|NCT03187626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111245341|NCT03187626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111245342|NCT03187626|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111245343|NCT03187626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111245344|NCT03117894|Acetaminophen|acetaminophen|mesh-list
111245345|NCT03117894|Etoricoxib|etoricoxib|mesh-list
111245346|NCT03117894|Morphine|morphine|mesh-list
111245347|NCT03117894|Remifentanil|remifentanil|mesh-list
111245348|NCT03117894|Ondansetron|ondansetron|mesh-list
111245349|NCT03117894|Propofol|propofol|mesh-list
111245350|NCT03117894|Ropivacaine|ropivacaine|mesh-list
111245351|NCT03117894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111245352|NCT03117894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111245353|NCT03117894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111245354|NCT03117894|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111245355|NCT03117894|Anesthetics, General|anesthetics, general|mesh-ancestor
111245356|NCT03117894|Anesthetics|anesthetics|mesh-ancestor
111245357|NCT03117894|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111245358|NCT03117894|Narcotics|narcotics|mesh-ancestor
111245359|NCT03117894|Analgesics|analgesics|mesh-ancestor
111245360|NCT03117894|Sensory System Agents|sensory system agents|mesh-ancestor
111245361|NCT03117894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111245362|NCT03117894|Anesthetics, Local|anesthetics, local|mesh-ancestor
111245363|NCT03117894|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111245364|NCT03117894|Antipyretics|antipyretics|mesh-ancestor
111245365|NCT03117894|Antiemetics|antiemetics|mesh-ancestor
111245366|NCT03117894|Autonomic Agents|autonomic agents|mesh-ancestor
111245367|NCT03117894|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111245368|NCT03117894|Antipruritics|antipruritics|mesh-ancestor
111245369|NCT03117894|Dermatologic Agents|dermatologic agents|mesh-ancestor
111245370|NCT03117894|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111245371|NCT03117894|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111245372|NCT03117894|Serotonin Agents|serotonin agents|mesh-ancestor
111245373|NCT03117894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111245374|NCT03117894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111245375|NCT03117894|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111245376|NCT03117894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111245377|NCT03117894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111245378|NCT03117894|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111245379|NCT03117894|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111245380|NCT03117894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111245381|NCT00357292|Azithromycin|azithromycin|mesh-list
111245382|NCT00357292|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111245383|NCT00357292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111245384|NCT05625802|Ropivacaine|ropivacaine|mesh-list
111245385|NCT05625802|Anesthetics, Local|anesthetics, local|mesh-ancestor
111245386|NCT05625802|Anesthetics|anesthetics|mesh-ancestor
111245387|NCT05625802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111245388|NCT05625802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111245389|NCT05625802|Sensory System Agents|sensory system agents|mesh-ancestor
111245390|NCT05625802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111245391|NCT03187548|Calcium|calcium|mesh-list
111245392|NCT03187548|Caseins|caseins|mesh-list
111245393|NCT03187548|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111245394|NCT03187548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111245395|NCT03187548|Chelating Agents|chelating agents|mesh-ancestor
111245396|NCT03187548|Sequestering Agents|sequestering agents|mesh-ancestor
111245397|NCT03187548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111245398|NCT02042326|Sirolimus|sirolimus|mesh-list
111245399|NCT02042326|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111245400|NCT02042326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111245401|NCT02042326|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111245402|NCT02042326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111245403|NCT02042326|Antifungal Agents|antifungal agents|mesh-ancestor
111245404|NCT02042326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111245405|NCT02042326|Immunologic Factors|immunologic factors|mesh-ancestor
111245406|NCT02042326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111245407|NCT05718544|Sufentanil|sufentanil|mesh-list
111245408|NCT05718544|Dexmedetomidine|dexmedetomidine|mesh-list
111245409|NCT05718544|Esketamine|esketamine|mesh-list
111245410|NCT05718544|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111245411|NCT05718544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111245412|NCT05718544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111245413|NCT05718544|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111245414|NCT05718544|Analgesics|analgesics|mesh-ancestor
111245415|NCT05718544|Sensory System Agents|sensory system agents|mesh-ancestor
111245416|NCT05718544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111245417|NCT05718544|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111245418|NCT05718544|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111245419|NCT05718544|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111245420|NCT05718544|Adrenergic Agents|adrenergic agents|mesh-ancestor
111245421|NCT05718544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111245422|NCT05718544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111245423|NCT05718544|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111245424|NCT05718544|Narcotics|narcotics|mesh-ancestor
111245425|NCT05718544|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111245426|NCT05718544|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111245427|NCT05718544|Anesthetics, General|anesthetics, general|mesh-ancestor
111245428|NCT05718544|Anesthetics|anesthetics|mesh-ancestor
111245429|NCT05718544|Antidepressive Agents|antidepressive agents|mesh-ancestor
111245430|NCT05718544|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111245431|NCT05616598|Ribavirin|ribavirin|mesh-list
111245432|NCT05616598|Sofosbuvir|sofosbuvir|mesh-list
111245433|NCT05616598|Simeprevir|simeprevir|mesh-list
111245434|NCT05616598|Antimetabolites|antimetabolites|mesh-ancestor
111245435|NCT05616598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111245436|NCT05616598|Antiviral Agents|antiviral agents|mesh-ancestor
111245437|NCT05616598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111245438|NCT05616598|Protease Inhibitors|protease inhibitors|mesh-ancestor
111245439|NCT05616598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111245440|NCT03187392|Lidocaine|lidocaine|mesh-list
111245441|NCT03187392|Anesthetics, Local|anesthetics, local|mesh-ancestor
111245442|NCT03187392|Anesthetics|anesthetics|mesh-ancestor
111245443|NCT03187392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111245444|NCT03187392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111245445|NCT03187392|Sensory System Agents|sensory system agents|mesh-ancestor
111245446|NCT03187392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111245447|NCT03187392|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111245448|NCT03187392|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111245449|NCT03187392|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111245450|NCT03187392|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111245451|NCT03187392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111245452|NCT01464268|Riboflavin|riboflavin|mesh-list
111245453|NCT01464268|Dextrans|dextrans|mesh-list
111245454|NCT01464268|Vitamin B Complex|vitamin b complex|mesh-ancestor
111245455|NCT01464268|Vitamins|vitamins|mesh-ancestor
111245456|NCT01464268|Micronutrients|micronutrients|mesh-ancestor
111245457|NCT01464268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111245458|NCT01464268|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111245459|NCT01464268|Dermatologic Agents|dermatologic agents|mesh-ancestor
111245460|NCT01464268|Anticoagulants|anticoagulants|mesh-ancestor
111245461|NCT01464268|Plasma Substitutes|plasma substitutes|mesh-ancestor
111245462|NCT01464268|Blood Substitutes|blood substitutes|mesh-ancestor
111245463|NCT00215787|Lansoprazole|lansoprazole|mesh-list
111245464|NCT00215787|Dexlansoprazole|dexlansoprazole|mesh-list
111245465|NCT00215787|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111245466|NCT00215787|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111245467|NCT00215787|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111245468|NCT00215787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111245469|NCT00215787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111245470|NCT05716906|Melatonin|melatonin|mesh-list
111245471|NCT05716906|Antioxidants|antioxidants|mesh-ancestor
111245472|NCT05716906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111245473|NCT05716906|Protective Agents|protective agents|mesh-ancestor
111245474|NCT05716906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111245475|NCT05716906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111245476|NCT00216099|Folic Acid|folic acid|mesh-list
111245477|NCT00216099|Vitamin B 12|vitamin b 12|mesh-list
111245478|NCT00216099|Hydroxocobalamin|hydroxocobalamin|mesh-list
111245479|NCT00216099|Pemetrexed|pemetrexed|mesh-list
111245480|NCT00216099|Vitamins|vitamins|mesh-ancestor
111245481|NCT00216099|Micronutrients|micronutrients|mesh-ancestor
111245482|NCT00216099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111245483|NCT00216099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111245484|NCT00216099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111245485|NCT00216099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111245486|NCT00216099|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111245487|NCT00216099|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111245488|NCT00216099|Hematinics|hematinics|mesh-ancestor
111245489|NCT00216099|Vitamin B Complex|vitamin b complex|mesh-ancestor
111245490|NCT04565925|Sildenafil Citrate|sildenafil citrate|mesh-list
111245491|NCT04565925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111245492|NCT04565925|Vasodilator Agents|vasodilator agents|mesh-ancestor
111245493|NCT04565925|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111245494|NCT04565925|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111245495|NCT04565925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111245496|NCT04565925|Urological Agents|urological agents|mesh-ancestor
111245497|NCT00039195|Prednisone|prednisone|mesh-list
111245498|NCT00039195|Cyclophosphamide|cyclophosphamide|mesh-list
111245499|NCT00039195|Ifosfamide|ifosfamide|mesh-list
111245500|NCT00039195|Rituximab|rituximab|mesh-list
111245501|NCT00039195|Carboplatin|carboplatin|mesh-list
111245502|NCT00039195|Doxorubicin|doxorubicin|mesh-list
111245503|NCT00039195|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111245504|NCT00039195|Etoposide|etoposide|mesh-list
111245505|NCT00039195|Vincristine|vincristine|mesh-list
111245506|NCT00039195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111245507|NCT00039195|Immunologic Factors|immunologic factors|mesh-ancestor
111245508|NCT00039195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111245509|NCT00039195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111245510|NCT00039195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111245511|NCT00039195|Alkylating Agents|alkylating agents|mesh-ancestor
111245512|NCT00039195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111245513|NCT00039195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111245514|NCT00039195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111245515|NCT00039195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111245516|NCT00039195|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111245517|NCT00039195|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111245518|NCT00039195|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111245519|NCT00039195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111245520|NCT00039195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111245521|NCT00039195|Glucocorticoids|glucocorticoids|mesh-ancestor
111245523|NCT00039195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111245524|NCT00039195|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111245525|NCT00039195|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111245526|NCT00039195|Tubulin Modulators|tubulin modulators|mesh-ancestor
111245527|NCT00039195|Antimitotic Agents|antimitotic agents|mesh-ancestor
111245528|NCT00039195|Mitosis Modulators|mitosis modulators|mesh-ancestor
111245529|NCT05591170|Cholecalciferol|cholecalciferol|mesh-list
111245530|NCT05591170|Vitamin D|vitamin d|mesh-list
111245531|NCT05591170|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111245532|NCT05591170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111245533|NCT05591170|Vitamins|vitamins|mesh-ancestor
111245534|NCT05591170|Micronutrients|micronutrients|mesh-ancestor
111245535|NCT05591170|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111245536|NCT00218439|Paroxetine|paroxetine|mesh-list
111245537|NCT00218439|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111245538|NCT00218439|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111245539|NCT00218439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111245540|NCT00218439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111245541|NCT00218439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111245542|NCT00218439|Serotonin Agents|serotonin agents|mesh-ancestor
111245543|NCT00218439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111245544|NCT00218439|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111245545|NCT00218439|Antidepressive Agents|antidepressive agents|mesh-ancestor
111245546|NCT00218439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111245547|NCT00218439|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111245548|NCT00218439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111245549|NCT00218439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111245550|NCT04344730|Dexamethasone|dexamethasone|mesh-list
111245551|NCT04344730|Dexamethasone acetate|dexamethasone acetate|mesh-list
111245552|NCT04344730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111245553|NCT04344730|Antiemetics|antiemetics|mesh-ancestor
111245554|NCT04344730|Autonomic Agents|autonomic agents|mesh-ancestor
111245555|NCT04344730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111245556|NCT04344730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111245557|NCT04344730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111245558|NCT04344730|Glucocorticoids|glucocorticoids|mesh-ancestor
111245559|NCT04344730|Hormones|hormones|mesh-ancestor
111245560|NCT04344730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111245561|NCT04344730|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111245562|NCT04344730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111245563|NCT05716672|Lazertinib|lazertinib|mesh-list
111245564|NCT05716672|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111245565|NCT05716672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111245566|NCT05716672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111245567|NCT00358384|Betamethasone|betamethasone|mesh-list
111245568|NCT00358384|Betamethasone Valerate|betamethasone valerate|mesh-list
111245569|NCT00358384|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
111245570|NCT00358384|Betamethasone benzoate|betamethasone benzoate|mesh-list
111245571|NCT00358384|Calcipotriene|calcipotriene|mesh-list
111245572|NCT00358384|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
111245573|NCT00358384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111245574|NCT00358384|Glucocorticoids|glucocorticoids|mesh-ancestor
111245575|NCT00358384|Hormones|hormones|mesh-ancestor
111245576|NCT00358384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111245577|NCT00358384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111245578|NCT00358384|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111245579|NCT00358384|Respiratory System Agents|respiratory system agents|mesh-ancestor
111245580|NCT00358384|Dermatologic Agents|dermatologic agents|mesh-ancestor
111245581|NCT02959060|Rifampin|rifampin|mesh-list
111245582|NCT02959060|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111245583|NCT02959060|Antitubercular Agents|antitubercular agents|mesh-ancestor
111245584|NCT02959060|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111245585|NCT02959060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111245586|NCT02959060|Leprostatic Agents|leprostatic agents|mesh-ancestor
111245587|NCT02959060|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111245588|NCT02959060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111245589|NCT02959060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111245590|NCT02959060|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111245591|NCT02959060|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111245592|NCT02959060|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
111245593|NCT02959060|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
111245594|NCT02959060|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
111245595|NCT02959060|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111245596|NCT00109005|Lenalidomide|lenalidomide|mesh-list
111245597|NCT00109005|Immunologic Factors|immunologic factors|mesh-ancestor
111245598|NCT00109005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111245599|NCT00109005|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111245600|NCT00109005|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111245601|NCT00109005|Growth Substances|growth substances|mesh-ancestor
111245602|NCT00109005|Growth Inhibitors|growth inhibitors|mesh-ancestor
111245603|NCT00109005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111245604|NCT05552950|Antiviral Agents|antiviral agents|mesh-list
111245605|NCT05552950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111245606|NCT05547100|Olanzapine|olanzapine|mesh-list
111245607|NCT05547100|Antiemetics|antiemetics|mesh-ancestor
111245608|NCT05547100|Autonomic Agents|autonomic agents|mesh-ancestor
111245609|NCT05547100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111245610|NCT05547100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111245611|NCT05547100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111245612|NCT05547100|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111245613|NCT05547100|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111245614|NCT05547100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111245615|NCT05547100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111245616|NCT05547100|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111245617|NCT05547100|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111245618|NCT05547100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110825140|NCT03903367|Narcotics|narcotics|mesh-ancestor
111245619|NCT05547100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111245620|NCT05547100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111245621|NCT05547100|Serotonin Agents|serotonin agents|mesh-ancestor
111245622|NCT00109473|Prednisone|prednisone|mesh-list
111245623|NCT00109473|Hormones|hormones|mesh-list
111245624|NCT00109473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111245625|NCT00109473|Glucocorticoids|glucocorticoids|mesh-ancestor
111245626|NCT00109473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111245627|NCT00109473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111245628|NCT00109473|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111245629|NCT00109473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111245630|NCT05136976|Rituximab|rituximab|mesh-list
111245631|NCT05136976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111245632|NCT05136976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111245633|NCT05136976|Immunologic Factors|immunologic factors|mesh-ancestor
111245634|NCT05136976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111245635|NCT05136976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111245636|NCT00044655|Olanzapine|olanzapine|mesh-list
111245637|NCT00044655|Risperidone|risperidone|mesh-list
111245638|NCT00044655|Aripiprazole|aripiprazole|mesh-list
111245639|NCT00044655|Quetiapine Fumarate|quetiapine fumarate|mesh-list
111245640|NCT00044655|Ziprasidone|ziprasidone|mesh-list
111245641|NCT00044655|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111245642|NCT00044655|Serotonin Agents|serotonin agents|mesh-ancestor
111245643|NCT00044655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111245644|NCT00044655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111245645|NCT00044655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111245646|NCT00044655|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111245647|NCT00044655|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111245648|NCT00044655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111245649|NCT00044655|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111245650|NCT00044655|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111245651|NCT00044655|Dopamine Agents|dopamine agents|mesh-ancestor
111245652|NCT00044655|Antiemetics|antiemetics|mesh-ancestor
111245653|NCT00044655|Autonomic Agents|autonomic agents|mesh-ancestor
111245654|NCT00044655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111245655|NCT00044655|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111245656|NCT00044655|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111245657|NCT00044655|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111245658|NCT00044655|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111245659|NCT00044655|Antidepressive Agents|antidepressive agents|mesh-ancestor
111245660|NCT00044655|Dopamine Agonists|dopamine agonists|mesh-ancestor
111245661|NCT00044655|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111245662|NCT00044655|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111245663|NCT00044655|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111245664|NCT00044655|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111245665|NCT05130892|Tranilast|tranilast|mesh-list
111245666|NCT05130892|Colchicine|colchicine|mesh-list
111245667|NCT05130892|Gout Suppressants|gout suppressants|mesh-ancestor
111245668|NCT05130892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111245669|NCT05130892|Tubulin Modulators|tubulin modulators|mesh-ancestor
111245670|NCT05130892|Antimitotic Agents|antimitotic agents|mesh-ancestor
111245671|NCT05130892|Mitosis Modulators|mitosis modulators|mesh-ancestor
111245672|NCT05130892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111245673|NCT05130892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111245674|NCT05130892|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111245675|NCT05130892|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111245676|NCT05130892|Analgesics|analgesics|mesh-ancestor
111245677|NCT05130892|Sensory System Agents|sensory system agents|mesh-ancestor
111245678|NCT05130892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111245679|NCT05130892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111245680|NCT05130892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111245681|NCT05130892|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111245682|NCT05130892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111245683|NCT05130892|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111245684|NCT05130892|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111245685|NCT05130892|Histamine Antagonists|histamine antagonists|mesh-ancestor
111245686|NCT05130892|Histamine Agents|histamine agents|mesh-ancestor
111245687|NCT05130892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111245688|NCT05130892|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111245689|NCT05130892|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111245690|NCT00223665|Leuprolide|leuprolide|mesh-list
111245691|NCT00223665|Flutamide|flutamide|mesh-list
111245692|NCT00223665|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111245693|NCT00223665|Fertility Agents|fertility agents|mesh-ancestor
111245694|NCT00223665|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111245695|NCT00223665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111245696|NCT00223665|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111245697|NCT00223665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111245698|NCT00223665|Androgen Antagonists|androgen antagonists|mesh-ancestor
111245699|NCT00223665|Hormone Antagonists|hormone antagonists|mesh-ancestor
111245700|NCT00223665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111245701|NCT05311540|Zinc Sulfate|zinc sulfate|mesh-list
111245702|NCT05311540|Astringents|astringents|mesh-ancestor
111245703|NCT05311540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111245704|NCT05311540|Dermatologic Agents|dermatologic agents|mesh-ancestor
111245705|NCT00223821|Oxybutynin|oxybutynin|mesh-list
111245706|NCT00223821|Parasympatholytics|parasympatholytics|mesh-ancestor
111245707|NCT00223821|Autonomic Agents|autonomic agents|mesh-ancestor
111245708|NCT00223821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111245709|NCT00223821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111245710|NCT00223821|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111245711|NCT00223821|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111245712|NCT00223821|Cholinergic Agents|cholinergic agents|mesh-ancestor
111245713|NCT00223821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111245714|NCT00223821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111245715|NCT00223821|Urological Agents|urological agents|mesh-ancestor
111245716|NCT00359164|Bevacizumab|bevacizumab|mesh-list
111245717|NCT00359164|Verteporfin|verteporfin|mesh-list
111245718|NCT00359164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111245719|NCT00359164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111245720|NCT00359164|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111245721|NCT00359164|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111245722|NCT00359164|Growth Substances|growth substances|mesh-ancestor
111245723|NCT00359164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111245724|NCT00359164|Growth Inhibitors|growth inhibitors|mesh-ancestor
111245725|NCT00359164|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111245726|NCT00359164|Dermatologic Agents|dermatologic agents|mesh-ancestor
111245727|NCT00224289|Latanoprost|latanoprost|mesh-list
111245728|NCT00224289|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
111245729|NCT00224289|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111245730|NCT00045435|Cyclosporine|cyclosporine|mesh-list
111245731|NCT00045435|Mycophenolic Acid|mycophenolic acid|mesh-list
111245732|NCT00045435|Fludarabine|fludarabine|mesh-list
110970040|NCT02487212|Emollients|emollients|mesh-ancestor
111245733|NCT00045435|Fludarabine phosphate|fludarabine phosphate|mesh-list
111245734|NCT00045435|Cyclosporins|cyclosporins|mesh-list
111245735|NCT00045435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111245736|NCT00045435|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111245737|NCT00045435|Antimetabolites|antimetabolites|mesh-ancestor
111245738|NCT00045435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111245739|NCT00045435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111245740|NCT00045435|Immunologic Factors|immunologic factors|mesh-ancestor
111245741|NCT00045435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111245742|NCT00045435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111245743|NCT00045435|Antifungal Agents|antifungal agents|mesh-ancestor
111245744|NCT00045435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111245745|NCT00045435|Dermatologic Agents|dermatologic agents|mesh-ancestor
111245746|NCT00045435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111245747|NCT00045435|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111245748|NCT00045435|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111245749|NCT00045435|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111245750|NCT00045435|Antitubercular Agents|antitubercular agents|mesh-ancestor
111245751|NCT00045435|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111245752|NCT00111657|Rasburicase|rasburicase|mesh-list
111245753|NCT00111657|Gout Suppressants|gout suppressants|mesh-ancestor
111245754|NCT00111657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111245755|NCT05292586|Beclomethasone|beclomethasone|mesh-list
111245756|NCT05292586|Formoterol Fumarate|formoterol fumarate|mesh-list
111245757|NCT05292586|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111245758|NCT05292586|Autonomic Agents|autonomic agents|mesh-ancestor
111245759|NCT05292586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111245760|NCT05292586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111245761|NCT05292586|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111245762|NCT05292586|Respiratory System Agents|respiratory system agents|mesh-ancestor
111245763|NCT05292586|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111245764|NCT05292586|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111245765|NCT05292586|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111245766|NCT05292586|Adrenergic Agents|adrenergic agents|mesh-ancestor
111245767|NCT05292586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111245768|NCT05292586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111245769|NCT05292586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111245770|NCT05292586|Glucocorticoids|glucocorticoids|mesh-ancestor
111245771|NCT05292586|Hormones|hormones|mesh-ancestor
111245772|NCT05292586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111245773|NCT02097303|Prednisone|prednisone|mesh-list
111245774|NCT02097303|Abiraterone Acetate|abiraterone acetate|mesh-list
111245775|NCT02097303|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
111245776|NCT02097303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111245777|NCT02097303|Glucocorticoids|glucocorticoids|mesh-ancestor
111245778|NCT02097303|Hormones|hormones|mesh-ancestor
111245779|NCT02097303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111245780|NCT02097303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111245781|NCT02097303|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111245782|NCT02097303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111245783|NCT02097303|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111245784|NCT02097303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111245785|NCT02097303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111245786|NCT02097303|Hormone Antagonists|hormone antagonists|mesh-ancestor
111245787|NCT02097303|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111245788|NCT00703326|Docetaxel|docetaxel|mesh-list
111245789|NCT00703326|Ramucirumab|ramucirumab|mesh-list
111245790|NCT00703326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111245791|NCT00703326|Tubulin Modulators|tubulin modulators|mesh-ancestor
111245792|NCT00703326|Antimitotic Agents|antimitotic agents|mesh-ancestor
111245793|NCT00703326|Mitosis Modulators|mitosis modulators|mesh-ancestor
111245794|NCT00703326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111245795|NCT02097537|Methacholine Chloride|methacholine chloride|mesh-list
111245796|NCT02097537|Miotics|miotics|mesh-ancestor
111245797|NCT02097537|Autonomic Agents|autonomic agents|mesh-ancestor
111245798|NCT02097537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111245799|NCT02097537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111245800|NCT02097537|Parasympathomimetics|parasympathomimetics|mesh-ancestor
111245801|NCT02097537|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
111245802|NCT02097537|Respiratory System Agents|respiratory system agents|mesh-ancestor
111245803|NCT02097537|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
111245804|NCT02097537|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111245805|NCT02097537|Cholinergic Agents|cholinergic agents|mesh-ancestor
111245806|NCT02097537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110970119|NCT02186145|Hormones|hormones|mesh-ancestor
111245807|NCT02097537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111245809|NCT02097849|Dimethyl Fumarate|dimethyl fumarate|mesh-list
111245810|NCT02097849|Vaccines|vaccines|mesh-list
111245811|NCT02097849|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
111245812|NCT02097849|Immunologic Factors|immunologic factors|mesh-ancestor
111245813|NCT02097849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111245814|NCT02097849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111245815|NCT02097849|Antiviral Agents|antiviral agents|mesh-ancestor
111245816|NCT02097849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111245817|NCT02097849|Dermatologic Agents|dermatologic agents|mesh-ancestor
111245818|NCT02097849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111245819|NCT00047697|Donepezil|donepezil|mesh-list
111245820|NCT00047697|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111245821|NCT00047697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111245822|NCT00047697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111245823|NCT00047697|Cholinergic Agents|cholinergic agents|mesh-ancestor
111245824|NCT00047697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111245825|NCT00047697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111245826|NCT00047697|Nootropic Agents|nootropic agents|mesh-ancestor
111245827|NCT05094154|Penicillins|penicillins|mesh-list
111245828|NCT05094154|Cephalosporins|cephalosporins|mesh-list
111245829|NCT05094154|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111245830|NCT05094154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111245831|NCT02437812|Metformin|metformin|mesh-list
111245832|NCT02437812|Paclitaxel|paclitaxel|mesh-list
111245833|NCT02437812|Carboplatin|carboplatin|mesh-list
111245834|NCT02437812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111245835|NCT02437812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111245836|NCT02437812|Tubulin Modulators|tubulin modulators|mesh-ancestor
111245837|NCT02437812|Antimitotic Agents|antimitotic agents|mesh-ancestor
111245838|NCT02437812|Mitosis Modulators|mitosis modulators|mesh-ancestor
111245839|NCT02437812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111245840|NCT02437812|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111245841|NCT02437812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111245842|NCT00112593|Cyclosporine|cyclosporine|mesh-list
111245843|NCT00112593|Mycophenolic Acid|mycophenolic acid|mesh-list
111245844|NCT00112593|Fludarabine|fludarabine|mesh-list
111245845|NCT00112593|Fludarabine phosphate|fludarabine phosphate|mesh-list
111245846|NCT00112593|Cyclosporins|cyclosporins|mesh-list
111245847|NCT00112593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111245848|NCT00112593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111245849|NCT00112593|Antimetabolites|antimetabolites|mesh-ancestor
111245850|NCT00112593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111245851|NCT00112593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111245852|NCT00112593|Immunologic Factors|immunologic factors|mesh-ancestor
111245853|NCT00112593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111245854|NCT00112593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111245855|NCT00112593|Antifungal Agents|antifungal agents|mesh-ancestor
111245856|NCT00112593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111245857|NCT00112593|Dermatologic Agents|dermatologic agents|mesh-ancestor
111245858|NCT00112593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111245859|NCT00112593|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111245860|NCT00112593|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111245861|NCT00112593|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111245862|NCT00112593|Antitubercular Agents|antitubercular agents|mesh-ancestor
111245863|NCT00112593|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111245864|NCT05280106|Citric Acid|citric acid|mesh-list
111245865|NCT05280106|Sodium Citrate|sodium citrate|mesh-list
111245866|NCT05280106|Dialysis Solutions|dialysis solutions|mesh-list
111245867|NCT05280106|Anticoagulants|anticoagulants|mesh-ancestor
111245868|NCT05280106|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
111245869|NCT05280106|Chelating Agents|chelating agents|mesh-ancestor
111245870|NCT05280106|Sequestering Agents|sequestering agents|mesh-ancestor
111245871|NCT05280106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111245872|NCT05280106|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111245873|NCT00112671|Sorafenib|sorafenib|mesh-list
111245874|NCT00112671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111245875|NCT00112671|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111245876|NCT00112671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111245877|NCT00112671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111245878|NCT05279092|Dexamethasone|dexamethasone|mesh-list
111245879|NCT05279092|Methylprednisolone|methylprednisolone|mesh-list
111245880|NCT05279092|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111245881|NCT05279092|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111245882|NCT05279092|Prednisolone|prednisolone|mesh-list
111245883|NCT05279092|Prednisolone acetate|prednisolone acetate|mesh-list
111245885|NCT05279092|Bupivacaine|bupivacaine|mesh-list
111245886|NCT05279092|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111245887|NCT05279092|Prednisolone phosphate|prednisolone phosphate|mesh-list
111245888|NCT05279092|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
111245889|NCT05279092|BB 1101|bb 1101|mesh-list
111245890|NCT05279092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111245891|NCT05279092|Antiemetics|antiemetics|mesh-ancestor
111245892|NCT05279092|Autonomic Agents|autonomic agents|mesh-ancestor
111245893|NCT05279092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111245894|NCT05279092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111245895|NCT05279092|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111245896|NCT05279092|Glucocorticoids|glucocorticoids|mesh-ancestor
111245897|NCT05279092|Hormones|hormones|mesh-ancestor
111245898|NCT05279092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111245899|NCT05279092|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111245900|NCT05279092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111245901|NCT05279092|Anesthetics, Local|anesthetics, local|mesh-ancestor
111245902|NCT05279092|Anesthetics|anesthetics|mesh-ancestor
111245903|NCT05279092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111245904|NCT05279092|Sensory System Agents|sensory system agents|mesh-ancestor
111245905|NCT05279092|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111245906|NCT05279092|Protective Agents|protective agents|mesh-ancestor
111245907|NCT05279092|Protease Inhibitors|protease inhibitors|mesh-ancestor
111245908|NCT05279092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111245909|NCT05279092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111245910|NCT02437656|Metformin|metformin|mesh-list
111245911|NCT02437656|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111245912|NCT02437656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111245913|NCT05273632|Tranexamic Acid|tranexamic acid|mesh-list
111245914|NCT05273632|Oxytocin|oxytocin|mesh-list
111245915|NCT05273632|Oxytocics|oxytocics|mesh-ancestor
111245916|NCT05273632|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111245917|NCT05273632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111245918|NCT05273632|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111245919|NCT05273632|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111245920|NCT05273632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111245921|NCT05273632|Hemostatics|hemostatics|mesh-ancestor
111245922|NCT05273632|Coagulants|coagulants|mesh-ancestor
111245923|NCT02429622|Paclitaxel|paclitaxel|mesh-list
111245924|NCT02429622|Nedaplatin|nedaplatin|mesh-list
111245925|NCT02429622|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111245926|NCT02429622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111245927|NCT02429622|Tubulin Modulators|tubulin modulators|mesh-ancestor
111245928|NCT02429622|Antimitotic Agents|antimitotic agents|mesh-ancestor
111245929|NCT02429622|Mitosis Modulators|mitosis modulators|mesh-ancestor
111245930|NCT02429622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111245931|NCT02429466|Guadecitabine|guadecitabine|mesh-list
111245932|NCT02429466|Azacitidine|azacitidine|mesh-list
111245933|NCT02429466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111245934|NCT02429466|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111245935|NCT02429466|Antimetabolites|antimetabolites|mesh-ancestor
111245936|NCT02429466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111245937|NCT02429466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111245938|NCT02429388|Sodium Channel Blockers|sodium channel blockers|mesh-list
111245939|NCT02429388|Spironolactone|spironolactone|mesh-list
111245940|NCT02429388|Diuretics|diuretics|mesh-list
111245941|NCT02429388|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-list
111245942|NCT02429388|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
111245943|NCT02429388|Hormone Antagonists|hormone antagonists|mesh-ancestor
111245944|NCT02429388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111245945|NCT02429388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111245946|NCT02429388|Natriuretic Agents|natriuretic agents|mesh-ancestor
111245947|NCT02429388|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111245948|NCT02429388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111245949|NCT02429232|Pioglitazone|pioglitazone|mesh-list
111245950|NCT02429232|Linagliptin|linagliptin|mesh-list
111245951|NCT02429232|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111245952|NCT02429232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111245953|NCT02429232|Incretins|incretins|mesh-ancestor
111245954|NCT02429232|Hormones|hormones|mesh-ancestor
111245955|NCT02429232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111245956|NCT02429232|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111245957|NCT02429232|Protease Inhibitors|protease inhibitors|mesh-ancestor
111245958|NCT02429232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111245959|NCT02429232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111245960|NCT03189732|Metformin|metformin|mesh-list
111245961|NCT03189732|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111245962|NCT03189732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111245963|NCT02437032|Menotropins|menotropins|mesh-list
111245964|NCT02437032|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111245965|NCT02437032|Fertility Agents|fertility agents|mesh-ancestor
111245966|NCT02437032|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111245967|NCT02437032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111245968|NCT05232994|Metformin|metformin|mesh-list
111245969|NCT05232994|Esomeprazole|esomeprazole|mesh-list
111245970|NCT05232994|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111245971|NCT05232994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111245972|NCT05232994|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111245973|NCT05232994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111245974|NCT05232994|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111245975|NCT05232994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111245976|NCT05232994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111245977|NCT02436798|Ondansetron|ondansetron|mesh-list
111245978|NCT02436798|Antiemetics|antiemetics|mesh-ancestor
111245979|NCT02436798|Autonomic Agents|autonomic agents|mesh-ancestor
111245980|NCT02436798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111245981|NCT02436798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111245982|NCT02436798|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111245983|NCT02436798|Antipruritics|antipruritics|mesh-ancestor
111245984|NCT02436798|Dermatologic Agents|dermatologic agents|mesh-ancestor
111245985|NCT02436798|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111245986|NCT02436798|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111245987|NCT02436798|Serotonin Agents|serotonin agents|mesh-ancestor
111245988|NCT02436798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111245989|NCT02436798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111245990|NCT03185130|Diphenhydramine|diphenhydramine|mesh-list
111245991|NCT03185130|Promethazine|promethazine|mesh-list
111245992|NCT03185130|Prochlorperazine|prochlorperazine|mesh-list
111245993|NCT03185130|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111245994|NCT03185130|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111245995|NCT03185130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111245996|NCT03185130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111245997|NCT03185130|Anesthetics, Local|anesthetics, local|mesh-ancestor
111245998|NCT03185130|Anesthetics|anesthetics|mesh-ancestor
111245999|NCT03185130|Sensory System Agents|sensory system agents|mesh-ancestor
111246000|NCT03185130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111246001|NCT03185130|Antiemetics|antiemetics|mesh-ancestor
111246002|NCT03185130|Autonomic Agents|autonomic agents|mesh-ancestor
111246003|NCT03185130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111246004|NCT03185130|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111246005|NCT03185130|Histamine Antagonists|histamine antagonists|mesh-ancestor
111246006|NCT03185130|Histamine Agents|histamine agents|mesh-ancestor
111246007|NCT03185130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111246008|NCT03185130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111246009|NCT03185130|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111246010|NCT03185130|Antipruritics|antipruritics|mesh-ancestor
111246011|NCT03185130|Dermatologic Agents|dermatologic agents|mesh-ancestor
111246012|NCT03185130|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111246013|NCT03185130|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111246014|NCT03185130|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111246015|NCT03185130|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111246016|NCT03185130|Dopamine Agents|dopamine agents|mesh-ancestor
111246017|NCT00358618|Propofol|propofol|mesh-list
111246018|NCT00358618|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111246019|NCT00358618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111246020|NCT00358618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111246021|NCT00358618|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111246022|NCT00358618|Anesthetics, General|anesthetics, general|mesh-ancestor
111246023|NCT00358618|Anesthetics|anesthetics|mesh-ancestor
111246024|NCT02428764|Carboplatin|carboplatin|mesh-list
111246025|NCT02428764|Gemcitabine|gemcitabine|mesh-list
111246026|NCT02428764|Nimotuzumab|nimotuzumab|mesh-list
111246027|NCT02428764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111246028|NCT02428764|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111246029|NCT02428764|Antimetabolites|antimetabolites|mesh-ancestor
111246030|NCT02428764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111246031|NCT02428764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111246032|NCT00358696|Tenofovir|tenofovir|mesh-list
111246033|NCT00358696|Antiviral Agents|antiviral agents|mesh-ancestor
111246034|NCT00358696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111246035|NCT00358696|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111246036|NCT00358696|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111246037|NCT00358696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111246038|NCT00358696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111246039|NCT00358696|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111246040|NCT00358696|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111246041|NCT05429476|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
111246042|NCT05429476|Plasminogen|plasminogen|mesh-list
111246043|NCT05429476|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111246044|NCT05429476|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111246045|NCT05429476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111246046|NCT00360178|Amlodipine|amlodipine|mesh-list
111246047|NCT00360178|Valsartan|valsartan|mesh-list
111246048|NCT00360178|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
111246049|NCT00360178|Candesartan|candesartan|mesh-list
111246050|NCT00360178|Candesartan cilexetil|candesartan cilexetil|mesh-list
111246051|NCT00360178|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111246052|NCT00360178|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111246053|NCT00360178|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111246054|NCT00360178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111246055|NCT00360178|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111246056|NCT00360178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111246057|NCT00360178|Vasodilator Agents|vasodilator agents|mesh-ancestor
111246058|NCT00360178|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111246059|NCT00360178|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111246060|NCT00360178|Diuretics|diuretics|mesh-ancestor
111246061|NCT00360178|Natriuretic Agents|natriuretic agents|mesh-ancestor
111246062|NCT00360178|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
111246063|NCT00421720|Sufentanil|sufentanil|mesh-list
111246064|NCT00421720|Remifentanil|remifentanil|mesh-list
111246065|NCT00421720|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111246066|NCT00421720|Narcotics|narcotics|mesh-ancestor
111246067|NCT00421720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111246068|NCT00421720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111246069|NCT00421720|Analgesics|analgesics|mesh-ancestor
111246070|NCT00421720|Sensory System Agents|sensory system agents|mesh-ancestor
111246071|NCT00421720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110825587|NCT03899077|Goserelin|goserelin|mesh-list
111246072|NCT00421720|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111246073|NCT00421720|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111246074|NCT00421720|Anesthetics, General|anesthetics, general|mesh-ancestor
111246075|NCT00421720|Anesthetics|anesthetics|mesh-ancestor
111246076|NCT05008276|Dextrans|dextrans|mesh-list
111246077|NCT05008276|Anticoagulants|anticoagulants|mesh-ancestor
111246078|NCT05008276|Plasma Substitutes|plasma substitutes|mesh-ancestor
111246079|NCT05008276|Blood Substitutes|blood substitutes|mesh-ancestor
111246080|NCT00358930|Beta-lapachone|beta-lapachone|mesh-list
111246081|NCT00358930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111246082|NCT00358930|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111246083|NCT00358930|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111246084|NCT00358930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111246085|NCT00358930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111246086|NCT00358930|Antiviral Agents|antiviral agents|mesh-ancestor
111246087|NCT04492306|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
111246088|NCT04492306|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
111246089|NCT04492306|Protective Agents|protective agents|mesh-ancestor
111246090|NCT04492306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111246091|NCT04492306|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111246092|NCT04492306|Antioxidants|antioxidants|mesh-ancestor
111246093|NCT04492306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111246094|NCT04468360|Pregnanolone|pregnanolone|mesh-list
111246095|NCT04468360|Brexanolone|brexanolone|mesh-list
111246096|NCT04468360|Anesthetics|anesthetics|mesh-ancestor
111246097|NCT04468360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111246098|NCT04468360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111246099|NCT04468360|Neurosteroids|neurosteroids|mesh-ancestor
111246100|NCT04468360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111246101|NCT04468360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111246102|NCT04468360|GABA Modulators|gaba modulators|mesh-ancestor
111246103|NCT04468360|GABA Agents|gaba agents|mesh-ancestor
111246104|NCT02977312|Imatinib Mesylate|imatinib mesylate|mesh-list
111246105|NCT02977312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111246106|NCT02977312|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111246107|NCT02977312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111246108|NCT02977312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110970422|NCT03316352|Bupivacaine|bupivacaine|mesh-list
111246109|NCT04907110|Niacinamide|niacinamide|mesh-list
111246110|NCT04907110|Vitamin B Complex|vitamin b complex|mesh-ancestor
111246112|NCT04907110|Micronutrients|micronutrients|mesh-ancestor
111246113|NCT04907110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111246114|NCT04394416|Imatinib Mesylate|imatinib mesylate|mesh-list
111246115|NCT04394416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111246116|NCT04394416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111246117|NCT04394416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111246118|NCT04394416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111246119|NCT04887298|Annamycin|annamycin|mesh-list
111246120|NCT04887298|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111246121|NCT04887298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111246122|NCT02977000|Propranolol|propranolol|mesh-list
111246123|NCT02977000|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111246124|NCT02977000|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111246125|NCT02977000|Adrenergic Agents|adrenergic agents|mesh-ancestor
111246126|NCT02977000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111246127|NCT02977000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111246128|NCT02977000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111246129|NCT02977000|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111246130|NCT02977000|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111246131|NCT02977000|Vasodilator Agents|vasodilator agents|mesh-ancestor
111246132|NCT02975986|Technetium Tc 99m Mertiatide|technetium tc 99m mertiatide|mesh-list
111246133|NCT02975986|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111246134|NCT02975986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111246135|NCT00112827|Cyclophosphamide|cyclophosphamide|mesh-list
111246136|NCT00112827|Melphalan|melphalan|mesh-list
111246137|NCT00112827|Lenalidomide|lenalidomide|mesh-list
111246138|NCT00112827|Lenograstim|lenograstim|mesh-list
111246139|NCT00112827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111246140|NCT00112827|Immunologic Factors|immunologic factors|mesh-ancestor
111246141|NCT00112827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111246142|NCT00112827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111246143|NCT00112827|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111246144|NCT00112827|Alkylating Agents|alkylating agents|mesh-ancestor
111246145|NCT00112827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111246146|NCT00112827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111246147|NCT00112827|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111246148|NCT00112827|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111246149|NCT00112827|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111246150|NCT00112827|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111246151|NCT00112827|Growth Substances|growth substances|mesh-ancestor
111246152|NCT00112827|Growth Inhibitors|growth inhibitors|mesh-ancestor
111246153|NCT04752111|Esmolol|esmolol|mesh-list
111246154|NCT04752111|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
111246155|NCT04752111|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111246156|NCT04752111|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111246157|NCT04752111|Adrenergic Agents|adrenergic agents|mesh-ancestor
111246158|NCT04752111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111246159|NCT04752111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111246160|NCT04752111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111246161|NCT04343170|Folic Acid|folic acid|mesh-list
111246162|NCT04343170|Vitamin B 12|vitamin b 12|mesh-list
111246163|NCT04343170|Hydroxocobalamin|hydroxocobalamin|mesh-list
111246164|NCT04343170|Epoetin Alfa|epoetin alfa|mesh-list
111246165|NCT04343170|Vitamins|vitamins|mesh-ancestor
111246166|NCT04343170|Micronutrients|micronutrients|mesh-ancestor
111246167|NCT04343170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111246168|NCT04343170|Hematinics|hematinics|mesh-ancestor
111246169|NCT04343170|Vitamin B Complex|vitamin b complex|mesh-ancestor
111246170|NCT00226239|Docetaxel|docetaxel|mesh-list
111246171|NCT00226239|Cetuximab|cetuximab|mesh-list
111246172|NCT00226239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111246173|NCT00226239|Tubulin Modulators|tubulin modulators|mesh-ancestor
111246174|NCT00226239|Antimitotic Agents|antimitotic agents|mesh-ancestor
111246175|NCT00226239|Mitosis Modulators|mitosis modulators|mesh-ancestor
111246176|NCT00226239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111246177|NCT00226239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111246178|NCT00227019|Vitamins|vitamins|mesh-list
111246179|NCT00227019|Folic Acid|folic acid|mesh-list
111246180|NCT00227019|Vitamin B 12|vitamin b 12|mesh-list
111246181|NCT00227019|Vitamin B Complex|vitamin b complex|mesh-list
111246182|NCT00227019|Dexamethasone|dexamethasone|mesh-list
111246183|NCT00227019|Bevacizumab|bevacizumab|mesh-list
111246184|NCT00227019|Pemetrexed|pemetrexed|mesh-list
111246185|NCT00227019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111246186|NCT00227019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111246187|NCT00227019|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111246188|NCT00227019|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111246189|NCT00227019|Growth Substances|growth substances|mesh-ancestor
111246190|NCT00227019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111246191|NCT00227019|Growth Inhibitors|growth inhibitors|mesh-ancestor
111246192|NCT00227019|Micronutrients|micronutrients|mesh-ancestor
111246193|NCT00227019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111246194|NCT00227019|Antiemetics|antiemetics|mesh-ancestor
111246195|NCT00227019|Autonomic Agents|autonomic agents|mesh-ancestor
111246196|NCT00227019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111246197|NCT00227019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111246198|NCT00227019|Glucocorticoids|glucocorticoids|mesh-ancestor
111246199|NCT00227019|Hormones|hormones|mesh-ancestor
111246200|NCT00227019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111246201|NCT00227019|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111246202|NCT00227019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111246203|NCT00227019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111246204|NCT00227019|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111246205|NCT00227019|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111246206|NCT00227019|Hematinics|hematinics|mesh-ancestor
111246207|NCT00113217|Bevacizumab|bevacizumab|mesh-list
111246208|NCT00113217|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111246209|NCT00113217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111246210|NCT00113217|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111246211|NCT00113217|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111246212|NCT00113217|Growth Substances|growth substances|mesh-ancestor
111246213|NCT00113217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111246214|NCT00113217|Growth Inhibitors|growth inhibitors|mesh-ancestor
111246215|NCT04718116|Tramadol|tramadol|mesh-list
111246216|NCT04718116|Tapentadol|tapentadol|mesh-list
111246217|NCT04718116|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111246218|NCT04718116|Narcotics|narcotics|mesh-ancestor
111246219|NCT04718116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111246220|NCT04718116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111246221|NCT04718116|Analgesics|analgesics|mesh-ancestor
111246222|NCT04718116|Sensory System Agents|sensory system agents|mesh-ancestor
111246223|NCT04718116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111246224|NCT04718116|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111246225|NCT04718116|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111246226|NCT04718116|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111246227|NCT04718116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111246228|NCT04718116|Adrenergic Agents|adrenergic agents|mesh-ancestor
111246229|NCT04718116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111246230|NCT04429503|Aflibercept|aflibercept|mesh-list
111246231|NCT04429503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111246232|NCT04429503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111246233|NCT04429503|Growth Substances|growth substances|mesh-ancestor
111246234|NCT04429503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111246235|NCT04429503|Growth Inhibitors|growth inhibitors|mesh-ancestor
111246236|NCT04429503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111246237|NCT04276792|Analgesics, Opioid|analgesics, opioid|mesh-list
111246238|NCT04276792|Narcotics|narcotics|mesh-ancestor
111246239|NCT04276792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111246240|NCT04276792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111246241|NCT04276792|Analgesics|analgesics|mesh-ancestor
111246242|NCT04276792|Sensory System Agents|sensory system agents|mesh-ancestor
111246243|NCT04276792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111246244|NCT00053703|Olanzapine|olanzapine|mesh-list
111246245|NCT00053703|Risperidone|risperidone|mesh-list
111246246|NCT00053703|Molindone|molindone|mesh-list
111246247|NCT00053703|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111246248|NCT00053703|Serotonin Agents|serotonin agents|mesh-ancestor
111246249|NCT00053703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111246250|NCT00053703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111246251|NCT00053703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111246252|NCT00053703|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111246253|NCT00053703|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111246254|NCT00053703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111246255|NCT00053703|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111246256|NCT00053703|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111246257|NCT00053703|Dopamine Agents|dopamine agents|mesh-ancestor
111246258|NCT00053703|Antiemetics|antiemetics|mesh-ancestor
111246259|NCT00053703|Autonomic Agents|autonomic agents|mesh-ancestor
111246260|NCT00053703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111246261|NCT00053703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111246262|NCT00053703|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111246263|NCT00053703|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111246264|NCT00053703|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111246265|NCT02975440|Rifampin|rifampin|mesh-list
111246266|NCT02975440|Midazolam|midazolam|mesh-list
111246267|NCT02975440|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111246268|NCT02975440|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111246269|NCT02975440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111246270|NCT02975440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111246271|NCT02975440|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111246272|NCT02975440|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111246273|NCT02975440|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111246274|NCT02975440|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111246275|NCT02975440|Anesthetics, General|anesthetics, general|mesh-ancestor
111246276|NCT02975440|Anesthetics|anesthetics|mesh-ancestor
111246277|NCT02975440|GABA Modulators|gaba modulators|mesh-ancestor
111246278|NCT02975440|GABA Agents|gaba agents|mesh-ancestor
111246279|NCT02975440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111246280|NCT02975440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111246281|NCT02975440|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111246282|NCT02975440|Antitubercular Agents|antitubercular agents|mesh-ancestor
111246283|NCT02975440|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111246284|NCT02975440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111246285|NCT02975440|Leprostatic Agents|leprostatic agents|mesh-ancestor
111246286|NCT02975440|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111246287|NCT02975440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111246288|NCT02975440|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111246289|NCT02975440|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111246290|NCT02975440|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
111246291|NCT02975440|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
111246292|NCT02975440|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
111246293|NCT02975440|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111246294|NCT00231309|Lenograstim|lenograstim|mesh-list
111246295|NCT00231309|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111246296|NCT00231309|Immunologic Factors|immunologic factors|mesh-ancestor
111246297|NCT00231309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111246298|NCT04267120|Pembrolizumab|pembrolizumab|mesh-list
111246299|NCT04267120|Lenvatinib|lenvatinib|mesh-list
111246300|NCT04267120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111246301|NCT04267120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111246302|NCT04267120|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111246303|NCT04267120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111246304|NCT04267120|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111246305|NCT04267120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111246306|NCT00232479|Carboplatin|carboplatin|mesh-list
111246307|NCT00232479|Docetaxel|docetaxel|mesh-list
111246308|NCT00232479|Trastuzumab|trastuzumab|mesh-list
111246309|NCT00232479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111246310|NCT00232479|Tubulin Modulators|tubulin modulators|mesh-ancestor
111246311|NCT00232479|Antimitotic Agents|antimitotic agents|mesh-ancestor
111246312|NCT00232479|Mitosis Modulators|mitosis modulators|mesh-ancestor
111246313|NCT00232479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111246314|NCT00232479|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111246315|NCT04710628|Pembrolizumab|pembrolizumab|mesh-list
111246316|NCT04710628|Lenvatinib|lenvatinib|mesh-list
111246317|NCT04710628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111246318|NCT04710628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111246319|NCT04710628|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111246320|NCT04710628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111246321|NCT04710628|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111246322|NCT04710628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111246323|NCT00233103|Sertraline|sertraline|mesh-list
111246324|NCT00233103|Antidepressive Agents|antidepressive agents|mesh-ancestor
111246325|NCT00233103|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111246326|NCT00233103|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111246327|NCT00233103|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111246328|NCT00233103|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111246329|NCT00233103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111246330|NCT00233103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111246331|NCT00233103|Serotonin Agents|serotonin agents|mesh-ancestor
111246332|NCT00233103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111246333|NCT00703014|Progesterone|progesterone|mesh-list
111246334|NCT00703014|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
111246335|NCT00703014|Ganirelix|ganirelix|mesh-list
111246336|NCT00703014|Progestins|progestins|mesh-ancestor
111246337|NCT00703014|Hormones|hormones|mesh-ancestor
111246338|NCT00703014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111246339|NCT00703014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111246340|NCT00703014|Hormone Antagonists|hormone antagonists|mesh-ancestor
111246341|NCT02433522|Rituximab|rituximab|mesh-list
111246342|NCT02433522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111246343|NCT02433522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111246344|NCT02433522|Immunologic Factors|immunologic factors|mesh-ancestor
111246345|NCT02433522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111246346|NCT02433522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111246347|NCT02433912|Acetaminophen|acetaminophen|mesh-list
111246348|NCT02433912|Chlorhexidine|chlorhexidine|mesh-list
111246349|NCT02433912|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
111246350|NCT02433912|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111246351|NCT02433912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111246352|NCT02433912|Disinfectants|disinfectants|mesh-ancestor
111246353|NCT02433912|Dermatologic Agents|dermatologic agents|mesh-ancestor
111246354|NCT02433912|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111246355|NCT02433912|Analgesics|analgesics|mesh-ancestor
111246356|NCT02433912|Sensory System Agents|sensory system agents|mesh-ancestor
111246357|NCT02433912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111246358|NCT02433912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111246359|NCT02433912|Antipyretics|antipyretics|mesh-ancestor
111246360|NCT02436486|Moxifloxacin|moxifloxacin|mesh-list
111246361|NCT02436486|(2-(6-fluoro-1H-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|(2-(6-fluoro-1h-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|mesh-list
111246362|NCT02436486|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111246363|NCT02436486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111246364|NCT02436486|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111246365|NCT02436486|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111246366|NCT02436486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111246367|NCT02436486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111246368|NCT02436486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111246369|NCT02436486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111246370|NCT02436486|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111246371|NCT02436486|Serotonin Agents|serotonin agents|mesh-ancestor
111246372|NCT02436486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111246373|NCT04342858|Listerine|listerine|mesh-list
111246374|NCT04342858|Fluorides|fluorides|mesh-list
111246375|NCT04342858|Sodium Fluoride|sodium fluoride|mesh-list
111246376|NCT04342858|Fluorides, Topical|fluorides, topical|mesh-list
111246377|NCT04342858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111246378|NCT04342858|Cariostatic Agents|cariostatic agents|mesh-ancestor
111246379|NCT04342858|Protective Agents|protective agents|mesh-ancestor
111246380|NCT04342858|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111246381|NCT04342858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111246382|NCT02429076|Propofol|propofol|mesh-list
111246383|NCT02429076|Sevoflurane|sevoflurane|mesh-list
111246384|NCT02429076|Methylphenidate|methylphenidate|mesh-list
111246385|NCT02429076|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111246386|NCT02429076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111246387|NCT02429076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111246388|NCT02429076|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111246389|NCT02429076|Anesthetics, General|anesthetics, general|mesh-ancestor
111246390|NCT02429076|Anesthetics|anesthetics|mesh-ancestor
111246391|NCT02429076|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111246392|NCT02429076|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111246393|NCT02429076|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111246394|NCT02429076|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111246395|NCT02429076|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111246396|NCT02429076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111246397|NCT02429076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111246398|NCT02429076|Dopamine Agents|dopamine agents|mesh-ancestor
111246399|NCT02429076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111246400|NCT00255177|Mifepristone|mifepristone|mesh-list
111246401|NCT00255177|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
111246402|NCT00255177|Abortifacient Agents|abortifacient agents|mesh-ancestor
111246403|NCT00255177|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111246404|NCT00255177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111246405|NCT00255177|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111246406|NCT00255177|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111246407|NCT00255177|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111246408|NCT00255177|Contraceptive Agents|contraceptive agents|mesh-ancestor
111246409|NCT00255177|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
111246410|NCT00255177|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
111246411|NCT00255177|Hormone Antagonists|hormone antagonists|mesh-ancestor
111246412|NCT00255177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111246413|NCT00255177|Luteolytic Agents|luteolytic agents|mesh-ancestor
111246414|NCT00255177|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111246415|NCT00255177|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
111246417|NCT04670224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111246418|NCT04670224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111246419|NCT00361114|Pyrimethamine|pyrimethamine|mesh-list
111246420|NCT00361114|Sulfadoxine|sulfadoxine|mesh-list
111246421|NCT00361114|Dapsone|dapsone|mesh-list
111246422|NCT00361114|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
111246423|NCT00361114|Chlorproguanil|chlorproguanil|mesh-list
111246424|NCT00361114|Antimalarials|antimalarials|mesh-ancestor
111246425|NCT00361114|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111246426|NCT00361114|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111246427|NCT00361114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111246428|NCT00361114|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111246429|NCT00361114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111246430|NCT00361114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111246431|NCT00361114|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111246432|NCT00361114|Leprostatic Agents|leprostatic agents|mesh-ancestor
111246433|NCT00361114|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111246434|NCT00702624|Hormones|hormones|mesh-list
111246435|NCT00702624|Progesterone|progesterone|mesh-list
111246436|NCT00702624|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
111246437|NCT00702624|Ganirelix|ganirelix|mesh-list
111246438|NCT00702624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111246439|NCT00702624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111246440|NCT00702624|Progestins|progestins|mesh-ancestor
111246441|NCT00702624|Hormone Antagonists|hormone antagonists|mesh-ancestor
111246442|NCT03915496|Abrocitinib|abrocitinib|mesh-list
111246443|NCT03915496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111246444|NCT03915496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111246445|NCT03915496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111246446|NCT00702546|Hormones|hormones|mesh-list
111246447|NCT00702546|Progesterone|progesterone|mesh-list
111246448|NCT00702546|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
111246449|NCT00702546|Ganirelix|ganirelix|mesh-list
111246450|NCT00702546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111246451|NCT00702546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111246452|NCT00702546|Progestins|progestins|mesh-ancestor
111246453|NCT00702546|Hormone Antagonists|hormone antagonists|mesh-ancestor
111246454|NCT01372410|Tiotropium Bromide|tiotropium bromide|mesh-list
111246455|NCT01372410|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111246456|NCT01372410|Autonomic Agents|autonomic agents|mesh-ancestor
111246457|NCT01372410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111246458|NCT01372410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111246459|NCT01372410|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111246460|NCT01372410|Respiratory System Agents|respiratory system agents|mesh-ancestor
111246461|NCT01372410|Parasympatholytics|parasympatholytics|mesh-ancestor
111246462|NCT01372410|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111246463|NCT01372410|Cholinergic Agents|cholinergic agents|mesh-ancestor
111246464|NCT01372410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111246465|NCT01372410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111246466|NCT02428686|Epoetin Alfa|epoetin alfa|mesh-list
111246467|NCT02428686|Hematinics|hematinics|mesh-ancestor
111246468|NCT02432976|Insulin|insulin|mesh-list
111246469|NCT02432976|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111246470|NCT02432976|Exenatide|exenatide|mesh-list
111246471|NCT02432976|Insulin Lispro|insulin lispro|mesh-list
111246472|NCT02432976|Incretins|incretins|mesh-list
111246473|NCT02432976|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111246474|NCT02432976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111246475|NCT02432976|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111246476|NCT02432976|Hormones|hormones|mesh-ancestor
111246477|NCT02432976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111246478|NCT02428374|Clopidogrel|clopidogrel|mesh-list
111246479|NCT02428374|Ticagrelor|ticagrelor|mesh-list
111246480|NCT02428374|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111246481|NCT02428374|Simvastatin|simvastatin|mesh-list
111246482|NCT02428374|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111246483|NCT02428374|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111246484|NCT02428374|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111246485|NCT02428374|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111246486|NCT02428374|Purinergic Agents|purinergic agents|mesh-ancestor
111246487|NCT02428374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111246488|NCT02428374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111246489|NCT02428374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111246490|NCT02428374|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111246491|NCT02428374|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111246492|NCT02428374|Antimetabolites|antimetabolites|mesh-ancestor
111246493|NCT02428374|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111246494|NCT02428374|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111246495|NCT02428374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111246496|NCT02428218|Dimethyl Fumarate|dimethyl fumarate|mesh-list
111246497|NCT02428218|Dermatologic Agents|dermatologic agents|mesh-ancestor
111246498|NCT02428218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111246499|NCT02428218|Immunologic Factors|immunologic factors|mesh-ancestor
111246500|NCT02428218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111246501|NCT04606576|Insulin|insulin|mesh-list
111246502|NCT04606576|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111246503|NCT04606576|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111246504|NCT04606576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111246505|NCT02428062|Phenylephrine|phenylephrine|mesh-list
111246506|NCT02428062|Dopamine|dopamine|mesh-list
111246507|NCT02428062|Epinephrine|epinephrine|mesh-list
111246508|NCT02428062|Oxymetazoline|oxymetazoline|mesh-list
111246509|NCT02428062|Norepinephrine|norepinephrine|mesh-list
111246510|NCT02428062|Ephedrine|ephedrine|mesh-list
111246511|NCT02428062|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
111246512|NCT02428062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111246513|NCT02428062|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111246514|NCT02428062|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111246515|NCT02428062|Adrenergic Agents|adrenergic agents|mesh-ancestor
111246516|NCT02428062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111246517|NCT02428062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111246518|NCT02428062|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111246519|NCT02428062|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111246520|NCT02428062|Autonomic Agents|autonomic agents|mesh-ancestor
111246521|NCT02428062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111246522|NCT02428062|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111246523|NCT02428062|Respiratory System Agents|respiratory system agents|mesh-ancestor
111246524|NCT02428062|Mydriatics|mydriatics|mesh-ancestor
111246525|NCT02428062|Sympathomimetics|sympathomimetics|mesh-ancestor
111246526|NCT02428062|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111246527|NCT02428062|Nasal Decongestants|nasal decongestants|mesh-ancestor
111246528|NCT02428062|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111246529|NCT02428062|Protective Agents|protective agents|mesh-ancestor
111246530|NCT02428062|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111246531|NCT02428062|Dopamine Agents|dopamine agents|mesh-ancestor
111246532|NCT04594798|Prednisone|prednisone|mesh-list
111246533|NCT04594798|Cyclophosphamide|cyclophosphamide|mesh-list
111246534|NCT04594798|Rituximab|rituximab|mesh-list
111246535|NCT04594798|Doxorubicin|doxorubicin|mesh-list
111246536|NCT04594798|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
111246537|NCT04594798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111246538|NCT04594798|Immunologic Factors|immunologic factors|mesh-ancestor
111246539|NCT04594798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111246540|NCT04594798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111246541|NCT04594798|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111246542|NCT04594798|Alkylating Agents|alkylating agents|mesh-ancestor
111246543|NCT04594798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111246544|NCT04594798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111246545|NCT04594798|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111246546|NCT04594798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111246547|NCT04594798|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111246548|NCT04594798|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111246549|NCT04594798|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111246550|NCT04594798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111246551|NCT04594798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111246552|NCT04594798|Glucocorticoids|glucocorticoids|mesh-ancestor
111246553|NCT04594798|Hormones|hormones|mesh-ancestor
111246554|NCT04594798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111246555|NCT04594798|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111246556|NCT04594798|Immunoconjugates|immunoconjugates|mesh-ancestor
111246557|NCT02432664|Midazolam|midazolam|mesh-list
111246558|NCT02432664|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111246559|NCT02432664|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111246560|NCT02432664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111246561|NCT02432664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111246562|NCT02432664|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111246563|NCT02432664|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111246564|NCT02432664|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111246565|NCT02432664|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111246566|NCT02432664|Anesthetics, General|anesthetics, general|mesh-ancestor
111246567|NCT02432664|Anesthetics|anesthetics|mesh-ancestor
111246568|NCT02432664|GABA Modulators|gaba modulators|mesh-ancestor
111246569|NCT02432664|GABA Agents|gaba agents|mesh-ancestor
111246570|NCT02432664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111246571|NCT02432664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111246572|NCT03189186|Pembrolizumab|pembrolizumab|mesh-list
111246573|NCT03189186|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111246574|NCT03189186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111246575|NCT03189186|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111246576|NCT03189186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111246577|NCT00361894|Enoxaparin|enoxaparin|mesh-list
111246578|NCT00361894|Rivaroxaban|rivaroxaban|mesh-list
111246579|NCT00361894|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111246580|NCT00361894|Antithrombins|antithrombins|mesh-ancestor
111246581|NCT00361894|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111246582|NCT00361894|Protease Inhibitors|protease inhibitors|mesh-ancestor
111246583|NCT00361894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111246584|NCT00361894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111246585|NCT00361894|Anticoagulants|anticoagulants|mesh-ancestor
111246586|NCT00361894|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111246587|NCT00361894|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111246588|NCT03185988|Trastuzumab|trastuzumab|mesh-list
111246589|NCT03185988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111246590|NCT03185988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111246591|NCT00361348|Heparin|heparin|mesh-list
111246592|NCT00361348|Anticoagulants|anticoagulants|mesh-ancestor
111246593|NCT00361348|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111246594|NCT00361348|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111246595|NCT00361348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111246596|NCT02431728|Melatonin|melatonin|mesh-list
111246597|NCT02431728|Antioxidants|antioxidants|mesh-ancestor
111246598|NCT02431728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111246599|NCT02431728|Protective Agents|protective agents|mesh-ancestor
111246600|NCT02431728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111246601|NCT02431728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111246602|NCT04343326|Menthol|menthol|mesh-list
111246603|NCT04343326|Antipruritics|antipruritics|mesh-ancestor
111246604|NCT04343326|Dermatologic Agents|dermatologic agents|mesh-ancestor
111246605|NCT00362206|Simvastatin|simvastatin|mesh-list
111246606|NCT00362206|Pravastatin|pravastatin|mesh-list
111246607|NCT00362206|Fenofibrate|fenofibrate|mesh-list
111246608|NCT00362206|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111246609|NCT00362206|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111246610|NCT00362206|Antimetabolites|antimetabolites|mesh-ancestor
111246611|NCT00362206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111246612|NCT00362206|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111246613|NCT00362206|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111246614|NCT00362206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111246615|NCT02314468|Glycerol|glycerol|mesh-list
111246616|NCT02314468|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
111246617|NCT02314468|Protective Agents|protective agents|mesh-ancestor
111246618|NCT02314468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111246619|NCT01704287|Paclitaxel|paclitaxel|mesh-list
111246620|NCT01704287|Carboplatin|carboplatin|mesh-list
111246621|NCT01704287|Pembrolizumab|pembrolizumab|mesh-list
111246622|NCT01704287|Temozolomide|temozolomide|mesh-list
111246623|NCT01704287|Dacarbazine|dacarbazine|mesh-list
111246624|NCT01704287|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111246625|NCT01704287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111246626|NCT01704287|Tubulin Modulators|tubulin modulators|mesh-ancestor
111246627|NCT01704287|Antimitotic Agents|antimitotic agents|mesh-ancestor
111246628|NCT01704287|Mitosis Modulators|mitosis modulators|mesh-ancestor
111246629|NCT01704287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111246630|NCT01704287|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111246631|NCT01704287|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111246632|NCT01704287|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111246633|NCT01704287|Alkylating Agents|alkylating agents|mesh-ancestor
111246634|NCT00362752|Norfloxacin|norfloxacin|mesh-list
111246635|NCT00362752|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111246636|NCT00362752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111246637|NCT00362752|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111246638|NCT00362752|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110970955|NCT02475824|Midazolam|midazolam|mesh-list
111246639|NCT00362752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111246640|NCT00362752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111246641|NCT00362752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111246642|NCT00362752|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111246643|NCT00362752|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111246644|NCT00118209|Prednisone|prednisone|mesh-list
111246645|NCT00118209|Cyclophosphamide|cyclophosphamide|mesh-list
111246646|NCT00118209|Rituximab|rituximab|mesh-list
111246647|NCT00118209|Doxorubicin|doxorubicin|mesh-list
111246648|NCT00118209|Etoposide|etoposide|mesh-list
111246649|NCT00118209|Vincristine|vincristine|mesh-list
111246650|NCT00118209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111246651|NCT00118209|Immunologic Factors|immunologic factors|mesh-ancestor
111246652|NCT00118209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111246653|NCT00118209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111246654|NCT00118209|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111246655|NCT00118209|Alkylating Agents|alkylating agents|mesh-ancestor
111246656|NCT00118209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111246657|NCT00118209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111246658|NCT00118209|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111246659|NCT00118209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111246660|NCT00118209|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111246661|NCT00118209|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111246662|NCT00118209|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111246663|NCT00118209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111246664|NCT00118209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111246665|NCT00118209|Glucocorticoids|glucocorticoids|mesh-ancestor
111246666|NCT00118209|Hormones|hormones|mesh-ancestor
111246667|NCT00118209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111246668|NCT00118209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111246669|NCT00118209|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111246670|NCT00118209|Tubulin Modulators|tubulin modulators|mesh-ancestor
111246671|NCT00118209|Antimitotic Agents|antimitotic agents|mesh-ancestor
111246672|NCT00118209|Mitosis Modulators|mitosis modulators|mesh-ancestor
111246673|NCT01897779|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-list
111246674|NCT01897779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111246675|NCT01897779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111246676|NCT01897779|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111246677|NCT01897779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111246678|NCT04342156|Hydroxychloroquine|hydroxychloroquine|mesh-list
111246679|NCT04342156|Antimalarials|antimalarials|mesh-ancestor
111246680|NCT04342156|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111246681|NCT04342156|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111246682|NCT04342156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111246683|NCT04342156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111246684|NCT04342156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111246685|NCT04342156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111246686|NCT01682837|Potassium Citrate|potassium citrate|mesh-list
111246687|NCT01682837|Magnesium citrate|magnesium citrate|mesh-list
111246688|NCT01682837|Citric Acid|citric acid|mesh-list
111246689|NCT01682837|Sodium Citrate|sodium citrate|mesh-list
111246690|NCT01682837|Anticoagulants|anticoagulants|mesh-ancestor
111246691|NCT01682837|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
111246692|NCT01682837|Chelating Agents|chelating agents|mesh-ancestor
111246693|NCT01682837|Sequestering Agents|sequestering agents|mesh-ancestor
111246694|NCT01682837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111246695|NCT01682837|Diuretics|diuretics|mesh-ancestor
111246696|NCT01682837|Natriuretic Agents|natriuretic agents|mesh-ancestor
111246697|NCT01682837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111246698|NCT01682837|Expectorants|expectorants|mesh-ancestor
111246699|NCT01682837|Respiratory System Agents|respiratory system agents|mesh-ancestor
111246700|NCT01682837|Cathartics|cathartics|mesh-ancestor
111246701|NCT01682837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111246702|NCT02213068|Mycophenolic Acid|mycophenolic acid|mesh-list
111246703|NCT02213068|Abatacept|abatacept|mesh-list
111246704|NCT02213068|Tacrolimus|tacrolimus|mesh-list
111246705|NCT02213068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111246706|NCT02213068|Immunologic Factors|immunologic factors|mesh-ancestor
111246707|NCT02213068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111246708|NCT02213068|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111246709|NCT02213068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111246710|NCT02213068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111246711|NCT02213068|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111246712|NCT02213068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111246713|NCT02213068|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111246714|NCT02213068|Antitubercular Agents|antitubercular agents|mesh-ancestor
111246715|NCT02213068|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111246716|NCT02213068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111246717|NCT02213068|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111246718|NCT02213068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111246719|NCT02213068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111246720|NCT00702234|Progesterone|progesterone|mesh-list
111246721|NCT00702234|Progestins|progestins|mesh-ancestor
111246722|NCT00702234|Hormones|hormones|mesh-ancestor
111246723|NCT00702234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111246724|NCT00702234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111246725|NCT04483284|Chlorotrianisene|chlorotrianisene|mesh-list
111246726|NCT04483284|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
111246727|NCT04483284|Estrogens|estrogens|mesh-ancestor
111246728|NCT04483284|Hormones|hormones|mesh-ancestor
111246729|NCT04483284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111246730|NCT04483284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111246731|NCT04483284|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111246732|NCT04483284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111246733|NCT00235833|Adalimumab|adalimumab|mesh-list
111246734|NCT00235833|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111246735|NCT00235833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111246736|NCT00235833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111246737|NCT00255801|Doxorubicin|doxorubicin|mesh-list
111246738|NCT00255801|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111246739|NCT00255801|Bexarotene|bexarotene|mesh-list
111246740|NCT00255801|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111246741|NCT00255801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111246742|NCT00255801|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111246743|NCT00255801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111246744|NCT00255801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111246745|NCT00255801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111246746|NCT02431416|Hormones|hormones|mesh-list
111246747|NCT02431416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111246748|NCT02431416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111246749|NCT04751955|Capecitabine|capecitabine|mesh-list
111246750|NCT04751955|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111246751|NCT04751955|Antimetabolites|antimetabolites|mesh-ancestor
111246752|NCT04751955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111246753|NCT04751955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111246754|NCT01682759|Metformin|metformin|mesh-list
111246755|NCT01682759|Insulin Glargine|insulin glargine|mesh-list
111246756|NCT01682759|Glimepiride|glimepiride|mesh-list
111246757|NCT01682759|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111246758|NCT01682759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111246759|NCT01682759|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111246760|NCT01682759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111246761|NCT01682759|Immunologic Factors|immunologic factors|mesh-ancestor
111246762|NCT01682681|Topiramate|topiramate|mesh-list
111246763|NCT01682681|Anticonvulsants|anticonvulsants|mesh-ancestor
111246764|NCT01682681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111246765|NCT01682681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111246766|NCT01682603|Botulinum Toxins|botulinum toxins|mesh-list
111246767|NCT01682603|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111246768|NCT01682603|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111246769|NCT01682603|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111246770|NCT01682603|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111246771|NCT01682603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111246772|NCT01682603|Cholinergic Agents|cholinergic agents|mesh-ancestor
111246773|NCT01682603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111246774|NCT01682603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111246775|NCT01682603|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111246776|NCT01682603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111246777|NCT03183024|Benralizumab|benralizumab|mesh-list
111246778|NCT03183024|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111246779|NCT03183024|Respiratory System Agents|respiratory system agents|mesh-ancestor
111246780|NCT00240981|Testosterone|testosterone|mesh-list
111246781|NCT00240981|Androgens|androgens|mesh-ancestor
111246782|NCT00240981|Hormones|hormones|mesh-ancestor
111246783|NCT00240981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111246784|NCT00240981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111246785|NCT01682213|Dabrafenib|dabrafenib|mesh-list
111246786|NCT01682213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111246787|NCT01682213|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111246788|NCT01682213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111246789|NCT01682213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111246790|NCT04134923|Corticosterone|corticosterone|mesh-list
111246791|NCT04134923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111246792|NCT02126553|Lenalidomide|lenalidomide|mesh-list
111246793|NCT02126553|Immunologic Factors|immunologic factors|mesh-ancestor
111246794|NCT02126553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111246795|NCT02126553|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111246796|NCT02126553|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111246797|NCT02126553|Growth Substances|growth substances|mesh-ancestor
111246798|NCT02126553|Growth Inhibitors|growth inhibitors|mesh-ancestor
111246799|NCT02126553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111246800|NCT01703741|Testosterone|testosterone|mesh-list
111246801|NCT01703741|Androgens|androgens|mesh-ancestor
111246802|NCT01703741|Hormones|hormones|mesh-ancestor
111246803|NCT01703741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111246804|NCT01703741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111246805|NCT02425176|Botulinum Toxins|botulinum toxins|mesh-list
111246806|NCT02425176|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111246807|NCT02425176|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111246808|NCT02425176|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
111246809|NCT02425176|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111246810|NCT02425176|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111246811|NCT02425176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111246812|NCT02425176|Cholinergic Agents|cholinergic agents|mesh-ancestor
111246813|NCT02425176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111246814|NCT02425176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111246815|NCT02425176|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111246816|NCT02425176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111246817|NCT02430714|Lenvatinib|lenvatinib|mesh-list
111246818|NCT02430714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111246819|NCT02430714|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111246820|NCT02430714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111246821|NCT02430714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111246822|NCT02425254|Acetaminophen|acetaminophen|mesh-list
111246823|NCT02425254|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111246824|NCT02425254|Analgesics|analgesics|mesh-ancestor
111246825|NCT02425254|Sensory System Agents|sensory system agents|mesh-ancestor
111246826|NCT02425254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111246827|NCT02425254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111246828|NCT02425254|Antipyretics|antipyretics|mesh-ancestor
111246829|NCT02426736|Dexamethasone|dexamethasone|mesh-list
111246830|NCT02426736|Bupivacaine|bupivacaine|mesh-list
111246831|NCT02426736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111246832|NCT02426736|Antiemetics|antiemetics|mesh-ancestor
111246833|NCT02426736|Autonomic Agents|autonomic agents|mesh-ancestor
111246834|NCT02426736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111246835|NCT02426736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111246836|NCT02426736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111246837|NCT02426736|Glucocorticoids|glucocorticoids|mesh-ancestor
111246838|NCT02426736|Hormones|hormones|mesh-ancestor
111246839|NCT02426736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111246840|NCT02426736|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111246841|NCT02426736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111246842|NCT02426736|Anesthetics, Local|anesthetics, local|mesh-ancestor
111246843|NCT02426736|Anesthetics|anesthetics|mesh-ancestor
111246844|NCT02426736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111246845|NCT02426736|Sensory System Agents|sensory system agents|mesh-ancestor
111246846|NCT03182634|Fulvestrant|fulvestrant|mesh-list
111246847|NCT03182634|Olaparib|olaparib|mesh-list
111246848|NCT03182634|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111246849|NCT03182634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111246850|NCT03182634|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
111246851|NCT03182634|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111246852|NCT03182634|Hormone Antagonists|hormone antagonists|mesh-ancestor
111246853|NCT03182634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111246854|NCT03182634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111246855|NCT03182634|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111246856|NCT03182634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111246857|NCT03182634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111246858|NCT03182322|Insulin|insulin|mesh-list
111246859|NCT03182322|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111246860|NCT03182322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111246861|NCT03185364|Sildenafil Citrate|sildenafil citrate|mesh-list
111246862|NCT03185364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111246863|NCT03185364|Vasodilator Agents|vasodilator agents|mesh-ancestor
111246864|NCT03185364|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111246865|NCT03185364|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111246866|NCT03185364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111246867|NCT03185364|Urological Agents|urological agents|mesh-ancestor
111246869|NCT02424552|Cholecalciferol|cholecalciferol|mesh-list
111246870|NCT02424552|Vitamins|vitamins|mesh-ancestor
111246871|NCT02424552|Micronutrients|micronutrients|mesh-ancestor
111246872|NCT02424552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111246873|NCT02424552|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111246874|NCT02424552|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111246875|NCT03182088|Norepinephrine|norepinephrine|mesh-list
111246876|NCT03182088|Bupivacaine|bupivacaine|mesh-list
111246877|NCT03182088|Anesthetics, Local|anesthetics, local|mesh-ancestor
111246878|NCT03182088|Anesthetics|anesthetics|mesh-ancestor
111246879|NCT03182088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111246880|NCT03182088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111246881|NCT03182088|Sensory System Agents|sensory system agents|mesh-ancestor
111246882|NCT03182088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111246883|NCT03182088|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111246884|NCT03182088|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111246885|NCT03182088|Adrenergic Agents|adrenergic agents|mesh-ancestor
111246886|NCT03182088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111246887|NCT03182088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111246888|NCT03182088|Sympathomimetics|sympathomimetics|mesh-ancestor
111246889|NCT03182088|Autonomic Agents|autonomic agents|mesh-ancestor
111246890|NCT03182088|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111246891|NCT02425878|Ulipristal acetate|ulipristal acetate|mesh-list
111246892|NCT02425878|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111246893|NCT02425878|Contraceptive Agents|contraceptive agents|mesh-ancestor
111246894|NCT02425878|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111246895|NCT02425878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111246896|NCT02425878|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111246897|NCT02425722|Linaclotide|linaclotide|mesh-list
111246898|NCT02425722|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
111246899|NCT02425722|Enzyme Activators|enzyme activators|mesh-ancestor
111246900|NCT02425722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111246901|NCT02425722|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111246902|NCT02061514|Propofol|propofol|mesh-list
111246903|NCT02061514|Desflurane|desflurane|mesh-list
111246904|NCT02061514|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111246905|NCT02061514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111246906|NCT02061514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111246907|NCT02061514|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111246908|NCT02061514|Anesthetics, General|anesthetics, general|mesh-ancestor
111246909|NCT02061514|Anesthetics|anesthetics|mesh-ancestor
111246910|NCT02061514|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111246911|NCT03183492|Vaccines|vaccines|mesh-list
111246912|NCT03183492|Immunologic Factors|immunologic factors|mesh-ancestor
111246913|NCT03183492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111246914|NCT02424318|Topiramate|topiramate|mesh-list
111246915|NCT02424318|Anticonvulsants|anticonvulsants|mesh-ancestor
111246916|NCT02424318|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111246917|NCT02424318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111246918|NCT03179280|Insulin|insulin|mesh-list
111246919|NCT03179280|Insulin Aspart|insulin aspart|mesh-list
111246920|NCT03179280|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111246921|NCT03179280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111246922|NCT01681433|Prednisone|prednisone|mesh-list
111246923|NCT01681433|Abiraterone Acetate|abiraterone acetate|mesh-list
111246924|NCT01681433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111246925|NCT01681433|Glucocorticoids|glucocorticoids|mesh-ancestor
111246926|NCT01681433|Hormones|hormones|mesh-ancestor
111246927|NCT01681433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111246928|NCT01681433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111246929|NCT01681433|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111246930|NCT01681433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111246931|NCT01681433|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111246932|NCT01681433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111246933|NCT01681433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111246934|NCT01681433|Hormone Antagonists|hormone antagonists|mesh-ancestor
111246935|NCT01681433|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111246936|NCT01703117|Riluzole|riluzole|mesh-list
111246937|NCT01703117|Anticonvulsants|anticonvulsants|mesh-ancestor
111246938|NCT01703117|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111246939|NCT01703117|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111246940|NCT01703117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111246941|NCT01703117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111246942|NCT01703117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111246943|NCT01703117|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111246944|NCT01703117|Protective Agents|protective agents|mesh-ancestor
111246945|NCT01702961|Cytarabine|cytarabine|mesh-list
111246946|NCT01702961|Etoposide|etoposide|mesh-list
111246947|NCT01702961|Rituximab|rituximab|mesh-list
111246948|NCT01702961|Melphalan|melphalan|mesh-list
111246949|NCT01702961|Carmustine|carmustine|mesh-list
111246950|NCT01702961|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111246951|NCT01702961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111246952|NCT01702961|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111246953|NCT01702961|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111246954|NCT01702961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111246955|NCT01702961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111246956|NCT01702961|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111246957|NCT01702961|Antimetabolites|antimetabolites|mesh-ancestor
111246958|NCT01702961|Antiviral Agents|antiviral agents|mesh-ancestor
111246959|NCT01702961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111246960|NCT01702961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111246961|NCT01702961|Immunologic Factors|immunologic factors|mesh-ancestor
111246962|NCT01702961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111246963|NCT01702961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111246964|NCT01702961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111246965|NCT01702961|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111246966|NCT01702961|Alkylating Agents|alkylating agents|mesh-ancestor
111246967|NCT01702961|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111246968|NCT01702025|Aminophylline|aminophylline|mesh-list
111246969|NCT01702025|Methazolamide|methazolamide|mesh-list
111246970|NCT01702025|Theophylline|theophylline|mesh-list
111246971|NCT01702025|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111246972|NCT01702025|Autonomic Agents|autonomic agents|mesh-ancestor
111246973|NCT01702025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111246974|NCT01702025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111246975|NCT01702025|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111246976|NCT01702025|Respiratory System Agents|respiratory system agents|mesh-ancestor
111246977|NCT01702025|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111246978|NCT01702025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111246979|NCT01702025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111246980|NCT01702025|Vasodilator Agents|vasodilator agents|mesh-ancestor
111246981|NCT01702025|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
111246982|NCT01702025|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111246983|NCT01702025|Purinergic Agents|purinergic agents|mesh-ancestor
111246984|NCT01702025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111246985|NCT01702025|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111246986|NCT01702025|Protective Agents|protective agents|mesh-ancestor
111246987|NCT01702025|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
111246988|NCT01702025|Diuretics|diuretics|mesh-ancestor
111246989|NCT01702025|Natriuretic Agents|natriuretic agents|mesh-ancestor
111246990|NCT01592747|Memantine|memantine|mesh-list
111246991|NCT01592747|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111246992|NCT01592747|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111246993|NCT01592747|Dopamine Agents|dopamine agents|mesh-ancestor
111246994|NCT01592747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111246995|NCT01592747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111246996|NCT01592747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111246997|NCT01592747|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111246998|NCT01592747|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111246999|NCT02425488|Coal Tar|coal tar|mesh-list
111247000|NCT02425488|Keratolytic Agents|keratolytic agents|mesh-ancestor
111247001|NCT02425488|Dermatologic Agents|dermatologic agents|mesh-ancestor
111247002|NCT02426112|Azithromycin|azithromycin|mesh-list
111247003|NCT02426112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111247004|NCT02426112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111247005|NCT03117192|Zinc Sulfate|zinc sulfate|mesh-list
111247006|NCT03117192|Astringents|astringents|mesh-ancestor
111247007|NCT03117192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111247008|NCT03117192|Dermatologic Agents|dermatologic agents|mesh-ancestor
111247009|NCT04768439|Vitamin D|vitamin d|mesh-list
111247010|NCT04768439|Ergocalciferols|ergocalciferols|mesh-list
111247011|NCT04768439|Cholecalciferol|cholecalciferol|mesh-list
111247012|NCT04768439|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
111247013|NCT04768439|Calcitriol|calcitriol|mesh-list
111247014|NCT04768439|Vitamins|vitamins|mesh-list
111247015|NCT04768439|Micronutrients|micronutrients|mesh-ancestor
111247016|NCT04768439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111247017|NCT04768439|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111247018|NCT04768439|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111247019|NCT04768439|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
111247020|NCT04768439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111247021|NCT04768439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111247022|NCT04768439|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111247023|NCT02421042|Lenvatinib|lenvatinib|mesh-list
111247024|NCT02421042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111247025|NCT02421042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111247026|NCT02421042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111247027|NCT02421042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111247028|NCT03181464|Lidocaine|lidocaine|mesh-list
111247029|NCT03181464|Anesthetics, Local|anesthetics, local|mesh-ancestor
111247030|NCT03181464|Anesthetics|anesthetics|mesh-ancestor
111247031|NCT03181464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111247032|NCT03181464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111247033|NCT03181464|Sensory System Agents|sensory system agents|mesh-ancestor
111247034|NCT03181464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111247035|NCT03181464|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111247036|NCT03181464|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111247037|NCT03181464|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111247038|NCT03181464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111247039|NCT03181464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111247040|NCT02423928|Cyclophosphamide|cyclophosphamide|mesh-list
111247041|NCT02423928|Ipilimumab|ipilimumab|mesh-list
111247042|NCT02423928|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111247043|NCT02423928|Immunologic Factors|immunologic factors|mesh-ancestor
111247044|NCT02423928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111247045|NCT02423928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111247046|NCT02423928|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111247047|NCT02423928|Alkylating Agents|alkylating agents|mesh-ancestor
111247048|NCT02423928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111247049|NCT02423928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111247050|NCT02423928|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111247051|NCT02423928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111247052|NCT02423928|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111247053|NCT02416128|Prednisolone|prednisolone|mesh-list
111247054|NCT02416128|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111247055|NCT02416128|Methylprednisolone|methylprednisolone|mesh-list
111247056|NCT02416128|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111247057|NCT02416128|Prednisolone acetate|prednisolone acetate|mesh-list
111247058|NCT02416128|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111247059|NCT02416128|Prednisolone phosphate|prednisolone phosphate|mesh-list
111247060|NCT02416128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111247061|NCT02416128|Glucocorticoids|glucocorticoids|mesh-ancestor
111247062|NCT02416128|Hormones|hormones|mesh-ancestor
111247063|NCT02416128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111247064|NCT02416128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111247065|NCT02416128|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111247066|NCT02416128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111247067|NCT02416128|Antiemetics|antiemetics|mesh-ancestor
111247068|NCT02416128|Autonomic Agents|autonomic agents|mesh-ancestor
111247069|NCT02416128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111247070|NCT02416128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111247071|NCT02416128|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111247072|NCT02416128|Protective Agents|protective agents|mesh-ancestor
111247073|NCT03106740|Minocycline|minocycline|mesh-list
111247074|NCT03106740|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111247075|NCT03106740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111247076|NCT03106818|Ketorolac|ketorolac|mesh-list
111247077|NCT03106818|Magnesium Sulfate|magnesium sulfate|mesh-list
111247078|NCT03106818|Bupivacaine|bupivacaine|mesh-list
111247079|NCT03106818|Anesthetics, Local|anesthetics, local|mesh-list
111247080|NCT03106818|Anesthetics|anesthetics|mesh-list
111247081|NCT03106818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111247082|NCT03106818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111247083|NCT03106818|Sensory System Agents|sensory system agents|mesh-ancestor
111247084|NCT03106818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111247085|NCT03106818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111247086|NCT03106818|Analgesics|analgesics|mesh-ancestor
111247087|NCT03106818|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111247088|NCT03106818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111247089|NCT03106818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111247090|NCT03106818|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111247091|NCT03106818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111247092|NCT03106818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111247093|NCT03106818|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111247095|NCT03106818|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111247096|NCT03106818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111247097|NCT03106818|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111247098|NCT03106818|Tocolytic Agents|tocolytic agents|mesh-ancestor
111247099|NCT03106818|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111247100|NCT01592045|Aldesleukin|aldesleukin|mesh-list
111247101|NCT01592045|Molgramostim|molgramostim|mesh-list
111247102|NCT01592045|Dinutuximab|dinutuximab|mesh-list
111247103|NCT01592045|Isotretinoin|isotretinoin|mesh-list
111247104|NCT01592045|Sargramostim|sargramostim|mesh-list
111247105|NCT01592045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111247106|NCT01592045|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111247107|NCT01592045|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111247108|NCT01592045|Antiviral Agents|antiviral agents|mesh-ancestor
111247109|NCT01592045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111247110|NCT01592045|Dermatologic Agents|dermatologic agents|mesh-ancestor
111247111|NCT01592045|Immunologic Factors|immunologic factors|mesh-ancestor
111247112|NCT01592045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111247113|NCT03178656|Sorafenib|sorafenib|mesh-list
111247114|NCT03178656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111247115|NCT03178656|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111247116|NCT03178656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111247117|NCT03178656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111247118|NCT01590797|Metformin|metformin|mesh-list
111247119|NCT01590797|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111247120|NCT01590797|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111247121|NCT01590797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111247122|NCT01590797|Incretins|incretins|mesh-ancestor
111247123|NCT01590797|Hormones|hormones|mesh-ancestor
111017738|NCT02079727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111247124|NCT01590797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111247125|NCT01590797|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111247126|NCT01590797|Protease Inhibitors|protease inhibitors|mesh-ancestor
111247127|NCT01590797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111247128|NCT01590797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111247129|NCT02415192|Amlodipine|amlodipine|mesh-list
111247130|NCT02415192|Valsartan|valsartan|mesh-list
111247131|NCT02415192|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111247132|NCT02415192|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111247133|NCT02415192|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111247134|NCT02415192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111247135|NCT02415192|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111247136|NCT02415192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111247137|NCT02415192|Vasodilator Agents|vasodilator agents|mesh-ancestor
111247138|NCT02415192|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111247139|NCT02415192|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111247140|NCT02415270|Menthol|menthol|mesh-list
111247141|NCT02415270|Nicotine|nicotine|mesh-list
111247142|NCT02415270|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111247143|NCT02415270|Autonomic Agents|autonomic agents|mesh-ancestor
111247144|NCT02415270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111247145|NCT02415270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111247146|NCT02415270|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111247147|NCT02415270|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111247148|NCT02415270|Cholinergic Agents|cholinergic agents|mesh-ancestor
111247149|NCT02415270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111247150|NCT02415270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111247151|NCT02415270|Antipruritics|antipruritics|mesh-ancestor
111247152|NCT02415270|Dermatologic Agents|dermatologic agents|mesh-ancestor
111247153|NCT02415114|Resveratrol|resveratrol|mesh-list
111247154|NCT02415114|Antioxidants|antioxidants|mesh-ancestor
111247155|NCT02415114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111247156|NCT02415114|Protective Agents|protective agents|mesh-ancestor
111247157|NCT02415114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111247158|NCT02415114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111247159|NCT02415114|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111247160|NCT03178422|Nicotine|nicotine|mesh-list
111247161|NCT03178422|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111247162|NCT03178422|Autonomic Agents|autonomic agents|mesh-ancestor
111247163|NCT03178422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111247164|NCT03178422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111247165|NCT03178422|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110971507|NCT01024608|Hormones|hormones|mesh-ancestor
111247167|NCT03178422|Cholinergic Agents|cholinergic agents|mesh-ancestor
111247168|NCT03178422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111247169|NCT03178422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111247170|NCT02420496|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
111247171|NCT02420496|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
111247172|NCT02420496|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111247173|NCT02414880|Rocuronium|rocuronium|mesh-list
111247174|NCT02414880|Neostigmine|neostigmine|mesh-list
111247175|NCT02414880|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
111247176|NCT02414880|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
111247177|NCT02414880|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111247178|NCT02414880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111247179|NCT02414880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111247180|NCT02414880|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111247181|NCT02414880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111247182|NCT02414880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111247183|NCT02414880|Cholinergic Agents|cholinergic agents|mesh-ancestor
111247184|NCT02414880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111247185|NCT02414880|Parasympathomimetics|parasympathomimetics|mesh-ancestor
111247186|NCT02414880|Autonomic Agents|autonomic agents|mesh-ancestor
111247187|NCT02423694|Dexetimide|dexetimide|mesh-list
111247188|NCT02423694|Citalopram|citalopram|mesh-list
111247189|NCT02423694|Escitalopram|escitalopram|mesh-list
111247190|NCT02423694|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111247191|NCT02423694|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111247192|NCT02423694|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111247193|NCT02423694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111247194|NCT02423694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111247195|NCT02423694|Serotonin Agents|serotonin agents|mesh-ancestor
110826715|NCT01100021|Doxazosin|doxazosin|mesh-list
111247196|NCT02423694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111247197|NCT02423694|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111247198|NCT02423694|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111247199|NCT02423694|Parasympatholytics|parasympatholytics|mesh-ancestor
111247200|NCT02423694|Autonomic Agents|autonomic agents|mesh-ancestor
111247201|NCT02423694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111247202|NCT02423694|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111247203|NCT02423694|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111247204|NCT02423694|Cholinergic Agents|cholinergic agents|mesh-ancestor
111247205|NCT02423694|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111247206|NCT02423694|Antidepressive Agents|antidepressive agents|mesh-ancestor
111247207|NCT02423694|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111247208|NCT02420418|Acetylcysteine|acetylcysteine|mesh-list
111247209|NCT02420418|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111247210|NCT02420418|Antiviral Agents|antiviral agents|mesh-ancestor
111247211|NCT02420418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111247212|NCT02420418|Expectorants|expectorants|mesh-ancestor
111247213|NCT02420418|Respiratory System Agents|respiratory system agents|mesh-ancestor
111247214|NCT02420418|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111247215|NCT02420418|Antioxidants|antioxidants|mesh-ancestor
111247216|NCT02420418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111247217|NCT02420418|Protective Agents|protective agents|mesh-ancestor
111247218|NCT02420418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111247219|NCT02420418|Antidotes|antidotes|mesh-ancestor
111247220|NCT02414802|Calcium, Dietary|calcium, dietary|mesh-list
111247221|NCT02414802|Heparin|heparin|mesh-list
111247222|NCT02414802|Calcium heparin|calcium heparin|mesh-list
111247223|NCT02414802|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
111247224|NCT02414802|Tinzaparin|tinzaparin|mesh-list
111247225|NCT02414802|Dalteparin|dalteparin|mesh-list
111247226|NCT02414802|Calcium|calcium|mesh-list
111247227|NCT02414802|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111247228|NCT02414802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111247229|NCT02414802|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111247230|NCT02414802|Anticoagulants|anticoagulants|mesh-ancestor
111247231|NCT02414802|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111247232|NCT02414802|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111247233|NCT02414802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111247234|NCT01701401|Sofosbuvir|sofosbuvir|mesh-list
111247235|NCT01701401|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
111247236|NCT01701401|Ledipasvir|ledipasvir|mesh-list
111247237|NCT01701401|Antiviral Agents|antiviral agents|mesh-ancestor
111247238|NCT01701401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111247239|NCT04482504|Vitamin D|vitamin d|mesh-list
111247240|NCT04482504|Vitamins|vitamins|mesh-ancestor
111247241|NCT04482504|Micronutrients|micronutrients|mesh-ancestor
111247242|NCT04482504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111247243|NCT04482504|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111247245|NCT02414568|Doxorubicin|doxorubicin|mesh-list
111247246|NCT02414568|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
111247247|NCT02414568|Vinblastine|vinblastine|mesh-list
111247248|NCT02414568|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111247249|NCT02414568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111247250|NCT02414568|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111247251|NCT02414568|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111247252|NCT02414568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111247253|NCT02414568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111247254|NCT02414568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111247255|NCT02414568|Glucocorticoids|glucocorticoids|mesh-ancestor
111247256|NCT02414568|Hormones|hormones|mesh-ancestor
111247257|NCT02414568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111247258|NCT02414568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111247259|NCT02414568|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111247260|NCT02414568|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111247261|NCT02414568|Alkylating Agents|alkylating agents|mesh-ancestor
111247262|NCT02414568|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111247263|NCT02414568|Tubulin Modulators|tubulin modulators|mesh-ancestor
111247264|NCT02414568|Antimitotic Agents|antimitotic agents|mesh-ancestor
111247265|NCT02414568|Mitosis Modulators|mitosis modulators|mesh-ancestor
111247266|NCT04348877|Antibodies|antibodies|mesh-list
111247267|NCT04348877|Immunologic Factors|immunologic factors|mesh-ancestor
111247268|NCT04348877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111247269|NCT03176628|Niacinamide|niacinamide|mesh-list
111247270|NCT03176628|Vitamin B Complex|vitamin b complex|mesh-ancestor
111247271|NCT03176628|Vitamins|vitamins|mesh-ancestor
111247272|NCT03176628|Micronutrients|micronutrients|mesh-ancestor
111247273|NCT03176628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111247274|NCT02414490|Immunoglobulins|immunoglobulins|mesh-list
111247275|NCT02414490|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111247276|NCT02414490|Antibodies|antibodies|mesh-list
111247277|NCT02414490|gamma-Globulins|gamma-globulins|mesh-list
111247278|NCT02414490|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
111247279|NCT02414490|Immunologic Factors|immunologic factors|mesh-ancestor
111247280|NCT02414490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111247281|NCT01590017|Cisplatin|cisplatin|mesh-list
111247282|NCT01590017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111247283|NCT01700621|Vaccines|vaccines|mesh-list
111247284|NCT01700621|Immunologic Factors|immunologic factors|mesh-ancestor
111247285|NCT01700621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111247286|NCT03178500|Clomiphene|clomiphene|mesh-list
111247287|NCT03178500|Enclomiphene|enclomiphene|mesh-list
111247288|NCT03178500|Zuclomiphene|zuclomiphene|mesh-list
111247289|NCT03178500|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111247290|NCT03178500|Hormone Antagonists|hormone antagonists|mesh-ancestor
111247291|NCT03178500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111247292|NCT03178500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111247293|NCT03178500|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111247294|NCT03178500|Fertility Agents|fertility agents|mesh-ancestor
111247295|NCT03178500|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111247296|NCT03178500|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111247297|NCT03178500|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111247298|NCT01700387|Topiramate|topiramate|mesh-list
111247299|NCT01700387|Botulinum Toxins|botulinum toxins|mesh-list
111247300|NCT01700387|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111247301|NCT01700387|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111247302|NCT01700387|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111247303|NCT01700387|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111247304|NCT01700387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111247305|NCT01700387|Cholinergic Agents|cholinergic agents|mesh-ancestor
111247306|NCT01700387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111247307|NCT01700387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111247308|NCT01700387|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111247309|NCT01700387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111247310|NCT01700387|Anticonvulsants|anticonvulsants|mesh-ancestor
111247311|NCT01700387|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111247312|NCT01699685|Glycopyrrolate|glycopyrrolate|mesh-list
111247313|NCT01699685|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111247314|NCT01699685|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111247315|NCT01699685|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111247316|NCT01699685|Cholinergic Agents|cholinergic agents|mesh-ancestor
111247317|NCT01699685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111247318|NCT01699685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111247319|NCT01699685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111247320|NCT01587989|Methotrexate|methotrexate|mesh-list
111247321|NCT01587989|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111247322|NCT01587989|Abortifacient Agents|abortifacient agents|mesh-ancestor
111247323|NCT01587989|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111247324|NCT01587989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111247325|NCT01587989|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111247326|NCT01587989|Antimetabolites|antimetabolites|mesh-ancestor
111247327|NCT01587989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111247328|NCT01587989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111247329|NCT01587989|Dermatologic Agents|dermatologic agents|mesh-ancestor
111247330|NCT01587989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111247331|NCT01587989|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111247332|NCT01587989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111247333|NCT01587989|Immunologic Factors|immunologic factors|mesh-ancestor
111247334|NCT01587989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111247335|NCT01587989|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111247336|NCT01697969|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
111247337|NCT01697969|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111247338|NCT01697969|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111247339|NCT01697969|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111247340|NCT01697969|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111247341|NCT01697969|Analgesics|analgesics|mesh-ancestor
111247342|NCT01697969|Sensory System Agents|sensory system agents|mesh-ancestor
111247343|NCT01697969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111247344|NCT01697969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111247345|NCT01697969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111247346|NCT01697969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111247347|NCT01697969|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111247348|NCT01697969|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
111247349|NCT01697969|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111247350|NCT01697969|Histamine Antagonists|histamine antagonists|mesh-ancestor
111247351|NCT01697969|Histamine Agents|histamine agents|mesh-ancestor
111247352|NCT01697969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111247353|NCT01697969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111247354|NCT01586819|Botulinum Toxins|botulinum toxins|mesh-list
111247355|NCT01586819|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111247356|NCT01586819|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111247357|NCT01586819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111247358|NCT01586819|Cholinergic Agents|cholinergic agents|mesh-ancestor
111247359|NCT01586819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111247360|NCT01586819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111247361|NCT01697579|Ondansetron|ondansetron|mesh-list
111247362|NCT01697579|Fosaprepitant|fosaprepitant|mesh-list
111247363|NCT01697579|Aprepitant|aprepitant|mesh-list
111247364|NCT01697579|Serotonin|serotonin|mesh-list
111247365|NCT01697579|Antiemetics|antiemetics|mesh-ancestor
111247366|NCT01697579|Autonomic Agents|autonomic agents|mesh-ancestor
111247367|NCT01697579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111247368|NCT01697579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111247369|NCT01697579|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111247370|NCT01697579|Antipruritics|antipruritics|mesh-ancestor
111247371|NCT01697579|Dermatologic Agents|dermatologic agents|mesh-ancestor
111247372|NCT01697579|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111247373|NCT01697579|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111247374|NCT01697579|Serotonin Agents|serotonin agents|mesh-ancestor
111247375|NCT01697579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111247376|NCT01697579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111247377|NCT01697579|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
111247378|NCT01697579|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111247379|NCT01586195|Vemurafenib|vemurafenib|mesh-list
111247380|NCT01586195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111247381|NCT01586195|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111247382|NCT01586195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111247383|NCT01586195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111247384|NCT01697345|Testosterone|testosterone|mesh-list
111247385|NCT01697345|Androgens|androgens|mesh-ancestor
111247386|NCT01697345|Hormones|hormones|mesh-ancestor
111247387|NCT01697345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111247388|NCT01697345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111247389|NCT03467386|Cyclophosphamide|cyclophosphamide|mesh-list
111247390|NCT03467386|Tacrolimus|tacrolimus|mesh-list
111247391|NCT03467386|Lenograstim|lenograstim|mesh-list
111247392|NCT03467386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111247393|NCT03467386|Immunologic Factors|immunologic factors|mesh-ancestor
111247394|NCT03467386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111247395|NCT03467386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111247396|NCT03467386|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111247397|NCT03467386|Alkylating Agents|alkylating agents|mesh-ancestor
111247398|NCT03467386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111247399|NCT03467386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111247400|NCT03467386|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111247401|NCT03467386|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111247402|NCT03467386|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111247403|NCT03467386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111247404|NCT03465592|Nivolumab|nivolumab|mesh-list
111247405|NCT03465592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111247406|NCT03465592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111247407|NCT03465592|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111247408|NCT03465592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111247409|NCT02441062|Edotreotide|edotreotide|mesh-list
111017826|NCT02085577|Ketamine|ketamine|mesh-list
111247410|NCT02441062|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111017945|NCT02091817|Oxytocin|oxytocin|mesh-list
111017976|NCT03557437|Amoxicillin|amoxicillin|mesh-list
111247411|NCT02441062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111247412|NCT02442700|Pitavastatin|pitavastatin|mesh-list
111018178|NCT02094469|Protective Agents|protective agents|mesh-ancestor
111018261|NCT02095717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111247413|NCT02442700|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111247414|NCT02442700|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111018408|NCT05054114|Antiviral Agents|antiviral agents|mesh-ancestor
111247415|NCT02442700|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111247416|NCT02442700|Antimetabolites|antimetabolites|mesh-ancestor
111247417|NCT02442700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111247418|NCT02442700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111247419|NCT02442700|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111247420|NCT00619528|Alemtuzumab|alemtuzumab|mesh-list
111247421|NCT00619528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111018924|NCT05041790|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111247422|NCT00619528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111247423|NCT00568672|Olanzapine|olanzapine|mesh-list
111247424|NCT00568672|Antiemetics|antiemetics|mesh-ancestor
111247425|NCT00568672|Autonomic Agents|autonomic agents|mesh-ancestor
111247426|NCT00568672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111247427|NCT00568672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111019226|NCT03093740|Sofosbuvir|sofosbuvir|mesh-list
111247428|NCT00568672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111247429|NCT00568672|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111247430|NCT00568672|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111247431|NCT00568672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111247432|NCT00568672|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111019508|NCT02119117|Coenzyme Q10|coenzyme q10|mesh-list
111247433|NCT00568672|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111247434|NCT00568672|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111019581|NCT05029076|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111019649|NCT03087890|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111247435|NCT00568672|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111247436|NCT00568672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111247437|NCT00568672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111247438|NCT00568672|Serotonin Agents|serotonin agents|mesh-ancestor
111247439|NCT02448862|Fentanyl|fentanyl|mesh-list
111247440|NCT02448862|Analgesics|analgesics|mesh-list
111247441|NCT02448862|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111247442|NCT02448862|Narcotics|narcotics|mesh-ancestor
111247443|NCT02448862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111247444|NCT02448862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111247445|NCT02448862|Sensory System Agents|sensory system agents|mesh-ancestor
111247446|NCT02448862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111247447|NCT02448862|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111247448|NCT02448862|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111247449|NCT02448862|Anesthetics, General|anesthetics, general|mesh-ancestor
111247450|NCT02448862|Anesthetics|anesthetics|mesh-ancestor
111247451|NCT01697267|Rituximab|rituximab|mesh-list
111247452|NCT01697267|Azathioprine|azathioprine|mesh-list
111247453|NCT01697267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111247454|NCT01697267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111247455|NCT01697267|Immunologic Factors|immunologic factors|mesh-ancestor
111247456|NCT01697267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111247457|NCT01697267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111020017|NCT02437162|Golimumab|golimumab|mesh-list
111247458|NCT01697267|Antimetabolites|antimetabolites|mesh-ancestor
111247459|NCT01697267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111247460|NCT01697267|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111020237|NCT05008250|Metoprolol|metoprolol|mesh-list
111247461|NCT01697267|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111020464|NCT02126995|Metadoxine|metadoxine|mesh-list
111247462|NCT00362986|Sunscreening Agents|sunscreening agents|mesh-list
111020529|NCT04993040|Tubulin Modulators|tubulin modulators|mesh-ancestor
111247463|NCT00362986|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111020681|NCT02458755|Atorvastatin|atorvastatin|mesh-list
111247464|NCT00362986|Protective Agents|protective agents|mesh-ancestor
111247465|NCT00362986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111247466|NCT00362986|Dermatologic Agents|dermatologic agents|mesh-ancestor
111247468|NCT00363376|Olanzapine|olanzapine|mesh-list
111247469|NCT00363376|Antiemetics|antiemetics|mesh-ancestor
111247470|NCT00363376|Autonomic Agents|autonomic agents|mesh-ancestor
111247471|NCT00363376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111247472|NCT00363376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111247473|NCT00363376|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111247474|NCT00363376|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111247475|NCT00363376|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111247476|NCT00363376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111247477|NCT00363376|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111247478|NCT00363376|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111020749|NCT02252341|Antiviral Agents|antiviral agents|mesh-ancestor
111020809|NCT03262545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111247479|NCT00363376|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111247480|NCT00363376|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111247481|NCT00363376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111247482|NCT00363376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111247483|NCT00363376|Serotonin Agents|serotonin agents|mesh-ancestor
111247484|NCT00363376|Anticonvulsants|anticonvulsants|mesh-ancestor
111247485|NCT00363376|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111247486|NCT00363376|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111247487|NCT02451202|Rocuronium|rocuronium|mesh-list
111247488|NCT02451202|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
111247489|NCT02451202|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
111247490|NCT02451202|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111247491|NCT02451202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111247492|NCT02451202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111247493|NCT02452060|Ketamine|ketamine|mesh-list
111247494|NCT02452060|Analgesics|analgesics|mesh-ancestor
111247495|NCT02452060|Sensory System Agents|sensory system agents|mesh-ancestor
111247496|NCT02452060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111247497|NCT02452060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111247498|NCT02452060|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111247499|NCT02452060|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111247500|NCT02452060|Anesthetics, General|anesthetics, general|mesh-ancestor
111247501|NCT02452060|Anesthetics|anesthetics|mesh-ancestor
111247502|NCT02452060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111247503|NCT02452060|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111247504|NCT02452060|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111247505|NCT02452060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111247506|NCT02452060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111247507|NCT01696955|Cetuximab|cetuximab|mesh-list
111247508|NCT01696955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111247509|NCT01696955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111020984|NCT02126293|Zinc|zinc|mesh-list
111247510|NCT02452528|Diphenhydramine|diphenhydramine|mesh-list
111247511|NCT02452528|Promethazine|promethazine|mesh-list
111247512|NCT02452528|Tenofovir|tenofovir|mesh-list
111247513|NCT02452528|Entecavir|entecavir|mesh-list
111247514|NCT02452528|Antiviral Agents|antiviral agents|mesh-ancestor
110738394|NCT05840952|Analgesics|analgesics|mesh-ancestor
111247515|NCT02452528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111247516|NCT02452528|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111247517|NCT02452528|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111021384|NCT04996160|Bortezomib|bortezomib|mesh-list
111247518|NCT02452528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111247519|NCT02452528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111247520|NCT02452528|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111021539|NCT02136511|Rituximab|rituximab|mesh-list
111247521|NCT02452528|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111247522|NCT02452528|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111021622|NCT03073850|Edoxaban|edoxaban|mesh-list
111247523|NCT02452528|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111021679|NCT03257241|Analgesics|analgesics|mesh-ancestor
111247524|NCT02452528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111247525|NCT02452528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111021755|NCT03249519|Cisplatin|cisplatin|mesh-list
111247526|NCT02452528|Anesthetics, Local|anesthetics, local|mesh-ancestor
111247527|NCT02452528|Anesthetics|anesthetics|mesh-ancestor
111021904|NCT03247257|Lidocaine|lidocaine|mesh-list
111247528|NCT02452528|Sensory System Agents|sensory system agents|mesh-ancestor
111247529|NCT02452528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111247530|NCT02452528|Antiemetics|antiemetics|mesh-ancestor
111247531|NCT02452528|Autonomic Agents|autonomic agents|mesh-ancestor
111247532|NCT02452528|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111247533|NCT02452528|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111247534|NCT02452528|Histamine Antagonists|histamine antagonists|mesh-ancestor
111247535|NCT02452528|Histamine Agents|histamine agents|mesh-ancestor
111247536|NCT02452528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111247537|NCT02452528|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111247538|NCT02452528|Antipruritics|antipruritics|mesh-ancestor
111247539|NCT02452528|Dermatologic Agents|dermatologic agents|mesh-ancestor
111247540|NCT02702388|Lenvatinib|lenvatinib|mesh-list
111247541|NCT02702388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111247542|NCT02702388|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111247543|NCT02702388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111247544|NCT02702388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111247545|NCT02456896|Oxcarbazepine|oxcarbazepine|mesh-list
111247546|NCT02456896|Anticonvulsants|anticonvulsants|mesh-ancestor
111247547|NCT02456896|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111247548|NCT02456896|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111247549|NCT02456896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111023017|NCT05019716|Podophyllotoxin|podophyllotoxin|mesh-list
111247550|NCT02456896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111247551|NCT02456896|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111023166|NCT04704453|Analgesics|analgesics|mesh-ancestor
111247552|NCT02456896|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111023235|NCT04504734|Analgesics|analgesics|mesh-ancestor
111023308|NCT04175431|Prednisone|prednisone|mesh-list
111247553|NCT01696877|Cyclophosphamide|cyclophosphamide|mesh-list
111247554|NCT01696877|Molgramostim|molgramostim|mesh-list
111247555|NCT01696877|Sargramostim|sargramostim|mesh-list
111023551|NCT03269994|Tazobactam|tazobactam|mesh-list
111247556|NCT01696877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111247557|NCT01696877|Immunologic Factors|immunologic factors|mesh-ancestor
111247558|NCT01696877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111247559|NCT01696877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111247560|NCT01696877|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111247561|NCT01696877|Alkylating Agents|alkylating agents|mesh-ancestor
111023839|NCT00062010|Keratolytic Agents|keratolytic agents|mesh-ancestor
111023922|NCT03567629|Antimetabolites|antimetabolites|mesh-ancestor
111023993|NCT05634824|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111247562|NCT01696877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111024074|NCT02452762|Vitamin D|vitamin d|mesh-list
111247563|NCT01696877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111247564|NCT01696877|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111247565|NCT02416102|Losartan|losartan|mesh-list
111024214|NCT03065504|Turmeric extract|turmeric extract|mesh-list
111247566|NCT02416102|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111247567|NCT02416102|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111024368|NCT04447352|Leucovorin|leucovorin|mesh-list
111247568|NCT02416102|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111247569|NCT02416102|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111024656|NCT00109837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111247570|NCT02416102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111247571|NCT02414256|Anesthetics|anesthetics|mesh-list
111024758|NCT00002462|Cobalt|cobalt|mesh-list
111247572|NCT02414256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110741913|NCT01220102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111247573|NCT02414256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111247574|NCT02458690|Dopamine|dopamine|mesh-list
111247575|NCT02458690|Norepinephrine|norepinephrine|mesh-list
111247576|NCT02458690|Antidepressive Agents|antidepressive agents|mesh-list
111247577|NCT02458690|Serotonin|serotonin|mesh-list
111247578|NCT02458690|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
111247579|NCT02458690|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-list
111247580|NCT02458690|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111247581|NCT02458690|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111247582|NCT02458690|Adrenergic Agents|adrenergic agents|mesh-ancestor
111247583|NCT02458690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111247584|NCT02458690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111247585|NCT02458690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111247586|NCT02458690|Sympathomimetics|sympathomimetics|mesh-ancestor
111247587|NCT02458690|Autonomic Agents|autonomic agents|mesh-ancestor
111247588|NCT02458690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111247589|NCT02458690|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111025694|NCT02055911|Ranibizumab|ranibizumab|mesh-list
111247590|NCT02458690|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111247591|NCT02458690|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111247592|NCT02458690|Dopamine Agents|dopamine agents|mesh-ancestor
111247593|NCT02458690|Protective Agents|protective agents|mesh-ancestor
111025985|NCT02796755|Protective Agents|protective agents|mesh-ancestor
111026055|NCT02378506|Sensory System Agents|sensory system agents|mesh-ancestor
111026128|NCT02347072|Tiotropium Bromide|tiotropium bromide|mesh-list
111247594|NCT02458690|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111247595|NCT02458690|Serotonin Agents|serotonin agents|mesh-ancestor
111026203|NCT02793947|Anesthetics, Local|anesthetics, local|mesh-ancestor
111247596|NCT02458690|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111247597|NCT02458690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111247598|NCT02458768|Menotropins|menotropins|mesh-list
111247599|NCT02458768|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111247600|NCT02458768|Fertility Agents|fertility agents|mesh-ancestor
111247601|NCT02458768|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111247602|NCT02458768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111247603|NCT02418676|Insulin|insulin|mesh-list
111247604|NCT02418676|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111247605|NCT02418676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111247606|NCT02419638|Dimethyl Fumarate|dimethyl fumarate|mesh-list
111247607|NCT02419638|Dermatologic Agents|dermatologic agents|mesh-ancestor
111247608|NCT02419638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111247609|NCT02419638|Immunologic Factors|immunologic factors|mesh-ancestor
111026853|NCT02083991|Glucocorticoids|glucocorticoids|mesh-ancestor
111247610|NCT02419638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111027005|NCT03241407|Antimetabolites|antimetabolites|mesh-ancestor
111247611|NCT02422836|Sunscreening Agents|sunscreening agents|mesh-list
111247612|NCT02422836|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111247613|NCT02422836|Protective Agents|protective agents|mesh-ancestor
111247614|NCT02422836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111247615|NCT02422836|Dermatologic Agents|dermatologic agents|mesh-ancestor
111247616|NCT03179514|Vasodilator Agents|vasodilator agents|mesh-list
111027443|NCT04920500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111247617|NCT03179514|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
111027520|NCT02081339|Ranibizumab|ranibizumab|mesh-list
111247618|NCT03179514|Lipid Regulating Agents|lipid regulating agents|mesh-list
111247619|NCT00707304|Lactoferrin|lactoferrin|mesh-list
111247620|NCT00707304|Talactoferrin alfa|talactoferrin alfa|mesh-list
111247621|NCT00707304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111247622|NCT00707304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111247623|NCT02423980|Glucagon|glucagon|mesh-list
111247624|NCT02423980|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
111247625|NCT02423980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111247626|NCT02423980|Hormones|hormones|mesh-ancestor
111247627|NCT02423980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111027816|NCT04485585|Tamsulosin|tamsulosin|mesh-list
111247628|NCT02423980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111247629|NCT02423980|Incretins|incretins|mesh-ancestor
111247630|NCT03176316|Naloxone|naloxone|mesh-list
111247631|NCT03176316|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111247632|NCT03176316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111027882|NCT03225963|Temozolomide|temozolomide|mesh-list
111247633|NCT03176316|Sensory System Agents|sensory system agents|mesh-ancestor
111247634|NCT03176316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111247635|NCT02419170|Cyclophosphamide|cyclophosphamide|mesh-list
111028021|NCT03224637|Antipyretics|antipyretics|mesh-ancestor
111247636|NCT02419170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111247637|NCT02419170|Immunologic Factors|immunologic factors|mesh-ancestor
111028095|NCT02254525|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111247638|NCT02419170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111247639|NCT02419170|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111028242|NCT03214653|Anesthetics, General|anesthetics, general|mesh-ancestor
111247640|NCT02419170|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111247641|NCT02419170|Alkylating Agents|alkylating agents|mesh-ancestor
111028393|NCT02141737|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111247642|NCT02419170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111028473|NCT03209115|Disinfectants|disinfectants|mesh-ancestor
111247643|NCT02419170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111028619|NCT02150317|Estrogens|estrogens|mesh-ancestor
111247644|NCT02419170|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111247645|NCT02974426|Cisplatin|cisplatin|mesh-list
111247646|NCT02974426|Carboplatin|carboplatin|mesh-list
111028920|NCT02446977|Riboflavin|riboflavin|mesh-list
111247647|NCT02974426|Pemetrexed|pemetrexed|mesh-list
111247648|NCT02974426|Vinorelbine|vinorelbine|mesh-list
111247649|NCT02974426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111247650|NCT02974426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111029151|NCT03196479|Anesthetics|anesthetics|mesh-ancestor
111029219|NCT02444949|Growth Substances|growth substances|mesh-ancestor
111247651|NCT02974426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111247652|NCT02974426|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111029367|NCT03190239|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111247653|NCT02974426|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111029442|NCT02622074|Antimitotic Agents|antimitotic agents|mesh-ancestor
111247654|NCT02974426|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111247655|NCT02974426|Tubulin Modulators|tubulin modulators|mesh-ancestor
111247656|NCT02974426|Antimitotic Agents|antimitotic agents|mesh-ancestor
111247657|NCT02974426|Mitosis Modulators|mitosis modulators|mesh-ancestor
111247658|NCT02413554|Rivastigmine|rivastigmine|mesh-list
111247659|NCT02413554|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111247660|NCT02413554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111029739|NCT04900766|Sensory System Agents|sensory system agents|mesh-ancestor
111029810|NCT04907864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111247661|NCT02413554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111247662|NCT02413554|Cholinergic Agents|cholinergic agents|mesh-ancestor
111247663|NCT02413554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111030055|NCT01596062|Everolimus|everolimus|mesh-list
111247664|NCT02413554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111247665|NCT02413554|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111030110|NCT02145559|Metformin|metformin|mesh-list
111247666|NCT02413554|Protective Agents|protective agents|mesh-ancestor
111247667|NCT02422602|Rivaroxaban|rivaroxaban|mesh-list
111247668|NCT02422602|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111247669|NCT02422602|Antithrombins|antithrombins|mesh-ancestor
111030410|NCT02157337|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111247670|NCT02422602|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111247671|NCT02422602|Protease Inhibitors|protease inhibitors|mesh-ancestor
111030657|NCT02791763|Glycine|glycine|mesh-list
111247672|NCT02422602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111030708|NCT02082665|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111030782|NCT01595438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111247673|NCT02422602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111247674|NCT02422602|Anticoagulants|anticoagulants|mesh-ancestor
111247675|NCT02465632|Clindamycin|clindamycin|mesh-list
111030927|NCT02089841|Artemether|artemether|mesh-list
111247676|NCT02465632|Clindamycin palmitate|clindamycin palmitate|mesh-list
111247677|NCT02465632|Clindamycin phosphate|clindamycin phosphate|mesh-list
111247678|NCT02465632|Benzoyl Peroxide|benzoyl peroxide|mesh-list
111247679|NCT02465632|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111247680|NCT02465632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111247681|NCT02465632|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111247682|NCT02465632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111031296|NCT02094833|Vaccines|vaccines|mesh-list
111247683|NCT02465632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111247684|NCT02465632|Dermatologic Agents|dermatologic agents|mesh-ancestor
111031527|NCT02103569|Norethindrone|norethindrone|mesh-list
111247685|NCT02703636|Rivastigmine|rivastigmine|mesh-list
111247686|NCT02703636|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111247687|NCT02703636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111247688|NCT02703636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111247689|NCT02703636|Cholinergic Agents|cholinergic agents|mesh-ancestor
110972002|NCT02191371|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111247690|NCT02703636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111247691|NCT02703636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111247692|NCT02703636|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111247693|NCT02703636|Protective Agents|protective agents|mesh-ancestor
111247694|NCT02422056|Tranexamic Acid|tranexamic acid|mesh-list
111247695|NCT02422056|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111247696|NCT02422056|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111247697|NCT02422056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111247698|NCT02422056|Hemostatics|hemostatics|mesh-ancestor
111031883|NCT04864496|Acetylcysteine|acetylcysteine|mesh-list
111247699|NCT02422056|Coagulants|coagulants|mesh-ancestor
111247700|NCT02466958|Milnacipran|milnacipran|mesh-list
111247701|NCT02466958|Levomilnacipran|levomilnacipran|mesh-list
111247702|NCT02466958|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111247703|NCT02466958|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111247704|NCT02466958|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111247705|NCT02466958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111032252|NCT02429271|Purinergic Agents|purinergic agents|mesh-ancestor
111247706|NCT02466958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111247707|NCT02466958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111247708|NCT02466958|Antidepressive Agents|antidepressive agents|mesh-ancestor
111247709|NCT02466958|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111247710|NCT02466958|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111247711|NCT02466958|Analgesics|analgesics|mesh-ancestor
111032622|NCT02427165|Respiratory System Agents|respiratory system agents|mesh-ancestor
111247712|NCT02466958|Sensory System Agents|sensory system agents|mesh-ancestor
111247713|NCT02466958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111247714|NCT02467504|Folic Acid|folic acid|mesh-list
111247715|NCT02467504|Loxoprofen|loxoprofen|mesh-list
111247716|NCT02467504|Hematinics|hematinics|mesh-ancestor
111247717|NCT02467504|Vitamin B Complex|vitamin b complex|mesh-ancestor
111247718|NCT02467504|Vitamins|vitamins|mesh-ancestor
111032875|NCT04770272|Paclitaxel|paclitaxel|mesh-list
111247719|NCT02467504|Micronutrients|micronutrients|mesh-ancestor
111032920|NCT00709371|Bupropion|bupropion|mesh-list
111247720|NCT02467504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111033070|NCT02336074|Antiviral Agents|antiviral agents|mesh-ancestor
111247721|NCT02467504|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111247722|NCT02467504|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111247723|NCT02467504|Analgesics|analgesics|mesh-ancestor
111247724|NCT02467504|Sensory System Agents|sensory system agents|mesh-ancestor
111033293|NCT04822064|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111247725|NCT02467504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111247726|NCT02467504|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111033440|NCT04806230|Mirtazapine|mirtazapine|mesh-list
111247727|NCT02467504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111247728|NCT02413086|Chitosan|chitosan|mesh-list
111247729|NCT02413086|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111247730|NCT02413086|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111247731|NCT02413086|Antimetabolites|antimetabolites|mesh-ancestor
111247732|NCT02413086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111033737|NCT02251847|Ezetimibe|ezetimibe|mesh-list
111033808|NCT03551171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111247733|NCT02413086|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111247734|NCT02413086|Chelating Agents|chelating agents|mesh-ancestor
111247735|NCT02413086|Sequestering Agents|sequestering agents|mesh-ancestor
111247736|NCT02413086|Hemostatics|hemostatics|mesh-ancestor
111247737|NCT02413086|Coagulants|coagulants|mesh-ancestor
111247738|NCT02468830|Mirabegron|mirabegron|mesh-list
111247739|NCT02468830|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
111247740|NCT02468830|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111247741|NCT02468830|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111247742|NCT02468830|Adrenergic Agents|adrenergic agents|mesh-ancestor
111247743|NCT02468830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111247744|NCT02468830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111247745|NCT02468830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111247746|NCT02468830|Urological Agents|urological agents|mesh-ancestor
111247747|NCT02470234|Methylphenidate|methylphenidate|mesh-list
111247748|NCT02470234|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111247749|NCT02470234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111247750|NCT02470234|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111247751|NCT02470234|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111034234|NCT02132897|Carbamazepine|carbamazepine|mesh-list
111034308|NCT03549611|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111034382|NCT02133755|Dopamine Agents|dopamine agents|mesh-ancestor
111247752|NCT02470234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111247753|NCT02470234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111034537|NCT04090190|Fesoterodine|fesoterodine|mesh-list
111247754|NCT02470234|Dopamine Agents|dopamine agents|mesh-ancestor
111247755|NCT02470234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111247756|NCT02418702|Ketamine|ketamine|mesh-list
111247757|NCT02418702|Analgesics|analgesics|mesh-ancestor
111247758|NCT02418702|Sensory System Agents|sensory system agents|mesh-ancestor
111247759|NCT02418702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111247760|NCT02418702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111247761|NCT02418702|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111247762|NCT02418702|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111247763|NCT02418702|Anesthetics, General|anesthetics, general|mesh-ancestor
111247764|NCT02418702|Anesthetics|anesthetics|mesh-ancestor
110972094|NCT02210169|Vancomycin|vancomycin|mesh-list
111247765|NCT02418702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111247766|NCT02418702|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111247767|NCT02418702|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111247768|NCT02418702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111247769|NCT02418702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111247770|NCT02412930|Tramadol|tramadol|mesh-list
111035431|NCT00109733|Hormones|hormones|mesh-list
111247771|NCT02412930|Bupivacaine|bupivacaine|mesh-list
111247772|NCT02412930|Anesthetics, Local|anesthetics, local|mesh-ancestor
111247773|NCT02412930|Anesthetics|anesthetics|mesh-ancestor
111247774|NCT02412930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111247775|NCT02412930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111247776|NCT02412930|Sensory System Agents|sensory system agents|mesh-ancestor
111247777|NCT02412930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111247778|NCT02412930|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111247779|NCT02412930|Narcotics|narcotics|mesh-ancestor
111247780|NCT02412930|Analgesics|analgesics|mesh-ancestor
111247781|NCT02432716|Insulin|insulin|mesh-list
111247782|NCT02432716|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111247783|NCT02432716|Insulin glulisine|insulin glulisine|mesh-list
111247784|NCT02432716|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111247785|NCT02432716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111247786|NCT02418624|Carboplatin|carboplatin|mesh-list
111247787|NCT02418624|Olaparib|olaparib|mesh-list
111247788|NCT02418624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111247789|NCT02418624|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111247790|NCT02418624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111247791|NCT02418624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111247792|NCT02440204|Remifentanil|remifentanil|mesh-list
111247793|NCT02440204|Sevoflurane|sevoflurane|mesh-list
111247794|NCT02440204|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111247795|NCT02440204|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111247796|NCT02440204|Anesthetics, General|anesthetics, general|mesh-ancestor
111247797|NCT02440204|Anesthetics|anesthetics|mesh-ancestor
111247798|NCT02440204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111247799|NCT02440204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111247800|NCT02440204|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111247801|NCT02440204|Narcotics|narcotics|mesh-ancestor
111035839|NCT02163655|Furosemide|furosemide|mesh-list
111247802|NCT02440204|Analgesics|analgesics|mesh-ancestor
111247803|NCT02440204|Sensory System Agents|sensory system agents|mesh-ancestor
111247804|NCT02440204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111247805|NCT02410590|Atropine|atropine|mesh-list
111247806|NCT02410590|Rocuronium|rocuronium|mesh-list
111247807|NCT02410590|Cisatracurium|cisatracurium|mesh-list
111247808|NCT02410590|Succinylcholine|succinylcholine|mesh-list
111247809|NCT02410590|Neostigmine|neostigmine|mesh-list
111247810|NCT02410590|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
111247811|NCT02410590|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
111247812|NCT02410590|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111247813|NCT02410590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111036358|NCT02417649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111036432|NCT02417337|Antipyretics|antipyretics|mesh-ancestor
111247814|NCT02410590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111247815|NCT02410590|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111036585|NCT03171987|Lidocaine|lidocaine|mesh-list
111036662|NCT02171455|Dabigatran|dabigatran|mesh-list
111247816|NCT02410590|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111036740|NCT05679050|Folfirinox|folfirinox|mesh-list
111247817|NCT02410590|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111247818|NCT02410590|Autonomic Agents|autonomic agents|mesh-ancestor
111247819|NCT02410590|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111247820|NCT02410590|Respiratory System Agents|respiratory system agents|mesh-ancestor
111247821|NCT02410590|Mydriatics|mydriatics|mesh-ancestor
111247822|NCT02410590|Parasympatholytics|parasympatholytics|mesh-ancestor
111247823|NCT02410590|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111247824|NCT02410590|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111247825|NCT02410590|Cholinergic Agents|cholinergic agents|mesh-ancestor
111036950|NCT02582684|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111247826|NCT02410590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111247827|NCT02410590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111247828|NCT02410590|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111247829|NCT02410590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111247830|NCT02410590|Parasympathomimetics|parasympathomimetics|mesh-ancestor
111037024|NCT02411331|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111247831|NCT02410590|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
111247832|NCT02517580|Vitamin K|vitamin k|mesh-list
111247833|NCT02517580|Vitamin K 2|vitamin k 2|mesh-list
111247834|NCT02517580|Vitamins|vitamins|mesh-ancestor
111247835|NCT02517580|Micronutrients|micronutrients|mesh-ancestor
111247836|NCT02517580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111037319|NCT00109681|Iloprost|iloprost|mesh-list
111247837|NCT02517580|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111247838|NCT02517580|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111247839|NCT02517580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111247840|NCT02517580|Hemostatics|hemostatics|mesh-ancestor
111247841|NCT02517580|Coagulants|coagulants|mesh-ancestor
111247843|NCT02522104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111247844|NCT02522104|Antisickling Agents|antisickling agents|mesh-ancestor
111247845|NCT02522104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111247846|NCT02522104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111247847|NCT02522104|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111247848|NCT02412150|Dexmedetomidine|dexmedetomidine|mesh-list
111247849|NCT02412150|Remifentanil|remifentanil|mesh-list
111247850|NCT02412150|Desflurane|desflurane|mesh-list
111247851|NCT02412150|Anesthetics|anesthetics|mesh-list
111247852|NCT02412150|Anesthetics, Inhalation|anesthetics, inhalation|mesh-list
111247853|NCT02412150|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111247854|NCT02412150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111247855|NCT02412150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111247856|NCT02412150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111247857|NCT02412150|Analgesics|analgesics|mesh-ancestor
111247858|NCT02412150|Sensory System Agents|sensory system agents|mesh-ancestor
111247859|NCT02412150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111247860|NCT02412150|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111247861|NCT02412150|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111247862|NCT02412150|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111247863|NCT02412150|Adrenergic Agents|adrenergic agents|mesh-ancestor
111247864|NCT02412150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111037529|NCT02175589|Colchicine|colchicine|mesh-list
111247865|NCT02412150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111037660|NCT02176135|Auranofin|auranofin|mesh-list
111247866|NCT02412150|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111247867|NCT02412150|Narcotics|narcotics|mesh-ancestor
111247868|NCT02412150|Anesthetics, General|anesthetics, general|mesh-ancestor
111247869|NCT02523196|Cholic Acids|cholic acids|mesh-list
111037880|NCT05532878|Anticoagulants|anticoagulants|mesh-ancestor
111247870|NCT02523196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111247871|NCT02418078|Anesthetics|anesthetics|mesh-list
111038178|NCT06009497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111247872|NCT02418078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111247873|NCT02418078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111247874|NCT03175926|Budesonide|budesonide|mesh-list
111247875|NCT03175926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111247876|NCT03175926|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111247877|NCT03175926|Autonomic Agents|autonomic agents|mesh-ancestor
111247878|NCT03175926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111247879|NCT03175926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111038321|NCT05955261|Azacitidine|azacitidine|mesh-list
111038395|NCT05918796|Dexamethasone|dexamethasone|mesh-list
111247880|NCT03175926|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111247881|NCT03175926|Respiratory System Agents|respiratory system agents|mesh-ancestor
111247882|NCT03175926|Glucocorticoids|glucocorticoids|mesh-ancestor
111247883|NCT03175926|Hormones|hormones|mesh-ancestor
111247884|NCT03175926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111247885|NCT02524054|Furosemide|furosemide|mesh-list
111247886|NCT02524054|Diuretics|diuretics|mesh-ancestor
111038937|NCT04259255|Edaravone|edaravone|mesh-list
111247887|NCT02524054|Natriuretic Agents|natriuretic agents|mesh-ancestor
111247888|NCT02524054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111247889|NCT02524054|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
111247890|NCT02524054|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111247891|NCT02524054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111247892|NCT03106662|Cyclophosphamide|cyclophosphamide|mesh-list
111247893|NCT03106662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111247894|NCT03106662|Immunologic Factors|immunologic factors|mesh-ancestor
111247895|NCT03106662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111247896|NCT03106662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111247897|NCT03106662|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111247898|NCT03106662|Alkylating Agents|alkylating agents|mesh-ancestor
111247899|NCT03106662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111247900|NCT03106662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111247901|NCT03106662|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111247902|NCT02417610|Hyaluronic Acid|hyaluronic acid|mesh-list
111247903|NCT02417610|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111247904|NCT02417610|Immunologic Factors|immunologic factors|mesh-ancestor
111247905|NCT02417610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111247906|NCT02417610|Viscosupplements|viscosupplements|mesh-ancestor
111247907|NCT02417610|Protective Agents|protective agents|mesh-ancestor
111247908|NCT03116490|Anesthetics|anesthetics|mesh-list
111247909|NCT03116490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111247910|NCT03116490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111247911|NCT02417298|Ketamine|ketamine|mesh-list
111247912|NCT02417298|Analgesics|analgesics|mesh-ancestor
111247913|NCT02417298|Sensory System Agents|sensory system agents|mesh-ancestor
111247914|NCT02417298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111247915|NCT02417298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111247916|NCT02417298|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111039349|NCT02182219|Nintedanib|nintedanib|mesh-list
111247917|NCT02417298|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111247918|NCT02417298|Anesthetics, General|anesthetics, general|mesh-ancestor
111247919|NCT02417298|Anesthetics|anesthetics|mesh-ancestor
111247920|NCT02417298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111247921|NCT02417298|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111247922|NCT02417298|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111247923|NCT02417298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111247924|NCT02417298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111247925|NCT02525536|Trebananib|trebananib|mesh-list
111247926|NCT02525536|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111247927|NCT02525536|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111247928|NCT02525536|Growth Substances|growth substances|mesh-ancestor
111247929|NCT02525536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111247930|NCT02525536|Growth Inhibitors|growth inhibitors|mesh-ancestor
111039989|NCT02184637|Piperaquine|piperaquine|mesh-list
111247931|NCT02525536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111247932|NCT02411994|Artesunate|artesunate|mesh-list
111247933|NCT02411994|Lumefantrine|lumefantrine|mesh-list
111247934|NCT02411994|Artemether|artemether|mesh-list
111040154|NCT02752633|Febuxostat|febuxostat|mesh-list
111040216|NCT04766996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111247935|NCT02411994|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
111247936|NCT02411994|Pyronaridine|pyronaridine|mesh-list
111040359|NCT05507372|Pimozide|pimozide|mesh-list
111040370|NCT02192203|Diclofenac|diclofenac|mesh-list
111247937|NCT02411994|Pyronaridine tetraphosphate, artesunate drug combination|pyronaridine tetraphosphate, artesunate drug combination|mesh-list
111247938|NCT02411994|Antimalarials|antimalarials|mesh-ancestor
111247939|NCT02411994|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111247940|NCT02411994|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111247941|NCT02411994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111247942|NCT02411994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111247943|NCT02411994|Antiviral Agents|antiviral agents|mesh-ancestor
111247944|NCT02411994|Schistosomicides|schistosomicides|mesh-ancestor
111247945|NCT02411994|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
111247946|NCT02411994|Anthelmintics|anthelmintics|mesh-ancestor
111247947|NCT02530294|Glycopyrrolate|glycopyrrolate|mesh-list
111247948|NCT02530294|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111040879|NCT02201563|Minocycline|minocycline|mesh-list
111247949|NCT02530294|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111247950|NCT02530294|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111247951|NCT02530294|Cholinergic Agents|cholinergic agents|mesh-ancestor
111247952|NCT02530294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111247953|NCT02530294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111041101|NCT05976568|Bevacizumab|bevacizumab|mesh-list
111247954|NCT02530294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111247955|NCT03177720|Ciprofloxacin|ciprofloxacin|mesh-list
111247956|NCT03177720|Imipenem|imipenem|mesh-list
111041389|NCT05430152|Naltrexone|naltrexone|mesh-list
111247957|NCT03177720|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111041474|NCT05157971|Cytarabine|cytarabine|mesh-list
111041540|NCT04916327|Antioxidants|antioxidants|mesh-list
111247958|NCT03177720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111247959|NCT03177720|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111247960|NCT03177720|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111247961|NCT03177720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111041761|NCT04140266|Tenofovir|tenofovir|mesh-list
111041831|NCT03926143|Maytansine|maytansine|mesh-list
111041906|NCT03480776|Aspirin|aspirin|mesh-list
111041984|NCT03297606|Immunologic Factors|immunologic factors|mesh-ancestor
111042059|NCT02799641|Sensory System Agents|sensory system agents|mesh-ancestor
111247962|NCT03177720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111247963|NCT03177720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111247964|NCT03177720|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111247965|NCT03177720|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111247966|NCT02411604|Tacrolimus|tacrolimus|mesh-list
111247967|NCT02411604|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111247968|NCT02411604|Immunologic Factors|immunologic factors|mesh-ancestor
111247969|NCT02411604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111247970|NCT02411604|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111247971|NCT02411604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111247972|NCT02411604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111247973|NCT03175380|BCG Vaccine|bcg vaccine|mesh-list
111042654|NCT00343408|Vitamins|vitamins|mesh-ancestor
111247974|NCT03175380|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111042728|NCT00093457|Sorafenib|sorafenib|mesh-list
111247975|NCT03175380|Immunologic Factors|immunologic factors|mesh-ancestor
111247976|NCT03175380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111247977|NCT02530528|Chlorhexidine|chlorhexidine|mesh-list
111247978|NCT02530528|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
111247979|NCT02530528|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111247980|NCT02530528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111247981|NCT02530528|Disinfectants|disinfectants|mesh-ancestor
111247982|NCT02530528|Dermatologic Agents|dermatologic agents|mesh-ancestor
111247983|NCT03174756|Chlorhexidine|chlorhexidine|mesh-list
111247984|NCT03174756|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111247985|NCT03174756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111247986|NCT03174756|Disinfectants|disinfectants|mesh-ancestor
111247987|NCT03174678|Dexmedetomidine|dexmedetomidine|mesh-list
111247988|NCT03174678|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111247989|NCT03174678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111042877|NCT05501288|Antitussive Agents|antitussive agents|mesh-ancestor
111247990|NCT03174678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111247991|NCT03174678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111247992|NCT03174678|Analgesics|analgesics|mesh-ancestor
111247993|NCT03174678|Sensory System Agents|sensory system agents|mesh-ancestor
111043067|NCT02205151|Vasodilator Agents|vasodilator agents|mesh-ancestor
111247994|NCT03174678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111247995|NCT03174678|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111247996|NCT03174678|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111247997|NCT03174678|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111247998|NCT03174678|Adrenergic Agents|adrenergic agents|mesh-ancestor
111247999|NCT03174678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111248000|NCT03174678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111248001|NCT02409498|Bupivacaine|bupivacaine|mesh-list
111248002|NCT02409498|Anesthetics, Local|anesthetics, local|mesh-ancestor
111248003|NCT02409498|Anesthetics|anesthetics|mesh-ancestor
111248004|NCT02409498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111248005|NCT02409498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111248006|NCT02409498|Sensory System Agents|sensory system agents|mesh-ancestor
111043499|NCT02398383|Hypoglycemic Agents|hypoglycemic agents|mesh-list
111248007|NCT02409498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111248009|NCT02409186|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111248010|NCT02409186|Cisplatin|cisplatin|mesh-list
111248011|NCT02409186|Nimotuzumab|nimotuzumab|mesh-list
111248012|NCT02409186|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111248013|NCT02409186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111248014|NCT02409186|Tubulin Modulators|tubulin modulators|mesh-ancestor
111248015|NCT02409186|Antimitotic Agents|antimitotic agents|mesh-ancestor
111248016|NCT02409186|Mitosis Modulators|mitosis modulators|mesh-ancestor
111248017|NCT02409186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111248018|NCT02409186|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111248019|NCT02410746|Ibuprofen|ibuprofen|mesh-list
111248020|NCT02410746|Morphine|morphine|mesh-list
111248021|NCT02410746|Levobupivacaine|levobupivacaine|mesh-list
111248022|NCT02410746|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111248023|NCT02410746|Narcotics|narcotics|mesh-ancestor
111248024|NCT02410746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111043714|NCT02226991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111248025|NCT02410746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111248026|NCT02410746|Analgesics|analgesics|mesh-ancestor
111248027|NCT02410746|Sensory System Agents|sensory system agents|mesh-ancestor
111248028|NCT02410746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111248029|NCT02410746|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111248030|NCT02410746|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111248031|NCT02410746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111248032|NCT02410746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111248033|NCT02410746|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111248034|NCT02410746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111248035|NCT02410746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111248036|NCT02410746|Anesthetics, Local|anesthetics, local|mesh-ancestor
111248037|NCT02410746|Anesthetics|anesthetics|mesh-ancestor
111248038|NCT03177174|Docetaxel|docetaxel|mesh-list
111248039|NCT03177174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111248040|NCT03177174|Tubulin Modulators|tubulin modulators|mesh-ancestor
111043841|NCT02149433|Prednisone|prednisone|mesh-list
111043914|NCT03167385|Apatinib|apatinib|mesh-list
111248041|NCT03177174|Antimitotic Agents|antimitotic agents|mesh-ancestor
111248042|NCT03177174|Mitosis Modulators|mitosis modulators|mesh-ancestor
111248043|NCT03177174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111248044|NCT03177252|Lidocaine|lidocaine|mesh-list
111248045|NCT03177252|Bupivacaine|bupivacaine|mesh-list
111248046|NCT03177252|Anesthetics, Local|anesthetics, local|mesh-ancestor
111044068|NCT02149901|Ephedrine|ephedrine|mesh-list
111248047|NCT03177252|Anesthetics|anesthetics|mesh-ancestor
111248048|NCT03177252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111044194|NCT04104685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111248049|NCT03177252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111248050|NCT03177252|Sensory System Agents|sensory system agents|mesh-ancestor
111248051|NCT03177252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111044371|NCT02151929|Everolimus|everolimus|mesh-list
111248052|NCT03177252|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111044419|NCT02150993|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111248053|NCT03177252|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111248054|NCT03177252|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111248055|NCT03177252|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111248056|NCT03177252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111248057|NCT02703324|Insulin Lispro|insulin lispro|mesh-list
111248058|NCT02703324|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111248059|NCT02703324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110762094|NCT03980769|Thiotepa|thiotepa|mesh-list
111248060|NCT02408562|Becaplermin|becaplermin|mesh-list
111248061|NCT02408562|Anticoagulants|anticoagulants|mesh-ancestor
111248062|NCT02408562|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
111248063|NCT02408562|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111045229|NCT02263495|Paclitaxel|paclitaxel|mesh-list
111248064|NCT02408562|Growth Substances|growth substances|mesh-ancestor
110972377|NCT03483870|Morphine|morphine|mesh-list
111248065|NCT02408562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111248067|NCT02701764|Analgesics|analgesics|mesh-ancestor
111248068|NCT02701764|Sensory System Agents|sensory system agents|mesh-ancestor
111248069|NCT02701764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111248070|NCT02701764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111248071|NCT02701764|Anticonvulsants|anticonvulsants|mesh-ancestor
111248072|NCT02701764|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111045597|NCT01499563|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111248073|NCT02701764|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111248074|NCT02701764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111045743|NCT02264587|Serotonin Agents|serotonin agents|mesh-ancestor
111045816|NCT01393639|Hormones|hormones|mesh-ancestor
111248075|NCT02701764|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111248076|NCT02701764|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111248077|NCT02701764|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111248078|NCT02701764|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111248079|NCT02701764|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111248080|NCT03174288|Spironolactone|spironolactone|mesh-list
111248081|NCT03174288|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
111248082|NCT03174288|Hormone Antagonists|hormone antagonists|mesh-ancestor
111248083|NCT03174288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111248084|NCT03174288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111248085|NCT03174288|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
111046407|NCT05014581|Norepinephrine|norepinephrine|mesh-list
111248086|NCT03174288|Diuretics|diuretics|mesh-ancestor
111248087|NCT03174288|Natriuretic Agents|natriuretic agents|mesh-ancestor
111248088|NCT02532010|Cytarabine|cytarabine|mesh-list
111248089|NCT02532010|Decitabine|decitabine|mesh-list
111248090|NCT02532010|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111248091|NCT02532010|Antimetabolites|antimetabolites|mesh-ancestor
111046700|NCT02764697|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
111046779|NCT05466500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111046856|NCT05526703|Antihypertensive Agents|antihypertensive agents|mesh-list
111046932|NCT02268019|Mydriatics|mydriatics|mesh-ancestor
111047006|NCT03949478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111248092|NCT02532010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111248093|NCT02532010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111248094|NCT02532010|Antiviral Agents|antiviral agents|mesh-ancestor
111248095|NCT02532010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111047304|NCT00934921|Autonomic Agents|autonomic agents|mesh-ancestor
111248096|NCT02532010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111248097|NCT02532010|Immunologic Factors|immunologic factors|mesh-ancestor
111248098|NCT02532010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111248099|NCT02532010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111248100|NCT02406300|Bupivacaine|bupivacaine|mesh-list
111248101|NCT02406300|Ropivacaine|ropivacaine|mesh-list
111047611|NCT03134443|Analgesics|analgesics|mesh-ancestor
111248102|NCT02406300|Levobupivacaine|levobupivacaine|mesh-list
111248103|NCT02406300|Sevoflurane|sevoflurane|mesh-list
111248104|NCT02406300|Desflurane|desflurane|mesh-list
111248105|NCT02406300|Anesthetics, Local|anesthetics, local|mesh-ancestor
111248106|NCT02406300|Anesthetics|anesthetics|mesh-ancestor
111248107|NCT02406300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111248108|NCT02406300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111248109|NCT02406300|Sensory System Agents|sensory system agents|mesh-ancestor
111047827|NCT00744367|Incretins|incretins|mesh-ancestor
111248110|NCT02406300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111248111|NCT02406300|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111047974|NCT00833521|GABA Agents|gaba agents|mesh-ancestor
111248112|NCT02406300|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111248113|NCT02406300|Anesthetics, General|anesthetics, general|mesh-ancestor
111248114|NCT02538016|Tolvaptan|tolvaptan|mesh-list
111048113|NCT00629551|Serotonin Agents|serotonin agents|mesh-ancestor
111248115|NCT02538016|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
111248116|NCT02538016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111048190|NCT02283775|Dexamethasone|dexamethasone|mesh-list
111048261|NCT00501709|Abatacept|abatacept|mesh-list
111248117|NCT02538016|Natriuretic Agents|natriuretic agents|mesh-ancestor
111048335|NCT02404623|Vitamin D|vitamin d|mesh-list
111248118|NCT02538016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111248119|NCT02406144|Dexamethasone|dexamethasone|mesh-list
111248120|NCT02406144|Lenalidomide|lenalidomide|mesh-list
111248121|NCT02406144|Ixazomib|ixazomib|mesh-list
111248122|NCT02406144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111248123|NCT02406144|Antiemetics|antiemetics|mesh-ancestor
111248124|NCT02406144|Autonomic Agents|autonomic agents|mesh-ancestor
111048867|NCT00583609|Laxatives|laxatives|mesh-ancestor
111248125|NCT02406144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111048940|NCT02403687|Topiramate|topiramate|mesh-list
111049007|NCT02403687|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111248126|NCT02406144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111049228|NCT02386449|Antacids|antacids|mesh-ancestor
111248127|NCT02406144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111049299|NCT00563563|Naltrexone|naltrexone|mesh-list
111248128|NCT02406144|Glucocorticoids|glucocorticoids|mesh-ancestor
111248129|NCT02406144|Hormones|hormones|mesh-ancestor
111049441|NCT02386059|Dermatologic Agents|dermatologic agents|mesh-ancestor
111049514|NCT00537043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111248130|NCT02406144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111248131|NCT02406144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111248132|NCT02406144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111248133|NCT02406144|Immunologic Factors|immunologic factors|mesh-ancestor
111248134|NCT02406144|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111248135|NCT02406144|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111248136|NCT02406144|Growth Substances|growth substances|mesh-ancestor
111248137|NCT02406144|Growth Inhibitors|growth inhibitors|mesh-ancestor
111248138|NCT02406144|Protease Inhibitors|protease inhibitors|mesh-ancestor
111248139|NCT02406144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111248140|NCT02406144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111050101|NCT02389179|Vitamin D|vitamin d|mesh-list
111248142|NCT02416752|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111050180|NCT02191319|Nevirapine|nevirapine|mesh-list
111248143|NCT02416752|Narcotics|narcotics|mesh-ancestor
111248144|NCT02416752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111050314|NCT00317395|Anticoagulants|anticoagulants|mesh-ancestor
111248145|NCT02416752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111248146|NCT02416752|Analgesics|analgesics|mesh-ancestor
111248147|NCT02416752|Sensory System Agents|sensory system agents|mesh-ancestor
111248148|NCT02416752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111248149|NCT02405910|Paclitaxel|paclitaxel|mesh-list
111248150|NCT02405910|Gemcitabine|gemcitabine|mesh-list
111248151|NCT02405910|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111248152|NCT02405910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111248153|NCT02405910|Tubulin Modulators|tubulin modulators|mesh-ancestor
111248154|NCT02405910|Antimitotic Agents|antimitotic agents|mesh-ancestor
111248155|NCT02405910|Mitosis Modulators|mitosis modulators|mesh-ancestor
111248156|NCT02405910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111050986|NCT02201225|Micronutrients|micronutrients|mesh-list
111248157|NCT02405910|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111248158|NCT02405910|Antimetabolites|antimetabolites|mesh-ancestor
111248159|NCT02539108|Vaccines|vaccines|mesh-list
111248160|NCT02539108|Immunologic Factors|immunologic factors|mesh-ancestor
111051287|NCT03528967|Aspirin|aspirin|mesh-list
111248161|NCT02539108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111248162|NCT02406066|Oxazepam|oxazepam|mesh-list
111248163|NCT02406066|Metyrapone|metyrapone|mesh-list
111248164|NCT02406066|Antimetabolites|antimetabolites|mesh-ancestor
111248165|NCT02406066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111248166|NCT02406066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111051585|NCT05667090|Micronutrients|micronutrients|mesh-ancestor
111248167|NCT02406066|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111051669|NCT05355740|Chlorhexidine|chlorhexidine|mesh-list
111248168|NCT02406066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111248169|NCT02406066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111248170|NCT02406066|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111248171|NCT02406066|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111248172|NCT02406066|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111248173|NCT02406066|GABA Modulators|gaba modulators|mesh-ancestor
111248174|NCT02406066|GABA Agents|gaba agents|mesh-ancestor
111248175|NCT02406066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111248176|NCT02408328|Caffeine|caffeine|mesh-list
111248177|NCT02408328|Caffeine citrate|caffeine citrate|mesh-list
111248178|NCT02408328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111052245|NCT02257697|Antimalarials|antimalarials|mesh-ancestor
111052321|NCT02296138|Tiotropium Bromide|tiotropium bromide|mesh-list
111248179|NCT02408328|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111052542|NCT02852057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111052620|NCT02739997|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111052714|NCT04467931|Analgesics|analgesics|mesh-ancestor
111052861|NCT02373579|Methotrexate|methotrexate|mesh-list
111248180|NCT02408328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111248181|NCT02408328|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111248182|NCT02408328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111248183|NCT02408328|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
111248184|NCT02408328|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111248185|NCT02408328|Purinergic Agents|purinergic agents|mesh-ancestor
111248186|NCT02408328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111248187|NCT02539342|Calcium|calcium|mesh-list
111248188|NCT02539342|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111248189|NCT02539342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111248190|NCT02405988|Remifentanil|remifentanil|mesh-list
111248191|NCT02405988|Naloxone|naloxone|mesh-list
111248192|NCT02405988|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111248193|NCT02405988|Narcotics|narcotics|mesh-ancestor
111248194|NCT02405988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111248195|NCT02405988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111248196|NCT02405988|Analgesics|analgesics|mesh-ancestor
111248197|NCT02405988|Sensory System Agents|sensory system agents|mesh-ancestor
111248198|NCT02405988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111248199|NCT02405988|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111248200|NCT02542150|Ethanol|ethanol|mesh-list
111248201|NCT02542150|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111248202|NCT02542150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111053289|NCT01672255|Fluoxetine|fluoxetine|mesh-list
111248203|NCT02542150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111248204|NCT02542150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111248205|NCT02542462|Vaccines|vaccines|mesh-list
111248206|NCT02542462|Immunologic Factors|immunologic factors|mesh-ancestor
111248207|NCT02542462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111248208|NCT03173898|Anesthetics|anesthetics|mesh-list
111248209|NCT03173898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111053577|NCT04465123|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
111248210|NCT03173898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111248211|NCT02408172|Metoprolol|metoprolol|mesh-list
110972530|NCT02471846|Atezolizumab|atezolizumab|mesh-list
111248212|NCT02408172|Amlodipine|amlodipine|mesh-list
111053730|NCT02227745|Dorzolamide|dorzolamide|mesh-list
111248213|NCT02408172|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111248214|NCT02408172|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111248215|NCT02408172|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111054017|NCT02351427|Bortezomib|bortezomib|mesh-list
111054092|NCT03541655|Sensory System Agents|sensory system agents|mesh-ancestor
111248216|NCT02408172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111054167|NCT02296567|Growth Substances|growth substances|mesh-ancestor
111248217|NCT02408172|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111248218|NCT02408172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111248219|NCT02408172|Vasodilator Agents|vasodilator agents|mesh-ancestor
111248220|NCT02408172|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111248221|NCT02408172|Sympatholytics|sympatholytics|mesh-ancestor
111248222|NCT02408172|Autonomic Agents|autonomic agents|mesh-ancestor
111248223|NCT02408172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111054464|NCT03149445|Metoprolol|metoprolol|mesh-list
111054536|NCT03145623|Antiviral Agents|antiviral agents|mesh-ancestor
111054624|NCT02342769|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111248224|NCT02408172|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
111248225|NCT02408172|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111248226|NCT02408172|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111248227|NCT02408172|Adrenergic Agents|adrenergic agents|mesh-ancestor
111248228|NCT02408172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111248229|NCT04481100|Itraconazole|itraconazole|mesh-list
111248230|NCT04481100|Antifungal Agents|antifungal agents|mesh-ancestor
111248231|NCT04481100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111248232|NCT04481100|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111248233|NCT04481100|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111248234|NCT04481100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111248235|NCT04481100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111248236|NCT04481100|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111248237|NCT04481100|Hormone Antagonists|hormone antagonists|mesh-ancestor
111248238|NCT04481100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111248239|NCT04481100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111248240|NCT04481100|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111248241|NCT02405598|Albuterol|albuterol|mesh-list
111248242|NCT02405598|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111248243|NCT02405598|Autonomic Agents|autonomic agents|mesh-ancestor
111248244|NCT02405598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111248245|NCT02405598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111248246|NCT02405598|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111248247|NCT02405598|Respiratory System Agents|respiratory system agents|mesh-ancestor
111248248|NCT02405598|Tocolytic Agents|tocolytic agents|mesh-ancestor
111054991|NCT03507127|Varenicline|varenicline|mesh-list
111248249|NCT02405598|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111248250|NCT02405598|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111248251|NCT02405598|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111248252|NCT02405598|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111248253|NCT02405598|Adrenergic Agents|adrenergic agents|mesh-ancestor
111248254|NCT02405598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111248255|NCT02405598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111248256|NCT03173508|Acetazolamide|acetazolamide|mesh-list
111248257|NCT03173508|Anticonvulsants|anticonvulsants|mesh-ancestor
111248258|NCT03173508|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
111248259|NCT03173508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111055140|NCT02340117|Antimetabolites|antimetabolites|mesh-ancestor
111055201|NCT02335281|Mesalamine|mesalamine|mesh-list
111055277|NCT02301481|Oxaliplatin|oxaliplatin|mesh-list
111248260|NCT03173508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111248261|NCT03173508|Diuretics|diuretics|mesh-ancestor
111248262|NCT03173508|Natriuretic Agents|natriuretic agents|mesh-ancestor
111248263|NCT03173508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111055506|NCT02292784|Atosiban|atosiban|mesh-list
111248264|NCT03173430|Blinatumomab|blinatumomab|mesh-list
111248265|NCT03173430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111248266|NCT02407782|Ivermectin|ivermectin|mesh-list
111248267|NCT02407782|Permethrin|permethrin|mesh-list
111248268|NCT02407782|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111248269|NCT02407782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111248270|NCT02407782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111055870|NCT02313337|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
111055943|NCT02313883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111248271|NCT02407782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111248272|NCT02405364|Dexamethasone|dexamethasone|mesh-list
111056093|NCT03499639|Ribavirin|ribavirin|mesh-list
111248273|NCT02405364|Lenalidomide|lenalidomide|mesh-list
111056168|NCT03499171|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111248274|NCT02405364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111248275|NCT02405364|Antiemetics|antiemetics|mesh-ancestor
111248276|NCT02405364|Autonomic Agents|autonomic agents|mesh-ancestor
111248277|NCT02405364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111248278|NCT02405364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111248279|NCT02405364|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111248280|NCT02405364|Glucocorticoids|glucocorticoids|mesh-ancestor
111248281|NCT02405364|Hormones|hormones|mesh-ancestor
111248282|NCT02405364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111248283|NCT02405364|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111248284|NCT02405364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111248285|NCT02405364|Immunologic Factors|immunologic factors|mesh-ancestor
111248286|NCT02405364|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111248287|NCT02405364|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111248288|NCT02405364|Growth Substances|growth substances|mesh-ancestor
111248289|NCT02405364|Growth Inhibitors|growth inhibitors|mesh-ancestor
111248290|NCT02405130|Epinephrine|epinephrine|mesh-list
111248291|NCT02405130|Racepinephrine|racepinephrine|mesh-list
111056750|NCT02262611|Diuretics|diuretics|mesh-ancestor
111056827|NCT01534403|Epratuzumab|epratuzumab|mesh-list
111248292|NCT02405130|Epinephryl borate|epinephryl borate|mesh-list
111248293|NCT02405130|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111056900|NCT02264171|Tamsulosin|tamsulosin|mesh-list
111248294|NCT02405130|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111248295|NCT02405130|Adrenergic Agents|adrenergic agents|mesh-ancestor
111057044|NCT00156065|Autonomic Agents|autonomic agents|mesh-ancestor
111248296|NCT02405130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111057124|NCT02267681|Fentanyl|fentanyl|mesh-list
111248297|NCT02405130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111057193|NCT02268149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111248298|NCT02405130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111057269|NCT01207115|Naproxen|naproxen|mesh-list
111248299|NCT02405130|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111248300|NCT02405130|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111248301|NCT02405130|Autonomic Agents|autonomic agents|mesh-ancestor
111248302|NCT02405130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111248303|NCT02405130|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111248304|NCT02405130|Respiratory System Agents|respiratory system agents|mesh-ancestor
111248305|NCT02405130|Mydriatics|mydriatics|mesh-ancestor
111248306|NCT02405130|Sympathomimetics|sympathomimetics|mesh-ancestor
111248307|NCT02405130|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111248308|NCT03171090|Anesthetics|anesthetics|mesh-list
111248309|NCT03171090|Anesthetics, Local|anesthetics, local|mesh-list
111248310|NCT03171090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111248311|NCT03171090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111057802|NCT04662723|Losartan|losartan|mesh-list
111057868|NCT02328963|Everolimus|everolimus|mesh-list
111057921|NCT02913495|Progesterone|progesterone|mesh-list
111058002|NCT03141645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111248312|NCT03171090|Sensory System Agents|sensory system agents|mesh-ancestor
111248313|NCT03171090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111248314|NCT02407470|Antilymphocyte Serum|antilymphocyte serum|mesh-list
111248315|NCT02407470|Immunologic Factors|immunologic factors|mesh-ancestor
111248316|NCT02407470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111248317|NCT02407470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111248318|NCT02407626|Propofol|propofol|mesh-list
111248319|NCT02407626|Sevoflurane|sevoflurane|mesh-list
111248320|NCT02407626|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111248321|NCT02407626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111058234|NCT02285062|Glucocorticoids|glucocorticoids|mesh-ancestor
111248322|NCT02407626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111248323|NCT02407626|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111248324|NCT02407626|Anesthetics, General|anesthetics, general|mesh-ancestor
111248325|NCT02407626|Anesthetics|anesthetics|mesh-ancestor
111248326|NCT02407626|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111248327|NCT02407626|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111248328|NCT02407392|Acetic Acid|acetic acid|mesh-list
111248329|NCT02407392|Retinol acetate|retinol acetate|mesh-list
111248330|NCT02407392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111248331|NCT02407392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111248332|NCT02407392|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111248333|NCT02407392|Immunologic Factors|immunologic factors|mesh-ancestor
111248334|NCT02407392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111248335|NCT02407392|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
111058306|NCT02038257|Petrolatum|petrolatum|mesh-list
111248336|NCT02407392|Protective Agents|protective agents|mesh-ancestor
111058363|NCT03140553|Carboplatin|carboplatin|mesh-list
111248337|NCT02407392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111248338|NCT02551432|Paclitaxel|paclitaxel|mesh-list
111248339|NCT02551432|Pembrolizumab|pembrolizumab|mesh-list
111248340|NCT02551432|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111248341|NCT02551432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111248342|NCT02551432|Tubulin Modulators|tubulin modulators|mesh-ancestor
111248343|NCT02551432|Antimitotic Agents|antimitotic agents|mesh-ancestor
111248344|NCT02551432|Mitosis Modulators|mitosis modulators|mesh-ancestor
111248345|NCT02551432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111248346|NCT02551432|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111248347|NCT02551432|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111248348|NCT02407548|Vitamin E|vitamin e|mesh-list
111248349|NCT02407548|Coenzyme Q10|coenzyme q10|mesh-list
111248350|NCT02407548|Ubiquinone|ubiquinone|mesh-list
111248351|NCT02407548|Vitamins|vitamins|mesh-ancestor
111248352|NCT02407548|Micronutrients|micronutrients|mesh-ancestor
111248353|NCT02407548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111248354|NCT02407548|Antioxidants|antioxidants|mesh-ancestor
111248355|NCT02407548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111248356|NCT02407548|Protective Agents|protective agents|mesh-ancestor
111248357|NCT01695317|Acetylcarnitine|acetylcarnitine|mesh-list
111248358|NCT01695317|Vitamin B Complex|vitamin b complex|mesh-ancestor
111248359|NCT01695317|Vitamins|vitamins|mesh-ancestor
111248360|NCT01695317|Micronutrients|micronutrients|mesh-ancestor
111248361|NCT01695317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111248362|NCT01695317|Nootropic Agents|nootropic agents|mesh-ancestor
111248363|NCT02551744|Pantoprazole|pantoprazole|mesh-list
111248364|NCT02551744|Famotidine|famotidine|mesh-list
111248365|NCT02551744|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
111248366|NCT02551744|Histamine H2 Antagonists|histamine h2 antagonists|mesh-list
111248367|NCT02551744|Histamine|histamine|mesh-list
111248368|NCT02551744|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111248369|NCT02551744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111248370|NCT02551744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111248371|NCT02551744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111248372|NCT02551744|Histamine Antagonists|histamine antagonists|mesh-ancestor
111248373|NCT02551744|Histamine Agents|histamine agents|mesh-ancestor
111248374|NCT02551744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111248375|NCT02551744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111248376|NCT02551744|Histamine Agonists|histamine agonists|mesh-ancestor
111248377|NCT04743544|Voriconazole|voriconazole|mesh-list
111248378|NCT04743544|Antifungal Agents|antifungal agents|mesh-ancestor
111248379|NCT04743544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111248380|NCT04743544|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111248381|NCT04743544|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111248382|NCT04743544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111248383|NCT04743544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111248384|NCT04743544|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111248385|NCT04743544|Hormone Antagonists|hormone antagonists|mesh-ancestor
111248386|NCT04743544|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111248387|NCT04743544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111248388|NCT04743544|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111248389|NCT04481802|Acemannan|acemannan|mesh-list
111248390|NCT04481802|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111248391|NCT04481802|Immunologic Factors|immunologic factors|mesh-ancestor
111248392|NCT04481802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111248393|NCT04481802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111248394|NCT04481802|Antiviral Agents|antiviral agents|mesh-ancestor
111248395|NCT04481802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111248396|NCT04481802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111248397|NCT02551822|Neurotransmitter Agents|neurotransmitter agents|mesh-list
111058677|NCT00875459|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111248398|NCT02551822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111058766|NCT05165966|Vaccines|vaccines|mesh-list
111058827|NCT05162222|Itraconazole|itraconazole|mesh-list
111058897|NCT04876534|Prednisolone phosphate|prednisolone phosphate|mesh-list
111248399|NCT02551822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111248400|NCT02407314|Aspirin|aspirin|mesh-list
111248401|NCT02407314|Ticagrelor|ticagrelor|mesh-list
111059044|NCT00838799|Pregabalin|pregabalin|mesh-list
111248402|NCT02407314|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111059116|NCT00927641|Analgesics|analgesics|mesh-ancestor
111059195|NCT00924833|Carvedilol|carvedilol|mesh-list
111248403|NCT02407314|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111059345|NCT05221658|Cisplatin|cisplatin|mesh-list
111059413|NCT02273050|Metformin|metformin|mesh-list
111248404|NCT02407314|Analgesics|analgesics|mesh-ancestor
111248405|NCT02407314|Sensory System Agents|sensory system agents|mesh-ancestor
111248406|NCT02407314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111248407|NCT02407314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111248408|NCT02407314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111248409|NCT02407314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111248410|NCT02407314|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111248411|NCT02407314|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111248412|NCT02407314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111248413|NCT02407314|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111248414|NCT02407314|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111248415|NCT02407314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111248416|NCT02407314|Antipyretics|antipyretics|mesh-ancestor
111059767|NCT04462003|Enoxaparin|enoxaparin|mesh-list
111248417|NCT02407314|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111248418|NCT02407314|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111248419|NCT02407314|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111248420|NCT02407314|Purinergic Agents|purinergic agents|mesh-ancestor
111248421|NCT02407314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111248422|NCT02407080|Interferons|interferons|mesh-list
111248423|NCT02407080|Interferon-alpha|interferon-alpha|mesh-list
111248424|NCT02407080|Interferon alpha-2|interferon alpha-2|mesh-list
111248425|NCT02407080|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
111060274|NCT00873275|Protective Agents|protective agents|mesh-ancestor
111248426|NCT02407080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111248427|NCT02407080|Antiviral Agents|antiviral agents|mesh-ancestor
111060426|NCT02266888|Rituximab|rituximab|mesh-list
111060494|NCT02280629|Analgesics|analgesics|mesh-ancestor
111248428|NCT02407080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111248429|NCT02407080|Immunologic Factors|immunologic factors|mesh-ancestor
111248430|NCT02407080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111248431|NCT04743622|Latanoprost|latanoprost|mesh-list
111060794|NCT05984173|Vitamin E|vitamin e|mesh-list
111248432|NCT04743622|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
111061018|NCT05736419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111248433|NCT04743622|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111248434|NCT02701296|Epinephrine|epinephrine|mesh-list
111248435|NCT02701296|Ropivacaine|ropivacaine|mesh-list
111248436|NCT02701296|Anesthetics, Local|anesthetics, local|mesh-ancestor
111248437|NCT02701296|Anesthetics|anesthetics|mesh-ancestor
111061290|NCT05201248|Prednisone|prednisone|mesh-list
111248438|NCT02701296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111061358|NCT05156658|Contraceptive Agents|contraceptive agents|mesh-ancestor
111248439|NCT02701296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110972752|NCT03481920|Avelumab|avelumab|mesh-list
111061550|NCT04573946|Vitamin D|vitamin d|mesh-list
111248440|NCT02701296|Sensory System Agents|sensory system agents|mesh-ancestor
111061675|NCT04240626|Anesthetics|anesthetics|mesh-ancestor
111248441|NCT02701296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111248442|NCT02701296|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111061834|NCT03691662|Timolol|timolol|mesh-list
111248443|NCT02701296|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111248444|NCT02701296|Adrenergic Agents|adrenergic agents|mesh-ancestor
111248445|NCT02701296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111248446|NCT02701296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111248447|NCT02701296|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111062118|NCT00869232|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111248448|NCT02701296|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111248449|NCT02701296|Autonomic Agents|autonomic agents|mesh-ancestor
111248450|NCT02701296|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111248451|NCT02701296|Respiratory System Agents|respiratory system agents|mesh-ancestor
111248452|NCT02701296|Mydriatics|mydriatics|mesh-ancestor
111248453|NCT02701296|Sympathomimetics|sympathomimetics|mesh-ancestor
111248454|NCT02701296|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111248455|NCT02558374|Timolol|timolol|mesh-list
111248456|NCT02558374|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111248457|NCT02558374|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111248458|NCT02558374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111248459|NCT02558374|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111248460|NCT02558374|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111062258|NCT02356588|Narcotics|narcotics|mesh-ancestor
111248461|NCT02558374|Adrenergic Agents|adrenergic agents|mesh-ancestor
111248462|NCT02558374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111248463|NCT02558374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111248464|NCT02558374|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111248465|NCT02558374|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111248466|NCT01582451|Insulin|insulin|mesh-list
111248467|NCT01582451|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111248468|NCT01582451|Insulin Glargine|insulin glargine|mesh-list
111248469|NCT01582451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111248470|NCT01582451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111062553|NCT02281721|Antacids|antacids|mesh-ancestor
111062692|NCT05944783|Dasatinib|dasatinib|mesh-list
111248471|NCT03115320|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
111062765|NCT05943990|Cyclophosphamide|cyclophosphamide|mesh-list
111248472|NCT03115320|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111062842|NCT05943158|Folic Acid|folic acid|mesh-list
111062914|NCT05901714|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111248473|NCT03115320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111248474|NCT03168828|Trospium chloride|trospium chloride|mesh-list
111248475|NCT03168828|Parasympatholytics|parasympatholytics|mesh-ancestor
111248476|NCT03168828|Autonomic Agents|autonomic agents|mesh-ancestor
111248477|NCT03168828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111248478|NCT03168828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111248479|NCT03168828|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111248480|NCT03168828|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111248481|NCT03168828|Cholinergic Agents|cholinergic agents|mesh-ancestor
111063210|NCT05060315|Treprostinil|treprostinil|mesh-list
111248482|NCT03168828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111248483|NCT03168828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111248484|NCT03168828|Urological Agents|urological agents|mesh-ancestor
111248485|NCT02562898|Paclitaxel|paclitaxel|mesh-list
111248486|NCT02562898|Gemcitabine|gemcitabine|mesh-list
111063521|NCT04068597|Antimetabolites|antimetabolites|mesh-ancestor
111063596|NCT03677141|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
111248487|NCT02562898|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111248488|NCT02562898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111063744|NCT03004287|Glucocorticoids|glucocorticoids|mesh-ancestor
111248489|NCT02562898|Tubulin Modulators|tubulin modulators|mesh-ancestor
111248490|NCT02562898|Antimitotic Agents|antimitotic agents|mesh-ancestor
110780967|NCT03680404|Tempol|tempol|mesh-list
111248491|NCT02562898|Mitosis Modulators|mitosis modulators|mesh-ancestor
111248492|NCT02562898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111248493|NCT02562898|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111248494|NCT02562898|Antimetabolites|antimetabolites|mesh-ancestor
111248495|NCT03168594|Cisplatin|cisplatin|mesh-list
111064046|NCT00542633|Insulin|insulin|mesh-list
111248496|NCT03168594|Irinotecan|irinotecan|mesh-list
111248497|NCT03168594|Etoposide|etoposide|mesh-list
111064184|NCT03336541|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111248498|NCT03168594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111064256|NCT02523313|Ipilimumab|ipilimumab|mesh-list
111248499|NCT03168594|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111248500|NCT03168594|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111248501|NCT03168594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111064476|NCT00356681|Motesanib diphosphate|motesanib diphosphate|mesh-list
111248502|NCT03168594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111064564|NCT00332657|Anecortave|anecortave|mesh-list
111248503|NCT03168594|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111248504|NCT03168594|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111248505|NCT02563834|Insulin|insulin|mesh-list
111248506|NCT02563834|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111248507|NCT02563834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111248508|NCT02564926|Dapagliflozin|dapagliflozin|mesh-list
111248509|NCT02564926|Glimepiride|glimepiride|mesh-list
111248510|NCT02564926|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111064768|NCT02479412|Adrenergic Agents|adrenergic agents|mesh-ancestor
111248511|NCT02564926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111248512|NCT02564926|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111248513|NCT02564926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111248514|NCT02564926|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111248515|NCT02564926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111248516|NCT02564926|Immunologic Factors|immunologic factors|mesh-ancestor
111248517|NCT02567968|Caffeine|caffeine|mesh-list
111248518|NCT02567968|Caffeine citrate|caffeine citrate|mesh-list
111064913|NCT05259007|Amoxicillin|amoxicillin|mesh-list
111248519|NCT02567968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111248520|NCT02567968|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111248521|NCT02567968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111248522|NCT02567968|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111248523|NCT02567968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111065130|NCT02447432|Vaccines|vaccines|mesh-list
111248524|NCT02567968|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
111248525|NCT02567968|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111248526|NCT02567968|Purinergic Agents|purinergic agents|mesh-ancestor
111248527|NCT02567968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111248528|NCT02571634|Fentanyl|fentanyl|mesh-list
111248529|NCT02571634|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111065584|NCT03529643|Dexmedetomidine|dexmedetomidine|mesh-list
111248530|NCT02571634|Narcotics|narcotics|mesh-ancestor
111248531|NCT02571634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111248532|NCT02571634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111248533|NCT02571634|Analgesics|analgesics|mesh-ancestor
111065805|NCT05455931|Mogamulizumab|mogamulizumab|mesh-list
111248534|NCT02571634|Sensory System Agents|sensory system agents|mesh-ancestor
111248535|NCT02571634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111248536|NCT02571634|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111066030|NCT04666636|Mirabegron|mirabegron|mesh-list
111248537|NCT02571634|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111066102|NCT04837924|Antipyretics|antipyretics|mesh-ancestor
111248538|NCT02571634|Anesthetics, General|anesthetics, general|mesh-ancestor
111248539|NCT02571634|Anesthetics|anesthetics|mesh-ancestor
111248540|NCT02404038|NuvaRing|nuvaring|mesh-list
111248541|NCT02404038|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
111248542|NCT02404038|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111248543|NCT02404038|Contraceptive Agents|contraceptive agents|mesh-ancestor
111066590|NCT02497976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111066664|NCT04002401|Immunologic Factors|immunologic factors|mesh-ancestor
111248544|NCT02404038|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111248545|NCT02404038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111248546|NCT02404038|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
111248547|NCT02404038|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111248548|NCT02404038|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111248549|NCT02404038|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111066803|NCT02246218|Protective Agents|protective agents|mesh-ancestor
111066879|NCT00692939|Antilymphocyte Serum|antilymphocyte serum|mesh-list
111248550|NCT02404038|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111066953|NCT03110679|Hyaluronic Acid|hyaluronic acid|mesh-list
111248551|NCT02404038|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
111248552|NCT02404038|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
111067251|NCT04542993|Antioxidants|antioxidants|mesh-ancestor
111248553|NCT02404038|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
111248554|NCT02574598|Docetaxel|docetaxel|mesh-list
111248555|NCT02574598|Pembrolizumab|pembrolizumab|mesh-list
111248556|NCT02574598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111248557|NCT02574598|Tubulin Modulators|tubulin modulators|mesh-ancestor
111248558|NCT02574598|Antimitotic Agents|antimitotic agents|mesh-ancestor
111248559|NCT02574598|Mitosis Modulators|mitosis modulators|mesh-ancestor
111067551|NCT02834403|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111248560|NCT02574598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111067631|NCT01190787|Glucocorticoids|glucocorticoids|mesh-ancestor
111248561|NCT02574598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111067699|NCT03510533|alpha-MSH|alpha-msh|mesh-list
111248562|NCT02574598|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111067872|NCT04406415|Nafamostat|nafamostat|mesh-list
111248563|NCT02574832|Lidocaine|lidocaine|mesh-list
111248564|NCT02574832|Fentanyl|fentanyl|mesh-list
111248565|NCT02574832|Anesthetics, Local|anesthetics, local|mesh-ancestor
111248566|NCT02574832|Anesthetics|anesthetics|mesh-ancestor
111248567|NCT02574832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111068065|NCT05158699|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111248568|NCT02574832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111248569|NCT02574832|Sensory System Agents|sensory system agents|mesh-ancestor
111248570|NCT02574832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111068306|NCT04539327|Rucaparib|rucaparib|mesh-list
111248571|NCT02574832|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111248572|NCT02574832|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111248573|NCT02574832|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111248574|NCT02574832|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111248575|NCT02574832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111248576|NCT02574832|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111248577|NCT02574832|Narcotics|narcotics|mesh-ancestor
111248578|NCT02574832|Analgesics|analgesics|mesh-ancestor
111248579|NCT02574832|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111248580|NCT02574832|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111248581|NCT02574832|Anesthetics, General|anesthetics, general|mesh-ancestor
111248582|NCT02406690|Leuprolide|leuprolide|mesh-list
111248583|NCT02406690|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
111248584|NCT02406690|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
111248585|NCT02406690|Estradiol|estradiol|mesh-list
111248586|NCT02406690|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
111248587|NCT02406690|Progesterone|progesterone|mesh-list
111248588|NCT02406690|Estrogens|estrogens|mesh-ancestor
110972906|NCT05779657|GABA Modulators|gaba modulators|mesh-ancestor
111248590|NCT02406690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111248591|NCT02406690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111248592|NCT02406690|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111248593|NCT02406690|Contraceptive Agents|contraceptive agents|mesh-ancestor
111068730|NCT05095467|Paclitaxel|paclitaxel|mesh-list
111248594|NCT02406690|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111248595|NCT02406690|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111248596|NCT02406690|Progestins|progestins|mesh-ancestor
111068869|NCT02228590|Emetics|emetics|mesh-ancestor
111069010|NCT03506009|Argatroban|argatroban|mesh-list
111248597|NCT02406690|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111248598|NCT02406690|Fertility Agents|fertility agents|mesh-ancestor
111248599|NCT02406690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111069158|NCT05098353|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111248600|NCT02406690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111248601|NCT04440696|Polystyrene sulfonic acid|polystyrene sulfonic acid|mesh-list
111248602|NCT04440696|Chelating Agents|chelating agents|mesh-ancestor
111248603|NCT04440696|Sequestering Agents|sequestering agents|mesh-ancestor
111248604|NCT04440696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111248605|NCT02974348|Acetaminophen|acetaminophen|mesh-list
111248606|NCT02974348|Amoxicillin|amoxicillin|mesh-list
111248607|NCT02974348|Artesunate|artesunate|mesh-list
111248608|NCT02974348|Lumefantrine|lumefantrine|mesh-list
111248609|NCT02974348|Piperaquine|piperaquine|mesh-list
111248610|NCT02974348|Artenimol|artenimol|mesh-list
111248611|NCT02974348|Mefloquine|mefloquine|mesh-list
111248612|NCT02974348|Quinine|quinine|mesh-list
111248613|NCT02974348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111248614|NCT02974348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111248615|NCT02974348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111248616|NCT02974348|Analgesics|analgesics|mesh-ancestor
111248617|NCT02974348|Sensory System Agents|sensory system agents|mesh-ancestor
111248618|NCT02974348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111248619|NCT02974348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111248620|NCT02974348|Antipyretics|antipyretics|mesh-ancestor
111248621|NCT02974348|Antimalarials|antimalarials|mesh-ancestor
111248622|NCT02974348|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111248623|NCT02974348|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111248624|NCT02974348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111248625|NCT02974348|Antiviral Agents|antiviral agents|mesh-ancestor
111248626|NCT02974348|Schistosomicides|schistosomicides|mesh-ancestor
111248627|NCT02974348|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
111248628|NCT02974348|Anthelmintics|anthelmintics|mesh-ancestor
111248629|NCT02974348|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
111248630|NCT02974348|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111248631|NCT03170310|Apatinib|apatinib|mesh-list
111248632|NCT03170310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111248633|NCT03170310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111248634|NCT03170310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111248635|NCT03170310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111248636|NCT00364000|Calcium|calcium|mesh-list
111248637|NCT00364000|Sevelamer|sevelamer|mesh-list
111248638|NCT00364000|Calcium acetate|calcium acetate|mesh-list
111248639|NCT00364000|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111248640|NCT00364000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111248641|NCT00364000|Chelating Agents|chelating agents|mesh-ancestor
111248642|NCT00364000|Sequestering Agents|sequestering agents|mesh-ancestor
111248643|NCT00364000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111248644|NCT00422188|Deoxycholic Acid|deoxycholic acid|mesh-list
111248645|NCT00422188|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
111248646|NCT00422188|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111248647|NCT02403804|Betaine|betaine|mesh-list
111069581|NCT03353233|Ropivacaine|ropivacaine|mesh-list
111248648|NCT02403804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111248649|NCT02403804|Lipotropic Agents|lipotropic agents|mesh-ancestor
111248650|NCT02403804|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111248651|NCT02403804|Antimetabolites|antimetabolites|mesh-ancestor
111248652|NCT02403804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111248653|NCT02403804|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111248654|NCT03169764|Leucovorin|leucovorin|mesh-list
111248655|NCT03169764|Cyclophosphamide|cyclophosphamide|mesh-list
111248656|NCT03169764|Bevacizumab|bevacizumab|mesh-list
111248657|NCT03169764|Fluorouracil|fluorouracil|mesh-list
111248658|NCT03169764|Capecitabine|capecitabine|mesh-list
111248659|NCT03169764|Nivolumab|nivolumab|mesh-list
111248660|NCT03169764|Cetuximab|cetuximab|mesh-list
111248661|NCT03169764|Fulvestrant|fulvestrant|mesh-list
111248662|NCT03169764|Avelumab|avelumab|mesh-list
111248663|NCT03169764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111248664|NCT03169764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111248665|NCT03169764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111070597|NCT02215252|Pregabalin|pregabalin|mesh-list
111070674|NCT03489395|Edoxaban|edoxaban|mesh-list
111248666|NCT03169764|Immunologic Factors|immunologic factors|mesh-ancestor
111070818|NCT00701207|Nicotine|nicotine|mesh-list
111248667|NCT03169764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111248668|NCT03169764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111070969|NCT03484091|Hylan|hylan|mesh-list
111248669|NCT03169764|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111248670|NCT03169764|Alkylating Agents|alkylating agents|mesh-ancestor
111248671|NCT03169764|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111248672|NCT03169764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111248673|NCT03169764|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111071324|NCT05134415|Menthol|menthol|mesh-list
111248674|NCT03169764|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111248675|NCT03169764|Growth Substances|growth substances|mesh-ancestor
111071475|NCT03470363|Sufentanil|sufentanil|mesh-list
111248676|NCT03169764|Growth Inhibitors|growth inhibitors|mesh-ancestor
111248677|NCT03169764|Antimetabolites|antimetabolites|mesh-ancestor
111248678|NCT03169764|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111248679|NCT03169764|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111248680|NCT03169764|Antidotes|antidotes|mesh-ancestor
111248681|NCT03169764|Protective Agents|protective agents|mesh-ancestor
111248682|NCT03169764|Vitamin B Complex|vitamin b complex|mesh-ancestor
111248683|NCT03169764|Vitamins|vitamins|mesh-ancestor
111248684|NCT03169764|Micronutrients|micronutrients|mesh-ancestor
111248685|NCT03169764|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111071995|NCT05579249|Dopamine Agents|dopamine agents|mesh-ancestor
111248686|NCT03169764|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
111248687|NCT03169764|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111248688|NCT03169764|Hormone Antagonists|hormone antagonists|mesh-ancestor
111072299|NCT05398055|Azithromycin|azithromycin|mesh-list
111248689|NCT03169764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111248690|NCT03874936|Dexamethasone|dexamethasone|mesh-list
111072592|NCT05101005|Sirolimus|sirolimus|mesh-list
111248691|NCT03874936|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111072668|NCT04830215|Dopamine Agonists|dopamine agonists|mesh-ancestor
111072740|NCT03461627|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111072814|NCT04628429|Analgesics|analgesics|mesh-ancestor
111248692|NCT03874936|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111248693|NCT03874936|Antiemetics|antiemetics|mesh-ancestor
111248694|NCT03874936|Autonomic Agents|autonomic agents|mesh-ancestor
111248695|NCT03874936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111248696|NCT03874936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111248697|NCT03874936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111248698|NCT03874936|Glucocorticoids|glucocorticoids|mesh-ancestor
111248699|NCT03874936|Hormones|hormones|mesh-ancestor
111073184|NCT05184335|RP5063|rp5063|mesh-list
111073259|NCT04921943|Rifampin|rifampin|mesh-list
111073328|NCT02418182|Acetaminophen|acetaminophen|mesh-list
111073479|NCT03445169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111073524|NCT03443843|Xhance|xhance|mesh-list
111248700|NCT03874936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111073630|NCT03433001|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111248701|NCT03874936|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111248702|NCT03874936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111248703|NCT02399592|Bevacizumab|bevacizumab|mesh-list
111073776|NCT05112471|Erythritol|erythritol|mesh-list
111248704|NCT02399592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111073921|NCT03874325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111073992|NCT03430505|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111248705|NCT02399592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111248706|NCT02399592|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111248707|NCT02399592|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111248708|NCT02399592|Growth Substances|growth substances|mesh-ancestor
111248709|NCT02399592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111248710|NCT02399592|Growth Inhibitors|growth inhibitors|mesh-ancestor
111248711|NCT03801304|Atezolizumab|atezolizumab|mesh-list
111248712|NCT03801304|Vinorelbine|vinorelbine|mesh-list
111248713|NCT03801304|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111074504|NCT03431701|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111074577|NCT03434197|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111074652|NCT03428425|Mitosis Modulators|mitosis modulators|mesh-ancestor
111074728|NCT03173053|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111248714|NCT03801304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111248715|NCT03801304|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111248716|NCT03801304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111248717|NCT03801304|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111248718|NCT03801304|Tubulin Modulators|tubulin modulators|mesh-ancestor
111248719|NCT03801304|Antimitotic Agents|antimitotic agents|mesh-ancestor
111248720|NCT03801304|Mitosis Modulators|mitosis modulators|mesh-ancestor
111248721|NCT02696850|Budesonide|budesonide|mesh-list
111248722|NCT02696850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111075022|NCT03415087|Anesthetics|anesthetics|mesh-ancestor
111248723|NCT02696850|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111248724|NCT02696850|Autonomic Agents|autonomic agents|mesh-ancestor
111248725|NCT02696850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111248726|NCT02696850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111248727|NCT02696850|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111075394|NCT02654145|Omalizumab|omalizumab|mesh-list
111075466|NCT03411109|Hydromorphone|hydromorphone|mesh-list
111075540|NCT04260477|Pyrazinamide|pyrazinamide|mesh-list
111075615|NCT04640571|Cathartics|cathartics|mesh-ancestor
111248728|NCT02696850|Respiratory System Agents|respiratory system agents|mesh-ancestor
111248729|NCT02696850|Glucocorticoids|glucocorticoids|mesh-ancestor
111248730|NCT02696850|Hormones|hormones|mesh-ancestor
111248731|NCT02696850|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111248732|NCT00365170|Insulin|insulin|mesh-list
111075842|NCT03411941|Aflibercept|aflibercept|mesh-list
111248733|NCT00365170|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111248734|NCT00365170|Insulin Aspart|insulin aspart|mesh-list
111075998|NCT03397537|Letrozole|letrozole|mesh-list
111248735|NCT00365170|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111248736|NCT00365170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111248737|NCT02403648|Glucagon|glucagon|mesh-list
111076135|NCT03407027|Immunologic Factors|immunologic factors|mesh-ancestor
111248738|NCT02403648|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
111076282|NCT03392623|Tretinoin|tretinoin|mesh-list
111076357|NCT03401177|Sensory System Agents|sensory system agents|mesh-ancestor
111248739|NCT02403648|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111248740|NCT02403648|Hormones|hormones|mesh-ancestor
111248741|NCT02403648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111076582|NCT04249297|Dydrogesterone|dydrogesterone|mesh-list
111248742|NCT02403648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111248743|NCT02403648|Incretins|incretins|mesh-ancestor
111248744|NCT02396862|Factor VIII|factor viii|mesh-list
111248745|NCT02396862|Coagulants|coagulants|mesh-ancestor
111248746|NCT02377492|Vasopressins|vasopressins|mesh-list
111248747|NCT02377492|Arginine Vasopressin|arginine vasopressin|mesh-list
111248748|NCT02377492|Hemostatics|hemostatics|mesh-ancestor
111248749|NCT02377492|Coagulants|coagulants|mesh-ancestor
111248750|NCT02377492|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111248751|NCT02377492|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
111248752|NCT02377492|Natriuretic Agents|natriuretic agents|mesh-ancestor
111248753|NCT02377492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111248754|NCT02594644|Aminolevulinic Acid|aminolevulinic acid|mesh-list
111077175|NCT03754153|Mydriatics|mydriatics|mesh-ancestor
111248755|NCT02594644|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111248756|NCT02594644|Dermatologic Agents|dermatologic agents|mesh-ancestor
111248757|NCT02601976|Ribavirin|ribavirin|mesh-list
111248758|NCT02601976|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
111077638|NCT03385057|Ibuprofen|ibuprofen|mesh-list
111248759|NCT02601976|Antimetabolites|antimetabolites|mesh-ancestor
111248760|NCT02601976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111248761|NCT02601976|Antiviral Agents|antiviral agents|mesh-ancestor
111248762|NCT02601976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111248763|NCT02603926|Pregnanolone|pregnanolone|mesh-list
111248764|NCT02603926|Brexanolone|brexanolone|mesh-list
111248765|NCT02603926|Anesthetics|anesthetics|mesh-ancestor
111248766|NCT02603926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111248767|NCT02603926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111248768|NCT02603926|Neurosteroids|neurosteroids|mesh-ancestor
111248769|NCT02603926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111248770|NCT02603926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111248771|NCT02603926|GABA Modulators|gaba modulators|mesh-ancestor
111248772|NCT02603926|GABA Agents|gaba agents|mesh-ancestor
111248773|NCT00365560|Tiotropium Bromide|tiotropium bromide|mesh-list
111248774|NCT00365560|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111248775|NCT00365560|Autonomic Agents|autonomic agents|mesh-ancestor
111248776|NCT00365560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111077981|NCT03371953|Vecuronium Bromide|vecuronium bromide|mesh-list
111248777|NCT00365560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111078055|NCT03369847|Hormones|hormones|mesh-ancestor
111248778|NCT00365560|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111248779|NCT00365560|Respiratory System Agents|respiratory system agents|mesh-ancestor
111248780|NCT00365560|Parasympatholytics|parasympatholytics|mesh-ancestor
111078202|NCT03362359|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
111078278|NCT02929485|Dopamine Agonists|dopamine agonists|mesh-ancestor
111078354|NCT04521049|Protease Inhibitors|protease inhibitors|mesh-ancestor
111248781|NCT00365560|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111248782|NCT00365560|Cholinergic Agents|cholinergic agents|mesh-ancestor
111248783|NCT00365560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111248784|NCT00365560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111248785|NCT02395926|Choline|choline|mesh-list
111248786|NCT02395926|Lipotropic Agents|lipotropic agents|mesh-ancestor
111248787|NCT02395926|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111248788|NCT02395926|Antimetabolites|antimetabolites|mesh-ancestor
111248789|NCT02395926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111248790|NCT02395926|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111248791|NCT02395926|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111248792|NCT02395926|Nootropic Agents|nootropic agents|mesh-ancestor
111248793|NCT02402868|Ketamine|ketamine|mesh-list
111248794|NCT02402868|Analgesics|analgesics|mesh-ancestor
111248795|NCT02402868|Sensory System Agents|sensory system agents|mesh-ancestor
111248796|NCT02402868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111248797|NCT02402868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111248798|NCT02402868|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111078562|NCT04278651|Hematinics|hematinics|mesh-ancestor
111248799|NCT02402868|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111248800|NCT02402868|Anesthetics, General|anesthetics, general|mesh-ancestor
111248801|NCT02402868|Anesthetics|anesthetics|mesh-ancestor
111078708|NCT02519335|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111248802|NCT02402868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111248803|NCT02402868|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111248804|NCT02402868|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111248805|NCT02402868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111248806|NCT02402868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111248807|NCT02402712|Docetaxel|docetaxel|mesh-list
111248808|NCT02402712|Trastuzumab|trastuzumab|mesh-list
111248809|NCT02402712|Pertuzumab|pertuzumab|mesh-list
111248810|NCT02402712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111079152|NCT04435587|Antimalarials|antimalarials|mesh-ancestor
111248811|NCT02402712|Tubulin Modulators|tubulin modulators|mesh-ancestor
111079451|NCT04943679|Antiviral Agents|antiviral agents|mesh-ancestor
111248812|NCT02402712|Antimitotic Agents|antimitotic agents|mesh-ancestor
111248813|NCT02402712|Mitosis Modulators|mitosis modulators|mesh-ancestor
111248814|NCT02402712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111248815|NCT02402712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111248816|NCT02395458|Amoxicillin|amoxicillin|mesh-list
111248817|NCT02395458|Metronidazole|metronidazole|mesh-list
111248818|NCT02395458|Clarithromycin|clarithromycin|mesh-list
111248819|NCT02395458|Omeprazole|omeprazole|mesh-list
111079667|NCT03346525|Penicillins|penicillins|mesh-list
111248820|NCT02395458|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111079817|NCT02517619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111248821|NCT02395458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111248823|NCT02395458|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111248824|NCT02395458|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111248825|NCT02395458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111080038|NCT02506777|Doxorubicin|doxorubicin|mesh-list
111080113|NCT02505997|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111248826|NCT02395458|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111248827|NCT02395458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111248828|NCT02395458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111080346|NCT02504125|Hemostatics|hemostatics|mesh-ancestor
111080439|NCT02509195|Lamivudine|lamivudine|mesh-list
111248829|NCT02395458|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111248830|NCT02395458|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111248831|NCT02395458|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111248832|NCT02402400|Ticagrelor|ticagrelor|mesh-list
111248833|NCT02402400|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111248834|NCT02402400|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111248835|NCT02402400|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111080631|NCT02499757|Nicotine|nicotine|mesh-list
111248836|NCT02402400|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111248837|NCT02402400|Purinergic Agents|purinergic agents|mesh-ancestor
111080755|NCT02493283|Dapsone|dapsone|mesh-list
111080779|NCT02493049|Domperidone|domperidone|mesh-list
111080862|NCT03335059|Mitomycins|mitomycins|mesh-list
111248838|NCT02402400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111248839|NCT02402400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111248840|NCT02402400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111248841|NCT02610868|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
111248842|NCT02610868|Botulinum Toxins|botulinum toxins|mesh-list
111248843|NCT02610868|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111081159|NCT03327727|Amebicides|amebicides|mesh-ancestor
111248844|NCT02610868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111248845|NCT02610868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111081232|NCT02488291|Sufentanil|sufentanil|mesh-list
111248846|NCT02610868|Cholinergic Agents|cholinergic agents|mesh-ancestor
111248847|NCT02610868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111081300|NCT02487823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111248848|NCT02610868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111248849|NCT02610868|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111248850|NCT02395068|Irinotecan|irinotecan|mesh-list
111248851|NCT02395068|Nimotuzumab|nimotuzumab|mesh-list
111248852|NCT02395068|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111081513|NCT02483689|Bupivacaine|bupivacaine|mesh-list
111248853|NCT02395068|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111248854|NCT02395068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111081664|NCT02485873|Protease Inhibitors|protease inhibitors|mesh-ancestor
111081739|NCT02476981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111248855|NCT02395068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111081817|NCT03103893|Sirolimus|sirolimus|mesh-list
111248856|NCT02395068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111248857|NCT02395068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111248858|NCT02616250|Ivermectin|ivermectin|mesh-list
111248859|NCT02616250|Brimonidine Tartrate|brimonidine tartrate|mesh-list
111248860|NCT02616250|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111248861|NCT02616250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111248862|NCT02616250|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111248863|NCT02616250|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111248864|NCT02616250|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111248865|NCT02616250|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111248866|NCT02616250|Adrenergic Agents|adrenergic agents|mesh-ancestor
111248867|NCT02616250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111248868|NCT02616250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111248869|NCT02616250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111248870|NCT02698410|Temozolomide|temozolomide|mesh-list
111248871|NCT02698410|Lanreotide|lanreotide|mesh-list
111248872|NCT02698410|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111248873|NCT02698410|Alkylating Agents|alkylating agents|mesh-ancestor
111248874|NCT02698410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111248875|NCT02698410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111248876|NCT00365638|Simvastatin|simvastatin|mesh-list
111082177|NCT02472613|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111248877|NCT00365638|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111248878|NCT00365638|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111248879|NCT00365638|Antimetabolites|antimetabolites|mesh-ancestor
111248880|NCT00365638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111082415|NCT05161741|Insulin|insulin|mesh-list
111248881|NCT00365638|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111248882|NCT00365638|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111248883|NCT00365638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111248884|NCT02699892|Rituximab|rituximab|mesh-list
111248885|NCT02699892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111248886|NCT02699892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111248887|NCT02699892|Immunologic Factors|immunologic factors|mesh-ancestor
111248888|NCT02699892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111082486|NCT04220125|Midazolam|midazolam|mesh-list
111082537|NCT03043729|Leucovorin|leucovorin|mesh-list
111248889|NCT02699892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111248890|NCT05731258|Doxorubicin|doxorubicin|mesh-list
111248891|NCT05731258|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111248892|NCT05731258|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111248893|NCT05731258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111082614|NCT02693821|Gabapentin|gabapentin|mesh-list
111248894|NCT05731258|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111248895|NCT05731258|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111248896|NCT05731258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111248897|NCT05731258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111248898|NCT04340908|Dapagliflozin|dapagliflozin|mesh-list
111248899|NCT04340908|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111248900|NCT04340908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111248901|NCT04340908|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111248902|NCT04340908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111248903|NCT05730634|Atorvastatin|atorvastatin|mesh-list
111248904|NCT05730634|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111248905|NCT05730634|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111082763|NCT03174847|Hormones|hormones|mesh-ancestor
111248906|NCT05730634|Antimetabolites|antimetabolites|mesh-ancestor
111082824|NCT02468323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111248907|NCT05730634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111248908|NCT05730634|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111082900|NCT03301285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111248909|NCT05730634|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111248910|NCT05730634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111248911|NCT05705830|Serotonin|serotonin|mesh-list
111248912|NCT05705830|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
111083040|NCT00702949|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111083113|NCT02466919|Metronidazole|metronidazole|mesh-list
111248913|NCT05705830|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111248914|NCT05705830|Serotonin Agents|serotonin agents|mesh-ancestor
111248915|NCT05705830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111248916|NCT05705830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111248917|NCT05705830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111083408|NCT03332095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111083483|NCT03295825|Heparin|heparin|mesh-list
111248918|NCT05705830|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111248919|NCT05705830|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111248920|NCT05745714|Cytarabine|cytarabine|mesh-list
111248921|NCT05745714|Dexamethasone|dexamethasone|mesh-list
111248922|NCT05745714|Cyclophosphamide|cyclophosphamide|mesh-list
111248923|NCT05745714|Venetoclax|venetoclax|mesh-list
111248924|NCT05745714|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111248925|NCT05745714|Immunologic Factors|immunologic factors|mesh-ancestor
111248926|NCT05745714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111248927|NCT05745714|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111083777|NCT03369119|Montelukast|montelukast|mesh-list
111248928|NCT05745714|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111248929|NCT05745714|Alkylating Agents|alkylating agents|mesh-ancestor
111083925|NCT04525235|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111248930|NCT05745714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111248931|NCT05745714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111248932|NCT05745714|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111248933|NCT05745714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111248934|NCT05745714|Antiemetics|antiemetics|mesh-ancestor
111248935|NCT05745714|Autonomic Agents|autonomic agents|mesh-ancestor
111248936|NCT05745714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111248937|NCT05745714|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111248938|NCT05745714|Glucocorticoids|glucocorticoids|mesh-ancestor
111248939|NCT05745714|Hormones|hormones|mesh-ancestor
111084368|NCT03264781|CycloProvera|cycloprovera|mesh-list
111248940|NCT05745714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111084440|NCT03365141|Glucocorticoids|glucocorticoids|mesh-ancestor
111248941|NCT05745714|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111248942|NCT05745714|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111248943|NCT05745714|Antimetabolites|antimetabolites|mesh-ancestor
111248944|NCT05745714|Antiviral Agents|antiviral agents|mesh-ancestor
111248945|NCT05745714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111248946|NCT02974270|Leuprolide|leuprolide|mesh-list
111248947|NCT02974270|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111248948|NCT02974270|Fertility Agents|fertility agents|mesh-ancestor
111248949|NCT02974270|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111248950|NCT02974270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111248951|NCT02974270|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111248952|NCT02974270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111248953|NCT03167268|Lycopene|lycopene|mesh-list
111248954|NCT03167268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111248955|NCT03167268|Antioxidants|antioxidants|mesh-ancestor
111248956|NCT03167268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111248957|NCT03167268|Protective Agents|protective agents|mesh-ancestor
111248958|NCT03167268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111248959|NCT03167268|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111248960|NCT03167268|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
111248961|NCT03167268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111248962|NCT04544098|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
111248963|NCT04544098|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111085513|NCT03363503|Xhance|xhance|mesh-list
111248964|NCT04544098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111248965|NCT04485052|Azacitidine|azacitidine|mesh-list
111248966|NCT04485052|Decitabine|decitabine|mesh-list
111085624|NCT03245281|Diuretics|diuretics|mesh-list
111248967|NCT04485052|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111248968|NCT04485052|Antimetabolites|antimetabolites|mesh-ancestor
111085842|NCT02454205|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111085917|NCT03237637|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111248969|NCT04485052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111248970|NCT04485052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111248971|NCT04485052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111248972|NCT02393898|Paclitaxel|paclitaxel|mesh-list
111086214|NCT03241381|Vitamin D|vitamin d|mesh-list
111248973|NCT02393898|Bevacizumab|bevacizumab|mesh-list
111248974|NCT02393898|Carboplatin|carboplatin|mesh-list
111086359|NCT02509091|Dimercaprol|dimercaprol|mesh-list
111248975|NCT02393898|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111248976|NCT02393898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111248977|NCT02393898|Tubulin Modulators|tubulin modulators|mesh-ancestor
111248978|NCT02393898|Antimitotic Agents|antimitotic agents|mesh-ancestor
111248979|NCT02393898|Mitosis Modulators|mitosis modulators|mesh-ancestor
111248980|NCT02393898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111248981|NCT02393898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111248982|NCT02393898|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111248983|NCT02393898|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111248984|NCT02393898|Growth Substances|growth substances|mesh-ancestor
111248985|NCT02393898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111248986|NCT02393898|Growth Inhibitors|growth inhibitors|mesh-ancestor
111248987|NCT04340128|Meglumine Antimoniate|meglumine antimoniate|mesh-list
111248988|NCT04340128|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111248989|NCT04340128|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111248990|NCT04340128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111087249|NCT03329339|Ascorbic Acid|ascorbic acid|mesh-list
111248991|NCT04258852|Nicotine|nicotine|mesh-list
111248992|NCT04258852|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111248993|NCT04258852|Autonomic Agents|autonomic agents|mesh-ancestor
111248994|NCT04258852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111248995|NCT04258852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111248996|NCT04258852|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111248997|NCT04258852|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111248998|NCT04258852|Cholinergic Agents|cholinergic agents|mesh-ancestor
111087702|NCT03239821|Codeine|codeine|mesh-list
111248999|NCT04258852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111087843|NCT03227653|Nevirapine|nevirapine|mesh-list
111249000|NCT04258852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111249001|NCT04145674|Methadone|methadone|mesh-list
111249002|NCT04145674|D-methadone|d-methadone|mesh-list
111249003|NCT04145674|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111249004|NCT04145674|Narcotics|narcotics|mesh-ancestor
111249005|NCT04145674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111249006|NCT04145674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111249007|NCT04145674|Analgesics|analgesics|mesh-ancestor
111088454|NCT03318029|Vitamin D|vitamin d|mesh-list
111249008|NCT04145674|Sensory System Agents|sensory system agents|mesh-ancestor
111088526|NCT03220555|Lidocaine|lidocaine|mesh-list
111249009|NCT04145674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111249010|NCT04145674|Antitussive Agents|antitussive agents|mesh-ancestor
111249011|NCT04145674|Respiratory System Agents|respiratory system agents|mesh-ancestor
111249012|NCT04145674|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111249013|NCT02394054|Vasopressins|vasopressins|mesh-list
111249014|NCT02394054|Arginine Vasopressin|arginine vasopressin|mesh-list
111249015|NCT02394054|Hemostatics|hemostatics|mesh-ancestor
111249016|NCT02394054|Coagulants|coagulants|mesh-ancestor
111249017|NCT02394054|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111249018|NCT02394054|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
111249019|NCT02394054|Natriuretic Agents|natriuretic agents|mesh-ancestor
111088966|NCT05713721|Dopamine|dopamine|mesh-list
111249020|NCT02394054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111249021|NCT02393664|Bupivacaine|bupivacaine|mesh-list
111249022|NCT02393664|Propofol|propofol|mesh-list
111249023|NCT02393664|Sevoflurane|sevoflurane|mesh-list
111249024|NCT02393664|Rocuronium|rocuronium|mesh-list
111249025|NCT02393664|Anesthetics, Local|anesthetics, local|mesh-ancestor
111249026|NCT02393664|Anesthetics|anesthetics|mesh-ancestor
111249027|NCT02393664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111249028|NCT02393664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111249029|NCT02393664|Sensory System Agents|sensory system agents|mesh-ancestor
111249030|NCT02393664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111249031|NCT02393664|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111249032|NCT02393664|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111249033|NCT02393664|Anesthetics, General|anesthetics, general|mesh-ancestor
111249034|NCT02393664|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111249035|NCT02393664|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111249036|NCT02393664|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
111249037|NCT02393664|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
111089987|NCT02470559|Analgesics|analgesics|mesh-ancestor
111090061|NCT02767427|Chlorhexidine|chlorhexidine|mesh-list
111249038|NCT02393664|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111249039|NCT02397642|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
110973352|NCT04301765|Androgens|androgens|mesh-ancestor
111090284|NCT02468297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111249040|NCT02397642|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111249041|NCT02397642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111249043|NCT02397486|Pentoxifylline|pentoxifylline|mesh-list
111249044|NCT02397486|Vitamins|vitamins|mesh-ancestor
111249045|NCT02397486|Micronutrients|micronutrients|mesh-ancestor
111090668|NCT00702923|Ipilimumab|ipilimumab|mesh-list
111249046|NCT02397486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111249047|NCT02397486|Antioxidants|antioxidants|mesh-ancestor
111090804|NCT03067935|Immunoconjugates|immunoconjugates|mesh-ancestor
111249048|NCT02397486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111249049|NCT02397486|Protective Agents|protective agents|mesh-ancestor
111249050|NCT02397486|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111091104|NCT04872257|Vitamin D|vitamin d|mesh-list
111249051|NCT02397486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111249052|NCT02397486|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111249053|NCT02397486|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111091252|NCT02462681|Ketamine|ketamine|mesh-list
111249054|NCT02397486|Vasodilator Agents|vasodilator agents|mesh-ancestor
111249055|NCT02397486|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111249056|NCT02393586|Amoxicillin|amoxicillin|mesh-list
111091471|NCT00379041|Hormones|hormones|mesh-ancestor
111249057|NCT02393586|Rifampin|rifampin|mesh-list
111091548|NCT00701363|Lanreotide|lanreotide|mesh-list
111249058|NCT02393586|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
111249059|NCT02393586|Clavulanic Acids|clavulanic acids|mesh-list
111091696|NCT03287427|Tislelizumab|tislelizumab|mesh-list
111249060|NCT02393586|Clavulanic Acid|clavulanic acid|mesh-list
111249061|NCT02393586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111249062|NCT02393586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111249063|NCT02393586|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111249064|NCT02393586|Antitubercular Agents|antitubercular agents|mesh-ancestor
111249065|NCT02393586|Leprostatic Agents|leprostatic agents|mesh-ancestor
111249066|NCT02393586|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111249067|NCT02393586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111249068|NCT02393586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111249069|NCT02393586|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111091923|NCT03293927|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111249070|NCT02393586|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111249071|NCT02393586|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
111091986|NCT04971291|Bupropion|bupropion|mesh-list
111092057|NCT00777127|Diclofenac|diclofenac|mesh-list
111249072|NCT02393586|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
111249073|NCT02393586|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
111092279|NCT02443285|Cefotaxime|cefotaxime|mesh-list
111249074|NCT02393586|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111249075|NCT02393586|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
111249076|NCT02393430|Rebamipide|rebamipide|mesh-list
111092500|NCT03268733|Folic Acid|folic acid|mesh-list
111249077|NCT02393430|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111249078|NCT02393430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111249079|NCT02393430|Antioxidants|antioxidants|mesh-ancestor
111092643|NCT02458079|Pentoxifylline|pentoxifylline|mesh-list
111249080|NCT02393430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111249081|NCT02393430|Protective Agents|protective agents|mesh-ancestor
111249082|NCT02393430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111249083|NCT02393430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111249084|NCT03453892|Pembrolizumab|pembrolizumab|mesh-list
111249085|NCT03453892|Nivolumab|nivolumab|mesh-list
111249086|NCT03453892|Ipilimumab|ipilimumab|mesh-list
111249087|NCT03453892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111249088|NCT03453892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111249089|NCT03453892|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111093233|NCT04951713|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111249090|NCT03453892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111249091|NCT00367120|Amoxicillin|amoxicillin|mesh-list
111249092|NCT00367120|Azithromycin|azithromycin|mesh-list
111249093|NCT00367120|Clavulanic Acid|clavulanic acid|mesh-list
111249094|NCT00367120|Clavulanic Acids|clavulanic acids|mesh-list
111093455|NCT04947189|Hormones|hormones|mesh-ancestor
111249095|NCT00367120|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
111249096|NCT00367120|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111249097|NCT00367120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111249098|NCT00367120|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
111249099|NCT00367120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111249100|NCT00367120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111249101|NCT03103750|Calcitriol|calcitriol|mesh-list
111249102|NCT03103750|Amphetamine|amphetamine|mesh-list
111249103|NCT03103750|Dextroamphetamine|dextroamphetamine|mesh-list
111249104|NCT03103750|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111249105|NCT03103750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111249106|NCT03103750|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
111249107|NCT03103750|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111249108|NCT03103750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111249109|NCT03103750|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111249110|NCT03103750|Vitamins|vitamins|mesh-ancestor
111249111|NCT03103750|Micronutrients|micronutrients|mesh-ancestor
111249112|NCT03103750|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111094186|NCT02157376|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
111249113|NCT03103750|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111249114|NCT03103750|Sympathomimetics|sympathomimetics|mesh-ancestor
111249115|NCT03103750|Autonomic Agents|autonomic agents|mesh-ancestor
111249116|NCT03103750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111094334|NCT02155738|Antipyretics|antipyretics|mesh-ancestor
111249117|NCT03103750|Dopamine Agents|dopamine agents|mesh-ancestor
111249118|NCT03103750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111249119|NCT03103750|Adrenergic Agents|adrenergic agents|mesh-ancestor
111249120|NCT03103750|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111249121|NCT03103750|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111249122|NCT03103750|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111249123|NCT02397330|Morphine|morphine|mesh-list
111094702|NCT04886193|Leucovorin|leucovorin|mesh-list
111249124|NCT02397330|Bupivacaine|bupivacaine|mesh-list
111249125|NCT02397330|Anesthetics, Local|anesthetics, local|mesh-ancestor
111249126|NCT02397330|Anesthetics|anesthetics|mesh-ancestor
111094778|NCT05257395|Letrozole|letrozole|mesh-list
111094923|NCT04865991|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111249127|NCT02397330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111249128|NCT02397330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111249129|NCT02397330|Sensory System Agents|sensory system agents|mesh-ancestor
111249130|NCT02397330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111249131|NCT02397330|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111249132|NCT02397330|Narcotics|narcotics|mesh-ancestor
111249133|NCT02397330|Analgesics|analgesics|mesh-ancestor
111249134|NCT03081052|Nitric Oxide|nitric oxide|mesh-list
111095462|NCT03047733|Tacrolimus|tacrolimus|mesh-list
111095523|NCT02505581|Metronidazole|metronidazole|mesh-list
111249135|NCT03081052|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111249136|NCT03081052|Autonomic Agents|autonomic agents|mesh-ancestor
111095597|NCT03213743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111249137|NCT03081052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111095677|NCT03209297|Salicylic Acid|salicylic acid|mesh-list
111249138|NCT03081052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111095764|NCT04429191|Antibodies|antibodies|mesh-list
111095890|NCT02117050|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111249139|NCT03081052|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111249140|NCT03081052|Respiratory System Agents|respiratory system agents|mesh-ancestor
111249141|NCT03081052|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111249142|NCT03081052|Antioxidants|antioxidants|mesh-ancestor
111096119|NCT04838145|Ribavirin|ribavirin|mesh-list
111249143|NCT03081052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111249144|NCT03081052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111096263|NCT04836819|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111249145|NCT03081052|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
111096332|NCT03038919|Anabolic Agents|anabolic agents|mesh-ancestor
111096481|NCT04427865|Lactoferrin|lactoferrin|mesh-list
111249146|NCT03081052|Vasodilator Agents|vasodilator agents|mesh-ancestor
111249147|NCT03081052|Gasotransmitters|gasotransmitters|mesh-ancestor
111249148|NCT03081052|Protective Agents|protective agents|mesh-ancestor
111249149|NCT02393196|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
111249150|NCT02393196|Plasma Substitutes|plasma substitutes|mesh-ancestor
111249151|NCT02393196|Blood Substitutes|blood substitutes|mesh-ancestor
111249152|NCT03015610|Lansoprazole|lansoprazole|mesh-list
111249153|NCT03015610|Dexlansoprazole|dexlansoprazole|mesh-list
111097071|NCT03202979|Trazodone|trazodone|mesh-list
111249154|NCT03015610|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111097145|NCT02450279|Anticoagulants|anticoagulants|mesh-ancestor
111249155|NCT03015610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111249156|NCT03015610|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111249157|NCT03015610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111097363|NCT04791345|Deflazacort|deflazacort|mesh-list
111249158|NCT03015610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111249159|NCT00422344|Sunitinib|sunitinib|mesh-list
111249160|NCT00422344|Everolimus|everolimus|mesh-list
111097512|NCT04790331|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111249161|NCT00422344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111249162|NCT00422344|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111249163|NCT00422344|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111249164|NCT00422344|Growth Substances|growth substances|mesh-ancestor
111249165|NCT00422344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111249166|NCT00422344|Growth Inhibitors|growth inhibitors|mesh-ancestor
111249167|NCT00422344|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111249168|NCT00422344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111249169|NCT00422344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111249170|NCT00422344|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111098180|NCT02109484|Vaccines|vaccines|mesh-list
111249171|NCT00422344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111249172|NCT00422344|Immunologic Factors|immunologic factors|mesh-ancestor
111249173|NCT00367276|Drospirenone|drospirenone|mesh-list
111249174|NCT00367276|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
111249175|NCT00367276|Hormone Antagonists|hormone antagonists|mesh-ancestor
111098399|NCT05551221|Tamsulosin|tamsulosin|mesh-list
111098475|NCT05539521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111098548|NCT05545059|Valsartan|valsartan|mesh-list
111098619|NCT04677855|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111098695|NCT02583477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111249176|NCT00367276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111098844|NCT02444351|Botulinum Toxins|botulinum toxins|mesh-list
111098916|NCT00977483|Thioctic Acid|thioctic acid|mesh-list
111098989|NCT04314843|Cyclophosphamide|cyclophosphamide|mesh-list
111249177|NCT00367276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111099140|NCT05562999|Anticonvulsants|anticonvulsants|mesh-ancestor
111099214|NCT05534685|Hormones|hormones|mesh-ancestor
111249178|NCT00367276|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
111249179|NCT00367276|Diuretics|diuretics|mesh-ancestor
111249180|NCT00367276|Natriuretic Agents|natriuretic agents|mesh-ancestor
111249181|NCT02546986|Pembrolizumab|pembrolizumab|mesh-list
111249182|NCT02546986|Azacitidine|azacitidine|mesh-list
111249183|NCT02546986|Cc-486|cc-486|mesh-list
111099583|NCT02573883|Clobetasol|clobetasol|mesh-list
111249184|NCT02546986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111249185|NCT02546986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111249186|NCT02546986|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111249187|NCT02546986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111099801|NCT02432027|Dermatologic Agents|dermatologic agents|mesh-ancestor
111249188|NCT02546986|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111249189|NCT02546986|Antimetabolites|antimetabolites|mesh-ancestor
111249190|NCT02546986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111249191|NCT02689206|Glycine|glycine|mesh-list
111249192|NCT02689206|Glycine Agents|glycine agents|mesh-ancestor
111249193|NCT02689206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111100019|NCT03183557|Zoledronic Acid|zoledronic acid|mesh-list
111249194|NCT02689206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111249195|NCT02689206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111249196|NCT01695239|Adalimumab|adalimumab|mesh-list
111249197|NCT01695239|Ixekizumab|ixekizumab|mesh-list
111100237|NCT03178955|Etanercept|etanercept|mesh-list
111249198|NCT01695239|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111249199|NCT01695239|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111249200|NCT01695239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111249201|NCT01695239|Dermatologic Agents|dermatologic agents|mesh-ancestor
111249202|NCT02163694|Paclitaxel|paclitaxel|mesh-list
111249203|NCT02163694|Carboplatin|carboplatin|mesh-list
111249204|NCT02163694|Veliparib|veliparib|mesh-list
111249205|NCT02163694|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111249206|NCT02163694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111249207|NCT02163694|Tubulin Modulators|tubulin modulators|mesh-ancestor
111249208|NCT02163694|Antimitotic Agents|antimitotic agents|mesh-ancestor
111249209|NCT02163694|Mitosis Modulators|mitosis modulators|mesh-ancestor
111100827|NCT02415803|Clopidogrel|clopidogrel|mesh-list
111249210|NCT02163694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111249211|NCT02163694|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111249212|NCT02163694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111249213|NCT01587352|Vorinostat|vorinostat|mesh-list
111101048|NCT02413853|Calcium|calcium|mesh-list
111249214|NCT01587352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111101130|NCT02569437|Hormones|hormones|mesh-ancestor
111101209|NCT02044822|Rituximab|rituximab|mesh-list
111249215|NCT01587352|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111101274|NCT05514015|Rituximab|rituximab|mesh-list
111249216|NCT01587352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111249217|NCT01587352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111249218|NCT00703222|Interleukin-2|interleukin-2|mesh-list
111249219|NCT00703222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111249220|NCT00703222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111249221|NCT00703222|Analgesics|analgesics|mesh-ancestor
111249222|NCT00703222|Sensory System Agents|sensory system agents|mesh-ancestor
111249223|NCT00703222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111249224|NCT00703222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111249225|NCT04449250|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
111249226|NCT04449250|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111249227|NCT04449250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111249228|NCT04449250|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111249229|NCT04449250|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111249230|NCT04449250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111249231|NCT04449250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111249232|NCT04449250|Dopamine Agents|dopamine agents|mesh-ancestor
111101631|NCT04289805|Letrozole|letrozole|mesh-list
111249233|NCT04449250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111249234|NCT04317430|Niclosamide|niclosamide|mesh-list
111249235|NCT04317430|Anticestodal Agents|anticestodal agents|mesh-ancestor
111249236|NCT04317430|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
111249237|NCT04317430|Anthelmintics|anthelmintics|mesh-ancestor
111249238|NCT04317430|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111102002|NCT02040532|Antimanic Agents|antimanic agents|mesh-ancestor
111102078|NCT02056288|Narcotics|narcotics|mesh-ancestor
111249239|NCT04317430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111249240|NCT04317430|Antinematodal Agents|antinematodal agents|mesh-ancestor
111249241|NCT04277884|Firibastat|firibastat|mesh-list
111249242|NCT04277884|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111249243|NCT00367822|Ropinirole|ropinirole|mesh-list
111249244|NCT00367822|Lisuride|lisuride|mesh-list
111249245|NCT00367822|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111249246|NCT00367822|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111249247|NCT00367822|Dopamine Agonists|dopamine agonists|mesh-ancestor
111249248|NCT00367822|Dopamine Agents|dopamine agents|mesh-ancestor
111249249|NCT00367822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111249250|NCT00367822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111249251|NCT00367822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111249252|NCT00367822|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111249253|NCT00367822|Serotonin Agents|serotonin agents|mesh-ancestor
111249254|NCT02643862|Omalizumab|omalizumab|mesh-list
111249255|NCT02643862|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111249256|NCT02643862|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111249257|NCT02643862|Respiratory System Agents|respiratory system agents|mesh-ancestor
111249258|NCT01694771|Tiotropium Bromide|tiotropium bromide|mesh-list
111249259|NCT01694771|Olodaterol|olodaterol|mesh-list
111249260|NCT01694771|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111249261|NCT01694771|Autonomic Agents|autonomic agents|mesh-ancestor
111249262|NCT01694771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111249263|NCT01694771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111249264|NCT01694771|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111249265|NCT01694771|Respiratory System Agents|respiratory system agents|mesh-ancestor
111249266|NCT01694771|Parasympatholytics|parasympatholytics|mesh-ancestor
111249267|NCT01694771|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111249268|NCT01694771|Cholinergic Agents|cholinergic agents|mesh-ancestor
111249269|NCT01694771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111249270|NCT01694771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111249271|NCT02651272|Macitentan|macitentan|mesh-list
111249272|NCT02651272|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
111249273|NCT02651272|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
111102371|NCT02055976|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111249274|NCT02651272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111249275|NCT02651272|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
111249276|NCT01582061|Pasireotide|pasireotide|mesh-list
111249277|NCT01582061|Hormones|hormones|mesh-ancestor
111249278|NCT01582061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111249279|NCT01582061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111249280|NCT01693523|Minocycline|minocycline|mesh-list
111249281|NCT01693523|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111249282|NCT01693523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111249283|NCT03924323|Escitalopram|escitalopram|mesh-list
111249284|NCT03924323|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111249285|NCT03924323|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111249286|NCT03924323|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111249287|NCT03924323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111249288|NCT03924323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111249289|NCT03924323|Serotonin Agents|serotonin agents|mesh-ancestor
111249290|NCT03924323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111249291|NCT01581281|Topiramate|topiramate|mesh-list
111249292|NCT01581281|Amitriptyline|amitriptyline|mesh-list
111249293|NCT01581281|Anticonvulsants|anticonvulsants|mesh-ancestor
111249294|NCT01581281|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111249295|NCT01581281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111249296|NCT01581281|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
111249297|NCT01581281|Antidepressive Agents|antidepressive agents|mesh-ancestor
111249298|NCT01581281|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111249299|NCT01581281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111249300|NCT01581281|Analgesics|analgesics|mesh-ancestor
111249301|NCT01581281|Sensory System Agents|sensory system agents|mesh-ancestor
111249302|NCT01581281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111249303|NCT01581281|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111249304|NCT01581281|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111249305|NCT01581281|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111249306|NCT01581281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111249307|NCT01581281|Adrenergic Agents|adrenergic agents|mesh-ancestor
111249308|NCT01581281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111249309|NCT01580969|Minocycline|minocycline|mesh-list
111249310|NCT01580969|Bevacizumab|bevacizumab|mesh-list
111249311|NCT01580969|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111249312|NCT01580969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111249313|NCT01580969|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111249314|NCT01580969|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111249315|NCT01580969|Growth Substances|growth substances|mesh-ancestor
111249316|NCT01580969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111249317|NCT01580969|Growth Inhibitors|growth inhibitors|mesh-ancestor
111249318|NCT01580969|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111249319|NCT01580969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111249320|NCT02696226|Aspirin|aspirin|mesh-list
111249321|NCT02696226|Warfarin|warfarin|mesh-list
111249322|NCT02696226|Clopidogrel|clopidogrel|mesh-list
111249323|NCT02696226|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111249324|NCT02696226|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111249325|NCT02696226|Analgesics|analgesics|mesh-ancestor
111249326|NCT02696226|Sensory System Agents|sensory system agents|mesh-ancestor
111249327|NCT02696226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111249328|NCT02696226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111249329|NCT02696226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111249330|NCT02696226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111249331|NCT02696226|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111249332|NCT02696226|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111249333|NCT02696226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111249334|NCT02696226|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111249335|NCT02696226|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111249336|NCT02696226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111249337|NCT02696226|Antipyretics|antipyretics|mesh-ancestor
111249338|NCT02696226|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111249339|NCT02696226|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110973658|NCT02061761|Nivolumab|nivolumab|mesh-list
111249340|NCT02696226|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111249341|NCT02696226|Purinergic Agents|purinergic agents|mesh-ancestor
111249342|NCT02696226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111249343|NCT02696226|Anticoagulants|anticoagulants|mesh-ancestor
111249344|NCT03167112|Leucovorin|leucovorin|mesh-list
111249345|NCT03167112|Fluorouracil|fluorouracil|mesh-list
111249346|NCT03167112|Oxaliplatin|oxaliplatin|mesh-list
111249347|NCT03167112|Irinotecan|irinotecan|mesh-list
111249348|NCT03167112|Antimetabolites|antimetabolites|mesh-ancestor
111249349|NCT03167112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111249350|NCT03167112|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111249351|NCT03167112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111249352|NCT03167112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111249353|NCT03167112|Immunologic Factors|immunologic factors|mesh-ancestor
111249354|NCT03167112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111249355|NCT03167112|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111249356|NCT03167112|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111249357|NCT03167112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111249358|NCT03167112|Antidotes|antidotes|mesh-ancestor
111249359|NCT03167112|Protective Agents|protective agents|mesh-ancestor
111249360|NCT03167112|Vitamin B Complex|vitamin b complex|mesh-ancestor
111249361|NCT03167112|Vitamins|vitamins|mesh-ancestor
111249362|NCT03167112|Micronutrients|micronutrients|mesh-ancestor
111249363|NCT01578785|Glatiramer Acetate|glatiramer acetate|mesh-list
111249364|NCT01578785|(T,G)-A-L|(t,g)-a-l|mesh-list
111249365|NCT01578785|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111249366|NCT01578785|Immunologic Factors|immunologic factors|mesh-ancestor
111249367|NCT01578785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111249368|NCT01578785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111249369|NCT01578785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111249370|NCT03167034|Acetazolamide|acetazolamide|mesh-list
111249371|NCT03167034|Anticonvulsants|anticonvulsants|mesh-ancestor
111249372|NCT03167034|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
111249373|NCT03167034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111249374|NCT03167034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111249375|NCT03167034|Diuretics|diuretics|mesh-ancestor
111249376|NCT03167034|Natriuretic Agents|natriuretic agents|mesh-ancestor
111249377|NCT03167034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111249378|NCT01578551|Metformin|metformin|mesh-list
111249379|NCT01578551|Biguanides|biguanides|mesh-list
111249380|NCT01578551|Paclitaxel|paclitaxel|mesh-list
111249381|NCT01578551|Bevacizumab|bevacizumab|mesh-list
111249382|NCT01578551|Carboplatin|carboplatin|mesh-list
111249383|NCT01578551|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111249384|NCT01578551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111249385|NCT01578551|Tubulin Modulators|tubulin modulators|mesh-ancestor
111249386|NCT01578551|Antimitotic Agents|antimitotic agents|mesh-ancestor
111249387|NCT01578551|Mitosis Modulators|mitosis modulators|mesh-ancestor
111249388|NCT01578551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111249389|NCT01578551|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111249390|NCT01578551|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111249391|NCT01578551|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111249392|NCT01578551|Growth Substances|growth substances|mesh-ancestor
111249393|NCT01578551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111249394|NCT01578551|Growth Inhibitors|growth inhibitors|mesh-ancestor
111249395|NCT01578551|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111249396|NCT01692197|Cytarabine|cytarabine|mesh-list
111249397|NCT01692197|Dexamethasone|dexamethasone|mesh-list
111249398|NCT01692197|Idarubicin|idarubicin|mesh-list
111249399|NCT01692197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111249400|NCT01692197|Antiemetics|antiemetics|mesh-ancestor
111249401|NCT01692197|Autonomic Agents|autonomic agents|mesh-ancestor
111249402|NCT01692197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111249403|NCT01692197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111249404|NCT01692197|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111249405|NCT01692197|Glucocorticoids|glucocorticoids|mesh-ancestor
111249406|NCT01692197|Hormones|hormones|mesh-ancestor
111249407|NCT01692197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111249408|NCT01692197|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111249409|NCT01692197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111249410|NCT01692197|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111249411|NCT01692197|Antimetabolites|antimetabolites|mesh-ancestor
111249412|NCT01692197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111249413|NCT01692197|Antiviral Agents|antiviral agents|mesh-ancestor
111249414|NCT01692197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111249415|NCT01692197|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111249416|NCT01692197|Immunologic Factors|immunologic factors|mesh-ancestor
111249417|NCT01692197|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111249418|NCT01692197|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111249419|NCT01692197|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111249420|NCT01692197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111249421|NCT03166644|Sufentanil|sufentanil|mesh-list
111249422|NCT03166644|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111249423|NCT03166644|Narcotics|narcotics|mesh-ancestor
111249424|NCT03166644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111249425|NCT03166644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111249426|NCT03166644|Analgesics|analgesics|mesh-ancestor
111249427|NCT03166644|Sensory System Agents|sensory system agents|mesh-ancestor
111249428|NCT03166644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111249429|NCT03166644|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111249430|NCT03166644|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111249431|NCT03166644|Anesthetics, General|anesthetics, general|mesh-ancestor
111249432|NCT03166644|Anesthetics|anesthetics|mesh-ancestor
111249433|NCT01691885|Fluticasone|fluticasone|mesh-list
111249435|NCT01691885|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111249436|NCT01691885|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111249437|NCT01691885|Autonomic Agents|autonomic agents|mesh-ancestor
111249438|NCT01691885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111249439|NCT01691885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111249440|NCT01691885|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111249441|NCT01691885|Respiratory System Agents|respiratory system agents|mesh-ancestor
111249442|NCT01691885|Dermatologic Agents|dermatologic agents|mesh-ancestor
111249443|NCT01691885|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111249444|NCT03166800|Ubiquinone|ubiquinone|mesh-list
111249445|NCT03166800|Micronutrients|micronutrients|mesh-ancestor
111249446|NCT03166800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111249447|NCT03166254|Pembrolizumab|pembrolizumab|mesh-list
111249448|NCT03166254|Vaccines|vaccines|mesh-list
111249449|NCT03166254|Poly ICLC|poly iclc|mesh-list
111249450|NCT03166254|Immunologic Factors|immunologic factors|mesh-ancestor
111249451|NCT03166254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111249452|NCT03166254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111249453|NCT03166254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111249454|NCT03166254|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111249455|NCT03166254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111249456|NCT03166254|Interferon Inducers|interferon inducers|mesh-ancestor
111249457|NCT02651428|Taurolidine|taurolidine|mesh-list
111249458|NCT02651428|Heparin|heparin|mesh-list
111249459|NCT02651428|Calcium heparin|calcium heparin|mesh-list
111249460|NCT02651428|Anticoagulants|anticoagulants|mesh-ancestor
111249461|NCT02651428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111249462|NCT02651428|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111249463|NCT02651428|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111249464|NCT02651428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111249465|NCT02651428|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111249466|NCT02651428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111249467|NCT02686164|Lenvatinib|lenvatinib|mesh-list
111249468|NCT02686164|Midazolam|midazolam|mesh-list
111249469|NCT02686164|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111249470|NCT02686164|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111249471|NCT02686164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111249472|NCT02686164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111249473|NCT02686164|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111249474|NCT02686164|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111249475|NCT02686164|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111249476|NCT02686164|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111249477|NCT02686164|Anesthetics, General|anesthetics, general|mesh-ancestor
111249478|NCT02686164|Anesthetics|anesthetics|mesh-ancestor
111249479|NCT02686164|GABA Modulators|gaba modulators|mesh-ancestor
111249480|NCT02686164|GABA Agents|gaba agents|mesh-ancestor
111249481|NCT02686164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111249482|NCT02686164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111249483|NCT02686164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111249484|NCT02686164|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111249485|NCT02686164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111249486|NCT02651584|Buprenorphine|buprenorphine|mesh-list
111249487|NCT02651584|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111249488|NCT02651584|Narcotics|narcotics|mesh-ancestor
111249489|NCT02651584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111249490|NCT02651584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111249491|NCT02651584|Analgesics|analgesics|mesh-ancestor
111249492|NCT02651584|Sensory System Agents|sensory system agents|mesh-ancestor
111249493|NCT02651584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111249494|NCT02651584|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111249495|NCT02685072|Progesterone|progesterone|mesh-list
111249496|NCT02685072|Progestins|progestins|mesh-ancestor
111249497|NCT02685072|Hormones|hormones|mesh-ancestor
111249498|NCT02685072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111249499|NCT02685072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111249500|NCT02653144|Dexamethasone|dexamethasone|mesh-list
111249501|NCT02653144|Dexmedetomidine|dexmedetomidine|mesh-list
111249502|NCT02653144|Ropivacaine|ropivacaine|mesh-list
111249503|NCT02653144|Anesthetics|anesthetics|mesh-list
111249504|NCT02653144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111249505|NCT02653144|Antiemetics|antiemetics|mesh-ancestor
111249506|NCT02653144|Autonomic Agents|autonomic agents|mesh-ancestor
111249507|NCT02653144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111249508|NCT02653144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111249509|NCT02653144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111249510|NCT02653144|Glucocorticoids|glucocorticoids|mesh-ancestor
111249511|NCT02653144|Hormones|hormones|mesh-ancestor
111249512|NCT02653144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111249513|NCT02653144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111249514|NCT02653144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111249515|NCT02653144|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111249516|NCT02653144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111249517|NCT02653144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111249518|NCT02653144|Analgesics|analgesics|mesh-ancestor
111249519|NCT02653144|Sensory System Agents|sensory system agents|mesh-ancestor
111249520|NCT02653144|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111249521|NCT02653144|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111249522|NCT02653144|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111249523|NCT02653144|Adrenergic Agents|adrenergic agents|mesh-ancestor
111249524|NCT02653144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111249525|NCT02653144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111249526|NCT02653144|Anesthetics, Local|anesthetics, local|mesh-ancestor
111249527|NCT00118365|Eflornithine|eflornithine|mesh-list
111249528|NCT00118365|Sulindac|sulindac|mesh-list
111249529|NCT00118365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111249530|NCT00118365|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
111249531|NCT00118365|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111249532|NCT00118365|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111249533|NCT00118365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111249534|NCT00118365|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
111249535|NCT00118365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111249536|NCT00118365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111249537|NCT00118365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111249538|NCT00118365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111249539|NCT00118365|Analgesics|analgesics|mesh-ancestor
111249540|NCT00118365|Sensory System Agents|sensory system agents|mesh-ancestor
111249541|NCT00118365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111249542|NCT00118365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111249543|NCT00118365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111249544|NCT00118365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111249545|NCT00118365|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111249546|NCT03165240|Eplerenone|eplerenone|mesh-list
111249547|NCT03165240|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
111249548|NCT03165240|Hormone Antagonists|hormone antagonists|mesh-ancestor
111249549|NCT03165240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111249550|NCT03165240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111249551|NCT03165240|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
111249552|NCT03165240|Diuretics|diuretics|mesh-ancestor
111249553|NCT03165240|Natriuretic Agents|natriuretic agents|mesh-ancestor
111249554|NCT03165240|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111249555|NCT01587079|Tiotropium Bromide|tiotropium bromide|mesh-list
111249556|NCT01587079|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111249557|NCT01587079|Autonomic Agents|autonomic agents|mesh-ancestor
111249558|NCT01587079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111249559|NCT01587079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111249560|NCT01587079|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111249561|NCT01587079|Respiratory System Agents|respiratory system agents|mesh-ancestor
111249562|NCT01587079|Parasympatholytics|parasympatholytics|mesh-ancestor
111249563|NCT01587079|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111249564|NCT01587079|Cholinergic Agents|cholinergic agents|mesh-ancestor
111249565|NCT01587079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111249566|NCT01587079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111249567|NCT03028909|Oseltamivir|oseltamivir|mesh-list
110973882|NCT00657878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111249568|NCT03028909|MEDI8852|medi8852|mesh-list
111249569|NCT03028909|Antiviral Agents|antiviral agents|mesh-ancestor
111249570|NCT03028909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111249571|NCT03028909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111249572|NCT03028909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111249574|NCT02654860|Bupivacaine|bupivacaine|mesh-list
111249575|NCT02654860|Anesthetics, Local|anesthetics, local|mesh-ancestor
111249576|NCT02654860|Anesthetics|anesthetics|mesh-ancestor
111249577|NCT02654860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111249578|NCT02654860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111249579|NCT02654860|Sensory System Agents|sensory system agents|mesh-ancestor
111249580|NCT02654860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111249581|NCT02654860|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111249582|NCT02654860|Analgesics|analgesics|mesh-ancestor
111249583|NCT02654860|Antipyretics|antipyretics|mesh-ancestor
111249584|NCT01587001|Acetylcysteine|acetylcysteine|mesh-list
111249585|NCT01587001|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111249586|NCT01587001|Antiviral Agents|antiviral agents|mesh-ancestor
111249587|NCT01587001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111249588|NCT01587001|Expectorants|expectorants|mesh-ancestor
111249589|NCT01587001|Respiratory System Agents|respiratory system agents|mesh-ancestor
111249590|NCT01587001|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111249591|NCT01587001|Antioxidants|antioxidants|mesh-ancestor
111249592|NCT01587001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111249593|NCT01587001|Protective Agents|protective agents|mesh-ancestor
111249594|NCT01587001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111249595|NCT01587001|Antidotes|antidotes|mesh-ancestor
111249596|NCT01568047|Levodopa|levodopa|mesh-list
111249597|NCT01568047|Carbidopa|carbidopa|mesh-list
111249598|NCT01568047|Opicapone|opicapone|mesh-list
111249599|NCT01568047|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111249600|NCT01568047|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111249601|NCT01568047|Dopamine Agents|dopamine agents|mesh-ancestor
111249602|NCT01568047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111249603|NCT01568047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111249604|NCT01568047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111249605|NCT01568047|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
111249606|NCT01568047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111249607|NCT01568047|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
111249608|NCT04782258|Tolvaptan|tolvaptan|mesh-list
111249609|NCT04782258|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
111249610|NCT04782258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111249611|NCT04782258|Natriuretic Agents|natriuretic agents|mesh-ancestor
111249612|NCT04782258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111249613|NCT01688921|Vaccines|vaccines|mesh-list
111249614|NCT01688921|Immunologic Factors|immunologic factors|mesh-ancestor
111249615|NCT01688921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111249616|NCT00118755|Bevacizumab|bevacizumab|mesh-list
111249617|NCT00118755|Capecitabine|capecitabine|mesh-list
111249618|NCT00118755|Oxaliplatin|oxaliplatin|mesh-list
111249619|NCT00118755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111249620|NCT00118755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111249621|NCT00118755|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111249622|NCT00118755|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111249623|NCT00118755|Growth Substances|growth substances|mesh-ancestor
111249624|NCT00118755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111249625|NCT00118755|Growth Inhibitors|growth inhibitors|mesh-ancestor
111249626|NCT00118755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111249627|NCT00118755|Antimetabolites|antimetabolites|mesh-ancestor
111249628|NCT00118755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111249629|NCT01541371|Paliperidone Palmitate|paliperidone palmitate|mesh-list
111249630|NCT01541371|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111249631|NCT01541371|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111249632|NCT01541371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111249633|NCT01541371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111249634|NCT01541371|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111249635|NCT01541371|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111249636|NCT01541371|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111249637|NCT01541371|Serotonin Agents|serotonin agents|mesh-ancestor
111249638|NCT01541371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111249639|NCT01541371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111249640|NCT01541371|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111249641|NCT01541371|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111249642|NCT01541371|Dopamine Agents|dopamine agents|mesh-ancestor
111249643|NCT02662036|Bupivacaine|bupivacaine|mesh-list
110973965|NCT02228031|Oxytocin|oxytocin|mesh-list
111249645|NCT02662036|Anesthetics|anesthetics|mesh-ancestor
111249646|NCT02662036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111249647|NCT02662036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111249648|NCT02662036|Sensory System Agents|sensory system agents|mesh-ancestor
111249649|NCT02662036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111249650|NCT01687673|Sirolimus|sirolimus|mesh-list
111249651|NCT01687673|Sorafenib|sorafenib|mesh-list
111249652|NCT01687673|Temsirolimus|temsirolimus|mesh-list
111249653|NCT01687673|MTOR Inhibitors|mtor inhibitors|mesh-list
111249654|NCT01687673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111249655|NCT01687673|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111249656|NCT01687673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111249657|NCT01687673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111249658|NCT01687673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111249659|NCT01687673|Immunologic Factors|immunologic factors|mesh-ancestor
111249660|NCT01687673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111249661|NCT01687673|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111249662|NCT01687673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111249663|NCT01687673|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111249664|NCT01687673|Antifungal Agents|antifungal agents|mesh-ancestor
111249665|NCT00121251|Gemcitabine|gemcitabine|mesh-list
111249666|NCT00121251|Capecitabine|capecitabine|mesh-list
111249667|NCT00121251|Sorafenib|sorafenib|mesh-list
111249668|NCT00121251|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111249669|NCT00121251|Antimetabolites|antimetabolites|mesh-ancestor
111249670|NCT00121251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111249671|NCT00121251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111249672|NCT00121251|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111249673|NCT00121251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111249674|NCT02664220|Povidone-Iodine|povidone-iodine|mesh-list
111249675|NCT02664220|Povidone|povidone|mesh-list
111249676|NCT02664220|Plasma Substitutes|plasma substitutes|mesh-ancestor
111249677|NCT02664220|Blood Substitutes|blood substitutes|mesh-ancestor
111249678|NCT02664220|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111249679|NCT02664220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111249680|NCT04339348|Lidocaine|lidocaine|mesh-list
111249681|NCT04339348|Prilocaine|prilocaine|mesh-list
111249682|NCT04339348|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
111249683|NCT04339348|Misoprostol|misoprostol|mesh-list
111249684|NCT04339348|Anesthetics, Local|anesthetics, local|mesh-ancestor
111249685|NCT04339348|Anesthetics|anesthetics|mesh-ancestor
111249686|NCT04339348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111249687|NCT04339348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111249688|NCT04339348|Sensory System Agents|sensory system agents|mesh-ancestor
111249689|NCT04339348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111249690|NCT04339348|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111249691|NCT04339348|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111249692|NCT04339348|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111249693|NCT04339348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111249694|NCT04339348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111249695|NCT04339348|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111249696|NCT04339348|Abortifacient Agents|abortifacient agents|mesh-ancestor
111249697|NCT04339348|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111249698|NCT04339348|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111249699|NCT04339348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111249700|NCT04339348|Oxytocics|oxytocics|mesh-ancestor
111249701|NCT04339348|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
111249702|NCT02664922|Ketamine|ketamine|mesh-list
111249703|NCT02664922|Remifentanil|remifentanil|mesh-list
111249704|NCT02664922|Propofol|propofol|mesh-list
111249705|NCT02664922|Sevoflurane|sevoflurane|mesh-list
111249706|NCT02664922|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111249707|NCT02664922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111249708|NCT02664922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111249709|NCT02664922|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111102430|NCT05499897|Anesthetics|anesthetics|mesh-list
111249710|NCT02664922|Anesthetics, General|anesthetics, general|mesh-ancestor
111249711|NCT02664922|Anesthetics|anesthetics|mesh-ancestor
111249712|NCT02664922|Analgesics|analgesics|mesh-ancestor
111249713|NCT02664922|Sensory System Agents|sensory system agents|mesh-ancestor
111249714|NCT02664922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111249715|NCT02664922|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111249716|NCT02664922|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111249717|NCT02664922|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110974028|NCT02723630|Lenvatinib|lenvatinib|mesh-list
111249718|NCT02664922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111249719|NCT02664922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111249720|NCT02664922|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111249721|NCT02664922|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111249722|NCT02664922|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111249723|NCT02664922|Narcotics|narcotics|mesh-ancestor
111249724|NCT02666950|Cytarabine|cytarabine|mesh-list
111249725|NCT02666950|Adavosertib|adavosertib|mesh-list
111249726|NCT02666950|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111249727|NCT02666950|Antimetabolites|antimetabolites|mesh-ancestor
111249728|NCT02666950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111249729|NCT02666950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111249730|NCT02666950|Antiviral Agents|antiviral agents|mesh-ancestor
111249731|NCT02666950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111249732|NCT02666950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111249733|NCT02666950|Immunologic Factors|immunologic factors|mesh-ancestor
111249734|NCT02666950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111249735|NCT02666950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111249736|NCT02668432|Amiodarone|amiodarone|mesh-list
111249737|NCT02668432|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111249738|NCT02668432|Vasodilator Agents|vasodilator agents|mesh-ancestor
111249739|NCT02668432|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
111249740|NCT02668432|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111249741|NCT02668432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111249742|NCT02668432|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111249743|NCT02668432|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111249744|NCT02668432|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111249745|NCT02668432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111249746|NCT02668432|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111249747|NCT02668432|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111249748|NCT02668432|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111249749|NCT01687283|Fluticasone|fluticasone|mesh-list
111249750|NCT01687283|Xhance|xhance|mesh-list
111249751|NCT01687283|Budesonide|budesonide|mesh-list
111249752|NCT01687283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111249753|NCT01687283|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111249754|NCT01687283|Autonomic Agents|autonomic agents|mesh-ancestor
111249755|NCT01687283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111249756|NCT01687283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111249757|NCT01687283|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111249758|NCT01687283|Respiratory System Agents|respiratory system agents|mesh-ancestor
111249759|NCT01687283|Dermatologic Agents|dermatologic agents|mesh-ancestor
111249760|NCT01687283|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111249761|NCT01687283|Glucocorticoids|glucocorticoids|mesh-ancestor
111249762|NCT01687283|Hormones|hormones|mesh-ancestor
111249763|NCT01687283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111249764|NCT02684370|Ustekinumab|ustekinumab|mesh-list
111249765|NCT02684370|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111249766|NCT02684370|Dermatologic Agents|dermatologic agents|mesh-ancestor
111249767|NCT02684370|Immunologic Factors|immunologic factors|mesh-ancestor
111249768|NCT02684370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111249769|NCT02669914|Durvalumab|durvalumab|mesh-list
111249770|NCT02669914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111249771|NCT02669914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111249772|NCT01686581|Botulinum Toxins|botulinum toxins|mesh-list
111249773|NCT01686581|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111249774|NCT01686581|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111249775|NCT01686581|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111249776|NCT01686581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111249777|NCT01686581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111249778|NCT01686581|Cholinergic Agents|cholinergic agents|mesh-ancestor
111249779|NCT01686581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111249780|NCT01686581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111249781|NCT01686581|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111249782|NCT01686581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111249783|NCT04739410|Ivermectin|ivermectin|mesh-list
111249784|NCT04739410|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111249785|NCT04739410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111249786|NCT02691936|Estrogens|estrogens|mesh-list
111249787|NCT02691936|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
111249788|NCT02691936|Hormones|hormones|mesh-ancestor
111249789|NCT02691936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111249790|NCT02691936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111249791|NCT04707742|Povidone-Iodine|povidone-iodine|mesh-list
111249792|NCT04707742|Hydrogen Peroxide|hydrogen peroxide|mesh-list
111249793|NCT04707742|Cetylpyridinium|cetylpyridinium|mesh-list
111249795|NCT04707742|Plasma Substitutes|plasma substitutes|mesh-ancestor
111249796|NCT04707742|Blood Substitutes|blood substitutes|mesh-ancestor
111249797|NCT04707742|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111249798|NCT04707742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111249799|NCT02680054|Insulin|insulin|mesh-list
111249800|NCT02680054|Insulin Aspart|insulin aspart|mesh-list
111249801|NCT02680054|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111249802|NCT02680054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111249803|NCT00367978|Amlodipine|amlodipine|mesh-list
111249804|NCT00367978|Benazepril|benazepril|mesh-list
111249805|NCT00367978|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111249806|NCT00367978|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111249807|NCT00367978|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111249808|NCT00367978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111249809|NCT00367978|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111249810|NCT00367978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111249811|NCT00367978|Vasodilator Agents|vasodilator agents|mesh-ancestor
111249812|NCT00367978|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
111249813|NCT00367978|Protease Inhibitors|protease inhibitors|mesh-ancestor
111249814|NCT00367978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111249815|NCT00368056|Eszopiclone|eszopiclone|mesh-list
111249816|NCT00368056|Zopiclone|zopiclone|mesh-list
111249817|NCT00368056|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111249818|NCT00368056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111249819|NCT00368056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111249820|NCT01685801|Ivacaftor|ivacaftor|mesh-list
111249821|NCT01685801|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
111249822|NCT01685801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111249823|NCT01685801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111249824|NCT01684943|Insulin|insulin|mesh-list
111249825|NCT01684943|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111249826|NCT01684943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111249827|NCT04739566|Trametinib|trametinib|mesh-list
111249828|NCT04739566|Dabrafenib|dabrafenib|mesh-list
111249829|NCT04739566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111249830|NCT04739566|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111249831|NCT04739566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111249832|NCT04739566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111249833|NCT05339542|Methylprednisolone|methylprednisolone|mesh-list
111249834|NCT05339542|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111249835|NCT05339542|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111249836|NCT05339542|Prednisolone|prednisolone|mesh-list
111249837|NCT05339542|Prednisolone acetate|prednisolone acetate|mesh-list
111249838|NCT05339542|Lidocaine|lidocaine|mesh-list
111249839|NCT05339542|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111249840|NCT05339542|Prednisolone phosphate|prednisolone phosphate|mesh-list
111249841|NCT05339542|Anesthetics, Local|anesthetics, local|mesh-ancestor
111249842|NCT05339542|Anesthetics|anesthetics|mesh-ancestor
111249843|NCT05339542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111249844|NCT05339542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111249845|NCT05339542|Sensory System Agents|sensory system agents|mesh-ancestor
111249846|NCT05339542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111249847|NCT05339542|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111249848|NCT05339542|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111249849|NCT05339542|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111249850|NCT05339542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111249851|NCT05339542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111249852|NCT05339542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111249853|NCT05339542|Antiemetics|antiemetics|mesh-ancestor
111249854|NCT05339542|Autonomic Agents|autonomic agents|mesh-ancestor
111249855|NCT05339542|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111249856|NCT05339542|Glucocorticoids|glucocorticoids|mesh-ancestor
111249857|NCT05339542|Hormones|hormones|mesh-ancestor
111249858|NCT05339542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111249859|NCT05339542|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111249860|NCT05339542|Protective Agents|protective agents|mesh-ancestor
111249861|NCT05339542|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111249862|NCT05339542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111249863|NCT03162900|Moxifloxacin|moxifloxacin|mesh-list
111249864|NCT03162900|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111249865|NCT03162900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111249866|NCT03162900|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111249867|NCT03162900|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111249868|NCT03162900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111249869|NCT03162900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111249870|NCT03162900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111249872|NCT00368602|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
111249873|NCT00368602|Adrenergic Antagonists|adrenergic antagonists|mesh-list
111249874|NCT00368602|Adrenergic Agents|adrenergic agents|mesh-ancestor
111249875|NCT00368602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111249876|NCT00368602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111249877|NCT00368602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111249878|NCT00368602|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111249879|NCT00368602|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111249880|NCT01683071|Bupivacaine|bupivacaine|mesh-list
111249881|NCT01683071|Anesthetics, Local|anesthetics, local|mesh-ancestor
111249882|NCT01683071|Anesthetics|anesthetics|mesh-ancestor
111249883|NCT01683071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111249884|NCT01683071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111249885|NCT01683071|Sensory System Agents|sensory system agents|mesh-ancestor
111249886|NCT01683071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111249887|NCT04707508|Metformin|metformin|mesh-list
111249888|NCT04707508|Valsartan|valsartan|mesh-list
111249889|NCT04707508|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111249890|NCT04707508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111249891|NCT04707508|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111249892|NCT04707508|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111249893|NCT04707508|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111249894|NCT04707508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111249895|NCT01567865|Vaccines|vaccines|mesh-list
111249896|NCT01567865|Immunologic Factors|immunologic factors|mesh-ancestor
111249897|NCT01567865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111249898|NCT05049226|Vaccines|vaccines|mesh-list
111249899|NCT05049226|Immunologic Factors|immunologic factors|mesh-ancestor
111249900|NCT05049226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111249901|NCT01567163|Docetaxel|docetaxel|mesh-list
111249902|NCT01567163|Ramucirumab|ramucirumab|mesh-list
111249903|NCT01567163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111249904|NCT01567163|Tubulin Modulators|tubulin modulators|mesh-ancestor
111249905|NCT01567163|Antimitotic Agents|antimitotic agents|mesh-ancestor
111249906|NCT01567163|Mitosis Modulators|mitosis modulators|mesh-ancestor
111249907|NCT01567163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111249908|NCT05002114|Cannabidiol|cannabidiol|mesh-list
111249909|NCT05002114|Anticonvulsants|anticonvulsants|mesh-ancestor
111249910|NCT04338802|Nintedanib|nintedanib|mesh-list
111249911|NCT04338802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111249912|NCT04338802|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111249913|NCT04338802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111249914|NCT04338802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111249915|NCT04395508|Trastuzumab|trastuzumab|mesh-list
111249916|NCT04395508|Pertuzumab|pertuzumab|mesh-list
111249917|NCT04395508|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111249918|NCT04395508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111249919|NCT00368914|Sirolimus|sirolimus|mesh-list
111249920|NCT00368914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111249921|NCT00368914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111249922|NCT00368914|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111249923|NCT00368914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111249924|NCT00368914|Antifungal Agents|antifungal agents|mesh-ancestor
111249925|NCT00368914|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111249926|NCT00368914|Immunologic Factors|immunologic factors|mesh-ancestor
111249927|NCT00368914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111249928|NCT01567085|Eculizumab|eculizumab|mesh-list
111249929|NCT01567085|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
111249930|NCT01567085|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111249931|NCT01567085|Immunologic Factors|immunologic factors|mesh-ancestor
111249932|NCT01567085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111249933|NCT04344184|Ascorbic Acid|ascorbic acid|mesh-list
111249934|NCT04344184|Vitamins|vitamins|mesh-ancestor
111249935|NCT04344184|Micronutrients|micronutrients|mesh-ancestor
111249936|NCT04344184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111249937|NCT04344184|Antioxidants|antioxidants|mesh-ancestor
111249938|NCT04344184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111249939|NCT04344184|Protective Agents|protective agents|mesh-ancestor
111249940|NCT01566773|Bromides|bromides|mesh-list
111249941|NCT01566773|Tiotropium Bromide|tiotropium bromide|mesh-list
111249942|NCT01566773|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111249943|NCT01566773|Autonomic Agents|autonomic agents|mesh-ancestor
111249944|NCT01566773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111249945|NCT01566773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111249946|NCT01566773|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111249947|NCT01566773|Respiratory System Agents|respiratory system agents|mesh-ancestor
111249948|NCT01566773|Parasympatholytics|parasympatholytics|mesh-ancestor
111249949|NCT01566773|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111249950|NCT01566773|Cholinergic Agents|cholinergic agents|mesh-ancestor
111249951|NCT01566773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111249952|NCT01566773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111249953|NCT01566773|Anticonvulsants|anticonvulsants|mesh-ancestor
111249955|NCT04134442|Anesthetics, Local|anesthetics, local|mesh-ancestor
111249956|NCT04134442|Anesthetics|anesthetics|mesh-ancestor
111249957|NCT04134442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111249958|NCT04134442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111249959|NCT04134442|Sensory System Agents|sensory system agents|mesh-ancestor
111249960|NCT04134442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111249961|NCT04103476|Bazedoxifene|bazedoxifene|mesh-list
111249962|NCT04103476|Estrogens|estrogens|mesh-list
111249963|NCT04103476|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
111249964|NCT04103476|Hormones|hormones|mesh-ancestor
111249965|NCT04103476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111249966|NCT04103476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111249967|NCT04103476|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111249968|NCT04103476|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111249969|NCT04103476|Hormone Antagonists|hormone antagonists|mesh-ancestor
111249970|NCT04103476|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111249971|NCT01566149|Mometasone Furoate|mometasone furoate|mesh-list
111249972|NCT01566149|Formoterol Fumarate|formoterol fumarate|mesh-list
111249973|NCT01566149|Mometasone Furoate, Formoterol Fumarate Drug Combination|mometasone furoate, formoterol fumarate drug combination|mesh-list
111249974|NCT01566149|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111249975|NCT01566149|Autonomic Agents|autonomic agents|mesh-ancestor
111249976|NCT01566149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111249977|NCT01566149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111249978|NCT01566149|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111249979|NCT01566149|Respiratory System Agents|respiratory system agents|mesh-ancestor
111249980|NCT01566149|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111249981|NCT01566149|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111249982|NCT01566149|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111249983|NCT01566149|Adrenergic Agents|adrenergic agents|mesh-ancestor
111249984|NCT01566149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111249985|NCT01566149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111249986|NCT01566149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111249987|NCT01566149|Dermatologic Agents|dermatologic agents|mesh-ancestor
111249988|NCT01566149|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111249989|NCT03417388|Aspirin|aspirin|mesh-list
111249990|NCT03417388|Losartan|losartan|mesh-list
111249991|NCT03417388|Lisinopril|lisinopril|mesh-list
111249992|NCT03417388|Atorvastatin|atorvastatin|mesh-list
111249993|NCT03417388|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111249994|NCT03417388|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111249995|NCT03417388|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111249996|NCT03417388|Analgesics|analgesics|mesh-ancestor
111249997|NCT03417388|Sensory System Agents|sensory system agents|mesh-ancestor
111249998|NCT03417388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111249999|NCT03417388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111250000|NCT03417388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111250001|NCT03417388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111250002|NCT03417388|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111250003|NCT03417388|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111102442|NCT02399657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111250004|NCT03417388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111250005|NCT03417388|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111250006|NCT03417388|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111250007|NCT03417388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111250008|NCT03417388|Antipyretics|antipyretics|mesh-ancestor
111250009|NCT03417388|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111250010|NCT03417388|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111250011|NCT03417388|Antimetabolites|antimetabolites|mesh-ancestor
111250012|NCT03417388|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111250013|NCT03417388|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111250014|NCT03417388|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111250015|NCT03417388|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111250016|NCT03417388|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111250017|NCT03417388|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111250018|NCT03417388|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
111250020|NCT03417388|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111250021|NCT03417388|Protective Agents|protective agents|mesh-ancestor
111250022|NCT02691702|Melatonin|melatonin|mesh-list
111250023|NCT02691702|Antioxidants|antioxidants|mesh-ancestor
111250024|NCT02691702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111250025|NCT02691702|Protective Agents|protective agents|mesh-ancestor
111250026|NCT02691702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111250027|NCT02691702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111250028|NCT01564277|Allopurinol|allopurinol|mesh-list
111250029|NCT01564277|Rasburicase|rasburicase|mesh-list
111250030|NCT01564277|Antimetabolites|antimetabolites|mesh-ancestor
111250031|NCT01564277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111250032|NCT01564277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111250033|NCT01564277|Gout Suppressants|gout suppressants|mesh-ancestor
111250034|NCT01564277|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111250035|NCT01564277|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111250036|NCT01564277|Antioxidants|antioxidants|mesh-ancestor
111250037|NCT01564277|Protective Agents|protective agents|mesh-ancestor
111250038|NCT01564277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111250039|NCT01563185|Ibuprofen|ibuprofen|mesh-list
111250040|NCT01563185|Famotidine|famotidine|mesh-list
111250041|NCT01563185|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111250042|NCT01563185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111250043|NCT01563185|Analgesics|analgesics|mesh-ancestor
111250044|NCT01563185|Sensory System Agents|sensory system agents|mesh-ancestor
111250045|NCT01563185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111250046|NCT01563185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111250047|NCT01563185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111250048|NCT01563185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111250049|NCT01563185|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111250050|NCT01563185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111250051|NCT01563185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111250052|NCT01563185|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111250053|NCT01563185|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111250054|NCT01563185|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
111250055|NCT01563185|Histamine Antagonists|histamine antagonists|mesh-ancestor
111250056|NCT01563185|Histamine Agents|histamine agents|mesh-ancestor
111250057|NCT01563185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111250058|NCT02974660|Protamines|protamines|mesh-list
111250059|NCT02974660|Heparin Antagonists|heparin antagonists|mesh-ancestor
111250060|NCT02974660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111250061|NCT02974660|Coagulants|coagulants|mesh-ancestor
111250062|NCT03305848|Nitroglycerin|nitroglycerin|mesh-list
111250063|NCT03305848|Vasodilator Agents|vasodilator agents|mesh-ancestor
111250064|NCT01563029|Fluticasone|fluticasone|mesh-list
111250065|NCT01563029|Xhance|xhance|mesh-list
111250066|NCT01563029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111250067|NCT01563029|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111250068|NCT01563029|Autonomic Agents|autonomic agents|mesh-ancestor
111250069|NCT01563029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111250070|NCT01563029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111250071|NCT01563029|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111250072|NCT01563029|Respiratory System Agents|respiratory system agents|mesh-ancestor
111250073|NCT01563029|Dermatologic Agents|dermatologic agents|mesh-ancestor
111250074|NCT01563029|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111250075|NCT03293368|Triamcinolone|triamcinolone|mesh-list
111250076|NCT03293368|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
111250077|NCT03293368|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
111250078|NCT03293368|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
111250079|NCT03293368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111250080|NCT03293368|Glucocorticoids|glucocorticoids|mesh-ancestor
111250081|NCT03293368|Hormones|hormones|mesh-ancestor
111250082|NCT03293368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111250083|NCT03293368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111250084|NCT03293368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111250085|NCT03293368|Immunologic Factors|immunologic factors|mesh-ancestor
111250086|NCT03293368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111250087|NCT03293368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111250088|NCT03273712|Octreotide|octreotide|mesh-list
111250089|NCT03273712|Edotreotide|edotreotide|mesh-list
111250090|NCT03273712|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111250091|NCT03273712|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111250092|NCT03273712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111250093|NCT03273712|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111250094|NCT03273712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111250095|NCT04113317|Lenograstim|lenograstim|mesh-list
111250096|NCT04113317|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111250097|NCT04113317|Immunologic Factors|immunologic factors|mesh-ancestor
111250098|NCT04113317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111250099|NCT04341844|Methylene Blue|methylene blue|mesh-list
111250100|NCT04341844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111250101|NCT04341844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111250102|NCT01561313|Adalimumab|adalimumab|mesh-list
111250103|NCT01561313|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111250104|NCT01561313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111250105|NCT01561313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111250106|NCT01561079|Buprenorphine|buprenorphine|mesh-list
111250107|NCT01561079|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111250108|NCT01561079|Narcotics|narcotics|mesh-ancestor
111250109|NCT01561079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111250110|NCT01561079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111250111|NCT01561079|Analgesics|analgesics|mesh-ancestor
111250112|NCT01561079|Sensory System Agents|sensory system agents|mesh-ancestor
111250113|NCT01561079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111250114|NCT01561079|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111250115|NCT01559675|Hydrocortisone|hydrocortisone|mesh-list
111250116|NCT01559675|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
111250117|NCT01559675|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
111250118|NCT01559675|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
111250119|NCT01559675|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111250120|NCT01559675|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111250121|NCT01559675|Methylprednisolone|methylprednisolone|mesh-list
111250122|NCT01559675|Prednisolone|prednisolone|mesh-list
111250123|NCT01559675|Prednisolone acetate|prednisolone acetate|mesh-list
111250124|NCT01559675|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111250125|NCT01559675|Prednisolone phosphate|prednisolone phosphate|mesh-list
111250126|NCT01559675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111250127|NCT01559675|Glucocorticoids|glucocorticoids|mesh-ancestor
111250128|NCT01559675|Hormones|hormones|mesh-ancestor
111250129|NCT01559675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111250130|NCT01559675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111250131|NCT01559675|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111250132|NCT01559675|Protective Agents|protective agents|mesh-ancestor
111250133|NCT01559675|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111250134|NCT01559675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111250135|NCT01559675|Antiemetics|antiemetics|mesh-ancestor
111250136|NCT01559675|Autonomic Agents|autonomic agents|mesh-ancestor
111250137|NCT01559675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111250138|NCT01559675|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111250139|NCT01374906|Pasireotide|pasireotide|mesh-list
111250140|NCT01374906|Hormones|hormones|mesh-ancestor
111250141|NCT01374906|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111250142|NCT01374906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111250143|NCT00362596|Acyclovir|acyclovir|mesh-list
111250144|NCT00362596|Antiviral Agents|antiviral agents|mesh-ancestor
111250145|NCT00362596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111250146|NCT02974504|Linagliptin|linagliptin|mesh-list
111250147|NCT02974504|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111250148|NCT02974504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111250149|NCT02974504|Incretins|incretins|mesh-ancestor
111250150|NCT02974504|Hormones|hormones|mesh-ancestor
111102445|NCT02399657|Glucocorticoids|glucocorticoids|mesh-ancestor
111250151|NCT02974504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111250152|NCT02974504|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111250153|NCT02974504|Protease Inhibitors|protease inhibitors|mesh-ancestor
111250154|NCT02974504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111250155|NCT02974504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111250156|NCT03013504|Cyclophosphamide|cyclophosphamide|mesh-list
111250157|NCT03013504|Docetaxel|docetaxel|mesh-list
111250158|NCT03013504|Trastuzumab|trastuzumab|mesh-list
111250159|NCT03013504|Epirubicin|epirubicin|mesh-list
111250160|NCT03013504|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111250161|NCT03013504|Immunologic Factors|immunologic factors|mesh-ancestor
111250162|NCT03013504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111250163|NCT03013504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111250164|NCT03013504|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111250165|NCT03013504|Alkylating Agents|alkylating agents|mesh-ancestor
111250166|NCT03013504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111250167|NCT03013504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111250168|NCT03013504|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111250169|NCT03013504|Tubulin Modulators|tubulin modulators|mesh-ancestor
111250170|NCT03013504|Antimitotic Agents|antimitotic agents|mesh-ancestor
111250171|NCT03013504|Mitosis Modulators|mitosis modulators|mesh-ancestor
111250172|NCT03013504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111250173|NCT03013504|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111250174|NCT03013504|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111250175|NCT03013504|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111250176|NCT03013504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111250177|NCT02683746|rGLP-1 protein|rglp-1 protein|mesh-list
111250178|NCT02683746|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
111250179|NCT02683746|Incretins|incretins|mesh-ancestor
111250180|NCT02683746|Hormones|hormones|mesh-ancestor
111250181|NCT02683746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111250182|NCT02683746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111250183|NCT01559129|Pomalidomide|pomalidomide|mesh-list
111250184|NCT01559129|Immunologic Factors|immunologic factors|mesh-ancestor
111250185|NCT01559129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111250186|NCT01559129|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111250187|NCT01559129|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111250188|NCT01559129|Growth Substances|growth substances|mesh-ancestor
111250189|NCT01559129|Growth Inhibitors|growth inhibitors|mesh-ancestor
111250190|NCT01559129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111250191|NCT02691468|Silicon|silicon|mesh-list
111250192|NCT02691468|Trace Elements|trace elements|mesh-ancestor
111250193|NCT02691468|Micronutrients|micronutrients|mesh-ancestor
111250194|NCT02691468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111250195|NCT03162120|Metoprolol|metoprolol|mesh-list
111250196|NCT03162120|Flecainide|flecainide|mesh-list
111250197|NCT03162120|Ranolazine|ranolazine|mesh-list
111250198|NCT03162120|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111250199|NCT03162120|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111250200|NCT03162120|Sympatholytics|sympatholytics|mesh-ancestor
111250201|NCT03162120|Autonomic Agents|autonomic agents|mesh-ancestor
111250202|NCT03162120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111250203|NCT03162120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111250204|NCT03162120|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
111250205|NCT03162120|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111250206|NCT03162120|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111250207|NCT03162120|Adrenergic Agents|adrenergic agents|mesh-ancestor
111250208|NCT03162120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111250209|NCT03162120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111250210|NCT03162120|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111250211|NCT03162120|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111250212|NCT03162120|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111250213|NCT02683668|Tiotropium Bromide|tiotropium bromide|mesh-list
111250214|NCT02683668|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111250215|NCT02683668|Autonomic Agents|autonomic agents|mesh-ancestor
111250216|NCT02683668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111250217|NCT02683668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111250218|NCT02683668|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111250219|NCT02683668|Respiratory System Agents|respiratory system agents|mesh-ancestor
111250220|NCT02683668|Parasympatholytics|parasympatholytics|mesh-ancestor
111250221|NCT02683668|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111250222|NCT02683668|Cholinergic Agents|cholinergic agents|mesh-ancestor
110678420|NCT00519428|Citalopram|citalopram|mesh-list
111250223|NCT02683668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111250224|NCT02683668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111250225|NCT03114228|Midostaurin|midostaurin|mesh-list
111250226|NCT03114228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111250227|NCT03114228|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111250228|NCT03114228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111250229|NCT03114228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111250230|NCT02678286|Meloxicam|meloxicam|mesh-list
111250231|NCT02678286|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111250232|NCT02678286|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111250233|NCT02678286|Analgesics|analgesics|mesh-ancestor
111250234|NCT02678286|Sensory System Agents|sensory system agents|mesh-ancestor
111250235|NCT02678286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111250236|NCT02678286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111250237|NCT02678286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111250238|NCT02678286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111250239|NCT02678286|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111250240|NCT02678286|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111250241|NCT02678286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111250242|NCT02678286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111250243|NCT03164694|Carboplatin|carboplatin|mesh-list
111250244|NCT03164694|Pemetrexed|pemetrexed|mesh-list
111250246|NCT03164694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111250247|NCT03164694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111250248|NCT03164694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111250249|NCT03164694|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111250250|NCT03164694|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111250251|NCT03164694|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111250252|NCT02930902|Paclitaxel|paclitaxel|mesh-list
111250253|NCT02930902|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111250254|NCT02930902|Gemcitabine|gemcitabine|mesh-list
111250255|NCT02930902|Pembrolizumab|pembrolizumab|mesh-list
111250256|NCT02930902|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111250257|NCT02930902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111250258|NCT02930902|Tubulin Modulators|tubulin modulators|mesh-ancestor
111250259|NCT02930902|Antimitotic Agents|antimitotic agents|mesh-ancestor
111250260|NCT02930902|Mitosis Modulators|mitosis modulators|mesh-ancestor
111250261|NCT02930902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111250262|NCT02930902|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111250263|NCT02930902|Antimetabolites|antimetabolites|mesh-ancestor
111250264|NCT02930902|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111250265|NCT02930902|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111250266|NCT02767804|Crizotinib|crizotinib|mesh-list
111250267|NCT02767804|Ensartinib|ensartinib|mesh-list
111250268|NCT02767804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111250269|NCT02767804|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111250270|NCT02767804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111250271|NCT02767804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111250272|NCT02741128|Vaccines|vaccines|mesh-list
111250273|NCT02741128|Immunologic Factors|immunologic factors|mesh-ancestor
111250274|NCT02741128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111250275|NCT01566721|Trastuzumab|trastuzumab|mesh-list
111250276|NCT01566721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111250277|NCT01566721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111250278|NCT01541215|Metformin|metformin|mesh-list
111250279|NCT01541215|Liraglutide|liraglutide|mesh-list
111250280|NCT01541215|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111250281|NCT01541215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111250282|NCT01541215|Incretins|incretins|mesh-ancestor
111250283|NCT01541215|Hormones|hormones|mesh-ancestor
111250284|NCT01541215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111250285|NCT01585987|Ipilimumab|ipilimumab|mesh-list
111250286|NCT01585987|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111250287|NCT01585987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111250288|NCT01585987|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111250289|NCT01585987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111250290|NCT01585831|Testosterone|testosterone|mesh-list
111250291|NCT01585831|Androgens|androgens|mesh-ancestor
111250292|NCT01585831|Hormones|hormones|mesh-ancestor
111250293|NCT01585831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111250294|NCT01585831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111250295|NCT01565941|Insulin|insulin|mesh-list
111250296|NCT01565941|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111250297|NCT01565941|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111250298|NCT01565941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111250299|NCT01558271|Liraglutide|liraglutide|mesh-list
111250300|NCT01558271|Dulaglutide|dulaglutide|mesh-list
111250301|NCT01558271|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111250302|NCT01558271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111250303|NCT01558271|Incretins|incretins|mesh-ancestor
111250304|NCT01558271|Hormones|hormones|mesh-ancestor
111250305|NCT01558271|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111250306|NCT01565707|Solifenacin Succinate|solifenacin succinate|mesh-list
111250307|NCT01565707|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111250308|NCT01565707|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111250309|NCT01565707|Cholinergic Agents|cholinergic agents|mesh-ancestor
111250310|NCT01565707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111250311|NCT01565707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111250312|NCT01565707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111250313|NCT01565707|Urological Agents|urological agents|mesh-ancestor
111250314|NCT01557569|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
111250315|NCT01557569|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111250316|NCT01557569|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111250317|NCT01557569|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111250318|NCT01557569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111250319|NCT01557569|Adrenergic Agents|adrenergic agents|mesh-ancestor
111250320|NCT01557569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111250321|NCT01557569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111250323|NCT04756271|Antibodies, Blocking|antibodies, blocking|mesh-list
111250324|NCT04756271|Immunologic Factors|immunologic factors|mesh-ancestor
111250325|NCT04756271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111250326|NCT01538719|Rilonacept|rilonacept|mesh-list
111250327|NCT01538719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111250328|NCT01537783|Chlorhexidine|chlorhexidine|mesh-list
111250329|NCT01537783|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
111250330|NCT01537783|Mupirocin|mupirocin|mesh-list
111250331|NCT01537783|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111250332|NCT01537783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111250333|NCT01537783|Disinfectants|disinfectants|mesh-ancestor
111250334|NCT01537783|Dermatologic Agents|dermatologic agents|mesh-ancestor
111250335|NCT01537783|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111250336|NCT01537783|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111250337|NCT01537783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111250338|NCT01537783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111250339|NCT01556165|Rasagiline|rasagiline|mesh-list
111250340|NCT01556165|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
111250341|NCT01556165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111250342|NCT01556165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111250343|NCT01556165|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111250344|NCT01556165|Protective Agents|protective agents|mesh-ancestor
111250345|NCT01556165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111250346|NCT01537549|Thioctic Acid|thioctic acid|mesh-list
111250347|NCT01537549|Acetylcarnitine|acetylcarnitine|mesh-list
111250348|NCT01537549|Antioxidants|antioxidants|mesh-ancestor
111250349|NCT01537549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111250350|NCT01537549|Protective Agents|protective agents|mesh-ancestor
111250351|NCT01537549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111250352|NCT01537549|Vitamin B Complex|vitamin b complex|mesh-ancestor
111250353|NCT01537549|Vitamins|vitamins|mesh-ancestor
111250354|NCT01537549|Micronutrients|micronutrients|mesh-ancestor
111250355|NCT01537549|Nootropic Agents|nootropic agents|mesh-ancestor
111250356|NCT01555931|Levonorgestrel|levonorgestrel|mesh-list
111250357|NCT01555931|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111250358|NCT01555931|Contraceptive Agents|contraceptive agents|mesh-ancestor
111250359|NCT01555931|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111250360|NCT01555931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111250361|NCT01555931|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111250362|NCT01555931|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111250363|NCT01555931|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111250364|NCT01583179|Buprenorphine|buprenorphine|mesh-list
111250365|NCT01583179|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111250366|NCT01583179|Narcotics|narcotics|mesh-ancestor
111250367|NCT01583179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111250368|NCT01583179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111250369|NCT01583179|Analgesics|analgesics|mesh-ancestor
111250370|NCT01583179|Sensory System Agents|sensory system agents|mesh-ancestor
111250371|NCT01583179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111250372|NCT01583179|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111250373|NCT01582945|Ketamine|ketamine|mesh-list
111250374|NCT01582945|Analgesics|analgesics|mesh-ancestor
111250375|NCT01582945|Sensory System Agents|sensory system agents|mesh-ancestor
111250376|NCT01582945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111250377|NCT01582945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111250378|NCT01582945|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111250379|NCT01582945|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111250380|NCT01582945|Anesthetics, General|anesthetics, general|mesh-ancestor
111250381|NCT01582945|Anesthetics|anesthetics|mesh-ancestor
111250382|NCT01582945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111250383|NCT01582945|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111250384|NCT01582945|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111250385|NCT01582945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111250386|NCT01582945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111250387|NCT01565083|Trastuzumab|trastuzumab|mesh-list
111250388|NCT01565083|Pertuzumab|pertuzumab|mesh-list
111250389|NCT01565083|Vinorelbine|vinorelbine|mesh-list
111250390|NCT01565083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111250391|NCT01565083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111250392|NCT01565083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111250393|NCT01565083|Tubulin Modulators|tubulin modulators|mesh-ancestor
111250394|NCT01565083|Antimitotic Agents|antimitotic agents|mesh-ancestor
111250395|NCT01565083|Mitosis Modulators|mitosis modulators|mesh-ancestor
111250396|NCT01565083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111250397|NCT01555151|Mometasone Furoate|mometasone furoate|mesh-list
111250398|NCT01555151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111250399|NCT01555151|Dermatologic Agents|dermatologic agents|mesh-ancestor
111250400|NCT01555151|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111250401|NCT01537081|Phenylpropanolamine|phenylpropanolamine|mesh-list
111250402|NCT01537081|Guaifenesin|guaifenesin|mesh-list
111250403|NCT01537081|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
111250404|NCT01537081|Expectorants|expectorants|mesh-ancestor
111250405|NCT01537081|Respiratory System Agents|respiratory system agents|mesh-ancestor
111250406|NCT01537081|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111250407|NCT01537081|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111250408|NCT01537081|Adrenergic Agents|adrenergic agents|mesh-ancestor
111250409|NCT01537081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111250410|NCT01537081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111250411|NCT01537081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111250412|NCT01537081|Appetite Depressants|appetite depressants|mesh-ancestor
111250413|NCT01537081|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111250414|NCT01537081|Sympathomimetics|sympathomimetics|mesh-ancestor
111250415|NCT01537081|Autonomic Agents|autonomic agents|mesh-ancestor
111250416|NCT01537081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111250417|NCT01537081|Nasal Decongestants|nasal decongestants|mesh-ancestor
111250418|NCT01537081|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111250419|NCT01555073|Celecoxib|celecoxib|mesh-list
111250420|NCT01555073|Pregabalin|pregabalin|mesh-list
111250421|NCT01555073|Analgesics|analgesics|mesh-ancestor
111250422|NCT01555073|Sensory System Agents|sensory system agents|mesh-ancestor
111250423|NCT01555073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111250424|NCT01555073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111250425|NCT01555073|Anticonvulsants|anticonvulsants|mesh-ancestor
111250426|NCT01555073|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111250427|NCT01555073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111250428|NCT01555073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111250429|NCT01555073|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111250430|NCT01555073|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111250431|NCT01555073|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111250432|NCT01555073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111250433|NCT01555073|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111250434|NCT01555073|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111250435|NCT01555073|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111250436|NCT01555073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111250437|NCT01555073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111250438|NCT01555073|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111250439|NCT01555073|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111250440|NCT01555073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111250441|NCT01582243|Vildagliptin|vildagliptin|mesh-list
111250442|NCT01582243|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111250443|NCT01582243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111102449|NCT02399657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111250444|NCT01582243|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111250445|NCT01582243|Protease Inhibitors|protease inhibitors|mesh-ancestor
111250446|NCT01582243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111250447|NCT01582243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111250448|NCT01536535|Prednisone|prednisone|mesh-list
111250449|NCT01536535|Mesalamine|mesalamine|mesh-list
111250450|NCT01536535|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111250451|NCT01536535|Glucocorticoids|glucocorticoids|mesh-ancestor
111250452|NCT01536535|Hormones|hormones|mesh-ancestor
111250453|NCT01536535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111250454|NCT01536535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111250455|NCT01536535|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111250456|NCT01536535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111250457|NCT01536535|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111250458|NCT01536535|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111250459|NCT01536535|Analgesics|analgesics|mesh-ancestor
111250460|NCT01536535|Sensory System Agents|sensory system agents|mesh-ancestor
111250461|NCT01536535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111250462|NCT01536535|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111250463|NCT01553747|Eluxadoline|eluxadoline|mesh-list
111250464|NCT01553747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111250465|NCT01536379|Belimumab|belimumab|mesh-list
111250466|NCT01536379|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111250467|NCT01536379|Immunologic Factors|immunologic factors|mesh-ancestor
111250468|NCT01536379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111250469|NCT01536067|Bortezomib|bortezomib|mesh-list
111250470|NCT01536067|Ofatumumab|ofatumumab|mesh-list
111250471|NCT01536067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111250472|NCT04410211|Midazolam|midazolam|mesh-list
111250473|NCT04410211|Sevoflurane|sevoflurane|mesh-list
111250474|NCT04410211|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111250475|NCT04410211|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111250476|NCT04410211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111250477|NCT04410211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111250478|NCT04410211|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111250479|NCT04410211|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111250480|NCT04410211|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111250481|NCT04410211|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111250482|NCT04410211|Anesthetics, General|anesthetics, general|mesh-ancestor
111250483|NCT04410211|Anesthetics|anesthetics|mesh-ancestor
111250484|NCT04410211|GABA Modulators|gaba modulators|mesh-ancestor
111250485|NCT04410211|GABA Agents|gaba agents|mesh-ancestor
111250486|NCT04410211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111250487|NCT04410211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111250488|NCT04410211|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111250489|NCT04410211|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111250490|NCT01582009|Everolimus|everolimus|mesh-list
111250491|NCT01582009|Panobinostat|panobinostat|mesh-list
111250492|NCT01582009|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
111250493|NCT01582009|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111250494|NCT01582009|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111250495|NCT01582009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111250496|NCT01582009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111250497|NCT01582009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111250498|NCT01582009|Immunologic Factors|immunologic factors|mesh-ancestor
111250499|NCT01582009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111250500|NCT01582009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111250501|NCT01553591|Eluxadoline|eluxadoline|mesh-list
111250502|NCT01553591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111250503|NCT01581931|Metformin|metformin|mesh-list
111250504|NCT01581931|Linagliptin|linagliptin|mesh-list
111250505|NCT01581931|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111250506|NCT01581931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111250507|NCT01581931|Incretins|incretins|mesh-ancestor
111250508|NCT01581931|Hormones|hormones|mesh-ancestor
111250509|NCT01581931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111250510|NCT01581931|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111250511|NCT01581931|Protease Inhibitors|protease inhibitors|mesh-ancestor
111250512|NCT01581931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111250513|NCT01581931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111250514|NCT01581307|Leucovorin|leucovorin|mesh-list
111250515|NCT01581307|Folic Acid|folic acid|mesh-list
111250516|NCT01581307|Fluorouracil|fluorouracil|mesh-list
111250517|NCT01581307|Oxaliplatin|oxaliplatin|mesh-list
111250518|NCT01581307|Levoleucovorin|levoleucovorin|mesh-list
111250519|NCT01581307|Antimetabolites|antimetabolites|mesh-ancestor
111250520|NCT01581307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111250521|NCT01581307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111250522|NCT01581307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111250523|NCT01581307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111250524|NCT01581307|Immunologic Factors|immunologic factors|mesh-ancestor
111250525|NCT01581307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111250526|NCT01581307|Antidotes|antidotes|mesh-ancestor
111250527|NCT01581307|Protective Agents|protective agents|mesh-ancestor
111250528|NCT01581307|Vitamin B Complex|vitamin b complex|mesh-ancestor
111250529|NCT01581307|Vitamins|vitamins|mesh-ancestor
111250530|NCT01581307|Micronutrients|micronutrients|mesh-ancestor
111250531|NCT01581307|Hematinics|hematinics|mesh-ancestor
111250532|NCT01580995|Valacyclovir|valacyclovir|mesh-list
111250533|NCT01580995|Antiviral Agents|antiviral agents|mesh-ancestor
111250534|NCT01580995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111250535|NCT01553279|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
111250536|NCT01553279|Immunologic Factors|immunologic factors|mesh-ancestor
111250537|NCT01553279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111250538|NCT01562743|Rotigotine|rotigotine|mesh-list
111250539|NCT01562743|Dopamine Agonists|dopamine agonists|mesh-ancestor
111250540|NCT01562743|Dopamine Agents|dopamine agents|mesh-ancestor
111250541|NCT01562743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111250542|NCT01562743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111250543|NCT01562743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111250544|NCT03028571|Trimethaphan|trimethaphan|mesh-list
111250545|NCT03028571|Trimethaphan camsylate|trimethaphan camsylate|mesh-list
111250546|NCT03028571|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111250547|NCT03028571|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111250549|NCT03028571|Autonomic Agents|autonomic agents|mesh-ancestor
111250550|NCT03028571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111250551|NCT03028571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111250552|NCT03028571|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
111250553|NCT03028571|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111250554|NCT03028571|Cholinergic Agents|cholinergic agents|mesh-ancestor
111250555|NCT03028571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111250556|NCT03028571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111250557|NCT03028571|Vasodilator Agents|vasodilator agents|mesh-ancestor
111250558|NCT01535443|Bromfenac|bromfenac|mesh-list
111250559|NCT01535443|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111250560|NCT01535443|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111250561|NCT01535443|Analgesics|analgesics|mesh-ancestor
111250562|NCT01535443|Sensory System Agents|sensory system agents|mesh-ancestor
111250563|NCT01535443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111250564|NCT01535443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111250565|NCT01535443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111250566|NCT01535443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111250567|NCT01535287|Dexmedetomidine|dexmedetomidine|mesh-list
111250568|NCT01535287|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111250569|NCT01535287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111250570|NCT01535287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111250571|NCT01535287|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111250572|NCT01535287|Analgesics|analgesics|mesh-ancestor
111250573|NCT01535287|Sensory System Agents|sensory system agents|mesh-ancestor
111250574|NCT01535287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111250575|NCT01535287|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111250576|NCT01535287|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111250577|NCT01535287|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111250578|NCT01535287|Adrenergic Agents|adrenergic agents|mesh-ancestor
111250579|NCT01535287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111250580|NCT01535287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111250581|NCT01549613|Vancomycin|vancomycin|mesh-list
111250582|NCT01549613|Daptomycin|daptomycin|mesh-list
111250583|NCT01549613|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111250584|NCT01549613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111250585|NCT04739189|Butyl phosphorotrithioate|butyl phosphorotrithioate|mesh-list
111250586|NCT04739189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111250587|NCT04739189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111250588|NCT01546883|Dabigatran|dabigatran|mesh-list
111250589|NCT01546883|Antithrombins|antithrombins|mesh-ancestor
111250590|NCT01546883|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111250591|NCT01546883|Protease Inhibitors|protease inhibitors|mesh-ancestor
111250592|NCT01546883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111102453|NCT02559687|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111250593|NCT01546883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111250594|NCT01546883|Anticoagulants|anticoagulants|mesh-ancestor
111250595|NCT01580293|Factor VIII|factor viii|mesh-list
111250596|NCT01580293|Coagulants|coagulants|mesh-ancestor
111250597|NCT01546649|Leuprolide|leuprolide|mesh-list
111250598|NCT01546649|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111250599|NCT01546649|Fertility Agents|fertility agents|mesh-ancestor
111250600|NCT01546649|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111250601|NCT01546649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111250602|NCT01546649|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111250603|NCT01546649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111250604|NCT02985983|Brodalumab|brodalumab|mesh-list
111250605|NCT02985983|Dermatologic Agents|dermatologic agents|mesh-ancestor
111250606|NCT01544309|Atorvastatin|atorvastatin|mesh-list
111250607|NCT01544309|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111250608|NCT01544309|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111250609|NCT01544309|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111250610|NCT01544309|Antimetabolites|antimetabolites|mesh-ancestor
111250611|NCT01544309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111250612|NCT01544309|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111250613|NCT01544309|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111250614|NCT01544309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111250615|NCT01544153|Nicotine|nicotine|mesh-list
111250616|NCT01544153|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111250617|NCT01544153|Autonomic Agents|autonomic agents|mesh-ancestor
111250618|NCT01544153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111250619|NCT01544153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111250620|NCT01544153|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111250621|NCT01544153|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111250622|NCT01544153|Cholinergic Agents|cholinergic agents|mesh-ancestor
111250623|NCT01544153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111250624|NCT01544153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111250625|NCT01543685|Celecoxib|celecoxib|mesh-list
111250626|NCT01543685|Indomethacin|indomethacin|mesh-list
111250627|NCT01543685|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111250628|NCT01543685|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111250629|NCT01543685|Analgesics|analgesics|mesh-ancestor
111250630|NCT01543685|Sensory System Agents|sensory system agents|mesh-ancestor
111250631|NCT01543685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111250632|NCT01543685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111250633|NCT01543685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111250634|NCT01543685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111250635|NCT01543685|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111250636|NCT01543685|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111250637|NCT01543685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111250638|NCT01543685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111250639|NCT01543685|Gout Suppressants|gout suppressants|mesh-ancestor
111250640|NCT01543685|Tocolytic Agents|tocolytic agents|mesh-ancestor
111250641|NCT01543685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111250642|NCT01540565|Veliparib|veliparib|mesh-list
111250643|NCT01540565|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111250644|NCT01540565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111250645|NCT01540565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111250646|NCT01540565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111250647|NCT01540487|Metformin|metformin|mesh-list
111250648|NCT01540487|Linagliptin|linagliptin|mesh-list
111250649|NCT01540487|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111250650|NCT01540487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111250651|NCT01540487|Incretins|incretins|mesh-ancestor
111250652|NCT01540487|Hormones|hormones|mesh-ancestor
111250653|NCT01540487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111250654|NCT01540487|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111250655|NCT01540487|Protease Inhibitors|protease inhibitors|mesh-ancestor
111250656|NCT01540487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111250657|NCT01540487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111250658|NCT01539317|Lidocaine|lidocaine|mesh-list
111250659|NCT01539317|Anesthetics, Local|anesthetics, local|mesh-ancestor
111250660|NCT01539317|Anesthetics|anesthetics|mesh-ancestor
111250661|NCT01539317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111250662|NCT01539317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111250663|NCT01539317|Sensory System Agents|sensory system agents|mesh-ancestor
111250664|NCT01539317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111250665|NCT01539317|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111250666|NCT01539317|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111250667|NCT01539317|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111250668|NCT01539317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111250669|NCT01539317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111250670|NCT01539083|Thalidomide|thalidomide|mesh-list
111250671|NCT01539083|Dexamethasone|dexamethasone|mesh-list
111250672|NCT01539083|Prednisolone|prednisolone|mesh-list
111250673|NCT01539083|Cyclophosphamide|cyclophosphamide|mesh-list
111250674|NCT01539083|Bortezomib|bortezomib|mesh-list
111250675|NCT01539083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111250676|NCT01539083|Immunologic Factors|immunologic factors|mesh-ancestor
111250677|NCT01539083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111250678|NCT01539083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111250679|NCT01539083|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111250680|NCT01539083|Alkylating Agents|alkylating agents|mesh-ancestor
111250681|NCT01539083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111250682|NCT01539083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111250683|NCT01539083|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111250684|NCT01539083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111250685|NCT01539083|Antiemetics|antiemetics|mesh-ancestor
111250686|NCT01539083|Autonomic Agents|autonomic agents|mesh-ancestor
111250687|NCT01539083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111250688|NCT01539083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111250689|NCT01539083|Glucocorticoids|glucocorticoids|mesh-ancestor
111250690|NCT01539083|Hormones|hormones|mesh-ancestor
111250691|NCT01539083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111250692|NCT01539083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111250693|NCT01539083|Leprostatic Agents|leprostatic agents|mesh-ancestor
111250694|NCT01539083|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111250695|NCT01539083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110974998|NCT02234193|Sympathomimetics|sympathomimetics|mesh-ancestor
111250696|NCT01539083|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111250697|NCT01539083|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111250698|NCT01539083|Growth Substances|growth substances|mesh-ancestor
111250699|NCT01539083|Growth Inhibitors|growth inhibitors|mesh-ancestor
111250700|NCT01537133|Fluticasone|fluticasone|mesh-list
111250701|NCT01537133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111250702|NCT01537133|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111250703|NCT01537133|Autonomic Agents|autonomic agents|mesh-ancestor
111250704|NCT01537133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111250705|NCT01537133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111250706|NCT01537133|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111250707|NCT01537133|Respiratory System Agents|respiratory system agents|mesh-ancestor
111250708|NCT01537133|Dermatologic Agents|dermatologic agents|mesh-ancestor
111250709|NCT01537133|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111250710|NCT01536587|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
111250711|NCT01536587|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111250712|NCT01536587|Autonomic Agents|autonomic agents|mesh-ancestor
111250713|NCT01536587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111250714|NCT01536587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111250715|NCT01536587|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111250716|NCT01536587|Respiratory System Agents|respiratory system agents|mesh-ancestor
111250717|NCT01536587|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111250718|NCT01536587|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111250719|NCT01536587|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111250720|NCT01536587|Adrenergic Agents|adrenergic agents|mesh-ancestor
111250721|NCT01536587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111250722|NCT01536587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111250723|NCT02985905|Zinc Sulfate|zinc sulfate|mesh-list
111250724|NCT02985905|Astringents|astringents|mesh-ancestor
111250725|NCT02985905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111250726|NCT02985905|Dermatologic Agents|dermatologic agents|mesh-ancestor
111250727|NCT01535261|Ranibizumab|ranibizumab|mesh-list
111250728|NCT01535261|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111250729|NCT01535261|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111250730|NCT01535261|Growth Substances|growth substances|mesh-ancestor
111250731|NCT01535261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111250732|NCT01535261|Growth Inhibitors|growth inhibitors|mesh-ancestor
111250733|NCT01535261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111250734|NCT01534637|Gemcitabine|gemcitabine|mesh-list
111250735|NCT01534637|Fluorouracil|fluorouracil|mesh-list
111250736|NCT01534637|Capecitabine|capecitabine|mesh-list
111250737|NCT01534637|Aprepitant|aprepitant|mesh-list
111250738|NCT01534637|Antiemetics|antiemetics|mesh-list
111250739|NCT01534637|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111250740|NCT01534637|Antimetabolites|antimetabolites|mesh-ancestor
111250741|NCT01534637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111250742|NCT01534637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111250743|NCT01534637|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111250744|NCT01534637|Immunologic Factors|immunologic factors|mesh-ancestor
111250745|NCT01534637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111250746|NCT01534637|Autonomic Agents|autonomic agents|mesh-ancestor
111250747|NCT01534637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111250748|NCT01534637|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111250749|NCT01534637|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
111250750|NCT01534637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111250751|NCT02655016|Niraparib|niraparib|mesh-list
111250752|NCT02655016|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111250753|NCT02655016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111250754|NCT02655016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111250755|NCT02655016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111250756|NCT01533935|Tiotropium Bromide|tiotropium bromide|mesh-list
111250757|NCT01533935|Olodaterol|olodaterol|mesh-list
111250758|NCT01533935|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111250759|NCT01533935|Autonomic Agents|autonomic agents|mesh-ancestor
111250760|NCT01533935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111250761|NCT01533935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111250762|NCT01533935|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111250763|NCT01533935|Respiratory System Agents|respiratory system agents|mesh-ancestor
111250764|NCT01533935|Parasympatholytics|parasympatholytics|mesh-ancestor
111250765|NCT01533935|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111250766|NCT01533935|Cholinergic Agents|cholinergic agents|mesh-ancestor
111250767|NCT01533935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111250768|NCT01533935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111250769|NCT01532687|Gemcitabine|gemcitabine|mesh-list
111250770|NCT01532687|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111250771|NCT01532687|Antimetabolites|antimetabolites|mesh-ancestor
111250772|NCT01532687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111250773|NCT01532687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111250774|NCT02677116|Doxorubicin|doxorubicin|mesh-list
111250775|NCT02677116|Irinotecan|irinotecan|mesh-list
111250776|NCT02677116|Vincristine|vincristine|mesh-list
111250777|NCT02677116|Ifosfamide|ifosfamide|mesh-list
111250778|NCT02677116|Olaratumab|olaratumab|mesh-list
111250779|NCT02677116|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111250780|NCT02677116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111250781|NCT02677116|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111250782|NCT02677116|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111250783|NCT02677116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111250784|NCT02677116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111250785|NCT02677116|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111250786|NCT02677116|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111250787|NCT02677116|Tubulin Modulators|tubulin modulators|mesh-ancestor
111250788|NCT02677116|Antimitotic Agents|antimitotic agents|mesh-ancestor
111250789|NCT02677116|Mitosis Modulators|mitosis modulators|mesh-ancestor
111250790|NCT02677116|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111250791|NCT02677116|Alkylating Agents|alkylating agents|mesh-ancestor
111250792|NCT02689518|Aflibercept|aflibercept|mesh-list
111250793|NCT02689518|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111250794|NCT02689518|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111250795|NCT02689518|Growth Substances|growth substances|mesh-ancestor
111250796|NCT02689518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111250797|NCT02689518|Growth Inhibitors|growth inhibitors|mesh-ancestor
111250798|NCT02689518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111250799|NCT02681094|Dapagliflozin|dapagliflozin|mesh-list
111250800|NCT02681094|Saxagliptin|saxagliptin|mesh-list
111250801|NCT02681094|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111250802|NCT02681094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111250803|NCT02681094|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111250804|NCT02681094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111250805|NCT02681094|Incretins|incretins|mesh-ancestor
111250806|NCT02681094|Hormones|hormones|mesh-ancestor
111250807|NCT02681094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111250808|NCT02681094|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111250809|NCT02681094|Protease Inhibitors|protease inhibitors|mesh-ancestor
111250810|NCT02681094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111250811|NCT03164304|Magnesium Sulfate|magnesium sulfate|mesh-list
111250812|NCT03164304|Analgesics|analgesics|mesh-ancestor
111250813|NCT03164304|Sensory System Agents|sensory system agents|mesh-ancestor
110679019|NCT05990400|Minoxidil|minoxidil|mesh-list
111250814|NCT03164304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111250815|NCT03164304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111250816|NCT03164304|Anesthetics|anesthetics|mesh-ancestor
111250817|NCT03164304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111250818|NCT03164304|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111250819|NCT03164304|Anticonvulsants|anticonvulsants|mesh-ancestor
111250820|NCT03164304|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111250821|NCT03164304|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111250822|NCT03164304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111250823|NCT03164304|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111250824|NCT03164304|Tocolytic Agents|tocolytic agents|mesh-ancestor
111250825|NCT03164304|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111250826|NCT02689284|Pembrolizumab|pembrolizumab|mesh-list
111250827|NCT02689284|Margetuximab|margetuximab|mesh-list
111250828|NCT02689284|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111250829|NCT02689284|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111250830|NCT02689284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111250831|NCT02689284|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111250832|NCT02689284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111250833|NCT02689284|Immunologic Factors|immunologic factors|mesh-ancestor
111250834|NCT02689284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111250835|NCT03165396|Propofol|propofol|mesh-list
111250836|NCT03165396|Sevoflurane|sevoflurane|mesh-list
111250837|NCT03165396|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111250838|NCT03165396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111250839|NCT03165396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111250840|NCT03165396|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111250841|NCT03165396|Anesthetics, General|anesthetics, general|mesh-ancestor
111250842|NCT03165396|Anesthetics|anesthetics|mesh-ancestor
111250843|NCT03165396|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111250844|NCT03165396|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111250845|NCT03164382|Sorafenib|sorafenib|mesh-list
111250846|NCT03164382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111250847|NCT03164382|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111250848|NCT03164382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111250849|NCT03164382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111250851|NCT03161340|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111250852|NCT03161340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111250853|NCT03161340|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111250854|NCT03161340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111250855|NCT03161340|Antifungal Agents|antifungal agents|mesh-ancestor
111250856|NCT03161340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111250857|NCT03161340|Immunologic Factors|immunologic factors|mesh-ancestor
111250858|NCT03161340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111250859|NCT03161574|Fluorouracil|fluorouracil|mesh-list
111250860|NCT03161574|Oxaliplatin|oxaliplatin|mesh-list
111250861|NCT03161574|Irinotecan|irinotecan|mesh-list
111250862|NCT03161574|Antimetabolites|antimetabolites|mesh-ancestor
111250863|NCT03161574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111250864|NCT03161574|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111250865|NCT03161574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111250866|NCT03161574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111250867|NCT03161574|Immunologic Factors|immunologic factors|mesh-ancestor
111250868|NCT03161574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111250869|NCT03161574|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111250870|NCT03161574|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111250871|NCT03161574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111250872|NCT03163914|Phenylephrine|phenylephrine|mesh-list
111250873|NCT03163914|Epinephrine|epinephrine|mesh-list
111250874|NCT03163914|Oxymetazoline|oxymetazoline|mesh-list
111250875|NCT03163914|Norepinephrine|norepinephrine|mesh-list
111250876|NCT03163914|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111250877|NCT03163914|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111250878|NCT03163914|Adrenergic Agents|adrenergic agents|mesh-ancestor
111250879|NCT03163914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111250880|NCT03163914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111250881|NCT03163914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111250882|NCT03163914|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111250883|NCT03163914|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111250884|NCT03163914|Autonomic Agents|autonomic agents|mesh-ancestor
111250885|NCT03163914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111250886|NCT03163914|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111102455|NCT03177317|Dexamethasone|dexamethasone|mesh-list
111250887|NCT03163914|Respiratory System Agents|respiratory system agents|mesh-ancestor
111250888|NCT03163914|Mydriatics|mydriatics|mesh-ancestor
111250889|NCT03163914|Sympathomimetics|sympathomimetics|mesh-ancestor
111250890|NCT03163914|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111250891|NCT03163914|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111250892|NCT03163914|Nasal Decongestants|nasal decongestants|mesh-ancestor
111250893|NCT03163914|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111250894|NCT03163914|Protective Agents|protective agents|mesh-ancestor
111250895|NCT03160872|Hormones|hormones|mesh-list
111250896|NCT03160872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111250897|NCT03160872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111250898|NCT03163680|Omeprazole|omeprazole|mesh-list
111250899|NCT03163680|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111250900|NCT03163680|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111250901|NCT03163680|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111250902|NCT03163680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111250903|NCT03163680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111250904|NCT04574232|Triamcinolone|triamcinolone|mesh-list
111250905|NCT04574232|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
111250906|NCT04574232|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
111250907|NCT04574232|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
111250908|NCT04574232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111250909|NCT04574232|Glucocorticoids|glucocorticoids|mesh-ancestor
111250910|NCT04574232|Hormones|hormones|mesh-ancestor
111250911|NCT04574232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111250912|NCT04574232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111250913|NCT04574232|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111250914|NCT04574232|Immunologic Factors|immunologic factors|mesh-ancestor
111250915|NCT04574232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111250916|NCT04574232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111250917|NCT05071716|Rifaximin|rifaximin|mesh-list
111250918|NCT05071716|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111250919|NCT05071716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111250920|NCT05071716|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111250921|NCT02680002|MF59 oil emulsion|mf59 oil emulsion|mesh-list
111250922|NCT02680002|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111250923|NCT02680002|Immunologic Factors|immunologic factors|mesh-ancestor
111250924|NCT02680002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111250925|NCT04557384|Ramucirumab|ramucirumab|mesh-list
111250926|NCT04557384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111250927|NCT04443348|Paclitaxel|paclitaxel|mesh-list
111250928|NCT04443348|Cyclophosphamide|cyclophosphamide|mesh-list
111250929|NCT04443348|Carboplatin|carboplatin|mesh-list
111250930|NCT04443348|Doxorubicin|doxorubicin|mesh-list
111250931|NCT04443348|Pembrolizumab|pembrolizumab|mesh-list
111250932|NCT04443348|Capecitabine|capecitabine|mesh-list
111250933|NCT04443348|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111250934|NCT04443348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111250935|NCT04443348|Tubulin Modulators|tubulin modulators|mesh-ancestor
111250936|NCT04443348|Antimitotic Agents|antimitotic agents|mesh-ancestor
111250937|NCT04443348|Mitosis Modulators|mitosis modulators|mesh-ancestor
111250938|NCT04443348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111250939|NCT04443348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111250940|NCT04443348|Immunologic Factors|immunologic factors|mesh-ancestor
111250941|NCT04443348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111250942|NCT04443348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111250943|NCT04443348|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111250944|NCT04443348|Alkylating Agents|alkylating agents|mesh-ancestor
111250945|NCT04443348|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111250946|NCT04443348|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111250947|NCT04443348|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111250948|NCT04443348|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111250949|NCT04443348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111250950|NCT04443348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111250951|NCT04443348|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111250952|NCT04443348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111250953|NCT04443348|Antimetabolites|antimetabolites|mesh-ancestor
111250954|NCT03161184|Sulfamethazine|sulfamethazine|mesh-list
111250955|NCT03161184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111250956|NCT05231850|Tislelizumab|tislelizumab|mesh-list
111250957|NCT05231850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111250958|NCT05231850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111250959|NCT03163212|Lactoferrin|lactoferrin|mesh-list
111250960|NCT03163212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111250961|NCT05007678|Leflunomide|leflunomide|mesh-list
111250962|NCT05007678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111250963|NCT05007678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111250964|NCT05007678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111250965|NCT05007678|Immunologic Factors|immunologic factors|mesh-ancestor
111250966|NCT05007678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111250967|NCT03161106|Lactulose|lactulose|mesh-list
111250968|NCT03161106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111250969|NCT02671500|Sofosbuvir|sofosbuvir|mesh-list
111250970|NCT02671500|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
111250971|NCT02671500|Velpatasvir|velpatasvir|mesh-list
111250972|NCT02671500|Antiviral Agents|antiviral agents|mesh-ancestor
111250973|NCT02671500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111250974|NCT02671266|Oxytocin|oxytocin|mesh-list
111250975|NCT02671266|Oxytocics|oxytocics|mesh-ancestor
111250976|NCT02671266|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111250977|NCT02671266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111250978|NCT03160404|Zolpidem|zolpidem|mesh-list
111250979|NCT03160404|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111250980|NCT03160404|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111250981|NCT03160404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111250982|NCT03160404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111250983|NCT03160404|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
111250984|NCT03160404|GABA Agonists|gaba agonists|mesh-ancestor
111250985|NCT03160404|GABA Agents|gaba agents|mesh-ancestor
111250986|NCT03160404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111250987|NCT03160404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111250988|NCT03162588|Epoetin Alfa|epoetin alfa|mesh-list
111250989|NCT03162588|Hematinics|hematinics|mesh-ancestor
111250990|NCT03320070|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
111250991|NCT03320070|Hormones|hormones|mesh-ancestor
111250992|NCT03320070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111250993|NCT03320070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111250994|NCT04977336|Acetaminophen|acetaminophen|mesh-list
111250995|NCT04977336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111250996|NCT04977336|Analgesics|analgesics|mesh-ancestor
111250997|NCT04977336|Sensory System Agents|sensory system agents|mesh-ancestor
111250998|NCT04977336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111250999|NCT04977336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111251000|NCT04977336|Antipyretics|antipyretics|mesh-ancestor
111251001|NCT03284424|Pembrolizumab|pembrolizumab|mesh-list
111251002|NCT03284424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111251003|NCT03284424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111251004|NCT03284424|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111251005|NCT03284424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111251006|NCT02674854|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111251007|NCT02674854|Latanoprost|latanoprost|mesh-list
111251008|NCT02674854|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111251009|NCT04036188|Vitamin D|vitamin d|mesh-list
111251010|NCT04036188|Cholecalciferol|cholecalciferol|mesh-list
111251011|NCT04036188|Triamcinolone|triamcinolone|mesh-list
111251012|NCT04036188|Vitamins|vitamins|mesh-ancestor
111251013|NCT04036188|Micronutrients|micronutrients|mesh-ancestor
111251014|NCT04036188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111251015|NCT04036188|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111251016|NCT04036188|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111251017|NCT04036188|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111251018|NCT04036188|Glucocorticoids|glucocorticoids|mesh-ancestor
111251019|NCT04036188|Hormones|hormones|mesh-ancestor
111251020|NCT04036188|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111251021|NCT02388516|Vitamin D|vitamin d|mesh-list
111251022|NCT02388516|Cholecalciferol|cholecalciferol|mesh-list
111251023|NCT02388516|Vitamins|vitamins|mesh-ancestor
111251024|NCT02388516|Micronutrients|micronutrients|mesh-ancestor
111251025|NCT02388516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111251026|NCT02388516|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111251027|NCT02388516|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111251028|NCT02669862|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111251029|NCT01531673|Ivacaftor|ivacaftor|mesh-list
111251030|NCT01531673|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
111251031|NCT01531673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110679235|NCT05669989|Dexamethasone|dexamethasone|mesh-list
111251032|NCT01531673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111251033|NCT01531205|Leuprolide|leuprolide|mesh-list
111251034|NCT01531205|Goserelin|goserelin|mesh-list
111251035|NCT01531205|Bicalutamide|bicalutamide|mesh-list
111251036|NCT01531205|Androgens|androgens|mesh-list
111251037|NCT01531205|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111251038|NCT01531205|Fertility Agents|fertility agents|mesh-ancestor
111251039|NCT01531205|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111251040|NCT01531205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111251041|NCT01531205|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111251042|NCT01531205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111251043|NCT01531205|Hormones|hormones|mesh-ancestor
111251044|NCT01531205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111251045|NCT01531205|Androgen Antagonists|androgen antagonists|mesh-ancestor
111251046|NCT01531205|Hormone Antagonists|hormone antagonists|mesh-ancestor
111251047|NCT02985671|Acetaminophen|acetaminophen|mesh-list
111251048|NCT02985671|Diclofenac|diclofenac|mesh-list
111251049|NCT02985671|Orphenadrine|orphenadrine|mesh-list
111251050|NCT02985671|Caffeine|caffeine|mesh-list
111251051|NCT02985671|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111251052|NCT02985671|Analgesics|analgesics|mesh-ancestor
111251053|NCT02985671|Sensory System Agents|sensory system agents|mesh-ancestor
111251054|NCT02985671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111251055|NCT02985671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111251056|NCT02985671|Antipyretics|antipyretics|mesh-ancestor
111251057|NCT02985671|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111251058|NCT02985671|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111251059|NCT02985671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111251060|NCT02985671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111251061|NCT02985671|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
111251062|NCT02985671|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111251063|NCT02985671|Purinergic Agents|purinergic agents|mesh-ancestor
111251064|NCT02985671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111251065|NCT02985671|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111251066|NCT02985671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111251067|NCT02985671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111251068|NCT02985671|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111251069|NCT02985671|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111251070|NCT02985671|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111251071|NCT02985671|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
111251072|NCT02985671|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111251073|NCT02985671|Parasympatholytics|parasympatholytics|mesh-ancestor
111251074|NCT02985671|Autonomic Agents|autonomic agents|mesh-ancestor
111251075|NCT02985671|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111251076|NCT02985671|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111251077|NCT02985671|Cholinergic Agents|cholinergic agents|mesh-ancestor
111251078|NCT02985671|Cytochrome P-450 CYP2B6 Inhibitors|cytochrome p-450 cyp2b6 inhibitors|mesh-ancestor
111251079|NCT02985671|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111251081|NCT01529645|Immunologic Factors|immunologic factors|mesh-ancestor
111251082|NCT01529645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111251083|NCT01528787|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111251084|NCT01528787|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111251085|NCT01528709|Atorvastatin|atorvastatin|mesh-list
111251086|NCT01528709|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111251087|NCT01528709|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111251088|NCT01528709|Antimetabolites|antimetabolites|mesh-ancestor
111251089|NCT01528709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111251090|NCT01528709|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111251091|NCT01528709|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111251092|NCT01528709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111251093|NCT01527383|Vaccines|vaccines|mesh-list
111251094|NCT01527383|Immunologic Factors|immunologic factors|mesh-ancestor
111251095|NCT01527383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111251096|NCT01526057|Rituximab|rituximab|mesh-list
111251097|NCT01526057|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111251098|NCT01526057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111251099|NCT01526057|Immunologic Factors|immunologic factors|mesh-ancestor
111251100|NCT01526057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111251101|NCT01526057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111251102|NCT01525901|Mitogens|mitogens|mesh-list
111251103|NCT01525901|Mecasermin|mecasermin|mesh-list
111251104|NCT01525901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111251105|NCT01525901|Mitosis Modulators|mitosis modulators|mesh-ancestor
111251106|NCT01525901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111251107|NCT01525901|Growth Substances|growth substances|mesh-ancestor
111251108|NCT00123123|Chlorhexidine|chlorhexidine|mesh-list
111251109|NCT00123123|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
111251110|NCT00123123|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111251111|NCT00123123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111251112|NCT00123123|Disinfectants|disinfectants|mesh-ancestor
111251113|NCT00123123|Dermatologic Agents|dermatologic agents|mesh-ancestor
111251114|NCT00242385|Protease Inhibitors|protease inhibitors|mesh-list
111251115|NCT00242385|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
111251116|NCT00242385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111251117|NCT00242385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111251118|NCT00242385|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
111251119|NCT00242385|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111251120|NCT00242619|Rosiglitazone|rosiglitazone|mesh-list
111251121|NCT00242619|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111251122|NCT00242619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111251123|NCT01899027|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111251124|NCT01899027|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111251125|NCT01899027|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111251126|NCT01899027|Antimetabolites|antimetabolites|mesh-ancestor
111251127|NCT01899027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111251128|NCT01899027|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111251129|NCT01899027|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111251130|NCT01899027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111251131|NCT00264381|Dalteparin|dalteparin|mesh-list
111251132|NCT00264381|Tinzaparin|tinzaparin|mesh-list
111251133|NCT00264381|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
111251134|NCT00264381|Anticoagulants|anticoagulants|mesh-ancestor
111251135|NCT00264381|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111251136|NCT00264381|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111251137|NCT00264381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111251138|NCT00246441|Paroxetine|paroxetine|mesh-list
111251139|NCT00246441|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111251140|NCT00246441|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111251141|NCT00246441|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111251142|NCT00246441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111251143|NCT00246441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111251144|NCT00246441|Serotonin Agents|serotonin agents|mesh-ancestor
111251145|NCT00246441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111251146|NCT00246441|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111251147|NCT00246441|Antidepressive Agents|antidepressive agents|mesh-ancestor
111251148|NCT00246441|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111251149|NCT00246441|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111251150|NCT00246441|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111251151|NCT00246441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111251153|NCT00246519|Metoprolol|metoprolol|mesh-list
111251154|NCT00246519|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
111251155|NCT00246519|Trichlormethiazide|trichlormethiazide|mesh-list
111251156|NCT00246519|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111251157|NCT00246519|Diuretics|diuretics|mesh-ancestor
111251158|NCT00246519|Natriuretic Agents|natriuretic agents|mesh-ancestor
111251159|NCT00246519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111251160|NCT00246519|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
111251161|NCT00246519|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111251162|NCT00246519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111251163|NCT00246519|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111251164|NCT00246519|Sympatholytics|sympatholytics|mesh-ancestor
111251165|NCT00246519|Autonomic Agents|autonomic agents|mesh-ancestor
111251166|NCT00246519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111251167|NCT00246519|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
111251168|NCT00246519|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111251169|NCT00246519|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111251170|NCT00246519|Adrenergic Agents|adrenergic agents|mesh-ancestor
111251171|NCT00246519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111251172|NCT00248547|Dexamethasone|dexamethasone|mesh-list
111251173|NCT00248547|Ondansetron|ondansetron|mesh-list
111251174|NCT00248547|Aprepitant|aprepitant|mesh-list
111251175|NCT00248547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111251176|NCT00248547|Antiemetics|antiemetics|mesh-ancestor
111251177|NCT00248547|Autonomic Agents|autonomic agents|mesh-ancestor
111251178|NCT00248547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111251179|NCT00248547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111251180|NCT00248547|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111251181|NCT00248547|Glucocorticoids|glucocorticoids|mesh-ancestor
111251182|NCT00248547|Hormones|hormones|mesh-ancestor
111251183|NCT00248547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111251184|NCT00248547|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111251185|NCT00248547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111251186|NCT00248547|Antipruritics|antipruritics|mesh-ancestor
111251187|NCT00248547|Dermatologic Agents|dermatologic agents|mesh-ancestor
111251188|NCT00248547|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111251189|NCT00248547|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111251190|NCT00248547|Serotonin Agents|serotonin agents|mesh-ancestor
111251191|NCT00248547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111251192|NCT00248547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111251193|NCT00248547|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
111251194|NCT01524887|Immunoglobulins|immunoglobulins|mesh-list
111251195|NCT01524887|Antibodies|antibodies|mesh-list
111251196|NCT01524887|gamma-Globulins|gamma-globulins|mesh-list
111251197|NCT01524887|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111251198|NCT01524887|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
111251199|NCT01524887|Immunologic Factors|immunologic factors|mesh-ancestor
111251200|NCT01524887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111251201|NCT00266799|Doxorubicin|doxorubicin|mesh-list
111251202|NCT00266799|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111251203|NCT00266799|Capecitabine|capecitabine|mesh-list
111251204|NCT00266799|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111251205|NCT00266799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111251206|NCT00266799|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111251207|NCT00266799|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111251208|NCT00266799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111251209|NCT00266799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111251210|NCT00266799|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111251211|NCT00266799|Antimetabolites|antimetabolites|mesh-ancestor
111251212|NCT00249249|Atorvastatin|atorvastatin|mesh-list
111251213|NCT00249249|Pitavastatin|pitavastatin|mesh-list
111251214|NCT00249249|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111251215|NCT00249249|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111251216|NCT00249249|Antimetabolites|antimetabolites|mesh-ancestor
111251217|NCT00249249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111251218|NCT00249249|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111251219|NCT00249249|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111251220|NCT00249249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111251221|NCT01522235|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111251222|NCT01522235|gamma-Globulins|gamma-globulins|mesh-list
111251223|NCT01522235|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
111251224|NCT01522235|Immunologic Factors|immunologic factors|mesh-ancestor
111251225|NCT01522235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111251226|NCT00125931|Pentazocine|pentazocine|mesh-list
111251227|NCT00125931|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111251228|NCT00125931|Narcotics|narcotics|mesh-ancestor
111251229|NCT00125931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111251230|NCT00125931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111251231|NCT00125931|Analgesics|analgesics|mesh-ancestor
111251232|NCT00125931|Sensory System Agents|sensory system agents|mesh-ancestor
111251233|NCT00125931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111251234|NCT00125931|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111251235|NCT00125931|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111251236|NCT00267111|Tetracaine|tetracaine|mesh-list
111251237|NCT00267111|Anesthetics, Local|anesthetics, local|mesh-ancestor
111251238|NCT00267111|Anesthetics|anesthetics|mesh-ancestor
111251239|NCT00267111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111251240|NCT00267111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111251241|NCT00267111|Sensory System Agents|sensory system agents|mesh-ancestor
111251242|NCT00267111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111251243|NCT01521923|Certolizumab Pegol|certolizumab pegol|mesh-list
111251244|NCT01521923|Methotrexate|methotrexate|mesh-list
111251245|NCT01521923|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111251246|NCT01521923|Abortifacient Agents|abortifacient agents|mesh-ancestor
111251247|NCT01521923|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111251248|NCT01521923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111251249|NCT01521923|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111251250|NCT01521923|Antimetabolites|antimetabolites|mesh-ancestor
111251251|NCT01521923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111251252|NCT01521923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111251253|NCT01521923|Dermatologic Agents|dermatologic agents|mesh-ancestor
111251254|NCT01521923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111251255|NCT01521923|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111251256|NCT01521923|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111251257|NCT01521923|Immunologic Factors|immunologic factors|mesh-ancestor
111251258|NCT01521923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111251259|NCT01521923|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111251260|NCT01521923|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111251261|NCT01521923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111251262|NCT05240781|Sirolimus|sirolimus|mesh-list
111251263|NCT05240781|Temsirolimus|temsirolimus|mesh-list
111251264|NCT05240781|MTOR Inhibitors|mtor inhibitors|mesh-list
111251265|NCT05240781|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111251266|NCT05240781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111251267|NCT05240781|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111251268|NCT05240781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111251269|NCT05240781|Antifungal Agents|antifungal agents|mesh-ancestor
111251270|NCT05240781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111251271|NCT05240781|Immunologic Factors|immunologic factors|mesh-ancestor
111251272|NCT05240781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111251273|NCT05240781|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111251274|NCT05240781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111251275|NCT05240781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111251276|NCT01520987|Opicapone|opicapone|mesh-list
111251277|NCT01520987|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
111251278|NCT01520987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111251279|NCT01520987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111251280|NCT01520987|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111251281|NCT01520987|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111251282|NCT00130923|Risperidone|risperidone|mesh-list
111251283|NCT00130923|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111251284|NCT00130923|Serotonin Agents|serotonin agents|mesh-ancestor
111251285|NCT00130923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111251286|NCT00130923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111251287|NCT00130923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111251288|NCT00130923|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111251289|NCT00130923|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111251290|NCT00130923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111251291|NCT00130923|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111251292|NCT00130923|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111251293|NCT00130923|Dopamine Agents|dopamine agents|mesh-ancestor
111251294|NCT04117581|Vitamin D|vitamin d|mesh-list
110975612|NCT01384383|Ledipasvir|ledipasvir|mesh-list
111251295|NCT04117581|Cholecalciferol|cholecalciferol|mesh-list
111251296|NCT04117581|Vitamins|vitamins|mesh-ancestor
111251297|NCT04117581|Micronutrients|micronutrients|mesh-ancestor
111251298|NCT04117581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111251299|NCT04117581|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111251300|NCT04117581|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111251302|NCT00272337|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111251303|NCT00272337|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111251304|NCT00272337|Analgesics|analgesics|mesh-ancestor
111251305|NCT00272337|Sensory System Agents|sensory system agents|mesh-ancestor
111251306|NCT00272337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111251307|NCT00272337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111251308|NCT00272337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111251309|NCT00272337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111251310|NCT00272337|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111251311|NCT00272337|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111251312|NCT00272337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111251313|NCT00272337|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111251314|NCT00272337|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111251315|NCT00272337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111251316|NCT00272337|Antipyretics|antipyretics|mesh-ancestor
111251317|NCT01562275|Ipatasertib|ipatasertib|mesh-list
111251318|NCT01562275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111251319|NCT01562275|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111251320|NCT01562275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111251321|NCT01562275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111251322|NCT01535053|Calcium, Dietary|calcium, dietary|mesh-list
111251323|NCT01535053|Leucovorin|leucovorin|mesh-list
111251324|NCT01535053|Folic Acid|folic acid|mesh-list
111251325|NCT01535053|Dactinomycin|dactinomycin|mesh-list
111251326|NCT01535053|Methotrexate|methotrexate|mesh-list
111251327|NCT01535053|Calcium|calcium|mesh-list
111251328|NCT01535053|Levoleucovorin|levoleucovorin|mesh-list
111251329|NCT01535053|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111251330|NCT01535053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111251331|NCT01535053|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111251332|NCT01535053|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111251333|NCT01535053|Abortifacient Agents|abortifacient agents|mesh-ancestor
111251334|NCT01535053|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111251335|NCT01535053|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111251336|NCT01535053|Antimetabolites|antimetabolites|mesh-ancestor
111251337|NCT01535053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111251338|NCT01535053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111251339|NCT01535053|Dermatologic Agents|dermatologic agents|mesh-ancestor
111251340|NCT01535053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111251341|NCT01535053|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111251342|NCT01535053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111251343|NCT01535053|Immunologic Factors|immunologic factors|mesh-ancestor
111251344|NCT01535053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111251345|NCT01535053|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111251346|NCT01535053|Antidotes|antidotes|mesh-ancestor
111251347|NCT01535053|Protective Agents|protective agents|mesh-ancestor
111251348|NCT01535053|Vitamin B Complex|vitamin b complex|mesh-ancestor
111251349|NCT01535053|Vitamins|vitamins|mesh-ancestor
111251350|NCT01535053|Micronutrients|micronutrients|mesh-ancestor
111251351|NCT01535053|Hematinics|hematinics|mesh-ancestor
111251352|NCT01535053|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111251353|NCT01535053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111251354|NCT01535053|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111251355|NCT01535053|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111251356|NCT03027635|Ciprofloxacin|ciprofloxacin|mesh-list
111251357|NCT03027635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111251358|NCT03027635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111251359|NCT03027635|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111251360|NCT03027635|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111251361|NCT03027635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111251362|NCT03027635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111251363|NCT03027635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111251364|NCT03027635|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111251365|NCT03027635|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111251366|NCT01520363|Dextromethorphan|dextromethorphan|mesh-list
111251367|NCT01520363|Antitussive Agents|antitussive agents|mesh-ancestor
111251368|NCT01520363|Respiratory System Agents|respiratory system agents|mesh-ancestor
111251369|NCT01520363|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111251370|NCT01520363|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111251371|NCT01520363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111251372|NCT01520363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111251373|NCT01520363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111251374|NCT01578499|Methotrexate|methotrexate|mesh-list
111251375|NCT01578499|Brentuximab Vedotin|brentuximab vedotin|mesh-list
111251376|NCT01578499|Bexarotene|bexarotene|mesh-list
111251377|NCT01578499|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111251378|NCT01578499|Abortifacient Agents|abortifacient agents|mesh-ancestor
111251379|NCT01578499|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111251380|NCT01578499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111251381|NCT01578499|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111251382|NCT01578499|Antimetabolites|antimetabolites|mesh-ancestor
111251383|NCT01578499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111251384|NCT01578499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111251385|NCT01578499|Dermatologic Agents|dermatologic agents|mesh-ancestor
111251386|NCT01578499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111251387|NCT01578499|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111251388|NCT01578499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111251389|NCT01578499|Immunologic Factors|immunologic factors|mesh-ancestor
111251390|NCT01578499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111251391|NCT01578499|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111251392|NCT01578499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111251393|NCT01578499|Immunotoxins|immunotoxins|mesh-ancestor
111251394|NCT01578499|Immunoconjugates|immunoconjugates|mesh-ancestor
111251395|NCT01561963|Rifampin|rifampin|mesh-list
111251396|NCT01561963|Apremilast|apremilast|mesh-list
111251397|NCT01561963|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111251398|NCT01561963|Antitubercular Agents|antitubercular agents|mesh-ancestor
111251399|NCT01561963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111251400|NCT01561963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111251401|NCT01561963|Leprostatic Agents|leprostatic agents|mesh-ancestor
111251402|NCT01561963|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111251403|NCT01561963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111251404|NCT01561963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111251405|NCT01561963|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111251406|NCT01561963|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111251407|NCT01561963|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
111251408|NCT01561963|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
111251409|NCT01561963|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
111251410|NCT01561963|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111251411|NCT01561963|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111251412|NCT01561963|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111251413|NCT01561963|Analgesics|analgesics|mesh-ancestor
111251414|NCT01561963|Sensory System Agents|sensory system agents|mesh-ancestor
111251415|NCT01561963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111251416|NCT01561963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111251417|NCT01561963|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111251418|NCT01561963|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111251419|NCT01561963|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
111251420|NCT01561963|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111251421|NCT04852003|Morphine|morphine|mesh-list
111251422|NCT04852003|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111251423|NCT04852003|Narcotics|narcotics|mesh-ancestor
111251424|NCT04852003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111251425|NCT04852003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111251426|NCT04852003|Analgesics|analgesics|mesh-ancestor
111251427|NCT04852003|Sensory System Agents|sensory system agents|mesh-ancestor
111251428|NCT04852003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111251429|NCT01534351|Tamsulosin|tamsulosin|mesh-list
111251430|NCT01534351|Finasteride|finasteride|mesh-list
111251431|NCT01534351|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111251432|NCT01534351|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111251433|NCT01534351|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111251434|NCT01534351|Adrenergic Agents|adrenergic agents|mesh-ancestor
111251435|NCT01534351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111251436|NCT01534351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111251437|NCT01534351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111251438|NCT01534351|Urological Agents|urological agents|mesh-ancestor
111251439|NCT01534351|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
111251440|NCT01534351|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111251441|NCT01534351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111251442|NCT01534351|Hormone Antagonists|hormone antagonists|mesh-ancestor
111251443|NCT01534351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110975763|NCT00703118|Ribavirin|ribavirin|mesh-list
111251444|NCT01534195|Prednisolone|prednisolone|mesh-list
111251445|NCT01534195|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111251446|NCT01534195|Methylprednisolone|methylprednisolone|mesh-list
111251447|NCT01534195|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111251448|NCT01534195|Prednisolone acetate|prednisolone acetate|mesh-list
111251449|NCT01534195|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111251450|NCT01534195|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111251451|NCT01534195|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111251452|NCT01534195|Prednisolone phosphate|prednisolone phosphate|mesh-list
111251453|NCT01534195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111251454|NCT01534195|Glucocorticoids|glucocorticoids|mesh-ancestor
111251455|NCT01534195|Hormones|hormones|mesh-ancestor
111251456|NCT01534195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111251457|NCT01534195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111251458|NCT01534195|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111251459|NCT01534195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111251460|NCT01534195|Antiemetics|antiemetics|mesh-ancestor
111251461|NCT01534195|Autonomic Agents|autonomic agents|mesh-ancestor
111251462|NCT01534195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111251463|NCT01534195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111251464|NCT01534195|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111251465|NCT01534195|Protective Agents|protective agents|mesh-ancestor
111251466|NCT01560949|Gemcitabine|gemcitabine|mesh-list
111251467|NCT01560949|Fluorouracil|fluorouracil|mesh-list
111251468|NCT01560949|Oxaliplatin|oxaliplatin|mesh-list
111251469|NCT01560949|Irinotecan|irinotecan|mesh-list
111251470|NCT01560949|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111251471|NCT01560949|Antimetabolites|antimetabolites|mesh-ancestor
111251472|NCT01560949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111251473|NCT01560949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111251474|NCT01560949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111251475|NCT01560949|Immunologic Factors|immunologic factors|mesh-ancestor
111251476|NCT01560949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111251477|NCT01560949|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111251478|NCT01560949|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111251479|NCT01560949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111251480|NCT03113448|Capsaicin|capsaicin|mesh-list
111251481|NCT03113448|Antipruritics|antipruritics|mesh-ancestor
111251482|NCT03113448|Dermatologic Agents|dermatologic agents|mesh-ancestor
111251483|NCT03113448|Sensory System Agents|sensory system agents|mesh-ancestor
111251484|NCT03113448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111251485|NCT03113448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111251486|NCT01533493|Memantine|memantine|mesh-list
111251487|NCT01533493|Methylphenidate|methylphenidate|mesh-list
111251488|NCT01533493|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111251489|NCT01533493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111251490|NCT01533493|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111251491|NCT01533493|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111251492|NCT01533493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111251493|NCT01533493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111251494|NCT01533493|Dopamine Agents|dopamine agents|mesh-ancestor
111251495|NCT01533493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111251496|NCT01533493|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111251497|NCT01533493|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111251498|NCT01533493|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111251499|NCT01533493|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111251500|NCT02388048|Ofatumumab|ofatumumab|mesh-list
111251501|NCT02388048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111251502|NCT02387892|Vitamin D|vitamin d|mesh-list
111251503|NCT02387892|Cholecalciferol|cholecalciferol|mesh-list
111251504|NCT02387892|Vitamins|vitamins|mesh-ancestor
111251505|NCT02387892|Micronutrients|micronutrients|mesh-ancestor
111251506|NCT02387892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111251507|NCT02387892|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111251508|NCT02387892|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111251509|NCT00133575|Vaccines|vaccines|mesh-list
111251510|NCT00133575|Immunologic Factors|immunologic factors|mesh-ancestor
111251511|NCT00133575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111251512|NCT00134043|Vorinostat|vorinostat|mesh-list
111251513|NCT00134043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111251514|NCT00134043|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111251515|NCT00134043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111251516|NCT00134043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111251517|NCT03715998|Ramipril|ramipril|mesh-list
111251518|NCT03715998|Firibastat|firibastat|mesh-list
111251519|NCT03715998|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
111251520|NCT03715998|Protease Inhibitors|protease inhibitors|mesh-ancestor
111251521|NCT03715998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111251522|NCT03715998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111251523|NCT03715998|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111251524|NCT01790529|Metronidazole|metronidazole|mesh-list
111251525|NCT01790529|Cefuroxime|cefuroxime|mesh-list
111251526|NCT01790529|Cefuroxime axetil|cefuroxime axetil|mesh-list
111251527|NCT01790529|Anesthetics|anesthetics|mesh-list
111251528|NCT01790529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111251529|NCT01790529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111251530|NCT01790529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111251531|NCT01790529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111251532|NCT01790529|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111251533|NCT01790529|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111251534|NCT01533181|Topotecan|topotecan|mesh-list
111251535|NCT01533181|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111251536|NCT01533181|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111251537|NCT01533181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111251538|NCT01533181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111251539|NCT01533181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111251540|NCT04641507|Tadalafil|tadalafil|mesh-list
111251541|NCT04641507|Tamsulosin|tamsulosin|mesh-list
111251542|NCT04641507|Vasodilator Agents|vasodilator agents|mesh-ancestor
111251543|NCT04641507|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111251544|NCT04641507|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111251545|NCT04641507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111251546|NCT04641507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111251547|NCT04641507|Urological Agents|urological agents|mesh-ancestor
111251548|NCT04641507|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111251549|NCT04641507|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111251550|NCT04641507|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111251551|NCT04641507|Adrenergic Agents|adrenergic agents|mesh-ancestor
111251552|NCT04641507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111251553|NCT04641507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111251554|NCT04489173|Trifluridine|trifluridine|mesh-list
111251555|NCT04489173|Antimetabolites|antimetabolites|mesh-ancestor
111251556|NCT04489173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111251557|NCT04489173|Antiviral Agents|antiviral agents|mesh-ancestor
111251558|NCT04489173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111251559|NCT00512070|Olanzapine|olanzapine|mesh-list
111251560|NCT00512070|Melatonin|melatonin|mesh-list
111251561|NCT00512070|Antioxidants|antioxidants|mesh-ancestor
111251562|NCT00512070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111251563|NCT00512070|Protective Agents|protective agents|mesh-ancestor
111251564|NCT00512070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111251565|NCT00512070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111251566|NCT00512070|Antiemetics|antiemetics|mesh-ancestor
111251567|NCT00512070|Autonomic Agents|autonomic agents|mesh-ancestor
111251568|NCT00512070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111251569|NCT00512070|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111251570|NCT00512070|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111251571|NCT00512070|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111251572|NCT00512070|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111251573|NCT00512070|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111251574|NCT00512070|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111251575|NCT00512070|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111251576|NCT00512070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111251577|NCT00512070|Serotonin Agents|serotonin agents|mesh-ancestor
111251578|NCT05668026|Venetoclax|venetoclax|mesh-list
111251579|NCT05668026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111251580|NCT05661552|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111251581|NCT05661552|Ezetimibe|ezetimibe|mesh-list
111251582|NCT05661552|Evolocumab|evolocumab|mesh-list
111251583|NCT05661552|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111251584|NCT05661552|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111251585|NCT05661552|Antimetabolites|antimetabolites|mesh-ancestor
111251586|NCT05661552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111251587|NCT05661552|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111251588|NCT05661552|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111251589|NCT05661552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111251590|NCT05661552|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
111251591|NCT05661552|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111251592|NCT05661552|Protease Inhibitors|protease inhibitors|mesh-ancestor
111251593|NCT03534102|Analgesics, Opioid|analgesics, opioid|mesh-list
111251594|NCT03534102|Narcotics|narcotics|mesh-ancestor
111251595|NCT03534102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111251596|NCT03534102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111251597|NCT03534102|Analgesics|analgesics|mesh-ancestor
111251598|NCT03534102|Sensory System Agents|sensory system agents|mesh-ancestor
111251599|NCT03534102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111251600|NCT04051203|Methylprednisolone|methylprednisolone|mesh-list
111251601|NCT04051203|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111251602|NCT04051203|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111251603|NCT04051203|Prednisolone|prednisolone|mesh-list
111251604|NCT04051203|Prednisolone acetate|prednisolone acetate|mesh-list
111251605|NCT04051203|Lidocaine|lidocaine|mesh-list
111251606|NCT04051203|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111251607|NCT04051203|Prednisolone phosphate|prednisolone phosphate|mesh-list
111251608|NCT04051203|Anesthetics, Local|anesthetics, local|mesh-ancestor
111251609|NCT04051203|Anesthetics|anesthetics|mesh-ancestor
111251610|NCT04051203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111251611|NCT04051203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111251612|NCT04051203|Sensory System Agents|sensory system agents|mesh-ancestor
111251613|NCT04051203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111251614|NCT04051203|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111251615|NCT04051203|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111251616|NCT04051203|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111251617|NCT04051203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111251618|NCT04051203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111251619|NCT04051203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111251620|NCT04051203|Antiemetics|antiemetics|mesh-ancestor
111251621|NCT04051203|Autonomic Agents|autonomic agents|mesh-ancestor
111251622|NCT04051203|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111251623|NCT04051203|Glucocorticoids|glucocorticoids|mesh-ancestor
111251624|NCT04051203|Hormones|hormones|mesh-ancestor
111251625|NCT04051203|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111251626|NCT04051203|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111251627|NCT04051203|Protective Agents|protective agents|mesh-ancestor
111251628|NCT04051203|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111251629|NCT04051203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111251630|NCT00144963|Dexamethasone|dexamethasone|mesh-list
111251631|NCT00144963|Vincristine|vincristine|mesh-list
111251632|NCT00144963|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111251633|NCT00144963|Antiemetics|antiemetics|mesh-ancestor
111251634|NCT00144963|Autonomic Agents|autonomic agents|mesh-ancestor
111251635|NCT00144963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111251636|NCT00144963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111251637|NCT00144963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111251638|NCT00144963|Glucocorticoids|glucocorticoids|mesh-ancestor
111251639|NCT00144963|Hormones|hormones|mesh-ancestor
111251640|NCT00144963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111251641|NCT00144963|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111251642|NCT00144963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111251643|NCT00144963|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111251644|NCT00144963|Tubulin Modulators|tubulin modulators|mesh-ancestor
111251645|NCT00144963|Antimitotic Agents|antimitotic agents|mesh-ancestor
111251646|NCT00144963|Mitosis Modulators|mitosis modulators|mesh-ancestor
111251647|NCT00144963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111251648|NCT02662764|Sufentanil|sufentanil|mesh-list
111251650|NCT02662764|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111251651|NCT02662764|Narcotics|narcotics|mesh-ancestor
111251652|NCT02662764|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111251653|NCT02662764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111251654|NCT02662764|Analgesics|analgesics|mesh-ancestor
111251655|NCT02662764|Sensory System Agents|sensory system agents|mesh-ancestor
111251656|NCT02662764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111251657|NCT02662764|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111251658|NCT02662764|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111251659|NCT02662764|Anesthetics, General|anesthetics, general|mesh-ancestor
111251660|NCT02662764|Anesthetics|anesthetics|mesh-ancestor
111251661|NCT01519817|Vaccines|vaccines|mesh-list
111251662|NCT01519817|Immunologic Factors|immunologic factors|mesh-ancestor
111251663|NCT01519817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111251664|NCT05549154|Vitamin D|vitamin d|mesh-list
111251665|NCT05549154|Ergocalciferols|ergocalciferols|mesh-list
111251666|NCT05549154|Cholecalciferol|cholecalciferol|mesh-list
111251667|NCT05549154|Vitamins|vitamins|mesh-list
111251668|NCT05549154|Micronutrients|micronutrients|mesh-ancestor
111251669|NCT05549154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111251670|NCT05549154|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110959163|NCT05681182|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111251671|NCT05549154|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111251672|NCT01518257|Botulinum Toxins|botulinum toxins|mesh-list
111251673|NCT01518257|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111251674|NCT01518257|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111251675|NCT01518257|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111251676|NCT01518257|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111251677|NCT01518257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111251678|NCT01518257|Cholinergic Agents|cholinergic agents|mesh-ancestor
111251679|NCT01518257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111251680|NCT01518257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111251681|NCT01518257|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111251682|NCT01518257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111251684|NCT02391636|Carbetocin|carbetocin|mesh-list
111251685|NCT02391636|Oxytocics|oxytocics|mesh-ancestor
111251686|NCT02391636|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111251687|NCT02391636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111251688|NCT01514357|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
111251689|NCT01514357|Natriuretic Agents|natriuretic agents|mesh-ancestor
111251690|NCT01514357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111251691|NCT02383212|Paclitaxel|paclitaxel|mesh-list
111251692|NCT02383212|Docetaxel|docetaxel|mesh-list
111251693|NCT02383212|Cyclophosphamide|cyclophosphamide|mesh-list
111251694|NCT02383212|Carboplatin|carboplatin|mesh-list
111251695|NCT02383212|Pemetrexed|pemetrexed|mesh-list
111251696|NCT02383212|Cemiplimab|cemiplimab|mesh-list
111251697|NCT02383212|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111251698|NCT02383212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111251699|NCT02383212|Tubulin Modulators|tubulin modulators|mesh-ancestor
111251700|NCT02383212|Antimitotic Agents|antimitotic agents|mesh-ancestor
111251701|NCT02383212|Mitosis Modulators|mitosis modulators|mesh-ancestor
111251702|NCT02383212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111251703|NCT02383212|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111251704|NCT02383212|Immunologic Factors|immunologic factors|mesh-ancestor
111251705|NCT02383212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111251706|NCT02383212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111251707|NCT02383212|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111251708|NCT02383212|Alkylating Agents|alkylating agents|mesh-ancestor
111251709|NCT02383212|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111251710|NCT02383212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111251711|NCT02383212|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111251712|NCT02383212|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111251713|NCT02383212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111251714|NCT01531387|Hydroxyurea|hydroxyurea|mesh-list
111251715|NCT01531387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111251716|NCT01531387|Antisickling Agents|antisickling agents|mesh-ancestor
111251717|NCT01531387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111251718|NCT01531387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111251719|NCT01531387|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111251720|NCT01531153|Galantamine|galantamine|mesh-list
111251721|NCT01531153|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111251722|NCT01531153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111251723|NCT01531153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111251724|NCT01531153|Cholinergic Agents|cholinergic agents|mesh-ancestor
111251725|NCT01531153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111251726|NCT01531153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111251727|NCT01531153|Parasympathomimetics|parasympathomimetics|mesh-ancestor
111251728|NCT01531153|Autonomic Agents|autonomic agents|mesh-ancestor
111251729|NCT01531153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111251730|NCT01531153|Nootropic Agents|nootropic agents|mesh-ancestor
111251731|NCT03027973|Tranexamic Acid|tranexamic acid|mesh-list
111251732|NCT03027973|Ulipristal acetate|ulipristal acetate|mesh-list
111251733|NCT03027973|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111251734|NCT03027973|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111251735|NCT03027973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111251736|NCT03027973|Hemostatics|hemostatics|mesh-ancestor
111251737|NCT03027973|Coagulants|coagulants|mesh-ancestor
111251738|NCT03027973|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111251739|NCT03027973|Contraceptive Agents|contraceptive agents|mesh-ancestor
111251740|NCT03027973|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111251741|NCT03027973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111251742|NCT03027973|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111251743|NCT01529749|Raltegravir Potassium|raltegravir potassium|mesh-list
111251744|NCT01529749|Losartan|losartan|mesh-list
111251745|NCT01529749|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111251746|NCT01529749|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111251747|NCT01529749|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111251748|NCT01529749|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111251749|NCT01529749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111251750|NCT01529749|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111251751|NCT01529749|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111251752|NCT01529749|Antiviral Agents|antiviral agents|mesh-ancestor
111251753|NCT01529749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111251754|NCT01529749|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111251755|NCT01529749|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111251756|NCT01529749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111251757|NCT01529515|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
111251758|NCT01529515|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
111251759|NCT01529515|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
111251760|NCT01529515|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111251761|NCT01528969|Sorbitol|sorbitol|mesh-list
111251762|NCT01528969|Cathartics|cathartics|mesh-ancestor
111251763|NCT01528969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111251764|NCT01514201|Temozolomide|temozolomide|mesh-list
111251765|NCT01514201|Veliparib|veliparib|mesh-list
111251766|NCT01514201|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111251767|NCT01514201|Alkylating Agents|alkylating agents|mesh-ancestor
111251768|NCT01514201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111251769|NCT01514201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111251770|NCT01514201|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111251771|NCT01514201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111251772|NCT02666664|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
111251773|NCT02666664|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111251774|NCT02666664|Antimetabolites|antimetabolites|mesh-ancestor
111251775|NCT02666664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111251776|NCT02666664|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111251777|NCT02666664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111251778|NCT02666664|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111251779|NCT02666664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111251780|NCT01528735|Ribavirin|ribavirin|mesh-list
111251781|NCT01528735|Antimetabolites|antimetabolites|mesh-ancestor
111251782|NCT01528735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111251783|NCT01528735|Antiviral Agents|antiviral agents|mesh-ancestor
111251784|NCT01528735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111251785|NCT02386488|Vortioxetine|vortioxetine|mesh-list
111251786|NCT02386488|Antidepressive Agents|antidepressive agents|mesh-ancestor
111251787|NCT02386488|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111251788|NCT02386488|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111251789|NCT02386488|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111251790|NCT02386488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111251791|NCT02386488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111251792|NCT02386488|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111251793|NCT02386488|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111251794|NCT02386488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111251795|NCT02386488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111251796|NCT02386488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111251797|NCT02386488|Serotonin Agents|serotonin agents|mesh-ancestor
111251798|NCT02386488|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111251799|NCT02386488|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111251800|NCT02386488|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111251801|NCT02386488|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111251802|NCT02661594|Moxifloxacin|moxifloxacin|mesh-list
111251803|NCT02661594|Amisulpride|amisulpride|mesh-list
111251804|NCT02661594|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111251805|NCT02661594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111251806|NCT02661594|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111251807|NCT02661594|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111251808|NCT02661594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111251809|NCT02661594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111251810|NCT02661594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111251811|NCT02661594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111251812|NCT02661594|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111251813|NCT02661594|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111251814|NCT02661594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111251815|NCT02661594|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111251816|NCT02661594|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111251817|NCT02661594|Dopamine Agents|dopamine agents|mesh-ancestor
111251818|NCT02661594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111251819|NCT02661594|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111251820|NCT02661594|Antidepressive Agents|antidepressive agents|mesh-ancestor
111251821|NCT02386566|Natalizumab|natalizumab|mesh-list
111251822|NCT02386566|Immunologic Factors|immunologic factors|mesh-ancestor
111251823|NCT02386566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111251824|NCT01528345|Fulvestrant|fulvestrant|mesh-list
111251825|NCT01528345|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111251826|NCT01528345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111251827|NCT01528345|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
111251828|NCT01528345|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111251829|NCT01528345|Hormone Antagonists|hormone antagonists|mesh-ancestor
111251830|NCT01528345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111251831|NCT01528345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111251832|NCT01511939|Diclofenac|diclofenac|mesh-list
111251833|NCT01511939|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
111251834|NCT01511939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
111251835|NCT01511939|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111251836|NCT01511939|Analgesics|analgesics|mesh-ancestor
111251837|NCT01511939|Sensory System Agents|sensory system agents|mesh-ancestor
111251838|NCT01511939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111251839|NCT01511939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111251840|NCT01511939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111251841|NCT01511939|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111251842|NCT01511939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111251843|NCT01511939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111251844|NCT02391480|Venetoclax|venetoclax|mesh-list
111251845|NCT02391480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111251846|NCT01576705|Leucovorin|leucovorin|mesh-list
111251847|NCT01576705|Folic Acid|folic acid|mesh-list
111251848|NCT01576705|Hormones|hormones|mesh-list
111251849|NCT01576705|Levoleucovorin|levoleucovorin|mesh-list
111251850|NCT01576705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111251851|NCT01576705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111251852|NCT01576705|Antidotes|antidotes|mesh-ancestor
111251853|NCT01576705|Protective Agents|protective agents|mesh-ancestor
111251854|NCT01576705|Vitamin B Complex|vitamin b complex|mesh-ancestor
111251855|NCT01576705|Vitamins|vitamins|mesh-ancestor
111251856|NCT01576705|Micronutrients|micronutrients|mesh-ancestor
111251857|NCT01576705|Hematinics|hematinics|mesh-ancestor
111251858|NCT02666430|Insulin Glargine|insulin glargine|mesh-list
111251859|NCT02666430|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111251860|NCT02666430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111251861|NCT02382666|Rolapitant|rolapitant|mesh-list
111251862|NCT02382666|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
111251863|NCT02382666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111251864|NCT02382666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111251865|NCT02382666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111251866|NCT00145041|Vincristine|vincristine|mesh-list
111251867|NCT00145041|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111251868|NCT00145041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111251869|NCT00145041|Tubulin Modulators|tubulin modulators|mesh-ancestor
111251870|NCT00145041|Antimitotic Agents|antimitotic agents|mesh-ancestor
111251871|NCT00145041|Mitosis Modulators|mitosis modulators|mesh-ancestor
111251872|NCT00145041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111251873|NCT04123561|Dexamethasone|dexamethasone|mesh-list
111251874|NCT04123561|Dexamethasone acetate|dexamethasone acetate|mesh-list
111251875|NCT04123561|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
111251876|NCT04123561|BB 1101|bb 1101|mesh-list
111251877|NCT04123561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111251878|NCT04123561|Antiemetics|antiemetics|mesh-ancestor
111251879|NCT04123561|Autonomic Agents|autonomic agents|mesh-ancestor
111251880|NCT04123561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111251881|NCT04123561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111251882|NCT04123561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111251883|NCT04123561|Glucocorticoids|glucocorticoids|mesh-ancestor
111251884|NCT04123561|Hormones|hormones|mesh-ancestor
111251885|NCT04123561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111251886|NCT04123561|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111251887|NCT04123561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111251888|NCT04123561|Protease Inhibitors|protease inhibitors|mesh-ancestor
111251889|NCT04123561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111251890|NCT04123561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111251891|NCT01510769|Febuxostat|febuxostat|mesh-list
111251892|NCT01510769|Lesinurad|lesinurad|mesh-list
111251893|NCT01510769|Gout Suppressants|gout suppressants|mesh-ancestor
111251894|NCT01510769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111251896|NCT02382354|Remifentanil|remifentanil|mesh-list
111251897|NCT02382354|Propofol|propofol|mesh-list
111251898|NCT02382354|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111251899|NCT02382354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111251900|NCT02382354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111251901|NCT02382354|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111251902|NCT02382354|Anesthetics, General|anesthetics, general|mesh-ancestor
111251903|NCT02382354|Anesthetics|anesthetics|mesh-ancestor
111251904|NCT02382354|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111251905|NCT02382354|Narcotics|narcotics|mesh-ancestor
111251906|NCT02382354|Analgesics|analgesics|mesh-ancestor
111251907|NCT02382354|Sensory System Agents|sensory system agents|mesh-ancestor
111251908|NCT02382354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111251909|NCT01510145|Travoprost|travoprost|mesh-list
111251910|NCT01510145|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111251911|NCT03027167|Aspirin|aspirin|mesh-list
111251912|NCT03027167|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111251913|NCT03027167|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111251914|NCT03027167|Analgesics|analgesics|mesh-ancestor
111251915|NCT03027167|Sensory System Agents|sensory system agents|mesh-ancestor
111251916|NCT03027167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111251917|NCT03027167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111251918|NCT03027167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111251919|NCT03027167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111251920|NCT03027167|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111251921|NCT03027167|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111251922|NCT03027167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111251923|NCT03027167|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111251924|NCT03027167|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111251925|NCT03027167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111251926|NCT03027167|Antipyretics|antipyretics|mesh-ancestor
111251927|NCT02382198|Glycopyrrolate|glycopyrrolate|mesh-list
111251928|NCT02382198|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111251929|NCT02382198|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111251930|NCT02382198|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111251931|NCT02382198|Cholinergic Agents|cholinergic agents|mesh-ancestor
111251932|NCT02382198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111251933|NCT02382198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111251934|NCT02382198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111251935|NCT02382432|Meperidine|meperidine|mesh-list
111251936|NCT02382432|Dexmedetomidine|dexmedetomidine|mesh-list
111251937|NCT02382432|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111251938|NCT02382432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111251939|NCT02382432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111251940|NCT02382432|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111251941|NCT02382432|Analgesics|analgesics|mesh-ancestor
111251942|NCT02382432|Sensory System Agents|sensory system agents|mesh-ancestor
111251943|NCT02382432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111251944|NCT02382432|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111251945|NCT02382432|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111251946|NCT02382432|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111251947|NCT02382432|Adrenergic Agents|adrenergic agents|mesh-ancestor
111251948|NCT02382432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111251949|NCT02382432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111251950|NCT02382432|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111251951|NCT02382432|Narcotics|narcotics|mesh-ancestor
111251952|NCT02382432|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111251953|NCT00145587|Antibodies|antibodies|mesh-list
111251954|NCT00145587|Immunologic Factors|immunologic factors|mesh-ancestor
111251955|NCT00145587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111251956|NCT04298463|Vancomycin|vancomycin|mesh-list
111251957|NCT04298463|Daptomycin|daptomycin|mesh-list
111251958|NCT04298463|Teicoplanin|teicoplanin|mesh-list
111251959|NCT04298463|Dalbavancin|dalbavancin|mesh-list
111251960|NCT04298463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111251961|NCT04298463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111251962|NCT02381964|Coenzyme Q10|coenzyme q10|mesh-list
111251963|NCT02381964|Vitamins|vitamins|mesh-ancestor
111251964|NCT02381964|Micronutrients|micronutrients|mesh-ancestor
111251965|NCT02381964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111251966|NCT01509053|Aripiprazole|aripiprazole|mesh-list
111251967|NCT01509053|Antidepressive Agents|antidepressive agents|mesh-ancestor
111251968|NCT01509053|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111251969|NCT01509053|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111251970|NCT01509053|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111251971|NCT01509053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111251972|NCT01509053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111251973|NCT01509053|Dopamine Agonists|dopamine agonists|mesh-ancestor
111251974|NCT01509053|Dopamine Agents|dopamine agents|mesh-ancestor
111251975|NCT01509053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111251976|NCT01509053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111251977|NCT01509053|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111251978|NCT01509053|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111251979|NCT01509053|Serotonin Agents|serotonin agents|mesh-ancestor
111251980|NCT01509053|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111251981|NCT01509053|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111251982|NCT01509053|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111251983|NCT01509053|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111251984|NCT01560403|Teduglutide|teduglutide|mesh-list
111251985|NCT01560403|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111251986|NCT01560403|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111251987|NCT01560403|Protective Agents|protective agents|mesh-ancestor
111251988|NCT01560403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111251989|NCT02100579|Bupivacaine|bupivacaine|mesh-list
111251990|NCT02100579|Anesthetics, Local|anesthetics, local|mesh-ancestor
111251991|NCT02100579|Anesthetics|anesthetics|mesh-ancestor
111251992|NCT02100579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111251993|NCT02100579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111251994|NCT02100579|Sensory System Agents|sensory system agents|mesh-ancestor
111251995|NCT02100579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111251996|NCT04251351|Acetaminophen|acetaminophen|mesh-list
111251997|NCT04251351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111251998|NCT04251351|Analgesics|analgesics|mesh-ancestor
111251999|NCT04251351|Sensory System Agents|sensory system agents|mesh-ancestor
111252000|NCT04251351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111252001|NCT04251351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111252002|NCT04251351|Antipyretics|antipyretics|mesh-ancestor
111252003|NCT02390700|Golimumab|golimumab|mesh-list
111252004|NCT02390700|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111252005|NCT02390700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111252006|NCT02390700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111252007|NCT02390700|Immunologic Factors|immunologic factors|mesh-ancestor
111252008|NCT02390700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111252009|NCT00284739|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
111252010|NCT00284739|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111252011|NCT00284739|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111252012|NCT00284739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111252013|NCT01527487|Cyclophosphamide|cyclophosphamide|mesh-list
111252014|NCT01527487|Docetaxel|docetaxel|mesh-list
111252015|NCT01527487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111252016|NCT01527487|Immunologic Factors|immunologic factors|mesh-ancestor
111252017|NCT01527487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111252018|NCT01527487|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111252019|NCT01527487|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111252020|NCT01527487|Alkylating Agents|alkylating agents|mesh-ancestor
111252021|NCT01527487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111252022|NCT01527487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111252023|NCT01527487|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111252024|NCT01527487|Tubulin Modulators|tubulin modulators|mesh-ancestor
111252025|NCT01527487|Antimitotic Agents|antimitotic agents|mesh-ancestor
111252026|NCT01527487|Mitosis Modulators|mitosis modulators|mesh-ancestor
111252027|NCT01506947|Darbepoetin alfa|darbepoetin alfa|mesh-list
111252028|NCT01506947|Hematinics|hematinics|mesh-ancestor
111252029|NCT00149643|Fluoxetine|fluoxetine|mesh-list
111252030|NCT00149643|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111252031|NCT00149643|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111252032|NCT00149643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111252033|NCT00149643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111252034|NCT00149643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111252035|NCT00149643|Serotonin Agents|serotonin agents|mesh-ancestor
111252036|NCT00149643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111252037|NCT00149643|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111252038|NCT00149643|Antidepressive Agents|antidepressive agents|mesh-ancestor
111252039|NCT00149643|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111252040|NCT00149643|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111252041|NCT00149643|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111252042|NCT00149643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111252043|NCT02381730|Aflibercept|aflibercept|mesh-list
111252044|NCT02381730|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111252045|NCT02381730|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111252046|NCT02381730|Growth Substances|growth substances|mesh-ancestor
111252047|NCT02381730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111252048|NCT02381730|Growth Inhibitors|growth inhibitors|mesh-ancestor
111252049|NCT02381730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111252050|NCT00149799|Escitalopram|escitalopram|mesh-list
111252051|NCT00149799|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111252052|NCT00149799|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111252053|NCT00149799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111252054|NCT00149799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111252055|NCT00149799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111252056|NCT00149799|Serotonin Agents|serotonin agents|mesh-ancestor
111252057|NCT00149799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111252058|NCT02390544|Melphalan|melphalan|mesh-list
111252059|NCT02390544|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111252060|NCT02390544|Alkylating Agents|alkylating agents|mesh-ancestor
111252061|NCT02390544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111252062|NCT02390544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111252063|NCT02390544|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111252064|NCT02390544|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111252065|NCT02390544|Immunologic Factors|immunologic factors|mesh-ancestor
111252066|NCT02390544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111252067|NCT01790997|Aspirin|aspirin|mesh-list
111252068|NCT01790997|Clopidogrel|clopidogrel|mesh-list
111252069|NCT01790997|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111252070|NCT01790997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111252071|NCT01790997|Analgesics|analgesics|mesh-ancestor
111252072|NCT01790997|Sensory System Agents|sensory system agents|mesh-ancestor
111252073|NCT01790997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111252074|NCT01790997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111252075|NCT01790997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111252076|NCT01790997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111252077|NCT01790997|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111252078|NCT01790997|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111252079|NCT01790997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111252080|NCT01790997|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111252081|NCT01790997|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111252082|NCT01790997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111252083|NCT01790997|Antipyretics|antipyretics|mesh-ancestor
111252084|NCT01790997|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111252085|NCT01790997|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111252086|NCT01790997|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111252087|NCT01790997|Purinergic Agents|purinergic agents|mesh-ancestor
111252088|NCT01790997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111252089|NCT02385474|Fluorides|fluorides|mesh-list
111252090|NCT02385474|Cariostatic Agents|cariostatic agents|mesh-ancestor
111252091|NCT02385474|Protective Agents|protective agents|mesh-ancestor
111252092|NCT02385474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111252093|NCT02390310|Lidocaine|lidocaine|mesh-list
111252094|NCT02390310|Prilocaine|prilocaine|mesh-list
111252095|NCT02390310|Anesthetics|anesthetics|mesh-list
111252096|NCT02390310|Anesthetics, Local|anesthetics, local|mesh-ancestor
111252097|NCT02390310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111252098|NCT02390310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111252099|NCT02390310|Sensory System Agents|sensory system agents|mesh-ancestor
111252100|NCT02390310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111252101|NCT02390310|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111252102|NCT02390310|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111252103|NCT02390310|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111252104|NCT02390310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111102493|NCT04480775|Hormones|hormones|mesh-ancestor
111252105|NCT02390310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111252106|NCT02381184|Clomiphene|clomiphene|mesh-list
111252107|NCT02381184|Enclomiphene|enclomiphene|mesh-list
111252108|NCT02381184|Zuclomiphene|zuclomiphene|mesh-list
111252109|NCT02381184|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111252110|NCT02381184|Hormone Antagonists|hormone antagonists|mesh-ancestor
111252111|NCT02381184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111252112|NCT02381184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111252113|NCT02381184|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111252114|NCT02381184|Fertility Agents|fertility agents|mesh-ancestor
111252115|NCT02381184|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111252116|NCT02381184|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111252117|NCT02381184|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111252118|NCT02381028|Emollients|emollients|mesh-list
110976432|NCT04642131|Caffeine|caffeine|mesh-list
111252119|NCT02381028|Dermatologic Agents|dermatologic agents|mesh-ancestor
111252121|NCT00326781|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111252122|NCT00326781|Autonomic Agents|autonomic agents|mesh-ancestor
111252123|NCT00326781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111252124|NCT00326781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111252125|NCT00326781|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111252126|NCT00326781|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111252127|NCT00326781|Cholinergic Agents|cholinergic agents|mesh-ancestor
111252128|NCT00326781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111252129|NCT00326781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111252130|NCT02385396|Folic Acid|folic acid|mesh-list
111252131|NCT02385396|Inositol|inositol|mesh-list
111252132|NCT02385396|Hematinics|hematinics|mesh-ancestor
111252133|NCT02385396|Vitamin B Complex|vitamin b complex|mesh-ancestor
111252134|NCT02385396|Vitamins|vitamins|mesh-ancestor
111252135|NCT02385396|Micronutrients|micronutrients|mesh-ancestor
111252136|NCT02385396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111252137|NCT05445414|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111252138|NCT05445414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111252139|NCT02979405|Phenylephrine|phenylephrine|mesh-list
111252140|NCT02979405|Oxymetazoline|oxymetazoline|mesh-list
111252141|NCT02979405|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111252142|NCT02979405|Mydriatics|mydriatics|mesh-ancestor
111252143|NCT02979405|Autonomic Agents|autonomic agents|mesh-ancestor
111252144|NCT02979405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111252145|NCT02979405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111252146|NCT02979405|Sympathomimetics|sympathomimetics|mesh-ancestor
111252147|NCT02979405|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111252148|NCT02979405|Nasal Decongestants|nasal decongestants|mesh-ancestor
111252149|NCT02979405|Respiratory System Agents|respiratory system agents|mesh-ancestor
111252150|NCT02979405|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111252151|NCT02979405|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111252152|NCT02979405|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111252153|NCT02979405|Adrenergic Agents|adrenergic agents|mesh-ancestor
111252154|NCT02979405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111252155|NCT02979405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111252156|NCT02979405|Protective Agents|protective agents|mesh-ancestor
111252157|NCT01791231|Canagliflozin|canagliflozin|mesh-list
111252158|NCT01791231|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111252159|NCT01791231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111252160|NCT01791231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111252161|NCT01791231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111252162|NCT01791309|Panitumumab|panitumumab|mesh-list
111252163|NCT01791309|Vemurafenib|vemurafenib|mesh-list
111252164|NCT01791309|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111252165|NCT01791309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111252166|NCT01791309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111252167|NCT01791309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111252168|NCT01791309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111252169|NCT00329433|Heparin|heparin|mesh-list
111252170|NCT00329433|Desirudin|desirudin|mesh-list
111252171|NCT00329433|Anticoagulants|anticoagulants|mesh-ancestor
111252172|NCT00329433|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111252173|NCT00329433|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111252174|NCT00329433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111252175|NCT03105960|Chlorhexidine|chlorhexidine|mesh-list
111252176|NCT03105960|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111252177|NCT03105960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111252178|NCT03105960|Disinfectants|disinfectants|mesh-ancestor
111252179|NCT02389842|Palbociclib|palbociclib|mesh-list
111252180|NCT02389842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111252181|NCT02389842|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111252182|NCT02389842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111252183|NCT02389842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111252184|NCT04932096|Melatonin|melatonin|mesh-list
111252185|NCT04932096|Antioxidants|antioxidants|mesh-ancestor
111252186|NCT04932096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111252187|NCT04932096|Protective Agents|protective agents|mesh-ancestor
111252188|NCT04932096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111252189|NCT04932096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111252190|NCT00289653|Nicotine|nicotine|mesh-list
111252191|NCT00289653|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110959164|NCT05681182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111252192|NCT00289653|Autonomic Agents|autonomic agents|mesh-ancestor
111252193|NCT00289653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111252194|NCT00289653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111252195|NCT00289653|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111252196|NCT00289653|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111252197|NCT00289653|Cholinergic Agents|cholinergic agents|mesh-ancestor
111252198|NCT00289653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111252199|NCT00289653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111252200|NCT00291135|Letrozole|letrozole|mesh-list
111252201|NCT00291135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111252202|NCT00291135|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111252203|NCT00291135|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111252204|NCT00291135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111252205|NCT00291135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111252206|NCT00291135|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111252207|NCT00291135|Hormone Antagonists|hormone antagonists|mesh-ancestor
111252208|NCT00291135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111252209|NCT00291135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111252210|NCT02103855|Abatacept|abatacept|mesh-list
111252211|NCT02103855|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111252212|NCT02103855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111252213|NCT02103855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111252214|NCT02103855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111252215|NCT02103855|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111252216|NCT02103855|Immunologic Factors|immunologic factors|mesh-ancestor
111252217|NCT02103855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111252218|NCT02103855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111252219|NCT03706053|Midodrine|midodrine|mesh-list
111252220|NCT03706053|Sympathomimetics|sympathomimetics|mesh-ancestor
111252221|NCT03706053|Autonomic Agents|autonomic agents|mesh-ancestor
111252222|NCT03706053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111252223|NCT03706053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111252224|NCT03706053|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111252225|NCT03706053|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111252226|NCT03706053|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111252227|NCT03706053|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111252228|NCT03706053|Adrenergic Agents|adrenergic agents|mesh-ancestor
111252229|NCT03706053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111252230|NCT03706053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111252231|NCT01504841|Etravirine|etravirine|mesh-list
111252232|NCT01504841|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111252233|NCT01504841|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111252234|NCT01504841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111252235|NCT01504841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111252236|NCT01504841|Antiviral Agents|antiviral agents|mesh-ancestor
111252237|NCT01504841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111252238|NCT00330915|Pemetrexed|pemetrexed|mesh-list
111252239|NCT00330915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111252240|NCT00330915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111252241|NCT00330915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111252242|NCT00330915|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111252243|NCT00330915|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111252244|NCT03026933|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111252245|NCT03026933|Calcium|calcium|mesh-list
111252246|NCT03026933|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111252247|NCT03026933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111252248|NCT03026933|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111252249|NCT03026933|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111252250|NCT03026933|Antimetabolites|antimetabolites|mesh-ancestor
111252251|NCT03026933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111252252|NCT03026933|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111252253|NCT03026933|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111252254|NCT03026933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111252255|NCT01502423|Adalimumab|adalimumab|mesh-list
111252256|NCT01502423|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111252257|NCT01502423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111252258|NCT01502423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111252259|NCT04861584|Gemcitabine|gemcitabine|mesh-list
111252260|NCT04861584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111252261|NCT04861584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111252262|NCT04861584|Antimetabolites|antimetabolites|mesh-ancestor
111252263|NCT04861584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111252264|NCT02388750|Palonosetron|palonosetron|mesh-list
111252265|NCT02388750|Antiemetics|antiemetics|mesh-ancestor
110976577|NCT02163434|Gabapentin|gabapentin|mesh-list
111252266|NCT02388750|Autonomic Agents|autonomic agents|mesh-ancestor
111252267|NCT02388750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111252268|NCT02388750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111252269|NCT02388750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111252270|NCT02388750|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111252271|NCT02388750|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111252272|NCT02388750|Serotonin Agents|serotonin agents|mesh-ancestor
111252273|NCT02388750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111252274|NCT02388750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111252275|NCT02388594|Cyclophosphamide|cyclophosphamide|mesh-list
111252276|NCT02388594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111252277|NCT02388594|Immunologic Factors|immunologic factors|mesh-ancestor
111252278|NCT02388594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111252279|NCT02388594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111252280|NCT02388594|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111252281|NCT02388594|Alkylating Agents|alkylating agents|mesh-ancestor
111252282|NCT02388594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111252283|NCT02388594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111252284|NCT02388594|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111252285|NCT01500317|Oxycodone|oxycodone|mesh-list
111252286|NCT01500317|Tapentadol|tapentadol|mesh-list
111252287|NCT01500317|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111252288|NCT01500317|Narcotics|narcotics|mesh-ancestor
111252289|NCT01500317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111252290|NCT01500317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111252291|NCT01500317|Analgesics|analgesics|mesh-ancestor
111252292|NCT01500317|Sensory System Agents|sensory system agents|mesh-ancestor
111252293|NCT01500317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111252294|NCT01500317|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111252295|NCT01500317|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111252296|NCT01500317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111252297|NCT01500317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111252298|NCT01500317|Adrenergic Agents|adrenergic agents|mesh-ancestor
111252299|NCT01500317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111252300|NCT02379546|Desflurane|desflurane|mesh-list
111252301|NCT02379546|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111252302|NCT02379546|Anesthetics, General|anesthetics, general|mesh-ancestor
111252303|NCT02379546|Anesthetics|anesthetics|mesh-ancestor
111252304|NCT02379546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111252305|NCT02379546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111252306|NCT00332163|Irinotecan|irinotecan|mesh-list
111252307|NCT00332163|Panitumumab|panitumumab|mesh-list
111252308|NCT00332163|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111252309|NCT00332163|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111252310|NCT00332163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111252311|NCT00332163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111252312|NCT00332163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111252313|NCT00332163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111252314|NCT02379000|Triamcinolone|triamcinolone|mesh-list
111252315|NCT02379000|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
111252316|NCT02379000|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
111252317|NCT02379000|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
111252318|NCT02379000|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111252319|NCT02379000|Glucocorticoids|glucocorticoids|mesh-ancestor
111252320|NCT02379000|Hormones|hormones|mesh-ancestor
111102500|NCT02416817|Hemostatics|hemostatics|mesh-ancestor
111252321|NCT02379000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111252322|NCT02379000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111252323|NCT02379000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111252324|NCT02379000|Immunologic Factors|immunologic factors|mesh-ancestor
111252325|NCT02379000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111252326|NCT02379000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111252327|NCT00333177|Risperidone|risperidone|mesh-list
111252328|NCT00333177|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111252329|NCT00333177|Serotonin Agents|serotonin agents|mesh-ancestor
111252330|NCT00333177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111252331|NCT00333177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111252332|NCT00333177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111252333|NCT00333177|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111252334|NCT00333177|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111252335|NCT00333177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111252336|NCT00333177|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111252337|NCT00333177|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111252338|NCT00333177|Dopamine Agents|dopamine agents|mesh-ancestor
111252339|NCT02379156|Midodrine|midodrine|mesh-list
111252340|NCT02379156|Sympathomimetics|sympathomimetics|mesh-ancestor
111252341|NCT02379156|Autonomic Agents|autonomic agents|mesh-ancestor
111252342|NCT02379156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111252343|NCT02379156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111252344|NCT02379156|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111252345|NCT02379156|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111252346|NCT02379156|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111252347|NCT02379156|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111252348|NCT02379156|Adrenergic Agents|adrenergic agents|mesh-ancestor
111252349|NCT02379156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111252350|NCT02379156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111252351|NCT00335283|Lansoprazole|lansoprazole|mesh-list
111252352|NCT00335283|Dexlansoprazole|dexlansoprazole|mesh-list
111252353|NCT00335283|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111252354|NCT00335283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111252355|NCT00335283|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111252356|NCT00335283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111252357|NCT00335283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111252358|NCT01500083|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
111252359|NCT01500083|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111252360|NCT01500083|Alkylating Agents|alkylating agents|mesh-ancestor
111252361|NCT01500083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111252362|NCT01500083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111252363|NCT02779257|Diazoxide|diazoxide|mesh-list
111252364|NCT02779257|Pasireotide|pasireotide|mesh-list
111252365|NCT02779257|Hormones|hormones|mesh-ancestor
111252366|NCT02779257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111252367|NCT02779257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111252368|NCT02779257|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111252369|NCT02779257|Vasodilator Agents|vasodilator agents|mesh-ancestor
111252370|NCT00295503|Bevacizumab|bevacizumab|mesh-list
111252371|NCT00295503|Pemetrexed|pemetrexed|mesh-list
111252372|NCT00295503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111252373|NCT00295503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111252374|NCT00295503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111252375|NCT00295503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111252376|NCT00295503|Growth Substances|growth substances|mesh-ancestor
111252377|NCT00295503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111252378|NCT00295503|Growth Inhibitors|growth inhibitors|mesh-ancestor
111252379|NCT00295503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111252380|NCT00295503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111252381|NCT00295503|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111252382|NCT00295503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111252383|NCT02371590|Lenalidomide|lenalidomide|mesh-list
111252384|NCT02371590|Obinutuzumab|obinutuzumab|mesh-list
111252385|NCT02371590|Immunologic Factors|immunologic factors|mesh-ancestor
111252386|NCT02371590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111252387|NCT02371590|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111252388|NCT02371590|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111252389|NCT02371590|Growth Substances|growth substances|mesh-ancestor
111252390|NCT02371590|Growth Inhibitors|growth inhibitors|mesh-ancestor
111252391|NCT02371590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111252392|NCT02371590|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111252393|NCT00298155|Ketoconazole|ketoconazole|mesh-list
111252394|NCT00298155|Goserelin|goserelin|mesh-list
111252395|NCT00298155|Bicalutamide|bicalutamide|mesh-list
111252396|NCT00298155|Dutasteride|dutasteride|mesh-list
111252397|NCT00298155|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111252398|NCT00298155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111252399|NCT00298155|Antifungal Agents|antifungal agents|mesh-ancestor
111252400|NCT00298155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111252401|NCT00298155|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111252402|NCT00298155|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111252403|NCT00298155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111252404|NCT00298155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111252405|NCT00298155|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111252406|NCT00298155|Hormone Antagonists|hormone antagonists|mesh-ancestor
111252407|NCT00298155|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111252408|NCT00298155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111252409|NCT00298155|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111252410|NCT00298155|Androgen Antagonists|androgen antagonists|mesh-ancestor
111252411|NCT00298155|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
110976729|NCT03050814|Vitamins|vitamins|mesh-ancestor
111252412|NCT01499849|Dexamethasone|dexamethasone|mesh-list
111252413|NCT01499849|Granisetron|granisetron|mesh-list
111252414|NCT01499849|Rolapitant|rolapitant|mesh-list
111252415|NCT01499849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111252416|NCT01499849|Antiemetics|antiemetics|mesh-ancestor
111252417|NCT01499849|Autonomic Agents|autonomic agents|mesh-ancestor
111252418|NCT01499849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111252419|NCT01499849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111252420|NCT01499849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111252421|NCT01499849|Glucocorticoids|glucocorticoids|mesh-ancestor
111252422|NCT01499849|Hormones|hormones|mesh-ancestor
111252423|NCT01499849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111252424|NCT01499849|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111252425|NCT01499849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111252426|NCT01499849|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111252427|NCT01499849|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111252428|NCT01499849|Serotonin Agents|serotonin agents|mesh-ancestor
111252429|NCT01499849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111252430|NCT01499849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111252431|NCT01499849|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
111252432|NCT00298233|Oseltamivir|oseltamivir|mesh-list
111252433|NCT00298233|Antiviral Agents|antiviral agents|mesh-ancestor
111252434|NCT00298233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111252435|NCT00298233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111252436|NCT00298233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111252437|NCT02376972|Rifaximin|rifaximin|mesh-list
111252438|NCT02376972|Metronidazole|metronidazole|mesh-list
111252439|NCT02376972|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111252440|NCT02376972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111252441|NCT02376972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111252442|NCT02376972|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111252443|NCT02376972|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111252444|NCT02378532|Chloroquine|chloroquine|mesh-list
111252445|NCT02378532|Temozolomide|temozolomide|mesh-list
111252446|NCT02378532|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111252447|NCT02378532|Alkylating Agents|alkylating agents|mesh-ancestor
111252448|NCT02378532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111252449|NCT02378532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111252450|NCT02378532|Amebicides|amebicides|mesh-ancestor
111252451|NCT02378532|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111252452|NCT02378532|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111252453|NCT02378532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111252454|NCT02378532|Antimalarials|antimalarials|mesh-ancestor
111252455|NCT02378532|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111252456|NCT01498679|Fluticasone|fluticasone|mesh-list
111252457|NCT01498679|Xhance|xhance|mesh-list
111252458|NCT01498679|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111252459|NCT01498679|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111252460|NCT01498679|Autonomic Agents|autonomic agents|mesh-ancestor
111252461|NCT01498679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111252462|NCT01498679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111252463|NCT01498679|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111252464|NCT01498679|Respiratory System Agents|respiratory system agents|mesh-ancestor
111252465|NCT01498679|Dermatologic Agents|dermatologic agents|mesh-ancestor
111252466|NCT01498679|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111252467|NCT01000467|Probucol|probucol|mesh-list
111252468|NCT01000467|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111252469|NCT01000467|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111252470|NCT01000467|Antimetabolites|antimetabolites|mesh-ancestor
111252471|NCT01000467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111252472|NCT01000467|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111252473|NCT01000467|Antioxidants|antioxidants|mesh-ancestor
111252474|NCT01000467|Protective Agents|protective agents|mesh-ancestor
111252475|NCT01000467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111252476|NCT00198315|Bleomycin|bleomycin|mesh-list
111252477|NCT00198315|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111252478|NCT00198315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111252479|NCT01559389|Solifenacin Succinate|solifenacin succinate|mesh-list
111252480|NCT01559389|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111252481|NCT01559389|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111252482|NCT01559389|Cholinergic Agents|cholinergic agents|mesh-ancestor
111252483|NCT01559389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111252484|NCT01559389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111252485|NCT01559389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111252486|NCT01559389|Urological Agents|urological agents|mesh-ancestor
111252487|NCT01526551|Vaccines|vaccines|mesh-list
111252488|NCT01526551|Immunologic Factors|immunologic factors|mesh-ancestor
111252489|NCT01526551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111252490|NCT04540692|Paclitaxel|paclitaxel|mesh-list
111252491|NCT04540692|Docetaxel|docetaxel|mesh-list
111252492|NCT04540692|Cyclophosphamide|cyclophosphamide|mesh-list
111252493|NCT04540692|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111252494|NCT04540692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111252495|NCT04540692|Tubulin Modulators|tubulin modulators|mesh-ancestor
111252496|NCT04540692|Antimitotic Agents|antimitotic agents|mesh-ancestor
111252497|NCT04540692|Mitosis Modulators|mitosis modulators|mesh-ancestor
111252498|NCT04540692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111252499|NCT04540692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111252500|NCT04540692|Immunologic Factors|immunologic factors|mesh-ancestor
111252501|NCT04540692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111252502|NCT04540692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111252503|NCT04540692|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111252504|NCT04540692|Alkylating Agents|alkylating agents|mesh-ancestor
111252505|NCT04540692|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111252506|NCT00343083|Paclitaxel|paclitaxel|mesh-list
111252507|NCT00343083|Carboplatin|carboplatin|mesh-list
111252508|NCT00343083|Cetuximab|cetuximab|mesh-list
111252509|NCT00343083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111252510|NCT00343083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111252511|NCT00343083|Tubulin Modulators|tubulin modulators|mesh-ancestor
111252512|NCT00343083|Antimitotic Agents|antimitotic agents|mesh-ancestor
111252513|NCT00343083|Mitosis Modulators|mitosis modulators|mesh-ancestor
111252514|NCT00343083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111252515|NCT00343083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111252516|NCT02376426|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
111252517|NCT02376426|Antiviral Agents|antiviral agents|mesh-ancestor
111252518|NCT02376426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111252519|NCT00343785|Cyclosporine|cyclosporine|mesh-list
111252520|NCT00343785|Cyclophosphamide|cyclophosphamide|mesh-list
111252521|NCT00343785|Methotrexate|methotrexate|mesh-list
111252522|NCT00343785|Cyclosporins|cyclosporins|mesh-list
111252523|NCT00343785|Thymoglobulin|thymoglobulin|mesh-list
111252524|NCT00343785|Antilymphocyte Serum|antilymphocyte serum|mesh-list
111252525|NCT00343785|Immunoglobulins|immunoglobulins|mesh-list
111252526|NCT00343785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111252527|NCT00343785|Immunologic Factors|immunologic factors|mesh-ancestor
111252528|NCT00343785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111252529|NCT00343785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111252530|NCT00343785|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111252531|NCT00343785|Alkylating Agents|alkylating agents|mesh-ancestor
111252532|NCT00343785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111252533|NCT00343785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111252534|NCT00343785|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111252535|NCT00343785|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111252536|NCT00343785|Abortifacient Agents|abortifacient agents|mesh-ancestor
111252537|NCT00343785|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111252538|NCT00343785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111252539|NCT00343785|Antimetabolites|antimetabolites|mesh-ancestor
111252540|NCT00343785|Dermatologic Agents|dermatologic agents|mesh-ancestor
111252541|NCT00343785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111252542|NCT00343785|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111252543|NCT00343785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111252544|NCT00343785|Antifungal Agents|antifungal agents|mesh-ancestor
111252545|NCT00343785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111252546|NCT00343785|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111252547|NCT00343863|Dexamethasone|dexamethasone|mesh-list
111252548|NCT00343863|Cyclophosphamide|cyclophosphamide|mesh-list
111252549|NCT00343863|Doxorubicin|doxorubicin|mesh-list
111252550|NCT00343863|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111252551|NCT00343863|Ondansetron|ondansetron|mesh-list
111252552|NCT00343863|Palonosetron|palonosetron|mesh-list
111252553|NCT00343863|Antiemetics|antiemetics|mesh-list
111252554|NCT00343863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111252555|NCT00343863|Immunologic Factors|immunologic factors|mesh-ancestor
111252556|NCT00343863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111252557|NCT00343863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111252558|NCT00343863|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111252559|NCT00343863|Alkylating Agents|alkylating agents|mesh-ancestor
111252560|NCT00343863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111252561|NCT00343863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111252562|NCT00343863|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110976920|NCT04604704|Naltrexone|naltrexone|mesh-list
111252563|NCT00343863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111252564|NCT00343863|Autonomic Agents|autonomic agents|mesh-ancestor
111252565|NCT00343863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111252566|NCT00343863|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111252567|NCT00343863|Glucocorticoids|glucocorticoids|mesh-ancestor
111252568|NCT00343863|Hormones|hormones|mesh-ancestor
111252569|NCT00343863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111252570|NCT00343863|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111252571|NCT00343863|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111252572|NCT00343863|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111252573|NCT00343863|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111252574|NCT00343863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111252575|NCT00343863|Antipruritics|antipruritics|mesh-ancestor
111252576|NCT00343863|Dermatologic Agents|dermatologic agents|mesh-ancestor
111252577|NCT00343863|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111252578|NCT00343863|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111252579|NCT00343863|Serotonin Agents|serotonin agents|mesh-ancestor
111252580|NCT00343863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111252581|NCT00344175|Simvastatin|simvastatin|mesh-list
111252582|NCT00344175|Pitavastatin|pitavastatin|mesh-list
111252583|NCT00344175|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111252584|NCT00344175|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111252585|NCT00344175|Antimetabolites|antimetabolites|mesh-ancestor
111252586|NCT00344175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111252587|NCT00344175|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111252588|NCT00344175|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111252589|NCT00344175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111252590|NCT00345033|Aripiprazole|aripiprazole|mesh-list
111252591|NCT00345033|Antidepressive Agents|antidepressive agents|mesh-ancestor
111252592|NCT00345033|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111252593|NCT00345033|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111252594|NCT00345033|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111252595|NCT00345033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111252596|NCT00345033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111252597|NCT00345033|Dopamine Agonists|dopamine agonists|mesh-ancestor
111252598|NCT00345033|Dopamine Agents|dopamine agents|mesh-ancestor
111252599|NCT00345033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111252600|NCT00345033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111252601|NCT00345033|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111252602|NCT00345033|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111252603|NCT00345033|Serotonin Agents|serotonin agents|mesh-ancestor
111252604|NCT00345033|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111252605|NCT00345033|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111252606|NCT00345033|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111252607|NCT00345033|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111252608|NCT00345969|Testosterone|testosterone|mesh-list
111252609|NCT00345969|Androgens|androgens|mesh-ancestor
111252610|NCT00345969|Hormones|hormones|mesh-ancestor
111252611|NCT00345969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111252612|NCT00345969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111252613|NCT01498445|Decitabine|decitabine|mesh-list
111252614|NCT01498445|Dasatinib|dasatinib|mesh-list
111252615|NCT01498445|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111252616|NCT01498445|Antimetabolites|antimetabolites|mesh-ancestor
111252617|NCT01498445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111252618|NCT01498445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111252619|NCT01498445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111252620|NCT01498445|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111252621|NCT01525615|Tiotropium Bromide|tiotropium bromide|mesh-list
111252622|NCT01525615|Olodaterol|olodaterol|mesh-list
111252623|NCT01525615|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111252624|NCT01525615|Autonomic Agents|autonomic agents|mesh-ancestor
111252625|NCT01525615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111252626|NCT01525615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111252627|NCT01525615|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111252628|NCT01525615|Respiratory System Agents|respiratory system agents|mesh-ancestor
111252629|NCT01525615|Parasympatholytics|parasympatholytics|mesh-ancestor
111252630|NCT01525615|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111252631|NCT01525615|Cholinergic Agents|cholinergic agents|mesh-ancestor
111252632|NCT01525615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111252633|NCT01525615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111252634|NCT00309465|Insulin|insulin|mesh-list
111252635|NCT00309465|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111252636|NCT00309465|Insulin Glargine|insulin glargine|mesh-list
111252637|NCT00309465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111252638|NCT00309465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111252639|NCT01791699|Moxonidine|moxonidine|mesh-list
111252640|NCT01791699|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111252641|NCT00302133|Naltrexone|naltrexone|mesh-list
111252642|NCT00302133|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111252643|NCT00302133|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111252644|NCT00302133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111252645|NCT00302133|Sensory System Agents|sensory system agents|mesh-ancestor
111252646|NCT00302133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111252647|NCT01525225|Metformin|metformin|mesh-list
111252648|NCT01525225|Saxagliptin|saxagliptin|mesh-list
111252649|NCT01525225|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111252650|NCT01525225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111252651|NCT01525225|Incretins|incretins|mesh-ancestor
111252652|NCT01525225|Hormones|hormones|mesh-ancestor
111252653|NCT01525225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111252654|NCT01525225|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111252655|NCT01525225|Protease Inhibitors|protease inhibitors|mesh-ancestor
111252656|NCT01525225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111252657|NCT01525225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111252658|NCT00304161|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
111252659|NCT00304161|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111252660|NCT00304161|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111252661|NCT00304161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111252662|NCT00304161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111252663|NCT00304161|Adrenergic Agents|adrenergic agents|mesh-ancestor
111252664|NCT00304161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111252665|NCT00304161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111252666|NCT02660580|Adalimumab|adalimumab|mesh-list
111252667|NCT02660580|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111252668|NCT02660580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111252669|NCT02660580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111252670|NCT01524991|Gemcitabine|gemcitabine|mesh-list
111252671|NCT01524991|Ipilimumab|ipilimumab|mesh-list
111252672|NCT01524991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111252673|NCT01524991|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111252674|NCT01524991|Antimetabolites|antimetabolites|mesh-ancestor
111252675|NCT01524991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111252676|NCT01524991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111252677|NCT01524991|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111252678|NCT04039230|Talazoparib|talazoparib|mesh-list
111252679|NCT04039230|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
111252680|NCT04039230|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111252681|NCT04039230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111252682|NCT04039230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111252683|NCT04039230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111252684|NCT04039230|Immunoconjugates|immunoconjugates|mesh-ancestor
111252685|NCT04039230|Immunologic Factors|immunologic factors|mesh-ancestor
111252686|NCT04039230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111252687|NCT01524913|Hyaluronic Acid|hyaluronic acid|mesh-list
111252688|NCT01524913|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111252689|NCT01524913|Immunologic Factors|immunologic factors|mesh-ancestor
111252690|NCT01524913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111252691|NCT01524913|Viscosupplements|viscosupplements|mesh-ancestor
111252692|NCT01524913|Protective Agents|protective agents|mesh-ancestor
111252693|NCT02376192|Phenylephrine|phenylephrine|mesh-list
111252694|NCT02376192|Oxymetazoline|oxymetazoline|mesh-list
111252695|NCT02376192|Ephedrine|ephedrine|mesh-list
111252696|NCT02376192|Bupivacaine|bupivacaine|mesh-list
111252697|NCT02376192|Anesthetics, Local|anesthetics, local|mesh-ancestor
111252698|NCT02376192|Anesthetics|anesthetics|mesh-ancestor
111252699|NCT02376192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111252700|NCT02376192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111252701|NCT02376192|Sensory System Agents|sensory system agents|mesh-ancestor
111252702|NCT02376192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111252703|NCT02376192|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111252704|NCT02376192|Mydriatics|mydriatics|mesh-ancestor
111252705|NCT02376192|Autonomic Agents|autonomic agents|mesh-ancestor
111252706|NCT02376192|Sympathomimetics|sympathomimetics|mesh-ancestor
111252707|NCT02376192|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111252708|NCT02376192|Nasal Decongestants|nasal decongestants|mesh-ancestor
111252709|NCT02376192|Respiratory System Agents|respiratory system agents|mesh-ancestor
111252710|NCT02376192|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111252711|NCT02376192|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111252712|NCT02376192|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110977058|NCT02639910|Venetoclax|venetoclax|mesh-list
111252713|NCT02376192|Adrenergic Agents|adrenergic agents|mesh-ancestor
111252714|NCT02376192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111252715|NCT02376192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111252716|NCT02376192|Protective Agents|protective agents|mesh-ancestor
111252717|NCT02376192|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111252718|NCT02375880|Gemcitabine|gemcitabine|mesh-list
111252719|NCT02375880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111252720|NCT02375880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111252721|NCT02375880|Antimetabolites|antimetabolites|mesh-ancestor
111252722|NCT02375880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111252723|NCT01524679|Interferons|interferons|mesh-list
111252724|NCT01524679|Interferon-alpha|interferon-alpha|mesh-list
111252725|NCT01524679|Interferon alpha-2|interferon alpha-2|mesh-list
111252726|NCT01524679|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
111252727|NCT01524679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111252728|NCT01524679|Antiviral Agents|antiviral agents|mesh-ancestor
111252729|NCT01524679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111252730|NCT01524679|Immunologic Factors|immunologic factors|mesh-ancestor
111252731|NCT01524679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111252732|NCT02365272|Amikacin|amikacin|mesh-list
111252733|NCT02365272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111252734|NCT02365272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111252735|NCT02369250|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111252736|NCT02369250|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111252737|NCT02369250|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111252738|NCT02369250|Antimetabolites|antimetabolites|mesh-ancestor
111252739|NCT02369250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111252740|NCT02369250|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111252741|NCT02369250|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111252742|NCT02369250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111252743|NCT04645602|Pembrolizumab|pembrolizumab|mesh-list
111252744|NCT04645602|Lenvatinib|lenvatinib|mesh-list
111252745|NCT04645602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111252746|NCT04645602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111252747|NCT04645602|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111252748|NCT04645602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111252749|NCT04645602|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111252750|NCT04645602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111252751|NCT01880541|Anesthetics|anesthetics|mesh-list
111252752|NCT01880541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111252753|NCT01880541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111252754|NCT02368860|Capecitabine|capecitabine|mesh-list
111252755|NCT02368860|Oxaliplatin|oxaliplatin|mesh-list
111252756|NCT02368860|Irinotecan|irinotecan|mesh-list
111252757|NCT02368860|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111252758|NCT02368860|Antimetabolites|antimetabolites|mesh-ancestor
110681238|NCT00047060|Immunologic Factors|immunologic factors|mesh-ancestor
111252759|NCT02368860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111252760|NCT02368860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111252761|NCT02368860|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111252762|NCT02368860|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111252763|NCT02368860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111252764|NCT02375646|Heparin|heparin|mesh-list
111252765|NCT02375646|Enoxaparin|enoxaparin|mesh-list
111252766|NCT02375646|Warfarin|warfarin|mesh-list
111252767|NCT02375646|Anticoagulants|anticoagulants|mesh-ancestor
111252768|NCT02375646|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111252769|NCT02375646|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111252770|NCT02375646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111252771|NCT01524289|Anacetrapib|anacetrapib|mesh-list
111252772|NCT01524289|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111252773|NCT01524289|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111252774|NCT01524289|Antimetabolites|antimetabolites|mesh-ancestor
111252775|NCT01524289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111252776|NCT01524289|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111252777|NCT01498289|Leucovorin|leucovorin|mesh-list
111252778|NCT01498289|Docetaxel|docetaxel|mesh-list
111252779|NCT01498289|Fluorouracil|fluorouracil|mesh-list
111252780|NCT01498289|Oxaliplatin|oxaliplatin|mesh-list
111252781|NCT01498289|Irinotecan|irinotecan|mesh-list
111252782|NCT01498289|Calcium|calcium|mesh-list
111252783|NCT01498289|Levoleucovorin|levoleucovorin|mesh-list
111252784|NCT01498289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111252785|NCT01498289|Tubulin Modulators|tubulin modulators|mesh-ancestor
111252786|NCT01498289|Antimitotic Agents|antimitotic agents|mesh-ancestor
111252787|NCT01498289|Mitosis Modulators|mitosis modulators|mesh-ancestor
111252788|NCT01498289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111252789|NCT01498289|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111252790|NCT01498289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111252791|NCT01498289|Antimetabolites|antimetabolites|mesh-ancestor
111252792|NCT01498289|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111252793|NCT01498289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111252794|NCT01498289|Immunologic Factors|immunologic factors|mesh-ancestor
111252795|NCT01498289|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111252796|NCT01498289|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111252797|NCT01498289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111252798|NCT01498289|Antidotes|antidotes|mesh-ancestor
111252799|NCT01498289|Protective Agents|protective agents|mesh-ancestor
111252800|NCT01498289|Vitamin B Complex|vitamin b complex|mesh-ancestor
111252801|NCT01498289|Vitamins|vitamins|mesh-ancestor
111252802|NCT01498289|Micronutrients|micronutrients|mesh-ancestor
111252803|NCT02364882|Sildenafil Citrate|sildenafil citrate|mesh-list
111252804|NCT02364882|Vasodilator Agents|vasodilator agents|mesh-ancestor
111252805|NCT02364882|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111252806|NCT02364882|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111252807|NCT02364882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111252808|NCT02364882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111252809|NCT02364882|Urological Agents|urological agents|mesh-ancestor
111252810|NCT02364804|Aprepitant|aprepitant|mesh-list
111252811|NCT02364804|Antiemetics|antiemetics|mesh-ancestor
111252812|NCT02364804|Autonomic Agents|autonomic agents|mesh-ancestor
111252813|NCT02364804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111252814|NCT02364804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111252815|NCT02364804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111252816|NCT02364804|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
111252817|NCT02364804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111252818|NCT02364804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111252819|NCT01524133|Sertraline|sertraline|mesh-list
111252820|NCT01524133|Antidepressive Agents|antidepressive agents|mesh-ancestor
111252821|NCT01524133|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111252822|NCT01524133|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111252823|NCT01524133|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111252824|NCT01524133|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111252825|NCT01524133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111252826|NCT01524133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111252827|NCT01524133|Serotonin Agents|serotonin agents|mesh-ancestor
111252828|NCT01524133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111252829|NCT02368470|Gemifloxacin|gemifloxacin|mesh-list
111252830|NCT02368470|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111252831|NCT02368470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111252832|NCT02368470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111252833|NCT02368470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111252834|NCT02368470|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111252835|NCT02368470|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111252836|NCT02368470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111252837|NCT04110301|Lenalidomide|lenalidomide|mesh-list
111252838|NCT04110301|Antibodies|antibodies|mesh-list
111252839|NCT04110301|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111252840|NCT04110301|Immunologic Factors|immunologic factors|mesh-ancestor
111252841|NCT04110301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111252842|NCT04110301|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111252843|NCT04110301|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111252844|NCT04110301|Growth Substances|growth substances|mesh-ancestor
111252845|NCT04110301|Growth Inhibitors|growth inhibitors|mesh-ancestor
111252846|NCT04110301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111252847|NCT05800587|Paclitaxel|paclitaxel|mesh-list
111252848|NCT05800587|Etoposide|etoposide|mesh-list
111252849|NCT05800587|Docetaxel|docetaxel|mesh-list
111252850|NCT05800587|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111252851|NCT05800587|Carboplatin|carboplatin|mesh-list
111252852|NCT05800587|Gemcitabine|gemcitabine|mesh-list
111252853|NCT05800587|Irinotecan|irinotecan|mesh-list
111252854|NCT05800587|Pemetrexed|pemetrexed|mesh-list
111252855|NCT05800587|Topotecan|topotecan|mesh-list
111252856|NCT05800587|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111252857|NCT05800587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111252858|NCT05800587|Tubulin Modulators|tubulin modulators|mesh-ancestor
111252859|NCT05800587|Antimitotic Agents|antimitotic agents|mesh-ancestor
111252860|NCT05800587|Mitosis Modulators|mitosis modulators|mesh-ancestor
111252861|NCT05800587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111252862|NCT05800587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111252863|NCT05800587|Antimetabolites|antimetabolites|mesh-ancestor
111252864|NCT05800587|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111252865|NCT05800587|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111252866|NCT05800587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111252867|NCT05800587|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111252869|NCT05800587|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111252870|NCT05800418|Ramucirumab|ramucirumab|mesh-list
111252871|NCT05800418|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111252872|NCT05800418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111252873|NCT05800418|Immunologic Factors|immunologic factors|mesh-ancestor
111252874|NCT05800418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111252875|NCT05800340|Paclitaxel|paclitaxel|mesh-list
111252876|NCT05800340|Carboplatin|carboplatin|mesh-list
111252877|NCT05800340|Pemetrexed|pemetrexed|mesh-list
111252878|NCT05800340|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111252879|NCT05800340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111252880|NCT05800340|Tubulin Modulators|tubulin modulators|mesh-ancestor
111252881|NCT05800340|Antimitotic Agents|antimitotic agents|mesh-ancestor
111252882|NCT05800340|Mitosis Modulators|mitosis modulators|mesh-ancestor
111252883|NCT05800340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111252884|NCT05800340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111252885|NCT05800340|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111252886|NCT05800340|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111252887|NCT05800301|Neurotransmitter Agents|neurotransmitter agents|mesh-list
111252888|NCT05800301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111252889|NCT05800301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111252890|NCT05800288|Propofol|propofol|mesh-list
111252891|NCT05800288|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111252892|NCT05800288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111252893|NCT05800288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111252894|NCT05800288|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111252895|NCT05800288|Anesthetics, General|anesthetics, general|mesh-ancestor
111252896|NCT05800288|Anesthetics|anesthetics|mesh-ancestor
111252897|NCT05800106|Sunitinib|sunitinib|mesh-list
111252898|NCT05800106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111252899|NCT05800106|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111252900|NCT05800106|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111252901|NCT05800106|Growth Substances|growth substances|mesh-ancestor
111252902|NCT05800106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111252903|NCT05800106|Growth Inhibitors|growth inhibitors|mesh-ancestor
111252904|NCT05800106|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111252905|NCT05800106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111252906|NCT05800106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111252907|NCT05800080|Oxaliplatin|oxaliplatin|mesh-list
111252908|NCT05800080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111252909|NCT05800054|Docetaxel|docetaxel|mesh-list
111252910|NCT05800054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111252911|NCT05800054|Tubulin Modulators|tubulin modulators|mesh-ancestor
111252912|NCT05800054|Antimitotic Agents|antimitotic agents|mesh-ancestor
111252913|NCT05800054|Mitosis Modulators|mitosis modulators|mesh-ancestor
111252914|NCT05800054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111252915|NCT05800041|Cyclophosphamide|cyclophosphamide|mesh-list
111252916|NCT05800041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111252917|NCT05800041|Immunologic Factors|immunologic factors|mesh-ancestor
111252918|NCT05800041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111252919|NCT05800041|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111252920|NCT05800041|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111252921|NCT05800041|Alkylating Agents|alkylating agents|mesh-ancestor
111252922|NCT05800041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111252923|NCT05800041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111252924|NCT05800041|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111252925|NCT05799924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
111252926|NCT05799924|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
111252927|NCT05799924|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111252928|NCT05799924|Analgesics|analgesics|mesh-ancestor
111252929|NCT05799924|Sensory System Agents|sensory system agents|mesh-ancestor
111252930|NCT05799924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111252931|NCT05799924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111252932|NCT05799924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111252933|NCT05799729|Ketamine|ketamine|mesh-list
111252934|NCT05799729|Analgesics|analgesics|mesh-ancestor
111252935|NCT05799729|Sensory System Agents|sensory system agents|mesh-ancestor
111252936|NCT05799729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111252937|NCT05799729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111252938|NCT05799729|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111252939|NCT05799729|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111252940|NCT05799729|Anesthetics, General|anesthetics, general|mesh-ancestor
111252941|NCT05799729|Anesthetics|anesthetics|mesh-ancestor
111252942|NCT05799729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111252943|NCT05799729|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111252945|NCT05799729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111252946|NCT05799729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111252947|NCT05799469|Cisplatin|cisplatin|mesh-list
111252948|NCT05799469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111252949|NCT05799443|Irinotecan|irinotecan|mesh-list
111252950|NCT05799443|Cetuximab|cetuximab|mesh-list
111252951|NCT05799443|Tislelizumab|tislelizumab|mesh-list
111252952|NCT05799443|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111252953|NCT05799443|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111252954|NCT05799443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111252955|NCT05799443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111252956|NCT05799443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111252957|NCT05799443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111252958|NCT05799300|Anesthetics|anesthetics|mesh-list
111252959|NCT05799300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111252960|NCT05799300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111252961|NCT05799105|Omeprazole|omeprazole|mesh-list
111252962|NCT05799105|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111252963|NCT05799105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111252964|NCT05799105|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111252965|NCT05799105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111252966|NCT05799105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111252967|NCT05799053|Peppermint oil|peppermint oil|mesh-list
111252968|NCT05799053|Antiemetics|antiemetics|mesh-ancestor
111252969|NCT05799053|Autonomic Agents|autonomic agents|mesh-ancestor
111252970|NCT05799053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111252971|NCT05799053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111252972|NCT05799053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111252973|NCT05799053|Parasympatholytics|parasympatholytics|mesh-ancestor
111252974|NCT05798936|Ethanol|ethanol|mesh-list
111252975|NCT05798936|Polidocanol|polidocanol|mesh-list
111252976|NCT05798936|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111252977|NCT05798936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111252978|NCT05798936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111252979|NCT05798936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111252980|NCT05798936|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
111252981|NCT05798936|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111252982|NCT05798871|Erythritol|erythritol|mesh-list
111252983|NCT05798871|Vasodilator Agents|vasodilator agents|mesh-ancestor
111252984|NCT05798819|Paclitaxel|paclitaxel|mesh-list
111252985|NCT05798819|Bevacizumab|bevacizumab|mesh-list
111252986|NCT05798819|Carboplatin|carboplatin|mesh-list
111252987|NCT05798819|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111252988|NCT05798819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111252989|NCT05798819|Tubulin Modulators|tubulin modulators|mesh-ancestor
111252990|NCT05798819|Antimitotic Agents|antimitotic agents|mesh-ancestor
111252991|NCT05798819|Mitosis Modulators|mitosis modulators|mesh-ancestor
111252992|NCT05798819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111252993|NCT05798819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111252994|NCT05798819|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111252995|NCT05798819|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111252996|NCT05798819|Growth Substances|growth substances|mesh-ancestor
111252997|NCT05798819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111252998|NCT05798819|Growth Inhibitors|growth inhibitors|mesh-ancestor
111252999|NCT05798728|Misoprostol|misoprostol|mesh-list
111253000|NCT05798728|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111253001|NCT05798728|Abortifacient Agents|abortifacient agents|mesh-ancestor
111253002|NCT05798728|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111253003|NCT05798728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111253004|NCT05798728|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111253005|NCT05798728|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111253006|NCT05798728|Oxytocics|oxytocics|mesh-ancestor
111253007|NCT05798715|Metformin|metformin|mesh-list
111253008|NCT05798715|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111253009|NCT05798715|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111253010|NCT05798715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111253011|NCT05798715|Incretins|incretins|mesh-ancestor
111253012|NCT05798715|Hormones|hormones|mesh-ancestor
111253013|NCT05798715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111253014|NCT05798715|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111253015|NCT05798715|Protease Inhibitors|protease inhibitors|mesh-ancestor
111253016|NCT05798715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111253017|NCT05798715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111253018|NCT05796167|Pimavanserin|pimavanserin|mesh-list
111253019|NCT05796167|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111253020|NCT05796167|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111253021|NCT05796167|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111253022|NCT05796167|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111253023|NCT05796167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111253024|NCT05796167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111253025|NCT05796167|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111253026|NCT05796167|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111253027|NCT05796167|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111253028|NCT05796167|Serotonin Agents|serotonin agents|mesh-ancestor
111253029|NCT05796167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111253030|NCT05796167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111253031|NCT05795491|Fluconazole|fluconazole|mesh-list
111253032|NCT05795491|Antifungal Agents|antifungal agents|mesh-list
111253033|NCT05795491|Clotrimazole|clotrimazole|mesh-list
111253034|NCT05795491|Miconazole|miconazole|mesh-list
111253035|NCT05795491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111253036|NCT05795491|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111253037|NCT05795491|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111253038|NCT05795491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111253039|NCT05795491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111253040|NCT05795491|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111253041|NCT05795491|Hormone Antagonists|hormone antagonists|mesh-ancestor
111253042|NCT05795491|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111253043|NCT05795491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111253044|NCT05795491|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111253045|NCT05795491|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111253046|NCT05795491|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111253047|NCT05795491|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111253048|NCT05788627|Lactulose|lactulose|mesh-list
111253049|NCT05788627|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111253050|NCT05777135|Propofol|propofol|mesh-list
111253051|NCT05777135|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111253052|NCT05777135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111253053|NCT05777135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111253054|NCT05777135|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111253055|NCT05777135|Anesthetics, General|anesthetics, general|mesh-ancestor
111253056|NCT05777135|Anesthetics|anesthetics|mesh-ancestor
111253057|NCT05771883|Lenalidomide|lenalidomide|mesh-list
111253058|NCT05771883|Immunologic Factors|immunologic factors|mesh-ancestor
111253059|NCT05771883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111253060|NCT05771883|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111253061|NCT05771883|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111253062|NCT05771883|Growth Substances|growth substances|mesh-ancestor
111253063|NCT05771883|Growth Inhibitors|growth inhibitors|mesh-ancestor
111253064|NCT05771883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111253065|NCT05767892|Carboplatin|carboplatin|mesh-list
111253066|NCT05767892|Pemetrexed|pemetrexed|mesh-list
111253067|NCT05767892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111253068|NCT05767892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111253069|NCT05767892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111253070|NCT05767892|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111253071|NCT05767892|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111253072|NCT05730816|Magnesium Sulfate|magnesium sulfate|mesh-list
111253073|NCT05730816|Analgesics|analgesics|mesh-ancestor
111253074|NCT05730816|Sensory System Agents|sensory system agents|mesh-ancestor
111253075|NCT05730816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111253076|NCT05730816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111253077|NCT05730816|Anesthetics|anesthetics|mesh-ancestor
111253078|NCT05730816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111253079|NCT05730816|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111253080|NCT05730816|Anticonvulsants|anticonvulsants|mesh-ancestor
111253081|NCT05730816|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111253082|NCT05730816|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111253083|NCT05730816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111253084|NCT05730816|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111253085|NCT05730816|Tocolytic Agents|tocolytic agents|mesh-ancestor
111253086|NCT05730816|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111253087|NCT05702333|Simendan|simendan|mesh-list
111253088|NCT05702333|Dobutamine|dobutamine|mesh-list
111253089|NCT05702333|Dopamine|dopamine|mesh-list
111253090|NCT05702333|Epinephrine|epinephrine|mesh-list
111253091|NCT05702333|Norepinephrine|norepinephrine|mesh-list
111253092|NCT05702333|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111253093|NCT05702333|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111253094|NCT05702333|Adrenergic Agents|adrenergic agents|mesh-ancestor
111253095|NCT05702333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111253096|NCT05702333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111253097|NCT05702333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111253098|NCT05702333|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111253099|NCT05702333|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111253100|NCT05702333|Autonomic Agents|autonomic agents|mesh-ancestor
111253101|NCT05702333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111253102|NCT05702333|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111253103|NCT05702333|Respiratory System Agents|respiratory system agents|mesh-ancestor
111253104|NCT05702333|Mydriatics|mydriatics|mesh-ancestor
111253105|NCT05702333|Sympathomimetics|sympathomimetics|mesh-ancestor
111253106|NCT05702333|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111253107|NCT05702333|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111253108|NCT05702333|Vasodilator Agents|vasodilator agents|mesh-ancestor
111253109|NCT05702333|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
111253110|NCT05702333|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111253111|NCT05702333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111253112|NCT05702333|Protective Agents|protective agents|mesh-ancestor
111253113|NCT05702333|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
111253114|NCT05702333|Dopamine Agents|dopamine agents|mesh-ancestor
111253115|NCT05671913|Ketamine|ketamine|mesh-list
111253116|NCT05671913|Analgesics|analgesics|mesh-ancestor
111253117|NCT05671913|Sensory System Agents|sensory system agents|mesh-ancestor
111253118|NCT05671913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111253119|NCT05671913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111253120|NCT05671913|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111253121|NCT05671913|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111253122|NCT05671913|Anesthetics, General|anesthetics, general|mesh-ancestor
111253123|NCT05671913|Anesthetics|anesthetics|mesh-ancestor
111253124|NCT05671913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111253125|NCT05671913|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111253126|NCT05671913|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111253127|NCT05671913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111253128|NCT05671913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111253129|NCT05668936|Moxifloxacin|moxifloxacin|mesh-list
111253130|NCT05668936|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
111253131|NCT05668936|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111253132|NCT05668936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111253133|NCT05668936|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111253134|NCT05668936|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111253135|NCT05668936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111253136|NCT05668936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111253137|NCT05668936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111253138|NCT05668936|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111253139|NCT05668936|Contraceptive Agents|contraceptive agents|mesh-ancestor
111253140|NCT05668936|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111253141|NCT05668936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111253142|NCT05668936|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
111253143|NCT05668936|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111253144|NCT05668936|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111253145|NCT05668676|Prednisone|prednisone|mesh-list
111253146|NCT05668676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111253147|NCT05668676|Glucocorticoids|glucocorticoids|mesh-ancestor
111253148|NCT05668676|Hormones|hormones|mesh-ancestor
111253149|NCT05668676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111253150|NCT05668676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111253151|NCT05668676|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111253152|NCT05668676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111253153|NCT05657990|Tamsulosin|tamsulosin|mesh-list
111253154|NCT05657990|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111253155|NCT05657990|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111253156|NCT05657990|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111253157|NCT05657990|Adrenergic Agents|adrenergic agents|mesh-ancestor
111253158|NCT05657990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111253159|NCT05657990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111253160|NCT05657990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111253161|NCT05657990|Urological Agents|urological agents|mesh-ancestor
111253162|NCT05627752|Docetaxel|docetaxel|mesh-list
111253163|NCT05627752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111253164|NCT05627752|Tubulin Modulators|tubulin modulators|mesh-ancestor
111253165|NCT05627752|Antimitotic Agents|antimitotic agents|mesh-ancestor
111253166|NCT05627752|Mitosis Modulators|mitosis modulators|mesh-ancestor
111253167|NCT05627752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111253168|NCT05609942|Azacitidine|azacitidine|mesh-list
111253169|NCT05609942|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111253170|NCT05609942|Antimetabolites|antimetabolites|mesh-ancestor
111253171|NCT05609942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111253172|NCT05609942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111253173|NCT05609942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111253174|NCT05590676|Metformin|metformin|mesh-list
111253175|NCT05590676|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111253176|NCT05590676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111253177|NCT05559814|Peppermint oil|peppermint oil|mesh-list
111253178|NCT05559814|Antiemetics|antiemetics|mesh-ancestor
111253179|NCT05559814|Autonomic Agents|autonomic agents|mesh-ancestor
111253180|NCT05559814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111253181|NCT05559814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111253182|NCT05559814|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111253183|NCT05559814|Parasympatholytics|parasympatholytics|mesh-ancestor
111253184|NCT05438420|Pembrolizumab|pembrolizumab|mesh-list
111253185|NCT05438420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111253186|NCT05438420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111253187|NCT05438420|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111253188|NCT05438420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111253189|NCT05419466|Melatonin|melatonin|mesh-list
111253190|NCT05419466|Antioxidants|antioxidants|mesh-ancestor
111253191|NCT05419466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111253192|NCT05419466|Protective Agents|protective agents|mesh-ancestor
111253193|NCT05419466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111253194|NCT05419466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111253195|NCT05382481|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
111253196|NCT05382481|Dalteparin|dalteparin|mesh-list
111253197|NCT05382481|Anticoagulants|anticoagulants|mesh-ancestor
111253198|NCT05382481|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111253199|NCT05382481|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111253200|NCT05382481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111253201|NCT05353283|Tenofovir|tenofovir|mesh-list
111253202|NCT05353283|Antiviral Agents|antiviral agents|mesh-ancestor
111253203|NCT05353283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111253204|NCT05353283|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111253205|NCT05353283|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111253206|NCT05353283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111253207|NCT05353283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111253208|NCT05353283|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111253209|NCT05353283|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111253210|NCT05323786|Anesthetics|anesthetics|mesh-list
111253211|NCT05323786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111253212|NCT05323786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111253213|NCT05262387|Insulin Lispro|insulin lispro|mesh-list
111253214|NCT05262387|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111253215|NCT05262387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111253216|NCT05221554|Tacrine|tacrine|mesh-list
111253217|NCT05221554|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111253218|NCT05221554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111253219|NCT05221554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111253220|NCT05221554|Cholinergic Agents|cholinergic agents|mesh-ancestor
111253221|NCT05221554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111253222|NCT05221554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111253223|NCT05221554|Parasympathomimetics|parasympathomimetics|mesh-ancestor
111253224|NCT05221554|Autonomic Agents|autonomic agents|mesh-ancestor
111253225|NCT05221554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111253226|NCT05221554|Nootropic Agents|nootropic agents|mesh-ancestor
111253227|NCT05162937|Antibodies|antibodies|mesh-list
111253228|NCT05162937|Immunologic Factors|immunologic factors|mesh-ancestor
111253229|NCT05162937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111253230|NCT04985500|Bupivacaine|bupivacaine|mesh-list
111253231|NCT04985500|Anesthetics, Local|anesthetics, local|mesh-ancestor
111253232|NCT04985500|Anesthetics|anesthetics|mesh-ancestor
111253233|NCT04985500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111253234|NCT04985500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111253235|NCT04985500|Sensory System Agents|sensory system agents|mesh-ancestor
111253236|NCT04985500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111253237|NCT04973670|Sivelestat|sivelestat|mesh-list
111253238|NCT04973670|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111253239|NCT04973670|Protease Inhibitors|protease inhibitors|mesh-ancestor
111253240|NCT04973670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111253241|NCT04973670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111253243|NCT04929626|Albuterol|albuterol|mesh-list
111253244|NCT04929626|Analgesics|analgesics|mesh-ancestor
111253245|NCT04929626|Sensory System Agents|sensory system agents|mesh-ancestor
111253246|NCT04929626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111253247|NCT04929626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111253248|NCT04929626|Anesthetics|anesthetics|mesh-ancestor
111253249|NCT04929626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111253250|NCT04929626|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111253251|NCT04929626|Anticonvulsants|anticonvulsants|mesh-ancestor
111253252|NCT04929626|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111253253|NCT04929626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111253254|NCT04929626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111253255|NCT04929626|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111253256|NCT04929626|Tocolytic Agents|tocolytic agents|mesh-ancestor
111253257|NCT04929626|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111253258|NCT04929626|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111253259|NCT04929626|Autonomic Agents|autonomic agents|mesh-ancestor
111253260|NCT04929626|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111253261|NCT04929626|Respiratory System Agents|respiratory system agents|mesh-ancestor
111253262|NCT04929626|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111253263|NCT04929626|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111253264|NCT04929626|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111253265|NCT04929626|Adrenergic Agents|adrenergic agents|mesh-ancestor
111253266|NCT04929626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111253267|NCT04908202|Deucravacitinib|deucravacitinib|mesh-list
111253268|NCT04908202|Dermatologic Agents|dermatologic agents|mesh-ancestor
111253269|NCT04908202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111253270|NCT04908202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111253271|NCT04908202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111253272|NCT04905316|Durvalumab|durvalumab|mesh-list
111253273|NCT04905316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111253274|NCT04905316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111253275|NCT04826198|Olaparib|olaparib|mesh-list
111253276|NCT04826198|Niraparib|niraparib|mesh-list
111253277|NCT04826198|Rucaparib|rucaparib|mesh-list
111253278|NCT04826198|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111253279|NCT04826198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111253280|NCT04826198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111253281|NCT04826198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111253282|NCT04808934|Rivaroxaban|rivaroxaban|mesh-list
111253283|NCT04808934|Apixaban|apixaban|mesh-list
111253284|NCT04808934|Dabigatran|dabigatran|mesh-list
111253285|NCT04808934|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111253286|NCT04808934|Antithrombins|antithrombins|mesh-ancestor
111253287|NCT04808934|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111253288|NCT04808934|Protease Inhibitors|protease inhibitors|mesh-ancestor
111253289|NCT04808934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111253290|NCT04808934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111253291|NCT04808934|Anticoagulants|anticoagulants|mesh-ancestor
111253292|NCT04754230|Tranexamic Acid|tranexamic acid|mesh-list
111253293|NCT04754230|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111253294|NCT04754230|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111253295|NCT04754230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111253296|NCT04754230|Hemostatics|hemostatics|mesh-ancestor
111253297|NCT04754230|Coagulants|coagulants|mesh-ancestor
111253298|NCT04733118|Trastuzumab|trastuzumab|mesh-list
111253299|NCT04733118|Pertuzumab|pertuzumab|mesh-list
111253300|NCT04733118|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
111253301|NCT04733118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111253302|NCT04733118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111253303|NCT04733118|Tubulin Modulators|tubulin modulators|mesh-ancestor
111253304|NCT04733118|Antimitotic Agents|antimitotic agents|mesh-ancestor
111253305|NCT04733118|Mitosis Modulators|mitosis modulators|mesh-ancestor
111253306|NCT04733118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111253307|NCT04733118|Immunotoxins|immunotoxins|mesh-ancestor
111253308|NCT04733118|Immunoconjugates|immunoconjugates|mesh-ancestor
111253309|NCT04733118|Immunologic Factors|immunologic factors|mesh-ancestor
111253310|NCT04733118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111253311|NCT04699461|Idelalisib|idelalisib|mesh-list
111253312|NCT04699461|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
111253313|NCT04699461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111253314|NCT04699461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111253315|NCT04699461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111253316|NCT04699461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111253317|NCT04659928|Hydrogen Peroxide|hydrogen peroxide|mesh-list
111253318|NCT04659928|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111253319|NCT04659928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111253320|NCT04653337|Norepinephrine|norepinephrine|mesh-list
111253321|NCT04653337|Serotonin|serotonin|mesh-list
111253322|NCT04653337|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-list
111253323|NCT04653337|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111253324|NCT04653337|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111253325|NCT04653337|Adrenergic Agents|adrenergic agents|mesh-ancestor
111253326|NCT04653337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111253327|NCT04653337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111253328|NCT04653337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111253329|NCT04653337|Sympathomimetics|sympathomimetics|mesh-ancestor
111253330|NCT04653337|Autonomic Agents|autonomic agents|mesh-ancestor
111253331|NCT04653337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111253332|NCT04653337|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111253333|NCT04653337|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111253334|NCT04653337|Serotonin Agents|serotonin agents|mesh-ancestor
111253335|NCT04653337|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111253336|NCT04653337|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111253337|NCT04561739|Sirolimus|sirolimus|mesh-list
111253338|NCT04561739|Paclitaxel|paclitaxel|mesh-list
111253339|NCT04561739|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111253340|NCT04561739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111253341|NCT04561739|Tubulin Modulators|tubulin modulators|mesh-ancestor
111253342|NCT04561739|Antimitotic Agents|antimitotic agents|mesh-ancestor
111253343|NCT04561739|Mitosis Modulators|mitosis modulators|mesh-ancestor
111253344|NCT04561739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111253345|NCT04561739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111253346|NCT04561739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111253347|NCT04561739|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111253348|NCT04561739|Antifungal Agents|antifungal agents|mesh-ancestor
111253349|NCT04561739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111253350|NCT04561739|Immunologic Factors|immunologic factors|mesh-ancestor
111253351|NCT04561739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111253352|NCT04539626|Ethinyl Estradiol|ethinyl estradiol|mesh-list
111253353|NCT04539626|Estradiol|estradiol|mesh-list
111253354|NCT04539626|Estrogens|estrogens|mesh-list
111253355|NCT04539626|Hormones|hormones|mesh-ancestor
111253356|NCT04539626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111253357|NCT04539626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111253358|NCT04539626|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111253359|NCT04539626|Contraceptive Agents|contraceptive agents|mesh-ancestor
111253360|NCT04539626|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111253361|NCT04539626|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111253362|NCT04539626|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111253363|NCT04539626|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111253364|NCT04521348|Antibodies|antibodies|mesh-list
111253365|NCT04521348|Immunoglobulins|immunoglobulins|mesh-list
111253366|NCT04521348|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
111253367|NCT04521348|Immunologic Factors|immunologic factors|mesh-ancestor
111253368|NCT04521348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111253369|NCT04521348|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111253370|NCT04521348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111253371|NCT04521348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111253372|NCT04512534|Antibodies|antibodies|mesh-list
111253373|NCT04512534|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
111253374|NCT04512534|Immunologic Factors|immunologic factors|mesh-ancestor
111253375|NCT04512534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111253376|NCT04512534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111253377|NCT04512534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111253378|NCT04486118|Lisinopril|lisinopril|mesh-list
111253379|NCT04486118|Benazepril|benazepril|mesh-list
111253380|NCT04486118|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
111253381|NCT04486118|Protease Inhibitors|protease inhibitors|mesh-ancestor
111253382|NCT04486118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111253383|NCT04486118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111253384|NCT04486118|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111253385|NCT04486118|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111253386|NCT04486118|Protective Agents|protective agents|mesh-ancestor
111253387|NCT04486118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111253388|NCT04442581|Pembrolizumab|pembrolizumab|mesh-list
111253389|NCT04442581|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111253390|NCT04442581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111253391|NCT04442581|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111253392|NCT04442581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111253394|NCT04436731|Phenylephrine|phenylephrine|mesh-list
111253395|NCT04436731|Oxymetazoline|oxymetazoline|mesh-list
111253396|NCT04436731|Norepinephrine|norepinephrine|mesh-list
111253397|NCT04436731|Dexmedetomidine|dexmedetomidine|mesh-list
111253398|NCT04436731|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111253399|NCT04436731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111253400|NCT04436731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111253401|NCT04436731|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111253402|NCT04436731|Analgesics|analgesics|mesh-ancestor
111253403|NCT04436731|Sensory System Agents|sensory system agents|mesh-ancestor
111253404|NCT04436731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111253405|NCT04436731|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111253406|NCT04436731|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111253407|NCT04436731|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111253408|NCT04436731|Adrenergic Agents|adrenergic agents|mesh-ancestor
111253409|NCT04436731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111253410|NCT04436731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111253411|NCT04436731|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111253412|NCT04436731|Mydriatics|mydriatics|mesh-ancestor
111253413|NCT04436731|Autonomic Agents|autonomic agents|mesh-ancestor
111253414|NCT04436731|Sympathomimetics|sympathomimetics|mesh-ancestor
111253415|NCT04436731|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111253416|NCT04436731|Nasal Decongestants|nasal decongestants|mesh-ancestor
111253417|NCT04436731|Respiratory System Agents|respiratory system agents|mesh-ancestor
111253418|NCT04436731|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111253419|NCT04436731|Protective Agents|protective agents|mesh-ancestor
111253420|NCT04436731|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111253421|NCT04436731|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111253422|NCT04436731|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111253423|NCT04423068|Contraceptive Agents|contraceptive agents|mesh-list
111253424|NCT04423068|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111253425|NCT04423068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111253426|NCT04364230|Poly ICLC|poly iclc|mesh-list
111253427|NCT04364230|Immunologic Factors|immunologic factors|mesh-ancestor
111253428|NCT04364230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111253429|NCT04364230|Interferon Inducers|interferon inducers|mesh-ancestor
111253430|NCT04268706|Fludarabine|fludarabine|mesh-list
111253431|NCT04268706|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
111253432|NCT04268706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111253433|NCT04268706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111253434|NCT04268706|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111253435|NCT04268706|Alkylating Agents|alkylating agents|mesh-ancestor
111253436|NCT04223609|Oxycodone|oxycodone|mesh-list
111253437|NCT04223609|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111253438|NCT04223609|Narcotics|narcotics|mesh-ancestor
111253439|NCT04223609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111253440|NCT04223609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111253441|NCT04223609|Analgesics|analgesics|mesh-ancestor
111253442|NCT04223609|Sensory System Agents|sensory system agents|mesh-ancestor
111253443|NCT04223609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111253444|NCT04118920|Insulin|insulin|mesh-list
111253445|NCT04118920|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111253446|NCT04118920|Lubricant Eye Drops|lubricant eye drops|mesh-list
111253447|NCT04118920|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111253448|NCT04118920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111253449|NCT04118920|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
111253450|NCT04118920|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111253451|NCT04083144|Varenicline|varenicline|mesh-list
111253452|NCT04083144|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111253453|NCT04083144|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111253454|NCT04083144|Cholinergic Agents|cholinergic agents|mesh-ancestor
111253455|NCT04083144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111253456|NCT04083144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111253457|NCT04083144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111253458|NCT04055818|Niacinamide|niacinamide|mesh-list
111253459|NCT04055818|Niacin|niacin|mesh-list
111253460|NCT04055818|Nicotinic Acids|nicotinic acids|mesh-list
111253461|NCT04055818|Decitabine|decitabine|mesh-list
111253462|NCT04055818|Tetrahydrouridine|tetrahydrouridine|mesh-list
111253463|NCT04055818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111253464|NCT04055818|Antimetabolites|antimetabolites|mesh-ancestor
111253465|NCT04055818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111253466|NCT04055818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111253467|NCT04055818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111253468|NCT04055818|Vitamin B Complex|vitamin b complex|mesh-ancestor
111253469|NCT04055818|Vitamins|vitamins|mesh-ancestor
111253470|NCT04055818|Micronutrients|micronutrients|mesh-ancestor
111253471|NCT04055818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111253472|NCT04055818|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111253473|NCT04055818|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111253474|NCT04055818|Vasodilator Agents|vasodilator agents|mesh-ancestor
111253475|NCT04047953|Paclitaxel|paclitaxel|mesh-list
111253476|NCT04047953|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111253477|NCT04047953|Oxaliplatin|oxaliplatin|mesh-list
111253478|NCT04047953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111253479|NCT04047953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111253480|NCT04047953|Tubulin Modulators|tubulin modulators|mesh-ancestor
111253481|NCT04047953|Antimitotic Agents|antimitotic agents|mesh-ancestor
111253482|NCT04047953|Mitosis Modulators|mitosis modulators|mesh-ancestor
111253483|NCT04047953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111253484|NCT03981900|Tofacitinib|tofacitinib|mesh-list
111253485|NCT03981900|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
111253486|NCT03981900|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111253487|NCT03981900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111253488|NCT03981900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111253489|NCT03958877|Interferons|interferons|mesh-list
111253490|NCT03958877|Interferon-beta|interferon-beta|mesh-list
111253491|NCT03958877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111253492|NCT03958877|Antiviral Agents|antiviral agents|mesh-ancestor
111253493|NCT03958877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111253494|NCT03958877|Immunologic Factors|immunologic factors|mesh-ancestor
111253495|NCT03958877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111253496|NCT03941288|Cannabidiol|cannabidiol|mesh-list
111253497|NCT03941288|Anticonvulsants|anticonvulsants|mesh-ancestor
111253498|NCT03925727|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111253499|NCT03925727|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111253500|NCT03864419|Prednisone|prednisone|mesh-list
111253501|NCT03864419|Cyclophosphamide|cyclophosphamide|mesh-list
111253502|NCT03864419|Rituximab|rituximab|mesh-list
111253503|NCT03864419|Doxorubicin|doxorubicin|mesh-list
111253504|NCT03864419|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111253505|NCT03864419|Methotrexate|methotrexate|mesh-list
111253506|NCT03864419|Etoposide|etoposide|mesh-list
111253507|NCT03864419|Vincristine|vincristine|mesh-list
111253508|NCT03864419|Daunorubicin|daunorubicin|mesh-list
111253509|NCT03864419|Podophyllotoxin|podophyllotoxin|mesh-list
111253510|NCT03864419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111253511|NCT03864419|Antibodies|antibodies|mesh-list
111253512|NCT03864419|Immunoglobulins|immunoglobulins|mesh-list
111253513|NCT03864419|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111253514|NCT03864419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111253515|NCT03864419|Immunologic Factors|immunologic factors|mesh-ancestor
111253516|NCT03864419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111253517|NCT03864419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111253518|NCT03864419|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111253519|NCT03864419|Alkylating Agents|alkylating agents|mesh-ancestor
111253520|NCT03864419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111253521|NCT03864419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111253522|NCT03864419|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111253523|NCT03864419|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111253524|NCT03864419|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111253525|NCT03864419|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111253526|NCT03864419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111253527|NCT03864419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111253528|NCT03864419|Glucocorticoids|glucocorticoids|mesh-ancestor
111253529|NCT03864419|Hormones|hormones|mesh-ancestor
111253530|NCT03864419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111253531|NCT03864419|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111253532|NCT03864419|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111253533|NCT03864419|Abortifacient Agents|abortifacient agents|mesh-ancestor
111253534|NCT03864419|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111253535|NCT03864419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111253536|NCT03864419|Antimetabolites|antimetabolites|mesh-ancestor
111253537|NCT03864419|Dermatologic Agents|dermatologic agents|mesh-ancestor
111253538|NCT03864419|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111253539|NCT03864419|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111253540|NCT03864419|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111253541|NCT03864419|Tubulin Modulators|tubulin modulators|mesh-ancestor
111253542|NCT03864419|Antimitotic Agents|antimitotic agents|mesh-ancestor
111253543|NCT03864419|Mitosis Modulators|mitosis modulators|mesh-ancestor
111253544|NCT03864419|Keratolytic Agents|keratolytic agents|mesh-ancestor
111253545|NCT03859427|Dexamethasone|dexamethasone|mesh-list
111253546|NCT03859427|Lenalidomide|lenalidomide|mesh-list
111253547|NCT03859427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111253548|NCT03859427|Antiemetics|antiemetics|mesh-ancestor
111253549|NCT03859427|Autonomic Agents|autonomic agents|mesh-ancestor
111253550|NCT03859427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111253551|NCT03859427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111253552|NCT03859427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111253553|NCT03859427|Glucocorticoids|glucocorticoids|mesh-ancestor
111253554|NCT03859427|Hormones|hormones|mesh-ancestor
111253555|NCT03859427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111253556|NCT03859427|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111253557|NCT03859427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111253558|NCT03859427|Immunologic Factors|immunologic factors|mesh-ancestor
111253559|NCT03859427|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111253560|NCT03859427|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111253561|NCT03859427|Growth Substances|growth substances|mesh-ancestor
111253562|NCT03859427|Growth Inhibitors|growth inhibitors|mesh-ancestor
111253563|NCT03856671|Metronidazole|metronidazole|mesh-list
111253564|NCT03856671|Neomycin|neomycin|mesh-list
111253565|NCT03856671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111253566|NCT03856671|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111253567|NCT03856671|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111253568|NCT03856671|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111253569|NCT03856671|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111253570|NCT03856671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111253571|NCT03856671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111253572|NCT03728361|Nivolumab|nivolumab|mesh-list
111253573|NCT03728361|Temozolomide|temozolomide|mesh-list
111253574|NCT03728361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111253575|NCT03728361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111253576|NCT03728361|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111253577|NCT03728361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111253578|NCT03728361|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111253579|NCT03728361|Alkylating Agents|alkylating agents|mesh-ancestor
111253580|NCT03662685|Coal Tar|coal tar|mesh-list
111253581|NCT03662685|Keratolytic Agents|keratolytic agents|mesh-ancestor
111253582|NCT03662685|Dermatologic Agents|dermatologic agents|mesh-ancestor
111253583|NCT03617328|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
111253584|NCT03617328|Poly ICLC|poly iclc|mesh-list
111253585|NCT03617328|Immunologic Factors|immunologic factors|mesh-ancestor
111253586|NCT03617328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111253587|NCT03617328|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111253588|NCT03617328|Interferon Inducers|interferon inducers|mesh-ancestor
111253589|NCT03391934|Leucovorin|leucovorin|mesh-list
111253590|NCT03391934|Fluorouracil|fluorouracil|mesh-list
111253591|NCT03391934|Irinotecan|irinotecan|mesh-list
111253592|NCT03391934|Cetuximab|cetuximab|mesh-list
111253593|NCT03391934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111253594|NCT03391934|Antimetabolites|antimetabolites|mesh-ancestor
111253595|NCT03391934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111253596|NCT03391934|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111253597|NCT03391934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111253598|NCT03391934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111253599|NCT03391934|Immunologic Factors|immunologic factors|mesh-ancestor
111253600|NCT03391934|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111253601|NCT03391934|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111253602|NCT03391934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111253603|NCT03391934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111253604|NCT03391934|Antidotes|antidotes|mesh-ancestor
111253605|NCT03391934|Protective Agents|protective agents|mesh-ancestor
111253606|NCT03391934|Vitamin B Complex|vitamin b complex|mesh-ancestor
111253607|NCT03391934|Vitamins|vitamins|mesh-ancestor
111253608|NCT03391934|Micronutrients|micronutrients|mesh-ancestor
111253609|NCT03333343|Gefitinib|gefitinib|mesh-list
111253610|NCT03333343|Trametinib|trametinib|mesh-list
111253611|NCT03333343|Nazartinib|nazartinib|mesh-list
111253612|NCT03333343|Naporafenib|naporafenib|mesh-list
111253613|NCT03333343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111253614|NCT03333343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111253615|NCT03333343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111253616|NCT03333343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111253617|NCT03326947|Docetaxel|docetaxel|mesh-list
111253618|NCT03326947|Fluorouracil|fluorouracil|mesh-list
111253619|NCT03326947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111253620|NCT03326947|Tubulin Modulators|tubulin modulators|mesh-ancestor
111253621|NCT03326947|Antimitotic Agents|antimitotic agents|mesh-ancestor
111253622|NCT03326947|Mitosis Modulators|mitosis modulators|mesh-ancestor
111253623|NCT03326947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111253624|NCT03326947|Antimetabolites|antimetabolites|mesh-ancestor
111253625|NCT03326947|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111253626|NCT03326947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111253627|NCT03326947|Immunologic Factors|immunologic factors|mesh-ancestor
111253628|NCT03326947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111253629|NCT03304639|Pembrolizumab|pembrolizumab|mesh-list
111253630|NCT03304639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111253631|NCT03304639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111253632|NCT03304639|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111253633|NCT03304639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111253634|NCT03289234|Edaravone|edaravone|mesh-list
111253635|NCT03289234|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111253636|NCT03289234|Antioxidants|antioxidants|mesh-ancestor
111253637|NCT03289234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111253638|NCT03289234|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111253639|NCT03289234|Protective Agents|protective agents|mesh-ancestor
111253640|NCT03289234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111253641|NCT03289208|Edaravone|edaravone|mesh-list
111253642|NCT03289208|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111253643|NCT03289208|Antioxidants|antioxidants|mesh-ancestor
111253644|NCT03289208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111253645|NCT03289208|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111253646|NCT03289208|Protective Agents|protective agents|mesh-ancestor
111253647|NCT03289208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111253648|NCT03244059|Belimumab|belimumab|mesh-list
111253649|NCT03244059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111253650|NCT03244059|Immunologic Factors|immunologic factors|mesh-ancestor
111253651|NCT03244059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111253652|NCT03036566|Lithium Carbonate|lithium carbonate|mesh-list
111253653|NCT03036566|Antidepressive Agents|antidepressive agents|mesh-ancestor
111253654|NCT03036566|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111253655|NCT03036566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111253656|NCT03036566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111253657|NCT03036566|Antimanic Agents|antimanic agents|mesh-ancestor
111253658|NCT03036566|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111253659|NCT03036566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111253660|NCT03036566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111253661|NCT03010228|Aluminum sulfate|aluminum sulfate|mesh-list
111253662|NCT03010228|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111253663|NCT03010228|Immunologic Factors|immunologic factors|mesh-ancestor
111253664|NCT03010228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111253665|NCT02927249|Aspirin|aspirin|mesh-list
111253666|NCT02927249|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111253667|NCT02927249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111253668|NCT02927249|Analgesics|analgesics|mesh-ancestor
111253669|NCT02927249|Sensory System Agents|sensory system agents|mesh-ancestor
111253670|NCT02927249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111253671|NCT02927249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111253672|NCT02927249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111253673|NCT02927249|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111253674|NCT02927249|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111253675|NCT02927249|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111253676|NCT02927249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111253677|NCT02927249|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111253678|NCT02927249|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111253679|NCT02927249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111253680|NCT02927249|Antipyretics|antipyretics|mesh-ancestor
111253681|NCT02918864|Oxytocin|oxytocin|mesh-list
111253682|NCT02918864|Oxytocics|oxytocics|mesh-ancestor
111253683|NCT02918864|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111253684|NCT02918864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111253685|NCT02890368|Interferons|interferons|mesh-list
111253686|NCT02890368|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
111253687|NCT02890368|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
111253688|NCT02890368|Immunoglobulin G|immunoglobulin g|mesh-list
111253689|NCT02890368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111253690|NCT02890368|Antiviral Agents|antiviral agents|mesh-ancestor
111253691|NCT02890368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111253692|NCT02890368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111253693|NCT02890368|Immunologic Factors|immunologic factors|mesh-ancestor
111253694|NCT02890368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110978009|NCT02557672|Thrombin|thrombin|mesh-list
110682176|NCT01010802|Hematinics|hematinics|mesh-ancestor
111253695|NCT02890368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111253696|NCT02754141|Nivolumab|nivolumab|mesh-list
111253697|NCT02754141|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111253698|NCT02754141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111253699|NCT02754141|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111253700|NCT02754141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111253701|NCT02659059|Paclitaxel|paclitaxel|mesh-list
111253702|NCT02659059|Cisplatin|cisplatin|mesh-list
111253703|NCT02659059|Carboplatin|carboplatin|mesh-list
111253704|NCT02659059|Nivolumab|nivolumab|mesh-list
111253705|NCT02659059|Pemetrexed|pemetrexed|mesh-list
111253706|NCT02659059|Ipilimumab|ipilimumab|mesh-list
111253707|NCT02659059|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111253708|NCT02659059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111253709|NCT02659059|Tubulin Modulators|tubulin modulators|mesh-ancestor
111253710|NCT02659059|Antimitotic Agents|antimitotic agents|mesh-ancestor
111253711|NCT02659059|Mitosis Modulators|mitosis modulators|mesh-ancestor
111253712|NCT02659059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111253713|NCT02659059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111253714|NCT02659059|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111253715|NCT02659059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111253716|NCT02659059|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111253717|NCT02659059|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111253718|NCT01997840|Dexamethasone|dexamethasone|mesh-list
111253719|NCT01997840|Dexamethasone acetate|dexamethasone acetate|mesh-list
111253720|NCT01997840|Pomalidomide|pomalidomide|mesh-list
111253721|NCT01997840|Ricolinostat|ricolinostat|mesh-list
111253722|NCT01997840|BB 1101|bb 1101|mesh-list
111253723|NCT01997840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111253724|NCT01997840|Antiemetics|antiemetics|mesh-ancestor
111253725|NCT01997840|Autonomic Agents|autonomic agents|mesh-ancestor
111253726|NCT01997840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111253727|NCT01997840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111253728|NCT01997840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111253729|NCT01997840|Glucocorticoids|glucocorticoids|mesh-ancestor
111253730|NCT01997840|Hormones|hormones|mesh-ancestor
111253731|NCT01997840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111253732|NCT01997840|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111253733|NCT01997840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111253734|NCT01997840|Protease Inhibitors|protease inhibitors|mesh-ancestor
111253735|NCT01997840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111253736|NCT01997840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111253737|NCT01997840|Immunologic Factors|immunologic factors|mesh-ancestor
111253738|NCT01997840|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111253739|NCT01997840|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111253740|NCT01997840|Growth Substances|growth substances|mesh-ancestor
111253741|NCT01997840|Growth Inhibitors|growth inhibitors|mesh-ancestor
111253742|NCT01997840|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111253743|NCT01505569|Etoposide|etoposide|mesh-list
111253744|NCT01505569|Carboplatin|carboplatin|mesh-list
111253745|NCT01505569|Melphalan|melphalan|mesh-list
111253746|NCT01505569|Busulfan|busulfan|mesh-list
111253747|NCT01505569|Ifosfamide|ifosfamide|mesh-list
111253748|NCT01505569|Thiotepa|thiotepa|mesh-list
111253749|NCT01505569|Lenograstim|lenograstim|mesh-list
111253751|NCT01505569|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111253752|NCT01505569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111253753|NCT01505569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111253754|NCT01505569|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111253755|NCT01505569|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111253756|NCT01505569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111253757|NCT01505569|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111253758|NCT01505569|Alkylating Agents|alkylating agents|mesh-ancestor
111253759|NCT01505569|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111253760|NCT01505569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111253761|NCT01505569|Immunologic Factors|immunologic factors|mesh-ancestor
111253762|NCT01505569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111253763|NCT01505569|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111253764|NCT01505569|Protective Agents|protective agents|mesh-ancestor
111253765|NCT02375178|Biguanides|biguanides|mesh-list
111253766|NCT02375178|Chlorhexidine|chlorhexidine|mesh-list
111253767|NCT02375178|Polihexanide|polihexanide|mesh-list
110978087|NCT02410343|Hormones|hormones|mesh-list
111253768|NCT02375178|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111253769|NCT02375178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111253770|NCT02375178|Disinfectants|disinfectants|mesh-ancestor
111253771|NCT02375178|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111253772|NCT02375178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111253773|NCT02375100|Acetaminophen|acetaminophen|mesh-list
111253774|NCT02375100|Tramadol|tramadol|mesh-list
111253775|NCT02375100|Analgesics|analgesics|mesh-list
111253776|NCT02375100|Bupivacaine|bupivacaine|mesh-list
111253777|NCT02375100|Anesthetics, Local|anesthetics, local|mesh-ancestor
111253778|NCT02375100|Anesthetics|anesthetics|mesh-ancestor
111253779|NCT02375100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111253780|NCT02375100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111253781|NCT02375100|Sensory System Agents|sensory system agents|mesh-ancestor
111253782|NCT02375100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111253783|NCT02375100|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111253784|NCT02375100|Antipyretics|antipyretics|mesh-ancestor
111253785|NCT02375100|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111253786|NCT02375100|Narcotics|narcotics|mesh-ancestor
111253787|NCT02364258|Atorvastatin|atorvastatin|mesh-list
111253788|NCT02364258|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111253789|NCT02364258|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111253790|NCT02364258|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111253791|NCT02364258|Antimetabolites|antimetabolites|mesh-ancestor
111253792|NCT02364258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111253793|NCT02364258|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111253794|NCT02364258|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111253795|NCT02364258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111253796|NCT02375022|Endostar protein|endostar protein|mesh-list
111253797|NCT02375022|Endostatins|endostatins|mesh-list
111253798|NCT02375022|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111253799|NCT02375022|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111253800|NCT02375022|Growth Substances|growth substances|mesh-ancestor
111253801|NCT02375022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111253802|NCT02375022|Growth Inhibitors|growth inhibitors|mesh-ancestor
111253803|NCT02375022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111253804|NCT01497899|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
111253805|NCT01497899|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111253806|NCT01497899|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111253807|NCT01497899|Antiviral Agents|antiviral agents|mesh-ancestor
111253808|NCT01497899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111253809|NCT01497275|Rituximab|rituximab|mesh-list
111253810|NCT01497275|Bortezomib|bortezomib|mesh-list
111253811|NCT01497275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111253812|NCT01497275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111253813|NCT01497275|Immunologic Factors|immunologic factors|mesh-ancestor
111253814|NCT01497275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111253815|NCT01497275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111253816|NCT01557517|Clobetasol|clobetasol|mesh-list
111253817|NCT01557517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111253818|NCT01557517|Glucocorticoids|glucocorticoids|mesh-ancestor
111253819|NCT01557517|Hormones|hormones|mesh-ancestor
111253820|NCT01557517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111253821|NCT01557517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111253822|NCT02363556|Misoprostol|misoprostol|mesh-list
111253823|NCT02363556|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111253824|NCT02363556|Abortifacient Agents|abortifacient agents|mesh-ancestor
111253825|NCT02363556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111253826|NCT02363556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111253827|NCT02363556|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111253828|NCT02363556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111253829|NCT02363556|Oxytocics|oxytocics|mesh-ancestor
111253830|NCT01497197|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
111253831|NCT01497197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111253832|NCT01497197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111253833|NCT01557283|Etanercept|etanercept|mesh-list
111253834|NCT01557283|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111253835|NCT01557283|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111253836|NCT01557283|Analgesics|analgesics|mesh-ancestor
111253837|NCT01557283|Sensory System Agents|sensory system agents|mesh-ancestor
111253838|NCT01557283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111253839|NCT01557283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111253840|NCT01557283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111253841|NCT01557283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111253842|NCT01557283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111253843|NCT01557283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111253844|NCT01557283|Immunologic Factors|immunologic factors|mesh-ancestor
111253845|NCT02374632|Octreotide|octreotide|mesh-list
111253846|NCT02374632|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111253847|NCT02374632|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111253848|NCT02374632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111253849|NCT02363400|Cisplatin|cisplatin|mesh-list
111253850|NCT02363400|Epirubicin|epirubicin|mesh-list
111253851|NCT02363400|Mitomycins|mitomycins|mesh-list
111253852|NCT02363400|Mitomycin|mitomycin|mesh-list
111253853|NCT02363400|Tegafur|tegafur|mesh-list
111253854|NCT02363400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111253855|NCT02363400|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111253856|NCT02363400|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111253857|NCT02363400|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111253858|NCT02363400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111253859|NCT02363400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111253860|NCT02363400|Alkylating Agents|alkylating agents|mesh-ancestor
111253861|NCT02363400|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111253862|NCT02363400|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111253863|NCT02363400|Antimetabolites|antimetabolites|mesh-ancestor
111253864|NCT00350025|Paclitaxel|paclitaxel|mesh-list
111253865|NCT00350025|Cetuximab|cetuximab|mesh-list
111253866|NCT00350025|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111253867|NCT00350025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111253868|NCT00350025|Tubulin Modulators|tubulin modulators|mesh-ancestor
111253869|NCT00350025|Antimitotic Agents|antimitotic agents|mesh-ancestor
111253870|NCT00350025|Mitosis Modulators|mitosis modulators|mesh-ancestor
111253871|NCT00350025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111253872|NCT00350025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111253873|NCT01496807|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
111253874|NCT01496807|Ipilimumab|ipilimumab|mesh-list
111253875|NCT01496807|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111253876|NCT01496807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111253877|NCT01496807|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111253878|NCT01496807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111253879|NCT01496807|Antiviral Agents|antiviral agents|mesh-ancestor
111253880|NCT01496807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111253881|NCT02374320|Bupivacaine|bupivacaine|mesh-list
111253882|NCT02374320|Anesthetics, Local|anesthetics, local|mesh-ancestor
111253883|NCT02374320|Anesthetics|anesthetics|mesh-ancestor
111253884|NCT02374320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111253885|NCT02374320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111253886|NCT02374320|Sensory System Agents|sensory system agents|mesh-ancestor
111253887|NCT02374320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111253888|NCT01496183|Olanzapine|olanzapine|mesh-list
111253889|NCT01496183|Antiemetics|antiemetics|mesh-ancestor
111253890|NCT01496183|Autonomic Agents|autonomic agents|mesh-ancestor
111253891|NCT01496183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111253892|NCT01496183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111253893|NCT01496183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111253894|NCT01496183|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111253895|NCT01496183|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111253896|NCT01496183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111253897|NCT01496183|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111253898|NCT01496183|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111253899|NCT01496183|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111253900|NCT01496183|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111253901|NCT01496183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111253902|NCT01496183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111253903|NCT01496183|Serotonin Agents|serotonin agents|mesh-ancestor
111253904|NCT01495793|Rotigotine|rotigotine|mesh-list
111253905|NCT01495793|Dopamine Agonists|dopamine agonists|mesh-ancestor
111253906|NCT01495793|Dopamine Agents|dopamine agents|mesh-ancestor
111253907|NCT01495793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111253908|NCT01495793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111253909|NCT01495793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111253910|NCT02374008|Dexamethasone|dexamethasone|mesh-list
111253911|NCT02374008|Ketorolac|ketorolac|mesh-list
111253912|NCT02374008|Ropivacaine|ropivacaine|mesh-list
111253913|NCT02374008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111253914|NCT02374008|Antiemetics|antiemetics|mesh-ancestor
111253915|NCT02374008|Autonomic Agents|autonomic agents|mesh-ancestor
111253916|NCT02374008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111253917|NCT02374008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111253918|NCT02374008|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111253919|NCT02374008|Glucocorticoids|glucocorticoids|mesh-ancestor
111253920|NCT02374008|Hormones|hormones|mesh-ancestor
111253921|NCT02374008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111253922|NCT02374008|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110978228|NCT03263390|Anti-Obesity Agents|anti-obesity agents|mesh-list
111253923|NCT02374008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111253924|NCT02374008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111253925|NCT02374008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111253926|NCT02374008|Anesthetics, Local|anesthetics, local|mesh-ancestor
111253927|NCT02374008|Anesthetics|anesthetics|mesh-ancestor
111253928|NCT02374008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111253929|NCT02374008|Sensory System Agents|sensory system agents|mesh-ancestor
111253930|NCT02374008|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111253931|NCT02374008|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111253932|NCT02374008|Analgesics|analgesics|mesh-ancestor
111253933|NCT02374008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111253934|NCT02374008|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111253935|NCT04505280|Lidocaine|lidocaine|mesh-list
111253936|NCT04505280|Anesthetics, Local|anesthetics, local|mesh-ancestor
111253937|NCT04505280|Anesthetics|anesthetics|mesh-ancestor
111253938|NCT04505280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111253939|NCT04505280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111253940|NCT04505280|Sensory System Agents|sensory system agents|mesh-ancestor
111253941|NCT04505280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111253942|NCT04505280|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111253943|NCT04505280|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111253944|NCT04505280|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111253945|NCT04505280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111253946|NCT04505280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111253947|NCT02366676|Hyaluronic Acid|hyaluronic acid|mesh-list
111253948|NCT02366676|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111253949|NCT02366676|Immunologic Factors|immunologic factors|mesh-ancestor
111253950|NCT02366676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111253951|NCT02366676|Viscosupplements|viscosupplements|mesh-ancestor
111253952|NCT02366676|Protective Agents|protective agents|mesh-ancestor
111253953|NCT02373384|Allopurinol|allopurinol|mesh-list
111253954|NCT02373384|Potassium Citrate|potassium citrate|mesh-list
111253955|NCT02373384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111253956|NCT02373384|Antimetabolites|antimetabolites|mesh-ancestor
111253957|NCT02373384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111253958|NCT02373384|Gout Suppressants|gout suppressants|mesh-ancestor
111253959|NCT02373384|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111253960|NCT02373384|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111253961|NCT02373384|Antioxidants|antioxidants|mesh-ancestor
111253962|NCT02373384|Protective Agents|protective agents|mesh-ancestor
111253963|NCT02373384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111253964|NCT02373384|Diuretics|diuretics|mesh-ancestor
111253965|NCT02373384|Natriuretic Agents|natriuretic agents|mesh-ancestor
111253966|NCT02373384|Expectorants|expectorants|mesh-ancestor
111253967|NCT02373384|Respiratory System Agents|respiratory system agents|mesh-ancestor
111253968|NCT01494467|Azelaic acid|azelaic acid|mesh-list
111253969|NCT01494467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111253970|NCT01494467|Dermatologic Agents|dermatologic agents|mesh-ancestor
111253971|NCT02881086|Cytarabine|cytarabine|mesh-list
111253972|NCT02881086|Dexamethasone|dexamethasone|mesh-list
111253973|NCT02881086|Prednisolone|prednisolone|mesh-list
111253974|NCT02881086|Cyclophosphamide|cyclophosphamide|mesh-list
111253975|NCT02881086|Rituximab|rituximab|mesh-list
111253976|NCT02881086|Methotrexate|methotrexate|mesh-list
111253977|NCT02881086|Fludarabine|fludarabine|mesh-list
111253978|NCT02881086|Vincristine|vincristine|mesh-list
111253979|NCT02881086|Doxorubicin|doxorubicin|mesh-list
111253980|NCT02881086|Daunorubicin|daunorubicin|mesh-list
111253981|NCT02881086|Asparaginase|asparaginase|mesh-list
111253982|NCT02881086|Mercaptopurine|mercaptopurine|mesh-list
111253983|NCT02881086|Idarubicin|idarubicin|mesh-list
111253984|NCT02881086|Pegaspargase|pegaspargase|mesh-list
111253985|NCT02881086|Vindesine|vindesine|mesh-list
111253986|NCT02881086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111253987|NCT02881086|Immunologic Factors|immunologic factors|mesh-ancestor
111253988|NCT02881086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111253989|NCT02881086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111253990|NCT02881086|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111253991|NCT02881086|Alkylating Agents|alkylating agents|mesh-ancestor
111253992|NCT02881086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111253993|NCT02881086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111253994|NCT02881086|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111253995|NCT02881086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111102574|NCT02697617|Pioglitazone|pioglitazone|mesh-list
111479677|NCT03783026|Apremilast|apremilast|mesh-list
111102579|NCT02396225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111480112|NCT04385550|Paclitaxel|paclitaxel|mesh-list
111480407|NCT04362384|Glucocorticoids|glucocorticoids|mesh-ancestor
111480482|NCT04358796|Perflubron|perflubron|mesh-list
111480567|NCT04355052|Camostat|camostat|mesh-list
111481086|NCT00704106|Entecavir|entecavir|mesh-list
111481150|NCT01326000|Cetuximab|cetuximab|mesh-list
111481224|NCT03030300|Metformin|metformin|mesh-list
111102607|NCT02396303|Oxytocics|oxytocics|mesh-ancestor
111481507|NCT03005496|Zinc|zinc|mesh-list
111482031|NCT05313828|Acyclovir|acyclovir|mesh-list
111482183|NCT01327638|Etoricoxib|etoricoxib|mesh-list
111482238|NCT00589056|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111253996|NCT02881086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111483002|NCT00728910|Niacin|niacin|mesh-list
111483050|NCT00733278|Copper|copper|mesh-list
111253997|NCT02881086|Antiemetics|antiemetics|mesh-ancestor
111483352|NCT00766116|Gemtuzumab|gemtuzumab|mesh-list
111483419|NCT00785772|Gabapentin|gabapentin|mesh-list
111253998|NCT02881086|Autonomic Agents|autonomic agents|mesh-ancestor
111483793|NCT00820872|Carboplatin|carboplatin|mesh-list
111483862|NCT02641236|Vancomycin|vancomycin|mesh-list
111484080|NCT00845130|Vitamins|vitamins|mesh-list
111484371|NCT00896064|Immunologic Factors|immunologic factors|mesh-ancestor
111484663|NCT00932022|Cholinergic Agents|cholinergic agents|mesh-ancestor
111484737|NCT00945750|Histamine Agents|histamine agents|mesh-ancestor
111102686|NCT05494047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111484978|NCT00997620|Xhance|xhance|mesh-list
111485028|NCT01000818|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111485104|NCT01007994|Adrenergic Agents|adrenergic agents|mesh-ancestor
110693451|NCT00345579|PENTA|penta|mesh-list
111485461|NCT01045122|Propofol|propofol|mesh-list
111485605|NCT05821192|Rituximab|rituximab|mesh-list
111485754|NCT06023862|Paclitaxel|paclitaxel|mesh-list
111485822|NCT02464696|Prednisolone|prednisolone|mesh-list
111485907|NCT01738139|Ipilimumab|ipilimumab|mesh-list
111486112|NCT05270863|Autonomic Agents|autonomic agents|mesh-ancestor
111486185|NCT05114837|Alkylating Agents|alkylating agents|mesh-ancestor
111486622|NCT03636451|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111486769|NCT01060098|Adalimumab|adalimumab|mesh-list
111487036|NCT01105650|Analgesics|analgesics|mesh-ancestor
111487265|NCT01129440|Fluorides|fluorides|mesh-list
111487346|NCT01144338|Exenatide|exenatide|mesh-list
111253999|NCT02881086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111102792|NCT05483439|Trastuzumab|trastuzumab|mesh-list
111102800|NCT05483439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111102838|NCT04543071|Antimetabolites|antimetabolites|mesh-ancestor
111488095|NCT01286454|Urological Agents|urological agents|mesh-ancestor
111488173|NCT01304082|Lidocaine|lidocaine|mesh-list
111488394|NCT01328964|Glucocorticoids|glucocorticoids|mesh-ancestor
111488526|NCT01339260|Hormones|hormones|mesh-ancestor
111102845|NCT05487807|Nicotine|nicotine|mesh-list
111102847|NCT05487807|Autonomic Agents|autonomic agents|mesh-ancestor
111102858|NCT05476731|Antifungal Agents|antifungal agents|mesh-list
111489345|NCT01535976|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111489418|NCT01548690|Antimetabolites|antimetabolites|mesh-ancestor
111489559|NCT01577706|Alprazolam|alprazolam|mesh-list
111489634|NCT05564442|Sensory System Agents|sensory system agents|mesh-ancestor
111489653|NCT05672394|Lidocaine|lidocaine|mesh-list
111103281|NCT02540265|Meloxicam|meloxicam|mesh-list
111103356|NCT03142893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111103575|NCT02530125|Pidilizumab|pidilizumab|mesh-list
111489673|NCT05672394|Autonomic Agents|autonomic agents|mesh-ancestor
111103727|NCT03163589|Epoetin Alfa|epoetin alfa|mesh-list
111489684|NCT05607342|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111104441|NCT04132427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111254000|NCT02881086|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111254001|NCT02881086|Glucocorticoids|glucocorticoids|mesh-ancestor
111105089|NCT03112577|Xhance|xhance|mesh-list
111489752|NCT02538666|Nivolumab|nivolumab|mesh-list
111254002|NCT02881086|Hormones|hormones|mesh-ancestor
111489765|NCT05120076|Antiemetics|antiemetics|mesh-ancestor
111105921|NCT02344589|Lidocaine|lidocaine|mesh-list
111106075|NCT02709889|Hormones|hormones|mesh-ancestor
111106435|NCT03187015|Entinostat|entinostat|mesh-list
111106652|NCT03191383|Vaccines|vaccines|mesh-list
111106931|NCT05076695|Trastuzumab|trastuzumab|mesh-list
111107001|NCT02428777|Narcotics|narcotics|mesh-ancestor
110824305|NCT03480646|Hormones|hormones|mesh-ancestor
111107340|NCT03139487|Protease Inhibitors|protease inhibitors|mesh-ancestor
111489873|NCT01605942|Hormones|hormones|mesh-ancestor
111107612|NCT02018458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111107760|NCT02415985|Lopinavir|lopinavir|mesh-list
111107829|NCT03180229|Antiemetics|antiemetics|mesh-ancestor
111489898|NCT01611948|Aprepitant|aprepitant|mesh-list
111108185|NCT05737511|Citalopram|citalopram|mesh-list
111108396|NCT02413021|Antiviral Agents|antiviral agents|mesh-ancestor
111489985|NCT01631682|Oxytocics|oxytocics|mesh-ancestor
111489990|NCT01631682|Adrenergic Agents|adrenergic agents|mesh-ancestor
111109287|NCT05102045|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111109361|NCT03477851|Analgesics|analgesics|mesh-ancestor
111109364|NCT02409199|Docetaxel|docetaxel|mesh-list
111109438|NCT03174067|Clonidine|clonidine|mesh-list
111109509|NCT02699125|Guanfacine|guanfacine|mesh-list
111109651|NCT02407171|Pembrolizumab|pembrolizumab|mesh-list
111109944|NCT02406703|Mepivacaine|mepivacaine|mesh-list
111110160|NCT03540875|Propofol|propofol|mesh-list
111490076|NCT01643616|Prilocaine|prilocaine|mesh-list
111110944|NCT04649398|Vasodilator Agents|vasodilator agents|mesh-ancestor
111111016|NCT03106363|Analgesics|analgesics|mesh-ancestor
111111089|NCT02695537|Cannabidiol|cannabidiol|mesh-list
111490094|NCT01644396|Adalimumab|adalimumab|mesh-list
111111605|NCT04184453|Deferiprone|deferiprone|mesh-list
111111965|NCT05124431|Everolimus|everolimus|mesh-list
111112022|NCT05676463|Antioxidants|antioxidants|mesh-ancestor
111490121|NCT01651806|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111112535|NCT05890534|Pycnogenols|pycnogenols|mesh-list
111113041|NCT03824704|Nivolumab|nivolumab|mesh-list
111490174|NCT01661946|Growth Substances|growth substances|mesh-ancestor
111490177|NCT01663272|Gemcitabine|gemcitabine|mesh-list
111113896|NCT02382523|Hormones|hormones|mesh-ancestor
111114251|NCT01995526|Insulin|insulin|mesh-list
111114327|NCT05070221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111114990|NCT03100019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111115133|NCT05058755|Antimetabolites|antimetabolites|mesh-ancestor
111115422|NCT01969084|Linagliptin|linagliptin|mesh-list
111115507|NCT02362165|Bortezomib|bortezomib|mesh-list
111115621|NCT02361619|Midazolam|midazolam|mesh-list
111115699|NCT01950364|Immunotoxins|immunotoxins|mesh-ancestor
111115761|NCT02357407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110832925|NCT03468790|Xhance|xhance|mesh-list
111115903|NCT01949116|Antimetabolites|antimetabolites|mesh-ancestor
111116056|NCT05032001|Biguanides|biguanides|mesh-list
111116126|NCT02349763|Dexamethasone|dexamethasone|mesh-list
111490320|NCT01707420|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111490323|NCT01707420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111116409|NCT02343679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111116478|NCT02343289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111490376|NCT05661942|Calcium|calcium|mesh-list
111490390|NCT05157360|Micronutrients|micronutrients|mesh-ancestor
111490436|NCT02130492|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
111490446|NCT01309074|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111118092|NCT05916742|Disinfectants|disinfectants|mesh-ancestor
111118188|NCT05916066|Niacin|niacin|mesh-list
111118522|NCT05912335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110959421|NCT02739984|Evolocumab|evolocumab|mesh-list
110959565|NCT05631730|Metoprolol|metoprolol|mesh-list
110959744|NCT02290470|Tubulin Modulators|tubulin modulators|mesh-ancestor
110959897|NCT03387098|Antimetabolites|antimetabolites|mesh-ancestor
110959962|NCT03386630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110960175|NCT03516630|Moxifloxacin|moxifloxacin|mesh-list
110960767|NCT03369782|Rocuronium|rocuronium|mesh-list
111490598|NCT04007874|Antioxidants|antioxidants|mesh-ancestor
110961166|NCT02293356|Nimotuzumab|nimotuzumab|mesh-list
110961601|NCT02303418|Oxytocin|oxytocin|mesh-list
111490633|NCT02987946|Nadroparin|nadroparin|mesh-list
110961957|NCT04509440|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110962105|NCT04508816|Cetuximab|cetuximab|mesh-list
110962610|NCT02317146|Magnesium Sulfate|magnesium sulfate|mesh-list
110962686|NCT04610476|Ixekizumab|ixekizumab|mesh-list
110962755|NCT05517538|Cholinergic Agents|cholinergic agents|mesh-ancestor
110962900|NCT03348098|Paclitaxel|paclitaxel|mesh-list
110963034|NCT04425226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110963099|NCT04294654|Vortioxetine|vortioxetine|mesh-list
110963162|NCT02319564|Hormones|hormones|mesh-ancestor
110963233|NCT05515120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111490702|NCT01740726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110963577|NCT00101907|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111490706|NCT01740726|Antidepressive Agents|antidepressive agents|mesh-ancestor
111490764|NCT01752426|Deuterium Oxide|deuterium oxide|mesh-list
110964344|NCT02172417|Ranitidine|ranitidine|mesh-list
110964413|NCT02172495|Bromides|bromides|mesh-list
110964983|NCT02182167|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110965051|NCT03339362|Antiemetics|antiemetics|mesh-ancestor
110965194|NCT02496494|Tacrolimus|tacrolimus|mesh-list
110965309|NCT03324542|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111490932|NCT01787916|Incretins|incretins|mesh-ancestor
110965731|NCT02560012|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110965804|NCT03322124|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110965875|NCT04442906|Adrenergic Agents|adrenergic agents|mesh-ancestor
110965954|NCT06036030|Primaquine|primaquine|mesh-list
110966264|NCT06005688|Analgesics|analgesics|mesh-ancestor
110966472|NCT05862285|Ipatasertib|ipatasertib|mesh-list
110967250|NCT05167825|Macitentan|macitentan|mesh-list
110967439|NCT05000294|Tivozanib|tivozanib|mesh-list
110967576|NCT04923893|Antiemetics|antiemetics|mesh-ancestor
110967614|NCT04919226|Vitamins|vitamins|mesh-ancestor
110968029|NCT04585789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111491120|NCT06019507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110968229|NCT04439292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110968292|NCT04379596|Antimetabolites|antimetabolites|mesh-ancestor
110968493|NCT04133636|Immunologic Factors|immunologic factors|mesh-ancestor
110968567|NCT04079738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110969145|NCT03220022|Antibodies|antibodies|mesh-list
110969327|NCT02730923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110969552|NCT01998971|Prednisone|prednisone|mesh-list
110969915|NCT03326960|Propofol|propofol|mesh-list
111491238|NCT06011772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111491248|NCT06011772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111491256|NCT06011772|Micronutrients|micronutrients|mesh-ancestor
110971842|NCT03533127|Growth Inhibitors|growth inhibitors|mesh-ancestor
110972414|NCT03483636|Lemborexant|lemborexant|mesh-list
111491366|NCT05968690|Vasodilator Agents|vasodilator agents|mesh-ancestor
111491398|NCT05933577|Pembrolizumab|pembrolizumab|mesh-list
110690336|NCT00381303|Ritonavir|ritonavir|mesh-list
110973342|NCT04382352|Immunologic Factors|immunologic factors|mesh-ancestor
110973541|NCT02787005|Pembrolizumab|pembrolizumab|mesh-list
111491468|NCT05890963|Ibalizumab|ibalizumab|mesh-list
110974175|NCT02224443|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
110974322|NCT02499900|(T,G)-A-L|(t,g)-a-l|mesh-list
110974799|NCT00702650|Hormones|hormones|mesh-ancestor
110974875|NCT04983498|Ondansetron|ondansetron|mesh-list
110975581|NCT01390545|Veltuzumab|veltuzumab|mesh-list
110975720|NCT01356849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110975791|NCT01302249|Latanoprost|latanoprost|mesh-list
110976019|NCT03135171|Pertuzumab|pertuzumab|mesh-list
110976158|NCT00818571|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110976233|NCT05088876|Acetaminophen|acetaminophen|mesh-list
110976499|NCT04440280|Antidotes|antidotes|mesh-ancestor
110976771|NCT02462252|Cyclosporine|cyclosporine|mesh-list
110977123|NCT00834873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110977695|NCT02461004|Ezetimibe|ezetimibe|mesh-list
111491708|NCT05677490|Vitamins|vitamins|mesh-ancestor
111491781|NCT05627232|Anesthetics|anesthetics|mesh-ancestor
111491995|NCT05377606|GABA Agents|gaba agents|mesh-ancestor
111492427|NCT04803201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111492498|NCT04753437|Antacids|antacids|mesh-ancestor
110977889|NCT03284762|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111492922|NCT04076579|Trabectedin|trabectedin|mesh-list
111493883|NCT00887146|Vincristine|vincristine|mesh-list
110977932|NCT03284294|Vitamin D|vitamin d|mesh-list
110977935|NCT03284294|Vitamins|vitamins|mesh-ancestor
110977976|NCT02737475|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111495021|NCT05574894|Hormones|hormones|mesh-list
111495456|NCT02024724|Dexamethasone|dexamethasone|mesh-list
110978002|NCT02459756|Citric Acid|citric acid|mesh-list
111495744|NCT02139540|Anesthetics|anesthetics|mesh-ancestor
111495960|NCT02209272|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111496023|NCT02233296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111496534|NCT02360124|Fluorides|fluorides|mesh-list
111496749|NCT05495568|Adalimumab|adalimumab|mesh-list
110978054|NCT04502381|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
110978056|NCT03264794|Gefitinib|gefitinib|mesh-list
111497264|NCT04509414|Anesthetics|anesthetics|mesh-ancestor
111497549|NCT01768338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111497592|NCT00281658|Paclitaxel|paclitaxel|mesh-list
111497738|NCT02464176|BB 1101|bb 1101|mesh-list
111497815|NCT02486016|Fentanyl|fentanyl|mesh-list
111497877|NCT02495454|Obinutuzumab|obinutuzumab|mesh-list
111254003|NCT02881086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111254004|NCT02881086|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111254005|NCT02881086|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111254006|NCT02881086|Abortifacient Agents|abortifacient agents|mesh-ancestor
111254007|NCT02881086|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111254008|NCT02881086|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111254009|NCT02881086|Antimetabolites|antimetabolites|mesh-ancestor
111254010|NCT02881086|Dermatologic Agents|dermatologic agents|mesh-ancestor
111254011|NCT02881086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111254012|NCT02881086|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111254013|NCT02881086|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111254014|NCT02881086|Antiviral Agents|antiviral agents|mesh-ancestor
111254015|NCT02881086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111254016|NCT02881086|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111254017|NCT02881086|Tubulin Modulators|tubulin modulators|mesh-ancestor
111254018|NCT02881086|Antimitotic Agents|antimitotic agents|mesh-ancestor
111254019|NCT02881086|Mitosis Modulators|mitosis modulators|mesh-ancestor
111254020|NCT02881086|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111254021|NCT02881086|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111254022|NCT02881086|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111254023|NCT03922542|Riboflavin|riboflavin|mesh-list
111254024|NCT03922542|Vitamin B Complex|vitamin b complex|mesh-ancestor
111254025|NCT03922542|Vitamins|vitamins|mesh-ancestor
111254026|NCT03922542|Micronutrients|micronutrients|mesh-ancestor
111254027|NCT03922542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111254028|NCT03922542|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111254029|NCT03922542|Dermatologic Agents|dermatologic agents|mesh-ancestor
111254030|NCT01493687|Azelaic acid|azelaic acid|mesh-list
111254031|NCT01493687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111254032|NCT01493687|Dermatologic Agents|dermatologic agents|mesh-ancestor
111254033|NCT02362308|Eplerenone|eplerenone|mesh-list
111254034|NCT02362308|Spironolactone|spironolactone|mesh-list
111254035|NCT02362308|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
111254036|NCT02362308|Mineralocorticoids|mineralocorticoids|mesh-list
111254037|NCT02362308|Hormone Antagonists|hormone antagonists|mesh-ancestor
111254038|NCT02362308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111254039|NCT02362308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111254040|NCT02362308|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
111254041|NCT02362308|Diuretics|diuretics|mesh-ancestor
111254042|NCT02362308|Natriuretic Agents|natriuretic agents|mesh-ancestor
111254043|NCT02362308|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111254044|NCT02362308|Hormones|hormones|mesh-ancestor
111254045|NCT02366208|Adefovir|adefovir|mesh-list
111254046|NCT02366208|Thymalfasin|thymalfasin|mesh-list
111254047|NCT02366208|Antiviral Agents|antiviral agents|mesh-ancestor
111254048|NCT02366208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111254049|NCT02366208|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111254050|NCT02366208|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111254051|NCT02366208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111254052|NCT02366208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111254053|NCT02366208|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111254054|NCT02366208|Immunologic Factors|immunologic factors|mesh-ancestor
111254055|NCT02366208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111254056|NCT02373462|Olmesartan|olmesartan|mesh-list
111254057|NCT02373462|Antihypertensive Agents|antihypertensive agents|mesh-list
111254058|NCT02373462|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111254059|NCT02373462|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111254060|NCT02373462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111254061|NCT01523587|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111254062|NCT01523587|Afatinib|afatinib|mesh-list
111254063|NCT01523587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111254064|NCT01523587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111254065|NCT01523587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111254066|NCT01523587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111254067|NCT00310401|Albuterol|albuterol|mesh-list
111254068|NCT00310401|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111254069|NCT00310401|Autonomic Agents|autonomic agents|mesh-ancestor
111254070|NCT00310401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111254071|NCT00310401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111254072|NCT00310401|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111254073|NCT00310401|Respiratory System Agents|respiratory system agents|mesh-ancestor
111254074|NCT00310401|Tocolytic Agents|tocolytic agents|mesh-ancestor
111254075|NCT00310401|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111254076|NCT00310401|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111254077|NCT00310401|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111254078|NCT00310401|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111254079|NCT00310401|Adrenergic Agents|adrenergic agents|mesh-ancestor
111254080|NCT00310401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111254081|NCT00310401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111254082|NCT00310791|Levonorgestrel|levonorgestrel|mesh-list
111254083|NCT00310791|Ethinyl Estradiol|ethinyl estradiol|mesh-list
111254084|NCT00310791|Hormones|hormones|mesh-list
111254085|NCT00310791|Estradiol|estradiol|mesh-list
111254086|NCT00310791|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
111254087|NCT00310791|Estrogens|estrogens|mesh-list
111254088|NCT00310791|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
111254089|NCT00310791|Progestins|progestins|mesh-list
111254090|NCT00310791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110706156|NCT00375674|Sunitinib|sunitinib|mesh-list
111254091|NCT00310791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111254092|NCT00310791|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111254093|NCT00310791|Contraceptive Agents|contraceptive agents|mesh-ancestor
111254094|NCT00310791|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111254095|NCT00310791|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111254096|NCT00310791|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111254097|NCT00310791|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111254098|NCT00310791|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111254099|NCT00310791|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111254100|NCT00310791|Immunologic Factors|immunologic factors|mesh-ancestor
111254101|NCT02362152|Diclofenac|diclofenac|mesh-list
111254102|NCT02362152|Fluorouracil|fluorouracil|mesh-list
111254103|NCT02362152|Imiquimod|imiquimod|mesh-list
111254104|NCT02362152|Antimetabolites|antimetabolites|mesh-ancestor
111254105|NCT02362152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111254106|NCT02362152|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111254107|NCT02362152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111254108|NCT02362152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111254109|NCT02362152|Immunologic Factors|immunologic factors|mesh-ancestor
111254110|NCT02362152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111254111|NCT02362152|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111254112|NCT02362152|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111254113|NCT02362152|Analgesics|analgesics|mesh-ancestor
111254114|NCT02362152|Sensory System Agents|sensory system agents|mesh-ancestor
111254115|NCT02362152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111254116|NCT02362152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111254117|NCT02362152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111254118|NCT02362152|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111254119|NCT02362152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111254120|NCT02362152|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111254121|NCT02362152|Interferon Inducers|interferon inducers|mesh-ancestor
111254122|NCT01493531|Allopurinol|allopurinol|mesh-list
111254123|NCT01493531|Lesinurad|lesinurad|mesh-list
111254124|NCT01493531|Antimetabolites|antimetabolites|mesh-ancestor
111254125|NCT01493531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111254126|NCT01493531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111254127|NCT01493531|Gout Suppressants|gout suppressants|mesh-ancestor
111254128|NCT01493531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111254129|NCT01493531|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111254130|NCT01493531|Antioxidants|antioxidants|mesh-ancestor
111254131|NCT01493531|Protective Agents|protective agents|mesh-ancestor
111254132|NCT01493531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111254133|NCT01493531|Uricosuric Agents|uricosuric agents|mesh-ancestor
111254134|NCT02105415|Ketamine|ketamine|mesh-list
111254135|NCT02105415|Propofol|propofol|mesh-list
111254136|NCT02105415|Etomidate|etomidate|mesh-list
111254137|NCT02105415|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111254138|NCT02105415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111254139|NCT02105415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111254140|NCT02105415|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111254141|NCT02105415|Anesthetics, General|anesthetics, general|mesh-ancestor
111254142|NCT02105415|Anesthetics|anesthetics|mesh-ancestor
111254143|NCT02105415|Analgesics|analgesics|mesh-ancestor
111254144|NCT02105415|Sensory System Agents|sensory system agents|mesh-ancestor
111254145|NCT02105415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111254146|NCT02105415|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111254147|NCT02105415|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111254148|NCT02105415|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111254149|NCT02105415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111254150|NCT02105415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111254151|NCT01523275|Mitomycins|mitomycins|mesh-list
111254152|NCT01523275|Mitomycin|mitomycin|mesh-list
111254153|NCT01523275|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111254154|NCT01523275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111254155|NCT01523275|Alkylating Agents|alkylating agents|mesh-ancestor
111254156|NCT01523275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111254157|NCT01523275|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111254158|NCT01523275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111254160|NCT00304707|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111254161|NCT00304707|Antidepressive Agents|antidepressive agents|mesh-ancestor
111254162|NCT00304707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111254163|NCT00304707|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111254164|NCT00304707|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111254165|NCT00304707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110978114|NCT03434379|Sorafenib|sorafenib|mesh-list
111254166|NCT00304707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111254167|NCT00304707|Dopamine Agents|dopamine agents|mesh-ancestor
111254168|NCT00304707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111254169|NCT00304707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111254170|NCT00304707|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111254171|NCT00304707|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111254172|NCT00304707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111254173|NCT04409483|Ritonavir|ritonavir|mesh-list
111254174|NCT04409483|Lopinavir|lopinavir|mesh-list
111254175|NCT04409483|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111254176|NCT04409483|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111254177|NCT04409483|Protease Inhibitors|protease inhibitors|mesh-ancestor
111254178|NCT04409483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111254179|NCT04409483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111254180|NCT04409483|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111254181|NCT04409483|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111254182|NCT04409483|Antiviral Agents|antiviral agents|mesh-ancestor
111254183|NCT04409483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111254184|NCT04409483|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111254185|NCT04409483|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111254186|NCT02365740|Insulin|insulin|mesh-list
111254187|NCT02365740|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111254188|NCT02365740|Hormones|hormones|mesh-list
111254189|NCT02365740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111254190|NCT02365740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111254191|NCT02365740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111254192|NCT02437110|Ritonavir|ritonavir|mesh-list
111254193|NCT02437110|Darunavir|darunavir|mesh-list
111254194|NCT02437110|Tenofovir|tenofovir|mesh-list
111254195|NCT02437110|Dolutegravir|dolutegravir|mesh-list
111254196|NCT02437110|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111254197|NCT02437110|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111254198|NCT02437110|Protease Inhibitors|protease inhibitors|mesh-ancestor
111254199|NCT02437110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111254200|NCT02437110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111254201|NCT02437110|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111254202|NCT02437110|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111254203|NCT02437110|Antiviral Agents|antiviral agents|mesh-ancestor
111254204|NCT02437110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111254205|NCT02437110|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111254206|NCT02437110|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111254207|NCT02437110|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111254208|NCT02437110|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111254209|NCT02437110|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111254210|NCT02437110|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111254211|NCT05267847|Anesthetics|anesthetics|mesh-list
111254212|NCT05267847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111254213|NCT05267847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111254214|NCT05267457|Vanadium|vanadium|mesh-list
111254215|NCT05267457|Trace Elements|trace elements|mesh-ancestor
111254216|NCT05267457|Micronutrients|micronutrients|mesh-ancestor
111254217|NCT05267457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111254218|NCT00351039|Bevacizumab|bevacizumab|mesh-list
111254219|NCT00351039|Pemetrexed|pemetrexed|mesh-list
111254220|NCT00351039|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111254221|NCT00351039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111254222|NCT00351039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111254223|NCT00351039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111254224|NCT00351039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111254225|NCT00351039|Growth Substances|growth substances|mesh-ancestor
111254226|NCT00351039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111254227|NCT00351039|Growth Inhibitors|growth inhibitors|mesh-ancestor
111254228|NCT00351039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111254229|NCT00351039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111254230|NCT00351039|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111254231|NCT00351039|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111254232|NCT00351039|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111254233|NCT02372916|Ranibizumab|ranibizumab|mesh-list
111254234|NCT02372916|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111254235|NCT02372916|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111254236|NCT02372916|Growth Substances|growth substances|mesh-ancestor
111254237|NCT02372916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111254238|NCT02372916|Growth Inhibitors|growth inhibitors|mesh-ancestor
111254239|NCT02372916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111254240|NCT02361528|Sargramostim|sargramostim|mesh-list
111254241|NCT02361528|Immunologic Factors|immunologic factors|mesh-ancestor
111254242|NCT02361528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111254243|NCT01572727|Paclitaxel|paclitaxel|mesh-list
111254244|NCT01572727|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111254245|NCT01572727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111254246|NCT01572727|Tubulin Modulators|tubulin modulators|mesh-ancestor
111254247|NCT01572727|Antimitotic Agents|antimitotic agents|mesh-ancestor
111254248|NCT01572727|Mitosis Modulators|mitosis modulators|mesh-ancestor
111254249|NCT01572727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111254250|NCT02359266|Vitamin D|vitamin d|mesh-list
111254251|NCT02359266|Cholecalciferol|cholecalciferol|mesh-list
111254252|NCT02359266|Vitamins|vitamins|mesh-ancestor
111254253|NCT02359266|Micronutrients|micronutrients|mesh-ancestor
111254254|NCT02359266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111254255|NCT02359266|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111254256|NCT02359266|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111254257|NCT02359500|Octreotide|octreotide|mesh-list
111254258|NCT02359500|Edotreotide|edotreotide|mesh-list
111254259|NCT02359500|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111254260|NCT02359500|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111254261|NCT02359500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111254262|NCT02359500|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111254263|NCT02359500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111254264|NCT02372526|Orlistat|orlistat|mesh-list
111254265|NCT02372526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111254266|NCT02372526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111254267|NCT02372526|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111254268|NCT02372526|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111254269|NCT02985697|Midazolam|midazolam|mesh-list
111254270|NCT02985697|Dexmedetomidine|dexmedetomidine|mesh-list
111254271|NCT02985697|Nitrous Oxide|nitrous oxide|mesh-list
111254272|NCT02985697|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111254273|NCT02985697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111254274|NCT02985697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111254275|NCT02985697|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111254276|NCT02985697|Analgesics|analgesics|mesh-ancestor
111254277|NCT02985697|Sensory System Agents|sensory system agents|mesh-ancestor
111254278|NCT02985697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111254279|NCT02985697|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111254280|NCT02985697|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111254281|NCT02985697|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111254282|NCT02985697|Adrenergic Agents|adrenergic agents|mesh-ancestor
111254283|NCT02985697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111254284|NCT02985697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111254285|NCT02985697|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111254286|NCT02985697|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111254287|NCT02985697|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111254288|NCT02985697|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111254289|NCT02985697|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111254290|NCT02985697|Anesthetics, General|anesthetics, general|mesh-ancestor
111254291|NCT02985697|Anesthetics|anesthetics|mesh-ancestor
111254292|NCT02985697|GABA Modulators|gaba modulators|mesh-ancestor
111254293|NCT02985697|GABA Agents|gaba agents|mesh-ancestor
111254294|NCT02985697|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111254295|NCT02372760|Lidocaine|lidocaine|mesh-list
111254296|NCT02372760|Anesthetics|anesthetics|mesh-list
111254297|NCT02372760|Anesthetics, Local|anesthetics, local|mesh-ancestor
111254298|NCT02372760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111254299|NCT02372760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111254300|NCT02372760|Sensory System Agents|sensory system agents|mesh-ancestor
111254301|NCT02372760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111254302|NCT02372760|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110978670|NCT04473261|Iodine|iodine|mesh-list
111254303|NCT02372760|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111254304|NCT02372760|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111254305|NCT02372760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111254306|NCT02372760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111254307|NCT00352911|Mifepristone|mifepristone|mesh-list
111254308|NCT00352911|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
111254309|NCT00352911|Abortifacient Agents|abortifacient agents|mesh-ancestor
111254310|NCT00352911|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111254311|NCT00352911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111254312|NCT00352911|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111254313|NCT00352911|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111254314|NCT00352911|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111254315|NCT00352911|Contraceptive Agents|contraceptive agents|mesh-ancestor
111254316|NCT00352911|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
111254317|NCT00352911|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
111254318|NCT00352911|Hormone Antagonists|hormone antagonists|mesh-ancestor
111254319|NCT00352911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111254320|NCT00352911|Luteolytic Agents|luteolytic agents|mesh-ancestor
111254321|NCT00352911|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111254322|NCT00352911|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
111254323|NCT00353301|Sirolimus|sirolimus|mesh-list
111254324|NCT00353301|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111254325|NCT00353301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111254326|NCT00353301|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111254327|NCT00353301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111254328|NCT00353301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111254329|NCT00353301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111254330|NCT00353301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111254331|NCT00353301|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111254332|NCT00353301|Antifungal Agents|antifungal agents|mesh-ancestor
111254333|NCT00353301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111254334|NCT00353301|Immunologic Factors|immunologic factors|mesh-ancestor
111254335|NCT00353301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111254336|NCT02372604|Cetirizine|cetirizine|mesh-list
111254337|NCT02372604|Levocetirizine|levocetirizine|mesh-list
111254338|NCT02372604|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
111254339|NCT02372604|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111254340|NCT02372604|Histamine Antagonists|histamine antagonists|mesh-ancestor
111254341|NCT02372604|Histamine Agents|histamine agents|mesh-ancestor
111254342|NCT02372604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111254343|NCT02372604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111254344|NCT02372604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111254345|NCT02372604|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111254346|NCT01792323|Insulin Lispro|insulin lispro|mesh-list
111254347|NCT01792323|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111254348|NCT01792323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111254349|NCT02358642|Lisinopril|lisinopril|mesh-list
111254350|NCT02358642|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
111254351|NCT02358642|Enzyme Inhibitors|enzyme inhibitors|mesh-list
111254352|NCT02358642|Protease Inhibitors|protease inhibitors|mesh-ancestor
111254353|NCT02358642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111254354|NCT02358642|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111254355|NCT02358642|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111254356|NCT02358642|Protective Agents|protective agents|mesh-ancestor
111254357|NCT02358642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111254358|NCT03160248|Apremilast|apremilast|mesh-list
111254359|NCT03160248|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111254360|NCT03160248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111254361|NCT03160248|Analgesics|analgesics|mesh-ancestor
111254362|NCT03160248|Sensory System Agents|sensory system agents|mesh-ancestor
111254363|NCT03160248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111254364|NCT03160248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111254365|NCT03160248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111254366|NCT03160248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111254367|NCT03160248|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
111254368|NCT03160248|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111254369|NCT03160248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111254370|NCT03160248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111254371|NCT01522651|Dronedarone|dronedarone|mesh-list
111254372|NCT01522651|Ranolazine|ranolazine|mesh-list
111254373|NCT01522651|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111254374|NCT01522651|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110978678|NCT01358968|Pemetrexed|pemetrexed|mesh-list
111254375|NCT01522651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111254376|NCT01522651|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111254377|NCT02372292|Furosemide|furosemide|mesh-list
111254378|NCT02372292|Diuretics|diuretics|mesh-ancestor
111254379|NCT02372292|Natriuretic Agents|natriuretic agents|mesh-ancestor
111254380|NCT02372292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110978116|NCT03434379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111254381|NCT02372292|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
111254382|NCT02372292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111254383|NCT02372292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111254384|NCT01554241|Vitamin D|vitamin d|mesh-list
111254385|NCT01554241|Cholecalciferol|cholecalciferol|mesh-list
111254386|NCT01554241|Vitamins|vitamins|mesh-ancestor
111254387|NCT01554241|Micronutrients|micronutrients|mesh-ancestor
111254388|NCT01554241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111254389|NCT01554241|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111254390|NCT01554241|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111254391|NCT02353026|Artesunate|artesunate|mesh-list
111254392|NCT02353026|Antimalarials|antimalarials|mesh-ancestor
111254393|NCT02353026|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111254394|NCT02353026|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111254395|NCT02353026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111254396|NCT02353026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111254397|NCT02353026|Antiviral Agents|antiviral agents|mesh-ancestor
111254398|NCT02353026|Schistosomicides|schistosomicides|mesh-ancestor
111254399|NCT02353026|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
111254400|NCT02353026|Anthelmintics|anthelmintics|mesh-ancestor
111254401|NCT01521559|Aflibercept|aflibercept|mesh-list
111254402|NCT01521559|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111254403|NCT01521559|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111254404|NCT01521559|Growth Substances|growth substances|mesh-ancestor
111254405|NCT01521559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111254406|NCT01521559|Growth Inhibitors|growth inhibitors|mesh-ancestor
111254407|NCT01521559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111254408|NCT04438980|Methylprednisolone|methylprednisolone|mesh-list
111254409|NCT04438980|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111254410|NCT04438980|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111254411|NCT04438980|Prednisolone|prednisolone|mesh-list
111254412|NCT04438980|Prednisolone acetate|prednisolone acetate|mesh-list
111254413|NCT04438980|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111254414|NCT04438980|Prednisolone phosphate|prednisolone phosphate|mesh-list
111254415|NCT04438980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111254416|NCT04438980|Antiemetics|antiemetics|mesh-ancestor
111254417|NCT04438980|Autonomic Agents|autonomic agents|mesh-ancestor
111254418|NCT04438980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111254419|NCT04438980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111254420|NCT04438980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111254421|NCT04438980|Glucocorticoids|glucocorticoids|mesh-ancestor
111254422|NCT04438980|Hormones|hormones|mesh-ancestor
111254423|NCT04438980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111254424|NCT04438980|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111254425|NCT04438980|Protective Agents|protective agents|mesh-ancestor
111254426|NCT04438980|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111254427|NCT04438980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111254428|NCT03824847|Clarithromycin|clarithromycin|mesh-list
111254429|NCT03824847|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111254430|NCT03824847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111254431|NCT03824847|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111254432|NCT03824847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111254433|NCT03824847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111254434|NCT03824847|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111254435|NCT03824847|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111254436|NCT01554163|Celecoxib|celecoxib|mesh-list
111254437|NCT01554163|Etoricoxib|etoricoxib|mesh-list
111254438|NCT01554163|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111254439|NCT01554163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111254440|NCT01554163|Analgesics|analgesics|mesh-ancestor
111254441|NCT01554163|Sensory System Agents|sensory system agents|mesh-ancestor
111254442|NCT01554163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111254443|NCT01554163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111254444|NCT01554163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111254445|NCT01554163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111254446|NCT01554163|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111254447|NCT01554163|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111254448|NCT01554163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111254449|NCT01554163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111254451|NCT02360826|Pravastatin|pravastatin|mesh-list
111254452|NCT02360826|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111254453|NCT02360826|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111254454|NCT02360826|Antimetabolites|antimetabolites|mesh-ancestor
111254455|NCT02360826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111254456|NCT02360826|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111254457|NCT02360826|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111254458|NCT02360826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111254459|NCT02361060|Atropine|atropine|mesh-list
111254460|NCT02361060|Neostigmine|neostigmine|mesh-list
111254461|NCT02361060|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111254462|NCT02361060|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111254463|NCT02361060|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111254464|NCT02361060|Autonomic Agents|autonomic agents|mesh-ancestor
111254465|NCT02361060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111254466|NCT02361060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111254467|NCT02361060|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111254468|NCT02361060|Respiratory System Agents|respiratory system agents|mesh-ancestor
111254469|NCT02361060|Mydriatics|mydriatics|mesh-ancestor
111254470|NCT02361060|Parasympatholytics|parasympatholytics|mesh-ancestor
111254471|NCT02361060|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111254472|NCT02361060|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111254473|NCT02361060|Cholinergic Agents|cholinergic agents|mesh-ancestor
111254474|NCT02361060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111254475|NCT02361060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111254476|NCT02361060|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111254477|NCT02361060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111254478|NCT02361060|Parasympathomimetics|parasympathomimetics|mesh-ancestor
111254479|NCT02360982|Fentanyl|fentanyl|mesh-list
111254480|NCT02360982|Propofol|propofol|mesh-list
111254481|NCT02360982|Bupivacaine|bupivacaine|mesh-list
111254482|NCT02360982|Rocuronium|rocuronium|mesh-list
111254483|NCT02360982|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111254484|NCT02360982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111254485|NCT02360982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111254486|NCT02360982|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111254487|NCT02360982|Anesthetics, General|anesthetics, general|mesh-ancestor
111254488|NCT02360982|Anesthetics|anesthetics|mesh-ancestor
111254489|NCT02360982|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111254490|NCT02360982|Narcotics|narcotics|mesh-ancestor
111254491|NCT02360982|Analgesics|analgesics|mesh-ancestor
111254492|NCT02360982|Sensory System Agents|sensory system agents|mesh-ancestor
111254493|NCT02360982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111254494|NCT02360982|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111254495|NCT02360982|Anesthetics, Local|anesthetics, local|mesh-ancestor
111254496|NCT02360982|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
111254497|NCT02360982|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
111254498|NCT02360982|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111254499|NCT03786237|ON 01910|on 01910|mesh-list
111254500|NCT03786237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111254501|NCT03786237|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111254502|NCT03786237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111254503|NCT03786237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111254504|NCT01553851|Trametinib|trametinib|mesh-list
111254505|NCT01553851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111254506|NCT01553851|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111254507|NCT01553851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111254508|NCT01553851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111254509|NCT02358018|Edotreotide|edotreotide|mesh-list
111254510|NCT02358018|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111254511|NCT02358018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111254512|NCT01552915|Methylphenidate|methylphenidate|mesh-list
111254513|NCT01552915|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
111254514|NCT01552915|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111254515|NCT01552915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111254516|NCT01552915|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111254517|NCT01552915|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111254518|NCT01552915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111254519|NCT01552915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111254520|NCT01552915|Dopamine Agents|dopamine agents|mesh-ancestor
111254521|NCT01552915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111254522|NCT02352714|Lidocaine|lidocaine|mesh-list
111254523|NCT02352714|Anesthetics, Local|anesthetics, local|mesh-ancestor
111254524|NCT02352714|Anesthetics|anesthetics|mesh-ancestor
111254525|NCT02352714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111254526|NCT02352714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111254527|NCT02352714|Sensory System Agents|sensory system agents|mesh-ancestor
111254528|NCT02352714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111254529|NCT02352714|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110978120|NCT03434379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111254530|NCT02352714|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111254531|NCT02352714|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111254532|NCT02352714|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111254533|NCT02352714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111254535|NCT03911557|Tremelimumab|tremelimumab|mesh-list
111254536|NCT03911557|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111254537|NCT03911557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111254538|NCT00356031|Bevacizumab|bevacizumab|mesh-list
111254539|NCT00356031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111254540|NCT00356031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111254541|NCT00356031|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111254542|NCT00356031|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111254543|NCT00356031|Growth Substances|growth substances|mesh-ancestor
111254544|NCT00356031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111254545|NCT00356031|Growth Inhibitors|growth inhibitors|mesh-ancestor
111254546|NCT02038842|Vaccines|vaccines|mesh-list
111254547|NCT02038842|Immunologic Factors|immunologic factors|mesh-ancestor
111254548|NCT02038842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111254549|NCT01790139|Simethicone|simethicone|mesh-list
111254550|NCT01790139|Antifoaming Agents|antifoaming agents|mesh-ancestor
111254551|NCT01790139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111254552|NCT01790139|Emollients|emollients|mesh-ancestor
111254553|NCT01790139|Dermatologic Agents|dermatologic agents|mesh-ancestor
111254554|NCT02360592|Interferons|interferons|mesh-list
111254555|NCT02360592|Interferon-alpha|interferon-alpha|mesh-list
111254556|NCT02360592|Interferon alpha-2|interferon alpha-2|mesh-list
111254557|NCT02360592|Entecavir|entecavir|mesh-list
111254558|NCT02360592|Interleukin-2|interleukin-2|mesh-list
111254559|NCT02360592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111254560|NCT02360592|Antiviral Agents|antiviral agents|mesh-ancestor
111254561|NCT02360592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111254562|NCT02360592|Immunologic Factors|immunologic factors|mesh-ancestor
111254563|NCT02360592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111254564|NCT02360592|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111254565|NCT02360592|Analgesics|analgesics|mesh-ancestor
111254566|NCT02360592|Sensory System Agents|sensory system agents|mesh-ancestor
111254567|NCT02360592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111254568|NCT02360202|Clobetasol|clobetasol|mesh-list
111254569|NCT02360202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111254570|NCT02360202|Glucocorticoids|glucocorticoids|mesh-ancestor
111254571|NCT02360202|Hormones|hormones|mesh-ancestor
111254572|NCT02360202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111254573|NCT02360202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111254574|NCT00322101|Cyclosporine|cyclosporine|mesh-list
111254575|NCT00322101|Mycophenolic Acid|mycophenolic acid|mesh-list
111254576|NCT00322101|Cyclophosphamide|cyclophosphamide|mesh-list
111254577|NCT00322101|Busulfan|busulfan|mesh-list
111254578|NCT00322101|Methotrexate|methotrexate|mesh-list
111254579|NCT00322101|Fludarabine|fludarabine|mesh-list
111254580|NCT00322101|Fludarabine phosphate|fludarabine phosphate|mesh-list
111254581|NCT00322101|Tacrolimus|tacrolimus|mesh-list
111254582|NCT00322101|Cyclosporins|cyclosporins|mesh-list
111254583|NCT00322101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111254584|NCT00322101|Immunologic Factors|immunologic factors|mesh-ancestor
111254585|NCT00322101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111254586|NCT00322101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111254587|NCT00322101|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111254588|NCT00322101|Alkylating Agents|alkylating agents|mesh-ancestor
111254589|NCT00322101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111254590|NCT00322101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111254591|NCT00322101|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111254592|NCT00322101|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111254593|NCT00322101|Abortifacient Agents|abortifacient agents|mesh-ancestor
111254594|NCT00322101|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111254595|NCT00322101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111254596|NCT00322101|Antimetabolites|antimetabolites|mesh-ancestor
111254597|NCT00322101|Dermatologic Agents|dermatologic agents|mesh-ancestor
111254598|NCT00322101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111254599|NCT00322101|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111254600|NCT00322101|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111254601|NCT00322101|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111254602|NCT00322101|Antifungal Agents|antifungal agents|mesh-ancestor
111254603|NCT00322101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111254604|NCT00322101|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111254605|NCT00322101|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111254606|NCT00322101|Antitubercular Agents|antitubercular agents|mesh-ancestor
111254607|NCT00322101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111254608|NCT02360046|Hydrocortisone|hydrocortisone|mesh-list
111254609|NCT02360046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111254610|NCT01552681|Immunoglobulins|immunoglobulins|mesh-list
111254611|NCT01552681|Immunologic Factors|immunologic factors|mesh-ancestor
111254612|NCT01552681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111254613|NCT02352402|Ticagrelor|ticagrelor|mesh-list
111254614|NCT02352402|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111254615|NCT02352402|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111254616|NCT02352402|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111254617|NCT02352402|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111254618|NCT02352402|Purinergic Agents|purinergic agents|mesh-ancestor
111254619|NCT02352402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111254620|NCT02352402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111254621|NCT02352402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111254622|NCT02357472|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
111254623|NCT02357472|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111254624|NCT02357472|Immunologic Factors|immunologic factors|mesh-ancestor
111254625|NCT02357472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111254626|NCT00322335|PENTA|penta|mesh-list
111254627|NCT00322335|Anticoagulants|anticoagulants|mesh-ancestor
111254628|NCT00322335|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111254629|NCT00322335|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111254630|NCT00322335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111254631|NCT03153852|Glycolic acid|glycolic acid|mesh-list
111254632|NCT03153852|Keratolytic Agents|keratolytic agents|mesh-ancestor
111254633|NCT03153852|Dermatologic Agents|dermatologic agents|mesh-ancestor
111254634|NCT04751175|Dexamethasone|dexamethasone|mesh-list
111254635|NCT04751175|Ketamine|ketamine|mesh-list
111254636|NCT04751175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111254637|NCT04751175|Antiemetics|antiemetics|mesh-ancestor
111254638|NCT04751175|Autonomic Agents|autonomic agents|mesh-ancestor
111254639|NCT04751175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111254640|NCT04751175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111254641|NCT04751175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111254642|NCT04751175|Glucocorticoids|glucocorticoids|mesh-ancestor
111254643|NCT04751175|Hormones|hormones|mesh-ancestor
111254644|NCT04751175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111254645|NCT04751175|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111254646|NCT04751175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111254647|NCT04751175|Analgesics|analgesics|mesh-ancestor
111254648|NCT04751175|Sensory System Agents|sensory system agents|mesh-ancestor
111254649|NCT04751175|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111254650|NCT04751175|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111254651|NCT04751175|Anesthetics, General|anesthetics, general|mesh-ancestor
111254652|NCT04751175|Anesthetics|anesthetics|mesh-ancestor
111254653|NCT04751175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111254654|NCT04751175|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111254655|NCT04751175|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111254656|NCT04751175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111254657|NCT04751175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111254658|NCT01792557|Phenol|phenol|mesh-list
111254659|NCT01792557|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111254660|NCT01792557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111254661|NCT01792557|Disinfectants|disinfectants|mesh-ancestor
111254662|NCT01792557|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
111254663|NCT01792557|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111254664|NCT01792713|Sertaconazole|sertaconazole|mesh-list
111254665|NCT01792713|Antifungal Agents|antifungal agents|mesh-ancestor
111254666|NCT01792713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111254667|NCT02352168|Budesonide|budesonide|mesh-list
111254668|NCT02352168|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111254669|NCT02352168|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111254670|NCT02352168|Autonomic Agents|autonomic agents|mesh-ancestor
111254671|NCT02352168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111254672|NCT02352168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111254673|NCT02352168|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111254674|NCT02352168|Respiratory System Agents|respiratory system agents|mesh-ancestor
111254675|NCT02352168|Glucocorticoids|glucocorticoids|mesh-ancestor
110978971|NCT03254186|Adrenergic Agents|adrenergic agents|mesh-ancestor
111254676|NCT02352168|Hormones|hormones|mesh-ancestor
111254677|NCT02352168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111254678|NCT02357004|Carvedilol|carvedilol|mesh-list
111254679|NCT02357004|Chlorthalidone|chlorthalidone|mesh-list
110706758|NCT00335738|Etoposide|etoposide|mesh-list
111254680|NCT02357004|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111254681|NCT02357004|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111254682|NCT02357004|Adrenergic Agents|adrenergic agents|mesh-ancestor
111254683|NCT02357004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111254684|NCT02357004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111254685|NCT02357004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111254686|NCT02357004|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111254687|NCT02357004|Antioxidants|antioxidants|mesh-ancestor
111254688|NCT02357004|Protective Agents|protective agents|mesh-ancestor
111254689|NCT02357004|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111254690|NCT02357004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111254691|NCT02357004|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111254692|NCT02357004|Vasodilator Agents|vasodilator agents|mesh-ancestor
111254693|NCT02357004|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111254694|NCT02357004|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111254695|NCT02357004|Diuretics|diuretics|mesh-ancestor
111254696|NCT02357004|Natriuretic Agents|natriuretic agents|mesh-ancestor
111254697|NCT02357004|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
111254698|NCT01570387|Dexamethasone|dexamethasone|mesh-list
111254699|NCT01570387|Dexamethasone acetate|dexamethasone acetate|mesh-list
111254700|NCT01570387|Pomalidomide|pomalidomide|mesh-list
111254701|NCT01570387|BB 1101|bb 1101|mesh-list
111254702|NCT01570387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111254703|NCT01570387|Antiemetics|antiemetics|mesh-ancestor
111254704|NCT01570387|Autonomic Agents|autonomic agents|mesh-ancestor
111254705|NCT01570387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111254706|NCT01570387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111254707|NCT01570387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111254708|NCT01570387|Glucocorticoids|glucocorticoids|mesh-ancestor
111254709|NCT01570387|Hormones|hormones|mesh-ancestor
111254710|NCT01570387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111254711|NCT01570387|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111254712|NCT01570387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111254713|NCT01570387|Protease Inhibitors|protease inhibitors|mesh-ancestor
111254714|NCT01570387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111254715|NCT01570387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111254716|NCT01570387|Immunologic Factors|immunologic factors|mesh-ancestor
111254717|NCT01570387|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111254718|NCT01570387|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111254719|NCT01570387|Growth Substances|growth substances|mesh-ancestor
111254720|NCT01570387|Growth Inhibitors|growth inhibitors|mesh-ancestor
111254721|NCT02348424|Solithromycin|solithromycin|mesh-list
111254722|NCT02348424|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111254723|NCT02348424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111254724|NCT01570309|Ergocalciferols|ergocalciferols|mesh-list
111254725|NCT01570309|Vitamin D|vitamin d|mesh-list
111254726|NCT01570309|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111254727|NCT01570309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111254728|NCT01570309|Vitamins|vitamins|mesh-ancestor
111254729|NCT01570309|Micronutrients|micronutrients|mesh-ancestor
111254730|NCT01570309|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111254731|NCT02356146|Tacrolimus|tacrolimus|mesh-list
111254732|NCT02356146|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111254733|NCT02356146|Immunologic Factors|immunologic factors|mesh-ancestor
111254734|NCT02356146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111254735|NCT02356146|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111254736|NCT02356146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111254737|NCT02356146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111254738|NCT01519921|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
111254739|NCT01519921|Antiviral Agents|antiviral agents|mesh-ancestor
111254740|NCT01519921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111254741|NCT01519765|Misoprostol|misoprostol|mesh-list
111254742|NCT01519765|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111254743|NCT01519765|Abortifacient Agents|abortifacient agents|mesh-ancestor
111254744|NCT01519765|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111254745|NCT01519765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111254746|NCT01519765|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111254747|NCT01519765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111254748|NCT01519765|Oxytocics|oxytocics|mesh-ancestor
111254749|NCT03147066|Flurbiprofen|flurbiprofen|mesh-list
111254750|NCT03147066|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
111254751|NCT03147066|Dezocine|dezocine|mesh-list
111254752|NCT03147066|Analgesics|analgesics|mesh-ancestor
111254753|NCT03147066|Sensory System Agents|sensory system agents|mesh-ancestor
111254754|NCT03147066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111254755|NCT03147066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111254756|NCT03147066|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111254757|NCT03147066|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111254758|NCT03147066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111254759|NCT03147066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111254760|NCT03147066|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111254761|NCT03147066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111254762|NCT03147066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111254763|NCT03147066|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111254764|NCT03147066|Narcotics|narcotics|mesh-ancestor
111254765|NCT03147066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111254766|NCT02351622|Dexamethasone|dexamethasone|mesh-list
111254767|NCT02351622|Caffeic acid|caffeic acid|mesh-list
111254768|NCT02351622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111254769|NCT02351622|Antiemetics|antiemetics|mesh-ancestor
111254770|NCT02351622|Autonomic Agents|autonomic agents|mesh-ancestor
111254771|NCT02351622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111254772|NCT02351622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111254773|NCT02351622|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111254774|NCT02351622|Glucocorticoids|glucocorticoids|mesh-ancestor
111254775|NCT02351622|Hormones|hormones|mesh-ancestor
111254776|NCT02351622|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111254777|NCT02351622|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111254778|NCT02351622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111254779|NCT02351622|Antioxidants|antioxidants|mesh-ancestor
111254780|NCT02351622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111254781|NCT02351622|Protective Agents|protective agents|mesh-ancestor
111254782|NCT01552603|Pancrelipase|pancrelipase|mesh-list
111254783|NCT01552603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111254784|NCT02348190|Heparin|heparin|mesh-list
111254785|NCT02348190|Anticoagulants|anticoagulants|mesh-ancestor
111254786|NCT02348190|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111254787|NCT02348190|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111254788|NCT02348190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111254789|NCT01552369|Valganciclovir|valganciclovir|mesh-list
111254790|NCT01552369|Antiviral Agents|antiviral agents|mesh-ancestor
111254791|NCT01552369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111254792|NCT02351232|Liraglutide|liraglutide|mesh-list
111254793|NCT02351232|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111254794|NCT02351232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111254795|NCT02351232|Incretins|incretins|mesh-ancestor
111254796|NCT02351232|Hormones|hormones|mesh-ancestor
111254797|NCT02351232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111254798|NCT02355756|Maxadilan protein, insect|maxadilan protein, insect|mesh-list
111254799|NCT02355756|Vasodilator Agents|vasodilator agents|mesh-ancestor
111254800|NCT03150030|Hypoglycemic Agents|hypoglycemic agents|mesh-list
111254801|NCT03150030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111254802|NCT02355678|Acetaminophen|acetaminophen|mesh-list
111254803|NCT02355678|Dexamethasone|dexamethasone|mesh-list
111254804|NCT02355678|Propacetamol|propacetamol|mesh-list
111254805|NCT02355678|Tramadol|tramadol|mesh-list
111254806|NCT02355678|Anesthetics|anesthetics|mesh-list
111254807|NCT02355678|Anesthetics, Local|anesthetics, local|mesh-list
111254808|NCT02355678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111254809|NCT02355678|Antiemetics|antiemetics|mesh-ancestor
111254810|NCT02355678|Autonomic Agents|autonomic agents|mesh-ancestor
111254811|NCT02355678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111254812|NCT02355678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111254813|NCT02355678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111254814|NCT02355678|Glucocorticoids|glucocorticoids|mesh-ancestor
111254815|NCT02355678|Hormones|hormones|mesh-ancestor
111254816|NCT02355678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111254817|NCT02355678|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111254818|NCT02355678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111254819|NCT02355678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111254820|NCT02355678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111254821|NCT02355678|Analgesics|analgesics|mesh-ancestor
111254822|NCT02355678|Sensory System Agents|sensory system agents|mesh-ancestor
111254823|NCT02355678|Antipyretics|antipyretics|mesh-ancestor
111254824|NCT02355678|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111254825|NCT02355678|Narcotics|narcotics|mesh-ancestor
111254826|NCT02355678|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111254827|NCT02355678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111254828|NCT02351310|Betamethasone|betamethasone|mesh-list
111254829|NCT02351310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111254830|NCT02351310|Glucocorticoids|glucocorticoids|mesh-ancestor
111254831|NCT02351310|Hormones|hormones|mesh-ancestor
111254832|NCT02351310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111254833|NCT02351310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111254834|NCT02351310|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111254835|NCT02351310|Respiratory System Agents|respiratory system agents|mesh-ancestor
111254836|NCT02347878|Aprepitant|aprepitant|mesh-list
111254837|NCT02347878|Antiemetics|antiemetics|mesh-ancestor
111254838|NCT02347878|Autonomic Agents|autonomic agents|mesh-ancestor
111254839|NCT02347878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111254840|NCT02347878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111254841|NCT02347878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111254842|NCT02347878|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
111254843|NCT02347878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111254844|NCT02347878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111254845|NCT02355522|Lidocaine|lidocaine|mesh-list
111254846|NCT02355522|Anesthetics, Local|anesthetics, local|mesh-ancestor
111254847|NCT02355522|Anesthetics|anesthetics|mesh-ancestor
111254848|NCT02355522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111254849|NCT02355522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111254850|NCT02355522|Sensory System Agents|sensory system agents|mesh-ancestor
111254851|NCT02355522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111254852|NCT02355522|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111254853|NCT02355522|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111254854|NCT02355522|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111254855|NCT02355522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111254856|NCT02355522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111254857|NCT02355054|Choline|choline|mesh-list
111254858|NCT02355054|Lipotropic Agents|lipotropic agents|mesh-ancestor
111254859|NCT02355054|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111254860|NCT02355054|Antimetabolites|antimetabolites|mesh-ancestor
111254861|NCT02355054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111254862|NCT02355054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111254863|NCT02355054|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111254864|NCT02355054|Nootropic Agents|nootropic agents|mesh-ancestor
111254865|NCT04478448|Favipiravir|favipiravir|mesh-list
111254866|NCT04478448|Antiviral Agents|antiviral agents|mesh-ancestor
111254867|NCT04478448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111254868|NCT04478526|Norepinephrine|norepinephrine|mesh-list
111254869|NCT04478526|Serotonin|serotonin|mesh-list
111254870|NCT04478526|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
111254871|NCT04478526|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-list
111254872|NCT04478526|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111254873|NCT04478526|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111254874|NCT04478526|Adrenergic Agents|adrenergic agents|mesh-ancestor
111254875|NCT04478526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111254876|NCT04478526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111254877|NCT04478526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111254878|NCT04478526|Sympathomimetics|sympathomimetics|mesh-ancestor
111254879|NCT04478526|Autonomic Agents|autonomic agents|mesh-ancestor
111254880|NCT04478526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111254881|NCT04478526|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111254882|NCT04478526|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111254883|NCT04478526|Serotonin Agents|serotonin agents|mesh-ancestor
111254884|NCT04478526|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111254885|NCT04478526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111254886|NCT01552057|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
111254887|NCT01552057|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111254888|NCT01552057|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111254889|NCT01552057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111254890|NCT01552057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111254891|NCT01552057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111254892|NCT01552057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111254893|NCT01552057|Analgesics|analgesics|mesh-ancestor
111254894|NCT01552057|Sensory System Agents|sensory system agents|mesh-ancestor
111254895|NCT01552057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111254896|NCT01552057|Antidepressive Agents|antidepressive agents|mesh-ancestor
111254897|NCT01552057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111254898|NCT01552057|Dopamine Agents|dopamine agents|mesh-ancestor
111254899|NCT02350686|Capecitabine|capecitabine|mesh-list
111254900|NCT02350686|Oxaliplatin|oxaliplatin|mesh-list
110979195|NCT02454764|Interferon-alpha|interferon-alpha|mesh-list
111254901|NCT02350686|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111254902|NCT02350686|Antimetabolites|antimetabolites|mesh-ancestor
111254903|NCT02350686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111254904|NCT02350686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111254906|NCT03159078|Polymyxins|polymyxins|mesh-list
111254907|NCT03159078|Polymyxin B|polymyxin b|mesh-list
111254908|NCT03159078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111254909|NCT03159078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111254910|NCT01551745|Bevacizumab|bevacizumab|mesh-list
111254911|NCT01551745|Vaccines|vaccines|mesh-list
111254912|NCT01551745|Immunologic Factors|immunologic factors|mesh-ancestor
111254913|NCT01551745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111254914|NCT01551745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111254915|NCT01551745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111254916|NCT01551745|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111254917|NCT01551745|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111254918|NCT01551745|Growth Substances|growth substances|mesh-ancestor
111254919|NCT01551745|Growth Inhibitors|growth inhibitors|mesh-ancestor
111254920|NCT02350530|Bevacizumab|bevacizumab|mesh-list
111254921|NCT02350530|Fluorouracil|fluorouracil|mesh-list
111254922|NCT02350530|Oxaliplatin|oxaliplatin|mesh-list
111254923|NCT02350530|Irinotecan|irinotecan|mesh-list
111254924|NCT02350530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111254925|NCT02350530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111254926|NCT02350530|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111254927|NCT02350530|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111254928|NCT02350530|Growth Substances|growth substances|mesh-ancestor
111254929|NCT02350530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111254930|NCT02350530|Growth Inhibitors|growth inhibitors|mesh-ancestor
111254931|NCT02350530|Antimetabolites|antimetabolites|mesh-ancestor
111254932|NCT02350530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111254933|NCT02350530|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111254934|NCT02350530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111254935|NCT02350530|Immunologic Factors|immunologic factors|mesh-ancestor
111254936|NCT02350530|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111254937|NCT02350530|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111254938|NCT02350530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111254939|NCT01569841|Insulin|insulin|mesh-list
111254940|NCT01569841|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111254941|NCT01569841|Insulin Glargine|insulin glargine|mesh-list
111254942|NCT01569841|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111254943|NCT01569841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111254944|NCT01550965|Adalimumab|adalimumab|mesh-list
111254945|NCT01550965|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111254946|NCT01550965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111254947|NCT01550965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111254948|NCT05265819|Hormones|hormones|mesh-list
111254949|NCT05265819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111254950|NCT05265819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111254951|NCT02353494|Piperaquine|piperaquine|mesh-list
111254952|NCT02353494|Artenimol|artenimol|mesh-list
111254953|NCT02353494|Antimalarials|antimalarials|mesh-ancestor
111254954|NCT02353494|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111254955|NCT02353494|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111254956|NCT02353494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111254957|NCT02353260|Docetaxel|docetaxel|mesh-list
111254958|NCT02353260|Fluorouracil|fluorouracil|mesh-list
111254959|NCT02353260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111254960|NCT02353260|Tubulin Modulators|tubulin modulators|mesh-ancestor
111254961|NCT02353260|Antimitotic Agents|antimitotic agents|mesh-ancestor
111254962|NCT02353260|Mitosis Modulators|mitosis modulators|mesh-ancestor
111254963|NCT02353260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111254964|NCT02353260|Antimetabolites|antimetabolites|mesh-ancestor
111254965|NCT02353260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111254966|NCT02353260|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111254967|NCT02353260|Immunologic Factors|immunologic factors|mesh-ancestor
111254968|NCT02353260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111254969|NCT03158610|Capecitabine|capecitabine|mesh-list
111254970|NCT03158610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111254971|NCT03158610|Antimetabolites|antimetabolites|mesh-ancestor
111254972|NCT03158610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111254973|NCT03158610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111254974|NCT00323739|Bevacizumab|bevacizumab|mesh-list
111254975|NCT00323739|Everolimus|everolimus|mesh-list
111254976|NCT00323739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111254977|NCT00323739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111254978|NCT00323739|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111254979|NCT00323739|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111254980|NCT00323739|Growth Substances|growth substances|mesh-ancestor
111254981|NCT00323739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111254982|NCT00323739|Growth Inhibitors|growth inhibitors|mesh-ancestor
111254983|NCT00323739|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111254984|NCT00323739|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111254985|NCT00323739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111254986|NCT00323739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111254987|NCT00323739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111254988|NCT00323739|Immunologic Factors|immunologic factors|mesh-ancestor
111254989|NCT02350218|Alprostadil|alprostadil|mesh-list
111254990|NCT02350218|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111254991|NCT02350218|Vasodilator Agents|vasodilator agents|mesh-ancestor
111254992|NCT02350218|Urological Agents|urological agents|mesh-ancestor
111254993|NCT00390429|Docetaxel|docetaxel|mesh-list
111254994|NCT00390429|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111254995|NCT00390429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111254996|NCT00390429|Tubulin Modulators|tubulin modulators|mesh-ancestor
111254997|NCT00390429|Antimitotic Agents|antimitotic agents|mesh-ancestor
111254998|NCT00390429|Mitosis Modulators|mitosis modulators|mesh-ancestor
111254999|NCT00390429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111255000|NCT00390429|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111255001|NCT00390429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111255002|NCT02349828|Acyclovir|acyclovir|mesh-list
111255003|NCT02349828|Antiviral Agents|antiviral agents|mesh-ancestor
111255004|NCT02349828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111255005|NCT02353182|Dexmedetomidine|dexmedetomidine|mesh-list
111255006|NCT02353182|Remifentanil|remifentanil|mesh-list
111255007|NCT02353182|Bupivacaine|bupivacaine|mesh-list
111255008|NCT02353182|Ropivacaine|ropivacaine|mesh-list
111255009|NCT02353182|Anesthetics, Local|anesthetics, local|mesh-ancestor
111255010|NCT02353182|Anesthetics|anesthetics|mesh-ancestor
111255011|NCT02353182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111255012|NCT02353182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111255013|NCT02353182|Sensory System Agents|sensory system agents|mesh-ancestor
111255014|NCT02353182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111255015|NCT02353182|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111255016|NCT02353182|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111255017|NCT02353182|Analgesics|analgesics|mesh-ancestor
111255018|NCT02353182|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111255019|NCT02353182|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111255020|NCT02353182|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111255021|NCT02353182|Adrenergic Agents|adrenergic agents|mesh-ancestor
111255022|NCT02353182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111255023|NCT02353182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111255024|NCT02353182|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111255025|NCT02353182|Narcotics|narcotics|mesh-ancestor
111255026|NCT02349516|Squalamine|squalamine|mesh-list
111255027|NCT02349516|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111255028|NCT02349516|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111255029|NCT02349516|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111255030|NCT02349516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111255031|NCT02349516|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
111255032|NCT02349516|Protective Agents|protective agents|mesh-ancestor
111255033|NCT02349516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111255034|NCT02349516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111255035|NCT02349516|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111255036|NCT02349516|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111255037|NCT02349516|Growth Substances|growth substances|mesh-ancestor
111255038|NCT02349516|Growth Inhibitors|growth inhibitors|mesh-ancestor
111255039|NCT02349594|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
111255040|NCT02349594|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
111255041|NCT02349594|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
111255042|NCT02349594|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111255043|NCT02346084|Maraviroc|maraviroc|mesh-list
111255044|NCT02346084|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
111255045|NCT02346084|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
111255046|NCT02346084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111255047|NCT02346084|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111255048|NCT02346084|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111255049|NCT02346084|Antiviral Agents|antiviral agents|mesh-ancestor
111255050|NCT02346084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111255051|NCT02346084|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
111255052|NCT03149250|Hemostatics|hemostatics|mesh-list
110979348|NCT05481970|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111255053|NCT03149250|Coagulants|coagulants|mesh-ancestor
111255054|NCT00391443|Bosentan|bosentan|mesh-list
111255055|NCT00391443|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111255056|NCT00391443|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
111255057|NCT00391443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111255058|NCT02343432|Triamcinolone|triamcinolone|mesh-list
111255059|NCT02343432|Bupivacaine|bupivacaine|mesh-list
111255060|NCT02343432|Anesthetics, Local|anesthetics, local|mesh-ancestor
111255061|NCT02343432|Anesthetics|anesthetics|mesh-ancestor
111255062|NCT02343432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111255063|NCT02343432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111255064|NCT02343432|Sensory System Agents|sensory system agents|mesh-ancestor
111255065|NCT02343432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111255066|NCT02343432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111255067|NCT02343432|Glucocorticoids|glucocorticoids|mesh-ancestor
111255068|NCT02343432|Hormones|hormones|mesh-ancestor
111255069|NCT02343432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111255070|NCT02349282|Vitamin D|vitamin d|mesh-list
111255071|NCT02349282|Cholecalciferol|cholecalciferol|mesh-list
111255072|NCT02349282|Calcifediol|calcifediol|mesh-list
111255073|NCT02349282|Vitamins|vitamins|mesh-ancestor
111255074|NCT02349282|Micronutrients|micronutrients|mesh-ancestor
111255075|NCT02349282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111255076|NCT02349282|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111255077|NCT02349282|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111255078|NCT02349204|Zaleplon|zaleplon|mesh-list
111255079|NCT02349204|Anticonvulsants|anticonvulsants|mesh-ancestor
111255080|NCT02349204|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111255081|NCT02349204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111255082|NCT02349204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111255083|NCT02349204|GABA Modulators|gaba modulators|mesh-ancestor
111255084|NCT02349204|GABA Agents|gaba agents|mesh-ancestor
111255085|NCT02349204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111255086|NCT02349204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111255087|NCT02345616|Nitric Oxide|nitric oxide|mesh-list
111255088|NCT02345616|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111255089|NCT02345616|Autonomic Agents|autonomic agents|mesh-ancestor
111255090|NCT02345616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111255091|NCT02345616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111255092|NCT02345616|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111255093|NCT02345616|Respiratory System Agents|respiratory system agents|mesh-ancestor
111255094|NCT02345616|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111255095|NCT02345616|Antioxidants|antioxidants|mesh-ancestor
111255096|NCT02345616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111255097|NCT02345616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111255098|NCT02345616|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
111255099|NCT02345616|Vasodilator Agents|vasodilator agents|mesh-ancestor
111255100|NCT02345616|Gasotransmitters|gasotransmitters|mesh-ancestor
111255101|NCT02345616|Protective Agents|protective agents|mesh-ancestor
111255102|NCT00391989|Dasatinib|dasatinib|mesh-list
111255103|NCT00391989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111255104|NCT00391989|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111255105|NCT00391989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111255106|NCT00391989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111255107|NCT03148704|Palonosetron|palonosetron|mesh-list
111255108|NCT03148704|Antiemetics|antiemetics|mesh-ancestor
111255109|NCT03148704|Autonomic Agents|autonomic agents|mesh-ancestor
111255110|NCT03148704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111255111|NCT03148704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111255112|NCT03148704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111255113|NCT03148704|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111255114|NCT03148704|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111255115|NCT03148704|Serotonin Agents|serotonin agents|mesh-ancestor
111255116|NCT03148704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111255117|NCT03148704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111255118|NCT01795287|Anesthetics|anesthetics|mesh-list
111255119|NCT01795287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111255120|NCT01795287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111255121|NCT04976283|Pioglitazone|pioglitazone|mesh-list
111255122|NCT04976283|Empagliflozin|empagliflozin|mesh-list
111255123|NCT04976283|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111255124|NCT04976283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111255125|NCT04976283|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111255126|NCT04976283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111255127|NCT02345304|Digoxin|digoxin|mesh-list
111255128|NCT02345304|Midazolam|midazolam|mesh-list
111255129|NCT02345304|Omeprazole|omeprazole|mesh-list
111255130|NCT02345304|Warfarin|warfarin|mesh-list
111255131|NCT02345304|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111255132|NCT02345304|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111255133|NCT02345304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111255134|NCT02345304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111255135|NCT02345304|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111255136|NCT02345304|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111255137|NCT02345304|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111255138|NCT02345304|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111255139|NCT02345304|Anesthetics, General|anesthetics, general|mesh-ancestor
111255140|NCT02345304|Anesthetics|anesthetics|mesh-ancestor
111255141|NCT02345304|GABA Modulators|gaba modulators|mesh-ancestor
111255142|NCT02345304|GABA Agents|gaba agents|mesh-ancestor
111255143|NCT02345304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111255144|NCT02345304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111255145|NCT02345304|Anticoagulants|anticoagulants|mesh-ancestor
111255146|NCT02345304|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111255147|NCT02345304|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111255148|NCT02345304|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111255149|NCT02345304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111255150|NCT02345304|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111255151|NCT02345304|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111255152|NCT02345304|Protective Agents|protective agents|mesh-ancestor
111255153|NCT01569295|Rituximab|rituximab|mesh-list
111255154|NCT01569295|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
111255155|NCT01569295|Idelalisib|idelalisib|mesh-list
111255156|NCT01569295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111255157|NCT01569295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111255158|NCT01569295|Immunologic Factors|immunologic factors|mesh-ancestor
111255159|NCT01569295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111255160|NCT01569295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111255161|NCT01569295|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111255162|NCT01569295|Alkylating Agents|alkylating agents|mesh-ancestor
111255163|NCT01569295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111255164|NCT01569295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111255165|NCT03112278|Salicylic Acid|salicylic acid|mesh-list
111255166|NCT03112278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111255167|NCT03112278|Antifungal Agents|antifungal agents|mesh-ancestor
111255168|NCT03112278|Keratolytic Agents|keratolytic agents|mesh-ancestor
111255169|NCT03112278|Dermatologic Agents|dermatologic agents|mesh-ancestor
111255170|NCT02345148|Esketamine|esketamine|mesh-list
111255171|NCT02345148|Antidepressive Agents|antidepressive agents|mesh-ancestor
111255172|NCT02345148|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111255173|NCT00394329|Beclomethasone|beclomethasone|mesh-list
111255174|NCT00394329|Albuterol|albuterol|mesh-list
111255175|NCT00394329|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111255176|NCT00394329|Autonomic Agents|autonomic agents|mesh-ancestor
111255177|NCT00394329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111255178|NCT00394329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111255179|NCT00394329|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111255180|NCT00394329|Respiratory System Agents|respiratory system agents|mesh-ancestor
111255181|NCT00394329|Tocolytic Agents|tocolytic agents|mesh-ancestor
111255182|NCT00394329|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111255183|NCT00394329|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111255184|NCT00394329|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111255185|NCT00394329|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111255186|NCT00394329|Adrenergic Agents|adrenergic agents|mesh-ancestor
111255187|NCT00394329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111255188|NCT00394329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111255189|NCT00394329|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111255190|NCT00394329|Glucocorticoids|glucocorticoids|mesh-ancestor
111255191|NCT00394329|Hormones|hormones|mesh-ancestor
111255192|NCT00394329|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111255193|NCT03146052|Simethicone|simethicone|mesh-list
111255194|NCT03146052|Bisacodyl|bisacodyl|mesh-list
111255195|NCT03146052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111255196|NCT03146052|Cathartics|cathartics|mesh-ancestor
111255197|NCT03146052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111255198|NCT03146052|Laxatives|laxatives|mesh-ancestor
111255199|NCT03146052|Antifoaming Agents|antifoaming agents|mesh-ancestor
111255200|NCT03146052|Emollients|emollients|mesh-ancestor
111255201|NCT03146052|Dermatologic Agents|dermatologic agents|mesh-ancestor
111255202|NCT01549951|Prednisone|prednisone|mesh-list
110979505|NCT03976973|Acetylcysteine|acetylcysteine|mesh-list
111255203|NCT01549951|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111255204|NCT01549951|Glucocorticoids|glucocorticoids|mesh-ancestor
111255205|NCT01549951|Hormones|hormones|mesh-ancestor
111255206|NCT01549951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111255208|NCT01549951|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111255209|NCT01549951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111255210|NCT03148314|Misoprostol|misoprostol|mesh-list
111255211|NCT03148314|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111255212|NCT03148314|Abortifacient Agents|abortifacient agents|mesh-ancestor
111255213|NCT03148314|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111255214|NCT03148314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111255215|NCT03148314|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111255216|NCT03148314|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111255217|NCT03148314|Oxytocics|oxytocics|mesh-ancestor
111255218|NCT01517893|Simvastatin|simvastatin|mesh-list
111255219|NCT01517893|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111255220|NCT01517893|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111255221|NCT01517893|Antimetabolites|antimetabolites|mesh-ancestor
111255222|NCT01517893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111255223|NCT01517893|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111255224|NCT01517893|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111255225|NCT01517893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111255226|NCT02344992|Insulin Lispro|insulin lispro|mesh-list
111255227|NCT02344992|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111255228|NCT02344992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111255229|NCT01489891|Lidocaine|lidocaine|mesh-list
111255230|NCT01489891|Anesthetics, Local|anesthetics, local|mesh-ancestor
111255231|NCT01489891|Anesthetics|anesthetics|mesh-ancestor
111255232|NCT01489891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111255233|NCT01489891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111255234|NCT01489891|Sensory System Agents|sensory system agents|mesh-ancestor
111255235|NCT01489891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111255236|NCT01489891|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111255237|NCT01489891|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111255238|NCT01489891|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111255239|NCT01489891|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111255240|NCT01489891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111255241|NCT02342574|Olorofim|olorofim|mesh-list
111255242|NCT02342574|Antifungal Agents|antifungal agents|mesh-ancestor
111255243|NCT02342574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111255244|NCT03148002|Lactulose|lactulose|mesh-list
111255245|NCT03148002|Sennosides|sennosides|mesh-list
111255246|NCT03148002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111255247|NCT03148002|Laxatives|laxatives|mesh-ancestor
111255248|NCT02342184|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111255249|NCT02342184|Immunologic Factors|immunologic factors|mesh-ancestor
111255250|NCT02342184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111255251|NCT00396201|Plerixafor|plerixafor|mesh-list
111255252|NCT00396201|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111255253|NCT00396201|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111255254|NCT00396201|Antiviral Agents|antiviral agents|mesh-ancestor
111255255|NCT00396201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111255256|NCT03145896|Vitamin D|vitamin d|mesh-list
111255257|NCT03145896|Vitamins|vitamins|mesh-ancestor
111255258|NCT03145896|Micronutrients|micronutrients|mesh-ancestor
111255259|NCT03145896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111255260|NCT03145896|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111255261|NCT02341872|Calcium|calcium|mesh-list
111255262|NCT02341872|Fluorides|fluorides|mesh-list
111255263|NCT02341872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111255264|NCT02341872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111255265|NCT02341872|Cariostatic Agents|cariostatic agents|mesh-ancestor
111255266|NCT02341872|Protective Agents|protective agents|mesh-ancestor
111255267|NCT00360399|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
111255268|NCT00360399|Escitalopram|escitalopram|mesh-list
111255269|NCT00360399|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111255270|NCT00360399|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111255271|NCT00360399|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111255272|NCT00360399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111255273|NCT00360399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111255274|NCT00360399|Serotonin Agents|serotonin agents|mesh-ancestor
111255275|NCT00360399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111255276|NCT00360399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111255277|NCT00360399|Antidepressive Agents|antidepressive agents|mesh-ancestor
111255278|NCT00360399|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110979572|NCT03716609|Chelating Agents|chelating agents|mesh-ancestor
111255279|NCT00360399|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111255280|NCT00360399|Analgesics|analgesics|mesh-ancestor
111255281|NCT00360399|Sensory System Agents|sensory system agents|mesh-ancestor
111255282|NCT00360399|Dopamine Agents|dopamine agents|mesh-ancestor
111255283|NCT02341794|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111255284|NCT02341794|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111255285|NCT02341794|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111255286|NCT02341794|Antimetabolites|antimetabolites|mesh-ancestor
111255287|NCT02341794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111255288|NCT02341794|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111255289|NCT02341794|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111255290|NCT02341794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111255291|NCT02344602|Febuxostat|febuxostat|mesh-list
111255292|NCT02344602|Gout Suppressants|gout suppressants|mesh-ancestor
111255293|NCT02344602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111255294|NCT02348268|Analgesics|analgesics|mesh-list
111255295|NCT02348268|Sensory System Agents|sensory system agents|mesh-ancestor
111255296|NCT02348268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111255297|NCT02348268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111255298|NCT02348346|Titanium dioxide|titanium dioxide|mesh-list
111255299|NCT02348346|Sunscreening Agents|sunscreening agents|mesh-ancestor
111255300|NCT02348346|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111255301|NCT02348346|Protective Agents|protective agents|mesh-ancestor
111255302|NCT02348346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111255303|NCT02348346|Dermatologic Agents|dermatologic agents|mesh-ancestor
111255304|NCT02348346|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111255305|NCT00361257|Minocycline|minocycline|mesh-list
111255306|NCT00361257|Tetracycline|tetracycline|mesh-list
111255307|NCT00361257|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111255308|NCT00361257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111255309|NCT00361257|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111255310|NCT00361257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111255311|NCT00361257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111255312|NCT02341404|Hydroxyflutamide|hydroxyflutamide|mesh-list
111255313|NCT02341404|Androgen Antagonists|androgen antagonists|mesh-ancestor
111255314|NCT02341404|Hormone Antagonists|hormone antagonists|mesh-ancestor
111255315|NCT02341404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111255316|NCT02341404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111255317|NCT02341638|Aspirin|aspirin|mesh-list
111255318|NCT02341638|Itraconazole|itraconazole|mesh-list
111255319|NCT02341638|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111255320|NCT02341638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111255321|NCT02341638|Analgesics|analgesics|mesh-ancestor
111255322|NCT02341638|Sensory System Agents|sensory system agents|mesh-ancestor
111255323|NCT02341638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111255324|NCT02341638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111255325|NCT02341638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111255326|NCT02341638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111255327|NCT02341638|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111255328|NCT02341638|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111255329|NCT02341638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111255330|NCT02341638|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111255331|NCT02341638|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111255332|NCT02341638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111255333|NCT02341638|Antipyretics|antipyretics|mesh-ancestor
111255334|NCT02341638|Antifungal Agents|antifungal agents|mesh-ancestor
111255335|NCT02341638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111255336|NCT02341638|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111255337|NCT02341638|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111255338|NCT02341638|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111255339|NCT02341638|Hormone Antagonists|hormone antagonists|mesh-ancestor
111255340|NCT02341638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111255341|NCT02341638|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111255342|NCT02337192|Chlorhexidine|chlorhexidine|mesh-list
111255343|NCT02337192|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
111255344|NCT02337192|Curcumin|curcumin|mesh-list
111255345|NCT02337192|Pulmonary Surfactants|pulmonary surfactants|mesh-list
111255346|NCT02337192|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111255347|NCT02337192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111255348|NCT02337192|Disinfectants|disinfectants|mesh-ancestor
111255349|NCT02337192|Dermatologic Agents|dermatologic agents|mesh-ancestor
111255350|NCT02337192|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111255351|NCT02337192|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111255352|NCT02337192|Analgesics|analgesics|mesh-ancestor
111255353|NCT02337192|Sensory System Agents|sensory system agents|mesh-ancestor
111255354|NCT02337192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111255355|NCT02337192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111255356|NCT02337192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111255357|NCT02337192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111255358|NCT02337192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111255359|NCT02337192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111255360|NCT02337192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111255361|NCT02337192|Respiratory System Agents|respiratory system agents|mesh-ancestor
111255362|NCT03111966|Grazoprevir|grazoprevir|mesh-list
111255363|NCT03111966|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
111255364|NCT03111966|Antiviral Agents|antiviral agents|mesh-ancestor
111255365|NCT03111966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111255366|NCT02343666|Plerixafor|plerixafor|mesh-list
111255367|NCT02343666|Carmustine|carmustine|mesh-list
111255368|NCT02343666|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
111255369|NCT02343666|Lenograstim|lenograstim|mesh-list
111255370|NCT02343666|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111255371|NCT02343666|Immunologic Factors|immunologic factors|mesh-ancestor
111255372|NCT02343666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111255373|NCT02343666|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111255374|NCT02343666|Alkylating Agents|alkylating agents|mesh-ancestor
111255375|NCT02343666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111255376|NCT02343666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111255377|NCT02343666|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111255378|NCT02343666|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111255379|NCT02343666|Antiviral Agents|antiviral agents|mesh-ancestor
111255380|NCT02343666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111255381|NCT02343666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111255382|NCT02332356|Adalimumab|adalimumab|mesh-list
111255383|NCT02332356|Infliximab|infliximab|mesh-list
111255384|NCT02332356|Azathioprine|azathioprine|mesh-list
111255385|NCT02332356|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111255386|NCT02332356|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111255387|NCT02332356|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111255388|NCT02332356|Dermatologic Agents|dermatologic agents|mesh-ancestor
111255389|NCT02332356|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111255390|NCT02332356|Antimetabolites|antimetabolites|mesh-ancestor
111255391|NCT02332356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111255392|NCT02332356|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111255393|NCT02332356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111255394|NCT02332356|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111255395|NCT02332356|Immunologic Factors|immunologic factors|mesh-ancestor
111255396|NCT02332356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111255397|NCT02340936|Lenalidomide|lenalidomide|mesh-list
111255398|NCT02340936|Immunologic Factors|immunologic factors|mesh-ancestor
111255399|NCT02340936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111255400|NCT02340936|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111255401|NCT02340936|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111255402|NCT02340936|Growth Substances|growth substances|mesh-ancestor
111255403|NCT02340936|Growth Inhibitors|growth inhibitors|mesh-ancestor
111255404|NCT02340936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111255405|NCT02332044|Bepotastine besilate|bepotastine besilate|mesh-list
111255406|NCT02332044|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111255407|NCT02337036|Tacrolimus|tacrolimus|mesh-list
111255408|NCT02337036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111255409|NCT02337036|Immunologic Factors|immunologic factors|mesh-ancestor
111255410|NCT02337036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111255411|NCT02337036|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111255412|NCT02337036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111255413|NCT02337036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111255414|NCT02336568|Oxytocin|oxytocin|mesh-list
111255415|NCT02336568|Oxytocics|oxytocics|mesh-ancestor
111255416|NCT02336568|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111255417|NCT02336568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111255418|NCT05253768|Glycerol|glycerol|mesh-list
111255419|NCT05253768|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
111255420|NCT05253768|Protective Agents|protective agents|mesh-ancestor
111255421|NCT05253768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111255422|NCT04630938|Lidocaine|lidocaine|mesh-list
111255423|NCT04630938|Morphine|morphine|mesh-list
111255424|NCT04630938|Anesthetics, Local|anesthetics, local|mesh-ancestor
111255425|NCT04630938|Anesthetics|anesthetics|mesh-ancestor
111255426|NCT04630938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111255427|NCT04630938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111255428|NCT04630938|Sensory System Agents|sensory system agents|mesh-ancestor
111255429|NCT04630938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111255430|NCT04630938|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111255431|NCT04630938|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111255432|NCT04630938|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111255433|NCT04630938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111255434|NCT04630938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111255435|NCT04630938|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111255436|NCT04630938|Narcotics|narcotics|mesh-ancestor
111255437|NCT04630938|Analgesics|analgesics|mesh-ancestor
111255438|NCT04594746|Amiodarone|amiodarone|mesh-list
111255439|NCT04594746|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111255440|NCT04594746|Vasodilator Agents|vasodilator agents|mesh-ancestor
111255441|NCT04594746|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
111255442|NCT04594746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111255443|NCT04594746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111255444|NCT04594746|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111255445|NCT04594746|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111255446|NCT04594746|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111255447|NCT04594746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111255448|NCT04594746|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111255449|NCT04594746|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111255450|NCT04594746|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111255451|NCT02790138|Ciprofloxacin|ciprofloxacin|mesh-list
111255452|NCT02790138|Vedolizumab|vedolizumab|mesh-list
111255453|NCT02790138|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111255454|NCT02790138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111255455|NCT02790138|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111255456|NCT02790138|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111255457|NCT02790138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111255458|NCT02790138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111255459|NCT02790138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111255460|NCT02790138|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111255461|NCT02790138|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111255462|NCT02790138|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111255463|NCT02339844|Aripiprazole|aripiprazole|mesh-list
111255464|NCT02339844|Antidepressive Agents|antidepressive agents|mesh-ancestor
111255465|NCT02339844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111255466|NCT02339844|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111255467|NCT02339844|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111255468|NCT02339844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111255469|NCT02339844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111255470|NCT02339844|Dopamine Agonists|dopamine agonists|mesh-ancestor
111255471|NCT02339844|Dopamine Agents|dopamine agents|mesh-ancestor
111255472|NCT02339844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111255473|NCT02339844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111255474|NCT02339844|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111255475|NCT02339844|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111255476|NCT02339844|Serotonin Agents|serotonin agents|mesh-ancestor
111255477|NCT02339844|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111255478|NCT02339844|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111255479|NCT02339844|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111255480|NCT02339844|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111255481|NCT00397839|Ibandronic Acid|ibandronic acid|mesh-list
111255482|NCT00397839|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111255483|NCT00397839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111255484|NCT02331576|Fentanyl|fentanyl|mesh-list
111255485|NCT02331576|Ropivacaine|ropivacaine|mesh-list
111255486|NCT02331576|Anesthetics, Local|anesthetics, local|mesh-ancestor
111255487|NCT02331576|Anesthetics|anesthetics|mesh-ancestor
111255488|NCT02331576|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111255489|NCT02331576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111255490|NCT02331576|Sensory System Agents|sensory system agents|mesh-ancestor
111255491|NCT02331576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111255492|NCT02331576|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111255493|NCT02331576|Narcotics|narcotics|mesh-ancestor
111255494|NCT02331576|Analgesics|analgesics|mesh-ancestor
111255495|NCT02331576|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111255496|NCT02331576|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111255497|NCT02331576|Anesthetics, General|anesthetics, general|mesh-ancestor
111255498|NCT00400803|Bevacizumab|bevacizumab|mesh-list
111255499|NCT00400803|Carboplatin|carboplatin|mesh-list
111255500|NCT00400803|Gemcitabine|gemcitabine|mesh-list
111255501|NCT00400803|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111255502|NCT00400803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111255503|NCT00400803|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111255504|NCT00400803|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111255506|NCT00400803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111255507|NCT00400803|Growth Inhibitors|growth inhibitors|mesh-ancestor
111255508|NCT00400803|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111255509|NCT00400803|Antimetabolites|antimetabolites|mesh-ancestor
111255510|NCT00400803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111255511|NCT04681443|Phenol|phenol|mesh-list
111255512|NCT04681443|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111255513|NCT04681443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111255514|NCT04681443|Disinfectants|disinfectants|mesh-ancestor
111255515|NCT04681443|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
111255516|NCT04681443|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111255517|NCT02339142|Methylprednisolone|methylprednisolone|mesh-list
111255518|NCT02339142|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111255519|NCT02339142|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111255520|NCT02339142|Prednisolone|prednisolone|mesh-list
111255521|NCT02339142|Prednisolone acetate|prednisolone acetate|mesh-list
111255522|NCT02339142|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111255523|NCT02339142|Prednisolone phosphate|prednisolone phosphate|mesh-list
111255524|NCT02339142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111255525|NCT02339142|Antiemetics|antiemetics|mesh-ancestor
111255526|NCT02339142|Autonomic Agents|autonomic agents|mesh-ancestor
111255527|NCT02339142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111255528|NCT02339142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111255529|NCT02339142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111255530|NCT02339142|Glucocorticoids|glucocorticoids|mesh-ancestor
111255531|NCT02339142|Hormones|hormones|mesh-ancestor
111255532|NCT02339142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111255533|NCT02339142|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111255534|NCT02339142|Protective Agents|protective agents|mesh-ancestor
111255535|NCT02339142|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111255536|NCT02339142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111255537|NCT00362817|Carboplatin|carboplatin|mesh-list
111255538|NCT00362817|Temozolomide|temozolomide|mesh-list
111255539|NCT00362817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111255540|NCT00362817|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111255541|NCT00362817|Alkylating Agents|alkylating agents|mesh-ancestor
111255542|NCT00362817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111255543|NCT02330952|Prednisone|prednisone|mesh-list
111255544|NCT02330952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111255545|NCT02330952|Glucocorticoids|glucocorticoids|mesh-ancestor
111255546|NCT02330952|Hormones|hormones|mesh-ancestor
111255547|NCT02330952|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111255548|NCT02330952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111255549|NCT02330952|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111255550|NCT02330952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111255551|NCT02338830|Progesterone|progesterone|mesh-list
111255552|NCT02338830|Progestins|progestins|mesh-ancestor
111255553|NCT02338830|Hormones|hormones|mesh-ancestor
111255554|NCT02338830|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111255555|NCT02338830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111255556|NCT00364377|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111255557|NCT00364377|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111255558|NCT00364377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111255559|NCT00364377|Incretins|incretins|mesh-ancestor
111255560|NCT00364377|Hormones|hormones|mesh-ancestor
111255561|NCT00364377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111255562|NCT00364377|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111255563|NCT00364377|Protease Inhibitors|protease inhibitors|mesh-ancestor
111255564|NCT00364377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111255565|NCT00364377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111255566|NCT04175886|Tofacitinib|tofacitinib|mesh-list
111255567|NCT04175886|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
111255568|NCT04175886|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111255569|NCT04175886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111255570|NCT04175886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111255571|NCT02338674|Tenofovir|tenofovir|mesh-list
111255572|NCT02338674|Telbivudine|telbivudine|mesh-list
111255573|NCT02338674|Antiviral Agents|antiviral agents|mesh-ancestor
111255574|NCT02338674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111255575|NCT02338674|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111255576|NCT02338674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111255577|NCT02338674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111255578|NCT02338674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111255579|NCT02338674|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111255580|NCT02338674|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111255581|NCT01826838|Dasatinib|dasatinib|mesh-list
111255582|NCT01826838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111255583|NCT01826838|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111255584|NCT01826838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111255585|NCT01826838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111255586|NCT00365391|Bevacizumab|bevacizumab|mesh-list
111255587|NCT00365391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111255588|NCT00365391|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111255589|NCT00365391|Antibodies|antibodies|mesh-list
111255590|NCT00365391|Immunoglobulins|immunoglobulins|mesh-list
111255591|NCT00365391|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111255592|NCT00365391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111255593|NCT00365391|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111255594|NCT00365391|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111255595|NCT00365391|Growth Substances|growth substances|mesh-ancestor
111255596|NCT00365391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111255597|NCT00365391|Growth Inhibitors|growth inhibitors|mesh-ancestor
111255598|NCT00365391|Immunologic Factors|immunologic factors|mesh-ancestor
111255599|NCT00365391|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111255600|NCT00365391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111255601|NCT00365391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111255602|NCT03105180|Mannitol|mannitol|mesh-list
111255603|NCT03105180|Sorbitol|sorbitol|mesh-list
111255604|NCT03105180|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
111255605|NCT03105180|Diuretics|diuretics|mesh-ancestor
111255606|NCT03105180|Natriuretic Agents|natriuretic agents|mesh-ancestor
111255607|NCT03105180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111255608|NCT03105180|Cathartics|cathartics|mesh-ancestor
111255609|NCT03105180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111255610|NCT02331030|Ropivacaine|ropivacaine|mesh-list
111255611|NCT02331030|Anesthetics, Local|anesthetics, local|mesh-ancestor
111255612|NCT02331030|Anesthetics|anesthetics|mesh-ancestor
111255613|NCT02331030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111255614|NCT02331030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111255615|NCT02331030|Sensory System Agents|sensory system agents|mesh-ancestor
111255616|NCT02331030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111255617|NCT04270929|Folfirinox|folfirinox|mesh-list
111255618|NCT04270929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111255619|NCT00401817|Bevacizumab|bevacizumab|mesh-list
111255620|NCT00401817|Rituximab|rituximab|mesh-list
111255621|NCT00401817|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111255622|NCT00401817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111255623|NCT00401817|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111255624|NCT00401817|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111255625|NCT00401817|Growth Substances|growth substances|mesh-ancestor
111255626|NCT00401817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111255627|NCT00401817|Growth Inhibitors|growth inhibitors|mesh-ancestor
111255628|NCT00401817|Immunologic Factors|immunologic factors|mesh-ancestor
111255629|NCT00401817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111255630|NCT04417179|Bupivacaine|bupivacaine|mesh-list
111255631|NCT04417179|Anesthetics, Local|anesthetics, local|mesh-ancestor
111255632|NCT04417179|Anesthetics|anesthetics|mesh-ancestor
111255633|NCT04417179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111255634|NCT04417179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111255635|NCT04417179|Sensory System Agents|sensory system agents|mesh-ancestor
111255636|NCT04417179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111255637|NCT02330796|Bucillamine|bucillamine|mesh-list
111255638|NCT02330796|Colchicine|colchicine|mesh-list
111255639|NCT02330796|Gout Suppressants|gout suppressants|mesh-ancestor
111255640|NCT02330796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111255641|NCT02330796|Tubulin Modulators|tubulin modulators|mesh-ancestor
111255642|NCT02330796|Antimitotic Agents|antimitotic agents|mesh-ancestor
111255643|NCT02330796|Mitosis Modulators|mitosis modulators|mesh-ancestor
111255644|NCT02330796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111255645|NCT02330796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111255646|NCT02330796|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111255647|NCT02330796|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111255648|NCT02330796|Analgesics|analgesics|mesh-ancestor
111255649|NCT02330796|Sensory System Agents|sensory system agents|mesh-ancestor
111255650|NCT02330796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111255651|NCT02330796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111255652|NCT02330796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111255653|NCT02330796|Antioxidants|antioxidants|mesh-ancestor
110979944|NCT03227432|Hormones|hormones|mesh-ancestor
111255654|NCT02330796|Protective Agents|protective agents|mesh-ancestor
111255655|NCT02330640|Clopidogrel|clopidogrel|mesh-list
111255656|NCT02330640|Ticagrelor|ticagrelor|mesh-list
111255657|NCT02330640|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111255658|NCT02330640|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111255659|NCT02330640|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111255660|NCT02330640|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111255661|NCT02330640|Purinergic Agents|purinergic agents|mesh-ancestor
111255662|NCT02330640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111255663|NCT02330640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111255664|NCT02330640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111255665|NCT02335398|Methadone|methadone|mesh-list
111255666|NCT02335398|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111255667|NCT02335398|Narcotics|narcotics|mesh-ancestor
111255668|NCT02335398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111255669|NCT02335398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111255670|NCT02335398|Analgesics|analgesics|mesh-ancestor
111255671|NCT02335398|Sensory System Agents|sensory system agents|mesh-ancestor
111255672|NCT02335398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111255673|NCT02335398|Antitussive Agents|antitussive agents|mesh-ancestor
111255674|NCT02335398|Respiratory System Agents|respiratory system agents|mesh-ancestor
111255675|NCT02338206|Hormones|hormones|mesh-list
111255676|NCT02338206|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111255677|NCT02338206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111255678|NCT02338050|Immunotoxin HA22|immunotoxin ha22|mesh-list
111255679|NCT02338050|Immunotoxins|immunotoxins|mesh-ancestor
111255680|NCT02338050|Immunoconjugates|immunoconjugates|mesh-ancestor
111255681|NCT02338050|Immunologic Factors|immunologic factors|mesh-ancestor
111255682|NCT02338050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111255683|NCT02338050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111255684|NCT02330406|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111255685|NCT02330406|Anagliptin|anagliptin|mesh-list
111255686|NCT02330406|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111255687|NCT02330406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111255688|NCT02330406|Incretins|incretins|mesh-ancestor
111255689|NCT02330406|Hormones|hormones|mesh-ancestor
111255690|NCT02330406|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111255691|NCT02330406|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111255692|NCT02330406|Protease Inhibitors|protease inhibitors|mesh-ancestor
111255693|NCT02330406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111255694|NCT02330406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111255695|NCT03906708|Carbon Monoxide|carbon monoxide|mesh-list
111255696|NCT03906708|Antimetabolites|antimetabolites|mesh-ancestor
111255697|NCT03906708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111255698|NCT03906708|Gasotransmitters|gasotransmitters|mesh-ancestor
111255699|NCT03906708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111255700|NCT03906708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111255701|NCT02337972|Povidone-Iodine|povidone-iodine|mesh-list
111255702|NCT02337972|Povidone|povidone|mesh-list
111255703|NCT02337972|Plasma Substitutes|plasma substitutes|mesh-ancestor
111255704|NCT02337972|Blood Substitutes|blood substitutes|mesh-ancestor
111255705|NCT02337972|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111255706|NCT02337972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111255707|NCT02335164|Hemagglutinins|hemagglutinins|mesh-list
111255708|NCT02335164|Agglutinins|agglutinins|mesh-ancestor
111255709|NCT02335164|Immunologic Factors|immunologic factors|mesh-ancestor
111255710|NCT02335164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111255711|NCT02335164|Coagulants|coagulants|mesh-ancestor
111255712|NCT00365859|Aripiprazole|aripiprazole|mesh-list
111255713|NCT00365859|Antidepressive Agents|antidepressive agents|mesh-ancestor
111255714|NCT00365859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111255715|NCT00365859|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111255716|NCT00365859|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111255717|NCT00365859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111255718|NCT00365859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111255719|NCT00365859|Dopamine Agonists|dopamine agonists|mesh-ancestor
111255720|NCT00365859|Dopamine Agents|dopamine agents|mesh-ancestor
111255721|NCT00365859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111255722|NCT00365859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111255723|NCT00365859|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111255724|NCT00365859|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111255725|NCT00365859|Serotonin Agents|serotonin agents|mesh-ancestor
111255726|NCT00365859|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111255727|NCT00365859|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111255728|NCT00365859|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111255729|NCT00365859|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111255730|NCT02337426|Temozolomide|temozolomide|mesh-list
111255731|NCT02337426|Dimethyl Fumarate|dimethyl fumarate|mesh-list
111255732|NCT02337426|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111255733|NCT02337426|Alkylating Agents|alkylating agents|mesh-ancestor
111255734|NCT02337426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111255735|NCT02337426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111255736|NCT02337426|Dermatologic Agents|dermatologic agents|mesh-ancestor
111255737|NCT02337426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111255738|NCT02337426|Immunologic Factors|immunologic factors|mesh-ancestor
111255739|NCT02337426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111255740|NCT03664830|Plerixafor|plerixafor|mesh-list
111255741|NCT03664830|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111255742|NCT03664830|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111255743|NCT03664830|Antiviral Agents|antiviral agents|mesh-ancestor
111255744|NCT03664830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111255745|NCT00407355|Ranibizumab|ranibizumab|mesh-list
111255746|NCT00407355|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111255747|NCT00407355|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111255748|NCT00407355|Growth Substances|growth substances|mesh-ancestor
111255749|NCT00407355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111255750|NCT00407355|Growth Inhibitors|growth inhibitors|mesh-ancestor
111255751|NCT00407355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111255752|NCT02334462|Aluminum Hydroxide|aluminum hydroxide|mesh-list
111255753|NCT02334462|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111255754|NCT02334462|Immunologic Factors|immunologic factors|mesh-ancestor
111255755|NCT02334462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111255756|NCT02334462|Antacids|antacids|mesh-ancestor
111255757|NCT02334462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111255758|NCT02334462|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111255759|NCT03144882|Curcumin|curcumin|mesh-list
111255760|NCT03144882|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111255761|NCT03144882|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111255762|NCT03144882|Analgesics|analgesics|mesh-ancestor
111255763|NCT03144882|Sensory System Agents|sensory system agents|mesh-ancestor
111255764|NCT03144882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111255765|NCT03144882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111255766|NCT03144882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111255767|NCT03144882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111255768|NCT03144882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111255769|NCT03144882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111255770|NCT03144882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111255771|NCT01793259|Methotrexate|methotrexate|mesh-list
111255772|NCT01793259|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111255773|NCT01793259|Abortifacient Agents|abortifacient agents|mesh-ancestor
111255774|NCT01793259|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111255775|NCT01793259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111255776|NCT01793259|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111255777|NCT01793259|Antimetabolites|antimetabolites|mesh-ancestor
111255778|NCT01793259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111255779|NCT01793259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111255780|NCT01793259|Dermatologic Agents|dermatologic agents|mesh-ancestor
111255781|NCT01793259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111255782|NCT01793259|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111255783|NCT01793259|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111255784|NCT01793259|Immunologic Factors|immunologic factors|mesh-ancestor
111255785|NCT01793259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111255786|NCT01793259|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111255787|NCT02329626|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
111255788|NCT02329626|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111255789|NCT02329626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111255790|NCT03111810|Prednisolone|prednisolone|mesh-list
111255791|NCT03111810|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111255792|NCT03111810|Methylprednisolone|methylprednisolone|mesh-list
111255793|NCT03111810|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111255794|NCT03111810|Prednisolone acetate|prednisolone acetate|mesh-list
111255795|NCT03111810|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111255796|NCT03111810|Prednisolone phosphate|prednisolone phosphate|mesh-list
111255797|NCT03111810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111255798|NCT03111810|Glucocorticoids|glucocorticoids|mesh-ancestor
111255799|NCT03111810|Hormones|hormones|mesh-ancestor
111255800|NCT03111810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111255801|NCT03111810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111255802|NCT03111810|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110980099|NCT03220880|Analgesics|analgesics|mesh-ancestor
111255803|NCT03111810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111255804|NCT03111810|Antiemetics|antiemetics|mesh-ancestor
111255805|NCT03111810|Autonomic Agents|autonomic agents|mesh-ancestor
111255806|NCT03111810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111255807|NCT03111810|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111255808|NCT03111810|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111255809|NCT03111810|Protective Agents|protective agents|mesh-ancestor
111255811|NCT02334150|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111255812|NCT02334150|Narcotics|narcotics|mesh-ancestor
111255813|NCT02334150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111255814|NCT02334150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111255815|NCT02334150|Analgesics|analgesics|mesh-ancestor
111255816|NCT02334150|Sensory System Agents|sensory system agents|mesh-ancestor
111255817|NCT02334150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111255818|NCT02334150|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111255819|NCT02334150|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111255820|NCT02334150|Anesthetics, General|anesthetics, general|mesh-ancestor
111255821|NCT02334150|Anesthetics|anesthetics|mesh-ancestor
111255822|NCT02326428|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
111255823|NCT02326428|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111255824|NCT02326428|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111255825|NCT02326428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111255826|NCT04477590|Metformin|metformin|mesh-list
111255827|NCT04477590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111255828|NCT04477590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111255829|NCT02333838|Fludarabine|fludarabine|mesh-list
111255830|NCT02333838|Fludarabine phosphate|fludarabine phosphate|mesh-list
111255831|NCT02333838|Busulfan|busulfan|mesh-list
111255832|NCT02333838|Thiotepa|thiotepa|mesh-list
111255833|NCT02333838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111255834|NCT02333838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111255835|NCT02333838|Antimetabolites|antimetabolites|mesh-ancestor
111255836|NCT02333838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111255837|NCT02333838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111255838|NCT02333838|Immunologic Factors|immunologic factors|mesh-ancestor
111255839|NCT02333838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111255840|NCT02333838|Alkylating Agents|alkylating agents|mesh-ancestor
111255841|NCT02333838|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111255842|NCT02333838|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111255843|NCT02326584|Cytarabine|cytarabine|mesh-list
111255844|NCT02326584|Daunorubicin|daunorubicin|mesh-list
111255845|NCT02326584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111255846|NCT02326584|Antimetabolites|antimetabolites|mesh-ancestor
111255847|NCT02326584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111255848|NCT02326584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111255849|NCT02326584|Antiviral Agents|antiviral agents|mesh-ancestor
111255850|NCT02326584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111255851|NCT02326584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111255852|NCT02326584|Immunologic Factors|immunologic factors|mesh-ancestor
111255853|NCT02326584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111255854|NCT02326584|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111255855|NCT02326584|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111255856|NCT02326584|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111255857|NCT02326584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111255858|NCT03111342|Lidocaine|lidocaine|mesh-list
111255859|NCT03111342|Anesthetics, Local|anesthetics, local|mesh-ancestor
111255860|NCT03111342|Anesthetics|anesthetics|mesh-ancestor
111255861|NCT03111342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111255862|NCT03111342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111255863|NCT03111342|Sensory System Agents|sensory system agents|mesh-ancestor
111255864|NCT03111342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111255865|NCT03111342|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111255866|NCT03111342|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111255867|NCT03111342|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111255868|NCT03111342|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111255869|NCT03111342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111255870|NCT03111420|Clopidogrel|clopidogrel|mesh-list
111255871|NCT03111420|Ticagrelor|ticagrelor|mesh-list
111255872|NCT03111420|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
111255873|NCT03111420|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111255874|NCT03111420|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111255875|NCT03111420|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110980166|NCT00580125|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111255876|NCT03111420|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111255877|NCT03111420|Purinergic Agents|purinergic agents|mesh-ancestor
111255878|NCT03111420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111255879|NCT03111420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111255880|NCT03111420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111255882|NCT02333682|Cholecalciferol|cholecalciferol|mesh-list
111255883|NCT02333682|Calcifediol|calcifediol|mesh-list
111255884|NCT02333682|Vitamins|vitamins|mesh-ancestor
111255885|NCT02333682|Micronutrients|micronutrients|mesh-ancestor
111255886|NCT02333682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111255887|NCT02333682|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111255888|NCT02333682|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111255889|NCT02328456|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111255890|NCT02328456|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111255891|NCT02326350|Aspirin|aspirin|mesh-list
111255892|NCT02326350|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111255893|NCT02326350|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111255894|NCT02326350|Analgesics|analgesics|mesh-ancestor
111255895|NCT02326350|Sensory System Agents|sensory system agents|mesh-ancestor
111255896|NCT02326350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111255897|NCT02326350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111255898|NCT02326350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111255899|NCT02326350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111255900|NCT02326350|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111255901|NCT02326350|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111255902|NCT02326350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111255903|NCT02326350|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111255904|NCT02326350|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111255905|NCT02326350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111255906|NCT02326350|Antipyretics|antipyretics|mesh-ancestor
111255907|NCT02326194|Vaccines|vaccines|mesh-list
111255908|NCT02326194|Immunologic Factors|immunologic factors|mesh-ancestor
111255909|NCT02326194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111255910|NCT02326038|Methylphenidate|methylphenidate|mesh-list
111255911|NCT02326038|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111255912|NCT02326038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111255913|NCT02326038|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111255914|NCT02326038|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111255915|NCT02326038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111255916|NCT02326038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111255917|NCT02326038|Dopamine Agents|dopamine agents|mesh-ancestor
111255918|NCT02326038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111255919|NCT00970866|Folic Acid|folic acid|mesh-list
111255920|NCT00970866|Micronutrients|micronutrients|mesh-list
111255921|NCT00970866|Trace Elements|trace elements|mesh-list
111255922|NCT00970866|Hematinics|hematinics|mesh-ancestor
111255923|NCT00970866|Vitamin B Complex|vitamin b complex|mesh-ancestor
111255924|NCT00970866|Vitamins|vitamins|mesh-ancestor
111255925|NCT00970866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111255926|NCT03145584|Bupivacaine|bupivacaine|mesh-list
111255927|NCT03145584|Anesthetics, Local|anesthetics, local|mesh-ancestor
111255928|NCT03145584|Anesthetics|anesthetics|mesh-ancestor
111255929|NCT03145584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111255930|NCT03145584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111255931|NCT03145584|Sensory System Agents|sensory system agents|mesh-ancestor
111255932|NCT03145584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111255933|NCT03145194|Ticagrelor|ticagrelor|mesh-list
111255934|NCT03145194|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111255935|NCT03145194|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111255936|NCT03145194|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111255937|NCT03145194|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111255938|NCT03145194|Purinergic Agents|purinergic agents|mesh-ancestor
111255939|NCT03145194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111255940|NCT03145194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111255941|NCT03145194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111255942|NCT03143946|Vitamins|vitamins|mesh-list
111255943|NCT03143946|Micronutrients|micronutrients|mesh-ancestor
111255944|NCT03143946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111255945|NCT02039700|Lesinurad|lesinurad|mesh-list
111255946|NCT02039700|Gout Suppressants|gout suppressants|mesh-ancestor
111255947|NCT02039700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111255948|NCT02039700|Uricosuric Agents|uricosuric agents|mesh-ancestor
111255949|NCT05076474|Orlistat|orlistat|mesh-list
111255950|NCT05076474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111255951|NCT05076474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111255952|NCT05076474|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111255953|NCT05076474|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111255954|NCT02328144|Metronidazole|metronidazole|mesh-list
111255955|NCT02328144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111255956|NCT02328144|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111255957|NCT02328144|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111255958|NCT02328144|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111255959|NCT02327676|Emtricitabine|emtricitabine|mesh-list
111255960|NCT02327676|Antiviral Agents|antiviral agents|mesh-ancestor
111255961|NCT02327676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111255962|NCT02327676|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111255963|NCT02327676|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111255964|NCT02327676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111255965|NCT02327676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111255966|NCT02327676|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111255967|NCT02327676|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111255968|NCT02333058|Treosulfan|treosulfan|mesh-list
111255969|NCT02333058|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111255970|NCT02333058|Alkylating Agents|alkylating agents|mesh-ancestor
111255971|NCT02333058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111255972|NCT02333058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111255973|NCT03111186|Acetaminophen|acetaminophen|mesh-list
111255974|NCT03111186|Ibuprofen|ibuprofen|mesh-list
111255975|NCT03111186|Oxycodone|oxycodone|mesh-list
111255976|NCT03111186|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111255977|NCT03111186|Analgesics|analgesics|mesh-ancestor
111255978|NCT03111186|Sensory System Agents|sensory system agents|mesh-ancestor
111255979|NCT03111186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111255980|NCT03111186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111255981|NCT03111186|Antipyretics|antipyretics|mesh-ancestor
111255982|NCT03111186|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111255983|NCT03111186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111255984|NCT03111186|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111255985|NCT03111186|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111255986|NCT03111186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111255987|NCT03111186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111255988|NCT03111186|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111255989|NCT03111186|Narcotics|narcotics|mesh-ancestor
111255990|NCT03111186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111255991|NCT02332512|Apatinib|apatinib|mesh-list
111255992|NCT02332512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111255993|NCT02332512|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110978154|NCT03265886|Bupivacaine|bupivacaine|mesh-list
111255994|NCT02332512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111255995|NCT02332512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111255996|NCT02327754|FYX-051|fyx-051|mesh-list
111255997|NCT02327754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111255998|NCT02327754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111255999|NCT03142620|Vitamin D|vitamin d|mesh-list
111256000|NCT03142620|Cholecalciferol|cholecalciferol|mesh-list
111256001|NCT03142620|Amoxicillin|amoxicillin|mesh-list
111256002|NCT03142620|Clarithromycin|clarithromycin|mesh-list
111256003|NCT03142620|Clavulanic Acid|clavulanic acid|mesh-list
111256004|NCT03142620|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
111256005|NCT03142620|Esomeprazole|esomeprazole|mesh-list
111256006|NCT03142620|Vitamins|vitamins|mesh-ancestor
111256007|NCT03142620|Micronutrients|micronutrients|mesh-ancestor
111256008|NCT03142620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111256009|NCT03142620|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111256010|NCT03142620|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111256011|NCT03142620|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111256012|NCT03142620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111256013|NCT03142620|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111256014|NCT03142620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111256015|NCT03142620|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111256016|NCT03142620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111256017|NCT03142620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111256018|NCT03142620|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111256019|NCT03142620|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111256020|NCT03142620|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111256021|NCT03142620|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
111256022|NCT03110952|alpha-Tocopherol|alpha-tocopherol|mesh-list
111256023|NCT03110952|Vaccines|vaccines|mesh-list
111256024|NCT03110952|Immunologic Factors|immunologic factors|mesh-ancestor
111256025|NCT03110952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110980315|NCT02549092|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111256026|NCT03110952|Antioxidants|antioxidants|mesh-ancestor
111256027|NCT03110952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111256028|NCT03110952|Protective Agents|protective agents|mesh-ancestor
111256029|NCT03110952|Vitamins|vitamins|mesh-ancestor
111256030|NCT03110952|Micronutrients|micronutrients|mesh-ancestor
111256031|NCT03143244|Ketorolac|ketorolac|mesh-list
111256032|NCT03143244|Midazolam|midazolam|mesh-list
111256033|NCT03143244|Dexmedetomidine|dexmedetomidine|mesh-list
111256034|NCT03143244|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111256035|NCT03143244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111256036|NCT03143244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111256037|NCT03143244|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111256038|NCT03143244|Analgesics|analgesics|mesh-ancestor
111256039|NCT03143244|Sensory System Agents|sensory system agents|mesh-ancestor
111256040|NCT03143244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111256041|NCT03143244|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111256042|NCT03143244|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111256043|NCT03143244|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111256044|NCT03143244|Adrenergic Agents|adrenergic agents|mesh-ancestor
111256045|NCT03143244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111256046|NCT03143244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111256047|NCT03143244|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111256048|NCT03143244|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111256049|NCT03143244|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111256050|NCT03143244|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111256051|NCT03143244|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111256052|NCT03143244|Anesthetics, General|anesthetics, general|mesh-ancestor
111256053|NCT03143244|Anesthetics|anesthetics|mesh-ancestor
111256054|NCT03143244|GABA Modulators|gaba modulators|mesh-ancestor
111256055|NCT03143244|GABA Agents|gaba agents|mesh-ancestor
111256056|NCT03143244|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111256057|NCT03143244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111256058|NCT03143244|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111256059|NCT03143244|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111256060|NCT03143244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111256061|NCT03838692|Ponatinib|ponatinib|mesh-list
111256062|NCT03838692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111256063|NCT03838692|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111256064|NCT03838692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111256065|NCT03838692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111256066|NCT03774186|Pancrelipase|pancrelipase|mesh-list
111256067|NCT03774186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111256068|NCT03505944|Venetoclax|venetoclax|mesh-list
111256069|NCT03505944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111256070|NCT01489189|Ranibizumab|ranibizumab|mesh-list
111256071|NCT01489189|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111256072|NCT01489189|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111256073|NCT01489189|Growth Substances|growth substances|mesh-ancestor
111256074|NCT01489189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111256075|NCT01489189|Growth Inhibitors|growth inhibitors|mesh-ancestor
111256076|NCT01489189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111256077|NCT01549873|Propofol|propofol|mesh-list
111256078|NCT01549873|Desflurane|desflurane|mesh-list
111256079|NCT01549873|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111256080|NCT01549873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111256081|NCT01549873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111256082|NCT01549873|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111256083|NCT01549873|Anesthetics, General|anesthetics, general|mesh-ancestor
111256084|NCT01549873|Anesthetics|anesthetics|mesh-ancestor
111256085|NCT01549873|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111256086|NCT04106401|Carbon Monoxide|carbon monoxide|mesh-list
111256087|NCT04106401|Antimetabolites|antimetabolites|mesh-ancestor
111256088|NCT04106401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111256089|NCT04106401|Gasotransmitters|gasotransmitters|mesh-ancestor
111256090|NCT04106401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111256091|NCT04106401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111256092|NCT01488487|Everolimus|everolimus|mesh-list
111256093|NCT01488487|Pasireotide|pasireotide|mesh-list
111256094|NCT01488487|Somatostatin|somatostatin|mesh-list
111256095|NCT01488487|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111256096|NCT01488487|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111256097|NCT01488487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111256098|NCT01488487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110980420|NCT00562497|Remestemcel-l|remestemcel-l|mesh-list
111256099|NCT01488487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111256100|NCT01488487|Immunologic Factors|immunologic factors|mesh-ancestor
111256101|NCT01488487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111256102|NCT01488487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111256104|NCT01488487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111256106|NCT03027115|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111256107|NCT03027115|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111256108|NCT03027115|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111256109|NCT03027115|Adrenergic Agents|adrenergic agents|mesh-ancestor
111256110|NCT03027115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111256111|NCT03027115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111256112|NCT03027115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111256113|NCT03027115|Urological Agents|urological agents|mesh-ancestor
111256114|NCT03026881|Paclitaxel|paclitaxel|mesh-list
111256115|NCT03026881|Apatinib|apatinib|mesh-list
111256116|NCT03026881|Fluzoparib|fluzoparib|mesh-list
111256117|NCT03026881|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111256118|NCT03026881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111256119|NCT03026881|Tubulin Modulators|tubulin modulators|mesh-ancestor
111256120|NCT03026881|Antimitotic Agents|antimitotic agents|mesh-ancestor
111256121|NCT03026881|Mitosis Modulators|mitosis modulators|mesh-ancestor
111256122|NCT03026881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111256123|NCT03026881|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111256124|NCT03026881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111256125|NCT03026881|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111256126|NCT01516879|Atorvastatin|atorvastatin|mesh-list
111256127|NCT01516879|Ezetimibe|ezetimibe|mesh-list
111256128|NCT01516879|Evolocumab|evolocumab|mesh-list
111256129|NCT01516879|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111256130|NCT01516879|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111256131|NCT01516879|Antimetabolites|antimetabolites|mesh-ancestor
111256132|NCT01516879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111256133|NCT01516879|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111256134|NCT01516879|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111256135|NCT01516879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111256136|NCT01516879|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
111256137|NCT01516879|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111256138|NCT01516879|Protease Inhibitors|protease inhibitors|mesh-ancestor
111256139|NCT01515865|Midodrine|midodrine|mesh-list
111256140|NCT01515865|Sympathomimetics|sympathomimetics|mesh-ancestor
111256141|NCT01515865|Autonomic Agents|autonomic agents|mesh-ancestor
111256142|NCT01515865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111256143|NCT01515865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111256144|NCT01515865|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111256145|NCT01515865|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111256146|NCT01515865|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111256147|NCT01515865|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111256148|NCT01515865|Adrenergic Agents|adrenergic agents|mesh-ancestor
111256149|NCT01515865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111256150|NCT01515865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111256151|NCT01547299|Leuprolide|leuprolide|mesh-list
111256152|NCT01547299|Dutasteride|dutasteride|mesh-list
111256153|NCT01547299|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111256154|NCT01547299|Fertility Agents|fertility agents|mesh-ancestor
111256155|NCT01547299|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111256156|NCT01547299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111256157|NCT01547299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111256158|NCT01547299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111256159|NCT01547299|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
111256160|NCT01547299|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111256161|NCT01547299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111256162|NCT01547299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111256163|NCT01547299|Hormone Antagonists|hormone antagonists|mesh-ancestor
111256164|NCT01547299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111256165|NCT04072107|Capecitabine|capecitabine|mesh-list
111256166|NCT04072107|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111256167|NCT04072107|Antimetabolites|antimetabolites|mesh-ancestor
111256168|NCT04072107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111256169|NCT04072107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111256170|NCT00411411|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111256171|NCT00411411|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111256172|NCT00411411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111256173|NCT00411411|Incretins|incretins|mesh-ancestor
111256174|NCT00411411|Hormones|hormones|mesh-ancestor
110980460|NCT01503515|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111256175|NCT00411411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111256176|NCT00411411|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111256178|NCT00411411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111256179|NCT00411411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111256180|NCT01794273|Phenylephrine|phenylephrine|mesh-list
111256181|NCT01794273|Oxymetazoline|oxymetazoline|mesh-list
111256182|NCT01794273|Ephedrine|ephedrine|mesh-list
111256183|NCT01794273|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111256184|NCT01794273|Mydriatics|mydriatics|mesh-ancestor
111256185|NCT01794273|Autonomic Agents|autonomic agents|mesh-ancestor
111256186|NCT01794273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111256187|NCT01794273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111256188|NCT01794273|Sympathomimetics|sympathomimetics|mesh-ancestor
111256189|NCT01794273|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111256190|NCT01794273|Nasal Decongestants|nasal decongestants|mesh-ancestor
111256191|NCT01794273|Respiratory System Agents|respiratory system agents|mesh-ancestor
111256192|NCT01794273|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111256193|NCT01794273|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111256194|NCT01794273|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111256195|NCT01794273|Adrenergic Agents|adrenergic agents|mesh-ancestor
111256196|NCT01794273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111256197|NCT01794273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111256198|NCT01794273|Protective Agents|protective agents|mesh-ancestor
111256199|NCT01794273|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111256200|NCT02109939|Psychotropic Drugs|psychotropic drugs|mesh-list
111256201|NCT01795599|Mifepristone|mifepristone|mesh-list
111256202|NCT01795599|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
111256203|NCT01795599|Abortifacient Agents|abortifacient agents|mesh-ancestor
111256204|NCT01795599|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111256205|NCT01795599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111256206|NCT01795599|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111256207|NCT01795599|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111256208|NCT01795599|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111256209|NCT01795599|Contraceptive Agents|contraceptive agents|mesh-ancestor
111256210|NCT01795599|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
110978161|NCT00728091|Satavaptan|satavaptan|mesh-list
111256211|NCT01795599|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
111256212|NCT01795599|Hormone Antagonists|hormone antagonists|mesh-ancestor
111256213|NCT01795599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111256214|NCT01795599|Luteolytic Agents|luteolytic agents|mesh-ancestor
111256215|NCT01795599|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111256216|NCT01795599|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
111256217|NCT01794351|Resveratrol|resveratrol|mesh-list
111256218|NCT01794351|Antioxidants|antioxidants|mesh-ancestor
111256219|NCT01794351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111256220|NCT01794351|Protective Agents|protective agents|mesh-ancestor
111256221|NCT01794351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111256222|NCT01794351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111256223|NCT01794351|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111256224|NCT04409431|Epinephrine|epinephrine|mesh-list
111256225|NCT04409431|Racepinephrine|racepinephrine|mesh-list
111256226|NCT04409431|Epinephryl borate|epinephryl borate|mesh-list
111256227|NCT04409431|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111256228|NCT04409431|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111256229|NCT04409431|Adrenergic Agents|adrenergic agents|mesh-ancestor
111256230|NCT04409431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111256231|NCT04409431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111256232|NCT04409431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111256233|NCT04409431|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111256234|NCT04409431|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111256235|NCT04409431|Autonomic Agents|autonomic agents|mesh-ancestor
111256236|NCT04409431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111256237|NCT04409431|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111256238|NCT04409431|Respiratory System Agents|respiratory system agents|mesh-ancestor
111256239|NCT04409431|Mydriatics|mydriatics|mesh-ancestor
111256240|NCT04409431|Sympathomimetics|sympathomimetics|mesh-ancestor
111256241|NCT04409431|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111256242|NCT01794507|Dexamethasone|dexamethasone|mesh-list
111256243|NCT01794507|Bortezomib|bortezomib|mesh-list
111256244|NCT01794507|Venetoclax|venetoclax|mesh-list
111256245|NCT01794507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111256246|NCT01794507|Antiemetics|antiemetics|mesh-ancestor
111256247|NCT01794507|Autonomic Agents|autonomic agents|mesh-ancestor
111256248|NCT01794507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111256249|NCT01794507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111256250|NCT01794507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111256251|NCT01794507|Glucocorticoids|glucocorticoids|mesh-ancestor
111256252|NCT01794507|Hormones|hormones|mesh-ancestor
111256253|NCT01794507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111256254|NCT01794507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111256255|NCT01794507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111256256|NCT00412425|Palonosetron|palonosetron|mesh-list
111256257|NCT00412425|Antiemetics|antiemetics|mesh-ancestor
111256258|NCT00412425|Autonomic Agents|autonomic agents|mesh-ancestor
111256259|NCT00412425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111256260|NCT00412425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111256261|NCT00412425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111256262|NCT00412425|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111256263|NCT00412425|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111256264|NCT00412425|Serotonin Agents|serotonin agents|mesh-ancestor
111256265|NCT00412425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111256266|NCT00412425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111256267|NCT01492361|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
111256268|NCT01492361|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111256269|NCT01492361|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111256270|NCT00415857|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
111256271|NCT00415857|Imatinib Mesylate|imatinib mesylate|mesh-list
111256272|NCT00415857|Vaccines|vaccines|mesh-list
111256273|NCT00415857|Sargramostim|sargramostim|mesh-list
111256274|NCT00415857|Immunologic Factors|immunologic factors|mesh-ancestor
111256275|NCT00415857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111256276|NCT00415857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111256277|NCT00415857|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111256278|NCT00415857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111256279|NCT00415857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111256280|NCT00415857|Antiviral Agents|antiviral agents|mesh-ancestor
111256281|NCT00415857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111256282|NCT03491631|Apatinib|apatinib|mesh-list
111256283|NCT03491631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110978166|NCT03275090|SMOFlipid|smoflipid|mesh-list
111256284|NCT03491631|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111256285|NCT03491631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111256286|NCT03491631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111256287|NCT04271007|Mometasone Furoate|mometasone furoate|mesh-list
111256288|NCT04271007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111256289|NCT04271007|Dermatologic Agents|dermatologic agents|mesh-ancestor
111256290|NCT04271007|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111256291|NCT00416793|Carboplatin|carboplatin|mesh-list
111256292|NCT00416793|Bortezomib|bortezomib|mesh-list
111256293|NCT00416793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111256294|NCT00417417|Rilonacept|rilonacept|mesh-list
111256295|NCT00417417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111256296|NCT00419445|3-(2,4-dimethoxybenzylidene)anabaseine|3-(2,4-dimethoxybenzylidene)anabaseine|mesh-list
111256297|NCT00419445|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111256298|NCT00419445|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111256299|NCT00419445|Cholinergic Agents|cholinergic agents|mesh-ancestor
111256300|NCT00419445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111256301|NCT00419445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111256302|NCT00419445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111256303|NCT00420459|Aripiprazole|aripiprazole|mesh-list
111256304|NCT00420459|Antidepressive Agents|antidepressive agents|mesh-ancestor
111256305|NCT00420459|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111256306|NCT00420459|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111256307|NCT00420459|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111256308|NCT00420459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111256309|NCT00420459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111256310|NCT00420459|Dopamine Agonists|dopamine agonists|mesh-ancestor
111256311|NCT00420459|Dopamine Agents|dopamine agents|mesh-ancestor
111256312|NCT00420459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111256313|NCT00420459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111256314|NCT00420459|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111256315|NCT00420459|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111256316|NCT00420459|Serotonin Agents|serotonin agents|mesh-ancestor
111256317|NCT00420459|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111256318|NCT00420459|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111256319|NCT00420459|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111256320|NCT00420459|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111256321|NCT00420771|Gabapentin|gabapentin|mesh-list
111256322|NCT00420771|Analgesics|analgesics|mesh-ancestor
111256323|NCT00420771|Sensory System Agents|sensory system agents|mesh-ancestor
111256324|NCT00420771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111256325|NCT00420771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111256327|NCT00420771|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111256328|NCT00420771|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111256329|NCT00420771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111256330|NCT00420771|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111256331|NCT00420771|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111256332|NCT00420771|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111256333|NCT00420771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111256334|NCT00420771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111256335|NCT00420771|Antimanic Agents|antimanic agents|mesh-ancestor
111256336|NCT00426153|Octreotide|octreotide|mesh-list
111256337|NCT00426153|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111256338|NCT00426153|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111256339|NCT00426153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111256340|NCT04750317|Tofacitinib|tofacitinib|mesh-list
111256341|NCT04750317|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
111256342|NCT04750317|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111256343|NCT04750317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111256344|NCT04750317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111256345|NCT01996449|Amlodipine|amlodipine|mesh-list
111256346|NCT01996449|Eplerenone|eplerenone|mesh-list
111256347|NCT01996449|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111256348|NCT01996449|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111256349|NCT01996449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111256350|NCT01996449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111256351|NCT01996449|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111256352|NCT01996449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111256353|NCT01996449|Vasodilator Agents|vasodilator agents|mesh-ancestor
111256354|NCT01996449|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
111256355|NCT01996449|Hormone Antagonists|hormone antagonists|mesh-ancestor
111256356|NCT01996449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111256357|NCT01996449|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
111256358|NCT01996449|Diuretics|diuretics|mesh-ancestor
111256359|NCT01996449|Natriuretic Agents|natriuretic agents|mesh-ancestor
111256360|NCT00426855|Bortezomib|bortezomib|mesh-list
111256361|NCT00426855|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
111256362|NCT00426855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111256363|NCT00426855|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111256364|NCT00426855|Alkylating Agents|alkylating agents|mesh-ancestor
111256365|NCT00426855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111256366|NCT01491737|Trastuzumab|trastuzumab|mesh-list
111256367|NCT01491737|Pertuzumab|pertuzumab|mesh-list
111256368|NCT01491737|Aromatase Inhibitors|aromatase inhibitors|mesh-list
111256369|NCT01491737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111256370|NCT01491737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111256371|NCT01491737|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111256372|NCT01491737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111256373|NCT01491737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111256374|NCT01491737|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111256375|NCT01491737|Hormone Antagonists|hormone antagonists|mesh-ancestor
111256376|NCT01491737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111256377|NCT01491737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111256378|NCT00427557|Rituximab|rituximab|mesh-list
111256379|NCT00427557|Fludarabine|fludarabine|mesh-list
111256380|NCT00427557|Fludarabine phosphate|fludarabine phosphate|mesh-list
111256381|NCT00427557|Melphalan|melphalan|mesh-list
111256382|NCT00427557|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111256383|NCT00427557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111256384|NCT00427557|Immunologic Factors|immunologic factors|mesh-ancestor
111256385|NCT00427557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111256386|NCT00427557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111256387|NCT00427557|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111256388|NCT00427557|Antimetabolites|antimetabolites|mesh-ancestor
111256389|NCT00427557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111256390|NCT00427557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111256391|NCT00427557|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111256392|NCT00427557|Alkylating Agents|alkylating agents|mesh-ancestor
111256393|NCT00427557|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111256394|NCT01487863|Abiraterone Acetate|abiraterone acetate|mesh-list
111256395|NCT01487863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111256396|NCT01487863|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111256397|NCT01487863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111256398|NCT01487863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111256399|NCT01487863|Hormone Antagonists|hormone antagonists|mesh-ancestor
111256400|NCT01487863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111256401|NCT01487863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111256402|NCT01487863|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111256404|NCT04088305|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111256405|NCT04088305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111256406|NCT00427791|Rituximab|rituximab|mesh-list
111256407|NCT00427791|Etoposide|etoposide|mesh-list
111256408|NCT00427791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111256409|NCT00427791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111256410|NCT00427791|Immunologic Factors|immunologic factors|mesh-ancestor
111256411|NCT00427791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111256412|NCT00427791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111256413|NCT00427791|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111256414|NCT00427791|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111256415|NCT00427791|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111256416|NCT00427791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111256417|NCT00427791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111256418|NCT01487161|Triamcinolone|triamcinolone|mesh-list
111256419|NCT01487161|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
111256420|NCT01487161|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
111256421|NCT01487161|FX006|fx006|mesh-list
111256422|NCT01487161|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
111256423|NCT01487161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111256424|NCT01487161|Glucocorticoids|glucocorticoids|mesh-ancestor
111256425|NCT01487161|Hormones|hormones|mesh-ancestor
111256426|NCT01487161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111256427|NCT01487161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111256428|NCT01487161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111256429|NCT01487161|Immunologic Factors|immunologic factors|mesh-ancestor
111256430|NCT01487161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111256431|NCT01487161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111256432|NCT00429507|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
111256433|NCT00429507|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111256434|NCT00429507|Analgesics|analgesics|mesh-ancestor
111256435|NCT00429507|Sensory System Agents|sensory system agents|mesh-ancestor
111256436|NCT00429507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111256437|NCT00429507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111256438|NCT01794897|Valacyclovir|valacyclovir|mesh-list
111256439|NCT01794897|Antiviral Agents|antiviral agents|mesh-ancestor
111256440|NCT01794897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111256441|NCT01794975|Ketamine|ketamine|mesh-list
111256442|NCT01794975|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
111256443|NCT01794975|Analgesics|analgesics|mesh-ancestor
111256444|NCT01794975|Sensory System Agents|sensory system agents|mesh-ancestor
111256445|NCT01794975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111256446|NCT01794975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111256447|NCT01794975|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111256448|NCT01794975|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111256449|NCT01794975|Anesthetics, General|anesthetics, general|mesh-ancestor
111256450|NCT01794975|Anesthetics|anesthetics|mesh-ancestor
111256451|NCT01794975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111256452|NCT01794975|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111256453|NCT01794975|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111256454|NCT01794975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111256455|NCT01794975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111256456|NCT01794975|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111256457|NCT01794975|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111256458|NCT01794975|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111256459|NCT01794975|Adrenergic Agents|adrenergic agents|mesh-ancestor
111256460|NCT05285787|Menaquinone 7|menaquinone 7|mesh-list
111256461|NCT05285787|Hemostatics|hemostatics|mesh-ancestor
111256462|NCT05285787|Coagulants|coagulants|mesh-ancestor
111256463|NCT01491035|Vortioxetine|vortioxetine|mesh-list
111256464|NCT01491035|Antidepressive Agents|antidepressive agents|mesh-ancestor
111256465|NCT01491035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111256466|NCT01491035|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111256467|NCT01491035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111256468|NCT01491035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110980756|NCT00658047|Methotrexate|methotrexate|mesh-list
111256469|NCT01491035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111256470|NCT01491035|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111256471|NCT01491035|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111256472|NCT01491035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111256473|NCT01491035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111256474|NCT01491035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111256475|NCT01491035|Serotonin Agents|serotonin agents|mesh-ancestor
111256476|NCT01491035|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111256477|NCT01491035|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111256478|NCT01491035|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111256479|NCT01491035|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111256480|NCT00375999|Docetaxel|docetaxel|mesh-list
111256481|NCT00375999|Epirubicin|epirubicin|mesh-list
111256482|NCT00375999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111256483|NCT00375999|Tubulin Modulators|tubulin modulators|mesh-ancestor
111256484|NCT00375999|Antimitotic Agents|antimitotic agents|mesh-ancestor
111256485|NCT00375999|Mitosis Modulators|mitosis modulators|mesh-ancestor
111256486|NCT00375999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111256487|NCT00375999|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111256488|NCT00375999|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111256489|NCT00375999|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111256490|NCT00375999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111256491|NCT04409327|Dactolisib|dactolisib|mesh-list
111256492|NCT04409327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111256493|NCT01488071|Vortioxetine|vortioxetine|mesh-list
111256494|NCT01488071|Agomelatine|agomelatine|mesh-list
111256495|NCT01488071|Antidepressive Agents|antidepressive agents|mesh-ancestor
111256496|NCT01488071|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111256497|NCT01488071|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111256498|NCT01488071|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111256499|NCT01488071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111256500|NCT01488071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110978169|NCT03275090|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111256501|NCT01488071|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111256502|NCT01488071|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111256503|NCT01488071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111256504|NCT01488071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111256505|NCT01488071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111256506|NCT01488071|Serotonin Agents|serotonin agents|mesh-ancestor
111256507|NCT01488071|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111256508|NCT01488071|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111256509|NCT01488071|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111256510|NCT01488071|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111256511|NCT01488071|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111256512|NCT01485887|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
111256513|NCT01485887|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111256514|NCT01485887|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111256515|NCT01485887|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111256516|NCT01485887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111256517|NCT01485887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111256518|NCT01485887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111256519|NCT01485887|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111256520|NCT01485887|Antidepressive Agents|antidepressive agents|mesh-ancestor
111256521|NCT01485887|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111256522|NCT01484951|Timolol|timolol|mesh-list
111256523|NCT01484951|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111256524|NCT01484951|Brinzolamide|brinzolamide|mesh-list
111256525|NCT01484951|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111256526|NCT01484951|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111256527|NCT01484951|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111256528|NCT01484951|Adrenergic Agents|adrenergic agents|mesh-ancestor
111256529|NCT01484951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111256530|NCT01484951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111256531|NCT01484951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111256532|NCT01484951|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111256533|NCT01484951|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111256534|NCT01484951|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
111256535|NCT01484951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111256536|NCT01484873|Exenatide|exenatide|mesh-list
111256537|NCT01484873|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111256538|NCT01484873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111256539|NCT01484873|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110980839|NCT04058899|Nalbuphine|nalbuphine|mesh-list
111256540|NCT01484873|Incretins|incretins|mesh-ancestor
111256541|NCT01484873|Hormones|hormones|mesh-ancestor
111256542|NCT01484873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111256543|NCT01486927|Factor VIII|factor viii|mesh-list
111256544|NCT01486927|Coagulants|coagulants|mesh-ancestor
111256545|NCT00379197|Naltrexone|naltrexone|mesh-list
111256546|NCT00379197|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111256547|NCT00379197|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111256548|NCT00379197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111256549|NCT00379197|Sensory System Agents|sensory system agents|mesh-ancestor
111256550|NCT00379197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111256551|NCT01513759|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
111256552|NCT01513759|Plasminogen|plasminogen|mesh-list
111256553|NCT01513759|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111256554|NCT01513759|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111256555|NCT01513759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111256556|NCT01484561|Tofacitinib|tofacitinib|mesh-list
111256557|NCT01484561|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
111256558|NCT01484561|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111256559|NCT01484561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111256560|NCT01484561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111256561|NCT01483625|Tiotropium Bromide|tiotropium bromide|mesh-list
111256562|NCT01483625|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111256563|NCT01483625|Autonomic Agents|autonomic agents|mesh-ancestor
111256564|NCT01483625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111256565|NCT01483625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111256566|NCT01483625|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111256567|NCT01483625|Respiratory System Agents|respiratory system agents|mesh-ancestor
111256568|NCT01483625|Parasympatholytics|parasympatholytics|mesh-ancestor
111256569|NCT01483625|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111256570|NCT01483625|Cholinergic Agents|cholinergic agents|mesh-ancestor
111256571|NCT01483625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111256572|NCT01483625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111256573|NCT01485991|Simeprevir|simeprevir|mesh-list
111256574|NCT01485991|Antiviral Agents|antiviral agents|mesh-ancestor
111256575|NCT01485991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111256576|NCT01485991|Protease Inhibitors|protease inhibitors|mesh-ancestor
111256577|NCT01485991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111256578|NCT01485991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111256579|NCT00379821|Azithromycin|azithromycin|mesh-list
111256580|NCT00379821|Artesunate|artesunate|mesh-list
111256581|NCT00379821|Chloroquine|chloroquine|mesh-list
111256582|NCT00379821|Atovaquone|atovaquone|mesh-list
111256583|NCT00379821|Proguanil|proguanil|mesh-list
111256584|NCT00379821|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
111256585|NCT00379821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111256586|NCT00379821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111256587|NCT00379821|Antimalarials|antimalarials|mesh-ancestor
111256588|NCT00379821|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111256589|NCT00379821|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111256590|NCT00379821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111256591|NCT00379821|Antiviral Agents|antiviral agents|mesh-ancestor
111256592|NCT00379821|Schistosomicides|schistosomicides|mesh-ancestor
111256593|NCT00379821|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
111256594|NCT00379821|Anthelmintics|anthelmintics|mesh-ancestor
111256595|NCT00379821|Amebicides|amebicides|mesh-ancestor
111256596|NCT00379821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111256597|NCT00379821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111256598|NCT00379821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111256599|NCT00379821|Antimetabolites|antimetabolites|mesh-ancestor
111256600|NCT01482767|Interferons|interferons|mesh-list
111256601|NCT01482767|Ribavirin|ribavirin|mesh-list
111256602|NCT01482767|Interferon-alpha|interferon-alpha|mesh-list
111256603|NCT01482767|Interferon alpha-2|interferon alpha-2|mesh-list
111256604|NCT01482767|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
111256605|NCT01482767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111256606|NCT01482767|Antiviral Agents|antiviral agents|mesh-ancestor
111256607|NCT01482767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111256608|NCT01482767|Antimetabolites|antimetabolites|mesh-ancestor
111256609|NCT01482767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111256610|NCT01482767|Immunologic Factors|immunologic factors|mesh-ancestor
111256611|NCT01482767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111256612|NCT00435591|Conivaptan|conivaptan|mesh-list
111256613|NCT00435591|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
111256614|NCT00435591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111256615|NCT00435591|Natriuretic Agents|natriuretic agents|mesh-ancestor
111256616|NCT00435591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111256617|NCT00439335|Vaccines|vaccines|mesh-list
111256618|NCT00439335|Immunologic Factors|immunologic factors|mesh-ancestor
111256619|NCT00439335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111256620|NCT01545817|Everolimus|everolimus|mesh-list
111256621|NCT01545817|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111256622|NCT01545817|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111256623|NCT01545817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111256624|NCT01545817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111256625|NCT01545817|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111256626|NCT01545817|Immunologic Factors|immunologic factors|mesh-ancestor
111256627|NCT01545817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111256628|NCT01545817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111256629|NCT01512979|Metformin|metformin|mesh-list
111256630|NCT01512979|Linagliptin|linagliptin|mesh-list
111256631|NCT01512979|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111256632|NCT01512979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111256633|NCT01512979|Incretins|incretins|mesh-ancestor
111256634|NCT01512979|Hormones|hormones|mesh-ancestor
111256635|NCT01512979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111256636|NCT01512979|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111256637|NCT01512979|Protease Inhibitors|protease inhibitors|mesh-ancestor
111256638|NCT01512979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111256639|NCT01512979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111256640|NCT00383565|Romidepsin|romidepsin|mesh-list
111256641|NCT00383565|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111256642|NCT00383565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111256643|NCT00383565|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111256644|NCT00383565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111256645|NCT00383565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111256646|NCT01512745|Apatinib|apatinib|mesh-list
111256647|NCT01512745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111256648|NCT01512745|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111256649|NCT01512745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111256650|NCT01512745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111256651|NCT01478321|Bevacizumab|bevacizumab|mesh-list
111256652|NCT01478321|Temozolomide|temozolomide|mesh-list
111256653|NCT01478321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111256654|NCT01478321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111256655|NCT01478321|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111256656|NCT01478321|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111256657|NCT01478321|Growth Substances|growth substances|mesh-ancestor
111256658|NCT01478321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111256659|NCT01478321|Growth Inhibitors|growth inhibitors|mesh-ancestor
111256660|NCT01478321|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111256661|NCT01478321|Alkylating Agents|alkylating agents|mesh-ancestor
111256662|NCT01478321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111256663|NCT01544491|Everolimus|everolimus|mesh-list
111256664|NCT01544491|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111256665|NCT01544491|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111256666|NCT01544491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111256667|NCT01544491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111256668|NCT01544491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111256669|NCT01544491|Immunologic Factors|immunologic factors|mesh-ancestor
111256670|NCT01544491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111256671|NCT01544491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111256672|NCT00383643|Sodium Oxybate|sodium oxybate|mesh-list
111256673|NCT00383643|Zolpidem|zolpidem|mesh-list
111256674|NCT00383643|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111256675|NCT00383643|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111256676|NCT00383643|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111256677|NCT00383643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111256678|NCT00383643|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
111256679|NCT00383643|GABA Agonists|gaba agonists|mesh-ancestor
111256680|NCT00383643|GABA Agents|gaba agents|mesh-ancestor
111256681|NCT00383643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111256682|NCT00383643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111256683|NCT00383643|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111256684|NCT00383643|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111256685|NCT00383643|Anesthetics, General|anesthetics, general|mesh-ancestor
111256686|NCT00383643|Anesthetics|anesthetics|mesh-ancestor
111256687|NCT00439413|Selegiline|selegiline|mesh-list
111256688|NCT00439413|Antidepressive Agents|antidepressive agents|mesh-ancestor
111256689|NCT00439413|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111256690|NCT00439413|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110980984|NCT02286453|Diclofenac|diclofenac|mesh-list
111256691|NCT00439413|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111256692|NCT00439413|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
111256693|NCT00439413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111256694|NCT00439413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111256695|NCT00439413|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111256696|NCT00439413|Protective Agents|protective agents|mesh-ancestor
111256697|NCT00439413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111256698|NCT01477853|Metformin|metformin|mesh-list
111256699|NCT01477853|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111256700|NCT01477853|Glimepiride|glimepiride|mesh-list
111256701|NCT01477853|Atorvastatin|atorvastatin|mesh-list
111256702|NCT01477853|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111256703|NCT01477853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111256704|NCT01477853|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111256705|NCT01477853|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111256706|NCT01477853|Antimetabolites|antimetabolites|mesh-ancestor
111256707|NCT01477853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111256708|NCT01477853|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111256709|NCT01477853|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111256710|NCT01477853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111256711|NCT01477853|Incretins|incretins|mesh-ancestor
111256712|NCT01477853|Hormones|hormones|mesh-ancestor
111256713|NCT01477853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111256714|NCT01477853|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111256715|NCT01477853|Protease Inhibitors|protease inhibitors|mesh-ancestor
111256716|NCT01477853|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111256717|NCT01477853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111256718|NCT01477853|Immunologic Factors|immunologic factors|mesh-ancestor
111256719|NCT00440505|Nicotine|nicotine|mesh-list
111256720|NCT00440505|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111256721|NCT00440505|Autonomic Agents|autonomic agents|mesh-ancestor
111256722|NCT00440505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111256723|NCT00440505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111256724|NCT00440505|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111256725|NCT00440505|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111256726|NCT00440505|Cholinergic Agents|cholinergic agents|mesh-ancestor
111256727|NCT00440505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111256728|NCT00440505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111256729|NCT00441285|Albendazole|albendazole|mesh-list
111256730|NCT00441285|Praziquantel|praziquantel|mesh-list
111256731|NCT00441285|Anthelmintics|anthelmintics|mesh-ancestor
111256732|NCT00441285|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111256733|NCT00441285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111256734|NCT00441285|Anticestodal Agents|anticestodal agents|mesh-ancestor
111256735|NCT00441285|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
111256736|NCT00441285|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111256737|NCT00441285|Tubulin Modulators|tubulin modulators|mesh-ancestor
111256738|NCT00441285|Antimitotic Agents|antimitotic agents|mesh-ancestor
111256739|NCT00441285|Mitosis Modulators|mitosis modulators|mesh-ancestor
111256740|NCT00441285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111256741|NCT00441285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111256742|NCT01796613|Ethinyl Estradiol|ethinyl estradiol|mesh-list
111256743|NCT01796613|Desogestrel|desogestrel|mesh-list
111256744|NCT01796613|Etonogestrel|etonogestrel|mesh-list
111256745|NCT01796613|NuvaRing|nuvaring|mesh-list
111256746|NCT01796613|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111256747|NCT01796613|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111256748|NCT01796613|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111256749|NCT01796613|Contraceptive Agents|contraceptive agents|mesh-ancestor
111256750|NCT01796613|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111256751|NCT01796613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111256752|NCT01796613|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111256753|NCT01796613|Estrogens|estrogens|mesh-ancestor
111256754|NCT01796613|Hormones|hormones|mesh-ancestor
111256755|NCT01796613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111256756|NCT01796613|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111256757|NCT01796613|Progestins|progestins|mesh-ancestor
111256758|NCT00442611|Abatacept|abatacept|mesh-list
111256759|NCT00442611|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111256760|NCT00442611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111256761|NCT00442611|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111256762|NCT00442611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111256763|NCT00442611|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111256764|NCT00442611|Immunologic Factors|immunologic factors|mesh-ancestor
111256765|NCT00442611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111256766|NCT00442611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111256767|NCT01511107|Amoxicillin|amoxicillin|mesh-list
111256768|NCT01511107|Clavulanic Acid|clavulanic acid|mesh-list
111256769|NCT01511107|Clavulanic Acids|clavulanic acids|mesh-list
111256770|NCT01511107|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
111256771|NCT01511107|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111256772|NCT01511107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111256773|NCT01511107|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
111256774|NCT01511107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111256775|NCT01511107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111256776|NCT00387621|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
111256777|NCT00387621|Natriuretic Agents|natriuretic agents|mesh-ancestor
111256778|NCT00387621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111256779|NCT00442689|Flutamide|flutamide|mesh-list
111256780|NCT00442689|Drospirenone|drospirenone|mesh-list
111256781|NCT00442689|Ethinyl Estradiol|ethinyl estradiol|mesh-list
111256782|NCT00442689|Estradiol|estradiol|mesh-list
111256783|NCT00442689|Estrogens|estrogens|mesh-ancestor
111256784|NCT00442689|Hormones|hormones|mesh-ancestor
111256785|NCT00442689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111256786|NCT00442689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111256787|NCT00442689|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111256788|NCT00442689|Contraceptive Agents|contraceptive agents|mesh-ancestor
111256789|NCT00442689|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111256790|NCT00442689|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111256791|NCT00442689|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111256792|NCT00442689|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111256793|NCT00442689|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
111256794|NCT00442689|Hormone Antagonists|hormone antagonists|mesh-ancestor
111256795|NCT00442689|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
111256796|NCT00442689|Diuretics|diuretics|mesh-ancestor
111256797|NCT00442689|Natriuretic Agents|natriuretic agents|mesh-ancestor
111256798|NCT00442689|Androgen Antagonists|androgen antagonists|mesh-ancestor
111256799|NCT00442689|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111256800|NCT00442689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111256801|NCT01484977|Lacosamide|lacosamide|mesh-list
111256802|NCT01484977|Anticonvulsants|anticonvulsants|mesh-ancestor
111256803|NCT01484977|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111256804|NCT01484977|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111256805|NCT01484977|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111256806|NCT01484977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111256807|NCT00442767|Insulin|insulin|mesh-list
111256808|NCT00442767|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111256809|NCT00442767|Pramlintide|pramlintide|mesh-list
111256810|NCT00442767|Islet Amyloid Polypeptide|islet amyloid polypeptide|mesh-list
111256811|NCT00442767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111256812|NCT00442767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111256813|NCT00442767|Appetite Depressants|appetite depressants|mesh-ancestor
111256814|NCT00442767|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111256815|NCT00442767|Amylin Receptor Agonists|amylin receptor agonists|mesh-ancestor
111256816|NCT00442767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111256817|NCT00445263|Tirofiban|tirofiban|mesh-list
111256818|NCT00445263|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111256819|NCT00445263|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111256820|NCT00445263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111256821|NCT00445263|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111256822|NCT00389493|Risperidone|risperidone|mesh-list
111256823|NCT00389493|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111256824|NCT00389493|Serotonin Agents|serotonin agents|mesh-ancestor
111256825|NCT00389493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111256826|NCT00389493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111256827|NCT00389493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111256828|NCT00389493|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111256829|NCT00389493|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111256830|NCT00389493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111256831|NCT00389493|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111256832|NCT00389493|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111256833|NCT00389493|Dopamine Agents|dopamine agents|mesh-ancestor
111256834|NCT04388709|Interferons|interferons|mesh-list
111256835|NCT04388709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111256836|NCT04388709|Antiviral Agents|antiviral agents|mesh-ancestor
111256837|NCT04388709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111256838|NCT00389805|Pemetrexed|pemetrexed|mesh-list
111256839|NCT00389805|Bortezomib|bortezomib|mesh-list
111256840|NCT00389805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111256841|NCT00389805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111256842|NCT00389805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111256843|NCT00389805|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111256844|NCT00389805|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111256845|NCT00456807|Vaccines|vaccines|mesh-list
111256846|NCT00456807|Immunologic Factors|immunologic factors|mesh-ancestor
111256847|NCT00456807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111256848|NCT00456885|Exenatide|exenatide|mesh-list
111256849|NCT00456885|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111256850|NCT00456885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111256851|NCT00456885|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111256852|NCT00456885|Incretins|incretins|mesh-ancestor
111256853|NCT00456885|Hormones|hormones|mesh-ancestor
111256854|NCT00456885|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111256855|NCT01475825|Mipomersen|mipomersen|mesh-list
111256856|NCT01475825|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111256857|NCT01475825|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111256858|NCT01475825|Antimetabolites|antimetabolites|mesh-ancestor
111256859|NCT01475825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111256860|NCT01475825|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111256861|NCT00457197|Quetiapine Fumarate|quetiapine fumarate|mesh-list
111256862|NCT00457197|Antidepressive Agents|antidepressive agents|mesh-ancestor
111256863|NCT00457197|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111256864|NCT00457197|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111256865|NCT00457197|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111256866|NCT00457197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110978178|NCT03382821|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
111256867|NCT00457197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111256868|NCT01484431|Tadalafil|tadalafil|mesh-list
111256869|NCT01484431|Vasodilator Agents|vasodilator agents|mesh-ancestor
111256870|NCT01484431|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111256871|NCT01484431|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111256872|NCT01484431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111256873|NCT01484431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111256874|NCT01484431|Urological Agents|urological agents|mesh-ancestor
111256875|NCT00445887|Levonorgestrel|levonorgestrel|mesh-list
111256876|NCT00445887|Norgestrel|norgestrel|mesh-list
111256877|NCT00445887|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111256878|NCT00445887|Contraceptive Agents|contraceptive agents|mesh-ancestor
111256879|NCT00445887|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111256880|NCT00445887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111256881|NCT00445887|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111256882|NCT00445887|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111256883|NCT00445887|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111256884|NCT00445887|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111256885|NCT01473953|Liraglutide|liraglutide|mesh-list
111256886|NCT01473953|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111256887|NCT01473953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111256888|NCT01473953|Incretins|incretins|mesh-ancestor
111256889|NCT01473953|Hormones|hormones|mesh-ancestor
111256890|NCT01473953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111256891|NCT00457977|Vaccines|vaccines|mesh-list
111256892|NCT00457977|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
111256893|NCT00457977|Immunologic Factors|immunologic factors|mesh-ancestor
111256894|NCT00457977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111256895|NCT01473563|Pemetrexed|pemetrexed|mesh-list
111256896|NCT01473563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111256897|NCT01473563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111256898|NCT01473563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111256899|NCT01473563|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111256900|NCT01473563|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111256901|NCT01795209|Ranibizumab|ranibizumab|mesh-list
111256902|NCT01795209|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111256903|NCT01795209|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111256904|NCT01795209|Growth Substances|growth substances|mesh-ancestor
111256905|NCT01795209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111256906|NCT01795209|Growth Inhibitors|growth inhibitors|mesh-ancestor
111256907|NCT01795209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111256908|NCT01484275|Siltuximab|siltuximab|mesh-list
111256909|NCT01484275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111256910|NCT01484197|Maleic acid|maleic acid|mesh-list
111256911|NCT01484197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111256912|NCT01484197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111256913|NCT01473407|Epoetin Alfa|epoetin alfa|mesh-list
111256914|NCT01473407|Hematinics|hematinics|mesh-ancestor
111256915|NCT04082897|Atezolizumab|atezolizumab|mesh-list
111256916|NCT04082897|Venetoclax|venetoclax|mesh-list
111256917|NCT04082897|Obinutuzumab|obinutuzumab|mesh-list
111256918|NCT04082897|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111256919|NCT04082897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111256920|NCT04082897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111256921|NCT04082897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111256922|NCT01544179|Pemetrexed|pemetrexed|mesh-list
111256923|NCT01544179|Gefitinib|gefitinib|mesh-list
111256924|NCT01544179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111256925|NCT01544179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111256926|NCT01544179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111256927|NCT01544179|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111256928|NCT01544179|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111256929|NCT01544179|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111256930|NCT01483651|Insulin|insulin|mesh-list
111256931|NCT01483651|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111256932|NCT01483651|Glucagon|glucagon|mesh-list
111256933|NCT01483651|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111256934|NCT01483651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111256935|NCT01483651|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111256936|NCT01483651|Hormones|hormones|mesh-ancestor
111256937|NCT01483651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111256938|NCT01464307|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
111256939|NCT01464307|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111256940|NCT01464307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111256941|NCT01464307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111256942|NCT01464307|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111256943|NCT01464307|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111256944|NCT01464307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111256945|NCT01464307|Cholinergic Agents|cholinergic agents|mesh-ancestor
111256946|NCT01464307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111256947|NCT01482169|Adenosine|adenosine|mesh-list
111256948|NCT01482169|Regadenoson|regadenoson|mesh-list
111256949|NCT01482169|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
111256950|NCT01482169|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
111256951|NCT01482169|Purinergic Agonists|purinergic agonists|mesh-ancestor
111256952|NCT01482169|Purinergic Agents|purinergic agents|mesh-ancestor
111256953|NCT01482169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111256954|NCT01482169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111256955|NCT01482169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111256956|NCT01482169|Analgesics|analgesics|mesh-ancestor
111256957|NCT01482169|Sensory System Agents|sensory system agents|mesh-ancestor
111256958|NCT01482169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111256959|NCT01482169|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111256960|NCT01482169|Vasodilator Agents|vasodilator agents|mesh-ancestor
111256961|NCT01481779|Insulin Lispro|insulin lispro|mesh-list
111256962|NCT01481779|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111256963|NCT01481779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111256964|NCT01509547|Varenicline|varenicline|mesh-list
111256965|NCT01509547|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111256966|NCT01509547|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111256967|NCT01509547|Cholinergic Agents|cholinergic agents|mesh-ancestor
111256968|NCT01509547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111256969|NCT01509547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111256970|NCT01509547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111256971|NCT01509079|Vitamin D|vitamin d|mesh-list
111256972|NCT01509079|Ergocalciferols|ergocalciferols|mesh-list
111256973|NCT01509079|Cholecalciferol|cholecalciferol|mesh-list
111256974|NCT01509079|Vitamins|vitamins|mesh-list
111256975|NCT01509079|Micronutrients|micronutrients|mesh-ancestor
111256976|NCT01509079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111256977|NCT01509079|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111256978|NCT01509079|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111256979|NCT04650217|Levodopa|levodopa|mesh-list
111256980|NCT04650217|Carbidopa|carbidopa|mesh-list
111256981|NCT04650217|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
111256982|NCT04650217|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111256983|NCT04650217|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111256984|NCT04650217|Dopamine Agents|dopamine agents|mesh-ancestor
111256985|NCT04650217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111256986|NCT04650217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111256987|NCT04650217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111256988|NCT04650217|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
111256989|NCT04650217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111256990|NCT04650217|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111256991|NCT04650217|Immunologic Factors|immunologic factors|mesh-ancestor
111256992|NCT04650217|Dopamine Agonists|dopamine agonists|mesh-ancestor
111256993|NCT01462435|Celecoxib|celecoxib|mesh-list
111256994|NCT01462435|Diclofenac|diclofenac|mesh-list
111256995|NCT01462435|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111256996|NCT01462435|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111256997|NCT01462435|Analgesics|analgesics|mesh-ancestor
111256998|NCT01462435|Sensory System Agents|sensory system agents|mesh-ancestor
111256999|NCT01462435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111257000|NCT01462435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111257001|NCT01462435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111257002|NCT01462435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111257003|NCT01462435|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111257004|NCT01462435|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111257005|NCT01462435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111257006|NCT01462435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111257007|NCT01472081|Nivolumab|nivolumab|mesh-list
111257008|NCT01472081|Ipilimumab|ipilimumab|mesh-list
111257009|NCT01472081|Sunitinib|sunitinib|mesh-list
111257010|NCT01472081|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111257011|NCT01472081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111257012|NCT01472081|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110978181|NCT03382821|Autonomic Agents|autonomic agents|mesh-ancestor
111257013|NCT01472081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111257014|NCT01472081|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111257015|NCT01472081|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111257016|NCT01472081|Growth Substances|growth substances|mesh-ancestor
111257017|NCT01472081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111257018|NCT01472081|Growth Inhibitors|growth inhibitors|mesh-ancestor
111257019|NCT01472081|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111257020|NCT01472081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111257021|NCT01471691|Ranibizumab|ranibizumab|mesh-list
111257022|NCT01471691|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111257023|NCT01471691|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111257024|NCT01471691|Growth Substances|growth substances|mesh-ancestor
111257025|NCT01471691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111257026|NCT01471691|Growth Inhibitors|growth inhibitors|mesh-ancestor
111257027|NCT01471691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111257028|NCT01471379|Milnacipran|milnacipran|mesh-list
111257029|NCT01471379|Levomilnacipran|levomilnacipran|mesh-list
111257030|NCT01471379|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111257031|NCT01471379|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111257032|NCT01471379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111257033|NCT01471379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111257034|NCT01471379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111257035|NCT01471379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111257036|NCT01471379|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111257037|NCT01471379|Analgesics|analgesics|mesh-ancestor
111257038|NCT01471379|Sensory System Agents|sensory system agents|mesh-ancestor
111257039|NCT01471379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111257040|NCT01471379|Antidepressive Agents|antidepressive agents|mesh-ancestor
111257041|NCT01471379|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111257042|NCT01470989|Triamcinolone|triamcinolone|mesh-list
111257043|NCT01470989|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
111257044|NCT01470989|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
111257045|NCT01470989|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
111257046|NCT01470989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111257047|NCT01470989|Glucocorticoids|glucocorticoids|mesh-ancestor
111257048|NCT01470989|Hormones|hormones|mesh-ancestor
111257049|NCT01470989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111257050|NCT01470989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111257051|NCT01470989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111257052|NCT01470989|Immunologic Factors|immunologic factors|mesh-ancestor
111257053|NCT01470989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111257054|NCT01470989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111257055|NCT01470599|Tofacitinib|tofacitinib|mesh-list
111257056|NCT01470599|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
111257057|NCT01470599|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111257058|NCT01470599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111257059|NCT01470599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111257060|NCT01469819|Lubiprostone|lubiprostone|mesh-list
111257061|NCT01469819|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
111257062|NCT01469819|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111257063|NCT01469819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110981354|NCT02712788|Protective Agents|protective agents|mesh-ancestor
111257065|NCT04618523|Lumefantrine|lumefantrine|mesh-list
111257066|NCT04618523|Artemether|artemether|mesh-list
111257067|NCT04618523|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
111257068|NCT04618523|Amodiaquine|amodiaquine|mesh-list
111257069|NCT04618523|Antimalarials|antimalarials|mesh-ancestor
111257070|NCT04618523|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111257071|NCT04618523|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111257072|NCT04618523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111257073|NCT04618523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111257074|NCT04618523|Antiviral Agents|antiviral agents|mesh-ancestor
111257075|NCT04618523|Schistosomicides|schistosomicides|mesh-ancestor
111257076|NCT04618523|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
111257077|NCT04618523|Anthelmintics|anthelmintics|mesh-ancestor
111257078|NCT01507831|Alirocumab|alirocumab|mesh-list
111257079|NCT01507831|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111257080|NCT01507831|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
111257081|NCT01507831|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111257082|NCT01507831|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111257083|NCT01507831|Antimetabolites|antimetabolites|mesh-ancestor
111257084|NCT01507831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111257085|NCT01507831|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111257086|NCT01507831|Protease Inhibitors|protease inhibitors|mesh-ancestor
111257087|NCT01507831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111257088|NCT01507831|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111257089|NCT01507831|Immunologic Factors|immunologic factors|mesh-ancestor
111257090|NCT01507831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111257091|NCT01479439|Losartan|losartan|mesh-list
111257092|NCT01479439|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111257093|NCT01479439|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111257094|NCT01479439|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111257095|NCT01479439|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111257096|NCT01479439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111257097|NCT01478971|Epoetin Alfa|epoetin alfa|mesh-list
111257098|NCT01478971|Hematinics|hematinics|mesh-ancestor
111257099|NCT01507051|Vitamin K|vitamin k|mesh-list
111257100|NCT01507051|Vitamin K 1|vitamin k 1|mesh-list
111257101|NCT01507051|Warfarin|warfarin|mesh-list
111257102|NCT01507051|Rivaroxaban|rivaroxaban|mesh-list
111257103|NCT01507051|Vitamins|vitamins|mesh-ancestor
111257104|NCT01507051|Micronutrients|micronutrients|mesh-ancestor
111257105|NCT01507051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111257106|NCT01507051|Anticoagulants|anticoagulants|mesh-ancestor
111257107|NCT01507051|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111257108|NCT01507051|Antithrombins|antithrombins|mesh-ancestor
111257109|NCT01507051|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111257110|NCT01507051|Protease Inhibitors|protease inhibitors|mesh-ancestor
111257111|NCT01507051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111257112|NCT01507051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111257113|NCT01507051|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111257114|NCT01507051|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111257115|NCT01507051|Hemostatics|hemostatics|mesh-ancestor
111257116|NCT01507051|Coagulants|coagulants|mesh-ancestor
111257117|NCT04079257|Eculizumab|eculizumab|mesh-list
111257118|NCT04079257|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
111257119|NCT04079257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111257120|NCT04079257|Immunologic Factors|immunologic factors|mesh-ancestor
111257121|NCT04079257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111257122|NCT01478113|Amphetamine|amphetamine|mesh-list
111257123|NCT01478113|Adderall|adderall|mesh-list
111257124|NCT01478113|Dextroamphetamine|dextroamphetamine|mesh-list
111257125|NCT01478113|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111257126|NCT01478113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111257127|NCT01478113|Sympathomimetics|sympathomimetics|mesh-ancestor
111257128|NCT01478113|Autonomic Agents|autonomic agents|mesh-ancestor
111257129|NCT01478113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111257130|NCT01478113|Dopamine Agents|dopamine agents|mesh-ancestor
111257131|NCT01478113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111257132|NCT01478113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111257133|NCT01478113|Adrenergic Agents|adrenergic agents|mesh-ancestor
111257134|NCT01478113|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111257135|NCT01478113|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111257136|NCT01478113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111257137|NCT01478113|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111257138|NCT01506271|Imipenem|imipenem|mesh-list
111257139|NCT01506271|Relebactam|relebactam|mesh-list
111257140|NCT01506271|Cilastatin|cilastatin|mesh-list
110981429|NCT00406809|Navitoclax|navitoclax|mesh-list
111257141|NCT01506271|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111257143|NCT01506271|Protease Inhibitors|protease inhibitors|mesh-ancestor
111257144|NCT01506271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111257145|NCT01506271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111257146|NCT01506271|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
111257147|NCT01506193|Vaccines|vaccines|mesh-list
111257148|NCT01506193|Immunologic Factors|immunologic factors|mesh-ancestor
111257149|NCT01506193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111257150|NCT01505881|Warfarin|warfarin|mesh-list
111257151|NCT01505881|Dabigatran|dabigatran|mesh-list
111257152|NCT01505881|Anticoagulants|anticoagulants|mesh-ancestor
111257153|NCT01505881|Antithrombins|antithrombins|mesh-ancestor
111257154|NCT01505881|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111257155|NCT01505881|Protease Inhibitors|protease inhibitors|mesh-ancestor
111257156|NCT01505881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111257157|NCT01505881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111257158|NCT01505647|Vaccines|vaccines|mesh-list
111257159|NCT01505647|Immunologic Factors|immunologic factors|mesh-ancestor
111257160|NCT01505647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111257161|NCT01477333|Treprostinil|treprostinil|mesh-list
111257162|NCT01477333|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111257163|NCT01505491|Adalimumab|adalimumab|mesh-list
111257164|NCT01505491|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111257165|NCT01505491|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111257166|NCT01505491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111257167|NCT01504867|Aspirin|aspirin|mesh-list
111257168|NCT01504867|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111257169|NCT01504867|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111257170|NCT01504867|Analgesics|analgesics|mesh-ancestor
111257171|NCT01504867|Sensory System Agents|sensory system agents|mesh-ancestor
111257172|NCT01504867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111257173|NCT01504867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111257174|NCT01504867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111257175|NCT01504867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111257176|NCT01504867|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111257177|NCT01504867|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111257178|NCT01504867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111257179|NCT01504867|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111257180|NCT01504867|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111257181|NCT01504867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111257182|NCT01504867|Antipyretics|antipyretics|mesh-ancestor
111257183|NCT01476475|Insulin|insulin|mesh-list
111257184|NCT01476475|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111257185|NCT01476475|Metformin|metformin|mesh-list
111257186|NCT01476475|Insulin Glargine|insulin glargine|mesh-list
111257187|NCT01476475|Lixisenatide|lixisenatide|mesh-list
111257188|NCT01476475|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111257189|NCT01476475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111257190|NCT01460719|Vaccines|vaccines|mesh-list
111257191|NCT01460719|Immunologic Factors|immunologic factors|mesh-ancestor
111257192|NCT01460719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111257193|NCT00527943|Vorapaxar|vorapaxar|mesh-list
111257194|NCT00527943|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111257195|NCT00448227|Famciclovir|famciclovir|mesh-list
111257196|NCT00448227|Antiviral Agents|antiviral agents|mesh-ancestor
111257197|NCT00448227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111257198|NCT00448227|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111257199|NCT00448227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111257200|NCT00448227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111257201|NCT00529191|Atorvastatin|atorvastatin|mesh-list
111257202|NCT00529191|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111257203|NCT00529191|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111257204|NCT00529191|Antimetabolites|antimetabolites|mesh-ancestor
111257205|NCT00529191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111257206|NCT00529191|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111257207|NCT00529191|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111257208|NCT00529191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111257209|NCT00449007|Bupropion|bupropion|mesh-list
111257210|NCT00449007|Fluoxetine|fluoxetine|mesh-list
111257211|NCT00449007|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111257212|NCT00449007|Antidepressive Agents|antidepressive agents|mesh-ancestor
111257213|NCT00449007|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111257214|NCT00449007|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111257215|NCT00449007|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111257216|NCT00449007|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110981516|NCT00405951|Docetaxel|docetaxel|mesh-list
111257217|NCT00449007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111257218|NCT00449007|Dopamine Agents|dopamine agents|mesh-ancestor
111257219|NCT00449007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111257220|NCT00449007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111257221|NCT00449007|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111257222|NCT00449007|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111257223|NCT00449007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111257224|NCT00449007|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111257225|NCT00449007|Serotonin Agents|serotonin agents|mesh-ancestor
111257226|NCT00460551|Zalutumumab|zalutumumab|mesh-list
111257227|NCT00460551|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111257228|NCT00460551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111257229|NCT01468181|Dulaglutide|dulaglutide|mesh-list
111257230|NCT01468181|Biguanides|biguanides|mesh-list
111257231|NCT01468181|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
111257232|NCT01468181|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
111257233|NCT01468181|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111257234|NCT01468181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111257235|NCT01468181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111257236|NCT01468181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111257237|NCT01693562|Durvalumab|durvalumab|mesh-list
111257238|NCT01693562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111257239|NCT01693562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111257240|NCT00461097|Immunomodulating Agents|immunomodulating agents|mesh-list
111257241|NCT00461097|Immunologic Factors|immunologic factors|mesh-ancestor
111257242|NCT00461097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111257243|NCT00531453|Thalidomide|thalidomide|mesh-list
111257244|NCT00531453|Dexamethasone|dexamethasone|mesh-list
111257245|NCT00531453|Dexamethasone acetate|dexamethasone acetate|mesh-list
111257246|NCT00531453|Cyclophosphamide|cyclophosphamide|mesh-list
111257247|NCT00531453|Bortezomib|bortezomib|mesh-list
111257248|NCT00531453|BB 1101|bb 1101|mesh-list
111257249|NCT00531453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111257250|NCT00531453|Immunologic Factors|immunologic factors|mesh-ancestor
111257251|NCT00531453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111257252|NCT00531453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111257253|NCT00531453|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111257254|NCT00531453|Alkylating Agents|alkylating agents|mesh-ancestor
111257255|NCT00531453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111257256|NCT00531453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111257257|NCT00531453|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111257258|NCT00531453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111257259|NCT00531453|Antiemetics|antiemetics|mesh-ancestor
111257260|NCT00531453|Autonomic Agents|autonomic agents|mesh-ancestor
111257261|NCT00531453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111257262|NCT00531453|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111257263|NCT00531453|Glucocorticoids|glucocorticoids|mesh-ancestor
111257264|NCT00531453|Hormones|hormones|mesh-ancestor
111257265|NCT00531453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111257266|NCT00531453|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111257267|NCT00531453|Protease Inhibitors|protease inhibitors|mesh-ancestor
111257268|NCT00531453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111257269|NCT00531453|Leprostatic Agents|leprostatic agents|mesh-ancestor
111257270|NCT00531453|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111257271|NCT00531453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111257272|NCT00531453|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111257273|NCT00531453|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111257274|NCT00531453|Growth Substances|growth substances|mesh-ancestor
111257275|NCT00531453|Growth Inhibitors|growth inhibitors|mesh-ancestor
111257276|NCT00531843|PENTA|penta|mesh-list
111257277|NCT00531843|Fondaparinux|fondaparinux|mesh-list
111257278|NCT00531843|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111257279|NCT00531843|Antithrombins|antithrombins|mesh-ancestor
111257280|NCT00531843|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111257281|NCT00531843|Protease Inhibitors|protease inhibitors|mesh-ancestor
111257282|NCT00531843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111257283|NCT00531843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111257284|NCT00531843|Anticoagulants|anticoagulants|mesh-ancestor
111257285|NCT00531843|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111257286|NCT00531843|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111257287|NCT02073461|Benzoyl Peroxide|benzoyl peroxide|mesh-list
111257288|NCT02073461|Dermatologic Agents|dermatologic agents|mesh-ancestor
111257289|NCT01590758|Pexiganan|pexiganan|mesh-list
111257290|NCT01590758|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111257291|NCT01590758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111257292|NCT00534417|Capecitabine|capecitabine|mesh-list
111257293|NCT00534417|Fulvestrant|fulvestrant|mesh-list
111257294|NCT00534417|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111257296|NCT00534417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111257297|NCT00534417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111257298|NCT00534417|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111257299|NCT00534417|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
111257300|NCT00534417|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111257301|NCT00534417|Hormone Antagonists|hormone antagonists|mesh-ancestor
111257302|NCT00534417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111257303|NCT00534417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111257304|NCT01692626|Pimecrolimus|pimecrolimus|mesh-list
111257305|NCT01692626|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111257306|NCT01692626|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111257307|NCT01692626|Analgesics|analgesics|mesh-ancestor
111257308|NCT01692626|Sensory System Agents|sensory system agents|mesh-ancestor
111257309|NCT01692626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110978186|NCT03382821|Hormones|hormones|mesh-ancestor
111257310|NCT01692626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111257311|NCT01692626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111257312|NCT01692626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111257313|NCT01692626|Dermatologic Agents|dermatologic agents|mesh-ancestor
111257314|NCT01692626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111257315|NCT01692626|Immunologic Factors|immunologic factors|mesh-ancestor
111257316|NCT01692626|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111257317|NCT01692626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111257318|NCT01692626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111257319|NCT00535587|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
111257320|NCT00535587|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111257321|NCT00535587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111257322|NCT00535587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111257323|NCT00535587|Cholinergic Agents|cholinergic agents|mesh-ancestor
111257324|NCT00535587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111257325|NCT00535587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111257326|NCT01475461|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111257327|NCT01475461|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111257328|NCT01475461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111257329|NCT01475461|Incretins|incretins|mesh-ancestor
111257330|NCT01475461|Hormones|hormones|mesh-ancestor
111257331|NCT01475461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111257332|NCT01475461|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111257333|NCT01475461|Protease Inhibitors|protease inhibitors|mesh-ancestor
111257334|NCT01475461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111257335|NCT01475461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111257336|NCT01589822|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
111257337|NCT01589822|Hemostatics|hemostatics|mesh-ancestor
111257338|NCT01589822|Coagulants|coagulants|mesh-ancestor
111257339|NCT01475071|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
111257340|NCT01475071|Aminolevulinic Acid|aminolevulinic acid|mesh-list
111257341|NCT01475071|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111257342|NCT01475071|Dermatologic Agents|dermatologic agents|mesh-ancestor
111257343|NCT01474993|Sulforaphane|sulforaphane|mesh-list
111257344|NCT01474993|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
111257345|NCT01474993|Protective Agents|protective agents|mesh-ancestor
111257346|NCT01474993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111257347|NCT01474993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111257348|NCT01691768|Tenofovir|tenofovir|mesh-list
111257349|NCT01691768|Antiviral Agents|antiviral agents|mesh-ancestor
111257350|NCT01691768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111257351|NCT01691768|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111257352|NCT01691768|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111257353|NCT01691768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111257354|NCT01691768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111257355|NCT01691768|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111257356|NCT01691768|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111257357|NCT01503229|Prednisone|prednisone|mesh-list
111257358|NCT01503229|Cortisone|cortisone|mesh-list
111257359|NCT01503229|Abiraterone Acetate|abiraterone acetate|mesh-list
111257360|NCT01503229|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111257361|NCT01503229|Glucocorticoids|glucocorticoids|mesh-ancestor
111257362|NCT01503229|Hormones|hormones|mesh-ancestor
111257363|NCT01503229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111257364|NCT01503229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111257365|NCT01503229|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111257366|NCT01503229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111257367|NCT01503229|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111257368|NCT01503229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111257369|NCT01503229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111257370|NCT01503229|Hormone Antagonists|hormone antagonists|mesh-ancestor
111257371|NCT01503229|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111257372|NCT01460407|Clarithromycin|clarithromycin|mesh-list
111257373|NCT01460407|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111257374|NCT01460407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111257375|NCT01460407|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111257376|NCT01460407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111257377|NCT01460407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111257378|NCT01460407|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111257379|NCT01460407|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111257380|NCT01502371|Mometasone Furoate|mometasone furoate|mesh-list
111257381|NCT01502371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111257382|NCT01502371|Dermatologic Agents|dermatologic agents|mesh-ancestor
111257383|NCT01502371|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111257384|NCT01588496|Evolocumab|evolocumab|mesh-list
111257385|NCT01588496|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
111257386|NCT01588496|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111257387|NCT01588496|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111257388|NCT01588496|Antimetabolites|antimetabolites|mesh-ancestor
111257389|NCT01588496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111257390|NCT01588496|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111257391|NCT01588496|Protease Inhibitors|protease inhibitors|mesh-ancestor
111257392|NCT01588496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111257393|NCT01588496|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111257394|NCT01502293|Interleukin-12|interleukin-12|mesh-list
111257395|NCT01502293|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111257396|NCT01502293|Immunologic Factors|immunologic factors|mesh-ancestor
111257397|NCT01502293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111257398|NCT01502293|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111257399|NCT01502293|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111257400|NCT01502293|Growth Substances|growth substances|mesh-ancestor
111257401|NCT01502293|Growth Inhibitors|growth inhibitors|mesh-ancestor
111257402|NCT01502293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111257403|NCT01588184|Bevacizumab|bevacizumab|mesh-list
111257404|NCT01588184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111257405|NCT01588184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111257406|NCT01588184|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111257407|NCT01588184|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111257408|NCT01588184|Growth Substances|growth substances|mesh-ancestor
111257409|NCT01588184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111257410|NCT01588184|Growth Inhibitors|growth inhibitors|mesh-ancestor
111257411|NCT01564862|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
111257412|NCT01564862|Vortioxetine|vortioxetine|mesh-list
111257413|NCT01564862|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111257414|NCT01564862|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111257415|NCT01564862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111257416|NCT01564862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111257417|NCT01564862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111257418|NCT01564862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111257419|NCT01564862|Analgesics|analgesics|mesh-ancestor
111257420|NCT01564862|Sensory System Agents|sensory system agents|mesh-ancestor
111257421|NCT01564862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111257422|NCT01564862|Antidepressive Agents|antidepressive agents|mesh-ancestor
111257423|NCT01564862|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111257424|NCT01564862|Dopamine Agents|dopamine agents|mesh-ancestor
111257425|NCT01564862|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111257426|NCT01564862|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111257427|NCT01564862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111257428|NCT01564862|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111257429|NCT01564862|Serotonin Agents|serotonin agents|mesh-ancestor
111257430|NCT01564862|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111257431|NCT01564862|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111257432|NCT01564862|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111257433|NCT01564862|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111257434|NCT04857164|Pembrolizumab|pembrolizumab|mesh-list
111257435|NCT04857164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111257436|NCT04857164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111257437|NCT04857164|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111257438|NCT04857164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110981742|NCT00299325|Rimonabant|rimonabant|mesh-list
111257439|NCT01467479|Interferons|interferons|mesh-list
111257440|NCT01467479|Ribavirin|ribavirin|mesh-list
111257441|NCT01467479|Interferon-alpha|interferon-alpha|mesh-list
111257442|NCT01467479|Interferon alpha-2|interferon alpha-2|mesh-list
111257443|NCT01467479|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
111257444|NCT01467479|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
111257445|NCT01467479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111257446|NCT01467479|Antiviral Agents|antiviral agents|mesh-ancestor
111257447|NCT01467479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111257448|NCT01467479|Antimetabolites|antimetabolites|mesh-ancestor
111257449|NCT01467479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111257450|NCT01467479|Immunologic Factors|immunologic factors|mesh-ancestor
111257451|NCT01467479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111257452|NCT01466387|Vaccines|vaccines|mesh-list
111257453|NCT01466387|Immunologic Factors|immunologic factors|mesh-ancestor
111257454|NCT01466387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111257455|NCT00535743|Bromides|bromides|mesh-list
111257456|NCT00535743|Rocuronium|rocuronium|mesh-list
111257457|NCT00535743|Anticonvulsants|anticonvulsants|mesh-ancestor
111257458|NCT00535743|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
111257459|NCT00535743|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
111257460|NCT00535743|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111257461|NCT00535743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111257462|NCT00535743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111257463|NCT01564784|Cytarabine|cytarabine|mesh-list
111257464|NCT01564784|Fludarabine|fludarabine|mesh-list
111257465|NCT01564784|Mitoxantrone|mitoxantrone|mesh-list
111257466|NCT01564784|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
111257467|NCT01564784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111257468|NCT01564784|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111257469|NCT01564784|Antimetabolites|antimetabolites|mesh-ancestor
111257470|NCT01564784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111257471|NCT01564784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111257472|NCT01564784|Immunologic Factors|immunologic factors|mesh-ancestor
111257473|NCT01564784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111257474|NCT01564784|Antiviral Agents|antiviral agents|mesh-ancestor
111257475|NCT01564784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111257476|NCT01564784|Analgesics|analgesics|mesh-ancestor
111257477|NCT01564784|Sensory System Agents|sensory system agents|mesh-ancestor
111257478|NCT01564784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111257479|NCT01564784|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111257480|NCT01564784|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111257481|NCT01564784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111257482|NCT01564784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111257483|NCT01564784|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111257484|NCT01564784|Immunotoxins|immunotoxins|mesh-ancestor
111257485|NCT01564784|Immunoconjugates|immunoconjugates|mesh-ancestor
111257486|NCT00536601|Cyclophosphamide|cyclophosphamide|mesh-list
111257487|NCT00536601|Melphalan|melphalan|mesh-list
111257488|NCT00536601|Busulfan|busulfan|mesh-list
111257489|NCT00536601|Thiotepa|thiotepa|mesh-list
111257490|NCT00536601|Carmustine|carmustine|mesh-list
111257491|NCT00536601|Carboplatin|carboplatin|mesh-list
111257492|NCT00536601|Etoposide|etoposide|mesh-list
111257493|NCT00536601|Etoposide phosphate|etoposide phosphate|mesh-list
111257494|NCT00536601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111257495|NCT00536601|Immunologic Factors|immunologic factors|mesh-ancestor
111257496|NCT00536601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111257497|NCT00536601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111257498|NCT00536601|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111257499|NCT00536601|Alkylating Agents|alkylating agents|mesh-ancestor
111257500|NCT00536601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111257501|NCT00536601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111257502|NCT00536601|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111257503|NCT00536601|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111257504|NCT00536601|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111257505|NCT00536601|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111257506|NCT00536601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111257507|NCT00536913|Budesonide|budesonide|mesh-list
111257508|NCT00536913|Formoterol Fumarate|formoterol fumarate|mesh-list
111257509|NCT00536913|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
111257510|NCT00536913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111257511|NCT00536913|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110981804|NCT03204032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111257512|NCT00536913|Autonomic Agents|autonomic agents|mesh-ancestor
111257513|NCT00536913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111257514|NCT00536913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111257515|NCT00536913|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111257516|NCT00536913|Respiratory System Agents|respiratory system agents|mesh-ancestor
111257517|NCT00536913|Glucocorticoids|glucocorticoids|mesh-ancestor
111257518|NCT00536913|Hormones|hormones|mesh-ancestor
111257519|NCT00536913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111257520|NCT00536913|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111257521|NCT00536913|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111257522|NCT00536913|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111257523|NCT00536913|Adrenergic Agents|adrenergic agents|mesh-ancestor
111257524|NCT00536913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111257525|NCT00536913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111257526|NCT00462423|Bevacizumab|bevacizumab|mesh-list
111257527|NCT00462423|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111257528|NCT00462423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111257529|NCT00462423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111257530|NCT00462423|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111257531|NCT00462423|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111257532|NCT00462423|Growth Substances|growth substances|mesh-ancestor
111257533|NCT00462423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111257534|NCT00462423|Growth Inhibitors|growth inhibitors|mesh-ancestor
111257535|NCT00461331|Insulin|insulin|mesh-list
111257536|NCT00461331|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111257537|NCT00461331|Insulin Aspart|insulin aspart|mesh-list
111257538|NCT00461331|Insulin, Long-Acting|insulin, long-acting|mesh-list
111257539|NCT00461331|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
111257540|NCT00461331|Insulin Lispro|insulin lispro|mesh-list
111257541|NCT00461331|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111257542|NCT00461331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111257543|NCT00462735|Fluorouracil|fluorouracil|mesh-list
111257544|NCT00462735|Cetuximab|cetuximab|mesh-list
111257545|NCT00462735|Hydroxyurea|hydroxyurea|mesh-list
111257546|NCT00462735|Antimetabolites|antimetabolites|mesh-ancestor
111257547|NCT00462735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111257548|NCT00462735|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111257549|NCT00462735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111257550|NCT00462735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111257551|NCT00462735|Immunologic Factors|immunologic factors|mesh-ancestor
111257552|NCT00462735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111257553|NCT00462735|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111257554|NCT00462735|Antisickling Agents|antisickling agents|mesh-ancestor
111257555|NCT00462735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111257556|NCT00462735|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111257557|NCT01690988|Ketamine|ketamine|mesh-list
111257558|NCT01690988|Analgesics|analgesics|mesh-ancestor
111257559|NCT01690988|Sensory System Agents|sensory system agents|mesh-ancestor
111257560|NCT01690988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111257561|NCT01690988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111257562|NCT01690988|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111257563|NCT01690988|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111257564|NCT01690988|Anesthetics, General|anesthetics, general|mesh-ancestor
111257565|NCT01690988|Anesthetics|anesthetics|mesh-ancestor
111257566|NCT01690988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111257567|NCT01690988|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111257568|NCT01690988|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111257569|NCT01690988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111257570|NCT01690988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111257571|NCT00463437|Vaccines|vaccines|mesh-list
111257572|NCT00463437|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
111257573|NCT00463437|Immunologic Factors|immunologic factors|mesh-ancestor
111257574|NCT00463437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111257575|NCT01466153|Rituximab|rituximab|mesh-list
111257576|NCT01466153|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
111257577|NCT01466153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111257578|NCT01466153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111257579|NCT01466153|Immunologic Factors|immunologic factors|mesh-ancestor
111257580|NCT01466153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111257581|NCT01466153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111257582|NCT01466153|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111257583|NCT01466153|Alkylating Agents|alkylating agents|mesh-ancestor
111257584|NCT01466153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111257585|NCT00464685|Dexamethasone|dexamethasone|mesh-list
111257586|NCT00464685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111257587|NCT00464685|Antiemetics|antiemetics|mesh-ancestor
111257588|NCT00464685|Autonomic Agents|autonomic agents|mesh-ancestor
111257589|NCT00464685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111257590|NCT00464685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111257591|NCT00464685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111257593|NCT00464685|Hormones|hormones|mesh-ancestor
111257594|NCT00464685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111257595|NCT00464685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111257596|NCT00464685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111257597|NCT01465997|Lacosamide|lacosamide|mesh-list
111257598|NCT01465997|Carbamazepine|carbamazepine|mesh-list
111257599|NCT01465997|Anticonvulsants|anticonvulsants|mesh-ancestor
111257600|NCT01465997|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111257601|NCT01465997|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111257602|NCT01465997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111257603|NCT01465997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111257604|NCT01465997|Antimanic Agents|antimanic agents|mesh-ancestor
111257605|NCT01465997|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111257606|NCT01465997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111257607|NCT01465997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111257608|NCT01465997|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111257609|NCT01465997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111257610|NCT01465997|Analgesics|analgesics|mesh-ancestor
111257611|NCT01465997|Sensory System Agents|sensory system agents|mesh-ancestor
111257612|NCT01465997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111257613|NCT01465997|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111257614|NCT01465997|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111257615|NCT00538863|Fentanyl|fentanyl|mesh-list
111257616|NCT00538863|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111257617|NCT00538863|Narcotics|narcotics|mesh-ancestor
111257618|NCT00538863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111257619|NCT00538863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111257620|NCT00538863|Analgesics|analgesics|mesh-ancestor
111257621|NCT00538863|Sensory System Agents|sensory system agents|mesh-ancestor
111257622|NCT00538863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111257623|NCT00538863|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111257624|NCT00538863|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111257625|NCT00538863|Anesthetics, General|anesthetics, general|mesh-ancestor
111257626|NCT00538863|Anesthetics|anesthetics|mesh-ancestor
111257627|NCT01465763|Tofacitinib|tofacitinib|mesh-list
111257628|NCT01465763|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
111257629|NCT01465763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111257630|NCT01465763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111257631|NCT01465763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111257632|NCT00540579|Gemcitabine|gemcitabine|mesh-list
111257633|NCT00540579|Pomalidomide|pomalidomide|mesh-list
111257634|NCT00540579|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111257635|NCT00540579|Antimetabolites|antimetabolites|mesh-ancestor
111257636|NCT00540579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111257637|NCT00540579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111257638|NCT00540579|Immunologic Factors|immunologic factors|mesh-ancestor
111257639|NCT00540579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111257640|NCT00540579|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111257641|NCT00540579|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111257642|NCT00540579|Growth Substances|growth substances|mesh-ancestor
111257643|NCT00540579|Growth Inhibitors|growth inhibitors|mesh-ancestor
111257644|NCT01690520|Cyclosporine|cyclosporine|mesh-list
111257645|NCT01690520|Mycophenolic Acid|mycophenolic acid|mesh-list
111257646|NCT01690520|Cyclophosphamide|cyclophosphamide|mesh-list
111257647|NCT01690520|Thiotepa|thiotepa|mesh-list
111257648|NCT01690520|Fludarabine|fludarabine|mesh-list
111257649|NCT01690520|Fludarabine phosphate|fludarabine phosphate|mesh-list
111257650|NCT01690520|Cyclosporins|cyclosporins|mesh-list
111257651|NCT01690520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111257652|NCT01690520|Immunologic Factors|immunologic factors|mesh-ancestor
111257653|NCT01690520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111257654|NCT01690520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111257655|NCT01690520|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111257656|NCT01690520|Alkylating Agents|alkylating agents|mesh-ancestor
111257657|NCT01690520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111257658|NCT01690520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111257659|NCT01690520|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111257660|NCT01690520|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111257661|NCT01690520|Antimetabolites|antimetabolites|mesh-ancestor
111257662|NCT01690520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111257663|NCT01690520|Antifungal Agents|antifungal agents|mesh-ancestor
111257664|NCT01690520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111257666|NCT01690520|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111257667|NCT01690520|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111257668|NCT01690520|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111257669|NCT01690520|Antitubercular Agents|antitubercular agents|mesh-ancestor
111257670|NCT01690520|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111257671|NCT04081337|Tirzepatide|tirzepatide|mesh-list
111257672|NCT04081337|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111257673|NCT04081337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111257674|NCT04081337|Incretins|incretins|mesh-ancestor
111257675|NCT04081337|Hormones|hormones|mesh-ancestor
111257676|NCT04081337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111257677|NCT00541671|Promethazine|promethazine|mesh-list
111257678|NCT00541671|Antipruritics|antipruritics|mesh-ancestor
111257679|NCT00541671|Dermatologic Agents|dermatologic agents|mesh-ancestor
111257680|NCT00541671|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111257681|NCT00541671|Histamine Antagonists|histamine antagonists|mesh-ancestor
111257682|NCT00541671|Histamine Agents|histamine agents|mesh-ancestor
111257683|NCT00541671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111257684|NCT00541671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111257685|NCT00541671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111257686|NCT00541671|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111257687|NCT01563536|Ritonavir|ritonavir|mesh-list
111257688|NCT01563536|Ribavirin|ribavirin|mesh-list
111257689|NCT01563536|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111257690|NCT01563536|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111257691|NCT01563536|Protease Inhibitors|protease inhibitors|mesh-ancestor
111257692|NCT01563536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111257693|NCT01563536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111257694|NCT01563536|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111257695|NCT01563536|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111257696|NCT01563536|Antiviral Agents|antiviral agents|mesh-ancestor
111257697|NCT01563536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111257698|NCT01563536|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111257699|NCT01563536|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111257700|NCT01563536|Antimetabolites|antimetabolites|mesh-ancestor
111257701|NCT01690052|Pilocarpine|pilocarpine|mesh-list
111257702|NCT01690052|Cevimeline|cevimeline|mesh-list
111257703|NCT01690052|Miotics|miotics|mesh-ancestor
111257704|NCT01690052|Autonomic Agents|autonomic agents|mesh-ancestor
111257705|NCT01690052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111257706|NCT01690052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111257707|NCT01690052|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
111257708|NCT01690052|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111257709|NCT01690052|Cholinergic Agents|cholinergic agents|mesh-ancestor
111257710|NCT01690052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111257711|NCT01690052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111257712|NCT01690052|Parasympathomimetics|parasympathomimetics|mesh-ancestor
111257713|NCT01689974|Ipilimumab|ipilimumab|mesh-list
111257714|NCT01689974|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111257715|NCT01689974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111257716|NCT01689974|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111257717|NCT01689974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111257718|NCT04750083|Carboplatin|carboplatin|mesh-list
111257719|NCT04750083|Pembrolizumab|pembrolizumab|mesh-list
111257720|NCT04750083|Pemetrexed|pemetrexed|mesh-list
111257721|NCT04750083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111257722|NCT04750083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111257723|NCT04750083|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111257724|NCT04750083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111257725|NCT04750083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111257726|NCT04750083|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111257727|NCT04750083|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111257728|NCT02954991|Nivolumab|nivolumab|mesh-list
111257729|NCT02954991|Mocetinostat|mocetinostat|mesh-list
111257730|NCT02954991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111257731|NCT02954991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111257732|NCT02954991|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111257733|NCT02954991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111257734|NCT02954991|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111257735|NCT02954991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111257736|NCT02892591|Oxycodone|oxycodone|mesh-list
111257737|NCT02892591|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111257738|NCT02892591|Narcotics|narcotics|mesh-ancestor
111257739|NCT02892591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111257740|NCT02892591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111257741|NCT02892591|Analgesics|analgesics|mesh-ancestor
111257742|NCT02892591|Sensory System Agents|sensory system agents|mesh-ancestor
111257743|NCT02892591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111257744|NCT00470301|Paclitaxel|paclitaxel|mesh-list
111257745|NCT00470301|Cyclophosphamide|cyclophosphamide|mesh-list
111257746|NCT00470301|Doxorubicin|doxorubicin|mesh-list
111257747|NCT00470301|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111257748|NCT00470301|Tipifarnib|tipifarnib|mesh-list
111257749|NCT00470301|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111257750|NCT00470301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111257751|NCT00470301|Tubulin Modulators|tubulin modulators|mesh-ancestor
111257752|NCT00470301|Antimitotic Agents|antimitotic agents|mesh-ancestor
111257753|NCT00470301|Mitosis Modulators|mitosis modulators|mesh-ancestor
111257754|NCT00470301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111257755|NCT00470301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111257756|NCT00470301|Immunologic Factors|immunologic factors|mesh-ancestor
111257757|NCT00470301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111257758|NCT00470301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111257759|NCT00470301|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111257760|NCT00470301|Alkylating Agents|alkylating agents|mesh-ancestor
111257761|NCT00470301|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111257762|NCT00470301|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111257763|NCT00470301|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111257764|NCT00470301|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111257765|NCT00470301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111257766|NCT00544713|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
111257767|NCT00544713|Lubricant Eye Drops|lubricant eye drops|mesh-list
111257768|NCT00544713|Glycerol|glycerol|mesh-list
111257769|NCT00544713|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
111257770|NCT00544713|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111257771|NCT00544713|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
111257772|NCT00544713|Protective Agents|protective agents|mesh-ancestor
111257773|NCT00544713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111257774|NCT00544713|Laxatives|laxatives|mesh-ancestor
111257775|NCT00544713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111257776|NCT00545181|Metronidazole|metronidazole|mesh-list
111257777|NCT00545181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111257778|NCT00545181|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111257779|NCT00545181|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111257780|NCT00545181|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111257781|NCT01797315|Sirolimus|sirolimus|mesh-list
111257782|NCT01797315|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111257783|NCT01797315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111257784|NCT01797315|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111257785|NCT01797315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111257786|NCT01797315|Antifungal Agents|antifungal agents|mesh-ancestor
111257787|NCT01797315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111257788|NCT01797315|Immunologic Factors|immunologic factors|mesh-ancestor
111257789|NCT01797315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111257790|NCT00471705|Miltefosine|miltefosine|mesh-list
111257791|NCT00471705|Meglumine Antimoniate|meglumine antimoniate|mesh-list
111257792|NCT00471705|Antifungal Agents|antifungal agents|mesh-ancestor
111257793|NCT00471705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111257794|NCT00471705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111257795|NCT00471705|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111257796|NCT00471705|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111257797|NCT00472797|Interferon beta-1a|interferon beta-1a|mesh-list
111257798|NCT00472797|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111257799|NCT00472797|Immunologic Factors|immunologic factors|mesh-ancestor
111257800|NCT00472797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111257801|NCT00472797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111257802|NCT00472797|Antiviral Agents|antiviral agents|mesh-ancestor
111257803|NCT00472797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111257804|NCT01458535|Ritonavir|ritonavir|mesh-list
111257805|NCT01458535|Ribavirin|ribavirin|mesh-list
111257806|NCT01458535|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111257807|NCT01458535|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111257808|NCT01458535|Protease Inhibitors|protease inhibitors|mesh-ancestor
111257809|NCT01458535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111257810|NCT01458535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111257811|NCT01458535|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111257812|NCT01458535|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111257813|NCT01458535|Antiviral Agents|antiviral agents|mesh-ancestor
111257814|NCT01458535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111257815|NCT01458535|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110982108|NCT00231153|Povidone|povidone|mesh-list
111257816|NCT01458535|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111257817|NCT01458535|Antimetabolites|antimetabolites|mesh-ancestor
111257818|NCT01464827|Ritonavir|ritonavir|mesh-list
111257819|NCT01464827|Ribavirin|ribavirin|mesh-list
111257820|NCT01464827|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111257821|NCT01464827|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111257822|NCT01464827|Protease Inhibitors|protease inhibitors|mesh-ancestor
111257823|NCT01464827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111257824|NCT01464827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111257825|NCT01464827|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111257826|NCT01464827|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111257827|NCT01464827|Antiviral Agents|antiviral agents|mesh-ancestor
111257828|NCT01464827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111257829|NCT01464827|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111257830|NCT01464827|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111257831|NCT01464827|Antimetabolites|antimetabolites|mesh-ancestor
111257832|NCT01463111|Lamotrigine|lamotrigine|mesh-list
111257833|NCT01463111|Valproic Acid|valproic acid|mesh-list
111257834|NCT01463111|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111257835|NCT01463111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111257836|NCT01463111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111257837|NCT01463111|Antimanic Agents|antimanic agents|mesh-ancestor
111257838|NCT01463111|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111257839|NCT01463111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111257840|NCT01463111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111257841|NCT01463111|Anticonvulsants|anticonvulsants|mesh-ancestor
111257842|NCT01463111|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111257843|NCT01463111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111257844|NCT01463111|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111257845|NCT01463111|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111257846|NCT01463111|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111257847|NCT01463111|GABA Agents|gaba agents|mesh-ancestor
111257848|NCT01463111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111257849|NCT01463033|Levetiracetam|levetiracetam|mesh-list
111257850|NCT01463033|Anticonvulsants|anticonvulsants|mesh-ancestor
111257851|NCT01463033|Nootropic Agents|nootropic agents|mesh-ancestor
111257852|NCT01461551|Propofol|propofol|mesh-list
111257853|NCT01461551|Sevoflurane|sevoflurane|mesh-list
111257854|NCT01461551|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111257855|NCT01461551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111257856|NCT01461551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111257857|NCT01461551|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111257858|NCT01461551|Anesthetics, General|anesthetics, general|mesh-ancestor
111257859|NCT01461551|Anesthetics|anesthetics|mesh-ancestor
111257860|NCT01461551|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111257861|NCT01461551|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111257862|NCT01460381|Quinidine|quinidine|mesh-list
111257863|NCT01460381|Quinidine gluconate|quinidine gluconate|mesh-list
111257864|NCT01460381|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111257865|NCT01460381|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111257866|NCT01460381|Adrenergic Agents|adrenergic agents|mesh-ancestor
111257867|NCT01460381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111257868|NCT01460381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111257869|NCT01460381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111257870|NCT01460381|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111257871|NCT01460381|Antimalarials|antimalarials|mesh-ancestor
111257872|NCT01460381|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111257873|NCT01460381|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111257874|NCT01460381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111257875|NCT01460381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111257876|NCT01460381|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111257877|NCT01460381|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111257878|NCT01460381|Cholinergic Agents|cholinergic agents|mesh-ancestor
111257879|NCT01460381|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111257880|NCT01460381|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111257881|NCT01460381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111257882|NCT01460381|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111257883|NCT01460381|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111257884|NCT00546897|Lenalidomide|lenalidomide|mesh-list
111257885|NCT00546897|Immunologic Factors|immunologic factors|mesh-ancestor
111257886|NCT00546897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111257887|NCT00546897|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111257888|NCT00546897|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111257889|NCT00546897|Growth Substances|growth substances|mesh-ancestor
111257890|NCT00546897|Growth Inhibitors|growth inhibitors|mesh-ancestor
111257891|NCT00546897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110982181|NCT00162279|Abatacept|abatacept|mesh-list
111257892|NCT00474123|Simvastatin|simvastatin|mesh-list
111257893|NCT00474123|Ezetimibe|ezetimibe|mesh-list
111257894|NCT00474123|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111257895|NCT00474123|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111257896|NCT00474123|Antimetabolites|antimetabolites|mesh-ancestor
111257897|NCT00474123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111257898|NCT00474123|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111257899|NCT00474123|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111257900|NCT00474123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111257901|NCT00474201|Ritonavir|ritonavir|mesh-list
111257902|NCT00474201|Lopinavir|lopinavir|mesh-list
111257903|NCT00474201|Gemfibrozil|gemfibrozil|mesh-list
111257904|NCT00474201|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111257905|NCT00474201|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111257906|NCT00474201|Protease Inhibitors|protease inhibitors|mesh-ancestor
111257907|NCT00474201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111257908|NCT00474201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111257909|NCT00474201|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111257910|NCT00474201|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111257911|NCT00474201|Antiviral Agents|antiviral agents|mesh-ancestor
111257912|NCT00474201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111257913|NCT00474201|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111257914|NCT00474201|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111257915|NCT00474201|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111257916|NCT00474201|Antimetabolites|antimetabolites|mesh-ancestor
111257917|NCT00474201|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111257918|NCT00474201|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
111257919|NCT00549393|Chlorhexidine|chlorhexidine|mesh-list
111257920|NCT00549393|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
111257921|NCT00549393|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111257922|NCT00549393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111257923|NCT00549393|Disinfectants|disinfectants|mesh-ancestor
111257924|NCT00549393|Dermatologic Agents|dermatologic agents|mesh-ancestor
111257925|NCT00549783|Botulinum Toxins|botulinum toxins|mesh-list
111257926|NCT00549783|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111257927|NCT00549783|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111257928|NCT00549783|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111257929|NCT00549783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111257930|NCT00549783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111257931|NCT00549783|Cholinergic Agents|cholinergic agents|mesh-ancestor
111257932|NCT00549783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111257933|NCT00549783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111257934|NCT00549783|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111257935|NCT00549783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111257936|NCT00475215|Rocuronium|rocuronium|mesh-list
111257937|NCT00475215|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
111257938|NCT00475215|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
111257939|NCT00475215|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111257940|NCT00475215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111257941|NCT00475215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111257942|NCT02733159|Pembrolizumab|pembrolizumab|mesh-list
111257943|NCT02733159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111257944|NCT02733159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111257945|NCT02733159|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111257946|NCT02733159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111257947|NCT00477087|Molgramostim|molgramostim|mesh-list
111257948|NCT00477087|Mitoxantrone|mitoxantrone|mesh-list
111257949|NCT00477087|Sargramostim|sargramostim|mesh-list
111257950|NCT00477087|Immunologic Factors|immunologic factors|mesh-ancestor
111257951|NCT00477087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111257952|NCT00477087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111257953|NCT00477087|Analgesics|analgesics|mesh-ancestor
111257954|NCT00477087|Sensory System Agents|sensory system agents|mesh-ancestor
111257955|NCT00477087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111257956|NCT00477087|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111257957|NCT00477087|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111257958|NCT00477087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111257959|NCT00477087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111257960|NCT04409912|Sirolimus|sirolimus|mesh-list
111257961|NCT04409912|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111257962|NCT04409912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111257963|NCT04409912|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111257964|NCT04409912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111257965|NCT04409912|Antifungal Agents|antifungal agents|mesh-ancestor
110982265|NCT03530085|Busulfan|busulfan|mesh-list
111257966|NCT04409912|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111257967|NCT04409912|Immunologic Factors|immunologic factors|mesh-ancestor
111257968|NCT04409912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111257969|NCT01473589|Vitamin D|vitamin d|mesh-list
111257970|NCT01473589|Teriparatide|teriparatide|mesh-list
111257971|NCT01473589|Calcium|calcium|mesh-list
111257972|NCT01473589|Vitamins|vitamins|mesh-ancestor
111257973|NCT01473589|Micronutrients|micronutrients|mesh-ancestor
111257974|NCT01473589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111257975|NCT01473589|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111257976|NCT01473589|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111257977|NCT00478335|Calcitonin|calcitonin|mesh-list
111257978|NCT00478335|Salmon calcitonin|salmon calcitonin|mesh-list
111257979|NCT00478335|Indomethacin|indomethacin|mesh-list
111257980|NCT00478335|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
111257981|NCT00478335|Amiloride|amiloride|mesh-list
111257982|NCT00478335|Sildenafil Citrate|sildenafil citrate|mesh-list
111257983|NCT00478335|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
111257984|NCT00478335|Katacalcin|katacalcin|mesh-list
111257985|NCT00478335|Vasodilator Agents|vasodilator agents|mesh-ancestor
111257986|NCT00478335|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111257987|NCT00478335|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111257988|NCT00478335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111257989|NCT00478335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111257990|NCT00478335|Urological Agents|urological agents|mesh-ancestor
111257991|NCT00478335|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111257992|NCT00478335|Diuretics|diuretics|mesh-ancestor
111257993|NCT00478335|Natriuretic Agents|natriuretic agents|mesh-ancestor
111257994|NCT00478335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111257995|NCT00478335|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
111257996|NCT00478335|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111257997|NCT00478335|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111257998|NCT00478335|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111257999|NCT00478335|Analgesics|analgesics|mesh-ancestor
111258000|NCT00478335|Sensory System Agents|sensory system agents|mesh-ancestor
111258001|NCT00478335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111258002|NCT00478335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111258003|NCT00478335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111258004|NCT00478335|Gout Suppressants|gout suppressants|mesh-ancestor
111258005|NCT00478335|Tocolytic Agents|tocolytic agents|mesh-ancestor
111258006|NCT00478335|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111258007|NCT00478335|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111258008|NCT00478335|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
111258009|NCT00478335|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111258010|NCT00478335|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
111258011|NCT00478335|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
111258012|NCT00478335|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111258013|NCT00478335|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111258014|NCT00478569|Hormones|hormones|mesh-list
111258015|NCT00478569|Parathyroid Hormone|parathyroid hormone|mesh-list
111258016|NCT00478569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111258017|NCT00478569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111258018|NCT00478569|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111258019|NCT00479037|Strontium ranelate|strontium ranelate|mesh-list
111258020|NCT00479037|Hormones|hormones|mesh-list
111258021|NCT00479037|Parathyroid Hormone|parathyroid hormone|mesh-list
111258022|NCT00479037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111258023|NCT00479037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111258024|NCT00479037|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111258025|NCT00479037|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111258026|NCT02985229|Misoprostol|misoprostol|mesh-list
111258027|NCT02985229|Mifepristone|mifepristone|mesh-list
111258028|NCT02985229|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111258029|NCT02985229|Abortifacient Agents|abortifacient agents|mesh-ancestor
111258030|NCT02985229|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111258031|NCT02985229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111258032|NCT02985229|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111258033|NCT02985229|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111258034|NCT02985229|Oxytocics|oxytocics|mesh-ancestor
111258035|NCT02985229|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
111258036|NCT02985229|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111258037|NCT02985229|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111258038|NCT02985229|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111258039|NCT02985229|Contraceptive Agents|contraceptive agents|mesh-ancestor
111258040|NCT02985229|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
111258041|NCT02985229|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
111258042|NCT02985229|Hormone Antagonists|hormone antagonists|mesh-ancestor
111258043|NCT02985229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111258044|NCT02985229|Luteolytic Agents|luteolytic agents|mesh-ancestor
111258045|NCT02985229|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111258046|NCT02985229|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
111258047|NCT00479115|Plerixafor|plerixafor|mesh-list
111258048|NCT00479115|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111258049|NCT00479115|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111258050|NCT00479115|Antiviral Agents|antiviral agents|mesh-ancestor
111258051|NCT00479115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111258052|NCT01472965|Ethanol|ethanol|mesh-list
111258053|NCT01472965|Heparin|heparin|mesh-list
111258054|NCT01472965|Calcium heparin|calcium heparin|mesh-list
111258055|NCT01472965|Anticoagulants|anticoagulants|mesh-ancestor
111258056|NCT01472965|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111258057|NCT01472965|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111258058|NCT01472965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111258059|NCT01472965|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111258060|NCT01472965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111258061|NCT01472965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111258062|NCT01472965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111258063|NCT00480987|Cytarabine|cytarabine|mesh-list
111258064|NCT00480987|Oxaliplatin|oxaliplatin|mesh-list
111258065|NCT00480987|Fludarabine|fludarabine|mesh-list
111258066|NCT00480987|Fludarabine phosphate|fludarabine phosphate|mesh-list
111258067|NCT00480987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111258068|NCT00480987|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111258069|NCT00480987|Antimetabolites|antimetabolites|mesh-ancestor
111258070|NCT00480987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111258071|NCT00480987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111258072|NCT00480987|Immunologic Factors|immunologic factors|mesh-ancestor
111258073|NCT00480987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111258074|NCT00480987|Antiviral Agents|antiviral agents|mesh-ancestor
111258075|NCT00480987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111258076|NCT01457053|Torsemide|torsemide|mesh-list
111258077|NCT01457053|Furosemide|furosemide|mesh-list
111258078|NCT01457053|Bumetanide|bumetanide|mesh-list
111258079|NCT01457053|Diuretics|diuretics|mesh-list
111258080|NCT01457053|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
111258081|NCT01457053|Natriuretic Agents|natriuretic agents|mesh-ancestor
111258082|NCT01457053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111258083|NCT01457053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111258084|NCT01457053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111258085|NCT01457053|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111258086|NCT04082767|Midazolam|midazolam|mesh-list
111258087|NCT04082767|Dexmedetomidine|dexmedetomidine|mesh-list
111258088|NCT04082767|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111258089|NCT04082767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111258090|NCT04082767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111258091|NCT04082767|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111258092|NCT04082767|Analgesics|analgesics|mesh-ancestor
111258093|NCT04082767|Sensory System Agents|sensory system agents|mesh-ancestor
111258094|NCT04082767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111258095|NCT04082767|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111258096|NCT04082767|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111258097|NCT04082767|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111258098|NCT04082767|Adrenergic Agents|adrenergic agents|mesh-ancestor
111258099|NCT04082767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111258100|NCT04082767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111258101|NCT04082767|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111258102|NCT04082767|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111258103|NCT04082767|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111258104|NCT04082767|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111258105|NCT04082767|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111258106|NCT04082767|Anesthetics, General|anesthetics, general|mesh-ancestor
111258107|NCT04082767|Anesthetics|anesthetics|mesh-ancestor
111258108|NCT04082767|GABA Modulators|gaba modulators|mesh-ancestor
111258109|NCT04082767|GABA Agents|gaba agents|mesh-ancestor
111258110|NCT00481845|Anastrozole|anastrozole|mesh-list
111258111|NCT00481845|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111258112|NCT00481845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111258113|NCT00481845|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111258114|NCT00481845|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111258115|NCT00481845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111258116|NCT00481845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111258117|NCT00481845|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111258118|NCT00481845|Hormone Antagonists|hormone antagonists|mesh-ancestor
111258119|NCT00481845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111258120|NCT00481845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111258121|NCT01472185|Ranolazine|ranolazine|mesh-list
111258122|NCT01472185|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111258123|NCT01472185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111258124|NCT01472185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111258125|NCT00482625|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111258126|NCT00482625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111258127|NCT00482625|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111258128|NCT00482625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111258129|NCT00482625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111258130|NCT00553839|Ketamine|ketamine|mesh-list
111258131|NCT00553839|Analgesics|analgesics|mesh-ancestor
111258132|NCT00553839|Sensory System Agents|sensory system agents|mesh-ancestor
111258133|NCT00553839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111258134|NCT00553839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111258135|NCT00553839|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111258136|NCT00553839|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111258137|NCT00553839|Anesthetics, General|anesthetics, general|mesh-ancestor
111258138|NCT00553839|Anesthetics|anesthetics|mesh-ancestor
111258139|NCT00553839|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111258140|NCT00553839|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111258141|NCT00553839|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111258142|NCT00553839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111258143|NCT00553839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111258144|NCT00554463|Etoposide|etoposide|mesh-list
111258145|NCT00554463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111258146|NCT00554463|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111258147|NCT00554463|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111258148|NCT00554463|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111258149|NCT00554463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111258150|NCT00554463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111258151|NCT00554853|Pioglitazone|pioglitazone|mesh-list
111258152|NCT00554853|Nitroglycerin|nitroglycerin|mesh-list
111258153|NCT00554853|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111258154|NCT00554853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111258155|NCT00554853|Vasodilator Agents|vasodilator agents|mesh-ancestor
111258156|NCT00556491|Minocycline|minocycline|mesh-list
111258157|NCT00556491|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111258158|NCT00556491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111258159|NCT02685969|Flutemetamol|flutemetamol|mesh-list
111258160|NCT02685969|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111258161|NCT02685969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111258162|NCT00485433|Epinephrine|epinephrine|mesh-list
111258163|NCT00485433|Bupivacaine|bupivacaine|mesh-list
111258164|NCT00485433|Anesthetics, Local|anesthetics, local|mesh-ancestor
111258165|NCT00485433|Anesthetics|anesthetics|mesh-ancestor
111258166|NCT00485433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111258167|NCT00485433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111258168|NCT00485433|Sensory System Agents|sensory system agents|mesh-ancestor
111258169|NCT00485433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111258170|NCT00485433|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111258171|NCT00485433|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111258172|NCT00485433|Adrenergic Agents|adrenergic agents|mesh-ancestor
111258173|NCT00485433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111258174|NCT00485433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111258175|NCT00485433|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111258176|NCT00485433|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111258177|NCT00485433|Autonomic Agents|autonomic agents|mesh-ancestor
111258178|NCT00485433|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111258179|NCT00485433|Respiratory System Agents|respiratory system agents|mesh-ancestor
111258180|NCT00485433|Mydriatics|mydriatics|mesh-ancestor
111258181|NCT00485433|Sympathomimetics|sympathomimetics|mesh-ancestor
111258182|NCT00485433|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111258183|NCT02850081|Atorvastatin|atorvastatin|mesh-list
111258184|NCT02850081|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
111258185|NCT02850081|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111258186|NCT02850081|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111258187|NCT02850081|Antimetabolites|antimetabolites|mesh-ancestor
111258188|NCT02850081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111258189|NCT02850081|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111258190|NCT02850081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111258191|NCT01456039|Romidepsin|romidepsin|mesh-list
111258192|NCT01456039|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111258193|NCT01456039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111258194|NCT01456039|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111258195|NCT01456039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111258196|NCT01456039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111258197|NCT01455415|Pregabalin|pregabalin|mesh-list
111258198|NCT01455415|Analgesics|analgesics|mesh-ancestor
111258199|NCT01455415|Sensory System Agents|sensory system agents|mesh-ancestor
111258200|NCT01455415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111258201|NCT01455415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111258202|NCT01455415|Anticonvulsants|anticonvulsants|mesh-ancestor
111258203|NCT01455415|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111258204|NCT01455415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111258205|NCT01455415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111258206|NCT01455415|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111258207|NCT01455415|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111258208|NCT01455415|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111258209|NCT01455415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111258210|NCT01455415|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111258211|NCT01471171|Bromides|bromides|mesh-list
111258212|NCT01471171|Anticonvulsants|anticonvulsants|mesh-ancestor
111258213|NCT01471093|Rebamipide|rebamipide|mesh-list
111258214|NCT01471093|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111258215|NCT01471093|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111258216|NCT01471093|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111258217|NCT01471093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111258218|NCT01471093|Antioxidants|antioxidants|mesh-ancestor
111258219|NCT01471093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111258220|NCT01471093|Protective Agents|protective agents|mesh-ancestor
111258221|NCT01471093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111258222|NCT01471093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111258223|NCT01471015|Darbepoetin alfa|darbepoetin alfa|mesh-list
111258224|NCT01471015|Hematinics|hematinics|mesh-ancestor
111258225|NCT01470469|Guanfacine|guanfacine|mesh-list
111258226|NCT01470469|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111258227|NCT01470469|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111258228|NCT01470469|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111258229|NCT01470469|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111258230|NCT01470469|Adrenergic Agents|adrenergic agents|mesh-ancestor
111258231|NCT01470469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111258232|NCT01470469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111258233|NCT01470469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111258234|NCT01470001|Solifenacin Succinate|solifenacin succinate|mesh-list
111258235|NCT01470001|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111258236|NCT01470001|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111258237|NCT01470001|Cholinergic Agents|cholinergic agents|mesh-ancestor
111258238|NCT01470001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111258239|NCT01470001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111258240|NCT01470001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111258241|NCT01470001|Urological Agents|urological agents|mesh-ancestor
111258242|NCT01469377|Cariprazine|cariprazine|mesh-list
111258243|NCT01469377|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111258244|NCT01469377|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111258245|NCT01469377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111258246|NCT01469377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111258247|NCT01469377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111258248|NCT01469221|Apaziquone|apaziquone|mesh-list
111258249|NCT01469221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111258250|NCT01453855|Travoprost|travoprost|mesh-list
111258251|NCT01453855|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111258252|NCT01453855|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111258253|NCT01453855|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111258254|NCT01469065|Nicotinic Acids|nicotinic acids|mesh-list
111258255|NCT01469065|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1h-imidazol-1-yl)propanamido)nicotinic acid|mesh-list
111258256|NCT01469065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111258257|NCT01469065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111258258|NCT01469065|Vitamin B Complex|vitamin b complex|mesh-ancestor
111258259|NCT01469065|Vitamins|vitamins|mesh-ancestor
111258260|NCT01469065|Micronutrients|micronutrients|mesh-ancestor
111258261|NCT01469065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111258262|NCT01586156|Carvedilol|carvedilol|mesh-list
111258263|NCT01586156|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111258264|NCT01586156|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111258265|NCT01586156|Adrenergic Agents|adrenergic agents|mesh-ancestor
111258266|NCT01586156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111258267|NCT01586156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111258268|NCT01586156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111258269|NCT01586156|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111258270|NCT01586156|Antioxidants|antioxidants|mesh-ancestor
111258271|NCT01586156|Protective Agents|protective agents|mesh-ancestor
111258272|NCT01586156|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111258273|NCT01586156|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111258274|NCT01586156|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111258275|NCT01586156|Vasodilator Agents|vasodilator agents|mesh-ancestor
111258276|NCT01586156|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111258277|NCT01586156|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111258278|NCT01459913|Interferons|interferons|mesh-list
111258279|NCT01459913|Ribavirin|ribavirin|mesh-list
111258280|NCT01459913|Interferon-alpha|interferon-alpha|mesh-list
111258281|NCT01459913|Interferon alpha-2|interferon alpha-2|mesh-list
111258282|NCT01459913|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
111258283|NCT01459913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111258284|NCT01459913|Antiviral Agents|antiviral agents|mesh-ancestor
111258285|NCT01459913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111258286|NCT01459913|Antimetabolites|antimetabolites|mesh-ancestor
111258287|NCT01459913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111258288|NCT01459913|Immunologic Factors|immunologic factors|mesh-ancestor
111258289|NCT01459913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111258290|NCT01458587|Aminolevulinic Acid|aminolevulinic acid|mesh-list
111258291|NCT01458587|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111258292|NCT01458587|Dermatologic Agents|dermatologic agents|mesh-ancestor
111258293|NCT01458275|Ciclesonide|ciclesonide|mesh-list
111258294|NCT01458275|Glucocorticoids|glucocorticoids|mesh-ancestor
111258295|NCT01458275|Hormones|hormones|mesh-ancestor
111258296|NCT01458275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111258297|NCT01458275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111258298|NCT01458275|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111258299|NCT02334527|Palbociclib|palbociclib|mesh-list
111258300|NCT02334527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111258301|NCT02334527|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111258302|NCT02334527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111258303|NCT02334527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111258304|NCT01688726|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111258305|NCT01688726|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111258306|NCT01457339|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
111258307|NCT01457339|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111258308|NCT01457339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111258309|NCT01457339|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111258310|NCT01457339|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111258311|NCT01457339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111258312|NCT01457339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111258313|NCT01457339|Dopamine Agents|dopamine agents|mesh-ancestor
111258314|NCT01457339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111258315|NCT01456169|Chlorthalidone|chlorthalidone|mesh-list
111258316|NCT01456169|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
111258317|NCT01456169|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111258318|NCT01456169|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111258319|NCT01456169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111258320|NCT01456169|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111258321|NCT01456169|Diuretics|diuretics|mesh-ancestor
111258322|NCT01456169|Natriuretic Agents|natriuretic agents|mesh-ancestor
111258323|NCT01456169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111258324|NCT01456169|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
111258325|NCT01456169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111258326|NCT01453595|Dactolisib|dactolisib|mesh-list
111258327|NCT01453595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111258328|NCT01585298|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
111258329|NCT01585298|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
111258330|NCT01585298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111258331|NCT01585298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111258332|NCT01585298|Immunologic Factors|immunologic factors|mesh-ancestor
111258333|NCT01585298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111258334|NCT04124198|Nimorazole|nimorazole|mesh-list
111258335|NCT04124198|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
111258336|NCT04124198|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111258337|NCT04124198|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111258338|NCT04124198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111258339|NCT01453205|Rituximab|rituximab|mesh-list
111258340|NCT01453205|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111258341|NCT01453205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111258342|NCT01453205|Immunologic Factors|immunologic factors|mesh-ancestor
111258343|NCT01453205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111258344|NCT01453205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111258345|NCT01453049|Glimepiride|glimepiride|mesh-list
111258346|NCT01453049|Rosiglitazone|rosiglitazone|mesh-list
111258347|NCT01453049|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111258348|NCT01453049|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111258349|NCT01453049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111258350|NCT01453049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111258351|NCT01453049|Immunologic Factors|immunologic factors|mesh-ancestor
111258352|NCT01452347|Warfarin|warfarin|mesh-list
111258353|NCT01452347|Dabigatran|dabigatran|mesh-list
111258354|NCT01452347|Anticoagulants|anticoagulants|mesh-ancestor
111258355|NCT01452347|Antithrombins|antithrombins|mesh-ancestor
111258356|NCT01452347|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111258357|NCT01452347|Protease Inhibitors|protease inhibitors|mesh-ancestor
111258358|NCT01452347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111258359|NCT01452347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111258360|NCT01451723|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
111258361|NCT01451723|Antioxidants|antioxidants|mesh-ancestor
111258362|NCT01451723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111258363|NCT01451723|Protective Agents|protective agents|mesh-ancestor
111258364|NCT01451723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111258365|NCT01451723|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
111258366|NCT01451723|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
111258367|NCT01451723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111258368|NCT01451723|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111258369|NCT01451645|Colchicine|colchicine|mesh-list
111258370|NCT01451645|Allopurinol|allopurinol|mesh-list
111258371|NCT01451645|Gout Suppressants|gout suppressants|mesh-ancestor
111258372|NCT01451645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111258373|NCT01451645|Tubulin Modulators|tubulin modulators|mesh-ancestor
111258374|NCT01451645|Antimitotic Agents|antimitotic agents|mesh-ancestor
111258375|NCT01451645|Mitosis Modulators|mitosis modulators|mesh-ancestor
111258376|NCT01451645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111258377|NCT01451645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111258378|NCT01451645|Antimetabolites|antimetabolites|mesh-ancestor
111258379|NCT01451645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111258380|NCT01451645|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111258381|NCT01451645|Antioxidants|antioxidants|mesh-ancestor
111258382|NCT01451645|Protective Agents|protective agents|mesh-ancestor
111258383|NCT01451645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111258384|NCT01450007|Dexamethasone|dexamethasone|mesh-list
111258385|NCT01450007|Dexamethasone acetate|dexamethasone acetate|mesh-list
111258386|NCT01450007|Ropivacaine|ropivacaine|mesh-list
111258387|NCT01450007|BB 1101|bb 1101|mesh-list
111258388|NCT01450007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111258389|NCT01450007|Antiemetics|antiemetics|mesh-ancestor
111258390|NCT01450007|Autonomic Agents|autonomic agents|mesh-ancestor
111258391|NCT01450007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111258392|NCT01450007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111258393|NCT01450007|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111258394|NCT01450007|Glucocorticoids|glucocorticoids|mesh-ancestor
111258395|NCT01450007|Hormones|hormones|mesh-ancestor
111258396|NCT01450007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111258397|NCT01450007|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111258398|NCT01450007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111258399|NCT01450007|Protease Inhibitors|protease inhibitors|mesh-ancestor
111258400|NCT01450007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111258401|NCT01450007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111258402|NCT01450007|Anesthetics, Local|anesthetics, local|mesh-ancestor
111258403|NCT01450007|Anesthetics|anesthetics|mesh-ancestor
111258404|NCT01450007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111258405|NCT01450007|Sensory System Agents|sensory system agents|mesh-ancestor
111258406|NCT01496365|Pregabalin|pregabalin|mesh-list
111258407|NCT01496365|Analgesics|analgesics|mesh-ancestor
111258408|NCT01496365|Sensory System Agents|sensory system agents|mesh-ancestor
111258409|NCT01496365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111258410|NCT01496365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111258411|NCT01496365|Anticonvulsants|anticonvulsants|mesh-ancestor
111258412|NCT01496365|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110982712|NCT02439788|Cyclophosphamide|cyclophosphamide|mesh-list
111258413|NCT01496365|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111258414|NCT01496365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111258415|NCT01496365|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111258416|NCT01496365|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111258417|NCT01496365|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111258418|NCT01496365|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111258419|NCT01496365|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111258420|NCT01468987|Insulin|insulin|mesh-list
111258421|NCT01468987|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111258422|NCT01468987|Insulin Glargine|insulin glargine|mesh-list
111258423|NCT01468987|Insulin Lispro|insulin lispro|mesh-list
111258424|NCT01468987|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111258425|NCT01468987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111258426|NCT01687712|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
111258427|NCT01687712|Hormones|hormones|mesh-ancestor
111258428|NCT01687712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111258429|NCT01687712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111258430|NCT01603628|Botulinum Toxins|botulinum toxins|mesh-list
111258431|NCT01603628|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111258432|NCT01603628|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111258433|NCT01603628|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111258434|NCT01603628|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111258435|NCT01603628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111258436|NCT01603628|Cholinergic Agents|cholinergic agents|mesh-ancestor
111258437|NCT01603628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111258438|NCT01603628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111258439|NCT01603628|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111258440|NCT01603628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111258441|NCT01453153|Gemcitabine|gemcitabine|mesh-list
111258442|NCT01453153|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111258443|NCT01453153|Antimetabolites|antimetabolites|mesh-ancestor
111258444|NCT01453153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111258445|NCT01453153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111258446|NCT01584440|Quinidine|quinidine|mesh-list
111258447|NCT01584440|Dextromethorphan|dextromethorphan|mesh-list
111258448|NCT01584440|Antitussive Agents|antitussive agents|mesh-ancestor
111258449|NCT01584440|Respiratory System Agents|respiratory system agents|mesh-ancestor
111258450|NCT01584440|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111258451|NCT01584440|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111258452|NCT01584440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111258453|NCT01584440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111258454|NCT01584440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111258455|NCT01584440|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111258456|NCT01584440|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111258457|NCT01584440|Adrenergic Agents|adrenergic agents|mesh-ancestor
111258458|NCT01584440|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111258459|NCT01584440|Antimalarials|antimalarials|mesh-ancestor
111258460|NCT01584440|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111258461|NCT01584440|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111258462|NCT01584440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111258463|NCT01584440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111258464|NCT01584440|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111258465|NCT01584440|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111258466|NCT01584440|Cholinergic Agents|cholinergic agents|mesh-ancestor
111258467|NCT01584440|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111258468|NCT01584440|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111258469|NCT01584440|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111258470|NCT01584440|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111258471|NCT01584440|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111258472|NCT01687478|Olanzapine|olanzapine|mesh-list
111258473|NCT01687478|Fluoxetine|fluoxetine|mesh-list
111258474|NCT01687478|Antiemetics|antiemetics|mesh-ancestor
111258475|NCT01687478|Autonomic Agents|autonomic agents|mesh-ancestor
111258476|NCT01687478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111258477|NCT01687478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111258478|NCT01687478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111258479|NCT01687478|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111258480|NCT01687478|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111258481|NCT01687478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111258482|NCT01687478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111258483|NCT01687478|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111258484|NCT01687478|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111258485|NCT01687478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110959165|NCT05681182|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111258486|NCT01687478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111258487|NCT01687478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111258488|NCT01687478|Serotonin Agents|serotonin agents|mesh-ancestor
111258489|NCT01687478|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111258490|NCT01687478|Antidepressive Agents|antidepressive agents|mesh-ancestor
111258491|NCT01687478|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111258492|NCT01687478|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111258493|NCT01687478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111258494|NCT01468909|Paclitaxel|paclitaxel|mesh-list
111258495|NCT01468909|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111258496|NCT01468909|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111258497|NCT01468909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111258498|NCT01468909|Tubulin Modulators|tubulin modulators|mesh-ancestor
111258499|NCT01468909|Antimitotic Agents|antimitotic agents|mesh-ancestor
111258500|NCT01468909|Mitosis Modulators|mitosis modulators|mesh-ancestor
111258501|NCT01468909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111258502|NCT01687166|Acifluorfen|acifluorfen|mesh-list
111258503|NCT01687166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111258504|NCT01687166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111258505|NCT01561976|Metformin|metformin|mesh-list
111258506|NCT01561976|Glimepiride|glimepiride|mesh-list
111258507|NCT01561976|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111258508|NCT01561976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111258509|NCT01561976|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111258510|NCT01561976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111258511|NCT01561976|Immunologic Factors|immunologic factors|mesh-ancestor
111258512|NCT01686932|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111258513|NCT01686932|Vildagliptin|vildagliptin|mesh-list
111258514|NCT01686932|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111258515|NCT01686932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111258516|NCT01686932|Incretins|incretins|mesh-ancestor
111258517|NCT01686932|Hormones|hormones|mesh-ancestor
111258518|NCT01686932|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111258519|NCT01686932|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111258520|NCT01686932|Protease Inhibitors|protease inhibitors|mesh-ancestor
111258521|NCT01686932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111258522|NCT01686932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111258523|NCT01468207|Adalimumab|adalimumab|mesh-list
111258524|NCT01468207|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111258525|NCT01468207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111258526|NCT01468207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111258527|NCT03026725|Calcium|calcium|mesh-list
111258528|NCT03026725|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111258529|NCT03026725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111258530|NCT01686152|Imiquimod|imiquimod|mesh-list
111258531|NCT01686152|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111258532|NCT01686152|Immunologic Factors|immunologic factors|mesh-ancestor
111258533|NCT01686152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111258534|NCT01686152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111258535|NCT01686152|Interferon Inducers|interferon inducers|mesh-ancestor
111258536|NCT01561898|Paliperidone Palmitate|paliperidone palmitate|mesh-list
111258537|NCT01561898|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111258538|NCT01561898|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111258539|NCT01561898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111258540|NCT01561898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111258541|NCT01561898|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111258542|NCT01561898|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111258543|NCT01561898|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111258544|NCT01561898|Serotonin Agents|serotonin agents|mesh-ancestor
111258545|NCT01561898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111258546|NCT01561898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111258547|NCT01561898|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111258548|NCT01561898|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111258549|NCT01561898|Dopamine Agents|dopamine agents|mesh-ancestor
111258550|NCT01452529|Hydrocodone|hydrocodone|mesh-list
111258551|NCT01452529|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111258552|NCT01452529|Narcotics|narcotics|mesh-ancestor
111258553|NCT01452529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111258554|NCT01452529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111258555|NCT01452529|Analgesics|analgesics|mesh-ancestor
111258556|NCT01452529|Sensory System Agents|sensory system agents|mesh-ancestor
111258557|NCT01452529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111258558|NCT01452529|Antitussive Agents|antitussive agents|mesh-ancestor
110982858|NCT02442362|Paclitaxel|paclitaxel|mesh-list
111258559|NCT01452529|Respiratory System Agents|respiratory system agents|mesh-ancestor
111258560|NCT01560416|Fulvestrant|fulvestrant|mesh-list
111258561|NCT01560416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111258562|NCT01560416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111258563|NCT01560416|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
111258564|NCT01560416|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111258565|NCT01560416|Hormone Antagonists|hormone antagonists|mesh-ancestor
111258566|NCT01560416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111258567|NCT01560416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111258568|NCT01685606|Immunomodulating Agents|immunomodulating agents|mesh-list
111258569|NCT01685606|Immunologic Factors|immunologic factors|mesh-ancestor
111258570|NCT01685606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111258571|NCT01685372|Vaccines|vaccines|mesh-list
111258572|NCT01685372|Immunologic Factors|immunologic factors|mesh-ancestor
111258573|NCT01685372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111258574|NCT01685138|Ceritinib|ceritinib|mesh-list
111258575|NCT01685138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111258576|NCT01685138|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111258577|NCT01685138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111258578|NCT01685138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111258579|NCT01685060|Ceritinib|ceritinib|mesh-list
111258580|NCT01685060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111258581|NCT01685060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111258582|NCT01685060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111258583|NCT01685060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111258584|NCT03887936|Testosterone|testosterone|mesh-list
111258585|NCT03887936|Androgens|androgens|mesh-ancestor
111258586|NCT03887936|Hormones|hormones|mesh-ancestor
111258587|NCT03887936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111258588|NCT03887936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111258589|NCT01684202|Tolvaptan|tolvaptan|mesh-list
111258590|NCT01684202|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
110978206|NCT00711555|Dexamethasone|dexamethasone|mesh-list
111258591|NCT01684202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111258592|NCT01684202|Natriuretic Agents|natriuretic agents|mesh-ancestor
111258593|NCT01684202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111258594|NCT01559090|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111258595|NCT01559090|Immunologic Factors|immunologic factors|mesh-ancestor
111258596|NCT01559090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111258597|NCT01683266|Insulin|insulin|mesh-list
111258598|NCT01683266|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111258599|NCT01683266|Insulin Glargine|insulin glargine|mesh-list
111258600|NCT01683266|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111258601|NCT01683266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111258602|NCT01467661|Anagrelide|anagrelide|mesh-list
111258603|NCT01467661|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111258604|NCT01467661|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111258605|NCT01467661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111258606|NCT01467661|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111258607|NCT01577186|Paliperidone Palmitate|paliperidone palmitate|mesh-list
111258608|NCT01577186|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111258609|NCT01577186|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111258610|NCT01577186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111258611|NCT01577186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111258612|NCT01577186|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111258613|NCT01577186|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111258614|NCT01577186|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111258615|NCT01577186|Serotonin Agents|serotonin agents|mesh-ancestor
111258616|NCT01577186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111258617|NCT01577186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111258618|NCT01577186|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111258619|NCT01577186|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111258620|NCT01577186|Dopamine Agents|dopamine agents|mesh-ancestor
111258621|NCT01559012|Clonidine|clonidine|mesh-list
111258622|NCT01559012|Analgesics|analgesics|mesh-ancestor
111258623|NCT01559012|Sensory System Agents|sensory system agents|mesh-ancestor
111258624|NCT01559012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111258625|NCT01559012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111258626|NCT01559012|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111258627|NCT01559012|Sympatholytics|sympatholytics|mesh-ancestor
111258628|NCT01559012|Autonomic Agents|autonomic agents|mesh-ancestor
111258629|NCT01559012|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111258630|NCT01559012|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111258631|NCT01559012|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111258632|NCT01559012|Adrenergic Agents|adrenergic agents|mesh-ancestor
111258633|NCT01559012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111258634|NCT01559012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111258636|NCT01451827|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
111258637|NCT01451827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111258638|NCT01451827|Natriuretic Agents|natriuretic agents|mesh-ancestor
111258639|NCT01451827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111258640|NCT01557920|Propofol|propofol|mesh-list
111258641|NCT01557920|Sevoflurane|sevoflurane|mesh-list
111258642|NCT01557920|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111258643|NCT01557920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111258644|NCT01557920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111258645|NCT01557920|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111258646|NCT01557920|Anesthetics, General|anesthetics, general|mesh-ancestor
111258647|NCT01557920|Anesthetics|anesthetics|mesh-ancestor
111258648|NCT01557920|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111258649|NCT01557920|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111258650|NCT01467583|PENTA|penta|mesh-list
111258651|NCT01467583|Fondaparinux|fondaparinux|mesh-list
111258652|NCT01467583|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111258653|NCT01467583|Antithrombins|antithrombins|mesh-ancestor
111258654|NCT01467583|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111258655|NCT01467583|Protease Inhibitors|protease inhibitors|mesh-ancestor
111258656|NCT01467583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111258657|NCT01467583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111258658|NCT01467583|Anticoagulants|anticoagulants|mesh-ancestor
111258659|NCT01467583|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111258660|NCT01467583|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111258661|NCT01576718|Fluticasone|fluticasone|mesh-list
111258662|NCT01576718|Xhance|xhance|mesh-list
111258663|NCT01576718|Albuterol|albuterol|mesh-list
111258664|NCT01576718|Adrenergic Agonists|adrenergic agonists|mesh-list
111258665|NCT01576718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111258666|NCT01576718|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111258667|NCT01576718|Autonomic Agents|autonomic agents|mesh-ancestor
111258668|NCT01576718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111258669|NCT01576718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111258670|NCT01576718|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111258671|NCT01576718|Respiratory System Agents|respiratory system agents|mesh-ancestor
111258672|NCT01576718|Dermatologic Agents|dermatologic agents|mesh-ancestor
111258673|NCT01576718|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111258674|NCT01576718|Tocolytic Agents|tocolytic agents|mesh-ancestor
111258675|NCT01576718|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111258676|NCT01576718|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111258677|NCT01576718|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111258678|NCT01576718|Adrenergic Agents|adrenergic agents|mesh-ancestor
111258679|NCT01576718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111258680|NCT01576718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111258681|NCT01493557|Pantoprazole|pantoprazole|mesh-list
111258682|NCT01493557|Dabigatran|dabigatran|mesh-list
111258683|NCT01493557|Antithrombins|antithrombins|mesh-ancestor
111258684|NCT01493557|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111258685|NCT01493557|Protease Inhibitors|protease inhibitors|mesh-ancestor
111258686|NCT01493557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111258687|NCT01493557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111258688|NCT01493557|Anticoagulants|anticoagulants|mesh-ancestor
111258689|NCT01493557|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111258690|NCT01493557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111258691|NCT01493557|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111258692|NCT01451749|Donepezil|donepezil|mesh-list
111258693|NCT01451749|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111258694|NCT01451749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111258695|NCT01451749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111258696|NCT01451749|Cholinergic Agents|cholinergic agents|mesh-ancestor
111258697|NCT01451749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111258698|NCT01451749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111258699|NCT01451749|Nootropic Agents|nootropic agents|mesh-ancestor
111258700|NCT01576484|Alirocumab|alirocumab|mesh-list
111258701|NCT01576484|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111258702|NCT01576484|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
111258703|NCT01576484|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111258704|NCT01576484|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111258705|NCT01576484|Antimetabolites|antimetabolites|mesh-ancestor
111258706|NCT01576484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110983022|NCT02433626|Cisplatin|cisplatin|mesh-list
111258707|NCT01576484|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111258708|NCT01576484|Protease Inhibitors|protease inhibitors|mesh-ancestor
111258709|NCT01576484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111258710|NCT01576484|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111258711|NCT01576484|Immunologic Factors|immunologic factors|mesh-ancestor
111258712|NCT01576484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111258713|NCT01467505|Interferons|interferons|mesh-list
111258714|NCT01467505|Ribavirin|ribavirin|mesh-list
111258715|NCT01467505|Interferon-alpha|interferon-alpha|mesh-list
111258716|NCT01467505|Interferon alpha-2|interferon alpha-2|mesh-list
111258717|NCT01467505|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
111258718|NCT01467505|Immunosuppressive Agents|immunosuppressive agents|mesh-list
111258719|NCT01467505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111258720|NCT01467505|Antiviral Agents|antiviral agents|mesh-ancestor
111258721|NCT01467505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111258722|NCT01467505|Antimetabolites|antimetabolites|mesh-ancestor
111258723|NCT01467505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111258724|NCT01467505|Immunologic Factors|immunologic factors|mesh-ancestor
111258725|NCT01467505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111258726|NCT01449929|Ritonavir|ritonavir|mesh-list
111258727|NCT01449929|Darunavir|darunavir|mesh-list
111258728|NCT01449929|Dolutegravir|dolutegravir|mesh-list
111258729|NCT01449929|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111258730|NCT01449929|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111258731|NCT01449929|Protease Inhibitors|protease inhibitors|mesh-ancestor
111258732|NCT01449929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111258733|NCT01449929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111258734|NCT01449929|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111258735|NCT01449929|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111258736|NCT01449929|Antiviral Agents|antiviral agents|mesh-ancestor
111258737|NCT01449929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111258738|NCT01449929|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111258739|NCT01449929|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111258740|NCT01449929|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111258741|NCT01449929|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111258742|NCT01451515|Cytarabine|cytarabine|mesh-list
111258743|NCT01451515|Dexamethasone|dexamethasone|mesh-list
111258744|NCT01451515|Prednisone|prednisone|mesh-list
111258745|NCT01451515|Prednisolone|prednisolone|mesh-list
111258746|NCT01451515|Hydrocortisone|hydrocortisone|mesh-list
111258747|NCT01451515|Cyclophosphamide|cyclophosphamide|mesh-list
111258748|NCT01451515|Doxorubicin|doxorubicin|mesh-list
111258749|NCT01451515|Methotrexate|methotrexate|mesh-list
111258750|NCT01451515|Etoposide|etoposide|mesh-list
111258751|NCT01451515|Vincristine|vincristine|mesh-list
111258752|NCT01451515|Daunorubicin|daunorubicin|mesh-list
111258753|NCT01451515|Asparaginase|asparaginase|mesh-list
111258754|NCT01451515|Mercaptopurine|mercaptopurine|mesh-list
111258755|NCT01451515|Clofarabine|clofarabine|mesh-list
111258756|NCT01451515|Pegaspargase|pegaspargase|mesh-list
111258757|NCT01451515|Thioguanine|thioguanine|mesh-list
111258758|NCT01451515|Antimetabolites|antimetabolites|mesh-list
111258759|NCT01451515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111258760|NCT01451515|Immunologic Factors|immunologic factors|mesh-ancestor
111258761|NCT01451515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111258762|NCT01451515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111258763|NCT01451515|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111258764|NCT01451515|Alkylating Agents|alkylating agents|mesh-ancestor
111258765|NCT01451515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111258766|NCT01451515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111258767|NCT01451515|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111258768|NCT01451515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111258769|NCT01451515|Antiemetics|antiemetics|mesh-ancestor
111258770|NCT01451515|Autonomic Agents|autonomic agents|mesh-ancestor
111258771|NCT01451515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111258772|NCT01451515|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111258773|NCT01451515|Glucocorticoids|glucocorticoids|mesh-ancestor
111258774|NCT01451515|Hormones|hormones|mesh-ancestor
111258775|NCT01451515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111258776|NCT01451515|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111258777|NCT01451515|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111258778|NCT01451515|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111258779|NCT01451515|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111258780|NCT01451515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111258781|NCT01451515|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111258782|NCT01451515|Abortifacient Agents|abortifacient agents|mesh-ancestor
111258783|NCT01451515|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111258784|NCT01451515|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111258785|NCT01451515|Dermatologic Agents|dermatologic agents|mesh-ancestor
111258786|NCT01451515|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111258787|NCT01451515|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111258788|NCT01451515|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111258789|NCT01451515|Antiviral Agents|antiviral agents|mesh-ancestor
111258790|NCT01451515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111258791|NCT01451515|Tubulin Modulators|tubulin modulators|mesh-ancestor
111258792|NCT01451515|Antimitotic Agents|antimitotic agents|mesh-ancestor
111258793|NCT01451515|Mitosis Modulators|mitosis modulators|mesh-ancestor
111258794|NCT01576406|Crizotinib|crizotinib|mesh-list
111258795|NCT01576406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111258796|NCT01576406|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111258797|NCT01576406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111258798|NCT01576406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111258799|NCT01576172|Prednisone|prednisone|mesh-list
111258800|NCT01576172|Cortisone|cortisone|mesh-list
111258801|NCT01576172|Abiraterone Acetate|abiraterone acetate|mesh-list
111258802|NCT01576172|Veliparib|veliparib|mesh-list
111258803|NCT01576172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111258804|NCT01576172|Glucocorticoids|glucocorticoids|mesh-ancestor
111258805|NCT01576172|Hormones|hormones|mesh-ancestor
111258806|NCT01576172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111258807|NCT01576172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111258808|NCT01576172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111258809|NCT01576172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111258810|NCT01576172|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111258811|NCT01576172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111258812|NCT01576172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111258813|NCT01576172|Hormone Antagonists|hormone antagonists|mesh-ancestor
111258814|NCT01576172|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110710903|NCT01086826|Antimetabolites|antimetabolites|mesh-ancestor
111258815|NCT01576172|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111258816|NCT01542788|Sofosbuvir|sofosbuvir|mesh-list
111258817|NCT01542788|Antiviral Agents|antiviral agents|mesh-ancestor
111258818|NCT01542788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111258819|NCT01541930|Metronidazole|metronidazole|mesh-list
111258820|NCT01541930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111258821|NCT01541930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111258822|NCT01541930|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111258823|NCT01541930|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111258824|NCT03028298|Sildenafil Citrate|sildenafil citrate|mesh-list
111258825|NCT03028298|Citric Acid|citric acid|mesh-list
111258826|NCT03028298|Sodium Citrate|sodium citrate|mesh-list
111258827|NCT03028298|Anticoagulants|anticoagulants|mesh-ancestor
111258828|NCT03028298|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
111258829|NCT03028298|Chelating Agents|chelating agents|mesh-ancestor
111258830|NCT03028298|Sequestering Agents|sequestering agents|mesh-ancestor
111258831|NCT03028298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111258832|NCT03028298|Vasodilator Agents|vasodilator agents|mesh-ancestor
111258833|NCT03028298|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111258834|NCT03028298|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111258835|NCT03028298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111258836|NCT03028298|Urological Agents|urological agents|mesh-ancestor
111258837|NCT01540838|Acetaminophen|acetaminophen|mesh-list
111258838|NCT01540838|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111258839|NCT01540838|Analgesics|analgesics|mesh-ancestor
111258840|NCT01540838|Sensory System Agents|sensory system agents|mesh-ancestor
111258841|NCT01540838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111258842|NCT01540838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111258843|NCT01540838|Antipyretics|antipyretics|mesh-ancestor
111258844|NCT01451203|Certolizumab Pegol|certolizumab pegol|mesh-list
111258845|NCT01451203|Methotrexate|methotrexate|mesh-list
111258846|NCT01451203|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111258847|NCT01451203|Abortifacient Agents|abortifacient agents|mesh-ancestor
111258848|NCT01451203|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111258849|NCT01451203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111258850|NCT01451203|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111258851|NCT01451203|Antimetabolites|antimetabolites|mesh-ancestor
111258852|NCT01451203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111258853|NCT01451203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111258854|NCT01451203|Dermatologic Agents|dermatologic agents|mesh-ancestor
111258855|NCT01451203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111258856|NCT01451203|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111258857|NCT01451203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111258858|NCT01451203|Immunologic Factors|immunologic factors|mesh-ancestor
111258859|NCT01451203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111258860|NCT01451203|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110983152|NCT02290431|Glucocorticoids|glucocorticoids|mesh-ancestor
111258861|NCT01451203|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111258862|NCT01451203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111258863|NCT01556438|Dexamethasone|dexamethasone|mesh-list
111258865|NCT01556438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111258866|NCT01556438|Antiemetics|antiemetics|mesh-ancestor
111258867|NCT01556438|Autonomic Agents|autonomic agents|mesh-ancestor
111258868|NCT01556438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111258869|NCT01556438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111258870|NCT01556438|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111258871|NCT01556438|Glucocorticoids|glucocorticoids|mesh-ancestor
111258872|NCT01556438|Hormones|hormones|mesh-ancestor
111258873|NCT01556438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111258874|NCT01556438|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111258875|NCT01556438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111258876|NCT02073487|Paclitaxel|paclitaxel|mesh-list
111258877|NCT02073487|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
111258878|NCT02073487|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111258879|NCT02073487|Trastuzumab|trastuzumab|mesh-list
111258880|NCT02073487|Lapatinib|lapatinib|mesh-list
111258881|NCT02073487|Pertuzumab|pertuzumab|mesh-list
111258882|NCT02073487|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111258883|NCT02073487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111258884|NCT02073487|Tubulin Modulators|tubulin modulators|mesh-ancestor
111258885|NCT02073487|Antimitotic Agents|antimitotic agents|mesh-ancestor
111258886|NCT02073487|Mitosis Modulators|mitosis modulators|mesh-ancestor
111258887|NCT02073487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111258888|NCT02073487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111258889|NCT02073487|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111258890|NCT02073487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111258891|NCT02073487|Immunotoxins|immunotoxins|mesh-ancestor
111258892|NCT02073487|Immunoconjugates|immunoconjugates|mesh-ancestor
111258893|NCT02073487|Immunologic Factors|immunologic factors|mesh-ancestor
111258894|NCT02073487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111258895|NCT01466491|Lidocaine|lidocaine|mesh-list
111258896|NCT01466491|Anesthetics, Local|anesthetics, local|mesh-ancestor
111258897|NCT01466491|Anesthetics|anesthetics|mesh-ancestor
111258898|NCT01466491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111258899|NCT01466491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111258900|NCT01466491|Sensory System Agents|sensory system agents|mesh-ancestor
111258901|NCT01466491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111258902|NCT01466491|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111258903|NCT01466491|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111258904|NCT01466491|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111258905|NCT01466491|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111258906|NCT01466491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111258907|NCT01466179|Blinatumomab|blinatumomab|mesh-list
111258908|NCT01466179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111258909|NCT01493089|Omeprazole, sodium bicarbonate drug combination|omeprazole, sodium bicarbonate drug combination|mesh-list
111258910|NCT01493089|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111258911|NCT01493089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111258912|NCT01493089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111258913|NCT01450813|Bromides|bromides|mesh-list
111258914|NCT01450813|Rocuronium|rocuronium|mesh-list
111258915|NCT01450813|Anticonvulsants|anticonvulsants|mesh-ancestor
111258916|NCT01450813|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
111258917|NCT01450813|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
111258918|NCT01450813|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111258919|NCT01450813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111258920|NCT01450813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111258921|NCT01539512|Rituximab|rituximab|mesh-list
111258922|NCT01539512|Idelalisib|idelalisib|mesh-list
111258923|NCT01539512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111258924|NCT01539512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111258925|NCT01539512|Immunologic Factors|immunologic factors|mesh-ancestor
111258926|NCT01539512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111258927|NCT01539512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111258928|NCT01539512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111258929|NCT01539512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111258930|NCT01449955|Sirolimus|sirolimus|mesh-list
111258931|NCT01449955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111258932|NCT01449955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111258933|NCT01449955|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111258934|NCT01449955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111258935|NCT01449955|Antifungal Agents|antifungal agents|mesh-ancestor
111258936|NCT01449955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111258937|NCT01449955|Immunologic Factors|immunologic factors|mesh-ancestor
111258938|NCT01449955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111258939|NCT01574612|Acyclovir|acyclovir|mesh-list
111258940|NCT01574612|Hydrocortisone|hydrocortisone|mesh-list
111258941|NCT01574612|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111258942|NCT01574612|Antiviral Agents|antiviral agents|mesh-ancestor
111258943|NCT01574612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111258944|NCT01573910|Moxifloxacin|moxifloxacin|mesh-list
111258945|NCT01573910|Ofloxacin|ofloxacin|mesh-list
111258946|NCT01573910|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111258947|NCT01573910|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111258948|NCT01573910|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111258949|NCT01573910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111258950|NCT01573910|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111258951|NCT01573910|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111258952|NCT01573910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111258953|NCT01573910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111258954|NCT01573910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111258955|NCT01573910|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111258956|NCT01573910|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111258957|NCT01573910|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111258958|NCT01491919|Lisinopril|lisinopril|mesh-list
111258959|NCT01491919|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
111258960|NCT01491919|Protease Inhibitors|protease inhibitors|mesh-ancestor
111258961|NCT01491919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110978251|NCT05488522|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111258962|NCT01491919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111258963|NCT01491919|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111258964|NCT01491919|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111258965|NCT01491919|Protective Agents|protective agents|mesh-ancestor
111258966|NCT01491919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111258967|NCT01573442|Testosterone|testosterone|mesh-list
111258968|NCT01573442|Androgens|androgens|mesh-ancestor
111258969|NCT01573442|Hormones|hormones|mesh-ancestor
111258970|NCT01573442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111258971|NCT01573442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111258972|NCT02319369|Azacitidine|azacitidine|mesh-list
111258973|NCT02319369|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111258974|NCT02319369|Antimetabolites|antimetabolites|mesh-ancestor
111258975|NCT02319369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111258976|NCT02319369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111258977|NCT02319369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111258978|NCT01491841|Rituximab|rituximab|mesh-list
111258979|NCT01491841|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
111258980|NCT01491841|Pixantrone|pixantrone|mesh-list
111258981|NCT01491841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111258982|NCT01491841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111258983|NCT01491841|Immunologic Factors|immunologic factors|mesh-ancestor
111258984|NCT01491841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111258985|NCT01491841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111258986|NCT01491841|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111258987|NCT01491841|Alkylating Agents|alkylating agents|mesh-ancestor
111258988|NCT01491841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111258989|NCT01491841|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111258990|NCT01491841|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111258991|NCT01491841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111258992|NCT00297063|Rosiglitazone|rosiglitazone|mesh-list
111258993|NCT00297063|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111258994|NCT00297063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111258995|NCT01553318|Ketotifen|ketotifen|mesh-list
111258996|NCT01553318|Antipruritics|antipruritics|mesh-ancestor
111258997|NCT01553318|Dermatologic Agents|dermatologic agents|mesh-ancestor
111258998|NCT01553318|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111258999|NCT01553318|Histamine Antagonists|histamine antagonists|mesh-ancestor
111259000|NCT01553318|Histamine Agents|histamine agents|mesh-ancestor
111259001|NCT01553318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111259002|NCT01553318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111259003|NCT01553318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111259004|NCT01553318|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111259005|NCT01572740|Liraglutide|liraglutide|mesh-list
111259006|NCT01572740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111259007|NCT01572740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111259008|NCT01572740|Incretins|incretins|mesh-ancestor
111259009|NCT01572740|Hormones|hormones|mesh-ancestor
111259010|NCT01572740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111259011|NCT01491607|Vaccines|vaccines|mesh-list
110983299|NCT02707952|Ritonavir|ritonavir|mesh-list
111259012|NCT01491607|Immunologic Factors|immunologic factors|mesh-ancestor
111259013|NCT01491607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111259014|NCT02338713|Calcium Carbonate|calcium carbonate|mesh-list
111259015|NCT02338713|Antacids|antacids|mesh-ancestor
111259016|NCT02338713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111259017|NCT02338713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111259018|NCT00557349|Omeprazole|omeprazole|mesh-list
111259019|NCT00557349|Famotidine|famotidine|mesh-list
111259020|NCT00557349|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111259021|NCT00557349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111259022|NCT00557349|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111259023|NCT00557349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111259024|NCT00557349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111259025|NCT00557349|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
111259026|NCT00557349|Histamine Antagonists|histamine antagonists|mesh-ancestor
111259027|NCT00557349|Histamine Agents|histamine agents|mesh-ancestor
111259028|NCT00557349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111259029|NCT00557349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111259030|NCT01553084|Nicotine|nicotine|mesh-list
111259031|NCT01553084|Varenicline|varenicline|mesh-list
111259032|NCT01553084|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111259033|NCT01553084|Autonomic Agents|autonomic agents|mesh-ancestor
111259034|NCT01553084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111259035|NCT01553084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111259036|NCT01553084|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111259037|NCT01553084|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111259038|NCT01553084|Cholinergic Agents|cholinergic agents|mesh-ancestor
111259039|NCT01553084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111259040|NCT01553084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111259041|NCT01552928|Moxifloxacin|moxifloxacin|mesh-list
111259042|NCT01552928|Anagrelide|anagrelide|mesh-list
111259043|NCT01552928|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111259044|NCT01552928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111259045|NCT01552928|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111259046|NCT01552928|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111259047|NCT01552928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111259048|NCT01552928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111259049|NCT01552928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111259050|NCT01552928|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111259051|NCT01552928|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111259052|NCT01552928|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111259053|NCT01448707|Ritonavir|ritonavir|mesh-list
111259054|NCT01448707|Darunavir|darunavir|mesh-list
111259055|NCT01448707|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111259056|NCT01448707|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111259057|NCT01448707|Protease Inhibitors|protease inhibitors|mesh-ancestor
111259058|NCT01448707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111259059|NCT01448707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111259060|NCT01448707|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111259061|NCT01448707|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111259062|NCT01448707|Antiviral Agents|antiviral agents|mesh-ancestor
111259063|NCT01448707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111259064|NCT01448707|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111259065|NCT01448707|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111259066|NCT01536704|Nicotine|nicotine|mesh-list
111259067|NCT01536704|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111259068|NCT01536704|Autonomic Agents|autonomic agents|mesh-ancestor
111259069|NCT01536704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111259070|NCT01536704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111259071|NCT01536704|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111259072|NCT01536704|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111259073|NCT01536704|Cholinergic Agents|cholinergic agents|mesh-ancestor
111259074|NCT01536704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111259075|NCT01536704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111259076|NCT04108676|Fluzoparib|fluzoparib|mesh-list
111259077|NCT04108676|Omeprazole|omeprazole|mesh-list
111259078|NCT04108676|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111259079|NCT04108676|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111259080|NCT04108676|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111259081|NCT04108676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111259082|NCT04108676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111259083|NCT04108676|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111259084|NCT04108676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111259085|NCT01552772|Aripiprazole|aripiprazole|mesh-list
111259086|NCT01552772|Antidepressive Agents|antidepressive agents|mesh-ancestor
111259087|NCT01552772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111259089|NCT01552772|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111259090|NCT01552772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111259091|NCT01552772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111259092|NCT01552772|Dopamine Agonists|dopamine agonists|mesh-ancestor
111259093|NCT01552772|Dopamine Agents|dopamine agents|mesh-ancestor
111259094|NCT01552772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111259095|NCT01552772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111259096|NCT01552772|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111259097|NCT01552772|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111259098|NCT01552772|Serotonin Agents|serotonin agents|mesh-ancestor
111259099|NCT01552772|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111259100|NCT01552772|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111259101|NCT01552772|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111259102|NCT01552772|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111259103|NCT01552694|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111259104|NCT01552694|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111259105|NCT01552694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111259106|NCT01552694|Incretins|incretins|mesh-ancestor
111259107|NCT01552694|Hormones|hormones|mesh-ancestor
110978254|NCT05488522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111259108|NCT01552694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111259109|NCT01552694|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111259110|NCT01552694|Protease Inhibitors|protease inhibitors|mesh-ancestor
111259111|NCT01552694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111259112|NCT01552694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111259113|NCT01464931|Denosumab|denosumab|mesh-list
111259114|NCT01464931|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111259115|NCT01464931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111259116|NCT01536392|Ondansetron|ondansetron|mesh-list
111259117|NCT01536392|Granisetron|granisetron|mesh-list
111259118|NCT01536392|Antiemetics|antiemetics|mesh-ancestor
111259119|NCT01536392|Autonomic Agents|autonomic agents|mesh-ancestor
111259120|NCT01536392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111259121|NCT01536392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111259122|NCT01536392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111259123|NCT01536392|Antipruritics|antipruritics|mesh-ancestor
111259124|NCT01536392|Dermatologic Agents|dermatologic agents|mesh-ancestor
111259125|NCT01536392|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111259126|NCT01536392|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111259127|NCT01536392|Serotonin Agents|serotonin agents|mesh-ancestor
111259128|NCT01536392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111259129|NCT01536392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111259130|NCT04767295|Paclitaxel|paclitaxel|mesh-list
111259131|NCT04767295|Carboplatin|carboplatin|mesh-list
111259132|NCT04767295|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111259133|NCT04767295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111259134|NCT04767295|Tubulin Modulators|tubulin modulators|mesh-ancestor
111259135|NCT04767295|Antimitotic Agents|antimitotic agents|mesh-ancestor
111259136|NCT04767295|Mitosis Modulators|mitosis modulators|mesh-ancestor
111259137|NCT04767295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111259138|NCT02118831|Bevacizumab|bevacizumab|mesh-list
111259139|NCT02118831|Ranibizumab|ranibizumab|mesh-list
111259140|NCT02118831|Aflibercept|aflibercept|mesh-list
111259141|NCT02118831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111259142|NCT02118831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111259143|NCT02118831|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111259144|NCT02118831|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111259145|NCT02118831|Growth Substances|growth substances|mesh-ancestor
111259146|NCT02118831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111259147|NCT02118831|Growth Inhibitors|growth inhibitors|mesh-ancestor
111259148|NCT00490269|Dronabinol|dronabinol|mesh-list
111259149|NCT00490269|Hallucinogens|hallucinogens|mesh-ancestor
111259150|NCT00490269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111259151|NCT00490269|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111259152|NCT00490269|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111259153|NCT00490269|Analgesics|analgesics|mesh-ancestor
111259154|NCT00490269|Sensory System Agents|sensory system agents|mesh-ancestor
111259155|NCT00490269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111259156|NCT00490269|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
111259157|NCT00490269|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
111259158|NCT00490269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111259159|NCT00490269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111259160|NCT00490269|Hormones|hormones|mesh-ancestor
110983450|NCT03626753|Antipyretics|antipyretics|mesh-ancestor
111259161|NCT00490269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111259162|NCT05621499|Lenvatinib|lenvatinib|mesh-list
111259163|NCT05621499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111259164|NCT05621499|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111259165|NCT05621499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111259166|NCT05621499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111259167|NCT01490125|Glycopyrrolate|glycopyrrolate|mesh-list
111259168|NCT01490125|Albuterol|albuterol|mesh-list
111259169|NCT01490125|Tiotropium Bromide|tiotropium bromide|mesh-list
111259170|NCT01490125|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111259171|NCT01490125|Autonomic Agents|autonomic agents|mesh-ancestor
111259172|NCT01490125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111259173|NCT01490125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111259174|NCT01490125|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111259175|NCT01490125|Respiratory System Agents|respiratory system agents|mesh-ancestor
111259176|NCT01490125|Parasympatholytics|parasympatholytics|mesh-ancestor
111259177|NCT01490125|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111259178|NCT01490125|Cholinergic Agents|cholinergic agents|mesh-ancestor
111259179|NCT01490125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111259180|NCT01490125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111259181|NCT01490125|Tocolytic Agents|tocolytic agents|mesh-ancestor
111259182|NCT01490125|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111259183|NCT01490125|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111259184|NCT01490125|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111259185|NCT01490125|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111259186|NCT01490125|Adrenergic Agents|adrenergic agents|mesh-ancestor
111259187|NCT01490125|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111259188|NCT01490125|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111259189|NCT00491751|Ascorbic Acid|ascorbic acid|mesh-list
111259190|NCT00491751|Atorvastatin|atorvastatin|mesh-list
111259191|NCT00491751|Vitamins|vitamins|mesh-ancestor
111259192|NCT00491751|Micronutrients|micronutrients|mesh-ancestor
111259193|NCT00491751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111259194|NCT00491751|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111259195|NCT00491751|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111259196|NCT00491751|Antimetabolites|antimetabolites|mesh-ancestor
111259197|NCT00491751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111259198|NCT00491751|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111259199|NCT00491751|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111259200|NCT00491751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111259201|NCT00491751|Antioxidants|antioxidants|mesh-ancestor
111259202|NCT00491751|Protective Agents|protective agents|mesh-ancestor
111259203|NCT01420549|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111259204|NCT01420549|Simvastatin|simvastatin|mesh-list
111259205|NCT01420549|Ezetimibe|ezetimibe|mesh-list
111259206|NCT01420549|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111259207|NCT01420549|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111259208|NCT01420549|Antimetabolites|antimetabolites|mesh-ancestor
111259209|NCT01420549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111259210|NCT01420549|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111259211|NCT01420549|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111259212|NCT01420549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111259213|NCT01440595|Ribavirin|ribavirin|mesh-list
111259214|NCT01440595|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
111259215|NCT01440595|Grazoprevir|grazoprevir|mesh-list
111259216|NCT01440595|Antimetabolites|antimetabolites|mesh-ancestor
111259217|NCT01440595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111259218|NCT01440595|Antiviral Agents|antiviral agents|mesh-ancestor
111259219|NCT01440595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111259220|NCT05560035|Lidocaine|lidocaine|mesh-list
111259221|NCT05560035|Anesthetics, Local|anesthetics, local|mesh-ancestor
111259222|NCT05560035|Anesthetics|anesthetics|mesh-ancestor
111259223|NCT05560035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111259224|NCT05560035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111259225|NCT05560035|Sensory System Agents|sensory system agents|mesh-ancestor
111259226|NCT05560035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111259227|NCT05560035|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111259228|NCT05560035|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111259229|NCT05560035|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111259230|NCT05560035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111259231|NCT05560035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111259232|NCT00497055|Aripiprazole|aripiprazole|mesh-list
111259233|NCT00497055|Antidepressive Agents|antidepressive agents|mesh-ancestor
111259234|NCT00497055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111259235|NCT00497055|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111259236|NCT00497055|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111259237|NCT00497055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111259238|NCT00497055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111259239|NCT00497055|Dopamine Agonists|dopamine agonists|mesh-ancestor
111259240|NCT00497055|Dopamine Agents|dopamine agents|mesh-ancestor
111259241|NCT00497055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111259242|NCT00497055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111259243|NCT00497055|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111259244|NCT00497055|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111259245|NCT00497055|Serotonin Agents|serotonin agents|mesh-ancestor
111259246|NCT00497055|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111259247|NCT00497055|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111259248|NCT00497055|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111259249|NCT00497055|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111259250|NCT00498615|Fasudil|fasudil|mesh-list
111259251|NCT00498615|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111259252|NCT00498615|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111259253|NCT00498615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111259254|NCT00498615|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111259255|NCT00498615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111259256|NCT00498615|Vasodilator Agents|vasodilator agents|mesh-ancestor
111259257|NCT00498615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111259258|NCT00498615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111259259|NCT00498927|Temozolomide|temozolomide|mesh-list
111259260|NCT00498927|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111259261|NCT00498927|Alkylating Agents|alkylating agents|mesh-ancestor
111259262|NCT00498927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111259263|NCT00498927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111259264|NCT00499473|Sunitinib|sunitinib|mesh-list
111259265|NCT00499473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111259266|NCT00499473|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111259267|NCT00499473|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111259268|NCT00499473|Growth Substances|growth substances|mesh-ancestor
111259269|NCT00499473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111259270|NCT00499473|Growth Inhibitors|growth inhibitors|mesh-ancestor
111259271|NCT00499473|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111259272|NCT00499473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111259273|NCT00499473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111259274|NCT00501891|Bevacizumab|bevacizumab|mesh-list
111259275|NCT00501891|Temozolomide|temozolomide|mesh-list
111259276|NCT00501891|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111259277|NCT00501891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111259278|NCT00501891|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111259279|NCT00501891|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111259280|NCT00501891|Growth Substances|growth substances|mesh-ancestor
111259281|NCT00501891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111259282|NCT00501891|Growth Inhibitors|growth inhibitors|mesh-ancestor
111259283|NCT00501891|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111259284|NCT00501891|Alkylating Agents|alkylating agents|mesh-ancestor
111259285|NCT00501891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111259286|NCT01798017|Misoprostol|misoprostol|mesh-list
111259287|NCT01798017|Mifepristone|mifepristone|mesh-list
111259288|NCT01798017|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111259289|NCT01798017|Abortifacient Agents|abortifacient agents|mesh-ancestor
111259290|NCT01798017|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111259291|NCT01798017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111259292|NCT01798017|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111259293|NCT01798017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111259294|NCT01798017|Oxytocics|oxytocics|mesh-ancestor
111259295|NCT01798017|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
111259296|NCT01798017|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111259297|NCT01798017|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111259298|NCT01798017|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111259299|NCT01798017|Contraceptive Agents|contraceptive agents|mesh-ancestor
111259300|NCT01798017|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
111259301|NCT01798017|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
111259302|NCT01798017|Hormone Antagonists|hormone antagonists|mesh-ancestor
111259303|NCT01798017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111259304|NCT01798017|Luteolytic Agents|luteolytic agents|mesh-ancestor
111259305|NCT01798017|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111259306|NCT01798017|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
110983603|NCT02429804|Listerine|listerine|mesh-list
111259307|NCT00502905|Fludarabine|fludarabine|mesh-list
111259308|NCT00502905|Fludarabine phosphate|fludarabine phosphate|mesh-list
111259309|NCT00502905|Busulfan|busulfan|mesh-list
111259310|NCT00502905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111259311|NCT00502905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111259312|NCT00502905|Antimetabolites|antimetabolites|mesh-ancestor
111259313|NCT00502905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111259314|NCT00502905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111259315|NCT00502905|Immunologic Factors|immunologic factors|mesh-ancestor
111259316|NCT00502905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111259317|NCT00502905|Alkylating Agents|alkylating agents|mesh-ancestor
111259318|NCT00502905|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111259319|NCT00502905|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111259320|NCT05418777|Trimethoprim|trimethoprim|mesh-list
111259321|NCT05418777|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
111259322|NCT05418777|Sulfamethoxazole|sulfamethoxazole|mesh-list
110978258|NCT05492968|Phenylephrine|phenylephrine|mesh-list
111259323|NCT05418777|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111259324|NCT05418777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111259325|NCT05418777|Antimalarials|antimalarials|mesh-ancestor
111259326|NCT05418777|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111259327|NCT05418777|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111259328|NCT05418777|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111259329|NCT05418777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111259330|NCT05418777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111259331|NCT05418777|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111259332|NCT05418777|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
111259333|NCT05418777|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111259334|NCT05418777|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111259335|NCT00505635|Interferons|interferons|mesh-list
111259336|NCT00505635|Interferon-alpha|interferon-alpha|mesh-list
111259337|NCT00505635|Interferon alpha-2|interferon alpha-2|mesh-list
111259338|NCT00505635|Thalidomide|thalidomide|mesh-list
111259339|NCT00505635|Cisplatin|cisplatin|mesh-list
111259340|NCT00505635|Temozolomide|temozolomide|mesh-list
111259341|NCT00505635|Interleukin-2|interleukin-2|mesh-list
111259342|NCT00505635|Vinblastine|vinblastine|mesh-list
111259343|NCT00505635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111259344|NCT00505635|Antiviral Agents|antiviral agents|mesh-ancestor
111259345|NCT00505635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111259346|NCT00505635|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111259347|NCT00505635|Alkylating Agents|alkylating agents|mesh-ancestor
111259348|NCT00505635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111259349|NCT00505635|Immunologic Factors|immunologic factors|mesh-ancestor
111259350|NCT00505635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111259351|NCT00505635|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111259352|NCT00505635|Analgesics|analgesics|mesh-ancestor
111259353|NCT00505635|Sensory System Agents|sensory system agents|mesh-ancestor
111259354|NCT00505635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111259355|NCT00505635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111259356|NCT00505635|Leprostatic Agents|leprostatic agents|mesh-ancestor
111259357|NCT00505635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111259358|NCT00505635|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111259359|NCT00505635|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111259360|NCT00505635|Growth Substances|growth substances|mesh-ancestor
111259361|NCT00505635|Growth Inhibitors|growth inhibitors|mesh-ancestor
111259362|NCT00505635|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111259363|NCT00505635|Tubulin Modulators|tubulin modulators|mesh-ancestor
111259364|NCT00505635|Antimitotic Agents|antimitotic agents|mesh-ancestor
111259365|NCT00505635|Mitosis Modulators|mitosis modulators|mesh-ancestor
111259366|NCT01842165|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
111259367|NCT01842165|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111259368|NCT01842165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111259369|NCT04479813|Moxonidine|moxonidine|mesh-list
110983673|NCT02428946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110983674|NCT02428946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110983675|NCT02428946|Dopamine Agonists|dopamine agonists|mesh-ancestor
110983676|NCT02428946|Dopamine Agents|dopamine agents|mesh-ancestor
110983677|NCT02428946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110983678|NCT02428946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110983679|NCT02428868|Tranexamic Acid|tranexamic acid|mesh-list
110983680|NCT02428868|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110983681|NCT02428868|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110983682|NCT02428868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111259370|NCT04479813|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111259371|NCT04474899|Amlodipine|amlodipine|mesh-list
111259372|NCT04474899|Moxonidine|moxonidine|mesh-list
111259373|NCT04474899|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111259374|NCT04474899|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111259375|NCT04474899|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111259376|NCT04474899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111259377|NCT04474899|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111259378|NCT04474899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111259379|NCT04474899|Vasodilator Agents|vasodilator agents|mesh-ancestor
111259380|NCT00511173|Warfarin|warfarin|mesh-list
111259381|NCT00511173|Anticoagulants|anticoagulants|mesh-ancestor
111259382|NCT01447927|Metformin|metformin|mesh-list
111259383|NCT01447927|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111259384|NCT01447927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111259385|NCT04037397|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
111259386|NCT00513747|Rituximab|rituximab|mesh-list
111259387|NCT00513747|Fludarabine|fludarabine|mesh-list
111259388|NCT00513747|Fludarabine phosphate|fludarabine phosphate|mesh-list
111259389|NCT00513747|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111259390|NCT00513747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111259391|NCT00513747|Immunologic Factors|immunologic factors|mesh-ancestor
111259392|NCT00513747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111259393|NCT00513747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111259394|NCT00513747|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111259395|NCT00513747|Antimetabolites|antimetabolites|mesh-ancestor
111259396|NCT00513747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111259397|NCT00513747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111259398|NCT00514137|Sunitinib|sunitinib|mesh-list
111259399|NCT00514137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111259400|NCT00514137|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111259401|NCT00514137|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111259402|NCT00514137|Growth Substances|growth substances|mesh-ancestor
111259403|NCT00514137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111259404|NCT00514137|Growth Inhibitors|growth inhibitors|mesh-ancestor
111259405|NCT00514137|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111259406|NCT00514137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111259407|NCT00514137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111259408|NCT00514215|Molgramostim|molgramostim|mesh-list
111259409|NCT00514215|Sargramostim|sargramostim|mesh-list
111259410|NCT00514215|Immunologic Factors|immunologic factors|mesh-ancestor
111259411|NCT00514215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111259412|NCT00514215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111259413|NCT03912909|Empagliflozin|empagliflozin|mesh-list
111259414|NCT03912909|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111259415|NCT03912909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111259416|NCT03912909|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111259417|NCT03912909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111259418|NCT02130063|Iron|iron|mesh-list
111259419|NCT02130063|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
111259420|NCT02130063|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
111259421|NCT02130063|Trace Elements|trace elements|mesh-ancestor
111259422|NCT02130063|Micronutrients|micronutrients|mesh-ancestor
111259423|NCT02130063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111259424|NCT02130063|Hematinics|hematinics|mesh-ancestor
111259425|NCT00515697|Ramucirumab|ramucirumab|mesh-list
111259426|NCT00515697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111259427|NCT00516165|Everolimus|everolimus|mesh-list
111259428|NCT00516165|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111259429|NCT00516165|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111259430|NCT00516165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111259431|NCT00516165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111259432|NCT00516165|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111259433|NCT00516165|Immunologic Factors|immunologic factors|mesh-ancestor
111259434|NCT00516165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111259435|NCT00516165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111259436|NCT03631173|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111259437|NCT03631173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111259438|NCT03419481|Pembrolizumab|pembrolizumab|mesh-list
111259439|NCT03419481|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111259440|NCT03419481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111259441|NCT03419481|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111259442|NCT03419481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111259443|NCT02132169|Cetirizine|cetirizine|mesh-list
111259444|NCT02132169|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111259445|NCT02132169|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110983746|NCT02427932|Gentamicins|gentamicins|mesh-list
111259446|NCT02132169|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111259447|NCT02132169|Histamine Antagonists|histamine antagonists|mesh-ancestor
111259448|NCT02132169|Histamine Agents|histamine agents|mesh-ancestor
111259449|NCT02132169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111259450|NCT02132169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111259451|NCT02132169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111259452|NCT03174405|Avelumab|avelumab|mesh-list
111259453|NCT03174405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111259454|NCT03174405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111259455|NCT00522795|Paclitaxel|paclitaxel|mesh-list
111259456|NCT00522795|Cisplatin|cisplatin|mesh-list
111259457|NCT00522795|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
111259458|NCT00522795|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111259459|NCT00522795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110978260|NCT05492968|Oxymetazoline|oxymetazoline|mesh-list
111259460|NCT00522795|Tubulin Modulators|tubulin modulators|mesh-ancestor
111259461|NCT00522795|Antimitotic Agents|antimitotic agents|mesh-ancestor
111259462|NCT00522795|Mitosis Modulators|mitosis modulators|mesh-ancestor
111259463|NCT00522795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111259464|NCT02871687|Simvastatin|simvastatin|mesh-list
111259465|NCT02871687|Pravastatin|pravastatin|mesh-list
111259466|NCT02871687|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111259467|NCT02871687|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111259468|NCT02871687|Antimetabolites|antimetabolites|mesh-ancestor
111259469|NCT02871687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111259470|NCT02871687|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111259471|NCT02871687|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111259472|NCT02871687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111259473|NCT00525057|Dalteparin|dalteparin|mesh-list
111259474|NCT00525057|Tinzaparin|tinzaparin|mesh-list
111259475|NCT00525057|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
111259476|NCT00525057|Anticoagulants|anticoagulants|mesh-ancestor
111259477|NCT00525057|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111259478|NCT00525057|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111259479|NCT00525057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111259480|NCT00525135|Valproic Acid|valproic acid|mesh-list
111259481|NCT00525135|Anticonvulsants|anticonvulsants|mesh-ancestor
111259482|NCT00525135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111259483|NCT00525135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111259484|NCT00525135|GABA Agents|gaba agents|mesh-ancestor
111259485|NCT00525135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111259486|NCT00525135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111259487|NCT00525135|Antimanic Agents|antimanic agents|mesh-ancestor
111259488|NCT00525135|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111259489|NCT00525135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111259490|NCT00525135|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111259491|NCT00525525|Bevacizumab|bevacizumab|mesh-list
111259492|NCT00525525|Temozolomide|temozolomide|mesh-list
111259493|NCT00525525|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111259494|NCT00525525|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111259495|NCT00525525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111259496|NCT00525525|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111259497|NCT00525525|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111259498|NCT00525525|Growth Substances|growth substances|mesh-ancestor
111259499|NCT00525525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111259500|NCT00525525|Growth Inhibitors|growth inhibitors|mesh-ancestor
111259501|NCT00525525|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111259502|NCT00525525|Alkylating Agents|alkylating agents|mesh-ancestor
111259503|NCT00525525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111259504|NCT00525525|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111259505|NCT00525525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111259506|NCT00525603|Cyclophosphamide|cyclophosphamide|mesh-list
111259507|NCT00525603|Rituximab|rituximab|mesh-list
111259508|NCT00525603|Fludarabine|fludarabine|mesh-list
111259509|NCT00525603|Fludarabine phosphate|fludarabine phosphate|mesh-list
111259510|NCT00525603|Alemtuzumab|alemtuzumab|mesh-list
111259511|NCT00525603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111259512|NCT00525603|Immunologic Factors|immunologic factors|mesh-ancestor
111259513|NCT00525603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111259514|NCT00525603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111259515|NCT00525603|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111259516|NCT00525603|Alkylating Agents|alkylating agents|mesh-ancestor
111259517|NCT00525603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111259518|NCT00525603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111259519|NCT00525603|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111259520|NCT00525603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111259521|NCT00525603|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111259522|NCT00525603|Antimetabolites|antimetabolites|mesh-ancestor
111259523|NCT00398307|Cisplatin|cisplatin|mesh-list
111259524|NCT00398307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111259525|NCT00564447|Azithromycin|azithromycin|mesh-list
111259526|NCT00564447|Moxifloxacin|moxifloxacin|mesh-list
111259527|NCT00564447|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111259528|NCT00564447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111259529|NCT00564447|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111259530|NCT00564447|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111259531|NCT00564447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110978262|NCT05492968|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111259532|NCT00564447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111259533|NCT00564447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111259534|NCT00564681|Botulinum Toxins|botulinum toxins|mesh-list
111259535|NCT00564681|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111259536|NCT00564681|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111259537|NCT00564681|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111259538|NCT00564681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111259539|NCT00564681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111259540|NCT00564681|Cholinergic Agents|cholinergic agents|mesh-ancestor
111259541|NCT00564681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111259542|NCT00564681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111259543|NCT00564681|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111259544|NCT00564681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111259545|NCT00525837|Varenicline|varenicline|mesh-list
111259546|NCT00525837|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111259547|NCT00525837|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111259548|NCT00525837|Cholinergic Agents|cholinergic agents|mesh-ancestor
111259549|NCT00525837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111259550|NCT00525837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111259551|NCT00525837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111259552|NCT00527475|Ranibizumab|ranibizumab|mesh-list
111259553|NCT00527475|Verteporfin|verteporfin|mesh-list
111259554|NCT00527475|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111259555|NCT00527475|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111259556|NCT00527475|Growth Substances|growth substances|mesh-ancestor
111259557|NCT00527475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111259558|NCT00527475|Growth Inhibitors|growth inhibitors|mesh-ancestor
111259559|NCT00527475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111259560|NCT00527475|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111259561|NCT00527475|Dermatologic Agents|dermatologic agents|mesh-ancestor
111259562|NCT01798251|Capecitabine|capecitabine|mesh-list
111259563|NCT01798251|Oxaliplatin|oxaliplatin|mesh-list
111259564|NCT01798251|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111259565|NCT01798251|Antimetabolites|antimetabolites|mesh-ancestor
111259566|NCT01798251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111259567|NCT01798251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111259568|NCT02121483|Empagliflozin|empagliflozin|mesh-list
111259569|NCT02121483|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111259570|NCT02121483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111259571|NCT02121483|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111259572|NCT02121483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111259573|NCT01572038|Paclitaxel|paclitaxel|mesh-list
111259574|NCT01572038|Docetaxel|docetaxel|mesh-list
111259575|NCT01572038|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111259576|NCT01572038|Trastuzumab|trastuzumab|mesh-list
111259577|NCT01572038|Pertuzumab|pertuzumab|mesh-list
111259578|NCT01572038|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111259579|NCT01572038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111259580|NCT01572038|Tubulin Modulators|tubulin modulators|mesh-ancestor
111259581|NCT01572038|Antimitotic Agents|antimitotic agents|mesh-ancestor
111259582|NCT01572038|Mitosis Modulators|mitosis modulators|mesh-ancestor
111259583|NCT01572038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111259584|NCT01572038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111259585|NCT01448213|Fluorometholone|fluorometholone|mesh-list
111259586|NCT01448213|Prednisolone|prednisolone|mesh-list
111259587|NCT01448213|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111259588|NCT01448213|Methylprednisolone|methylprednisolone|mesh-list
111259589|NCT01448213|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111259590|NCT01448213|Prednisolone acetate|prednisolone acetate|mesh-list
111259591|NCT01448213|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111259592|NCT01448213|Prednisolone phosphate|prednisolone phosphate|mesh-list
111259593|NCT01448213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111259594|NCT01448213|Glucocorticoids|glucocorticoids|mesh-ancestor
111259595|NCT01448213|Hormones|hormones|mesh-ancestor
110959166|NCT05681182|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111259596|NCT01448213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111259597|NCT01448213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111259598|NCT01448213|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111259599|NCT01448213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111259600|NCT01448213|Antiemetics|antiemetics|mesh-ancestor
111259601|NCT01448213|Autonomic Agents|autonomic agents|mesh-ancestor
111259602|NCT01448213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111259603|NCT01448213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111259604|NCT01448213|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111259605|NCT01448213|Protective Agents|protective agents|mesh-ancestor
111259606|NCT01448213|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111259607|NCT01448057|Acetaminophen|acetaminophen|mesh-list
111259608|NCT01448057|Dimethindene|dimethindene|mesh-list
111259609|NCT01448057|Phenylephrine|phenylephrine|mesh-list
111259610|NCT01448057|Oxymetazoline|oxymetazoline|mesh-list
111259611|NCT01448057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111259612|NCT01448057|Analgesics|analgesics|mesh-ancestor
111259613|NCT01448057|Sensory System Agents|sensory system agents|mesh-ancestor
111259614|NCT01448057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111259615|NCT01448057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111259616|NCT01448057|Antipyretics|antipyretics|mesh-ancestor
111259617|NCT01448057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111259618|NCT01448057|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111259619|NCT01448057|Mydriatics|mydriatics|mesh-ancestor
111259620|NCT01448057|Autonomic Agents|autonomic agents|mesh-ancestor
111259621|NCT01448057|Sympathomimetics|sympathomimetics|mesh-ancestor
111259622|NCT01448057|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111259623|NCT01448057|Nasal Decongestants|nasal decongestants|mesh-ancestor
111259624|NCT01448057|Respiratory System Agents|respiratory system agents|mesh-ancestor
111259625|NCT01448057|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111259626|NCT01448057|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111259627|NCT01448057|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111259628|NCT01448057|Adrenergic Agents|adrenergic agents|mesh-ancestor
111259629|NCT01448057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111259630|NCT01448057|Protective Agents|protective agents|mesh-ancestor
111259631|NCT01448057|Antipruritics|antipruritics|mesh-ancestor
111259632|NCT01448057|Dermatologic Agents|dermatologic agents|mesh-ancestor
111259633|NCT01448057|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111259634|NCT01448057|Histamine Antagonists|histamine antagonists|mesh-ancestor
111259635|NCT01448057|Histamine Agents|histamine agents|mesh-ancestor
111259636|NCT01448057|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111259637|NCT05246631|Dexamethasone|dexamethasone|mesh-list
111259638|NCT05246631|Dexamethasone acetate|dexamethasone acetate|mesh-list
111259639|NCT05246631|Haloperidol|haloperidol|mesh-list
111259640|NCT05246631|Haloperidol decanoate|haloperidol decanoate|mesh-list
111259641|NCT05246631|BB 1101|bb 1101|mesh-list
111259642|NCT05246631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111259643|NCT05246631|Antiemetics|antiemetics|mesh-ancestor
111259644|NCT05246631|Autonomic Agents|autonomic agents|mesh-ancestor
111259645|NCT05246631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111259646|NCT05246631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111259647|NCT05246631|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111259648|NCT05246631|Glucocorticoids|glucocorticoids|mesh-ancestor
111259649|NCT05246631|Hormones|hormones|mesh-ancestor
111259650|NCT05246631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111259651|NCT05246631|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111259652|NCT05246631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111259653|NCT05246631|Protease Inhibitors|protease inhibitors|mesh-ancestor
111259654|NCT05246631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111259655|NCT05246631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111259656|NCT05246631|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111259657|NCT05246631|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111259658|NCT05246631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111259659|NCT05246631|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111259660|NCT05246631|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111259661|NCT05246631|Dopamine Agents|dopamine agents|mesh-ancestor
111259662|NCT05246631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111259663|NCT05246631|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111259664|NCT01447433|Calcium Carbonate|calcium carbonate|mesh-list
111259665|NCT01447433|Calcium|calcium|mesh-list
111259666|NCT01447433|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111259667|NCT01447433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111259668|NCT01447433|Antacids|antacids|mesh-ancestor
111259669|NCT01447433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111259670|NCT01447433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111259671|NCT01798875|Metformin|metformin|mesh-list
111259672|NCT01798875|Contraceptive Agents|contraceptive agents|mesh-list
111259673|NCT01798875|Contraceptives, Oral|contraceptives, oral|mesh-list
111259674|NCT01798875|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111259675|NCT01798875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111259676|NCT01798875|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111259677|NCT01798875|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111259678|NCT05362851|Celecoxib|celecoxib|mesh-list
111259679|NCT05362851|Tramadol|tramadol|mesh-list
111259680|NCT05362851|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111259681|NCT05362851|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111259682|NCT05362851|Analgesics|analgesics|mesh-ancestor
111259683|NCT05362851|Sensory System Agents|sensory system agents|mesh-ancestor
111259684|NCT05362851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111259685|NCT05362851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111259686|NCT05362851|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111259687|NCT05362851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111259688|NCT05362851|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111259689|NCT05362851|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111259690|NCT05362851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111259691|NCT05362851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111259692|NCT05362851|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111259693|NCT05362851|Narcotics|narcotics|mesh-ancestor
111259694|NCT05362851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111259695|NCT04408235|Enoxaparin|enoxaparin|mesh-list
111259696|NCT04408235|Anticoagulants|anticoagulants|mesh-ancestor
111259697|NCT04408235|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111259698|NCT04408235|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111259699|NCT04408235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111259700|NCT01446809|Doxorubicin|doxorubicin|mesh-list
111259701|NCT01446809|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111259702|NCT01446809|Ifosfamide|ifosfamide|mesh-list
111259703|NCT01446809|Isophosphamide mustard|isophosphamide mustard|mesh-list
111259704|NCT01446809|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111259705|NCT01446809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111259706|NCT01446809|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111259707|NCT01446809|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111259708|NCT01446809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111259709|NCT01446809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111259710|NCT01446809|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111259711|NCT01446809|Alkylating Agents|alkylating agents|mesh-ancestor
111259712|NCT03357159|Cyclophosphamide|cyclophosphamide|mesh-list
111259713|NCT03357159|Antilymphocyte Serum|antilymphocyte serum|mesh-list
111259714|NCT03357159|Immunoglobulins|immunoglobulins|mesh-list
111259715|NCT03357159|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111259716|NCT03357159|Antibodies|antibodies|mesh-list
111259717|NCT03357159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111259718|NCT03357159|Immunologic Factors|immunologic factors|mesh-ancestor
111259719|NCT03357159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111259720|NCT03357159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111259721|NCT03357159|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111259722|NCT03357159|Alkylating Agents|alkylating agents|mesh-ancestor
111259723|NCT03357159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111259724|NCT03357159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111259725|NCT03357159|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111259726|NCT04387929|Antibodies|antibodies|mesh-list
111259727|NCT04387929|Immunologic Factors|immunologic factors|mesh-ancestor
111259728|NCT04387929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111259729|NCT05361291|Dexamethasone|dexamethasone|mesh-list
111259730|NCT05361291|Lidocaine|lidocaine|mesh-list
111259731|NCT05361291|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111259732|NCT05361291|Antiemetics|antiemetics|mesh-ancestor
111259733|NCT05361291|Autonomic Agents|autonomic agents|mesh-ancestor
111259734|NCT05361291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111259735|NCT05361291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111259736|NCT05361291|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111259737|NCT05361291|Glucocorticoids|glucocorticoids|mesh-ancestor
111259738|NCT05361291|Hormones|hormones|mesh-ancestor
111259739|NCT05361291|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111259740|NCT05361291|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111259741|NCT05361291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111259742|NCT05361291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111259743|NCT05361291|Anesthetics, Local|anesthetics, local|mesh-ancestor
111259744|NCT05361291|Anesthetics|anesthetics|mesh-ancestor
111259745|NCT05361291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111259746|NCT05361291|Sensory System Agents|sensory system agents|mesh-ancestor
111259747|NCT05361291|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111259748|NCT05361291|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111259749|NCT05361291|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111259750|NCT05361291|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111259751|NCT01445951|Insulin|insulin|mesh-list
111259752|NCT01445951|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111259753|NCT01445951|Insulin Aspart|insulin aspart|mesh-list
111259754|NCT01445951|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111259755|NCT01445951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111259756|NCT03169101|Nicotine|nicotine|mesh-list
111259757|NCT03169101|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111259758|NCT03169101|Autonomic Agents|autonomic agents|mesh-ancestor
111259759|NCT03169101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111259760|NCT03169101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111259761|NCT03169101|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111259762|NCT03169101|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111259763|NCT03169101|Cholinergic Agents|cholinergic agents|mesh-ancestor
111259764|NCT03169101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111259765|NCT03169101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111259766|NCT05219877|Levofloxacin|levofloxacin|mesh-list
111259767|NCT05219877|Ofloxacin|ofloxacin|mesh-list
111259768|NCT05219877|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111259769|NCT05219877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111259770|NCT05219877|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111259771|NCT05219877|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111259772|NCT05219877|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111259773|NCT05219877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111259774|NCT05219877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111259775|NCT05219877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111259776|NCT05219877|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111259777|NCT05219877|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111259778|NCT00513435|Saracatinib|saracatinib|mesh-list
111259779|NCT00513435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111259780|NCT00513435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111259781|NCT00513435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111259782|NCT05214339|Bevacizumab|bevacizumab|mesh-list
111259783|NCT05214339|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111259784|NCT05214339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111259785|NCT05214339|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111259786|NCT05214339|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111259787|NCT05214339|Growth Substances|growth substances|mesh-ancestor
111259788|NCT05214339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111259789|NCT05214339|Growth Inhibitors|growth inhibitors|mesh-ancestor
111259790|NCT01444781|Vaccines|vaccines|mesh-list
111259791|NCT01444781|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
111259792|NCT01444781|Immunologic Factors|immunologic factors|mesh-ancestor
111259793|NCT01444781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111259794|NCT02431845|Fluoxetine|fluoxetine|mesh-list
111259795|NCT02431845|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111259796|NCT02431845|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111259797|NCT02431845|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111259798|NCT02431845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111259799|NCT02431845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111259800|NCT02431845|Serotonin Agents|serotonin agents|mesh-ancestor
111259801|NCT02431845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111259802|NCT02431845|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111259803|NCT02431845|Antidepressive Agents|antidepressive agents|mesh-ancestor
111259804|NCT02431845|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111259805|NCT02431845|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111259806|NCT02431845|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111259807|NCT02431845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111259808|NCT01443923|Interferons|interferons|mesh-list
111259809|NCT01443923|Ribavirin|ribavirin|mesh-list
111259810|NCT01443923|Interferon-alpha|interferon-alpha|mesh-list
111259811|NCT01443923|Interferon alpha-2|interferon alpha-2|mesh-list
111259812|NCT01443923|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
111259813|NCT01443923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111259814|NCT01443923|Antiviral Agents|antiviral agents|mesh-ancestor
111259815|NCT01443923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111259816|NCT01443923|Antimetabolites|antimetabolites|mesh-ancestor
111259817|NCT01443923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111259818|NCT01443923|Immunologic Factors|immunologic factors|mesh-ancestor
111259819|NCT01443923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111259820|NCT00569673|Docetaxel|docetaxel|mesh-list
111259821|NCT00569673|Trabectedin|trabectedin|mesh-list
111259822|NCT00569673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111259823|NCT00569673|Tubulin Modulators|tubulin modulators|mesh-ancestor
111259824|NCT00569673|Antimitotic Agents|antimitotic agents|mesh-ancestor
111259825|NCT00569673|Mitosis Modulators|mitosis modulators|mesh-ancestor
111259826|NCT00569673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111259827|NCT00569673|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111259828|NCT00569673|Alkylating Agents|alkylating agents|mesh-ancestor
111259830|NCT01551212|Tacrolimus|tacrolimus|mesh-list
111259831|NCT01551212|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111259832|NCT01551212|Immunologic Factors|immunologic factors|mesh-ancestor
111259833|NCT01551212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111259834|NCT01551212|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111259835|NCT01551212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111259836|NCT01551212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111259837|NCT01551212|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111259838|NCT01551212|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111259839|NCT01551212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111259840|NCT00573261|Pregabalin|pregabalin|mesh-list
111259841|NCT00573261|Analgesics|analgesics|mesh-ancestor
111259842|NCT00573261|Sensory System Agents|sensory system agents|mesh-ancestor
111259843|NCT00573261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111259844|NCT00573261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111259845|NCT00573261|Anticonvulsants|anticonvulsants|mesh-ancestor
111259846|NCT00573261|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111259847|NCT00573261|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111259848|NCT00573261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111259849|NCT00573261|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111259850|NCT00573261|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111259851|NCT00573261|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111259852|NCT00573261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111259853|NCT00573261|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111259854|NCT04268199|Bortezomib|bortezomib|mesh-list
111259855|NCT04268199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111259856|NCT04514211|Propofol|propofol|mesh-list
111259857|NCT04514211|Sevoflurane|sevoflurane|mesh-list
111259858|NCT04514211|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111259859|NCT04514211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111259860|NCT04514211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111259861|NCT04514211|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111259862|NCT04514211|Anesthetics, General|anesthetics, general|mesh-ancestor
111259863|NCT04514211|Anesthetics|anesthetics|mesh-ancestor
111259864|NCT04514211|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111259865|NCT04514211|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111259866|NCT00574197|Mycophenolic Acid|mycophenolic acid|mesh-list
111259867|NCT00574197|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111259868|NCT00574197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111259869|NCT00574197|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111259870|NCT00574197|Antitubercular Agents|antitubercular agents|mesh-ancestor
111259871|NCT00574197|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111259872|NCT00574197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111259873|NCT00574197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111259874|NCT00574197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111259875|NCT00574587|Paclitaxel|paclitaxel|mesh-list
111259876|NCT00574587|Cyclophosphamide|cyclophosphamide|mesh-list
111259877|NCT00574587|Doxorubicin|doxorubicin|mesh-list
111259878|NCT00574587|Trastuzumab|trastuzumab|mesh-list
111259879|NCT00574587|Vorinostat|vorinostat|mesh-list
111259880|NCT00574587|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111259881|NCT00574587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111259882|NCT00574587|Tubulin Modulators|tubulin modulators|mesh-ancestor
111259883|NCT00574587|Antimitotic Agents|antimitotic agents|mesh-ancestor
111259884|NCT00574587|Mitosis Modulators|mitosis modulators|mesh-ancestor
111259885|NCT00574587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111259886|NCT00574587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111259887|NCT00574587|Immunologic Factors|immunologic factors|mesh-ancestor
111259888|NCT00574587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111259889|NCT00574587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111259890|NCT00574587|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111259891|NCT00574587|Alkylating Agents|alkylating agents|mesh-ancestor
111259892|NCT00574587|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111259893|NCT00574587|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111259894|NCT00574587|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111259895|NCT00574587|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111259896|NCT00574587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111259897|NCT00574587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111259898|NCT00574587|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111259899|NCT00603993|Adalimumab|adalimumab|mesh-list
111259900|NCT00603993|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111259901|NCT00603993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111259902|NCT00603993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111259903|NCT00575367|Azithromycin|azithromycin|mesh-list
111259904|NCT00575367|Moxifloxacin|moxifloxacin|mesh-list
111259905|NCT00575367|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111259906|NCT00575367|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111259907|NCT00575367|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
111259908|NCT00575367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111259909|NCT00575367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111259910|NCT00575367|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111259911|NCT00575367|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111259912|NCT00575367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111259913|NCT00575367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111259914|NCT00575367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111259915|NCT00575367|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111259916|NCT00575367|Contraceptive Agents|contraceptive agents|mesh-ancestor
111259917|NCT00575367|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111259918|NCT00575367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111259919|NCT00575367|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
111259920|NCT00575367|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111259921|NCT00575367|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111259922|NCT00604461|Bevacizumab|bevacizumab|mesh-list
111259923|NCT00604461|Carboplatin|carboplatin|mesh-list
111259924|NCT00604461|Pemetrexed|pemetrexed|mesh-list
111259925|NCT00604461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111259926|NCT00604461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111259927|NCT00604461|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111259928|NCT00604461|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111259929|NCT00604461|Growth Substances|growth substances|mesh-ancestor
111259930|NCT00604461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111259931|NCT00604461|Growth Inhibitors|growth inhibitors|mesh-ancestor
111259932|NCT00604461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111259933|NCT00604461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111259934|NCT00604461|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111259935|NCT00604461|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111259936|NCT04417569|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
111259937|NCT04417569|Estradiol|estradiol|mesh-list
111259938|NCT04417569|Progesterone|progesterone|mesh-list
111259939|NCT04417569|Hormones|hormones|mesh-ancestor
111259940|NCT04417569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111259941|NCT04417569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111259942|NCT04417569|Estrogens|estrogens|mesh-ancestor
111259943|NCT04417569|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111259944|NCT04417569|Progestins|progestins|mesh-ancestor
111259945|NCT01550744|Ustekinumab|ustekinumab|mesh-list
111259946|NCT01550744|Dermatologic Agents|dermatologic agents|mesh-ancestor
111259947|NCT00606489|Ibuprofen|ibuprofen|mesh-list
111259948|NCT00606489|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111259949|NCT00606489|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111259950|NCT00606489|Analgesics|analgesics|mesh-ancestor
111259951|NCT00606489|Sensory System Agents|sensory system agents|mesh-ancestor
111259952|NCT00606489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111259953|NCT00606489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111259954|NCT00606489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111259955|NCT00606489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111259956|NCT00606489|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111259957|NCT00606489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111259958|NCT00606489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111259959|NCT00578331|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
111259960|NCT00578331|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111259961|NCT00578331|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111259962|NCT00578331|Analgesics|analgesics|mesh-ancestor
111259963|NCT00578331|Sensory System Agents|sensory system agents|mesh-ancestor
111259964|NCT00578331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111259965|NCT00578331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111259966|NCT00578331|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111259967|NCT00578331|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111259968|NCT00578331|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110712072|NCT00058552|Pertuzumab|pertuzumab|mesh-list
111259969|NCT00578331|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110984280|NCT02416388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111259970|NCT00578331|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111259971|NCT00578331|Histamine Antagonists|histamine antagonists|mesh-ancestor
111259972|NCT00578331|Histamine Agents|histamine agents|mesh-ancestor
111259973|NCT00578331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111259974|NCT00578331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111259975|NCT00607113|Bevacizumab|bevacizumab|mesh-list
111259976|NCT00607113|Everolimus|everolimus|mesh-list
111259977|NCT00607113|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111259978|NCT00607113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111259979|NCT00607113|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111259980|NCT00607113|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111259981|NCT00607113|Growth Substances|growth substances|mesh-ancestor
111259982|NCT00607113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111259983|NCT00607113|Growth Inhibitors|growth inhibitors|mesh-ancestor
111259984|NCT00607113|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111259985|NCT00607113|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111259986|NCT00607113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111259987|NCT00607113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111259988|NCT00607113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111259989|NCT00607113|Immunologic Factors|immunologic factors|mesh-ancestor
111259990|NCT01549964|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111259991|NCT01549964|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111259992|NCT01549964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111259993|NCT01549964|Incretins|incretins|mesh-ancestor
111259994|NCT01549964|Hormones|hormones|mesh-ancestor
111259995|NCT01549964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111259996|NCT01549964|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111259997|NCT01549964|Protease Inhibitors|protease inhibitors|mesh-ancestor
111259998|NCT01549964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111259999|NCT01549964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111260000|NCT00579111|Fludarabine|fludarabine|mesh-list
111260001|NCT00579111|Busulfan|busulfan|mesh-list
111260002|NCT00579111|Alemtuzumab|alemtuzumab|mesh-list
111260003|NCT00579111|Tacrolimus|tacrolimus|mesh-list
111260004|NCT00579111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111260005|NCT00579111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111260006|NCT00579111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111260007|NCT00579111|Immunologic Factors|immunologic factors|mesh-ancestor
111260008|NCT00579111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111260009|NCT00579111|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111260010|NCT00579111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111260011|NCT00579111|Alkylating Agents|alkylating agents|mesh-ancestor
111260012|NCT00579111|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111260013|NCT00579111|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111260014|NCT00579111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111260015|NCT04363437|Colchicine|colchicine|mesh-list
111260016|NCT04363437|Gout Suppressants|gout suppressants|mesh-ancestor
111260017|NCT04363437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111260018|NCT04363437|Tubulin Modulators|tubulin modulators|mesh-ancestor
111260019|NCT04363437|Antimitotic Agents|antimitotic agents|mesh-ancestor
111260020|NCT04363437|Mitosis Modulators|mitosis modulators|mesh-ancestor
111260021|NCT04363437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111260022|NCT04363437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111260023|NCT01570244|Levonorgestrel|levonorgestrel|mesh-list
111260024|NCT01570244|Ethinyl Estradiol|ethinyl estradiol|mesh-list
111260025|NCT01570244|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111260026|NCT01570244|Contraceptive Agents|contraceptive agents|mesh-ancestor
111260027|NCT01570244|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111260028|NCT01570244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111260029|NCT01570244|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111260030|NCT01570244|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111260031|NCT01570244|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111260032|NCT01570244|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111260033|NCT01570244|Estrogens|estrogens|mesh-ancestor
111260034|NCT01570244|Hormones|hormones|mesh-ancestor
111260035|NCT01570244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111260036|NCT00579813|Pioglitazone|pioglitazone|mesh-list
111260037|NCT00579813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111260038|NCT00579813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111260039|NCT01549886|Rituximab|rituximab|mesh-list
111260040|NCT01549886|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111260041|NCT01549886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111260042|NCT01549886|Immunologic Factors|immunologic factors|mesh-ancestor
111260043|NCT01549886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111260044|NCT01549886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111260045|NCT00610311|Aldesleukin|aldesleukin|mesh-list
111260046|NCT00610311|Cyclophosphamide|cyclophosphamide|mesh-list
111260047|NCT00610311|Fludarabine|fludarabine|mesh-list
111260048|NCT00610311|Fludarabine phosphate|fludarabine phosphate|mesh-list
111260049|NCT00610311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111260050|NCT00610311|Immunologic Factors|immunologic factors|mesh-ancestor
111260051|NCT00610311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111260052|NCT00610311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111260053|NCT00610311|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111260054|NCT00610311|Alkylating Agents|alkylating agents|mesh-ancestor
111260055|NCT00610311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111260056|NCT00610311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111260057|NCT00610311|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111260058|NCT00610311|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111260059|NCT00610311|Antimetabolites|antimetabolites|mesh-ancestor
111260060|NCT00610311|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111260061|NCT00610311|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111260062|NCT00610311|Antiviral Agents|antiviral agents|mesh-ancestor
111260063|NCT00610311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111260064|NCT00581061|Solifenacin Succinate|solifenacin succinate|mesh-list
111260065|NCT00581061|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111260066|NCT00581061|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111260067|NCT00581061|Cholinergic Agents|cholinergic agents|mesh-ancestor
111260068|NCT00581061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111260069|NCT00581061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111260070|NCT00581061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111260071|NCT00581061|Urological Agents|urological agents|mesh-ancestor
111260072|NCT01549652|Morphine|morphine|mesh-list
111260073|NCT01549652|Ondansetron|ondansetron|mesh-list
111260074|NCT01549652|Naloxone|naloxone|mesh-list
111260075|NCT01549652|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111260076|NCT01549652|Narcotics|narcotics|mesh-ancestor
111260077|NCT01549652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111260078|NCT01549652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111260079|NCT01549652|Analgesics|analgesics|mesh-ancestor
111260080|NCT01549652|Sensory System Agents|sensory system agents|mesh-ancestor
111260081|NCT01549652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111260082|NCT01549652|Antiemetics|antiemetics|mesh-ancestor
111260083|NCT01549652|Autonomic Agents|autonomic agents|mesh-ancestor
111260084|NCT01549652|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111260085|NCT01549652|Antipruritics|antipruritics|mesh-ancestor
111260086|NCT01549652|Dermatologic Agents|dermatologic agents|mesh-ancestor
111260087|NCT01549652|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111260088|NCT01549652|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111260089|NCT01549652|Serotonin Agents|serotonin agents|mesh-ancestor
111260090|NCT01549652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111260091|NCT01549652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111260092|NCT01549652|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111260093|NCT01569464|Rotigotine|rotigotine|mesh-list
111260094|NCT01569464|Dopamine Agonists|dopamine agonists|mesh-ancestor
111260095|NCT01569464|Dopamine Agents|dopamine agents|mesh-ancestor
111260096|NCT01569464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111260097|NCT01569464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111260098|NCT01569464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111260099|NCT01534520|Lidocaine|lidocaine|mesh-list
111260100|NCT01534520|Anesthetics, Local|anesthetics, local|mesh-ancestor
111260101|NCT01534520|Anesthetics|anesthetics|mesh-ancestor
111260102|NCT01534520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111260103|NCT01534520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111260104|NCT01534520|Sensory System Agents|sensory system agents|mesh-ancestor
111260105|NCT01534520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111260106|NCT01534520|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111260107|NCT01534520|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111260108|NCT01534520|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111260109|NCT01534520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111260110|NCT01534520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111260111|NCT00611325|Bevacizumab|bevacizumab|mesh-list
111260112|NCT00611325|Bortezomib|bortezomib|mesh-list
111260113|NCT00611325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111260114|NCT00611325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111260115|NCT00611325|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111260116|NCT00611325|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111260117|NCT00611325|Growth Substances|growth substances|mesh-ancestor
111260118|NCT00611325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110984449|NCT03116672|Diclofenac|diclofenac|mesh-list
111260119|NCT00611325|Growth Inhibitors|growth inhibitors|mesh-ancestor
111260120|NCT00611403|Cyclosporine|cyclosporine|mesh-list
111260121|NCT00611403|Lubricant Eye Drops|lubricant eye drops|mesh-list
111260122|NCT00611403|Cyclosporins|cyclosporins|mesh-list
111260123|NCT00611403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111260124|NCT00611403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111260125|NCT00611403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111260126|NCT00611403|Immunologic Factors|immunologic factors|mesh-ancestor
111260127|NCT00611403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111260128|NCT00611403|Antifungal Agents|antifungal agents|mesh-ancestor
111260129|NCT00611403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111260130|NCT00611403|Dermatologic Agents|dermatologic agents|mesh-ancestor
111260131|NCT00611403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111260132|NCT00611403|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111260133|NCT00611403|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
111260134|NCT00611403|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111260135|NCT01534208|Enclomiphene|enclomiphene|mesh-list
111260136|NCT01534208|Clomiphene|clomiphene|mesh-list
111260137|NCT01534208|Zuclomiphene|zuclomiphene|mesh-list
111260138|NCT01534208|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111260139|NCT01534208|Hormone Antagonists|hormone antagonists|mesh-ancestor
111260140|NCT01534208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111260141|NCT01534208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111260142|NCT01534208|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111260143|NCT01534208|Fertility Agents|fertility agents|mesh-ancestor
111260144|NCT01534208|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111260145|NCT01534208|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111260146|NCT01534208|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111260147|NCT01548638|Galantamine|galantamine|mesh-list
111260148|NCT01548638|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111260149|NCT01548638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111260150|NCT01548638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111260151|NCT01548638|Cholinergic Agents|cholinergic agents|mesh-ancestor
111260152|NCT01548638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111260153|NCT01548638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111260154|NCT01548638|Parasympathomimetics|parasympathomimetics|mesh-ancestor
111260155|NCT01548638|Autonomic Agents|autonomic agents|mesh-ancestor
111260156|NCT01548638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111260157|NCT01548638|Nootropic Agents|nootropic agents|mesh-ancestor
111260158|NCT00612339|Bevacizumab|bevacizumab|mesh-list
111260159|NCT00612339|Temozolomide|temozolomide|mesh-list
111260160|NCT00612339|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111260161|NCT00612339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111260162|NCT00612339|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111260163|NCT00612339|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111260164|NCT00612339|Growth Substances|growth substances|mesh-ancestor
111260165|NCT00612339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111260166|NCT00612339|Growth Inhibitors|growth inhibitors|mesh-ancestor
111260167|NCT00612339|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111260168|NCT00612339|Alkylating Agents|alkylating agents|mesh-ancestor
111260169|NCT00612339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111260170|NCT01533428|Capsaicin|capsaicin|mesh-list
111260171|NCT01533428|Antipruritics|antipruritics|mesh-ancestor
111260172|NCT01533428|Dermatologic Agents|dermatologic agents|mesh-ancestor
111260173|NCT01533428|Sensory System Agents|sensory system agents|mesh-ancestor
111260174|NCT01533428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111260175|NCT01533428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111260176|NCT04066725|Aspirin|aspirin|mesh-list
111260177|NCT04066725|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111260178|NCT04066725|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111260179|NCT04066725|Analgesics|analgesics|mesh-ancestor
111260180|NCT04066725|Sensory System Agents|sensory system agents|mesh-ancestor
111260181|NCT04066725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111260182|NCT04066725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111260183|NCT04066725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111260184|NCT04066725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111260185|NCT04066725|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111260186|NCT04066725|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111260187|NCT04066725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111260188|NCT04066725|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111260189|NCT04066725|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111260190|NCT04066725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111260191|NCT04066725|Antipyretics|antipyretics|mesh-ancestor
111260192|NCT01517984|Mycophenolic Acid|mycophenolic acid|mesh-list
111260193|NCT01517984|Prednisone|prednisone|mesh-list
111260194|NCT01517984|Tacrolimus|tacrolimus|mesh-list
111260195|NCT01517984|Thymoglobulin|thymoglobulin|mesh-list
111260196|NCT01517984|Antilymphocyte Serum|antilymphocyte serum|mesh-list
111260197|NCT01517984|Immunosuppressive Agents|immunosuppressive agents|mesh-list
111260198|NCT01517984|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
111260199|NCT01517984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111260200|NCT01517984|Glucocorticoids|glucocorticoids|mesh-ancestor
111260201|NCT01517984|Hormones|hormones|mesh-ancestor
111260202|NCT01517984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111260203|NCT01517984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111260204|NCT01517984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111260205|NCT01517984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111260206|NCT01517984|Immunologic Factors|immunologic factors|mesh-ancestor
111260207|NCT01517984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111260208|NCT01517984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111260209|NCT01517984|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111260210|NCT01517984|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111260211|NCT01517984|Antitubercular Agents|antitubercular agents|mesh-ancestor
111260212|NCT01517984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111260213|NCT01517984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111260214|NCT00612573|Doxycycline|doxycycline|mesh-list
111260215|NCT00612573|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111260216|NCT00612573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111260217|NCT00612573|Antimalarials|antimalarials|mesh-ancestor
111260218|NCT00612573|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111260219|NCT00612573|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111260220|NCT00614445|Pyridoxine|pyridoxine|mesh-list
111260221|NCT00614445|Vitamin B 6|vitamin b 6|mesh-list
111260222|NCT00614445|Doxylamine|doxylamine|mesh-list
111260223|NCT00614445|Doxylamine succinate|doxylamine succinate|mesh-list
111260224|NCT00614445|Vitamin B Complex|vitamin b complex|mesh-ancestor
111260225|NCT00614445|Vitamins|vitamins|mesh-ancestor
111260226|NCT00614445|Micronutrients|micronutrients|mesh-ancestor
111260227|NCT00614445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111260228|NCT00614445|Antiemetics|antiemetics|mesh-ancestor
111260229|NCT00614445|Autonomic Agents|autonomic agents|mesh-ancestor
111260230|NCT00614445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111260231|NCT00614445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111260232|NCT00614445|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111260233|NCT00614445|Histamine Antagonists|histamine antagonists|mesh-ancestor
111260234|NCT00614445|Histamine Agents|histamine agents|mesh-ancestor
111260235|NCT00614445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111260236|NCT00614445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111260237|NCT00583011|Anesthetics|anesthetics|mesh-list
111260238|NCT00583011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111260239|NCT00583011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111260240|NCT01547390|Aspirin|aspirin|mesh-list
111260241|NCT01547390|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111260242|NCT01547390|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111260243|NCT01547390|Analgesics|analgesics|mesh-ancestor
111260244|NCT01547390|Sensory System Agents|sensory system agents|mesh-ancestor
111260245|NCT01547390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111260246|NCT01547390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111260247|NCT01547390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111260248|NCT01547390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111260249|NCT01547390|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111260250|NCT01547390|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111260251|NCT01547390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111260252|NCT01547390|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111260253|NCT01547390|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111260254|NCT01547390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111260255|NCT01547390|Antipyretics|antipyretics|mesh-ancestor
111260256|NCT01546922|Hydrocortisone|hydrocortisone|mesh-list
111260257|NCT01546922|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111260258|NCT00615927|Imatinib Mesylate|imatinib mesylate|mesh-list
111260259|NCT00615927|Hydroxyurea|hydroxyurea|mesh-list
111260260|NCT00615927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111260261|NCT00615927|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111260262|NCT00615927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111260263|NCT00615927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111260264|NCT00615927|Antisickling Agents|antisickling agents|mesh-ancestor
111260265|NCT00615927|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111260266|NCT01532648|Budesonide|budesonide|mesh-list
111260267|NCT01532648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111260268|NCT01532648|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111260269|NCT01532648|Autonomic Agents|autonomic agents|mesh-ancestor
111260270|NCT01532648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111260271|NCT01532648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111260272|NCT01532648|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111260273|NCT01532648|Respiratory System Agents|respiratory system agents|mesh-ancestor
111260274|NCT01532648|Glucocorticoids|glucocorticoids|mesh-ancestor
111260276|NCT01532648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111260277|NCT00617097|Ketorolac|ketorolac|mesh-list
111260278|NCT00617097|Lidocaine|lidocaine|mesh-list
111260279|NCT00617097|Anesthetics, Local|anesthetics, local|mesh-ancestor
111260280|NCT00617097|Anesthetics|anesthetics|mesh-ancestor
111260281|NCT00617097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111260282|NCT00617097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111260283|NCT00617097|Sensory System Agents|sensory system agents|mesh-ancestor
111260284|NCT00617097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111260285|NCT00617097|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111260286|NCT00617097|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111260287|NCT00617097|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111260288|NCT00617097|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111260289|NCT00617097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111260290|NCT00617097|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111260291|NCT00617097|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111260292|NCT00617097|Analgesics|analgesics|mesh-ancestor
111260293|NCT00617097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111260294|NCT00617097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111260295|NCT00617097|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111260296|NCT00617097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111260297|NCT01532414|Enclomiphene|enclomiphene|mesh-list
111260298|NCT01532414|Clomiphene|clomiphene|mesh-list
111260299|NCT01532414|Zuclomiphene|zuclomiphene|mesh-list
111260300|NCT01532414|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111260301|NCT01532414|Hormone Antagonists|hormone antagonists|mesh-ancestor
111260302|NCT01532414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111260303|NCT01532414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111260304|NCT01532414|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111260305|NCT01532414|Fertility Agents|fertility agents|mesh-ancestor
111260306|NCT01532414|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111260307|NCT01532414|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111260308|NCT01532414|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111260309|NCT01441973|Elotuzumab|elotuzumab|mesh-list
111260310|NCT01441973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111260311|NCT02074709|Bupivacaine|bupivacaine|mesh-list
111260312|NCT02074709|Anesthetics, Local|anesthetics, local|mesh-ancestor
111260313|NCT02074709|Anesthetics|anesthetics|mesh-ancestor
111260314|NCT02074709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111260315|NCT02074709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111260316|NCT02074709|Sensory System Agents|sensory system agents|mesh-ancestor
111260317|NCT02074709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111260318|NCT03571191|Denosumab|denosumab|mesh-list
111260319|NCT03571191|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111260320|NCT03571191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111260321|NCT01575899|Amoxicillin|amoxicillin|mesh-list
111260322|NCT01575899|Clarithromycin|clarithromycin|mesh-list
111260323|NCT01575899|Levofloxacin|levofloxacin|mesh-list
111260324|NCT01575899|Ofloxacin|ofloxacin|mesh-list
111260325|NCT01575899|Clavulanic Acid|clavulanic acid|mesh-list
111260326|NCT01575899|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
111260327|NCT01575899|Rabeprazole|rabeprazole|mesh-list
111260328|NCT01575899|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111260329|NCT01575899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111260330|NCT01575899|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111260331|NCT01575899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111260332|NCT01575899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111260333|NCT01575899|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111260334|NCT01575899|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111260335|NCT01575899|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111260336|NCT01575899|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111260337|NCT01575899|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111260338|NCT01575899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111260339|NCT01575899|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111260340|NCT01575899|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111260341|NCT01575899|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111260342|NCT01575899|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111260343|NCT01575899|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
111260344|NCT01440881|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
111260345|NCT01440881|Natriuretic Agents|natriuretic agents|mesh-ancestor
111260346|NCT01440881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111260347|NCT00620061|Lubiprostone|lubiprostone|mesh-list
111260348|NCT00620061|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
111260349|NCT00620061|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111260350|NCT00620061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111260351|NCT04122443|Acetaminophen|acetaminophen|mesh-list
111260352|NCT04122443|Oxycodone|oxycodone|mesh-list
111260353|NCT04122443|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111260354|NCT04122443|Analgesics|analgesics|mesh-ancestor
111260355|NCT04122443|Sensory System Agents|sensory system agents|mesh-ancestor
111260356|NCT04122443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111260357|NCT04122443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111260358|NCT04122443|Antipyretics|antipyretics|mesh-ancestor
111260359|NCT04122443|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111260360|NCT04122443|Narcotics|narcotics|mesh-ancestor
111260361|NCT04122443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111260362|NCT00587769|Bupropion|bupropion|mesh-list
111260363|NCT00587769|Varenicline|varenicline|mesh-list
111260364|NCT00587769|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111260365|NCT00587769|Antidepressive Agents|antidepressive agents|mesh-ancestor
111260366|NCT00587769|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111260367|NCT00587769|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111260368|NCT00587769|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111260369|NCT00587769|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111260370|NCT00587769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111260371|NCT00587769|Dopamine Agents|dopamine agents|mesh-ancestor
111260372|NCT00587769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111260373|NCT00587769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111260374|NCT00587769|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111260375|NCT00587769|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111260376|NCT00587769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111260377|NCT00587769|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111260378|NCT00587769|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111260379|NCT00587769|Cholinergic Agents|cholinergic agents|mesh-ancestor
111260380|NCT00623181|Vaccines|vaccines|mesh-list
111260381|NCT00623181|Immunologic Factors|immunologic factors|mesh-ancestor
111260382|NCT00623181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111260383|NCT03433833|Digoxin|digoxin|mesh-list
111260384|NCT03433833|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111260385|NCT03433833|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111260386|NCT03433833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111260387|NCT03433833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111260388|NCT03433833|Protective Agents|protective agents|mesh-ancestor
111260389|NCT03433833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111260390|NCT01574651|Glycopyrrolate|glycopyrrolate|mesh-list
111260391|NCT01574651|Formoterol Fumarate|formoterol fumarate|mesh-list
111260392|NCT01574651|Tiotropium Bromide|tiotropium bromide|mesh-list
111260393|NCT01574651|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111260394|NCT01574651|Autonomic Agents|autonomic agents|mesh-ancestor
111260395|NCT01574651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111260396|NCT01574651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111260397|NCT01574651|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111260398|NCT01574651|Respiratory System Agents|respiratory system agents|mesh-ancestor
111260399|NCT01574651|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111260400|NCT01574651|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111260401|NCT01574651|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111260402|NCT01574651|Adrenergic Agents|adrenergic agents|mesh-ancestor
111260403|NCT01574651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111260404|NCT01574651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111260405|NCT01574651|Parasympatholytics|parasympatholytics|mesh-ancestor
111260406|NCT01574651|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110978285|NCT02457026|Verteporfin|verteporfin|mesh-list
111260407|NCT01574651|Cholinergic Agents|cholinergic agents|mesh-ancestor
111260408|NCT01574651|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111260409|NCT01574651|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111260410|NCT03179163|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
111260411|NCT03179163|Enalapril|enalapril|mesh-list
111260412|NCT03179163|Captopril|captopril|mesh-list
111260413|NCT03179163|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111260414|NCT03179163|Diuretics|diuretics|mesh-ancestor
111260415|NCT03179163|Natriuretic Agents|natriuretic agents|mesh-ancestor
111260416|NCT03179163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111260417|NCT03179163|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
111260418|NCT03179163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111260419|NCT03179163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110984733|NCT03171740|Analgesics|analgesics|mesh-ancestor
111260420|NCT03179163|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
111260421|NCT03179163|Protease Inhibitors|protease inhibitors|mesh-ancestor
111260422|NCT03179163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111260423|NCT01440803|Teriparatide|teriparatide|mesh-list
111260424|NCT01440803|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111260425|NCT01440803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111260426|NCT01440803|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111260427|NCT05247177|Dexmedetomidine|dexmedetomidine|mesh-list
111260428|NCT05247177|Ketamine|ketamine|mesh-list
111260429|NCT05247177|Anesthetics|anesthetics|mesh-list
111260430|NCT05247177|Sevoflurane|sevoflurane|mesh-list
111260431|NCT05247177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111260432|NCT05247177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111260433|NCT05247177|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111260434|NCT05247177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111260435|NCT05247177|Analgesics|analgesics|mesh-ancestor
111260436|NCT05247177|Sensory System Agents|sensory system agents|mesh-ancestor
111260437|NCT05247177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111260438|NCT05247177|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111260439|NCT05247177|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111260440|NCT05247177|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111260441|NCT05247177|Adrenergic Agents|adrenergic agents|mesh-ancestor
111260442|NCT05247177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111260443|NCT05247177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111260444|NCT05247177|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111260445|NCT05247177|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111260446|NCT05247177|Anesthetics, General|anesthetics, general|mesh-ancestor
111260447|NCT05247177|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111260448|NCT05247177|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111260449|NCT05247177|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111260450|NCT05247177|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111260451|NCT00624195|Etravirine|etravirine|mesh-list
111260452|NCT00624195|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
111260453|NCT00624195|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111260454|NCT00624195|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111260455|NCT00624195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111260456|NCT00624195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111260457|NCT00624195|Antiviral Agents|antiviral agents|mesh-ancestor
111260458|NCT00624195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111260459|NCT01516970|Ritonavir|ritonavir|mesh-list
111260460|NCT01516970|Lopinavir|lopinavir|mesh-list
111260461|NCT01516970|Darunavir|darunavir|mesh-list
111260462|NCT01516970|Zidovudine|zidovudine|mesh-list
111260463|NCT01516970|Efavirenz|efavirenz|mesh-list
111260464|NCT01516970|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111260465|NCT01516970|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111260466|NCT01516970|Protease Inhibitors|protease inhibitors|mesh-ancestor
111260467|NCT01516970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111260468|NCT01516970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111260469|NCT01516970|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111260470|NCT01516970|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111260471|NCT01516970|Antiviral Agents|antiviral agents|mesh-ancestor
111260472|NCT01516970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111260473|NCT01516970|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111260474|NCT01516970|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111260475|NCT01516970|Antimetabolites|antimetabolites|mesh-ancestor
111260476|NCT01516970|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111260477|NCT01516970|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111260478|NCT01516970|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111260479|NCT01516970|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111260480|NCT01516970|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111260481|NCT01516970|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111260482|NCT01516970|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111260483|NCT02140593|Rocuronium|rocuronium|mesh-list
111260484|NCT02140593|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
111260485|NCT02140593|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
111260486|NCT02140593|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111260487|NCT02140593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111260488|NCT02140593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111260489|NCT01516892|Botulinum Toxins|botulinum toxins|mesh-list
111260490|NCT01516892|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111260491|NCT01516892|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111260492|NCT01516892|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111260493|NCT01516892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111260494|NCT01516892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111260495|NCT01516892|Cholinergic Agents|cholinergic agents|mesh-ancestor
111260496|NCT01516892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111260497|NCT01516892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111260498|NCT01516892|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111260499|NCT01516892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111260501|NCT00668811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111260502|NCT00668811|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111260503|NCT00668811|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111260504|NCT00668811|Growth Substances|growth substances|mesh-ancestor
111260505|NCT00668811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111260506|NCT00668811|Growth Inhibitors|growth inhibitors|mesh-ancestor
111260507|NCT00668811|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111260508|NCT00668811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111260509|NCT00668811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111260510|NCT02776605|Prednisone|prednisone|mesh-list
111260511|NCT02776605|Methotrexate|methotrexate|mesh-list
111260512|NCT02776605|Vincristine|vincristine|mesh-list
111260513|NCT02776605|Daunorubicin|daunorubicin|mesh-list
111260514|NCT02776605|Mercaptopurine|mercaptopurine|mesh-list
111260515|NCT02776605|Ponatinib|ponatinib|mesh-list
111260516|NCT02776605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111260517|NCT02776605|Glucocorticoids|glucocorticoids|mesh-ancestor
111260518|NCT02776605|Hormones|hormones|mesh-ancestor
111260519|NCT02776605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111260520|NCT02776605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111260521|NCT02776605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111260522|NCT02776605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111260523|NCT02776605|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111260524|NCT02776605|Abortifacient Agents|abortifacient agents|mesh-ancestor
111260525|NCT02776605|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111260526|NCT02776605|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111260527|NCT02776605|Antimetabolites|antimetabolites|mesh-ancestor
111260528|NCT02776605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111260529|NCT02776605|Dermatologic Agents|dermatologic agents|mesh-ancestor
111260530|NCT02776605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111260531|NCT02776605|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111260532|NCT02776605|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111260533|NCT02776605|Immunologic Factors|immunologic factors|mesh-ancestor
111260534|NCT02776605|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111260535|NCT02776605|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111260536|NCT02776605|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111260537|NCT02776605|Tubulin Modulators|tubulin modulators|mesh-ancestor
111260538|NCT02776605|Antimitotic Agents|antimitotic agents|mesh-ancestor
111260539|NCT02776605|Mitosis Modulators|mitosis modulators|mesh-ancestor
111260540|NCT02776605|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111260541|NCT02776605|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111260542|NCT02776605|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111260543|NCT02776605|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111260544|NCT00627861|Metoprolol|metoprolol|mesh-list
111260545|NCT00627861|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111260546|NCT00627861|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111260547|NCT00627861|Sympatholytics|sympatholytics|mesh-ancestor
111260548|NCT00627861|Autonomic Agents|autonomic agents|mesh-ancestor
111260549|NCT00627861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111260550|NCT00627861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111260551|NCT00627861|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
111260552|NCT00627861|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111260553|NCT00627861|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111260554|NCT00627861|Adrenergic Agents|adrenergic agents|mesh-ancestor
111260555|NCT00627861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111260556|NCT00627861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111260557|NCT00669279|Atenolol|atenolol|mesh-list
111260558|NCT00669279|Carvedilol|carvedilol|mesh-list
111260559|NCT00669279|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111260560|NCT00669279|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111260561|NCT00669279|Adrenergic Agents|adrenergic agents|mesh-ancestor
111260562|NCT00669279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111260563|NCT00669279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111260564|NCT00669279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111260565|NCT00669279|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111260566|NCT00669279|Antioxidants|antioxidants|mesh-ancestor
111260567|NCT00669279|Protective Agents|protective agents|mesh-ancestor
111260568|NCT00669279|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111260569|NCT00669279|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111260570|NCT00669279|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111260571|NCT00669279|Vasodilator Agents|vasodilator agents|mesh-ancestor
111260572|NCT00669279|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111260573|NCT00669279|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111260574|NCT00669279|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111260575|NCT00669279|Sympatholytics|sympatholytics|mesh-ancestor
111260576|NCT00669279|Autonomic Agents|autonomic agents|mesh-ancestor
111260577|NCT00669279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111260578|NCT00669279|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
111260579|NCT02394795|Calcium, Dietary|calcium, dietary|mesh-list
111260580|NCT02394795|Leucovorin|leucovorin|mesh-list
111260581|NCT02394795|Bevacizumab|bevacizumab|mesh-list
111260582|NCT02394795|Panitumumab|panitumumab|mesh-list
111260583|NCT02394795|Oxaliplatin|oxaliplatin|mesh-list
111260584|NCT02394795|Fluorouracil|fluorouracil|mesh-list
111260585|NCT02394795|Calcium|calcium|mesh-list
111260586|NCT02394795|Levoleucovorin|levoleucovorin|mesh-list
111260587|NCT02394795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111260588|NCT02394795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111260589|NCT02394795|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111260590|NCT02394795|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111260591|NCT02394795|Growth Substances|growth substances|mesh-ancestor
111260592|NCT02394795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111260593|NCT02394795|Growth Inhibitors|growth inhibitors|mesh-ancestor
111260594|NCT02394795|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111260595|NCT02394795|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111260596|NCT02394795|Antimetabolites|antimetabolites|mesh-ancestor
111260597|NCT02394795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111260598|NCT02394795|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111260599|NCT02394795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111260600|NCT02394795|Immunologic Factors|immunologic factors|mesh-ancestor
111260601|NCT02394795|Antidotes|antidotes|mesh-ancestor
111260602|NCT02394795|Protective Agents|protective agents|mesh-ancestor
111260603|NCT02394795|Vitamin B Complex|vitamin b complex|mesh-ancestor
111260604|NCT02394795|Vitamins|vitamins|mesh-ancestor
111260605|NCT02394795|Micronutrients|micronutrients|mesh-ancestor
111260606|NCT01546688|Zonisamide|zonisamide|mesh-list
111260607|NCT01546688|Anticonvulsants|anticonvulsants|mesh-ancestor
111260608|NCT01546688|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111260609|NCT01546688|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111260610|NCT01546688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111260611|NCT01546688|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111260612|NCT01546688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111260613|NCT04409522|Melatonin|melatonin|mesh-list
111260614|NCT04409522|Antioxidants|antioxidants|mesh-ancestor
111260615|NCT04409522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111260616|NCT04409522|Protective Agents|protective agents|mesh-ancestor
111260617|NCT04409522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111260618|NCT04409522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111260619|NCT00672243|Sirolimus|sirolimus|mesh-list
111260620|NCT00672243|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111260621|NCT00672243|Temsirolimus|temsirolimus|mesh-list
111260622|NCT00672243|MTOR Inhibitors|mtor inhibitors|mesh-list
111260623|NCT00672243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111260624|NCT00672243|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111260625|NCT00672243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111260626|NCT00672243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111260627|NCT00672243|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111260628|NCT00672243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111260629|NCT00672243|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111260630|NCT00672243|Antifungal Agents|antifungal agents|mesh-ancestor
111260631|NCT00672243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111260632|NCT00672243|Immunologic Factors|immunologic factors|mesh-ancestor
111260633|NCT00672243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111260634|NCT04105946|Dexmedetomidine|dexmedetomidine|mesh-list
111260635|NCT04105946|Remifentanil|remifentanil|mesh-list
111260636|NCT04105946|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111260637|NCT04105946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111260638|NCT04105946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111260639|NCT04105946|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111260640|NCT04105946|Analgesics|analgesics|mesh-ancestor
111260641|NCT04105946|Sensory System Agents|sensory system agents|mesh-ancestor
111260642|NCT04105946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111260643|NCT04105946|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111260644|NCT04105946|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111260645|NCT04105946|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111260646|NCT04105946|Adrenergic Agents|adrenergic agents|mesh-ancestor
111260647|NCT04105946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111260648|NCT04105946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111260649|NCT04105946|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111260650|NCT04105946|Narcotics|narcotics|mesh-ancestor
111260651|NCT01440569|Darunavir|darunavir|mesh-list
111260652|NCT01440569|Cobicistat|cobicistat|mesh-list
111260653|NCT01440569|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111260654|NCT01440569|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111260655|NCT01440569|Protease Inhibitors|protease inhibitors|mesh-ancestor
111260656|NCT01440569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111260657|NCT01440569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111260658|NCT01440569|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111260659|NCT01440569|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111260660|NCT01440569|Antiviral Agents|antiviral agents|mesh-ancestor
111260661|NCT01440569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111260662|NCT01440569|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111260663|NCT01440569|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111260664|NCT00629499|Paclitaxel|paclitaxel|mesh-list
111260665|NCT00629499|Cyclophosphamide|cyclophosphamide|mesh-list
111260666|NCT00629499|Trastuzumab|trastuzumab|mesh-list
111260667|NCT00629499|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111260668|NCT00629499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111260669|NCT00629499|Tubulin Modulators|tubulin modulators|mesh-ancestor
111260670|NCT00629499|Antimitotic Agents|antimitotic agents|mesh-ancestor
111260671|NCT00629499|Mitosis Modulators|mitosis modulators|mesh-ancestor
111260672|NCT00629499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111260673|NCT00629499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111260674|NCT00629499|Immunologic Factors|immunologic factors|mesh-ancestor
111260675|NCT00629499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111260676|NCT00629499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111260677|NCT00629499|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111260678|NCT00629499|Alkylating Agents|alkylating agents|mesh-ancestor
111260679|NCT00629499|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111260680|NCT00629499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111260681|NCT00631449|Raltegravir Potassium|raltegravir potassium|mesh-list
111260682|NCT00631449|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111260683|NCT00631449|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111260684|NCT00631449|Antiviral Agents|antiviral agents|mesh-ancestor
111260685|NCT00631449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111260686|NCT00631449|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111260687|NCT00631449|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111260688|NCT00631449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111260689|NCT00631449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111260690|NCT01546142|Deoxycholic Acid|deoxycholic acid|mesh-list
111260691|NCT01546142|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
111260692|NCT01546142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111260693|NCT00632619|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
111260694|NCT00632619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111260695|NCT01440101|Natalizumab|natalizumab|mesh-list
111260696|NCT01440101|Immunologic Factors|immunologic factors|mesh-ancestor
111260697|NCT01440101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111260698|NCT01530464|Ambrisentan|ambrisentan|mesh-list
111260699|NCT01530464|Aminophylline|aminophylline|mesh-list
111260700|NCT01530464|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111260701|NCT01530464|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111260702|NCT01530464|Autonomic Agents|autonomic agents|mesh-ancestor
111260703|NCT01530464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111260704|NCT01530464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111260705|NCT01530464|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111260706|NCT01530464|Respiratory System Agents|respiratory system agents|mesh-ancestor
111260707|NCT01530464|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111260708|NCT01530464|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111260709|NCT01530464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111260710|NCT01530464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111260711|NCT01530464|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
111260712|NCT01530464|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111260713|NCT01530464|Purinergic Agents|purinergic agents|mesh-ancestor
111260714|NCT01530464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111260715|NCT01530464|Protective Agents|protective agents|mesh-ancestor
111260716|NCT00633399|Ziprasidone|ziprasidone|mesh-list
111260717|NCT00633399|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111260718|NCT00633399|Serotonin Agents|serotonin agents|mesh-ancestor
111260719|NCT00633399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111260720|NCT00633399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111260721|NCT00633399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111260722|NCT00633399|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111260723|NCT00633399|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111260724|NCT00633399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111260725|NCT00633399|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111260726|NCT00633399|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111260727|NCT00633399|Dopamine Agents|dopamine agents|mesh-ancestor
111260728|NCT01077843|Etoricoxib|etoricoxib|mesh-list
111260729|NCT01077843|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
111260730|NCT01077843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
111260731|NCT01077843|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111260732|NCT01077843|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111260733|NCT01077843|Analgesics|analgesics|mesh-ancestor
111260734|NCT01077843|Sensory System Agents|sensory system agents|mesh-ancestor
111260735|NCT01077843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111260736|NCT01077843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111260737|NCT01077843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111260738|NCT01077843|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111260739|NCT01077843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111260740|NCT01077843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111260741|NCT00673959|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111260742|NCT00673959|Lubricant Eye Drops|lubricant eye drops|mesh-list
111260743|NCT00673959|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111260744|NCT00635817|Leuprolide|leuprolide|mesh-list
111260745|NCT00635817|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111260746|NCT00635817|Fertility Agents|fertility agents|mesh-ancestor
111260747|NCT00635817|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111260748|NCT00635817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111260749|NCT00635817|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111260750|NCT00635817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111260751|NCT01439945|Magnesium Oxide|magnesium oxide|mesh-list
111260752|NCT01439945|Antacids|antacids|mesh-ancestor
111260753|NCT01439945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111260754|NCT01439945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111260755|NCT00651963|Ezetimibe|ezetimibe|mesh-list
111260756|NCT00651963|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111260757|NCT00651963|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111260758|NCT00651963|Antimetabolites|antimetabolites|mesh-ancestor
111260759|NCT00651963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111260760|NCT00651963|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111260761|NCT00674115|Omeprazole|omeprazole|mesh-list
111260762|NCT00674115|Omeprazole, sodium bicarbonate drug combination|omeprazole, sodium bicarbonate drug combination|mesh-list
111260763|NCT00674115|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111260764|NCT00674115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111260765|NCT00674115|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111260766|NCT00674115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111260767|NCT00674115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111260768|NCT02142153|Olorofim|olorofim|mesh-list
111260769|NCT02142153|Antifungal Agents|antifungal agents|mesh-ancestor
111260770|NCT02142153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111260771|NCT00674583|Vaccines|vaccines|mesh-list
111260772|NCT00674583|Immunologic Factors|immunologic factors|mesh-ancestor
111260773|NCT00674583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111260774|NCT01420081|Gedatolisib|gedatolisib|mesh-list
111260775|NCT01420081|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111260776|NCT01420081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111260777|NCT01420081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111260778|NCT01439867|Cinacalcet|cinacalcet|mesh-list
111260779|NCT01439867|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111260780|NCT01439867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111260781|NCT01439867|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
111260782|NCT01439867|Hormone Antagonists|hormone antagonists|mesh-ancestor
111260783|NCT01439867|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111260784|NCT00637923|Ribavirin|ribavirin|mesh-list
111260785|NCT00637923|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
111260786|NCT00637923|Nitazoxanide|nitazoxanide|mesh-list
111260787|NCT00637923|Antimetabolites|antimetabolites|mesh-ancestor
111260788|NCT00637923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111260789|NCT00637923|Antiviral Agents|antiviral agents|mesh-ancestor
111260790|NCT00637923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111260791|NCT00637923|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110985107|NCT02404064|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111260792|NCT01439711|Letrozole|letrozole|mesh-list
111260793|NCT01439711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111260794|NCT01439711|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111260795|NCT01439711|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111260796|NCT01439711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111260797|NCT01439711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111260798|NCT01439711|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111260799|NCT01439711|Hormone Antagonists|hormone antagonists|mesh-ancestor
111260800|NCT01439711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111260801|NCT01439711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111260802|NCT01439555|Simvastatin|simvastatin|mesh-list
111260803|NCT01439555|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111260804|NCT01439555|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111260805|NCT01439555|Antimetabolites|antimetabolites|mesh-ancestor
111260806|NCT01439555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111260807|NCT01439555|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111260808|NCT01439555|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111260809|NCT01439555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111260810|NCT00674739|Imiquimod|imiquimod|mesh-list
111260811|NCT00674739|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111260812|NCT00674739|Immunologic Factors|immunologic factors|mesh-ancestor
111260813|NCT00674739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111260814|NCT00674739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111260815|NCT00674739|Interferon Inducers|interferon inducers|mesh-ancestor
111260816|NCT00675909|Midazolam|midazolam|mesh-list
111260817|NCT00675909|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111260818|NCT00675909|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111260819|NCT00675909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111260820|NCT00675909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111260821|NCT00675909|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111260822|NCT00675909|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111260823|NCT00675909|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111260824|NCT00675909|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111260825|NCT00675909|Anesthetics, General|anesthetics, general|mesh-ancestor
111260826|NCT00675909|Anesthetics|anesthetics|mesh-ancestor
111260827|NCT00675909|GABA Modulators|gaba modulators|mesh-ancestor
111260828|NCT00675909|GABA Agents|gaba agents|mesh-ancestor
111260829|NCT00675909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111260830|NCT00675909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111260831|NCT03027908|Fluorides|fluorides|mesh-list
111260832|NCT03027908|Cariostatic Agents|cariostatic agents|mesh-ancestor
111260833|NCT03027908|Protective Agents|protective agents|mesh-ancestor
111260834|NCT03027908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111260835|NCT00638937|Saracatinib|saracatinib|mesh-list
111260836|NCT00638937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111260837|NCT00638937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111260838|NCT00638937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111260839|NCT01439009|Tolvaptan|tolvaptan|mesh-list
111260840|NCT01439009|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
111260841|NCT01439009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111260842|NCT01439009|Natriuretic Agents|natriuretic agents|mesh-ancestor
110712967|NCT01323491|Nicotine|nicotine|mesh-list
111260843|NCT01439009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111260844|NCT00675987|Losartan|losartan|mesh-list
111260845|NCT00675987|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111260846|NCT00675987|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111260847|NCT00675987|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111260848|NCT00675987|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111260849|NCT00675987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111260850|NCT00639717|Etanercept|etanercept|mesh-list
111260851|NCT00639717|Methoxsalen|methoxsalen|mesh-list
111260852|NCT00639717|Tacrolimus|tacrolimus|mesh-list
111260853|NCT00639717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111260854|NCT00639717|Immunologic Factors|immunologic factors|mesh-ancestor
111260855|NCT00639717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111260856|NCT00639717|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111260857|NCT00639717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111260858|NCT00639717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111260859|NCT00639717|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111260860|NCT00639717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111260861|NCT00639717|Analgesics|analgesics|mesh-ancestor
111260862|NCT00639717|Sensory System Agents|sensory system agents|mesh-ancestor
111260863|NCT00639717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111260864|NCT00639717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110985183|NCT03170726|Analgesics|analgesics|mesh-ancestor
111260865|NCT00639717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111260866|NCT00639717|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111260867|NCT00639717|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111260868|NCT00639717|Dermatologic Agents|dermatologic agents|mesh-ancestor
111260870|NCT01571453|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
111260871|NCT01571453|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111260872|NCT01571453|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111260873|NCT01571453|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111260874|NCT01571453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111260875|NCT01571453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111260876|NCT01571453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111260877|NCT01571453|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111260878|NCT01571453|Antidepressive Agents|antidepressive agents|mesh-ancestor
111260879|NCT01571453|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111260880|NCT01571453|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111260881|NCT01571453|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111260882|NCT01571453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111260883|NCT01571453|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111260884|NCT01571453|Serotonin Agents|serotonin agents|mesh-ancestor
111260885|NCT01571453|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111260886|NCT01571453|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111260887|NCT01571453|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111260888|NCT01571453|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111260889|NCT04120961|Hirudins|hirudins|mesh-list
111260890|NCT04120961|Bivalirudin|bivalirudin|mesh-list
111260891|NCT04120961|Antithrombins|antithrombins|mesh-ancestor
111260892|NCT04120961|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111260893|NCT04120961|Protease Inhibitors|protease inhibitors|mesh-ancestor
111260894|NCT04120961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111260895|NCT04120961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111260896|NCT04120961|Anticoagulants|anticoagulants|mesh-ancestor
111260897|NCT04120961|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111260898|NCT04120961|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111260899|NCT04410263|Dimercaprol|dimercaprol|mesh-list
111260900|NCT04410263|Chelating Agents|chelating agents|mesh-ancestor
111260901|NCT04410263|Sequestering Agents|sequestering agents|mesh-ancestor
111260902|NCT04410263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111260903|NCT01444651|Tadalafil|tadalafil|mesh-list
111260904|NCT01444651|Vasodilator Agents|vasodilator agents|mesh-ancestor
111260905|NCT01444651|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111260906|NCT01444651|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111260907|NCT01444651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111260908|NCT01444651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111260909|NCT01444651|Urological Agents|urological agents|mesh-ancestor
111260910|NCT01570751|Insulin|insulin|mesh-list
111260911|NCT01570751|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111260912|NCT01570751|Insulin Glargine|insulin glargine|mesh-list
111260913|NCT01570751|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111260914|NCT01570751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111260915|NCT01419535|Mifepristone|mifepristone|mesh-list
111260916|NCT01419535|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
111260917|NCT01419535|Abortifacient Agents|abortifacient agents|mesh-ancestor
111260918|NCT01419535|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111260919|NCT01419535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111260920|NCT01419535|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111260921|NCT01419535|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111260922|NCT01419535|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111260923|NCT01419535|Contraceptive Agents|contraceptive agents|mesh-ancestor
111260924|NCT01419535|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
111260925|NCT01419535|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
111260926|NCT01419535|Hormone Antagonists|hormone antagonists|mesh-ancestor
111260927|NCT01419535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111260928|NCT01419535|Luteolytic Agents|luteolytic agents|mesh-ancestor
111260929|NCT01419535|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111260930|NCT01419535|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
111260931|NCT01438151|Infliximab|infliximab|mesh-list
111260932|NCT01438151|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111260933|NCT01438151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111260934|NCT01438151|Dermatologic Agents|dermatologic agents|mesh-ancestor
111260935|NCT01438151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111260936|NCT01438151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111260937|NCT02141451|Rituximab|rituximab|mesh-list
111260938|NCT02141451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111260939|NCT02141451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111260940|NCT02141451|Immunologic Factors|immunologic factors|mesh-ancestor
111260941|NCT02141451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111260942|NCT02141451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111260944|NCT01418365|Mesalamine|mesalamine|mesh-list
111260945|NCT01418365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111260946|NCT01418365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111260947|NCT01418365|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111260948|NCT01418365|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111260949|NCT01418365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111260950|NCT01418365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111260951|NCT01418365|Analgesics|analgesics|mesh-ancestor
111260952|NCT01418365|Sensory System Agents|sensory system agents|mesh-ancestor
111260953|NCT01418365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111260954|NCT01418365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111260955|NCT01418365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111260956|NCT01418365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111260957|NCT02075125|Ticagrelor|ticagrelor|mesh-list
111260958|NCT02075125|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
111260959|NCT02075125|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111260960|NCT02075125|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111260961|NCT02075125|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111260962|NCT02075125|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111260963|NCT02075125|Purinergic Agents|purinergic agents|mesh-ancestor
111260964|NCT02075125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111260965|NCT02075125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111260966|NCT02075125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111260967|NCT00678015|Masoprocol|masoprocol|mesh-list
111260968|NCT00678015|Antioxidants|antioxidants|mesh-ancestor
111260969|NCT00678015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111260970|NCT00678015|Protective Agents|protective agents|mesh-ancestor
111260971|NCT00678015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111260972|NCT00678015|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
111260973|NCT00678015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111260974|NCT00678015|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111260975|NCT00678015|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111260976|NCT00678015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111260977|NCT00678015|Analgesics|analgesics|mesh-ancestor
111260978|NCT00678015|Sensory System Agents|sensory system agents|mesh-ancestor
111260979|NCT00678015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111260980|NCT00678015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111260981|NCT00678015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111260982|NCT01437995|Fluticasone|fluticasone|mesh-list
111260983|NCT01437995|Xhance|xhance|mesh-list
111260984|NCT01437995|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
111260985|NCT01437995|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
111260986|NCT01437995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111260987|NCT01437995|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111260988|NCT01437995|Autonomic Agents|autonomic agents|mesh-ancestor
111260989|NCT01437995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111260990|NCT01437995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111260991|NCT01437995|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111260992|NCT01437995|Respiratory System Agents|respiratory system agents|mesh-ancestor
111260993|NCT01437995|Dermatologic Agents|dermatologic agents|mesh-ancestor
111260994|NCT01437995|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111260995|NCT01437995|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111260996|NCT01437995|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111260997|NCT01437995|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111260998|NCT01437995|Adrenergic Agents|adrenergic agents|mesh-ancestor
111260999|NCT01437995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111261000|NCT01437995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111261001|NCT01437995|Glucocorticoids|glucocorticoids|mesh-ancestor
111261002|NCT01437995|Hormones|hormones|mesh-ancestor
111261003|NCT01437995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111261004|NCT01437995|Sympathomimetics|sympathomimetics|mesh-ancestor
111261005|NCT00641745|Risperidone|risperidone|mesh-list
111261006|NCT00641745|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
111261007|NCT00641745|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111261008|NCT00641745|Serotonin Agents|serotonin agents|mesh-ancestor
111261009|NCT00641745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111261010|NCT00641745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110985336|NCT02289261|Morphine|morphine|mesh-list
111261011|NCT00641745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111261012|NCT00641745|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111261013|NCT00641745|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111261014|NCT00641745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111261015|NCT00641745|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111261016|NCT00641745|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111261017|NCT00641745|Dopamine Agents|dopamine agents|mesh-ancestor
111261018|NCT00641745|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
111261019|NCT00641745|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111261020|NCT00641745|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111261021|NCT00641745|Adrenergic Agents|adrenergic agents|mesh-ancestor
111261022|NCT00641745|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111261023|NCT00641745|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111261024|NCT01799109|Magnesium Sulfate|magnesium sulfate|mesh-list
111261026|NCT01799109|Analgesics|analgesics|mesh-ancestor
111261027|NCT01799109|Sensory System Agents|sensory system agents|mesh-ancestor
111261028|NCT01799109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111261029|NCT01799109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111261030|NCT01799109|Anesthetics|anesthetics|mesh-ancestor
111261031|NCT01799109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111261032|NCT01799109|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111261033|NCT01799109|Anticonvulsants|anticonvulsants|mesh-ancestor
111261034|NCT01799109|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111261035|NCT01799109|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111261036|NCT01799109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111261037|NCT01799109|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111261038|NCT01799109|Tocolytic Agents|tocolytic agents|mesh-ancestor
111261039|NCT01799109|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111261040|NCT01799109|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111261041|NCT01799109|Autonomic Agents|autonomic agents|mesh-ancestor
111261042|NCT01799109|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111261043|NCT01799109|Respiratory System Agents|respiratory system agents|mesh-ancestor
111261044|NCT01799109|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111261045|NCT01799109|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111261046|NCT01799109|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111261047|NCT01799109|Adrenergic Agents|adrenergic agents|mesh-ancestor
111261048|NCT01799109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111261049|NCT00588159|Diphenhydramine|diphenhydramine|mesh-list
111261050|NCT00588159|Promethazine|promethazine|mesh-list
111261051|NCT00588159|Gabapentin|gabapentin|mesh-list
111261052|NCT00588159|Analgesics|analgesics|mesh-ancestor
111261053|NCT00588159|Sensory System Agents|sensory system agents|mesh-ancestor
111261054|NCT00588159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111261055|NCT00588159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111261056|NCT00588159|Anticonvulsants|anticonvulsants|mesh-ancestor
111261057|NCT00588159|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111261058|NCT00588159|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111261059|NCT00588159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111261060|NCT00588159|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111261061|NCT00588159|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111261062|NCT00588159|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111261063|NCT00588159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111261064|NCT00588159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111261065|NCT00588159|Antimanic Agents|antimanic agents|mesh-ancestor
111261066|NCT00588159|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111261067|NCT00588159|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111261068|NCT00588159|Anesthetics, Local|anesthetics, local|mesh-ancestor
111261069|NCT00588159|Anesthetics|anesthetics|mesh-ancestor
111261070|NCT00588159|Antiemetics|antiemetics|mesh-ancestor
111261071|NCT00588159|Autonomic Agents|autonomic agents|mesh-ancestor
111261072|NCT00588159|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111261073|NCT00588159|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111261074|NCT00588159|Histamine Antagonists|histamine antagonists|mesh-ancestor
111261075|NCT00588159|Histamine Agents|histamine agents|mesh-ancestor
111261076|NCT00588159|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111261077|NCT00588159|Antipruritics|antipruritics|mesh-ancestor
111261078|NCT00588159|Dermatologic Agents|dermatologic agents|mesh-ancestor
111261079|NCT01439347|Vincristine|vincristine|mesh-list
111261080|NCT01439347|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111261081|NCT01439347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111261082|NCT01439347|Tubulin Modulators|tubulin modulators|mesh-ancestor
111261083|NCT01439347|Antimitotic Agents|antimitotic agents|mesh-ancestor
111261084|NCT01439347|Mitosis Modulators|mitosis modulators|mesh-ancestor
111261085|NCT01439347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111261086|NCT00680823|Ropivacaine|ropivacaine|mesh-list
111261087|NCT00680823|Anesthetics, Local|anesthetics, local|mesh-ancestor
111261088|NCT00680823|Anesthetics|anesthetics|mesh-ancestor
111261089|NCT00680823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111261090|NCT00680823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111261091|NCT00680823|Sensory System Agents|sensory system agents|mesh-ancestor
111261092|NCT00680823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111261093|NCT00589329|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111261094|NCT00589329|Metronidazole|metronidazole|mesh-list
111261095|NCT00589329|Erythromycin|erythromycin|mesh-list
111261096|NCT00589329|Erythromycin Estolate|erythromycin estolate|mesh-list
111261097|NCT00589329|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
111261098|NCT00589329|Erythromycin stearate|erythromycin stearate|mesh-list
111261099|NCT00589329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111261100|NCT00589329|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111261101|NCT00589329|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111261102|NCT00589329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111261103|NCT00589329|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111261104|NCT00589329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111261105|NCT00589329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111261106|NCT01438957|Dexmedetomidine|dexmedetomidine|mesh-list
111261107|NCT01438957|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111261108|NCT01438957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111261109|NCT01438957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111261110|NCT01438957|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111261111|NCT01438957|Analgesics|analgesics|mesh-ancestor
111261112|NCT01438957|Sensory System Agents|sensory system agents|mesh-ancestor
111261113|NCT01438957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111261114|NCT01438957|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111261115|NCT01438957|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111261116|NCT01438957|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111261117|NCT01438957|Adrenergic Agents|adrenergic agents|mesh-ancestor
111261118|NCT01438957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111261119|NCT01438957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111261120|NCT00589563|Sirolimus|sirolimus|mesh-list
111261121|NCT00589563|Cyclophosphamide|cyclophosphamide|mesh-list
111261122|NCT00589563|Melphalan|melphalan|mesh-list
111261123|NCT00589563|Methotrexate|methotrexate|mesh-list
111261124|NCT00589563|Fludarabine|fludarabine|mesh-list
111261125|NCT00589563|Fludarabine phosphate|fludarabine phosphate|mesh-list
111261126|NCT00589563|Etoposide|etoposide|mesh-list
111261127|NCT00589563|Tacrolimus|tacrolimus|mesh-list
111261128|NCT00589563|Antilymphocyte Serum|antilymphocyte serum|mesh-list
111261129|NCT00589563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111261130|NCT00589563|Immunologic Factors|immunologic factors|mesh-ancestor
111261131|NCT00589563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111261132|NCT00589563|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111261133|NCT00589563|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111261134|NCT00589563|Alkylating Agents|alkylating agents|mesh-ancestor
110978298|NCT02457026|Growth Substances|growth substances|mesh-ancestor
111261135|NCT00589563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111261136|NCT00589563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111261137|NCT00589563|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111261138|NCT00589563|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111261139|NCT00589563|Abortifacient Agents|abortifacient agents|mesh-ancestor
111261140|NCT00589563|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111261141|NCT00589563|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111261142|NCT00589563|Antimetabolites|antimetabolites|mesh-ancestor
111261143|NCT00589563|Dermatologic Agents|dermatologic agents|mesh-ancestor
111261144|NCT00589563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111261145|NCT00589563|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111261146|NCT00589563|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111261147|NCT00589563|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111261148|NCT00589563|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111261149|NCT00589563|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111261150|NCT00589563|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111261151|NCT00589563|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111261152|NCT00589563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111261153|NCT00589563|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111261154|NCT00589563|Antifungal Agents|antifungal agents|mesh-ancestor
111261155|NCT00645333|Docetaxel|docetaxel|mesh-list
111261156|NCT00645333|3-(4-((4-chlorophenyl)sulfonyl)-4-(2,5-difluorophenyl)cyclohexyl)propanoic acid|3-(4-((4-chlorophenyl)sulfonyl)-4-(2,5-difluorophenyl)cyclohexyl)propanoic acid|mesh-list
111261157|NCT00645333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111261158|NCT00645333|Tubulin Modulators|tubulin modulators|mesh-ancestor
111261159|NCT00645333|Antimitotic Agents|antimitotic agents|mesh-ancestor
110985485|NCT02296281|Pirfenidone|pirfenidone|mesh-list
111261160|NCT00645333|Mitosis Modulators|mitosis modulators|mesh-ancestor
111261161|NCT00645333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111261162|NCT00645333|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
111261163|NCT00645333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111261164|NCT00646581|Insulin|insulin|mesh-list
111261165|NCT00646581|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111261166|NCT00646581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111261167|NCT00646581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111261168|NCT00648375|Propranolol|propranolol|mesh-list
111261169|NCT00648375|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111261170|NCT00648375|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111261171|NCT00648375|Adrenergic Agents|adrenergic agents|mesh-ancestor
111261172|NCT00648375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111261173|NCT00648375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111261174|NCT00648375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111261175|NCT00648375|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111261176|NCT00648375|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111261177|NCT00648375|Vasodilator Agents|vasodilator agents|mesh-ancestor
111261178|NCT00654069|Niacin|niacin|mesh-list
111261179|NCT00654069|Niacinamide|niacinamide|mesh-list
111261180|NCT00654069|Nicotinic Acids|nicotinic acids|mesh-list
111261181|NCT00654069|Oxycodone|oxycodone|mesh-list
111261182|NCT00654069|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111261183|NCT00654069|Narcotics|narcotics|mesh-ancestor
111261184|NCT00654069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111261185|NCT00654069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111261186|NCT00654069|Analgesics|analgesics|mesh-ancestor
111261187|NCT00654069|Sensory System Agents|sensory system agents|mesh-ancestor
111261188|NCT00654069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111261189|NCT00654069|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111261190|NCT00654069|Antimetabolites|antimetabolites|mesh-ancestor
111261191|NCT00654069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111261192|NCT00654069|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111261193|NCT00654069|Vasodilator Agents|vasodilator agents|mesh-ancestor
111261194|NCT00654069|Vitamin B Complex|vitamin b complex|mesh-ancestor
111261195|NCT00654069|Vitamins|vitamins|mesh-ancestor
111261196|NCT00654069|Micronutrients|micronutrients|mesh-ancestor
111261197|NCT00654147|Ritonavir|ritonavir|mesh-list
111261198|NCT00654147|Lopinavir|lopinavir|mesh-list
111261199|NCT00654147|Tenofovir|tenofovir|mesh-list
111261200|NCT00654147|Emtricitabine|emtricitabine|mesh-list
111261201|NCT00654147|Raltegravir Potassium|raltegravir potassium|mesh-list
111261202|NCT00654147|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111261203|NCT00654147|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111261204|NCT00654147|Protease Inhibitors|protease inhibitors|mesh-ancestor
111261205|NCT00654147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111261206|NCT00654147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111261207|NCT00654147|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111261208|NCT00654147|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111261209|NCT00654147|Antiviral Agents|antiviral agents|mesh-ancestor
111261210|NCT00654147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111261211|NCT00654147|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111261212|NCT00654147|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111261213|NCT00654147|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111261214|NCT00654147|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111261215|NCT00654147|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111261216|NCT00654147|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111261217|NCT01438489|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111261218|NCT01438489|Immunologic Factors|immunologic factors|mesh-ancestor
111261219|NCT01438489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111261220|NCT00654927|4-Aminopyridine|4-aminopyridine|mesh-list
111261221|NCT00654927|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
111261222|NCT00654927|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111261223|NCT00654927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111261224|NCT00655083|MEN 11420|men 11420|mesh-list
111261225|NCT00655083|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111261226|NCT00655083|Autonomic Agents|autonomic agents|mesh-ancestor
111261227|NCT00655083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111261228|NCT00655083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111261229|NCT00655083|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111261230|NCT00655083|Respiratory System Agents|respiratory system agents|mesh-ancestor
111261231|NCT01418209|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
111261232|NCT01418209|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
111261233|NCT01418209|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
111261234|NCT01418209|Estradiol|estradiol|mesh-list
111261235|NCT01418209|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
111261237|NCT01418209|Estrogens|estrogens|mesh-ancestor
111261238|NCT01418209|Hormones|hormones|mesh-ancestor
111261239|NCT01418209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111261240|NCT01418209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111261241|NCT01418209|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111261242|NCT01418209|Contraceptive Agents|contraceptive agents|mesh-ancestor
111261243|NCT01418209|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111261244|NCT01418209|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111261245|NCT01418209|Progestins|progestins|mesh-ancestor
111261246|NCT01418209|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111261247|NCT01418209|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111261248|NCT01418209|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111261249|NCT01418209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111261250|NCT01418209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111261251|NCT01418209|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111261252|NCT01418209|Antidepressive Agents|antidepressive agents|mesh-ancestor
111261253|NCT01418209|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111261254|NCT00655473|Dalcetrapib|dalcetrapib|mesh-list
111261255|NCT00655473|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111261256|NCT00655473|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111261257|NCT00655473|Antimetabolites|antimetabolites|mesh-ancestor
111261258|NCT00655473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111261259|NCT00655473|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111261260|NCT01570361|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
111261261|NCT01417195|Menotropins|menotropins|mesh-list
111261262|NCT01417195|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
111261263|NCT01417195|Hormones|hormones|mesh-ancestor
111261264|NCT01417195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111261265|NCT01417195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111261266|NCT01417195|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111261267|NCT01417195|Fertility Agents|fertility agents|mesh-ancestor
111261268|NCT01417195|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111261269|NCT00656487|Rimonabant|rimonabant|mesh-list
111261270|NCT00656487|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111261271|NCT00656487|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
111261272|NCT00656487|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
111261273|NCT00656487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111261274|NCT00656487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111261275|NCT00656487|Hormones|hormones|mesh-ancestor
111261276|NCT00656487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111261277|NCT00656487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111261278|NCT01438411|Cholic Acids|cholic acids|mesh-list
111261279|NCT01438411|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111261280|NCT01438177|Chloroquine|chloroquine|mesh-list
111261281|NCT01438177|Cyclophosphamide|cyclophosphamide|mesh-list
111261282|NCT01438177|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
111261283|NCT01438177|Bortezomib|bortezomib|mesh-list
111261284|NCT01438177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111261285|NCT01438177|Immunologic Factors|immunologic factors|mesh-ancestor
111261286|NCT01438177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111261287|NCT01438177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111261288|NCT01438177|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111261289|NCT01438177|Alkylating Agents|alkylating agents|mesh-ancestor
111261290|NCT01438177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111261291|NCT01438177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111261292|NCT01438177|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111261293|NCT01438177|Amebicides|amebicides|mesh-ancestor
111261294|NCT01438177|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111261295|NCT01438177|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111261296|NCT01438177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111261297|NCT01438177|Antimalarials|antimalarials|mesh-ancestor
111261298|NCT01442779|Interferons|interferons|mesh-list
111261299|NCT01442779|Interferon-alpha|interferon-alpha|mesh-list
111261300|NCT01442779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111261301|NCT01442779|Antiviral Agents|antiviral agents|mesh-ancestor
111261302|NCT01442779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111261303|NCT01442779|Immunologic Factors|immunologic factors|mesh-ancestor
111261304|NCT01442779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111261305|NCT01436201|Dulaglutide|dulaglutide|mesh-list
111261306|NCT01436201|Digoxin|digoxin|mesh-list
111261307|NCT01436201|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111261308|NCT01436201|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111261309|NCT01436201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111261310|NCT01436201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111261312|NCT01436201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111261313|NCT01436201|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111261314|NCT01437397|Bromides|bromides|mesh-list
111261315|NCT01437397|Formoterol Fumarate|formoterol fumarate|mesh-list
111261316|NCT01437397|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111261317|NCT01437397|Autonomic Agents|autonomic agents|mesh-ancestor
111261318|NCT01437397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111261319|NCT01437397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111261320|NCT01437397|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111261321|NCT01437397|Respiratory System Agents|respiratory system agents|mesh-ancestor
111261322|NCT01437397|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111261323|NCT01437397|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111261324|NCT01437397|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111261325|NCT01437397|Adrenergic Agents|adrenergic agents|mesh-ancestor
111261326|NCT01437397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111261327|NCT01437397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111261328|NCT01437397|Anticonvulsants|anticonvulsants|mesh-ancestor
111261329|NCT04070833|Vitamin D|vitamin d|mesh-list
111261330|NCT04070833|Ergocalciferols|ergocalciferols|mesh-list
111261331|NCT04070833|Cholecalciferol|cholecalciferol|mesh-list
111261332|NCT04070833|Vitamins|vitamins|mesh-list
111261333|NCT04070833|Micronutrients|micronutrients|mesh-ancestor
111261334|NCT04070833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111261335|NCT04070833|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111261336|NCT04070833|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111261337|NCT01442155|Capecitabine|capecitabine|mesh-list
111261338|NCT01442155|Oxaliplatin|oxaliplatin|mesh-list
111261339|NCT01442155|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111261340|NCT01442155|Antimetabolites|antimetabolites|mesh-ancestor
111261341|NCT01442155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111261342|NCT01442155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111261343|NCT01416181|Natalizumab|natalizumab|mesh-list
111261344|NCT01416181|Immunologic Factors|immunologic factors|mesh-ancestor
111261345|NCT01416181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111261346|NCT03026023|Ribavirin|ribavirin|mesh-list
111261347|NCT03026023|Grazoprevir|grazoprevir|mesh-list
111261348|NCT03026023|Antimetabolites|antimetabolites|mesh-ancestor
111261349|NCT03026023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111261350|NCT03026023|Antiviral Agents|antiviral agents|mesh-ancestor
111261351|NCT03026023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111261352|NCT01441765|Pidilizumab|pidilizumab|mesh-list
111261353|NCT01441765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111261354|NCT01441765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111261355|NCT01419665|Rituximab|rituximab|mesh-list
111261356|NCT01419665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111261357|NCT01419665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111261358|NCT01419665|Immunologic Factors|immunologic factors|mesh-ancestor
111261359|NCT01419665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111261360|NCT01419665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111261361|NCT01436305|Mycophenolic Acid|mycophenolic acid|mesh-list
111261362|NCT01436305|Methylprednisolone|methylprednisolone|mesh-list
111261363|NCT01436305|Alemtuzumab|alemtuzumab|mesh-list
111261364|NCT01436305|Abatacept|abatacept|mesh-list
111261365|NCT01436305|Tacrolimus|tacrolimus|mesh-list
111261366|NCT01436305|Basiliximab|basiliximab|mesh-list
111261367|NCT01436305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111261368|NCT01436305|Immunologic Factors|immunologic factors|mesh-ancestor
111261369|NCT01436305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111261370|NCT01436305|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111261371|NCT01436305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111261372|NCT01436305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111261373|NCT01436305|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111261374|NCT01436305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111261375|NCT01436305|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111261376|NCT01436305|Antitubercular Agents|antitubercular agents|mesh-ancestor
111261377|NCT01436305|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111261378|NCT01436305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111261379|NCT01436305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111261380|NCT01436305|Antiemetics|antiemetics|mesh-ancestor
111261381|NCT01436305|Autonomic Agents|autonomic agents|mesh-ancestor
111261382|NCT01436305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111261383|NCT01436305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111261384|NCT01436305|Glucocorticoids|glucocorticoids|mesh-ancestor
111261385|NCT01436305|Hormones|hormones|mesh-ancestor
111261386|NCT01436305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111261388|NCT01436305|Protective Agents|protective agents|mesh-ancestor
111261389|NCT01436305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111261390|NCT01436305|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111261391|NCT01436305|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111261392|NCT01436149|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
111261393|NCT01436149|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111261394|NCT01436149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111261395|NCT01436149|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111261396|NCT01436149|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111261397|NCT01436149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111261398|NCT01436149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111261399|NCT01436149|Dopamine Agents|dopamine agents|mesh-ancestor
111261400|NCT01436149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111261401|NCT01415401|Timolol|timolol|mesh-list
111261402|NCT01415401|Brinzolamide|brinzolamide|mesh-list
111261403|NCT01415401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111261404|NCT01415401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111261405|NCT01415401|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111261406|NCT01415401|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111261407|NCT01415401|Adrenergic Agents|adrenergic agents|mesh-ancestor
111261408|NCT01415401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111261409|NCT01415401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111261410|NCT01415401|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111261411|NCT01415401|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111261412|NCT01415401|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
111261413|NCT01414855|Prednisone|prednisone|mesh-list
111261414|NCT01414855|Cyclophosphamide|cyclophosphamide|mesh-list
111261415|NCT01414855|Doxorubicin|doxorubicin|mesh-list
111261416|NCT01414855|Vincristine|vincristine|mesh-list
111261417|NCT01414855|Obinutuzumab|obinutuzumab|mesh-list
111261418|NCT01414855|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111261419|NCT01414855|Immunologic Factors|immunologic factors|mesh-ancestor
111261420|NCT01414855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111261421|NCT01414855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111261422|NCT01414855|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111261423|NCT01414855|Alkylating Agents|alkylating agents|mesh-ancestor
111261424|NCT01414855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111261425|NCT01414855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111261426|NCT01414855|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110978304|NCT03919526|Fludarabine|fludarabine|mesh-list
111261427|NCT01414855|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111261428|NCT01414855|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111261429|NCT01414855|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111261430|NCT01414855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111261431|NCT01414855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111261432|NCT01414855|Glucocorticoids|glucocorticoids|mesh-ancestor
111261433|NCT01414855|Hormones|hormones|mesh-ancestor
111261434|NCT01414855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111261435|NCT01414855|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111261436|NCT01414855|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111261437|NCT01414855|Tubulin Modulators|tubulin modulators|mesh-ancestor
111261438|NCT01414855|Antimitotic Agents|antimitotic agents|mesh-ancestor
111261439|NCT01414855|Mitosis Modulators|mitosis modulators|mesh-ancestor
111261440|NCT01414855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111261441|NCT02074735|Choline|choline|mesh-list
111261442|NCT02074735|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
111261443|NCT02074735|Lipotropic Agents|lipotropic agents|mesh-ancestor
111261444|NCT02074735|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111261445|NCT02074735|Antimetabolites|antimetabolites|mesh-ancestor
111261446|NCT02074735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111261447|NCT02074735|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111261448|NCT02074735|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111261449|NCT02074735|Nootropic Agents|nootropic agents|mesh-ancestor
111261450|NCT01527110|Zanamivir|zanamivir|mesh-list
111261451|NCT01527110|Antiviral Agents|antiviral agents|mesh-ancestor
111261452|NCT01527110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111261453|NCT01527110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111261454|NCT01527110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111261455|NCT01441063|Zidovudine|zidovudine|mesh-list
111261456|NCT01441063|Valganciclovir|valganciclovir|mesh-list
111261457|NCT01441063|Antimetabolites|antimetabolites|mesh-ancestor
111261458|NCT01441063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111261459|NCT01441063|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111261460|NCT01441063|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111261461|NCT01441063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111261462|NCT01441063|Antiviral Agents|antiviral agents|mesh-ancestor
111261463|NCT01441063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111261464|NCT01441063|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111261465|NCT01441063|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111261466|NCT01436071|Fluticasone|fluticasone|mesh-list
111261467|NCT01436071|Xhance|xhance|mesh-list
111261468|NCT01436071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111261469|NCT01436071|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111261470|NCT01436071|Autonomic Agents|autonomic agents|mesh-ancestor
111261471|NCT01436071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111261472|NCT01436071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111261473|NCT01436071|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111261474|NCT01436071|Respiratory System Agents|respiratory system agents|mesh-ancestor
111261475|NCT01436071|Dermatologic Agents|dermatologic agents|mesh-ancestor
111261476|NCT01436071|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111261477|NCT01514864|Dasatinib|dasatinib|mesh-list
111261478|NCT01514864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111261479|NCT01514864|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111261480|NCT01514864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111261481|NCT01514864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111261482|NCT01514240|Mesalamine|mesalamine|mesh-list
111261483|NCT01514240|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111261484|NCT01514240|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111261485|NCT01514240|Analgesics|analgesics|mesh-ancestor
111261486|NCT01514240|Sensory System Agents|sensory system agents|mesh-ancestor
111261487|NCT01514240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111261488|NCT01514240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111261489|NCT01514240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111261490|NCT01514240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111261491|NCT01435759|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
111261492|NCT01435759|Antidepressive Agents|antidepressive agents|mesh-list
111261493|NCT01435759|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111261494|NCT01435759|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111261495|NCT01435759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111261496|NCT01435759|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111261497|NCT01435759|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111261498|NCT01435759|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111261499|NCT01435759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111261500|NCT01435759|Dopamine Agents|dopamine agents|mesh-ancestor
111261501|NCT01435759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111261502|NCT04061239|Cytarabine|cytarabine|mesh-list
111261503|NCT04061239|Azacitidine|azacitidine|mesh-list
111261504|NCT04061239|Daunorubicin|daunorubicin|mesh-list
111261505|NCT04061239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111261506|NCT04061239|Antimetabolites|antimetabolites|mesh-ancestor
111261507|NCT04061239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111261508|NCT04061239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111261509|NCT04061239|Antiviral Agents|antiviral agents|mesh-ancestor
111261510|NCT04061239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111261511|NCT04061239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111261512|NCT04061239|Immunologic Factors|immunologic factors|mesh-ancestor
111261513|NCT04061239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111261514|NCT04061239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111261515|NCT04061239|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111261516|NCT04061239|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111261517|NCT04061239|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111261518|NCT01393405|Methotrexate|methotrexate|mesh-list
111261519|NCT01393405|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111261520|NCT01393405|Abortifacient Agents|abortifacient agents|mesh-ancestor
111261521|NCT01393405|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111261522|NCT01393405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111261523|NCT01393405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111261524|NCT01393405|Antimetabolites|antimetabolites|mesh-ancestor
111261525|NCT01393405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111261526|NCT01393405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111261527|NCT01393405|Dermatologic Agents|dermatologic agents|mesh-ancestor
111261528|NCT01393405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111261529|NCT01393405|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111261530|NCT01393405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111261531|NCT01393405|Immunologic Factors|immunologic factors|mesh-ancestor
110985856|NCT02402972|Protective Agents|protective agents|mesh-ancestor
111261532|NCT01393405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111261533|NCT01393405|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111261534|NCT01419197|Trastuzumab|trastuzumab|mesh-list
111261535|NCT01419197|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
111261536|NCT01419197|Maytansine|maytansine|mesh-list
111261537|NCT01419197|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111261538|NCT01419197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111261539|NCT01419197|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111261540|NCT01419197|Tubulin Modulators|tubulin modulators|mesh-ancestor
111261541|NCT01419197|Antimitotic Agents|antimitotic agents|mesh-ancestor
111261542|NCT01419197|Mitosis Modulators|mitosis modulators|mesh-ancestor
111261543|NCT01419197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111261544|NCT01419197|Immunotoxins|immunotoxins|mesh-ancestor
111261545|NCT01419197|Immunoconjugates|immunoconjugates|mesh-ancestor
111261546|NCT01419197|Immunologic Factors|immunologic factors|mesh-ancestor
111261547|NCT01419197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111261548|NCT01414075|Iron|iron|mesh-list
111261549|NCT01414075|Trace Elements|trace elements|mesh-ancestor
111261550|NCT01414075|Micronutrients|micronutrients|mesh-ancestor
111261551|NCT01414075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111261552|NCT01513460|Glycopyrrolate|glycopyrrolate|mesh-list
111261553|NCT01513460|Tiotropium Bromide|tiotropium bromide|mesh-list
111261554|NCT01513460|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111261555|NCT01513460|Autonomic Agents|autonomic agents|mesh-ancestor
111261556|NCT01513460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111261557|NCT01513460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111261558|NCT01513460|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111261559|NCT01513460|Respiratory System Agents|respiratory system agents|mesh-ancestor
111261560|NCT01513460|Parasympatholytics|parasympatholytics|mesh-ancestor
111261561|NCT01513460|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111261562|NCT01513460|Cholinergic Agents|cholinergic agents|mesh-ancestor
111261563|NCT01513460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111261564|NCT01513460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111261565|NCT01513460|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111261566|NCT01513460|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111261567|NCT01418339|Aripiprazole|aripiprazole|mesh-list
111261568|NCT01418339|Antidepressive Agents|antidepressive agents|mesh-ancestor
111261569|NCT01418339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111261570|NCT01418339|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111261571|NCT01418339|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111261572|NCT01418339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111261573|NCT01418339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111261574|NCT01418339|Dopamine Agonists|dopamine agonists|mesh-ancestor
111261575|NCT01418339|Dopamine Agents|dopamine agents|mesh-ancestor
111261576|NCT01418339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111261577|NCT01418339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111261578|NCT01418339|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111261579|NCT01418339|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111261580|NCT01418339|Serotonin Agents|serotonin agents|mesh-ancestor
111261581|NCT01418339|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111261582|NCT01418339|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111261583|NCT01418339|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111261584|NCT01418339|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111261585|NCT01417481|Glycine|glycine|mesh-list
111261586|NCT01417481|Glycine Agents|glycine agents|mesh-ancestor
111261587|NCT01417481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111261588|NCT01417481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111261589|NCT01417481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111261590|NCT01392469|Imatinib Mesylate|imatinib mesylate|mesh-list
111261591|NCT01392469|Bosentan|bosentan|mesh-list
111261592|NCT01392469|Sildenafil Citrate|sildenafil citrate|mesh-list
111261593|NCT01392469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111261594|NCT01392469|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111261595|NCT01392469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111261596|NCT01392469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111261597|NCT01392469|Vasodilator Agents|vasodilator agents|mesh-ancestor
111261598|NCT01392469|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111261599|NCT01392469|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111261600|NCT01392469|Urological Agents|urological agents|mesh-ancestor
111261601|NCT01392469|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111261602|NCT01392469|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
111261603|NCT01435577|Tapentadol|tapentadol|mesh-list
111261604|NCT01435577|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111261605|NCT01435577|Narcotics|narcotics|mesh-ancestor
111261606|NCT01435577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111261607|NCT01435577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111261609|NCT01435577|Sensory System Agents|sensory system agents|mesh-ancestor
111261610|NCT01435577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111261611|NCT01435577|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111261612|NCT01435577|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111261613|NCT01435577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111261614|NCT01435577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111261615|NCT01435577|Adrenergic Agents|adrenergic agents|mesh-ancestor
111261616|NCT01435577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111261617|NCT04039087|Sildenafil Citrate|sildenafil citrate|mesh-list
111261618|NCT04039087|Vasodilator Agents|vasodilator agents|mesh-ancestor
111261619|NCT04039087|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111261620|NCT04039087|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111261621|NCT04039087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111261622|NCT04039087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111261623|NCT04039087|Urological Agents|urological agents|mesh-ancestor
111261624|NCT01411891|Chlorhexidine|chlorhexidine|mesh-list
111261625|NCT01411891|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111261626|NCT01411891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111261627|NCT01411891|Disinfectants|disinfectants|mesh-ancestor
111261628|NCT01416389|Lenograstim|lenograstim|mesh-list
111261629|NCT01416389|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111261630|NCT01416389|Immunologic Factors|immunologic factors|mesh-ancestor
111261631|NCT01416389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111261632|NCT04497155|Norepinephrine|norepinephrine|mesh-list
111261633|NCT04497155|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111261634|NCT04497155|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111261635|NCT04497155|Adrenergic Agents|adrenergic agents|mesh-ancestor
111261636|NCT04497155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111261637|NCT04497155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111261638|NCT04497155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111261639|NCT04497155|Sympathomimetics|sympathomimetics|mesh-ancestor
111261640|NCT04497155|Autonomic Agents|autonomic agents|mesh-ancestor
111261641|NCT04497155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111261642|NCT04497155|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111261643|NCT01544348|Omalizumab|omalizumab|mesh-list
111261644|NCT01544348|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111261645|NCT01544348|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111261646|NCT01544348|Respiratory System Agents|respiratory system agents|mesh-ancestor
111261647|NCT01416155|Natalizumab|natalizumab|mesh-list
111261648|NCT01416155|Immunologic Factors|immunologic factors|mesh-ancestor
111261649|NCT01416155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111261650|NCT01415921|Bromides|bromides|mesh-list
111261651|NCT01415921|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
111261652|NCT01415921|Anticonvulsants|anticonvulsants|mesh-ancestor
111261653|NCT01415921|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111261654|NCT01415921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111261655|NCT01415921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111261656|NCT01415921|Cholinergic Agents|cholinergic agents|mesh-ancestor
111261657|NCT01415921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111261658|NCT01415921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111261659|NCT01415531|Nebivolol|nebivolol|mesh-list
111261660|NCT01415531|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111261661|NCT01415531|Vasodilator Agents|vasodilator agents|mesh-ancestor
111261662|NCT01415531|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
111261663|NCT01415531|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111261664|NCT01415531|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111261665|NCT01415531|Adrenergic Agents|adrenergic agents|mesh-ancestor
111261666|NCT01415531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111261667|NCT01415531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111261668|NCT01415531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111261669|NCT01544114|Naproxen|naproxen|mesh-list
111261670|NCT01544114|Esomeprazole|esomeprazole|mesh-list
111261671|NCT01544114|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111261672|NCT01544114|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111261673|NCT01544114|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111261674|NCT01544114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111261675|NCT01544114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111261676|NCT01544114|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111261677|NCT01544114|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111261678|NCT01544114|Analgesics|analgesics|mesh-ancestor
111261679|NCT01544114|Sensory System Agents|sensory system agents|mesh-ancestor
111261680|NCT01544114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111261681|NCT01544114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111261682|NCT01544114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111261683|NCT01544114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111261684|NCT01544114|Gout Suppressants|gout suppressants|mesh-ancestor
111261685|NCT01544114|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111261686|NCT01410799|Hormones|hormones|mesh-list
111261687|NCT01410799|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
111261688|NCT01410799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111261689|NCT01410799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111261690|NCT01432171|Lacosamide|lacosamide|mesh-list
111261691|NCT01432171|Anticonvulsants|anticonvulsants|mesh-ancestor
111261692|NCT01432171|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111261693|NCT01432171|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111261694|NCT01432171|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111261695|NCT01432171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111261696|NCT04046263|Ferric Compounds|ferric compounds|mesh-list
111261697|NCT04046263|Hematinics|hematinics|mesh-ancestor
111261698|NCT01414205|Obinutuzumab|obinutuzumab|mesh-list
111261699|NCT01414205|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111261700|NCT01414205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111261701|NCT01413503|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
111261702|NCT01413503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111261703|NCT01413503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111261704|NCT01413503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111261705|NCT01413503|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111261706|NCT01413191|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111261707|NCT01413191|Immunologic Factors|immunologic factors|mesh-ancestor
111261708|NCT01413191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111261709|NCT05021562|Niraparib|niraparib|mesh-list
111261710|NCT05021562|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111261711|NCT05021562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111261712|NCT05021562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111261713|NCT05021562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111261714|NCT01412957|Panitumumab|panitumumab|mesh-list
111261715|NCT01412957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111261716|NCT01412957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111261717|NCT04973826|Aztreonam|aztreonam|mesh-list
111261718|NCT04973826|Avibactam|avibactam|mesh-list
111261719|NCT04973826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110713849|NCT03950362|Avelumab|avelumab|mesh-list
111261720|NCT04973826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111261721|NCT04973826|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
111261722|NCT04973826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111261723|NCT04973826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111261724|NCT05387616|Obinutuzumab|obinutuzumab|mesh-list
111261725|NCT05387616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111261726|NCT05387616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111261727|NCT03025841|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
111261728|NCT03025841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111261729|NCT03025841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111261730|NCT01432457|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
111261731|NCT01432457|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111261732|NCT01432457|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111261733|NCT01432457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111261734|NCT01432457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111261735|NCT01432457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111261736|NCT01432457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111261737|NCT01432457|Antidepressive Agents|antidepressive agents|mesh-ancestor
111261738|NCT01432457|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111261739|NCT05062278|Hydroxyurea|hydroxyurea|mesh-list
111261740|NCT05062278|Vinblastine|vinblastine|mesh-list
111261741|NCT05062278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111261742|NCT05062278|Antisickling Agents|antisickling agents|mesh-ancestor
111261743|NCT05062278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111261744|NCT05062278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111261745|NCT05062278|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111261746|NCT05062278|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111261747|NCT05062278|Tubulin Modulators|tubulin modulators|mesh-ancestor
111261748|NCT05062278|Antimitotic Agents|antimitotic agents|mesh-ancestor
111261749|NCT05062278|Mitosis Modulators|mitosis modulators|mesh-ancestor
111261750|NCT02823990|Nivolumab|nivolumab|mesh-list
111261751|NCT02823990|Interleukin-2|interleukin-2|mesh-list
111261752|NCT02823990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111261753|NCT02823990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111261754|NCT02823990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111261755|NCT02823990|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111261756|NCT02823990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111261757|NCT02823990|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111261758|NCT02823990|Analgesics|analgesics|mesh-ancestor
111261759|NCT02823990|Sensory System Agents|sensory system agents|mesh-ancestor
111261760|NCT02823990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111261761|NCT02427126|Aspirin|aspirin|mesh-list
111261762|NCT02427126|Apixaban|apixaban|mesh-list
111261763|NCT02427126|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111261764|NCT02427126|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111261765|NCT02427126|Analgesics|analgesics|mesh-ancestor
111261766|NCT02427126|Sensory System Agents|sensory system agents|mesh-ancestor
111261767|NCT02427126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111261768|NCT02427126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111261769|NCT02427126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111261770|NCT02427126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111261771|NCT02427126|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111261772|NCT02427126|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111261773|NCT02427126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111261774|NCT02427126|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111261775|NCT02427126|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111261776|NCT02427126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111261777|NCT02427126|Antipyretics|antipyretics|mesh-ancestor
111261778|NCT02427126|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111261779|NCT02427126|Antithrombins|antithrombins|mesh-ancestor
111261780|NCT02427126|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111261781|NCT02427126|Protease Inhibitors|protease inhibitors|mesh-ancestor
111261782|NCT02427126|Anticoagulants|anticoagulants|mesh-ancestor
111261783|NCT04807920|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111261784|NCT04807920|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111261785|NCT04807920|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111261786|NCT04807920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111261787|NCT04807920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111261788|NCT04807920|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111261789|NCT04807920|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111261790|NCT04807920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111261791|NCT04807920|Cholinergic Agents|cholinergic agents|mesh-ancestor
111261792|NCT04807920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111261793|NCT00658515|Dalcetrapib|dalcetrapib|mesh-list
111261794|NCT00658515|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111261795|NCT00658515|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111261796|NCT00658515|Antimetabolites|antimetabolites|mesh-ancestor
111261797|NCT00658515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111261798|NCT00658515|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111261799|NCT04797312|Sufentanil|sufentanil|mesh-list
111261800|NCT04797312|Remifentanil|remifentanil|mesh-list
111261801|NCT04797312|Analgesics, Opioid|analgesics, opioid|mesh-list
111261802|NCT04797312|Anesthetics|anesthetics|mesh-ancestor
111261803|NCT04797312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111261804|NCT04797312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111261805|NCT04797312|Narcotics|narcotics|mesh-ancestor
111261806|NCT04797312|Analgesics|analgesics|mesh-ancestor
111261807|NCT04797312|Sensory System Agents|sensory system agents|mesh-ancestor
111261808|NCT04797312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111261809|NCT04797312|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111261810|NCT04797312|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111261811|NCT04797312|Anesthetics, General|anesthetics, general|mesh-ancestor
111261812|NCT05080140|Ezetimibe|ezetimibe|mesh-list
111261813|NCT05080140|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111261814|NCT05080140|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111261815|NCT05080140|Antimetabolites|antimetabolites|mesh-ancestor
111261816|NCT05080140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111261817|NCT05080140|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111261818|NCT01390441|Acetaminophen|acetaminophen|mesh-list
111261819|NCT01390441|Loratadine|loratadine|mesh-list
111261820|NCT01390441|Methylprednisolone|methylprednisolone|mesh-list
111261821|NCT01390441|Rituximab|rituximab|mesh-list
111261822|NCT01390441|Methotrexate|methotrexate|mesh-list
111261823|NCT01390441|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111261824|NCT01390441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111261825|NCT01390441|Immunologic Factors|immunologic factors|mesh-ancestor
111261826|NCT01390441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111261827|NCT01390441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111261828|NCT01390441|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111261829|NCT01390441|Abortifacient Agents|abortifacient agents|mesh-ancestor
111261830|NCT01390441|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111261831|NCT01390441|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111261832|NCT01390441|Antimetabolites|antimetabolites|mesh-ancestor
111261833|NCT01390441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111261834|NCT01390441|Dermatologic Agents|dermatologic agents|mesh-ancestor
111261835|NCT01390441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111261836|NCT01390441|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111261837|NCT01390441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111261838|NCT01390441|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111261839|NCT01390441|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111261840|NCT01390441|Analgesics|analgesics|mesh-ancestor
111261841|NCT01390441|Sensory System Agents|sensory system agents|mesh-ancestor
111261842|NCT01390441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111261843|NCT01390441|Antipyretics|antipyretics|mesh-ancestor
111261844|NCT01390441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111261845|NCT01390441|Antiemetics|antiemetics|mesh-ancestor
111261846|NCT01390441|Autonomic Agents|autonomic agents|mesh-ancestor
111261847|NCT01390441|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111261848|NCT01390441|Glucocorticoids|glucocorticoids|mesh-ancestor
111261849|NCT01390441|Hormones|hormones|mesh-ancestor
111261850|NCT01390441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111261851|NCT01390441|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111261852|NCT01390441|Protective Agents|protective agents|mesh-ancestor
111261853|NCT01390441|Antipruritics|antipruritics|mesh-ancestor
111261854|NCT01390441|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111261855|NCT01390441|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
111261856|NCT01390441|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111261857|NCT01390441|Histamine Antagonists|histamine antagonists|mesh-ancestor
111261858|NCT01390441|Histamine Agents|histamine agents|mesh-ancestor
111261859|NCT01390441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111261860|NCT03142542|Udenafil|udenafil|mesh-list
111261861|NCT03142542|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111261862|NCT03142542|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111261863|NCT03142542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111261864|NCT03142542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111261865|NCT03025867|Niraparib|niraparib|mesh-list
111261866|NCT03025867|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111261867|NCT03025867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111261868|NCT03025867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111261869|NCT03025867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111261870|NCT01412879|Leucovorin|leucovorin|mesh-list
111261871|NCT01412879|Cytarabine|cytarabine|mesh-list
111261872|NCT01412879|Dexamethasone|dexamethasone|mesh-list
111261873|NCT01412879|Cyclophosphamide|cyclophosphamide|mesh-list
111261874|NCT01412879|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
111261875|NCT01412879|Rituximab|rituximab|mesh-list
111261876|NCT01412879|Doxorubicin|doxorubicin|mesh-list
111261877|NCT01412879|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111261878|NCT01412879|Methotrexate|methotrexate|mesh-list
111261879|NCT01412879|Vincristine|vincristine|mesh-list
111261880|NCT01412879|Levoleucovorin|levoleucovorin|mesh-list
111261881|NCT01412879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111261882|NCT01412879|Immunologic Factors|immunologic factors|mesh-ancestor
111261883|NCT01412879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111261884|NCT01412879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111261885|NCT01412879|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111261886|NCT01412879|Alkylating Agents|alkylating agents|mesh-ancestor
111261887|NCT01412879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111261888|NCT01412879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111261889|NCT01412879|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111261890|NCT01412879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111261891|NCT01412879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111261892|NCT01412879|Antiemetics|antiemetics|mesh-ancestor
111261893|NCT01412879|Autonomic Agents|autonomic agents|mesh-ancestor
111261894|NCT01412879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111261895|NCT01412879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111261896|NCT01412879|Glucocorticoids|glucocorticoids|mesh-ancestor
111261897|NCT01412879|Hormones|hormones|mesh-ancestor
111261898|NCT01412879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111261899|NCT01412879|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111261900|NCT01412879|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111261901|NCT01412879|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111261902|NCT01412879|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111261903|NCT01412879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111261904|NCT01412879|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111261905|NCT01412879|Abortifacient Agents|abortifacient agents|mesh-ancestor
111261906|NCT01412879|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111261907|NCT01412879|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111261908|NCT01412879|Antimetabolites|antimetabolites|mesh-ancestor
111261909|NCT01412879|Dermatologic Agents|dermatologic agents|mesh-ancestor
111261910|NCT01412879|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111261911|NCT01412879|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111261912|NCT01412879|Antiviral Agents|antiviral agents|mesh-ancestor
111261913|NCT01412879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111261914|NCT01412879|Antidotes|antidotes|mesh-ancestor
111261915|NCT01412879|Protective Agents|protective agents|mesh-ancestor
111261916|NCT01412879|Vitamin B Complex|vitamin b complex|mesh-ancestor
111261917|NCT01412879|Vitamins|vitamins|mesh-ancestor
111261918|NCT01412879|Micronutrients|micronutrients|mesh-ancestor
111261919|NCT01412879|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111261920|NCT01412879|Tubulin Modulators|tubulin modulators|mesh-ancestor
111261921|NCT01412879|Antimitotic Agents|antimitotic agents|mesh-ancestor
111261922|NCT01412879|Mitosis Modulators|mitosis modulators|mesh-ancestor
111261923|NCT03143010|Dexmedetomidine|dexmedetomidine|mesh-list
111261924|NCT03143010|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111261925|NCT03143010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111261926|NCT03143010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111261927|NCT03143010|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111261928|NCT03143010|Analgesics|analgesics|mesh-ancestor
111261929|NCT03143010|Sensory System Agents|sensory system agents|mesh-ancestor
111261930|NCT03143010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111261931|NCT03143010|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111261932|NCT03143010|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111261933|NCT03143010|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111261934|NCT03143010|Adrenergic Agents|adrenergic agents|mesh-ancestor
111261935|NCT03143010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111261936|NCT03143010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111261937|NCT03142776|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111261938|NCT03142776|Clarithromycin|clarithromycin|mesh-list
111261939|NCT03142776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111261940|NCT03142776|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111261941|NCT03142776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111261942|NCT03142776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111261943|NCT03142776|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111261944|NCT03142776|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111261945|NCT01430611|Vaccines|vaccines|mesh-list
111261946|NCT01430611|Immunologic Factors|immunologic factors|mesh-ancestor
111261947|NCT01430611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111261948|NCT03140826|Meropenem|meropenem|mesh-list
111261949|NCT03140826|Tazobactam|tazobactam|mesh-list
111261950|NCT03140826|Piperacillin|piperacillin|mesh-list
111261951|NCT03140826|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
111261952|NCT03140826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111261953|NCT03140826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111261954|NCT03140826|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
111261955|NCT03140826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111261956|NCT03140826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111261957|NCT01389973|Ustekinumab|ustekinumab|mesh-list
111261958|NCT01389973|Dermatologic Agents|dermatologic agents|mesh-ancestor
111261959|NCT04529460|Antibodies|antibodies|mesh-list
111261960|NCT04529460|Immunologic Factors|immunologic factors|mesh-ancestor
111261961|NCT04529460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111261962|NCT04032067|Finasteride|finasteride|mesh-list
111261963|NCT04032067|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
111261964|NCT04032067|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111261965|NCT04032067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111261966|NCT04032067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111261967|NCT04032067|Hormone Antagonists|hormone antagonists|mesh-ancestor
111261968|NCT04032067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111261969|NCT04032067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111261970|NCT04032067|Urological Agents|urological agents|mesh-ancestor
111261971|NCT00659295|Insulin Detemir|insulin detemir|mesh-list
111261972|NCT00659295|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111261973|NCT00659295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111261974|NCT01430455|Tranylcypromine|tranylcypromine|mesh-list
111261975|NCT01430455|Antidepressive Agents|antidepressive agents|mesh-ancestor
111261976|NCT01430455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111261977|NCT01430455|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
111261978|NCT01430455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111261979|NCT01430455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111261980|NCT01430455|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110986304|NCT03504033|Desflurane|desflurane|mesh-list
111261981|NCT01430455|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111261982|NCT01430455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111261983|NCT01430455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111261985|NCT04051957|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
111261986|NCT04051957|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
111261987|NCT04051957|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
111261988|NCT04051957|Diuretics|diuretics|mesh-ancestor
111261989|NCT04051957|Natriuretic Agents|natriuretic agents|mesh-ancestor
111261990|NCT04051957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111261991|NCT04051957|Vasodilator Agents|vasodilator agents|mesh-ancestor
111261992|NCT04051957|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
111261993|NCT04051957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111261994|NCT00591123|Leucovorin|leucovorin|mesh-list
111261995|NCT00591123|Fluorouracil|fluorouracil|mesh-list
111261996|NCT00591123|Oxaliplatin|oxaliplatin|mesh-list
111261997|NCT00591123|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111261998|NCT00591123|Levoleucovorin|levoleucovorin|mesh-list
111261999|NCT00591123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111262000|NCT00591123|Antimetabolites|antimetabolites|mesh-ancestor
111262001|NCT00591123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111262002|NCT00591123|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111262003|NCT00591123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111262004|NCT00591123|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111262005|NCT00591123|Immunologic Factors|immunologic factors|mesh-ancestor
111262006|NCT00591123|Antidotes|antidotes|mesh-ancestor
111262007|NCT00591123|Protective Agents|protective agents|mesh-ancestor
111262008|NCT00591123|Vitamin B Complex|vitamin b complex|mesh-ancestor
111262009|NCT00591123|Vitamins|vitamins|mesh-ancestor
111262010|NCT00591123|Micronutrients|micronutrients|mesh-ancestor
111262011|NCT00591123|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111262012|NCT00591123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111262013|NCT04149990|Valsartan|valsartan|mesh-list
111262014|NCT04149990|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
111262015|NCT04149990|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111262016|NCT04149990|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111262017|NCT04149990|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111262018|NCT04149990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111262019|NCT00591825|Cycloserine|cycloserine|mesh-list
111262020|NCT00591825|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111262021|NCT00591825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111262022|NCT00591825|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111262023|NCT00591825|Antitubercular Agents|antitubercular agents|mesh-ancestor
111262024|NCT00591825|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111262025|NCT00591825|Antimetabolites|antimetabolites|mesh-ancestor
111262026|NCT00591825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111262027|NCT01429285|Hydromorphone|hydromorphone|mesh-list
111262028|NCT01429285|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111262029|NCT01429285|Narcotics|narcotics|mesh-ancestor
111262030|NCT01429285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111262031|NCT01429285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111262032|NCT01429285|Analgesics|analgesics|mesh-ancestor
111262033|NCT01429285|Sensory System Agents|sensory system agents|mesh-ancestor
111262034|NCT01429285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111262035|NCT00594945|Clonazepam|clonazepam|mesh-list
111262036|NCT00594945|Anticonvulsants|anticonvulsants|mesh-ancestor
111262037|NCT00594945|GABA Modulators|gaba modulators|mesh-ancestor
111262038|NCT00594945|GABA Agents|gaba agents|mesh-ancestor
111262039|NCT00594945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111262040|NCT00594945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111262041|NCT00594945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111262042|NCT00595101|Latanoprost|latanoprost|mesh-list
111262043|NCT00595101|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
111262044|NCT00595101|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111262045|NCT00660075|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111262046|NCT00660075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111262047|NCT00660075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111262048|NCT00660075|Incretins|incretins|mesh-ancestor
111262049|NCT00660075|Hormones|hormones|mesh-ancestor
111262050|NCT00660075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111262051|NCT00660075|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111262052|NCT00660075|Protease Inhibitors|protease inhibitors|mesh-ancestor
111262053|NCT00660075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111262054|NCT00660075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111262055|NCT05174052|Dapagliflozin|dapagliflozin|mesh-list
111262056|NCT05174052|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111262057|NCT05174052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111262058|NCT05174052|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111262059|NCT05174052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111262060|NCT01429051|Fentanyl|fentanyl|mesh-list
111262061|NCT01429051|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111262062|NCT01429051|Narcotics|narcotics|mesh-ancestor
111262063|NCT01429051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111262064|NCT01429051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111262065|NCT01429051|Analgesics|analgesics|mesh-ancestor
111262066|NCT01429051|Sensory System Agents|sensory system agents|mesh-ancestor
111262067|NCT01429051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111262068|NCT01429051|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111262069|NCT01429051|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111262070|NCT01429051|Anesthetics, General|anesthetics, general|mesh-ancestor
111262071|NCT01429051|Anesthetics|anesthetics|mesh-ancestor
111262072|NCT03968562|Doxycycline|doxycycline|mesh-list
111262073|NCT03968562|Petrolatum|petrolatum|mesh-list
111262074|NCT03968562|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111262075|NCT03968562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111262076|NCT03968562|Antimalarials|antimalarials|mesh-ancestor
111262077|NCT03968562|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111262078|NCT03968562|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111262079|NCT03968562|Emollients|emollients|mesh-ancestor
111262080|NCT03968562|Dermatologic Agents|dermatologic agents|mesh-ancestor
111262081|NCT03425292|Bevacizumab|bevacizumab|mesh-list
111262082|NCT03425292|Nivolumab|nivolumab|mesh-list
111262083|NCT03425292|Ipilimumab|ipilimumab|mesh-list
111262084|NCT03425292|Temozolomide|temozolomide|mesh-list
111262085|NCT03425292|Lomustine|lomustine|mesh-list
110978317|NCT05492812|Antioxidants|antioxidants|mesh-ancestor
111262086|NCT03425292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111262087|NCT03425292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111262088|NCT03425292|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111262089|NCT03425292|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111262090|NCT03425292|Growth Substances|growth substances|mesh-ancestor
111262091|NCT03425292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111262092|NCT03425292|Growth Inhibitors|growth inhibitors|mesh-ancestor
111262093|NCT03425292|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111262094|NCT03425292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111262095|NCT03425292|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111262096|NCT03425292|Alkylating Agents|alkylating agents|mesh-ancestor
111262097|NCT00596271|Vaccines|vaccines|mesh-list
111262098|NCT00596271|Immunologic Factors|immunologic factors|mesh-ancestor
111262099|NCT00596271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111262100|NCT03139422|Tranexamic Acid|tranexamic acid|mesh-list
111262101|NCT03139422|Calcium Dobesilate|calcium dobesilate|mesh-list
111262102|NCT03139422|Calcium|calcium|mesh-list
111262103|NCT03139422|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111262104|NCT03139422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111262105|NCT03139422|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111262106|NCT03139422|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111262107|NCT03139422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111262108|NCT03139422|Hemostatics|hemostatics|mesh-ancestor
111262109|NCT03139422|Coagulants|coagulants|mesh-ancestor
111262110|NCT01428583|Naltrexone|naltrexone|mesh-list
111262111|NCT01428583|Oxycodone|oxycodone|mesh-list
111262112|NCT01428583|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111262113|NCT01428583|Narcotics|narcotics|mesh-ancestor
111262114|NCT01428583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111262115|NCT01428583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111262116|NCT01428583|Analgesics|analgesics|mesh-ancestor
111262117|NCT01428583|Sensory System Agents|sensory system agents|mesh-ancestor
111262118|NCT01428583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111262119|NCT01428583|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111262120|NCT01428583|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111262121|NCT00660543|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
111262122|NCT00660543|Hematinics|hematinics|mesh-ancestor
111262123|NCT00660543|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
111262124|NCT00660543|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111262125|NCT01428193|Flutamide|flutamide|mesh-list
111262126|NCT01428193|Estradiol|estradiol|mesh-list
111262127|NCT01428193|Progesterone|progesterone|mesh-list
111262128|NCT01428193|Estrogens|estrogens|mesh-ancestor
111262129|NCT01428193|Hormones|hormones|mesh-ancestor
111262130|NCT01428193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111262131|NCT01428193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111262132|NCT01428193|Progestins|progestins|mesh-ancestor
111262133|NCT01428193|Androgen Antagonists|androgen antagonists|mesh-ancestor
111262134|NCT01428193|Hormone Antagonists|hormone antagonists|mesh-ancestor
111262135|NCT01428193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111262136|NCT01428193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111262137|NCT03864276|Propofol|propofol|mesh-list
111262138|NCT03864276|Desflurane|desflurane|mesh-list
111262139|NCT03864276|Anesthetics|anesthetics|mesh-ancestor
111262140|NCT03864276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111262141|NCT03864276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111262142|NCT03864276|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111262143|NCT03864276|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111262144|NCT03864276|Anesthetics, General|anesthetics, general|mesh-ancestor
111262145|NCT03864276|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111262146|NCT05083026|Antibodies|antibodies|mesh-list
111262147|NCT05083026|Antibodies, Blocking|antibodies, blocking|mesh-list
111262148|NCT05083026|Immunologic Factors|immunologic factors|mesh-ancestor
111262149|NCT05083026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111262150|NCT03141918|Curcumin|curcumin|mesh-list
111262151|NCT03141918|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111262152|NCT03141918|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111262153|NCT03141918|Analgesics|analgesics|mesh-ancestor
111262154|NCT03141918|Sensory System Agents|sensory system agents|mesh-ancestor
111262155|NCT03141918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111262156|NCT03141918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111262157|NCT03141918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111262158|NCT03141918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111262159|NCT03141918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111262160|NCT03141918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111262161|NCT03141918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111262162|NCT01427803|Naproxen|naproxen|mesh-list
111262163|NCT01427803|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111262164|NCT01427803|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111262165|NCT01427803|Analgesics|analgesics|mesh-ancestor
111262166|NCT01427803|Sensory System Agents|sensory system agents|mesh-ancestor
111262167|NCT01427803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111262168|NCT01427803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111262169|NCT01427803|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111262170|NCT01427803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111262171|NCT01427803|Gout Suppressants|gout suppressants|mesh-ancestor
111262172|NCT01427803|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111262173|NCT01427803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111262174|NCT01427803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111262175|NCT03139500|Midazolam|midazolam|mesh-list
111262176|NCT03139500|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111262177|NCT03139500|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111262178|NCT03139500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111262179|NCT03139500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111262180|NCT03139500|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111262181|NCT03139500|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111262182|NCT03139500|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111262183|NCT03139500|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111262184|NCT03139500|Anesthetics, General|anesthetics, general|mesh-ancestor
111262185|NCT03139500|Anesthetics|anesthetics|mesh-ancestor
111262186|NCT03139500|GABA Modulators|gaba modulators|mesh-ancestor
111262187|NCT03139500|GABA Agents|gaba agents|mesh-ancestor
111262188|NCT03139500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111262189|NCT03139500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111262190|NCT00661479|Brimonidine Tartrate|brimonidine tartrate|mesh-list
111262191|NCT00661479|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111262192|NCT00661479|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111262193|NCT00661479|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111262194|NCT00661479|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111262195|NCT00661479|Adrenergic Agents|adrenergic agents|mesh-ancestor
111262196|NCT00661479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111262197|NCT00661479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111262198|NCT00661479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111262199|NCT04476966|Mirabegron|mirabegron|mesh-list
111262200|NCT04476966|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
111262201|NCT04476966|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111262202|NCT04476966|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111262203|NCT04476966|Adrenergic Agents|adrenergic agents|mesh-ancestor
111262204|NCT04476966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111262205|NCT04476966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111262206|NCT04476966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111262207|NCT04476966|Urological Agents|urological agents|mesh-ancestor
111262208|NCT03821610|Cyclophosphamide|cyclophosphamide|mesh-list
110986555|NCT02441439|Iron|iron|mesh-list
111262209|NCT03821610|Melphalan|melphalan|mesh-list
111262210|NCT03821610|Fludarabine|fludarabine|mesh-list
111262211|NCT03821610|Alemtuzumab|alemtuzumab|mesh-list
111262212|NCT03821610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111262213|NCT03821610|Immunologic Factors|immunologic factors|mesh-ancestor
111262214|NCT03821610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111262215|NCT03821610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111262216|NCT03821610|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111262217|NCT03821610|Alkylating Agents|alkylating agents|mesh-ancestor
111262218|NCT03821610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111262219|NCT03821610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111262220|NCT03821610|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111262221|NCT03821610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111262222|NCT00683163|Ibandronic Acid|ibandronic acid|mesh-list
111262223|NCT00683163|Parathyroid Hormone|parathyroid hormone|mesh-list
111262224|NCT00683163|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111262225|NCT00683163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111262226|NCT00683163|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111262227|NCT04044001|Isoniazid|isoniazid|mesh-list
111262228|NCT04044001|Pyrazinamide|pyrazinamide|mesh-list
111262229|NCT04044001|Ethambutol|ethambutol|mesh-list
111262230|NCT04044001|Dolutegravir|dolutegravir|mesh-list
111262231|NCT04044001|Antitubercular Agents|antitubercular agents|mesh-ancestor
111262232|NCT04044001|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111262233|NCT04044001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111262234|NCT04044001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111262235|NCT04044001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111262236|NCT04044001|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
111262237|NCT04044001|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111262238|NCT04044001|Antimetabolites|antimetabolites|mesh-ancestor
111262239|NCT04044001|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111262240|NCT04044001|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111262241|NCT04044001|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111262242|NCT04044001|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111262243|NCT04044001|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111262244|NCT04044001|Antiviral Agents|antiviral agents|mesh-ancestor
111262245|NCT00684723|Lovastatin|lovastatin|mesh-list
111262246|NCT00684723|L 647318|l 647318|mesh-list
111262247|NCT00684723|Dihydromevinolin|dihydromevinolin|mesh-list
111262248|NCT00684723|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111262249|NCT00684723|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111262250|NCT00684723|Antimetabolites|antimetabolites|mesh-ancestor
111262251|NCT00684723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111262252|NCT00684723|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111262253|NCT00684723|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111262254|NCT00684723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111262255|NCT01405027|Interferons|interferons|mesh-list
111262256|NCT01405027|Ribavirin|ribavirin|mesh-list
111262257|NCT01405027|Interferon-alpha|interferon-alpha|mesh-list
111262258|NCT01405027|Interferon alpha-2|interferon alpha-2|mesh-list
111262259|NCT01405027|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
111262260|NCT01405027|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
111262261|NCT01405027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111262262|NCT01405027|Antiviral Agents|antiviral agents|mesh-ancestor
111262263|NCT01405027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111262264|NCT01405027|Antimetabolites|antimetabolites|mesh-ancestor
111262265|NCT01405027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111262266|NCT01405027|Immunologic Factors|immunologic factors|mesh-ancestor
111262267|NCT01405027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111262268|NCT00663039|Oxytocin|oxytocin|mesh-list
111262269|NCT00663039|Oxytocics|oxytocics|mesh-ancestor
111262270|NCT00663039|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111262271|NCT00663039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111262272|NCT04387539|Sofosbuvir|sofosbuvir|mesh-list
111262273|NCT04387539|Simeprevir|simeprevir|mesh-list
111262274|NCT04387539|Antiviral Agents|antiviral agents|mesh-ancestor
111262275|NCT04387539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111262276|NCT04387539|Protease Inhibitors|protease inhibitors|mesh-ancestor
111262277|NCT04387539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111262278|NCT04387539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111262279|NCT00664755|Nicotine|nicotine|mesh-list
111262280|NCT00664755|Varenicline|varenicline|mesh-list
111262281|NCT00664755|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111262282|NCT00664755|Autonomic Agents|autonomic agents|mesh-ancestor
111262283|NCT00664755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111262284|NCT00664755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111262285|NCT00664755|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111262286|NCT00664755|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111262287|NCT00664755|Cholinergic Agents|cholinergic agents|mesh-ancestor
111262288|NCT00664755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111262289|NCT00664755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111262290|NCT01525628|Tolbutamide|tolbutamide|mesh-list
111262291|NCT01525628|Interferons|interferons|mesh-list
111262292|NCT01525628|Tenofovir|tenofovir|mesh-list
111262293|NCT01525628|Ribavirin|ribavirin|mesh-list
111262294|NCT01525628|Midazolam|midazolam|mesh-list
111262295|NCT01525628|Caffeine|caffeine|mesh-list
111262296|NCT01525628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111262297|NCT01525628|Antiviral Agents|antiviral agents|mesh-ancestor
111262298|NCT01525628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111262299|NCT01525628|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111262300|NCT01525628|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111262301|NCT01525628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111262302|NCT01525628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111262303|NCT01525628|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111262304|NCT01525628|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111262305|NCT01525628|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111262306|NCT01525628|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111262307|NCT01525628|Anesthetics, General|anesthetics, general|mesh-ancestor
111262308|NCT01525628|Anesthetics|anesthetics|mesh-ancestor
111262309|NCT01525628|GABA Modulators|gaba modulators|mesh-ancestor
111262310|NCT01525628|GABA Agents|gaba agents|mesh-ancestor
111262311|NCT01525628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111262312|NCT01525628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111262313|NCT01525628|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111262314|NCT01525628|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111262315|NCT01525628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111262316|NCT01525628|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111262317|NCT01525628|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111262318|NCT01525628|Antimetabolites|antimetabolites|mesh-ancestor
111262319|NCT01525628|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111262320|NCT01525628|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111262321|NCT01525628|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
111262322|NCT01525628|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111262323|NCT01525628|Purinergic Agents|purinergic agents|mesh-ancestor
111262324|NCT01525628|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111262325|NCT02320695|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111262326|NCT02320695|Bacitracin zinc, neomycin sulfate, polymyxin B, drug combination|bacitracin zinc, neomycin sulfate, polymyxin b, drug combination|mesh-list
111262327|NCT02320695|Bacitracin|bacitracin|mesh-list
111262328|NCT02320695|Neomycin|neomycin|mesh-list
111262329|NCT02320695|Polymyxin B|polymyxin b|mesh-list
111262330|NCT02320695|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
111262331|NCT02320695|Ethanol|ethanol|mesh-list
111262332|NCT02320695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111262333|NCT02320695|Antitubercular Agents|antitubercular agents|mesh-ancestor
111262334|NCT02320695|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111262335|NCT02320695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111262336|NCT02320695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111262337|NCT02320695|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111262338|NCT02320695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111262339|NCT02320695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111262340|NCT01426009|Bromides|bromides|mesh-list
111262341|NCT01426009|Tiotropium Bromide|tiotropium bromide|mesh-list
111262342|NCT01426009|Ipratropium|ipratropium|mesh-list
111262343|NCT01426009|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111262344|NCT01426009|Autonomic Agents|autonomic agents|mesh-ancestor
111262345|NCT01426009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111262346|NCT01426009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111262347|NCT01426009|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111262348|NCT01426009|Respiratory System Agents|respiratory system agents|mesh-ancestor
111262349|NCT01426009|Parasympatholytics|parasympatholytics|mesh-ancestor
111262350|NCT01426009|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111262351|NCT01426009|Cholinergic Agents|cholinergic agents|mesh-ancestor
111262352|NCT01426009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111262353|NCT01426009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111262354|NCT01426009|Anticonvulsants|anticonvulsants|mesh-ancestor
111262355|NCT01543958|Sevelamer|sevelamer|mesh-list
111262356|NCT01543958|Chelating Agents|chelating agents|mesh-ancestor
111262357|NCT01543958|Sequestering Agents|sequestering agents|mesh-ancestor
111262358|NCT01543958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111262359|NCT04880928|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111262360|NCT04880928|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111262361|NCT01411085|Risperidone|risperidone|mesh-list
111262362|NCT01411085|Desipramine|desipramine|mesh-list
111262363|NCT01411085|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111262364|NCT01411085|Serotonin Agents|serotonin agents|mesh-ancestor
111262365|NCT01411085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111262366|NCT01411085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111262367|NCT01411085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111262368|NCT01411085|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111262369|NCT01411085|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111262370|NCT01411085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111262371|NCT01411085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111262372|NCT01411085|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111262373|NCT01411085|Dopamine Agents|dopamine agents|mesh-ancestor
111262374|NCT01411085|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
111262375|NCT01411085|Antidepressive Agents|antidepressive agents|mesh-ancestor
111262376|NCT01411085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111262377|NCT01411085|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111262378|NCT01411085|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111262379|NCT01411085|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111262380|NCT01411085|Adrenergic Agents|adrenergic agents|mesh-ancestor
111262381|NCT01404949|Arsenic Trioxide|arsenic trioxide|mesh-list
111262383|NCT01404949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111262384|NCT01404949|Keratolytic Agents|keratolytic agents|mesh-ancestor
111262385|NCT01404949|Dermatologic Agents|dermatologic agents|mesh-ancestor
111262386|NCT01431521|Pioglitazone|pioglitazone|mesh-list
111262387|NCT01431521|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111262388|NCT01431521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111262389|NCT00601965|Escitalopram|escitalopram|mesh-list
111262390|NCT00601965|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111262391|NCT00601965|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111262392|NCT00601965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111262393|NCT00601965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111262394|NCT00601965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111262395|NCT00601965|Serotonin Agents|serotonin agents|mesh-ancestor
111262396|NCT00601965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111262397|NCT04751994|Sorbitol|sorbitol|mesh-list
111262398|NCT04751994|Cathartics|cathartics|mesh-ancestor
111262399|NCT04751994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111262400|NCT00687453|Insulin Glargine|insulin glargine|mesh-list
111262401|NCT00687453|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111262402|NCT00687453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111262403|NCT00602043|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
111262404|NCT00602043|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111262405|NCT00602043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111262406|NCT02998437|Amoxicillin|amoxicillin|mesh-list
111262407|NCT02998437|Clarithromycin|clarithromycin|mesh-list
111262408|NCT02998437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111262409|NCT02998437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111262410|NCT02998437|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111262411|NCT02998437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111262412|NCT02998437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111262413|NCT02998437|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111262414|NCT02998437|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111262415|NCT02618148|Estrogens|estrogens|mesh-list
111262416|NCT02618148|Hormones|hormones|mesh-ancestor
111262417|NCT02618148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111262418|NCT02618148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111262419|NCT04680936|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111262420|NCT01404325|Everolimus|everolimus|mesh-list
111262421|NCT01404325|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111262422|NCT01404325|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111262423|NCT01404325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111262424|NCT01404325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111262425|NCT01404325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111262426|NCT01404325|Immunologic Factors|immunologic factors|mesh-ancestor
111262427|NCT01404325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111262428|NCT01404325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111262429|NCT00602355|Sertraline|sertraline|mesh-list
111262430|NCT00602355|Antidepressive Agents|antidepressive agents|mesh-ancestor
111262431|NCT00602355|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111262432|NCT00602355|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111262433|NCT00602355|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111262434|NCT00602355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111262435|NCT00602355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111262436|NCT00602355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111262437|NCT00602355|Serotonin Agents|serotonin agents|mesh-ancestor
111262438|NCT00602355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111262439|NCT01425463|Glycine|glycine|mesh-list
111262440|NCT01425463|Glycine Agents|glycine agents|mesh-ancestor
111262441|NCT01425463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111262442|NCT01425463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111262443|NCT01425463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111262444|NCT02144259|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
111262445|NCT02144259|Medroxyprogesterone|medroxyprogesterone|mesh-list
111262446|NCT02144259|Etonogestrel|etonogestrel|mesh-list
111262447|NCT02144259|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111262448|NCT02144259|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111262449|NCT02144259|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111262450|NCT02144259|Contraceptive Agents|contraceptive agents|mesh-ancestor
111262451|NCT02144259|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111262452|NCT02144259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111262453|NCT02144259|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111262454|NCT02144259|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111262455|NCT02144259|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
111262456|NCT02144259|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111262457|NCT02144259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111262458|NCT04655586|Heparin|heparin|mesh-list
111262459|NCT04655586|Protein C|protein c|mesh-list
111262460|NCT04655586|Anticoagulants|anticoagulants|mesh-list
111262461|NCT04655586|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111262462|NCT04655586|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111262463|NCT04655586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111262464|NCT01388647|Carboplatin|carboplatin|mesh-list
111262465|NCT01388647|Trastuzumab|trastuzumab|mesh-list
111262466|NCT01388647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111262467|NCT01388647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111262468|NCT03140982|Propofol|propofol|mesh-list
111262469|NCT03140982|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111262470|NCT03140982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111262471|NCT03140982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111262472|NCT03140982|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111262473|NCT03140982|Anesthetics, General|anesthetics, general|mesh-ancestor
111262474|NCT03140982|Anesthetics|anesthetics|mesh-ancestor
111262475|NCT05392686|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
111262476|NCT05392686|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
111262477|NCT05392686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111262478|NCT05392686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111262479|NCT05392686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111262480|NCT05392686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111262481|NCT00705003|Melatonin|melatonin|mesh-list
111262482|NCT00705003|Buspirone|buspirone|mesh-list
111262483|NCT00705003|Antioxidants|antioxidants|mesh-ancestor
111262484|NCT00705003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111262485|NCT00705003|Protective Agents|protective agents|mesh-ancestor
111262486|NCT00705003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111262487|NCT00705003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111262488|NCT00705003|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111262489|NCT00705003|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111262490|NCT00705003|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111262491|NCT00705003|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111262492|NCT00705003|Serotonin Agents|serotonin agents|mesh-ancestor
111262493|NCT00705003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111262494|NCT03110640|Cyclophosphamide|cyclophosphamide|mesh-list
111262495|NCT03110640|Fludarabine|fludarabine|mesh-list
111262496|NCT03110640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111262497|NCT03110640|Immunologic Factors|immunologic factors|mesh-ancestor
111262498|NCT03110640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111262499|NCT03110640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111262500|NCT03110640|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111262501|NCT03110640|Alkylating Agents|alkylating agents|mesh-ancestor
111262502|NCT03110640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111262503|NCT03110640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111262504|NCT03110640|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111262505|NCT00690495|Propofol|propofol|mesh-list
111262506|NCT00690495|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111262507|NCT00690495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111262508|NCT00690495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111262509|NCT00690495|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111262510|NCT00690495|Anesthetics, General|anesthetics, general|mesh-ancestor
111262511|NCT00690495|Anesthetics|anesthetics|mesh-ancestor
111262512|NCT00691197|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
111262513|NCT00691197|Glycerol|glycerol|mesh-list
111262514|NCT00691197|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
111262515|NCT00691197|Protective Agents|protective agents|mesh-ancestor
111262516|NCT00691197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111262517|NCT00691197|Laxatives|laxatives|mesh-ancestor
111262518|NCT00691197|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111262519|NCT02997969|Vaccines|vaccines|mesh-list
111262520|NCT02997969|MF59 oil emulsion|mf59 oil emulsion|mesh-list
111262521|NCT02997969|Immunologic Factors|immunologic factors|mesh-ancestor
111262522|NCT02997969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111262523|NCT02997969|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111262524|NCT04351230|Trastuzumab|trastuzumab|mesh-list
111262525|NCT04351230|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
111262526|NCT04351230|Maytansine|maytansine|mesh-list
111262527|NCT04351230|Immunoconjugates|immunoconjugates|mesh-list
111262528|NCT04351230|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111262529|NCT04351230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111262530|NCT04351230|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111262531|NCT04351230|Tubulin Modulators|tubulin modulators|mesh-ancestor
111262532|NCT04351230|Antimitotic Agents|antimitotic agents|mesh-ancestor
111262533|NCT04351230|Mitosis Modulators|mitosis modulators|mesh-ancestor
111262534|NCT04351230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111262535|NCT04351230|Immunotoxins|immunotoxins|mesh-ancestor
111262536|NCT04351230|Immunologic Factors|immunologic factors|mesh-ancestor
111262537|NCT04351230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111262538|NCT05392374|TIC10 compound|tic10 compound|mesh-list
111262539|NCT05392374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111262540|NCT04028388|Docetaxel|docetaxel|mesh-list
111262541|NCT04028388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111262542|NCT04028388|Tubulin Modulators|tubulin modulators|mesh-ancestor
111262543|NCT04028388|Antimitotic Agents|antimitotic agents|mesh-ancestor
111262544|NCT04028388|Mitosis Modulators|mitosis modulators|mesh-ancestor
111262545|NCT04028388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111262546|NCT01402063|Temozolomide|temozolomide|mesh-list
111262547|NCT01402063|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
111262548|NCT01402063|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111262549|NCT01402063|Alkylating Agents|alkylating agents|mesh-ancestor
111262550|NCT01402063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111262551|NCT01402063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111262552|NCT01796301|Teriparatide|teriparatide|mesh-list
111262553|NCT01796301|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111262554|NCT01796301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111262555|NCT01796301|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111262556|NCT00868179|Dabigatran|dabigatran|mesh-list
111262557|NCT00868179|Antithrombins|antithrombins|mesh-ancestor
111262558|NCT00868179|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111262559|NCT00868179|Protease Inhibitors|protease inhibitors|mesh-ancestor
111262560|NCT00868179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111262561|NCT00868179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111262562|NCT00868179|Anticoagulants|anticoagulants|mesh-ancestor
111262563|NCT01204905|Raltegravir Potassium|raltegravir potassium|mesh-list
111262564|NCT01204905|Maraviroc|maraviroc|mesh-list
111262565|NCT01204905|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111262566|NCT01204905|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111262567|NCT01204905|Antiviral Agents|antiviral agents|mesh-ancestor
111262568|NCT01204905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111262569|NCT01204905|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111262570|NCT01204905|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111262571|NCT01204905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111262572|NCT01204905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111262573|NCT01204905|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
111262574|NCT01204905|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
111262575|NCT01204905|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
111262576|NCT00691665|Fluticasone|fluticasone|mesh-list
111262577|NCT00691665|Xhance|xhance|mesh-list
111262578|NCT00691665|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
111262579|NCT00691665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111262580|NCT00691665|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111262581|NCT00691665|Autonomic Agents|autonomic agents|mesh-ancestor
111262582|NCT00691665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111262583|NCT00691665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111262584|NCT00691665|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110986930|NCT03625739|Antimetabolites|antimetabolites|mesh-ancestor
111262585|NCT00691665|Respiratory System Agents|respiratory system agents|mesh-ancestor
111262586|NCT00691665|Dermatologic Agents|dermatologic agents|mesh-ancestor
111262587|NCT00691665|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111262588|NCT00691665|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111262589|NCT00691665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111262590|NCT00691665|Analgesics|analgesics|mesh-ancestor
111262591|NCT00691665|Sensory System Agents|sensory system agents|mesh-ancestor
111262592|NCT00691665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111262593|NCT00691665|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
111262594|NCT00691665|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111262595|NCT00691665|Histamine Antagonists|histamine antagonists|mesh-ancestor
111262596|NCT00691665|Histamine Agents|histamine agents|mesh-ancestor
111262597|NCT00691665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111262598|NCT00691665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111262599|NCT01388335|Warfarin|warfarin|mesh-list
111262600|NCT01388335|Anticoagulants|anticoagulants|mesh-ancestor
111262601|NCT00713583|Levodopa|levodopa|mesh-list
111262602|NCT00713583|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111262603|NCT00713583|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111262604|NCT00713583|Dopamine Agents|dopamine agents|mesh-ancestor
111262605|NCT00713583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111262606|NCT00713583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111262607|NCT00713583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111262608|NCT03359460|Lenalidomide|lenalidomide|mesh-list
111262609|NCT03359460|Immunologic Factors|immunologic factors|mesh-ancestor
111262610|NCT03359460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111262611|NCT03359460|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111262612|NCT03359460|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111262613|NCT03359460|Growth Substances|growth substances|mesh-ancestor
111262614|NCT03359460|Growth Inhibitors|growth inhibitors|mesh-ancestor
111262615|NCT03359460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111262616|NCT03025477|Paclitaxel|paclitaxel|mesh-list
111262617|NCT03025477|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111262618|NCT03025477|Cisplatin|cisplatin|mesh-list
111262619|NCT03025477|Carboplatin|carboplatin|mesh-list
111262620|NCT03025477|Epirubicin|epirubicin|mesh-list
111262621|NCT03025477|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111262622|NCT03025477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111262623|NCT03025477|Tubulin Modulators|tubulin modulators|mesh-ancestor
111262624|NCT03025477|Antimitotic Agents|antimitotic agents|mesh-ancestor
111262625|NCT03025477|Mitosis Modulators|mitosis modulators|mesh-ancestor
111262626|NCT03025477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111262627|NCT03025477|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111262628|NCT03025477|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111262629|NCT03025477|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111262630|NCT03025477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111262631|NCT03147378|Docetaxel|docetaxel|mesh-list
111262632|NCT03147378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111262633|NCT03147378|Tubulin Modulators|tubulin modulators|mesh-ancestor
111262634|NCT03147378|Antimitotic Agents|antimitotic agents|mesh-ancestor
111262635|NCT03147378|Mitosis Modulators|mitosis modulators|mesh-ancestor
111262636|NCT03147378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111262637|NCT00159744|Olanzapine|olanzapine|mesh-list
111262638|NCT00159744|Asenapine|asenapine|mesh-list
111262639|NCT00159744|Antiemetics|antiemetics|mesh-ancestor
111262640|NCT00159744|Autonomic Agents|autonomic agents|mesh-ancestor
111262641|NCT00159744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111262642|NCT00159744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111262643|NCT00159744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111262644|NCT00159744|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111262645|NCT00159744|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111262646|NCT00159744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111262647|NCT00159744|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111262648|NCT00159744|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111262649|NCT00159744|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111262650|NCT00159744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111262651|NCT00159744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111262652|NCT00159744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111262653|NCT00159744|Serotonin Agents|serotonin agents|mesh-ancestor
111262654|NCT04041973|Lumefantrine|lumefantrine|mesh-list
111262655|NCT04041973|Artemether|artemether|mesh-list
111262656|NCT04041973|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
111262657|NCT04041973|Antimalarials|antimalarials|mesh-ancestor
111262658|NCT04041973|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111262659|NCT04041973|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111262660|NCT04041973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111262661|NCT02914470|Atezolizumab|atezolizumab|mesh-list
111262662|NCT02914470|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111262663|NCT02914470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111262664|NCT02914470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111262665|NCT02914470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111262667|NCT05088330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111262668|NCT00695097|Rituximab|rituximab|mesh-list
111262669|NCT00695097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111262670|NCT00695097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111262671|NCT00695097|Immunologic Factors|immunologic factors|mesh-ancestor
111262672|NCT00695097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111262673|NCT00695097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111262674|NCT01795911|Interferons|interferons|mesh-list
111262675|NCT01795911|Ribavirin|ribavirin|mesh-list
111262676|NCT01795911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111262677|NCT01795911|Antiviral Agents|antiviral agents|mesh-ancestor
111262678|NCT01795911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111262679|NCT01795911|Antimetabolites|antimetabolites|mesh-ancestor
111262680|NCT01795911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111262681|NCT03137316|Hormones|hormones|mesh-list
111262682|NCT03137316|Parathyroid Hormone|parathyroid hormone|mesh-list
111262683|NCT03137316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111262684|NCT03137316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111262685|NCT03137316|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111262686|NCT03137082|Guanfacine|guanfacine|mesh-list
111262687|NCT03137082|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111262688|NCT03137082|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111262689|NCT03137082|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111262690|NCT03137082|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111262691|NCT03137082|Adrenergic Agents|adrenergic agents|mesh-ancestor
111262692|NCT03137082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111262693|NCT03137082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111262694|NCT03137082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111262695|NCT05088174|Cyclosporine|cyclosporine|mesh-list
111262696|NCT05088174|Cyclosporins|cyclosporins|mesh-list
111262697|NCT05088174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111262698|NCT05088174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111262699|NCT05088174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111262700|NCT05088174|Immunologic Factors|immunologic factors|mesh-ancestor
111262701|NCT05088174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111262702|NCT05088174|Antifungal Agents|antifungal agents|mesh-ancestor
111262703|NCT05088174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111262704|NCT05088174|Dermatologic Agents|dermatologic agents|mesh-ancestor
111262705|NCT05088174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111262706|NCT05088174|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111262707|NCT00695409|Cytarabine|cytarabine|mesh-list
111262708|NCT00695409|Rituximab|rituximab|mesh-list
111262709|NCT00695409|Etoposide|etoposide|mesh-list
111262710|NCT00695409|Etoposide phosphate|etoposide phosphate|mesh-list
111262711|NCT00695409|Melphalan|melphalan|mesh-list
111262712|NCT00695409|Carmustine|carmustine|mesh-list
111262713|NCT00695409|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111262714|NCT00695409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111262715|NCT00695409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111262716|NCT00695409|Immunologic Factors|immunologic factors|mesh-ancestor
111262717|NCT00695409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111262718|NCT00695409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111262719|NCT00695409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111262720|NCT00695409|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111262721|NCT00695409|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111262722|NCT00695409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111262723|NCT00695409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111262724|NCT00695409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111262725|NCT00695409|Antimetabolites|antimetabolites|mesh-ancestor
111262726|NCT00695409|Antiviral Agents|antiviral agents|mesh-ancestor
111262727|NCT00695409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111262728|NCT00695409|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111262729|NCT00695409|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111262730|NCT00695409|Alkylating Agents|alkylating agents|mesh-ancestor
111262731|NCT00695409|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111262732|NCT03469050|Rifaximin|rifaximin|mesh-list
111262733|NCT03469050|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111262734|NCT03469050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111262735|NCT03469050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111262736|NCT05087706|Bicalutamide|bicalutamide|mesh-list
111262737|NCT05087706|Leuprolide|leuprolide|mesh-list
111262738|NCT05087706|Androgen Antagonists|androgen antagonists|mesh-ancestor
111262739|NCT05087706|Hormone Antagonists|hormone antagonists|mesh-ancestor
111262740|NCT05087706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111262741|NCT05087706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111262742|NCT05087706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111262743|NCT05087706|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111262744|NCT05087706|Fertility Agents|fertility agents|mesh-ancestor
111262745|NCT05087706|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111262746|NCT05087706|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111262748|NCT02990403|Prednisone|prednisone|mesh-list
111262749|NCT02990403|Heparin|heparin|mesh-list
111262750|NCT02990403|Dydrogesterone|dydrogesterone|mesh-list
111262751|NCT02990403|Immunoglobulins|immunoglobulins|mesh-list
111262752|NCT02990403|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111262753|NCT02990403|Antibodies|antibodies|mesh-list
111262754|NCT02990403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111262755|NCT02990403|Glucocorticoids|glucocorticoids|mesh-ancestor
111262756|NCT02990403|Hormones|hormones|mesh-ancestor
111262757|NCT02990403|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111262758|NCT02990403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111262759|NCT02990403|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111262760|NCT02990403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111262761|NCT02990403|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111262762|NCT02990403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111262763|NCT02990403|Analgesics|analgesics|mesh-ancestor
111262764|NCT02990403|Sensory System Agents|sensory system agents|mesh-ancestor
111262765|NCT02990403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111262766|NCT02990403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111262767|NCT02990403|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111262768|NCT02990403|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111262769|NCT02990403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111262770|NCT02990403|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111262771|NCT02990403|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111262772|NCT02990403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111262773|NCT02990403|Antipyretics|antipyretics|mesh-ancestor
111262774|NCT02990403|Anticoagulants|anticoagulants|mesh-ancestor
111262775|NCT02990403|Immunologic Factors|immunologic factors|mesh-ancestor
111262776|NCT02990403|Progestins|progestins|mesh-ancestor
111262777|NCT00697203|Pravastatin|pravastatin|mesh-list
111262778|NCT00697203|Dalcetrapib|dalcetrapib|mesh-list
111262779|NCT00697203|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111262780|NCT00697203|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111262781|NCT00697203|Antimetabolites|antimetabolites|mesh-ancestor
111262782|NCT00697203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111262783|NCT00697203|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111262784|NCT00697203|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111262785|NCT00697203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111262786|NCT05086848|Leucovorin|leucovorin|mesh-list
111262787|NCT05086848|Fluorouracil|fluorouracil|mesh-list
111262788|NCT05086848|Irinotecan|irinotecan|mesh-list
111262789|NCT05086848|Antimetabolites|antimetabolites|mesh-ancestor
111262790|NCT05086848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111262791|NCT05086848|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111262792|NCT05086848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111262793|NCT05086848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111262794|NCT05086848|Immunologic Factors|immunologic factors|mesh-ancestor
111262795|NCT05086848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111262796|NCT05086848|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111262797|NCT05086848|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111262798|NCT05086848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111262799|NCT05086848|Antidotes|antidotes|mesh-ancestor
111262800|NCT05086848|Protective Agents|protective agents|mesh-ancestor
111262801|NCT05086848|Vitamin B Complex|vitamin b complex|mesh-ancestor
111262802|NCT05086848|Vitamins|vitamins|mesh-ancestor
111262803|NCT05086848|Micronutrients|micronutrients|mesh-ancestor
111262804|NCT00830895|Everolimus|everolimus|mesh-list
111262805|NCT00830895|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111262806|NCT00830895|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111262807|NCT00830895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111262808|NCT00830895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111262809|NCT00830895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111262810|NCT00830895|Immunologic Factors|immunologic factors|mesh-ancestor
111262811|NCT00830895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111262812|NCT00830895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111262813|NCT01158417|Resveratrol|resveratrol|mesh-list
111262814|NCT01158417|Antioxidants|antioxidants|mesh-ancestor
111262815|NCT01158417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111262816|NCT01158417|Protective Agents|protective agents|mesh-ancestor
111262817|NCT01158417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111262818|NCT01158417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111262819|NCT01158417|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111262820|NCT05086614|Thymalfasin|thymalfasin|mesh-list
111262821|NCT05086614|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111262822|NCT05086614|Immunologic Factors|immunologic factors|mesh-ancestor
111262823|NCT05086614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111262824|NCT01795131|Vitamin B 12|vitamin b 12|mesh-list
111262825|NCT01795131|Hydroxocobalamin|hydroxocobalamin|mesh-list
111262826|NCT01795131|Vitamins|vitamins|mesh-ancestor
111262827|NCT01795131|Micronutrients|micronutrients|mesh-ancestor
111262828|NCT01795131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111262829|NCT01795131|Vitamin B Complex|vitamin b complex|mesh-ancestor
111262830|NCT01795131|Hematinics|hematinics|mesh-ancestor
111262831|NCT03137004|Docetaxel|docetaxel|mesh-list
111262832|NCT03137004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111262833|NCT03137004|Tubulin Modulators|tubulin modulators|mesh-ancestor
111262834|NCT03137004|Antimitotic Agents|antimitotic agents|mesh-ancestor
111262835|NCT03137004|Mitosis Modulators|mitosis modulators|mesh-ancestor
111262836|NCT03137004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111262837|NCT03113994|Calcium, Dietary|calcium, dietary|mesh-list
111262838|NCT03113994|Vitamin D|vitamin d|mesh-list
111262839|NCT03113994|Coenzyme Q10|coenzyme q10|mesh-list
111262840|NCT03113994|Ubiquinone|ubiquinone|mesh-list
111262841|NCT03113994|Calcium Carbonate|calcium carbonate|mesh-list
111262842|NCT03113994|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111262843|NCT03113994|Calcium|calcium|mesh-list
111262844|NCT03113994|Vitamins|vitamins|mesh-ancestor
111262845|NCT03113994|Micronutrients|micronutrients|mesh-ancestor
111262846|NCT03113994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111262847|NCT03113994|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111262848|NCT03113994|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111262849|NCT03113994|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111262850|NCT03113994|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111262851|NCT03113994|Antimetabolites|antimetabolites|mesh-ancestor
111262852|NCT03113994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111262853|NCT03113994|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111262854|NCT03113994|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111262855|NCT03113994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111262856|NCT03113994|Antacids|antacids|mesh-ancestor
111262857|NCT03113994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111262858|NCT02003742|Tamsulosin|tamsulosin|mesh-list
111262859|NCT02003742|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111262860|NCT02003742|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111262861|NCT02003742|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111262862|NCT02003742|Adrenergic Agents|adrenergic agents|mesh-ancestor
111262863|NCT02003742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111262864|NCT02003742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111262865|NCT02003742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111262866|NCT02003742|Urological Agents|urological agents|mesh-ancestor
111262867|NCT03134118|Nivolumab|nivolumab|mesh-list
111262868|NCT03134118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111262869|NCT03134118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111262870|NCT03134118|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111262871|NCT03134118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111262872|NCT05085912|Ethanol|ethanol|mesh-list
111262873|NCT05085912|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111262874|NCT05085912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111262875|NCT05085912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111262876|NCT05085912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111262877|NCT02339415|Edoxaban|edoxaban|mesh-list
111262878|NCT02339415|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111262879|NCT02339415|Antithrombins|antithrombins|mesh-ancestor
111262880|NCT02339415|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111262881|NCT02339415|Protease Inhibitors|protease inhibitors|mesh-ancestor
111262882|NCT02339415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111262883|NCT02339415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111262884|NCT02339415|Anticoagulants|anticoagulants|mesh-ancestor
111262885|NCT02998047|Lintuzumab|lintuzumab|mesh-list
111262886|NCT02998047|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111262887|NCT02998047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111262888|NCT03110172|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
111262889|NCT03110172|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111262890|NCT03110172|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111262891|NCT03110172|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111262892|NCT03110172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111262894|NCT03110172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111262895|NCT03110172|Analgesics|analgesics|mesh-ancestor
111262896|NCT03110172|Sensory System Agents|sensory system agents|mesh-ancestor
111262897|NCT03110172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111262898|NCT03110172|Antidepressive Agents|antidepressive agents|mesh-ancestor
111262899|NCT03110172|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111262900|NCT03110172|Dopamine Agents|dopamine agents|mesh-ancestor
111262901|NCT01400503|Siltuximab|siltuximab|mesh-list
111262902|NCT01400503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111262903|NCT00706719|Enclomiphene|enclomiphene|mesh-list
111262904|NCT00706719|Clomiphene|clomiphene|mesh-list
111262905|NCT00706719|Zuclomiphene|zuclomiphene|mesh-list
111262906|NCT00706719|Testosterone|testosterone|mesh-list
111262907|NCT00706719|Androgens|androgens|mesh-ancestor
111262908|NCT00706719|Hormones|hormones|mesh-ancestor
111262909|NCT00706719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111262910|NCT00706719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111262911|NCT00706719|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111262912|NCT00706719|Hormone Antagonists|hormone antagonists|mesh-ancestor
111262913|NCT00706719|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111262914|NCT00706719|Fertility Agents|fertility agents|mesh-ancestor
111262915|NCT00706719|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111262916|NCT00706719|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111262917|NCT00706719|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111262918|NCT05079672|Dexmedetomidine|dexmedetomidine|mesh-list
111262919|NCT05079672|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111262920|NCT05079672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111262921|NCT05079672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111262922|NCT05079672|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111262923|NCT05079672|Analgesics|analgesics|mesh-ancestor
111262924|NCT05079672|Sensory System Agents|sensory system agents|mesh-ancestor
111262925|NCT05079672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111262926|NCT05079672|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111262927|NCT05079672|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111262928|NCT05079672|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111262929|NCT05079672|Adrenergic Agents|adrenergic agents|mesh-ancestor
111262930|NCT05079672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111262931|NCT05079672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111262932|NCT04766827|Paclitaxel|paclitaxel|mesh-list
111262933|NCT04766827|Docetaxel|docetaxel|mesh-list
111262934|NCT04766827|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111262935|NCT04766827|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111262936|NCT04766827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111262937|NCT04766827|Tubulin Modulators|tubulin modulators|mesh-ancestor
111262938|NCT04766827|Antimitotic Agents|antimitotic agents|mesh-ancestor
111262939|NCT04766827|Mitosis Modulators|mitosis modulators|mesh-ancestor
111262940|NCT04766827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111262941|NCT02960568|Primaquine|primaquine|mesh-list
111262942|NCT02960568|Antimalarials|antimalarials|mesh-ancestor
111262943|NCT02960568|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111262944|NCT02960568|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111262945|NCT02960568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111262946|NCT02996409|Lidocaine|lidocaine|mesh-list
111262947|NCT02996409|Anesthetics, Local|anesthetics, local|mesh-ancestor
111262948|NCT02996409|Anesthetics|anesthetics|mesh-ancestor
111262949|NCT02996409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111262950|NCT02996409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111262951|NCT02996409|Sensory System Agents|sensory system agents|mesh-ancestor
111262952|NCT02996409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111262953|NCT02996409|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111262954|NCT02996409|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111262955|NCT02996409|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111262956|NCT02996409|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111262957|NCT02996409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111262958|NCT02864004|Apomorphine|apomorphine|mesh-list
111262959|NCT02864004|Emetics|emetics|mesh-ancestor
111262960|NCT02864004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111262961|NCT02864004|Autonomic Agents|autonomic agents|mesh-ancestor
111262962|NCT02864004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111262963|NCT02864004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111262964|NCT02864004|Dopamine Agonists|dopamine agonists|mesh-ancestor
111262965|NCT02864004|Dopamine Agents|dopamine agents|mesh-ancestor
111262966|NCT02864004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111262967|NCT02864004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111262968|NCT01421719|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111262969|NCT01421719|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110978339|NCT05487742|Analgesics|analgesics|mesh-ancestor
111262970|NCT01421719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111262971|NCT01421719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111262972|NCT01421719|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111262973|NCT01421719|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111262974|NCT01421719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111262975|NCT01421719|Cholinergic Agents|cholinergic agents|mesh-ancestor
111262976|NCT01421719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111262977|NCT01421641|Lidocaine|lidocaine|mesh-list
111262978|NCT01421641|Anesthetics, Local|anesthetics, local|mesh-ancestor
111262979|NCT01421641|Anesthetics|anesthetics|mesh-ancestor
111262980|NCT01421641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111262981|NCT01421641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111262982|NCT01421641|Sensory System Agents|sensory system agents|mesh-ancestor
111262983|NCT01421641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111262984|NCT01421641|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111262985|NCT01421641|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111262986|NCT01421641|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111262987|NCT01421641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111262988|NCT01421641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111262989|NCT05068206|Bevacizumab|bevacizumab|mesh-list
111262990|NCT05068206|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111262991|NCT05068206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111262992|NCT05068206|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111262993|NCT05068206|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111262994|NCT05068206|Growth Substances|growth substances|mesh-ancestor
111262995|NCT05068206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111262996|NCT05068206|Growth Inhibitors|growth inhibitors|mesh-ancestor
111262997|NCT05063370|Simendan|simendan|mesh-list
111262998|NCT05063370|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111262999|NCT05063370|Vasodilator Agents|vasodilator agents|mesh-ancestor
111263000|NCT05063370|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
111263001|NCT05063370|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111263002|NCT05063370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111263003|NCT05063370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111263004|NCT05063370|Protective Agents|protective agents|mesh-ancestor
111263005|NCT05063370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111263006|NCT01421017|Cyclophosphamide|cyclophosphamide|mesh-list
111263007|NCT01421017|Imiquimod|imiquimod|mesh-list
111263008|NCT01421017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111263009|NCT01421017|Immunologic Factors|immunologic factors|mesh-ancestor
111263010|NCT01421017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111263011|NCT01421017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111263012|NCT01421017|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111263013|NCT01421017|Alkylating Agents|alkylating agents|mesh-ancestor
111263014|NCT01421017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111263015|NCT01421017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111263016|NCT01421017|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111263017|NCT01421017|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111263018|NCT01421017|Interferon Inducers|interferon inducers|mesh-ancestor
111263019|NCT04951050|Sirolimus|sirolimus|mesh-list
111263020|NCT04951050|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111263021|NCT04951050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111263022|NCT04951050|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111263023|NCT04951050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111263024|NCT04951050|Antifungal Agents|antifungal agents|mesh-ancestor
111263025|NCT04951050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111263026|NCT04951050|Immunologic Factors|immunologic factors|mesh-ancestor
111263027|NCT04951050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111263028|NCT05089344|Clomiphene|clomiphene|mesh-list
111263029|NCT05089344|Enclomiphene|enclomiphene|mesh-list
111263030|NCT05089344|Zuclomiphene|zuclomiphene|mesh-list
111263031|NCT05089344|Hormones|hormones|mesh-list
111263032|NCT05089344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111263033|NCT05089344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111263034|NCT05089344|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111263035|NCT05089344|Hormone Antagonists|hormone antagonists|mesh-ancestor
111263036|NCT05089344|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111263037|NCT05089344|Fertility Agents|fertility agents|mesh-ancestor
111263038|NCT05089344|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111263039|NCT05089344|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111263040|NCT05089344|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111263041|NCT01400113|Asenapine|asenapine|mesh-list
111263042|NCT01400113|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111263043|NCT01400113|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111263044|NCT01400113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111263045|NCT01400113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111263046|NCT01400113|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111263047|NCT01399723|Amoxicillin|amoxicillin|mesh-list
111263048|NCT01399723|Penicillins|penicillins|mesh-list
111263049|NCT01399723|Penicillin G|penicillin g|mesh-list
111263050|NCT01399723|Penicillin G Benzathine|penicillin g benzathine|mesh-list
111263051|NCT01399723|Penicillin G Procaine|penicillin g procaine|mesh-list
111263052|NCT01399723|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111263053|NCT01399723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111263054|NCT04726098|Dexamethasone|dexamethasone|mesh-list
111263055|NCT04726098|Dexamethasone acetate|dexamethasone acetate|mesh-list
111263056|NCT04726098|BB 1101|bb 1101|mesh-list
111263057|NCT04726098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111263058|NCT04726098|Antiemetics|antiemetics|mesh-ancestor
111263059|NCT04726098|Autonomic Agents|autonomic agents|mesh-ancestor
111263060|NCT04726098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111263061|NCT04726098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111263062|NCT04726098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111263063|NCT04726098|Glucocorticoids|glucocorticoids|mesh-ancestor
111263064|NCT04726098|Hormones|hormones|mesh-ancestor
111263065|NCT04726098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111263066|NCT04726098|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111263067|NCT04726098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111263068|NCT04726098|Protease Inhibitors|protease inhibitors|mesh-ancestor
111263069|NCT04726098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111263070|NCT04726098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111263071|NCT05088720|Misoprostol|misoprostol|mesh-list
111263072|NCT05088720|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111263073|NCT05088720|Abortifacient Agents|abortifacient agents|mesh-ancestor
111263074|NCT05088720|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111263075|NCT05088720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111263076|NCT05088720|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111263077|NCT05088720|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111263078|NCT05088720|Oxytocics|oxytocics|mesh-ancestor
111263079|NCT01383499|Bromides|bromides|mesh-list
111263080|NCT01383499|Tiotropium Bromide|tiotropium bromide|mesh-list
111263081|NCT01383499|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111263082|NCT01383499|Autonomic Agents|autonomic agents|mesh-ancestor
111263083|NCT01383499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111263084|NCT01383499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111263085|NCT01383499|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111263086|NCT01383499|Respiratory System Agents|respiratory system agents|mesh-ancestor
111263087|NCT01383499|Parasympatholytics|parasympatholytics|mesh-ancestor
111263088|NCT01383499|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111263089|NCT01383499|Cholinergic Agents|cholinergic agents|mesh-ancestor
111263090|NCT01383499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111263091|NCT01383499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111263092|NCT01383499|Anticonvulsants|anticonvulsants|mesh-ancestor
111263093|NCT05084118|Landiolol|landiolol|mesh-list
111263094|NCT05084118|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111263095|NCT05084118|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111263096|NCT05084118|Adrenergic Agents|adrenergic agents|mesh-ancestor
111263097|NCT05084118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111263098|NCT05084118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111263099|NCT05084118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111263100|NCT05084118|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111263101|NCT03025009|Insulin|insulin|mesh-list
111263102|NCT03025009|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111263103|NCT03025009|Insulin Glargine|insulin glargine|mesh-list
111263104|NCT03025009|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111263105|NCT03025009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111263106|NCT03135912|Terbinafine|terbinafine|mesh-list
111263107|NCT03135912|Antifungal Agents|antifungal agents|mesh-ancestor
111263108|NCT03135912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111263109|NCT03135912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111263110|NCT03135912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111263111|NCT01397461|Retapamulin|retapamulin|mesh-list
111263112|NCT01397461|Ozenoxacin|ozenoxacin|mesh-list
111263113|NCT01397461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111263114|NCT01397461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111263115|NCT01397461|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111263116|NCT01397461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111263117|NCT01397461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111263118|NCT01397461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111263120|NCT04335084|Vitamins|vitamins|mesh-list
111263121|NCT04335084|Hydroxychloroquine|hydroxychloroquine|mesh-list
111263122|NCT04335084|Micronutrients|micronutrients|mesh-ancestor
111263123|NCT04335084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111263124|NCT04335084|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111263125|NCT04335084|Antimalarials|antimalarials|mesh-ancestor
111263126|NCT04335084|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111263127|NCT04335084|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111263128|NCT04335084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111263129|NCT04335084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111263130|NCT04335084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111263131|NCT04335084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111263132|NCT02996019|Etrolizumab|etrolizumab|mesh-list
111263133|NCT02996019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111263134|NCT02996019|Immunologic Factors|immunologic factors|mesh-ancestor
111263135|NCT02996019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111263136|NCT02997501|Osimertinib|osimertinib|mesh-list
111263137|NCT02997501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111263138|NCT02997501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111263139|NCT02997501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111263140|NCT02997501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111263141|NCT02998827|Thalidomide|thalidomide|mesh-list
111263142|NCT02998827|Infliximab|infliximab|mesh-list
111263143|NCT02998827|Azathioprine|azathioprine|mesh-list
111263144|NCT02998827|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111263145|NCT02998827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111263146|NCT02998827|Dermatologic Agents|dermatologic agents|mesh-ancestor
111263147|NCT02998827|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111263148|NCT02998827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111263149|NCT02998827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111263150|NCT02998827|Immunologic Factors|immunologic factors|mesh-ancestor
111263151|NCT02998827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111263152|NCT02998827|Leprostatic Agents|leprostatic agents|mesh-ancestor
111263153|NCT02998827|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111263154|NCT02998827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111263155|NCT02998827|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111263156|NCT02998827|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111263157|NCT02998827|Growth Substances|growth substances|mesh-ancestor
111263158|NCT02998827|Growth Inhibitors|growth inhibitors|mesh-ancestor
111263159|NCT02998827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111263160|NCT02998827|Antimetabolites|antimetabolites|mesh-ancestor
111263161|NCT02998827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111263162|NCT02998827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111263163|NCT02995707|Thalidomide|thalidomide|mesh-list
111263164|NCT02995707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111263165|NCT02995707|Immunologic Factors|immunologic factors|mesh-ancestor
111263166|NCT02995707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111263167|NCT02995707|Leprostatic Agents|leprostatic agents|mesh-ancestor
111263168|NCT02995707|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111263169|NCT02995707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111263170|NCT02995707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111263171|NCT02995707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111263172|NCT02995707|Growth Substances|growth substances|mesh-ancestor
111263173|NCT02995707|Growth Inhibitors|growth inhibitors|mesh-ancestor
111263174|NCT02995707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111263175|NCT01270035|Adalimumab|adalimumab|mesh-list
111263176|NCT01270035|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111263177|NCT01270035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111263178|NCT01270035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111263179|NCT01396447|Cariprazine|cariprazine|mesh-list
111263180|NCT01396447|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111263181|NCT01396447|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111263182|NCT01396447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111263183|NCT01396447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111263184|NCT01396447|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111263185|NCT00704379|Sertraline|sertraline|mesh-list
111263186|NCT00704379|Antidepressive Agents|antidepressive agents|mesh-ancestor
111263187|NCT00704379|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111263188|NCT00704379|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111263189|NCT00704379|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111263190|NCT00704379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111263191|NCT00704379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111263192|NCT00704379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111263193|NCT00704379|Serotonin Agents|serotonin agents|mesh-ancestor
111263194|NCT00704379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111263195|NCT02991495|Vaccines|vaccines|mesh-list
111263196|NCT02991495|Immunologic Factors|immunologic factors|mesh-ancestor
111263197|NCT02991495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111263198|NCT04449042|Anesthetics|anesthetics|mesh-list
111263199|NCT04449042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111263200|NCT04449042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111263201|NCT04341090|Apatinib|apatinib|mesh-list
111263202|NCT04341090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111263203|NCT04341090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111263204|NCT04341090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111263205|NCT04341090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111263206|NCT04413396|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111263207|NCT04413396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111263208|NCT04089150|Leucovorin|leucovorin|mesh-list
111263209|NCT04089150|Paclitaxel|paclitaxel|mesh-list
111263210|NCT04089150|Gemcitabine|gemcitabine|mesh-list
111263211|NCT04089150|Fluorouracil|fluorouracil|mesh-list
111263212|NCT04089150|Capecitabine|capecitabine|mesh-list
111263213|NCT04089150|Oxaliplatin|oxaliplatin|mesh-list
111263214|NCT04089150|Irinotecan|irinotecan|mesh-list
111263215|NCT04089150|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111263216|NCT04089150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111263217|NCT04089150|Tubulin Modulators|tubulin modulators|mesh-ancestor
111263218|NCT04089150|Antimitotic Agents|antimitotic agents|mesh-ancestor
111263219|NCT04089150|Mitosis Modulators|mitosis modulators|mesh-ancestor
111263220|NCT04089150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111263221|NCT04089150|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111263222|NCT04089150|Antimetabolites|antimetabolites|mesh-ancestor
111263223|NCT04089150|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111263224|NCT04089150|Immunologic Factors|immunologic factors|mesh-ancestor
111263225|NCT04089150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111263226|NCT04089150|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111263227|NCT04089150|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111263228|NCT04089150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111263229|NCT04089150|Antidotes|antidotes|mesh-ancestor
111263230|NCT04089150|Protective Agents|protective agents|mesh-ancestor
111263231|NCT04089150|Vitamin B Complex|vitamin b complex|mesh-ancestor
111263232|NCT04089150|Vitamins|vitamins|mesh-ancestor
111263233|NCT04089150|Micronutrients|micronutrients|mesh-ancestor
111263234|NCT02076919|Acrizanib|acrizanib|mesh-list
111263235|NCT02076919|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
111263236|NCT02076919|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111263237|NCT02076919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111263238|NCT02076919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111263239|NCT02076919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111263240|NCT02076997|Methotrexate|methotrexate|mesh-list
111263241|NCT02076997|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111263242|NCT02076997|Abortifacient Agents|abortifacient agents|mesh-ancestor
111263243|NCT02076997|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111263244|NCT02076997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111263245|NCT02076997|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111263246|NCT02076997|Antimetabolites|antimetabolites|mesh-ancestor
111263247|NCT02076997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111263248|NCT02076997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111263249|NCT02076997|Dermatologic Agents|dermatologic agents|mesh-ancestor
111263250|NCT02076997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111263251|NCT02076997|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111263252|NCT02076997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111263253|NCT02076997|Immunologic Factors|immunologic factors|mesh-ancestor
111263254|NCT02076997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111263255|NCT02076997|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111263256|NCT05365165|Sevoflurane|sevoflurane|mesh-list
111263257|NCT05365165|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111263258|NCT05365165|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111263259|NCT05365165|Anesthetics, General|anesthetics, general|mesh-ancestor
111263260|NCT05365165|Anesthetics|anesthetics|mesh-ancestor
111263261|NCT05365165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111263262|NCT05365165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111263263|NCT03925350|Niraparib|niraparib|mesh-list
111263264|NCT03925350|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111263265|NCT03925350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111263266|NCT03925350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110987588|NCT02311101|Mitomycins|mitomycins|mesh-list
111263267|NCT03925350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111263268|NCT00707967|Vaccines|vaccines|mesh-list
111263269|NCT00707967|Immunologic Factors|immunologic factors|mesh-ancestor
111263270|NCT00707967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111263271|NCT02994381|Ozanimod|ozanimod|mesh-list
111263272|NCT02994381|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
111263273|NCT02994381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111263274|NCT02994381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111263275|NCT02994381|Immunologic Factors|immunologic factors|mesh-ancestor
111263276|NCT02994381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111263277|NCT00716079|Metoprolol|metoprolol|mesh-list
111263278|NCT00716079|Clonidine|clonidine|mesh-list
111263279|NCT00716079|Labetalol|labetalol|mesh-list
111263280|NCT00716079|Hydralazine|hydralazine|mesh-list
111263281|NCT00716079|Nicardipine|nicardipine|mesh-list
111263282|NCT00716079|Phentolamine|phentolamine|mesh-list
111263283|NCT00716079|Urapidil|urapidil|mesh-list
111263284|NCT00716079|Enalaprilat|enalaprilat|mesh-list
111263285|NCT00716079|Esmolol|esmolol|mesh-list
111263286|NCT00716079|Glycerol|glycerol|mesh-list
111263287|NCT00716079|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111263288|NCT00716079|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111263289|NCT00716079|Sympatholytics|sympatholytics|mesh-ancestor
111263290|NCT00716079|Autonomic Agents|autonomic agents|mesh-ancestor
111263291|NCT00716079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111263292|NCT00716079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111263293|NCT00716079|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
111263294|NCT00716079|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111263295|NCT00716079|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111263296|NCT00716079|Adrenergic Agents|adrenergic agents|mesh-ancestor
111263297|NCT00716079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111263298|NCT00716079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111263299|NCT00716079|Analgesics|analgesics|mesh-ancestor
111263300|NCT00716079|Sensory System Agents|sensory system agents|mesh-ancestor
111263301|NCT00716079|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111263302|NCT00716079|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111263303|NCT00716079|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111263304|NCT00716079|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
111263305|NCT00716079|Protective Agents|protective agents|mesh-ancestor
111263306|NCT00716079|Sympathomimetics|sympathomimetics|mesh-ancestor
111263307|NCT00716079|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111263308|NCT00716079|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111263309|NCT00716079|Vasodilator Agents|vasodilator agents|mesh-ancestor
111263310|NCT00716079|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111263311|NCT00716079|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111263312|NCT00716079|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111263313|NCT00716079|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111263314|NCT00716079|Serotonin Agents|serotonin agents|mesh-ancestor
111263315|NCT00716079|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
111263316|NCT00716079|Protease Inhibitors|protease inhibitors|mesh-ancestor
111263317|NCT00716079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111263318|NCT01270191|Exenatide|exenatide|mesh-list
111263319|NCT01270191|Isophane Insulin, Human|isophane insulin, human|mesh-list
111263320|NCT01270191|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111263321|NCT01270191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111263322|NCT01270191|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111263323|NCT01270191|Incretins|incretins|mesh-ancestor
111263324|NCT01270191|Hormones|hormones|mesh-ancestor
111263325|NCT01270191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111263326|NCT02999919|Bupivacaine|bupivacaine|mesh-list
111263327|NCT02999919|Anesthetics, Local|anesthetics, local|mesh-ancestor
111263328|NCT02999919|Anesthetics|anesthetics|mesh-ancestor
111263329|NCT02999919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111263330|NCT02999919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111263331|NCT02999919|Sensory System Agents|sensory system agents|mesh-ancestor
111263332|NCT02999919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111263333|NCT04526652|Dexmedetomidine|dexmedetomidine|mesh-list
111263334|NCT04526652|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111263335|NCT04526652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111263336|NCT04526652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111263337|NCT04526652|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111263338|NCT04526652|Analgesics|analgesics|mesh-ancestor
111263339|NCT04526652|Sensory System Agents|sensory system agents|mesh-ancestor
111263340|NCT04526652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111263341|NCT04526652|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110987666|NCT04912427|Bortezomib|bortezomib|mesh-list
111263342|NCT04526652|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111263343|NCT04526652|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111263344|NCT04526652|Adrenergic Agents|adrenergic agents|mesh-ancestor
111263345|NCT04526652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111263346|NCT04526652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111263347|NCT01381549|Imipenem|imipenem|mesh-list
111263348|NCT01381549|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
111263349|NCT01381549|Cilastatin|cilastatin|mesh-list
111263350|NCT01381549|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111263351|NCT01381549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111263352|NCT01381549|Protease Inhibitors|protease inhibitors|mesh-ancestor
111263353|NCT01381549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111263354|NCT01381549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111263355|NCT00159432|Bevacizumab|bevacizumab|mesh-list
111263356|NCT00159432|Capecitabine|capecitabine|mesh-list
111263357|NCT00159432|Oxaliplatin|oxaliplatin|mesh-list
111263358|NCT00159432|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111263359|NCT00159432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111263360|NCT00159432|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111263361|NCT00159432|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111263362|NCT00159432|Growth Substances|growth substances|mesh-ancestor
111263363|NCT00159432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111263364|NCT00159432|Growth Inhibitors|growth inhibitors|mesh-ancestor
111263365|NCT00159432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111263366|NCT00159432|Antimetabolites|antimetabolites|mesh-ancestor
111263367|NCT00159432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111263368|NCT02969850|Vitamin D|vitamin d|mesh-list
111263369|NCT02969850|Calcium|calcium|mesh-list
111263370|NCT02969850|Vitamins|vitamins|mesh-ancestor
111263371|NCT02969850|Micronutrients|micronutrients|mesh-ancestor
111263372|NCT02969850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111263373|NCT02969850|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111263374|NCT02969850|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111263375|NCT02339766|Morphine|morphine|mesh-list
111263376|NCT02339766|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111263377|NCT02339766|Narcotics|narcotics|mesh-ancestor
111263378|NCT02339766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111263379|NCT02339766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111263380|NCT02339766|Analgesics|analgesics|mesh-ancestor
111263381|NCT02339766|Sensory System Agents|sensory system agents|mesh-ancestor
111263382|NCT02339766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111263383|NCT04287660|Clarithromycin|clarithromycin|mesh-list
111263384|NCT04287660|Dexamethasone|dexamethasone|mesh-list
111263385|NCT04287660|Lenalidomide|lenalidomide|mesh-list
111263386|NCT04287660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111263387|NCT04287660|Antiemetics|antiemetics|mesh-ancestor
111263388|NCT04287660|Autonomic Agents|autonomic agents|mesh-ancestor
111263389|NCT04287660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111263390|NCT04287660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111263391|NCT04287660|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111263392|NCT04287660|Glucocorticoids|glucocorticoids|mesh-ancestor
111263393|NCT04287660|Hormones|hormones|mesh-ancestor
111263394|NCT04287660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111263395|NCT04287660|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111263396|NCT04287660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111263397|NCT04287660|Immunologic Factors|immunologic factors|mesh-ancestor
111263398|NCT04287660|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111263399|NCT04287660|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111263400|NCT04287660|Growth Substances|growth substances|mesh-ancestor
111263401|NCT04287660|Growth Inhibitors|growth inhibitors|mesh-ancestor
111263402|NCT04287660|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111263403|NCT04287660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111263404|NCT04287660|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111263405|NCT04287660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111263406|NCT04287660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111263407|NCT04287660|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111263408|NCT04287660|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111263409|NCT01396057|Dexamethasone|dexamethasone|mesh-list
111263410|NCT01396057|Ranibizumab|ranibizumab|mesh-list
111263411|NCT01396057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111263412|NCT01396057|Antiemetics|antiemetics|mesh-ancestor
111263413|NCT01396057|Autonomic Agents|autonomic agents|mesh-ancestor
111263414|NCT01396057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110987734|NCT02323347|Progesterone|progesterone|mesh-list
111263415|NCT01396057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111263416|NCT01396057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111263417|NCT01396057|Glucocorticoids|glucocorticoids|mesh-ancestor
111263418|NCT01396057|Hormones|hormones|mesh-ancestor
111263419|NCT01396057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111263420|NCT01396057|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111263421|NCT01396057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111263422|NCT01396057|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111263423|NCT01396057|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111263424|NCT01396057|Growth Substances|growth substances|mesh-ancestor
111263425|NCT01396057|Growth Inhibitors|growth inhibitors|mesh-ancestor
111263426|NCT02419560|Venetoclax|venetoclax|mesh-list
111263427|NCT02419560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111263428|NCT04011163|Morphine|morphine|mesh-list
111263429|NCT04011163|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111263430|NCT04011163|Narcotics|narcotics|mesh-ancestor
111263431|NCT04011163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111263432|NCT04011163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111263433|NCT04011163|Analgesics|analgesics|mesh-ancestor
111263434|NCT04011163|Sensory System Agents|sensory system agents|mesh-ancestor
111263435|NCT04011163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111263436|NCT00704847|Calcitonin|calcitonin|mesh-list
111263437|NCT00704847|Salmon calcitonin|salmon calcitonin|mesh-list
111263438|NCT00704847|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
111263439|NCT00704847|Katacalcin|katacalcin|mesh-list
111263440|NCT00704847|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111263441|NCT00704847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111263442|NCT00704847|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111263443|NCT00704847|Vasodilator Agents|vasodilator agents|mesh-ancestor
111263444|NCT03393468|Dapivirine|dapivirine|mesh-list
111263445|NCT03393468|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111263446|NCT03393468|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111263447|NCT03393468|Antiviral Agents|antiviral agents|mesh-ancestor
111263448|NCT03393468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111263449|NCT05091606|Anesthetics|anesthetics|mesh-list
111263450|NCT05091606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111263451|NCT05091606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111263452|NCT01395901|Ondansetron|ondansetron|mesh-list
111263453|NCT01395901|Palonosetron|palonosetron|mesh-list
111263454|NCT01395901|Antiemetics|antiemetics|mesh-ancestor
111263455|NCT01395901|Autonomic Agents|autonomic agents|mesh-ancestor
111263456|NCT01395901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111263457|NCT01395901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111263458|NCT01395901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111263459|NCT01395901|Antipruritics|antipruritics|mesh-ancestor
111263460|NCT01395901|Dermatologic Agents|dermatologic agents|mesh-ancestor
111263461|NCT01395901|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111263462|NCT01395901|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111263463|NCT01395901|Serotonin Agents|serotonin agents|mesh-ancestor
111263464|NCT01395901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111263465|NCT01395901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111263466|NCT01395823|Vitamin D|vitamin d|mesh-list
111263467|NCT01395823|Ergocalciferols|ergocalciferols|mesh-list
111263468|NCT01395823|Vitamins|vitamins|mesh-ancestor
111263469|NCT01395823|Micronutrients|micronutrients|mesh-ancestor
111263470|NCT01395823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111263471|NCT01395823|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111263472|NCT01395823|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111263473|NCT02993991|Durvalumab|durvalumab|mesh-list
111263474|NCT02993991|Mocetinostat|mocetinostat|mesh-list
111263475|NCT02993991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111263476|NCT02993991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111263477|NCT02993991|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111263478|NCT02993991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111263479|NCT02993991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111263480|NCT00158184|Oxycodone|oxycodone|mesh-list
111263481|NCT00158184|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111263482|NCT00158184|Narcotics|narcotics|mesh-ancestor
111263483|NCT00158184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111263484|NCT00158184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111263485|NCT00158184|Analgesics|analgesics|mesh-ancestor
111263486|NCT00158184|Sensory System Agents|sensory system agents|mesh-ancestor
111263487|NCT00158184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111263488|NCT02405520|Vaccines|vaccines|mesh-list
111263489|NCT02405520|Immunologic Factors|immunologic factors|mesh-ancestor
111263490|NCT02405520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111263492|NCT02993835|Trace Elements|trace elements|mesh-ancestor
111263493|NCT02993835|Micronutrients|micronutrients|mesh-ancestor
111263494|NCT02993835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111263495|NCT05091138|Buprenorphine|buprenorphine|mesh-list
111263496|NCT05091138|Bupivacaine|bupivacaine|mesh-list
111263497|NCT05091138|Anesthetics, Local|anesthetics, local|mesh-ancestor
111263498|NCT05091138|Anesthetics|anesthetics|mesh-ancestor
111263499|NCT05091138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111263500|NCT05091138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111263501|NCT05091138|Sensory System Agents|sensory system agents|mesh-ancestor
111263502|NCT05091138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111263503|NCT05091138|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111263504|NCT05091138|Narcotics|narcotics|mesh-ancestor
111263505|NCT05091138|Analgesics|analgesics|mesh-ancestor
111263506|NCT05091138|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111263507|NCT02999295|Nivolumab|nivolumab|mesh-list
111263508|NCT02999295|Ramucirumab|ramucirumab|mesh-list
111263509|NCT02999295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111263510|NCT02999295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111263511|NCT02999295|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111263512|NCT02999295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111263513|NCT02998905|Aspirin|aspirin|mesh-list
111263514|NCT02998905|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111263515|NCT02998905|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111263516|NCT02998905|Analgesics|analgesics|mesh-ancestor
111263517|NCT02998905|Sensory System Agents|sensory system agents|mesh-ancestor
111263518|NCT02998905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111263519|NCT02998905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111263520|NCT02998905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111263521|NCT02998905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111263522|NCT02998905|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111263523|NCT02998905|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111263524|NCT02998905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111263525|NCT02998905|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111263526|NCT02998905|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111263527|NCT02998905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111263528|NCT02998905|Antipyretics|antipyretics|mesh-ancestor
111263529|NCT02993367|3-n-butylphthalide|3-n-butylphthalide|mesh-list
111263530|NCT02993367|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111263531|NCT02993367|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111263532|NCT02993367|Protective Agents|protective agents|mesh-ancestor
111263533|NCT02993367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111263534|NCT05094492|Fluorides|fluorides|mesh-list
111263535|NCT05094492|Fluorides, Topical|fluorides, topical|mesh-list
111263536|NCT05094492|Cariostatic Agents|cariostatic agents|mesh-ancestor
111263537|NCT05094492|Protective Agents|protective agents|mesh-ancestor
111263538|NCT05094492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111263539|NCT01380691|Phenylethyl Alcohol|phenylethyl alcohol|mesh-list
111263540|NCT01380691|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111263541|NCT01380691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111263542|NCT01380691|Disinfectants|disinfectants|mesh-ancestor
111263543|NCT05094414|Valacyclovir|valacyclovir|mesh-list
111263544|NCT05094414|Antiviral Agents|antiviral agents|mesh-ancestor
111263545|NCT05094414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111263546|NCT04386447|Oxytocin|oxytocin|mesh-list
111263547|NCT04386447|Oxytocics|oxytocics|mesh-ancestor
111263548|NCT04386447|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111263549|NCT04386447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111263550|NCT02993133|Mycophenolic Acid|mycophenolic acid|mesh-list
111263551|NCT02993133|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111263552|NCT02993133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111263553|NCT02993133|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111263554|NCT02993133|Antitubercular Agents|antitubercular agents|mesh-ancestor
111263555|NCT02993133|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111263556|NCT02993133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111263557|NCT02993133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110978359|NCT02456948|Minocycline|minocycline|mesh-list
111263558|NCT02993133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111263559|NCT01380535|Methoxsalen|methoxsalen|mesh-list
111263560|NCT01380535|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111263561|NCT01380535|Dermatologic Agents|dermatologic agents|mesh-ancestor
111263562|NCT00725361|Ambrisentan|ambrisentan|mesh-list
111263563|NCT00725361|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111263564|NCT02816424|TEMPO|tempo|mesh-list
111263565|NCT02816424|Antioxidants|antioxidants|mesh-ancestor
111263566|NCT02816424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111263567|NCT02816424|Protective Agents|protective agents|mesh-ancestor
111263568|NCT02816424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111263569|NCT01275885|Cholecalciferol|cholecalciferol|mesh-list
111263570|NCT01275885|Vitamin D|vitamin d|mesh-list
111263571|NCT01275885|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111263572|NCT01275885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111263573|NCT01275885|Vitamins|vitamins|mesh-ancestor
111263574|NCT01275885|Micronutrients|micronutrients|mesh-ancestor
111263575|NCT01275885|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111263576|NCT02794896|Fentanyl|fentanyl|mesh-list
111263577|NCT02794896|Propofol|propofol|mesh-list
111263578|NCT02794896|Sevoflurane|sevoflurane|mesh-list
111263579|NCT02794896|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111263580|NCT02794896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111263581|NCT02794896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111263582|NCT02794896|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111263583|NCT02794896|Anesthetics, General|anesthetics, general|mesh-ancestor
111263584|NCT02794896|Anesthetics|anesthetics|mesh-ancestor
111263585|NCT02794896|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111263586|NCT02794896|Narcotics|narcotics|mesh-ancestor
111263587|NCT02794896|Analgesics|analgesics|mesh-ancestor
111263588|NCT02794896|Sensory System Agents|sensory system agents|mesh-ancestor
111263589|NCT02794896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111263590|NCT02794896|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111263591|NCT02794896|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111263592|NCT02794896|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111263593|NCT01271283|Lenalidomide|lenalidomide|mesh-list
111263594|NCT01271283|Immunologic Factors|immunologic factors|mesh-ancestor
111263595|NCT01271283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111263596|NCT01271283|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111263597|NCT01271283|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111263598|NCT01271283|Growth Substances|growth substances|mesh-ancestor
111263599|NCT01271283|Growth Inhibitors|growth inhibitors|mesh-ancestor
111263600|NCT01271283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111263601|NCT01271439|Cetuximab|cetuximab|mesh-list
111263602|NCT01271439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111263603|NCT01271439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111263604|NCT01271517|Insulin, Isophane|insulin, isophane|mesh-list
111263605|NCT01271517|Isophane Insulin, Human|isophane insulin, human|mesh-list
111263606|NCT01271517|Isophane insulin, beef|isophane insulin, beef|mesh-list
111263607|NCT01271517|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111263608|NCT01271517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111263609|NCT05090592|Atropine|atropine|mesh-list
111263610|NCT05090592|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111263611|NCT05090592|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111263612|NCT05090592|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111263613|NCT05090592|Autonomic Agents|autonomic agents|mesh-ancestor
111263614|NCT05090592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111263615|NCT05090592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111263616|NCT05090592|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111263617|NCT05090592|Respiratory System Agents|respiratory system agents|mesh-ancestor
111263618|NCT05090592|Mydriatics|mydriatics|mesh-ancestor
111263619|NCT05090592|Parasympatholytics|parasympatholytics|mesh-ancestor
111263620|NCT05090592|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111263621|NCT05090592|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111263622|NCT05090592|Cholinergic Agents|cholinergic agents|mesh-ancestor
111263623|NCT05090592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111263624|NCT05090592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111263625|NCT02992665|Ionophores|ionophores|mesh-list
111263626|NCT02992665|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111263627|NCT02992665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111263628|NCT05093478|Lidocaine|lidocaine|mesh-list
111263629|NCT05093478|Capsaicin|capsaicin|mesh-list
111263630|NCT05093478|Anesthetics, Local|anesthetics, local|mesh-ancestor
111263631|NCT05093478|Anesthetics|anesthetics|mesh-ancestor
111263632|NCT05093478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111263633|NCT05093478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111263634|NCT05093478|Sensory System Agents|sensory system agents|mesh-ancestor
111263635|NCT05093478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111263636|NCT05093478|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111263637|NCT05093478|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111263638|NCT05093478|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111263639|NCT05093478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111263640|NCT05093478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111263641|NCT05093478|Antipruritics|antipruritics|mesh-ancestor
111263642|NCT05093478|Dermatologic Agents|dermatologic agents|mesh-ancestor
111263643|NCT00725751|Interferons|interferons|mesh-list
111263644|NCT00725751|Ribavirin|ribavirin|mesh-list
111263645|NCT00725751|Interferon-alpha|interferon-alpha|mesh-list
111263646|NCT00725751|Interferon alpha-2|interferon alpha-2|mesh-list
111263647|NCT00725751|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
111263648|NCT00725751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111263649|NCT00725751|Antiviral Agents|antiviral agents|mesh-ancestor
111263650|NCT00725751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111263651|NCT00725751|Antimetabolites|antimetabolites|mesh-ancestor
111263652|NCT00725751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111263653|NCT00725751|Immunologic Factors|immunologic factors|mesh-ancestor
111263654|NCT00725751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111263655|NCT05364385|Budesonide|budesonide|mesh-list
111263656|NCT05364385|Pulmonary Surfactants|pulmonary surfactants|mesh-list
111263657|NCT05364385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111263658|NCT05364385|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111263659|NCT05364385|Autonomic Agents|autonomic agents|mesh-ancestor
111263660|NCT05364385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111263661|NCT05364385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111263662|NCT05364385|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111263663|NCT05364385|Respiratory System Agents|respiratory system agents|mesh-ancestor
111263664|NCT05364385|Glucocorticoids|glucocorticoids|mesh-ancestor
111263665|NCT05364385|Hormones|hormones|mesh-ancestor
111263666|NCT05364385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111263667|NCT00726375|Etanercept|etanercept|mesh-list
111263668|NCT00726375|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111263669|NCT00726375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111263670|NCT00726375|Analgesics|analgesics|mesh-ancestor
111263671|NCT00726375|Sensory System Agents|sensory system agents|mesh-ancestor
111263672|NCT00726375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111263673|NCT00726375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111263674|NCT00726375|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111263675|NCT00726375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111263676|NCT00726375|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111263677|NCT00726375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111263678|NCT00726375|Immunologic Factors|immunologic factors|mesh-ancestor
111263679|NCT05363059|Hypoglycemic Agents|hypoglycemic agents|mesh-list
111263680|NCT05363059|Antihypertensive Agents|antihypertensive agents|mesh-list
111263681|NCT05363059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111263682|NCT01394185|Dronabinol|dronabinol|mesh-list
111263683|NCT01394185|Hallucinogens|hallucinogens|mesh-ancestor
111263684|NCT01394185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111263685|NCT01394185|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111263686|NCT01394185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111263687|NCT01394185|Analgesics|analgesics|mesh-ancestor
111263688|NCT01394185|Sensory System Agents|sensory system agents|mesh-ancestor
111263689|NCT01394185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111263690|NCT01394185|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
111263691|NCT01394185|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
111263692|NCT01394185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111263693|NCT01394185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111263694|NCT01394185|Hormones|hormones|mesh-ancestor
111263695|NCT01394185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111263696|NCT04361851|Pembrolizumab|pembrolizumab|mesh-list
111263697|NCT04361851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111263698|NCT04361851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111263699|NCT04361851|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111263700|NCT04361851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111263701|NCT04407715|Anesthetics|anesthetics|mesh-list
111263702|NCT04407715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111263703|NCT04407715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111263704|NCT00727857|Metformin|metformin|mesh-list
111263705|NCT00727857|Pioglitazone|pioglitazone|mesh-list
111263706|NCT00727857|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111263707|NCT00727857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111263708|NCT05092152|Propofol|propofol|mesh-list
111263709|NCT05092152|Esketamine|esketamine|mesh-list
111263710|NCT05092152|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111263711|NCT05092152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111263712|NCT05092152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111263713|NCT05092152|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111263714|NCT05092152|Anesthetics, General|anesthetics, general|mesh-ancestor
111263715|NCT05092152|Anesthetics|anesthetics|mesh-ancestor
111263716|NCT05092152|Antidepressive Agents|antidepressive agents|mesh-ancestor
111263717|NCT05092152|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111263718|NCT05081700|Ocrelizumab|ocrelizumab|mesh-list
111263719|NCT05081700|Immunologic Factors|immunologic factors|mesh-ancestor
111263720|NCT05081700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111263721|NCT05001360|Nivolumab|nivolumab|mesh-list
111263722|NCT05001360|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
111263723|NCT05001360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111263724|NCT05001360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111263725|NCT05001360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111263726|NCT05022810|Acetaminophen|acetaminophen|mesh-list
111263727|NCT05022810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111263728|NCT05022810|Analgesics|analgesics|mesh-ancestor
111263729|NCT05022810|Sensory System Agents|sensory system agents|mesh-ancestor
111263730|NCT05022810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111263731|NCT05022810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111263732|NCT05022810|Antipyretics|antipyretics|mesh-ancestor
111263733|NCT01525550|Sunitinib|sunitinib|mesh-list
111263734|NCT01525550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111263735|NCT01525550|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111263736|NCT01525550|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111263737|NCT01525550|Growth Substances|growth substances|mesh-ancestor
111263738|NCT01525550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111263739|NCT01525550|Growth Inhibitors|growth inhibitors|mesh-ancestor
111263740|NCT01525550|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111263741|NCT01525550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111263742|NCT01525550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111263743|NCT04730232|Paclitaxel|paclitaxel|mesh-list
111263744|NCT04730232|Tislelizumab|tislelizumab|mesh-list
111263745|NCT04730232|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111263746|NCT04730232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111263747|NCT04730232|Tubulin Modulators|tubulin modulators|mesh-ancestor
111263748|NCT04730232|Antimitotic Agents|antimitotic agents|mesh-ancestor
111263749|NCT04730232|Mitosis Modulators|mitosis modulators|mesh-ancestor
111263750|NCT04730232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111263751|NCT04730232|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111263752|NCT04701918|Pembrolizumab|pembrolizumab|mesh-list
111263753|NCT04701918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111263754|NCT04701918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111263755|NCT04701918|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111263756|NCT04701918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111263757|NCT04540848|Bupivacaine|bupivacaine|mesh-list
111263758|NCT04540848|Anesthetics, Local|anesthetics, local|mesh-ancestor
111263759|NCT04540848|Anesthetics|anesthetics|mesh-ancestor
111263760|NCT04540848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111263761|NCT04540848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111263762|NCT04540848|Sensory System Agents|sensory system agents|mesh-ancestor
111263763|NCT04540848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111263764|NCT04793100|Aflibercept|aflibercept|mesh-list
111263765|NCT04793100|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111263766|NCT04793100|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111263767|NCT04793100|Growth Substances|growth substances|mesh-ancestor
111263768|NCT04793100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111263769|NCT04793100|Growth Inhibitors|growth inhibitors|mesh-ancestor
111263770|NCT04793100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111263771|NCT04760028|Anesthetics|anesthetics|mesh-list
111263772|NCT04760028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111263773|NCT04760028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111263774|NCT05366101|Valsartan|valsartan|mesh-list
111263775|NCT05366101|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
111263776|NCT05366101|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111263777|NCT05366101|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111263778|NCT05366101|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111263779|NCT05366101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111263780|NCT04993560|Vaccines|vaccines|mesh-list
111263781|NCT04993560|Immunologic Factors|immunologic factors|mesh-ancestor
111263782|NCT04993560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111263783|NCT05365555|Anesthetics|anesthetics|mesh-list
111263784|NCT05365555|Ropivacaine|ropivacaine|mesh-list
111263785|NCT05365555|Anesthetics, Local|anesthetics, local|mesh-list
111263786|NCT05365555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111263787|NCT05365555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111263788|NCT05365555|Sensory System Agents|sensory system agents|mesh-ancestor
111263789|NCT05365555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111263790|NCT01525238|Dapagliflozin|dapagliflozin|mesh-list
111263791|NCT01525238|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111263792|NCT01525238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111263793|NCT01525238|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111263794|NCT01525238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111263795|NCT05374356|Morphine|morphine|mesh-list
111263796|NCT05374356|Bupivacaine|bupivacaine|mesh-list
111263797|NCT05374356|Anesthetics, Local|anesthetics, local|mesh-ancestor
111263798|NCT05374356|Anesthetics|anesthetics|mesh-ancestor
111263799|NCT05374356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111263800|NCT05374356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111263801|NCT05374356|Sensory System Agents|sensory system agents|mesh-ancestor
111263802|NCT05374356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111263803|NCT05374356|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111263804|NCT05374356|Narcotics|narcotics|mesh-ancestor
111263805|NCT05374356|Analgesics|analgesics|mesh-ancestor
111263806|NCT00717405|Bevacizumab|bevacizumab|mesh-list
111263807|NCT00717405|Trastuzumab|trastuzumab|mesh-list
111263808|NCT00717405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111263809|NCT00717405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111263810|NCT00717405|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111263811|NCT00717405|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111263812|NCT00717405|Growth Substances|growth substances|mesh-ancestor
111263813|NCT00717405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111263814|NCT00717405|Growth Inhibitors|growth inhibitors|mesh-ancestor
111263815|NCT01276977|Zolmitriptan|zolmitriptan|mesh-list
111263816|NCT01276977|Eletriptan|eletriptan|mesh-list
111263817|NCT01276977|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111263818|NCT01276977|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111263819|NCT01276977|Serotonin Agents|serotonin agents|mesh-ancestor
111263820|NCT01276977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111263821|NCT01276977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111263822|NCT01276977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111263823|NCT03832699|Dydrogesterone|dydrogesterone|mesh-list
111263824|NCT03832699|Progesterone|progesterone|mesh-list
111263825|NCT03832699|Progestins|progestins|mesh-ancestor
111263826|NCT03832699|Hormones|hormones|mesh-ancestor
111263827|NCT03832699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111263828|NCT03832699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111263829|NCT01277289|Dexamethasone|dexamethasone|mesh-list
111263830|NCT01277289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111263831|NCT01277289|Antiemetics|antiemetics|mesh-ancestor
111263832|NCT01277289|Autonomic Agents|autonomic agents|mesh-ancestor
111263833|NCT01277289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111263834|NCT01277289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111263835|NCT01277289|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111263836|NCT01277289|Glucocorticoids|glucocorticoids|mesh-ancestor
111263837|NCT01277289|Hormones|hormones|mesh-ancestor
111263838|NCT01277289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111263839|NCT01277289|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111263840|NCT01277289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111263841|NCT01525082|Bevacizumab|bevacizumab|mesh-list
111263842|NCT01525082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111263843|NCT01525082|Capecitabine|capecitabine|mesh-list
111263844|NCT01525082|Temozolomide|temozolomide|mesh-list
111263845|NCT01525082|Antibodies|antibodies|mesh-list
111263846|NCT01525082|Immunoglobulins|immunoglobulins|mesh-list
111263847|NCT01525082|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111263848|NCT01525082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111263849|NCT01525082|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111263850|NCT01525082|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111263851|NCT01525082|Growth Substances|growth substances|mesh-ancestor
111263852|NCT01525082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111263853|NCT01525082|Growth Inhibitors|growth inhibitors|mesh-ancestor
111263854|NCT01525082|Immunologic Factors|immunologic factors|mesh-ancestor
111263855|NCT01525082|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111263856|NCT01525082|Antimetabolites|antimetabolites|mesh-ancestor
111263857|NCT01525082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111263858|NCT01525082|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111263859|NCT01525082|Alkylating Agents|alkylating agents|mesh-ancestor
111263860|NCT03599791|Fluticasone|fluticasone|mesh-list
111263861|NCT03599791|Xhance|xhance|mesh-list
111263862|NCT03599791|Azelastine|azelastine|mesh-list
111263863|NCT03599791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111263864|NCT03599791|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111263865|NCT03599791|Autonomic Agents|autonomic agents|mesh-ancestor
111263866|NCT03599791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111263867|NCT03599791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111263868|NCT03599791|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111263869|NCT03599791|Respiratory System Agents|respiratory system agents|mesh-ancestor
111263870|NCT03599791|Dermatologic Agents|dermatologic agents|mesh-ancestor
111263871|NCT03599791|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111263872|NCT03599791|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
111263873|NCT03599791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111263874|NCT03599791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111263875|NCT03599791|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
111263876|NCT03599791|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111263877|NCT03599791|Histamine Antagonists|histamine antagonists|mesh-ancestor
111263879|NCT03599791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111263880|NCT01488578|Tolterodine Tartrate|tolterodine tartrate|mesh-list
111263881|NCT01488578|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111263882|NCT01488578|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111263883|NCT01488578|Cholinergic Agents|cholinergic agents|mesh-ancestor
111263884|NCT01488578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111263885|NCT01488578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111263886|NCT01488578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111263887|NCT01488578|Urological Agents|urological agents|mesh-ancestor
111263888|NCT00720369|Ubiquinone|ubiquinone|mesh-list
111263889|NCT00720369|Coenzyme Q10|coenzyme q10|mesh-list
111263890|NCT00720369|Micronutrients|micronutrients|mesh-ancestor
111263891|NCT00720369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111263892|NCT00720369|Vitamins|vitamins|mesh-ancestor
111263893|NCT01524770|Dulaglutide|dulaglutide|mesh-list
111263894|NCT01524770|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111263895|NCT01524770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111263896|NCT04088864|Cyclophosphamide|cyclophosphamide|mesh-list
111263897|NCT04088864|Fludarabine|fludarabine|mesh-list
111263898|NCT04088864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111263899|NCT04088864|Immunologic Factors|immunologic factors|mesh-ancestor
111263900|NCT04088864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111263901|NCT04088864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111263902|NCT04088864|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111263903|NCT04088864|Alkylating Agents|alkylating agents|mesh-ancestor
111263904|NCT04088864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111263905|NCT04088864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111263906|NCT04088864|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111263907|NCT02991339|Dexamethasone|dexamethasone|mesh-list
111263908|NCT02991339|Dexamethasone acetate|dexamethasone acetate|mesh-list
111263909|NCT02991339|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
111263910|NCT02991339|BB 1101|bb 1101|mesh-list
111263911|NCT02991339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111263912|NCT02991339|Antiemetics|antiemetics|mesh-ancestor
111263913|NCT02991339|Autonomic Agents|autonomic agents|mesh-ancestor
111263914|NCT02991339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111263915|NCT02991339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111263916|NCT02991339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111263917|NCT02991339|Glucocorticoids|glucocorticoids|mesh-ancestor
111263918|NCT02991339|Hormones|hormones|mesh-ancestor
111263919|NCT02991339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111263920|NCT02991339|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111263921|NCT02991339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111263922|NCT02991339|Protease Inhibitors|protease inhibitors|mesh-ancestor
111263923|NCT02991339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111263924|NCT02991339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111263925|NCT04018105|Metformin|metformin|mesh-list
111263926|NCT04018105|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111263927|NCT04018105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111263928|NCT05632549|Biotin|biotin|mesh-list
111263929|NCT05632549|Vitamin B Complex|vitamin b complex|mesh-ancestor
111263930|NCT05632549|Vitamins|vitamins|mesh-ancestor
111263931|NCT05632549|Micronutrients|micronutrients|mesh-ancestor
111263932|NCT05632549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111263933|NCT00721617|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
111263934|NCT00721617|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
111263935|NCT00721617|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
111263936|NCT00721617|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111263937|NCT03597997|Propofol|propofol|mesh-list
111263938|NCT03597997|Sevoflurane|sevoflurane|mesh-list
111263939|NCT03597997|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111263940|NCT03597997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111263941|NCT03597997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111263942|NCT03597997|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111263943|NCT03597997|Anesthetics, General|anesthetics, general|mesh-ancestor
111263944|NCT03597997|Anesthetics|anesthetics|mesh-ancestor
111263945|NCT03597997|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111263946|NCT03597997|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111263947|NCT01277835|Lidocaine|lidocaine|mesh-list
111263948|NCT01277835|Anesthetics, Local|anesthetics, local|mesh-ancestor
111263949|NCT01277835|Anesthetics|anesthetics|mesh-ancestor
111263950|NCT01277835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111263951|NCT01277835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111263952|NCT01277835|Sensory System Agents|sensory system agents|mesh-ancestor
111263953|NCT01277835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111263954|NCT01277835|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111263955|NCT01277835|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111263956|NCT01277835|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111263957|NCT01277835|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111263958|NCT01277835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111263960|NCT01431287|Olodaterol|olodaterol|mesh-list
111263961|NCT01431287|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111263962|NCT01431287|Autonomic Agents|autonomic agents|mesh-ancestor
111263963|NCT01431287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111263964|NCT01431287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111263965|NCT01431287|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111263966|NCT01431287|Respiratory System Agents|respiratory system agents|mesh-ancestor
111263967|NCT01431287|Parasympatholytics|parasympatholytics|mesh-ancestor
111263968|NCT01431287|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111263969|NCT01431287|Cholinergic Agents|cholinergic agents|mesh-ancestor
111263970|NCT01431287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111263971|NCT01431287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111263972|NCT05632159|Anesthetics|anesthetics|mesh-list
111263973|NCT05632159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111263974|NCT05632159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111263975|NCT04017013|Lidocaine|lidocaine|mesh-list
111263976|NCT04017013|Anesthetics, Local|anesthetics, local|mesh-ancestor
111263977|NCT04017013|Anesthetics|anesthetics|mesh-ancestor
111263978|NCT04017013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111263979|NCT04017013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111263980|NCT04017013|Sensory System Agents|sensory system agents|mesh-ancestor
111263981|NCT04017013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111263982|NCT04017013|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111263983|NCT04017013|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111263984|NCT04017013|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111263985|NCT04017013|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111263986|NCT04017013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111263987|NCT01277913|Vitamin D|vitamin d|mesh-list
111263988|NCT01277913|Ergocalciferols|ergocalciferols|mesh-list
111263989|NCT01277913|Cholecalciferol|cholecalciferol|mesh-list
111263990|NCT01277913|Vitamins|vitamins|mesh-list
111263991|NCT01277913|Micronutrients|micronutrients|mesh-ancestor
111263992|NCT01277913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110978376|NCT02713490|Anesthetics|anesthetics|mesh-ancestor
111263993|NCT01277913|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111263994|NCT01277913|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111263995|NCT05631847|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
111263996|NCT05631847|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111263997|NCT05631847|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111263998|NCT05631847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111263999|NCT00729807|Pentamidine|pentamidine|mesh-list
111264000|NCT00729807|Antifungal Agents|antifungal agents|mesh-ancestor
111264001|NCT00729807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111264002|NCT00729807|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111264003|NCT00729807|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111264004|NCT00729807|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
111264005|NCT03590119|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
111264006|NCT03590119|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111264007|NCT03590119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111264008|NCT03592693|Vitamins|vitamins|mesh-list
111264009|NCT03592693|Hydrocortisone|hydrocortisone|mesh-list
111264010|NCT03592693|Micronutrients|micronutrients|mesh-ancestor
111264011|NCT03592693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111264012|NCT03592693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111264013|NCT00730353|Paclitaxel|paclitaxel|mesh-list
111264014|NCT00730353|Sunitinib|sunitinib|mesh-list
111264015|NCT00730353|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111264016|NCT00730353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111264017|NCT00730353|Tubulin Modulators|tubulin modulators|mesh-ancestor
111264018|NCT00730353|Antimitotic Agents|antimitotic agents|mesh-ancestor
111264019|NCT00730353|Mitosis Modulators|mitosis modulators|mesh-ancestor
111264020|NCT00730353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111264021|NCT00730353|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111264022|NCT00730353|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111264023|NCT00730353|Growth Substances|growth substances|mesh-ancestor
111264024|NCT00730353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111264025|NCT00730353|Growth Inhibitors|growth inhibitors|mesh-ancestor
111264026|NCT00730353|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111264027|NCT00730353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111264028|NCT01272531|Valproic Acid|valproic acid|mesh-list
111264029|NCT01272531|Lithium Carbonate|lithium carbonate|mesh-list
111264030|NCT01272531|Anticonvulsants|anticonvulsants|mesh-ancestor
111264031|NCT01272531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111264032|NCT01272531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111264033|NCT01272531|GABA Agents|gaba agents|mesh-ancestor
111264034|NCT01272531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111264035|NCT01272531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111264036|NCT01272531|Antimanic Agents|antimanic agents|mesh-ancestor
111264037|NCT01272531|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111264038|NCT01272531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111264039|NCT01272531|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111264040|NCT01272531|Antidepressive Agents|antidepressive agents|mesh-ancestor
111264041|NCT01272609|Timolol|timolol|mesh-list
111264042|NCT01272609|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111264043|NCT01272609|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111264044|NCT01272609|Adrenergic Agents|adrenergic agents|mesh-ancestor
111264045|NCT01272609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111264046|NCT01272609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111264047|NCT01272609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111264048|NCT01272609|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111264049|NCT01272609|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111264050|NCT03595189|Cilastatin|cilastatin|mesh-list
111264051|NCT03595189|Protease Inhibitors|protease inhibitors|mesh-ancestor
111264052|NCT03595189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111264053|NCT03595189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111264054|NCT01410227|Factor VIII|factor viii|mesh-list
111264055|NCT01410227|Coagulants|coagulants|mesh-ancestor
111264056|NCT01274559|Niacin|niacin|mesh-list
111264057|NCT01274559|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111264058|NCT01274559|Antimetabolites|antimetabolites|mesh-ancestor
111264059|NCT01274559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111264060|NCT01274559|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111264061|NCT01274559|Vasodilator Agents|vasodilator agents|mesh-ancestor
111264062|NCT01274559|Vitamin B Complex|vitamin b complex|mesh-ancestor
111264063|NCT01274559|Vitamins|vitamins|mesh-ancestor
111264064|NCT01274559|Micronutrients|micronutrients|mesh-ancestor
111264065|NCT01274559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111264066|NCT01409993|Sildenafil Citrate|sildenafil citrate|mesh-list
111264067|NCT01409993|Vasodilator Agents|vasodilator agents|mesh-ancestor
111264068|NCT01409993|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111264069|NCT01409993|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111264070|NCT01409993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111264071|NCT01409993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111264072|NCT01409993|Urological Agents|urological agents|mesh-ancestor
111264073|NCT01409915|Molgramostim|molgramostim|mesh-list
111264074|NCT01409915|Sargramostim|sargramostim|mesh-list
111264075|NCT01409915|Immunologic Factors|immunologic factors|mesh-ancestor
111264076|NCT01409915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111264077|NCT01409915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111264078|NCT01272921|Bupivacaine|bupivacaine|mesh-list
111264079|NCT01272921|Ropivacaine|ropivacaine|mesh-list
111264080|NCT01272921|Anesthetics, Local|anesthetics, local|mesh-ancestor
111264081|NCT01272921|Anesthetics|anesthetics|mesh-ancestor
111264082|NCT01272921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111264083|NCT01272921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111264084|NCT01272921|Sensory System Agents|sensory system agents|mesh-ancestor
111264085|NCT01272921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111264086|NCT01409837|Lisinopril|lisinopril|mesh-list
111264087|NCT01409837|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
111264088|NCT01409837|Protease Inhibitors|protease inhibitors|mesh-ancestor
111264089|NCT01409837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111264090|NCT01409837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111264091|NCT01409837|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111264092|NCT01409837|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111264093|NCT01409837|Protective Agents|protective agents|mesh-ancestor
111264094|NCT01409837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111264095|NCT01278459|Atorvastatin|atorvastatin|mesh-list
110988400|NCT03703427|Capecitabine|capecitabine|mesh-list
111264096|NCT01278459|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111264097|NCT01278459|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111264098|NCT01278459|Antimetabolites|antimetabolites|mesh-ancestor
111264099|NCT01278459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111264100|NCT01278459|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111264101|NCT01278459|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111264102|NCT01278459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111264103|NCT00731055|Varenicline|varenicline|mesh-list
111264104|NCT00731055|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111264105|NCT00731055|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111264106|NCT00731055|Cholinergic Agents|cholinergic agents|mesh-ancestor
111264107|NCT00731055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111264108|NCT00731055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111264109|NCT00731055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111264110|NCT03594565|Fluticasone|fluticasone|mesh-list
111264111|NCT03594565|Xhance|xhance|mesh-list
111264112|NCT03594565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111264113|NCT03594565|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111264114|NCT03594565|Autonomic Agents|autonomic agents|mesh-ancestor
111264115|NCT03594565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111264116|NCT03594565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111264117|NCT03594565|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111264118|NCT03594565|Respiratory System Agents|respiratory system agents|mesh-ancestor
111264119|NCT03594565|Dermatologic Agents|dermatologic agents|mesh-ancestor
111264120|NCT03594565|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111264121|NCT01430585|Letrozole|letrozole|mesh-list
111264122|NCT01430585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111264123|NCT01430585|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111264124|NCT01430585|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111264125|NCT01430585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111264126|NCT01430585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111264127|NCT01430585|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111264128|NCT01430585|Hormone Antagonists|hormone antagonists|mesh-ancestor
111264129|NCT01430585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111264130|NCT01430585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111264131|NCT04005859|Lidocaine|lidocaine|mesh-list
111264132|NCT04005859|Anesthetics, Local|anesthetics, local|mesh-ancestor
111264133|NCT04005859|Anesthetics|anesthetics|mesh-ancestor
111264134|NCT04005859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111264135|NCT04005859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111264136|NCT04005859|Sensory System Agents|sensory system agents|mesh-ancestor
111264137|NCT04005859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111264138|NCT04005859|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111264139|NCT04005859|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111264140|NCT04005859|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111264141|NCT04005859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111264142|NCT04005859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111264143|NCT05633719|Carboplatin|carboplatin|mesh-list
111264144|NCT05633719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111264145|NCT01408901|Molgramostim|molgramostim|mesh-list
111264146|NCT01408901|Sargramostim|sargramostim|mesh-list
111264147|NCT01408901|Immunologic Factors|immunologic factors|mesh-ancestor
111264148|NCT01408901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111264149|NCT01408901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111264150|NCT02080195|Mycophenolic Acid|mycophenolic acid|mesh-list
111264151|NCT02080195|Cyclophosphamide|cyclophosphamide|mesh-list
111264152|NCT02080195|Fludarabine|fludarabine|mesh-list
111264153|NCT02080195|Tacrolimus|tacrolimus|mesh-list
111264154|NCT02080195|Thymoglobulin|thymoglobulin|mesh-list
111264155|NCT02080195|Antilymphocyte Serum|antilymphocyte serum|mesh-list
111264156|NCT02080195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111264157|NCT02080195|Immunologic Factors|immunologic factors|mesh-ancestor
111264158|NCT02080195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111264159|NCT02080195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111264160|NCT02080195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111264161|NCT02080195|Alkylating Agents|alkylating agents|mesh-ancestor
111264162|NCT02080195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111264163|NCT02080195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111264164|NCT02080195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111264165|NCT02080195|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111264166|NCT02080195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111264167|NCT02080195|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111264168|NCT02080195|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111264169|NCT02080195|Antitubercular Agents|antitubercular agents|mesh-ancestor
111264170|NCT02080195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111264171|NCT02080195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111264172|NCT04044131|Sorbitol|sorbitol|mesh-list
111264173|NCT04044131|Cathartics|cathartics|mesh-ancestor
111264174|NCT04044131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111264175|NCT01428713|Tranexamic Acid|tranexamic acid|mesh-list
111264176|NCT01428713|Contraceptive Agents|contraceptive agents|mesh-list
111264177|NCT01428713|Contraceptives, Oral|contraceptives, oral|mesh-list
111264178|NCT01428713|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
111264179|NCT01428713|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111264180|NCT01428713|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111264181|NCT01428713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111264182|NCT01428713|Hemostatics|hemostatics|mesh-ancestor
111264183|NCT01428713|Coagulants|coagulants|mesh-ancestor
111264184|NCT01428713|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111264185|NCT01428713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111264186|NCT01428713|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111264187|NCT01408043|Plerixafor|plerixafor|mesh-list
111264188|NCT01408043|Etoposide|etoposide|mesh-list
111264189|NCT01408043|Etoposide phosphate|etoposide phosphate|mesh-list
111264190|NCT01408043|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111264191|NCT01408043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111264192|NCT01408043|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111264193|NCT01408043|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111264194|NCT01408043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111264195|NCT01408043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111264196|NCT01408043|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111264197|NCT01408043|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111264198|NCT01408043|Antiviral Agents|antiviral agents|mesh-ancestor
111264199|NCT01408043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111264200|NCT00219349|Escitalopram|escitalopram|mesh-list
111264201|NCT00219349|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111264202|NCT00219349|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111264203|NCT00219349|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111264204|NCT00219349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111264205|NCT00219349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111264206|NCT00219349|Serotonin Agents|serotonin agents|mesh-ancestor
111264207|NCT00219349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111264208|NCT00218257|Progesterone|progesterone|mesh-list
111264209|NCT00218257|Progestins|progestins|mesh-ancestor
111264210|NCT00218257|Hormones|hormones|mesh-ancestor
111264211|NCT00218257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111264212|NCT00218257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111264213|NCT01523366|Clopidogrel|clopidogrel|mesh-list
111264214|NCT01523366|Ticagrelor|ticagrelor|mesh-list
111264215|NCT01523366|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111264216|NCT01523366|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111264217|NCT01523366|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111264218|NCT01523366|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111264219|NCT01523366|Purinergic Agents|purinergic agents|mesh-ancestor
111264220|NCT01523366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111264221|NCT01523366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111264222|NCT01523366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111264223|NCT03024697|Anesthetics|anesthetics|mesh-list
111264224|NCT03024697|Anesthetics, Local|anesthetics, local|mesh-list
111264225|NCT03024697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111264226|NCT03024697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111264227|NCT03024697|Sensory System Agents|sensory system agents|mesh-ancestor
111264228|NCT03024697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111264229|NCT01427933|Ramucirumab|ramucirumab|mesh-list
111264230|NCT01427933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111264231|NCT00217087|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
111264232|NCT00217087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111264233|NCT00217087|Dermatologic Agents|dermatologic agents|mesh-ancestor
111264234|NCT00217087|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111264235|NCT03780127|Fenfluramine|fenfluramine|mesh-list
111264236|NCT03780127|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111264237|NCT03780127|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111264238|NCT03780127|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111264239|NCT03780127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111264240|NCT03780127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111264241|NCT03780127|Serotonin Agents|serotonin agents|mesh-ancestor
111264242|NCT03780127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111264243|NCT01406873|Mexiletine|mexiletine|mesh-list
111264244|NCT01406873|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111264245|NCT01406873|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111264246|NCT01406873|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111264247|NCT01406873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111264248|NCT01406873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111264249|NCT01406795|Heparin|heparin|mesh-list
111264250|NCT01406795|Anticoagulants|anticoagulants|mesh-ancestor
111264251|NCT01406795|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111264252|NCT01406795|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111264253|NCT01406795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111264254|NCT01406015|Spironolactone|spironolactone|mesh-list
111264255|NCT01406015|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
111264256|NCT01406015|Hormone Antagonists|hormone antagonists|mesh-ancestor
111264257|NCT01406015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111264258|NCT01406015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111264259|NCT01406015|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
111264260|NCT01406015|Diuretics|diuretics|mesh-ancestor
111264261|NCT01406015|Natriuretic Agents|natriuretic agents|mesh-ancestor
111264262|NCT00215137|Escitalopram|escitalopram|mesh-list
111264263|NCT00215137|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111264264|NCT00215137|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111264265|NCT00215137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111264266|NCT00215137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111264267|NCT00215137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111264268|NCT00215137|Serotonin Agents|serotonin agents|mesh-ancestor
111264269|NCT00215137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111264270|NCT04406779|Hormones|hormones|mesh-list
111264271|NCT04406779|Autoantibodies|autoantibodies|mesh-list
111264272|NCT04406779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111264273|NCT04406779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111264274|NCT04406779|Immunologic Factors|immunologic factors|mesh-ancestor
111264275|NCT00214201|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
111264276|NCT00214201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111264277|NCT00214201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111264278|NCT03598075|Pramlintide|pramlintide|mesh-list
111264279|NCT03598075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111264280|NCT03598075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111264281|NCT03597919|Vaccines|vaccines|mesh-list
111264282|NCT03597919|Immunologic Factors|immunologic factors|mesh-ancestor
111264283|NCT03597919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111264284|NCT04001413|Durvalumab|durvalumab|mesh-list
111264285|NCT04001413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111264286|NCT04001413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111264287|NCT01677858|Dexamethasone|dexamethasone|mesh-list
111264288|NCT01677858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111264289|NCT01677858|Antiemetics|antiemetics|mesh-ancestor
111264290|NCT01677858|Autonomic Agents|autonomic agents|mesh-ancestor
111264291|NCT01677858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111264292|NCT01677858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111264293|NCT01677858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111264294|NCT01677858|Glucocorticoids|glucocorticoids|mesh-ancestor
111264295|NCT01677858|Hormones|hormones|mesh-ancestor
111264296|NCT01677858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111264297|NCT01677858|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111264298|NCT01677858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111264299|NCT03027284|Gemcitabine|gemcitabine|mesh-list
111264300|NCT03027284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111264301|NCT03027284|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111264302|NCT03027284|Antimetabolites|antimetabolites|mesh-ancestor
111264303|NCT03027284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111264304|NCT03592069|Amoxicillin|amoxicillin|mesh-list
111264305|NCT03592069|Metronidazole|metronidazole|mesh-list
111264306|NCT03592069|Clarithromycin|clarithromycin|mesh-list
111264307|NCT03592069|Esomeprazole|esomeprazole|mesh-list
111264308|NCT03592069|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111264309|NCT03592069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111264310|NCT03592069|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111264311|NCT03592069|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111264312|NCT03592069|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111264313|NCT03592069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111264314|NCT03592069|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111264315|NCT03592069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111264316|NCT03592069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111264317|NCT03592069|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111264318|NCT03592069|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110959167|NCT05681182|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111264320|NCT03591991|Empagliflozin|empagliflozin|mesh-list
111264321|NCT03591991|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111264322|NCT03591991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111264323|NCT03591991|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111264324|NCT03591991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111264325|NCT03591913|Misoprostol|misoprostol|mesh-list
111264326|NCT03591913|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111264327|NCT03591913|Abortifacient Agents|abortifacient agents|mesh-ancestor
111264328|NCT03591913|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111264329|NCT03591913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111264330|NCT03591913|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111264331|NCT03591913|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111264332|NCT03591913|Oxytocics|oxytocics|mesh-ancestor
111264333|NCT04198129|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111264334|NCT04198129|Amoxicillin|amoxicillin|mesh-list
111264335|NCT04198129|Clindamycin|clindamycin|mesh-list
111264336|NCT04198129|Clindamycin palmitate|clindamycin palmitate|mesh-list
111264337|NCT04198129|Clindamycin phosphate|clindamycin phosphate|mesh-list
111264338|NCT04198129|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
111264339|NCT04198129|Ampicillin|ampicillin|mesh-list
111264340|NCT04198129|Sultamicillin|sultamicillin|mesh-list
111264341|NCT04198129|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
111264342|NCT04198129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111264343|NCT04198129|Antitubercular Agents|antitubercular agents|mesh-ancestor
111264344|NCT04198129|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111264345|NCT04198129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111264346|NCT04198129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111264347|NCT04198129|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
111264348|NCT03591757|Tolcapone|tolcapone|mesh-list
111264349|NCT03591757|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111264350|NCT03591757|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111264351|NCT03591757|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
111264352|NCT03591757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111264353|NCT03591757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111264354|NCT04438434|Chlorhexidine|chlorhexidine|mesh-list
111264355|NCT04438434|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
111264356|NCT04438434|Hydrogen Peroxide|hydrogen peroxide|mesh-list
111264357|NCT04438434|Hyaluronic Acid|hyaluronic acid|mesh-list
111264358|NCT04438434|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111264359|NCT04438434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111264360|NCT04438434|Disinfectants|disinfectants|mesh-ancestor
111264361|NCT04438434|Dermatologic Agents|dermatologic agents|mesh-ancestor
111264362|NCT04438434|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111264363|NCT04438434|Immunologic Factors|immunologic factors|mesh-ancestor
111264364|NCT04438434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111264365|NCT04438434|Viscosupplements|viscosupplements|mesh-ancestor
111264366|NCT04438434|Protective Agents|protective agents|mesh-ancestor
111264367|NCT03591679|Oxytocin|oxytocin|mesh-list
111264368|NCT03591679|Oxytocics|oxytocics|mesh-ancestor
111264369|NCT03591679|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111264370|NCT03591679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111264371|NCT04197817|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111264372|NCT04197817|Antibodies|antibodies|mesh-list
111264373|NCT04197817|Immunoglobulins|immunoglobulins|mesh-list
111264374|NCT04197817|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111264375|NCT04197817|Immunologic Factors|immunologic factors|mesh-ancestor
111264376|NCT04197817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111264377|NCT04197817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111264378|NCT04585854|Caffeine|caffeine|mesh-list
111264379|NCT04585854|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111264380|NCT04585854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111264381|NCT04585854|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111264382|NCT04585854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111264383|NCT04585854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111264384|NCT04585854|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
111264385|NCT04585854|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111264386|NCT04585854|Purinergic Agents|purinergic agents|mesh-ancestor
111264387|NCT04585854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111264388|NCT03481842|Axitinib|axitinib|mesh-list
111264389|NCT03481842|Afatinib|afatinib|mesh-list
111264390|NCT03481842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111264391|NCT03481842|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111264392|NCT03481842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110988696|NCT03487107|Sofosbuvir|sofosbuvir|mesh-list
111264393|NCT03481842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111264395|NCT04197739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111264396|NCT04197739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111264397|NCT03449706|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
111264398|NCT03449706|Antiviral Agents|antiviral agents|mesh-ancestor
111264399|NCT03449706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111264400|NCT04197349|Sumatriptan|sumatriptan|mesh-list
111264401|NCT04197349|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111264402|NCT04197349|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111264403|NCT04197349|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111264404|NCT04197349|Serotonin Agents|serotonin agents|mesh-ancestor
111264405|NCT04197349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111264406|NCT04197349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111264407|NCT04197349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111264408|NCT03422094|Nivolumab|nivolumab|mesh-list
111264409|NCT03422094|Ipilimumab|ipilimumab|mesh-list
111264410|NCT03422094|Poly ICLC|poly iclc|mesh-list
111264411|NCT03422094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111264412|NCT03422094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111264413|NCT03422094|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111264414|NCT03422094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111264415|NCT03422094|Interferon Inducers|interferon inducers|mesh-ancestor
111264416|NCT03422094|Immunologic Factors|immunologic factors|mesh-ancestor
111264417|NCT03422094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111264418|NCT04356534|Antibodies|antibodies|mesh-list
111264419|NCT04356534|Immunologic Factors|immunologic factors|mesh-ancestor
111264420|NCT04356534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111264421|NCT03591289|Bromides|bromides|mesh-list
111264422|NCT03591289|Rocuronium|rocuronium|mesh-list
111264423|NCT03591289|Anticonvulsants|anticonvulsants|mesh-ancestor
111264424|NCT03591289|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
111264425|NCT03591289|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
111264426|NCT03591289|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111264427|NCT03591289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111264428|NCT03591289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111264429|NCT05338866|Capecitabine|capecitabine|mesh-list
111264430|NCT05338866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111264431|NCT05338866|Antimetabolites|antimetabolites|mesh-ancestor
111264432|NCT05338866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111264433|NCT05338866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111264434|NCT02471118|Adalimumab|adalimumab|mesh-list
111264435|NCT02471118|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111264436|NCT02471118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111264437|NCT02471118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111264438|NCT04197115|Vitamins|vitamins|mesh-list
111264439|NCT04197115|Ascorbic Acid|ascorbic acid|mesh-list
111264440|NCT04197115|Vitamin B Complex|vitamin b complex|mesh-list
111264441|NCT04197115|Hydrocortisone|hydrocortisone|mesh-list
111264442|NCT04197115|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
111264443|NCT04197115|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
111264444|NCT04197115|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
111264445|NCT04197115|Micronutrients|micronutrients|mesh-ancestor
111264446|NCT04197115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111264447|NCT04197115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111264448|NCT04197115|Antioxidants|antioxidants|mesh-ancestor
111264449|NCT04197115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111264450|NCT04197115|Protective Agents|protective agents|mesh-ancestor
111264451|NCT02467452|Tiotropium Bromide|tiotropium bromide|mesh-list
111264452|NCT02467452|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111264453|NCT02467452|Autonomic Agents|autonomic agents|mesh-ancestor
111264454|NCT02467452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111264455|NCT02467452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111264456|NCT02467452|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111264457|NCT02467452|Respiratory System Agents|respiratory system agents|mesh-ancestor
111264458|NCT02467452|Parasympatholytics|parasympatholytics|mesh-ancestor
111264459|NCT02467452|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111264460|NCT02467452|Cholinergic Agents|cholinergic agents|mesh-ancestor
111264461|NCT02467452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111264462|NCT02467452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111264463|NCT03590587|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
111264464|NCT03590587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111264465|NCT03590587|Glucocorticoids|glucocorticoids|mesh-ancestor
111264466|NCT03590587|Hormones|hormones|mesh-ancestor
111264467|NCT03590587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111264468|NCT03590587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111264469|NCT03590431|Iodine|iodine|mesh-list
111264470|NCT03590431|Cadexomer iodine|cadexomer iodine|mesh-list
111264471|NCT03590431|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111264472|NCT03590431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111264473|NCT03590431|Trace Elements|trace elements|mesh-ancestor
111264474|NCT03590431|Micronutrients|micronutrients|mesh-ancestor
111264475|NCT03590431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111264476|NCT03980665|Arsenic Trioxide|arsenic trioxide|mesh-list
111264477|NCT03980665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111264478|NCT05102448|Methotrexate|methotrexate|mesh-list
111264479|NCT05102448|Tofacitinib|tofacitinib|mesh-list
111264480|NCT05102448|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111264481|NCT05102448|Abortifacient Agents|abortifacient agents|mesh-ancestor
111264482|NCT05102448|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111264483|NCT05102448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111264484|NCT05102448|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111264485|NCT05102448|Antimetabolites|antimetabolites|mesh-ancestor
111264486|NCT05102448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111264487|NCT05102448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111264488|NCT05102448|Dermatologic Agents|dermatologic agents|mesh-ancestor
111264489|NCT05102448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111264490|NCT05102448|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111264491|NCT05102448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111264492|NCT05102448|Immunologic Factors|immunologic factors|mesh-ancestor
111264493|NCT05102448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111264494|NCT05102448|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111264495|NCT05102448|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
111264496|NCT05102448|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111264497|NCT03599323|Clotrimazole|clotrimazole|mesh-list
111264498|NCT03599323|Miconazole|miconazole|mesh-list
111264499|NCT03599323|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111264500|NCT03599323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111264501|NCT03599323|Antifungal Agents|antifungal agents|mesh-ancestor
111264502|NCT03599323|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111264503|NCT03599323|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111264504|NCT03599323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111264505|NCT03599323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111264506|NCT03599323|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111264507|NCT03599323|Hormone Antagonists|hormone antagonists|mesh-ancestor
111264508|NCT03599323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111264509|NCT03599323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111264510|NCT03599323|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111264511|NCT03599323|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111264512|NCT04195867|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
111264513|NCT04195867|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111264514|NCT04195867|Autonomic Agents|autonomic agents|mesh-ancestor
111264515|NCT04195867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111264516|NCT04195867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111264517|NCT04195867|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111264518|NCT04195867|Respiratory System Agents|respiratory system agents|mesh-ancestor
111264519|NCT04195867|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111264520|NCT04195867|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111264521|NCT04195867|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111264522|NCT04195867|Adrenergic Agents|adrenergic agents|mesh-ancestor
111264523|NCT04195867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111264524|NCT04195867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111264525|NCT05102058|Dexmedetomidine|dexmedetomidine|mesh-list
111264526|NCT05102058|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111264527|NCT05102058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111264528|NCT05102058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111264529|NCT05102058|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111264530|NCT05102058|Analgesics|analgesics|mesh-ancestor
111264531|NCT05102058|Sensory System Agents|sensory system agents|mesh-ancestor
111264532|NCT05102058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111264533|NCT05102058|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111264534|NCT05102058|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111264535|NCT05102058|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111264536|NCT05102058|Adrenergic Agents|adrenergic agents|mesh-ancestor
111264537|NCT05102058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111264538|NCT05102058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111264539|NCT03956797|Anesthetics|anesthetics|mesh-list
110988850|NCT05565352|Anesthetics|anesthetics|mesh-ancestor
111264540|NCT03956797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111264541|NCT03956797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111264542|NCT03598777|Botulinum Toxins|botulinum toxins|mesh-list
111264543|NCT03598777|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111264544|NCT03598777|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111264545|NCT03598777|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111264546|NCT03598777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111264547|NCT03598777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111264548|NCT03598777|Cholinergic Agents|cholinergic agents|mesh-ancestor
111264549|NCT03598777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111264550|NCT03598777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111264551|NCT03598777|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111264552|NCT03598777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111264553|NCT04195243|Dapagliflozin|dapagliflozin|mesh-list
111264554|NCT04195243|Empagliflozin|empagliflozin|mesh-list
111264555|NCT04195243|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111264556|NCT04195243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111264557|NCT04195243|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111264558|NCT04195243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111264559|NCT04195321|Phenylephrine|phenylephrine|mesh-list
111264560|NCT04195321|Oxymetazoline|oxymetazoline|mesh-list
111264561|NCT04195321|Norepinephrine|norepinephrine|mesh-list
111264562|NCT04195321|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111264563|NCT04195321|Mydriatics|mydriatics|mesh-ancestor
111264564|NCT04195321|Autonomic Agents|autonomic agents|mesh-ancestor
111264565|NCT04195321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111264566|NCT04195321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111264567|NCT04195321|Sympathomimetics|sympathomimetics|mesh-ancestor
111264568|NCT04195321|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111264569|NCT04195321|Nasal Decongestants|nasal decongestants|mesh-ancestor
111264570|NCT04195321|Respiratory System Agents|respiratory system agents|mesh-ancestor
111264571|NCT04195321|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111264572|NCT04195321|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111264573|NCT04195321|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111264574|NCT04195321|Adrenergic Agents|adrenergic agents|mesh-ancestor
111264575|NCT04195321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111264576|NCT04195321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111264577|NCT04195321|Protective Agents|protective agents|mesh-ancestor
111264578|NCT06012760|Epoetin Alfa|epoetin alfa|mesh-list
111264579|NCT06012760|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
111264580|NCT06012760|Hematinics|hematinics|mesh-ancestor
111264581|NCT06012695|Temozolomide|temozolomide|mesh-list
111264582|NCT06012695|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111264583|NCT06012695|Alkylating Agents|alkylating agents|mesh-ancestor
111264584|NCT06012695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111264585|NCT06012695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111264586|NCT06012682|Metformin|metformin|mesh-list
111264587|NCT06012682|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111264588|NCT06012682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111264589|NCT06012552|Tianeptine|tianeptine|mesh-list
111264590|NCT06012552|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
111264591|NCT06012552|Antidepressive Agents|antidepressive agents|mesh-ancestor
111264592|NCT06012552|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111264593|NCT06012500|Xenon|xenon|mesh-list
111264594|NCT06012500|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111264595|NCT06012500|Anesthetics, General|anesthetics, general|mesh-ancestor
111264596|NCT06012500|Anesthetics|anesthetics|mesh-ancestor
111264597|NCT06012500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111264598|NCT06012500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111264599|NCT06012435|Docetaxel|docetaxel|mesh-list
111264600|NCT06012435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111264601|NCT06012435|Tubulin Modulators|tubulin modulators|mesh-ancestor
111264602|NCT06012435|Antimitotic Agents|antimitotic agents|mesh-ancestor
111264603|NCT06012435|Mitosis Modulators|mitosis modulators|mesh-ancestor
111264604|NCT06012435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111264605|NCT06012383|Bortezomib|bortezomib|mesh-list
111264606|NCT06012383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111264607|NCT06012279|Dapagliflozin|dapagliflozin|mesh-list
111264608|NCT06012279|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
111264609|NCT06012279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111264610|NCT06012279|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111264611|NCT06012279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111264612|NCT06012266|Dapagliflozin|dapagliflozin|mesh-list
111264613|NCT06012266|Empagliflozin|empagliflozin|mesh-list
111264614|NCT06012266|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111264615|NCT06012266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111264616|NCT06012266|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111264617|NCT06012266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111264619|NCT06012175|Antioxidants|antioxidants|mesh-ancestor
111264620|NCT06012175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111264621|NCT06012175|Protective Agents|protective agents|mesh-ancestor
111264622|NCT06012175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111264623|NCT06012175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111264624|NCT06012097|Diclofenac|diclofenac|mesh-list
111264625|NCT06012097|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111264626|NCT06012097|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111264627|NCT06012097|Analgesics|analgesics|mesh-ancestor
111264628|NCT06012097|Sensory System Agents|sensory system agents|mesh-ancestor
111264629|NCT06012097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111264630|NCT06012097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111264631|NCT06012097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111264632|NCT06012097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111264633|NCT06012097|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111264634|NCT06012097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111264635|NCT06012097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111264636|NCT06011980|Growth Inhibitors|growth inhibitors|mesh-list
111264637|NCT06011980|Growth Substances|growth substances|mesh-ancestor
111264638|NCT06011980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111264639|NCT06011798|Aflibercept|aflibercept|mesh-list
111264640|NCT06011798|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111264641|NCT06011798|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111264642|NCT06011798|Growth Substances|growth substances|mesh-ancestor
111264643|NCT06011798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111264644|NCT06011798|Growth Inhibitors|growth inhibitors|mesh-ancestor
111264645|NCT06011798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111264646|NCT06011629|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
111264647|NCT06011629|Laxatives|laxatives|mesh-ancestor
111264648|NCT06011629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111264649|NCT06011460|Clozapine|clozapine|mesh-list
111264650|NCT06011460|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111264651|NCT06011460|Serotonin Agents|serotonin agents|mesh-ancestor
111264652|NCT06011460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111264653|NCT06011460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111264654|NCT06011460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111264655|NCT06011460|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111264656|NCT06011460|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111264657|NCT06011460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111264658|NCT06011460|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111264659|NCT06011460|GABA Antagonists|gaba antagonists|mesh-ancestor
111264660|NCT06011460|GABA Agents|gaba agents|mesh-ancestor
111264661|NCT06011421|Anesthetics|anesthetics|mesh-list
111264662|NCT06011421|Anesthetics, Local|anesthetics, local|mesh-list
111264663|NCT06011421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111264664|NCT06011421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111264665|NCT06011421|Sensory System Agents|sensory system agents|mesh-ancestor
111264666|NCT06011421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111264667|NCT06011343|Meglumine Antimoniate|meglumine antimoniate|mesh-list
111264668|NCT06011343|Tofacitinib|tofacitinib|mesh-list
111264669|NCT06011343|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
111264670|NCT06011343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111264671|NCT06011343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111264672|NCT06011343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111264673|NCT06011343|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111264674|NCT06011343|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111264675|NCT06011343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111264676|NCT06011265|Mirabegron|mirabegron|mesh-list
111264677|NCT06011265|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
111264678|NCT06011265|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111264679|NCT06011265|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111264680|NCT06011265|Adrenergic Agents|adrenergic agents|mesh-ancestor
111264681|NCT06011265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111264682|NCT06011265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111264683|NCT06011265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111264684|NCT06011265|Urological Agents|urological agents|mesh-ancestor
111264685|NCT06011083|Betamethasone|betamethasone|mesh-list
111264686|NCT06011083|Betamethasone Valerate|betamethasone valerate|mesh-list
111264687|NCT06011083|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
110959168|NCT03521700|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111264688|NCT06011083|Betamethasone benzoate|betamethasone benzoate|mesh-list
111264689|NCT06011083|Calcipotriene|calcipotriene|mesh-list
111264690|NCT06011083|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
111264691|NCT06011083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111264692|NCT06011083|Glucocorticoids|glucocorticoids|mesh-ancestor
111264693|NCT06011083|Hormones|hormones|mesh-ancestor
111264694|NCT06011083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111264695|NCT06011083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111264696|NCT06011083|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111264697|NCT06011083|Respiratory System Agents|respiratory system agents|mesh-ancestor
111264698|NCT06011083|Dermatologic Agents|dermatologic agents|mesh-ancestor
111264699|NCT06011005|Benzocaine|benzocaine|mesh-list
111264700|NCT06011005|Ethyl Chloride|ethyl chloride|mesh-list
111264701|NCT06011005|Anesthetics, Local|anesthetics, local|mesh-ancestor
111264702|NCT06011005|Anesthetics|anesthetics|mesh-ancestor
111264703|NCT06011005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111264704|NCT06011005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111264705|NCT06011005|Sensory System Agents|sensory system agents|mesh-ancestor
111264706|NCT06011005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111264707|NCT06010992|Nitazoxanide|nitazoxanide|mesh-list
111264708|NCT06010992|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111264709|NCT06010992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111264710|NCT06010745|Biotin|biotin|mesh-list
111264711|NCT06010745|Silicon|silicon|mesh-list
111264712|NCT06010745|Vitamin B Complex|vitamin b complex|mesh-ancestor
111264713|NCT06010745|Vitamins|vitamins|mesh-ancestor
111264714|NCT06010745|Micronutrients|micronutrients|mesh-ancestor
111264715|NCT06010745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111264716|NCT06010745|Trace Elements|trace elements|mesh-ancestor
111264717|NCT06010719|Amoxicillin|amoxicillin|mesh-list
111264718|NCT06010719|Azithromycin|azithromycin|mesh-list
111264719|NCT06010719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111264720|NCT06010719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111264721|NCT06010628|Tenecteplase|tenecteplase|mesh-list
111264722|NCT06010628|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111264723|NCT06010628|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111264724|NCT06010628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111264725|NCT06010368|Tranexamic Acid|tranexamic acid|mesh-list
111264726|NCT06010368|Oxytocin|oxytocin|mesh-list
111264727|NCT06010368|Oxytocics|oxytocics|mesh-ancestor
111264728|NCT06010368|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111264729|NCT06010368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111264730|NCT06010368|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111264731|NCT06010368|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111264732|NCT06010368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111264733|NCT06010368|Hemostatics|hemostatics|mesh-ancestor
111264734|NCT06010368|Coagulants|coagulants|mesh-ancestor
111264735|NCT06010121|Vitamin D|vitamin d|mesh-list
111264736|NCT06010121|Ergocalciferols|ergocalciferols|mesh-list
111264737|NCT06010121|Cholecalciferol|cholecalciferol|mesh-list
111264738|NCT06010121|Vitamins|vitamins|mesh-list
111264739|NCT06010121|Micronutrients|micronutrients|mesh-ancestor
111264740|NCT06010121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111264741|NCT06010121|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111264742|NCT06010121|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111264743|NCT06008990|Buprenorphine|buprenorphine|mesh-list
111264744|NCT06008990|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111264745|NCT06008990|Narcotics|narcotics|mesh-ancestor
111264746|NCT06008990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111264747|NCT06008990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111264748|NCT06008990|Analgesics|analgesics|mesh-ancestor
111264749|NCT06008990|Sensory System Agents|sensory system agents|mesh-ancestor
111264750|NCT06008990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111264751|NCT06008990|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111264752|NCT06008002|Tramadol|tramadol|mesh-list
111264753|NCT06008002|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111264754|NCT06008002|Narcotics|narcotics|mesh-ancestor
111264755|NCT06008002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111264756|NCT06008002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111264757|NCT06008002|Analgesics|analgesics|mesh-ancestor
111264758|NCT06008002|Sensory System Agents|sensory system agents|mesh-ancestor
111264759|NCT06008002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111264760|NCT05996627|Belumosudil|belumosudil|mesh-list
111264761|NCT05996627|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111264762|NCT05996627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111264763|NCT05996627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111264764|NCT05996133|Dexamethasone|dexamethasone|mesh-list
111264765|NCT05996133|Epinephrine|epinephrine|mesh-list
111264766|NCT05996133|Bupivacaine|bupivacaine|mesh-list
111264768|NCT05996133|Antiemetics|antiemetics|mesh-ancestor
111264769|NCT05996133|Autonomic Agents|autonomic agents|mesh-ancestor
111264770|NCT05996133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111264771|NCT05996133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111264772|NCT05996133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111264773|NCT05996133|Glucocorticoids|glucocorticoids|mesh-ancestor
111264774|NCT05996133|Hormones|hormones|mesh-ancestor
111264775|NCT05996133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111264776|NCT05996133|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111264777|NCT05996133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111264778|NCT05996133|Anesthetics, Local|anesthetics, local|mesh-ancestor
111264779|NCT05996133|Anesthetics|anesthetics|mesh-ancestor
111264780|NCT05996133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111264781|NCT05996133|Sensory System Agents|sensory system agents|mesh-ancestor
111264782|NCT05996133|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111264783|NCT05996133|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111264784|NCT05996133|Adrenergic Agents|adrenergic agents|mesh-ancestor
111264785|NCT05996133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111264786|NCT05996133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111264787|NCT05996133|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111264788|NCT05996133|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111264789|NCT05996133|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111264790|NCT05996133|Respiratory System Agents|respiratory system agents|mesh-ancestor
111264791|NCT05996133|Mydriatics|mydriatics|mesh-ancestor
111264792|NCT05996133|Sympathomimetics|sympathomimetics|mesh-ancestor
111264793|NCT05996133|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111264794|NCT05967286|Olaparib|olaparib|mesh-list
111264795|NCT05967286|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
111264796|NCT05967286|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-list
111264797|NCT05967286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111264798|NCT05967286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111264799|NCT05967286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111264800|NCT05935774|Atezolizumab|atezolizumab|mesh-list
111264801|NCT05935774|Trabedersen|trabedersen|mesh-list
111264802|NCT05935774|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111264803|NCT05935774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111264804|NCT05935774|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111264805|NCT05935774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111264806|NCT05926440|Vaccines|vaccines|mesh-list
111264807|NCT05926440|Somatomedin B|somatomedin b|mesh-list
111264808|NCT05926440|Immunologic Factors|immunologic factors|mesh-ancestor
111264809|NCT05926440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111264810|NCT05926440|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
111264811|NCT05926440|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111264812|NCT05926440|Protease Inhibitors|protease inhibitors|mesh-ancestor
111264813|NCT05926440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111264814|NCT05926440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111264815|NCT05868525|Aspirin|aspirin|mesh-list
111264816|NCT05868525|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111264817|NCT05868525|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111264818|NCT05868525|Analgesics|analgesics|mesh-ancestor
111264819|NCT05868525|Sensory System Agents|sensory system agents|mesh-ancestor
111264820|NCT05868525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111264821|NCT05868525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111264822|NCT05868525|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111264823|NCT05868525|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111264824|NCT05868525|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111264825|NCT05868525|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111264826|NCT05868525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111264827|NCT05868525|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111264828|NCT05868525|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111264829|NCT05868525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111264830|NCT05868525|Antipyretics|antipyretics|mesh-ancestor
111264831|NCT05846789|Carboplatin|carboplatin|mesh-list
111264832|NCT05846789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111264833|NCT05837455|Anastrozole|anastrozole|mesh-list
111264834|NCT05837455|Taxane|taxane|mesh-list
111264835|NCT05837455|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111264836|NCT05837455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111264837|NCT05837455|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111264838|NCT05837455|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111264839|NCT05837455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110989155|NCT02682602|Tacrine|tacrine|mesh-list
111264840|NCT05837455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111264841|NCT05837455|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111264842|NCT05837455|Hormone Antagonists|hormone antagonists|mesh-ancestor
111264843|NCT05837455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111264844|NCT05837455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111264845|NCT05817851|Vitamins|vitamins|mesh-list
111264846|NCT05817851|Thiamine|thiamine|mesh-list
111264847|NCT05817851|Micronutrients|micronutrients|mesh-ancestor
111264848|NCT05817851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111264849|NCT05817851|Vitamin B Complex|vitamin b complex|mesh-ancestor
111264850|NCT05802693|Mitogens|mitogens|mesh-list
111264851|NCT05802693|Mitosis Modulators|mitosis modulators|mesh-ancestor
111264852|NCT05802693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111264853|NCT05799521|Glycine|glycine|mesh-list
111264854|NCT05799521|Glycine Agents|glycine agents|mesh-ancestor
111264855|NCT05799521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111264856|NCT05799521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111264857|NCT05799521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111264858|NCT05784870|Ferrous succinate|ferrous succinate|mesh-list
111264859|NCT05784870|Hematinics|hematinics|mesh-ancestor
111264860|NCT05767684|Nivolumab|nivolumab|mesh-list
111264861|NCT05767684|Lenvatinib|lenvatinib|mesh-list
111264862|NCT05767684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111264863|NCT05767684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111264864|NCT05767684|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111264865|NCT05767684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111264866|NCT05767684|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111264867|NCT05767684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111264868|NCT05734794|Rituximab|rituximab|mesh-list
111264869|NCT05734794|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111264870|NCT05734794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111264871|NCT05734794|Immunologic Factors|immunologic factors|mesh-ancestor
111264872|NCT05734794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111264873|NCT05734794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111264874|NCT05706870|Clobetasol|clobetasol|mesh-list
111264875|NCT05706870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111264876|NCT05706870|Glucocorticoids|glucocorticoids|mesh-ancestor
111264877|NCT05706870|Hormones|hormones|mesh-ancestor
111264878|NCT05706870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111264879|NCT05706870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111264880|NCT05705128|Dexmedetomidine|dexmedetomidine|mesh-list
111264881|NCT05705128|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111264882|NCT05705128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111264883|NCT05705128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111264884|NCT05705128|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111264885|NCT05705128|Analgesics|analgesics|mesh-ancestor
111264886|NCT05705128|Sensory System Agents|sensory system agents|mesh-ancestor
111264887|NCT05705128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111264888|NCT05705128|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111264889|NCT05705128|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111264890|NCT05705128|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111264891|NCT05705128|Adrenergic Agents|adrenergic agents|mesh-ancestor
111264892|NCT05705128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111264893|NCT05705128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111264894|NCT05668650|Pembrolizumab|pembrolizumab|mesh-list
111264895|NCT05668650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111264896|NCT05668650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111264897|NCT05668650|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111264898|NCT05668650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111264899|NCT05650554|Vaccines|vaccines|mesh-list
111264900|NCT05650554|Immunologic Factors|immunologic factors|mesh-ancestor
111264901|NCT05650554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111264902|NCT05633667|Paclitaxel|paclitaxel|mesh-list
111264903|NCT05633667|Docetaxel|docetaxel|mesh-list
111264904|NCT05633667|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111264905|NCT05633667|Carboplatin|carboplatin|mesh-list
111264906|NCT05633667|Nivolumab|nivolumab|mesh-list
111264907|NCT05633667|Pemetrexed|pemetrexed|mesh-list
111264908|NCT05633667|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
111264909|NCT05633667|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111264910|NCT05633667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111264911|NCT05633667|Tubulin Modulators|tubulin modulators|mesh-ancestor
111264912|NCT05633667|Antimitotic Agents|antimitotic agents|mesh-ancestor
111264913|NCT05633667|Mitosis Modulators|mitosis modulators|mesh-ancestor
111264914|NCT05633667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111264915|NCT05633667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111264916|NCT05633667|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111264917|NCT05633667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111264918|NCT05633667|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111264919|NCT05633667|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111264920|NCT05633667|Immunoconjugates|immunoconjugates|mesh-ancestor
111264921|NCT05633667|Immunologic Factors|immunologic factors|mesh-ancestor
111264922|NCT05633667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111264923|NCT05630859|Vaccines|vaccines|mesh-list
111264924|NCT05630859|Immunologic Factors|immunologic factors|mesh-ancestor
111264925|NCT05630859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111264926|NCT05630781|Suvorexant|suvorexant|mesh-list
111264927|NCT05630781|Methylphenidate|methylphenidate|mesh-list
111264928|NCT05630781|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111264929|NCT05630781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111264930|NCT05630781|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111264931|NCT05630781|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111264932|NCT05630781|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111264933|NCT05630781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111264934|NCT05630781|Dopamine Agents|dopamine agents|mesh-ancestor
111264935|NCT05630781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111264936|NCT05630781|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111264937|NCT05630781|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111264938|NCT05630781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111264939|NCT05630781|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
111264940|NCT05605093|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
111264941|NCT05605093|Protease Inhibitors|protease inhibitors|mesh-list
111264942|NCT05605093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111264943|NCT05605093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111264944|NCT05605093|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111264945|NCT05605093|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111264946|NCT05605093|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111264947|NCT05605093|Antiviral Agents|antiviral agents|mesh-ancestor
111264948|NCT05605093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111264949|NCT05576077|Pembrolizumab|pembrolizumab|mesh-list
111264950|NCT05576077|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111264951|NCT05576077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111264952|NCT05576077|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111264953|NCT05576077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111264954|NCT05575518|Rifamycins|rifamycins|mesh-list
111264955|NCT05575518|Fluoroquinolones|fluoroquinolones|mesh-list
111264956|NCT05575518|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111264957|NCT05575518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111264958|NCT05575518|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111264959|NCT05575518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111264960|NCT05575518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111264961|NCT05491226|Pembrolizumab|pembrolizumab|mesh-list
111264962|NCT05491226|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111264963|NCT05491226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111264964|NCT05491226|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111264965|NCT05491226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111264966|NCT05479045|Nivolumab|nivolumab|mesh-list
111264967|NCT05479045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111264968|NCT05479045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111264969|NCT05479045|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111264970|NCT05479045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111264971|NCT05468320|Prednisone|prednisone|mesh-list
111264972|NCT05468320|Prednisolone|prednisolone|mesh-list
111264973|NCT05468320|Antibodies|antibodies|mesh-list
111264974|NCT05468320|Immunologic Factors|immunologic factors|mesh-ancestor
111264975|NCT05468320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111264976|NCT05468320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111264977|NCT05468320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111264978|NCT05468320|Glucocorticoids|glucocorticoids|mesh-ancestor
111264979|NCT05468320|Hormones|hormones|mesh-ancestor
111264980|NCT05468320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111264981|NCT05468320|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111264982|NCT05461794|Docetaxel|docetaxel|mesh-list
111264983|NCT05461794|Irinotecan|irinotecan|mesh-list
111264984|NCT05461794|Tislelizumab|tislelizumab|mesh-list
111264985|NCT05461794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111264986|NCT05461794|Tubulin Modulators|tubulin modulators|mesh-ancestor
111264987|NCT05461794|Antimitotic Agents|antimitotic agents|mesh-ancestor
111264988|NCT05461794|Mitosis Modulators|mitosis modulators|mesh-ancestor
111264989|NCT05461794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111264990|NCT05461794|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111264991|NCT05461794|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111264992|NCT05461794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111264993|NCT05461794|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111264995|NCT05458765|Emtricitabine|emtricitabine|mesh-list
111264996|NCT05458765|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
111264997|NCT05458765|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
111264998|NCT05458765|Antiviral Agents|antiviral agents|mesh-ancestor
111264999|NCT05458765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111265000|NCT05458765|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111265001|NCT05458765|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111265002|NCT05458765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111265003|NCT05458765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111265004|NCT05458765|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111265005|NCT05458765|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111265006|NCT05442983|Probenecid|probenecid|mesh-list
111265007|NCT05442983|Uricosuric Agents|uricosuric agents|mesh-ancestor
111265008|NCT05442983|Gout Suppressants|gout suppressants|mesh-ancestor
111265009|NCT05442983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111265010|NCT05413304|Temozolomide|temozolomide|mesh-list
111265011|NCT05413304|Dialysis Solutions|dialysis solutions|mesh-list
111265012|NCT05413304|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111265013|NCT05413304|Alkylating Agents|alkylating agents|mesh-ancestor
111265014|NCT05413304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111265015|NCT05413304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111265016|NCT05413304|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111265017|NCT05404945|Doxorubicin|doxorubicin|mesh-list
111265018|NCT05404945|Pembrolizumab|pembrolizumab|mesh-list
111265019|NCT05404945|Dacarbazine|dacarbazine|mesh-list
111265020|NCT05404945|Brentuximab Vedotin|brentuximab vedotin|mesh-list
111265021|NCT05404945|Vinblastine|vinblastine|mesh-list
111265022|NCT05404945|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111265023|NCT05404945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111265024|NCT05404945|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111265025|NCT05404945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111265026|NCT05404945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111265027|NCT05404945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111265028|NCT05404945|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111265029|NCT05404945|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111265030|NCT05404945|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111265031|NCT05404945|Alkylating Agents|alkylating agents|mesh-ancestor
111265032|NCT05404945|Immunotoxins|immunotoxins|mesh-ancestor
111265033|NCT05404945|Immunoconjugates|immunoconjugates|mesh-ancestor
111265034|NCT05404945|Immunologic Factors|immunologic factors|mesh-ancestor
111265035|NCT05404945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111265036|NCT05404945|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111265037|NCT05404945|Tubulin Modulators|tubulin modulators|mesh-ancestor
111265038|NCT05404945|Antimitotic Agents|antimitotic agents|mesh-ancestor
111265039|NCT05404945|Mitosis Modulators|mitosis modulators|mesh-ancestor
111265040|NCT05382559|Cetuximab|cetuximab|mesh-list
111265041|NCT05382559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111265042|NCT05382559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111265043|NCT05381909|Paclitaxel|paclitaxel|mesh-list
111265044|NCT05381909|Carboplatin|carboplatin|mesh-list
111265045|NCT05381909|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111265046|NCT05381909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111265047|NCT05381909|Tubulin Modulators|tubulin modulators|mesh-ancestor
111265048|NCT05381909|Antimitotic Agents|antimitotic agents|mesh-ancestor
111265049|NCT05381909|Mitosis Modulators|mitosis modulators|mesh-ancestor
111265050|NCT05381909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111265051|NCT05305989|Belumosudil|belumosudil|mesh-list
111265052|NCT05305989|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111265053|NCT05305989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111265054|NCT05305989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111265055|NCT05279456|Myeloma Proteins|myeloma proteins|mesh-list
111265056|NCT05279456|Paraproteins|paraproteins|mesh-list
111265057|NCT05279456|Immunologic Factors|immunologic factors|mesh-ancestor
111265058|NCT05279456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111265059|NCT05276830|Dexmedetomidine|dexmedetomidine|mesh-list
111265060|NCT05276830|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111265061|NCT05276830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111265062|NCT05276830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111265063|NCT05276830|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111265064|NCT05276830|Analgesics|analgesics|mesh-ancestor
111265065|NCT05276830|Sensory System Agents|sensory system agents|mesh-ancestor
111265066|NCT05276830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111265067|NCT05276830|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111265068|NCT05276830|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111265069|NCT05276830|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111265070|NCT05276830|Adrenergic Agents|adrenergic agents|mesh-ancestor
111265071|NCT05276830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111265072|NCT05276830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111265073|NCT05200845|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111265074|NCT05194735|Aldesleukin|aldesleukin|mesh-list
111265075|NCT05194735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111265076|NCT05194735|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111265077|NCT05194735|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111265078|NCT05194735|Antiviral Agents|antiviral agents|mesh-ancestor
111265079|NCT05194735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111265080|NCT05172791|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111265081|NCT05172791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111265082|NCT05116085|Tislelizumab|tislelizumab|mesh-list
111265083|NCT05116085|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111265084|NCT05116085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111265085|NCT05114421|Pembrolizumab|pembrolizumab|mesh-list
111265086|NCT05114421|Lenvatinib|lenvatinib|mesh-list
111265087|NCT05114421|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111265088|NCT05114421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111265089|NCT05114421|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111265090|NCT05114421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111265091|NCT05114421|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111265092|NCT05114421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111265093|NCT05070364|Interferons|interferons|mesh-list
111265094|NCT05070364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111265095|NCT05070364|Antiviral Agents|antiviral agents|mesh-ancestor
111265096|NCT05070364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111265097|NCT05060068|Ketamine|ketamine|mesh-list
111265098|NCT05060068|Esketamine|esketamine|mesh-list
111265099|NCT05060068|Analgesics|analgesics|mesh-ancestor
111265100|NCT05060068|Sensory System Agents|sensory system agents|mesh-ancestor
111265101|NCT05060068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111265102|NCT05060068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111265103|NCT05060068|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111265104|NCT05060068|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111265105|NCT05060068|Anesthetics, General|anesthetics, general|mesh-ancestor
111265106|NCT05060068|Anesthetics|anesthetics|mesh-ancestor
111265107|NCT05060068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111265108|NCT05060068|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111265109|NCT05060068|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111265110|NCT05060068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111265111|NCT05060068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111265112|NCT05060068|Antidepressive Agents|antidepressive agents|mesh-ancestor
111265113|NCT05060068|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111265114|NCT05043350|Loratadine|loratadine|mesh-list
111265115|NCT05043350|Famotidine|famotidine|mesh-list
111265116|NCT05043350|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111265117|NCT05043350|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111265118|NCT05043350|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
111265119|NCT05043350|Histamine Antagonists|histamine antagonists|mesh-ancestor
111265120|NCT05043350|Histamine Agents|histamine agents|mesh-ancestor
111265121|NCT05043350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111265122|NCT05043350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111265123|NCT05043350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111265124|NCT05043350|Antipruritics|antipruritics|mesh-ancestor
111265125|NCT05043350|Dermatologic Agents|dermatologic agents|mesh-ancestor
111265126|NCT05043350|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111265127|NCT05043350|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
111265128|NCT05043350|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111265129|NCT05036681|Pembrolizumab|pembrolizumab|mesh-list
111265130|NCT05036681|Futibatinib|futibatinib|mesh-list
111265131|NCT05036681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111265132|NCT05036681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111265133|NCT05036681|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111265134|NCT05036681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111265135|NCT05010772|Decitabine|decitabine|mesh-list
111265136|NCT05010772|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
111265137|NCT05010772|Venetoclax|venetoclax|mesh-list
111265138|NCT05010772|Ivosidenib|ivosidenib|mesh-list
111265139|NCT05010772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111265141|NCT05010772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111265142|NCT05010772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111265143|NCT05010772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111265144|NCT04985266|Tamoxifen|tamoxifen|mesh-list
111265145|NCT04985266|Letrozole|letrozole|mesh-list
111265146|NCT04985266|Fulvestrant|fulvestrant|mesh-list
111265147|NCT04985266|Palbociclib|palbociclib|mesh-list
111265148|NCT04985266|Anastrozole|anastrozole|mesh-list
111265149|NCT04985266|Exemestane|exemestane|mesh-list
111265150|NCT04985266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111265151|NCT04985266|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111265152|NCT04985266|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111265153|NCT04985266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111265154|NCT04985266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111265155|NCT04985266|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111265156|NCT04985266|Hormone Antagonists|hormone antagonists|mesh-ancestor
111265157|NCT04985266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111265158|NCT04985266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111265159|NCT04985266|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111265160|NCT04985266|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111265161|NCT04985266|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111265162|NCT04985266|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111265163|NCT04985266|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
111265164|NCT04985266|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111265165|NCT04947020|Metformin|metformin|mesh-list
111265166|NCT04947020|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111265167|NCT04947020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111265168|NCT04896697|Atezolizumab|atezolizumab|mesh-list
111265169|NCT04896697|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111265170|NCT04896697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111265171|NCT04896697|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111265172|NCT04896697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111265173|NCT04862468|Dexamethasone|dexamethasone|mesh-list
111265174|NCT04862468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111265175|NCT04862468|Antiemetics|antiemetics|mesh-ancestor
111265176|NCT04862468|Autonomic Agents|autonomic agents|mesh-ancestor
111265177|NCT04862468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111265178|NCT04862468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111265179|NCT04862468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111265180|NCT04862468|Glucocorticoids|glucocorticoids|mesh-ancestor
111265181|NCT04862468|Hormones|hormones|mesh-ancestor
111265182|NCT04862468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111265183|NCT04862468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111265184|NCT04862468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111265185|NCT04814927|Copper|copper|mesh-list
111265186|NCT04814927|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
111265187|NCT04814927|Levonorgestrel|levonorgestrel|mesh-list
111265188|NCT04814927|Medroxyprogesterone|medroxyprogesterone|mesh-list
111265189|NCT04814927|Etonogestrel|etonogestrel|mesh-list
111265190|NCT04814927|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111265191|NCT04814927|Contraceptive Agents|contraceptive agents|mesh-ancestor
111265192|NCT04814927|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111265193|NCT04814927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111265194|NCT04814927|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111265195|NCT04814927|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111265196|NCT04814927|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111265197|NCT04814927|Trace Elements|trace elements|mesh-ancestor
111265198|NCT04814927|Micronutrients|micronutrients|mesh-ancestor
111265199|NCT04814927|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111265200|NCT04814927|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
111265201|NCT04814927|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111265202|NCT04814927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111265203|NCT04747912|Dexamethasone|dexamethasone|mesh-list
111265204|NCT04747912|Dexamethasone acetate|dexamethasone acetate|mesh-list
111265205|NCT04747912|Methotrexate|methotrexate|mesh-list
111265206|NCT04747912|Vincristine|vincristine|mesh-list
111265207|NCT04747912|Dasatinib|dasatinib|mesh-list
111265208|NCT04747912|Ponatinib|ponatinib|mesh-list
111265209|NCT04747912|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
111265210|NCT04747912|BB 1101|bb 1101|mesh-list
111265211|NCT04747912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111265212|NCT04747912|Antiemetics|antiemetics|mesh-ancestor
111265213|NCT04747912|Autonomic Agents|autonomic agents|mesh-ancestor
111265214|NCT04747912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111265215|NCT04747912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111265216|NCT04747912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111265217|NCT04747912|Glucocorticoids|glucocorticoids|mesh-ancestor
111265218|NCT04747912|Hormones|hormones|mesh-ancestor
111265219|NCT04747912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111265220|NCT04747912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111265221|NCT04747912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111265222|NCT04747912|Protease Inhibitors|protease inhibitors|mesh-ancestor
111265223|NCT04747912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111265224|NCT04747912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111265225|NCT04747912|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111265226|NCT04747912|Abortifacient Agents|abortifacient agents|mesh-ancestor
111265227|NCT04747912|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111265228|NCT04747912|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111265229|NCT04747912|Antimetabolites|antimetabolites|mesh-ancestor
111265230|NCT04747912|Dermatologic Agents|dermatologic agents|mesh-ancestor
111265231|NCT04747912|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111265232|NCT04747912|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111265233|NCT04747912|Immunologic Factors|immunologic factors|mesh-ancestor
111265234|NCT04747912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111265235|NCT04747912|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111265236|NCT04747912|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111265237|NCT04747912|Tubulin Modulators|tubulin modulators|mesh-ancestor
111265238|NCT04747912|Antimitotic Agents|antimitotic agents|mesh-ancestor
111265239|NCT04747912|Mitosis Modulators|mitosis modulators|mesh-ancestor
111265240|NCT04747912|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111265241|NCT04747912|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111265242|NCT04747912|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111265243|NCT04747912|Immunotoxins|immunotoxins|mesh-ancestor
111265244|NCT04747912|Immunoconjugates|immunoconjugates|mesh-ancestor
111265245|NCT04728230|Carboplatin|carboplatin|mesh-list
111265246|NCT04728230|Etoposide|etoposide|mesh-list
111265247|NCT04728230|Etoposide phosphate|etoposide phosphate|mesh-list
111265248|NCT04728230|Durvalumab|durvalumab|mesh-list
111265249|NCT04728230|Olaparib|olaparib|mesh-list
111265250|NCT04728230|Podophyllotoxin|podophyllotoxin|mesh-list
111265251|NCT04728230|Immunoglobulins|immunoglobulins|mesh-list
111265252|NCT04728230|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111265253|NCT04728230|Immunoglobulin G|immunoglobulin g|mesh-list
111265254|NCT04728230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111265255|NCT04728230|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111265256|NCT04728230|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111265257|NCT04728230|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111265258|NCT04728230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111265259|NCT04728230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111265260|NCT04728230|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111265261|NCT04728230|Immunologic Factors|immunologic factors|mesh-ancestor
111265262|NCT04728230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111265263|NCT04728230|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111265264|NCT04728230|Keratolytic Agents|keratolytic agents|mesh-ancestor
111265265|NCT04728230|Dermatologic Agents|dermatologic agents|mesh-ancestor
111265266|NCT04728230|Tubulin Modulators|tubulin modulators|mesh-ancestor
111265267|NCT04728230|Antimitotic Agents|antimitotic agents|mesh-ancestor
111265268|NCT04728230|Mitosis Modulators|mitosis modulators|mesh-ancestor
111265269|NCT04649385|Tislelizumab|tislelizumab|mesh-list
111265270|NCT04649385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111265271|NCT04649385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111265272|NCT04606446|Letrozole|letrozole|mesh-list
111265273|NCT04606446|Fulvestrant|fulvestrant|mesh-list
111265274|NCT04606446|Palbociclib|palbociclib|mesh-list
111265275|NCT04606446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111265276|NCT04606446|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111265277|NCT04606446|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111265278|NCT04606446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111265279|NCT04606446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111265280|NCT04606446|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111265281|NCT04606446|Hormone Antagonists|hormone antagonists|mesh-ancestor
111265282|NCT04606446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111265283|NCT04606446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111265284|NCT04606446|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111265285|NCT04606446|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
111265286|NCT04606446|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111265287|NCT04603911|Dexamethasone|dexamethasone|mesh-list
111265288|NCT04603911|Clonidine|clonidine|mesh-list
111265289|NCT04603911|Epinephrine|epinephrine|mesh-list
111265290|NCT04603911|Bupivacaine|bupivacaine|mesh-list
111265291|NCT04603911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111265292|NCT04603911|Antiemetics|antiemetics|mesh-ancestor
111265293|NCT04603911|Autonomic Agents|autonomic agents|mesh-ancestor
111265294|NCT04603911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111265295|NCT04603911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111265296|NCT04603911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111265297|NCT04603911|Glucocorticoids|glucocorticoids|mesh-ancestor
111265299|NCT04603911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111265300|NCT04603911|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111265301|NCT04603911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111265302|NCT04603911|Anesthetics, Local|anesthetics, local|mesh-ancestor
111265303|NCT04603911|Anesthetics|anesthetics|mesh-ancestor
111265304|NCT04603911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111265305|NCT04603911|Sensory System Agents|sensory system agents|mesh-ancestor
111265306|NCT04603911|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111265307|NCT04603911|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111265308|NCT04603911|Adrenergic Agents|adrenergic agents|mesh-ancestor
111265309|NCT04603911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111265310|NCT04603911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111265311|NCT04603911|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111265312|NCT04603911|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111265313|NCT04603911|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111265314|NCT04603911|Respiratory System Agents|respiratory system agents|mesh-ancestor
111265315|NCT04603911|Mydriatics|mydriatics|mesh-ancestor
111265316|NCT04603911|Sympathomimetics|sympathomimetics|mesh-ancestor
111265317|NCT04603911|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111265318|NCT04603911|Analgesics|analgesics|mesh-ancestor
111265319|NCT04603911|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111265320|NCT04603911|Sympatholytics|sympatholytics|mesh-ancestor
111265321|NCT04603911|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111265322|NCT04597424|Doxycycline|doxycycline|mesh-list
111265323|NCT04597424|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111265324|NCT04597424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111265325|NCT04597424|Antimalarials|antimalarials|mesh-ancestor
111265326|NCT04597424|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111265327|NCT04597424|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111265328|NCT04548661|Povidone-Iodine|povidone-iodine|mesh-list
111265329|NCT04548661|Povidone|povidone|mesh-list
111265330|NCT04548661|Plasma Substitutes|plasma substitutes|mesh-ancestor
111265331|NCT04548661|Blood Substitutes|blood substitutes|mesh-ancestor
111265332|NCT04548661|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111265333|NCT04548661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111265334|NCT04501978|Remdesivir|remdesivir|mesh-list
111265335|NCT04501978|Cilgavimab and tixagevimab drug combination|cilgavimab and tixagevimab drug combination|mesh-list
111265336|NCT04501978|Bamlanivimab|bamlanivimab|mesh-list
111265337|NCT04501978|Sotrovimab|sotrovimab|mesh-list
111265338|NCT04501978|Antimetabolites|antimetabolites|mesh-ancestor
111265339|NCT04501978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111265340|NCT04501978|Antiviral Agents|antiviral agents|mesh-ancestor
111265341|NCT04501978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111265342|NCT04487067|Bevacizumab|bevacizumab|mesh-list
111265343|NCT04487067|Atezolizumab|atezolizumab|mesh-list
111265344|NCT04487067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111265345|NCT04487067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111265346|NCT04487067|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111265347|NCT04487067|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111265348|NCT04487067|Growth Substances|growth substances|mesh-ancestor
111265349|NCT04487067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111265350|NCT04487067|Growth Inhibitors|growth inhibitors|mesh-ancestor
111265351|NCT04487067|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111265352|NCT04487067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111265353|NCT04348747|Pembrolizumab|pembrolizumab|mesh-list
111265354|NCT04348747|Vaccines|vaccines|mesh-list
111265355|NCT04348747|Immunologic Factors|immunologic factors|mesh-ancestor
111265356|NCT04348747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111265357|NCT04348747|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111265358|NCT04348747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111265359|NCT04348747|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111265360|NCT04348747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111265361|NCT04342819|Empagliflozin|empagliflozin|mesh-list
111265362|NCT04342819|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
111265363|NCT04342819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110989679|NCT03484611|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111265364|NCT04342819|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111265365|NCT04342819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111265366|NCT04318080|Tislelizumab|tislelizumab|mesh-list
111265367|NCT04318080|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111265368|NCT04318080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111265369|NCT04187248|Asparaginase|asparaginase|mesh-list
111265370|NCT04187248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111265371|NCT04156087|Gemcitabine|gemcitabine|mesh-list
111265373|NCT04156087|Tremelimumab|tremelimumab|mesh-list
111265374|NCT04156087|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111265375|NCT04156087|Antimetabolites|antimetabolites|mesh-ancestor
111265376|NCT04156087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111265377|NCT04156087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111265378|NCT04156087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111265379|NCT04112212|Vedolizumab|vedolizumab|mesh-list
111265380|NCT04112212|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111265381|NCT04107077|Mitomycins|mitomycins|mesh-list
111265382|NCT04107077|Mitomycin|mitomycin|mesh-list
111265383|NCT04107077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111265384|NCT04107077|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111265385|NCT04107077|Alkylating Agents|alkylating agents|mesh-ancestor
111265386|NCT04107077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111265387|NCT04107077|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111265388|NCT04107077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111265389|NCT04051320|Leuprolide|leuprolide|mesh-list
111265390|NCT04051320|Estradiol|estradiol|mesh-list
111265391|NCT04051320|Progesterone|progesterone|mesh-list
111265392|NCT04051320|Estrogens|estrogens|mesh-ancestor
111265393|NCT04051320|Hormones|hormones|mesh-ancestor
111265394|NCT04051320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111265395|NCT04051320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111265396|NCT04051320|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111265397|NCT04051320|Progestins|progestins|mesh-ancestor
111265398|NCT04051320|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111265399|NCT04051320|Fertility Agents|fertility agents|mesh-ancestor
111265400|NCT04051320|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111265401|NCT04051320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111265402|NCT04049669|Cyclophosphamide|cyclophosphamide|mesh-list
111265403|NCT04049669|Temozolomide|temozolomide|mesh-list
111265404|NCT04049669|Lomustine|lomustine|mesh-list
111265405|NCT04049669|Etoposide|etoposide|mesh-list
111265406|NCT04049669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111265407|NCT04049669|Immunologic Factors|immunologic factors|mesh-ancestor
111265408|NCT04049669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111265409|NCT04049669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111265410|NCT04049669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111265411|NCT04049669|Alkylating Agents|alkylating agents|mesh-ancestor
111265412|NCT04049669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111265413|NCT04049669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111265414|NCT04049669|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111265415|NCT04049669|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111265416|NCT04049669|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111265417|NCT04049669|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111265418|NCT04049669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111265419|NCT03990961|Pembrolizumab|pembrolizumab|mesh-list
111265420|NCT03990961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111265421|NCT03990961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111265422|NCT03990961|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111265423|NCT03990961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111265424|NCT03841526|Insulin|insulin|mesh-list
111265425|NCT03841526|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111265426|NCT03841526|Glucagon|glucagon|mesh-list
111265427|NCT03841526|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
111265428|NCT03841526|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111265429|NCT03841526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111265430|NCT03841526|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111265431|NCT03841526|Hormones|hormones|mesh-ancestor
111265432|NCT03841526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111265433|NCT03841526|Incretins|incretins|mesh-ancestor
111265434|NCT03834506|Dexamethasone|dexamethasone|mesh-list
111265435|NCT03834506|Prednisone|prednisone|mesh-list
111265436|NCT03834506|Docetaxel|docetaxel|mesh-list
111265437|NCT03834506|Pembrolizumab|pembrolizumab|mesh-list
110989806|NCT05339386|Xenon|xenon|mesh-list
111265438|NCT03834506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111265439|NCT03834506|Antiemetics|antiemetics|mesh-ancestor
111265440|NCT03834506|Autonomic Agents|autonomic agents|mesh-ancestor
111265441|NCT03834506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111265442|NCT03834506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111265443|NCT03834506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111265444|NCT03834506|Glucocorticoids|glucocorticoids|mesh-ancestor
111265445|NCT03834506|Hormones|hormones|mesh-ancestor
111265446|NCT03834506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111265447|NCT03834506|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111265448|NCT03834506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111265449|NCT03834506|Tubulin Modulators|tubulin modulators|mesh-ancestor
111265450|NCT03834506|Antimitotic Agents|antimitotic agents|mesh-ancestor
111265451|NCT03834506|Mitosis Modulators|mitosis modulators|mesh-ancestor
111265452|NCT03834506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111265453|NCT03834506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111265454|NCT03834506|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111265455|NCT03734016|Zanubrutinib|zanubrutinib|mesh-list
111265456|NCT03734016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111265457|NCT03734016|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111265458|NCT03734016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111265459|NCT03734016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111265460|NCT03709680|Cyclophosphamide|cyclophosphamide|mesh-list
111265461|NCT03709680|Temozolomide|temozolomide|mesh-list
111265462|NCT03709680|Irinotecan|irinotecan|mesh-list
111265463|NCT03709680|Topotecan|topotecan|mesh-list
111265464|NCT03709680|Palbociclib|palbociclib|mesh-list
111265465|NCT03709680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111265466|NCT03709680|Immunologic Factors|immunologic factors|mesh-ancestor
111265467|NCT03709680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111265468|NCT03709680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111265469|NCT03709680|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111265470|NCT03709680|Alkylating Agents|alkylating agents|mesh-ancestor
111265471|NCT03709680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111265472|NCT03709680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111265473|NCT03709680|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111265474|NCT03709680|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111265475|NCT03709680|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111265476|NCT03709680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111265477|NCT03709680|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111265478|NCT03603808|Vaccines|vaccines|mesh-list
111265479|NCT03603808|Immunologic Factors|immunologic factors|mesh-ancestor
111265480|NCT03603808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111265481|NCT03537196|Ribavirin|ribavirin|mesh-list
111265482|NCT03537196|Sofosbuvir|sofosbuvir|mesh-list
111265483|NCT03537196|Antimetabolites|antimetabolites|mesh-ancestor
111265484|NCT03537196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111265485|NCT03537196|Antiviral Agents|antiviral agents|mesh-ancestor
111265486|NCT03537196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111265487|NCT03518060|Dolutegravir, rilpivirine drug combination|dolutegravir, rilpivirine drug combination|mesh-list
111265488|NCT03518060|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111265489|NCT03518060|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111265490|NCT03518060|Antiviral Agents|antiviral agents|mesh-ancestor
111265491|NCT03518060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111265492|NCT03498521|Bevacizumab|bevacizumab|mesh-list
111265493|NCT03498521|Carboplatin|carboplatin|mesh-list
111265494|NCT03498521|Gemcitabine|gemcitabine|mesh-list
111265495|NCT03498521|Trastuzumab|trastuzumab|mesh-list
111265496|NCT03498521|Atezolizumab|atezolizumab|mesh-list
111265497|NCT03498521|Olaparib|olaparib|mesh-list
111265498|NCT03498521|Pertuzumab|pertuzumab|mesh-list
111265499|NCT03498521|Vemurafenib|vemurafenib|mesh-list
111265500|NCT03498521|Ipatasertib|ipatasertib|mesh-list
111265501|NCT03498521|Ivosidenib|ivosidenib|mesh-list
111265502|NCT03498521|Entrectinib|entrectinib|mesh-list
111265503|NCT03498521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111265504|NCT03498521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111265505|NCT03498521|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111265506|NCT03498521|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111265507|NCT03498521|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111265508|NCT03498521|Growth Substances|growth substances|mesh-ancestor
111265509|NCT03498521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111265510|NCT03498521|Growth Inhibitors|growth inhibitors|mesh-ancestor
111265511|NCT03498521|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111265512|NCT03498521|Antimetabolites|antimetabolites|mesh-ancestor
111265513|NCT03498521|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111265514|NCT03498521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111265515|NCT03498521|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111265516|NCT03498521|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111265517|NCT03474744|Rituximab|rituximab|mesh-list
111265518|NCT03474744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111265519|NCT03474744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111265520|NCT03474744|Immunologic Factors|immunologic factors|mesh-ancestor
111265521|NCT03474744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111265522|NCT03474744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111265523|NCT03367871|Paclitaxel|paclitaxel|mesh-list
111265524|NCT03367871|Bevacizumab|bevacizumab|mesh-list
111265525|NCT03367871|Carboplatin|carboplatin|mesh-list
111265526|NCT03367871|Pembrolizumab|pembrolizumab|mesh-list
111265527|NCT03367871|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111265528|NCT03367871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111265529|NCT03367871|Tubulin Modulators|tubulin modulators|mesh-ancestor
111265530|NCT03367871|Antimitotic Agents|antimitotic agents|mesh-ancestor
111265531|NCT03367871|Mitosis Modulators|mitosis modulators|mesh-ancestor
111265532|NCT03367871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111265533|NCT03367871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111265534|NCT03367871|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111265535|NCT03367871|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111265536|NCT03367871|Growth Substances|growth substances|mesh-ancestor
111265537|NCT03367871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111265538|NCT03367871|Growth Inhibitors|growth inhibitors|mesh-ancestor
111265539|NCT03367871|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111265540|NCT03340064|Levetiracetam|levetiracetam|mesh-list
111265541|NCT03340064|Anticonvulsants|anticonvulsants|mesh-ancestor
111265542|NCT03340064|Nootropic Agents|nootropic agents|mesh-ancestor
111265543|NCT03312400|Danazol|danazol|mesh-list
111265544|NCT03312400|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111265545|NCT03312400|Hormone Antagonists|hormone antagonists|mesh-ancestor
111265546|NCT03312400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111265547|NCT03312400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111265548|NCT03277638|Pembrolizumab|pembrolizumab|mesh-list
111265549|NCT03277638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111265550|NCT03277638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111265551|NCT03277638|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111265552|NCT03277638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111265553|NCT03191786|Gemcitabine|gemcitabine|mesh-list
111265554|NCT03191786|Atezolizumab|atezolizumab|mesh-list
111265555|NCT03191786|Vinorelbine|vinorelbine|mesh-list
111265556|NCT03191786|Antibodies|antibodies|mesh-list
111265557|NCT03191786|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111265558|NCT03191786|Immunologic Factors|immunologic factors|mesh-ancestor
111265559|NCT03191786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111265560|NCT03191786|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111265561|NCT03191786|Antimetabolites|antimetabolites|mesh-ancestor
111265562|NCT03191786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111265563|NCT03191786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111265564|NCT03191786|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111265565|NCT03191786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111265566|NCT03191786|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111265567|NCT03191786|Tubulin Modulators|tubulin modulators|mesh-ancestor
111265568|NCT03191786|Antimitotic Agents|antimitotic agents|mesh-ancestor
111265569|NCT03191786|Mitosis Modulators|mitosis modulators|mesh-ancestor
111265570|NCT03180684|Imiquimod|imiquimod|mesh-list
111265571|NCT03180684|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111265572|NCT03180684|Immunologic Factors|immunologic factors|mesh-ancestor
111265573|NCT03180684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111265574|NCT03180684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111265575|NCT03180684|Interferon Inducers|interferon inducers|mesh-ancestor
111265576|NCT03161652|Ranibizumab|ranibizumab|mesh-list
111265577|NCT03161652|Dopamine|dopamine|mesh-list
111265578|NCT03161652|Sulpiride|sulpiride|mesh-list
111265579|NCT03161652|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111265580|NCT03161652|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111265581|NCT03161652|Growth Substances|growth substances|mesh-ancestor
111265582|NCT03161652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111265583|NCT03161652|Growth Inhibitors|growth inhibitors|mesh-ancestor
111265584|NCT03161652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111265585|NCT03161652|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111265586|NCT03161652|Sympathomimetics|sympathomimetics|mesh-ancestor
111265587|NCT03161652|Autonomic Agents|autonomic agents|mesh-ancestor
111265588|NCT03161652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111265589|NCT03161652|Dopamine Agents|dopamine agents|mesh-ancestor
111265590|NCT03161652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111265591|NCT03161652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111265592|NCT03161652|Protective Agents|protective agents|mesh-ancestor
111265593|NCT03161652|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111265594|NCT03161652|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111265595|NCT03161652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111265596|NCT03161652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111265597|NCT03161652|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111265598|NCT03161652|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111265599|NCT03161652|Antidepressive Agents|antidepressive agents|mesh-ancestor
111265600|NCT03131037|Valacyclovir|valacyclovir|mesh-list
111265601|NCT03131037|Antiviral Agents|antiviral agents|mesh-ancestor
111265602|NCT03131037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111265603|NCT02992457|Interferons|interferons|mesh-list
111265604|NCT02992457|Ribavirin|ribavirin|mesh-list
111265605|NCT02992457|Interferon-alpha|interferon-alpha|mesh-list
111265606|NCT02992457|Interferon alpha-2|interferon alpha-2|mesh-list
111265607|NCT02992457|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
111265608|NCT02992457|Sofosbuvir|sofosbuvir|mesh-list
111265609|NCT02992457|Ledipasvir|ledipasvir|mesh-list
111265610|NCT02992457|Simeprevir|simeprevir|mesh-list
111265611|NCT02992457|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
111265612|NCT02992457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111265613|NCT02992457|Antiviral Agents|antiviral agents|mesh-ancestor
111265614|NCT02992457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111265615|NCT02992457|Antimetabolites|antimetabolites|mesh-ancestor
111265616|NCT02992457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111265617|NCT02992457|Immunologic Factors|immunologic factors|mesh-ancestor
111265618|NCT02992457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111265619|NCT02992457|Protease Inhibitors|protease inhibitors|mesh-ancestor
111265620|NCT02992457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111265621|NCT02884648|Bevacizumab|bevacizumab|mesh-list
111265622|NCT02884648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111265623|NCT02884648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111265624|NCT02884648|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111265625|NCT02884648|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111265626|NCT02884648|Growth Substances|growth substances|mesh-ancestor
111265627|NCT02884648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111265628|NCT02884648|Growth Inhibitors|growth inhibitors|mesh-ancestor
111265629|NCT02864953|Glyburide|glyburide|mesh-list
111265630|NCT02864953|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111265631|NCT02864953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111265632|NCT02829424|Methotrexate|methotrexate|mesh-list
111265633|NCT02829424|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111265634|NCT02829424|Abortifacient Agents|abortifacient agents|mesh-ancestor
111265635|NCT02829424|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111265636|NCT02829424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111265637|NCT02829424|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111265638|NCT02829424|Antimetabolites|antimetabolites|mesh-ancestor
111265639|NCT02829424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111265640|NCT02829424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111265641|NCT02829424|Dermatologic Agents|dermatologic agents|mesh-ancestor
111265642|NCT02829424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111265643|NCT02829424|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111265644|NCT02829424|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111265645|NCT02829424|Immunologic Factors|immunologic factors|mesh-ancestor
111265646|NCT02829424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111265647|NCT02829424|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111265648|NCT02740920|Pembrolizumab|pembrolizumab|mesh-list
111265649|NCT02740920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111265650|NCT02740920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111265651|NCT02740920|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111265652|NCT02740920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111265653|NCT02543983|Ketamine|ketamine|mesh-list
111265654|NCT02543983|Analgesics|analgesics|mesh-ancestor
111265655|NCT02543983|Sensory System Agents|sensory system agents|mesh-ancestor
111265656|NCT02543983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111265657|NCT02543983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111265658|NCT02543983|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111265659|NCT02543983|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111265660|NCT02543983|Anesthetics, General|anesthetics, general|mesh-ancestor
111265661|NCT02543983|Anesthetics|anesthetics|mesh-ancestor
111265662|NCT02543983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111265663|NCT02543983|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111265664|NCT02543983|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111265665|NCT02543983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111265666|NCT02543983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111265667|NCT02515227|Pembrolizumab|pembrolizumab|mesh-list
111265668|NCT02515227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111265669|NCT02515227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111265670|NCT02515227|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111265671|NCT02515227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111265672|NCT02369458|Mitomycins|mitomycins|mesh-list
111265673|NCT02369458|Mitomycin|mitomycin|mesh-list
111265674|NCT02369458|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111265675|NCT02369458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111265676|NCT02369458|Alkylating Agents|alkylating agents|mesh-ancestor
111265677|NCT02369458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111265678|NCT02369458|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111265679|NCT02369458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111265680|NCT02122172|Afatinib|afatinib|mesh-list
111265681|NCT02122172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111265682|NCT02122172|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111265683|NCT02122172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111265684|NCT02122172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111265685|NCT02105766|Sirolimus|sirolimus|mesh-list
111265686|NCT02105766|Cyclophosphamide|cyclophosphamide|mesh-list
111265687|NCT02105766|Alemtuzumab|alemtuzumab|mesh-list
111265688|NCT02105766|Pentostatin|pentostatin|mesh-list
111265689|NCT02105766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111265690|NCT02105766|Immunologic Factors|immunologic factors|mesh-ancestor
111265691|NCT02105766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111265692|NCT02105766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111265693|NCT02105766|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111265694|NCT02105766|Alkylating Agents|alkylating agents|mesh-ancestor
111265695|NCT02105766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111265696|NCT02105766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111265697|NCT02105766|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111265698|NCT02105766|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111265699|NCT02105766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111265700|NCT02105766|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111265701|NCT02105766|Antifungal Agents|antifungal agents|mesh-ancestor
111265702|NCT02105766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111265703|NCT02105766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111265704|NCT02105766|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
111265705|NCT02052609|Brodalumab|brodalumab|mesh-list
111265706|NCT02052609|Dermatologic Agents|dermatologic agents|mesh-ancestor
111265707|NCT02031939|Capecitabine|capecitabine|mesh-list
111265708|NCT02031939|Oxaliplatin|oxaliplatin|mesh-list
111265709|NCT02031939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111265710|NCT02031939|Antimetabolites|antimetabolites|mesh-ancestor
111265711|NCT02031939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111265712|NCT02031939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111265713|NCT01997190|Valacyclovir|valacyclovir|mesh-list
111265714|NCT01997190|Antiviral Agents|antiviral agents|mesh-ancestor
111265715|NCT01997190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111265716|NCT01391962|Sunitinib|sunitinib|mesh-list
111265717|NCT01391962|Cediranib|cediranib|mesh-list
111265718|NCT01391962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111265719|NCT01391962|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111265720|NCT01391962|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111265721|NCT01391962|Growth Substances|growth substances|mesh-ancestor
111265722|NCT01391962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111265723|NCT01391962|Growth Inhibitors|growth inhibitors|mesh-ancestor
111265724|NCT01391962|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111265725|NCT01391962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111265726|NCT01391962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111265727|NCT01327781|Tamoxifen|tamoxifen|mesh-list
111265728|NCT01327781|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111265729|NCT01327781|Hormone Antagonists|hormone antagonists|mesh-ancestor
111265730|NCT01327781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111265731|NCT01327781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111265732|NCT01327781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111265733|NCT01327781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111265734|NCT01327781|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111265735|NCT01327781|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111265736|NCT01327781|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111265737|NCT01154920|Paclitaxel|paclitaxel|mesh-list
111265738|NCT01154920|Docetaxel|docetaxel|mesh-list
111265739|NCT01154920|Cisplatin|cisplatin|mesh-list
111265740|NCT01154920|Carboplatin|carboplatin|mesh-list
111265741|NCT01154920|Fluorouracil|fluorouracil|mesh-list
111265742|NCT01154920|Cetuximab|cetuximab|mesh-list
111265743|NCT01154920|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110959169|NCT03521700|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111265744|NCT01154920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111265745|NCT01154920|Tubulin Modulators|tubulin modulators|mesh-ancestor
111265746|NCT01154920|Antimitotic Agents|antimitotic agents|mesh-ancestor
111265747|NCT01154920|Mitosis Modulators|mitosis modulators|mesh-ancestor
111265748|NCT01154920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111265749|NCT01154920|Antimetabolites|antimetabolites|mesh-ancestor
111265750|NCT01154920|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111265751|NCT01154920|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111265752|NCT01154920|Immunologic Factors|immunologic factors|mesh-ancestor
111265753|NCT01154920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111265754|NCT01154920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111265755|NCT01028963|Pioglitazone|pioglitazone|mesh-list
111265756|NCT01028963|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111265757|NCT01028963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111265758|NCT00792948|Calcium, Dietary|calcium, dietary|mesh-list
111265759|NCT00792948|Leucovorin|leucovorin|mesh-list
111265760|NCT00792948|Folic Acid|folic acid|mesh-list
111265761|NCT00792948|Cytarabine|cytarabine|mesh-list
111265762|NCT00792948|Sirolimus|sirolimus|mesh-list
111265763|NCT00792948|Dexamethasone|dexamethasone|mesh-list
111265764|NCT00792948|Dexamethasone acetate|dexamethasone acetate|mesh-list
111265765|NCT00792948|Prednisone|prednisone|mesh-list
111265766|NCT00792948|Methylprednisolone|methylprednisolone|mesh-list
111265767|NCT00792948|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111265768|NCT00792948|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111265769|NCT00792948|Prednisolone|prednisolone|mesh-list
111265770|NCT00792948|Prednisolone acetate|prednisolone acetate|mesh-list
111265771|NCT00792948|Cortisone|cortisone|mesh-list
111265772|NCT00792948|Cyclophosphamide|cyclophosphamide|mesh-list
111265773|NCT00792948|Doxorubicin|doxorubicin|mesh-list
111265774|NCT00792948|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111265775|NCT00792948|Methotrexate|methotrexate|mesh-list
111265776|NCT00792948|Etoposide|etoposide|mesh-list
111265777|NCT00792948|Vincristine|vincristine|mesh-list
111265778|NCT00792948|Etoposide phosphate|etoposide phosphate|mesh-list
111265779|NCT00792948|Dasatinib|dasatinib|mesh-list
111265780|NCT00792948|Podophyllotoxin|podophyllotoxin|mesh-list
111265781|NCT00792948|Tacrolimus|tacrolimus|mesh-list
111265782|NCT00792948|Lenograstim|lenograstim|mesh-list
111265783|NCT00792948|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111265784|NCT00792948|Prednisolone phosphate|prednisolone phosphate|mesh-list
111265785|NCT00792948|BB 1101|bb 1101|mesh-list
111265786|NCT00792948|Calcium|calcium|mesh-list
111265787|NCT00792948|Levoleucovorin|levoleucovorin|mesh-list
111265788|NCT00792948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111265789|NCT00792948|Immunologic Factors|immunologic factors|mesh-ancestor
111265790|NCT00792948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111265791|NCT00792948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111265792|NCT00792948|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111265793|NCT00792948|Alkylating Agents|alkylating agents|mesh-ancestor
111265794|NCT00792948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111265795|NCT00792948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111265796|NCT00792948|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111265797|NCT00792948|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111265798|NCT00792948|Antiemetics|antiemetics|mesh-ancestor
111265799|NCT00792948|Autonomic Agents|autonomic agents|mesh-ancestor
111265800|NCT00792948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111265801|NCT00792948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111265802|NCT00792948|Glucocorticoids|glucocorticoids|mesh-ancestor
111265803|NCT00792948|Hormones|hormones|mesh-ancestor
111265804|NCT00792948|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111265805|NCT00792948|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111265806|NCT00792948|Protease Inhibitors|protease inhibitors|mesh-ancestor
111265807|NCT00792948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111265808|NCT00792948|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111265809|NCT00792948|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111265810|NCT00792948|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111265811|NCT00792948|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111265812|NCT00792948|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111265813|NCT00792948|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111265814|NCT00792948|Abortifacient Agents|abortifacient agents|mesh-ancestor
111265815|NCT00792948|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111265816|NCT00792948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111265817|NCT00792948|Antimetabolites|antimetabolites|mesh-ancestor
111265818|NCT00792948|Dermatologic Agents|dermatologic agents|mesh-ancestor
110959170|NCT03521700|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111265819|NCT00792948|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111265820|NCT00792948|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111265821|NCT00792948|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111265822|NCT00792948|Antiviral Agents|antiviral agents|mesh-ancestor
111265823|NCT00792948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111265824|NCT00792948|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111265825|NCT00792948|Antidotes|antidotes|mesh-ancestor
111265826|NCT00792948|Protective Agents|protective agents|mesh-ancestor
111265827|NCT00792948|Vitamin B Complex|vitamin b complex|mesh-ancestor
111265829|NCT00792948|Micronutrients|micronutrients|mesh-ancestor
111265830|NCT00792948|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111265831|NCT00792948|Tubulin Modulators|tubulin modulators|mesh-ancestor
111265832|NCT00792948|Antimitotic Agents|antimitotic agents|mesh-ancestor
111265833|NCT00792948|Mitosis Modulators|mitosis modulators|mesh-ancestor
111265834|NCT00792948|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111265835|NCT00792948|Antifungal Agents|antifungal agents|mesh-ancestor
111265836|NCT00792948|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110717946|NCT03530800|Hormones|hormones|mesh-ancestor
111265837|NCT00792948|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111265838|NCT00792948|Hematinics|hematinics|mesh-ancestor
111265839|NCT00792948|Keratolytic Agents|keratolytic agents|mesh-ancestor
111265840|NCT00754845|Letrozole|letrozole|mesh-list
111265841|NCT00754845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111265842|NCT00754845|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111265843|NCT00754845|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111265844|NCT00754845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111265845|NCT00754845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111265846|NCT00754845|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111265847|NCT00754845|Hormone Antagonists|hormone antagonists|mesh-ancestor
111265848|NCT00754845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111265849|NCT00754845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111265850|NCT00751270|Valacyclovir|valacyclovir|mesh-list
111265851|NCT00751270|Antiviral Agents|antiviral agents|mesh-ancestor
111265852|NCT00751270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111265853|NCT00715611|Carboplatin|carboplatin|mesh-list
111265854|NCT00715611|Pemetrexed|pemetrexed|mesh-list
111265855|NCT00715611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111265856|NCT00715611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111265857|NCT00715611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111265858|NCT00715611|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111265859|NCT00715611|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111265860|NCT00638612|Valacyclovir|valacyclovir|mesh-list
111265861|NCT00638612|Antiviral Agents|antiviral agents|mesh-ancestor
111265862|NCT00638612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111265863|NCT00634231|Valacyclovir|valacyclovir|mesh-list
111265864|NCT00634231|Antiviral Agents|antiviral agents|mesh-ancestor
111265865|NCT00634231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111265866|NCT00602641|Thalidomide|thalidomide|mesh-list
111265867|NCT00602641|Prednisone|prednisone|mesh-list
111265868|NCT00602641|Cortisone|cortisone|mesh-list
111265869|NCT00602641|Lenalidomide|lenalidomide|mesh-list
111265870|NCT00602641|Melphalan|melphalan|mesh-list
111265871|NCT00602641|Mechlorethamine|mechlorethamine|mesh-list
111265872|NCT00602641|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
111265873|NCT00602641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111265874|NCT00602641|Glucocorticoids|glucocorticoids|mesh-ancestor
111265875|NCT00602641|Hormones|hormones|mesh-ancestor
111265876|NCT00602641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111265877|NCT00602641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111265878|NCT00602641|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111265879|NCT00602641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111265880|NCT00602641|Immunologic Factors|immunologic factors|mesh-ancestor
111265881|NCT00602641|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111265882|NCT00602641|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111265883|NCT00602641|Growth Substances|growth substances|mesh-ancestor
111265884|NCT00602641|Growth Inhibitors|growth inhibitors|mesh-ancestor
111265885|NCT00602641|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111265886|NCT00602641|Alkylating Agents|alkylating agents|mesh-ancestor
111265887|NCT00602641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111265888|NCT00602641|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111265889|NCT00602641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111265890|NCT00602641|Leprostatic Agents|leprostatic agents|mesh-ancestor
111265891|NCT00602641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111265892|NCT00602641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111265893|NCT00555555|Factor VIII|factor viii|mesh-list
111265894|NCT00555555|Coagulants|coagulants|mesh-ancestor
111265895|NCT00312039|Lamivudine|lamivudine|mesh-list
110959171|NCT03521700|Antimetabolites|antimetabolites|mesh-ancestor
111265896|NCT00312039|Dexelvucitabine|dexelvucitabine|mesh-list
111265897|NCT00312039|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111265898|NCT00312039|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111265899|NCT00312039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111265900|NCT00312039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111265901|NCT00312039|Antiviral Agents|antiviral agents|mesh-ancestor
111265902|NCT00312039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111265903|NCT00312039|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111265904|NCT00312039|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111265905|NCT00095784|Decitabine|decitabine|mesh-list
111265906|NCT00095784|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111265907|NCT00095784|Antimetabolites|antimetabolites|mesh-ancestor
111265908|NCT00095784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111265909|NCT00095784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111265910|NCT00095784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111265911|NCT00083174|Exemestane|exemestane|mesh-list
111265912|NCT00083174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111265913|NCT00083174|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111265914|NCT00083174|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111265915|NCT00083174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111265916|NCT00083174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111265917|NCT00083174|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111265918|NCT00083174|Hormone Antagonists|hormone antagonists|mesh-ancestor
111265919|NCT00083174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111265920|NCT00083174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111265921|NCT00070499|Imatinib Mesylate|imatinib mesylate|mesh-list
111265922|NCT00070499|Dasatinib|dasatinib|mesh-list
111265923|NCT00070499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111265924|NCT00070499|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111265925|NCT00070499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111265926|NCT00070499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111265927|NCT00066573|Anastrozole|anastrozole|mesh-list
111265928|NCT00066573|Exemestane|exemestane|mesh-list
111265929|NCT00066573|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111265930|NCT00066573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111265931|NCT00066573|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111265932|NCT00066573|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111265933|NCT00066573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111265934|NCT00066573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111265935|NCT00066573|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111265936|NCT00066573|Hormone Antagonists|hormone antagonists|mesh-ancestor
111265937|NCT00066573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111265938|NCT00066573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111265939|NCT03965845|Palbociclib|palbociclib|mesh-list
111265940|NCT03965845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111265941|NCT03965845|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111265942|NCT03965845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111265943|NCT03965845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111265944|NCT04766359|Paclitaxel|paclitaxel|mesh-list
111265945|NCT04766359|Cisplatin|cisplatin|mesh-list
111265946|NCT04766359|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111265947|NCT04766359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111265948|NCT04766359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111265949|NCT04766359|Tubulin Modulators|tubulin modulators|mesh-ancestor
111265950|NCT04766359|Antimitotic Agents|antimitotic agents|mesh-ancestor
111265951|NCT04766359|Mitosis Modulators|mitosis modulators|mesh-ancestor
111265952|NCT04766359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111265953|NCT04020601|Ropivacaine|ropivacaine|mesh-list
111265954|NCT04020601|Anesthetics, Local|anesthetics, local|mesh-ancestor
111265955|NCT04020601|Anesthetics|anesthetics|mesh-ancestor
111265956|NCT04020601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111265957|NCT04020601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111265958|NCT04020601|Sensory System Agents|sensory system agents|mesh-ancestor
111265959|NCT04020601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111265960|NCT03964051|Omalizumab|omalizumab|mesh-list
111265961|NCT03964051|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111265962|NCT03964051|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111265963|NCT03964051|Respiratory System Agents|respiratory system agents|mesh-ancestor
111265964|NCT03973489|Methamphetamine|methamphetamine|mesh-list
111265965|NCT03973489|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111265966|NCT03973489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111265967|NCT03973489|Sympathomimetics|sympathomimetics|mesh-ancestor
111265968|NCT03973489|Autonomic Agents|autonomic agents|mesh-ancestor
111265969|NCT03973489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111265970|NCT03973489|Dopamine Agents|dopamine agents|mesh-ancestor
111265971|NCT03973489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111265972|NCT03973489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111265974|NCT03973489|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111265975|NCT03973489|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111265976|NCT03973489|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111265977|NCT03973489|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111265978|NCT04193137|Captopril|captopril|mesh-list
111265979|NCT04193137|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
111265980|NCT04193137|Protease Inhibitors|protease inhibitors|mesh-ancestor
111265981|NCT04193137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110718089|NCT00421343|Cholecalciferol|cholecalciferol|mesh-list
111265982|NCT04193137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111265983|NCT04193137|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111265984|NCT05060484|Vaccines|vaccines|mesh-list
111265985|NCT05060484|Immunologic Factors|immunologic factors|mesh-ancestor
111265986|NCT05060484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111265987|NCT04193059|Paclitaxel|paclitaxel|mesh-list
111265988|NCT04193059|Docetaxel|docetaxel|mesh-list
111265989|NCT04193059|Cyclophosphamide|cyclophosphamide|mesh-list
111265990|NCT04193059|Carboplatin|carboplatin|mesh-list
111265991|NCT04193059|Trastuzumab|trastuzumab|mesh-list
111265992|NCT04193059|Epirubicin|epirubicin|mesh-list
111265993|NCT04193059|Pertuzumab|pertuzumab|mesh-list
111265994|NCT04193059|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111265995|NCT04193059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111265996|NCT04193059|Tubulin Modulators|tubulin modulators|mesh-ancestor
111265997|NCT04193059|Antimitotic Agents|antimitotic agents|mesh-ancestor
111265998|NCT04193059|Mitosis Modulators|mitosis modulators|mesh-ancestor
111265999|NCT04193059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111266000|NCT04193059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111266001|NCT04193059|Immunologic Factors|immunologic factors|mesh-ancestor
111266002|NCT04193059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111266003|NCT04193059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111266004|NCT04193059|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111266005|NCT04193059|Alkylating Agents|alkylating agents|mesh-ancestor
111266006|NCT04193059|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111266007|NCT04193059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111266008|NCT04193059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111266009|NCT04193059|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111266010|NCT04193059|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111266011|NCT04193059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111266012|NCT04028869|Glycyrrhizic Acid|glycyrrhizic acid|mesh-list
111266013|NCT04028869|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111266014|NCT05092074|Sofosbuvir|sofosbuvir|mesh-list
111266015|NCT05092074|Velpatasvir|velpatasvir|mesh-list
111266016|NCT05092074|Antiviral Agents|antiviral agents|mesh-ancestor
111266017|NCT05092074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111266018|NCT02080273|Listerine|listerine|mesh-list
111266019|NCT02080273|Sodium Fluoride|sodium fluoride|mesh-list
111266020|NCT02080273|Cariostatic Agents|cariostatic agents|mesh-ancestor
111266021|NCT02080273|Protective Agents|protective agents|mesh-ancestor
111266022|NCT02080273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111266023|NCT02080273|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111266024|NCT02080273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111266025|NCT04199143|Nitrous Oxide|nitrous oxide|mesh-list
111266026|NCT04199143|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111266027|NCT04199143|Anesthetics, General|anesthetics, general|mesh-ancestor
111266028|NCT04199143|Anesthetics|anesthetics|mesh-ancestor
111266029|NCT04199143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111266030|NCT04199143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111266031|NCT04199143|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111266032|NCT04199143|Analgesics|analgesics|mesh-ancestor
111266033|NCT04199143|Sensory System Agents|sensory system agents|mesh-ancestor
111266034|NCT04199143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111266035|NCT04616274|Venetoclax|venetoclax|mesh-list
111266036|NCT04616274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111266037|NCT04613622|Venetoclax|venetoclax|mesh-list
111266038|NCT04613622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111266039|NCT04021225|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111266040|NCT04021225|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111266041|NCT05096676|Oxytocin|oxytocin|mesh-list
111266042|NCT05096676|Oxytocics|oxytocics|mesh-ancestor
111266043|NCT05096676|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111266044|NCT05096676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111266045|NCT03948763|Pembrolizumab|pembrolizumab|mesh-list
111266046|NCT03948763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111266047|NCT03948763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110959294|NCT04217356|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111266048|NCT03948763|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111266049|NCT03948763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111266050|NCT05096520|Lidocaine|lidocaine|mesh-list
111266051|NCT05096520|Anesthetics, Local|anesthetics, local|mesh-ancestor
111266052|NCT05096520|Anesthetics|anesthetics|mesh-ancestor
111266053|NCT05096520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111266054|NCT05096520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111266055|NCT05096520|Sensory System Agents|sensory system agents|mesh-ancestor
111266056|NCT05096520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111266057|NCT05096520|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111266058|NCT05096520|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111266059|NCT05096520|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111266060|NCT05096520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111266061|NCT05096520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111266062|NCT03832465|Levofloxacin|levofloxacin|mesh-list
111266063|NCT03832465|Ofloxacin|ofloxacin|mesh-list
111266064|NCT03832465|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111266065|NCT03832465|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111266066|NCT03832465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111266067|NCT03832465|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111266068|NCT03832465|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111266069|NCT03832465|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111266070|NCT03832465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111266071|NCT03832465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111266072|NCT03832465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111266073|NCT03832465|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111266074|NCT03832465|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111266075|NCT04190173|Prucalopride|prucalopride|mesh-list
111266076|NCT04190173|Laxatives|laxatives|mesh-ancestor
111266077|NCT04190173|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111266078|NCT04190173|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
111266079|NCT04190173|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111266080|NCT04190173|Serotonin Agents|serotonin agents|mesh-ancestor
111266081|NCT04190173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111266082|NCT04190173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111266083|NCT04190173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111266084|NCT01272219|Liraglutide|liraglutide|mesh-list
111266085|NCT01272219|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111266086|NCT01272219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111266087|NCT01272219|Incretins|incretins|mesh-ancestor
111266088|NCT01272219|Hormones|hormones|mesh-ancestor
111266089|NCT01272219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111266090|NCT04020133|Epinephrine|epinephrine|mesh-list
111266091|NCT04020133|Bupivacaine|bupivacaine|mesh-list
111266092|NCT04020133|Anesthetics, Local|anesthetics, local|mesh-ancestor
111266093|NCT04020133|Anesthetics|anesthetics|mesh-ancestor
111266094|NCT04020133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111266095|NCT04020133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111266096|NCT04020133|Sensory System Agents|sensory system agents|mesh-ancestor
111266097|NCT04020133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111266098|NCT04020133|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111266099|NCT04020133|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111266100|NCT04020133|Adrenergic Agents|adrenergic agents|mesh-ancestor
111266101|NCT04020133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111266102|NCT04020133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111266103|NCT04020133|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111266104|NCT04020133|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111266105|NCT04020133|Autonomic Agents|autonomic agents|mesh-ancestor
111266106|NCT04020133|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111266107|NCT04020133|Respiratory System Agents|respiratory system agents|mesh-ancestor
111266108|NCT04020133|Mydriatics|mydriatics|mesh-ancestor
111266109|NCT04020133|Sympathomimetics|sympathomimetics|mesh-ancestor
111266110|NCT04020133|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111266111|NCT04565574|Rifampin|rifampin|mesh-list
111266112|NCT04565574|Rabeprazole|rabeprazole|mesh-list
111266113|NCT04565574|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111266114|NCT04565574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111266115|NCT04565574|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111266116|NCT04565574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111266117|NCT04565574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111266118|NCT04565574|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111266119|NCT04565574|Antitubercular Agents|antitubercular agents|mesh-ancestor
111266120|NCT04565574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111266121|NCT04565574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111266122|NCT04565574|Leprostatic Agents|leprostatic agents|mesh-ancestor
111266123|NCT04565574|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111266124|NCT04565574|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111266125|NCT04565574|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111266126|NCT04565574|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
111266127|NCT04565574|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
111266128|NCT04565574|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
111266129|NCT04565574|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111266130|NCT01270971|Tavaborole|tavaborole|mesh-list
111266131|NCT01270971|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111266132|NCT01270971|Antifungal Agents|antifungal agents|mesh-ancestor
111266133|NCT01270971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111266134|NCT04026841|Antibodies|antibodies|mesh-list
111266135|NCT04026841|Immunologic Factors|immunologic factors|mesh-ancestor
111266136|NCT04026841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111266137|NCT04128774|Dexamethasone|dexamethasone|mesh-list
111266138|NCT04128774|Dexamethasone acetate|dexamethasone acetate|mesh-list
111266139|NCT04128774|BB 1101|bb 1101|mesh-list
111266140|NCT04128774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111266141|NCT04128774|Antiemetics|antiemetics|mesh-ancestor
111266142|NCT04128774|Autonomic Agents|autonomic agents|mesh-ancestor
111266143|NCT04128774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111266144|NCT04128774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111266145|NCT04128774|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111266146|NCT04128774|Glucocorticoids|glucocorticoids|mesh-ancestor
111266147|NCT04128774|Hormones|hormones|mesh-ancestor
111266148|NCT04128774|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111266149|NCT04128774|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111266150|NCT04128774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111266151|NCT04128774|Protease Inhibitors|protease inhibitors|mesh-ancestor
111266152|NCT04128774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111266153|NCT04128774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111266154|NCT00732225|Hyaluronic Acid|hyaluronic acid|mesh-list
111266155|NCT00732225|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111266156|NCT00732225|Immunologic Factors|immunologic factors|mesh-ancestor
111266157|NCT00732225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111266158|NCT00732225|Viscosupplements|viscosupplements|mesh-ancestor
111266159|NCT00732225|Protective Agents|protective agents|mesh-ancestor
111266160|NCT04026685|Phenylephrine|phenylephrine|mesh-list
111266161|NCT04026685|Oxymetazoline|oxymetazoline|mesh-list
111266162|NCT04026685|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111266163|NCT04026685|Mydriatics|mydriatics|mesh-ancestor
111266164|NCT04026685|Autonomic Agents|autonomic agents|mesh-ancestor
111266165|NCT04026685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111266166|NCT04026685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111266167|NCT04026685|Sympathomimetics|sympathomimetics|mesh-ancestor
111266168|NCT04026685|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111266169|NCT04026685|Nasal Decongestants|nasal decongestants|mesh-ancestor
111266170|NCT04026685|Respiratory System Agents|respiratory system agents|mesh-ancestor
111266171|NCT04026685|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111266172|NCT04026685|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111266173|NCT04026685|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111266174|NCT04026685|Adrenergic Agents|adrenergic agents|mesh-ancestor
111266175|NCT04026685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111266176|NCT04026685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111266177|NCT04026685|Protective Agents|protective agents|mesh-ancestor
111266178|NCT00751179|Bromides|bromides|mesh-list
111266179|NCT00751179|Rocuronium|rocuronium|mesh-list
111266180|NCT00751179|Succinylcholine|succinylcholine|mesh-list
111266181|NCT00751179|Anticonvulsants|anticonvulsants|mesh-ancestor
111266182|NCT00751179|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
111266183|NCT00751179|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
111266184|NCT00751179|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111266185|NCT00751179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111266186|NCT00751179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111266187|NCT00751179|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
111266188|NCT01273233|Vaccines|vaccines|mesh-list
111266189|NCT01273233|Immunologic Factors|immunologic factors|mesh-ancestor
111266190|NCT01273233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111266191|NCT01277211|NuvaRing|nuvaring|mesh-list
111266192|NCT01277211|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111266193|NCT01277211|Contraceptive Agents|contraceptive agents|mesh-ancestor
111266194|NCT01277211|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111266195|NCT01277211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111266196|NCT04022161|Nitric Oxide|nitric oxide|mesh-list
111266197|NCT04022161|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111266198|NCT04022161|Autonomic Agents|autonomic agents|mesh-ancestor
111266199|NCT04022161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111266200|NCT04022161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111266201|NCT04022161|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111266202|NCT04022161|Respiratory System Agents|respiratory system agents|mesh-ancestor
111266203|NCT04022161|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111266204|NCT04022161|Antioxidants|antioxidants|mesh-ancestor
111266205|NCT04022161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111266206|NCT04022161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111266207|NCT04022161|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
111266208|NCT04022161|Vasodilator Agents|vasodilator agents|mesh-ancestor
111266209|NCT04022161|Gasotransmitters|gasotransmitters|mesh-ancestor
111266210|NCT04022161|Protective Agents|protective agents|mesh-ancestor
111266211|NCT01676220|Insulin|insulin|mesh-list
111266212|NCT01676220|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111266213|NCT01676220|Insulin Glargine|insulin glargine|mesh-list
111266214|NCT01676220|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111266215|NCT01676220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111266216|NCT01275105|Brimonidine Tartrate|brimonidine tartrate|mesh-list
111266217|NCT01275105|Phenylephrine|phenylephrine|mesh-list
111266218|NCT01275105|Oxymetazoline|oxymetazoline|mesh-list
111266219|NCT01275105|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111266220|NCT01275105|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111266221|NCT01275105|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111266222|NCT01275105|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111266223|NCT01275105|Adrenergic Agents|adrenergic agents|mesh-ancestor
111266224|NCT01275105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111266225|NCT01275105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111266226|NCT01275105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111266227|NCT01275105|Sympathomimetics|sympathomimetics|mesh-ancestor
111266228|NCT01275105|Autonomic Agents|autonomic agents|mesh-ancestor
111266229|NCT01275105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111266230|NCT01275105|Nasal Decongestants|nasal decongestants|mesh-ancestor
111266231|NCT01275105|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111266232|NCT01275105|Respiratory System Agents|respiratory system agents|mesh-ancestor
111266233|NCT01275105|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111266234|NCT01275105|Mydriatics|mydriatics|mesh-ancestor
111266235|NCT01275105|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111266236|NCT01275105|Protective Agents|protective agents|mesh-ancestor
111266237|NCT01270347|Levofloxacin|levofloxacin|mesh-list
111266238|NCT01270347|Ofloxacin|ofloxacin|mesh-list
111266239|NCT01270347|Tobramycin|tobramycin|mesh-list
111266240|NCT01270347|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111266241|NCT01270347|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111266242|NCT01270347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111266243|NCT01270347|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111266244|NCT01270347|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111266245|NCT01270347|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111266246|NCT01270347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111266247|NCT01270347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111266248|NCT01270347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111266249|NCT01270347|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111266250|NCT01270347|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111266251|NCT03608436|Bromides|bromides|mesh-list
111266252|NCT03608436|Rocuronium|rocuronium|mesh-list
111266253|NCT03608436|Anticonvulsants|anticonvulsants|mesh-ancestor
111266254|NCT03608436|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
111266255|NCT03608436|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
111266256|NCT03608436|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111266257|NCT03608436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111266258|NCT03608436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111266259|NCT04025671|Naloxone|naloxone|mesh-list
111266260|NCT04025671|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111266261|NCT04025671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111266262|NCT04025671|Sensory System Agents|sensory system agents|mesh-ancestor
111266263|NCT04025671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111266264|NCT03412188|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111266265|NCT03412188|gamma-Globulins|gamma-globulins|mesh-list
111266266|NCT03412188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111266267|NCT03412188|Immunologic Factors|immunologic factors|mesh-ancestor
111266268|NCT03412188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111266269|NCT03412188|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111266270|NCT03412188|Glucocorticoids|glucocorticoids|mesh-ancestor
111266271|NCT03412188|Hormones|hormones|mesh-ancestor
111266272|NCT03412188|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111266273|NCT03412188|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111266274|NCT03412188|Protective Agents|protective agents|mesh-ancestor
111266275|NCT03412188|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111266276|NCT01278849|Vadimezan|vadimezan|mesh-list
111266277|NCT01278849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111266278|NCT04949412|Vitamin D|vitamin d|mesh-list
111266279|NCT04949412|Vitamins|vitamins|mesh-ancestor
111266280|NCT04949412|Micronutrients|micronutrients|mesh-ancestor
111266281|NCT04949412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111266282|NCT04949412|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111266283|NCT04022473|Dimethyl Fumarate|dimethyl fumarate|mesh-list
111266284|NCT04022473|Dermatologic Agents|dermatologic agents|mesh-ancestor
111266285|NCT04022473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111266286|NCT04022473|Immunologic Factors|immunologic factors|mesh-ancestor
111266287|NCT04022473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111266288|NCT01485614|Metformin|metformin|mesh-list
111266289|NCT01485614|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111266290|NCT01485614|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111266291|NCT01485614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111266292|NCT01485614|Incretins|incretins|mesh-ancestor
111266293|NCT01485614|Hormones|hormones|mesh-ancestor
111266294|NCT01485614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111266295|NCT01485614|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111266296|NCT01485614|Protease Inhibitors|protease inhibitors|mesh-ancestor
111266297|NCT01485614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111266298|NCT01485614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111266299|NCT00722553|Vitamins|vitamins|mesh-list
111266300|NCT00722553|Folic Acid|folic acid|mesh-list
111266301|NCT00722553|Vitamin B 12|vitamin b 12|mesh-list
111266302|NCT00722553|Vitamin B Complex|vitamin b complex|mesh-list
111266303|NCT00722553|10-deazaaminopterin|10-deazaaminopterin|mesh-list
111266304|NCT00722553|Aminopterin|aminopterin|mesh-list
111266305|NCT00722553|Micronutrients|micronutrients|mesh-ancestor
111266306|NCT00722553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111266307|NCT00722553|Hematinics|hematinics|mesh-ancestor
111266308|NCT00722553|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111266309|NCT00722553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111266310|NCT00722553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111266311|NCT00722553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111266312|NCT03022747|Allopurinol|allopurinol|mesh-list
111266313|NCT03022747|Antimetabolites|antimetabolites|mesh-ancestor
111266314|NCT03022747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111266315|NCT03022747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111266316|NCT03022747|Gout Suppressants|gout suppressants|mesh-ancestor
111266317|NCT03022747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111266318|NCT03022747|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111266319|NCT03022747|Antioxidants|antioxidants|mesh-ancestor
111266320|NCT03022747|Protective Agents|protective agents|mesh-ancestor
111266321|NCT03022747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111266322|NCT03928015|Analgesics|analgesics|mesh-list
111266323|NCT03928015|Dronabinol|dronabinol|mesh-list
111266324|NCT03928015|Sensory System Agents|sensory system agents|mesh-ancestor
111266325|NCT03928015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111266326|NCT03928015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111266327|NCT03928015|Hallucinogens|hallucinogens|mesh-ancestor
111266328|NCT03928015|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111266329|NCT03928015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111266330|NCT03928015|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
111266331|NCT03928015|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
111266332|NCT03928015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111266333|NCT03928015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111266334|NCT03928015|Hormones|hormones|mesh-ancestor
111266335|NCT03928015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111266336|NCT00735969|Ribavirin|ribavirin|mesh-list
111266337|NCT00735969|Antimetabolites|antimetabolites|mesh-ancestor
111266338|NCT00735969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111266339|NCT00735969|Antiviral Agents|antiviral agents|mesh-ancestor
111266340|NCT00735969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111266341|NCT03229512|Sildenafil Citrate|sildenafil citrate|mesh-list
111266342|NCT03229512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111266343|NCT03229512|Vasodilator Agents|vasodilator agents|mesh-ancestor
110978429|NCT03797924|Ropivacaine|ropivacaine|mesh-list
111266344|NCT03229512|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111266345|NCT03229512|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111266346|NCT03229512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111266347|NCT03229512|Urological Agents|urological agents|mesh-ancestor
111266348|NCT01279083|Timolol|timolol|mesh-list
110990655|NCT05124340|Vaccines|vaccines|mesh-list
111266349|NCT01279083|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111266350|NCT01279083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111266351|NCT01279083|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111266352|NCT01279083|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111266353|NCT01279083|Adrenergic Agents|adrenergic agents|mesh-ancestor
111266354|NCT01279083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111266355|NCT01279083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111266356|NCT01279083|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111266357|NCT01279083|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111266359|NCT03022201|Antiemetics|antiemetics|mesh-ancestor
111266360|NCT03022201|Autonomic Agents|autonomic agents|mesh-ancestor
111266361|NCT03022201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111266362|NCT03022201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111266363|NCT03022201|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111266364|NCT03022201|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111266365|NCT03022201|Dopamine Agents|dopamine agents|mesh-ancestor
111266366|NCT03022201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111266367|NCT03022201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111266368|NCT04716114|Cytarabine|cytarabine|mesh-list
111266369|NCT04716114|Fludarabine|fludarabine|mesh-list
111266370|NCT04716114|Azacitidine|azacitidine|mesh-list
111266371|NCT04716114|Homoharringtonine|homoharringtonine|mesh-list
111266372|NCT04716114|Aclarubicin|aclarubicin|mesh-list
111266373|NCT04716114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111266374|NCT04716114|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111266375|NCT04716114|Antimetabolites|antimetabolites|mesh-ancestor
111266376|NCT04716114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111266377|NCT04716114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111266378|NCT04716114|Immunologic Factors|immunologic factors|mesh-ancestor
111266379|NCT04716114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111266380|NCT04716114|Antiviral Agents|antiviral agents|mesh-ancestor
111266381|NCT04716114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111266382|NCT04716114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111266383|NCT04716114|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111266384|NCT04716114|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111266385|NCT04716114|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111266386|NCT04716114|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111266387|NCT04716114|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111266388|NCT00752973|Malathion|malathion|mesh-list
111266389|NCT00752973|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111266390|NCT00752973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111266391|NCT00752973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111266392|NCT00752973|Cholinergic Agents|cholinergic agents|mesh-ancestor
111266393|NCT00752973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111266394|NCT00752973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111266395|NCT04025593|Prednisone|prednisone|mesh-list
111266396|NCT04025593|Cyclophosphamide|cyclophosphamide|mesh-list
111266397|NCT04025593|Rituximab|rituximab|mesh-list
111266398|NCT04025593|Doxorubicin|doxorubicin|mesh-list
111266399|NCT04025593|Vincristine|vincristine|mesh-list
111266400|NCT04025593|Lenalidomide|lenalidomide|mesh-list
111266401|NCT04025593|Decitabine|decitabine|mesh-list
111266402|NCT04025593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111266403|NCT04025593|Immunologic Factors|immunologic factors|mesh-ancestor
111266404|NCT04025593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111266405|NCT04025593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111266406|NCT04025593|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111266407|NCT04025593|Alkylating Agents|alkylating agents|mesh-ancestor
111266408|NCT04025593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111266409|NCT04025593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111266410|NCT04025593|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111266411|NCT04025593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111266412|NCT04025593|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111266413|NCT04025593|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111266414|NCT04025593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111266415|NCT04025593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111266416|NCT04025593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111266417|NCT04025593|Glucocorticoids|glucocorticoids|mesh-ancestor
111266418|NCT04025593|Hormones|hormones|mesh-ancestor
111266419|NCT04025593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111266420|NCT04025593|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111266421|NCT04025593|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111266422|NCT04025593|Tubulin Modulators|tubulin modulators|mesh-ancestor
111266423|NCT04025593|Antimitotic Agents|antimitotic agents|mesh-ancestor
110990742|NCT02387918|Hormones|hormones|mesh-ancestor
111266424|NCT04025593|Mitosis Modulators|mitosis modulators|mesh-ancestor
111266425|NCT04025593|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111266426|NCT04025593|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111266427|NCT04025593|Growth Substances|growth substances|mesh-ancestor
111266428|NCT04025593|Growth Inhibitors|growth inhibitors|mesh-ancestor
111266429|NCT04025593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111266430|NCT04025593|Antimetabolites|antimetabolites|mesh-ancestor
111266431|NCT01279707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111266432|NCT01279707|Epratuzumab|epratuzumab|mesh-list
111266433|NCT01279707|Veltuzumab|veltuzumab|mesh-list
111266434|NCT01279707|Antibodies|antibodies|mesh-list
111266435|NCT01279707|Immunoglobulins|immunoglobulins|mesh-list
111266436|NCT01279707|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111266437|NCT01279707|Immunologic Factors|immunologic factors|mesh-ancestor
111266438|NCT01279707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111266439|NCT01279707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111266440|NCT02957292|Levonorgestrel|levonorgestrel|mesh-list
111266441|NCT02957292|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111266442|NCT02957292|Contraceptive Agents|contraceptive agents|mesh-ancestor
111266443|NCT02957292|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111266444|NCT02957292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111266445|NCT02957292|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111266446|NCT02957292|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111266447|NCT02957292|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111266448|NCT01273779|Talactoferrin alfa|talactoferrin alfa|mesh-list
111266449|NCT01273779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111266450|NCT03022123|Prednisone|prednisone|mesh-list
111266451|NCT03022123|Cyclophosphamide|cyclophosphamide|mesh-list
111266452|NCT03022123|Doxorubicin|doxorubicin|mesh-list
111266453|NCT03022123|Vincristine|vincristine|mesh-list
111266454|NCT03022123|Epirubicin|epirubicin|mesh-list
111266455|NCT03022123|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111266456|NCT03022123|Immunologic Factors|immunologic factors|mesh-ancestor
111266457|NCT03022123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111266458|NCT03022123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111266459|NCT03022123|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111266460|NCT03022123|Alkylating Agents|alkylating agents|mesh-ancestor
111266461|NCT03022123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111266462|NCT03022123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111266463|NCT03022123|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111266464|NCT03022123|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111266465|NCT03022123|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111266466|NCT03022123|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111266467|NCT03022123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111266468|NCT03022123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111266469|NCT03022123|Glucocorticoids|glucocorticoids|mesh-ancestor
111266470|NCT03022123|Hormones|hormones|mesh-ancestor
111266471|NCT03022123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111266472|NCT03022123|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111266473|NCT03022123|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111266474|NCT03022123|Tubulin Modulators|tubulin modulators|mesh-ancestor
111266475|NCT03022123|Antimitotic Agents|antimitotic agents|mesh-ancestor
111266476|NCT03022123|Mitosis Modulators|mitosis modulators|mesh-ancestor
111266477|NCT00722865|Bevacizumab|bevacizumab|mesh-list
111266478|NCT00722865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111266479|NCT00722865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111266480|NCT00722865|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111266481|NCT00722865|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111266482|NCT00722865|Growth Substances|growth substances|mesh-ancestor
111266483|NCT00722865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111266484|NCT00722865|Growth Inhibitors|growth inhibitors|mesh-ancestor
111266485|NCT02700529|Ubenimex|ubenimex|mesh-list
111266486|NCT02700529|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111266487|NCT02700529|Immunologic Factors|immunologic factors|mesh-ancestor
111266488|NCT02700529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110718591|NCT03972462|Sirolimus|sirolimus|mesh-list
111266489|NCT02700529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111266490|NCT02700529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111266491|NCT02700529|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111266492|NCT02700529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111266493|NCT02700529|Protease Inhibitors|protease inhibitors|mesh-ancestor
111266494|NCT02700529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111266495|NCT02700529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111266496|NCT02700529|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111266497|NCT02700529|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111266498|NCT02700529|Antiviral Agents|antiviral agents|mesh-ancestor
111266499|NCT04146493|Heparin|heparin|mesh-list
111266500|NCT04146493|Anticoagulants|anticoagulants|mesh-ancestor
111266501|NCT04146493|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111266502|NCT04146493|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111266503|NCT04146493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111266505|NCT00723099|Mycophenolic Acid|mycophenolic acid|mesh-list
111266506|NCT00723099|Cyclophosphamide|cyclophosphamide|mesh-list
111266507|NCT00723099|Fludarabine|fludarabine|mesh-list
111266508|NCT00723099|Fludarabine phosphate|fludarabine phosphate|mesh-list
111266509|NCT00723099|Cyclosporins|cyclosporins|mesh-list
111266510|NCT00723099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111266511|NCT00723099|Immunologic Factors|immunologic factors|mesh-ancestor
111266512|NCT00723099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111266513|NCT00723099|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111266514|NCT00723099|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111266515|NCT00723099|Alkylating Agents|alkylating agents|mesh-ancestor
111266516|NCT00723099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111266517|NCT00723099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111266518|NCT00723099|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111266519|NCT00723099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111266520|NCT00723099|Antimetabolites|antimetabolites|mesh-ancestor
111266521|NCT00723099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111266522|NCT00723099|Antifungal Agents|antifungal agents|mesh-ancestor
111266523|NCT00723099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111266524|NCT00723099|Dermatologic Agents|dermatologic agents|mesh-ancestor
111266525|NCT00723099|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111266526|NCT00723099|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111266527|NCT00723099|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111266528|NCT00723099|Antitubercular Agents|antitubercular agents|mesh-ancestor
111266529|NCT00723099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111266530|NCT01508936|Reslizumab|reslizumab|mesh-list
111266531|NCT01508936|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111266532|NCT01508936|Respiratory System Agents|respiratory system agents|mesh-ancestor
111266533|NCT04146259|Alfacalcidol|alfacalcidol|mesh-list
111266534|NCT04146259|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
111266535|NCT04146259|Calcium Carbonate|calcium carbonate|mesh-list
111266536|NCT04146259|Calcium|calcium|mesh-list
111266537|NCT04146259|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111266538|NCT04146259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111266539|NCT04146259|Antacids|antacids|mesh-ancestor
111266540|NCT04146259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111266541|NCT04146259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111266542|NCT04146259|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111266543|NCT04146259|Vitamins|vitamins|mesh-ancestor
111266544|NCT04146259|Micronutrients|micronutrients|mesh-ancestor
111266545|NCT05100186|Dexamethasone|dexamethasone|mesh-list
111266546|NCT05100186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111266547|NCT05100186|Antiemetics|antiemetics|mesh-ancestor
111266548|NCT05100186|Autonomic Agents|autonomic agents|mesh-ancestor
111266549|NCT05100186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111266550|NCT05100186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111266551|NCT05100186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111266552|NCT05100186|Glucocorticoids|glucocorticoids|mesh-ancestor
111266553|NCT05100186|Hormones|hormones|mesh-ancestor
111266554|NCT05100186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111266555|NCT05100186|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111266556|NCT05100186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111266557|NCT04323462|Insulin|insulin|mesh-list
111266558|NCT04323462|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111266559|NCT04323462|Insulin Glargine|insulin glargine|mesh-list
111266560|NCT04323462|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111266561|NCT04323462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111266562|NCT00723177|Ibudilast|ibudilast|mesh-list
111266563|NCT00723177|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111266564|NCT00723177|Autonomic Agents|autonomic agents|mesh-ancestor
111266565|NCT00723177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111266566|NCT00723177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111266567|NCT00723177|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111266568|NCT00723177|Respiratory System Agents|respiratory system agents|mesh-ancestor
111266569|NCT00723177|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111266570|NCT00723177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111266571|NCT00723177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111266572|NCT00723177|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111266573|NCT00723177|Vasodilator Agents|vasodilator agents|mesh-ancestor
111266574|NCT04318392|Dimercaprol|dimercaprol|mesh-list
111266575|NCT04318392|Chelating Agents|chelating agents|mesh-ancestor
111266576|NCT04318392|Sequestering Agents|sequestering agents|mesh-ancestor
111266577|NCT04318392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111266578|NCT04698434|Esketamine|esketamine|mesh-list
111266579|NCT04698434|Antidepressive Agents|antidepressive agents|mesh-ancestor
111266580|NCT04698434|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111266581|NCT04142749|Oltipraz|oltipraz|mesh-list
111266582|NCT04142749|Antiviral Agents|antiviral agents|mesh-ancestor
111266583|NCT04142749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111266584|NCT04142749|Schistosomicides|schistosomicides|mesh-ancestor
111266585|NCT04142749|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
111266586|NCT04142749|Anthelmintics|anthelmintics|mesh-ancestor
111266587|NCT04142749|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111266588|NCT04142749|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
111266589|NCT04142749|Protective Agents|protective agents|mesh-ancestor
111266590|NCT04142749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111266591|NCT04142749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111266592|NCT04142749|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111266593|NCT04142749|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111266594|NCT04142749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111266595|NCT04142749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111266596|NCT01508702|Lesinurad|lesinurad|mesh-list
111266597|NCT01508702|Gout Suppressants|gout suppressants|mesh-ancestor
111266598|NCT01508702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111266599|NCT01508702|Uricosuric Agents|uricosuric agents|mesh-ancestor
111266600|NCT04024813|Seladelpar|seladelpar|mesh-list
111266601|NCT04024813|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111266602|NCT04024813|Antimetabolites|antimetabolites|mesh-ancestor
111266603|NCT04024813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111266604|NCT04024813|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111266605|NCT01276041|Paclitaxel|paclitaxel|mesh-list
111266606|NCT01276041|Trastuzumab|trastuzumab|mesh-list
111266607|NCT01276041|Pertuzumab|pertuzumab|mesh-list
111266608|NCT01276041|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111266609|NCT01276041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111266610|NCT01276041|Tubulin Modulators|tubulin modulators|mesh-ancestor
111266611|NCT01276041|Antimitotic Agents|antimitotic agents|mesh-ancestor
111266612|NCT01276041|Mitosis Modulators|mitosis modulators|mesh-ancestor
111266613|NCT01276041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111266614|NCT01276041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111266615|NCT04150770|Infliximab|infliximab|mesh-list
111266616|NCT04150770|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111266617|NCT04150770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111266618|NCT04150770|Dermatologic Agents|dermatologic agents|mesh-ancestor
111266619|NCT04150770|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111266620|NCT04150770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111266621|NCT04026438|Potassium phosphate|potassium phosphate|mesh-list
111266622|NCT04026438|Cariostatic Agents|cariostatic agents|mesh-ancestor
111266623|NCT04026438|Protective Agents|protective agents|mesh-ancestor
111266624|NCT04026438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111266625|NCT01275339|Tadalafil|tadalafil|mesh-list
111266626|NCT01275339|Vasodilator Agents|vasodilator agents|mesh-ancestor
111266627|NCT01275339|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111266628|NCT01275339|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111266629|NCT01275339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111266630|NCT01275339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111266631|NCT01275339|Urological Agents|urological agents|mesh-ancestor
111266632|NCT01520402|Warfarin|warfarin|mesh-list
111266633|NCT01520402|Anticoagulants|anticoagulants|mesh-list
111266634|NCT00738543|Povidone-Iodine|povidone-iodine|mesh-list
111266635|NCT00738543|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111266636|NCT00738543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111266637|NCT05108220|Cannabidiol|cannabidiol|mesh-list
111266638|NCT05108220|Anticonvulsants|anticonvulsants|mesh-ancestor
111266639|NCT03027674|Nifedipine|nifedipine|mesh-list
111266640|NCT03027674|Sildenafil Citrate|sildenafil citrate|mesh-list
111266641|NCT03027674|Vasodilator Agents|vasodilator agents|mesh-ancestor
111266642|NCT03027674|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111266643|NCT03027674|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111266644|NCT03027674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111266645|NCT03027674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111266646|NCT03027674|Urological Agents|urological agents|mesh-ancestor
111266647|NCT03027674|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111266648|NCT03027674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111266649|NCT03027674|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111266650|NCT03027674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111266651|NCT03027674|Tocolytic Agents|tocolytic agents|mesh-ancestor
111266652|NCT03027674|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111266653|NCT04094948|Clenbuterol|clenbuterol|mesh-list
111266654|NCT04094948|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111266655|NCT04094948|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111266656|NCT04094948|Adrenergic Agents|adrenergic agents|mesh-ancestor
111266657|NCT04094948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111266658|NCT04094948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111266659|NCT04094948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111266660|NCT04094948|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111266661|NCT04094948|Autonomic Agents|autonomic agents|mesh-ancestor
111266662|NCT04094948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111266663|NCT04094948|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111266664|NCT04094948|Respiratory System Agents|respiratory system agents|mesh-ancestor
111266665|NCT04094948|Sympathomimetics|sympathomimetics|mesh-ancestor
111266666|NCT04023565|Perindopril|perindopril|mesh-list
111266667|NCT04023565|Moxonidine|moxonidine|mesh-list
111266668|NCT04023565|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
111266669|NCT04023565|Protease Inhibitors|protease inhibitors|mesh-ancestor
111266670|NCT04023565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111266671|NCT04023565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111266672|NCT04023565|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111266673|NCT01506908|Nicotine|nicotine|mesh-list
111266674|NCT01506908|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111266675|NCT01506908|Autonomic Agents|autonomic agents|mesh-ancestor
111266676|NCT01506908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111266677|NCT01506908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111266678|NCT01506908|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111266679|NCT01506908|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111266680|NCT01506908|Cholinergic Agents|cholinergic agents|mesh-ancestor
111266681|NCT01506908|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111266682|NCT01506908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111266683|NCT01519778|Tedizolid|tedizolid|mesh-list
111266684|NCT01519778|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111266685|NCT01519778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111266686|NCT04144933|Acetaminophen|acetaminophen|mesh-list
111266687|NCT04144933|Dexamethasone|dexamethasone|mesh-list
111266688|NCT04144933|Lidocaine|lidocaine|mesh-list
111266689|NCT04144933|Magnesium Sulfate|magnesium sulfate|mesh-list
111266690|NCT04144933|Sufentanil|sufentanil|mesh-list
111266691|NCT04144933|Dexmedetomidine|dexmedetomidine|mesh-list
111266692|NCT04144933|Ketamine|ketamine|mesh-list
111266693|NCT04144933|Gabapentin|gabapentin|mesh-list
111266695|NCT04144933|Analgesics, Opioid|analgesics, opioid|mesh-list
111266696|NCT04144933|Ondansetron|ondansetron|mesh-list
111266697|NCT04144933|Sevoflurane|sevoflurane|mesh-list
111266698|NCT04144933|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111266699|NCT04144933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111266700|NCT04144933|Antiemetics|antiemetics|mesh-ancestor
111266701|NCT04144933|Autonomic Agents|autonomic agents|mesh-ancestor
111266702|NCT04144933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111266703|NCT04144933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111266704|NCT04144933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111266705|NCT04144933|Glucocorticoids|glucocorticoids|mesh-ancestor
111266706|NCT04144933|Hormones|hormones|mesh-ancestor
111266707|NCT04144933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111266708|NCT04144933|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111266709|NCT04144933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111266710|NCT04144933|Anesthetics, Local|anesthetics, local|mesh-ancestor
111266711|NCT04144933|Anesthetics|anesthetics|mesh-ancestor
111266712|NCT04144933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111266713|NCT04144933|Sensory System Agents|sensory system agents|mesh-ancestor
111266714|NCT04144933|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111266715|NCT04144933|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111266716|NCT04144933|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111266717|NCT04144933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111266718|NCT04144933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111266719|NCT04144933|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111266720|NCT04144933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111266721|NCT04144933|Analgesics|analgesics|mesh-ancestor
111266722|NCT04144933|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111266723|NCT04144933|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111266724|NCT04144933|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111266725|NCT04144933|Adrenergic Agents|adrenergic agents|mesh-ancestor
111266726|NCT04144933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111266727|NCT04144933|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111266728|NCT04144933|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111266729|NCT04144933|Anesthetics, General|anesthetics, general|mesh-ancestor
110991080|NCT04058743|Cobalt|cobalt|mesh-list
111266730|NCT04144933|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111266731|NCT04144933|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111266732|NCT04144933|Antipyretics|antipyretics|mesh-ancestor
111266733|NCT04144933|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111266734|NCT04144933|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111266735|NCT04144933|Anticonvulsants|anticonvulsants|mesh-ancestor
111266736|NCT04144933|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111266737|NCT04144933|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111266738|NCT04144933|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111266739|NCT04144933|Antimanic Agents|antimanic agents|mesh-ancestor
111266740|NCT04144933|Narcotics|narcotics|mesh-ancestor
111266741|NCT04144933|Antipruritics|antipruritics|mesh-ancestor
111266742|NCT04144933|Dermatologic Agents|dermatologic agents|mesh-ancestor
111266743|NCT04144933|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111266744|NCT04144933|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111266745|NCT04144933|Serotonin Agents|serotonin agents|mesh-ancestor
111266746|NCT04144933|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111266747|NCT04144933|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111266748|NCT04144933|Tocolytic Agents|tocolytic agents|mesh-ancestor
111266749|NCT04144933|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111266750|NCT04144933|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111266751|NCT04149067|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111266752|NCT04149067|Dapagliflozin|dapagliflozin|mesh-list
111266753|NCT04149067|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111266754|NCT04149067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111266755|NCT04149067|Incretins|incretins|mesh-ancestor
111266756|NCT04149067|Hormones|hormones|mesh-ancestor
111266757|NCT04149067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111266758|NCT04149067|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111266759|NCT04149067|Protease Inhibitors|protease inhibitors|mesh-ancestor
111266760|NCT04149067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111266761|NCT04149067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111266762|NCT04149067|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111266763|NCT04022941|Sodium Benzoate|sodium benzoate|mesh-list
111266764|NCT04022941|Antifungal Agents|antifungal agents|mesh-ancestor
111266765|NCT04022941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111266766|NCT05087862|Anesthetics|anesthetics|mesh-list
111266767|NCT05087862|Anesthetics, Local|anesthetics, local|mesh-list
111266768|NCT05087862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111266769|NCT05087862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111266770|NCT05087862|Sensory System Agents|sensory system agents|mesh-ancestor
111266771|NCT05087862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111266772|NCT01519700|Lenograstim|lenograstim|mesh-list
111266773|NCT01519700|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111266774|NCT01519700|Immunologic Factors|immunologic factors|mesh-ancestor
111266775|NCT01519700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111266776|NCT04143685|Misoprostol|misoprostol|mesh-list
111266777|NCT04143685|Oxytocin|oxytocin|mesh-list
111266778|NCT04143685|Oxytocics|oxytocics|mesh-ancestor
111266779|NCT04143685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111266780|NCT04143685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111266781|NCT04143685|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111266782|NCT04143685|Abortifacient Agents|abortifacient agents|mesh-ancestor
111266783|NCT04143685|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111266784|NCT04143685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111266785|NCT04148599|Lidocaine|lidocaine|mesh-list
111266786|NCT04148599|Dexmedetomidine|dexmedetomidine|mesh-list
111266787|NCT04148599|Anesthetics, Local|anesthetics, local|mesh-ancestor
111266788|NCT04148599|Anesthetics|anesthetics|mesh-ancestor
111266789|NCT04148599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111266790|NCT04148599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111266791|NCT04148599|Sensory System Agents|sensory system agents|mesh-ancestor
111266792|NCT04148599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111266793|NCT04148599|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111266794|NCT04148599|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111266795|NCT04148599|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111266796|NCT04148599|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111266797|NCT04148599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111266798|NCT04148599|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111266799|NCT04148599|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111266800|NCT04148599|Analgesics|analgesics|mesh-ancestor
111266801|NCT04148599|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111266802|NCT04148599|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111266803|NCT04148599|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111266804|NCT04148599|Adrenergic Agents|adrenergic agents|mesh-ancestor
111266805|NCT04148599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111266806|NCT04930458|Listerine|listerine|mesh-list
111266807|NCT04930458|Calcium|calcium|mesh-list
111266808|NCT04930458|Fluorides|fluorides|mesh-list
111266809|NCT04930458|Sodium Fluoride|sodium fluoride|mesh-list
111266810|NCT04930458|Fluorides, Topical|fluorides, topical|mesh-list
111266811|NCT04930458|Caseins|caseins|mesh-list
111266812|NCT04930458|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111266813|NCT04930458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111266814|NCT04930458|Cariostatic Agents|cariostatic agents|mesh-ancestor
111266815|NCT04930458|Protective Agents|protective agents|mesh-ancestor
111266816|NCT04930458|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111266817|NCT04930458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111266818|NCT04930458|Chelating Agents|chelating agents|mesh-ancestor
111266819|NCT04930458|Sequestering Agents|sequestering agents|mesh-ancestor
111266820|NCT04930458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111266821|NCT04917588|Lidocaine|lidocaine|mesh-list
111266822|NCT04917588|Anesthetics, Local|anesthetics, local|mesh-ancestor
111266823|NCT04917588|Anesthetics|anesthetics|mesh-ancestor
111266824|NCT04917588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111266825|NCT04917588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111266826|NCT04917588|Sensory System Agents|sensory system agents|mesh-ancestor
111266827|NCT04917588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111266828|NCT04917588|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111266829|NCT04917588|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111266830|NCT04917588|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111266831|NCT04917588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111266832|NCT04917588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111266833|NCT05101356|Antineoplastic Agents|antineoplastic agents|mesh-list
111266834|NCT05101356|Vaccines|vaccines|mesh-list
111266835|NCT05101356|Sargramostim|sargramostim|mesh-list
111266836|NCT05101356|Immunologic Factors|immunologic factors|mesh-ancestor
111266837|NCT05101356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111266838|NCT04022317|Insulin|insulin|mesh-list
111266839|NCT04022317|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111266840|NCT04022317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111266841|NCT05099250|Magnesium Sulfate|magnesium sulfate|mesh-list
111266842|NCT05099250|Bupivacaine|bupivacaine|mesh-list
111266843|NCT05099250|Anesthetics, Local|anesthetics, local|mesh-ancestor
111266844|NCT05099250|Anesthetics|anesthetics|mesh-ancestor
111266845|NCT05099250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111266846|NCT05099250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111266847|NCT05099250|Sensory System Agents|sensory system agents|mesh-ancestor
111266848|NCT05099250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111266849|NCT05099250|Analgesics|analgesics|mesh-ancestor
111266850|NCT05099250|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111266851|NCT05099250|Anticonvulsants|anticonvulsants|mesh-ancestor
111266852|NCT05099250|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111266853|NCT05099250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111266854|NCT05099250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111266855|NCT05099250|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111266856|NCT05099250|Tocolytic Agents|tocolytic agents|mesh-ancestor
111266857|NCT05099250|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111266858|NCT04143451|Imiquimod|imiquimod|mesh-list
111266859|NCT04143451|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111266860|NCT04143451|Immunologic Factors|immunologic factors|mesh-ancestor
111266861|NCT04143451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111266862|NCT04143451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111266863|NCT04143451|Interferon Inducers|interferon inducers|mesh-ancestor
111266864|NCT05105412|Gemcitabine|gemcitabine|mesh-list
111266865|NCT05105412|Lenalidomide|lenalidomide|mesh-list
111266866|NCT05105412|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111266867|NCT05105412|Antimetabolites|antimetabolites|mesh-ancestor
111266868|NCT05105412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111266869|NCT05105412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111266870|NCT05105412|Immunologic Factors|immunologic factors|mesh-ancestor
111266871|NCT05105412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111266872|NCT05105412|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111266873|NCT05105412|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111266874|NCT05105412|Growth Substances|growth substances|mesh-ancestor
111266875|NCT05105412|Growth Inhibitors|growth inhibitors|mesh-ancestor
111266876|NCT04766047|Dexmedetomidine|dexmedetomidine|mesh-list
111266877|NCT04766047|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111266878|NCT04766047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111266879|NCT04766047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111266880|NCT04766047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111266881|NCT04766047|Analgesics|analgesics|mesh-ancestor
111266882|NCT04766047|Sensory System Agents|sensory system agents|mesh-ancestor
111266883|NCT04766047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111266884|NCT04766047|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111266885|NCT04766047|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111266886|NCT04766047|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111266887|NCT04766047|Adrenergic Agents|adrenergic agents|mesh-ancestor
111266888|NCT04766047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111266889|NCT04766047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111266891|NCT02080819|Carbidopa|carbidopa|mesh-list
111266892|NCT02080819|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111266893|NCT02080819|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111266894|NCT02080819|Dopamine Agents|dopamine agents|mesh-ancestor
111266895|NCT02080819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111266896|NCT02080819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111266897|NCT02080819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111266898|NCT02080819|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
111266899|NCT02080819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111266900|NCT05104788|Carboplatin|carboplatin|mesh-list
111266901|NCT05104788|Pemetrexed|pemetrexed|mesh-list
111266902|NCT05104788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111266903|NCT05104788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111266904|NCT05104788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111266905|NCT05104788|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111266906|NCT05104788|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111266907|NCT04405843|Ivermectin|ivermectin|mesh-list
111266908|NCT04405843|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111266909|NCT04405843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111266910|NCT04316364|Paclitaxel|paclitaxel|mesh-list
111266911|NCT04316364|Carboplatin|carboplatin|mesh-list
111266912|NCT04316364|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111266913|NCT04316364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111266914|NCT04316364|Tubulin Modulators|tubulin modulators|mesh-ancestor
111266915|NCT04316364|Antimitotic Agents|antimitotic agents|mesh-ancestor
111266916|NCT04316364|Mitosis Modulators|mitosis modulators|mesh-ancestor
111266917|NCT04316364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111266918|NCT03916003|Primaquine|primaquine|mesh-list
111266919|NCT03916003|Antimalarials|antimalarials|mesh-ancestor
111266920|NCT03916003|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111266921|NCT03916003|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111266922|NCT03916003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111266923|NCT04781478|Chlorhexidine|chlorhexidine|mesh-list
111266924|NCT04781478|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111266925|NCT04781478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111266926|NCT04781478|Disinfectants|disinfectants|mesh-ancestor
111266927|NCT04018872|Itraconazole|itraconazole|mesh-list
111266928|NCT04018872|Antifungal Agents|antifungal agents|mesh-ancestor
111266929|NCT04018872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111266930|NCT04018872|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111266931|NCT04018872|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111266932|NCT04018872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111266933|NCT04018872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111266934|NCT04018872|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111266935|NCT04018872|Hormone Antagonists|hormone antagonists|mesh-ancestor
111266936|NCT04018872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111266937|NCT04018872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111266938|NCT04018872|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111266939|NCT05076786|Carboplatin|carboplatin|mesh-list
111266940|NCT05076786|Etoposide|etoposide|mesh-list
111266941|NCT05076786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111266942|NCT05076786|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111266943|NCT05076786|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111266944|NCT05076786|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111266945|NCT05076786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111266946|NCT05076786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111266947|NCT03476317|Vancomycin|vancomycin|mesh-list
111266948|NCT03476317|Ciprofloxacin|ciprofloxacin|mesh-list
111266949|NCT03476317|Neomycin|neomycin|mesh-list
111266950|NCT03476317|Fluconazole|fluconazole|mesh-list
111266951|NCT03476317|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
111266952|NCT03476317|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111266953|NCT03476317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111266954|NCT03476317|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111266955|NCT03476317|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111266957|NCT03476317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111266958|NCT03476317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111266959|NCT03476317|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111266960|NCT03476317|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111266961|NCT03476317|Antifungal Agents|antifungal agents|mesh-ancestor
111266962|NCT03476317|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111266963|NCT03476317|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111266964|NCT03476317|Hormone Antagonists|hormone antagonists|mesh-ancestor
111266965|NCT03476317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111266966|NCT03476317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111266967|NCT03476317|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111266968|NCT03476317|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111266969|NCT03476317|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111266970|NCT03476317|Laxatives|laxatives|mesh-ancestor
111266971|NCT03476317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111266972|NCT02658084|Trastuzumab|trastuzumab|mesh-list
111266973|NCT02658084|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
111266974|NCT02658084|Vinorelbine|vinorelbine|mesh-list
111266975|NCT02658084|Maytansine|maytansine|mesh-list
111266976|NCT02658084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111266977|NCT02658084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111266978|NCT02658084|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111266979|NCT02658084|Tubulin Modulators|tubulin modulators|mesh-ancestor
111266980|NCT02658084|Antimitotic Agents|antimitotic agents|mesh-ancestor
111266981|NCT02658084|Mitosis Modulators|mitosis modulators|mesh-ancestor
111266982|NCT02658084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111266983|NCT02658084|Immunotoxins|immunotoxins|mesh-ancestor
111266984|NCT02658084|Immunoconjugates|immunoconjugates|mesh-ancestor
111266985|NCT02658084|Immunologic Factors|immunologic factors|mesh-ancestor
111266986|NCT02658084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111266987|NCT03588871|Hydrogen Peroxide|hydrogen peroxide|mesh-list
111266988|NCT03588871|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111266989|NCT03588871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111266990|NCT03588715|Interferons|interferons|mesh-list
111266991|NCT03588715|Interferon-alpha|interferon-alpha|mesh-list
111266992|NCT03588715|Interferon alpha-2|interferon alpha-2|mesh-list
111266993|NCT03588715|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
111266994|NCT03588715|Antibodies, Blocking|antibodies, blocking|mesh-list
111266995|NCT03588715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111266996|NCT03588715|Antiviral Agents|antiviral agents|mesh-ancestor
111266997|NCT03588715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111266998|NCT03588715|Immunologic Factors|immunologic factors|mesh-ancestor
111266999|NCT03588715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111267000|NCT04528758|Rhodamine 6G|rhodamine 6g|mesh-list
111267001|NCT04528758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111267002|NCT04140409|Octreotide|octreotide|mesh-list
111267003|NCT04140409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111267004|NCT04140409|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111267005|NCT04140409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111267006|NCT04527432|Antibodies|antibodies|mesh-list
111267007|NCT04527432|Immunologic Factors|immunologic factors|mesh-ancestor
111267008|NCT04527432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111267009|NCT03912805|Botulinum Toxins|botulinum toxins|mesh-list
111267010|NCT03912805|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111267011|NCT03912805|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111267012|NCT03912805|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111267013|NCT03912805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111267014|NCT03912805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111267015|NCT03912805|Cholinergic Agents|cholinergic agents|mesh-ancestor
111267016|NCT03912805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111267017|NCT03912805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111267018|NCT03912805|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111267019|NCT03912805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111267020|NCT04642950|Sargramostim|sargramostim|mesh-list
111267021|NCT04642950|Immunologic Factors|immunologic factors|mesh-ancestor
111267022|NCT04642950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111267023|NCT04374240|Tretazicar|tretazicar|mesh-list
111267024|NCT04374240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111267025|NCT05109390|Cyclosporine|cyclosporine|mesh-list
111267026|NCT05109390|Simethicone|simethicone|mesh-list
111267027|NCT05109390|Omeprazole|omeprazole|mesh-list
111267028|NCT05109390|Anti-Ulcer Agents|anti-ulcer agents|mesh-list
111267029|NCT05109390|Calcium Carbonate|calcium carbonate|mesh-list
111267030|NCT05109390|Magnesium Hydroxide|magnesium hydroxide|mesh-list
111267031|NCT05109390|Aluminum hydroxide, magnesium hydroxide, drug combination|aluminum hydroxide, magnesium hydroxide, drug combination|mesh-list
111267032|NCT05109390|Antacids|antacids|mesh-list
111267033|NCT05109390|Tacrolimus|tacrolimus|mesh-list
111267034|NCT05109390|Cyclosporins|cyclosporins|mesh-list
111267035|NCT05109390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111267036|NCT05109390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111267037|NCT05109390|Immunologic Factors|immunologic factors|mesh-ancestor
111267038|NCT05109390|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111267039|NCT05109390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111267040|NCT05109390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111267041|NCT05109390|Antifungal Agents|antifungal agents|mesh-ancestor
111267042|NCT05109390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111267043|NCT05109390|Dermatologic Agents|dermatologic agents|mesh-ancestor
111267044|NCT05109390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111267045|NCT05109390|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111267046|NCT05109390|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111267047|NCT05109390|Antifoaming Agents|antifoaming agents|mesh-ancestor
111267048|NCT05109390|Emollients|emollients|mesh-ancestor
111267049|NCT04030182|Vitamin D|vitamin d|mesh-list
111267050|NCT04030182|Vitamins|vitamins|mesh-ancestor
111267051|NCT04030182|Micronutrients|micronutrients|mesh-ancestor
111267052|NCT04030182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111267053|NCT04030182|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111267054|NCT05109312|Acetaminophen|acetaminophen|mesh-list
111267055|NCT05109312|Ibuprofen|ibuprofen|mesh-list
111267056|NCT05109312|Bupivacaine|bupivacaine|mesh-list
111267057|NCT05109312|Anesthetics, Local|anesthetics, local|mesh-ancestor
111267058|NCT05109312|Anesthetics|anesthetics|mesh-ancestor
111267059|NCT05109312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111267060|NCT05109312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111267061|NCT05109312|Sensory System Agents|sensory system agents|mesh-ancestor
111267062|NCT05109312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111267063|NCT05109312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111267064|NCT05109312|Analgesics|analgesics|mesh-ancestor
111267065|NCT05109312|Antipyretics|antipyretics|mesh-ancestor
111267066|NCT05109312|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111267067|NCT05109312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111267068|NCT05109312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111267069|NCT05109312|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111267070|NCT05109312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111267071|NCT05109312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111267072|NCT03661632|Nivolumab|nivolumab|mesh-list
111267073|NCT03661632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111267074|NCT03661632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111267075|NCT03661632|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111267076|NCT03661632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111267077|NCT04748250|Phytoestrogens|phytoestrogens|mesh-list
111267078|NCT04748250|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
111267079|NCT04748250|Estrogens|estrogens|mesh-ancestor
111267080|NCT04748250|Hormones|hormones|mesh-ancestor
111267081|NCT04748250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111267082|NCT04748250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111267083|NCT04726878|Acetaminophen|acetaminophen|mesh-list
111267084|NCT04726878|Oxycodone|oxycodone|mesh-list
111267085|NCT04726878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111267086|NCT04726878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111267087|NCT04726878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111267088|NCT04726878|Analgesics|analgesics|mesh-ancestor
111267089|NCT04726878|Sensory System Agents|sensory system agents|mesh-ancestor
111267090|NCT04726878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111267091|NCT04726878|Antipyretics|antipyretics|mesh-ancestor
111267092|NCT04726878|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111267093|NCT04726878|Narcotics|narcotics|mesh-ancestor
111267094|NCT04525638|Nivolumab|nivolumab|mesh-list
111267095|NCT04525638|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
111267096|NCT04525638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111267097|NCT04525638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111267098|NCT04525638|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111267099|NCT04525638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111267100|NCT04525638|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111267101|NCT01482962|Gemcitabine|gemcitabine|mesh-list
111267102|NCT01482962|Romidepsin|romidepsin|mesh-list
111267103|NCT01482962|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111267104|NCT01482962|Antimetabolites|antimetabolites|mesh-ancestor
111267105|NCT01482962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111267106|NCT01482962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111267107|NCT01482962|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111267108|NCT01482962|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111267110|NCT04701060|Apatinib|apatinib|mesh-list
111267111|NCT04701060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111267112|NCT04701060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111267113|NCT04701060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111267114|NCT04701060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111267115|NCT05116098|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
111267116|NCT05116098|Antioxidants|antioxidants|mesh-ancestor
111267117|NCT05116098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111267118|NCT05116098|Protective Agents|protective agents|mesh-ancestor
111267119|NCT05116098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111267120|NCT05116098|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
111267121|NCT05116098|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
111267122|NCT05116098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111267123|NCT05116098|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111267124|NCT04464408|Favipiravir|favipiravir|mesh-list
111267125|NCT04464408|Antiviral Agents|antiviral agents|mesh-ancestor
111267126|NCT04464408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111267127|NCT04339218|Carboplatin|carboplatin|mesh-list
111267128|NCT04339218|Pembrolizumab|pembrolizumab|mesh-list
111267129|NCT04339218|Pemetrexed|pemetrexed|mesh-list
111267130|NCT04339218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111267131|NCT04339218|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111267132|NCT04339218|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111267133|NCT04339218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111267134|NCT04339218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111267135|NCT04339218|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111267136|NCT04339218|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111267137|NCT03895801|Prednisone|prednisone|mesh-list
111267138|NCT03895801|Glucocorticoids|glucocorticoids|mesh-list
111267139|NCT03895801|Vilobelimab|vilobelimab|mesh-list
111267140|NCT03895801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111267141|NCT03895801|Hormones|hormones|mesh-ancestor
111267142|NCT03895801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111267143|NCT03895801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111267144|NCT03895801|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111267145|NCT03895801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111267146|NCT03895801|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
111267147|NCT03895801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111267148|NCT03895801|Immunologic Factors|immunologic factors|mesh-ancestor
111267149|NCT03021421|Bupivacaine|bupivacaine|mesh-list
111267150|NCT03021421|Anesthetics, Local|anesthetics, local|mesh-ancestor
111267151|NCT03021421|Anesthetics|anesthetics|mesh-ancestor
111267152|NCT03021421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111267153|NCT03021421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111267154|NCT03021421|Sensory System Agents|sensory system agents|mesh-ancestor
111267155|NCT03021421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111267156|NCT04521582|Amlodipine|amlodipine|mesh-list
111267157|NCT04521582|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111267158|NCT04521582|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111267159|NCT04521582|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111267160|NCT04521582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111267161|NCT04521582|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111267162|NCT04521582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111267163|NCT04521582|Vasodilator Agents|vasodilator agents|mesh-ancestor
111267164|NCT03588091|Docetaxel|docetaxel|mesh-list
111267165|NCT03588091|Trastuzumab|trastuzumab|mesh-list
111267166|NCT03588091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111267167|NCT03588091|Tubulin Modulators|tubulin modulators|mesh-ancestor
111267168|NCT03588091|Antimitotic Agents|antimitotic agents|mesh-ancestor
111267169|NCT03588091|Mitosis Modulators|mitosis modulators|mesh-ancestor
111267170|NCT03588091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111267171|NCT03588091|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111267172|NCT05065554|Rituximab|rituximab|mesh-list
111267173|NCT05065554|Acalabrutinib|acalabrutinib|mesh-list
111267174|NCT05065554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111267175|NCT05065554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111267176|NCT05065554|Immunologic Factors|immunologic factors|mesh-ancestor
111267177|NCT05065554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111267178|NCT05065554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111267179|NCT04436172|Anesthetics|anesthetics|mesh-list
111267180|NCT04436172|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111267181|NCT04436172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111267183|NCT03587779|Desflurane|desflurane|mesh-list
111267184|NCT03587779|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111267185|NCT03587779|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111267186|NCT03587779|Anesthetics, General|anesthetics, general|mesh-ancestor
111267187|NCT03587779|Anesthetics|anesthetics|mesh-ancestor
111267188|NCT03587779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111267189|NCT03587779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111267190|NCT04405921|Azithromycin|azithromycin|mesh-list
111267191|NCT04405921|Hydroxychloroquine|hydroxychloroquine|mesh-list
111267192|NCT04405921|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111267193|NCT04405921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111267194|NCT04405921|Antimalarials|antimalarials|mesh-ancestor
111267195|NCT04405921|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111267196|NCT04405921|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111267197|NCT04405921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111267198|NCT04405921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111267199|NCT04405921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111267200|NCT04516902|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
111267201|NCT04516902|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
111267202|NCT04516902|Hallucinogens|hallucinogens|mesh-ancestor
111267203|NCT04516902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111267204|NCT04516902|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111267205|NCT04516902|Serotonin Agents|serotonin agents|mesh-ancestor
111267206|NCT04516902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111267207|NCT04516902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111267208|NCT04516902|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111267209|NCT04516902|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111267210|NCT04516902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111267211|NCT04516902|Adrenergic Agents|adrenergic agents|mesh-ancestor
111267212|NCT04516902|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111267213|NCT04516902|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111267214|NCT03581149|Ascorbic Acid|ascorbic acid|mesh-list
111267215|NCT03581149|Magnesium citrate|magnesium citrate|mesh-list
111267216|NCT03581149|Picosulfate sodium|picosulfate sodium|mesh-list
111267217|NCT03581149|Laxatives|laxatives|mesh-list
111267218|NCT03581149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111267219|NCT03581149|Antioxidants|antioxidants|mesh-ancestor
111267220|NCT03581149|Protective Agents|protective agents|mesh-ancestor
111267221|NCT03581149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111267222|NCT03581149|Vitamins|vitamins|mesh-ancestor
111267223|NCT03581149|Micronutrients|micronutrients|mesh-ancestor
111267224|NCT03581149|Cathartics|cathartics|mesh-ancestor
111267225|NCT03581149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111267226|NCT04765267|Vitamin D|vitamin d|mesh-list
111267227|NCT04765267|Cholecalciferol|cholecalciferol|mesh-list
111267228|NCT04765267|Zinc Sulfate|zinc sulfate|mesh-list
111267229|NCT04765267|Vitamins|vitamins|mesh-ancestor
111267230|NCT04765267|Micronutrients|micronutrients|mesh-ancestor
110719330|NCT01261546|Dexamethasone|dexamethasone|mesh-list
111267231|NCT04765267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111267232|NCT04765267|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111267233|NCT04765267|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111267234|NCT04765267|Astringents|astringents|mesh-ancestor
111267235|NCT04765267|Dermatologic Agents|dermatologic agents|mesh-ancestor
111267236|NCT05583409|Osimertinib|osimertinib|mesh-list
111267237|NCT05583409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111267238|NCT05583409|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111267239|NCT05583409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111267240|NCT05583409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111267241|NCT03020953|Estrogens|estrogens|mesh-list
111267242|NCT03020953|Hormones|hormones|mesh-ancestor
111267243|NCT03020953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111267244|NCT03020953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111267245|NCT05583175|Venetoclax|venetoclax|mesh-list
111267246|NCT05583175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111267247|NCT03580681|Vitamin E|vitamin e|mesh-list
111267248|NCT03580681|Vitamins|vitamins|mesh-ancestor
111267249|NCT03580681|Micronutrients|micronutrients|mesh-ancestor
111267250|NCT03580681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111267251|NCT03580681|Antioxidants|antioxidants|mesh-ancestor
111267252|NCT03580681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111267253|NCT03580681|Protective Agents|protective agents|mesh-ancestor
111267254|NCT03452826|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111267255|NCT03452826|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
111267256|NCT03452826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110991560|NCT05506787|Esketamine|esketamine|mesh-list
111267257|NCT03452826|Antitubercular Agents|antitubercular agents|mesh-ancestor
111267258|NCT05040126|Linezolid|linezolid|mesh-list
111267259|NCT05040126|Bedaquiline|bedaquiline|mesh-list
111267260|NCT05040126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111267261|NCT05040126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111267262|NCT05040126|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111267263|NCT05040126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111267264|NCT05040126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111267265|NCT05040126|Antitubercular Agents|antitubercular agents|mesh-ancestor
111267266|NCT03069300|Acetylcysteine|acetylcysteine|mesh-list
111267267|NCT03069300|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111267268|NCT03069300|Antiviral Agents|antiviral agents|mesh-ancestor
111267269|NCT03069300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111267270|NCT03069300|Expectorants|expectorants|mesh-ancestor
111267271|NCT03069300|Respiratory System Agents|respiratory system agents|mesh-ancestor
111267272|NCT03069300|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111267273|NCT03069300|Antioxidants|antioxidants|mesh-ancestor
111267274|NCT03069300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111267275|NCT03069300|Protective Agents|protective agents|mesh-ancestor
111267276|NCT03069300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111267277|NCT03069300|Antidotes|antidotes|mesh-ancestor
111267278|NCT05582317|Simvastatin|simvastatin|mesh-list
111267279|NCT05582317|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111267280|NCT05582317|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111267281|NCT05582317|Antimetabolites|antimetabolites|mesh-ancestor
111267282|NCT05582317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111267283|NCT05582317|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111267284|NCT05582317|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111267285|NCT05582317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111267286|NCT03891355|Dexamethasone|dexamethasone|mesh-list
111267287|NCT03891355|Lenalidomide|lenalidomide|mesh-list
111267288|NCT03891355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111267289|NCT03891355|Antiemetics|antiemetics|mesh-ancestor
111267290|NCT03891355|Autonomic Agents|autonomic agents|mesh-ancestor
111267291|NCT03891355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111267292|NCT03891355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111267293|NCT03891355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111267294|NCT03891355|Glucocorticoids|glucocorticoids|mesh-ancestor
111267295|NCT03891355|Hormones|hormones|mesh-ancestor
111267296|NCT03891355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111267297|NCT03891355|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111267298|NCT03891355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111267299|NCT03891355|Immunologic Factors|immunologic factors|mesh-ancestor
111267300|NCT03891355|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111267301|NCT03891355|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111267302|NCT03891355|Growth Substances|growth substances|mesh-ancestor
111267303|NCT03891355|Growth Inhibitors|growth inhibitors|mesh-ancestor
111267304|NCT05582083|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
111267305|NCT05582083|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111267306|NCT05582083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111267307|NCT05582083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111267308|NCT03954132|Cholinergic Agents|cholinergic agents|mesh-list
111267309|NCT03954132|Muscarinic Antagonists|muscarinic antagonists|mesh-list
111267310|NCT03954132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111267311|NCT03954132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111267312|NCT03954132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111267313|NCT03954132|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111267314|NCT03580291|Mycophenolic Acid|mycophenolic acid|mesh-list
111267315|NCT03580291|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111267316|NCT03580291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111267317|NCT03580291|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111267318|NCT03580291|Antitubercular Agents|antitubercular agents|mesh-ancestor
111267319|NCT03580291|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111267320|NCT03580291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111267321|NCT03580291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111267322|NCT03580291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111267323|NCT02936388|Cisplatin|cisplatin|mesh-list
111267324|NCT02936388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111267325|NCT03586141|Chrysarobin|chrysarobin|mesh-list
111267326|NCT03586141|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111267327|NCT03586141|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111267328|NCT03586141|Analgesics|analgesics|mesh-ancestor
111267329|NCT03586141|Sensory System Agents|sensory system agents|mesh-ancestor
111267330|NCT03586141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111267332|NCT03586141|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111267333|NCT03586141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111267334|NCT03020563|Bupivacaine|bupivacaine|mesh-list
111267335|NCT03020563|Anesthetics, Local|anesthetics, local|mesh-ancestor
111267336|NCT03020563|Anesthetics|anesthetics|mesh-ancestor
111267337|NCT03020563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111267338|NCT03020563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111267339|NCT03020563|Sensory System Agents|sensory system agents|mesh-ancestor
111267340|NCT03020563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111267341|NCT04591626|Insulin Glargine|insulin glargine|mesh-list
111267342|NCT04591626|Dulaglutide|dulaglutide|mesh-list
111267343|NCT04591626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111267344|NCT04591626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111267345|NCT04518306|Amlodipine|amlodipine|mesh-list
111267346|NCT04518306|Telmisartan|telmisartan|mesh-list
111267347|NCT04518306|Indapamide|indapamide|mesh-list
111267348|NCT04518306|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111267349|NCT04518306|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111267350|NCT04518306|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111267351|NCT04518306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111267352|NCT04518306|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111267353|NCT04518306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111267354|NCT04518306|Vasodilator Agents|vasodilator agents|mesh-ancestor
111267355|NCT04518306|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111267356|NCT04518306|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111267357|NCT04518306|Diuretics|diuretics|mesh-ancestor
111267358|NCT04518306|Natriuretic Agents|natriuretic agents|mesh-ancestor
111267359|NCT04518306|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
111267360|NCT03580135|Propolis|propolis|mesh-list
111267361|NCT03580135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111267362|NCT01890252|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111267363|NCT03901573|Atezolizumab|atezolizumab|mesh-list
111267364|NCT03901573|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111267365|NCT03901573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111267366|NCT03901573|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111267367|NCT03901573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111267368|NCT03585829|Prednisolone|prednisolone|mesh-list
111267369|NCT03585829|Hydrocortisone|hydrocortisone|mesh-list
111267370|NCT03585829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111267371|NCT03585829|Glucocorticoids|glucocorticoids|mesh-ancestor
111267372|NCT03585829|Hormones|hormones|mesh-ancestor
111267373|NCT03585829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111267374|NCT03585829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111267375|NCT03585829|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110978455|NCT02458742|Anesthetics|anesthetics|mesh-ancestor
111267376|NCT03585829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111267377|NCT05701969|Melatonin|melatonin|mesh-list
111267378|NCT05701969|Antioxidants|antioxidants|mesh-ancestor
111267379|NCT05701969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111267380|NCT05701969|Protective Agents|protective agents|mesh-ancestor
111267381|NCT05701969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111267382|NCT05701969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111267383|NCT03585751|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111267384|NCT03585751|Simvastatin|simvastatin|mesh-list
111267385|NCT03585751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111267386|NCT03585751|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111267387|NCT03585751|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111267388|NCT03585751|Antimetabolites|antimetabolites|mesh-ancestor
111267389|NCT03585751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111267390|NCT03585751|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111267391|NCT03585751|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111267392|NCT03585751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111267393|NCT03583333|Linezolid|linezolid|mesh-list
111267394|NCT03583333|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111267395|NCT03583333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111267396|NCT03583333|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111267397|NCT03583333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111267398|NCT03583333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111267399|NCT03585673|Docetaxel|docetaxel|mesh-list
111267400|NCT03585673|Oxaliplatin|oxaliplatin|mesh-list
111267401|NCT03585673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111267402|NCT03585673|Tubulin Modulators|tubulin modulators|mesh-ancestor
111267403|NCT03585673|Antimitotic Agents|antimitotic agents|mesh-ancestor
111267404|NCT03585673|Mitosis Modulators|mitosis modulators|mesh-ancestor
111267405|NCT03585673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111267406|NCT01602510|Lamotrigine|lamotrigine|mesh-list
111267407|NCT01602510|Anticonvulsants|anticonvulsants|mesh-ancestor
111267408|NCT01602510|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111267409|NCT01602510|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111267410|NCT01602510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111267411|NCT01602510|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111267412|NCT01602510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111267413|NCT01602510|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111267414|NCT01602510|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111267415|NCT01602510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111267416|NCT01602510|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111267417|NCT01602510|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111267418|NCT03899467|Androgens|androgens|mesh-list
111267419|NCT03899467|Androgen Receptor Antagonists|androgen receptor antagonists|mesh-list
111267420|NCT03899467|Hormones|hormones|mesh-ancestor
111267421|NCT03899467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111267422|NCT03899467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111267423|NCT03899467|Androgen Antagonists|androgen antagonists|mesh-ancestor
111267424|NCT03899467|Hormone Antagonists|hormone antagonists|mesh-ancestor
111267425|NCT05701813|Inositol|inositol|mesh-list
111267426|NCT05701813|Vitamin B Complex|vitamin b complex|mesh-ancestor
111267427|NCT05701813|Vitamins|vitamins|mesh-ancestor
111267428|NCT05701813|Micronutrients|micronutrients|mesh-ancestor
111267429|NCT05701813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111267430|NCT03586219|Analgesics, Opioid|analgesics, opioid|mesh-list
111267431|NCT03586219|Narcotics|narcotics|mesh-ancestor
111267432|NCT03586219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111267433|NCT03586219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111267434|NCT03586219|Analgesics|analgesics|mesh-ancestor
111267435|NCT03586219|Sensory System Agents|sensory system agents|mesh-ancestor
111267436|NCT03586219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111267437|NCT05118984|Azithromycin|azithromycin|mesh-list
111267438|NCT05118984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111267439|NCT05118984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111267440|NCT04514328|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
111267441|NCT04514328|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111267442|NCT04514328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111267443|NCT02802852|Lenograstim|lenograstim|mesh-list
111267444|NCT02802852|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111267445|NCT02802852|Immunologic Factors|immunologic factors|mesh-ancestor
111267446|NCT02802852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111267447|NCT01236456|Cyclophosphamide|cyclophosphamide|mesh-list
111267448|NCT01236456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111267449|NCT01236456|Immunologic Factors|immunologic factors|mesh-ancestor
111267450|NCT01236456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111267451|NCT01236456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111267452|NCT01236456|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111267453|NCT01236456|Alkylating Agents|alkylating agents|mesh-ancestor
111267454|NCT01236456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111267455|NCT01236456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111267456|NCT01236456|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111267457|NCT05118048|Chrysarobin|chrysarobin|mesh-list
111267458|NCT05118048|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111267459|NCT05118048|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111267460|NCT05118048|Analgesics|analgesics|mesh-ancestor
111267461|NCT05118048|Sensory System Agents|sensory system agents|mesh-ancestor
111267462|NCT05118048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111267463|NCT05118048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111267464|NCT05118048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111267465|NCT05118048|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111267466|NCT04405375|Dexamethasone|dexamethasone|mesh-list
111267467|NCT04405375|Etoposide|etoposide|mesh-list
111267468|NCT04405375|Pegaspargase|pegaspargase|mesh-list
111267469|NCT04405375|Gemcitabine|gemcitabine|mesh-list
111267470|NCT04405375|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111267471|NCT04405375|Antiemetics|antiemetics|mesh-ancestor
111267472|NCT04405375|Autonomic Agents|autonomic agents|mesh-ancestor
111267473|NCT04405375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111267474|NCT04405375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111267475|NCT04405375|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111267476|NCT04405375|Glucocorticoids|glucocorticoids|mesh-ancestor
111267477|NCT04405375|Hormones|hormones|mesh-ancestor
111267478|NCT04405375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111267479|NCT04405375|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111267480|NCT04405375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111267481|NCT04405375|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111267482|NCT04405375|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111267483|NCT04405375|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111267484|NCT04405375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111267485|NCT04405375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111267486|NCT04405375|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111267487|NCT04405375|Antimetabolites|antimetabolites|mesh-ancestor
111267489|NCT03158857|Antiviral Agents|antiviral agents|mesh-ancestor
111267490|NCT03158857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111267491|NCT03029611|Paclitaxel|paclitaxel|mesh-list
111267492|NCT03029611|Carboplatin|carboplatin|mesh-list
111267493|NCT03029611|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111267494|NCT03029611|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111267495|NCT03029611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111267496|NCT03029611|Tubulin Modulators|tubulin modulators|mesh-ancestor
111267497|NCT03029611|Antimitotic Agents|antimitotic agents|mesh-ancestor
111267498|NCT03029611|Mitosis Modulators|mitosis modulators|mesh-ancestor
111267499|NCT03029611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111267500|NCT03589495|Acetylcysteine|acetylcysteine|mesh-list
111267501|NCT03589495|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111267502|NCT03589495|Antiviral Agents|antiviral agents|mesh-ancestor
111267503|NCT03589495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111267504|NCT03589495|Expectorants|expectorants|mesh-ancestor
111267505|NCT03589495|Respiratory System Agents|respiratory system agents|mesh-ancestor
111267506|NCT03589495|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111267507|NCT03589495|Antioxidants|antioxidants|mesh-ancestor
111267508|NCT03589495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111267509|NCT03589495|Protective Agents|protective agents|mesh-ancestor
111267510|NCT03589495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111267511|NCT03589495|Antidotes|antidotes|mesh-ancestor
111267512|NCT03159559|Hypoglycemic Agents|hypoglycemic agents|mesh-list
111267513|NCT03159559|Alprostadil|alprostadil|mesh-list
111267514|NCT03159559|Clopidogrel|clopidogrel|mesh-list
111267515|NCT03159559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111267516|NCT03159559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111267517|NCT03159559|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111267518|NCT03159559|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111267519|NCT03159559|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111267520|NCT03159559|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111267521|NCT03159559|Purinergic Agents|purinergic agents|mesh-ancestor
111267522|NCT03159559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111267523|NCT03159559|Vasodilator Agents|vasodilator agents|mesh-ancestor
111267524|NCT03159559|Urological Agents|urological agents|mesh-ancestor
111267525|NCT03159403|Oritavancin|oritavancin|mesh-list
111267526|NCT03159403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111267527|NCT03159403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111267528|NCT03583567|Chlorpheniramine|chlorpheniramine|mesh-list
111267529|NCT03583567|Ranitidine|ranitidine|mesh-list
111267530|NCT03583567|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
111267531|NCT03583567|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111267532|NCT03583567|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111267533|NCT03583567|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
111267534|NCT03583567|Histamine Antagonists|histamine antagonists|mesh-ancestor
111267535|NCT03583567|Histamine Agents|histamine agents|mesh-ancestor
111267536|NCT03583567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111267537|NCT03583567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111267538|NCT03583567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111267539|NCT03583567|Antipruritics|antipruritics|mesh-ancestor
111267540|NCT03583567|Dermatologic Agents|dermatologic agents|mesh-ancestor
111267541|NCT03583567|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111267542|NCT03583567|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111267543|NCT03583489|Ondansetron|ondansetron|mesh-list
111267544|NCT03583489|Antiemetics|antiemetics|mesh-ancestor
111267545|NCT03583489|Autonomic Agents|autonomic agents|mesh-ancestor
111267546|NCT03583489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111267547|NCT03583489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111267548|NCT03583489|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111267549|NCT03583489|Antipruritics|antipruritics|mesh-ancestor
111267550|NCT03583489|Dermatologic Agents|dermatologic agents|mesh-ancestor
111267551|NCT03583489|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110991865|NCT04675710|Pembrolizumab|pembrolizumab|mesh-list
110991866|NCT04675710|Trametinib|trametinib|mesh-list
110991867|NCT04675710|Dabrafenib|dabrafenib|mesh-list
110991868|NCT04675710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111267552|NCT03583489|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111267553|NCT03583489|Serotonin Agents|serotonin agents|mesh-ancestor
111267554|NCT03583489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111267555|NCT03583489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111267556|NCT03158935|Aldesleukin|aldesleukin|mesh-list
111267557|NCT03158935|Cyclophosphamide|cyclophosphamide|mesh-list
111267558|NCT03158935|Pembrolizumab|pembrolizumab|mesh-list
111267559|NCT03158935|Fludarabine|fludarabine|mesh-list
111267560|NCT03158935|Interleukin-2|interleukin-2|mesh-list
111267561|NCT03158935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111267562|NCT03158935|Immunologic Factors|immunologic factors|mesh-ancestor
111267563|NCT03158935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111267564|NCT03158935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111267565|NCT03158935|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111267566|NCT03158935|Alkylating Agents|alkylating agents|mesh-ancestor
111267567|NCT03158935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111267568|NCT03158935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111267569|NCT03158935|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111267570|NCT03158935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111267571|NCT03158935|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111267572|NCT03158935|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111267573|NCT03158935|Analgesics|analgesics|mesh-ancestor
111267574|NCT03158935|Sensory System Agents|sensory system agents|mesh-ancestor
111267575|NCT03158935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111267576|NCT03158935|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111267577|NCT03158935|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111267578|NCT03158935|Antiviral Agents|antiviral agents|mesh-ancestor
111267579|NCT03158935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111267580|NCT04818372|Dexamethasone|dexamethasone|mesh-list
111267581|NCT04818372|Lenalidomide|lenalidomide|mesh-list
111267582|NCT04818372|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111267583|NCT04818372|Antiemetics|antiemetics|mesh-ancestor
111267584|NCT04818372|Autonomic Agents|autonomic agents|mesh-ancestor
111267585|NCT04818372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111267586|NCT04818372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111267587|NCT04818372|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111267588|NCT04818372|Glucocorticoids|glucocorticoids|mesh-ancestor
111267589|NCT04818372|Hormones|hormones|mesh-ancestor
111267590|NCT04818372|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111267591|NCT04818372|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111267592|NCT04818372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111267593|NCT04818372|Immunologic Factors|immunologic factors|mesh-ancestor
111267594|NCT04818372|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111267595|NCT04818372|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110719689|NCT01264432|Veliparib|veliparib|mesh-list
111267596|NCT04818372|Growth Substances|growth substances|mesh-ancestor
111267597|NCT04818372|Growth Inhibitors|growth inhibitors|mesh-ancestor
111267598|NCT01462578|Azacitidine|azacitidine|mesh-list
111267599|NCT01462578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111267600|NCT01462578|Antimetabolites|antimetabolites|mesh-ancestor
111267601|NCT01462578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111267602|NCT01462578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111267603|NCT01462578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111267604|NCT03059173|Inositol|inositol|mesh-list
111267605|NCT03059173|Clomiphene|clomiphene|mesh-list
111267606|NCT03059173|Enclomiphene|enclomiphene|mesh-list
111267607|NCT03059173|Zuclomiphene|zuclomiphene|mesh-list
111267608|NCT03059173|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111267609|NCT03059173|Hormone Antagonists|hormone antagonists|mesh-ancestor
111267610|NCT03059173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111267611|NCT03059173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111267612|NCT03059173|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111267613|NCT03059173|Fertility Agents|fertility agents|mesh-ancestor
111267614|NCT03059173|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111267615|NCT03059173|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111267616|NCT03059173|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111267617|NCT03059173|Vitamin B Complex|vitamin b complex|mesh-ancestor
111267618|NCT03059173|Vitamins|vitamins|mesh-ancestor
111267619|NCT03059173|Micronutrients|micronutrients|mesh-ancestor
111267620|NCT05122338|Lidocaine|lidocaine|mesh-list
111267621|NCT05122338|Ropivacaine|ropivacaine|mesh-list
111267622|NCT05122338|Esketamine|esketamine|mesh-list
111267623|NCT05122338|Anesthetics, Local|anesthetics, local|mesh-ancestor
111267624|NCT05122338|Anesthetics|anesthetics|mesh-ancestor
111267625|NCT05122338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111267626|NCT05122338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111267627|NCT05122338|Sensory System Agents|sensory system agents|mesh-ancestor
111267628|NCT05122338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111267629|NCT05122338|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111267630|NCT05122338|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111267631|NCT05122338|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111267632|NCT05122338|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111267633|NCT05122338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111267634|NCT05122338|Antidepressive Agents|antidepressive agents|mesh-ancestor
111267635|NCT05122338|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111267636|NCT03157843|Heparin|heparin|mesh-list
111267637|NCT03157843|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
111267638|NCT03157843|Tinzaparin|tinzaparin|mesh-list
111267639|NCT03157843|Dalteparin|dalteparin|mesh-list
111267640|NCT03157843|Anticoagulants|anticoagulants|mesh-ancestor
111267641|NCT03157843|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111267642|NCT03157843|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111267643|NCT03157843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111267644|NCT03589027|Ritonavir|ritonavir|mesh-list
111267645|NCT03589027|Darunavir|darunavir|mesh-list
111267646|NCT03589027|Rilpivirine|rilpivirine|mesh-list
111267647|NCT03589027|Levonorgestrel|levonorgestrel|mesh-list
111267648|NCT03589027|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111267649|NCT03589027|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111267650|NCT03589027|Protease Inhibitors|protease inhibitors|mesh-ancestor
111267651|NCT03589027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111267652|NCT03589027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111267653|NCT03589027|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111267654|NCT03589027|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111267655|NCT03589027|Antiviral Agents|antiviral agents|mesh-ancestor
111267656|NCT03589027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111267657|NCT03589027|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111267658|NCT03589027|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111267659|NCT03589027|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111267660|NCT03589027|Contraceptive Agents|contraceptive agents|mesh-ancestor
111267661|NCT03589027|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111267662|NCT03589027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111267663|NCT03589027|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111267664|NCT03589027|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111267665|NCT03589027|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111267666|NCT03589027|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111267667|NCT03589027|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111267668|NCT03874494|Aripiprazole|aripiprazole|mesh-list
111267669|NCT03874494|Brexpiprazole|brexpiprazole|mesh-list
111267670|NCT03874494|Antidepressive Agents|antidepressive agents|mesh-ancestor
111267671|NCT03874494|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111267672|NCT03874494|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111267673|NCT03874494|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111267674|NCT03874494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111267675|NCT03874494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111267676|NCT03874494|Dopamine Agonists|dopamine agonists|mesh-ancestor
111267677|NCT03874494|Dopamine Agents|dopamine agents|mesh-ancestor
111267678|NCT03874494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111267679|NCT03874494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111267680|NCT03874494|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111267681|NCT03874494|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111267682|NCT03874494|Serotonin Agents|serotonin agents|mesh-ancestor
111267683|NCT03874494|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111267684|NCT03874494|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111267685|NCT03874494|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111267686|NCT03874494|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111267687|NCT03156439|Huperzine A|huperzine a|mesh-list
111267688|NCT03156439|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111267689|NCT03156439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111267690|NCT03156439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111267691|NCT03156439|Cholinergic Agents|cholinergic agents|mesh-ancestor
111267692|NCT03156439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111267693|NCT03156439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111267694|NCT03156439|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111267695|NCT03156439|Protective Agents|protective agents|mesh-ancestor
111267696|NCT04436328|Anti-Infective Agents|anti-infective agents|mesh-list
111267697|NCT04436328|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111267698|NCT03156361|Insulin|insulin|mesh-list
111267699|NCT03156361|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111267700|NCT03156361|Insulin Lispro|insulin lispro|mesh-list
111267701|NCT03156361|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111267702|NCT03156361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110959295|NCT03389126|Avelumab|avelumab|mesh-list
111267703|NCT05690035|Tislelizumab|tislelizumab|mesh-list
111267704|NCT05690035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111267705|NCT05690035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111267706|NCT05002530|Vitamin D|vitamin d|mesh-list
111267707|NCT05002530|Ergocalciferols|ergocalciferols|mesh-list
111267708|NCT05002530|Cholecalciferol|cholecalciferol|mesh-list
111267709|NCT05002530|Vitamins|vitamins|mesh-list
111267710|NCT05002530|Tretinoin|tretinoin|mesh-list
111267711|NCT05002530|Isotretinoin|isotretinoin|mesh-list
111267712|NCT05002530|Micronutrients|micronutrients|mesh-ancestor
111267713|NCT05002530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111267714|NCT05002530|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111267715|NCT05002530|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111267716|NCT05002530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111267717|NCT05002530|Keratolytic Agents|keratolytic agents|mesh-ancestor
111267718|NCT05002530|Dermatologic Agents|dermatologic agents|mesh-ancestor
111267719|NCT03583021|Neostigmine|neostigmine|mesh-list
111267720|NCT03583021|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111267721|NCT03583021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111267722|NCT03583021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111267723|NCT03583021|Cholinergic Agents|cholinergic agents|mesh-ancestor
111267724|NCT03583021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111267725|NCT03583021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111267726|NCT03583021|Parasympathomimetics|parasympathomimetics|mesh-ancestor
111267727|NCT03583021|Autonomic Agents|autonomic agents|mesh-ancestor
111267728|NCT03583021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111267729|NCT03155971|Paclitaxel|paclitaxel|mesh-list
111267730|NCT03155971|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111267731|NCT03155971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111267732|NCT03155971|Tubulin Modulators|tubulin modulators|mesh-ancestor
111267733|NCT03155971|Antimitotic Agents|antimitotic agents|mesh-ancestor
111267734|NCT03155971|Mitosis Modulators|mitosis modulators|mesh-ancestor
111267735|NCT03155971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111267736|NCT03582319|Formaldehyde|formaldehyde|mesh-list
111267737|NCT03582319|Disinfectants|disinfectants|mesh-ancestor
111267738|NCT03582319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111267739|NCT00307242|Adefovir|adefovir|mesh-list
111267740|NCT00307242|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
111267741|NCT00307242|Antiviral Agents|antiviral agents|mesh-ancestor
111267742|NCT00307242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111267743|NCT00307242|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111267744|NCT00307242|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111267745|NCT00307242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111267746|NCT00307242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111267747|NCT03582007|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111267748|NCT03582007|Murepavadin|murepavadin|mesh-list
111267749|NCT03582007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111267750|NCT05120622|Tremelimumab|tremelimumab|mesh-list
111267751|NCT05120622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111267752|NCT02895373|Alprostadil|alprostadil|mesh-list
111267753|NCT02895373|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111267754|NCT02895373|Vasodilator Agents|vasodilator agents|mesh-ancestor
111267755|NCT02895373|Urological Agents|urological agents|mesh-ancestor
111267756|NCT05698771|Niacinamide|niacinamide|mesh-list
111267757|NCT05698771|Niacin|niacin|mesh-list
111267758|NCT05698771|Nicotinic Acids|nicotinic acids|mesh-list
111267759|NCT05698771|Vitamin B Complex|vitamin b complex|mesh-ancestor
111267760|NCT05698771|Vitamins|vitamins|mesh-ancestor
111267761|NCT05698771|Micronutrients|micronutrients|mesh-ancestor
111267762|NCT05698771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111267763|NCT05698771|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111267764|NCT05698771|Antimetabolites|antimetabolites|mesh-ancestor
111267765|NCT05698771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111267766|NCT05698771|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111267767|NCT05698771|Vasodilator Agents|vasodilator agents|mesh-ancestor
111267768|NCT03156907|Buprenorphine|buprenorphine|mesh-list
111267769|NCT03156907|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111267770|NCT03156907|Narcotics|narcotics|mesh-ancestor
111267771|NCT03156907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111267772|NCT03156907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111267773|NCT03156907|Analgesics|analgesics|mesh-ancestor
111267774|NCT03156907|Sensory System Agents|sensory system agents|mesh-ancestor
111267775|NCT03156907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111267776|NCT03156907|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111267777|NCT03156829|Betamethasone|betamethasone|mesh-list
110992093|NCT04084860|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111267778|NCT03156829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111267779|NCT03156829|Glucocorticoids|glucocorticoids|mesh-ancestor
111267780|NCT03156829|Hormones|hormones|mesh-ancestor
111267781|NCT03156829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111267782|NCT03156829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111267784|NCT03156829|Respiratory System Agents|respiratory system agents|mesh-ancestor
111267785|NCT05229276|Bone wax|bone wax|mesh-list
111267786|NCT05229276|Hemostatics|hemostatics|mesh-ancestor
111267787|NCT05229276|Coagulants|coagulants|mesh-ancestor
111267788|NCT03581773|Folic Acid|folic acid|mesh-list
111267789|NCT03581773|Hematinics|hematinics|mesh-ancestor
111267790|NCT03581773|Vitamin B Complex|vitamin b complex|mesh-ancestor
111267791|NCT03581773|Vitamins|vitamins|mesh-ancestor
111267792|NCT03581773|Micronutrients|micronutrients|mesh-ancestor
111267793|NCT03581773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111267794|NCT04425174|Anesthetics|anesthetics|mesh-list
111267795|NCT04425174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111267796|NCT04425174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111267797|NCT05119452|Adalimumab|adalimumab|mesh-list
111267798|NCT05119452|Infliximab|infliximab|mesh-list
111267799|NCT05119452|Golimumab|golimumab|mesh-list
111267800|NCT05119452|Certolizumab Pegol|certolizumab pegol|mesh-list
111267801|NCT05119452|Etanercept|etanercept|mesh-list
111267802|NCT05119452|Antirheumatic Agents|antirheumatic agents|mesh-list
111267803|NCT05119452|Tofacitinib|tofacitinib|mesh-list
111267804|NCT05119452|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111267805|NCT05119452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111267806|NCT05119452|Dermatologic Agents|dermatologic agents|mesh-ancestor
111267807|NCT05119452|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111267808|NCT05119452|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111267809|NCT05119452|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111267810|NCT05119452|Analgesics|analgesics|mesh-ancestor
111267811|NCT05119452|Sensory System Agents|sensory system agents|mesh-ancestor
111267812|NCT05119452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111267813|NCT05119452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111267814|NCT05119452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111267815|NCT05119452|Immunologic Factors|immunologic factors|mesh-ancestor
111267816|NCT05119452|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
111267817|NCT05119452|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111267818|NCT05119452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111267819|NCT05119452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111267820|NCT02788591|Esomeprazole|esomeprazole|mesh-list
111267821|NCT02788591|Omeprazole|omeprazole|mesh-list
111267822|NCT02788591|Pantoprazole|pantoprazole|mesh-list
111267823|NCT02788591|Lansoprazole|lansoprazole|mesh-list
111267824|NCT02788591|Sucralfate|sucralfate|mesh-list
111267825|NCT02788591|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
111267826|NCT02788591|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111267827|NCT02788591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111267828|NCT02788591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111267829|NCT02788591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111267830|NCT05229042|Ricolinostat|ricolinostat|mesh-list
111267831|NCT05229042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111267832|NCT05229042|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111267833|NCT05229042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111267834|NCT05229042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111267835|NCT01670305|Photosensitizing Agents|photosensitizing agents|mesh-list
111267836|NCT01670305|Dermatologic Agents|dermatologic agents|mesh-ancestor
111267837|NCT03076164|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111267838|NCT03076164|Trametinib|trametinib|mesh-list
111267839|NCT03076164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111267840|NCT03076164|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111267841|NCT03076164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111267842|NCT03076164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111267843|NCT03155893|Moxifloxacin|moxifloxacin|mesh-list
111267844|NCT03155893|Adafosbuvir|adafosbuvir|mesh-list
111267845|NCT03155893|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
111267846|NCT03155893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111267847|NCT03155893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111267848|NCT03155893|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111267849|NCT03155893|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111267850|NCT03155893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111267851|NCT03155893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111267852|NCT03155893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111267853|NCT03155893|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111267854|NCT03155893|Contraceptive Agents|contraceptive agents|mesh-ancestor
111267855|NCT03155893|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111267856|NCT03155893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111267857|NCT03155893|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
111267858|NCT03155893|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111267859|NCT03155893|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111267860|NCT03155893|Antiviral Agents|antiviral agents|mesh-ancestor
111267861|NCT01670773|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
111267862|NCT01670773|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111267863|NCT01670773|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111267864|NCT01670773|Analgesics|analgesics|mesh-ancestor
111267865|NCT01670773|Sensory System Agents|sensory system agents|mesh-ancestor
111267866|NCT01670773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111267867|NCT01670773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111267868|NCT01670773|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111267869|NCT01670773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111267870|NCT05228418|Naltrexone|naltrexone|mesh-list
111267871|NCT05228418|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111267872|NCT05228418|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111267873|NCT05228418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111267874|NCT05228418|Sensory System Agents|sensory system agents|mesh-ancestor
111267875|NCT05228418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111267876|NCT01676233|Insulin|insulin|mesh-list
111267877|NCT01676233|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111267878|NCT01676233|Insulin Glargine|insulin glargine|mesh-list
111267879|NCT01676233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111267880|NCT01676233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111267881|NCT01670929|Progesterone|progesterone|mesh-list
111267882|NCT01670929|Progestins|progestins|mesh-ancestor
111267883|NCT01670929|Hormones|hormones|mesh-ancestor
111267884|NCT01670929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111267885|NCT01670929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111267886|NCT02673996|Phenylephrine|phenylephrine|mesh-list
111267887|NCT02673996|Isoproterenol|isoproterenol|mesh-list
111267888|NCT02673996|Oxymetazoline|oxymetazoline|mesh-list
111267889|NCT02673996|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111267890|NCT02673996|Mydriatics|mydriatics|mesh-ancestor
111267891|NCT02673996|Autonomic Agents|autonomic agents|mesh-ancestor
111267892|NCT02673996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111267893|NCT02673996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111267894|NCT02673996|Sympathomimetics|sympathomimetics|mesh-ancestor
111267895|NCT02673996|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111267896|NCT02673996|Nasal Decongestants|nasal decongestants|mesh-ancestor
111267897|NCT02673996|Respiratory System Agents|respiratory system agents|mesh-ancestor
111267898|NCT02673996|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111267899|NCT02673996|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111267900|NCT02673996|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111267901|NCT02673996|Adrenergic Agents|adrenergic agents|mesh-ancestor
111267902|NCT02673996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111267903|NCT02673996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111267904|NCT02673996|Protective Agents|protective agents|mesh-ancestor
111267905|NCT02673996|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111267906|NCT02673996|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111267907|NCT02673996|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111267908|NCT04746937|Nitazoxanide|nitazoxanide|mesh-list
111267909|NCT04746937|Norfloxacin|norfloxacin|mesh-list
111267910|NCT04746937|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111267911|NCT04746937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111267912|NCT04746937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111267913|NCT04746937|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111267914|NCT04746937|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111267915|NCT04746937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111267916|NCT04746937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111267917|NCT04746937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111267918|NCT04746937|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111267919|NCT04746937|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111267920|NCT05220319|Methylprednisolone|methylprednisolone|mesh-list
111267921|NCT05220319|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111267922|NCT05220319|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111267923|NCT05220319|Prednisolone|prednisolone|mesh-list
111267924|NCT05220319|Prednisolone acetate|prednisolone acetate|mesh-list
111267925|NCT05220319|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111267926|NCT05220319|Prednisolone phosphate|prednisolone phosphate|mesh-list
111267927|NCT05220319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111267928|NCT05220319|Antiemetics|antiemetics|mesh-ancestor
111267929|NCT05220319|Autonomic Agents|autonomic agents|mesh-ancestor
111267930|NCT05220319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111267931|NCT05220319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111267932|NCT05220319|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111267934|NCT05220319|Hormones|hormones|mesh-ancestor
111267935|NCT05220319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111267936|NCT05220319|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111267937|NCT05220319|Protective Agents|protective agents|mesh-ancestor
111267938|NCT05220319|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111267939|NCT05220319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111267940|NCT03155035|Vitamin D|vitamin d|mesh-list
111267941|NCT03155035|Albendazole|albendazole|mesh-list
111267942|NCT03155035|Calcium|calcium|mesh-list
111267943|NCT03155035|Vitamins|vitamins|mesh-ancestor
111267944|NCT03155035|Micronutrients|micronutrients|mesh-ancestor
111267945|NCT03155035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111267946|NCT03155035|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111267947|NCT03155035|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111267948|NCT03155035|Anthelmintics|anthelmintics|mesh-ancestor
111267949|NCT03155035|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111267950|NCT03155035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111267951|NCT03155035|Anticestodal Agents|anticestodal agents|mesh-ancestor
111267952|NCT03155035|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
111267953|NCT03155035|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111267954|NCT03155035|Tubulin Modulators|tubulin modulators|mesh-ancestor
111267955|NCT03155035|Antimitotic Agents|antimitotic agents|mesh-ancestor
111267956|NCT03155035|Mitosis Modulators|mitosis modulators|mesh-ancestor
111267957|NCT03155035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111267958|NCT03155035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111267959|NCT04497870|Peppermint oil|peppermint oil|mesh-list
111267960|NCT04497870|Menthol|menthol|mesh-list
111267961|NCT04497870|Antipruritics|antipruritics|mesh-ancestor
111267962|NCT04497870|Dermatologic Agents|dermatologic agents|mesh-ancestor
111267963|NCT04497870|Antiemetics|antiemetics|mesh-ancestor
111267964|NCT04497870|Autonomic Agents|autonomic agents|mesh-ancestor
111267965|NCT04497870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111267966|NCT04497870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111267967|NCT04497870|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111267968|NCT04497870|Parasympatholytics|parasympatholytics|mesh-ancestor
111267969|NCT03154723|Vitamin A|vitamin a|mesh-list
111267970|NCT03154723|Vitamins|vitamins|mesh-ancestor
111267971|NCT03154723|Micronutrients|micronutrients|mesh-ancestor
111267972|NCT03154723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111267973|NCT04080908|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
111267974|NCT04080908|Hematinics|hematinics|mesh-ancestor
111267975|NCT04080908|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
111267976|NCT04080908|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111267977|NCT02653482|Dapagliflozin|dapagliflozin|mesh-list
111267978|NCT02653482|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111267979|NCT02653482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111267980|NCT02653482|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111267981|NCT02653482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111267982|NCT03154567|Yohimbine|yohimbine|mesh-list
111267983|NCT03154567|Mydriatics|mydriatics|mesh-ancestor
111267984|NCT03154567|Autonomic Agents|autonomic agents|mesh-ancestor
111267985|NCT03154567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111267986|NCT03154567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111267987|NCT03154567|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
111267988|NCT03154567|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111267989|NCT03154567|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111267990|NCT03154567|Adrenergic Agents|adrenergic agents|mesh-ancestor
111267991|NCT03154567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111267992|NCT03154567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111267993|NCT03154567|Urological Agents|urological agents|mesh-ancestor
111267994|NCT04310748|Anesthetics|anesthetics|mesh-list
111267995|NCT04310748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111267996|NCT04310748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111267997|NCT03154645|Ibuprofen|ibuprofen|mesh-list
111267998|NCT03154645|Acetazolamide|acetazolamide|mesh-list
111267999|NCT03154645|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111268000|NCT03154645|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111268001|NCT03154645|Analgesics|analgesics|mesh-ancestor
111268002|NCT03154645|Sensory System Agents|sensory system agents|mesh-ancestor
111268003|NCT03154645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111268004|NCT03154645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111268005|NCT03154645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111268006|NCT03154645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111268007|NCT03154645|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110992322|NCT02306161|Mitosis Modulators|mitosis modulators|mesh-ancestor
111268008|NCT03154645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111268009|NCT03154645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111268010|NCT03154645|Anticonvulsants|anticonvulsants|mesh-ancestor
111268011|NCT03154645|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
111268012|NCT03154645|Diuretics|diuretics|mesh-ancestor
111268013|NCT03154645|Natriuretic Agents|natriuretic agents|mesh-ancestor
111268014|NCT01631292|Vitamin D|vitamin d|mesh-list
111268015|NCT01631292|Ergocalciferols|ergocalciferols|mesh-list
111268016|NCT01631292|Cholecalciferol|cholecalciferol|mesh-list
111268017|NCT01631292|Vitamins|vitamins|mesh-list
111268018|NCT01631292|Micronutrients|micronutrients|mesh-ancestor
111268019|NCT01631292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111268020|NCT01631292|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111268021|NCT01631292|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111268022|NCT01671709|Montelukast|montelukast|mesh-list
111268023|NCT01671709|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111268024|NCT01671709|Respiratory System Agents|respiratory system agents|mesh-ancestor
111268025|NCT01671709|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
111268026|NCT01671709|Hormone Antagonists|hormone antagonists|mesh-ancestor
111268027|NCT01671709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111268028|NCT01671709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111268029|NCT01671709|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
111268030|NCT01671709|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111268031|NCT01671709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111268032|NCT05222256|Simendan|simendan|mesh-list
111268033|NCT05222256|Epinephrine|epinephrine|mesh-list
111268034|NCT05222256|Racepinephrine|racepinephrine|mesh-list
111268035|NCT05222256|Epinephryl borate|epinephryl borate|mesh-list
111268036|NCT05222256|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111268037|NCT05222256|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111268038|NCT05222256|Adrenergic Agents|adrenergic agents|mesh-ancestor
111268039|NCT05222256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111268040|NCT05222256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111268041|NCT05222256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110720134|NCT01281748|Hormones|hormones|mesh-ancestor
111268042|NCT05222256|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111268043|NCT05222256|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111268044|NCT05222256|Autonomic Agents|autonomic agents|mesh-ancestor
111268045|NCT05222256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111268046|NCT05222256|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111268047|NCT05222256|Respiratory System Agents|respiratory system agents|mesh-ancestor
111268048|NCT05222256|Mydriatics|mydriatics|mesh-ancestor
111268049|NCT05222256|Sympathomimetics|sympathomimetics|mesh-ancestor
111268050|NCT05222256|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111268051|NCT05222256|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111268052|NCT05222256|Vasodilator Agents|vasodilator agents|mesh-ancestor
111268053|NCT05222256|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
111268054|NCT05222256|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111268055|NCT05222256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111268056|NCT05222256|Protective Agents|protective agents|mesh-ancestor
111268057|NCT01671787|Tenofovir|tenofovir|mesh-list
111268058|NCT01671787|Antiviral Agents|antiviral agents|mesh-ancestor
111268059|NCT01671787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111268060|NCT01671787|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111268061|NCT01671787|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111268062|NCT01671787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111268063|NCT01671787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111268064|NCT01671787|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111268065|NCT01671787|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111268066|NCT05229510|Ribavirin|ribavirin|mesh-list
111268067|NCT05229510|Antimetabolites|antimetabolites|mesh-ancestor
111268068|NCT05229510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111268069|NCT05229510|Antiviral Agents|antiviral agents|mesh-ancestor
111268070|NCT05229510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111268071|NCT01362348|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111268072|NCT01362348|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111268073|NCT03154489|Acenocoumarol|acenocoumarol|mesh-list
111268074|NCT03154489|Anticoagulants|anticoagulants|mesh-ancestor
111268075|NCT00698022|Risperidone|risperidone|mesh-list
111268076|NCT00698022|Mifepristone|mifepristone|mesh-list
111268077|NCT00698022|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111268078|NCT00698022|Serotonin Agents|serotonin agents|mesh-ancestor
111268079|NCT00698022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111268080|NCT00698022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111268081|NCT00698022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111268082|NCT00698022|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111268083|NCT00698022|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111268084|NCT00698022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111268086|NCT00698022|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111268087|NCT00698022|Dopamine Agents|dopamine agents|mesh-ancestor
111268088|NCT00698022|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
111268089|NCT00698022|Abortifacient Agents|abortifacient agents|mesh-ancestor
111268090|NCT00698022|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111268091|NCT00698022|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111268092|NCT00698022|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111268093|NCT00698022|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111268094|NCT00698022|Contraceptive Agents|contraceptive agents|mesh-ancestor
111268095|NCT00698022|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
111268096|NCT00698022|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
111268097|NCT00698022|Hormone Antagonists|hormone antagonists|mesh-ancestor
111268098|NCT00698022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111268099|NCT00698022|Luteolytic Agents|luteolytic agents|mesh-ancestor
111268100|NCT00698022|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111268101|NCT00698022|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
111268102|NCT02570503|Ketorolac|ketorolac|mesh-list
111268103|NCT02570503|Clonidine|clonidine|mesh-list
111268104|NCT02570503|Epinephrine|epinephrine|mesh-list
111268105|NCT02570503|Ropivacaine|ropivacaine|mesh-list
111268106|NCT02570503|Anesthetics, Local|anesthetics, local|mesh-ancestor
111268107|NCT02570503|Anesthetics|anesthetics|mesh-ancestor
111268108|NCT02570503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111268109|NCT02570503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111268110|NCT02570503|Sensory System Agents|sensory system agents|mesh-ancestor
111268111|NCT02570503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111268112|NCT02570503|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111268113|NCT02570503|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111268114|NCT02570503|Adrenergic Agents|adrenergic agents|mesh-ancestor
111268115|NCT02570503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110978469|NCT02403310|Antiviral Agents|antiviral agents|mesh-ancestor
111268116|NCT02570503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111268117|NCT02570503|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111268118|NCT02570503|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111268119|NCT02570503|Autonomic Agents|autonomic agents|mesh-ancestor
111268120|NCT02570503|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111268121|NCT02570503|Respiratory System Agents|respiratory system agents|mesh-ancestor
111268122|NCT02570503|Mydriatics|mydriatics|mesh-ancestor
111268123|NCT02570503|Sympathomimetics|sympathomimetics|mesh-ancestor
111268124|NCT02570503|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111268125|NCT02570503|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111268126|NCT02570503|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111268127|NCT02570503|Analgesics|analgesics|mesh-ancestor
111268128|NCT02570503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111268129|NCT02570503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111268130|NCT02570503|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111268131|NCT02570503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111268132|NCT02570503|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111268133|NCT02570503|Sympatholytics|sympatholytics|mesh-ancestor
111268134|NCT02570503|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111268135|NCT02492269|Dexmedetomidine|dexmedetomidine|mesh-list
111268136|NCT02492269|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111268137|NCT02492269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111268138|NCT02492269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111268139|NCT02492269|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111268140|NCT02492269|Analgesics|analgesics|mesh-ancestor
111268141|NCT02492269|Sensory System Agents|sensory system agents|mesh-ancestor
111268142|NCT02492269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111268143|NCT02492269|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111268144|NCT02492269|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111268145|NCT02492269|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111268146|NCT02492269|Adrenergic Agents|adrenergic agents|mesh-ancestor
111268147|NCT02492269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111268148|NCT02492269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111268149|NCT05561179|Hyaluronic Acid|hyaluronic acid|mesh-list
111268150|NCT05561179|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111268151|NCT05561179|Immunologic Factors|immunologic factors|mesh-ancestor
110992479|NCT01256398|Antimetabolites|antimetabolites|mesh-ancestor
110992480|NCT01256398|Dermatologic Agents|dermatologic agents|mesh-ancestor
110992481|NCT01256398|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110992482|NCT01256398|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110992483|NCT01256398|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111268152|NCT05561179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111268153|NCT05561179|Viscosupplements|viscosupplements|mesh-ancestor
111268154|NCT05561179|Protective Agents|protective agents|mesh-ancestor
111268156|NCT02467153|Cholecalciferol|cholecalciferol|mesh-list
111268157|NCT02467153|Vitamins|vitamins|mesh-ancestor
111268158|NCT02467153|Micronutrients|micronutrients|mesh-ancestor
111268159|NCT02467153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111268160|NCT02467153|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111268161|NCT02467153|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111268162|NCT04933903|Nivolumab|nivolumab|mesh-list
111268163|NCT04933903|Ipilimumab|ipilimumab|mesh-list
111268164|NCT04933903|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111268165|NCT04933903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111268166|NCT04933903|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111268167|NCT04933903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111268168|NCT03153163|Trastuzumab|trastuzumab|mesh-list
111268169|NCT03153163|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
111268170|NCT03153163|Maytansine|maytansine|mesh-list
111268171|NCT03153163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111268172|NCT03153163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111268173|NCT03153163|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111268174|NCT03153163|Tubulin Modulators|tubulin modulators|mesh-ancestor
111268175|NCT03153163|Antimitotic Agents|antimitotic agents|mesh-ancestor
111268176|NCT03153163|Mitosis Modulators|mitosis modulators|mesh-ancestor
111268177|NCT03153163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111268178|NCT03153163|Immunotoxins|immunotoxins|mesh-ancestor
111268179|NCT03153163|Immunoconjugates|immunoconjugates|mesh-ancestor
111268180|NCT03153163|Immunologic Factors|immunologic factors|mesh-ancestor
111268181|NCT03153163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111268182|NCT03153085|Ipilimumab|ipilimumab|mesh-list
111268183|NCT03153085|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111268184|NCT03153085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111268185|NCT03153085|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111268186|NCT03153085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111268187|NCT03589339|Pembrolizumab|pembrolizumab|mesh-list
111268188|NCT03589339|Nivolumab|nivolumab|mesh-list
111268189|NCT03589339|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111268190|NCT03589339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111268191|NCT03589339|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111268192|NCT03589339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111268193|NCT03463525|Osimertinib|osimertinib|mesh-list
111268194|NCT03463525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111268195|NCT03463525|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111268196|NCT03463525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111268197|NCT03463525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111268198|NCT01675128|Irinotecan|irinotecan|mesh-list
111268199|NCT01675128|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111268200|NCT01675128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111268201|NCT01675128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111268202|NCT01675128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111268203|NCT01675128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111268204|NCT02626507|Fulvestrant|fulvestrant|mesh-list
111268205|NCT02626507|Goserelin|goserelin|mesh-list
111268206|NCT02626507|Palbociclib|palbociclib|mesh-list
111268207|NCT02626507|Gedatolisib|gedatolisib|mesh-list
111268208|NCT02626507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111268209|NCT02626507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111268210|NCT02626507|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
111268211|NCT02626507|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111268212|NCT02626507|Hormone Antagonists|hormone antagonists|mesh-ancestor
111268213|NCT02626507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111268214|NCT02626507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111268215|NCT02626507|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111268216|NCT02626507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111268217|NCT02626507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111268218|NCT03413995|Rucaparib|rucaparib|mesh-list
111268219|NCT03413995|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111268220|NCT03413995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111268221|NCT03413995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111268222|NCT03413995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111268223|NCT03243175|Apixaban|apixaban|mesh-list
111268224|NCT03243175|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111268225|NCT03243175|Antithrombins|antithrombins|mesh-ancestor
111268226|NCT03243175|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111268227|NCT03243175|Protease Inhibitors|protease inhibitors|mesh-ancestor
111268228|NCT03243175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111268229|NCT03243175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111268230|NCT03243175|Anticoagulants|anticoagulants|mesh-ancestor
111268231|NCT04764955|Vitamin D|vitamin d|mesh-list
111268232|NCT04764955|Cholecalciferol|cholecalciferol|mesh-list
111268233|NCT04764955|Vitamins|vitamins|mesh-ancestor
111268234|NCT04764955|Micronutrients|micronutrients|mesh-ancestor
111268235|NCT04764955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111268236|NCT04764955|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111268237|NCT04764955|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111268238|NCT03126331|Nivolumab|nivolumab|mesh-list
111268239|NCT03126331|Ipilimumab|ipilimumab|mesh-list
111268240|NCT03126331|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111268241|NCT03126331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111268242|NCT03126331|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111268243|NCT03126331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111268244|NCT01674127|Methyldopa|methyldopa|mesh-list
111268245|NCT01674127|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111268246|NCT01674127|Sympatholytics|sympatholytics|mesh-ancestor
111268247|NCT01674127|Autonomic Agents|autonomic agents|mesh-ancestor
111268248|NCT01674127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111268249|NCT01674127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111268250|NCT01674127|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111268251|NCT01674127|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111268252|NCT01674127|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111268253|NCT01674127|Adrenergic Agents|adrenergic agents|mesh-ancestor
111268254|NCT01674127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110978471|NCT02403310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111268255|NCT01674127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111268256|NCT02081443|Ticagrelor|ticagrelor|mesh-list
111268257|NCT02081443|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111268258|NCT02081443|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111268259|NCT02081443|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111268260|NCT02081443|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111268261|NCT02081443|Purinergic Agents|purinergic agents|mesh-ancestor
111268262|NCT02081443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111268263|NCT02081443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111268264|NCT02081443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111268265|NCT01674205|Vaccines|vaccines|mesh-list
111268266|NCT01674205|Immunologic Factors|immunologic factors|mesh-ancestor
111268267|NCT01674205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111268268|NCT02646475|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
111268269|NCT02646475|Angiotensin II|angiotensin ii|mesh-list
111268270|NCT02646475|Angiotensinogen|angiotensinogen|mesh-list
111268271|NCT02646475|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111268272|NCT02646475|Vasodilator Agents|vasodilator agents|mesh-ancestor
111268273|NCT02646475|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111268274|NCT02646475|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111268275|NCT02646475|Protease Inhibitors|protease inhibitors|mesh-ancestor
111268276|NCT02646475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111268277|NCT02646475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111268278|NCT03151057|Idelalisib|idelalisib|mesh-list
111268279|NCT03151057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111268280|NCT03151057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111268281|NCT03151057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111268282|NCT01674283|Glucagon|glucagon|mesh-list
111268283|NCT01674283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111268284|NCT01674283|Hormones|hormones|mesh-ancestor
111268285|NCT01674283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111268286|NCT01674283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111268287|NCT04404517|Adalimumab|adalimumab|mesh-list
111268288|NCT04404517|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111268289|NCT04404517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111268290|NCT04404517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111268291|NCT01674517|Montelukast|montelukast|mesh-list
111268292|NCT01674517|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111268293|NCT01674517|Respiratory System Agents|respiratory system agents|mesh-ancestor
111268294|NCT01674517|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
111268295|NCT01674517|Hormone Antagonists|hormone antagonists|mesh-ancestor
111268296|NCT01674517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111268297|NCT01674517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111268298|NCT01674517|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
111268299|NCT01674517|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111268300|NCT01674517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111268301|NCT01923649|Lanreotide|lanreotide|mesh-list
111268302|NCT01923649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111268303|NCT01670071|Risperidone|risperidone|mesh-list
111268304|NCT01670071|Paliperidone Palmitate|paliperidone palmitate|mesh-list
111268305|NCT01670071|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111268306|NCT01670071|Serotonin Agents|serotonin agents|mesh-ancestor
111268307|NCT01670071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111268308|NCT01670071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111268309|NCT01670071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111268310|NCT01670071|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111268311|NCT01670071|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111268312|NCT01670071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111268313|NCT01670071|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111268314|NCT01670071|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111268315|NCT01670071|Dopamine Agents|dopamine agents|mesh-ancestor
111268316|NCT01670071|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111268317|NCT01670071|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111268318|NCT01427309|Vaccines|vaccines|mesh-list
111268319|NCT01427309|Immunologic Factors|immunologic factors|mesh-ancestor
111268320|NCT01427309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111268321|NCT01426373|Deoxycholic Acid|deoxycholic acid|mesh-list
111268322|NCT01426373|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
111268323|NCT01426373|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111268324|NCT03855007|Hydroxychloroquine|hydroxychloroquine|mesh-list
111268325|NCT03855007|Prednisone|prednisone|mesh-list
111268326|NCT03855007|Methotrexate|methotrexate|mesh-list
111268327|NCT03855007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111268328|NCT03855007|Glucocorticoids|glucocorticoids|mesh-ancestor
111268329|NCT03855007|Hormones|hormones|mesh-ancestor
111268330|NCT03855007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111268331|NCT03855007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111268332|NCT03855007|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111268333|NCT03855007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111268334|NCT03855007|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111268335|NCT03855007|Abortifacient Agents|abortifacient agents|mesh-ancestor
111268336|NCT03855007|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111268337|NCT03855007|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111268338|NCT03855007|Antimetabolites|antimetabolites|mesh-ancestor
111268339|NCT03855007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111268340|NCT03855007|Dermatologic Agents|dermatologic agents|mesh-ancestor
111268341|NCT03855007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111268342|NCT03855007|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111268343|NCT03855007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111268344|NCT03855007|Immunologic Factors|immunologic factors|mesh-ancestor
111268345|NCT03855007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111268346|NCT03855007|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111268347|NCT03855007|Antimalarials|antimalarials|mesh-ancestor
111268348|NCT03855007|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111268349|NCT03855007|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111268350|NCT03855007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111268351|NCT03852901|Empagliflozin|empagliflozin|mesh-list
111268352|NCT03852901|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111268353|NCT03852901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111268354|NCT03852901|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111268355|NCT03852901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111268356|NCT01675999|Leucovorin|leucovorin|mesh-list
111268357|NCT01675999|Cetuximab|cetuximab|mesh-list
111268358|NCT01675999|Fluorouracil|fluorouracil|mesh-list
111268359|NCT01675999|Oxaliplatin|oxaliplatin|mesh-list
111268360|NCT01675999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111268361|NCT01675999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111268362|NCT01675999|Antimetabolites|antimetabolites|mesh-ancestor
111268363|NCT01675999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111268364|NCT01675999|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111268365|NCT01675999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111268366|NCT01675999|Immunologic Factors|immunologic factors|mesh-ancestor
111268367|NCT01675999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111268368|NCT01675999|Antidotes|antidotes|mesh-ancestor
111268369|NCT01675999|Protective Agents|protective agents|mesh-ancestor
111268370|NCT01675999|Vitamin B Complex|vitamin b complex|mesh-ancestor
111268371|NCT01675999|Vitamins|vitamins|mesh-ancestor
111268372|NCT01675999|Micronutrients|micronutrients|mesh-ancestor
111268373|NCT01425359|Ranolazine|ranolazine|mesh-list
111268374|NCT01425359|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111268375|NCT01425359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111268376|NCT01425359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111268377|NCT04404751|Folic Acid|folic acid|mesh-list
111268378|NCT04404751|Vitamin B 12|vitamin b 12|mesh-list
111268379|NCT04404751|Hydroxocobalamin|hydroxocobalamin|mesh-list
111268380|NCT04404751|Iron|iron|mesh-list
111268381|NCT04404751|Vitamins|vitamins|mesh-ancestor
111268382|NCT04404751|Micronutrients|micronutrients|mesh-ancestor
111268383|NCT04404751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111268384|NCT04404751|Trace Elements|trace elements|mesh-ancestor
111268385|NCT04404751|Hematinics|hematinics|mesh-ancestor
111268386|NCT04404751|Vitamin B Complex|vitamin b complex|mesh-ancestor
111268387|NCT01403051|Calcium, Dietary|calcium, dietary|mesh-list
111268388|NCT01403051|Vitamin D|vitamin d|mesh-list
111268389|NCT01403051|Ergocalciferols|ergocalciferols|mesh-list
111268390|NCT01403051|Cholecalciferol|cholecalciferol|mesh-list
111268391|NCT01403051|Vitamins|vitamins|mesh-list
111268392|NCT01403051|Calcium Carbonate|calcium carbonate|mesh-list
111268393|NCT01403051|Calcium|calcium|mesh-list
111268394|NCT01403051|Micronutrients|micronutrients|mesh-ancestor
111268395|NCT01403051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111268396|NCT01403051|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111268397|NCT01403051|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111268398|NCT01403051|Antacids|antacids|mesh-ancestor
111268399|NCT01403051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111268400|NCT01403051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111268401|NCT03873337|Nicotine|nicotine|mesh-list
111268402|NCT03873337|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111268403|NCT03873337|Autonomic Agents|autonomic agents|mesh-ancestor
111268404|NCT03873337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111268405|NCT03873337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111268406|NCT03873337|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111268407|NCT03873337|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111268408|NCT03873337|Cholinergic Agents|cholinergic agents|mesh-ancestor
111268409|NCT03873337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111268410|NCT03873337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111268411|NCT04115748|Adalimumab|adalimumab|mesh-list
111268412|NCT04115748|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111268413|NCT04115748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111268414|NCT04115748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111268415|NCT04747015|Oxytocin|oxytocin|mesh-list
111268416|NCT04747015|Oxytocics|oxytocics|mesh-ancestor
111268417|NCT04747015|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111268418|NCT04747015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111268419|NCT04747171|Dexmedetomidine|dexmedetomidine|mesh-list
111268420|NCT04747171|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111268421|NCT04747171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111268422|NCT04747171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111268423|NCT04747171|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111268424|NCT04747171|Analgesics|analgesics|mesh-ancestor
111268425|NCT04747171|Sensory System Agents|sensory system agents|mesh-ancestor
111268426|NCT04747171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111268427|NCT04747171|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111268428|NCT04747171|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111268429|NCT04747171|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111268430|NCT04747171|Adrenergic Agents|adrenergic agents|mesh-ancestor
111268431|NCT04747171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111268432|NCT04747171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111268433|NCT02082769|Allopurinol|allopurinol|mesh-list
111268434|NCT02082769|Febuxostat|febuxostat|mesh-list
111268435|NCT02082769|Antimetabolites|antimetabolites|mesh-ancestor
111268436|NCT02082769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111268437|NCT02082769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111268438|NCT02082769|Gout Suppressants|gout suppressants|mesh-ancestor
111268439|NCT02082769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111268440|NCT02082769|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111268441|NCT02082769|Antioxidants|antioxidants|mesh-ancestor
111268442|NCT02082769|Protective Agents|protective agents|mesh-ancestor
111268443|NCT02082769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111268444|NCT03751423|Fentanyl|fentanyl|mesh-list
111268445|NCT03751423|Ketamine|ketamine|mesh-list
111268446|NCT03751423|Morphine|morphine|mesh-list
111268447|NCT03751423|Analgesics|analgesics|mesh-ancestor
110992786|NCT02669264|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
111268448|NCT03751423|Sensory System Agents|sensory system agents|mesh-ancestor
111268449|NCT03751423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111268450|NCT03751423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111268451|NCT03751423|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111268452|NCT03751423|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111268453|NCT03751423|Anesthetics, General|anesthetics, general|mesh-ancestor
111268455|NCT03751423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111268456|NCT03751423|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111268457|NCT03751423|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111268458|NCT03751423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111268459|NCT03751423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111268460|NCT03751423|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111268461|NCT03751423|Narcotics|narcotics|mesh-ancestor
111268462|NCT03751423|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111268463|NCT03745729|Allopurinol|allopurinol|mesh-list
111268464|NCT03745729|Antimetabolites|antimetabolites|mesh-ancestor
111268465|NCT03745729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111268466|NCT03745729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111268467|NCT03745729|Gout Suppressants|gout suppressants|mesh-ancestor
111268468|NCT03745729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111268469|NCT03745729|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111268470|NCT03745729|Antioxidants|antioxidants|mesh-ancestor
111268471|NCT03745729|Protective Agents|protective agents|mesh-ancestor
111268472|NCT03745729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111268473|NCT04904952|Acetylcysteine|acetylcysteine|mesh-list
111268474|NCT04904952|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111268475|NCT04904952|Antiviral Agents|antiviral agents|mesh-ancestor
110978479|NCT01665274|Oxaliplatin|oxaliplatin|mesh-list
111268476|NCT04904952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111268477|NCT04904952|Expectorants|expectorants|mesh-ancestor
111268478|NCT04904952|Respiratory System Agents|respiratory system agents|mesh-ancestor
111268479|NCT04904952|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111268480|NCT04904952|Antioxidants|antioxidants|mesh-ancestor
111268481|NCT04904952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111268482|NCT04904952|Protective Agents|protective agents|mesh-ancestor
111268483|NCT04904952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111268484|NCT04904952|Antidotes|antidotes|mesh-ancestor
111268485|NCT03661411|Aspirin|aspirin|mesh-list
111268486|NCT03661411|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
111268487|NCT03661411|Clopidogrel|clopidogrel|mesh-list
111268488|NCT03661411|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111268489|NCT03661411|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111268490|NCT03661411|Analgesics|analgesics|mesh-ancestor
111268491|NCT03661411|Sensory System Agents|sensory system agents|mesh-ancestor
111268492|NCT03661411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111268493|NCT03661411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111268494|NCT03661411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111268495|NCT03661411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111268496|NCT03661411|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111268497|NCT03661411|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111268498|NCT03661411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111268499|NCT03661411|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111268500|NCT03661411|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111268501|NCT03661411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111268502|NCT03661411|Antipyretics|antipyretics|mesh-ancestor
111268503|NCT03661411|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111268504|NCT03661411|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111268505|NCT03661411|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111268506|NCT03661411|Purinergic Agents|purinergic agents|mesh-ancestor
111268507|NCT03661411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111268508|NCT03742297|Dexamethasone|dexamethasone|mesh-list
111268509|NCT03742297|Prednisone|prednisone|mesh-list
111268510|NCT03742297|Lenalidomide|lenalidomide|mesh-list
111268511|NCT03742297|Bortezomib|bortezomib|mesh-list
111268512|NCT03742297|Melphalan|melphalan|mesh-list
111268513|NCT03742297|Daratumumab|daratumumab|mesh-list
111268514|NCT03742297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111268515|NCT03742297|Antiemetics|antiemetics|mesh-ancestor
111268516|NCT03742297|Autonomic Agents|autonomic agents|mesh-ancestor
111268517|NCT03742297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111268518|NCT03742297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111268519|NCT03742297|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111268520|NCT03742297|Glucocorticoids|glucocorticoids|mesh-ancestor
111268521|NCT03742297|Hormones|hormones|mesh-ancestor
111268522|NCT03742297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111268523|NCT03742297|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111268524|NCT03742297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111268525|NCT03742297|Immunologic Factors|immunologic factors|mesh-ancestor
111268526|NCT03742297|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111268527|NCT03742297|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111268528|NCT03742297|Growth Substances|growth substances|mesh-ancestor
111268529|NCT03742297|Growth Inhibitors|growth inhibitors|mesh-ancestor
111268530|NCT03742297|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111268531|NCT03742297|Alkylating Agents|alkylating agents|mesh-ancestor
111268532|NCT03742297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111268533|NCT03742297|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111268534|NCT03742297|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111268535|NCT01677403|Tobramycin|tobramycin|mesh-list
111268536|NCT01677403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111268537|NCT01677403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111268538|NCT03742141|Glycopyrrolate|glycopyrrolate|mesh-list
111268539|NCT03742141|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111268540|NCT03742141|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111268541|NCT03742141|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111268542|NCT03742141|Cholinergic Agents|cholinergic agents|mesh-ancestor
111268543|NCT03742141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111268544|NCT03742141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111268545|NCT03742141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111268546|NCT03441750|Metformin|metformin|mesh-list
111268547|NCT03441750|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111268548|NCT03441750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111268549|NCT03660553|Insulin|insulin|mesh-list
111268550|NCT03660553|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111268551|NCT03660553|Insulin Glargine|insulin glargine|mesh-list
111268552|NCT03660553|Insulin Aspart|insulin aspart|mesh-list
111268553|NCT03660553|Insulin Lispro|insulin lispro|mesh-list
111268554|NCT03660553|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111268555|NCT03660553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111268556|NCT04527744|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111268557|NCT04527744|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111268558|NCT04527744|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111268559|NCT04527744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111268560|NCT04527744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111268561|NCT04527744|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111268562|NCT04527744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111268563|NCT04527744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111268564|NCT04527744|Cholinergic Agents|cholinergic agents|mesh-ancestor
111268565|NCT04527744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111268566|NCT03825757|Aspirin|aspirin|mesh-list
111268567|NCT03825757|Salicylic Acid|salicylic acid|mesh-list
111268568|NCT03825757|Salicylates|salicylates|mesh-list
111268569|NCT03825757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111268570|NCT03825757|Antifungal Agents|antifungal agents|mesh-ancestor
111268571|NCT03825757|Keratolytic Agents|keratolytic agents|mesh-ancestor
111268572|NCT03825757|Dermatologic Agents|dermatologic agents|mesh-ancestor
111268573|NCT03825757|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111268574|NCT03825757|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111268575|NCT03825757|Analgesics|analgesics|mesh-ancestor
111268576|NCT03825757|Sensory System Agents|sensory system agents|mesh-ancestor
111268577|NCT03825757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111268578|NCT03825757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111268579|NCT03825757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111268580|NCT03825757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111268581|NCT03825757|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111268582|NCT03825757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111268583|NCT03825757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111268584|NCT03825757|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111268585|NCT03825757|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111268586|NCT03825757|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111268587|NCT03825757|Antipyretics|antipyretics|mesh-ancestor
111268588|NCT03657433|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
111268589|NCT03657433|Hematinics|hematinics|mesh-ancestor
111268590|NCT03657433|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
111268591|NCT03657433|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111268592|NCT04827030|Ropivacaine|ropivacaine|mesh-list
111268593|NCT04827030|Anesthetics, Local|anesthetics, local|mesh-ancestor
111268594|NCT04827030|Anesthetics|anesthetics|mesh-ancestor
111268595|NCT04827030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111268596|NCT04827030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111268597|NCT04827030|Sensory System Agents|sensory system agents|mesh-ancestor
111268598|NCT04827030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111268599|NCT03651895|Metformin|metformin|mesh-list
111268600|NCT03651895|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111268601|NCT03651895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111268602|NCT02398656|Tenecteplase|tenecteplase|mesh-list
111268603|NCT02398656|Clopidogrel|clopidogrel|mesh-list
111268604|NCT02398656|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111268605|NCT02398656|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111268606|NCT02398656|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111268607|NCT02398656|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111268608|NCT02398656|Purinergic Agents|purinergic agents|mesh-ancestor
111268609|NCT02398656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111268610|NCT02398656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111268611|NCT02398656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111268612|NCT02398656|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111268613|NCT02398656|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111268614|NCT03807037|Tocotrienols|tocotrienols|mesh-list
111268615|NCT03807037|Vitamin E|vitamin e|mesh-list
111268616|NCT03807037|Tocopherols|tocopherols|mesh-list
111268617|NCT03807037|Tocovid|tocovid|mesh-list
111268618|NCT03807037|Antioxidants|antioxidants|mesh-ancestor
111268619|NCT03807037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111268620|NCT03807037|Protective Agents|protective agents|mesh-ancestor
111268621|NCT03807037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111268622|NCT03807037|Vitamins|vitamins|mesh-ancestor
111268623|NCT03807037|Micronutrients|micronutrients|mesh-ancestor
111268624|NCT03805399|Sirolimus|sirolimus|mesh-list
111268625|NCT03805399|Paclitaxel|paclitaxel|mesh-list
111268626|NCT03805399|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111268627|NCT03805399|Capecitabine|capecitabine|mesh-list
111268628|NCT03805399|Everolimus|everolimus|mesh-list
111268629|NCT03805399|Apatinib|apatinib|mesh-list
111268630|NCT03805399|Temsirolimus|temsirolimus|mesh-list
111268631|NCT03805399|MTOR Inhibitors|mtor inhibitors|mesh-list
111268632|NCT03805399|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
111268633|NCT03805399|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111268634|NCT03805399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111268635|NCT03805399|Tubulin Modulators|tubulin modulators|mesh-ancestor
111268636|NCT03805399|Antimitotic Agents|antimitotic agents|mesh-ancestor
111268637|NCT03805399|Mitosis Modulators|mitosis modulators|mesh-ancestor
111268638|NCT03805399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111268639|NCT03805399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111268640|NCT03805399|Antimetabolites|antimetabolites|mesh-ancestor
111268641|NCT03805399|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111268642|NCT03805399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111268643|NCT03805399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111268644|NCT03805399|Immunologic Factors|immunologic factors|mesh-ancestor
111268645|NCT03805399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111268646|NCT03805399|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111268647|NCT03805399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111268648|NCT03805399|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111268649|NCT03805399|Antifungal Agents|antifungal agents|mesh-ancestor
111268650|NCT02652624|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
111268651|NCT02652624|Antiviral Agents|antiviral agents|mesh-ancestor
111268652|NCT02652624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111268653|NCT02652624|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111268654|NCT02652624|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111268655|NCT03637075|Insulin|insulin|mesh-list
111268656|NCT03637075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111268657|NCT03637075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111268658|NCT04403503|Thrombin|thrombin|mesh-list
111268659|NCT04403503|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
111268660|NCT04403503|Hemostatics|hemostatics|mesh-ancestor
111268661|NCT04403503|Coagulants|coagulants|mesh-ancestor
111268662|NCT00249795|Irbesartan|irbesartan|mesh-list
111268663|NCT00249795|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111268664|NCT00249795|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111268665|NCT00249795|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111268666|NCT00249795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111268667|NCT04404127|Basiliximab|basiliximab|mesh-list
111268668|NCT04404127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111268669|NCT04404127|Immunologic Factors|immunologic factors|mesh-ancestor
111268670|NCT04404127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111268671|NCT02651220|Adapalene|adapalene|mesh-list
111268672|NCT02651220|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
111268673|NCT02651220|Benzoyl Peroxide|benzoyl peroxide|mesh-list
111268674|NCT02651220|Dermatologic Agents|dermatologic agents|mesh-ancestor
111268675|NCT02651220|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111268676|NCT02651220|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111268677|NCT02651220|Analgesics|analgesics|mesh-ancestor
111268678|NCT02651220|Sensory System Agents|sensory system agents|mesh-ancestor
111268679|NCT02651220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111268680|NCT02651220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111268681|NCT02651220|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111268682|NCT02651220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111268684|NCT01279551|Nitroglycerin|nitroglycerin|mesh-list
111268685|NCT01279551|Anesthetics, Local|anesthetics, local|mesh-ancestor
111268686|NCT01279551|Anesthetics|anesthetics|mesh-ancestor
111268687|NCT01279551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111268688|NCT01279551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111268689|NCT01279551|Sensory System Agents|sensory system agents|mesh-ancestor
111268690|NCT01279551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111268691|NCT01279551|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111268692|NCT01279551|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111268693|NCT01279551|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111268694|NCT01279551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111268695|NCT01279551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111268696|NCT01279551|Vasodilator Agents|vasodilator agents|mesh-ancestor
111268697|NCT03738696|Bupivacaine|bupivacaine|mesh-list
111268698|NCT03738696|Ropivacaine|ropivacaine|mesh-list
111268699|NCT03738696|Anesthetics, Local|anesthetics, local|mesh-ancestor
111268700|NCT03738696|Anesthetics|anesthetics|mesh-ancestor
111268701|NCT03738696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111268702|NCT03738696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111268703|NCT03738696|Sensory System Agents|sensory system agents|mesh-ancestor
111268704|NCT03738696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111268705|NCT00780403|Cetirizine|cetirizine|mesh-list
111268706|NCT00780403|Desloratadine|desloratadine|mesh-list
111268707|NCT00780403|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111268708|NCT00780403|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
111268709|NCT00780403|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111268710|NCT00780403|Histamine Antagonists|histamine antagonists|mesh-ancestor
111268711|NCT00780403|Histamine Agents|histamine agents|mesh-ancestor
111268712|NCT00780403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111268713|NCT00780403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111268714|NCT00780403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111268715|NCT00780403|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111268716|NCT00780403|Cholinergic Agents|cholinergic agents|mesh-ancestor
111268717|NCT03704610|Infliximab|infliximab|mesh-list
111268718|NCT03704610|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111268719|NCT03704610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111268720|NCT03704610|Dermatologic Agents|dermatologic agents|mesh-ancestor
111268721|NCT03704610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111268722|NCT03704610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111268723|NCT01979796|Nicotine|nicotine|mesh-list
111268724|NCT01979796|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111268725|NCT01979796|Autonomic Agents|autonomic agents|mesh-ancestor
111268726|NCT01979796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111268727|NCT01979796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111268728|NCT01979796|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111268729|NCT01979796|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111268730|NCT01979796|Cholinergic Agents|cholinergic agents|mesh-ancestor
111268731|NCT01979796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111268732|NCT01979796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111268733|NCT03628339|Tepotinib|tepotinib|mesh-list
111268734|NCT03628339|Midazolam|midazolam|mesh-list
111268735|NCT03628339|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111268736|NCT03628339|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111268737|NCT03628339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111268738|NCT03628339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111268739|NCT03628339|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111268740|NCT03628339|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111268741|NCT03628339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111268742|NCT03628339|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111268743|NCT03628339|Anesthetics, General|anesthetics, general|mesh-ancestor
111268744|NCT03628339|Anesthetics|anesthetics|mesh-ancestor
111268745|NCT03628339|GABA Modulators|gaba modulators|mesh-ancestor
111268746|NCT03628339|GABA Agents|gaba agents|mesh-ancestor
111268747|NCT03628339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111268748|NCT03628339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111268749|NCT03628339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111268750|NCT04412694|Dexamethasone|dexamethasone|mesh-list
111268751|NCT04412694|Dexamethasone acetate|dexamethasone acetate|mesh-list
111268752|NCT04412694|BB 1101|bb 1101|mesh-list
111268753|NCT04412694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111268754|NCT04412694|Antiemetics|antiemetics|mesh-ancestor
111268755|NCT04412694|Autonomic Agents|autonomic agents|mesh-ancestor
111268756|NCT04412694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111268757|NCT04412694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111268758|NCT04412694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111268759|NCT04412694|Glucocorticoids|glucocorticoids|mesh-ancestor
111268760|NCT04412694|Hormones|hormones|mesh-ancestor
111268761|NCT04412694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111268762|NCT04412694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111268763|NCT04412694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111268764|NCT04412694|Protease Inhibitors|protease inhibitors|mesh-ancestor
111268765|NCT04412694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111268766|NCT04412694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111268767|NCT03627715|Propagermanium|propagermanium|mesh-list
111268768|NCT03627715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111268769|NCT03627715|Interferon Inducers|interferon inducers|mesh-ancestor
111268770|NCT03627715|Immunologic Factors|immunologic factors|mesh-ancestor
111268771|NCT03627715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111268772|NCT00246753|Lapatinib|lapatinib|mesh-list
111268773|NCT00246753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111268774|NCT00246753|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111268775|NCT00246753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111268776|NCT00246753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111268777|NCT02083861|Oxymetazoline|oxymetazoline|mesh-list
111268778|NCT02083861|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111268779|NCT02083861|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111268780|NCT02083861|Adrenergic Agents|adrenergic agents|mesh-ancestor
111268781|NCT02083861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111268782|NCT02083861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111268783|NCT02083861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111268784|NCT02083861|Sympathomimetics|sympathomimetics|mesh-ancestor
111268785|NCT02083861|Autonomic Agents|autonomic agents|mesh-ancestor
111268786|NCT02083861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111268787|NCT02083861|Nasal Decongestants|nasal decongestants|mesh-ancestor
111268788|NCT02083861|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111268789|NCT02083861|Respiratory System Agents|respiratory system agents|mesh-ancestor
111268790|NCT00246129|Alemtuzumab|alemtuzumab|mesh-list
111268791|NCT00246129|Daclizumab|daclizumab|mesh-list
111268792|NCT00246129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111268793|NCT00246129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111268794|NCT00246129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111268795|NCT00246129|Immunologic Factors|immunologic factors|mesh-ancestor
111268796|NCT00246129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111268797|NCT01274247|Benzocaine|benzocaine|mesh-list
111268798|NCT01274247|Anesthetics, Local|anesthetics, local|mesh-ancestor
111268799|NCT01274247|Anesthetics|anesthetics|mesh-ancestor
111268800|NCT01274247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111268801|NCT01274247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111268802|NCT01274247|Sensory System Agents|sensory system agents|mesh-ancestor
111268803|NCT01274247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111268804|NCT03783715|Ketoprofen|ketoprofen|mesh-list
111268805|NCT03783715|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111268806|NCT03783715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111268807|NCT03783715|Analgesics|analgesics|mesh-ancestor
111268808|NCT03783715|Sensory System Agents|sensory system agents|mesh-ancestor
111268809|NCT03783715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111268810|NCT03783715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111268811|NCT03783715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111268812|NCT03783715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111268813|NCT03783715|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111268814|NCT03783715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111268815|NCT03783715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111268816|NCT01279629|Tazarotene|tazarotene|mesh-list
111268817|NCT01279629|Calcipotriene|calcipotriene|mesh-list
111268818|NCT01279629|Dermatologic Agents|dermatologic agents|mesh-ancestor
111268819|NCT01279629|Keratolytic Agents|keratolytic agents|mesh-ancestor
111268820|NCT01274325|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
111268821|NCT01274325|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111268822|NCT01274325|Autonomic Agents|autonomic agents|mesh-ancestor
111268823|NCT01274325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111268824|NCT01274325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111268825|NCT01274325|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111268826|NCT01274325|Respiratory System Agents|respiratory system agents|mesh-ancestor
111268827|NCT01274325|Glucocorticoids|glucocorticoids|mesh-ancestor
111268828|NCT01274325|Hormones|hormones|mesh-ancestor
111268829|NCT01274325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111268830|NCT01274325|Sympathomimetics|sympathomimetics|mesh-ancestor
111268831|NCT04502394|Acalabrutinib|acalabrutinib|mesh-list
111268832|NCT04502394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111268833|NCT01274403|Thalidomide|thalidomide|mesh-list
111268835|NCT01274403|Melphalan|melphalan|mesh-list
111268836|NCT01274403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111268837|NCT01274403|Glucocorticoids|glucocorticoids|mesh-ancestor
111268838|NCT01274403|Hormones|hormones|mesh-ancestor
111268839|NCT01274403|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111268840|NCT01274403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111268841|NCT01274403|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111268842|NCT01274403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111268843|NCT01274403|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111268844|NCT01274403|Alkylating Agents|alkylating agents|mesh-ancestor
111268845|NCT01274403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111268846|NCT01274403|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111268847|NCT01274403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111268848|NCT01274403|Immunologic Factors|immunologic factors|mesh-ancestor
111268849|NCT01274403|Leprostatic Agents|leprostatic agents|mesh-ancestor
111268850|NCT01274403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111268851|NCT01274403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111268852|NCT01274403|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111268853|NCT01274403|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111268854|NCT01274403|Growth Substances|growth substances|mesh-ancestor
111268855|NCT01274403|Growth Inhibitors|growth inhibitors|mesh-ancestor
111268856|NCT03700099|Docetaxel|docetaxel|mesh-list
111268857|NCT03700099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111268858|NCT03700099|Tubulin Modulators|tubulin modulators|mesh-ancestor
111268859|NCT03700099|Antimitotic Agents|antimitotic agents|mesh-ancestor
111268860|NCT03700099|Mitosis Modulators|mitosis modulators|mesh-ancestor
111268861|NCT03700099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111268862|NCT01274481|Iloprost|iloprost|mesh-list
111268863|NCT01274481|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111268864|NCT01274481|Vasodilator Agents|vasodilator agents|mesh-ancestor
111268865|NCT00245583|Topiramate|topiramate|mesh-list
111268866|NCT00245583|Anticonvulsants|anticonvulsants|mesh-ancestor
111268867|NCT00245583|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111268868|NCT00245583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111268869|NCT01379989|Carboplatin|carboplatin|mesh-list
111268870|NCT01379989|Doxorubicin|doxorubicin|mesh-list
111268871|NCT01379989|Trabectedin|trabectedin|mesh-list
111268872|NCT01379989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111268873|NCT01379989|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111268874|NCT01379989|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111268875|NCT01379989|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111268876|NCT01379989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111268877|NCT01379989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111268878|NCT01379989|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111268879|NCT01379989|Alkylating Agents|alkylating agents|mesh-ancestor
111268880|NCT02652156|Bupivacaine|bupivacaine|mesh-list
111268881|NCT02652156|Ropivacaine|ropivacaine|mesh-list
111268882|NCT02652156|Anesthetics, Local|anesthetics, local|mesh-ancestor
111268883|NCT02652156|Anesthetics|anesthetics|mesh-ancestor
111268884|NCT02652156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111268885|NCT02652156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111268886|NCT02652156|Sensory System Agents|sensory system agents|mesh-ancestor
111268887|NCT02652156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111268888|NCT03699865|Nicotine|nicotine|mesh-list
111268889|NCT03699865|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111268890|NCT03699865|Autonomic Agents|autonomic agents|mesh-ancestor
111268891|NCT03699865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111268892|NCT03699865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111268893|NCT03699865|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111268894|NCT03699865|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111268895|NCT03699865|Cholinergic Agents|cholinergic agents|mesh-ancestor
111268896|NCT03699865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111268897|NCT03699865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111268898|NCT00754923|Sorafenib|sorafenib|mesh-list
111268899|NCT00754923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111268900|NCT00754923|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111268901|NCT00754923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111268902|NCT00754923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111268903|NCT00746421|Quetiapine Fumarate|quetiapine fumarate|mesh-list
111268904|NCT00746421|Antidepressive Agents|antidepressive agents|mesh-ancestor
111268905|NCT00746421|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111268906|NCT00746421|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111268907|NCT00746421|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110993237|NCT02380352|Amoxicillin|amoxicillin|mesh-list
111268908|NCT00746421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111268909|NCT00746421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111268911|NCT02117076|Analgesics|analgesics|mesh-ancestor
111268912|NCT02117076|Sensory System Agents|sensory system agents|mesh-ancestor
111268913|NCT02117076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111268914|NCT02117076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111268915|NCT02117076|Anticonvulsants|anticonvulsants|mesh-ancestor
111268916|NCT02117076|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111268917|NCT02117076|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111268918|NCT02117076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111268919|NCT02117076|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111268920|NCT02117076|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111268921|NCT02117076|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111268922|NCT02117076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111268923|NCT02117076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111268924|NCT02117076|Antimanic Agents|antimanic agents|mesh-ancestor
111268925|NCT01274793|Mosapride|mosapride|mesh-list
111268926|NCT01274793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111268927|NCT01274793|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111268928|NCT01274793|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111268929|NCT01274793|Serotonin Agents|serotonin agents|mesh-ancestor
111268930|NCT01274793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111268931|NCT01274793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111268932|NCT00746889|Triamcinolone|triamcinolone|mesh-list
111268933|NCT00746889|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
111268934|NCT00746889|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
111268935|NCT00746889|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
111268936|NCT00746889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111268937|NCT00746889|Glucocorticoids|glucocorticoids|mesh-ancestor
111268938|NCT00746889|Hormones|hormones|mesh-ancestor
111268939|NCT00746889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111268940|NCT00746889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111268941|NCT00746889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111268942|NCT00746889|Immunologic Factors|immunologic factors|mesh-ancestor
111268943|NCT00746889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111268944|NCT00746889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111268945|NCT01675050|Cyproheptadine|cyproheptadine|mesh-list
111268946|NCT01675050|Antipruritics|antipruritics|mesh-ancestor
111268947|NCT01675050|Dermatologic Agents|dermatologic agents|mesh-ancestor
111268948|NCT01675050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111268949|NCT01675050|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111268950|NCT01675050|Histamine Antagonists|histamine antagonists|mesh-ancestor
111268951|NCT01675050|Histamine Agents|histamine agents|mesh-ancestor
111268952|NCT01675050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111268953|NCT01675050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111268954|NCT01675050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111268955|NCT01675050|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111268956|NCT01675050|Serotonin Agents|serotonin agents|mesh-ancestor
111268957|NCT01675050|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111268958|NCT00756093|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111268959|NCT00756093|Lubricant Eye Drops|lubricant eye drops|mesh-list
111268960|NCT00756093|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111268961|NCT00816582|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
111268962|NCT00816582|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111268963|NCT00816582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111268964|NCT03771313|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
111268965|NCT03771313|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111268966|NCT03771313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111268967|NCT03600649|Cyclophosphamide|cyclophosphamide|mesh-list
111268968|NCT03600649|Topotecan|topotecan|mesh-list
111268969|NCT03600649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111268970|NCT03600649|Immunologic Factors|immunologic factors|mesh-ancestor
111268971|NCT03600649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111268972|NCT03600649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111268973|NCT03600649|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111268974|NCT03600649|Alkylating Agents|alkylating agents|mesh-ancestor
111268975|NCT03600649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111268976|NCT03600649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111268977|NCT03600649|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111268978|NCT03600649|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111268979|NCT03600649|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111268980|NCT03600649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111268981|NCT00244881|Cediranib|cediranib|mesh-list
111268982|NCT00244881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111268983|NCT00244881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111268984|NCT00244881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111268985|NCT00244881|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111268986|NCT00530517|Sumatriptan|sumatriptan|mesh-list
111268987|NCT00530517|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111268988|NCT00530517|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111268989|NCT00530517|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111268990|NCT00530517|Serotonin Agents|serotonin agents|mesh-ancestor
111268991|NCT00530517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111268992|NCT00530517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111268993|NCT00530517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111268994|NCT05123976|Olanzapine|olanzapine|mesh-list
110978489|NCT04560166|Irinotecan|irinotecan|mesh-list
111268995|NCT05123976|Antiemetics|antiemetics|mesh-ancestor
111268996|NCT05123976|Autonomic Agents|autonomic agents|mesh-ancestor
111268997|NCT05123976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111268998|NCT05123976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111268999|NCT05123976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111269000|NCT05123976|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111269001|NCT05123976|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111269002|NCT05123976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111269003|NCT05123976|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111269004|NCT05123976|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111269005|NCT05123976|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111269006|NCT05123976|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111269007|NCT05123976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111269008|NCT05123976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111269009|NCT05123976|Serotonin Agents|serotonin agents|mesh-ancestor
111269010|NCT00005803|Cytarabine|cytarabine|mesh-list
111269011|NCT00005803|Cyclosporine|cyclosporine|mesh-list
111269012|NCT00005803|Mycophenolic Acid|mycophenolic acid|mesh-list
111269013|NCT00005803|Cyclophosphamide|cyclophosphamide|mesh-list
111269014|NCT00005803|Melphalan|melphalan|mesh-list
111269015|NCT00005803|Mechlorethamine|mechlorethamine|mesh-list
111269016|NCT00005803|Carmustine|carmustine|mesh-list
111269017|NCT00005803|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
111269018|NCT00005803|Fludarabine|fludarabine|mesh-list
111269019|NCT00005803|Fludarabine phosphate|fludarabine phosphate|mesh-list
111269020|NCT00005803|Etoposide|etoposide|mesh-list
111269021|NCT00005803|Etoposide phosphate|etoposide phosphate|mesh-list
111269022|NCT00005803|Podophyllotoxin|podophyllotoxin|mesh-list
111269023|NCT00005803|Cyclosporins|cyclosporins|mesh-list
111269024|NCT00005803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111269025|NCT00005803|Immunologic Factors|immunologic factors|mesh-ancestor
111269026|NCT00005803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111269027|NCT00005803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111269028|NCT00005803|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111269029|NCT00005803|Alkylating Agents|alkylating agents|mesh-ancestor
111269030|NCT00005803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111269031|NCT00005803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111269032|NCT00005803|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111269033|NCT00005803|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111269034|NCT00005803|Antimetabolites|antimetabolites|mesh-ancestor
111269035|NCT00005803|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111269036|NCT00005803|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111269037|NCT00005803|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111269038|NCT00005803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111269039|NCT00005803|Antiviral Agents|antiviral agents|mesh-ancestor
111269040|NCT00005803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111269041|NCT00005803|Antifungal Agents|antifungal agents|mesh-ancestor
111269042|NCT00005803|Dermatologic Agents|dermatologic agents|mesh-ancestor
111269043|NCT00005803|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111269044|NCT00005803|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111269045|NCT00005803|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111269046|NCT00005803|Antitubercular Agents|antitubercular agents|mesh-ancestor
111269047|NCT00005803|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111269048|NCT00005803|Keratolytic Agents|keratolytic agents|mesh-ancestor
111269049|NCT00005803|Tubulin Modulators|tubulin modulators|mesh-ancestor
111269050|NCT00005803|Antimitotic Agents|antimitotic agents|mesh-ancestor
111269051|NCT00005803|Mitosis Modulators|mitosis modulators|mesh-ancestor
111269052|NCT00244725|Warfarin|warfarin|mesh-list
111269053|NCT00244725|Anticoagulants|anticoagulants|mesh-ancestor
111269054|NCT02649894|Silver Nitrate|silver nitrate|mesh-list
111269055|NCT02649894|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111269056|NCT02649894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111269057|NCT04185012|Benralizumab|benralizumab|mesh-list
111269058|NCT04185012|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111269059|NCT04185012|Respiratory System Agents|respiratory system agents|mesh-ancestor
111269060|NCT01275183|Raltegravir Potassium|raltegravir potassium|mesh-list
111269062|NCT01275183|Docetaxel|docetaxel|mesh-list
111269063|NCT01275183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111269064|NCT01275183|Tubulin Modulators|tubulin modulators|mesh-ancestor
111269065|NCT01275183|Antimitotic Agents|antimitotic agents|mesh-ancestor
111269066|NCT01275183|Mitosis Modulators|mitosis modulators|mesh-ancestor
111269067|NCT01275183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111269068|NCT01275183|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111269069|NCT01275183|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111269070|NCT01275183|Antiviral Agents|antiviral agents|mesh-ancestor
111269071|NCT01275183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111269072|NCT01275183|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111269073|NCT01275183|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111269074|NCT01275183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111269075|NCT05126004|Acetylcysteine|acetylcysteine|mesh-list
111269076|NCT05126004|Azacitidine|azacitidine|mesh-list
111269077|NCT05126004|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111269078|NCT05126004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111269079|NCT05126004|Antimetabolites|antimetabolites|mesh-ancestor
111269080|NCT05126004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111269081|NCT05126004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111269082|NCT05126004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111269083|NCT05126004|Antiviral Agents|antiviral agents|mesh-ancestor
111269084|NCT05126004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111269085|NCT05126004|Expectorants|expectorants|mesh-ancestor
111269086|NCT05126004|Respiratory System Agents|respiratory system agents|mesh-ancestor
111269087|NCT05126004|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111269088|NCT05126004|Antioxidants|antioxidants|mesh-ancestor
111269089|NCT05126004|Protective Agents|protective agents|mesh-ancestor
111269090|NCT05126004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111269091|NCT05126004|Antidotes|antidotes|mesh-ancestor
111269092|NCT03672643|Crizotinib|crizotinib|mesh-list
111269093|NCT03672643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111269094|NCT03672643|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111269095|NCT03672643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111269096|NCT03672643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111269097|NCT00350701|Methyltestosterone|methyltestosterone|mesh-list
111269098|NCT00350701|Testosterone|testosterone|mesh-list
111269099|NCT00350701|Testosterone undecanoate|testosterone undecanoate|mesh-list
111269100|NCT00350701|Testosterone enanthate|testosterone enanthate|mesh-list
111269101|NCT00350701|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
111269102|NCT00350701|Androgens|androgens|mesh-ancestor
111269103|NCT00350701|Hormones|hormones|mesh-ancestor
111269104|NCT00350701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111269105|NCT00350701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111269106|NCT00350701|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111269107|NCT00350701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111269108|NCT00350701|Anabolic Agents|anabolic agents|mesh-ancestor
111269109|NCT04277247|Botulinum Toxins|botulinum toxins|mesh-list
111269110|NCT04277247|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111269111|NCT04277247|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111269112|NCT04277247|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111269113|NCT04277247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111269114|NCT04277247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111269115|NCT04277247|Cholinergic Agents|cholinergic agents|mesh-ancestor
111269116|NCT04277247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111269117|NCT04277247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111269118|NCT04277247|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111269119|NCT04277247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111269120|NCT01505114|Tenofovir|tenofovir|mesh-list
111269121|NCT01505114|Emtricitabine|emtricitabine|mesh-list
111269122|NCT01505114|Maraviroc|maraviroc|mesh-list
111269123|NCT01505114|Antiviral Agents|antiviral agents|mesh-ancestor
111269124|NCT01505114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111269125|NCT01505114|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111269126|NCT01505114|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111269127|NCT01505114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111269128|NCT01505114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111269129|NCT01505114|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111269130|NCT01505114|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111269131|NCT01505114|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
111269132|NCT01505114|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
111269133|NCT01505114|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
111269134|NCT04761757|Antidepressive Agents|antidepressive agents|mesh-list
111269135|NCT04761757|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111269136|NCT04187898|Cyclophosphamide|cyclophosphamide|mesh-list
111269137|NCT04187898|Docetaxel|docetaxel|mesh-list
111269138|NCT04187898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111269139|NCT04187898|Immunologic Factors|immunologic factors|mesh-ancestor
111269140|NCT04187898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111269141|NCT04187898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111269142|NCT04187898|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111269143|NCT04187898|Alkylating Agents|alkylating agents|mesh-ancestor
111269144|NCT04187898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111269145|NCT04187898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111269146|NCT04187898|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111269147|NCT04187898|Tubulin Modulators|tubulin modulators|mesh-ancestor
111269148|NCT04187898|Antimitotic Agents|antimitotic agents|mesh-ancestor
111269149|NCT04187898|Mitosis Modulators|mitosis modulators|mesh-ancestor
111269150|NCT00243867|Paclitaxel|paclitaxel|mesh-list
111269151|NCT00243867|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111269152|NCT00243867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111269153|NCT00243867|Tubulin Modulators|tubulin modulators|mesh-ancestor
111269154|NCT00243867|Antimitotic Agents|antimitotic agents|mesh-ancestor
111269155|NCT00243867|Mitosis Modulators|mitosis modulators|mesh-ancestor
111269156|NCT00243867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111269157|NCT01679899|Vildagliptin|vildagliptin|mesh-list
111269158|NCT01679899|Gliclazide|gliclazide|mesh-list
111269159|NCT01679899|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111269160|NCT01679899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111269161|NCT01679899|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111269162|NCT01679899|Protease Inhibitors|protease inhibitors|mesh-ancestor
111269163|NCT01679899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111269164|NCT01679899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111269165|NCT01276821|Epinephrine|epinephrine|mesh-list
111269166|NCT01276821|Racepinephrine|racepinephrine|mesh-list
111269167|NCT01276821|Epinephryl borate|epinephryl borate|mesh-list
111269168|NCT01276821|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111269169|NCT01276821|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111269170|NCT01276821|Adrenergic Agents|adrenergic agents|mesh-ancestor
111269171|NCT01276821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111269172|NCT01276821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111269173|NCT01276821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111269174|NCT01276821|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111269175|NCT01276821|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111269176|NCT01276821|Autonomic Agents|autonomic agents|mesh-ancestor
111269177|NCT01276821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111269178|NCT01276821|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111269179|NCT01276821|Respiratory System Agents|respiratory system agents|mesh-ancestor
111269180|NCT01276821|Mydriatics|mydriatics|mesh-ancestor
111269181|NCT01276821|Sympathomimetics|sympathomimetics|mesh-ancestor
111269182|NCT01276821|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111269183|NCT00245037|Cyclosporine|cyclosporine|mesh-list
111269184|NCT00245037|Mycophenolic Acid|mycophenolic acid|mesh-list
111269185|NCT00245037|Methotrexate|methotrexate|mesh-list
111269186|NCT00245037|Fludarabine phosphate|fludarabine phosphate|mesh-list
111269187|NCT00245037|Fludarabine|fludarabine|mesh-list
111269188|NCT00245037|Busulfan|busulfan|mesh-list
111269189|NCT00245037|Phenytoin|phenytoin|mesh-list
111269190|NCT00245037|Cyclosporins|cyclosporins|mesh-list
111269191|NCT00245037|Lenograstim|lenograstim|mesh-list
111269192|NCT00245037|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111269193|NCT00245037|Abortifacient Agents|abortifacient agents|mesh-ancestor
111269194|NCT00245037|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111269195|NCT00245037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111269196|NCT00245037|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111269197|NCT00245037|Antimetabolites|antimetabolites|mesh-ancestor
111269198|NCT00245037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111269199|NCT00245037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111269200|NCT00245037|Dermatologic Agents|dermatologic agents|mesh-ancestor
111269201|NCT00245037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111269202|NCT00245037|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111269203|NCT00245037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111269204|NCT00245037|Immunologic Factors|immunologic factors|mesh-ancestor
111269205|NCT00245037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111269206|NCT00245037|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111269207|NCT00245037|Antifungal Agents|antifungal agents|mesh-ancestor
111269208|NCT00245037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110993547|NCT02368730|Hemostatics|hemostatics|mesh-ancestor
111269209|NCT00245037|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111269210|NCT00245037|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111269211|NCT00245037|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111269212|NCT00245037|Antitubercular Agents|antitubercular agents|mesh-ancestor
111269213|NCT00245037|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111269214|NCT00245037|Alkylating Agents|alkylating agents|mesh-ancestor
111269215|NCT00245037|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111269216|NCT00245037|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111269217|NCT00245037|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111269218|NCT00245037|Anticonvulsants|anticonvulsants|mesh-ancestor
111269219|NCT00245037|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111269220|NCT00245037|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110978492|NCT04560166|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111269221|NCT00245037|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111269222|NCT00245037|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
111269223|NCT00245037|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111269224|NCT00241839|Allopurinol|allopurinol|mesh-list
111269225|NCT00241839|Chlorthalidone|chlorthalidone|mesh-list
111269226|NCT00241839|Antimetabolites|antimetabolites|mesh-ancestor
111269227|NCT00241839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111269228|NCT00241839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111269229|NCT00241839|Gout Suppressants|gout suppressants|mesh-ancestor
111269230|NCT00241839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111269231|NCT00241839|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111269232|NCT00241839|Antioxidants|antioxidants|mesh-ancestor
111269233|NCT00241839|Protective Agents|protective agents|mesh-ancestor
111269234|NCT00241839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111269235|NCT00241839|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111269236|NCT00241839|Diuretics|diuretics|mesh-ancestor
111269237|NCT00241839|Natriuretic Agents|natriuretic agents|mesh-ancestor
111269238|NCT00241839|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
111269239|NCT00241839|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111269240|NCT05347381|Dexamethasone|dexamethasone|mesh-list
111269241|NCT05347381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111269242|NCT05347381|Antiemetics|antiemetics|mesh-ancestor
111269243|NCT05347381|Autonomic Agents|autonomic agents|mesh-ancestor
111269244|NCT05347381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111269245|NCT05347381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111269246|NCT05347381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111269247|NCT05347381|Glucocorticoids|glucocorticoids|mesh-ancestor
111269248|NCT05347381|Hormones|hormones|mesh-ancestor
111269249|NCT05347381|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111269250|NCT05347381|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111269251|NCT05347381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111269252|NCT02651688|Enclomiphene|enclomiphene|mesh-list
111269253|NCT02651688|Clomiphene|clomiphene|mesh-list
111269254|NCT02651688|Zuclomiphene|zuclomiphene|mesh-list
111269255|NCT02651688|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111269256|NCT02651688|Hormone Antagonists|hormone antagonists|mesh-ancestor
111269257|NCT02651688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111269258|NCT02651688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111269259|NCT02651688|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111269260|NCT02651688|Fertility Agents|fertility agents|mesh-ancestor
111269261|NCT02651688|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111269262|NCT02651688|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111269263|NCT02651688|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111269264|NCT01276353|Donepezil|donepezil|mesh-list
111269265|NCT01276353|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111269266|NCT01276353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111269267|NCT01276353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111269268|NCT01276353|Cholinergic Agents|cholinergic agents|mesh-ancestor
111269269|NCT01276353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111269270|NCT01276353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111269271|NCT01276353|Nootropic Agents|nootropic agents|mesh-ancestor
111269272|NCT03809013|Trastuzumab|trastuzumab|mesh-list
111269273|NCT03809013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111269274|NCT03809013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111269275|NCT03807921|Aspirin|aspirin|mesh-list
111269276|NCT03807921|Warfarin|warfarin|mesh-list
111269277|NCT03807921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111269278|NCT03807921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111269279|NCT03807921|Analgesics|analgesics|mesh-ancestor
111269280|NCT03807921|Sensory System Agents|sensory system agents|mesh-ancestor
111269281|NCT03807921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111269282|NCT03807921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111269283|NCT03807921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110993613|NCT02920177|Glucocorticoids|glucocorticoids|mesh-ancestor
111269284|NCT03807921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111269285|NCT03807921|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111269286|NCT03807921|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111269287|NCT03807921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111269288|NCT03807921|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111269289|NCT03807921|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111269290|NCT03807921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111269291|NCT03807921|Antipyretics|antipyretics|mesh-ancestor
111269292|NCT03807921|Anticoagulants|anticoagulants|mesh-ancestor
111269293|NCT01675609|Brimonidine Tartrate|brimonidine tartrate|mesh-list
111269294|NCT01675609|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111269295|NCT01675609|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111269296|NCT01675609|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111269297|NCT01675609|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111269298|NCT01675609|Adrenergic Agents|adrenergic agents|mesh-ancestor
111269299|NCT01675609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111269300|NCT01675609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111269301|NCT01675609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111269302|NCT01673659|Mometasone Furoate|mometasone furoate|mesh-list
111269303|NCT01673659|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111269304|NCT01673659|Dermatologic Agents|dermatologic agents|mesh-ancestor
111269305|NCT01673659|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111269306|NCT00762177|Triclosan|triclosan|mesh-list
111269307|NCT00762177|Fluorides|fluorides|mesh-list
111269308|NCT00762177|Tin Fluorides|tin fluorides|mesh-list
111269309|NCT00762177|Cariostatic Agents|cariostatic agents|mesh-ancestor
111269310|NCT00762177|Protective Agents|protective agents|mesh-ancestor
111269311|NCT00762177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111269312|NCT00762177|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111269313|NCT00762177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111269314|NCT00762177|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
111269315|NCT00762177|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111269316|NCT00762177|Antimetabolites|antimetabolites|mesh-ancestor
111269317|NCT00762177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111269318|NCT00762177|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111269319|NCT03458455|Pembrolizumab|pembrolizumab|mesh-list
111269320|NCT03458455|Nivolumab|nivolumab|mesh-list
111269321|NCT03458455|Ipilimumab|ipilimumab|mesh-list
111269322|NCT03458455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111269323|NCT03458455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111269324|NCT03458455|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111269325|NCT03458455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111269326|NCT02536794|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111269327|NCT02536794|Durvalumab|durvalumab|mesh-list
111269328|NCT02536794|Ipilimumab|ipilimumab|mesh-list
111269329|NCT02536794|Tremelimumab|tremelimumab|mesh-list
111269330|NCT02536794|Antibodies|antibodies|mesh-list
111269331|NCT02536794|Immunoglobulins|immunoglobulins|mesh-list
111269332|NCT02536794|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111269333|NCT02536794|Immunologic Factors|immunologic factors|mesh-ancestor
111269334|NCT02536794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111269335|NCT02536794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111269336|NCT02536794|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111269337|NCT02536794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111269338|NCT00777855|Rifampin|rifampin|mesh-list
111269339|NCT00777855|Warfarin|warfarin|mesh-list
111269340|NCT00777855|Anticoagulants|anticoagulants|mesh-ancestor
111269341|NCT00777855|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111269342|NCT00777855|Antitubercular Agents|antitubercular agents|mesh-ancestor
111269343|NCT00777855|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111269344|NCT00777855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111269345|NCT00777855|Leprostatic Agents|leprostatic agents|mesh-ancestor
111269346|NCT00777855|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111269347|NCT00777855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111269348|NCT00777855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111269349|NCT00777855|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111269350|NCT00777855|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111269351|NCT00777855|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
111269352|NCT00777855|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
111269353|NCT00777855|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
111269354|NCT00777855|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111269355|NCT03523429|Blinatumomab|blinatumomab|mesh-list
111269356|NCT03523429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111269357|NCT05125380|Acetic Acid|acetic acid|mesh-list
111269358|NCT05125380|Retinol acetate|retinol acetate|mesh-list
111269359|NCT05125380|Lugol's solution|lugol's solution|mesh-list
111269360|NCT05125380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111269361|NCT05125380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111269362|NCT05125380|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111269363|NCT05125380|Immunologic Factors|immunologic factors|mesh-ancestor
111269364|NCT05125380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111269365|NCT05125380|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
111269366|NCT05125380|Protective Agents|protective agents|mesh-ancestor
111269367|NCT05125380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111269368|NCT05125380|Hemostatics|hemostatics|mesh-ancestor
111269369|NCT05125380|Coagulants|coagulants|mesh-ancestor
111269370|NCT00762645|Travoprost|travoprost|mesh-list
111269371|NCT00762645|Pilocarpine|pilocarpine|mesh-list
111269372|NCT00762645|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111269373|NCT00762645|Miotics|miotics|mesh-ancestor
111269374|NCT00762645|Autonomic Agents|autonomic agents|mesh-ancestor
111269375|NCT00762645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111269376|NCT00762645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111269377|NCT00762645|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
111269378|NCT00762645|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111269379|NCT00762645|Cholinergic Agents|cholinergic agents|mesh-ancestor
111269380|NCT00762645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111269381|NCT00762645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111269382|NCT02403193|Spartalizumab|spartalizumab|mesh-list
111269383|NCT02403193|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111269384|NCT02403193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111269385|NCT02403193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111269386|NCT02403193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111269387|NCT03807297|Dexmedetomidine|dexmedetomidine|mesh-list
111269388|NCT03807297|Nitrous Oxide|nitrous oxide|mesh-list
111269389|NCT03807297|Propofol|propofol|mesh-list
111269390|NCT03807297|Sevoflurane|sevoflurane|mesh-list
111269391|NCT03807297|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111269392|NCT03807297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111269393|NCT03807297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111269394|NCT03807297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111269395|NCT03807297|Analgesics|analgesics|mesh-ancestor
111269396|NCT03807297|Sensory System Agents|sensory system agents|mesh-ancestor
111269397|NCT03807297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111269398|NCT03807297|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111269399|NCT03807297|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111269400|NCT03807297|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111269401|NCT03807297|Adrenergic Agents|adrenergic agents|mesh-ancestor
111269402|NCT03807297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111269403|NCT03807297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111269404|NCT03807297|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111269405|NCT03807297|Anesthetics, General|anesthetics, general|mesh-ancestor
111269406|NCT03807297|Anesthetics|anesthetics|mesh-ancestor
111269407|NCT03807297|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111269408|NCT03807297|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111269409|NCT05387148|Cannabidiol|cannabidiol|mesh-list
111269410|NCT05387148|Anticonvulsants|anticonvulsants|mesh-ancestor
111269411|NCT03809637|Pemetrexed|pemetrexed|mesh-list
111269412|NCT03809637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111269413|NCT03809637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111269414|NCT03809637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111269415|NCT03809637|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111269416|NCT03809637|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111269417|NCT03513445|Epinephrine|epinephrine|mesh-list
111269418|NCT03513445|Morphine|morphine|mesh-list
111269419|NCT03513445|Ropivacaine|ropivacaine|mesh-list
111269420|NCT03513445|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111269421|NCT03513445|Narcotics|narcotics|mesh-ancestor
111269422|NCT03513445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111269423|NCT03513445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111269424|NCT03513445|Analgesics|analgesics|mesh-ancestor
111269425|NCT03513445|Sensory System Agents|sensory system agents|mesh-ancestor
111269426|NCT03513445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111269427|NCT03513445|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111269428|NCT03513445|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111269429|NCT03513445|Adrenergic Agents|adrenergic agents|mesh-ancestor
111269430|NCT03513445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111269431|NCT03513445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111269432|NCT03513445|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111269433|NCT03513445|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111269434|NCT03513445|Autonomic Agents|autonomic agents|mesh-ancestor
111269435|NCT03513445|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111269436|NCT03513445|Respiratory System Agents|respiratory system agents|mesh-ancestor
111269437|NCT03513445|Mydriatics|mydriatics|mesh-ancestor
111269438|NCT03513445|Sympathomimetics|sympathomimetics|mesh-ancestor
111269439|NCT03513445|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111269440|NCT03513445|Anesthetics, Local|anesthetics, local|mesh-ancestor
111269441|NCT03513445|Anesthetics|anesthetics|mesh-ancestor
111269442|NCT03802071|Doxorubicin|doxorubicin|mesh-list
111269443|NCT03802071|Durvalumab|durvalumab|mesh-list
111269444|NCT03802071|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111269445|NCT03802071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111269446|NCT03802071|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111269447|NCT03802071|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111269448|NCT03802071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111269449|NCT03802071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111269450|NCT03802071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111269451|NCT03809793|Acipimox|acipimox|mesh-list
111269452|NCT03809793|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111269453|NCT03809793|Antimetabolites|antimetabolites|mesh-ancestor
111269454|NCT03809793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111269455|NCT03809793|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111269457|NCT00758667|Protective Agents|protective agents|mesh-ancestor
111269458|NCT00758667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111269459|NCT05041920|Omeprazole|omeprazole|mesh-list
111269460|NCT05041920|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111269461|NCT05041920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111269462|NCT05041920|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111269463|NCT05041920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111269464|NCT05041920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111269465|NCT03508921|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111269466|NCT03508921|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
111269467|NCT03508921|Trimethoprim|trimethoprim|mesh-list
111269468|NCT03508921|Sulfamethoxazole|sulfamethoxazole|mesh-list
111269469|NCT03508921|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111269470|NCT03508921|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111269471|NCT03508921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111269472|NCT03508921|Antitubercular Agents|antitubercular agents|mesh-ancestor
111269473|NCT03508921|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111269474|NCT03508921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111269475|NCT03508921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111269476|NCT03508921|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111269477|NCT03508921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111269478|NCT03508921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111269479|NCT03508921|Cholinergic Agents|cholinergic agents|mesh-ancestor
111269480|NCT03508921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111269481|NCT03508921|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111269482|NCT03508921|Antimalarials|antimalarials|mesh-ancestor
111269483|NCT03508921|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111269484|NCT03508921|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111269485|NCT03508921|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111269486|NCT03508921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111269487|NCT03508921|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111269488|NCT03508921|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
111269489|NCT03508921|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111269490|NCT03506113|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111269491|NCT03506113|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
111269492|NCT03506113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111269493|NCT03506113|Antitubercular Agents|antitubercular agents|mesh-ancestor
111269494|NCT04412850|Magnesium Sulfate|magnesium sulfate|mesh-list
111269495|NCT04412850|Analgesics|analgesics|mesh-ancestor
111269496|NCT04412850|Sensory System Agents|sensory system agents|mesh-ancestor
111269497|NCT04412850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111269498|NCT04412850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111269499|NCT04412850|Anesthetics|anesthetics|mesh-ancestor
111269500|NCT04412850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111269501|NCT04412850|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111269502|NCT04412850|Anticonvulsants|anticonvulsants|mesh-ancestor
111269503|NCT04412850|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111269504|NCT04412850|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111269505|NCT04412850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111269506|NCT04412850|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111269507|NCT04412850|Tocolytic Agents|tocolytic agents|mesh-ancestor
110993866|NCT03656965|Acyclovir|acyclovir|mesh-list
111269508|NCT04412850|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111269509|NCT00778167|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111269510|NCT00778167|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111269511|NCT00778167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111269512|NCT00778167|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111269513|NCT00778167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111269514|NCT00778167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111269515|NCT00778167|Immunologic Factors|immunologic factors|mesh-ancestor
111269516|NCT00778167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111269517|NCT00778869|Infliximab|infliximab|mesh-list
111269518|NCT00778869|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111269519|NCT00778869|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111269520|NCT00778869|Dermatologic Agents|dermatologic agents|mesh-ancestor
111269521|NCT00778869|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111269522|NCT00778869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111269523|NCT05008536|Fludarabine|fludarabine|mesh-list
111269524|NCT05008536|Cyclophosphamide|cyclophosphamide|mesh-list
111269525|NCT05008536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111269526|NCT05008536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111269527|NCT05008536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111269528|NCT05008536|Immunologic Factors|immunologic factors|mesh-ancestor
111269529|NCT05008536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111269530|NCT05008536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111269531|NCT05008536|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111269532|NCT05008536|Alkylating Agents|alkylating agents|mesh-ancestor
111269533|NCT05008536|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111269534|NCT04345419|Remdesivir|remdesivir|mesh-list
111269535|NCT04345419|Antimetabolites|antimetabolites|mesh-ancestor
111269536|NCT04345419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111269537|NCT04345419|Antiviral Agents|antiviral agents|mesh-ancestor
111269538|NCT04345419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111269539|NCT01480076|4-Aminopyridine|4-aminopyridine|mesh-list
111269540|NCT01480076|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
111269541|NCT01480076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111269542|NCT01480076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111269543|NCT00759525|Glycyrrhetinic Acid|glycyrrhetinic acid|mesh-list
111269544|NCT00759525|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111269545|NCT00759603|Rituximab|rituximab|mesh-list
111269546|NCT00759603|Lenalidomide|lenalidomide|mesh-list
111269547|NCT00759603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111269548|NCT00759603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111269549|NCT00759603|Immunologic Factors|immunologic factors|mesh-ancestor
111269550|NCT00759603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111269551|NCT00759603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111269552|NCT00759603|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111269553|NCT00759603|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111269554|NCT00759603|Growth Substances|growth substances|mesh-ancestor
111269555|NCT00759603|Growth Inhibitors|growth inhibitors|mesh-ancestor
111269556|NCT03809325|Paliperidone Palmitate|paliperidone palmitate|mesh-list
111269557|NCT03809325|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111269558|NCT03809325|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111269559|NCT03809325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111269560|NCT03809325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111269561|NCT03809325|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111269562|NCT03809325|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111269563|NCT03809325|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111269564|NCT03809325|Serotonin Agents|serotonin agents|mesh-ancestor
111269565|NCT03809325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111269566|NCT03809325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111269567|NCT03809325|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111269568|NCT03809325|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111269569|NCT03809325|Dopamine Agents|dopamine agents|mesh-ancestor
111269570|NCT03510390|Metformin|metformin|mesh-list
111269571|NCT03510390|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111269572|NCT03510390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111269573|NCT03806673|Bupivacaine|bupivacaine|mesh-list
111269574|NCT03806673|Anesthetics, Local|anesthetics, local|mesh-ancestor
111269575|NCT03806673|Anesthetics|anesthetics|mesh-ancestor
111269576|NCT03806673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111269577|NCT03806673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111269578|NCT03806673|Sensory System Agents|sensory system agents|mesh-ancestor
111269579|NCT03806673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111269580|NCT03291990|Temozolomide|temozolomide|mesh-list
111269581|NCT03291990|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111269582|NCT03291990|Alkylating Agents|alkylating agents|mesh-ancestor
111269583|NCT03291990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111269584|NCT03291990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111269585|NCT03806595|Lidocaine|lidocaine|mesh-list
111269586|NCT03806595|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111269587|NCT03806595|Anesthetics, Local|anesthetics, local|mesh-ancestor
111269588|NCT03806595|Anesthetics|anesthetics|mesh-ancestor
111269589|NCT03806595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111269590|NCT03806595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111269591|NCT03806595|Sensory System Agents|sensory system agents|mesh-ancestor
111269592|NCT03806595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111269593|NCT03806595|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111269594|NCT03806595|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111269595|NCT03806595|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111269596|NCT03806595|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111269597|NCT03806595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111269598|NCT03807999|Paclitaxel|paclitaxel|mesh-list
111269599|NCT03807999|Gemcitabine|gemcitabine|mesh-list
111269600|NCT03807999|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111269601|NCT03807999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111269602|NCT03807999|Tubulin Modulators|tubulin modulators|mesh-ancestor
111269603|NCT03807999|Antimitotic Agents|antimitotic agents|mesh-ancestor
111269604|NCT03807999|Mitosis Modulators|mitosis modulators|mesh-ancestor
111269605|NCT03807999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111269606|NCT03807999|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111269607|NCT03807999|Antimetabolites|antimetabolites|mesh-ancestor
111269608|NCT04762147|Acetaminophen|acetaminophen|mesh-list
111269609|NCT04762147|Fentanyl|fentanyl|mesh-list
111269610|NCT04762147|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111269611|NCT04762147|Narcotics|narcotics|mesh-ancestor
111269612|NCT04762147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111269613|NCT04762147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111269614|NCT04762147|Analgesics|analgesics|mesh-ancestor
111269615|NCT04762147|Sensory System Agents|sensory system agents|mesh-ancestor
111269616|NCT04762147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111269617|NCT04762147|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111269618|NCT04762147|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111269619|NCT04762147|Anesthetics, General|anesthetics, general|mesh-ancestor
111269620|NCT04762147|Anesthetics|anesthetics|mesh-ancestor
111269621|NCT04762147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111269622|NCT04762147|Antipyretics|antipyretics|mesh-ancestor
111269623|NCT04273737|Amantadine|amantadine|mesh-list
111269624|NCT04273737|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111269625|NCT04273737|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111269626|NCT04273737|Antiviral Agents|antiviral agents|mesh-ancestor
111269627|NCT04273737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111269628|NCT04273737|Dopamine Agents|dopamine agents|mesh-ancestor
111269629|NCT04273737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111269630|NCT04273737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111269631|NCT04273737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111269632|NCT04273737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111269633|NCT04273737|Analgesics|analgesics|mesh-ancestor
111269634|NCT04273737|Sensory System Agents|sensory system agents|mesh-ancestor
111269635|NCT04273737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111269636|NCT02963064|Antibodies|antibodies|mesh-list
111269637|NCT02963064|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111269638|NCT02963064|Immunologic Factors|immunologic factors|mesh-ancestor
111269639|NCT02963064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111269640|NCT04183062|Gemcitabine|gemcitabine|mesh-list
111269641|NCT04183062|Docetaxel|docetaxel|mesh-list
111269642|NCT04183062|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111269643|NCT04183062|Antimetabolites|antimetabolites|mesh-ancestor
111269644|NCT04183062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111269645|NCT04183062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111269646|NCT04183062|Tubulin Modulators|tubulin modulators|mesh-ancestor
111269647|NCT04183062|Antimitotic Agents|antimitotic agents|mesh-ancestor
111269648|NCT04183062|Mitosis Modulators|mitosis modulators|mesh-ancestor
111269649|NCT04325880|Tamsulosin|tamsulosin|mesh-list
111269650|NCT04325880|Solifenacin Succinate|solifenacin succinate|mesh-list
111269651|NCT04325880|Mirabegron|mirabegron|mesh-list
111269652|NCT04325880|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111269653|NCT04325880|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111269654|NCT04325880|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111269655|NCT04325880|Adrenergic Agents|adrenergic agents|mesh-ancestor
111269656|NCT04325880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111269657|NCT04325880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111269658|NCT04325880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111269659|NCT04325880|Urological Agents|urological agents|mesh-ancestor
111269660|NCT04325880|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111269661|NCT04325880|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111269662|NCT04325880|Cholinergic Agents|cholinergic agents|mesh-ancestor
111269663|NCT04325880|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
111269664|NCT04325880|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111269665|NCT04325880|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111269666|NCT04846218|Triptorelin Pamoate|triptorelin pamoate|mesh-list
111269667|NCT04846218|Progesterone|progesterone|mesh-list
111269668|NCT04846218|Progestins|progestins|mesh-ancestor
111269669|NCT04846218|Hormones|hormones|mesh-ancestor
111269670|NCT04846218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111269671|NCT04846218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111269672|NCT04846218|Luteolytic Agents|luteolytic agents|mesh-ancestor
111269673|NCT04846218|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111269674|NCT04846218|Contraceptive Agents|contraceptive agents|mesh-ancestor
111269675|NCT04846218|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111269676|NCT04846218|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111269677|NCT04846218|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111269678|NCT04846218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111269679|NCT04152486|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
111269680|NCT04152486|Antiviral Agents|antiviral agents|mesh-ancestor
111269681|NCT04152486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111269682|NCT02512692|Gemcitabine|gemcitabine|mesh-list
111269683|NCT02512692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111269684|NCT02512692|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111269685|NCT02512692|Antimetabolites|antimetabolites|mesh-ancestor
111269686|NCT02512692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111269687|NCT01594398|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111269688|NCT01594398|Exemestane|exemestane|mesh-list
111269689|NCT01594398|Entinostat|entinostat|mesh-list
111269690|NCT01594398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111269691|NCT01594398|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111269692|NCT01594398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111269693|NCT01594398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111269694|NCT01594398|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111269695|NCT01594398|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111269696|NCT01594398|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111269697|NCT01594398|Hormone Antagonists|hormone antagonists|mesh-ancestor
111269698|NCT01594398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111269699|NCT01594398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111269700|NCT01594398|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111269701|NCT00782379|Mycophenolic Acid|mycophenolic acid|mesh-list
111269702|NCT00782379|Cyclophosphamide|cyclophosphamide|mesh-list
111269703|NCT00782379|Busulfan|busulfan|mesh-list
111269704|NCT00782379|Fludarabine|fludarabine|mesh-list
111269705|NCT00782379|Fludarabine phosphate|fludarabine phosphate|mesh-list
111269706|NCT00782379|Tacrolimus|tacrolimus|mesh-list
111269707|NCT00782379|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111269708|NCT00782379|Immunologic Factors|immunologic factors|mesh-ancestor
111269709|NCT00782379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111269710|NCT00782379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111269711|NCT00782379|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111269712|NCT00782379|Alkylating Agents|alkylating agents|mesh-ancestor
111269713|NCT00782379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111269714|NCT00782379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111269715|NCT00782379|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111269716|NCT00782379|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111269717|NCT00782379|Antimetabolites|antimetabolites|mesh-ancestor
111269718|NCT00782379|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111269719|NCT00782379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111269720|NCT00782379|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111269721|NCT00782379|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111269722|NCT00782379|Antitubercular Agents|antitubercular agents|mesh-ancestor
111269723|NCT00782379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111269724|NCT00782379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111269725|NCT04572828|Naproxen|naproxen|mesh-list
110978510|NCT03258476|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111269726|NCT04572828|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111269727|NCT04572828|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111269728|NCT04572828|Analgesics|analgesics|mesh-ancestor
111269729|NCT04572828|Sensory System Agents|sensory system agents|mesh-ancestor
111269730|NCT04572828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111269731|NCT04572828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111269732|NCT04572828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111269733|NCT04572828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110994059|NCT03664115|Itraconazole|itraconazole|mesh-list
111269734|NCT04572828|Gout Suppressants|gout suppressants|mesh-ancestor
111269735|NCT04572828|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111269736|NCT04572828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111269737|NCT04572828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111269738|NCT05134350|Omeprazole|omeprazole|mesh-list
111269739|NCT05134350|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111269740|NCT05134350|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111269741|NCT05134350|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111269742|NCT05134350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111269743|NCT05134350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111269744|NCT05134194|Gemcitabine|gemcitabine|mesh-list
111269745|NCT05134194|Capecitabine|capecitabine|mesh-list
111269746|NCT05134194|Vinorelbine|vinorelbine|mesh-list
111269747|NCT05134194|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111269748|NCT05134194|Antimetabolites|antimetabolites|mesh-ancestor
111269749|NCT05134194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111269750|NCT05134194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111269751|NCT05134194|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111269752|NCT05134194|Tubulin Modulators|tubulin modulators|mesh-ancestor
111269753|NCT05134194|Antimitotic Agents|antimitotic agents|mesh-ancestor
111269754|NCT05134194|Mitosis Modulators|mitosis modulators|mesh-ancestor
111269755|NCT00761085|Morphine|morphine|mesh-list
111269756|NCT00761085|Methadone|methadone|mesh-list
111269757|NCT00761085|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111269758|NCT00761085|Narcotics|narcotics|mesh-ancestor
111269759|NCT00761085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111269760|NCT00761085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111269761|NCT00761085|Analgesics|analgesics|mesh-ancestor
111269762|NCT00761085|Sensory System Agents|sensory system agents|mesh-ancestor
111269763|NCT00761085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111269764|NCT00761085|Antitussive Agents|antitussive agents|mesh-ancestor
111269765|NCT00761085|Respiratory System Agents|respiratory system agents|mesh-ancestor
111269766|NCT02145039|Cyclophosphamide|cyclophosphamide|mesh-list
111269767|NCT02145039|Fludarabine|fludarabine|mesh-list
111269768|NCT02145039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111269769|NCT02145039|Immunologic Factors|immunologic factors|mesh-ancestor
111269770|NCT02145039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111269771|NCT02145039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111269772|NCT02145039|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111269773|NCT02145039|Alkylating Agents|alkylating agents|mesh-ancestor
111269774|NCT02145039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111269775|NCT02145039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111269776|NCT02145039|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111269777|NCT03806049|Paclitaxel|paclitaxel|mesh-list
111269778|NCT03806049|Bevacizumab|bevacizumab|mesh-list
111269779|NCT03806049|Carboplatin|carboplatin|mesh-list
111269780|NCT03806049|Niraparib|niraparib|mesh-list
111269781|NCT03806049|Dostarlimab|dostarlimab|mesh-list
111269782|NCT03806049|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111269783|NCT03806049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111269784|NCT03806049|Tubulin Modulators|tubulin modulators|mesh-ancestor
111269785|NCT03806049|Antimitotic Agents|antimitotic agents|mesh-ancestor
111269786|NCT03806049|Mitosis Modulators|mitosis modulators|mesh-ancestor
111269787|NCT03806049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111269788|NCT03806049|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111269789|NCT03806049|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111269790|NCT03806049|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111269791|NCT03806049|Growth Substances|growth substances|mesh-ancestor
111269792|NCT03806049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111269793|NCT03806049|Growth Inhibitors|growth inhibitors|mesh-ancestor
111269794|NCT03806049|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111269795|NCT03806049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111269796|NCT00089479|Capecitabine|capecitabine|mesh-list
111269797|NCT00089479|Docetaxel|docetaxel|mesh-list
111269798|NCT00089479|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111269799|NCT00089479|Antimetabolites|antimetabolites|mesh-ancestor
110721896|NCT03855826|Amiodarone|amiodarone|mesh-list
111269800|NCT00089479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111269801|NCT00089479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111269802|NCT00089479|Tubulin Modulators|tubulin modulators|mesh-ancestor
111269803|NCT00089479|Antimitotic Agents|antimitotic agents|mesh-ancestor
111269804|NCT00089479|Mitosis Modulators|mitosis modulators|mesh-ancestor
111269805|NCT01463306|Pregabalin|pregabalin|mesh-list
111269806|NCT01463306|Analgesics|analgesics|mesh-ancestor
111269807|NCT01463306|Sensory System Agents|sensory system agents|mesh-ancestor
111269808|NCT01463306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111269809|NCT01463306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111269810|NCT01463306|Anticonvulsants|anticonvulsants|mesh-ancestor
111269811|NCT01463306|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111269812|NCT01463306|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111269813|NCT01463306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111269814|NCT01463306|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111269815|NCT01463306|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111269816|NCT01463306|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111269817|NCT01463306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111269818|NCT01463306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111269819|NCT05055726|Benzydamine|benzydamine|mesh-list
111269820|NCT05055726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111269821|NCT00765375|Botulinum Toxins|botulinum toxins|mesh-list
111269822|NCT00765375|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111269823|NCT00765375|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111269824|NCT00765375|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111269825|NCT00765375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111269826|NCT00765375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111269827|NCT00765375|Cholinergic Agents|cholinergic agents|mesh-ancestor
111269828|NCT00765375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111269829|NCT00765375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111269830|NCT00765375|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111269831|NCT00765375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111269832|NCT03451591|Cilostazol|cilostazol|mesh-list
111269833|NCT03451591|Isosorbide|isosorbide|mesh-list
111269834|NCT03451591|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
111269835|NCT03451591|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
111269836|NCT03451591|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111269837|NCT03451591|Autonomic Agents|autonomic agents|mesh-ancestor
111269838|NCT03451591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111269839|NCT03451591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111269840|NCT03451591|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111269841|NCT03451591|Respiratory System Agents|respiratory system agents|mesh-ancestor
111269842|NCT03451591|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111269843|NCT03451591|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111269844|NCT03451591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111269845|NCT03451591|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111269846|NCT03451591|Vasodilator Agents|vasodilator agents|mesh-ancestor
111269847|NCT03451591|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111269848|NCT03451591|Protective Agents|protective agents|mesh-ancestor
111269849|NCT03451591|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
111269850|NCT03451591|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111269851|NCT03451591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111269852|NCT03451591|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
111269853|NCT03451591|Diuretics|diuretics|mesh-ancestor
111269854|NCT03451591|Natriuretic Agents|natriuretic agents|mesh-ancestor
111269855|NCT03451591|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
111269856|NCT05744115|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
111269857|NCT05744115|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111269858|NCT05744115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111269859|NCT01677559|Paclitaxel|paclitaxel|mesh-list
111269860|NCT01677559|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111269861|NCT01677559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111269862|NCT01677559|Tubulin Modulators|tubulin modulators|mesh-ancestor
111269863|NCT01677559|Antimitotic Agents|antimitotic agents|mesh-ancestor
111269864|NCT01677559|Mitosis Modulators|mitosis modulators|mesh-ancestor
111269865|NCT01677559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111269866|NCT05132712|Losartan|losartan|mesh-list
111269867|NCT05132712|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111269868|NCT05132712|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111269869|NCT05132712|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111269870|NCT05132712|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110721968|NCT03849508|Nasal Decongestants|nasal decongestants|mesh-ancestor
111269871|NCT05132712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111269872|NCT02149173|Deoxyglucose|deoxyglucose|mesh-list
111269873|NCT02149173|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
111269874|NCT02149173|Fluorides|fluorides|mesh-list
111269875|NCT02149173|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111269876|NCT02149173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111269877|NCT02149173|Cariostatic Agents|cariostatic agents|mesh-ancestor
111269878|NCT02149173|Protective Agents|protective agents|mesh-ancestor
111269879|NCT02149173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111269880|NCT02149173|Antimetabolites|antimetabolites|mesh-ancestor
111269881|NCT02149173|Antiviral Agents|antiviral agents|mesh-ancestor
111269882|NCT02149173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111269883|NCT04789434|Tislelizumab|tislelizumab|mesh-list
111269884|NCT04789434|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
111269885|NCT04789434|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111269886|NCT04789434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111269887|NCT04789434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111269889|NCT03805503|Procaine|procaine|mesh-list
111269890|NCT03805503|Anesthetics, Local|anesthetics, local|mesh-ancestor
111269891|NCT03805503|Anesthetics|anesthetics|mesh-ancestor
111269892|NCT03805503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111269893|NCT03805503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111269894|NCT03805503|Sensory System Agents|sensory system agents|mesh-ancestor
111269895|NCT03805503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111269896|NCT01504412|Pregabalin|pregabalin|mesh-list
111269897|NCT01504412|Analgesics|analgesics|mesh-ancestor
111269898|NCT01504412|Sensory System Agents|sensory system agents|mesh-ancestor
111269899|NCT01504412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111269900|NCT01504412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111269901|NCT01504412|Anticonvulsants|anticonvulsants|mesh-ancestor
111269902|NCT01504412|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111269903|NCT01504412|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111269904|NCT01504412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111269905|NCT01504412|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111269906|NCT01504412|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111269907|NCT01504412|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111269908|NCT01504412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111269909|NCT01504412|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111269910|NCT04702464|Fluconazole|fluconazole|mesh-list
111269911|NCT04702464|Antifungal Agents|antifungal agents|mesh-ancestor
111269912|NCT04702464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111269913|NCT04702464|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111269914|NCT04702464|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111269915|NCT04702464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111269916|NCT04702464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111269917|NCT04702464|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111269918|NCT04702464|Hormone Antagonists|hormone antagonists|mesh-ancestor
111269919|NCT04702464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111269920|NCT04702464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111269921|NCT04702464|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111269922|NCT04702464|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111269923|NCT00088465|Olanzapine|olanzapine|mesh-list
111269924|NCT00088465|Antiemetics|antiemetics|mesh-ancestor
111269925|NCT00088465|Autonomic Agents|autonomic agents|mesh-ancestor
111269926|NCT00088465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111269927|NCT00088465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111269928|NCT00088465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111269929|NCT00088465|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111269930|NCT00088465|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111269931|NCT00088465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111269932|NCT00088465|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111269933|NCT00088465|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111269934|NCT00088465|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111269935|NCT00088465|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111269936|NCT00088465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111269937|NCT00088465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111269938|NCT00088465|Serotonin Agents|serotonin agents|mesh-ancestor
111269939|NCT04405674|Paclitaxel|paclitaxel|mesh-list
111269940|NCT04405674|Bevacizumab|bevacizumab|mesh-list
111269941|NCT04405674|Carboplatin|carboplatin|mesh-list
111269942|NCT04405674|Pemetrexed|pemetrexed|mesh-list
111269943|NCT04405674|Tislelizumab|tislelizumab|mesh-list
110722041|NCT03853642|Antioxidants|antioxidants|mesh-ancestor
111269944|NCT04405674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111269945|NCT04405674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111269946|NCT04405674|Tubulin Modulators|tubulin modulators|mesh-ancestor
111269947|NCT04405674|Antimitotic Agents|antimitotic agents|mesh-ancestor
111269948|NCT04405674|Mitosis Modulators|mitosis modulators|mesh-ancestor
111269949|NCT04405674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111269950|NCT04405674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111269951|NCT04405674|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111269952|NCT04405674|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111269953|NCT04405674|Growth Substances|growth substances|mesh-ancestor
111269954|NCT04405674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111269955|NCT04405674|Growth Inhibitors|growth inhibitors|mesh-ancestor
111269956|NCT04405674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111269957|NCT04405674|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111269958|NCT04405674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111269959|NCT00088153|Progesterone|progesterone|mesh-list
111269960|NCT00088153|Estrogens|estrogens|mesh-list
111269961|NCT00088153|Progestins|progestins|mesh-ancestor
111269962|NCT00088153|Hormones|hormones|mesh-ancestor
111269963|NCT00088153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111269964|NCT00088153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111269965|NCT02074358|Apixaban|apixaban|mesh-list
111269966|NCT02074358|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111269967|NCT02074358|Antithrombins|antithrombins|mesh-ancestor
111269968|NCT02074358|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111269969|NCT02074358|Protease Inhibitors|protease inhibitors|mesh-ancestor
111269970|NCT02074358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111269971|NCT02074358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111269972|NCT02074358|Anticoagulants|anticoagulants|mesh-ancestor
111269973|NCT05743725|Magnesium Sulfate|magnesium sulfate|mesh-list
111269974|NCT05743725|Dexmedetomidine|dexmedetomidine|mesh-list
111269975|NCT05743725|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111269976|NCT05743725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111269977|NCT05743725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111269978|NCT05743725|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111269979|NCT05743725|Analgesics|analgesics|mesh-ancestor
111269980|NCT05743725|Sensory System Agents|sensory system agents|mesh-ancestor
111269981|NCT05743725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111269982|NCT05743725|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111269983|NCT05743725|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111269984|NCT05743725|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111269985|NCT05743725|Adrenergic Agents|adrenergic agents|mesh-ancestor
111269986|NCT05743725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111269987|NCT05743725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111269988|NCT05743725|Anesthetics|anesthetics|mesh-ancestor
111269989|NCT05743725|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111269990|NCT05743725|Anticonvulsants|anticonvulsants|mesh-ancestor
111269991|NCT05743725|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111269992|NCT05743725|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111269993|NCT05743725|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111269994|NCT05743725|Tocolytic Agents|tocolytic agents|mesh-ancestor
111269995|NCT05743725|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111269996|NCT05547321|Pembrolizumab|pembrolizumab|mesh-list
111269997|NCT05547321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111269998|NCT05547321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111269999|NCT05547321|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111270000|NCT05547321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111270001|NCT04912518|Dexmedetomidine|dexmedetomidine|mesh-list
111270002|NCT04912518|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111270003|NCT04912518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111270004|NCT04912518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111270005|NCT04912518|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111270006|NCT04912518|Analgesics|analgesics|mesh-ancestor
111270007|NCT04912518|Sensory System Agents|sensory system agents|mesh-ancestor
111270008|NCT04912518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111270009|NCT04912518|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111270010|NCT04912518|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111270011|NCT04912518|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111270012|NCT04912518|Adrenergic Agents|adrenergic agents|mesh-ancestor
111270013|NCT04912518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111270014|NCT04912518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111270015|NCT00087685|Everolimus|everolimus|mesh-list
111270016|NCT00087685|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111270017|NCT00087685|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111270018|NCT00087685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111270019|NCT00087685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111270020|NCT00087685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111270021|NCT00087685|Immunologic Factors|immunologic factors|mesh-ancestor
111270022|NCT00087685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111270023|NCT00087685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111270024|NCT04094558|Lactulose|lactulose|mesh-list
111270025|NCT04094558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111270026|NCT01502228|Sunitinib|sunitinib|mesh-list
111270027|NCT01502228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111270028|NCT01502228|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111270029|NCT01502228|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111270030|NCT01502228|Growth Substances|growth substances|mesh-ancestor
111270031|NCT01502228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111270032|NCT01502228|Growth Inhibitors|growth inhibitors|mesh-ancestor
111270033|NCT01502228|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111270034|NCT01502228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111270035|NCT01502228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111270036|NCT05011812|Ritonavir|ritonavir|mesh-list
111270037|NCT05011812|Midazolam|midazolam|mesh-list
111270038|NCT05011812|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111270039|NCT05011812|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111270040|NCT05011812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111270041|NCT05011812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111270042|NCT05011812|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111270043|NCT05011812|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111270044|NCT05011812|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111270045|NCT05011812|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111270046|NCT05011812|Anesthetics, General|anesthetics, general|mesh-ancestor
111270047|NCT05011812|Anesthetics|anesthetics|mesh-ancestor
111270048|NCT05011812|GABA Modulators|gaba modulators|mesh-ancestor
111270049|NCT05011812|GABA Agents|gaba agents|mesh-ancestor
111270050|NCT05011812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111270051|NCT05011812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111270052|NCT05011812|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111270053|NCT05011812|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111270054|NCT05011812|Protease Inhibitors|protease inhibitors|mesh-ancestor
111270055|NCT05011812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111270056|NCT05011812|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111270057|NCT05011812|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111270058|NCT05011812|Antiviral Agents|antiviral agents|mesh-ancestor
111270059|NCT05011812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111270060|NCT05011812|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111270061|NCT05011812|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111270062|NCT05535231|Curcumin|curcumin|mesh-list
111270063|NCT05535231|Turmeric extract|turmeric extract|mesh-list
111270064|NCT05535231|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111270065|NCT05535231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111270066|NCT05535231|Analgesics|analgesics|mesh-ancestor
111270067|NCT05535231|Sensory System Agents|sensory system agents|mesh-ancestor
111270068|NCT05535231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111270069|NCT05535231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111270070|NCT05535231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111270071|NCT05535231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111270072|NCT05535231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111270073|NCT05535231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111270074|NCT05535231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111270075|NCT05535231|Antioxidants|antioxidants|mesh-ancestor
111270076|NCT05535231|Protective Agents|protective agents|mesh-ancestor
111270077|NCT01502072|Ribavirin|ribavirin|mesh-list
111270078|NCT01502072|Antimetabolites|antimetabolites|mesh-ancestor
111270079|NCT01502072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111270080|NCT01502072|Antiviral Agents|antiviral agents|mesh-ancestor
111270081|NCT01502072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111270082|NCT01462370|Acetaminophen|acetaminophen|mesh-list
111270083|NCT01462370|Ibuprofen|ibuprofen|mesh-list
111270084|NCT01462370|Etoricoxib|etoricoxib|mesh-list
111270085|NCT01462370|Caffeine|caffeine|mesh-list
111270086|NCT01462370|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111270087|NCT01462370|Analgesics|analgesics|mesh-ancestor
111270088|NCT01462370|Sensory System Agents|sensory system agents|mesh-ancestor
111270089|NCT01462370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111270090|NCT01462370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111270091|NCT01462370|Antipyretics|antipyretics|mesh-ancestor
111270092|NCT01462370|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111270093|NCT01462370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111270094|NCT01462370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111270095|NCT01462370|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111270096|NCT01462370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111270097|NCT01462370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111270098|NCT01462370|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111270099|NCT01462370|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111270100|NCT01462370|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
111270101|NCT01462370|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111270102|NCT01462370|Purinergic Agents|purinergic agents|mesh-ancestor
110994430|NCT03660917|Riluzole|riluzole|mesh-list
110994431|NCT03660917|Anticonvulsants|anticonvulsants|mesh-ancestor
110994433|NCT03660917|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111270103|NCT01462370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111270104|NCT01462370|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111270105|NCT05743179|Zoledronic Acid|zoledronic acid|mesh-list
111270106|NCT05743179|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111270107|NCT05743179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111270108|NCT01479764|Glycopyrrolate|glycopyrrolate|mesh-list
111270109|NCT01479764|Neostigmine|neostigmine|mesh-list
111270110|NCT01479764|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111270111|NCT01479764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111270112|NCT01479764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111270113|NCT01479764|Cholinergic Agents|cholinergic agents|mesh-ancestor
111270114|NCT01479764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111270115|NCT01479764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111270116|NCT01479764|Parasympathomimetics|parasympathomimetics|mesh-ancestor
111270117|NCT01479764|Autonomic Agents|autonomic agents|mesh-ancestor
111270118|NCT01479764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111270119|NCT01479764|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111270120|NCT01479764|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111270121|NCT01479764|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111270122|NCT01479530|Rasagiline|rasagiline|mesh-list
111270123|NCT01479530|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
111270124|NCT01479530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111270125|NCT01479530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111270126|NCT01479530|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111270127|NCT01479530|Protective Agents|protective agents|mesh-ancestor
111270128|NCT01479530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111270129|NCT01479374|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
111270130|NCT01479374|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111270131|NCT01479374|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111270132|NCT01479374|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111270133|NCT01479374|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111270134|NCT01479374|Analgesics|analgesics|mesh-ancestor
111270135|NCT01479374|Sensory System Agents|sensory system agents|mesh-ancestor
111270136|NCT01479374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111270137|NCT01479374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111270138|NCT01479374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111270139|NCT01479374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111270140|NCT01479374|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111270141|NCT01479374|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
111270142|NCT01479374|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111270143|NCT01479374|Histamine Antagonists|histamine antagonists|mesh-ancestor
111270144|NCT01479374|Histamine Agents|histamine agents|mesh-ancestor
111270145|NCT01479374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111270146|NCT01479374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111270147|NCT00087529|Rituximab|rituximab|mesh-list
111270148|NCT00087529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111270149|NCT00087529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111270150|NCT00087529|Immunologic Factors|immunologic factors|mesh-ancestor
111270151|NCT00087529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111270152|NCT00087529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111270153|NCT00794313|Topiramate|topiramate|mesh-list
111270154|NCT00794313|Amantadine|amantadine|mesh-list
111270155|NCT00794313|Anticonvulsants|anticonvulsants|mesh-ancestor
111270156|NCT00794313|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111270157|NCT00794313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111270158|NCT00794313|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111270159|NCT00794313|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111270160|NCT00794313|Antiviral Agents|antiviral agents|mesh-ancestor
111270161|NCT00794313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111270162|NCT00794313|Dopamine Agents|dopamine agents|mesh-ancestor
111270163|NCT00794313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111270164|NCT00794313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111270165|NCT00794313|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111270166|NCT00794313|Analgesics|analgesics|mesh-ancestor
111270167|NCT00794313|Sensory System Agents|sensory system agents|mesh-ancestor
111270168|NCT00794313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111270169|NCT05743101|Levofloxacin|levofloxacin|mesh-list
111270170|NCT05743101|Ofloxacin|ofloxacin|mesh-list
111270171|NCT05743101|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111270172|NCT05743101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111270173|NCT05743101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111270174|NCT05743101|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111270175|NCT05743101|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111270176|NCT05743101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111270177|NCT05743101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111270178|NCT05743101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111270179|NCT05743101|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111270180|NCT05743101|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111270181|NCT01500434|Aspirin|aspirin|mesh-list
111270182|NCT01500434|Ticlopidine|ticlopidine|mesh-list
111270183|NCT01500434|Clopidogrel|clopidogrel|mesh-list
111270184|NCT01500434|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111270185|NCT01500434|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111270186|NCT01500434|Analgesics|analgesics|mesh-ancestor
111270187|NCT01500434|Sensory System Agents|sensory system agents|mesh-ancestor
111270188|NCT01500434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111270189|NCT01500434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111270190|NCT01500434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111270191|NCT01500434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111270192|NCT01500434|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111270193|NCT01500434|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111270194|NCT01500434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111270195|NCT01500434|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111270196|NCT01500434|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111270197|NCT01500434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111270198|NCT01500434|Antipyretics|antipyretics|mesh-ancestor
111270199|NCT01500434|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111270200|NCT01500434|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111270201|NCT01500434|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111270202|NCT01500434|Purinergic Agents|purinergic agents|mesh-ancestor
111270203|NCT01500434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111270204|NCT01500434|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111270205|NCT01500434|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111270206|NCT00087139|Epothilones|epothilones|mesh-list
111270207|NCT00087139|Epothilone B|epothilone b|mesh-list
111270208|NCT00087139|Tubulin Modulators|tubulin modulators|mesh-ancestor
111270209|NCT00087139|Antimitotic Agents|antimitotic agents|mesh-ancestor
111270210|NCT00087139|Mitosis Modulators|mitosis modulators|mesh-ancestor
111270211|NCT00087139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111270212|NCT00087139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111270213|NCT00794547|Calcitriol|calcitriol|mesh-list
111270214|NCT00794547|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111270215|NCT00794547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111270216|NCT00794547|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
111270217|NCT00794547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111270218|NCT00794547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111270219|NCT00794547|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111270220|NCT00794547|Vitamins|vitamins|mesh-ancestor
111270221|NCT00794547|Micronutrients|micronutrients|mesh-ancestor
111270222|NCT00794547|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111270223|NCT03493165|Everolimus|everolimus|mesh-list
111270224|NCT03493165|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111270225|NCT03493165|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111270226|NCT03493165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111270227|NCT03493165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111270228|NCT03493165|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111270229|NCT03493165|Immunologic Factors|immunologic factors|mesh-ancestor
111270230|NCT03493165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111270231|NCT03493165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111270232|NCT00786825|Somatostatin|somatostatin|mesh-list
111270233|NCT00786825|Hormones|hormones|mesh-ancestor
111270234|NCT00786825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111270235|NCT00786825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111270236|NCT00768261|Memantine|memantine|mesh-list
111270237|NCT00768261|Donepezil|donepezil|mesh-list
111270238|NCT00768261|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111270239|NCT00768261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111270240|NCT00768261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111270241|NCT00768261|Cholinergic Agents|cholinergic agents|mesh-ancestor
111270242|NCT00768261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111270243|NCT00768261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111270244|NCT00768261|Nootropic Agents|nootropic agents|mesh-ancestor
111270245|NCT00768261|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111270246|NCT00768261|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111270247|NCT00768261|Dopamine Agents|dopamine agents|mesh-ancestor
111270248|NCT00768261|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111270249|NCT00768261|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111270250|NCT03804723|Prednisone|prednisone|mesh-list
111270251|NCT03804723|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111270252|NCT03804723|Glucocorticoids|glucocorticoids|mesh-ancestor
111270253|NCT03804723|Hormones|hormones|mesh-ancestor
111270254|NCT03804723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111270255|NCT03804723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111270256|NCT03804723|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111270257|NCT03804723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111270258|NCT00797277|Lorazepam|lorazepam|mesh-list
111270259|NCT00797277|Haloperidol|haloperidol|mesh-list
111270260|NCT00797277|Olanzapine|olanzapine|mesh-list
111270261|NCT00797277|Haloperidol decanoate|haloperidol decanoate|mesh-list
111270262|NCT00797277|Antiemetics|antiemetics|mesh-ancestor
111270263|NCT00797277|Autonomic Agents|autonomic agents|mesh-ancestor
111270264|NCT00797277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111270265|NCT00797277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111270266|NCT00797277|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111270267|NCT00797277|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111270268|NCT00797277|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111270269|NCT00797277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111270270|NCT00797277|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111270271|NCT00797277|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111270272|NCT00797277|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111270273|NCT00797277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111270274|NCT00797277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111270275|NCT00797277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111270276|NCT00797277|Serotonin Agents|serotonin agents|mesh-ancestor
111270277|NCT00797277|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111270278|NCT00797277|Dopamine Agents|dopamine agents|mesh-ancestor
111270279|NCT00797277|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111270280|NCT00797277|Anticonvulsants|anticonvulsants|mesh-ancestor
111270281|NCT00797277|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111270282|NCT00797277|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111270283|NCT00797277|GABA Modulators|gaba modulators|mesh-ancestor
111270284|NCT00797277|GABA Agents|gaba agents|mesh-ancestor
111270285|NCT03837015|Estradiol|estradiol|mesh-list
111270286|NCT03837015|Estrogens|estrogens|mesh-ancestor
111270287|NCT03837015|Hormones|hormones|mesh-ancestor
111270288|NCT03837015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111270289|NCT03837015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111270290|NCT01500278|Adalimumab|adalimumab|mesh-list
111270291|NCT01500278|Certolizumab Pegol|certolizumab pegol|mesh-list
111270292|NCT01500278|Methotrexate|methotrexate|mesh-list
111270293|NCT01500278|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111270294|NCT01500278|Abortifacient Agents|abortifacient agents|mesh-ancestor
111270295|NCT01500278|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111270296|NCT01500278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111270297|NCT01500278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111270298|NCT01500278|Antimetabolites|antimetabolites|mesh-ancestor
111270299|NCT01500278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111270300|NCT01500278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111270301|NCT01500278|Dermatologic Agents|dermatologic agents|mesh-ancestor
111270302|NCT01500278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111270303|NCT01500278|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111270304|NCT01500278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111270305|NCT01500278|Immunologic Factors|immunologic factors|mesh-ancestor
111270306|NCT01500278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111270307|NCT01500278|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111270308|NCT01500278|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111270309|NCT01500278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111270310|NCT00086281|Zolpidem|zolpidem|mesh-list
111270311|NCT00086281|Modafinil|modafinil|mesh-list
111270312|NCT00086281|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111270313|NCT00086281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111270314|NCT00086281|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
111270315|NCT00086281|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111270316|NCT00086281|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111270317|NCT00086281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111270318|NCT00086281|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111270319|NCT00086281|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111270320|NCT00086281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111270321|NCT00086281|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
111270322|NCT00086281|GABA Agonists|gaba agonists|mesh-ancestor
111270323|NCT00086281|GABA Agents|gaba agents|mesh-ancestor
111270324|NCT00086281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111270325|NCT00787761|Cyclophosphamide|cyclophosphamide|mesh-list
111270326|NCT00787761|Busulfan|busulfan|mesh-list
111270327|NCT00787761|Methotrexate|methotrexate|mesh-list
111270328|NCT00787761|Fludarabine|fludarabine|mesh-list
111270329|NCT00787761|Fludarabine phosphate|fludarabine phosphate|mesh-list
111270330|NCT00787761|Tacrolimus|tacrolimus|mesh-list
111270331|NCT00787761|Thymoglobulin|thymoglobulin|mesh-list
111270332|NCT00787761|Antilymphocyte Serum|antilymphocyte serum|mesh-list
111270333|NCT00787761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111270334|NCT00787761|Immunologic Factors|immunologic factors|mesh-ancestor
111270335|NCT00787761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111270336|NCT00787761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111270337|NCT00787761|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111270338|NCT00787761|Alkylating Agents|alkylating agents|mesh-ancestor
111270339|NCT00787761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111270340|NCT00787761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111270341|NCT00787761|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111270342|NCT00787761|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111270343|NCT00787761|Abortifacient Agents|abortifacient agents|mesh-ancestor
111270344|NCT00787761|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111270345|NCT00787761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111270346|NCT00787761|Antimetabolites|antimetabolites|mesh-ancestor
111270347|NCT00787761|Dermatologic Agents|dermatologic agents|mesh-ancestor
111270348|NCT00787761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111270349|NCT00787761|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111270350|NCT00787761|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111270351|NCT00787761|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111270352|NCT01478828|Lovastatin|lovastatin|mesh-list
111270353|NCT01478828|L 647318|l 647318|mesh-list
111270354|NCT01478828|Dihydromevinolin|dihydromevinolin|mesh-list
111270355|NCT01478828|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111270356|NCT01478828|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111270357|NCT01478828|Antimetabolites|antimetabolites|mesh-ancestor
111270358|NCT01478828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111270359|NCT01478828|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111270360|NCT01478828|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111270361|NCT01478828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111270362|NCT00085423|Aldesleukin|aldesleukin|mesh-list
111270363|NCT00085423|Cyclophosphamide|cyclophosphamide|mesh-list
111270364|NCT00085423|Fludarabine|fludarabine|mesh-list
111270365|NCT00085423|Fludarabine phosphate|fludarabine phosphate|mesh-list
111270366|NCT00085423|Interleukin-2|interleukin-2|mesh-list
111270367|NCT00085423|Molgramostim|molgramostim|mesh-list
111270368|NCT00085423|Sargramostim|sargramostim|mesh-list
111270369|NCT00085423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111270370|NCT00085423|Immunologic Factors|immunologic factors|mesh-ancestor
111270371|NCT00085423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111270372|NCT00085423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111270373|NCT00085423|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111270374|NCT00085423|Alkylating Agents|alkylating agents|mesh-ancestor
111270375|NCT00085423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111270376|NCT00085423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111270377|NCT00085423|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111270378|NCT00085423|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111270379|NCT00085423|Antimetabolites|antimetabolites|mesh-ancestor
111270380|NCT00085423|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111270381|NCT00085423|Analgesics|analgesics|mesh-ancestor
111270382|NCT00085423|Sensory System Agents|sensory system agents|mesh-ancestor
111270383|NCT00085423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111270384|NCT00085423|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111270385|NCT00085423|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111270386|NCT00085423|Antiviral Agents|antiviral agents|mesh-ancestor
111270387|NCT00085423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111270388|NCT04079192|Umirolimus|umirolimus|mesh-list
111270389|NCT04079192|Paclitaxel|paclitaxel|mesh-list
111270390|NCT04079192|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111270391|NCT04079192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111270392|NCT04079192|Tubulin Modulators|tubulin modulators|mesh-ancestor
111270393|NCT04079192|Antimitotic Agents|antimitotic agents|mesh-ancestor
111270394|NCT04079192|Mitosis Modulators|mitosis modulators|mesh-ancestor
111270395|NCT04079192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111270396|NCT04079192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111270397|NCT04079192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111270398|NCT04079192|Immunologic Factors|immunologic factors|mesh-ancestor
111270399|NCT04079192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111270400|NCT03087877|Acetaminophen|acetaminophen|mesh-list
111270401|NCT03087877|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111270402|NCT03087877|Analgesics|analgesics|mesh-ancestor
111270403|NCT03087877|Sensory System Agents|sensory system agents|mesh-ancestor
111270404|NCT03087877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111270405|NCT03087877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111270406|NCT03087877|Antipyretics|antipyretics|mesh-ancestor
111270407|NCT05742477|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111270408|NCT05742477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111270409|NCT03447379|Aspirin|aspirin|mesh-list
111270410|NCT03447379|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111270411|NCT03447379|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111270412|NCT03447379|Analgesics|analgesics|mesh-ancestor
111270413|NCT03447379|Sensory System Agents|sensory system agents|mesh-ancestor
111270414|NCT03447379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111270415|NCT03447379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111270416|NCT03447379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111270417|NCT03447379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111270418|NCT03447379|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111270419|NCT03447379|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111270420|NCT03447379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111270421|NCT03447379|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111270422|NCT03447379|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111270423|NCT03447379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111270424|NCT03447379|Antipyretics|antipyretics|mesh-ancestor
111270425|NCT03803553|Fluorouracil|fluorouracil|mesh-list
111270426|NCT03803553|Nivolumab|nivolumab|mesh-list
111270427|NCT03803553|Irinotecan|irinotecan|mesh-list
111270428|NCT03803553|Cetuximab|cetuximab|mesh-list
111270429|NCT03803553|Antimetabolites|antimetabolites|mesh-ancestor
111270430|NCT03803553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111270431|NCT03803553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111270432|NCT03803553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111270433|NCT03803553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111270434|NCT03803553|Immunologic Factors|immunologic factors|mesh-ancestor
111270435|NCT03803553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111270436|NCT03803553|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111270437|NCT03803553|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111270438|NCT03803553|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111270439|NCT03803553|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111270440|NCT03803553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111270441|NCT05740449|Decitabine|decitabine|mesh-list
111270442|NCT05740449|Venetoclax|venetoclax|mesh-list
111270443|NCT05740449|Navitoclax|navitoclax|mesh-list
111270444|NCT05740449|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111270445|NCT05740449|Antimetabolites|antimetabolites|mesh-ancestor
111270446|NCT05740449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111270447|NCT05740449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111270448|NCT05740449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111270449|NCT01677949|Cyclophosphamide|cyclophosphamide|mesh-list
111270450|NCT01677949|Etoposide|etoposide|mesh-list
111270451|NCT01677949|Clofarabine|clofarabine|mesh-list
111270452|NCT01677949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111270453|NCT01677949|Immunologic Factors|immunologic factors|mesh-ancestor
111270454|NCT01677949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111270455|NCT01677949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111270456|NCT01677949|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111270457|NCT01677949|Alkylating Agents|alkylating agents|mesh-ancestor
111270458|NCT01677949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111270459|NCT01677949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111270460|NCT01677949|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111270461|NCT01677949|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111270462|NCT01677949|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111270463|NCT01677949|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111270464|NCT01677949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111270465|NCT01677949|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111270466|NCT01677949|Antimetabolites|antimetabolites|mesh-ancestor
111270467|NCT03483883|Gemcitabine|gemcitabine|mesh-list
111270468|NCT03483883|Avelumab|avelumab|mesh-list
111270469|NCT03483883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111270470|NCT03483883|Antimetabolites|antimetabolites|mesh-ancestor
111270471|NCT03483883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111270472|NCT03483883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111270473|NCT03483883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111270474|NCT03482167|Niacinamide|niacinamide|mesh-list
111270475|NCT03482167|Vitamin B Complex|vitamin b complex|mesh-ancestor
111270476|NCT03482167|Vitamins|vitamins|mesh-ancestor
111270477|NCT03482167|Micronutrients|micronutrients|mesh-ancestor
111270478|NCT03482167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111270479|NCT00799227|Dexamethasone|dexamethasone|mesh-list
111270480|NCT00799227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111270481|NCT00799227|Antiemetics|antiemetics|mesh-ancestor
111270482|NCT00799227|Autonomic Agents|autonomic agents|mesh-ancestor
111270483|NCT00799227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111270484|NCT00799227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111270485|NCT00799227|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111270486|NCT00799227|Glucocorticoids|glucocorticoids|mesh-ancestor
111270488|NCT00799227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111270489|NCT00799227|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111270490|NCT00799227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111270491|NCT03439267|Calcium|calcium|mesh-list
111270492|NCT03439267|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111270493|NCT03439267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111270494|NCT00770133|Ketotifen|ketotifen|mesh-list
111270495|NCT00770133|Naphazoline|naphazoline|mesh-list
111270496|NCT00770133|Antipruritics|antipruritics|mesh-ancestor
111270497|NCT00770133|Dermatologic Agents|dermatologic agents|mesh-ancestor
111270498|NCT00770133|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111270499|NCT00770133|Histamine Antagonists|histamine antagonists|mesh-ancestor
111270500|NCT00770133|Histamine Agents|histamine agents|mesh-ancestor
111270501|NCT00770133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111270502|NCT00770133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111270503|NCT00770133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111270504|NCT00770133|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111270505|NCT00770133|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111270506|NCT00770133|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111270507|NCT00770133|Adrenergic Agents|adrenergic agents|mesh-ancestor
111270508|NCT00770133|Nasal Decongestants|nasal decongestants|mesh-ancestor
111270509|NCT00770133|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111270510|NCT00770133|Respiratory System Agents|respiratory system agents|mesh-ancestor
111270511|NCT00770757|Pomalidomide|pomalidomide|mesh-list
111270512|NCT00770757|Immunologic Factors|immunologic factors|mesh-ancestor
111270513|NCT00770757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111270514|NCT00770757|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111270515|NCT00770757|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111270516|NCT00770757|Growth Substances|growth substances|mesh-ancestor
111270517|NCT00770757|Growth Inhibitors|growth inhibitors|mesh-ancestor
111270518|NCT00770757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111270519|NCT01425281|Everolimus|everolimus|mesh-list
111270520|NCT01425281|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111270521|NCT01425281|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111270522|NCT01425281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111270523|NCT01425281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111270524|NCT01425281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111270525|NCT01425281|Immunologic Factors|immunologic factors|mesh-ancestor
111270526|NCT01425281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111270527|NCT01425281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111270528|NCT04384653|Furosemide|furosemide|mesh-list
111270529|NCT04384653|Diuretics|diuretics|mesh-ancestor
111270530|NCT04384653|Natriuretic Agents|natriuretic agents|mesh-ancestor
111270531|NCT04384653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111270532|NCT04384653|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
111270533|NCT04384653|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111270534|NCT04384653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111270535|NCT04113720|Dexmedetomidine|dexmedetomidine|mesh-list
111270536|NCT04113720|Levobupivacaine|levobupivacaine|mesh-list
111270537|NCT04113720|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111270538|NCT04113720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111270539|NCT04113720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111270540|NCT04113720|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111270541|NCT04113720|Analgesics|analgesics|mesh-ancestor
111270542|NCT04113720|Sensory System Agents|sensory system agents|mesh-ancestor
111270543|NCT04113720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111270544|NCT04113720|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111270545|NCT04113720|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111270546|NCT04113720|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111270547|NCT04113720|Adrenergic Agents|adrenergic agents|mesh-ancestor
111270548|NCT04113720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111270549|NCT04113720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111270550|NCT04113720|Anesthetics, Local|anesthetics, local|mesh-ancestor
111270551|NCT04113720|Anesthetics|anesthetics|mesh-ancestor
111270552|NCT01402817|Sunitinib|sunitinib|mesh-list
111270553|NCT01402817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111270554|NCT01402817|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111270555|NCT01402817|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111270556|NCT01402817|Growth Substances|growth substances|mesh-ancestor
111270557|NCT01402817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111270558|NCT01402817|Growth Inhibitors|growth inhibitors|mesh-ancestor
111270559|NCT01402817|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111270560|NCT01402817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111270561|NCT01402817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111270562|NCT01425203|Ribavirin|ribavirin|mesh-list
111270563|NCT01425203|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
111270564|NCT01425203|Antimetabolites|antimetabolites|mesh-ancestor
111270565|NCT01425203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111270566|NCT01425203|Antiviral Agents|antiviral agents|mesh-ancestor
111270567|NCT01425203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111270568|NCT04215120|Epoetin Alfa|epoetin alfa|mesh-list
111270569|NCT04215120|Hematinics|hematinics|mesh-ancestor
111270570|NCT00081289|Leucovorin|leucovorin|mesh-list
111270571|NCT00081289|Folic Acid|folic acid|mesh-list
111270572|NCT00081289|Fluorouracil|fluorouracil|mesh-list
111270573|NCT00081289|Capecitabine|capecitabine|mesh-list
111270574|NCT00081289|Oxaliplatin|oxaliplatin|mesh-list
111270575|NCT00081289|Irinotecan|irinotecan|mesh-list
111270576|NCT00081289|Levoleucovorin|levoleucovorin|mesh-list
111270577|NCT00081289|Antimetabolites|antimetabolites|mesh-ancestor
111270578|NCT00081289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111270579|NCT00081289|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111270580|NCT00081289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111270581|NCT00081289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111270582|NCT00081289|Immunologic Factors|immunologic factors|mesh-ancestor
111270583|NCT00081289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111270584|NCT00081289|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111270585|NCT00081289|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111270586|NCT00081289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111270587|NCT00081289|Antidotes|antidotes|mesh-ancestor
111270588|NCT00081289|Protective Agents|protective agents|mesh-ancestor
111270589|NCT00081289|Vitamin B Complex|vitamin b complex|mesh-ancestor
111270590|NCT00081289|Vitamins|vitamins|mesh-ancestor
111270591|NCT00081289|Micronutrients|micronutrients|mesh-ancestor
111270592|NCT00081289|Hematinics|hematinics|mesh-ancestor
111270593|NCT01478594|Bevacizumab|bevacizumab|mesh-list
111270594|NCT01478594|Tivozanib|tivozanib|mesh-list
111270595|NCT01478594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111270596|NCT01478594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111270597|NCT01478594|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111270598|NCT01478594|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110722761|NCT01200784|Niacin|niacin|mesh-list
111270599|NCT01478594|Growth Substances|growth substances|mesh-ancestor
111270600|NCT01478594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111270601|NCT01478594|Growth Inhibitors|growth inhibitors|mesh-ancestor
111270602|NCT01478594|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111270603|NCT01478594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111270604|NCT01478594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111270605|NCT01424813|Albuterol|albuterol|mesh-list
111270606|NCT01424813|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111270607|NCT01424813|Autonomic Agents|autonomic agents|mesh-ancestor
111270608|NCT01424813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111270609|NCT01424813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111270610|NCT01424813|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111270611|NCT01424813|Respiratory System Agents|respiratory system agents|mesh-ancestor
111270612|NCT01424813|Tocolytic Agents|tocolytic agents|mesh-ancestor
111270613|NCT01424813|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111270614|NCT01424813|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111270615|NCT01424813|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111270616|NCT01424813|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111270617|NCT01424813|Adrenergic Agents|adrenergic agents|mesh-ancestor
111270618|NCT01424813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111270619|NCT01424813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111270620|NCT03480061|Dexmedetomidine|dexmedetomidine|mesh-list
111270621|NCT03480061|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111270622|NCT03480061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111270623|NCT03480061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111270624|NCT03480061|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111270625|NCT03480061|Analgesics|analgesics|mesh-ancestor
111270626|NCT03480061|Sensory System Agents|sensory system agents|mesh-ancestor
111270627|NCT03480061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111270628|NCT03480061|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111270629|NCT03480061|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111270630|NCT03480061|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111270631|NCT03480061|Adrenergic Agents|adrenergic agents|mesh-ancestor
111270632|NCT03480061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111270633|NCT03480061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111270634|NCT03389022|Ketamine|ketamine|mesh-list
111270635|NCT03389022|Analgesics|analgesics|mesh-ancestor
111270636|NCT03389022|Sensory System Agents|sensory system agents|mesh-ancestor
111270637|NCT03389022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111270638|NCT03389022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111270639|NCT03389022|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111270640|NCT03389022|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111270641|NCT03389022|Anesthetics, General|anesthetics, general|mesh-ancestor
111270642|NCT03389022|Anesthetics|anesthetics|mesh-ancestor
111270643|NCT03389022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111270644|NCT03389022|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111270645|NCT03389022|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111270646|NCT03389022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111270647|NCT03389022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111270648|NCT00080899|Fenretinide|fenretinide|mesh-list
111270649|NCT00080899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111270650|NCT00080899|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
111270651|NCT00080899|Protective Agents|protective agents|mesh-ancestor
111270652|NCT00080899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111270653|NCT03627858|Beclomethasone|beclomethasone|mesh-list
111270654|NCT03627858|Glycopyrrolate|glycopyrrolate|mesh-list
111270655|NCT03627858|Formoterol Fumarate|formoterol fumarate|mesh-list
111270656|NCT03627858|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111270657|NCT03627858|Autonomic Agents|autonomic agents|mesh-ancestor
111270658|NCT03627858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111270659|NCT03627858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111270660|NCT03627858|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111270661|NCT03627858|Respiratory System Agents|respiratory system agents|mesh-ancestor
111270662|NCT03627858|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111270663|NCT03627858|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111270664|NCT03627858|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111270665|NCT03627858|Adrenergic Agents|adrenergic agents|mesh-ancestor
111270666|NCT03627858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111270667|NCT03627858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111270668|NCT03627858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111270669|NCT03627858|Glucocorticoids|glucocorticoids|mesh-ancestor
111270670|NCT03627858|Hormones|hormones|mesh-ancestor
111270671|NCT03627858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111270672|NCT03627858|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111270673|NCT03627858|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111270674|NCT03627858|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111270675|NCT03627858|Cholinergic Agents|cholinergic agents|mesh-ancestor
111270676|NCT03086785|Apatinib|apatinib|mesh-list
111270677|NCT03086785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111270678|NCT03086785|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111270679|NCT03086785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111270680|NCT03086785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111270681|NCT03259698|Tenofovir|tenofovir|mesh-list
111270682|NCT03259698|Emtricitabine|emtricitabine|mesh-list
111270683|NCT03259698|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
111270684|NCT03259698|Antiviral Agents|antiviral agents|mesh-ancestor
111270685|NCT03259698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111270686|NCT03259698|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111270687|NCT03259698|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111270688|NCT03259698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111270689|NCT03259698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111270690|NCT03259698|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111270691|NCT03259698|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111270692|NCT00089635|Panitumumab|panitumumab|mesh-list
111270693|NCT00089635|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111270694|NCT00089635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111270695|NCT03445728|Nicorandil|nicorandil|mesh-list
111270696|NCT03445728|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111270697|NCT03445728|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111270698|NCT03445728|Vasodilator Agents|vasodilator agents|mesh-ancestor
111270699|NCT03445728|Vitamin B Complex|vitamin b complex|mesh-ancestor
111270700|NCT03445728|Vitamins|vitamins|mesh-ancestor
111270701|NCT03445728|Micronutrients|micronutrients|mesh-ancestor
111270702|NCT03445728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111270703|NCT02795520|OTS167|ots167|mesh-list
111270704|NCT02795520|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111270705|NCT02795520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110995046|NCT03648697|Cyclophosphamide|cyclophosphamide|mesh-list
111270706|NCT02795520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111270707|NCT03159000|Lidocaine|lidocaine|mesh-list
111270708|NCT03159000|Bupivacaine|bupivacaine|mesh-list
111270709|NCT03159000|Anesthetics, Local|anesthetics, local|mesh-ancestor
111270710|NCT03159000|Anesthetics|anesthetics|mesh-ancestor
111270711|NCT03159000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111270712|NCT03159000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111270713|NCT03159000|Sensory System Agents|sensory system agents|mesh-ancestor
111270714|NCT03159000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111270715|NCT03159000|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111270716|NCT03159000|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111270717|NCT03159000|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111270718|NCT03159000|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111270719|NCT03159000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111270720|NCT00086671|Antibodies|antibodies|mesh-list
111270721|NCT00086671|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111270722|NCT00086671|Immunologic Factors|immunologic factors|mesh-ancestor
111270723|NCT00086671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111270724|NCT02464878|Etanercept|etanercept|mesh-list
111270725|NCT02464878|Thymoglobulin|thymoglobulin|mesh-list
111270726|NCT02464878|Antilymphocyte Serum|antilymphocyte serum|mesh-list
111270727|NCT02464878|Basiliximab|basiliximab|mesh-list
111270728|NCT02464878|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
111270729|NCT02464878|Protein C Inhibitor|protein c inhibitor|mesh-list
111270730|NCT02464878|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111270731|NCT02464878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111270732|NCT02464878|Analgesics|analgesics|mesh-ancestor
111270733|NCT02464878|Sensory System Agents|sensory system agents|mesh-ancestor
111270734|NCT02464878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111270735|NCT02464878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111270736|NCT02464878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111270737|NCT02464878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111270738|NCT02464878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111270739|NCT02464878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111270740|NCT02464878|Immunologic Factors|immunologic factors|mesh-ancestor
111270741|NCT02464878|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
111270742|NCT02464878|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111270743|NCT02464878|Protease Inhibitors|protease inhibitors|mesh-ancestor
111270744|NCT02464878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111270745|NCT02464878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111270746|NCT02010606|Bevacizumab|bevacizumab|mesh-list
111270747|NCT02010606|Temozolomide|temozolomide|mesh-list
111270748|NCT02010606|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111270749|NCT02010606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111270750|NCT02010606|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111270751|NCT02010606|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111270752|NCT02010606|Growth Substances|growth substances|mesh-ancestor
111270753|NCT02010606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111270754|NCT02010606|Growth Inhibitors|growth inhibitors|mesh-ancestor
111270755|NCT02010606|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111270756|NCT02010606|Alkylating Agents|alkylating agents|mesh-ancestor
111270757|NCT02010606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111270758|NCT00084253|Ritonavir|ritonavir|mesh-list
111270759|NCT00084253|Atazanavir Sulfate|atazanavir sulfate|mesh-list
111270760|NCT00084253|Lamivudine|lamivudine|mesh-list
111270761|NCT00084253|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111270762|NCT00084253|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111270763|NCT00084253|Protease Inhibitors|protease inhibitors|mesh-ancestor
111270764|NCT00084253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111270765|NCT00084253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111270766|NCT00084253|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111270767|NCT00084253|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111270768|NCT00084253|Antiviral Agents|antiviral agents|mesh-ancestor
111270769|NCT00084253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111270770|NCT00084253|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111270771|NCT00084253|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111270772|NCT00084253|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111270773|NCT00084253|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111270774|NCT02951364|Sofosbuvir|sofosbuvir|mesh-list
111270775|NCT02951364|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
111270776|NCT02951364|Ledipasvir|ledipasvir|mesh-list
111270777|NCT02951364|Antiviral Agents|antiviral agents|mesh-ancestor
111270778|NCT02951364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111270779|NCT01678417|Rituximab|rituximab|mesh-list
111270780|NCT01678417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111270781|NCT01678417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111270782|NCT01678417|Immunologic Factors|immunologic factors|mesh-ancestor
111270783|NCT01678417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111270784|NCT01678417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111270786|NCT00083941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111270787|NCT00083941|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111270788|NCT00083941|Analgesics|analgesics|mesh-ancestor
111270789|NCT00083941|Sensory System Agents|sensory system agents|mesh-ancestor
111270790|NCT00083941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111270791|NCT00083941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111270792|NCT02856438|Dexamethasone|dexamethasone|mesh-list
111270793|NCT02856438|Lenalidomide|lenalidomide|mesh-list
111270794|NCT02856438|Elotuzumab|elotuzumab|mesh-list
111270795|NCT02856438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111270796|NCT02856438|Antiemetics|antiemetics|mesh-ancestor
111270797|NCT02856438|Autonomic Agents|autonomic agents|mesh-ancestor
111270798|NCT02856438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111270799|NCT02856438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111270800|NCT02856438|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111270801|NCT02856438|Glucocorticoids|glucocorticoids|mesh-ancestor
111270802|NCT02856438|Hormones|hormones|mesh-ancestor
111270803|NCT02856438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111270804|NCT02856438|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111270805|NCT02856438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111270806|NCT02856438|Immunologic Factors|immunologic factors|mesh-ancestor
111270807|NCT02856438|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111270808|NCT02856438|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111270809|NCT02856438|Growth Substances|growth substances|mesh-ancestor
111270810|NCT02856438|Growth Inhibitors|growth inhibitors|mesh-ancestor
111270811|NCT01678495|Plasminogen|plasminogen|mesh-list
111270812|NCT01678495|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
111270813|NCT01678495|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111270814|NCT01678495|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111270815|NCT01678495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111270816|NCT01678573|Abiraterone Acetate|abiraterone acetate|mesh-list
111270817|NCT01678573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111270818|NCT01678573|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111270819|NCT01678573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111270820|NCT01678573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111270821|NCT01678573|Hormone Antagonists|hormone antagonists|mesh-ancestor
111270822|NCT01678573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111270823|NCT01678573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111270824|NCT01678573|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111270825|NCT01678651|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
111270826|NCT01678651|Hormones|hormones|mesh-ancestor
111270827|NCT01678651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111270828|NCT01678651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111270829|NCT03084523|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
111270830|NCT03084523|Hematinics|hematinics|mesh-ancestor
111270831|NCT03084523|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
111270832|NCT03084523|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111270833|NCT04094090|Riboflavin|riboflavin|mesh-list
111270834|NCT04094090|Vitamin B Complex|vitamin b complex|mesh-ancestor
111270835|NCT04094090|Vitamins|vitamins|mesh-ancestor
111270836|NCT04094090|Micronutrients|micronutrients|mesh-ancestor
111270837|NCT04094090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111270838|NCT04094090|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111270839|NCT04094090|Dermatologic Agents|dermatologic agents|mesh-ancestor
111270840|NCT04670796|Trastuzumab|trastuzumab|mesh-list
111270841|NCT04670796|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111270842|NCT04670796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111270843|NCT01019616|Paclitaxel|paclitaxel|mesh-list
111270844|NCT01019616|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111270845|NCT01019616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111270846|NCT01019616|Tubulin Modulators|tubulin modulators|mesh-ancestor
111270847|NCT01019616|Antimitotic Agents|antimitotic agents|mesh-ancestor
111270848|NCT01019616|Mitosis Modulators|mitosis modulators|mesh-ancestor
111270849|NCT01019616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111270850|NCT03086395|Obinutuzumab|obinutuzumab|mesh-list
111270851|NCT03086395|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111270852|NCT03086395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111270853|NCT03083197|Azithromycin|azithromycin|mesh-list
111270854|NCT03083197|Doxycycline|doxycycline|mesh-list
111270855|NCT03083197|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110995194|NCT03645109|Vitamin D|vitamin d|mesh-list
111270856|NCT03083197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111270857|NCT03083197|Antimalarials|antimalarials|mesh-ancestor
111270858|NCT03083197|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111270859|NCT03083197|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111270860|NCT03086239|Rovalpituzumab tesirine|rovalpituzumab tesirine|mesh-list
111270861|NCT03086239|Immunoconjugates|immunoconjugates|mesh-ancestor
111270862|NCT03086239|Immunologic Factors|immunologic factors|mesh-ancestor
111270863|NCT03086239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111270864|NCT01678963|Squalamine|squalamine|mesh-list
111270865|NCT01678963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111270866|NCT01678963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111270867|NCT01678963|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
111270868|NCT01678963|Protective Agents|protective agents|mesh-ancestor
111270869|NCT01678963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111270870|NCT01678963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111270871|NCT01678963|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111270872|NCT01678963|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110978554|NCT03798080|Insulin|insulin|mesh-list
111270873|NCT01678963|Growth Substances|growth substances|mesh-ancestor
111270874|NCT01678963|Growth Inhibitors|growth inhibitors|mesh-ancestor
111270875|NCT00790335|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
111270876|NCT00790335|Plasminogen|plasminogen|mesh-list
111270877|NCT00790335|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111270878|NCT00790335|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111270879|NCT00790335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111270880|NCT05136534|Anesthetics|anesthetics|mesh-list
111270881|NCT05136534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111270882|NCT05136534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111270883|NCT05135442|Bortezomib|bortezomib|mesh-list
111270884|NCT05135442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111270885|NCT05130684|Paclitaxel|paclitaxel|mesh-list
111270886|NCT05130684|Cisplatin|cisplatin|mesh-list
111270887|NCT05130684|Nivolumab|nivolumab|mesh-list
111270888|NCT05130684|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111270889|NCT05130684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111270890|NCT05130684|Tubulin Modulators|tubulin modulators|mesh-ancestor
111270891|NCT05130684|Antimitotic Agents|antimitotic agents|mesh-ancestor
111270892|NCT05130684|Mitosis Modulators|mitosis modulators|mesh-ancestor
111270893|NCT05130684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111270894|NCT05130684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111270895|NCT05130684|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111270896|NCT04402411|Analgesics, Opioid|analgesics, opioid|mesh-list
111270897|NCT04402411|Narcotics|narcotics|mesh-ancestor
111270898|NCT04402411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111270899|NCT04402411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111270900|NCT04402411|Analgesics|analgesics|mesh-ancestor
111270901|NCT04402411|Sensory System Agents|sensory system agents|mesh-ancestor
111270902|NCT04402411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111270903|NCT05265507|Glycopyrrolate|glycopyrrolate|mesh-list
111270904|NCT05265507|Ondansetron|ondansetron|mesh-list
111270905|NCT05265507|Antiemetics|antiemetics|mesh-ancestor
111270906|NCT05265507|Autonomic Agents|autonomic agents|mesh-ancestor
111270907|NCT05265507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111270908|NCT05265507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111270909|NCT05265507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111270910|NCT05265507|Antipruritics|antipruritics|mesh-ancestor
111270911|NCT05265507|Dermatologic Agents|dermatologic agents|mesh-ancestor
111270912|NCT05265507|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111270913|NCT05265507|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111270914|NCT05265507|Serotonin Agents|serotonin agents|mesh-ancestor
111270915|NCT05265507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111270916|NCT05265507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111270917|NCT05265507|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111270918|NCT05265507|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111270919|NCT05265507|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111270920|NCT05265507|Cholinergic Agents|cholinergic agents|mesh-ancestor
111270921|NCT05135286|Brimonidine Tartrate|brimonidine tartrate|mesh-list
111270922|NCT05135286|Carbachol|carbachol|mesh-list
111270923|NCT05135286|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111270924|NCT05135286|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111270925|NCT05135286|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111270926|NCT05135286|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111270927|NCT05135286|Adrenergic Agents|adrenergic agents|mesh-ancestor
111270928|NCT05135286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111270929|NCT05135286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111270930|NCT05135286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111270931|NCT05135286|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111270932|NCT05135286|Miotics|miotics|mesh-ancestor
111270933|NCT05135286|Autonomic Agents|autonomic agents|mesh-ancestor
111270934|NCT05135286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111270935|NCT05135286|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111270936|NCT05135286|Cholinergic Agents|cholinergic agents|mesh-ancestor
111270937|NCT05135286|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111270938|NCT05135286|Analgesics|analgesics|mesh-ancestor
111270939|NCT05135286|Sensory System Agents|sensory system agents|mesh-ancestor
111270940|NCT05135286|Protective Agents|protective agents|mesh-ancestor
111270941|NCT03089671|Vitamins|vitamins|mesh-list
111270942|NCT03089671|Riboflavin|riboflavin|mesh-list
111270943|NCT03089671|Vitamin B Complex|vitamin b complex|mesh-list
111270944|NCT03089671|Micronutrients|micronutrients|mesh-ancestor
111270945|NCT03089671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111270946|NCT03089671|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111270947|NCT03089671|Dermatologic Agents|dermatologic agents|mesh-ancestor
111270948|NCT05136924|Varenicline|varenicline|mesh-list
111270949|NCT05136924|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111270950|NCT05136924|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111270951|NCT05136924|Cholinergic Agents|cholinergic agents|mesh-ancestor
111270952|NCT05136924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111270953|NCT05136924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111270954|NCT05136924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111270955|NCT00791037|Cyclophosphamide|cyclophosphamide|mesh-list
111270956|NCT00791037|Sargramostim|sargramostim|mesh-list
111270957|NCT00791037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111270958|NCT00791037|Immunologic Factors|immunologic factors|mesh-ancestor
111270959|NCT00791037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111270960|NCT00791037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111270961|NCT00791037|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111270962|NCT00791037|Alkylating Agents|alkylating agents|mesh-ancestor
111270963|NCT00791037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111270964|NCT00791037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111270965|NCT00791037|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111270966|NCT04403191|Ondansetron|ondansetron|mesh-list
111270967|NCT04403191|Antiemetics|antiemetics|mesh-ancestor
111270968|NCT04403191|Autonomic Agents|autonomic agents|mesh-ancestor
111270969|NCT04403191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111270970|NCT04403191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111270971|NCT04403191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111270972|NCT04403191|Antipruritics|antipruritics|mesh-ancestor
111270973|NCT04403191|Dermatologic Agents|dermatologic agents|mesh-ancestor
111270974|NCT04403191|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111270975|NCT04403191|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111270976|NCT04403191|Serotonin Agents|serotonin agents|mesh-ancestor
111270977|NCT04403191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111270978|NCT04403191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111270979|NCT04383093|Tadalafil|tadalafil|mesh-list
111270980|NCT04383093|Tamsulosin|tamsulosin|mesh-list
111270981|NCT04383093|Vasodilator Agents|vasodilator agents|mesh-ancestor
111270982|NCT04383093|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111270983|NCT04383093|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111270984|NCT04383093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111270985|NCT04383093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111270986|NCT04383093|Urological Agents|urological agents|mesh-ancestor
111270987|NCT04383093|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111270988|NCT04383093|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111270989|NCT04383093|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111270990|NCT04383093|Adrenergic Agents|adrenergic agents|mesh-ancestor
111270991|NCT04383093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111270992|NCT04383093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111270993|NCT05301660|Nicotine|nicotine|mesh-list
111270994|NCT05301660|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111270995|NCT05301660|Autonomic Agents|autonomic agents|mesh-ancestor
111270996|NCT05301660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111270997|NCT05301660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111270998|NCT05301660|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111270999|NCT05301660|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111271000|NCT05301660|Cholinergic Agents|cholinergic agents|mesh-ancestor
111271001|NCT05301660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111271002|NCT05301660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111271003|NCT01401959|Trastuzumab|trastuzumab|mesh-list
111271004|NCT01401959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111271005|NCT01401959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111271006|NCT04767035|Midazolam|midazolam|mesh-list
111271007|NCT04767035|Ketamine|ketamine|mesh-list
111271008|NCT04767035|Analgesics|analgesics|mesh-ancestor
111271009|NCT04767035|Sensory System Agents|sensory system agents|mesh-ancestor
111271010|NCT04767035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111271011|NCT04767035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111271012|NCT04767035|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111271013|NCT04767035|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111271014|NCT04767035|Anesthetics, General|anesthetics, general|mesh-ancestor
111271015|NCT04767035|Anesthetics|anesthetics|mesh-ancestor
111271016|NCT04767035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111271017|NCT04767035|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111271018|NCT04767035|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111271019|NCT04767035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111271020|NCT04767035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111271021|NCT04767035|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111271022|NCT04767035|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111271023|NCT04767035|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111271024|NCT04767035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111271025|NCT04767035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111271026|NCT04767035|GABA Modulators|gaba modulators|mesh-ancestor
111271027|NCT04767035|GABA Agents|gaba agents|mesh-ancestor
111271028|NCT03081169|Heparin|heparin|mesh-list
111271029|NCT03081169|Enoxaparin|enoxaparin|mesh-list
111271030|NCT03081169|Enoxaparin sodium|enoxaparin sodium|mesh-list
111271031|NCT03081169|Anticoagulants|anticoagulants|mesh-ancestor
111271032|NCT03081169|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111271033|NCT03081169|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111271034|NCT03081169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111271035|NCT03803163|Treprostinil|treprostinil|mesh-list
111271036|NCT03803163|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111271037|NCT05287308|Paclitaxel|paclitaxel|mesh-list
111271038|NCT05287308|Docetaxel|docetaxel|mesh-list
111271039|NCT05287308|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111271040|NCT05287308|Cyclophosphamide|cyclophosphamide|mesh-list
111271041|NCT05287308|Doxorubicin|doxorubicin|mesh-list
111271042|NCT05287308|Epirubicin|epirubicin|mesh-list
111271043|NCT05287308|Pirarubicin|pirarubicin|mesh-list
111271044|NCT05287308|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111271045|NCT05287308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111271046|NCT05287308|Tubulin Modulators|tubulin modulators|mesh-ancestor
111271047|NCT05287308|Antimitotic Agents|antimitotic agents|mesh-ancestor
111271048|NCT05287308|Mitosis Modulators|mitosis modulators|mesh-ancestor
111271049|NCT05287308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111271050|NCT05287308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111271051|NCT05287308|Immunologic Factors|immunologic factors|mesh-ancestor
111271052|NCT05287308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111271053|NCT05287308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111271054|NCT05287308|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111271055|NCT05287308|Alkylating Agents|alkylating agents|mesh-ancestor
111271056|NCT05287308|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111271057|NCT05287308|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111271058|NCT05287308|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111271059|NCT05287308|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111271060|NCT05287308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111271061|NCT00801723|Budesonide|budesonide|mesh-list
111271062|NCT00801723|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111271063|NCT00801723|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111271064|NCT00801723|Autonomic Agents|autonomic agents|mesh-ancestor
111271065|NCT00801723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111271066|NCT00801723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111271067|NCT00801723|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111271068|NCT00801723|Respiratory System Agents|respiratory system agents|mesh-ancestor
111271069|NCT00801723|Glucocorticoids|glucocorticoids|mesh-ancestor
111271070|NCT00801723|Hormones|hormones|mesh-ancestor
111271071|NCT00801723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111271072|NCT05346211|Curcumin|curcumin|mesh-list
111271073|NCT05346211|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111271074|NCT05346211|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111271075|NCT05346211|Analgesics|analgesics|mesh-ancestor
111271076|NCT05346211|Sensory System Agents|sensory system agents|mesh-ancestor
111271077|NCT05346211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111271078|NCT05346211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111271079|NCT05346211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111271080|NCT05346211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111271081|NCT05346211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111271082|NCT05346211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111271083|NCT05346211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111271084|NCT05694897|Magnesium Sulfate|magnesium sulfate|mesh-list
111271085|NCT05694897|Bupivacaine|bupivacaine|mesh-list
111271086|NCT05694897|Anesthetics, Local|anesthetics, local|mesh-ancestor
111271087|NCT05694897|Anesthetics|anesthetics|mesh-ancestor
111271088|NCT05694897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111271089|NCT05694897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111271090|NCT05694897|Sensory System Agents|sensory system agents|mesh-ancestor
111271091|NCT05694897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111271092|NCT05694897|Analgesics|analgesics|mesh-ancestor
111271093|NCT05694897|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111271094|NCT05694897|Anticonvulsants|anticonvulsants|mesh-ancestor
111271095|NCT05694897|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111271096|NCT05694897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111271097|NCT05694897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111271098|NCT05694897|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111271099|NCT05694897|Tocolytic Agents|tocolytic agents|mesh-ancestor
111271100|NCT05694897|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111271101|NCT01478048|Dexamethasone|dexamethasone|mesh-list
111271102|NCT01478048|Dexamethasone acetate|dexamethasone acetate|mesh-list
111271103|NCT01478048|Bortezomib|bortezomib|mesh-list
111271104|NCT01478048|Elotuzumab|elotuzumab|mesh-list
111271105|NCT01478048|BB 1101|bb 1101|mesh-list
111271106|NCT01478048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111271107|NCT01478048|Antiemetics|antiemetics|mesh-ancestor
111271108|NCT01478048|Autonomic Agents|autonomic agents|mesh-ancestor
111271109|NCT01478048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111271110|NCT01478048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111271111|NCT01478048|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111271112|NCT01478048|Glucocorticoids|glucocorticoids|mesh-ancestor
111271113|NCT01478048|Hormones|hormones|mesh-ancestor
111271114|NCT01478048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111271115|NCT01478048|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111271116|NCT01478048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111271117|NCT01478048|Protease Inhibitors|protease inhibitors|mesh-ancestor
111271118|NCT01478048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111271119|NCT01478048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111271120|NCT04585776|Insulin|insulin|mesh-list
111271121|NCT04585776|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111271122|NCT04585776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111271123|NCT01401647|Lidocaine|lidocaine|mesh-list
111271124|NCT01401647|Amiodarone|amiodarone|mesh-list
111271125|NCT01401647|Anesthetics, Local|anesthetics, local|mesh-ancestor
111271126|NCT01401647|Anesthetics|anesthetics|mesh-ancestor
111271127|NCT01401647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111271128|NCT01401647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111271129|NCT01401647|Sensory System Agents|sensory system agents|mesh-ancestor
111271130|NCT01401647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111271131|NCT01401647|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111271132|NCT01401647|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111271133|NCT01401647|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111271134|NCT01401647|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111271135|NCT01401647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111271136|NCT01401647|Vasodilator Agents|vasodilator agents|mesh-ancestor
111271137|NCT01401647|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
111271138|NCT01401647|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111271139|NCT01401647|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111271140|NCT01401647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111271141|NCT01401647|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111271142|NCT01401647|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111271143|NCT01401647|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111271144|NCT01423253|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
111271145|NCT01423253|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111271146|NCT01423253|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111271147|NCT01423253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111271148|NCT01423253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111271149|NCT01423253|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111271150|NCT01423253|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
111271151|NCT01423253|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111271152|NCT01423253|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111271153|NCT01423253|Adrenergic Agents|adrenergic agents|mesh-ancestor
111271154|NCT01423253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111271155|NCT01423253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111271156|NCT01423253|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111271157|NCT01423253|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111271158|NCT01423253|Serotonin Agents|serotonin agents|mesh-ancestor
111271159|NCT01423253|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111271160|NCT01423253|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111271161|NCT01423253|Dopamine Agents|dopamine agents|mesh-ancestor
111271162|NCT03088891|Antioxidants|antioxidants|mesh-list
111271163|NCT03088891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111271164|NCT03088891|Protective Agents|protective agents|mesh-ancestor
111271165|NCT03088891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111271166|NCT01477892|Remifentanil|remifentanil|mesh-list
111271167|NCT01477892|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111271168|NCT01477892|Narcotics|narcotics|mesh-ancestor
111271169|NCT01477892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111271170|NCT01477892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111271171|NCT01477892|Analgesics|analgesics|mesh-ancestor
111271172|NCT01477892|Sensory System Agents|sensory system agents|mesh-ancestor
111271173|NCT01477892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111271174|NCT00801801|Docetaxel|docetaxel|mesh-list
111271175|NCT00801801|Sorafenib|sorafenib|mesh-list
111271176|NCT00801801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111271177|NCT00801801|Tubulin Modulators|tubulin modulators|mesh-ancestor
111271178|NCT00801801|Antimitotic Agents|antimitotic agents|mesh-ancestor
111271179|NCT00801801|Mitosis Modulators|mitosis modulators|mesh-ancestor
111271180|NCT00801801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111271181|NCT00801801|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111271182|NCT00801801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111271183|NCT01499576|Acetic Acid|acetic acid|mesh-list
111271184|NCT01499576|Retinol acetate|retinol acetate|mesh-list
111271185|NCT01499576|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111271186|NCT01499576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111271187|NCT01499576|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111271188|NCT01499576|Immunologic Factors|immunologic factors|mesh-ancestor
111271189|NCT01499576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111271190|NCT01499576|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
111271191|NCT01499576|Protective Agents|protective agents|mesh-ancestor
111271192|NCT01499576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111271193|NCT04546074|Pembrolizumab|pembrolizumab|mesh-list
111271194|NCT04546074|Imatinib Mesylate|imatinib mesylate|mesh-list
111271195|NCT04546074|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111271196|NCT04546074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111271197|NCT04546074|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111271198|NCT04546074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111271199|NCT04546074|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111271200|NCT04546074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111271201|NCT00802113|Fludarabine|fludarabine|mesh-list
111271202|NCT00802113|Busulfan|busulfan|mesh-list
111271203|NCT00802113|Antilymphocyte Serum|antilymphocyte serum|mesh-list
111271204|NCT00802113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111271205|NCT00802113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111271206|NCT00802113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111271207|NCT00802113|Immunologic Factors|immunologic factors|mesh-ancestor
111271208|NCT00802113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111271209|NCT00802113|Alkylating Agents|alkylating agents|mesh-ancestor
111271210|NCT00802113|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111271211|NCT00802113|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111271212|NCT03084601|Calcium|calcium|mesh-list
111271213|NCT03084601|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111271214|NCT03084601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111271215|NCT00791973|Fluticasone|fluticasone|mesh-list
111271216|NCT00791973|Xhance|xhance|mesh-list
111271217|NCT00791973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111271218|NCT00791973|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111271219|NCT00791973|Autonomic Agents|autonomic agents|mesh-ancestor
111271220|NCT00791973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111271221|NCT00791973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111271222|NCT00791973|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111271223|NCT00791973|Respiratory System Agents|respiratory system agents|mesh-ancestor
111271224|NCT00791973|Dermatologic Agents|dermatologic agents|mesh-ancestor
111271225|NCT00791973|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111271226|NCT00773955|Acetic Acid|acetic acid|mesh-list
111271227|NCT00773955|Retinol acetate|retinol acetate|mesh-list
111271228|NCT00773955|Gossypol acetic acid|gossypol acetic acid|mesh-list
110995560|NCT03465345|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111271229|NCT00773955|Gossypol|gossypol|mesh-list
111271230|NCT00773955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111271231|NCT00773955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111271232|NCT00773955|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111271233|NCT00773955|Immunologic Factors|immunologic factors|mesh-ancestor
111271234|NCT00773955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111271235|NCT00773955|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
111271236|NCT00773955|Protective Agents|protective agents|mesh-ancestor
111271237|NCT00773955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111271238|NCT00773955|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
111271239|NCT00773955|Contraceptive Agents|contraceptive agents|mesh-ancestor
111271240|NCT00773955|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111271241|NCT00773955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111271242|NCT00773955|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111271243|NCT00773955|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
111271244|NCT00773955|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
111271245|NCT01421459|Insulin Glargine|insulin glargine|mesh-list
111271246|NCT01421459|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111271247|NCT01421459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111271248|NCT01498952|Sorafenib|sorafenib|mesh-list
111271249|NCT01498952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111271250|NCT01498952|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111271251|NCT01498952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111271252|NCT01498952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111271253|NCT04499196|Glucocorticoids|glucocorticoids|mesh-list
111271254|NCT04499196|Hormones|hormones|mesh-ancestor
111271255|NCT04499196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111271256|NCT04499196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111271257|NCT04608266|Camostat|camostat|mesh-list
111271258|NCT04608266|Protease Inhibitors|protease inhibitors|mesh-ancestor
111271259|NCT04608266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111271260|NCT04608266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111271261|NCT04608266|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
111271262|NCT04608266|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111271263|NCT00774267|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
111271264|NCT00774267|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111271265|NCT00774267|Hormone Antagonists|hormone antagonists|mesh-ancestor
111271266|NCT00774267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111271267|NCT00774267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111271268|NCT00774267|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111271269|NCT00774267|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111271270|NCT00774267|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111271271|NCT04460352|Leucovorin|leucovorin|mesh-list
111271272|NCT04460352|Paclitaxel|paclitaxel|mesh-list
111271273|NCT04460352|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111271274|NCT04460352|Carboplatin|carboplatin|mesh-list
111271275|NCT04460352|Fluorouracil|fluorouracil|mesh-list
111271276|NCT04460352|Oxaliplatin|oxaliplatin|mesh-list
111271277|NCT04460352|Calcium|calcium|mesh-list
111271278|NCT04460352|Levoleucovorin|levoleucovorin|mesh-list
111271279|NCT04460352|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111271280|NCT04460352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111271281|NCT04460352|Tubulin Modulators|tubulin modulators|mesh-ancestor
111271282|NCT04460352|Antimitotic Agents|antimitotic agents|mesh-ancestor
111271283|NCT04460352|Mitosis Modulators|mitosis modulators|mesh-ancestor
111271284|NCT04460352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111271285|NCT04460352|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111271286|NCT04460352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111271287|NCT04460352|Antimetabolites|antimetabolites|mesh-ancestor
111271288|NCT04460352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111271289|NCT04460352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111271290|NCT04460352|Immunologic Factors|immunologic factors|mesh-ancestor
111271291|NCT04460352|Antidotes|antidotes|mesh-ancestor
111271292|NCT04460352|Protective Agents|protective agents|mesh-ancestor
111271293|NCT04460352|Vitamin B Complex|vitamin b complex|mesh-ancestor
111271294|NCT04460352|Vitamins|vitamins|mesh-ancestor
111271295|NCT04460352|Micronutrients|micronutrients|mesh-ancestor
111271296|NCT03083353|Isradipine|isradipine|mesh-list
111271297|NCT03083353|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111271298|NCT03083353|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111271299|NCT03083353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111271300|NCT03083353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111271301|NCT03083353|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111271302|NCT03083353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111271303|NCT03083353|Vasodilator Agents|vasodilator agents|mesh-ancestor
111271304|NCT01421303|Etanercept|etanercept|mesh-list
111271305|NCT01421303|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111271306|NCT01421303|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111271307|NCT01421303|Analgesics|analgesics|mesh-ancestor
111271308|NCT01421303|Sensory System Agents|sensory system agents|mesh-ancestor
111271309|NCT01421303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111271310|NCT01421303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111271311|NCT01421303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111271312|NCT01421303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111271313|NCT01421303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111271314|NCT01421303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111271315|NCT01421303|Immunologic Factors|immunologic factors|mesh-ancestor
111271316|NCT03703375|Gemcitabine|gemcitabine|mesh-list
111271317|NCT03703375|Azacitidine|azacitidine|mesh-list
111271318|NCT03703375|Romidepsin|romidepsin|mesh-list
111271319|NCT03703375|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111271320|NCT03703375|Antimetabolites|antimetabolites|mesh-ancestor
111271321|NCT03703375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111271322|NCT03703375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111271323|NCT03703375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111271324|NCT03703375|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111271325|NCT03703375|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111271326|NCT05303688|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
111271327|NCT05303688|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111271328|NCT05303688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111271329|NCT05303688|Analgesics|analgesics|mesh-ancestor
111271330|NCT05303688|Sensory System Agents|sensory system agents|mesh-ancestor
111271331|NCT05303688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111271332|NCT05303688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111271333|NCT05303688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111271334|NCT05303688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111271335|NCT04383717|Azithromycin|azithromycin|mesh-list
111271336|NCT04383717|Hydroxychloroquine|hydroxychloroquine|mesh-list
111271337|NCT04383717|Levamisole|levamisole|mesh-list
111271338|NCT04383717|Inosine Pranobex|inosine pranobex|mesh-list
111271339|NCT04383717|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111271340|NCT04383717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111271341|NCT04383717|Antimalarials|antimalarials|mesh-ancestor
111271342|NCT04383717|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111271343|NCT04383717|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111271344|NCT04383717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111271345|NCT04383717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111271346|NCT04383717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111271347|NCT04383717|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111271348|NCT04383717|Immunologic Factors|immunologic factors|mesh-ancestor
111271349|NCT04383717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111271350|NCT04383717|Antinematodal Agents|antinematodal agents|mesh-ancestor
111271351|NCT04383717|Anthelmintics|anthelmintics|mesh-ancestor
111271352|NCT04383717|Antiviral Agents|antiviral agents|mesh-ancestor
111271353|NCT01400243|Nicotine|nicotine|mesh-list
111271354|NCT01400243|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111271355|NCT01400243|Autonomic Agents|autonomic agents|mesh-ancestor
111271356|NCT01400243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111271357|NCT01400243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111271358|NCT01400243|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111271359|NCT01400243|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111271360|NCT01400243|Cholinergic Agents|cholinergic agents|mesh-ancestor
111271361|NCT01400243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111271362|NCT01400243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111271363|NCT00809055|Caffeine|caffeine|mesh-list
111271364|NCT00809055|Caffeine citrate|caffeine citrate|mesh-list
111271365|NCT00809055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111271366|NCT00809055|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111271367|NCT00809055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111271368|NCT00809055|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111271369|NCT00809055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111271370|NCT00809055|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
111271371|NCT00809055|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111271372|NCT00809055|Purinergic Agents|purinergic agents|mesh-ancestor
111271373|NCT00809055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111271374|NCT01421225|Insulin|insulin|mesh-list
111271375|NCT01421225|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111271376|NCT01421225|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111271377|NCT01421225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111271378|NCT03082885|Thymalfasin|thymalfasin|mesh-list
111271379|NCT03082885|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111271380|NCT03082885|Immunologic Factors|immunologic factors|mesh-ancestor
111271381|NCT03082885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111271382|NCT04382781|Immunosuppressive Agents|immunosuppressive agents|mesh-list
111271383|NCT04382781|Immunologic Factors|immunologic factors|mesh-ancestor
111271384|NCT04382781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111271385|NCT05688631|Antioxidants|antioxidants|mesh-list
111271386|NCT05688631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111271387|NCT05688631|Protective Agents|protective agents|mesh-ancestor
111271388|NCT05688631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111271389|NCT04348032|Apatinib|apatinib|mesh-list
111271390|NCT04348032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111271391|NCT04348032|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111271392|NCT04348032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111271393|NCT04348032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111271394|NCT01474772|Pregabalin|pregabalin|mesh-list
111271395|NCT01474772|Analgesics|analgesics|mesh-ancestor
111271396|NCT01474772|Sensory System Agents|sensory system agents|mesh-ancestor
111271397|NCT01474772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111271398|NCT01474772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111271399|NCT01474772|Anticonvulsants|anticonvulsants|mesh-ancestor
111271400|NCT01474772|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111271401|NCT01474772|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111271402|NCT01474772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111271403|NCT01474772|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111271404|NCT01474772|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111271405|NCT01474772|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111271406|NCT01474772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111271407|NCT01474772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111271408|NCT03082339|Cortisone|cortisone|mesh-list
111271409|NCT03082339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111271410|NCT03801759|Adefovir|adefovir|mesh-list
111271411|NCT03801759|Digoxin|digoxin|mesh-list
111271412|NCT03801759|Furosemide|furosemide|mesh-list
111271413|NCT03801759|Diuretics|diuretics|mesh-ancestor
111271414|NCT03801759|Natriuretic Agents|natriuretic agents|mesh-ancestor
111271415|NCT03801759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111271416|NCT03801759|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
111271417|NCT03801759|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111271418|NCT03801759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111271419|NCT03801759|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111271420|NCT03801759|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111271421|NCT03801759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111271422|NCT03801759|Protective Agents|protective agents|mesh-ancestor
111271423|NCT03801759|Antiviral Agents|antiviral agents|mesh-ancestor
111271424|NCT03801759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111271425|NCT03801759|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111271426|NCT03801759|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111271427|NCT01421147|Insulin Lispro|insulin lispro|mesh-list
111271428|NCT01421147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111271429|NCT01421147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111271430|NCT03082573|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
111271431|NCT03082573|Hormones|hormones|mesh-ancestor
111271432|NCT03082573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111271433|NCT03082573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111271434|NCT01497938|Insulin|insulin|mesh-list
111271435|NCT01497938|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111271436|NCT01497938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111271437|NCT03092154|Hypolipidemic Agents|hypolipidemic agents|mesh-list
111271438|NCT03092154|Antimetabolites|antimetabolites|mesh-ancestor
111271439|NCT03092154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111271440|NCT03092154|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111271441|NCT04301310|Rifampin|rifampin|mesh-list
111271442|NCT04301310|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111271443|NCT04301310|Antitubercular Agents|antitubercular agents|mesh-ancestor
111271444|NCT04301310|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111271445|NCT04301310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111271446|NCT04301310|Leprostatic Agents|leprostatic agents|mesh-ancestor
111271447|NCT04301310|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111271448|NCT04301310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111271449|NCT04301310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111271450|NCT04301310|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111271451|NCT04301310|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111271452|NCT04301310|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
111271453|NCT04301310|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
111271454|NCT04301310|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
111271455|NCT04301310|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111271456|NCT03026894|Salicylic Acid|salicylic acid|mesh-list
111271457|NCT03026894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111271458|NCT03026894|Antifungal Agents|antifungal agents|mesh-ancestor
111271459|NCT03026894|Keratolytic Agents|keratolytic agents|mesh-ancestor
111271460|NCT03026894|Dermatologic Agents|dermatologic agents|mesh-ancestor
111271462|NCT00804609|Morphine|morphine|mesh-list
111271463|NCT00804609|Anesthetics|anesthetics|mesh-list
111271464|NCT00804609|Anesthetics, Local|anesthetics, local|mesh-ancestor
111271465|NCT00804609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111271466|NCT00804609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111271467|NCT00804609|Sensory System Agents|sensory system agents|mesh-ancestor
111271468|NCT00804609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111271469|NCT00804609|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111271470|NCT00804609|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111271471|NCT00804609|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111271472|NCT00804609|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111271473|NCT00804609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111271474|NCT00804609|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111271475|NCT00804609|Narcotics|narcotics|mesh-ancestor
111271476|NCT00804609|Analgesics|analgesics|mesh-ancestor
111271477|NCT03082183|Rifampin|rifampin|mesh-list
111271478|NCT03082183|BI 425809|bi 425809|mesh-list
111271479|NCT03082183|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111271480|NCT03082183|Antitubercular Agents|antitubercular agents|mesh-ancestor
111271481|NCT03082183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111271482|NCT03082183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111271483|NCT03082183|Leprostatic Agents|leprostatic agents|mesh-ancestor
111271484|NCT03082183|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111271485|NCT03082183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111271486|NCT03082183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111271487|NCT03082183|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111271488|NCT03082183|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111271489|NCT03082183|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
111271490|NCT03082183|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
111271491|NCT03082183|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
111271492|NCT03082183|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111271493|NCT03082183|Nootropic Agents|nootropic agents|mesh-ancestor
111271494|NCT00804999|Hydrogen Peroxide|hydrogen peroxide|mesh-list
111271495|NCT00804999|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111271496|NCT00804999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111271497|NCT04283604|Methylphenidate|methylphenidate|mesh-list
111271498|NCT04283604|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111271499|NCT04283604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111271500|NCT04283604|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111271501|NCT04283604|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111271502|NCT04283604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110978596|NCT05498896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111271503|NCT04283604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111271504|NCT04283604|Dopamine Agents|dopamine agents|mesh-ancestor
111271505|NCT04283604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111271506|NCT00810303|Efavirenz|efavirenz|mesh-list
111271507|NCT00810303|Ezetimibe|ezetimibe|mesh-list
111271508|NCT00810303|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111271509|NCT00810303|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111271510|NCT00810303|Antimetabolites|antimetabolites|mesh-ancestor
111271511|NCT00810303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111271512|NCT00810303|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111271513|NCT00810303|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111271514|NCT00810303|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111271515|NCT00810303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111271516|NCT00810303|Antiviral Agents|antiviral agents|mesh-ancestor
111271517|NCT00810303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111271518|NCT00810303|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111271519|NCT00810303|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111271520|NCT00810303|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111271521|NCT00810303|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111271522|NCT00810303|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111271523|NCT00810303|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111271524|NCT04401085|Antibodies|antibodies|mesh-list
111271525|NCT04401085|Immunologic Factors|immunologic factors|mesh-ancestor
111271526|NCT04401085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111271527|NCT05645107|Immunoglobulins|immunoglobulins|mesh-list
111271528|NCT05645107|gamma-Globulins|gamma-globulins|mesh-list
111271529|NCT05645107|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111271530|NCT05645107|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
111271531|NCT05645107|Immunologic Factors|immunologic factors|mesh-ancestor
111271532|NCT05645107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111271533|NCT04227756|Psilocybin|psilocybin|mesh-list
111271534|NCT04227756|Mescaline|mescaline|mesh-list
111271535|NCT04227756|Hallucinogens|hallucinogens|mesh-ancestor
111271536|NCT04227756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111271537|NCT04227756|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111271538|NCT04227756|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111271539|NCT04227756|Serotonin Agents|serotonin agents|mesh-ancestor
111271540|NCT04227756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111271541|NCT04227756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111271542|NCT01460342|Tadalafil|tadalafil|mesh-list
111271543|NCT01460342|Vasodilator Agents|vasodilator agents|mesh-ancestor
111271544|NCT01460342|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111271545|NCT01460342|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111271546|NCT01460342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111271547|NCT01460342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111271548|NCT01460342|Urological Agents|urological agents|mesh-ancestor
111271549|NCT00775671|Metoprolol|metoprolol|mesh-list
111271550|NCT00775671|Nebivolol|nebivolol|mesh-list
111271551|NCT00775671|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111271552|NCT00775671|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111271553|NCT00775671|Sympatholytics|sympatholytics|mesh-ancestor
111271554|NCT00775671|Autonomic Agents|autonomic agents|mesh-ancestor
111271555|NCT00775671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111271556|NCT00775671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111271557|NCT00775671|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
111271558|NCT00775671|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111271559|NCT00775671|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111271560|NCT00775671|Adrenergic Agents|adrenergic agents|mesh-ancestor
111271561|NCT00775671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111271562|NCT00775671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111271563|NCT00775671|Vasodilator Agents|vasodilator agents|mesh-ancestor
111271564|NCT00775671|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
111271565|NCT00775671|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111271566|NCT00775671|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111271567|NCT03800745|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
111271568|NCT03800745|Laxatives|laxatives|mesh-ancestor
111271569|NCT03800745|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111271570|NCT01459796|Rilonacept|rilonacept|mesh-list
111271571|NCT01459796|Allopurinol|allopurinol|mesh-list
111271572|NCT01459796|Antimetabolites|antimetabolites|mesh-ancestor
111271573|NCT01459796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111271574|NCT01459796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111271575|NCT01459796|Gout Suppressants|gout suppressants|mesh-ancestor
110723683|NCT00145496|Olanzapine|olanzapine|mesh-list
111271576|NCT01459796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111271577|NCT01459796|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111271578|NCT01459796|Antioxidants|antioxidants|mesh-ancestor
111271579|NCT01459796|Protective Agents|protective agents|mesh-ancestor
111271580|NCT01459796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111271581|NCT01459796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111271582|NCT04721691|Cannabidiol|cannabidiol|mesh-list
111271583|NCT04721691|Anticonvulsants|anticonvulsants|mesh-ancestor
111271584|NCT04760821|Trimetazidine|trimetazidine|mesh-list
111271585|NCT04760821|Vasodilator Agents|vasodilator agents|mesh-ancestor
111271586|NCT04382079|Propolis|propolis|mesh-list
111271587|NCT04382079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111271588|NCT05688007|Hormones|hormones|mesh-list
111271589|NCT05688007|Parathyroid Hormone|parathyroid hormone|mesh-list
111271590|NCT05688007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111271591|NCT05688007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111271592|NCT05688007|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111271593|NCT01459718|Deferasirox|deferasirox|mesh-list
111271594|NCT01459718|Deferoxamine|deferoxamine|mesh-list
111271595|NCT01459718|Iron Chelating Agents|iron chelating agents|mesh-ancestor
111271596|NCT01459718|Chelating Agents|chelating agents|mesh-ancestor
111271597|NCT01459718|Sequestering Agents|sequestering agents|mesh-ancestor
111271598|NCT01459718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111271599|NCT01459718|Siderophores|siderophores|mesh-ancestor
111271600|NCT04918407|Empagliflozin|empagliflozin|mesh-list
111271601|NCT04918407|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111271602|NCT04918407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111271603|NCT04918407|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111271604|NCT04918407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110995951|NCT02978417|Naltrexone|naltrexone|mesh-list
111271605|NCT04989660|Phenol|phenol|mesh-list
111271606|NCT04989660|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111271607|NCT04989660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111271608|NCT04989660|Disinfectants|disinfectants|mesh-ancestor
111271609|NCT04989660|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
111271610|NCT04989660|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111271611|NCT03081325|Immunomodulating Agents|immunomodulating agents|mesh-list
111271612|NCT03081325|Immunologic Factors|immunologic factors|mesh-ancestor
111271613|NCT03081325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111271614|NCT04384731|Poractant alfa|poractant alfa|mesh-list
111271615|NCT04384731|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
111271616|NCT04384731|Respiratory System Agents|respiratory system agents|mesh-ancestor
111271617|NCT05042466|Psilocybin|psilocybin|mesh-list
111271618|NCT05042466|Hallucinogens|hallucinogens|mesh-ancestor
111271619|NCT05042466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111271620|NCT05042466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111271621|NCT05615467|Metformin|metformin|mesh-list
111271622|NCT05615467|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111271623|NCT05615467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111271624|NCT03800433|Pentoxifylline|pentoxifylline|mesh-list
111271625|NCT03800433|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111271626|NCT03800433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111271627|NCT03800433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111271628|NCT03800433|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111271629|NCT03800433|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111271630|NCT03800433|Protective Agents|protective agents|mesh-ancestor
111271631|NCT03800433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111271632|NCT03800433|Vasodilator Agents|vasodilator agents|mesh-ancestor
111271633|NCT03800433|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111271634|NCT03800433|Antioxidants|antioxidants|mesh-ancestor
111271635|NCT03395899|Bevacizumab|bevacizumab|mesh-list
111271636|NCT03395899|Atezolizumab|atezolizumab|mesh-list
111271637|NCT03395899|Ipatasertib|ipatasertib|mesh-list
111271638|NCT03395899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111271639|NCT03395899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111271640|NCT03395899|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111271641|NCT03395899|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111271642|NCT03395899|Growth Substances|growth substances|mesh-ancestor
111271643|NCT03395899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111271644|NCT03395899|Growth Inhibitors|growth inhibitors|mesh-ancestor
111271645|NCT03395899|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111271646|NCT03395899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111271647|NCT03395899|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111271648|NCT03395899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111271649|NCT05602597|Itraconazole|itraconazole|mesh-list
111271650|NCT05602597|Fluconazole|fluconazole|mesh-list
111271651|NCT05602597|Rifampin|rifampin|mesh-list
111271652|NCT05602597|Rabeprazole|rabeprazole|mesh-list
111271653|NCT05602597|Antifungal Agents|antifungal agents|mesh-ancestor
111271654|NCT05602597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111271655|NCT05602597|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111271656|NCT05602597|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111271657|NCT05602597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111271658|NCT05602597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111271659|NCT05602597|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111271660|NCT05602597|Hormone Antagonists|hormone antagonists|mesh-ancestor
111271661|NCT05602597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111271662|NCT05602597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111271663|NCT05602597|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111271664|NCT05602597|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111271665|NCT05602597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111271666|NCT05602597|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111271667|NCT05602597|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111271668|NCT05602597|Antitubercular Agents|antitubercular agents|mesh-ancestor
111271669|NCT05602597|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111271670|NCT05602597|Leprostatic Agents|leprostatic agents|mesh-ancestor
111271671|NCT05602597|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111271672|NCT05602597|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111271673|NCT05602597|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111271674|NCT05602597|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
111271675|NCT05602597|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
111271676|NCT05602597|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
111271677|NCT05602597|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111271678|NCT05602597|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110713126|NCT01029743|PENTA|penta|mesh-list
111271679|NCT05602597|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111271680|NCT04608201|Nicotine|nicotine|mesh-list
111271681|NCT04608201|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111271682|NCT04608201|Autonomic Agents|autonomic agents|mesh-ancestor
111271683|NCT04608201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111271684|NCT04608201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111271685|NCT04608201|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111271686|NCT04608201|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111271687|NCT04608201|Cholinergic Agents|cholinergic agents|mesh-ancestor
111271688|NCT04608201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111271689|NCT04608201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111271690|NCT04110444|Sildenafil Citrate|sildenafil citrate|mesh-list
111271691|NCT04110444|Vasodilator Agents|vasodilator agents|mesh-ancestor
111271692|NCT04110444|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111271693|NCT04110444|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111271694|NCT04110444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111271695|NCT04110444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111271696|NCT04110444|Urological Agents|urological agents|mesh-ancestor
111271697|NCT04951986|Levofloxacin|levofloxacin|mesh-list
111271698|NCT04951986|Rifampin|rifampin|mesh-list
111271699|NCT04951986|Isoniazid|isoniazid|mesh-list
111271700|NCT04951986|Pyrazinamide|pyrazinamide|mesh-list
111271701|NCT04951986|Ethambutol|ethambutol|mesh-list
111271702|NCT04951986|Prednisone|prednisone|mesh-list
111271703|NCT04951986|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111271704|NCT04951986|Glucocorticoids|glucocorticoids|mesh-ancestor
111271705|NCT04951986|Hormones|hormones|mesh-ancestor
111271706|NCT04951986|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111271707|NCT04951986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111271708|NCT04951986|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111271709|NCT04951986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111271710|NCT04951986|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111271711|NCT04951986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111271712|NCT04951986|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111271713|NCT04951986|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111271714|NCT04951986|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111271715|NCT04951986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111271716|NCT04951986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111271717|NCT04951986|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111271718|NCT04951986|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111271719|NCT04951986|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110723830|NCT00142584|Adrenergic Agents|adrenergic agents|mesh-ancestor
111271720|NCT04951986|Antitubercular Agents|antitubercular agents|mesh-ancestor
111271721|NCT04951986|Leprostatic Agents|leprostatic agents|mesh-ancestor
111271722|NCT04951986|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111271723|NCT04951986|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111271724|NCT04951986|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111271725|NCT04951986|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
111271726|NCT04951986|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
111271727|NCT04951986|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
111271728|NCT04951986|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111271729|NCT04951986|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
111271730|NCT04951986|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111271731|NCT04951986|Antimetabolites|antimetabolites|mesh-ancestor
111271732|NCT04951986|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111271733|NCT04278859|Antibodies|antibodies|mesh-list
111271734|NCT04278859|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111271735|NCT04278859|Immunologic Factors|immunologic factors|mesh-ancestor
111271736|NCT04278859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111271737|NCT04484337|Cabotegravir|cabotegravir|mesh-list
111271738|NCT04484337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
111271739|NCT04484337|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
111271740|NCT04484337|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111271741|NCT04484337|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111271742|NCT04484337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111271743|NCT04484337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111271744|NCT04484337|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111271745|NCT04484337|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111271746|NCT04484337|Antiviral Agents|antiviral agents|mesh-ancestor
111271747|NCT04484337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111271748|NCT04484337|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111271749|NCT04484337|Analgesics|analgesics|mesh-ancestor
111271750|NCT04484337|Sensory System Agents|sensory system agents|mesh-ancestor
111271751|NCT04484337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111271752|NCT04484337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111271753|NCT04484337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111271754|NCT01474538|Insulin|insulin|mesh-list
111271755|NCT01474538|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111271756|NCT01474538|Insulin Aspart|insulin aspart|mesh-list
111271757|NCT01474538|Insulin Lispro|insulin lispro|mesh-list
111271758|NCT01474538|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111271759|NCT01474538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111271760|NCT04278703|Oxycodone|oxycodone|mesh-list
111271761|NCT04278703|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111271762|NCT04278703|Narcotics|narcotics|mesh-ancestor
111271763|NCT04278703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111271764|NCT04278703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111271765|NCT04278703|Analgesics|analgesics|mesh-ancestor
111271766|NCT04278703|Sensory System Agents|sensory system agents|mesh-ancestor
111271767|NCT04278703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111271768|NCT02647788|Acetaminophen|acetaminophen|mesh-list
111271769|NCT02647788|Ibuprofen|ibuprofen|mesh-list
111271770|NCT02647788|Codeine|codeine|mesh-list
111271771|NCT02647788|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111271772|NCT02647788|Analgesics|analgesics|mesh-ancestor
111271773|NCT02647788|Sensory System Agents|sensory system agents|mesh-ancestor
111271774|NCT02647788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111271775|NCT02647788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111271776|NCT02647788|Antipyretics|antipyretics|mesh-ancestor
111271777|NCT02647788|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111271778|NCT02647788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111271779|NCT02647788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111271780|NCT02647788|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111271781|NCT02647788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111271782|NCT02647788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111271783|NCT02647788|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111271784|NCT02647788|Narcotics|narcotics|mesh-ancestor
111271785|NCT02647788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111271786|NCT02647788|Antitussive Agents|antitussive agents|mesh-ancestor
111271787|NCT02647788|Respiratory System Agents|respiratory system agents|mesh-ancestor
111271788|NCT04382859|Bupivacaine|bupivacaine|mesh-list
111271789|NCT04382859|Anesthetics, Local|anesthetics, local|mesh-ancestor
111271790|NCT04382859|Anesthetics|anesthetics|mesh-ancestor
111271791|NCT04382859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111271792|NCT04382859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111271793|NCT04382859|Sensory System Agents|sensory system agents|mesh-ancestor
111271794|NCT04382859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111271795|NCT03318133|Anesthetics|anesthetics|mesh-list
111271796|NCT03318133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111271797|NCT03318133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111271798|NCT04520217|Imipramine|imipramine|mesh-list
111271799|NCT04520217|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
111271800|NCT04520217|Antidepressive Agents|antidepressive agents|mesh-ancestor
111271801|NCT04520217|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111271802|NCT04520217|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111271803|NCT04520217|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111271804|NCT04520217|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111271805|NCT04520217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111271806|NCT04520217|Adrenergic Agents|adrenergic agents|mesh-ancestor
111271807|NCT04520217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111271808|NCT04520217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111271809|NCT04134663|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
111271810|NCT04134663|Oxytocin|oxytocin|mesh-list
111271811|NCT04134663|Oxytocics|oxytocics|mesh-ancestor
111271812|NCT04134663|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111271813|NCT04134663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111271814|NCT05431764|Gemcitabine|gemcitabine|mesh-list
111271815|NCT05431764|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
111271816|NCT05431764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111271817|NCT05431764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111271818|NCT05431764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111271819|NCT05431764|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111271820|NCT05431764|Antimetabolites|antimetabolites|mesh-ancestor
111271821|NCT04311411|Liraglutide|liraglutide|mesh-list
111271822|NCT04311411|Tirzepatide|tirzepatide|mesh-list
111271823|NCT04311411|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111271824|NCT04311411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111271825|NCT04311411|Incretins|incretins|mesh-ancestor
111271826|NCT04311411|Hormones|hormones|mesh-ancestor
111271827|NCT04311411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111271828|NCT00843531|Everolimus|everolimus|mesh-list
111271829|NCT00843531|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111271830|NCT00843531|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111271831|NCT00843531|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111271832|NCT00843531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111271833|NCT00843531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111271834|NCT00843531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111271835|NCT00843531|Immunologic Factors|immunologic factors|mesh-ancestor
111271836|NCT00843531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111271837|NCT00843531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111271838|NCT00812877|Calcium|calcium|mesh-list
111271839|NCT00812877|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111271840|NCT00812877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111271841|NCT00813111|Epinephrine|epinephrine|mesh-list
111271842|NCT00813111|Bupivacaine|bupivacaine|mesh-list
111271843|NCT00813111|Anesthetics, Local|anesthetics, local|mesh-ancestor
111271844|NCT00813111|Anesthetics|anesthetics|mesh-ancestor
111271845|NCT00813111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111271846|NCT00813111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111271847|NCT00813111|Sensory System Agents|sensory system agents|mesh-ancestor
111271848|NCT00813111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111271849|NCT00813111|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111271850|NCT00813111|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111271851|NCT00813111|Adrenergic Agents|adrenergic agents|mesh-ancestor
111271852|NCT00813111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111271853|NCT00813111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111271854|NCT00813111|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111271855|NCT00813111|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111271856|NCT00813111|Autonomic Agents|autonomic agents|mesh-ancestor
111271857|NCT00813111|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111271858|NCT00813111|Respiratory System Agents|respiratory system agents|mesh-ancestor
111271859|NCT00813111|Mydriatics|mydriatics|mesh-ancestor
111271860|NCT00813111|Sympathomimetics|sympathomimetics|mesh-ancestor
111271861|NCT00813111|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111271862|NCT00845481|Calcitriol|calcitriol|mesh-list
111271863|NCT00845481|Betamethasone|betamethasone|mesh-list
111271864|NCT00845481|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111271865|NCT00845481|Glucocorticoids|glucocorticoids|mesh-ancestor
111271866|NCT00845481|Hormones|hormones|mesh-ancestor
111271867|NCT00845481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111271868|NCT00845481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111271869|NCT00845481|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111271870|NCT00845481|Respiratory System Agents|respiratory system agents|mesh-ancestor
111271871|NCT00845481|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111271872|NCT00845481|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
111271873|NCT00845481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111271874|NCT00845481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111271875|NCT00845481|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111271876|NCT00845481|Vitamins|vitamins|mesh-ancestor
111271877|NCT00845481|Micronutrients|micronutrients|mesh-ancestor
111271878|NCT00845481|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111271879|NCT03641001|Micronutrients|micronutrients|mesh-list
111271880|NCT03641001|Trace Elements|trace elements|mesh-list
111271881|NCT03641001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111271882|NCT01421069|Etanercept|etanercept|mesh-list
111271883|NCT01421069|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111271884|NCT01421069|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111271885|NCT01421069|Analgesics|analgesics|mesh-ancestor
111271886|NCT01421069|Sensory System Agents|sensory system agents|mesh-ancestor
111271887|NCT01421069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111271888|NCT01421069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111271889|NCT01421069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111271890|NCT01421069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111271891|NCT01421069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111271892|NCT01421069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111271893|NCT01421069|Immunologic Factors|immunologic factors|mesh-ancestor
111271894|NCT04276233|Albuterol|albuterol|mesh-list
111271895|NCT04276233|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111271896|NCT04276233|Autonomic Agents|autonomic agents|mesh-ancestor
111271897|NCT04276233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111271898|NCT04276233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111271899|NCT04276233|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111271900|NCT04276233|Respiratory System Agents|respiratory system agents|mesh-ancestor
111271901|NCT04276233|Tocolytic Agents|tocolytic agents|mesh-ancestor
111271902|NCT04276233|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111271903|NCT04276233|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111271904|NCT04276233|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111271905|NCT04276233|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111271906|NCT04276233|Adrenergic Agents|adrenergic agents|mesh-ancestor
111271907|NCT04276233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111271908|NCT04276233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111271910|NCT04681430|Camostat|camostat|mesh-list
111271911|NCT04681430|Protease Inhibitors|protease inhibitors|mesh-ancestor
111271912|NCT04681430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111271913|NCT04681430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111271914|NCT04681430|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
111271915|NCT04681430|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111271916|NCT04681430|Anticoagulants|anticoagulants|mesh-ancestor
111271917|NCT03309475|Psychotropic Drugs|psychotropic drugs|mesh-list
111271918|NCT00814671|Rifampin|rifampin|mesh-list
111271919|NCT00814671|Rifapentine|rifapentine|mesh-list
111271920|NCT00814671|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111271921|NCT00814671|Antitubercular Agents|antitubercular agents|mesh-ancestor
111271922|NCT00814671|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111271923|NCT00814671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111271924|NCT00814671|Leprostatic Agents|leprostatic agents|mesh-ancestor
111271925|NCT00814671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111271926|NCT00814671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111271927|NCT00814671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111271928|NCT00814671|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111271929|NCT00814671|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111271930|NCT00814671|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
111271931|NCT00814671|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
111271932|NCT00814671|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
111271933|NCT00814671|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111271934|NCT03379051|Lenalidomide|lenalidomide|mesh-list
111271935|NCT03379051|Venetoclax|venetoclax|mesh-list
111271936|NCT03379051|Immunologic Factors|immunologic factors|mesh-ancestor
111271937|NCT03379051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111271938|NCT03379051|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111271939|NCT03379051|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111271940|NCT03379051|Growth Substances|growth substances|mesh-ancestor
111271941|NCT03379051|Growth Inhibitors|growth inhibitors|mesh-ancestor
111271942|NCT03379051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111271943|NCT01473836|Metronidazole|metronidazole|mesh-list
111271944|NCT01473836|Ceftriaxone|ceftriaxone|mesh-list
111271945|NCT01473836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111271946|NCT01473836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111271947|NCT01473836|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111271948|NCT01473836|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111271949|NCT03340909|Prednisolone|prednisolone|mesh-list
111271950|NCT03340909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111271951|NCT03340909|Glucocorticoids|glucocorticoids|mesh-ancestor
111271952|NCT03340909|Hormones|hormones|mesh-ancestor
111271953|NCT03340909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111271954|NCT03340909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111271955|NCT03340909|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111271956|NCT03340909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111271957|NCT05686915|Cobalt|cobalt|mesh-list
111271958|NCT05686915|Chromium|chromium|mesh-list
111271959|NCT05686915|Trace Elements|trace elements|mesh-ancestor
111271960|NCT05686915|Micronutrients|micronutrients|mesh-ancestor
111271961|NCT05686915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111271962|NCT03674151|Povidone|povidone|mesh-list
111271963|NCT03674151|Plasma Substitutes|plasma substitutes|mesh-ancestor
111271964|NCT03674151|Blood Substitutes|blood substitutes|mesh-ancestor
111271965|NCT03643965|Budesonide|budesonide|mesh-list
111271966|NCT03643965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111271967|NCT03643965|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111271968|NCT03643965|Autonomic Agents|autonomic agents|mesh-ancestor
111271969|NCT03643965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111271970|NCT03643965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111271971|NCT03643965|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111271972|NCT03643965|Respiratory System Agents|respiratory system agents|mesh-ancestor
111271973|NCT03643965|Glucocorticoids|glucocorticoids|mesh-ancestor
111271974|NCT03643965|Hormones|hormones|mesh-ancestor
111271975|NCT03643965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111271976|NCT02979522|Doxorubicin|doxorubicin|mesh-list
111271977|NCT02979522|Dacarbazine|dacarbazine|mesh-list
111271978|NCT02979522|Brentuximab Vedotin|brentuximab vedotin|mesh-list
110996312|NCT03443037|Analgesics|analgesics|mesh-ancestor
111271979|NCT02979522|Vinblastine|vinblastine|mesh-list
111271980|NCT02979522|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111271981|NCT02979522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111271982|NCT02979522|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111271983|NCT02979522|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111271984|NCT02979522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111271985|NCT02979522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111271986|NCT02979522|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111271987|NCT02979522|Alkylating Agents|alkylating agents|mesh-ancestor
111271988|NCT02979522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111271989|NCT02979522|Immunotoxins|immunotoxins|mesh-ancestor
111271990|NCT02979522|Immunoconjugates|immunoconjugates|mesh-ancestor
111271991|NCT02979522|Immunologic Factors|immunologic factors|mesh-ancestor
111271992|NCT02979522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111271993|NCT02979522|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111271994|NCT02979522|Tubulin Modulators|tubulin modulators|mesh-ancestor
111271995|NCT02979522|Antimitotic Agents|antimitotic agents|mesh-ancestor
111271996|NCT02979522|Mitosis Modulators|mitosis modulators|mesh-ancestor
111271997|NCT01420679|10-deazaaminopterin|10-deazaaminopterin|mesh-list
111271998|NCT01420679|Aminopterin|aminopterin|mesh-list
111271999|NCT01420679|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111272000|NCT01420679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111272001|NCT01420679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111272002|NCT01420679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111272003|NCT00851409|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
111272004|NCT00851409|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
111272005|NCT00851409|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111272006|NCT00851409|Immunologic Factors|immunologic factors|mesh-ancestor
111272007|NCT00851409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111272009|NCT04401007|Anesthetics, Local|anesthetics, local|mesh-ancestor
111272010|NCT04401007|Anesthetics|anesthetics|mesh-ancestor
111272011|NCT04401007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111272012|NCT04401007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111272013|NCT04401007|Sensory System Agents|sensory system agents|mesh-ancestor
111272014|NCT04401007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111272015|NCT04401007|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111272016|NCT04401007|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111272017|NCT04401007|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111272018|NCT04401007|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111272019|NCT04401007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111272020|NCT01496846|Lidocaine|lidocaine|mesh-list
111272021|NCT01496846|Carticaine|carticaine|mesh-list
111272022|NCT01496846|Anesthetics, Local|anesthetics, local|mesh-ancestor
111272023|NCT01496846|Anesthetics|anesthetics|mesh-ancestor
111272024|NCT01496846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111272025|NCT01496846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111272026|NCT01496846|Sensory System Agents|sensory system agents|mesh-ancestor
111272027|NCT01496846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111272028|NCT01496846|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111272029|NCT01496846|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111272030|NCT01496846|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111272031|NCT01496846|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111272032|NCT01496846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111272033|NCT00964002|Efavirenz|efavirenz|mesh-list
111272034|NCT00964002|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111272035|NCT00964002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111272036|NCT00964002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111272037|NCT00964002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111272038|NCT00964002|Antiviral Agents|antiviral agents|mesh-ancestor
111272039|NCT00964002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111272040|NCT00964002|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111272041|NCT00964002|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111272042|NCT00964002|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111272043|NCT00964002|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111272044|NCT00964002|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111272045|NCT00964002|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111272046|NCT00818337|Aspirin|aspirin|mesh-list
111272047|NCT00818337|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111272048|NCT00818337|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111272049|NCT00818337|Analgesics|analgesics|mesh-ancestor
110959296|NCT03389126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111272050|NCT00818337|Sensory System Agents|sensory system agents|mesh-ancestor
111272051|NCT00818337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111272052|NCT00818337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111272053|NCT00818337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111272054|NCT00818337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111272055|NCT00818337|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111272056|NCT00818337|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111272057|NCT00818337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111272058|NCT00818337|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111272059|NCT00818337|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111272060|NCT00818337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111272062|NCT02577120|Decanoic acid|decanoic acid|mesh-list
111272063|NCT02577120|Petrolatum|petrolatum|mesh-list
111272064|NCT02577120|Emollients|emollients|mesh-ancestor
111272065|NCT02577120|Dermatologic Agents|dermatologic agents|mesh-ancestor
111272066|NCT02577120|Antifungal Agents|antifungal agents|mesh-ancestor
111272067|NCT02577120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111272068|NCT01399697|Methotrexate|methotrexate|mesh-list
111272069|NCT01399697|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111272070|NCT01399697|Abortifacient Agents|abortifacient agents|mesh-ancestor
111272071|NCT01399697|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111272072|NCT01399697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111272073|NCT01399697|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111272074|NCT01399697|Antimetabolites|antimetabolites|mesh-ancestor
111272075|NCT01399697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111272076|NCT01399697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111272077|NCT01399697|Dermatologic Agents|dermatologic agents|mesh-ancestor
111272078|NCT01399697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111272079|NCT01399697|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111272080|NCT01399697|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111272081|NCT01399697|Immunologic Factors|immunologic factors|mesh-ancestor
111272082|NCT01399697|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111272083|NCT01399697|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111272084|NCT00853671|Adenosine|adenosine|mesh-list
111272085|NCT00853671|Analgesics|analgesics|mesh-ancestor
111272086|NCT00853671|Sensory System Agents|sensory system agents|mesh-ancestor
111272087|NCT00853671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111272088|NCT00853671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111272089|NCT00853671|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111272090|NCT00853671|Vasodilator Agents|vasodilator agents|mesh-ancestor
111272091|NCT00853671|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
111272092|NCT00853671|Purinergic Agonists|purinergic agonists|mesh-ancestor
111272093|NCT00853671|Purinergic Agents|purinergic agents|mesh-ancestor
111272094|NCT00853671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111272095|NCT00853671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111272096|NCT00818805|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
111272097|NCT00818805|Tranilast|tranilast|mesh-list
111272098|NCT00818805|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111272099|NCT00818805|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111272100|NCT00818805|Analgesics|analgesics|mesh-ancestor
111272101|NCT00818805|Sensory System Agents|sensory system agents|mesh-ancestor
111272102|NCT00818805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111272103|NCT00818805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111272104|NCT00818805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111272105|NCT00818805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111272106|NCT00818805|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111272107|NCT00818805|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
111272108|NCT00818805|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111272109|NCT00818805|Histamine Antagonists|histamine antagonists|mesh-ancestor
111272110|NCT00818805|Histamine Agents|histamine agents|mesh-ancestor
111272111|NCT00818805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111272112|NCT00818805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111272113|NCT00818805|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111272114|NCT00818805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111272115|NCT00818805|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111272116|NCT00818805|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111272117|NCT00854061|Prednisone|prednisone|mesh-list
111272118|NCT00854061|Prednisolone acetate|prednisolone acetate|mesh-list
111272119|NCT00854061|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111272120|NCT00854061|Methylprednisolone|methylprednisolone|mesh-list
111272121|NCT00854061|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111272122|NCT00854061|Prednisolone|prednisolone|mesh-list
111272123|NCT00854061|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111272124|NCT00854061|Prednisolone phosphate|prednisolone phosphate|mesh-list
111272125|NCT00854061|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111272126|NCT00854061|Glucocorticoids|glucocorticoids|mesh-ancestor
111272127|NCT00854061|Hormones|hormones|mesh-ancestor
111272128|NCT00854061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111272129|NCT00854061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111272130|NCT00854061|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111272131|NCT00854061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111272132|NCT00854061|Antiemetics|antiemetics|mesh-ancestor
111272133|NCT00854061|Autonomic Agents|autonomic agents|mesh-ancestor
111272134|NCT00854061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111272135|NCT00854061|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111272136|NCT00854061|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111272137|NCT00854061|Protective Agents|protective agents|mesh-ancestor
111272138|NCT01473602|Vitamin D|vitamin d|mesh-list
111272139|NCT01473602|Teriparatide|teriparatide|mesh-list
111272140|NCT01473602|Calcium|calcium|mesh-list
111272141|NCT01473602|Vitamins|vitamins|mesh-ancestor
111272142|NCT01473602|Micronutrients|micronutrients|mesh-ancestor
111272143|NCT01473602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111272144|NCT01473602|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111272145|NCT01473602|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111272146|NCT03336073|Dexamethasone|dexamethasone|mesh-list
111272147|NCT03336073|Cyclophosphamide|cyclophosphamide|mesh-list
111272148|NCT03336073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111272149|NCT03336073|Immunologic Factors|immunologic factors|mesh-ancestor
111272150|NCT03336073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111272151|NCT03336073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111272152|NCT03336073|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111272153|NCT03336073|Alkylating Agents|alkylating agents|mesh-ancestor
111272154|NCT03336073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111272155|NCT03336073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111272156|NCT03336073|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111272157|NCT03336073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111272158|NCT03336073|Antiemetics|antiemetics|mesh-ancestor
111272159|NCT03336073|Autonomic Agents|autonomic agents|mesh-ancestor
111272160|NCT03336073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111272161|NCT03336073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111272162|NCT03336073|Glucocorticoids|glucocorticoids|mesh-ancestor
111272163|NCT03336073|Hormones|hormones|mesh-ancestor
111272164|NCT03336073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111272165|NCT03336073|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111272166|NCT01496612|Buspirone|buspirone|mesh-list
111272167|NCT01496612|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111272168|NCT01496612|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111272169|NCT01496612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111272170|NCT01496612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111272171|NCT01496612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111272172|NCT01496612|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111272173|NCT01496612|Serotonin Agents|serotonin agents|mesh-ancestor
111272174|NCT01496612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111272175|NCT01496612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111272176|NCT00790218|Adenosine|adenosine|mesh-list
111272177|NCT00790218|Analgesics|analgesics|mesh-ancestor
111272178|NCT00790218|Sensory System Agents|sensory system agents|mesh-ancestor
111272179|NCT00790218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111272180|NCT00790218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111272181|NCT00790218|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111272182|NCT00790218|Vasodilator Agents|vasodilator agents|mesh-ancestor
111272183|NCT00790218|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
111272184|NCT00790218|Purinergic Agonists|purinergic agonists|mesh-ancestor
111272185|NCT00790218|Purinergic Agents|purinergic agents|mesh-ancestor
111272186|NCT00790218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111272187|NCT00790218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111272188|NCT03300427|Valsartan|valsartan|mesh-list
111272189|NCT03300427|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
111272190|NCT03300427|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111272191|NCT03300427|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111272192|NCT03300427|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111272193|NCT03300427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111272194|NCT00818961|Cyclophosphamide|cyclophosphamide|mesh-list
111272195|NCT00818961|Busulfan|busulfan|mesh-list
111272196|NCT00818961|Rituximab|rituximab|mesh-list
110996553|NCT01061333|Nedocromil|nedocromil|mesh-list
111272197|NCT00818961|Methotrexate|methotrexate|mesh-list
111272199|NCT00818961|Fludarabine phosphate|fludarabine phosphate|mesh-list
111272200|NCT00818961|Alemtuzumab|alemtuzumab|mesh-list
111272201|NCT00818961|Tacrolimus|tacrolimus|mesh-list
111272202|NCT00818961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111272203|NCT00818961|Immunologic Factors|immunologic factors|mesh-ancestor
111272204|NCT00818961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111272205|NCT00818961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111272206|NCT00818961|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111272207|NCT00818961|Alkylating Agents|alkylating agents|mesh-ancestor
111272208|NCT00818961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111272209|NCT00818961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111272210|NCT00818961|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111272211|NCT00818961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111272212|NCT00818961|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111272213|NCT00818961|Abortifacient Agents|abortifacient agents|mesh-ancestor
111272214|NCT00818961|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111272215|NCT00818961|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111272216|NCT00818961|Antimetabolites|antimetabolites|mesh-ancestor
111272217|NCT00818961|Dermatologic Agents|dermatologic agents|mesh-ancestor
111272218|NCT00818961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111272219|NCT00818961|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111272220|NCT00818961|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111272221|NCT00818961|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111272222|NCT05431218|Cholecalciferol|cholecalciferol|mesh-list
111272223|NCT05431218|Vitamin D|vitamin d|mesh-list
111272224|NCT05431218|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111272225|NCT05431218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111272226|NCT05431218|Vitamins|vitamins|mesh-ancestor
111272227|NCT05431218|Micronutrients|micronutrients|mesh-ancestor
111272228|NCT05431218|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111272229|NCT05431062|Bupivacaine|bupivacaine|mesh-list
111272230|NCT05431062|Anesthetics, Local|anesthetics, local|mesh-ancestor
111272231|NCT05431062|Anesthetics|anesthetics|mesh-ancestor
111272232|NCT05431062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111272233|NCT05431062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111272234|NCT05431062|Sensory System Agents|sensory system agents|mesh-ancestor
111272235|NCT05431062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111272236|NCT00819507|Fluocinonide|fluocinonide|mesh-list
111272237|NCT00819507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111272238|NCT00819507|Glucocorticoids|glucocorticoids|mesh-ancestor
111272239|NCT00819507|Hormones|hormones|mesh-ancestor
111272240|NCT00819507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111272241|NCT00819507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111272242|NCT00819507|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111272243|NCT03696121|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
111272244|NCT03696121|Hemostatics|hemostatics|mesh-ancestor
111272245|NCT03696121|Coagulants|coagulants|mesh-ancestor
111272246|NCT03696121|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
111272247|NCT03696121|Natriuretic Agents|natriuretic agents|mesh-ancestor
111272248|NCT03696121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111272249|NCT01457924|Ofatumumab|ofatumumab|mesh-list
111272250|NCT01457924|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111272251|NCT01457924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111272252|NCT01457924|Immunologic Factors|immunologic factors|mesh-ancestor
111272253|NCT01457924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111272254|NCT05237115|Amoxicillin|amoxicillin|mesh-list
111272255|NCT05237115|Clarithromycin|clarithromycin|mesh-list
111272256|NCT05237115|Esomeprazole|esomeprazole|mesh-list
111272257|NCT05237115|Bismuth|bismuth|mesh-list
111272258|NCT05237115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111272259|NCT05237115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111272260|NCT05237115|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111272261|NCT05237115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111272262|NCT05237115|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111272263|NCT05237115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111272264|NCT05237115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111272265|NCT05237115|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111272266|NCT05237115|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111272267|NCT05237115|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111272268|NCT05237115|Antacids|antacids|mesh-ancestor
111272269|NCT04040621|Ceftazidime|ceftazidime|mesh-list
111272270|NCT04040621|Avibactam|avibactam|mesh-list
111272271|NCT04040621|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
111272272|NCT04040621|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111272273|NCT04040621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111272274|NCT04040621|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
111272275|NCT04040621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111272276|NCT04040621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111272277|NCT00856791|ON 01910|on 01910|mesh-list
111272278|NCT00856791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111272279|NCT00856791|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111272280|NCT00856791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111272281|NCT00856791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111272282|NCT00857493|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
111272283|NCT00857493|Antiviral Agents|antiviral agents|mesh-ancestor
111272284|NCT00857493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111272285|NCT05236569|Tranexamic Acid|tranexamic acid|mesh-list
111272286|NCT05236569|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111272287|NCT05236569|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111272288|NCT05236569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111272289|NCT05236569|Hemostatics|hemostatics|mesh-ancestor
111272290|NCT05236569|Coagulants|coagulants|mesh-ancestor
111272291|NCT00857727|Dexmedetomidine|dexmedetomidine|mesh-list
111272292|NCT00857727|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111272293|NCT00857727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111272294|NCT00857727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111272295|NCT00857727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111272296|NCT00857727|Analgesics|analgesics|mesh-ancestor
111272297|NCT00857727|Sensory System Agents|sensory system agents|mesh-ancestor
111272298|NCT00857727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111272299|NCT00857727|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111272300|NCT00857727|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111272301|NCT00857727|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111272302|NCT00857727|Adrenergic Agents|adrenergic agents|mesh-ancestor
111272303|NCT00857727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110724444|NCT01306318|Eperisone|eperisone|mesh-list
111272304|NCT00857727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111272305|NCT00857961|Testosterone|testosterone|mesh-list
111272306|NCT00857961|Androgens|androgens|mesh-ancestor
111272307|NCT00857961|Hormones|hormones|mesh-ancestor
111272308|NCT00857961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111272309|NCT00857961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111272310|NCT03839433|Ciclesonide|ciclesonide|mesh-list
111272311|NCT03839433|Glucocorticoids|glucocorticoids|mesh-ancestor
111272312|NCT03839433|Hormones|hormones|mesh-ancestor
111272313|NCT03839433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111272314|NCT03839433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111272315|NCT03839433|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111272316|NCT05033041|Metoclopramide|metoclopramide|mesh-list
111272317|NCT05033041|Antiemetics|antiemetics|mesh-ancestor
111272318|NCT05033041|Autonomic Agents|autonomic agents|mesh-ancestor
111272319|NCT05033041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111272320|NCT05033041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111272321|NCT05033041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111272322|NCT05033041|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111272323|NCT05033041|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111272324|NCT05033041|Dopamine Agents|dopamine agents|mesh-ancestor
111272325|NCT05033041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111272326|NCT05033041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111272327|NCT00823797|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
111272328|NCT00823797|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111272329|NCT00823797|Alkylating Agents|alkylating agents|mesh-ancestor
111272330|NCT00823797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111272331|NCT00823797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111272332|NCT00824733|Trastuzumab|trastuzumab|mesh-list
111272333|NCT00824733|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111272334|NCT00824733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111272335|NCT02150499|Albuterol|albuterol|mesh-list
111272336|NCT02150499|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111272337|NCT02150499|Autonomic Agents|autonomic agents|mesh-ancestor
111272338|NCT02150499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111272339|NCT02150499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111272340|NCT02150499|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111272341|NCT02150499|Respiratory System Agents|respiratory system agents|mesh-ancestor
111272342|NCT02150499|Tocolytic Agents|tocolytic agents|mesh-ancestor
111272343|NCT02150499|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111272344|NCT02150499|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111272345|NCT02150499|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111272346|NCT02150499|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111272347|NCT02150499|Adrenergic Agents|adrenergic agents|mesh-ancestor
111272348|NCT02150499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111272349|NCT02150499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111272350|NCT03287947|Nintedanib|nintedanib|mesh-list
111272351|NCT03287947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111272352|NCT03287947|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111272353|NCT03287947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111272354|NCT03287947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111272355|NCT05685667|Hyaluronic Acid|hyaluronic acid|mesh-list
111272356|NCT05685667|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111272357|NCT05685667|Immunologic Factors|immunologic factors|mesh-ancestor
111272358|NCT05685667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111272359|NCT05685667|Viscosupplements|viscosupplements|mesh-ancestor
111272360|NCT05685667|Protective Agents|protective agents|mesh-ancestor
111272361|NCT00859131|Thymoglobulin|thymoglobulin|mesh-list
111272362|NCT00859131|Antilymphocyte Serum|antilymphocyte serum|mesh-list
111272363|NCT00859131|Daclizumab|daclizumab|mesh-list
111272364|NCT00859131|Immunologic Factors|immunologic factors|mesh-ancestor
111272365|NCT00859131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111272366|NCT00859131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111272367|NCT00859833|Adenosine|adenosine|mesh-list
111272368|NCT00859833|Regadenoson|regadenoson|mesh-list
111272369|NCT00859833|Analgesics|analgesics|mesh-ancestor
111272370|NCT00859833|Sensory System Agents|sensory system agents|mesh-ancestor
111272371|NCT00859833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111272372|NCT00859833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111272373|NCT00859833|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111272374|NCT00859833|Vasodilator Agents|vasodilator agents|mesh-ancestor
111272375|NCT00859833|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
111272376|NCT00859833|Purinergic Agonists|purinergic agonists|mesh-ancestor
111272377|NCT00859833|Purinergic Agents|purinergic agents|mesh-ancestor
111272378|NCT00859833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111272379|NCT00859833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111272380|NCT00859833|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
111272381|NCT02154477|Insulin|insulin|mesh-list
111272382|NCT02154477|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111272383|NCT02154477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111272384|NCT00860379|Selenium|selenium|mesh-list
111272385|NCT00860379|Antioxidants|antioxidants|mesh-ancestor
111272386|NCT00860379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111272387|NCT00860379|Protective Agents|protective agents|mesh-ancestor
111272388|NCT00860379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111272389|NCT00860379|Trace Elements|trace elements|mesh-ancestor
111272390|NCT00860379|Micronutrients|micronutrients|mesh-ancestor
111272391|NCT00860457|Rituximab|rituximab|mesh-list
111272392|NCT00860457|Fludarabine|fludarabine|mesh-list
111272393|NCT00860457|Lenalidomide|lenalidomide|mesh-list
111272394|NCT00860457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111272395|NCT00860457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111272396|NCT00860457|Immunologic Factors|immunologic factors|mesh-ancestor
111272397|NCT00860457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111272398|NCT00860457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111272399|NCT00860457|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111272400|NCT00860457|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111272401|NCT00860457|Growth Substances|growth substances|mesh-ancestor
111272402|NCT00860457|Growth Inhibitors|growth inhibitors|mesh-ancestor
111272403|NCT00827073|Lidocaine|lidocaine|mesh-list
111272404|NCT00827073|Tetracaine|tetracaine|mesh-list
111272405|NCT00827073|Anesthetics, Local|anesthetics, local|mesh-ancestor
111272406|NCT00827073|Anesthetics|anesthetics|mesh-ancestor
111272407|NCT00827073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111272408|NCT00827073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111272409|NCT00827073|Sensory System Agents|sensory system agents|mesh-ancestor
111272410|NCT00827073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111272411|NCT00827073|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111272412|NCT00827073|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111272413|NCT00827073|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111272414|NCT00827073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111272415|NCT00827073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111272416|NCT00860847|Ubiquinone|ubiquinone|mesh-list
111272417|NCT00860847|Coenzyme Q10|coenzyme q10|mesh-list
111272418|NCT00860847|Micronutrients|micronutrients|mesh-ancestor
111272419|NCT00860847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110996764|NCT02481310|Antimetabolites|antimetabolites|mesh-ancestor
111272420|NCT00860847|Vitamins|vitamins|mesh-ancestor
111272421|NCT04347733|Triamcinolone|triamcinolone|mesh-list
111272422|NCT04347733|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
111272423|NCT04347733|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
111272424|NCT04347733|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
111272425|NCT04347733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111272426|NCT04347733|Glucocorticoids|glucocorticoids|mesh-ancestor
111272427|NCT04347733|Hormones|hormones|mesh-ancestor
111272428|NCT04347733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111272429|NCT04347733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111272430|NCT04347733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111272431|NCT04347733|Immunologic Factors|immunologic factors|mesh-ancestor
111272432|NCT04347733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111272433|NCT04347733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111272434|NCT02155101|Ritonavir|ritonavir|mesh-list
111272435|NCT02155101|Lopinavir|lopinavir|mesh-list
111272436|NCT02155101|Atazanavir Sulfate|atazanavir sulfate|mesh-list
111272437|NCT02155101|Darunavir|darunavir|mesh-list
111272438|NCT02155101|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111272439|NCT02155101|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111272440|NCT02155101|Protease Inhibitors|protease inhibitors|mesh-ancestor
111272441|NCT02155101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111272442|NCT02155101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111272443|NCT02155101|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111272444|NCT02155101|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111272445|NCT02155101|Antiviral Agents|antiviral agents|mesh-ancestor
111272446|NCT02155101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111272447|NCT02155101|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111272448|NCT02155101|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111272449|NCT02155257|Gabapentin|gabapentin|mesh-list
111272450|NCT02155257|Modafinil|modafinil|mesh-list
111272451|NCT02155257|Analgesics|analgesics|mesh-ancestor
110724574|NCT05571748|Vitamins|vitamins|mesh-ancestor
111272452|NCT02155257|Sensory System Agents|sensory system agents|mesh-ancestor
111272453|NCT02155257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111272454|NCT02155257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111272455|NCT02155257|Anticonvulsants|anticonvulsants|mesh-ancestor
111272456|NCT02155257|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111272457|NCT02155257|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111272458|NCT02155257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111272459|NCT02155257|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111272460|NCT02155257|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111272461|NCT02155257|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111272462|NCT02155257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111272463|NCT02155257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111272464|NCT02155257|Antimanic Agents|antimanic agents|mesh-ancestor
111272465|NCT02155257|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111272466|NCT02155257|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
111272467|NCT02155257|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111272468|NCT02155257|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111272469|NCT03243019|Sirolimus|sirolimus|mesh-list
111272470|NCT03243019|Temsirolimus|temsirolimus|mesh-list
111272471|NCT03243019|MTOR Inhibitors|mtor inhibitors|mesh-list
111272472|NCT03243019|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111272473|NCT03243019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111272474|NCT03243019|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111272475|NCT03243019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111272476|NCT03243019|Antifungal Agents|antifungal agents|mesh-ancestor
111272477|NCT03243019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111272478|NCT03243019|Immunologic Factors|immunologic factors|mesh-ancestor
111272479|NCT03243019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111272480|NCT03243019|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111272481|NCT03243019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111272482|NCT03243019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111272483|NCT04382625|Hydroxychloroquine|hydroxychloroquine|mesh-list
111272484|NCT04382625|Antimalarials|antimalarials|mesh-ancestor
111272485|NCT04382625|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111272486|NCT04382625|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111272487|NCT04382625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111272488|NCT04382625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111272489|NCT04382625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111272490|NCT04382625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111272491|NCT01673646|Pasireotide|pasireotide|mesh-list
111272492|NCT01673646|Hormones|hormones|mesh-ancestor
111272493|NCT01673646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111272494|NCT01673646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111272495|NCT00862563|Topiramate|topiramate|mesh-list
111272496|NCT00862563|Zonisamide|zonisamide|mesh-list
111272497|NCT00862563|Levetiracetam|levetiracetam|mesh-list
111272498|NCT00862563|Anticonvulsants|anticonvulsants|mesh-ancestor
111272499|NCT00862563|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111272500|NCT00862563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111272501|NCT00862563|Nootropic Agents|nootropic agents|mesh-ancestor
111272502|NCT00862563|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111272503|NCT00862563|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111272504|NCT00862563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111272505|NCT00862563|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111272506|NCT04278937|Azithromycin|azithromycin|mesh-list
111272507|NCT04278937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111272508|NCT04278937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111272509|NCT02647944|Liraglutide|liraglutide|mesh-list
111272510|NCT02647944|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111272511|NCT02647944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111272512|NCT02647944|Incretins|incretins|mesh-ancestor
111272513|NCT02647944|Hormones|hormones|mesh-ancestor
111272514|NCT02647944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111272515|NCT04278469|Antineoplastic Agents|antineoplastic agents|mesh-list
111272516|NCT04278547|Valganciclovir|valganciclovir|mesh-list
111272517|NCT04278547|Antiviral Agents|antiviral agents|mesh-ancestor
111272518|NCT04278547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111272519|NCT00863109|Ribavirin|ribavirin|mesh-list
111272520|NCT00863109|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
111272521|NCT00863109|Antimetabolites|antimetabolites|mesh-ancestor
111272522|NCT00863109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111272523|NCT00863109|Antiviral Agents|antiviral agents|mesh-ancestor
111272524|NCT00863109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111272525|NCT03238807|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
111272526|NCT03238807|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111272527|NCT03238807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111272528|NCT05246371|Dexmedetomidine|dexmedetomidine|mesh-list
111272529|NCT05246371|Propofol|propofol|mesh-list
111272530|NCT05246371|Desflurane|desflurane|mesh-list
111272531|NCT05246371|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111272532|NCT05246371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111272533|NCT05246371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111272534|NCT05246371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111272535|NCT05246371|Analgesics|analgesics|mesh-ancestor
111272536|NCT05246371|Sensory System Agents|sensory system agents|mesh-ancestor
111272537|NCT05246371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111272538|NCT05246371|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111272539|NCT05246371|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111272540|NCT05246371|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111272541|NCT05246371|Adrenergic Agents|adrenergic agents|mesh-ancestor
111272542|NCT05246371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111272543|NCT05246371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111272544|NCT05246371|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111272545|NCT05246371|Anesthetics, General|anesthetics, general|mesh-ancestor
111272546|NCT05246371|Anesthetics|anesthetics|mesh-ancestor
111272547|NCT05246371|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111272548|NCT00863265|Ezetimibe|ezetimibe|mesh-list
111272549|NCT00863265|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111272550|NCT00863265|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111272551|NCT00863265|Antimetabolites|antimetabolites|mesh-ancestor
111272552|NCT00863265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111272553|NCT00863265|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111272554|NCT00831675|Vaccines|vaccines|mesh-list
111272555|NCT00831675|Immunologic Factors|immunologic factors|mesh-ancestor
111272556|NCT00831675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111272557|NCT01397825|Rituximab|rituximab|mesh-list
111272558|NCT01397825|Vincristine|vincristine|mesh-list
111272559|NCT01397825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111272560|NCT01397825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111272561|NCT01397825|Immunologic Factors|immunologic factors|mesh-ancestor
111272562|NCT01397825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111272563|NCT01397825|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111272564|NCT01397825|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111272565|NCT01397825|Tubulin Modulators|tubulin modulators|mesh-ancestor
111272566|NCT01397825|Antimitotic Agents|antimitotic agents|mesh-ancestor
111272567|NCT01397825|Mitosis Modulators|mitosis modulators|mesh-ancestor
111272568|NCT01397825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111272569|NCT05353764|Ropivacaine|ropivacaine|mesh-list
111272570|NCT05353764|Anesthetics, Local|anesthetics, local|mesh-ancestor
111272571|NCT05353764|Anesthetics|anesthetics|mesh-ancestor
111272572|NCT05353764|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111272573|NCT05353764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111272574|NCT05353764|Sensory System Agents|sensory system agents|mesh-ancestor
111272575|NCT05353764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111272577|NCT00831987|Immunologic Factors|immunologic factors|mesh-ancestor
111272578|NCT00831987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111272579|NCT05239884|Nicotine|nicotine|mesh-list
111272580|NCT05239884|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111272581|NCT05239884|Autonomic Agents|autonomic agents|mesh-ancestor
111272582|NCT05239884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111272583|NCT05239884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111272584|NCT05239884|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111272585|NCT05239884|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111272586|NCT05239884|Cholinergic Agents|cholinergic agents|mesh-ancestor
111272587|NCT05239884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111272588|NCT05239884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111272589|NCT03836352|Cyclophosphamide|cyclophosphamide|mesh-list
111272590|NCT03836352|Pembrolizumab|pembrolizumab|mesh-list
111272591|NCT03836352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111272592|NCT03836352|Immunologic Factors|immunologic factors|mesh-ancestor
111272593|NCT03836352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111272594|NCT03836352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111272595|NCT03836352|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111272596|NCT03836352|Alkylating Agents|alkylating agents|mesh-ancestor
111272597|NCT03836352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111272598|NCT03836352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111272599|NCT03836352|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111272600|NCT03836352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111272601|NCT03836352|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111272602|NCT01397201|Fluticasone|fluticasone|mesh-list
111272603|NCT01397201|Xhance|xhance|mesh-list
111272604|NCT01397201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111272605|NCT01397201|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111272606|NCT01397201|Autonomic Agents|autonomic agents|mesh-ancestor
111272607|NCT01397201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111272608|NCT01397201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111272609|NCT01397201|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111272610|NCT01397201|Respiratory System Agents|respiratory system agents|mesh-ancestor
111272611|NCT01397201|Dermatologic Agents|dermatologic agents|mesh-ancestor
111272612|NCT01397201|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111272613|NCT04845919|Aminolevulinic Acid|aminolevulinic acid|mesh-list
111272614|NCT04845919|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111272615|NCT04845919|Dermatologic Agents|dermatologic agents|mesh-ancestor
111272616|NCT00834171|Loteprednol Etabonate|loteprednol etabonate|mesh-list
111272617|NCT00834171|Tobramycin|tobramycin|mesh-list
111272618|NCT00834171|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111272619|NCT00834171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111272620|NCT00834171|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111272621|NCT02985437|Pulmonary Surfactants|pulmonary surfactants|mesh-list
111272622|NCT02985437|Respiratory System Agents|respiratory system agents|mesh-ancestor
111272623|NCT05205577|Iodine|iodine|mesh-list
111272624|NCT05205577|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111272625|NCT05205577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111272626|NCT05205577|Trace Elements|trace elements|mesh-ancestor
111272627|NCT05205577|Micronutrients|micronutrients|mesh-ancestor
111272628|NCT05205577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111272629|NCT00835185|Leucovorin|leucovorin|mesh-list
111272630|NCT00835185|Folic Acid|folic acid|mesh-list
111272631|NCT00835185|Oxaliplatin|oxaliplatin|mesh-list
111272632|NCT00835185|Necitumumab|necitumumab|mesh-list
111272633|NCT00835185|Levoleucovorin|levoleucovorin|mesh-list
111272634|NCT00835185|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111272635|NCT00835185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111272636|NCT00835185|Antidotes|antidotes|mesh-ancestor
111272637|NCT00835185|Protective Agents|protective agents|mesh-ancestor
111272638|NCT00835185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111272639|NCT00835185|Vitamin B Complex|vitamin b complex|mesh-ancestor
111272640|NCT00835185|Vitamins|vitamins|mesh-ancestor
111272641|NCT00835185|Micronutrients|micronutrients|mesh-ancestor
111272642|NCT00835185|Hematinics|hematinics|mesh-ancestor
111272643|NCT00835185|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111272644|NCT00835185|Immunologic Factors|immunologic factors|mesh-ancestor
111272645|NCT04399525|Cetirizine|cetirizine|mesh-list
111272646|NCT04399525|Loratadine|loratadine|mesh-list
111272647|NCT04399525|Levocetirizine|levocetirizine|mesh-list
111272648|NCT04399525|Desloratadine|desloratadine|mesh-list
110996981|NCT02971007|Amebicides|amebicides|mesh-ancestor
111272649|NCT04399525|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
111272650|NCT04399525|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111272651|NCT04399525|Histamine Antagonists|histamine antagonists|mesh-ancestor
111272652|NCT04399525|Histamine Agents|histamine agents|mesh-ancestor
111272654|NCT04399525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111272655|NCT04399525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111272656|NCT04399525|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111272657|NCT04399525|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111272658|NCT04399525|Cholinergic Agents|cholinergic agents|mesh-ancestor
111272659|NCT04399525|Antipruritics|antipruritics|mesh-ancestor
111272660|NCT04399525|Dermatologic Agents|dermatologic agents|mesh-ancestor
111272661|NCT00864123|Cycloserine|cycloserine|mesh-list
111272662|NCT00864123|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111272663|NCT00864123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111272664|NCT00864123|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111272665|NCT00864123|Antitubercular Agents|antitubercular agents|mesh-ancestor
111272666|NCT00864123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111272667|NCT00864123|Antimetabolites|antimetabolites|mesh-ancestor
111272668|NCT00864123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111272669|NCT03858465|Phenylephrine|phenylephrine|mesh-list
111272670|NCT03858465|Oxymetazoline|oxymetazoline|mesh-list
111272671|NCT03858465|Ephedrine|ephedrine|mesh-list
111272672|NCT03858465|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111272673|NCT03858465|Mydriatics|mydriatics|mesh-ancestor
111272674|NCT03858465|Autonomic Agents|autonomic agents|mesh-ancestor
111272675|NCT03858465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111272676|NCT03858465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111272677|NCT03858465|Sympathomimetics|sympathomimetics|mesh-ancestor
111272678|NCT03858465|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111272679|NCT03858465|Nasal Decongestants|nasal decongestants|mesh-ancestor
111272680|NCT03858465|Respiratory System Agents|respiratory system agents|mesh-ancestor
111272681|NCT03858465|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111272682|NCT03858465|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111272683|NCT03858465|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111272684|NCT03858465|Adrenergic Agents|adrenergic agents|mesh-ancestor
111272685|NCT03858465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111272686|NCT03858465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111272687|NCT03858465|Protective Agents|protective agents|mesh-ancestor
111272688|NCT03858465|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111272689|NCT00867789|Trimethoprim|trimethoprim|mesh-list
111272690|NCT00867789|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
111272691|NCT00867789|Sulfamethoxazole|sulfamethoxazole|mesh-list
111272692|NCT00867789|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111272693|NCT00867789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111272694|NCT00867789|Antimalarials|antimalarials|mesh-ancestor
111272695|NCT00867789|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111272696|NCT00867789|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111272697|NCT00867789|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111272698|NCT00867789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111272699|NCT00867789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111272700|NCT00867789|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111272701|NCT00867789|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
111272702|NCT00867789|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111272703|NCT00867789|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111272704|NCT01396421|Brexpiprazole|brexpiprazole|mesh-list
111272705|NCT01396421|Serotonin Agents|serotonin agents|mesh-ancestor
111272706|NCT01396421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111272707|NCT01396421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111272708|NCT01396421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111272709|NCT01396421|Dopamine Agonists|dopamine agonists|mesh-ancestor
111272710|NCT01396421|Dopamine Agents|dopamine agents|mesh-ancestor
111272711|NCT04797013|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
111272712|NCT04797013|Plasminogen|plasminogen|mesh-list
111272713|NCT04797013|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111272714|NCT04797013|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111272715|NCT04797013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111272716|NCT00838695|Phenylephrine|phenylephrine|mesh-list
111272717|NCT00838695|Oxymetazoline|oxymetazoline|mesh-list
111272718|NCT00838695|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111272719|NCT00838695|Mydriatics|mydriatics|mesh-ancestor
111272720|NCT00838695|Autonomic Agents|autonomic agents|mesh-ancestor
111272721|NCT00838695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111272722|NCT00838695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111272723|NCT00838695|Sympathomimetics|sympathomimetics|mesh-ancestor
111272724|NCT00838695|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111272725|NCT00838695|Nasal Decongestants|nasal decongestants|mesh-ancestor
111272726|NCT00838695|Respiratory System Agents|respiratory system agents|mesh-ancestor
111272727|NCT00838695|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111272728|NCT00838695|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111272729|NCT00838695|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111272730|NCT00838695|Adrenergic Agents|adrenergic agents|mesh-ancestor
111272731|NCT00838695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111272732|NCT00838695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111272733|NCT00838695|Protective Agents|protective agents|mesh-ancestor
111272734|NCT04775173|Sirolimus|sirolimus|mesh-list
111272735|NCT04775173|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111272736|NCT04775173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111272737|NCT04775173|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111272738|NCT04775173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111272739|NCT04775173|Antifungal Agents|antifungal agents|mesh-ancestor
111272740|NCT04775173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111272741|NCT04775173|Immunologic Factors|immunologic factors|mesh-ancestor
111272742|NCT04775173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111272743|NCT01396265|Rifampin|rifampin|mesh-list
111272744|NCT01396265|Afatinib|afatinib|mesh-list
111272745|NCT01396265|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111272746|NCT01396265|Antitubercular Agents|antitubercular agents|mesh-ancestor
111272747|NCT01396265|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111272748|NCT01396265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111272749|NCT01396265|Leprostatic Agents|leprostatic agents|mesh-ancestor
111272750|NCT01396265|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111272751|NCT01396265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111272752|NCT01396265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111272753|NCT01396265|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111272754|NCT01396265|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111272755|NCT01396265|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
111272756|NCT01396265|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
111272757|NCT01396265|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
111272758|NCT01396265|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111272759|NCT01396265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111272760|NCT01396265|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111272761|NCT04760431|Paclitaxel|paclitaxel|mesh-list
111272762|NCT04760431|Docetaxel|docetaxel|mesh-list
111272763|NCT04760431|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111272764|NCT04760431|Trastuzumab|trastuzumab|mesh-list
111272765|NCT04760431|Pertuzumab|pertuzumab|mesh-list
111272766|NCT04760431|Taxane|taxane|mesh-list
111272767|NCT04760431|Tucatinib|tucatinib|mesh-list
111272768|NCT04760431|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
111272769|NCT04760431|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111272770|NCT04760431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111272771|NCT04760431|Tubulin Modulators|tubulin modulators|mesh-ancestor
111272772|NCT04760431|Antimitotic Agents|antimitotic agents|mesh-ancestor
111272773|NCT04760431|Mitosis Modulators|mitosis modulators|mesh-ancestor
111272774|NCT04760431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111272775|NCT04760431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111272776|NCT04760431|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111272777|NCT04760431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111272778|NCT00839319|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
111272779|NCT00839319|Testosterone|testosterone|mesh-list
111272780|NCT00839319|Acyline|acyline|mesh-list
111272781|NCT00839319|Androgens|androgens|mesh-ancestor
111272782|NCT00839319|Hormones|hormones|mesh-ancestor
111272783|NCT00839319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111272784|NCT00839319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111272785|NCT00839319|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111272786|NCT00839319|Hormone Antagonists|hormone antagonists|mesh-ancestor
111272787|NCT00868959|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
111272788|NCT00868959|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111272789|NCT00868959|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111272790|NCT00868959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111272791|NCT00868959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111272792|NCT00868959|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111272793|NCT00868959|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
111272794|NCT00868959|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111272795|NCT00868959|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111272796|NCT00868959|Adrenergic Agents|adrenergic agents|mesh-ancestor
111272797|NCT00868959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111272798|NCT00868959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111272799|NCT00868959|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111272800|NCT00868959|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111272801|NCT00868959|Serotonin Agents|serotonin agents|mesh-ancestor
111272802|NCT00868959|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111272803|NCT00868959|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111272804|NCT00868959|Dopamine Agents|dopamine agents|mesh-ancestor
111272805|NCT02647866|KHK4083|khk4083|mesh-list
111272806|NCT02647866|Dermatologic Agents|dermatologic agents|mesh-ancestor
111272807|NCT02246127|Everolimus|everolimus|mesh-list
111272808|NCT02246127|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111272809|NCT02246127|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111272810|NCT02246127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111272811|NCT02246127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111272812|NCT02246127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111272813|NCT02246127|Immunologic Factors|immunologic factors|mesh-ancestor
111272814|NCT02246127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111272815|NCT02246127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111272816|NCT04277923|SMOFlipid|smoflipid|mesh-list
111272817|NCT04277923|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
111272818|NCT04277923|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
111272819|NCT04277923|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111272820|NCT00870363|Efavirenz|efavirenz|mesh-list
111272821|NCT00870363|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
111272822|NCT00870363|Raltegravir Potassium|raltegravir potassium|mesh-list
111272823|NCT00870363|Maraviroc|maraviroc|mesh-list
111272824|NCT00870363|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111272825|NCT00870363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111272826|NCT00870363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111272827|NCT00870363|Antiviral Agents|antiviral agents|mesh-ancestor
111272828|NCT00870363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111272829|NCT00870363|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111272830|NCT00870363|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111272831|NCT00870363|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111272832|NCT00870363|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111272833|NCT00870363|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111272834|NCT00870363|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111272835|NCT00870363|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111272836|NCT00870363|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111272837|NCT00870363|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111272838|NCT00870363|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111272839|NCT00870363|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
111272840|NCT00870363|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
111272841|NCT00870363|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
111272842|NCT03104634|Bromides|bromides|mesh-list
111272843|NCT03104634|Formoterol Fumarate|formoterol fumarate|mesh-list
111272844|NCT03104634|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111272845|NCT03104634|Autonomic Agents|autonomic agents|mesh-ancestor
111272846|NCT03104634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111272847|NCT03104634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111272848|NCT03104634|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111272849|NCT03104634|Respiratory System Agents|respiratory system agents|mesh-ancestor
111272850|NCT03104634|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111272851|NCT03104634|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111272852|NCT03104634|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111272853|NCT03104634|Adrenergic Agents|adrenergic agents|mesh-ancestor
111272854|NCT03104634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111272855|NCT03104634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111272856|NCT03104634|Anticonvulsants|anticonvulsants|mesh-ancestor
111272857|NCT00871689|Aldesleukin|aldesleukin|mesh-list
111272858|NCT00871689|Cyclophosphamide|cyclophosphamide|mesh-list
111272859|NCT00871689|Fludarabine|fludarabine|mesh-list
111272860|NCT00871689|Fludarabine phosphate|fludarabine phosphate|mesh-list
111272861|NCT00871689|Interleukin-2|interleukin-2|mesh-list
111272862|NCT00871689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111272863|NCT00871689|Immunologic Factors|immunologic factors|mesh-ancestor
111272864|NCT00871689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111272865|NCT00871689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111272866|NCT00871689|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111272867|NCT00871689|Alkylating Agents|alkylating agents|mesh-ancestor
111272868|NCT00871689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111272869|NCT00871689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111272870|NCT00871689|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111272871|NCT00871689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111272872|NCT00871689|Antimetabolites|antimetabolites|mesh-ancestor
111272873|NCT00871689|Antiviral Agents|antiviral agents|mesh-ancestor
111272874|NCT00871689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111272875|NCT00871689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111272877|NCT00871689|Sensory System Agents|sensory system agents|mesh-ancestor
111272878|NCT00871689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111272879|NCT00871689|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111272880|NCT00871689|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111272881|NCT02084797|Vasopressins|vasopressins|mesh-list
111272882|NCT02084797|Arginine Vasopressin|arginine vasopressin|mesh-list
111272883|NCT02084797|Tolvaptan|tolvaptan|mesh-list
111272884|NCT02084797|Hemostatics|hemostatics|mesh-ancestor
111272885|NCT02084797|Coagulants|coagulants|mesh-ancestor
111272886|NCT02084797|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111272887|NCT02084797|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
111272888|NCT02084797|Natriuretic Agents|natriuretic agents|mesh-ancestor
111272889|NCT02084797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111272890|NCT02084797|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
111272891|NCT02084797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111272892|NCT00873327|Tazobactam|tazobactam|mesh-list
111272893|NCT00873327|Piperacillin|piperacillin|mesh-list
111272894|NCT00873327|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
111272895|NCT00873327|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111272896|NCT00873327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111272897|NCT00873327|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
111272898|NCT00873327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111272899|NCT00873327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111272900|NCT04816890|Insulin Lispro|insulin lispro|mesh-list
111272901|NCT04816890|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111272902|NCT04816890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111272903|NCT01392677|Dapagliflozin|dapagliflozin|mesh-list
111272904|NCT01392677|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111272905|NCT01392677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111272906|NCT01392677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111272907|NCT01392677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111272908|NCT00841971|Fluconazole|fluconazole|mesh-list
111272909|NCT00841971|Anidulafungin|anidulafungin|mesh-list
111272910|NCT00841971|Antifungal Agents|antifungal agents|mesh-ancestor
111272911|NCT00841971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111272912|NCT00841971|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111272913|NCT00841971|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111272914|NCT00841971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111272915|NCT00841971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111272916|NCT00841971|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111272917|NCT00841971|Hormone Antagonists|hormone antagonists|mesh-ancestor
111272918|NCT00841971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111272919|NCT00841971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111272920|NCT00841971|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111272921|NCT00841971|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111272922|NCT00842751|Finasteride|finasteride|mesh-list
111272923|NCT00842751|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
111272924|NCT00842751|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111272925|NCT00842751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111272926|NCT00842751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111272927|NCT00842751|Hormone Antagonists|hormone antagonists|mesh-ancestor
111272928|NCT00842751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111272929|NCT00842751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111272930|NCT00842751|Urological Agents|urological agents|mesh-ancestor
111272931|NCT03104010|Hormones|hormones|mesh-list
111272932|NCT03104010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111272933|NCT03104010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111272934|NCT03907969|AZD7648|azd7648|mesh-list
111272935|NCT03907969|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111272936|NCT03907969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111272937|NCT03907969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111272938|NCT04399213|Histamine|histamine|mesh-list
111272939|NCT04399213|Histamine phosphate|histamine phosphate|mesh-list
111272940|NCT04399213|Histamine Agonists|histamine agonists|mesh-ancestor
111272941|NCT04399213|Histamine Agents|histamine agents|mesh-ancestor
111272942|NCT04399213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111272943|NCT04399213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111272944|NCT04399213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111272945|NCT02154243|Midodrine|midodrine|mesh-list
111272946|NCT02154243|Sympathomimetics|sympathomimetics|mesh-ancestor
111272947|NCT02154243|Autonomic Agents|autonomic agents|mesh-ancestor
111272948|NCT02154243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111272949|NCT02154243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111272950|NCT02154243|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111272951|NCT02154243|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111272952|NCT02154243|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111272953|NCT02154243|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111272954|NCT02154243|Adrenergic Agents|adrenergic agents|mesh-ancestor
111272955|NCT02154243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111272956|NCT02154243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111272958|NCT03995004|Melatonin|melatonin|mesh-list
111272959|NCT03995004|Sodium sulfate|sodium sulfate|mesh-list
111272960|NCT03995004|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111272961|NCT03995004|Antiemetics|antiemetics|mesh-ancestor
111272962|NCT03995004|Autonomic Agents|autonomic agents|mesh-ancestor
111272963|NCT03995004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111272964|NCT03995004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111272965|NCT03995004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111272966|NCT03995004|Glucocorticoids|glucocorticoids|mesh-ancestor
111272967|NCT03995004|Hormones|hormones|mesh-ancestor
111272968|NCT03995004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111272969|NCT03995004|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110978618|NCT02743221|Antimetabolites|antimetabolites|mesh-ancestor
111272970|NCT03995004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111272971|NCT03995004|Antioxidants|antioxidants|mesh-ancestor
111272972|NCT03995004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111272973|NCT03995004|Protective Agents|protective agents|mesh-ancestor
111272974|NCT03995004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111272975|NCT03995004|Cathartics|cathartics|mesh-ancestor
111272976|NCT03249181|Dolutegravir|dolutegravir|mesh-list
111272977|NCT03249181|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111272978|NCT03249181|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111272979|NCT03249181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111272980|NCT03249181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111272981|NCT03249181|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111272982|NCT03249181|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111272983|NCT03249181|Antiviral Agents|antiviral agents|mesh-ancestor
111272984|NCT03249181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111272985|NCT03216447|Tacrolimus|tacrolimus|mesh-list
111272986|NCT03216447|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111272987|NCT03216447|Immunologic Factors|immunologic factors|mesh-ancestor
111272988|NCT03216447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111272989|NCT03216447|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111272990|NCT03216447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111272991|NCT03216447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111272992|NCT04669938|Immunologic Factors|immunologic factors|mesh-list
111272993|NCT04669938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111272994|NCT03957876|Cytarabine|cytarabine|mesh-list
111272995|NCT03957876|Daunorubicin|daunorubicin|mesh-list
111272996|NCT03957876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111272997|NCT03957876|Antimetabolites|antimetabolites|mesh-ancestor
111272998|NCT03957876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111272999|NCT03957876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111273000|NCT03957876|Antiviral Agents|antiviral agents|mesh-ancestor
111273001|NCT03957876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111273002|NCT03957876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111273003|NCT03957876|Immunologic Factors|immunologic factors|mesh-ancestor
111273004|NCT03957876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111273005|NCT03957876|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111273006|NCT03957876|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111273007|NCT03957876|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111273008|NCT03957876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111273009|NCT03837925|Atorvastatin|atorvastatin|mesh-list
111273010|NCT03837925|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111273011|NCT03837925|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111273012|NCT03837925|Antimetabolites|antimetabolites|mesh-ancestor
111273013|NCT03837925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111273014|NCT03837925|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111273015|NCT03837925|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111273016|NCT03837925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111273017|NCT04398589|Dexmedetomidine|dexmedetomidine|mesh-list
111273018|NCT04398589|Ropivacaine|ropivacaine|mesh-list
111273019|NCT04398589|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111273020|NCT04398589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111273021|NCT04398589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111273022|NCT04398589|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111273023|NCT04398589|Analgesics|analgesics|mesh-ancestor
111273024|NCT04398589|Sensory System Agents|sensory system agents|mesh-ancestor
111273025|NCT04398589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111273026|NCT04398589|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111273027|NCT04398589|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111273028|NCT04398589|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111273029|NCT04398589|Adrenergic Agents|adrenergic agents|mesh-ancestor
111273030|NCT04398589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111273031|NCT04398589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111273032|NCT04398589|Anesthetics, Local|anesthetics, local|mesh-ancestor
111273033|NCT04398589|Anesthetics|anesthetics|mesh-ancestor
111273034|NCT00874887|Moxifloxacin|moxifloxacin|mesh-list
111273035|NCT00874887|Gatifloxacin|gatifloxacin|mesh-list
111273036|NCT00874887|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111273037|NCT00874887|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111273038|NCT00874887|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111273039|NCT00874887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111273040|NCT00874887|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111273041|NCT00874887|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110978622|NCT03955887|Dimercaprol|dimercaprol|mesh-list
111273042|NCT00874887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111273043|NCT00874887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111273044|NCT00874887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111273045|NCT03882060|Epoetin Alfa|epoetin alfa|mesh-list
111273046|NCT03882060|Hematinics|hematinics|mesh-ancestor
111273047|NCT00875277|Betamethasone|betamethasone|mesh-list
111273048|NCT00875277|Betamethasone Valerate|betamethasone valerate|mesh-list
111273049|NCT00875277|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
111273050|NCT00875277|Betamethasone benzoate|betamethasone benzoate|mesh-list
111273051|NCT00875277|Calcipotriene|calcipotriene|mesh-list
111273052|NCT00875277|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
111273053|NCT00875277|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111273054|NCT00875277|Glucocorticoids|glucocorticoids|mesh-ancestor
111273055|NCT00875277|Hormones|hormones|mesh-ancestor
111273056|NCT00875277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111273057|NCT00875277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111273058|NCT00875277|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111273059|NCT00875277|Respiratory System Agents|respiratory system agents|mesh-ancestor
111273060|NCT00875277|Dermatologic Agents|dermatologic agents|mesh-ancestor
111273061|NCT04634539|Paclitaxel|paclitaxel|mesh-list
111273062|NCT04634539|Gemcitabine|gemcitabine|mesh-list
111273063|NCT04634539|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111273064|NCT04634539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111273065|NCT04634539|Tubulin Modulators|tubulin modulators|mesh-ancestor
111273066|NCT04634539|Antimitotic Agents|antimitotic agents|mesh-ancestor
111273067|NCT04634539|Mitosis Modulators|mitosis modulators|mesh-ancestor
111273068|NCT04634539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111273069|NCT04634539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111273070|NCT04634539|Antimetabolites|antimetabolites|mesh-ancestor
111273071|NCT03750786|Leucovorin|leucovorin|mesh-list
111273072|NCT03750786|Antidotes|antidotes|mesh-ancestor
111273073|NCT03750786|Protective Agents|protective agents|mesh-ancestor
111273074|NCT03750786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111273075|NCT03750786|Vitamin B Complex|vitamin b complex|mesh-ancestor
111273076|NCT03750786|Vitamins|vitamins|mesh-ancestor
111273077|NCT03750786|Micronutrients|micronutrients|mesh-ancestor
111273078|NCT04457245|Fluorides|fluorides|mesh-list
111273079|NCT04457245|Cariostatic Agents|cariostatic agents|mesh-ancestor
111273080|NCT04457245|Protective Agents|protective agents|mesh-ancestor
111273081|NCT04457245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111273082|NCT01395017|Dasatinib|dasatinib|mesh-list
111273083|NCT01395017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111273084|NCT01395017|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111273085|NCT01395017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111273086|NCT01395017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111273087|NCT03235986|Poractant alfa|poractant alfa|mesh-list
111273088|NCT03235986|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
111273089|NCT03235986|Respiratory System Agents|respiratory system agents|mesh-ancestor
111273090|NCT03657342|Cyclosporine|cyclosporine|mesh-list
111273091|NCT03657342|Cyclosporins|cyclosporins|mesh-list
111273092|NCT03657342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111273093|NCT03657342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111273094|NCT03657342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111273095|NCT03657342|Immunologic Factors|immunologic factors|mesh-ancestor
111273096|NCT03657342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111273097|NCT03657342|Antifungal Agents|antifungal agents|mesh-ancestor
111273098|NCT03657342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111273099|NCT03657342|Dermatologic Agents|dermatologic agents|mesh-ancestor
111273100|NCT03657342|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111273101|NCT03657342|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111273103|NCT03600090|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111273104|NCT03600090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111273105|NCT03600090|Tubulin Modulators|tubulin modulators|mesh-ancestor
111273106|NCT03600090|Antimitotic Agents|antimitotic agents|mesh-ancestor
111273107|NCT03600090|Mitosis Modulators|mitosis modulators|mesh-ancestor
111273108|NCT03600090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111273109|NCT02912988|Letrozole|letrozole|mesh-list
111273110|NCT02912988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111273111|NCT02912988|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111273112|NCT02912988|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111273113|NCT02912988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111273114|NCT02912988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111273115|NCT02912988|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111273116|NCT02912988|Hormone Antagonists|hormone antagonists|mesh-ancestor
110978623|NCT03955887|Chelating Agents|chelating agents|mesh-ancestor
111273117|NCT02912988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111273118|NCT02912988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111273119|NCT03103074|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
111273120|NCT03103074|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111273121|NCT03103074|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111273122|NCT03103074|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111273123|NCT03103074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111273124|NCT03103074|Cholinergic Agents|cholinergic agents|mesh-ancestor
111273125|NCT03103074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111273126|NCT03103074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111273127|NCT00876915|Dalteparin|dalteparin|mesh-list
111273128|NCT00876915|Tinzaparin|tinzaparin|mesh-list
111273129|NCT00876915|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
111273130|NCT00876915|Anticoagulants|anticoagulants|mesh-ancestor
111273131|NCT00876915|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111273132|NCT00876915|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111273133|NCT00876915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111273134|NCT02854488|Ipilimumab|ipilimumab|mesh-list
111273135|NCT02854488|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111273136|NCT02854488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111273137|NCT02854488|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111273138|NCT02854488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111273139|NCT00896181|Carboplatin|carboplatin|mesh-list
111273140|NCT00896181|Docetaxel|docetaxel|mesh-list
111273141|NCT00896181|Fluorouracil|fluorouracil|mesh-list
111273142|NCT00896181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111273143|NCT00896181|Tubulin Modulators|tubulin modulators|mesh-ancestor
111273144|NCT00896181|Antimitotic Agents|antimitotic agents|mesh-ancestor
111273145|NCT00896181|Mitosis Modulators|mitosis modulators|mesh-ancestor
111273146|NCT00896181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111273147|NCT00896181|Antimetabolites|antimetabolites|mesh-ancestor
111273148|NCT00896181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111273149|NCT00896181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111273150|NCT00896181|Immunologic Factors|immunologic factors|mesh-ancestor
111273151|NCT00896181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111273152|NCT02647320|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111273153|NCT02647320|Firuglipel|firuglipel|mesh-list
111273154|NCT02647320|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111273155|NCT02647320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111273156|NCT02647320|Incretins|incretins|mesh-ancestor
111273157|NCT02647320|Hormones|hormones|mesh-ancestor
111273158|NCT02647320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111273159|NCT02647320|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111273160|NCT02647320|Protease Inhibitors|protease inhibitors|mesh-ancestor
111273161|NCT02647320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111273162|NCT02647320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111273163|NCT03457896|Trastuzumab|trastuzumab|mesh-list
111273164|NCT03457896|Cetuximab|cetuximab|mesh-list
111273165|NCT03457896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111273166|NCT03457896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111273167|NCT04380597|Betamethasone|betamethasone|mesh-list
111273168|NCT04380597|Betamethasone Valerate|betamethasone valerate|mesh-list
111273169|NCT04380597|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
111273170|NCT04380597|Betamethasone benzoate|betamethasone benzoate|mesh-list
111273171|NCT04380597|Calcipotriene|calcipotriene|mesh-list
111273172|NCT04380597|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
111273173|NCT04380597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111273174|NCT04380597|Glucocorticoids|glucocorticoids|mesh-ancestor
111273175|NCT04380597|Hormones|hormones|mesh-ancestor
111273176|NCT04380597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111273177|NCT04380597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111273178|NCT04380597|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111273179|NCT04380597|Respiratory System Agents|respiratory system agents|mesh-ancestor
111273180|NCT04380597|Dermatologic Agents|dermatologic agents|mesh-ancestor
111273181|NCT03214731|Artesunate|artesunate|mesh-list
111273182|NCT03214731|Antimalarials|antimalarials|mesh-ancestor
111273183|NCT03214731|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111273184|NCT03214731|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111273185|NCT03214731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111273186|NCT03214731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111273187|NCT03214731|Antiviral Agents|antiviral agents|mesh-ancestor
111273188|NCT03214731|Schistosomicides|schistosomicides|mesh-ancestor
111273189|NCT03214731|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
111273190|NCT03214731|Anthelmintics|anthelmintics|mesh-ancestor
111273191|NCT04424862|Cyclosporine|cyclosporine|mesh-list
111273192|NCT04424862|Mycophenolic Acid|mycophenolic acid|mesh-list
111273193|NCT04424862|Prednisone|prednisone|mesh-list
111273194|NCT04424862|Cyclosporins|cyclosporins|mesh-list
111273195|NCT04424862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111273196|NCT04424862|Glucocorticoids|glucocorticoids|mesh-ancestor
111273197|NCT04424862|Hormones|hormones|mesh-ancestor
111273198|NCT04424862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111273199|NCT04424862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111273200|NCT04424862|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111273201|NCT04424862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111273202|NCT04424862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111273203|NCT04424862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111273204|NCT04424862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111273205|NCT04424862|Immunologic Factors|immunologic factors|mesh-ancestor
111273206|NCT04424862|Antifungal Agents|antifungal agents|mesh-ancestor
111273207|NCT04424862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111273208|NCT04424862|Dermatologic Agents|dermatologic agents|mesh-ancestor
111273209|NCT04424862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111273210|NCT04424862|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111273211|NCT04424862|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111273212|NCT04424862|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111273213|NCT04424862|Antitubercular Agents|antitubercular agents|mesh-ancestor
111273214|NCT04424862|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111273215|NCT00882687|Lifitegrast|lifitegrast|mesh-list
111273216|NCT00882687|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
111273217|NCT00882687|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111273218|NCT04313166|Copper|copper|mesh-list
111273219|NCT04313166|Trace Elements|trace elements|mesh-ancestor
111273220|NCT04313166|Micronutrients|micronutrients|mesh-ancestor
111273221|NCT04313166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111273222|NCT00883233|Adapalene|adapalene|mesh-list
111273223|NCT00883233|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111273224|NCT00883233|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111273225|NCT00883233|Analgesics|analgesics|mesh-ancestor
111273226|NCT00883233|Sensory System Agents|sensory system agents|mesh-ancestor
111273227|NCT00883233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111273228|NCT00883233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111273229|NCT00883233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111273230|NCT00883233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111273231|NCT00883233|Dermatologic Agents|dermatologic agents|mesh-ancestor
111273232|NCT01394939|Irinotecan|irinotecan|mesh-list
111273233|NCT01394939|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111273234|NCT01394939|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111273235|NCT01394939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111273236|NCT01394939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111273237|NCT01394939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111273238|NCT01394627|Eplerenone|eplerenone|mesh-list
111273239|NCT01394627|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
111273240|NCT01394627|Hormone Antagonists|hormone antagonists|mesh-ancestor
111273241|NCT01394627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111273242|NCT01394627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111273243|NCT01394627|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
111273244|NCT01394627|Diuretics|diuretics|mesh-ancestor
111273245|NCT01394627|Natriuretic Agents|natriuretic agents|mesh-ancestor
111273246|NCT01394627|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111273247|NCT02288377|Lanreotide|lanreotide|mesh-list
110959297|NCT03389126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111273248|NCT02288377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111273250|NCT04133532|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111273251|NCT04133532|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111273252|NCT04133532|Sympatholytics|sympatholytics|mesh-ancestor
111273253|NCT04133532|Autonomic Agents|autonomic agents|mesh-ancestor
111273254|NCT04133532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111273255|NCT04133532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111273256|NCT04133532|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
111273257|NCT04133532|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111273258|NCT04133532|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111273259|NCT04133532|Adrenergic Agents|adrenergic agents|mesh-ancestor
111273260|NCT04133532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111273261|NCT04133532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111273262|NCT01391663|Alogliptin|alogliptin|mesh-list
111273263|NCT01391663|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111273264|NCT01391663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111273265|NCT01391663|Incretins|incretins|mesh-ancestor
111273266|NCT01391663|Hormones|hormones|mesh-ancestor
111273267|NCT01391663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111273268|NCT01391663|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111273269|NCT01391663|Protease Inhibitors|protease inhibitors|mesh-ancestor
111273270|NCT01391663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111273271|NCT01391663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111273272|NCT03176173|Immunomodulating Agents|immunomodulating agents|mesh-list
111273273|NCT03176173|Immunologic Factors|immunologic factors|mesh-ancestor
111273274|NCT03176173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111273275|NCT05072106|Bosentan|bosentan|mesh-list
111273276|NCT05072106|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111273277|NCT05072106|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
111273278|NCT05072106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111273279|NCT03838497|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
111273280|NCT03838497|Immunologic Factors|immunologic factors|mesh-ancestor
111273281|NCT03838497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111273282|NCT05071482|Imatinib Mesylate|imatinib mesylate|mesh-list
111273283|NCT05071482|Flumatinib|flumatinib|mesh-list
111273284|NCT05071482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111273285|NCT05071482|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111273286|NCT05071482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111273287|NCT05071482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111273288|NCT03213249|Gentamicins|gentamicins|mesh-list
111273289|NCT03213249|Cefazolin|cefazolin|mesh-list
111273290|NCT03213249|Bacitracin|bacitracin|mesh-list
111273291|NCT03213249|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111273292|NCT03213249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111273293|NCT03213249|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111273294|NCT03213249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111273295|NCT03213249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111273296|NCT03213249|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111273297|NCT03317067|Dexmedetomidine|dexmedetomidine|mesh-list
111273298|NCT03317067|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111273299|NCT03317067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111273300|NCT03317067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111273301|NCT03317067|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111273302|NCT03317067|Analgesics|analgesics|mesh-ancestor
111273303|NCT03317067|Sensory System Agents|sensory system agents|mesh-ancestor
111273304|NCT03317067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111273305|NCT03317067|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111273306|NCT03317067|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111273307|NCT03317067|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111273308|NCT03317067|Adrenergic Agents|adrenergic agents|mesh-ancestor
111273309|NCT03317067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111273310|NCT03317067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111273311|NCT04440007|Abivertinib|abivertinib|mesh-list
111273312|NCT04440007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111273313|NCT04440007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111273314|NCT04440007|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111273315|NCT00888459|Nicotine|nicotine|mesh-list
111273316|NCT00888459|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111273317|NCT00888459|Autonomic Agents|autonomic agents|mesh-ancestor
111273318|NCT00888459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111273319|NCT00888459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111273320|NCT00888459|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111273321|NCT00888459|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111273322|NCT00888459|Cholinergic Agents|cholinergic agents|mesh-ancestor
111273323|NCT00888459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111273324|NCT00888459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111273325|NCT05312541|Bupivacaine|bupivacaine|mesh-list
111273326|NCT05312541|Anesthetics, Local|anesthetics, local|mesh-list
111273327|NCT05312541|Anesthetics|anesthetics|mesh-list
111273328|NCT05312541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111273329|NCT05312541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111273330|NCT05312541|Sensory System Agents|sensory system agents|mesh-ancestor
111273331|NCT05312541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111273332|NCT04398823|Polidocanol|polidocanol|mesh-list
111273333|NCT04398823|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
111273334|NCT04398823|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111273335|NCT04410913|Psilocybin|psilocybin|mesh-list
111273336|NCT04410913|Hallucinogens|hallucinogens|mesh-ancestor
111273337|NCT04410913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111273338|NCT04410913|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111273339|NCT02013336|Cyclophosphamide|cyclophosphamide|mesh-list
111273340|NCT02013336|Irinotecan|irinotecan|mesh-list
111273341|NCT02013336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111273342|NCT02013336|Immunologic Factors|immunologic factors|mesh-ancestor
111273343|NCT02013336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111273344|NCT02013336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111273345|NCT02013336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111273346|NCT02013336|Alkylating Agents|alkylating agents|mesh-ancestor
111273347|NCT02013336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111273348|NCT02013336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111273349|NCT02013336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111273350|NCT02013336|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111273351|NCT02013336|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111273352|NCT02013336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111273353|NCT04397653|Ezetimibe|ezetimibe|mesh-list
111273354|NCT04397653|Evolocumab|evolocumab|mesh-list
111273355|NCT04397653|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111273356|NCT04397653|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111273357|NCT04397653|Antimetabolites|antimetabolites|mesh-ancestor
111273358|NCT04397653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111273359|NCT04397653|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111273360|NCT04397653|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
111273361|NCT04397653|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111273362|NCT04397653|Protease Inhibitors|protease inhibitors|mesh-ancestor
111273363|NCT04397653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111273364|NCT03212781|Ferrous fumarate|ferrous fumarate|mesh-list
111273365|NCT03212781|Dextrans|dextrans|mesh-list
111273366|NCT03212781|Iron-Dextran Complex|iron-dextran complex|mesh-list
111273367|NCT03212781|Anticoagulants|anticoagulants|mesh-ancestor
111273368|NCT03212781|Plasma Substitutes|plasma substitutes|mesh-ancestor
111273369|NCT03212781|Blood Substitutes|blood substitutes|mesh-ancestor
111273370|NCT03212781|Trace Elements|trace elements|mesh-ancestor
111273371|NCT03212781|Micronutrients|micronutrients|mesh-ancestor
111273372|NCT03212781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111273373|NCT03212781|Hematinics|hematinics|mesh-ancestor
111273374|NCT03212937|Carboplatin|carboplatin|mesh-list
111273375|NCT03212937|Etoposide|etoposide|mesh-list
111273376|NCT03212937|Ifosfamide|ifosfamide|mesh-list
111273377|NCT03212937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111273378|NCT03212937|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111273379|NCT03212937|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111273380|NCT03212937|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111273381|NCT03212937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111273382|NCT03212937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111273383|NCT03212937|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111273384|NCT03212937|Alkylating Agents|alkylating agents|mesh-ancestor
111273385|NCT04397497|Mavrilimumab|mavrilimumab|mesh-list
111273386|NCT04397497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111273387|NCT04412538|Vaccines|vaccines|mesh-list
111273388|NCT04412538|Immunologic Factors|immunologic factors|mesh-ancestor
111273389|NCT04412538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111273390|NCT04397341|Docetaxel|docetaxel|mesh-list
111273391|NCT04397341|Fluorouracil|fluorouracil|mesh-list
111273392|NCT04397341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111273393|NCT04397341|Tubulin Modulators|tubulin modulators|mesh-ancestor
111273394|NCT04397341|Antimitotic Agents|antimitotic agents|mesh-ancestor
111273395|NCT04397341|Mitosis Modulators|mitosis modulators|mesh-ancestor
111273396|NCT04397341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111273397|NCT04397341|Antimetabolites|antimetabolites|mesh-ancestor
111273398|NCT04397341|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111273399|NCT04397341|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111273400|NCT04397341|Immunologic Factors|immunologic factors|mesh-ancestor
111273401|NCT04397341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111273402|NCT03940326|Levetiracetam|levetiracetam|mesh-list
111273403|NCT03940326|Valproic Acid|valproic acid|mesh-list
111273404|NCT03940326|Anticonvulsants|anticonvulsants|mesh-ancestor
111273405|NCT03940326|Nootropic Agents|nootropic agents|mesh-ancestor
111273406|NCT03940326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111273407|NCT03940326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111273408|NCT03940326|GABA Agents|gaba agents|mesh-ancestor
111273409|NCT03940326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111273410|NCT03940326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111273411|NCT03940326|Antimanic Agents|antimanic agents|mesh-ancestor
111273412|NCT03940326|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111273413|NCT03940326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111273414|NCT03940326|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111273415|NCT04347889|Hydroxychloroquine|hydroxychloroquine|mesh-list
111273416|NCT04347889|Antimalarials|antimalarials|mesh-ancestor
111273417|NCT04347889|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111273418|NCT04347889|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111273419|NCT04347889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111273420|NCT04347889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111273421|NCT04347889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111273422|NCT04347889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111273423|NCT01473524|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
111273424|NCT01473524|Cathartics|cathartics|mesh-ancestor
111273425|NCT01473524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111273426|NCT01390649|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111273427|NCT01390649|Immunologic Factors|immunologic factors|mesh-ancestor
111273428|NCT01390649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111273429|NCT03696355|GDC-0084|gdc-0084|mesh-list
111273430|NCT03696355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111273431|NCT03696355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111273432|NCT03882996|Atorvastatin|atorvastatin|mesh-list
111273433|NCT03882996|Ezetimibe|ezetimibe|mesh-list
111273434|NCT03882996|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111273435|NCT03882996|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111273436|NCT03882996|Antimetabolites|antimetabolites|mesh-ancestor
111273437|NCT03882996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111273438|NCT03882996|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111273439|NCT03882996|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111273440|NCT03882996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111273441|NCT04383691|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
111273442|NCT04383691|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111273443|NCT04383691|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111273444|NCT04383691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111273445|NCT04383691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111273446|NCT04383691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111273447|NCT04383691|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
111273448|NCT04383691|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111273449|NCT04383691|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111273450|NCT04383691|Adrenergic Agents|adrenergic agents|mesh-ancestor
111273451|NCT04383691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111273452|NCT04383691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111273453|NCT04383691|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111273454|NCT04383691|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111273455|NCT04383691|Serotonin Agents|serotonin agents|mesh-ancestor
111273456|NCT04383691|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111273457|NCT04383691|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111273458|NCT04383691|Dopamine Agents|dopamine agents|mesh-ancestor
111273459|NCT05070468|Dexamethasone|dexamethasone|mesh-list
111273460|NCT05070468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111273461|NCT05070468|Antiemetics|antiemetics|mesh-ancestor
111273462|NCT05070468|Autonomic Agents|autonomic agents|mesh-ancestor
111273463|NCT05070468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111273464|NCT05070468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111273465|NCT05070468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111273466|NCT05070468|Glucocorticoids|glucocorticoids|mesh-ancestor
111273467|NCT05070468|Hormones|hormones|mesh-ancestor
111273468|NCT05070468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111273469|NCT05070468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111273470|NCT05070468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111273471|NCT01390181|Losartan|losartan|mesh-list
111273472|NCT01390181|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111273473|NCT01390181|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111273474|NCT01390181|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111273475|NCT01390181|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111273476|NCT01390181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111273477|NCT02641080|Aspirin|aspirin|mesh-list
111273478|NCT02641080|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111273479|NCT02641080|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111273480|NCT02641080|Analgesics|analgesics|mesh-ancestor
111273481|NCT02641080|Sensory System Agents|sensory system agents|mesh-ancestor
111273482|NCT02641080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111273483|NCT02641080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111273484|NCT02641080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111273485|NCT02641080|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111273486|NCT02641080|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111273487|NCT02641080|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111273488|NCT02641080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111273489|NCT02641080|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111273490|NCT02641080|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111273491|NCT02641080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111273492|NCT02641080|Antipyretics|antipyretics|mesh-ancestor
111273493|NCT03101280|Atezolizumab|atezolizumab|mesh-list
111273494|NCT03101280|Rucaparib|rucaparib|mesh-list
111273495|NCT03101280|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111273496|NCT03101280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111273497|NCT03101280|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111273498|NCT03101280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111273499|NCT03101280|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111273500|NCT03101280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111273501|NCT04015739|Bevacizumab|bevacizumab|mesh-list
111273502|NCT04015739|Durvalumab|durvalumab|mesh-list
111273503|NCT04015739|Olaparib|olaparib|mesh-list
111273504|NCT04015739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111273505|NCT04015739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111273506|NCT04015739|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111273507|NCT04015739|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111273508|NCT04015739|Growth Substances|growth substances|mesh-ancestor
111273509|NCT04015739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111273510|NCT04015739|Growth Inhibitors|growth inhibitors|mesh-ancestor
111273511|NCT04015739|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111273512|NCT04015739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111273513|NCT04015739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111273514|NCT03867318|Atorvastatin|atorvastatin|mesh-list
111273515|NCT03867318|Ezetimibe|ezetimibe|mesh-list
111273516|NCT03867318|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111273517|NCT03867318|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111273518|NCT03867318|Antimetabolites|antimetabolites|mesh-ancestor
111273519|NCT03867318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111273520|NCT03867318|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111273521|NCT03867318|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111273522|NCT03867318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111273523|NCT01876771|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
111273524|NCT01876771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111273525|NCT01876771|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111273526|NCT05360615|Empagliflozin|empagliflozin|mesh-list
111273527|NCT05360615|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111273528|NCT05360615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111273529|NCT05360615|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111273530|NCT05360615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111273531|NCT04381377|Bromides|bromides|mesh-list
111273532|NCT04381377|Anticonvulsants|anticonvulsants|mesh-ancestor
111273533|NCT01457846|Paclitaxel|paclitaxel|mesh-list
111273534|NCT01457846|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111273535|NCT01457846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111273536|NCT01457846|Tubulin Modulators|tubulin modulators|mesh-ancestor
111273537|NCT01457846|Antimitotic Agents|antimitotic agents|mesh-ancestor
111273538|NCT01457846|Mitosis Modulators|mitosis modulators|mesh-ancestor
111273539|NCT01457846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111273540|NCT04032119|Epinephrine|epinephrine|mesh-list
111273541|NCT04032119|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111273542|NCT04032119|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111273543|NCT04032119|Adrenergic Agents|adrenergic agents|mesh-ancestor
111273544|NCT04032119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111273545|NCT04032119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111273546|NCT04032119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111273547|NCT04032119|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111273548|NCT04032119|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111273550|NCT04032119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111273551|NCT04032119|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111273552|NCT04032119|Respiratory System Agents|respiratory system agents|mesh-ancestor
111273553|NCT04032119|Mydriatics|mydriatics|mesh-ancestor
111273554|NCT04032119|Sympathomimetics|sympathomimetics|mesh-ancestor
111273555|NCT04032119|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111273556|NCT03211455|Lidocaine|lidocaine|mesh-list
111273557|NCT03211455|Anesthetics, Local|anesthetics, local|mesh-ancestor
111273558|NCT03211455|Anesthetics|anesthetics|mesh-ancestor
110725676|NCT03763396|Hormone Antagonists|hormone antagonists|mesh-ancestor
111273559|NCT03211455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111273560|NCT03211455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111273561|NCT03211455|Sensory System Agents|sensory system agents|mesh-ancestor
111273562|NCT03211455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111273563|NCT03211455|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111273564|NCT03211455|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111273565|NCT03211455|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111273566|NCT03211455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111273567|NCT03211455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111273568|NCT04375033|Buprenorphine|buprenorphine|mesh-list
111273569|NCT04375033|Naloxone|naloxone|mesh-list
111273570|NCT04375033|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111273571|NCT04375033|Narcotics|narcotics|mesh-ancestor
111273572|NCT04375033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111273573|NCT04375033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111273574|NCT04375033|Analgesics|analgesics|mesh-ancestor
111273575|NCT04375033|Sensory System Agents|sensory system agents|mesh-ancestor
111273576|NCT04375033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111273577|NCT04375033|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111273578|NCT03172819|Pembrolizumab|pembrolizumab|mesh-list
111273579|NCT03172819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111273580|NCT03172819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111273581|NCT03172819|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111273582|NCT03172819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111273583|NCT01389323|Interferons|interferons|mesh-list
111273584|NCT01389323|Ribavirin|ribavirin|mesh-list
111273585|NCT01389323|Interferon-alpha|interferon-alpha|mesh-list
111273586|NCT01389323|Interferon alpha-2|interferon alpha-2|mesh-list
111273587|NCT01389323|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
111273588|NCT01389323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111273589|NCT01389323|Antiviral Agents|antiviral agents|mesh-ancestor
111273590|NCT01389323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111273591|NCT01389323|Antimetabolites|antimetabolites|mesh-ancestor
111273592|NCT01389323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111273593|NCT01389323|Immunologic Factors|immunologic factors|mesh-ancestor
111273594|NCT01389323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111273595|NCT05310591|Nivolumab|nivolumab|mesh-list
111273596|NCT05310591|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111273597|NCT05310591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111273598|NCT05310591|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111273599|NCT05310591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111273600|NCT05314569|Fentanyl|fentanyl|mesh-list
111273601|NCT05314569|Midazolam|midazolam|mesh-list
111273602|NCT05314569|Dexmedetomidine|dexmedetomidine|mesh-list
111273603|NCT05314569|Ketamine|ketamine|mesh-list
111273604|NCT05314569|Isoflurane|isoflurane|mesh-list
111273605|NCT05314569|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111273606|NCT05314569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111273607|NCT05314569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111273608|NCT05314569|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111273609|NCT05314569|Analgesics|analgesics|mesh-ancestor
111273610|NCT05314569|Sensory System Agents|sensory system agents|mesh-ancestor
111273611|NCT05314569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111273612|NCT05314569|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111273613|NCT05314569|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111273614|NCT05314569|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111273615|NCT05314569|Adrenergic Agents|adrenergic agents|mesh-ancestor
111273616|NCT05314569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111273617|NCT05314569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111273618|NCT05314569|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111273619|NCT05314569|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111273620|NCT05314569|Anesthetics, General|anesthetics, general|mesh-ancestor
111273621|NCT05314569|Anesthetics|anesthetics|mesh-ancestor
111273622|NCT05314569|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111273623|NCT05314569|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111273625|NCT05314569|Narcotics|narcotics|mesh-ancestor
111273626|NCT05314569|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111273627|NCT05314569|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111273628|NCT05314569|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111273629|NCT05314569|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111273630|NCT05314569|GABA Modulators|gaba modulators|mesh-ancestor
111273631|NCT05314569|GABA Agents|gaba agents|mesh-ancestor
111273632|NCT05314569|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111273633|NCT01494818|Hydrogen Peroxide|hydrogen peroxide|mesh-list
111273634|NCT01494818|Contact Lens Solutions|contact lens solutions|mesh-list
111273635|NCT01494818|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111273636|NCT01494818|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111273637|NCT01494818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111273638|NCT01494818|Disinfectants|disinfectants|mesh-ancestor
111273639|NCT03167905|Fentanyl|fentanyl|mesh-list
111273640|NCT03167905|Meperidine|meperidine|mesh-list
111273641|NCT03167905|Remifentanil|remifentanil|mesh-list
111273642|NCT03167905|Nitrous Oxide|nitrous oxide|mesh-list
111273643|NCT03167905|Ropivacaine|ropivacaine|mesh-list
111273644|NCT03167905|Entonox|entonox|mesh-list
111273645|NCT03167905|Anesthetics, Local|anesthetics, local|mesh-ancestor
111273646|NCT03167905|Anesthetics|anesthetics|mesh-ancestor
111273647|NCT03167905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111273648|NCT03167905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111273649|NCT03167905|Sensory System Agents|sensory system agents|mesh-ancestor
111273650|NCT03167905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111273651|NCT03167905|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111273652|NCT03167905|Narcotics|narcotics|mesh-ancestor
111273653|NCT03167905|Analgesics|analgesics|mesh-ancestor
111273654|NCT03167905|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111273655|NCT03167905|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111273656|NCT03167905|Anesthetics, General|anesthetics, general|mesh-ancestor
111273657|NCT03167905|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111273658|NCT03167905|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111273659|NCT03167905|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
111273660|NCT02638389|Sirolimus|sirolimus|mesh-list
111273661|NCT02638389|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111273662|NCT02638389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111273663|NCT02638389|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111273664|NCT02638389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111273665|NCT02638389|Antifungal Agents|antifungal agents|mesh-ancestor
111273666|NCT02638389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111273667|NCT02638389|Immunologic Factors|immunologic factors|mesh-ancestor
111273668|NCT02638389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111273669|NCT01494584|Ezogabine|ezogabine|mesh-list
111273670|NCT01494584|Anticonvulsants|anticonvulsants|mesh-ancestor
111273671|NCT01494584|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111273672|NCT01494584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111273673|NCT03211143|Esomeprazole|esomeprazole|mesh-list
111273674|NCT03211143|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111273675|NCT03211143|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111273676|NCT03211143|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111273677|NCT03211143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111273678|NCT03211143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111273679|NCT01388543|Atazanavir Sulfate|atazanavir sulfate|mesh-list
111273680|NCT01388543|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111273681|NCT01388543|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111273682|NCT01388543|Protease Inhibitors|protease inhibitors|mesh-ancestor
111273683|NCT01388543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111273684|NCT01388543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111273685|NCT01388543|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111273686|NCT01388543|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111273687|NCT01388543|Antiviral Agents|antiviral agents|mesh-ancestor
111273688|NCT01388543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111273689|NCT00882895|Mycophenolic Acid|mycophenolic acid|mesh-list
111273690|NCT00882895|Methylprednisolone|methylprednisolone|mesh-list
111273691|NCT00882895|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111273692|NCT00882895|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111273693|NCT00882895|Prednisolone|prednisolone|mesh-list
111273694|NCT00882895|Prednisolone acetate|prednisolone acetate|mesh-list
111273695|NCT00882895|Tacrolimus|tacrolimus|mesh-list
111273696|NCT00882895|Thymoglobulin|thymoglobulin|mesh-list
111273697|NCT00882895|Antilymphocyte Serum|antilymphocyte serum|mesh-list
111273698|NCT00882895|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111273699|NCT00882895|Prednisolone phosphate|prednisolone phosphate|mesh-list
111273700|NCT00882895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111273701|NCT00882895|Immunologic Factors|immunologic factors|mesh-ancestor
111273702|NCT00882895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111273703|NCT00882895|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111273704|NCT00882895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111273705|NCT00882895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111273706|NCT00882895|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111273707|NCT00882895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111273708|NCT00882895|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111273709|NCT00882895|Antitubercular Agents|antitubercular agents|mesh-ancestor
111273710|NCT00882895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111273711|NCT00882895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111273712|NCT00882895|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111273713|NCT00882895|Antiemetics|antiemetics|mesh-ancestor
111273714|NCT00882895|Autonomic Agents|autonomic agents|mesh-ancestor
111273715|NCT00882895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111273716|NCT00882895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111273717|NCT00882895|Glucocorticoids|glucocorticoids|mesh-ancestor
111273718|NCT00882895|Hormones|hormones|mesh-ancestor
111273719|NCT00882895|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111273720|NCT00882895|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111273721|NCT00882895|Protective Agents|protective agents|mesh-ancestor
111273722|NCT00882895|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111273723|NCT00900237|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
111273724|NCT00900237|Oxcarbazepine|oxcarbazepine|mesh-list
111273725|NCT00900237|Anticonvulsants|anticonvulsants|mesh-ancestor
111273726|NCT00900237|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111273727|NCT00900237|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111273728|NCT00900237|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111273729|NCT00900237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111273730|NCT00900237|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111273731|NCT00900237|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111273732|NCT00893997|Vaccines|vaccines|mesh-list
111273733|NCT00893997|Immunologic Factors|immunologic factors|mesh-ancestor
111273734|NCT00893997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111273735|NCT00512317|Ganaxolone|ganaxolone|mesh-list
111273736|NCT00512317|Neurosteroids|neurosteroids|mesh-ancestor
111273737|NCT00512317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111273738|NCT00512317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111273739|NCT00512317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111273740|NCT00512317|GABA Modulators|gaba modulators|mesh-ancestor
111273741|NCT00512317|GABA Agents|gaba agents|mesh-ancestor
111273742|NCT01494506|Leucovorin|leucovorin|mesh-list
111273743|NCT01494506|Fluorouracil|fluorouracil|mesh-list
111273744|NCT01494506|Antimetabolites|antimetabolites|mesh-ancestor
111273745|NCT01494506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111273746|NCT01494506|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111273747|NCT01494506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111273748|NCT01494506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111273749|NCT01494506|Immunologic Factors|immunologic factors|mesh-ancestor
111273750|NCT01494506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111273751|NCT01494506|Antidotes|antidotes|mesh-ancestor
111273752|NCT01494506|Protective Agents|protective agents|mesh-ancestor
111273753|NCT01494506|Vitamin B Complex|vitamin b complex|mesh-ancestor
111273754|NCT01494506|Vitamins|vitamins|mesh-ancestor
111273755|NCT01494506|Micronutrients|micronutrients|mesh-ancestor
111273756|NCT03024905|Misoprostol|misoprostol|mesh-list
111273757|NCT03024905|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111273758|NCT03024905|Abortifacient Agents|abortifacient agents|mesh-ancestor
111273759|NCT03024905|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111273760|NCT03024905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111273761|NCT03024905|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111273762|NCT03024905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111273763|NCT03024905|Oxytocics|oxytocics|mesh-ancestor
111273764|NCT02643420|Cyclophosphamide|cyclophosphamide|mesh-list
111273765|NCT02643420|Docetaxel|docetaxel|mesh-list
111273766|NCT02643420|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111273767|NCT02643420|Immunologic Factors|immunologic factors|mesh-ancestor
111273768|NCT02643420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111273769|NCT02643420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111273770|NCT02643420|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111273771|NCT02643420|Alkylating Agents|alkylating agents|mesh-ancestor
111273772|NCT02643420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111273773|NCT02643420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111273774|NCT02643420|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111273775|NCT02643420|Tubulin Modulators|tubulin modulators|mesh-ancestor
111273776|NCT02643420|Antimitotic Agents|antimitotic agents|mesh-ancestor
111273777|NCT02643420|Mitosis Modulators|mitosis modulators|mesh-ancestor
111273778|NCT01830465|Rituximab|rituximab|mesh-list
111273779|NCT01830465|Bortezomib|bortezomib|mesh-list
111273780|NCT01830465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111273781|NCT01830465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111273782|NCT01830465|Immunologic Factors|immunologic factors|mesh-ancestor
110978633|NCT03370263|Belimumab|belimumab|mesh-list
111273783|NCT01830465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111273784|NCT01830465|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111273785|NCT00894465|Midazolam|midazolam|mesh-list
111273786|NCT00894465|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111273787|NCT00894465|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111273788|NCT00894465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111273789|NCT00894465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111273790|NCT00894465|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111273791|NCT00894465|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111273792|NCT00894465|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111273793|NCT00894465|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111273794|NCT00894465|Anesthetics, General|anesthetics, general|mesh-ancestor
111273795|NCT00894465|Anesthetics|anesthetics|mesh-ancestor
111273796|NCT00894465|GABA Modulators|gaba modulators|mesh-ancestor
111273797|NCT00894465|GABA Agents|gaba agents|mesh-ancestor
111273798|NCT00894465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111273799|NCT00894465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111273800|NCT01456130|Alogliptin|alogliptin|mesh-list
111273801|NCT01456130|Insulin, Short-Acting|insulin, short-acting|mesh-list
111273802|NCT01456130|Secretagogues|secretagogues|mesh-list
111273803|NCT01456130|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111273804|NCT01456130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111273805|NCT01456130|Incretins|incretins|mesh-ancestor
111273806|NCT01456130|Hormones|hormones|mesh-ancestor
111273807|NCT01456130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111273808|NCT01456130|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111273809|NCT01456130|Protease Inhibitors|protease inhibitors|mesh-ancestor
111273810|NCT01456130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111273811|NCT01456130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111273812|NCT03479671|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
111273813|NCT03479671|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
111273814|NCT03479671|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
111273815|NCT03479671|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111273816|NCT03219645|Aspirin|aspirin|mesh-list
111273817|NCT03219645|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111273818|NCT03219645|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111273819|NCT03219645|Analgesics|analgesics|mesh-ancestor
111273820|NCT03219645|Sensory System Agents|sensory system agents|mesh-ancestor
111273821|NCT03219645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111273822|NCT03219645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111273823|NCT03219645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111273824|NCT03219645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111273825|NCT03219645|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111273826|NCT03219645|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111273827|NCT03219645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111273828|NCT03219645|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111273829|NCT03219645|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111273830|NCT03219645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111273831|NCT03219645|Antipyretics|antipyretics|mesh-ancestor
111273832|NCT04435314|Nitazoxanide|nitazoxanide|mesh-list
111273833|NCT04435314|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111273834|NCT04435314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111273835|NCT03102450|Benzalkonium Compounds|benzalkonium compounds|mesh-list
111273836|NCT03102450|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111273837|NCT03102450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111273838|NCT01387607|Pregabalin|pregabalin|mesh-list
111273839|NCT01387607|Analgesics|analgesics|mesh-ancestor
111273840|NCT01387607|Sensory System Agents|sensory system agents|mesh-ancestor
111273841|NCT01387607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111273842|NCT01387607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111273843|NCT01387607|Anticonvulsants|anticonvulsants|mesh-ancestor
111273844|NCT01387607|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111273845|NCT01387607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111273846|NCT01387607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111273847|NCT01387607|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111273848|NCT01387607|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111273849|NCT01387607|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111273850|NCT01387607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111273851|NCT01387607|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111273852|NCT05069454|Vaccines|vaccines|mesh-list
111273853|NCT05069454|Immunologic Factors|immunologic factors|mesh-ancestor
111273854|NCT05069454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111273855|NCT05069688|Rifampin|rifampin|mesh-list
111273856|NCT05069688|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111273857|NCT05069688|Antitubercular Agents|antitubercular agents|mesh-ancestor
111273858|NCT05069688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111273859|NCT05069688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111273860|NCT05069688|Leprostatic Agents|leprostatic agents|mesh-ancestor
111273861|NCT05069688|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111273862|NCT05069688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111273863|NCT05069688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111273864|NCT05069688|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111273865|NCT05069688|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111273866|NCT05069688|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
111273867|NCT05069688|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
111273868|NCT05069688|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
111273869|NCT05069688|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111273870|NCT01830777|Cytarabine|cytarabine|mesh-list
111273871|NCT01830777|Etoposide|etoposide|mesh-list
111273872|NCT01830777|Mitoxantrone|mitoxantrone|mesh-list
111273873|NCT01830777|Brentuximab Vedotin|brentuximab vedotin|mesh-list
111273874|NCT01830777|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111273875|NCT01830777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111273876|NCT01830777|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111273877|NCT01830777|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111273878|NCT01830777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111273879|NCT01830777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111273880|NCT01830777|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111273881|NCT01830777|Antimetabolites|antimetabolites|mesh-ancestor
111273882|NCT01830777|Antiviral Agents|antiviral agents|mesh-ancestor
111273883|NCT01830777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111273884|NCT01830777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111273885|NCT01830777|Immunologic Factors|immunologic factors|mesh-ancestor
111273886|NCT01830777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111273887|NCT01830777|Analgesics|analgesics|mesh-ancestor
111273888|NCT01830777|Sensory System Agents|sensory system agents|mesh-ancestor
111273889|NCT01830777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111273890|NCT01830777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111273891|NCT01830777|Immunotoxins|immunotoxins|mesh-ancestor
111273892|NCT01830777|Immunoconjugates|immunoconjugates|mesh-ancestor
111273893|NCT03218631|Oxandrolone|oxandrolone|mesh-list
111273894|NCT03218631|Androgens|androgens|mesh-ancestor
111273895|NCT03218631|Hormones|hormones|mesh-ancestor
111273896|NCT03218631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111273897|NCT03218631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111273898|NCT03218631|Anabolic Agents|anabolic agents|mesh-ancestor
111273899|NCT03451045|Dronabinol|dronabinol|mesh-list
111273900|NCT03451045|Lenabasum|lenabasum|mesh-list
111273901|NCT03451045|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
111273902|NCT03451045|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
111273903|NCT03451045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111273904|NCT03451045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111273905|NCT03451045|Hormones|hormones|mesh-ancestor
111273906|NCT03451045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111273907|NCT03451045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111273908|NCT03451045|Hallucinogens|hallucinogens|mesh-ancestor
111273909|NCT03451045|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111273910|NCT03451045|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111273911|NCT03451045|Analgesics|analgesics|mesh-ancestor
111273912|NCT03451045|Sensory System Agents|sensory system agents|mesh-ancestor
111273913|NCT03451045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111273914|NCT01831011|Aspirin|aspirin|mesh-list
111273915|NCT01831011|Cinepazide|cinepazide|mesh-list
111273916|NCT01831011|3-(2,2,2-trimethylhydrazine)propionate|3-(2,2,2-trimethylhydrazine)propionate|mesh-list
111273917|NCT01831011|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111273918|NCT01831011|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111273919|NCT01831011|Analgesics|analgesics|mesh-ancestor
111273920|NCT01831011|Sensory System Agents|sensory system agents|mesh-ancestor
111273921|NCT01831011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111273922|NCT01831011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111273923|NCT01831011|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111273924|NCT01831011|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111273925|NCT01831011|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111273926|NCT01831011|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111273927|NCT01831011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111273928|NCT01831011|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111273929|NCT01831011|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111273930|NCT01831011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111273931|NCT01831011|Antipyretics|antipyretics|mesh-ancestor
111273932|NCT01831011|Vasodilator Agents|vasodilator agents|mesh-ancestor
111273933|NCT01831011|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111273934|NCT01831011|Immunologic Factors|immunologic factors|mesh-ancestor
111273935|NCT03218709|Vitamins|vitamins|mesh-list
111273936|NCT03218709|Micronutrients|micronutrients|mesh-ancestor
111273937|NCT03218709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111273938|NCT03218553|Dexamethasone|dexamethasone|mesh-list
111273939|NCT03218553|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111273940|NCT03218553|Antiemetics|antiemetics|mesh-ancestor
111273941|NCT03218553|Autonomic Agents|autonomic agents|mesh-ancestor
111273942|NCT03218553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111273943|NCT03218553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111273944|NCT03218553|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111273945|NCT03218553|Glucocorticoids|glucocorticoids|mesh-ancestor
111273946|NCT03218553|Hormones|hormones|mesh-ancestor
111273947|NCT03218553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111273948|NCT03218553|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111273949|NCT03218553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111273950|NCT03430843|Paclitaxel|paclitaxel|mesh-list
111273951|NCT03430843|Docetaxel|docetaxel|mesh-list
111273952|NCT03430843|Irinotecan|irinotecan|mesh-list
111273953|NCT03430843|Tislelizumab|tislelizumab|mesh-list
111273954|NCT03430843|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111273955|NCT03430843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111273956|NCT03430843|Tubulin Modulators|tubulin modulators|mesh-ancestor
111273957|NCT03430843|Antimitotic Agents|antimitotic agents|mesh-ancestor
111273958|NCT03430843|Mitosis Modulators|mitosis modulators|mesh-ancestor
111273959|NCT03430843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111273960|NCT03430843|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111273961|NCT03430843|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111273962|NCT03430843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111273963|NCT03430843|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111273964|NCT01386125|Mometasone Furoate|mometasone furoate|mesh-list
111273965|NCT01386125|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111273966|NCT01386125|Dermatologic Agents|dermatologic agents|mesh-ancestor
111273967|NCT01386125|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111273968|NCT01831323|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111273969|NCT01831323|Rifaximin|rifaximin|mesh-list
111273970|NCT01831323|Mesalamine|mesalamine|mesh-list
111273971|NCT01831323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
111273972|NCT01831323|Psyllium|psyllium|mesh-list
111273973|NCT01831323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111273974|NCT01831323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111273975|NCT01831323|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111273976|NCT01831323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111273977|NCT01831323|Analgesics|analgesics|mesh-ancestor
111273978|NCT01831323|Sensory System Agents|sensory system agents|mesh-ancestor
111273979|NCT01831323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111273980|NCT01831323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111273981|NCT01831323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111273982|NCT01831323|Cathartics|cathartics|mesh-ancestor
111273983|NCT03221400|Leucovorin|leucovorin|mesh-list
111273984|NCT03221400|Folic Acid|folic acid|mesh-list
111273985|NCT03221400|Fluorouracil|fluorouracil|mesh-list
111273986|NCT03221400|Niraparib|niraparib|mesh-list
111273987|NCT03221400|Levoleucovorin|levoleucovorin|mesh-list
111273988|NCT03221400|Antimetabolites|antimetabolites|mesh-ancestor
111273989|NCT03221400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111273990|NCT03221400|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111273991|NCT03221400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111273992|NCT03221400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111273993|NCT03221400|Immunologic Factors|immunologic factors|mesh-ancestor
111273994|NCT03221400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111273995|NCT03221400|Antidotes|antidotes|mesh-ancestor
111273996|NCT03221400|Protective Agents|protective agents|mesh-ancestor
111273997|NCT03221400|Vitamin B Complex|vitamin b complex|mesh-ancestor
111273998|NCT03221400|Vitamins|vitamins|mesh-ancestor
111273999|NCT03221400|Micronutrients|micronutrients|mesh-ancestor
111274000|NCT03221400|Hematinics|hematinics|mesh-ancestor
111274001|NCT03221400|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111274002|NCT03221400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111274003|NCT01384877|Lidocaine|lidocaine|mesh-list
111274004|NCT01384877|Anesthetics, Local|anesthetics, local|mesh-ancestor
111274005|NCT01384877|Anesthetics|anesthetics|mesh-ancestor
111274006|NCT01384877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111274007|NCT01384877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111274008|NCT01384877|Sensory System Agents|sensory system agents|mesh-ancestor
111274009|NCT01384877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111274010|NCT01384877|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111274011|NCT01384877|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111274012|NCT01384877|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111274013|NCT01384877|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111274014|NCT01384877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111274016|NCT00114517|Estradiol|estradiol|mesh-list
111274017|NCT00114517|Estrogens|estrogens|mesh-list
111274018|NCT00114517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111274019|NCT00114517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111274020|NCT01831479|Olmesartan|olmesartan|mesh-list
111274021|NCT01831479|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
111274022|NCT01831479|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111274023|NCT01831479|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111274024|NCT01831479|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111274025|NCT01831479|Antimetabolites|antimetabolites|mesh-ancestor
111274026|NCT01831479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111274027|NCT01831479|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111274028|NCT01831479|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111274029|NCT01831479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111274030|NCT01831479|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111274031|NCT01831479|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111274032|NCT01831479|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111274033|NCT03099720|Ropivacaine|ropivacaine|mesh-list
111274034|NCT03099720|Anesthetics, Local|anesthetics, local|mesh-ancestor
111274035|NCT03099720|Anesthetics|anesthetics|mesh-ancestor
111274036|NCT03099720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111274037|NCT03099720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111274038|NCT03099720|Sensory System Agents|sensory system agents|mesh-ancestor
111274039|NCT03099720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111274040|NCT03025295|Dexmedetomidine|dexmedetomidine|mesh-list
111274041|NCT03025295|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111274042|NCT03025295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111274043|NCT03025295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111274044|NCT03025295|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111274045|NCT03025295|Analgesics|analgesics|mesh-ancestor
111274046|NCT03025295|Sensory System Agents|sensory system agents|mesh-ancestor
111274047|NCT03025295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111274048|NCT03025295|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111274049|NCT03025295|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111274050|NCT03025295|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111274051|NCT03025295|Adrenergic Agents|adrenergic agents|mesh-ancestor
111274052|NCT03025295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111274053|NCT03025295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111274054|NCT01471574|Interferons|interferons|mesh-list
111274055|NCT01471574|Ribavirin|ribavirin|mesh-list
111274056|NCT01471574|Interferon-alpha|interferon-alpha|mesh-list
111274057|NCT01471574|Interferon alpha-2|interferon alpha-2|mesh-list
111274058|NCT01471574|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
111274059|NCT01471574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111274060|NCT01471574|Antiviral Agents|antiviral agents|mesh-ancestor
111274061|NCT01471574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111274062|NCT01471574|Antimetabolites|antimetabolites|mesh-ancestor
111274063|NCT01471574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111274064|NCT01471574|Immunologic Factors|immunologic factors|mesh-ancestor
111274065|NCT01471574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111274066|NCT01383707|Leucovorin|leucovorin|mesh-list
111274067|NCT01383707|Bevacizumab|bevacizumab|mesh-list
111274068|NCT01383707|Fluorouracil|fluorouracil|mesh-list
111274069|NCT01383707|Oxaliplatin|oxaliplatin|mesh-list
111274070|NCT01383707|Levoleucovorin|levoleucovorin|mesh-list
111274071|NCT01383707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111274072|NCT01383707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111274073|NCT01383707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111274074|NCT01383707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111274075|NCT01383707|Growth Substances|growth substances|mesh-ancestor
111274076|NCT01383707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111274077|NCT01383707|Growth Inhibitors|growth inhibitors|mesh-ancestor
111274078|NCT01383707|Antimetabolites|antimetabolites|mesh-ancestor
110998424|NCT03147092|Analgesics|analgesics|mesh-ancestor
111274079|NCT01383707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111274080|NCT01383707|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111274081|NCT01383707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111274082|NCT01383707|Immunologic Factors|immunologic factors|mesh-ancestor
111274083|NCT01383707|Antidotes|antidotes|mesh-ancestor
111274084|NCT01383707|Protective Agents|protective agents|mesh-ancestor
111274085|NCT01383707|Vitamin B Complex|vitamin b complex|mesh-ancestor
111274086|NCT01383707|Vitamins|vitamins|mesh-ancestor
111274087|NCT01383707|Micronutrients|micronutrients|mesh-ancestor
111274088|NCT01839357|Rivaroxaban|rivaroxaban|mesh-list
111274089|NCT01839357|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111274090|NCT01839357|Antithrombins|antithrombins|mesh-ancestor
111274091|NCT01839357|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111274092|NCT01839357|Protease Inhibitors|protease inhibitors|mesh-ancestor
111274093|NCT01839357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111274094|NCT01839357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111274095|NCT01839357|Anticoagulants|anticoagulants|mesh-ancestor
111274096|NCT03306901|Fluorouracil|fluorouracil|mesh-list
111274097|NCT03306901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111274098|NCT03306901|Antimetabolites|antimetabolites|mesh-ancestor
111274099|NCT03306901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111274100|NCT03306901|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111274101|NCT03306901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111274102|NCT03306901|Immunologic Factors|immunologic factors|mesh-ancestor
111274103|NCT03306901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111274104|NCT01455428|Pregabalin|pregabalin|mesh-list
111274105|NCT01455428|Analgesics|analgesics|mesh-ancestor
111274106|NCT01455428|Sensory System Agents|sensory system agents|mesh-ancestor
111274107|NCT01455428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111274108|NCT01455428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111274109|NCT01455428|Anticonvulsants|anticonvulsants|mesh-ancestor
111274110|NCT01455428|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111274111|NCT01455428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111274112|NCT01455428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111274113|NCT01455428|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111274114|NCT01455428|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111274115|NCT01455428|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111274116|NCT01455428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111274117|NCT01455428|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111274118|NCT01831947|Ranibizumab|ranibizumab|mesh-list
111274119|NCT01831947|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111274120|NCT01831947|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111274121|NCT01831947|Growth Substances|growth substances|mesh-ancestor
111274122|NCT01831947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111274123|NCT01831947|Growth Inhibitors|growth inhibitors|mesh-ancestor
111274124|NCT01831947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111274125|NCT01383161|Curcumin|curcumin|mesh-list
111274126|NCT01383161|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111274127|NCT01383161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111274128|NCT01383161|Analgesics|analgesics|mesh-ancestor
111274129|NCT01383161|Sensory System Agents|sensory system agents|mesh-ancestor
111274130|NCT01383161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111274131|NCT01383161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111274132|NCT01383161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111274133|NCT01383161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111274134|NCT01383161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111274135|NCT01383161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111274136|NCT01383161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111274137|NCT00894699|Sufentanil|sufentanil|mesh-list
111274138|NCT00894699|Triazolam|triazolam|mesh-list
111274139|NCT00894699|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111274140|NCT00894699|Narcotics|narcotics|mesh-ancestor
111274141|NCT00894699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111274142|NCT00894699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111274143|NCT00894699|Analgesics|analgesics|mesh-ancestor
111274144|NCT00894699|Sensory System Agents|sensory system agents|mesh-ancestor
111274145|NCT00894699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111274146|NCT00894699|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111274147|NCT00894699|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111274148|NCT00894699|Anesthetics, General|anesthetics, general|mesh-ancestor
111274149|NCT00894699|Anesthetics|anesthetics|mesh-ancestor
111274150|NCT00894699|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111274151|NCT00894699|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111274152|NCT00894699|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111274153|NCT00894699|GABA Modulators|gaba modulators|mesh-ancestor
111274154|NCT00894699|GABA Agents|gaba agents|mesh-ancestor
111274155|NCT00894699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111274156|NCT00894699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111274157|NCT03087019|Pembrolizumab|pembrolizumab|mesh-list
111274158|NCT03087019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111274159|NCT03087019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111274160|NCT03087019|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111274161|NCT03087019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111274162|NCT01382225|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111274163|NCT01382225|Hyaluronic Acid|hyaluronic acid|mesh-list
111274164|NCT01382225|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111274165|NCT01382225|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111274166|NCT01382225|Immunologic Factors|immunologic factors|mesh-ancestor
111274167|NCT01382225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111274168|NCT01382225|Viscosupplements|viscosupplements|mesh-ancestor
111274169|NCT01382225|Protective Agents|protective agents|mesh-ancestor
111274171|NCT01381679|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111274172|NCT01381679|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111274173|NCT01381679|Antimetabolites|antimetabolites|mesh-ancestor
111274174|NCT01381679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111274175|NCT01381679|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111274176|NCT01832415|Bevacizumab|bevacizumab|mesh-list
111274177|NCT01832415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111274178|NCT01832415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111274179|NCT01832415|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111274180|NCT01832415|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111274181|NCT01832415|Growth Substances|growth substances|mesh-ancestor
111274182|NCT01832415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111274183|NCT01832415|Growth Inhibitors|growth inhibitors|mesh-ancestor
111274184|NCT01455194|Ciclesonide|ciclesonide|mesh-list
111274185|NCT01455194|Glucocorticoids|glucocorticoids|mesh-ancestor
111274186|NCT01455194|Hormones|hormones|mesh-ancestor
111274187|NCT01455194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111274188|NCT01455194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111274189|NCT01455194|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111274190|NCT03216759|Dexmedetomidine|dexmedetomidine|mesh-list
111274191|NCT03216759|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111274192|NCT03216759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111274193|NCT03216759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111274194|NCT03216759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111274195|NCT03216759|Analgesics|analgesics|mesh-ancestor
111274196|NCT03216759|Sensory System Agents|sensory system agents|mesh-ancestor
111274197|NCT03216759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111274198|NCT03216759|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111274199|NCT03216759|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111274200|NCT03216759|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111274201|NCT03216759|Adrenergic Agents|adrenergic agents|mesh-ancestor
111274202|NCT03216759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111274203|NCT03216759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111274204|NCT01832571|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
111274205|NCT01832571|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111274206|NCT01832571|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111274207|NCT01832571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111274208|NCT01832571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111274209|NCT01832571|Antiviral Agents|antiviral agents|mesh-ancestor
111274210|NCT01832571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111274211|NCT01832571|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111274212|NCT01832571|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111274213|NCT03216915|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
111274214|NCT03216915|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
111274215|NCT03216915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111274216|NCT03216915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111274217|NCT03216915|Immunologic Factors|immunologic factors|mesh-ancestor
111274218|NCT03216915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111274219|NCT04007393|Topiramate|topiramate|mesh-list
111274220|NCT04007393|Phentermine|phentermine|mesh-list
111274221|NCT04007393|Anticonvulsants|anticonvulsants|mesh-ancestor
111274222|NCT04007393|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111274223|NCT04007393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111274224|NCT04007393|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111274225|NCT04007393|Appetite Depressants|appetite depressants|mesh-ancestor
111274226|NCT04007393|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111274228|NCT04007393|Autonomic Agents|autonomic agents|mesh-ancestor
111274229|NCT04007393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111274230|NCT04007393|Adrenergic Agents|adrenergic agents|mesh-ancestor
111274231|NCT04007393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111274232|NCT04007393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111274233|NCT05368805|Dabigatran|dabigatran|mesh-list
111274234|NCT05368805|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111274235|NCT05368805|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111274236|NCT05368805|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111274237|NCT05368805|Antimetabolites|antimetabolites|mesh-ancestor
111274238|NCT05368805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111274239|NCT05368805|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111274240|NCT05368805|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111274241|NCT05368805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111274242|NCT05368805|Antithrombins|antithrombins|mesh-ancestor
111274243|NCT05368805|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111274244|NCT05368805|Protease Inhibitors|protease inhibitors|mesh-ancestor
111274245|NCT05368805|Anticoagulants|anticoagulants|mesh-ancestor
111274246|NCT03304717|Tenofovir|tenofovir|mesh-list
111274247|NCT03304717|Emtricitabine|emtricitabine|mesh-list
111274248|NCT03304717|Antiviral Agents|antiviral agents|mesh-ancestor
111274249|NCT03304717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111274250|NCT03304717|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111274251|NCT03304717|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111274252|NCT03304717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111274253|NCT03304717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111274254|NCT03304717|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111274255|NCT03304717|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111274256|NCT01839981|Thioctic Acid|thioctic acid|mesh-list
111274257|NCT01839981|Antioxidants|antioxidants|mesh-ancestor
111274258|NCT01839981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111274259|NCT01839981|Protective Agents|protective agents|mesh-ancestor
111274260|NCT01839981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111274261|NCT01839981|Vitamin B Complex|vitamin b complex|mesh-ancestor
111274262|NCT01839981|Vitamins|vitamins|mesh-ancestor
111274263|NCT01839981|Micronutrients|micronutrients|mesh-ancestor
111274264|NCT03081156|Glycopyrrolate|glycopyrrolate|mesh-list
111274265|NCT03081156|Formoterol Fumarate|formoterol fumarate|mesh-list
111274266|NCT03081156|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111274267|NCT03081156|Autonomic Agents|autonomic agents|mesh-ancestor
111274268|NCT03081156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111274269|NCT03081156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111274270|NCT03081156|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111274271|NCT03081156|Respiratory System Agents|respiratory system agents|mesh-ancestor
111274272|NCT03081156|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111274273|NCT03081156|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111274274|NCT03081156|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111274275|NCT03081156|Adrenergic Agents|adrenergic agents|mesh-ancestor
111274276|NCT03081156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111274277|NCT03081156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111274278|NCT03081156|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111274279|NCT03081156|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111274280|NCT03081156|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111274281|NCT03081156|Cholinergic Agents|cholinergic agents|mesh-ancestor
111274282|NCT01494350|Gentamicins|gentamicins|mesh-list
111274283|NCT01494350|Paromomycin|paromomycin|mesh-list
111274284|NCT01494350|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111274285|NCT01494350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111274286|NCT01494350|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111274287|NCT01494350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111274288|NCT01494350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111274289|NCT01494350|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111274290|NCT01494350|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111274291|NCT02135484|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
111274292|NCT02135484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111274293|NCT03258385|Vitamin B 12|vitamin b 12|mesh-list
111274294|NCT03258385|Hydroxocobalamin|hydroxocobalamin|mesh-list
111274295|NCT03258385|Vitamins|vitamins|mesh-ancestor
111274296|NCT03258385|Micronutrients|micronutrients|mesh-ancestor
111274297|NCT03258385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111274298|NCT03258385|Vitamin B Complex|vitamin b complex|mesh-ancestor
111274299|NCT03258385|Hematinics|hematinics|mesh-ancestor
111274300|NCT03024515|Analgesics, Opioid|analgesics, opioid|mesh-list
111274301|NCT03024515|Narcotics|narcotics|mesh-ancestor
111274302|NCT03024515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111274303|NCT03024515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111274304|NCT03024515|Analgesics|analgesics|mesh-ancestor
111274305|NCT03024515|Sensory System Agents|sensory system agents|mesh-ancestor
111274306|NCT03024515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111274307|NCT01834911|Tetrabenazine|tetrabenazine|mesh-list
111274308|NCT01834911|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111274309|NCT01834911|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111274310|NCT01834911|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111274311|NCT01834911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111274312|NCT01834911|Adrenergic Agents|adrenergic agents|mesh-ancestor
111274313|NCT01834911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111274314|NCT01834911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111274315|NCT04287829|Pembrolizumab|pembrolizumab|mesh-list
111274316|NCT04287829|Lenvatinib|lenvatinib|mesh-list
111274317|NCT04287829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111274318|NCT04287829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111274319|NCT04287829|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111274320|NCT04287829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111274321|NCT04287829|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111274322|NCT04287829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111274323|NCT03083821|Entecavir|entecavir|mesh-list
111274324|NCT03083821|Antiviral Agents|antiviral agents|mesh-ancestor
111274325|NCT03083821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111274326|NCT05367869|Methylene Blue|methylene blue|mesh-list
111274327|NCT05367869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111274328|NCT05367869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111274329|NCT01720095|Niacin|niacin|mesh-list
111274330|NCT01720095|Nicotinic Acids|nicotinic acids|mesh-list
111274331|NCT01720095|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111274332|NCT01720095|Antimetabolites|antimetabolites|mesh-ancestor
111274333|NCT01720095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111274334|NCT01720095|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111274335|NCT01720095|Vasodilator Agents|vasodilator agents|mesh-ancestor
111274336|NCT01720095|Vitamin B Complex|vitamin b complex|mesh-ancestor
111274337|NCT01720095|Vitamins|vitamins|mesh-ancestor
111274338|NCT01720095|Micronutrients|micronutrients|mesh-ancestor
111274339|NCT01720095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111274340|NCT03836157|Bevacizumab|bevacizumab|mesh-list
111274341|NCT03836157|Maytansine|maytansine|mesh-list
111274342|NCT03836157|Mirvetuximab soravtansine|mirvetuximab soravtansine|mesh-list
111274343|NCT03836157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111274344|NCT03836157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111274345|NCT03836157|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111274346|NCT03836157|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111274347|NCT03836157|Growth Substances|growth substances|mesh-ancestor
111274348|NCT03836157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111274349|NCT03836157|Growth Inhibitors|growth inhibitors|mesh-ancestor
111274350|NCT03836157|Immunoconjugates|immunoconjugates|mesh-ancestor
111274351|NCT03836157|Immunologic Factors|immunologic factors|mesh-ancestor
111274352|NCT03836157|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111274353|NCT03836157|Tubulin Modulators|tubulin modulators|mesh-ancestor
111274354|NCT03836157|Antimitotic Agents|antimitotic agents|mesh-ancestor
111274355|NCT03836157|Mitosis Modulators|mitosis modulators|mesh-ancestor
111274356|NCT03836157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111274357|NCT03080545|Calcitriol|calcitriol|mesh-list
111274358|NCT03080545|Betamethasone|betamethasone|mesh-list
111274359|NCT03080545|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
111274360|NCT03080545|Calcipotriene|calcipotriene|mesh-list
111274361|NCT03080545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111274362|NCT03080545|Glucocorticoids|glucocorticoids|mesh-ancestor
111274363|NCT03080545|Hormones|hormones|mesh-ancestor
111274364|NCT03080545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111274365|NCT03080545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111274366|NCT03080545|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111274367|NCT03080545|Respiratory System Agents|respiratory system agents|mesh-ancestor
111274368|NCT03080545|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111274369|NCT03080545|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
111274370|NCT03080545|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111274371|NCT03080545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111274372|NCT03080545|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111274373|NCT03080545|Vitamins|vitamins|mesh-ancestor
111274374|NCT03080545|Micronutrients|micronutrients|mesh-ancestor
111274375|NCT03080545|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111274376|NCT03080545|Dermatologic Agents|dermatologic agents|mesh-ancestor
111274377|NCT03101124|Tranexamic Acid|tranexamic acid|mesh-list
111274378|NCT03101124|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111274379|NCT03101124|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111274380|NCT03101124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111274381|NCT03101124|Hemostatics|hemostatics|mesh-ancestor
111274382|NCT03101124|Coagulants|coagulants|mesh-ancestor
111274383|NCT02985203|Vinorelbine|vinorelbine|mesh-list
111274384|NCT02985203|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111274385|NCT02985203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111274386|NCT02985203|Tubulin Modulators|tubulin modulators|mesh-ancestor
111274387|NCT02985203|Antimitotic Agents|antimitotic agents|mesh-ancestor
111274388|NCT02985203|Mitosis Modulators|mitosis modulators|mesh-ancestor
111274389|NCT02985203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111274390|NCT04283617|Insulin|insulin|mesh-list
111274391|NCT04283617|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111274392|NCT04283617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111274393|NCT05247619|Paclitaxel|paclitaxel|mesh-list
111274394|NCT05247619|Bevacizumab|bevacizumab|mesh-list
111274395|NCT05247619|Carboplatin|carboplatin|mesh-list
111274396|NCT05247619|Tislelizumab|tislelizumab|mesh-list
111274397|NCT05247619|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111274398|NCT05247619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111274399|NCT05247619|Tubulin Modulators|tubulin modulators|mesh-ancestor
111274400|NCT05247619|Antimitotic Agents|antimitotic agents|mesh-ancestor
111274401|NCT05247619|Mitosis Modulators|mitosis modulators|mesh-ancestor
111274402|NCT05247619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111274403|NCT05247619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111274404|NCT05247619|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111274405|NCT05247619|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111274406|NCT05247619|Growth Substances|growth substances|mesh-ancestor
111274407|NCT05247619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111274408|NCT05247619|Growth Inhibitors|growth inhibitors|mesh-ancestor
111274409|NCT04018937|Fludarabine|fludarabine|mesh-list
111274410|NCT04018937|Melphalan|melphalan|mesh-list
111274411|NCT04018937|Alemtuzumab|alemtuzumab|mesh-list
111274412|NCT04018937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111274413|NCT04018937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111274414|NCT04018937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111274415|NCT04018937|Immunologic Factors|immunologic factors|mesh-ancestor
111274416|NCT04018937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111274417|NCT04018937|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111274418|NCT04018937|Alkylating Agents|alkylating agents|mesh-ancestor
111274419|NCT04018937|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111274420|NCT04018937|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111274421|NCT00805584|Desloratadine|desloratadine|mesh-list
111274422|NCT00805584|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111274423|NCT00805584|Cholinergic Agents|cholinergic agents|mesh-ancestor
111274424|NCT00805584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111274425|NCT00805584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111274426|NCT00805584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111274427|NCT00805584|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
111274428|NCT00805584|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111274429|NCT00805584|Histamine Antagonists|histamine antagonists|mesh-ancestor
111274430|NCT00805584|Histamine Agents|histamine agents|mesh-ancestor
111274431|NCT01833351|Vitamins|vitamins|mesh-list
111274432|NCT01833351|Ascorbic Acid|ascorbic acid|mesh-list
111274433|NCT01833351|Micronutrients|micronutrients|mesh-ancestor
111274434|NCT01833351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111274435|NCT01833351|Antioxidants|antioxidants|mesh-ancestor
111274436|NCT01833351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111274437|NCT01833351|Protective Agents|protective agents|mesh-ancestor
111274438|NCT03187405|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
111274439|NCT03187405|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111274440|NCT03187405|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111274441|NCT03187405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111274442|NCT05066958|Antiviral Agents|antiviral agents|mesh-list
111274443|NCT05066958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111274444|NCT00218543|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
111274445|NCT00218543|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111274446|NCT00218543|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111274447|NCT00218543|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111274448|NCT00218543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111274449|NCT00218543|Adrenergic Agents|adrenergic agents|mesh-ancestor
111274450|NCT00218543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111274451|NCT00218543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111274453|NCT00795522|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111274454|NCT00795522|Cholinergic Agents|cholinergic agents|mesh-ancestor
111274455|NCT00795522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111274456|NCT00795522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111274457|NCT00795522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111274458|NCT00795522|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
111274459|NCT00795522|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111274460|NCT00795522|Histamine Antagonists|histamine antagonists|mesh-ancestor
111274461|NCT00795522|Histamine Agents|histamine agents|mesh-ancestor
111274462|NCT00910845|Botulinum Toxins|botulinum toxins|mesh-list
111274463|NCT00910845|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111274464|NCT00910845|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111274465|NCT00910845|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111274466|NCT00910845|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111274467|NCT00910845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111274468|NCT00910845|Cholinergic Agents|cholinergic agents|mesh-ancestor
111274469|NCT00910845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111274470|NCT00910845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111274471|NCT00910845|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111274472|NCT00910845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111274473|NCT05243251|Olanzapine|olanzapine|mesh-list
111274474|NCT05243251|Antiemetics|antiemetics|mesh-ancestor
111274475|NCT05243251|Autonomic Agents|autonomic agents|mesh-ancestor
111274476|NCT05243251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111274477|NCT05243251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111274478|NCT05243251|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111274479|NCT05243251|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111274480|NCT05243251|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111274481|NCT05243251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111274482|NCT05243251|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111274483|NCT05243251|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111274484|NCT05243251|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111274485|NCT05243251|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111274486|NCT05243251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111274487|NCT05243251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111274488|NCT05243251|Serotonin Agents|serotonin agents|mesh-ancestor
111274489|NCT05242705|Cystatins|cystatins|mesh-list
111274490|NCT05242705|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
111274491|NCT05242705|Protease Inhibitors|protease inhibitors|mesh-ancestor
111274492|NCT05242705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111274493|NCT05242705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111274494|NCT00216671|Risperidone|risperidone|mesh-list
111274495|NCT00216671|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111274496|NCT00216671|Serotonin Agents|serotonin agents|mesh-ancestor
111274497|NCT00216671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111274498|NCT00216671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111274499|NCT00216671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111274500|NCT00216671|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111274501|NCT00216671|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111274502|NCT00216671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111274503|NCT00216671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111274504|NCT00216671|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111274505|NCT00216671|Dopamine Agents|dopamine agents|mesh-ancestor
111274506|NCT00783354|Loratadine|loratadine|mesh-list
111274507|NCT00783354|Desloratadine|desloratadine|mesh-list
111274508|NCT00783354|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111274509|NCT00783354|Cholinergic Agents|cholinergic agents|mesh-ancestor
111274510|NCT00783354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111274511|NCT00783354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111274512|NCT00783354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111274513|NCT00783354|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
111274514|NCT00783354|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111274515|NCT00783354|Histamine Antagonists|histamine antagonists|mesh-ancestor
111274516|NCT00783354|Histamine Agents|histamine agents|mesh-ancestor
111274517|NCT00783354|Antipruritics|antipruritics|mesh-ancestor
111274518|NCT00783354|Dermatologic Agents|dermatologic agents|mesh-ancestor
111274519|NCT00783354|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111274520|NCT01833663|Solifenacin Succinate|solifenacin succinate|mesh-list
111274521|NCT01833663|Estrogens|estrogens|mesh-list
111274522|NCT01833663|Hormones|hormones|mesh-ancestor
111274523|NCT01833663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111274524|NCT01833663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111274525|NCT01833663|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111274526|NCT01833663|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111274527|NCT01833663|Cholinergic Agents|cholinergic agents|mesh-ancestor
111274528|NCT01833663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111274529|NCT01833663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111274530|NCT01833663|Urological Agents|urological agents|mesh-ancestor
111274531|NCT01720875|Dexamethasone|dexamethasone|mesh-list
111274532|NCT01720875|Bortezomib|bortezomib|mesh-list
111274533|NCT01720875|Vorinostat|vorinostat|mesh-list
111274534|NCT01720875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111274535|NCT01720875|Antiemetics|antiemetics|mesh-ancestor
111274536|NCT01720875|Autonomic Agents|autonomic agents|mesh-ancestor
111274537|NCT01720875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111274538|NCT01720875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111274539|NCT01720875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111274540|NCT01720875|Glucocorticoids|glucocorticoids|mesh-ancestor
111274541|NCT01720875|Hormones|hormones|mesh-ancestor
111274542|NCT01720875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111274543|NCT01720875|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111274544|NCT01720875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111274545|NCT01720875|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111274546|NCT01720875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111274547|NCT01720875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111274548|NCT04277143|Daptomycin|daptomycin|mesh-list
111274549|NCT04277143|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111274550|NCT04277143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111274551|NCT00750750|Mometasone Furoate|mometasone furoate|mesh-list
111274552|NCT00750750|Amoxicillin|amoxicillin|mesh-list
111274553|NCT00750750|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111274554|NCT00750750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111274555|NCT00750750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111274556|NCT00750750|Dermatologic Agents|dermatologic agents|mesh-ancestor
111274557|NCT00750750|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111274558|NCT05066802|Folfirinox|folfirinox|mesh-list
111274559|NCT05066802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111274560|NCT04379739|Apatinib|apatinib|mesh-list
111274561|NCT04379739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111274562|NCT04379739|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111274563|NCT04379739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111274564|NCT04379739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111274565|NCT05066568|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
111274566|NCT05066568|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111274567|NCT05066568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111274568|NCT05248633|Dexamethasone|dexamethasone|mesh-list
111274569|NCT05248633|Lenalidomide|lenalidomide|mesh-list
111274570|NCT05248633|Bortezomib|bortezomib|mesh-list
111274571|NCT05248633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111274572|NCT05248633|Antiemetics|antiemetics|mesh-ancestor
111274573|NCT05248633|Autonomic Agents|autonomic agents|mesh-ancestor
111274574|NCT05248633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111274575|NCT05248633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111274576|NCT05248633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111274577|NCT05248633|Glucocorticoids|glucocorticoids|mesh-ancestor
111274578|NCT05248633|Hormones|hormones|mesh-ancestor
111274579|NCT05248633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111274580|NCT05248633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111274581|NCT05248633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111274582|NCT05248633|Immunologic Factors|immunologic factors|mesh-ancestor
111274583|NCT05248633|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111274584|NCT05248633|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111274585|NCT05248633|Growth Substances|growth substances|mesh-ancestor
111274586|NCT05248633|Growth Inhibitors|growth inhibitors|mesh-ancestor
111274587|NCT00216203|Pemetrexed|pemetrexed|mesh-list
111274588|NCT00216203|Cetuximab|cetuximab|mesh-list
111274589|NCT00216203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111274590|NCT00216203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111274591|NCT00216203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111274592|NCT00216203|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111274593|NCT00216203|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111274594|NCT00216203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111274595|NCT01727271|Interferons|interferons|mesh-list
111274596|NCT01727271|Tenofovir|tenofovir|mesh-list
111274597|NCT01727271|Interferon-alpha|interferon-alpha|mesh-list
111274598|NCT01727271|Interferon alpha-2|interferon alpha-2|mesh-list
111274599|NCT01727271|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
111274600|NCT01727271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111274601|NCT01727271|Antiviral Agents|antiviral agents|mesh-ancestor
111274602|NCT01727271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111274603|NCT01727271|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111274604|NCT01727271|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111274605|NCT01727271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111274606|NCT01727271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111274607|NCT01727271|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111274608|NCT01727271|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111274609|NCT01727271|Immunologic Factors|immunologic factors|mesh-ancestor
111274610|NCT01727271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111274611|NCT00653796|Atorvastatin|atorvastatin|mesh-list
111274612|NCT00653796|Ezetimibe|ezetimibe|mesh-list
111274613|NCT00653796|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111274614|NCT00653796|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111274615|NCT00653796|Antimetabolites|antimetabolites|mesh-ancestor
111274616|NCT00653796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111274617|NCT00653796|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111274618|NCT00653796|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111274619|NCT00653796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111274620|NCT01833819|Lidocaine|lidocaine|mesh-list
111274621|NCT01833819|Dexmedetomidine|dexmedetomidine|mesh-list
111274622|NCT01833819|Remifentanil|remifentanil|mesh-list
111274623|NCT01833819|Anesthetics, Local|anesthetics, local|mesh-ancestor
111274624|NCT01833819|Anesthetics|anesthetics|mesh-ancestor
111274625|NCT01833819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111274626|NCT01833819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111274627|NCT01833819|Sensory System Agents|sensory system agents|mesh-ancestor
111274628|NCT01833819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111274629|NCT01833819|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111274630|NCT01833819|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111274631|NCT01833819|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111274632|NCT01833819|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111274633|NCT01833819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111274634|NCT01833819|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111274635|NCT01833819|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111274636|NCT01833819|Analgesics|analgesics|mesh-ancestor
111274637|NCT01833819|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111274638|NCT01833819|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111274639|NCT01833819|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111274640|NCT01833819|Adrenergic Agents|adrenergic agents|mesh-ancestor
111274641|NCT01833819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111274642|NCT01833819|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111274643|NCT01833819|Narcotics|narcotics|mesh-ancestor
111274644|NCT05244109|Antibodies|antibodies|mesh-list
111274645|NCT05244109|Immunoglobulins|immunoglobulins|mesh-list
111274646|NCT05244109|Immunologic Factors|immunologic factors|mesh-ancestor
111274647|NCT05244109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111274648|NCT00651144|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111274649|NCT00651144|Ezetimibe|ezetimibe|mesh-list
111274650|NCT00651144|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111274651|NCT00651144|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111274652|NCT00651144|Antimetabolites|antimetabolites|mesh-ancestor
111274653|NCT00651144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111274654|NCT00651144|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111274655|NCT00651144|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111274656|NCT00651144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111274657|NCT01721031|Tramadol|tramadol|mesh-list
111274658|NCT01721031|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111274659|NCT01721031|Narcotics|narcotics|mesh-ancestor
111274660|NCT01721031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111274661|NCT01721031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111274662|NCT01721031|Analgesics|analgesics|mesh-ancestor
111274663|NCT01721031|Sensory System Agents|sensory system agents|mesh-ancestor
111274664|NCT01721031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111274665|NCT03218683|Venetoclax|venetoclax|mesh-list
111274666|NCT03218683|AZD5991|azd5991|mesh-list
111274667|NCT03218683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111274668|NCT03182491|Anaphylatoxins|anaphylatoxins|mesh-list
111274669|NCT03182491|Immunologic Factors|immunologic factors|mesh-ancestor
111274670|NCT03182491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111274671|NCT04378647|Brentuximab Vedotin|brentuximab vedotin|mesh-list
111274672|NCT04378647|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111274673|NCT04378647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111274674|NCT04378647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111274675|NCT04378647|Immunotoxins|immunotoxins|mesh-ancestor
110999036|NCT02343536|Glucocorticoids|glucocorticoids|mesh-ancestor
111274676|NCT04378647|Immunoconjugates|immunoconjugates|mesh-ancestor
111274677|NCT04378647|Immunologic Factors|immunologic factors|mesh-ancestor
111274678|NCT04378647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111274679|NCT00370890|Gemcitabine|gemcitabine|mesh-list
111274680|NCT00370890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111274681|NCT00370890|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111274682|NCT00370890|Antimetabolites|antimetabolites|mesh-ancestor
111274683|NCT00370890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111274684|NCT02669953|Aflibercept|aflibercept|mesh-list
111274685|NCT02669953|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111274686|NCT02669953|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111274687|NCT02669953|Growth Substances|growth substances|mesh-ancestor
111274688|NCT02669953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111274689|NCT02669953|Growth Inhibitors|growth inhibitors|mesh-ancestor
111274690|NCT02669953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111274691|NCT01721655|Spironolactone|spironolactone|mesh-list
111274692|NCT01721655|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
111274693|NCT01721655|Hormone Antagonists|hormone antagonists|mesh-ancestor
111274694|NCT01721655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111274695|NCT01721655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111274696|NCT01721655|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
111274697|NCT01721655|Diuretics|diuretics|mesh-ancestor
111274698|NCT01721655|Natriuretic Agents|natriuretic agents|mesh-ancestor
111274699|NCT00904995|Voriconazole|voriconazole|mesh-list
111274700|NCT00904995|Antifungal Agents|antifungal agents|mesh-ancestor
111274701|NCT00904995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111274702|NCT00904995|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111274703|NCT00904995|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111274704|NCT00904995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111274705|NCT00904995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111274706|NCT00904995|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111274707|NCT00904995|Hormone Antagonists|hormone antagonists|mesh-ancestor
111274708|NCT00904995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111274709|NCT00904995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111274710|NCT00904995|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111274711|NCT05249725|Irsogladine|irsogladine|mesh-list
111274712|NCT05249725|Hydrotalcite|hydrotalcite|mesh-list
111274713|NCT05249725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111274714|NCT05249725|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111274715|NCT05249725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111274716|NCT05249725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111274717|NCT05249725|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111274718|NCT05249725|Protective Agents|protective agents|mesh-ancestor
111274719|NCT05249725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111274720|NCT05249725|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
111274722|NCT01834209|Prednisone|prednisone|mesh-list
111274723|NCT01834209|Prednisolone|prednisolone|mesh-list
111274724|NCT01834209|Abiraterone Acetate|abiraterone acetate|mesh-list
111274725|NCT01834209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111274726|NCT01834209|Glucocorticoids|glucocorticoids|mesh-ancestor
111274727|NCT01834209|Hormones|hormones|mesh-ancestor
111274728|NCT01834209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111274729|NCT01834209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111274730|NCT01834209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111274731|NCT01834209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111274732|NCT01834209|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111274733|NCT01834209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111274734|NCT01834209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111274735|NCT01834209|Hormone Antagonists|hormone antagonists|mesh-ancestor
111274736|NCT01834209|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111274737|NCT05241535|Moxifloxacin|moxifloxacin|mesh-list
111274738|NCT05241535|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111274739|NCT05241535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111274740|NCT05241535|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111274741|NCT05241535|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111274742|NCT05241535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111274743|NCT05241535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111274744|NCT05241535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111274745|NCT02488135|Hemostatics|hemostatics|mesh-list
111274746|NCT02488135|Coagulants|coagulants|mesh-ancestor
111274747|NCT01727973|Doxycycline|doxycycline|mesh-list
111274748|NCT01727973|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111274749|NCT01727973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111274750|NCT01727973|Antimalarials|antimalarials|mesh-ancestor
111274751|NCT01727973|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111274752|NCT01727973|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111274753|NCT03100734|Etanercept|etanercept|mesh-list
111274754|NCT03100734|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111274755|NCT03100734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111274756|NCT03100734|Analgesics|analgesics|mesh-ancestor
111274757|NCT03100734|Sensory System Agents|sensory system agents|mesh-ancestor
111274758|NCT03100734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111274759|NCT03100734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111274760|NCT03100734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111274761|NCT03100734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111274762|NCT03100734|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111274763|NCT03100734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111274764|NCT03100734|Immunologic Factors|immunologic factors|mesh-ancestor
111274765|NCT05243706|Loratadine|loratadine|mesh-list
111274766|NCT05243706|Antipruritics|antipruritics|mesh-ancestor
111274767|NCT05243706|Dermatologic Agents|dermatologic agents|mesh-ancestor
111274768|NCT05243706|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111274769|NCT05243706|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
111274770|NCT05243706|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111274771|NCT05243706|Histamine Antagonists|histamine antagonists|mesh-ancestor
111274772|NCT05243706|Histamine Agents|histamine agents|mesh-ancestor
111274773|NCT05243706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111274774|NCT05243706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111274775|NCT05243706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111274776|NCT01728051|Melphalan|melphalan|mesh-list
111274777|NCT01728051|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111274778|NCT01728051|Alkylating Agents|alkylating agents|mesh-ancestor
111274779|NCT01728051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111274780|NCT01728051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111274781|NCT01728051|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111274782|NCT01728051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111274783|NCT01728051|Immunologic Factors|immunologic factors|mesh-ancestor
111274784|NCT01728051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111274785|NCT01722201|Risperidone|risperidone|mesh-list
111274786|NCT01722201|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111274787|NCT01722201|Serotonin Agents|serotonin agents|mesh-ancestor
111274788|NCT01722201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111274789|NCT01722201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111274790|NCT01722201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111274791|NCT01722201|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111274792|NCT01722201|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111274793|NCT01722201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111274794|NCT01722201|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111274795|NCT01722201|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111274796|NCT01722201|Dopamine Agents|dopamine agents|mesh-ancestor
111274797|NCT01722513|Alprostadil|alprostadil|mesh-list
111274798|NCT01722513|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111274799|NCT01722513|Vasodilator Agents|vasodilator agents|mesh-ancestor
111274800|NCT01722513|Urological Agents|urological agents|mesh-ancestor
111274801|NCT03179995|Octreotide|octreotide|mesh-list
111274802|NCT03179995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111274803|NCT03179995|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111274804|NCT03179995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111274805|NCT01728441|Paclitaxel|paclitaxel|mesh-list
111274806|NCT01728441|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111274807|NCT01728441|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111274808|NCT01728441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111274809|NCT01728441|Tubulin Modulators|tubulin modulators|mesh-ancestor
111274810|NCT01728441|Antimitotic Agents|antimitotic agents|mesh-ancestor
111274811|NCT01728441|Mitosis Modulators|mitosis modulators|mesh-ancestor
111274812|NCT01728441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111274813|NCT03099408|Metronidazole|metronidazole|mesh-list
111274814|NCT03099408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111274815|NCT03099408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111274816|NCT03099408|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111274817|NCT03099408|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111274818|NCT04984200|Mydriatics|mydriatics|mesh-list
111274819|NCT04984200|Autonomic Agents|autonomic agents|mesh-ancestor
111274820|NCT04984200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111274821|NCT04984200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111274822|NCT00912873|Ropivacaine|ropivacaine|mesh-list
111274823|NCT00912873|Anesthetics, Local|anesthetics, local|mesh-ancestor
111274824|NCT00912873|Anesthetics|anesthetics|mesh-ancestor
111274825|NCT00912873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111274826|NCT00912873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111274827|NCT00912873|Sensory System Agents|sensory system agents|mesh-ancestor
111274828|NCT00912873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111274829|NCT01494038|Isoniazid|isoniazid|mesh-list
111274830|NCT01494038|Antitubercular Agents|antitubercular agents|mesh-ancestor
111274831|NCT01494038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111274832|NCT01494038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111274833|NCT01494038|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
111274834|NCT01494038|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111274835|NCT01494038|Antimetabolites|antimetabolites|mesh-ancestor
111274836|NCT01494038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111274837|NCT01494038|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111274838|NCT05059782|Coal Tar|coal tar|mesh-list
111274839|NCT05059782|Keratolytic Agents|keratolytic agents|mesh-ancestor
111274840|NCT05059782|Dermatologic Agents|dermatologic agents|mesh-ancestor
111274841|NCT05242081|Sufentanil|sufentanil|mesh-list
111274842|NCT05242081|Ketamine|ketamine|mesh-list
111274843|NCT05242081|Esketamine|esketamine|mesh-list
111274844|NCT05242081|Analgesics|analgesics|mesh-ancestor
111274845|NCT05242081|Sensory System Agents|sensory system agents|mesh-ancestor
111274846|NCT05242081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111274847|NCT05242081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111274848|NCT05242081|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111274849|NCT05242081|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111274850|NCT05242081|Anesthetics, General|anesthetics, general|mesh-ancestor
111274851|NCT05242081|Anesthetics|anesthetics|mesh-ancestor
111274852|NCT05242081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111274853|NCT05242081|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111274854|NCT05242081|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111274855|NCT05242081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111274856|NCT05242081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111274857|NCT05242081|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111274858|NCT05242081|Narcotics|narcotics|mesh-ancestor
111274859|NCT05242081|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111274860|NCT05242081|Antidepressive Agents|antidepressive agents|mesh-ancestor
111274861|NCT05242081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111274862|NCT04412304|Dalteparin|dalteparin|mesh-list
111274863|NCT04412304|Tinzaparin|tinzaparin|mesh-list
111274864|NCT04412304|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
111274865|NCT04412304|Anticoagulants|anticoagulants|mesh-ancestor
111274866|NCT04412304|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111274867|NCT04412304|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111274868|NCT04412304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111274869|NCT00915603|Paclitaxel|paclitaxel|mesh-list
111274870|NCT00915603|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111274871|NCT00915603|Bevacizumab|bevacizumab|mesh-list
111274872|NCT00915603|Everolimus|everolimus|mesh-list
111274873|NCT00915603|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111274874|NCT00915603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111274875|NCT00915603|Tubulin Modulators|tubulin modulators|mesh-ancestor
111274876|NCT00915603|Antimitotic Agents|antimitotic agents|mesh-ancestor
111274877|NCT00915603|Mitosis Modulators|mitosis modulators|mesh-ancestor
111274878|NCT00915603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111274879|NCT00915603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111274880|NCT00915603|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111274881|NCT00915603|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111274882|NCT00915603|Growth Substances|growth substances|mesh-ancestor
111274883|NCT00915603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111274884|NCT00915603|Growth Inhibitors|growth inhibitors|mesh-ancestor
111274885|NCT00915603|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111274886|NCT00915603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111274887|NCT00915603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111274888|NCT00915603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111274889|NCT00915603|Immunologic Factors|immunologic factors|mesh-ancestor
111274890|NCT01929265|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
111274891|NCT01929265|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111274892|NCT01929265|Alkylating Agents|alkylating agents|mesh-ancestor
111274893|NCT01929265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111274894|NCT01929265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111274895|NCT01929421|Gemcitabine|gemcitabine|mesh-list
111274896|NCT01929421|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111274897|NCT01929421|Antimetabolites|antimetabolites|mesh-ancestor
111274898|NCT01929421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111274899|NCT01929421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111274900|NCT04474002|Picosulfate sodium|picosulfate sodium|mesh-list
110999261|NCT02344940|Tamoxifen|tamoxifen|mesh-list
111274902|NCT04474002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111274903|NCT01929577|Peficitinib|peficitinib|mesh-list
111274904|NCT01929577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111274905|NCT01929577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111274906|NCT01929577|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111274907|NCT01929577|Immunologic Factors|immunologic factors|mesh-ancestor
111274908|NCT01929577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111274909|NCT03142321|Vedolizumab|vedolizumab|mesh-list
111274910|NCT03142321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111274911|NCT01929655|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
111274912|NCT01929655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111274913|NCT03836703|Iron|iron|mesh-list
111274914|NCT03836703|Trace Elements|trace elements|mesh-ancestor
111274915|NCT03836703|Micronutrients|micronutrients|mesh-ancestor
111274916|NCT03836703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111274917|NCT02398825|Ponatinib|ponatinib|mesh-list
111274918|NCT02398825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111274919|NCT02398825|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111274920|NCT02398825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111274921|NCT02398825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111274922|NCT01723059|Amoxicillin|amoxicillin|mesh-list
111274923|NCT01723059|Metronidazole|metronidazole|mesh-list
111274924|NCT01723059|Clarithromycin|clarithromycin|mesh-list
111274925|NCT01723059|Omeprazole|omeprazole|mesh-list
111274926|NCT01723059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111274927|NCT01723059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111274928|NCT01723059|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111274929|NCT01723059|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111274930|NCT01723059|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111274931|NCT01723059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111274932|NCT01723059|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111274933|NCT01723059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111274934|NCT01723059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111274935|NCT01723059|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111274936|NCT01723059|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111274937|NCT01723059|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111274938|NCT04379271|Calcium|calcium|mesh-list
111274939|NCT04379271|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111274940|NCT04379271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111274941|NCT01728909|Oxytocin|oxytocin|mesh-list
111274942|NCT01728909|Oxytocics|oxytocics|mesh-ancestor
111274943|NCT01728909|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111274944|NCT01728909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111274945|NCT01922713|Vitamin A|vitamin a|mesh-list
111274946|NCT01922713|Beta Carotene|beta carotene|mesh-list
111274947|NCT01922713|Retinol palmitate|retinol palmitate|mesh-list
111274948|NCT01922713|Vitamins|vitamins|mesh-ancestor
111274949|NCT01922713|Micronutrients|micronutrients|mesh-ancestor
111274950|NCT01922713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111274951|NCT01922713|Antioxidants|antioxidants|mesh-ancestor
111274952|NCT01922713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111274953|NCT01922713|Protective Agents|protective agents|mesh-ancestor
111274954|NCT01922713|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
111274955|NCT01922713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111274956|NCT01922713|Provitamins|provitamins|mesh-ancestor
111274957|NCT05061732|Amoxicillin|amoxicillin|mesh-list
111274958|NCT05061732|Metronidazole|metronidazole|mesh-list
111274959|NCT05061732|Clarithromycin|clarithromycin|mesh-list
111274960|NCT05061732|Doxycycline|doxycycline|mesh-list
111274961|NCT05061732|Levofloxacin|levofloxacin|mesh-list
111274962|NCT05061732|Tetracycline|tetracycline|mesh-list
111274963|NCT05061732|Potassium Citrate|potassium citrate|mesh-list
111274964|NCT05061732|Rabeprazole|rabeprazole|mesh-list
111274965|NCT05061732|Bismuth|bismuth|mesh-list
111274966|NCT05061732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111274967|NCT05061732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111274968|NCT05061732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111274969|NCT05061732|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111274970|NCT05061732|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111274971|NCT05061732|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111274972|NCT05061732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111274973|NCT05061732|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111274974|NCT05061732|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111274975|NCT05061732|Antimalarials|antimalarials|mesh-ancestor
111274976|NCT05061732|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111274977|NCT05061732|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111274978|NCT05061732|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111274979|NCT05061732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111274980|NCT05061732|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111274981|NCT05061732|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111274982|NCT05061732|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111274983|NCT05061732|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111274984|NCT05061732|Antacids|antacids|mesh-ancestor
111274985|NCT05061732|Diuretics|diuretics|mesh-ancestor
111274986|NCT05061732|Natriuretic Agents|natriuretic agents|mesh-ancestor
111274987|NCT05061732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111274988|NCT05061732|Expectorants|expectorants|mesh-ancestor
111274989|NCT05061732|Respiratory System Agents|respiratory system agents|mesh-ancestor
111274990|NCT02391571|Naltrexone|naltrexone|mesh-list
111274991|NCT02391571|Oxycodone|oxycodone|mesh-list
111274992|NCT02391571|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111274993|NCT02391571|Narcotics|narcotics|mesh-ancestor
111274994|NCT02391571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111274995|NCT02391571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111274996|NCT02391571|Analgesics|analgesics|mesh-ancestor
111274997|NCT02391571|Sensory System Agents|sensory system agents|mesh-ancestor
111274998|NCT02391571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111274999|NCT02391571|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111275000|NCT02391571|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111275001|NCT01728987|Cholecalciferol|cholecalciferol|mesh-list
111275002|NCT01728987|Vitamin D|vitamin d|mesh-list
111275003|NCT01728987|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111275004|NCT01728987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111275005|NCT01728987|Vitamins|vitamins|mesh-ancestor
111275006|NCT01728987|Micronutrients|micronutrients|mesh-ancestor
111275007|NCT01728987|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111275008|NCT01834989|Mitogens|mitogens|mesh-list
111275009|NCT01834989|Mitosis Modulators|mitosis modulators|mesh-ancestor
111275010|NCT01834989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111275011|NCT01835067|Ranibizumab|ranibizumab|mesh-list
111275012|NCT01835067|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
111275013|NCT01835067|Plasminogen|plasminogen|mesh-list
111275014|NCT01835067|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111275015|NCT01835067|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111275016|NCT01835067|Growth Substances|growth substances|mesh-ancestor
111275017|NCT01835067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111275018|NCT01835067|Growth Inhibitors|growth inhibitors|mesh-ancestor
111275019|NCT01835067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111275020|NCT01835067|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111275021|NCT01835067|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111275022|NCT01835067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111275023|NCT03100422|Armin|armin|mesh-list
111275024|NCT03100422|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111275025|NCT03100422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111275026|NCT03100422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111275027|NCT03100422|Cholinergic Agents|cholinergic agents|mesh-ancestor
111275028|NCT03100422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111275029|NCT03100422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111275030|NCT00639769|Cisplatin|cisplatin|mesh-list
111275031|NCT00639769|Irinotecan|irinotecan|mesh-list
111275032|NCT00639769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111275033|NCT00639769|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111275034|NCT00639769|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111275035|NCT00639769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111275036|NCT00639769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111275037|NCT01723371|Carvedilol|carvedilol|mesh-list
111275038|NCT01723371|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111275039|NCT01723371|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111275040|NCT01723371|Adrenergic Agents|adrenergic agents|mesh-ancestor
111275041|NCT01723371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111275042|NCT01723371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111275043|NCT01723371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111275044|NCT01723371|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111275045|NCT01723371|Antioxidants|antioxidants|mesh-ancestor
111275046|NCT01723371|Protective Agents|protective agents|mesh-ancestor
111275047|NCT01723371|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111275048|NCT01723371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111275049|NCT01723371|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111275050|NCT01723371|Vasodilator Agents|vasodilator agents|mesh-ancestor
111275051|NCT01723371|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111275052|NCT01723371|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111275053|NCT00639457|Pioglitazone|pioglitazone|mesh-list
111275054|NCT00639457|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111275055|NCT00639457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111275056|NCT05057286|Botulinum Toxins|botulinum toxins|mesh-list
111275057|NCT05057286|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111275058|NCT05057286|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111275059|NCT05057286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111275060|NCT05057286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111275061|NCT05057286|Cholinergic Agents|cholinergic agents|mesh-ancestor
111275062|NCT05057286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111275063|NCT05057286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111275064|NCT05057286|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111275065|NCT05057286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111275066|NCT01723527|Buprenorphine|buprenorphine|mesh-list
111275067|NCT01723527|Methadone|methadone|mesh-list
111275068|NCT01723527|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111275069|NCT01723527|Narcotics|narcotics|mesh-ancestor
111275070|NCT01723527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111275071|NCT01723527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111275072|NCT01723527|Analgesics|analgesics|mesh-ancestor
111275073|NCT01723527|Sensory System Agents|sensory system agents|mesh-ancestor
111275074|NCT01723527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111275075|NCT01723527|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111275076|NCT01723527|Antitussive Agents|antitussive agents|mesh-ancestor
111275077|NCT01723527|Respiratory System Agents|respiratory system agents|mesh-ancestor
111275078|NCT00639223|Pravastatin|pravastatin|mesh-list
111275079|NCT00639223|Red yeast rice|red yeast rice|mesh-list
111275080|NCT00639223|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111275081|NCT00639223|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111275082|NCT00639223|Antimetabolites|antimetabolites|mesh-ancestor
111275083|NCT00639223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111275084|NCT00639223|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111275085|NCT00639223|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111275086|NCT00639223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111275087|NCT01723683|Pulmonary Surfactants|pulmonary surfactants|mesh-list
111275088|NCT01723683|Respiratory System Agents|respiratory system agents|mesh-ancestor
111275089|NCT03519984|Cytarabine|cytarabine|mesh-list
111275090|NCT03519984|Vincristine|vincristine|mesh-list
111275091|NCT03519984|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111275092|NCT03519984|Antimetabolites|antimetabolites|mesh-ancestor
111275093|NCT03519984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111275094|NCT03519984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111275095|NCT03519984|Antiviral Agents|antiviral agents|mesh-ancestor
111275096|NCT03519984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111275097|NCT03519984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111275098|NCT03519984|Immunologic Factors|immunologic factors|mesh-ancestor
111275099|NCT03519984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111275100|NCT03519984|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111275101|NCT03519984|Tubulin Modulators|tubulin modulators|mesh-ancestor
111275102|NCT03519984|Antimitotic Agents|antimitotic agents|mesh-ancestor
111275103|NCT03519984|Mitosis Modulators|mitosis modulators|mesh-ancestor
111275104|NCT05056896|Aspirin|aspirin|mesh-list
111275105|NCT05056896|Salicylic Acid|salicylic acid|mesh-list
111275106|NCT05056896|Salicylates|salicylates|mesh-list
111275107|NCT05056896|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111275108|NCT05056896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111275109|NCT05056896|Analgesics|analgesics|mesh-ancestor
111275110|NCT05056896|Sensory System Agents|sensory system agents|mesh-ancestor
111275111|NCT05056896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111275112|NCT05056896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111275113|NCT05056896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111275114|NCT05056896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111275115|NCT05056896|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111275116|NCT05056896|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111275117|NCT05056896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111275118|NCT05056896|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111275119|NCT05056896|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111275120|NCT05056896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111275121|NCT05056896|Antipyretics|antipyretics|mesh-ancestor
111275122|NCT05056896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111275123|NCT05056896|Antifungal Agents|antifungal agents|mesh-ancestor
111275124|NCT05056896|Keratolytic Agents|keratolytic agents|mesh-ancestor
111275125|NCT05056896|Dermatologic Agents|dermatologic agents|mesh-ancestor
111275126|NCT00638989|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111275127|NCT00638989|Immunologic Factors|immunologic factors|mesh-ancestor
111275128|NCT00638989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111275129|NCT01835691|Vitamin D|vitamin d|mesh-list
111275130|NCT01835691|Ergocalciferols|ergocalciferols|mesh-list
111275131|NCT01835691|Cholecalciferol|cholecalciferol|mesh-list
111275132|NCT01835691|Vitamins|vitamins|mesh-list
111275133|NCT01835691|Micronutrients|micronutrients|mesh-ancestor
111275134|NCT01835691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111275135|NCT01835691|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111275136|NCT01835691|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111275137|NCT01729767|Acyclovir|acyclovir|mesh-list
111275138|NCT01729767|Antiviral Agents|antiviral agents|mesh-ancestor
111275139|NCT01729767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111275140|NCT00913263|Flutamide|flutamide|mesh-list
111275141|NCT00913263|Hydroxyflutamide|hydroxyflutamide|mesh-list
111275142|NCT00913263|Androgen Antagonists|androgen antagonists|mesh-ancestor
111275143|NCT00913263|Hormone Antagonists|hormone antagonists|mesh-ancestor
111275144|NCT00913263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111275145|NCT00913263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111275146|NCT00913263|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111275147|NCT00913263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111275148|NCT04377867|Abatacept|abatacept|mesh-list
111275149|NCT04377867|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111275150|NCT04377867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111275151|NCT04377867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111275152|NCT04377867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111275153|NCT04377867|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111275154|NCT04377867|Immunologic Factors|immunologic factors|mesh-ancestor
111275155|NCT04377867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111275156|NCT04377867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111275157|NCT00637273|Pioglitazone|pioglitazone|mesh-list
111275158|NCT00637273|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111275159|NCT00637273|Exenatide|exenatide|mesh-list
111275160|NCT00637273|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111275161|NCT00637273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111275162|NCT00637273|Incretins|incretins|mesh-ancestor
111275163|NCT00637273|Hormones|hormones|mesh-ancestor
111275164|NCT00637273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111275165|NCT00637273|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111275166|NCT00637273|Protease Inhibitors|protease inhibitors|mesh-ancestor
111275167|NCT00637273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111275168|NCT00637273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111275169|NCT00637273|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111275170|NCT01923259|Donepezil|donepezil|mesh-list
111275171|NCT01923259|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111275172|NCT01923259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111275173|NCT01923259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111275174|NCT01923259|Cholinergic Agents|cholinergic agents|mesh-ancestor
111275175|NCT01923259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111275176|NCT01923259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111275177|NCT01923259|Nootropic Agents|nootropic agents|mesh-ancestor
111275178|NCT01923337|Irinotecan|irinotecan|mesh-list
111275179|NCT01923337|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111275180|NCT01923337|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111275181|NCT01923337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111275182|NCT01923337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111275183|NCT01923337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111275184|NCT03098160|Ipilimumab|ipilimumab|mesh-list
111275185|NCT03098160|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111275186|NCT03098160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111275187|NCT03098160|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111275188|NCT03098160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111275189|NCT01720563|Leucovorin|leucovorin|mesh-list
111275190|NCT01720563|Tegafur|tegafur|mesh-list
111275191|NCT01720563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111275192|NCT01720563|Antidotes|antidotes|mesh-ancestor
111275193|NCT01720563|Protective Agents|protective agents|mesh-ancestor
111275194|NCT01720563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111275195|NCT01720563|Vitamin B Complex|vitamin b complex|mesh-ancestor
111275196|NCT01720563|Vitamins|vitamins|mesh-ancestor
111275197|NCT01720563|Micronutrients|micronutrients|mesh-ancestor
111275198|NCT01720563|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111275199|NCT01720563|Antimetabolites|antimetabolites|mesh-ancestor
111275200|NCT01720563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111275201|NCT01724385|Bevacizumab|bevacizumab|mesh-list
111275202|NCT01724385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111275203|NCT01724385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111275204|NCT01724385|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110999558|NCT02994719|Analgesics|analgesics|mesh-ancestor
111275205|NCT01724385|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111275206|NCT01724385|Growth Substances|growth substances|mesh-ancestor
111275207|NCT01724385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111275208|NCT01724385|Growth Inhibitors|growth inhibitors|mesh-ancestor
111275210|NCT04377789|Antioxidants|antioxidants|mesh-ancestor
111275211|NCT04377789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111275212|NCT04377789|Protective Agents|protective agents|mesh-ancestor
111275213|NCT04377789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111275214|NCT00988117|Rivastigmine|rivastigmine|mesh-list
111275215|NCT00988117|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111275216|NCT00988117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111275217|NCT00988117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111275218|NCT00988117|Cholinergic Agents|cholinergic agents|mesh-ancestor
111275219|NCT00988117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111275220|NCT00988117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111275221|NCT00988117|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111275222|NCT00988117|Protective Agents|protective agents|mesh-ancestor
111275223|NCT01728753|Favipiravir|favipiravir|mesh-list
111275224|NCT01728753|Antiviral Agents|antiviral agents|mesh-ancestor
111275225|NCT01728753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111275226|NCT01724619|Dihydrotestosterone|dihydrotestosterone|mesh-list
111275227|NCT01724619|Androgens|androgens|mesh-ancestor
111275228|NCT01724619|Hormones|hormones|mesh-ancestor
111275229|NCT01724619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111275230|NCT01724619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111275231|NCT05045508|Varenicline|varenicline|mesh-list
111275232|NCT05045508|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111275233|NCT05045508|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111275234|NCT05045508|Cholinergic Agents|cholinergic agents|mesh-ancestor
111275235|NCT05045508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111275236|NCT05045508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111275237|NCT05045508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111275238|NCT00637195|Vaccines|vaccines|mesh-list
111275239|NCT00637195|Immunologic Factors|immunologic factors|mesh-ancestor
111275240|NCT00637195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111275241|NCT05045274|Aspirin|aspirin|mesh-list
111275242|NCT05045274|Dapagliflozin|dapagliflozin|mesh-list
111275243|NCT05045274|Angiotensin II|angiotensin ii|mesh-list
111275244|NCT05045274|Giapreza|giapreza|mesh-list
111275245|NCT05045274|Clopidogrel|clopidogrel|mesh-list
111275246|NCT05045274|Ticagrelor|ticagrelor|mesh-list
111275247|NCT05045274|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
111275248|NCT05045274|Enzyme Inhibitors|enzyme inhibitors|mesh-list
111275249|NCT05045274|Angiotensinogen|angiotensinogen|mesh-list
111275250|NCT05045274|Diuretics|diuretics|mesh-list
111275251|NCT05045274|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
111275252|NCT05045274|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
111275253|NCT05045274|Mineralocorticoids|mineralocorticoids|mesh-list
111275254|NCT05045274|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
111275255|NCT05045274|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
111275256|NCT05045274|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111275257|NCT05045274|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111275258|NCT05045274|Analgesics|analgesics|mesh-ancestor
111275259|NCT05045274|Sensory System Agents|sensory system agents|mesh-ancestor
111275260|NCT05045274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111275261|NCT05045274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111275262|NCT05045274|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111275263|NCT05045274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111275264|NCT05045274|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111275265|NCT05045274|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111275266|NCT05045274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111275267|NCT05045274|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111275268|NCT05045274|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111275269|NCT05045274|Antipyretics|antipyretics|mesh-ancestor
111275270|NCT05045274|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111275271|NCT05045274|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111275272|NCT05045274|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111275273|NCT05045274|Purinergic Agents|purinergic agents|mesh-ancestor
111275274|NCT05045274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111275275|NCT05045274|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111275276|NCT05045274|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111275277|NCT05045274|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111275278|NCT05045274|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111275279|NCT05045274|Antimetabolites|antimetabolites|mesh-ancestor
111275280|NCT05045274|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111275281|NCT05045274|Natriuretic Agents|natriuretic agents|mesh-ancestor
111275282|NCT05045274|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111275283|NCT05045274|Adrenergic Agents|adrenergic agents|mesh-ancestor
111275284|NCT05045274|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111275285|NCT05045274|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111275286|NCT05045274|Protease Inhibitors|protease inhibitors|mesh-ancestor
111275287|NCT05045274|Hormones|hormones|mesh-ancestor
111275288|NCT05045274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111275289|NCT05045274|Hormone Antagonists|hormone antagonists|mesh-ancestor
111275290|NCT05045274|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
111275291|NCT01721733|Ubiquinone|ubiquinone|mesh-list
111275292|NCT01721733|Micronutrients|micronutrients|mesh-ancestor
111275293|NCT01721733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111275294|NCT01720485|Prednisolone|prednisolone|mesh-list
111275295|NCT01720485|Betamethasone|betamethasone|mesh-list
111275296|NCT01720485|Desloratadine|desloratadine|mesh-list
111275297|NCT01720485|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
111275298|NCT01720485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111275299|NCT01720485|Glucocorticoids|glucocorticoids|mesh-ancestor
111275300|NCT01720485|Hormones|hormones|mesh-ancestor
111275301|NCT01720485|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111275302|NCT01720485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111275303|NCT01720485|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111275304|NCT01720485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111275305|NCT01720485|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111275306|NCT01720485|Respiratory System Agents|respiratory system agents|mesh-ancestor
111275307|NCT01720485|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111275308|NCT01720485|Cholinergic Agents|cholinergic agents|mesh-ancestor
111275309|NCT01720485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111275310|NCT01720485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111275311|NCT01720485|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
111275312|NCT01720485|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111275313|NCT01720485|Histamine Antagonists|histamine antagonists|mesh-ancestor
111275314|NCT01720485|Histamine Agents|histamine agents|mesh-ancestor
111275315|NCT01726725|Desflurane|desflurane|mesh-list
111275316|NCT01726725|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111275317|NCT01726725|Anesthetics, General|anesthetics, general|mesh-ancestor
111275318|NCT01726725|Anesthetics|anesthetics|mesh-ancestor
111275319|NCT01726725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111275320|NCT01726725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111275321|NCT05044728|Paclitaxel|paclitaxel|mesh-list
111275322|NCT05044728|Carboplatin|carboplatin|mesh-list
111275323|NCT05044728|Antibodies|antibodies|mesh-list
111275324|NCT05044728|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111275325|NCT05044728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111275326|NCT05044728|Tubulin Modulators|tubulin modulators|mesh-ancestor
111275327|NCT05044728|Antimitotic Agents|antimitotic agents|mesh-ancestor
111275328|NCT05044728|Mitosis Modulators|mitosis modulators|mesh-ancestor
111275329|NCT05044728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111275330|NCT05044728|Immunologic Factors|immunologic factors|mesh-ancestor
111275331|NCT05044728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111275332|NCT05054478|Daratumumab|daratumumab|mesh-list
111275333|NCT05054478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111275334|NCT01041807|Losartan|losartan|mesh-list
111275335|NCT01041807|Amlodipine|amlodipine|mesh-list
111275336|NCT01041807|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111275337|NCT01041807|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111275338|NCT01041807|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111275339|NCT01041807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111275340|NCT01041807|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111275341|NCT01041807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111275342|NCT01041807|Vasodilator Agents|vasodilator agents|mesh-ancestor
111275343|NCT01041807|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111275344|NCT01041807|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111275345|NCT01041807|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111275346|NCT01724931|Aminopterin|aminopterin|mesh-list
111275347|NCT01724931|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111275348|NCT01724931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111275349|NCT01724931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111275350|NCT00635089|Reslizumab|reslizumab|mesh-list
111275351|NCT00635089|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111275352|NCT00635089|Respiratory System Agents|respiratory system agents|mesh-ancestor
111275353|NCT01725009|Levetiracetam|levetiracetam|mesh-list
111275354|NCT01725009|Anticonvulsants|anticonvulsants|mesh-ancestor
111275355|NCT01725009|Nootropic Agents|nootropic agents|mesh-ancestor
111275356|NCT01725087|Tapentadol|tapentadol|mesh-list
111275357|NCT01725087|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111275358|NCT01725087|Narcotics|narcotics|mesh-ancestor
111275359|NCT01725087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111275360|NCT01725087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111275361|NCT01725087|Analgesics|analgesics|mesh-ancestor
111275362|NCT01725087|Sensory System Agents|sensory system agents|mesh-ancestor
111275363|NCT01725087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111275364|NCT01725087|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111275365|NCT01725087|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111275366|NCT01725087|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111275367|NCT01725087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111275368|NCT01725087|Adrenergic Agents|adrenergic agents|mesh-ancestor
111275369|NCT01725087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111275370|NCT00634543|Acetaminophen|acetaminophen|mesh-list
111275371|NCT00634543|Gabapentin|gabapentin|mesh-list
111275372|NCT00634543|Tramadol|tramadol|mesh-list
111275373|NCT00634543|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111275374|NCT00634543|Analgesics|analgesics|mesh-ancestor
111275375|NCT00634543|Sensory System Agents|sensory system agents|mesh-ancestor
111275376|NCT00634543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111275377|NCT00634543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111275378|NCT00634543|Antipyretics|antipyretics|mesh-ancestor
111275379|NCT00634543|Anticonvulsants|anticonvulsants|mesh-ancestor
111275380|NCT00634543|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111275381|NCT00634543|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111275382|NCT00634543|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111275383|NCT00634543|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111275384|NCT00634543|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111275385|NCT00634543|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111275386|NCT00634543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111275387|NCT00634543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111275388|NCT00634543|Antimanic Agents|antimanic agents|mesh-ancestor
111275389|NCT00634543|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111275390|NCT00634543|Narcotics|narcotics|mesh-ancestor
111275391|NCT05054322|Fluticasone|fluticasone|mesh-list
111275393|NCT05054322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111275394|NCT05054322|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111275395|NCT05054322|Autonomic Agents|autonomic agents|mesh-ancestor
111275396|NCT05054322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111275397|NCT05054322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111275398|NCT05054322|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111275399|NCT05054322|Respiratory System Agents|respiratory system agents|mesh-ancestor
111275400|NCT05054322|Dermatologic Agents|dermatologic agents|mesh-ancestor
111275401|NCT05054322|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111275402|NCT00985465|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
111275403|NCT00985465|Immunologic Factors|immunologic factors|mesh-ancestor
111275404|NCT00985465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111275405|NCT03097380|Tiotropium Bromide|tiotropium bromide|mesh-list
111275406|NCT03097380|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111275407|NCT03097380|Autonomic Agents|autonomic agents|mesh-ancestor
111275408|NCT03097380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111275409|NCT03097380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111275410|NCT03097380|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111275411|NCT03097380|Respiratory System Agents|respiratory system agents|mesh-ancestor
111275412|NCT03097380|Parasympatholytics|parasympatholytics|mesh-ancestor
111275413|NCT03097380|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111275414|NCT03097380|Cholinergic Agents|cholinergic agents|mesh-ancestor
111275415|NCT03097380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111275416|NCT03097380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111275417|NCT04759729|Vitamin D|vitamin d|mesh-list
111275418|NCT04759729|Ergocalciferols|ergocalciferols|mesh-list
111275419|NCT04759729|Cholecalciferol|cholecalciferol|mesh-list
111275420|NCT04759729|Vitamins|vitamins|mesh-list
111275421|NCT04759729|Micronutrients|micronutrients|mesh-ancestor
111275422|NCT04759729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111275423|NCT04759729|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111275424|NCT04759729|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111275425|NCT05053386|Epirubicin|epirubicin|mesh-list
111275426|NCT05053386|Idarubicin|idarubicin|mesh-list
111275427|NCT05053386|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111275428|NCT05053386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111275429|NCT05053386|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111275430|NCT05053386|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111275431|NCT05053386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111275432|NCT05053386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111275434|NCT01725243|Oxytocics|oxytocics|mesh-ancestor
111275435|NCT01725243|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111275436|NCT01725243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111275437|NCT01725477|Methylene Blue|methylene blue|mesh-list
111275438|NCT01725477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111275439|NCT01725477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111275440|NCT03096990|Apremilast|apremilast|mesh-list
111275441|NCT03096990|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111275442|NCT03096990|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111275443|NCT03096990|Analgesics|analgesics|mesh-ancestor
111275444|NCT03096990|Sensory System Agents|sensory system agents|mesh-ancestor
111275445|NCT03096990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111275446|NCT03096990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111275447|NCT03096990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111275448|NCT03096990|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111275449|NCT03096990|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
111275450|NCT03096990|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111275451|NCT03096990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111275452|NCT03096990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111275453|NCT01725555|Podophyllotoxin|podophyllotoxin|mesh-list
111275454|NCT01725555|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111275455|NCT01725555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111275456|NCT01725555|Keratolytic Agents|keratolytic agents|mesh-ancestor
111275457|NCT01725555|Dermatologic Agents|dermatologic agents|mesh-ancestor
111275458|NCT01725555|Tubulin Modulators|tubulin modulators|mesh-ancestor
111275459|NCT01725555|Antimitotic Agents|antimitotic agents|mesh-ancestor
111275460|NCT01725555|Mitosis Modulators|mitosis modulators|mesh-ancestor
111275461|NCT01725555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111275462|NCT01048671|Raltegravir Potassium|raltegravir potassium|mesh-list
111275463|NCT01048671|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111275464|NCT01048671|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111275465|NCT01048671|Antiviral Agents|antiviral agents|mesh-ancestor
111275466|NCT01048671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111275467|NCT01048671|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111275468|NCT01048671|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111275469|NCT01048671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111275470|NCT01048671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111275471|NCT03836781|Chlorhexidine|chlorhexidine|mesh-list
111275472|NCT03836781|Ketorolac|ketorolac|mesh-list
111275473|NCT03836781|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111275474|NCT03836781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111275475|NCT03836781|Disinfectants|disinfectants|mesh-ancestor
111275476|NCT03836781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111275477|NCT03836781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111275478|NCT03836781|Analgesics|analgesics|mesh-ancestor
111275479|NCT03836781|Sensory System Agents|sensory system agents|mesh-ancestor
111275480|NCT03836781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111275481|NCT03836781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111275482|NCT03836781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111275483|NCT03836781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111275484|NCT03836781|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111275485|NCT03836781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111275486|NCT03836781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111275487|NCT01360866|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
111275488|NCT01360866|Fluoxetine|fluoxetine|mesh-list
111275489|NCT01360866|Paroxetine|paroxetine|mesh-list
111275490|NCT01360866|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
111275491|NCT01360866|Sertraline|sertraline|mesh-list
111275492|NCT01360866|Escitalopram|escitalopram|mesh-list
111275493|NCT01360866|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111275494|NCT01360866|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111275495|NCT01360866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111275496|NCT01360866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111275497|NCT01360866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111275498|NCT01360866|Serotonin Agents|serotonin agents|mesh-ancestor
111275499|NCT01360866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111275500|NCT01360866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111275501|NCT01360866|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111275502|NCT01360866|Antidepressive Agents|antidepressive agents|mesh-ancestor
111275503|NCT01360866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111275504|NCT01360866|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111275506|NCT01360866|Sensory System Agents|sensory system agents|mesh-ancestor
111275507|NCT01360866|Dopamine Agents|dopamine agents|mesh-ancestor
111275508|NCT01360866|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111275509|NCT01360866|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111275510|NCT01360866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111275511|NCT00984061|Clarithromycin|clarithromycin|mesh-list
111275512|NCT00984061|Colchicine|colchicine|mesh-list
111275513|NCT00984061|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111275514|NCT00984061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111275515|NCT00984061|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111275516|NCT00984061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111275517|NCT00984061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111275518|NCT00984061|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111275519|NCT00984061|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111275520|NCT00984061|Gout Suppressants|gout suppressants|mesh-ancestor
111275521|NCT00984061|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111275522|NCT00984061|Tubulin Modulators|tubulin modulators|mesh-ancestor
111275523|NCT00984061|Antimitotic Agents|antimitotic agents|mesh-ancestor
111275524|NCT00984061|Mitosis Modulators|mitosis modulators|mesh-ancestor
111275525|NCT00984061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111275526|NCT01046643|Estradiol|estradiol|mesh-list
111275527|NCT01046643|Progesterone|progesterone|mesh-list
111275528|NCT01046643|Estrogens|estrogens|mesh-ancestor
111275529|NCT01046643|Hormones|hormones|mesh-ancestor
111275530|NCT01046643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111275531|NCT01046643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111275532|NCT01046643|Progestins|progestins|mesh-ancestor
111275533|NCT03096756|Avasopasem manganese|avasopasem manganese|mesh-list
111275534|NCT03096756|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111275535|NCT03096756|Antioxidants|antioxidants|mesh-ancestor
111275536|NCT03096756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111275537|NCT03096756|Protective Agents|protective agents|mesh-ancestor
111275538|NCT03096756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111275539|NCT00983905|Colchicine|colchicine|mesh-list
111275540|NCT00983905|Theophylline|theophylline|mesh-list
111275541|NCT00983905|Gout Suppressants|gout suppressants|mesh-ancestor
111275542|NCT00983905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111275543|NCT00983905|Tubulin Modulators|tubulin modulators|mesh-ancestor
111275544|NCT00983905|Antimitotic Agents|antimitotic agents|mesh-ancestor
111275545|NCT00983905|Mitosis Modulators|mitosis modulators|mesh-ancestor
111275546|NCT00983905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111275547|NCT00983905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111275548|NCT00983905|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111275549|NCT00983905|Autonomic Agents|autonomic agents|mesh-ancestor
111275550|NCT00983905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111275551|NCT00983905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111275552|NCT00983905|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111275553|NCT00983905|Respiratory System Agents|respiratory system agents|mesh-ancestor
111275554|NCT00983905|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111275555|NCT00983905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111275556|NCT00983905|Vasodilator Agents|vasodilator agents|mesh-ancestor
111275557|NCT00983905|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
111275558|NCT00983905|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111275559|NCT00983905|Purinergic Agents|purinergic agents|mesh-ancestor
111275560|NCT00983905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111275561|NCT01046565|Adapalene|adapalene|mesh-list
111275562|NCT01046565|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111275563|NCT01046565|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111275564|NCT01046565|Analgesics|analgesics|mesh-ancestor
111275565|NCT01046565|Sensory System Agents|sensory system agents|mesh-ancestor
111275566|NCT01046565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111275567|NCT01046565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111275568|NCT01046565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111275569|NCT01046565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111275570|NCT01046565|Dermatologic Agents|dermatologic agents|mesh-ancestor
111275571|NCT01046253|Lansoprazole|lansoprazole|mesh-list
111275572|NCT01046253|Dexlansoprazole|dexlansoprazole|mesh-list
111275573|NCT01046253|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111275574|NCT01046253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111275575|NCT01046253|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111275576|NCT01046253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111275577|NCT01046253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111275578|NCT05050656|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
111275579|NCT05050656|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111275580|NCT05050656|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111275581|NCT05050656|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111275582|NCT05050656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111275583|NCT05050656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111275584|NCT05050656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111275585|NCT05050656|Analgesics|analgesics|mesh-ancestor
111275586|NCT05050656|Sensory System Agents|sensory system agents|mesh-ancestor
111275587|NCT05050656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111275588|NCT05050656|Antidepressive Agents|antidepressive agents|mesh-ancestor
111275589|NCT05050656|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111275590|NCT05050656|Dopamine Agents|dopamine agents|mesh-ancestor
111275591|NCT00983515|Ritonavir|ritonavir|mesh-list
111275592|NCT00983515|Colchicine|colchicine|mesh-list
111275593|NCT00983515|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111275594|NCT00983515|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111275595|NCT00983515|Protease Inhibitors|protease inhibitors|mesh-ancestor
111275596|NCT00983515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111275597|NCT00983515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111275598|NCT00983515|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111275599|NCT00983515|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111275600|NCT00983515|Antiviral Agents|antiviral agents|mesh-ancestor
111275601|NCT00983515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111275602|NCT00983515|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111275603|NCT00983515|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111275604|NCT00983515|Gout Suppressants|gout suppressants|mesh-ancestor
111275605|NCT00983515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111275606|NCT00983515|Tubulin Modulators|tubulin modulators|mesh-ancestor
111275607|NCT00983515|Antimitotic Agents|antimitotic agents|mesh-ancestor
111275608|NCT00983515|Mitosis Modulators|mitosis modulators|mesh-ancestor
111275609|NCT00983515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111275610|NCT05033574|Hormones|hormones|mesh-list
111275611|NCT05033574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111275612|NCT05033574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111275613|NCT05050188|Lansoprazole|lansoprazole|mesh-list
111275614|NCT05050188|Dexlansoprazole|dexlansoprazole|mesh-list
111275615|NCT05050188|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111275616|NCT05050188|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111275617|NCT05050188|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111275618|NCT05050188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111275619|NCT05050188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111275620|NCT04434378|Tamsulosin|tamsulosin|mesh-list
111275621|NCT04434378|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111275622|NCT04434378|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111275623|NCT04434378|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111275624|NCT04434378|Adrenergic Agents|adrenergic agents|mesh-ancestor
111275625|NCT04434378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111275626|NCT04434378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111275627|NCT04434378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111275628|NCT04434378|Urological Agents|urological agents|mesh-ancestor
111275629|NCT00981799|Cyclophosphamide|cyclophosphamide|mesh-list
111275630|NCT00981799|Methotrexate|methotrexate|mesh-list
111275631|NCT00981799|Etoposide|etoposide|mesh-list
111275632|NCT00981799|Lenograstim|lenograstim|mesh-list
111275633|NCT00981799|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111275634|NCT00981799|Immunologic Factors|immunologic factors|mesh-ancestor
111275635|NCT00981799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111275636|NCT00981799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111275637|NCT00981799|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111275638|NCT00981799|Alkylating Agents|alkylating agents|mesh-ancestor
111275639|NCT00981799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111275640|NCT00981799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111275641|NCT00981799|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111275642|NCT00981799|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111275643|NCT00981799|Abortifacient Agents|abortifacient agents|mesh-ancestor
111275644|NCT00981799|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111275645|NCT00981799|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111275646|NCT00981799|Antimetabolites|antimetabolites|mesh-ancestor
111275647|NCT00981799|Dermatologic Agents|dermatologic agents|mesh-ancestor
111275648|NCT00981799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111275649|NCT00981799|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111275650|NCT00981799|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111275651|NCT00981799|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111275652|NCT00981799|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111275653|NCT00981799|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111275654|NCT00981799|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111275655|NCT05033106|Bevacizumab|bevacizumab|mesh-list
111275656|NCT05033106|Ranibizumab|ranibizumab|mesh-list
111275657|NCT05033106|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111275658|NCT05033106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111275659|NCT05033106|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111275660|NCT05033106|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111275661|NCT05033106|Growth Substances|growth substances|mesh-ancestor
111275662|NCT05033106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111275663|NCT05033106|Growth Inhibitors|growth inhibitors|mesh-ancestor
111275664|NCT03095040|Everolimus|everolimus|mesh-list
111275665|NCT03095040|Vorolanib|vorolanib|mesh-list
111275666|NCT03095040|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111275667|NCT03095040|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111275668|NCT03095040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111275669|NCT03095040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111275670|NCT03095040|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111275671|NCT03095040|Immunologic Factors|immunologic factors|mesh-ancestor
111275672|NCT03095040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111275673|NCT03095040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111275674|NCT03099499|TIC10 compound|tic10 compound|mesh-list
111275675|NCT03099499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111275676|NCT03096522|Phenytoin|phenytoin|mesh-list
111275677|NCT03096522|Anticonvulsants|anticonvulsants|mesh-ancestor
111275678|NCT03096522|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111275679|NCT03096522|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111275680|NCT03096522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111275681|NCT03096522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111275682|NCT03096522|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
111275683|NCT03096522|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111275684|NCT01045161|Bromides|bromides|mesh-list
111275685|NCT01045161|Anticonvulsants|anticonvulsants|mesh-ancestor
111275686|NCT05032248|Tacrolimus|tacrolimus|mesh-list
111275687|NCT05032248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111275688|NCT05032248|Immunologic Factors|immunologic factors|mesh-ancestor
111275689|NCT05032248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111275690|NCT05032248|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111275691|NCT05032248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111275692|NCT05032248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111275693|NCT00633217|Fluticasone|fluticasone|mesh-list
111275694|NCT00633217|Xhance|xhance|mesh-list
111275695|NCT00633217|Norflurane|norflurane|mesh-list
111275696|NCT00633217|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
111275697|NCT00633217|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
111275698|NCT00633217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111275699|NCT00633217|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111275700|NCT00633217|Autonomic Agents|autonomic agents|mesh-ancestor
111275701|NCT00633217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111275702|NCT00633217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111275703|NCT00633217|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111275704|NCT00633217|Respiratory System Agents|respiratory system agents|mesh-ancestor
111275705|NCT00633217|Dermatologic Agents|dermatologic agents|mesh-ancestor
111275706|NCT00633217|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111275707|NCT00633217|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111275708|NCT00633217|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111275709|NCT00633217|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111275710|NCT00633217|Adrenergic Agents|adrenergic agents|mesh-ancestor
111275711|NCT00633217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111275712|NCT00633217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111275713|NCT00633217|Glucocorticoids|glucocorticoids|mesh-ancestor
111275714|NCT00633217|Hormones|hormones|mesh-ancestor
111275715|NCT00633217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111275716|NCT00633217|Sympathomimetics|sympathomimetics|mesh-ancestor
111275717|NCT00633217|Anesthetics|anesthetics|mesh-ancestor
111275718|NCT00633217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111275719|NCT01673490|Tamsulosin|tamsulosin|mesh-list
111275720|NCT01673490|Dutasteride|dutasteride|mesh-list
111275721|NCT01673490|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111275722|NCT01673490|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111275723|NCT01673490|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111275724|NCT01673490|Adrenergic Agents|adrenergic agents|mesh-ancestor
111275725|NCT01673490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111275726|NCT01673490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111275727|NCT01673490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111275728|NCT01673490|Urological Agents|urological agents|mesh-ancestor
111275729|NCT01673490|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
111275730|NCT01673490|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111275731|NCT01673490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111275732|NCT01673490|Hormone Antagonists|hormone antagonists|mesh-ancestor
111275733|NCT01673490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111275734|NCT00633061|Enoxaparin|enoxaparin|mesh-list
111275735|NCT00633061|Anticoagulants|anticoagulants|mesh-ancestor
111275736|NCT00633061|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111275737|NCT00633061|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111275738|NCT00633061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111275739|NCT00632827|Leucovorin|leucovorin|mesh-list
111275740|NCT00632827|Cytarabine|cytarabine|mesh-list
111275741|NCT00632827|Cyclophosphamide|cyclophosphamide|mesh-list
111275742|NCT00632827|Carmustine|carmustine|mesh-list
111275743|NCT00632827|Gemcitabine|gemcitabine|mesh-list
111275744|NCT00632827|Doxorubicin|doxorubicin|mesh-list
111275745|NCT00632827|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111275746|NCT00632827|Methotrexate|methotrexate|mesh-list
111275747|NCT00632827|Etoposide|etoposide|mesh-list
111275748|NCT00632827|Vincristine|vincristine|mesh-list
111275749|NCT00632827|Vinorelbine|vinorelbine|mesh-list
111275750|NCT00632827|Denileukin diftitox|denileukin diftitox|mesh-list
111275751|NCT00632827|Lenograstim|lenograstim|mesh-list
111275752|NCT00632827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111275753|NCT00632827|Immunologic Factors|immunologic factors|mesh-ancestor
111275754|NCT00632827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111275755|NCT00632827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111275756|NCT00632827|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111275757|NCT00632827|Alkylating Agents|alkylating agents|mesh-ancestor
111275758|NCT00632827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111275759|NCT00632827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111275760|NCT00632827|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111275761|NCT00632827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111275762|NCT00632827|Antimetabolites|antimetabolites|mesh-ancestor
111275763|NCT00632827|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111275764|NCT00632827|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111275765|NCT00632827|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111275766|NCT00632827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111275767|NCT00632827|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111275768|NCT00632827|Abortifacient Agents|abortifacient agents|mesh-ancestor
111275769|NCT00632827|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111275770|NCT00632827|Dermatologic Agents|dermatologic agents|mesh-ancestor
111275771|NCT00632827|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111275772|NCT00632827|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111275773|NCT00632827|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111275774|NCT00632827|Antiviral Agents|antiviral agents|mesh-ancestor
111275775|NCT00632827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111275776|NCT00632827|Antidotes|antidotes|mesh-ancestor
111275777|NCT00632827|Protective Agents|protective agents|mesh-ancestor
111275778|NCT00632827|Vitamin B Complex|vitamin b complex|mesh-ancestor
111275779|NCT00632827|Vitamins|vitamins|mesh-ancestor
111275780|NCT00632827|Micronutrients|micronutrients|mesh-ancestor
111275781|NCT00632827|Tubulin Modulators|tubulin modulators|mesh-ancestor
111275782|NCT00632827|Antimitotic Agents|antimitotic agents|mesh-ancestor
111275783|NCT00632827|Mitosis Modulators|mitosis modulators|mesh-ancestor
111275784|NCT00632827|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111275785|NCT00214019|Fluticasone|fluticasone|mesh-list
111275786|NCT00214019|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
111275787|NCT00214019|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
111275788|NCT00214019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111275789|NCT00214019|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111275790|NCT00214019|Autonomic Agents|autonomic agents|mesh-ancestor
111275791|NCT00214019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111275792|NCT00214019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111275793|NCT00214019|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111275794|NCT00214019|Respiratory System Agents|respiratory system agents|mesh-ancestor
111275795|NCT00214019|Dermatologic Agents|dermatologic agents|mesh-ancestor
111275796|NCT00214019|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111275797|NCT00214019|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111275798|NCT00214019|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111275799|NCT00214019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111275800|NCT00214019|Adrenergic Agents|adrenergic agents|mesh-ancestor
111275801|NCT00214019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111275802|NCT00214019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111275803|NCT00214019|Glucocorticoids|glucocorticoids|mesh-ancestor
111275804|NCT00214019|Hormones|hormones|mesh-ancestor
111275805|NCT00214019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111275806|NCT00214019|Sympathomimetics|sympathomimetics|mesh-ancestor
111275807|NCT03097848|Sorafenib|sorafenib|mesh-list
111275808|NCT03097848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111275809|NCT03097848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111275810|NCT03097848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111275811|NCT03097848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111275812|NCT05047848|Fulvestrant|fulvestrant|mesh-list
111275813|NCT05047848|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111275814|NCT05047848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111275815|NCT05047848|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
111275816|NCT05047848|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111275817|NCT05047848|Hormone Antagonists|hormone antagonists|mesh-ancestor
111275818|NCT05047848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111275819|NCT05047848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111275820|NCT00210119|Imatinib Mesylate|imatinib mesylate|mesh-list
111275821|NCT00210119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111275822|NCT00210119|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111275823|NCT00210119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111275824|NCT00210119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111275825|NCT01044459|Bromides|bromides|mesh-list
111275826|NCT01044459|Anticonvulsants|anticonvulsants|mesh-ancestor
111275827|NCT01837329|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
111275828|NCT01837329|Chelating Agents|chelating agents|mesh-ancestor
111275829|NCT01837329|Sequestering Agents|sequestering agents|mesh-ancestor
111275830|NCT01837329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111275831|NCT01837329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111275832|NCT01837329|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111275833|NCT01837329|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111275834|NCT01837329|Growth Substances|growth substances|mesh-ancestor
111275835|NCT01837329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111275836|NCT01837329|Growth Inhibitors|growth inhibitors|mesh-ancestor
111275837|NCT01837329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111275838|NCT05040906|Rituximab|rituximab|mesh-list
111275839|NCT05040906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111275840|NCT05040906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111275841|NCT05040906|Immunologic Factors|immunologic factors|mesh-ancestor
111275842|NCT05040906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111275843|NCT05040906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111275844|NCT01044303|Mycophenolic Acid|mycophenolic acid|mesh-list
111275845|NCT01044303|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111275846|NCT01044303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111275847|NCT01044303|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111275848|NCT01044303|Antitubercular Agents|antitubercular agents|mesh-ancestor
111275849|NCT01044303|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111275850|NCT01044303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111275851|NCT01044303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111275852|NCT01044303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111275853|NCT05040828|Montelukast|montelukast|mesh-list
111275854|NCT05040828|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111275855|NCT05040828|Respiratory System Agents|respiratory system agents|mesh-ancestor
111275856|NCT05040828|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
111275857|NCT05040828|Hormone Antagonists|hormone antagonists|mesh-ancestor
111275858|NCT05040828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111275859|NCT05040828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111275860|NCT05040828|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
111275861|NCT05040828|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111275862|NCT05040828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111275863|NCT00983437|Modafinil|modafinil|mesh-list
111275864|NCT00983437|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111275865|NCT00983437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111275866|NCT00983437|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
111275867|NCT00983437|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111275868|NCT00983437|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111275869|NCT00983437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111275870|NCT05031234|Morphine|morphine|mesh-list
111275871|NCT05031234|Anesthetics|anesthetics|mesh-list
111275872|NCT05031234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111275873|NCT05031234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111275874|NCT05031234|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111275875|NCT05031234|Narcotics|narcotics|mesh-ancestor
111275876|NCT05031234|Analgesics|analgesics|mesh-ancestor
111275877|NCT05031234|Sensory System Agents|sensory system agents|mesh-ancestor
111275878|NCT05031234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111275879|NCT03599609|Simvastatin|simvastatin|mesh-list
111275880|NCT03599609|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111275881|NCT03599609|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111275882|NCT03599609|Antimetabolites|antimetabolites|mesh-ancestor
111275883|NCT03599609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111275884|NCT03599609|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111275885|NCT03599609|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111275886|NCT03599609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111275887|NCT05040594|Lidocaine|lidocaine|mesh-list
111275888|NCT05040594|Anesthetics, Local|anesthetics, local|mesh-ancestor
111275889|NCT05040594|Anesthetics|anesthetics|mesh-ancestor
111275890|NCT05040594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111275891|NCT05040594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111275892|NCT05040594|Sensory System Agents|sensory system agents|mesh-ancestor
111275893|NCT05040594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111275894|NCT05040594|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111275895|NCT05040594|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111275896|NCT05040594|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111275897|NCT05040594|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111275898|NCT05040594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111275899|NCT01042977|Dapagliflozin|dapagliflozin|mesh-list
111275900|NCT01042977|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111275901|NCT01042977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111275902|NCT01042977|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111275903|NCT01042977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111275904|NCT03598673|Nebivolol|nebivolol|mesh-list
111275905|NCT03598673|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111275906|NCT03598673|Vasodilator Agents|vasodilator agents|mesh-ancestor
111275907|NCT03598673|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
111275908|NCT03598673|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111275909|NCT03598673|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111275910|NCT03598673|Adrenergic Agents|adrenergic agents|mesh-ancestor
111275911|NCT03598673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111275912|NCT03598673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111275913|NCT03598673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111275914|NCT05039580|Dexamethasone|dexamethasone|mesh-list
111275915|NCT05039580|Antibodies|antibodies|mesh-list
111275916|NCT05039580|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111275917|NCT05039580|Immunologic Factors|immunologic factors|mesh-ancestor
111275918|NCT05039580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111275919|NCT05039580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111275920|NCT05039580|Antiemetics|antiemetics|mesh-ancestor
111275921|NCT05039580|Autonomic Agents|autonomic agents|mesh-ancestor
111275922|NCT05039580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111275923|NCT05039580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111275924|NCT05039580|Glucocorticoids|glucocorticoids|mesh-ancestor
111275925|NCT05039580|Hormones|hormones|mesh-ancestor
111275926|NCT05039580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111275927|NCT05039580|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111275928|NCT05039580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111275929|NCT05025228|Acetaminophen|acetaminophen|mesh-list
111275930|NCT05025228|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111275931|NCT05025228|Analgesics|analgesics|mesh-ancestor
111275932|NCT05025228|Sensory System Agents|sensory system agents|mesh-ancestor
111275933|NCT05025228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111275934|NCT05025228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111275935|NCT05025228|Antipyretics|antipyretics|mesh-ancestor
111275936|NCT05025072|Hydroxyurea|hydroxyurea|mesh-list
111275937|NCT05025072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111275938|NCT05025072|Antisickling Agents|antisickling agents|mesh-ancestor
111275939|NCT05025072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111275940|NCT05025072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111275941|NCT05025072|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111275942|NCT05024604|Progesterone|progesterone|mesh-list
111275943|NCT05024604|Progestins|progestins|mesh-ancestor
111275944|NCT05024604|Hormones|hormones|mesh-ancestor
111275945|NCT05024604|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111275946|NCT05024604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111275947|NCT03597893|Oxytocin|oxytocin|mesh-list
111275948|NCT03597893|Oxytocics|oxytocics|mesh-ancestor
111275949|NCT03597893|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111275950|NCT03597893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111275951|NCT01041573|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
111275952|NCT01041573|Immunologic Factors|immunologic factors|mesh-ancestor
111275953|NCT01041573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111275954|NCT05024448|Prednisone|prednisone|mesh-list
111275955|NCT05024448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111275956|NCT05024448|Glucocorticoids|glucocorticoids|mesh-ancestor
111275957|NCT05024448|Hormones|hormones|mesh-ancestor
111275958|NCT05024448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111275959|NCT05024448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111275960|NCT05024448|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111275961|NCT05024448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111275962|NCT03596957|Tolvaptan|tolvaptan|mesh-list
111275963|NCT03596957|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
111275964|NCT03596957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111275965|NCT03596957|Natriuretic Agents|natriuretic agents|mesh-ancestor
111275966|NCT03596957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111275967|NCT03408015|Lifitegrast|lifitegrast|mesh-list
111275968|NCT03408015|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
111275969|NCT03408015|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111275970|NCT01041495|Cyclobenzaprine|cyclobenzaprine|mesh-list
111275971|NCT01041495|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
111275972|NCT01041495|Antidepressive Agents|antidepressive agents|mesh-ancestor
111275973|NCT01041495|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111275974|NCT01041495|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
111275975|NCT01041495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111275976|NCT01041495|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111275977|NCT01041495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111275978|NCT01041495|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111275979|NCT01041495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111275980|NCT03407937|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
111275981|NCT03407937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111275982|NCT03407937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111275983|NCT03596099|Acetic Acid|acetic acid|mesh-list
111275984|NCT03596099|Retinol acetate|retinol acetate|mesh-list
111275985|NCT03596099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111275986|NCT03596099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111275987|NCT03596099|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111275988|NCT03596099|Immunologic Factors|immunologic factors|mesh-ancestor
111275989|NCT03596099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111275990|NCT03596099|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
111275991|NCT03596099|Protective Agents|protective agents|mesh-ancestor
111275992|NCT03596099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111275993|NCT01041417|Molgramostim|molgramostim|mesh-list
111275994|NCT01041417|Sargramostim|sargramostim|mesh-list
111275995|NCT01041417|Immunologic Factors|immunologic factors|mesh-ancestor
111275996|NCT01041417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111275997|NCT01041417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111275998|NCT03595397|Magnesium Sulfate|magnesium sulfate|mesh-list
111275999|NCT03595397|Fentanyl|fentanyl|mesh-list
111276000|NCT03595397|Bupivacaine|bupivacaine|mesh-list
111276001|NCT03595397|Anesthetics, Local|anesthetics, local|mesh-ancestor
111276002|NCT03595397|Anesthetics|anesthetics|mesh-ancestor
111276003|NCT03595397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111276004|NCT03595397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111276005|NCT03595397|Sensory System Agents|sensory system agents|mesh-ancestor
111276006|NCT03595397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111276007|NCT03595397|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111276008|NCT03595397|Narcotics|narcotics|mesh-ancestor
111276009|NCT03595397|Analgesics|analgesics|mesh-ancestor
111276010|NCT03595397|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111276011|NCT03595397|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111276012|NCT03595397|Anesthetics, General|anesthetics, general|mesh-ancestor
111276013|NCT03595397|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111276014|NCT03595397|Anticonvulsants|anticonvulsants|mesh-ancestor
111276015|NCT03595397|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111276016|NCT03595397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111276017|NCT03595397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111276018|NCT03595397|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111276019|NCT03595397|Tocolytic Agents|tocolytic agents|mesh-ancestor
111276020|NCT03595397|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111276021|NCT03595319|Sevoflurane|sevoflurane|mesh-list
111276022|NCT03595319|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111276023|NCT03595319|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111276024|NCT03595319|Anesthetics, General|anesthetics, general|mesh-ancestor
111276025|NCT03595319|Anesthetics|anesthetics|mesh-ancestor
111276026|NCT03595319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111276027|NCT03595319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111276028|NCT01040871|Prednisone|prednisone|mesh-list
111276029|NCT01040871|Cyclophosphamide|cyclophosphamide|mesh-list
111276030|NCT01040871|Rituximab|rituximab|mesh-list
111276031|NCT01040871|Doxorubicin|doxorubicin|mesh-list
111276032|NCT01040871|Vincristine|vincristine|mesh-list
111276033|NCT01040871|Bortezomib|bortezomib|mesh-list
111276034|NCT01040871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111276035|NCT01040871|Immunologic Factors|immunologic factors|mesh-ancestor
111276036|NCT01040871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111276037|NCT01040871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110978708|NCT03251690|Emtricitabine|emtricitabine|mesh-list
111276038|NCT01040871|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111276039|NCT01040871|Alkylating Agents|alkylating agents|mesh-ancestor
111276040|NCT01040871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111276041|NCT01040871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111276042|NCT01040871|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111276043|NCT01040871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111276044|NCT01040871|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111276045|NCT01040871|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111276046|NCT01040871|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111276047|NCT01040871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111276048|NCT01040871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111276049|NCT01040871|Glucocorticoids|glucocorticoids|mesh-ancestor
111276050|NCT01040871|Hormones|hormones|mesh-ancestor
111276051|NCT01040871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111276052|NCT01040871|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111276053|NCT01040871|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111276054|NCT01040871|Tubulin Modulators|tubulin modulators|mesh-ancestor
111276055|NCT01040871|Antimitotic Agents|antimitotic agents|mesh-ancestor
111276056|NCT01040871|Mitosis Modulators|mitosis modulators|mesh-ancestor
111276057|NCT01040169|Calcium Carbonate|calcium carbonate|mesh-list
111276058|NCT01040169|Calcium|calcium|mesh-list
111276059|NCT01040169|Fluorides|fluorides|mesh-list
111276060|NCT01040169|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111276061|NCT01040169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111276062|NCT01040169|Cariostatic Agents|cariostatic agents|mesh-ancestor
111276063|NCT01040169|Protective Agents|protective agents|mesh-ancestor
111276064|NCT01040169|Antacids|antacids|mesh-ancestor
111276065|NCT01040169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111276066|NCT01040169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111276067|NCT01044381|Luliconazole|luliconazole|mesh-list
111276068|NCT01044381|Antifungal Agents|antifungal agents|mesh-ancestor
111276069|NCT01044381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111276070|NCT03594461|Aflibercept|aflibercept|mesh-list
111276071|NCT03594461|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111276072|NCT03594461|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111276073|NCT03594461|Growth Substances|growth substances|mesh-ancestor
111276074|NCT03594461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111276075|NCT03594461|Growth Inhibitors|growth inhibitors|mesh-ancestor
111276076|NCT03594461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111276077|NCT03407703|Grazoprevir|grazoprevir|mesh-list
111276078|NCT03407703|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
111276079|NCT03407703|Antiviral Agents|antiviral agents|mesh-ancestor
111276080|NCT03407703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111276081|NCT03594149|Levofloxacin|levofloxacin|mesh-list
111276082|NCT03594149|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111276083|NCT03594149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111276084|NCT03594149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111276085|NCT03594149|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111276086|NCT03594149|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111276087|NCT03594149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111276088|NCT03594149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111276089|NCT03594149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111276090|NCT03594149|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111276091|NCT03594149|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111276092|NCT00916539|Calpastatin|calpastatin|mesh-list
111276093|NCT00916539|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
111276094|NCT00916539|Protease Inhibitors|protease inhibitors|mesh-ancestor
111276095|NCT00916539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111276096|NCT00916539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111276097|NCT03593447|Ribavirin|ribavirin|mesh-list
111276098|NCT03593447|Yimitasvir|yimitasvir|mesh-list
111276099|NCT03593447|Antimetabolites|antimetabolites|mesh-ancestor
111276100|NCT03593447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111276101|NCT03593447|Antiviral Agents|antiviral agents|mesh-ancestor
111000459|NCT03111446|Anesthetics|anesthetics|mesh-list
111276102|NCT03593447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111276104|NCT03593291|Dalteparin|dalteparin|mesh-list
111276105|NCT03593291|Anticoagulants|anticoagulants|mesh-ancestor
111276106|NCT03593291|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111276107|NCT03593291|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111276108|NCT03593291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111276109|NCT03593135|Metformin|metformin|mesh-list
111276110|NCT03593135|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111276111|NCT03593135|Acetic Acid|acetic acid|mesh-list
111276112|NCT03593135|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111276113|NCT03593135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111276114|NCT03593135|Incretins|incretins|mesh-ancestor
111276115|NCT03593135|Hormones|hormones|mesh-ancestor
111276116|NCT03593135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111276117|NCT03593135|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111276118|NCT03593135|Protease Inhibitors|protease inhibitors|mesh-ancestor
111276119|NCT03593135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111276120|NCT03593135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111276121|NCT03593135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111276122|NCT03593135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111276123|NCT03592901|Anesthetics|anesthetics|mesh-list
111276124|NCT03592901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111276125|NCT03592901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111276126|NCT03830385|Carboplatin|carboplatin|mesh-list
111276127|NCT03830385|Bleomycin|bleomycin|mesh-list
111276128|NCT03830385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111276129|NCT03830385|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111276130|NCT03592823|Hydroxychloroquine|hydroxychloroquine|mesh-list
111276131|NCT03592823|Antimalarials|antimalarials|mesh-ancestor
111276132|NCT03592823|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111276133|NCT03592823|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111276134|NCT03592823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111276135|NCT03592823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111276136|NCT03592823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111276137|NCT03592823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111276138|NCT03592667|Dapagliflozin|dapagliflozin|mesh-list
111276139|NCT03592667|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111276140|NCT03592667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111276141|NCT03592667|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111276142|NCT03592667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111276143|NCT03406689|Nepafenac|nepafenac|mesh-list
111276144|NCT03406689|Lubricant Eye Drops|lubricant eye drops|mesh-list
111276145|NCT03406689|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
111276146|NCT03406689|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111276147|NCT03406689|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111276148|NCT03406689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111276149|NCT03406689|Analgesics|analgesics|mesh-ancestor
111276150|NCT03406689|Sensory System Agents|sensory system agents|mesh-ancestor
111276151|NCT03406689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111276152|NCT03406689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111276153|NCT03406689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111276154|NCT03406689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111276155|NCT03591575|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111276156|NCT03591575|Deferiprone|deferiprone|mesh-list
111276157|NCT03591575|Iron Chelating Agents|iron chelating agents|mesh-ancestor
111276158|NCT03591575|Chelating Agents|chelating agents|mesh-ancestor
111276159|NCT03591575|Sequestering Agents|sequestering agents|mesh-ancestor
111276160|NCT03591575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111276161|NCT03406533|Fentanyl|fentanyl|mesh-list
111276162|NCT03406533|Midazolam|midazolam|mesh-list
111276163|NCT03406533|Dexmedetomidine|dexmedetomidine|mesh-list
111276164|NCT03406533|Remifentanil|remifentanil|mesh-list
111276165|NCT03406533|Propofol|propofol|mesh-list
111276166|NCT03406533|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111276167|NCT03406533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111276168|NCT03406533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111276169|NCT03406533|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111276170|NCT03406533|Analgesics|analgesics|mesh-ancestor
111276171|NCT03406533|Sensory System Agents|sensory system agents|mesh-ancestor
111276172|NCT03406533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111276173|NCT03406533|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111276174|NCT03406533|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111276175|NCT03406533|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111276176|NCT03406533|Adrenergic Agents|adrenergic agents|mesh-ancestor
111276177|NCT03406533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111276178|NCT03406533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111276179|NCT03406533|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111276180|NCT03406533|Anesthetics, General|anesthetics, general|mesh-ancestor
111276181|NCT03406533|Anesthetics|anesthetics|mesh-ancestor
111276182|NCT03406533|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111276183|NCT03406533|Narcotics|narcotics|mesh-ancestor
111276184|NCT03406533|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111276185|NCT03406533|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111276186|NCT03406533|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111276187|NCT03406533|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111276188|NCT03406533|GABA Modulators|gaba modulators|mesh-ancestor
111276189|NCT03406533|GABA Agents|gaba agents|mesh-ancestor
111276190|NCT03591341|Melatonin|melatonin|mesh-list
111276191|NCT03591341|Antioxidants|antioxidants|mesh-ancestor
111276192|NCT03591341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111276193|NCT03591341|Protective Agents|protective agents|mesh-ancestor
111276194|NCT03591341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111276195|NCT03591341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111276196|NCT04377399|Vitamin D|vitamin d|mesh-list
111276197|NCT04377399|Vitamins|vitamins|mesh-ancestor
111276198|NCT04377399|Micronutrients|micronutrients|mesh-ancestor
111276199|NCT04377399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111276200|NCT04377399|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111276201|NCT03400995|Ziresovir|ziresovir|mesh-list
111276202|NCT03400995|Antiviral Agents|antiviral agents|mesh-ancestor
111276203|NCT03400995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111276204|NCT03590873|Vasopressins|vasopressins|mesh-list
111276205|NCT03590873|Arginine Vasopressin|arginine vasopressin|mesh-list
111276206|NCT03590873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111276207|NCT03590873|Hemostatics|hemostatics|mesh-ancestor
111276208|NCT03590873|Coagulants|coagulants|mesh-ancestor
111276209|NCT03590873|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111276210|NCT03590873|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
111276211|NCT03590873|Natriuretic Agents|natriuretic agents|mesh-ancestor
111276212|NCT02155335|Golimumab|golimumab|mesh-list
111276213|NCT02155335|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111276214|NCT02155335|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111276215|NCT02155335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111276216|NCT02155335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111276217|NCT02155335|Immunologic Factors|immunologic factors|mesh-ancestor
111276218|NCT02155335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111276219|NCT05024526|Edaravone|edaravone|mesh-list
111276220|NCT05024526|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111276221|NCT05024526|Antioxidants|antioxidants|mesh-ancestor
111276222|NCT05024526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111276223|NCT05024526|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111276224|NCT05024526|Protective Agents|protective agents|mesh-ancestor
111276225|NCT05024526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111276226|NCT03597035|Spironolactone|spironolactone|mesh-list
111276227|NCT03597035|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
111276228|NCT03597035|Hormone Antagonists|hormone antagonists|mesh-ancestor
111276229|NCT03597035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111276230|NCT03597035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111276231|NCT03597035|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
111276232|NCT03597035|Diuretics|diuretics|mesh-ancestor
111276233|NCT03597035|Natriuretic Agents|natriuretic agents|mesh-ancestor
111276234|NCT03400683|Letrozole|letrozole|mesh-list
111276235|NCT03400683|Misoprostol|misoprostol|mesh-list
111276236|NCT03400683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111276237|NCT03400683|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111276238|NCT03400683|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110728363|NCT00110396|Antiviral Agents|antiviral agents|mesh-ancestor
111276239|NCT03400683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111276240|NCT03400683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111276241|NCT03400683|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111276242|NCT03400683|Hormone Antagonists|hormone antagonists|mesh-ancestor
111276243|NCT03400683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111276244|NCT03400683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111276245|NCT03400683|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111276246|NCT03400683|Abortifacient Agents|abortifacient agents|mesh-ancestor
111276247|NCT03400683|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111276248|NCT03400683|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111276249|NCT03400683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111276250|NCT03400683|Oxytocics|oxytocics|mesh-ancestor
111276251|NCT05037240|Quercetin|quercetin|mesh-list
111276252|NCT05037240|Antioxidants|antioxidants|mesh-ancestor
111276253|NCT05037240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111276254|NCT05037240|Protective Agents|protective agents|mesh-ancestor
111276255|NCT05037240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111276256|NCT05037006|Anesthetics|anesthetics|mesh-list
111276257|NCT05037006|Sevoflurane|sevoflurane|mesh-list
111276258|NCT05037006|Neostigmine|neostigmine|mesh-list
111276259|NCT05037006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111276260|NCT05037006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111276261|NCT05037006|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111276262|NCT05037006|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111276263|NCT05037006|Anesthetics, General|anesthetics, general|mesh-ancestor
111276264|NCT05037006|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111276265|NCT05037006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111276266|NCT05037006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111276267|NCT05037006|Cholinergic Agents|cholinergic agents|mesh-ancestor
111276268|NCT05037006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111276269|NCT05037006|Parasympathomimetics|parasympathomimetics|mesh-ancestor
111276270|NCT05037006|Autonomic Agents|autonomic agents|mesh-ancestor
111276271|NCT05037006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111276272|NCT03093090|Furosemide|furosemide|mesh-list
111276273|NCT03093090|Diuretics|diuretics|mesh-ancestor
111276274|NCT03093090|Natriuretic Agents|natriuretic agents|mesh-ancestor
111276275|NCT03093090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111276276|NCT03093090|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
111276277|NCT03093090|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111276278|NCT03093090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111276279|NCT03093168|Cyclophosphamide|cyclophosphamide|mesh-list
111276280|NCT03093168|Fludarabine|fludarabine|mesh-list
111276281|NCT03093168|Idecabtagene vicleucel|idecabtagene vicleucel|mesh-list
111276282|NCT03093168|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111276283|NCT03093168|Immunologic Factors|immunologic factors|mesh-ancestor
111276284|NCT03093168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111276285|NCT03093168|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111276286|NCT03093168|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111276287|NCT03093168|Alkylating Agents|alkylating agents|mesh-ancestor
111276288|NCT03093168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111276289|NCT03093168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111276290|NCT03093168|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111276291|NCT03093168|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111276292|NCT04377321|Colchicine|colchicine|mesh-list
111276293|NCT04377321|Gout Suppressants|gout suppressants|mesh-ancestor
111276294|NCT04377321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111276295|NCT04377321|Tubulin Modulators|tubulin modulators|mesh-ancestor
111276296|NCT04377321|Antimitotic Agents|antimitotic agents|mesh-ancestor
111276297|NCT04377321|Mitosis Modulators|mitosis modulators|mesh-ancestor
111276298|NCT04377321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111276299|NCT04377321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111276300|NCT05018364|Epoetin Alfa|epoetin alfa|mesh-list
111276301|NCT05018364|Hematinics|hematinics|mesh-ancestor
111276302|NCT03593213|Cariprazine|cariprazine|mesh-list
111276303|NCT03593213|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111276304|NCT03593213|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111276305|NCT03593213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111276306|NCT03593213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111276307|NCT03593213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111276308|NCT05023824|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
111276309|NCT05023824|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111276310|NCT05023824|Adrenergic Agents|adrenergic agents|mesh-ancestor
111276311|NCT05023824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111276312|NCT05023824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111276313|NCT05023824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111276314|NCT03595163|Folic Acid|folic acid|mesh-list
111276315|NCT03595163|Vitamin B Complex|vitamin b complex|mesh-list
111276316|NCT03595163|Propofol|propofol|mesh-list
111276317|NCT03595163|Sevoflurane|sevoflurane|mesh-list
111276318|NCT03595163|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111276319|NCT03595163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111276320|NCT03595163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111276321|NCT03595163|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111276322|NCT03595163|Anesthetics, General|anesthetics, general|mesh-ancestor
111276323|NCT03595163|Anesthetics|anesthetics|mesh-ancestor
111276324|NCT03595163|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111276325|NCT03595163|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111276326|NCT03595163|Hematinics|hematinics|mesh-ancestor
111276327|NCT03595163|Vitamins|vitamins|mesh-ancestor
111276328|NCT03595163|Micronutrients|micronutrients|mesh-ancestor
111276329|NCT03404115|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111276330|NCT03404115|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111276331|NCT04199819|Entecavir|entecavir|mesh-list
111276332|NCT04199819|Antiviral Agents|antiviral agents|mesh-ancestor
111276333|NCT04199819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111276334|NCT00918723|Cyclophosphamide|cyclophosphamide|mesh-list
111276335|NCT00918723|Rituximab|rituximab|mesh-list
111276336|NCT00918723|Fludarabine|fludarabine|mesh-list
111276337|NCT00918723|Fludarabine phosphate|fludarabine phosphate|mesh-list
111276338|NCT00918723|Vorinostat|vorinostat|mesh-list
111276339|NCT00918723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111276340|NCT00918723|Immunologic Factors|immunologic factors|mesh-ancestor
111276341|NCT00918723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111276342|NCT00918723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111276343|NCT00918723|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111276344|NCT00918723|Alkylating Agents|alkylating agents|mesh-ancestor
111276345|NCT00918723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111276346|NCT00918723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111276347|NCT00918723|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111276348|NCT00918723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111276349|NCT00918723|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111276350|NCT00918723|Antimetabolites|antimetabolites|mesh-ancestor
111276351|NCT00918723|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111276352|NCT00918723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111276353|NCT04192331|Paclitaxel|paclitaxel|mesh-list
111276354|NCT04192331|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111276355|NCT04192331|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111276356|NCT04192331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111276357|NCT04192331|Tubulin Modulators|tubulin modulators|mesh-ancestor
111276358|NCT04192331|Antimitotic Agents|antimitotic agents|mesh-ancestor
111276359|NCT04192331|Mitosis Modulators|mitosis modulators|mesh-ancestor
111276360|NCT04192331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111276361|NCT00919035|Temsirolimus|temsirolimus|mesh-list
111276362|NCT00919035|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111276363|NCT00919035|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111276364|NCT00919035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111276365|NCT00919035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111276366|NCT00919035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111276367|NCT00919035|Immunologic Factors|immunologic factors|mesh-ancestor
111276368|NCT00919035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111276369|NCT00919035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111276370|NCT03969953|Rivaroxaban|rivaroxaban|mesh-list
111276371|NCT03969953|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111276372|NCT03969953|Antithrombins|antithrombins|mesh-ancestor
111276373|NCT03969953|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111276374|NCT03969953|Protease Inhibitors|protease inhibitors|mesh-ancestor
111276375|NCT03969953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111276376|NCT03969953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111276377|NCT03969953|Anticoagulants|anticoagulants|mesh-ancestor
111276378|NCT04374981|Celecoxib|celecoxib|mesh-list
111276379|NCT04374981|Montelukast|montelukast|mesh-list
111276380|NCT04374981|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111276381|NCT04374981|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111276382|NCT04374981|Analgesics|analgesics|mesh-ancestor
111276383|NCT04374981|Sensory System Agents|sensory system agents|mesh-ancestor
111276384|NCT04374981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111276385|NCT04374981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111276386|NCT04374981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111276387|NCT04374981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111276388|NCT04374981|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111276389|NCT04374981|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111276390|NCT04374981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111276391|NCT04374981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111276392|NCT04374981|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111276393|NCT04374981|Respiratory System Agents|respiratory system agents|mesh-ancestor
111276394|NCT04374981|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
111276395|NCT04374981|Hormone Antagonists|hormone antagonists|mesh-ancestor
111276396|NCT04374981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111276397|NCT04374981|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
111276398|NCT04374981|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111276399|NCT03092544|Dimethyl Fumarate|dimethyl fumarate|mesh-list
111276400|NCT03092544|Dermatologic Agents|dermatologic agents|mesh-ancestor
111276401|NCT03092544|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111276402|NCT03092544|Immunologic Factors|immunologic factors|mesh-ancestor
111276403|NCT03092544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110959303|NCT04446104|Hydroxychloroquine|hydroxychloroquine|mesh-list
111276404|NCT03090516|Donepezil|donepezil|mesh-list
111276405|NCT03090516|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111276406|NCT03090516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111276407|NCT03090516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111276408|NCT03090516|Cholinergic Agents|cholinergic agents|mesh-ancestor
111276409|NCT03090516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111276410|NCT03090516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111276411|NCT03090516|Nootropic Agents|nootropic agents|mesh-ancestor
111276412|NCT04198571|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
111276413|NCT04198571|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111276414|NCT04198571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111276415|NCT03092310|Pancrelipase|pancrelipase|mesh-list
111276416|NCT03092310|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111276417|NCT03405207|Vitamin D|vitamin d|mesh-list
111276418|NCT03405207|Cholecalciferol|cholecalciferol|mesh-list
111276419|NCT03405207|Vitamins|vitamins|mesh-ancestor
111276420|NCT03405207|Micronutrients|micronutrients|mesh-ancestor
111276421|NCT03405207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111276422|NCT03405207|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111276423|NCT03405207|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111276424|NCT04197323|Alprostadil|alprostadil|mesh-list
111276425|NCT04197323|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111276426|NCT04197323|Vasodilator Agents|vasodilator agents|mesh-ancestor
111276427|NCT04197323|Urological Agents|urological agents|mesh-ancestor
111276428|NCT04196855|Teriparatide|teriparatide|mesh-list
111276429|NCT04196855|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111276430|NCT04196855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111276431|NCT04196855|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111276432|NCT04196621|Lubricant Eye Drops|lubricant eye drops|mesh-list
111276433|NCT04196621|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
111276434|NCT04196621|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111276435|NCT04196309|Heparin|heparin|mesh-list
111276436|NCT04196309|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
111276437|NCT04196309|Tinzaparin|tinzaparin|mesh-list
111276438|NCT04196309|Dalteparin|dalteparin|mesh-list
111276439|NCT04196309|Anticoagulants|anticoagulants|mesh-ancestor
111276440|NCT04196309|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111276441|NCT04196309|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111276442|NCT04196309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111276443|NCT03090048|Vitamin A|vitamin a|mesh-list
111276444|NCT03090048|Azithromycin|azithromycin|mesh-list
111276445|NCT03090048|Retinol palmitate|retinol palmitate|mesh-list
111276446|NCT03090048|Vitamins|vitamins|mesh-ancestor
111276447|NCT03090048|Micronutrients|micronutrients|mesh-ancestor
111276448|NCT03090048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111276449|NCT03090048|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111276450|NCT03090048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111276451|NCT03090048|Antioxidants|antioxidants|mesh-ancestor
111276452|NCT03090048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111276453|NCT03090048|Protective Agents|protective agents|mesh-ancestor
111276454|NCT03090048|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
111276455|NCT03090048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111276456|NCT04195997|Heparin|heparin|mesh-list
111276457|NCT04195997|Bivalirudin|bivalirudin|mesh-list
111276458|NCT04195997|Anticoagulants|anticoagulants|mesh-ancestor
111276459|NCT04195997|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111276460|NCT04195997|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111276461|NCT04195997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111276462|NCT04195997|Antithrombins|antithrombins|mesh-ancestor
111276463|NCT04195997|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111276464|NCT04195997|Protease Inhibitors|protease inhibitors|mesh-ancestor
111276465|NCT04195997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111276466|NCT05023122|Vitamin D|vitamin d|mesh-list
111276467|NCT05023122|Cholecalciferol|cholecalciferol|mesh-list
111276468|NCT05023122|Calcium|calcium|mesh-list
111276469|NCT05023122|Vitamins|vitamins|mesh-ancestor
111276470|NCT05023122|Micronutrients|micronutrients|mesh-ancestor
111276471|NCT05023122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111276472|NCT05023122|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111276473|NCT05023122|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111276474|NCT04195373|Flucytosine|flucytosine|mesh-list
111276475|NCT04195373|Antifungal Agents|antifungal agents|mesh-ancestor
111276476|NCT04195373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111276477|NCT04195373|Antimetabolites|antimetabolites|mesh-ancestor
111276478|NCT04195373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111276479|NCT04194827|Adalimumab|adalimumab|mesh-list
111276480|NCT04194827|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111276481|NCT04194827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111276482|NCT04194827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111276483|NCT04194905|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
111276484|NCT04194905|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
111276485|NCT04194905|Levonorgestrel|levonorgestrel|mesh-list
111276486|NCT04194905|Ethinyl Estradiol|ethinyl estradiol|mesh-list
111276487|NCT04194905|Estradiol|estradiol|mesh-list
111276488|NCT04194905|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
111276489|NCT04194905|Estrogens|estrogens|mesh-ancestor
111276490|NCT04194905|Hormones|hormones|mesh-ancestor
111276491|NCT04194905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111276492|NCT04194905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111276493|NCT04194905|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111276494|NCT04194905|Contraceptive Agents|contraceptive agents|mesh-ancestor
111276495|NCT04194905|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111276496|NCT04194905|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111276497|NCT04194905|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110728624|NCT00401531|Vaccines|vaccines|mesh-list
111276498|NCT04194905|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111276499|NCT04194905|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111276500|NCT05017428|Niacinamide|niacinamide|mesh-list
111276501|NCT05017428|Niacin|niacin|mesh-list
111276502|NCT05017428|Nicotinic Acids|nicotinic acids|mesh-list
111276503|NCT05017428|Vitamin B Complex|vitamin b complex|mesh-ancestor
111276504|NCT05017428|Vitamins|vitamins|mesh-ancestor
111276505|NCT05017428|Micronutrients|micronutrients|mesh-ancestor
111276506|NCT05017428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111276507|NCT05017428|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111276508|NCT05017428|Antimetabolites|antimetabolites|mesh-ancestor
111276509|NCT05017428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111276510|NCT05017428|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111276511|NCT05017428|Vasodilator Agents|vasodilator agents|mesh-ancestor
111276512|NCT04196231|Insulin|insulin|mesh-list
111276513|NCT04196231|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111276514|NCT04196231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111276515|NCT04196231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111276516|NCT00013611|Aldesleukin|aldesleukin|mesh-list
111276517|NCT00013611|Interleukin-2|interleukin-2|mesh-list
111276518|NCT00013611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111276519|NCT00013611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111276520|NCT00013611|Analgesics|analgesics|mesh-ancestor
111276521|NCT00013611|Sensory System Agents|sensory system agents|mesh-ancestor
111276522|NCT00013611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111276523|NCT00013611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111276524|NCT00013611|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111276525|NCT00013611|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111276526|NCT00013611|Antiviral Agents|antiviral agents|mesh-ancestor
111276527|NCT00013611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111276528|NCT04194515|Metformin|metformin|mesh-list
111276529|NCT04194515|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111276530|NCT04194515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111276531|NCT03094182|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
111276532|NCT03094182|Hematinics|hematinics|mesh-ancestor
111276533|NCT05017116|Entecavir|entecavir|mesh-list
111276534|NCT05017116|Antiviral Agents|antiviral agents|mesh-ancestor
111276535|NCT05017116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111276536|NCT05022030|Cetuximab|cetuximab|mesh-list
111276537|NCT05022030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111276538|NCT05022030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111276539|NCT04192643|Tranexamic Acid|tranexamic acid|mesh-list
111276540|NCT04192643|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111276541|NCT04192643|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111276542|NCT04192643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111276543|NCT04192643|Hemostatics|hemostatics|mesh-ancestor
111276544|NCT04192643|Coagulants|coagulants|mesh-ancestor
111276545|NCT03753659|Pembrolizumab|pembrolizumab|mesh-list
111276546|NCT03753659|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111276547|NCT03753659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111276548|NCT03753659|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111276549|NCT03753659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111276550|NCT00010257|Paclitaxel|paclitaxel|mesh-list
111276551|NCT00010257|Carboplatin|carboplatin|mesh-list
111276552|NCT00010257|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111276553|NCT00010257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111276554|NCT00010257|Tubulin Modulators|tubulin modulators|mesh-ancestor
111276555|NCT00010257|Antimitotic Agents|antimitotic agents|mesh-ancestor
111276556|NCT00010257|Mitosis Modulators|mitosis modulators|mesh-ancestor
111276557|NCT00010257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111276558|NCT05022186|Cannabidiol|cannabidiol|mesh-list
111276559|NCT05022186|Tramiprosate|tramiprosate|mesh-list
110959304|NCT04446104|Ivermectin|ivermectin|mesh-list
111276560|NCT05022186|Anticonvulsants|anticonvulsants|mesh-ancestor
111276561|NCT05022186|GABA Agonists|gaba agonists|mesh-ancestor
111276563|NCT05022186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111276564|NCT05022186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111276565|NCT05022186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111276566|NCT02240043|Hormones|hormones|mesh-list
111276567|NCT02240043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111276568|NCT02240043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111276569|NCT03404037|Endostatins|endostatins|mesh-list
111276570|NCT03404037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111276571|NCT03404037|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111276572|NCT03404037|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111276573|NCT03404037|Growth Substances|growth substances|mesh-ancestor
111276574|NCT03404037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111276575|NCT03404037|Growth Inhibitors|growth inhibitors|mesh-ancestor
111276576|NCT02240199|Lidocaine|lidocaine|mesh-list
111276577|NCT02240199|Pregabalin|pregabalin|mesh-list
111276578|NCT02240199|Anesthetics, Local|anesthetics, local|mesh-ancestor
111276579|NCT02240199|Anesthetics|anesthetics|mesh-ancestor
111276580|NCT02240199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111276581|NCT02240199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111276582|NCT02240199|Sensory System Agents|sensory system agents|mesh-ancestor
111276583|NCT02240199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111276584|NCT02240199|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111276585|NCT02240199|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111276586|NCT02240199|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111276587|NCT02240199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111276588|NCT02240199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111276589|NCT02240199|Analgesics|analgesics|mesh-ancestor
111276590|NCT02240199|Anticonvulsants|anticonvulsants|mesh-ancestor
111276591|NCT02240199|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111276592|NCT02240199|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111276593|NCT02240199|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111276594|NCT02240199|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111276595|NCT02240199|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111276596|NCT04190927|Estradiol|estradiol|mesh-list
111276597|NCT04190927|Progesterone|progesterone|mesh-list
111276598|NCT04190927|Estrogens|estrogens|mesh-ancestor
111276599|NCT04190927|Hormones|hormones|mesh-ancestor
111276600|NCT04190927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111276601|NCT04190927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111276602|NCT04190927|Progestins|progestins|mesh-ancestor
111276603|NCT00919191|Adapalene|adapalene|mesh-list
111276604|NCT00919191|Tretinoin|tretinoin|mesh-list
111276605|NCT00919191|Benzoyl Peroxide|benzoyl peroxide|mesh-list
111276606|NCT00919191|Dermatologic Agents|dermatologic agents|mesh-ancestor
111276607|NCT00919191|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111276608|NCT00919191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111276609|NCT00919191|Analgesics|analgesics|mesh-ancestor
111276610|NCT00919191|Sensory System Agents|sensory system agents|mesh-ancestor
111276611|NCT00919191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111276612|NCT00919191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111276613|NCT00919191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111276614|NCT00919191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111276615|NCT00919191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111276616|NCT00919191|Keratolytic Agents|keratolytic agents|mesh-ancestor
111276617|NCT05021406|Carvedilol|carvedilol|mesh-list
111276618|NCT05021406|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111276619|NCT05021406|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111276620|NCT05021406|Adrenergic Agents|adrenergic agents|mesh-ancestor
111276621|NCT05021406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111276622|NCT05021406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111276623|NCT05021406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111276624|NCT05021406|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111276625|NCT05021406|Antioxidants|antioxidants|mesh-ancestor
111276626|NCT05021406|Protective Agents|protective agents|mesh-ancestor
111276627|NCT05021406|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111276628|NCT05021406|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111276629|NCT05021406|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111276630|NCT05021406|Vasodilator Agents|vasodilator agents|mesh-ancestor
111276631|NCT05021406|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111276632|NCT05021406|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111276633|NCT04766177|Bumetanide|bumetanide|mesh-list
111276634|NCT04766177|Diuretics|diuretics|mesh-ancestor
111276635|NCT04766177|Natriuretic Agents|natriuretic agents|mesh-ancestor
111276636|NCT04766177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111276637|NCT04766177|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
111276638|NCT04766177|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111276639|NCT04766177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111276641|NCT04466280|Antimalarials|antimalarials|mesh-ancestor
111276642|NCT04466280|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111276643|NCT04466280|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111276644|NCT04466280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111276645|NCT04466280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111276646|NCT04466280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111276647|NCT04466280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111276648|NCT05016180|Ropivacaine|ropivacaine|mesh-list
111276649|NCT05016180|Anesthetics, Local|anesthetics, local|mesh-ancestor
111276650|NCT05016180|Anesthetics|anesthetics|mesh-ancestor
111276651|NCT05016180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111276652|NCT05016180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111276653|NCT05016180|Sensory System Agents|sensory system agents|mesh-ancestor
111276654|NCT05016180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111276655|NCT03023501|Gabapentin|gabapentin|mesh-list
111276656|NCT03023501|Analgesics|analgesics|mesh-ancestor
111276657|NCT03023501|Sensory System Agents|sensory system agents|mesh-ancestor
111276658|NCT03023501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111276659|NCT03023501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111276660|NCT03023501|Anticonvulsants|anticonvulsants|mesh-ancestor
111276661|NCT03023501|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111276662|NCT03023501|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111276663|NCT03023501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111276664|NCT03023501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111276665|NCT03023501|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111276666|NCT03023501|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111276667|NCT03023501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111276668|NCT03023501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111276669|NCT03023501|Antimanic Agents|antimanic agents|mesh-ancestor
111276670|NCT05015322|Methylprednisolone|methylprednisolone|mesh-list
111276671|NCT05015322|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111276672|NCT05015322|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111276673|NCT05015322|Prednisolone|prednisolone|mesh-list
111276674|NCT05015322|Prednisolone acetate|prednisolone acetate|mesh-list
111276675|NCT05015322|Bupivacaine|bupivacaine|mesh-list
111276676|NCT05015322|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111276677|NCT05015322|Prednisolone phosphate|prednisolone phosphate|mesh-list
111276678|NCT05015322|Anesthetics, Local|anesthetics, local|mesh-ancestor
111276679|NCT05015322|Anesthetics|anesthetics|mesh-ancestor
111276680|NCT05015322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111276681|NCT05015322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111276682|NCT05015322|Sensory System Agents|sensory system agents|mesh-ancestor
111276683|NCT05015322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111276684|NCT05015322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111276685|NCT05015322|Antiemetics|antiemetics|mesh-ancestor
111276686|NCT05015322|Autonomic Agents|autonomic agents|mesh-ancestor
111276687|NCT05015322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111276688|NCT05015322|Glucocorticoids|glucocorticoids|mesh-ancestor
111276689|NCT05015322|Hormones|hormones|mesh-ancestor
111276690|NCT05015322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111276691|NCT05015322|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111276692|NCT05015322|Protective Agents|protective agents|mesh-ancestor
111276693|NCT05015322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111276694|NCT05015322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111276695|NCT05021250|Ethiodized Oil|ethiodized oil|mesh-list
111276696|NCT05021250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111276697|NCT00919503|Cyclosporine|cyclosporine|mesh-list
111276698|NCT00919503|Mycophenolic Acid|mycophenolic acid|mesh-list
111276699|NCT00919503|Methotrexate|methotrexate|mesh-list
111276700|NCT00919503|Fludarabine phosphate|fludarabine phosphate|mesh-list
111276701|NCT00919503|Fludarabine|fludarabine|mesh-list
111276702|NCT00919503|Treosulfan|treosulfan|mesh-list
111276703|NCT00919503|Busulfan|busulfan|mesh-list
111276704|NCT00919503|Tacrolimus|tacrolimus|mesh-list
111276705|NCT00919503|Cyclosporins|cyclosporins|mesh-list
111276706|NCT00919503|Thymoglobulin|thymoglobulin|mesh-list
111276707|NCT00919503|Antilymphocyte Serum|antilymphocyte serum|mesh-list
111276708|NCT00919503|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111276709|NCT00919503|Abortifacient Agents|abortifacient agents|mesh-ancestor
111276710|NCT00919503|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111276711|NCT00919503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111276712|NCT00919503|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111276714|NCT00919503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111276715|NCT00919503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111276716|NCT00919503|Dermatologic Agents|dermatologic agents|mesh-ancestor
111276717|NCT00919503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111276718|NCT00919503|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111276719|NCT00919503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111276720|NCT00919503|Immunologic Factors|immunologic factors|mesh-ancestor
111276721|NCT00919503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111276722|NCT00919503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111276723|NCT00919503|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111276724|NCT00919503|Antifungal Agents|antifungal agents|mesh-ancestor
111276725|NCT00919503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111276726|NCT00919503|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111276727|NCT00919503|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111276728|NCT00919503|Antitubercular Agents|antitubercular agents|mesh-ancestor
111276729|NCT00919503|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111276730|NCT00919503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111276731|NCT00919503|Alkylating Agents|alkylating agents|mesh-ancestor
111276732|NCT00919503|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111276733|NCT05020704|Empagliflozin|empagliflozin|mesh-list
111276734|NCT05020704|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111276735|NCT05020704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111276736|NCT05020704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111276737|NCT05020704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111276738|NCT02979665|Ranibizumab|ranibizumab|mesh-list
111276739|NCT02979665|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111276740|NCT02979665|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111276741|NCT02979665|Growth Substances|growth substances|mesh-ancestor
111276742|NCT02979665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111276743|NCT02979665|Growth Inhibitors|growth inhibitors|mesh-ancestor
111276744|NCT02979665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111276745|NCT03092076|Ticagrelor|ticagrelor|mesh-list
111276746|NCT03092076|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111276747|NCT03092076|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111276748|NCT03092076|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111276749|NCT03092076|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111276750|NCT03092076|Purinergic Agents|purinergic agents|mesh-ancestor
111276751|NCT03092076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111276752|NCT03092076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111276753|NCT03092076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111276754|NCT04193501|Melatonin|melatonin|mesh-list
111276755|NCT04193501|Antioxidants|antioxidants|mesh-ancestor
111276756|NCT04193501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111276757|NCT04193501|Protective Agents|protective agents|mesh-ancestor
111276758|NCT04193501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111276759|NCT04193501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111276760|NCT04374279|Bicalutamide|bicalutamide|mesh-list
111276761|NCT04374279|Androgen Antagonists|androgen antagonists|mesh-ancestor
111276762|NCT04374279|Hormone Antagonists|hormone antagonists|mesh-ancestor
111276763|NCT04374279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111276764|NCT04374279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111276765|NCT04374279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111276766|NCT02240433|Sorafenib|sorafenib|mesh-list
111276767|NCT02240433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111276768|NCT02240433|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111276769|NCT02240433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111276770|NCT02240433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111276771|NCT03403647|Vitamin D|vitamin d|mesh-list
111276772|NCT03403647|Vitamins|vitamins|mesh-ancestor
111276773|NCT03403647|Micronutrients|micronutrients|mesh-ancestor
111276774|NCT03403647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111276775|NCT03403647|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111276776|NCT05014464|Crizotinib|crizotinib|mesh-list
111276777|NCT05014464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111276778|NCT05014464|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111276779|NCT05014464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111276780|NCT05014464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111276781|NCT03403101|Oxaliplatin|oxaliplatin|mesh-list
111276782|NCT03403101|Irinotecan|irinotecan|mesh-list
111276783|NCT03403101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111001126|NCT03143036|Hormones|hormones|mesh-ancestor
111276784|NCT03403101|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111276785|NCT03403101|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111276786|NCT03403101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111276787|NCT03403101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111276788|NCT00211757|Valproic Acid|valproic acid|mesh-list
111276789|NCT00211757|Anticonvulsants|anticonvulsants|mesh-ancestor
111276790|NCT00211757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111276791|NCT00211757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111276792|NCT00211757|GABA Agents|gaba agents|mesh-ancestor
111276793|NCT00211757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111276794|NCT00211757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111276795|NCT00211757|Antimanic Agents|antimanic agents|mesh-ancestor
111276796|NCT00211757|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111276797|NCT00211757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111276798|NCT00211757|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111276800|NCT04373967|Liraglutide|liraglutide|mesh-list
111276801|NCT04373967|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111276802|NCT04373967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111276803|NCT04373967|Incretins|incretins|mesh-ancestor
111276804|NCT04373967|Hormones|hormones|mesh-ancestor
111276805|NCT04373967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111276806|NCT04026191|Hyaluronic Acid|hyaluronic acid|mesh-list
111276807|NCT04026191|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111276808|NCT04026191|Immunologic Factors|immunologic factors|mesh-ancestor
111276809|NCT04026191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111276810|NCT04026191|Viscosupplements|viscosupplements|mesh-ancestor
111276811|NCT04026191|Protective Agents|protective agents|mesh-ancestor
111276812|NCT04022057|Ropivacaine|ropivacaine|mesh-list
111276813|NCT04022057|Anesthetics, Local|anesthetics, local|mesh-ancestor
111276814|NCT04022057|Anesthetics|anesthetics|mesh-ancestor
111276815|NCT04022057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111276816|NCT04022057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111276817|NCT04022057|Sensory System Agents|sensory system agents|mesh-ancestor
111276818|NCT04022057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111276819|NCT00921843|Methadone|methadone|mesh-list
111276820|NCT00921843|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111276821|NCT00921843|Narcotics|narcotics|mesh-ancestor
111276822|NCT00921843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111276823|NCT00921843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111276824|NCT00921843|Analgesics|analgesics|mesh-ancestor
111276825|NCT00921843|Sensory System Agents|sensory system agents|mesh-ancestor
111276826|NCT00921843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111276827|NCT00921843|Antitussive Agents|antitussive agents|mesh-ancestor
111276828|NCT00921843|Respiratory System Agents|respiratory system agents|mesh-ancestor
111276829|NCT04020653|Ferrous citrate|ferrous citrate|mesh-list
111276830|NCT04020653|Lumefantrine|lumefantrine|mesh-list
111276831|NCT04020653|Artemether|artemether|mesh-list
111276832|NCT04020653|Artemisinins|artemisinins|mesh-list
111276833|NCT04020653|Artemisinin|artemisinin|mesh-list
111276834|NCT04020653|Aminolevulinic Acid|aminolevulinic acid|mesh-list
111276835|NCT04020653|Citric Acid|citric acid|mesh-list
111276836|NCT04020653|Sodium Citrate|sodium citrate|mesh-list
111276837|NCT04020653|Anticoagulants|anticoagulants|mesh-ancestor
111276838|NCT04020653|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
111276839|NCT04020653|Chelating Agents|chelating agents|mesh-ancestor
111276840|NCT04020653|Sequestering Agents|sequestering agents|mesh-ancestor
111276841|NCT04020653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111276842|NCT04020653|Antimalarials|antimalarials|mesh-ancestor
111276843|NCT04020653|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111276844|NCT04020653|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111276845|NCT04020653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111276846|NCT04020653|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111276847|NCT04020653|Dermatologic Agents|dermatologic agents|mesh-ancestor
111276848|NCT04020653|Trace Elements|trace elements|mesh-ancestor
111276849|NCT04020653|Micronutrients|micronutrients|mesh-ancestor
111276850|NCT04020653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111276851|NCT05008458|Arginine Vasopressin|arginine vasopressin|mesh-list
111276852|NCT05008458|Hemostatics|hemostatics|mesh-ancestor
111276853|NCT05008458|Coagulants|coagulants|mesh-ancestor
111276854|NCT05008458|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111276855|NCT05008458|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
111276856|NCT05008458|Natriuretic Agents|natriuretic agents|mesh-ancestor
111276857|NCT05008458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111276858|NCT02080637|Ambrisentan|ambrisentan|mesh-list
111276859|NCT02080637|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111276860|NCT05019690|Paclitaxel|paclitaxel|mesh-list
111276861|NCT05019690|Apatinib|apatinib|mesh-list
111276862|NCT05019690|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111276863|NCT05019690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111276864|NCT05019690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111276865|NCT05019690|Tubulin Modulators|tubulin modulators|mesh-ancestor
111276866|NCT05019690|Antimitotic Agents|antimitotic agents|mesh-ancestor
111276867|NCT05019690|Mitosis Modulators|mitosis modulators|mesh-ancestor
111276868|NCT05019690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111276869|NCT05019690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111276870|NCT05019690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111276871|NCT04029467|Dexmedetomidine|dexmedetomidine|mesh-list
111276872|NCT04029467|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111276873|NCT04029467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111276874|NCT04029467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111276875|NCT04029467|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111276876|NCT04029467|Analgesics|analgesics|mesh-ancestor
111276877|NCT04029467|Sensory System Agents|sensory system agents|mesh-ancestor
111276878|NCT04029467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111276879|NCT04029467|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111276880|NCT04029467|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111276881|NCT04029467|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111276882|NCT04029467|Adrenergic Agents|adrenergic agents|mesh-ancestor
111276883|NCT04029467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111276884|NCT04029467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111276885|NCT03402321|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
111276886|NCT03402321|Hemostatics|hemostatics|mesh-ancestor
111276887|NCT03402321|Coagulants|coagulants|mesh-ancestor
111276888|NCT03402165|Sofosbuvir|sofosbuvir|mesh-list
111276889|NCT03402165|Ledipasvir|ledipasvir|mesh-list
111276890|NCT03402165|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
111276891|NCT03402165|Antiviral Agents|antiviral agents|mesh-ancestor
111276892|NCT03402165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111276893|NCT03402087|Leucovorin|leucovorin|mesh-list
111276894|NCT03402087|Methotrexate|methotrexate|mesh-list
111276895|NCT03402087|Deucravacitinib|deucravacitinib|mesh-list
111276896|NCT03402087|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111276897|NCT03402087|Abortifacient Agents|abortifacient agents|mesh-ancestor
111276898|NCT03402087|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111276899|NCT03402087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111276900|NCT03402087|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111276901|NCT03402087|Antimetabolites|antimetabolites|mesh-ancestor
111276902|NCT03402087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111276903|NCT03402087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111276904|NCT03402087|Dermatologic Agents|dermatologic agents|mesh-ancestor
111276905|NCT03402087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111276906|NCT03402087|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111276907|NCT03402087|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111276908|NCT03402087|Immunologic Factors|immunologic factors|mesh-ancestor
111276909|NCT03402087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111276910|NCT03402087|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111276911|NCT03402087|Antidotes|antidotes|mesh-ancestor
111276912|NCT03402087|Protective Agents|protective agents|mesh-ancestor
111276913|NCT03402087|Vitamin B Complex|vitamin b complex|mesh-ancestor
111276914|NCT03402087|Vitamins|vitamins|mesh-ancestor
111276915|NCT03402087|Micronutrients|micronutrients|mesh-ancestor
111276916|NCT03402087|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111276917|NCT04020263|Simendan|simendan|mesh-list
111276918|NCT04020263|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111276919|NCT04020263|Vasodilator Agents|vasodilator agents|mesh-ancestor
111276920|NCT04020263|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
111276921|NCT04020263|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111276922|NCT04020263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111276923|NCT04020263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111276924|NCT04020263|Protective Agents|protective agents|mesh-ancestor
111276925|NCT04020263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111276926|NCT05013060|Butyric Acid|butyric acid|mesh-list
111276927|NCT05013060|Histamine Antagonists|histamine antagonists|mesh-ancestor
111276928|NCT05013060|Histamine Agents|histamine agents|mesh-ancestor
111276929|NCT05013060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111276930|NCT05013060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111276931|NCT05013060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111276932|NCT05008068|Simvastatin|simvastatin|mesh-list
111276933|NCT05008068|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111276934|NCT05008068|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111276935|NCT05008068|Antimetabolites|antimetabolites|mesh-ancestor
111276936|NCT05008068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111276937|NCT05008068|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111276938|NCT05008068|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111276939|NCT05008068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111276940|NCT00925119|Atenolol|atenolol|mesh-list
111276941|NCT00925119|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111276942|NCT00925119|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111276943|NCT00925119|Sympatholytics|sympatholytics|mesh-ancestor
111276944|NCT00925119|Autonomic Agents|autonomic agents|mesh-ancestor
111276945|NCT00925119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111276946|NCT00925119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111276947|NCT00925119|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
111276948|NCT00925119|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111276949|NCT00925119|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111276950|NCT00925119|Adrenergic Agents|adrenergic agents|mesh-ancestor
111276951|NCT00925119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111276952|NCT00925119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111276953|NCT04020809|Atezolizumab|atezolizumab|mesh-list
111276954|NCT04020809|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111276955|NCT04020809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111276956|NCT04020809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111276957|NCT04020809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111276958|NCT04027751|Tropisetron|tropisetron|mesh-list
111276959|NCT04027751|Antiemetics|antiemetics|mesh-ancestor
111276960|NCT04027751|Autonomic Agents|autonomic agents|mesh-ancestor
111276961|NCT04027751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111276962|NCT04027751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111276963|NCT04027751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111276964|NCT04027751|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111276965|NCT04027751|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111276966|NCT04027751|Serotonin Agents|serotonin agents|mesh-ancestor
111276967|NCT04027751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111276968|NCT04027751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111276969|NCT05018988|Vitamin D|vitamin d|mesh-list
111276970|NCT05018988|Ergocalciferols|ergocalciferols|mesh-list
111276971|NCT05018988|Cholecalciferol|cholecalciferol|mesh-list
111276972|NCT05018988|Vitamins|vitamins|mesh-list
111276973|NCT05018988|Micronutrients|micronutrients|mesh-ancestor
111276974|NCT05018988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111276975|NCT05018988|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111276976|NCT05018988|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111276977|NCT02241759|Moxifloxacin|moxifloxacin|mesh-list
111276978|NCT02241759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111276979|NCT02241759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111276980|NCT02241759|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111276981|NCT02241759|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111276982|NCT02241759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111276983|NCT02241759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111276984|NCT02241759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111276985|NCT04434144|Azithromycin|azithromycin|mesh-list
111276986|NCT04434144|Doxycycline|doxycycline|mesh-list
111276987|NCT04434144|Hydroxychloroquine|hydroxychloroquine|mesh-list
111276988|NCT04434144|Ivermectin|ivermectin|mesh-list
111276989|NCT04434144|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111276990|NCT04434144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111276991|NCT04434144|Antimalarials|antimalarials|mesh-ancestor
111276992|NCT04434144|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111276993|NCT04434144|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111276994|NCT04434144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111276995|NCT04434144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111276996|NCT04434144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111276997|NCT04957914|Insulin Glargine|insulin glargine|mesh-list
111276998|NCT04957914|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111276999|NCT04957914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111277000|NCT04027283|Erythritol|erythritol|mesh-list
111277001|NCT04027283|Vasodilator Agents|vasodilator agents|mesh-ancestor
111277002|NCT04028141|Ketamine|ketamine|mesh-list
111277003|NCT04028141|Propofol|propofol|mesh-list
111277004|NCT04028141|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111277005|NCT04028141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111277006|NCT04028141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111277007|NCT04028141|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111277008|NCT04028141|Anesthetics, General|anesthetics, general|mesh-ancestor
111277009|NCT04028141|Anesthetics|anesthetics|mesh-ancestor
111277010|NCT04028141|Analgesics|analgesics|mesh-ancestor
111277011|NCT04028141|Sensory System Agents|sensory system agents|mesh-ancestor
111277012|NCT04028141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111277013|NCT04028141|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111277014|NCT04028141|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111277015|NCT04028141|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111277016|NCT04028141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111277017|NCT04028141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111277018|NCT03401541|Vitamin D|vitamin d|mesh-list
111277019|NCT03401541|Calcifediol|calcifediol|mesh-list
111277020|NCT03401541|Ergocalciferols|ergocalciferols|mesh-list
111277021|NCT03401541|Vitamins|vitamins|mesh-ancestor
111277022|NCT03401541|Micronutrients|micronutrients|mesh-ancestor
111277023|NCT03401541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111277024|NCT03401541|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111277025|NCT03401541|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111277026|NCT03953261|Curcumin|curcumin|mesh-list
111277027|NCT03953261|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111277028|NCT03953261|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111277029|NCT03953261|Analgesics|analgesics|mesh-ancestor
111277030|NCT03953261|Sensory System Agents|sensory system agents|mesh-ancestor
111277031|NCT03953261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111277032|NCT03953261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111277033|NCT03953261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111277034|NCT03953261|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111277035|NCT03953261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111277036|NCT03953261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111277037|NCT03953261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111277038|NCT02242149|Diacerein|diacerein|mesh-list
111277039|NCT02242149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111277040|NCT03022565|Vorinostat|vorinostat|mesh-list
111277041|NCT03022565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111277042|NCT03022565|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111277043|NCT03022565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111277044|NCT03022565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111277045|NCT03079050|Dexlansoprazole|dexlansoprazole|mesh-list
111277046|NCT03079050|Lansoprazole|lansoprazole|mesh-list
111277047|NCT03079050|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111277048|NCT03079050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111277049|NCT03079050|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111277050|NCT03079050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111277051|NCT03079050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111277052|NCT03834129|Dexmedetomidine|dexmedetomidine|mesh-list
111277053|NCT03834129|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111277054|NCT03834129|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111277055|NCT03834129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111277056|NCT03834129|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111277057|NCT03834129|Analgesics|analgesics|mesh-ancestor
111277058|NCT03834129|Sensory System Agents|sensory system agents|mesh-ancestor
111277059|NCT03834129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111277060|NCT03834129|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111277061|NCT03834129|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111277062|NCT03834129|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111277063|NCT03834129|Adrenergic Agents|adrenergic agents|mesh-ancestor
111277064|NCT03834129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111277065|NCT03834129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111277066|NCT05001204|68Ga-NOTA-RM26|68ga-nota-rm26|mesh-list
111277067|NCT05001204|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111277068|NCT05001204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111277069|NCT03022409|Olaparib|olaparib|mesh-list
111277070|NCT03022409|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111277071|NCT03022409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111277072|NCT03022409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111277073|NCT03022409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111277074|NCT03833895|Phenylephrine|phenylephrine|mesh-list
111277075|NCT03833895|Oxymetazoline|oxymetazoline|mesh-list
111277076|NCT03833895|Norepinephrine|norepinephrine|mesh-list
111277077|NCT03833895|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111277078|NCT03833895|Mydriatics|mydriatics|mesh-ancestor
111277079|NCT03833895|Autonomic Agents|autonomic agents|mesh-ancestor
111277080|NCT03833895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111277081|NCT03833895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111277082|NCT03833895|Sympathomimetics|sympathomimetics|mesh-ancestor
111277083|NCT03833895|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111277084|NCT03833895|Nasal Decongestants|nasal decongestants|mesh-ancestor
111277085|NCT03833895|Respiratory System Agents|respiratory system agents|mesh-ancestor
111277086|NCT03833895|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111277087|NCT03833895|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111277088|NCT03833895|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111277089|NCT03833895|Adrenergic Agents|adrenergic agents|mesh-ancestor
111277090|NCT03833895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111277091|NCT03833895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111277092|NCT03833895|Protective Agents|protective agents|mesh-ancestor
111479183|NCT05509699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111479184|NCT05509699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111479185|NCT05509699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111479186|NCT05441215|Ritonavir|ritonavir|mesh-list
111479187|NCT05441215|Nirmatrelvir|nirmatrelvir|mesh-list
111479188|NCT05441215|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111479189|NCT05441215|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111479190|NCT05441215|Protease Inhibitors|protease inhibitors|mesh-ancestor
111479191|NCT05441215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111479192|NCT05441215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111479193|NCT05441215|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111479194|NCT05441215|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111479195|NCT05441215|Antiviral Agents|antiviral agents|mesh-ancestor
111479196|NCT05441215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111479197|NCT05441215|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111479198|NCT05441215|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111479199|NCT05431777|Avelumab|avelumab|mesh-list
111479200|NCT05431777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111479201|NCT05431777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111479202|NCT05327647|Bicalutamide|bicalutamide|mesh-list
111479203|NCT05327647|Androgen Antagonists|androgen antagonists|mesh-list
111479204|NCT05327647|Nonsteroidal Anti-Androgens|nonsteroidal anti-androgens|mesh-list
111479205|NCT05327647|Hormone Antagonists|hormone antagonists|mesh-ancestor
111479206|NCT05327647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111479207|NCT05327647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111479208|NCT05327647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111479209|NCT05259527|Vitamin D|vitamin d|mesh-list
111479210|NCT05259527|Ergocalciferols|ergocalciferols|mesh-list
111479211|NCT05259527|Cholecalciferol|cholecalciferol|mesh-list
111479212|NCT05259527|Vitamins|vitamins|mesh-list
111479213|NCT05259527|Micronutrients|micronutrients|mesh-ancestor
111479214|NCT05259527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111479215|NCT05259527|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111479216|NCT05259527|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111479217|NCT05256641|Acalabrutinib|acalabrutinib|mesh-list
111479218|NCT05256641|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
111479219|NCT05256641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111479220|NCT05256641|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111479221|NCT05256641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111479222|NCT05256641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111479223|NCT05187377|Hormones|hormones|mesh-list
111479224|NCT05187377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111479225|NCT05187377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111479226|NCT05177588|Metformin|metformin|mesh-list
111479227|NCT05177588|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110978812|NCT02455856|Itraconazole|itraconazole|mesh-list
111479228|NCT05177588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111479229|NCT05171660|Bevacizumab|bevacizumab|mesh-list
111479230|NCT05171660|Capecitabine|capecitabine|mesh-list
111479231|NCT05171660|Oxaliplatin|oxaliplatin|mesh-list
111479232|NCT05171660|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111479233|NCT05171660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111479234|NCT05171660|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111479235|NCT05171660|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111479236|NCT05171660|Growth Substances|growth substances|mesh-ancestor
111479237|NCT05171660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111479238|NCT05171660|Growth Inhibitors|growth inhibitors|mesh-ancestor
111479239|NCT05171660|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111479240|NCT05171660|Antimetabolites|antimetabolites|mesh-ancestor
111479241|NCT05171660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111479242|NCT05133258|Ciprofloxacin|ciprofloxacin|mesh-list
111479243|NCT05133258|Dexamethasone|dexamethasone|mesh-list
111479244|NCT05133258|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111479245|NCT05133258|Antiemetics|antiemetics|mesh-ancestor
111479246|NCT05133258|Autonomic Agents|autonomic agents|mesh-ancestor
111479247|NCT05133258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111479248|NCT05133258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111479249|NCT05133258|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111479250|NCT05133258|Glucocorticoids|glucocorticoids|mesh-ancestor
111479251|NCT05133258|Hormones|hormones|mesh-ancestor
111001504|NCT05392166|Calcium|calcium|mesh-list
111277093|NCT02242227|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
111277094|NCT02242227|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111277095|NCT02242227|Autonomic Agents|autonomic agents|mesh-ancestor
111277096|NCT02242227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111277097|NCT02242227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111277098|NCT02242227|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111277099|NCT02242227|Respiratory System Agents|respiratory system agents|mesh-ancestor
111277100|NCT02242227|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111277101|NCT02242227|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111277102|NCT02242227|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111277103|NCT02242227|Adrenergic Agents|adrenergic agents|mesh-ancestor
111277104|NCT02242227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111277105|NCT02242227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111277106|NCT05000892|Paclitaxel|paclitaxel|mesh-list
111277107|NCT05000892|Carboplatin|carboplatin|mesh-list
111277108|NCT05000892|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111277109|NCT05000892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111277110|NCT05000892|Tubulin Modulators|tubulin modulators|mesh-ancestor
111277111|NCT05000892|Antimitotic Agents|antimitotic agents|mesh-ancestor
111277112|NCT05000892|Mitosis Modulators|mitosis modulators|mesh-ancestor
111277113|NCT05000892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111277114|NCT04372407|Itraconazole|itraconazole|mesh-list
111277115|NCT04372407|Antifungal Agents|antifungal agents|mesh-ancestor
111277116|NCT04372407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111277117|NCT04372407|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111277118|NCT04372407|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111277119|NCT04372407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111277120|NCT04372407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111277121|NCT04372407|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111277122|NCT04372407|Hormone Antagonists|hormone antagonists|mesh-ancestor
111277123|NCT04372407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111277124|NCT04372407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111277125|NCT04372407|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111277126|NCT02242383|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
111277127|NCT02242383|Telmisartan|telmisartan|mesh-list
111277128|NCT02242383|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111277129|NCT02242383|Diuretics|diuretics|mesh-ancestor
111277130|NCT02242383|Natriuretic Agents|natriuretic agents|mesh-ancestor
111277131|NCT02242383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111277132|NCT02242383|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
111277133|NCT02242383|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111277134|NCT02242383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111277135|NCT02242383|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111277136|NCT02242383|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111277137|NCT04366089|Azithromycin|azithromycin|mesh-list
111277138|NCT04366089|Hydroxychloroquine|hydroxychloroquine|mesh-list
111277139|NCT04366089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111277140|NCT04366089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111277141|NCT04366089|Antimalarials|antimalarials|mesh-ancestor
111277142|NCT04366089|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111277143|NCT04366089|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111277144|NCT04366089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111277145|NCT04366089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111277146|NCT04366089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111277147|NCT03079830|Pirinitramide|pirinitramide|mesh-list
111277148|NCT03079830|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111277149|NCT03079830|Narcotics|narcotics|mesh-ancestor
111277150|NCT03079830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111277151|NCT03079830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111277152|NCT03079830|Analgesics|analgesics|mesh-ancestor
111277153|NCT03079830|Sensory System Agents|sensory system agents|mesh-ancestor
111277154|NCT03079830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111277155|NCT02242695|Clotrimazole|clotrimazole|mesh-list
111277156|NCT02242695|Dequalinium|dequalinium|mesh-list
111277157|NCT02242695|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111277158|NCT02242695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111277159|NCT02242695|Antifungal Agents|antifungal agents|mesh-ancestor
111277160|NCT02242695|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111277161|NCT02242695|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111277162|NCT02242695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111277163|NCT02242695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111277164|NCT02242695|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111277165|NCT02242695|Hormone Antagonists|hormone antagonists|mesh-ancestor
111277166|NCT02242695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111277168|NCT04999800|Pembrolizumab|pembrolizumab|mesh-list
111277169|NCT04999800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111277170|NCT04999800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111277171|NCT04999800|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111277172|NCT04999800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111277173|NCT02242851|Telmisartan|telmisartan|mesh-list
111277174|NCT02242851|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111277175|NCT02242851|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111277176|NCT02242851|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111277177|NCT02242851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111277178|NCT04999878|Dexamethasone|dexamethasone|mesh-list
111277179|NCT04999878|Gemcitabine|gemcitabine|mesh-list
111277180|NCT04999878|Etoposide|etoposide|mesh-list
111277181|NCT04999878|Cisplatin|cisplatin|mesh-list
111277182|NCT04999878|Pegaspargase|pegaspargase|mesh-list
111277183|NCT04999878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111277184|NCT04999878|Antiemetics|antiemetics|mesh-ancestor
111277185|NCT04999878|Autonomic Agents|autonomic agents|mesh-ancestor
111277186|NCT04999878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111277187|NCT04999878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111277188|NCT04999878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111277189|NCT04999878|Glucocorticoids|glucocorticoids|mesh-ancestor
111277190|NCT04999878|Hormones|hormones|mesh-ancestor
111277191|NCT04999878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111277192|NCT04999878|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111277193|NCT04999878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111277194|NCT04999878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111277195|NCT04999878|Antimetabolites|antimetabolites|mesh-ancestor
111277196|NCT04999878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111277197|NCT04999878|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111277198|NCT04999878|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111277199|NCT04999878|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111277200|NCT04999878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111277201|NCT02242929|Imiquimod|imiquimod|mesh-list
111277202|NCT02242929|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111277203|NCT02242929|Immunologic Factors|immunologic factors|mesh-ancestor
111277204|NCT02242929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111277205|NCT02242929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111277206|NCT02242929|Interferon Inducers|interferon inducers|mesh-ancestor
111277207|NCT04457856|Plonmarlimab|plonmarlimab|mesh-list
111277208|NCT04457856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111277209|NCT04457856|Antiviral Agents|antiviral agents|mesh-ancestor
111277210|NCT04457856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111277211|NCT05006898|Brimonidine Tartrate|brimonidine tartrate|mesh-list
111277212|NCT05006898|Oxymetazoline|oxymetazoline|mesh-list
111277213|NCT05006898|Pilocarpine|pilocarpine|mesh-list
111277214|NCT05006898|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111277215|NCT05006898|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111277216|NCT05006898|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111277217|NCT05006898|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111277218|NCT05006898|Adrenergic Agents|adrenergic agents|mesh-ancestor
111277219|NCT05006898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111277220|NCT05006898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111277221|NCT05006898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111277222|NCT05006898|Sympathomimetics|sympathomimetics|mesh-ancestor
111277223|NCT05006898|Autonomic Agents|autonomic agents|mesh-ancestor
111277224|NCT05006898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111277225|NCT05006898|Nasal Decongestants|nasal decongestants|mesh-ancestor
111277226|NCT05006898|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111277227|NCT05006898|Respiratory System Agents|respiratory system agents|mesh-ancestor
111277228|NCT05006898|Miotics|miotics|mesh-ancestor
111277229|NCT05006898|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
111277230|NCT05006898|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111277231|NCT05006898|Cholinergic Agents|cholinergic agents|mesh-ancestor
111277232|NCT02243241|Moxifloxacin|moxifloxacin|mesh-list
111277233|NCT02243241|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
111277234|NCT02243241|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111277235|NCT02243241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111277236|NCT02243241|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111277237|NCT02243241|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111277238|NCT02243241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111001646|NCT03137498|Ketorolac|ketorolac|mesh-list
111277239|NCT02243241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111277240|NCT02243241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111277241|NCT02243241|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111277242|NCT02243241|Contraceptive Agents|contraceptive agents|mesh-ancestor
111277243|NCT02243241|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111277244|NCT02243241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111277245|NCT02243241|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
111277246|NCT02243241|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111277247|NCT02243241|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111277249|NCT04365309|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111277250|NCT04365309|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111277251|NCT04365309|Analgesics|analgesics|mesh-ancestor
111277252|NCT04365309|Sensory System Agents|sensory system agents|mesh-ancestor
111277253|NCT04365309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111277254|NCT04365309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111277255|NCT04365309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111277256|NCT04365309|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111277257|NCT04365309|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111277258|NCT04365309|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111277259|NCT04365309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111277260|NCT04365309|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111277261|NCT04365309|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111277262|NCT04365309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111277263|NCT04365309|Antipyretics|antipyretics|mesh-ancestor
111277264|NCT02243553|Vitamin K|vitamin k|mesh-list
111277265|NCT02243553|Ritonavir|ritonavir|mesh-list
111277266|NCT02243553|Tipranavir|tipranavir|mesh-list
111277267|NCT02243553|Digoxin|digoxin|mesh-list
111277268|NCT02243553|Midazolam|midazolam|mesh-list
111277269|NCT02243553|Dextromethorphan|dextromethorphan|mesh-list
111277270|NCT02243553|Caffeine|caffeine|mesh-list
111277271|NCT02243553|Omeprazole|omeprazole|mesh-list
111277272|NCT02243553|Warfarin|warfarin|mesh-list
111277273|NCT02243553|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111277274|NCT02243553|Vitamins|vitamins|mesh-ancestor
111277275|NCT02243553|Micronutrients|micronutrients|mesh-ancestor
111277276|NCT02243553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111277277|NCT02243553|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111277278|NCT02243553|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111277279|NCT02243553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111277280|NCT02243553|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111277281|NCT02243553|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111277282|NCT02243553|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111277283|NCT02243553|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111277284|NCT02243553|Anesthetics, General|anesthetics, general|mesh-ancestor
111277285|NCT02243553|Anesthetics|anesthetics|mesh-ancestor
111277286|NCT02243553|GABA Modulators|gaba modulators|mesh-ancestor
111277287|NCT02243553|GABA Agents|gaba agents|mesh-ancestor
111277288|NCT02243553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111277289|NCT02243553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111277290|NCT02243553|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111277291|NCT02243553|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111277292|NCT02243553|Protease Inhibitors|protease inhibitors|mesh-ancestor
111277293|NCT02243553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111277294|NCT02243553|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111277295|NCT02243553|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111277296|NCT02243553|Antiviral Agents|antiviral agents|mesh-ancestor
111277297|NCT02243553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111277298|NCT02243553|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111277299|NCT02243553|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111277300|NCT02243553|Anticoagulants|anticoagulants|mesh-ancestor
111277301|NCT02243553|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111277302|NCT02243553|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111277303|NCT02243553|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
111277304|NCT02243553|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111277305|NCT02243553|Purinergic Agents|purinergic agents|mesh-ancestor
111277306|NCT02243553|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111277307|NCT02243553|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111277308|NCT02243553|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111277309|NCT02243553|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111277310|NCT02243553|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111277311|NCT02243553|Protective Agents|protective agents|mesh-ancestor
111277312|NCT02243553|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111277313|NCT02243553|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111277314|NCT02243553|Hemostatics|hemostatics|mesh-ancestor
111277315|NCT02243553|Coagulants|coagulants|mesh-ancestor
111277316|NCT02243553|Antitussive Agents|antitussive agents|mesh-ancestor
111277317|NCT02243553|Respiratory System Agents|respiratory system agents|mesh-ancestor
111277318|NCT02243553|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111277319|NCT02243553|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111277320|NCT00922233|Levonorgestrel|levonorgestrel|mesh-list
111277321|NCT00922233|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111277322|NCT00922233|Contraceptive Agents|contraceptive agents|mesh-ancestor
111277323|NCT00922233|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111277324|NCT00922233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111277325|NCT00922233|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111277326|NCT00922233|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111277327|NCT00922233|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111277328|NCT05006664|Prednisone|prednisone|mesh-list
111277329|NCT05006664|Cyclophosphamide|cyclophosphamide|mesh-list
111277330|NCT05006664|Doxorubicin|doxorubicin|mesh-list
111277331|NCT05006664|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111277332|NCT05006664|Etoposide|etoposide|mesh-list
111277333|NCT05006664|Etoposide phosphate|etoposide phosphate|mesh-list
111277334|NCT05006664|Brentuximab Vedotin|brentuximab vedotin|mesh-list
111277335|NCT05006664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111277336|NCT05006664|Immunologic Factors|immunologic factors|mesh-ancestor
111277337|NCT05006664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111277338|NCT05006664|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111277339|NCT05006664|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111277340|NCT05006664|Alkylating Agents|alkylating agents|mesh-ancestor
111277341|NCT05006664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111277342|NCT05006664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111277343|NCT05006664|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111277344|NCT05006664|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111277345|NCT05006664|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111277346|NCT05006664|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111277347|NCT05006664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111277348|NCT05006664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111277349|NCT05006664|Glucocorticoids|glucocorticoids|mesh-ancestor
111277350|NCT05006664|Hormones|hormones|mesh-ancestor
111277351|NCT05006664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111277352|NCT05006664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111277353|NCT05006664|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111277354|NCT05006664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111277355|NCT05006664|Immunotoxins|immunotoxins|mesh-ancestor
111277356|NCT05006664|Immunoconjugates|immunoconjugates|mesh-ancestor
111277357|NCT04346901|Methimazole|methimazole|mesh-list
111277358|NCT04346901|Antithyroid Agents|antithyroid agents|mesh-ancestor
111277359|NCT04346901|Hormone Antagonists|hormone antagonists|mesh-ancestor
111277360|NCT04346901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111277361|NCT04346901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111277362|NCT02244021|Brentuximab Vedotin|brentuximab vedotin|mesh-list
111277363|NCT02244021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111277364|NCT02244021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111277365|NCT02244021|Immunotoxins|immunotoxins|mesh-ancestor
111277366|NCT02244021|Immunoconjugates|immunoconjugates|mesh-ancestor
111277367|NCT02244021|Immunologic Factors|immunologic factors|mesh-ancestor
111277368|NCT02244021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111277369|NCT04364451|Asparaginase|asparaginase|mesh-list
111277370|NCT04364451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111277371|NCT02245269|Ritonavir|ritonavir|mesh-list
111277372|NCT02245269|Tipranavir|tipranavir|mesh-list
111277373|NCT02245269|Atorvastatin|atorvastatin|mesh-list
111277374|NCT02245269|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111277375|NCT02245269|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111277376|NCT02245269|Antimetabolites|antimetabolites|mesh-ancestor
111277377|NCT02245269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111277378|NCT02245269|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111277379|NCT02245269|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111277380|NCT02245269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111277381|NCT02245269|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111277382|NCT02245269|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111277383|NCT02245269|Protease Inhibitors|protease inhibitors|mesh-ancestor
111277384|NCT02245269|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111277385|NCT02245269|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111277386|NCT02245269|Antiviral Agents|antiviral agents|mesh-ancestor
111277387|NCT02245269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111277388|NCT02245269|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111277389|NCT02245269|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111277390|NCT04364139|Metoprolol|metoprolol|mesh-list
111277391|NCT04364139|Amlodipine|amlodipine|mesh-list
111277392|NCT04364139|Ramipril|ramipril|mesh-list
111277393|NCT04364139|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111277394|NCT04364139|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111277395|NCT04364139|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111277396|NCT04364139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111277397|NCT04364139|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111277398|NCT04364139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111277399|NCT04364139|Vasodilator Agents|vasodilator agents|mesh-ancestor
111277400|NCT04364139|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111277401|NCT04364139|Sympatholytics|sympatholytics|mesh-ancestor
111277402|NCT04364139|Autonomic Agents|autonomic agents|mesh-ancestor
111277403|NCT04364139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111277404|NCT04364139|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
111277405|NCT04364139|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111277406|NCT04364139|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111277407|NCT04364139|Adrenergic Agents|adrenergic agents|mesh-ancestor
111277408|NCT04364139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111277409|NCT04364139|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
111277410|NCT04364139|Protease Inhibitors|protease inhibitors|mesh-ancestor
111277411|NCT04364139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111277412|NCT02244255|Tamsulosin|tamsulosin|mesh-list
111277413|NCT02244255|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111277414|NCT02244255|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111277415|NCT02244255|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111277416|NCT02244255|Adrenergic Agents|adrenergic agents|mesh-ancestor
111277417|NCT02244255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111277418|NCT02244255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111277419|NCT02244255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111277420|NCT02244255|Urological Agents|urological agents|mesh-ancestor
111277421|NCT04363827|Hydroxychloroquine|hydroxychloroquine|mesh-list
111277422|NCT04363827|Antimalarials|antimalarials|mesh-ancestor
111277423|NCT04363827|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111277424|NCT04363827|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111277425|NCT04363827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111277426|NCT04363827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111277427|NCT04363827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111277428|NCT04363827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111277429|NCT00923949|Pioglitazone|pioglitazone|mesh-list
111277430|NCT00923949|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111277431|NCT00923949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111277432|NCT04376541|Fentanyl|fentanyl|mesh-list
111277433|NCT04376541|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111277434|NCT04376541|Narcotics|narcotics|mesh-ancestor
111277435|NCT04376541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111277436|NCT04376541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111277437|NCT04376541|Analgesics|analgesics|mesh-ancestor
111277438|NCT04376541|Sensory System Agents|sensory system agents|mesh-ancestor
111277439|NCT04376541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111277440|NCT04376541|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111277441|NCT04376541|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111277442|NCT04376541|Anesthetics, General|anesthetics, general|mesh-ancestor
111277443|NCT04376541|Anesthetics|anesthetics|mesh-ancestor
111277444|NCT04376307|Anesthetics|anesthetics|mesh-list
111277445|NCT04376307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111277446|NCT04376307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111277447|NCT02244489|Capecitabine|capecitabine|mesh-list
111277448|NCT02244489|Oxaliplatin|oxaliplatin|mesh-list
111277449|NCT02244489|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
111277450|NCT02244489|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111277451|NCT02244489|Antimetabolites|antimetabolites|mesh-ancestor
111277452|NCT02244489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111277453|NCT02244489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111277454|NCT02244489|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111277455|NCT02244489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111277456|NCT02244567|Metformin|metformin|mesh-list
111277457|NCT02244567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111277458|NCT02244567|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111277459|NCT04376073|Niraparib|niraparib|mesh-list
111277460|NCT04376073|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111277461|NCT04376073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111277462|NCT04376073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111277463|NCT04376073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110959305|NCT04446104|Povidone-Iodine|povidone-iodine|mesh-list
111277465|NCT04999176|Rivaroxaban|rivaroxaban|mesh-list
111277466|NCT04999176|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111277467|NCT04999176|Antithrombins|antithrombins|mesh-ancestor
111277468|NCT04999176|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111277469|NCT04999176|Protease Inhibitors|protease inhibitors|mesh-ancestor
111277470|NCT04999176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111277471|NCT04999176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111277472|NCT04999176|Anticoagulants|anticoagulants|mesh-ancestor
111277473|NCT04999176|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111277474|NCT04999176|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111277475|NCT04363203|Azithromycin|azithromycin|mesh-list
111277476|NCT04363203|Hydroxychloroquine|hydroxychloroquine|mesh-list
110978840|NCT03251222|Analgesics|analgesics|mesh-ancestor
111277477|NCT04363203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111277478|NCT04363203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111277479|NCT04363203|Antimalarials|antimalarials|mesh-ancestor
111277480|NCT04363203|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111277481|NCT04363203|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111277482|NCT04363203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111277483|NCT04363203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111277484|NCT04363203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111277485|NCT04363359|Vaccines|vaccines|mesh-list
111277486|NCT04363359|Immunologic Factors|immunologic factors|mesh-ancestor
111277487|NCT04363359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111277488|NCT02244879|Resveratrol|resveratrol|mesh-list
111277489|NCT02244879|Antioxidants|antioxidants|mesh-ancestor
111277490|NCT02244879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111277491|NCT02244879|Protective Agents|protective agents|mesh-ancestor
111277492|NCT02244879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111277493|NCT02244879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111277494|NCT02244879|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111277495|NCT04362735|Vedolizumab|vedolizumab|mesh-list
111277496|NCT04362735|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111277497|NCT04375995|Nitric Oxide|nitric oxide|mesh-list
111277498|NCT04375995|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111277499|NCT04375995|Autonomic Agents|autonomic agents|mesh-ancestor
111277500|NCT04375995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111277501|NCT04375995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111277502|NCT04375995|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111277503|NCT04375995|Respiratory System Agents|respiratory system agents|mesh-ancestor
111277504|NCT04375995|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111277505|NCT04375995|Antioxidants|antioxidants|mesh-ancestor
111277506|NCT04375995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111277507|NCT04375995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111277508|NCT04375995|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
111277509|NCT04375995|Vasodilator Agents|vasodilator agents|mesh-ancestor
111277510|NCT04375995|Gasotransmitters|gasotransmitters|mesh-ancestor
111277511|NCT04375995|Protective Agents|protective agents|mesh-ancestor
111277512|NCT04365231|Azithromycin|azithromycin|mesh-list
111277513|NCT04365231|Hydroxychloroquine|hydroxychloroquine|mesh-list
111277514|NCT04365231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111277515|NCT04365231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111277516|NCT04365231|Antimalarials|antimalarials|mesh-ancestor
111277517|NCT04365231|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111277518|NCT04365231|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111277519|NCT04365231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111277520|NCT04365231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111277521|NCT04365231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111277522|NCT04993014|Trastuzumab|trastuzumab|mesh-list
111277523|NCT04993014|Pertuzumab|pertuzumab|mesh-list
111277524|NCT04993014|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111277525|NCT04993014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111277526|NCT05005494|Magnesium Sulfate|magnesium sulfate|mesh-list
111277527|NCT05005494|Analgesics|analgesics|mesh-ancestor
111277528|NCT05005494|Sensory System Agents|sensory system agents|mesh-ancestor
111277529|NCT05005494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111277530|NCT05005494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111277531|NCT05005494|Anesthetics|anesthetics|mesh-ancestor
111277532|NCT05005494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111277533|NCT05005494|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111277534|NCT05005494|Anticonvulsants|anticonvulsants|mesh-ancestor
111277535|NCT05005494|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111277536|NCT05005494|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111277537|NCT05005494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111277538|NCT05005494|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111277539|NCT05005494|Tocolytic Agents|tocolytic agents|mesh-ancestor
111277540|NCT05005494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111277542|NCT04025567|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111277543|NCT04025567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111277544|NCT03074994|Anesthetics|anesthetics|mesh-list
111277545|NCT03074994|Anesthetics, Local|anesthetics, local|mesh-list
111277546|NCT03074994|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111277547|NCT03074994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111277548|NCT03074994|Sensory System Agents|sensory system agents|mesh-ancestor
111277549|NCT03074994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111277550|NCT04025177|Indomethacin|indomethacin|mesh-list
111277551|NCT04025177|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111277552|NCT04025177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111277553|NCT04025177|Analgesics|analgesics|mesh-ancestor
111277554|NCT04025177|Sensory System Agents|sensory system agents|mesh-ancestor
111277555|NCT04025177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111277556|NCT04025177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111277557|NCT04025177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111277558|NCT04025177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111277559|NCT04025177|Gout Suppressants|gout suppressants|mesh-ancestor
111277560|NCT04025177|Tocolytic Agents|tocolytic agents|mesh-ancestor
111277561|NCT04025177|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111277562|NCT04025177|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111277563|NCT04025177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111277564|NCT04025177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111277565|NCT04358055|Hyaluronic Acid|hyaluronic acid|mesh-list
111277566|NCT04358055|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111277567|NCT04358055|Immunologic Factors|immunologic factors|mesh-ancestor
111277568|NCT04358055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111277569|NCT04358055|Viscosupplements|viscosupplements|mesh-ancestor
111277570|NCT04358055|Protective Agents|protective agents|mesh-ancestor
111277571|NCT04147325|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
111277572|NCT04147325|Antiviral Agents|antiviral agents|mesh-ancestor
111277573|NCT04147325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111277574|NCT02985281|Ribavirin|ribavirin|mesh-list
111277575|NCT02985281|Sofosbuvir|sofosbuvir|mesh-list
111277576|NCT02985281|Antimetabolites|antimetabolites|mesh-ancestor
111277577|NCT02985281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111277578|NCT02985281|Antiviral Agents|antiviral agents|mesh-ancestor
111277579|NCT02985281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111277580|NCT00927849|Nitroglycerin|nitroglycerin|mesh-list
111277581|NCT00927849|Botulinum Toxins|botulinum toxins|mesh-list
111277582|NCT00927849|Glycerol|glycerol|mesh-list
111277583|NCT00927849|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111277584|NCT00927849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111277585|NCT00927849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111277586|NCT00927849|Cholinergic Agents|cholinergic agents|mesh-ancestor
111277587|NCT00927849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111277588|NCT00927849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111277589|NCT00927849|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
111277590|NCT00927849|Protective Agents|protective agents|mesh-ancestor
111277591|NCT00927849|Vasodilator Agents|vasodilator agents|mesh-ancestor
111277592|NCT04149587|Brodalumab|brodalumab|mesh-list
111277593|NCT04149587|Dermatologic Agents|dermatologic agents|mesh-ancestor
111277594|NCT02985125|Everolimus|everolimus|mesh-list
111277595|NCT02985125|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111277596|NCT02985125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111277597|NCT02985125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111277598|NCT02985125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111277599|NCT02985125|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111277600|NCT02985125|Immunologic Factors|immunologic factors|mesh-ancestor
111277601|NCT02985125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111277602|NCT02985125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111277603|NCT04912596|Albuterol|albuterol|mesh-list
111277604|NCT04912596|Procaterol|procaterol|mesh-list
111277605|NCT04912596|Methacholine Chloride|methacholine chloride|mesh-list
111277606|NCT04912596|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111277607|NCT04912596|Autonomic Agents|autonomic agents|mesh-ancestor
111277608|NCT04912596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111277609|NCT04912596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111277610|NCT04912596|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111277611|NCT04912596|Respiratory System Agents|respiratory system agents|mesh-ancestor
111277612|NCT04912596|Tocolytic Agents|tocolytic agents|mesh-ancestor
111277613|NCT04912596|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111277614|NCT04912596|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111277615|NCT04912596|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111277616|NCT04912596|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111277617|NCT04912596|Adrenergic Agents|adrenergic agents|mesh-ancestor
111277618|NCT04912596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111277619|NCT04912596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111277620|NCT04912596|Miotics|miotics|mesh-ancestor
111277621|NCT04912596|Parasympathomimetics|parasympathomimetics|mesh-ancestor
111277622|NCT04912596|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
111277623|NCT04912596|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
110978856|NCT03250910|Velpatasvir|velpatasvir|mesh-list
111277624|NCT04912596|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111277625|NCT04912596|Cholinergic Agents|cholinergic agents|mesh-ancestor
111277626|NCT04912596|Sympathomimetics|sympathomimetics|mesh-ancestor
111277627|NCT00936741|Mifepristone|mifepristone|mesh-list
111277628|NCT00936741|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
111277629|NCT00936741|Abortifacient Agents|abortifacient agents|mesh-ancestor
111277630|NCT00936741|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111277631|NCT00936741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111277632|NCT00936741|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111277633|NCT00936741|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111277634|NCT00936741|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111277635|NCT00936741|Contraceptive Agents|contraceptive agents|mesh-ancestor
111277636|NCT00936741|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
111277637|NCT00936741|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
111277638|NCT00936741|Hormone Antagonists|hormone antagonists|mesh-ancestor
111277639|NCT00936741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111277640|NCT00936741|Luteolytic Agents|luteolytic agents|mesh-ancestor
111277641|NCT00936741|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111277642|NCT00936741|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
111277643|NCT04024865|Domperidone|domperidone|mesh-list
111277644|NCT04024865|Antiemetics|antiemetics|mesh-ancestor
111277645|NCT04024865|Autonomic Agents|autonomic agents|mesh-ancestor
111277646|NCT04024865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111277647|NCT04024865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111277648|NCT04024865|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111277649|NCT04024865|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111277650|NCT04024865|Dopamine Agents|dopamine agents|mesh-ancestor
111277651|NCT04024865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111277652|NCT04024865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111277653|NCT04024241|Cytarabine|cytarabine|mesh-list
111277654|NCT04024241|Mitoxantrone|mitoxantrone|mesh-list
111277655|NCT04024241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111277656|NCT04024241|Antimetabolites|antimetabolites|mesh-ancestor
111277657|NCT04024241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111277658|NCT04024241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111277659|NCT04024241|Antiviral Agents|antiviral agents|mesh-ancestor
111277660|NCT04024241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111277661|NCT04024241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111277662|NCT04024241|Immunologic Factors|immunologic factors|mesh-ancestor
111277663|NCT04024241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111277664|NCT04024241|Analgesics|analgesics|mesh-ancestor
111277665|NCT04024241|Sensory System Agents|sensory system agents|mesh-ancestor
111277666|NCT04024241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111277667|NCT04024241|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111277668|NCT04024241|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111277669|NCT04024241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111277670|NCT04996290|Ropivacaine|ropivacaine|mesh-list
111277671|NCT04996290|Anesthetics, Local|anesthetics, local|mesh-ancestor
111277672|NCT04996290|Anesthetics|anesthetics|mesh-ancestor
111277673|NCT04996290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111277674|NCT04996290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111277675|NCT04996290|Sensory System Agents|sensory system agents|mesh-ancestor
111277676|NCT04996290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111277677|NCT04023617|Docetaxel|docetaxel|mesh-list
111277678|NCT04023617|Nivolumab|nivolumab|mesh-list
111277679|NCT04023617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111277680|NCT04023617|Tubulin Modulators|tubulin modulators|mesh-ancestor
111277681|NCT04023617|Antimitotic Agents|antimitotic agents|mesh-ancestor
111277682|NCT04023617|Mitosis Modulators|mitosis modulators|mesh-ancestor
110959306|NCT04446104|Povidone|povidone|mesh-list
110959307|NCT04446104|Antimalarials|antimalarials|mesh-ancestor
110959308|NCT04446104|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110959309|NCT04446104|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110959310|NCT04446104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110959311|NCT04446104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110959312|NCT04446104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110959313|NCT04446104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110959314|NCT04446104|Plasma Substitutes|plasma substitutes|mesh-ancestor
111277683|NCT04023617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111277684|NCT04023617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111277685|NCT04023617|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111277686|NCT04023149|Aldesleukin|aldesleukin|mesh-list
111277687|NCT04023149|Interleukin-2|interleukin-2|mesh-list
111277688|NCT04023149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111277689|NCT04023149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111277690|NCT04023149|Analgesics|analgesics|mesh-ancestor
111277691|NCT04023149|Sensory System Agents|sensory system agents|mesh-ancestor
111277692|NCT04023149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111277693|NCT04023149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111277694|NCT04023149|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111277695|NCT04023149|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111277696|NCT04023149|Antiviral Agents|antiviral agents|mesh-ancestor
111277697|NCT04023149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111277698|NCT04023305|Sevoflurane|sevoflurane|mesh-list
111277699|NCT04023305|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111277700|NCT04023305|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111277701|NCT04023305|Anesthetics, General|anesthetics, general|mesh-ancestor
111277702|NCT04023305|Anesthetics|anesthetics|mesh-ancestor
111277703|NCT04023305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111277704|NCT04023305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111277705|NCT04149275|Nivolumab|nivolumab|mesh-list
111277706|NCT04149275|Ipilimumab|ipilimumab|mesh-list
111277707|NCT04149275|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
111277708|NCT04149275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111277709|NCT04149275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111277710|NCT04149275|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111277711|NCT04149275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111277712|NCT04149275|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111277713|NCT04149275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111277714|NCT04148963|Loxapine|loxapine|mesh-list
111277715|NCT04148963|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111277716|NCT04148963|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111277717|NCT04148963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111277718|NCT04148963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111277719|NCT04148963|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111277720|NCT04148963|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111277721|NCT04148963|Dopamine Agents|dopamine agents|mesh-ancestor
111277722|NCT04148963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111277723|NCT04148963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111277724|NCT04022837|Pantoprazole|pantoprazole|mesh-list
111277725|NCT04022837|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111277726|NCT04022837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111277727|NCT04022837|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111277728|NCT04022837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111277729|NCT04022837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111277730|NCT04022993|Insulin Glargine|insulin glargine|mesh-list
111277731|NCT04022993|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111277732|NCT04022993|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111277733|NCT04022993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111277734|NCT04148885|Paclitaxel|paclitaxel|mesh-list
111277735|NCT04148885|Carboplatin|carboplatin|mesh-list
111277736|NCT04148885|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111277737|NCT04148885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111277738|NCT04148885|Tubulin Modulators|tubulin modulators|mesh-ancestor
111277739|NCT04148885|Antimitotic Agents|antimitotic agents|mesh-ancestor
111277740|NCT04148885|Mitosis Modulators|mitosis modulators|mesh-ancestor
111277741|NCT04148885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111277742|NCT04022525|Leflunomide|leflunomide|mesh-list
111277743|NCT04022525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111277744|NCT04022525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111277745|NCT04022525|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111277746|NCT04022525|Immunologic Factors|immunologic factors|mesh-ancestor
111277747|NCT04022525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111277748|NCT04022291|Insulin|insulin|mesh-list
111277749|NCT04022291|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111277750|NCT04022291|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111277751|NCT04022291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111277752|NCT03074448|Picosulfate sodium|picosulfate sodium|mesh-list
111277753|NCT03074448|Cathartics|cathartics|mesh-ancestor
111277754|NCT03074448|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111277755|NCT04021433|Ketamine|ketamine|mesh-list
111277756|NCT04021433|Analgesics|analgesics|mesh-ancestor
111277757|NCT04021433|Sensory System Agents|sensory system agents|mesh-ancestor
111277758|NCT04021433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111277759|NCT04021433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111277760|NCT04021433|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111277761|NCT04021433|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111277762|NCT04021433|Anesthetics, General|anesthetics, general|mesh-ancestor
111277763|NCT04021433|Anesthetics|anesthetics|mesh-ancestor
111277764|NCT04021433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111277765|NCT04021433|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111277766|NCT04021433|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111277767|NCT04021433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111277768|NCT04021433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111277769|NCT04147481|Anesthetics|anesthetics|mesh-list
111277770|NCT04147481|Anesthetics, Local|anesthetics, local|mesh-list
111277771|NCT04147481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111277772|NCT04147481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111277773|NCT04147481|Sensory System Agents|sensory system agents|mesh-ancestor
111277774|NCT04147481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111277775|NCT04148261|Hydrocortisone|hydrocortisone|mesh-list
111277776|NCT04148261|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
111277777|NCT04148261|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
111277778|NCT04148261|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
111277779|NCT04148261|Epinephrine|epinephrine|mesh-list
111277780|NCT04148261|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111277781|NCT04148261|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111277782|NCT04148261|Adrenergic Agents|adrenergic agents|mesh-ancestor
111277783|NCT04148261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111277784|NCT04148261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111277785|NCT04148261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111277786|NCT04148261|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111277787|NCT04148261|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111277788|NCT04148261|Autonomic Agents|autonomic agents|mesh-ancestor
111277789|NCT04148261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111277790|NCT04148261|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111277791|NCT04148261|Respiratory System Agents|respiratory system agents|mesh-ancestor
111277792|NCT04148261|Mydriatics|mydriatics|mesh-ancestor
111277793|NCT04148261|Sympathomimetics|sympathomimetics|mesh-ancestor
111277794|NCT04148261|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111277795|NCT04148261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111277796|NCT03072264|Fluoxetine|fluoxetine|mesh-list
111277797|NCT03072264|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111277798|NCT03072264|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111277799|NCT03072264|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111277800|NCT03072264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111277801|NCT03072264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111277802|NCT03072264|Serotonin Agents|serotonin agents|mesh-ancestor
111277803|NCT03072264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111277804|NCT03072264|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111277805|NCT03072264|Antidepressive Agents|antidepressive agents|mesh-ancestor
111277806|NCT03072264|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111277807|NCT03072264|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111277808|NCT03072264|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111277809|NCT03072264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111277810|NCT04991064|Titanium dioxide|titanium dioxide|mesh-list
111277811|NCT04991064|Sunscreening Agents|sunscreening agents|mesh-ancestor
111277812|NCT04991064|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111277813|NCT04991064|Protective Agents|protective agents|mesh-ancestor
111277814|NCT04991064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111277815|NCT04991064|Dermatologic Agents|dermatologic agents|mesh-ancestor
111277816|NCT04991064|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111277817|NCT00928083|Artefenomel|artefenomel|mesh-list
111277818|NCT00928083|Antimalarials|antimalarials|mesh-ancestor
111277819|NCT00928083|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111277820|NCT00928083|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111277821|NCT00928083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111277822|NCT04996446|Tislelizumab|tislelizumab|mesh-list
111277823|NCT04996446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111277824|NCT04996446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111277825|NCT04361721|Erenumab|erenumab|mesh-list
111277826|NCT04361721|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
111277827|NCT04361721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111277828|NCT04361721|Analgesics|analgesics|mesh-ancestor
111277829|NCT04361721|Sensory System Agents|sensory system agents|mesh-ancestor
111277830|NCT04361721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110959315|NCT04446104|Blood Substitutes|blood substitutes|mesh-ancestor
111277831|NCT04361721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111277833|NCT04361643|Immunologic Factors|immunologic factors|mesh-ancestor
111277834|NCT04361643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111277835|NCT04361643|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111277836|NCT04361643|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111277837|NCT04361643|Growth Substances|growth substances|mesh-ancestor
111277838|NCT04361643|Growth Inhibitors|growth inhibitors|mesh-ancestor
111277839|NCT04361643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111277840|NCT04406051|Norepinephrine|norepinephrine|mesh-list
111277841|NCT04406051|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111277842|NCT04406051|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111277843|NCT04406051|Adrenergic Agents|adrenergic agents|mesh-ancestor
111277844|NCT04406051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111277845|NCT04406051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111277846|NCT04406051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111277847|NCT04406051|Sympathomimetics|sympathomimetics|mesh-ancestor
111277848|NCT04406051|Autonomic Agents|autonomic agents|mesh-ancestor
111277849|NCT04406051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111277850|NCT04406051|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111277851|NCT04991298|Fentanyl|fentanyl|mesh-list
111277852|NCT04991298|Midazolam|midazolam|mesh-list
111277853|NCT04991298|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111277854|NCT04991298|Narcotics|narcotics|mesh-ancestor
111277855|NCT04991298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111277856|NCT04991298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111277857|NCT04991298|Analgesics|analgesics|mesh-ancestor
111277858|NCT04991298|Sensory System Agents|sensory system agents|mesh-ancestor
111277859|NCT04991298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111277860|NCT04991298|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111277861|NCT04991298|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111277862|NCT04991298|Anesthetics, General|anesthetics, general|mesh-ancestor
111277863|NCT04991298|Anesthetics|anesthetics|mesh-ancestor
111277864|NCT04991298|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111277865|NCT04991298|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111277866|NCT04991298|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111277867|NCT04991298|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111277868|NCT04991298|GABA Modulators|gaba modulators|mesh-ancestor
111277869|NCT04991298|GABA Agents|gaba agents|mesh-ancestor
111277870|NCT04991298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111277871|NCT04991298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111277872|NCT04361175|Letrozole|letrozole|mesh-list
111277873|NCT04361175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111277874|NCT04361175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111277875|NCT04361175|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111277876|NCT04361175|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111277877|NCT04361175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111277878|NCT04361175|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111277879|NCT04361175|Hormone Antagonists|hormone antagonists|mesh-ancestor
111277880|NCT04361175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111277881|NCT04361175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111277882|NCT04368819|Allopurinol|allopurinol|mesh-list
111277883|NCT04368819|Antimetabolites|antimetabolites|mesh-ancestor
111277884|NCT04368819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111277885|NCT04368819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111277886|NCT04368819|Gout Suppressants|gout suppressants|mesh-ancestor
111277887|NCT04368819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111277888|NCT04368819|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111277889|NCT04368819|Antioxidants|antioxidants|mesh-ancestor
111277890|NCT04368819|Protective Agents|protective agents|mesh-ancestor
111277891|NCT04368819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111277892|NCT04368585|Simethicone|simethicone|mesh-list
111277893|NCT04368585|Omeprazole|omeprazole|mesh-list
111277894|NCT04368585|Aluminum Hydroxide|aluminum hydroxide|mesh-list
111277895|NCT04368585|Magnesium Hydroxide|magnesium hydroxide|mesh-list
111277896|NCT04368585|Aluminum hydroxide, magnesium hydroxide, drug combination|aluminum hydroxide, magnesium hydroxide, drug combination|mesh-list
110978870|NCT02283801|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111277897|NCT04368585|Aluminum hydroxide, magnesium hydroxide, simethicone drug combination|aluminum hydroxide, magnesium hydroxide, simethicone drug combination|mesh-list
111277898|NCT04368585|TEMPO|tempo|mesh-list
111277899|NCT04368585|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111277900|NCT04368585|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111277901|NCT04368585|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111277902|NCT04368585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111277903|NCT04368585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111277904|NCT04368585|Antifoaming Agents|antifoaming agents|mesh-ancestor
111277905|NCT04368585|Emollients|emollients|mesh-ancestor
111277906|NCT04368585|Dermatologic Agents|dermatologic agents|mesh-ancestor
111277907|NCT04368585|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111277908|NCT04368585|Immunologic Factors|immunologic factors|mesh-ancestor
111277909|NCT04368585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111277910|NCT04368585|Antacids|antacids|mesh-ancestor
111277911|NCT04368585|Antioxidants|antioxidants|mesh-ancestor
111277912|NCT04368585|Protective Agents|protective agents|mesh-ancestor
111277913|NCT04361331|Lenvatinib|lenvatinib|mesh-list
111277914|NCT04361331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111277915|NCT04361331|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111277916|NCT04361331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111277917|NCT04361331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111277918|NCT04990830|Heparin|heparin|mesh-list
111277919|NCT04990830|Enoxaparin|enoxaparin|mesh-list
111277920|NCT04990830|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
111277921|NCT04990830|Tinzaparin|tinzaparin|mesh-list
111277922|NCT04990830|Dalteparin|dalteparin|mesh-list
111277923|NCT04990830|Enoxaparin sodium|enoxaparin sodium|mesh-list
111277924|NCT04990830|Anticoagulants|anticoagulants|mesh-ancestor
111277925|NCT04990830|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111277926|NCT04990830|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111277927|NCT04990830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111277928|NCT04361409|Rituximab|rituximab|mesh-list
111277929|NCT04361409|Gemcitabine|gemcitabine|mesh-list
111277930|NCT04361409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111277931|NCT04361409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111277932|NCT04361409|Immunologic Factors|immunologic factors|mesh-ancestor
111277933|NCT04361409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111277934|NCT04361409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111277935|NCT04361409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111277936|NCT04361409|Antimetabolites|antimetabolites|mesh-ancestor
111277937|NCT04361409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111277938|NCT04368273|Antibodies|antibodies|mesh-list
111277939|NCT04368273|Immunologic Factors|immunologic factors|mesh-ancestor
111277940|NCT04368273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111277941|NCT04995354|Mitogens|mitogens|mesh-list
111277942|NCT04995354|Mitosis Modulators|mitosis modulators|mesh-ancestor
111277943|NCT04995354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111277944|NCT04368351|Azithromycin|azithromycin|mesh-list
111277945|NCT04368351|Hydroxychloroquine|hydroxychloroquine|mesh-list
111277946|NCT04368351|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111277947|NCT04368351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111277948|NCT04368351|Antimalarials|antimalarials|mesh-ancestor
111277949|NCT04368351|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111277950|NCT04368351|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111277951|NCT04368351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111277952|NCT04368351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111277953|NCT04368351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111277954|NCT04360785|Methotrexate|methotrexate|mesh-list
111277955|NCT04360785|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111277956|NCT04360785|Abortifacient Agents|abortifacient agents|mesh-ancestor
111277957|NCT04360785|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111277958|NCT04360785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111277959|NCT04360785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111277960|NCT04360785|Antimetabolites|antimetabolites|mesh-ancestor
111277961|NCT04360785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111277962|NCT04360785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111277963|NCT04360785|Dermatologic Agents|dermatologic agents|mesh-ancestor
111277964|NCT04360785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111277965|NCT04360785|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111277966|NCT04360785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111277967|NCT04360785|Immunologic Factors|immunologic factors|mesh-ancestor
111277968|NCT04360785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111277969|NCT04360785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111277970|NCT04360317|Docetaxel|docetaxel|mesh-list
111277971|NCT04360317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111277972|NCT04360317|Tubulin Modulators|tubulin modulators|mesh-ancestor
111277973|NCT04360317|Antimitotic Agents|antimitotic agents|mesh-ancestor
111277974|NCT04360317|Mitosis Modulators|mitosis modulators|mesh-ancestor
111277975|NCT04360317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111277976|NCT03074136|Sodium Hypochlorite|sodium hypochlorite|mesh-list
111277977|NCT03074136|Eusol|eusol|mesh-list
111277978|NCT03074136|Disinfectants|disinfectants|mesh-ancestor
111277979|NCT03074136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111277980|NCT04146155|Liraglutide|liraglutide|mesh-list
111277981|NCT04146155|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111277982|NCT04146155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111277983|NCT04146155|Incretins|incretins|mesh-ancestor
111277985|NCT04146155|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111277986|NCT04990752|Urinastatin|urinastatin|mesh-list
111277987|NCT04990752|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
111277988|NCT04990752|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111277989|NCT04990752|Protease Inhibitors|protease inhibitors|mesh-ancestor
111277990|NCT04990752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111277991|NCT04990752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111277992|NCT02245191|Phenylephrine|phenylephrine|mesh-list
111277993|NCT02245191|Oxymetazoline|oxymetazoline|mesh-list
111277994|NCT02245191|Ephedrine|ephedrine|mesh-list
111277995|NCT02245191|Metaraminol|metaraminol|mesh-list
111277996|NCT02245191|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111277997|NCT02245191|Mydriatics|mydriatics|mesh-ancestor
111277998|NCT02245191|Autonomic Agents|autonomic agents|mesh-ancestor
111277999|NCT02245191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111278000|NCT02245191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111278001|NCT02245191|Sympathomimetics|sympathomimetics|mesh-ancestor
111278002|NCT02245191|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111278003|NCT02245191|Nasal Decongestants|nasal decongestants|mesh-ancestor
111278004|NCT02245191|Respiratory System Agents|respiratory system agents|mesh-ancestor
111278005|NCT02245191|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111278006|NCT02245191|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111278007|NCT02245191|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111278008|NCT02245191|Adrenergic Agents|adrenergic agents|mesh-ancestor
111278009|NCT02245191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111278010|NCT02245191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111278011|NCT02245191|Protective Agents|protective agents|mesh-ancestor
111278012|NCT02245191|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111278013|NCT04145921|Tacrine|tacrine|mesh-list
111278014|NCT04145921|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111278015|NCT04145921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111278016|NCT04145921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111278017|NCT04145921|Cholinergic Agents|cholinergic agents|mesh-ancestor
111278018|NCT04145921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111278019|NCT04145921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111278020|NCT04145921|Parasympathomimetics|parasympathomimetics|mesh-ancestor
111278021|NCT04145921|Autonomic Agents|autonomic agents|mesh-ancestor
111278022|NCT04145921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111278023|NCT04145921|Nootropic Agents|nootropic agents|mesh-ancestor
111278024|NCT04145687|Metformin|metformin|mesh-list
111278025|NCT04145687|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111278026|NCT04145687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111278027|NCT04359615|Hydroxychloroquine|hydroxychloroquine|mesh-list
111278028|NCT04359615|Favipiravir|favipiravir|mesh-list
111278029|NCT04359615|Antimalarials|antimalarials|mesh-ancestor
111278030|NCT04359615|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111278031|NCT04359615|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111278032|NCT04359615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111278033|NCT04359615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111278034|NCT04359615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111278035|NCT04359615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111278036|NCT04359615|Antiviral Agents|antiviral agents|mesh-ancestor
111278037|NCT02635386|Metformin|metformin|mesh-list
111278038|NCT02635386|Dapagliflozin|dapagliflozin|mesh-list
111278039|NCT02635386|Exenatide|exenatide|mesh-list
111278040|NCT02635386|Topiramate|topiramate|mesh-list
111278041|NCT02635386|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
111278042|NCT02635386|Phentermine|phentermine|mesh-list
111278043|NCT02635386|Glucagon|glucagon|mesh-list
111278044|NCT02635386|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
111278045|NCT02635386|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111278046|NCT02635386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111278047|NCT02635386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111278048|NCT02635386|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111278049|NCT02635386|Incretins|incretins|mesh-ancestor
111278050|NCT02635386|Hormones|hormones|mesh-ancestor
111278051|NCT02635386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111278052|NCT02635386|Anticonvulsants|anticonvulsants|mesh-ancestor
111278053|NCT02635386|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111278054|NCT02635386|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111278055|NCT02635386|Appetite Depressants|appetite depressants|mesh-ancestor
111278056|NCT02635386|Sympathomimetics|sympathomimetics|mesh-ancestor
111278057|NCT02635386|Autonomic Agents|autonomic agents|mesh-ancestor
111278058|NCT02635386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111278059|NCT02635386|Adrenergic Agents|adrenergic agents|mesh-ancestor
111002530|NCT05582694|UB-421|ub-421|mesh-list
111278060|NCT02635386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111278061|NCT00934635|Risperidone|risperidone|mesh-list
111278062|NCT00934635|Paliperidone Palmitate|paliperidone palmitate|mesh-list
111278063|NCT00934635|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111278064|NCT00934635|Serotonin Agents|serotonin agents|mesh-ancestor
111278065|NCT00934635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111278066|NCT00934635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111278067|NCT00934635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111278068|NCT00934635|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111278069|NCT00934635|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111278070|NCT00934635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111278071|NCT00934635|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111278072|NCT00934635|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111278073|NCT00934635|Dopamine Agents|dopamine agents|mesh-ancestor
111278074|NCT00934635|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111278075|NCT00934635|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111278076|NCT04359537|Hydroxychloroquine|hydroxychloroquine|mesh-list
111278077|NCT04359537|Antimalarials|antimalarials|mesh-ancestor
111278078|NCT04359537|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111278079|NCT04359537|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111278080|NCT04359537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111278081|NCT04359537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111278082|NCT04359537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111278083|NCT04359537|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111278084|NCT03922997|Atezolizumab|atezolizumab|mesh-list
111278085|NCT03922997|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111278086|NCT03922997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111278087|NCT03922997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111278088|NCT03922997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111278089|NCT04356417|Antimalarials|antimalarials|mesh-list
111278090|NCT04356417|Enzyme Inhibitors|enzyme inhibitors|mesh-list
111278091|NCT04356417|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
111278092|NCT04356417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111278093|NCT04356417|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111278094|NCT04356417|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111278095|NCT04356417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111278096|NCT04355949|Vitamin D|vitamin d|mesh-list
111278097|NCT04355949|Ergocalciferols|ergocalciferols|mesh-list
111278098|NCT04355949|Cholecalciferol|cholecalciferol|mesh-list
111278099|NCT04355949|Vitamins|vitamins|mesh-list
111278100|NCT04355949|Folic Acid|folic acid|mesh-list
111278101|NCT04355949|Vitamin B 12|vitamin b 12|mesh-list
111278102|NCT04355949|Hydroxocobalamin|hydroxocobalamin|mesh-list
111278103|NCT04355949|Vitamin B Complex|vitamin b complex|mesh-list
111278104|NCT04355949|Micronutrients|micronutrients|mesh-ancestor
111278105|NCT04355949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111278106|NCT04355949|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111278107|NCT04355949|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111278108|NCT04355949|Hematinics|hematinics|mesh-ancestor
111278109|NCT05580887|Paclitaxel|paclitaxel|mesh-list
111278110|NCT05580887|Cyclophosphamide|cyclophosphamide|mesh-list
111278111|NCT05580887|Carboplatin|carboplatin|mesh-list
111278112|NCT05580887|Doxorubicin|doxorubicin|mesh-list
111278113|NCT05580887|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111278114|NCT05580887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111278115|NCT05580887|Tubulin Modulators|tubulin modulators|mesh-ancestor
111278116|NCT05580887|Antimitotic Agents|antimitotic agents|mesh-ancestor
111278117|NCT05580887|Mitosis Modulators|mitosis modulators|mesh-ancestor
111278118|NCT05580887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111278119|NCT05580887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111278120|NCT05580887|Immunologic Factors|immunologic factors|mesh-ancestor
111278121|NCT05580887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111278122|NCT05580887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111278123|NCT05580887|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111278124|NCT05580887|Alkylating Agents|alkylating agents|mesh-ancestor
111278125|NCT05580887|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111278126|NCT05580887|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111278127|NCT05580887|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111278128|NCT05580887|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111278129|NCT05580887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111278130|NCT04994262|Menthol|menthol|mesh-list
111278131|NCT04994262|Antipruritics|antipruritics|mesh-ancestor
111278132|NCT04994262|Dermatologic Agents|dermatologic agents|mesh-ancestor
111278133|NCT00939159|Panobinostat|panobinostat|mesh-list
111278134|NCT00939159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111278135|NCT00939159|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111278136|NCT00939159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111278137|NCT00939159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111278139|NCT05620641|Ondansetron|ondansetron|mesh-list
111278140|NCT05620641|Analgesics|analgesics|mesh-ancestor
111278141|NCT05620641|Sensory System Agents|sensory system agents|mesh-ancestor
111278142|NCT05620641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111278143|NCT05620641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111278144|NCT05620641|Anticonvulsants|anticonvulsants|mesh-ancestor
111278145|NCT05620641|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111278146|NCT05620641|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111278147|NCT05620641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111278148|NCT05620641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111278149|NCT05620641|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111278150|NCT05620641|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111278151|NCT05620641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111278152|NCT05620641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111278153|NCT05620641|Antimanic Agents|antimanic agents|mesh-ancestor
111278154|NCT05620641|Antiemetics|antiemetics|mesh-ancestor
111278155|NCT05620641|Autonomic Agents|autonomic agents|mesh-ancestor
111278156|NCT05620641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111278157|NCT05620641|Antipruritics|antipruritics|mesh-ancestor
111278158|NCT05620641|Dermatologic Agents|dermatologic agents|mesh-ancestor
111278159|NCT05620641|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111278160|NCT05620641|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111278161|NCT05620641|Serotonin Agents|serotonin agents|mesh-ancestor
111278162|NCT04144439|Butyric Acid|butyric acid|mesh-list
111278163|NCT04144439|Histamine Antagonists|histamine antagonists|mesh-ancestor
111278164|NCT04144439|Histamine Agents|histamine agents|mesh-ancestor
111278165|NCT04144439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111278166|NCT04144439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111278167|NCT04144439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111278168|NCT04994574|Tiotropium Bromide|tiotropium bromide|mesh-list
111278169|NCT04994574|Olodaterol|olodaterol|mesh-list
111278170|NCT04994574|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111278171|NCT04994574|Autonomic Agents|autonomic agents|mesh-ancestor
111278172|NCT04994574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111278173|NCT04994574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111278174|NCT04994574|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111278175|NCT04994574|Respiratory System Agents|respiratory system agents|mesh-ancestor
111278176|NCT04994574|Parasympatholytics|parasympatholytics|mesh-ancestor
111278177|NCT04994574|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111278178|NCT04994574|Cholinergic Agents|cholinergic agents|mesh-ancestor
111278179|NCT04994574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111278180|NCT04994574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111278181|NCT04355637|Budesonide|budesonide|mesh-list
111278182|NCT04355637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111278183|NCT04355637|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111278184|NCT04355637|Autonomic Agents|autonomic agents|mesh-ancestor
111278185|NCT04355637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111278186|NCT04355637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111278187|NCT04355637|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111278188|NCT04355637|Respiratory System Agents|respiratory system agents|mesh-ancestor
111278189|NCT04355637|Glucocorticoids|glucocorticoids|mesh-ancestor
111278190|NCT04355637|Hormones|hormones|mesh-ancestor
111278191|NCT04355637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111278192|NCT04367025|Oxaliplatin|oxaliplatin|mesh-list
111278193|NCT04367025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111278194|NCT03076710|Bupivacaine|bupivacaine|mesh-list
111278195|NCT03076710|Anesthetics, Local|anesthetics, local|mesh-ancestor
111278196|NCT03076710|Anesthetics|anesthetics|mesh-ancestor
111278197|NCT03076710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111278198|NCT03076710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111278199|NCT03076710|Sensory System Agents|sensory system agents|mesh-ancestor
111278200|NCT03076710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111278201|NCT04143581|Empagliflozin|empagliflozin|mesh-list
111278202|NCT04143581|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111278203|NCT04143581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111278204|NCT04143581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111278205|NCT04143581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111278206|NCT03071172|Triptorelin Pamoate|triptorelin pamoate|mesh-list
111278207|NCT03071172|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
111278208|NCT03071172|Progesterone|progesterone|mesh-list
111278209|NCT03071172|Hormones|hormones|mesh-ancestor
111278210|NCT03071172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111278211|NCT03071172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111278212|NCT03071172|Progestins|progestins|mesh-ancestor
111278213|NCT03071172|Luteolytic Agents|luteolytic agents|mesh-ancestor
111278214|NCT03071172|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111278215|NCT03071172|Contraceptive Agents|contraceptive agents|mesh-ancestor
111278216|NCT03071172|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111278217|NCT03071172|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111278218|NCT03071172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111278219|NCT03071172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111278220|NCT03070938|Anti-Infective Agents|anti-infective agents|mesh-list
111278221|NCT03070938|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111278222|NCT04143815|Botulinum Toxins|botulinum toxins|mesh-list
111278223|NCT04143815|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111278224|NCT04143815|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111278225|NCT04143815|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111278226|NCT04143815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111278227|NCT04143815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111278228|NCT04143815|Cholinergic Agents|cholinergic agents|mesh-ancestor
111278229|NCT04143815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111278230|NCT04143815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111278231|NCT04143815|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111278232|NCT04143815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111278233|NCT04355247|Methylprednisolone|methylprednisolone|mesh-list
111278234|NCT04355247|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111278235|NCT04355247|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111278236|NCT04355247|Prednisolone|prednisolone|mesh-list
111278237|NCT04355247|Prednisolone acetate|prednisolone acetate|mesh-list
111278238|NCT04355247|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111278239|NCT04355247|Prednisolone phosphate|prednisolone phosphate|mesh-list
111278240|NCT04355247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111278241|NCT04355247|Antiemetics|antiemetics|mesh-ancestor
111278242|NCT04355247|Autonomic Agents|autonomic agents|mesh-ancestor
111278243|NCT04355247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111278244|NCT04355247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111278245|NCT04355247|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111278246|NCT04355247|Glucocorticoids|glucocorticoids|mesh-ancestor
111278247|NCT04355247|Hormones|hormones|mesh-ancestor
111278248|NCT04355247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111278249|NCT04355247|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111278250|NCT04355247|Protective Agents|protective agents|mesh-ancestor
111278251|NCT04355247|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111278252|NCT04355247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111278253|NCT03903809|Epoetin Alfa|epoetin alfa|mesh-list
111278254|NCT03903809|Hematinics|hematinics|mesh-ancestor
111278255|NCT04987554|Immunoferon|immunoferon|mesh-list
111278256|NCT04987554|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111278257|NCT04987554|Immunologic Factors|immunologic factors|mesh-ancestor
111278258|NCT04987554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111278259|NCT04358367|Dexmedetomidine|dexmedetomidine|mesh-list
111278260|NCT04358367|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111278261|NCT04358367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111278262|NCT04358367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111278263|NCT04358367|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111278264|NCT04358367|Analgesics|analgesics|mesh-ancestor
111278265|NCT04358367|Sensory System Agents|sensory system agents|mesh-ancestor
111278266|NCT04358367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111278267|NCT04358367|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111278268|NCT04358367|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111278269|NCT04358367|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111278270|NCT04358367|Adrenergic Agents|adrenergic agents|mesh-ancestor
111278271|NCT04358367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111278272|NCT04358367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111278273|NCT04358523|Sofosbuvir|sofosbuvir|mesh-list
111278274|NCT04358523|Antiviral Agents|antiviral agents|mesh-ancestor
111278275|NCT04358523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111278276|NCT03917303|Adalimumab|adalimumab|mesh-list
111278277|NCT03917303|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111278278|NCT03917303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111278279|NCT03917303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111278280|NCT03070860|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
111278281|NCT03070860|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111278282|NCT03070860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111278283|NCT05583149|Cyclophosphamide|cyclophosphamide|mesh-list
111278284|NCT05583149|Fludarabine|fludarabine|mesh-list
111278285|NCT05583149|Acalabrutinib|acalabrutinib|mesh-list
111278286|NCT05583149|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111278287|NCT05583149|Immunologic Factors|immunologic factors|mesh-ancestor
111278288|NCT05583149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111278289|NCT05583149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111278290|NCT05583149|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111278291|NCT05583149|Alkylating Agents|alkylating agents|mesh-ancestor
111278292|NCT05583149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111278293|NCT05583149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111278294|NCT05583149|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111278295|NCT04366869|Salicylic Acid|salicylic acid|mesh-list
111278296|NCT04366869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111278297|NCT04366869|Antifungal Agents|antifungal agents|mesh-ancestor
111278298|NCT04366869|Keratolytic Agents|keratolytic agents|mesh-ancestor
111278299|NCT04366869|Dermatologic Agents|dermatologic agents|mesh-ancestor
111278300|NCT04989270|Anesthetics|anesthetics|mesh-list
111278301|NCT04989270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111278302|NCT04989270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111278303|NCT04346823|Sevoflurane|sevoflurane|mesh-list
111278304|NCT04346823|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111278305|NCT04346823|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111278306|NCT04346823|Anesthetics, General|anesthetics, general|mesh-ancestor
111278307|NCT04346823|Anesthetics|anesthetics|mesh-ancestor
111278308|NCT04346823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111278309|NCT04346823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111278310|NCT05582837|Topiramate|topiramate|mesh-list
111278311|NCT05582837|Nortriptyline|nortriptyline|mesh-list
111278312|NCT05582837|Anticonvulsants|anticonvulsants|mesh-ancestor
111278313|NCT05582837|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111278314|NCT05582837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111278315|NCT05582837|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
111278316|NCT05582837|Antidepressive Agents|antidepressive agents|mesh-ancestor
111278317|NCT05582837|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111278318|NCT05582837|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111278319|NCT05582837|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111278320|NCT05582837|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111278321|NCT05582837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111278322|NCT05582837|Adrenergic Agents|adrenergic agents|mesh-ancestor
111278323|NCT05582837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111278324|NCT04728633|Carmustine|carmustine|mesh-list
111278325|NCT04728633|Ethiodized Oil|ethiodized oil|mesh-list
111278326|NCT04728633|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111278327|NCT04728633|Alkylating Agents|alkylating agents|mesh-ancestor
111278328|NCT04728633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111278329|NCT04728633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111278330|NCT05003700|Lenvatinib|lenvatinib|mesh-list
111278331|NCT05003700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111278332|NCT05003700|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111278333|NCT05003700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111278334|NCT05003700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111278335|NCT04143191|Sorafenib|sorafenib|mesh-list
111278336|NCT04143191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111278337|NCT04143191|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111278338|NCT04143191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111278339|NCT04143191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111278340|NCT03647657|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
111278341|NCT03647657|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111278342|NCT03647657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111278343|NCT04461288|Nicotine|nicotine|mesh-list
111278344|NCT04461288|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111278345|NCT04461288|Autonomic Agents|autonomic agents|mesh-ancestor
111278346|NCT04461288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111278347|NCT04461288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111278348|NCT04461288|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111278349|NCT04461288|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111278350|NCT04461288|Cholinergic Agents|cholinergic agents|mesh-ancestor
111278351|NCT04461288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111002777|NCT05286814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111002778|NCT05286814|Antidotes|antidotes|mesh-ancestor
111002779|NCT05286814|Protective Agents|protective agents|mesh-ancestor
111002780|NCT05286814|Vitamin B Complex|vitamin b complex|mesh-ancestor
111002781|NCT05286814|Vitamins|vitamins|mesh-ancestor
111002782|NCT05286814|Micronutrients|micronutrients|mesh-ancestor
111002783|NCT05282121|Empagliflozin|empagliflozin|mesh-list
111002784|NCT05282121|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111002786|NCT05282121|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111278352|NCT04461288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111278353|NCT05582135|Morphine|morphine|mesh-list
111278354|NCT05582135|Esketamine|esketamine|mesh-list
111278355|NCT05582135|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111278356|NCT05582135|Narcotics|narcotics|mesh-ancestor
111278357|NCT05582135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111278358|NCT05582135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111278359|NCT05582135|Analgesics|analgesics|mesh-ancestor
111278360|NCT05582135|Sensory System Agents|sensory system agents|mesh-ancestor
111278361|NCT05582135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111278362|NCT05582135|Antidepressive Agents|antidepressive agents|mesh-ancestor
111278363|NCT05582135|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111278364|NCT03070704|Liraglutide|liraglutide|mesh-list
111278365|NCT03070704|Xultophy|xultophy|mesh-list
111278366|NCT03070704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111278367|NCT03070704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111278368|NCT03070704|Incretins|incretins|mesh-ancestor
111278369|NCT03070704|Hormones|hormones|mesh-ancestor
111278370|NCT03070704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111278371|NCT03069768|Varenicline|varenicline|mesh-list
111278372|NCT03069768|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111278373|NCT03069768|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111278374|NCT03069768|Cholinergic Agents|cholinergic agents|mesh-ancestor
111278375|NCT03069768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111278376|NCT03069768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111278377|NCT03069768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111278378|NCT04141553|Diltiazem|diltiazem|mesh-list
111278379|NCT04141553|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111278380|NCT04141553|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111278381|NCT04141553|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111278382|NCT04141553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111278383|NCT04141553|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111278384|NCT04141553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111278385|NCT04141553|Vasodilator Agents|vasodilator agents|mesh-ancestor
111278386|NCT04141163|Metformin|metformin|mesh-list
111278387|NCT04141163|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111278388|NCT04141163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111278389|NCT00942825|Cisplatin|cisplatin|mesh-list
111278390|NCT00942825|Pemetrexed|pemetrexed|mesh-list
111278391|NCT00942825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111278392|NCT00942825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111278393|NCT00942825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111278394|NCT00942825|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111278395|NCT00942825|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111278396|NCT04544943|Gentamicins|gentamicins|mesh-list
111278397|NCT04544943|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111278398|NCT04544943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111278399|NCT04544943|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111278400|NCT04544943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111278401|NCT04544943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111278402|NCT04140461|Amphotericin B|amphotericin b|mesh-list
111278403|NCT04140461|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
111278404|NCT04140461|Flucytosine|flucytosine|mesh-list
111278405|NCT04140461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111278406|NCT04140461|Amebicides|amebicides|mesh-ancestor
111278407|NCT04140461|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111278408|NCT04140461|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111278409|NCT04140461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111278410|NCT04140461|Antifungal Agents|antifungal agents|mesh-ancestor
111278411|NCT04140461|Antimetabolites|antimetabolites|mesh-ancestor
111002855|NCT05103332|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111002856|NCT05103332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111002857|NCT05103332|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111002858|NCT05103332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111002859|NCT05103332|Vasodilator Agents|vasodilator agents|mesh-ancestor
111002860|NCT05103332|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111002861|NCT05103332|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111002862|NCT05103332|Diuretics|diuretics|mesh-ancestor
111002863|NCT05103332|Natriuretic Agents|natriuretic agents|mesh-ancestor
111002864|NCT05103332|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
111002865|NCT05102721|Avelumab|avelumab|mesh-list
111002866|NCT05102721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111002867|NCT05102721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111002868|NCT05083481|Pembrolizumab|pembrolizumab|mesh-list
111002873|NCT05048784|Sotorasib|sotorasib|mesh-list
111278412|NCT04140461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111278414|NCT03021629|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
111278415|NCT03021629|Vitamins|vitamins|mesh-ancestor
111278416|NCT03021629|Micronutrients|micronutrients|mesh-ancestor
111278417|NCT03021629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111278418|NCT03021629|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111278419|NCT03021395|Decitabine|decitabine|mesh-list
111278420|NCT03021395|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111278421|NCT03021395|Antimetabolites|antimetabolites|mesh-ancestor
111278422|NCT03021395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111278423|NCT03021395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111278424|NCT03021395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111278425|NCT03021317|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
111278426|NCT03021317|Hormones|hormones|mesh-ancestor
111278427|NCT03021317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111278428|NCT03021317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111278429|NCT04987632|Letrozole|letrozole|mesh-list
111278430|NCT04987632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111278431|NCT04987632|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111278432|NCT04987632|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111278433|NCT04987632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111278434|NCT04987632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111278435|NCT04987632|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111278436|NCT04987632|Hormone Antagonists|hormone antagonists|mesh-ancestor
111278437|NCT04987632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111278438|NCT04987632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111278439|NCT03032367|Bedaquiline|bedaquiline|mesh-list
111278440|NCT03032367|Antitubercular Agents|antitubercular agents|mesh-ancestor
111278441|NCT03032367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111278442|NCT03032367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111278443|NCT02634606|Tocotrienols|tocotrienols|mesh-list
111278444|NCT02634606|Vitamin E|vitamin e|mesh-list
111278445|NCT02634606|Tocopherols|tocopherols|mesh-list
111278446|NCT02634606|Antioxidants|antioxidants|mesh-ancestor
111278447|NCT02634606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111278448|NCT02634606|Protective Agents|protective agents|mesh-ancestor
111278449|NCT02634606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111278450|NCT02634606|Vitamins|vitamins|mesh-ancestor
111278451|NCT02634606|Micronutrients|micronutrients|mesh-ancestor
111278452|NCT05002686|Paclitaxel|paclitaxel|mesh-list
111278453|NCT05002686|Capecitabine|capecitabine|mesh-list
111278454|NCT05002686|Oxaliplatin|oxaliplatin|mesh-list
111278455|NCT05002686|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111278456|NCT05002686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111278457|NCT05002686|Tubulin Modulators|tubulin modulators|mesh-ancestor
111278458|NCT05002686|Antimitotic Agents|antimitotic agents|mesh-ancestor
111278459|NCT05002686|Mitosis Modulators|mitosis modulators|mesh-ancestor
111278460|NCT05002686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111278461|NCT05002686|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111278462|NCT05002686|Antimetabolites|antimetabolites|mesh-ancestor
111278463|NCT03588689|Ropivacaine|ropivacaine|mesh-list
111278464|NCT03588689|Anesthetics, Local|anesthetics, local|mesh-ancestor
111278465|NCT03588689|Anesthetics|anesthetics|mesh-ancestor
111278466|NCT03588689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111278467|NCT03588689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111278468|NCT03588689|Sensory System Agents|sensory system agents|mesh-ancestor
111278469|NCT03588689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111278470|NCT04985526|Octenidine|octenidine|mesh-list
111278471|NCT04985526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111278472|NCT04985526|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111278473|NCT03588611|Hirudins|hirudins|mesh-list
111278474|NCT03588611|Bivalirudin|bivalirudin|mesh-list
111278475|NCT03588611|Antithrombins|antithrombins|mesh-ancestor
111278476|NCT03588611|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111278477|NCT03588611|Protease Inhibitors|protease inhibitors|mesh-ancestor
111278478|NCT03588611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111002939|NCT04895709|Docetaxel|docetaxel|mesh-list
111002940|NCT04895709|Nivolumab|nivolumab|mesh-list
111002941|NCT04895709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111002942|NCT04895709|Tubulin Modulators|tubulin modulators|mesh-ancestor
111002943|NCT04895709|Antimitotic Agents|antimitotic agents|mesh-ancestor
111002944|NCT04895709|Mitosis Modulators|mitosis modulators|mesh-ancestor
111002945|NCT04895709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111002946|NCT04895709|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111002948|NCT04894123|Trifluridine|trifluridine|mesh-list
111278479|NCT03588611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111278480|NCT03588611|Anticoagulants|anticoagulants|mesh-ancestor
111278481|NCT03588611|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111278482|NCT03588611|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111278483|NCT03588533|Capecitabine|capecitabine|mesh-list
111278484|NCT03588533|Trastuzumab|trastuzumab|mesh-list
111278485|NCT03588533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111278486|NCT03588533|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111278487|NCT03588533|Antimetabolites|antimetabolites|mesh-ancestor
111278488|NCT03588533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111278489|NCT03588533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111278490|NCT03068442|Flutemetamol|flutemetamol|mesh-list
111278491|NCT03068442|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111278492|NCT03068442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111278493|NCT00939705|Topiramate|topiramate|mesh-list
111278494|NCT00939705|Anticonvulsants|anticonvulsants|mesh-ancestor
111278495|NCT00939705|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111278496|NCT00939705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111278497|NCT05001672|Tenofovir|tenofovir|mesh-list
111278498|NCT05001672|Antiviral Agents|antiviral agents|mesh-ancestor
111278499|NCT05001672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111278500|NCT05001672|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111278501|NCT05001672|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111278502|NCT05001672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111278503|NCT05001672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111278504|NCT05001672|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111278505|NCT05001672|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111278506|NCT04354545|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111278507|NCT04354545|Lifitegrast|lifitegrast|mesh-list
111278508|NCT04354545|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111278509|NCT03587285|Goserelin|goserelin|mesh-list
111278510|NCT03587285|Abiraterone Acetate|abiraterone acetate|mesh-list
111278511|NCT03587285|Bicalutamide|bicalutamide|mesh-list
111278512|NCT03587285|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111278513|NCT03587285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111278514|NCT03587285|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111278515|NCT03587285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111278516|NCT03587285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111278517|NCT03587285|Hormone Antagonists|hormone antagonists|mesh-ancestor
111278518|NCT03587285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111278519|NCT03587285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111278520|NCT03587285|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111278521|NCT03587285|Androgen Antagonists|androgen antagonists|mesh-ancestor
111278522|NCT03587129|Apatinib|apatinib|mesh-list
111278523|NCT03587129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111278524|NCT03587129|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111278525|NCT03587129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111278526|NCT03587129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111278527|NCT02245503|Tamsulosin|tamsulosin|mesh-list
111003006|NCT04873362|Atezolizumab|atezolizumab|mesh-list
111003007|NCT04873362|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
111003008|NCT04873362|Maytansine|maytansine|mesh-list
111003009|NCT04873362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111003010|NCT04873362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111003011|NCT04873362|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111003012|NCT04873362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111003013|NCT04873362|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111003014|NCT04873362|Tubulin Modulators|tubulin modulators|mesh-ancestor
111003015|NCT04873362|Antimitotic Agents|antimitotic agents|mesh-ancestor
111003016|NCT04873362|Mitosis Modulators|mitosis modulators|mesh-ancestor
111003017|NCT04873362|Immunotoxins|immunotoxins|mesh-ancestor
111003018|NCT04873362|Immunoconjugates|immunoconjugates|mesh-ancestor
111003019|NCT04873362|Immunologic Factors|immunologic factors|mesh-ancestor
111003020|NCT04873362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111003021|NCT04856904|Trifarotene|trifarotene|mesh-list
111003022|NCT04856904|Dermatologic Agents|dermatologic agents|mesh-ancestor
111003023|NCT04849845|Insulin|insulin|mesh-list
111003024|NCT04849845|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111003025|NCT04849845|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111003026|NCT04849845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111003054|NCT04827576|Docetaxel|docetaxel|mesh-list
111003055|NCT04827576|Magrolimab|magrolimab|mesh-list
111003056|NCT04827576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111003057|NCT04827576|Tubulin Modulators|tubulin modulators|mesh-ancestor
111003058|NCT04827576|Antimitotic Agents|antimitotic agents|mesh-ancestor
111278528|NCT02245503|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111278529|NCT02245503|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111278530|NCT02245503|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111278531|NCT02245503|Adrenergic Agents|adrenergic agents|mesh-ancestor
111278532|NCT02245503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111278533|NCT02245503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111278534|NCT02245503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111278535|NCT02245503|Urological Agents|urological agents|mesh-ancestor
111278536|NCT03586817|Palonosetron|palonosetron|mesh-list
111278537|NCT03586817|Fosaprepitant|fosaprepitant|mesh-list
111278538|NCT03586817|Aprepitant|aprepitant|mesh-list
111278539|NCT03586817|Antiemetics|antiemetics|mesh-ancestor
111278540|NCT03586817|Autonomic Agents|autonomic agents|mesh-ancestor
111278541|NCT03586817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111278542|NCT03586817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111278543|NCT03586817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111278544|NCT03586817|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111278545|NCT03586817|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111278546|NCT03586817|Serotonin Agents|serotonin agents|mesh-ancestor
111278547|NCT03586817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111278548|NCT03586817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111278549|NCT03586817|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
111278550|NCT03891173|Vinorelbine|vinorelbine|mesh-list
111278551|NCT03891173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111278552|NCT03891173|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111278553|NCT03891173|Tubulin Modulators|tubulin modulators|mesh-ancestor
111278554|NCT03891173|Antimitotic Agents|antimitotic agents|mesh-ancestor
111278555|NCT03891173|Mitosis Modulators|mitosis modulators|mesh-ancestor
111278556|NCT03891173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111278557|NCT03585725|Ribavirin|ribavirin|mesh-list
111278558|NCT03585725|Antimetabolites|antimetabolites|mesh-ancestor
111278559|NCT03585725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111278560|NCT03585725|Antiviral Agents|antiviral agents|mesh-ancestor
111278561|NCT03585725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111278562|NCT03585569|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111278563|NCT03585569|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111278564|NCT03585569|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111278565|NCT03585569|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111278566|NCT03585569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111278567|NCT03585569|Cholinergic Agents|cholinergic agents|mesh-ancestor
111278568|NCT03585569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111278569|NCT03585569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111278570|NCT03585569|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111278571|NCT03585569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111278572|NCT03585179|Tranexamic Acid|tranexamic acid|mesh-list
111278573|NCT03585179|Hydroquinone|hydroquinone|mesh-list
111278574|NCT03585179|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111278575|NCT03585179|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111278576|NCT03585179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111278577|NCT03585179|Hemostatics|hemostatics|mesh-ancestor
111278578|NCT03585179|Coagulants|coagulants|mesh-ancestor
111278579|NCT03585179|Antioxidants|antioxidants|mesh-ancestor
111278580|NCT03585179|Protective Agents|protective agents|mesh-ancestor
111278581|NCT03585179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111278582|NCT03585179|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111278583|NCT03585101|Grazoprevir|grazoprevir|mesh-list
111278584|NCT03585101|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
111278585|NCT03585101|Antiviral Agents|antiviral agents|mesh-ancestor
111278586|NCT03585101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111278587|NCT03584087|Terlipressin|terlipressin|mesh-list
111278588|NCT03584087|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111278589|NCT03584087|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111278590|NCT03834363|Fentanyl|fentanyl|mesh-list
111278591|NCT03834363|Morphine|morphine|mesh-list
111278592|NCT03834363|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111003084|NCT04758871|Hormones|hormones|mesh-ancestor
111003085|NCT04758871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111003086|NCT04758871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111003087|NCT04756037|Relugolix|relugolix|mesh-list
111003088|NCT04756037|Androgen Antagonists|androgen antagonists|mesh-ancestor
111003089|NCT04756037|Hormone Antagonists|hormone antagonists|mesh-ancestor
111003090|NCT04756037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111003091|NCT04756037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111003094|NCT04737603|Naloxone|naloxone|mesh-list
111278593|NCT03834363|Narcotics|narcotics|mesh-ancestor
111278594|NCT03834363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111278595|NCT03834363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111278596|NCT03834363|Analgesics|analgesics|mesh-ancestor
111278597|NCT03834363|Sensory System Agents|sensory system agents|mesh-ancestor
111278598|NCT03834363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111278599|NCT03834363|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111278600|NCT03834363|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111278601|NCT03834363|Anesthetics, General|anesthetics, general|mesh-ancestor
111278602|NCT03834363|Anesthetics|anesthetics|mesh-ancestor
111278603|NCT03031353|Misoprostol|misoprostol|mesh-list
111278604|NCT03031353|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111278605|NCT03031353|Abortifacient Agents|abortifacient agents|mesh-ancestor
111278606|NCT03031353|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111278607|NCT03031353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111278608|NCT03031353|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111278609|NCT03031353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111278610|NCT03031353|Oxytocics|oxytocics|mesh-ancestor
111278612|NCT05702957|Clomiphene|clomiphene|mesh-list
111278613|NCT05702957|Enclomiphene|enclomiphene|mesh-list
111278614|NCT05702957|Zuclomiphene|zuclomiphene|mesh-list
111278615|NCT05702957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111278616|NCT05702957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111278617|NCT05702957|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111278618|NCT05702957|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111278619|NCT05702957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111278620|NCT05702957|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111278621|NCT05702957|Hormone Antagonists|hormone antagonists|mesh-ancestor
111278622|NCT05702957|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111278623|NCT05702957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111278624|NCT05702957|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111278625|NCT05702957|Fertility Agents|fertility agents|mesh-ancestor
111278626|NCT05702957|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110978906|NCT03245996|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111278627|NCT05702957|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111278628|NCT05702957|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111278629|NCT04405505|Paclitaxel|paclitaxel|mesh-list
111278630|NCT04405505|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111278631|NCT04405505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111278632|NCT04405505|Tubulin Modulators|tubulin modulators|mesh-ancestor
111278633|NCT04405505|Antimitotic Agents|antimitotic agents|mesh-ancestor
111278634|NCT04405505|Mitosis Modulators|mitosis modulators|mesh-ancestor
111278635|NCT04405505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111278636|NCT03580733|Caspofungin|caspofungin|mesh-list
111278637|NCT03580733|Antifungal Agents|antifungal agents|mesh-list
111278638|NCT03580733|Clotrimazole|clotrimazole|mesh-list
111278639|NCT03580733|Miconazole|miconazole|mesh-list
111278640|NCT03580733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111278641|NCT03580733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111278642|NCT03580733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111278643|NCT03580733|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111278644|NCT03580733|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111278645|NCT03580733|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111278646|NCT03580733|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111278647|NCT03580733|Hormone Antagonists|hormone antagonists|mesh-ancestor
111278648|NCT03580733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111278649|NCT03580733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111278650|NCT03580733|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111278651|NCT03580733|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111278652|NCT03461445|Tacrolimus|tacrolimus|mesh-list
111278653|NCT03461445|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111278654|NCT03461445|Immunologic Factors|immunologic factors|mesh-ancestor
111278655|NCT03461445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111278656|NCT03461445|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111278657|NCT03461445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111278658|NCT03461445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111278659|NCT04939662|Bevacizumab|bevacizumab|mesh-list
111278660|NCT04939662|Olaparib|olaparib|mesh-list
111278661|NCT04939662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111278662|NCT04939662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111278663|NCT04939662|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111278664|NCT04939662|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111278665|NCT04939662|Growth Substances|growth substances|mesh-ancestor
111003162|NCT04629248|Acetaminophen|acetaminophen|mesh-list
111278666|NCT04939662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111278667|NCT04939662|Growth Inhibitors|growth inhibitors|mesh-ancestor
111278668|NCT04939662|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111278669|NCT04939662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111278670|NCT04939662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111278671|NCT05581979|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
111278672|NCT05581979|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111278673|NCT05581979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111278674|NCT05331144|Losartan|losartan|mesh-list
111278675|NCT05331144|Amlodipine|amlodipine|mesh-list
111278676|NCT05331144|Calcium Channel Blockers|calcium channel blockers|mesh-list
111278677|NCT05331144|Angiotensin II|angiotensin ii|mesh-list
111278678|NCT05331144|Giapreza|giapreza|mesh-list
111278679|NCT05331144|Calcium|calcium|mesh-list
111278680|NCT05331144|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
111278681|NCT05331144|Angiotensinogen|angiotensinogen|mesh-list
111278682|NCT05331144|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111278683|NCT05331144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111278684|NCT05331144|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111278685|NCT05331144|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111278686|NCT05331144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111278687|NCT05331144|Vasodilator Agents|vasodilator agents|mesh-ancestor
111278688|NCT05331144|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111278689|NCT05331144|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111278690|NCT05331144|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111278691|NCT05331144|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111278692|NCT05331144|Protease Inhibitors|protease inhibitors|mesh-ancestor
111278693|NCT05331144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111278694|NCT00951561|Ibuprofen|ibuprofen|mesh-list
111278695|NCT00951561|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111278696|NCT00951561|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111278697|NCT00951561|Analgesics|analgesics|mesh-ancestor
111278698|NCT00951561|Sensory System Agents|sensory system agents|mesh-ancestor
111278699|NCT00951561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111278700|NCT00951561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111278701|NCT00951561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111278702|NCT00951561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111278703|NCT00951561|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111278704|NCT00951561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111278705|NCT00951561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111278706|NCT03031119|Atorvastatin|atorvastatin|mesh-list
111278707|NCT03031119|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111278708|NCT03031119|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111278709|NCT03031119|Antimetabolites|antimetabolites|mesh-ancestor
111278710|NCT03031119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111278711|NCT03031119|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111278712|NCT03031119|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111278713|NCT03031119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111278714|NCT03076203|Niraparib|niraparib|mesh-list
111278715|NCT03076203|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
111278716|NCT03076203|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111278717|NCT03076203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111278718|NCT03076203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111278719|NCT03076203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111278720|NCT02943057|Ganciclovir|ganciclovir|mesh-list
111278721|NCT02943057|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
111278722|NCT02943057|Antiviral Agents|antiviral agents|mesh-ancestor
111278723|NCT02943057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111278724|NCT02943057|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111278725|NCT02943057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111278726|NCT02943057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111278727|NCT03581903|Vaccines|vaccines|mesh-list
111278728|NCT03581903|Immunologic Factors|immunologic factors|mesh-ancestor
111278729|NCT03581903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111278730|NCT02783547|Azacitidine|azacitidine|mesh-list
111278731|NCT02783547|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111278732|NCT02783547|Antimetabolites|antimetabolites|mesh-ancestor
111278733|NCT02783547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111278734|NCT02783547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111278735|NCT02783547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111278736|NCT02555007|Vinorelbine|vinorelbine|mesh-list
111278737|NCT02555007|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111278738|NCT02555007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111278739|NCT02555007|Tubulin Modulators|tubulin modulators|mesh-ancestor
111278740|NCT02555007|Antimitotic Agents|antimitotic agents|mesh-ancestor
111278741|NCT02555007|Mitosis Modulators|mitosis modulators|mesh-ancestor
111278742|NCT02555007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111278743|NCT03898037|Metformin|metformin|mesh-list
111278744|NCT03898037|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111278745|NCT03898037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111278746|NCT04982874|Furosemide|furosemide|mesh-list
111278747|NCT04982874|Diuretics|diuretics|mesh-ancestor
111278748|NCT04982874|Natriuretic Agents|natriuretic agents|mesh-ancestor
111278749|NCT04982874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111278750|NCT04982874|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
111278751|NCT04982874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111278752|NCT04982874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111278753|NCT03897491|Aminolevulinic Acid|aminolevulinic acid|mesh-list
111278754|NCT03897491|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111278755|NCT03897491|Dermatologic Agents|dermatologic agents|mesh-ancestor
111278756|NCT03068208|Methylene Blue|methylene blue|mesh-list
111278757|NCT03068208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110978908|NCT03245996|Sympatholytics|sympatholytics|mesh-ancestor
111278758|NCT03068208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111278759|NCT03067974|Ketamine|ketamine|mesh-list
111278760|NCT03067974|Analgesics|analgesics|mesh-ancestor
111278761|NCT03067974|Sensory System Agents|sensory system agents|mesh-ancestor
111278762|NCT03067974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111278763|NCT03067974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111278764|NCT03067974|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111278765|NCT03067974|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111278766|NCT03067974|Anesthetics, General|anesthetics, general|mesh-ancestor
111278767|NCT03067974|Anesthetics|anesthetics|mesh-ancestor
111278768|NCT03067974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111278769|NCT03067974|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111278770|NCT03067974|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111278771|NCT03067974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111278772|NCT03067974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111278773|NCT03582137|Cannabidiol|cannabidiol|mesh-list
111278774|NCT03582137|Anticonvulsants|anticonvulsants|mesh-ancestor
111278775|NCT04405193|Acetylcysteine|acetylcysteine|mesh-list
111278776|NCT04405193|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111278777|NCT04405193|Antiviral Agents|antiviral agents|mesh-ancestor
111278778|NCT04405193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111278779|NCT04405193|Expectorants|expectorants|mesh-ancestor
111278780|NCT04405193|Respiratory System Agents|respiratory system agents|mesh-ancestor
111278781|NCT04405193|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111278782|NCT04405193|Antioxidants|antioxidants|mesh-ancestor
111278783|NCT04405193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111278784|NCT04405193|Protective Agents|protective agents|mesh-ancestor
111278785|NCT04405193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111278786|NCT04405193|Antidotes|antidotes|mesh-ancestor
111278787|NCT05227833|Pantoprazole|pantoprazole|mesh-list
111278788|NCT05227833|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111278789|NCT05227833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111278790|NCT05227833|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111278791|NCT05227833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111278792|NCT05227833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111278793|NCT05083299|Sarpogrelate|sarpogrelate|mesh-list
111278794|NCT05083299|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111278795|NCT05083299|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111278796|NCT05083299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111278797|NCT05083299|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111278798|NCT05083299|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111278799|NCT05083299|Serotonin Agents|serotonin agents|mesh-ancestor
111278800|NCT05083299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111278801|NCT05083299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111278802|NCT05701475|Benzoyl Peroxide|benzoyl peroxide|mesh-list
111278803|NCT05701475|Dermatologic Agents|dermatologic agents|mesh-ancestor
111278804|NCT03035253|Antibodies, Bispecific|antibodies, bispecific|mesh-list
111278805|NCT03035253|Immunologic Factors|immunologic factors|mesh-ancestor
111278806|NCT03035253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111278807|NCT04405271|Tenofovir|tenofovir|mesh-list
111278808|NCT04405271|Emtricitabine|emtricitabine|mesh-list
111278809|NCT04405271|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
111278810|NCT04405271|Antiviral Agents|antiviral agents|mesh-ancestor
111278811|NCT04405271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111278812|NCT04405271|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111278813|NCT04405271|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111278814|NCT04405271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111278815|NCT04405271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111278816|NCT04405271|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111278817|NCT04405271|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111278818|NCT03034941|Metformin|metformin|mesh-list
111278819|NCT03034941|Liraglutide|liraglutide|mesh-list
111278820|NCT03034941|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111278821|NCT03034941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111278822|NCT03034941|Incretins|incretins|mesh-ancestor
111278823|NCT03034941|Hormones|hormones|mesh-ancestor
111278824|NCT03034941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111278825|NCT03030105|Scopolamine|scopolamine|mesh-list
111278826|NCT03030105|Donepezil|donepezil|mesh-list
111278827|NCT03030105|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
111278828|NCT03030105|BPN14770|bpn14770|mesh-list
111278829|NCT03030105|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111278830|NCT03030105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111278831|NCT03030105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111278832|NCT03030105|Cholinergic Agents|cholinergic agents|mesh-ancestor
111278833|NCT03030105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111278834|NCT03030105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111278835|NCT03030105|Nootropic Agents|nootropic agents|mesh-ancestor
111278836|NCT03030105|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111278837|NCT03030105|Antiemetics|antiemetics|mesh-ancestor
111278838|NCT03030105|Autonomic Agents|autonomic agents|mesh-ancestor
111278839|NCT03030105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111278840|NCT03030105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111278841|NCT03030105|Mydriatics|mydriatics|mesh-ancestor
111278842|NCT03030105|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111278843|NCT03030105|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111278844|NCT03030105|Parasympatholytics|parasympatholytics|mesh-ancestor
111278845|NCT03030105|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
111278846|NCT03030105|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111278847|NCT03067896|Magnesium Sulfate|magnesium sulfate|mesh-list
111278848|NCT03067896|Dexmedetomidine|dexmedetomidine|mesh-list
111278849|NCT03067896|Bupivacaine|bupivacaine|mesh-list
111278850|NCT03067896|Anesthetics, Local|anesthetics, local|mesh-ancestor
111278851|NCT03067896|Anesthetics|anesthetics|mesh-ancestor
111278852|NCT03067896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111278853|NCT03067896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111278854|NCT03067896|Sensory System Agents|sensory system agents|mesh-ancestor
111278855|NCT03067896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111278856|NCT03067896|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111278857|NCT03067896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111278858|NCT03067896|Analgesics|analgesics|mesh-ancestor
111278859|NCT03067896|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111278860|NCT03067896|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111278861|NCT03067896|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111278862|NCT03067896|Adrenergic Agents|adrenergic agents|mesh-ancestor
111278863|NCT03067896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111278864|NCT03067896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111278865|NCT03067896|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111278866|NCT03067896|Anticonvulsants|anticonvulsants|mesh-ancestor
111278867|NCT03067896|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111278868|NCT03067896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111278869|NCT03067896|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111278870|NCT03067896|Tocolytic Agents|tocolytic agents|mesh-ancestor
111278871|NCT03067896|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111278872|NCT03034707|Biotin|biotin|mesh-list
111278873|NCT03034707|Vitamin B Complex|vitamin b complex|mesh-ancestor
111278874|NCT03034707|Vitamins|vitamins|mesh-ancestor
111278875|NCT03034707|Micronutrients|micronutrients|mesh-ancestor
111278876|NCT03034707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111278877|NCT03067740|Dexmedetomidine|dexmedetomidine|mesh-list
111278878|NCT03067740|Bupivacaine|bupivacaine|mesh-list
111278879|NCT03067740|Anesthetics, Local|anesthetics, local|mesh-ancestor
111278880|NCT03067740|Anesthetics|anesthetics|mesh-ancestor
111278881|NCT03067740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111278882|NCT03067740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111278883|NCT03067740|Sensory System Agents|sensory system agents|mesh-ancestor
111278884|NCT03067740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111278885|NCT03067740|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111278886|NCT03067740|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111278887|NCT03067740|Analgesics|analgesics|mesh-ancestor
111278888|NCT03067740|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111003395|NCT04338204|Tofacitinib|tofacitinib|mesh-list
111278889|NCT03067740|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111278890|NCT03067740|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111278891|NCT03067740|Adrenergic Agents|adrenergic agents|mesh-ancestor
111278892|NCT03067740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111278893|NCT03067740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111278894|NCT05730114|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
111278895|NCT03027843|Hormones|hormones|mesh-list
111278896|NCT03027843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111278897|NCT03027843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111278898|NCT03068832|Poly I-C|poly i-c|mesh-list
111278899|NCT03068832|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
111278900|NCT03068832|Poly ICLC|poly iclc|mesh-list
111278901|NCT03068832|Interferon Inducers|interferon inducers|mesh-ancestor
111278902|NCT03068832|Immunologic Factors|immunologic factors|mesh-ancestor
111278903|NCT03068832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111278904|NCT03068832|Laxatives|laxatives|mesh-ancestor
111278905|NCT03068832|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111278906|NCT03068832|Antiviral Agents|antiviral agents|mesh-ancestor
111278907|NCT03068832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111278908|NCT04801797|Cytarabine|cytarabine|mesh-list
111278909|NCT04801797|Azacitidine|azacitidine|mesh-list
111278910|NCT04801797|Daunorubicin|daunorubicin|mesh-list
111278911|NCT04801797|Venetoclax|venetoclax|mesh-list
111278912|NCT04801797|Idarubicin|idarubicin|mesh-list
111278913|NCT04801797|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111278914|NCT04801797|Antimetabolites|antimetabolites|mesh-ancestor
111278915|NCT04801797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111278916|NCT04801797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111278917|NCT04801797|Antiviral Agents|antiviral agents|mesh-ancestor
111278918|NCT04801797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111278919|NCT04801797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111278920|NCT04801797|Immunologic Factors|immunologic factors|mesh-ancestor
111278921|NCT04801797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111278922|NCT04801797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111278923|NCT04801797|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111278924|NCT04801797|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111278925|NCT04801797|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111278926|NCT03033537|Verapamil|verapamil|mesh-list
111278927|NCT03033537|Calcium Channel Blockers|calcium channel blockers|mesh-list
111278928|NCT03033537|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111278929|NCT03033537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111278930|NCT03033537|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111278931|NCT03033537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111278932|NCT03033537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111278933|NCT03033537|Vasodilator Agents|vasodilator agents|mesh-ancestor
111278934|NCT01670435|Ciprofloxacin|ciprofloxacin|mesh-list
111278935|NCT01670435|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111278936|NCT01670435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111278937|NCT01670435|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111278938|NCT01670435|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111278939|NCT01670435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111278940|NCT01670435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111278941|NCT01670435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111278942|NCT01670435|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111278943|NCT01670435|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111278944|NCT03069144|Calcitriol|calcitriol|mesh-list
111278945|NCT03069144|Calcipotriene|calcipotriene|mesh-list
111278946|NCT03069144|Dermatologic Agents|dermatologic agents|mesh-ancestor
111278947|NCT03069144|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111278948|NCT03069144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111278949|NCT03069144|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
111278950|NCT03069144|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111278951|NCT03069144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111278952|NCT03069144|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111278953|NCT03069144|Vitamins|vitamins|mesh-ancestor
111278954|NCT03069144|Micronutrients|micronutrients|mesh-ancestor
111278955|NCT03069144|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111278956|NCT03017703|Eplerenone|eplerenone|mesh-list
111278957|NCT03017703|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
111278958|NCT03017703|Hormone Antagonists|hormone antagonists|mesh-ancestor
111278959|NCT03017703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111278960|NCT03017703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111278961|NCT03017703|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
111278962|NCT03017703|Diuretics|diuretics|mesh-ancestor
111278963|NCT03017703|Natriuretic Agents|natriuretic agents|mesh-ancestor
111278964|NCT03017703|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111278965|NCT01670669|Prucalopride|prucalopride|mesh-list
111278966|NCT01670669|Laxatives|laxatives|mesh-ancestor
111278967|NCT01670669|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111278968|NCT01670669|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
111278969|NCT01670669|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111278970|NCT01670669|Serotonin Agents|serotonin agents|mesh-ancestor
111278971|NCT01670669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111278972|NCT01670669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111278973|NCT01670669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111278974|NCT00946023|Mycophenolic Acid|mycophenolic acid|mesh-list
111278975|NCT00946023|Cyclophosphamide|cyclophosphamide|mesh-list
111278976|NCT00946023|Rituximab|rituximab|mesh-list
111278977|NCT00946023|Fludarabine|fludarabine|mesh-list
111278978|NCT00946023|Tacrolimus|tacrolimus|mesh-list
111278979|NCT00946023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111278980|NCT00946023|Immunologic Factors|immunologic factors|mesh-ancestor
111278981|NCT00946023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111278982|NCT00946023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111278983|NCT00946023|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111278984|NCT00946023|Alkylating Agents|alkylating agents|mesh-ancestor
111278985|NCT00946023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111278986|NCT00946023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111278987|NCT00946023|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111278988|NCT00946023|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111278989|NCT00946023|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111278990|NCT00946023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111278991|NCT00946023|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111278992|NCT00946023|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111278993|NCT00946023|Antitubercular Agents|antitubercular agents|mesh-ancestor
111278994|NCT00946023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111278995|NCT00946023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111278996|NCT01672151|Sirolimus|sirolimus|mesh-list
111278997|NCT01672151|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111278998|NCT01672151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111278999|NCT01672151|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111279000|NCT01672151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111279001|NCT01672151|Antifungal Agents|antifungal agents|mesh-ancestor
111279002|NCT01672151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111279003|NCT01672151|Immunologic Factors|immunologic factors|mesh-ancestor
111279004|NCT01672151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111279005|NCT01672229|Bortezomib|bortezomib|mesh-list
111279006|NCT01672229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111279007|NCT01672307|Minoxidil|minoxidil|mesh-list
111279008|NCT01672307|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111279009|NCT01672307|Vasodilator Agents|vasodilator agents|mesh-ancestor
111279010|NCT03067194|Celecoxib|celecoxib|mesh-list
111279011|NCT03067194|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111279012|NCT03067194|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111279013|NCT03067194|Analgesics|analgesics|mesh-ancestor
111279014|NCT03067194|Sensory System Agents|sensory system agents|mesh-ancestor
111279015|NCT03067194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111279016|NCT03067194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111279017|NCT03067194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111279018|NCT03067194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111279019|NCT03067194|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111279020|NCT03067194|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111279021|NCT03067194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111279022|NCT03067194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111279023|NCT05629494|Ibuprofen|ibuprofen|mesh-list
111279024|NCT05629494|Naproxen|naproxen|mesh-list
111279025|NCT05629494|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111279026|NCT05629494|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111279027|NCT05629494|Analgesics|analgesics|mesh-ancestor
111279028|NCT05629494|Sensory System Agents|sensory system agents|mesh-ancestor
111279029|NCT05629494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111279030|NCT05629494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111279031|NCT05629494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111279032|NCT05629494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111279033|NCT05629494|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111279034|NCT05629494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111279035|NCT05629494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111279036|NCT05629494|Gout Suppressants|gout suppressants|mesh-ancestor
111279037|NCT00952653|Midazolam|midazolam|mesh-list
111279038|NCT00952653|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
111279039|NCT00952653|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111279040|NCT00952653|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111279041|NCT00952653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111279042|NCT00952653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111279043|NCT00952653|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111279044|NCT00952653|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111279045|NCT00952653|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111279046|NCT00952653|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111279047|NCT00952653|Anesthetics, General|anesthetics, general|mesh-ancestor
111279048|NCT00952653|Anesthetics|anesthetics|mesh-ancestor
111279049|NCT00952653|GABA Modulators|gaba modulators|mesh-ancestor
111279050|NCT00952653|GABA Agents|gaba agents|mesh-ancestor
111279051|NCT00952653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111279052|NCT00952653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111279053|NCT00952653|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111279054|NCT00952653|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111279055|NCT00952653|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111279056|NCT00952653|Antidepressive Agents|antidepressive agents|mesh-ancestor
111279057|NCT01673087|Dexamethasone|dexamethasone|mesh-list
111279058|NCT01673087|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
111279059|NCT01673087|Cosyntropin|cosyntropin|mesh-list
111279060|NCT01673087|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
111279061|NCT01673087|Metyrapone|metyrapone|mesh-list
111279062|NCT01673087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111279063|NCT01673087|Antiemetics|antiemetics|mesh-ancestor
111279064|NCT01673087|Autonomic Agents|autonomic agents|mesh-ancestor
111279065|NCT01673087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111279066|NCT01673087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111279067|NCT01673087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111279068|NCT01673087|Glucocorticoids|glucocorticoids|mesh-ancestor
111279069|NCT01673087|Hormones|hormones|mesh-ancestor
111279070|NCT01673087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111279071|NCT01673087|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111279072|NCT01673087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111279073|NCT01673087|Antimetabolites|antimetabolites|mesh-ancestor
111279074|NCT01673087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111279075|NCT01673087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111279076|NCT02299505|Ceritinib|ceritinib|mesh-list
111279077|NCT02299505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111279078|NCT02299505|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111279079|NCT02299505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111279080|NCT02299505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111279081|NCT01673399|Atosiban|atosiban|mesh-list
111279082|NCT01673399|Hormone Antagonists|hormone antagonists|mesh-ancestor
111279083|NCT01673399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111279084|NCT01673399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111279085|NCT01673399|Tocolytic Agents|tocolytic agents|mesh-ancestor
111279086|NCT01673399|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111279087|NCT02235701|Ifosfamide|ifosfamide|mesh-list
111279088|NCT02235701|Doxorubicin|doxorubicin|mesh-list
111279089|NCT02235701|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111279090|NCT02235701|Alkylating Agents|alkylating agents|mesh-ancestor
111279091|NCT02235701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111279092|NCT02235701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111279093|NCT02235701|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111279094|NCT02235701|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111279095|NCT02235701|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111279096|NCT02235701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111279097|NCT01674257|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
111279098|NCT01674257|Fluorides|fluorides|mesh-list
111279099|NCT01674257|Cariostatic Agents|cariostatic agents|mesh-ancestor
111279100|NCT01674257|Protective Agents|protective agents|mesh-ancestor
111279101|NCT01674257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111279102|NCT01674257|Hematinics|hematinics|mesh-ancestor
111279103|NCT01674257|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
111279104|NCT01674257|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111279105|NCT01674413|Adalimumab|adalimumab|mesh-list
111279106|NCT01674413|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111279107|NCT01674413|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111279108|NCT01674413|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111279109|NCT00953121|Bevacizumab|bevacizumab|mesh-list
111279110|NCT00953121|Carboplatin|carboplatin|mesh-list
111279111|NCT00953121|Irinotecan|irinotecan|mesh-list
111279112|NCT00953121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111279113|NCT00953121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111279114|NCT00953121|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111279115|NCT00953121|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111279116|NCT00953121|Growth Substances|growth substances|mesh-ancestor
111279117|NCT00953121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111279118|NCT00953121|Growth Inhibitors|growth inhibitors|mesh-ancestor
111279119|NCT00953121|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111279120|NCT00953121|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111279121|NCT00953121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111279122|NCT00953121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111279123|NCT03017391|Dexamethasone|dexamethasone|mesh-list
111279124|NCT03017391|Metoclopramide|metoclopramide|mesh-list
111279125|NCT03017391|Granisetron|granisetron|mesh-list
111279126|NCT03017391|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111279127|NCT03017391|Antiemetics|antiemetics|mesh-ancestor
111279128|NCT03017391|Autonomic Agents|autonomic agents|mesh-ancestor
111279129|NCT03017391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111279130|NCT03017391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111279131|NCT03017391|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111279132|NCT03017391|Glucocorticoids|glucocorticoids|mesh-ancestor
111279133|NCT03017391|Hormones|hormones|mesh-ancestor
111279134|NCT03017391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111279135|NCT03017391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111279136|NCT03017391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111279137|NCT03017391|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111279138|NCT03017391|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111279139|NCT03017391|Dopamine Agents|dopamine agents|mesh-ancestor
111279140|NCT03017391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111279141|NCT03017391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111279142|NCT03017391|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111279143|NCT03017391|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111279144|NCT03017391|Serotonin Agents|serotonin agents|mesh-ancestor
111279145|NCT00953199|Lidocaine|lidocaine|mesh-list
111279146|NCT00953199|Anesthetics, Local|anesthetics, local|mesh-ancestor
111279147|NCT00953199|Anesthetics|anesthetics|mesh-ancestor
111279148|NCT00953199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111279149|NCT00953199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111279150|NCT00953199|Sensory System Agents|sensory system agents|mesh-ancestor
111279151|NCT00953199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111279152|NCT00953199|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111279153|NCT00953199|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111279154|NCT00953199|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111279155|NCT00953199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111279156|NCT00953199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111279157|NCT03033147|Amoxicillin|amoxicillin|mesh-list
111279158|NCT03033147|Clavulanic Acid|clavulanic acid|mesh-list
111279159|NCT03033147|Clavulanic Acids|clavulanic acids|mesh-list
111279160|NCT03033147|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
111279161|NCT03033147|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111279162|NCT03033147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111279163|NCT03033147|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
111279164|NCT03033147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111279165|NCT03033147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111279166|NCT01675895|Lidocaine|lidocaine|mesh-list
111279167|NCT01675895|Levobupivacaine|levobupivacaine|mesh-list
111279168|NCT01675895|Anesthetics|anesthetics|mesh-list
111279169|NCT01675895|Anesthetics, Local|anesthetics, local|mesh-ancestor
111279170|NCT01675895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111279171|NCT01675895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111279172|NCT01675895|Sensory System Agents|sensory system agents|mesh-ancestor
111279173|NCT01675895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111279174|NCT01675895|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111279175|NCT01675895|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111279176|NCT01675895|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111279177|NCT01675895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111279178|NCT01675895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111279179|NCT01675973|Ranolazine|ranolazine|mesh-list
111279180|NCT01675973|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111279181|NCT01675973|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111279182|NCT01675973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111279183|NCT04764851|Ecopipam|ecopipam|mesh-list
111279184|NCT04764851|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111003691|NCT03742245|Olaparib|olaparib|mesh-list
111279185|NCT04764851|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111279186|NCT04764851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111279187|NCT04764851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111279188|NCT04764851|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111279189|NCT04764851|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111279190|NCT04764851|Dopamine Agents|dopamine agents|mesh-ancestor
111279191|NCT04764851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111279192|NCT04764851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111279194|NCT00956085|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111279195|NCT00956085|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111279196|NCT00956085|Dopamine Agents|dopamine agents|mesh-ancestor
111279197|NCT00956085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111279198|NCT00956085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111279199|NCT00956085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111279200|NCT00956085|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111279201|NCT00956085|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111279202|NCT01005459|Bupivacaine|bupivacaine|mesh-list
111279203|NCT01005459|Tetracaine|tetracaine|mesh-list
111279204|NCT01005459|Anesthetics, Local|anesthetics, local|mesh-ancestor
111279205|NCT01005459|Anesthetics|anesthetics|mesh-ancestor
111279206|NCT01005459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111279207|NCT01005459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111279208|NCT01005459|Sensory System Agents|sensory system agents|mesh-ancestor
111279209|NCT01005459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111279210|NCT01676285|Metoprolol|metoprolol|mesh-list
111279211|NCT01676285|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111279212|NCT01676285|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111279213|NCT01676285|Sympatholytics|sympatholytics|mesh-ancestor
111279214|NCT01676285|Autonomic Agents|autonomic agents|mesh-ancestor
111279215|NCT01676285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111279216|NCT01676285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111279217|NCT01676285|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
111279218|NCT01676285|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111279219|NCT01676285|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111279220|NCT01676285|Adrenergic Agents|adrenergic agents|mesh-ancestor
111279221|NCT01676285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111279222|NCT01676285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111279223|NCT01676363|Diflunisal|diflunisal|mesh-list
111279224|NCT01676363|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111279225|NCT01676363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111279226|NCT01676363|Analgesics|analgesics|mesh-ancestor
111279227|NCT01676363|Sensory System Agents|sensory system agents|mesh-ancestor
111279228|NCT01676363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111279229|NCT01676363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111279230|NCT01676363|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111279231|NCT01676363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111279232|NCT01676363|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111279233|NCT01676363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111279234|NCT01676363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111279235|NCT00956709|Ropivacaine|ropivacaine|mesh-list
111279236|NCT00956709|Levobupivacaine|levobupivacaine|mesh-list
111279237|NCT00956709|Anesthetics, Local|anesthetics, local|mesh-ancestor
111279238|NCT00956709|Anesthetics|anesthetics|mesh-ancestor
111279239|NCT00956709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111279240|NCT00956709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111279241|NCT00956709|Sensory System Agents|sensory system agents|mesh-ancestor
111279242|NCT00956709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111279243|NCT00957333|Ketamine|ketamine|mesh-list
111279244|NCT00957333|Analgesics|analgesics|mesh-ancestor
111279245|NCT00957333|Sensory System Agents|sensory system agents|mesh-ancestor
111279246|NCT00957333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111279247|NCT00957333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111279248|NCT00957333|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111279249|NCT00957333|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111279250|NCT00957333|Anesthetics, General|anesthetics, general|mesh-ancestor
111279251|NCT00957333|Anesthetics|anesthetics|mesh-ancestor
111279252|NCT00957333|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111279253|NCT00957333|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111279254|NCT00957333|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111279255|NCT00957333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111279256|NCT00957333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111279257|NCT02159547|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
111279258|NCT02159547|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111279259|NCT02159547|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111279260|NCT02159547|Analgesics|analgesics|mesh-ancestor
111279261|NCT02159547|Sensory System Agents|sensory system agents|mesh-ancestor
111279262|NCT02159547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111279263|NCT02159547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111279264|NCT02159547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111279265|NCT02159547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111279266|NCT00958035|Bimatoprost|bimatoprost|mesh-list
111279267|NCT00958035|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111279268|NCT00958035|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111279269|NCT01011075|Paclitaxel|paclitaxel|mesh-list
111279270|NCT01011075|Imatinib Mesylate|imatinib mesylate|mesh-list
111279271|NCT01011075|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111279272|NCT01011075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111279273|NCT01011075|Tubulin Modulators|tubulin modulators|mesh-ancestor
111279274|NCT01011075|Antimitotic Agents|antimitotic agents|mesh-ancestor
111279275|NCT01011075|Mitosis Modulators|mitosis modulators|mesh-ancestor
111279276|NCT01011075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111279277|NCT01011075|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111279278|NCT01011075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111279279|NCT00958581|Tranexamic Acid|tranexamic acid|mesh-list
111279280|NCT00958581|Aminocaproic Acid|aminocaproic acid|mesh-list
111279281|NCT00958581|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111279282|NCT00958581|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111279283|NCT00958581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111279284|NCT00958581|Hemostatics|hemostatics|mesh-ancestor
111279285|NCT00958581|Coagulants|coagulants|mesh-ancestor
111279286|NCT01012089|Daptomycin|daptomycin|mesh-list
111279287|NCT01012089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111279288|NCT01012089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111279289|NCT04265651|Infigratinib|infigratinib|mesh-list
111279290|NCT04265651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111279291|NCT04055753|Doxorubicin|doxorubicin|mesh-list
111279292|NCT04055753|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111279293|NCT04055753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111279294|NCT04055753|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111279295|NCT04055753|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111279296|NCT04055753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111279297|NCT04055753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111279298|NCT03871361|Abatacept|abatacept|mesh-list
111279299|NCT03871361|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111279300|NCT03871361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111279301|NCT03871361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111279302|NCT03871361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111279303|NCT03871361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111279304|NCT03871361|Immunologic Factors|immunologic factors|mesh-ancestor
111279305|NCT03871361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111279306|NCT03871361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111279307|NCT03589547|Durvalumab|durvalumab|mesh-list
111279308|NCT03589547|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111279309|NCT03589547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111279310|NCT04764383|Histamine|histamine|mesh-list
111279311|NCT04764383|Histamine Agonists|histamine agonists|mesh-ancestor
111279312|NCT04764383|Histamine Agents|histamine agents|mesh-ancestor
111279313|NCT04764383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111279314|NCT04764383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111279315|NCT04764383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111279316|NCT03016611|Ticagrelor|ticagrelor|mesh-list
111279317|NCT03016611|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
111279318|NCT03016611|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111279319|NCT03016611|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111279320|NCT03016611|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111279321|NCT03016611|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111279322|NCT03016611|Purinergic Agents|purinergic agents|mesh-ancestor
111279323|NCT03016611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111279324|NCT03016611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111279325|NCT03016611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111279326|NCT00961233|Budesonide|budesonide|mesh-list
111279327|NCT00961233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111279328|NCT00961233|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111279329|NCT00961233|Autonomic Agents|autonomic agents|mesh-ancestor
111279330|NCT00961233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111279331|NCT00961233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111279332|NCT00961233|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111279333|NCT00961233|Respiratory System Agents|respiratory system agents|mesh-ancestor
111003835|NCT03215706|Ipilimumab|ipilimumab|mesh-list
111279334|NCT00961233|Glucocorticoids|glucocorticoids|mesh-ancestor
111279335|NCT00961233|Hormones|hormones|mesh-ancestor
111279336|NCT00961233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111279337|NCT00962871|Tenofovir|tenofovir|mesh-list
111279338|NCT00962871|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
111279339|NCT00962871|Antiviral Agents|antiviral agents|mesh-ancestor
111279340|NCT00962871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111279341|NCT00962871|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111279342|NCT00962871|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111279343|NCT00962871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111279344|NCT00962871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111279345|NCT00962871|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111279346|NCT00962871|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111279347|NCT01014351|Paclitaxel|paclitaxel|mesh-list
111279348|NCT01014351|Carboplatin|carboplatin|mesh-list
111279349|NCT01014351|Everolimus|everolimus|mesh-list
111279350|NCT01014351|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111279351|NCT01014351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111279352|NCT01014351|Tubulin Modulators|tubulin modulators|mesh-ancestor
111279353|NCT01014351|Antimitotic Agents|antimitotic agents|mesh-ancestor
111279354|NCT01014351|Mitosis Modulators|mitosis modulators|mesh-ancestor
111279355|NCT01014351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111279356|NCT01014351|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111279357|NCT01014351|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111279358|NCT01014351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111279359|NCT01014351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111279360|NCT01014351|Immunologic Factors|immunologic factors|mesh-ancestor
111279361|NCT01014351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111279362|NCT01014741|Ibutilide|ibutilide|mesh-list
111279363|NCT01014741|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111279364|NCT01015443|Cyclophosphamide|cyclophosphamide|mesh-list
111279365|NCT01015443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111279366|NCT01015443|Immunologic Factors|immunologic factors|mesh-ancestor
111279367|NCT01015443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111279368|NCT01015443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111279369|NCT01015443|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111279370|NCT01015443|Alkylating Agents|alkylating agents|mesh-ancestor
111279371|NCT01015443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111279372|NCT01015443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111279373|NCT01015443|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111279374|NCT00962949|Angiotensin II|angiotensin ii|mesh-list
111279375|NCT00962949|Giapreza|giapreza|mesh-list
111279376|NCT00962949|Angiotensinogen|angiotensinogen|mesh-list
111279377|NCT00962949|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111279378|NCT00962949|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111279379|NCT00962949|Protease Inhibitors|protease inhibitors|mesh-ancestor
111279380|NCT00962949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111279381|NCT00962949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111279382|NCT01244789|Paclitaxel|paclitaxel|mesh-list
111279383|NCT01244789|Carboplatin|carboplatin|mesh-list
111279384|NCT01244789|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111279385|NCT01244789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111279386|NCT01244789|Tubulin Modulators|tubulin modulators|mesh-ancestor
111279387|NCT01244789|Antimitotic Agents|antimitotic agents|mesh-ancestor
111279388|NCT01244789|Mitosis Modulators|mitosis modulators|mesh-ancestor
111279389|NCT01244789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111279390|NCT02631876|Paclitaxel|paclitaxel|mesh-list
111279391|NCT02631876|Maytansine|maytansine|mesh-list
111279392|NCT02631876|Doxorubicin|doxorubicin|mesh-list
111279393|NCT02631876|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111279394|NCT02631876|Topotecan|topotecan|mesh-list
111279395|NCT02631876|Mirvetuximab soravtansine|mirvetuximab soravtansine|mesh-list
111279396|NCT02631876|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111279397|NCT02631876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111279398|NCT02631876|Tubulin Modulators|tubulin modulators|mesh-ancestor
111279399|NCT02631876|Antimitotic Agents|antimitotic agents|mesh-ancestor
111279400|NCT02631876|Mitosis Modulators|mitosis modulators|mesh-ancestor
111279401|NCT02631876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111279402|NCT02631876|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111279403|NCT02631876|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111279404|NCT02631876|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111279405|NCT02631876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111279406|NCT02631876|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111279407|NCT02631876|Immunoconjugates|immunoconjugates|mesh-ancestor
111279408|NCT02631876|Immunologic Factors|immunologic factors|mesh-ancestor
111279409|NCT02631876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111279410|NCT03156179|Calcium|calcium|mesh-list
111279411|NCT03156179|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111279412|NCT03156179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111279413|NCT04436796|Pancrelipase|pancrelipase|mesh-list
111279414|NCT04436796|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111279415|NCT02081963|Amikacin|amikacin|mesh-list
111279416|NCT02081963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111279417|NCT02081963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111279418|NCT04765085|Aripiprazole|aripiprazole|mesh-list
111279419|NCT04765085|Antidepressive Agents|antidepressive agents|mesh-ancestor
111279420|NCT04765085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111279421|NCT04765085|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111279422|NCT04765085|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111279423|NCT04765085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111279424|NCT04765085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111279425|NCT04765085|Dopamine Agonists|dopamine agonists|mesh-ancestor
111279426|NCT04765085|Dopamine Agents|dopamine agents|mesh-ancestor
111279427|NCT04765085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111279428|NCT04765085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111279429|NCT04765085|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111279430|NCT04765085|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111279431|NCT04765085|Serotonin Agents|serotonin agents|mesh-ancestor
111279432|NCT04765085|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111279433|NCT04765085|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111279434|NCT04765085|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111279435|NCT04765085|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111279436|NCT02633046|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
111279437|NCT02633046|Hormones|hormones|mesh-ancestor
111279438|NCT02633046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111279439|NCT02633046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111279440|NCT03881345|Anticoagulants|anticoagulants|mesh-list
111279441|NCT01676597|Rifaximin|rifaximin|mesh-list
111279442|NCT01676597|Pentoxifylline|pentoxifylline|mesh-list
111279443|NCT01676597|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111279444|NCT01676597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111279445|NCT01676597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111279446|NCT01676597|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111279447|NCT01676597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111279448|NCT01676597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111279449|NCT01676597|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111279450|NCT01676597|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111279451|NCT01676597|Protective Agents|protective agents|mesh-ancestor
111279452|NCT01676597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111279453|NCT01676597|Vasodilator Agents|vasodilator agents|mesh-ancestor
111279454|NCT01676597|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111279455|NCT01676597|Antioxidants|antioxidants|mesh-ancestor
111279456|NCT05540964|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
111279457|NCT05540964|Antiviral Agents|antiviral agents|mesh-ancestor
111279458|NCT05540964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111279459|NCT04364802|Iodine|iodine|mesh-list
111279460|NCT04364802|Cadexomer iodine|cadexomer iodine|mesh-list
111279461|NCT04364802|Povidone-Iodine|povidone-iodine|mesh-list
111279462|NCT04364802|Povidone|povidone|mesh-list
111279463|NCT04364802|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111279464|NCT04364802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111279465|NCT04364802|Trace Elements|trace elements|mesh-ancestor
111279466|NCT04364802|Micronutrients|micronutrients|mesh-ancestor
111279467|NCT04364802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111279468|NCT04364802|Plasma Substitutes|plasma substitutes|mesh-ancestor
111279469|NCT04364802|Blood Substitutes|blood substitutes|mesh-ancestor
111279470|NCT03155087|Metformin|metformin|mesh-list
111279471|NCT03155087|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111279472|NCT03155087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111279473|NCT03867617|Immunosuppressive Agents|immunosuppressive agents|mesh-list
111279474|NCT03867617|Immunologic Factors|immunologic factors|mesh-ancestor
111279475|NCT03867617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111279476|NCT00963105|Lenalidomide|lenalidomide|mesh-list
111279477|NCT00963105|Immunologic Factors|immunologic factors|mesh-ancestor
111279478|NCT00963105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111279479|NCT00963105|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111279480|NCT00963105|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111279481|NCT00963105|Growth Substances|growth substances|mesh-ancestor
111279482|NCT00963105|Growth Inhibitors|growth inhibitors|mesh-ancestor
111279483|NCT00963105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111279484|NCT04879992|Amoxicillin|amoxicillin|mesh-list
111279485|NCT04879992|Metronidazole|metronidazole|mesh-list
111279486|NCT04879992|Tetracycline|tetracycline|mesh-list
111279487|NCT04879992|Rifabutin|rifabutin|mesh-list
111279488|NCT04879992|Potassium Citrate|potassium citrate|mesh-list
111279489|NCT04879992|Esomeprazole|esomeprazole|mesh-list
111279490|NCT04879992|Bismuth|bismuth|mesh-list
111279491|NCT04879992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111279492|NCT04879992|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111279493|NCT04879992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111279494|NCT04879992|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111279495|NCT04879992|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111279496|NCT04879992|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111279497|NCT04879992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111279498|NCT04879992|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111279499|NCT04879992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111279500|NCT04879992|Antacids|antacids|mesh-ancestor
111279501|NCT04879992|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111279502|NCT04879992|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111279503|NCT04879992|Antitubercular Agents|antitubercular agents|mesh-ancestor
111279504|NCT04879992|Diuretics|diuretics|mesh-ancestor
111279505|NCT04879992|Natriuretic Agents|natriuretic agents|mesh-ancestor
111279506|NCT04879992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111279507|NCT04879992|Expectorants|expectorants|mesh-ancestor
111279508|NCT04879992|Respiratory System Agents|respiratory system agents|mesh-ancestor
111279509|NCT01016691|Bimatoprost|bimatoprost|mesh-list
111279510|NCT01016691|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111279511|NCT04181736|Guanfacine|guanfacine|mesh-list
111279512|NCT04181736|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111279513|NCT04181736|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111279514|NCT04181736|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111279515|NCT04181736|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111279516|NCT04181736|Adrenergic Agents|adrenergic agents|mesh-ancestor
111279517|NCT04181736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111279518|NCT04181736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111279519|NCT04181736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111279520|NCT04404491|Capecitabine|capecitabine|mesh-list
111279521|NCT04404491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111279522|NCT04404491|Antimetabolites|antimetabolites|mesh-ancestor
111279523|NCT04404491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111279524|NCT04404491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111279525|NCT03861299|Anesthetics|anesthetics|mesh-list
111279526|NCT03861299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111279527|NCT03861299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111279528|NCT05573568|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
111279529|NCT05573568|Hallucinogens|hallucinogens|mesh-ancestor
111279530|NCT05573568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111279531|NCT05573568|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111279532|NCT05573568|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111279533|NCT05573568|Serotonin Agents|serotonin agents|mesh-ancestor
111279534|NCT05573568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111279535|NCT05573568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111279536|NCT05573568|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111279537|NCT03858491|Cobicistat|cobicistat|mesh-list
111279538|NCT03858491|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111279539|NCT03858491|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111279540|NCT03858491|Antiviral Agents|antiviral agents|mesh-ancestor
111279541|NCT03858491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111279542|NCT03858491|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111279543|NCT03858491|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111279544|NCT03858491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111279545|NCT03858491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111279546|NCT01672788|Metformin|metformin|mesh-list
111279547|NCT01672788|Empagliflozin|empagliflozin|mesh-list
111279548|NCT01672788|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111279549|NCT01672788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111279550|NCT01672788|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111279551|NCT01672788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111279552|NCT02705963|Trametinib|trametinib|mesh-list
111279553|NCT02705963|Ethinyl Estradiol|ethinyl estradiol|mesh-list
111279554|NCT02705963|Norethindrone|norethindrone|mesh-list
111279555|NCT02705963|Norethindrone Acetate|norethindrone acetate|mesh-list
111279556|NCT02705963|Contraceptive Agents|contraceptive agents|mesh-list
111279557|NCT02705963|Contraceptives, Oral|contraceptives, oral|mesh-list
111279558|NCT02705963|Estradiol|estradiol|mesh-list
111279559|NCT02705963|Estrogens|estrogens|mesh-ancestor
111279560|NCT02705963|Hormones|hormones|mesh-ancestor
111279561|NCT02705963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111279562|NCT02705963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111279563|NCT02705963|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111279564|NCT02705963|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111279565|NCT02705963|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111279566|NCT02705963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111279567|NCT02705963|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111279568|NCT02705963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111279569|NCT02705963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111279570|NCT02705963|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111279571|NCT02705963|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111279572|NCT03065868|Clarithromycin|clarithromycin|mesh-list
111279573|NCT03065868|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111279574|NCT03065868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111279575|NCT03065868|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111279576|NCT03065868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111279577|NCT03065868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111279578|NCT03065868|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111279579|NCT03065868|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111279580|NCT03840239|Capecitabine|capecitabine|mesh-list
111279581|NCT03840239|Oxaliplatin|oxaliplatin|mesh-list
111279582|NCT03840239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111279583|NCT03840239|Antimetabolites|antimetabolites|mesh-ancestor
111279584|NCT03840239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111279585|NCT03840239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111279586|NCT02632110|Aminolevulinic Acid|aminolevulinic acid|mesh-list
111279587|NCT02632110|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111279588|NCT02632110|Dermatologic Agents|dermatologic agents|mesh-ancestor
111279589|NCT03830723|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
111279590|NCT03830723|Hormones|hormones|mesh-ancestor
111279591|NCT03830723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111279592|NCT03830723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111279593|NCT03829319|Carboplatin|carboplatin|mesh-list
111279594|NCT03829319|Pembrolizumab|pembrolizumab|mesh-list
111279595|NCT03829319|Pemetrexed|pemetrexed|mesh-list
111279596|NCT03829319|Lenvatinib|lenvatinib|mesh-list
111279597|NCT03829319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111279598|NCT03829319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111279599|NCT03829319|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111279600|NCT03829319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111279601|NCT03829319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111279602|NCT03829319|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111279603|NCT03829319|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111279604|NCT03829319|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111279605|NCT03814109|Niacin|niacin|mesh-list
111279606|NCT03814109|Indapamide|indapamide|mesh-list
111279607|NCT03814109|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111279608|NCT03814109|Diuretics|diuretics|mesh-ancestor
111279609|NCT03814109|Natriuretic Agents|natriuretic agents|mesh-ancestor
111279610|NCT03814109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111279611|NCT03814109|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
111279612|NCT03814109|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111279613|NCT03814109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111279614|NCT03814109|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111279615|NCT03814109|Antimetabolites|antimetabolites|mesh-ancestor
111279616|NCT03814109|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111279617|NCT03814109|Vasodilator Agents|vasodilator agents|mesh-ancestor
111279618|NCT03814109|Vitamin B Complex|vitamin b complex|mesh-ancestor
111279619|NCT03814109|Vitamins|vitamins|mesh-ancestor
111279620|NCT03814109|Micronutrients|micronutrients|mesh-ancestor
111279621|NCT01016769|Sirolimus|sirolimus|mesh-list
111279622|NCT01016769|Paclitaxel|paclitaxel|mesh-list
111279623|NCT01016769|Carboplatin|carboplatin|mesh-list
111279624|NCT01016769|Temsirolimus|temsirolimus|mesh-list
111279625|NCT01016769|MTOR Inhibitors|mtor inhibitors|mesh-list
111279626|NCT01016769|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111279627|NCT01016769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111279628|NCT01016769|Tubulin Modulators|tubulin modulators|mesh-ancestor
111279629|NCT01016769|Antimitotic Agents|antimitotic agents|mesh-ancestor
111279630|NCT01016769|Mitosis Modulators|mitosis modulators|mesh-ancestor
111279631|NCT01016769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111279632|NCT01016769|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111279633|NCT01016769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111279634|NCT01016769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111279635|NCT01016769|Immunologic Factors|immunologic factors|mesh-ancestor
111279636|NCT01016769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111279637|NCT01016769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111279638|NCT01016769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111279639|NCT01016769|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111279640|NCT01016769|Antifungal Agents|antifungal agents|mesh-ancestor
111279641|NCT03019809|Plerixafor|plerixafor|mesh-list
111279642|NCT03019809|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111279643|NCT03019809|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111279644|NCT03019809|Antiviral Agents|antiviral agents|mesh-ancestor
111279645|NCT03019809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111279646|NCT00964353|Warfarin|warfarin|mesh-list
111279647|NCT00964353|Anticoagulants|anticoagulants|mesh-ancestor
111279648|NCT00964431|Celecoxib|celecoxib|mesh-list
111279649|NCT00964431|Indomethacin|indomethacin|mesh-list
111279650|NCT00964431|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111279651|NCT00964431|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111279652|NCT00964431|Analgesics|analgesics|mesh-ancestor
111279653|NCT00964431|Sensory System Agents|sensory system agents|mesh-ancestor
111279654|NCT00964431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111279655|NCT00964431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111279656|NCT00964431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111279657|NCT00964431|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111279658|NCT00964431|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111279659|NCT00964431|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111279660|NCT00964431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111279661|NCT00964431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111279662|NCT00964431|Gout Suppressants|gout suppressants|mesh-ancestor
111279663|NCT00964431|Tocolytic Agents|tocolytic agents|mesh-ancestor
111279664|NCT00964431|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111279665|NCT05475054|Liver Extracts|liver extracts|mesh-list
111279666|NCT05475054|Hematinics|hematinics|mesh-ancestor
111279667|NCT01017003|Colchicine|colchicine|mesh-list
111279668|NCT01017003|Gout Suppressants|gout suppressants|mesh-ancestor
111279669|NCT01017003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111279670|NCT01017003|Tubulin Modulators|tubulin modulators|mesh-ancestor
111279671|NCT01017003|Antimitotic Agents|antimitotic agents|mesh-ancestor
111279672|NCT01017003|Mitosis Modulators|mitosis modulators|mesh-ancestor
111279673|NCT01017003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111279674|NCT01017003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111279675|NCT01017237|Midazolam|midazolam|mesh-list
111279676|NCT01017237|Dexmedetomidine|dexmedetomidine|mesh-list
111279677|NCT01017237|Ketamine|ketamine|mesh-list
111279678|NCT01017237|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111279679|NCT01017237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111279680|NCT01017237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111279681|NCT01017237|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111279682|NCT01017237|Analgesics|analgesics|mesh-ancestor
111279683|NCT01017237|Sensory System Agents|sensory system agents|mesh-ancestor
111279684|NCT01017237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111279685|NCT01017237|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111279686|NCT01017237|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111279687|NCT01017237|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111279688|NCT01017237|Adrenergic Agents|adrenergic agents|mesh-ancestor
111279689|NCT01017237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111279690|NCT01017237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111279691|NCT01017237|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111279692|NCT01017237|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111279693|NCT01017237|Anesthetics, General|anesthetics, general|mesh-ancestor
111279694|NCT01017237|Anesthetics|anesthetics|mesh-ancestor
111279695|NCT01017237|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111279696|NCT01017237|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111279697|NCT01017237|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111279698|NCT01017237|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111279699|NCT01017237|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111279700|NCT01017237|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111279701|NCT01017237|GABA Modulators|gaba modulators|mesh-ancestor
111279702|NCT01017237|GABA Agents|gaba agents|mesh-ancestor
111279703|NCT04442412|Vitamin D|vitamin d|mesh-list
111279704|NCT04442412|Cholecalciferol|cholecalciferol|mesh-list
111279705|NCT04442412|Vitamins|vitamins|mesh-ancestor
111279706|NCT04442412|Micronutrients|micronutrients|mesh-ancestor
111279707|NCT04442412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111279708|NCT04442412|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111279709|NCT04442412|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111279710|NCT01018095|Metronidazole|metronidazole|mesh-list
111279711|NCT01018095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111279712|NCT01018095|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111279713|NCT01018095|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111004236|NCT00736450|Glucocorticoids|glucocorticoids|mesh-ancestor
111279714|NCT01018095|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111279715|NCT03788759|Thioctic Acid|thioctic acid|mesh-list
111279716|NCT03788759|Antioxidants|antioxidants|mesh-ancestor
111279717|NCT03788759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111279718|NCT03788759|Protective Agents|protective agents|mesh-ancestor
111279719|NCT03788759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111279720|NCT03788759|Vitamin B Complex|vitamin b complex|mesh-ancestor
111279721|NCT03788759|Vitamins|vitamins|mesh-ancestor
111279722|NCT03788759|Micronutrients|micronutrients|mesh-ancestor
111279723|NCT00967551|Zinc|zinc|mesh-list
111279724|NCT00967551|Trace Elements|trace elements|mesh-list
111279725|NCT00967551|Micronutrients|micronutrients|mesh-list
111279726|NCT00967551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111279727|NCT03778073|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
111279728|NCT03778073|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111279729|NCT03778073|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111279730|NCT03778073|Alkylating Agents|alkylating agents|mesh-ancestor
111279731|NCT03778073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111279732|NCT03778073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111279733|NCT03778073|Immunologic Factors|immunologic factors|mesh-ancestor
111279734|NCT03778073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111279735|NCT00970203|Vaccines|vaccines|mesh-list
111279736|NCT00970203|Androgens|androgens|mesh-list
111279737|NCT00970203|Immunologic Factors|immunologic factors|mesh-ancestor
111279738|NCT00970203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111279739|NCT00970203|Hormones|hormones|mesh-ancestor
111279740|NCT00970203|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111279741|NCT00971295|Metformin|metformin|mesh-list
111279742|NCT00971295|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
111279743|NCT00971295|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111279744|NCT00971295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111279745|NCT00971295|Anticonvulsants|anticonvulsants|mesh-ancestor
111279746|NCT00971295|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111279747|NCT00971295|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111279748|NCT00971295|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111279749|NCT00971295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111279750|NCT00954681|Quetiapine Fumarate|quetiapine fumarate|mesh-list
111279751|NCT00954681|Antidepressive Agents|antidepressive agents|mesh-ancestor
111279752|NCT00954681|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111279753|NCT00954681|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111279754|NCT00954681|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111279755|NCT00954681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111279756|NCT00954681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111279757|NCT00971841|Paclitaxel|paclitaxel|mesh-list
111279758|NCT00971841|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111279759|NCT00971841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111279760|NCT00971841|Tubulin Modulators|tubulin modulators|mesh-ancestor
111279761|NCT00971841|Antimitotic Agents|antimitotic agents|mesh-ancestor
111279762|NCT00971841|Mitosis Modulators|mitosis modulators|mesh-ancestor
111279763|NCT00971841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111279764|NCT05395299|Ethylene|ethylene|mesh-list
111279765|NCT05395299|Plant Growth Regulators|plant growth regulators|mesh-ancestor
111279766|NCT05395299|Growth Substances|growth substances|mesh-ancestor
111279767|NCT05395299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111279768|NCT02246049|Leucovorin|leucovorin|mesh-list
111279769|NCT02246049|Bevacizumab|bevacizumab|mesh-list
111279770|NCT02246049|Fluorouracil|fluorouracil|mesh-list
111279771|NCT02246049|Oxaliplatin|oxaliplatin|mesh-list
111279772|NCT02246049|Irinotecan|irinotecan|mesh-list
111279773|NCT02246049|Calcium|calcium|mesh-list
111279774|NCT02246049|Levoleucovorin|levoleucovorin|mesh-list
111279775|NCT02246049|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111279776|NCT02246049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111279777|NCT02246049|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111279778|NCT02246049|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111279779|NCT02246049|Growth Substances|growth substances|mesh-ancestor
111279780|NCT02246049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111279781|NCT02246049|Growth Inhibitors|growth inhibitors|mesh-ancestor
111279782|NCT02246049|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111279783|NCT02246049|Antimetabolites|antimetabolites|mesh-ancestor
111279784|NCT02246049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111279785|NCT02246049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111279786|NCT02246049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111279787|NCT02246049|Immunologic Factors|immunologic factors|mesh-ancestor
111279788|NCT02246049|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111279789|NCT02246049|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111279790|NCT02246049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111279791|NCT02246049|Antidotes|antidotes|mesh-ancestor
111279792|NCT02246049|Protective Agents|protective agents|mesh-ancestor
111279793|NCT02246049|Vitamin B Complex|vitamin b complex|mesh-ancestor
111279795|NCT02246049|Micronutrients|micronutrients|mesh-ancestor
111279796|NCT05395143|Zinc Sulfate|zinc sulfate|mesh-list
111279797|NCT05395143|Astringents|astringents|mesh-ancestor
111279798|NCT05395143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111279799|NCT05395143|Dermatologic Agents|dermatologic agents|mesh-ancestor
111279800|NCT05394909|Methylprednisolone|methylprednisolone|mesh-list
111279801|NCT05394909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111279802|NCT05394909|Antiemetics|antiemetics|mesh-ancestor
111279803|NCT05394909|Autonomic Agents|autonomic agents|mesh-ancestor
111279804|NCT05394909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111279805|NCT05394909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111279806|NCT05394909|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111279807|NCT05394909|Glucocorticoids|glucocorticoids|mesh-ancestor
111279808|NCT05394909|Hormones|hormones|mesh-ancestor
111279809|NCT05394909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111279810|NCT05394909|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111279811|NCT05394909|Protective Agents|protective agents|mesh-ancestor
111279812|NCT05694858|Lidocaine|lidocaine|mesh-list
111279813|NCT05694858|Anesthetics, Local|anesthetics, local|mesh-ancestor
111279814|NCT05694858|Anesthetics|anesthetics|mesh-ancestor
111279815|NCT05694858|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111279816|NCT05694858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111279817|NCT05694858|Sensory System Agents|sensory system agents|mesh-ancestor
111279818|NCT05694858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111279819|NCT05694858|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111279820|NCT05694858|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111279821|NCT05694858|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111279822|NCT05694858|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111279823|NCT05694858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111279824|NCT02159859|Ertapenem|ertapenem|mesh-list
111279825|NCT02159859|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111279826|NCT02159859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111279827|NCT00974493|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111279828|NCT00974493|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
111279829|NCT00974493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111279830|NCT00974493|Antitubercular Agents|antitubercular agents|mesh-ancestor
111279831|NCT02083679|Paclitaxel|paclitaxel|mesh-list
111279832|NCT02083679|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111279833|NCT02083679|Cisplatin|cisplatin|mesh-list
111279834|NCT02083679|Carboplatin|carboplatin|mesh-list
111279835|NCT02083679|Gemcitabine|gemcitabine|mesh-list
111279836|NCT02083679|Pemetrexed|pemetrexed|mesh-list
111279837|NCT02083679|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111279838|NCT02083679|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111279839|NCT02083679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111279840|NCT02083679|Tubulin Modulators|tubulin modulators|mesh-ancestor
111279841|NCT02083679|Antimitotic Agents|antimitotic agents|mesh-ancestor
111279842|NCT02083679|Mitosis Modulators|mitosis modulators|mesh-ancestor
111279843|NCT02083679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111279844|NCT02083679|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111279845|NCT02083679|Antimetabolites|antimetabolites|mesh-ancestor
111279846|NCT02083679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111279847|NCT02083679|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111279848|NCT02083679|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111279849|NCT02083679|Immunologic Factors|immunologic factors|mesh-ancestor
111279850|NCT02083679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111279851|NCT01672710|Niacin|niacin|mesh-list
111279852|NCT01672710|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111279853|NCT01672710|Antimetabolites|antimetabolites|mesh-ancestor
111279854|NCT01672710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111279855|NCT01672710|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111279856|NCT01672710|Vasodilator Agents|vasodilator agents|mesh-ancestor
111279857|NCT01672710|Vitamin B Complex|vitamin b complex|mesh-ancestor
111279858|NCT01672710|Vitamins|vitamins|mesh-ancestor
111279859|NCT01672710|Micronutrients|micronutrients|mesh-ancestor
111279860|NCT01672710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111279861|NCT03766763|Venetoclax|venetoclax|mesh-list
111279862|NCT03766763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111279863|NCT04790448|Irinotecan|irinotecan|mesh-list
111279864|NCT04790448|Camptothecin|camptothecin|mesh-list
111279865|NCT04790448|Cetuximab|cetuximab|mesh-list
111279866|NCT04790448|Vemurafenib|vemurafenib|mesh-list
111279867|NCT04790448|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111279868|NCT04790448|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111279869|NCT04790448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111279870|NCT04790448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111279871|NCT04790448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111279872|NCT04790448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111279873|NCT04790448|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111279874|NCT04790448|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111279875|NCT04784052|Cyclophosphamide|cyclophosphamide|mesh-list
111279876|NCT04784052|Rituximab|rituximab|mesh-list
111279877|NCT04784052|Fludarabine|fludarabine|mesh-list
111279878|NCT04784052|Thymoglobulin|thymoglobulin|mesh-list
111279879|NCT04784052|Antilymphocyte Serum|antilymphocyte serum|mesh-list
111279880|NCT04784052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111279881|NCT04784052|Immunologic Factors|immunologic factors|mesh-ancestor
111279882|NCT04784052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111279883|NCT04784052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111279884|NCT04784052|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111279885|NCT04784052|Alkylating Agents|alkylating agents|mesh-ancestor
111279886|NCT04784052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111279887|NCT04784052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111279888|NCT04784052|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111279889|NCT04784052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111279890|NCT00976521|Abciximab|abciximab|mesh-list
111279891|NCT00976521|Anticoagulants|anticoagulants|mesh-ancestor
111279892|NCT00976521|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111279893|NCT04410588|Fentanyl|fentanyl|mesh-list
111279894|NCT04410588|Levobupivacaine|levobupivacaine|mesh-list
111279895|NCT04410588|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111279896|NCT04410588|Narcotics|narcotics|mesh-ancestor
111279897|NCT04410588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111279898|NCT04410588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111279899|NCT04410588|Analgesics|analgesics|mesh-ancestor
111279900|NCT04410588|Sensory System Agents|sensory system agents|mesh-ancestor
111279901|NCT04410588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111279902|NCT04410588|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111279903|NCT04410588|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111279904|NCT04410588|Anesthetics, General|anesthetics, general|mesh-ancestor
111279905|NCT04410588|Anesthetics|anesthetics|mesh-ancestor
111279906|NCT04410588|Anesthetics, Local|anesthetics, local|mesh-ancestor
111279907|NCT05303220|Branebrutinib|branebrutinib|mesh-list
111279908|NCT05303220|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111279909|NCT05303220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111279910|NCT05303220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111279911|NCT04444830|Ketorolac|ketorolac|mesh-list
111279912|NCT04444830|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111279913|NCT04444830|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111279914|NCT04444830|Analgesics|analgesics|mesh-ancestor
111279915|NCT04444830|Sensory System Agents|sensory system agents|mesh-ancestor
111279916|NCT04444830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111279917|NCT04444830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111279918|NCT04444830|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111279919|NCT04444830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111279920|NCT04444830|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111279921|NCT04444830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111279922|NCT04444830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111279923|NCT01273259|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
111279924|NCT01273259|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111279925|NCT01273259|Immunologic Factors|immunologic factors|mesh-ancestor
111279926|NCT01273259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111279927|NCT03738917|Bromides|bromides|mesh-list
111279928|NCT03738917|Dextromethorphan|dextromethorphan|mesh-list
111279929|NCT03738917|Ipratropium|ipratropium|mesh-list
111279930|NCT03738917|Cholinergic Antagonists|cholinergic antagonists|mesh-list
111279931|NCT03738917|Anticonvulsants|anticonvulsants|mesh-ancestor
111279932|NCT03738917|Antitussive Agents|antitussive agents|mesh-ancestor
111279933|NCT03738917|Respiratory System Agents|respiratory system agents|mesh-ancestor
111279934|NCT03738917|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111279935|NCT03738917|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111279936|NCT03738917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111279937|NCT03738917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111279938|NCT03738917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111279939|NCT03738917|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111279940|NCT03738917|Autonomic Agents|autonomic agents|mesh-ancestor
111279941|NCT03738917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111279942|NCT03738917|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111279943|NCT03738917|Cholinergic Agents|cholinergic agents|mesh-ancestor
111279944|NCT00976599|Methotrexate|methotrexate|mesh-list
111279945|NCT00976599|Tofacitinib|tofacitinib|mesh-list
111279946|NCT00976599|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111279947|NCT00976599|Abortifacient Agents|abortifacient agents|mesh-ancestor
111279948|NCT00976599|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111279949|NCT00976599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111279950|NCT00976599|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111279951|NCT00976599|Antimetabolites|antimetabolites|mesh-ancestor
111279952|NCT00976599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111279953|NCT00976599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111279954|NCT00976599|Dermatologic Agents|dermatologic agents|mesh-ancestor
111279955|NCT00976599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111279956|NCT00976599|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111279957|NCT00976599|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111279958|NCT00976599|Immunologic Factors|immunologic factors|mesh-ancestor
111279959|NCT00976599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111279960|NCT00976599|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111279961|NCT00976599|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
111279962|NCT00976599|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111279963|NCT02630472|Quinine|quinine|mesh-list
111279964|NCT02630472|Antimalarials|antimalarials|mesh-ancestor
111279965|NCT02630472|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111279966|NCT02630472|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111279967|NCT02630472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111279968|NCT02630472|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
111279969|NCT02630472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111279970|NCT02630472|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111279971|NCT02630472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111279972|NCT02630472|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111279973|NCT02630472|Analgesics|analgesics|mesh-ancestor
111279974|NCT02630472|Sensory System Agents|sensory system agents|mesh-ancestor
111279975|NCT03729011|Propofol|propofol|mesh-list
111279976|NCT03729011|Sevoflurane|sevoflurane|mesh-list
111279977|NCT03729011|Desflurane|desflurane|mesh-list
111279978|NCT03729011|Isoflurane|isoflurane|mesh-list
111279979|NCT03729011|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111279980|NCT03729011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111279981|NCT03729011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111279982|NCT03729011|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111279983|NCT03729011|Anesthetics, General|anesthetics, general|mesh-ancestor
111279984|NCT03729011|Anesthetics|anesthetics|mesh-ancestor
111279985|NCT03729011|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111279986|NCT03729011|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111279987|NCT05264922|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
111279988|NCT05264922|Hemostatics|hemostatics|mesh-ancestor
111279989|NCT05264922|Coagulants|coagulants|mesh-ancestor
111279990|NCT00977769|Oxytocin|oxytocin|mesh-list
111279991|NCT00977769|Carbetocin|carbetocin|mesh-list
111279992|NCT00977769|Oxytocics|oxytocics|mesh-ancestor
111279993|NCT00977769|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111279994|NCT00977769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111279995|NCT03725501|Ranibizumab|ranibizumab|mesh-list
111279996|NCT03725501|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111279997|NCT03725501|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111279998|NCT03725501|Growth Substances|growth substances|mesh-ancestor
111279999|NCT03725501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111280000|NCT03725501|Growth Inhibitors|growth inhibitors|mesh-ancestor
111280001|NCT03725501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111280002|NCT00979017|Bevacizumab|bevacizumab|mesh-list
111280003|NCT00979017|Irinotecan|irinotecan|mesh-list
111280004|NCT00979017|Temozolomide|temozolomide|mesh-list
111280005|NCT00979017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111280006|NCT00979017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111280007|NCT00979017|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111280008|NCT00979017|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111280009|NCT00979017|Growth Substances|growth substances|mesh-ancestor
111280010|NCT00979017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111280011|NCT00979017|Growth Inhibitors|growth inhibitors|mesh-ancestor
111280012|NCT00979017|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111280013|NCT00979017|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111280014|NCT00979017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111280015|NCT00979017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111280016|NCT00979017|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111280017|NCT00979017|Alkylating Agents|alkylating agents|mesh-ancestor
111280018|NCT01670526|Rivastigmine|rivastigmine|mesh-list
111280019|NCT01670526|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
111280020|NCT01670526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111280021|NCT01670526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111280022|NCT01670526|Cholinergic Agents|cholinergic agents|mesh-ancestor
111280023|NCT01670526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111280024|NCT01670526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111280025|NCT01670526|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111280026|NCT01670526|Protective Agents|protective agents|mesh-ancestor
111280027|NCT00945035|Etoricoxib|etoricoxib|mesh-list
111280028|NCT00945035|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111280029|NCT00945035|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111280030|NCT00945035|Analgesics|analgesics|mesh-ancestor
111280031|NCT00945035|Sensory System Agents|sensory system agents|mesh-ancestor
111280032|NCT00945035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111280033|NCT00945035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111280034|NCT00945035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111280035|NCT00945035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111280036|NCT00945035|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111280037|NCT00945035|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111280038|NCT00945035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111280039|NCT00945035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111280040|NCT03720431|Pembrolizumab|pembrolizumab|mesh-list
111280041|NCT03720431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111280042|NCT03720431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111280043|NCT03720431|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111280044|NCT03720431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111280045|NCT05386953|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111280046|NCT05176548|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111280047|NCT05176548|Myeloma Proteins|myeloma proteins|mesh-list
111280048|NCT05176548|Paraproteins|paraproteins|mesh-list
111280049|NCT05176548|Immunologic Factors|immunologic factors|mesh-ancestor
111280050|NCT05176548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111280051|NCT03719105|Dexamethasone|dexamethasone|mesh-list
111280052|NCT03719105|Prednisone|prednisone|mesh-list
111280053|NCT03719105|Cyclophosphamide|cyclophosphamide|mesh-list
111280054|NCT03719105|Ifosfamide|ifosfamide|mesh-list
111280055|NCT03719105|Doxorubicin|doxorubicin|mesh-list
111280056|NCT03719105|Methotrexate|methotrexate|mesh-list
111280057|NCT03719105|Etoposide|etoposide|mesh-list
111280058|NCT03719105|Brentuximab Vedotin|brentuximab vedotin|mesh-list
111280059|NCT03719105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111280060|NCT03719105|Immunologic Factors|immunologic factors|mesh-ancestor
111280061|NCT03719105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111280062|NCT03719105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111280063|NCT03719105|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111280064|NCT03719105|Alkylating Agents|alkylating agents|mesh-ancestor
111280065|NCT03719105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111280066|NCT03719105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111280067|NCT03719105|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111280068|NCT03719105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111280069|NCT03719105|Antiemetics|antiemetics|mesh-ancestor
111280070|NCT03719105|Autonomic Agents|autonomic agents|mesh-ancestor
111280071|NCT03719105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111280072|NCT03719105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111280073|NCT03719105|Glucocorticoids|glucocorticoids|mesh-ancestor
111280074|NCT03719105|Hormones|hormones|mesh-ancestor
111280075|NCT03719105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111280076|NCT03719105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111280077|NCT03719105|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111280078|NCT03719105|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111280079|NCT03719105|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111280080|NCT03719105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111280081|NCT03719105|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111280082|NCT03719105|Abortifacient Agents|abortifacient agents|mesh-ancestor
111280083|NCT03719105|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111280084|NCT03719105|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111280085|NCT03719105|Antimetabolites|antimetabolites|mesh-ancestor
111280086|NCT03719105|Dermatologic Agents|dermatologic agents|mesh-ancestor
111280087|NCT03719105|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111280088|NCT03719105|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111280089|NCT03719105|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111280090|NCT03719105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111280091|NCT03719105|Immunotoxins|immunotoxins|mesh-ancestor
111280092|NCT03719105|Immunoconjugates|immunoconjugates|mesh-ancestor
111280093|NCT00979875|Insulin|insulin|mesh-list
111280094|NCT00979875|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111280095|NCT00979875|Insulin Aspart|insulin aspart|mesh-list
111004597|NCT05947825|Tubulin Modulators|tubulin modulators|mesh-ancestor
111280096|NCT00979875|Insulin Lispro|insulin lispro|mesh-list
111280097|NCT00979875|Insulin glulisine|insulin glulisine|mesh-list
111280098|NCT00979875|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111280099|NCT00979875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111280100|NCT03710603|Dexamethasone|dexamethasone|mesh-list
111280101|NCT03710603|Dexamethasone acetate|dexamethasone acetate|mesh-list
111280102|NCT03710603|Lenalidomide|lenalidomide|mesh-list
111280104|NCT03710603|Daratumumab|daratumumab|mesh-list
111280105|NCT03710603|BB 1101|bb 1101|mesh-list
111280106|NCT03710603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111280107|NCT03710603|Antiemetics|antiemetics|mesh-ancestor
111280108|NCT03710603|Autonomic Agents|autonomic agents|mesh-ancestor
111280109|NCT03710603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111280110|NCT03710603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111280111|NCT03710603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111280112|NCT03710603|Glucocorticoids|glucocorticoids|mesh-ancestor
111280113|NCT03710603|Hormones|hormones|mesh-ancestor
111280114|NCT03710603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111280115|NCT03710603|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111280116|NCT03710603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111280117|NCT03710603|Protease Inhibitors|protease inhibitors|mesh-ancestor
111280118|NCT03710603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111280119|NCT03710603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111280120|NCT03710603|Immunologic Factors|immunologic factors|mesh-ancestor
111280121|NCT03710603|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111280122|NCT03710603|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111280123|NCT03710603|Growth Substances|growth substances|mesh-ancestor
111280124|NCT03710603|Growth Inhibitors|growth inhibitors|mesh-ancestor
111280125|NCT02630706|Metformin|metformin|mesh-list
111280126|NCT02630706|Glimepiride|glimepiride|mesh-list
111280127|NCT02630706|Ertugliflozin|ertugliflozin|mesh-list
111280128|NCT02630706|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111280129|NCT02630706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111280130|NCT02630706|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111280131|NCT02630706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111280132|NCT02630706|Immunologic Factors|immunologic factors|mesh-ancestor
111280133|NCT02630706|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111280134|NCT02630706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111280135|NCT04763057|Calcium|calcium|mesh-list
111280136|NCT04763057|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111280137|NCT04763057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111280138|NCT03702179|Durvalumab|durvalumab|mesh-list
111280139|NCT03702179|Tremelimumab|tremelimumab|mesh-list
111280140|NCT03702179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111280141|NCT03702179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111280142|NCT01677143|Bupivacaine|bupivacaine|mesh-list
111280143|NCT01677143|Anesthetics, Local|anesthetics, local|mesh-ancestor
111280144|NCT01677143|Anesthetics|anesthetics|mesh-ancestor
111280145|NCT01677143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111280146|NCT01677143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111280147|NCT01677143|Sensory System Agents|sensory system agents|mesh-ancestor
111280148|NCT01677143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111280149|NCT03692663|Cyclophosphamide|cyclophosphamide|mesh-list
111280150|NCT03692663|Fludarabine|fludarabine|mesh-list
110732471|NCT04893785|Temozolomide|temozolomide|mesh-list
111280151|NCT03692663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111280152|NCT03692663|Immunologic Factors|immunologic factors|mesh-ancestor
111280153|NCT03692663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111280154|NCT03692663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111280155|NCT03692663|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111280156|NCT03692663|Alkylating Agents|alkylating agents|mesh-ancestor
111280157|NCT03692663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111280158|NCT03692663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111280159|NCT03692663|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111280160|NCT02084069|Atorvastatin|atorvastatin|mesh-list
111280161|NCT02084069|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111280162|NCT02084069|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111280163|NCT02084069|Antimetabolites|antimetabolites|mesh-ancestor
111280164|NCT02084069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111280165|NCT02084069|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111280166|NCT02084069|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111280167|NCT02084069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111280168|NCT03685331|Fulvestrant|fulvestrant|mesh-list
111280169|NCT03685331|Olaparib|olaparib|mesh-list
111280170|NCT03685331|Palbociclib|palbociclib|mesh-list
111280171|NCT03685331|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111280172|NCT03685331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111280173|NCT03685331|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
111280175|NCT03685331|Hormone Antagonists|hormone antagonists|mesh-ancestor
111280176|NCT03685331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111280177|NCT03685331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111280178|NCT03685331|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111280179|NCT03685331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111280180|NCT03685331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111280181|NCT03685331|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111280182|NCT04626024|Imatinib Mesylate|imatinib mesylate|mesh-list
111280183|NCT04626024|Dasatinib|dasatinib|mesh-list
111280184|NCT04626024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111280185|NCT04626024|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111280186|NCT04626024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111280187|NCT04626024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111280188|NCT00981045|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
111280189|NCT00981045|Hematinics|hematinics|mesh-ancestor
111280190|NCT00981435|Prednisolone|prednisolone|mesh-list
111280191|NCT00981435|Prednisolone acetate|prednisolone acetate|mesh-list
111280192|NCT00981435|Ketorolac|ketorolac|mesh-list
111280193|NCT00981435|Lubricant Eye Drops|lubricant eye drops|mesh-list
111280194|NCT00981435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111280195|NCT00981435|Glucocorticoids|glucocorticoids|mesh-ancestor
111280196|NCT00981435|Hormones|hormones|mesh-ancestor
111280197|NCT00981435|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111280198|NCT00981435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111280199|NCT00981435|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111280200|NCT00981435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111280201|NCT00981435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111280202|NCT00981435|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111280203|NCT00981435|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111280204|NCT00981435|Analgesics|analgesics|mesh-ancestor
111280205|NCT00981435|Sensory System Agents|sensory system agents|mesh-ancestor
111280206|NCT00981435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111280207|NCT00981435|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111280208|NCT00981435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111280209|NCT00981435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111280210|NCT00981435|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
111280211|NCT00981435|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111280212|NCT00981669|Vaccines|vaccines|mesh-list
111280213|NCT00981669|Immunologic Factors|immunologic factors|mesh-ancestor
111280214|NCT00981669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111280215|NCT00981825|Listerine|listerine|mesh-list
111280216|NCT00981825|Triclosan|triclosan|mesh-list
111280217|NCT00981825|Fluorides|fluorides|mesh-list
111280218|NCT00981825|Sodium Fluoride|sodium fluoride|mesh-list
111280219|NCT00981825|Cariostatic Agents|cariostatic agents|mesh-ancestor
111280220|NCT00981825|Protective Agents|protective agents|mesh-ancestor
111280221|NCT00981825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111280222|NCT00981825|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111280223|NCT00981825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111280224|NCT00981825|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
111280225|NCT00981825|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111280226|NCT00981825|Antimetabolites|antimetabolites|mesh-ancestor
111280227|NCT00981825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111280228|NCT00981825|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111280229|NCT00983307|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111280230|NCT00983307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111280231|NCT00983307|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111280232|NCT00983307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111280233|NCT00983307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111280234|NCT04762745|Thalidomide|thalidomide|mesh-list
111280235|NCT04762745|Dexamethasone|dexamethasone|mesh-list
111280236|NCT04762745|Dexamethasone acetate|dexamethasone acetate|mesh-list
111280237|NCT04762745|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
111280238|NCT04762745|Pomalidomide|pomalidomide|mesh-list
111280239|NCT04762745|BB 1101|bb 1101|mesh-list
111280240|NCT04762745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111280241|NCT04762745|Antiemetics|antiemetics|mesh-ancestor
111280242|NCT04762745|Autonomic Agents|autonomic agents|mesh-ancestor
111280243|NCT04762745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111280244|NCT04762745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111280245|NCT04762745|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111280246|NCT04762745|Glucocorticoids|glucocorticoids|mesh-ancestor
111280247|NCT04762745|Hormones|hormones|mesh-ancestor
111280248|NCT04762745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111280249|NCT04762745|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111280250|NCT04762745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111280251|NCT04762745|Protease Inhibitors|protease inhibitors|mesh-ancestor
111280252|NCT04762745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111280253|NCT04762745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111280254|NCT04762745|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111280255|NCT04762745|Alkylating Agents|alkylating agents|mesh-ancestor
111280256|NCT04762745|Immunologic Factors|immunologic factors|mesh-ancestor
111280257|NCT04762745|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111280258|NCT04762745|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111280259|NCT04762745|Growth Substances|growth substances|mesh-ancestor
111280260|NCT04762745|Growth Inhibitors|growth inhibitors|mesh-ancestor
111280261|NCT04762745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111280262|NCT04762745|Leprostatic Agents|leprostatic agents|mesh-ancestor
111280263|NCT04762745|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111280264|NCT04762745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111280265|NCT00983541|Gemcitabine|gemcitabine|mesh-list
111280266|NCT00983541|Fluorouracil|fluorouracil|mesh-list
111280267|NCT00983541|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111280268|NCT00983541|Antimetabolites|antimetabolites|mesh-ancestor
111280269|NCT00983541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111280270|NCT00983541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111280271|NCT00983541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111280272|NCT00983541|Immunologic Factors|immunologic factors|mesh-ancestor
111280273|NCT00983541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111280274|NCT03667703|Famotidine|famotidine|mesh-list
111280275|NCT03667703|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111280276|NCT03667703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111280277|NCT03667703|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
111280278|NCT03667703|Histamine Antagonists|histamine antagonists|mesh-ancestor
111280279|NCT03667703|Histamine Agents|histamine agents|mesh-ancestor
111280280|NCT03667703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111280281|NCT03667703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111280282|NCT03667703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111280283|NCT05074056|Ketorolac|ketorolac|mesh-list
111280284|NCT05074056|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111280285|NCT05074056|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111280286|NCT05074056|Analgesics|analgesics|mesh-ancestor
111280287|NCT05074056|Sensory System Agents|sensory system agents|mesh-ancestor
111280288|NCT05074056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111280289|NCT05074056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111280290|NCT05074056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111280291|NCT05074056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111280292|NCT05074056|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111280293|NCT05074056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111280294|NCT05074056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111280295|NCT03656549|Pemetrexed|pemetrexed|mesh-list
111280296|NCT03656549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111280297|NCT03656549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111280298|NCT03656549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111280299|NCT03656549|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111280300|NCT03656549|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111280301|NCT03062904|Methacholine Chloride|methacholine chloride|mesh-list
111280302|NCT03062904|Bronchodilator Agents|bronchodilator agents|mesh-list
111280303|NCT03062904|Miotics|miotics|mesh-ancestor
111280304|NCT03062904|Autonomic Agents|autonomic agents|mesh-ancestor
111280305|NCT03062904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111280306|NCT03062904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111280307|NCT03062904|Parasympathomimetics|parasympathomimetics|mesh-ancestor
111280308|NCT03062904|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
111280309|NCT03062904|Respiratory System Agents|respiratory system agents|mesh-ancestor
111280310|NCT03062904|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
111280311|NCT03062904|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111280312|NCT03062904|Cholinergic Agents|cholinergic agents|mesh-ancestor
111280313|NCT03062904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111280314|NCT03062904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111280315|NCT03062904|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111280316|NCT00986583|Succinylcholine|succinylcholine|mesh-list
111280317|NCT00986583|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
111004820|NCT05838287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111004821|NCT05832047|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111004825|NCT05825066|Paclitaxel|paclitaxel|mesh-list
111280318|NCT00986583|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
111280320|NCT00986583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111280321|NCT00986583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111280322|NCT05056974|UB-421|ub-421|mesh-list
111280323|NCT05056974|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111280324|NCT05056974|Antiviral Agents|antiviral agents|mesh-ancestor
111280325|NCT05056974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111280326|NCT03643913|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
111280327|NCT03643913|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111280328|NCT03643913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111280329|NCT03643913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111280330|NCT04762511|Vaccines|vaccines|mesh-list
111280331|NCT04762511|Immunologic Factors|immunologic factors|mesh-ancestor
111280332|NCT04762511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111280333|NCT04762901|Paclitaxel|paclitaxel|mesh-list
111280334|NCT04762901|Cyclophosphamide|cyclophosphamide|mesh-list
111280335|NCT04762901|Carboplatin|carboplatin|mesh-list
111280336|NCT04762901|Doxorubicin|doxorubicin|mesh-list
111280337|NCT04762901|Niraparib|niraparib|mesh-list
111280338|NCT04762901|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111280339|NCT04762901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111280340|NCT04762901|Tubulin Modulators|tubulin modulators|mesh-ancestor
111280341|NCT04762901|Antimitotic Agents|antimitotic agents|mesh-ancestor
111280342|NCT04762901|Mitosis Modulators|mitosis modulators|mesh-ancestor
111280343|NCT04762901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111280344|NCT04762901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111280345|NCT04762901|Immunologic Factors|immunologic factors|mesh-ancestor
111280346|NCT04762901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111280347|NCT04762901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111280348|NCT04762901|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111280349|NCT04762901|Alkylating Agents|alkylating agents|mesh-ancestor
111280350|NCT04762901|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111280351|NCT04762901|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111280352|NCT04762901|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111280353|NCT04762901|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111280354|NCT04762901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111280355|NCT04762901|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111280356|NCT00988143|Vaccines|vaccines|mesh-list
111280357|NCT00988143|Immunologic Factors|immunologic factors|mesh-ancestor
111280358|NCT00988143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111280359|NCT03018171|Clonidine|clonidine|mesh-list
111280360|NCT03018171|Sufentanil|sufentanil|mesh-list
111280361|NCT03018171|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111280362|NCT03018171|Narcotics|narcotics|mesh-ancestor
111280363|NCT03018171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111280364|NCT03018171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111280365|NCT03018171|Analgesics|analgesics|mesh-ancestor
111280366|NCT03018171|Sensory System Agents|sensory system agents|mesh-ancestor
111280367|NCT03018171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111280368|NCT03018171|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111280369|NCT03018171|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111280370|NCT03018171|Anesthetics, General|anesthetics, general|mesh-ancestor
111280371|NCT03018171|Anesthetics|anesthetics|mesh-ancestor
111280372|NCT03018171|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111280373|NCT03018171|Sympatholytics|sympatholytics|mesh-ancestor
111280374|NCT03018171|Autonomic Agents|autonomic agents|mesh-ancestor
111280375|NCT03018171|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111280376|NCT03018171|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111280377|NCT03018171|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111280378|NCT03018171|Adrenergic Agents|adrenergic agents|mesh-ancestor
111280379|NCT03018171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111280380|NCT03018171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111280381|NCT03638375|Interferons|interferons|mesh-list
111280382|NCT03638375|Interferon-alpha|interferon-alpha|mesh-list
111280383|NCT03638375|Nivolumab|nivolumab|mesh-list
111280384|NCT03638375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111280385|NCT03638375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111280386|NCT03638375|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111280387|NCT03638375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111280388|NCT03638375|Antiviral Agents|antiviral agents|mesh-ancestor
111280389|NCT03638375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111280390|NCT03638375|Immunologic Factors|immunologic factors|mesh-ancestor
111280391|NCT03638375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111280392|NCT00989157|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
111004896|NCT05680129|Metformin|metformin|mesh-list
111280393|NCT00989157|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111280394|NCT00989157|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111280395|NCT00989157|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111280396|NCT00989157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111280397|NCT00989157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111280398|NCT00989157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111280399|NCT00989157|Analgesics|analgesics|mesh-ancestor
111280400|NCT00989157|Sensory System Agents|sensory system agents|mesh-ancestor
111280401|NCT00989157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111280402|NCT00989157|Antidepressive Agents|antidepressive agents|mesh-ancestor
111280403|NCT00989157|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111280404|NCT00989157|Dopamine Agents|dopamine agents|mesh-ancestor
111280405|NCT00990561|Clobetasol|clobetasol|mesh-list
111280406|NCT00990561|Halobetasol|halobetasol|mesh-list
111280407|NCT00990561|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111280408|NCT00990561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111280409|NCT00990561|Glucocorticoids|glucocorticoids|mesh-ancestor
111280410|NCT00990561|Hormones|hormones|mesh-ancestor
111280411|NCT00990561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111280412|NCT00990561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111280413|NCT03018015|Ibuprofen|ibuprofen|mesh-list
111280414|NCT03018015|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111280415|NCT03018015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111280416|NCT03018015|Analgesics|analgesics|mesh-ancestor
111280417|NCT03018015|Sensory System Agents|sensory system agents|mesh-ancestor
111280418|NCT03018015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111280419|NCT03018015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111280420|NCT03018015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111280421|NCT03018015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111280422|NCT03018015|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111280423|NCT03018015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111280424|NCT03018015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111280425|NCT03614741|Tinzaparin|tinzaparin|mesh-list
111280426|NCT03614741|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
111280427|NCT03614741|Dalteparin|dalteparin|mesh-list
111280428|NCT03614741|Anticoagulants|anticoagulants|mesh-ancestor
111280429|NCT03614741|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111280430|NCT03614741|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111280431|NCT03614741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111280432|NCT03609593|Rituximab|rituximab|mesh-list
111280433|NCT03609593|Venetoclax|venetoclax|mesh-list
111280434|NCT03609593|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
111280435|NCT03609593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111280436|NCT03609593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111280437|NCT03609593|Immunologic Factors|immunologic factors|mesh-ancestor
111280438|NCT03609593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111280439|NCT03609593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111280440|NCT03609593|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111280441|NCT03609593|Alkylating Agents|alkylating agents|mesh-ancestor
111280442|NCT03609593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111280443|NCT00004547|Paclitaxel|paclitaxel|mesh-list
111280444|NCT00004547|Cisplatin|cisplatin|mesh-list
111280445|NCT00004547|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111280446|NCT00004547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111280447|NCT00004547|Tubulin Modulators|tubulin modulators|mesh-ancestor
111280448|NCT00004547|Antimitotic Agents|antimitotic agents|mesh-ancestor
111280449|NCT00004547|Mitosis Modulators|mitosis modulators|mesh-ancestor
111280450|NCT00004547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111280451|NCT00005669|Metformin|metformin|mesh-list
111280452|NCT00005669|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111280453|NCT00005669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111280454|NCT02089997|Risedronic Acid|risedronic acid|mesh-list
111280455|NCT02089997|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111280456|NCT02089997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111280457|NCT02089997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111280458|NCT02089997|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111280459|NCT02089997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111280460|NCT02089997|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111280461|NCT01363661|Molsidomine|molsidomine|mesh-list
111280462|NCT01363661|Vasodilator Agents|vasodilator agents|mesh-ancestor
111280463|NCT01363661|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
111280464|NCT01363661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111280465|NCT02628600|Amikacin|amikacin|mesh-list
111004978|NCT05261269|Niraparib|niraparib|mesh-list
111280466|NCT02628600|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111280467|NCT02628600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111280468|NCT00006101|Eflornithine|eflornithine|mesh-list
111280469|NCT00006101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111280470|NCT00006101|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
111280471|NCT00006101|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111280472|NCT00006101|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111280473|NCT00006101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111280474|NCT00006101|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
111280475|NCT00006101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111280476|NCT00006101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111280477|NCT00591318|Ceftriaxone|ceftriaxone|mesh-list
111280478|NCT00591318|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111280479|NCT00591318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111280480|NCT00991029|Clopidogrel|clopidogrel|mesh-list
111280481|NCT00991029|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111280482|NCT00991029|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111280483|NCT00991029|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111280484|NCT00991029|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111280485|NCT00991029|Purinergic Agents|purinergic agents|mesh-ancestor
111280486|NCT00991029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111280487|NCT00991029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111280488|NCT00991029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111280489|NCT00991809|Diphenhydramine|diphenhydramine|mesh-list
111280490|NCT00991809|Promethazine|promethazine|mesh-list
111280491|NCT00991809|Alfentanil|alfentanil|mesh-list
111280492|NCT00991809|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111280493|NCT00991809|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111280494|NCT00991809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111280495|NCT00991809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111280496|NCT00991809|Anesthetics, Local|anesthetics, local|mesh-ancestor
111280497|NCT00991809|Anesthetics|anesthetics|mesh-ancestor
111280498|NCT00991809|Sensory System Agents|sensory system agents|mesh-ancestor
111280499|NCT00991809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111280500|NCT00991809|Antiemetics|antiemetics|mesh-ancestor
111280501|NCT00991809|Autonomic Agents|autonomic agents|mesh-ancestor
111280502|NCT00991809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111280503|NCT00991809|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111280504|NCT00991809|Histamine Antagonists|histamine antagonists|mesh-ancestor
111280505|NCT00991809|Histamine Agents|histamine agents|mesh-ancestor
111280506|NCT00991809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111280507|NCT00991809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111280508|NCT00991809|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111280509|NCT00991809|Antipruritics|antipruritics|mesh-ancestor
111280510|NCT00991809|Dermatologic Agents|dermatologic agents|mesh-ancestor
111280511|NCT00991809|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111280512|NCT00991809|Narcotics|narcotics|mesh-ancestor
111280513|NCT00991809|Analgesics|analgesics|mesh-ancestor
111280514|NCT00991809|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111280515|NCT00991809|Anesthetics, General|anesthetics, general|mesh-ancestor
111280516|NCT02627274|Trastuzumab|trastuzumab|mesh-list
111280517|NCT02627274|Cetuximab|cetuximab|mesh-list
111280518|NCT02627274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111280519|NCT02627274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111280520|NCT04982016|Methamphetamine|methamphetamine|mesh-list
111280521|NCT04982016|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111280522|NCT04982016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111280523|NCT04982016|Sympathomimetics|sympathomimetics|mesh-ancestor
111280524|NCT04982016|Autonomic Agents|autonomic agents|mesh-ancestor
111280525|NCT04982016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111280526|NCT04982016|Dopamine Agents|dopamine agents|mesh-ancestor
111280527|NCT04982016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111280528|NCT04982016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111280529|NCT04982016|Adrenergic Agents|adrenergic agents|mesh-ancestor
111280530|NCT04982016|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111280531|NCT04982016|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111280532|NCT04982016|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111280533|NCT04982016|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111280534|NCT00994929|Oprelvekin|oprelvekin|mesh-list
111280535|NCT00994929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111280536|NCT00929253|Buprenorphine|buprenorphine|mesh-list
111280537|NCT00929253|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
111280538|NCT00929253|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111280539|NCT00929253|Narcotics|narcotics|mesh-ancestor
111005050|NCT04938453|Nintedanib|nintedanib|mesh-list
111280540|NCT00929253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111280542|NCT00929253|Analgesics|analgesics|mesh-ancestor
111280543|NCT00929253|Sensory System Agents|sensory system agents|mesh-ancestor
111280544|NCT00929253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111280545|NCT00929253|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111280546|NCT00771693|Insulin Aspart|insulin aspart|mesh-list
111280547|NCT00771693|Insulin, Long-Acting|insulin, long-acting|mesh-list
111280548|NCT00771693|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
111280549|NCT00771693|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111280550|NCT00771693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111280551|NCT04374903|Sirolimus|sirolimus|mesh-list
111280552|NCT04374903|Azithromycin|azithromycin|mesh-list
111280553|NCT04374903|Hydroxychloroquine|hydroxychloroquine|mesh-list
111280554|NCT04374903|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111280555|NCT04374903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111280556|NCT04374903|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111280557|NCT04374903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111280558|NCT04374903|Antifungal Agents|antifungal agents|mesh-ancestor
111280559|NCT04374903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111280560|NCT04374903|Immunologic Factors|immunologic factors|mesh-ancestor
111280561|NCT04374903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111280562|NCT04374903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111280563|NCT04374903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111280564|NCT04374903|Antimalarials|antimalarials|mesh-ancestor
111280565|NCT04374903|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111280566|NCT04374903|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111280567|NCT04374903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111280568|NCT03062982|Fluzoparib|fluzoparib|mesh-list
111280569|NCT03062982|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111280570|NCT03062982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110978976|NCT03254186|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111280571|NCT03062982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111280572|NCT03062982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111280573|NCT03062436|Tin Fluorides|tin fluorides|mesh-list
111280574|NCT03062436|Cariostatic Agents|cariostatic agents|mesh-ancestor
111280575|NCT03062436|Protective Agents|protective agents|mesh-ancestor
111280576|NCT03062436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111280577|NCT03500874|Leucovorin|leucovorin|mesh-list
111280578|NCT03500874|Fluorouracil|fluorouracil|mesh-list
111280579|NCT03500874|Floxuridine|floxuridine|mesh-list
111280580|NCT03500874|Oxaliplatin|oxaliplatin|mesh-list
111280581|NCT03500874|Antimetabolites|antimetabolites|mesh-ancestor
111280582|NCT03500874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111280583|NCT03500874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111280584|NCT03500874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111280585|NCT03500874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111280586|NCT03500874|Immunologic Factors|immunologic factors|mesh-ancestor
111280587|NCT03500874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111280588|NCT03500874|Antidotes|antidotes|mesh-ancestor
111280589|NCT03500874|Protective Agents|protective agents|mesh-ancestor
111280590|NCT03500874|Vitamin B Complex|vitamin b complex|mesh-ancestor
111280591|NCT03500874|Vitamins|vitamins|mesh-ancestor
111280592|NCT03500874|Micronutrients|micronutrients|mesh-ancestor
111280593|NCT00997113|Alfentanil|alfentanil|mesh-list
111280594|NCT00997113|Propofol|propofol|mesh-list
111280595|NCT00997113|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111280596|NCT00997113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111280597|NCT00997113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111280598|NCT00997113|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111280599|NCT00997113|Anesthetics, General|anesthetics, general|mesh-ancestor
111280600|NCT00997113|Anesthetics|anesthetics|mesh-ancestor
111280601|NCT00997113|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111280602|NCT00997113|Narcotics|narcotics|mesh-ancestor
111280603|NCT00997113|Analgesics|analgesics|mesh-ancestor
111280604|NCT00997113|Sensory System Agents|sensory system agents|mesh-ancestor
111280605|NCT00997113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111280606|NCT04981704|Itraconazole|itraconazole|mesh-list
111280607|NCT04981704|Phenytoin|phenytoin|mesh-list
111280608|NCT04981704|Paroxetine|paroxetine|mesh-list
111280609|NCT04981704|Antifungal Agents|antifungal agents|mesh-ancestor
111280610|NCT04981704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111280611|NCT04981704|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111280612|NCT04981704|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111005120|NCT04679948|GABA Agents|gaba agents|mesh-ancestor
111280613|NCT04981704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111280614|NCT04981704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111280615|NCT04981704|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111280616|NCT04981704|Hormone Antagonists|hormone antagonists|mesh-ancestor
111280617|NCT04981704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111280618|NCT04981704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111280619|NCT04981704|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111280620|NCT04981704|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111280621|NCT04981704|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111280622|NCT04981704|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111280623|NCT04981704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111280624|NCT04981704|Serotonin Agents|serotonin agents|mesh-ancestor
111280625|NCT04981704|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111280626|NCT04981704|Antidepressive Agents|antidepressive agents|mesh-ancestor
111280627|NCT04981704|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111280628|NCT04981704|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111280629|NCT04981704|Anticonvulsants|anticonvulsants|mesh-ancestor
111280630|NCT04981704|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111280631|NCT04981704|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111280632|NCT04981704|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
111280633|NCT04981704|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111280634|NCT02163837|Rifaximin|rifaximin|mesh-list
111280635|NCT02163837|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111280636|NCT02163837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111280637|NCT02163837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111280638|NCT04974060|Remifentanil|remifentanil|mesh-list
111280639|NCT04974060|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111280640|NCT04974060|Narcotics|narcotics|mesh-ancestor
111280641|NCT04974060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111280642|NCT04974060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111280643|NCT04974060|Analgesics|analgesics|mesh-ancestor
111280644|NCT04974060|Sensory System Agents|sensory system agents|mesh-ancestor
111280645|NCT04974060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111280646|NCT01021761|Ketorolac|ketorolac|mesh-list
111280647|NCT01021761|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
111280648|NCT01021761|Nepafenac|nepafenac|mesh-list
111280649|NCT01021761|Bromfenac|bromfenac|mesh-list
111280650|NCT01021761|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111280651|NCT01021761|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111280652|NCT01021761|Analgesics|analgesics|mesh-ancestor
111280653|NCT01021761|Sensory System Agents|sensory system agents|mesh-ancestor
111280654|NCT01021761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111280655|NCT01021761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111280656|NCT01021761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111280657|NCT01021761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111280658|NCT01021761|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111280659|NCT01021761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111280660|NCT01021761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111280661|NCT04973904|Paclitaxel|paclitaxel|mesh-list
111280662|NCT04973904|Bevacizumab|bevacizumab|mesh-list
111280663|NCT04973904|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111280664|NCT04973904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111280665|NCT04973904|Tubulin Modulators|tubulin modulators|mesh-ancestor
111280666|NCT04973904|Antimitotic Agents|antimitotic agents|mesh-ancestor
111280667|NCT04973904|Mitosis Modulators|mitosis modulators|mesh-ancestor
111280668|NCT04973904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111280669|NCT04973904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111280670|NCT04973904|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111280671|NCT04973904|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111280672|NCT04973904|Growth Substances|growth substances|mesh-ancestor
111280673|NCT04973904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111280674|NCT04973904|Growth Inhibitors|growth inhibitors|mesh-ancestor
111280675|NCT00998049|Plerixafor|plerixafor|mesh-list
111280676|NCT00998049|Lenograstim|lenograstim|mesh-list
111280677|NCT00998049|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111280678|NCT00998049|Immunologic Factors|immunologic factors|mesh-ancestor
111280679|NCT00998049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111280680|NCT00998049|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111280681|NCT00998049|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111280682|NCT00998049|Antiviral Agents|antiviral agents|mesh-ancestor
111280683|NCT00998049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111280684|NCT00998205|Atropine|atropine|mesh-list
111280685|NCT00998205|Dobutamine|dobutamine|mesh-list
111280686|NCT00998205|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111280687|NCT00998205|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111280688|NCT00998205|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111280689|NCT00998205|Autonomic Agents|autonomic agents|mesh-ancestor
111280690|NCT00998205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111005198|NCT04491084|Antibodies|antibodies|mesh-list
111280691|NCT00998205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111280692|NCT00998205|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111280693|NCT00998205|Respiratory System Agents|respiratory system agents|mesh-ancestor
111280694|NCT00998205|Mydriatics|mydriatics|mesh-ancestor
111280695|NCT00998205|Parasympatholytics|parasympatholytics|mesh-ancestor
111280696|NCT00998205|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111280697|NCT00998205|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111280698|NCT00998205|Cholinergic Agents|cholinergic agents|mesh-ancestor
111280699|NCT00998205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111280700|NCT00998205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111280701|NCT00998205|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111280702|NCT00998205|Sympathomimetics|sympathomimetics|mesh-ancestor
111280703|NCT00998205|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
111280704|NCT00998205|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111280705|NCT00998205|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111280706|NCT00998205|Adrenergic Agents|adrenergic agents|mesh-ancestor
111280707|NCT00998205|Protective Agents|protective agents|mesh-ancestor
111280708|NCT02626182|Sildenafil Citrate|sildenafil citrate|mesh-list
111280709|NCT02626182|Vasodilator Agents|vasodilator agents|mesh-ancestor
111280710|NCT02626182|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111280711|NCT02626182|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111280712|NCT02626182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111280713|NCT02626182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111280714|NCT02626182|Urological Agents|urological agents|mesh-ancestor
111280715|NCT01023477|Chloroquine|chloroquine|mesh-list
111280716|NCT01023477|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
111280717|NCT01023477|Amebicides|amebicides|mesh-ancestor
111280718|NCT01023477|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111280719|NCT01023477|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111280720|NCT01023477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111280721|NCT01023477|Antimalarials|antimalarials|mesh-ancestor
111280722|NCT01023477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111280723|NCT01023477|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111280724|NCT01023477|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111280725|NCT01023477|Analgesics|analgesics|mesh-ancestor
111280726|NCT01023477|Sensory System Agents|sensory system agents|mesh-ancestor
111280727|NCT01023477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111280728|NCT01023477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111280729|NCT01023477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111280730|NCT01023477|Filaricides|filaricides|mesh-ancestor
111280731|NCT01023477|Antinematodal Agents|antinematodal agents|mesh-ancestor
111280732|NCT01023477|Anthelmintics|anthelmintics|mesh-ancestor
111280734|NCT01023711|Immunologic Factors|immunologic factors|mesh-ancestor
111280735|NCT01023711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111280736|NCT01001403|Nafamostat|nafamostat|mesh-list
111280737|NCT01001403|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111280738|NCT01001403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111280739|NCT01001403|Analgesics|analgesics|mesh-ancestor
111280740|NCT01001403|Sensory System Agents|sensory system agents|mesh-ancestor
111280741|NCT01001403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111280742|NCT01001403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111280743|NCT01001403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111280744|NCT01001403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111280745|NCT01001403|Anticoagulants|anticoagulants|mesh-ancestor
111280746|NCT01001403|Protease Inhibitors|protease inhibitors|mesh-ancestor
111280747|NCT01001403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111280748|NCT01001403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111280749|NCT01001403|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
111280750|NCT01001403|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111280751|NCT01001403|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
111280752|NCT01001403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111280753|NCT01001403|Immunologic Factors|immunologic factors|mesh-ancestor
111280754|NCT01024335|Naltrexone|naltrexone|mesh-list
111280755|NCT01024335|Dronabinol|dronabinol|mesh-list
111280756|NCT01024335|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111280757|NCT01024335|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111280758|NCT01024335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111280759|NCT01024335|Sensory System Agents|sensory system agents|mesh-ancestor
111280760|NCT01024335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111280761|NCT01024335|Hallucinogens|hallucinogens|mesh-ancestor
111280762|NCT01024335|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111280763|NCT01024335|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111280764|NCT01024335|Analgesics|analgesics|mesh-ancestor
111280765|NCT01024335|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
111280766|NCT01024335|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
111280767|NCT01024335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111280768|NCT01024335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111280770|NCT01024335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111280771|NCT01001559|Norepinephrine|norepinephrine|mesh-list
111280772|NCT01001559|Serotonin|serotonin|mesh-list
111280773|NCT01001559|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
111280774|NCT01001559|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-list
111280775|NCT01001559|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111280776|NCT01001559|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111280777|NCT01001559|Adrenergic Agents|adrenergic agents|mesh-ancestor
111280778|NCT01001559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111280779|NCT01001559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111280780|NCT01001559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111280781|NCT01001559|Sympathomimetics|sympathomimetics|mesh-ancestor
111280782|NCT01001559|Autonomic Agents|autonomic agents|mesh-ancestor
111280783|NCT01001559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111280784|NCT01001559|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111280785|NCT01001559|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111280786|NCT01001559|Serotonin Agents|serotonin agents|mesh-ancestor
111280787|NCT01001559|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111280788|NCT01001559|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111280789|NCT01025427|Tenofovir|tenofovir|mesh-list
111280790|NCT01025427|Emtricitabine|emtricitabine|mesh-list
111280791|NCT01025427|Raltegravir Potassium|raltegravir potassium|mesh-list
111280792|NCT01025427|Antiviral Agents|antiviral agents|mesh-ancestor
111280793|NCT01025427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111280794|NCT01025427|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111280795|NCT01025427|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111280796|NCT01025427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111280797|NCT01025427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111280798|NCT01025427|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111280799|NCT01025427|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111280800|NCT01025427|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111280801|NCT01025427|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111280802|NCT02162433|Dexmedetomidine|dexmedetomidine|mesh-list
111280803|NCT02162433|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111280804|NCT02162433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111280805|NCT02162433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111280806|NCT02162433|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111280807|NCT02162433|Analgesics|analgesics|mesh-ancestor
111280808|NCT02162433|Sensory System Agents|sensory system agents|mesh-ancestor
111280809|NCT02162433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111280810|NCT02162433|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111280811|NCT02162433|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111280812|NCT02162433|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111280813|NCT02162433|Adrenergic Agents|adrenergic agents|mesh-ancestor
111280814|NCT02162433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111280815|NCT02162433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111280816|NCT01004991|Prednisone|prednisone|mesh-list
111280817|NCT01004991|Cyclophosphamide|cyclophosphamide|mesh-list
111280818|NCT01004991|Rituximab|rituximab|mesh-list
111280819|NCT01004991|Doxorubicin|doxorubicin|mesh-list
111280820|NCT01004991|Vincristine|vincristine|mesh-list
111280821|NCT01004991|Azacitidine|azacitidine|mesh-list
111280822|NCT01004991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111280823|NCT01004991|Immunologic Factors|immunologic factors|mesh-ancestor
111280824|NCT01004991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111280825|NCT01004991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111280826|NCT01004991|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111280827|NCT01004991|Alkylating Agents|alkylating agents|mesh-ancestor
111280828|NCT01004991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111280829|NCT01004991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111280830|NCT01004991|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111280831|NCT01004991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111280832|NCT01004991|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111280833|NCT01004991|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111280834|NCT01004991|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111280835|NCT01004991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111280836|NCT01004991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111280837|NCT01004991|Glucocorticoids|glucocorticoids|mesh-ancestor
111280838|NCT01004991|Hormones|hormones|mesh-ancestor
111280839|NCT01004991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111280840|NCT01004991|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111280841|NCT01004991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111280842|NCT01004991|Tubulin Modulators|tubulin modulators|mesh-ancestor
111280843|NCT01004991|Antimitotic Agents|antimitotic agents|mesh-ancestor
111280844|NCT01004991|Mitosis Modulators|mitosis modulators|mesh-ancestor
111280845|NCT01004991|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111280847|NCT03063060|Vitamin D|vitamin d|mesh-list
111280848|NCT03063060|Calcium|calcium|mesh-list
111280849|NCT03063060|Vitamins|vitamins|mesh-ancestor
111280850|NCT03063060|Micronutrients|micronutrients|mesh-ancestor
111280851|NCT03063060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111280852|NCT03063060|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111280853|NCT03063060|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111280854|NCT03115047|Meperidine|meperidine|mesh-list
111280855|NCT03115047|Dexmedetomidine|dexmedetomidine|mesh-list
111280856|NCT03115047|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111280857|NCT03115047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111280858|NCT03115047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111280859|NCT03115047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111280860|NCT03115047|Analgesics|analgesics|mesh-ancestor
111280861|NCT03115047|Sensory System Agents|sensory system agents|mesh-ancestor
111280862|NCT03115047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111280863|NCT03115047|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110978984|NCT05483062|Fluorides|fluorides|mesh-list
111280864|NCT03115047|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111280865|NCT03115047|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111280866|NCT03115047|Adrenergic Agents|adrenergic agents|mesh-ancestor
111280867|NCT03115047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111280868|NCT03115047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111280869|NCT03115047|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111280870|NCT03115047|Narcotics|narcotics|mesh-ancestor
111280871|NCT03115047|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111280872|NCT01026909|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
111280873|NCT01026909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111280874|NCT03015519|rGLP-1 protein|rglp-1 protein|mesh-list
111280875|NCT03015519|Incretins|incretins|mesh-ancestor
111280876|NCT03015519|Hormones|hormones|mesh-ancestor
111280877|NCT03015519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111280878|NCT03015519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111280879|NCT01030653|Voriconazole|voriconazole|mesh-list
111280880|NCT01030653|Antifungal Agents|antifungal agents|mesh-ancestor
111280881|NCT01030653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111280882|NCT01030653|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111280883|NCT01030653|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111280884|NCT01030653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111280885|NCT01030653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111280886|NCT01030653|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111280887|NCT01030653|Hormone Antagonists|hormone antagonists|mesh-ancestor
111280888|NCT01030653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111280889|NCT01030653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111280890|NCT01030653|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111280891|NCT01031043|Bethanechol|bethanechol|mesh-list
111280892|NCT01031043|Parasympathomimetics|parasympathomimetics|mesh-ancestor
111280893|NCT01031043|Autonomic Agents|autonomic agents|mesh-ancestor
111280894|NCT01031043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111280895|NCT01031043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111280896|NCT01031043|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
111280897|NCT01031043|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111280898|NCT01031043|Cholinergic Agents|cholinergic agents|mesh-ancestor
111280899|NCT01031043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111280900|NCT01031043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111280901|NCT01050153|Aspirin|aspirin|mesh-list
111280902|NCT01050153|Dalteparin|dalteparin|mesh-list
111280903|NCT01050153|Tinzaparin|tinzaparin|mesh-list
111280904|NCT01050153|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
111280905|NCT01050153|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111280906|NCT01050153|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111280907|NCT01050153|Analgesics|analgesics|mesh-ancestor
111280908|NCT01050153|Sensory System Agents|sensory system agents|mesh-ancestor
111280909|NCT01050153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111280910|NCT01050153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111280911|NCT01050153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111280912|NCT01050153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111280913|NCT01050153|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111280914|NCT01050153|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111280915|NCT01050153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111280916|NCT01050153|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111280917|NCT01050153|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111280918|NCT01050153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111280919|NCT01050153|Antipyretics|antipyretics|mesh-ancestor
111280920|NCT01050153|Anticoagulants|anticoagulants|mesh-ancestor
111280921|NCT04358133|Morphine|morphine|mesh-list
111280922|NCT04358133|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111280923|NCT04358133|Narcotics|narcotics|mesh-ancestor
111280924|NCT04358133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111280925|NCT04358133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111280926|NCT04358133|Analgesics|analgesics|mesh-ancestor
111280927|NCT04358133|Sensory System Agents|sensory system agents|mesh-ancestor
111280928|NCT04358133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111280929|NCT01032759|Memantine|memantine|mesh-list
111280930|NCT01032759|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111280931|NCT01032759|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111280932|NCT01032759|Dopamine Agents|dopamine agents|mesh-ancestor
111280933|NCT01032759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111280934|NCT01032759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111280935|NCT01032759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111280936|NCT01032759|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111280937|NCT01032759|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111280938|NCT01032993|Ubiquinone|ubiquinone|mesh-list
111280939|NCT01032993|Coenzyme Q10|coenzyme q10|mesh-list
111280940|NCT01032993|Micronutrients|micronutrients|mesh-ancestor
111280941|NCT01032993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111280942|NCT01032993|Vitamins|vitamins|mesh-ancestor
111280943|NCT01033773|Metformin|metformin|mesh-list
111280944|NCT01033773|Hypoglycemic Agents|hypoglycemic agents|mesh-list
111280945|NCT01033773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111280946|NCT01053507|Naproxen|naproxen|mesh-list
111280947|NCT01053507|Sumatriptan|sumatriptan|mesh-list
111280948|NCT01053507|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111280949|NCT01053507|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111280950|NCT01053507|Analgesics|analgesics|mesh-ancestor
111280951|NCT01053507|Sensory System Agents|sensory system agents|mesh-ancestor
111280952|NCT01053507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111280953|NCT01053507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111280954|NCT01053507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111280955|NCT01053507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111280956|NCT01053507|Gout Suppressants|gout suppressants|mesh-ancestor
111280957|NCT01053507|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111280958|NCT01053507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111280959|NCT01053507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111280960|NCT01053507|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111280961|NCT01053507|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111280962|NCT01053507|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111280963|NCT01053507|Serotonin Agents|serotonin agents|mesh-ancestor
111280964|NCT01053507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111280965|NCT01053819|Etanercept|etanercept|mesh-list
111280966|NCT01053819|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111280967|NCT01053819|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111280968|NCT01053819|Analgesics|analgesics|mesh-ancestor
111280969|NCT01053819|Sensory System Agents|sensory system agents|mesh-ancestor
111280970|NCT01053819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111280971|NCT01053819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111280972|NCT01053819|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111280973|NCT01053819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111280974|NCT01053819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111280975|NCT01053819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111280976|NCT01053819|Immunologic Factors|immunologic factors|mesh-ancestor
111280977|NCT01054911|Sunitinib|sunitinib|mesh-list
111280978|NCT01054911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111280979|NCT01054911|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111280980|NCT01054911|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111280981|NCT01054911|Growth Substances|growth substances|mesh-ancestor
111280982|NCT01054911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111280983|NCT01054911|Growth Inhibitors|growth inhibitors|mesh-ancestor
111280984|NCT01054911|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111280985|NCT01054911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111280986|NCT01054911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111280987|NCT01055223|Troglitazone|troglitazone|mesh-list
111005500|NCT03511118|Tocolytic Agents|tocolytic agents|mesh-ancestor
111280988|NCT01055223|Amiloride|amiloride|mesh-list
111280989|NCT01055223|Spironolactone|spironolactone|mesh-list
111280990|NCT01055223|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
111280991|NCT01055223|Hormone Antagonists|hormone antagonists|mesh-ancestor
111280992|NCT01055223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111280993|NCT01055223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111280994|NCT01055223|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
111280995|NCT01055223|Diuretics|diuretics|mesh-ancestor
111280996|NCT01055223|Natriuretic Agents|natriuretic agents|mesh-ancestor
111280997|NCT01055223|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
111280998|NCT01055223|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111280999|NCT01055223|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111281000|NCT01055223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111281001|NCT01055223|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
111281002|NCT01055223|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111281003|NCT02168361|Interferons|interferons|mesh-list
111281004|NCT02168361|Ribavirin|ribavirin|mesh-list
111281005|NCT02168361|Interferon-alpha|interferon-alpha|mesh-list
111281006|NCT02168361|Interferon alpha-2|interferon alpha-2|mesh-list
111281007|NCT02168361|Sofosbuvir|sofosbuvir|mesh-list
111281008|NCT02168361|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
111281009|NCT02168361|Simeprevir|simeprevir|mesh-list
111281010|NCT02168361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111281011|NCT02168361|Antiviral Agents|antiviral agents|mesh-ancestor
111281012|NCT02168361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111281013|NCT02168361|Antimetabolites|antimetabolites|mesh-ancestor
111281014|NCT02168361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111281015|NCT02168361|Immunologic Factors|immunologic factors|mesh-ancestor
111281016|NCT02168361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111281017|NCT02168361|Protease Inhibitors|protease inhibitors|mesh-ancestor
111281018|NCT02168361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111281019|NCT01360554|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111281020|NCT01360554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111281021|NCT01360554|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111281022|NCT01360554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111281023|NCT01360554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111281024|NCT01055769|Linezolid|linezolid|mesh-list
111281025|NCT01055769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111281026|NCT01055769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111281027|NCT01055769|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111281028|NCT01055769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111281029|NCT01055769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111281030|NCT01057017|Panitumumab|panitumumab|mesh-list
111281031|NCT01057017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111281032|NCT01057017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111281033|NCT04972032|Estrogens|estrogens|mesh-list
111281034|NCT04972032|Hyaluronic Acid|hyaluronic acid|mesh-list
111281035|NCT04972032|Hormones|hormones|mesh-ancestor
111281036|NCT04972032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111281037|NCT04972032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111281038|NCT04972032|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111281039|NCT04972032|Immunologic Factors|immunologic factors|mesh-ancestor
111281040|NCT04972032|Viscosupplements|viscosupplements|mesh-ancestor
111281041|NCT04972032|Protective Agents|protective agents|mesh-ancestor
111281042|NCT04432662|Darbepoetin alfa|darbepoetin alfa|mesh-list
111281043|NCT04432662|Hematinics|hematinics|mesh-ancestor
111281044|NCT04152564|Bupivacaine|bupivacaine|mesh-list
111281045|NCT04152564|Levobupivacaine|levobupivacaine|mesh-list
111281046|NCT04152564|Anesthetics, Local|anesthetics, local|mesh-ancestor
111281047|NCT04152564|Anesthetics|anesthetics|mesh-ancestor
111281048|NCT04152564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111281049|NCT04152564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111281050|NCT04152564|Sensory System Agents|sensory system agents|mesh-ancestor
111281051|NCT04152564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111281052|NCT04977960|Canrenone|canrenone|mesh-list
111281053|NCT04977960|Canrenoic Acid|canrenoic acid|mesh-list
111281054|NCT04977960|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
111281055|NCT04977960|Hormone Antagonists|hormone antagonists|mesh-ancestor
111281056|NCT04977960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111281057|NCT04977960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111281058|NCT04977960|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
111281059|NCT04977960|Diuretics|diuretics|mesh-ancestor
111281060|NCT04977960|Natriuretic Agents|natriuretic agents|mesh-ancestor
111281061|NCT05593809|Technetium Tc 99m Dimercaptosuccinic Acid|technetium tc 99m dimercaptosuccinic acid|mesh-list
111281062|NCT05593809|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111005573|NCT03277924|Antimetabolites|antimetabolites|mesh-ancestor
111281063|NCT05593809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111281064|NCT05593731|Melatonin|melatonin|mesh-list
111281065|NCT05593731|Antioxidants|antioxidants|mesh-ancestor
111281066|NCT05593731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111281067|NCT05593731|Protective Agents|protective agents|mesh-ancestor
111281068|NCT05593731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111281069|NCT05593731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111281070|NCT01062009|Zinc Sulfate|zinc sulfate|mesh-list
111281071|NCT01062009|Astringents|astringents|mesh-ancestor
111281072|NCT01062009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111281073|NCT01062009|Dermatologic Agents|dermatologic agents|mesh-ancestor
111281074|NCT01062165|Caspofungin|caspofungin|mesh-list
111281075|NCT01062165|Antifungal Agents|antifungal agents|mesh-ancestor
111281076|NCT01062165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111281077|NCT01062165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111281078|NCT01062165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111281079|NCT04041843|Apixaban|apixaban|mesh-list
111281080|NCT04041843|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111281081|NCT04041843|Antithrombins|antithrombins|mesh-ancestor
111281082|NCT04041843|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111281083|NCT04041843|Protease Inhibitors|protease inhibitors|mesh-ancestor
111281084|NCT04041843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111281085|NCT04041843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111281086|NCT04041843|Anticoagulants|anticoagulants|mesh-ancestor
111281087|NCT01068873|Ritonavir|ritonavir|mesh-list
111281088|NCT01068873|Lopinavir|lopinavir|mesh-list
111281089|NCT01068873|Maraviroc|maraviroc|mesh-list
111281090|NCT01068873|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111281091|NCT01068873|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111281092|NCT01068873|Protease Inhibitors|protease inhibitors|mesh-ancestor
111281093|NCT01068873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111281094|NCT01068873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111281095|NCT01068873|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111281096|NCT01068873|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111281097|NCT01068873|Antiviral Agents|antiviral agents|mesh-ancestor
111281098|NCT01068873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111281099|NCT01068873|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111281100|NCT01068873|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111281101|NCT01068873|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
111281102|NCT01068873|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
111281103|NCT01068873|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
111281104|NCT01072773|Dexamethasone|dexamethasone|mesh-list
111281105|NCT01072773|Cyclophosphamide|cyclophosphamide|mesh-list
111281106|NCT01072773|Bortezomib|bortezomib|mesh-list
111281107|NCT01072773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111281108|NCT01072773|Immunologic Factors|immunologic factors|mesh-ancestor
111281109|NCT01072773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111281110|NCT01072773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111281111|NCT01072773|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111281112|NCT01072773|Alkylating Agents|alkylating agents|mesh-ancestor
111281113|NCT01072773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111281114|NCT01072773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111281115|NCT01072773|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111281116|NCT01072773|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111281117|NCT01072773|Antiemetics|antiemetics|mesh-ancestor
111281118|NCT01072773|Autonomic Agents|autonomic agents|mesh-ancestor
111281119|NCT01072773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111281120|NCT01072773|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111281121|NCT01072773|Glucocorticoids|glucocorticoids|mesh-ancestor
111281122|NCT01072773|Hormones|hormones|mesh-ancestor
111281123|NCT01072773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111281124|NCT01072773|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111281125|NCT03013647|Aminolevulinic Acid|aminolevulinic acid|mesh-list
111281126|NCT03013647|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
111281127|NCT03013647|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111281128|NCT03013647|Dermatologic Agents|dermatologic agents|mesh-ancestor
111281129|NCT01074177|Afatinib|afatinib|mesh-list
111281130|NCT01074177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111281131|NCT01074177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111281132|NCT01074177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111281133|NCT01074177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111281134|NCT01076283|Cyproheptadine|cyproheptadine|mesh-list
111281135|NCT01076283|Baclofen|baclofen|mesh-list
111281136|NCT01076283|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
111281137|NCT01076283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111281138|NCT01076283|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111281139|NCT01076283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111281140|NCT01076283|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
111281141|NCT01076283|GABA Agonists|gaba agonists|mesh-ancestor
111281142|NCT01076283|GABA Agents|gaba agents|mesh-ancestor
111281143|NCT01076283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111281144|NCT01076283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111281145|NCT01076283|Antipruritics|antipruritics|mesh-ancestor
111281146|NCT01076283|Dermatologic Agents|dermatologic agents|mesh-ancestor
111281147|NCT01076283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111281148|NCT01076283|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111281149|NCT01076283|Histamine Antagonists|histamine antagonists|mesh-ancestor
111281150|NCT01076283|Histamine Agents|histamine agents|mesh-ancestor
111281151|NCT01076283|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111281152|NCT01076283|Serotonin Agents|serotonin agents|mesh-ancestor
111281153|NCT01076283|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111281154|NCT03805581|Defibrotide|defibrotide|mesh-list
111281155|NCT03805581|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111281156|NCT03805581|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111281157|NCT03805581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111281158|NCT03805581|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111281159|NCT01076985|Ritonavir|ritonavir|mesh-list
111281160|NCT01076985|Lopinavir|lopinavir|mesh-list
111281161|NCT01076985|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111281162|NCT01076985|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111281163|NCT01076985|Protease Inhibitors|protease inhibitors|mesh-ancestor
111281164|NCT01076985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111281165|NCT01076985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111281166|NCT01076985|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111281167|NCT01076985|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111281168|NCT01076985|Antiviral Agents|antiviral agents|mesh-ancestor
111281169|NCT01076985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111281170|NCT01076985|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111281171|NCT01076985|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111281172|NCT02176005|Moxifloxacin|moxifloxacin|mesh-list
111281173|NCT02176005|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111281174|NCT02176005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111281175|NCT02176005|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111281176|NCT02176005|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111281177|NCT02176005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111281178|NCT02176005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111281179|NCT02176005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111281180|NCT05539911|Fentanyl|fentanyl|mesh-list
111281181|NCT05539911|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111281182|NCT05539911|Narcotics|narcotics|mesh-ancestor
111281183|NCT05539911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111281184|NCT05539911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111281185|NCT05539911|Analgesics|analgesics|mesh-ancestor
111281186|NCT05539911|Sensory System Agents|sensory system agents|mesh-ancestor
111281187|NCT05539911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111281188|NCT05539911|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111281189|NCT05539911|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111281190|NCT05539911|Anesthetics, General|anesthetics, general|mesh-ancestor
111281191|NCT05539911|Anesthetics|anesthetics|mesh-ancestor
111281192|NCT03589833|Methotrexate|methotrexate|mesh-list
111281193|NCT03589833|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111281194|NCT03589833|Abortifacient Agents|abortifacient agents|mesh-ancestor
111281195|NCT03589833|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111281196|NCT03589833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111281197|NCT03589833|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111281198|NCT03589833|Antimetabolites|antimetabolites|mesh-ancestor
111281199|NCT03589833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111281200|NCT03589833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111281201|NCT03589833|Dermatologic Agents|dermatologic agents|mesh-ancestor
111281202|NCT03589833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111281203|NCT03589833|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111281204|NCT03589833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111281205|NCT03589833|Immunologic Factors|immunologic factors|mesh-ancestor
111281206|NCT03589833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111281207|NCT03589833|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111281208|NCT01077921|Propranolol|propranolol|mesh-list
111281209|NCT01077921|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111281210|NCT01077921|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111281211|NCT01077921|Adrenergic Agents|adrenergic agents|mesh-ancestor
111281212|NCT01077921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111281213|NCT01077921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111281214|NCT01077921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111281215|NCT01077921|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111281216|NCT01077921|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111281217|NCT01077921|Vasodilator Agents|vasodilator agents|mesh-ancestor
111281218|NCT05498181|Valsartan|valsartan|mesh-list
111281219|NCT05498181|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
111281220|NCT05498181|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111281221|NCT05498181|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111281222|NCT05498181|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111281223|NCT05498181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111281224|NCT04970238|Simendan|simendan|mesh-list
111281225|NCT04970238|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111281226|NCT04970238|Vasodilator Agents|vasodilator agents|mesh-ancestor
111281227|NCT04970238|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
111281228|NCT04970238|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111281229|NCT04970238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111281230|NCT04970238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111281231|NCT04970238|Protective Agents|protective agents|mesh-ancestor
111281232|NCT04970238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111281233|NCT02169453|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
111281234|NCT02169453|Opicapone|opicapone|mesh-list
111281235|NCT02169453|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111281236|NCT02169453|Immunologic Factors|immunologic factors|mesh-ancestor
111281237|NCT02169453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111281238|NCT02169453|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111281239|NCT02169453|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111281240|NCT02169453|Dopamine Agonists|dopamine agonists|mesh-ancestor
111281241|NCT02169453|Dopamine Agents|dopamine agents|mesh-ancestor
111281242|NCT02169453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111281243|NCT02169453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111281244|NCT02169453|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
111281245|NCT02169453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111281246|NCT01822314|Paclitaxel|paclitaxel|mesh-list
111281247|NCT01822314|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111281248|NCT01822314|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111281249|NCT01822314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111281250|NCT01822314|Tubulin Modulators|tubulin modulators|mesh-ancestor
111281251|NCT01822314|Antimitotic Agents|antimitotic agents|mesh-ancestor
111281252|NCT01822314|Mitosis Modulators|mitosis modulators|mesh-ancestor
111281253|NCT01822314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111281254|NCT01765296|Celecoxib|celecoxib|mesh-list
111281255|NCT01765296|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111281256|NCT01765296|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111281257|NCT01765296|Analgesics|analgesics|mesh-ancestor
111281258|NCT01765296|Sensory System Agents|sensory system agents|mesh-ancestor
111281259|NCT01765296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111281260|NCT01765296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111281261|NCT01765296|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111281262|NCT01765296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111281263|NCT01765296|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111281264|NCT01765296|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111281265|NCT01765296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111281266|NCT01765296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111281267|NCT01081041|Carboplatin|carboplatin|mesh-list
111281268|NCT01081041|Fluorouracil|fluorouracil|mesh-list
111281269|NCT01081041|Cetuximab|cetuximab|mesh-list
111281270|NCT01081041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111281271|NCT01081041|Antimetabolites|antimetabolites|mesh-ancestor
111281272|NCT01081041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111281273|NCT01081041|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111281274|NCT01081041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111281275|NCT01081041|Immunologic Factors|immunologic factors|mesh-ancestor
111281276|NCT01081041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111281277|NCT01081041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111281278|NCT03022617|Apremilast|apremilast|mesh-list
111281279|NCT03022617|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111281280|NCT03022617|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111281281|NCT03022617|Analgesics|analgesics|mesh-ancestor
111281282|NCT03022617|Sensory System Agents|sensory system agents|mesh-ancestor
111281283|NCT03022617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111281284|NCT03022617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111281285|NCT03022617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111005801|NCT05738694|Axitinib|axitinib|mesh-list
111281286|NCT03022617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111281287|NCT03022617|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
111281288|NCT03022617|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111281289|NCT03022617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111281290|NCT03022617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111281291|NCT02089685|Pembrolizumab|pembrolizumab|mesh-list
111281292|NCT02089685|Ipilimumab|ipilimumab|mesh-list
111281293|NCT02089685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111281294|NCT02089685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111281295|NCT02089685|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111281296|NCT02089685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111281297|NCT01088295|Telmisartan|telmisartan|mesh-list
111281298|NCT01088295|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111281299|NCT01088295|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111281300|NCT01088295|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111281301|NCT01088295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111281302|NCT03013335|Nivolumab|nivolumab|mesh-list
111281303|NCT03013335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111281304|NCT03013335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111281305|NCT03013335|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111281306|NCT03013335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111281307|NCT04730531|Epinephrine|epinephrine|mesh-list
111281308|NCT04730531|Bupivacaine|bupivacaine|mesh-list
111281309|NCT04730531|Anesthetics, Local|anesthetics, local|mesh-ancestor
111281310|NCT04730531|Anesthetics|anesthetics|mesh-ancestor
111281311|NCT04730531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111281312|NCT04730531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111281313|NCT04730531|Sensory System Agents|sensory system agents|mesh-ancestor
111281314|NCT04730531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111281315|NCT04730531|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111281316|NCT04730531|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111281317|NCT04730531|Adrenergic Agents|adrenergic agents|mesh-ancestor
111281318|NCT04730531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111281319|NCT04730531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111281320|NCT04730531|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111281321|NCT04730531|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111281322|NCT04730531|Autonomic Agents|autonomic agents|mesh-ancestor
111281323|NCT04730531|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111281324|NCT04730531|Respiratory System Agents|respiratory system agents|mesh-ancestor
111281325|NCT04730531|Mydriatics|mydriatics|mesh-ancestor
111281326|NCT04730531|Sympathomimetics|sympathomimetics|mesh-ancestor
111281327|NCT04730531|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111281328|NCT05569733|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
111281329|NCT05569733|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111281330|NCT05569733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111281331|NCT05853341|Rivastigmine|rivastigmine|mesh-list
111281332|NCT05853341|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111281333|NCT05853341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111281334|NCT05853341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111281335|NCT05853341|Cholinergic Agents|cholinergic agents|mesh-ancestor
111281336|NCT05853341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111281337|NCT05853341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111281338|NCT05853341|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111281339|NCT05853341|Protective Agents|protective agents|mesh-ancestor
111281340|NCT05853289|Analgesics, Opioid|analgesics, opioid|mesh-list
111281341|NCT05853289|Narcotics|narcotics|mesh-ancestor
111281342|NCT05853289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111281343|NCT05853289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111281344|NCT05853289|Analgesics|analgesics|mesh-ancestor
111281345|NCT05853289|Sensory System Agents|sensory system agents|mesh-ancestor
111281346|NCT05853289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111281347|NCT05853224|Lidocaine|lidocaine|mesh-list
111281348|NCT05853224|Hyaluronic Acid|hyaluronic acid|mesh-list
111281349|NCT05853224|Anesthetics, Local|anesthetics, local|mesh-ancestor
111281350|NCT05853224|Anesthetics|anesthetics|mesh-ancestor
111281351|NCT05853224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111281352|NCT05853224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111281353|NCT05853224|Sensory System Agents|sensory system agents|mesh-ancestor
111281354|NCT05853224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111281355|NCT05853224|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111281356|NCT05853224|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111281357|NCT05853224|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111281358|NCT05853224|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111281359|NCT05853224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111281360|NCT05853224|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111281361|NCT05853224|Immunologic Factors|immunologic factors|mesh-ancestor
111281362|NCT05853224|Viscosupplements|viscosupplements|mesh-ancestor
111281363|NCT05853224|Protective Agents|protective agents|mesh-ancestor
111281364|NCT05853172|Paclitaxel|paclitaxel|mesh-list
111281365|NCT05853172|Apatinib|apatinib|mesh-list
111281366|NCT05853172|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111281367|NCT05853172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111281368|NCT05853172|Tubulin Modulators|tubulin modulators|mesh-ancestor
111281369|NCT05853172|Antimitotic Agents|antimitotic agents|mesh-ancestor
111281370|NCT05853172|Mitosis Modulators|mitosis modulators|mesh-ancestor
111281371|NCT05853172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111281372|NCT05853172|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111281373|NCT05853172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111281374|NCT05853263|Acetaminophen|acetaminophen|mesh-list
111281375|NCT05853263|Morphine|morphine|mesh-list
111281376|NCT05853263|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111281377|NCT05853263|Narcotics|narcotics|mesh-ancestor
111281378|NCT05853263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111281379|NCT05853263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111281380|NCT05853263|Analgesics|analgesics|mesh-ancestor
111281381|NCT05853263|Sensory System Agents|sensory system agents|mesh-ancestor
111281382|NCT05853263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111281383|NCT05853263|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111281384|NCT05853263|Antipyretics|antipyretics|mesh-ancestor
111281385|NCT03001869|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
111281386|NCT03001869|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111281387|NCT03001869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111281388|NCT05852873|Ritonavir|ritonavir|mesh-list
111281389|NCT05852873|Nirmatrelvir|nirmatrelvir|mesh-list
111281390|NCT05852873|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
111281391|NCT05852873|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111281392|NCT05852873|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111281393|NCT05852873|Protease Inhibitors|protease inhibitors|mesh-ancestor
111281394|NCT05852873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111281395|NCT05852873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111281396|NCT05852873|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111281397|NCT05852873|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111281398|NCT05852873|Antiviral Agents|antiviral agents|mesh-ancestor
111281399|NCT05852873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111281400|NCT05852873|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111281401|NCT05852873|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111281402|NCT05852847|Danazol|danazol|mesh-list
111281403|NCT05852847|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111281404|NCT05852847|Hormone Antagonists|hormone antagonists|mesh-ancestor
111281405|NCT05852847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111281406|NCT05852847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111281407|NCT05852704|Dapagliflozin|dapagliflozin|mesh-list
111281408|NCT05852704|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111281409|NCT05852704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111281410|NCT05852704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111281411|NCT05852704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111281412|NCT05852496|Vitamin D|vitamin d|mesh-list
111281413|NCT05852496|Vitamins|vitamins|mesh-ancestor
111281414|NCT05852496|Micronutrients|micronutrients|mesh-ancestor
111281415|NCT05852496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111281416|NCT05852496|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111281417|NCT05852223|Pembrolizumab|pembrolizumab|mesh-list
111281418|NCT05852223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111281419|NCT05852223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111281420|NCT05852223|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111281421|NCT05852223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111281422|NCT05852197|Anticoagulants|anticoagulants|mesh-list
111281423|NCT05852197|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
111281424|NCT05852119|Anticoagulants|anticoagulants|mesh-list
111281425|NCT05852093|Celecoxib|celecoxib|mesh-list
110959316|NCT04446104|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110959317|NCT03388970|Vitamin K|vitamin k|mesh-list
110959318|NCT03388970|Vitamin K 1|vitamin k 1|mesh-list
110959319|NCT03388970|Vitamins|vitamins|mesh-ancestor
110959320|NCT03388970|Micronutrients|micronutrients|mesh-ancestor
110959321|NCT03388970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110959322|NCT03388970|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110959323|NCT03388970|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111005950|NCT05487794|Androgens|androgens|mesh-ancestor
111281426|NCT05852093|Buprenorphine|buprenorphine|mesh-list
111281427|NCT05852093|Tizanidine|tizanidine|mesh-list
111281428|NCT05852093|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111281429|NCT05852093|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111281430|NCT05852093|Analgesics|analgesics|mesh-ancestor
111281431|NCT05852093|Sensory System Agents|sensory system agents|mesh-ancestor
111281432|NCT05852093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111281433|NCT05852093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111281434|NCT05852093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111281435|NCT05852093|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111281436|NCT05852093|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111281437|NCT05852093|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111281438|NCT05852093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111281439|NCT05852093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111281440|NCT05852093|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111281441|NCT05852093|Narcotics|narcotics|mesh-ancestor
111281442|NCT05852093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111281443|NCT05852093|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111281444|NCT05852093|Anticonvulsants|anticonvulsants|mesh-ancestor
111281445|NCT05852093|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
111281446|NCT05852093|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111281447|NCT05852093|Parasympatholytics|parasympatholytics|mesh-ancestor
111281448|NCT05852093|Autonomic Agents|autonomic agents|mesh-ancestor
111281449|NCT05852093|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111281450|NCT05852093|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111281451|NCT05852093|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111281452|NCT05852093|Adrenergic Agents|adrenergic agents|mesh-ancestor
111281453|NCT05852093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111281454|NCT05849129|Ascorbic Acid|ascorbic acid|mesh-list
111281455|NCT05849129|Vitamins|vitamins|mesh-ancestor
111281456|NCT05849129|Micronutrients|micronutrients|mesh-ancestor
111281457|NCT05849129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111281458|NCT05849129|Antioxidants|antioxidants|mesh-ancestor
111281459|NCT05849129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111281460|NCT05849129|Protective Agents|protective agents|mesh-ancestor
111281461|NCT05848843|Durvalumab|durvalumab|mesh-list
111281462|NCT05848843|Adagrasib|adagrasib|mesh-list
111281463|NCT05848843|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111281464|NCT05848843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111281465|NCT05845762|Obinutuzumab|obinutuzumab|mesh-list
111281466|NCT05845762|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111281467|NCT05845762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111281468|NCT05830396|Ambroxol|ambroxol|mesh-list
111281469|NCT05830396|Expectorants|expectorants|mesh-ancestor
111281470|NCT05830396|Respiratory System Agents|respiratory system agents|mesh-ancestor
111281471|NCT05817656|Sucralfate|sucralfate|mesh-list
111281472|NCT05817656|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111281473|NCT05817656|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111281474|NCT05810311|Darbepoetin alfa|darbepoetin alfa|mesh-list
111281475|NCT05810311|Hematinics|hematinics|mesh-ancestor
111281476|NCT05809297|Ciclopirox|ciclopirox|mesh-list
111281477|NCT05809297|Chitosan|chitosan|mesh-list
111281478|NCT05809297|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111281479|NCT05809297|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111281480|NCT05809297|Antimetabolites|antimetabolites|mesh-ancestor
111281481|NCT05809297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111281482|NCT05809297|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111281483|NCT05809297|Chelating Agents|chelating agents|mesh-ancestor
111281484|NCT05809297|Sequestering Agents|sequestering agents|mesh-ancestor
111281485|NCT05809297|Hemostatics|hemostatics|mesh-ancestor
111281486|NCT05809297|Coagulants|coagulants|mesh-ancestor
111281487|NCT05809297|Antifungal Agents|antifungal agents|mesh-ancestor
111281488|NCT05809297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111281489|NCT05807412|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111281490|NCT05807412|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111281491|NCT05807412|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111281492|NCT05807412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111281493|NCT05807412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111281494|NCT05807412|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111281495|NCT05807412|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111281496|NCT05807412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111281497|NCT05807412|Cholinergic Agents|cholinergic agents|mesh-ancestor
111006023|NCT05367492|Varenicline|varenicline|mesh-list
111006024|NCT05367492|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111281498|NCT05807412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111281499|NCT05770375|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
111281500|NCT05770375|Hallucinogens|hallucinogens|mesh-ancestor
111281501|NCT05770375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111281502|NCT05770375|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111281503|NCT05770375|Serotonin Agents|serotonin agents|mesh-ancestor
111281504|NCT05770375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111281505|NCT05770375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111281506|NCT05770375|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111281507|NCT05770375|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111281508|NCT05770375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111281509|NCT05770375|Adrenergic Agents|adrenergic agents|mesh-ancestor
111281510|NCT05745987|Vaccines|vaccines|mesh-list
111281511|NCT05745987|Immunologic Factors|immunologic factors|mesh-ancestor
111281512|NCT05745987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111281513|NCT05736198|Dexmedetomidine|dexmedetomidine|mesh-list
111281514|NCT05736198|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111281515|NCT05736198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111281516|NCT05736198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111281517|NCT05736198|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111281518|NCT05736198|Analgesics|analgesics|mesh-ancestor
111281519|NCT05736198|Sensory System Agents|sensory system agents|mesh-ancestor
111281520|NCT05736198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111281521|NCT05736198|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111281522|NCT05736198|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111281523|NCT05736198|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111281524|NCT05736198|Adrenergic Agents|adrenergic agents|mesh-ancestor
111281525|NCT05736198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111281526|NCT05736198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111281527|NCT05734495|Venetoclax|venetoclax|mesh-list
111281528|NCT05734495|Pirtobrutinib|pirtobrutinib|mesh-list
111281529|NCT05734495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111281530|NCT05734495|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111281531|NCT05734495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111281532|NCT05734495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111281533|NCT05729503|Lidocaine|lidocaine|mesh-list
111281534|NCT05729503|Anesthetics, Local|anesthetics, local|mesh-ancestor
111281535|NCT05729503|Anesthetics|anesthetics|mesh-ancestor
111281536|NCT05729503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111281537|NCT05729503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111281538|NCT05729503|Sensory System Agents|sensory system agents|mesh-ancestor
111281539|NCT05729503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111281540|NCT05729503|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111281541|NCT05729503|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111281542|NCT05729503|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111281543|NCT05729503|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111281544|NCT05729503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111281545|NCT05725876|Ustekinumab|ustekinumab|mesh-list
111281546|NCT05725876|Dermatologic Agents|dermatologic agents|mesh-ancestor
111281547|NCT05720390|Quinine|quinine|mesh-list
111281548|NCT05720390|Antimalarials|antimalarials|mesh-ancestor
111281549|NCT05720390|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111281550|NCT05720390|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111281551|NCT05720390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111281552|NCT05720390|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
111281553|NCT05720390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111281554|NCT05720390|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111281555|NCT05720390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111281556|NCT05720390|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111281557|NCT05720390|Analgesics|analgesics|mesh-ancestor
111281558|NCT05720390|Sensory System Agents|sensory system agents|mesh-ancestor
111281559|NCT05711641|Lidocaine|lidocaine|mesh-list
111281560|NCT05711641|Anesthetics, Local|anesthetics, local|mesh-ancestor
111281561|NCT05711641|Anesthetics|anesthetics|mesh-ancestor
111281562|NCT05711641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111281563|NCT05711641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111281564|NCT05711641|Sensory System Agents|sensory system agents|mesh-ancestor
111281565|NCT05711641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111281566|NCT05711641|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111281567|NCT05711641|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111006096|NCT05295927|Glucocorticoids|glucocorticoids|mesh-ancestor
111006097|NCT05295927|Hormones|hormones|mesh-ancestor
111006098|NCT05295927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111006099|NCT05295927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111006100|NCT05295927|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111006101|NCT05295927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111006102|NCT05295927|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111281568|NCT05711641|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111281569|NCT05711641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111281570|NCT05711641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111281572|NCT05702970|Vitamins|vitamins|mesh-ancestor
111281573|NCT05702970|Micronutrients|micronutrients|mesh-ancestor
111281574|NCT05702970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111281575|NCT05702970|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111281576|NCT05693467|Dexamethasone|dexamethasone|mesh-list
111281577|NCT05693467|Ropivacaine|ropivacaine|mesh-list
111281578|NCT05693467|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111281579|NCT05693467|Antiemetics|antiemetics|mesh-ancestor
111281580|NCT05693467|Autonomic Agents|autonomic agents|mesh-ancestor
111281581|NCT05693467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111281582|NCT05693467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111281583|NCT05693467|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111281584|NCT05693467|Glucocorticoids|glucocorticoids|mesh-ancestor
111281585|NCT05693467|Hormones|hormones|mesh-ancestor
111281586|NCT05693467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111281587|NCT05693467|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111281588|NCT05693467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111281589|NCT05693467|Anesthetics, Local|anesthetics, local|mesh-ancestor
111281590|NCT05693467|Anesthetics|anesthetics|mesh-ancestor
111281591|NCT05693467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111281592|NCT05693467|Sensory System Agents|sensory system agents|mesh-ancestor
111281593|NCT05682339|Quinine|quinine|mesh-list
111281594|NCT05682339|Antimalarials|antimalarials|mesh-ancestor
111281595|NCT05682339|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111281596|NCT05682339|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111281597|NCT05682339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111281598|NCT05682339|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
111281599|NCT05682339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111281600|NCT05682339|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111281601|NCT05682339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111281602|NCT05682339|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111281603|NCT05682339|Analgesics|analgesics|mesh-ancestor
111281604|NCT05682339|Sensory System Agents|sensory system agents|mesh-ancestor
111281605|NCT05658887|Gabapentin|gabapentin|mesh-list
111281606|NCT05658887|Analgesics|analgesics|mesh-ancestor
111281607|NCT05658887|Sensory System Agents|sensory system agents|mesh-ancestor
111281608|NCT05658887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111281609|NCT05658887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111281610|NCT05658887|Anticonvulsants|anticonvulsants|mesh-ancestor
111281611|NCT05658887|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111281612|NCT05658887|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111281613|NCT05658887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111281614|NCT05658887|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111281615|NCT05658887|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111281616|NCT05658887|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111281617|NCT05658887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111281618|NCT05658887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111281619|NCT05658887|Antimanic Agents|antimanic agents|mesh-ancestor
111281620|NCT05652283|Pamiparib|pamiparib|mesh-list
111281621|NCT05652283|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111281622|NCT05652283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111281623|NCT05652283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111281624|NCT05652283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111281625|NCT05651282|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
111281626|NCT05651282|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111281627|NCT05651282|Contraceptive Agents|contraceptive agents|mesh-ancestor
111281628|NCT05651282|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111281629|NCT05651282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111281630|NCT05651282|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111281631|NCT05651282|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
111281632|NCT05651282|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111281633|NCT05651282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111281634|NCT05627115|Tislelizumab|tislelizumab|mesh-list
111281635|NCT05627115|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111281636|NCT05627115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111281637|NCT05626920|Disulfiram|disulfiram|mesh-list
111281638|NCT05626920|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111281639|NCT05626920|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
111281640|NCT05626920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111281641|NCT05626920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111281642|NCT05605366|Minocycline|minocycline|mesh-list
111281643|NCT05605366|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111281644|NCT05605366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111281645|NCT05572255|Cenobamate|cenobamate|mesh-list
111281646|NCT05572255|Anticonvulsants|anticonvulsants|mesh-ancestor
111281647|NCT05531123|Gemcitabine|gemcitabine|mesh-list
111281648|NCT05531123|Tislelizumab|tislelizumab|mesh-list
111281649|NCT05531123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111281650|NCT05531123|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111281651|NCT05531123|Antimetabolites|antimetabolites|mesh-ancestor
111281652|NCT05531123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111281653|NCT05531123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111281654|NCT05523609|Vitamin D|vitamin d|mesh-list
111281655|NCT05523609|Letrozole|letrozole|mesh-list
111281656|NCT05523609|Vitamins|vitamins|mesh-ancestor
111281657|NCT05523609|Micronutrients|micronutrients|mesh-ancestor
111281658|NCT05523609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111281659|NCT05523609|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111281660|NCT05523609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111281661|NCT05523609|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111281662|NCT05523609|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111281663|NCT05523609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111281664|NCT05523609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111281665|NCT05523609|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111281666|NCT05523609|Hormone Antagonists|hormone antagonists|mesh-ancestor
111281667|NCT05523609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111281668|NCT05483465|Niacinamide|niacinamide|mesh-list
111281669|NCT05483465|Niacin|niacin|mesh-list
111281670|NCT05483465|Nicotinic Acids|nicotinic acids|mesh-list
111281671|NCT05483465|Vitamin B Complex|vitamin b complex|mesh-ancestor
111281672|NCT05483465|Vitamins|vitamins|mesh-ancestor
111281673|NCT05483465|Micronutrients|micronutrients|mesh-ancestor
111281674|NCT05483465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111281675|NCT05483465|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111281676|NCT05483465|Antimetabolites|antimetabolites|mesh-ancestor
111281677|NCT05483465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111281678|NCT05483465|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111281679|NCT05483465|Vasodilator Agents|vasodilator agents|mesh-ancestor
111281680|NCT05477108|Budesonide|budesonide|mesh-list
111281681|NCT05477108|Formoterol Fumarate|formoterol fumarate|mesh-list
111281682|NCT05477108|Charcoal|charcoal|mesh-list
111281683|NCT05477108|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111281684|NCT05477108|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111281685|NCT05477108|Autonomic Agents|autonomic agents|mesh-ancestor
111281686|NCT05477108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111281687|NCT05477108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111281688|NCT05477108|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111281689|NCT05477108|Respiratory System Agents|respiratory system agents|mesh-ancestor
111281690|NCT05477108|Glucocorticoids|glucocorticoids|mesh-ancestor
111281691|NCT05477108|Hormones|hormones|mesh-ancestor
111281692|NCT05477108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111281693|NCT05477108|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111281694|NCT05477108|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111281695|NCT05477108|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111281696|NCT05477108|Adrenergic Agents|adrenergic agents|mesh-ancestor
111281697|NCT05477108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111281698|NCT05477108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111281699|NCT05477108|Antidotes|antidotes|mesh-ancestor
111281700|NCT05477108|Protective Agents|protective agents|mesh-ancestor
111281701|NCT05464979|Fentanyl|fentanyl|mesh-list
111281702|NCT05464979|Midazolam|midazolam|mesh-list
111281703|NCT05464979|Ketamine|ketamine|mesh-list
111281704|NCT05464979|Esketamine|esketamine|mesh-list
111281705|NCT05464979|Analgesics|analgesics|mesh-ancestor
111281706|NCT05464979|Sensory System Agents|sensory system agents|mesh-ancestor
111281707|NCT05464979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111281708|NCT05464979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111281709|NCT05464979|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111281710|NCT05464979|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111006244|NCT05024344|Sensory System Agents|sensory system agents|mesh-ancestor
111006245|NCT04997304|Albuterol|albuterol|mesh-list
111006246|NCT04997304|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111006247|NCT04997304|Autonomic Agents|autonomic agents|mesh-ancestor
111006248|NCT04997304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111006249|NCT04997304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111006250|NCT04997304|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111006258|NCT04997304|Tocolytic Agents|tocolytic agents|mesh-ancestor
111281711|NCT05464979|Anesthetics, General|anesthetics, general|mesh-ancestor
111281712|NCT05464979|Anesthetics|anesthetics|mesh-ancestor
111281713|NCT05464979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111281714|NCT05464979|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111281715|NCT05464979|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111281716|NCT05464979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111281717|NCT05464979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111281718|NCT05464979|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111281719|NCT05464979|Narcotics|narcotics|mesh-ancestor
111281720|NCT05464979|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111281721|NCT05464979|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111281722|NCT05464979|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111281723|NCT05464979|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111281724|NCT05464979|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111281725|NCT05464979|GABA Modulators|gaba modulators|mesh-ancestor
111281726|NCT05464979|GABA Agents|gaba agents|mesh-ancestor
111281727|NCT05464979|Antidepressive Agents|antidepressive agents|mesh-ancestor
111281728|NCT05442463|Captopril|captopril|mesh-list
111281729|NCT05442463|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
111281730|NCT05442463|Protease Inhibitors|protease inhibitors|mesh-ancestor
111281731|NCT05442463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111281732|NCT05442463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111281733|NCT05442463|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111281734|NCT05435222|Psychotropic Drugs|psychotropic drugs|mesh-list
111281735|NCT05402319|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111281736|NCT05402319|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
111281737|NCT05402319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111281738|NCT05402319|Antitubercular Agents|antitubercular agents|mesh-ancestor
111281739|NCT05398289|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111281740|NCT05398289|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
111281741|NCT05398289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111281742|NCT05398289|Antitubercular Agents|antitubercular agents|mesh-ancestor
111281743|NCT05384938|Benralizumab|benralizumab|mesh-list
111281744|NCT05384938|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111281745|NCT05384938|Respiratory System Agents|respiratory system agents|mesh-ancestor
111281746|NCT05373108|Macitentan|macitentan|mesh-list
111281747|NCT05373108|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
111281748|NCT05373108|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
111281749|NCT05373108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111281750|NCT05373108|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
111281751|NCT05368753|Lidocaine|lidocaine|mesh-list
111281752|NCT05368753|Ropivacaine|ropivacaine|mesh-list
111281753|NCT05368753|Anesthetics, Local|anesthetics, local|mesh-ancestor
111281754|NCT05368753|Anesthetics|anesthetics|mesh-ancestor
111281755|NCT05368753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111281756|NCT05368753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111281757|NCT05368753|Sensory System Agents|sensory system agents|mesh-ancestor
111281758|NCT05368753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111281759|NCT05368753|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111281760|NCT05368753|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111281761|NCT05368753|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111281762|NCT05368753|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111281763|NCT05368753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111281764|NCT05363514|Naltrexone|naltrexone|mesh-list
111281765|NCT05363514|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111281766|NCT05363514|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111281767|NCT05363514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111281768|NCT05363514|Sensory System Agents|sensory system agents|mesh-ancestor
111281769|NCT05363514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111281770|NCT05345691|Denosumab|denosumab|mesh-list
111281771|NCT05345691|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111281772|NCT05345691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111281773|NCT05325073|Epoetin Alfa|epoetin alfa|mesh-list
111281774|NCT05325073|Hematinics|hematinics|mesh-ancestor
111281775|NCT05314998|Leucovorin|leucovorin|mesh-list
111281776|NCT05314998|Folic Acid|folic acid|mesh-list
111281777|NCT05314998|Gemcitabine|gemcitabine|mesh-list
111281778|NCT05314998|Fluorouracil|fluorouracil|mesh-list
111281779|NCT05314998|Capecitabine|capecitabine|mesh-list
111281780|NCT05314998|Oxaliplatin|oxaliplatin|mesh-list
111281781|NCT05314998|Irinotecan|irinotecan|mesh-list
111281782|NCT05314998|Levoleucovorin|levoleucovorin|mesh-list
111281783|NCT05314998|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111281784|NCT05314998|Antimetabolites|antimetabolites|mesh-ancestor
111281785|NCT05314998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111281786|NCT05314998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111281787|NCT05314998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111281788|NCT05314998|Immunologic Factors|immunologic factors|mesh-ancestor
111281789|NCT05314998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111281790|NCT05314998|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111281791|NCT05314998|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111281792|NCT05314998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111281793|NCT05314998|Antidotes|antidotes|mesh-ancestor
111281794|NCT05314998|Protective Agents|protective agents|mesh-ancestor
111281795|NCT05314998|Vitamin B Complex|vitamin b complex|mesh-ancestor
111281796|NCT05314998|Vitamins|vitamins|mesh-ancestor
111281797|NCT05314998|Micronutrients|micronutrients|mesh-ancestor
111281798|NCT05314998|Hematinics|hematinics|mesh-ancestor
111281799|NCT05284344|Hypoglycemic Agents|hypoglycemic agents|mesh-list
111281800|NCT05284344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111281801|NCT05269615|Valsartan|valsartan|mesh-list
111281802|NCT05269615|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111281803|NCT05269615|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111281804|NCT05269615|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111281805|NCT05269615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111281806|NCT05250895|Misonidazole|misonidazole|mesh-list
111281807|NCT05250895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111281808|NCT05250895|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111281809|NCT05250895|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111281810|NCT05250895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111281811|NCT05219409|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111281812|NCT05219409|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111281813|NCT05219409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111281814|NCT05219409|Incretins|incretins|mesh-ancestor
111281815|NCT05219409|Hormones|hormones|mesh-ancestor
111281816|NCT05219409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111281817|NCT05219409|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111281818|NCT05219409|Protease Inhibitors|protease inhibitors|mesh-ancestor
111281819|NCT05219409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111281820|NCT05219409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111281821|NCT05196932|Antibodies|antibodies|mesh-list
111281822|NCT05196932|Immunologic Factors|immunologic factors|mesh-ancestor
111281823|NCT05196932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111281824|NCT05194111|Valsartan|valsartan|mesh-list
111281825|NCT05194111|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
111281826|NCT05194111|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111281827|NCT05194111|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111281828|NCT05194111|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111281829|NCT05194111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111281830|NCT05189756|Aprepitant|aprepitant|mesh-list
110979038|NCT03253250|Tenofovir|tenofovir|mesh-list
111281831|NCT05189756|Fosaprepitant|fosaprepitant|mesh-list
111281832|NCT05189756|Antiemetics|antiemetics|mesh-ancestor
111281833|NCT05189756|Autonomic Agents|autonomic agents|mesh-ancestor
111281834|NCT05189756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111281835|NCT05189756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111281836|NCT05189756|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111281837|NCT05189756|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
111281838|NCT05189756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111281839|NCT05189756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111281840|NCT05181150|Glucagon|glucagon|mesh-list
111281841|NCT05181150|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
111281842|NCT05181150|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111281843|NCT05181150|Hormones|hormones|mesh-ancestor
111281844|NCT05181150|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111281845|NCT05181150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111281846|NCT05181150|Incretins|incretins|mesh-ancestor
111281847|NCT05174637|Immunoconjugates|immunoconjugates|mesh-list
111281848|NCT05174637|Immunologic Factors|immunologic factors|mesh-ancestor
111281849|NCT05174637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111281850|NCT05151159|Antibodies|antibodies|mesh-list
111281851|NCT05151159|Immunologic Factors|immunologic factors|mesh-ancestor
111281852|NCT05151159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111281853|NCT05144529|Nivolumab|nivolumab|mesh-list
111281854|NCT05144529|Ipilimumab|ipilimumab|mesh-list
111281855|NCT05144529|Evolocumab|evolocumab|mesh-list
111281856|NCT05144529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111281857|NCT05144529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111281858|NCT05144529|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111281859|NCT05144529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111281860|NCT05144529|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
111281861|NCT05144529|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111006407|NCT04685772|Hormones|hormones|mesh-ancestor
111281862|NCT05144529|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111281863|NCT05144529|Antimetabolites|antimetabolites|mesh-ancestor
111281864|NCT05144529|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111281865|NCT05144529|Protease Inhibitors|protease inhibitors|mesh-ancestor
111281866|NCT05144529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111281867|NCT05144529|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111281868|NCT05132920|Dexamethasone|dexamethasone|mesh-list
111281869|NCT05132920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111281870|NCT05132920|Antiemetics|antiemetics|mesh-ancestor
111281871|NCT05132920|Autonomic Agents|autonomic agents|mesh-ancestor
111281872|NCT05132920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111281873|NCT05132920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111281874|NCT05132920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111281875|NCT05132920|Glucocorticoids|glucocorticoids|mesh-ancestor
111281876|NCT05132920|Hormones|hormones|mesh-ancestor
111281877|NCT05132920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111281878|NCT05132920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111281879|NCT05132920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111281880|NCT05129085|Dexamethasone|dexamethasone|mesh-list
111281881|NCT05129085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111281882|NCT05129085|Antiemetics|antiemetics|mesh-ancestor
111281883|NCT05129085|Autonomic Agents|autonomic agents|mesh-ancestor
111281884|NCT05129085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111281885|NCT05129085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111281886|NCT05129085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111281887|NCT05129085|Glucocorticoids|glucocorticoids|mesh-ancestor
111281888|NCT05129085|Hormones|hormones|mesh-ancestor
111281889|NCT05129085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111281890|NCT05129085|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111281891|NCT05129085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111281892|NCT05099471|Dexamethasone|dexamethasone|mesh-list
111281893|NCT05099471|Cyclophosphamide|cyclophosphamide|mesh-list
111281894|NCT05099471|Rituximab|rituximab|mesh-list
111281895|NCT05099471|Venetoclax|venetoclax|mesh-list
111281896|NCT05099471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111281897|NCT05099471|Immunologic Factors|immunologic factors|mesh-ancestor
111281898|NCT05099471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111281899|NCT05099471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111281900|NCT05099471|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111281901|NCT05099471|Alkylating Agents|alkylating agents|mesh-ancestor
111281902|NCT05099471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111281903|NCT05099471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111281904|NCT05099471|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111281905|NCT05099471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111281906|NCT05099471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111281907|NCT05099471|Antiemetics|antiemetics|mesh-ancestor
111281908|NCT05099471|Autonomic Agents|autonomic agents|mesh-ancestor
111281909|NCT05099471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111281910|NCT05099471|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111281911|NCT05099471|Glucocorticoids|glucocorticoids|mesh-ancestor
111281912|NCT05099471|Hormones|hormones|mesh-ancestor
111281913|NCT05099471|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111281914|NCT05099471|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111281915|NCT05087693|Albuterol|albuterol|mesh-list
111281916|NCT05087693|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111281917|NCT05087693|Autonomic Agents|autonomic agents|mesh-ancestor
111281918|NCT05087693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111281919|NCT05087693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111281920|NCT05087693|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111281921|NCT05087693|Respiratory System Agents|respiratory system agents|mesh-ancestor
111281922|NCT05087693|Tocolytic Agents|tocolytic agents|mesh-ancestor
111281923|NCT05087693|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111281924|NCT05087693|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111281925|NCT05087693|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111281926|NCT05087693|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111281927|NCT05087693|Adrenergic Agents|adrenergic agents|mesh-ancestor
111281928|NCT05087693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111281929|NCT05087693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111281930|NCT05081583|Midazolam|midazolam|mesh-list
111281931|NCT05081583|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111281932|NCT05081583|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111281933|NCT05081583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111281934|NCT05081583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111281935|NCT05081583|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111006475|NCT04535141|Olanzapine|olanzapine|mesh-list
111281936|NCT05081583|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111281938|NCT05081583|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111281939|NCT05081583|Anesthetics, General|anesthetics, general|mesh-ancestor
111281940|NCT05081583|Anesthetics|anesthetics|mesh-ancestor
111281941|NCT05081583|GABA Modulators|gaba modulators|mesh-ancestor
111281942|NCT05081583|GABA Agents|gaba agents|mesh-ancestor
111281943|NCT05081583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111281944|NCT05081583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111281945|NCT05070754|Cantharidin|cantharidin|mesh-list
111281946|NCT05070754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111281947|NCT05070754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111281948|NCT05067387|Dronabinol|dronabinol|mesh-list
111281949|NCT05067387|Hallucinogens|hallucinogens|mesh-ancestor
111281950|NCT05067387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111281951|NCT05067387|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111281952|NCT05067387|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111281953|NCT05067387|Analgesics|analgesics|mesh-ancestor
111281954|NCT05067387|Sensory System Agents|sensory system agents|mesh-ancestor
111281955|NCT05067387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111281956|NCT05067387|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
111281957|NCT05067387|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
111281958|NCT05067387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111281959|NCT05067387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111281960|NCT05067387|Hormones|hormones|mesh-ancestor
111281961|NCT05067387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111281962|NCT05060731|Iron|iron|mesh-list
111281963|NCT05060731|Trace Elements|trace elements|mesh-ancestor
111281964|NCT05060731|Micronutrients|micronutrients|mesh-ancestor
111281965|NCT05060731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111281966|NCT05052099|Bevacizumab|bevacizumab|mesh-list
111281967|NCT05052099|Atezolizumab|atezolizumab|mesh-list
111281968|NCT05052099|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111281969|NCT05052099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111281970|NCT05052099|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111281971|NCT05052099|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111281972|NCT05052099|Growth Substances|growth substances|mesh-ancestor
111281973|NCT05052099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111281974|NCT05052099|Growth Inhibitors|growth inhibitors|mesh-ancestor
111281975|NCT05052099|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111281976|NCT05052099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111281977|NCT05050253|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111281978|NCT05037487|Dronabinol|dronabinol|mesh-list
111281979|NCT05037487|Hallucinogens|hallucinogens|mesh-ancestor
111281980|NCT05037487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111281981|NCT05037487|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111281982|NCT05037487|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111281983|NCT05037487|Analgesics|analgesics|mesh-ancestor
111281984|NCT05037487|Sensory System Agents|sensory system agents|mesh-ancestor
111281985|NCT05037487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111281986|NCT05037487|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
111281987|NCT05037487|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
111281988|NCT05037487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111281989|NCT05037487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111281990|NCT05037487|Hormones|hormones|mesh-ancestor
111281991|NCT05037487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111281992|NCT05030441|Ivosidenib|ivosidenib|mesh-list
111281993|NCT05030441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111281994|NCT05030441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111281995|NCT05030441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111281996|NCT05001074|Tacrolimus|tacrolimus|mesh-list
111281997|NCT05001074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111281998|NCT05001074|Immunologic Factors|immunologic factors|mesh-ancestor
111281999|NCT05001074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111282000|NCT05001074|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111282001|NCT05001074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111282002|NCT05001074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111282003|NCT04985890|UB-421|ub-421|mesh-list
111282004|NCT04985890|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111282005|NCT04985890|Antiviral Agents|antiviral agents|mesh-ancestor
111282006|NCT04985890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111282007|NCT04946461|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
111282008|NCT04946461|Dextroamphetamine|dextroamphetamine|mesh-list
111282009|NCT04946461|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111006545|NCT04326283|Trametinib|trametinib|mesh-list
111282010|NCT04946461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111282011|NCT04946461|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111282012|NCT04946461|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111282013|NCT04946461|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111282014|NCT04946461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111282015|NCT04946461|Dopamine Agents|dopamine agents|mesh-ancestor
111282016|NCT04946461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111282018|NCT04928664|Anesthetics, Local|anesthetics, local|mesh-ancestor
111282019|NCT04928664|Anesthetics|anesthetics|mesh-ancestor
111282020|NCT04928664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111282021|NCT04928664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111282022|NCT04928664|Sensory System Agents|sensory system agents|mesh-ancestor
111282023|NCT04928664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111282024|NCT04916392|Bupivacaine|bupivacaine|mesh-list
111282025|NCT04916392|Anesthetics, Local|anesthetics, local|mesh-ancestor
111282026|NCT04916392|Anesthetics|anesthetics|mesh-ancestor
111282027|NCT04916392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111282028|NCT04916392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111282029|NCT04916392|Sensory System Agents|sensory system agents|mesh-ancestor
111282030|NCT04916392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111282031|NCT04903119|Trametinib|trametinib|mesh-list
111282032|NCT04903119|Dabrafenib|dabrafenib|mesh-list
111282033|NCT04903119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111282034|NCT04903119|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111282035|NCT04903119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111282036|NCT04903119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111282037|NCT04899115|Vancomycin|vancomycin|mesh-list
111282038|NCT04899115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111282039|NCT04899115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111282040|NCT04871594|Nivolumab|nivolumab|mesh-list
111282041|NCT04871594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111282042|NCT04871594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111282043|NCT04871594|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111282044|NCT04871594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111282045|NCT04868903|Vitamin D|vitamin d|mesh-list
111282046|NCT04868903|Cholecalciferol|cholecalciferol|mesh-list
111282047|NCT04868903|Vitamins|vitamins|mesh-ancestor
111282048|NCT04868903|Micronutrients|micronutrients|mesh-ancestor
111282049|NCT04868903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111282050|NCT04868903|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111282051|NCT04868903|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111282052|NCT04859530|Lugol's solution|lugol's solution|mesh-list
111282053|NCT04859530|Hemostatics|hemostatics|mesh-ancestor
111282054|NCT04859530|Coagulants|coagulants|mesh-ancestor
111282055|NCT04851301|Naloxone|naloxone|mesh-list
111282056|NCT04851301|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111282057|NCT04851301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111282058|NCT04851301|Sensory System Agents|sensory system agents|mesh-ancestor
111282059|NCT04851301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111282060|NCT04801966|Pembrolizumab|pembrolizumab|mesh-list
111282061|NCT04801966|Nivolumab|nivolumab|mesh-list
111282062|NCT04801966|Atezolizumab|atezolizumab|mesh-list
111282063|NCT04801966|Olaparib|olaparib|mesh-list
111282064|NCT04801966|Palbociclib|palbociclib|mesh-list
111282065|NCT04801966|Trametinib|trametinib|mesh-list
111282066|NCT04801966|Vemurafenib|vemurafenib|mesh-list
111282067|NCT04801966|Dabrafenib|dabrafenib|mesh-list
111282068|NCT04801966|Talazoparib|talazoparib|mesh-list
111282069|NCT04801966|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111282070|NCT04801966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111282071|NCT04801966|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111282072|NCT04801966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111282073|NCT04801966|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111282074|NCT04801966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111282075|NCT04801966|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111282076|NCT04789915|Memantine|memantine|mesh-list
111282077|NCT04789915|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111282078|NCT04789915|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111282079|NCT04789915|Dopamine Agents|dopamine agents|mesh-ancestor
111282080|NCT04789915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111282081|NCT04789915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111282082|NCT04789915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111282083|NCT04789915|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111282084|NCT04789915|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111282085|NCT04771299|Cariprazine|cariprazine|mesh-list
111282086|NCT04771299|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111282087|NCT04771299|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111282088|NCT04771299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111282089|NCT04771299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111282090|NCT04771299|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111282091|NCT04725656|Nicotine|nicotine|mesh-list
111282092|NCT04725656|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111282093|NCT04725656|Autonomic Agents|autonomic agents|mesh-ancestor
111282094|NCT04725656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111282095|NCT04725656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111282096|NCT04725656|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111282097|NCT04725656|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111282098|NCT04725656|Cholinergic Agents|cholinergic agents|mesh-ancestor
111282099|NCT04725656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111282100|NCT04725656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111282101|NCT04704063|Vitamin E|vitamin e|mesh-list
111282102|NCT04704063|Tocopherols|tocopherols|mesh-list
111282103|NCT04704063|Tocotrienols|tocotrienols|mesh-list
111282104|NCT04704063|Tocovid|tocovid|mesh-list
111282105|NCT04704063|Vitamins|vitamins|mesh-ancestor
111282106|NCT04704063|Micronutrients|micronutrients|mesh-ancestor
111282107|NCT04704063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111282108|NCT04704063|Antioxidants|antioxidants|mesh-ancestor
111282109|NCT04704063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111282110|NCT04704063|Protective Agents|protective agents|mesh-ancestor
111282111|NCT04703036|Acetylcysteine|acetylcysteine|mesh-list
111282112|NCT04703036|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111282113|NCT04703036|Glycine|glycine|mesh-list
111282114|NCT04703036|Antiviral Agents|antiviral agents|mesh-ancestor
111282115|NCT04703036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111282116|NCT04703036|Expectorants|expectorants|mesh-ancestor
111282117|NCT04703036|Respiratory System Agents|respiratory system agents|mesh-ancestor
111282118|NCT04703036|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111282119|NCT04703036|Antioxidants|antioxidants|mesh-ancestor
111282120|NCT04703036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111282121|NCT04703036|Protective Agents|protective agents|mesh-ancestor
111282122|NCT04703036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111282123|NCT04703036|Antidotes|antidotes|mesh-ancestor
111282124|NCT04703036|Glycine Agents|glycine agents|mesh-ancestor
111282125|NCT04703036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111282126|NCT04636255|Calcium|calcium|mesh-list
111282127|NCT04636255|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111282128|NCT04636255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111282129|NCT04635176|Dexamethasone|dexamethasone|mesh-list
111282130|NCT04635176|Epinephrine|epinephrine|mesh-list
111282131|NCT04635176|Bupivacaine|bupivacaine|mesh-list
111282132|NCT04635176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111282133|NCT04635176|Antiemetics|antiemetics|mesh-ancestor
111282134|NCT04635176|Autonomic Agents|autonomic agents|mesh-ancestor
111282135|NCT04635176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111282136|NCT04635176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111282137|NCT04635176|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111282138|NCT04635176|Glucocorticoids|glucocorticoids|mesh-ancestor
111282139|NCT04635176|Hormones|hormones|mesh-ancestor
111282140|NCT04635176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111282141|NCT04635176|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111282142|NCT04635176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111282143|NCT04635176|Anesthetics, Local|anesthetics, local|mesh-ancestor
111282144|NCT04635176|Anesthetics|anesthetics|mesh-ancestor
111282145|NCT04635176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111282146|NCT04635176|Sensory System Agents|sensory system agents|mesh-ancestor
111282147|NCT04635176|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111282148|NCT04635176|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111282149|NCT04635176|Adrenergic Agents|adrenergic agents|mesh-ancestor
111282150|NCT04635176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111282151|NCT04635176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111282152|NCT04635176|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111282153|NCT04635176|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111282154|NCT04635176|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111282155|NCT04635176|Respiratory System Agents|respiratory system agents|mesh-ancestor
111282156|NCT04635176|Mydriatics|mydriatics|mesh-ancestor
111282157|NCT04635176|Sympathomimetics|sympathomimetics|mesh-ancestor
111282158|NCT04635176|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111282159|NCT04625907|Dactinomycin|dactinomycin|mesh-list
111282160|NCT04625907|Cyclophosphamide|cyclophosphamide|mesh-list
111282161|NCT04625907|Temozolomide|temozolomide|mesh-list
111282162|NCT04625907|Ifosfamide|ifosfamide|mesh-list
111282163|NCT04625907|Doxorubicin|doxorubicin|mesh-list
111282164|NCT04625907|Irinotecan|irinotecan|mesh-list
111282165|NCT04625907|Vincristine|vincristine|mesh-list
111282166|NCT04625907|Vinorelbine|vinorelbine|mesh-list
111282167|NCT04625907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111282168|NCT04625907|Immunologic Factors|immunologic factors|mesh-ancestor
111282169|NCT04625907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111282170|NCT04625907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111282171|NCT04625907|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111282172|NCT04625907|Alkylating Agents|alkylating agents|mesh-ancestor
111282173|NCT04625907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111282174|NCT04625907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111282175|NCT04625907|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111282176|NCT04625907|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111282177|NCT04625907|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111282178|NCT04625907|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111282179|NCT04625907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111282180|NCT04625907|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111282181|NCT04625907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111282182|NCT04625907|Tubulin Modulators|tubulin modulators|mesh-ancestor
111282183|NCT04625907|Antimitotic Agents|antimitotic agents|mesh-ancestor
111282184|NCT04625907|Mitosis Modulators|mitosis modulators|mesh-ancestor
111282185|NCT04625907|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111282186|NCT04625907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111282187|NCT04625907|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111282188|NCT04625907|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111282189|NCT04623086|Insulin|insulin|mesh-list
111282190|NCT04623086|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111282191|NCT04623086|Insulin Glargine|insulin glargine|mesh-list
111282192|NCT04623086|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111282193|NCT04623086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111282194|NCT04574713|Candesartan|candesartan|mesh-list
111282195|NCT04574713|Candesartan cilexetil|candesartan cilexetil|mesh-list
111282196|NCT04574713|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111282197|NCT04574713|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111282198|NCT04574713|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111282199|NCT04574713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111282200|NCT04569877|Molgramostim|molgramostim|mesh-list
111282201|NCT04569877|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111282202|NCT04569877|Sargramostim|sargramostim|mesh-list
111282203|NCT04569877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111282204|NCT04569877|Immunologic Factors|immunologic factors|mesh-ancestor
111282205|NCT04569877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111282206|NCT04550234|Allopurinol|allopurinol|mesh-list
111282207|NCT04550234|Verinurad|verinurad|mesh-list
111282208|NCT04550234|Antimetabolites|antimetabolites|mesh-ancestor
111282209|NCT04550234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111282210|NCT04550234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111282211|NCT04550234|Gout Suppressants|gout suppressants|mesh-ancestor
111282212|NCT04550234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111282213|NCT04550234|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111282214|NCT04550234|Antioxidants|antioxidants|mesh-ancestor
111282215|NCT04550234|Protective Agents|protective agents|mesh-ancestor
111282216|NCT04550234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111282217|NCT04541797|Empagliflozin|empagliflozin|mesh-list
111282218|NCT04541797|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111282219|NCT04541797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111282220|NCT04541797|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111282221|NCT04541797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111282222|NCT04540666|Propofol|propofol|mesh-list
111282223|NCT04540666|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111282224|NCT04540666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111282225|NCT04540666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111282226|NCT04540666|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111282227|NCT04540666|Anesthetics, General|anesthetics, general|mesh-ancestor
111282228|NCT04540666|Anesthetics|anesthetics|mesh-ancestor
111282229|NCT04530383|Metformin|metformin|mesh-list
111282230|NCT04530383|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111282231|NCT04530383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111282232|NCT04507555|Antidepressive Agents|antidepressive agents|mesh-list
111282233|NCT04507555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111282234|NCT04431245|Entecavir|entecavir|mesh-list
111282235|NCT04431245|Antiviral Agents|antiviral agents|mesh-ancestor
111282236|NCT04431245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111006776|NCT03896633|Brinzolamide|brinzolamide|mesh-list
111282237|NCT04421248|Methylphenidate|methylphenidate|mesh-list
111282238|NCT04421248|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111282239|NCT04421248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111282240|NCT04421248|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111282241|NCT04421248|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111282242|NCT04421248|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111282243|NCT04421248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111282244|NCT04421248|Dopamine Agents|dopamine agents|mesh-ancestor
111282245|NCT04421248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111282246|NCT04355572|Vitamin D|vitamin d|mesh-list
111282247|NCT04355572|Vitamins|vitamins|mesh-ancestor
111282248|NCT04355572|Micronutrients|micronutrients|mesh-ancestor
111282249|NCT04355572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111282250|NCT04355572|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111282251|NCT04310059|Folic Acid|folic acid|mesh-list
111282252|NCT04310059|Hematinics|hematinics|mesh-ancestor
111282253|NCT04310059|Vitamin B Complex|vitamin b complex|mesh-ancestor
111282254|NCT04310059|Vitamins|vitamins|mesh-ancestor
111282255|NCT04310059|Micronutrients|micronutrients|mesh-ancestor
111282256|NCT04310059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111282257|NCT04303780|Docetaxel|docetaxel|mesh-list
111282258|NCT04303780|Sotorasib|sotorasib|mesh-list
111282259|NCT04303780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111282260|NCT04303780|Tubulin Modulators|tubulin modulators|mesh-ancestor
111282261|NCT04303780|Antimitotic Agents|antimitotic agents|mesh-ancestor
111282262|NCT04303780|Mitosis Modulators|mitosis modulators|mesh-ancestor
111282263|NCT04303780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111282264|NCT04303780|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111282265|NCT04303780|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111282266|NCT04303689|Colchicine|colchicine|mesh-list
111282267|NCT04303689|Gout Suppressants|gout suppressants|mesh-ancestor
111282268|NCT04303689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111282269|NCT04303689|Tubulin Modulators|tubulin modulators|mesh-ancestor
111282270|NCT04303689|Antimitotic Agents|antimitotic agents|mesh-ancestor
111282271|NCT04303689|Mitosis Modulators|mitosis modulators|mesh-ancestor
111282272|NCT04303689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111282273|NCT04303689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111282274|NCT04217278|Cytarabine|cytarabine|mesh-list
111282275|NCT04217278|Fludarabine|fludarabine|mesh-list
111282276|NCT04217278|Busulfan|busulfan|mesh-list
111282277|NCT04217278|Thiotepa|thiotepa|mesh-list
111282278|NCT04217278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111282279|NCT04217278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111282280|NCT04217278|Antimetabolites|antimetabolites|mesh-ancestor
111282281|NCT04217278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111282282|NCT04217278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111282283|NCT04217278|Immunologic Factors|immunologic factors|mesh-ancestor
111282284|NCT04217278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111282285|NCT04217278|Antiviral Agents|antiviral agents|mesh-ancestor
111282286|NCT04217278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111282287|NCT04217278|Alkylating Agents|alkylating agents|mesh-ancestor
111282288|NCT04217278|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111282289|NCT04217278|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111282290|NCT04202809|Durvalumab|durvalumab|mesh-list
111282291|NCT04202809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111282292|NCT04202809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111282293|NCT04177953|Carboplatin|carboplatin|mesh-list
111282294|NCT04177953|Nivolumab|nivolumab|mesh-list
111282295|NCT04177953|Pemetrexed|pemetrexed|mesh-list
111282296|NCT04177953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111282297|NCT04177953|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111282298|NCT04177953|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111282299|NCT04177953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111282300|NCT04177953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111282301|NCT04177953|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111282302|NCT04177953|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111282303|NCT04063579|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
111282304|NCT04063579|Natriuretic Agents|natriuretic agents|mesh-ancestor
111282305|NCT04063579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111282306|NCT04061512|Dexamethasone|dexamethasone|mesh-list
111282307|NCT04061512|Cyclophosphamide|cyclophosphamide|mesh-list
111282308|NCT04061512|Rituximab|rituximab|mesh-list
111282309|NCT04061512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111282310|NCT04061512|Immunologic Factors|immunologic factors|mesh-ancestor
111282311|NCT04061512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111006850|NCT03739619|Gemcitabine|gemcitabine|mesh-list
111282312|NCT04061512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111282313|NCT04061512|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111282314|NCT04061512|Alkylating Agents|alkylating agents|mesh-ancestor
110979068|NCT05478382|Pregabalin|pregabalin|mesh-list
111282315|NCT04061512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111282316|NCT04061512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111282317|NCT04061512|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111282318|NCT04061512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111282319|NCT04061512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111282320|NCT04061512|Antiemetics|antiemetics|mesh-ancestor
111282321|NCT04061512|Autonomic Agents|autonomic agents|mesh-ancestor
111282322|NCT04061512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111282323|NCT04061512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111282324|NCT04061512|Glucocorticoids|glucocorticoids|mesh-ancestor
111282325|NCT04061512|Hormones|hormones|mesh-ancestor
111282326|NCT04061512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111282327|NCT04061512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111282328|NCT04036461|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-list
111282329|NCT04036461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111282330|NCT04036461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111282331|NCT04019548|Cisplatin|cisplatin|mesh-list
111282332|NCT04019548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111282333|NCT04006925|Sodium Oxybate|sodium oxybate|mesh-list
111282334|NCT04006925|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111282335|NCT04006925|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111282336|NCT04006925|Anesthetics, General|anesthetics, general|mesh-ancestor
111282337|NCT04006925|Anesthetics|anesthetics|mesh-ancestor
111282338|NCT04006925|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111282339|NCT04006925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111282340|NCT04002271|Propofol|propofol|mesh-list
111282341|NCT04002271|Sevoflurane|sevoflurane|mesh-list
111282342|NCT04002271|Anesthetics|anesthetics|mesh-ancestor
111282343|NCT04002271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111282344|NCT04002271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111282345|NCT04002271|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111282346|NCT04002271|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111282347|NCT04002271|Anesthetics, General|anesthetics, general|mesh-ancestor
111282348|NCT04002271|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111282349|NCT04002271|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111282350|NCT03972592|Sirolimus|sirolimus|mesh-list
111282351|NCT03972592|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111282352|NCT03972592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111282353|NCT03972592|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111282354|NCT03972592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111282355|NCT03972592|Antifungal Agents|antifungal agents|mesh-ancestor
111282356|NCT03972592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111282357|NCT03972592|Immunologic Factors|immunologic factors|mesh-ancestor
111282358|NCT03972592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111282359|NCT03889743|Dexamethasone|dexamethasone|mesh-list
111282360|NCT03889743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111282361|NCT03889743|Antiemetics|antiemetics|mesh-ancestor
111282362|NCT03889743|Autonomic Agents|autonomic agents|mesh-ancestor
111282363|NCT03889743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111282364|NCT03889743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111282365|NCT03889743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111282366|NCT03889743|Glucocorticoids|glucocorticoids|mesh-ancestor
111282367|NCT03889743|Hormones|hormones|mesh-ancestor
111282368|NCT03889743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111282369|NCT03889743|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111282370|NCT03889743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111282371|NCT03875872|Propofol|propofol|mesh-list
111282372|NCT03875872|Anesthetics|anesthetics|mesh-list
111282373|NCT03875872|Anesthetics, Inhalation|anesthetics, inhalation|mesh-list
111282374|NCT03875872|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111282375|NCT03875872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111282376|NCT03875872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111282377|NCT03875872|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111282378|NCT03875872|Anesthetics, General|anesthetics, general|mesh-ancestor
111282379|NCT03859908|Ethanol|ethanol|mesh-list
111282380|NCT03859908|Chlorhexidine|chlorhexidine|mesh-list
111282381|NCT03859908|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
111282382|NCT03859908|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111282383|NCT03859908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111282384|NCT03859908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111282385|NCT03859908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111282386|NCT03859908|Disinfectants|disinfectants|mesh-ancestor
111282387|NCT03859908|Dermatologic Agents|dermatologic agents|mesh-ancestor
111282388|NCT03825536|Methamphetamine|methamphetamine|mesh-list
111282389|NCT03825536|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111282390|NCT03825536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111006919|NCT03072771|Cytarabine|cytarabine|mesh-list
111282391|NCT03825536|Sympathomimetics|sympathomimetics|mesh-ancestor
111282392|NCT03825536|Autonomic Agents|autonomic agents|mesh-ancestor
111282393|NCT03825536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111282394|NCT03825536|Dopamine Agents|dopamine agents|mesh-ancestor
111282395|NCT03825536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111282396|NCT03825536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111282397|NCT03825536|Adrenergic Agents|adrenergic agents|mesh-ancestor
111282398|NCT03825536|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111282399|NCT03825536|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111282400|NCT03825536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111282401|NCT03825536|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111282402|NCT03797196|Mycophenolic Acid|mycophenolic acid|mesh-list
111282403|NCT03797196|Everolimus|everolimus|mesh-list
111282404|NCT03797196|Tacrolimus|tacrolimus|mesh-list
111282405|NCT03797196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111282406|NCT03797196|Immunologic Factors|immunologic factors|mesh-ancestor
111282407|NCT03797196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111282408|NCT03797196|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111282409|NCT03797196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111282410|NCT03797196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111282411|NCT03797196|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111282412|NCT03797196|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111282413|NCT03797196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111282414|NCT03797196|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111282415|NCT03797196|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111282416|NCT03797196|Antitubercular Agents|antitubercular agents|mesh-ancestor
111282417|NCT03797196|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111282418|NCT03797196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111282419|NCT03775382|Ascorbic Acid|ascorbic acid|mesh-list
111282420|NCT03775382|Vitamins|vitamins|mesh-ancestor
111282421|NCT03775382|Micronutrients|micronutrients|mesh-ancestor
111282422|NCT03775382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111282423|NCT03775382|Antioxidants|antioxidants|mesh-ancestor
111282424|NCT03775382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111282425|NCT03775382|Protective Agents|protective agents|mesh-ancestor
111282426|NCT03747432|Dexmedetomidine|dexmedetomidine|mesh-list
111282427|NCT03747432|Propofol|propofol|mesh-list
111282428|NCT03747432|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111282429|NCT03747432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111282430|NCT03747432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111282431|NCT03747432|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111282432|NCT03747432|Analgesics|analgesics|mesh-ancestor
111282433|NCT03747432|Sensory System Agents|sensory system agents|mesh-ancestor
111282434|NCT03747432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111282435|NCT03747432|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111282436|NCT03747432|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111282437|NCT03747432|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111282438|NCT03747432|Adrenergic Agents|adrenergic agents|mesh-ancestor
111282439|NCT03747432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111282440|NCT03747432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111282441|NCT03747432|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111282442|NCT03747432|Anesthetics, General|anesthetics, general|mesh-ancestor
111282443|NCT03747432|Anesthetics|anesthetics|mesh-ancestor
111282444|NCT03724019|Ketamine|ketamine|mesh-list
111282445|NCT03724019|Analgesics|analgesics|mesh-ancestor
111282446|NCT03724019|Sensory System Agents|sensory system agents|mesh-ancestor
111282447|NCT03724019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111282448|NCT03724019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111282449|NCT03724019|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111282450|NCT03724019|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111282451|NCT03724019|Anesthetics, General|anesthetics, general|mesh-ancestor
111282452|NCT03724019|Anesthetics|anesthetics|mesh-ancestor
111282453|NCT03724019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111282454|NCT03724019|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111282455|NCT03724019|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111282456|NCT03724019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111282457|NCT03724019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111282458|NCT03697512|Rituximab|rituximab|mesh-list
111282459|NCT03697512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111282460|NCT03697512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111282461|NCT03697512|Immunologic Factors|immunologic factors|mesh-ancestor
111282462|NCT03697512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111282463|NCT03697512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111282464|NCT03667651|Decanoic acid|decanoic acid|mesh-list
111282465|NCT03667651|Antifungal Agents|antifungal agents|mesh-ancestor
111282466|NCT03667651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111282467|NCT03649633|Vitamins|vitamins|mesh-list
111282468|NCT03649633|Hydrocortisone|hydrocortisone|mesh-list
111282469|NCT03649633|Micronutrients|micronutrients|mesh-ancestor
111282470|NCT03649633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111282471|NCT03649633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111282472|NCT03620903|Rituximab|rituximab|mesh-list
111282473|NCT03620903|Bortezomib|bortezomib|mesh-list
111282474|NCT03620903|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111282475|NCT03620903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111282476|NCT03620903|Immunologic Factors|immunologic factors|mesh-ancestor
111282477|NCT03620903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111282478|NCT03620903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111282479|NCT03497156|Lercanidipine|lercanidipine|mesh-list
111282480|NCT03497156|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111282481|NCT03497156|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111282482|NCT03497156|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111282483|NCT03497156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111282484|NCT03497156|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111282485|NCT03497156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111282486|NCT03471117|Pioglitazone|pioglitazone|mesh-list
111282487|NCT03471117|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111282488|NCT03471117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111282489|NCT03464292|Capsaicin|capsaicin|mesh-list
111282490|NCT03464292|Antipruritics|antipruritics|mesh-ancestor
111282491|NCT03464292|Dermatologic Agents|dermatologic agents|mesh-ancestor
111282492|NCT03464292|Sensory System Agents|sensory system agents|mesh-ancestor
111282493|NCT03464292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111282494|NCT03464292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111282495|NCT03448718|Olaparib|olaparib|mesh-list
111282496|NCT03448718|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111282497|NCT03448718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111282498|NCT03448718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111282499|NCT03448718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111282500|NCT03435939|Losartan|losartan|mesh-list
111282501|NCT03435939|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111282502|NCT03435939|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111282503|NCT03435939|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111282504|NCT03435939|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111282505|NCT03435939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111282506|NCT03422393|Venetoclax|venetoclax|mesh-list
111282507|NCT03422393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111282508|NCT03385226|Pembrolizumab|pembrolizumab|mesh-list
111282509|NCT03385226|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111282510|NCT03385226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111282511|NCT03385226|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111282512|NCT03385226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111282513|NCT03377543|Aspirin|aspirin|mesh-list
111282514|NCT03377543|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
111282515|NCT03377543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
111282516|NCT03377543|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111282517|NCT03377543|Analgesics|analgesics|mesh-ancestor
111282518|NCT03377543|Sensory System Agents|sensory system agents|mesh-ancestor
111282519|NCT03377543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111282520|NCT03377543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111282521|NCT03377543|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111282522|NCT03377543|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111282523|NCT03377543|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111282524|NCT03377543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111282525|NCT03377543|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111282526|NCT03377543|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111282527|NCT03377543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111282528|NCT03377543|Antipyretics|antipyretics|mesh-ancestor
111282529|NCT03365908|Ropivacaine|ropivacaine|mesh-list
111282530|NCT03365908|Anesthetics, Local|anesthetics, local|mesh-ancestor
111282531|NCT03365908|Anesthetics|anesthetics|mesh-ancestor
111282532|NCT03365908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111282533|NCT03365908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111282534|NCT03365908|Sensory System Agents|sensory system agents|mesh-ancestor
111282535|NCT03365908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111282536|NCT03362047|Macitentan|macitentan|mesh-list
111282537|NCT03362047|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
111282538|NCT03362047|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
111282539|NCT03362047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111282540|NCT03362047|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
111282541|NCT03337919|Nivolumab|nivolumab|mesh-list
111282542|NCT03337919|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111282543|NCT03337919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111282544|NCT03337919|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111282545|NCT03337919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111282546|NCT03334305|Vaccines|vaccines|mesh-list
111282547|NCT03334305|Immunologic Factors|immunologic factors|mesh-ancestor
111282548|NCT03334305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111282549|NCT03236324|Epinephrine|epinephrine|mesh-list
111282550|NCT03236324|Bupivacaine|bupivacaine|mesh-list
111282551|NCT03236324|Anesthetics, Local|anesthetics, local|mesh-ancestor
111282552|NCT03236324|Anesthetics|anesthetics|mesh-ancestor
111282553|NCT03236324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111282554|NCT03236324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111282555|NCT03236324|Sensory System Agents|sensory system agents|mesh-ancestor
111282556|NCT03236324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111282557|NCT03236324|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111282558|NCT03236324|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111282559|NCT03236324|Adrenergic Agents|adrenergic agents|mesh-ancestor
111282560|NCT03236324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111282561|NCT03236324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111282562|NCT03236324|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111282563|NCT03236324|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111282564|NCT03236324|Autonomic Agents|autonomic agents|mesh-ancestor
111282565|NCT03236324|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111282566|NCT03236324|Respiratory System Agents|respiratory system agents|mesh-ancestor
111282567|NCT03236324|Mydriatics|mydriatics|mesh-ancestor
111282568|NCT03236324|Sympathomimetics|sympathomimetics|mesh-ancestor
111282569|NCT03236324|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111282570|NCT03229850|Insulin Lispro|insulin lispro|mesh-list
111282571|NCT03229850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111282572|NCT03229850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111282573|NCT03229538|Methylprednisolone|methylprednisolone|mesh-list
111282574|NCT03229538|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111282575|NCT03229538|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111282576|NCT03229538|Prednisolone|prednisolone|mesh-list
111282577|NCT03229538|Prednisolone acetate|prednisolone acetate|mesh-list
111282578|NCT03229538|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111282579|NCT03229538|Prednisolone phosphate|prednisolone phosphate|mesh-list
111282580|NCT03229538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111282581|NCT03229538|Antiemetics|antiemetics|mesh-ancestor
111282582|NCT03229538|Autonomic Agents|autonomic agents|mesh-ancestor
111282583|NCT03229538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111282584|NCT03229538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111282585|NCT03229538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111282586|NCT03229538|Glucocorticoids|glucocorticoids|mesh-ancestor
111282587|NCT03229538|Hormones|hormones|mesh-ancestor
111282588|NCT03229538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111282589|NCT03229538|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111282590|NCT03229538|Protective Agents|protective agents|mesh-ancestor
111282591|NCT03229538|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111282592|NCT03229538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111282593|NCT03148795|Talazoparib|talazoparib|mesh-list
111282594|NCT03148795|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111282595|NCT03148795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111282596|NCT03148795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111282597|NCT03148795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111282598|NCT03070054|Epinephrine|epinephrine|mesh-list
111282599|NCT03070054|Bupivacaine|bupivacaine|mesh-list
111282600|NCT03070054|Anesthetics, Local|anesthetics, local|mesh-ancestor
111282601|NCT03070054|Anesthetics|anesthetics|mesh-ancestor
111282602|NCT03070054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111282603|NCT03070054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111282604|NCT03070054|Sensory System Agents|sensory system agents|mesh-ancestor
111282605|NCT03070054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111282606|NCT03070054|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111282607|NCT03070054|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111282608|NCT03070054|Adrenergic Agents|adrenergic agents|mesh-ancestor
111282609|NCT03070054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111282610|NCT03070054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111282611|NCT03070054|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111282612|NCT03070054|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111282613|NCT03070054|Autonomic Agents|autonomic agents|mesh-ancestor
111007144|NCT01305499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111282614|NCT03070054|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111282615|NCT03070054|Respiratory System Agents|respiratory system agents|mesh-ancestor
111282617|NCT03070054|Sympathomimetics|sympathomimetics|mesh-ancestor
111282618|NCT03070054|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111282619|NCT03040778|Vitamin E|vitamin e|mesh-list
111282620|NCT03040778|Tocopherols|tocopherols|mesh-list
111282621|NCT03040778|Tocotrienols|tocotrienols|mesh-list
111282622|NCT03040778|alpha-Tocopherol|alpha-tocopherol|mesh-list
111282623|NCT03040778|Pentoxifylline|pentoxifylline|mesh-list
111282624|NCT03040778|Vitamins|vitamins|mesh-ancestor
111282625|NCT03040778|Micronutrients|micronutrients|mesh-ancestor
111282626|NCT03040778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111282627|NCT03040778|Antioxidants|antioxidants|mesh-ancestor
111282628|NCT03040778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111282629|NCT03040778|Protective Agents|protective agents|mesh-ancestor
111282630|NCT03040778|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111282631|NCT03040778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111282632|NCT03040778|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111282633|NCT03040778|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111282634|NCT03040778|Vasodilator Agents|vasodilator agents|mesh-ancestor
111282635|NCT03040778|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111282636|NCT02962414|Everolimus|everolimus|mesh-list
111282637|NCT02962414|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111282638|NCT02962414|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111282639|NCT02962414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111282640|NCT02962414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111282641|NCT02962414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111282642|NCT02962414|Immunologic Factors|immunologic factors|mesh-ancestor
111282643|NCT02962414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111282644|NCT02962414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111282645|NCT02959047|Alirocumab|alirocumab|mesh-list
111282646|NCT02959047|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
111282647|NCT02959047|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111282648|NCT02959047|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111282649|NCT02959047|Antimetabolites|antimetabolites|mesh-ancestor
111282650|NCT02959047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111282651|NCT02959047|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111282652|NCT02959047|Protease Inhibitors|protease inhibitors|mesh-ancestor
111282653|NCT02959047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111282654|NCT02959047|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111282655|NCT02895750|Metformin|metformin|mesh-list
111282656|NCT02895750|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111282657|NCT02895750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111282658|NCT02895360|Lisavanbulin|lisavanbulin|mesh-list
111282659|NCT02895360|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111282660|NCT02895360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111282661|NCT02895360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111282662|NCT02895360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111282663|NCT02890784|Dasatinib|dasatinib|mesh-list
111282664|NCT02890784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111282665|NCT02890784|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111282666|NCT02890784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111282667|NCT02890784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111282668|NCT02863809|Riboflavin|riboflavin|mesh-list
111282669|NCT02863809|Dextrans|dextrans|mesh-list
111282670|NCT02863809|Vitamins|vitamins|mesh-ancestor
111282671|NCT02863809|Micronutrients|micronutrients|mesh-ancestor
110979090|NCT03249740|Growth Substances|growth substances|mesh-ancestor
111282672|NCT02863809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111282673|NCT02863809|Vitamin B Complex|vitamin b complex|mesh-ancestor
111282674|NCT02863809|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111282675|NCT02863809|Dermatologic Agents|dermatologic agents|mesh-ancestor
111282676|NCT02863809|Anticoagulants|anticoagulants|mesh-ancestor
111282677|NCT02863809|Plasma Substitutes|plasma substitutes|mesh-ancestor
111282678|NCT02863809|Blood Substitutes|blood substitutes|mesh-ancestor
111282679|NCT02829957|Rivaroxaban|rivaroxaban|mesh-list
111282680|NCT02829957|Apixaban|apixaban|mesh-list
111282681|NCT02829957|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111282682|NCT02829957|Antithrombins|antithrombins|mesh-ancestor
111282683|NCT02829957|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111282684|NCT02829957|Protease Inhibitors|protease inhibitors|mesh-ancestor
111282685|NCT02829957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111282686|NCT02829957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111282687|NCT02829957|Anticoagulants|anticoagulants|mesh-ancestor
111282688|NCT02823028|Nicotine|nicotine|mesh-list
111282689|NCT02823028|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111282690|NCT02823028|Autonomic Agents|autonomic agents|mesh-ancestor
111282691|NCT02823028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111282692|NCT02823028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111282693|NCT02823028|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111282694|NCT02823028|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111282695|NCT02823028|Cholinergic Agents|cholinergic agents|mesh-ancestor
111282696|NCT02823028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111282697|NCT02823028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111282698|NCT02785224|Vasopressins|vasopressins|mesh-list
111282699|NCT02785224|Arginine Vasopressin|arginine vasopressin|mesh-list
111282700|NCT02785224|Epinephrine|epinephrine|mesh-list
111282701|NCT02785224|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111282702|NCT02785224|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111282703|NCT02785224|Adrenergic Agents|adrenergic agents|mesh-ancestor
111282704|NCT02785224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111282705|NCT02785224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111282706|NCT02785224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111282707|NCT02785224|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111282708|NCT02785224|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111282709|NCT02785224|Autonomic Agents|autonomic agents|mesh-ancestor
111282710|NCT02785224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111282711|NCT02785224|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111282712|NCT02785224|Respiratory System Agents|respiratory system agents|mesh-ancestor
111282713|NCT02785224|Mydriatics|mydriatics|mesh-ancestor
111282714|NCT02785224|Sympathomimetics|sympathomimetics|mesh-ancestor
111282715|NCT02785224|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111282716|NCT02785224|Hemostatics|hemostatics|mesh-ancestor
111282717|NCT02785224|Coagulants|coagulants|mesh-ancestor
111282718|NCT02785224|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
111282719|NCT02785224|Natriuretic Agents|natriuretic agents|mesh-ancestor
111282720|NCT02768363|Valacyclovir|valacyclovir|mesh-list
111282721|NCT02768363|Antiviral Agents|antiviral agents|mesh-ancestor
111282722|NCT02768363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111282723|NCT02729805|Ketamine|ketamine|mesh-list
111282724|NCT02729805|Analgesics|analgesics|mesh-ancestor
111282725|NCT02729805|Sensory System Agents|sensory system agents|mesh-ancestor
111282726|NCT02729805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111282727|NCT02729805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111282728|NCT02729805|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111282729|NCT02729805|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111282730|NCT02729805|Anesthetics, General|anesthetics, general|mesh-ancestor
111282731|NCT02729805|Anesthetics|anesthetics|mesh-ancestor
111282732|NCT02729805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111282733|NCT02729805|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111282734|NCT02729805|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111282735|NCT02729805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111282736|NCT02729805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111282737|NCT02616666|Dapagliflozin|dapagliflozin|mesh-list
111282738|NCT02616666|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111282739|NCT02616666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111282740|NCT02616666|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111282741|NCT02616666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111282742|NCT02521311|Clemastine|clemastine|mesh-list
111282743|NCT02521311|Antipruritics|antipruritics|mesh-ancestor
111282744|NCT02521311|Dermatologic Agents|dermatologic agents|mesh-ancestor
111282745|NCT02521311|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111282746|NCT02521311|Histamine Antagonists|histamine antagonists|mesh-ancestor
111282747|NCT02521311|Histamine Agents|histamine agents|mesh-ancestor
111282748|NCT02521311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111282749|NCT02521311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111282750|NCT02521311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111282751|NCT02521311|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111282752|NCT02508038|Zoledronic Acid|zoledronic acid|mesh-list
111282753|NCT02508038|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111282754|NCT02508038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111282755|NCT02437045|Meropenem|meropenem|mesh-list
111282756|NCT02437045|Tazobactam|tazobactam|mesh-list
111282757|NCT02437045|Piperacillin|piperacillin|mesh-list
111282758|NCT02437045|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
111282759|NCT02437045|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111282760|NCT02437045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111282761|NCT02437045|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
111282762|NCT02437045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111282763|NCT02437045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111282764|NCT02308527|Cyclophosphamide|cyclophosphamide|mesh-list
111282765|NCT02308527|Temozolomide|temozolomide|mesh-list
111282766|NCT02308527|Bevacizumab|bevacizumab|mesh-list
111282767|NCT02308527|Irinotecan|irinotecan|mesh-list
111282768|NCT02308527|Topotecan|topotecan|mesh-list
111282769|NCT02308527|Dinutuximab|dinutuximab|mesh-list
111282770|NCT02308527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111282771|NCT02308527|Immunologic Factors|immunologic factors|mesh-ancestor
111282772|NCT02308527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111282773|NCT02308527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111282774|NCT02308527|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111282775|NCT02308527|Alkylating Agents|alkylating agents|mesh-ancestor
111282776|NCT02308527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111282777|NCT02308527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111282778|NCT02308527|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111282779|NCT02308527|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111282780|NCT02308527|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111282781|NCT02308527|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111282782|NCT02308527|Growth Substances|growth substances|mesh-ancestor
111282783|NCT02308527|Growth Inhibitors|growth inhibitors|mesh-ancestor
111282784|NCT02308527|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111282785|NCT02308527|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111282786|NCT02308527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111282787|NCT02308072|Olaparib|olaparib|mesh-list
111282788|NCT02308072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111282789|NCT02308072|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111282790|NCT02308072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111282791|NCT02308072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111282792|NCT02289079|Bupivacaine|bupivacaine|mesh-list
111282793|NCT02289079|Anesthetics, Local|anesthetics, local|mesh-ancestor
111282794|NCT02289079|Anesthetics|anesthetics|mesh-ancestor
111282795|NCT02289079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111282796|NCT02289079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111282797|NCT02289079|Sensory System Agents|sensory system agents|mesh-ancestor
111282798|NCT02289079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111282799|NCT02131753|Cladribine|cladribine|mesh-list
111282800|NCT02131753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111282801|NCT02131753|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111282802|NCT02131753|Immunologic Factors|immunologic factors|mesh-ancestor
111282803|NCT02131753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111282804|NCT02101788|Tamoxifen|tamoxifen|mesh-list
111282805|NCT02101788|Paclitaxel|paclitaxel|mesh-list
111282806|NCT02101788|Doxorubicin|doxorubicin|mesh-list
111282807|NCT02101788|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111282808|NCT02101788|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111282809|NCT02101788|Letrozole|letrozole|mesh-list
111282810|NCT02101788|Topotecan|topotecan|mesh-list
111282811|NCT02101788|Trametinib|trametinib|mesh-list
111282812|NCT02101788|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
111282813|NCT02101788|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111282814|NCT02101788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111282815|NCT02101788|Tubulin Modulators|tubulin modulators|mesh-ancestor
111282816|NCT02101788|Antimitotic Agents|antimitotic agents|mesh-ancestor
111282817|NCT02101788|Mitosis Modulators|mitosis modulators|mesh-ancestor
111282818|NCT02101788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111282819|NCT02101788|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111282820|NCT02101788|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111282821|NCT02101788|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111282822|NCT02101788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111282823|NCT02101788|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111282824|NCT02101788|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111282825|NCT02101788|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111282826|NCT02101788|Hormone Antagonists|hormone antagonists|mesh-ancestor
111282827|NCT02101788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111282828|NCT02101788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111282829|NCT02101788|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111282830|NCT02101788|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111282831|NCT02101788|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111282832|NCT02101788|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111282833|NCT02101788|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111282834|NCT02101788|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111282835|NCT02101788|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
111282836|NCT02101788|Protective Agents|protective agents|mesh-ancestor
111282837|NCT02101788|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111282838|NCT02101788|Antioxidants|antioxidants|mesh-ancestor
111282839|NCT02079740|Trametinib|trametinib|mesh-list
111282840|NCT02079740|Navitoclax|navitoclax|mesh-list
111282841|NCT02079740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111282842|NCT02079740|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111282843|NCT02079740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111282844|NCT02079740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111282845|NCT02058706|Leuprolide|leuprolide|mesh-list
111282846|NCT02058706|Goserelin|goserelin|mesh-list
111282847|NCT02058706|Bicalutamide|bicalutamide|mesh-list
111282848|NCT02058706|Androgens|androgens|mesh-list
111282849|NCT02058706|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111282850|NCT02058706|Fertility Agents|fertility agents|mesh-ancestor
111282851|NCT02058706|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111282852|NCT02058706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111282853|NCT02058706|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111282854|NCT02058706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111282855|NCT02058706|Hormones|hormones|mesh-ancestor
111282856|NCT02058706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111282857|NCT02058706|Androgen Antagonists|androgen antagonists|mesh-ancestor
111282858|NCT02058706|Hormone Antagonists|hormone antagonists|mesh-ancestor
111282859|NCT01644110|Pomalidomide|pomalidomide|mesh-list
111282860|NCT01644110|Immunologic Factors|immunologic factors|mesh-ancestor
111282861|NCT01644110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111282862|NCT01644110|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111282863|NCT01644110|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111282864|NCT01644110|Growth Substances|growth substances|mesh-ancestor
111282865|NCT01644110|Growth Inhibitors|growth inhibitors|mesh-ancestor
111282866|NCT01644110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111282867|NCT01478542|Rituximab|rituximab|mesh-list
111282868|NCT01478542|Vincristine|vincristine|mesh-list
111282869|NCT01478542|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111282870|NCT01478542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111282871|NCT01478542|Immunologic Factors|immunologic factors|mesh-ancestor
111282872|NCT01478542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111282873|NCT01478542|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111282874|NCT01478542|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111282875|NCT01478542|Tubulin Modulators|tubulin modulators|mesh-ancestor
111282876|NCT01478542|Antimitotic Agents|antimitotic agents|mesh-ancestor
111282877|NCT01478542|Mitosis Modulators|mitosis modulators|mesh-ancestor
111282878|NCT01478542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111282879|NCT01406678|Sufentanil|sufentanil|mesh-list
111282880|NCT01406678|Dsuvia|dsuvia|mesh-list
111282881|NCT01406678|Isoflurane|isoflurane|mesh-list
111282882|NCT01406678|Anesthetics|anesthetics|mesh-ancestor
111282883|NCT01406678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111282884|NCT01406678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111282885|NCT01406678|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111282886|NCT01406678|Narcotics|narcotics|mesh-ancestor
111282887|NCT01406678|Analgesics|analgesics|mesh-ancestor
111282888|NCT01406678|Sensory System Agents|sensory system agents|mesh-ancestor
111282889|NCT01406678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111282890|NCT01406678|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111282891|NCT01406678|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111282892|NCT01406678|Anesthetics, General|anesthetics, general|mesh-ancestor
111282893|NCT01406678|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111282894|NCT01397929|Lisavanbulin|lisavanbulin|mesh-list
111282895|NCT01397929|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111282896|NCT01397929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111282897|NCT01397929|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111282898|NCT01397929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111282899|NCT01370330|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
111282900|NCT01370330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111282901|NCT01370330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111282902|NCT01370330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111282903|NCT01370330|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111282904|NCT00843323|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
111282905|NCT00843323|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111282906|NCT00843323|Dermatologic Agents|dermatologic agents|mesh-ancestor
111282907|NCT00695214|Propofol|propofol|mesh-list
111282908|NCT00695214|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111282909|NCT00695214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111282910|NCT00695214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111282911|NCT00695214|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111282912|NCT00695214|Anesthetics, General|anesthetics, general|mesh-ancestor
111282913|NCT00695214|Anesthetics|anesthetics|mesh-ancestor
111282914|NCT00678327|Prednisolone|prednisolone|mesh-list
111282915|NCT00678327|Cyclophosphamide|cyclophosphamide|mesh-list
111282916|NCT00678327|Dacarbazine|dacarbazine|mesh-list
111282917|NCT00678327|Doxorubicin|doxorubicin|mesh-list
111282918|NCT00678327|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111282919|NCT00678327|Etoposide|etoposide|mesh-list
111282920|NCT00678327|Vincristine|vincristine|mesh-list
111282921|NCT00678327|Bleomycin|bleomycin|mesh-list
111282922|NCT00678327|Vinblastine|vinblastine|mesh-list
111282923|NCT00678327|Procarbazine|procarbazine|mesh-list
111282924|NCT00678327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111282925|NCT00678327|Immunologic Factors|immunologic factors|mesh-ancestor
111282926|NCT00678327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111282927|NCT00678327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111282928|NCT00678327|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111282929|NCT00678327|Alkylating Agents|alkylating agents|mesh-ancestor
111282930|NCT00678327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111282931|NCT00678327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111282932|NCT00678327|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111282933|NCT00678327|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111282934|NCT00678327|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111282935|NCT00678327|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111282936|NCT00678327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111282937|NCT00678327|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111282938|NCT00678327|Tubulin Modulators|tubulin modulators|mesh-ancestor
111282939|NCT00678327|Antimitotic Agents|antimitotic agents|mesh-ancestor
111282940|NCT00678327|Mitosis Modulators|mitosis modulators|mesh-ancestor
111282941|NCT00678327|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111282942|NCT00678327|Glucocorticoids|glucocorticoids|mesh-ancestor
111282943|NCT00678327|Hormones|hormones|mesh-ancestor
111282944|NCT00678327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111282945|NCT00678327|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111282946|NCT00602667|Cyclophosphamide|cyclophosphamide|mesh-list
111282947|NCT00602667|Cisplatin|cisplatin|mesh-list
111282948|NCT00602667|Carboplatin|carboplatin|mesh-list
111282949|NCT00602667|Methotrexate|methotrexate|mesh-list
111282950|NCT00602667|Etoposide|etoposide|mesh-list
111282951|NCT00602667|Etoposide phosphate|etoposide phosphate|mesh-list
111282952|NCT00602667|Vincristine|vincristine|mesh-list
111282953|NCT00602667|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111282954|NCT00602667|Topotecan|topotecan|mesh-list
111282955|NCT00602667|Vinblastine|vinblastine|mesh-list
111282956|NCT00602667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111282957|NCT00602667|Immunologic Factors|immunologic factors|mesh-ancestor
111282958|NCT00602667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111282959|NCT00602667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111282960|NCT00602667|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111282961|NCT00602667|Alkylating Agents|alkylating agents|mesh-ancestor
111282962|NCT00602667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111282963|NCT00602667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111282964|NCT00602667|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111282965|NCT00602667|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111282966|NCT00602667|Abortifacient Agents|abortifacient agents|mesh-ancestor
111282967|NCT00602667|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111282968|NCT00602667|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111282969|NCT00602667|Antimetabolites|antimetabolites|mesh-ancestor
111282970|NCT00602667|Dermatologic Agents|dermatologic agents|mesh-ancestor
111282971|NCT00602667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111282972|NCT00602667|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111282973|NCT00602667|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111282974|NCT00602667|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111282975|NCT00602667|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111282976|NCT00602667|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111282977|NCT00602667|Tubulin Modulators|tubulin modulators|mesh-ancestor
111282978|NCT00602667|Antimitotic Agents|antimitotic agents|mesh-ancestor
111282979|NCT00602667|Mitosis Modulators|mitosis modulators|mesh-ancestor
111282980|NCT00602667|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111282981|NCT00602667|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111282982|NCT00544466|Fludarabine|fludarabine|mesh-list
111282983|NCT00544466|Fludarabine phosphate|fludarabine phosphate|mesh-list
111282984|NCT00544466|Melphalan|melphalan|mesh-list
111282985|NCT00544466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111282986|NCT00544466|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111282987|NCT00544466|Antimetabolites|antimetabolites|mesh-ancestor
111282988|NCT00544466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111282989|NCT00544466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111282990|NCT00544466|Immunologic Factors|immunologic factors|mesh-ancestor
111282991|NCT00544466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111282992|NCT00544466|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111282993|NCT00544466|Alkylating Agents|alkylating agents|mesh-ancestor
111282994|NCT00544466|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111282995|NCT00519675|Alitretinoin|alitretinoin|mesh-list
111282996|NCT00519675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111282997|NCT00519675|Dermatologic Agents|dermatologic agents|mesh-ancestor
111282999|NCT00492999|Dexamethasone|dexamethasone|mesh-list
111283000|NCT00492999|Fluorouracil|fluorouracil|mesh-list
111283001|NCT00492999|Oxaliplatin|oxaliplatin|mesh-list
111283002|NCT00492999|Irinotecan|irinotecan|mesh-list
111283003|NCT00492999|Floxuridine|floxuridine|mesh-list
111283004|NCT00492999|Calcium|calcium|mesh-list
111283005|NCT00492999|Levoleucovorin|levoleucovorin|mesh-list
111283006|NCT00492999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111283007|NCT00492999|Antiemetics|antiemetics|mesh-ancestor
111283008|NCT00492999|Autonomic Agents|autonomic agents|mesh-ancestor
111283009|NCT00492999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111283010|NCT00492999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111283011|NCT00492999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111283012|NCT00492999|Glucocorticoids|glucocorticoids|mesh-ancestor
111283013|NCT00492999|Hormones|hormones|mesh-ancestor
111283014|NCT00492999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111283015|NCT00492999|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111283016|NCT00492999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111283017|NCT00492999|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111283018|NCT00492999|Antimetabolites|antimetabolites|mesh-ancestor
111283019|NCT00492999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111283020|NCT00492999|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111283021|NCT00492999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111283022|NCT00492999|Immunologic Factors|immunologic factors|mesh-ancestor
111283023|NCT00492999|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111283024|NCT00492999|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111283025|NCT00492999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111283026|NCT00492999|Antidotes|antidotes|mesh-ancestor
111283027|NCT00492999|Protective Agents|protective agents|mesh-ancestor
111283028|NCT00492999|Vitamin B Complex|vitamin b complex|mesh-ancestor
111283029|NCT00492999|Vitamins|vitamins|mesh-ancestor
111283030|NCT00492999|Micronutrients|micronutrients|mesh-ancestor
111283031|NCT00413439|Isavuconazole|isavuconazole|mesh-list
111283032|NCT00413439|Antifungal Agents|antifungal agents|mesh-ancestor
111283033|NCT00413439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111283034|NCT00374075|Valproic Acid|valproic acid|mesh-list
111283035|NCT00374075|Anticonvulsants|anticonvulsants|mesh-ancestor
111283036|NCT00374075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111283037|NCT00374075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111283038|NCT00374075|GABA Agents|gaba agents|mesh-ancestor
111283039|NCT00374075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111283040|NCT00374075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111283041|NCT00374075|Antimanic Agents|antimanic agents|mesh-ancestor
111283042|NCT00374075|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111283043|NCT00374075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111283044|NCT00374075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111283045|NCT00309621|Alitretinoin|alitretinoin|mesh-list
111283046|NCT00309621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111283047|NCT00309621|Dermatologic Agents|dermatologic agents|mesh-ancestor
111283048|NCT00124475|Alitretinoin|alitretinoin|mesh-list
111283049|NCT00124475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111283050|NCT00124475|Dermatologic Agents|dermatologic agents|mesh-ancestor
111283051|NCT00124436|Alitretinoin|alitretinoin|mesh-list
111283052|NCT00124436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111283053|NCT00124436|Dermatologic Agents|dermatologic agents|mesh-ancestor
111283054|NCT00112931|Rituximab|rituximab|mesh-list
111283055|NCT00112931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111283056|NCT00112931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111283057|NCT00112931|Immunologic Factors|immunologic factors|mesh-ancestor
111283058|NCT00112931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111283059|NCT00112931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111283060|NCT00110110|Cyclosporine|cyclosporine|mesh-list
111283061|NCT00110110|Carboplatin|carboplatin|mesh-list
111283062|NCT00110110|Etoposide|etoposide|mesh-list
111283063|NCT00110110|Vincristine|vincristine|mesh-list
111283064|NCT00110110|Cyclosporins|cyclosporins|mesh-list
111283065|NCT00110110|Lenograstim|lenograstim|mesh-list
111283066|NCT00110110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111283067|NCT00110110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111283068|NCT00110110|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111283069|NCT00110110|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111283070|NCT00110110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111283071|NCT00110110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111283072|NCT00110110|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111283073|NCT00110110|Immunologic Factors|immunologic factors|mesh-ancestor
111283074|NCT00110110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111283075|NCT00110110|Tubulin Modulators|tubulin modulators|mesh-ancestor
111283076|NCT00110110|Antimitotic Agents|antimitotic agents|mesh-ancestor
111283077|NCT00110110|Mitosis Modulators|mitosis modulators|mesh-ancestor
111283078|NCT00110110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111283079|NCT00110110|Antifungal Agents|antifungal agents|mesh-ancestor
111283080|NCT00110110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111283081|NCT00110110|Dermatologic Agents|dermatologic agents|mesh-ancestor
111283082|NCT00110110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111283083|NCT00110110|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111283084|NCT05307003|Quetiapine Fumarate|quetiapine fumarate|mesh-list
111283086|NCT05307003|Antidepressive Agents|antidepressive agents|mesh-ancestor
111283087|NCT05307003|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111283088|NCT05307003|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111283089|NCT05307003|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111283090|NCT05307003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111283091|NCT05307003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111283092|NCT05307003|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111283093|NCT05307003|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111283094|NCT05307003|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111283095|NCT05307003|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111283096|NCT05307003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111283097|NCT05307003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111283098|NCT05307003|Serotonin Agents|serotonin agents|mesh-ancestor
111283099|NCT05307003|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111283100|NCT03153917|Hydrocortisone|hydrocortisone|mesh-list
111283101|NCT03153917|Melatonin|melatonin|mesh-list
111283102|NCT03153917|Antioxidants|antioxidants|mesh-ancestor
111283103|NCT03153917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111283104|NCT03153917|Protective Agents|protective agents|mesh-ancestor
111283105|NCT03153917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111283106|NCT03153917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111283107|NCT03153917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111283108|NCT01096875|Atorvastatin|atorvastatin|mesh-list
111283109|NCT01096875|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111283110|NCT01096875|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111283111|NCT01096875|Antimetabolites|antimetabolites|mesh-ancestor
111283112|NCT01096875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111283113|NCT01096875|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111283114|NCT01096875|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111283115|NCT01096875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111283116|NCT01097343|Clopidogrel|clopidogrel|mesh-list
111283117|NCT01097343|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111283118|NCT01097343|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111283119|NCT01097343|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111283120|NCT01097343|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111283121|NCT01097343|Purinergic Agents|purinergic agents|mesh-ancestor
111283122|NCT01097343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111283123|NCT01097343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111283124|NCT01097343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111283125|NCT03580187|Morphine|morphine|mesh-list
111283126|NCT03580187|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111283127|NCT03580187|Narcotics|narcotics|mesh-ancestor
111283128|NCT03580187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111283129|NCT03580187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111283130|NCT03580187|Analgesics|analgesics|mesh-ancestor
111283131|NCT03580187|Sensory System Agents|sensory system agents|mesh-ancestor
111283132|NCT03580187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111283133|NCT01098747|Ibuprofen|ibuprofen|mesh-list
111283134|NCT01098747|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111283135|NCT01098747|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111283136|NCT01098747|Analgesics|analgesics|mesh-ancestor
111283137|NCT01098747|Sensory System Agents|sensory system agents|mesh-ancestor
111283138|NCT01098747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111283139|NCT01098747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111283140|NCT01098747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111283141|NCT01098747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111283142|NCT01098747|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111283143|NCT01098747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111283144|NCT01098747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111283145|NCT02085161|Tiotropium Bromide|tiotropium bromide|mesh-list
111283146|NCT02085161|Olodaterol|olodaterol|mesh-list
111283147|NCT02085161|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111283148|NCT02085161|Autonomic Agents|autonomic agents|mesh-ancestor
111007676|NCT03136406|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111283149|NCT02085161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111283150|NCT02085161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111283151|NCT02085161|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111283152|NCT02085161|Respiratory System Agents|respiratory system agents|mesh-ancestor
111283154|NCT02085161|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111283155|NCT02085161|Cholinergic Agents|cholinergic agents|mesh-ancestor
111283156|NCT02085161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111283157|NCT02085161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111283158|NCT01034553|Bortezomib|bortezomib|mesh-list
111283159|NCT01034553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111283160|NCT01035333|Orlistat|orlistat|mesh-list
111283161|NCT01035333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111283162|NCT01035333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111283163|NCT01035333|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111283164|NCT01035333|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111283165|NCT05073549|Anti-Infective Agents|anti-infective agents|mesh-list
111283166|NCT05073549|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111283167|NCT03152981|Remifentanil|remifentanil|mesh-list
111283168|NCT03152981|Propofol|propofol|mesh-list
111283169|NCT03152981|Desflurane|desflurane|mesh-list
111283170|NCT03152981|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111283171|NCT03152981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111283172|NCT03152981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111283173|NCT03152981|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111283174|NCT03152981|Anesthetics, General|anesthetics, general|mesh-ancestor
111283175|NCT03152981|Anesthetics|anesthetics|mesh-ancestor
111283176|NCT03152981|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111283177|NCT03152981|Narcotics|narcotics|mesh-ancestor
111283178|NCT03152981|Analgesics|analgesics|mesh-ancestor
111283179|NCT03152981|Sensory System Agents|sensory system agents|mesh-ancestor
111283180|NCT03152981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111283181|NCT03152981|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111283182|NCT05384015|Carboplatin|carboplatin|mesh-list
111283183|NCT05384015|Pembrolizumab|pembrolizumab|mesh-list
111283184|NCT05384015|Etoposide|etoposide|mesh-list
111283185|NCT05384015|Etoposide phosphate|etoposide phosphate|mesh-list
111283186|NCT05384015|Lenvatinib|lenvatinib|mesh-list
111283187|NCT05384015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111283188|NCT05384015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111283189|NCT05384015|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111283190|NCT05384015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111283191|NCT05384015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111283192|NCT05384015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111283193|NCT05384015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111283194|NCT05384015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111283195|NCT05384015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111283196|NCT03572387|Azacitidine|azacitidine|mesh-list
111283197|NCT03572387|Tretinoin|tretinoin|mesh-list
111283198|NCT03572387|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111283199|NCT03572387|Antimetabolites|antimetabolites|mesh-ancestor
111283200|NCT03572387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111283201|NCT03572387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111283202|NCT03572387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111283203|NCT03572387|Keratolytic Agents|keratolytic agents|mesh-ancestor
111283204|NCT03572387|Dermatologic Agents|dermatologic agents|mesh-ancestor
111283205|NCT04728971|Caspofungin|caspofungin|mesh-list
111283206|NCT04728971|Micafungin|micafungin|mesh-list
111283207|NCT04728971|Antifungal Agents|antifungal agents|mesh-ancestor
111283208|NCT04728971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111283209|NCT04728971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111283210|NCT04728971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111283211|NCT03568643|Amoxicillin|amoxicillin|mesh-list
111283212|NCT03568643|Azithromycin|azithromycin|mesh-list
111283213|NCT03568643|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111283214|NCT03568643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111283215|NCT01100931|Paclitaxel|paclitaxel|mesh-list
111283216|NCT01100931|Carboplatin|carboplatin|mesh-list
111283217|NCT01100931|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111283218|NCT01100931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111283219|NCT01100931|Tubulin Modulators|tubulin modulators|mesh-ancestor
111283220|NCT01100931|Antimitotic Agents|antimitotic agents|mesh-ancestor
111283221|NCT01100931|Mitosis Modulators|mitosis modulators|mesh-ancestor
111283222|NCT01100931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111283223|NCT01101867|Insulin Aspart|insulin aspart|mesh-list
111007752|NCT03600493|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111283224|NCT01101867|Insulin, Long-Acting|insulin, long-acting|mesh-list
111283225|NCT01101867|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
111283227|NCT01101867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111283228|NCT03013959|Pyranoprofen|pyranoprofen|mesh-list
111283229|NCT03013959|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111283230|NCT03013959|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111283231|NCT03013959|Analgesics|analgesics|mesh-ancestor
111283232|NCT03013959|Sensory System Agents|sensory system agents|mesh-ancestor
111283233|NCT03013959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111283234|NCT03013959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111283235|NCT03013959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111283236|NCT03013959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111283237|NCT03013959|Gout Suppressants|gout suppressants|mesh-ancestor
111283238|NCT02246595|Vilobelimab|vilobelimab|mesh-list
111283239|NCT02246595|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
111283240|NCT02246595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111283241|NCT02246595|Immunologic Factors|immunologic factors|mesh-ancestor
111283242|NCT02246595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111283243|NCT01106859|Zolpidem|zolpidem|mesh-list
111283244|NCT01106859|Zopiclone|zopiclone|mesh-list
111283245|NCT01106859|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111283246|NCT01106859|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111283247|NCT01106859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111283248|NCT01106859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111283249|NCT01106859|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
111283250|NCT01106859|GABA Agonists|gaba agonists|mesh-ancestor
111283251|NCT01106859|GABA Agents|gaba agents|mesh-ancestor
111283252|NCT01106859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111283253|NCT01106859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111283254|NCT01042509|Rituximab|rituximab|mesh-list
111283255|NCT01042509|Alemtuzumab|alemtuzumab|mesh-list
111283256|NCT01042509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111283257|NCT01042509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111283258|NCT01042509|Immunologic Factors|immunologic factors|mesh-ancestor
111283259|NCT01042509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111283260|NCT01042509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111283261|NCT04814355|Celecoxib|celecoxib|mesh-list
111283262|NCT04814355|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111283263|NCT04814355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111283264|NCT04814355|Analgesics|analgesics|mesh-ancestor
111283265|NCT04814355|Sensory System Agents|sensory system agents|mesh-ancestor
111283266|NCT04814355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111283267|NCT04814355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111283268|NCT04814355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111283269|NCT04814355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111283270|NCT04814355|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111283271|NCT04814355|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111283272|NCT04814355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111283273|NCT04814355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111283274|NCT02179671|Docetaxel|docetaxel|mesh-list
111283275|NCT02179671|Gefitinib|gefitinib|mesh-list
111283276|NCT02179671|Tremelimumab|tremelimumab|mesh-list
111283277|NCT02179671|Osimertinib|osimertinib|mesh-list
111283278|NCT02179671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111283279|NCT02179671|Tubulin Modulators|tubulin modulators|mesh-ancestor
111283280|NCT02179671|Antimitotic Agents|antimitotic agents|mesh-ancestor
111283281|NCT02179671|Mitosis Modulators|mitosis modulators|mesh-ancestor
111283282|NCT02179671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111283283|NCT02179671|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111283284|NCT02179671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111283285|NCT01110135|Dexamethasone|dexamethasone|mesh-list
111283286|NCT01110135|Etoposide|etoposide|mesh-list
111283287|NCT01110135|Etoposide phosphate|etoposide phosphate|mesh-list
111283288|NCT01110135|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
111283289|NCT01110135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111283290|NCT01110135|Antiemetics|antiemetics|mesh-ancestor
111283291|NCT01110135|Autonomic Agents|autonomic agents|mesh-ancestor
111283292|NCT01110135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111283293|NCT01110135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111283294|NCT01110135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111283295|NCT01110135|Glucocorticoids|glucocorticoids|mesh-ancestor
111283296|NCT01110135|Hormones|hormones|mesh-ancestor
111283297|NCT01110135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111283298|NCT01110135|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111283299|NCT01110135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111283300|NCT01110135|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111283301|NCT01110135|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111283302|NCT01110135|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111283303|NCT01110135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111283304|NCT01110135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111283305|NCT01110135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111283306|NCT01110135|Alkylating Agents|alkylating agents|mesh-ancestor
111283307|NCT01112241|Albuterol|albuterol|mesh-list
111283308|NCT01112241|Tiotropium Bromide|tiotropium bromide|mesh-list
111283309|NCT01112241|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111283310|NCT01112241|Autonomic Agents|autonomic agents|mesh-ancestor
111283311|NCT01112241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111283312|NCT01112241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111283313|NCT01112241|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111283314|NCT01112241|Respiratory System Agents|respiratory system agents|mesh-ancestor
111283315|NCT01112241|Parasympatholytics|parasympatholytics|mesh-ancestor
111283316|NCT01112241|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111283317|NCT01112241|Cholinergic Agents|cholinergic agents|mesh-ancestor
111283318|NCT01112241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111283319|NCT01112241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111283320|NCT01112241|Tocolytic Agents|tocolytic agents|mesh-ancestor
111283321|NCT01112241|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111283322|NCT01112241|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111283323|NCT01112241|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111283324|NCT01112241|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111283325|NCT01112241|Adrenergic Agents|adrenergic agents|mesh-ancestor
111283326|NCT03013881|Trastuzumab|trastuzumab|mesh-list
111283327|NCT03013881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111283328|NCT03013881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111283329|NCT02174913|Fentanyl|fentanyl|mesh-list
111283330|NCT02174913|Propofol|propofol|mesh-list
111283331|NCT02174913|Atracurium|atracurium|mesh-list
111283332|NCT02174913|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111283333|NCT02174913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111283334|NCT02174913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111283335|NCT02174913|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111283336|NCT02174913|Anesthetics, General|anesthetics, general|mesh-ancestor
111283337|NCT02174913|Anesthetics|anesthetics|mesh-ancestor
111283338|NCT02174913|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111283339|NCT02174913|Narcotics|narcotics|mesh-ancestor
111283340|NCT02174913|Analgesics|analgesics|mesh-ancestor
111283341|NCT02174913|Sensory System Agents|sensory system agents|mesh-ancestor
111283342|NCT02174913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110979106|NCT03249506|Glucagon|glucagon|mesh-list
111283343|NCT02174913|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111283344|NCT02174913|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
111283345|NCT02174913|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
111283346|NCT02174913|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111283347|NCT02174913|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
111283348|NCT02174913|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111283349|NCT02174913|Cholinergic Agents|cholinergic agents|mesh-ancestor
111283350|NCT02174913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111283351|NCT02174913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111283352|NCT01114503|Methylprednisolone|methylprednisolone|mesh-list
111283353|NCT01114503|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111283354|NCT01114503|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111283355|NCT01114503|Prednisolone|prednisolone|mesh-list
111283356|NCT01114503|Prednisolone acetate|prednisolone acetate|mesh-list
111283357|NCT01114503|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111283358|NCT01114503|Prednisolone phosphate|prednisolone phosphate|mesh-list
111283359|NCT01114503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111283360|NCT01114503|Antiemetics|antiemetics|mesh-ancestor
111283361|NCT01114503|Autonomic Agents|autonomic agents|mesh-ancestor
111283362|NCT01114503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111283363|NCT01114503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111283364|NCT01114503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111283365|NCT01114503|Glucocorticoids|glucocorticoids|mesh-ancestor
111283366|NCT01114503|Hormones|hormones|mesh-ancestor
111283367|NCT01114503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111283368|NCT01114503|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111283369|NCT01114503|Protective Agents|protective agents|mesh-ancestor
111283370|NCT01114503|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111283371|NCT01114503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111283372|NCT03015831|Colchicine|colchicine|mesh-list
111283373|NCT03015831|Gout Suppressants|gout suppressants|mesh-ancestor
111283374|NCT03015831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111007906|NCT04362566|Bupivacaine|bupivacaine|mesh-list
111283375|NCT03015831|Tubulin Modulators|tubulin modulators|mesh-ancestor
111283376|NCT03015831|Antimitotic Agents|antimitotic agents|mesh-ancestor
111283377|NCT03015831|Mitosis Modulators|mitosis modulators|mesh-ancestor
111283378|NCT03015831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111283379|NCT03015831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111283380|NCT01114581|Phenylpropanolamine|phenylpropanolamine|mesh-list
111283381|NCT01114581|Guaifenesin|guaifenesin|mesh-list
111283382|NCT01114581|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
111283383|NCT01114581|Expectorants|expectorants|mesh-ancestor
111283384|NCT01114581|Respiratory System Agents|respiratory system agents|mesh-ancestor
111283385|NCT01114581|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111283386|NCT01114581|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111283387|NCT01114581|Adrenergic Agents|adrenergic agents|mesh-ancestor
111283388|NCT01114581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111283389|NCT01114581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111283390|NCT01114581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111283391|NCT01114581|Appetite Depressants|appetite depressants|mesh-ancestor
111283392|NCT01114581|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111283393|NCT01114581|Sympathomimetics|sympathomimetics|mesh-ancestor
111283394|NCT01114581|Autonomic Agents|autonomic agents|mesh-ancestor
111283395|NCT01114581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111283396|NCT01114581|Nasal Decongestants|nasal decongestants|mesh-ancestor
111283397|NCT01114581|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111283398|NCT01114893|Travoprost|travoprost|mesh-list
111283399|NCT01114893|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111283400|NCT01114971|Labetalol|labetalol|mesh-list
111283401|NCT01114971|Fentanyl|fentanyl|mesh-list
111283402|NCT01114971|Esmolol|esmolol|mesh-list
111283403|NCT01114971|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111283404|NCT01114971|Narcotics|narcotics|mesh-ancestor
111283405|NCT01114971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111283406|NCT01114971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111283407|NCT01114971|Analgesics|analgesics|mesh-ancestor
111283408|NCT01114971|Sensory System Agents|sensory system agents|mesh-ancestor
111283409|NCT01114971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111283410|NCT01114971|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111283411|NCT01114971|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111283412|NCT01114971|Anesthetics, General|anesthetics, general|mesh-ancestor
111283413|NCT01114971|Anesthetics|anesthetics|mesh-ancestor
111283414|NCT01114971|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110735915|NCT04090710|Nivolumab|nivolumab|mesh-list
111283415|NCT01114971|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111283416|NCT01114971|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111283417|NCT01114971|Adrenergic Agents|adrenergic agents|mesh-ancestor
111283418|NCT01114971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111283419|NCT01114971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111283420|NCT01114971|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111283421|NCT01114971|Sympathomimetics|sympathomimetics|mesh-ancestor
111283422|NCT01114971|Autonomic Agents|autonomic agents|mesh-ancestor
111283423|NCT01114971|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111283424|NCT01114971|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111283425|NCT01044693|Metoprolol|metoprolol|mesh-list
111283426|NCT01044693|Nebivolol|nebivolol|mesh-list
111283427|NCT01044693|Sildenafil Citrate|sildenafil citrate|mesh-list
111283428|NCT01044693|Vasodilator Agents|vasodilator agents|mesh-ancestor
111283429|NCT01044693|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111283430|NCT01044693|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111283431|NCT01044693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111283432|NCT01044693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111283433|NCT01044693|Urological Agents|urological agents|mesh-ancestor
111283434|NCT01044693|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111283435|NCT01044693|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111283436|NCT01044693|Sympatholytics|sympatholytics|mesh-ancestor
111283437|NCT01044693|Autonomic Agents|autonomic agents|mesh-ancestor
111283438|NCT01044693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111283439|NCT01044693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111283440|NCT01044693|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
111283441|NCT01044693|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111283442|NCT01044693|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111283443|NCT01044693|Adrenergic Agents|adrenergic agents|mesh-ancestor
111283444|NCT01044693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111283445|NCT01044693|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
111283446|NCT01044693|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111283447|NCT01044693|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111283448|NCT01115517|Bevacizumab|bevacizumab|mesh-list
111283449|NCT01115517|Mitomycins|mitomycins|mesh-list
111283450|NCT01115517|Mitomycin|mitomycin|mesh-list
111283451|NCT01115517|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111283452|NCT01115517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111283453|NCT01115517|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111283454|NCT01115517|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111283455|NCT01115517|Growth Substances|growth substances|mesh-ancestor
111283456|NCT01115517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111283457|NCT01115517|Growth Inhibitors|growth inhibitors|mesh-ancestor
111283458|NCT01115517|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111283459|NCT01115517|Alkylating Agents|alkylating agents|mesh-ancestor
111283460|NCT01115517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111283461|NCT01115517|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111283462|NCT01115517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111283464|NCT03015675|Vitamins|vitamins|mesh-ancestor
111283465|NCT03015675|Micronutrients|micronutrients|mesh-ancestor
111283466|NCT03015675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111283467|NCT03015675|Antioxidants|antioxidants|mesh-ancestor
111283468|NCT03015675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111283469|NCT03015675|Protective Agents|protective agents|mesh-ancestor
111283470|NCT01044771|Tenofovir|tenofovir|mesh-list
111283471|NCT01044771|Raltegravir Potassium|raltegravir potassium|mesh-list
111283472|NCT01044771|Antiviral Agents|antiviral agents|mesh-ancestor
111283473|NCT01044771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111283474|NCT01044771|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111283475|NCT01044771|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111283476|NCT01044771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111283477|NCT01044771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111283478|NCT01044771|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111283479|NCT01044771|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111283480|NCT01044771|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111283481|NCT01044771|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111283482|NCT01115673|Acetaminophen|acetaminophen|mesh-list
111283483|NCT01115673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111283484|NCT01115673|Analgesics|analgesics|mesh-ancestor
111283485|NCT01115673|Sensory System Agents|sensory system agents|mesh-ancestor
111283486|NCT01115673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111283487|NCT01115673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111283488|NCT01115673|Antipyretics|antipyretics|mesh-ancestor
111283489|NCT01116921|Pulmonary Surfactants|pulmonary surfactants|mesh-list
111283490|NCT01116921|Respiratory System Agents|respiratory system agents|mesh-ancestor
111283491|NCT04582383|Doxycycline|doxycycline|mesh-list
111283492|NCT04582383|Spironolactone|spironolactone|mesh-list
111283493|NCT04582383|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111283494|NCT04582383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111283495|NCT04582383|Antimalarials|antimalarials|mesh-ancestor
111283496|NCT04582383|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111283497|NCT04582383|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111283498|NCT04582383|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
111283499|NCT04582383|Hormone Antagonists|hormone antagonists|mesh-ancestor
111283500|NCT04582383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111283501|NCT04582383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111283502|NCT04582383|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
111283503|NCT04582383|Diuretics|diuretics|mesh-ancestor
111283504|NCT04582383|Natriuretic Agents|natriuretic agents|mesh-ancestor
111283505|NCT01118091|Aldesleukin|aldesleukin|mesh-list
111283506|NCT01118091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111283507|NCT01118091|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111283508|NCT01118091|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111283509|NCT01118091|Antiviral Agents|antiviral agents|mesh-ancestor
111283510|NCT01118091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111283511|NCT01045551|Apremilast|apremilast|mesh-list
111283512|NCT01045551|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111283513|NCT01045551|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111283514|NCT01045551|Analgesics|analgesics|mesh-ancestor
111283515|NCT01045551|Sensory System Agents|sensory system agents|mesh-ancestor
111283516|NCT01045551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111283517|NCT01045551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111283518|NCT01045551|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111283519|NCT01045551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111283520|NCT01045551|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
111283521|NCT01045551|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111283522|NCT01045551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111283523|NCT01045551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111283524|NCT01047189|Clindamycin|clindamycin|mesh-list
111008054|NCT02237729|Adalimumab|adalimumab|mesh-list
111283525|NCT01047189|Clindamycin palmitate|clindamycin palmitate|mesh-list
111283526|NCT01047189|Clindamycin phosphate|clindamycin phosphate|mesh-list
111283527|NCT01047189|Tretinoin|tretinoin|mesh-list
111283528|NCT01047189|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111283529|NCT01047189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111283530|NCT01047189|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111283531|NCT01047189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111283532|NCT01047189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111283533|NCT01047189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111283534|NCT01047189|Keratolytic Agents|keratolytic agents|mesh-ancestor
111283535|NCT01047189|Dermatologic Agents|dermatologic agents|mesh-ancestor
111283536|NCT03012945|Anesthetics|anesthetics|mesh-list
111283537|NCT03012945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111283538|NCT03012945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111283539|NCT01121211|Testosterone|testosterone|mesh-list
111283540|NCT01121211|Androgens|androgens|mesh-ancestor
111283541|NCT01121211|Hormones|hormones|mesh-ancestor
111283542|NCT01121211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111283543|NCT01121211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111283544|NCT01162551|Sirolimus|sirolimus|mesh-list
111283545|NCT01162551|Methotrexate|methotrexate|mesh-list
111283546|NCT01162551|Temsirolimus|temsirolimus|mesh-list
111283547|NCT01162551|MTOR Inhibitors|mtor inhibitors|mesh-list
111283548|NCT01162551|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111283549|NCT01162551|Abortifacient Agents|abortifacient agents|mesh-ancestor
111283550|NCT01162551|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111283551|NCT01162551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111283552|NCT01162551|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111283553|NCT01162551|Antimetabolites|antimetabolites|mesh-ancestor
111283554|NCT01162551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111283555|NCT01162551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111283556|NCT01162551|Dermatologic Agents|dermatologic agents|mesh-ancestor
111283557|NCT01162551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111283558|NCT01162551|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111283559|NCT01162551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111283560|NCT01162551|Immunologic Factors|immunologic factors|mesh-ancestor
111283561|NCT01162551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111283562|NCT01162551|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111283563|NCT01162551|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111283564|NCT01162551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111283565|NCT01162551|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111283566|NCT01162551|Antifungal Agents|antifungal agents|mesh-ancestor
111283567|NCT01162551|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111283568|NCT01163097|Heparin|heparin|mesh-list
111283569|NCT01163097|Anticoagulants|anticoagulants|mesh-ancestor
111283570|NCT01163097|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111283571|NCT01163097|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111283572|NCT01163097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111283573|NCT03013101|Antibodies|antibodies|mesh-list
111283574|NCT03013101|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111283575|NCT03013101|Immunologic Factors|immunologic factors|mesh-ancestor
111283576|NCT03013101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111283577|NCT03088137|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
111283578|NCT03088137|Hormones|hormones|mesh-ancestor
111283579|NCT03088137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111283580|NCT03088137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111283581|NCT01165047|Nitric Oxide|nitric oxide|mesh-list
111283582|NCT01165047|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111283583|NCT01165047|Autonomic Agents|autonomic agents|mesh-ancestor
111283584|NCT01165047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111283585|NCT01165047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111283586|NCT01165047|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111283587|NCT01165047|Respiratory System Agents|respiratory system agents|mesh-ancestor
111283588|NCT01165047|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111283589|NCT01165047|Antioxidants|antioxidants|mesh-ancestor
111283590|NCT01165047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111283591|NCT01165047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111283592|NCT01165047|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
111283593|NCT01165047|Vasodilator Agents|vasodilator agents|mesh-ancestor
111283594|NCT01165047|Gasotransmitters|gasotransmitters|mesh-ancestor
111283595|NCT01165047|Protective Agents|protective agents|mesh-ancestor
111283596|NCT01166997|Heparin|heparin|mesh-list
111283597|NCT01166997|Calcium heparin|calcium heparin|mesh-list
111283598|NCT01166997|Anticoagulants|anticoagulants|mesh-ancestor
111283599|NCT01166997|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111283600|NCT01166997|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111283601|NCT01166997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111283602|NCT02802969|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
111283603|NCT02802969|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111283604|NCT02802969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111283605|NCT01170117|Olanzapine|olanzapine|mesh-list
111283606|NCT01170117|Antiemetics|antiemetics|mesh-ancestor
111283607|NCT01170117|Autonomic Agents|autonomic agents|mesh-ancestor
111283608|NCT01170117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111283609|NCT01170117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111283610|NCT01170117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111283611|NCT01170117|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111283612|NCT01170117|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111283613|NCT01170117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111283614|NCT01170117|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111283615|NCT01170117|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111283616|NCT01170117|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111283617|NCT01170117|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111283618|NCT01170117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111283619|NCT01170117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111283620|NCT01170117|Serotonin Agents|serotonin agents|mesh-ancestor
111283621|NCT01172145|Modafinil|modafinil|mesh-list
111283622|NCT01172145|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111283623|NCT01172145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111283624|NCT01172145|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
111283625|NCT01172145|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111283626|NCT01172145|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111283627|NCT01172145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110979118|NCT03249662|Bupivacaine|bupivacaine|mesh-list
111283628|NCT01175343|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
111283629|NCT01175343|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-list
111283630|NCT01175343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111283631|NCT01175343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111283632|NCT01176435|Levodopa|levodopa|mesh-list
111283633|NCT01176435|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111283634|NCT01176435|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111283635|NCT01176435|Dopamine Agents|dopamine agents|mesh-ancestor
111283636|NCT01176435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111283637|NCT01176435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111283638|NCT01176435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111283639|NCT01176591|Aprepitant|aprepitant|mesh-list
111283640|NCT01176591|Fosaprepitant|fosaprepitant|mesh-list
111283641|NCT01176591|Antiemetics|antiemetics|mesh-ancestor
111283642|NCT01176591|Autonomic Agents|autonomic agents|mesh-ancestor
111283643|NCT01176591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111283644|NCT01176591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111283645|NCT01176591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111283646|NCT01176591|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
111283647|NCT01176591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111283648|NCT01176591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111283649|NCT01176981|Methotrexate|methotrexate|mesh-list
111283650|NCT01176981|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111283651|NCT01176981|Abortifacient Agents|abortifacient agents|mesh-ancestor
111283652|NCT01176981|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111283653|NCT01176981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111283654|NCT01176981|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111283655|NCT01176981|Antimetabolites|antimetabolites|mesh-ancestor
111283656|NCT01176981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111283657|NCT01176981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111283658|NCT01176981|Dermatologic Agents|dermatologic agents|mesh-ancestor
111283659|NCT01176981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111283660|NCT01176981|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111283661|NCT01176981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111283662|NCT01176981|Immunologic Factors|immunologic factors|mesh-ancestor
111283663|NCT01176981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111283664|NCT01176981|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111283665|NCT01126593|Bupivacaine|bupivacaine|mesh-list
111283666|NCT01126593|Anesthetics, Local|anesthetics, local|mesh-ancestor
111283667|NCT01126593|Anesthetics|anesthetics|mesh-ancestor
111283668|NCT01126593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111283669|NCT01126593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111283670|NCT01126593|Sensory System Agents|sensory system agents|mesh-ancestor
111283671|NCT01126593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111283672|NCT01181349|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
111283674|NCT01181349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111283675|NCT01181349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111283676|NCT01126671|Vitamin D|vitamin d|mesh-list
111283677|NCT01126671|Vitamins|vitamins|mesh-ancestor
111283678|NCT01126671|Micronutrients|micronutrients|mesh-ancestor
111283679|NCT01126671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111283680|NCT01126671|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111283681|NCT01182675|Plerixafor|plerixafor|mesh-list
111283682|NCT01182675|Alemtuzumab|alemtuzumab|mesh-list
111283683|NCT01182675|Lenograstim|lenograstim|mesh-list
111283684|NCT01182675|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111283685|NCT01182675|Immunologic Factors|immunologic factors|mesh-ancestor
111283686|NCT01182675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111283687|NCT01182675|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111283688|NCT01182675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111283689|NCT01182675|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111283690|NCT01182675|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111283691|NCT01182675|Antiviral Agents|antiviral agents|mesh-ancestor
111283692|NCT01182675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111283693|NCT01129245|Celecoxib|celecoxib|mesh-list
111283694|NCT01129245|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111283695|NCT01129245|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111283696|NCT01129245|Analgesics|analgesics|mesh-ancestor
111283697|NCT01129245|Sensory System Agents|sensory system agents|mesh-ancestor
111283698|NCT01129245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111283699|NCT01129245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111283700|NCT01129245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111283701|NCT01129245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111283702|NCT01129245|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111283703|NCT01129245|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111283704|NCT01129245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111283705|NCT01129245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111283706|NCT01183533|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
111283707|NCT01183533|Plasminogen|plasminogen|mesh-list
111283708|NCT01183533|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111283709|NCT01183533|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111283710|NCT01183533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111283711|NCT01187355|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111283712|NCT01188369|Simendan|simendan|mesh-list
111283713|NCT01188369|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111283714|NCT01188369|Vasodilator Agents|vasodilator agents|mesh-ancestor
111283715|NCT01188369|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
111283716|NCT01188369|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111283717|NCT01188369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111283718|NCT01188369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111283719|NCT01188369|Protective Agents|protective agents|mesh-ancestor
111283720|NCT01188369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111283721|NCT01135329|Mycophenolic Acid|mycophenolic acid|mesh-list
111283722|NCT01135329|Cyclophosphamide|cyclophosphamide|mesh-list
111283723|NCT01135329|Busulfan|busulfan|mesh-list
111283724|NCT01135329|Fludarabine|fludarabine|mesh-list
111283725|NCT01135329|Tacrolimus|tacrolimus|mesh-list
111283726|NCT01135329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111283727|NCT01135329|Immunologic Factors|immunologic factors|mesh-ancestor
111283728|NCT01135329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111283729|NCT01135329|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111283730|NCT01135329|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111283731|NCT01135329|Alkylating Agents|alkylating agents|mesh-ancestor
111283732|NCT01135329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111283733|NCT01135329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111283734|NCT01135329|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111283735|NCT01135329|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111283736|NCT01135329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111283737|NCT01135329|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111283738|NCT01135329|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111283739|NCT01135329|Antitubercular Agents|antitubercular agents|mesh-ancestor
111283740|NCT01135329|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111283741|NCT01135329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111283742|NCT03012009|Lidocaine|lidocaine|mesh-list
111283743|NCT03012009|Epinephrine|epinephrine|mesh-list
111283744|NCT03012009|Racepinephrine|racepinephrine|mesh-list
111283745|NCT03012009|Anesthetics, Local|anesthetics, local|mesh-list
111283746|NCT03012009|Anesthetics|anesthetics|mesh-list
111283747|NCT03012009|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
111283748|NCT03012009|Epinephryl borate|epinephryl borate|mesh-list
111283749|NCT03012009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111283750|NCT03012009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111283751|NCT03012009|Sensory System Agents|sensory system agents|mesh-ancestor
111283752|NCT03012009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111283753|NCT03012009|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111283754|NCT03012009|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111283755|NCT03012009|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111283756|NCT03012009|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111283757|NCT03012009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111283758|NCT03012009|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111283759|NCT03012009|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111283760|NCT03012009|Adrenergic Agents|adrenergic agents|mesh-ancestor
111283761|NCT03012009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111283762|NCT03012009|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111283763|NCT03012009|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111283764|NCT03012009|Autonomic Agents|autonomic agents|mesh-ancestor
111283765|NCT03012009|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111283766|NCT03012009|Respiratory System Agents|respiratory system agents|mesh-ancestor
111283767|NCT03012009|Mydriatics|mydriatics|mesh-ancestor
111283768|NCT03012009|Sympathomimetics|sympathomimetics|mesh-ancestor
111283769|NCT03012009|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111283770|NCT03012009|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111283771|NCT03012009|Dermatologic Agents|dermatologic agents|mesh-ancestor
111283772|NCT04403555|Ivermectin|ivermectin|mesh-list
111283773|NCT04403555|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111283774|NCT04403555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111283775|NCT03565835|Prednisone|prednisone|mesh-list
111283776|NCT03565835|Abiraterone Acetate|abiraterone acetate|mesh-list
111283777|NCT03565835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111283778|NCT03565835|Glucocorticoids|glucocorticoids|mesh-ancestor
111283779|NCT03565835|Hormones|hormones|mesh-ancestor
111283780|NCT03565835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111283781|NCT03565835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111283782|NCT03565835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111283783|NCT03565835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111283784|NCT03565835|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111283785|NCT03565835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111283786|NCT03565835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111283787|NCT03565835|Hormone Antagonists|hormone antagonists|mesh-ancestor
111283788|NCT03565835|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111283789|NCT01624259|Metformin|metformin|mesh-list
111283790|NCT01624259|Liraglutide|liraglutide|mesh-list
111283791|NCT01624259|Dulaglutide|dulaglutide|mesh-list
111283792|NCT01624259|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111283793|NCT01624259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111283794|NCT01624259|Incretins|incretins|mesh-ancestor
111283795|NCT01624259|Hormones|hormones|mesh-ancestor
111283796|NCT01624259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111283797|NCT02081183|Mycophenolic Acid|mycophenolic acid|mesh-list
111283798|NCT02081183|Prednisone|prednisone|mesh-list
111283799|NCT02081183|Cyclophosphamide|cyclophosphamide|mesh-list
111283800|NCT02081183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111283801|NCT02081183|Immunologic Factors|immunologic factors|mesh-ancestor
111283802|NCT02081183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111283803|NCT02081183|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111283804|NCT02081183|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111283805|NCT02081183|Alkylating Agents|alkylating agents|mesh-ancestor
111283806|NCT02081183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111283807|NCT02081183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111283808|NCT02081183|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111283809|NCT02081183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111283810|NCT02081183|Glucocorticoids|glucocorticoids|mesh-ancestor
111283811|NCT02081183|Hormones|hormones|mesh-ancestor
111283812|NCT02081183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111283813|NCT02081183|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111283814|NCT02081183|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111283815|NCT02081183|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111283816|NCT02081183|Antitubercular Agents|antitubercular agents|mesh-ancestor
111283817|NCT02081183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111283818|NCT02081183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111283819|NCT02081183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111283820|NCT02080403|Chlorhexidine|chlorhexidine|mesh-list
111008356|NCT04504851|Rifampin|rifampin|mesh-list
111283821|NCT02080403|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
111283822|NCT02080403|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111283823|NCT02080403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111283824|NCT02080403|Disinfectants|disinfectants|mesh-ancestor
111283825|NCT02080403|Dermatologic Agents|dermatologic agents|mesh-ancestor
111283826|NCT02079077|Aspirin|aspirin|mesh-list
111283827|NCT02079077|Hydroxychloroquine|hydroxychloroquine|mesh-list
111283828|NCT02079077|Antimalarials|antimalarials|mesh-ancestor
111283829|NCT02079077|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111283830|NCT02079077|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111283831|NCT02079077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111283832|NCT02079077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111283833|NCT02079077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111283834|NCT02079077|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111283835|NCT02079077|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111283836|NCT02079077|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111283837|NCT02079077|Analgesics|analgesics|mesh-ancestor
111283838|NCT02079077|Sensory System Agents|sensory system agents|mesh-ancestor
111283839|NCT02079077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111283840|NCT02079077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111283841|NCT02079077|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111283842|NCT02079077|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111283843|NCT02079077|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111283844|NCT02079077|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111283845|NCT02079077|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111283846|NCT02079077|Antipyretics|antipyretics|mesh-ancestor
111283847|NCT03547271|Vaccines|vaccines|mesh-list
111283848|NCT03547271|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
111283849|NCT03547271|Immunologic Factors|immunologic factors|mesh-ancestor
111283850|NCT03547271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111283851|NCT01191255|Sevelamer|sevelamer|mesh-list
111283852|NCT01191255|Chelating Agents|chelating agents|mesh-ancestor
111283853|NCT01191255|Sequestering Agents|sequestering agents|mesh-ancestor
111283854|NCT01191255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111283855|NCT02078219|Allopurinol|allopurinol|mesh-list
111283856|NCT02078219|Verinurad|verinurad|mesh-list
111283857|NCT02078219|Antimetabolites|antimetabolites|mesh-ancestor
111283858|NCT02078219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111283859|NCT02078219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111283860|NCT02078219|Gout Suppressants|gout suppressants|mesh-ancestor
111283861|NCT02078219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111283862|NCT02078219|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111283863|NCT02078219|Antioxidants|antioxidants|mesh-ancestor
111283864|NCT02078219|Protective Agents|protective agents|mesh-ancestor
111283865|NCT02078219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111283866|NCT03536039|Prednisone|prednisone|mesh-list
111283867|NCT03536039|Cyclophosphamide|cyclophosphamide|mesh-list
111283868|NCT03536039|Rituximab|rituximab|mesh-list
111283869|NCT03536039|Doxorubicin|doxorubicin|mesh-list
111283870|NCT03536039|Vincristine|vincristine|mesh-list
111283871|NCT03536039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111283872|NCT03536039|Immunologic Factors|immunologic factors|mesh-ancestor
111283873|NCT03536039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111283874|NCT03536039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111283875|NCT03536039|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111283876|NCT03536039|Alkylating Agents|alkylating agents|mesh-ancestor
111283877|NCT03536039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111283878|NCT03536039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111283879|NCT03536039|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111283880|NCT03536039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111283881|NCT03536039|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111283882|NCT03536039|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111283883|NCT03536039|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111283884|NCT03536039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111283885|NCT03536039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111283886|NCT03536039|Glucocorticoids|glucocorticoids|mesh-ancestor
111283887|NCT03536039|Hormones|hormones|mesh-ancestor
111283888|NCT03536039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111283889|NCT03536039|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111283890|NCT03536039|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111283891|NCT03536039|Tubulin Modulators|tubulin modulators|mesh-ancestor
111283892|NCT03536039|Antimitotic Agents|antimitotic agents|mesh-ancestor
111283893|NCT03536039|Mitosis Modulators|mitosis modulators|mesh-ancestor
111283894|NCT02075255|Benralizumab|benralizumab|mesh-list
111283895|NCT02075255|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111283896|NCT02075255|Respiratory System Agents|respiratory system agents|mesh-ancestor
111283897|NCT03532217|Nivolumab|nivolumab|mesh-list
111283898|NCT03532217|Ipilimumab|ipilimumab|mesh-list
111283899|NCT03532217|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111283900|NCT03532217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111283901|NCT03532217|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111283902|NCT03532217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111283903|NCT03529487|Phenylephrine|phenylephrine|mesh-list
111283904|NCT03529487|Oxymetazoline|oxymetazoline|mesh-list
111283905|NCT03529487|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111283906|NCT03529487|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111283907|NCT03529487|Adrenergic Agents|adrenergic agents|mesh-ancestor
111283908|NCT03529487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111283909|NCT03529487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111283910|NCT03529487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111283911|NCT03529487|Sympathomimetics|sympathomimetics|mesh-ancestor
111283912|NCT03529487|Autonomic Agents|autonomic agents|mesh-ancestor
111283913|NCT03529487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111283914|NCT03529487|Nasal Decongestants|nasal decongestants|mesh-ancestor
110979125|NCT03249428|Nicotine|nicotine|mesh-list
111283915|NCT03529487|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111283916|NCT03529487|Respiratory System Agents|respiratory system agents|mesh-ancestor
111283917|NCT03529487|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111283918|NCT03529487|Mydriatics|mydriatics|mesh-ancestor
111283919|NCT03529487|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111283920|NCT03529487|Protective Agents|protective agents|mesh-ancestor
111283921|NCT03527927|Muscarinic Antagonists|muscarinic antagonists|mesh-list
111283922|NCT03527927|Cholinergic Agents|cholinergic agents|mesh-ancestor
111283923|NCT03527927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111283924|NCT03527927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111283925|NCT03527927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111283926|NCT03527927|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111283927|NCT03527147|Rituximab|rituximab|mesh-list
111283928|NCT03527147|Magrolimab|magrolimab|mesh-list
111283929|NCT03527147|Acalabrutinib|acalabrutinib|mesh-list
111283930|NCT03527147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111283931|NCT03527147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111283932|NCT03527147|Immunologic Factors|immunologic factors|mesh-ancestor
111283933|NCT03527147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111283934|NCT03527147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111283935|NCT03527069|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111283936|NCT03527069|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111283937|NCT03527069|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111283938|NCT03527069|Antimetabolites|antimetabolites|mesh-ancestor
111283939|NCT03527069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111283940|NCT03527069|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111283941|NCT03527069|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111283942|NCT03527069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111283943|NCT01677611|Resveratrol|resveratrol|mesh-list
111283944|NCT01677611|Antioxidants|antioxidants|mesh-ancestor
111283945|NCT01677611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111283946|NCT01677611|Protective Agents|protective agents|mesh-ancestor
111283947|NCT01677611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111283948|NCT01677611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111283949|NCT01677611|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111283950|NCT01191723|Moxifloxacin|moxifloxacin|mesh-list
111283951|NCT01191723|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111283952|NCT01191723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111283953|NCT01191723|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111283954|NCT01191723|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111283955|NCT01191723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111283956|NCT01191723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111283957|NCT01191723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111283958|NCT01193049|Prednisone|prednisone|mesh-list
111283959|NCT01193049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111283960|NCT01193049|Glucocorticoids|glucocorticoids|mesh-ancestor
111283961|NCT01193049|Hormones|hormones|mesh-ancestor
111283962|NCT01193049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111283963|NCT01193049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111283964|NCT01193049|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111283965|NCT01193049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111283966|NCT01679951|Methotrexate|methotrexate|mesh-list
111283967|NCT01679951|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111283968|NCT01679951|Abortifacient Agents|abortifacient agents|mesh-ancestor
111283969|NCT01679951|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111283970|NCT01679951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111283971|NCT01679951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111283972|NCT01679951|Antimetabolites|antimetabolites|mesh-ancestor
111283973|NCT01679951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111283974|NCT01679951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111283975|NCT01679951|Dermatologic Agents|dermatologic agents|mesh-ancestor
111283976|NCT01679951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111283977|NCT01679951|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111283978|NCT01679951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111283979|NCT01679951|Immunologic Factors|immunologic factors|mesh-ancestor
111283980|NCT01679951|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111283981|NCT01679951|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111283982|NCT01194297|Vaccines|vaccines|mesh-list
111283983|NCT01194297|Immunologic Factors|immunologic factors|mesh-ancestor
111283984|NCT01194297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111283985|NCT01194453|Folic Acid|folic acid|mesh-list
111283986|NCT01194453|Vitamin B 12|vitamin b 12|mesh-list
111283987|NCT01194453|Dexamethasone|dexamethasone|mesh-list
111283988|NCT01194453|Cisplatin|cisplatin|mesh-list
111283989|NCT01194453|Gemcitabine|gemcitabine|mesh-list
111283990|NCT01194453|Vitamins|vitamins|mesh-ancestor
111283991|NCT01194453|Micronutrients|micronutrients|mesh-ancestor
111283992|NCT01194453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111283993|NCT01194453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111283994|NCT01194453|Antiemetics|antiemetics|mesh-ancestor
111283995|NCT01194453|Autonomic Agents|autonomic agents|mesh-ancestor
111283996|NCT01194453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111283997|NCT01194453|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111283998|NCT01194453|Glucocorticoids|glucocorticoids|mesh-ancestor
111283999|NCT01194453|Hormones|hormones|mesh-ancestor
111284000|NCT01194453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111284001|NCT01194453|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111284002|NCT01194453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111284003|NCT01194453|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111284004|NCT01194453|Antimetabolites|antimetabolites|mesh-ancestor
111284005|NCT01194453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111284006|NCT01194453|Hematinics|hematinics|mesh-ancestor
111284007|NCT01194453|Vitamin B Complex|vitamin b complex|mesh-ancestor
111284008|NCT03507413|Metformin|metformin|mesh-list
111284009|NCT03507413|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111284010|NCT03507413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111284011|NCT01195467|Tenofovir|tenofovir|mesh-list
111284012|NCT01195467|Emtricitabine|emtricitabine|mesh-list
111284013|NCT01195467|Efavirenz|efavirenz|mesh-list
111284014|NCT01195467|Raltegravir Potassium|raltegravir potassium|mesh-list
111284015|NCT01195467|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
111284016|NCT01195467|Antiviral Agents|antiviral agents|mesh-ancestor
111284017|NCT01195467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111284018|NCT01195467|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111284019|NCT01195467|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111284020|NCT01195467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111284021|NCT01195467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111284022|NCT01195467|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111284023|NCT01195467|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111284024|NCT01195467|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111284025|NCT01195467|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111284026|NCT01195467|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111284027|NCT01195467|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111284028|NCT01195467|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111284029|NCT01195467|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111284030|NCT01195467|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111284031|NCT01195467|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111284032|NCT01677221|Benzoyl Peroxide|benzoyl peroxide|mesh-list
111284033|NCT01677221|Dermatologic Agents|dermatologic agents|mesh-ancestor
111284034|NCT01195779|Vaccines|vaccines|mesh-list
111284035|NCT01195779|Immunologic Factors|immunologic factors|mesh-ancestor
111284036|NCT01195779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111284037|NCT02405585|Leucovorin|leucovorin|mesh-list
111284038|NCT02405585|Gemcitabine|gemcitabine|mesh-list
111284039|NCT02405585|Fluorouracil|fluorouracil|mesh-list
111284040|NCT02405585|Oxaliplatin|oxaliplatin|mesh-list
111284041|NCT02405585|Irinotecan|irinotecan|mesh-list
111284042|NCT02405585|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111284043|NCT02405585|Antimetabolites|antimetabolites|mesh-ancestor
111284044|NCT02405585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111284045|NCT02405585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111284046|NCT02405585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111284047|NCT02405585|Immunologic Factors|immunologic factors|mesh-ancestor
111284048|NCT02405585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111284049|NCT02405585|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111284050|NCT02405585|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111284051|NCT02405585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111284052|NCT02405585|Antidotes|antidotes|mesh-ancestor
111284053|NCT02405585|Protective Agents|protective agents|mesh-ancestor
111284054|NCT02405585|Vitamin B Complex|vitamin b complex|mesh-ancestor
111284055|NCT02405585|Vitamins|vitamins|mesh-ancestor
111284056|NCT02405585|Micronutrients|micronutrients|mesh-ancestor
111284057|NCT03491345|Avelumab|avelumab|mesh-list
111284058|NCT03491345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111284059|NCT03491345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111284060|NCT00089999|Lapatinib|lapatinib|mesh-list
111284061|NCT00089999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111284062|NCT00089999|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111284063|NCT00089999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111284064|NCT00089999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111284065|NCT03454451|Pembrolizumab|pembrolizumab|mesh-list
111284066|NCT03454451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111284067|NCT03454451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111284068|NCT03454451|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111284069|NCT03454451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111284070|NCT00089843|Risedronic Acid|risedronic acid|mesh-list
111284071|NCT00089843|Etidronic Acid|etidronic acid|mesh-list
111284072|NCT00089843|Methyltestosterone|methyltestosterone|mesh-list
111284073|NCT00089843|Testosterone|testosterone|mesh-list
111284074|NCT00089843|Testosterone undecanoate|testosterone undecanoate|mesh-list
111284075|NCT00089843|Testosterone enanthate|testosterone enanthate|mesh-list
111284076|NCT00089843|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
111284077|NCT00089843|Androgens|androgens|mesh-ancestor
111284078|NCT00089843|Hormones|hormones|mesh-ancestor
111284079|NCT00089843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111284080|NCT00089843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111284081|NCT00089843|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111284082|NCT00089843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111284083|NCT00089843|Anabolic Agents|anabolic agents|mesh-ancestor
111284084|NCT00089843|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111284085|NCT00089843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111284086|NCT00089843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111284087|NCT00089843|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111284088|NCT00089843|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111284089|NCT01677923|Metformin|metformin|mesh-list
111284090|NCT01677923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111284091|NCT01677923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111284092|NCT00089297|Paclitaxel|paclitaxel|mesh-list
111284093|NCT00089297|Carboplatin|carboplatin|mesh-list
111284094|NCT00089297|Cetuximab|cetuximab|mesh-list
111284095|NCT00089297|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111284096|NCT00089297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111284097|NCT00089297|Tubulin Modulators|tubulin modulators|mesh-ancestor
111284098|NCT00089297|Antimitotic Agents|antimitotic agents|mesh-ancestor
111284099|NCT00089297|Mitosis Modulators|mitosis modulators|mesh-ancestor
111284100|NCT00089297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111284101|NCT00089297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111284102|NCT01678001|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
111284103|NCT01678001|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111284104|NCT01678001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111284105|NCT01678001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111284106|NCT01678001|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111284107|NCT01678001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111284108|NCT01678001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111284109|NCT01678001|Cholinergic Agents|cholinergic agents|mesh-ancestor
111284110|NCT01678001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111284111|NCT03482297|Midodrine|midodrine|mesh-list
111284112|NCT03482297|Sympathomimetics|sympathomimetics|mesh-ancestor
111284113|NCT03482297|Autonomic Agents|autonomic agents|mesh-ancestor
111284114|NCT03482297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111284115|NCT03482297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111284116|NCT03482297|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111284117|NCT03482297|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111284118|NCT03482297|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111284119|NCT03482297|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111008660|NCT03347721|Lidocaine|lidocaine|mesh-list
111284120|NCT03482297|Adrenergic Agents|adrenergic agents|mesh-ancestor
111284121|NCT03482297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111284122|NCT03482297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111284123|NCT00088907|Docetaxel|docetaxel|mesh-list
111284124|NCT00088907|Gefitinib|gefitinib|mesh-list
111284125|NCT00088907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111284126|NCT00088907|Tubulin Modulators|tubulin modulators|mesh-ancestor
111284127|NCT00088907|Antimitotic Agents|antimitotic agents|mesh-ancestor
111284128|NCT00088907|Mitosis Modulators|mitosis modulators|mesh-ancestor
111284129|NCT00088907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111284130|NCT00088907|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111284131|NCT00088907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111284132|NCT00088829|Paclitaxel|paclitaxel|mesh-list
111284133|NCT00088829|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111284134|NCT00088829|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111284135|NCT00088829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111284136|NCT00088829|Tubulin Modulators|tubulin modulators|mesh-ancestor
111284137|NCT00088829|Antimitotic Agents|antimitotic agents|mesh-ancestor
111284138|NCT00088829|Mitosis Modulators|mitosis modulators|mesh-ancestor
111284139|NCT00088829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111284140|NCT00088595|Pasireotide|pasireotide|mesh-list
111284141|NCT00088595|Hormones|hormones|mesh-ancestor
111284142|NCT00088595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111284143|NCT00088595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111284144|NCT01678079|Calcium, Dietary|calcium, dietary|mesh-list
111284145|NCT01678079|Calcium|calcium|mesh-list
111284146|NCT01678079|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111284147|NCT01678079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111284148|NCT01678079|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111284149|NCT01678235|Insulin|insulin|mesh-list
111284150|NCT01678235|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111284151|NCT01678235|Insulin Aspart|insulin aspart|mesh-list
111284152|NCT01678235|Insulin glulisine|insulin glulisine|mesh-list
111284153|NCT01678235|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111284154|NCT01678235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111284155|NCT01197495|Hyaluronic Acid|hyaluronic acid|mesh-list
111284156|NCT01197495|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111284157|NCT01197495|Immunologic Factors|immunologic factors|mesh-ancestor
111284158|NCT01197495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111284159|NCT01197495|Viscosupplements|viscosupplements|mesh-ancestor
111284160|NCT01197495|Protective Agents|protective agents|mesh-ancestor
111284161|NCT01197573|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
111284162|NCT01197573|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111284163|NCT01197573|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111284164|NCT01197573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111284165|NCT03011931|Simvastatin|simvastatin|mesh-list
111284166|NCT03011931|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111284167|NCT03011931|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111284168|NCT03011931|Antimetabolites|antimetabolites|mesh-ancestor
111284169|NCT03011931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111284170|NCT03011931|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111284171|NCT03011931|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111284172|NCT03011931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111284173|NCT02185131|Mirtazapine|mirtazapine|mesh-list
111284174|NCT02185131|Antidepressive Agents|antidepressive agents|mesh-ancestor
111284175|NCT02185131|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111284176|NCT02185131|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111284177|NCT02185131|Histamine Antagonists|histamine antagonists|mesh-ancestor
111284178|NCT02185131|Histamine Agents|histamine agents|mesh-ancestor
111284179|NCT02185131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111284180|NCT02185131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111284181|NCT02185131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111284182|NCT02185131|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111284183|NCT02185131|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111284184|NCT02185131|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111284185|NCT02185131|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
111284186|NCT02185131|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111284187|NCT02185131|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111284188|NCT02185131|Adrenergic Agents|adrenergic agents|mesh-ancestor
111284189|NCT02185131|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111284190|NCT02185131|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111284191|NCT02185131|Serotonin Agents|serotonin agents|mesh-ancestor
111284192|NCT02185131|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111284193|NCT00085709|Cytarabine|cytarabine|mesh-list
111284194|NCT00085709|Daunorubicin|daunorubicin|mesh-list
111284195|NCT00085709|Gemtuzumab|gemtuzumab|mesh-list
111284196|NCT00085709|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111284197|NCT00085709|Antimetabolites|antimetabolites|mesh-ancestor
111284198|NCT00085709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111284199|NCT00085709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111284200|NCT00085709|Antiviral Agents|antiviral agents|mesh-ancestor
111284201|NCT00085709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111284202|NCT00085709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111284203|NCT00085709|Immunologic Factors|immunologic factors|mesh-ancestor
110979139|NCT03243500|Anesthetics|anesthetics|mesh-ancestor
111284204|NCT00085709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111284205|NCT00085709|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111284206|NCT00085709|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111284207|NCT00085709|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111284208|NCT00085709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111284209|NCT00085709|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111284210|NCT00085709|Immunotoxins|immunotoxins|mesh-ancestor
111284211|NCT00085709|Immunoconjugates|immunoconjugates|mesh-ancestor
111284212|NCT01201863|Testosterone|testosterone|mesh-list
111284213|NCT01201863|Androgens|androgens|mesh-ancestor
111284214|NCT01201863|Hormones|hormones|mesh-ancestor
111284215|NCT01201863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111284216|NCT01201863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111284217|NCT01202253|Anidulafungin|anidulafungin|mesh-list
111284218|NCT01202253|Antifungal Agents|antifungal agents|mesh-ancestor
111284219|NCT01202253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111284220|NCT01678703|Misoprostol|misoprostol|mesh-list
111284221|NCT01678703|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111284222|NCT01678703|Abortifacient Agents|abortifacient agents|mesh-ancestor
111284223|NCT01678703|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111284224|NCT01678703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111284225|NCT01678703|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111284226|NCT01678703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111284227|NCT01678703|Oxytocics|oxytocics|mesh-ancestor
111284228|NCT00085631|Cisplatin|cisplatin|mesh-list
111284229|NCT00085631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111284230|NCT01141491|Vaccines|vaccines|mesh-list
111284231|NCT01141491|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
111284232|NCT01141491|Immunologic Factors|immunologic factors|mesh-ancestor
111284233|NCT01141491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111284234|NCT01141569|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
111284235|NCT01141569|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-list
111284236|NCT01141569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111284237|NCT01141569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111284238|NCT01141725|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
111284239|NCT01141725|Idarubicin|idarubicin|mesh-list
111284240|NCT01141725|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111284241|NCT01141725|Alkylating Agents|alkylating agents|mesh-ancestor
111284242|NCT01141725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111284243|NCT01141725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111284244|NCT01141725|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111284245|NCT01141725|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111284246|NCT01141725|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111284247|NCT01141725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111284248|NCT01202721|Atenolol|atenolol|mesh-list
111284249|NCT01202721|Telmisartan|telmisartan|mesh-list
111284250|NCT01202721|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111284251|NCT01202721|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111284252|NCT01202721|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111284253|NCT01202721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111284254|NCT01202721|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111284255|NCT01202721|Sympatholytics|sympatholytics|mesh-ancestor
111284256|NCT01202721|Autonomic Agents|autonomic agents|mesh-ancestor
111284257|NCT01202721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111284258|NCT01202721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111284259|NCT01202721|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
111284260|NCT01202721|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111284261|NCT01202721|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111284262|NCT01202721|Adrenergic Agents|adrenergic agents|mesh-ancestor
111284263|NCT01202721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111284264|NCT00084617|Capecitabine|capecitabine|mesh-list
111284265|NCT00084617|Oxaliplatin|oxaliplatin|mesh-list
111284266|NCT00084617|Irinotecan|irinotecan|mesh-list
111284267|NCT00084617|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111284268|NCT00084617|Antimetabolites|antimetabolites|mesh-ancestor
111284269|NCT00084617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111284270|NCT00084617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111284271|NCT00084617|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111284272|NCT00084617|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111284273|NCT00084617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111284274|NCT01203189|Ketoconazole|ketoconazole|mesh-list
111284275|NCT01203189|Antifungal Agents|antifungal agents|mesh-ancestor
111284276|NCT01203189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111284277|NCT01203189|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111284278|NCT01203189|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111284279|NCT01203189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111284280|NCT01203189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111284281|NCT01203189|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111284282|NCT01203189|Hormone Antagonists|hormone antagonists|mesh-ancestor
111284283|NCT01203189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111284284|NCT01203189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111284285|NCT01203189|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111284286|NCT01204203|Zoledronic Acid|zoledronic acid|mesh-list
111284287|NCT01204203|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111284288|NCT01204203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111284289|NCT01679327|Calcium, Dietary|calcium, dietary|mesh-list
111284290|NCT01679327|Leucovorin|leucovorin|mesh-list
111284291|NCT01679327|Bevacizumab|bevacizumab|mesh-list
111284292|NCT01679327|Oxaliplatin|oxaliplatin|mesh-list
111284293|NCT01679327|Calcium|calcium|mesh-list
111284294|NCT01679327|Levoleucovorin|levoleucovorin|mesh-list
111284295|NCT01679327|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111284296|NCT01679327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111284297|NCT01679327|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111284298|NCT01679327|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111284299|NCT01679327|Growth Substances|growth substances|mesh-ancestor
111284300|NCT01679327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111284301|NCT01679327|Growth Inhibitors|growth inhibitors|mesh-ancestor
111284302|NCT01679327|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111284303|NCT01679327|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111284304|NCT01679327|Antidotes|antidotes|mesh-ancestor
111284305|NCT01679327|Protective Agents|protective agents|mesh-ancestor
111284306|NCT01679327|Vitamin B Complex|vitamin b complex|mesh-ancestor
111284307|NCT01679327|Vitamins|vitamins|mesh-ancestor
111284308|NCT01679327|Micronutrients|micronutrients|mesh-ancestor
111284309|NCT01206387|Desoximetasone|desoximetasone|mesh-list
111284310|NCT01206387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111284311|NCT01206387|Glucocorticoids|glucocorticoids|mesh-ancestor
111284312|NCT01206387|Hormones|hormones|mesh-ancestor
111284313|NCT01206387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111284314|NCT01206387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111284315|NCT01679561|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
111284316|NCT01679561|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
111284317|NCT01679561|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
111284318|NCT01679561|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111284319|NCT01679639|Rifampin|rifampin|mesh-list
111284320|NCT01679639|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111284321|NCT01679639|Antitubercular Agents|antitubercular agents|mesh-ancestor
111284322|NCT01679639|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111284323|NCT01679639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111284324|NCT01679639|Leprostatic Agents|leprostatic agents|mesh-ancestor
111284325|NCT01679639|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111284326|NCT01679639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111284327|NCT01679639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111284328|NCT01679639|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111284329|NCT01679639|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111284330|NCT01679639|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
111284331|NCT01679639|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
111284332|NCT01679639|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
111284333|NCT01679639|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111284334|NCT01679795|Tibolone|tibolone|mesh-list
111284335|NCT01679795|Androgen Antagonists|androgen antagonists|mesh-ancestor
111284336|NCT01679795|Hormone Antagonists|hormone antagonists|mesh-ancestor
111284337|NCT01679795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111284338|NCT01679795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111284339|NCT01679795|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111284340|NCT01679795|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111284341|NCT01679795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111284342|NCT01679795|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111284343|NCT01679795|Anabolic Agents|anabolic agents|mesh-ancestor
111284344|NCT01679795|Hormones|hormones|mesh-ancestor
111284345|NCT01206465|Fluorouracil|fluorouracil|mesh-list
111284346|NCT01206465|Antimetabolites|antimetabolites|mesh-ancestor
111284347|NCT01206465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111284348|NCT01206465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111284349|NCT01206465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111284350|NCT01206465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111284351|NCT01206465|Immunologic Factors|immunologic factors|mesh-ancestor
111284352|NCT01206465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111284353|NCT01207401|Lidocaine|lidocaine|mesh-list
111284354|NCT01207401|Anesthetics, Local|anesthetics, local|mesh-ancestor
111284355|NCT01207401|Anesthetics|anesthetics|mesh-ancestor
111284356|NCT01207401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111284357|NCT01207401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111284358|NCT01207401|Sensory System Agents|sensory system agents|mesh-ancestor
111284359|NCT01207401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111284360|NCT01207401|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111284361|NCT01207401|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111284362|NCT01207401|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111284363|NCT01207401|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111284364|NCT01207401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111284365|NCT04761731|Tacrolimus|tacrolimus|mesh-list
111284366|NCT04761731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111284367|NCT04761731|Immunologic Factors|immunologic factors|mesh-ancestor
111284368|NCT04761731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111284369|NCT04761731|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111284370|NCT04761731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111284371|NCT04761731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111284372|NCT03087539|Abciximab|abciximab|mesh-list
111284373|NCT03087539|Anticoagulants|anticoagulants|mesh-ancestor
111284374|NCT03087539|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111284375|NCT03087149|Vitamin D|vitamin d|mesh-list
111284376|NCT03087149|Vitamins|vitamins|mesh-ancestor
111284377|NCT03087149|Micronutrients|micronutrients|mesh-ancestor
111284378|NCT03087149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111284379|NCT03087149|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111284380|NCT03086681|Cisplatin|cisplatin|mesh-list
111284381|NCT03086681|Endostar protein|endostar protein|mesh-list
111284382|NCT03086681|Endostatins|endostatins|mesh-list
111284383|NCT03086681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111284384|NCT03086681|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111284385|NCT03086681|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111284386|NCT03086681|Growth Substances|growth substances|mesh-ancestor
111284387|NCT03086681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111284388|NCT03086681|Growth Inhibitors|growth inhibitors|mesh-ancestor
111284389|NCT03086759|Triamcinolone|triamcinolone|mesh-list
111284390|NCT03086759|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
111284391|NCT03086759|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
111284392|NCT03086759|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
111284393|NCT03086759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111284394|NCT03086759|Glucocorticoids|glucocorticoids|mesh-ancestor
111284395|NCT03086759|Hormones|hormones|mesh-ancestor
111284396|NCT03086759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111284397|NCT03086759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111284398|NCT03086759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111284399|NCT03086759|Immunologic Factors|immunologic factors|mesh-ancestor
111284400|NCT03086759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111284401|NCT03086759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111284402|NCT03086291|Simvastatin|simvastatin|mesh-list
111284403|NCT03086291|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111284404|NCT03086291|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111284405|NCT03086291|Antimetabolites|antimetabolites|mesh-ancestor
111284406|NCT03086291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111284407|NCT03086291|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111284408|NCT03086291|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111284409|NCT03086291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111284410|NCT03086915|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
111284411|NCT03086915|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111284412|NCT03086915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111284413|NCT03086915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111284414|NCT01209195|Paclitaxel|paclitaxel|mesh-list
111284415|NCT01209195|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111284416|NCT01209195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111284417|NCT01209195|Tubulin Modulators|tubulin modulators|mesh-ancestor
111284418|NCT01209195|Antimitotic Agents|antimitotic agents|mesh-ancestor
111284419|NCT01209195|Mitosis Modulators|mitosis modulators|mesh-ancestor
111284420|NCT01209195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111284421|NCT03084809|Leucovorin|leucovorin|mesh-list
111284422|NCT03084809|Oxaliplatin|oxaliplatin|mesh-list
111284423|NCT03084809|Fluorouracil|fluorouracil|mesh-list
111284424|NCT03084809|Levoleucovorin|levoleucovorin|mesh-list
111284425|NCT03084809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111284426|NCT03084809|Antidotes|antidotes|mesh-ancestor
111284427|NCT03084809|Protective Agents|protective agents|mesh-ancestor
111284428|NCT03084809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111284429|NCT03084809|Vitamin B Complex|vitamin b complex|mesh-ancestor
111284430|NCT03084809|Vitamins|vitamins|mesh-ancestor
111284431|NCT03084809|Micronutrients|micronutrients|mesh-ancestor
111284432|NCT03084809|Antimetabolites|antimetabolites|mesh-ancestor
111284433|NCT03084809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111284434|NCT03084809|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111284435|NCT03084809|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111284436|NCT03084809|Immunologic Factors|immunologic factors|mesh-ancestor
111284437|NCT01144143|Methylprednisolone|methylprednisolone|mesh-list
111284438|NCT01144143|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111284439|NCT01144143|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111284440|NCT01144143|Prednisolone|prednisolone|mesh-list
111284441|NCT01144143|Prednisolone acetate|prednisolone acetate|mesh-list
111284442|NCT01144143|Infliximab|infliximab|mesh-list
111284443|NCT01144143|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111284444|NCT01144143|Prednisolone phosphate|prednisolone phosphate|mesh-list
111284445|NCT01144143|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111284446|NCT01144143|Antiemetics|antiemetics|mesh-ancestor
111284447|NCT01144143|Autonomic Agents|autonomic agents|mesh-ancestor
111284448|NCT01144143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111284449|NCT01144143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111284450|NCT01144143|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111284451|NCT01144143|Glucocorticoids|glucocorticoids|mesh-ancestor
111284452|NCT01144143|Hormones|hormones|mesh-ancestor
111284453|NCT01144143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111284454|NCT01144143|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111284455|NCT01144143|Protective Agents|protective agents|mesh-ancestor
111284456|NCT01144143|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111284457|NCT01144143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111284458|NCT01144143|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111284459|NCT01144143|Dermatologic Agents|dermatologic agents|mesh-ancestor
111284460|NCT01144143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111284461|NCT03084575|Glycerol|glycerol|mesh-list
111284462|NCT03084575|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
111284463|NCT03084575|Protective Agents|protective agents|mesh-ancestor
111284464|NCT03084575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111284465|NCT01212471|Bromfenac|bromfenac|mesh-list
111284466|NCT01212471|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111284467|NCT01212471|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111284468|NCT01212471|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111284469|NCT01212471|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111284470|NCT01212471|Analgesics|analgesics|mesh-ancestor
111284471|NCT01212471|Sensory System Agents|sensory system agents|mesh-ancestor
111284472|NCT01212471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111284473|NCT01212471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111284474|NCT01212471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111284475|NCT01212471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111284476|NCT03084419|Abatacept|abatacept|mesh-list
111284477|NCT03084419|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111284478|NCT03084419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111284479|NCT03084419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111284480|NCT03084419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111284481|NCT03084419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111284482|NCT03084419|Immunologic Factors|immunologic factors|mesh-ancestor
111284483|NCT03084419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111284484|NCT03084419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111284485|NCT03084029|Oxytocin|oxytocin|mesh-list
111284486|NCT03084029|Oxytocics|oxytocics|mesh-ancestor
111284487|NCT03084029|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111284488|NCT03084029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111284489|NCT04278053|Inositol|inositol|mesh-list
111284490|NCT04278053|Vitamin B Complex|vitamin b complex|mesh-ancestor
111284491|NCT04278053|Vitamins|vitamins|mesh-ancestor
111009025|NCT04501809|Oxytocics|oxytocics|mesh-ancestor
111284492|NCT04278053|Micronutrients|micronutrients|mesh-ancestor
111284493|NCT04278053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111284494|NCT05346107|Paclitaxel|paclitaxel|mesh-list
111284495|NCT05346107|Cyclophosphamide|cyclophosphamide|mesh-list
111284496|NCT05346107|Doxorubicin|doxorubicin|mesh-list
111284497|NCT05346107|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111284498|NCT05346107|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111284499|NCT05346107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111284500|NCT05346107|Tubulin Modulators|tubulin modulators|mesh-ancestor
111284501|NCT05346107|Antimitotic Agents|antimitotic agents|mesh-ancestor
111284502|NCT05346107|Mitosis Modulators|mitosis modulators|mesh-ancestor
111284503|NCT05346107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111284504|NCT05346107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111284505|NCT05346107|Immunologic Factors|immunologic factors|mesh-ancestor
111284506|NCT05346107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111284507|NCT05346107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111284508|NCT05346107|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111284509|NCT05346107|Alkylating Agents|alkylating agents|mesh-ancestor
111284510|NCT05346107|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111284511|NCT05346107|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111284512|NCT05346107|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111284513|NCT05346107|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111284514|NCT05346107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111284515|NCT03082001|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111284516|NCT00083915|Thalidomide|thalidomide|mesh-list
111284517|NCT00083915|Dexamethasone|dexamethasone|mesh-list
111284518|NCT00083915|Cyclophosphamide|cyclophosphamide|mesh-list
111284519|NCT00083915|Melphalan|melphalan|mesh-list
111284520|NCT00083915|Cisplatin|cisplatin|mesh-list
111284521|NCT00083915|Doxorubicin|doxorubicin|mesh-list
111284522|NCT00083915|Etoposide|etoposide|mesh-list
111284523|NCT00083915|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111284524|NCT00083915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111284525|NCT00083915|Immunologic Factors|immunologic factors|mesh-ancestor
111284526|NCT00083915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111284527|NCT00083915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111284528|NCT00083915|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111284529|NCT00083915|Alkylating Agents|alkylating agents|mesh-ancestor
111284530|NCT00083915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111284531|NCT00083915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111284532|NCT00083915|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111284533|NCT00083915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111284534|NCT00083915|Antiemetics|antiemetics|mesh-ancestor
111284535|NCT00083915|Autonomic Agents|autonomic agents|mesh-ancestor
111284536|NCT00083915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111284537|NCT00083915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111284538|NCT00083915|Glucocorticoids|glucocorticoids|mesh-ancestor
111284539|NCT00083915|Hormones|hormones|mesh-ancestor
111284540|NCT00083915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111284541|NCT00083915|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111284542|NCT00083915|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111284543|NCT00083915|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111284544|NCT00083915|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111284545|NCT00083915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111284546|NCT00083915|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111284547|NCT00083915|Leprostatic Agents|leprostatic agents|mesh-ancestor
111284548|NCT00083915|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111284549|NCT00083915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111284550|NCT00083915|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111284551|NCT00083915|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111284552|NCT00083915|Growth Substances|growth substances|mesh-ancestor
111284553|NCT00083915|Growth Inhibitors|growth inhibitors|mesh-ancestor
111284554|NCT04401839|Oxytocin|oxytocin|mesh-list
111284555|NCT04401839|Oxytocics|oxytocics|mesh-ancestor
111284556|NCT04401839|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111284557|NCT04401839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111284558|NCT04761185|Raltitrexed|raltitrexed|mesh-list
111284559|NCT04761185|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111284560|NCT04761185|Antimetabolites|antimetabolites|mesh-ancestor
111284561|NCT04761185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111284562|NCT04761185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111284563|NCT04761185|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111284564|NCT04761185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111284565|NCT01144455|Gemcitabine|gemcitabine|mesh-list
111284566|NCT01144455|Phosphoramide Mustards|phosphoramide mustards|mesh-list
111284567|NCT01144455|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111284568|NCT01144455|Antimetabolites|antimetabolites|mesh-ancestor
111284569|NCT01144455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111009101|NCT02511483|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111284570|NCT01144455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111284571|NCT01144455|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111284572|NCT01144455|Alkylating Agents|alkylating agents|mesh-ancestor
111284574|NCT03080675|Micronutrients|micronutrients|mesh-ancestor
111284575|NCT03080675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111284576|NCT03080363|Lidocaine|lidocaine|mesh-list
111284577|NCT03080363|Bupivacaine|bupivacaine|mesh-list
111284578|NCT03080363|Anesthetics, Local|anesthetics, local|mesh-ancestor
111284579|NCT03080363|Anesthetics|anesthetics|mesh-ancestor
111284580|NCT03080363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111284581|NCT03080363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111284582|NCT03080363|Sensory System Agents|sensory system agents|mesh-ancestor
111284583|NCT03080363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111284584|NCT03080363|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111284585|NCT03080363|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111284586|NCT03080363|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111284587|NCT03080363|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111284588|NCT03080363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111284589|NCT01145001|Nicotine|nicotine|mesh-list
111284590|NCT01145001|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111284591|NCT01145001|Autonomic Agents|autonomic agents|mesh-ancestor
111284592|NCT01145001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111284593|NCT01145001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111284594|NCT01145001|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111284595|NCT01145001|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111284596|NCT01145001|Cholinergic Agents|cholinergic agents|mesh-ancestor
111284597|NCT01145001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111284598|NCT01145001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111284599|NCT03011463|Clarithromycin|clarithromycin|mesh-list
111284600|NCT03011463|Ranitidine|ranitidine|mesh-list
111284601|NCT03011463|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
111284602|NCT03011463|Trospium chloride|trospium chloride|mesh-list
111284603|NCT03011463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111284604|NCT03011463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111284605|NCT03011463|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111284606|NCT03011463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111284607|NCT03011463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111284608|NCT03011463|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111284609|NCT03011463|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111284610|NCT03011463|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111284611|NCT03011463|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111284612|NCT03011463|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
111284613|NCT03011463|Histamine Antagonists|histamine antagonists|mesh-ancestor
111284614|NCT03011463|Histamine Agents|histamine agents|mesh-ancestor
111284615|NCT03011463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111284616|NCT03011463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111284617|NCT03011463|Parasympatholytics|parasympatholytics|mesh-ancestor
111284618|NCT03011463|Autonomic Agents|autonomic agents|mesh-ancestor
111284619|NCT03011463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111284620|NCT03011463|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111284621|NCT03011463|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111284622|NCT03011463|Cholinergic Agents|cholinergic agents|mesh-ancestor
111284623|NCT03011463|Urological Agents|urological agents|mesh-ancestor
111284624|NCT01214109|Pramipexole|pramipexole|mesh-list
111284625|NCT01214109|Antioxidants|antioxidants|mesh-ancestor
111284626|NCT01214109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111284627|NCT01214109|Protective Agents|protective agents|mesh-ancestor
111284628|NCT01214109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111284629|NCT01214109|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111284630|NCT01214109|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111284631|NCT01214109|Dopamine Agonists|dopamine agonists|mesh-ancestor
111284632|NCT01214109|Dopamine Agents|dopamine agents|mesh-ancestor
111284633|NCT01214109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111284634|NCT05688761|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
111284635|NCT05688761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111284636|NCT05688761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111284637|NCT01215123|Bevacizumab|bevacizumab|mesh-list
111284638|NCT01215123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111284639|NCT01215123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111284640|NCT01215123|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111284641|NCT01215123|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111284642|NCT01215123|Growth Substances|growth substances|mesh-ancestor
111284643|NCT01215123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111284644|NCT01215123|Growth Inhibitors|growth inhibitors|mesh-ancestor
111284645|NCT05688449|Fentanyl|fentanyl|mesh-list
111284646|NCT05688449|Bupivacaine|bupivacaine|mesh-list
111284647|NCT05688449|Anesthetics, Local|anesthetics, local|mesh-ancestor
111284648|NCT05688449|Anesthetics|anesthetics|mesh-ancestor
111284649|NCT05688449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111284650|NCT05688449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111284651|NCT05688449|Sensory System Agents|sensory system agents|mesh-ancestor
111284652|NCT05688449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111284653|NCT05688449|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111284654|NCT05688449|Narcotics|narcotics|mesh-ancestor
111284655|NCT05688449|Analgesics|analgesics|mesh-ancestor
111284656|NCT05688449|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111284657|NCT05688449|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111284658|NCT05688449|Anesthetics, General|anesthetics, general|mesh-ancestor
111284659|NCT04401137|Topiramate|topiramate|mesh-list
111284660|NCT04401137|Anticonvulsants|anticonvulsants|mesh-ancestor
111284661|NCT04401137|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111284662|NCT04401137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111284663|NCT02189889|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
111284664|NCT02189889|Hematinics|hematinics|mesh-ancestor
111284665|NCT02189889|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
111284666|NCT02189889|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111284667|NCT01148745|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
111284668|NCT01148745|Hematinics|hematinics|mesh-ancestor
111284669|NCT01148745|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
111284670|NCT01148745|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111284671|NCT04761029|Tramadol|tramadol|mesh-list
111284672|NCT04761029|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111284673|NCT04761029|Narcotics|narcotics|mesh-ancestor
111284674|NCT04761029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111284675|NCT04761029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111284676|NCT04761029|Analgesics|analgesics|mesh-ancestor
111284677|NCT04761029|Sensory System Agents|sensory system agents|mesh-ancestor
111284678|NCT04761029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111284679|NCT05687981|Dexamethasone|dexamethasone|mesh-list
111284680|NCT05687981|Bupivacaine|bupivacaine|mesh-list
111284681|NCT05687981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111284682|NCT05687981|Antiemetics|antiemetics|mesh-ancestor
111284683|NCT05687981|Autonomic Agents|autonomic agents|mesh-ancestor
111284684|NCT05687981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111284685|NCT05687981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111284686|NCT05687981|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111284687|NCT05687981|Glucocorticoids|glucocorticoids|mesh-ancestor
111284688|NCT05687981|Hormones|hormones|mesh-ancestor
111284689|NCT05687981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111284690|NCT05687981|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111284691|NCT05687981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111284692|NCT05687981|Anesthetics, Local|anesthetics, local|mesh-ancestor
111284693|NCT05687981|Anesthetics|anesthetics|mesh-ancestor
111284694|NCT05687981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111284695|NCT05687981|Sensory System Agents|sensory system agents|mesh-ancestor
111284696|NCT05687747|FAPI-46|fapi-46|mesh-list
111284697|NCT05687747|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111284698|NCT05687747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111284699|NCT05687669|Phentolamine|phentolamine|mesh-list
111284700|NCT05687669|Nitroglycerin|nitroglycerin|mesh-list
111284701|NCT05687669|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111284702|NCT05687669|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111284703|NCT05687669|Adrenergic Agents|adrenergic agents|mesh-ancestor
111284704|NCT05687669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111284705|NCT05687669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111284706|NCT05687669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111284707|NCT05687669|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111284708|NCT05687669|Vasodilator Agents|vasodilator agents|mesh-ancestor
111284709|NCT04400747|Vitamin D|vitamin d|mesh-list
111284710|NCT04400747|Cholecalciferol|cholecalciferol|mesh-list
111284711|NCT04400747|Vitamins|vitamins|mesh-ancestor
111284712|NCT04400747|Micronutrients|micronutrients|mesh-ancestor
111284713|NCT04400747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111284714|NCT04400747|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111284715|NCT04400747|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111284716|NCT02190903|Anesthetics|anesthetics|mesh-list
111284717|NCT02190903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111284718|NCT02190903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111284719|NCT03369041|Irinotecan|irinotecan|mesh-list
111009257|NCT02513433|Bupivacaine|bupivacaine|mesh-list
111284720|NCT03369041|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111284721|NCT03369041|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111284722|NCT03369041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111284723|NCT03369041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111284724|NCT03369041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111284726|NCT01149759|Cyclosporins|cyclosporins|mesh-list
111284727|NCT01149759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111284728|NCT01149759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111284729|NCT01149759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111284730|NCT01149759|Immunologic Factors|immunologic factors|mesh-ancestor
111284731|NCT01149759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111284732|NCT01149759|Antifungal Agents|antifungal agents|mesh-ancestor
111284733|NCT01149759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111284734|NCT01149759|Dermatologic Agents|dermatologic agents|mesh-ancestor
111284735|NCT01149759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111284736|NCT01149759|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111284737|NCT01216761|Iodine|iodine|mesh-list
111284738|NCT01216761|Chlorhexidine|chlorhexidine|mesh-list
111284739|NCT01216761|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
111284740|NCT01216761|Cadexomer iodine|cadexomer iodine|mesh-list
111284741|NCT01216761|Povidone-Iodine|povidone-iodine|mesh-list
111284742|NCT01216761|Povidone|povidone|mesh-list
111284743|NCT01216761|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111284744|NCT01216761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111284745|NCT01216761|Disinfectants|disinfectants|mesh-ancestor
111284746|NCT01216761|Dermatologic Agents|dermatologic agents|mesh-ancestor
111284747|NCT01216761|Trace Elements|trace elements|mesh-ancestor
111284748|NCT01216761|Micronutrients|micronutrients|mesh-ancestor
111284749|NCT01216761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111284750|NCT01216761|Plasma Substitutes|plasma substitutes|mesh-ancestor
111284751|NCT01216761|Blood Substitutes|blood substitutes|mesh-ancestor
111284752|NCT04279379|Decitabine|decitabine|mesh-list
111284753|NCT04279379|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111284754|NCT04279379|Antimetabolites|antimetabolites|mesh-ancestor
111284755|NCT04279379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111284756|NCT04279379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111284757|NCT04279379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111284758|NCT01150461|Losartan|losartan|mesh-list
111284759|NCT01150461|Angiotensin II|angiotensin ii|mesh-list
111284760|NCT01150461|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
111284761|NCT01150461|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111284762|NCT01150461|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111284763|NCT01150461|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111284764|NCT01150461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111284765|NCT01150461|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111284766|NCT01218399|Budesonide|budesonide|mesh-list
111284767|NCT01218399|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
111284768|NCT01218399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111284769|NCT01218399|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111284770|NCT01218399|Autonomic Agents|autonomic agents|mesh-ancestor
111284771|NCT01218399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111284772|NCT01218399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111284773|NCT01218399|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111284774|NCT01218399|Respiratory System Agents|respiratory system agents|mesh-ancestor
111284775|NCT01218399|Glucocorticoids|glucocorticoids|mesh-ancestor
111284776|NCT01218399|Hormones|hormones|mesh-ancestor
111284777|NCT01218399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111284778|NCT01219881|Sevoflurane|sevoflurane|mesh-list
111284779|NCT01219881|Desflurane|desflurane|mesh-list
111284780|NCT01219881|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111284781|NCT01219881|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111284782|NCT01219881|Anesthetics, General|anesthetics, general|mesh-ancestor
111284783|NCT01219881|Anesthetics|anesthetics|mesh-ancestor
111284784|NCT01219881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111284785|NCT01219881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111284786|NCT01220973|Celecoxib|celecoxib|mesh-list
111284787|NCT01220973|Atorvastatin|atorvastatin|mesh-list
111284788|NCT01220973|Calcium|calcium|mesh-list
111284789|NCT01220973|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111284790|NCT01220973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111284791|NCT01220973|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111284792|NCT01220973|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111284793|NCT01220973|Antimetabolites|antimetabolites|mesh-ancestor
111284794|NCT01220973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111284795|NCT01220973|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111009331|NCT02513355|Cisplatin|cisplatin|mesh-list
111284796|NCT01220973|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111284797|NCT01220973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111284798|NCT01220973|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111284799|NCT01220973|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111284800|NCT01220973|Analgesics|analgesics|mesh-ancestor
111284801|NCT01220973|Sensory System Agents|sensory system agents|mesh-ancestor
111284802|NCT01220973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111284803|NCT01220973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111284804|NCT01220973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111284805|NCT01220973|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111284806|NCT01220973|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111284807|NCT05375747|Propofol|propofol|mesh-list
111284808|NCT05375747|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111284809|NCT05375747|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111284810|NCT05375747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111284811|NCT05375747|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111284812|NCT05375747|Anesthetics, General|anesthetics, general|mesh-ancestor
111284813|NCT05375747|Anesthetics|anesthetics|mesh-ancestor
111284814|NCT01221207|Calpastatin|calpastatin|mesh-list
111284815|NCT01221207|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
111284816|NCT01221207|Protease Inhibitors|protease inhibitors|mesh-ancestor
111284817|NCT01221207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111284818|NCT01221207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111284819|NCT03296813|Torsemide|torsemide|mesh-list
111284820|NCT03296813|Furosemide|furosemide|mesh-list
111284821|NCT03296813|Diuretics|diuretics|mesh-ancestor
111284822|NCT03296813|Natriuretic Agents|natriuretic agents|mesh-ancestor
111284823|NCT03296813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111284824|NCT03296813|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
111284825|NCT03296813|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111284826|NCT03296813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111284827|NCT03296813|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111284828|NCT03289949|Ketanserin|ketanserin|mesh-list
111284829|NCT03289949|Psilocybin|psilocybin|mesh-list
111284830|NCT03289949|Hallucinogens|hallucinogens|mesh-ancestor
111284831|NCT03289949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111284832|NCT03289949|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111284833|NCT03289949|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111284834|NCT03289949|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111284835|NCT03289949|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111284836|NCT03289949|Serotonin Agents|serotonin agents|mesh-ancestor
111284837|NCT03289949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111284838|NCT03289949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111284839|NCT01222299|Bepotastine besilate|bepotastine besilate|mesh-list
111284840|NCT01222299|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111284841|NCT04400045|Treosulfan|treosulfan|mesh-list
111284842|NCT04400045|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111284843|NCT04400045|Alkylating Agents|alkylating agents|mesh-ancestor
111284844|NCT04400045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111284845|NCT04400045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111284846|NCT01222689|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111284847|NCT01222689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111284848|NCT01222689|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111284849|NCT01222689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111284850|NCT01222689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111284851|NCT01153581|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
111284852|NCT01153581|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
111284853|NCT01153581|Estradiol|estradiol|mesh-list
111284854|NCT01153581|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
111284855|NCT01153581|Progesterone|progesterone|mesh-list
111284856|NCT01153581|Ganirelix|ganirelix|mesh-list
111284857|NCT01153581|Estrogens|estrogens|mesh-ancestor
111284858|NCT01153581|Hormones|hormones|mesh-ancestor
111284859|NCT01153581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111284860|NCT01153581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111284861|NCT01153581|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111284862|NCT01153581|Contraceptive Agents|contraceptive agents|mesh-ancestor
111284863|NCT01153581|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111284864|NCT01153581|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111284865|NCT01153581|Progestins|progestins|mesh-ancestor
111284866|NCT01153581|Hormone Antagonists|hormone antagonists|mesh-ancestor
111284867|NCT04278599|Zinc|zinc|mesh-list
111284868|NCT04278599|Trace Elements|trace elements|mesh-ancestor
111284869|NCT04278599|Micronutrients|micronutrients|mesh-ancestor
111284870|NCT04278599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111284872|NCT05277623|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
111284873|NCT05277623|Diuretics|diuretics|mesh-ancestor
111284874|NCT05277623|Natriuretic Agents|natriuretic agents|mesh-ancestor
111284875|NCT05277623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111284876|NCT01224015|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111284877|NCT01224015|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111284878|NCT01224015|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111284879|NCT01224015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111284880|NCT01224015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111284881|NCT01224015|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111284882|NCT01224015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111284883|NCT01224015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111284884|NCT01224015|Cholinergic Agents|cholinergic agents|mesh-ancestor
111284885|NCT01224015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111284886|NCT04760327|Cisplatin|cisplatin|mesh-list
111284887|NCT04760327|Bleomycin|bleomycin|mesh-list
111284888|NCT04760327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111284889|NCT04760327|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111284890|NCT01225263|Vitamin D|vitamin d|mesh-list
111284891|NCT01225263|Simvastatin|simvastatin|mesh-list
111284892|NCT01225263|Vitamins|vitamins|mesh-ancestor
111284893|NCT01225263|Micronutrients|micronutrients|mesh-ancestor
111284894|NCT01225263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111284895|NCT01225263|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111284896|NCT01225263|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111284897|NCT01225263|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111284898|NCT01225263|Antimetabolites|antimetabolites|mesh-ancestor
111284899|NCT01225263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111284900|NCT01225263|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111284901|NCT01225263|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111284902|NCT01225263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111284903|NCT04278287|Paclitaxel|paclitaxel|mesh-list
111284904|NCT04278287|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111284905|NCT04278287|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111284906|NCT04278287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111284907|NCT04278287|Tubulin Modulators|tubulin modulators|mesh-ancestor
111284908|NCT04278287|Antimitotic Agents|antimitotic agents|mesh-ancestor
111284909|NCT04278287|Mitosis Modulators|mitosis modulators|mesh-ancestor
111284910|NCT04278287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111284911|NCT05162027|Erenumab|erenumab|mesh-list
111284912|NCT05162027|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
111284913|NCT05162027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111284914|NCT05162027|Analgesics|analgesics|mesh-ancestor
111284915|NCT05162027|Sensory System Agents|sensory system agents|mesh-ancestor
111284916|NCT05162027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111284917|NCT05162027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111284918|NCT03278717|Olaparib|olaparib|mesh-list
111284919|NCT03278717|Cediranib|cediranib|mesh-list
111284920|NCT03278717|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111284921|NCT03278717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111284922|NCT03278717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111284923|NCT03278717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111284924|NCT03278717|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111284925|NCT01227993|Finasteride|finasteride|mesh-list
111284926|NCT01227993|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
111284927|NCT01227993|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111284928|NCT01227993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111284929|NCT01227993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111284930|NCT01227993|Hormone Antagonists|hormone antagonists|mesh-ancestor
111284931|NCT01227993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111284932|NCT01227993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111284933|NCT01227993|Urological Agents|urological agents|mesh-ancestor
111284934|NCT01155999|Tobramycin|tobramycin|mesh-list
111284935|NCT01155999|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111284936|NCT01155999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111284937|NCT03275597|Durvalumab|durvalumab|mesh-list
111284938|NCT03275597|Tremelimumab|tremelimumab|mesh-list
111284939|NCT03275597|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111284940|NCT03275597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111284941|NCT01228149|Acetazolamide|acetazolamide|mesh-list
111284942|NCT01228149|Anticonvulsants|anticonvulsants|mesh-ancestor
111284943|NCT01228149|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
111284944|NCT01228149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111284945|NCT01228149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111284946|NCT01228149|Diuretics|diuretics|mesh-ancestor
111284947|NCT01228149|Natriuretic Agents|natriuretic agents|mesh-ancestor
111284948|NCT01228149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111284949|NCT04989413|Dronabinol|dronabinol|mesh-list
111284950|NCT04989413|Cannabidiol|cannabidiol|mesh-list
111284951|NCT04989413|Anticonvulsants|anticonvulsants|mesh-ancestor
111284952|NCT04989413|Hallucinogens|hallucinogens|mesh-ancestor
111284953|NCT04989413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111284954|NCT04989413|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111284955|NCT04989413|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111284956|NCT04989413|Analgesics|analgesics|mesh-ancestor
111284957|NCT04989413|Sensory System Agents|sensory system agents|mesh-ancestor
111284958|NCT04989413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111284959|NCT04989413|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
111284960|NCT04989413|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
111284961|NCT04989413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111284962|NCT04989413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111284963|NCT04989413|Hormones|hormones|mesh-ancestor
111284964|NCT04989413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111284965|NCT04986839|Acetaminophen|acetaminophen|mesh-list
111284966|NCT04986839|Ibuprofen|ibuprofen|mesh-list
111284967|NCT04986839|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111284968|NCT04986839|Analgesics|analgesics|mesh-ancestor
111284969|NCT04986839|Sensory System Agents|sensory system agents|mesh-ancestor
111284970|NCT04986839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111284971|NCT04986839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111284972|NCT04986839|Antipyretics|antipyretics|mesh-ancestor
111284973|NCT04986839|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111284974|NCT04986839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111284975|NCT04986839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111284976|NCT04986839|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111284977|NCT04986839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111284978|NCT04986839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111284979|NCT04968587|Dialysis Solutions|dialysis solutions|mesh-list
111284980|NCT04968587|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111284981|NCT02192541|Aflibercept|aflibercept|mesh-list
111284982|NCT02192541|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111284983|NCT02192541|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111284984|NCT02192541|Growth Substances|growth substances|mesh-ancestor
111284985|NCT02192541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111284986|NCT02192541|Growth Inhibitors|growth inhibitors|mesh-ancestor
111284987|NCT02192541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111284988|NCT01156701|Zanamivir|zanamivir|mesh-list
111284989|NCT01156701|Antiviral Agents|antiviral agents|mesh-ancestor
111284990|NCT01156701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111284991|NCT01156701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111284992|NCT01156701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111284993|NCT04937153|Pembrolizumab|pembrolizumab|mesh-list
111284994|NCT04937153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111284995|NCT04937153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111284996|NCT04937153|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111284997|NCT04937153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111284998|NCT03266081|Bupivacaine|bupivacaine|mesh-list
111284999|NCT03266081|Anesthetics, Local|anesthetics, local|mesh-ancestor
111285000|NCT03266081|Anesthetics|anesthetics|mesh-ancestor
111285001|NCT03266081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111285002|NCT03266081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111285003|NCT03266081|Sensory System Agents|sensory system agents|mesh-ancestor
111285004|NCT03266081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111285005|NCT03010995|Prazosin|prazosin|mesh-list
111285006|NCT03010995|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111285007|NCT03010995|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111285008|NCT03010995|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111285009|NCT03010995|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111285010|NCT03010995|Adrenergic Agents|adrenergic agents|mesh-ancestor
111285011|NCT03010995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111285012|NCT03010995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111285013|NCT03010995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111285014|NCT01230177|Etanercept|etanercept|mesh-list
111285015|NCT01230177|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111285016|NCT01230177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111285017|NCT01230177|Analgesics|analgesics|mesh-ancestor
111285018|NCT01230177|Sensory System Agents|sensory system agents|mesh-ancestor
111285019|NCT01230177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111285020|NCT01230177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111285021|NCT01230177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111285022|NCT01230177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111285023|NCT01230177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111285024|NCT01230177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111285025|NCT01230177|Immunologic Factors|immunologic factors|mesh-ancestor
111285026|NCT02984657|Anesthetics|anesthetics|mesh-list
111285027|NCT02984657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111285028|NCT02984657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111285029|NCT01158651|Everolimus|everolimus|mesh-list
111285030|NCT01158651|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111285031|NCT01158651|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111285032|NCT01158651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111285033|NCT01158651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111285034|NCT01158651|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111285035|NCT01158651|Immunologic Factors|immunologic factors|mesh-ancestor
111285036|NCT01158651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111285037|NCT01158651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111285038|NCT04852679|Lanreotide|lanreotide|mesh-list
111285039|NCT04852679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111285040|NCT03262103|Poly I-C|poly i-c|mesh-list
111285041|NCT03262103|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
111285042|NCT03262103|Poly ICLC|poly iclc|mesh-list
111285043|NCT03262103|Interferon Inducers|interferon inducers|mesh-ancestor
111285044|NCT03262103|Immunologic Factors|immunologic factors|mesh-ancestor
111285045|NCT03262103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111285046|NCT03262103|Laxatives|laxatives|mesh-ancestor
111285047|NCT03262103|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111285048|NCT03262103|Antiviral Agents|antiviral agents|mesh-ancestor
111285049|NCT03262103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111285050|NCT04777643|Cannabidiol|cannabidiol|mesh-list
111285051|NCT04777643|Anticonvulsants|anticonvulsants|mesh-ancestor
111285052|NCT04775225|Lidocaine|lidocaine|mesh-list
111285053|NCT04775225|Anesthetics, Local|anesthetics, local|mesh-ancestor
111285054|NCT04775225|Anesthetics|anesthetics|mesh-ancestor
111285055|NCT04775225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111285056|NCT04775225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111285057|NCT04775225|Sensory System Agents|sensory system agents|mesh-ancestor
111285058|NCT04775225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111285059|NCT04775225|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111285060|NCT04775225|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111285061|NCT04775225|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111285062|NCT04775225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111285063|NCT04775225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111285064|NCT04731467|Paclitaxel|paclitaxel|mesh-list
111285065|NCT04731467|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111285066|NCT04731467|Gemcitabine|gemcitabine|mesh-list
111285067|NCT04731467|Nivolumab|nivolumab|mesh-list
111285068|NCT04731467|Fluorouracil|fluorouracil|mesh-list
111285069|NCT04731467|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111285070|NCT04731467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111285071|NCT04731467|Tubulin Modulators|tubulin modulators|mesh-ancestor
111285072|NCT04731467|Antimitotic Agents|antimitotic agents|mesh-ancestor
111285073|NCT04731467|Mitosis Modulators|mitosis modulators|mesh-ancestor
111285074|NCT04731467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111285075|NCT04731467|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111285076|NCT04731467|Antimetabolites|antimetabolites|mesh-ancestor
111285077|NCT04731467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111285078|NCT04731467|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111285079|NCT04731467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111285080|NCT04731467|Immunologic Factors|immunologic factors|mesh-ancestor
111285081|NCT04731467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111285082|NCT04685915|Acalabrutinib|acalabrutinib|mesh-list
111285083|NCT04685915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111285084|NCT04399187|Sodium Hypochlorite|sodium hypochlorite|mesh-list
111285086|NCT04399187|Disinfectants|disinfectants|mesh-ancestor
111285087|NCT04399187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111285088|NCT03239561|JNJ-64326067|jnj-64326067|mesh-list
111285089|NCT03239561|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111285090|NCT03239561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111285091|NCT04746365|Hydroxychloroquine|hydroxychloroquine|mesh-list
111285092|NCT04746365|Ivermectin|ivermectin|mesh-list
111285093|NCT04746365|Antimalarials|antimalarials|mesh-ancestor
111285094|NCT04746365|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111285095|NCT04746365|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111285096|NCT04746365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111285097|NCT04746365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111285098|NCT04746365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111285099|NCT04746365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111285100|NCT04399343|Dexmedetomidine|dexmedetomidine|mesh-list
111285101|NCT04399343|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111285102|NCT04399343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111285103|NCT04399343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111285104|NCT04399343|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111285106|NCT04399343|Sensory System Agents|sensory system agents|mesh-ancestor
111285107|NCT04399343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111285108|NCT04399343|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111285109|NCT04399343|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111285110|NCT04399343|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111285111|NCT04399343|Adrenergic Agents|adrenergic agents|mesh-ancestor
111285112|NCT04399343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111285113|NCT04399343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111285114|NCT03676049|Cannabidiol|cannabidiol|mesh-list
111285115|NCT03676049|Anticonvulsants|anticonvulsants|mesh-ancestor
111285116|NCT03233633|Cannabidiol|cannabidiol|mesh-list
111285117|NCT03233633|Anticonvulsants|anticonvulsants|mesh-ancestor
111285118|NCT02984345|Caseins|caseins|mesh-list
111285119|NCT02984345|Chelating Agents|chelating agents|mesh-ancestor
111285120|NCT02984345|Sequestering Agents|sequestering agents|mesh-ancestor
111285121|NCT02984345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111285122|NCT01232205|Micronutrients|micronutrients|mesh-list
111285123|NCT01232205|Trace Elements|trace elements|mesh-list
111285124|NCT01232205|Antioxidants|antioxidants|mesh-list
111285125|NCT01232205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111285126|NCT01232205|Protective Agents|protective agents|mesh-ancestor
111285127|NCT01232205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111285128|NCT04584125|Riboflavin|riboflavin|mesh-list
111285129|NCT04584125|Flavin Mononucleotide|flavin mononucleotide|mesh-list
111285130|NCT04584125|Dextrans|dextrans|mesh-list
111285131|NCT04584125|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111285132|NCT04584125|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111285133|NCT04584125|Vitamin B Complex|vitamin b complex|mesh-ancestor
111285134|NCT04584125|Vitamins|vitamins|mesh-ancestor
111285135|NCT04584125|Micronutrients|micronutrients|mesh-ancestor
111285136|NCT04584125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111285137|NCT04584125|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111285138|NCT04584125|Dermatologic Agents|dermatologic agents|mesh-ancestor
111285139|NCT04584125|Anticoagulants|anticoagulants|mesh-ancestor
111285140|NCT04584125|Plasma Substitutes|plasma substitutes|mesh-ancestor
111285141|NCT04584125|Blood Substitutes|blood substitutes|mesh-ancestor
111285142|NCT04348409|Nitazoxanide|nitazoxanide|mesh-list
111285143|NCT04348409|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111285144|NCT04348409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111285145|NCT01158885|Cytarabine|cytarabine|mesh-list
111285146|NCT01158885|Methotrexate|methotrexate|mesh-list
111285147|NCT01158885|Clofarabine|clofarabine|mesh-list
111285148|NCT01158885|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111285149|NCT01158885|Abortifacient Agents|abortifacient agents|mesh-ancestor
111285150|NCT01158885|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111285151|NCT01158885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111285152|NCT01158885|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111285153|NCT01158885|Antimetabolites|antimetabolites|mesh-ancestor
111285154|NCT01158885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111285155|NCT01158885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111285156|NCT01158885|Dermatologic Agents|dermatologic agents|mesh-ancestor
111285157|NCT01158885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111285158|NCT01158885|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111285159|NCT01158885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111285160|NCT01158885|Immunologic Factors|immunologic factors|mesh-ancestor
111285161|NCT01158885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111285162|NCT01158885|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111285163|NCT01158885|Antiviral Agents|antiviral agents|mesh-ancestor
111285164|NCT01158885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111285165|NCT01232829|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
111285166|NCT01232829|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
111285167|NCT01232829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111285168|NCT01232829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111009706|NCT02246179|Prilocaine|prilocaine|mesh-list
111285169|NCT01233921|Mitogens|mitogens|mesh-list
111285170|NCT01233921|Mitosis Modulators|mitosis modulators|mesh-ancestor
111285171|NCT01233921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111285173|NCT03226301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111285174|NCT01236105|Charcoal|charcoal|mesh-list
111285175|NCT01236105|Antidotes|antidotes|mesh-ancestor
111285176|NCT01236105|Protective Agents|protective agents|mesh-ancestor
111285177|NCT01236105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111285178|NCT04533347|Tafenoquine|tafenoquine|mesh-list
111285179|NCT04533347|Antimalarials|antimalarials|mesh-ancestor
111285180|NCT04533347|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111285181|NCT04533347|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111285182|NCT04533347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111285183|NCT01160445|Aldesleukin|aldesleukin|mesh-list
111285184|NCT01160445|Zanolimumab|zanolimumab|mesh-list
111285185|NCT01160445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111285186|NCT01160445|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111285187|NCT01160445|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111285188|NCT01160445|Antiviral Agents|antiviral agents|mesh-ancestor
111285189|NCT01160445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111285190|NCT01160445|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111285191|NCT01237041|Niacin|niacin|mesh-list
111285192|NCT01237041|Niacinamide|niacinamide|mesh-list
111285193|NCT01237041|Nicotinic Acids|nicotinic acids|mesh-list
111285194|NCT01237041|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111285195|NCT01237041|Antimetabolites|antimetabolites|mesh-ancestor
111285196|NCT01237041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111285197|NCT01237041|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111285198|NCT01237041|Vasodilator Agents|vasodilator agents|mesh-ancestor
111285199|NCT01237041|Vitamin B Complex|vitamin b complex|mesh-ancestor
111285200|NCT01237041|Vitamins|vitamins|mesh-ancestor
111285201|NCT01237041|Micronutrients|micronutrients|mesh-ancestor
111285202|NCT01237041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111285203|NCT01237197|Exenatide|exenatide|mesh-list
111285204|NCT01237197|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111285205|NCT01237197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111285206|NCT01237197|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111285207|NCT01237197|Incretins|incretins|mesh-ancestor
111285208|NCT01237197|Hormones|hormones|mesh-ancestor
111285209|NCT01237197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111285210|NCT01237353|Rabeprazole|rabeprazole|mesh-list
111285211|NCT01237353|Betaine|betaine|mesh-list
111285212|NCT01237353|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111285213|NCT01237353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111285214|NCT01237353|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111285215|NCT01237353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111285216|NCT01237353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111285217|NCT01237353|Lipotropic Agents|lipotropic agents|mesh-ancestor
111285218|NCT01237353|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111285219|NCT01237353|Antimetabolites|antimetabolites|mesh-ancestor
111285220|NCT01237353|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111285221|NCT04410341|Vildagliptin|vildagliptin|mesh-list
111285222|NCT04410341|Escitalopram|escitalopram|mesh-list
111285223|NCT04410341|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111285224|NCT04410341|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111285225|NCT04410341|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111285226|NCT04410341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111285227|NCT04410341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111285228|NCT04410341|Serotonin Agents|serotonin agents|mesh-ancestor
111285229|NCT04410341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111285230|NCT04410341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111285231|NCT04410341|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111285232|NCT04410341|Protease Inhibitors|protease inhibitors|mesh-ancestor
111285233|NCT04410341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111285234|NCT03010761|Moclobemide|moclobemide|mesh-list
111285235|NCT03010761|Escitalopram|escitalopram|mesh-list
111285236|NCT03010761|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111285237|NCT03010761|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111285238|NCT03010761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111285239|NCT03010761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111285240|NCT03010761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111285241|NCT03010761|Serotonin Agents|serotonin agents|mesh-ancestor
111285242|NCT03010761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111285243|NCT03010761|Antidepressive Agents|antidepressive agents|mesh-ancestor
111285244|NCT03010761|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111285245|NCT03010761|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
111009834|NCT04482686|Zinc|zinc|mesh-list
111285246|NCT03010761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111285247|NCT01243593|Anesthetics|anesthetics|mesh-list
111285248|NCT01243593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111285249|NCT01243593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111285250|NCT04362761|Ivacaftor|ivacaftor|mesh-list
111285251|NCT04362761|Elexacaftor|elexacaftor|mesh-list
111285252|NCT04362761|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
111285253|NCT04362761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111285254|NCT04362761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111285255|NCT01162005|Tacrolimus|tacrolimus|mesh-list
111285256|NCT01162005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111285257|NCT01162005|Immunologic Factors|immunologic factors|mesh-ancestor
111285258|NCT01162005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111285259|NCT01162005|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111285260|NCT01162005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111285261|NCT01162005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111285262|NCT04354649|Hydroxychloroquine|hydroxychloroquine|mesh-list
111285263|NCT04354649|Antimalarials|antimalarials|mesh-ancestor
111285264|NCT04354649|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111285265|NCT04354649|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111285266|NCT04354649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111285267|NCT04354649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111285268|NCT04354649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111285269|NCT04354649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111285270|NCT01244451|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
111285271|NCT01244451|Ofatumumab|ofatumumab|mesh-list
111285272|NCT01244451|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111285273|NCT01244451|Alkylating Agents|alkylating agents|mesh-ancestor
111285274|NCT01244451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111285275|NCT01244451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111285276|NCT01246401|Naltrexone|naltrexone|mesh-list
111285277|NCT01246401|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111285278|NCT01246401|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111285279|NCT01246401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111285280|NCT01246401|Sensory System Agents|sensory system agents|mesh-ancestor
111285281|NCT01246401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111285282|NCT05627375|Anticoagulants|anticoagulants|mesh-list
111285283|NCT01281501|Scopolamine|scopolamine|mesh-list
111285284|NCT01281501|Pantoprazole|pantoprazole|mesh-list
111285285|NCT01281501|Anti-Ulcer Agents|anti-ulcer agents|mesh-list
111285286|NCT01281501|Antacids|antacids|mesh-list
111285287|NCT01281501|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
111285288|NCT01281501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111285289|NCT01281501|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111285290|NCT01281501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111285291|NCT01281501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111285292|NCT01281501|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111285293|NCT01281501|Antiemetics|antiemetics|mesh-ancestor
111285294|NCT01281501|Autonomic Agents|autonomic agents|mesh-ancestor
111285295|NCT01281501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111285296|NCT01281501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111285297|NCT01281501|Mydriatics|mydriatics|mesh-ancestor
111285298|NCT01281501|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111285299|NCT01281501|Cholinergic Agents|cholinergic agents|mesh-ancestor
111285300|NCT01281501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111285301|NCT01281501|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111285302|NCT01281501|Parasympatholytics|parasympatholytics|mesh-ancestor
111285303|NCT03353831|Bevacizumab|bevacizumab|mesh-list
111285304|NCT03353831|Atezolizumab|atezolizumab|mesh-list
111285305|NCT03353831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111285306|NCT03353831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111285307|NCT03353831|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111285308|NCT03353831|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111285309|NCT03353831|Growth Substances|growth substances|mesh-ancestor
111285310|NCT03353831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111285311|NCT03353831|Growth Inhibitors|growth inhibitors|mesh-ancestor
111285312|NCT03353831|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111285313|NCT03353831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111285314|NCT01246713|Acetaminophen|acetaminophen|mesh-list
111285315|NCT01246713|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111285316|NCT01246713|Analgesics|analgesics|mesh-ancestor
111285317|NCT01246713|Sensory System Agents|sensory system agents|mesh-ancestor
111285318|NCT01246713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111285319|NCT01246713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111285320|NCT01246713|Antipyretics|antipyretics|mesh-ancestor
111009863|NCT03580889|Mydriatics|mydriatics|mesh-ancestor
111285322|NCT01246791|Norethindrone|norethindrone|mesh-list
111285323|NCT01246791|Norinyl|norinyl|mesh-list
111285324|NCT01246791|Estradiol|estradiol|mesh-list
111285325|NCT01246791|Estrogens|estrogens|mesh-ancestor
111285326|NCT01246791|Hormones|hormones|mesh-ancestor
111285327|NCT01246791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111285328|NCT01246791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111285329|NCT01246791|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111285330|NCT01246791|Contraceptive Agents|contraceptive agents|mesh-ancestor
111285331|NCT01246791|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111285332|NCT01246791|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111285333|NCT01246791|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111285334|NCT01246791|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111285335|NCT01246791|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111285336|NCT01246791|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
111285337|NCT04319081|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-list
111285338|NCT04319081|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111285339|NCT04319081|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111285340|NCT04319081|Antimetabolites|antimetabolites|mesh-ancestor
111285341|NCT04319081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111285342|NCT04319081|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111285343|NCT04319081|Protease Inhibitors|protease inhibitors|mesh-ancestor
111285344|NCT04319081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111285345|NCT04319081|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111285346|NCT05345639|Ropivacaine|ropivacaine|mesh-list
111285347|NCT05345639|Anesthetics|anesthetics|mesh-ancestor
111285348|NCT05345639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111285349|NCT05345639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111285350|NCT05345639|Anesthetics, Local|anesthetics, local|mesh-ancestor
111285351|NCT05345639|Sensory System Agents|sensory system agents|mesh-ancestor
111285352|NCT05345639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111285353|NCT04303325|Esketamine|esketamine|mesh-list
111285354|NCT04303325|Antidepressive Agents|antidepressive agents|mesh-ancestor
111285355|NCT04303325|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111285356|NCT04248335|Midazolam|midazolam|mesh-list
111285357|NCT04248335|Pantoprazole|pantoprazole|mesh-list
111285358|NCT04248335|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111285359|NCT04248335|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111285360|NCT04248335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111285361|NCT04248335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111285362|NCT04248335|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111285363|NCT04248335|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111285364|NCT04248335|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111285365|NCT04248335|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111285366|NCT04248335|Anesthetics, General|anesthetics, general|mesh-ancestor
111285367|NCT04248335|Anesthetics|anesthetics|mesh-ancestor
111285368|NCT04248335|GABA Modulators|gaba modulators|mesh-ancestor
111285369|NCT04248335|GABA Agents|gaba agents|mesh-ancestor
111285370|NCT04248335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111285371|NCT04248335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111285372|NCT04248335|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111285373|NCT04248335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111285374|NCT04248335|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111285375|NCT04248335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111285376|NCT04746209|Blinatumomab|blinatumomab|mesh-list
111285377|NCT04746209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111285378|NCT04176419|Acetaminophen|acetaminophen|mesh-list
111285379|NCT04176419|Celecoxib|celecoxib|mesh-list
111285380|NCT04176419|Lidocaine|lidocaine|mesh-list
111285381|NCT04176419|Ketamine|ketamine|mesh-list
111285382|NCT04176419|Gabapentin|gabapentin|mesh-list
111285383|NCT04176419|Anesthetics, Local|anesthetics, local|mesh-ancestor
111285384|NCT04176419|Anesthetics|anesthetics|mesh-ancestor
111285385|NCT04176419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111285386|NCT04176419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111285387|NCT04176419|Sensory System Agents|sensory system agents|mesh-ancestor
111285388|NCT04176419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111285389|NCT04176419|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111285390|NCT04176419|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111285391|NCT04176419|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111285392|NCT04176419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111285393|NCT04176419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111285394|NCT04176419|Analgesics|analgesics|mesh-ancestor
111285395|NCT04176419|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111009942|NCT03579875|Busulfan|busulfan|mesh-list
111285396|NCT04176419|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111285397|NCT04176419|Anesthetics, General|anesthetics, general|mesh-ancestor
111285398|NCT04176419|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111285399|NCT04176419|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111285400|NCT04176419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111285401|NCT04176419|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111285402|NCT04176419|Antipyretics|antipyretics|mesh-ancestor
111285403|NCT04176419|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111285404|NCT04176419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111285405|NCT04176419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111285406|NCT04176419|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111285407|NCT04176419|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111285408|NCT04176419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111285409|NCT04176419|Anticonvulsants|anticonvulsants|mesh-ancestor
111285410|NCT04176419|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111285411|NCT04176419|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111285412|NCT04176419|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111285413|NCT04176419|Antimanic Agents|antimanic agents|mesh-ancestor
111285414|NCT04168931|Trastuzumab|trastuzumab|mesh-list
111285415|NCT04168931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111285416|NCT04168931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111285417|NCT03211949|Mepivacaine|mepivacaine|mesh-list
111285418|NCT03211949|Anesthetics, Local|anesthetics, local|mesh-ancestor
111285419|NCT03211949|Anesthetics|anesthetics|mesh-ancestor
111285420|NCT03211949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111285421|NCT03211949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111285422|NCT03211949|Sensory System Agents|sensory system agents|mesh-ancestor
111285423|NCT03211949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111285424|NCT01285635|Docetaxel|docetaxel|mesh-list
111285425|NCT01285635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111285426|NCT01285635|Tubulin Modulators|tubulin modulators|mesh-ancestor
111285427|NCT01285635|Antimitotic Agents|antimitotic agents|mesh-ancestor
111285428|NCT01285635|Mitosis Modulators|mitosis modulators|mesh-ancestor
111285429|NCT01285635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111285430|NCT01286259|Disulfiram|disulfiram|mesh-list
111285431|NCT01286259|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111285432|NCT01286259|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
111285433|NCT01286259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111285434|NCT01286259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111285435|NCT01286805|Bupivacaine|bupivacaine|mesh-list
111285436|NCT01286805|Anesthetics, Local|anesthetics, local|mesh-ancestor
111285437|NCT01286805|Anesthetics|anesthetics|mesh-ancestor
111285438|NCT01286805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111285439|NCT01286805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111285440|NCT01286805|Sensory System Agents|sensory system agents|mesh-ancestor
111285441|NCT01286805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111285442|NCT01288521|Ketoconazole|ketoconazole|mesh-list
111285443|NCT01288521|Tacrolimus|tacrolimus|mesh-list
111285444|NCT01288521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111285445|NCT01288521|Immunologic Factors|immunologic factors|mesh-ancestor
111285446|NCT01288521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111285447|NCT01288521|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111285448|NCT01288521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111285449|NCT01288521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111285450|NCT01288521|Antifungal Agents|antifungal agents|mesh-ancestor
111285451|NCT01288521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111285452|NCT01288521|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111285453|NCT01288521|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111285454|NCT01288521|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111285455|NCT01288521|Hormone Antagonists|hormone antagonists|mesh-ancestor
111285456|NCT01288521|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111285457|NCT01288521|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111285458|NCT00632749|Cytarabine|cytarabine|mesh-list
111285459|NCT00632749|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111285460|NCT00632749|Antimetabolites|antimetabolites|mesh-ancestor
111285461|NCT00632749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111285462|NCT00632749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111285463|NCT00632749|Antiviral Agents|antiviral agents|mesh-ancestor
111285464|NCT00632749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111285465|NCT00632749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111285466|NCT00632749|Immunologic Factors|immunologic factors|mesh-ancestor
111285467|NCT00632749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111285468|NCT01289067|Satraplatin|satraplatin|mesh-list
111285469|NCT01289067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111285470|NCT00632359|Lenalidomide|lenalidomide|mesh-list
111285471|NCT00632359|Immunologic Factors|immunologic factors|mesh-ancestor
111285472|NCT00632359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111285473|NCT00632359|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111285474|NCT00632359|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111285475|NCT00632359|Growth Substances|growth substances|mesh-ancestor
111285476|NCT00632359|Growth Inhibitors|growth inhibitors|mesh-ancestor
111285477|NCT00632359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111285478|NCT03954899|Melatonin|melatonin|mesh-list
111285479|NCT03954899|Antioxidants|antioxidants|mesh-ancestor
111285480|NCT03954899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111285481|NCT03954899|Protective Agents|protective agents|mesh-ancestor
111285482|NCT03954899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111285483|NCT03954899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111285484|NCT03934307|Irbesartan|irbesartan|mesh-list
111285485|NCT03934307|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111285486|NCT03934307|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111285487|NCT03934307|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111285488|NCT03934307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111285489|NCT03924635|Budesonide|budesonide|mesh-list
111285490|NCT03924635|Albuterol|albuterol|mesh-list
111285491|NCT03924635|Formoterol Fumarate|formoterol fumarate|mesh-list
111285492|NCT03924635|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
111285493|NCT03924635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111285494|NCT03924635|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111285495|NCT03924635|Autonomic Agents|autonomic agents|mesh-ancestor
111285496|NCT03924635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111285497|NCT03924635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111285498|NCT03924635|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111285499|NCT03924635|Respiratory System Agents|respiratory system agents|mesh-ancestor
111285500|NCT03924635|Glucocorticoids|glucocorticoids|mesh-ancestor
111285501|NCT03924635|Hormones|hormones|mesh-ancestor
111285502|NCT03924635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111285503|NCT03924635|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111285504|NCT03924635|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111285505|NCT03924635|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111285506|NCT03924635|Adrenergic Agents|adrenergic agents|mesh-ancestor
111285507|NCT03924635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111285508|NCT03924635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111285509|NCT03924635|Tocolytic Agents|tocolytic agents|mesh-ancestor
111285510|NCT03924635|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111285511|NCT04398251|Febuxostat|febuxostat|mesh-list
111285512|NCT04398251|Gout Suppressants|gout suppressants|mesh-ancestor
111285513|NCT04398251|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111285514|NCT00632203|Temozolomide|temozolomide|mesh-list
111285515|NCT00632203|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111285516|NCT00632203|Alkylating Agents|alkylating agents|mesh-ancestor
111285517|NCT00632203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111285518|NCT00632203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111285519|NCT01289457|Cytarabine|cytarabine|mesh-list
111285520|NCT01289457|Fludarabine|fludarabine|mesh-list
111285521|NCT01289457|Idarubicin|idarubicin|mesh-list
111285522|NCT01289457|Clofarabine|clofarabine|mesh-list
111285523|NCT01289457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111285524|NCT01289457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111285525|NCT01289457|Antimetabolites|antimetabolites|mesh-ancestor
111285526|NCT01289457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111285527|NCT01289457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111285528|NCT01289457|Immunologic Factors|immunologic factors|mesh-ancestor
111285529|NCT01289457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111285530|NCT01289457|Antiviral Agents|antiviral agents|mesh-ancestor
111285531|NCT01289457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111285532|NCT01289457|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111285533|NCT01289457|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111285534|NCT01289457|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111285535|NCT01289457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111285536|NCT03830333|Metronidazole|metronidazole|mesh-list
111285537|NCT03830333|Meropenem|meropenem|mesh-list
111285538|NCT03830333|Tazobactam|tazobactam|mesh-list
111285539|NCT03830333|Ceftolozane|ceftolozane|mesh-list
111285540|NCT03830333|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
111285541|NCT03830333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111285542|NCT03830333|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111285543|NCT03830333|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111285544|NCT03830333|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111285545|NCT03830333|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
111285546|NCT03830333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111285547|NCT03830333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111285548|NCT03830333|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111285549|NCT01251315|Acetylcysteine|acetylcysteine|mesh-list
111285550|NCT01251315|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111285551|NCT01251315|Antiviral Agents|antiviral agents|mesh-ancestor
111285552|NCT01251315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111285553|NCT01251315|Expectorants|expectorants|mesh-ancestor
111285554|NCT01251315|Respiratory System Agents|respiratory system agents|mesh-ancestor
111285555|NCT01251315|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111285556|NCT01251315|Antioxidants|antioxidants|mesh-ancestor
111285557|NCT01251315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111285558|NCT01251315|Protective Agents|protective agents|mesh-ancestor
111285559|NCT01251315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111285560|NCT01251315|Antidotes|antidotes|mesh-ancestor
111285561|NCT03810287|Domperidone|domperidone|mesh-list
111285562|NCT03810287|Antiemetics|antiemetics|mesh-ancestor
111285563|NCT03810287|Autonomic Agents|autonomic agents|mesh-ancestor
111285564|NCT03810287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111285565|NCT03810287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111285566|NCT03810287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111285567|NCT03810287|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111285568|NCT03810287|Dopamine Agents|dopamine agents|mesh-ancestor
111285569|NCT03810287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111285570|NCT03810287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111285571|NCT03749057|Rivaroxaban|rivaroxaban|mesh-list
111285572|NCT03749057|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111285573|NCT03749057|Antithrombins|antithrombins|mesh-ancestor
111285574|NCT03749057|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111285575|NCT03749057|Protease Inhibitors|protease inhibitors|mesh-ancestor
111285576|NCT03749057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111285577|NCT03749057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111285578|NCT03749057|Anticoagulants|anticoagulants|mesh-ancestor
111285579|NCT01290237|Vancomycin|vancomycin|mesh-list
111285580|NCT01290237|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111285581|NCT01290237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111285582|NCT03613727|Ascorbic Acid|ascorbic acid|mesh-list
111285583|NCT03613727|Vitamins|vitamins|mesh-ancestor
111285584|NCT03613727|Micronutrients|micronutrients|mesh-ancestor
111285585|NCT03613727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111285586|NCT03613727|Antioxidants|antioxidants|mesh-ancestor
111285587|NCT03613727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111285588|NCT03613727|Protective Agents|protective agents|mesh-ancestor
111285589|NCT01251393|Biperiden|biperiden|mesh-list
111285590|NCT01251393|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111285591|NCT01251393|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111285592|NCT01251393|Parasympatholytics|parasympatholytics|mesh-ancestor
111285593|NCT01251393|Autonomic Agents|autonomic agents|mesh-ancestor
111285594|NCT01251393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111285595|NCT01251393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111285596|NCT01251393|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111285597|NCT01251393|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111285598|NCT01251393|Cholinergic Agents|cholinergic agents|mesh-ancestor
111285599|NCT01251393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111285600|NCT01251393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111285601|NCT00631969|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
111285602|NCT00631969|Vasodilator Agents|vasodilator agents|mesh-ancestor
111285603|NCT00631969|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111285604|NCT00631969|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111285605|NCT00631969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111285606|NCT00631969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111285607|NCT00631969|Urological Agents|urological agents|mesh-ancestor
111285608|NCT01255137|Axitinib|axitinib|mesh-list
111285609|NCT01255137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111285610|NCT01255137|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111285611|NCT01255137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111285612|NCT01255137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111285613|NCT01255449|Albuterol|albuterol|mesh-list
111285614|NCT01255449|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111285615|NCT01255449|Autonomic Agents|autonomic agents|mesh-ancestor
111285616|NCT01255449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111285617|NCT01255449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111285618|NCT01255449|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111285619|NCT01255449|Respiratory System Agents|respiratory system agents|mesh-ancestor
111285620|NCT01255449|Tocolytic Agents|tocolytic agents|mesh-ancestor
111010165|NCT02495415|Fenretinide|fenretinide|mesh-list
111285621|NCT01255449|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111285622|NCT01255449|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111285623|NCT01255449|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111285624|NCT01255449|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111285625|NCT01255449|Adrenergic Agents|adrenergic agents|mesh-ancestor
111285626|NCT01255449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111285627|NCT01255449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111285628|NCT00631657|Mirtazapine|mirtazapine|mesh-list
111285629|NCT00631657|Antidepressive Agents|antidepressive agents|mesh-ancestor
111285630|NCT00631657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111285631|NCT00631657|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111285632|NCT00631657|Histamine Antagonists|histamine antagonists|mesh-ancestor
111285633|NCT00631657|Histamine Agents|histamine agents|mesh-ancestor
111285634|NCT00631657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111285635|NCT00631657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111285636|NCT00631657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111285637|NCT00631657|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111285638|NCT00631657|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111285639|NCT00631657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111285640|NCT00631657|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
111285641|NCT00631657|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111285642|NCT00631657|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111285643|NCT00631657|Adrenergic Agents|adrenergic agents|mesh-ancestor
111285644|NCT00631657|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111285645|NCT00631657|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111285646|NCT00631657|Serotonin Agents|serotonin agents|mesh-ancestor
111285647|NCT00631657|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111285649|NCT01257087|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111285650|NCT01257087|Insulin Glargine|insulin glargine|mesh-list
111285651|NCT01257087|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111285652|NCT01257087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111285653|NCT00631189|Atorvastatin|atorvastatin|mesh-list
111285654|NCT00631189|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111285655|NCT00631189|Pravastatin|pravastatin|mesh-list
111285656|NCT00631189|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111285657|NCT00631189|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111285658|NCT00631189|Antimetabolites|antimetabolites|mesh-ancestor
111285659|NCT00631189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111285660|NCT00631189|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111285661|NCT00631189|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111285662|NCT00631189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111285663|NCT00630877|Aspirin|aspirin|mesh-list
111285664|NCT00630877|Niacin|niacin|mesh-list
111285665|NCT00630877|Niacinamide|niacinamide|mesh-list
111285666|NCT00630877|Nicotinic Acids|nicotinic acids|mesh-list
111285667|NCT00630877|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111285668|NCT00630877|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111285669|NCT00630877|Analgesics|analgesics|mesh-ancestor
111285670|NCT00630877|Sensory System Agents|sensory system agents|mesh-ancestor
111285671|NCT00630877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111285672|NCT00630877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111285673|NCT00630877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111285674|NCT00630877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111285675|NCT00630877|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111285676|NCT00630877|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111285677|NCT00630877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111285678|NCT00630877|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111285679|NCT00630877|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111285680|NCT00630877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111285681|NCT00630877|Antipyretics|antipyretics|mesh-ancestor
111285682|NCT00630877|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111285683|NCT00630877|Antimetabolites|antimetabolites|mesh-ancestor
111285684|NCT00630877|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111285685|NCT00630877|Vasodilator Agents|vasodilator agents|mesh-ancestor
111285686|NCT00630877|Vitamin B Complex|vitamin b complex|mesh-ancestor
111285687|NCT00630877|Vitamins|vitamins|mesh-ancestor
111285688|NCT00630877|Micronutrients|micronutrients|mesh-ancestor
111285689|NCT04557163|Itraconazole|itraconazole|mesh-list
111285690|NCT04557163|Antifungal Agents|antifungal agents|mesh-ancestor
111285691|NCT04557163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111285692|NCT04557163|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111285693|NCT04557163|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111285694|NCT04557163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111285695|NCT04557163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111010232|NCT03566329|Lidocaine|lidocaine|mesh-list
111285696|NCT04557163|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111285697|NCT04557163|Hormone Antagonists|hormone antagonists|mesh-ancestor
111285698|NCT04557163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111285699|NCT04557163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111285700|NCT04557163|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111285701|NCT02915783|Everolimus|everolimus|mesh-list
111285702|NCT02915783|Lenvatinib|lenvatinib|mesh-list
111285703|NCT02915783|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111285704|NCT02915783|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111285705|NCT02915783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111285706|NCT02915783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111285707|NCT02915783|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111285708|NCT02915783|Immunologic Factors|immunologic factors|mesh-ancestor
111285709|NCT02915783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111285710|NCT02915783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111285711|NCT02736149|Ubenimex|ubenimex|mesh-list
111285712|NCT02736149|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111285713|NCT02736149|Immunologic Factors|immunologic factors|mesh-ancestor
111285714|NCT02736149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111285715|NCT02736149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111285716|NCT02736149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111285717|NCT02736149|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111285718|NCT02736149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111285719|NCT02736149|Protease Inhibitors|protease inhibitors|mesh-ancestor
111285720|NCT02736149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111285721|NCT02736149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111285722|NCT02736149|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111285723|NCT02736149|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111285724|NCT02736149|Antiviral Agents|antiviral agents|mesh-ancestor
111285725|NCT02307149|Ipilimumab|ipilimumab|mesh-list
111285726|NCT02307149|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111285727|NCT02307149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111285728|NCT02307149|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111285729|NCT02307149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111285730|NCT04397393|Midazolam|midazolam|mesh-list
111285731|NCT04397393|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111285732|NCT04397393|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111285733|NCT04397393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111285734|NCT04397393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111285735|NCT04397393|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111285736|NCT04397393|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111285737|NCT04397393|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111285738|NCT04397393|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111285739|NCT04397393|Anesthetics, General|anesthetics, general|mesh-ancestor
111285740|NCT04397393|Anesthetics|anesthetics|mesh-ancestor
111285741|NCT04397393|GABA Modulators|gaba modulators|mesh-ancestor
111285742|NCT04397393|GABA Agents|gaba agents|mesh-ancestor
111285743|NCT04397393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111285744|NCT04397393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111285745|NCT01176461|Nivolumab|nivolumab|mesh-list
111285746|NCT01176461|Vaccines|vaccines|mesh-list
111285747|NCT01176461|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
111285748|NCT01176461|Immunologic Factors|immunologic factors|mesh-ancestor
111285749|NCT01176461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111285750|NCT01176461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111285751|NCT01176461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111285752|NCT01176461|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111285753|NCT01176461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111285754|NCT01176461|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111285755|NCT00630331|Vaccines|vaccines|mesh-list
111285756|NCT00630331|Immunologic Factors|immunologic factors|mesh-ancestor
111285757|NCT00630331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111285758|NCT04555291|Ropivacaine|ropivacaine|mesh-list
111285759|NCT04555291|Anesthetics, Local|anesthetics, local|mesh-ancestor
111285760|NCT04555291|Anesthetics|anesthetics|mesh-ancestor
111285761|NCT04555291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111285762|NCT04555291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111285763|NCT04555291|Sensory System Agents|sensory system agents|mesh-ancestor
111285764|NCT04555291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111285765|NCT04275115|Midazolam|midazolam|mesh-list
111285766|NCT04275115|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111285767|NCT04275115|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111285768|NCT04275115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111285769|NCT04275115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111285770|NCT04275115|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111285771|NCT04275115|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111285772|NCT04275115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111285773|NCT04275115|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111285774|NCT04275115|Anesthetics, General|anesthetics, general|mesh-ancestor
111285775|NCT04275115|Anesthetics|anesthetics|mesh-ancestor
111285776|NCT04275115|GABA Modulators|gaba modulators|mesh-ancestor
111285777|NCT04275115|GABA Agents|gaba agents|mesh-ancestor
111285778|NCT04275115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111285779|NCT04275115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111285780|NCT00633997|Vildagliptin|vildagliptin|mesh-list
111285781|NCT00633997|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111285782|NCT00633997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111285783|NCT00633997|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111285784|NCT00633997|Protease Inhibitors|protease inhibitors|mesh-ancestor
111285785|NCT00633997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111285786|NCT00633997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111285787|NCT04559347|Bupivacaine|bupivacaine|mesh-list
111285788|NCT04559347|Ropivacaine|ropivacaine|mesh-list
111285789|NCT04559347|Anesthetics, Local|anesthetics, local|mesh-ancestor
111285790|NCT04559347|Anesthetics|anesthetics|mesh-ancestor
111285791|NCT04559347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111285792|NCT04559347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111285793|NCT04559347|Sensory System Agents|sensory system agents|mesh-ancestor
111285794|NCT04559347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111285795|NCT00631111|Aspirin|aspirin|mesh-list
111285796|NCT00631111|Ibuprofen|ibuprofen|mesh-list
111285797|NCT00631111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111285798|NCT00631111|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111285799|NCT00631111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111285800|NCT00631111|Analgesics|analgesics|mesh-ancestor
111285801|NCT00631111|Sensory System Agents|sensory system agents|mesh-ancestor
111285802|NCT00631111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111285803|NCT00631111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111285804|NCT00631111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111285805|NCT00631111|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111285806|NCT00631111|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111285807|NCT00631111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111285808|NCT00631111|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111285809|NCT00631111|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111285810|NCT00631111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111285811|NCT00631111|Antipyretics|antipyretics|mesh-ancestor
111285812|NCT00630799|Leuprolide|leuprolide|mesh-list
111285813|NCT00630799|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111285814|NCT00630799|Fertility Agents|fertility agents|mesh-ancestor
111285815|NCT00630799|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111285816|NCT00630799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111285817|NCT00630799|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111285818|NCT00630799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111285819|NCT01925287|Curcumin|curcumin|mesh-list
111285820|NCT01925287|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111285821|NCT01925287|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111285822|NCT01925287|Analgesics|analgesics|mesh-ancestor
111285823|NCT01925287|Sensory System Agents|sensory system agents|mesh-ancestor
111285824|NCT01925287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111285825|NCT01925287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111285826|NCT01925287|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111285827|NCT01925287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111285828|NCT01925287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111285829|NCT01925287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111285830|NCT01925287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111285831|NCT01924273|Talaporfin|talaporfin|mesh-list
111285832|NCT01924273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111285833|NCT01924273|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111285834|NCT01924273|Dermatologic Agents|dermatologic agents|mesh-ancestor
111285835|NCT04828343|Rozanolixizumab|rozanolixizumab|mesh-list
111285836|NCT04828343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111285837|NCT04828343|Immunologic Factors|immunologic factors|mesh-ancestor
111285838|NCT04828343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111285839|NCT04276649|Calcium Carbonate|calcium carbonate|mesh-list
111285840|NCT04276649|Antacids|antacids|mesh-ancestor
111285841|NCT04276649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111285842|NCT04276649|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111285843|NCT04553419|Cephalexin|cephalexin|mesh-list
111285844|NCT04553419|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111285845|NCT04553419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111285846|NCT03097783|Lidocaine|lidocaine|mesh-list
111285847|NCT03097783|Anesthetics, Local|anesthetics, local|mesh-ancestor
111285848|NCT03097783|Anesthetics|anesthetics|mesh-ancestor
111285849|NCT03097783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111285850|NCT03097783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111285851|NCT03097783|Sensory System Agents|sensory system agents|mesh-ancestor
111285852|NCT03097783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111285853|NCT03097783|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111285854|NCT03097783|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111285855|NCT03097783|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111285856|NCT03097783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111285857|NCT03097783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111285858|NCT04346407|Dronabinol|dronabinol|mesh-list
111285859|NCT04346407|Hallucinogens|hallucinogens|mesh-ancestor
111285860|NCT04346407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111285861|NCT04346407|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111285862|NCT04346407|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111285863|NCT04346407|Analgesics|analgesics|mesh-ancestor
111285864|NCT04346407|Sensory System Agents|sensory system agents|mesh-ancestor
111285865|NCT04346407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111285866|NCT04346407|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
111285867|NCT04346407|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
111285868|NCT04346407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111285869|NCT04346407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111285870|NCT04346407|Hormones|hormones|mesh-ancestor
111285871|NCT04346407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111285872|NCT04397549|Morphine|morphine|mesh-list
111285873|NCT04397549|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111285874|NCT04397549|Narcotics|narcotics|mesh-ancestor
111285875|NCT04397549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111285876|NCT04397549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111285877|NCT04397549|Analgesics|analgesics|mesh-ancestor
111285878|NCT04397549|Sensory System Agents|sensory system agents|mesh-ancestor
111285879|NCT04397549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111285880|NCT03080441|Midodrine|midodrine|mesh-list
111285881|NCT03080441|Sympathomimetics|sympathomimetics|mesh-ancestor
111285882|NCT03080441|Autonomic Agents|autonomic agents|mesh-ancestor
111285883|NCT03080441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111285884|NCT03080441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111285885|NCT03080441|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111285886|NCT03080441|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111285887|NCT03080441|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111285888|NCT03080441|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111285889|NCT03080441|Adrenergic Agents|adrenergic agents|mesh-ancestor
111285890|NCT03080441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111285891|NCT03080441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111285892|NCT01925755|Rivaroxaban|rivaroxaban|mesh-list
111285893|NCT01925755|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111285894|NCT01925755|Antithrombins|antithrombins|mesh-ancestor
111285895|NCT01925755|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111285896|NCT01925755|Protease Inhibitors|protease inhibitors|mesh-ancestor
111285897|NCT01925755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111285898|NCT01925755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111285899|NCT01925755|Anticoagulants|anticoagulants|mesh-ancestor
111285900|NCT01920919|Dexamethasone|dexamethasone|mesh-list
111285901|NCT01920919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111285902|NCT01920919|Antiemetics|antiemetics|mesh-ancestor
111285903|NCT01920919|Autonomic Agents|autonomic agents|mesh-ancestor
111285904|NCT01920919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111285905|NCT01920919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111285906|NCT01920919|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111285907|NCT01920919|Glucocorticoids|glucocorticoids|mesh-ancestor
111285908|NCT01920919|Hormones|hormones|mesh-ancestor
111285909|NCT01920919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111285910|NCT01920919|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111285911|NCT01920919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111285912|NCT01925911|Midazolam|midazolam|mesh-list
111285913|NCT01925911|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111285914|NCT01925911|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111285915|NCT01925911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111285916|NCT01925911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111285917|NCT01925911|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111285918|NCT01925911|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111285919|NCT01925911|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111010465|NCT02502981|Hormones|hormones|mesh-ancestor
111285920|NCT01925911|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111285921|NCT01925911|Anesthetics, General|anesthetics, general|mesh-ancestor
111285922|NCT01925911|Anesthetics|anesthetics|mesh-ancestor
111285923|NCT01925911|GABA Modulators|gaba modulators|mesh-ancestor
111285924|NCT01925911|GABA Agents|gaba agents|mesh-ancestor
111285925|NCT01925911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111285926|NCT01925911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111285927|NCT05241431|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
111285928|NCT05241431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111285929|NCT05241431|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111285930|NCT05241431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111285931|NCT01921231|Bupivacaine|bupivacaine|mesh-list
111285932|NCT01921231|Prilocaine|prilocaine|mesh-list
111285933|NCT01921231|Anesthetics, Local|anesthetics, local|mesh-ancestor
111285934|NCT01921231|Anesthetics|anesthetics|mesh-ancestor
111285935|NCT01921231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111285936|NCT01921231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111285937|NCT01921231|Sensory System Agents|sensory system agents|mesh-ancestor
111285938|NCT01921231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111285939|NCT03056833|Paclitaxel|paclitaxel|mesh-list
111285940|NCT03056833|Carboplatin|carboplatin|mesh-list
111285941|NCT03056833|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111285942|NCT03056833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111285943|NCT03056833|Tubulin Modulators|tubulin modulators|mesh-ancestor
111285944|NCT03056833|Antimitotic Agents|antimitotic agents|mesh-ancestor
111285945|NCT03056833|Mitosis Modulators|mitosis modulators|mesh-ancestor
111285946|NCT03056833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111285947|NCT05240261|Quetiapine Fumarate|quetiapine fumarate|mesh-list
111285948|NCT05240261|Antidepressive Agents|antidepressive agents|mesh-ancestor
111285949|NCT05240261|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111285950|NCT05240261|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111285951|NCT05240261|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111285952|NCT05240261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111285953|NCT05240261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111285954|NCT03148457|Rivaroxaban|rivaroxaban|mesh-list
111285955|NCT03148457|Apixaban|apixaban|mesh-list
111285956|NCT03148457|Edoxaban|edoxaban|mesh-list
111285957|NCT03148457|Dabigatran|dabigatran|mesh-list
111285958|NCT03148457|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111285959|NCT03148457|Antithrombins|antithrombins|mesh-ancestor
111285960|NCT03148457|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111285961|NCT03148457|Protease Inhibitors|protease inhibitors|mesh-ancestor
111285962|NCT03148457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111285963|NCT03148457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111285964|NCT03148457|Anticoagulants|anticoagulants|mesh-ancestor
111285965|NCT01926379|Isoniazid|isoniazid|mesh-list
111285966|NCT01926379|Antitubercular Agents|antitubercular agents|mesh-ancestor
111285967|NCT01926379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111285968|NCT01926379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111285969|NCT01926379|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
111285970|NCT01926379|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111285971|NCT01926379|Antimetabolites|antimetabolites|mesh-ancestor
111285972|NCT01926379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111285973|NCT01926379|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111285974|NCT03351647|Ustekinumab|ustekinumab|mesh-list
111285975|NCT03351647|Dermatologic Agents|dermatologic agents|mesh-ancestor
111285976|NCT02392637|Paclitaxel|paclitaxel|mesh-list
111285977|NCT02392637|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111285978|NCT02392637|Cisplatin|cisplatin|mesh-list
111285979|NCT02392637|Gemcitabine|gemcitabine|mesh-list
111285980|NCT02392637|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111285981|NCT02392637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111285982|NCT02392637|Tubulin Modulators|tubulin modulators|mesh-ancestor
111285983|NCT02392637|Antimitotic Agents|antimitotic agents|mesh-ancestor
111285984|NCT02392637|Mitosis Modulators|mitosis modulators|mesh-ancestor
111285985|NCT02392637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111285986|NCT02392637|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111285987|NCT02392637|Antimetabolites|antimetabolites|mesh-ancestor
111285988|NCT05600881|Methylphenidate|methylphenidate|mesh-list
111285989|NCT05600881|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111285990|NCT05600881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111285991|NCT05600881|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111285992|NCT05600881|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111285993|NCT05600881|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111285994|NCT05600881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111010534|NCT02493933|Acetylcysteine|acetylcysteine|mesh-list
111285995|NCT05600881|Dopamine Agents|dopamine agents|mesh-ancestor
111285996|NCT05600881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111285997|NCT01926769|Metformin|metformin|mesh-list
111285998|NCT01926769|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111285999|NCT01926769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111286000|NCT04394143|Mannitol|mannitol|mesh-list
111286001|NCT04394143|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
111286002|NCT04394143|Diuretics|diuretics|mesh-ancestor
111286003|NCT04394143|Natriuretic Agents|natriuretic agents|mesh-ancestor
111286004|NCT04394143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111286005|NCT00639509|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111286006|NCT00639509|Immunologic Factors|immunologic factors|mesh-ancestor
111286007|NCT00639509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111286008|NCT01926847|Riociguat|riociguat|mesh-list
111286009|NCT01926847|Enzyme Activators|enzyme activators|mesh-ancestor
111286010|NCT01926847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111286011|NCT05586815|Minocycline|minocycline|mesh-list
111286012|NCT05586815|Colistin|colistin|mesh-list
111286013|NCT05586815|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111286014|NCT05586815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111286015|NCT05607901|Hydrocortisone|hydrocortisone|mesh-list
111286016|NCT05607901|Tacrolimus|tacrolimus|mesh-list
111286017|NCT05607901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111286018|NCT05607901|Immunologic Factors|immunologic factors|mesh-ancestor
111286019|NCT05607901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111286020|NCT05607901|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111286021|NCT05607901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111286022|NCT05607901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111286023|NCT05607901|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111286024|NCT03133325|Lidocaine|lidocaine|mesh-list
111286025|NCT03133325|Anesthetics, Local|anesthetics, local|mesh-ancestor
111286026|NCT03133325|Anesthetics|anesthetics|mesh-ancestor
111286027|NCT03133325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111286028|NCT03133325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111286029|NCT03133325|Sensory System Agents|sensory system agents|mesh-ancestor
111286030|NCT03133325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111286031|NCT03133325|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111286032|NCT03133325|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111286033|NCT03133325|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111286034|NCT03133325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111286035|NCT03133325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111286036|NCT00638963|Temozolomide|temozolomide|mesh-list
111286037|NCT00638963|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111286038|NCT00638963|Alkylating Agents|alkylating agents|mesh-ancestor
111286039|NCT00638963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111286040|NCT00638963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111286041|NCT04278677|Melatonin|melatonin|mesh-list
111286042|NCT04278677|Antioxidants|antioxidants|mesh-ancestor
111286043|NCT04278677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111286044|NCT04278677|Protective Agents|protective agents|mesh-ancestor
111286045|NCT04278677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111286046|NCT04278677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111286047|NCT00638027|Memantine|memantine|mesh-list
111286048|NCT00638027|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111286049|NCT00638027|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111286050|NCT00638027|Dopamine Agents|dopamine agents|mesh-ancestor
111286051|NCT00638027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111286052|NCT00638027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111286053|NCT00638027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111286054|NCT00638027|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111286055|NCT00638027|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111286056|NCT03342911|Paclitaxel|paclitaxel|mesh-list
111286057|NCT03342911|Carboplatin|carboplatin|mesh-list
111286058|NCT03342911|Nivolumab|nivolumab|mesh-list
111286059|NCT03342911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111286060|NCT03342911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111286061|NCT03342911|Tubulin Modulators|tubulin modulators|mesh-ancestor
111286062|NCT03342911|Antimitotic Agents|antimitotic agents|mesh-ancestor
111286063|NCT03342911|Mitosis Modulators|mitosis modulators|mesh-ancestor
111286064|NCT03342911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111286065|NCT03342911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111286066|NCT03342911|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111286067|NCT05607199|Calcium|calcium|mesh-list
111286068|NCT05607199|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111286069|NCT05607199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111286070|NCT01927315|Fenofibrate|fenofibrate|mesh-list
111286071|NCT01927315|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111286072|NCT01927315|Antimetabolites|antimetabolites|mesh-ancestor
111286073|NCT01927315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111286074|NCT01927315|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111286075|NCT00636155|Cyclophosphamide|cyclophosphamide|mesh-list
111286076|NCT00636155|Rituximab|rituximab|mesh-list
111286077|NCT00636155|Fludarabine|fludarabine|mesh-list
111286078|NCT00636155|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111286079|NCT00636155|Immunologic Factors|immunologic factors|mesh-ancestor
111286080|NCT00636155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111286081|NCT00636155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111286082|NCT00636155|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111286083|NCT00636155|Alkylating Agents|alkylating agents|mesh-ancestor
111286084|NCT00636155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111286085|NCT00636155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111286086|NCT00636155|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111286087|NCT00636155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111286088|NCT00634907|Warfarin|warfarin|mesh-list
111286089|NCT00634907|Anticoagulants|anticoagulants|mesh-ancestor
111286090|NCT04124497|Dexamethasone|dexamethasone|mesh-list
111286091|NCT04124497|Daratumumab|daratumumab|mesh-list
111286092|NCT04124497|Pomalidomide|pomalidomide|mesh-list
111286093|NCT04124497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111286094|NCT04124497|Antiemetics|antiemetics|mesh-ancestor
111286095|NCT04124497|Autonomic Agents|autonomic agents|mesh-ancestor
111286096|NCT04124497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111286097|NCT04124497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111286098|NCT04124497|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111286099|NCT04124497|Glucocorticoids|glucocorticoids|mesh-ancestor
111286100|NCT04124497|Hormones|hormones|mesh-ancestor
111286101|NCT04124497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111286102|NCT04124497|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111286103|NCT04124497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111286104|NCT04124497|Immunologic Factors|immunologic factors|mesh-ancestor
111286105|NCT04124497|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111286106|NCT04124497|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111286107|NCT04124497|Growth Substances|growth substances|mesh-ancestor
111286108|NCT04124497|Growth Inhibitors|growth inhibitors|mesh-ancestor
111286109|NCT04127851|Cyclosporine|cyclosporine|mesh-list
111286110|NCT04127851|Cyclosporins|cyclosporins|mesh-list
111286111|NCT04127851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111286112|NCT04127851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111286113|NCT04127851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111286114|NCT04127851|Immunologic Factors|immunologic factors|mesh-ancestor
111286115|NCT04127851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111286116|NCT04127851|Antifungal Agents|antifungal agents|mesh-ancestor
111286117|NCT04127851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111286118|NCT04127851|Dermatologic Agents|dermatologic agents|mesh-ancestor
111286119|NCT04127851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111286120|NCT04127851|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111286121|NCT04394533|Bupivacaine|bupivacaine|mesh-list
111286122|NCT04394533|Prilocaine|prilocaine|mesh-list
111286123|NCT04394533|Anesthetics, Local|anesthetics, local|mesh-ancestor
111286124|NCT04394533|Anesthetics|anesthetics|mesh-ancestor
111286125|NCT04394533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111286126|NCT04394533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111286127|NCT04394533|Sensory System Agents|sensory system agents|mesh-ancestor
111286128|NCT04394533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111286129|NCT05602129|Heparin|heparin|mesh-list
111286130|NCT05602129|Calcium heparin|calcium heparin|mesh-list
111286131|NCT05602129|Anticoagulants|anticoagulants|mesh-ancestor
111286132|NCT05602129|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111286133|NCT05602129|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111286134|NCT05602129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111286135|NCT01928563|Udenafil|udenafil|mesh-list
111286136|NCT01928563|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111286137|NCT01928563|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111286138|NCT01928563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111286139|NCT01928563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111286140|NCT04129255|Octreotide|octreotide|mesh-list
111286141|NCT04129255|Somatostatin|somatostatin|mesh-list
111286142|NCT04129255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111286143|NCT04129255|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111010682|NCT04496037|Immunologic Factors|immunologic factors|mesh-ancestor
111286144|NCT04129255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111286145|NCT04129255|Hormones|hormones|mesh-ancestor
111286146|NCT04129255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111286147|NCT04129255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111286149|NCT03422731|Antiviral Agents|antiviral agents|mesh-ancestor
111286150|NCT03422731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111286151|NCT04129489|Cannabidiol|cannabidiol|mesh-list
111286152|NCT04129489|Anticonvulsants|anticonvulsants|mesh-ancestor
111286153|NCT04128787|Omeprazole|omeprazole|mesh-list
111286154|NCT04128787|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111286155|NCT04128787|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111286156|NCT04128787|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111286157|NCT04128787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111286158|NCT04128787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111286159|NCT04394377|Heparin|heparin|mesh-list
111286160|NCT04394377|Enoxaparin|enoxaparin|mesh-list
111286161|NCT04394377|Calcium heparin|calcium heparin|mesh-list
111286162|NCT04394377|Rivaroxaban|rivaroxaban|mesh-list
111286163|NCT04394377|Enoxaparin sodium|enoxaparin sodium|mesh-list
111286164|NCT04394377|Anticoagulants|anticoagulants|mesh-ancestor
111286165|NCT04394377|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111286166|NCT04394377|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111286167|NCT04394377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111286168|NCT04394377|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111286169|NCT04394377|Antithrombins|antithrombins|mesh-ancestor
111286170|NCT04394377|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111286171|NCT04394377|Protease Inhibitors|protease inhibitors|mesh-ancestor
111286172|NCT04394377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111286173|NCT02984293|Atorvastatin|atorvastatin|mesh-list
111286174|NCT02984293|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111286175|NCT02984293|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111286176|NCT02984293|Antimetabolites|antimetabolites|mesh-ancestor
111286177|NCT02984293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111286178|NCT02984293|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111286179|NCT02984293|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111286180|NCT02984293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111286181|NCT01929187|Amorolfine|amorolfine|mesh-list
111286182|NCT01929187|Antifungal Agents|antifungal agents|mesh-ancestor
111286183|NCT01929187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111286184|NCT00634751|Capecitabine|capecitabine|mesh-list
111286185|NCT00634751|Oxaliplatin|oxaliplatin|mesh-list
111286186|NCT00634751|Sorafenib|sorafenib|mesh-list
111286187|NCT00634751|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111286188|NCT00634751|Antimetabolites|antimetabolites|mesh-ancestor
111286189|NCT00634751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111286190|NCT00634751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111286191|NCT00634751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111286192|NCT00634751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111286193|NCT04396223|Methotrexate|methotrexate|mesh-list
111286194|NCT04396223|Avelumab|avelumab|mesh-list
111286195|NCT04396223|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111286196|NCT04396223|Abortifacient Agents|abortifacient agents|mesh-ancestor
111286197|NCT04396223|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111286198|NCT04396223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111286199|NCT04396223|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111286200|NCT04396223|Antimetabolites|antimetabolites|mesh-ancestor
111286201|NCT04396223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111286202|NCT04396223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111286203|NCT04396223|Dermatologic Agents|dermatologic agents|mesh-ancestor
111286204|NCT04396223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111286205|NCT04396223|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111286206|NCT04396223|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111286207|NCT04396223|Immunologic Factors|immunologic factors|mesh-ancestor
111286208|NCT04396223|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111286209|NCT04396223|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111286210|NCT04396223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111286211|NCT04396067|Tretinoin|tretinoin|mesh-list
111286212|NCT04396067|Isotretinoin|isotretinoin|mesh-list
111286213|NCT04396067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111286214|NCT04396067|Keratolytic Agents|keratolytic agents|mesh-ancestor
111286215|NCT04396067|Dermatologic Agents|dermatologic agents|mesh-ancestor
111286216|NCT05608213|Lenvatinib|lenvatinib|mesh-list
111286217|NCT05608213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111286218|NCT05608213|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111286219|NCT05608213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111010758|NCT03336801|Propofol|propofol|mesh-list
111286220|NCT05608213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111286221|NCT04124107|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
111286222|NCT04124107|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111286223|NCT04124107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111286224|NCT03015259|Budesonide|budesonide|mesh-list
111286225|NCT03015259|Formoterol Fumarate|formoterol fumarate|mesh-list
111286226|NCT03015259|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
111286227|NCT03015259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111286228|NCT03015259|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111286229|NCT03015259|Autonomic Agents|autonomic agents|mesh-ancestor
111286230|NCT03015259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111286231|NCT03015259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111286232|NCT03015259|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111286233|NCT03015259|Respiratory System Agents|respiratory system agents|mesh-ancestor
111286234|NCT03015259|Glucocorticoids|glucocorticoids|mesh-ancestor
111286235|NCT03015259|Hormones|hormones|mesh-ancestor
111286236|NCT03015259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111286237|NCT03015259|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111286238|NCT03015259|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111286239|NCT03015259|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111286240|NCT03015259|Adrenergic Agents|adrenergic agents|mesh-ancestor
111286241|NCT03015259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111286242|NCT03015259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111286243|NCT03236545|Estradiol|estradiol|mesh-list
111286244|NCT03236545|Estrogens|estrogens|mesh-list
111286245|NCT03236545|Hormones|hormones|mesh-ancestor
111286246|NCT03236545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111286247|NCT03236545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111286248|NCT04126993|Apatinib|apatinib|mesh-list
111286249|NCT04126993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111286250|NCT04126993|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111286251|NCT04126993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111286252|NCT04126993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111286253|NCT04274803|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
111286254|NCT04274803|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
111286255|NCT04274803|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
111286256|NCT04274803|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111286257|NCT03292861|Mycophenolic Acid|mycophenolic acid|mesh-list
111286258|NCT03292861|Sirolimus|sirolimus|mesh-list
111286259|NCT03292861|Tacrolimus|tacrolimus|mesh-list
111286260|NCT03292861|Thymoglobulin|thymoglobulin|mesh-list
111286261|NCT03292861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111286262|NCT03292861|Immunologic Factors|immunologic factors|mesh-ancestor
111286263|NCT03292861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111286264|NCT03292861|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111286265|NCT03292861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111286266|NCT03292861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111286267|NCT03292861|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111286268|NCT03292861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111286269|NCT03292861|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111286270|NCT03292861|Antitubercular Agents|antitubercular agents|mesh-ancestor
111286271|NCT03292861|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111286272|NCT03292861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111286273|NCT03292861|Antifungal Agents|antifungal agents|mesh-ancestor
111286274|NCT03828175|Anesthetics|anesthetics|mesh-list
111286275|NCT03828175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111286276|NCT03828175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111286277|NCT04392973|Hydroxychloroquine|hydroxychloroquine|mesh-list
111286278|NCT04392973|Favipiravir|favipiravir|mesh-list
111286279|NCT04392973|Antimalarials|antimalarials|mesh-ancestor
111286280|NCT04392973|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111286281|NCT04392973|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111286282|NCT04392973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111286283|NCT04392973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111286284|NCT04392973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111286285|NCT04392973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111286286|NCT04392973|Antiviral Agents|antiviral agents|mesh-ancestor
111286287|NCT03267277|Sodium thiosulfate|sodium thiosulfate|mesh-list
111286288|NCT03267277|Antidotes|antidotes|mesh-ancestor
111286289|NCT03267277|Protective Agents|protective agents|mesh-ancestor
111286290|NCT03267277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111286291|NCT03267277|Antioxidants|antioxidants|mesh-ancestor
111286292|NCT03267277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111286293|NCT03267277|Antitubercular Agents|antitubercular agents|mesh-ancestor
111286294|NCT03267277|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111010831|NCT03329547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111286295|NCT03267277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111286296|NCT03267277|Chelating Agents|chelating agents|mesh-ancestor
111286297|NCT03267277|Sequestering Agents|sequestering agents|mesh-ancestor
111286298|NCT00634049|Isavuconazole|isavuconazole|mesh-list
111286299|NCT00634049|Antifungal Agents|antifungal agents|mesh-ancestor
111286300|NCT00634049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111286301|NCT04123249|Propofol|propofol|mesh-list
111286302|NCT04123249|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
111286303|NCT04123249|Anesthetics|anesthetics|mesh-list
111286304|NCT04123249|Sevoflurane|sevoflurane|mesh-list
111286305|NCT04123249|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111286306|NCT04123249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111286307|NCT04123249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111286308|NCT04123249|Anesthetics, General|anesthetics, general|mesh-ancestor
111286309|NCT04123249|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111286310|NCT04123249|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111286311|NCT03336203|Allopurinol|allopurinol|mesh-list
111286312|NCT03336203|Febuxostat|febuxostat|mesh-list
111286313|NCT03336203|Antimetabolites|antimetabolites|mesh-ancestor
111286314|NCT03336203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111286315|NCT03336203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111286316|NCT03336203|Gout Suppressants|gout suppressants|mesh-ancestor
111286317|NCT03336203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111286318|NCT03336203|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111286319|NCT03336203|Antioxidants|antioxidants|mesh-ancestor
111286320|NCT03336203|Protective Agents|protective agents|mesh-ancestor
111286321|NCT03336203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111286322|NCT04274413|Adrenergic Agents|adrenergic agents|mesh-list
111286323|NCT04274413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111286324|NCT04274413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111286325|NCT04274413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111286326|NCT04274257|Rituximab|rituximab|mesh-list
111286327|NCT04274257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111286328|NCT04274257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111286329|NCT04274257|Immunologic Factors|immunologic factors|mesh-ancestor
111286330|NCT04274257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111286331|NCT04274257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111286332|NCT03831815|Rocuronium|rocuronium|mesh-list
111286333|NCT03831815|Cisatracurium|cisatracurium|mesh-list
111286334|NCT03831815|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
111286335|NCT03831815|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
111286336|NCT03831815|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111286337|NCT03831815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111286338|NCT03831815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111286339|NCT00632099|Progesterone|progesterone|mesh-list
111286340|NCT00632099|Progestins|progestins|mesh-ancestor
111286341|NCT00632099|Hormones|hormones|mesh-ancestor
111286342|NCT00632099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111286343|NCT00632099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111286344|NCT03827629|Naloxone|naloxone|mesh-list
111286345|NCT03827629|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111286346|NCT03827629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111286347|NCT03827629|Sensory System Agents|sensory system agents|mesh-ancestor
111286348|NCT03827629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111286349|NCT00631475|Bosentan|bosentan|mesh-list
111286350|NCT00631475|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111286351|NCT00631475|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
111286352|NCT00631475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111286353|NCT03826615|Gabapentin|gabapentin|mesh-list
111286354|NCT03826615|Analgesics|analgesics|mesh-ancestor
111286355|NCT03826615|Sensory System Agents|sensory system agents|mesh-ancestor
111286356|NCT03826615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111286357|NCT03826615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111286358|NCT03826615|Anticonvulsants|anticonvulsants|mesh-ancestor
111286359|NCT03826615|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111286360|NCT03826615|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111286361|NCT03826615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111286362|NCT03826615|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111286363|NCT03826615|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111286364|NCT03826615|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111286365|NCT03826615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111286366|NCT03826615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111286367|NCT03826615|Antimanic Agents|antimanic agents|mesh-ancestor
111286368|NCT04124887|Calcium, Dietary|calcium, dietary|mesh-list
111286369|NCT04124887|Listerine|listerine|mesh-list
111010912|NCT05112692|Triptorelin Pamoate|triptorelin pamoate|mesh-list
111286370|NCT04124887|Calcium|calcium|mesh-list
111286371|NCT04124887|Fluorides|fluorides|mesh-list
111286372|NCT04124887|Sodium Fluoride|sodium fluoride|mesh-list
111286373|NCT04124887|Caseins|caseins|mesh-list
111286374|NCT04124887|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111286375|NCT04124887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111286376|NCT04124887|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111286377|NCT04124887|Cariostatic Agents|cariostatic agents|mesh-ancestor
111286378|NCT04124887|Protective Agents|protective agents|mesh-ancestor
111286379|NCT04124887|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111286380|NCT04124887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111286381|NCT04124887|Chelating Agents|chelating agents|mesh-ancestor
111286382|NCT04124887|Sequestering Agents|sequestering agents|mesh-ancestor
111286383|NCT04124887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111286384|NCT04121767|Warfarin|warfarin|mesh-list
111286385|NCT04121767|Edoxaban|edoxaban|mesh-list
111286386|NCT04121767|Anticoagulants|anticoagulants|mesh-ancestor
111286387|NCT04121767|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111286388|NCT04121767|Antithrombins|antithrombins|mesh-ancestor
111286389|NCT04121767|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111286390|NCT04121767|Protease Inhibitors|protease inhibitors|mesh-ancestor
111286391|NCT04121767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111286392|NCT04121767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111286393|NCT04121689|Caseins|caseins|mesh-list
111286394|NCT04121689|Chelating Agents|chelating agents|mesh-ancestor
111286395|NCT04121689|Sequestering Agents|sequestering agents|mesh-ancestor
111286396|NCT04121689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111286397|NCT03830827|Vortioxetine|vortioxetine|mesh-list
111286398|NCT03830827|Antidepressive Agents|antidepressive agents|mesh-ancestor
111286399|NCT03830827|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111286400|NCT03830827|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111286401|NCT03830827|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111286402|NCT03830827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111286403|NCT03830827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111286404|NCT03830827|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111286405|NCT03830827|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111286406|NCT03830827|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111286407|NCT03830827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111286408|NCT03830827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111286409|NCT03830827|Serotonin Agents|serotonin agents|mesh-ancestor
111286410|NCT03830827|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111286411|NCT03830827|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111286412|NCT03830827|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111286413|NCT03830827|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111286414|NCT03098563|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
111286415|NCT03098563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111286416|NCT03098485|Azithromycin|azithromycin|mesh-list
111286417|NCT03098485|Levofloxacin|levofloxacin|mesh-list
111286418|NCT03098485|Cefpodoxime|cefpodoxime|mesh-list
111286419|NCT03098485|Cefpodoxime proxetil|cefpodoxime proxetil|mesh-list
111286420|NCT03098485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111286421|NCT03098485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111286422|NCT03098485|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111286423|NCT03098485|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111286424|NCT03098485|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111286425|NCT03098485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111286426|NCT03098485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111286427|NCT03098485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111286428|NCT03098485|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111286429|NCT03098485|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111286430|NCT04121533|Vitamin D|vitamin d|mesh-list
111286431|NCT04121533|Cholecalciferol|cholecalciferol|mesh-list
111286432|NCT04121533|Vitamins|vitamins|mesh-ancestor
111286433|NCT04121533|Micronutrients|micronutrients|mesh-ancestor
111286434|NCT04121533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111286435|NCT04121533|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111286436|NCT04121533|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111286437|NCT03822169|Choline|choline|mesh-list
111286438|NCT03822169|Lipotropic Agents|lipotropic agents|mesh-ancestor
111286439|NCT03822169|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111286440|NCT03822169|Antimetabolites|antimetabolites|mesh-ancestor
111286441|NCT03822169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111286442|NCT03822169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111286443|NCT03822169|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111286444|NCT03822169|Nootropic Agents|nootropic agents|mesh-ancestor
111286445|NCT03825601|Flumazenil|flumazenil|mesh-list
111286446|NCT03825601|Antidotes|antidotes|mesh-ancestor
111286447|NCT03825601|Protective Agents|protective agents|mesh-ancestor
111286448|NCT03825601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111286449|NCT03825601|GABA Modulators|gaba modulators|mesh-ancestor
111286450|NCT03825601|GABA Agents|gaba agents|mesh-ancestor
111286451|NCT03825601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111286452|NCT03825601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111286453|NCT03821701|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
111286454|NCT03821701|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111286455|NCT03821701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111286456|NCT03825445|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
111286457|NCT03825445|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111286458|NCT03825445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111286459|NCT03064867|Rituximab|rituximab|mesh-list
111286460|NCT03064867|Carboplatin|carboplatin|mesh-list
111286461|NCT03064867|Etoposide|etoposide|mesh-list
111286462|NCT03064867|Venetoclax|venetoclax|mesh-list
111286463|NCT03064867|Ifosfamide|ifosfamide|mesh-list
111286464|NCT03064867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111286465|NCT03064867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111286466|NCT03064867|Immunologic Factors|immunologic factors|mesh-ancestor
111286467|NCT03064867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111286468|NCT03064867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111286469|NCT03064867|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111286470|NCT03064867|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111286471|NCT03064867|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111286472|NCT03064867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111286473|NCT03064867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111286474|NCT03064867|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111286475|NCT03064867|Alkylating Agents|alkylating agents|mesh-ancestor
111286476|NCT03824743|Plasma-lyte 148|plasma-lyte 148|mesh-list
111286477|NCT03824743|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
111286478|NCT03824743|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111286479|NCT03824665|Fentanyl|fentanyl|mesh-list
111286480|NCT03824665|Nalbuphine|nalbuphine|mesh-list
111286481|NCT03824665|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111286482|NCT03824665|Narcotics|narcotics|mesh-ancestor
111286483|NCT03824665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111286484|NCT03824665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111286485|NCT03824665|Analgesics|analgesics|mesh-ancestor
111286486|NCT03824665|Sensory System Agents|sensory system agents|mesh-ancestor
111286487|NCT03824665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111286488|NCT03824665|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111286489|NCT03824665|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111286490|NCT03824665|Anesthetics, General|anesthetics, general|mesh-ancestor
111286491|NCT03824665|Anesthetics|anesthetics|mesh-ancestor
111286492|NCT04120831|Abatacept|abatacept|mesh-list
111286493|NCT04120831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111286494|NCT04120831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111286495|NCT04120831|Immunologic Factors|immunologic factors|mesh-ancestor
111286496|NCT04120831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111286497|NCT04120831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111286498|NCT04120831|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111286499|NCT04120831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111286500|NCT04120831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111286501|NCT00631163|Deferasirox|deferasirox|mesh-list
111286502|NCT00631163|Iron Chelating Agents|iron chelating agents|mesh-ancestor
111286503|NCT00631163|Chelating Agents|chelating agents|mesh-ancestor
111286504|NCT00631163|Sequestering Agents|sequestering agents|mesh-ancestor
111286505|NCT00631163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111286506|NCT04120519|Thalidomide|thalidomide|mesh-list
111286507|NCT04120519|Dexamethasone|dexamethasone|mesh-list
111286508|NCT04120519|Cyclophosphamide|cyclophosphamide|mesh-list
111286509|NCT04120519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111286510|NCT04120519|Immunologic Factors|immunologic factors|mesh-ancestor
111286511|NCT04120519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111286512|NCT04120519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111286513|NCT04120519|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111286514|NCT04120519|Alkylating Agents|alkylating agents|mesh-ancestor
111286515|NCT04120519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111286516|NCT04120519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111286517|NCT04120519|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111011059|NCT04493229|Oxytocics|oxytocics|mesh-ancestor
111286518|NCT04120519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111286519|NCT04120519|Antiemetics|antiemetics|mesh-ancestor
111286520|NCT04120519|Autonomic Agents|autonomic agents|mesh-ancestor
111286521|NCT04120519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111286522|NCT04120519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111286523|NCT04120519|Glucocorticoids|glucocorticoids|mesh-ancestor
111286524|NCT04120519|Hormones|hormones|mesh-ancestor
111286525|NCT04120519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111286526|NCT04120519|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111286527|NCT04120519|Leprostatic Agents|leprostatic agents|mesh-ancestor
111286528|NCT04120519|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111286529|NCT04120519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111286530|NCT04120519|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111286531|NCT04120519|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111286532|NCT04120519|Growth Substances|growth substances|mesh-ancestor
111286533|NCT04120519|Growth Inhibitors|growth inhibitors|mesh-ancestor
111286534|NCT00631007|Pioglitazone|pioglitazone|mesh-list
111286535|NCT00631007|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111286536|NCT00631007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111286537|NCT03014167|Albendazole|albendazole|mesh-list
111286538|NCT03014167|Anthelmintics|anthelmintics|mesh-ancestor
111286539|NCT03014167|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111286540|NCT03014167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111286541|NCT03014167|Anticestodal Agents|anticestodal agents|mesh-ancestor
111286542|NCT03014167|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
111286543|NCT03014167|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111286544|NCT03014167|Tubulin Modulators|tubulin modulators|mesh-ancestor
111286545|NCT03014167|Antimitotic Agents|antimitotic agents|mesh-ancestor
111286546|NCT03014167|Mitosis Modulators|mitosis modulators|mesh-ancestor
111286547|NCT03014167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111286548|NCT03014167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111286549|NCT00630539|Tamoxifen|tamoxifen|mesh-list
111286550|NCT00630539|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111286551|NCT00630539|Hormone Antagonists|hormone antagonists|mesh-ancestor
111286552|NCT00630539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111286553|NCT00630539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111286554|NCT00630539|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111286555|NCT00630539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111286556|NCT00630539|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111286557|NCT00630539|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111286558|NCT00630539|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111286559|NCT00634829|Albuterol|albuterol|mesh-list
111286560|NCT00634829|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111286561|NCT00634829|Autonomic Agents|autonomic agents|mesh-ancestor
111286562|NCT00634829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111286563|NCT00634829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111286564|NCT00634829|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111286565|NCT00634829|Respiratory System Agents|respiratory system agents|mesh-ancestor
111286566|NCT00634829|Tocolytic Agents|tocolytic agents|mesh-ancestor
111286567|NCT00634829|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111286568|NCT00634829|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111286569|NCT00634829|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111286570|NCT00634829|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111286571|NCT00634829|Adrenergic Agents|adrenergic agents|mesh-ancestor
111286572|NCT00634829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111286573|NCT00634829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111286574|NCT00634517|Albuterol|albuterol|mesh-list
111286575|NCT00634517|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111286576|NCT00634517|Autonomic Agents|autonomic agents|mesh-ancestor
111286577|NCT00634517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111286578|NCT00634517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111286579|NCT00634517|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111286580|NCT00634517|Respiratory System Agents|respiratory system agents|mesh-ancestor
111286581|NCT00634517|Tocolytic Agents|tocolytic agents|mesh-ancestor
111286582|NCT00634517|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111286583|NCT00634517|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111286584|NCT00634517|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111286585|NCT00634517|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111286586|NCT00634517|Adrenergic Agents|adrenergic agents|mesh-ancestor
111286587|NCT00634517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111286588|NCT00634517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111286589|NCT01920113|Dexmedetomidine|dexmedetomidine|mesh-list
111286590|NCT01920113|Remifentanil|remifentanil|mesh-list
111286591|NCT01920113|Propofol|propofol|mesh-list
111286592|NCT01920113|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111286593|NCT01920113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111286594|NCT01920113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111286595|NCT01920113|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111286596|NCT01920113|Analgesics|analgesics|mesh-ancestor
111286597|NCT01920113|Sensory System Agents|sensory system agents|mesh-ancestor
111286598|NCT01920113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111286599|NCT01920113|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111286600|NCT01920113|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111286601|NCT01920113|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111286602|NCT01920113|Adrenergic Agents|adrenergic agents|mesh-ancestor
111286603|NCT01920113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111286604|NCT01920113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111286605|NCT01920113|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111286606|NCT01920113|Anesthetics, General|anesthetics, general|mesh-ancestor
111286607|NCT01920113|Anesthetics|anesthetics|mesh-ancestor
111286608|NCT01920113|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111286609|NCT01920113|Narcotics|narcotics|mesh-ancestor
111286610|NCT01920191|Poly ICLC|poly iclc|mesh-list
111286611|NCT01920191|Interferon Inducers|interferon inducers|mesh-ancestor
111286612|NCT01920191|Immunologic Factors|immunologic factors|mesh-ancestor
111286613|NCT01920191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111286614|NCT01920269|Mitomycins|mitomycins|mesh-list
111286615|NCT01920269|Mitomycin|mitomycin|mesh-list
111286616|NCT01920269|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111286617|NCT01920269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111286618|NCT01920269|Alkylating Agents|alkylating agents|mesh-ancestor
111286619|NCT01920269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111286620|NCT01920269|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111286621|NCT01920269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111286622|NCT02921893|Dexamethasone|dexamethasone|mesh-list
111286623|NCT02921893|Dexamethasone acetate|dexamethasone acetate|mesh-list
111286624|NCT02921893|Lenalidomide|lenalidomide|mesh-list
111286625|NCT02921893|Ixazomib|ixazomib|mesh-list
111286626|NCT02921893|Ichthammol|ichthammol|mesh-list
111286627|NCT02921893|BB 1101|bb 1101|mesh-list
111286628|NCT02921893|Glycine|glycine|mesh-list
111286629|NCT02921893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111286630|NCT02921893|Antiemetics|antiemetics|mesh-ancestor
111286631|NCT02921893|Autonomic Agents|autonomic agents|mesh-ancestor
111286632|NCT02921893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111286633|NCT02921893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111286634|NCT02921893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111286635|NCT02921893|Glucocorticoids|glucocorticoids|mesh-ancestor
111286636|NCT02921893|Hormones|hormones|mesh-ancestor
111286637|NCT02921893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111286638|NCT02921893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111286639|NCT02921893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111286640|NCT02921893|Protease Inhibitors|protease inhibitors|mesh-ancestor
111286641|NCT02921893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111286642|NCT02921893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111286643|NCT02921893|Immunologic Factors|immunologic factors|mesh-ancestor
111286644|NCT02921893|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111286645|NCT02921893|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111286646|NCT02921893|Growth Substances|growth substances|mesh-ancestor
111286647|NCT02921893|Growth Inhibitors|growth inhibitors|mesh-ancestor
111286648|NCT02921893|Dermatologic Agents|dermatologic agents|mesh-ancestor
111286649|NCT02921893|Glycine Agents|glycine agents|mesh-ancestor
111286650|NCT02921893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111286651|NCT01920503|Doxorubicin|doxorubicin|mesh-list
111286652|NCT01920503|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111286653|NCT01920503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111286654|NCT01920503|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111286655|NCT01920503|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111286656|NCT01920503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111286657|NCT01920503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111286658|NCT01293825|Ziprasidone|ziprasidone|mesh-list
111286659|NCT01293825|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111286660|NCT01293825|Serotonin Agents|serotonin agents|mesh-ancestor
111286661|NCT01293825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111286662|NCT01293825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111286663|NCT01293825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111286664|NCT01293825|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111286665|NCT01293825|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111286666|NCT01293825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111286667|NCT01293825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111286668|NCT01293825|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111286669|NCT01293825|Dopamine Agents|dopamine agents|mesh-ancestor
111011209|NCT03109119|Anesthetics|anesthetics|mesh-ancestor
111286670|NCT03009513|Glimepiride|glimepiride|mesh-list
111286671|NCT03009513|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111286672|NCT03009513|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111286673|NCT03009513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111286674|NCT03009513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111286675|NCT03009513|Immunologic Factors|immunologic factors|mesh-ancestor
111286676|NCT02983591|Misoprostol|misoprostol|mesh-list
111286677|NCT02983591|Oxytocin|oxytocin|mesh-list
111286678|NCT02983591|Oxytocics|oxytocics|mesh-ancestor
111286679|NCT02983591|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111286680|NCT02983591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111286681|NCT02983591|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111286682|NCT02983591|Abortifacient Agents|abortifacient agents|mesh-ancestor
111286683|NCT02983591|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111286684|NCT02983591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111286685|NCT03829891|Insulin Glargine|insulin glargine|mesh-list
111286686|NCT03829891|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111286687|NCT03829891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111286688|NCT03115151|Fentanyl|fentanyl|mesh-list
111286689|NCT03115151|Hydromorphone|hydromorphone|mesh-list
111286690|NCT03115151|Bupivacaine|bupivacaine|mesh-list
111286691|NCT03115151|Anesthetics, Local|anesthetics, local|mesh-ancestor
111286692|NCT03115151|Anesthetics|anesthetics|mesh-ancestor
111286693|NCT03115151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111286694|NCT03115151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111286695|NCT03115151|Sensory System Agents|sensory system agents|mesh-ancestor
111286696|NCT03115151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111286697|NCT03115151|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111286698|NCT03115151|Narcotics|narcotics|mesh-ancestor
111286699|NCT03115151|Analgesics|analgesics|mesh-ancestor
111286700|NCT03115151|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111286701|NCT03115151|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111286702|NCT03115151|Anesthetics, General|anesthetics, general|mesh-ancestor
111286703|NCT01263717|Hormones|hormones|mesh-list
111286704|NCT01263717|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
111286705|NCT01263717|Tesamorelin|tesamorelin|mesh-list
111286706|NCT01263717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111286707|NCT01263717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111286708|NCT01263717|Growth Substances|growth substances|mesh-ancestor
111286709|NCT04120753|Amlodipine|amlodipine|mesh-list
111286710|NCT04120753|Olmesartan|olmesartan|mesh-list
111286711|NCT04120753|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111286712|NCT04120753|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111286713|NCT04120753|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111286714|NCT04120753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111286715|NCT04120753|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111286716|NCT04120753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111286717|NCT04120753|Vasodilator Agents|vasodilator agents|mesh-ancestor
111286718|NCT04120753|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111286719|NCT04120753|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111286720|NCT01921361|Dexmedetomidine|dexmedetomidine|mesh-list
111286721|NCT01921361|Levobupivacaine|levobupivacaine|mesh-list
111286722|NCT01921361|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111286723|NCT01921361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111286724|NCT01921361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111286725|NCT01921361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111286726|NCT01921361|Analgesics|analgesics|mesh-ancestor
111286727|NCT01921361|Sensory System Agents|sensory system agents|mesh-ancestor
111286728|NCT01921361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111286729|NCT01921361|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111286730|NCT01921361|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111286731|NCT01921361|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111286732|NCT01921361|Adrenergic Agents|adrenergic agents|mesh-ancestor
111286733|NCT01921361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111286734|NCT01921361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111286735|NCT01921361|Anesthetics, Local|anesthetics, local|mesh-ancestor
111286736|NCT01921361|Anesthetics|anesthetics|mesh-ancestor
111286737|NCT01921673|Docetaxel|docetaxel|mesh-list
111286738|NCT01921673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111286739|NCT01921673|Tubulin Modulators|tubulin modulators|mesh-ancestor
111286740|NCT01921673|Antimitotic Agents|antimitotic agents|mesh-ancestor
111286741|NCT01921673|Mitosis Modulators|mitosis modulators|mesh-ancestor
111286742|NCT01921673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111286743|NCT01921985|Terlipressin|terlipressin|mesh-list
111286744|NCT01921985|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111011285|NCT03333369|Levodopa|levodopa|mesh-list
111286745|NCT01921985|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111286747|NCT02943733|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111286748|NCT02943733|Alkylating Agents|alkylating agents|mesh-ancestor
111286749|NCT02943733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111286750|NCT02943733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111286751|NCT01922141|Amlodipine|amlodipine|mesh-list
111286752|NCT01922141|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
111286753|NCT01922141|Ramipril|ramipril|mesh-list
111286754|NCT01922141|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111286755|NCT01922141|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111286756|NCT01922141|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111286757|NCT01922141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111286758|NCT01922141|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111286759|NCT01922141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111286760|NCT01922141|Vasodilator Agents|vasodilator agents|mesh-ancestor
111286761|NCT01922141|Diuretics|diuretics|mesh-ancestor
111286762|NCT01922141|Natriuretic Agents|natriuretic agents|mesh-ancestor
111286763|NCT01922141|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
111286764|NCT01922141|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
111286765|NCT01922141|Protease Inhibitors|protease inhibitors|mesh-ancestor
111286766|NCT01922141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111286767|NCT03828019|Cyclosporine|cyclosporine|mesh-list
111286768|NCT03828019|Adalimumab|adalimumab|mesh-list
111286769|NCT03828019|Methotrexate|methotrexate|mesh-list
111286770|NCT03828019|Azathioprine|azathioprine|mesh-list
111286771|NCT03828019|Tacrolimus|tacrolimus|mesh-list
111286772|NCT03828019|Cyclosporins|cyclosporins|mesh-list
111286773|NCT03828019|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111286774|NCT03828019|Abortifacient Agents|abortifacient agents|mesh-ancestor
111286775|NCT03828019|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111286776|NCT03828019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111286777|NCT03828019|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111286778|NCT03828019|Antimetabolites|antimetabolites|mesh-ancestor
111286779|NCT03828019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111286780|NCT03828019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111286781|NCT03828019|Dermatologic Agents|dermatologic agents|mesh-ancestor
111286782|NCT03828019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111286783|NCT03828019|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111286784|NCT03828019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111286785|NCT03828019|Immunologic Factors|immunologic factors|mesh-ancestor
111286786|NCT03828019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111286787|NCT03828019|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111286788|NCT03828019|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111286789|NCT03828019|Antifungal Agents|antifungal agents|mesh-ancestor
111286790|NCT03828019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111286791|NCT03828019|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111286792|NCT03828019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111286793|NCT03111485|Levodopa|levodopa|mesh-list
111286794|NCT03111485|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
111286795|NCT03111485|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111286796|NCT03111485|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111286797|NCT03111485|Dopamine Agents|dopamine agents|mesh-ancestor
111286798|NCT03111485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111286799|NCT03111485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111286800|NCT03111485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111286801|NCT03111485|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111286802|NCT03111485|Immunologic Factors|immunologic factors|mesh-ancestor
111286803|NCT03111485|Dopamine Agonists|dopamine agonists|mesh-ancestor
111286804|NCT02856295|Enoxaparin|enoxaparin|mesh-list
111286805|NCT02856295|Anticoagulants|anticoagulants|mesh-ancestor
111286806|NCT02856295|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111286807|NCT02856295|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111286808|NCT02856295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111286809|NCT01266447|Topotecan|topotecan|mesh-list
111286810|NCT01266447|Veliparib|veliparib|mesh-list
111286811|NCT01266447|Lenograstim|lenograstim|mesh-list
111286812|NCT01266447|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111286813|NCT01266447|Immunologic Factors|immunologic factors|mesh-ancestor
111286814|NCT01266447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111286815|NCT01266447|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111286816|NCT01266447|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111286817|NCT01266447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111286818|NCT01266447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111286819|NCT01266447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111286820|NCT01266447|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111286821|NCT01922375|Naftopidil|naftopidil|mesh-list
111286822|NCT01922375|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111286823|NCT01922375|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111286824|NCT01922375|Adrenergic Agents|adrenergic agents|mesh-ancestor
111286825|NCT01922375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111286826|NCT01922375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111286827|NCT01922375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111286828|NCT01922375|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111286829|NCT01922375|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111286830|NCT01922375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111286831|NCT01922375|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111286832|NCT01922375|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111286833|NCT03823339|Liraglutide|liraglutide|mesh-list
111286834|NCT03823339|Xultophy|xultophy|mesh-list
111286835|NCT03823339|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111286836|NCT03823339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111286837|NCT03823339|Incretins|incretins|mesh-ancestor
111286838|NCT03823339|Hormones|hormones|mesh-ancestor
111286839|NCT03823339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111286840|NCT01922687|Amlodipine|amlodipine|mesh-list
111286841|NCT01922687|Atorvastatin|atorvastatin|mesh-list
111286842|NCT01922687|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111286843|NCT01922687|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111286844|NCT01922687|Antimetabolites|antimetabolites|mesh-ancestor
111286845|NCT01922687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111286846|NCT01922687|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111286847|NCT01922687|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111286848|NCT01922687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111286849|NCT01922687|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111286850|NCT01922687|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111286851|NCT01922687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111286852|NCT01922687|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111286853|NCT01922687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111286854|NCT01922687|Vasodilator Agents|vasodilator agents|mesh-ancestor
111286855|NCT01268553|Treprostinil|treprostinil|mesh-list
111286856|NCT01268553|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111286857|NCT01922999|Melatonin|melatonin|mesh-list
111286858|NCT01922999|Antioxidants|antioxidants|mesh-ancestor
111286859|NCT01922999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111286860|NCT01922999|Protective Agents|protective agents|mesh-ancestor
111286861|NCT01922999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111286862|NCT01922999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111286863|NCT01268943|Capecitabine|capecitabine|mesh-list
111286864|NCT01268943|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111286865|NCT01268943|Antimetabolites|antimetabolites|mesh-ancestor
111286866|NCT01268943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111286867|NCT01268943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111286868|NCT01923077|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111286869|NCT01923077|Simvastatin|simvastatin|mesh-list
111286870|NCT01923077|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111286871|NCT01923077|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111286872|NCT01923077|Antimetabolites|antimetabolites|mesh-ancestor
111286873|NCT01923077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111286874|NCT01923077|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111286875|NCT01923077|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111286876|NCT01923077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111286877|NCT01269801|Botulinum Toxins|botulinum toxins|mesh-list
111286878|NCT01269801|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111286879|NCT01269801|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111286880|NCT01269801|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111286881|NCT01269801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111286882|NCT01269801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111286883|NCT01269801|Cholinergic Agents|cholinergic agents|mesh-ancestor
111286884|NCT01269801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111286885|NCT01269801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111286886|NCT01269801|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111286887|NCT01269801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111286888|NCT01297335|Clonidine|clonidine|mesh-list
111286889|NCT01297335|Analgesics|analgesics|mesh-ancestor
111286890|NCT01297335|Sensory System Agents|sensory system agents|mesh-ancestor
111286891|NCT01297335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111011435|NCT03321825|Immunologic Factors|immunologic factors|mesh-ancestor
111286892|NCT01297335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111286893|NCT01297335|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111286894|NCT01297335|Sympatholytics|sympatholytics|mesh-ancestor
111286895|NCT01297335|Autonomic Agents|autonomic agents|mesh-ancestor
111286896|NCT01297335|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111286897|NCT01297335|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111286898|NCT01297335|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111286899|NCT01297335|Adrenergic Agents|adrenergic agents|mesh-ancestor
111286900|NCT01297335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111286901|NCT01297335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111286902|NCT05498129|Micronutrients|micronutrients|mesh-list
111286903|NCT05498129|Trace Elements|trace elements|mesh-list
111286904|NCT05498129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111286905|NCT01270659|Acetaminophen|acetaminophen|mesh-list
111286906|NCT01270659|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
111286907|NCT01270659|Fentanyl|fentanyl|mesh-list
111286908|NCT01270659|Oxycodone|oxycodone|mesh-list
111286909|NCT01270659|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111286910|NCT01270659|Narcotics|narcotics|mesh-ancestor
111286911|NCT01270659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111286912|NCT01270659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111286913|NCT01270659|Analgesics|analgesics|mesh-ancestor
111286914|NCT01270659|Sensory System Agents|sensory system agents|mesh-ancestor
111286915|NCT01270659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111286916|NCT01270659|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111286917|NCT01270659|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111286918|NCT01270659|Anesthetics, General|anesthetics, general|mesh-ancestor
111286919|NCT01270659|Anesthetics|anesthetics|mesh-ancestor
111286920|NCT01270659|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111286921|NCT01270659|Antipyretics|antipyretics|mesh-ancestor
111286922|NCT01270659|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111286923|NCT01270659|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111286924|NCT01270659|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111286925|NCT01271907|Aldesleukin|aldesleukin|mesh-list
111286926|NCT01271907|Cyclophosphamide|cyclophosphamide|mesh-list
111286927|NCT01271907|Fludarabine|fludarabine|mesh-list
111286928|NCT01271907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111286929|NCT01271907|Immunologic Factors|immunologic factors|mesh-ancestor
111286930|NCT01271907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111286931|NCT01271907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111286932|NCT01271907|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111286933|NCT01271907|Alkylating Agents|alkylating agents|mesh-ancestor
111286934|NCT01271907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111286935|NCT01271907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111286936|NCT01271907|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111286937|NCT01271907|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111286938|NCT01271907|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111286939|NCT01271907|Antiviral Agents|antiviral agents|mesh-ancestor
111286940|NCT01271907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111286941|NCT01929941|Paclitaxel|paclitaxel|mesh-list
111286942|NCT01929941|Gemcitabine|gemcitabine|mesh-list
111286943|NCT01929941|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111286944|NCT01929941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111286945|NCT01929941|Tubulin Modulators|tubulin modulators|mesh-ancestor
111286946|NCT01929941|Antimitotic Agents|antimitotic agents|mesh-ancestor
111286947|NCT01929941|Mitosis Modulators|mitosis modulators|mesh-ancestor
111286948|NCT01929941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111286949|NCT01929941|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111286950|NCT01929941|Antimetabolites|antimetabolites|mesh-ancestor
111286951|NCT01920737|Leucovorin|leucovorin|mesh-list
111286952|NCT01920737|Cytarabine|cytarabine|mesh-list
111286953|NCT01920737|Dexamethasone|dexamethasone|mesh-list
111286954|NCT01920737|Prednisone|prednisone|mesh-list
111286955|NCT01920737|Cyclophosphamide|cyclophosphamide|mesh-list
111286956|NCT01920737|Methotrexate|methotrexate|mesh-list
111286957|NCT01920737|Vincristine|vincristine|mesh-list
111286958|NCT01920737|Daunorubicin|daunorubicin|mesh-list
111286959|NCT01920737|Asparaginase|asparaginase|mesh-list
111286960|NCT01920737|Mercaptopurine|mercaptopurine|mesh-list
111286961|NCT01920737|Pegaspargase|pegaspargase|mesh-list
111286962|NCT01920737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111286963|NCT01920737|Immunologic Factors|immunologic factors|mesh-ancestor
111286964|NCT01920737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111286965|NCT01920737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111286966|NCT01920737|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111286967|NCT01920737|Alkylating Agents|alkylating agents|mesh-ancestor
111286968|NCT01920737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111286969|NCT01920737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111286970|NCT01920737|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111286971|NCT01920737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111286972|NCT01920737|Antiemetics|antiemetics|mesh-ancestor
111286973|NCT01920737|Autonomic Agents|autonomic agents|mesh-ancestor
111286974|NCT01920737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111286975|NCT01920737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111286976|NCT01920737|Glucocorticoids|glucocorticoids|mesh-ancestor
111286977|NCT01920737|Hormones|hormones|mesh-ancestor
111286978|NCT01920737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111286979|NCT01920737|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111286980|NCT01920737|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111286981|NCT01920737|Abortifacient Agents|abortifacient agents|mesh-ancestor
111286982|NCT01920737|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111286983|NCT01920737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111286984|NCT01920737|Antimetabolites|antimetabolites|mesh-ancestor
111286985|NCT01920737|Dermatologic Agents|dermatologic agents|mesh-ancestor
111286986|NCT01920737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111286987|NCT01920737|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111286988|NCT01920737|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111286989|NCT01920737|Antiviral Agents|antiviral agents|mesh-ancestor
111286990|NCT01920737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111286991|NCT01920737|Antidotes|antidotes|mesh-ancestor
111286992|NCT01920737|Protective Agents|protective agents|mesh-ancestor
111286993|NCT01920737|Vitamin B Complex|vitamin b complex|mesh-ancestor
111286994|NCT01920737|Vitamins|vitamins|mesh-ancestor
111286995|NCT01920737|Micronutrients|micronutrients|mesh-ancestor
111286996|NCT01920737|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111286997|NCT01920737|Tubulin Modulators|tubulin modulators|mesh-ancestor
111286998|NCT01920737|Antimitotic Agents|antimitotic agents|mesh-ancestor
111286999|NCT01920737|Mitosis Modulators|mitosis modulators|mesh-ancestor
111287000|NCT01920737|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111287001|NCT01920737|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111287002|NCT01920737|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111287003|NCT01922843|Calcitriol|calcitriol|mesh-list
111287004|NCT01922843|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111287005|NCT01922843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111287006|NCT01922843|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
111287007|NCT01922843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111287008|NCT01922843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111287009|NCT01922843|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111287010|NCT01922843|Vitamins|vitamins|mesh-ancestor
111287011|NCT01922843|Micronutrients|micronutrients|mesh-ancestor
111287012|NCT01922843|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111287013|NCT01302483|Lidocaine|lidocaine|mesh-list
111287014|NCT01302483|Phenylephrine|phenylephrine|mesh-list
111287015|NCT01302483|Oxymetazoline|oxymetazoline|mesh-list
111287016|NCT01302483|Tetracaine|tetracaine|mesh-list
111287017|NCT01302483|Anesthetics, Local|anesthetics, local|mesh-ancestor
111287018|NCT01302483|Anesthetics|anesthetics|mesh-ancestor
111287019|NCT01302483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111287020|NCT01302483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111287021|NCT01302483|Sensory System Agents|sensory system agents|mesh-ancestor
111287022|NCT01302483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111287023|NCT01302483|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110979244|NCT03061331|Ivacaftor|ivacaftor|mesh-list
111287024|NCT01302483|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111287025|NCT01302483|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111287026|NCT01302483|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111287027|NCT01302483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111287028|NCT01302483|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111287029|NCT01302483|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111287030|NCT01302483|Adrenergic Agents|adrenergic agents|mesh-ancestor
111287031|NCT01302483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111287032|NCT01302483|Sympathomimetics|sympathomimetics|mesh-ancestor
111287033|NCT01302483|Autonomic Agents|autonomic agents|mesh-ancestor
111287034|NCT01302483|Nasal Decongestants|nasal decongestants|mesh-ancestor
111287035|NCT01302483|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111287036|NCT01302483|Respiratory System Agents|respiratory system agents|mesh-ancestor
111287037|NCT01302483|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111287038|NCT01302483|Mydriatics|mydriatics|mesh-ancestor
111287039|NCT01302483|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111287040|NCT01302483|Protective Agents|protective agents|mesh-ancestor
111287041|NCT04769583|Metronidazole|metronidazole|mesh-list
111287042|NCT04769583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111287043|NCT04769583|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111287044|NCT04769583|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111011584|NCT02489955|Amikacin|amikacin|mesh-list
111287045|NCT04769583|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111287046|NCT01279317|Acetic Acid|acetic acid|mesh-list
111287047|NCT01279317|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111287048|NCT01279317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111287049|NCT01304589|Milnacipran|milnacipran|mesh-list
111287050|NCT01304589|Levomilnacipran|levomilnacipran|mesh-list
111287051|NCT01304589|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111287052|NCT01304589|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111287053|NCT01304589|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111287054|NCT01304589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111287055|NCT01304589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111287056|NCT01304589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111287057|NCT01304589|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111287058|NCT01304589|Analgesics|analgesics|mesh-ancestor
111287059|NCT01304589|Sensory System Agents|sensory system agents|mesh-ancestor
111287060|NCT01304589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111287061|NCT01304589|Antidepressive Agents|antidepressive agents|mesh-ancestor
111287062|NCT01304589|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111287063|NCT01280409|Metformin|metformin|mesh-list
111287064|NCT01280409|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111287065|NCT01280409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111287066|NCT01926197|Leucovorin|leucovorin|mesh-list
111287067|NCT01926197|Fluorouracil|fluorouracil|mesh-list
111287068|NCT01926197|Oxaliplatin|oxaliplatin|mesh-list
111287069|NCT01926197|Irinotecan|irinotecan|mesh-list
111287070|NCT01926197|Camptothecin|camptothecin|mesh-list
111287071|NCT01926197|Antimetabolites|antimetabolites|mesh-ancestor
111287072|NCT01926197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111287073|NCT01926197|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111287074|NCT01926197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111287075|NCT01926197|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111287076|NCT01926197|Immunologic Factors|immunologic factors|mesh-ancestor
111287077|NCT01926197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111287078|NCT01926197|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111287079|NCT01926197|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111287080|NCT01926197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111287081|NCT01926197|Antidotes|antidotes|mesh-ancestor
111287082|NCT01926197|Protective Agents|protective agents|mesh-ancestor
111287083|NCT01926197|Vitamin B Complex|vitamin b complex|mesh-ancestor
111287084|NCT01926197|Vitamins|vitamins|mesh-ancestor
111287085|NCT01926197|Micronutrients|micronutrients|mesh-ancestor
111287086|NCT01926197|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111287087|NCT01923545|Lenograstim|lenograstim|mesh-list
111287088|NCT01923545|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111287089|NCT01923545|Immunologic Factors|immunologic factors|mesh-ancestor
111287090|NCT01923545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111287091|NCT01925027|Sirolimus|sirolimus|mesh-list
111287092|NCT01925027|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111287093|NCT01925027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111287094|NCT01925027|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111287095|NCT01925027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111287096|NCT01925027|Antifungal Agents|antifungal agents|mesh-ancestor
111287097|NCT01925027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111287098|NCT01925027|Immunologic Factors|immunologic factors|mesh-ancestor
111287099|NCT01925027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111287100|NCT01305213|Bevacizumab|bevacizumab|mesh-list
111287101|NCT01305213|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111287102|NCT01305213|Fosbretabulin|fosbretabulin|mesh-list
111287103|NCT01305213|Endothelial Growth Factors|endothelial growth factors|mesh-list
111287104|NCT01305213|Antibodies|antibodies|mesh-list
111287105|NCT01305213|Immunoglobulins|immunoglobulins|mesh-list
111287106|NCT01305213|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111287107|NCT01305213|Immunoglobulin G|immunoglobulin g|mesh-list
111287108|NCT01305213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111287109|NCT01305213|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111287110|NCT01305213|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111287111|NCT01305213|Growth Substances|growth substances|mesh-ancestor
111287112|NCT01305213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111287113|NCT01305213|Growth Inhibitors|growth inhibitors|mesh-ancestor
111287114|NCT01305213|Immunologic Factors|immunologic factors|mesh-ancestor
111287115|NCT01305213|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111287116|NCT00989963|Beraprost|beraprost|mesh-list
111287117|NCT00989963|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111287118|NCT00989963|Vasodilator Agents|vasodilator agents|mesh-ancestor
111287119|NCT01339299|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
111287120|NCT01339299|Hormones|hormones|mesh-list
111287121|NCT01339299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111287122|NCT01339299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111287123|NCT01339299|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111287124|NCT01307007|Dextrans|dextrans|mesh-list
111287125|NCT01307007|Iron-Dextran Complex|iron-dextran complex|mesh-list
111287126|NCT01307007|Anticoagulants|anticoagulants|mesh-ancestor
111287127|NCT01307007|Plasma Substitutes|plasma substitutes|mesh-ancestor
111287128|NCT01307007|Blood Substitutes|blood substitutes|mesh-ancestor
111287129|NCT01307007|Hematinics|hematinics|mesh-ancestor
111287130|NCT02197455|Tofacitinib|tofacitinib|mesh-list
111287131|NCT02197455|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
111287132|NCT02197455|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111287133|NCT02197455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111287134|NCT02197455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111287135|NCT03101501|Mitomycins|mitomycins|mesh-list
111287136|NCT03101501|Mitomycin|mitomycin|mesh-list
111287137|NCT03101501|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111287138|NCT03101501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111287139|NCT03101501|Alkylating Agents|alkylating agents|mesh-ancestor
111287140|NCT03101501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111287141|NCT03101501|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111287142|NCT03101501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111287143|NCT01923623|Ropivacaine|ropivacaine|mesh-list
111287144|NCT01923623|Anesthetics, Local|anesthetics, local|mesh-ancestor
111287145|NCT01923623|Anesthetics|anesthetics|mesh-ancestor
111287146|NCT01923623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111287147|NCT01923623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111287148|NCT01923623|Sensory System Agents|sensory system agents|mesh-ancestor
111287149|NCT01923623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111287150|NCT01923857|Enclomiphene|enclomiphene|mesh-list
111287151|NCT01923857|Clomiphene|clomiphene|mesh-list
111287152|NCT01923857|Zuclomiphene|zuclomiphene|mesh-list
111287153|NCT01923857|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111287154|NCT01923857|Hormone Antagonists|hormone antagonists|mesh-ancestor
111287155|NCT01923857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111287156|NCT01923857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111287157|NCT01923857|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111287158|NCT01923857|Fertility Agents|fertility agents|mesh-ancestor
111287159|NCT01923857|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111287160|NCT01923857|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111287161|NCT01923857|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111287162|NCT03100253|Adalimumab|adalimumab|mesh-list
111287163|NCT03100253|Infliximab|infliximab|mesh-list
111287164|NCT03100253|Golimumab|golimumab|mesh-list
111287165|NCT03100253|Certolizumab Pegol|certolizumab pegol|mesh-list
111287166|NCT03100253|Etanercept|etanercept|mesh-list
111287167|NCT03100253|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111287168|NCT03100253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111287169|NCT03100253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111287170|NCT03100253|Dermatologic Agents|dermatologic agents|mesh-ancestor
111287171|NCT03100253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111287172|NCT03100253|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111287173|NCT03100253|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111287174|NCT03100253|Analgesics|analgesics|mesh-ancestor
111287175|NCT03100253|Sensory System Agents|sensory system agents|mesh-ancestor
111287176|NCT03100253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111287177|NCT03100253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111287178|NCT03100253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111287179|NCT03100253|Immunologic Factors|immunologic factors|mesh-ancestor
111287180|NCT01924091|Dapivirine|dapivirine|mesh-list
111287181|NCT01924091|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111287182|NCT01924091|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111287183|NCT01924091|Antiviral Agents|antiviral agents|mesh-ancestor
111287184|NCT01924091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111287185|NCT03485729|TIC10 compound|tic10 compound|mesh-list
111287186|NCT03485729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111287187|NCT01924325|Aspirin|aspirin|mesh-list
111287188|NCT01924325|Apixaban|apixaban|mesh-list
111287189|NCT01924325|Clopidogrel|clopidogrel|mesh-list
111287190|NCT01924325|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111287191|NCT01924325|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111287192|NCT01924325|Analgesics|analgesics|mesh-ancestor
111287193|NCT01924325|Sensory System Agents|sensory system agents|mesh-ancestor
111287194|NCT01924325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111287195|NCT01924325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111287196|NCT01924325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111287197|NCT01924325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111287198|NCT01924325|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111287199|NCT01924325|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111287200|NCT01924325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111287201|NCT01924325|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111287202|NCT01924325|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111287203|NCT01924325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111287204|NCT01924325|Antipyretics|antipyretics|mesh-ancestor
111287205|NCT01924325|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111287206|NCT01924325|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111287207|NCT01924325|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111287208|NCT01924325|Purinergic Agents|purinergic agents|mesh-ancestor
111287209|NCT01924325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111287210|NCT01924325|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111287211|NCT01924325|Antithrombins|antithrombins|mesh-ancestor
111287212|NCT01924325|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111287213|NCT01924325|Protease Inhibitors|protease inhibitors|mesh-ancestor
111287214|NCT01924325|Anticoagulants|anticoagulants|mesh-ancestor
111287215|NCT01924481|Theobromine|theobromine|mesh-list
111287217|NCT01924481|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111287218|NCT01924481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111287219|NCT01924481|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111287220|NCT01924481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111287221|NCT01924481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111287222|NCT01924481|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
111287223|NCT01924481|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111287224|NCT01924481|Purinergic Agents|purinergic agents|mesh-ancestor
111287225|NCT01924481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111287226|NCT01924481|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111287227|NCT01924481|Autonomic Agents|autonomic agents|mesh-ancestor
111287228|NCT01924481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111287229|NCT01924481|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111287230|NCT01924481|Respiratory System Agents|respiratory system agents|mesh-ancestor
111287231|NCT01924481|Vasodilator Agents|vasodilator agents|mesh-ancestor
111287232|NCT01924637|Insulin|insulin|mesh-list
111287233|NCT01924637|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111287234|NCT01924637|Insulin Aspart|insulin aspart|mesh-list
111287235|NCT01924637|Insulin, Long-Acting|insulin, long-acting|mesh-list
111287236|NCT01924637|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
111287237|NCT01924637|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111287238|NCT01924637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111287239|NCT01925729|Phenylephrine|phenylephrine|mesh-list
111287240|NCT01925729|Pseudoephedrine|pseudoephedrine|mesh-list
111287241|NCT01925729|Oxymetazoline|oxymetazoline|mesh-list
111287242|NCT01925729|Ephedrine|ephedrine|mesh-list
111287243|NCT01925729|Histamine|histamine|mesh-list
111287244|NCT01925729|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111287245|NCT01925729|Autonomic Agents|autonomic agents|mesh-ancestor
111287246|NCT01925729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111287247|NCT01925729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111287248|NCT01925729|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111287249|NCT01925729|Respiratory System Agents|respiratory system agents|mesh-ancestor
111287250|NCT01925729|Nasal Decongestants|nasal decongestants|mesh-ancestor
110739738|NCT00001880|Immunologic Factors|immunologic factors|mesh-ancestor
111287251|NCT01925729|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111287252|NCT01925729|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111287253|NCT01925729|Sympathomimetics|sympathomimetics|mesh-ancestor
111287254|NCT01925729|Adrenergic Agents|adrenergic agents|mesh-ancestor
111287255|NCT01925729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111287256|NCT01925729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111287257|NCT01925729|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111287258|NCT01925729|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111287259|NCT01925729|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111287260|NCT01925729|Mydriatics|mydriatics|mesh-ancestor
111287261|NCT01925729|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111287262|NCT01925729|Protective Agents|protective agents|mesh-ancestor
111287263|NCT01925729|Histamine Agonists|histamine agonists|mesh-ancestor
111287264|NCT01925729|Histamine Agents|histamine agents|mesh-ancestor
111287265|NCT01926587|Azacitidine|azacitidine|mesh-list
111287266|NCT01926587|ON 01910|on 01910|mesh-list
111287267|NCT01926587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111287268|NCT01926587|Antimetabolites|antimetabolites|mesh-ancestor
111287269|NCT01926587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111287270|NCT01926587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111287271|NCT01926587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111287272|NCT01926587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111011817|NCT00584246|Pregabalin|pregabalin|mesh-list
111287273|NCT01922765|Amoxicillin|amoxicillin|mesh-list
111287274|NCT01922765|Metronidazole|metronidazole|mesh-list
111287275|NCT01922765|Clarithromycin|clarithromycin|mesh-list
111287276|NCT01922765|Rabeprazole|rabeprazole|mesh-list
111287277|NCT01922765|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111287278|NCT01922765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111287279|NCT01922765|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111287280|NCT01922765|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111287281|NCT01922765|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111287282|NCT01922765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111287283|NCT01922765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111287284|NCT01922765|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111287285|NCT01922765|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111287286|NCT01922765|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111287287|NCT01922765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111287288|NCT01922765|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111287289|NCT01926665|Dexamethasone|dexamethasone|mesh-list
111287290|NCT01926665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111287291|NCT01926665|Antiemetics|antiemetics|mesh-ancestor
111287292|NCT01926665|Autonomic Agents|autonomic agents|mesh-ancestor
111287293|NCT01926665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111287294|NCT01926665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111287295|NCT01926665|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111287296|NCT01926665|Glucocorticoids|glucocorticoids|mesh-ancestor
111287297|NCT01926665|Hormones|hormones|mesh-ancestor
111287298|NCT01926665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111287299|NCT01926665|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111287300|NCT01926665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111287301|NCT01926821|Sizofiran|sizofiran|mesh-list
111287302|NCT01926821|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111287303|NCT01926821|Immunologic Factors|immunologic factors|mesh-ancestor
111287304|NCT01926821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111287305|NCT01926821|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111287306|NCT01926821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111287307|NCT01926899|Bortezomib|bortezomib|mesh-list
111287308|NCT01926899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111287309|NCT03430661|Clopidogrel|clopidogrel|mesh-list
111287310|NCT03430661|Ticagrelor|ticagrelor|mesh-list
111287311|NCT03430661|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
111287312|NCT03430661|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111287313|NCT03430661|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111287314|NCT03430661|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111287315|NCT03430661|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111287316|NCT03430661|Purinergic Agents|purinergic agents|mesh-ancestor
111287317|NCT03430661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111287318|NCT03430661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111287319|NCT03430661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111287320|NCT01927835|Vaccines|vaccines|mesh-list
111287321|NCT01927835|Immunologic Factors|immunologic factors|mesh-ancestor
111287322|NCT01927835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111287323|NCT01927913|Deferasirox|deferasirox|mesh-list
111287324|NCT01927913|Iron Chelating Agents|iron chelating agents|mesh-ancestor
111287325|NCT01927913|Chelating Agents|chelating agents|mesh-ancestor
111287326|NCT01927913|Sequestering Agents|sequestering agents|mesh-ancestor
111287327|NCT01927913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111287328|NCT01928069|Montelukast|montelukast|mesh-list
111287329|NCT01928069|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111287330|NCT01928069|Respiratory System Agents|respiratory system agents|mesh-ancestor
111287331|NCT01928069|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
111287332|NCT01928069|Hormone Antagonists|hormone antagonists|mesh-ancestor
111287333|NCT01928069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111287334|NCT01928069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111287335|NCT01928069|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
111287336|NCT01928069|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111287337|NCT01928069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111287338|NCT01928459|Infigratinib|infigratinib|mesh-list
111287339|NCT01928459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111287340|NCT01928537|ON 01910|on 01910|mesh-list
111287341|NCT01928537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111287342|NCT01928537|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111287343|NCT01928537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111287344|NCT01928537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111287345|NCT01307397|Vemurafenib|vemurafenib|mesh-list
111287346|NCT01307397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111287347|NCT01307397|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111011884|NCT02486445|Anticoagulants|anticoagulants|mesh-ancestor
111287348|NCT01307397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111287349|NCT01307397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111287351|NCT01929161|Oxytocics|oxytocics|mesh-ancestor
111287352|NCT01929161|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111287353|NCT01929161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111287354|NCT03373877|9H-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-N-(1-methylethyl)-|9h-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-n-(1-methylethyl)-|mesh-list
111287355|NCT03373877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111287356|NCT04552535|Afatinib|afatinib|mesh-list
111287357|NCT04552535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111287358|NCT04552535|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111287359|NCT04552535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111287360|NCT04552535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111287361|NCT02197767|Rituximab|rituximab|mesh-list
111287362|NCT02197767|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111287363|NCT02197767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111287364|NCT02197767|Immunologic Factors|immunologic factors|mesh-ancestor
111287365|NCT02197767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111287366|NCT02197767|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111287367|NCT01342029|Ranolazine|ranolazine|mesh-list
111287368|NCT01342029|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111287369|NCT01342029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111287370|NCT01342029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111287371|NCT01342107|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111287372|NCT05601479|Acetylcarnitine|acetylcarnitine|mesh-list
111287373|NCT05601479|Vitamin B Complex|vitamin b complex|mesh-ancestor
111287374|NCT05601479|Vitamins|vitamins|mesh-ancestor
111287375|NCT05601479|Micronutrients|micronutrients|mesh-ancestor
111287376|NCT05601479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111287377|NCT05601479|Nootropic Agents|nootropic agents|mesh-ancestor
111287378|NCT04275245|Meplazumab|meplazumab|mesh-list
111287379|NCT04275245|Antiviral Agents|antiviral agents|mesh-ancestor
111287380|NCT04275245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111287381|NCT01346085|Thymoglobulin|thymoglobulin|mesh-list
111287382|NCT01346085|Immunologic Factors|immunologic factors|mesh-ancestor
111287383|NCT01346085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111287384|NCT01346085|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111287385|NCT04394897|Remifentanil|remifentanil|mesh-list
111287386|NCT04394897|Propofol|propofol|mesh-list
111287387|NCT04394897|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111287388|NCT04394897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111287389|NCT04394897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111287390|NCT04394897|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111287391|NCT04394897|Anesthetics, General|anesthetics, general|mesh-ancestor
111287392|NCT04394897|Anesthetics|anesthetics|mesh-ancestor
111287393|NCT04394897|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111287394|NCT04394897|Narcotics|narcotics|mesh-ancestor
111287395|NCT04394897|Analgesics|analgesics|mesh-ancestor
111287396|NCT04394897|Sensory System Agents|sensory system agents|mesh-ancestor
111287397|NCT04394897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111287398|NCT05607641|Ketorolac|ketorolac|mesh-list
111287399|NCT05607641|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
111287400|NCT05607641|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111287401|NCT05607641|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111287402|NCT05607641|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111287403|NCT05607641|Analgesics|analgesics|mesh-ancestor
111287404|NCT05607641|Sensory System Agents|sensory system agents|mesh-ancestor
111287405|NCT05607641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111287406|NCT05607641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111287407|NCT05607641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111287408|NCT05607641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111287409|NCT05607641|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111287410|NCT05607641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111287411|NCT05607641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111287412|NCT05603039|Bevacizumab|bevacizumab|mesh-list
111287413|NCT05603039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111287414|NCT05603039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111287415|NCT05603039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111287416|NCT05603039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111287417|NCT05603039|Growth Substances|growth substances|mesh-ancestor
111287418|NCT05603039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111287419|NCT05603039|Growth Inhibitors|growth inhibitors|mesh-ancestor
111287420|NCT05609903|Paclitaxel|paclitaxel|mesh-list
111287421|NCT05609903|Atezolizumab|atezolizumab|mesh-list
111287422|NCT05609903|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111287423|NCT05609903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111287424|NCT05609903|Tubulin Modulators|tubulin modulators|mesh-ancestor
111287425|NCT05609903|Antimitotic Agents|antimitotic agents|mesh-ancestor
111287426|NCT05609903|Mitosis Modulators|mitosis modulators|mesh-ancestor
111287427|NCT05609903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111287428|NCT05609903|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111287429|NCT05609903|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111287431|NCT04161599|Cefuroxime|cefuroxime|mesh-list
111287432|NCT04161599|Cefuroxime axetil|cefuroxime axetil|mesh-list
111287433|NCT04161599|Picosulfate sodium|picosulfate sodium|mesh-list
111287434|NCT04161599|Magnesium Oxide|magnesium oxide|mesh-list
111287435|NCT04161599|Citric Acid|citric acid|mesh-list
111287436|NCT04161599|Sodium Citrate|sodium citrate|mesh-list
111287437|NCT04161599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111287438|NCT04161599|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111287439|NCT04161599|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111287440|NCT04161599|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111287441|NCT04161599|Anticoagulants|anticoagulants|mesh-ancestor
111287442|NCT04161599|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
111287443|NCT04161599|Chelating Agents|chelating agents|mesh-ancestor
111287444|NCT04161599|Sequestering Agents|sequestering agents|mesh-ancestor
111287445|NCT04161599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111287446|NCT04161599|Cathartics|cathartics|mesh-ancestor
111287447|NCT04161599|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111287448|NCT04161599|Antacids|antacids|mesh-ancestor
111287449|NCT04759235|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
111287450|NCT04759235|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111287451|NCT04759235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111287452|NCT05608499|Clobetasol|clobetasol|mesh-list
111287453|NCT05608499|Halobetasol|halobetasol|mesh-list
111287454|NCT05608499|Tazarotene|tazarotene|mesh-list
111287455|NCT05608499|Dermatologic Agents|dermatologic agents|mesh-ancestor
111287456|NCT05608499|Keratolytic Agents|keratolytic agents|mesh-ancestor
111287457|NCT05608499|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111287458|NCT05608499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111287459|NCT05608499|Glucocorticoids|glucocorticoids|mesh-ancestor
111287460|NCT05608499|Hormones|hormones|mesh-ancestor
111287461|NCT05608499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111287462|NCT05608499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111287463|NCT05601167|Ritonavir|ritonavir|mesh-list
111287464|NCT05601167|Nirmatrelvir|nirmatrelvir|mesh-list
111287465|NCT05601167|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
111287466|NCT05601167|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111287467|NCT05601167|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111287468|NCT05601167|Protease Inhibitors|protease inhibitors|mesh-ancestor
111287469|NCT05601167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111287470|NCT05601167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111287471|NCT05601167|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111287472|NCT05601167|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111287473|NCT05601167|Antiviral Agents|antiviral agents|mesh-ancestor
111287474|NCT05601167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111287475|NCT05601167|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111287476|NCT05601167|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111287477|NCT05605613|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
111287478|NCT05605613|Antibodies|antibodies|mesh-list
111287479|NCT05605613|Immunologic Factors|immunologic factors|mesh-ancestor
111287480|NCT05605613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111287481|NCT05605613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111287482|NCT05605613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111287483|NCT05605613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111287484|NCT05602259|Dimercaprol|dimercaprol|mesh-list
111287485|NCT05602259|Chelating Agents|chelating agents|mesh-ancestor
111287486|NCT05602259|Sequestering Agents|sequestering agents|mesh-ancestor
111287487|NCT05602259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111287488|NCT04393883|Pembrolizumab|pembrolizumab|mesh-list
111287489|NCT04393883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111287490|NCT04393883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111287491|NCT04393883|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111287492|NCT04393883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111287493|NCT05603975|Esketamine|esketamine|mesh-list
111287494|NCT05603975|Antidepressive Agents|antidepressive agents|mesh-ancestor
111287495|NCT05603975|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111287496|NCT04120363|Methyltestosterone|methyltestosterone|mesh-list
111287497|NCT04120363|Testosterone|testosterone|mesh-list
111287498|NCT04120363|Testosterone undecanoate|testosterone undecanoate|mesh-list
111287499|NCT04120363|Testosterone enanthate|testosterone enanthate|mesh-list
111287500|NCT04120363|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
111287501|NCT04120363|Androgens|androgens|mesh-ancestor
111287502|NCT04120363|Hormones|hormones|mesh-ancestor
111287503|NCT04120363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111287504|NCT04120363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111287505|NCT04120363|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111287506|NCT04120363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111287507|NCT04120363|Anabolic Agents|anabolic agents|mesh-ancestor
111287508|NCT04125745|CXA-10|cxa-10|mesh-list
111287509|NCT04125745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111287510|NCT04393805|Heparin|heparin|mesh-list
111287511|NCT04393805|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
111287512|NCT04393805|Tinzaparin|tinzaparin|mesh-list
111287513|NCT04393805|Dalteparin|dalteparin|mesh-list
111287514|NCT04393805|Anticoagulants|anticoagulants|mesh-ancestor
111287515|NCT04393805|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111287516|NCT04393805|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111287517|NCT04393805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111287518|NCT04122755|Buprenorphine|buprenorphine|mesh-list
111287519|NCT04122755|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111287520|NCT04122755|Narcotics|narcotics|mesh-ancestor
111287521|NCT04122755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111287522|NCT04122755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111287523|NCT04122755|Analgesics|analgesics|mesh-ancestor
111287524|NCT04122755|Sensory System Agents|sensory system agents|mesh-ancestor
111287525|NCT04122755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111287526|NCT04122755|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111287527|NCT04129697|Dexamethasone|dexamethasone|mesh-list
111287528|NCT04129697|Methylprednisolone|methylprednisolone|mesh-list
111287529|NCT04129697|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111287530|NCT04129697|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111287531|NCT04129697|Prednisolone|prednisolone|mesh-list
111287532|NCT04129697|Prednisolone acetate|prednisolone acetate|mesh-list
111287533|NCT04129697|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111287534|NCT04129697|Prednisolone phosphate|prednisolone phosphate|mesh-list
111287535|NCT04129697|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111287536|NCT04129697|Antiemetics|antiemetics|mesh-ancestor
111287537|NCT04129697|Autonomic Agents|autonomic agents|mesh-ancestor
111287538|NCT04129697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111287539|NCT04129697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111287540|NCT04129697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111287541|NCT04129697|Glucocorticoids|glucocorticoids|mesh-ancestor
111287542|NCT04129697|Hormones|hormones|mesh-ancestor
111287543|NCT04129697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111287544|NCT04129697|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111287545|NCT04129697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111287546|NCT04129697|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111287547|NCT04129697|Protective Agents|protective agents|mesh-ancestor
111287548|NCT04128137|Fludrocortisone|fludrocortisone|mesh-list
111287549|NCT04128137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111287550|NCT05793892|Lidocaine|lidocaine|mesh-list
111287551|NCT05793892|Tetracaine|tetracaine|mesh-list
111287552|NCT05793892|Anesthetics, Local|anesthetics, local|mesh-ancestor
111287553|NCT05793892|Anesthetics|anesthetics|mesh-ancestor
111287554|NCT05793892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111287555|NCT05793892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111287556|NCT05793892|Sensory System Agents|sensory system agents|mesh-ancestor
111287557|NCT05793892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111287558|NCT05793892|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111287559|NCT05793892|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111287560|NCT05793892|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111287561|NCT05793892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111287562|NCT05793892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111287563|NCT05793359|Methylprednisolone|methylprednisolone|mesh-list
111287564|NCT05793359|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111287565|NCT05793359|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111287566|NCT05793359|Prednisolone|prednisolone|mesh-list
111287567|NCT05793359|Prednisolone acetate|prednisolone acetate|mesh-list
111287568|NCT05793359|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111287569|NCT05793359|Prednisolone phosphate|prednisolone phosphate|mesh-list
111287570|NCT05793359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111287571|NCT05793359|Antiemetics|antiemetics|mesh-ancestor
111287572|NCT05793359|Autonomic Agents|autonomic agents|mesh-ancestor
111287573|NCT05793359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111287574|NCT05793359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111287575|NCT05793359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111287576|NCT05793359|Glucocorticoids|glucocorticoids|mesh-ancestor
111287578|NCT05793359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111287579|NCT05793359|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111287580|NCT05793359|Protective Agents|protective agents|mesh-ancestor
111287581|NCT05793359|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111287582|NCT05793359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111287583|NCT05793268|Tenofovir|tenofovir|mesh-list
111287584|NCT05793268|Entecavir|entecavir|mesh-list
111287585|NCT05793268|Antiviral Agents|antiviral agents|mesh-ancestor
111287586|NCT05793268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111287587|NCT05793268|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111287588|NCT05793268|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111287589|NCT05793268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111287590|NCT05793268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111287591|NCT05793268|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111287592|NCT05793268|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111287593|NCT05792995|Pembrolizumab|pembrolizumab|mesh-list
111287594|NCT05792995|Nivolumab|nivolumab|mesh-list
111287595|NCT05792995|Durvalumab|durvalumab|mesh-list
111287596|NCT05792995|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111287597|NCT05792995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111287598|NCT05792995|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111287599|NCT05792995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111287600|NCT05792878|Interferons|interferons|mesh-list
111287601|NCT05792878|Interferon-alpha|interferon-alpha|mesh-list
111287602|NCT05792878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111287603|NCT05792878|Antiviral Agents|antiviral agents|mesh-ancestor
111287604|NCT05792878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111287605|NCT05792878|Immunologic Factors|immunologic factors|mesh-ancestor
111287606|NCT05792878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111287607|NCT05792865|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
111287608|NCT05792865|Antiviral Agents|antiviral agents|mesh-ancestor
111287609|NCT05792865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111287610|NCT05792761|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
111287611|NCT05792761|Antiviral Agents|antiviral agents|mesh-ancestor
111287612|NCT05792761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111287613|NCT05792748|Hemostatics|hemostatics|mesh-list
111287614|NCT05792748|Coagulants|coagulants|mesh-ancestor
111287615|NCT05792644|Crizotinib|crizotinib|mesh-list
111287616|NCT05792644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111287617|NCT05792644|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111287618|NCT05792644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111287619|NCT05792644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111287620|NCT05792410|Bevacizumab|bevacizumab|mesh-list
111287621|NCT05792410|Fulvestrant|fulvestrant|mesh-list
111287622|NCT05792410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111287623|NCT05792410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111287624|NCT05792410|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111287625|NCT05792410|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111287626|NCT05792410|Growth Substances|growth substances|mesh-ancestor
111287627|NCT05792410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111287628|NCT05792410|Growth Inhibitors|growth inhibitors|mesh-ancestor
111287629|NCT05792410|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111287630|NCT05792410|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
111287631|NCT05792410|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111287632|NCT05792410|Hormone Antagonists|hormone antagonists|mesh-ancestor
111287633|NCT05792410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111287634|NCT05792111|Triamcinolone|triamcinolone|mesh-list
111287635|NCT05792111|Lidocaine|lidocaine|mesh-list
111287636|NCT05792111|Bupivacaine|bupivacaine|mesh-list
111287637|NCT05792111|Anesthetics, Local|anesthetics, local|mesh-ancestor
111287638|NCT05792111|Anesthetics|anesthetics|mesh-ancestor
111287639|NCT05792111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111287640|NCT05792111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111287641|NCT05792111|Sensory System Agents|sensory system agents|mesh-ancestor
111287642|NCT05792111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111287643|NCT05792111|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111287644|NCT05792111|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111287645|NCT05792111|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111287646|NCT05792111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111287647|NCT05792111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111287648|NCT05792111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111287649|NCT05792111|Glucocorticoids|glucocorticoids|mesh-ancestor
111287650|NCT05792111|Hormones|hormones|mesh-ancestor
111287651|NCT05792111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111287652|NCT05789732|Tadalafil|tadalafil|mesh-list
111287653|NCT05789732|Silodosin|silodosin|mesh-list
111287654|NCT05789732|Vasodilator Agents|vasodilator agents|mesh-ancestor
111287655|NCT05789732|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111287656|NCT05789732|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111287657|NCT05789732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111287658|NCT05789732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111287659|NCT05789732|Urological Agents|urological agents|mesh-ancestor
111287660|NCT05789732|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111287661|NCT05789732|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111287662|NCT05789732|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111287663|NCT05789732|Adrenergic Agents|adrenergic agents|mesh-ancestor
111287664|NCT05789732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111287665|NCT05789732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111287666|NCT05789615|Letermovir|letermovir|mesh-list
111287667|NCT05789615|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111287668|NCT05789615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111287669|NCT05789615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111287670|NCT05789615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111287671|NCT05789615|Antiviral Agents|antiviral agents|mesh-ancestor
111287672|NCT05789615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111287673|NCT05783817|Methamphetamine|methamphetamine|mesh-list
111287674|NCT05783817|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111287675|NCT05783817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111287676|NCT05783817|Sympathomimetics|sympathomimetics|mesh-ancestor
111287677|NCT05783817|Autonomic Agents|autonomic agents|mesh-ancestor
111287678|NCT05783817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111287679|NCT05783817|Dopamine Agents|dopamine agents|mesh-ancestor
111287680|NCT05783817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111287681|NCT05783817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111287682|NCT05783817|Adrenergic Agents|adrenergic agents|mesh-ancestor
111287683|NCT05783817|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111287684|NCT05783817|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111287685|NCT05783817|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111287686|NCT05783817|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111287687|NCT05761080|Amoxicillin|amoxicillin|mesh-list
111287688|NCT05761080|Clavulanic Acids|clavulanic acids|mesh-list
111287689|NCT05761080|Clavulanic Acid|clavulanic acid|mesh-list
111287690|NCT05761080|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
111287691|NCT05761080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111287692|NCT05761080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111287693|NCT05761080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111287694|NCT05761080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111287695|NCT05761080|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
111287696|NCT05743764|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111287697|NCT05743764|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111287698|NCT05737186|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
111287699|NCT05737186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111287700|NCT05737186|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111287701|NCT05737186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111287702|NCT05700669|Olaparib|olaparib|mesh-list
111287703|NCT05700669|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111287704|NCT05700669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111287705|NCT05700669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111287706|NCT05700669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111287707|NCT05652660|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111287708|NCT05652660|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111287709|NCT05652660|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111287710|NCT05652660|Antimetabolites|antimetabolites|mesh-ancestor
111287711|NCT05652660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111287712|NCT05652660|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111287713|NCT05652660|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111287714|NCT05652660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111287715|NCT05593575|Valsartan|valsartan|mesh-list
111287716|NCT05593575|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111287717|NCT05593575|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111287718|NCT05593575|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111287719|NCT05593575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111287720|NCT05558137|Mivacurium|mivacurium|mesh-list
111287721|NCT05558137|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
111287722|NCT05558137|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
111287723|NCT05558137|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111287724|NCT05558137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111287725|NCT05558137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111287726|NCT05505214|Mometasone Furoate|mometasone furoate|mesh-list
111287727|NCT05505214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111287728|NCT05505214|Dermatologic Agents|dermatologic agents|mesh-ancestor
111287729|NCT05505214|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111287730|NCT05501769|Everolimus|everolimus|mesh-list
111287731|NCT05501769|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111287732|NCT05501769|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111287733|NCT05501769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111287734|NCT05501769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111287735|NCT05501769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111287736|NCT05501769|Immunologic Factors|immunologic factors|mesh-ancestor
111287737|NCT05501769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111287738|NCT05501769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111287739|NCT05463224|Lazertinib|lazertinib|mesh-list
111287740|NCT05463224|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111287741|NCT05463224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111287742|NCT05463224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111287743|NCT05456932|Iron|iron|mesh-list
111287744|NCT05456932|Ferrous fumarate|ferrous fumarate|mesh-list
111287745|NCT05456932|Ferric maltol|ferric maltol|mesh-list
111287746|NCT05456932|Trace Elements|trace elements|mesh-ancestor
111287747|NCT05456932|Micronutrients|micronutrients|mesh-ancestor
111287748|NCT05456932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111287749|NCT05456932|Hematinics|hematinics|mesh-ancestor
111287750|NCT05447780|Anesthetics|anesthetics|mesh-list
111287751|NCT05447780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111287752|NCT05447780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111287753|NCT05437289|Cilgavimab and tixagevimab drug combination|cilgavimab and tixagevimab drug combination|mesh-list
111287754|NCT05437289|Antiviral Agents|antiviral agents|mesh-ancestor
111287755|NCT05437289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111287756|NCT05389930|Ethanol|ethanol|mesh-list
111287757|NCT05389930|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111287758|NCT05389930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111287759|NCT05389930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111287760|NCT05389930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111287761|NCT05382546|Ketorolac|ketorolac|mesh-list
111287762|NCT05382546|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
111287763|NCT05382546|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111287764|NCT05382546|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111287765|NCT05382546|Analgesics|analgesics|mesh-ancestor
111287766|NCT05382546|Sensory System Agents|sensory system agents|mesh-ancestor
111287767|NCT05382546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111287768|NCT05382546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111287769|NCT05382546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111287770|NCT05382546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111287771|NCT05382546|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111287772|NCT05382546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111287773|NCT05382546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111287774|NCT05351554|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111287775|NCT05351554|Immunologic Factors|immunologic factors|mesh-ancestor
111287776|NCT05351554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111287777|NCT05278351|Irinotecan|irinotecan|mesh-list
111287778|NCT05278351|Cetuximab|cetuximab|mesh-list
111287779|NCT05278351|Tislelizumab|tislelizumab|mesh-list
111287780|NCT05278351|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111287781|NCT05278351|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111287782|NCT05278351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111287783|NCT05278351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111287784|NCT05278351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111287785|NCT05278351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111287786|NCT05269628|Dronabinol|dronabinol|mesh-list
111287787|NCT05269628|Cannabidiol|cannabidiol|mesh-list
111287788|NCT05269628|Anticonvulsants|anticonvulsants|mesh-ancestor
111287789|NCT05269628|Hallucinogens|hallucinogens|mesh-ancestor
111287790|NCT05269628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111287791|NCT05269628|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111287792|NCT05269628|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111287793|NCT05269628|Analgesics|analgesics|mesh-ancestor
111287794|NCT05269628|Sensory System Agents|sensory system agents|mesh-ancestor
111287795|NCT05269628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111287796|NCT05269628|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
111287797|NCT05269628|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
111287798|NCT05269628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111287799|NCT05269628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111287800|NCT05269628|Hormones|hormones|mesh-ancestor
111287801|NCT05269628|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111287802|NCT05263700|FAPI-46|fapi-46|mesh-list
111287803|NCT05263700|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111287804|NCT05263700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111287805|NCT05257447|Baclofen|baclofen|mesh-list
111287806|NCT05257447|Chlorzoxazone|chlorzoxazone|mesh-list
111287807|NCT05257447|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
111287808|NCT05257447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111287809|NCT05257447|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111287810|NCT05257447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111287811|NCT05257447|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
111287812|NCT05257447|GABA Agonists|gaba agonists|mesh-ancestor
111287813|NCT05257447|GABA Agents|gaba agents|mesh-ancestor
111287814|NCT05257447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111287815|NCT05257447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111287816|NCT05211154|Diclofenac|diclofenac|mesh-list
111287817|NCT05211154|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111287818|NCT05211154|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111287819|NCT05211154|Analgesics|analgesics|mesh-ancestor
111287820|NCT05211154|Sensory System Agents|sensory system agents|mesh-ancestor
111287821|NCT05211154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111287822|NCT05211154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111287823|NCT05211154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111287824|NCT05211154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111287825|NCT05211154|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111287826|NCT05211154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111287827|NCT05211154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111287828|NCT05128344|Vigabatrin|vigabatrin|mesh-list
111287829|NCT05128344|Anticonvulsants|anticonvulsants|mesh-ancestor
111287830|NCT05128344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111287831|NCT05128344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111287832|NCT05128344|GABA Agents|gaba agents|mesh-ancestor
111287833|NCT05128344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111287834|NCT05128344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111287835|NCT05093296|Naltrexone|naltrexone|mesh-list
111287836|NCT05093296|Oxytocin|oxytocin|mesh-list
111287837|NCT05093296|Oxytocics|oxytocics|mesh-ancestor
111287838|NCT05093296|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111287839|NCT05093296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111287840|NCT05093296|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111287841|NCT05093296|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111287842|NCT05093296|Sensory System Agents|sensory system agents|mesh-ancestor
111287843|NCT05093296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111287844|NCT05071833|Peppermint oil|peppermint oil|mesh-list
111287845|NCT05071833|Antiemetics|antiemetics|mesh-ancestor
111287846|NCT05071833|Autonomic Agents|autonomic agents|mesh-ancestor
111287847|NCT05071833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111287848|NCT05071833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111287849|NCT05071833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111287850|NCT05071833|Parasympatholytics|parasympatholytics|mesh-ancestor
111287851|NCT05023369|Dexamethasone|dexamethasone|mesh-list
111287852|NCT05023369|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111287853|NCT05023369|Antiemetics|antiemetics|mesh-ancestor
111287854|NCT05023369|Autonomic Agents|autonomic agents|mesh-ancestor
111287855|NCT05023369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111287856|NCT05023369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111287857|NCT05023369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111287858|NCT05023369|Glucocorticoids|glucocorticoids|mesh-ancestor
111287859|NCT05023369|Hormones|hormones|mesh-ancestor
111287860|NCT05023369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111287861|NCT05023369|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111287862|NCT05023369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111287863|NCT04818632|Everolimus|everolimus|mesh-list
111287864|NCT04818632|Palbociclib|palbociclib|mesh-list
111287865|NCT04818632|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111287866|NCT04818632|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111287867|NCT04818632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111287868|NCT04818632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111287869|NCT04818632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111287870|NCT04818632|Immunologic Factors|immunologic factors|mesh-ancestor
111287871|NCT04818632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111287872|NCT04818632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111287873|NCT04729101|Lansoprazole|lansoprazole|mesh-list
111287875|NCT04729101|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111287876|NCT04729101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111287877|NCT04729101|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111287878|NCT04729101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111287879|NCT04729101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111287880|NCT04713969|Pantoprazole|pantoprazole|mesh-list
111287881|NCT04713969|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111287882|NCT04713969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111287883|NCT04713969|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111287884|NCT04713969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111287885|NCT04713969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111287886|NCT04707872|Antibodies|antibodies|mesh-list
111287887|NCT04707872|Immunologic Factors|immunologic factors|mesh-ancestor
111287888|NCT04707872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111287889|NCT04673448|Niraparib|niraparib|mesh-list
111287890|NCT04673448|Dostarlimab|dostarlimab|mesh-list
111287891|NCT04673448|Immunoglobulins|immunoglobulins|mesh-list
111287892|NCT04673448|Immunoglobulin G|immunoglobulin g|mesh-list
111287893|NCT04673448|Immunologic Factors|immunologic factors|mesh-ancestor
111287894|NCT04673448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111287895|NCT04673448|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111287896|NCT04673448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111287897|NCT04673448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111287898|NCT04673448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111287899|NCT04670081|Niacinamide|niacinamide|mesh-list
111287900|NCT04670081|Niacin|niacin|mesh-list
111287901|NCT04670081|Nicotinic Acids|nicotinic acids|mesh-list
111287902|NCT04670081|Psilocybin|psilocybin|mesh-list
111287903|NCT04670081|Vitamin B Complex|vitamin b complex|mesh-ancestor
111287904|NCT04670081|Vitamins|vitamins|mesh-ancestor
111287905|NCT04670081|Micronutrients|micronutrients|mesh-ancestor
110740398|NCT01056497|Thioctic Acid|thioctic acid|mesh-list
111287906|NCT04670081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111287907|NCT04670081|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111287908|NCT04670081|Antimetabolites|antimetabolites|mesh-ancestor
111287909|NCT04670081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111287910|NCT04670081|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111287911|NCT04670081|Vasodilator Agents|vasodilator agents|mesh-ancestor
111287912|NCT04670081|Hallucinogens|hallucinogens|mesh-ancestor
111287913|NCT04670081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111287914|NCT04648280|Fostemsavir|fostemsavir|mesh-list
111287915|NCT04648280|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111287916|NCT04648280|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111287917|NCT04648280|Antiviral Agents|antiviral agents|mesh-ancestor
111287918|NCT04648280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111287919|NCT04648280|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
111287920|NCT04648280|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
111287921|NCT04648280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111287922|NCT04602377|Pembrolizumab|pembrolizumab|mesh-list
111287923|NCT04602377|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111287924|NCT04602377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111287925|NCT04602377|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111287926|NCT04602377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111287927|NCT04601961|Propofol|propofol|mesh-list
111287928|NCT04601961|Sevoflurane|sevoflurane|mesh-list
111287929|NCT04601961|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111287930|NCT04601961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111287931|NCT04601961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111287932|NCT04601961|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111287933|NCT04601961|Anesthetics, General|anesthetics, general|mesh-ancestor
111287934|NCT04601961|Anesthetics|anesthetics|mesh-ancestor
111287935|NCT04601961|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111287936|NCT04601961|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111287937|NCT04551430|Nivolumab|nivolumab|mesh-list
111287938|NCT04551430|Ipilimumab|ipilimumab|mesh-list
111287939|NCT04551430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111287940|NCT04551430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111287941|NCT04551430|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111287942|NCT04551430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111287943|NCT04513314|Valproic Acid|valproic acid|mesh-list
111287944|NCT04513314|Quetiapine Fumarate|quetiapine fumarate|mesh-list
111287945|NCT04513314|Antidepressive Agents|antidepressive agents|mesh-ancestor
111287946|NCT04513314|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111287947|NCT04513314|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111287948|NCT04513314|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111287949|NCT04513314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111287950|NCT04513314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111287951|NCT04513314|Anticonvulsants|anticonvulsants|mesh-ancestor
111287952|NCT04513314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111287953|NCT04513314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111287954|NCT04513314|GABA Agents|gaba agents|mesh-ancestor
111287955|NCT04513314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111287956|NCT04513314|Antimanic Agents|antimanic agents|mesh-ancestor
111287957|NCT04469868|Analgesics, Opioid|analgesics, opioid|mesh-list
111287958|NCT04469868|Narcotics|narcotics|mesh-ancestor
111287959|NCT04469868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111287960|NCT04469868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111287961|NCT04469868|Analgesics|analgesics|mesh-ancestor
111287962|NCT04469868|Sensory System Agents|sensory system agents|mesh-ancestor
111287963|NCT04469868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111287964|NCT04451187|Zopiclone|zopiclone|mesh-list
111287965|NCT04451187|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111287966|NCT04451187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111287967|NCT04451187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111287968|NCT04363697|Dapagliflozin|dapagliflozin|mesh-list
111287969|NCT04363697|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111287970|NCT04363697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111287971|NCT04363697|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111287972|NCT04363697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111287973|NCT04287049|Azithromycin|azithromycin|mesh-list
111287974|NCT04287049|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111287975|NCT04287049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111287976|NCT04282629|Milrinone|milrinone|mesh-list
111287977|NCT04282629|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111287978|NCT04282629|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111287979|NCT04282629|Vasodilator Agents|vasodilator agents|mesh-ancestor
111287980|NCT04282629|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
111287981|NCT04282629|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111287982|NCT04282629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111287983|NCT04282629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111287984|NCT04282629|Protective Agents|protective agents|mesh-ancestor
111287985|NCT04282629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111287986|NCT04275492|Pramipexole|pramipexole|mesh-list
111287987|NCT04275492|Antioxidants|antioxidants|mesh-ancestor
111287988|NCT04275492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111287989|NCT04275492|Protective Agents|protective agents|mesh-ancestor
111287990|NCT04275492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111287991|NCT04275492|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111287992|NCT04275492|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111287993|NCT04275492|Dopamine Agonists|dopamine agonists|mesh-ancestor
111287994|NCT04275492|Dopamine Agents|dopamine agents|mesh-ancestor
111287995|NCT04275492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111287996|NCT04265105|Fluticasone|fluticasone|mesh-list
111287997|NCT04265105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111287998|NCT04265105|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111287999|NCT04265105|Autonomic Agents|autonomic agents|mesh-ancestor
111288000|NCT04265105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111288001|NCT04265105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111288002|NCT04265105|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111288003|NCT04265105|Respiratory System Agents|respiratory system agents|mesh-ancestor
111288004|NCT04265105|Dermatologic Agents|dermatologic agents|mesh-ancestor
111288005|NCT04265105|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111288006|NCT04246229|Bilirubin|bilirubin|mesh-list
111288007|NCT04246229|Antioxidants|antioxidants|mesh-ancestor
111288008|NCT04246229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111288009|NCT04246229|Protective Agents|protective agents|mesh-ancestor
111288010|NCT04246229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111288011|NCT04239703|Antibodies|antibodies|mesh-list
111288012|NCT04239703|Immunologic Factors|immunologic factors|mesh-ancestor
111288013|NCT04239703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111288014|NCT04031833|Amphotericin B|amphotericin b|mesh-list
111288015|NCT04031833|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
111288016|NCT04031833|Amebicides|amebicides|mesh-ancestor
111288017|NCT04031833|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111288018|NCT04031833|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111288019|NCT04031833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111288020|NCT04031833|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111288021|NCT04031833|Antifungal Agents|antifungal agents|mesh-ancestor
111288022|NCT03943875|Vaccines|vaccines|mesh-list
111288023|NCT03943875|Immunologic Factors|immunologic factors|mesh-ancestor
111288024|NCT03943875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111288025|NCT03908307|Dexamethasone|dexamethasone|mesh-list
111288026|NCT03908307|Dexamethasone acetate|dexamethasone acetate|mesh-list
111288027|NCT03908307|BB 1101|bb 1101|mesh-list
111288028|NCT03908307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111288029|NCT03908307|Antiemetics|antiemetics|mesh-ancestor
111288030|NCT03908307|Autonomic Agents|autonomic agents|mesh-ancestor
111288031|NCT03908307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111288032|NCT03908307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111288033|NCT03908307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111288034|NCT03908307|Glucocorticoids|glucocorticoids|mesh-ancestor
111288035|NCT03908307|Hormones|hormones|mesh-ancestor
111288036|NCT03908307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111288037|NCT03908307|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111288038|NCT03908307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111288039|NCT03908307|Protease Inhibitors|protease inhibitors|mesh-ancestor
111288040|NCT03908307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111288041|NCT03908307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111288042|NCT03841058|Abaloparatide|abaloparatide|mesh-list
111288043|NCT03841058|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111288044|NCT03841058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111288045|NCT03723564|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111288046|NCT03688789|Hydrocortisone|hydrocortisone|mesh-list
111288047|NCT03688789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111288048|NCT03684590|Analgesics, Opioid|analgesics, opioid|mesh-list
111288049|NCT03684590|Narcotics|narcotics|mesh-ancestor
111288050|NCT03684590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111288051|NCT03684590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111288052|NCT03684590|Analgesics|analgesics|mesh-ancestor
111288053|NCT03684590|Sensory System Agents|sensory system agents|mesh-ancestor
111288054|NCT03684590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111288055|NCT03492775|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
111288056|NCT03492775|Obinutuzumab|obinutuzumab|mesh-list
111288057|NCT03492775|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111288058|NCT03492775|Alkylating Agents|alkylating agents|mesh-ancestor
111288059|NCT03492775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111288060|NCT03492775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111288061|NCT03492775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111288062|NCT03385304|Iodine|iodine|mesh-list
111288063|NCT03385304|Chlorhexidine|chlorhexidine|mesh-list
111288064|NCT03385304|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
111288065|NCT03385304|Povidone-Iodine|povidone-iodine|mesh-list
111288066|NCT03385304|Povidone|povidone|mesh-list
111288067|NCT03385304|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111288068|NCT03385304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111288069|NCT03385304|Disinfectants|disinfectants|mesh-ancestor
111288070|NCT03385304|Dermatologic Agents|dermatologic agents|mesh-ancestor
111288071|NCT03385304|Trace Elements|trace elements|mesh-ancestor
111288072|NCT03385304|Micronutrients|micronutrients|mesh-ancestor
111288073|NCT03385304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111288074|NCT03385304|Plasma Substitutes|plasma substitutes|mesh-ancestor
111288075|NCT03385304|Blood Substitutes|blood substitutes|mesh-ancestor
111288076|NCT03351998|Atorvastatin|atorvastatin|mesh-list
111288077|NCT03351998|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111288078|NCT03351998|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111288079|NCT03351998|Antimetabolites|antimetabolites|mesh-ancestor
111288080|NCT03351998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111288081|NCT03351998|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111288082|NCT03351998|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111288083|NCT03351998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111288084|NCT03285568|Palbociclib|palbociclib|mesh-list
111288085|NCT03285568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111288086|NCT03285568|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111288087|NCT03285568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111288088|NCT03285568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111288089|NCT03117816|Interferons|interferons|mesh-list
111288090|NCT03117816|Interferon-alpha|interferon-alpha|mesh-list
111288091|NCT03117816|Interferon alpha-2|interferon alpha-2|mesh-list
111288092|NCT03117816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111288093|NCT03117816|Antiviral Agents|antiviral agents|mesh-ancestor
111288094|NCT03117816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111288095|NCT03117816|Immunologic Factors|immunologic factors|mesh-ancestor
111288096|NCT03117816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111288097|NCT03038802|Vaccines|vaccines|mesh-list
111288098|NCT03038802|Immunologic Factors|immunologic factors|mesh-ancestor
111288099|NCT03038802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111288100|NCT02938793|Durvalumab|durvalumab|mesh-list
111288101|NCT02938793|Tremelimumab|tremelimumab|mesh-list
111288102|NCT02938793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111288103|NCT02938793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111288104|NCT02837094|Insulin|insulin|mesh-list
111288105|NCT02837094|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111288106|NCT02837094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111288107|NCT02836925|Sofosbuvir|sofosbuvir|mesh-list
111288108|NCT02836925|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
111288109|NCT02836925|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
111288110|NCT02836925|Ledipasvir|ledipasvir|mesh-list
111288111|NCT02836925|Velpatasvir|velpatasvir|mesh-list
111288112|NCT02836925|Antiviral Agents|antiviral agents|mesh-ancestor
111288113|NCT02836925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111288114|NCT02756962|Cytarabine|cytarabine|mesh-list
111288115|NCT02756962|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111288116|NCT02756962|Antimetabolites|antimetabolites|mesh-ancestor
111288117|NCT02756962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111288118|NCT02756962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111288119|NCT02756962|Antiviral Agents|antiviral agents|mesh-ancestor
111288120|NCT02756962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111288121|NCT02756962|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111288122|NCT02756962|Immunologic Factors|immunologic factors|mesh-ancestor
111288123|NCT02756962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111288124|NCT02728037|Lidocaine|lidocaine|mesh-list
111288125|NCT02728037|Magnesium Sulfate|magnesium sulfate|mesh-list
111288126|NCT02728037|Anesthetics, Local|anesthetics, local|mesh-ancestor
111288127|NCT02728037|Anesthetics|anesthetics|mesh-ancestor
111288128|NCT02728037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111288129|NCT02728037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111288130|NCT02728037|Sensory System Agents|sensory system agents|mesh-ancestor
111288131|NCT02728037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111288132|NCT02728037|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111288133|NCT02728037|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111288134|NCT02728037|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111288135|NCT02728037|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111288136|NCT02728037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111288137|NCT02728037|Analgesics|analgesics|mesh-ancestor
111288138|NCT02728037|Anticonvulsants|anticonvulsants|mesh-ancestor
111288139|NCT02728037|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111288140|NCT02728037|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111288141|NCT02728037|Tocolytic Agents|tocolytic agents|mesh-ancestor
111288142|NCT02728037|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111288143|NCT02546440|Dimethyl Fumarate|dimethyl fumarate|mesh-list
111288144|NCT02546440|Dermatologic Agents|dermatologic agents|mesh-ancestor
111288145|NCT02546440|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111288146|NCT02546440|Immunologic Factors|immunologic factors|mesh-ancestor
111288147|NCT02546440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111288148|NCT02392572|TIC10 compound|tic10 compound|mesh-list
111288149|NCT02392572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111288150|NCT02275780|Ritonavir|ritonavir|mesh-list
111288151|NCT02275780|Darunavir|darunavir|mesh-list
111288152|NCT02275780|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
111288153|NCT02275780|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111288154|NCT02275780|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111288155|NCT02275780|Protease Inhibitors|protease inhibitors|mesh-ancestor
111288156|NCT02275780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111288157|NCT02275780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111288158|NCT02275780|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111288159|NCT02275780|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111288160|NCT02275780|Antiviral Agents|antiviral agents|mesh-ancestor
111288161|NCT02275780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111288162|NCT02275780|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111288163|NCT02275780|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111288164|NCT02275780|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111288165|NCT02275780|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111288166|NCT02158091|Cyclophosphamide|cyclophosphamide|mesh-list
111288167|NCT02158091|Rituximab|rituximab|mesh-list
111288168|NCT02158091|Fludarabine|fludarabine|mesh-list
111288169|NCT02158091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111288170|NCT02158091|Immunologic Factors|immunologic factors|mesh-ancestor
111288171|NCT02158091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111288172|NCT02158091|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111288173|NCT02158091|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111288174|NCT02158091|Alkylating Agents|alkylating agents|mesh-ancestor
111288175|NCT02158091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111288176|NCT02158091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111012718|NCT05790577|Niacin|niacin|mesh-list
111288177|NCT02158091|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111288178|NCT02158091|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111288179|NCT00545077|Bevacizumab|bevacizumab|mesh-list
111288180|NCT00545077|Letrozole|letrozole|mesh-list
111288181|NCT00545077|Fulvestrant|fulvestrant|mesh-list
111288182|NCT00545077|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111288183|NCT00545077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111288184|NCT00545077|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111288185|NCT00545077|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111288186|NCT00545077|Growth Substances|growth substances|mesh-ancestor
111288187|NCT00545077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111288188|NCT00545077|Growth Inhibitors|growth inhibitors|mesh-ancestor
111288189|NCT00545077|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111288190|NCT00545077|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111288191|NCT00545077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111288192|NCT00545077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111288193|NCT00545077|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111288194|NCT00545077|Hormone Antagonists|hormone antagonists|mesh-ancestor
111288195|NCT00545077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111288196|NCT00545077|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111288197|NCT00545077|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
111288198|NCT00251433|Docetaxel|docetaxel|mesh-list
111288199|NCT00251433|Trastuzumab|trastuzumab|mesh-list
111288200|NCT00251433|Lapatinib|lapatinib|mesh-list
111288201|NCT00251433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111288202|NCT00251433|Tubulin Modulators|tubulin modulators|mesh-ancestor
111288203|NCT00251433|Antimitotic Agents|antimitotic agents|mesh-ancestor
111288204|NCT00251433|Mitosis Modulators|mitosis modulators|mesh-ancestor
111288205|NCT00251433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111288206|NCT00251433|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111288207|NCT00251433|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111288208|NCT00251433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111288209|NCT00130533|Capecitabine|capecitabine|mesh-list
111288210|NCT00130533|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111288211|NCT00130533|Antimetabolites|antimetabolites|mesh-ancestor
111288212|NCT00130533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111288213|NCT00130533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111288214|NCT00129935|Cyclophosphamide|cyclophosphamide|mesh-list
111288215|NCT00129935|Docetaxel|docetaxel|mesh-list
111288216|NCT00129935|Capecitabine|capecitabine|mesh-list
111288217|NCT00129935|Epirubicin|epirubicin|mesh-list
111288218|NCT00129935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111288219|NCT00129935|Immunologic Factors|immunologic factors|mesh-ancestor
111288220|NCT00129935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111288221|NCT00129935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111288222|NCT00129935|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111288223|NCT00129935|Alkylating Agents|alkylating agents|mesh-ancestor
111288224|NCT00129935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111288225|NCT00129935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111288226|NCT00129935|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111288227|NCT00129935|Tubulin Modulators|tubulin modulators|mesh-ancestor
111288228|NCT00129935|Antimitotic Agents|antimitotic agents|mesh-ancestor
111288229|NCT00129935|Mitosis Modulators|mitosis modulators|mesh-ancestor
111288230|NCT00129935|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111288231|NCT00129935|Antimetabolites|antimetabolites|mesh-ancestor
111288232|NCT00129935|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111288233|NCT00129935|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111288234|NCT00129935|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111288235|NCT00129935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111288236|NCT02760667|Cisplatin|cisplatin|mesh-list
111288237|NCT02760667|Carboplatin|carboplatin|mesh-list
111288238|NCT02760667|Docetaxel|docetaxel|mesh-list
111288239|NCT02760667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111288240|NCT02760667|Tubulin Modulators|tubulin modulators|mesh-ancestor
111288241|NCT02760667|Antimitotic Agents|antimitotic agents|mesh-ancestor
111288242|NCT02760667|Mitosis Modulators|mitosis modulators|mesh-ancestor
111288243|NCT02760667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111288244|NCT04127357|Fluorides|fluorides|mesh-list
111288245|NCT04127357|Cariostatic Agents|cariostatic agents|mesh-ancestor
111288246|NCT04127357|Protective Agents|protective agents|mesh-ancestor
111288247|NCT04127357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111288248|NCT01450111|Lacosamide|lacosamide|mesh-list
111288249|NCT01450111|Anticonvulsants|anticonvulsants|mesh-ancestor
111288250|NCT01450111|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111288251|NCT01450111|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111288252|NCT01450111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111288253|NCT01450111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111288254|NCT02697253|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111288255|NCT02697253|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111288256|NCT02697253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111288258|NCT02697253|Hormones|hormones|mesh-ancestor
111288259|NCT02697253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111288260|NCT02697253|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111288261|NCT02697253|Protease Inhibitors|protease inhibitors|mesh-ancestor
111288262|NCT02697253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111288263|NCT02697253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111288264|NCT02660905|Tenofovir|tenofovir|mesh-list
111288265|NCT02660905|Emtricitabine|emtricitabine|mesh-list
111288266|NCT02660905|Sofosbuvir|sofosbuvir|mesh-list
111288267|NCT02660905|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
111288268|NCT02660905|Rilpivirine|rilpivirine|mesh-list
111288269|NCT02660905|Ledipasvir|ledipasvir|mesh-list
111288270|NCT02660905|Antiviral Agents|antiviral agents|mesh-ancestor
111288271|NCT02660905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111288272|NCT02660905|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111288273|NCT02660905|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111288274|NCT02660905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111288275|NCT02660905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111288276|NCT02660905|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111288277|NCT02660905|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111288278|NCT03822715|Aromatase Inhibitors|aromatase inhibitors|mesh-list
111288279|NCT03822715|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111288280|NCT03822715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111288281|NCT03822715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111288282|NCT03822715|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111288283|NCT03822715|Hormone Antagonists|hormone antagonists|mesh-ancestor
111288284|NCT03822715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111288285|NCT03822715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111288286|NCT01450345|Pregabalin|pregabalin|mesh-list
111288287|NCT01450345|Analgesics|analgesics|mesh-ancestor
111288288|NCT01450345|Sensory System Agents|sensory system agents|mesh-ancestor
111288289|NCT01450345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111288290|NCT01450345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111288291|NCT01450345|Anticonvulsants|anticonvulsants|mesh-ancestor
111288292|NCT01450345|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111288293|NCT01450345|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111288294|NCT01450345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111288295|NCT01450345|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111288296|NCT01450345|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111288297|NCT01450345|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111288298|NCT01450345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111288299|NCT01450345|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111288300|NCT03822559|Timolol|timolol|mesh-list
111288301|NCT03822559|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111288302|NCT03822559|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111288303|NCT03822559|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111288304|NCT03822559|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111288305|NCT03822559|Adrenergic Agents|adrenergic agents|mesh-ancestor
111288306|NCT03822559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111288307|NCT03822559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111288308|NCT03822559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111288309|NCT03822559|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111288310|NCT03822559|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111288311|NCT01647828|Paclitaxel|paclitaxel|mesh-list
111288312|NCT01647828|Gemcitabine|gemcitabine|mesh-list
111288313|NCT01647828|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111288314|NCT01647828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111288315|NCT01647828|Tubulin Modulators|tubulin modulators|mesh-ancestor
111288316|NCT01647828|Antimitotic Agents|antimitotic agents|mesh-ancestor
111288317|NCT01647828|Mitosis Modulators|mitosis modulators|mesh-ancestor
111288318|NCT01647828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111288319|NCT01647828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111288320|NCT01647828|Antimetabolites|antimetabolites|mesh-ancestor
111288321|NCT03825367|Nivolumab|nivolumab|mesh-list
111288322|NCT03825367|Azacitidine|azacitidine|mesh-list
111288323|NCT03825367|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111288324|NCT03825367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111288325|NCT03825367|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111288326|NCT03825367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111288327|NCT03825367|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111288328|NCT03825367|Antimetabolites|antimetabolites|mesh-ancestor
111288329|NCT03825367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111288330|NCT04273321|Methylprednisolone|methylprednisolone|mesh-list
111288331|NCT04273321|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111288332|NCT04273321|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111288333|NCT04273321|Prednisolone|prednisolone|mesh-list
111288334|NCT04273321|Prednisolone acetate|prednisolone acetate|mesh-list
111288335|NCT04273321|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111288336|NCT04273321|Prednisolone phosphate|prednisolone phosphate|mesh-list
111288337|NCT04273321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111288338|NCT04273321|Antiemetics|antiemetics|mesh-ancestor
111288339|NCT04273321|Autonomic Agents|autonomic agents|mesh-ancestor
111288340|NCT04273321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111288341|NCT04273321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111288342|NCT04273321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111288343|NCT04273321|Glucocorticoids|glucocorticoids|mesh-ancestor
111288344|NCT04273321|Hormones|hormones|mesh-ancestor
111288345|NCT04273321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111288346|NCT04273321|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111288347|NCT04273321|Protective Agents|protective agents|mesh-ancestor
111288348|NCT04273321|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111288349|NCT04273321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111288350|NCT01243476|Lenalidomide|lenalidomide|mesh-list
111288351|NCT01243476|Immunologic Factors|immunologic factors|mesh-ancestor
111288352|NCT01243476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111288353|NCT01243476|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111288354|NCT01243476|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111288355|NCT01243476|Growth Substances|growth substances|mesh-ancestor
111288356|NCT01243476|Growth Inhibitors|growth inhibitors|mesh-ancestor
111288357|NCT01243476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111288358|NCT01453933|Raltegravir Potassium|raltegravir potassium|mesh-list
111288359|NCT01453933|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111288360|NCT01453933|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111288361|NCT01453933|Antiviral Agents|antiviral agents|mesh-ancestor
111288362|NCT01453933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111288363|NCT01453933|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111288364|NCT01453933|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111288365|NCT01453933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111288366|NCT01453933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111288367|NCT04976478|Nimotuzumab|nimotuzumab|mesh-list
111288368|NCT04976478|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111288369|NCT04976478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111288370|NCT01454011|Methyltestosterone|methyltestosterone|mesh-list
111288371|NCT01454011|Testosterone|testosterone|mesh-list
111288372|NCT01454011|Testosterone undecanoate|testosterone undecanoate|mesh-list
111288373|NCT01454011|Testosterone enanthate|testosterone enanthate|mesh-list
111288374|NCT01454011|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
111288375|NCT01454011|Androgens|androgens|mesh-ancestor
111288376|NCT01454011|Hormones|hormones|mesh-ancestor
111288377|NCT01454011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111288378|NCT01454011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111288379|NCT01454011|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111288380|NCT01454011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111288381|NCT01454011|Anabolic Agents|anabolic agents|mesh-ancestor
111288382|NCT03060018|Oxitropium|oxitropium|mesh-list
111288383|NCT03060018|Parasympatholytics|parasympatholytics|mesh-ancestor
111288384|NCT03060018|Autonomic Agents|autonomic agents|mesh-ancestor
111288385|NCT03060018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111288386|NCT03060018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111288387|NCT04976088|Diclofenac|diclofenac|mesh-list
111288388|NCT04976088|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
111288389|NCT04976088|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111288390|NCT04976088|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111288391|NCT04976088|Analgesics|analgesics|mesh-ancestor
111288392|NCT04976088|Sensory System Agents|sensory system agents|mesh-ancestor
111288393|NCT04976088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111288394|NCT04976088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111288395|NCT04976088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111288396|NCT04976088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111288397|NCT04976088|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111288398|NCT04976088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111288399|NCT04976088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111288400|NCT04975932|Chlorotrianisene|chlorotrianisene|mesh-list
111288401|NCT04975932|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
111288402|NCT04975932|Estrogens|estrogens|mesh-ancestor
111288403|NCT04975932|Hormones|hormones|mesh-ancestor
111288404|NCT04975932|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111288405|NCT04975932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111288406|NCT04975932|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111288407|NCT04975932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111288408|NCT04968132|Analgesics, Opioid|analgesics, opioid|mesh-list
111288409|NCT04968132|Narcotics|narcotics|mesh-ancestor
111288410|NCT04968132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111288411|NCT04968132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111288412|NCT04968132|Analgesics|analgesics|mesh-ancestor
111288413|NCT04968132|Sensory System Agents|sensory system agents|mesh-ancestor
111288414|NCT04968132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111288415|NCT01454479|Lapatinib|lapatinib|mesh-list
111288416|NCT01454479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111288417|NCT01454479|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111288418|NCT01454479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111288419|NCT01454479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111288420|NCT03061032|Ribavirin|ribavirin|mesh-list
111288421|NCT03061032|Sofosbuvir|sofosbuvir|mesh-list
111288422|NCT03061032|Ledipasvir|ledipasvir|mesh-list
111288423|NCT03061032|Antimetabolites|antimetabolites|mesh-ancestor
111288424|NCT03061032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111288425|NCT03061032|Antiviral Agents|antiviral agents|mesh-ancestor
111288426|NCT03061032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111288427|NCT02911831|Tranexamic Acid|tranexamic acid|mesh-list
111288428|NCT02911831|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111288429|NCT02911831|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111288430|NCT02911831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111288431|NCT02911831|Hemostatics|hemostatics|mesh-ancestor
111288432|NCT02911831|Coagulants|coagulants|mesh-ancestor
111288433|NCT03061734|Acetaminophen|acetaminophen|mesh-list
111288434|NCT03061734|Naltrexone|naltrexone|mesh-list
111288435|NCT03061734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111288436|NCT03061734|Analgesics|analgesics|mesh-ancestor
111288437|NCT03061734|Sensory System Agents|sensory system agents|mesh-ancestor
111288438|NCT03061734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111288439|NCT03061734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111288440|NCT03061734|Antipyretics|antipyretics|mesh-ancestor
111288441|NCT03061734|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111288442|NCT03061734|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111288443|NCT03061656|Cyclophosphamide|cyclophosphamide|mesh-list
111288444|NCT03061656|Melphalan|melphalan|mesh-list
111288445|NCT03061656|Thiotepa|thiotepa|mesh-list
111288446|NCT03061656|Carboplatin|carboplatin|mesh-list
111288447|NCT03061656|Etoposide|etoposide|mesh-list
111288448|NCT03061656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111288449|NCT03061656|Immunologic Factors|immunologic factors|mesh-ancestor
111288450|NCT03061656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111288451|NCT03061656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111288452|NCT03061656|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111288453|NCT03061656|Alkylating Agents|alkylating agents|mesh-ancestor
111288454|NCT03061656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111288455|NCT03061656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111288456|NCT03061656|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111288457|NCT03061656|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111288458|NCT03061656|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111288459|NCT03061656|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111288460|NCT03061656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111288461|NCT02906761|Aspirin|aspirin|mesh-list
111288462|NCT02906761|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111288463|NCT02906761|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111288464|NCT02906761|Analgesics|analgesics|mesh-ancestor
111288465|NCT02906761|Sensory System Agents|sensory system agents|mesh-ancestor
111288466|NCT02906761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111288467|NCT02906761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111288468|NCT02906761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111288469|NCT02906761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111288470|NCT02906761|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111288471|NCT02906761|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111288472|NCT02906761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111288473|NCT02906761|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111288474|NCT02906761|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111288475|NCT02906761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111288476|NCT02906761|Antipyretics|antipyretics|mesh-ancestor
111013017|NCT04937738|Leucovorin|leucovorin|mesh-list
111288478|NCT01455025|Lenograstim|lenograstim|mesh-list
111288479|NCT01455025|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111288480|NCT01455025|Immunologic Factors|immunologic factors|mesh-ancestor
111288481|NCT01455025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111288482|NCT01455025|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111288483|NCT01455025|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111288484|NCT01455025|Antiviral Agents|antiviral agents|mesh-ancestor
111288485|NCT01455025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111288486|NCT03060798|Desflurane|desflurane|mesh-list
111288487|NCT03060798|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111288488|NCT03060798|Anesthetics, General|anesthetics, general|mesh-ancestor
111288489|NCT03060798|Anesthetics|anesthetics|mesh-ancestor
111288490|NCT03060798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111288491|NCT03060798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111288492|NCT01451593|Phenytoin|phenytoin|mesh-list
111288493|NCT01451593|Anticonvulsants|anticonvulsants|mesh-ancestor
111288494|NCT01451593|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111288495|NCT01451593|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111288496|NCT01451593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111288497|NCT01451593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111288498|NCT01451593|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
111288499|NCT01451593|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111288500|NCT01455103|BMS-936559|bms-936559|mesh-list
111288501|NCT01455103|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111288502|NCT01455103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111288503|NCT01455103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111288504|NCT01455103|Immunologic Factors|immunologic factors|mesh-ancestor
111288505|NCT01455103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111288506|NCT04975074|Iron|iron|mesh-list
111288507|NCT04975074|Ferrous succinate|ferrous succinate|mesh-list
111288508|NCT04975074|Trace Elements|trace elements|mesh-ancestor
111288509|NCT04975074|Micronutrients|micronutrients|mesh-ancestor
111288510|NCT04975074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111288511|NCT04975074|Hematinics|hematinics|mesh-ancestor
111288512|NCT04963998|Copper|copper|mesh-list
111288513|NCT04963998|Trace Elements|trace elements|mesh-ancestor
111288514|NCT04963998|Micronutrients|micronutrients|mesh-ancestor
111288515|NCT04963998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111288516|NCT01451905|Liraglutide|liraglutide|mesh-list
111288517|NCT01451905|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111288518|NCT01451905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111288519|NCT01451905|Incretins|incretins|mesh-ancestor
111288520|NCT01451905|Hormones|hormones|mesh-ancestor
111288521|NCT01451905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111288522|NCT01455649|Cyclosporine|cyclosporine|mesh-list
111288523|NCT01455649|Everolimus|everolimus|mesh-list
111288524|NCT01455649|Tacrolimus|tacrolimus|mesh-list
111288525|NCT01455649|Cyclosporins|cyclosporins|mesh-list
111288526|NCT01455649|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
111288527|NCT01455649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111288528|NCT01455649|Immunologic Factors|immunologic factors|mesh-ancestor
111288529|NCT01455649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111288530|NCT01455649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111288531|NCT01455649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111288532|NCT01455649|Antifungal Agents|antifungal agents|mesh-ancestor
111288533|NCT01455649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111288534|NCT01455649|Dermatologic Agents|dermatologic agents|mesh-ancestor
111288535|NCT01455649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111288536|NCT01455649|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111288537|NCT01455649|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111288538|NCT01455649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111288539|NCT04974294|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
111288540|NCT04974294|Immunologic Factors|immunologic factors|mesh-ancestor
111288541|NCT04974294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111288542|NCT01452139|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
111288543|NCT01452139|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111288544|NCT04852458|Hydrocortisone|hydrocortisone|mesh-list
111288545|NCT04852458|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
111288546|NCT04852458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111288547|NCT01455883|Glimepiride|glimepiride|mesh-list
111288548|NCT01455883|Exenatide|exenatide|mesh-list
111288549|NCT01455883|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111288550|NCT01455883|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111288551|NCT01455883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111013097|NCT04570956|Tamoxifen|tamoxifen|mesh-list
111288552|NCT01455883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111288553|NCT01455883|Immunologic Factors|immunologic factors|mesh-ancestor
111288554|NCT01455883|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111288556|NCT01455883|Hormones|hormones|mesh-ancestor
111288557|NCT01455883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111288558|NCT01452217|Secretin|secretin|mesh-list
111288559|NCT01452217|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111288560|NCT01452217|Hormones|hormones|mesh-ancestor
111288561|NCT01452217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111288562|NCT01452217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111288563|NCT04966884|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
111288564|NCT04966884|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111288565|NCT04966884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111288566|NCT04966884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111288567|NCT02637583|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
111288568|NCT02637583|Immunologic Factors|immunologic factors|mesh-ancestor
111288569|NCT02637583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111288570|NCT04954560|Losartan|losartan|mesh-list
111288571|NCT04954560|Eprosartan|eprosartan|mesh-list
111288572|NCT04954560|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111288573|NCT04954560|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111288574|NCT04954560|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111288575|NCT04954560|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111288576|NCT04954560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111288577|NCT04954560|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
111288578|NCT01456117|Pioglitazone|pioglitazone|mesh-list
111288579|NCT01456117|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111288580|NCT01456117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111288581|NCT03829345|Olaparib|olaparib|mesh-list
111288582|NCT03829345|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111288583|NCT03829345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111288584|NCT03829345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111288585|NCT03829345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111288586|NCT01456351|Rituximab|rituximab|mesh-list
111288587|NCT01456351|Fludarabine|fludarabine|mesh-list
111288588|NCT01456351|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
111288589|NCT01456351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111288590|NCT01456351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111288591|NCT01456351|Immunologic Factors|immunologic factors|mesh-ancestor
111288592|NCT01456351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111288593|NCT01456351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111288594|NCT01456351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111288595|NCT01456351|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111288596|NCT01456351|Alkylating Agents|alkylating agents|mesh-ancestor
111288597|NCT02541955|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
111288598|NCT02541955|Hormones|hormones|mesh-ancestor
111288599|NCT02541955|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111288600|NCT02541955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111288601|NCT01452685|Leuprolide|leuprolide|mesh-list
111288602|NCT01452685|Relugolix|relugolix|mesh-list
111288603|NCT01452685|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111288604|NCT01452685|Fertility Agents|fertility agents|mesh-ancestor
111288605|NCT01452685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111288606|NCT01452685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111288607|NCT01452685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111288608|NCT01452685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111288609|NCT01452685|Androgen Antagonists|androgen antagonists|mesh-ancestor
111288610|NCT01452685|Hormone Antagonists|hormone antagonists|mesh-ancestor
111288611|NCT01452685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111288612|NCT01452763|Lansoprazole|lansoprazole|mesh-list
111288613|NCT01452763|Dexlansoprazole|dexlansoprazole|mesh-list
111288614|NCT01452763|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111288615|NCT01452763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111288616|NCT01452763|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111288617|NCT01452763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111288618|NCT01452763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111288619|NCT04954014|Bevacizumab|bevacizumab|mesh-list
111288620|NCT04954014|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111288621|NCT04954014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111288622|NCT04954014|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111288623|NCT04954014|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111288624|NCT04954014|Growth Substances|growth substances|mesh-ancestor
111288625|NCT04954014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111288626|NCT04954014|Growth Inhibitors|growth inhibitors|mesh-ancestor
111288627|NCT00988559|Imiquimod|imiquimod|mesh-list
111288628|NCT00988559|Vaccines|vaccines|mesh-list
111288629|NCT00988559|Immunologic Factors|immunologic factors|mesh-ancestor
111288630|NCT00988559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111288631|NCT00988559|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111288632|NCT00988559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111288633|NCT00988559|Interferon Inducers|interferon inducers|mesh-ancestor
111288634|NCT00988169|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111288635|NCT00988169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111288636|NCT00988169|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111288637|NCT00988169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111288638|NCT00988169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111288639|NCT02967133|Paclitaxel|paclitaxel|mesh-list
111288640|NCT02967133|Nivolumab|nivolumab|mesh-list
111288641|NCT02967133|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111288642|NCT02967133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111288643|NCT02967133|Tubulin Modulators|tubulin modulators|mesh-ancestor
111288644|NCT02967133|Antimitotic Agents|antimitotic agents|mesh-ancestor
111288645|NCT02967133|Mitosis Modulators|mitosis modulators|mesh-ancestor
111288646|NCT02967133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111288647|NCT02967133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111288648|NCT02967133|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111288649|NCT04961970|Leucovorin|leucovorin|mesh-list
111288650|NCT04961970|Gemcitabine|gemcitabine|mesh-list
111288651|NCT04961970|Fluorouracil|fluorouracil|mesh-list
111288652|NCT04961970|Oxaliplatin|oxaliplatin|mesh-list
111288653|NCT04961970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111288654|NCT04961970|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111288655|NCT04961970|Antimetabolites|antimetabolites|mesh-ancestor
111288656|NCT04961970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111288657|NCT04961970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111288658|NCT04961970|Immunologic Factors|immunologic factors|mesh-ancestor
111288659|NCT04961970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111288660|NCT04961970|Antidotes|antidotes|mesh-ancestor
111288661|NCT04961970|Protective Agents|protective agents|mesh-ancestor
111288662|NCT04961970|Vitamin B Complex|vitamin b complex|mesh-ancestor
111288663|NCT04961970|Vitamins|vitamins|mesh-ancestor
111288664|NCT04961970|Micronutrients|micronutrients|mesh-ancestor
111288665|NCT01311687|Dexamethasone|dexamethasone|mesh-list
111288666|NCT01311687|Pomalidomide|pomalidomide|mesh-list
111288667|NCT01311687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111288668|NCT01311687|Antiemetics|antiemetics|mesh-ancestor
111288669|NCT01311687|Autonomic Agents|autonomic agents|mesh-ancestor
111288670|NCT01311687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111288671|NCT01311687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111288672|NCT01311687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111288673|NCT01311687|Glucocorticoids|glucocorticoids|mesh-ancestor
111288674|NCT01311687|Hormones|hormones|mesh-ancestor
111288675|NCT01311687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111288676|NCT01311687|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111288677|NCT01311687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111288678|NCT01311687|Immunologic Factors|immunologic factors|mesh-ancestor
111288679|NCT01311687|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111288680|NCT01311687|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111288681|NCT01311687|Growth Substances|growth substances|mesh-ancestor
111288682|NCT01311687|Growth Inhibitors|growth inhibitors|mesh-ancestor
111288683|NCT00988091|Hyaluronic Acid|hyaluronic acid|mesh-list
111288684|NCT00988091|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111288685|NCT00988091|Immunologic Factors|immunologic factors|mesh-ancestor
111288686|NCT00988091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111288687|NCT00988091|Viscosupplements|viscosupplements|mesh-ancestor
111288688|NCT00988091|Protective Agents|protective agents|mesh-ancestor
111288689|NCT04965324|Anesthetics|anesthetics|mesh-list
111288690|NCT04965324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111288691|NCT04965324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111288692|NCT04961268|Acetaminophen|acetaminophen|mesh-list
111288693|NCT04961268|Ibuprofen|ibuprofen|mesh-list
111288694|NCT04961268|Tramadol|tramadol|mesh-list
111288695|NCT04961268|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111288696|NCT04961268|Analgesics|analgesics|mesh-ancestor
111288697|NCT04961268|Sensory System Agents|sensory system agents|mesh-ancestor
111013245|NCT04126200|Growth Inhibitors|growth inhibitors|mesh-ancestor
111288698|NCT04961268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111288699|NCT04961268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111288700|NCT04961268|Antipyretics|antipyretics|mesh-ancestor
111288701|NCT04961268|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111288702|NCT04961268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111288704|NCT04961268|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111288705|NCT04961268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111288706|NCT04961268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111288707|NCT04961268|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111288708|NCT04961268|Narcotics|narcotics|mesh-ancestor
111288709|NCT04961268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111288710|NCT03828643|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111288711|NCT03828643|Immunologic Factors|immunologic factors|mesh-ancestor
111288712|NCT03828643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111288713|NCT01346397|Cyclosporine|cyclosporine|mesh-list
111288714|NCT01346397|Tacrolimus|tacrolimus|mesh-list
111288715|NCT01346397|Cyclosporins|cyclosporins|mesh-list
111288716|NCT01346397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111288717|NCT01346397|Immunologic Factors|immunologic factors|mesh-ancestor
111288718|NCT01346397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111288719|NCT01346397|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111288720|NCT01346397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111288721|NCT01346397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111288722|NCT01346397|Antifungal Agents|antifungal agents|mesh-ancestor
111288723|NCT01346397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111288724|NCT01346397|Dermatologic Agents|dermatologic agents|mesh-ancestor
111288725|NCT01346397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111288726|NCT01347255|Betamethasone|betamethasone|mesh-list
111288727|NCT01347255|Betamethasone Valerate|betamethasone valerate|mesh-list
111288728|NCT01347255|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
111288729|NCT01347255|Betamethasone benzoate|betamethasone benzoate|mesh-list
111288730|NCT01347255|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
111288731|NCT01347255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111288732|NCT01347255|Glucocorticoids|glucocorticoids|mesh-ancestor
111288733|NCT01347255|Hormones|hormones|mesh-ancestor
111288734|NCT01347255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111288735|NCT01347255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111288736|NCT01347255|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111288737|NCT01347255|Respiratory System Agents|respiratory system agents|mesh-ancestor
111288738|NCT04392427|Ribavirin|ribavirin|mesh-list
111288739|NCT04392427|Ivermectin|ivermectin|mesh-list
111288740|NCT04392427|Nitazoxanide|nitazoxanide|mesh-list
111288741|NCT04392427|Antimetabolites|antimetabolites|mesh-ancestor
111288742|NCT04392427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111288743|NCT04392427|Antiviral Agents|antiviral agents|mesh-ancestor
111288744|NCT04392427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111288745|NCT04392427|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111288746|NCT01457131|Cyclophosphamide|cyclophosphamide|mesh-list
111288747|NCT01457131|Fludarabine|fludarabine|mesh-list
111288748|NCT01457131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111288749|NCT01457131|Immunologic Factors|immunologic factors|mesh-ancestor
111288750|NCT01457131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111288751|NCT01457131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111288752|NCT01457131|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111288753|NCT01457131|Alkylating Agents|alkylating agents|mesh-ancestor
111288754|NCT01457131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111288755|NCT01457131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111288756|NCT01457131|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111288757|NCT03057990|Pyrimethamine|pyrimethamine|mesh-list
111288758|NCT03057990|Antimalarials|antimalarials|mesh-ancestor
111288759|NCT03057990|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111288760|NCT03057990|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111288761|NCT03057990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111288762|NCT03057990|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111288763|NCT03057990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111288764|NCT03057990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111288765|NCT01455337|Prednisolone|prednisolone|mesh-list
111288766|NCT01455337|Pentoxifylline|pentoxifylline|mesh-list
111288767|NCT01455337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111288768|NCT01455337|Glucocorticoids|glucocorticoids|mesh-ancestor
111288769|NCT01455337|Hormones|hormones|mesh-ancestor
111288770|NCT01455337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111288771|NCT01455337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111288772|NCT01455337|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111288773|NCT01455337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111288774|NCT01455337|Protective Agents|protective agents|mesh-ancestor
111288775|NCT01455337|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111288776|NCT01455337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111288777|NCT01455337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111288778|NCT01455337|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111288779|NCT01455337|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111288780|NCT01455337|Vasodilator Agents|vasodilator agents|mesh-ancestor
111288781|NCT01455337|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111288782|NCT01455337|Antioxidants|antioxidants|mesh-ancestor
111288783|NCT03059316|Labetalol|labetalol|mesh-list
111288784|NCT03059316|Nitroglycerin|nitroglycerin|mesh-list
111288785|NCT03059316|Vasodilator Agents|vasodilator agents|mesh-ancestor
111288786|NCT03059316|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111288787|NCT03059316|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111288788|NCT03059316|Adrenergic Agents|adrenergic agents|mesh-ancestor
111288789|NCT03059316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111288790|NCT03059316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111288791|NCT03059316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111288792|NCT03059316|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111288793|NCT03059316|Sympathomimetics|sympathomimetics|mesh-ancestor
111288794|NCT03059316|Autonomic Agents|autonomic agents|mesh-ancestor
111288795|NCT03059316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111288796|NCT03059316|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111288797|NCT03059316|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111288798|NCT01312389|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
111288799|NCT01312389|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
111288800|NCT01312389|Immunologic Factors|immunologic factors|mesh-ancestor
111288801|NCT01312389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111288802|NCT01312389|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111288803|NCT01312389|Antiviral Agents|antiviral agents|mesh-ancestor
111288804|NCT01312389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111288805|NCT04943952|Asparaginase|asparaginase|mesh-list
111288806|NCT04943952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111288807|NCT01352637|Cycloserine|cycloserine|mesh-list
111288808|NCT01352637|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111288809|NCT01352637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111288810|NCT01352637|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111288811|NCT01352637|Antitubercular Agents|antitubercular agents|mesh-ancestor
111288812|NCT01352637|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111288813|NCT01352637|Antimetabolites|antimetabolites|mesh-ancestor
111288814|NCT01352637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111288815|NCT03058536|Progesterone|progesterone|mesh-list
111288816|NCT03058536|Progestins|progestins|mesh-ancestor
111288817|NCT03058536|Hormones|hormones|mesh-ancestor
111288818|NCT03058536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111288819|NCT03058536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111288820|NCT01314417|Methotrexate|methotrexate|mesh-list
111288821|NCT01314417|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111288822|NCT01314417|Abortifacient Agents|abortifacient agents|mesh-ancestor
111288823|NCT01314417|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111288824|NCT01314417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111288825|NCT01314417|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111288826|NCT01314417|Antimetabolites|antimetabolites|mesh-ancestor
111288827|NCT01314417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111288828|NCT01314417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111288829|NCT01314417|Dermatologic Agents|dermatologic agents|mesh-ancestor
111288830|NCT01314417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111288831|NCT01314417|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111288832|NCT01314417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111288833|NCT01314417|Immunologic Factors|immunologic factors|mesh-ancestor
111288834|NCT01314417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111288835|NCT01314417|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111288836|NCT01457911|Metformin|metformin|mesh-list
111288837|NCT01457911|Glimepiride|glimepiride|mesh-list
111288838|NCT01457911|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111288839|NCT01457911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111288840|NCT01457911|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111288841|NCT01457911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111288842|NCT01457911|Immunologic Factors|immunologic factors|mesh-ancestor
111288843|NCT02893423|Ropivacaine|ropivacaine|mesh-list
111288844|NCT02893423|Anesthetics, Local|anesthetics, local|mesh-ancestor
111288845|NCT02893423|Anesthetics|anesthetics|mesh-ancestor
111288846|NCT02893423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111288847|NCT02893423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111288848|NCT02893423|Sensory System Agents|sensory system agents|mesh-ancestor
111288849|NCT02893423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111288850|NCT05586919|Ethanol|ethanol|mesh-list
111288851|NCT05586919|Polidocanol|polidocanol|mesh-list
111288852|NCT05586919|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111288853|NCT05586919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111288854|NCT05586919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111288855|NCT05586919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111288856|NCT05586919|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
111288857|NCT05586919|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111288859|NCT01890889|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111288860|NCT01890889|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111288861|NCT01890889|Antimetabolites|antimetabolites|mesh-ancestor
111288862|NCT01890889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111288863|NCT01890889|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111288864|NCT04951752|Ropivacaine|ropivacaine|mesh-list
111288865|NCT04951752|Anesthetics, Local|anesthetics, local|mesh-ancestor
111288866|NCT04951752|Anesthetics|anesthetics|mesh-ancestor
111288867|NCT04951752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111288868|NCT04951752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111288869|NCT04951752|Sensory System Agents|sensory system agents|mesh-ancestor
111288870|NCT04951752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111288871|NCT01315665|Sulforaphane|sulforaphane|mesh-list
111288872|NCT01315665|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
111288873|NCT01315665|Protective Agents|protective agents|mesh-ancestor
111288874|NCT01315665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111288875|NCT01315665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111288876|NCT01454089|Carboplatin|carboplatin|mesh-list
111288877|NCT01454089|Gemcitabine|gemcitabine|mesh-list
111288878|NCT01454089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111288879|NCT01454089|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111288880|NCT01454089|Antimetabolites|antimetabolites|mesh-ancestor
111288881|NCT01454089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111288882|NCT01457989|Ezogabine|ezogabine|mesh-list
111288883|NCT01457989|Anticonvulsants|anticonvulsants|mesh-ancestor
111288884|NCT01457989|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111288885|NCT01457989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111288886|NCT01458067|GSK2636771|gsk2636771|mesh-list
111288887|NCT01458067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111288888|NCT01458067|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111288889|NCT01458067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111288890|NCT01458067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111288891|NCT01458223|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111288892|NCT01458223|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
111288893|NCT01458223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111288894|NCT01458223|Antitubercular Agents|antitubercular agents|mesh-ancestor
111288895|NCT04959786|Ribavirin|ribavirin|mesh-list
111288896|NCT04959786|Ivermectin|ivermectin|mesh-list
111288897|NCT04959786|Nitazoxanide|nitazoxanide|mesh-list
111288898|NCT04959786|Antimetabolites|antimetabolites|mesh-ancestor
111288899|NCT04959786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111288900|NCT04959786|Antiviral Agents|antiviral agents|mesh-ancestor
111288901|NCT04959786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111288902|NCT04959786|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111288903|NCT01452451|Exenatide|exenatide|mesh-list
111288904|NCT01452451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111288905|NCT01452451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111288906|NCT01452451|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111288907|NCT01452451|Incretins|incretins|mesh-ancestor
111288908|NCT01452451|Hormones|hormones|mesh-ancestor
111288909|NCT01452451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111288910|NCT04951128|Anesthetics|anesthetics|mesh-list
111288911|NCT04951128|Anesthetics, Local|anesthetics, local|mesh-list
111288912|NCT04951128|Tranexamic Acid|tranexamic acid|mesh-list
111288913|NCT04951128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111288914|NCT04951128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111288915|NCT04951128|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111288916|NCT04951128|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111288917|NCT04951128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111288918|NCT04951128|Hemostatics|hemostatics|mesh-ancestor
111288919|NCT04951128|Coagulants|coagulants|mesh-ancestor
111288920|NCT04951128|Sensory System Agents|sensory system agents|mesh-ancestor
111288921|NCT04951128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111288922|NCT01458301|Leuprolide|leuprolide|mesh-list
111288923|NCT01458301|Relugolix|relugolix|mesh-list
111288924|NCT01458301|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111288925|NCT01458301|Fertility Agents|fertility agents|mesh-ancestor
111288926|NCT01458301|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111288927|NCT01458301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111288928|NCT01458301|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111013472|NCT03339635|Hormones|hormones|mesh-ancestor
111288930|NCT01458301|Androgen Antagonists|androgen antagonists|mesh-ancestor
111288931|NCT01458301|Hormone Antagonists|hormone antagonists|mesh-ancestor
111288932|NCT01458301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111288933|NCT03059238|Celecoxib|celecoxib|mesh-list
111288934|NCT03059238|Parecoxib|parecoxib|mesh-list
111288935|NCT03059238|Oxycodone|oxycodone|mesh-list
111288936|NCT03059238|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111288937|NCT03059238|Narcotics|narcotics|mesh-ancestor
111288938|NCT03059238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111288939|NCT03059238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111288940|NCT03059238|Analgesics|analgesics|mesh-ancestor
111288941|NCT03059238|Sensory System Agents|sensory system agents|mesh-ancestor
111288942|NCT03059238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111288943|NCT03059238|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111288944|NCT03059238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111288945|NCT03059238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111288946|NCT03059238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111288947|NCT03059238|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111288948|NCT03059238|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111288949|NCT03059238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111288950|NCT03059238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111288951|NCT01891201|Oxytocin|oxytocin|mesh-list
111288952|NCT01891201|Oxytocics|oxytocics|mesh-ancestor
111288953|NCT01891201|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111288954|NCT01891201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111288955|NCT04942002|Methylprednisolone|methylprednisolone|mesh-list
111288956|NCT04942002|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111288957|NCT04942002|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111288958|NCT04942002|Prednisolone|prednisolone|mesh-list
111288959|NCT04942002|Prednisolone acetate|prednisolone acetate|mesh-list
111288960|NCT04942002|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111288961|NCT04942002|Prednisolone phosphate|prednisolone phosphate|mesh-list
111288962|NCT04942002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111288963|NCT04942002|Antiemetics|antiemetics|mesh-ancestor
111288964|NCT04942002|Autonomic Agents|autonomic agents|mesh-ancestor
111288965|NCT04942002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111288966|NCT04942002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111288967|NCT04942002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111288968|NCT04942002|Glucocorticoids|glucocorticoids|mesh-ancestor
111288969|NCT04942002|Hormones|hormones|mesh-ancestor
111288970|NCT04942002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111288971|NCT04942002|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111288972|NCT04942002|Protective Agents|protective agents|mesh-ancestor
111288973|NCT04942002|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111288974|NCT04942002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111288975|NCT01891435|Acetaminophen|acetaminophen|mesh-list
111288976|NCT01891435|Diclofenac|diclofenac|mesh-list
111288977|NCT01891435|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111288978|NCT01891435|Analgesics|analgesics|mesh-ancestor
111288979|NCT01891435|Sensory System Agents|sensory system agents|mesh-ancestor
111288980|NCT01891435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111288981|NCT01891435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111288982|NCT01891435|Antipyretics|antipyretics|mesh-ancestor
111288983|NCT01891435|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111288984|NCT01891435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111288985|NCT01891435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111288986|NCT01891435|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111288987|NCT01891435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111288988|NCT01891435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111288989|NCT01458769|Atazanavir Sulfate|atazanavir sulfate|mesh-list
111288990|NCT01458769|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111288991|NCT01458769|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111288992|NCT01458769|Protease Inhibitors|protease inhibitors|mesh-ancestor
111288993|NCT01458769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111288994|NCT01458769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111288995|NCT01458769|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111288996|NCT01458769|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111288997|NCT01458769|Antiviral Agents|antiviral agents|mesh-ancestor
111288998|NCT01458769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111288999|NCT01458847|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111289000|NCT04941846|Nimodipine|nimodipine|mesh-list
111289001|NCT04941846|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111289002|NCT04941846|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111289003|NCT04941846|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111289004|NCT04941846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111289005|NCT04941846|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111289006|NCT04941846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111289007|NCT04941846|Vasodilator Agents|vasodilator agents|mesh-ancestor
111289008|NCT01891513|Losartan|losartan|mesh-list
111289009|NCT01891513|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
111289010|NCT01891513|Perindopril|perindopril|mesh-list
111289011|NCT01891513|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
111289012|NCT01891513|Diuretics|diuretics|mesh-list
111289013|NCT01891513|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
111289014|NCT01891513|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
111289015|NCT01891513|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111289016|NCT01891513|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111289017|NCT01891513|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111289018|NCT01891513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111289019|NCT01891513|Natriuretic Agents|natriuretic agents|mesh-ancestor
111289020|NCT01891513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111289021|NCT01891513|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111289022|NCT01891513|Protease Inhibitors|protease inhibitors|mesh-ancestor
111289023|NCT01891513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111289024|NCT04843423|Cariprazine|cariprazine|mesh-list
111289025|NCT04843423|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111289026|NCT04843423|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111289027|NCT04843423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111289028|NCT04843423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111289029|NCT04843423|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111289030|NCT01459081|Zanamivir|zanamivir|mesh-list
111289031|NCT01459081|Antiviral Agents|antiviral agents|mesh-ancestor
111289032|NCT01459081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111289033|NCT01459081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111289034|NCT01459081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111289035|NCT04421196|Analgesics, Opioid|analgesics, opioid|mesh-list
111289036|NCT04421196|Analgesics|analgesics|mesh-list
111289037|NCT04421196|Narcotics|narcotics|mesh-ancestor
111289038|NCT04421196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111289039|NCT04421196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111289040|NCT04421196|Sensory System Agents|sensory system agents|mesh-ancestor
111289041|NCT04421196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111289042|NCT01459315|Dolutegravir|dolutegravir|mesh-list
111289043|NCT01459315|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111289044|NCT01459315|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111289045|NCT01459315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111289046|NCT01459315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111289047|NCT01459315|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111289048|NCT01459315|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111289049|NCT01459315|Antiviral Agents|antiviral agents|mesh-ancestor
111289050|NCT01459315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111289051|NCT04948788|Gemcitabine|gemcitabine|mesh-list
111289052|NCT04948788|Oxaliplatin|oxaliplatin|mesh-list
111289053|NCT04948788|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111289054|NCT04948788|Antimetabolites|antimetabolites|mesh-ancestor
111289055|NCT04948788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111289056|NCT04948788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111289057|NCT02865811|Doxorubicin|doxorubicin|mesh-list
111289058|NCT02865811|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111289059|NCT02865811|Pembrolizumab|pembrolizumab|mesh-list
111289060|NCT02865811|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111289061|NCT02865811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111289062|NCT02865811|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111289063|NCT02865811|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111289064|NCT02865811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111289065|NCT02865811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111289066|NCT02865811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111289067|NCT02865811|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111289068|NCT03058224|Acetaminophen|acetaminophen|mesh-list
111289069|NCT03058224|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111289070|NCT03058224|Analgesics|analgesics|mesh-ancestor
111289071|NCT03058224|Sensory System Agents|sensory system agents|mesh-ancestor
111289072|NCT03058224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111289073|NCT03058224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111289074|NCT03058224|Antipyretics|antipyretics|mesh-ancestor
111289075|NCT04957212|Carboplatin|carboplatin|mesh-list
111289076|NCT04957212|Docetaxel|docetaxel|mesh-list
111289077|NCT04957212|Trastuzumab|trastuzumab|mesh-list
111013618|NCT02134327|Anesthetics, General|anesthetics, general|mesh-ancestor
111289078|NCT04957212|Pertuzumab|pertuzumab|mesh-list
111289079|NCT04957212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111289080|NCT04957212|Tubulin Modulators|tubulin modulators|mesh-ancestor
111289081|NCT04957212|Antimitotic Agents|antimitotic agents|mesh-ancestor
111289082|NCT04957212|Mitosis Modulators|mitosis modulators|mesh-ancestor
111289083|NCT04957212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111289084|NCT04957212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111289085|NCT02879617|Durvalumab|durvalumab|mesh-list
111289086|NCT02879617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111289087|NCT02879617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111289088|NCT04390789|Calcium|calcium|mesh-list
111289089|NCT04390789|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111289090|NCT04390789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111289091|NCT04947774|Immunomodulating Agents|immunomodulating agents|mesh-list
111289092|NCT04947774|Immunologic Factors|immunologic factors|mesh-ancestor
111289093|NCT04947774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111289094|NCT04948164|Naproxen|naproxen|mesh-list
111289095|NCT04948164|Sumatriptan|sumatriptan|mesh-list
111289096|NCT04948164|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111289097|NCT04948164|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111289098|NCT04948164|Analgesics|analgesics|mesh-ancestor
111289099|NCT04948164|Sensory System Agents|sensory system agents|mesh-ancestor
111289100|NCT04948164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111289101|NCT04948164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111289102|NCT04948164|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111289103|NCT04948164|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111289104|NCT04948164|Gout Suppressants|gout suppressants|mesh-ancestor
111289105|NCT04948164|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111289106|NCT04948164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111289107|NCT04948164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111289108|NCT04948164|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111289109|NCT04948164|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111289110|NCT04948164|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111289111|NCT04948164|Serotonin Agents|serotonin agents|mesh-ancestor
111289112|NCT04948164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111289113|NCT02808871|Pirfenidone|pirfenidone|mesh-list
111289114|NCT02808871|Analgesics|analgesics|mesh-ancestor
111289115|NCT02808871|Sensory System Agents|sensory system agents|mesh-ancestor
111289116|NCT02808871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111289117|NCT02808871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111289118|NCT02808871|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111289119|NCT02808871|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111289120|NCT02808871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111289121|NCT02808871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111289122|NCT02808871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111289123|NCT01892683|Propofol|propofol|mesh-list
111289124|NCT01892683|Anesthetics|anesthetics|mesh-ancestor
111289125|NCT01892683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111289126|NCT01892683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111289127|NCT01892683|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111289128|NCT01892683|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111289129|NCT01892683|Anesthetics, General|anesthetics, general|mesh-ancestor
111289130|NCT01459627|Ticagrelor|ticagrelor|mesh-list
111289131|NCT01459627|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
111289132|NCT01459627|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111289133|NCT01459627|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111289134|NCT01459627|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111289135|NCT01459627|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111289136|NCT01459627|Purinergic Agents|purinergic agents|mesh-ancestor
111289137|NCT01459627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111289138|NCT01459627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111289139|NCT01459627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111289140|NCT02467621|Pantoprazole|pantoprazole|mesh-list
111289141|NCT02467621|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111289142|NCT02467621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111289143|NCT02467621|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111289144|NCT02467621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111289145|NCT02467621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111289146|NCT04937946|Fentanyl|fentanyl|mesh-list
111289147|NCT04937946|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111289148|NCT04937946|Narcotics|narcotics|mesh-ancestor
111289149|NCT04937946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111289150|NCT04937946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111013694|NCT01404754|Serotonin Agents|serotonin agents|mesh-ancestor
111289151|NCT04937946|Analgesics|analgesics|mesh-ancestor
111289152|NCT04937946|Sensory System Agents|sensory system agents|mesh-ancestor
111289153|NCT04937946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111289154|NCT04937946|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111289155|NCT04937946|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111289156|NCT04937946|Anesthetics, General|anesthetics, general|mesh-ancestor
111289157|NCT04937946|Anesthetics|anesthetics|mesh-ancestor
111289158|NCT05160987|Midazolam|midazolam|mesh-list
111289159|NCT05160987|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111289160|NCT05160987|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111289161|NCT05160987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111289162|NCT05160987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111289163|NCT05160987|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111289164|NCT05160987|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111289165|NCT05160987|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111289166|NCT05160987|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111289167|NCT05160987|Anesthetics, General|anesthetics, general|mesh-ancestor
111289168|NCT05160987|Anesthetics|anesthetics|mesh-ancestor
111289169|NCT05160987|GABA Modulators|gaba modulators|mesh-ancestor
111289170|NCT05160987|GABA Agents|gaba agents|mesh-ancestor
111289171|NCT05160987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111289172|NCT05160987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111289173|NCT01892995|Ketamine|ketamine|mesh-list
111289174|NCT01892995|Analgesics|analgesics|mesh-ancestor
111289175|NCT01892995|Sensory System Agents|sensory system agents|mesh-ancestor
111289176|NCT01892995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111289177|NCT01892995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111289178|NCT01892995|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111289179|NCT01892995|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111289180|NCT01892995|Anesthetics, General|anesthetics, general|mesh-ancestor
111289181|NCT01892995|Anesthetics|anesthetics|mesh-ancestor
111289182|NCT01892995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111289183|NCT01892995|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111289184|NCT01892995|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111289185|NCT01892995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111289186|NCT01892995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111289187|NCT04938102|Botulinum Toxins|botulinum toxins|mesh-list
111289188|NCT04938102|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111289189|NCT04938102|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111289190|NCT04938102|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111289191|NCT04938102|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111289192|NCT04938102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111289193|NCT04938102|Cholinergic Agents|cholinergic agents|mesh-ancestor
111289194|NCT04938102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111289195|NCT04938102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111289196|NCT04938102|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111289197|NCT04938102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111289198|NCT02181075|Doxorubicin|doxorubicin|mesh-list
111289199|NCT02181075|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111289200|NCT02181075|Liver Extracts|liver extracts|mesh-list
111289201|NCT02181075|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111289202|NCT02181075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111289203|NCT02181075|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111289204|NCT02181075|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111289205|NCT02181075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111289206|NCT02181075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111289207|NCT02181075|Hematinics|hematinics|mesh-ancestor
111289208|NCT01359735|Bacitracin|bacitracin|mesh-list
111289209|NCT01359735|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111289210|NCT01359735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111289211|NCT01359735|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111289212|NCT01361217|Midazolam|midazolam|mesh-list
111289213|NCT01361217|Dextromethorphan|dextromethorphan|mesh-list
111289214|NCT01361217|Caffeine|caffeine|mesh-list
111289215|NCT01361217|Fluoxetine|fluoxetine|mesh-list
111289216|NCT01361217|Omeprazole|omeprazole|mesh-list
111289217|NCT01361217|Lovastatin|lovastatin|mesh-list
111289218|NCT01361217|L 647318|l 647318|mesh-list
111289219|NCT01361217|Dihydromevinolin|dihydromevinolin|mesh-list
111289220|NCT01361217|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111289221|NCT01361217|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111289222|NCT01361217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111289223|NCT01361217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111289224|NCT01361217|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111289225|NCT01361217|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111289226|NCT01361217|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111289227|NCT01361217|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111289228|NCT01361217|Anesthetics, General|anesthetics, general|mesh-ancestor
111289229|NCT01361217|Anesthetics|anesthetics|mesh-ancestor
111289230|NCT01361217|GABA Modulators|gaba modulators|mesh-ancestor
111289231|NCT01361217|GABA Agents|gaba agents|mesh-ancestor
111289232|NCT01361217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111289233|NCT01361217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111289234|NCT01361217|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111289235|NCT01361217|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111289236|NCT01361217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111289237|NCT01361217|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
111289238|NCT01361217|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111289239|NCT01361217|Purinergic Agents|purinergic agents|mesh-ancestor
111289240|NCT01361217|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111289241|NCT01361217|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111289242|NCT01361217|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111289243|NCT01361217|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111289244|NCT01361217|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111289245|NCT01361217|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111289246|NCT01361217|Serotonin Agents|serotonin agents|mesh-ancestor
111289247|NCT01361217|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111289248|NCT01361217|Antidepressive Agents|antidepressive agents|mesh-ancestor
111289249|NCT01361217|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111289250|NCT01361217|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111289251|NCT01361217|Antitussive Agents|antitussive agents|mesh-ancestor
111289252|NCT01361217|Respiratory System Agents|respiratory system agents|mesh-ancestor
111289253|NCT01361217|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111289254|NCT01361217|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111289255|NCT01361217|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111289256|NCT01361217|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111289257|NCT01361217|Antimetabolites|antimetabolites|mesh-ancestor
111289258|NCT01361217|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111289259|NCT01361217|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111289260|NCT04271839|Fluticasone|fluticasone|mesh-list
111289261|NCT04271839|Formoterol Fumarate|formoterol fumarate|mesh-list
111289262|NCT04271839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111289263|NCT04271839|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111289264|NCT04271839|Autonomic Agents|autonomic agents|mesh-ancestor
111289265|NCT04271839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111289266|NCT04271839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111289267|NCT04271839|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111289268|NCT04271839|Respiratory System Agents|respiratory system agents|mesh-ancestor
111289269|NCT04271839|Dermatologic Agents|dermatologic agents|mesh-ancestor
111289270|NCT04271839|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111289271|NCT04271839|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111289272|NCT04271839|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111289273|NCT04271839|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111289274|NCT04271839|Adrenergic Agents|adrenergic agents|mesh-ancestor
111289275|NCT04271839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111289276|NCT04271839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111289277|NCT04945434|Methamphetamine|methamphetamine|mesh-list
111289278|NCT04945434|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111289279|NCT04945434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111289280|NCT04945434|Sympathomimetics|sympathomimetics|mesh-ancestor
111289281|NCT04945434|Autonomic Agents|autonomic agents|mesh-ancestor
111289282|NCT04945434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111289283|NCT04945434|Dopamine Agents|dopamine agents|mesh-ancestor
111289284|NCT04945434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111289285|NCT04945434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111289286|NCT04945434|Adrenergic Agents|adrenergic agents|mesh-ancestor
111289287|NCT04945434|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111289288|NCT04945434|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111289289|NCT04945434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111289290|NCT04945434|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111289291|NCT04411758|Propolis|propolis|mesh-list
111289292|NCT04411758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111289293|NCT04408560|Acetaminophen|acetaminophen|mesh-list
111289294|NCT04408560|Analgesics|analgesics|mesh-list
111289295|NCT04408560|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111289296|NCT04408560|Sensory System Agents|sensory system agents|mesh-ancestor
111289297|NCT04408560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111289298|NCT04408560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111289299|NCT04408560|Antipyretics|antipyretics|mesh-ancestor
111013842|NCT02259985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111289301|NCT04844905|Piperaquine|piperaquine|mesh-list
111289302|NCT04844905|Artenimol|artenimol|mesh-list
111289303|NCT04844905|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111289304|NCT04844905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111289305|NCT04844905|Antimalarials|antimalarials|mesh-ancestor
111289306|NCT04844905|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111289307|NCT04418856|Methamphetamine|methamphetamine|mesh-list
111289308|NCT04418856|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111289309|NCT04418856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111289310|NCT04418856|Sympathomimetics|sympathomimetics|mesh-ancestor
111289311|NCT04418856|Autonomic Agents|autonomic agents|mesh-ancestor
111289312|NCT04418856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111289313|NCT04418856|Dopamine Agents|dopamine agents|mesh-ancestor
111289314|NCT04418856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111289315|NCT04418856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111289316|NCT04418856|Adrenergic Agents|adrenergic agents|mesh-ancestor
111289317|NCT04418856|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111289318|NCT04418856|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111289319|NCT04418856|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111289320|NCT04418856|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111289321|NCT01454635|Sertraline|sertraline|mesh-list
111289322|NCT01454635|Antidepressive Agents|antidepressive agents|mesh-ancestor
111289323|NCT01454635|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111289324|NCT01454635|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111289325|NCT01454635|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111289326|NCT01454635|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111289327|NCT01454635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111289328|NCT01454635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111289329|NCT01454635|Serotonin Agents|serotonin agents|mesh-ancestor
111289330|NCT01454635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111289331|NCT02196831|Tesamorelin|tesamorelin|mesh-list
111289332|NCT02196831|Growth Substances|growth substances|mesh-ancestor
111289333|NCT02196831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111289334|NCT04944966|Lumefantrine|lumefantrine|mesh-list
111289335|NCT04944966|Artemether|artemether|mesh-list
111289336|NCT04944966|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
111289337|NCT04944966|Antimalarials|antimalarials|mesh-ancestor
111289338|NCT04944966|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111289339|NCT04944966|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111289340|NCT04944966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111289341|NCT04955262|Nivolumab|nivolumab|mesh-list
111289342|NCT04955262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111289343|NCT04955262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111289344|NCT04955262|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111289345|NCT04955262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111289346|NCT01363479|Dexamethasone|dexamethasone|mesh-list
111289347|NCT01363479|Palonosetron|palonosetron|mesh-list
111289348|NCT01363479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111289349|NCT01363479|Antiemetics|antiemetics|mesh-ancestor
111289350|NCT01363479|Autonomic Agents|autonomic agents|mesh-ancestor
111289351|NCT01363479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111289352|NCT01363479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111289353|NCT01363479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111289354|NCT01363479|Glucocorticoids|glucocorticoids|mesh-ancestor
111289355|NCT01363479|Hormones|hormones|mesh-ancestor
111289356|NCT01363479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111289357|NCT01363479|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111289358|NCT01363479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111289359|NCT01363479|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111289360|NCT01363479|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111289361|NCT01363479|Serotonin Agents|serotonin agents|mesh-ancestor
111289362|NCT01363479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111289363|NCT01363479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111289364|NCT01893385|Vitamin D|vitamin d|mesh-list
111289365|NCT01893385|Vitamins|vitamins|mesh-ancestor
111289366|NCT01893385|Micronutrients|micronutrients|mesh-ancestor
111289367|NCT01893385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111289368|NCT01893385|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111289369|NCT04935450|Dimercaprol|dimercaprol|mesh-list
111289370|NCT04935450|Chelating Agents|chelating agents|mesh-ancestor
111289371|NCT04935450|Sequestering Agents|sequestering agents|mesh-ancestor
111289372|NCT04935450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111289373|NCT02181231|Buprenorphine|buprenorphine|mesh-list
111289374|NCT02181231|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
111289375|NCT02181231|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111289376|NCT02181231|Narcotics|narcotics|mesh-ancestor
111289377|NCT02181231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111289378|NCT02181231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111289379|NCT02181231|Analgesics|analgesics|mesh-ancestor
111289380|NCT02181231|Sensory System Agents|sensory system agents|mesh-ancestor
111289381|NCT02181231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111289382|NCT02181231|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111289383|NCT02181231|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111289384|NCT02181231|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111289385|NCT02181231|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111289386|NCT02181231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111289387|NCT02181231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111289388|NCT02181231|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111289389|NCT02181231|Antidepressive Agents|antidepressive agents|mesh-ancestor
111289390|NCT02181231|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111289391|NCT01364259|Amifostine|amifostine|mesh-list
111289392|NCT01364259|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111289393|NCT01364259|Protective Agents|protective agents|mesh-ancestor
111289394|NCT01364259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111289395|NCT01321437|Axitinib|axitinib|mesh-list
111289396|NCT01321437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111289397|NCT01321437|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111289398|NCT01321437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111289399|NCT01321437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111289400|NCT01365585|Sildenafil Citrate|sildenafil citrate|mesh-list
111289401|NCT01365585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111289402|NCT01365585|Vasodilator Agents|vasodilator agents|mesh-ancestor
111289403|NCT01365585|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111289404|NCT01365585|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111289405|NCT01365585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111289406|NCT01365585|Urological Agents|urological agents|mesh-ancestor
111289407|NCT02664181|Nivolumab|nivolumab|mesh-list
111289408|NCT02664181|Decitabine|decitabine|mesh-list
111289409|NCT02664181|Tetrahydrouridine|tetrahydrouridine|mesh-list
111289410|NCT02664181|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111289411|NCT02664181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111289412|NCT02664181|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111289413|NCT02664181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111289414|NCT02664181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111289415|NCT02664181|Antimetabolites|antimetabolites|mesh-ancestor
111289416|NCT02664181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111289417|NCT04407390|Niacinamide|niacinamide|mesh-list
111289419|NCT04407390|Nicotinic Acids|nicotinic acids|mesh-list
111289420|NCT04407390|Vitamin B Complex|vitamin b complex|mesh-ancestor
111289421|NCT04407390|Vitamins|vitamins|mesh-ancestor
111289422|NCT04407390|Micronutrients|micronutrients|mesh-ancestor
111289423|NCT04407390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111289424|NCT04407390|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111289425|NCT04407390|Antimetabolites|antimetabolites|mesh-ancestor
111289426|NCT04407390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111289427|NCT04407390|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111289428|NCT04407390|Vasodilator Agents|vasodilator agents|mesh-ancestor
111289429|NCT02181387|Acetaminophen|acetaminophen|mesh-list
111289430|NCT02181387|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111289431|NCT02181387|Analgesics|analgesics|mesh-ancestor
111289432|NCT02181387|Sensory System Agents|sensory system agents|mesh-ancestor
111289433|NCT02181387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111289434|NCT02181387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111289435|NCT02181387|Antipyretics|antipyretics|mesh-ancestor
111289436|NCT04921878|Mitoxantrone|mitoxantrone|mesh-list
111289437|NCT04921878|Analgesics|analgesics|mesh-ancestor
111289438|NCT04921878|Sensory System Agents|sensory system agents|mesh-ancestor
111289439|NCT04921878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111289440|NCT04921878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111289441|NCT04921878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111289442|NCT04921878|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111289443|NCT04921878|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111289444|NCT04921878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111289445|NCT04921878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111289446|NCT04351347|Ivermectin|ivermectin|mesh-list
111289447|NCT04351347|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111289448|NCT04351347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111289449|NCT04932564|Leflunomide|leflunomide|mesh-list
111289450|NCT04932564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111289451|NCT04932564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111289452|NCT04932564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111289453|NCT04932564|Immunologic Factors|immunologic factors|mesh-ancestor
111289454|NCT04932564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111289456|NCT04921566|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111289457|NCT04921566|Diuretics|diuretics|mesh-ancestor
111289458|NCT04921566|Natriuretic Agents|natriuretic agents|mesh-ancestor
111289459|NCT04921566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111289460|NCT04921566|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
111289461|NCT04921566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111289462|NCT04921566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111289463|NCT02655601|Manganese|manganese|mesh-list
111289464|NCT02655601|Temozolomide|temozolomide|mesh-list
111289465|NCT02655601|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111289466|NCT02655601|Alkylating Agents|alkylating agents|mesh-ancestor
111289467|NCT02655601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111289468|NCT02655601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111289469|NCT02655601|Trace Elements|trace elements|mesh-ancestor
111289470|NCT02655601|Micronutrients|micronutrients|mesh-ancestor
111289471|NCT02655601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111289472|NCT02652247|Dimercaprol|dimercaprol|mesh-list
111289473|NCT02652247|Chelating Agents|chelating agents|mesh-ancestor
111289474|NCT02652247|Sequestering Agents|sequestering agents|mesh-ancestor
111289475|NCT02652247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111289476|NCT01365819|Varenicline|varenicline|mesh-list
111289477|NCT01365819|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111289478|NCT01365819|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111289479|NCT01365819|Cholinergic Agents|cholinergic agents|mesh-ancestor
111289480|NCT01365819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111289481|NCT01365819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111289482|NCT01365819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111289483|NCT02635555|Phenylephrine|phenylephrine|mesh-list
111289484|NCT02635555|Oxymetazoline|oxymetazoline|mesh-list
111289485|NCT02635555|Ephedrine|ephedrine|mesh-list
111289486|NCT02635555|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111289487|NCT02635555|Mydriatics|mydriatics|mesh-ancestor
111289488|NCT02635555|Autonomic Agents|autonomic agents|mesh-ancestor
111289489|NCT02635555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111289490|NCT02635555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111289491|NCT02635555|Sympathomimetics|sympathomimetics|mesh-ancestor
111289492|NCT02635555|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111289493|NCT02635555|Nasal Decongestants|nasal decongestants|mesh-ancestor
111289494|NCT02635555|Respiratory System Agents|respiratory system agents|mesh-ancestor
111289495|NCT02635555|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111289496|NCT02635555|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111289497|NCT02635555|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111289498|NCT02635555|Adrenergic Agents|adrenergic agents|mesh-ancestor
111289499|NCT02635555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111289500|NCT02635555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111289501|NCT02635555|Protective Agents|protective agents|mesh-ancestor
111289502|NCT02635555|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111289503|NCT01893541|Propranolol|propranolol|mesh-list
111289504|NCT01893541|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111289505|NCT01893541|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111289506|NCT01893541|Adrenergic Agents|adrenergic agents|mesh-ancestor
111289507|NCT01893541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111289508|NCT01893541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111289509|NCT01893541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111289510|NCT01893541|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111289511|NCT01893541|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111289512|NCT01893541|Vasodilator Agents|vasodilator agents|mesh-ancestor
111289513|NCT02849899|Vildagliptin|vildagliptin|mesh-list
111289514|NCT02849899|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111289515|NCT02849899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111289516|NCT02849899|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111289517|NCT02849899|Protease Inhibitors|protease inhibitors|mesh-ancestor
111289518|NCT02849899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111289519|NCT02849899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111289520|NCT01369875|Aldesleukin|aldesleukin|mesh-list
111289521|NCT01369875|Cyclophosphamide|cyclophosphamide|mesh-list
111289522|NCT01369875|Fludarabine|fludarabine|mesh-list
111289523|NCT01369875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111289524|NCT01369875|Immunologic Factors|immunologic factors|mesh-ancestor
111289525|NCT01369875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111289526|NCT01369875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111289527|NCT01369875|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111289528|NCT01369875|Alkylating Agents|alkylating agents|mesh-ancestor
111289529|NCT01369875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111289530|NCT01369875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111289531|NCT01369875|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111289532|NCT01369875|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111289533|NCT01369875|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111289534|NCT01369875|Antiviral Agents|antiviral agents|mesh-ancestor
111289535|NCT01369875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111289536|NCT02620189|Adalimumab|adalimumab|mesh-list
111289537|NCT02620189|Certolizumab Pegol|certolizumab pegol|mesh-list
111289538|NCT02620189|Etanercept|etanercept|mesh-list
111289539|NCT02620189|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111289540|NCT02620189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111289541|NCT02620189|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111289542|NCT02620189|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111289543|NCT02620189|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111289544|NCT02620189|Analgesics|analgesics|mesh-ancestor
111289545|NCT02620189|Sensory System Agents|sensory system agents|mesh-ancestor
111289546|NCT02620189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111289547|NCT02620189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111289548|NCT02620189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111289549|NCT02620189|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111289550|NCT02620189|Immunologic Factors|immunologic factors|mesh-ancestor
111289551|NCT02763319|Rituximab|rituximab|mesh-list
111289552|NCT02763319|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
111289553|NCT02763319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111289554|NCT02763319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111289555|NCT02763319|Immunologic Factors|immunologic factors|mesh-ancestor
111289556|NCT02763319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111289557|NCT02763319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111289558|NCT02763319|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111289559|NCT02763319|Alkylating Agents|alkylating agents|mesh-ancestor
111289560|NCT02763319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111289561|NCT01323153|Dalcetrapib|dalcetrapib|mesh-list
111289562|NCT01323153|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111289563|NCT01323153|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111289564|NCT01323153|Antimetabolites|antimetabolites|mesh-ancestor
111289565|NCT01323153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111289566|NCT01323153|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111289567|NCT02594371|Paclitaxel|paclitaxel|mesh-list
111289568|NCT02594371|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111289569|NCT02594371|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111289570|NCT02594371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111289571|NCT02594371|Tubulin Modulators|tubulin modulators|mesh-ancestor
111289572|NCT02594371|Antimitotic Agents|antimitotic agents|mesh-ancestor
111289573|NCT02594371|Mitosis Modulators|mitosis modulators|mesh-ancestor
111289574|NCT02594371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111289575|NCT02197065|Atorvastatin|atorvastatin|mesh-list
111289576|NCT02197065|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111289577|NCT02197065|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111289578|NCT02197065|Antimetabolites|antimetabolites|mesh-ancestor
111289579|NCT02197065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111289580|NCT02197065|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111289581|NCT02197065|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111289582|NCT02197065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111289583|NCT04405596|Ambroxol|ambroxol|mesh-list
111289584|NCT04405596|Expectorants|expectorants|mesh-ancestor
111289585|NCT04405596|Respiratory System Agents|respiratory system agents|mesh-ancestor
111289586|NCT01375491|Doxycycline|doxycycline|mesh-list
111289587|NCT01375491|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111289588|NCT01375491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111289589|NCT01375491|Antimalarials|antimalarials|mesh-ancestor
111289590|NCT01375491|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111289591|NCT01375491|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111289592|NCT02591251|Povidone-Iodine|povidone-iodine|mesh-list
111289593|NCT02591251|Povidone|povidone|mesh-list
111289594|NCT02591251|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111289595|NCT02591251|Plasma Substitutes|plasma substitutes|mesh-ancestor
111289596|NCT02591251|Blood Substitutes|blood substitutes|mesh-ancestor
111289597|NCT02591251|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111289598|NCT02591251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111289599|NCT01325181|Ranibizumab|ranibizumab|mesh-list
111289600|NCT01325181|Verteporfin|verteporfin|mesh-list
111289601|NCT01325181|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111289602|NCT01325181|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111289603|NCT01325181|Growth Substances|growth substances|mesh-ancestor
111289604|NCT01325181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111289605|NCT01325181|Growth Inhibitors|growth inhibitors|mesh-ancestor
111289606|NCT01325181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111289607|NCT01325181|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111289608|NCT01325181|Dermatologic Agents|dermatologic agents|mesh-ancestor
111289609|NCT02754037|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
111289610|NCT02754037|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111289611|NCT02754037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111289612|NCT04238637|Durvalumab|durvalumab|mesh-list
111289613|NCT04238637|Tremelimumab|tremelimumab|mesh-list
111289614|NCT04238637|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111289615|NCT04238637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111289616|NCT02588443|Paclitaxel|paclitaxel|mesh-list
111289617|NCT02588443|Gemcitabine|gemcitabine|mesh-list
111289618|NCT02588443|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111289619|NCT02588443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111289620|NCT02588443|Tubulin Modulators|tubulin modulators|mesh-ancestor
111289621|NCT02588443|Antimitotic Agents|antimitotic agents|mesh-ancestor
111289622|NCT02588443|Mitosis Modulators|mitosis modulators|mesh-ancestor
111289623|NCT02588443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111289624|NCT02588443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111289625|NCT02588443|Antimetabolites|antimetabolites|mesh-ancestor
111289626|NCT02582359|Cytarabine|cytarabine|mesh-list
111289627|NCT02582359|Daunorubicin|daunorubicin|mesh-list
111289628|NCT02582359|Ixazomib|ixazomib|mesh-list
111289629|NCT02582359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111289630|NCT02582359|Antimetabolites|antimetabolites|mesh-ancestor
111289631|NCT02582359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111289632|NCT02582359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111289633|NCT02582359|Antiviral Agents|antiviral agents|mesh-ancestor
111289634|NCT02582359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111289635|NCT02582359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111289636|NCT02582359|Immunologic Factors|immunologic factors|mesh-ancestor
111289637|NCT02582359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111289638|NCT02582359|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111289639|NCT02582359|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111289640|NCT02582359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111289641|NCT02582359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111289642|NCT02582359|Protease Inhibitors|protease inhibitors|mesh-ancestor
111289643|NCT00227253|Hormones|hormones|mesh-list
111289644|NCT00227253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111289645|NCT00227253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111289646|NCT05021809|Calcium|calcium|mesh-list
111289647|NCT05021809|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111289648|NCT05021809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111289649|NCT02730715|Thymoglobulin|thymoglobulin|mesh-list
111289650|NCT02730715|Antilymphocyte Serum|antilymphocyte serum|mesh-list
111289651|NCT02730715|Basiliximab|basiliximab|mesh-list
111289652|NCT02730715|Immunologic Factors|immunologic factors|mesh-ancestor
111289653|NCT02730715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111289654|NCT02730715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111289655|NCT04919460|Tolonium Chloride|tolonium chloride|mesh-list
111289656|NCT04919460|Hemostatics|hemostatics|mesh-ancestor
111289657|NCT04919460|Coagulants|coagulants|mesh-ancestor
111289658|NCT04919460|Heparin Antagonists|heparin antagonists|mesh-ancestor
111289659|NCT04919460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111289660|NCT04037241|Leucovorin|leucovorin|mesh-list
111289661|NCT04037241|Paclitaxel|paclitaxel|mesh-list
111289662|NCT04037241|Gemcitabine|gemcitabine|mesh-list
111289663|NCT04037241|Capecitabine|capecitabine|mesh-list
111289664|NCT04037241|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111289665|NCT04037241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111289666|NCT04037241|Tubulin Modulators|tubulin modulators|mesh-ancestor
111289667|NCT04037241|Antimitotic Agents|antimitotic agents|mesh-ancestor
111289668|NCT04037241|Mitosis Modulators|mitosis modulators|mesh-ancestor
111289669|NCT04037241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111289670|NCT04037241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111289671|NCT04037241|Antimetabolites|antimetabolites|mesh-ancestor
111289672|NCT04037241|Antidotes|antidotes|mesh-ancestor
111289673|NCT04037241|Protective Agents|protective agents|mesh-ancestor
111289674|NCT04037241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111289675|NCT04037241|Vitamin B Complex|vitamin b complex|mesh-ancestor
111289676|NCT04037241|Vitamins|vitamins|mesh-ancestor
111289678|NCT04912128|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
111289679|NCT04912128|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111289680|NCT04912128|Growth Substances|growth substances|mesh-ancestor
111289681|NCT04912128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111289682|NCT04912128|Growth Inhibitors|growth inhibitors|mesh-ancestor
111289683|NCT04912128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111289684|NCT01327677|Fentanyl|fentanyl|mesh-list
111289685|NCT01327677|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111289686|NCT01327677|Narcotics|narcotics|mesh-ancestor
111289687|NCT01327677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111289688|NCT01327677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111289689|NCT01327677|Analgesics|analgesics|mesh-ancestor
111289690|NCT01327677|Sensory System Agents|sensory system agents|mesh-ancestor
111289691|NCT01327677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111289692|NCT01327677|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111289693|NCT01327677|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111289694|NCT01327677|Anesthetics, General|anesthetics, general|mesh-ancestor
111289695|NCT01327677|Anesthetics|anesthetics|mesh-ancestor
111289696|NCT03054480|Botulinum Toxins|botulinum toxins|mesh-list
111289697|NCT03054480|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111289698|NCT03054480|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111289699|NCT03054480|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111289700|NCT03054480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111289701|NCT03054480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111289702|NCT03054480|Cholinergic Agents|cholinergic agents|mesh-ancestor
111289703|NCT03054480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111289704|NCT03054480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111289705|NCT03054480|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111289706|NCT03054480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111289707|NCT04918914|Dapsone|dapsone|mesh-list
111289708|NCT04918914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111289709|NCT04918914|Antimalarials|antimalarials|mesh-ancestor
111289710|NCT04918914|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111289711|NCT04918914|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111289712|NCT04918914|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111289713|NCT04918914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111289714|NCT04918914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111289715|NCT04918914|Leprostatic Agents|leprostatic agents|mesh-ancestor
111289716|NCT04918914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111289717|NCT04918524|Aspirin|aspirin|mesh-list
111289718|NCT04918524|Hydroxychloroquine|hydroxychloroquine|mesh-list
111289719|NCT04918524|Prednisone|prednisone|mesh-list
111289720|NCT04918524|Heparin|heparin|mesh-list
111289721|NCT04918524|Enoxaparin|enoxaparin|mesh-list
111289722|NCT04918524|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
111289723|NCT04918524|Tinzaparin|tinzaparin|mesh-list
111289724|NCT04918524|Dalteparin|dalteparin|mesh-list
111289725|NCT04918524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111289726|NCT04918524|Glucocorticoids|glucocorticoids|mesh-ancestor
111289727|NCT04918524|Hormones|hormones|mesh-ancestor
111289728|NCT04918524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111289729|NCT04918524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111289730|NCT04918524|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111289731|NCT04918524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111289732|NCT04918524|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111289733|NCT04918524|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111289734|NCT04918524|Analgesics|analgesics|mesh-ancestor
111289735|NCT04918524|Sensory System Agents|sensory system agents|mesh-ancestor
111289736|NCT04918524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111289737|NCT04918524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111289738|NCT04918524|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111289739|NCT04918524|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111289740|NCT04918524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111289741|NCT04918524|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111289742|NCT04918524|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111289743|NCT04918524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111289744|NCT04918524|Antipyretics|antipyretics|mesh-ancestor
111289745|NCT04918524|Anticoagulants|anticoagulants|mesh-ancestor
111289746|NCT04918524|Antimalarials|antimalarials|mesh-ancestor
111289747|NCT04918524|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111289748|NCT04918524|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111289749|NCT04918524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111289750|NCT01328379|4-Aminopyridine|4-aminopyridine|mesh-list
111289751|NCT01328379|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
111289752|NCT01328379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111289753|NCT01328379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111289754|NCT05586763|Promethazine|promethazine|mesh-list
111289755|NCT05586763|Diphenhydramine|diphenhydramine|mesh-list
111289756|NCT05586763|Metoclopramide|metoclopramide|mesh-list
111289757|NCT05586763|Antiemetics|antiemetics|mesh-ancestor
111289758|NCT05586763|Autonomic Agents|autonomic agents|mesh-ancestor
111289759|NCT05586763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111289760|NCT05586763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111289761|NCT05586763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111289762|NCT05586763|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111289763|NCT05586763|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111289764|NCT05586763|Dopamine Agents|dopamine agents|mesh-ancestor
111289765|NCT05586763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111289766|NCT05586763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111289767|NCT05586763|Antipruritics|antipruritics|mesh-ancestor
111289768|NCT05586763|Dermatologic Agents|dermatologic agents|mesh-ancestor
111289769|NCT05586763|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111289770|NCT05586763|Histamine Antagonists|histamine antagonists|mesh-ancestor
111289771|NCT05586763|Histamine Agents|histamine agents|mesh-ancestor
111289772|NCT05586763|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111289773|NCT05586763|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111289774|NCT05586763|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111289775|NCT05586763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111289776|NCT05586763|Anesthetics, Local|anesthetics, local|mesh-ancestor
111289777|NCT05586763|Anesthetics|anesthetics|mesh-ancestor
111289778|NCT05586763|Sensory System Agents|sensory system agents|mesh-ancestor
111289779|NCT01328769|Febuxostat|febuxostat|mesh-list
111289780|NCT01328769|Gout Suppressants|gout suppressants|mesh-ancestor
111289781|NCT01328769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111289782|NCT02552641|Amoxicillin|amoxicillin|mesh-list
111289783|NCT02552641|Clarithromycin|clarithromycin|mesh-list
111289784|NCT02552641|Esomeprazole|esomeprazole|mesh-list
111289785|NCT02552641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111289786|NCT02552641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111289787|NCT02552641|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111289788|NCT02552641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111289789|NCT02552641|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111289790|NCT02552641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111289791|NCT02552641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111289792|NCT02552641|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111289793|NCT02552641|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111289794|NCT02552641|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111289795|NCT02620020|Fasinumab|fasinumab|mesh-list
111289796|NCT02620020|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111289797|NCT02620020|Analgesics|analgesics|mesh-ancestor
111289798|NCT02620020|Sensory System Agents|sensory system agents|mesh-ancestor
111289799|NCT02620020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111289800|NCT02620020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111289801|NCT02551237|Capecitabine|capecitabine|mesh-list
111289802|NCT02551237|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111289803|NCT02551237|Antimetabolites|antimetabolites|mesh-ancestor
111289804|NCT02551237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111289805|NCT02551237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111289806|NCT01378299|Methyltestosterone|methyltestosterone|mesh-list
111289807|NCT01378299|Testosterone|testosterone|mesh-list
111289808|NCT01378299|Testosterone undecanoate|testosterone undecanoate|mesh-list
111289809|NCT01378299|Testosterone enanthate|testosterone enanthate|mesh-list
111289810|NCT01378299|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
111289811|NCT01378299|Androgens|androgens|mesh-ancestor
111289812|NCT01378299|Hormones|hormones|mesh-ancestor
111289813|NCT01378299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111289814|NCT01378299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111289815|NCT01378299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111289816|NCT01378299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111289817|NCT01378299|Anabolic Agents|anabolic agents|mesh-ancestor
111289818|NCT04929522|Anesthetics|anesthetics|mesh-list
111289819|NCT04929522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111289820|NCT04929522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111289821|NCT02549833|Poly I-C|poly i-c|mesh-list
111289822|NCT02549833|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
111289823|NCT02549833|Poly ICLC|poly iclc|mesh-list
111289824|NCT02549833|Interferon Inducers|interferon inducers|mesh-ancestor
111289825|NCT02549833|Immunologic Factors|immunologic factors|mesh-ancestor
111289826|NCT02549833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111014368|NCT03424460|Coagulants|coagulants|mesh-ancestor
111289827|NCT02549833|Laxatives|laxatives|mesh-ancestor
111289828|NCT02549833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111289830|NCT02549833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111289831|NCT02542969|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111289832|NCT02542969|Simvastatin|simvastatin|mesh-list
111289833|NCT02542969|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111289834|NCT02542969|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111289835|NCT02542969|Antimetabolites|antimetabolites|mesh-ancestor
111289836|NCT02542969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111289837|NCT02542969|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111289838|NCT02542969|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111289839|NCT02542969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111289840|NCT04928586|Pirfenidone|pirfenidone|mesh-list
111289841|NCT04928586|Analgesics|analgesics|mesh-ancestor
111289842|NCT04928586|Sensory System Agents|sensory system agents|mesh-ancestor
111289843|NCT04928586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111289844|NCT04928586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111289845|NCT04928586|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111289846|NCT04928586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111289847|NCT04928586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111289848|NCT04928586|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111289849|NCT04928586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111289850|NCT03054168|Goserelin|goserelin|mesh-list
111289851|NCT03054168|Testosterone|testosterone|mesh-list
111289852|NCT03054168|Hormones|hormones|mesh-ancestor
111289853|NCT03054168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111289854|NCT03054168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111289855|NCT03054168|Androgens|androgens|mesh-ancestor
111289856|NCT03054168|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111289857|NCT03054168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111289858|NCT02518945|Dapagliflozin|dapagliflozin|mesh-list
111289859|NCT02518945|Liraglutide|liraglutide|mesh-list
111289860|NCT02518945|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111289861|NCT02518945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111289862|NCT02518945|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111289863|NCT02518945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111289864|NCT02518945|Incretins|incretins|mesh-ancestor
111289865|NCT02518945|Hormones|hormones|mesh-ancestor
111289866|NCT02518945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111289867|NCT04757779|Docetaxel|docetaxel|mesh-list
111289868|NCT04757779|Irinotecan|irinotecan|mesh-list
111289869|NCT04757779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111289870|NCT04757779|Tubulin Modulators|tubulin modulators|mesh-ancestor
111289871|NCT04757779|Antimitotic Agents|antimitotic agents|mesh-ancestor
111289872|NCT04757779|Mitosis Modulators|mitosis modulators|mesh-ancestor
111289873|NCT04757779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111289874|NCT04757779|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111289875|NCT04757779|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111289876|NCT04757779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111289877|NCT03053856|Paclitaxel|paclitaxel|mesh-list
111289878|NCT03053856|Pembrolizumab|pembrolizumab|mesh-list
111289879|NCT03053856|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111289880|NCT03053856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111289881|NCT03053856|Tubulin Modulators|tubulin modulators|mesh-ancestor
111289882|NCT03053856|Antimitotic Agents|antimitotic agents|mesh-ancestor
111289883|NCT03053856|Mitosis Modulators|mitosis modulators|mesh-ancestor
111289884|NCT03053856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111289885|NCT03053856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111289886|NCT03053856|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111289887|NCT02489695|Axitinib|axitinib|mesh-list
111289888|NCT02489695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111289889|NCT02489695|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111289890|NCT02489695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111289891|NCT02489695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111289892|NCT03053388|Nitric Oxide|nitric oxide|mesh-list
111289893|NCT03053388|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111289894|NCT03053388|Autonomic Agents|autonomic agents|mesh-ancestor
111289895|NCT03053388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111289896|NCT03053388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111289897|NCT03053388|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111289898|NCT03053388|Respiratory System Agents|respiratory system agents|mesh-ancestor
111289899|NCT03053388|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111289900|NCT03053388|Antioxidants|antioxidants|mesh-ancestor
111289901|NCT03053388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111289902|NCT03053388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111289903|NCT03053388|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
111289904|NCT03053388|Vasodilator Agents|vasodilator agents|mesh-ancestor
111289905|NCT03053388|Gasotransmitters|gasotransmitters|mesh-ancestor
111289906|NCT03053388|Protective Agents|protective agents|mesh-ancestor
111289908|NCT03053544|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111289909|NCT03053544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111289910|NCT02384083|Dexamethasone|dexamethasone|mesh-list
111289911|NCT02384083|Pomalidomide|pomalidomide|mesh-list
111289912|NCT02384083|Filanesib|filanesib|mesh-list
111289913|NCT02384083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111289914|NCT02384083|Antiemetics|antiemetics|mesh-ancestor
111289915|NCT02384083|Autonomic Agents|autonomic agents|mesh-ancestor
111289916|NCT02384083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111289917|NCT02384083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111289918|NCT02384083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111289919|NCT02384083|Glucocorticoids|glucocorticoids|mesh-ancestor
111289920|NCT02384083|Hormones|hormones|mesh-ancestor
111289921|NCT02384083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111289922|NCT02384083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111289923|NCT02384083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111289924|NCT02384083|Immunologic Factors|immunologic factors|mesh-ancestor
111289925|NCT02384083|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111289926|NCT02384083|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111289927|NCT02384083|Growth Substances|growth substances|mesh-ancestor
111289928|NCT02384083|Growth Inhibitors|growth inhibitors|mesh-ancestor
111289929|NCT02384083|Antimitotic Agents|antimitotic agents|mesh-ancestor
111289930|NCT02384083|Mitosis Modulators|mitosis modulators|mesh-ancestor
111289931|NCT02384083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111289932|NCT04926480|Anesthetics|anesthetics|mesh-list
111289933|NCT04926480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111289934|NCT04926480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111289935|NCT03053622|Mirikizumab|mirikizumab|mesh-list
111289936|NCT03053622|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111289937|NCT03053622|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111289938|NCT03053622|Analgesics|analgesics|mesh-ancestor
111289939|NCT03053622|Sensory System Agents|sensory system agents|mesh-ancestor
111289940|NCT03053622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111289941|NCT03053622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111289942|NCT03053622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111289943|NCT03053622|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111289944|NCT03053622|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111289945|NCT03053622|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111289946|NCT02380573|Methylene Blue|methylene blue|mesh-list
111289947|NCT02380573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111289948|NCT02380573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111289949|NCT02461537|Mitoxantrone|mitoxantrone|mesh-list
111289950|NCT02461537|Analgesics|analgesics|mesh-ancestor
111289951|NCT02461537|Sensory System Agents|sensory system agents|mesh-ancestor
111289952|NCT02461537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111289953|NCT02461537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111289954|NCT02461537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111289955|NCT02461537|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111289956|NCT02461537|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111289957|NCT02461537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111289958|NCT02461537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111289959|NCT05028673|Aluminum Hydroxide|aluminum hydroxide|mesh-list
111289960|NCT05028673|Antacids|antacids|mesh-list
111289961|NCT05028673|Magnesium Hydroxide|magnesium hydroxide|mesh-list
111289962|NCT05028673|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111289963|NCT05028673|Immunologic Factors|immunologic factors|mesh-ancestor
111289964|NCT05028673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111289965|NCT05028673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111289966|NCT05028673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111289967|NCT04916574|Antibodies|antibodies|mesh-list
111289968|NCT04916574|Immunologic Factors|immunologic factors|mesh-ancestor
111289969|NCT04916574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111289970|NCT02460445|Cyproterone Acetate|cyproterone acetate|mesh-list
111289971|NCT02460445|Ethinyl Estradiol|ethinyl estradiol|mesh-list
111289972|NCT02460445|Cyproterone|cyproterone|mesh-list
111289973|NCT02460445|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111289974|NCT02460445|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111289975|NCT02460445|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111289976|NCT02460445|Contraceptive Agents|contraceptive agents|mesh-ancestor
111014528|NCT02445586|Docetaxel|docetaxel|mesh-list
111289977|NCT02460445|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111289978|NCT02460445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111289979|NCT02460445|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111289980|NCT02460445|Estrogens|estrogens|mesh-ancestor
111289981|NCT02460445|Hormones|hormones|mesh-ancestor
111289982|NCT02460445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111289983|NCT02460445|Androgen Antagonists|androgen antagonists|mesh-ancestor
111289984|NCT02460445|Hormone Antagonists|hormone antagonists|mesh-ancestor
111289985|NCT02460445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111289986|NCT02460445|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
111289987|NCT02455687|Budesonide|budesonide|mesh-list
111289988|NCT02455687|Magnesium Sulfate|magnesium sulfate|mesh-list
111289989|NCT02455687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111289990|NCT02455687|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111289991|NCT02455687|Autonomic Agents|autonomic agents|mesh-ancestor
111289992|NCT02455687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111289993|NCT02455687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111289994|NCT02455687|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111289995|NCT02455687|Respiratory System Agents|respiratory system agents|mesh-ancestor
111289996|NCT02455687|Glucocorticoids|glucocorticoids|mesh-ancestor
111289997|NCT02455687|Hormones|hormones|mesh-ancestor
111289998|NCT02455687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111289999|NCT02455687|Analgesics|analgesics|mesh-ancestor
111290000|NCT02455687|Sensory System Agents|sensory system agents|mesh-ancestor
111290001|NCT02455687|Anesthetics|anesthetics|mesh-ancestor
111290002|NCT02455687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111290003|NCT02455687|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111290004|NCT02455687|Anticonvulsants|anticonvulsants|mesh-ancestor
111290005|NCT02455687|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110979349|NCT05481970|Narcotics|narcotics|mesh-ancestor
111290006|NCT02455687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111290007|NCT02455687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111290008|NCT02455687|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111290009|NCT02455687|Tocolytic Agents|tocolytic agents|mesh-ancestor
111290010|NCT02455687|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111290011|NCT05023837|Pembrolizumab|pembrolizumab|mesh-list
111290012|NCT05023837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111290013|NCT05023837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111290014|NCT05023837|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111290015|NCT05023837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111290016|NCT02358967|Vitamin E|vitamin e|mesh-list
111290017|NCT02358967|Tocopherols|tocopherols|mesh-list
111290018|NCT02358967|Tocotrienols|tocotrienols|mesh-list
111290019|NCT02358967|Vitamins|vitamins|mesh-ancestor
111290020|NCT02358967|Micronutrients|micronutrients|mesh-ancestor
111290021|NCT02358967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111290022|NCT02358967|Antioxidants|antioxidants|mesh-ancestor
111290023|NCT02358967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111290024|NCT02358967|Protective Agents|protective agents|mesh-ancestor
111290025|NCT03052998|Ivermectin|ivermectin|mesh-list
111290026|NCT03052998|Anticonvulsants|anticonvulsants|mesh-list
111290027|NCT03052998|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111290028|NCT03052998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111290029|NCT05586061|Tislelizumab|tislelizumab|mesh-list
111290030|NCT05586061|Disitamab vedotin|disitamab vedotin|mesh-list
111290031|NCT05586061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111290032|NCT05586061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111290033|NCT05586061|Immunoconjugates|immunoconjugates|mesh-ancestor
111290034|NCT05586061|Immunologic Factors|immunologic factors|mesh-ancestor
111290035|NCT05586061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111290036|NCT02354131|Bevacizumab|bevacizumab|mesh-list
111290037|NCT02354131|Niraparib|niraparib|mesh-list
111290038|NCT02354131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111290039|NCT02354131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111290040|NCT02354131|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111290041|NCT02354131|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111290042|NCT02354131|Growth Substances|growth substances|mesh-ancestor
111290043|NCT02354131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111290044|NCT02354131|Growth Inhibitors|growth inhibitors|mesh-ancestor
111290045|NCT02354131|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111290046|NCT02354131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111290047|NCT02354131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111290048|NCT02352337|Gemcitabine|gemcitabine|mesh-list
111014574|NCT05283356|Purinergic Agents|purinergic agents|mesh-ancestor
111290049|NCT02352337|Folfirinox|folfirinox|mesh-list
111290050|NCT02352337|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111290051|NCT02352337|Antimetabolites|antimetabolites|mesh-ancestor
111290052|NCT02352337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111290053|NCT02352337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111290055|NCT02349217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111290056|NCT02827201|Paclitaxel|paclitaxel|mesh-list
111290057|NCT02827201|Gemcitabine|gemcitabine|mesh-list
111290058|NCT02827201|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111290059|NCT02827201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111290060|NCT02827201|Tubulin Modulators|tubulin modulators|mesh-ancestor
111290061|NCT02827201|Antimitotic Agents|antimitotic agents|mesh-ancestor
111290062|NCT02827201|Mitosis Modulators|mitosis modulators|mesh-ancestor
111290063|NCT02827201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111290064|NCT02827201|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111290065|NCT02827201|Antimetabolites|antimetabolites|mesh-ancestor
111290066|NCT02346253|Leuprolide|leuprolide|mesh-list
111290067|NCT02346253|Goserelin|goserelin|mesh-list
111290068|NCT02346253|Triptorelin Pamoate|triptorelin pamoate|mesh-list
111290069|NCT02346253|Bicalutamide|bicalutamide|mesh-list
111290070|NCT02346253|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111290071|NCT02346253|Fertility Agents|fertility agents|mesh-ancestor
111290072|NCT02346253|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111290073|NCT02346253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111290074|NCT02346253|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111290075|NCT02346253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111290076|NCT02346253|Androgen Antagonists|androgen antagonists|mesh-ancestor
111290077|NCT02346253|Hormone Antagonists|hormone antagonists|mesh-ancestor
111290078|NCT02346253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111290079|NCT02346253|Luteolytic Agents|luteolytic agents|mesh-ancestor
111290080|NCT02346253|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111290081|NCT02346253|Contraceptive Agents|contraceptive agents|mesh-ancestor
111290082|NCT02346253|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111290083|NCT01378377|Niacinamide|niacinamide|mesh-list
111290084|NCT01378377|Sirolimus|sirolimus|mesh-list
111290085|NCT01378377|Temsirolimus|temsirolimus|mesh-list
111290086|NCT01378377|MTOR Inhibitors|mtor inhibitors|mesh-list
111290087|NCT01378377|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111290088|NCT01378377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111290089|NCT01378377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111290090|NCT01378377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111290091|NCT01378377|Immunologic Factors|immunologic factors|mesh-ancestor
111290092|NCT01378377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111290093|NCT01378377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111290094|NCT01378377|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111290095|NCT01378377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111290096|NCT01378377|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111290097|NCT01378377|Antifungal Agents|antifungal agents|mesh-ancestor
111290098|NCT01378377|Vitamin B Complex|vitamin b complex|mesh-ancestor
111290099|NCT01378377|Vitamins|vitamins|mesh-ancestor
111290100|NCT01378377|Micronutrients|micronutrients|mesh-ancestor
111290101|NCT03009045|Tedizolid|tedizolid|mesh-list
111290102|NCT03009045|Tedizolid phosphate|tedizolid phosphate|mesh-list
111290103|NCT03009045|Oxazolidinones|oxazolidinones|mesh-list
111290104|NCT03009045|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111290105|NCT03009045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111290106|NCT03009045|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111290107|NCT03009045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111290108|NCT03009045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111290109|NCT04907838|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
111290110|NCT04907838|BQ 788|bq 788|mesh-list
111290111|NCT04907838|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111290112|NCT04907838|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
111290113|NCT04907838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111290114|NCT04907838|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
111290115|NCT03056274|Metformin|metformin|mesh-list
111290116|NCT03056274|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
111290117|NCT03056274|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111290118|NCT03056274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111290119|NCT03056274|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
111290120|NCT03056274|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111290121|NCT03056118|Aspirin|aspirin|mesh-list
111290122|NCT03056118|Clopidogrel|clopidogrel|mesh-list
111290123|NCT03056118|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111290124|NCT03056118|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111014645|NCT05217758|Hormone Antagonists|hormone antagonists|mesh-ancestor
111290125|NCT03056118|Analgesics|analgesics|mesh-ancestor
111290126|NCT03056118|Sensory System Agents|sensory system agents|mesh-ancestor
111290127|NCT03056118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111290128|NCT03056118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111290129|NCT03056118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111290130|NCT03056118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111290131|NCT03056118|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111290132|NCT03056118|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111290133|NCT03056118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111290134|NCT03056118|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111290135|NCT03056118|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111290136|NCT03056118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111290137|NCT03056118|Antipyretics|antipyretics|mesh-ancestor
111290138|NCT03056118|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111290139|NCT03056118|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111290140|NCT03056118|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111290141|NCT03056118|Purinergic Agents|purinergic agents|mesh-ancestor
111290142|NCT03056118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111290143|NCT04923516|Aminolevulinic Acid|aminolevulinic acid|mesh-list
111290144|NCT04923516|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111290145|NCT04923516|Dermatologic Agents|dermatologic agents|mesh-ancestor
111290146|NCT00987935|Sorafenib|sorafenib|mesh-list
111290147|NCT00987935|Nintedanib|nintedanib|mesh-list
111290148|NCT00987935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111290149|NCT00987935|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111290150|NCT00987935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111290151|NCT00987935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111290152|NCT00987467|Cyclosporine|cyclosporine|mesh-list
111290153|NCT00987467|Cyclosporins|cyclosporins|mesh-list
111290154|NCT00987467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111290155|NCT00987467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111290156|NCT00987467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111290157|NCT00987467|Immunologic Factors|immunologic factors|mesh-ancestor
111290158|NCT00987467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111290159|NCT00987467|Antifungal Agents|antifungal agents|mesh-ancestor
111290160|NCT00987467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111290161|NCT00987467|Dermatologic Agents|dermatologic agents|mesh-ancestor
111290162|NCT00987467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111290163|NCT00987467|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111290164|NCT05874440|Tenofovir|tenofovir|mesh-list
111290165|NCT05874440|Antiviral Agents|antiviral agents|mesh-ancestor
111290166|NCT05874440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111290167|NCT05874440|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111290168|NCT05874440|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111290169|NCT05874440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111290170|NCT05874440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111290171|NCT05874440|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111290172|NCT05874440|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111290173|NCT05874180|Metformin|metformin|mesh-list
111290174|NCT05874180|Linagliptin|linagliptin|mesh-list
111290175|NCT05874180|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111290176|NCT05874180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111290177|NCT05874180|Incretins|incretins|mesh-ancestor
111290178|NCT05874180|Hormones|hormones|mesh-ancestor
111290179|NCT05874180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111290180|NCT05874180|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111290181|NCT05874180|Protease Inhibitors|protease inhibitors|mesh-ancestor
111290182|NCT05874180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111290183|NCT05874180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111290184|NCT05874167|Metformin|metformin|mesh-list
111290185|NCT05874167|Linagliptin|linagliptin|mesh-list
111290186|NCT05874167|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111290187|NCT05874167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111290188|NCT05874167|Incretins|incretins|mesh-ancestor
111290189|NCT05874167|Hormones|hormones|mesh-ancestor
111290190|NCT05874167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111290191|NCT05874167|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111290192|NCT05874167|Protease Inhibitors|protease inhibitors|mesh-ancestor
111290193|NCT05874167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111290194|NCT05874167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111290195|NCT05873972|Cetuximab|cetuximab|mesh-list
111290196|NCT05873972|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111290197|NCT05873972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111290198|NCT05873751|Vaccines|vaccines|mesh-list
111290199|NCT05873751|Immunologic Factors|immunologic factors|mesh-ancestor
111290200|NCT05873751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111290201|NCT05873738|Nicotine|nicotine|mesh-list
111290202|NCT05873738|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111290203|NCT05873738|Autonomic Agents|autonomic agents|mesh-ancestor
111290204|NCT05873738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111290205|NCT05873738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111290206|NCT05873738|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111290207|NCT05873738|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111290208|NCT05873738|Cholinergic Agents|cholinergic agents|mesh-ancestor
111290209|NCT05873738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111290210|NCT05873738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111290211|NCT05873673|Ubiquinone|ubiquinone|mesh-list
111290212|NCT05873673|Coenzyme Q10|coenzyme q10|mesh-list
111290213|NCT05873673|Micronutrients|micronutrients|mesh-ancestor
111290214|NCT05873673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111290215|NCT05873673|Vitamins|vitamins|mesh-ancestor
111290216|NCT05873465|Fentanyl|fentanyl|mesh-list
111290217|NCT05873465|Midazolam|midazolam|mesh-list
111290218|NCT05873465|Propofol|propofol|mesh-list
111290219|NCT05873465|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111290220|NCT05873465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111290221|NCT05873465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111290222|NCT05873465|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111290223|NCT05873465|Anesthetics, General|anesthetics, general|mesh-ancestor
111290224|NCT05873465|Anesthetics|anesthetics|mesh-ancestor
111290225|NCT05873465|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111290226|NCT05873465|Narcotics|narcotics|mesh-ancestor
111290227|NCT05873465|Analgesics|analgesics|mesh-ancestor
110979360|NCT03248648|Anesthetics|anesthetics|mesh-ancestor
111290228|NCT05873465|Sensory System Agents|sensory system agents|mesh-ancestor
111290229|NCT05873465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111290230|NCT05873465|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111290231|NCT05873465|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111290232|NCT05873465|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111290233|NCT05873465|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111290234|NCT05873465|GABA Modulators|gaba modulators|mesh-ancestor
111290235|NCT05873465|GABA Agents|gaba agents|mesh-ancestor
111290236|NCT05873465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111290237|NCT05873465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111290238|NCT05873192|Talazoparib|talazoparib|mesh-list
111290239|NCT05873192|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111290240|NCT05873192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111290241|NCT05873192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111290242|NCT05873192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111290243|NCT05872932|Botulinum Toxins|botulinum toxins|mesh-list
111290244|NCT05872932|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111290245|NCT05872932|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111290246|NCT05872932|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111290247|NCT05872932|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111290248|NCT05872932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111290249|NCT05872932|Cholinergic Agents|cholinergic agents|mesh-ancestor
111290250|NCT05872932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111290251|NCT05872932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111290252|NCT05872932|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111290253|NCT05872932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111290254|NCT05872867|Pembrolizumab|pembrolizumab|mesh-list
111290255|NCT05872867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111290256|NCT05872867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111290257|NCT05872867|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111290258|NCT05872867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111290259|NCT05872698|Carvedilol|carvedilol|mesh-list
111290260|NCT05872698|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111290261|NCT05872698|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111290262|NCT05872698|Adrenergic Agents|adrenergic agents|mesh-ancestor
111290263|NCT05872698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111290264|NCT05872698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111290265|NCT05872698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111290266|NCT05872698|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111290267|NCT05872698|Antioxidants|antioxidants|mesh-ancestor
111290268|NCT05872698|Protective Agents|protective agents|mesh-ancestor
111290269|NCT05872698|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111290270|NCT05872698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111290271|NCT05872698|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111290272|NCT05872698|Vasodilator Agents|vasodilator agents|mesh-ancestor
111290273|NCT05872698|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111290274|NCT05872698|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111290275|NCT05872568|Mycophenolic Acid|mycophenolic acid|mesh-list
111290276|NCT05872568|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111290278|NCT05872568|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111290279|NCT05872568|Antitubercular Agents|antitubercular agents|mesh-ancestor
111290280|NCT05872568|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111290281|NCT05872568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111290282|NCT05872568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111290283|NCT05872568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111290284|NCT05872555|Antipsychotic Agents|antipsychotic agents|mesh-list
111290285|NCT05872555|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111290286|NCT05872555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111290287|NCT05872555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111290288|NCT05872555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111290289|NCT05872386|Buprenorphine|buprenorphine|mesh-list
111290290|NCT05872386|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111290291|NCT05872386|Narcotics|narcotics|mesh-ancestor
111290292|NCT05872386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111290293|NCT05872386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111290294|NCT05872386|Analgesics|analgesics|mesh-ancestor
111290295|NCT05872386|Sensory System Agents|sensory system agents|mesh-ancestor
111290296|NCT05872386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111290297|NCT05872386|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111290298|NCT05872087|Midazolam|midazolam|mesh-list
111290299|NCT05872087|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111290300|NCT05872087|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111290301|NCT05872087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111290302|NCT05872087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111290303|NCT05872087|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111290304|NCT05872087|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111290305|NCT05872087|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111290306|NCT05872087|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111290307|NCT05872087|Anesthetics, General|anesthetics, general|mesh-ancestor
111290308|NCT05872087|Anesthetics|anesthetics|mesh-ancestor
111290309|NCT05872087|GABA Modulators|gaba modulators|mesh-ancestor
111290310|NCT05872087|GABA Agents|gaba agents|mesh-ancestor
111290311|NCT05872087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111290312|NCT05872087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111290313|NCT05871619|Fluorides|fluorides|mesh-list
111290314|NCT05871619|Fluorides, Topical|fluorides, topical|mesh-list
111290315|NCT05871619|Cariostatic Agents|cariostatic agents|mesh-ancestor
111290316|NCT05871619|Protective Agents|protective agents|mesh-ancestor
111290317|NCT05871619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111290318|NCT05871177|Hyaluronic Acid|hyaluronic acid|mesh-list
111290319|NCT05871177|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111290320|NCT05871177|Immunologic Factors|immunologic factors|mesh-ancestor
111290321|NCT05871177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111290322|NCT05871177|Viscosupplements|viscosupplements|mesh-ancestor
111290323|NCT05871177|Protective Agents|protective agents|mesh-ancestor
111290324|NCT05870800|Leucovorin|leucovorin|mesh-list
111290325|NCT05870800|Fluorouracil|fluorouracil|mesh-list
111290326|NCT05870800|Capecitabine|capecitabine|mesh-list
111290327|NCT05870800|Oxaliplatin|oxaliplatin|mesh-list
111290328|NCT05870800|Atezolizumab|atezolizumab|mesh-list
111290329|NCT05870800|Antimetabolites|antimetabolites|mesh-ancestor
111290330|NCT05870800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111290331|NCT05870800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111290332|NCT05870800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111290333|NCT05870800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111290334|NCT05870800|Immunologic Factors|immunologic factors|mesh-ancestor
111290335|NCT05870800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111290336|NCT05870800|Antidotes|antidotes|mesh-ancestor
111290337|NCT05870800|Protective Agents|protective agents|mesh-ancestor
111290338|NCT05870800|Vitamin B Complex|vitamin b complex|mesh-ancestor
111290339|NCT05870800|Vitamins|vitamins|mesh-ancestor
111290340|NCT05870800|Micronutrients|micronutrients|mesh-ancestor
111290341|NCT05870800|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111290342|NCT05870800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111290343|NCT05869357|Turmeric extract|turmeric extract|mesh-list
111290344|NCT05869357|Antioxidants|antioxidants|mesh-ancestor
111290345|NCT05869357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111290346|NCT05869357|Protective Agents|protective agents|mesh-ancestor
111290347|NCT05869357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111290348|NCT05869188|Isotretinoin|isotretinoin|mesh-list
111290349|NCT05869188|Dermatologic Agents|dermatologic agents|mesh-ancestor
111290350|NCT05868889|Trabectedin|trabectedin|mesh-list
111014869|NCT02470611|Alendronate|alendronate|mesh-list
111290351|NCT05868889|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111290352|NCT05868889|Alkylating Agents|alkylating agents|mesh-ancestor
111290353|NCT05868889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111290354|NCT05868889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111290355|NCT05868174|Peposertib|peposertib|mesh-list
111290356|NCT05868174|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111290357|NCT05868174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111290358|NCT05868174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111290359|NCT05865457|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111290360|NCT05865457|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111290361|NCT05865379|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111290362|NCT05865379|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111290363|NCT05849740|Daratumumab|daratumumab|mesh-list
111290364|NCT05849740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111290365|NCT05811676|Tranexamic Acid|tranexamic acid|mesh-list
111290366|NCT05811676|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111290367|NCT05811676|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111290368|NCT05811676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111290369|NCT05811676|Hemostatics|hemostatics|mesh-ancestor
111290370|NCT05811676|Coagulants|coagulants|mesh-ancestor
111290371|NCT05797467|Bevacizumab|bevacizumab|mesh-list
111290372|NCT05797467|Cetuximab|cetuximab|mesh-list
111290373|NCT05797467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111290374|NCT05797467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111290375|NCT05797467|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111290376|NCT05797467|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111290377|NCT05797467|Growth Substances|growth substances|mesh-ancestor
111290378|NCT05797467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111290379|NCT05797467|Growth Inhibitors|growth inhibitors|mesh-ancestor
111290380|NCT05796973|Atorvastatin|atorvastatin|mesh-list
111290381|NCT05796973|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111290382|NCT05796973|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111290383|NCT05796973|Antimetabolites|antimetabolites|mesh-ancestor
111290384|NCT05796973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111290385|NCT05796973|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111290386|NCT05796973|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111290387|NCT05796973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111290388|NCT05739123|Relugolix|relugolix|mesh-list
111290389|NCT05739123|Androgen Antagonists|androgen antagonists|mesh-ancestor
111290390|NCT05739123|Hormone Antagonists|hormone antagonists|mesh-ancestor
111290391|NCT05739123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111290392|NCT05739123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111290393|NCT05733923|Sodium Hypochlorite|sodium hypochlorite|mesh-list
111290394|NCT05733923|Eusol|eusol|mesh-list
111290395|NCT05733923|Disinfectants|disinfectants|mesh-ancestor
111290396|NCT05733923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111290397|NCT05733741|Benoxinate|benoxinate|mesh-list
111290398|NCT05733741|Hyaluronic Acid|hyaluronic acid|mesh-list
111290399|NCT05733741|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111290400|NCT05733741|Immunologic Factors|immunologic factors|mesh-ancestor
111290401|NCT05733741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111290402|NCT05733741|Viscosupplements|viscosupplements|mesh-ancestor
111290403|NCT05733741|Protective Agents|protective agents|mesh-ancestor
111290404|NCT05733741|Anesthetics, Local|anesthetics, local|mesh-ancestor
111290405|NCT05733741|Anesthetics|anesthetics|mesh-ancestor
111290406|NCT05733741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111290407|NCT05733741|Sensory System Agents|sensory system agents|mesh-ancestor
111290408|NCT05733741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111290409|NCT05711082|Dopamine|dopamine|mesh-list
111290410|NCT05711082|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111290411|NCT05711082|Sympathomimetics|sympathomimetics|mesh-ancestor
111290412|NCT05711082|Autonomic Agents|autonomic agents|mesh-ancestor
111290413|NCT05711082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111290414|NCT05711082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111290415|NCT05711082|Dopamine Agents|dopamine agents|mesh-ancestor
111290416|NCT05711082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111290417|NCT05711082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111290418|NCT05711082|Protective Agents|protective agents|mesh-ancestor
111290419|NCT05689463|Immunoglobulins|immunoglobulins|mesh-list
111290420|NCT05689463|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111290421|NCT05689463|Antibodies|antibodies|mesh-list
111290422|NCT05689463|Immunologic Factors|immunologic factors|mesh-ancestor
111290423|NCT05689463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111290424|NCT05686993|Nifedipine|nifedipine|mesh-list
111290425|NCT05686993|Cinnarizine|cinnarizine|mesh-list
111290426|NCT05686993|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111290427|NCT05686993|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111290428|NCT05686993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111290429|NCT05686993|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111290430|NCT05686993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111290431|NCT05686993|Vasodilator Agents|vasodilator agents|mesh-ancestor
111290432|NCT05686993|Tocolytic Agents|tocolytic agents|mesh-ancestor
111290433|NCT05686993|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111290434|NCT05686993|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111290435|NCT05686993|Histamine Antagonists|histamine antagonists|mesh-ancestor
111290436|NCT05686993|Histamine Agents|histamine agents|mesh-ancestor
111290437|NCT05686993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111290438|NCT05673577|Cetuximab|cetuximab|mesh-list
111290439|NCT05673577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111290440|NCT05673577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111290441|NCT05658146|Sulconazole|sulconazole|mesh-list
111290442|NCT05658146|Antifungal Agents|antifungal agents|mesh-ancestor
111290443|NCT05658146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111290444|NCT05533164|Rituximab|rituximab|mesh-list
111290445|NCT05533164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111290446|NCT05533164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111290447|NCT05533164|Immunologic Factors|immunologic factors|mesh-ancestor
111290448|NCT05533164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111290449|NCT05533164|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111290450|NCT05533125|Rituximab|rituximab|mesh-list
111290451|NCT05533125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111290452|NCT05533125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111290453|NCT05533125|Immunologic Factors|immunologic factors|mesh-ancestor
111290454|NCT05533125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111290455|NCT05533125|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111290456|NCT05407584|Paclitaxel|paclitaxel|mesh-list
111290457|NCT05407584|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111290458|NCT05407584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111290459|NCT05407584|Tubulin Modulators|tubulin modulators|mesh-ancestor
111290460|NCT05407584|Antimitotic Agents|antimitotic agents|mesh-ancestor
111290461|NCT05407584|Mitosis Modulators|mitosis modulators|mesh-ancestor
111290462|NCT05407584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111290463|NCT05335122|Bimatoprost|bimatoprost|mesh-list
111290464|NCT05335122|Travoprost|travoprost|mesh-list
111290465|NCT05335122|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111290466|NCT05321251|Insulin|insulin|mesh-list
111290467|NCT05321251|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111290468|NCT05321251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111290469|NCT05294588|Ciprofloxacin|ciprofloxacin|mesh-list
111290470|NCT05294588|Ceftriaxone|ceftriaxone|mesh-list
111290471|NCT05294588|Cefixime|cefixime|mesh-list
111290472|NCT05294588|Vaccines|vaccines|mesh-list
111290473|NCT05294588|Immunologic Factors|immunologic factors|mesh-ancestor
111290474|NCT05294588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111290475|NCT05294588|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111290476|NCT05294588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111290477|NCT05294588|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111290478|NCT05294588|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111290479|NCT05294588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111290480|NCT05294588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111290481|NCT05294588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111290482|NCT05294588|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111290483|NCT05294588|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111290484|NCT05188508|Pembrolizumab|pembrolizumab|mesh-list
111290485|NCT05188508|Temozolomide|temozolomide|mesh-list
111290486|NCT05188508|Olaparib|olaparib|mesh-list
111290487|NCT05188508|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111290488|NCT05188508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111290489|NCT05188508|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111290490|NCT05188508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111290491|NCT05188508|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111290492|NCT05188508|Alkylating Agents|alkylating agents|mesh-ancestor
111290493|NCT05188508|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111290494|NCT05188508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111290495|NCT05170139|Caffeine|caffeine|mesh-list
111290496|NCT05170139|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111290497|NCT05170139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111290498|NCT05170139|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111290499|NCT05170139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111290500|NCT05170139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111290501|NCT05170139|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
111290502|NCT05170139|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111290503|NCT05170139|Purinergic Agents|purinergic agents|mesh-ancestor
111290504|NCT05170139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111290505|NCT05140811|Azacitidine|azacitidine|mesh-list
111290506|NCT05140811|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111290507|NCT05140811|Antimetabolites|antimetabolites|mesh-ancestor
111290508|NCT05140811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111290509|NCT05140811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111290510|NCT05140811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111290511|NCT05096169|Citric Acid|citric acid|mesh-list
111290512|NCT05096169|Sodium Citrate|sodium citrate|mesh-list
111290513|NCT05096169|Clomiphene|clomiphene|mesh-list
111290514|NCT05096169|Enclomiphene|enclomiphene|mesh-list
111290515|NCT05096169|Zuclomiphene|zuclomiphene|mesh-list
111290516|NCT05096169|Anticoagulants|anticoagulants|mesh-ancestor
111290517|NCT05096169|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
111290518|NCT05096169|Chelating Agents|chelating agents|mesh-ancestor
111290519|NCT05096169|Sequestering Agents|sequestering agents|mesh-ancestor
111290520|NCT05096169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111290521|NCT05096169|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111290522|NCT05096169|Hormone Antagonists|hormone antagonists|mesh-ancestor
111290523|NCT05096169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111290524|NCT05096169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111290525|NCT05096169|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111290526|NCT05096169|Fertility Agents|fertility agents|mesh-ancestor
111290527|NCT05096169|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111290528|NCT05096169|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111290529|NCT05096169|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111290530|NCT05079841|Oxytocin|oxytocin|mesh-list
111290531|NCT05079841|Oxytocics|oxytocics|mesh-ancestor
111290532|NCT05079841|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111290533|NCT05079841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111290534|NCT05046184|Midazolam|midazolam|mesh-list
111290535|NCT05046184|Ketamine|ketamine|mesh-list
111290536|NCT05046184|Analgesics|analgesics|mesh-ancestor
111290537|NCT05046184|Sensory System Agents|sensory system agents|mesh-ancestor
111290538|NCT05046184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111290539|NCT05046184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111290540|NCT05046184|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111290541|NCT05046184|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111290542|NCT05046184|Anesthetics, General|anesthetics, general|mesh-ancestor
111290543|NCT05046184|Anesthetics|anesthetics|mesh-ancestor
111290544|NCT05046184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111290545|NCT05046184|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111290546|NCT05046184|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111290547|NCT05046184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111290548|NCT05046184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111290549|NCT05046184|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111290550|NCT05046184|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111290551|NCT05046184|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111290552|NCT05046184|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111290553|NCT05046184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111290554|NCT05046184|GABA Modulators|gaba modulators|mesh-ancestor
111290555|NCT05046184|GABA Agents|gaba agents|mesh-ancestor
111290556|NCT05033522|Sorafenib|sorafenib|mesh-list
111290557|NCT05033522|Lenvatinib|lenvatinib|mesh-list
111290558|NCT05033522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111290559|NCT05033522|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111290560|NCT05033522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111290561|NCT05033522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111290562|NCT05020028|Cannabidiol|cannabidiol|mesh-list
111290563|NCT05020028|Anticonvulsants|anticonvulsants|mesh-ancestor
111290564|NCT04976868|Pimecrolimus|pimecrolimus|mesh-list
111290565|NCT04976868|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111290566|NCT04976868|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111290567|NCT04976868|Analgesics|analgesics|mesh-ancestor
111290568|NCT04976868|Sensory System Agents|sensory system agents|mesh-ancestor
111290569|NCT04976868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111290570|NCT04976868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111290571|NCT04976868|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111290572|NCT04976868|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111290573|NCT04976868|Dermatologic Agents|dermatologic agents|mesh-ancestor
111290574|NCT04976868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111290575|NCT04976868|Immunologic Factors|immunologic factors|mesh-ancestor
111290576|NCT04976868|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111290577|NCT04976868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111290578|NCT04976868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111290579|NCT04944654|Emtricitabine|emtricitabine|mesh-list
111015114|NCT02058667|Paclitaxel|paclitaxel|mesh-list
111290580|NCT04944654|Antiviral Agents|antiviral agents|mesh-ancestor
111290581|NCT04944654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111290582|NCT04944654|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111290583|NCT04944654|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111290584|NCT04944654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111290585|NCT04944654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111290586|NCT04944654|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111290587|NCT04944654|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111290588|NCT04939623|Benzoic Acid|benzoic acid|mesh-list
111290589|NCT04939623|Probenecid|probenecid|mesh-list
111290590|NCT04939623|Uricosuric Agents|uricosuric agents|mesh-ancestor
111290591|NCT04939623|Gout Suppressants|gout suppressants|mesh-ancestor
111290592|NCT04939623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111290593|NCT04939623|Antifungal Agents|antifungal agents|mesh-ancestor
111290594|NCT04939623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111290595|NCT04886232|Lidocaine|lidocaine|mesh-list
111290596|NCT04886232|Anesthetics, Local|anesthetics, local|mesh-ancestor
111290597|NCT04886232|Anesthetics|anesthetics|mesh-ancestor
111290598|NCT04886232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111290599|NCT04886232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111290600|NCT04886232|Sensory System Agents|sensory system agents|mesh-ancestor
111290601|NCT04886232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111290602|NCT04886232|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111290603|NCT04886232|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111290604|NCT04886232|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111290605|NCT04886232|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111290606|NCT04886232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111290607|NCT04885712|Metformin|metformin|mesh-list
111290608|NCT04885712|Pioglitazone|pioglitazone|mesh-list
111290609|NCT04885712|Dapagliflozin|dapagliflozin|mesh-list
111290610|NCT04885712|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111290611|NCT04885712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111290612|NCT04885712|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111290613|NCT04885712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111290614|NCT04843046|Pioglitazone|pioglitazone|mesh-list
111290615|NCT04843046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111290616|NCT04843046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111290617|NCT04789499|Theophylline|theophylline|mesh-list
111290618|NCT04789499|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111290619|NCT04789499|Autonomic Agents|autonomic agents|mesh-ancestor
111290620|NCT04789499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111290621|NCT04789499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111290622|NCT04789499|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111290623|NCT04789499|Respiratory System Agents|respiratory system agents|mesh-ancestor
111290624|NCT04789499|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111290625|NCT04789499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111290626|NCT04789499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111290627|NCT04789499|Vasodilator Agents|vasodilator agents|mesh-ancestor
111290628|NCT04789499|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
111290629|NCT04789499|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111290630|NCT04789499|Purinergic Agents|purinergic agents|mesh-ancestor
111290631|NCT04789499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111290632|NCT04774380|Carboplatin|carboplatin|mesh-list
111290633|NCT04774380|Etoposide|etoposide|mesh-list
111290634|NCT04774380|Durvalumab|durvalumab|mesh-list
111290635|NCT04774380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111290636|NCT04774380|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111290637|NCT04774380|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111290638|NCT04774380|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111290639|NCT04774380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111290640|NCT04774380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111290641|NCT04774380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111290642|NCT04706130|Artesunate|artesunate|mesh-list
111290643|NCT04706130|Primaquine|primaquine|mesh-list
111290644|NCT04706130|Antimalarials|antimalarials|mesh-ancestor
111290645|NCT04706130|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111290646|NCT04706130|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111290647|NCT04706130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111290648|NCT04706130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111290649|NCT04706130|Antiviral Agents|antiviral agents|mesh-ancestor
111290650|NCT04706130|Schistosomicides|schistosomicides|mesh-ancestor
111290651|NCT04706130|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
111290652|NCT04706130|Anthelmintics|anthelmintics|mesh-ancestor
111290653|NCT04697823|Hyaluronic Acid|hyaluronic acid|mesh-list
111290654|NCT04697823|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111290655|NCT04697823|Immunologic Factors|immunologic factors|mesh-ancestor
111290656|NCT04697823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111290657|NCT04697823|Viscosupplements|viscosupplements|mesh-ancestor
111290658|NCT04697823|Protective Agents|protective agents|mesh-ancestor
111290659|NCT04674462|Vaccines|vaccines|mesh-list
111290660|NCT04674462|Immunologic Factors|immunologic factors|mesh-ancestor
111290661|NCT04674462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111290662|NCT04657016|Tirzepatide|tirzepatide|mesh-list
111290663|NCT04657016|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111290664|NCT04657016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111290665|NCT04657016|Incretins|incretins|mesh-ancestor
111290666|NCT04657016|Hormones|hormones|mesh-ancestor
111290667|NCT04657016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111290668|NCT04638036|Cetuximab|cetuximab|mesh-list
111290669|NCT04638036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111290670|NCT04638036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111290671|NCT04593758|Hydroxychloroquine|hydroxychloroquine|mesh-list
111290672|NCT04593758|Antimalarials|antimalarials|mesh-ancestor
111290673|NCT04593758|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111290674|NCT04593758|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111290675|NCT04593758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111290676|NCT04593758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111290677|NCT04593758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111290678|NCT04593758|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111290679|NCT04560010|Tranexamic Acid|tranexamic acid|mesh-list
111290680|NCT04560010|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111290681|NCT04560010|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111290682|NCT04560010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111290683|NCT04560010|Hemostatics|hemostatics|mesh-ancestor
111290684|NCT04560010|Coagulants|coagulants|mesh-ancestor
111290685|NCT04558866|Methyltestosterone|methyltestosterone|mesh-list
111290686|NCT04558866|Testosterone|testosterone|mesh-list
111290687|NCT04558866|Testosterone undecanoate|testosterone undecanoate|mesh-list
111290688|NCT04558866|Testosterone enanthate|testosterone enanthate|mesh-list
111290689|NCT04558866|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
111290690|NCT04558866|Androgens|androgens|mesh-ancestor
111290691|NCT04558866|Hormones|hormones|mesh-ancestor
111290692|NCT04558866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111290693|NCT04558866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111290694|NCT04558866|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111290695|NCT04558866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111290696|NCT04558866|Anabolic Agents|anabolic agents|mesh-ancestor
111290697|NCT04397679|Chloroquine|chloroquine|mesh-list
111290698|NCT04397679|Temozolomide|temozolomide|mesh-list
111290699|NCT04397679|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111290700|NCT04397679|Alkylating Agents|alkylating agents|mesh-ancestor
111290701|NCT04397679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111290702|NCT04397679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111290703|NCT04397679|Amebicides|amebicides|mesh-ancestor
111290704|NCT04397679|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111290705|NCT04397679|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111290706|NCT04397679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111290707|NCT04397679|Antimalarials|antimalarials|mesh-ancestor
111290708|NCT04397679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111290709|NCT04363164|Methyltestosterone|methyltestosterone|mesh-list
111290710|NCT04363164|Testosterone|testosterone|mesh-list
111290711|NCT04363164|Testosterone undecanoate|testosterone undecanoate|mesh-list
111290712|NCT04363164|Testosterone enanthate|testosterone enanthate|mesh-list
111290713|NCT04363164|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
111290714|NCT04363164|Androgens|androgens|mesh-ancestor
111290715|NCT04363164|Hormones|hormones|mesh-ancestor
111290716|NCT04363164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111290717|NCT04363164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111290718|NCT04363164|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111290719|NCT04363164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111290720|NCT04363164|Anabolic Agents|anabolic agents|mesh-ancestor
111290721|NCT04258423|Everolimus|everolimus|mesh-list
111290722|NCT04258423|Tacrolimus|tacrolimus|mesh-list
111290723|NCT04258423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111290724|NCT04258423|Immunologic Factors|immunologic factors|mesh-ancestor
111290725|NCT04258423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111290726|NCT04258423|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111290727|NCT04258423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111290728|NCT04258423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111290729|NCT04258423|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111290730|NCT04258423|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111290731|NCT04258423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111290732|NCT04211987|Cytarabine|cytarabine|mesh-list
111290733|NCT04211987|Methotrexate|methotrexate|mesh-list
111290735|NCT04211987|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111290736|NCT04211987|Antimetabolites|antimetabolites|mesh-ancestor
111290737|NCT04211987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111290738|NCT04211987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111290739|NCT04211987|Antiviral Agents|antiviral agents|mesh-ancestor
111290740|NCT04211987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111290741|NCT04211987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111290742|NCT04211987|Immunologic Factors|immunologic factors|mesh-ancestor
111290743|NCT04211987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111290744|NCT04211987|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111290745|NCT04211987|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111290746|NCT04211987|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111290747|NCT04211987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111290748|NCT04211987|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111290749|NCT04211987|Abortifacient Agents|abortifacient agents|mesh-ancestor
111290750|NCT04211987|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111290751|NCT04211987|Dermatologic Agents|dermatologic agents|mesh-ancestor
111290752|NCT04211987|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111290753|NCT04211987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111290754|NCT04211987|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111290755|NCT04190433|Carvedilol|carvedilol|mesh-list
111290756|NCT04190433|Lisinopril|lisinopril|mesh-list
111290757|NCT04190433|Spironolactone|spironolactone|mesh-list
111290758|NCT04190433|Pravastatin|pravastatin|mesh-list
111290759|NCT04190433|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
111290760|NCT04190433|Hormone Antagonists|hormone antagonists|mesh-ancestor
111290761|NCT04190433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111290762|NCT04190433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111290763|NCT04190433|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
111290764|NCT04190433|Diuretics|diuretics|mesh-ancestor
111290765|NCT04190433|Natriuretic Agents|natriuretic agents|mesh-ancestor
111290766|NCT04190433|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111290767|NCT04190433|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111290768|NCT04190433|Adrenergic Agents|adrenergic agents|mesh-ancestor
111290769|NCT04190433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111290770|NCT04190433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111290771|NCT04190433|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111290772|NCT04190433|Antioxidants|antioxidants|mesh-ancestor
111290773|NCT04190433|Protective Agents|protective agents|mesh-ancestor
111290774|NCT04190433|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111290775|NCT04190433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111290776|NCT04190433|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111290777|NCT04190433|Vasodilator Agents|vasodilator agents|mesh-ancestor
111290778|NCT04190433|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111290779|NCT04190433|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111290780|NCT04190433|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111290781|NCT04190433|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111290782|NCT04190433|Antimetabolites|antimetabolites|mesh-ancestor
111290783|NCT04190433|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111290784|NCT04190433|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111290785|NCT04190433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111290786|NCT04190433|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
111290787|NCT04190433|Protease Inhibitors|protease inhibitors|mesh-ancestor
111290788|NCT04190433|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111290789|NCT04177810|Plerixafor|plerixafor|mesh-list
111290790|NCT04177810|Cemiplimab|cemiplimab|mesh-list
111290791|NCT04177810|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111290792|NCT04177810|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111290793|NCT04177810|Antiviral Agents|antiviral agents|mesh-ancestor
111290794|NCT04177810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111290795|NCT04177810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111290796|NCT04177810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111290797|NCT04163900|Gemcitabine|gemcitabine|mesh-list
111290798|NCT04163900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111290799|NCT04163900|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111290800|NCT04163900|Antimetabolites|antimetabolites|mesh-ancestor
111290801|NCT04163900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111290802|NCT04146038|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
111290803|NCT04146038|Sodium Salicylate|sodium salicylate|mesh-list
111290804|NCT04146038|Azacitidine|azacitidine|mesh-list
111290805|NCT04146038|Decitabine|decitabine|mesh-list
111290806|NCT04146038|Venetoclax|venetoclax|mesh-list
111290807|NCT04146038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111290808|NCT04146038|Antimetabolites|antimetabolites|mesh-ancestor
111290809|NCT04146038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111290810|NCT04146038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111290811|NCT04146038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111290812|NCT04146038|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111290813|NCT04146038|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111290814|NCT04146038|Analgesics|analgesics|mesh-ancestor
111290815|NCT04146038|Sensory System Agents|sensory system agents|mesh-ancestor
111290816|NCT04146038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111290817|NCT04146038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111290818|NCT04146038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111290819|NCT04146038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111290820|NCT04146038|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111290821|NCT04109885|Diphenhydramine|diphenhydramine|mesh-list
111290822|NCT04109885|Promethazine|promethazine|mesh-list
111290823|NCT04109885|Prochlorperazine|prochlorperazine|mesh-list
111290824|NCT04109885|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111290825|NCT04109885|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111290826|NCT04109885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111290827|NCT04109885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111290828|NCT04109885|Anesthetics, Local|anesthetics, local|mesh-ancestor
111290829|NCT04109885|Anesthetics|anesthetics|mesh-ancestor
111290830|NCT04109885|Sensory System Agents|sensory system agents|mesh-ancestor
111290831|NCT04109885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111290832|NCT04109885|Antiemetics|antiemetics|mesh-ancestor
111290833|NCT04109885|Autonomic Agents|autonomic agents|mesh-ancestor
111290834|NCT04109885|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111290835|NCT04109885|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111290836|NCT04109885|Histamine Antagonists|histamine antagonists|mesh-ancestor
111290837|NCT04109885|Histamine Agents|histamine agents|mesh-ancestor
111290838|NCT04109885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111290839|NCT04109885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111290840|NCT04109885|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111290841|NCT04109885|Antipruritics|antipruritics|mesh-ancestor
111290842|NCT04109885|Dermatologic Agents|dermatologic agents|mesh-ancestor
111290843|NCT04109885|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111290844|NCT04109885|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111290845|NCT04109885|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111290846|NCT04109885|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111290847|NCT04109885|Dopamine Agents|dopamine agents|mesh-ancestor
111290848|NCT04087668|Anesthetics|anesthetics|mesh-list
111290849|NCT04087668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111290850|NCT04087668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111290851|NCT04025372|Bicalutamide|bicalutamide|mesh-list
111290852|NCT04025372|Androgen Antagonists|androgen antagonists|mesh-ancestor
111290853|NCT04025372|Hormone Antagonists|hormone antagonists|mesh-ancestor
111290854|NCT04025372|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111290855|NCT04025372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111290856|NCT04025372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111290857|NCT04006873|Ivacaftor|ivacaftor|mesh-list
111290858|NCT04006873|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
111290859|NCT04006873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111290860|NCT04006873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111290861|NCT03942419|Atropine|atropine|mesh-list
111290862|NCT03942419|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111290863|NCT03942419|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111290864|NCT03942419|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111290865|NCT03942419|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111290866|NCT03942419|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111290867|NCT03942419|Autonomic Agents|autonomic agents|mesh-ancestor
111290868|NCT03942419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111290869|NCT03942419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111290870|NCT03942419|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111290871|NCT03942419|Respiratory System Agents|respiratory system agents|mesh-ancestor
111290872|NCT03942419|Mydriatics|mydriatics|mesh-ancestor
111290873|NCT03942419|Parasympatholytics|parasympatholytics|mesh-ancestor
111290874|NCT03942419|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111290875|NCT03942419|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111290876|NCT03942419|Cholinergic Agents|cholinergic agents|mesh-ancestor
111290877|NCT03942419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111290878|NCT03942419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111290879|NCT03820310|Immunomodulating Agents|immunomodulating agents|mesh-list
111290880|NCT03820310|Immunologic Factors|immunologic factors|mesh-ancestor
111290881|NCT03820310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111290882|NCT03780673|Rifaximin|rifaximin|mesh-list
111290884|NCT03780673|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111290885|NCT03780673|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111290886|NCT03780673|Antimetabolites|antimetabolites|mesh-ancestor
111290887|NCT03780673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111290888|NCT03780673|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111290889|NCT03780673|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111290890|NCT03780673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111290891|NCT03780673|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111290892|NCT03780673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111290893|NCT03780673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111290894|NCT03769311|Cetuximab|cetuximab|mesh-list
111290895|NCT03769311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110979371|NCT03241784|Interleukin-2|interleukin-2|mesh-list
111290896|NCT03769311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111290897|NCT03767335|Trastuzumab|trastuzumab|mesh-list
111290898|NCT03767335|Fulvestrant|fulvestrant|mesh-list
111290899|NCT03767335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111290900|NCT03767335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111290901|NCT03767335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111290902|NCT03767335|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
111290903|NCT03767335|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111290904|NCT03767335|Hormone Antagonists|hormone antagonists|mesh-ancestor
111290905|NCT03767335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111290906|NCT03767335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111290907|NCT03745430|Ramucirumab|ramucirumab|mesh-list
111290908|NCT03745430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111290909|NCT03651882|Oxytocin|oxytocin|mesh-list
111290910|NCT03651882|Carbetocin|carbetocin|mesh-list
111290911|NCT03651882|Oxytocics|oxytocics|mesh-ancestor
111290912|NCT03651882|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111290913|NCT03651882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111290914|NCT03636932|Acetylcysteine|acetylcysteine|mesh-list
111290915|NCT03636932|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111290916|NCT03636932|Antiviral Agents|antiviral agents|mesh-ancestor
111290917|NCT03636932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111290918|NCT03636932|Expectorants|expectorants|mesh-ancestor
111290919|NCT03636932|Respiratory System Agents|respiratory system agents|mesh-ancestor
111290920|NCT03636932|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111290921|NCT03636932|Antioxidants|antioxidants|mesh-ancestor
111290922|NCT03636932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111290923|NCT03636932|Protective Agents|protective agents|mesh-ancestor
111290924|NCT03636932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111290925|NCT03636932|Antidotes|antidotes|mesh-ancestor
111290926|NCT05910554|Metformin|metformin|mesh-list
111290927|NCT05910554|Glyburide|glyburide|mesh-list
111290928|NCT05910554|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111290929|NCT05910554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111290930|NCT05910476|Ezetimibe|ezetimibe|mesh-list
111290931|NCT05910476|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111290932|NCT05910476|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111290933|NCT05910476|Antimetabolites|antimetabolites|mesh-ancestor
111290934|NCT05910476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111290935|NCT05910476|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111290936|NCT05910450|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111290937|NCT05910177|Etoposide|etoposide|mesh-list
111290938|NCT05910177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111290939|NCT05910177|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111290940|NCT05910177|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111290941|NCT05910177|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111290942|NCT05910177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111290943|NCT05910177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111290944|NCT05910125|Aspirin|aspirin|mesh-list
111290945|NCT05910125|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
111290946|NCT05910125|Clopidogrel|clopidogrel|mesh-list
111290947|NCT05910125|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111290948|NCT05910125|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111290949|NCT05910125|Analgesics|analgesics|mesh-ancestor
111290950|NCT05910125|Sensory System Agents|sensory system agents|mesh-ancestor
111290951|NCT05910125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111290952|NCT05910125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111290953|NCT05910125|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111290954|NCT05910125|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111290955|NCT05910125|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111290956|NCT05910125|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111290957|NCT05910125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111290958|NCT05910125|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111290959|NCT05910125|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111290960|NCT05910125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111290961|NCT05910125|Antipyretics|antipyretics|mesh-ancestor
111290962|NCT05910125|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111290963|NCT05910125|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111290964|NCT05910125|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111290965|NCT05910125|Purinergic Agents|purinergic agents|mesh-ancestor
111290966|NCT05910125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111290967|NCT05910034|Docetaxel|docetaxel|mesh-list
111290968|NCT05910034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111290969|NCT05910034|Tubulin Modulators|tubulin modulators|mesh-ancestor
111290970|NCT05910034|Antimitotic Agents|antimitotic agents|mesh-ancestor
111290971|NCT05910034|Mitosis Modulators|mitosis modulators|mesh-ancestor
111290972|NCT05910034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111290973|NCT05909852|Adalimumab|adalimumab|mesh-list
111290974|NCT05909852|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111290975|NCT05909852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111290976|NCT05909852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111290977|NCT05909826|Dexamethasone|dexamethasone|mesh-list
111290978|NCT05909826|Cyclophosphamide|cyclophosphamide|mesh-list
111290979|NCT05909826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111290980|NCT05909826|Immunologic Factors|immunologic factors|mesh-ancestor
111290981|NCT05909826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111290982|NCT05909826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111290983|NCT05909826|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111290984|NCT05909826|Alkylating Agents|alkylating agents|mesh-ancestor
111290985|NCT05909826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111290986|NCT05909826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111290987|NCT05909826|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111290988|NCT05909826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111290989|NCT05909826|Antiemetics|antiemetics|mesh-ancestor
111290990|NCT05909826|Autonomic Agents|autonomic agents|mesh-ancestor
111290991|NCT05909826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111290992|NCT05909826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111290993|NCT05909826|Glucocorticoids|glucocorticoids|mesh-ancestor
111290994|NCT05909826|Hormones|hormones|mesh-ancestor
111290995|NCT05909826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111290996|NCT05909826|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111290997|NCT05909800|Fenofibrate|fenofibrate|mesh-list
111290998|NCT05909800|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111290999|NCT05909800|Antimetabolites|antimetabolites|mesh-ancestor
111291000|NCT05909800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111291001|NCT05909800|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111291002|NCT05909462|Triamcinolone|triamcinolone|mesh-list
111291003|NCT05909462|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
111291004|NCT05909462|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
111291005|NCT05909462|Lidocaine|lidocaine|mesh-list
111291006|NCT05909462|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
111291007|NCT05909462|Anesthetics, Local|anesthetics, local|mesh-ancestor
111291008|NCT05909462|Anesthetics|anesthetics|mesh-ancestor
111291009|NCT05909462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111291010|NCT05909462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111291011|NCT05909462|Sensory System Agents|sensory system agents|mesh-ancestor
111291012|NCT05909462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111291013|NCT05909462|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111291014|NCT05909462|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111291015|NCT05909462|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111291016|NCT05909462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111291017|NCT05909462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111291018|NCT05909462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111291019|NCT05909462|Glucocorticoids|glucocorticoids|mesh-ancestor
111291020|NCT05909462|Hormones|hormones|mesh-ancestor
111291021|NCT05909462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111291022|NCT05909462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111291023|NCT05909462|Immunologic Factors|immunologic factors|mesh-ancestor
111291024|NCT05909462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111291025|NCT05909423|Pembrolizumab|pembrolizumab|mesh-list
111291026|NCT05909423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111291027|NCT05909423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111291028|NCT05909423|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111291029|NCT05909423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111291030|NCT05909293|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111291031|NCT05909293|Venetoclax|venetoclax|mesh-list
111291033|NCT05909293|Lenograstim|lenograstim|mesh-list
111291034|NCT05909293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111291035|NCT05909293|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111291036|NCT05909293|Immunologic Factors|immunologic factors|mesh-ancestor
111291037|NCT05909293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111291038|NCT05909293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111291039|NCT05909293|Autonomic Agents|autonomic agents|mesh-ancestor
111291040|NCT05909293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111291041|NCT05909293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111291042|NCT05909215|Dexmedetomidine|dexmedetomidine|mesh-list
111291043|NCT05909215|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111291044|NCT05909215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111291045|NCT05909215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111291046|NCT05909215|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111291047|NCT05909215|Analgesics|analgesics|mesh-ancestor
111291048|NCT05909215|Sensory System Agents|sensory system agents|mesh-ancestor
111291049|NCT05909215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111291050|NCT05909215|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111291051|NCT05909215|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111291052|NCT05909215|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111291053|NCT05909215|Adrenergic Agents|adrenergic agents|mesh-ancestor
111291054|NCT05909215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111291055|NCT05909215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111291056|NCT05909137|Immunomodulating Agents|immunomodulating agents|mesh-list
111291057|NCT05909137|Immunologic Factors|immunologic factors|mesh-ancestor
111291058|NCT05909137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111291059|NCT05909072|Tranexamic Acid|tranexamic acid|mesh-list
111291060|NCT05909072|Hyaluronic Acid|hyaluronic acid|mesh-list
111291061|NCT05909072|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111291062|NCT05909072|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111291063|NCT05909072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111291064|NCT05909072|Hemostatics|hemostatics|mesh-ancestor
111291065|NCT05909072|Coagulants|coagulants|mesh-ancestor
111291066|NCT05909072|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111291067|NCT05909072|Immunologic Factors|immunologic factors|mesh-ancestor
111291068|NCT05909072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111291069|NCT05909072|Viscosupplements|viscosupplements|mesh-ancestor
111291070|NCT05909072|Protective Agents|protective agents|mesh-ancestor
111291071|NCT05909059|Cyclophosphamide|cyclophosphamide|mesh-list
111291072|NCT05909059|Fludarabine|fludarabine|mesh-list
111291073|NCT05909059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111291074|NCT05909059|Immunologic Factors|immunologic factors|mesh-ancestor
111291075|NCT05909059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111291076|NCT05909059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111291077|NCT05909059|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111291078|NCT05909059|Alkylating Agents|alkylating agents|mesh-ancestor
111291079|NCT05909059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111291080|NCT05909059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111291081|NCT05909059|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111291082|NCT05908864|Magnesium Sulfate|magnesium sulfate|mesh-list
111291083|NCT05908864|Analgesics|analgesics|mesh-ancestor
111291084|NCT05908864|Sensory System Agents|sensory system agents|mesh-ancestor
111291085|NCT05908864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111291086|NCT05908864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111291087|NCT05908864|Anesthetics|anesthetics|mesh-ancestor
111291088|NCT05908864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111291089|NCT05908864|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111291090|NCT05908864|Anticonvulsants|anticonvulsants|mesh-ancestor
111291091|NCT05908864|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111291092|NCT05908864|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111291093|NCT05908864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111291094|NCT05908864|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111291095|NCT05908864|Tocolytic Agents|tocolytic agents|mesh-ancestor
111291096|NCT05908864|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111291097|NCT05908851|Ketorolac|ketorolac|mesh-list
111291098|NCT05908851|Epinephrine|epinephrine|mesh-list
111291099|NCT05908851|Morphine|morphine|mesh-list
111291100|NCT05908851|Ropivacaine|ropivacaine|mesh-list
111291101|NCT05908851|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111291102|NCT05908851|Narcotics|narcotics|mesh-ancestor
111291103|NCT05908851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111291104|NCT05908851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111291105|NCT05908851|Analgesics|analgesics|mesh-ancestor
111291106|NCT05908851|Sensory System Agents|sensory system agents|mesh-ancestor
111291107|NCT05908851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111291108|NCT05908851|Anesthetics, Local|anesthetics, local|mesh-ancestor
111291109|NCT05908851|Anesthetics|anesthetics|mesh-ancestor
111291110|NCT05908851|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110979378|NCT03242096|Sirolimus|sirolimus|mesh-list
111291111|NCT05908851|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111291112|NCT05908851|Adrenergic Agents|adrenergic agents|mesh-ancestor
111291113|NCT05908851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111291114|NCT05908851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111291115|NCT05908851|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111291116|NCT05908851|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111291117|NCT05908851|Autonomic Agents|autonomic agents|mesh-ancestor
111291118|NCT05908851|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111291119|NCT05908851|Respiratory System Agents|respiratory system agents|mesh-ancestor
111291120|NCT05908851|Mydriatics|mydriatics|mesh-ancestor
111291121|NCT05908851|Sympathomimetics|sympathomimetics|mesh-ancestor
111291122|NCT05908851|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111291123|NCT05908851|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111291124|NCT05908851|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111291125|NCT05908851|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111291126|NCT05908851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111291127|NCT05908851|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111291128|NCT05908851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111291129|NCT05906121|Lidocaine|lidocaine|mesh-list
111291130|NCT05906121|Ketamine|ketamine|mesh-list
111291131|NCT05906121|Anesthetics, Local|anesthetics, local|mesh-ancestor
111291132|NCT05906121|Anesthetics|anesthetics|mesh-ancestor
111291133|NCT05906121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111291134|NCT05906121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111291135|NCT05906121|Sensory System Agents|sensory system agents|mesh-ancestor
111291136|NCT05906121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111291137|NCT05906121|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111291138|NCT05906121|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111291139|NCT05906121|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111291140|NCT05906121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111291141|NCT05906121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111291142|NCT05906121|Analgesics|analgesics|mesh-ancestor
111291143|NCT05906121|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111291144|NCT05906121|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111291145|NCT05906121|Anesthetics, General|anesthetics, general|mesh-ancestor
111291146|NCT05906121|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111291147|NCT05906121|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111291148|NCT05906121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111291149|NCT05904587|Imidacloprid|imidacloprid|mesh-list
111291150|NCT05904587|Cholinergic Agents|cholinergic agents|mesh-ancestor
111291151|NCT05904587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111291152|NCT05904587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111291153|NCT05904587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111291154|NCT05904457|Bevacizumab|bevacizumab|mesh-list
111291155|NCT05904457|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111291156|NCT05904457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111291157|NCT05904457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111291158|NCT05904457|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111291159|NCT05904457|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111291160|NCT05904457|Growth Substances|growth substances|mesh-ancestor
111291161|NCT05904457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111291162|NCT05904457|Growth Inhibitors|growth inhibitors|mesh-ancestor
111291163|NCT05904457|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111291164|NCT05904457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111291165|NCT05904457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111291166|NCT05904275|Dexamethasone|dexamethasone|mesh-list
111291167|NCT05904275|Ropivacaine|ropivacaine|mesh-list
111291168|NCT05904275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111291169|NCT05904275|Antiemetics|antiemetics|mesh-ancestor
111291170|NCT05904275|Autonomic Agents|autonomic agents|mesh-ancestor
111291171|NCT05904275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111291172|NCT05904275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111291173|NCT05904275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111291174|NCT05904275|Glucocorticoids|glucocorticoids|mesh-ancestor
111291175|NCT05904275|Hormones|hormones|mesh-ancestor
111291176|NCT05904275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111291177|NCT05904275|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111291178|NCT05904275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111291179|NCT05904275|Anesthetics, Local|anesthetics, local|mesh-ancestor
111015686|NCT03308253|Vancomycin|vancomycin|mesh-list
111291180|NCT05904275|Anesthetics|anesthetics|mesh-ancestor
111291181|NCT05904275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111291182|NCT05904275|Sensory System Agents|sensory system agents|mesh-ancestor
111291183|NCT05904184|Calcium, Dietary|calcium, dietary|mesh-list
111291184|NCT05904184|Calcium|calcium|mesh-list
111291185|NCT05904184|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111291186|NCT05904184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111291187|NCT05904184|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111291188|NCT05904119|Lomustine|lomustine|mesh-list
111291189|NCT05904119|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111291190|NCT05904119|Alkylating Agents|alkylating agents|mesh-ancestor
111291191|NCT05904119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111291192|NCT05904119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111291193|NCT05904080|Nivolumab|nivolumab|mesh-list
111291194|NCT05904080|Ipilimumab|ipilimumab|mesh-list
111291195|NCT05904080|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111291196|NCT05904080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111291197|NCT05904080|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111291198|NCT05904080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111291199|NCT05904002|Budesonide|budesonide|mesh-list
111291200|NCT05904002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111291201|NCT05904002|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111291202|NCT05904002|Autonomic Agents|autonomic agents|mesh-ancestor
111291203|NCT05904002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111291204|NCT05904002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111291205|NCT05904002|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111291206|NCT05904002|Respiratory System Agents|respiratory system agents|mesh-ancestor
111291207|NCT05904002|Glucocorticoids|glucocorticoids|mesh-ancestor
111291208|NCT05904002|Hormones|hormones|mesh-ancestor
111291209|NCT05904002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111291210|NCT05903963|Midazolam|midazolam|mesh-list
111291211|NCT05903963|Dexmedetomidine|dexmedetomidine|mesh-list
111291212|NCT05903963|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111291213|NCT05903963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111291214|NCT05903963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111291215|NCT05903963|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111291216|NCT05903963|Analgesics|analgesics|mesh-ancestor
111291217|NCT05903963|Sensory System Agents|sensory system agents|mesh-ancestor
111291218|NCT05903963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111291219|NCT05903963|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111291220|NCT05903963|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111291221|NCT05903963|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111291222|NCT05903963|Adrenergic Agents|adrenergic agents|mesh-ancestor
111291223|NCT05903963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111291224|NCT05903963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111291225|NCT05903963|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111291226|NCT05903963|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111291227|NCT05903963|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111291228|NCT05903963|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111291229|NCT05903963|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111291230|NCT05903963|Anesthetics, General|anesthetics, general|mesh-ancestor
111291231|NCT05903963|Anesthetics|anesthetics|mesh-ancestor
111291232|NCT05903963|GABA Modulators|gaba modulators|mesh-ancestor
111291233|NCT05903963|GABA Agents|gaba agents|mesh-ancestor
111291234|NCT05903937|Melphalan|melphalan|mesh-list
111291235|NCT05903937|Interleukin-2|interleukin-2|mesh-list
111291236|NCT05903937|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111291237|NCT05903937|Alkylating Agents|alkylating agents|mesh-ancestor
111291238|NCT05903937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111291239|NCT05903937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111291240|NCT05903937|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111291241|NCT05903937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111291242|NCT05903937|Immunologic Factors|immunologic factors|mesh-ancestor
111291243|NCT05903937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111291244|NCT05903937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111291245|NCT05903937|Analgesics|analgesics|mesh-ancestor
111291246|NCT05903937|Sensory System Agents|sensory system agents|mesh-ancestor
111291247|NCT05903937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111291248|NCT05903833|Pembrolizumab|pembrolizumab|mesh-list
111291249|NCT05903833|Lenvatinib|lenvatinib|mesh-list
111291250|NCT05903833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111291251|NCT05903833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111291252|NCT05903833|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111291253|NCT05903833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111291254|NCT05903833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111291255|NCT05903833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111291256|NCT05903807|FAPI-46|fapi-46|mesh-list
111291257|NCT05903807|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111291258|NCT05903807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111291259|NCT05903755|Methamphetamine|methamphetamine|mesh-list
111291260|NCT05903755|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111291261|NCT05903755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111291262|NCT05903755|Sympathomimetics|sympathomimetics|mesh-ancestor
111291263|NCT05903755|Autonomic Agents|autonomic agents|mesh-ancestor
111291264|NCT05903755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111291265|NCT05903755|Dopamine Agents|dopamine agents|mesh-ancestor
111291266|NCT05903755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111291267|NCT05903755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111291268|NCT05903755|Adrenergic Agents|adrenergic agents|mesh-ancestor
111291269|NCT05903755|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111291270|NCT05903755|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111291271|NCT05903755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111291272|NCT05903755|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111291273|NCT05903716|Isotretinoin|isotretinoin|mesh-list
111291274|NCT05903716|Hormones|hormones|mesh-list
111291275|NCT05903716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111291276|NCT05903716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111291277|NCT05903716|Dermatologic Agents|dermatologic agents|mesh-ancestor
111291278|NCT05903703|Canagliflozin|canagliflozin|mesh-list
111291279|NCT05903703|Gemcitabine|gemcitabine|mesh-list
111291280|NCT05903703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111291281|NCT05903703|Antimetabolites|antimetabolites|mesh-ancestor
111291282|NCT05903703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111291283|NCT05903703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111291284|NCT05903703|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111291285|NCT05903703|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111291286|NCT05903703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111291287|NCT05903456|Lenvatinib|lenvatinib|mesh-list
111291288|NCT05903456|Immunologic Factors|immunologic factors|mesh-list
111291289|NCT05903456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111291290|NCT05903456|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111291291|NCT05903456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111291292|NCT05903456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111291293|NCT05903456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111291294|NCT05903326|Dexmedetomidine|dexmedetomidine|mesh-list
111291295|NCT05903326|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111291296|NCT05903326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111291297|NCT05903326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111291298|NCT05903326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111291299|NCT05903326|Analgesics|analgesics|mesh-ancestor
111291300|NCT05903326|Sensory System Agents|sensory system agents|mesh-ancestor
111291301|NCT05903326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111291302|NCT05903326|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111291303|NCT05903326|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111291304|NCT05903326|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111291305|NCT05903326|Adrenergic Agents|adrenergic agents|mesh-ancestor
111291306|NCT05903326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111291307|NCT05903326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111291308|NCT05903131|Levonorgestrel|levonorgestrel|mesh-list
111291309|NCT05903131|Progestins|progestins|mesh-list
111291310|NCT05903131|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111291311|NCT05903131|Contraceptive Agents|contraceptive agents|mesh-ancestor
111291312|NCT05903131|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111291313|NCT05903131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111291314|NCT05903131|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111291315|NCT05903131|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111291316|NCT05903131|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111291317|NCT05903131|Hormones|hormones|mesh-ancestor
111291318|NCT05903131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111291319|NCT05903040|Lasmiditan|lasmiditan|mesh-list
111291320|NCT05903040|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111291321|NCT05903040|Serotonin Agents|serotonin agents|mesh-ancestor
111291322|NCT05903040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111291323|NCT05903040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111291324|NCT05903040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111291325|NCT05902819|Minocycline|minocycline|mesh-list
111291326|NCT05902819|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111015831|NCT03307941|Fluorouracil|fluorouracil|mesh-list
111291327|NCT05902819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111291328|NCT05902754|Sulforaphane|sulforaphane|mesh-list
111291329|NCT05902754|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
111291330|NCT05902754|Protective Agents|protective agents|mesh-ancestor
111291331|NCT05902754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111291332|NCT05902754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111291333|NCT05902728|Itraconazole|itraconazole|mesh-list
111291334|NCT05902728|Rifampin|rifampin|mesh-list
111291335|NCT05902728|Antifungal Agents|antifungal agents|mesh-ancestor
111291336|NCT05902728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111291337|NCT05902728|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111291338|NCT05902728|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111291339|NCT05902728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111291340|NCT05902728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111291341|NCT05902728|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111291342|NCT05902728|Hormone Antagonists|hormone antagonists|mesh-ancestor
111291343|NCT05902728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111291344|NCT05902728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111291345|NCT05902728|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111291346|NCT05902728|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111291347|NCT05902728|Antitubercular Agents|antitubercular agents|mesh-ancestor
111291348|NCT05902728|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111291349|NCT05902728|Leprostatic Agents|leprostatic agents|mesh-ancestor
111291350|NCT05902728|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111291351|NCT05902728|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111291352|NCT05902728|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111291353|NCT05902728|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
111291354|NCT05902728|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
111291355|NCT05902728|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
111291356|NCT05902728|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111291357|NCT05902468|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
111291358|NCT05902468|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
111291359|NCT05902468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111291360|NCT05902429|Cladribine|cladribine|mesh-list
111291361|NCT05902429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111291362|NCT05902429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111291363|NCT05902429|Immunologic Factors|immunologic factors|mesh-ancestor
111291364|NCT05902429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111291365|NCT05901428|Cyclophosphamide|cyclophosphamide|mesh-list
111291366|NCT05901428|Carboplatin|carboplatin|mesh-list
111291367|NCT05901428|Docetaxel|docetaxel|mesh-list
111291368|NCT05901428|Epirubicin|epirubicin|mesh-list
111291369|NCT05901428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111291370|NCT05901428|Immunologic Factors|immunologic factors|mesh-ancestor
111291371|NCT05901428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111291372|NCT05901428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111291373|NCT05901428|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111291374|NCT05901428|Alkylating Agents|alkylating agents|mesh-ancestor
111291375|NCT05901428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111291376|NCT05901428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111291377|NCT05901428|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111291378|NCT05901428|Tubulin Modulators|tubulin modulators|mesh-ancestor
111291379|NCT05901428|Antimitotic Agents|antimitotic agents|mesh-ancestor
111291380|NCT05901428|Mitosis Modulators|mitosis modulators|mesh-ancestor
111291381|NCT05901428|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111291382|NCT05901428|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111291383|NCT05901428|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111291384|NCT05901428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111291385|NCT05899140|Clindamycin|clindamycin|mesh-list
111291386|NCT05899140|Clindamycin palmitate|clindamycin palmitate|mesh-list
111291387|NCT05899140|Clindamycin phosphate|clindamycin phosphate|mesh-list
111291388|NCT05899140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111291389|NCT05899140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111291390|NCT05899140|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111291391|NCT05899140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111291392|NCT05899140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111291393|NCT05895383|Nitrous Oxide|nitrous oxide|mesh-list
111291394|NCT05895383|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111291395|NCT05895383|Anesthetics, General|anesthetics, general|mesh-ancestor
111291396|NCT05895383|Anesthetics|anesthetics|mesh-ancestor
111291397|NCT05895383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111291398|NCT05895383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111291399|NCT05895383|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111291400|NCT05895383|Analgesics|analgesics|mesh-ancestor
111291401|NCT05895383|Sensory System Agents|sensory system agents|mesh-ancestor
111291402|NCT05895383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111291403|NCT05893030|Anesthetics|anesthetics|mesh-list
111291404|NCT05893030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111291405|NCT05893030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111291406|NCT05885685|Nabilone|nabilone|mesh-list
111291407|NCT05885685|Antiemetics|antiemetics|mesh-ancestor
111291408|NCT05885685|Autonomic Agents|autonomic agents|mesh-ancestor
111291409|NCT05885685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111291410|NCT05885685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111291411|NCT05885685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111291412|NCT05885685|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111291413|NCT05885685|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111291414|NCT05885685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111291415|NCT05885685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111291416|NCT05861570|Triamcinolone|triamcinolone|mesh-list
111291417|NCT05861570|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
111291418|NCT05861570|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
111291419|NCT05861570|Lidocaine|lidocaine|mesh-list
111291420|NCT05861570|Hyaluronic Acid|hyaluronic acid|mesh-list
111291421|NCT05861570|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
111291422|NCT05861570|Anesthetics, Local|anesthetics, local|mesh-ancestor
111291423|NCT05861570|Anesthetics|anesthetics|mesh-ancestor
111291424|NCT05861570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111291425|NCT05861570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111291426|NCT05861570|Sensory System Agents|sensory system agents|mesh-ancestor
111291427|NCT05861570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111291428|NCT05861570|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111291429|NCT05861570|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111291430|NCT05861570|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111291431|NCT05861570|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111291432|NCT05861570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111291433|NCT05861570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111291434|NCT05861570|Glucocorticoids|glucocorticoids|mesh-ancestor
111291435|NCT05861570|Hormones|hormones|mesh-ancestor
111291436|NCT05861570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111291437|NCT05861570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111291438|NCT05861570|Immunologic Factors|immunologic factors|mesh-ancestor
111291439|NCT05861570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111291440|NCT05861570|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111291441|NCT05861570|Viscosupplements|viscosupplements|mesh-ancestor
111291442|NCT05861570|Protective Agents|protective agents|mesh-ancestor
111291443|NCT05857163|Amoxicillin|amoxicillin|mesh-list
111291444|NCT05857163|Clarithromycin|clarithromycin|mesh-list
111291445|NCT05857163|Potassium Citrate|potassium citrate|mesh-list
111291446|NCT05857163|Rabeprazole|rabeprazole|mesh-list
111291447|NCT05857163|Bismuth|bismuth|mesh-list
111291448|NCT05857163|Citric Acid|citric acid|mesh-list
111291449|NCT05857163|Sodium Citrate|sodium citrate|mesh-list
111291450|NCT05857163|Anticoagulants|anticoagulants|mesh-ancestor
111291451|NCT05857163|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
111291452|NCT05857163|Chelating Agents|chelating agents|mesh-ancestor
111291453|NCT05857163|Sequestering Agents|sequestering agents|mesh-ancestor
111291454|NCT05857163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111291455|NCT05857163|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111291456|NCT05857163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111291457|NCT05857163|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111291458|NCT05857163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111291459|NCT05857163|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111291460|NCT05857163|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111291461|NCT05857163|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111291462|NCT05857163|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111291463|NCT05857163|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111291464|NCT05857163|Antacids|antacids|mesh-ancestor
111291465|NCT05857163|Diuretics|diuretics|mesh-ancestor
111291466|NCT05857163|Natriuretic Agents|natriuretic agents|mesh-ancestor
111291467|NCT05857163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111291468|NCT05857163|Expectorants|expectorants|mesh-ancestor
111291469|NCT05857163|Respiratory System Agents|respiratory system agents|mesh-ancestor
111291470|NCT05839301|Vaccines|vaccines|mesh-list
111291471|NCT05839301|Immunologic Factors|immunologic factors|mesh-ancestor
111291472|NCT05839301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111291473|NCT05821556|Paclitaxel|paclitaxel|mesh-list
111291474|NCT05821556|Gemcitabine|gemcitabine|mesh-list
111291475|NCT05821556|Capecitabine|capecitabine|mesh-list
111015980|NCT03301233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111291476|NCT05821556|Valproic Acid|valproic acid|mesh-list
111291477|NCT05821556|Simvastatin|simvastatin|mesh-list
111291478|NCT05821556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111291479|NCT05821556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111291480|NCT05821556|Tubulin Modulators|tubulin modulators|mesh-ancestor
111291481|NCT05821556|Antimitotic Agents|antimitotic agents|mesh-ancestor
111291482|NCT05821556|Mitosis Modulators|mitosis modulators|mesh-ancestor
111291483|NCT05821556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111291484|NCT05821556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111291485|NCT05821556|Antimetabolites|antimetabolites|mesh-ancestor
111291486|NCT05821556|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111291487|NCT05821556|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111291488|NCT05821556|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111291489|NCT05821556|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111291490|NCT05821556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111291491|NCT05821556|Anticonvulsants|anticonvulsants|mesh-ancestor
111291492|NCT05821556|GABA Agents|gaba agents|mesh-ancestor
111291493|NCT05821556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111291494|NCT05821556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111291495|NCT05821556|Antimanic Agents|antimanic agents|mesh-ancestor
111291496|NCT05821556|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111291497|NCT05821556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111291498|NCT05821556|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111291499|NCT05797376|Rivaroxaban|rivaroxaban|mesh-list
111291500|NCT05797376|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111291501|NCT05797376|Antithrombins|antithrombins|mesh-ancestor
111291502|NCT05797376|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111291503|NCT05797376|Protease Inhibitors|protease inhibitors|mesh-ancestor
111291504|NCT05797376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111291505|NCT05797376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111291506|NCT05797376|Anticoagulants|anticoagulants|mesh-ancestor
111291507|NCT05774717|Tranexamic Acid|tranexamic acid|mesh-list
111291508|NCT05774717|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111291509|NCT05774717|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111291510|NCT05774717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111291511|NCT05774717|Hemostatics|hemostatics|mesh-ancestor
111291512|NCT05774717|Coagulants|coagulants|mesh-ancestor
111291513|NCT05767359|Cyclophosphamide|cyclophosphamide|mesh-list
111291514|NCT05767359|Fludarabine|fludarabine|mesh-list
111291515|NCT05767359|Fludarabine phosphate|fludarabine phosphate|mesh-list
111291516|NCT05767359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111291517|NCT05767359|Immunologic Factors|immunologic factors|mesh-ancestor
111291518|NCT05767359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111291519|NCT05767359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111291520|NCT05767359|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111291521|NCT05767359|Alkylating Agents|alkylating agents|mesh-ancestor
111291522|NCT05767359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111291523|NCT05767359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111291524|NCT05767359|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111291525|NCT05767359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111291526|NCT05767359|Antimetabolites|antimetabolites|mesh-ancestor
111291527|NCT05733286|Suvorexant|suvorexant|mesh-list
111291528|NCT05733286|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111291529|NCT05733286|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111291530|NCT05733286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111291531|NCT05733286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111291532|NCT05733286|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
111291533|NCT05733286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111291534|NCT05733286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111291535|NCT05708755|Valganciclovir|valganciclovir|mesh-list
111291536|NCT05708755|Antiviral Agents|antiviral agents|mesh-ancestor
111291537|NCT05708755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111291538|NCT05704647|Nivolumab|nivolumab|mesh-list
111291539|NCT05704647|Relatlimab|relatlimab|mesh-list
111291540|NCT05704647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111291541|NCT05704647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111291542|NCT05704647|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111291543|NCT05704647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111291544|NCT05689424|Insulin Lispro|insulin lispro|mesh-list
111291545|NCT05689424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111291546|NCT05689424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111291547|NCT05683171|Rituximab|rituximab|mesh-list
111291548|NCT05683171|Lenalidomide|lenalidomide|mesh-list
111291549|NCT05683171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111291550|NCT05683171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111291551|NCT05683171|Immunologic Factors|immunologic factors|mesh-ancestor
111016047|NCT02467946|Immunotoxins|immunotoxins|mesh-ancestor
111291552|NCT05683171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111291553|NCT05683171|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111291554|NCT05683171|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111291555|NCT05683171|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111291556|NCT05683171|Growth Substances|growth substances|mesh-ancestor
111291557|NCT05683171|Growth Inhibitors|growth inhibitors|mesh-ancestor
111291558|NCT05678257|Leucovorin|leucovorin|mesh-list
111291559|NCT05678257|Bevacizumab|bevacizumab|mesh-list
111291560|NCT05678257|Fluorouracil|fluorouracil|mesh-list
111291561|NCT05678257|Irinotecan|irinotecan|mesh-list
111291562|NCT05678257|Levoleucovorin|levoleucovorin|mesh-list
111291563|NCT05678257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111291564|NCT05678257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111291565|NCT05678257|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111291566|NCT05678257|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111291567|NCT05678257|Growth Substances|growth substances|mesh-ancestor
111291568|NCT05678257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111291569|NCT05678257|Growth Inhibitors|growth inhibitors|mesh-ancestor
111291570|NCT05678257|Antimetabolites|antimetabolites|mesh-ancestor
111291571|NCT05678257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111291572|NCT05678257|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111291573|NCT05678257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111291574|NCT05678257|Immunologic Factors|immunologic factors|mesh-ancestor
111291575|NCT05678257|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111291576|NCT05678257|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111291577|NCT05678257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111291578|NCT05678257|Antidotes|antidotes|mesh-ancestor
111291579|NCT05678257|Protective Agents|protective agents|mesh-ancestor
111291580|NCT05678257|Vitamin B Complex|vitamin b complex|mesh-ancestor
111291581|NCT05678257|Vitamins|vitamins|mesh-ancestor
111291582|NCT05678257|Micronutrients|micronutrients|mesh-ancestor
111291583|NCT05677633|Sargramostim|sargramostim|mesh-list
111291584|NCT05677633|Immunologic Factors|immunologic factors|mesh-ancestor
111291585|NCT05677633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111291586|NCT05669625|Vaccines|vaccines|mesh-list
111291587|NCT05669625|Immunologic Factors|immunologic factors|mesh-ancestor
111291588|NCT05669625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111291589|NCT05663411|Cinacalcet|cinacalcet|mesh-list
111291590|NCT05663411|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111291591|NCT05663411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111291592|NCT05663411|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
111291593|NCT05663411|Hormone Antagonists|hormone antagonists|mesh-ancestor
111291594|NCT05663411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111291595|NCT05634785|Cyclophosphamide|cyclophosphamide|mesh-list
111291596|NCT05634785|Fludarabine|fludarabine|mesh-list
111291597|NCT05634785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111291598|NCT05634785|Immunologic Factors|immunologic factors|mesh-ancestor
111291599|NCT05634785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111291600|NCT05634785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111291601|NCT05634785|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111291602|NCT05634785|Alkylating Agents|alkylating agents|mesh-ancestor
111291603|NCT05634785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111291604|NCT05634785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111291605|NCT05634785|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111291606|NCT05600231|Listerine|listerine|mesh-list
111291607|NCT05600231|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
111291608|NCT05600231|Sodium Fluoride|sodium fluoride|mesh-list
111291609|NCT05600231|Cariostatic Agents|cariostatic agents|mesh-ancestor
111291610|NCT05600231|Protective Agents|protective agents|mesh-ancestor
111291611|NCT05600231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111291612|NCT05600231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111291613|NCT05554627|Aripiprazole|aripiprazole|mesh-list
111291614|NCT05554627|Esketamine|esketamine|mesh-list
111291615|NCT05554627|Antidepressive Agents|antidepressive agents|mesh-ancestor
111291616|NCT05554627|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111291617|NCT05554627|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111291618|NCT05554627|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111291619|NCT05554627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111291620|NCT05554627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111291621|NCT05554627|Dopamine Agonists|dopamine agonists|mesh-ancestor
111291622|NCT05554627|Dopamine Agents|dopamine agents|mesh-ancestor
111291623|NCT05554627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111291624|NCT05554627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111016137|NCT04491357|Calcium|calcium|mesh-list
111291625|NCT05554627|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111291626|NCT05554627|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111291627|NCT05554627|Serotonin Agents|serotonin agents|mesh-ancestor
111291628|NCT05554627|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111291629|NCT05554627|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111291630|NCT05554627|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111291631|NCT05554627|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111291632|NCT05542381|Loteprednol Etabonate|loteprednol etabonate|mesh-list
111291633|NCT05542381|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111291634|NCT05542381|Lubricant Eye Drops|lubricant eye drops|mesh-list
111291635|NCT05542381|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111291636|NCT05542381|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111291637|NCT05510895|Cetuximab|cetuximab|mesh-list
111291638|NCT05510895|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111291639|NCT05510895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111291640|NCT05489731|Osimertinib|osimertinib|mesh-list
111291641|NCT05489731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111291642|NCT05489731|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111291643|NCT05489731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111291644|NCT05489731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111291645|NCT05478291|Vitamin D|vitamin d|mesh-list
111291646|NCT05478291|Vitamins|vitamins|mesh-ancestor
111291647|NCT05478291|Micronutrients|micronutrients|mesh-ancestor
111291648|NCT05478291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111291649|NCT05478291|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111291650|NCT05472792|Tamoxifen|tamoxifen|mesh-list
111291651|NCT05472792|Toremifene|toremifene|mesh-list
111291652|NCT05472792|Letrozole|letrozole|mesh-list
111291653|NCT05472792|Fulvestrant|fulvestrant|mesh-list
111291654|NCT05472792|Anastrozole|anastrozole|mesh-list
111291655|NCT05472792|Exemestane|exemestane|mesh-list
111291656|NCT05472792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111291657|NCT05472792|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111291658|NCT05472792|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111291659|NCT05472792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111291660|NCT05472792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111291661|NCT05472792|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111291662|NCT05472792|Hormone Antagonists|hormone antagonists|mesh-ancestor
111291663|NCT05472792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111291664|NCT05472792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111291665|NCT05472792|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111291666|NCT05472792|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111291667|NCT05472792|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111291668|NCT05472792|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111291669|NCT05472792|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
111291670|NCT05467293|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111291671|NCT05467293|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111291672|NCT05464836|Venetoclax|venetoclax|mesh-list
111291673|NCT05464836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111291674|NCT05463367|Acetaminophen|acetaminophen|mesh-list
111291675|NCT05463367|Naproxen|naproxen|mesh-list
111291676|NCT05463367|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
111291677|NCT05463367|Oxymorphone|oxymorphone|mesh-list
111291678|NCT05463367|Morphine|morphine|mesh-list
111291679|NCT05463367|Oxycodone|oxycodone|mesh-list
111291680|NCT05463367|Tramadol|tramadol|mesh-list
111291681|NCT05463367|Hydrocodone|hydrocodone|mesh-list
111291682|NCT05463367|Codeine|codeine|mesh-list
111291683|NCT05463367|Levodopa|levodopa|mesh-list
111291684|NCT05463367|Carbidopa|carbidopa|mesh-list
111291685|NCT05463367|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
111291686|NCT05463367|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111291687|NCT05463367|Narcotics|narcotics|mesh-ancestor
111291688|NCT05463367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111291689|NCT05463367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111291690|NCT05463367|Analgesics|analgesics|mesh-ancestor
111291691|NCT05463367|Sensory System Agents|sensory system agents|mesh-ancestor
111291692|NCT05463367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111291693|NCT05463367|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111291694|NCT05463367|Antipyretics|antipyretics|mesh-ancestor
111291695|NCT05463367|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111291696|NCT05463367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111291697|NCT05463367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111291698|NCT05463367|Gout Suppressants|gout suppressants|mesh-ancestor
111291699|NCT05463367|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111291700|NCT05463367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111291701|NCT05463367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111291702|NCT05463367|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111291703|NCT05463367|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111291704|NCT05463367|Dopamine Agents|dopamine agents|mesh-ancestor
111291705|NCT05463367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111291706|NCT05463367|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
111291707|NCT05463367|Antitussive Agents|antitussive agents|mesh-ancestor
111291708|NCT05463367|Respiratory System Agents|respiratory system agents|mesh-ancestor
111291709|NCT05463367|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111291710|NCT05463367|Immunologic Factors|immunologic factors|mesh-ancestor
111291711|NCT05463367|Dopamine Agonists|dopamine agonists|mesh-ancestor
111291712|NCT05463367|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111291713|NCT05436535|Triamcinolone|triamcinolone|mesh-list
111291714|NCT05436535|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
111291715|NCT05436535|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
111291716|NCT05436535|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
111291717|NCT05436535|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111291718|NCT05436535|Glucocorticoids|glucocorticoids|mesh-ancestor
111291719|NCT05436535|Hormones|hormones|mesh-ancestor
111291720|NCT05436535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111291721|NCT05436535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111291722|NCT05436535|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111291723|NCT05436535|Immunologic Factors|immunologic factors|mesh-ancestor
111291724|NCT05436535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111291725|NCT05436535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111291726|NCT05401097|Azacitidine|azacitidine|mesh-list
111291727|NCT05401097|Venetoclax|venetoclax|mesh-list
111291728|NCT05401097|Ivosidenib|ivosidenib|mesh-list
111291729|NCT05401097|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111291730|NCT05401097|Antimetabolites|antimetabolites|mesh-ancestor
111291731|NCT05401097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111291732|NCT05401097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111291733|NCT05401097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111291734|NCT05395091|Denosumab|denosumab|mesh-list
111291735|NCT05395091|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111291736|NCT05395091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111291737|NCT05391828|Cimetidine|cimetidine|mesh-list
111291738|NCT05391828|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111291739|NCT05391828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111291740|NCT05391828|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110979426|NCT03241706|Hormones|hormones|mesh-ancestor
111291741|NCT05391828|Histamine Antagonists|histamine antagonists|mesh-ancestor
111291742|NCT05391828|Histamine Agents|histamine agents|mesh-ancestor
111291743|NCT05391828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111291744|NCT05391828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111291745|NCT05391828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111291746|NCT05391828|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111291747|NCT05391828|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111291748|NCT05391828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111291749|NCT05382871|Vaccines|vaccines|mesh-list
111291750|NCT05382871|Immunologic Factors|immunologic factors|mesh-ancestor
111291751|NCT05382871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111291752|NCT05377242|Curcumin|curcumin|mesh-list
111291753|NCT05377242|Resveratrol|resveratrol|mesh-list
111291754|NCT05377242|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111291755|NCT05377242|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111291756|NCT05377242|Analgesics|analgesics|mesh-ancestor
111291757|NCT05377242|Sensory System Agents|sensory system agents|mesh-ancestor
111291758|NCT05377242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111291759|NCT05377242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111291760|NCT05377242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111291761|NCT05377242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111291762|NCT05377242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111291763|NCT05377242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111291764|NCT05377242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111291765|NCT05377242|Antioxidants|antioxidants|mesh-ancestor
111291766|NCT05377242|Protective Agents|protective agents|mesh-ancestor
111291767|NCT05377242|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111291768|NCT05374954|Vaccines|vaccines|mesh-list
111291769|NCT05374954|Immunologic Factors|immunologic factors|mesh-ancestor
111291770|NCT05374954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111291771|NCT05363007|Leucovorin|leucovorin|mesh-list
111291772|NCT05363007|Irinotecan|irinotecan|mesh-list
111291773|NCT05363007|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111291774|NCT05363007|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111291775|NCT05363007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111291776|NCT05363007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111291777|NCT05363007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111291778|NCT05363007|Antidotes|antidotes|mesh-ancestor
111291779|NCT05363007|Protective Agents|protective agents|mesh-ancestor
111291780|NCT05363007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111016254|NCT03449888|Calcium|calcium|mesh-list
111291781|NCT05363007|Vitamin B Complex|vitamin b complex|mesh-ancestor
111291782|NCT05363007|Vitamins|vitamins|mesh-ancestor
111291783|NCT05363007|Micronutrients|micronutrients|mesh-ancestor
111291784|NCT05360160|Venetoclax|venetoclax|mesh-list
111291785|NCT05360160|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
111291786|NCT05360160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111291787|NCT05360160|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111291788|NCT05360160|Antimetabolites|antimetabolites|mesh-ancestor
111291789|NCT05360160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111291790|NCT05351606|Bupropion|bupropion|mesh-list
111291791|NCT05351606|Nicotine|nicotine|mesh-list
111291792|NCT05351606|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111291793|NCT05351606|Autonomic Agents|autonomic agents|mesh-ancestor
111291794|NCT05351606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111291795|NCT05351606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111291796|NCT05351606|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111291797|NCT05351606|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111291798|NCT05351606|Cholinergic Agents|cholinergic agents|mesh-ancestor
111291799|NCT05351606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111291800|NCT05351606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111291801|NCT05351606|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111291802|NCT05351606|Antidepressive Agents|antidepressive agents|mesh-ancestor
111291803|NCT05351606|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111291804|NCT05351606|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111291805|NCT05351606|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111291806|NCT05351606|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111291807|NCT05351606|Dopamine Agents|dopamine agents|mesh-ancestor
111291808|NCT05351606|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111291809|NCT05351606|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111291810|NCT05351606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111291811|NCT05346159|Androgens|androgens|mesh-list
111291812|NCT05346159|Hormones|hormones|mesh-ancestor
111291813|NCT05346159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111291814|NCT05346159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111291815|NCT05338723|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111291816|NCT05338723|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111291817|NCT05338723|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111291818|NCT05338723|Antimetabolites|antimetabolites|mesh-ancestor
111291819|NCT05338723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111291820|NCT05338723|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111291821|NCT05338723|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111291822|NCT05338723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111291823|NCT05329545|Immunoconjugates|immunoconjugates|mesh-list
111291824|NCT05329545|Immunologic Factors|immunologic factors|mesh-ancestor
111291825|NCT05329545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111291826|NCT05329090|Rituximab|rituximab|mesh-list
111291827|NCT05329090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111291828|NCT05329090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111291829|NCT05329090|Immunologic Factors|immunologic factors|mesh-ancestor
111291830|NCT05329090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111291831|NCT05329090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111291832|NCT05328154|Diphosphonates|diphosphonates|mesh-list
111291833|NCT05328154|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111291834|NCT05328154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111291835|NCT05324059|Pregabalin|pregabalin|mesh-list
111291836|NCT05324059|Tramadol|tramadol|mesh-list
111291837|NCT05324059|Analgesics|analgesics|mesh-ancestor
111291838|NCT05324059|Sensory System Agents|sensory system agents|mesh-ancestor
111291839|NCT05324059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111291840|NCT05324059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111291841|NCT05324059|Anticonvulsants|anticonvulsants|mesh-ancestor
111291842|NCT05324059|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111291843|NCT05324059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111291844|NCT05324059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111291845|NCT05324059|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111291846|NCT05324059|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111291847|NCT05324059|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111291848|NCT05324059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111291849|NCT05324059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111291850|NCT05324059|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111291851|NCT05324059|Narcotics|narcotics|mesh-ancestor
111291852|NCT05303636|Drospirenone|drospirenone|mesh-list
111291853|NCT05303636|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
111291854|NCT05303636|Hormone Antagonists|hormone antagonists|mesh-ancestor
111291855|NCT05303636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111291856|NCT05303636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111291857|NCT05303636|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
111291859|NCT05303636|Natriuretic Agents|natriuretic agents|mesh-ancestor
111291860|NCT05226429|Vaccines|vaccines|mesh-list
111291861|NCT05226429|Immunologic Factors|immunologic factors|mesh-ancestor
111291862|NCT05226429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111291863|NCT05212012|Methadone|methadone|mesh-list
111291864|NCT05212012|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111291865|NCT05212012|Narcotics|narcotics|mesh-ancestor
111291866|NCT05212012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111291867|NCT05212012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111291868|NCT05212012|Analgesics|analgesics|mesh-ancestor
111291869|NCT05212012|Sensory System Agents|sensory system agents|mesh-ancestor
111291870|NCT05212012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111291871|NCT05212012|Antitussive Agents|antitussive agents|mesh-ancestor
111291872|NCT05212012|Respiratory System Agents|respiratory system agents|mesh-ancestor
111291873|NCT05198804|Niraparib|niraparib|mesh-list
111291874|NCT05198804|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111291875|NCT05198804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111291876|NCT05198804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111291877|NCT05198804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111291878|NCT05197439|Dexmedetomidine|dexmedetomidine|mesh-list
111291879|NCT05197439|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111291880|NCT05197439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111291881|NCT05197439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111291882|NCT05197439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111291883|NCT05197439|Analgesics|analgesics|mesh-ancestor
111291884|NCT05197439|Sensory System Agents|sensory system agents|mesh-ancestor
111291885|NCT05197439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111291886|NCT05197439|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111291887|NCT05197439|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111291888|NCT05197439|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111291889|NCT05197439|Adrenergic Agents|adrenergic agents|mesh-ancestor
111291890|NCT05197439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111291891|NCT05197439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111291892|NCT05169372|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
111291893|NCT05169372|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111291894|NCT05169372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111291895|NCT05169060|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
111291896|NCT05169060|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111291897|NCT05169060|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111291898|NCT05169060|Analgesics|analgesics|mesh-ancestor
111291899|NCT05169060|Sensory System Agents|sensory system agents|mesh-ancestor
111291900|NCT05169060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111291901|NCT05169060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111291902|NCT05169060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111291903|NCT05169060|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111291904|NCT05153408|Carboplatin|carboplatin|mesh-list
111291905|NCT05153408|Pemetrexed|pemetrexed|mesh-list
111291906|NCT05153408|Osimertinib|osimertinib|mesh-list
111291907|NCT05153408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111291908|NCT05153408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111291909|NCT05153408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111291910|NCT05153408|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111291911|NCT05153408|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111291912|NCT05153408|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111291913|NCT05114980|Parathyroid Hormone|parathyroid hormone|mesh-list
111291914|NCT05114980|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111291915|NCT05114980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111291916|NCT05100628|Doxorubicin|doxorubicin|mesh-list
111291917|NCT05100628|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111291918|NCT05100628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111291919|NCT05100628|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111291920|NCT05100628|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111291921|NCT05100628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111291922|NCT05100628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111291923|NCT05091619|Vaccines|vaccines|mesh-list
111291924|NCT05091619|Immunologic Factors|immunologic factors|mesh-ancestor
111291925|NCT05091619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111291926|NCT05089916|Osimertinib|osimertinib|mesh-list
111291927|NCT05089916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111291928|NCT05089916|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111291929|NCT05089916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111291930|NCT05089916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111291932|NCT05089370|Decitabine|decitabine|mesh-list
111291933|NCT05089370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111291934|NCT05089370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111291935|NCT05089370|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111291936|NCT05089370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111291937|NCT05089370|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111291938|NCT05089370|Antimetabolites|antimetabolites|mesh-ancestor
111291939|NCT05089370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111291940|NCT05086250|Ketamine|ketamine|mesh-list
111291941|NCT05086250|Analgesics|analgesics|mesh-ancestor
111291942|NCT05086250|Sensory System Agents|sensory system agents|mesh-ancestor
111291943|NCT05086250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111291944|NCT05086250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111291945|NCT05086250|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111291946|NCT05086250|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111291947|NCT05086250|Anesthetics, General|anesthetics, general|mesh-ancestor
111291948|NCT05086250|Anesthetics|anesthetics|mesh-ancestor
111291949|NCT05086250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111291950|NCT05086250|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111291951|NCT05086250|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111291952|NCT05086250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111291953|NCT05086250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111291954|NCT05084911|Pyronaridine tetraphosphate, artesunate drug combination|pyronaridine tetraphosphate, artesunate drug combination|mesh-list
111291955|NCT05084911|Antiviral Agents|antiviral agents|mesh-ancestor
111291956|NCT05084911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111291957|NCT05081388|Casirivimab and imdevimab drug combination|casirivimab and imdevimab drug combination|mesh-list
111291958|NCT05081388|Antiviral Agents|antiviral agents|mesh-ancestor
111291959|NCT05081388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111291960|NCT05076149|Ivacaftor|ivacaftor|mesh-list
111291961|NCT05076149|Elexacaftor|elexacaftor|mesh-list
111291962|NCT05076149|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
111291963|NCT05076149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111291964|NCT05076149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111291965|NCT05054374|Fulvestrant|fulvestrant|mesh-list
111291966|NCT05054374|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111291967|NCT05054374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111291968|NCT05054374|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
111291969|NCT05054374|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111291970|NCT05054374|Hormone Antagonists|hormone antagonists|mesh-ancestor
111291971|NCT05054374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111291972|NCT05054374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111291973|NCT05039177|Cetuximab|cetuximab|mesh-list
111291974|NCT05039177|Palbociclib|palbociclib|mesh-list
111291975|NCT05039177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111291976|NCT05039177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111291977|NCT05039177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111291978|NCT05039177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111291979|NCT05039177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111291980|NCT05027308|Teduglutide|teduglutide|mesh-list
111291981|NCT05027308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111291982|NCT05027308|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111291983|NCT05027308|Protective Agents|protective agents|mesh-ancestor
111291984|NCT05027308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111291985|NCT05025800|Rituximab|rituximab|mesh-list
111291986|NCT05025800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111291987|NCT05025800|Lenalidomide|lenalidomide|mesh-list
111291988|NCT05025800|Antibodies|antibodies|mesh-list
111291989|NCT05025800|Immunoglobulins|immunoglobulins|mesh-list
111291990|NCT05025800|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111291991|NCT05025800|Immunologic Factors|immunologic factors|mesh-ancestor
111291992|NCT05025800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111291993|NCT05025800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111291994|NCT05025800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111291995|NCT05025800|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111291996|NCT05025800|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111291997|NCT05025800|Growth Substances|growth substances|mesh-ancestor
111291998|NCT05025800|Growth Inhibitors|growth inhibitors|mesh-ancestor
111291999|NCT05017246|Lidocaine|lidocaine|mesh-list
111292000|NCT05017246|Morphine|morphine|mesh-list
111292001|NCT05017246|Bupivacaine|bupivacaine|mesh-list
111292002|NCT05017246|Anesthetics, Local|anesthetics, local|mesh-ancestor
111292003|NCT05017246|Anesthetics|anesthetics|mesh-ancestor
111292004|NCT05017246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111292005|NCT05017246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111292006|NCT05017246|Sensory System Agents|sensory system agents|mesh-ancestor
111292007|NCT05017246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111292008|NCT05017246|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111292009|NCT05017246|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111292010|NCT05017246|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111292011|NCT05017246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111292012|NCT05017246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111292013|NCT05017246|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111292014|NCT05017246|Narcotics|narcotics|mesh-ancestor
111292015|NCT05017246|Analgesics|analgesics|mesh-ancestor
111292016|NCT05007041|Vaccines|vaccines|mesh-list
111292017|NCT05007041|Immunologic Factors|immunologic factors|mesh-ancestor
111292018|NCT05007041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111292019|NCT05001555|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
111292020|NCT05001555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111292021|NCT05001555|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111292022|NCT05001555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111292023|NCT05001555|Analgesics|analgesics|mesh-ancestor
111292024|NCT05001555|Sensory System Agents|sensory system agents|mesh-ancestor
111292025|NCT05001555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111292026|NCT05001555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111292027|NCT05001555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111292028|NCT04995003|Pembrolizumab|pembrolizumab|mesh-list
111292029|NCT04995003|Nivolumab|nivolumab|mesh-list
111292030|NCT04995003|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
111292031|NCT04995003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111292032|NCT04995003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111292033|NCT04995003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111292034|NCT04983888|Obinutuzumab|obinutuzumab|mesh-list
111292035|NCT04983888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111292036|NCT04983888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111292037|NCT04978675|Fluorides|fluorides|mesh-list
111292038|NCT04978675|Cariostatic Agents|cariostatic agents|mesh-ancestor
111292039|NCT04978675|Protective Agents|protective agents|mesh-ancestor
111292040|NCT04978675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111292041|NCT04977024|Vaccines|vaccines|mesh-list
111292042|NCT04977024|Immunologic Factors|immunologic factors|mesh-ancestor
111292043|NCT04977024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111292044|NCT04883255|Dronabinol|dronabinol|mesh-list
111292045|NCT04883255|Cannabidiol|cannabidiol|mesh-list
111292046|NCT04883255|Anticonvulsants|anticonvulsants|mesh-ancestor
111292047|NCT04883255|Hallucinogens|hallucinogens|mesh-ancestor
111292048|NCT04883255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111292049|NCT04883255|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111292050|NCT04883255|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111292051|NCT04883255|Analgesics|analgesics|mesh-ancestor
111292052|NCT04883255|Sensory System Agents|sensory system agents|mesh-ancestor
111292053|NCT04883255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111292054|NCT04883255|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
111292055|NCT04883255|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
111292056|NCT04883255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111292057|NCT04883255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111292058|NCT04883255|Hormones|hormones|mesh-ancestor
111292059|NCT04883255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111292060|NCT04880850|Insulin|insulin|mesh-list
111292061|NCT04880850|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111292062|NCT04880850|Insulin Glargine|insulin glargine|mesh-list
111292063|NCT04880850|Insulin Aspart|insulin aspart|mesh-list
111292064|NCT04880850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111292065|NCT04880850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111292066|NCT04874194|Venetoclax|venetoclax|mesh-list
111292067|NCT04874194|Homoharringtonine|homoharringtonine|mesh-list
111292068|NCT04874194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111292069|NCT04874194|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111292070|NCT04874194|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111292071|NCT04874194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111292072|NCT04874194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111292073|NCT04868838|Daratumumab|daratumumab|mesh-list
111016546|NCT03299517|Anesthetics|anesthetics|mesh-ancestor
111292074|NCT04868838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111292075|NCT04863638|Vaccines|vaccines|mesh-list
111292076|NCT04863638|Immunologic Factors|immunologic factors|mesh-ancestor
111292077|NCT04863638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111292078|NCT04855617|Ocrelizumab|ocrelizumab|mesh-list
111292079|NCT04855617|Immunologic Factors|immunologic factors|mesh-ancestor
111292080|NCT04855617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111292081|NCT04790786|Sotrovimab|sotrovimab|mesh-list
111292082|NCT04790786|Bamlanivimab|bamlanivimab|mesh-list
111292083|NCT04790786|Casirivimab and imdevimab drug combination|casirivimab and imdevimab drug combination|mesh-list
111292084|NCT04790786|Antiviral Agents|antiviral agents|mesh-ancestor
111292085|NCT04790786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111292086|NCT04786210|Triamcinolone|triamcinolone|mesh-list
111292087|NCT04786210|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
111292088|NCT04786210|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
111292089|NCT04786210|Fluorouracil|fluorouracil|mesh-list
111292090|NCT04786210|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
111292091|NCT04786210|Antimetabolites|antimetabolites|mesh-ancestor
111292092|NCT04786210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111292093|NCT04786210|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111292094|NCT04786210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111292095|NCT04786210|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111292096|NCT04786210|Immunologic Factors|immunologic factors|mesh-ancestor
111292097|NCT04786210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111292098|NCT04786210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111292099|NCT04786210|Glucocorticoids|glucocorticoids|mesh-ancestor
111292100|NCT04786210|Hormones|hormones|mesh-ancestor
111292101|NCT04786210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111292102|NCT04786210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111292103|NCT04785950|Levonorgestrel|levonorgestrel|mesh-list
111292104|NCT04785950|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111292105|NCT04785950|Contraceptive Agents|contraceptive agents|mesh-ancestor
111292106|NCT04785950|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111292107|NCT04785950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111292108|NCT04785950|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111292109|NCT04785950|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111292110|NCT04785950|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111292111|NCT04743505|Osimertinib|osimertinib|mesh-list
111292112|NCT04743505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111292113|NCT04743505|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111292114|NCT04743505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111292115|NCT04743505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111292116|NCT04729322|Metronidazole|metronidazole|mesh-list
111292117|NCT04729322|Vancomycin|vancomycin|mesh-list
111292118|NCT04729322|Neomycin|neomycin|mesh-list
111292119|NCT04729322|Pembrolizumab|pembrolizumab|mesh-list
111292120|NCT04729322|Nivolumab|nivolumab|mesh-list
111292121|NCT04729322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111292122|NCT04729322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111292123|NCT04729322|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111292124|NCT04729322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111292125|NCT04729322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111292126|NCT04729322|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111292127|NCT04729322|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111292128|NCT04729322|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111292129|NCT04729322|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111292130|NCT04729322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111292131|NCT04724252|Gabapentin|gabapentin|mesh-list
111292132|NCT04724252|Analgesics|analgesics|mesh-ancestor
111292133|NCT04724252|Sensory System Agents|sensory system agents|mesh-ancestor
111292134|NCT04724252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111292135|NCT04724252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111292136|NCT04724252|Anticonvulsants|anticonvulsants|mesh-ancestor
111292137|NCT04724252|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111292138|NCT04724252|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111292139|NCT04724252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111292140|NCT04724252|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111292141|NCT04724252|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111292142|NCT04724252|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111292143|NCT04724252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111292144|NCT04724252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111292145|NCT04724252|Antimanic Agents|antimanic agents|mesh-ancestor
111292146|NCT04670068|Cyclophosphamide|cyclophosphamide|mesh-list
111292147|NCT04670068|Fludarabine|fludarabine|mesh-list
111292148|NCT04670068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111292149|NCT04670068|Immunologic Factors|immunologic factors|mesh-ancestor
111292150|NCT04670068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111292151|NCT04670068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111016619|NCT00398294|Antimetabolites|antimetabolites|mesh-ancestor
111292152|NCT04670068|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111292153|NCT04670068|Alkylating Agents|alkylating agents|mesh-ancestor
110979440|NCT03237416|GABA Modulators|gaba modulators|mesh-ancestor
111292154|NCT04670068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111292155|NCT04670068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111292156|NCT04670068|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111292157|NCT04622267|Anti-Infective Agents|anti-infective agents|mesh-list
111292158|NCT04622267|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111292160|NCT04618289|Cholecalciferol|cholecalciferol|mesh-list
111292161|NCT04618289|Vitamins|vitamins|mesh-ancestor
111292162|NCT04618289|Micronutrients|micronutrients|mesh-ancestor
111292163|NCT04618289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111292164|NCT04618289|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111292165|NCT04618289|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111292166|NCT04617795|Insulin|insulin|mesh-list
111292167|NCT04617795|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111292168|NCT04617795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111292169|NCT04588441|Adenosine|adenosine|mesh-list
111292170|NCT04588441|Analgesics|analgesics|mesh-ancestor
111292171|NCT04588441|Sensory System Agents|sensory system agents|mesh-ancestor
111292172|NCT04588441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111292173|NCT04588441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111292174|NCT04588441|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111292175|NCT04588441|Vasodilator Agents|vasodilator agents|mesh-ancestor
111292176|NCT04588441|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
111292177|NCT04588441|Purinergic Agonists|purinergic agonists|mesh-ancestor
111292178|NCT04588441|Purinergic Agents|purinergic agents|mesh-ancestor
111292179|NCT04588441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111292180|NCT04588441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111292181|NCT04578015|Metronidazole|metronidazole|mesh-list
111292182|NCT04578015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111292183|NCT04578015|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111292184|NCT04578015|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111292185|NCT04578015|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111292186|NCT04555044|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
111292187|NCT04555044|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
111292188|NCT04555044|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
111292189|NCT04555044|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111292190|NCT04534205|Pembrolizumab|pembrolizumab|mesh-list
111292191|NCT04534205|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111292192|NCT04534205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111292193|NCT04534205|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111292194|NCT04534205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111292195|NCT04510207|Vaccines|vaccines|mesh-list
111292196|NCT04510207|Immunologic Factors|immunologic factors|mesh-ancestor
111292197|NCT04510207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111292198|NCT04445519|Latanoprost|latanoprost|mesh-list
111292199|NCT04445519|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
111292200|NCT04445519|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111292201|NCT04420585|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
111292202|NCT04420585|Hemostatics|hemostatics|mesh-ancestor
111292203|NCT04420585|Coagulants|coagulants|mesh-ancestor
111292204|NCT04420585|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
111292205|NCT04420585|Natriuretic Agents|natriuretic agents|mesh-ancestor
111292206|NCT04420585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111292207|NCT04396496|Daratumumab|daratumumab|mesh-list
111292208|NCT04396496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111292209|NCT04354103|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
111292210|NCT04354103|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111292211|NCT04354103|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111292212|NCT04354103|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111292213|NCT04354103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111292214|NCT04354103|Adrenergic Agents|adrenergic agents|mesh-ancestor
111292215|NCT04354103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111292216|NCT04354103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111292217|NCT04268303|Dexmedetomidine|dexmedetomidine|mesh-list
111292218|NCT04268303|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111292219|NCT04268303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111292220|NCT04268303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111292221|NCT04268303|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111292222|NCT04268303|Analgesics|analgesics|mesh-ancestor
110979459|NCT04094519|Digoxin|digoxin|mesh-list
111292223|NCT04268303|Sensory System Agents|sensory system agents|mesh-ancestor
111292224|NCT04268303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111292225|NCT04268303|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111292226|NCT04268303|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111292227|NCT04268303|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111292228|NCT04268303|Adrenergic Agents|adrenergic agents|mesh-ancestor
111292229|NCT04268303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111292230|NCT04268303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111292231|NCT04267497|Amphotericin B|amphotericin b|mesh-list
111292232|NCT04267497|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
111292233|NCT04267497|Amebicides|amebicides|mesh-ancestor
111292234|NCT04267497|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111292235|NCT04267497|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111292236|NCT04267497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111292237|NCT04267497|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111292238|NCT04267497|Antifungal Agents|antifungal agents|mesh-ancestor
111292239|NCT04266730|Pembrolizumab|pembrolizumab|mesh-list
111292240|NCT04266730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111292241|NCT04266730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111292242|NCT04266730|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111292243|NCT04266730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111292244|NCT04263831|Aldesleukin|aldesleukin|mesh-list
111292245|NCT04263831|Interleukin-2|interleukin-2|mesh-list
111292246|NCT04263831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111292247|NCT04263831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111292248|NCT04263831|Analgesics|analgesics|mesh-ancestor
111292249|NCT04263831|Sensory System Agents|sensory system agents|mesh-ancestor
111292250|NCT04263831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111292251|NCT04263831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111292252|NCT04263831|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111292253|NCT04263831|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111292254|NCT04263831|Antiviral Agents|antiviral agents|mesh-ancestor
111292255|NCT04263831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111292256|NCT04249687|Botulinum Toxins|botulinum toxins|mesh-list
111292257|NCT04249687|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111292258|NCT04249687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111292259|NCT04249687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111292260|NCT04249687|Cholinergic Agents|cholinergic agents|mesh-ancestor
111292261|NCT04249687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111292262|NCT04249687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111292263|NCT04249583|Botulinum Toxins|botulinum toxins|mesh-list
111292264|NCT04249583|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111292265|NCT04249583|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111292266|NCT04249583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111292267|NCT04249583|Cholinergic Agents|cholinergic agents|mesh-ancestor
111292268|NCT04249583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111292269|NCT04249583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111292270|NCT04239092|Cyclophosphamide|cyclophosphamide|mesh-list
111292271|NCT04239092|Temozolomide|temozolomide|mesh-list
111292272|NCT04239092|Irinotecan|irinotecan|mesh-list
111292273|NCT04239092|Topotecan|topotecan|mesh-list
111292274|NCT04239092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111292275|NCT04239092|Immunologic Factors|immunologic factors|mesh-ancestor
111292276|NCT04239092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111292277|NCT04239092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111292278|NCT04239092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111292279|NCT04239092|Alkylating Agents|alkylating agents|mesh-ancestor
111292280|NCT04239092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111292281|NCT04239092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111292282|NCT04239092|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111292283|NCT04239092|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111292284|NCT04239092|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111292285|NCT04239092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111292286|NCT04225260|Botulinum Toxins|botulinum toxins|mesh-list
111292287|NCT04225260|Neurotransmitter Agents|neurotransmitter agents|mesh-list
110979467|NCT04094519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111292288|NCT04225260|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111292289|NCT04225260|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111292290|NCT04225260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111292291|NCT04225260|Cholinergic Agents|cholinergic agents|mesh-ancestor
111292292|NCT04225260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111292293|NCT04224740|Cisplatin|cisplatin|mesh-list
111292294|NCT04224740|Carboplatin|carboplatin|mesh-list
111292295|NCT04224740|Pembrolizumab|pembrolizumab|mesh-list
111292296|NCT04224740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111292297|NCT04224740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111292298|NCT04224740|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111292299|NCT04224740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111292300|NCT04223765|Cyclophosphamide|cyclophosphamide|mesh-list
111292301|NCT04223765|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
111292302|NCT04223765|Fludarabine|fludarabine|mesh-list
111292303|NCT04223765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111292304|NCT04223765|Immunologic Factors|immunologic factors|mesh-ancestor
111292305|NCT04223765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111292306|NCT04223765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111292307|NCT04223765|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111292308|NCT04223765|Alkylating Agents|alkylating agents|mesh-ancestor
111292309|NCT04223765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111292310|NCT04223765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111292311|NCT04223765|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111292312|NCT04205227|Pembrolizumab|pembrolizumab|mesh-list
111292313|NCT04205227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111292314|NCT04205227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111292315|NCT04205227|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111292316|NCT04205227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111292317|NCT04159155|Paclitaxel|paclitaxel|mesh-list
111292318|NCT04159155|Carboplatin|carboplatin|mesh-list
111292319|NCT04159155|Niraparib|niraparib|mesh-list
111292320|NCT04159155|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111292321|NCT04159155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111292322|NCT04159155|Tubulin Modulators|tubulin modulators|mesh-ancestor
111292323|NCT04159155|Antimitotic Agents|antimitotic agents|mesh-ancestor
111292324|NCT04159155|Mitosis Modulators|mitosis modulators|mesh-ancestor
111292325|NCT04159155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111292326|NCT04159155|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111292327|NCT04159155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111292328|NCT04117074|Bupivacaine|bupivacaine|mesh-list
111292329|NCT04117074|Anesthetics, Local|anesthetics, local|mesh-ancestor
111292330|NCT04117074|Anesthetics|anesthetics|mesh-ancestor
111292331|NCT04117074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111292332|NCT04117074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111292333|NCT04117074|Sensory System Agents|sensory system agents|mesh-ancestor
111292334|NCT04117074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111292335|NCT04108858|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111292336|NCT04108858|Trastuzumab|trastuzumab|mesh-list
111292337|NCT04108858|Pertuzumab|pertuzumab|mesh-list
111292338|NCT04108858|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
111292339|NCT04108858|Antibodies|antibodies|mesh-list
111292340|NCT04108858|Immunoglobulins|immunoglobulins|mesh-list
111292341|NCT04108858|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111292342|NCT04108858|Immunologic Factors|immunologic factors|mesh-ancestor
111292343|NCT04108858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111292344|NCT04108858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111292345|NCT04094675|Sirolimus|sirolimus|mesh-list
111292346|NCT04094675|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111292347|NCT04094675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111292348|NCT04094675|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111292349|NCT04094675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111292350|NCT04094675|Antifungal Agents|antifungal agents|mesh-ancestor
111292351|NCT04094675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111292352|NCT04094675|Immunologic Factors|immunologic factors|mesh-ancestor
111292353|NCT04094675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111292354|NCT04092452|PF-06700841|pf-06700841|mesh-list
111292355|NCT04092452|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111292356|NCT04092452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111292357|NCT04092452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111292358|NCT04046614|Nivolumab|nivolumab|mesh-list
111292359|NCT04046614|Nintedanib|nintedanib|mesh-list
111292360|NCT04046614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111292361|NCT04046614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111292362|NCT04046614|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111292363|NCT04046614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111292364|NCT04046614|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111292365|NCT04046614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111292366|NCT04029116|Fluconazole|fluconazole|mesh-list
111292367|NCT04029116|Ibrexafungerp|ibrexafungerp|mesh-list
111292368|NCT04029116|Antifungal Agents|antifungal agents|mesh-ancestor
111292369|NCT04029116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111016842|NCT03464019|Etripamil|etripamil|mesh-list
111292370|NCT04029116|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111292371|NCT04029116|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111292372|NCT04029116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111292373|NCT04029116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111292374|NCT04029116|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111292375|NCT04029116|Hormone Antagonists|hormone antagonists|mesh-ancestor
111292376|NCT04029116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111292377|NCT04029116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111292378|NCT04029116|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111292379|NCT04029116|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111292380|NCT04025489|Vitamin D|vitamin d|mesh-list
111292381|NCT04025489|Vitamins|vitamins|mesh-ancestor
111292382|NCT04025489|Micronutrients|micronutrients|mesh-ancestor
111292383|NCT04025489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111292384|NCT04025489|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111292385|NCT03998839|Pyrimethamine|pyrimethamine|mesh-list
111292386|NCT03998839|Sulfadoxine|sulfadoxine|mesh-list
111292387|NCT03998839|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
111292388|NCT03998839|Antimalarials|antimalarials|mesh-ancestor
111292389|NCT03998839|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111292390|NCT03998839|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111292391|NCT03998839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111292392|NCT03998839|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111292393|NCT03998839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111292394|NCT03998839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111292395|NCT03998839|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111292396|NCT03962894|Prednisolone|prednisolone|mesh-list
111292397|NCT03962894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111292398|NCT03962894|Glucocorticoids|glucocorticoids|mesh-ancestor
111292399|NCT03962894|Hormones|hormones|mesh-ancestor
111292400|NCT03962894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111292401|NCT03962894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111292402|NCT03962894|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111292403|NCT03962894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111292404|NCT03926026|Fluticasone|fluticasone|mesh-list
111292405|NCT03926026|Xhance|xhance|mesh-list
111292406|NCT03926026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111292407|NCT03926026|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111292408|NCT03926026|Autonomic Agents|autonomic agents|mesh-ancestor
111292409|NCT03926026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111292410|NCT03926026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111292411|NCT03926026|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111292412|NCT03926026|Respiratory System Agents|respiratory system agents|mesh-ancestor
111292413|NCT03926026|Dermatologic Agents|dermatologic agents|mesh-ancestor
111292414|NCT03926026|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111292415|NCT03917082|Tamoxifen|tamoxifen|mesh-list
111292416|NCT03917082|Aromatase Inhibitors|aromatase inhibitors|mesh-list
111292417|NCT03917082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111292418|NCT03917082|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111292419|NCT03917082|Hormone Antagonists|hormone antagonists|mesh-ancestor
111292420|NCT03917082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111292421|NCT03917082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111292422|NCT03917082|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111292423|NCT03917082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111292424|NCT03917082|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111292425|NCT03917082|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111292426|NCT03917082|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111292427|NCT03917082|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111292428|NCT03917082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111292429|NCT03875690|Methylprednisolone|methylprednisolone|mesh-list
111292430|NCT03875690|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111292431|NCT03875690|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111292432|NCT03875690|Prednisolone|prednisolone|mesh-list
111292433|NCT03875690|Prednisolone acetate|prednisolone acetate|mesh-list
111292434|NCT03875690|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111292435|NCT03875690|Prednisolone phosphate|prednisolone phosphate|mesh-list
111292436|NCT03875690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111292437|NCT03875690|Antiemetics|antiemetics|mesh-ancestor
111292438|NCT03875690|Autonomic Agents|autonomic agents|mesh-ancestor
111292439|NCT03875690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111292440|NCT03875690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111292441|NCT03875690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111292442|NCT03875690|Glucocorticoids|glucocorticoids|mesh-ancestor
111292443|NCT03875690|Hormones|hormones|mesh-ancestor
111292444|NCT03875690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111292445|NCT03875690|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111292446|NCT03875690|Protective Agents|protective agents|mesh-ancestor
111292447|NCT03875690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111292448|NCT03875690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111292449|NCT03856216|Rituximab|rituximab|mesh-list
111292450|NCT03856216|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111292451|NCT03856216|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
111292452|NCT03856216|Methotrexate|methotrexate|mesh-list
111292453|NCT03856216|Fludarabine|fludarabine|mesh-list
111292454|NCT03856216|Melphalan|melphalan|mesh-list
111292455|NCT03856216|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
111292456|NCT03856216|Mechlorethamine|mechlorethamine|mesh-list
111292457|NCT03856216|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
111292458|NCT03856216|Antibodies|antibodies|mesh-list
111292459|NCT03856216|Immunoglobulins|immunoglobulins|mesh-list
111292460|NCT03856216|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111292461|NCT03856216|Lenograstim|lenograstim|mesh-list
111292462|NCT03856216|Tacrolimus|tacrolimus|mesh-list
111292463|NCT03856216|Antilymphocyte Serum|antilymphocyte serum|mesh-list
111292464|NCT03856216|Immunologic Factors|immunologic factors|mesh-ancestor
111292465|NCT03856216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111292466|NCT03856216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111292467|NCT03856216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111292468|NCT03856216|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111292469|NCT03856216|Abortifacient Agents|abortifacient agents|mesh-ancestor
111292470|NCT03856216|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111292471|NCT03856216|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111292472|NCT03856216|Antimetabolites|antimetabolites|mesh-ancestor
111292473|NCT03856216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111292474|NCT03856216|Dermatologic Agents|dermatologic agents|mesh-ancestor
111292475|NCT03856216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111292476|NCT03856216|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111292477|NCT03856216|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111292478|NCT03856216|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111292479|NCT03856216|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111292480|NCT03856216|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111292481|NCT03856216|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111292482|NCT03856216|Alkylating Agents|alkylating agents|mesh-ancestor
111292483|NCT03856216|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110979477|NCT03107702|Melatonin|melatonin|mesh-list
111292484|NCT03856216|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111292485|NCT03856216|Immunotoxins|immunotoxins|mesh-ancestor
111292486|NCT03856216|Immunoconjugates|immunoconjugates|mesh-ancestor
111292487|NCT03834493|Pembrolizumab|pembrolizumab|mesh-list
111292488|NCT03834493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111292489|NCT03834493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111292490|NCT03834493|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111292491|NCT03834493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111292492|NCT03808610|Cytarabine|cytarabine|mesh-list
111292493|NCT03808610|6-methoxypurine arabinoside|6-methoxypurine arabinoside|mesh-list
111292494|NCT03808610|Dexamethasone|dexamethasone|mesh-list
111292495|NCT03808610|Dexamethasone acetate|dexamethasone acetate|mesh-list
111292496|NCT03808610|Prednisone|prednisone|mesh-list
111292497|NCT03808610|Cortisone|cortisone|mesh-list
111292498|NCT03808610|Cyclophosphamide|cyclophosphamide|mesh-list
111292499|NCT03808610|Rituximab|rituximab|mesh-list
111292500|NCT03808610|Methotrexate|methotrexate|mesh-list
111292501|NCT03808610|Vincristine|vincristine|mesh-list
111292502|NCT03808610|Venetoclax|venetoclax|mesh-list
111292503|NCT03808610|Asparaginase|asparaginase|mesh-list
111292504|NCT03808610|Pegaspargase|pegaspargase|mesh-list
111292505|NCT03808610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111292506|NCT03808610|Antibodies|antibodies|mesh-list
111292507|NCT03808610|Immunoglobulins|immunoglobulins|mesh-list
111292508|NCT03808610|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111292509|NCT03808610|BB 1101|bb 1101|mesh-list
111292510|NCT03808610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111292511|NCT03808610|Immunologic Factors|immunologic factors|mesh-ancestor
111292512|NCT03808610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111292513|NCT03808610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111292514|NCT03808610|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111292515|NCT03808610|Alkylating Agents|alkylating agents|mesh-ancestor
111292516|NCT03808610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111292517|NCT03808610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111292518|NCT03808610|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111292519|NCT03808610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111292520|NCT03808610|Antiemetics|antiemetics|mesh-ancestor
111292521|NCT03808610|Autonomic Agents|autonomic agents|mesh-ancestor
111292522|NCT03808610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111292523|NCT03808610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111292524|NCT03808610|Glucocorticoids|glucocorticoids|mesh-ancestor
111292525|NCT03808610|Hormones|hormones|mesh-ancestor
111292526|NCT03808610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111292527|NCT03808610|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111292528|NCT03808610|Protease Inhibitors|protease inhibitors|mesh-ancestor
111292529|NCT03808610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111292530|NCT03808610|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111292531|NCT03808610|Abortifacient Agents|abortifacient agents|mesh-ancestor
111292532|NCT03808610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111292533|NCT03808610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111292534|NCT03808610|Antimetabolites|antimetabolites|mesh-ancestor
111292535|NCT03808610|Dermatologic Agents|dermatologic agents|mesh-ancestor
111292536|NCT03808610|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111292537|NCT03808610|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111292538|NCT03808610|Antiviral Agents|antiviral agents|mesh-ancestor
111292539|NCT03808610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111292540|NCT03808610|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111292541|NCT03808610|Tubulin Modulators|tubulin modulators|mesh-ancestor
111292542|NCT03808610|Antimitotic Agents|antimitotic agents|mesh-ancestor
111292543|NCT03808610|Mitosis Modulators|mitosis modulators|mesh-ancestor
111292544|NCT03739996|Cabotegravir|cabotegravir|mesh-list
111292545|NCT03739996|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
111292546|NCT03739996|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111292547|NCT03739996|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111292548|NCT03739996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111292549|NCT03739996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111292550|NCT03739996|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111292551|NCT03739996|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111292552|NCT03739996|Antiviral Agents|antiviral agents|mesh-ancestor
111292553|NCT03739996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111292554|NCT03739996|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111292555|NCT03734029|Paclitaxel|paclitaxel|mesh-list
111292556|NCT03734029|Camptothecin|camptothecin|mesh-list
111292557|NCT03734029|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111292558|NCT03734029|Gemcitabine|gemcitabine|mesh-list
111292559|NCT03734029|Capecitabine|capecitabine|mesh-list
111292560|NCT03734029|Trastuzumab|trastuzumab|mesh-list
111292561|NCT03734029|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
111292562|NCT03734029|Immunoconjugates|immunoconjugates|mesh-list
111292563|NCT03734029|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111292564|NCT03734029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111292565|NCT03734029|Tubulin Modulators|tubulin modulators|mesh-ancestor
111292566|NCT03734029|Antimitotic Agents|antimitotic agents|mesh-ancestor
111292567|NCT03734029|Mitosis Modulators|mitosis modulators|mesh-ancestor
111292568|NCT03734029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111292569|NCT03734029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111292570|NCT03734029|Antimetabolites|antimetabolites|mesh-ancestor
111292571|NCT03734029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111292572|NCT03734029|Immunologic Factors|immunologic factors|mesh-ancestor
111292573|NCT03734029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111292574|NCT03734029|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111292575|NCT03734029|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111292576|NCT03734029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111292577|NCT03732820|Olaparib|olaparib|mesh-list
111292578|NCT03732820|Abiraterone Acetate|abiraterone acetate|mesh-list
111292579|NCT03732820|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111292580|NCT03732820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111292581|NCT03732820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111292582|NCT03732820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111292583|NCT03732820|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111292584|NCT03732820|Hormone Antagonists|hormone antagonists|mesh-ancestor
111292585|NCT03732820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111292586|NCT03732820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111292587|NCT03732820|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111292588|NCT03721068|Cyclophosphamide|cyclophosphamide|mesh-list
111292589|NCT03721068|Fludarabine|fludarabine|mesh-list
111292590|NCT03721068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111292591|NCT03721068|Immunologic Factors|immunologic factors|mesh-ancestor
111292592|NCT03721068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111292593|NCT03721068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111292594|NCT03721068|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111292595|NCT03721068|Alkylating Agents|alkylating agents|mesh-ancestor
111292596|NCT03721068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111292597|NCT03721068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111292598|NCT03721068|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111292599|NCT03705962|Tobramycin|tobramycin|mesh-list
111017062|NCT02066077|Anesthetics, General|anesthetics, general|mesh-ancestor
111292600|NCT03705962|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111292601|NCT03705962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111292602|NCT03693183|Ketorolac|ketorolac|mesh-list
111292603|NCT03693183|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
111292604|NCT03693183|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111292605|NCT03693183|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111292606|NCT03693183|Analgesics|analgesics|mesh-ancestor
111292607|NCT03693183|Sensory System Agents|sensory system agents|mesh-ancestor
111292608|NCT03693183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111292609|NCT03693183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111292610|NCT03693183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111292611|NCT03693183|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111292612|NCT03693183|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111292613|NCT03693183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111292614|NCT03693183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111292615|NCT03679650|Decitabine|decitabine|mesh-list
111292616|NCT03679650|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111292617|NCT03679650|Antimetabolites|antimetabolites|mesh-ancestor
111292618|NCT03679650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111292619|NCT03679650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111292620|NCT03679650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111292621|NCT03661307|Decitabine|decitabine|mesh-list
111292622|NCT03661307|Venetoclax|venetoclax|mesh-list
111292623|NCT03661307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111292624|NCT03661307|Antimetabolites|antimetabolites|mesh-ancestor
111292625|NCT03661307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111292626|NCT03661307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111292627|NCT03661307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111292628|NCT03657797|Latanoprost|latanoprost|mesh-list
111292629|NCT03657797|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
111292630|NCT03657797|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111292631|NCT03631043|Lenalidomide|lenalidomide|mesh-list
111292632|NCT03631043|Vaccines|vaccines|mesh-list
111292633|NCT03631043|Immunologic Factors|immunologic factors|mesh-ancestor
111292634|NCT03631043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111292635|NCT03631043|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111292636|NCT03631043|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111292637|NCT03631043|Growth Substances|growth substances|mesh-ancestor
111292638|NCT03631043|Growth Inhibitors|growth inhibitors|mesh-ancestor
111292639|NCT03631043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111292640|NCT03610711|Nivolumab|nivolumab|mesh-list
111292641|NCT03610711|Relatlimab|relatlimab|mesh-list
111292642|NCT03610711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111292643|NCT03610711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111292644|NCT03610711|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111292645|NCT03610711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111292646|NCT03579446|Oxymorphone|oxymorphone|mesh-list
111292647|NCT03579446|Morphine|morphine|mesh-list
111292648|NCT03579446|Oxycodone|oxycodone|mesh-list
111292649|NCT03579446|Hydromorphone|hydromorphone|mesh-list
111292650|NCT03579446|Hydrocodone|hydrocodone|mesh-list
111292651|NCT03579446|Levorphanol|levorphanol|mesh-list
111292652|NCT03579446|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111292653|NCT03579446|Narcotics|narcotics|mesh-ancestor
111292654|NCT03579446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111292655|NCT03579446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111292656|NCT03579446|Analgesics|analgesics|mesh-ancestor
111292657|NCT03579446|Sensory System Agents|sensory system agents|mesh-ancestor
111292658|NCT03579446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111292659|NCT03579446|Antitussive Agents|antitussive agents|mesh-ancestor
111292660|NCT03579446|Respiratory System Agents|respiratory system agents|mesh-ancestor
111292661|NCT03579446|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111292662|NCT03546361|Pembrolizumab|pembrolizumab|mesh-list
111292663|NCT03546361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111292664|NCT03546361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111292665|NCT03546361|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111292666|NCT03546361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111292667|NCT03473574|Gemcitabine|gemcitabine|mesh-list
111292668|NCT03473574|Durvalumab|durvalumab|mesh-list
111292669|NCT03473574|Tremelimumab|tremelimumab|mesh-list
111292670|NCT03473574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111292671|NCT03473574|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111292672|NCT03473574|Antimetabolites|antimetabolites|mesh-ancestor
111292673|NCT03473574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111292674|NCT03473574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111292675|NCT03472040|Berotralstat|berotralstat|mesh-list
111292676|NCT03472040|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111292677|NCT03472040|Protease Inhibitors|protease inhibitors|mesh-ancestor
111292678|NCT03472040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111292679|NCT03472040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111292680|NCT03428126|Durvalumab|durvalumab|mesh-list
111292681|NCT03428126|Trametinib|trametinib|mesh-list
111292682|NCT03428126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111292683|NCT03428126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111292684|NCT03428126|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111292685|NCT03428126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111292686|NCT03428126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111292687|NCT03424018|Natriuretic Peptide, C-Type|natriuretic peptide, c-type|mesh-list
111292688|NCT03424018|Natriuretic Agents|natriuretic agents|mesh-ancestor
111292689|NCT03424018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111292690|NCT03416530|TIC10 compound|tic10 compound|mesh-list
111292691|NCT03416530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111292692|NCT03345810|Paclitaxel|paclitaxel|mesh-list
111292693|NCT03345810|Vinorelbine|vinorelbine|mesh-list
111292694|NCT03345810|Carboplatin|carboplatin|mesh-list
111292695|NCT03345810|Gemcitabine|gemcitabine|mesh-list
111292696|NCT03345810|Durvalumab|durvalumab|mesh-list
111292697|NCT03345810|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111292698|NCT03345810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111292699|NCT03345810|Tubulin Modulators|tubulin modulators|mesh-ancestor
111292700|NCT03345810|Antimitotic Agents|antimitotic agents|mesh-ancestor
111292701|NCT03345810|Mitosis Modulators|mitosis modulators|mesh-ancestor
111292702|NCT03345810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111292703|NCT03345810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111292704|NCT03345810|Antimetabolites|antimetabolites|mesh-ancestor
111292705|NCT03345810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111292706|NCT03344965|Olaparib|olaparib|mesh-list
111292707|NCT03344965|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111292708|NCT03344965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111292709|NCT03344965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111292710|NCT03344965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111292711|NCT03323385|Meloxicam|meloxicam|mesh-list
111292712|NCT03323385|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111292713|NCT03323385|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111292714|NCT03323385|Analgesics|analgesics|mesh-ancestor
111292715|NCT03323385|Sensory System Agents|sensory system agents|mesh-ancestor
111292716|NCT03323385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111292717|NCT03323385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111292718|NCT03323385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111292719|NCT03323385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111292720|NCT03323385|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111292721|NCT03323385|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111292722|NCT03323385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111292723|NCT03323385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111292724|NCT03298451|Sorafenib|sorafenib|mesh-list
111292725|NCT03298451|Durvalumab|durvalumab|mesh-list
111292726|NCT03298451|Tremelimumab|tremelimumab|mesh-list
111292727|NCT03298451|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111292728|NCT03298451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111292729|NCT03298451|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111292730|NCT03298451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111292731|NCT03298451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111292732|NCT03298451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111292733|NCT03298451|Immunologic Factors|immunologic factors|mesh-ancestor
111292734|NCT03298451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111292735|NCT03295396|TIC10 compound|tic10 compound|mesh-list
111292736|NCT03295396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111292737|NCT03248479|Azacitidine|azacitidine|mesh-list
111292738|NCT03248479|Magrolimab|magrolimab|mesh-list
111292739|NCT03248479|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111292740|NCT03248479|Antimetabolites|antimetabolites|mesh-ancestor
111292741|NCT03248479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111292742|NCT03248479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111292743|NCT03248479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111292744|NCT03248479|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111292745|NCT03215719|Cisplatin|cisplatin|mesh-list
111292746|NCT03215719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111292747|NCT03197467|Pembrolizumab|pembrolizumab|mesh-list
111292748|NCT03197467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111292749|NCT03197467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111292750|NCT03197467|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111292751|NCT03197467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111292752|NCT03172299|Aflibercept|aflibercept|mesh-list
111292753|NCT03172299|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111292754|NCT03172299|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111292755|NCT03172299|Growth Substances|growth substances|mesh-ancestor
111292756|NCT03172299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111292757|NCT03172299|Growth Inhibitors|growth inhibitors|mesh-ancestor
111292758|NCT03172299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111292759|NCT03132636|Cemiplimab|cemiplimab|mesh-list
111292760|NCT03132636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111292761|NCT03132636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111292762|NCT03089983|Isoniazid|isoniazid|mesh-list
111292763|NCT03089983|Rifapentine|rifapentine|mesh-list
111292764|NCT03089983|Buprenorphine|buprenorphine|mesh-list
111292765|NCT03089983|Methadone|methadone|mesh-list
111292766|NCT03089983|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
111292767|NCT03089983|Naloxone|naloxone|mesh-list
111292768|NCT03089983|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111292769|NCT03089983|Narcotics|narcotics|mesh-ancestor
111292770|NCT03089983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111292771|NCT03089983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111292772|NCT03089983|Analgesics|analgesics|mesh-ancestor
111292773|NCT03089983|Sensory System Agents|sensory system agents|mesh-ancestor
111292774|NCT03089983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111292775|NCT03089983|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111292776|NCT03089983|Antitussive Agents|antitussive agents|mesh-ancestor
111292777|NCT03089983|Respiratory System Agents|respiratory system agents|mesh-ancestor
111292778|NCT03089983|Antitubercular Agents|antitubercular agents|mesh-ancestor
111292779|NCT03089983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111292780|NCT03089983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111292781|NCT03089983|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
111292782|NCT03089983|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111292783|NCT03089983|Antimetabolites|antimetabolites|mesh-ancestor
111292784|NCT03089983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111292785|NCT03089983|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111292786|NCT03089983|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111292787|NCT03089983|Leprostatic Agents|leprostatic agents|mesh-ancestor
111292788|NCT03079999|Aspirin|aspirin|mesh-list
111292789|NCT03079999|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111292790|NCT03079999|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111292791|NCT03079999|Analgesics|analgesics|mesh-ancestor
111292792|NCT03079999|Sensory System Agents|sensory system agents|mesh-ancestor
111292793|NCT03079999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111292794|NCT03079999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111292795|NCT03079999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111292796|NCT03079999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111292797|NCT03079999|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111292798|NCT03079999|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111292799|NCT03079999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111292800|NCT03079999|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111292801|NCT03079999|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111292802|NCT03079999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111292803|NCT03079999|Antipyretics|antipyretics|mesh-ancestor
111292804|NCT03070184|Metoprolol|metoprolol|mesh-list
111292805|NCT03070184|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111292806|NCT03070184|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111292807|NCT03070184|Sympatholytics|sympatholytics|mesh-ancestor
111292808|NCT03070184|Autonomic Agents|autonomic agents|mesh-ancestor
111292809|NCT03070184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111292810|NCT03070184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111292811|NCT03070184|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
111292812|NCT03070184|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111292813|NCT03070184|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111292814|NCT03070184|Adrenergic Agents|adrenergic agents|mesh-ancestor
111292815|NCT03070184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111292816|NCT03070184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111292817|NCT03047993|Azacitidine|azacitidine|mesh-list
111292818|NCT03047993|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111292819|NCT03047993|Antimetabolites|antimetabolites|mesh-ancestor
111292820|NCT03047993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111292821|NCT03047993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111292822|NCT03047993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111292823|NCT03044587|Leucovorin|leucovorin|mesh-list
111292824|NCT03044587|Gemcitabine|gemcitabine|mesh-list
111292825|NCT03044587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111292826|NCT03044587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111292827|NCT03044587|Antimetabolites|antimetabolites|mesh-ancestor
111292828|NCT03044587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111292829|NCT03044587|Antidotes|antidotes|mesh-ancestor
111292830|NCT03044587|Protective Agents|protective agents|mesh-ancestor
111292831|NCT03044587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111292832|NCT03044587|Vitamin B Complex|vitamin b complex|mesh-ancestor
111292833|NCT03044587|Vitamins|vitamins|mesh-ancestor
111292834|NCT03044587|Micronutrients|micronutrients|mesh-ancestor
111292835|NCT03029403|Cyclophosphamide|cyclophosphamide|mesh-list
111292836|NCT03029403|Pembrolizumab|pembrolizumab|mesh-list
111292837|NCT03029403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111292838|NCT03029403|Immunologic Factors|immunologic factors|mesh-ancestor
111292839|NCT03029403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111292840|NCT03029403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111292841|NCT03029403|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111292842|NCT03029403|Alkylating Agents|alkylating agents|mesh-ancestor
111292843|NCT03029403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111292844|NCT03029403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111292845|NCT03029403|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111292846|NCT03029403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111292847|NCT03029403|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111292848|NCT03003962|Paclitaxel|paclitaxel|mesh-list
111292849|NCT03003962|Cisplatin|cisplatin|mesh-list
111292850|NCT03003962|Carboplatin|carboplatin|mesh-list
111292851|NCT03003962|Gemcitabine|gemcitabine|mesh-list
111292852|NCT03003962|Pemetrexed|pemetrexed|mesh-list
111292853|NCT03003962|Durvalumab|durvalumab|mesh-list
111292854|NCT03003962|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111292855|NCT03003962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111292856|NCT03003962|Tubulin Modulators|tubulin modulators|mesh-ancestor
111292857|NCT03003962|Antimitotic Agents|antimitotic agents|mesh-ancestor
111292858|NCT03003962|Mitosis Modulators|mitosis modulators|mesh-ancestor
111292859|NCT03003962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111292860|NCT03003962|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111292861|NCT03003962|Antimetabolites|antimetabolites|mesh-ancestor
111292862|NCT03003962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111292863|NCT03003962|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111292864|NCT03003962|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111292865|NCT03003962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111292866|NCT02947620|Metformin|metformin|mesh-list
111292867|NCT02947620|Atorvastatin|atorvastatin|mesh-list
111292868|NCT02947620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111292869|NCT02947620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111292870|NCT02947620|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111292871|NCT02947620|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111292872|NCT02947620|Antimetabolites|antimetabolites|mesh-ancestor
111292873|NCT02947620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111292874|NCT02947620|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111292875|NCT02947620|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111292876|NCT02947620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111292877|NCT02869789|Nivolumab|nivolumab|mesh-list
111292878|NCT02869789|Ipilimumab|ipilimumab|mesh-list
111292879|NCT02869789|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111292880|NCT02869789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111292881|NCT02869789|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111292882|NCT02869789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111292883|NCT02863445|Levonorgestrel|levonorgestrel|mesh-list
111292884|NCT02863445|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111292885|NCT02863445|Contraceptive Agents|contraceptive agents|mesh-ancestor
111292886|NCT02863445|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111292887|NCT02863445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111292888|NCT02863445|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111292889|NCT02863445|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111292890|NCT02863445|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111292891|NCT02696993|Nivolumab|nivolumab|mesh-list
111292892|NCT02696993|Ipilimumab|ipilimumab|mesh-list
111292893|NCT02696993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111292894|NCT02696993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111292895|NCT02696993|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111292896|NCT02696993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111292897|NCT02671890|Gemcitabine|gemcitabine|mesh-list
111292898|NCT02671890|Disulfiram|disulfiram|mesh-list
111292899|NCT02671890|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111292900|NCT02671890|Antimetabolites|antimetabolites|mesh-ancestor
111292901|NCT02671890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111017362|NCT02076529|Autonomic Agents|autonomic agents|mesh-ancestor
111292902|NCT02671890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111292903|NCT02671890|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111292904|NCT02671890|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
111292905|NCT02671890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111292906|NCT02661282|Temozolomide|temozolomide|mesh-list
111292907|NCT02661282|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111292908|NCT02661282|Alkylating Agents|alkylating agents|mesh-ancestor
111292909|NCT02661282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111292910|NCT02661282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111292911|NCT02659527|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
111292912|NCT02659527|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111292913|NCT02659527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111292914|NCT02634333|Aflibercept|aflibercept|mesh-list
111292915|NCT02634333|Endothelial Growth Factors|endothelial growth factors|mesh-list
111292916|NCT02634333|Mitogens|mitogens|mesh-list
111292917|NCT02634333|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111292918|NCT02634333|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111292919|NCT02634333|Growth Substances|growth substances|mesh-ancestor
111292920|NCT02634333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111292921|NCT02634333|Growth Inhibitors|growth inhibitors|mesh-ancestor
111292922|NCT02634333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111292923|NCT02634333|Mitosis Modulators|mitosis modulators|mesh-ancestor
111292924|NCT02634333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111292925|NCT02586857|Acalabrutinib|acalabrutinib|mesh-list
111292926|NCT02586857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111292927|NCT02515630|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
111292928|NCT02515630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111292929|NCT02515630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111292930|NCT02515630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111292931|NCT02450331|Atezolizumab|atezolizumab|mesh-list
111292932|NCT02450331|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111292933|NCT02450331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111292934|NCT02450331|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111292935|NCT02450331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111292936|NCT02397720|Nivolumab|nivolumab|mesh-list
111292937|NCT02397720|Ipilimumab|ipilimumab|mesh-list
111292938|NCT02397720|Azacitidine|azacitidine|mesh-list
111292939|NCT02397720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111292940|NCT02397720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111292941|NCT02397720|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111292942|NCT02397720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111292943|NCT02397720|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111292944|NCT02397720|Antimetabolites|antimetabolites|mesh-ancestor
111292945|NCT02397720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111292946|NCT02391025|Citric Acid|citric acid|mesh-list
111292947|NCT02391025|Sodium Citrate|sodium citrate|mesh-list
111292948|NCT02391025|Anticoagulants|anticoagulants|mesh-ancestor
111292949|NCT02391025|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
111292950|NCT02391025|Chelating Agents|chelating agents|mesh-ancestor
111292951|NCT02391025|Sequestering Agents|sequestering agents|mesh-ancestor
111292952|NCT02391025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111292953|NCT02386800|Panobinostat|panobinostat|mesh-list
111292954|NCT02386800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111292955|NCT02386800|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111292956|NCT02386800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111292957|NCT02386800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111292958|NCT02335944|Nazartinib|nazartinib|mesh-list
111292959|NCT02335944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111292960|NCT02326974|Pertuzumab|pertuzumab|mesh-list
111292961|NCT02326974|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111292962|NCT02326974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111292963|NCT02299518|Cytarabine|cytarabine|mesh-list
111292964|NCT02299518|Etoposide|etoposide|mesh-list
111292965|NCT02299518|Mitoxantrone|mitoxantrone|mesh-list
111292966|NCT02299518|Etoposide phosphate|etoposide phosphate|mesh-list
111292967|NCT02299518|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111292968|NCT02299518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111292969|NCT02299518|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111292970|NCT02299518|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111292971|NCT02299518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110979534|NCT03247400|Antimetabolites|antimetabolites|mesh-ancestor
111292972|NCT02299518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111292973|NCT02299518|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111292974|NCT02299518|Antimetabolites|antimetabolites|mesh-ancestor
111292975|NCT02299518|Antiviral Agents|antiviral agents|mesh-ancestor
111292977|NCT02299518|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111292978|NCT02299518|Immunologic Factors|immunologic factors|mesh-ancestor
111292979|NCT02299518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111292980|NCT02299518|Analgesics|analgesics|mesh-ancestor
111292981|NCT02299518|Sensory System Agents|sensory system agents|mesh-ancestor
111292982|NCT02299518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111292983|NCT02257138|Decitabine|decitabine|mesh-list
111292984|NCT02257138|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111292985|NCT02257138|Antimetabolites|antimetabolites|mesh-ancestor
111292986|NCT02257138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111292987|NCT02257138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111292988|NCT02257138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111292989|NCT02246621|Letrozole|letrozole|mesh-list
111292990|NCT02246621|Anastrozole|anastrozole|mesh-list
111292991|NCT02246621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111292992|NCT02246621|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111292993|NCT02246621|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111292994|NCT02246621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111292995|NCT02246621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111292996|NCT02246621|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111292997|NCT02246621|Hormone Antagonists|hormone antagonists|mesh-ancestor
111292998|NCT02246621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111292999|NCT02246621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111293000|NCT02246621|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111293001|NCT02214550|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
111293002|NCT02214550|Norinyl|norinyl|mesh-list
111293003|NCT02214550|Mestranol|mestranol|mesh-list
111293004|NCT02214550|Norethindrone|norethindrone|mesh-list
111293005|NCT02214550|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
111293006|NCT02214550|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111293007|NCT02214550|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111293008|NCT02214550|Contraceptive Agents|contraceptive agents|mesh-ancestor
111293009|NCT02214550|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111293010|NCT02214550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111293011|NCT02214550|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111293012|NCT02214550|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111293013|NCT02214550|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
111293014|NCT02214550|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111293015|NCT02214550|Estrogens|estrogens|mesh-ancestor
111293016|NCT02214550|Hormones|hormones|mesh-ancestor
111293017|NCT02214550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111293018|NCT02200445|Aldesleukin|aldesleukin|mesh-list
111293019|NCT02200445|Interleukin-2|interleukin-2|mesh-list
111293020|NCT02200445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111293021|NCT02200445|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111293022|NCT02200445|Analgesics|analgesics|mesh-ancestor
111293023|NCT02200445|Sensory System Agents|sensory system agents|mesh-ancestor
111293024|NCT02200445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111293025|NCT02200445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111293026|NCT02200445|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111293027|NCT02200445|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111293028|NCT02200445|Antiviral Agents|antiviral agents|mesh-ancestor
111293029|NCT02200445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111293030|NCT02180711|Rituximab|rituximab|mesh-list
111293031|NCT02180711|Lenalidomide|lenalidomide|mesh-list
111293032|NCT02180711|Acalabrutinib|acalabrutinib|mesh-list
111293033|NCT02180711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111293034|NCT02180711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111293035|NCT02180711|Immunologic Factors|immunologic factors|mesh-ancestor
111293036|NCT02180711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111293037|NCT02180711|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111293038|NCT02180711|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111293039|NCT02180711|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111293040|NCT02180711|Growth Substances|growth substances|mesh-ancestor
111293041|NCT02180711|Growth Inhibitors|growth inhibitors|mesh-ancestor
111293042|NCT02151084|Gemcitabine|gemcitabine|mesh-list
111293043|NCT02151084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111293044|NCT02151084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111293045|NCT02151084|Antimetabolites|antimetabolites|mesh-ancestor
111293046|NCT02151084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111293047|NCT02120352|Rilpivirine|rilpivirine|mesh-list
111293048|NCT02120352|Cabotegravir|cabotegravir|mesh-list
111293049|NCT02120352|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111293050|NCT02120352|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111293051|NCT02120352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111293052|NCT02120352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111293053|NCT02120352|Antiviral Agents|antiviral agents|mesh-ancestor
111293054|NCT02120352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111293055|NCT02120352|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111293056|NCT02120352|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111293057|NCT02120352|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111293058|NCT02120352|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111293059|NCT02058693|Amphetamine|amphetamine|mesh-list
111293061|NCT02058693|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111293062|NCT02058693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111293063|NCT02058693|Sympathomimetics|sympathomimetics|mesh-ancestor
111293064|NCT02058693|Autonomic Agents|autonomic agents|mesh-ancestor
111293065|NCT02058693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111293066|NCT02058693|Dopamine Agents|dopamine agents|mesh-ancestor
111293067|NCT02058693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111293068|NCT02058693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111293069|NCT02058693|Adrenergic Agents|adrenergic agents|mesh-ancestor
111293070|NCT02058693|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111293071|NCT02058693|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111293072|NCT02058693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111293073|NCT02058693|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111293074|NCT02047513|Paclitaxel|paclitaxel|mesh-list
111293075|NCT02047513|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111293076|NCT02047513|Gemcitabine|gemcitabine|mesh-list
111293077|NCT02047513|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111293078|NCT02047513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111293079|NCT02047513|Tubulin Modulators|tubulin modulators|mesh-ancestor
111293080|NCT02047513|Antimitotic Agents|antimitotic agents|mesh-ancestor
111293081|NCT02047513|Mitosis Modulators|mitosis modulators|mesh-ancestor
111293082|NCT02047513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111293083|NCT02047513|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111293084|NCT02047513|Antimetabolites|antimetabolites|mesh-ancestor
111293085|NCT02007044|Rituximab|rituximab|mesh-list
111293086|NCT02007044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111293087|NCT02007044|Antibodies|antibodies|mesh-list
111293088|NCT02007044|Immunoglobulins|immunoglobulins|mesh-list
111293089|NCT02007044|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111293090|NCT02007044|Immunologic Factors|immunologic factors|mesh-ancestor
111293091|NCT02007044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111293092|NCT02007044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111293093|NCT02007044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111293094|NCT01991873|Leucovorin|leucovorin|mesh-list
111293095|NCT01991873|Folic Acid|folic acid|mesh-list
111293096|NCT01991873|Fluorouracil|fluorouracil|mesh-list
111293097|NCT01991873|Oxaliplatin|oxaliplatin|mesh-list
111293098|NCT01991873|Panitumumab|panitumumab|mesh-list
111293099|NCT01991873|Levoleucovorin|levoleucovorin|mesh-list
111293100|NCT01991873|Antimetabolites|antimetabolites|mesh-ancestor
111293101|NCT01991873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111293102|NCT01991873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111293103|NCT01991873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111293104|NCT01991873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111293105|NCT01991873|Immunologic Factors|immunologic factors|mesh-ancestor
111293106|NCT01991873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111293107|NCT01991873|Antidotes|antidotes|mesh-ancestor
111293108|NCT01991873|Protective Agents|protective agents|mesh-ancestor
111293109|NCT01991873|Vitamin B Complex|vitamin b complex|mesh-ancestor
111293110|NCT01991873|Vitamins|vitamins|mesh-ancestor
111293111|NCT01991873|Micronutrients|micronutrients|mesh-ancestor
111293112|NCT01991873|Hematinics|hematinics|mesh-ancestor
111293113|NCT01991873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111293114|NCT01878617|Cyclophosphamide|cyclophosphamide|mesh-list
111293115|NCT01878617|Gemcitabine|gemcitabine|mesh-list
111293116|NCT01878617|Vincristine|vincristine|mesh-list
111293117|NCT01878617|Pemetrexed|pemetrexed|mesh-list
111293118|NCT01878617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111293119|NCT01878617|Immunologic Factors|immunologic factors|mesh-ancestor
111293120|NCT01878617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111293121|NCT01878617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111293122|NCT01878617|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111293123|NCT01878617|Alkylating Agents|alkylating agents|mesh-ancestor
111293124|NCT01878617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111293125|NCT01878617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111293126|NCT01878617|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111293127|NCT01878617|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111293128|NCT01878617|Antimetabolites|antimetabolites|mesh-ancestor
111293129|NCT01878617|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111293130|NCT01878617|Tubulin Modulators|tubulin modulators|mesh-ancestor
111293131|NCT01878617|Antimitotic Agents|antimitotic agents|mesh-ancestor
111293132|NCT01878617|Mitosis Modulators|mitosis modulators|mesh-ancestor
111293133|NCT01878617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111293134|NCT01878617|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111293135|NCT01878617|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111293137|NCT01843556|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111293138|NCT01843556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111293139|NCT01843556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111293140|NCT01843556|Cholinergic Agents|cholinergic agents|mesh-ancestor
111293141|NCT01843556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111293142|NCT01843556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111293143|NCT01843556|Nootropic Agents|nootropic agents|mesh-ancestor
111293144|NCT01787487|Azacitidine|azacitidine|mesh-list
111293145|NCT01787487|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111293146|NCT01787487|Antimetabolites|antimetabolites|mesh-ancestor
111293147|NCT01787487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111293148|NCT01787487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111293149|NCT01787487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111293150|NCT01751425|Imatinib Mesylate|imatinib mesylate|mesh-list
111293151|NCT01751425|Dasatinib|dasatinib|mesh-list
111293152|NCT01751425|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
111293153|NCT01751425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111293154|NCT01751425|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111293155|NCT01751425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111293156|NCT01751425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111293157|NCT01618136|Paclitaxel|paclitaxel|mesh-list
111293158|NCT01618136|Carboplatin|carboplatin|mesh-list
111293159|NCT01618136|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111293160|NCT01618136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111293161|NCT01618136|Tubulin Modulators|tubulin modulators|mesh-ancestor
111293162|NCT01618136|Antimitotic Agents|antimitotic agents|mesh-ancestor
111293163|NCT01618136|Mitosis Modulators|mitosis modulators|mesh-ancestor
111293164|NCT01618136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111293165|NCT01539031|Donepezil|donepezil|mesh-list
111293166|NCT01539031|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111293167|NCT01539031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111293168|NCT01539031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111293169|NCT01539031|Cholinergic Agents|cholinergic agents|mesh-ancestor
111293170|NCT01539031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111293171|NCT01539031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111293172|NCT01539031|Nootropic Agents|nootropic agents|mesh-ancestor
111293173|NCT01508312|Brentuximab Vedotin|brentuximab vedotin|mesh-list
111293174|NCT01508312|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111293175|NCT01508312|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111293176|NCT01508312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111293177|NCT01508312|Immunotoxins|immunotoxins|mesh-ancestor
111293178|NCT01508312|Immunoconjugates|immunoconjugates|mesh-ancestor
111293179|NCT01508312|Immunologic Factors|immunologic factors|mesh-ancestor
111293180|NCT01508312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111293181|NCT01375140|Prednisone|prednisone|mesh-list
111293182|NCT01375140|Lenalidomide|lenalidomide|mesh-list
111293183|NCT01375140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111293184|NCT01375140|Glucocorticoids|glucocorticoids|mesh-ancestor
111293185|NCT01375140|Hormones|hormones|mesh-ancestor
111293186|NCT01375140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111293187|NCT01375140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111293188|NCT01375140|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111293189|NCT01375140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111293190|NCT01375140|Immunologic Factors|immunologic factors|mesh-ancestor
111293191|NCT01375140|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111293192|NCT01375140|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111293193|NCT01375140|Growth Substances|growth substances|mesh-ancestor
111293194|NCT01375140|Growth Inhibitors|growth inhibitors|mesh-ancestor
111293195|NCT01328171|Folic Acid|folic acid|mesh-list
111293196|NCT01328171|Vitamin B Complex|vitamin b complex|mesh-list
111293197|NCT01328171|Oxaliplatin|oxaliplatin|mesh-list
111293198|NCT01328171|Irinotecan|irinotecan|mesh-list
111293199|NCT01328171|Panitumumab|panitumumab|mesh-list
111293200|NCT01328171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111293201|NCT01328171|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111293202|NCT01328171|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111293203|NCT01328171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111293204|NCT01328171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111293205|NCT01328171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111293207|NCT01328171|Vitamins|vitamins|mesh-ancestor
111293208|NCT01328171|Micronutrients|micronutrients|mesh-ancestor
111293209|NCT01328171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111293210|NCT01288963|Aldesleukin|aldesleukin|mesh-list
111293211|NCT01288963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111293212|NCT01288963|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111293213|NCT01288963|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111293214|NCT01288963|Antiviral Agents|antiviral agents|mesh-ancestor
111293215|NCT01288963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111293216|NCT01269190|Proflavine|proflavine|mesh-list
111293217|NCT01269190|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111293218|NCT01269190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111293219|NCT01248715|Oseltamivir|oseltamivir|mesh-list
111293220|NCT01248715|Antiviral Agents|antiviral agents|mesh-ancestor
111293221|NCT01248715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111293222|NCT01248715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111293223|NCT01248715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111293224|NCT00963040|Oxytocin|oxytocin|mesh-list
111293225|NCT00963040|Oxytocics|oxytocics|mesh-ancestor
111293226|NCT00963040|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111293227|NCT00963040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111293228|NCT00941109|Decitabine|decitabine|mesh-list
111293229|NCT00941109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111293230|NCT00941109|Antimetabolites|antimetabolites|mesh-ancestor
111293231|NCT00941109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111293232|NCT00941109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111293233|NCT00941109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111293234|NCT00908050|Botulinum Toxins|botulinum toxins|mesh-list
111293235|NCT00908050|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111293236|NCT00908050|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111293237|NCT00908050|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111293238|NCT00908050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111293239|NCT00908050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111293240|NCT00908050|Cholinergic Agents|cholinergic agents|mesh-ancestor
111293241|NCT00908050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111293242|NCT00908050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111293243|NCT00908050|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111293244|NCT00908050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111293245|NCT00812214|Eszopiclone|eszopiclone|mesh-list
111293246|NCT00812214|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111293247|NCT00812214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111293248|NCT00812214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111293249|NCT00658814|Azacitidine|azacitidine|mesh-list
111293250|NCT00658814|Gemtuzumab|gemtuzumab|mesh-list
111293251|NCT00658814|Calicheamicins|calicheamicins|mesh-list
111293252|NCT00658814|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111293253|NCT00658814|Antimetabolites|antimetabolites|mesh-ancestor
111293254|NCT00658814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111293255|NCT00658814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111293256|NCT00658814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111293257|NCT00658814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111293258|NCT00658814|Immunotoxins|immunotoxins|mesh-ancestor
111293259|NCT00658814|Immunoconjugates|immunoconjugates|mesh-ancestor
111293260|NCT00658814|Immunologic Factors|immunologic factors|mesh-ancestor
111293261|NCT00658814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111293262|NCT00658814|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111293263|NCT00444613|Vitamin B 12|vitamin b 12|mesh-list
111293264|NCT00444613|Vitamin B Complex|vitamin b complex|mesh-ancestor
111293265|NCT00444613|Vitamins|vitamins|mesh-ancestor
111293266|NCT00444613|Micronutrients|micronutrients|mesh-ancestor
111293267|NCT00444613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111293268|NCT00217425|Prednisone|prednisone|mesh-list
111293269|NCT00217425|Cyclophosphamide|cyclophosphamide|mesh-list
111293270|NCT00217425|Bevacizumab|bevacizumab|mesh-list
111293271|NCT00217425|Doxorubicin|doxorubicin|mesh-list
111293272|NCT00217425|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111293273|NCT00217425|Vincristine|vincristine|mesh-list
111293274|NCT00217425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111293275|NCT00217425|Immunologic Factors|immunologic factors|mesh-ancestor
111293276|NCT00217425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111293277|NCT00217425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111017735|NCT02079727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111293278|NCT00217425|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111293280|NCT00217425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111293281|NCT00217425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111293282|NCT00217425|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111293283|NCT00217425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111293284|NCT00217425|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111293285|NCT00217425|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111293286|NCT00217425|Growth Substances|growth substances|mesh-ancestor
111293287|NCT00217425|Growth Inhibitors|growth inhibitors|mesh-ancestor
111293288|NCT00217425|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111293289|NCT00217425|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111293290|NCT00217425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111293291|NCT00217425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111293292|NCT00217425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111293293|NCT00217425|Glucocorticoids|glucocorticoids|mesh-ancestor
111293294|NCT00217425|Hormones|hormones|mesh-ancestor
111293295|NCT00217425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111293296|NCT00217425|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111293297|NCT00217425|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111293298|NCT00217425|Tubulin Modulators|tubulin modulators|mesh-ancestor
111293299|NCT00217425|Antimitotic Agents|antimitotic agents|mesh-ancestor
111293300|NCT00217425|Mitosis Modulators|mitosis modulators|mesh-ancestor
111293301|NCT00209599|Fospropofol|fospropofol|mesh-list
111293302|NCT00209599|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111293303|NCT00209599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111293304|NCT00209599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111293305|NCT00060567|Irinotecan|irinotecan|mesh-list
111293306|NCT00060567|N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|mesh-list
111293307|NCT00060567|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111293308|NCT00060567|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111293309|NCT00060567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111293310|NCT00060567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111293311|NCT00060567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111293312|NCT00060567|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
111293313|NCT00049348|Gemcitabine|gemcitabine|mesh-list
111293314|NCT00049348|Fluorouracil|fluorouracil|mesh-list
111293315|NCT00049348|Epoetin Alfa|epoetin alfa|mesh-list
111293316|NCT00049348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111293317|NCT00049348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111293318|NCT00049348|Antimetabolites|antimetabolites|mesh-ancestor
111293319|NCT00049348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111293320|NCT00049348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111293321|NCT00049348|Immunologic Factors|immunologic factors|mesh-ancestor
111293322|NCT00049348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111293323|NCT00049348|Hematinics|hematinics|mesh-ancestor
111293324|NCT00004125|Tamoxifen|tamoxifen|mesh-list
111293325|NCT00004125|Paclitaxel|paclitaxel|mesh-list
111293326|NCT00004125|Docetaxel|docetaxel|mesh-list
111293327|NCT00004125|Cyclophosphamide|cyclophosphamide|mesh-list
111293328|NCT00004125|Doxorubicin|doxorubicin|mesh-list
111293329|NCT00004125|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111293330|NCT00004125|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111293331|NCT00004125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111293332|NCT00004125|Tubulin Modulators|tubulin modulators|mesh-ancestor
111293333|NCT00004125|Antimitotic Agents|antimitotic agents|mesh-ancestor
111293334|NCT00004125|Mitosis Modulators|mitosis modulators|mesh-ancestor
111293335|NCT00004125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111293336|NCT00004125|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111293337|NCT00004125|Immunologic Factors|immunologic factors|mesh-ancestor
111293338|NCT00004125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111293339|NCT00004125|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111293340|NCT00004125|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111293341|NCT00004125|Alkylating Agents|alkylating agents|mesh-ancestor
111293342|NCT00004125|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111293343|NCT00004125|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111293344|NCT00004125|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111293345|NCT00004125|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111293346|NCT00004125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111293347|NCT00004125|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111293348|NCT00004125|Hormone Antagonists|hormone antagonists|mesh-ancestor
111293349|NCT00004125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111293350|NCT00004125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111293351|NCT00004125|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111293352|NCT00004125|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111293353|NCT00004125|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111293354|NCT00002981|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
111293355|NCT00002981|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111293356|NCT00002981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111293357|NCT03452865|Esomeprazole|esomeprazole|mesh-list
111293358|NCT03452865|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111293359|NCT03452865|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111293360|NCT03452865|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111293361|NCT03452865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111293362|NCT03452865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111293363|NCT03446001|Methylene Blue|methylene blue|mesh-list
111293364|NCT03446001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111293365|NCT03446001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111293366|NCT03345095|Temozolomide|temozolomide|mesh-list
111293367|NCT03345095|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111293368|NCT03345095|Alkylating Agents|alkylating agents|mesh-ancestor
111293369|NCT03345095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111293370|NCT03345095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111293371|NCT03208231|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
111293372|NCT03208231|Antiviral Agents|antiviral agents|mesh-ancestor
111293373|NCT03208231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111293374|NCT03198000|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111293375|NCT03198000|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111293376|NCT03152058|Certolizumab Pegol|certolizumab pegol|mesh-list
111293377|NCT03152058|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111293378|NCT03152058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111293379|NCT03152058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111293380|NCT03152058|Immunologic Factors|immunologic factors|mesh-ancestor
111293381|NCT03152058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111293382|NCT03152058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111293383|NCT03113617|Gastrin-Releasing Peptide|gastrin-releasing peptide|mesh-list
111293384|NCT03113617|Bombesin|bombesin|mesh-list
111293385|NCT03113617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111293386|NCT03113617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111293387|NCT03113617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111293388|NCT03113617|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111293389|NCT03102242|Atezolizumab|atezolizumab|mesh-list
111293390|NCT03102242|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111293391|NCT03102242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111293392|NCT03102242|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111293393|NCT03102242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111293394|NCT03090776|Ketamine|ketamine|mesh-list
111293395|NCT03090776|Analgesics|analgesics|mesh-ancestor
111293396|NCT03090776|Sensory System Agents|sensory system agents|mesh-ancestor
111293397|NCT03090776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111293398|NCT03090776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111293399|NCT03090776|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111293400|NCT03090776|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111293401|NCT03090776|Anesthetics, General|anesthetics, general|mesh-ancestor
111293402|NCT03090776|Anesthetics|anesthetics|mesh-ancestor
111293403|NCT03090776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111293404|NCT03090776|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111293405|NCT03090776|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111293406|NCT03090776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111293407|NCT03090776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111293408|NCT02994784|Melphalan|melphalan|mesh-list
111293409|NCT02994784|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111293410|NCT02994784|Alkylating Agents|alkylating agents|mesh-ancestor
111293411|NCT02994784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111293412|NCT02994784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111293413|NCT02994784|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111293414|NCT02994784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111293415|NCT02994784|Immunologic Factors|immunologic factors|mesh-ancestor
111293416|NCT02994784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111293417|NCT02966847|Anesthetics|anesthetics|mesh-list
111293418|NCT02966847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111293419|NCT02966847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111293420|NCT02884440|Ropivacaine|ropivacaine|mesh-list
111293421|NCT02884440|Anesthetics|anesthetics|mesh-ancestor
111293422|NCT02884440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111293423|NCT02884440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111017886|NCT02085655|Leprostatic Agents|leprostatic agents|mesh-ancestor
111293424|NCT02884440|Anesthetics, Local|anesthetics, local|mesh-ancestor
111293425|NCT02884440|Sensory System Agents|sensory system agents|mesh-ancestor
111293426|NCT02884440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111293428|NCT02851303|Methadone|methadone|mesh-list
111293429|NCT02851303|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111293430|NCT02851303|Narcotics|narcotics|mesh-ancestor
111293431|NCT02851303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111293432|NCT02851303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111293433|NCT02851303|Analgesics|analgesics|mesh-ancestor
111293434|NCT02851303|Sensory System Agents|sensory system agents|mesh-ancestor
111293435|NCT02851303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111293436|NCT02851303|Antitussive Agents|antitussive agents|mesh-ancestor
111293437|NCT02851303|Respiratory System Agents|respiratory system agents|mesh-ancestor
111293438|NCT02775500|Apremilast|apremilast|mesh-list
111293439|NCT02775500|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111293440|NCT02775500|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111293441|NCT02775500|Analgesics|analgesics|mesh-ancestor
111293442|NCT02775500|Sensory System Agents|sensory system agents|mesh-ancestor
111293443|NCT02775500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111293444|NCT02775500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111293445|NCT02775500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111293446|NCT02775500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111293447|NCT02775500|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
111293448|NCT02775500|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111293449|NCT02775500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111293450|NCT02775500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111293451|NCT02549170|Immunoglobulins|immunoglobulins|mesh-list
111293452|NCT02549170|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111293453|NCT02549170|Antibodies|antibodies|mesh-list
111293454|NCT02549170|Immunoglobulin G|immunoglobulin g|mesh-list
111293455|NCT02549170|gamma-Globulins|gamma-globulins|mesh-list
111293456|NCT02549170|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
111293457|NCT02549170|Immunologic Factors|immunologic factors|mesh-ancestor
111293458|NCT02549170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111293459|NCT02384122|Octreotide|octreotide|mesh-list
111293460|NCT02384122|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111293461|NCT02384122|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111293462|NCT02384122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111293463|NCT02363335|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111293464|NCT02363335|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111293465|NCT02363335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111293466|NCT02363335|Incretins|incretins|mesh-ancestor
111293467|NCT02363335|Hormones|hormones|mesh-ancestor
111293468|NCT02363335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111293469|NCT02363335|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111293470|NCT02363335|Protease Inhibitors|protease inhibitors|mesh-ancestor
111293471|NCT02363335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111293472|NCT02363335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111293473|NCT02271919|Nicotine|nicotine|mesh-list
111293474|NCT02271919|Varenicline|varenicline|mesh-list
111293475|NCT02271919|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111293476|NCT02271919|Autonomic Agents|autonomic agents|mesh-ancestor
111293477|NCT02271919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111293478|NCT02271919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111293479|NCT02271919|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111293480|NCT02271919|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111293481|NCT02271919|Cholinergic Agents|cholinergic agents|mesh-ancestor
111293482|NCT02271919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111293483|NCT02271919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111293484|NCT02103361|Ustekinumab|ustekinumab|mesh-list
111293485|NCT02103361|Dermatologic Agents|dermatologic agents|mesh-ancestor
111293486|NCT01918397|Levofloxacin|levofloxacin|mesh-list
111293487|NCT01918397|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111293488|NCT01918397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111293489|NCT01918397|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111293490|NCT01918397|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111293491|NCT01918397|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110979540|NCT05480566|Autonomic Agents|autonomic agents|mesh-ancestor
111293492|NCT01918397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111293493|NCT01918397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111293494|NCT01918397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111293495|NCT01918397|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111293496|NCT01918397|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111293497|NCT01883024|Insulin|insulin|mesh-list
111293498|NCT01883024|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111293499|NCT01883024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111293500|NCT01611116|Sirolimus|sirolimus|mesh-list
111293501|NCT01611116|Temsirolimus|temsirolimus|mesh-list
111293502|NCT01611116|MTOR Inhibitors|mtor inhibitors|mesh-list
111293503|NCT01611116|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111293504|NCT01611116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111293505|NCT01611116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111293506|NCT01611116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111293507|NCT01611116|Immunologic Factors|immunologic factors|mesh-ancestor
111293508|NCT01611116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111293509|NCT01611116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111293510|NCT01611116|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111293511|NCT01611116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111293512|NCT01611116|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111293513|NCT01611116|Antifungal Agents|antifungal agents|mesh-ancestor
111293514|NCT01576315|Itraconazole|itraconazole|mesh-list
111293515|NCT01576315|Voriconazole|voriconazole|mesh-list
111293516|NCT01576315|Antifungal Agents|antifungal agents|mesh-ancestor
111293517|NCT01576315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111293518|NCT01576315|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111293519|NCT01576315|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111293520|NCT01576315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111293521|NCT01576315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111293522|NCT01576315|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111293523|NCT01576315|Hormone Antagonists|hormone antagonists|mesh-ancestor
111293524|NCT01576315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111293525|NCT01576315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111293526|NCT01576315|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111293527|NCT01388387|Tacrolimus|tacrolimus|mesh-list
111293528|NCT01388387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111293529|NCT01388387|Immunologic Factors|immunologic factors|mesh-ancestor
111293530|NCT01388387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111293531|NCT01388387|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111293532|NCT01388387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111293533|NCT01388387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111293534|NCT01039090|Dopamine|dopamine|mesh-list
111293535|NCT01039090|Apomorphine|apomorphine|mesh-list
111293536|NCT01039090|Dopamine Agonists|dopamine agonists|mesh-list
111293537|NCT01039090|Emetics|emetics|mesh-ancestor
111293538|NCT01039090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111293539|NCT01039090|Autonomic Agents|autonomic agents|mesh-ancestor
111293540|NCT01039090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111293541|NCT01039090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111293542|NCT01039090|Dopamine Agents|dopamine agents|mesh-ancestor
111293543|NCT01039090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111293544|NCT01039090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111293545|NCT01039090|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111293546|NCT01039090|Sympathomimetics|sympathomimetics|mesh-ancestor
111293547|NCT01039090|Protective Agents|protective agents|mesh-ancestor
111293548|NCT00819637|Albuterol|albuterol|mesh-list
111293549|NCT00819637|Formoterol Fumarate|formoterol fumarate|mesh-list
111293550|NCT00819637|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111293551|NCT00819637|Autonomic Agents|autonomic agents|mesh-ancestor
111293552|NCT00819637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111293553|NCT00819637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111293554|NCT00819637|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111293555|NCT00819637|Respiratory System Agents|respiratory system agents|mesh-ancestor
111293556|NCT00819637|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111293557|NCT00819637|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111293558|NCT00819637|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111293559|NCT00819637|Adrenergic Agents|adrenergic agents|mesh-ancestor
111293560|NCT00819637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111293561|NCT00819637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111293562|NCT00819637|Tocolytic Agents|tocolytic agents|mesh-ancestor
111293563|NCT00819637|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111293564|NCT00593060|Sirolimus|sirolimus|mesh-list
111293565|NCT00593060|Cetuximab|cetuximab|mesh-list
111293566|NCT00593060|Temsirolimus|temsirolimus|mesh-list
111293567|NCT00593060|MTOR Inhibitors|mtor inhibitors|mesh-list
111293568|NCT00593060|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111293569|NCT00593060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111293570|NCT00593060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111293571|NCT00593060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111293572|NCT00593060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111293573|NCT00593060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111293574|NCT00593060|Immunologic Factors|immunologic factors|mesh-ancestor
111293575|NCT00593060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111293576|NCT00593060|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111293577|NCT00593060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111293578|NCT00593060|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111293579|NCT00593060|Antifungal Agents|antifungal agents|mesh-ancestor
111293580|NCT00287105|Imatinib Mesylate|imatinib mesylate|mesh-list
111293581|NCT00287105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111293582|NCT00287105|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111293583|NCT00287105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111293584|NCT00287105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111293586|NCT01332357|Xhance|xhance|mesh-list
111293587|NCT01332357|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
111293588|NCT01332357|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
111293589|NCT01332357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111293590|NCT01332357|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111293591|NCT01332357|Autonomic Agents|autonomic agents|mesh-ancestor
111293592|NCT01332357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111293593|NCT01332357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111293594|NCT01332357|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111293595|NCT01332357|Respiratory System Agents|respiratory system agents|mesh-ancestor
111293596|NCT01332357|Dermatologic Agents|dermatologic agents|mesh-ancestor
111293597|NCT01332357|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111293598|NCT01332357|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111293599|NCT01332357|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111293600|NCT01332357|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111293601|NCT01332357|Adrenergic Agents|adrenergic agents|mesh-ancestor
111293602|NCT01332357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111293603|NCT01332357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111293604|NCT01332357|Glucocorticoids|glucocorticoids|mesh-ancestor
111293605|NCT01332357|Hormones|hormones|mesh-ancestor
111293606|NCT01332357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111293607|NCT01332357|Sympathomimetics|sympathomimetics|mesh-ancestor
111293608|NCT04914936|Rifampin|rifampin|mesh-list
111293609|NCT04914936|Acalabrutinib|acalabrutinib|mesh-list
111293610|NCT04914936|Omeprazole|omeprazole|mesh-list
111293611|NCT04914936|Calcium Carbonate|calcium carbonate|mesh-list
111293612|NCT04914936|Calcium|calcium|mesh-list
111293613|NCT04914936|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111293614|NCT04914936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111293615|NCT04914936|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111293616|NCT04914936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111293617|NCT04914936|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111293618|NCT04914936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111293619|NCT04914936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111293620|NCT04914936|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111293621|NCT04914936|Antitubercular Agents|antitubercular agents|mesh-ancestor
111293622|NCT04914936|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111293623|NCT04914936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111293624|NCT04914936|Leprostatic Agents|leprostatic agents|mesh-ancestor
111293625|NCT04914936|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111293626|NCT04914936|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111293627|NCT04914936|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111293628|NCT04914936|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
111293629|NCT04914936|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
111293630|NCT04914936|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
111293631|NCT04914936|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111293632|NCT04914936|Antacids|antacids|mesh-ancestor
111293633|NCT04914936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111293634|NCT04914390|Paclitaxel|paclitaxel|mesh-list
111293635|NCT04914390|Tislelizumab|tislelizumab|mesh-list
111293636|NCT04914390|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111293637|NCT04914390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111293638|NCT04914390|Tubulin Modulators|tubulin modulators|mesh-ancestor
111293639|NCT04914390|Antimitotic Agents|antimitotic agents|mesh-ancestor
111293640|NCT04914390|Mitosis Modulators|mitosis modulators|mesh-ancestor
111293641|NCT04914390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111293642|NCT04914390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111293643|NCT03054948|SMOFlipid|smoflipid|mesh-list
111293644|NCT03054948|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
111293645|NCT03054948|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
111293646|NCT03054948|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111293647|NCT00986921|Mifepristone|mifepristone|mesh-list
111293648|NCT00986921|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
111293650|NCT00986921|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111293651|NCT00986921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111293652|NCT00986921|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111293653|NCT00986921|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111293654|NCT00986921|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111293655|NCT00986921|Contraceptive Agents|contraceptive agents|mesh-ancestor
111293656|NCT00986921|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
111293657|NCT00986921|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
111293658|NCT00986921|Hormone Antagonists|hormone antagonists|mesh-ancestor
111293659|NCT00986921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111293660|NCT00986921|Luteolytic Agents|luteolytic agents|mesh-ancestor
111293661|NCT00986921|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111293662|NCT00986921|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
111293663|NCT01383759|Dexamethasone|dexamethasone|mesh-list
111293664|NCT01383759|Dexamethasone acetate|dexamethasone acetate|mesh-list
111293665|NCT01383759|Bortezomib|bortezomib|mesh-list
111293666|NCT01383759|BB 1101|bb 1101|mesh-list
111293667|NCT01383759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111293668|NCT01383759|Antiemetics|antiemetics|mesh-ancestor
111293669|NCT01383759|Autonomic Agents|autonomic agents|mesh-ancestor
111293670|NCT01383759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111293671|NCT01383759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111293672|NCT01383759|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111293673|NCT01383759|Glucocorticoids|glucocorticoids|mesh-ancestor
111293674|NCT01383759|Hormones|hormones|mesh-ancestor
111293675|NCT01383759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111293676|NCT01383759|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111293677|NCT01383759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111293678|NCT01383759|Protease Inhibitors|protease inhibitors|mesh-ancestor
111293679|NCT01383759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111293680|NCT01383759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111293681|NCT01384539|Cholecalciferol|cholecalciferol|mesh-list
111293682|NCT01384539|Vitamin D|vitamin d|mesh-list
111293683|NCT01384539|Calcitriol|calcitriol|mesh-list
111293684|NCT01384539|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111293685|NCT01384539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111293686|NCT01384539|Vitamins|vitamins|mesh-ancestor
111293687|NCT01384539|Micronutrients|micronutrients|mesh-ancestor
111293688|NCT01384539|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111293689|NCT01384539|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
111293690|NCT01384539|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111293691|NCT01384539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111293692|NCT01384539|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111293693|NCT04902222|Morphine|morphine|mesh-list
111293694|NCT04902222|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111293695|NCT04902222|Narcotics|narcotics|mesh-ancestor
111293696|NCT04902222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111293697|NCT04902222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111293698|NCT04902222|Analgesics|analgesics|mesh-ancestor
111293699|NCT04902222|Sensory System Agents|sensory system agents|mesh-ancestor
111293700|NCT04902222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111293701|NCT04904406|Lamivudine|lamivudine|mesh-list
111293702|NCT04904406|Abacavir|abacavir|mesh-list
111293703|NCT04904406|Dolutegravir|dolutegravir|mesh-list
111293704|NCT04904406|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111293705|NCT04904406|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111293706|NCT04904406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111293707|NCT04904406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111293708|NCT04904406|Antiviral Agents|antiviral agents|mesh-ancestor
111293709|NCT04904406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111293710|NCT04904406|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111293711|NCT04904406|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111293712|NCT04904406|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111293713|NCT04904406|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111293714|NCT00985751|Vaccines|vaccines|mesh-list
111293715|NCT00985751|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
111293716|NCT00985751|Immunologic Factors|immunologic factors|mesh-ancestor
111293717|NCT00985751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111293718|NCT02429557|Midodrine|midodrine|mesh-list
111293719|NCT02429557|Sympathomimetics|sympathomimetics|mesh-ancestor
111018165|NCT02094469|Cilostazol|cilostazol|mesh-list
111293720|NCT02429557|Autonomic Agents|autonomic agents|mesh-ancestor
111293721|NCT02429557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111293722|NCT02429557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111293723|NCT02429557|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111293724|NCT02429557|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111293725|NCT02429557|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111293726|NCT02429557|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111293727|NCT02429557|Adrenergic Agents|adrenergic agents|mesh-ancestor
111293728|NCT02429557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111293729|NCT02429557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111293730|NCT03052140|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111293731|NCT03052140|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111293733|NCT04884516|Vitamins|vitamins|mesh-ancestor
111293734|NCT04884516|Micronutrients|micronutrients|mesh-ancestor
111293735|NCT04884516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111293736|NCT04346329|Hydroxychloroquine|hydroxychloroquine|mesh-list
111293737|NCT04346329|Antimalarials|antimalarials|mesh-ancestor
111293738|NCT04346329|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111293739|NCT04346329|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111293740|NCT04346329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111293741|NCT04346329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111293742|NCT04346329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111293743|NCT04346329|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111293744|NCT02422381|Gemcitabine|gemcitabine|mesh-list
111293745|NCT02422381|Pembrolizumab|pembrolizumab|mesh-list
111293746|NCT02422381|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111293747|NCT02422381|Antimetabolites|antimetabolites|mesh-ancestor
111293748|NCT02422381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111293749|NCT02422381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111293750|NCT02422381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111293751|NCT02422381|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111293752|NCT04883736|Tretinoin|tretinoin|mesh-list
111293753|NCT04883736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111293754|NCT04883736|Keratolytic Agents|keratolytic agents|mesh-ancestor
111293755|NCT04883736|Dermatologic Agents|dermatologic agents|mesh-ancestor
111293756|NCT02312557|Pembrolizumab|pembrolizumab|mesh-list
111293757|NCT02312557|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111293758|NCT02312557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111293759|NCT02312557|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111293760|NCT02312557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111293761|NCT01387815|Adalimumab|adalimumab|mesh-list
111293762|NCT01387815|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111293763|NCT01387815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111293764|NCT01387815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111293765|NCT04883034|Analgesics|analgesics|mesh-list
111293766|NCT04883034|Sensory System Agents|sensory system agents|mesh-ancestor
111293767|NCT04883034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111293768|NCT04883034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111293769|NCT01596504|Metformin|metformin|mesh-list
111293770|NCT01596504|Insulin Glargine|insulin glargine|mesh-list
111293771|NCT01596504|Liraglutide|liraglutide|mesh-list
111293772|NCT01596504|Lixisenatide|lixisenatide|mesh-list
111293773|NCT01596504|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111293774|NCT01596504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111293775|NCT01596504|Incretins|incretins|mesh-ancestor
111293776|NCT01596504|Hormones|hormones|mesh-ancestor
111293777|NCT01596504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111293778|NCT02394769|Aspirin|aspirin|mesh-list
111293779|NCT02394769|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111293780|NCT02394769|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111293781|NCT02394769|Analgesics|analgesics|mesh-ancestor
111293782|NCT02394769|Sensory System Agents|sensory system agents|mesh-ancestor
111293783|NCT02394769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111293784|NCT02394769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111293785|NCT02394769|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111293786|NCT02394769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111293787|NCT02394769|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110746312|NCT03877874|Sympathomimetics|sympathomimetics|mesh-ancestor
111293788|NCT02394769|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111293789|NCT02394769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111293790|NCT02394769|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111018235|NCT02095405|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111018236|NCT02095405|Purinergic Agents|purinergic agents|mesh-ancestor
111018237|NCT02095405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111018243|NCT02096965|Tolvaptan|tolvaptan|mesh-list
111018244|NCT02096965|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
111018255|NCT02095717|Curcumin|curcumin|mesh-list
111293791|NCT02394769|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111293792|NCT02394769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111293793|NCT02394769|Antipyretics|antipyretics|mesh-ancestor
111293794|NCT01334229|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111293795|NCT01334229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111293796|NCT01334229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111293797|NCT01334229|Incretins|incretins|mesh-ancestor
111293798|NCT01334229|Hormones|hormones|mesh-ancestor
111293799|NCT01334229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111293800|NCT01334229|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111293801|NCT01334229|Protease Inhibitors|protease inhibitors|mesh-ancestor
111293802|NCT01334229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111293803|NCT01334229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111293804|NCT01390077|Nitisinone|nitisinone|mesh-list
111293805|NCT01390077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111293806|NCT01390077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111293807|NCT02292979|Doxorubicin|doxorubicin|mesh-list
111293808|NCT02292979|Bleomycin|bleomycin|mesh-list
111293809|NCT02292979|Dacarbazine|dacarbazine|mesh-list
111293810|NCT02292979|Brentuximab Vedotin|brentuximab vedotin|mesh-list
111293811|NCT02292979|Vinblastine|vinblastine|mesh-list
111293812|NCT02292979|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111293813|NCT02292979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111293814|NCT02292979|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111293815|NCT02292979|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111293816|NCT02292979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111293817|NCT02292979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111293818|NCT02292979|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111293819|NCT02292979|Alkylating Agents|alkylating agents|mesh-ancestor
111293820|NCT02292979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111293821|NCT02292979|Immunotoxins|immunotoxins|mesh-ancestor
111293822|NCT02292979|Immunoconjugates|immunoconjugates|mesh-ancestor
111293823|NCT02292979|Immunologic Factors|immunologic factors|mesh-ancestor
111293824|NCT02292979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111293825|NCT02292979|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111293826|NCT02292979|Tubulin Modulators|tubulin modulators|mesh-ancestor
111293827|NCT02292979|Antimitotic Agents|antimitotic agents|mesh-ancestor
111293828|NCT02292979|Mitosis Modulators|mitosis modulators|mesh-ancestor
111293829|NCT02394535|Paclitaxel|paclitaxel|mesh-list
111293830|NCT02394535|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111293831|NCT02394535|Capecitabine|capecitabine|mesh-list
111293832|NCT02394535|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111293833|NCT02394535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111293834|NCT02394535|Tubulin Modulators|tubulin modulators|mesh-ancestor
111293835|NCT02394535|Antimitotic Agents|antimitotic agents|mesh-ancestor
111293836|NCT02394535|Mitosis Modulators|mitosis modulators|mesh-ancestor
111293837|NCT02394535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111293838|NCT02394535|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111293839|NCT02394535|Antimetabolites|antimetabolites|mesh-ancestor
111293840|NCT02285959|Bevacizumab|bevacizumab|mesh-list
111293841|NCT02285959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111293842|NCT02285959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111293843|NCT02285959|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111293844|NCT02285959|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111293845|NCT02285959|Growth Substances|growth substances|mesh-ancestor
111293846|NCT02285959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111293847|NCT02285959|Growth Inhibitors|growth inhibitors|mesh-ancestor
111293848|NCT01404429|Methotrexate|methotrexate|mesh-list
111293849|NCT01404429|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111293850|NCT01404429|Abortifacient Agents|abortifacient agents|mesh-ancestor
111293851|NCT01404429|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111293852|NCT01404429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111293853|NCT01404429|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111293854|NCT01404429|Antimetabolites|antimetabolites|mesh-ancestor
110979544|NCT05480566|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111293855|NCT01404429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111293856|NCT01404429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111293857|NCT01404429|Dermatologic Agents|dermatologic agents|mesh-ancestor
111293858|NCT01404429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111293859|NCT01404429|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111293860|NCT01404429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111293861|NCT01404429|Immunologic Factors|immunologic factors|mesh-ancestor
111293862|NCT01404429|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111293863|NCT01404429|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111293864|NCT03051906|Cetuximab|cetuximab|mesh-list
111293865|NCT03051906|Durvalumab|durvalumab|mesh-list
111293866|NCT03051906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111293867|NCT03051906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111293868|NCT01390233|Dinoprostone|dinoprostone|mesh-list
111293869|NCT01390233|Oxytocics|oxytocics|mesh-ancestor
111293870|NCT01390233|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111293871|NCT01390233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111293872|NCT03051360|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-list
111293873|NCT03051360|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111293874|NCT03051360|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111293875|NCT03051360|Antimetabolites|antimetabolites|mesh-ancestor
111293876|NCT03051360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111293877|NCT03051360|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111293878|NCT03051360|Protease Inhibitors|protease inhibitors|mesh-ancestor
111293879|NCT03051360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111293880|NCT03051360|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111293881|NCT05026567|Midazolam|midazolam|mesh-list
111293882|NCT05026567|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111293883|NCT05026567|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111293884|NCT05026567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111293885|NCT05026567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111293886|NCT05026567|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111293887|NCT05026567|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111293888|NCT05026567|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111293889|NCT05026567|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111293890|NCT05026567|Anesthetics, General|anesthetics, general|mesh-ancestor
111293891|NCT05026567|Anesthetics|anesthetics|mesh-ancestor
111293892|NCT05026567|GABA Modulators|gaba modulators|mesh-ancestor
111293893|NCT05026567|GABA Agents|gaba agents|mesh-ancestor
111293894|NCT05026567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111293895|NCT05026567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111293896|NCT01391013|Ritonavir|ritonavir|mesh-list
111293897|NCT01391013|Darunavir|darunavir|mesh-list
111293898|NCT01391013|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
111293899|NCT01391013|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111293900|NCT01391013|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111293901|NCT01391013|Protease Inhibitors|protease inhibitors|mesh-ancestor
111293902|NCT01391013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111293903|NCT01391013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111293904|NCT01391013|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111293905|NCT01391013|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111293906|NCT01391013|Antiviral Agents|antiviral agents|mesh-ancestor
111293907|NCT01391013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111293908|NCT01391013|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111293909|NCT01391013|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111293910|NCT01391013|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111293911|NCT01891747|Bevacizumab|bevacizumab|mesh-list
111293912|NCT01891747|Temozolomide|temozolomide|mesh-list
111293913|NCT01891747|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111293914|NCT01891747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111293915|NCT01891747|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111293916|NCT01891747|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111293917|NCT01891747|Growth Substances|growth substances|mesh-ancestor
111293918|NCT01891747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111293919|NCT01891747|Growth Inhibitors|growth inhibitors|mesh-ancestor
111293920|NCT01891747|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111293921|NCT01891747|Alkylating Agents|alkylating agents|mesh-ancestor
111293922|NCT01891747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111293923|NCT04899570|Prednisone|prednisone|mesh-list
111293924|NCT04899570|Cyclophosphamide|cyclophosphamide|mesh-list
111293925|NCT04899570|Rituximab|rituximab|mesh-list
111293926|NCT04899570|Epirubicin|epirubicin|mesh-list
111293927|NCT04899570|Zanubrutinib|zanubrutinib|mesh-list
111293928|NCT04899570|Vindesine|vindesine|mesh-list
111293929|NCT04899570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111293930|NCT04899570|Immunologic Factors|immunologic factors|mesh-ancestor
111293931|NCT04899570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111293932|NCT04899570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111293933|NCT04899570|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111293934|NCT04899570|Alkylating Agents|alkylating agents|mesh-ancestor
111293935|NCT04899570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111293936|NCT04899570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111293937|NCT04899570|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111293938|NCT04899570|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111293939|NCT04899570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111293940|NCT04899570|Glucocorticoids|glucocorticoids|mesh-ancestor
111018384|NCT03993717|Vaccines|vaccines|mesh-list
111293941|NCT04899570|Hormones|hormones|mesh-ancestor
111293942|NCT04899570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111293943|NCT04899570|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111293944|NCT04899570|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111293945|NCT04899570|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111293946|NCT04899570|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111293947|NCT04899570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111293948|NCT04899570|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111293949|NCT04899570|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111293950|NCT04899570|Tubulin Modulators|tubulin modulators|mesh-ancestor
111293951|NCT04899570|Antimitotic Agents|antimitotic agents|mesh-ancestor
111293952|NCT04899570|Mitosis Modulators|mitosis modulators|mesh-ancestor
111293953|NCT02274415|Vaccines|vaccines|mesh-list
111293954|NCT02274415|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
111293955|NCT02274415|Immunologic Factors|immunologic factors|mesh-ancestor
111293956|NCT02274415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111293957|NCT03049878|Acetaminophen|acetaminophen|mesh-list
111293958|NCT03049878|Codeine|codeine|mesh-list
111293959|NCT03049878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111293960|NCT03049878|Analgesics|analgesics|mesh-ancestor
111293961|NCT03049878|Sensory System Agents|sensory system agents|mesh-ancestor
111293962|NCT03049878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111293963|NCT03049878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111293964|NCT03049878|Antipyretics|antipyretics|mesh-ancestor
111293965|NCT03049878|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111293966|NCT03049878|Narcotics|narcotics|mesh-ancestor
111293967|NCT03049878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111293968|NCT03049878|Antitussive Agents|antitussive agents|mesh-ancestor
111293969|NCT03049878|Respiratory System Agents|respiratory system agents|mesh-ancestor
111293970|NCT01391325|Allopurinol|allopurinol|mesh-list
111293971|NCT01391325|Antimetabolites|antimetabolites|mesh-ancestor
111293972|NCT01391325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111293973|NCT01391325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111293974|NCT01391325|Gout Suppressants|gout suppressants|mesh-ancestor
111293975|NCT01391325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111293976|NCT01391325|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111293977|NCT01391325|Antioxidants|antioxidants|mesh-ancestor
111293978|NCT01391325|Protective Agents|protective agents|mesh-ancestor
111293979|NCT01391325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111293980|NCT04891458|Dexmedetomidine|dexmedetomidine|mesh-list
111293981|NCT04891458|Anesthetics|anesthetics|mesh-list
111293982|NCT04891458|Propofol|propofol|mesh-list
111293983|NCT04891458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111293984|NCT04891458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111293985|NCT04891458|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111293986|NCT04891458|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111293987|NCT04891458|Analgesics|analgesics|mesh-ancestor
111293988|NCT04891458|Sensory System Agents|sensory system agents|mesh-ancestor
111293989|NCT04891458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111293990|NCT04891458|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111293991|NCT04891458|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111293992|NCT04891458|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111293993|NCT04891458|Adrenergic Agents|adrenergic agents|mesh-ancestor
111293994|NCT04891458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111293995|NCT04891458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111293996|NCT04891458|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111293997|NCT04891458|Anesthetics, General|anesthetics, general|mesh-ancestor
111293998|NCT04899414|Dexamethasone|dexamethasone|mesh-list
111293999|NCT04899414|Azacitidine|azacitidine|mesh-list
111294000|NCT04899414|Tislelizumab|tislelizumab|mesh-list
111294001|NCT04899414|Pegaspargase|pegaspargase|mesh-list
111294002|NCT04899414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111294003|NCT04899414|Antiemetics|antiemetics|mesh-ancestor
110746532|NCT01269866|Analgesics|analgesics|mesh-ancestor
111294004|NCT04899414|Autonomic Agents|autonomic agents|mesh-ancestor
111294005|NCT04899414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111294006|NCT04899414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111294007|NCT04899414|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111294008|NCT04899414|Glucocorticoids|glucocorticoids|mesh-ancestor
111294009|NCT04899414|Hormones|hormones|mesh-ancestor
111294010|NCT04899414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111294011|NCT04899414|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111294012|NCT04899414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111294013|NCT04899414|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111294014|NCT04899414|Antimetabolites|antimetabolites|mesh-ancestor
111294015|NCT04899414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111294016|NCT04899414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111294017|NCT04899414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111294018|NCT03008655|Tranexamic Acid|tranexamic acid|mesh-list
111294019|NCT03008655|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111294020|NCT03008655|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111294021|NCT03008655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111294022|NCT03008655|Hemostatics|hemostatics|mesh-ancestor
111294023|NCT03008655|Coagulants|coagulants|mesh-ancestor
111294024|NCT01894633|Chloroquine|chloroquine|mesh-list
111294025|NCT01894633|Amebicides|amebicides|mesh-ancestor
111294026|NCT01894633|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111294027|NCT01894633|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111294028|NCT01894633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111294029|NCT01894633|Antimalarials|antimalarials|mesh-ancestor
111294030|NCT01894633|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111294031|NCT05585671|Belimumab|belimumab|mesh-list
111294032|NCT05585671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111294033|NCT05585671|Immunologic Factors|immunologic factors|mesh-ancestor
111294034|NCT05585671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111294035|NCT01391559|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
111294036|NCT01391559|Formoterol Fumarate|formoterol fumarate|mesh-list
111294037|NCT01391559|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111294038|NCT01391559|Autonomic Agents|autonomic agents|mesh-ancestor
111294039|NCT01391559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111294040|NCT01391559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111294041|NCT01391559|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111294042|NCT01391559|Respiratory System Agents|respiratory system agents|mesh-ancestor
111294043|NCT01391559|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111294044|NCT01391559|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111294045|NCT01391559|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111294046|NCT01391559|Adrenergic Agents|adrenergic agents|mesh-ancestor
111294047|NCT01391559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111294048|NCT01391559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111294049|NCT01335789|Oxytocin|oxytocin|mesh-list
111294050|NCT01335789|Oxytocics|oxytocics|mesh-ancestor
111294051|NCT01335789|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111294052|NCT01335789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111294053|NCT02202135|Vancomycin|vancomycin|mesh-list
111294054|NCT02202135|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
111294055|NCT02202135|Aztreonam|aztreonam|mesh-list
111294056|NCT02202135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111294057|NCT02202135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111294058|NCT05585281|Fluzoparib|fluzoparib|mesh-list
111294059|NCT05585281|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111294060|NCT05585281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111294061|NCT05585281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111294062|NCT05585281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111294063|NCT01335867|Vigabatrin|vigabatrin|mesh-list
111294064|NCT01335867|Anticonvulsants|anticonvulsants|mesh-ancestor
111294065|NCT01335867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111294066|NCT01335867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111294067|NCT01335867|GABA Agents|gaba agents|mesh-ancestor
111294068|NCT01335867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111294069|NCT01335867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111294070|NCT01894711|Trastuzumab|trastuzumab|mesh-list
111294071|NCT01894711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111294072|NCT01894711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111294073|NCT00985439|Celecoxib|celecoxib|mesh-list
111294074|NCT00985439|Diclofenac|diclofenac|mesh-list
111294075|NCT00985439|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111294076|NCT00985439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111294077|NCT00985439|Analgesics|analgesics|mesh-ancestor
111294078|NCT00985439|Sensory System Agents|sensory system agents|mesh-ancestor
111294079|NCT00985439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111294080|NCT00985439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111294081|NCT00985439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111294082|NCT00985439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111294083|NCT00985439|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111294084|NCT00985439|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111294085|NCT00985439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111294086|NCT00985439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111294087|NCT02984111|Epoetin Alfa|epoetin alfa|mesh-list
111294088|NCT02984111|Hematinics|hematinics|mesh-ancestor
111294089|NCT04412148|Triamcinolone|triamcinolone|mesh-list
111018542|NCT05052008|Erenumab|erenumab|mesh-list
111294090|NCT04412148|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
111294091|NCT04412148|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
111294092|NCT04412148|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
111294093|NCT04412148|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111294094|NCT04412148|Glucocorticoids|glucocorticoids|mesh-ancestor
111294095|NCT04412148|Hormones|hormones|mesh-ancestor
111294096|NCT04412148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111294097|NCT04412148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111294098|NCT04412148|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111294099|NCT04412148|Immunologic Factors|immunologic factors|mesh-ancestor
111294100|NCT04412148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111294101|NCT04412148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111294102|NCT04890522|Gemcitabine|gemcitabine|mesh-list
111294103|NCT04890522|Fluorouracil|fluorouracil|mesh-list
111294104|NCT04890522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111294105|NCT04890522|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111294106|NCT04890522|Antimetabolites|antimetabolites|mesh-ancestor
111294107|NCT04890522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111294108|NCT04890522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111294109|NCT04890522|Immunologic Factors|immunologic factors|mesh-ancestor
111294110|NCT04890522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111294111|NCT01525069|Dexamethasone|dexamethasone|mesh-list
111294112|NCT01525069|Gemcitabine|gemcitabine|mesh-list
111294113|NCT01525069|Oxaliplatin|oxaliplatin|mesh-list
111294114|NCT01525069|Floxuridine|floxuridine|mesh-list
111294115|NCT01525069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111294116|NCT01525069|Antiemetics|antiemetics|mesh-ancestor
111294117|NCT01525069|Autonomic Agents|autonomic agents|mesh-ancestor
111294118|NCT01525069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111294119|NCT01525069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111294120|NCT01525069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111294121|NCT01525069|Glucocorticoids|glucocorticoids|mesh-ancestor
111294122|NCT01525069|Hormones|hormones|mesh-ancestor
111294123|NCT01525069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111294124|NCT01525069|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111294125|NCT01525069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111294126|NCT01525069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111294127|NCT01525069|Antimetabolites|antimetabolites|mesh-ancestor
111294128|NCT01525069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111294129|NCT04898946|Vaccines|vaccines|mesh-list
111294130|NCT04898946|Immunologic Factors|immunologic factors|mesh-ancestor
111294131|NCT04898946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111294132|NCT02249065|Brimonidine Tartrate|brimonidine tartrate|mesh-list
111294133|NCT02249065|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111294134|NCT02249065|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111294135|NCT02249065|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111294136|NCT02249065|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111294137|NCT02249065|Adrenergic Agents|adrenergic agents|mesh-ancestor
111294138|NCT02249065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111294139|NCT02249065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111294140|NCT02249065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111294141|NCT00983957|Moxifloxacin|moxifloxacin|mesh-list
111294142|NCT00983957|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
111294143|NCT00983957|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111294144|NCT00983957|Contraceptive Agents|contraceptive agents|mesh-ancestor
111294145|NCT00983957|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111294146|NCT00983957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111294147|NCT00983957|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
111294148|NCT00983957|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111294149|NCT00983957|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111294150|NCT00983957|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111294151|NCT00983957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111294152|NCT00983957|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111294153|NCT00983957|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111294154|NCT00983957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111294155|NCT00983957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111294156|NCT00983957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111294157|NCT01894867|Magnesium Oxide|magnesium oxide|mesh-list
111294158|NCT01894867|Antacids|antacids|mesh-ancestor
111294159|NCT01894867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111294160|NCT01894867|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111294161|NCT01521403|Metronidazole|metronidazole|mesh-list
111294162|NCT01521403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111294163|NCT01521403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111294164|NCT01521403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111294165|NCT01521403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111018614|NCT02103049|Ezetimibe|ezetimibe|mesh-list
111294167|NCT04881942|Nicotine|nicotine|mesh-list
111294168|NCT04881942|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111294169|NCT04881942|Autonomic Agents|autonomic agents|mesh-ancestor
111294170|NCT04881942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111294171|NCT04881942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111294172|NCT04881942|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111294173|NCT04881942|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111294174|NCT04881942|Cholinergic Agents|cholinergic agents|mesh-ancestor
111294175|NCT04881942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111294176|NCT04881942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111294177|NCT04881942|Antipruritics|antipruritics|mesh-ancestor
111294178|NCT04881942|Dermatologic Agents|dermatologic agents|mesh-ancestor
111294179|NCT04882020|Hydrocortisone|hydrocortisone|mesh-list
111294180|NCT04882020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111294181|NCT04126811|Apatinib|apatinib|mesh-list
111294182|NCT04126811|Ifosfamide|ifosfamide|mesh-list
111294183|NCT04126811|Isophosphamide mustard|isophosphamide mustard|mesh-list
111294184|NCT04126811|Pirarubicin|pirarubicin|mesh-list
111294185|NCT04126811|Doxorubicin|doxorubicin|mesh-list
111294186|NCT04126811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111294187|NCT04126811|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111294188|NCT04126811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111294189|NCT04126811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111294190|NCT04126811|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111294191|NCT04126811|Alkylating Agents|alkylating agents|mesh-ancestor
111294192|NCT04126811|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111294193|NCT04126811|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111294194|NCT04126811|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111294195|NCT01406223|Bupropion|bupropion|mesh-list
111294196|NCT01406223|Nicotine|nicotine|mesh-list
111294197|NCT01406223|Varenicline|varenicline|mesh-list
111294198|NCT01406223|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111294199|NCT01406223|Autonomic Agents|autonomic agents|mesh-ancestor
111294200|NCT01406223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111294201|NCT01406223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111294202|NCT01406223|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111294203|NCT01406223|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111294204|NCT01406223|Cholinergic Agents|cholinergic agents|mesh-ancestor
111294205|NCT01406223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111294206|NCT01406223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111294207|NCT01406223|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111294208|NCT01406223|Antidepressive Agents|antidepressive agents|mesh-ancestor
111294209|NCT01406223|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111294210|NCT01406223|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111294211|NCT01406223|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111294212|NCT01406223|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111294213|NCT01406223|Dopamine Agents|dopamine agents|mesh-ancestor
111294214|NCT01406223|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111294215|NCT01406223|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111294216|NCT01406223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111294217|NCT02230969|Interferons|interferons|mesh-list
111294218|NCT02230969|Interferon-beta|interferon-beta|mesh-list
111294219|NCT02230969|Interferon beta-1a|interferon beta-1a|mesh-list
111294220|NCT02230969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111294221|NCT02230969|Antiviral Agents|antiviral agents|mesh-ancestor
111294222|NCT02230969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111294223|NCT02230969|Immunologic Factors|immunologic factors|mesh-ancestor
111294224|NCT02230969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111294225|NCT02230969|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111294226|NCT04881474|Ibuprofen|ibuprofen|mesh-list
111294227|NCT04881474|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111294228|NCT04881474|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111294229|NCT04881474|Analgesics|analgesics|mesh-ancestor
111294230|NCT04881474|Sensory System Agents|sensory system agents|mesh-ancestor
111294231|NCT04881474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111294232|NCT04881474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111294233|NCT04881474|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111294234|NCT04881474|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111294235|NCT04881474|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111294236|NCT04881474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111294237|NCT04881474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111294238|NCT00981149|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
111294239|NCT00981149|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111294240|NCT00981149|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111294241|NCT00981149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111294242|NCT00981149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111294243|NCT00981149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111294244|NCT00981149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111294245|NCT00981149|Analgesics|analgesics|mesh-ancestor
111294246|NCT00981149|Sensory System Agents|sensory system agents|mesh-ancestor
111294247|NCT00981149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111294248|NCT00981149|Antidepressive Agents|antidepressive agents|mesh-ancestor
111294249|NCT00981149|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111294250|NCT00981149|Dopamine Agents|dopamine agents|mesh-ancestor
111294251|NCT04881006|Dapagliflozin|dapagliflozin|mesh-list
111294252|NCT04881006|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111294253|NCT04881006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111294254|NCT04881006|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111294255|NCT04881006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111294257|NCT01595646|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111294258|NCT01595646|Insulin Detemir|insulin detemir|mesh-list
111294259|NCT01595646|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111294260|NCT01595646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111294261|NCT01907191|Bupivacaine|bupivacaine|mesh-list
111294262|NCT01907191|Anesthetics, Local|anesthetics, local|mesh-ancestor
111294263|NCT01907191|Anesthetics|anesthetics|mesh-ancestor
111294264|NCT01907191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111294265|NCT01907191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111294266|NCT01907191|Sensory System Agents|sensory system agents|mesh-ancestor
111294267|NCT01907191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111294268|NCT01395537|Paclitaxel|paclitaxel|mesh-list
111294269|NCT01395537|Carboplatin|carboplatin|mesh-list
111294270|NCT01395537|Lapatinib|lapatinib|mesh-list
111294271|NCT01395537|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111294272|NCT01395537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111294273|NCT01395537|Tubulin Modulators|tubulin modulators|mesh-ancestor
111294274|NCT01395537|Antimitotic Agents|antimitotic agents|mesh-ancestor
111294275|NCT01395537|Mitosis Modulators|mitosis modulators|mesh-ancestor
111294276|NCT01395537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111294277|NCT01395537|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111294278|NCT01395537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111294279|NCT04898712|Tranexamic Acid|tranexamic acid|mesh-list
111294280|NCT04898712|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111294281|NCT04898712|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111294282|NCT04898712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111294283|NCT04898712|Hemostatics|hemostatics|mesh-ancestor
111294284|NCT04898712|Coagulants|coagulants|mesh-ancestor
111294285|NCT04898556|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
111294286|NCT04898556|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111294287|NCT04898556|Immunologic Factors|immunologic factors|mesh-ancestor
111294288|NCT04898556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111294289|NCT02317549|Tranexamic Acid|tranexamic acid|mesh-list
111294290|NCT02317549|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111294291|NCT02317549|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111294292|NCT02317549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111294293|NCT02317549|Hemostatics|hemostatics|mesh-ancestor
111294294|NCT02317549|Coagulants|coagulants|mesh-ancestor
111294295|NCT05583643|Calcium, Dietary|calcium, dietary|mesh-list
111294296|NCT05583643|Atorvastatin|atorvastatin|mesh-list
111294297|NCT05583643|Calcium|calcium|mesh-list
111294298|NCT05583643|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111294299|NCT05583643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111294300|NCT05583643|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111294301|NCT05583643|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111294302|NCT05583643|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111294303|NCT05583643|Antimetabolites|antimetabolites|mesh-ancestor
111294304|NCT05583643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111294305|NCT05583643|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111294306|NCT05583643|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111294307|NCT05583643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111294308|NCT02225275|Lenalidomide|lenalidomide|mesh-list
111294309|NCT02225275|Obinutuzumab|obinutuzumab|mesh-list
111294310|NCT02225275|Immunologic Factors|immunologic factors|mesh-ancestor
111294311|NCT02225275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111294312|NCT02225275|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111294313|NCT02225275|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111294314|NCT02225275|Growth Substances|growth substances|mesh-ancestor
111018758|NCT04718805|Darunavir|darunavir|mesh-list
111294315|NCT02225275|Growth Inhibitors|growth inhibitors|mesh-ancestor
111294316|NCT02225275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111294317|NCT02225275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111294318|NCT01897441|Paclitaxel|paclitaxel|mesh-list
111294319|NCT01897441|Cyclophosphamide|cyclophosphamide|mesh-list
111294320|NCT01897441|Doxorubicin|doxorubicin|mesh-list
111294321|NCT01897441|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111294322|NCT01897441|Trastuzumab|trastuzumab|mesh-list
111294323|NCT01897441|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111294324|NCT01897441|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111294325|NCT01897441|Antibodies|antibodies|mesh-list
111294326|NCT01897441|Immunoglobulins|immunoglobulins|mesh-list
111294327|NCT01897441|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111294328|NCT01897441|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111294329|NCT01897441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111294330|NCT01897441|Tubulin Modulators|tubulin modulators|mesh-ancestor
111294331|NCT01897441|Antimitotic Agents|antimitotic agents|mesh-ancestor
111294332|NCT01897441|Mitosis Modulators|mitosis modulators|mesh-ancestor
111294333|NCT01897441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111294334|NCT01897441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111294335|NCT01897441|Immunologic Factors|immunologic factors|mesh-ancestor
111294336|NCT01897441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111294337|NCT01897441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111294338|NCT01897441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111294339|NCT01897441|Alkylating Agents|alkylating agents|mesh-ancestor
111294340|NCT01897441|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111294341|NCT01897441|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111294342|NCT01897441|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111294343|NCT01897441|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111294344|NCT01897441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111294345|NCT01411137|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
111294346|NCT01411137|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111294347|NCT01411137|Immunologic Factors|immunologic factors|mesh-ancestor
111294348|NCT01411137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111294349|NCT01411137|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111294350|NCT01411137|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111294351|NCT01411137|Dopamine Agonists|dopamine agonists|mesh-ancestor
111294352|NCT01411137|Dopamine Agents|dopamine agents|mesh-ancestor
111294353|NCT01411137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111294354|NCT01411137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111294355|NCT04430556|Sertraline|sertraline|mesh-list
111294356|NCT04430556|Antidepressive Agents|antidepressive agents|mesh-ancestor
111294357|NCT04430556|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111294358|NCT04430556|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111294359|NCT04430556|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111294360|NCT04430556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111294361|NCT04430556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111294362|NCT04430556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111294363|NCT04430556|Serotonin Agents|serotonin agents|mesh-ancestor
111294364|NCT04430556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111294365|NCT04897854|Folfirinox|folfirinox|mesh-list
111294366|NCT04897854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111294367|NCT01892527|Cetuximab|cetuximab|mesh-list
111294368|NCT01892527|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111294369|NCT01892527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111294370|NCT01399827|Methylphenidate|methylphenidate|mesh-list
111294371|NCT01399827|Amphetamine|amphetamine|mesh-list
111294372|NCT01399827|Adderall|adderall|mesh-list
111294373|NCT01399827|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
111294374|NCT01399827|Dextroamphetamine|dextroamphetamine|mesh-list
111294375|NCT01399827|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
111294376|NCT01399827|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111294377|NCT01399827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111294378|NCT01399827|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111294379|NCT01399827|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111294380|NCT01399827|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111294381|NCT01399827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111294382|NCT01399827|Dopamine Agents|dopamine agents|mesh-ancestor
111294383|NCT01399827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111294384|NCT01399827|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111294385|NCT01399827|Adrenergic Agents|adrenergic agents|mesh-ancestor
111294386|NCT01399827|Sympathomimetics|sympathomimetics|mesh-ancestor
111294387|NCT01399827|Autonomic Agents|autonomic agents|mesh-ancestor
111294388|NCT01399827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111294389|NCT04897386|Pemetrexed|pemetrexed|mesh-list
111294390|NCT04897386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111294391|NCT04897386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111294392|NCT04897386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111294393|NCT04897386|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111294394|NCT04897386|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111294395|NCT04879446|Mitogens|mitogens|mesh-list
111294396|NCT04879446|Mitosis Modulators|mitosis modulators|mesh-ancestor
111294397|NCT04879446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111294398|NCT02618382|Tranexamic Acid|tranexamic acid|mesh-list
111294399|NCT02618382|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111294400|NCT02618382|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111294401|NCT02618382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111294402|NCT02618382|Hemostatics|hemostatics|mesh-ancestor
111294403|NCT02618382|Coagulants|coagulants|mesh-ancestor
111294404|NCT02196961|Nivolumab|nivolumab|mesh-list
111294405|NCT02196961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111294406|NCT02196961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111294407|NCT02196961|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111294408|NCT02196961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111294409|NCT02177071|Infliximab|infliximab|mesh-list
111294410|NCT02177071|Methotrexate|methotrexate|mesh-list
111294411|NCT02177071|Mercaptopurine|mercaptopurine|mesh-list
111294412|NCT02177071|Azathioprine|azathioprine|mesh-list
111294413|NCT02177071|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111294414|NCT02177071|Abortifacient Agents|abortifacient agents|mesh-ancestor
111294415|NCT02177071|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111294416|NCT02177071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111294417|NCT02177071|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111294418|NCT02177071|Antimetabolites|antimetabolites|mesh-ancestor
111294419|NCT02177071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111294420|NCT02177071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111294421|NCT02177071|Dermatologic Agents|dermatologic agents|mesh-ancestor
111294422|NCT02177071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111294423|NCT02177071|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111294424|NCT02177071|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111294425|NCT02177071|Immunologic Factors|immunologic factors|mesh-ancestor
111294426|NCT02177071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111294427|NCT02177071|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111294428|NCT02177071|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111294429|NCT02177071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111294430|NCT02177071|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111294431|NCT04889196|Fluorides|fluorides|mesh-list
111294432|NCT04889196|Cariostatic Agents|cariostatic agents|mesh-ancestor
111294433|NCT04889196|Protective Agents|protective agents|mesh-ancestor
111294434|NCT04889196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111294435|NCT03049176|Tenofovir|tenofovir|mesh-list
111294436|NCT03049176|Emtricitabine|emtricitabine|mesh-list
111294437|NCT03049176|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
111294438|NCT03049176|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
111294439|NCT03049176|Antiviral Agents|antiviral agents|mesh-ancestor
111294440|NCT03049176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111294441|NCT03049176|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111294442|NCT03049176|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111294443|NCT03049176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111294444|NCT03049176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111294445|NCT03049176|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111294446|NCT01895023|Midazolam|midazolam|mesh-list
111294447|NCT01895023|Dexmedetomidine|dexmedetomidine|mesh-list
111294448|NCT01895023|GABA Modulators|gaba modulators|mesh-list
111294449|NCT01895023|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111294450|NCT01895023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111294451|NCT01895023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111294452|NCT01895023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111294453|NCT01895023|Analgesics|analgesics|mesh-ancestor
111294454|NCT01895023|Sensory System Agents|sensory system agents|mesh-ancestor
111294455|NCT01895023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111294456|NCT01895023|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111294457|NCT01895023|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111294458|NCT01895023|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111294459|NCT01895023|Adrenergic Agents|adrenergic agents|mesh-ancestor
111294460|NCT01895023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111294461|NCT01895023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111294462|NCT01895023|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111294463|NCT01895023|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111294464|NCT01895023|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111294465|NCT01895023|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111294466|NCT01895023|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111294467|NCT01895023|Anesthetics, General|anesthetics, general|mesh-ancestor
111294468|NCT01895023|Anesthetics|anesthetics|mesh-ancestor
111294469|NCT01895023|GABA Agents|gaba agents|mesh-ancestor
111294470|NCT04888728|Nebivolol|nebivolol|mesh-list
111294471|NCT04888728|Paroxetine|paroxetine|mesh-list
111294472|NCT04888728|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111294473|NCT04888728|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111294474|NCT04888728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111294475|NCT04888728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111294476|NCT04888728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111294477|NCT04888728|Serotonin Agents|serotonin agents|mesh-ancestor
111294478|NCT04888728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111294479|NCT04888728|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111294480|NCT04888728|Antidepressive Agents|antidepressive agents|mesh-ancestor
111294481|NCT04888728|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111294482|NCT04888728|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111294483|NCT04888728|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111294484|NCT04888728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111294485|NCT04888728|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111294486|NCT04888728|Vasodilator Agents|vasodilator agents|mesh-ancestor
111294487|NCT04888728|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
111294488|NCT04888728|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111294489|NCT04888728|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111294490|NCT04888728|Adrenergic Agents|adrenergic agents|mesh-ancestor
111294491|NCT04125719|Nivolumab|nivolumab|mesh-list
111294492|NCT04125719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111294493|NCT04125719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111294494|NCT04125719|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111294495|NCT04125719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111294496|NCT01428973|Mycophenolic Acid|mycophenolic acid|mesh-list
111294497|NCT01428973|Sirolimus|sirolimus|mesh-list
111294498|NCT01428973|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111294499|NCT01428973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111294500|NCT01428973|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111294501|NCT01428973|Antitubercular Agents|antitubercular agents|mesh-ancestor
111294502|NCT01428973|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111294503|NCT01428973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111294504|NCT01428973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111294505|NCT01428973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111294506|NCT01428973|Antifungal Agents|antifungal agents|mesh-ancestor
111294507|NCT01428973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111294508|NCT01428973|Immunologic Factors|immunologic factors|mesh-ancestor
111294509|NCT01428973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111294510|NCT01421797|Dexamethasone|dexamethasone|mesh-list
111294511|NCT01421797|Cosyntropin|cosyntropin|mesh-list
111294512|NCT01421797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111294513|NCT01421797|Antiemetics|antiemetics|mesh-ancestor
111294514|NCT01421797|Autonomic Agents|autonomic agents|mesh-ancestor
111294515|NCT01421797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111294516|NCT01421797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111294517|NCT01421797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111294518|NCT01421797|Glucocorticoids|glucocorticoids|mesh-ancestor
111294519|NCT01421797|Hormones|hormones|mesh-ancestor
111294520|NCT01421797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111294521|NCT01421797|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111294522|NCT01421797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111294523|NCT01475643|Loteprednol Etabonate|loteprednol etabonate|mesh-list
111294524|NCT01475643|Prednisolone|prednisolone|mesh-list
111294525|NCT01475643|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111294526|NCT01475643|Methylprednisolone|methylprednisolone|mesh-list
111294527|NCT01475643|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111294528|NCT01475643|Prednisolone acetate|prednisolone acetate|mesh-list
111294529|NCT01475643|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111294530|NCT01475643|Prednisolone phosphate|prednisolone phosphate|mesh-list
111294531|NCT01475643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111294532|NCT01475643|Glucocorticoids|glucocorticoids|mesh-ancestor
111294533|NCT01475643|Hormones|hormones|mesh-ancestor
111294534|NCT01475643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111294535|NCT01475643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111294536|NCT01475643|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111294537|NCT01475643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111294538|NCT01475643|Antiemetics|antiemetics|mesh-ancestor
111294539|NCT01475643|Autonomic Agents|autonomic agents|mesh-ancestor
111294540|NCT01475643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111294541|NCT01475643|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111294542|NCT01475643|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111294543|NCT01475643|Protective Agents|protective agents|mesh-ancestor
111294544|NCT01475643|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111294545|NCT01846663|Rifaximin|rifaximin|mesh-list
111294546|NCT01846663|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111294547|NCT01846663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111294548|NCT01846663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111294549|NCT03004001|Atorvastatin|atorvastatin|mesh-list
111294550|NCT03004001|Alirocumab|alirocumab|mesh-list
111294551|NCT03004001|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111294552|NCT03004001|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111294553|NCT03004001|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111294554|NCT03004001|Antimetabolites|antimetabolites|mesh-ancestor
111294555|NCT03004001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111294556|NCT03004001|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111294557|NCT03004001|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111294558|NCT03004001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111294559|NCT03004001|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
111294560|NCT03004001|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111294561|NCT03004001|Protease Inhibitors|protease inhibitors|mesh-ancestor
111294562|NCT03004001|Immunologic Factors|immunologic factors|mesh-ancestor
111294563|NCT03004001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111294564|NCT04124003|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111294565|NCT04124003|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111294566|NCT04124003|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111294567|NCT04124003|Antimetabolites|antimetabolites|mesh-ancestor
111294568|NCT04124003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111294569|NCT04124003|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111294570|NCT04124003|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111294571|NCT04124003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111294572|NCT03237377|Durvalumab|durvalumab|mesh-list
111294573|NCT03237377|Tremelimumab|tremelimumab|mesh-list
111294574|NCT03237377|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111294575|NCT03237377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111294576|NCT04124081|Entecavir|entecavir|mesh-list
111294577|NCT04124081|Antiviral Agents|antiviral agents|mesh-ancestor
111294578|NCT04124081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111294579|NCT04123925|Nivolumab|nivolumab|mesh-list
111294580|NCT04123925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111294581|NCT04123925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111294582|NCT04123925|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111294583|NCT04123925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111294584|NCT04759079|Antiemetics|antiemetics|mesh-list
111294585|NCT04759079|Autonomic Agents|autonomic agents|mesh-ancestor
111294586|NCT04759079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111294587|NCT04759079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111294588|NCT04759079|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111294589|NCT03048942|Paclitaxel|paclitaxel|mesh-list
111294590|NCT03048942|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111294591|NCT03048942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111294592|NCT03048942|Tubulin Modulators|tubulin modulators|mesh-ancestor
111294593|NCT03048942|Antimitotic Agents|antimitotic agents|mesh-ancestor
111294594|NCT03048942|Mitosis Modulators|mitosis modulators|mesh-ancestor
111294595|NCT03048942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111294596|NCT04393025|Clopidogrel|clopidogrel|mesh-list
111294597|NCT04393025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111294598|NCT04393025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111294599|NCT04393025|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111294600|NCT04393025|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111294601|NCT04393025|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111294602|NCT04393025|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111294603|NCT04393025|Purinergic Agents|purinergic agents|mesh-ancestor
111294604|NCT04393025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111294605|NCT05580445|Gemcitabine|gemcitabine|mesh-list
111294606|NCT05580445|Conteltinib|conteltinib|mesh-list
111294607|NCT05580445|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111294608|NCT05580445|Antimetabolites|antimetabolites|mesh-ancestor
111294609|NCT05580445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111294610|NCT05580445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111294611|NCT05580445|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111294612|NCT05580445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111294613|NCT05257902|Choline|choline|mesh-list
111294615|NCT05257902|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111294616|NCT05257902|Antimetabolites|antimetabolites|mesh-ancestor
111294617|NCT05257902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111294618|NCT05257902|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111294619|NCT05257902|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111294620|NCT05257902|Nootropic Agents|nootropic agents|mesh-ancestor
111294621|NCT02143219|Leucovorin|leucovorin|mesh-list
111294622|NCT02143219|Folic Acid|folic acid|mesh-list
111294623|NCT02143219|Irinotecan|irinotecan|mesh-list
111294624|NCT02143219|Oxaliplatin|oxaliplatin|mesh-list
111294625|NCT02143219|Levoleucovorin|levoleucovorin|mesh-list
111294626|NCT02143219|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111294627|NCT02143219|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111294628|NCT02143219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111294629|NCT02143219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111294630|NCT02143219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111294631|NCT02143219|Antidotes|antidotes|mesh-ancestor
111294632|NCT02143219|Protective Agents|protective agents|mesh-ancestor
111294633|NCT02143219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111294634|NCT02143219|Vitamin B Complex|vitamin b complex|mesh-ancestor
111294635|NCT02143219|Vitamins|vitamins|mesh-ancestor
111294636|NCT02143219|Micronutrients|micronutrients|mesh-ancestor
111294637|NCT02143219|Hematinics|hematinics|mesh-ancestor
111294638|NCT04122911|Temozolomide|temozolomide|mesh-list
111294639|NCT04122911|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111294640|NCT04122911|Alkylating Agents|alkylating agents|mesh-ancestor
111294641|NCT04122911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111294642|NCT04122911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111294643|NCT04122599|Melatonin|melatonin|mesh-list
111294644|NCT04122599|Antioxidants|antioxidants|mesh-ancestor
111294645|NCT04122599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111294646|NCT04122599|Protective Agents|protective agents|mesh-ancestor
111294647|NCT04122599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111294648|NCT04122599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111294649|NCT01475955|Aminolevulinic Acid|aminolevulinic acid|mesh-list
111294650|NCT01475955|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111294651|NCT01475955|Dermatologic Agents|dermatologic agents|mesh-ancestor
111294652|NCT03048474|Nivolumab|nivolumab|mesh-list
111294653|NCT03048474|Ipilimumab|ipilimumab|mesh-list
111294654|NCT03048474|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111294655|NCT03048474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111294656|NCT03048474|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111294657|NCT03048474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111294658|NCT04121975|Endostar protein|endostar protein|mesh-list
111294659|NCT04121975|Endostatins|endostatins|mesh-list
111294660|NCT04121975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111294661|NCT04121975|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111294662|NCT04121975|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111294663|NCT04121975|Growth Substances|growth substances|mesh-ancestor
111294664|NCT04121975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111294665|NCT04121975|Growth Inhibitors|growth inhibitors|mesh-ancestor
111294666|NCT02139319|Botulinum Toxins|botulinum toxins|mesh-list
111294667|NCT02139319|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111294668|NCT02139319|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111294669|NCT02139319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111294670|NCT02139319|Cholinergic Agents|cholinergic agents|mesh-ancestor
111294671|NCT02139319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111294672|NCT02139319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111294673|NCT03830957|Metoprolol|metoprolol|mesh-list
111294674|NCT03830957|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111294675|NCT03830957|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111294676|NCT03830957|Sympatholytics|sympatholytics|mesh-ancestor
111294677|NCT03830957|Autonomic Agents|autonomic agents|mesh-ancestor
111294678|NCT03830957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111294679|NCT03830957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111294680|NCT03830957|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
111294681|NCT03830957|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111294682|NCT03830957|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111294683|NCT03830957|Adrenergic Agents|adrenergic agents|mesh-ancestor
111294684|NCT03830957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111294685|NCT03830957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111294686|NCT04121819|Cytarabine|cytarabine|mesh-list
111294687|NCT04121819|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111294688|NCT04121819|Antimetabolites|antimetabolites|mesh-ancestor
111294689|NCT04121819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111294690|NCT04121819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111294692|NCT04121819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111294693|NCT04121819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111294694|NCT04121819|Immunologic Factors|immunologic factors|mesh-ancestor
111294695|NCT04121819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111294696|NCT01476267|Dalcetrapib|dalcetrapib|mesh-list
111294697|NCT01476267|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111294698|NCT01476267|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111294699|NCT01476267|Antimetabolites|antimetabolites|mesh-ancestor
111294700|NCT01476267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111294701|NCT01476267|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111294702|NCT05189730|Paclitaxel|paclitaxel|mesh-list
111294703|NCT05189730|Carboplatin|carboplatin|mesh-list
111294704|NCT05189730|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111294705|NCT05189730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111294706|NCT05189730|Tubulin Modulators|tubulin modulators|mesh-ancestor
111294707|NCT05189730|Antimitotic Agents|antimitotic agents|mesh-ancestor
111294708|NCT05189730|Mitosis Modulators|mitosis modulators|mesh-ancestor
111294709|NCT05189730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111294710|NCT04121273|Immunomodulating Agents|immunomodulating agents|mesh-list
111294711|NCT04121273|Immunologic Factors|immunologic factors|mesh-ancestor
111294712|NCT04121273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111294713|NCT01476345|Insulin Glargine|insulin glargine|mesh-list
111294714|NCT01476345|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111294715|NCT01476345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111294716|NCT04121039|Apatinib|apatinib|mesh-list
111294717|NCT04121039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111294718|NCT04121039|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111294719|NCT04121039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111294720|NCT04121039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111294721|NCT01401543|Tadalafil|tadalafil|mesh-list
111294722|NCT01401543|Vasodilator Agents|vasodilator agents|mesh-ancestor
111294723|NCT01401543|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111294724|NCT01401543|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111294725|NCT01401543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111294726|NCT01401543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111294727|NCT01401543|Urological Agents|urological agents|mesh-ancestor
111294728|NCT04120259|Metformin|metformin|mesh-list
111294729|NCT04120259|Acetic Acid|acetic acid|mesh-list
111294730|NCT04120259|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111294731|NCT04120259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111294732|NCT04120259|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111294733|NCT04120259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111294734|NCT04392102|Niraparib|niraparib|mesh-list
111294735|NCT04392102|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111294736|NCT04392102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111294737|NCT04392102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111294738|NCT04392102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111294739|NCT05256342|Etoricoxib|etoricoxib|mesh-list
111294740|NCT05256342|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
111294741|NCT05256342|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111294742|NCT05256342|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111294743|NCT05256342|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111294744|NCT05256342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111294745|NCT05256342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111294746|NCT05256342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111294747|NCT05256342|Analgesics|analgesics|mesh-ancestor
111294748|NCT05256342|Sensory System Agents|sensory system agents|mesh-ancestor
111294749|NCT05256342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111294750|NCT05256342|Antidepressive Agents|antidepressive agents|mesh-ancestor
111294751|NCT05256342|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111294752|NCT05256342|Dopamine Agents|dopamine agents|mesh-ancestor
111294753|NCT05256342|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111294754|NCT05256342|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111294755|NCT05256342|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111294756|NCT05256342|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111294757|NCT05256342|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111294758|NCT05256342|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111294759|NCT05256342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111294760|NCT02117167|Pemetrexed|pemetrexed|mesh-list
111294761|NCT02117167|Durvalumab|durvalumab|mesh-list
111294762|NCT02117167|Olaparib|olaparib|mesh-list
111294763|NCT02117167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111294764|NCT02117167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111294765|NCT02117167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111294766|NCT02117167|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111294767|NCT02117167|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111294768|NCT02117167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111294769|NCT02117167|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111294770|NCT01895881|Estradiol|estradiol|mesh-list
111294771|NCT01895881|Estrogens|estrogens|mesh-ancestor
111294772|NCT01895881|Hormones|hormones|mesh-ancestor
111294773|NCT01895881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111294774|NCT01895881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111294775|NCT04537962|Listerine|listerine|mesh-list
111294776|NCT04537962|Cetylpyridinium|cetylpyridinium|mesh-list
111294777|NCT04537962|Fluorides|fluorides|mesh-list
111294778|NCT04537962|Sodium Fluoride|sodium fluoride|mesh-list
111294779|NCT04537962|Fluorophosphate|fluorophosphate|mesh-list
111294780|NCT04537962|Tin Fluorides|tin fluorides|mesh-list
111294781|NCT04537962|Cariostatic Agents|cariostatic agents|mesh-ancestor
111294782|NCT04537962|Protective Agents|protective agents|mesh-ancestor
111294783|NCT04537962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111294784|NCT04537962|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111294785|NCT04537962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111294786|NCT04126733|Nivolumab|nivolumab|mesh-list
111294787|NCT04126733|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111294788|NCT04126733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111294789|NCT04126733|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111294790|NCT04126733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111294791|NCT04387734|Ocrelizumab|ocrelizumab|mesh-list
111294792|NCT04387734|Immunologic Factors|immunologic factors|mesh-ancestor
111294793|NCT04387734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111294794|NCT04885764|Vaccines|vaccines|mesh-list
111294795|NCT04885764|Immunologic Factors|immunologic factors|mesh-ancestor
111294796|NCT04885764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111294797|NCT04311606|Aflibercept|aflibercept|mesh-list
111294798|NCT04311606|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111294799|NCT04311606|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111294800|NCT04311606|Growth Substances|growth substances|mesh-ancestor
111294801|NCT04311606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111294802|NCT04311606|Growth Inhibitors|growth inhibitors|mesh-ancestor
111294803|NCT04311606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111294804|NCT02980835|Dexamethasone|dexamethasone|mesh-list
111294805|NCT02980835|Epinephrine|epinephrine|mesh-list
111294806|NCT02980835|Ropivacaine|ropivacaine|mesh-list
111294807|NCT02980835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111294808|NCT02980835|Antiemetics|antiemetics|mesh-ancestor
111294809|NCT02980835|Autonomic Agents|autonomic agents|mesh-ancestor
111294810|NCT02980835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111294811|NCT02980835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111294812|NCT02980835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111294813|NCT02980835|Glucocorticoids|glucocorticoids|mesh-ancestor
111294814|NCT02980835|Hormones|hormones|mesh-ancestor
111294815|NCT02980835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111294816|NCT02980835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111294817|NCT02980835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111294818|NCT02980835|Anesthetics, Local|anesthetics, local|mesh-ancestor
111294819|NCT02980835|Anesthetics|anesthetics|mesh-ancestor
111294820|NCT02980835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111294821|NCT02980835|Sensory System Agents|sensory system agents|mesh-ancestor
111294822|NCT02980835|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111294823|NCT02980835|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111294824|NCT02980835|Adrenergic Agents|adrenergic agents|mesh-ancestor
111294825|NCT02980835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111294826|NCT02980835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111294827|NCT02980835|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111294828|NCT02980835|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111294829|NCT02980835|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111294830|NCT02980835|Respiratory System Agents|respiratory system agents|mesh-ancestor
111294831|NCT02980835|Mydriatics|mydriatics|mesh-ancestor
111294832|NCT02980835|Sympathomimetics|sympathomimetics|mesh-ancestor
111294833|NCT02980835|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111294834|NCT03824327|Papaverine|papaverine|mesh-list
111019279|NCT03090698|Viscosupplements|viscosupplements|mesh-ancestor
111294835|NCT03824327|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111294836|NCT03824327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111294837|NCT03824327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111294838|NCT03824327|Vasodilator Agents|vasodilator agents|mesh-ancestor
111294839|NCT03824327|Urological Agents|urological agents|mesh-ancestor
111294840|NCT04871724|Fluconazole|fluconazole|mesh-list
111294841|NCT04871724|Antifungal Agents|antifungal agents|mesh-ancestor
111294842|NCT04871724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111294843|NCT04871724|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111294844|NCT04871724|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111294845|NCT04871724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111294846|NCT04871724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111294847|NCT04871724|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111294848|NCT04871724|Hormone Antagonists|hormone antagonists|mesh-ancestor
111294849|NCT04871724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111294850|NCT04871724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111294851|NCT04871724|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111294852|NCT04871724|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111294853|NCT04871802|Taxifolin|taxifolin|mesh-list
111294854|NCT04871802|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111294855|NCT04871802|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111294856|NCT04871802|Analgesics|analgesics|mesh-ancestor
111294857|NCT04871802|Sensory System Agents|sensory system agents|mesh-ancestor
111294858|NCT04871802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111294859|NCT04871802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111294860|NCT04871802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111294861|NCT04871802|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111294862|NCT04871646|Nafamostat|nafamostat|mesh-list
111294863|NCT04871646|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111294864|NCT04871646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111294865|NCT04871646|Analgesics|analgesics|mesh-ancestor
111294866|NCT04871646|Sensory System Agents|sensory system agents|mesh-ancestor
111294867|NCT04871646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111294868|NCT04871646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111294869|NCT04871646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111294870|NCT04871646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111294871|NCT04871646|Anticoagulants|anticoagulants|mesh-ancestor
111294872|NCT04871646|Protease Inhibitors|protease inhibitors|mesh-ancestor
111294873|NCT04871646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110979566|NCT02453516|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111294874|NCT04871646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111294875|NCT04871646|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
111294876|NCT04871646|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111294877|NCT04871646|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
111294878|NCT04871646|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111294879|NCT04871646|Immunologic Factors|immunologic factors|mesh-ancestor
111294880|NCT03748680|Oxaliplatin|oxaliplatin|mesh-list
111294881|NCT03748680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111294882|NCT03589014|Propranolol|propranolol|mesh-list
111294883|NCT03589014|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111294884|NCT03589014|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111294885|NCT03589014|Adrenergic Agents|adrenergic agents|mesh-ancestor
111294886|NCT03589014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111294887|NCT03589014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111294888|NCT03589014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111294889|NCT03589014|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111294890|NCT03589014|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111294891|NCT03589014|Vasodilator Agents|vasodilator agents|mesh-ancestor
111294892|NCT04884906|Paclitaxel|paclitaxel|mesh-list
111294893|NCT04884906|Cisplatin|cisplatin|mesh-list
111294894|NCT04884906|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111294895|NCT04884906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111294896|NCT04884906|Tubulin Modulators|tubulin modulators|mesh-ancestor
111294897|NCT04884906|Antimitotic Agents|antimitotic agents|mesh-ancestor
111294898|NCT04884906|Mitosis Modulators|mitosis modulators|mesh-ancestor
111294899|NCT04884906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111294900|NCT03826589|Avelumab|avelumab|mesh-list
111294901|NCT03826589|Axitinib|axitinib|mesh-list
111294902|NCT03826589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111294903|NCT03826589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111294904|NCT03826589|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111294905|NCT03826589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111294906|NCT03826589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111294907|NCT03046758|Metronidazole|metronidazole|mesh-list
111294908|NCT03046758|Fosfomycin|fosfomycin|mesh-list
111294909|NCT03046758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111294910|NCT03046758|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111294911|NCT03046758|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111294912|NCT03046758|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111294913|NCT04382664|Nivolumab|nivolumab|mesh-list
111294914|NCT04382664|Ipilimumab|ipilimumab|mesh-list
111294915|NCT04382664|Sargramostim|sargramostim|mesh-list
111294916|NCT04382664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111294917|NCT04382664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111294918|NCT04382664|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111294919|NCT04382664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111294920|NCT04382664|Immunologic Factors|immunologic factors|mesh-ancestor
111294921|NCT04382664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111294922|NCT04392479|Aflibercept|aflibercept|mesh-list
111294923|NCT04392479|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111294924|NCT04392479|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111294925|NCT04392479|Growth Substances|growth substances|mesh-ancestor
111294926|NCT04392479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111294927|NCT04392479|Growth Inhibitors|growth inhibitors|mesh-ancestor
111294928|NCT04392479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111294929|NCT03825887|Morphine|morphine|mesh-list
111294930|NCT03825887|Nalbuphine|nalbuphine|mesh-list
111294931|NCT03825887|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111294932|NCT03825887|Narcotics|narcotics|mesh-ancestor
111294933|NCT03825887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111294934|NCT03825887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111294935|NCT03825887|Analgesics|analgesics|mesh-ancestor
111294936|NCT03825887|Sensory System Agents|sensory system agents|mesh-ancestor
111294937|NCT03825887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111294938|NCT03825809|Acetaminophen|acetaminophen|mesh-list
111294939|NCT03825809|Celecoxib|celecoxib|mesh-list
111294940|NCT03825809|Ketorolac|ketorolac|mesh-list
111294941|NCT03825809|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
111294942|NCT03825809|Diazepam|diazepam|mesh-list
111294943|NCT03825809|Gabapentin|gabapentin|mesh-list
111294944|NCT03825809|Hydrocodone|hydrocodone|mesh-list
111294945|NCT03825809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111294946|NCT03825809|Analgesics|analgesics|mesh-ancestor
111294947|NCT03825809|Sensory System Agents|sensory system agents|mesh-ancestor
111294948|NCT03825809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111294949|NCT03825809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111294950|NCT03825809|Antipyretics|antipyretics|mesh-ancestor
111294951|NCT03825809|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111294952|NCT03825809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111294953|NCT03825809|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111294954|NCT03825809|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111294955|NCT03825809|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111294956|NCT03825809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111294957|NCT03825809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111294958|NCT03825809|Anticonvulsants|anticonvulsants|mesh-ancestor
111294959|NCT03825809|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111294960|NCT03825809|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111294961|NCT03825809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111294962|NCT03825809|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111294963|NCT03825809|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111294964|NCT03825809|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111294965|NCT03825809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111294966|NCT03825809|Antimanic Agents|antimanic agents|mesh-ancestor
111294967|NCT03825809|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111294968|NCT03825809|Narcotics|narcotics|mesh-ancestor
111294969|NCT03825809|Antitussive Agents|antitussive agents|mesh-ancestor
111294970|NCT03825809|Respiratory System Agents|respiratory system agents|mesh-ancestor
111294971|NCT03825809|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111294972|NCT03825809|Antiemetics|antiemetics|mesh-ancestor
111294973|NCT03825809|Autonomic Agents|autonomic agents|mesh-ancestor
111294974|NCT03825809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111294975|NCT03825809|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111294976|NCT03825809|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
111294977|NCT03825809|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111294978|NCT03825809|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111294979|NCT03825809|Anesthetics, General|anesthetics, general|mesh-ancestor
111294980|NCT03825809|Anesthetics|anesthetics|mesh-ancestor
111294981|NCT03825809|GABA Modulators|gaba modulators|mesh-ancestor
111294982|NCT03825809|GABA Agents|gaba agents|mesh-ancestor
111294983|NCT03824717|Ropivacaine|ropivacaine|mesh-list
111294984|NCT03824717|Anesthetics, Local|anesthetics, local|mesh-ancestor
111294985|NCT03824717|Anesthetics|anesthetics|mesh-ancestor
111294986|NCT03824717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111294987|NCT03824717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111294988|NCT03824717|Sensory System Agents|sensory system agents|mesh-ancestor
111294989|NCT03824717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111294990|NCT04392557|Metformin|metformin|mesh-list
111294991|NCT04392557|Pioglitazone|pioglitazone|mesh-list
111294992|NCT04392557|Alogliptin|alogliptin|mesh-list
111294993|NCT04392557|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111294994|NCT04392557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111294995|NCT04392557|Incretins|incretins|mesh-ancestor
111294996|NCT04392557|Hormones|hormones|mesh-ancestor
111294997|NCT04392557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111294998|NCT04392557|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111294999|NCT04392557|Protease Inhibitors|protease inhibitors|mesh-ancestor
111295000|NCT04392557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111295001|NCT04392557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111295002|NCT02115373|Tepotinib|tepotinib|mesh-list
111295003|NCT02115373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111295004|NCT03824171|Cholecalciferol|cholecalciferol|mesh-list
111295005|NCT03824171|Vitamin D|vitamin d|mesh-list
111295006|NCT03824171|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
111295007|NCT03824171|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111295008|NCT03824171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111295009|NCT03824171|Vitamins|vitamins|mesh-ancestor
111295010|NCT03824171|Micronutrients|micronutrients|mesh-ancestor
111295011|NCT03824171|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111295012|NCT03824171|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111295013|NCT03824171|Hormone Antagonists|hormone antagonists|mesh-ancestor
111295014|NCT03824171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111295015|NCT03824171|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111295016|NCT03824171|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111295017|NCT02946125|Phenylephrine|phenylephrine|mesh-list
111295018|NCT02946125|Oxymetazoline|oxymetazoline|mesh-list
111295019|NCT02946125|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111295020|NCT02946125|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111295021|NCT02946125|Mydriatics|mydriatics|mesh-ancestor
111295022|NCT02946125|Autonomic Agents|autonomic agents|mesh-ancestor
111295023|NCT02946125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111295024|NCT02946125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111295025|NCT02946125|Sympathomimetics|sympathomimetics|mesh-ancestor
111295026|NCT02946125|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111295027|NCT02946125|Nasal Decongestants|nasal decongestants|mesh-ancestor
111295028|NCT02946125|Respiratory System Agents|respiratory system agents|mesh-ancestor
111295029|NCT02946125|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111295030|NCT02946125|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111295031|NCT02946125|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111295032|NCT02946125|Adrenergic Agents|adrenergic agents|mesh-ancestor
111295033|NCT02946125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111295034|NCT02946125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111295035|NCT02946125|Protective Agents|protective agents|mesh-ancestor
111295036|NCT02946125|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111295037|NCT01895257|Leucovorin|leucovorin|mesh-list
111295038|NCT01895257|Fluorouracil|fluorouracil|mesh-list
111295039|NCT01895257|Levoleucovorin|levoleucovorin|mesh-list
111295040|NCT01895257|Antidotes|antidotes|mesh-ancestor
111295041|NCT01895257|Protective Agents|protective agents|mesh-ancestor
111295042|NCT01895257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111295043|NCT01895257|Vitamin B Complex|vitamin b complex|mesh-ancestor
111295044|NCT01895257|Vitamins|vitamins|mesh-ancestor
111295045|NCT01895257|Micronutrients|micronutrients|mesh-ancestor
111295046|NCT01895257|Antimetabolites|antimetabolites|mesh-ancestor
111295047|NCT01895257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111295048|NCT01895257|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111295049|NCT01895257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111295050|NCT01895257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111295051|NCT01895257|Immunologic Factors|immunologic factors|mesh-ancestor
111295052|NCT04392713|Ivermectin|ivermectin|mesh-list
111295053|NCT04392713|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111295054|NCT04392713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111295055|NCT03823625|Nivolumab|nivolumab|mesh-list
111295056|NCT03823625|Ipilimumab|ipilimumab|mesh-list
111295057|NCT03823625|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111295058|NCT03823625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111295059|NCT03823625|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111295060|NCT03823625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111295061|NCT02053909|Aspirin|aspirin|mesh-list
111295062|NCT02053909|Ticagrelor|ticagrelor|mesh-list
111295063|NCT02053909|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111295064|NCT02053909|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111295065|NCT02053909|Analgesics|analgesics|mesh-ancestor
111295066|NCT02053909|Sensory System Agents|sensory system agents|mesh-ancestor
111295067|NCT02053909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111295068|NCT02053909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111295069|NCT02053909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111295070|NCT02053909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111295071|NCT02053909|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111295072|NCT02053909|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111295073|NCT02053909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111295074|NCT02053909|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111295075|NCT02053909|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111295076|NCT02053909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111295077|NCT02053909|Antipyretics|antipyretics|mesh-ancestor
111295078|NCT02053909|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111295079|NCT02053909|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111295080|NCT02053909|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111295081|NCT02053909|Purinergic Agents|purinergic agents|mesh-ancestor
111295082|NCT02053909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111295083|NCT02863991|TIC10 compound|tic10 compound|mesh-list
111295084|NCT02863991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111295085|NCT02860091|Ropivacaine|ropivacaine|mesh-list
111295086|NCT02860091|Anesthetics, Local|anesthetics, local|mesh-ancestor
111295087|NCT02860091|Anesthetics|anesthetics|mesh-ancestor
111295088|NCT02860091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111295089|NCT02860091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111295090|NCT02860091|Sensory System Agents|sensory system agents|mesh-ancestor
111295091|NCT02860091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111295092|NCT02858219|Botulinum Toxins|botulinum toxins|mesh-list
111295093|NCT02858219|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111295094|NCT02858219|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111295095|NCT02858219|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111295096|NCT02858219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111295097|NCT02858219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111295098|NCT02858219|Cholinergic Agents|cholinergic agents|mesh-ancestor
111295099|NCT02858219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111295100|NCT02858219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111295101|NCT02858219|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111295102|NCT02858219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111295103|NCT03823781|Milrinone|milrinone|mesh-list
111295104|NCT03823781|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111295105|NCT03823781|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111295106|NCT03823781|Vasodilator Agents|vasodilator agents|mesh-ancestor
111295107|NCT03823781|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
111295108|NCT03823781|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111295109|NCT03823781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111295110|NCT03823781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111295111|NCT03823781|Protective Agents|protective agents|mesh-ancestor
111295112|NCT03823781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111295113|NCT03823079|Irinotecan|irinotecan|mesh-list
111295114|NCT03823079|Raltitrexed|raltitrexed|mesh-list
111295115|NCT03823079|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111295116|NCT03823079|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111295117|NCT03823079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111295118|NCT03823079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111295119|NCT03823079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111295120|NCT03823079|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111295121|NCT03823079|Antimetabolites|antimetabolites|mesh-ancestor
111295122|NCT03823079|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111295123|NCT02839265|Flt3 ligand protein|flt3 ligand protein|mesh-list
111295124|NCT02839265|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111295125|NCT02839265|Immunologic Factors|immunologic factors|mesh-ancestor
111295126|NCT02839265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111295127|NCT02839265|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111295128|NCT02839265|Protective Agents|protective agents|mesh-ancestor
111295129|NCT00988247|Beclomethasone|beclomethasone|mesh-list
111295130|NCT00988247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111295131|NCT00988247|Glucocorticoids|glucocorticoids|mesh-ancestor
111295132|NCT00988247|Hormones|hormones|mesh-ancestor
111295133|NCT00988247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111295134|NCT00988247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111295135|NCT00988247|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111295136|NCT00988247|Respiratory System Agents|respiratory system agents|mesh-ancestor
111295137|NCT02832401|Caffeine|caffeine|mesh-list
111019575|NCT02119273|Hormones|hormones|mesh-ancestor
111295138|NCT02832401|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111295139|NCT02832401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111295140|NCT02832401|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111295141|NCT02832401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111295142|NCT02832401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111295143|NCT02832401|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
111295144|NCT02832401|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111295145|NCT02832401|Purinergic Agents|purinergic agents|mesh-ancestor
111295146|NCT02832401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111295147|NCT03044808|Lidocaine|lidocaine|mesh-list
111295148|NCT03044808|Anesthetics, Local|anesthetics, local|mesh-ancestor
111295149|NCT03044808|Anesthetics|anesthetics|mesh-ancestor
111295150|NCT03044808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111295151|NCT03044808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111295152|NCT03044808|Sensory System Agents|sensory system agents|mesh-ancestor
111295153|NCT03044808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111295154|NCT03044808|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111295155|NCT03044808|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111295156|NCT03044808|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111295157|NCT03044808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111295158|NCT03044808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111295159|NCT04430166|Antibodies|antibodies|mesh-list
111295160|NCT04430166|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111295161|NCT04430166|Immunologic Factors|immunologic factors|mesh-ancestor
111295162|NCT04430166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111295163|NCT04877106|Metformin|metformin|mesh-list
111295164|NCT04877106|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111295165|NCT04877106|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111295166|NCT04877106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111295167|NCT04877106|Incretins|incretins|mesh-ancestor
111295168|NCT04877106|Hormones|hormones|mesh-ancestor
111295169|NCT04877106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111295170|NCT04877106|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111295171|NCT04877106|Protease Inhibitors|protease inhibitors|mesh-ancestor
111295172|NCT04877106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111295173|NCT04877106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111295174|NCT00981617|ALKS-33|alks-33|mesh-list
111295175|NCT00981617|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111295176|NCT00981617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111295177|NCT00981617|Sensory System Agents|sensory system agents|mesh-ancestor
111295178|NCT00981617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111295179|NCT04876716|Voriconazole|voriconazole|mesh-list
111295180|NCT04876716|Posaconazole|posaconazole|mesh-list
111295181|NCT04876716|Isavuconazole|isavuconazole|mesh-list
111295182|NCT04876716|Anidulafungin|anidulafungin|mesh-list
111295183|NCT04876716|Antifungal Agents|antifungal agents|mesh-ancestor
111295184|NCT04876716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111295185|NCT04876716|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111295186|NCT04876716|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111295187|NCT04876716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111295188|NCT04876716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111295189|NCT04876716|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111295190|NCT04876716|Hormone Antagonists|hormone antagonists|mesh-ancestor
111295191|NCT04876716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111295192|NCT04876716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111295193|NCT04876716|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111295194|NCT04876716|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
111295195|NCT04876716|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111295196|NCT04876716|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111295197|NCT04865250|Paclitaxel|paclitaxel|mesh-list
111295198|NCT04865250|Carboplatin|carboplatin|mesh-list
111295199|NCT04865250|Atezolizumab|atezolizumab|mesh-list
111295200|NCT04865250|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111295201|NCT04865250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111295202|NCT04865250|Tubulin Modulators|tubulin modulators|mesh-ancestor
111295203|NCT04865250|Antimitotic Agents|antimitotic agents|mesh-ancestor
111295204|NCT04865250|Mitosis Modulators|mitosis modulators|mesh-ancestor
111295205|NCT04865250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111295206|NCT04865250|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111295207|NCT04865250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111295208|NCT04865562|Methyltestosterone|methyltestosterone|mesh-list
111295209|NCT04865562|Testosterone|testosterone|mesh-list
111295210|NCT04865562|Testosterone undecanoate|testosterone undecanoate|mesh-list
111295211|NCT04865562|Testosterone enanthate|testosterone enanthate|mesh-list
111295212|NCT04865562|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
111295213|NCT04865562|Androgens|androgens|mesh-ancestor
111295214|NCT04865562|Hormones|hormones|mesh-ancestor
111295215|NCT04865562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111295216|NCT04865562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111295217|NCT04865562|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111295218|NCT04865562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111295219|NCT04865562|Anabolic Agents|anabolic agents|mesh-ancestor
111295220|NCT04864782|Paclitaxel|paclitaxel|mesh-list
111295221|NCT04864782|Carboplatin|carboplatin|mesh-list
111295222|NCT04864782|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111295223|NCT04864782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111295224|NCT04864782|Tubulin Modulators|tubulin modulators|mesh-ancestor
111295225|NCT04864782|Antimitotic Agents|antimitotic agents|mesh-ancestor
111295226|NCT04864782|Mitosis Modulators|mitosis modulators|mesh-ancestor
111295227|NCT04864782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111295228|NCT04875858|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
111295229|NCT04875858|Immunologic Factors|immunologic factors|mesh-ancestor
111295230|NCT04875858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111295231|NCT04385940|Vitamin D|vitamin d|mesh-list
111295232|NCT04385940|Cholecalciferol|cholecalciferol|mesh-list
111295233|NCT04385940|Vitamins|vitamins|mesh-ancestor
111295234|NCT04385940|Micronutrients|micronutrients|mesh-ancestor
111295235|NCT04385940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111295236|NCT04385940|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111295237|NCT04385940|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111295238|NCT00984659|Fluticasone|fluticasone|mesh-list
111295239|NCT00984659|Xhance|xhance|mesh-list
111295240|NCT00984659|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
111295241|NCT00984659|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111295242|NCT00984659|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111295243|NCT00984659|Autonomic Agents|autonomic agents|mesh-ancestor
111295244|NCT00984659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111295245|NCT00984659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111295246|NCT00984659|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111295247|NCT00984659|Respiratory System Agents|respiratory system agents|mesh-ancestor
111295248|NCT00984659|Dermatologic Agents|dermatologic agents|mesh-ancestor
111295249|NCT00984659|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111295250|NCT00984659|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111295251|NCT00984659|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111295252|NCT00984659|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111295253|NCT00984659|Adrenergic Agents|adrenergic agents|mesh-ancestor
111295254|NCT00984659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111295255|NCT00984659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111295256|NCT04864314|Superoxide Dismutase|superoxide dismutase|mesh-list
111295257|NCT04864314|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111295258|NCT04864314|Antioxidants|antioxidants|mesh-ancestor
111295259|NCT04864314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111295260|NCT04864314|Protective Agents|protective agents|mesh-ancestor
111295261|NCT04864314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111295262|NCT04874844|Antibodies|antibodies|mesh-list
111295263|NCT04874844|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111295264|NCT04874844|Immunologic Factors|immunologic factors|mesh-ancestor
111295265|NCT04874844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111295266|NCT03046290|Lidocaine|lidocaine|mesh-list
111295267|NCT03046290|Ropivacaine|ropivacaine|mesh-list
111295268|NCT03046290|Anesthetics, Local|anesthetics, local|mesh-ancestor
111295269|NCT03046290|Anesthetics|anesthetics|mesh-ancestor
111295270|NCT03046290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111295271|NCT03046290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111295272|NCT03046290|Sensory System Agents|sensory system agents|mesh-ancestor
111295273|NCT03046290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111295274|NCT03046290|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111295275|NCT03046290|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111295276|NCT03046290|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111295277|NCT03046290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111295278|NCT03046290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111295279|NCT04874688|Provitamins|provitamins|mesh-list
111295280|NCT04874688|Beta Carotene|beta carotene|mesh-list
111295281|NCT04874688|Vitamins|vitamins|mesh-ancestor
111295282|NCT04874688|Micronutrients|micronutrients|mesh-ancestor
111295283|NCT04874688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111295284|NCT02612064|Fluorides|fluorides|mesh-list
111295285|NCT02612064|Tin Fluorides|tin fluorides|mesh-list
111295286|NCT02612064|Fluorophosphate|fluorophosphate|mesh-list
111295287|NCT02612064|Cariostatic Agents|cariostatic agents|mesh-ancestor
111019727|NCT03553537|Prednisone|prednisone|mesh-list
111295288|NCT02612064|Protective Agents|protective agents|mesh-ancestor
111295289|NCT02612064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111295290|NCT04553003|Prednisone|prednisone|mesh-list
111295291|NCT04553003|Methylprednisolone|methylprednisolone|mesh-list
111295292|NCT04553003|Choline|choline|mesh-list
111295293|NCT04553003|Polyene phosphatidylcholine|polyene phosphatidylcholine|mesh-list
111295294|NCT04553003|Glucocorticoids|glucocorticoids|mesh-list
111295295|NCT04553003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111295296|NCT04553003|Hormones|hormones|mesh-ancestor
111295297|NCT04553003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111295298|NCT04553003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111295299|NCT04553003|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111295300|NCT04553003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111295301|NCT04553003|Antiemetics|antiemetics|mesh-ancestor
111295302|NCT04553003|Autonomic Agents|autonomic agents|mesh-ancestor
111295303|NCT04553003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111295304|NCT04553003|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111295305|NCT04553003|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111295306|NCT04553003|Protective Agents|protective agents|mesh-ancestor
111295307|NCT04553003|Lipotropic Agents|lipotropic agents|mesh-ancestor
111295308|NCT04553003|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111295309|NCT04553003|Antimetabolites|antimetabolites|mesh-ancestor
111295310|NCT04553003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111295311|NCT04553003|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111295312|NCT04553003|Nootropic Agents|nootropic agents|mesh-ancestor
111295313|NCT03044184|Tranylcypromine|tranylcypromine|mesh-list
111295314|NCT03044184|Tranexamic Acid|tranexamic acid|mesh-list
111295315|NCT03044184|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111295316|NCT03044184|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111295317|NCT03044184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111295318|NCT03044184|Hemostatics|hemostatics|mesh-ancestor
111295319|NCT03044184|Coagulants|coagulants|mesh-ancestor
111295320|NCT03044184|Antidepressive Agents|antidepressive agents|mesh-ancestor
111295321|NCT03044184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111295322|NCT03044184|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
111295323|NCT03044184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111295324|NCT03044184|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111295325|NCT03044184|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111295326|NCT03044184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111295327|NCT03044184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111295328|NCT03047772|Atorvastatin|atorvastatin|mesh-list
111295329|NCT03047772|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111295330|NCT03047772|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111295331|NCT03047772|Antimetabolites|antimetabolites|mesh-ancestor
111295332|NCT03047772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111295333|NCT03047772|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111295334|NCT03047772|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111295335|NCT03047772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111295336|NCT03047538|Amlodipine|amlodipine|mesh-list
111295337|NCT03047538|Perindopril|perindopril|mesh-list
111295338|NCT03047538|Atorvastatin|atorvastatin|mesh-list
111295339|NCT03047538|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111295340|NCT03047538|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111295341|NCT03047538|Antimetabolites|antimetabolites|mesh-ancestor
111295342|NCT03047538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111295343|NCT03047538|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111295344|NCT03047538|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111295345|NCT03047538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111295346|NCT03047538|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111295347|NCT03047538|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111295348|NCT03047538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111295349|NCT03047538|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111295350|NCT03047538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111295351|NCT03047538|Vasodilator Agents|vasodilator agents|mesh-ancestor
111295352|NCT03047538|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
111295353|NCT03047538|Protease Inhibitors|protease inhibitors|mesh-ancestor
111295354|NCT01728805|Vorinostat|vorinostat|mesh-list
111295355|NCT01728805|Mogamulizumab|mogamulizumab|mesh-list
111295356|NCT01728805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111295357|NCT01728805|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111295358|NCT01728805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111295359|NCT01728805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111295360|NCT03822065|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
111295361|NCT03822065|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111295362|NCT03822065|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111295363|NCT03822065|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111295364|NCT03822065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111295365|NCT03822065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111295366|NCT03822065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111295367|NCT03822065|Antidepressive Agents|antidepressive agents|mesh-ancestor
111295368|NCT03822065|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111295369|NCT03821987|Cyclophosphamide|cyclophosphamide|mesh-list
111295370|NCT03821987|Busulfan|busulfan|mesh-list
111295371|NCT03821987|Fludarabine|fludarabine|mesh-list
111295372|NCT03821987|Thymoglobulin|thymoglobulin|mesh-list
111295373|NCT03821987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111295374|NCT03821987|Immunologic Factors|immunologic factors|mesh-ancestor
111295375|NCT03821987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111295376|NCT03821987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111295377|NCT03821987|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111295378|NCT03821987|Alkylating Agents|alkylating agents|mesh-ancestor
111295379|NCT03821987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111295380|NCT03821987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111295381|NCT03821987|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111295382|NCT04273763|Interferons|interferons|mesh-list
111295383|NCT04273763|Bromhexine|bromhexine|mesh-list
111295384|NCT04273763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111295385|NCT04273763|Antiviral Agents|antiviral agents|mesh-ancestor
111295386|NCT04273763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111295387|NCT04273763|Expectorants|expectorants|mesh-ancestor
111295388|NCT04273763|Respiratory System Agents|respiratory system agents|mesh-ancestor
111295389|NCT03820193|Acetaminophen|acetaminophen|mesh-list
111295390|NCT03820193|Celecoxib|celecoxib|mesh-list
111295391|NCT03820193|Ketorolac|ketorolac|mesh-list
111295392|NCT03820193|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
111295393|NCT03820193|Diazepam|diazepam|mesh-list
111295394|NCT03820193|Gabapentin|gabapentin|mesh-list
111295395|NCT03820193|Hydrocodone|hydrocodone|mesh-list
111295396|NCT03820193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111295397|NCT03820193|Analgesics|analgesics|mesh-ancestor
111295398|NCT03820193|Sensory System Agents|sensory system agents|mesh-ancestor
111295399|NCT03820193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111295400|NCT03820193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111295401|NCT03820193|Antipyretics|antipyretics|mesh-ancestor
111295402|NCT03820193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111295403|NCT03820193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111295404|NCT03820193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111295405|NCT03820193|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111295406|NCT03820193|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111295407|NCT03820193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111295408|NCT03820193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111295409|NCT03820193|Anticonvulsants|anticonvulsants|mesh-ancestor
111295410|NCT03820193|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111295411|NCT03820193|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111295412|NCT03820193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111295413|NCT03820193|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111295414|NCT03820193|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111295415|NCT03820193|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111295416|NCT03820193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111295417|NCT03820193|Antimanic Agents|antimanic agents|mesh-ancestor
111295418|NCT03820193|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111295419|NCT03820193|Narcotics|narcotics|mesh-ancestor
111295420|NCT03820193|Antitussive Agents|antitussive agents|mesh-ancestor
111295421|NCT03820193|Respiratory System Agents|respiratory system agents|mesh-ancestor
111295422|NCT03820193|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111295423|NCT03820193|Antiemetics|antiemetics|mesh-ancestor
111295424|NCT03820193|Autonomic Agents|autonomic agents|mesh-ancestor
111295425|NCT03820193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111295426|NCT03820193|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111295427|NCT03820193|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
111295428|NCT03820193|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111295429|NCT03820193|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111295430|NCT03820193|Anesthetics, General|anesthetics, general|mesh-ancestor
111295431|NCT03820193|Anesthetics|anesthetics|mesh-ancestor
111295432|NCT03820193|GABA Modulators|gaba modulators|mesh-ancestor
111295433|NCT03820193|GABA Agents|gaba agents|mesh-ancestor
111295434|NCT03820037|Opicapone|opicapone|mesh-list
111295435|NCT03820037|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
111295436|NCT03820037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111295437|NCT03820037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111295438|NCT03820037|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111295439|NCT03820037|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111295440|NCT03829007|Durvalumab|durvalumab|mesh-list
111295441|NCT03829007|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111295442|NCT03829007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111295443|NCT03829007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111295444|NCT03829007|Immunologic Factors|immunologic factors|mesh-ancestor
111295445|NCT03829007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111295446|NCT02614560|Fludarabine|fludarabine|mesh-list
111295447|NCT02614560|Melphalan|melphalan|mesh-list
111295448|NCT02614560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111295449|NCT02614560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111295450|NCT02614560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111295451|NCT02614560|Immunologic Factors|immunologic factors|mesh-ancestor
111295452|NCT02614560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111295453|NCT02614560|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111295454|NCT02614560|Alkylating Agents|alkylating agents|mesh-ancestor
111295455|NCT02614560|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111295456|NCT03828929|Thiamine|thiamine|mesh-list
111295457|NCT03828929|Vitamins|vitamins|mesh-ancestor
111295458|NCT03828929|Micronutrients|micronutrients|mesh-ancestor
111295459|NCT03828929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111295460|NCT03828929|Vitamin B Complex|vitamin b complex|mesh-ancestor
111295461|NCT04873440|Manganese|manganese|mesh-list
111295462|NCT04873440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111295463|NCT04873440|Trace Elements|trace elements|mesh-ancestor
111295464|NCT04873440|Micronutrients|micronutrients|mesh-ancestor
111295465|NCT04867980|Moxifloxacin|moxifloxacin|mesh-list
111295466|NCT04867980|Acalabrutinib|acalabrutinib|mesh-list
111295467|NCT04867980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111295468|NCT04867980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111295469|NCT04867980|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111295470|NCT04867980|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111295471|NCT04867980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111295472|NCT04867980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111295473|NCT04867980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111295474|NCT01450241|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111295475|NCT01450241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111295476|NCT04391621|Triamcinolone|triamcinolone|mesh-list
111295477|NCT04391621|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
111295478|NCT04391621|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
111295479|NCT04391621|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
111295480|NCT04391621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111295481|NCT04391621|Glucocorticoids|glucocorticoids|mesh-ancestor
111295482|NCT04391621|Hormones|hormones|mesh-ancestor
111295483|NCT04391621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111295484|NCT04391621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111295485|NCT04391621|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111295486|NCT04391621|Immunologic Factors|immunologic factors|mesh-ancestor
111295487|NCT04391621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111295488|NCT04391621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111295489|NCT01669122|Nicotine|nicotine|mesh-list
111295490|NCT01669122|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111295491|NCT01669122|Autonomic Agents|autonomic agents|mesh-ancestor
111295492|NCT01669122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111295493|NCT01669122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111295494|NCT01669122|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111295495|NCT01669122|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111295496|NCT01669122|Cholinergic Agents|cholinergic agents|mesh-ancestor
111295497|NCT01669122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111295498|NCT01669122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111295499|NCT03629483|Dexmedetomidine|dexmedetomidine|mesh-list
111295500|NCT03629483|Ropivacaine|ropivacaine|mesh-list
111295501|NCT03629483|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111295502|NCT03629483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111295503|NCT03629483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111295504|NCT03629483|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111295505|NCT03629483|Analgesics|analgesics|mesh-ancestor
111295506|NCT03629483|Sensory System Agents|sensory system agents|mesh-ancestor
111295507|NCT03629483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111295508|NCT03629483|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111295509|NCT03629483|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111295510|NCT03629483|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111295511|NCT03629483|Adrenergic Agents|adrenergic agents|mesh-ancestor
111295512|NCT03629483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111295513|NCT03629483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111295514|NCT03629483|Anesthetics, Local|anesthetics, local|mesh-ancestor
111295515|NCT03629483|Anesthetics|anesthetics|mesh-ancestor
111295516|NCT04873284|Dexamethasone|dexamethasone|mesh-list
111295518|NCT04873284|Fosaprepitant|fosaprepitant|mesh-list
111295519|NCT04873284|Granisetron|granisetron|mesh-list
111295520|NCT04873284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111295521|NCT04873284|Antiemetics|antiemetics|mesh-ancestor
111295522|NCT04873284|Autonomic Agents|autonomic agents|mesh-ancestor
111295523|NCT04873284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111295524|NCT04873284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111295525|NCT04873284|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111295526|NCT04873284|Glucocorticoids|glucocorticoids|mesh-ancestor
111295527|NCT04873284|Hormones|hormones|mesh-ancestor
111295528|NCT04873284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111295529|NCT04873284|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111295530|NCT04873284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111295531|NCT04873284|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
111295532|NCT04873284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111295533|NCT04873284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111295534|NCT04873284|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111295535|NCT04873284|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111295536|NCT04873284|Serotonin Agents|serotonin agents|mesh-ancestor
111295537|NCT01450865|Flupirtine|flupirtine|mesh-list
111295538|NCT01450865|Analgesics|analgesics|mesh-ancestor
111295539|NCT01450865|Sensory System Agents|sensory system agents|mesh-ancestor
111295540|NCT01450865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111295541|NCT01450865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111295542|NCT01308619|Doxycycline|doxycycline|mesh-list
111295543|NCT01308619|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111295544|NCT01308619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111295545|NCT01308619|Antimalarials|antimalarials|mesh-ancestor
111295546|NCT01308619|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111295547|NCT01308619|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111295548|NCT02611752|Buprenorphine|buprenorphine|mesh-list
111295549|NCT02611752|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111295550|NCT02611752|Narcotics|narcotics|mesh-ancestor
111295551|NCT02611752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111295552|NCT02611752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111295553|NCT02611752|Analgesics|analgesics|mesh-ancestor
111295554|NCT02611752|Sensory System Agents|sensory system agents|mesh-ancestor
111295555|NCT02611752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111295556|NCT02611752|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111295557|NCT01307605|Rituximab|rituximab|mesh-list
111295558|NCT01307605|Lenalidomide|lenalidomide|mesh-list
111295559|NCT01307605|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111295560|NCT01307605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111295561|NCT01307605|Immunologic Factors|immunologic factors|mesh-ancestor
111295562|NCT01307605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111295563|NCT01307605|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111295564|NCT01307605|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111295565|NCT01307605|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111295566|NCT01307605|Growth Substances|growth substances|mesh-ancestor
111295567|NCT01307605|Growth Inhibitors|growth inhibitors|mesh-ancestor
111295568|NCT04758689|Methotrexate|methotrexate|mesh-list
111295569|NCT04758689|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111295570|NCT04758689|Abortifacient Agents|abortifacient agents|mesh-ancestor
111295571|NCT04758689|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111295572|NCT04758689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111295573|NCT04758689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111295574|NCT04758689|Antimetabolites|antimetabolites|mesh-ancestor
111295575|NCT04758689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111295576|NCT04758689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111295577|NCT04758689|Dermatologic Agents|dermatologic agents|mesh-ancestor
111295578|NCT04758689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111295579|NCT04758689|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111295580|NCT04758689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111295581|NCT04758689|Immunologic Factors|immunologic factors|mesh-ancestor
111295582|NCT04758689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111295583|NCT04758689|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111295584|NCT01451333|Efavirenz|efavirenz|mesh-list
111295585|NCT01451333|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111295586|NCT01451333|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111295587|NCT01451333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111295588|NCT01451333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111295589|NCT01451333|Antiviral Agents|antiviral agents|mesh-ancestor
111295590|NCT01451333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111020028|NCT02123563|Listerine|listerine|mesh-list
111295591|NCT01451333|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111295592|NCT01451333|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111295593|NCT01451333|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111295594|NCT01451333|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111295595|NCT01451333|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111295596|NCT01451333|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111295597|NCT01702831|Lenalidomide|lenalidomide|mesh-list
111295598|NCT01702831|Melphalan|melphalan|mesh-list
111295599|NCT01702831|Busulfan|busulfan|mesh-list
111295600|NCT01702831|Immunologic Factors|immunologic factors|mesh-ancestor
111295601|NCT01702831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111295602|NCT01702831|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111295603|NCT01702831|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111295604|NCT01702831|Growth Substances|growth substances|mesh-ancestor
111295605|NCT01702831|Growth Inhibitors|growth inhibitors|mesh-ancestor
111295606|NCT01702831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111295607|NCT01702831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111295608|NCT01702831|Alkylating Agents|alkylating agents|mesh-ancestor
111295609|NCT01702831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111295610|NCT01702831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111295611|NCT01702831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111295612|NCT03045510|Decitabine|decitabine|mesh-list
111295613|NCT03045510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111295614|NCT03045510|Antimetabolites|antimetabolites|mesh-ancestor
111295615|NCT03045510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111295616|NCT03045510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111295617|NCT03045510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111295618|NCT01451879|Miglustat|miglustat|mesh-list
111295619|NCT01451879|Rituximab|rituximab|mesh-list
111295620|NCT01451879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111295621|NCT01451879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111295622|NCT01451879|Immunologic Factors|immunologic factors|mesh-ancestor
111295623|NCT01451879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111295624|NCT01451879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111295625|NCT01451879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111295626|NCT01451879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111295627|NCT01451879|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111295628|NCT01451879|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111295629|NCT01451879|Antiviral Agents|antiviral agents|mesh-ancestor
111295630|NCT01451879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111295631|NCT01451879|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
111295632|NCT01451879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111295633|NCT03045198|Azithromycin|azithromycin|mesh-list
111295634|NCT03045198|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111295635|NCT03045198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111295636|NCT01452113|Vildagliptin|vildagliptin|mesh-list
111295637|NCT01452113|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111295638|NCT01452113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111295639|NCT01452113|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111295640|NCT01452113|Protease Inhibitors|protease inhibitors|mesh-ancestor
111295641|NCT01452113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111295642|NCT01452113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111295643|NCT02022709|Fluvoxamine|fluvoxamine|mesh-list
111295644|NCT02022709|Sertraline|sertraline|mesh-list
111295645|NCT02022709|Fluoxetine|fluoxetine|mesh-list
111295646|NCT02022709|Paroxetine|paroxetine|mesh-list
111295647|NCT02022709|Citalopram|citalopram|mesh-list
111295648|NCT02022709|Antidepressive Agents|antidepressive agents|mesh-ancestor
111295649|NCT02022709|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111295650|NCT02022709|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111295651|NCT02022709|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111295652|NCT02022709|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111295653|NCT02022709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111295654|NCT02022709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111295655|NCT02022709|Serotonin Agents|serotonin agents|mesh-ancestor
111295656|NCT02022709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111295657|NCT02022709|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111295658|NCT02022709|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111295659|NCT02022709|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111295660|NCT02022709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111295661|NCT02022709|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111295662|NCT02022709|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111295663|NCT02022709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111020101|NCT02406586|Analgesics|analgesics|mesh-ancestor
111295664|NCT02022709|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111295665|NCT02022709|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111295666|NCT02635841|Deferiprone|deferiprone|mesh-list
111295667|NCT02635841|Iron Chelating Agents|iron chelating agents|mesh-ancestor
111295668|NCT02635841|Chelating Agents|chelating agents|mesh-ancestor
111295669|NCT02635841|Sequestering Agents|sequestering agents|mesh-ancestor
111295670|NCT02635841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111295671|NCT01452659|Relugolix|relugolix|mesh-list
111295672|NCT01452659|Androgen Antagonists|androgen antagonists|mesh-ancestor
111295673|NCT01452659|Hormone Antagonists|hormone antagonists|mesh-ancestor
111295674|NCT01452659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111295675|NCT01452659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111295676|NCT01896349|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
111295677|NCT01896349|Amitriptyline|amitriptyline|mesh-list
111295678|NCT01896349|Risperidone|risperidone|mesh-list
111295679|NCT01896349|Sulpiride|sulpiride|mesh-list
111295680|NCT01896349|Mirtazapine|mirtazapine|mesh-list
111295681|NCT01896349|Fluvoxamine|fluvoxamine|mesh-list
111295682|NCT01896349|Trazodone|trazodone|mesh-list
111295683|NCT01896349|Tranylcypromine|tranylcypromine|mesh-list
111295684|NCT01896349|Citalopram|citalopram|mesh-list
111295685|NCT01896349|Bupropion|bupropion|mesh-list
111295686|NCT01896349|Sertraline|sertraline|mesh-list
111295687|NCT01896349|Fluoxetine|fluoxetine|mesh-list
111295688|NCT01896349|Paroxetine|paroxetine|mesh-list
111295689|NCT01896349|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
111295690|NCT01896349|Nortriptyline|nortriptyline|mesh-list
111295691|NCT01896349|Imipramine|imipramine|mesh-list
111295692|NCT01896349|Clomipramine|clomipramine|mesh-list
111295693|NCT01896349|Antidepressive Agents|antidepressive agents|mesh-list
111295694|NCT01896349|Escitalopram|escitalopram|mesh-list
111295695|NCT01896349|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111295696|NCT01896349|Serotonin Agents|serotonin agents|mesh-ancestor
111295697|NCT01896349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111295698|NCT01896349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111295699|NCT01896349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111295700|NCT01896349|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111295701|NCT01896349|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111295702|NCT01896349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111295703|NCT01896349|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111295704|NCT01896349|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111295705|NCT01896349|Dopamine Agents|dopamine agents|mesh-ancestor
111295706|NCT01896349|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111295707|NCT01896349|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111295708|NCT01896349|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111295709|NCT01896349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111295710|NCT01896349|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111295711|NCT01896349|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111295712|NCT01896349|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111295713|NCT01896349|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111295714|NCT01896349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111295715|NCT01896349|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111295716|NCT01896349|Analgesics|analgesics|mesh-ancestor
111295717|NCT01896349|Sensory System Agents|sensory system agents|mesh-ancestor
111295718|NCT01896349|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111295719|NCT01896349|Histamine Antagonists|histamine antagonists|mesh-ancestor
111295720|NCT01896349|Histamine Agents|histamine agents|mesh-ancestor
111295721|NCT01896349|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111295722|NCT01896349|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
111295723|NCT01896349|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111295724|NCT01896349|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111295725|NCT01896349|Adrenergic Agents|adrenergic agents|mesh-ancestor
111295726|NCT01896349|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111295727|NCT01896349|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111295728|NCT01896349|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
111295729|NCT01896349|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111295730|NCT01896349|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111295731|NCT01896349|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111295732|NCT01896349|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111295733|NCT01896349|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
111295734|NCT01452737|Bisacodyl|bisacodyl|mesh-list
111295735|NCT01452737|Cathartics|cathartics|mesh-ancestor
111295736|NCT01452737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111295737|NCT01452737|Laxatives|laxatives|mesh-ancestor
111295738|NCT00595933|Muramidase|muramidase|mesh-list
111295739|NCT00595933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111295740|NCT00580489|Fentanyl|fentanyl|mesh-list
111295741|NCT00580489|Morphine|morphine|mesh-list
111295742|NCT00580489|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111295743|NCT00580489|Narcotics|narcotics|mesh-ancestor
111295744|NCT00580489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111295745|NCT00580489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111295746|NCT00580489|Analgesics|analgesics|mesh-ancestor
111295747|NCT00580489|Sensory System Agents|sensory system agents|mesh-ancestor
111295748|NCT00580489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111295749|NCT00580489|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111295750|NCT00580489|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111295751|NCT00580489|Anesthetics, General|anesthetics, general|mesh-ancestor
111295752|NCT00580489|Anesthetics|anesthetics|mesh-ancestor
111295753|NCT01659307|Aspirin|aspirin|mesh-list
111295754|NCT01659307|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111295755|NCT01659307|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111295756|NCT01659307|Analgesics|analgesics|mesh-ancestor
111295757|NCT01659307|Sensory System Agents|sensory system agents|mesh-ancestor
111295758|NCT01659307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111295759|NCT01659307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111295760|NCT01659307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111295761|NCT01659307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111295762|NCT01659307|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111295763|NCT01659307|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111295764|NCT01659307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111295765|NCT01659307|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111295766|NCT01659307|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111295767|NCT01659307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111295768|NCT01659307|Antipyretics|antipyretics|mesh-ancestor
111295769|NCT01594476|Levonorgestrel|levonorgestrel|mesh-list
111295770|NCT01594476|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111295771|NCT01594476|Contraceptive Agents|contraceptive agents|mesh-ancestor
111295772|NCT01594476|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111295773|NCT01594476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111295774|NCT01594476|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111295775|NCT01594476|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111295776|NCT01594476|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111295777|NCT04391231|Pentoxifylline|pentoxifylline|mesh-list
111295778|NCT04391231|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111295779|NCT04391231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111295780|NCT04391231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110748310|NCT03854942|Naltrexone|naltrexone|mesh-list
111295781|NCT04391231|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111295782|NCT04391231|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111295783|NCT04391231|Protective Agents|protective agents|mesh-ancestor
111295784|NCT04391231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111295785|NCT04391231|Vasodilator Agents|vasodilator agents|mesh-ancestor
111295786|NCT04391231|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111295787|NCT04391231|Antioxidants|antioxidants|mesh-ancestor
111295788|NCT04872270|Caffeine|caffeine|mesh-list
111295789|NCT04872270|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111295790|NCT04872270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111295791|NCT04872270|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111295792|NCT04872270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111295793|NCT04872270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111295794|NCT04872270|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
111295795|NCT04872270|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111295796|NCT04872270|Purinergic Agents|purinergic agents|mesh-ancestor
111295797|NCT04872270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111295798|NCT04872192|Anesthetics|anesthetics|mesh-list
111295799|NCT04872192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111295800|NCT04872192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111295801|NCT01624285|Sorafenib|sorafenib|mesh-list
111295802|NCT01624285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111295803|NCT01624285|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111295804|NCT01624285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111295805|NCT01624285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111295806|NCT01454609|Clonidine|clonidine|mesh-list
111295807|NCT01454609|Bupivacaine|bupivacaine|mesh-list
111295808|NCT01454609|Anesthetics, Local|anesthetics, local|mesh-ancestor
111295809|NCT01454609|Anesthetics|anesthetics|mesh-ancestor
111295810|NCT01454609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111295811|NCT01454609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111295812|NCT01454609|Sensory System Agents|sensory system agents|mesh-ancestor
111295813|NCT01454609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111295814|NCT01454609|Analgesics|analgesics|mesh-ancestor
111295815|NCT01454609|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111295816|NCT01454609|Sympatholytics|sympatholytics|mesh-ancestor
111295817|NCT01454609|Autonomic Agents|autonomic agents|mesh-ancestor
111295818|NCT01454609|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111295819|NCT01454609|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111295820|NCT01454609|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111295821|NCT01454609|Adrenergic Agents|adrenergic agents|mesh-ancestor
111295822|NCT01454609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111295823|NCT01454609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111295824|NCT03042234|Insulin|insulin|mesh-list
111295825|NCT03042234|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111295826|NCT03042234|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111295827|NCT03042234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111295828|NCT02905799|Resveratrol|resveratrol|mesh-list
111295829|NCT02905799|Antioxidants|antioxidants|mesh-ancestor
111295830|NCT02905799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111295831|NCT02905799|Protective Agents|protective agents|mesh-ancestor
111295832|NCT02905799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111295833|NCT02905799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111295834|NCT02905799|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111295835|NCT00469183|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
111295836|NCT00469183|Tretinoin|tretinoin|mesh-list
111295837|NCT00469183|Hydroquinone|hydroquinone|mesh-list
111295838|NCT00469183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111295839|NCT00469183|Keratolytic Agents|keratolytic agents|mesh-ancestor
111295840|NCT00469183|Dermatologic Agents|dermatologic agents|mesh-ancestor
111295841|NCT00469183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111295842|NCT00469183|Glucocorticoids|glucocorticoids|mesh-ancestor
111295843|NCT00469183|Hormones|hormones|mesh-ancestor
111295844|NCT00469183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111295845|NCT00469183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111295846|NCT00469183|Antioxidants|antioxidants|mesh-ancestor
111295847|NCT00469183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111295848|NCT00469183|Protective Agents|protective agents|mesh-ancestor
111295849|NCT00469183|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111295850|NCT01455935|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
111295851|NCT01455935|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111295852|NCT01455935|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111295853|NCT01455935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111295854|NCT00468715|Bicalutamide|bicalutamide|mesh-list
111295855|NCT00468715|Androgen Antagonists|androgen antagonists|mesh-ancestor
111295856|NCT00468715|Hormone Antagonists|hormone antagonists|mesh-ancestor
111295857|NCT00468715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111295858|NCT00468715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111295859|NCT00468715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111295860|NCT01456247|Lansoprazole|lansoprazole|mesh-list
111295861|NCT01456247|Dexlansoprazole|dexlansoprazole|mesh-list
111295862|NCT01456247|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111295863|NCT01456247|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111295864|NCT01456247|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111295865|NCT01456247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111295866|NCT01456247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111295867|NCT01456325|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111295868|NCT01456325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111295869|NCT01456325|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111295870|NCT01456325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111295871|NCT01456325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111295872|NCT04866498|Analgesics|analgesics|mesh-list
111295873|NCT04866498|Sensory System Agents|sensory system agents|mesh-ancestor
111295874|NCT04866498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111295875|NCT04866498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111295876|NCT04866654|Nivolumab|nivolumab|mesh-list
111295877|NCT04866654|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111295878|NCT04866654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111295879|NCT04866654|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111295880|NCT04866654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111295881|NCT01456715|Vaccines|vaccines|mesh-list
111295882|NCT01456715|Immunologic Factors|immunologic factors|mesh-ancestor
111295883|NCT01456715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111295884|NCT01895569|Metformin|metformin|mesh-list
111295885|NCT01895569|Pioglitazone|pioglitazone|mesh-list
111295886|NCT01895569|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111295887|NCT01895569|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111295888|NCT01895569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111295889|NCT01895569|Incretins|incretins|mesh-ancestor
111295890|NCT01895569|Hormones|hormones|mesh-ancestor
111295891|NCT01895569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111295892|NCT01895569|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111295893|NCT01895569|Protease Inhibitors|protease inhibitors|mesh-ancestor
111295894|NCT01895569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111295895|NCT01895569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111295896|NCT01457261|Albuterol|albuterol|mesh-list
111295897|NCT01457261|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111295898|NCT01457261|Autonomic Agents|autonomic agents|mesh-ancestor
111295899|NCT01457261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111295900|NCT01457261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111295901|NCT01457261|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111295902|NCT01457261|Respiratory System Agents|respiratory system agents|mesh-ancestor
111295903|NCT01457261|Tocolytic Agents|tocolytic agents|mesh-ancestor
111295904|NCT01457261|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111295905|NCT01457261|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111295906|NCT01457261|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111295907|NCT01457261|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111295908|NCT01457261|Adrenergic Agents|adrenergic agents|mesh-ancestor
111295909|NCT01457261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111295910|NCT01457261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111295911|NCT01457495|Edetic Acid|edetic acid|mesh-list
111295912|NCT01457495|Pentetic Acid|pentetic acid|mesh-list
111295913|NCT01457495|Antidotes|antidotes|mesh-ancestor
111295914|NCT01457495|Protective Agents|protective agents|mesh-ancestor
111295915|NCT01457495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111295916|NCT01457495|Chelating Agents|chelating agents|mesh-ancestor
111295917|NCT01457495|Sequestering Agents|sequestering agents|mesh-ancestor
111295918|NCT01457495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111295919|NCT01457495|Iron Chelating Agents|iron chelating agents|mesh-ancestor
111295920|NCT01457495|Anticoagulants|anticoagulants|mesh-ancestor
111295921|NCT01457495|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
111295922|NCT04778137|Omalizumab|omalizumab|mesh-list
111295923|NCT04778137|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111295924|NCT04778137|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111295925|NCT04778137|Respiratory System Agents|respiratory system agents|mesh-ancestor
111295926|NCT01458041|Iloprost|iloprost|mesh-list
111295927|NCT01458041|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111295928|NCT01458041|Vasodilator Agents|vasodilator agents|mesh-ancestor
111295929|NCT02610816|Fluticasone|fluticasone|mesh-list
111295930|NCT02610816|Xhance|xhance|mesh-list
111295931|NCT02610816|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111295932|NCT02610816|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111295933|NCT02610816|Autonomic Agents|autonomic agents|mesh-ancestor
111295934|NCT02610816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111295935|NCT02610816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111295936|NCT02610816|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111295937|NCT02610816|Respiratory System Agents|respiratory system agents|mesh-ancestor
111295938|NCT02610816|Dermatologic Agents|dermatologic agents|mesh-ancestor
111295939|NCT02610816|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111295940|NCT00332605|Acetylcysteine|acetylcysteine|mesh-list
111295941|NCT00332605|Naltrexone|naltrexone|mesh-list
111295942|NCT00332605|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111295943|NCT00332605|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111295944|NCT00332605|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111295945|NCT00332605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111295946|NCT00332605|Sensory System Agents|sensory system agents|mesh-ancestor
111295947|NCT00332605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111295948|NCT00332605|Antiviral Agents|antiviral agents|mesh-ancestor
111295949|NCT00332605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111295950|NCT00332605|Expectorants|expectorants|mesh-ancestor
111295951|NCT00332605|Respiratory System Agents|respiratory system agents|mesh-ancestor
111295952|NCT00332605|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111295953|NCT00332605|Antioxidants|antioxidants|mesh-ancestor
111295954|NCT00332605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111295955|NCT00332605|Protective Agents|protective agents|mesh-ancestor
111295956|NCT00332605|Antidotes|antidotes|mesh-ancestor
111295957|NCT01458743|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
111295958|NCT01458743|Cephalosporins|cephalosporins|mesh-list
111295959|NCT01458743|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111295960|NCT01458743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111295961|NCT01415583|Dexamethasone|dexamethasone|mesh-list
111295962|NCT01415583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111295963|NCT01415583|Antiemetics|antiemetics|mesh-ancestor
111295964|NCT01415583|Autonomic Agents|autonomic agents|mesh-ancestor
111295965|NCT01415583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111295966|NCT01415583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111295967|NCT01415583|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111295968|NCT01415583|Glucocorticoids|glucocorticoids|mesh-ancestor
111295969|NCT01415583|Hormones|hormones|mesh-ancestor
111295970|NCT01415583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111295971|NCT01415583|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111295972|NCT01415583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111295973|NCT01458977|Tenofovir|tenofovir|mesh-list
111295974|NCT01458977|Emtricitabine|emtricitabine|mesh-list
111295975|NCT01458977|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
111295976|NCT01458977|Antiviral Agents|antiviral agents|mesh-ancestor
111295977|NCT01458977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111295978|NCT01458977|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111295979|NCT01458977|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111295980|NCT01458977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111295981|NCT01458977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111295982|NCT01458977|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111295983|NCT01458977|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111295984|NCT02508311|Albuterol|albuterol|mesh-list
111295985|NCT02508311|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111295986|NCT02508311|Autonomic Agents|autonomic agents|mesh-ancestor
111295987|NCT02508311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111295988|NCT02508311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111295989|NCT02508311|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111295990|NCT02508311|Respiratory System Agents|respiratory system agents|mesh-ancestor
111295991|NCT02508311|Tocolytic Agents|tocolytic agents|mesh-ancestor
111295992|NCT02508311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111295993|NCT02508311|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111295994|NCT02508311|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111295995|NCT02508311|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111295996|NCT02508311|Adrenergic Agents|adrenergic agents|mesh-ancestor
111295997|NCT02508311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111295998|NCT02508311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111295999|NCT00256399|Alfuzosin|alfuzosin|mesh-list
111296000|NCT00256399|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111296001|NCT00256399|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111296002|NCT00256399|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111296003|NCT00256399|Adrenergic Agents|adrenergic agents|mesh-ancestor
111296004|NCT00256399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111296005|NCT00256399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111296006|NCT00256399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111296007|NCT00256399|Urological Agents|urological agents|mesh-ancestor
111296008|NCT01459133|Insulin|insulin|mesh-list
111296009|NCT01459133|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111296010|NCT01459133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111296011|NCT01459211|Dexamethasone|dexamethasone|mesh-list
111296012|NCT01459211|Lenalidomide|lenalidomide|mesh-list
111296013|NCT01459211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111296014|NCT01459211|Antiemetics|antiemetics|mesh-ancestor
111296015|NCT01459211|Autonomic Agents|autonomic agents|mesh-ancestor
111296016|NCT01459211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111296017|NCT01459211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111296018|NCT01459211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111296019|NCT01459211|Glucocorticoids|glucocorticoids|mesh-ancestor
111296020|NCT01459211|Hormones|hormones|mesh-ancestor
111296021|NCT01459211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111296022|NCT01459211|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111296023|NCT01459211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111296024|NCT01459211|Immunologic Factors|immunologic factors|mesh-ancestor
111296025|NCT01459211|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111296026|NCT01459211|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111296027|NCT01459211|Growth Substances|growth substances|mesh-ancestor
111296028|NCT01459211|Growth Inhibitors|growth inhibitors|mesh-ancestor
111296029|NCT00198991|Cytarabine|cytarabine|mesh-list
111296030|NCT00198991|Dexamethasone|dexamethasone|mesh-list
111296031|NCT00198991|Prednisolone|prednisolone|mesh-list
111296032|NCT00198991|Cyclophosphamide|cyclophosphamide|mesh-list
111296033|NCT00198991|Methotrexate|methotrexate|mesh-list
111296034|NCT00198991|Fludarabine|fludarabine|mesh-list
111296035|NCT00198991|Etoposide|etoposide|mesh-list
111296036|NCT00198991|Etoposide phosphate|etoposide phosphate|mesh-list
111296037|NCT00198991|Vincristine|vincristine|mesh-list
111296038|NCT00198991|Doxorubicin|doxorubicin|mesh-list
111296039|NCT00198991|Daunorubicin|daunorubicin|mesh-list
111296040|NCT00198991|Asparaginase|asparaginase|mesh-list
111296041|NCT00198991|Mercaptopurine|mercaptopurine|mesh-list
111296042|NCT00198991|Idarubicin|idarubicin|mesh-list
111296043|NCT00198991|Cladribine|cladribine|mesh-list
111296044|NCT00198991|Thioguanine|thioguanine|mesh-list
111296045|NCT00198991|Vindesine|vindesine|mesh-list
111296046|NCT00198991|Teniposide|teniposide|mesh-list
111296047|NCT00198991|Pegaspargase|pegaspargase|mesh-list
111296048|NCT00198991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111296049|NCT00198991|Immunologic Factors|immunologic factors|mesh-ancestor
111296050|NCT00198991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111296051|NCT00198991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111296052|NCT00198991|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111296053|NCT00198991|Alkylating Agents|alkylating agents|mesh-ancestor
111296054|NCT00198991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111296055|NCT00198991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111296056|NCT00198991|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111296057|NCT00198991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111296058|NCT00198991|Antiemetics|antiemetics|mesh-ancestor
111296059|NCT00198991|Autonomic Agents|autonomic agents|mesh-ancestor
111296060|NCT00198991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111296061|NCT00198991|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111296062|NCT00198991|Glucocorticoids|glucocorticoids|mesh-ancestor
111296063|NCT00198991|Hormones|hormones|mesh-ancestor
111296064|NCT00198991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111296065|NCT00198991|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111296066|NCT00198991|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111296067|NCT00198991|Abortifacient Agents|abortifacient agents|mesh-ancestor
111296068|NCT00198991|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111296069|NCT00198991|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111296070|NCT00198991|Antimetabolites|antimetabolites|mesh-ancestor
111296071|NCT00198991|Dermatologic Agents|dermatologic agents|mesh-ancestor
111296072|NCT00198991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111296073|NCT00198991|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111296074|NCT00198991|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111296075|NCT00198991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111296076|NCT00198991|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111296077|NCT00198991|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111296078|NCT00198991|Antiviral Agents|antiviral agents|mesh-ancestor
111296079|NCT00198991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111296080|NCT00198991|Tubulin Modulators|tubulin modulators|mesh-ancestor
111296081|NCT00198991|Antimitotic Agents|antimitotic agents|mesh-ancestor
111296082|NCT00198991|Mitosis Modulators|mitosis modulators|mesh-ancestor
111296083|NCT00198991|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111296084|NCT01459367|Lansoprazole|lansoprazole|mesh-list
111296085|NCT01459367|Dexlansoprazole|dexlansoprazole|mesh-list
111296086|NCT01459367|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111296087|NCT01459367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111296088|NCT01459367|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111296089|NCT01459367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111296090|NCT01459367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111296091|NCT04777591|Bupivacaine|bupivacaine|mesh-list
111296092|NCT04777591|Anesthetics, Local|anesthetics, local|mesh-ancestor
111296093|NCT04777591|Anesthetics|anesthetics|mesh-ancestor
111296094|NCT04777591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111296095|NCT04777591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111296096|NCT04777591|Sensory System Agents|sensory system agents|mesh-ancestor
111296097|NCT04777591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111296098|NCT01459601|Cabergoline|cabergoline|mesh-list
111296099|NCT01459601|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111296100|NCT01459601|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111296101|NCT01459601|Dopamine Agonists|dopamine agonists|mesh-ancestor
111296102|NCT01459601|Dopamine Agents|dopamine agents|mesh-ancestor
111296103|NCT01459601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111296104|NCT01459601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111296105|NCT01459601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111296106|NCT01418001|Gemcitabine|gemcitabine|mesh-list
111296107|NCT01418001|Docetaxel|docetaxel|mesh-list
111296108|NCT01418001|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111296109|NCT01418001|Antimetabolites|antimetabolites|mesh-ancestor
111296110|NCT01418001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111296111|NCT01418001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111296112|NCT01418001|Tubulin Modulators|tubulin modulators|mesh-ancestor
111296113|NCT01418001|Antimitotic Agents|antimitotic agents|mesh-ancestor
111296114|NCT01418001|Mitosis Modulators|mitosis modulators|mesh-ancestor
111296115|NCT00394147|Gemcitabine|gemcitabine|mesh-list
111296116|NCT00394147|Pemetrexed|pemetrexed|mesh-list
111296117|NCT00394147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111296118|NCT00394147|Antimetabolites|antimetabolites|mesh-ancestor
111296119|NCT00394147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111296120|NCT00394147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111296121|NCT00394147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111296122|NCT00394147|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111296123|NCT00394147|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111296124|NCT04776889|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111296125|NCT04776889|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111296126|NCT04776889|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111296127|NCT04776889|Antimetabolites|antimetabolites|mesh-ancestor
111296128|NCT04776889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111296129|NCT04776889|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111296130|NCT04776889|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111296131|NCT04776889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111296132|NCT01542255|Cyclophosphamide|cyclophosphamide|mesh-list
111296133|NCT01542255|Dacarbazine|dacarbazine|mesh-list
111296134|NCT01542255|Vinblastine|vinblastine|mesh-list
111296135|NCT01542255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111296136|NCT01542255|Immunologic Factors|immunologic factors|mesh-ancestor
111296137|NCT01542255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111296138|NCT01542255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111296139|NCT01542255|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111296140|NCT01542255|Alkylating Agents|alkylating agents|mesh-ancestor
111296141|NCT01542255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111296142|NCT01542255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111296143|NCT01542255|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111296144|NCT01542255|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111296145|NCT01542255|Tubulin Modulators|tubulin modulators|mesh-ancestor
111296146|NCT01542255|Antimitotic Agents|antimitotic agents|mesh-ancestor
111296147|NCT01542255|Mitosis Modulators|mitosis modulators|mesh-ancestor
111296148|NCT01456481|Midodrine|midodrine|mesh-list
111296149|NCT01456481|Sympathomimetics|sympathomimetics|mesh-ancestor
111296150|NCT01456481|Autonomic Agents|autonomic agents|mesh-ancestor
111296151|NCT01456481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111296152|NCT01456481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111296153|NCT01456481|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111296154|NCT01456481|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111296155|NCT01456481|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111296156|NCT01456481|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111296157|NCT01456481|Adrenergic Agents|adrenergic agents|mesh-ancestor
111296158|NCT01456481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111296159|NCT01456481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111296160|NCT04776655|Leucovorin|leucovorin|mesh-list
111296161|NCT04776655|Bevacizumab|bevacizumab|mesh-list
111296162|NCT04776655|Cetuximab|cetuximab|mesh-list
111296163|NCT04776655|Fluorouracil|fluorouracil|mesh-list
111296164|NCT04776655|Irinotecan|irinotecan|mesh-list
111296165|NCT04776655|Calcium|calcium|mesh-list
111296166|NCT04776655|Levoleucovorin|levoleucovorin|mesh-list
111296167|NCT04776655|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111296168|NCT04776655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111296169|NCT04776655|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111296170|NCT04776655|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111296171|NCT04776655|Growth Substances|growth substances|mesh-ancestor
111296172|NCT04776655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111296173|NCT04776655|Growth Inhibitors|growth inhibitors|mesh-ancestor
111296174|NCT04776655|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111296175|NCT04776655|Antimetabolites|antimetabolites|mesh-ancestor
111296176|NCT04776655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111296177|NCT04776655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111296178|NCT04776655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111296179|NCT04776655|Immunologic Factors|immunologic factors|mesh-ancestor
111296180|NCT04776655|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111296181|NCT04776655|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111296182|NCT04776655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111296183|NCT04776655|Antidotes|antidotes|mesh-ancestor
111296184|NCT04776655|Protective Agents|protective agents|mesh-ancestor
111296185|NCT04776655|Vitamin B Complex|vitamin b complex|mesh-ancestor
111296186|NCT04776655|Vitamins|vitamins|mesh-ancestor
111296187|NCT04776655|Micronutrients|micronutrients|mesh-ancestor
111296188|NCT01455233|Moxifloxacin|moxifloxacin|mesh-list
111296189|NCT01455233|Besifloxacin|besifloxacin|mesh-list
111296190|NCT01455233|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111296191|NCT01455233|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
111296192|NCT01455233|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111296193|NCT01455233|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111296194|NCT01455233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111296195|NCT01455233|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111296196|NCT01455233|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111296197|NCT01455233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111296198|NCT01455233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111296199|NCT01455233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111296200|NCT01455233|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111296201|NCT01455233|Contraceptive Agents|contraceptive agents|mesh-ancestor
111296202|NCT01455233|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111296203|NCT01455233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111296204|NCT01455233|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
111296205|NCT01455233|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111296206|NCT01455233|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111296207|NCT01459679|Riboflavin|riboflavin|mesh-list
111296208|NCT01459679|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111296209|NCT01459679|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111296210|NCT01459679|Vitamin B Complex|vitamin b complex|mesh-ancestor
111296211|NCT01459679|Vitamins|vitamins|mesh-ancestor
111296212|NCT01459679|Micronutrients|micronutrients|mesh-ancestor
111296213|NCT01459679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111296214|NCT01459679|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111296215|NCT01459679|Dermatologic Agents|dermatologic agents|mesh-ancestor
111296216|NCT00048295|Alicaforsen|alicaforsen|mesh-list
111296217|NCT00048295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111296218|NCT00048295|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111296219|NCT00048295|Immunologic Factors|immunologic factors|mesh-ancestor
111296220|NCT00048295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111296221|NCT01455857|Exenatide|exenatide|mesh-list
111296222|NCT01455857|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111296223|NCT01455857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111296224|NCT01455857|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111296225|NCT01455857|Incretins|incretins|mesh-ancestor
111296226|NCT01455857|Hormones|hormones|mesh-ancestor
110979644|NCT01662310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111296227|NCT01455857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111296228|NCT03043248|Digoxin|digoxin|mesh-list
111296229|NCT03043248|Midazolam|midazolam|mesh-list
111296230|NCT03043248|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111296231|NCT03043248|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111296232|NCT03043248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111296233|NCT03043248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111296234|NCT03043248|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111296235|NCT03043248|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111296236|NCT03043248|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111296237|NCT03043248|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111296238|NCT03043248|Anesthetics, General|anesthetics, general|mesh-ancestor
111296239|NCT03043248|Anesthetics|anesthetics|mesh-ancestor
111296240|NCT03043248|GABA Modulators|gaba modulators|mesh-ancestor
111296241|NCT03043248|GABA Agents|gaba agents|mesh-ancestor
111296242|NCT03043248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111296243|NCT03043248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111296244|NCT03043248|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111296245|NCT03043248|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111296246|NCT03043248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111296247|NCT03043248|Protective Agents|protective agents|mesh-ancestor
111296248|NCT04843631|Ustekinumab|ustekinumab|mesh-list
111296249|NCT04843631|Dermatologic Agents|dermatologic agents|mesh-ancestor
111296250|NCT03043326|Tenofovir|tenofovir|mesh-list
111296251|NCT03043326|Emtricitabine|emtricitabine|mesh-list
111296252|NCT03043326|Antiviral Agents|antiviral agents|mesh-ancestor
111296253|NCT03043326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111296254|NCT03043326|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111296255|NCT03043326|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111296256|NCT03043326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111296257|NCT03043326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111296258|NCT03043326|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111296259|NCT03043326|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111296260|NCT04845737|Vitamin D|vitamin d|mesh-list
111296261|NCT04845737|Vitamins|vitamins|mesh-ancestor
111296262|NCT04845737|Micronutrients|micronutrients|mesh-ancestor
111296263|NCT04845737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111296264|NCT04845737|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111296265|NCT04849715|Rituximab|rituximab|mesh-list
111296266|NCT04849715|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
111296267|NCT04849715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111296268|NCT04849715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111296269|NCT04849715|Immunologic Factors|immunologic factors|mesh-ancestor
111296270|NCT04849715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111296271|NCT04849715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111296272|NCT04849715|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111296273|NCT04849715|Alkylating Agents|alkylating agents|mesh-ancestor
111296274|NCT04849715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111296275|NCT03044964|Ranolazine|ranolazine|mesh-list
111296276|NCT03044964|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111296277|NCT03044964|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111296278|NCT03044964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111296279|NCT01419639|Everolimus|everolimus|mesh-list
111296280|NCT01419639|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111296281|NCT01419639|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111296282|NCT01419639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111296283|NCT01419639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111296284|NCT01419639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111296285|NCT01419639|Immunologic Factors|immunologic factors|mesh-ancestor
111296286|NCT01419639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111296287|NCT01419639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111296288|NCT02856893|Gefitinib|gefitinib|mesh-list
111296289|NCT02856893|Osimertinib|osimertinib|mesh-list
111296290|NCT02856893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111296291|NCT02856893|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111296292|NCT02856893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111296293|NCT02856893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111296294|NCT01419795|Rituximab|rituximab|mesh-list
111296295|NCT01419795|Lenalidomide|lenalidomide|mesh-list
111296296|NCT01419795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111296297|NCT01419795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111296298|NCT01419795|Immunologic Factors|immunologic factors|mesh-ancestor
111296299|NCT01419795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111296300|NCT01419795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111296301|NCT01419795|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111296302|NCT01419795|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111296303|NCT01419795|Growth Substances|growth substances|mesh-ancestor
111296304|NCT01419795|Growth Inhibitors|growth inhibitors|mesh-ancestor
111296305|NCT04783753|Itraconazole|itraconazole|mesh-list
111296306|NCT04783753|Quinidine|quinidine|mesh-list
111296307|NCT04783753|Carbamazepine|carbamazepine|mesh-list
111296308|NCT04783753|Antifungal Agents|antifungal agents|mesh-ancestor
111296309|NCT04783753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111296310|NCT04783753|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111296311|NCT04783753|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111296312|NCT04783753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111296313|NCT04783753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111296314|NCT04783753|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111296315|NCT04783753|Hormone Antagonists|hormone antagonists|mesh-ancestor
111296316|NCT04783753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111296317|NCT04783753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111296318|NCT04783753|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111296319|NCT04783753|Anticonvulsants|anticonvulsants|mesh-ancestor
111296320|NCT04783753|Antimanic Agents|antimanic agents|mesh-ancestor
111296321|NCT04783753|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111296322|NCT04783753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111296323|NCT04783753|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111296324|NCT04783753|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111296325|NCT04783753|Analgesics|analgesics|mesh-ancestor
111296326|NCT04783753|Sensory System Agents|sensory system agents|mesh-ancestor
111296327|NCT04783753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111296328|NCT04783753|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111296329|NCT04783753|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111296330|NCT04783753|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111296331|NCT04783753|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111296332|NCT04783753|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111296333|NCT04783753|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111296334|NCT04783753|Adrenergic Agents|adrenergic agents|mesh-ancestor
111296335|NCT04783753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111296336|NCT04783753|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111296337|NCT04783753|Antimalarials|antimalarials|mesh-ancestor
111296338|NCT04783753|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111296339|NCT04783753|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111296340|NCT04783753|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111296341|NCT04783753|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111296342|NCT04783753|Cholinergic Agents|cholinergic agents|mesh-ancestor
111296343|NCT04783753|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111296344|NCT04783753|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111296345|NCT02856581|Varenicline|varenicline|mesh-list
111296346|NCT02856581|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111296347|NCT02856581|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111296348|NCT02856581|Cholinergic Agents|cholinergic agents|mesh-ancestor
111296349|NCT02856581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111296350|NCT02856581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111296351|NCT02856581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111296352|NCT03042000|Capecitabine|capecitabine|mesh-list
111296353|NCT03042000|Oxaliplatin|oxaliplatin|mesh-list
111296354|NCT03042000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111296355|NCT03042000|Antimetabolites|antimetabolites|mesh-ancestor
111296356|NCT03042000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111296357|NCT03042000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111296358|NCT01039285|Poractant alfa|poractant alfa|mesh-list
111296359|NCT01039285|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
111296360|NCT01039285|Respiratory System Agents|respiratory system agents|mesh-ancestor
111296361|NCT03043482|Calcitriol|calcitriol|mesh-list
111296362|NCT03043482|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111296363|NCT03043482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111296364|NCT03043482|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
111296365|NCT03043482|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111296366|NCT03043482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111296367|NCT03043482|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111296368|NCT03043482|Vitamins|vitamins|mesh-ancestor
111296369|NCT03043482|Micronutrients|micronutrients|mesh-ancestor
111296370|NCT03043482|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111296371|NCT04775563|Vaccines|vaccines|mesh-list
111296372|NCT04775563|Immunologic Factors|immunologic factors|mesh-ancestor
111296373|NCT04775563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111296374|NCT01480089|Ropivacaine|ropivacaine|mesh-list
111296375|NCT01480089|Anesthetics, Local|anesthetics, local|mesh-ancestor
111296376|NCT01480089|Anesthetics|anesthetics|mesh-ancestor
111296377|NCT01480089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111296378|NCT01480089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111296379|NCT01480089|Sensory System Agents|sensory system agents|mesh-ancestor
111296380|NCT01480089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111296381|NCT03523975|Rituximab|rituximab|mesh-list
111296382|NCT03523975|Lenalidomide|lenalidomide|mesh-list
111296383|NCT03523975|Venetoclax|venetoclax|mesh-list
111296384|NCT03523975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111296385|NCT03523975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111296386|NCT03523975|Immunologic Factors|immunologic factors|mesh-ancestor
111296387|NCT03523975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111296388|NCT03523975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111296389|NCT03523975|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111296390|NCT03523975|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111296391|NCT03523975|Growth Substances|growth substances|mesh-ancestor
111296392|NCT03523975|Growth Inhibitors|growth inhibitors|mesh-ancestor
111296393|NCT01542645|Fentanyl|fentanyl|mesh-list
111296394|NCT01542645|Analgesics, Opioid|analgesics, opioid|mesh-list
111296395|NCT01542645|Methadone|methadone|mesh-list
111296396|NCT01542645|Narcotics|narcotics|mesh-ancestor
111296397|NCT01542645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111296398|NCT01542645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111296399|NCT01542645|Analgesics|analgesics|mesh-ancestor
111296400|NCT01542645|Sensory System Agents|sensory system agents|mesh-ancestor
111296401|NCT01542645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111296402|NCT01542645|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111296403|NCT01542645|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111296404|NCT01542645|Anesthetics, General|anesthetics, general|mesh-ancestor
111296405|NCT01542645|Anesthetics|anesthetics|mesh-ancestor
111296406|NCT01542645|Antitussive Agents|antitussive agents|mesh-ancestor
111296407|NCT01542645|Respiratory System Agents|respiratory system agents|mesh-ancestor
111296408|NCT04857450|Ketamine|ketamine|mesh-list
111296409|NCT04857450|Etomidate|etomidate|mesh-list
111296410|NCT04857450|Analgesics|analgesics|mesh-ancestor
111296411|NCT04857450|Sensory System Agents|sensory system agents|mesh-ancestor
111296412|NCT04857450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111296413|NCT04857450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111296414|NCT04857450|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111296415|NCT04857450|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111296416|NCT04857450|Anesthetics, General|anesthetics, general|mesh-ancestor
111296417|NCT04857450|Anesthetics|anesthetics|mesh-ancestor
111296418|NCT04857450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111296419|NCT04857450|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111296420|NCT04857450|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111296421|NCT04857450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111296422|NCT04857450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111296423|NCT04857450|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111296424|NCT01420653|Acetaminophen|acetaminophen|mesh-list
111296425|NCT01420653|Ibuprofen|ibuprofen|mesh-list
111296426|NCT01420653|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111296427|NCT01420653|Analgesics|analgesics|mesh-ancestor
111296428|NCT01420653|Sensory System Agents|sensory system agents|mesh-ancestor
111296429|NCT01420653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111296430|NCT01420653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111296431|NCT01420653|Antipyretics|antipyretics|mesh-ancestor
111296432|NCT01420653|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111296433|NCT01420653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111296434|NCT01420653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111296435|NCT01420653|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111296436|NCT01420653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111296437|NCT01420653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111296438|NCT03042936|Insulin|insulin|mesh-list
111296439|NCT03042936|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111296440|NCT03042936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111296441|NCT01421355|Atazanavir Sulfate|atazanavir sulfate|mesh-list
111296442|NCT01421355|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111296443|NCT01421355|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111296444|NCT01421355|Protease Inhibitors|protease inhibitors|mesh-ancestor
111296445|NCT01421355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111296446|NCT01421355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111296447|NCT01421355|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111296448|NCT01421355|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111296449|NCT01421355|Antiviral Agents|antiviral agents|mesh-ancestor
111296450|NCT01421355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111296451|NCT04844957|Vitamin D|vitamin d|mesh-list
111296452|NCT04844957|Ergocalciferols|ergocalciferols|mesh-list
111296453|NCT04844957|Cholecalciferol|cholecalciferol|mesh-list
111296454|NCT04844957|Vitamins|vitamins|mesh-list
111296455|NCT04844957|Micronutrients|micronutrients|mesh-ancestor
111296456|NCT04844957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111296457|NCT04844957|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111296458|NCT04844957|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111296459|NCT04782115|RC28-E protein|rc28-e protein|mesh-list
111296460|NCT04782115|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111296461|NCT04782115|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111296462|NCT04782115|Growth Substances|growth substances|mesh-ancestor
111296463|NCT04782115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111296464|NCT04782115|Growth Inhibitors|growth inhibitors|mesh-ancestor
111296465|NCT04782115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111296466|NCT01421589|Hormones|hormones|mesh-list
111296467|NCT01421589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111296468|NCT01421589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111296469|NCT01422135|Contraceptive Agents|contraceptive agents|mesh-list
111296470|NCT01422135|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111296471|NCT01422135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111296472|NCT00962845|Hydroxychloroquine|hydroxychloroquine|mesh-list
111296473|NCT00962845|Antimalarials|antimalarials|mesh-ancestor
111296474|NCT00962845|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111296475|NCT00962845|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111296476|NCT00962845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111296477|NCT00962845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111296478|NCT00962845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111296479|NCT00962845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111296480|NCT04390685|Tacrolimus|tacrolimus|mesh-list
111296481|NCT04390685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111296482|NCT04390685|Immunologic Factors|immunologic factors|mesh-ancestor
111296483|NCT04390685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111296484|NCT04390685|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111296485|NCT04390685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111296486|NCT04390685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111296487|NCT04848246|Bupropion|bupropion|mesh-list
111296488|NCT04848246|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111296489|NCT04848246|Antidepressive Agents|antidepressive agents|mesh-ancestor
111296490|NCT04848246|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111296491|NCT04848246|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111296492|NCT04848246|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111296493|NCT04848246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111296494|NCT04848246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111296495|NCT04848246|Dopamine Agents|dopamine agents|mesh-ancestor
111296496|NCT04848246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111296497|NCT04848246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111020960|NCT04997564|Tenofovir|tenofovir|mesh-list
111296498|NCT04848246|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111296499|NCT04848246|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111296500|NCT04848246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111296501|NCT04842071|Listerine|listerine|mesh-list
111296502|NCT04842071|Fluorides|fluorides|mesh-list
111296503|NCT04842071|Sodium Fluoride|sodium fluoride|mesh-list
111296504|NCT04842071|Cariostatic Agents|cariostatic agents|mesh-ancestor
111296505|NCT04842071|Protective Agents|protective agents|mesh-ancestor
111296506|NCT04842071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111296507|NCT04842071|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111296508|NCT04842071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111296509|NCT04774627|Olaparib|olaparib|mesh-list
111296510|NCT04774627|Niraparib|niraparib|mesh-list
111296511|NCT04774627|Talazoparib|talazoparib|mesh-list
111296512|NCT04774627|Veliparib|veliparib|mesh-list
111296513|NCT04774627|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
111296514|NCT04774627|Rucaparib|rucaparib|mesh-list
111296515|NCT04774627|Pamiparib|pamiparib|mesh-list
111296516|NCT04774627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111296517|NCT04774627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111296518|NCT04774627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111296519|NCT01545141|Interferons|interferons|mesh-list
111296520|NCT01545141|Interferon-alpha|interferon-alpha|mesh-list
111296521|NCT01545141|Interferon alpha-2|interferon alpha-2|mesh-list
111296522|NCT01545141|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
111296523|NCT01545141|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
111296524|NCT01545141|Poly I-C|poly i-c|mesh-list
111296525|NCT01545141|Celecoxib|celecoxib|mesh-list
111296526|NCT01545141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111296527|NCT01545141|Antiviral Agents|antiviral agents|mesh-ancestor
111296528|NCT01545141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111296529|NCT01545141|Immunologic Factors|immunologic factors|mesh-ancestor
111296530|NCT01545141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111296531|NCT01545141|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111296532|NCT01545141|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111296533|NCT01545141|Analgesics|analgesics|mesh-ancestor
111296534|NCT01545141|Sensory System Agents|sensory system agents|mesh-ancestor
111296535|NCT01545141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111296536|NCT01545141|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111296537|NCT01545141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111296538|NCT01545141|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111296539|NCT01545141|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111296540|NCT01545141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111296541|NCT01545141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111296542|NCT01545141|Interferon Inducers|interferon inducers|mesh-ancestor
111296543|NCT04855968|Analgesics|analgesics|mesh-list
111296544|NCT04855968|Sensory System Agents|sensory system agents|mesh-ancestor
111296545|NCT04855968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111296546|NCT04855968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111296547|NCT01545765|Lidocaine|lidocaine|mesh-list
111296548|NCT01545765|Tetracaine|tetracaine|mesh-list
111296549|NCT01545765|Anesthetics, Local|anesthetics, local|mesh-ancestor
111296550|NCT01545765|Anesthetics|anesthetics|mesh-ancestor
111296551|NCT01545765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111296552|NCT01545765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111296553|NCT01545765|Sensory System Agents|sensory system agents|mesh-ancestor
111296554|NCT01545765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111296555|NCT01545765|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111296556|NCT01545765|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111296557|NCT01545765|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111296558|NCT01545765|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111296559|NCT01545765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111296560|NCT04856124|Ketamine|ketamine|mesh-list
111296561|NCT04856124|Esketamine|esketamine|mesh-list
111296562|NCT04856124|Analgesics|analgesics|mesh-ancestor
111296563|NCT04856124|Sensory System Agents|sensory system agents|mesh-ancestor
111296564|NCT04856124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111296565|NCT04856124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111296566|NCT04856124|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111296567|NCT04856124|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111296568|NCT04856124|Anesthetics, General|anesthetics, general|mesh-ancestor
111296569|NCT04856124|Anesthetics|anesthetics|mesh-ancestor
111296570|NCT04856124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111296571|NCT04856124|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111296572|NCT04856124|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111296573|NCT04856124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111296574|NCT04856124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111296575|NCT04856124|Antidepressive Agents|antidepressive agents|mesh-ancestor
111296576|NCT04856124|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111296577|NCT04028479|Immunomodulating Agents|immunomodulating agents|mesh-list
111296578|NCT04028479|Immunologic Factors|immunologic factors|mesh-ancestor
111296579|NCT04028479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111296580|NCT02208297|Loteprednol Etabonate|loteprednol etabonate|mesh-list
111296581|NCT02208297|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111296582|NCT04847622|Remdesivir|remdesivir|mesh-list
111296583|NCT04847622|Antimetabolites|antimetabolites|mesh-ancestor
111296584|NCT04847622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111296585|NCT04847622|Antiviral Agents|antiviral agents|mesh-ancestor
111296586|NCT04847622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111296587|NCT04781803|Cyclosporine|cyclosporine|mesh-list
111296588|NCT04781803|Cyclosporins|cyclosporins|mesh-list
111296589|NCT04781803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111296590|NCT04781803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111296591|NCT04781803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111296592|NCT04781803|Immunologic Factors|immunologic factors|mesh-ancestor
111296593|NCT04781803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111296594|NCT04781803|Antifungal Agents|antifungal agents|mesh-ancestor
111296595|NCT04781803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111296596|NCT04781803|Dermatologic Agents|dermatologic agents|mesh-ancestor
111296597|NCT04781803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111296598|NCT04781803|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111296599|NCT01422369|Ritonavir|ritonavir|mesh-list
111296600|NCT01422369|Darunavir|darunavir|mesh-list
111296601|NCT01422369|Pitavastatin|pitavastatin|mesh-list
111296602|NCT01422369|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111296603|NCT01422369|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111296604|NCT01422369|Protease Inhibitors|protease inhibitors|mesh-ancestor
111296605|NCT01422369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111296606|NCT01422369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111296607|NCT01422369|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111296608|NCT01422369|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111296609|NCT01422369|Antiviral Agents|antiviral agents|mesh-ancestor
111296610|NCT01422369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111296611|NCT01422369|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111296612|NCT01422369|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111296613|NCT01422369|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111296614|NCT01422369|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111296615|NCT01422369|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111296616|NCT01422369|Antimetabolites|antimetabolites|mesh-ancestor
111296617|NCT01422369|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111296618|NCT05023343|Ropivacaine|ropivacaine|mesh-list
111296619|NCT05023343|Anesthetics, Local|anesthetics, local|mesh-ancestor
111296620|NCT05023343|Anesthetics|anesthetics|mesh-ancestor
111296621|NCT05023343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111296622|NCT05023343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111296623|NCT05023343|Sensory System Agents|sensory system agents|mesh-ancestor
111296624|NCT05023343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111296625|NCT04859556|Dipivefrin|dipivefrin|mesh-list
111296626|NCT04859556|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111296627|NCT04859556|Adrenergic Agents|adrenergic agents|mesh-ancestor
111296628|NCT04859556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111296629|NCT04859556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111296630|NCT04859556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111296631|NCT04781335|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111296632|NCT04781335|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111296633|NCT04781335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111296634|NCT04781335|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111296635|NCT04773301|Ropivacaine|ropivacaine|mesh-list
111296636|NCT04773301|Levobupivacaine|levobupivacaine|mesh-list
111296637|NCT04773301|Anesthetics, Local|anesthetics, local|mesh-ancestor
111296638|NCT04773301|Anesthetics|anesthetics|mesh-ancestor
111296639|NCT04773301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111296640|NCT04773301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111296641|NCT04773301|Sensory System Agents|sensory system agents|mesh-ancestor
111296642|NCT04773301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111296643|NCT04780945|Olaparib|olaparib|mesh-list
111296644|NCT04780945|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111296645|NCT04780945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111296646|NCT04780945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111296647|NCT04780945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111296648|NCT05021315|Povidone-Iodine|povidone-iodine|mesh-list
111021084|NCT04991012|Immunologic Factors|immunologic factors|mesh-ancestor
111296649|NCT05021315|Povidone|povidone|mesh-list
111296650|NCT05021315|Plasma Substitutes|plasma substitutes|mesh-ancestor
111296651|NCT05021315|Blood Substitutes|blood substitutes|mesh-ancestor
111296652|NCT05021315|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111296653|NCT05021315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111296654|NCT01427517|Acetylcysteine|acetylcysteine|mesh-list
111296655|NCT01427517|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111296656|NCT01427517|Antiviral Agents|antiviral agents|mesh-ancestor
111296657|NCT01427517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111296658|NCT01427517|Expectorants|expectorants|mesh-ancestor
111296659|NCT01427517|Respiratory System Agents|respiratory system agents|mesh-ancestor
111296660|NCT01427517|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111296661|NCT01427517|Antioxidants|antioxidants|mesh-ancestor
111296662|NCT01427517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111296663|NCT01427517|Protective Agents|protective agents|mesh-ancestor
111296664|NCT01427517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111296665|NCT01427517|Antidotes|antidotes|mesh-ancestor
111296666|NCT02835131|Pasireotide|pasireotide|mesh-list
111296667|NCT02835131|Hormones|hormones|mesh-ancestor
111296668|NCT02835131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111296669|NCT02835131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111296670|NCT04846452|Paclitaxel|paclitaxel|mesh-list
111296671|NCT04846452|Carboplatin|carboplatin|mesh-list
111296672|NCT04846452|Pemetrexed|pemetrexed|mesh-list
111296673|NCT04846452|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111296674|NCT04846452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111296675|NCT04846452|Tubulin Modulators|tubulin modulators|mesh-ancestor
111296676|NCT04846452|Antimitotic Agents|antimitotic agents|mesh-ancestor
111296677|NCT04846452|Mitosis Modulators|mitosis modulators|mesh-ancestor
111296678|NCT04846452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111296679|NCT04846452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111296680|NCT04846452|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111296681|NCT04846452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111296682|NCT04859244|Remdesivir|remdesivir|mesh-list
111296683|NCT04859244|GS-441524|gs-441524|mesh-list
111296684|NCT04859244|Antimetabolites|antimetabolites|mesh-ancestor
111296685|NCT04859244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111296686|NCT04859244|Antiviral Agents|antiviral agents|mesh-ancestor
111296687|NCT04859244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111296688|NCT05028725|Lugol's solution|lugol's solution|mesh-list
111296689|NCT05028725|Hemostatics|hemostatics|mesh-ancestor
111296690|NCT05028725|Coagulants|coagulants|mesh-ancestor
111296691|NCT04779853|Antibodies|antibodies|mesh-list
111296692|NCT04779853|Immunologic Factors|immunologic factors|mesh-ancestor
111296693|NCT04779853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111296694|NCT04855110|Warfarin|warfarin|mesh-list
111296695|NCT04855110|Anticoagulants|anticoagulants|mesh-ancestor
111296696|NCT01485393|Dexmedetomidine|dexmedetomidine|mesh-list
111296697|NCT01485393|Zolpidem|zolpidem|mesh-list
111296698|NCT01485393|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111296699|NCT01485393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111296700|NCT01485393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111296701|NCT01485393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111296702|NCT01485393|Analgesics|analgesics|mesh-ancestor
111296703|NCT01485393|Sensory System Agents|sensory system agents|mesh-ancestor
111296704|NCT01485393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111296705|NCT01485393|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111296706|NCT01485393|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111296707|NCT01485393|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111296708|NCT01485393|Adrenergic Agents|adrenergic agents|mesh-ancestor
111296709|NCT01485393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111296710|NCT01485393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111296711|NCT01485393|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111296712|NCT01485393|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
111296713|NCT01485393|GABA Agonists|gaba agonists|mesh-ancestor
111296714|NCT01485393|GABA Agents|gaba agents|mesh-ancestor
111296715|NCT04772521|Nicotine|nicotine|mesh-list
111296716|NCT04772521|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111296717|NCT04772521|Autonomic Agents|autonomic agents|mesh-ancestor
111296718|NCT04772521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111296719|NCT04772521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111296720|NCT04772521|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111296721|NCT04772521|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111296722|NCT04772521|Cholinergic Agents|cholinergic agents|mesh-ancestor
111296723|NCT04772521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111296724|NCT04772521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111296725|NCT04772287|Paclitaxel|paclitaxel|mesh-list
111296726|NCT04772287|Vinorelbine|vinorelbine|mesh-list
111296727|NCT04772287|Docetaxel|docetaxel|mesh-list
111296728|NCT04772287|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111296729|NCT04772287|Cisplatin|cisplatin|mesh-list
111296730|NCT04772287|Carboplatin|carboplatin|mesh-list
111296731|NCT04772287|Gemcitabine|gemcitabine|mesh-list
111296732|NCT04772287|Pemetrexed|pemetrexed|mesh-list
111296733|NCT04772287|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111296734|NCT04772287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111296735|NCT04772287|Tubulin Modulators|tubulin modulators|mesh-ancestor
111296736|NCT04772287|Antimitotic Agents|antimitotic agents|mesh-ancestor
111296737|NCT04772287|Mitosis Modulators|mitosis modulators|mesh-ancestor
111296738|NCT04772287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111296739|NCT04772287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111296740|NCT04772287|Antimetabolites|antimetabolites|mesh-ancestor
111296741|NCT04772287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111296742|NCT04772287|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111296743|NCT04772287|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111296744|NCT01890005|Aspirin|aspirin|mesh-list
111296745|NCT01890005|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111296746|NCT01890005|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111296747|NCT01890005|Analgesics|analgesics|mesh-ancestor
111296748|NCT01890005|Sensory System Agents|sensory system agents|mesh-ancestor
111296749|NCT01890005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111296750|NCT01890005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111296751|NCT01890005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111296752|NCT01890005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111296753|NCT01890005|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111296754|NCT01890005|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111296755|NCT01890005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111296756|NCT01890005|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111296757|NCT01890005|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111296758|NCT01890005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111296759|NCT01890005|Antipyretics|antipyretics|mesh-ancestor
111296760|NCT04854252|Fentanyl|fentanyl|mesh-list
111296761|NCT04854252|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111296762|NCT04854252|Narcotics|narcotics|mesh-ancestor
111296763|NCT04854252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111296764|NCT04854252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111296765|NCT04854252|Analgesics|analgesics|mesh-ancestor
111296766|NCT04854252|Sensory System Agents|sensory system agents|mesh-ancestor
111296767|NCT04854252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111296768|NCT04854252|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111296769|NCT04854252|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111296770|NCT04854252|Anesthetics, General|anesthetics, general|mesh-ancestor
111296771|NCT04854252|Anesthetics|anesthetics|mesh-ancestor
111296772|NCT03040830|Progesterone|progesterone|mesh-list
111296773|NCT03040830|Progestins|progestins|mesh-ancestor
111296774|NCT03040830|Hormones|hormones|mesh-ancestor
111296775|NCT03040830|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111296776|NCT03040830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111296777|NCT04390295|Metformin|metformin|mesh-list
111296778|NCT04390295|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111296779|NCT04390295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111296780|NCT03030235|Dapagliflozin|dapagliflozin|mesh-list
111296781|NCT03030235|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111296782|NCT03030235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111296783|NCT03030235|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111296784|NCT03030235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111296785|NCT04845672|Chlorhexidine|chlorhexidine|mesh-list
111296786|NCT04845672|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
111296787|NCT04845672|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111296788|NCT04845672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111296789|NCT04845672|Disinfectants|disinfectants|mesh-ancestor
111296790|NCT04845672|Dermatologic Agents|dermatologic agents|mesh-ancestor
111296791|NCT01890629|Metformin|metformin|mesh-list
111296792|NCT01890629|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111296793|NCT01890629|Glimepiride|glimepiride|mesh-list
111296794|NCT01890629|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111296795|NCT01890629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111296796|NCT01890629|Incretins|incretins|mesh-ancestor
111296797|NCT01890629|Hormones|hormones|mesh-ancestor
111296798|NCT01890629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111296799|NCT01890629|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111296800|NCT01890629|Protease Inhibitors|protease inhibitors|mesh-ancestor
111296801|NCT01890629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111296802|NCT01890629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111021233|NCT03070028|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111296803|NCT01890629|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111296804|NCT01890629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111296805|NCT01890629|Immunologic Factors|immunologic factors|mesh-ancestor
111296806|NCT01890863|Fluticasone|fluticasone|mesh-list
111296807|NCT01890863|Xhance|xhance|mesh-list
111296808|NCT01890863|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
111296809|NCT01890863|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
111296810|NCT01890863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111296811|NCT01890863|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111296812|NCT01890863|Autonomic Agents|autonomic agents|mesh-ancestor
111296813|NCT01890863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111296814|NCT01890863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111296815|NCT01890863|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111296816|NCT01890863|Respiratory System Agents|respiratory system agents|mesh-ancestor
111296817|NCT01890863|Dermatologic Agents|dermatologic agents|mesh-ancestor
111296818|NCT01890863|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111296819|NCT01890863|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111296820|NCT01890863|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111296821|NCT01890863|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111296822|NCT01890863|Adrenergic Agents|adrenergic agents|mesh-ancestor
111296823|NCT01890863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111296824|NCT01890863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111296825|NCT01890863|Glucocorticoids|glucocorticoids|mesh-ancestor
111296826|NCT01890863|Hormones|hormones|mesh-ancestor
111296827|NCT01890863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111296828|NCT01890863|Sympathomimetics|sympathomimetics|mesh-ancestor
111296829|NCT02955511|Pyrithione zinc|pyrithione zinc|mesh-list
111296830|NCT02955511|Keratolytic Agents|keratolytic agents|mesh-ancestor
111296831|NCT02955511|Dermatologic Agents|dermatologic agents|mesh-ancestor
111296832|NCT01890941|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111296833|NCT01890941|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111296834|NCT01891019|Thalidomide|thalidomide|mesh-list
111296835|NCT01891019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111296836|NCT01891019|Immunologic Factors|immunologic factors|mesh-ancestor
111296837|NCT01891019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111296838|NCT01891019|Leprostatic Agents|leprostatic agents|mesh-ancestor
111296839|NCT01891019|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111296840|NCT01891019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111296841|NCT01891019|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111296842|NCT01891019|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111296843|NCT01891019|Growth Substances|growth substances|mesh-ancestor
111296844|NCT01891019|Growth Inhibitors|growth inhibitors|mesh-ancestor
111296845|NCT01891019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111296846|NCT04374474|Budesonide|budesonide|mesh-list
111296847|NCT04374474|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111296848|NCT04374474|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111296849|NCT04374474|Autonomic Agents|autonomic agents|mesh-ancestor
111296850|NCT04374474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111296851|NCT04374474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111296852|NCT04374474|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111296853|NCT04374474|Respiratory System Agents|respiratory system agents|mesh-ancestor
111296854|NCT04374474|Glucocorticoids|glucocorticoids|mesh-ancestor
111296855|NCT04374474|Hormones|hormones|mesh-ancestor
111296856|NCT04374474|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111296857|NCT02983097|Cytarabine|cytarabine|mesh-list
111296858|NCT02983097|Dexamethasone|dexamethasone|mesh-list
111296859|NCT02983097|Rituximab|rituximab|mesh-list
111296860|NCT02983097|Carboplatin|carboplatin|mesh-list
111296861|NCT02983097|Lenalidomide|lenalidomide|mesh-list
111296862|NCT02983097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111296863|NCT02983097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111296864|NCT02983097|Immunologic Factors|immunologic factors|mesh-ancestor
111296865|NCT02983097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111296866|NCT02983097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111296867|NCT02983097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111296868|NCT02983097|Antiemetics|antiemetics|mesh-ancestor
111296869|NCT02983097|Autonomic Agents|autonomic agents|mesh-ancestor
111296870|NCT02983097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111296871|NCT02983097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111296872|NCT02983097|Glucocorticoids|glucocorticoids|mesh-ancestor
111296873|NCT02983097|Hormones|hormones|mesh-ancestor
111296874|NCT02983097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111296875|NCT02983097|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111296876|NCT02983097|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111296877|NCT02983097|Antimetabolites|antimetabolites|mesh-ancestor
111296878|NCT02983097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111296879|NCT02983097|Antiviral Agents|antiviral agents|mesh-ancestor
111296880|NCT02983097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111296881|NCT02983097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111296882|NCT02983097|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111296883|NCT02983097|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111296884|NCT02983097|Growth Substances|growth substances|mesh-ancestor
111296885|NCT02983097|Growth Inhibitors|growth inhibitors|mesh-ancestor
111296887|NCT01891175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111296888|NCT01891175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111296889|NCT02347865|Denosumab|denosumab|mesh-list
111296890|NCT02347865|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111296891|NCT02347865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111296892|NCT01550367|Hydroxychloroquine|hydroxychloroquine|mesh-list
111296893|NCT01550367|Aldesleukin|aldesleukin|mesh-list
111296894|NCT01550367|Antimalarials|antimalarials|mesh-ancestor
111296895|NCT01550367|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111296896|NCT01550367|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111296897|NCT01550367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111296898|NCT01550367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111296899|NCT01550367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111296900|NCT01550367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111296901|NCT01550367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111296902|NCT01550367|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111296903|NCT01550367|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111296904|NCT01550367|Antiviral Agents|antiviral agents|mesh-ancestor
111296905|NCT01427595|Metformin|metformin|mesh-list
111296906|NCT01427595|Progesterone|progesterone|mesh-list
111296907|NCT01427595|Estradiol|estradiol|mesh-list
111296908|NCT01427595|Estrogens|estrogens|mesh-list
111296909|NCT01427595|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111296910|NCT01427595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111296911|NCT01427595|Progestins|progestins|mesh-ancestor
111296912|NCT01427595|Hormones|hormones|mesh-ancestor
111296913|NCT01427595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111296914|NCT04390061|Hydroxychloroquine|hydroxychloroquine|mesh-list
111296915|NCT04390061|Tofacitinib|tofacitinib|mesh-list
111296916|NCT04390061|Antimalarials|antimalarials|mesh-ancestor
111296917|NCT04390061|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111296918|NCT04390061|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111296919|NCT04390061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111296920|NCT04390061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111296921|NCT04390061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111296922|NCT04390061|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111296923|NCT04390061|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
111296924|NCT04390061|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111296925|NCT01892813|Bupropion|bupropion|mesh-list
111296926|NCT01892813|Nicotine|nicotine|mesh-list
111296927|NCT01892813|Varenicline|varenicline|mesh-list
111296928|NCT01892813|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111296929|NCT01892813|Autonomic Agents|autonomic agents|mesh-ancestor
111296930|NCT01892813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111296931|NCT01892813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111296932|NCT01892813|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111296933|NCT01892813|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111296934|NCT01892813|Cholinergic Agents|cholinergic agents|mesh-ancestor
111296935|NCT01892813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111296936|NCT01892813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111296937|NCT01892813|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111296938|NCT01892813|Antidepressive Agents|antidepressive agents|mesh-ancestor
111296939|NCT01892813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111296940|NCT01892813|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111296941|NCT01892813|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111296942|NCT01892813|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111296943|NCT01892813|Dopamine Agents|dopamine agents|mesh-ancestor
111296944|NCT01892813|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111296945|NCT01892813|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111296946|NCT01892813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111296947|NCT00716443|Lidocaine|lidocaine|mesh-list
111296948|NCT00716443|Tetracaine|tetracaine|mesh-list
111296949|NCT00716443|Benzocaine|benzocaine|mesh-list
111296950|NCT00716443|Anesthetics, Local|anesthetics, local|mesh-ancestor
111296951|NCT00716443|Anesthetics|anesthetics|mesh-ancestor
110979676|NCT03628625|Oxytocics|oxytocics|mesh-ancestor
111296952|NCT00716443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111296953|NCT00716443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111296954|NCT00716443|Sensory System Agents|sensory system agents|mesh-ancestor
111296955|NCT00716443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111296956|NCT00716443|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111296957|NCT00716443|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111296958|NCT00716443|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111296959|NCT00716443|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111296960|NCT00716443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111296961|NCT00650143|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111296962|NCT00650143|Lenograstim|lenograstim|mesh-list
111296963|NCT00650143|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111296964|NCT00650143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111296965|NCT00650143|Incretins|incretins|mesh-ancestor
111296966|NCT00650143|Hormones|hormones|mesh-ancestor
111296967|NCT00650143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111296968|NCT00650143|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111296969|NCT00650143|Protease Inhibitors|protease inhibitors|mesh-ancestor
111296970|NCT00650143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111296971|NCT00650143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111296972|NCT00650143|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111296973|NCT00650143|Immunologic Factors|immunologic factors|mesh-ancestor
111296974|NCT04770961|Ropivacaine|ropivacaine|mesh-list
111296975|NCT04770961|Anesthetics, Local|anesthetics, local|mesh-ancestor
111296976|NCT04770961|Anesthetics|anesthetics|mesh-ancestor
111296977|NCT04770961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111296978|NCT04770961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111296979|NCT04770961|Sensory System Agents|sensory system agents|mesh-ancestor
111296980|NCT04770961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111296981|NCT04753489|Rivaroxaban|rivaroxaban|mesh-list
111296982|NCT04753489|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111296983|NCT04753489|Antithrombins|antithrombins|mesh-ancestor
111296984|NCT04753489|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111296985|NCT04753489|Protease Inhibitors|protease inhibitors|mesh-ancestor
111296986|NCT04753489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111296987|NCT04753489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111296988|NCT04753489|Anticoagulants|anticoagulants|mesh-ancestor
111296989|NCT04769557|Acetaminophen|acetaminophen|mesh-list
111296990|NCT04769557|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111296991|NCT04769557|Analgesics|analgesics|mesh-ancestor
111296992|NCT04769557|Sensory System Agents|sensory system agents|mesh-ancestor
111296993|NCT04769557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111296994|NCT04769557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111296995|NCT04769557|Antipyretics|antipyretics|mesh-ancestor
111296996|NCT05606497|Dexamethasone|dexamethasone|mesh-list
111296997|NCT05606497|Betamethasone|betamethasone|mesh-list
111296998|NCT05606497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111296999|NCT05606497|Antiemetics|antiemetics|mesh-ancestor
111297000|NCT05606497|Autonomic Agents|autonomic agents|mesh-ancestor
111297001|NCT05606497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111297002|NCT05606497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111297003|NCT05606497|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111297004|NCT05606497|Glucocorticoids|glucocorticoids|mesh-ancestor
111297005|NCT05606497|Hormones|hormones|mesh-ancestor
111297006|NCT05606497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111297007|NCT05606497|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111297008|NCT05606497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111297009|NCT05606497|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111297010|NCT05606497|Respiratory System Agents|respiratory system agents|mesh-ancestor
111297011|NCT04778917|Heparin|heparin|mesh-list
111297012|NCT04778917|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
111297013|NCT04778917|Tinzaparin|tinzaparin|mesh-list
111297014|NCT04778917|Dalteparin|dalteparin|mesh-list
111297015|NCT04778917|Calcium heparin|calcium heparin|mesh-list
111297016|NCT04778917|Calcium|calcium|mesh-list
111297017|NCT04778917|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111297018|NCT04778917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111297019|NCT04778917|Anticoagulants|anticoagulants|mesh-ancestor
111297020|NCT04778917|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111297021|NCT04778917|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111297022|NCT04778917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111297023|NCT02213289|Nivolumab|nivolumab|mesh-list
111297024|NCT02213289|Trastuzumab|trastuzumab|mesh-list
111297025|NCT02213289|Bemarituzumab|bemarituzumab|mesh-list
111297026|NCT02213289|Ramucirumab|ramucirumab|mesh-list
111297027|NCT02213289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111297028|NCT02213289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111297029|NCT02213289|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111297030|NCT02213289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111297031|NCT05606107|Tofacitinib|tofacitinib|mesh-list
111297032|NCT05606107|Glucocorticoids|glucocorticoids|mesh-list
111297033|NCT05606107|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
111297034|NCT05606107|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111297035|NCT05606107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111297036|NCT05606107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111297037|NCT05606107|Hormones|hormones|mesh-ancestor
111297038|NCT05606107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111297039|NCT05606107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111297040|NCT00053989|Mycophenolic Acid|mycophenolic acid|mesh-list
111297041|NCT00053989|Methylprednisolone|methylprednisolone|mesh-list
111297042|NCT00053989|Cyclophosphamide|cyclophosphamide|mesh-list
111297043|NCT00053989|Fludarabine|fludarabine|mesh-list
111297044|NCT00053989|Fludarabine phosphate|fludarabine phosphate|mesh-list
111297045|NCT00053989|Tacrolimus|tacrolimus|mesh-list
111297046|NCT00053989|Antilymphocyte Serum|antilymphocyte serum|mesh-list
111297047|NCT00053989|Sargramostim|sargramostim|mesh-list
111297048|NCT00053989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111297049|NCT00053989|Immunologic Factors|immunologic factors|mesh-ancestor
111297050|NCT00053989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111297051|NCT00053989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111297052|NCT00053989|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111297053|NCT00053989|Alkylating Agents|alkylating agents|mesh-ancestor
111297054|NCT00053989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111297055|NCT00053989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111297056|NCT00053989|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111297057|NCT00053989|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111297058|NCT00053989|Antimetabolites|antimetabolites|mesh-ancestor
111297059|NCT00053989|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111297060|NCT00053989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111297061|NCT00053989|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111297062|NCT00053989|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111297063|NCT00053989|Antitubercular Agents|antitubercular agents|mesh-ancestor
111297064|NCT00053989|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111297065|NCT00053989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111297066|NCT00053989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111297067|NCT00053989|Antiemetics|antiemetics|mesh-ancestor
111297068|NCT00053989|Autonomic Agents|autonomic agents|mesh-ancestor
111297069|NCT00053989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111297070|NCT00053989|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111297071|NCT00053989|Glucocorticoids|glucocorticoids|mesh-ancestor
111297072|NCT00053989|Hormones|hormones|mesh-ancestor
111297073|NCT00053989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111297074|NCT00053989|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111297075|NCT00053989|Protective Agents|protective agents|mesh-ancestor
111297076|NCT02740595|Nicotine|nicotine|mesh-list
111297077|NCT02740595|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111297078|NCT02740595|Autonomic Agents|autonomic agents|mesh-ancestor
111297079|NCT02740595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111297080|NCT02740595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111297081|NCT02740595|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111297082|NCT02740595|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111297083|NCT02740595|Cholinergic Agents|cholinergic agents|mesh-ancestor
111297084|NCT02740595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111297085|NCT02740595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111297086|NCT02214615|Carbamazepine|carbamazepine|mesh-list
111297087|NCT02214615|Anticonvulsants|anticonvulsants|mesh-ancestor
111297088|NCT02214615|Antimanic Agents|antimanic agents|mesh-ancestor
111297089|NCT02214615|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111297090|NCT02214615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111297091|NCT02214615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111297092|NCT02214615|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111297093|NCT02214615|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111297094|NCT02214615|Analgesics|analgesics|mesh-ancestor
111297095|NCT02214615|Sensory System Agents|sensory system agents|mesh-ancestor
111297096|NCT02214615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111297097|NCT02214615|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111297098|NCT02214615|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110979678|NCT02553928|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111297099|NCT02214615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111297100|NCT02214615|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111297101|NCT02214615|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111297102|NCT02661503|Dexamethasone|dexamethasone|mesh-list
111297103|NCT02661503|Prednisone|prednisone|mesh-list
111297104|NCT02661503|Cyclophosphamide|cyclophosphamide|mesh-list
111297105|NCT02661503|Dacarbazine|dacarbazine|mesh-list
111297106|NCT02661503|Doxorubicin|doxorubicin|mesh-list
111297107|NCT02661503|Etoposide|etoposide|mesh-list
111297109|NCT02661503|Bleomycin|bleomycin|mesh-list
111297110|NCT02661503|Brentuximab Vedotin|brentuximab vedotin|mesh-list
111297111|NCT02661503|Procarbazine|procarbazine|mesh-list
111297112|NCT02661503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111297113|NCT02661503|Immunologic Factors|immunologic factors|mesh-ancestor
111297114|NCT02661503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111297115|NCT02661503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111297116|NCT02661503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111297117|NCT02661503|Alkylating Agents|alkylating agents|mesh-ancestor
111297118|NCT02661503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111297119|NCT02661503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111297120|NCT02661503|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111297121|NCT02661503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111297122|NCT02661503|Antiemetics|antiemetics|mesh-ancestor
111297123|NCT02661503|Autonomic Agents|autonomic agents|mesh-ancestor
111297124|NCT02661503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111297125|NCT02661503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111297126|NCT02661503|Glucocorticoids|glucocorticoids|mesh-ancestor
111297127|NCT02661503|Hormones|hormones|mesh-ancestor
111297128|NCT02661503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111297129|NCT02661503|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111297130|NCT02661503|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111297131|NCT02661503|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111297132|NCT02661503|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111297133|NCT02661503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111297134|NCT02661503|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111297135|NCT02661503|Tubulin Modulators|tubulin modulators|mesh-ancestor
111297136|NCT02661503|Antimitotic Agents|antimitotic agents|mesh-ancestor
111297137|NCT02661503|Mitosis Modulators|mitosis modulators|mesh-ancestor
111297138|NCT02661503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111297139|NCT02661503|Immunotoxins|immunotoxins|mesh-ancestor
111297140|NCT02661503|Immunoconjugates|immunoconjugates|mesh-ancestor
111297141|NCT01430091|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
111297142|NCT01430091|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111297143|NCT03040752|Nifedipine|nifedipine|mesh-list
111297144|NCT03040752|Ritodrine|ritodrine|mesh-list
111297145|NCT03040752|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111297146|NCT03040752|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111297147|NCT03040752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111297148|NCT03040752|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111297149|NCT03040752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111297150|NCT03040752|Vasodilator Agents|vasodilator agents|mesh-ancestor
111297151|NCT03040752|Tocolytic Agents|tocolytic agents|mesh-ancestor
111297152|NCT03040752|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111297153|NCT03040752|Sympathomimetics|sympathomimetics|mesh-ancestor
111297154|NCT03040752|Autonomic Agents|autonomic agents|mesh-ancestor
111297155|NCT03040752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111297156|NCT03040752|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111297157|NCT03040752|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111297158|NCT03040752|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111297159|NCT03040752|Adrenergic Agents|adrenergic agents|mesh-ancestor
111297160|NCT03040752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111297161|NCT01668654|Ezogabine|ezogabine|mesh-list
111297162|NCT01668654|Anticonvulsants|anticonvulsants|mesh-ancestor
111297163|NCT01668654|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111297164|NCT01668654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111297165|NCT01431105|Atorvastatin|atorvastatin|mesh-list
111297166|NCT01431105|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111297167|NCT01431105|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111297168|NCT01431105|Antimetabolites|antimetabolites|mesh-ancestor
111297169|NCT01431105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111297170|NCT01431105|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111297171|NCT01431105|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111297172|NCT01431105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111297173|NCT03038958|Prilocaine|prilocaine|mesh-list
111297174|NCT03038958|Chloroprocaine|chloroprocaine|mesh-list
111297175|NCT03038958|Anesthetics, Local|anesthetics, local|mesh-ancestor
111297176|NCT03038958|Anesthetics|anesthetics|mesh-ancestor
111297177|NCT03038958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111297178|NCT03038958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111297179|NCT03038958|Sensory System Agents|sensory system agents|mesh-ancestor
111297180|NCT03038958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111297181|NCT04840290|Paclitaxel|paclitaxel|mesh-list
111297182|NCT04840290|Carboplatin|carboplatin|mesh-list
111297183|NCT04840290|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111297184|NCT04840290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111297185|NCT04840290|Tubulin Modulators|tubulin modulators|mesh-ancestor
111297186|NCT04840290|Antimitotic Agents|antimitotic agents|mesh-ancestor
111297187|NCT04840290|Mitosis Modulators|mitosis modulators|mesh-ancestor
111297188|NCT04840290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111297189|NCT02630069|Choline|choline|mesh-list
111297190|NCT02630069|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
111297191|NCT02630069|Lipotropic Agents|lipotropic agents|mesh-ancestor
111297192|NCT02630069|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111297193|NCT02630069|Antimetabolites|antimetabolites|mesh-ancestor
111297194|NCT02630069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111297195|NCT02630069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111297196|NCT02630069|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111297197|NCT02630069|Nootropic Agents|nootropic agents|mesh-ancestor
111297198|NCT01431339|Vancomycin|vancomycin|mesh-list
111297199|NCT01431339|Linezolid|linezolid|mesh-list
111297200|NCT01431339|Dalbavancin|dalbavancin|mesh-list
111297201|NCT01431339|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111297202|NCT01431339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111297203|NCT01431339|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111297204|NCT01431339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111297205|NCT01431339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111297206|NCT02596685|Nicotine|nicotine|mesh-list
111297207|NCT02596685|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111297208|NCT02596685|Autonomic Agents|autonomic agents|mesh-ancestor
111297209|NCT02596685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111297210|NCT02596685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111297211|NCT02596685|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111297212|NCT02596685|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111297213|NCT02596685|Cholinergic Agents|cholinergic agents|mesh-ancestor
111297214|NCT02596685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111297215|NCT02596685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111297216|NCT01431573|Lithium Carbonate|lithium carbonate|mesh-list
111297217|NCT01431573|Antidepressive Agents|antidepressive agents|mesh-ancestor
111297218|NCT01431573|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111297219|NCT01431573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111297220|NCT01431573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111297221|NCT01431573|Antimanic Agents|antimanic agents|mesh-ancestor
111297222|NCT01431573|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111297223|NCT01431573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111297224|NCT01431573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111297225|NCT04843644|Propolis|propolis|mesh-list
111297226|NCT04843644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111297227|NCT02588105|Leucovorin|leucovorin|mesh-list
111297228|NCT02588105|Folic Acid|folic acid|mesh-list
111297229|NCT02588105|Fluorouracil|fluorouracil|mesh-list
111297230|NCT02588105|Irinotecan|irinotecan|mesh-list
111297231|NCT02588105|Olaparib|olaparib|mesh-list
111297232|NCT02588105|AZD0156|azd0156|mesh-list
111297233|NCT02588105|Levoleucovorin|levoleucovorin|mesh-list
111297234|NCT02588105|Antimetabolites|antimetabolites|mesh-ancestor
111297235|NCT02588105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111297236|NCT02588105|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111297237|NCT02588105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111297238|NCT02588105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111297239|NCT02588105|Immunologic Factors|immunologic factors|mesh-ancestor
111297240|NCT02588105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111297241|NCT02588105|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111297242|NCT02588105|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111297243|NCT02588105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111297244|NCT02588105|Antidotes|antidotes|mesh-ancestor
111297245|NCT02588105|Protective Agents|protective agents|mesh-ancestor
111297246|NCT02588105|Vitamin B Complex|vitamin b complex|mesh-ancestor
111297247|NCT02588105|Vitamins|vitamins|mesh-ancestor
111297248|NCT02588105|Micronutrients|micronutrients|mesh-ancestor
111297249|NCT02588105|Hematinics|hematinics|mesh-ancestor
111297250|NCT02588105|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111297251|NCT02588105|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111297252|NCT01488279|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111297253|NCT01488279|Dexamethasone|dexamethasone|mesh-list
111297254|NCT01488279|Dexamethasone acetate|dexamethasone acetate|mesh-list
111297255|NCT01488279|BB 1101|bb 1101|mesh-list
111297256|NCT01488279|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111297257|NCT01488279|Antiemetics|antiemetics|mesh-ancestor
111297258|NCT01488279|Autonomic Agents|autonomic agents|mesh-ancestor
111297259|NCT01488279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111297260|NCT01488279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111297261|NCT01488279|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111297262|NCT01488279|Glucocorticoids|glucocorticoids|mesh-ancestor
111297264|NCT01488279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111297265|NCT01488279|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111297266|NCT01488279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111297267|NCT01488279|Protease Inhibitors|protease inhibitors|mesh-ancestor
111297268|NCT01488279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111297269|NCT01488279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111297270|NCT01488279|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111297271|NCT01488279|Incretins|incretins|mesh-ancestor
111297272|NCT01488279|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111297273|NCT01490073|Nitroglycerin|nitroglycerin|mesh-list
111297274|NCT01490073|Vasodilator Agents|vasodilator agents|mesh-ancestor
111297275|NCT03008109|Endostatins|endostatins|mesh-list
111297276|NCT03008109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111297277|NCT03008109|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111297278|NCT03008109|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111297279|NCT03008109|Growth Substances|growth substances|mesh-ancestor
111297280|NCT03008109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111297281|NCT03008109|Growth Inhibitors|growth inhibitors|mesh-ancestor
111297282|NCT02562443|ON 01910|on 01910|mesh-list
111297283|NCT02562443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111297284|NCT02562443|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111297285|NCT02562443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111297286|NCT02562443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111297287|NCT04843098|Paclitaxel|paclitaxel|mesh-list
111297288|NCT04843098|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111297289|NCT04843098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111297290|NCT04843098|Tubulin Modulators|tubulin modulators|mesh-ancestor
111297291|NCT04843098|Antimitotic Agents|antimitotic agents|mesh-ancestor
111297292|NCT04843098|Mitosis Modulators|mitosis modulators|mesh-ancestor
111297293|NCT04843098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111297294|NCT01490931|Ketorolac|ketorolac|mesh-list
111297295|NCT01490931|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111297296|NCT01490931|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111297297|NCT01490931|Analgesics|analgesics|mesh-ancestor
111297298|NCT01490931|Sensory System Agents|sensory system agents|mesh-ancestor
111297299|NCT01490931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111297300|NCT01490931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111297301|NCT01490931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111297302|NCT01490931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111297303|NCT01490931|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111297304|NCT01490931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111297305|NCT01490931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111297306|NCT02562365|Cyclophosphamide|cyclophosphamide|mesh-list
111297307|NCT02562365|Carboplatin|carboplatin|mesh-list
111297308|NCT02562365|Etoposide|etoposide|mesh-list
111297309|NCT02562365|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111297310|NCT02562365|Immunologic Factors|immunologic factors|mesh-ancestor
111297311|NCT02562365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111297312|NCT02562365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111297313|NCT02562365|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111297314|NCT02562365|Alkylating Agents|alkylating agents|mesh-ancestor
111297315|NCT02562365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111297316|NCT02562365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111297317|NCT02562365|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111297318|NCT02562365|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111297319|NCT02562365|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111297320|NCT02562365|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111297321|NCT02562365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111297322|NCT01491633|Dasatinib|dasatinib|mesh-list
111297323|NCT01491633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111297324|NCT01491633|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111297325|NCT01491633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111297326|NCT01491633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111297327|NCT01433913|Metformin|metformin|mesh-list
111297328|NCT01433913|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111297329|NCT01433913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111297330|NCT04839198|Nicotine|nicotine|mesh-list
111297331|NCT04839198|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111297332|NCT04839198|Autonomic Agents|autonomic agents|mesh-ancestor
111297333|NCT04839198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111297334|NCT04839198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111297335|NCT04839198|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111297336|NCT04839198|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111297337|NCT04839198|Cholinergic Agents|cholinergic agents|mesh-ancestor
111297338|NCT04839198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111297339|NCT04839198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111297340|NCT02509793|Tetrabenazine|tetrabenazine|mesh-list
111297341|NCT02509793|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111297342|NCT02509793|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111297343|NCT02509793|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111297344|NCT02509793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111297345|NCT02509793|Adrenergic Agents|adrenergic agents|mesh-ancestor
111297346|NCT02509793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111297347|NCT02509793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111297348|NCT02508467|Fisogatinib|fisogatinib|mesh-list
111297349|NCT02508467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111297350|NCT05586347|Nicardipine|nicardipine|mesh-list
111297351|NCT05586347|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111297352|NCT05586347|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111297353|NCT05586347|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111297354|NCT05586347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111297355|NCT05586347|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111297356|NCT05586347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111297357|NCT05586347|Vasodilator Agents|vasodilator agents|mesh-ancestor
111297358|NCT01436799|Alfentanil|alfentanil|mesh-list
111297359|NCT01436799|Propofol|propofol|mesh-list
111297360|NCT01436799|Desflurane|desflurane|mesh-list
111297361|NCT01436799|Rocuronium|rocuronium|mesh-list
111297362|NCT01436799|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111297363|NCT01436799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111297364|NCT01436799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111297365|NCT01436799|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111297366|NCT01436799|Anesthetics, General|anesthetics, general|mesh-ancestor
111297367|NCT01436799|Anesthetics|anesthetics|mesh-ancestor
111297368|NCT01436799|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
111297369|NCT01436799|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
111297370|NCT01436799|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111297371|NCT01436799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111297372|NCT01436799|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111297373|NCT01436799|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111297374|NCT01436799|Narcotics|narcotics|mesh-ancestor
111297375|NCT01436799|Analgesics|analgesics|mesh-ancestor
111297376|NCT01436799|Sensory System Agents|sensory system agents|mesh-ancestor
111297377|NCT04851132|Durvalumab|durvalumab|mesh-list
111297378|NCT04851132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111297379|NCT04851132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111297380|NCT02504489|Docetaxel|docetaxel|mesh-list
111297381|NCT02504489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111297382|NCT02504489|Tubulin Modulators|tubulin modulators|mesh-ancestor
111297383|NCT02504489|Antimitotic Agents|antimitotic agents|mesh-ancestor
111297384|NCT02504489|Mitosis Modulators|mitosis modulators|mesh-ancestor
111297385|NCT02504489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111297386|NCT02479451|Theophylline|theophylline|mesh-list
111297387|NCT02479451|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111297388|NCT02479451|Autonomic Agents|autonomic agents|mesh-ancestor
111297389|NCT02479451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111297390|NCT02479451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111297391|NCT02479451|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111297392|NCT02479451|Respiratory System Agents|respiratory system agents|mesh-ancestor
111297393|NCT02479451|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111297394|NCT02479451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110749915|NCT00307151|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111297395|NCT02479451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111297396|NCT02479451|Vasodilator Agents|vasodilator agents|mesh-ancestor
111297397|NCT02479451|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
111297398|NCT02479451|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111297399|NCT02479451|Purinergic Agents|purinergic agents|mesh-ancestor
111297400|NCT02479451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111297401|NCT02424617|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111297402|NCT02424617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111297403|NCT02424617|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111297404|NCT02424617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111297405|NCT02424617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111297406|NCT02415413|Dexamethasone|dexamethasone|mesh-list
111297407|NCT02415413|Lenalidomide|lenalidomide|mesh-list
111297408|NCT02415413|Melphalan|melphalan|mesh-list
111297409|NCT02415413|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111297410|NCT02415413|Antiemetics|antiemetics|mesh-ancestor
111297411|NCT02415413|Autonomic Agents|autonomic agents|mesh-ancestor
111297412|NCT02415413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111297413|NCT02415413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111297414|NCT02415413|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111297415|NCT02415413|Glucocorticoids|glucocorticoids|mesh-ancestor
111297416|NCT02415413|Hormones|hormones|mesh-ancestor
111297417|NCT02415413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111297418|NCT02415413|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111297419|NCT02415413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111297420|NCT02415413|Immunologic Factors|immunologic factors|mesh-ancestor
111297421|NCT02415413|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111297422|NCT02415413|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111297423|NCT02415413|Growth Substances|growth substances|mesh-ancestor
111297424|NCT02415413|Growth Inhibitors|growth inhibitors|mesh-ancestor
111297425|NCT02415413|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111297426|NCT02415413|Alkylating Agents|alkylating agents|mesh-ancestor
111297427|NCT02415413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111297428|NCT02415413|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111297429|NCT02415413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111297430|NCT01894061|Bevacizumab|bevacizumab|mesh-list
111297431|NCT01894061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111297432|NCT01894061|Antibodies|antibodies|mesh-list
111297433|NCT01894061|Immunoglobulins|immunoglobulins|mesh-list
111297434|NCT01894061|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111297435|NCT01894061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111297436|NCT01894061|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111297437|NCT01894061|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111297438|NCT01894061|Growth Substances|growth substances|mesh-ancestor
111297439|NCT01894061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111297440|NCT01894061|Growth Inhibitors|growth inhibitors|mesh-ancestor
111297441|NCT01894061|Immunologic Factors|immunologic factors|mesh-ancestor
111297442|NCT01561053|Immunoglobulins|immunoglobulins|mesh-list
111297443|NCT01561053|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111297444|NCT01561053|Antibodies|antibodies|mesh-list
111297445|NCT01561053|Immunologic Factors|immunologic factors|mesh-ancestor
111297446|NCT01561053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111297447|NCT01561833|Sorafenib|sorafenib|mesh-list
111297448|NCT01561833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111297449|NCT01561833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111297450|NCT01561833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111297451|NCT01561833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111297452|NCT02607306|Insulin|insulin|mesh-list
111297453|NCT02607306|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111297454|NCT02607306|Liraglutide|liraglutide|mesh-list
111297455|NCT02607306|Insulin, Long-Acting|insulin, long-acting|mesh-list
111297456|NCT02607306|Xultophy|xultophy|mesh-list
111297457|NCT02607306|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111297458|NCT02607306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111297459|NCT02607306|Incretins|incretins|mesh-ancestor
111297460|NCT02607306|Hormones|hormones|mesh-ancestor
111297461|NCT02607306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110979686|NCT03908255|Vitamins|vitamins|mesh-list
111297462|NCT03040128|Minocycline|minocycline|mesh-list
111297463|NCT03040128|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111297464|NCT03040128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111297465|NCT04850040|Oxaliplatin|oxaliplatin|mesh-list
111297466|NCT04850040|Apatinib|apatinib|mesh-list
111297467|NCT04850040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111297468|NCT04850040|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111297469|NCT04850040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111297470|NCT04850040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111297471|NCT03038334|Magnesium Sulfate|magnesium sulfate|mesh-list
111297472|NCT03038334|Analgesics|analgesics|mesh-ancestor
111297473|NCT03038334|Sensory System Agents|sensory system agents|mesh-ancestor
111297474|NCT03038334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111297475|NCT03038334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111297476|NCT03038334|Anesthetics|anesthetics|mesh-ancestor
111297477|NCT03038334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111297478|NCT03038334|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111297479|NCT03038334|Anticonvulsants|anticonvulsants|mesh-ancestor
111297480|NCT03038334|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111297481|NCT03038334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111297482|NCT03038334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111297483|NCT03038334|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111297484|NCT03038334|Tocolytic Agents|tocolytic agents|mesh-ancestor
111297485|NCT03038334|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111297486|NCT01441245|Furosemide|furosemide|mesh-list
111297487|NCT01441245|Diuretics|diuretics|mesh-ancestor
111297488|NCT01441245|Natriuretic Agents|natriuretic agents|mesh-ancestor
111297489|NCT01441245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111297490|NCT01441245|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
111297491|NCT01441245|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111297492|NCT01441245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111297493|NCT01563081|Cetirizine|cetirizine|mesh-list
111297494|NCT01563081|Levocetirizine|levocetirizine|mesh-list
111297495|NCT01563081|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
111297496|NCT01563081|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111297497|NCT01563081|Histamine Antagonists|histamine antagonists|mesh-ancestor
111297498|NCT01563081|Histamine Agents|histamine agents|mesh-ancestor
111297499|NCT01563081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111297500|NCT01563081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111297501|NCT01563081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111297502|NCT01563081|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111297503|NCT02278601|Fentanyl|fentanyl|mesh-list
111297504|NCT02278601|Ropivacaine|ropivacaine|mesh-list
111297505|NCT02278601|Anesthetics, Local|anesthetics, local|mesh-list
111297506|NCT02278601|Anesthetics|anesthetics|mesh-list
111297507|NCT02278601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111297508|NCT02278601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111297509|NCT02278601|Sensory System Agents|sensory system agents|mesh-ancestor
111297510|NCT02278601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111297511|NCT02278601|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111297512|NCT02278601|Narcotics|narcotics|mesh-ancestor
111297513|NCT02278601|Analgesics|analgesics|mesh-ancestor
111297514|NCT02278601|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111297515|NCT02278601|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111297516|NCT02278601|Anesthetics, General|anesthetics, general|mesh-ancestor
111297517|NCT04833738|Triamcinolone|triamcinolone|mesh-list
111297518|NCT04833738|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
111297519|NCT04833738|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
111297520|NCT04833738|Hyaluronic Acid|hyaluronic acid|mesh-list
111297521|NCT04833738|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
111297522|NCT04833738|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111297523|NCT04833738|Glucocorticoids|glucocorticoids|mesh-ancestor
111297524|NCT04833738|Hormones|hormones|mesh-ancestor
111297525|NCT04833738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111297526|NCT04833738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111297527|NCT04833738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111297528|NCT04833738|Immunologic Factors|immunologic factors|mesh-ancestor
111297529|NCT04833738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111297530|NCT04833738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111297531|NCT04833738|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111297532|NCT04833738|Viscosupplements|viscosupplements|mesh-ancestor
111297533|NCT04833738|Protective Agents|protective agents|mesh-ancestor
111297534|NCT01441401|Gabapentin|gabapentin|mesh-list
111297535|NCT01441401|Analgesics|analgesics|mesh-ancestor
111297536|NCT01441401|Sensory System Agents|sensory system agents|mesh-ancestor
111297537|NCT01441401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111297538|NCT01441401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111297539|NCT01441401|Anticonvulsants|anticonvulsants|mesh-ancestor
111297540|NCT01441401|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111297541|NCT01441401|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111297542|NCT01441401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111297543|NCT01441401|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111297544|NCT01441401|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111297545|NCT01441401|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111297546|NCT01441401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111297547|NCT01441401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111297548|NCT01441401|Antimanic Agents|antimanic agents|mesh-ancestor
111297549|NCT02268695|Docetaxel|docetaxel|mesh-list
111297550|NCT02268695|Cetuximab|cetuximab|mesh-list
111297551|NCT02268695|Lenograstim|lenograstim|mesh-list
111297552|NCT02268695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111297553|NCT02268695|Tubulin Modulators|tubulin modulators|mesh-ancestor
111297554|NCT02268695|Antimitotic Agents|antimitotic agents|mesh-ancestor
111297555|NCT02268695|Mitosis Modulators|mitosis modulators|mesh-ancestor
111297556|NCT02268695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111297557|NCT02268695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111297558|NCT02268695|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111021998|NCT03576053|Lidocaine|lidocaine|mesh-list
111297559|NCT02268695|Immunologic Factors|immunologic factors|mesh-ancestor
111297560|NCT02268695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111297562|NCT01495923|Analgesics|analgesics|mesh-ancestor
111297563|NCT01495923|Sensory System Agents|sensory system agents|mesh-ancestor
111297564|NCT01495923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111297565|NCT01495923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111297566|NCT01495923|Anticonvulsants|anticonvulsants|mesh-ancestor
111297567|NCT01495923|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111297568|NCT01495923|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111297569|NCT01495923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111297570|NCT01495923|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111297571|NCT01495923|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111297572|NCT01495923|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111297573|NCT01495923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111297574|NCT01495923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111297575|NCT01495923|Antimanic Agents|antimanic agents|mesh-ancestor
111297576|NCT03037944|Drospirenone|drospirenone|mesh-list
111297577|NCT03037944|Levonorgestrel|levonorgestrel|mesh-list
111297578|NCT03037944|Ethinyl Estradiol|ethinyl estradiol|mesh-list
111297579|NCT03037944|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
111297580|NCT03037944|Estradiol|estradiol|mesh-list
111297581|NCT03037944|Estrogens|estrogens|mesh-ancestor
111297582|NCT03037944|Hormones|hormones|mesh-ancestor
111297583|NCT03037944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111297584|NCT03037944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111297585|NCT03037944|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111297586|NCT03037944|Contraceptive Agents|contraceptive agents|mesh-ancestor
111297587|NCT03037944|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111297588|NCT03037944|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111297589|NCT03037944|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111297590|NCT03037944|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111297591|NCT03037944|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111297592|NCT03037944|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
111297593|NCT03037944|Hormone Antagonists|hormone antagonists|mesh-ancestor
111297594|NCT03037944|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
111297595|NCT03037944|Diuretics|diuretics|mesh-ancestor
111297596|NCT03037944|Natriuretic Agents|natriuretic agents|mesh-ancestor
111297597|NCT03039426|Diclofenac|diclofenac|mesh-list
111297598|NCT03039426|Bupivacaine|bupivacaine|mesh-list
111297599|NCT03039426|Anesthetics, Local|anesthetics, local|mesh-ancestor
111297600|NCT03039426|Anesthetics|anesthetics|mesh-ancestor
111297601|NCT03039426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111297602|NCT03039426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111297603|NCT03039426|Sensory System Agents|sensory system agents|mesh-ancestor
111297604|NCT03039426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111297605|NCT03039426|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111297606|NCT03039426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111297607|NCT03039426|Analgesics|analgesics|mesh-ancestor
111297608|NCT03039426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111297609|NCT03039426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111297610|NCT03039426|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111297611|NCT03039426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111297612|NCT03039426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111297613|NCT02205515|Everolimus|everolimus|mesh-list
111297614|NCT02205515|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111297615|NCT02205515|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111297616|NCT02205515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111297617|NCT02205515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111297618|NCT02205515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111297619|NCT02205515|Immunologic Factors|immunologic factors|mesh-ancestor
111297620|NCT02205515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111297621|NCT02205515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111297622|NCT04833036|Irinotecan|irinotecan|mesh-list
111297623|NCT04833036|Cetuximab|cetuximab|mesh-list
111297624|NCT04833036|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111297625|NCT04833036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111297626|NCT04833036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111297627|NCT04833036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111297628|NCT04833036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111297629|NCT04833036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111297630|NCT04832880|Remdesivir|remdesivir|mesh-list
111297631|NCT04832880|Dexamethasone|dexamethasone|mesh-list
111297632|NCT04832880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111297633|NCT04832880|Antiemetics|antiemetics|mesh-ancestor
111297634|NCT04832880|Autonomic Agents|autonomic agents|mesh-ancestor
111297635|NCT04832880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111297636|NCT04832880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111297637|NCT04832880|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111297638|NCT04832880|Glucocorticoids|glucocorticoids|mesh-ancestor
111297639|NCT04832880|Hormones|hormones|mesh-ancestor
111297640|NCT04832880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111297641|NCT04832880|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111297642|NCT04832880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111297643|NCT04832880|Antimetabolites|antimetabolites|mesh-ancestor
111297644|NCT04832880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111297645|NCT04832880|Antiviral Agents|antiviral agents|mesh-ancestor
111297646|NCT04832880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111297647|NCT01447017|Carbamide Peroxide|carbamide peroxide|mesh-list
111297648|NCT01447017|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111297649|NCT01447017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111297650|NCT01894295|Vitamin D|vitamin d|mesh-list
111297651|NCT01894295|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
111297652|NCT01894295|Vitamins|vitamins|mesh-ancestor
111297653|NCT01894295|Micronutrients|micronutrients|mesh-ancestor
111297654|NCT01894295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111297655|NCT01894295|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111297656|NCT04788186|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
111297657|NCT04788186|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111297658|NCT04788186|Adrenergic Agents|adrenergic agents|mesh-ancestor
111297659|NCT04788186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111297660|NCT04788186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111297661|NCT04788186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111297662|NCT01498419|Moxifloxacin|moxifloxacin|mesh-list
111297663|NCT01498419|Pyrazinamide|pyrazinamide|mesh-list
111297664|NCT01498419|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111297665|NCT01498419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111297666|NCT01498419|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111297667|NCT01498419|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111297668|NCT01498419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111297669|NCT01498419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111297670|NCT01498419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111297671|NCT01498419|Antitubercular Agents|antitubercular agents|mesh-ancestor
111297672|NCT04824924|Venetoclax|venetoclax|mesh-list
111297673|NCT04824924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111297674|NCT04553705|Quinine|quinine|mesh-list
111297675|NCT04553705|Antimalarials|antimalarials|mesh-ancestor
111297676|NCT04553705|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111297677|NCT04553705|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111297678|NCT04553705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111297679|NCT04553705|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
111297680|NCT04553705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111297681|NCT04553705|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111297682|NCT04553705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111297683|NCT04553705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111297684|NCT04553705|Analgesics|analgesics|mesh-ancestor
111297685|NCT04553705|Sensory System Agents|sensory system agents|mesh-ancestor
111297686|NCT02140151|Ranibizumab|ranibizumab|mesh-list
111297687|NCT02140151|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111297688|NCT02140151|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111297689|NCT02140151|Growth Substances|growth substances|mesh-ancestor
111297690|NCT02140151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111297691|NCT02140151|Growth Inhibitors|growth inhibitors|mesh-ancestor
111297692|NCT02140151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111297693|NCT02135315|Isosorbide|isosorbide|mesh-list
111297694|NCT02135315|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
111297695|NCT02135315|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
111297696|NCT02135315|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
111297697|NCT02135315|Diuretics|diuretics|mesh-ancestor
111297698|NCT02135315|Natriuretic Agents|natriuretic agents|mesh-ancestor
111297699|NCT02135315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111297700|NCT02135315|Vasodilator Agents|vasodilator agents|mesh-ancestor
111297701|NCT02135315|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
111297702|NCT02135315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111297703|NCT01894373|Immunomodulating Agents|immunomodulating agents|mesh-list
111297704|NCT01894373|Immunologic Factors|immunologic factors|mesh-ancestor
111297705|NCT01894373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111297706|NCT02117297|Gemtuzumab|gemtuzumab|mesh-list
111297707|NCT02117297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111297708|NCT02117297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111297709|NCT02117297|Immunotoxins|immunotoxins|mesh-ancestor
111297710|NCT02117297|Immunoconjugates|immunoconjugates|mesh-ancestor
111297711|NCT02117297|Immunologic Factors|immunologic factors|mesh-ancestor
111297712|NCT02117297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111297713|NCT04837170|Ketamine|ketamine|mesh-list
111297714|NCT04837170|Esketamine|esketamine|mesh-list
111297715|NCT04837170|Analgesics|analgesics|mesh-ancestor
111297716|NCT04837170|Sensory System Agents|sensory system agents|mesh-ancestor
111297717|NCT04837170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111297718|NCT04837170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111297719|NCT04837170|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111297720|NCT04837170|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111297721|NCT04837170|Anesthetics, General|anesthetics, general|mesh-ancestor
111297722|NCT04837170|Anesthetics|anesthetics|mesh-ancestor
111297723|NCT04837170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111297724|NCT04837170|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111297725|NCT04837170|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111297726|NCT04837170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111297727|NCT04837170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111297728|NCT04837170|Antidepressive Agents|antidepressive agents|mesh-ancestor
111297729|NCT04837170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111297730|NCT04824612|Triamcinolone|triamcinolone|mesh-list
111297731|NCT04824612|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
111297732|NCT04824612|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
111297733|NCT04824612|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
111297734|NCT04824612|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111297735|NCT04824612|Glucocorticoids|glucocorticoids|mesh-ancestor
111297736|NCT04824612|Hormones|hormones|mesh-ancestor
111297737|NCT04824612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111297738|NCT04824612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111297739|NCT04824612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111297740|NCT04824612|Immunologic Factors|immunologic factors|mesh-ancestor
111297741|NCT04824612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111297742|NCT04824612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111297743|NCT02113553|Triptorelin Pamoate|triptorelin pamoate|mesh-list
111297744|NCT02113553|Luteolytic Agents|luteolytic agents|mesh-ancestor
111297745|NCT02113553|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111297746|NCT02113553|Contraceptive Agents|contraceptive agents|mesh-ancestor
111297747|NCT02113553|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111297748|NCT02113553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111297749|NCT02113553|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111297750|NCT02113553|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111297751|NCT02113553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111297752|NCT02099591|Naloxegol|naloxegol|mesh-list
111297753|NCT02099591|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111297754|NCT02099591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111297755|NCT02099591|Sensory System Agents|sensory system agents|mesh-ancestor
111297756|NCT02099591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111297757|NCT01568073|Levodopa|levodopa|mesh-list
110959172|NCT03521700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110959173|NCT03521700|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110959174|NCT03521700|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110959175|NCT03521700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110959176|NCT02144025|Cyclosporine|cyclosporine|mesh-list
110959177|NCT02144025|Cyclosporins|cyclosporins|mesh-list
110959178|NCT02144025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110959179|NCT02144025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110959180|NCT02144025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110959181|NCT02144025|Immunologic Factors|immunologic factors|mesh-ancestor
110959182|NCT02144025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110959183|NCT02144025|Antifungal Agents|antifungal agents|mesh-ancestor
110959184|NCT02144025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110959185|NCT02144025|Dermatologic Agents|dermatologic agents|mesh-ancestor
110959186|NCT02144025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110959187|NCT02144025|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110959188|NCT03523650|Propranolol|propranolol|mesh-list
110959189|NCT03523650|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110959190|NCT03523650|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110959191|NCT03523650|Adrenergic Agents|adrenergic agents|mesh-ancestor
110959192|NCT03523650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110959193|NCT03523650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110959194|NCT03523650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110959195|NCT03523650|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110959196|NCT03523650|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110959197|NCT03523650|Vasodilator Agents|vasodilator agents|mesh-ancestor
110959198|NCT01025505|Imatinib Mesylate|imatinib mesylate|mesh-list
111022223|NCT02135887|Leucovorin|leucovorin|mesh-list
111297759|NCT01568073|Opicapone|opicapone|mesh-list
111297760|NCT01568073|Entacapone|entacapone|mesh-list
111297761|NCT01568073|Benserazide|benserazide|mesh-list
111297762|NCT01568073|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111297763|NCT01568073|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111297764|NCT01568073|Dopamine Agents|dopamine agents|mesh-ancestor
111297765|NCT01568073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111297766|NCT01568073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111297767|NCT01568073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111297768|NCT01568073|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
111297769|NCT01568073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111297770|NCT01568073|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
111297771|NCT04274933|Capecitabine|capecitabine|mesh-list
111297772|NCT04274933|Venetoclax|venetoclax|mesh-list
111297773|NCT04274933|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111297774|NCT04274933|Antimetabolites|antimetabolites|mesh-ancestor
111297775|NCT04274933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111297776|NCT04274933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111297777|NCT02603952|Oseltamivir|oseltamivir|mesh-list
111297778|NCT02603952|MEDI8852|medi8852|mesh-list
111297779|NCT02603952|Antiviral Agents|antiviral agents|mesh-ancestor
111297780|NCT02603952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111297781|NCT02603952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111297782|NCT02603952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111297783|NCT02062463|Budesonide|budesonide|mesh-list
111297784|NCT02062463|Formoterol Fumarate|formoterol fumarate|mesh-list
111297785|NCT02062463|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
111297786|NCT02062463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111297787|NCT02062463|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111297788|NCT02062463|Autonomic Agents|autonomic agents|mesh-ancestor
111297789|NCT02062463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111297790|NCT02062463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111297791|NCT02062463|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111297792|NCT02062463|Respiratory System Agents|respiratory system agents|mesh-ancestor
111297793|NCT02062463|Glucocorticoids|glucocorticoids|mesh-ancestor
111297794|NCT02062463|Hormones|hormones|mesh-ancestor
111297795|NCT02062463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111297796|NCT02062463|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111297797|NCT02062463|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111297798|NCT02062463|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111297799|NCT02062463|Adrenergic Agents|adrenergic agents|mesh-ancestor
111297800|NCT02062463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110979701|NCT03246776|Hormones|hormones|mesh-ancestor
111297801|NCT02062463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111297802|NCT01501929|Metoprolol|metoprolol|mesh-list
111297803|NCT01501929|Nebivolol|nebivolol|mesh-list
111297804|NCT01501929|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111297805|NCT01501929|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111297806|NCT01501929|Sympatholytics|sympatholytics|mesh-ancestor
111297807|NCT01501929|Autonomic Agents|autonomic agents|mesh-ancestor
111297808|NCT01501929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111297809|NCT01501929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111297810|NCT01501929|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
111297811|NCT01501929|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111297812|NCT01501929|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111297813|NCT01501929|Adrenergic Agents|adrenergic agents|mesh-ancestor
111297814|NCT01501929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111297815|NCT01501929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111297816|NCT01501929|Vasodilator Agents|vasodilator agents|mesh-ancestor
111297817|NCT01501929|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
111297818|NCT01501929|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111297819|NCT01501929|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111297820|NCT05618496|Hyaluronic Acid|hyaluronic acid|mesh-list
111297821|NCT05618496|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111297822|NCT05618496|Immunologic Factors|immunologic factors|mesh-ancestor
111297823|NCT05618496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111297824|NCT05618496|Viscosupplements|viscosupplements|mesh-ancestor
111297825|NCT05618496|Protective Agents|protective agents|mesh-ancestor
111297826|NCT02049593|Irinotecan|irinotecan|mesh-list
111297827|NCT02049593|Temozolomide|temozolomide|mesh-list
111297828|NCT02049593|Talazoparib|talazoparib|mesh-list
111297829|NCT02049593|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
111297830|NCT02049593|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111297831|NCT02049593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111022264|NCT03570281|Enoxaparin|enoxaparin|mesh-list
111297832|NCT02049593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111297833|NCT02049593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111297834|NCT02049593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111297835|NCT02049593|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111297836|NCT02049593|Alkylating Agents|alkylating agents|mesh-ancestor
111297838|NCT02049047|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111297839|NCT02049047|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111297840|NCT02049047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111297841|NCT02049047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111297842|NCT02049047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111297843|NCT02049047|Immunologic Factors|immunologic factors|mesh-ancestor
111297844|NCT02049047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111297845|NCT02049047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111297846|NCT04778358|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
111297847|NCT04778358|Hormones|hormones|mesh-ancestor
111297848|NCT04778358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111297849|NCT04778358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111297850|NCT01449747|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111297851|NCT01449747|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111297852|NCT01449747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111297853|NCT01449747|Incretins|incretins|mesh-ancestor
111297854|NCT01449747|Hormones|hormones|mesh-ancestor
111297855|NCT01449747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111297856|NCT01449747|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111297857|NCT01449747|Protease Inhibitors|protease inhibitors|mesh-ancestor
111297858|NCT01449747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111297859|NCT01449747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111297860|NCT03035838|Fosaprepitant|fosaprepitant|mesh-list
111297861|NCT03035838|Aprepitant|aprepitant|mesh-list
111297862|NCT03035838|Antiemetics|antiemetics|mesh-ancestor
111297863|NCT03035838|Autonomic Agents|autonomic agents|mesh-ancestor
111297864|NCT03035838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111297865|NCT03035838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111297866|NCT03035838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111297867|NCT03035838|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
111297868|NCT03035838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111297869|NCT03035838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111297870|NCT01569087|Lenograstim|lenograstim|mesh-list
111297871|NCT01569087|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111297872|NCT01569087|Immunologic Factors|immunologic factors|mesh-ancestor
111297873|NCT01569087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111297874|NCT02024087|Sorafenib|sorafenib|mesh-list
111297875|NCT02024087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111297876|NCT02024087|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111297877|NCT02024087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111297878|NCT02024087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111297879|NCT01895621|Thioctic Acid|thioctic acid|mesh-list
111297880|NCT01895621|Antioxidants|antioxidants|mesh-ancestor
111297881|NCT01895621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111297882|NCT01895621|Protective Agents|protective agents|mesh-ancestor
111297883|NCT01895621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111297884|NCT01895621|Vitamin B Complex|vitamin b complex|mesh-ancestor
111297885|NCT01895621|Vitamins|vitamins|mesh-ancestor
111297886|NCT01895621|Micronutrients|micronutrients|mesh-ancestor
111297887|NCT01517711|Tramadol|tramadol|mesh-list
111297888|NCT01517711|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111297889|NCT01517711|Narcotics|narcotics|mesh-ancestor
111297890|NCT01517711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111297891|NCT01517711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111297892|NCT01517711|Analgesics|analgesics|mesh-ancestor
111297893|NCT01517711|Sensory System Agents|sensory system agents|mesh-ancestor
111297894|NCT01517711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111297895|NCT04836078|Chitosan|chitosan|mesh-list
111297896|NCT04836078|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111297897|NCT04836078|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111297898|NCT04836078|Antimetabolites|antimetabolites|mesh-ancestor
111297899|NCT04836078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111297900|NCT04836078|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111297901|NCT04836078|Chelating Agents|chelating agents|mesh-ancestor
111297902|NCT04836078|Sequestering Agents|sequestering agents|mesh-ancestor
111297903|NCT04836078|Hemostatics|hemostatics|mesh-ancestor
111297904|NCT04836078|Coagulants|coagulants|mesh-ancestor
111022344|NCT02138773|Tamsulosin|tamsulosin|mesh-list
111297905|NCT00055237|Bevacizumab|bevacizumab|mesh-list
111297906|NCT00055237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111297907|NCT00055237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111297908|NCT00055237|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111297909|NCT00055237|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111297910|NCT00055237|Growth Substances|growth substances|mesh-ancestor
111297911|NCT00055237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111297912|NCT00055237|Growth Inhibitors|growth inhibitors|mesh-ancestor
111297913|NCT04836156|Cyclophosphamide|cyclophosphamide|mesh-list
111297914|NCT04836156|Carboplatin|carboplatin|mesh-list
111297915|NCT04836156|Docetaxel|docetaxel|mesh-list
111297916|NCT04836156|Epirubicin|epirubicin|mesh-list
111297917|NCT04836156|Phenobarbital|phenobarbital|mesh-list
111297918|NCT04836156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111297919|NCT04836156|Immunologic Factors|immunologic factors|mesh-ancestor
111297920|NCT04836156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111297921|NCT04836156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111297922|NCT04836156|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111297923|NCT04836156|Alkylating Agents|alkylating agents|mesh-ancestor
111297924|NCT04836156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111297925|NCT04836156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111297926|NCT04836156|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111297927|NCT04836156|Tubulin Modulators|tubulin modulators|mesh-ancestor
111297928|NCT04836156|Antimitotic Agents|antimitotic agents|mesh-ancestor
111297929|NCT04836156|Mitosis Modulators|mitosis modulators|mesh-ancestor
111297930|NCT04836156|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111297931|NCT04836156|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111297932|NCT04836156|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111297933|NCT04836156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111297934|NCT04836156|Anticonvulsants|anticonvulsants|mesh-ancestor
111297935|NCT04836156|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111297936|NCT04836156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111297937|NCT04836156|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111297938|NCT04836156|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111297939|NCT04836156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111297940|NCT04836156|GABA Modulators|gaba modulators|mesh-ancestor
111297941|NCT04836156|GABA Agents|gaba agents|mesh-ancestor
111297942|NCT04836156|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111297943|NCT04836156|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111297944|NCT04836156|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111297945|NCT01502787|Metoprolol|metoprolol|mesh-list
111297946|NCT01502787|Nebivolol|nebivolol|mesh-list
111297947|NCT01502787|Angiotensin II|angiotensin ii|mesh-list
111297948|NCT01502787|Giapreza|giapreza|mesh-list
111297949|NCT01502787|Angiotensinogen|angiotensinogen|mesh-list
111297950|NCT01502787|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111297951|NCT01502787|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111297952|NCT01502787|Sympatholytics|sympatholytics|mesh-ancestor
111297953|NCT01502787|Autonomic Agents|autonomic agents|mesh-ancestor
111297954|NCT01502787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111297955|NCT01502787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111297956|NCT01502787|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
111297957|NCT01502787|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111297958|NCT01502787|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111297959|NCT01502787|Adrenergic Agents|adrenergic agents|mesh-ancestor
111297960|NCT01502787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111297961|NCT01502787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111297962|NCT01502787|Vasodilator Agents|vasodilator agents|mesh-ancestor
111297963|NCT01502787|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
111297964|NCT01502787|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111297965|NCT01502787|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111297966|NCT01502787|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111297967|NCT01502787|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111297968|NCT01502787|Protease Inhibitors|protease inhibitors|mesh-ancestor
111297969|NCT01502787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111297970|NCT04829916|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111297971|NCT04835922|Anesthetics|anesthetics|mesh-list
111297972|NCT04835922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111297973|NCT04835922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111297974|NCT00153985|Fludarabine|fludarabine|mesh-list
111297975|NCT00153985|Alemtuzumab|alemtuzumab|mesh-list
111297976|NCT00153985|Busulfan|busulfan|mesh-list
111297977|NCT00153985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111297978|NCT00153985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111297979|NCT00153985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111297980|NCT00153985|Immunologic Factors|immunologic factors|mesh-ancestor
111022414|NCT02130661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111297981|NCT00153985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111297982|NCT00153985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111297983|NCT00153985|Alkylating Agents|alkylating agents|mesh-ancestor
111297984|NCT00153985|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111297985|NCT00153985|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111297986|NCT02318303|Mometasone Furoate|mometasone furoate|mesh-list
111297987|NCT02318303|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
111297988|NCT02318303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111297989|NCT02318303|Dermatologic Agents|dermatologic agents|mesh-ancestor
111297990|NCT02318303|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111297991|NCT02318303|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111297992|NCT02318303|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111297993|NCT02318303|Analgesics|analgesics|mesh-ancestor
111297994|NCT02318303|Sensory System Agents|sensory system agents|mesh-ancestor
111297995|NCT02318303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111297996|NCT02318303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111297997|NCT02318303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111297998|NCT02318303|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
111297999|NCT02318303|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111298000|NCT02318303|Histamine Antagonists|histamine antagonists|mesh-ancestor
111298001|NCT02318303|Histamine Agents|histamine agents|mesh-ancestor
111298002|NCT02318303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111298003|NCT02318303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111298004|NCT01451775|Empagliflozin|empagliflozin|mesh-list
111298005|NCT01451775|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111298006|NCT01451775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111298007|NCT01451775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111298008|NCT01451775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111298009|NCT04304040|Antibodies|antibodies|mesh-list
111298010|NCT04304040|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111298011|NCT04304040|Immunologic Factors|immunologic factors|mesh-ancestor
111298012|NCT04304040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111298013|NCT00156013|Clofarabine|clofarabine|mesh-list
111298014|NCT00156013|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111298015|NCT00156013|Antimetabolites|antimetabolites|mesh-ancestor
111298016|NCT00156013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111298017|NCT00156013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111298018|NCT01358669|Denosumab|denosumab|mesh-list
111298019|NCT01358669|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111298020|NCT01358669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111298021|NCT00156247|Acitretin|acitretin|mesh-list
111298022|NCT00156247|Keratolytic Agents|keratolytic agents|mesh-ancestor
111298023|NCT00156247|Dermatologic Agents|dermatologic agents|mesh-ancestor
111298024|NCT00156715|Quetiapine Fumarate|quetiapine fumarate|mesh-list
111298025|NCT00156715|Antidepressive Agents|antidepressive agents|mesh-ancestor
111298026|NCT00156715|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111298027|NCT00156715|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111298028|NCT00156715|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111298029|NCT00156715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111298030|NCT00156715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111298031|NCT01573533|Rituximab|rituximab|mesh-list
111298032|NCT01573533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111298033|NCT01573533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111298034|NCT01573533|Immunologic Factors|immunologic factors|mesh-ancestor
111298035|NCT01573533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111298036|NCT01573533|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111298037|NCT01455519|Hydromorphone|hydromorphone|mesh-list
111298038|NCT01455519|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111298039|NCT01455519|Narcotics|narcotics|mesh-ancestor
111298040|NCT01455519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111298041|NCT01455519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111298042|NCT01455519|Analgesics|analgesics|mesh-ancestor
111298043|NCT01455519|Sensory System Agents|sensory system agents|mesh-ancestor
111298044|NCT01455519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111298045|NCT00157573|Sargramostim|sargramostim|mesh-list
111298046|NCT00157573|Immunologic Factors|immunologic factors|mesh-ancestor
111298047|NCT00157573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111298048|NCT04822038|Vitamin D|vitamin d|mesh-list
111298049|NCT04822038|Cholecalciferol|cholecalciferol|mesh-list
111298050|NCT04822038|Vitamins|vitamins|mesh-ancestor
111298051|NCT04822038|Micronutrients|micronutrients|mesh-ancestor
111298052|NCT04822038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111298053|NCT04822038|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111298054|NCT04822038|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111298055|NCT01576809|Acetaminophen|acetaminophen|mesh-list
111298056|NCT01576809|Phenylpropanolamine|phenylpropanolamine|mesh-list
111298057|NCT01576809|Phenylephrine|phenylephrine|mesh-list
111298058|NCT01576809|Oxymetazoline|oxymetazoline|mesh-list
111298059|NCT01576809|Guaifenesin|guaifenesin|mesh-list
111298060|NCT01576809|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
111298061|NCT01576809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111298062|NCT01576809|Analgesics|analgesics|mesh-ancestor
111298063|NCT01576809|Sensory System Agents|sensory system agents|mesh-ancestor
111298064|NCT01576809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111298065|NCT01576809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111298066|NCT01576809|Antipyretics|antipyretics|mesh-ancestor
111298067|NCT01576809|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111298068|NCT01576809|Mydriatics|mydriatics|mesh-ancestor
111298069|NCT01576809|Autonomic Agents|autonomic agents|mesh-ancestor
111298070|NCT01576809|Sympathomimetics|sympathomimetics|mesh-ancestor
111298071|NCT01576809|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111298072|NCT01576809|Nasal Decongestants|nasal decongestants|mesh-ancestor
111298073|NCT01576809|Respiratory System Agents|respiratory system agents|mesh-ancestor
111298074|NCT01576809|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111298075|NCT01576809|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111298076|NCT01576809|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111298077|NCT01576809|Adrenergic Agents|adrenergic agents|mesh-ancestor
111298078|NCT01576809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111298079|NCT01576809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111298080|NCT01576809|Protective Agents|protective agents|mesh-ancestor
111298081|NCT01576809|Expectorants|expectorants|mesh-ancestor
111298082|NCT01576809|Appetite Depressants|appetite depressants|mesh-ancestor
111298083|NCT01576809|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111298085|NCT01456143|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111298086|NCT01456143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111298087|NCT01456299|Remifentanil|remifentanil|mesh-list
111298088|NCT01456299|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111298089|NCT01456299|Narcotics|narcotics|mesh-ancestor
111298090|NCT01456299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111298091|NCT01456299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111298092|NCT01456299|Analgesics|analgesics|mesh-ancestor
111298093|NCT01456299|Sensory System Agents|sensory system agents|mesh-ancestor
111298094|NCT01456299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111298095|NCT00158743|Digoxin|digoxin|mesh-list
111298096|NCT00158743|Antibodies|antibodies|mesh-list
111298097|NCT00158743|Immunoglobulin Fab Fragments|immunoglobulin fab fragments|mesh-list
111298098|NCT00158743|Immunologic Factors|immunologic factors|mesh-ancestor
111298099|NCT00158743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111298100|NCT00158743|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111298101|NCT00158743|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111298102|NCT00158743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111298103|NCT00158743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111298104|NCT00158743|Protective Agents|protective agents|mesh-ancestor
111298105|NCT00161473|Prazosin|prazosin|mesh-list
111298106|NCT00161473|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111298107|NCT00161473|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111298108|NCT00161473|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111298109|NCT00161473|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111298110|NCT00161473|Adrenergic Agents|adrenergic agents|mesh-ancestor
111298111|NCT00161473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111298112|NCT00161473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111298113|NCT00161473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111298114|NCT01319981|Cytarabine|cytarabine|mesh-list
111298115|NCT01319981|Dexamethasone|dexamethasone|mesh-list
111298116|NCT01319981|Methylprednisolone|methylprednisolone|mesh-list
111298117|NCT01319981|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111298118|NCT01319981|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111298119|NCT01319981|Prednisolone|prednisolone|mesh-list
111298120|NCT01319981|Prednisolone acetate|prednisolone acetate|mesh-list
111298121|NCT01319981|Cyclophosphamide|cyclophosphamide|mesh-list
111298122|NCT01319981|Rituximab|rituximab|mesh-list
111298123|NCT01319981|Doxorubicin|doxorubicin|mesh-list
111298124|NCT01319981|Methotrexate|methotrexate|mesh-list
111298125|NCT01319981|Vincristine|vincristine|mesh-list
111298126|NCT01319981|Imatinib Mesylate|imatinib mesylate|mesh-list
111298127|NCT01319981|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111298128|NCT01319981|Prednisolone phosphate|prednisolone phosphate|mesh-list
111298129|NCT01319981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111298130|NCT01319981|Immunologic Factors|immunologic factors|mesh-ancestor
111298131|NCT01319981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111022567|NCT03568721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111298132|NCT01319981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111298133|NCT01319981|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111298134|NCT01319981|Alkylating Agents|alkylating agents|mesh-ancestor
111298135|NCT01319981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111298136|NCT01319981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111298137|NCT01319981|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111298138|NCT01319981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111298139|NCT01319981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111298140|NCT01319981|Antiemetics|antiemetics|mesh-ancestor
111298141|NCT01319981|Autonomic Agents|autonomic agents|mesh-ancestor
111298142|NCT01319981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111298143|NCT01319981|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111298144|NCT01319981|Glucocorticoids|glucocorticoids|mesh-ancestor
111298145|NCT01319981|Hormones|hormones|mesh-ancestor
111298146|NCT01319981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111298147|NCT01319981|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111298148|NCT01319981|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111298149|NCT01319981|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111298150|NCT01319981|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111298151|NCT01319981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111298152|NCT01319981|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111298153|NCT01319981|Abortifacient Agents|abortifacient agents|mesh-ancestor
111298154|NCT01319981|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111298155|NCT01319981|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111298156|NCT01319981|Antimetabolites|antimetabolites|mesh-ancestor
111298157|NCT01319981|Dermatologic Agents|dermatologic agents|mesh-ancestor
111298158|NCT01319981|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111298159|NCT01319981|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111298160|NCT01319981|Antiviral Agents|antiviral agents|mesh-ancestor
111298161|NCT01319981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111298162|NCT01319981|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111298163|NCT01319981|Tubulin Modulators|tubulin modulators|mesh-ancestor
111298164|NCT01319981|Antimitotic Agents|antimitotic agents|mesh-ancestor
111298165|NCT01319981|Mitosis Modulators|mitosis modulators|mesh-ancestor
111298166|NCT01319981|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111298167|NCT01319981|Protective Agents|protective agents|mesh-ancestor
111298168|NCT01319981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111298169|NCT01458561|Thrombin|thrombin|mesh-list
111298170|NCT01458561|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
111298171|NCT01458561|Hemostatics|hemostatics|mesh-ancestor
111298172|NCT01458561|Coagulants|coagulants|mesh-ancestor
111298173|NCT00065611|Dexamethasone|dexamethasone|mesh-list
111298174|NCT00065611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111298175|NCT00065611|Antiemetics|antiemetics|mesh-ancestor
111298176|NCT00065611|Autonomic Agents|autonomic agents|mesh-ancestor
111298177|NCT00065611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111298178|NCT00065611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111298179|NCT00065611|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111298180|NCT00065611|Glucocorticoids|glucocorticoids|mesh-ancestor
111298181|NCT00065611|Hormones|hormones|mesh-ancestor
111298182|NCT00065611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111298183|NCT00065611|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111298184|NCT00065611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111298185|NCT00066781|Gemcitabine|gemcitabine|mesh-list
111298186|NCT00066781|Irinotecan|irinotecan|mesh-list
111298187|NCT00066781|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111298188|NCT00066781|Antimetabolites|antimetabolites|mesh-ancestor
111298189|NCT00066781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111298190|NCT00066781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111298191|NCT00066781|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111298192|NCT00066781|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111298193|NCT00066781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111298194|NCT01431755|Lidocaine|lidocaine|mesh-list
111298195|NCT01431755|Hyaluronic Acid|hyaluronic acid|mesh-list
111298196|NCT01431755|Anesthetics, Local|anesthetics, local|mesh-ancestor
111298197|NCT01431755|Anesthetics|anesthetics|mesh-ancestor
111298198|NCT01431755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111298199|NCT01431755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111298200|NCT01431755|Sensory System Agents|sensory system agents|mesh-ancestor
111298201|NCT01431755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111298202|NCT01431755|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111298203|NCT01431755|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111298204|NCT01431755|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111298205|NCT01431755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111298206|NCT01431755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111298208|NCT01431755|Immunologic Factors|immunologic factors|mesh-ancestor
111298209|NCT01431755|Viscosupplements|viscosupplements|mesh-ancestor
111298210|NCT01431755|Protective Agents|protective agents|mesh-ancestor
111298211|NCT00066937|Benztropine|benztropine|mesh-list
111298212|NCT00066937|Nortriptyline|nortriptyline|mesh-list
111298213|NCT00066937|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
111298214|NCT00066937|Antidepressive Agents|antidepressive agents|mesh-ancestor
111298215|NCT00066937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111298216|NCT00066937|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111298217|NCT00066937|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111298218|NCT00066937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111298219|NCT00066937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111298220|NCT00066937|Adrenergic Agents|adrenergic agents|mesh-ancestor
111298221|NCT00066937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111298222|NCT00066937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111298223|NCT00066937|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111298224|NCT00066937|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111298225|NCT00066937|Parasympatholytics|parasympatholytics|mesh-ancestor
111298226|NCT00066937|Autonomic Agents|autonomic agents|mesh-ancestor
111298227|NCT00066937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111298228|NCT00066937|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111298229|NCT00066937|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111298230|NCT00066937|Cholinergic Agents|cholinergic agents|mesh-ancestor
111298231|NCT00066937|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111298232|NCT00066937|Dopamine Agents|dopamine agents|mesh-ancestor
111298233|NCT01064375|Cyclophosphamide|cyclophosphamide|mesh-list
111298234|NCT01064375|Molgramostim|molgramostim|mesh-list
111298235|NCT01064375|Sargramostim|sargramostim|mesh-list
111298236|NCT01064375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111298237|NCT01064375|Immunologic Factors|immunologic factors|mesh-ancestor
111298238|NCT01064375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111298239|NCT01064375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111298240|NCT01064375|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111298241|NCT01064375|Alkylating Agents|alkylating agents|mesh-ancestor
111298242|NCT01064375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111298243|NCT01064375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111298244|NCT01064375|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111298245|NCT01061411|Sunitinib|sunitinib|mesh-list
111298246|NCT01061411|Dalteparin|dalteparin|mesh-list
111298247|NCT01061411|Tinzaparin|tinzaparin|mesh-list
111298248|NCT01061411|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
111298249|NCT01061411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111298250|NCT01061411|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111298251|NCT01061411|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111298252|NCT01061411|Growth Substances|growth substances|mesh-ancestor
111298253|NCT01061411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111298254|NCT01061411|Growth Inhibitors|growth inhibitors|mesh-ancestor
111298255|NCT01061411|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111298256|NCT01061411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111298257|NCT01061411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111298258|NCT01061411|Anticoagulants|anticoagulants|mesh-ancestor
111298259|NCT01061411|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111298260|NCT01061411|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111298261|NCT01505673|Liraglutide|liraglutide|mesh-list
111298262|NCT01505673|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111298263|NCT01505673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111298264|NCT01505673|Incretins|incretins|mesh-ancestor
111298265|NCT01505673|Hormones|hormones|mesh-ancestor
111298266|NCT01505673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111298267|NCT04834986|Lenvatinib|lenvatinib|mesh-list
111298268|NCT04834986|Tislelizumab|tislelizumab|mesh-list
111298269|NCT04834986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111298270|NCT04834986|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111298271|NCT04834986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111298272|NCT04834986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111298273|NCT04834986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111298274|NCT04827966|Calcium, Dietary|calcium, dietary|mesh-list
111298275|NCT04827966|Listerine|listerine|mesh-list
111298276|NCT04827966|Calcium|calcium|mesh-list
111298277|NCT04827966|Fluorides|fluorides|mesh-list
111298278|NCT04827966|Sodium Fluoride|sodium fluoride|mesh-list
111298279|NCT04827966|Caseins|caseins|mesh-list
111298280|NCT04827966|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111298281|NCT04827966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111022713|NCT05934669|GABA Modulators|gaba modulators|mesh-ancestor
111298282|NCT04827966|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111298283|NCT04827966|Cariostatic Agents|cariostatic agents|mesh-ancestor
111298284|NCT04827966|Protective Agents|protective agents|mesh-ancestor
111298285|NCT04827966|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111298286|NCT04827966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111298287|NCT04827966|Chelating Agents|chelating agents|mesh-ancestor
111298288|NCT04827966|Sequestering Agents|sequestering agents|mesh-ancestor
111298289|NCT04827966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111298290|NCT02247141|Immunoglobulins|immunoglobulins|mesh-list
111298291|NCT02247141|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111298292|NCT02247141|Antibodies|antibodies|mesh-list
111298293|NCT02247141|Immunologic Factors|immunologic factors|mesh-ancestor
111298294|NCT02247141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111298295|NCT01896245|Sevoflurane|sevoflurane|mesh-list
111298296|NCT01896245|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111298297|NCT01896245|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111298298|NCT01896245|Anesthetics, General|anesthetics, general|mesh-ancestor
111298299|NCT01896245|Anesthetics|anesthetics|mesh-ancestor
111298300|NCT01896245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111298301|NCT01896245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111298302|NCT04821804|Hyaluronic Acid|hyaluronic acid|mesh-list
111298303|NCT04821804|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111298304|NCT04821804|Immunologic Factors|immunologic factors|mesh-ancestor
111298305|NCT04821804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111298306|NCT04821804|Viscosupplements|viscosupplements|mesh-ancestor
111298307|NCT04821804|Protective Agents|protective agents|mesh-ancestor
111298308|NCT04835064|Paclitaxel|paclitaxel|mesh-list
111298309|NCT04835064|Gemcitabine|gemcitabine|mesh-list
111298310|NCT04835064|Folfirinox|folfirinox|mesh-list
111298311|NCT04835064|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111298312|NCT04835064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111298313|NCT04835064|Tubulin Modulators|tubulin modulators|mesh-ancestor
111298314|NCT04835064|Antimitotic Agents|antimitotic agents|mesh-ancestor
111298315|NCT04835064|Mitosis Modulators|mitosis modulators|mesh-ancestor
111298316|NCT04835064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111298317|NCT04835064|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111298318|NCT04835064|Antimetabolites|antimetabolites|mesh-ancestor
111298319|NCT00819221|Doxorubicin|doxorubicin|mesh-list
111298320|NCT00819221|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111298321|NCT00819221|Olaparib|olaparib|mesh-list
111298322|NCT00819221|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111298323|NCT00819221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111298324|NCT00819221|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111298325|NCT00819221|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111298326|NCT00819221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111298327|NCT00819221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111298328|NCT00819221|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111298329|NCT01507779|Vaccines|vaccines|mesh-list
111298330|NCT01507779|Immunologic Factors|immunologic factors|mesh-ancestor
111298331|NCT01507779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111298332|NCT01896323|Ketoconazole|ketoconazole|mesh-list
111298333|NCT01896323|Antifungal Agents|antifungal agents|mesh-ancestor
111298334|NCT01896323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111298335|NCT01896323|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111298336|NCT01896323|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111298337|NCT01896323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111298338|NCT01896323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111298339|NCT01896323|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111298340|NCT01896323|Hormone Antagonists|hormone antagonists|mesh-ancestor
111298341|NCT01896323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111298342|NCT01896323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111298343|NCT01896323|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111298344|NCT00068341|Carboplatin|carboplatin|mesh-list
111298345|NCT00068341|Docetaxel|docetaxel|mesh-list
111298346|NCT00068341|Trastuzumab|trastuzumab|mesh-list
111298347|NCT00068341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111298348|NCT00068341|Tubulin Modulators|tubulin modulators|mesh-ancestor
111298349|NCT00068341|Antimitotic Agents|antimitotic agents|mesh-ancestor
111298350|NCT00068341|Mitosis Modulators|mitosis modulators|mesh-ancestor
111298351|NCT00068341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111298352|NCT00068341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111298353|NCT02605824|Acetylcysteine|acetylcysteine|mesh-list
111022791|NCT05901519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111298354|NCT02605824|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111298355|NCT02605824|Antiviral Agents|antiviral agents|mesh-ancestor
111298356|NCT02605824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111298357|NCT02605824|Expectorants|expectorants|mesh-ancestor
111298358|NCT02605824|Respiratory System Agents|respiratory system agents|mesh-ancestor
111298359|NCT02605824|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111298360|NCT02605824|Antioxidants|antioxidants|mesh-ancestor
111298361|NCT02605824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111298362|NCT02605824|Protective Agents|protective agents|mesh-ancestor
111298363|NCT02605824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111298364|NCT02605824|Antidotes|antidotes|mesh-ancestor
111298365|NCT01896661|Amlodipine|amlodipine|mesh-list
111298366|NCT01896661|Chlorthalidone|chlorthalidone|mesh-list
111298367|NCT01896661|Calcium Channel Blockers|calcium channel blockers|mesh-list
111298368|NCT01896661|Amiloride|amiloride|mesh-list
111298369|NCT01896661|Calcium|calcium|mesh-list
111298370|NCT01896661|Diuretics|diuretics|mesh-list
111298371|NCT01896661|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111298372|NCT01896661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111298373|NCT01896661|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111298374|NCT01896661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111298375|NCT01896661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111298376|NCT01896661|Vasodilator Agents|vasodilator agents|mesh-ancestor
111298377|NCT01896661|Natriuretic Agents|natriuretic agents|mesh-ancestor
111298378|NCT01896661|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
111298379|NCT01896661|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
111298380|NCT01896661|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111298381|NCT01896661|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
111298382|NCT01896661|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
111298383|NCT01462773|Interferons|interferons|mesh-list
111298384|NCT01462773|Interferon-alpha|interferon-alpha|mesh-list
111298385|NCT01462773|Interferon alpha-2|interferon alpha-2|mesh-list
111298386|NCT01462773|Bortezomib|bortezomib|mesh-list
111298387|NCT01462773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111298388|NCT01462773|Antiviral Agents|antiviral agents|mesh-ancestor
111298389|NCT01462773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111298390|NCT01462773|Immunologic Factors|immunologic factors|mesh-ancestor
111298391|NCT01462773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111298392|NCT02096029|Nicotine|nicotine|mesh-list
111298393|NCT02096029|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111298394|NCT02096029|Autonomic Agents|autonomic agents|mesh-ancestor
111298395|NCT02096029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111298396|NCT02096029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111298397|NCT02096029|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111298398|NCT02096029|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111298399|NCT02096029|Cholinergic Agents|cholinergic agents|mesh-ancestor
111298400|NCT02096029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111298401|NCT02096029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111298402|NCT02205801|Bupivacaine|bupivacaine|mesh-list
111298403|NCT02205801|Anesthetics, Local|anesthetics, local|mesh-ancestor
111298404|NCT02205801|Anesthetics|anesthetics|mesh-ancestor
111298405|NCT02205801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111298406|NCT02205801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111298407|NCT02205801|Sensory System Agents|sensory system agents|mesh-ancestor
111298408|NCT02205801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111298409|NCT02096107|Everolimus|everolimus|mesh-list
111298410|NCT02096107|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111298411|NCT02096107|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111298412|NCT02096107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111298413|NCT02096107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111298414|NCT02096107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111298415|NCT02096107|Immunologic Factors|immunologic factors|mesh-ancestor
111298416|NCT02096107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111298417|NCT02096107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111298418|NCT04834440|Ropivacaine|ropivacaine|mesh-list
111298419|NCT04834440|Anesthetics, Local|anesthetics, local|mesh-ancestor
111298420|NCT04834440|Anesthetics|anesthetics|mesh-ancestor
111298421|NCT04834440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111298422|NCT04834440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111298423|NCT04834440|Sensory System Agents|sensory system agents|mesh-ancestor
111298424|NCT04834440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111298425|NCT00068575|Interferons|interferons|mesh-list
111298426|NCT00068575|Interferon-alpha|interferon-alpha|mesh-list
111298427|NCT00068575|Interferon alpha-2|interferon alpha-2|mesh-list
111298428|NCT00068575|Cisplatin|cisplatin|mesh-list
111298429|NCT00068575|Fluorouracil|fluorouracil|mesh-list
111298430|NCT00068575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111022865|NCT05643170|Xanomeline|xanomeline|mesh-list
111298431|NCT00068575|Antimetabolites|antimetabolites|mesh-ancestor
111298432|NCT00068575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111298433|NCT00068575|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111298434|NCT00068575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111298435|NCT00068575|Immunologic Factors|immunologic factors|mesh-ancestor
111298436|NCT00068575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111298437|NCT00068575|Antiviral Agents|antiviral agents|mesh-ancestor
111298438|NCT00068575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111298439|NCT00784823|Bortezomib|bortezomib|mesh-list
111298440|NCT00784823|Melphalan|melphalan|mesh-list
111298441|NCT00784823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111298442|NCT00784823|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111298443|NCT00784823|Alkylating Agents|alkylating agents|mesh-ancestor
111298444|NCT00784823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111298445|NCT00784823|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111298446|NCT00784823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111298447|NCT00784823|Immunologic Factors|immunologic factors|mesh-ancestor
111298448|NCT00784823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111298449|NCT04428684|Goserelin|goserelin|mesh-list
111298450|NCT04428684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111298451|NCT04428684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111298452|NCT01509105|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
111298453|NCT01509105|Immunologic Factors|immunologic factors|mesh-ancestor
111298454|NCT01509105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111298455|NCT00773357|Guanfacine|guanfacine|mesh-list
111298456|NCT00773357|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111298457|NCT00773357|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111298458|NCT00773357|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111298459|NCT00773357|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111298460|NCT00773357|Adrenergic Agents|adrenergic agents|mesh-ancestor
111298461|NCT00773357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111298462|NCT00773357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111298463|NCT00773357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111298464|NCT05617950|Salicylic Acid|salicylic acid|mesh-list
111298465|NCT05617950|Salicylates|salicylates|mesh-list
111298466|NCT05617950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111298467|NCT05617950|Antifungal Agents|antifungal agents|mesh-ancestor
111298468|NCT05617950|Keratolytic Agents|keratolytic agents|mesh-ancestor
111298469|NCT05617950|Dermatologic Agents|dermatologic agents|mesh-ancestor
111298470|NCT05617950|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111298471|NCT05617950|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111298472|NCT05617950|Analgesics|analgesics|mesh-ancestor
111298473|NCT05617950|Sensory System Agents|sensory system agents|mesh-ancestor
111298474|NCT05617950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111298475|NCT05617950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111298476|NCT05617950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111298477|NCT05617950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111298478|NCT05617950|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111298479|NCT05617950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111298480|NCT05617950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111298481|NCT04834752|Esomeprazole|esomeprazole|mesh-list
111298482|NCT04834752|Omeprazole|omeprazole|mesh-list
111298483|NCT04834752|Rabeprazole|rabeprazole|mesh-list
111298484|NCT04834752|Pantoprazole|pantoprazole|mesh-list
111298485|NCT04834752|Lansoprazole|lansoprazole|mesh-list
111298486|NCT04834752|Dexlansoprazole|dexlansoprazole|mesh-list
111298487|NCT04834752|Famotidine|famotidine|mesh-list
111298488|NCT04834752|Ranitidine|ranitidine|mesh-list
111298489|NCT04834752|Cimetidine|cimetidine|mesh-list
111298490|NCT04834752|Nizatidine|nizatidine|mesh-list
111298491|NCT04834752|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111298492|NCT04834752|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111298493|NCT04834752|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111298494|NCT04834752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111298495|NCT04834752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111298496|NCT04834752|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
111298497|NCT04834752|Histamine Antagonists|histamine antagonists|mesh-ancestor
111298498|NCT04834752|Histamine Agents|histamine agents|mesh-ancestor
111298499|NCT04834752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111298500|NCT04834752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111298501|NCT04834752|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111298502|NCT04834752|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111298503|NCT04834674|Apatinib|apatinib|mesh-list
110959199|NCT01025505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111298504|NCT04834674|Antibodies|antibodies|mesh-list
111298505|NCT04834674|Immunologic Factors|immunologic factors|mesh-ancestor
111298506|NCT04834674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111298507|NCT04834674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111298508|NCT04834674|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111298509|NCT04834674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111298510|NCT04834674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111298511|NCT04826406|Apatinib|apatinib|mesh-list
111298512|NCT04826406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111298513|NCT04826406|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111298514|NCT04826406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111298515|NCT04826406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111298516|NCT05617872|Acetic Acid|acetic acid|mesh-list
111298517|NCT05617872|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111298518|NCT05617872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111298519|NCT04198727|Capecitabine|capecitabine|mesh-list
111298520|NCT04198727|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111298521|NCT04198727|Antimetabolites|antimetabolites|mesh-ancestor
111298522|NCT04198727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111298523|NCT04198727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111298524|NCT00437255|Betamethasone|betamethasone|mesh-list
111298525|NCT00437255|Betamethasone Valerate|betamethasone valerate|mesh-list
111298526|NCT00437255|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
111298527|NCT00437255|Betamethasone benzoate|betamethasone benzoate|mesh-list
111298528|NCT00437255|Clobetasol|clobetasol|mesh-list
111298529|NCT00437255|Calcipotriene|calcipotriene|mesh-list
111298530|NCT00437255|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
111298531|NCT00437255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111298532|NCT00437255|Glucocorticoids|glucocorticoids|mesh-ancestor
111298533|NCT00437255|Hormones|hormones|mesh-ancestor
111298534|NCT00437255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111298535|NCT00437255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111298536|NCT00437255|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111298537|NCT00437255|Respiratory System Agents|respiratory system agents|mesh-ancestor
111298538|NCT00437255|Dermatologic Agents|dermatologic agents|mesh-ancestor
111298539|NCT02324673|Cannabidiol|cannabidiol|mesh-list
111298540|NCT02324673|Anticonvulsants|anticonvulsants|mesh-ancestor
111298541|NCT00373217|Paclitaxel|paclitaxel|mesh-list
111298542|NCT00373217|Carboplatin|carboplatin|mesh-list
111298543|NCT00373217|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111298544|NCT00373217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111298545|NCT00373217|Tubulin Modulators|tubulin modulators|mesh-ancestor
111298546|NCT00373217|Antimitotic Agents|antimitotic agents|mesh-ancestor
111298547|NCT00373217|Mitosis Modulators|mitosis modulators|mesh-ancestor
111298548|NCT00373217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111298549|NCT02605122|Amoxicillin|amoxicillin|mesh-list
111298550|NCT02605122|Azithromycin|azithromycin|mesh-list
111298551|NCT02605122|Ceftriaxone|ceftriaxone|mesh-list
111298552|NCT02605122|Erythromycin|erythromycin|mesh-list
111298553|NCT02605122|Erythromycin Estolate|erythromycin estolate|mesh-list
111298554|NCT02605122|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
111298555|NCT02605122|Erythromycin stearate|erythromycin stearate|mesh-list
111298556|NCT02605122|Ampicillin|ampicillin|mesh-list
111298557|NCT02605122|Clavulanic Acids|clavulanic acids|mesh-list
111298558|NCT02605122|Clavulanic Acid|clavulanic acid|mesh-list
111298559|NCT02605122|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
111298560|NCT02605122|Solithromycin|solithromycin|mesh-list
111298561|NCT02605122|Erythromycin lactobionate|erythromycin lactobionate|mesh-list
111298562|NCT02605122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111298563|NCT02605122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111298564|NCT02605122|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111298565|NCT02605122|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111298566|NCT02605122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111298567|NCT02605122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111298568|NCT02605122|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
111298569|NCT01579305|Lidocaine|lidocaine|mesh-list
111298570|NCT01579305|Anesthetics, Local|anesthetics, local|mesh-ancestor
111298571|NCT01579305|Anesthetics|anesthetics|mesh-ancestor
111298572|NCT01579305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111298573|NCT01579305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111298574|NCT01579305|Sensory System Agents|sensory system agents|mesh-ancestor
111298575|NCT01579305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111298576|NCT01579305|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111298577|NCT01579305|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111298578|NCT01579305|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111298579|NCT01579305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111298580|NCT01579305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111298581|NCT00212147|Nitrous Oxide|nitrous oxide|mesh-list
111298582|NCT00212147|Anesthetics|anesthetics|mesh-list
111298583|NCT00212147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111298584|NCT00212147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111298585|NCT00212147|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111298586|NCT00212147|Anesthetics, General|anesthetics, general|mesh-ancestor
111298587|NCT00212147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111298588|NCT00212147|Analgesics|analgesics|mesh-ancestor
111298589|NCT00212147|Sensory System Agents|sensory system agents|mesh-ancestor
111298590|NCT00212147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111298591|NCT04820010|Insulin|insulin|mesh-list
111298592|NCT04820010|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111298593|NCT04820010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111298594|NCT04819776|Iloperidone|iloperidone|mesh-list
111298595|NCT04819776|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111298596|NCT04819776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111298597|NCT04819776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111298598|NCT04819776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111298599|NCT04819776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111298600|NCT01454102|Paclitaxel|paclitaxel|mesh-list
111298601|NCT01454102|Bevacizumab|bevacizumab|mesh-list
111298602|NCT01454102|Carboplatin|carboplatin|mesh-list
111298603|NCT01454102|Gemcitabine|gemcitabine|mesh-list
111298604|NCT01454102|Nivolumab|nivolumab|mesh-list
111298605|NCT01454102|Pemetrexed|pemetrexed|mesh-list
111298606|NCT01454102|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111298607|NCT01454102|Ipilimumab|ipilimumab|mesh-list
111298608|NCT01454102|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111298609|NCT01454102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111298610|NCT01454102|Tubulin Modulators|tubulin modulators|mesh-ancestor
111298611|NCT01454102|Antimitotic Agents|antimitotic agents|mesh-ancestor
111298612|NCT01454102|Mitosis Modulators|mitosis modulators|mesh-ancestor
111298613|NCT01454102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111298614|NCT01454102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111298615|NCT01454102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111298616|NCT01454102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111298617|NCT01454102|Growth Substances|growth substances|mesh-ancestor
111298618|NCT01454102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111298619|NCT01454102|Growth Inhibitors|growth inhibitors|mesh-ancestor
111298620|NCT01454102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111298621|NCT01454102|Antimetabolites|antimetabolites|mesh-ancestor
111298622|NCT01454102|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111298623|NCT01454102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111298624|NCT01454102|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111298625|NCT01454102|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111298626|NCT01454102|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111298627|NCT04192253|Paclitaxel|paclitaxel|mesh-list
111298628|NCT04192253|Carboplatin|carboplatin|mesh-list
111298629|NCT04192253|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111298630|NCT04192253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111298631|NCT04192253|Tubulin Modulators|tubulin modulators|mesh-ancestor
111298632|NCT04192253|Antimitotic Agents|antimitotic agents|mesh-ancestor
111298633|NCT04192253|Mitosis Modulators|mitosis modulators|mesh-ancestor
111298634|NCT04192253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111298635|NCT04825938|Paclitaxel|paclitaxel|mesh-list
111298636|NCT04825938|Carboplatin|carboplatin|mesh-list
111298637|NCT04825938|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111298638|NCT04825938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111298639|NCT04825938|Tubulin Modulators|tubulin modulators|mesh-ancestor
111298640|NCT04825938|Antimitotic Agents|antimitotic agents|mesh-ancestor
111298641|NCT04825938|Mitosis Modulators|mitosis modulators|mesh-ancestor
111298642|NCT04825938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111298643|NCT04826016|Paclitaxel|paclitaxel|mesh-list
111298644|NCT04826016|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111298645|NCT04826016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111298646|NCT04826016|Tubulin Modulators|tubulin modulators|mesh-ancestor
111298647|NCT04826016|Antimitotic Agents|antimitotic agents|mesh-ancestor
111298648|NCT04826016|Mitosis Modulators|mitosis modulators|mesh-ancestor
111298649|NCT04826016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111298650|NCT01509807|Morphine|morphine|mesh-list
111298651|NCT01509807|Bupivacaine|bupivacaine|mesh-list
111298652|NCT01509807|Anesthetics, Local|anesthetics, local|mesh-ancestor
111298653|NCT01509807|Anesthetics|anesthetics|mesh-ancestor
111298654|NCT01509807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111298655|NCT01509807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111298656|NCT01509807|Sensory System Agents|sensory system agents|mesh-ancestor
111298657|NCT01509807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111298658|NCT01509807|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111298659|NCT01509807|Narcotics|narcotics|mesh-ancestor
111298660|NCT01509807|Analgesics|analgesics|mesh-ancestor
111298661|NCT00070135|Methotrexate|methotrexate|mesh-list
111298662|NCT00070135|Fludarabine phosphate|fludarabine phosphate|mesh-list
111298663|NCT00070135|Fludarabine|fludarabine|mesh-list
111298664|NCT00070135|Busulfan|busulfan|mesh-list
111298665|NCT00070135|Tacrolimus|tacrolimus|mesh-list
111298666|NCT00070135|Antilymphocyte Serum|antilymphocyte serum|mesh-list
111298667|NCT00070135|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111298668|NCT00070135|Abortifacient Agents|abortifacient agents|mesh-ancestor
111298669|NCT00070135|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111298670|NCT00070135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111298671|NCT00070135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111298672|NCT00070135|Antimetabolites|antimetabolites|mesh-ancestor
111298673|NCT00070135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111298674|NCT00070135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111298675|NCT00070135|Dermatologic Agents|dermatologic agents|mesh-ancestor
111298676|NCT00070135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111298677|NCT00070135|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111298678|NCT00070135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111298679|NCT00070135|Immunologic Factors|immunologic factors|mesh-ancestor
111298680|NCT00070135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111298681|NCT00070135|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111298682|NCT00070135|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111298683|NCT00070135|Alkylating Agents|alkylating agents|mesh-ancestor
111298684|NCT00070135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111298685|NCT00070135|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111298686|NCT01583985|Analgesics, Opioid|analgesics, opioid|mesh-list
111298687|NCT01583985|Narcotics|narcotics|mesh-ancestor
111298688|NCT01583985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111298689|NCT01583985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111298690|NCT01583985|Analgesics|analgesics|mesh-ancestor
111298691|NCT01583985|Sensory System Agents|sensory system agents|mesh-ancestor
111298692|NCT01583985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111298693|NCT04816344|Anesthetics|anesthetics|mesh-list
111298694|NCT04816344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111298695|NCT04816344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111298696|NCT01467999|Guanfacine|guanfacine|mesh-list
111298697|NCT01467999|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111298698|NCT01467999|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111298699|NCT01467999|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111298700|NCT01467999|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111298701|NCT01467999|Adrenergic Agents|adrenergic agents|mesh-ancestor
111298702|NCT01467999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111298703|NCT01467999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111298704|NCT01467999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111298705|NCT05617482|Anesthetics|anesthetics|mesh-list
111298706|NCT05617482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111298707|NCT05617482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111298708|NCT01470027|Acetylcysteine|acetylcysteine|mesh-list
111298709|NCT01470027|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111298710|NCT01470027|Antiviral Agents|antiviral agents|mesh-ancestor
111298711|NCT01470027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111298712|NCT01470027|Expectorants|expectorants|mesh-ancestor
111298713|NCT01470027|Respiratory System Agents|respiratory system agents|mesh-ancestor
111298714|NCT01470027|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111298715|NCT01470027|Antioxidants|antioxidants|mesh-ancestor
111298716|NCT01470027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111298717|NCT01470027|Protective Agents|protective agents|mesh-ancestor
111298718|NCT01470027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111298719|NCT01470027|Antidotes|antidotes|mesh-ancestor
111298720|NCT01470651|Modafinil|modafinil|mesh-list
111298721|NCT01470651|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111298722|NCT01470651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111298723|NCT01470651|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
111298724|NCT01470651|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111298725|NCT01470651|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111298726|NCT01470651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111298727|NCT01512225|Domperidone|domperidone|mesh-list
111298728|NCT01512225|Maleic acid|maleic acid|mesh-list
111298729|NCT01512225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111298730|NCT01512225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111298731|NCT01512225|Antiemetics|antiemetics|mesh-ancestor
111298732|NCT01512225|Autonomic Agents|autonomic agents|mesh-ancestor
111298733|NCT01512225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111298734|NCT01512225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111298735|NCT01512225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111298736|NCT01512225|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111298737|NCT01512225|Dopamine Agents|dopamine agents|mesh-ancestor
111298738|NCT01512225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111298739|NCT01472445|Vitamin D|vitamin d|mesh-list
111298740|NCT01472445|Cholecalciferol|cholecalciferol|mesh-list
111298741|NCT01472445|Vitamins|vitamins|mesh-ancestor
111298742|NCT01472445|Micronutrients|micronutrients|mesh-ancestor
111298743|NCT01472445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111298744|NCT01472445|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111298745|NCT01472445|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111298746|NCT04782089|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
111298747|NCT04782089|Fluzoparib|fluzoparib|mesh-list
111298748|NCT04782089|Antibodies|antibodies|mesh-list
111298749|NCT04782089|Immunologic Factors|immunologic factors|mesh-ancestor
111298750|NCT04782089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111298751|NCT04782089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111298752|NCT04782089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110979724|NCT03851081|Mitosis Modulators|mitosis modulators|mesh-ancestor
111298753|NCT04782089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111298754|NCT02604342|Docetaxel|docetaxel|mesh-list
111298755|NCT02604342|Pemetrexed|pemetrexed|mesh-list
111298756|NCT02604342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111298757|NCT02604342|Tubulin Modulators|tubulin modulators|mesh-ancestor
111298758|NCT02604342|Antimitotic Agents|antimitotic agents|mesh-ancestor
111298759|NCT02604342|Mitosis Modulators|mitosis modulators|mesh-ancestor
111298760|NCT02604342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111298761|NCT02604342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111298762|NCT02604342|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111298763|NCT02604342|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111298764|NCT04781777|Insulin|insulin|mesh-list
111298765|NCT04781777|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111298766|NCT04781777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111298767|NCT04781075|Bupivacaine|bupivacaine|mesh-list
111298768|NCT04781075|Anesthetics, Local|anesthetics, local|mesh-ancestor
111298769|NCT04781075|Anesthetics|anesthetics|mesh-ancestor
111298770|NCT04781075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111298771|NCT04781075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111298772|NCT04781075|Sensory System Agents|sensory system agents|mesh-ancestor
111298773|NCT04781075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111298774|NCT01586091|Fexofenadine|fexofenadine|mesh-list
111298775|NCT01586091|Levocetirizine|levocetirizine|mesh-list
111298776|NCT01586091|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
111298777|NCT01586091|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111298778|NCT01586091|Histamine Antagonists|histamine antagonists|mesh-ancestor
111298779|NCT01586091|Histamine Agents|histamine agents|mesh-ancestor
111298780|NCT01586091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111298781|NCT01586091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111298782|NCT01586091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111298783|NCT01586091|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111298784|NCT05565573|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
111298785|NCT05565573|Levonorgestrel|levonorgestrel|mesh-list
111298786|NCT05565573|Medroxyprogesterone|medroxyprogesterone|mesh-list
111298787|NCT05565573|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111298788|NCT05565573|Contraceptive Agents|contraceptive agents|mesh-ancestor
111298789|NCT05565573|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111298790|NCT05565573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111298791|NCT05565573|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111298792|NCT05565573|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111298793|NCT05565573|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111298794|NCT05565573|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111298795|NCT05565573|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
111298796|NCT05565573|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111298797|NCT05565573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111298798|NCT04389359|Hydroxychloroquine|hydroxychloroquine|mesh-list
111298799|NCT04389359|Antimalarials|antimalarials|mesh-ancestor
111298800|NCT04389359|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111298801|NCT04389359|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111298802|NCT04389359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111298803|NCT04389359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111298804|NCT04389359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111298805|NCT04389359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111298806|NCT01587027|Aminophylline|aminophylline|mesh-list
111298807|NCT01587027|Methazolamide|methazolamide|mesh-list
111298808|NCT01587027|Theophylline|theophylline|mesh-list
111298809|NCT01587027|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111298810|NCT01587027|Autonomic Agents|autonomic agents|mesh-ancestor
111298812|NCT01587027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111298813|NCT01587027|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111298814|NCT01587027|Respiratory System Agents|respiratory system agents|mesh-ancestor
111298815|NCT01587027|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111298816|NCT01587027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111298817|NCT01587027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111298818|NCT01587027|Vasodilator Agents|vasodilator agents|mesh-ancestor
111298819|NCT01587027|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
111298820|NCT01587027|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111298821|NCT01587027|Purinergic Agents|purinergic agents|mesh-ancestor
111298822|NCT01587027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111298823|NCT01587027|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111298824|NCT01587027|Protective Agents|protective agents|mesh-ancestor
111298825|NCT01587027|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
111298826|NCT01587027|Diuretics|diuretics|mesh-ancestor
111298827|NCT01587027|Natriuretic Agents|natriuretic agents|mesh-ancestor
111298828|NCT01471340|Mometasone Furoate|mometasone furoate|mesh-list
111298829|NCT01471340|Prednisone|prednisone|mesh-list
111298830|NCT01471340|Prednisolone|prednisolone|mesh-list
111298831|NCT01471340|Albuterol|albuterol|mesh-list
111298832|NCT01471340|Formoterol Fumarate|formoterol fumarate|mesh-list
111298833|NCT01471340|Mometasone Furoate, Formoterol Fumarate Drug Combination|mometasone furoate, formoterol fumarate drug combination|mesh-list
111298834|NCT01471340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111298835|NCT01471340|Glucocorticoids|glucocorticoids|mesh-ancestor
111298836|NCT01471340|Hormones|hormones|mesh-ancestor
111298837|NCT01471340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111298838|NCT01471340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111298839|NCT01471340|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111298840|NCT01471340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111298841|NCT01471340|Autonomic Agents|autonomic agents|mesh-ancestor
111298842|NCT01471340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111298843|NCT01471340|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111298844|NCT01471340|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111298845|NCT01471340|Respiratory System Agents|respiratory system agents|mesh-ancestor
111298846|NCT01471340|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111298847|NCT01471340|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111298848|NCT01471340|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111298849|NCT01471340|Adrenergic Agents|adrenergic agents|mesh-ancestor
111298850|NCT01471340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111298851|NCT01471340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111298852|NCT01471340|Tocolytic Agents|tocolytic agents|mesh-ancestor
111298853|NCT01471340|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111298854|NCT01471340|Dermatologic Agents|dermatologic agents|mesh-ancestor
111298855|NCT01471340|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111298856|NCT04754789|Aspirin|aspirin|mesh-list
111298857|NCT04754789|Ticagrelor|ticagrelor|mesh-list
111298858|NCT04754789|Atorvastatin|atorvastatin|mesh-list
111298859|NCT04754789|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111298860|NCT04754789|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111298861|NCT04754789|Analgesics|analgesics|mesh-ancestor
111298862|NCT04754789|Sensory System Agents|sensory system agents|mesh-ancestor
111298863|NCT04754789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111298864|NCT04754789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111298865|NCT04754789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111298866|NCT04754789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111298867|NCT04754789|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111298868|NCT04754789|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111298869|NCT04754789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111298870|NCT04754789|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111298871|NCT04754789|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111298872|NCT04754789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111298873|NCT04754789|Antipyretics|antipyretics|mesh-ancestor
111298874|NCT04754789|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111298875|NCT04754789|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111298876|NCT04754789|Antimetabolites|antimetabolites|mesh-ancestor
111298877|NCT04754789|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111023312|NCT04175431|Hormones|hormones|mesh-ancestor
111023313|NCT04175431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111023314|NCT04175431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111023315|NCT04175431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111023316|NCT04175431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111023317|NCT04175431|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111298878|NCT04754789|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111298879|NCT04754789|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111298880|NCT04754789|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111298881|NCT04754789|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111298882|NCT04754789|Purinergic Agents|purinergic agents|mesh-ancestor
111298883|NCT04754789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111298884|NCT04817904|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111298885|NCT04817904|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111298886|NCT04817904|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111298887|NCT04817904|Antimetabolites|antimetabolites|mesh-ancestor
111298888|NCT04817904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111298889|NCT04817904|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111298890|NCT04817904|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111298891|NCT04817904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111298892|NCT04815408|Paclitaxel|paclitaxel|mesh-list
111298893|NCT04815408|Carboplatin|carboplatin|mesh-list
111298894|NCT04815408|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111298895|NCT04815408|Tislelizumab|tislelizumab|mesh-list
111298896|NCT04815408|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111298897|NCT04815408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111298898|NCT04815408|Tubulin Modulators|tubulin modulators|mesh-ancestor
111298899|NCT04815408|Antimitotic Agents|antimitotic agents|mesh-ancestor
111298900|NCT04815408|Mitosis Modulators|mitosis modulators|mesh-ancestor
111298901|NCT04815408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111298902|NCT04815408|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111298903|NCT04778813|Artesunate|artesunate|mesh-list
111298904|NCT04778813|Lumefantrine|lumefantrine|mesh-list
111298905|NCT04778813|Artemether|artemether|mesh-list
111298906|NCT04778813|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
111298907|NCT04778813|Artenimol|artenimol|mesh-list
111298908|NCT04778813|Pyronaridine|pyronaridine|mesh-list
111298909|NCT04778813|Antimalarials|antimalarials|mesh-ancestor
111298910|NCT04778813|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111298911|NCT04778813|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111298912|NCT04778813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111298913|NCT04778813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111298914|NCT04778813|Antiviral Agents|antiviral agents|mesh-ancestor
111298915|NCT04778813|Schistosomicides|schistosomicides|mesh-ancestor
111298916|NCT04778813|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
111298917|NCT04778813|Anthelmintics|anthelmintics|mesh-ancestor
111298918|NCT04817982|Dexamethasone|dexamethasone|mesh-list
111298919|NCT04817982|Dexamethasone acetate|dexamethasone acetate|mesh-list
111298920|NCT04817982|Lidocaine|lidocaine|mesh-list
111298921|NCT04817982|BB 1101|bb 1101|mesh-list
111298922|NCT04817982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111298923|NCT04817982|Antiemetics|antiemetics|mesh-ancestor
111298924|NCT04817982|Autonomic Agents|autonomic agents|mesh-ancestor
111298925|NCT04817982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111298926|NCT04817982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111298927|NCT04817982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111298928|NCT04817982|Glucocorticoids|glucocorticoids|mesh-ancestor
111298929|NCT04817982|Hormones|hormones|mesh-ancestor
111298930|NCT04817982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111298931|NCT04817982|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111298932|NCT04817982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111298933|NCT04817982|Protease Inhibitors|protease inhibitors|mesh-ancestor
111298934|NCT04817982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111298935|NCT04817982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111298936|NCT04817982|Anesthetics, Local|anesthetics, local|mesh-ancestor
111298937|NCT04817982|Anesthetics|anesthetics|mesh-ancestor
111298938|NCT04817982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111298939|NCT04817982|Sensory System Agents|sensory system agents|mesh-ancestor
111298940|NCT04817982|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111298941|NCT04817982|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111298942|NCT04817982|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111298943|NCT04817982|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111298944|NCT04779047|Ritonavir|ritonavir|mesh-list
111298945|NCT04779047|Lopinavir|lopinavir|mesh-list
111298946|NCT04779047|Hydroxychloroquine|hydroxychloroquine|mesh-list
111298947|NCT04779047|Ivermectin|ivermectin|mesh-list
111298948|NCT04779047|Remdesivir|remdesivir|mesh-list
111298949|NCT04779047|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111298950|NCT04779047|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111298951|NCT04779047|Protease Inhibitors|protease inhibitors|mesh-ancestor
111298952|NCT04779047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111298953|NCT04779047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111298954|NCT04779047|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111298955|NCT04779047|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111298956|NCT04779047|Antiviral Agents|antiviral agents|mesh-ancestor
111298957|NCT04779047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111298958|NCT04779047|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111298959|NCT04779047|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111298960|NCT04779047|Antimalarials|antimalarials|mesh-ancestor
111298961|NCT04779047|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111298962|NCT04779047|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111298963|NCT04779047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111298964|NCT04779047|Antimetabolites|antimetabolites|mesh-ancestor
111298966|NCT04427826|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111298967|NCT04427826|Narcotics|narcotics|mesh-ancestor
110979730|NCT03851081|Immunologic Factors|immunologic factors|mesh-ancestor
111298968|NCT04427826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111298969|NCT04427826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111298970|NCT04427826|Analgesics|analgesics|mesh-ancestor
111298971|NCT04427826|Sensory System Agents|sensory system agents|mesh-ancestor
111298972|NCT04427826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111298973|NCT01515345|Clopidogrel|clopidogrel|mesh-list
111298974|NCT01515345|Ticagrelor|ticagrelor|mesh-list
111298975|NCT01515345|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
111298976|NCT01515345|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111298977|NCT01515345|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111298978|NCT01515345|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111298979|NCT01515345|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111298980|NCT01515345|Purinergic Agents|purinergic agents|mesh-ancestor
111298981|NCT01515345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111298982|NCT01515345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111298983|NCT01515345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111298984|NCT01492400|Dexamethasone|dexamethasone|mesh-list
111298985|NCT01492400|Ranibizumab|ranibizumab|mesh-list
111298986|NCT01492400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111298987|NCT01492400|Antiemetics|antiemetics|mesh-ancestor
111298988|NCT01492400|Autonomic Agents|autonomic agents|mesh-ancestor
111298989|NCT01492400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111298990|NCT01492400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111298991|NCT01492400|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111298992|NCT01492400|Glucocorticoids|glucocorticoids|mesh-ancestor
111298993|NCT01492400|Hormones|hormones|mesh-ancestor
111298994|NCT01492400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111298995|NCT01492400|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111298996|NCT01492400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111298997|NCT01492400|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111298998|NCT01492400|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111298999|NCT01492400|Growth Substances|growth substances|mesh-ancestor
111299000|NCT01492400|Growth Inhibitors|growth inhibitors|mesh-ancestor
111299001|NCT00168337|Dexamethasone|dexamethasone|mesh-list
111299002|NCT00168337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111299003|NCT00168337|Antiemetics|antiemetics|mesh-ancestor
111299004|NCT00168337|Autonomic Agents|autonomic agents|mesh-ancestor
111299005|NCT00168337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111299006|NCT00168337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111299007|NCT00168337|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111299008|NCT00168337|Glucocorticoids|glucocorticoids|mesh-ancestor
111299009|NCT00168337|Hormones|hormones|mesh-ancestor
111299010|NCT00168337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111299011|NCT00168337|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111299012|NCT00168337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111299013|NCT01515657|Aspirin|aspirin|mesh-list
111299014|NCT01515657|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111299015|NCT01515657|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111299016|NCT01515657|Analgesics|analgesics|mesh-ancestor
111299017|NCT01515657|Sensory System Agents|sensory system agents|mesh-ancestor
111299018|NCT01515657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111299019|NCT01515657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111299020|NCT01515657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111299021|NCT01515657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111299022|NCT01515657|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111299023|NCT01515657|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111299024|NCT01515657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111299025|NCT01515657|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111299026|NCT01515657|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111299027|NCT01515657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111299028|NCT01515657|Antipyretics|antipyretics|mesh-ancestor
111299029|NCT01515891|Opicapone|opicapone|mesh-list
111299030|NCT01515891|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
111299031|NCT01515891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111299032|NCT01515891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111299033|NCT01515891|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111299034|NCT01515891|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111299035|NCT00073957|Cytarabine|cytarabine|mesh-list
111299036|NCT00073957|Rituximab|rituximab|mesh-list
111299037|NCT00073957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111299038|NCT00073957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111299039|NCT00073957|Immunologic Factors|immunologic factors|mesh-ancestor
111299040|NCT00073957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111299041|NCT00073957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111299042|NCT00073957|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111299043|NCT00073957|Antimetabolites|antimetabolites|mesh-ancestor
111299044|NCT00073957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111299045|NCT00073957|Antiviral Agents|antiviral agents|mesh-ancestor
111299046|NCT00073957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111299047|NCT00073957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111299048|NCT04354428|Folic Acid|folic acid|mesh-list
111299049|NCT04354428|Ascorbic Acid|ascorbic acid|mesh-list
111299050|NCT04354428|Ritonavir|ritonavir|mesh-list
111299051|NCT04354428|Lopinavir|lopinavir|mesh-list
111299052|NCT04354428|Azithromycin|azithromycin|mesh-list
111299053|NCT04354428|Hydroxychloroquine|hydroxychloroquine|mesh-list
111299054|NCT04354428|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111299055|NCT04354428|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111299056|NCT04354428|Protease Inhibitors|protease inhibitors|mesh-ancestor
111299057|NCT04354428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111299058|NCT04354428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111299059|NCT04354428|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111299060|NCT04354428|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111299061|NCT04354428|Antiviral Agents|antiviral agents|mesh-ancestor
111299062|NCT04354428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111299063|NCT04354428|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111299064|NCT04354428|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111299065|NCT04354428|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111299066|NCT04354428|Antimalarials|antimalarials|mesh-ancestor
111299067|NCT04354428|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111299068|NCT04354428|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111299069|NCT04354428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111299070|NCT04354428|Hematinics|hematinics|mesh-ancestor
111299071|NCT04354428|Vitamin B Complex|vitamin b complex|mesh-ancestor
111299072|NCT04354428|Vitamins|vitamins|mesh-ancestor
111299073|NCT04354428|Micronutrients|micronutrients|mesh-ancestor
111299074|NCT04354428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111299075|NCT04354428|Antioxidants|antioxidants|mesh-ancestor
111299076|NCT04354428|Protective Agents|protective agents|mesh-ancestor
111299077|NCT02090075|Warfarin|warfarin|mesh-list
111299078|NCT02090075|Apixaban|apixaban|mesh-list
111299079|NCT02090075|Anticoagulants|anticoagulants|mesh-ancestor
111299080|NCT02090075|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111299081|NCT02090075|Antithrombins|antithrombins|mesh-ancestor
111299082|NCT02090075|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111299083|NCT02090075|Protease Inhibitors|protease inhibitors|mesh-ancestor
111299084|NCT02090075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111299085|NCT02090075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111299086|NCT04817202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111299087|NCT04817202|Antibodies|antibodies|mesh-list
111299088|NCT04817202|Immunoglobulins|immunoglobulins|mesh-list
111299089|NCT04817202|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111299090|NCT04817202|Immunologic Factors|immunologic factors|mesh-ancestor
111299091|NCT04817202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111299092|NCT04817202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111299093|NCT04775303|Cyclosporine|cyclosporine|mesh-list
111299094|NCT04775303|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111299095|NCT04775303|Cyclosporins|cyclosporins|mesh-list
111299096|NCT04775303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111299097|NCT04775303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111299098|NCT04775303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111299099|NCT04775303|Immunologic Factors|immunologic factors|mesh-ancestor
111299100|NCT04775303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111299101|NCT04775303|Antifungal Agents|antifungal agents|mesh-ancestor
111299102|NCT04775303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111299103|NCT04775303|Dermatologic Agents|dermatologic agents|mesh-ancestor
111299104|NCT04775303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111299105|NCT04775303|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111299106|NCT04775303|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111299107|NCT04816968|Vancomycin|vancomycin|mesh-list
111299108|NCT04816968|Meropenem|meropenem|mesh-list
111299109|NCT04816968|Tazobactam|tazobactam|mesh-list
111299110|NCT04816968|Piperacillin|piperacillin|mesh-list
111299111|NCT04816968|Cefepime|cefepime|mesh-list
111299112|NCT04816968|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
111299113|NCT04816968|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111299114|NCT04816968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111299115|NCT04816968|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
111299116|NCT04816968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111299117|NCT04816968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111299118|NCT02210247|Bupivacaine|bupivacaine|mesh-list
111299119|NCT02210247|Anesthetics, Local|anesthetics, local|mesh-ancestor
111299120|NCT02210247|Anesthetics|anesthetics|mesh-ancestor
111299121|NCT02210247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111299122|NCT02210247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111299123|NCT02210247|Sensory System Agents|sensory system agents|mesh-ancestor
111299124|NCT02210247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111299125|NCT04775459|Pulmonary Surfactants|pulmonary surfactants|mesh-list
111299126|NCT04775459|Respiratory System Agents|respiratory system agents|mesh-ancestor
111299127|NCT04806438|Lidocaine|lidocaine|mesh-list
111299128|NCT04806438|Anesthetics, Local|anesthetics, local|mesh-ancestor
111299129|NCT04806438|Anesthetics|anesthetics|mesh-ancestor
111299130|NCT04806438|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111299131|NCT04806438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111299132|NCT04806438|Sensory System Agents|sensory system agents|mesh-ancestor
111299133|NCT04806438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111299134|NCT04806438|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111299135|NCT04806438|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111299136|NCT04806438|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111299137|NCT04806438|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111299138|NCT04806438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111299139|NCT00074035|Pentostatin|pentostatin|mesh-list
111299140|NCT00074035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111299141|NCT00074035|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
111299142|NCT00074035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111299143|NCT00074035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111299144|NCT01591317|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
111299145|NCT01591317|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111299146|NCT00074815|Fluvoxamine|fluvoxamine|mesh-list
111299147|NCT00074815|Citalopram|citalopram|mesh-list
111299148|NCT00074815|Fluoxetine|fluoxetine|mesh-list
111299149|NCT00074815|Paroxetine|paroxetine|mesh-list
111299150|NCT00074815|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
111299151|NCT00074815|Sertraline|sertraline|mesh-list
111299152|NCT00074815|Clomipramine|clomipramine|mesh-list
111299153|NCT00074815|Escitalopram|escitalopram|mesh-list
111299154|NCT00074815|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
111299155|NCT00074815|Serotonin|serotonin|mesh-list
111299156|NCT00074815|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111299157|NCT00074815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111299158|NCT00074815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111299159|NCT00074815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111299160|NCT00074815|Serotonin Agents|serotonin agents|mesh-ancestor
111299161|NCT00074815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111299162|NCT00074815|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111299163|NCT00074815|Antidepressive Agents|antidepressive agents|mesh-ancestor
111299164|NCT00074815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111299165|NCT00074815|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111299166|NCT00074815|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111299167|NCT00074815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111299168|NCT00074815|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111299169|NCT00074815|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111299170|NCT00074815|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111299171|NCT00074815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111299172|NCT00074815|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111299173|NCT00074815|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111299174|NCT00074815|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111299175|NCT00074815|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
111299176|NCT04772729|Insulin|insulin|mesh-list
111299177|NCT04772729|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111299178|NCT04772729|Insulin Aspart|insulin aspart|mesh-list
111299179|NCT04772729|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111299180|NCT04772729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111299181|NCT05562375|Tolonium Chloride|tolonium chloride|mesh-list
111023613|NCT02677038|Olaparib|olaparib|mesh-list
111299182|NCT05562375|Hemostatics|hemostatics|mesh-ancestor
111299183|NCT05562375|Coagulants|coagulants|mesh-ancestor
111299184|NCT05562375|Heparin Antagonists|heparin antagonists|mesh-ancestor
111299185|NCT05562375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111299186|NCT00075829|Thalidomide|thalidomide|mesh-list
111299187|NCT00075829|Dexamethasone|dexamethasone|mesh-list
111299188|NCT00075829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111299189|NCT00075829|Antiemetics|antiemetics|mesh-ancestor
111299190|NCT00075829|Autonomic Agents|autonomic agents|mesh-ancestor
111299191|NCT00075829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111299192|NCT00075829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111299193|NCT00075829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111299194|NCT00075829|Glucocorticoids|glucocorticoids|mesh-ancestor
111299195|NCT00075829|Hormones|hormones|mesh-ancestor
111299196|NCT00075829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111299197|NCT00075829|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111299198|NCT00075829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111299199|NCT00075829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111299200|NCT00075829|Immunologic Factors|immunologic factors|mesh-ancestor
111299201|NCT00075829|Leprostatic Agents|leprostatic agents|mesh-ancestor
111299202|NCT00075829|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111299203|NCT00075829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111299204|NCT00075829|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111299205|NCT00075829|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111299206|NCT00075829|Growth Substances|growth substances|mesh-ancestor
111299207|NCT00075829|Growth Inhibitors|growth inhibitors|mesh-ancestor
111299208|NCT02218203|Lidocaine|lidocaine|mesh-list
111299209|NCT02218203|Dextromethorphan|dextromethorphan|mesh-list
111299210|NCT02218203|Anesthetics, Local|anesthetics, local|mesh-ancestor
111299211|NCT02218203|Anesthetics|anesthetics|mesh-ancestor
111299212|NCT02218203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111299213|NCT02218203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111299214|NCT02218203|Sensory System Agents|sensory system agents|mesh-ancestor
111299215|NCT02218203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111299216|NCT02218203|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111299217|NCT02218203|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111299218|NCT02218203|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111299219|NCT02218203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111299220|NCT02218203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111299221|NCT02218203|Antitussive Agents|antitussive agents|mesh-ancestor
111299222|NCT02218203|Respiratory System Agents|respiratory system agents|mesh-ancestor
111299223|NCT02218203|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111299224|NCT02218203|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111299225|NCT02218203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111299226|NCT04771715|Pembrolizumab|pembrolizumab|mesh-list
111299227|NCT04771715|Nivolumab|nivolumab|mesh-list
111299228|NCT04771715|Tislelizumab|tislelizumab|mesh-list
111299229|NCT04771715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111299230|NCT04771715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111299231|NCT04771715|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111299232|NCT04771715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111299233|NCT04771559|Antibodies|antibodies|mesh-list
111299234|NCT04771559|Immunologic Factors|immunologic factors|mesh-ancestor
111299235|NCT04771559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111299236|NCT02592876|Rituximab|rituximab|mesh-list
111299237|NCT02592876|Carboplatin|carboplatin|mesh-list
111299238|NCT02592876|Etoposide|etoposide|mesh-list
111299239|NCT02592876|Ifosfamide|ifosfamide|mesh-list
111299240|NCT02592876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111299241|NCT02592876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111299242|NCT02592876|Immunologic Factors|immunologic factors|mesh-ancestor
111299243|NCT02592876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111299244|NCT02592876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111299245|NCT02592876|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111299246|NCT02592876|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111299247|NCT02592876|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111299248|NCT02592876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111299249|NCT02592876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111299250|NCT02592876|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111299251|NCT02592876|Alkylating Agents|alkylating agents|mesh-ancestor
111299252|NCT00585559|Acetaminophen|acetaminophen|mesh-list
111299253|NCT00585559|Acetylcysteine|acetylcysteine|mesh-list
111299254|NCT00585559|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111299255|NCT00585559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111299256|NCT00585559|Analgesics|analgesics|mesh-ancestor
111299257|NCT00585559|Sensory System Agents|sensory system agents|mesh-ancestor
111299258|NCT00585559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111299259|NCT00585559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111299261|NCT00585559|Antiviral Agents|antiviral agents|mesh-ancestor
111299262|NCT00585559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111299263|NCT00585559|Expectorants|expectorants|mesh-ancestor
111299264|NCT00585559|Respiratory System Agents|respiratory system agents|mesh-ancestor
111299265|NCT00585559|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111299266|NCT00585559|Antioxidants|antioxidants|mesh-ancestor
111299267|NCT00585559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111299268|NCT00585559|Protective Agents|protective agents|mesh-ancestor
111299269|NCT00585559|Antidotes|antidotes|mesh-ancestor
111299270|NCT02763137|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
111299271|NCT02763137|Carbidopa|carbidopa|mesh-list
111299272|NCT02763137|Levodopa|levodopa|mesh-list
111299273|NCT02763137|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111299274|NCT02763137|Immunologic Factors|immunologic factors|mesh-ancestor
111299275|NCT02763137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111299276|NCT02763137|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111299277|NCT02763137|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111299278|NCT02763137|Dopamine Agonists|dopamine agonists|mesh-ancestor
111299279|NCT02763137|Dopamine Agents|dopamine agents|mesh-ancestor
111299280|NCT02763137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111299281|NCT02763137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111299282|NCT02763137|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
111299283|NCT02763137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111299284|NCT01896739|Vaccines|vaccines|mesh-list
111299285|NCT01896739|Immunologic Factors|immunologic factors|mesh-ancestor
111299286|NCT01896739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111299287|NCT00176839|Cyclophosphamide|cyclophosphamide|mesh-list
111299288|NCT00176839|Melphalan|melphalan|mesh-list
111299289|NCT00176839|Busulfan|busulfan|mesh-list
111299290|NCT00176839|Antilymphocyte Serum|antilymphocyte serum|mesh-list
111299291|NCT00176839|Lenograstim|lenograstim|mesh-list
111299292|NCT00176839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111299293|NCT00176839|Immunologic Factors|immunologic factors|mesh-ancestor
111299294|NCT00176839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111299295|NCT00176839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111299296|NCT00176839|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111299297|NCT00176839|Alkylating Agents|alkylating agents|mesh-ancestor
111299298|NCT00176839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111299299|NCT00176839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111299300|NCT00176839|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111299301|NCT00176839|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111299302|NCT00176917|Cyclophosphamide|cyclophosphamide|mesh-list
111299303|NCT00176917|Busulfan|busulfan|mesh-list
111299304|NCT00176917|Thymoglobulin|thymoglobulin|mesh-list
111299305|NCT00176917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111299306|NCT00176917|Immunologic Factors|immunologic factors|mesh-ancestor
111299307|NCT00176917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111299308|NCT00176917|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111299309|NCT00176917|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111299310|NCT00176917|Alkylating Agents|alkylating agents|mesh-ancestor
111299311|NCT00176917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111299312|NCT00176917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111299313|NCT00176917|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111299314|NCT02664155|Vitamin K|vitamin k|mesh-list
111299315|NCT02664155|Heparin|heparin|mesh-list
111299316|NCT02664155|Rivaroxaban|rivaroxaban|mesh-list
111299317|NCT02664155|Apixaban|apixaban|mesh-list
111299318|NCT02664155|Vitamins|vitamins|mesh-ancestor
111299319|NCT02664155|Micronutrients|micronutrients|mesh-ancestor
111299320|NCT02664155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111299321|NCT02664155|Anticoagulants|anticoagulants|mesh-ancestor
111299322|NCT02664155|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111299323|NCT02664155|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111299324|NCT02664155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111299325|NCT02664155|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111299326|NCT02664155|Antithrombins|antithrombins|mesh-ancestor
111299327|NCT02664155|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111299328|NCT02664155|Protease Inhibitors|protease inhibitors|mesh-ancestor
111299329|NCT02664155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111299330|NCT02664155|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111299331|NCT02664155|Hemostatics|hemostatics|mesh-ancestor
111299332|NCT02664155|Coagulants|coagulants|mesh-ancestor
111299333|NCT04770389|Ezetimibe|ezetimibe|mesh-list
111299334|NCT04770389|Hypolipidemic Agents|hypolipidemic agents|mesh-list
110979738|NCT03239600|Antimetabolites|antimetabolites|mesh-ancestor
111299335|NCT04770389|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111299336|NCT04770389|Antimetabolites|antimetabolites|mesh-ancestor
111299337|NCT04770389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111299338|NCT04770389|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111299339|NCT04753619|Niclosamide|niclosamide|mesh-list
111299340|NCT04753619|Anticestodal Agents|anticestodal agents|mesh-ancestor
111299341|NCT04753619|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
111299342|NCT04753619|Anthelmintics|anthelmintics|mesh-ancestor
111299343|NCT04753619|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111299344|NCT04753619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111299345|NCT04753619|Antinematodal Agents|antinematodal agents|mesh-ancestor
111299346|NCT01492088|Brentuximab Vedotin|brentuximab vedotin|mesh-list
111299347|NCT01492088|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111299348|NCT01492088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111299349|NCT01492088|Immunotoxins|immunotoxins|mesh-ancestor
111299350|NCT01492088|Immunoconjugates|immunoconjugates|mesh-ancestor
111299351|NCT01492088|Immunologic Factors|immunologic factors|mesh-ancestor
111299352|NCT01492088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111299353|NCT04753151|Tranexamic Acid|tranexamic acid|mesh-list
111299354|NCT04753151|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111299355|NCT04753151|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111299356|NCT04753151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111299357|NCT04753151|Hemostatics|hemostatics|mesh-ancestor
111299358|NCT04753151|Coagulants|coagulants|mesh-ancestor
111299360|NCT05606315|Propofol|propofol|mesh-list
111299361|NCT05606315|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111299362|NCT05606315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111299363|NCT05606315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111299364|NCT05606315|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111299365|NCT05606315|Anesthetics, General|anesthetics, general|mesh-ancestor
111299366|NCT05606315|Anesthetics|anesthetics|mesh-ancestor
111299367|NCT05606315|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111299368|NCT05606315|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111299369|NCT05606315|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111299370|NCT05606315|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111299371|NCT05606315|GABA Modulators|gaba modulators|mesh-ancestor
111299372|NCT05606315|GABA Agents|gaba agents|mesh-ancestor
111299373|NCT05606315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111299374|NCT05606315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111299375|NCT05605925|Ivermectin|ivermectin|mesh-list
111299376|NCT05605925|Lumefantrine|lumefantrine|mesh-list
111299377|NCT05605925|Artemether|artemether|mesh-list
111299378|NCT05605925|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
111299379|NCT05605925|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111299380|NCT05605925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111299381|NCT05605925|Antimalarials|antimalarials|mesh-ancestor
111299382|NCT05605925|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111299383|NCT01520727|Opicapone|opicapone|mesh-list
111299384|NCT01520727|Entacapone|entacapone|mesh-list
111299385|NCT01520727|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
111299386|NCT01520727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111299387|NCT01520727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111299388|NCT01520727|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111299389|NCT01520727|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111299390|NCT02503709|Cyclin-Dependent Kinase Inhibitor Proteins|cyclin-dependent kinase inhibitor proteins|mesh-list
111299391|NCT02503709|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111299392|NCT02503709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111299393|NCT02503709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111299394|NCT01855607|Menthol|menthol|mesh-list
111299395|NCT01855607|Antipruritics|antipruritics|mesh-ancestor
111299396|NCT01855607|Dermatologic Agents|dermatologic agents|mesh-ancestor
111299397|NCT01596699|Fludarabine|fludarabine|mesh-list
111299398|NCT01596699|Busulfan|busulfan|mesh-list
111299399|NCT01596699|Alemtuzumab|alemtuzumab|mesh-list
111299400|NCT01596699|Clofarabine|clofarabine|mesh-list
111299401|NCT01596699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111299402|NCT01596699|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111299403|NCT01596699|Antimetabolites|antimetabolites|mesh-ancestor
111299404|NCT01596699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111299405|NCT01596699|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111299406|NCT01596699|Immunologic Factors|immunologic factors|mesh-ancestor
111299407|NCT01596699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111299408|NCT01596699|Alkylating Agents|alkylating agents|mesh-ancestor
111299409|NCT01596699|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111299410|NCT01596699|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111299411|NCT01596699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111299412|NCT01148849|Margetuximab|margetuximab|mesh-list
111299413|NCT01148849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111299415|NCT05605301|Antimetabolites|antimetabolites|mesh-ancestor
111299416|NCT05605301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111299417|NCT05605301|Antiviral Agents|antiviral agents|mesh-ancestor
111299418|NCT05605301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111299419|NCT05566743|Capecitabine|capecitabine|mesh-list
111299420|NCT05566743|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111299421|NCT05566743|Antimetabolites|antimetabolites|mesh-ancestor
111299422|NCT05566743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111299423|NCT05566743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111299424|NCT05596721|Azithromycin|azithromycin|mesh-list
111299425|NCT05596721|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111299426|NCT05596721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111299427|NCT00076687|Botulinum Toxins|botulinum toxins|mesh-list
111299428|NCT00076687|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111299429|NCT00076687|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111299430|NCT00076687|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111299431|NCT00076687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111299432|NCT00076687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111299433|NCT00076687|Cholinergic Agents|cholinergic agents|mesh-ancestor
111299434|NCT00076687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111299435|NCT00076687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111299436|NCT00076687|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111299437|NCT00076687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111299438|NCT01525173|Brimonidine Tartrate|brimonidine tartrate|mesh-list
111299439|NCT01525173|Bimatoprost|bimatoprost|mesh-list
111299440|NCT01525173|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111299441|NCT01525173|Latanoprost|latanoprost|mesh-list
111299442|NCT01525173|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111299443|NCT01525173|Lubricant Eye Drops|lubricant eye drops|mesh-list
111299444|NCT01525173|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111299445|NCT01525173|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111299446|NCT01525173|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111299447|NCT01525173|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111299448|NCT01525173|Adrenergic Agents|adrenergic agents|mesh-ancestor
111299449|NCT01525173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111299450|NCT01525173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111299451|NCT01525173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111299452|NCT03007563|Bilirubin|bilirubin|mesh-list
111299453|NCT03007563|Antioxidants|antioxidants|mesh-ancestor
111299454|NCT03007563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111299455|NCT03007563|Protective Agents|protective agents|mesh-ancestor
111299456|NCT03007563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111299457|NCT05331131|Ketamine|ketamine|mesh-list
111299458|NCT05331131|Analgesics|analgesics|mesh-ancestor
111299459|NCT05331131|Sensory System Agents|sensory system agents|mesh-ancestor
111299460|NCT05331131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111299461|NCT05331131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111299462|NCT05331131|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111299463|NCT05331131|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111299464|NCT05331131|Anesthetics, General|anesthetics, general|mesh-ancestor
111299465|NCT05331131|Anesthetics|anesthetics|mesh-ancestor
111299466|NCT05331131|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111299467|NCT05331131|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111299468|NCT05331131|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111299469|NCT05331131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111299470|NCT05331131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111299471|NCT01526577|Ticagrelor|ticagrelor|mesh-list
111299472|NCT01526577|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
111299473|NCT01526577|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111299474|NCT01526577|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111299475|NCT01526577|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111299476|NCT01526577|Purinergic Agents|purinergic agents|mesh-ancestor
111299477|NCT01526577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111299478|NCT01526577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111299479|NCT01526577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111299480|NCT01894451|Bevacizumab|bevacizumab|mesh-list
111299481|NCT01894451|89Zr-bevacizumab|89zr-bevacizumab|mesh-list
111299482|NCT01894451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110979748|NCT02966093|Lenvatinib|lenvatinib|mesh-list
111299483|NCT01894451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111299484|NCT01894451|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111023919|NCT03567629|Growth Inhibitors|growth inhibitors|mesh-ancestor
111299485|NCT01894451|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111299486|NCT01894451|Growth Substances|growth substances|mesh-ancestor
111299487|NCT01894451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111299488|NCT01894451|Growth Inhibitors|growth inhibitors|mesh-ancestor
111299489|NCT01894451|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111299490|NCT01894451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111299491|NCT01527045|Calcium, Dietary|calcium, dietary|mesh-list
111299492|NCT01527045|Cyclosporine|cyclosporine|mesh-list
111299493|NCT01527045|Mycophenolic Acid|mycophenolic acid|mesh-list
111299494|NCT01527045|Fludarabine|fludarabine|mesh-list
111299495|NCT01527045|Fludarabine phosphate|fludarabine phosphate|mesh-list
111299496|NCT01527045|Atorvastatin|atorvastatin|mesh-list
111299497|NCT01527045|Calcium|calcium|mesh-list
111299498|NCT01527045|Cyclosporins|cyclosporins|mesh-list
111299499|NCT01527045|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111299500|NCT01527045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111299501|NCT01527045|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111299502|NCT01527045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111299503|NCT01527045|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111299504|NCT01527045|Antimetabolites|antimetabolites|mesh-ancestor
111299505|NCT01527045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111299506|NCT01527045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111299507|NCT01527045|Immunologic Factors|immunologic factors|mesh-ancestor
111299508|NCT01527045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111299509|NCT01527045|Antifungal Agents|antifungal agents|mesh-ancestor
111299510|NCT01527045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111299511|NCT01527045|Dermatologic Agents|dermatologic agents|mesh-ancestor
111299512|NCT01527045|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111299513|NCT01527045|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111299514|NCT01527045|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111299515|NCT01527045|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111299516|NCT01527045|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111299517|NCT01527045|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111299518|NCT01527045|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111299519|NCT01527045|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111299520|NCT01527045|Antitubercular Agents|antitubercular agents|mesh-ancestor
111299521|NCT01527045|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111299522|NCT00078403|Ribavirin|ribavirin|mesh-list
111299523|NCT00078403|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
111299524|NCT00078403|Antimetabolites|antimetabolites|mesh-ancestor
111299525|NCT00078403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111299526|NCT00078403|Antiviral Agents|antiviral agents|mesh-ancestor
111299527|NCT00078403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111299528|NCT01976585|Poly ICLC|poly iclc|mesh-list
111299529|NCT01976585|Interferon Inducers|interferon inducers|mesh-ancestor
111299530|NCT01976585|Immunologic Factors|immunologic factors|mesh-ancestor
111299531|NCT01976585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111299532|NCT01527513|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
111299533|NCT01527513|Anticonvulsants|anticonvulsants|mesh-ancestor
111299534|NCT01527513|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111299535|NCT01527513|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111299536|NCT01527513|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111299537|NCT01527513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111299538|NCT03001635|Oxytocin|oxytocin|mesh-list
111299539|NCT03001635|Oxytocics|oxytocics|mesh-ancestor
111299540|NCT03001635|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111299541|NCT03001635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111299542|NCT02592798|Abatacept|abatacept|mesh-list
111299543|NCT02592798|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111299544|NCT02592798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111299545|NCT02592798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111299546|NCT02592798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111299547|NCT02592798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111299548|NCT02592798|Immunologic Factors|immunologic factors|mesh-ancestor
111299549|NCT02592798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111299550|NCT02592798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111299551|NCT01530243|Tolterodine Tartrate|tolterodine tartrate|mesh-list
111299552|NCT01530243|Terazosin|terazosin|mesh-list
111299553|NCT01530243|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111299554|NCT01530243|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111299555|NCT01530243|Cholinergic Agents|cholinergic agents|mesh-ancestor
111299556|NCT01530243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111299557|NCT01530243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111299558|NCT01530243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111299559|NCT01530243|Urological Agents|urological agents|mesh-ancestor
111299560|NCT01530243|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111299561|NCT01530243|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111299562|NCT01530243|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111299563|NCT01530243|Adrenergic Agents|adrenergic agents|mesh-ancestor
111299564|NCT04797546|Morphine|morphine|mesh-list
111299565|NCT04797546|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111299566|NCT04797546|Narcotics|narcotics|mesh-ancestor
111299567|NCT04797546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111299568|NCT04797546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111299569|NCT04797546|Analgesics|analgesics|mesh-ancestor
111299570|NCT04797546|Sensory System Agents|sensory system agents|mesh-ancestor
111299571|NCT04797546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111299572|NCT02980809|Apatinib|apatinib|mesh-list
111299573|NCT02980809|Topotecan|topotecan|mesh-list
111299574|NCT02980809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111299575|NCT02980809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111299576|NCT02980809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111299577|NCT02980809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111299578|NCT02980809|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111299579|NCT02980809|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111299580|NCT00078559|Acetaminophen|acetaminophen|mesh-list
111299581|NCT00078559|Diphenhydramine|diphenhydramine|mesh-list
111299582|NCT00078559|Promethazine|promethazine|mesh-list
111299583|NCT00078559|Sirolimus|sirolimus|mesh-list
111299584|NCT00078559|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
111299585|NCT00078559|Nystatin|nystatin|mesh-list
111299586|NCT00078559|Clotrimazole|clotrimazole|mesh-list
111299587|NCT00078559|Miconazole|miconazole|mesh-list
111299588|NCT00078559|Pentamidine|pentamidine|mesh-list
111299589|NCT00078559|Trimethoprim|trimethoprim|mesh-list
111299590|NCT00078559|Valganciclovir|valganciclovir|mesh-list
111299591|NCT00078559|Acyclovir|acyclovir|mesh-list
111299592|NCT00078559|Methylprednisolone|methylprednisolone|mesh-list
111299593|NCT00078559|Alemtuzumab|alemtuzumab|mesh-list
111299594|NCT00078559|Tacrolimus|tacrolimus|mesh-list
111299595|NCT00078559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111299596|NCT00078559|Immunologic Factors|immunologic factors|mesh-ancestor
111299597|NCT00078559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111299598|NCT00078559|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111299599|NCT00078559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111299600|NCT00078559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111299601|NCT00078559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111299602|NCT00078559|Analgesics|analgesics|mesh-ancestor
111299603|NCT00078559|Sensory System Agents|sensory system agents|mesh-ancestor
111299604|NCT00078559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111299605|NCT00078559|Antipyretics|antipyretics|mesh-ancestor
111299606|NCT00078559|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111299607|NCT00078559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111299608|NCT00078559|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111299609|NCT00078559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111299610|NCT00078559|Antifungal Agents|antifungal agents|mesh-ancestor
111299611|NCT00078559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111299612|NCT00078559|Antiemetics|antiemetics|mesh-ancestor
111299613|NCT00078559|Autonomic Agents|autonomic agents|mesh-ancestor
111299614|NCT00078559|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111299615|NCT00078559|Glucocorticoids|glucocorticoids|mesh-ancestor
111299616|NCT00078559|Hormones|hormones|mesh-ancestor
111299617|NCT00078559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111299618|NCT00078559|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111299619|NCT00078559|Protective Agents|protective agents|mesh-ancestor
111299620|NCT00078559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111299621|NCT00078559|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111299622|NCT00078559|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111299623|NCT00078559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111299624|NCT00078559|Anesthetics, Local|anesthetics, local|mesh-ancestor
111299625|NCT00078559|Anesthetics|anesthetics|mesh-ancestor
111299626|NCT00078559|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111299627|NCT00078559|Histamine Antagonists|histamine antagonists|mesh-ancestor
111299628|NCT00078559|Histamine Agents|histamine agents|mesh-ancestor
111299629|NCT00078559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111299630|NCT00078559|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111299631|NCT00078559|Antipruritics|antipruritics|mesh-ancestor
111299632|NCT00078559|Dermatologic Agents|dermatologic agents|mesh-ancestor
111299633|NCT00078559|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111299634|NCT00078559|Antimalarials|antimalarials|mesh-ancestor
111299635|NCT00078559|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111299636|NCT00078559|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111299637|NCT00078559|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111299638|NCT00078559|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111299639|NCT00078559|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
111299640|NCT00078559|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111299642|NCT00078559|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111299643|NCT00078559|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111299644|NCT00078559|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111299645|NCT00078559|Hormone Antagonists|hormone antagonists|mesh-ancestor
111299646|NCT00078559|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111299647|NCT00078559|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111299648|NCT00078559|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
111299649|NCT00078559|Ionophores|ionophores|mesh-ancestor
111299650|NCT00078559|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111299651|NCT00081653|Ibandronic Acid|ibandronic acid|mesh-list
111299652|NCT00081653|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111299653|NCT00081653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111299654|NCT00078715|Yohimbine|yohimbine|mesh-list
111299655|NCT00078715|Mydriatics|mydriatics|mesh-ancestor
111299656|NCT00078715|Autonomic Agents|autonomic agents|mesh-ancestor
111299657|NCT00078715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111299658|NCT00078715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111299659|NCT00078715|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
111299660|NCT00078715|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111299661|NCT00078715|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111299662|NCT00078715|Adrenergic Agents|adrenergic agents|mesh-ancestor
111299663|NCT00078715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111299664|NCT00078715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111299665|NCT00078715|Urological Agents|urological agents|mesh-ancestor
111299666|NCT04805034|Antiviral Agents|antiviral agents|mesh-list
111299667|NCT04805034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111299668|NCT01530399|Tranexamic Acid|tranexamic acid|mesh-list
111299669|NCT01530399|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111299670|NCT01530399|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111299671|NCT01530399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111299672|NCT01530399|Hemostatics|hemostatics|mesh-ancestor
111299673|NCT01530399|Coagulants|coagulants|mesh-ancestor
111299674|NCT01531803|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111299675|NCT02596620|Amoxicillin|amoxicillin|mesh-list
111299676|NCT02596620|Metronidazole|metronidazole|mesh-list
111299677|NCT02596620|Levofloxacin|levofloxacin|mesh-list
111299678|NCT02596620|Esomeprazole|esomeprazole|mesh-list
111299679|NCT02596620|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111299680|NCT02596620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111299681|NCT02596620|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111299682|NCT02596620|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111299683|NCT02596620|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111299684|NCT02596620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111299685|NCT02596620|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111299686|NCT02596620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111299687|NCT02596620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111299688|NCT02596620|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111299689|NCT02596620|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111299690|NCT02596620|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111299691|NCT02596620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111299692|NCT02596620|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111299693|NCT02596620|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111299694|NCT01531959|Midodrine|midodrine|mesh-list
111299695|NCT01531959|Sympathomimetics|sympathomimetics|mesh-ancestor
111299696|NCT01531959|Autonomic Agents|autonomic agents|mesh-ancestor
111299697|NCT01531959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111299698|NCT01531959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111299699|NCT01531959|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111299700|NCT01531959|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111299701|NCT01531959|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111299702|NCT01531959|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111299703|NCT01531959|Adrenergic Agents|adrenergic agents|mesh-ancestor
111299704|NCT01531959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110752231|NCT01316068|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111299705|NCT01531959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111299706|NCT01532349|Cholecalciferol|cholecalciferol|mesh-list
111299707|NCT01532349|Vitamin D|vitamin d|mesh-list
111299708|NCT01532349|Vitamins|vitamins|mesh-ancestor
111299709|NCT01532349|Micronutrients|micronutrients|mesh-ancestor
111299710|NCT01532349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111024143|NCT02396758|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111299711|NCT01532349|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111299712|NCT01532349|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111299713|NCT03001089|Fludrocortisone|fludrocortisone|mesh-list
111299714|NCT03001089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111299715|NCT01533207|Gemcitabine|gemcitabine|mesh-list
111299716|NCT01533207|Docetaxel|docetaxel|mesh-list
111299717|NCT01533207|Doxorubicin|doxorubicin|mesh-list
111299718|NCT01533207|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111299719|NCT01533207|Lenograstim|lenograstim|mesh-list
111299720|NCT01533207|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111299721|NCT01533207|Antimetabolites|antimetabolites|mesh-ancestor
111299722|NCT01533207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111299723|NCT01533207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111299724|NCT01533207|Tubulin Modulators|tubulin modulators|mesh-ancestor
111299725|NCT01533207|Antimitotic Agents|antimitotic agents|mesh-ancestor
111299726|NCT01533207|Mitosis Modulators|mitosis modulators|mesh-ancestor
111299727|NCT01533207|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111299728|NCT01533207|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111299729|NCT01533207|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111299730|NCT01533207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111299731|NCT01533207|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111299732|NCT01533207|Immunologic Factors|immunologic factors|mesh-ancestor
111299733|NCT01533207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111299734|NCT00182767|Doxorubicin|doxorubicin|mesh-list
111299735|NCT00182767|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111299736|NCT00182767|Epothilone B|epothilone b|mesh-list
111299737|NCT00182767|Epothilones|epothilones|mesh-list
111299738|NCT00182767|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111299739|NCT00182767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111299740|NCT00182767|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111299741|NCT00182767|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111299742|NCT00182767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111299743|NCT00182767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111299744|NCT00182767|Tubulin Modulators|tubulin modulators|mesh-ancestor
111299745|NCT00182767|Antimitotic Agents|antimitotic agents|mesh-ancestor
111299746|NCT00182767|Mitosis Modulators|mitosis modulators|mesh-ancestor
111299747|NCT01533597|Tamsulosin|tamsulosin|mesh-list
111299748|NCT01533597|Solifenacin Succinate|solifenacin succinate|mesh-list
111299749|NCT01533597|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111299750|NCT01533597|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111299751|NCT01533597|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111299752|NCT01533597|Adrenergic Agents|adrenergic agents|mesh-ancestor
111299753|NCT01533597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111299754|NCT01533597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111299755|NCT01533597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111299756|NCT01533597|Urological Agents|urological agents|mesh-ancestor
111299757|NCT01533597|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111299758|NCT01533597|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111299759|NCT01533597|Cholinergic Agents|cholinergic agents|mesh-ancestor
111299760|NCT03006627|Morphine|morphine|mesh-list
111299761|NCT03006627|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111299762|NCT03006627|Narcotics|narcotics|mesh-ancestor
111299763|NCT03006627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111299764|NCT03006627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111299765|NCT03006627|Analgesics|analgesics|mesh-ancestor
111299766|NCT03006627|Sensory System Agents|sensory system agents|mesh-ancestor
111299767|NCT03006627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111299768|NCT04796688|Cyclophosphamide|cyclophosphamide|mesh-list
111299769|NCT04796688|Fludarabine|fludarabine|mesh-list
111299770|NCT04796688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111299771|NCT04796688|Immunologic Factors|immunologic factors|mesh-ancestor
111299772|NCT04796688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111299773|NCT04796688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111299774|NCT04796688|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111299775|NCT04796688|Alkylating Agents|alkylating agents|mesh-ancestor
111299776|NCT04796688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111299777|NCT04796688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111299778|NCT04796688|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111299779|NCT01535001|Acetaminophen|acetaminophen|mesh-list
111299780|NCT01535001|Pantoprazole|pantoprazole|mesh-list
111299781|NCT01535001|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111299782|NCT01535001|Analgesics|analgesics|mesh-ancestor
111299783|NCT01535001|Sensory System Agents|sensory system agents|mesh-ancestor
111299784|NCT01535001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111299785|NCT01535001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111299786|NCT01535001|Antipyretics|antipyretics|mesh-ancestor
111299787|NCT01535001|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111299788|NCT01535001|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111299789|NCT01535001|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111299791|NCT01535001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111299792|NCT03000777|Melatonin|melatonin|mesh-list
111299793|NCT03000777|Antioxidants|antioxidants|mesh-ancestor
111299794|NCT03000777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111299795|NCT03000777|Protective Agents|protective agents|mesh-ancestor
111299796|NCT03000777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111299797|NCT03000777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111299798|NCT03006003|Alendronate|alendronate|mesh-list
111299799|NCT03006003|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
111299800|NCT03006003|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111299801|NCT03006003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111299802|NCT03006003|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111299803|NCT03006003|Hormone Antagonists|hormone antagonists|mesh-ancestor
111299804|NCT03006003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111299805|NCT03006003|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111299806|NCT03006003|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111299807|NCT04426734|Dexamethasone|dexamethasone|mesh-list
111299808|NCT04426734|Prednisolone|prednisolone|mesh-list
111299809|NCT04426734|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111299810|NCT04426734|Methylprednisolone|methylprednisolone|mesh-list
111299811|NCT04426734|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111299812|NCT04426734|Prednisolone acetate|prednisolone acetate|mesh-list
111299813|NCT04426734|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111299814|NCT04426734|Prednisolone phosphate|prednisolone phosphate|mesh-list
111299815|NCT04426734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111299816|NCT04426734|Antiemetics|antiemetics|mesh-ancestor
111299817|NCT04426734|Autonomic Agents|autonomic agents|mesh-ancestor
111299818|NCT04426734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111299819|NCT04426734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111299820|NCT04426734|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111299821|NCT04426734|Glucocorticoids|glucocorticoids|mesh-ancestor
111299822|NCT04426734|Hormones|hormones|mesh-ancestor
111299823|NCT04426734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111299824|NCT04426734|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111299825|NCT04426734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111299826|NCT04426734|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111299827|NCT04426734|Protective Agents|protective agents|mesh-ancestor
111299828|NCT03006081|Aflibercept|aflibercept|mesh-list
111299829|NCT03006081|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111299830|NCT03006081|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111299831|NCT03006081|Growth Substances|growth substances|mesh-ancestor
111299832|NCT03006081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111299833|NCT03006081|Growth Inhibitors|growth inhibitors|mesh-ancestor
111299834|NCT03006081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111299835|NCT01535937|Midazolam|midazolam|mesh-list
111299836|NCT01535937|Ketamine|ketamine|mesh-list
111299837|NCT01535937|Analgesics|analgesics|mesh-ancestor
111299838|NCT01535937|Sensory System Agents|sensory system agents|mesh-ancestor
111299839|NCT01535937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111299840|NCT01535937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111299841|NCT01535937|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111299842|NCT01535937|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111299843|NCT01535937|Anesthetics, General|anesthetics, general|mesh-ancestor
111299844|NCT01535937|Anesthetics|anesthetics|mesh-ancestor
111299845|NCT01535937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111299846|NCT01535937|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111299847|NCT01535937|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111299848|NCT01535937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111299849|NCT01535937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111299850|NCT01535937|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111299851|NCT01535937|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111299852|NCT01535937|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111299853|NCT01535937|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111299854|NCT01535937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111299855|NCT01535937|GABA Modulators|gaba modulators|mesh-ancestor
111299856|NCT01535937|GABA Agents|gaba agents|mesh-ancestor
111299857|NCT04813848|Fluorides|fluorides|mesh-list
111299858|NCT04813848|Cariostatic Agents|cariostatic agents|mesh-ancestor
111299859|NCT04813848|Protective Agents|protective agents|mesh-ancestor
111299860|NCT04813848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111299861|NCT02999841|Vildagliptin|vildagliptin|mesh-list
111299862|NCT02999841|Acarbose|acarbose|mesh-list
111299863|NCT02999841|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111299864|NCT02999841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111299865|NCT02999841|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111299866|NCT02999841|Protease Inhibitors|protease inhibitors|mesh-ancestor
111299867|NCT02999841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111299868|NCT02999841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111299869|NCT02999841|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
111299870|NCT01537029|Cyclophosphamide|cyclophosphamide|mesh-list
111299871|NCT01537029|Doxorubicin|doxorubicin|mesh-list
111299872|NCT01537029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111299873|NCT01537029|Immunologic Factors|immunologic factors|mesh-ancestor
111299874|NCT01537029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111299875|NCT01537029|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111299876|NCT01537029|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111299877|NCT01537029|Alkylating Agents|alkylating agents|mesh-ancestor
111299878|NCT01537029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111299879|NCT01537029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111299880|NCT01537029|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111299881|NCT01537029|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111299882|NCT01537029|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111299883|NCT01537029|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111299884|NCT01537029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111299885|NCT01667562|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111299886|NCT01667562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111299887|NCT01667562|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111299888|NCT01667562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111299889|NCT01667562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111299890|NCT04803318|Everolimus|everolimus|mesh-list
111299891|NCT04803318|Lenvatinib|lenvatinib|mesh-list
111299892|NCT04803318|Trametinib|trametinib|mesh-list
111299893|NCT04803318|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111299894|NCT04803318|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111299895|NCT04803318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111299896|NCT04803318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111299897|NCT04803318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111299898|NCT04803318|Immunologic Factors|immunologic factors|mesh-ancestor
111299899|NCT04803318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111299900|NCT04803318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111299901|NCT01537185|Aluminum sulfate|aluminum sulfate|mesh-list
111299902|NCT01537185|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111299903|NCT01537185|Immunologic Factors|immunologic factors|mesh-ancestor
111299904|NCT01537185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111299905|NCT04803162|Omeprazole|omeprazole|mesh-list
111299906|NCT04803162|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111299907|NCT04803162|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111299908|NCT04803162|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111299909|NCT04803162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111299910|NCT04803162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111299911|NCT02999217|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
111299912|NCT02999217|Hematinics|hematinics|mesh-ancestor
111299913|NCT02595528|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111299914|NCT02595528|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111299915|NCT02980965|Cyclophosphamide|cyclophosphamide|mesh-list
111299916|NCT02980965|Docetaxel|docetaxel|mesh-list
111299917|NCT02980965|Fluorouracil|fluorouracil|mesh-list
111299918|NCT02980965|Letrozole|letrozole|mesh-list
111299919|NCT02980965|Epirubicin|epirubicin|mesh-list
111299920|NCT02980965|Leuprolide|leuprolide|mesh-list
111299921|NCT02980965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111299922|NCT02980965|Immunologic Factors|immunologic factors|mesh-ancestor
111299923|NCT02980965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111299924|NCT02980965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111299925|NCT02980965|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111299926|NCT02980965|Alkylating Agents|alkylating agents|mesh-ancestor
111299927|NCT02980965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111299928|NCT02980965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110979753|NCT03229616|Cyclophosphamide|cyclophosphamide|mesh-list
111299929|NCT02980965|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111299930|NCT02980965|Tubulin Modulators|tubulin modulators|mesh-ancestor
111299931|NCT02980965|Antimitotic Agents|antimitotic agents|mesh-ancestor
111299932|NCT02980965|Mitosis Modulators|mitosis modulators|mesh-ancestor
111299933|NCT02980965|Antimetabolites|antimetabolites|mesh-ancestor
111299934|NCT02980965|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111299935|NCT02980965|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111299936|NCT02980965|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111299937|NCT02980965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111299938|NCT02980965|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111299939|NCT02980965|Hormone Antagonists|hormone antagonists|mesh-ancestor
111299940|NCT02980965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111299941|NCT02980965|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111299942|NCT02980965|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111299943|NCT02980965|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111299944|NCT02980965|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111299945|NCT02980965|Fertility Agents|fertility agents|mesh-ancestor
111299946|NCT02980965|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111299947|NCT02980965|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111299949|NCT01538745|Morphine|morphine|mesh-list
111299950|NCT01538745|Analgesics|analgesics|mesh-ancestor
111299951|NCT01538745|Sensory System Agents|sensory system agents|mesh-ancestor
111299952|NCT01538745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111299953|NCT01538745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111299954|NCT01538745|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111299955|NCT01538745|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111299956|NCT01538745|Anesthetics, General|anesthetics, general|mesh-ancestor
111299957|NCT01538745|Anesthetics|anesthetics|mesh-ancestor
111299958|NCT01538745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111299959|NCT01538745|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111299960|NCT01538745|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111299961|NCT01538745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111299962|NCT01538745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111299963|NCT01538745|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111299964|NCT01538745|Narcotics|narcotics|mesh-ancestor
111299965|NCT04803240|Hyaluronic Acid|hyaluronic acid|mesh-list
111299966|NCT04803240|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111299967|NCT04803240|Immunologic Factors|immunologic factors|mesh-ancestor
111299968|NCT04803240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111299969|NCT04803240|Viscosupplements|viscosupplements|mesh-ancestor
111299970|NCT04803240|Protective Agents|protective agents|mesh-ancestor
111299971|NCT01539135|Methylene Blue|methylene blue|mesh-list
111299972|NCT01539135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111299973|NCT01539135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111299974|NCT04426578|Perhexiline|perhexiline|mesh-list
111299975|NCT04426578|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111299976|NCT04426578|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111299977|NCT04426578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111299978|NCT04426578|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111299979|NCT04426578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111299980|NCT04426578|Vasodilator Agents|vasodilator agents|mesh-ancestor
111299981|NCT04802928|Isoniazid|isoniazid|mesh-list
111299982|NCT04802928|Antitubercular Agents|antitubercular agents|mesh-ancestor
111299983|NCT04802928|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111299984|NCT04802928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111299985|NCT04802928|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
111299986|NCT04802928|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111299987|NCT04802928|Antimetabolites|antimetabolites|mesh-ancestor
111299988|NCT04802928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111299989|NCT04802928|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111299990|NCT05365425|Choline|choline|mesh-list
111299991|NCT05365425|Policosanol|policosanol|mesh-list
111299992|NCT05365425|Fenofibrate|fenofibrate|mesh-list
111299993|NCT05365425|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111299994|NCT05365425|Antimetabolites|antimetabolites|mesh-ancestor
111299995|NCT05365425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111299996|NCT05365425|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111299997|NCT05365425|Lipotropic Agents|lipotropic agents|mesh-ancestor
111299998|NCT05365425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111299999|NCT05365425|Nootropic Agents|nootropic agents|mesh-ancestor
111300000|NCT05365425|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111300001|NCT05365425|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111300002|NCT02595450|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111300003|NCT02595450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111300004|NCT02595450|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111300005|NCT02595450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111300006|NCT02595450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111300007|NCT04794738|Morphine|morphine|mesh-list
111300008|NCT04794738|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111300009|NCT04794738|Narcotics|narcotics|mesh-ancestor
111300010|NCT04794738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111300011|NCT04794738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111300012|NCT04794738|Analgesics|analgesics|mesh-ancestor
111300013|NCT04794738|Sensory System Agents|sensory system agents|mesh-ancestor
111300014|NCT04794738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111300015|NCT04794426|Fluorides|fluorides|mesh-list
111300016|NCT04794426|Cariostatic Agents|cariostatic agents|mesh-ancestor
111300017|NCT04794426|Protective Agents|protective agents|mesh-ancestor
111300018|NCT04794426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111300019|NCT04794504|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111300020|NCT04794504|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111300021|NCT04794504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111300022|NCT04794504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111300023|NCT04794504|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111300024|NCT04794504|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111300025|NCT04794504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111300026|NCT04794504|Cholinergic Agents|cholinergic agents|mesh-ancestor
111300027|NCT04794504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111300028|NCT05073315|Adalimumab|adalimumab|mesh-list
111300029|NCT05073315|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111300030|NCT05073315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111300031|NCT05073315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111300032|NCT02591238|Melatonin|melatonin|mesh-list
111300033|NCT02591238|Antioxidants|antioxidants|mesh-ancestor
111300034|NCT02591238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111300035|NCT02591238|Protective Agents|protective agents|mesh-ancestor
111300036|NCT02591238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111300037|NCT02591238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111300038|NCT02221947|Bryostatin 1|bryostatin 1|mesh-list
111300039|NCT02221947|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111300040|NCT02221947|Immunologic Factors|immunologic factors|mesh-ancestor
111300041|NCT02221947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111300042|NCT02221947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111300043|NCT04793256|Listerine|listerine|mesh-list
111300044|NCT04793256|Fluorides|fluorides|mesh-list
111300045|NCT04793256|Sodium Fluoride|sodium fluoride|mesh-list
111300046|NCT04793256|Fluorides, Topical|fluorides, topical|mesh-list
111300047|NCT04793256|Cariostatic Agents|cariostatic agents|mesh-ancestor
111300048|NCT04793256|Protective Agents|protective agents|mesh-ancestor
111300049|NCT04793256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111300050|NCT04793256|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111300051|NCT04793256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111300052|NCT03004521|Quetiapine Fumarate|quetiapine fumarate|mesh-list
111300053|NCT03004521|Antidepressive Agents|antidepressive agents|mesh-ancestor
111300054|NCT03004521|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111300055|NCT03004521|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111300056|NCT03004521|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111300057|NCT03004521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111300058|NCT03004521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111300059|NCT04792710|Metronidazole|metronidazole|mesh-list
111300060|NCT04792710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111300061|NCT04792710|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111300062|NCT04792710|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111300063|NCT04792710|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111300064|NCT04792398|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
111300065|NCT04792398|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111300066|NCT04792398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111300067|NCT04792398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111300068|NCT04792398|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111300069|NCT04792398|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111300070|NCT04792398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111300071|NCT04792398|Cholinergic Agents|cholinergic agents|mesh-ancestor
111300072|NCT04792398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111300073|NCT04814433|Lidocaine|lidocaine|mesh-list
111300074|NCT04814433|Epinephrine|epinephrine|mesh-list
111300075|NCT04814433|Racepinephrine|racepinephrine|mesh-list
111300076|NCT04814433|Bupivacaine|bupivacaine|mesh-list
111300077|NCT04814433|Tranexamic Acid|tranexamic acid|mesh-list
111300078|NCT04814433|Aminocaproic Acid|aminocaproic acid|mesh-list
111300079|NCT04814433|Thrombin|thrombin|mesh-list
111300080|NCT04814433|Epinephryl borate|epinephryl borate|mesh-list
111300081|NCT04814433|Anesthetics, Local|anesthetics, local|mesh-ancestor
111300082|NCT04814433|Anesthetics|anesthetics|mesh-ancestor
111300083|NCT04814433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111300084|NCT04814433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111300085|NCT04814433|Sensory System Agents|sensory system agents|mesh-ancestor
111300086|NCT04814433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111300087|NCT04814433|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111300088|NCT04814433|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111300089|NCT04814433|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111300090|NCT04814433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111300091|NCT04814433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111300092|NCT04814433|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111300093|NCT04814433|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111300094|NCT04814433|Hemostatics|hemostatics|mesh-ancestor
111300095|NCT04814433|Coagulants|coagulants|mesh-ancestor
111300096|NCT04814433|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111300097|NCT04814433|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111300098|NCT04814433|Adrenergic Agents|adrenergic agents|mesh-ancestor
111300099|NCT04814433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111300100|NCT04814433|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111300101|NCT04814433|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111300102|NCT04814433|Autonomic Agents|autonomic agents|mesh-ancestor
111300103|NCT04814433|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111300104|NCT04814433|Respiratory System Agents|respiratory system agents|mesh-ancestor
111300105|NCT04814433|Mydriatics|mydriatics|mesh-ancestor
111300106|NCT04814433|Sympathomimetics|sympathomimetics|mesh-ancestor
111300107|NCT04814433|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111300108|NCT03004209|Epoetin Alfa|epoetin alfa|mesh-list
111300109|NCT03004209|Hematinics|hematinics|mesh-ancestor
111300110|NCT04800978|Durvalumab|durvalumab|mesh-list
111300111|NCT04800978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111300112|NCT04800978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111300113|NCT04791774|Caseins|caseins|mesh-list
111300114|NCT04791774|Chelating Agents|chelating agents|mesh-ancestor
111300115|NCT04791774|Sequestering Agents|sequestering agents|mesh-ancestor
111300116|NCT04791774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111300117|NCT00183469|Lamotrigine|lamotrigine|mesh-list
111300118|NCT00183469|Valproic Acid|valproic acid|mesh-list
111300119|NCT00183469|Anticonvulsants|anticonvulsants|mesh-ancestor
111300120|NCT00183469|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111300121|NCT00183469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111300122|NCT00183469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111300123|NCT00183469|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111300124|NCT00183469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111300125|NCT00183469|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111300126|NCT00183469|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111300127|NCT00183469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111300128|NCT00183469|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111300129|NCT00183469|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111300130|NCT00183469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111300131|NCT00183469|GABA Agents|gaba agents|mesh-ancestor
111300132|NCT00183469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111300133|NCT00183469|Antimanic Agents|antimanic agents|mesh-ancestor
111300134|NCT02248155|Pramipexole|pramipexole|mesh-list
111300135|NCT02248155|Antioxidants|antioxidants|mesh-ancestor
111300136|NCT02248155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111300137|NCT02248155|Protective Agents|protective agents|mesh-ancestor
111300138|NCT02248155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111300139|NCT02248155|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111300140|NCT02248155|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111300141|NCT02248155|Dopamine Agonists|dopamine agonists|mesh-ancestor
111300142|NCT02248155|Dopamine Agents|dopamine agents|mesh-ancestor
111300143|NCT02248155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111300144|NCT02597946|Paclitaxel|paclitaxel|mesh-list
111300145|NCT02597946|Afatinib|afatinib|mesh-list
111300146|NCT02597946|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111300147|NCT02597946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111300148|NCT02597946|Tubulin Modulators|tubulin modulators|mesh-ancestor
111300149|NCT02597946|Antimitotic Agents|antimitotic agents|mesh-ancestor
111300150|NCT02597946|Mitosis Modulators|mitosis modulators|mesh-ancestor
111300151|NCT02597946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111300152|NCT02597946|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111300153|NCT02597946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111300154|NCT02248233|Nimodipine|nimodipine|mesh-list
111300155|NCT02248233|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
111300156|NCT02248233|Nootropic Agents|nootropic agents|mesh-ancestor
111300157|NCT02248233|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111300158|NCT02248233|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111300159|NCT02248233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111300160|NCT02248233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111300161|NCT02248233|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111300162|NCT02248233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111300163|NCT02248233|Vasodilator Agents|vasodilator agents|mesh-ancestor
111300164|NCT04790838|Fluticasone|fluticasone|mesh-list
111300165|NCT04790838|Xhance|xhance|mesh-list
111300166|NCT04790838|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
111300167|NCT04790838|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
111300168|NCT04790838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111300169|NCT04790838|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111300170|NCT04790838|Autonomic Agents|autonomic agents|mesh-ancestor
111300171|NCT04790838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111300172|NCT04790838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111300173|NCT04790838|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111300174|NCT04790838|Respiratory System Agents|respiratory system agents|mesh-ancestor
111300175|NCT04790838|Dermatologic Agents|dermatologic agents|mesh-ancestor
111300176|NCT04790838|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111300177|NCT04790838|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111300178|NCT04790838|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111300179|NCT04790838|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111300180|NCT04790838|Adrenergic Agents|adrenergic agents|mesh-ancestor
111300181|NCT04790838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111300182|NCT04790838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111300183|NCT04790838|Glucocorticoids|glucocorticoids|mesh-ancestor
111300184|NCT04790838|Hormones|hormones|mesh-ancestor
111300185|NCT04790838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111300186|NCT04790838|Sympathomimetics|sympathomimetics|mesh-ancestor
111300187|NCT03003273|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111300188|NCT03003273|Amoxicillin|amoxicillin|mesh-list
111300189|NCT03003273|Levofloxacin|levofloxacin|mesh-list
111300190|NCT03003273|Clavulanic Acids|clavulanic acids|mesh-list
111300191|NCT03003273|Clavulanic Acid|clavulanic acid|mesh-list
111300192|NCT03003273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111300193|NCT03003273|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111300194|NCT03003273|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111300195|NCT03003273|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111300196|NCT03003273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111300197|NCT03003273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111300198|NCT03003273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111300199|NCT03003273|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111300200|NCT03003273|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111300201|NCT03003273|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
111300202|NCT05571345|Oxycodone|oxycodone|mesh-list
111300203|NCT05571345|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111300204|NCT05571345|Narcotics|narcotics|mesh-ancestor
111300205|NCT05571345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111300206|NCT05571345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111300207|NCT05571345|Analgesics|analgesics|mesh-ancestor
111300208|NCT05571345|Sensory System Agents|sensory system agents|mesh-ancestor
111300209|NCT05571345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111300210|NCT02981121|Metformin|metformin|mesh-list
111300211|NCT02981121|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111300212|NCT02981121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111300213|NCT02597478|Fentanyl|fentanyl|mesh-list
111300214|NCT02597478|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111300215|NCT02597478|Narcotics|narcotics|mesh-ancestor
111300216|NCT02597478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111300217|NCT02597478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111300218|NCT02597478|Analgesics|analgesics|mesh-ancestor
111300219|NCT02597478|Sensory System Agents|sensory system agents|mesh-ancestor
111300220|NCT02597478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111300221|NCT02597478|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111300222|NCT02597478|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111300223|NCT02597478|Anesthetics, General|anesthetics, general|mesh-ancestor
111300224|NCT02597478|Anesthetics|anesthetics|mesh-ancestor
110752753|NCT04070768|Venetoclax|venetoclax|mesh-list
111300225|NCT04811274|Dimercaprol|dimercaprol|mesh-list
111300226|NCT04811274|Chelating Agents|chelating agents|mesh-ancestor
111300227|NCT04811274|Sequestering Agents|sequestering agents|mesh-ancestor
111300228|NCT04811274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111300229|NCT04799184|Epinephrine|epinephrine|mesh-list
111300230|NCT04799184|Racepinephrine|racepinephrine|mesh-list
111300231|NCT04799184|Bupivacaine|bupivacaine|mesh-list
111300232|NCT04799184|Levobupivacaine|levobupivacaine|mesh-list
111300233|NCT04799184|Epinephryl borate|epinephryl borate|mesh-list
111300234|NCT04799184|Anesthetics, Local|anesthetics, local|mesh-ancestor
111300235|NCT04799184|Anesthetics|anesthetics|mesh-ancestor
111300236|NCT04799184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111300237|NCT04799184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111300238|NCT04799184|Sensory System Agents|sensory system agents|mesh-ancestor
111300239|NCT04799184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111300240|NCT04799184|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111300241|NCT04799184|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111300242|NCT04799184|Adrenergic Agents|adrenergic agents|mesh-ancestor
111300243|NCT04799184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111300244|NCT04799184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111300245|NCT04799184|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111300246|NCT04799184|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111300248|NCT04799184|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111300249|NCT04799184|Respiratory System Agents|respiratory system agents|mesh-ancestor
111300250|NCT04799184|Mydriatics|mydriatics|mesh-ancestor
111300251|NCT04799184|Sympathomimetics|sympathomimetics|mesh-ancestor
111300252|NCT04799184|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111300253|NCT05562297|Paclitaxel|paclitaxel|mesh-list
111300254|NCT05562297|Gemcitabine|gemcitabine|mesh-list
111300255|NCT05562297|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111300256|NCT05562297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111300257|NCT05562297|Tubulin Modulators|tubulin modulators|mesh-ancestor
111300258|NCT05562297|Antimitotic Agents|antimitotic agents|mesh-ancestor
111300259|NCT05562297|Mitosis Modulators|mitosis modulators|mesh-ancestor
111300260|NCT05562297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111300261|NCT05562297|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111300262|NCT05562297|Antimetabolites|antimetabolites|mesh-ancestor
111300263|NCT03003195|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
111300264|NCT03003195|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111300265|NCT03003195|Immunologic Factors|immunologic factors|mesh-ancestor
111300266|NCT03003195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111300267|NCT04790136|Cannabidiol|cannabidiol|mesh-list
111300268|NCT04790136|Anticonvulsants|anticonvulsants|mesh-ancestor
111300269|NCT03003039|Rituximab|rituximab|mesh-list
111300270|NCT03003039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111300271|NCT03003039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111300272|NCT03003039|Immunologic Factors|immunologic factors|mesh-ancestor
111300273|NCT03003039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111300274|NCT03003039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111300275|NCT03002961|Buprenorphine|buprenorphine|mesh-list
111300276|NCT03002961|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
111300277|NCT03002961|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111300278|NCT03002961|Narcotics|narcotics|mesh-ancestor
111300279|NCT03002961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111300280|NCT03002961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111300281|NCT03002961|Analgesics|analgesics|mesh-ancestor
111300282|NCT03002961|Sensory System Agents|sensory system agents|mesh-ancestor
111300283|NCT03002961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111300284|NCT03002961|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111300285|NCT03002805|Doxorubicin|doxorubicin|mesh-list
111300286|NCT03002805|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111300287|NCT03002805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111300288|NCT03002805|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111300289|NCT03002805|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111300290|NCT03002805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111300291|NCT03002805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111300292|NCT04214691|Acetaminophen|acetaminophen|mesh-list
111300293|NCT04214691|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111300294|NCT04214691|Analgesics|analgesics|mesh-ancestor
111300295|NCT04214691|Sensory System Agents|sensory system agents|mesh-ancestor
111300296|NCT04214691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111300297|NCT04214691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111300298|NCT04214691|Antipyretics|antipyretics|mesh-ancestor
111300299|NCT04786158|Apomorphine|apomorphine|mesh-list
111300300|NCT04786158|Emetics|emetics|mesh-ancestor
111300301|NCT04786158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111300302|NCT04786158|Autonomic Agents|autonomic agents|mesh-ancestor
111300303|NCT04786158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111300304|NCT04786158|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111300305|NCT04786158|Dopamine Agonists|dopamine agonists|mesh-ancestor
111300306|NCT04786158|Dopamine Agents|dopamine agents|mesh-ancestor
111300307|NCT04786158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111300308|NCT04786158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111300309|NCT03002493|Rifampin|rifampin|mesh-list
111300310|NCT03002493|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111300311|NCT03002493|Antitubercular Agents|antitubercular agents|mesh-ancestor
111024745|NCT04661852|Alkylating Agents|alkylating agents|mesh-ancestor
111024746|NCT04661852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111024747|NCT04661852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111024748|NCT04661852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111024749|NCT04661852|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111024750|NCT04661852|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111300312|NCT03002493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111300313|NCT03002493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111300314|NCT03002493|Leprostatic Agents|leprostatic agents|mesh-ancestor
111300315|NCT03002493|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111300316|NCT03002493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111300317|NCT03002493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111300318|NCT03002493|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111300319|NCT03002493|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111300320|NCT03002493|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
111300321|NCT03002493|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
111300322|NCT03002493|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
111300323|NCT03002493|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111300324|NCT04786470|Ropivacaine|ropivacaine|mesh-list
111300325|NCT04786470|Anesthetics, Local|anesthetics, local|mesh-ancestor
111300326|NCT04786470|Anesthetics|anesthetics|mesh-ancestor
111300327|NCT04786470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111300328|NCT04786470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111300329|NCT04786470|Sensory System Agents|sensory system agents|mesh-ancestor
111300330|NCT04786470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111300331|NCT02219997|Methamphetamine|methamphetamine|mesh-list
111300332|NCT02219997|beta-Endorphin|beta-endorphin|mesh-list
111300333|NCT02219997|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
111300334|NCT02219997|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
111300335|NCT02219997|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111300336|NCT02219997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111300337|NCT02219997|Sympathomimetics|sympathomimetics|mesh-ancestor
111300338|NCT02219997|Autonomic Agents|autonomic agents|mesh-ancestor
111300339|NCT02219997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111300340|NCT02219997|Dopamine Agents|dopamine agents|mesh-ancestor
111300341|NCT02219997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111300342|NCT02219997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111300343|NCT02219997|Adrenergic Agents|adrenergic agents|mesh-ancestor
111300344|NCT02219997|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111300345|NCT02219997|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111300346|NCT02219997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111300347|NCT02219997|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111300348|NCT02219997|Hormones|hormones|mesh-ancestor
111300349|NCT02219997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111300350|NCT04786002|Busulfan|busulfan|mesh-list
111300351|NCT04786002|Alkylating Agents|alkylating agents|mesh-ancestor
111300352|NCT04786002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111300353|NCT04786002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111300354|NCT04786002|Immunologic Factors|immunologic factors|mesh-ancestor
111300355|NCT04786002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111300356|NCT04786002|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111300357|NCT04786002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111300358|NCT04786002|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111300359|NCT04788654|Acetaminophen|acetaminophen|mesh-list
111300360|NCT04788654|Dexamethasone|dexamethasone|mesh-list
111300361|NCT04788654|Celecoxib|celecoxib|mesh-list
111300362|NCT04788654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111300363|NCT04788654|Antiemetics|antiemetics|mesh-ancestor
111300364|NCT04788654|Autonomic Agents|autonomic agents|mesh-ancestor
111300365|NCT04788654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111300366|NCT04788654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111300367|NCT04788654|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111300368|NCT04788654|Glucocorticoids|glucocorticoids|mesh-ancestor
111300369|NCT04788654|Hormones|hormones|mesh-ancestor
111300370|NCT04788654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111300371|NCT04788654|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111300372|NCT04788654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111300373|NCT04788654|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111300374|NCT04788654|Analgesics|analgesics|mesh-ancestor
111300375|NCT04788654|Sensory System Agents|sensory system agents|mesh-ancestor
111300376|NCT04788654|Antipyretics|antipyretics|mesh-ancestor
111300377|NCT04788654|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111300378|NCT04788654|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111300379|NCT04788654|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111300380|NCT04788654|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111300381|NCT04788654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111300382|NCT04788654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111300383|NCT04785768|Morphine|morphine|mesh-list
111300384|NCT04785768|Hydromorphone|hydromorphone|mesh-list
111300385|NCT04785768|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111300386|NCT04785768|Narcotics|narcotics|mesh-ancestor
111300387|NCT04785768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111300388|NCT04785768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111300389|NCT04785768|Analgesics|analgesics|mesh-ancestor
111300390|NCT04785768|Sensory System Agents|sensory system agents|mesh-ancestor
111300391|NCT04785768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111300392|NCT02223351|Ritonavir|ritonavir|mesh-list
111300393|NCT02223351|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111300394|NCT02223351|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111300395|NCT02223351|Protease Inhibitors|protease inhibitors|mesh-ancestor
111300396|NCT02223351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111300397|NCT02223351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111300398|NCT02223351|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111300399|NCT02223351|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111300400|NCT02223351|Antiviral Agents|antiviral agents|mesh-ancestor
111300401|NCT02223351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111300402|NCT02223351|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111300403|NCT02223351|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111300404|NCT02223429|Vasopressins|vasopressins|mesh-list
111300405|NCT02223429|Arginine Vasopressin|arginine vasopressin|mesh-list
111300406|NCT02223429|Oxytocin|oxytocin|mesh-list
111300407|NCT02223429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111300408|NCT02223429|Oxytocics|oxytocics|mesh-ancestor
111300409|NCT02223429|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111300410|NCT02223429|Hemostatics|hemostatics|mesh-ancestor
111300411|NCT02223429|Coagulants|coagulants|mesh-ancestor
111300412|NCT02223429|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111300413|NCT02223429|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
111300414|NCT02223429|Natriuretic Agents|natriuretic agents|mesh-ancestor
111300415|NCT03002649|Tofacitinib|tofacitinib|mesh-list
111300416|NCT03002649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111300417|NCT03002649|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
111300418|NCT03002649|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111300419|NCT03002649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111300420|NCT04785222|Dexmedetomidine|dexmedetomidine|mesh-list
111300421|NCT04785222|Bupivacaine|bupivacaine|mesh-list
111300422|NCT04785222|Anesthetics, Local|anesthetics, local|mesh-ancestor
111300423|NCT04785222|Anesthetics|anesthetics|mesh-ancestor
111300424|NCT04785222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111300425|NCT04785222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111300426|NCT04785222|Sensory System Agents|sensory system agents|mesh-ancestor
111300427|NCT04785222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111300428|NCT04785222|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111300429|NCT04785222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111300430|NCT04785222|Analgesics|analgesics|mesh-ancestor
111300431|NCT04785222|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111300432|NCT04785222|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111300433|NCT04785222|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111300434|NCT04785222|Adrenergic Agents|adrenergic agents|mesh-ancestor
111300435|NCT04785222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111300436|NCT04785222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111300437|NCT04808856|Methylprednisolone|methylprednisolone|mesh-list
111300438|NCT04808856|Hormones|hormones|mesh-list
111300439|NCT04808856|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
111300440|NCT04808856|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
111300441|NCT04808856|beta-Endorphin|beta-endorphin|mesh-list
111300442|NCT04808856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111300443|NCT04808856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111300444|NCT04808856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111300445|NCT04808856|Antiemetics|antiemetics|mesh-ancestor
111300446|NCT04808856|Autonomic Agents|autonomic agents|mesh-ancestor
111300447|NCT04808856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111300448|NCT04808856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111300449|NCT04808856|Glucocorticoids|glucocorticoids|mesh-ancestor
111300450|NCT04808856|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111300451|NCT04808856|Protective Agents|protective agents|mesh-ancestor
111300452|NCT04808856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111300453|NCT04808856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111300454|NCT02247687|Raltegravir Potassium|raltegravir potassium|mesh-list
111300455|NCT02247687|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
111300456|NCT02247687|Protease Inhibitors|protease inhibitors|mesh-list
111300457|NCT02247687|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111300458|NCT02247687|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111024893|NCT04368533|Fluorides|fluorides|mesh-list
111300459|NCT02247687|Antiviral Agents|antiviral agents|mesh-ancestor
111300460|NCT02247687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111300461|NCT02247687|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111300462|NCT02247687|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111300463|NCT02247687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111300464|NCT02247687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111300465|NCT02247687|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111300467|NCT04784988|Coagulants|coagulants|mesh-ancestor
111300468|NCT04784910|Lansoprazole|lansoprazole|mesh-list
111300469|NCT04784910|Dexlansoprazole|dexlansoprazole|mesh-list
111300470|NCT04784910|Fexuprazan|fexuprazan|mesh-list
111300471|NCT04784910|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111300472|NCT04784910|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111300473|NCT04784910|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111300474|NCT04784910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111300475|NCT04784910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111300476|NCT01625013|Hylan|hylan|mesh-list
111300477|NCT01625013|Viscosupplements|viscosupplements|mesh-ancestor
111300478|NCT01625013|Protective Agents|protective agents|mesh-ancestor
111300479|NCT01625013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111300480|NCT00083551|Interferons|interferons|mesh-list
111300481|NCT00083551|Cytarabine|cytarabine|mesh-list
111300482|NCT00083551|Interferon-alpha|interferon-alpha|mesh-list
111300483|NCT00083551|Interferon alpha-2|interferon alpha-2|mesh-list
111300484|NCT00083551|Thalidomide|thalidomide|mesh-list
111300485|NCT00083551|Dexamethasone|dexamethasone|mesh-list
111300486|NCT00083551|Cyclophosphamide|cyclophosphamide|mesh-list
111300487|NCT00083551|Melphalan|melphalan|mesh-list
111300488|NCT00083551|Carmustine|carmustine|mesh-list
111300489|NCT00083551|Cisplatin|cisplatin|mesh-list
111300490|NCT00083551|Doxorubicin|doxorubicin|mesh-list
111300491|NCT00083551|Etoposide|etoposide|mesh-list
111300492|NCT00083551|Vincristine|vincristine|mesh-list
111300493|NCT00083551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111300494|NCT00083551|Immunologic Factors|immunologic factors|mesh-ancestor
111300495|NCT00083551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111300496|NCT00083551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111300497|NCT00083551|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111300498|NCT00083551|Alkylating Agents|alkylating agents|mesh-ancestor
111300499|NCT00083551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111300500|NCT00083551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111300501|NCT00083551|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111300502|NCT00083551|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111300503|NCT00083551|Antiemetics|antiemetics|mesh-ancestor
111300504|NCT00083551|Autonomic Agents|autonomic agents|mesh-ancestor
111300505|NCT00083551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111300506|NCT00083551|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111300507|NCT00083551|Glucocorticoids|glucocorticoids|mesh-ancestor
111300508|NCT00083551|Hormones|hormones|mesh-ancestor
111300509|NCT00083551|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111300510|NCT00083551|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111300511|NCT00083551|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111300512|NCT00083551|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111300513|NCT00083551|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111300514|NCT00083551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111300515|NCT00083551|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111300516|NCT00083551|Antiviral Agents|antiviral agents|mesh-ancestor
111300517|NCT00083551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111300518|NCT00083551|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111300519|NCT00083551|Antimetabolites|antimetabolites|mesh-ancestor
111300520|NCT00083551|Tubulin Modulators|tubulin modulators|mesh-ancestor
111300521|NCT00083551|Antimitotic Agents|antimitotic agents|mesh-ancestor
111300522|NCT00083551|Mitosis Modulators|mitosis modulators|mesh-ancestor
111300523|NCT00083551|Leprostatic Agents|leprostatic agents|mesh-ancestor
111300524|NCT00083551|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111300525|NCT00083551|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111300526|NCT00083551|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111300527|NCT00083551|Growth Substances|growth substances|mesh-ancestor
111300528|NCT00083551|Growth Inhibitors|growth inhibitors|mesh-ancestor
111300529|NCT01625169|Etravirine|etravirine|mesh-list
111300530|NCT01625169|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111300531|NCT01625169|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111300532|NCT01625169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111300533|NCT01625169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110959200|NCT01025505|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111300534|NCT01625169|Antiviral Agents|antiviral agents|mesh-ancestor
111300535|NCT01625169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111300536|NCT03933813|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
111300537|NCT03933813|Hematinics|hematinics|mesh-ancestor
111300538|NCT01628601|Timolol|timolol|mesh-list
111300539|NCT01628601|Bimatoprost|bimatoprost|mesh-list
111300540|NCT01628601|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111300541|NCT01628601|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111300542|NCT01628601|Adrenergic Agents|adrenergic agents|mesh-ancestor
111300543|NCT01628601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111300544|NCT01628601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111300545|NCT01628601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111300546|NCT01628601|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111300547|NCT01628601|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111300548|NCT01470248|Arsenic Trioxide|arsenic trioxide|mesh-list
111300549|NCT01470248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111300550|NCT04091022|Eflornithine|eflornithine|mesh-list
111300551|NCT04091022|Diclofenac|diclofenac|mesh-list
111300552|NCT04091022|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111300553|NCT04091022|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111300554|NCT04091022|Analgesics|analgesics|mesh-ancestor
111300555|NCT04091022|Sensory System Agents|sensory system agents|mesh-ancestor
111300556|NCT04091022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111300557|NCT04091022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111300558|NCT04091022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111300559|NCT04091022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111300560|NCT04091022|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111300561|NCT04091022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111300562|NCT04091022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111300563|NCT04091022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111300564|NCT04091022|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
111300565|NCT04091022|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111300566|NCT04091022|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111300567|NCT04091022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111300568|NCT04091022|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
111300569|NCT01490918|Metformin|metformin|mesh-list
111300570|NCT01490918|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111300571|NCT01490918|Acarbose|acarbose|mesh-list
111300572|NCT01490918|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111300573|NCT01490918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111300574|NCT01490918|Incretins|incretins|mesh-ancestor
111300575|NCT01490918|Hormones|hormones|mesh-ancestor
111300576|NCT01490918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111300577|NCT01490918|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111300578|NCT01490918|Protease Inhibitors|protease inhibitors|mesh-ancestor
111300579|NCT01490918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111300580|NCT01490918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111300581|NCT01490918|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
111300582|NCT02230995|Metformin|metformin|mesh-list
111300583|NCT02230995|Empagliflozin|empagliflozin|mesh-list
111300584|NCT02230995|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111300585|NCT02230995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111300586|NCT02230995|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111300587|NCT02230995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111300588|NCT02995083|Methylprednisolone|methylprednisolone|mesh-list
111300589|NCT02995083|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111300590|NCT02995083|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111300591|NCT02995083|Prednisolone|prednisolone|mesh-list
111300592|NCT02995083|Prednisolone acetate|prednisolone acetate|mesh-list
111300593|NCT02995083|Lidocaine|lidocaine|mesh-list
111300594|NCT02995083|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111300595|NCT02995083|Prednisolone phosphate|prednisolone phosphate|mesh-list
111300596|NCT02995083|Anesthetics, Local|anesthetics, local|mesh-ancestor
111300597|NCT02995083|Anesthetics|anesthetics|mesh-ancestor
111300598|NCT02995083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111300599|NCT02995083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111300600|NCT02995083|Sensory System Agents|sensory system agents|mesh-ancestor
111300601|NCT02995083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111300602|NCT02995083|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111300603|NCT02995083|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111300604|NCT02995083|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111300605|NCT02995083|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111300606|NCT02995083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111300607|NCT02995083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111300608|NCT02995083|Antiemetics|antiemetics|mesh-ancestor
111300609|NCT02995083|Autonomic Agents|autonomic agents|mesh-ancestor
111300610|NCT02995083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111300611|NCT02995083|Glucocorticoids|glucocorticoids|mesh-ancestor
111300613|NCT02995083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111300614|NCT02995083|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111300615|NCT02995083|Protective Agents|protective agents|mesh-ancestor
111300616|NCT02995083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111300617|NCT02995083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111300618|NCT04426422|Metformin|metformin|mesh-list
111300619|NCT04426422|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111300620|NCT04426422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111300621|NCT05471700|Azacitidine|azacitidine|mesh-list
111300622|NCT05471700|Venetoclax|venetoclax|mesh-list
111300623|NCT05471700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111300624|NCT05471700|Antimetabolites|antimetabolites|mesh-ancestor
111300625|NCT05471700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111300626|NCT05471700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111300627|NCT05471700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111300628|NCT01632423|Bimatoprost|bimatoprost|mesh-list
111300629|NCT01632423|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111300630|NCT05466318|Cytarabine|cytarabine|mesh-list
111300631|NCT05466318|Gemcitabine|gemcitabine|mesh-list
111300632|NCT05466318|Etoposide|etoposide|mesh-list
111300633|NCT05466318|Melphalan|melphalan|mesh-list
111300634|NCT05466318|Busulfan|busulfan|mesh-list
111300635|NCT05466318|Carmustine|carmustine|mesh-list
111300636|NCT05466318|Cladribine|cladribine|mesh-list
111300637|NCT05466318|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111300638|NCT05466318|Antimetabolites|antimetabolites|mesh-ancestor
111300639|NCT05466318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111300640|NCT05466318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111300641|NCT05466318|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111300642|NCT05466318|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111300643|NCT05466318|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111300644|NCT05466318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111300645|NCT05466318|Antiviral Agents|antiviral agents|mesh-ancestor
111300646|NCT05466318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111300647|NCT05466318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111300648|NCT05466318|Immunologic Factors|immunologic factors|mesh-ancestor
111300649|NCT05466318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111300650|NCT05466318|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111300651|NCT05466318|Alkylating Agents|alkylating agents|mesh-ancestor
111300652|NCT05466318|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111300653|NCT01633827|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
111300654|NCT01633827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111300655|NCT01633827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111300656|NCT01469546|Axitinib|axitinib|mesh-list
111300657|NCT01469546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111300658|NCT01469546|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111300659|NCT01469546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111300660|NCT01469546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111300661|NCT03281811|Aminolevulinic Acid|aminolevulinic acid|mesh-list
111300662|NCT03281811|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111300663|NCT03281811|Dermatologic Agents|dermatologic agents|mesh-ancestor
111300664|NCT05613894|177Lu-PSMA-617|177lu-psma-617|mesh-list
111300665|NCT05613894|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111300666|NCT05613894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111300667|NCT00081263|Celecoxib|celecoxib|mesh-list
111300668|NCT00081263|Benzenesulfonamide|benzenesulfonamide|mesh-list
111300669|NCT00081263|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111300670|NCT00081263|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111300671|NCT00081263|Analgesics|analgesics|mesh-ancestor
111300672|NCT00081263|Sensory System Agents|sensory system agents|mesh-ancestor
111300673|NCT00081263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111300674|NCT00081263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111300675|NCT00081263|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111300676|NCT00081263|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111300677|NCT00081263|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111300678|NCT00081263|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111300679|NCT00081263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111300680|NCT00081263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111300681|NCT00081263|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
111300682|NCT03138603|Metoprolol|metoprolol|mesh-list
111300683|NCT03138603|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111300684|NCT03138603|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111300685|NCT03138603|Sympatholytics|sympatholytics|mesh-ancestor
111300686|NCT03138603|Autonomic Agents|autonomic agents|mesh-ancestor
111025116|NCT03545347|Hormones|hormones|mesh-ancestor
111300687|NCT03138603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111300688|NCT03138603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111300689|NCT03138603|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
111300690|NCT03138603|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111300691|NCT03138603|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111300692|NCT03138603|Adrenergic Agents|adrenergic agents|mesh-ancestor
111300693|NCT03138603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111300694|NCT03138603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111300695|NCT05087381|Cyproheptadine|cyproheptadine|mesh-list
111300696|NCT05087381|Niclosamide|niclosamide|mesh-list
111300697|NCT05087381|Fluvoxamine|fluvoxamine|mesh-list
111300698|NCT05087381|Bromhexine|bromhexine|mesh-list
111300699|NCT05087381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111300700|NCT05087381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111300701|NCT05087381|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111300702|NCT05087381|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111300703|NCT05087381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111300704|NCT05087381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111300705|NCT05087381|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111300706|NCT05087381|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111300707|NCT05087381|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111300708|NCT05087381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111300709|NCT05087381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111300710|NCT05087381|Serotonin Agents|serotonin agents|mesh-ancestor
111300711|NCT05087381|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111300712|NCT05087381|Antidepressive Agents|antidepressive agents|mesh-ancestor
111300713|NCT05087381|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111300714|NCT05087381|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111300715|NCT05087381|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111300716|NCT05087381|Anticestodal Agents|anticestodal agents|mesh-ancestor
111300717|NCT05087381|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
111300718|NCT05087381|Anthelmintics|anthelmintics|mesh-ancestor
111300719|NCT05087381|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111300720|NCT05087381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111300721|NCT05087381|Antinematodal Agents|antinematodal agents|mesh-ancestor
111300722|NCT05087381|Antipruritics|antipruritics|mesh-ancestor
111300723|NCT05087381|Dermatologic Agents|dermatologic agents|mesh-ancestor
111300724|NCT05087381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111300725|NCT05087381|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111300726|NCT05087381|Histamine Antagonists|histamine antagonists|mesh-ancestor
111300727|NCT05087381|Histamine Agents|histamine agents|mesh-ancestor
111300728|NCT05087381|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111300729|NCT05087381|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111300730|NCT05087381|Expectorants|expectorants|mesh-ancestor
111300731|NCT05087381|Respiratory System Agents|respiratory system agents|mesh-ancestor
111300732|NCT00080483|Methyltestosterone|methyltestosterone|mesh-list
111300733|NCT00080483|Testosterone|testosterone|mesh-list
111300734|NCT00080483|Testosterone undecanoate|testosterone undecanoate|mesh-list
111300735|NCT00080483|Testosterone enanthate|testosterone enanthate|mesh-list
111300736|NCT00080483|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
111300737|NCT00080483|Androgens|androgens|mesh-ancestor
111300738|NCT00080483|Hormones|hormones|mesh-ancestor
111300739|NCT00080483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111300740|NCT00080483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111300741|NCT00080483|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111300742|NCT00080483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111300743|NCT00080483|Anabolic Agents|anabolic agents|mesh-ancestor
111300744|NCT05248620|Amoxicillin|amoxicillin|mesh-list
111300745|NCT05248620|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111300746|NCT05248620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111300747|NCT01639599|Dexamethasone|dexamethasone|mesh-list
111300748|NCT01639599|Dexamethasone acetate|dexamethasone acetate|mesh-list
111300749|NCT01639599|Haloperidol|haloperidol|mesh-list
111300750|NCT01639599|Haloperidol decanoate|haloperidol decanoate|mesh-list
111300751|NCT01639599|BB 1101|bb 1101|mesh-list
111300752|NCT01639599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111300753|NCT01639599|Antiemetics|antiemetics|mesh-ancestor
111300754|NCT01639599|Autonomic Agents|autonomic agents|mesh-ancestor
111300755|NCT01639599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111300756|NCT01639599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111300757|NCT01639599|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111300758|NCT01639599|Glucocorticoids|glucocorticoids|mesh-ancestor
111300759|NCT01639599|Hormones|hormones|mesh-ancestor
111300760|NCT01639599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111300761|NCT01639599|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111300762|NCT01639599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111300763|NCT01639599|Protease Inhibitors|protease inhibitors|mesh-ancestor
111300764|NCT01639599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111300765|NCT01639599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111300766|NCT01639599|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111300767|NCT01639599|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111300768|NCT01639599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111300769|NCT01639599|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111300770|NCT01639599|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111300771|NCT01639599|Dopamine Agents|dopamine agents|mesh-ancestor
111300772|NCT01639599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111300773|NCT01639599|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111300774|NCT00089141|Mycophenolic Acid|mycophenolic acid|mesh-list
111300775|NCT00089141|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111300776|NCT00089141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111300777|NCT00089141|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111300778|NCT00089141|Antitubercular Agents|antitubercular agents|mesh-ancestor
111300779|NCT00089141|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111300780|NCT00089141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111300781|NCT00089141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111300782|NCT00089141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111300783|NCT02227329|Ethanol|ethanol|mesh-list
111300784|NCT02227329|Heparin|heparin|mesh-list
111300785|NCT02227329|Calcium heparin|calcium heparin|mesh-list
111300786|NCT02227329|Anticoagulants|anticoagulants|mesh-ancestor
111300787|NCT02227329|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111300788|NCT02227329|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111300789|NCT02227329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111300790|NCT02227329|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111300791|NCT02227329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111300792|NCT02227329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111300793|NCT02227329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111300794|NCT05615142|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
111300795|NCT05615142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111300796|NCT05615142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111300797|NCT05615142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111300798|NCT02227485|Chlorhexidine|chlorhexidine|mesh-list
111300799|NCT02227485|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111300800|NCT02227485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111300801|NCT02227485|Disinfectants|disinfectants|mesh-ancestor
111300802|NCT03172897|Dexmedetomidine|dexmedetomidine|mesh-list
111300803|NCT03172897|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111300804|NCT03172897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111300805|NCT03172897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111300806|NCT03172897|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111300807|NCT03172897|Analgesics|analgesics|mesh-ancestor
111300808|NCT03172897|Sensory System Agents|sensory system agents|mesh-ancestor
111300809|NCT03172897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111300810|NCT03172897|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111300811|NCT03172897|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111300812|NCT03172897|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111300813|NCT03172897|Adrenergic Agents|adrenergic agents|mesh-ancestor
111300814|NCT03172897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111300815|NCT03172897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111300816|NCT00086723|Captopril|captopril|mesh-list
111300817|NCT00086723|Plasminogen|plasminogen|mesh-list
111300818|NCT00086723|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
111300819|NCT00086723|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111300820|NCT00086723|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111300821|NCT00086723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111300822|NCT00086723|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
111300823|NCT00086723|Protease Inhibitors|protease inhibitors|mesh-ancestor
111300824|NCT00086723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111300825|NCT00086723|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111300826|NCT03849534|Salicylic Acid|salicylic acid|mesh-list
111300827|NCT03849534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111300828|NCT03849534|Antifungal Agents|antifungal agents|mesh-ancestor
111300829|NCT03849534|Keratolytic Agents|keratolytic agents|mesh-ancestor
111300830|NCT03849534|Dermatologic Agents|dermatologic agents|mesh-ancestor
111300831|NCT05346419|Vitamin D|vitamin d|mesh-list
111300832|NCT05346419|Risedronic Acid|risedronic acid|mesh-list
111300833|NCT05346419|Vitamins|vitamins|mesh-ancestor
111300834|NCT05346419|Micronutrients|micronutrients|mesh-ancestor
111300835|NCT05346419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111300836|NCT05346419|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111300837|NCT05346419|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111300838|NCT05346419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111300839|NCT05346419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111300840|NCT05346419|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111300842|NCT00084409|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111300843|NCT00084409|Vasodilator Agents|vasodilator agents|mesh-ancestor
111300844|NCT03831165|Acyclovir|acyclovir|mesh-list
111300845|NCT03831165|Melatonin|melatonin|mesh-list
111300846|NCT03831165|Antioxidants|antioxidants|mesh-ancestor
111300847|NCT03831165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111300848|NCT03831165|Protective Agents|protective agents|mesh-ancestor
111300849|NCT03831165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111300850|NCT03831165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111300851|NCT03831165|Antiviral Agents|antiviral agents|mesh-ancestor
111300852|NCT03831165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111300853|NCT00088621|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
111300854|NCT00088621|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111300855|NCT00088621|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111300856|NCT00088621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111300857|NCT00088621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111300858|NCT00088621|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111300859|NCT00088621|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
111300860|NCT00088621|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111300861|NCT00088621|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111300862|NCT00088621|Adrenergic Agents|adrenergic agents|mesh-ancestor
111300863|NCT00088621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111300864|NCT00088621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111300865|NCT00088621|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111300866|NCT00088621|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111300867|NCT00088621|Serotonin Agents|serotonin agents|mesh-ancestor
111300868|NCT00088621|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111300869|NCT00088621|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111300870|NCT00088621|Dopamine Agents|dopamine agents|mesh-ancestor
111300871|NCT03849651|Cyclophosphamide|cyclophosphamide|mesh-list
111300872|NCT03849651|Melphalan|melphalan|mesh-list
111300873|NCT03849651|Thiotepa|thiotepa|mesh-list
111300874|NCT03849651|Fludarabine|fludarabine|mesh-list
111300875|NCT03849651|Blinatumomab|blinatumomab|mesh-list
111300876|NCT03849651|Thymoglobulin|thymoglobulin|mesh-list
111300877|NCT03849651|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111300878|NCT03849651|Immunologic Factors|immunologic factors|mesh-ancestor
111300879|NCT03849651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111300880|NCT03849651|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111300881|NCT03849651|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111300882|NCT03849651|Alkylating Agents|alkylating agents|mesh-ancestor
111300883|NCT03849651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111300884|NCT03849651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111300885|NCT03849651|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111300886|NCT05574985|Vaccines|vaccines|mesh-list
111300887|NCT05574985|Immunologic Factors|immunologic factors|mesh-ancestor
111300888|NCT05574985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111300889|NCT01642485|Moxifloxacin|moxifloxacin|mesh-list
111300890|NCT01642485|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
111300891|NCT01642485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111300892|NCT01642485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111300893|NCT01642485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111300894|NCT01642485|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111300895|NCT01642485|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111300896|NCT01642485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111300897|NCT01642485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111300898|NCT01642485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111300899|NCT01642485|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111300900|NCT01642485|Contraceptive Agents|contraceptive agents|mesh-ancestor
111300901|NCT01642485|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111300902|NCT01642485|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
111300903|NCT01642485|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111300904|NCT01642485|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111300905|NCT04773366|Cytarabine|cytarabine|mesh-list
111300906|NCT04773366|Prednisone|prednisone|mesh-list
111300907|NCT04773366|Vincristine|vincristine|mesh-list
111300908|NCT04773366|Mercaptopurine|mercaptopurine|mesh-list
111300909|NCT04773366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111300910|NCT04773366|Glucocorticoids|glucocorticoids|mesh-ancestor
111300911|NCT04773366|Hormones|hormones|mesh-ancestor
111300912|NCT04773366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111300913|NCT04773366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111300914|NCT04773366|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111300915|NCT04773366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111300916|NCT04773366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111300917|NCT04773366|Antimetabolites|antimetabolites|mesh-ancestor
111300918|NCT04773366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111300919|NCT04773366|Antiviral Agents|antiviral agents|mesh-ancestor
111300920|NCT04773366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111300921|NCT04773366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111300922|NCT04773366|Immunologic Factors|immunologic factors|mesh-ancestor
111300923|NCT04773366|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111300924|NCT04773366|Tubulin Modulators|tubulin modulators|mesh-ancestor
111300925|NCT04773366|Antimitotic Agents|antimitotic agents|mesh-ancestor
111300926|NCT04773366|Mitosis Modulators|mitosis modulators|mesh-ancestor
111300927|NCT04773366|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111300928|NCT04773366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111300929|NCT04714541|Ketamine|ketamine|mesh-list
111300930|NCT04714541|Analgesics|analgesics|mesh-ancestor
111300931|NCT04714541|Sensory System Agents|sensory system agents|mesh-ancestor
111300932|NCT04714541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111300933|NCT04714541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111300934|NCT04714541|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111300935|NCT04714541|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111300936|NCT04714541|Anesthetics, General|anesthetics, general|mesh-ancestor
111300937|NCT04714541|Anesthetics|anesthetics|mesh-ancestor
111300938|NCT04714541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111300939|NCT04714541|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111300940|NCT04714541|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111300941|NCT04714541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111300942|NCT04714541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111300943|NCT02414724|Gemcitabine|gemcitabine|mesh-list
111300944|NCT02414724|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111300945|NCT02414724|Antimetabolites|antimetabolites|mesh-ancestor
111300946|NCT02414724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111300947|NCT02414724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111300948|NCT00187681|Metformin|metformin|mesh-list
111300949|NCT00187681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111300950|NCT00187681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111300951|NCT00083759|Natalizumab|natalizumab|mesh-list
111300952|NCT00083759|Immunologic Factors|immunologic factors|mesh-ancestor
111300953|NCT00083759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111300954|NCT02412228|Dexamethasone|dexamethasone|mesh-list
111300955|NCT02412228|Cyclophosphamide|cyclophosphamide|mesh-list
111300956|NCT02412228|Ixazomib|ixazomib|mesh-list
111300957|NCT02412228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111300958|NCT02412228|Immunologic Factors|immunologic factors|mesh-ancestor
111300959|NCT02412228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111300960|NCT02412228|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111300961|NCT02412228|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111300962|NCT02412228|Alkylating Agents|alkylating agents|mesh-ancestor
111300963|NCT02412228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111300964|NCT02412228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111300965|NCT02412228|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111300966|NCT02412228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111300967|NCT02412228|Antiemetics|antiemetics|mesh-ancestor
111300968|NCT02412228|Autonomic Agents|autonomic agents|mesh-ancestor
111300969|NCT02412228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111300970|NCT02412228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111300971|NCT02412228|Glucocorticoids|glucocorticoids|mesh-ancestor
111300972|NCT02412228|Hormones|hormones|mesh-ancestor
111300973|NCT02412228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111300974|NCT02412228|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111300975|NCT02412228|Protease Inhibitors|protease inhibitors|mesh-ancestor
111300976|NCT02412228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111300977|NCT03693807|Gemcitabine|gemcitabine|mesh-list
111300978|NCT03693807|Fluorouracil|fluorouracil|mesh-list
111300979|NCT03693807|Floxuridine|floxuridine|mesh-list
111300980|NCT03693807|Oxaliplatin|oxaliplatin|mesh-list
111300981|NCT03693807|Irinotecan|irinotecan|mesh-list
111300982|NCT03693807|Cetuximab|cetuximab|mesh-list
111300983|NCT03693807|Panitumumab|panitumumab|mesh-list
111300984|NCT03693807|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111300985|NCT03693807|Antimetabolites|antimetabolites|mesh-ancestor
111300986|NCT03693807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111300987|NCT03693807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111300988|NCT03693807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111300989|NCT03693807|Immunologic Factors|immunologic factors|mesh-ancestor
111300990|NCT03693807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111300991|NCT03693807|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111300992|NCT03693807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111300993|NCT03693807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111300994|NCT03693807|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111300995|NCT01646151|Bimatoprost|bimatoprost|mesh-list
111300996|NCT01646151|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111300997|NCT03692481|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
111300998|NCT03692481|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111300999|NCT03692481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111301000|NCT01828710|Folic Acid|folic acid|mesh-list
111301001|NCT01828710|Inositol|inositol|mesh-list
111301002|NCT01828710|Hematinics|hematinics|mesh-ancestor
111301003|NCT01828710|Vitamin B Complex|vitamin b complex|mesh-ancestor
111301004|NCT01828710|Vitamins|vitamins|mesh-ancestor
111301005|NCT01828710|Micronutrients|micronutrients|mesh-ancestor
111301006|NCT01828710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111301007|NCT00088699|Ketamine|ketamine|mesh-list
111301008|NCT00088699|Analgesics|analgesics|mesh-ancestor
111301009|NCT00088699|Sensory System Agents|sensory system agents|mesh-ancestor
111301010|NCT00088699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111301011|NCT00088699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111301012|NCT00088699|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111301013|NCT00088699|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111301014|NCT00088699|Anesthetics, General|anesthetics, general|mesh-ancestor
111301015|NCT00088699|Anesthetics|anesthetics|mesh-ancestor
111301016|NCT00088699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111301017|NCT00088699|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111301018|NCT00088699|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111301019|NCT00088699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111301020|NCT00088699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111301021|NCT00089011|Mycophenolic Acid|mycophenolic acid|mesh-list
111301022|NCT00089011|Fludarabine|fludarabine|mesh-list
111301023|NCT00089011|Fludarabine phosphate|fludarabine phosphate|mesh-list
111301024|NCT00089011|Tacrolimus|tacrolimus|mesh-list
111301025|NCT00089011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111301026|NCT00089011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111301027|NCT00089011|Antimetabolites|antimetabolites|mesh-ancestor
111301028|NCT00089011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111301029|NCT00089011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111301030|NCT00089011|Immunologic Factors|immunologic factors|mesh-ancestor
110979775|NCT03234842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111301031|NCT00089011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111301032|NCT00089011|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111301033|NCT00089011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111301034|NCT00089011|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111301035|NCT00089011|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111301036|NCT00089011|Antitubercular Agents|antitubercular agents|mesh-ancestor
111301037|NCT00089011|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111301038|NCT00089011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111301039|NCT01898377|Mycophenolic Acid|mycophenolic acid|mesh-list
111301040|NCT01898377|Imatinib Mesylate|imatinib mesylate|mesh-list
111301041|NCT01898377|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111301042|NCT01898377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111301043|NCT01898377|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111301044|NCT01898377|Antitubercular Agents|antitubercular agents|mesh-ancestor
111301045|NCT01898377|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111301046|NCT01898377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111301047|NCT01898377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111301048|NCT01898377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111301049|NCT01898377|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111301050|NCT00347412|Paclitaxel|paclitaxel|mesh-list
111301051|NCT00347412|Carboplatin|carboplatin|mesh-list
111301052|NCT00347412|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111301053|NCT00347412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111301054|NCT00347412|Tubulin Modulators|tubulin modulators|mesh-ancestor
111301055|NCT00347412|Antimitotic Agents|antimitotic agents|mesh-ancestor
111301056|NCT00347412|Mitosis Modulators|mitosis modulators|mesh-ancestor
111301057|NCT00347412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111301058|NCT00189475|Montelukast|montelukast|mesh-list
111301059|NCT00189475|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111301060|NCT00189475|Respiratory System Agents|respiratory system agents|mesh-ancestor
111301061|NCT00189475|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
111025489|NCT02051153|Modafinil|modafinil|mesh-list
111301062|NCT00189475|Hormone Antagonists|hormone antagonists|mesh-ancestor
111301063|NCT00189475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111301064|NCT00189475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111301065|NCT00189475|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
111301066|NCT00189475|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111301067|NCT00189475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111301069|NCT00091273|Freund's Adjuvant|freund's adjuvant|mesh-list
111301070|NCT00091273|Immunologic Factors|immunologic factors|mesh-ancestor
111301071|NCT00091273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111301072|NCT00091273|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111301073|NCT00193375|Bevacizumab|bevacizumab|mesh-list
111301074|NCT00193375|Carboplatin|carboplatin|mesh-list
111301075|NCT00193375|Irinotecan|irinotecan|mesh-list
111301076|NCT00193375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111301077|NCT00193375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111301078|NCT00193375|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111301079|NCT00193375|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111301080|NCT00193375|Growth Substances|growth substances|mesh-ancestor
111301081|NCT00193375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111301082|NCT00193375|Growth Inhibitors|growth inhibitors|mesh-ancestor
111301083|NCT00193375|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111301084|NCT00193375|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111301085|NCT00193375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111301086|NCT00193375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111301087|NCT00193453|Gemcitabine|gemcitabine|mesh-list
111301088|NCT00193453|Docetaxel|docetaxel|mesh-list
111301089|NCT00193453|Cetuximab|cetuximab|mesh-list
111301090|NCT00193453|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111301091|NCT00193453|Antimetabolites|antimetabolites|mesh-ancestor
111301092|NCT00193453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111301093|NCT00193453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111301094|NCT00193453|Tubulin Modulators|tubulin modulators|mesh-ancestor
111301095|NCT00193453|Antimitotic Agents|antimitotic agents|mesh-ancestor
111301096|NCT00193453|Mitosis Modulators|mitosis modulators|mesh-ancestor
111301097|NCT00193453|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111301098|NCT05614518|Methylene diphosphonate|methylene diphosphonate|mesh-list
111301099|NCT05614518|Listerine|listerine|mesh-list
111301100|NCT05614518|Fluorides|fluorides|mesh-list
111301101|NCT05614518|Sodium Fluoride|sodium fluoride|mesh-list
111301102|NCT05614518|Cariostatic Agents|cariostatic agents|mesh-ancestor
111301103|NCT05614518|Protective Agents|protective agents|mesh-ancestor
111301104|NCT05614518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111301105|NCT05614518|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111301106|NCT05614518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111301107|NCT05614518|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111301108|NCT00091507|Insulin|insulin|mesh-list
111301109|NCT00091507|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111301110|NCT00091507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111301111|NCT05611086|Acetylcysteine|acetylcysteine|mesh-list
111301112|NCT05611086|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111301113|NCT05611086|Antiviral Agents|antiviral agents|mesh-ancestor
111301114|NCT05611086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111301115|NCT05611086|Expectorants|expectorants|mesh-ancestor
111301116|NCT05611086|Respiratory System Agents|respiratory system agents|mesh-ancestor
111301117|NCT05611086|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111301118|NCT05611086|Antioxidants|antioxidants|mesh-ancestor
111301119|NCT05611086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111301120|NCT05611086|Protective Agents|protective agents|mesh-ancestor
111301121|NCT05611086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111301122|NCT05611086|Antidotes|antidotes|mesh-ancestor
111301123|NCT05614440|Tramadol|tramadol|mesh-list
111301124|NCT05614440|Anesthetics|anesthetics|mesh-list
111301125|NCT05614440|Anesthetics, Local|anesthetics, local|mesh-list
111301126|NCT05614440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111301127|NCT05614440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111301128|NCT05614440|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111301129|NCT05614440|Narcotics|narcotics|mesh-ancestor
111301130|NCT05614440|Analgesics|analgesics|mesh-ancestor
111301131|NCT05614440|Sensory System Agents|sensory system agents|mesh-ancestor
111301132|NCT05614440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111301133|NCT05613192|Vitamin D|vitamin d|mesh-list
111301134|NCT05613192|Cholecalciferol|cholecalciferol|mesh-list
111301135|NCT05613192|Vitamins|vitamins|mesh-ancestor
111301136|NCT05613192|Micronutrients|micronutrients|mesh-ancestor
111301137|NCT05613192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111025561|NCT02052323|Artesunate|artesunate|mesh-list
111301138|NCT05613192|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111301139|NCT05613192|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111301141|NCT00194779|Vinorelbine|vinorelbine|mesh-list
111301142|NCT00194779|Cyclophosphamide|cyclophosphamide|mesh-list
111301143|NCT00194779|Doxorubicin|doxorubicin|mesh-list
111301144|NCT00194779|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111301145|NCT00194779|Capecitabine|capecitabine|mesh-list
111301146|NCT00194779|Methotrexate|methotrexate|mesh-list
111301147|NCT00194779|Trastuzumab|trastuzumab|mesh-list
111301148|NCT00194779|Letrozole|letrozole|mesh-list
111301149|NCT00194779|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111301150|NCT00194779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111301151|NCT00194779|Tubulin Modulators|tubulin modulators|mesh-ancestor
111301152|NCT00194779|Antimitotic Agents|antimitotic agents|mesh-ancestor
111301153|NCT00194779|Mitosis Modulators|mitosis modulators|mesh-ancestor
111301154|NCT00194779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111301155|NCT00194779|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111301156|NCT00194779|Immunologic Factors|immunologic factors|mesh-ancestor
111301157|NCT00194779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111301158|NCT00194779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111301159|NCT00194779|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111301160|NCT00194779|Alkylating Agents|alkylating agents|mesh-ancestor
111301161|NCT00194779|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111301162|NCT00194779|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111301163|NCT00194779|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111301164|NCT00194779|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111301165|NCT00194779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111301166|NCT00194779|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111301167|NCT00194779|Antimetabolites|antimetabolites|mesh-ancestor
111301168|NCT00194779|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111301169|NCT00194779|Abortifacient Agents|abortifacient agents|mesh-ancestor
111301170|NCT00194779|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111301171|NCT00194779|Dermatologic Agents|dermatologic agents|mesh-ancestor
111301172|NCT00194779|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111301173|NCT00194779|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111301174|NCT00194779|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111301175|NCT00194779|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111301176|NCT00194779|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111301177|NCT00194779|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111301178|NCT00194779|Hormone Antagonists|hormone antagonists|mesh-ancestor
111301179|NCT00194779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111301180|NCT00194779|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111301181|NCT00194779|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111301182|NCT00194779|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111301183|NCT00194779|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111301184|NCT05474664|Camostat|camostat|mesh-list
111301185|NCT05474664|Protease Inhibitors|protease inhibitors|mesh-ancestor
111301186|NCT05474664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111301187|NCT05474664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111301188|NCT05474664|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
111301189|NCT05474664|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111301190|NCT02096575|Nitrous Oxide|nitrous oxide|mesh-list
111301191|NCT02096575|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111301192|NCT02096575|Anesthetics, General|anesthetics, general|mesh-ancestor
111301193|NCT02096575|Anesthetics|anesthetics|mesh-ancestor
111301194|NCT02096575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111301195|NCT02096575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111301196|NCT02096575|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111301197|NCT02096575|Analgesics|analgesics|mesh-ancestor
111301198|NCT02096575|Sensory System Agents|sensory system agents|mesh-ancestor
111301199|NCT02096575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111301200|NCT04338984|Fentanyl|fentanyl|mesh-list
111301201|NCT04338984|Ropivacaine|ropivacaine|mesh-list
111301202|NCT04338984|Anesthetics|anesthetics|mesh-list
111301203|NCT04338984|Anesthetics, General|anesthetics, general|mesh-list
111301204|NCT04338984|Anesthetics, Local|anesthetics, local|mesh-ancestor
111301205|NCT04338984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111301206|NCT04338984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111301207|NCT04338984|Sensory System Agents|sensory system agents|mesh-ancestor
111301208|NCT04338984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111301209|NCT04338984|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111301210|NCT04338984|Narcotics|narcotics|mesh-ancestor
111301211|NCT04338984|Analgesics|analgesics|mesh-ancestor
111301212|NCT04338984|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111301213|NCT04338984|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111301214|NCT00095563|Lapatinib|lapatinib|mesh-list
111301215|NCT00095563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111301216|NCT00095563|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111301217|NCT00095563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111301218|NCT00095563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111301219|NCT05473806|Pioglitazone|pioglitazone|mesh-list
111301220|NCT05473806|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111301221|NCT05473806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111301222|NCT00089609|Thalidomide|thalidomide|mesh-list
111301223|NCT00089609|Prednisone|prednisone|mesh-list
111301224|NCT00089609|Bevacizumab|bevacizumab|mesh-list
111301225|NCT00089609|Docetaxel|docetaxel|mesh-list
111301226|NCT00089609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111301227|NCT00089609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111301228|NCT00089609|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111301229|NCT00089609|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111301230|NCT00089609|Growth Substances|growth substances|mesh-ancestor
111301231|NCT00089609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111301232|NCT00089609|Growth Inhibitors|growth inhibitors|mesh-ancestor
111301233|NCT00089609|Tubulin Modulators|tubulin modulators|mesh-ancestor
111301234|NCT00089609|Antimitotic Agents|antimitotic agents|mesh-ancestor
111301235|NCT00089609|Mitosis Modulators|mitosis modulators|mesh-ancestor
111301236|NCT00089609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111301237|NCT00089609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111301238|NCT00089609|Glucocorticoids|glucocorticoids|mesh-ancestor
111301239|NCT00089609|Hormones|hormones|mesh-ancestor
111301240|NCT00089609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111301241|NCT00089609|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111301242|NCT00089609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111301243|NCT00089609|Immunologic Factors|immunologic factors|mesh-ancestor
111301244|NCT00089609|Leprostatic Agents|leprostatic agents|mesh-ancestor
111301245|NCT00089609|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111301246|NCT00089609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111301247|NCT04661514|Psilocybin|psilocybin|mesh-list
111301248|NCT04661514|Hallucinogens|hallucinogens|mesh-ancestor
111301249|NCT04661514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111301250|NCT04661514|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111301251|NCT00195403|Etanercept|etanercept|mesh-list
111301252|NCT00195403|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111301253|NCT00195403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111301254|NCT00195403|Analgesics|analgesics|mesh-ancestor
111301255|NCT00195403|Sensory System Agents|sensory system agents|mesh-ancestor
111301256|NCT00195403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111301257|NCT00195403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111301258|NCT00195403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111301259|NCT00195403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111301260|NCT00195403|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111301261|NCT00195403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111301262|NCT00195403|Immunologic Factors|immunologic factors|mesh-ancestor
111301263|NCT04643327|Levetiracetam|levetiracetam|mesh-list
111301264|NCT04643327|Anticonvulsants|anticonvulsants|mesh-ancestor
111301265|NCT04643327|Nootropic Agents|nootropic agents|mesh-ancestor
111301266|NCT00095875|Carboplatin|carboplatin|mesh-list
111301267|NCT00095875|Docetaxel|docetaxel|mesh-list
111301268|NCT00095875|Fluorouracil|fluorouracil|mesh-list
111301269|NCT00095875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111301270|NCT00095875|Tubulin Modulators|tubulin modulators|mesh-ancestor
111301271|NCT00095875|Antimitotic Agents|antimitotic agents|mesh-ancestor
111301272|NCT00095875|Mitosis Modulators|mitosis modulators|mesh-ancestor
111301273|NCT00095875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111301274|NCT00095875|Antimetabolites|antimetabolites|mesh-ancestor
111301275|NCT00095875|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111301276|NCT00095875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111301277|NCT00095875|Immunologic Factors|immunologic factors|mesh-ancestor
111301278|NCT00095875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111301279|NCT03086993|Gemcitabine|gemcitabine|mesh-list
111301280|NCT03086993|Melphalan|melphalan|mesh-list
111301281|NCT03086993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111301282|NCT03086993|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111301283|NCT03086993|Antimetabolites|antimetabolites|mesh-ancestor
111301284|NCT03086993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111301285|NCT03086993|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111301286|NCT03086993|Alkylating Agents|alkylating agents|mesh-ancestor
111301287|NCT03086993|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111301288|NCT03086993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111301289|NCT03086993|Immunologic Factors|immunologic factors|mesh-ancestor
111301290|NCT03086993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111301291|NCT04089072|Phenylephrine|phenylephrine|mesh-list
111301292|NCT04089072|Oxymetazoline|oxymetazoline|mesh-list
111301293|NCT04089072|Methylene Blue|methylene blue|mesh-list
111301294|NCT04089072|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111301295|NCT04089072|Mydriatics|mydriatics|mesh-ancestor
111301296|NCT04089072|Autonomic Agents|autonomic agents|mesh-ancestor
111301297|NCT04089072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111301298|NCT04089072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111301299|NCT04089072|Sympathomimetics|sympathomimetics|mesh-ancestor
111301300|NCT04089072|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111301301|NCT04089072|Nasal Decongestants|nasal decongestants|mesh-ancestor
111301302|NCT04089072|Respiratory System Agents|respiratory system agents|mesh-ancestor
111301303|NCT04089072|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111301304|NCT04089072|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111301305|NCT04089072|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111301306|NCT04089072|Adrenergic Agents|adrenergic agents|mesh-ancestor
111301307|NCT04089072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111301308|NCT04089072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111301309|NCT04089072|Protective Agents|protective agents|mesh-ancestor
111301310|NCT04089072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111301311|NCT00006227|Paclitaxel|paclitaxel|mesh-list
111301312|NCT00006227|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111301313|NCT00006227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111301314|NCT00006227|Tubulin Modulators|tubulin modulators|mesh-ancestor
111301315|NCT00006227|Antimitotic Agents|antimitotic agents|mesh-ancestor
111301316|NCT00006227|Mitosis Modulators|mitosis modulators|mesh-ancestor
111301317|NCT00006227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111301318|NCT00097669|Folic Acid|folic acid|mesh-list
111301319|NCT00097669|Hematinics|hematinics|mesh-ancestor
111301320|NCT00097669|Vitamin B Complex|vitamin b complex|mesh-ancestor
111301321|NCT00097669|Vitamins|vitamins|mesh-ancestor
111301322|NCT00097669|Micronutrients|micronutrients|mesh-ancestor
111301323|NCT00097669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111301324|NCT05612880|Androgens|androgens|mesh-list
111301325|NCT05612880|Hormones|hormones|mesh-ancestor
111301326|NCT05612880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111301327|NCT05612880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111301328|NCT00010439|Alendronate|alendronate|mesh-list
111301329|NCT00010439|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111301330|NCT00010439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111301331|NCT05468892|Trifluridine|trifluridine|mesh-list
111301332|NCT05468892|Panitumumab|panitumumab|mesh-list
111301333|NCT05468892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111301334|NCT05468892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111301335|NCT05468892|Antimetabolites|antimetabolites|mesh-ancestor
111301336|NCT05468892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111301337|NCT05468892|Antiviral Agents|antiviral agents|mesh-ancestor
111301338|NCT05468892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111301339|NCT00200161|Temozolomide|temozolomide|mesh-list
111301340|NCT00200161|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111301341|NCT00200161|Alkylating Agents|alkylating agents|mesh-ancestor
111301342|NCT00200161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111301343|NCT00200161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111301344|NCT00016913|Paclitaxel|paclitaxel|mesh-list
111301345|NCT00016913|Carboplatin|carboplatin|mesh-list
111301346|NCT00016913|Leuprolide|leuprolide|mesh-list
111301347|NCT00016913|Goserelin|goserelin|mesh-list
111301348|NCT00016913|Estramustine|estramustine|mesh-list
111301349|NCT00016913|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111301350|NCT00016913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111301351|NCT00016913|Tubulin Modulators|tubulin modulators|mesh-ancestor
111301352|NCT00016913|Antimitotic Agents|antimitotic agents|mesh-ancestor
111301353|NCT00016913|Mitosis Modulators|mitosis modulators|mesh-ancestor
111301354|NCT00016913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111301355|NCT00016913|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111301356|NCT00016913|Fertility Agents|fertility agents|mesh-ancestor
111301357|NCT00016913|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111301358|NCT00016913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111301359|NCT00016913|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111301360|NCT00016913|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111301361|NCT00016913|Alkylating Agents|alkylating agents|mesh-ancestor
111301362|NCT00023309|Lamivudine|lamivudine|mesh-list
111301363|NCT00023309|Adefovir|adefovir|mesh-list
111301364|NCT00023309|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
111301365|NCT00023309|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111301366|NCT00023309|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111301367|NCT00023309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111301368|NCT00023309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111301369|NCT00023309|Antiviral Agents|antiviral agents|mesh-ancestor
111301370|NCT00023309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111301371|NCT00023309|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111301372|NCT00023309|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111301373|NCT02233101|Tranexamic Acid|tranexamic acid|mesh-list
111301374|NCT02233101|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111301375|NCT02233101|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111301376|NCT02233101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111301377|NCT02233101|Hemostatics|hemostatics|mesh-ancestor
111301378|NCT02233101|Coagulants|coagulants|mesh-ancestor
111301379|NCT00098059|Famciclovir|famciclovir|mesh-list
111301380|NCT00098059|Antiviral Agents|antiviral agents|mesh-ancestor
111301381|NCT00098059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111301382|NCT00098059|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111301383|NCT00098059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111301384|NCT00098059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111301385|NCT02440581|Alendronate|alendronate|mesh-list
111301386|NCT02440581|Teriparatide|teriparatide|mesh-list
111301387|NCT02440581|Cinacalcet|cinacalcet|mesh-list
111301388|NCT02440581|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111301389|NCT02440581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111301390|NCT02440581|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111301391|NCT02440581|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
111301392|NCT02440581|Hormone Antagonists|hormone antagonists|mesh-ancestor
111301393|NCT02440581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111301394|NCT01359150|Tofacitinib|tofacitinib|mesh-list
111301395|NCT01359150|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
111301396|NCT01359150|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111301397|NCT01359150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111301398|NCT01359150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111301399|NCT00098371|Alvocidib|alvocidib|mesh-list
111301400|NCT00098371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111301401|NCT00098371|Growth Inhibitors|growth inhibitors|mesh-ancestor
111301402|NCT00098371|Growth Substances|growth substances|mesh-ancestor
111301403|NCT00098371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111301404|NCT00098371|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111301405|NCT00098371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111301406|NCT00098371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111301407|NCT04745988|Leucovorin|leucovorin|mesh-list
111301408|NCT04745988|Docetaxel|docetaxel|mesh-list
111301409|NCT04745988|Pembrolizumab|pembrolizumab|mesh-list
111301410|NCT04745988|Fluorouracil|fluorouracil|mesh-list
111301411|NCT04745988|Oxaliplatin|oxaliplatin|mesh-list
111301412|NCT04745988|Lenvatinib|lenvatinib|mesh-list
111301413|NCT04745988|Levoleucovorin|levoleucovorin|mesh-list
111301414|NCT04745988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111301415|NCT04745988|Tubulin Modulators|tubulin modulators|mesh-ancestor
111301416|NCT04745988|Antimitotic Agents|antimitotic agents|mesh-ancestor
111301417|NCT04745988|Mitosis Modulators|mitosis modulators|mesh-ancestor
111301418|NCT04745988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111301419|NCT04745988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111301420|NCT04745988|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111301421|NCT04745988|Antimetabolites|antimetabolites|mesh-ancestor
111301422|NCT04745988|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111301423|NCT04745988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111301424|NCT04745988|Immunologic Factors|immunologic factors|mesh-ancestor
111301425|NCT04745988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111301426|NCT04745988|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111301427|NCT04745988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111301428|NCT04745988|Antidotes|antidotes|mesh-ancestor
111301429|NCT04745988|Protective Agents|protective agents|mesh-ancestor
111301430|NCT04745988|Vitamin B Complex|vitamin b complex|mesh-ancestor
111301431|NCT04745988|Vitamins|vitamins|mesh-ancestor
111301432|NCT04745988|Micronutrients|micronutrients|mesh-ancestor
111301433|NCT01647945|Tacrolimus|tacrolimus|mesh-list
111301434|NCT01647945|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111301435|NCT01647945|Immunologic Factors|immunologic factors|mesh-ancestor
111301436|NCT01647945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111301437|NCT01647945|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111301438|NCT01647945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111301439|NCT01647945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111301440|NCT00100165|3-(2,4-dimethoxybenzylidene)anabaseine|3-(2,4-dimethoxybenzylidene)anabaseine|mesh-list
111301441|NCT00100165|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111301442|NCT00100165|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111301443|NCT00100165|Cholinergic Agents|cholinergic agents|mesh-ancestor
111301444|NCT00100165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111301445|NCT00100165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111301446|NCT00100165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111301447|NCT04351191|Hydroxychloroquine|hydroxychloroquine|mesh-list
111301448|NCT04351191|Chloroquine|chloroquine|mesh-list
111301449|NCT04351191|Antimalarials|antimalarials|mesh-ancestor
111301450|NCT04351191|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111301451|NCT04351191|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111301452|NCT04351191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111301453|NCT04351191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111301454|NCT04351191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111301455|NCT04351191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111301456|NCT04351191|Amebicides|amebicides|mesh-ancestor
111301457|NCT01469000|Pemetrexed|pemetrexed|mesh-list
111301458|NCT01469000|Gefitinib|gefitinib|mesh-list
111301459|NCT01469000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111301460|NCT01469000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111301461|NCT01469000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111301462|NCT01469000|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111301463|NCT01469000|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111301464|NCT01469000|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111301465|NCT00201877|Rituximab|rituximab|mesh-list
111301466|NCT00201877|Bortezomib|bortezomib|mesh-list
111301467|NCT00201877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111301468|NCT00201877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111301469|NCT00201877|Immunologic Factors|immunologic factors|mesh-ancestor
111301470|NCT00201877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111301471|NCT00201877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111301472|NCT05399628|Pulmonary Surfactants|pulmonary surfactants|mesh-list
111301473|NCT05399628|Respiratory System Agents|respiratory system agents|mesh-ancestor
111301474|NCT01490060|Dexamethasone|dexamethasone|mesh-list
111301475|NCT01490060|Dexamethasone acetate|dexamethasone acetate|mesh-list
111301476|NCT01490060|Doxorubicin|doxorubicin|mesh-list
111301477|NCT01490060|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111301478|NCT01490060|Vincristine|vincristine|mesh-list
111301479|NCT01490060|Ifosfamide|ifosfamide|mesh-list
111301480|NCT01490060|Isophosphamide mustard|isophosphamide mustard|mesh-list
111301481|NCT01490060|Fosaprepitant|fosaprepitant|mesh-list
111301482|NCT01490060|Aprepitant|aprepitant|mesh-list
111301483|NCT01490060|BB 1101|bb 1101|mesh-list
111301484|NCT01490060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111301485|NCT01490060|Antiemetics|antiemetics|mesh-ancestor
111301486|NCT01490060|Autonomic Agents|autonomic agents|mesh-ancestor
111301487|NCT01490060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111301488|NCT01490060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111301489|NCT01490060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111301490|NCT01490060|Glucocorticoids|glucocorticoids|mesh-ancestor
111301491|NCT01490060|Hormones|hormones|mesh-ancestor
111301492|NCT01490060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111301493|NCT01490060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111301494|NCT01490060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111301495|NCT01490060|Protease Inhibitors|protease inhibitors|mesh-ancestor
111301496|NCT01490060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111301497|NCT01490060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111301498|NCT01490060|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111301499|NCT01490060|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111301500|NCT01490060|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111301501|NCT01490060|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111301502|NCT01490060|Tubulin Modulators|tubulin modulators|mesh-ancestor
111301503|NCT01490060|Antimitotic Agents|antimitotic agents|mesh-ancestor
111301504|NCT01490060|Mitosis Modulators|mitosis modulators|mesh-ancestor
111301505|NCT01490060|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111301506|NCT01490060|Alkylating Agents|alkylating agents|mesh-ancestor
111301507|NCT01490060|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
111301508|NCT01490060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111301509|NCT04090736|Azacitidine|azacitidine|mesh-list
111301510|NCT04090736|Pevonedistat|pevonedistat|mesh-list
111301511|NCT04090736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111301512|NCT04090736|Antimetabolites|antimetabolites|mesh-ancestor
111301513|NCT04090736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111301514|NCT04090736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111301515|NCT04090736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111301516|NCT05557344|Acetaminophen|acetaminophen|mesh-list
111301517|NCT05557344|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111301518|NCT05557344|Analgesics|analgesics|mesh-ancestor
111301519|NCT05557344|Sensory System Agents|sensory system agents|mesh-ancestor
111301520|NCT05557344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111301521|NCT05557344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111301522|NCT05557344|Antipyretics|antipyretics|mesh-ancestor
111301523|NCT00101413|Sorafenib|sorafenib|mesh-list
111301524|NCT00101413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111301525|NCT00101413|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111301526|NCT00101413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111301527|NCT00101413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111301528|NCT01246869|Deoxyglucose|deoxyglucose|mesh-list
111301529|NCT01246869|Imidazole|imidazole|mesh-list
111301530|NCT01246869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111301531|NCT01246869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111301532|NCT01246869|Antimetabolites|antimetabolites|mesh-ancestor
111301533|NCT01246869|Antiviral Agents|antiviral agents|mesh-ancestor
111301534|NCT01246869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111301535|NCT01452152|Clopidogrel|clopidogrel|mesh-list
111301536|NCT01452152|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
111301537|NCT01452152|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111301538|NCT01452152|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111301539|NCT01452152|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111301540|NCT01452152|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111301541|NCT01452152|Purinergic Agents|purinergic agents|mesh-ancestor
111301542|NCT01452152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111301543|NCT01452152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111301544|NCT01452152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111301545|NCT01451762|Diphenhydramine|diphenhydramine|mesh-list
111301546|NCT01451762|Promethazine|promethazine|mesh-list
111301547|NCT01451762|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111301548|NCT01451762|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111301549|NCT01451762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111301550|NCT01451762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111301551|NCT01451762|Anesthetics, Local|anesthetics, local|mesh-ancestor
111301552|NCT01451762|Anesthetics|anesthetics|mesh-ancestor
111301553|NCT01451762|Sensory System Agents|sensory system agents|mesh-ancestor
111301554|NCT01451762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111301555|NCT01451762|Antiemetics|antiemetics|mesh-ancestor
111301556|NCT01451762|Autonomic Agents|autonomic agents|mesh-ancestor
111301557|NCT01451762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111301558|NCT01451762|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111301559|NCT01451762|Histamine Antagonists|histamine antagonists|mesh-ancestor
111301560|NCT01451762|Histamine Agents|histamine agents|mesh-ancestor
111301561|NCT01451762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111301562|NCT01451762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111301563|NCT01451762|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111301564|NCT01451762|Antipruritics|antipruritics|mesh-ancestor
111301565|NCT01451762|Dermatologic Agents|dermatologic agents|mesh-ancestor
111301566|NCT01654107|Nicotine|nicotine|mesh-list
111301567|NCT01654107|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111301568|NCT01654107|Autonomic Agents|autonomic agents|mesh-ancestor
111301569|NCT01654107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111301570|NCT01654107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111301571|NCT01654107|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111301572|NCT01654107|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111301573|NCT01654107|Cholinergic Agents|cholinergic agents|mesh-ancestor
111301574|NCT01654107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111301575|NCT01654107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111301576|NCT03085680|Curcumin|curcumin|mesh-list
111301577|NCT03085680|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111301578|NCT03085680|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111301579|NCT03085680|Analgesics|analgesics|mesh-ancestor
111301580|NCT03085680|Sensory System Agents|sensory system agents|mesh-ancestor
111301581|NCT03085680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111301582|NCT03085680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111301583|NCT03085680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111301584|NCT03085680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111301585|NCT03085680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111301586|NCT03085680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111301587|NCT03085680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111301588|NCT01468844|Minocycline|minocycline|mesh-list
111301589|NCT01468844|Bevacizumab|bevacizumab|mesh-list
111301590|NCT01468844|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111301591|NCT01468844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111301592|NCT01468844|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111301593|NCT01468844|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111301594|NCT01468844|Growth Substances|growth substances|mesh-ancestor
111301595|NCT01468844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111301596|NCT01468844|Growth Inhibitors|growth inhibitors|mesh-ancestor
111301597|NCT01468844|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111301598|NCT01468844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111301599|NCT03029598|Carboplatin|carboplatin|mesh-list
111301600|NCT03029598|Pembrolizumab|pembrolizumab|mesh-list
111301601|NCT03029598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111301602|NCT03029598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111301603|NCT03029598|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111301604|NCT03029598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111301605|NCT01451606|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
111301606|NCT01451606|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111301607|NCT01451606|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111301608|NCT01451606|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111301609|NCT01451606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111301610|NCT01451606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111301611|NCT01451606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111301612|NCT01451606|Analgesics|analgesics|mesh-ancestor
111301613|NCT01451606|Sensory System Agents|sensory system agents|mesh-ancestor
111301614|NCT01451606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111301615|NCT01451606|Antidepressive Agents|antidepressive agents|mesh-ancestor
111301616|NCT01451606|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111301617|NCT01451606|Dopamine Agents|dopamine agents|mesh-ancestor
111301618|NCT00204373|Lansoprazole|lansoprazole|mesh-list
111301619|NCT00204373|Dexlansoprazole|dexlansoprazole|mesh-list
111301620|NCT00204373|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111301621|NCT00204373|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111301622|NCT00204373|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111301623|NCT00204373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111301624|NCT00204373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111301625|NCT01655043|Regadenoson|regadenoson|mesh-list
111301626|NCT01655043|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
111301627|NCT01655043|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
111301628|NCT01655043|Purinergic Agonists|purinergic agonists|mesh-ancestor
111301629|NCT01655043|Purinergic Agents|purinergic agents|mesh-ancestor
111301630|NCT01655043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111301631|NCT01655043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111301632|NCT01655043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111301633|NCT00473343|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
111301634|NCT00473343|Aminolevulinic Acid|aminolevulinic acid|mesh-list
111301635|NCT00473343|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111301636|NCT00473343|Dermatologic Agents|dermatologic agents|mesh-ancestor
111301637|NCT00032591|Thrombin|thrombin|mesh-list
111301638|NCT00032591|Hemostatics|hemostatics|mesh-ancestor
111301639|NCT00032591|Coagulants|coagulants|mesh-ancestor
111301640|NCT01660191|Atorvastatin|atorvastatin|mesh-list
111301641|NCT01660191|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111301642|NCT01660191|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111301643|NCT01660191|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111301644|NCT01660191|Antimetabolites|antimetabolites|mesh-ancestor
111301645|NCT01660191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111301646|NCT01660191|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111301647|NCT01660191|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111301648|NCT01660191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111301649|NCT00033917|Indomethacin|indomethacin|mesh-list
111301650|NCT00033917|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111301651|NCT00033917|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111301652|NCT00033917|Analgesics|analgesics|mesh-ancestor
111301653|NCT00033917|Sensory System Agents|sensory system agents|mesh-ancestor
111301654|NCT00033917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111301655|NCT00033917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111301656|NCT00033917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111301657|NCT00033917|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111301658|NCT00033917|Gout Suppressants|gout suppressants|mesh-ancestor
111301659|NCT00033917|Tocolytic Agents|tocolytic agents|mesh-ancestor
111301660|NCT00033917|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111301661|NCT00033917|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111301662|NCT00033917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111301663|NCT00033917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111301664|NCT00036569|Interferons|interferons|mesh-list
111301665|NCT00036569|Interferon-alpha|interferon-alpha|mesh-list
111301666|NCT00036569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111301667|NCT00036569|Antiviral Agents|antiviral agents|mesh-ancestor
110959201|NCT01025505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111301668|NCT00036569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111301669|NCT00036569|Immunologic Factors|immunologic factors|mesh-ancestor
111301670|NCT00036569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111301671|NCT01660893|Phenylephrine|phenylephrine|mesh-list
111301672|NCT01660893|Oxymetazoline|oxymetazoline|mesh-list
111301674|NCT01660893|Anesthetics, Local|anesthetics, local|mesh-ancestor
111301675|NCT01660893|Anesthetics|anesthetics|mesh-ancestor
111301676|NCT01660893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111301677|NCT01660893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111301678|NCT01660893|Sensory System Agents|sensory system agents|mesh-ancestor
111301679|NCT01660893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111301680|NCT01660893|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111301681|NCT01660893|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111301682|NCT01660893|Adrenergic Agents|adrenergic agents|mesh-ancestor
111301683|NCT01660893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111301684|NCT01660893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111301685|NCT01660893|Sympathomimetics|sympathomimetics|mesh-ancestor
111301686|NCT01660893|Autonomic Agents|autonomic agents|mesh-ancestor
111301687|NCT01660893|Nasal Decongestants|nasal decongestants|mesh-ancestor
111301688|NCT01660893|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111301689|NCT01660893|Respiratory System Agents|respiratory system agents|mesh-ancestor
111301690|NCT01660893|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111301691|NCT01660893|Mydriatics|mydriatics|mesh-ancestor
111301692|NCT01660893|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111301693|NCT01660893|Protective Agents|protective agents|mesh-ancestor
111301694|NCT01661283|Bevacizumab|bevacizumab|mesh-list
111301695|NCT01661283|Everolimus|everolimus|mesh-list
111301696|NCT01661283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111301697|NCT01661283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111301698|NCT01661283|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111301699|NCT01661283|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111301700|NCT01661283|Growth Substances|growth substances|mesh-ancestor
111301701|NCT01661283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111301702|NCT01661283|Growth Inhibitors|growth inhibitors|mesh-ancestor
111301703|NCT01661283|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111301704|NCT01661283|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111301705|NCT01661283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111301706|NCT01661283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111301707|NCT01661283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111301708|NCT01661283|Immunologic Factors|immunologic factors|mesh-ancestor
111301709|NCT01946373|Cyclophosphamide|cyclophosphamide|mesh-list
111301710|NCT01946373|Fludarabine|fludarabine|mesh-list
111301711|NCT01946373|Fludarabine phosphate|fludarabine phosphate|mesh-list
111301712|NCT01946373|Interleukin-2|interleukin-2|mesh-list
111301713|NCT01946373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111301714|NCT01946373|Immunologic Factors|immunologic factors|mesh-ancestor
111301715|NCT01946373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111301716|NCT01946373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111301717|NCT01946373|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111301718|NCT01946373|Alkylating Agents|alkylating agents|mesh-ancestor
111301719|NCT01946373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111301720|NCT01946373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111301721|NCT01946373|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111301722|NCT01946373|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111301723|NCT01946373|Antimetabolites|antimetabolites|mesh-ancestor
111301724|NCT01946373|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111301725|NCT01946373|Analgesics|analgesics|mesh-ancestor
111301726|NCT01946373|Sensory System Agents|sensory system agents|mesh-ancestor
111301727|NCT01946373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111301728|NCT01662297|Quetiapine Fumarate|quetiapine fumarate|mesh-list
111301729|NCT01662297|Trazodone|trazodone|mesh-list
111301730|NCT01662297|Antidepressive Agents|antidepressive agents|mesh-ancestor
111301731|NCT01662297|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111301732|NCT01662297|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111301733|NCT01662297|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111301734|NCT01662297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111301735|NCT01662297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111301736|NCT01662297|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111301737|NCT01662297|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111301738|NCT01662297|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111301739|NCT01662297|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111301740|NCT01662297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111301741|NCT01662297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111026163|NCT02064881|Metformin|metformin|mesh-list
111301743|NCT01662297|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111301744|NCT01600287|Propofol|propofol|mesh-list
111301745|NCT01600287|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111301746|NCT01600287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111301747|NCT01600287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111301748|NCT01600287|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111301749|NCT01600287|Anesthetics, General|anesthetics, general|mesh-ancestor
111301750|NCT01600287|Anesthetics|anesthetics|mesh-ancestor
111301751|NCT00040937|Thalidomide|thalidomide|mesh-list
111301752|NCT00040937|Dexamethasone|dexamethasone|mesh-list
111301753|NCT00040937|Prednisone|prednisone|mesh-list
111301754|NCT00040937|Cyclophosphamide|cyclophosphamide|mesh-list
111301755|NCT00040937|Melphalan|melphalan|mesh-list
111301756|NCT00040937|Sargramostim|sargramostim|mesh-list
111301757|NCT00040937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111301758|NCT00040937|Immunologic Factors|immunologic factors|mesh-ancestor
111301759|NCT00040937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111301760|NCT00040937|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111301761|NCT00040937|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111301762|NCT00040937|Alkylating Agents|alkylating agents|mesh-ancestor
111301763|NCT00040937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111301764|NCT00040937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111301765|NCT00040937|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111301766|NCT00040937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111301767|NCT00040937|Antiemetics|antiemetics|mesh-ancestor
111301768|NCT00040937|Autonomic Agents|autonomic agents|mesh-ancestor
110979786|NCT03228992|Analgesics|analgesics|mesh-ancestor
111301769|NCT00040937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111301770|NCT00040937|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111301771|NCT00040937|Glucocorticoids|glucocorticoids|mesh-ancestor
111301772|NCT00040937|Hormones|hormones|mesh-ancestor
111301773|NCT00040937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111301774|NCT00040937|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111301775|NCT00040937|Leprostatic Agents|leprostatic agents|mesh-ancestor
111301776|NCT00040937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111301777|NCT00040937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111301778|NCT00040937|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111301779|NCT00040937|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111301780|NCT00040937|Growth Substances|growth substances|mesh-ancestor
111301781|NCT00040937|Growth Inhibitors|growth inhibitors|mesh-ancestor
111301782|NCT04756895|Vancomycin|vancomycin|mesh-list
111301783|NCT04756895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111301784|NCT04756895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111301785|NCT02234115|Leuprolide|leuprolide|mesh-list
111301786|NCT02234115|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111301787|NCT02234115|Fertility Agents|fertility agents|mesh-ancestor
111301788|NCT02234115|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111301789|NCT02234115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111301790|NCT02234115|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111301791|NCT02234115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111301792|NCT02234427|Aspirin|aspirin|mesh-list
111301793|NCT02234427|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111301794|NCT02234427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111301795|NCT02234427|Analgesics|analgesics|mesh-ancestor
111301796|NCT02234427|Sensory System Agents|sensory system agents|mesh-ancestor
111301797|NCT02234427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111301798|NCT02234427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111301799|NCT02234427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111301800|NCT02234427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111301801|NCT02234427|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111301802|NCT02234427|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111301803|NCT02234427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111301804|NCT02234427|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111301805|NCT02234427|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111301806|NCT02234427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111301807|NCT02234427|Antipyretics|antipyretics|mesh-ancestor
111301808|NCT00041717|4-Aminopyridine|4-aminopyridine|mesh-list
111301809|NCT00041717|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
111301810|NCT00041717|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111301811|NCT00041717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111301812|NCT01663935|Levodopa|levodopa|mesh-list
111301813|NCT01663935|Carbidopa|carbidopa|mesh-list
111301814|NCT01663935|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111301815|NCT01663935|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111301816|NCT01663935|Dopamine Agents|dopamine agents|mesh-ancestor
111301817|NCT01663935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111301818|NCT01663935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111301819|NCT01663935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111301820|NCT01663935|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
111301821|NCT01663935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111301822|NCT01664559|Ketorolac|ketorolac|mesh-list
111301823|NCT01664559|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111301824|NCT01664559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111301825|NCT01664559|Analgesics|analgesics|mesh-ancestor
111301826|NCT01664559|Sensory System Agents|sensory system agents|mesh-ancestor
111301827|NCT01664559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111301828|NCT01664559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111301829|NCT01664559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111301830|NCT01664559|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111301831|NCT01664559|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111301832|NCT01664559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111301833|NCT01664559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111301834|NCT00046475|Midodrine|midodrine|mesh-list
111301835|NCT00046475|Sympathomimetics|sympathomimetics|mesh-ancestor
111301836|NCT00046475|Autonomic Agents|autonomic agents|mesh-ancestor
111301837|NCT00046475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111301838|NCT00046475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111301839|NCT00046475|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111301840|NCT00046475|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111301841|NCT00046475|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111301842|NCT00046475|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111301843|NCT00046475|Adrenergic Agents|adrenergic agents|mesh-ancestor
111301844|NCT00046475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111301845|NCT00046475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111301846|NCT01894685|Mesalamine|mesalamine|mesh-list
111301847|NCT01894685|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111301848|NCT01894685|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111301849|NCT01894685|Analgesics|analgesics|mesh-ancestor
111301850|NCT01894685|Sensory System Agents|sensory system agents|mesh-ancestor
111301851|NCT01894685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111301852|NCT01894685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111301853|NCT01894685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111301854|NCT01894685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111301855|NCT01695291|Minocycline|minocycline|mesh-list
111301856|NCT01695291|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111301857|NCT01695291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111301858|NCT00048737|Cyclophosphamide|cyclophosphamide|mesh-list
111301859|NCT00048737|Rituximab|rituximab|mesh-list
111301860|NCT00048737|Fludarabine|fludarabine|mesh-list
111301861|NCT00048737|Fludarabine phosphate|fludarabine phosphate|mesh-list
111301862|NCT00048737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111301863|NCT00048737|Immunologic Factors|immunologic factors|mesh-ancestor
111301864|NCT00048737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111301865|NCT00048737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111301866|NCT00048737|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111301867|NCT00048737|Alkylating Agents|alkylating agents|mesh-ancestor
111301868|NCT00048737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111301869|NCT00048737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111301870|NCT00048737|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111301871|NCT00048737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111301872|NCT00048737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111301873|NCT00048737|Antimetabolites|antimetabolites|mesh-ancestor
111301874|NCT01604109|6-chloro-2-(1-piperazinyl)pyrazine|6-chloro-2-(1-piperazinyl)pyrazine|mesh-list
111301875|NCT01604109|Caseins|caseins|mesh-list
111301876|NCT01604109|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111301877|NCT01604109|Serotonin Agents|serotonin agents|mesh-ancestor
111301878|NCT01604109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111301879|NCT01604109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111301880|NCT01604109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111301881|NCT01604109|Chelating Agents|chelating agents|mesh-ancestor
111301882|NCT01604109|Sequestering Agents|sequestering agents|mesh-ancestor
111301883|NCT01666197|Diclofenac|diclofenac|mesh-list
111301884|NCT01666197|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111301885|NCT01666197|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111301886|NCT01666197|Analgesics|analgesics|mesh-ancestor
111301887|NCT01666197|Sensory System Agents|sensory system agents|mesh-ancestor
111301888|NCT01666197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111301889|NCT01666197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111301890|NCT01666197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111301891|NCT01666197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111301892|NCT01666197|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111301893|NCT01666197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111301894|NCT01666197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111301895|NCT01697709|Quetiapine Fumarate|quetiapine fumarate|mesh-list
111301896|NCT01697709|Antidepressive Agents|antidepressive agents|mesh-ancestor
111301897|NCT01697709|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111301898|NCT01697709|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111301899|NCT01697709|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111301900|NCT01697709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111301901|NCT01697709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111301902|NCT00048815|Citalopram|citalopram|mesh-list
111301903|NCT00048815|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111301904|NCT00048815|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111301905|NCT00048815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111301906|NCT00048815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111301907|NCT00048815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111301908|NCT00048815|Serotonin Agents|serotonin agents|mesh-ancestor
111301909|NCT00048815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111301910|NCT00048815|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111301911|NCT00048815|Antidepressive Agents|antidepressive agents|mesh-ancestor
110754446|NCT01352650|Plerixafor|plerixafor|mesh-list
111301912|NCT00048815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111301913|NCT01605903|Acetaminophen|acetaminophen|mesh-list
111301914|NCT01605903|Ibuprofen|ibuprofen|mesh-list
111301915|NCT01605903|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111301916|NCT01605903|Analgesics|analgesics|mesh-ancestor
111301917|NCT01605903|Sensory System Agents|sensory system agents|mesh-ancestor
111301918|NCT01605903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111301919|NCT01605903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111301920|NCT01605903|Antipyretics|antipyretics|mesh-ancestor
111301921|NCT01605903|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111301922|NCT01605903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111301923|NCT01605903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111301924|NCT01605903|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111301925|NCT01605903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111301926|NCT01605903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111301927|NCT00048893|Metronidazole|metronidazole|mesh-list
111301928|NCT00048893|Paclitaxel|paclitaxel|mesh-list
111301929|NCT00048893|Cyclophosphamide|cyclophosphamide|mesh-list
111301930|NCT00048893|Doxorubicin|doxorubicin|mesh-list
111301931|NCT00048893|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111301932|NCT00048893|Fludarabine|fludarabine|mesh-list
111301933|NCT00048893|Fludarabine phosphate|fludarabine phosphate|mesh-list
111301934|NCT00048893|Vaccines|vaccines|mesh-list
111301935|NCT00048893|Sargramostim|sargramostim|mesh-list
111301936|NCT00048893|Immunologic Factors|immunologic factors|mesh-ancestor
111301937|NCT00048893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111301938|NCT00048893|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111301939|NCT00048893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111301940|NCT00048893|Tubulin Modulators|tubulin modulators|mesh-ancestor
111301941|NCT00048893|Antimitotic Agents|antimitotic agents|mesh-ancestor
111301942|NCT00048893|Mitosis Modulators|mitosis modulators|mesh-ancestor
111301943|NCT00048893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111301944|NCT00048893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111301945|NCT00048893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111301946|NCT00048893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111301947|NCT00048893|Alkylating Agents|alkylating agents|mesh-ancestor
111301948|NCT00048893|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111301949|NCT00048893|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111301950|NCT00048893|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111301951|NCT00048893|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111301952|NCT00048893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111301953|NCT00048893|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111301954|NCT00048893|Antimetabolites|antimetabolites|mesh-ancestor
111301955|NCT00048893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111301956|NCT00048893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111301957|NCT00048893|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111301958|NCT00048893|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111301959|NCT01607853|Calcitriol|calcitriol|mesh-list
111301960|NCT01607853|Betamethasone|betamethasone|mesh-list
111301961|NCT01607853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111301962|NCT01607853|Glucocorticoids|glucocorticoids|mesh-ancestor
111301963|NCT01607853|Hormones|hormones|mesh-ancestor
111301964|NCT01607853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111301965|NCT01607853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111301966|NCT01607853|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111301967|NCT01607853|Respiratory System Agents|respiratory system agents|mesh-ancestor
111301968|NCT01607853|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111301969|NCT01607853|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
111301970|NCT01607853|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111301971|NCT01607853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111301972|NCT01607853|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111301974|NCT01607853|Micronutrients|micronutrients|mesh-ancestor
111301975|NCT01607853|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111301976|NCT03089723|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111301977|NCT01700517|Anesthetics|anesthetics|mesh-list
111301978|NCT01700517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111301979|NCT01700517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111301980|NCT00101647|Dasatinib|dasatinib|mesh-list
111301981|NCT00101647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111301982|NCT00101647|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111301983|NCT00101647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111301984|NCT00101647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111301985|NCT01669785|Listerine|listerine|mesh-list
111301986|NCT01669785|Fluorides|fluorides|mesh-list
111301987|NCT01669785|Sodium Fluoride|sodium fluoride|mesh-list
111301988|NCT01669785|Cariostatic Agents|cariostatic agents|mesh-ancestor
111301989|NCT01669785|Protective Agents|protective agents|mesh-ancestor
111301990|NCT01669785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111301991|NCT01669785|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111301992|NCT01669785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111301993|NCT05327491|Sotorasib|sotorasib|mesh-list
111301994|NCT05327491|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111301995|NCT05327491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111301996|NCT05327491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111301997|NCT05327491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111301998|NCT03089645|Docetaxel|docetaxel|mesh-list
111301999|NCT03089645|Durvalumab|durvalumab|mesh-list
111302000|NCT03089645|Tremelimumab|tremelimumab|mesh-list
111302001|NCT03089645|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111302002|NCT03089645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111302003|NCT03089645|Tubulin Modulators|tubulin modulators|mesh-ancestor
111302004|NCT03089645|Antimitotic Agents|antimitotic agents|mesh-ancestor
111302005|NCT03089645|Mitosis Modulators|mitosis modulators|mesh-ancestor
111302006|NCT03089645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111302007|NCT03089645|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111302008|NCT03089645|Immunologic Factors|immunologic factors|mesh-ancestor
111302009|NCT03089645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111302010|NCT02587962|Pembrolizumab|pembrolizumab|mesh-list
111302011|NCT02587962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111302012|NCT02587962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111302013|NCT02587962|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111302014|NCT02587962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111302015|NCT01671423|Prednisone|prednisone|mesh-list
111302016|NCT01671423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111302017|NCT01671423|Glucocorticoids|glucocorticoids|mesh-ancestor
111302018|NCT01671423|Hormones|hormones|mesh-ancestor
111302019|NCT01671423|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111302020|NCT01671423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111302021|NCT01671423|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111302022|NCT01671423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111302023|NCT02092181|Mirabegron|mirabegron|mesh-list
111302024|NCT02092181|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
111302025|NCT02092181|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111302026|NCT02092181|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111302027|NCT02092181|Adrenergic Agents|adrenergic agents|mesh-ancestor
111302028|NCT02092181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111302029|NCT02092181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111302030|NCT02092181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111302031|NCT02092181|Urological Agents|urological agents|mesh-ancestor
111302032|NCT01672827|Flutemetamol|flutemetamol|mesh-list
111302033|NCT01672827|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111302034|NCT01672827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111302035|NCT01700907|Sevoflurane|sevoflurane|mesh-list
111302036|NCT01700907|Desflurane|desflurane|mesh-list
111302037|NCT01700907|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111302038|NCT01700907|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111302039|NCT01700907|Anesthetics, General|anesthetics, general|mesh-ancestor
111026444|NCT03060044|Glucocorticoids|glucocorticoids|mesh-ancestor
111302040|NCT01700907|Anesthetics|anesthetics|mesh-ancestor
111302041|NCT01700907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111302042|NCT01700907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111302044|NCT03089567|Fluorides|fluorides|mesh-list
111302045|NCT03089567|Sodium Fluoride|sodium fluoride|mesh-list
111302046|NCT03089567|Cariostatic Agents|cariostatic agents|mesh-ancestor
111302047|NCT03089567|Protective Agents|protective agents|mesh-ancestor
111302048|NCT03089567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111302049|NCT03089567|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111302050|NCT03089567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111302051|NCT03431987|Ethanol|ethanol|mesh-list
111302052|NCT03431987|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111302053|NCT03431987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111302054|NCT03431987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111302055|NCT03431987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111302056|NCT01612221|Acetylcysteine|acetylcysteine|mesh-list
111302057|NCT01612221|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111302058|NCT01612221|Antiviral Agents|antiviral agents|mesh-ancestor
111302059|NCT01612221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111302060|NCT01612221|Expectorants|expectorants|mesh-ancestor
111302061|NCT01612221|Respiratory System Agents|respiratory system agents|mesh-ancestor
111302062|NCT01612221|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111302063|NCT01612221|Antioxidants|antioxidants|mesh-ancestor
111302064|NCT01612221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111302065|NCT01612221|Protective Agents|protective agents|mesh-ancestor
111302066|NCT01612221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111302067|NCT01612221|Antidotes|antidotes|mesh-ancestor
111302068|NCT00105001|Mycophenolic Acid|mycophenolic acid|mesh-list
111302069|NCT00105001|Sirolimus|sirolimus|mesh-list
111302070|NCT00105001|Fludarabine|fludarabine|mesh-list
111302071|NCT00105001|Fludarabine phosphate|fludarabine phosphate|mesh-list
111302072|NCT00105001|Tacrolimus|tacrolimus|mesh-list
111302073|NCT00105001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111302074|NCT00105001|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111302075|NCT00105001|Antimetabolites|antimetabolites|mesh-ancestor
111302076|NCT00105001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111302077|NCT00105001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111302078|NCT00105001|Immunologic Factors|immunologic factors|mesh-ancestor
111302079|NCT00105001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111302080|NCT00105001|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111302081|NCT00105001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111302082|NCT00105001|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111302083|NCT00105001|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111302084|NCT00105001|Antitubercular Agents|antitubercular agents|mesh-ancestor
111302085|NCT00105001|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111302086|NCT00105001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111302087|NCT00105001|Antifungal Agents|antifungal agents|mesh-ancestor
111302088|NCT02642640|Melatonin|melatonin|mesh-list
111302089|NCT02642640|Antioxidants|antioxidants|mesh-ancestor
111302090|NCT02642640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111302091|NCT02642640|Protective Agents|protective agents|mesh-ancestor
111302092|NCT02642640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111302093|NCT02642640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111302094|NCT01701375|Palbociclib|palbociclib|mesh-list
111302095|NCT01701375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111302096|NCT01701375|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111302097|NCT01701375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111302098|NCT01701375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111302099|NCT05556408|Propofol|propofol|mesh-list
111302100|NCT05556408|Succinylcholine|succinylcholine|mesh-list
111302101|NCT05556408|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111302102|NCT05556408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111302103|NCT05556408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111302104|NCT05556408|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111302105|NCT05556408|Anesthetics, General|anesthetics, general|mesh-ancestor
111302106|NCT05556408|Anesthetics|anesthetics|mesh-ancestor
111302107|NCT05556408|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
111302108|NCT05556408|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
111302109|NCT05556408|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111302110|NCT05556408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111302111|NCT00054353|Cyclosporine|cyclosporine|mesh-list
111302112|NCT00054353|Mycophenolic Acid|mycophenolic acid|mesh-list
111302113|NCT00054353|Fludarabine|fludarabine|mesh-list
111302114|NCT00054353|Fludarabine phosphate|fludarabine phosphate|mesh-list
111302115|NCT00054353|Melphalan|melphalan|mesh-list
111302116|NCT00054353|Cyclosporins|cyclosporins|mesh-list
111302117|NCT00054353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111302118|NCT00054353|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111302119|NCT00054353|Antimetabolites|antimetabolites|mesh-ancestor
111302120|NCT00054353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111302121|NCT00054353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111302122|NCT00054353|Immunologic Factors|immunologic factors|mesh-ancestor
111302123|NCT00054353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111302124|NCT00054353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111302125|NCT00054353|Antifungal Agents|antifungal agents|mesh-ancestor
111302126|NCT00054353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111302127|NCT00054353|Dermatologic Agents|dermatologic agents|mesh-ancestor
111302128|NCT00054353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111302129|NCT00054353|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111302130|NCT00054353|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111302131|NCT00054353|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111302132|NCT00054353|Antitubercular Agents|antitubercular agents|mesh-ancestor
111302133|NCT00054353|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111302134|NCT00054353|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111302135|NCT00054353|Alkylating Agents|alkylating agents|mesh-ancestor
111302136|NCT00054353|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111302137|NCT00208975|Cyclophosphamide|cyclophosphamide|mesh-list
111302138|NCT00208975|Rituximab|rituximab|mesh-list
111302139|NCT00208975|Fludarabine|fludarabine|mesh-list
111302140|NCT00208975|Mitoxantrone|mitoxantrone|mesh-list
111302141|NCT00208975|Sargramostim|sargramostim|mesh-list
111302142|NCT00208975|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111302143|NCT00208975|Immunologic Factors|immunologic factors|mesh-ancestor
111302144|NCT00208975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111302145|NCT00208975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111302146|NCT00208975|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111302147|NCT00208975|Alkylating Agents|alkylating agents|mesh-ancestor
111302148|NCT00208975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111302149|NCT00208975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111302150|NCT00208975|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111302151|NCT00208975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111302152|NCT00208975|Analgesics|analgesics|mesh-ancestor
111302153|NCT00208975|Sensory System Agents|sensory system agents|mesh-ancestor
111302154|NCT00208975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111302155|NCT00208975|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111302156|NCT00208975|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111302157|NCT00208975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111302158|NCT01702233|Dexamethasone|dexamethasone|mesh-list
111302159|NCT01702233|Dexamethasone acetate|dexamethasone acetate|mesh-list
111302160|NCT01702233|BB 1101|bb 1101|mesh-list
111302161|NCT01702233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111302162|NCT01702233|Antiemetics|antiemetics|mesh-ancestor
111302163|NCT01702233|Autonomic Agents|autonomic agents|mesh-ancestor
111302164|NCT01702233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111302165|NCT01702233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111302166|NCT01702233|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111302167|NCT01702233|Glucocorticoids|glucocorticoids|mesh-ancestor
111302168|NCT01702233|Hormones|hormones|mesh-ancestor
111302169|NCT01702233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111302170|NCT01702233|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111302171|NCT01702233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111302172|NCT01702233|Protease Inhibitors|protease inhibitors|mesh-ancestor
111302173|NCT01702233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111302174|NCT01702233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111302175|NCT01852890|Ascorbic Acid|ascorbic acid|mesh-list
111302176|NCT01852890|Gemcitabine|gemcitabine|mesh-list
111302177|NCT01852890|Vitamins|vitamins|mesh-ancestor
111302178|NCT01852890|Micronutrients|micronutrients|mesh-ancestor
111302179|NCT01852890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111302180|NCT01852890|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111302181|NCT01852890|Antimetabolites|antimetabolites|mesh-ancestor
111302182|NCT01852890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111302183|NCT01852890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111302184|NCT01852890|Antioxidants|antioxidants|mesh-ancestor
111302185|NCT01852890|Protective Agents|protective agents|mesh-ancestor
111302186|NCT05555628|Salicylic Acid|salicylic acid|mesh-list
111302187|NCT05555628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111302188|NCT05555628|Antifungal Agents|antifungal agents|mesh-ancestor
111302189|NCT05555628|Keratolytic Agents|keratolytic agents|mesh-ancestor
111302190|NCT05555628|Dermatologic Agents|dermatologic agents|mesh-ancestor
111302191|NCT00217399|Sorafenib|sorafenib|mesh-list
111302192|NCT00217399|Anastrozole|anastrozole|mesh-list
111302193|NCT00217399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111302194|NCT00217399|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111302195|NCT00217399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111302196|NCT00217399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111302197|NCT00217399|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111302198|NCT00217399|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111302199|NCT00217399|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111302200|NCT00217399|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111302201|NCT00217399|Hormone Antagonists|hormone antagonists|mesh-ancestor
111302202|NCT00217399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111302203|NCT00217399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111302204|NCT04739670|Bevacizumab|bevacizumab|mesh-list
111302205|NCT04739670|Atezolizumab|atezolizumab|mesh-list
111302206|NCT04739670|Carboplatin|carboplatin|mesh-list
111302207|NCT04739670|Gemcitabine|gemcitabine|mesh-list
111302208|NCT04739670|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111302209|NCT04739670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111302210|NCT04739670|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111302211|NCT04739670|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111302212|NCT04739670|Growth Substances|growth substances|mesh-ancestor
111302213|NCT04739670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111302214|NCT04739670|Growth Inhibitors|growth inhibitors|mesh-ancestor
111302215|NCT04739670|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111302216|NCT04739670|Antimetabolites|antimetabolites|mesh-ancestor
111302217|NCT04739670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111302218|NCT04739670|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111302219|NCT05286619|Carboplatin|carboplatin|mesh-list
111302220|NCT05286619|Gemcitabine|gemcitabine|mesh-list
111302221|NCT05286619|Pembrolizumab|pembrolizumab|mesh-list
111302222|NCT05286619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111302223|NCT05286619|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111302224|NCT05286619|Antimetabolites|antimetabolites|mesh-ancestor
111302225|NCT05286619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111302226|NCT05286619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111302227|NCT05286619|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111302228|NCT04329624|Simendan|simendan|mesh-list
111302229|NCT04329624|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111302230|NCT04329624|Vasodilator Agents|vasodilator agents|mesh-ancestor
111302231|NCT04329624|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
111302232|NCT04329624|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111302233|NCT04329624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111302234|NCT04329624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111302235|NCT04329624|Protective Agents|protective agents|mesh-ancestor
111302236|NCT04329624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111302237|NCT00559182|Omeprazole|omeprazole|mesh-list
111302238|NCT00559182|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111302239|NCT00559182|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111302240|NCT00559182|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111302241|NCT00559182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111302242|NCT00559182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111302243|NCT00218023|Naltrexone|naltrexone|mesh-list
111302244|NCT00218023|Levodopa|levodopa|mesh-list
111302245|NCT00218023|Carbidopa|carbidopa|mesh-list
111302246|NCT00218023|Modafinil|modafinil|mesh-list
111302247|NCT00218023|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111302248|NCT00218023|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111302249|NCT00218023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111302250|NCT00218023|Sensory System Agents|sensory system agents|mesh-ancestor
111302251|NCT00218023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111302252|NCT00218023|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111302253|NCT00218023|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111302254|NCT00218023|Dopamine Agents|dopamine agents|mesh-ancestor
111302255|NCT00218023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111302256|NCT00218023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111302257|NCT00218023|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
111302258|NCT00218023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111302259|NCT00218023|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111302260|NCT00218023|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
111302261|NCT00218023|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111302262|NCT00218023|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111302263|NCT00054665|Prednisone|prednisone|mesh-list
111302264|NCT00054665|Cyclophosphamide|cyclophosphamide|mesh-list
111302265|NCT00054665|Doxorubicin|doxorubicin|mesh-list
111302266|NCT00054665|Etoposide|etoposide|mesh-list
111302267|NCT00054665|Vincristine|vincristine|mesh-list
111302268|NCT00054665|Bortezomib|bortezomib|mesh-list
111302269|NCT00054665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111302270|NCT00054665|Immunologic Factors|immunologic factors|mesh-ancestor
111302271|NCT00054665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111302272|NCT00054665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111302273|NCT00054665|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111302274|NCT00054665|Alkylating Agents|alkylating agents|mesh-ancestor
111302275|NCT00054665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111302276|NCT00054665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111302277|NCT00054665|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111302278|NCT00054665|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111302279|NCT00054665|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111302280|NCT00054665|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111302281|NCT00054665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111302282|NCT00054665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111302283|NCT00054665|Glucocorticoids|glucocorticoids|mesh-ancestor
111302284|NCT00054665|Hormones|hormones|mesh-ancestor
111302285|NCT00054665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111302286|NCT00054665|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111302287|NCT00054665|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111302288|NCT00054665|Tubulin Modulators|tubulin modulators|mesh-ancestor
111302289|NCT00054665|Antimitotic Agents|antimitotic agents|mesh-ancestor
111302290|NCT00054665|Mitosis Modulators|mitosis modulators|mesh-ancestor
111302291|NCT00476190|Cytarabine|cytarabine|mesh-list
111302292|NCT00476190|Dexamethasone|dexamethasone|mesh-list
111302293|NCT00476190|Hydrocortisone|hydrocortisone|mesh-list
111302294|NCT00476190|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
111302295|NCT00476190|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
111302296|NCT00476190|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
111302297|NCT00476190|Cyclophosphamide|cyclophosphamide|mesh-list
111302298|NCT00476190|Doxorubicin|doxorubicin|mesh-list
111302299|NCT00476190|Methotrexate|methotrexate|mesh-list
111302300|NCT00476190|Etoposide|etoposide|mesh-list
111302301|NCT00476190|Vincristine|vincristine|mesh-list
111302302|NCT00476190|Asparaginase|asparaginase|mesh-list
111302303|NCT00476190|Pegaspargase|pegaspargase|mesh-list
111302304|NCT00476190|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111302305|NCT00476190|Immunologic Factors|immunologic factors|mesh-ancestor
111302306|NCT00476190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111302307|NCT00476190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111302308|NCT00476190|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111302309|NCT00476190|Alkylating Agents|alkylating agents|mesh-ancestor
111302310|NCT00476190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111302311|NCT00476190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111302312|NCT00476190|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111302313|NCT00476190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111302314|NCT00476190|Antiemetics|antiemetics|mesh-ancestor
111302315|NCT00476190|Autonomic Agents|autonomic agents|mesh-ancestor
111302316|NCT00476190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111302317|NCT00476190|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111302318|NCT00476190|Glucocorticoids|glucocorticoids|mesh-ancestor
111302319|NCT00476190|Hormones|hormones|mesh-ancestor
111302320|NCT00476190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111302321|NCT00476190|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111302322|NCT00476190|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111302323|NCT00476190|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111302324|NCT00476190|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111302325|NCT00476190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111302326|NCT00476190|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111302327|NCT00476190|Abortifacient Agents|abortifacient agents|mesh-ancestor
111302328|NCT00476190|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111302329|NCT00476190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111302330|NCT00476190|Antimetabolites|antimetabolites|mesh-ancestor
111302331|NCT00476190|Dermatologic Agents|dermatologic agents|mesh-ancestor
111302332|NCT00476190|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111302333|NCT00476190|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111302334|NCT00476190|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111302335|NCT00476190|Antiviral Agents|antiviral agents|mesh-ancestor
111302336|NCT00476190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111302337|NCT00476190|Tubulin Modulators|tubulin modulators|mesh-ancestor
111302338|NCT00476190|Antimitotic Agents|antimitotic agents|mesh-ancestor
111302339|NCT00476190|Mitosis Modulators|mitosis modulators|mesh-ancestor
111302340|NCT00057551|Antidepressive Agents|antidepressive agents|mesh-list
111302341|NCT00057551|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111302342|NCT05555316|Lenvatinib|lenvatinib|mesh-list
111302343|NCT05555316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111302344|NCT05555316|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111302345|NCT05555316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111302346|NCT05555316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111302347|NCT00218491|Acetylcysteine|acetylcysteine|mesh-list
111302348|NCT00218491|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111302349|NCT00218491|Antiviral Agents|antiviral agents|mesh-ancestor
111302350|NCT00218491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111302351|NCT00218491|Expectorants|expectorants|mesh-ancestor
111302352|NCT00218491|Respiratory System Agents|respiratory system agents|mesh-ancestor
111302353|NCT00218491|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111302354|NCT00218491|Antioxidants|antioxidants|mesh-ancestor
111302355|NCT00218491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111302356|NCT00218491|Protective Agents|protective agents|mesh-ancestor
111302357|NCT00218491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111302358|NCT00218491|Antidotes|antidotes|mesh-ancestor
111302359|NCT05700864|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111302360|NCT05700864|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111302361|NCT00221299|Risedronic Acid|risedronic acid|mesh-list
111302362|NCT00221299|Hormones|hormones|mesh-list
111302363|NCT00221299|Parathyroid Hormone|parathyroid hormone|mesh-list
111302364|NCT00221299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111302365|NCT00221299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111302366|NCT00221299|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111302367|NCT00221299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111302368|NCT00221299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111302369|NCT00221299|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111302370|NCT00221299|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111302371|NCT05554848|Magnesium Sulfate|magnesium sulfate|mesh-list
111302372|NCT05554848|Dexmedetomidine|dexmedetomidine|mesh-list
111302373|NCT05554848|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111302374|NCT05554848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111302375|NCT05554848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111302376|NCT05554848|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111302377|NCT05554848|Analgesics|analgesics|mesh-ancestor
111302378|NCT05554848|Sensory System Agents|sensory system agents|mesh-ancestor
111302379|NCT05554848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111302380|NCT05554848|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111302381|NCT05554848|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111302382|NCT05554848|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111302383|NCT05554848|Adrenergic Agents|adrenergic agents|mesh-ancestor
111302384|NCT05554848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111302385|NCT05554848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111302386|NCT05554848|Anesthetics|anesthetics|mesh-ancestor
111302387|NCT05554848|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111302388|NCT05554848|Anticonvulsants|anticonvulsants|mesh-ancestor
111302389|NCT05554848|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111302390|NCT05554848|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111302391|NCT05554848|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111302392|NCT05554848|Tocolytic Agents|tocolytic agents|mesh-ancestor
111302393|NCT05554848|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111302394|NCT00057785|Fluorouracil|fluorouracil|mesh-list
111302395|NCT00057785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111302396|NCT00057785|Antimetabolites|antimetabolites|mesh-ancestor
111302397|NCT00057785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111302398|NCT00057785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111302399|NCT00057785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111302400|NCT00057785|Immunologic Factors|immunologic factors|mesh-ancestor
111302401|NCT00057785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111302402|NCT05554224|Liver Extracts|liver extracts|mesh-list
111302403|NCT05554224|Hematinics|hematinics|mesh-ancestor
111302404|NCT05548998|Anesthetics|anesthetics|mesh-list
111302405|NCT05548998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111302406|NCT05548998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111302407|NCT01666782|Vaccines|vaccines|mesh-list
111302408|NCT01666782|Immunologic Factors|immunologic factors|mesh-ancestor
111302409|NCT01666782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111302410|NCT00058019|Epothilones|epothilones|mesh-list
111302411|NCT00058019|Epothilone B|epothilone b|mesh-list
111302412|NCT00058019|Tubulin Modulators|tubulin modulators|mesh-ancestor
111302413|NCT00058019|Antimitotic Agents|antimitotic agents|mesh-ancestor
111302414|NCT00058019|Mitosis Modulators|mitosis modulators|mesh-ancestor
111302415|NCT00058019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111302416|NCT00058019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111302417|NCT01439360|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
111302418|NCT01439360|Immunologic Factors|immunologic factors|mesh-ancestor
111302419|NCT01439360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111302421|NCT00110461|Antidepressive Agents|antidepressive agents|mesh-ancestor
111302422|NCT00110461|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111302423|NCT00110461|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111302424|NCT00110461|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111302425|NCT00110461|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111302426|NCT00110461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111302427|NCT00110461|Dopamine Agonists|dopamine agonists|mesh-ancestor
111302428|NCT00110461|Dopamine Agents|dopamine agents|mesh-ancestor
111302429|NCT00110461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111302430|NCT00110461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111302431|NCT00110461|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111302432|NCT00110461|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111302433|NCT00110461|Serotonin Agents|serotonin agents|mesh-ancestor
111302434|NCT00110461|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111302435|NCT00110461|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111302436|NCT00110461|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111302437|NCT00110461|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111302438|NCT00061373|Aspirin|aspirin|mesh-list
111302439|NCT00061373|Tinzaparin|tinzaparin|mesh-list
111302440|NCT00061373|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
111302441|NCT00061373|Dalteparin|dalteparin|mesh-list
111302442|NCT00061373|Eptifibatide|eptifibatide|mesh-list
111302443|NCT00061373|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111302444|NCT00061373|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111302445|NCT00061373|Analgesics|analgesics|mesh-ancestor
111302446|NCT00061373|Sensory System Agents|sensory system agents|mesh-ancestor
111302447|NCT00061373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111302448|NCT00061373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111302449|NCT00061373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111302450|NCT00061373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111302451|NCT00061373|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111302452|NCT00061373|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111302453|NCT00061373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111302454|NCT00061373|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111302455|NCT00061373|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111302456|NCT00061373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111302457|NCT00061373|Antipyretics|antipyretics|mesh-ancestor
111302458|NCT00061373|Anticoagulants|anticoagulants|mesh-ancestor
111302459|NCT01897337|Aprepitant|aprepitant|mesh-list
111302460|NCT01897337|Antiemetics|antiemetics|mesh-ancestor
111302461|NCT01897337|Autonomic Agents|autonomic agents|mesh-ancestor
111302462|NCT01897337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111302463|NCT01897337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111302464|NCT01897337|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111302465|NCT01897337|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
111302466|NCT01897337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111302467|NCT01897337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111302468|NCT03089333|Dapagliflozin|dapagliflozin|mesh-list
111302469|NCT03089333|Glyburide|glyburide|mesh-list
111302470|NCT03089333|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111302471|NCT03089333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111302472|NCT03089333|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111302473|NCT03089333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111302474|NCT00112723|Alvocidib|alvocidib|mesh-list
111302475|NCT00112723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111302476|NCT00112723|Growth Inhibitors|growth inhibitors|mesh-ancestor
111302477|NCT00112723|Growth Substances|growth substances|mesh-ancestor
111302478|NCT00112723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111302479|NCT00112723|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111302480|NCT00112723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111302481|NCT00112723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111302482|NCT04327206|Vaccines|vaccines|mesh-list
111302483|NCT04327206|BCG Vaccine|bcg vaccine|mesh-list
111302484|NCT04327206|Immunologic Factors|immunologic factors|mesh-ancestor
111302485|NCT04327206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111302486|NCT04327206|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111302487|NCT05700006|Aromatase Inhibitors|aromatase inhibitors|mesh-list
111302488|NCT05700006|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111302489|NCT05700006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111026894|NCT04947566|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111302490|NCT05700006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111302491|NCT05700006|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111302492|NCT05700006|Hormone Antagonists|hormone antagonists|mesh-ancestor
111302493|NCT05700006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111302494|NCT05700006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111302495|NCT00115297|Montelukast|montelukast|mesh-list
111302496|NCT00115297|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111302497|NCT00115297|Respiratory System Agents|respiratory system agents|mesh-ancestor
111302498|NCT00115297|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
111302499|NCT00115297|Hormone Antagonists|hormone antagonists|mesh-ancestor
111302500|NCT00115297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111302501|NCT00115297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111302502|NCT00115297|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
111302503|NCT00115297|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111302504|NCT00115297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111302506|NCT00116857|Antidepressive Agents|antidepressive agents|mesh-ancestor
111302507|NCT00116857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111302508|NCT00116857|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111302509|NCT00116857|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111302510|NCT00116857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111302511|NCT00116857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111302512|NCT00116857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111302513|NCT00116857|Serotonin Agents|serotonin agents|mesh-ancestor
111302514|NCT00116857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111302515|NCT05547828|Tislelizumab|tislelizumab|mesh-list
111302516|NCT05547828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111302517|NCT05547828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111302518|NCT01672983|Ritonavir|ritonavir|mesh-list
111302519|NCT01672983|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111302520|NCT01672983|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111302521|NCT01672983|Protease Inhibitors|protease inhibitors|mesh-ancestor
111302522|NCT01672983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111302523|NCT01672983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111302524|NCT01672983|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111302525|NCT01672983|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111302526|NCT01672983|Antiviral Agents|antiviral agents|mesh-ancestor
111302527|NCT01672983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111302528|NCT01672983|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111302529|NCT01672983|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111302530|NCT00117715|Dextromethorphan|dextromethorphan|mesh-list
111302531|NCT00117715|Caffeine|caffeine|mesh-list
111302532|NCT00117715|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111302533|NCT00117715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111302534|NCT00117715|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111302535|NCT00117715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111302536|NCT00117715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111302537|NCT00117715|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
111302538|NCT00117715|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111302539|NCT00117715|Purinergic Agents|purinergic agents|mesh-ancestor
111302540|NCT00117715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111302541|NCT00117715|Antitussive Agents|antitussive agents|mesh-ancestor
111302542|NCT00117715|Respiratory System Agents|respiratory system agents|mesh-ancestor
111302543|NCT00117715|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111302544|NCT00117715|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111302545|NCT00228943|Tryptophan|tryptophan|mesh-list
111302546|NCT00228943|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111302547|NCT00228943|Antidepressive Agents|antidepressive agents|mesh-ancestor
111302548|NCT00228943|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111302549|NCT01879085|Gemcitabine|gemcitabine|mesh-list
111302550|NCT01879085|Docetaxel|docetaxel|mesh-list
111302551|NCT01879085|Vorinostat|vorinostat|mesh-list
111302552|NCT01879085|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111302553|NCT01879085|Antimetabolites|antimetabolites|mesh-ancestor
111302554|NCT01879085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111302555|NCT01879085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111302556|NCT01879085|Tubulin Modulators|tubulin modulators|mesh-ancestor
111302557|NCT01879085|Antimitotic Agents|antimitotic agents|mesh-ancestor
111302558|NCT01879085|Mitosis Modulators|mitosis modulators|mesh-ancestor
111302559|NCT01879085|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111302560|NCT01879085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111302561|NCT01439204|Abatacept|abatacept|mesh-list
111302562|NCT01439204|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111026973|NCT03241563|Triamcinolone|triamcinolone|mesh-list
111302563|NCT01439204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111302564|NCT01439204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111302565|NCT01439204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111302566|NCT01439204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111302567|NCT01439204|Immunologic Factors|immunologic factors|mesh-ancestor
111302568|NCT01439204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111302569|NCT01439204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111302570|NCT00063635|Vitamin E|vitamin e|mesh-list
111302571|NCT00063635|Metformin|metformin|mesh-list
111302572|NCT00063635|Vitamins|vitamins|mesh-ancestor
111302573|NCT00063635|Micronutrients|micronutrients|mesh-ancestor
111302574|NCT00063635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111302575|NCT00063635|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111302576|NCT00063635|Antioxidants|antioxidants|mesh-ancestor
111302577|NCT00063635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111302578|NCT00063635|Protective Agents|protective agents|mesh-ancestor
111302579|NCT01439126|Clonidine|clonidine|mesh-list
111302580|NCT01439126|Analgesics|analgesics|mesh-ancestor
111302581|NCT01439126|Sensory System Agents|sensory system agents|mesh-ancestor
111302582|NCT01439126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111302583|NCT01439126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111302584|NCT01439126|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111302585|NCT01439126|Sympatholytics|sympatholytics|mesh-ancestor
111302586|NCT01439126|Autonomic Agents|autonomic agents|mesh-ancestor
111302587|NCT01439126|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111302588|NCT01439126|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111302589|NCT01439126|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111302590|NCT01439126|Adrenergic Agents|adrenergic agents|mesh-ancestor
111302591|NCT01439126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111302592|NCT01439126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111302593|NCT00066677|Docetaxel|docetaxel|mesh-list
111302594|NCT00066677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111302595|NCT00066677|Tubulin Modulators|tubulin modulators|mesh-ancestor
111302596|NCT00066677|Antimitotic Agents|antimitotic agents|mesh-ancestor
111302597|NCT00066677|Mitosis Modulators|mitosis modulators|mesh-ancestor
111302598|NCT00066677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111302599|NCT01615731|Digoxin|digoxin|mesh-list
111302600|NCT01615731|Misoprostol|misoprostol|mesh-list
111302601|NCT01615731|Mifepristone|mifepristone|mesh-list
111302602|NCT01615731|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111302603|NCT01615731|Abortifacient Agents|abortifacient agents|mesh-ancestor
111302604|NCT01615731|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111302605|NCT01615731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111302606|NCT01615731|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111302607|NCT01615731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111302608|NCT01615731|Oxytocics|oxytocics|mesh-ancestor
111302609|NCT01615731|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111302610|NCT01615731|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111302611|NCT01615731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111302612|NCT01615731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111302613|NCT01615731|Protective Agents|protective agents|mesh-ancestor
111302614|NCT01615731|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
111302615|NCT01615731|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111302616|NCT01615731|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111302617|NCT01615731|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111302618|NCT01615731|Contraceptive Agents|contraceptive agents|mesh-ancestor
111302619|NCT01615731|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
111302620|NCT01615731|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
111302621|NCT01615731|Hormone Antagonists|hormone antagonists|mesh-ancestor
111302622|NCT01615731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111302623|NCT01615731|Luteolytic Agents|luteolytic agents|mesh-ancestor
111302624|NCT01615731|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111302625|NCT01615731|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
111302626|NCT02334800|Palbociclib|palbociclib|mesh-list
111302627|NCT02334800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111302628|NCT02334800|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111302629|NCT02334800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111302630|NCT02334800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111302631|NCT01665144|Siponimod|siponimod|mesh-list
111302632|NCT01665144|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
111302633|NCT01665144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111302634|NCT01665144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111302635|NCT01665144|Immunologic Factors|immunologic factors|mesh-ancestor
111302636|NCT01665144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111302637|NCT01675635|Morphine|morphine|mesh-list
111302638|NCT01675635|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111302639|NCT01675635|Narcotics|narcotics|mesh-ancestor
111302640|NCT01675635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111302641|NCT01675635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111302642|NCT01675635|Analgesics|analgesics|mesh-ancestor
111302643|NCT01675635|Sensory System Agents|sensory system agents|mesh-ancestor
111302644|NCT01675635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111302645|NCT01615809|Amphotericin B|amphotericin b|mesh-list
111302646|NCT01615809|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
111302647|NCT01615809|Amebicides|amebicides|mesh-ancestor
111302648|NCT01615809|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111302649|NCT01615809|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111302650|NCT01615809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111302651|NCT01615809|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111302652|NCT01615809|Antifungal Agents|antifungal agents|mesh-ancestor
111302653|NCT01676415|Mometasone Furoate|mometasone furoate|mesh-list
111302654|NCT01676415|Prednisone|prednisone|mesh-list
111302655|NCT01676415|Glucocorticoids|glucocorticoids|mesh-list
111302656|NCT01676415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111302657|NCT01676415|Hormones|hormones|mesh-ancestor
111302658|NCT01676415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111302659|NCT01676415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111302660|NCT01676415|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111302661|NCT01676415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111302662|NCT01676415|Dermatologic Agents|dermatologic agents|mesh-ancestor
111302663|NCT01676415|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111302664|NCT05547516|Gemcitabine|gemcitabine|mesh-list
111302665|NCT05547516|Epirubicin|epirubicin|mesh-list
111302666|NCT05547516|Mitomycins|mitomycins|mesh-list
111302667|NCT05547516|Mitomycin|mitomycin|mesh-list
111302668|NCT05547516|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111302669|NCT05547516|Antimetabolites|antimetabolites|mesh-ancestor
111302670|NCT05547516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111302671|NCT05547516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111302672|NCT05547516|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111302673|NCT05547516|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111302674|NCT05547516|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111302675|NCT05547516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111302676|NCT05547516|Alkylating Agents|alkylating agents|mesh-ancestor
111302677|NCT05547516|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111302678|NCT01678443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111302679|NCT01678443|Antibodies|antibodies|mesh-list
111302680|NCT01678443|Immunoglobulins|immunoglobulins|mesh-list
111302681|NCT01678443|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111302682|NCT01678443|Immunologic Factors|immunologic factors|mesh-ancestor
111302683|NCT01678443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111302684|NCT01678443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111302685|NCT01707225|Octreotide|octreotide|mesh-list
111302686|NCT01707225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111302687|NCT01707225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111302688|NCT01707225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111302689|NCT01707381|Timolol|timolol|mesh-list
111302690|NCT01707381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111302691|NCT01707381|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111302692|NCT01707381|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111302693|NCT01707381|Adrenergic Agents|adrenergic agents|mesh-ancestor
111302694|NCT01707381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111302695|NCT01707381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111302696|NCT01707381|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111302697|NCT01707381|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111302698|NCT05552586|Melatonin|melatonin|mesh-list
111302699|NCT05552586|Antioxidants|antioxidants|mesh-ancestor
111302700|NCT05552586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111302701|NCT05552586|Protective Agents|protective agents|mesh-ancestor
111302702|NCT05552586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111302703|NCT05552586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111302704|NCT00069329|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
111302705|NCT00069329|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111302706|NCT00072449|Rituximab|rituximab|mesh-list
111302707|NCT00072449|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111302708|NCT00072449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111302709|NCT00072449|Immunologic Factors|immunologic factors|mesh-ancestor
111302710|NCT00072449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111027118|NCT02453607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111302711|NCT00072449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111302712|NCT04756661|Misoprostol|misoprostol|mesh-list
111302714|NCT04756661|Carbetocin|carbetocin|mesh-list
111302715|NCT04756661|Oxytocics|oxytocics|mesh-ancestor
111302716|NCT04756661|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111302717|NCT04756661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111302718|NCT04756661|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111302719|NCT04756661|Abortifacient Agents|abortifacient agents|mesh-ancestor
111302720|NCT04756661|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111302721|NCT04756661|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111302722|NCT01708629|Ustekinumab|ustekinumab|mesh-list
111302723|NCT01708629|Brodalumab|brodalumab|mesh-list
111302724|NCT01708629|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111302725|NCT01708629|Dermatologic Agents|dermatologic agents|mesh-ancestor
111302726|NCT01708629|Immunologic Factors|immunologic factors|mesh-ancestor
111302727|NCT01708629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111302728|NCT00073073|Vitamin D|vitamin d|mesh-list
111302729|NCT00073073|Exemestane|exemestane|mesh-list
111302730|NCT00073073|Calcium Carbonate|calcium carbonate|mesh-list
111302731|NCT00073073|Calcium|calcium|mesh-list
111302732|NCT00073073|Vitamins|vitamins|mesh-ancestor
111302733|NCT00073073|Micronutrients|micronutrients|mesh-ancestor
111302734|NCT00073073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111302735|NCT00073073|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111302736|NCT00073073|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111302737|NCT00073073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111302738|NCT00073073|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111302739|NCT00073073|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111302740|NCT00073073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111302741|NCT00073073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111302742|NCT00073073|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111302743|NCT00073073|Hormone Antagonists|hormone antagonists|mesh-ancestor
111302744|NCT00073073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111302745|NCT00073073|Antacids|antacids|mesh-ancestor
111302746|NCT00073073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111302747|NCT01466660|Gefitinib|gefitinib|mesh-list
111302748|NCT01466660|Afatinib|afatinib|mesh-list
111302749|NCT01466660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111302750|NCT01466660|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111302751|NCT01466660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111302752|NCT01466660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111302753|NCT00075335|Plerixafor|plerixafor|mesh-list
111302754|NCT00075335|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111302755|NCT00075335|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111302756|NCT00075335|Antiviral Agents|antiviral agents|mesh-ancestor
111302757|NCT00075335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111302758|NCT01680549|Gabapentin|gabapentin|mesh-list
111302759|NCT01680549|Analgesics|analgesics|mesh-ancestor
111302760|NCT01680549|Sensory System Agents|sensory system agents|mesh-ancestor
111302761|NCT01680549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111302762|NCT01680549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111302763|NCT01680549|Anticonvulsants|anticonvulsants|mesh-ancestor
111302764|NCT01680549|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111302765|NCT01680549|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111302766|NCT01680549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111302767|NCT01680549|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111302768|NCT01680549|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111302769|NCT01680549|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111302770|NCT01680549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111302771|NCT01680549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111302772|NCT01680549|Antimanic Agents|antimanic agents|mesh-ancestor
111302773|NCT01466348|Acetaminophen|acetaminophen|mesh-list
111302774|NCT01466348|Caffeine|caffeine|mesh-list
111302775|NCT01466348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111302776|NCT01466348|Analgesics|analgesics|mesh-ancestor
111302777|NCT01466348|Sensory System Agents|sensory system agents|mesh-ancestor
111302778|NCT01466348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111302779|NCT01466348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111302780|NCT01466348|Antipyretics|antipyretics|mesh-ancestor
111302781|NCT01466348|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111302782|NCT01466348|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111302783|NCT01466348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111302784|NCT01466348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111302785|NCT01466348|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
111302786|NCT01466348|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111302787|NCT01466348|Purinergic Agents|purinergic agents|mesh-ancestor
111302788|NCT01466348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111302789|NCT01466270|Donepezil|donepezil|mesh-list
111302790|NCT01466270|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111302792|NCT01466270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111302793|NCT01466270|Cholinergic Agents|cholinergic agents|mesh-ancestor
111302794|NCT01466270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111302795|NCT01466270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111302796|NCT01466270|Nootropic Agents|nootropic agents|mesh-ancestor
111302797|NCT02235987|Octreotide|octreotide|mesh-list
111302798|NCT02235987|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111302799|NCT02235987|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111302800|NCT02235987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111302801|NCT01466192|Ribavirin|ribavirin|mesh-list
111302802|NCT01466192|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
111302803|NCT01466192|Antimetabolites|antimetabolites|mesh-ancestor
111302804|NCT01466192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111302805|NCT01466192|Antiviral Agents|antiviral agents|mesh-ancestor
111302806|NCT01466192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111302807|NCT00120523|Pimecrolimus|pimecrolimus|mesh-list
111302808|NCT00120523|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111302809|NCT00120523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111302810|NCT00120523|Analgesics|analgesics|mesh-ancestor
111302811|NCT00120523|Sensory System Agents|sensory system agents|mesh-ancestor
111302812|NCT00120523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111302813|NCT00120523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111302814|NCT00120523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111302815|NCT00120523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111302816|NCT00120523|Dermatologic Agents|dermatologic agents|mesh-ancestor
111302817|NCT00120523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111302818|NCT00120523|Immunologic Factors|immunologic factors|mesh-ancestor
111302819|NCT00120523|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111302820|NCT00120523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111302821|NCT00120523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111302822|NCT01438814|Metformin|metformin|mesh-list
111302823|NCT01438814|Linagliptin|linagliptin|mesh-list
111302824|NCT01438814|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111302825|NCT01438814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111302826|NCT01438814|Incretins|incretins|mesh-ancestor
111302827|NCT01438814|Hormones|hormones|mesh-ancestor
111302828|NCT01438814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111302829|NCT01438814|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111302830|NCT01438814|Protease Inhibitors|protease inhibitors|mesh-ancestor
111302831|NCT01438814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111302832|NCT01438814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111302833|NCT04425876|Fluzoparib|fluzoparib|mesh-list
111302834|NCT04425876|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111302835|NCT04425876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111302836|NCT04425876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111302837|NCT04425876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111302838|NCT01681095|Tryptophan|tryptophan|mesh-list
111302839|NCT01681095|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111302840|NCT01681095|Antidepressive Agents|antidepressive agents|mesh-ancestor
111302841|NCT01681095|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111302842|NCT00121225|Vorinostat|vorinostat|mesh-list
111302843|NCT00121225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111302844|NCT00121225|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111302845|NCT00121225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111302846|NCT00121225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111302847|NCT05134987|Insulin Detemir|insulin detemir|mesh-list
111302848|NCT05134987|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111302849|NCT05134987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111302850|NCT05545800|Insulin|insulin|mesh-list
111302851|NCT05545800|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111302852|NCT05545800|Metformin|metformin|mesh-list
111302853|NCT05545800|Insulin Glargine|insulin glargine|mesh-list
111302854|NCT05545800|Empagliflozin|empagliflozin|mesh-list
111302855|NCT05545800|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111302856|NCT05545800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111302857|NCT05545800|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111302858|NCT05545800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111302859|NCT00230737|Melatonin|melatonin|mesh-list
111302860|NCT00230737|Antioxidants|antioxidants|mesh-ancestor
111302861|NCT00230737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111302862|NCT00230737|Protective Agents|protective agents|mesh-ancestor
111302863|NCT00230737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111302864|NCT00230737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111302865|NCT04425564|Capecitabine|capecitabine|mesh-list
111302866|NCT04425564|Oxaliplatin|oxaliplatin|mesh-list
111302867|NCT04425564|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111302868|NCT04425564|Antimetabolites|antimetabolites|mesh-ancestor
110979802|NCT02452502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111302869|NCT04425564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111302870|NCT04425564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111302871|NCT01686165|Rituximab|rituximab|mesh-list
111302872|NCT01686165|Belinostat|belinostat|mesh-list
111302873|NCT01686165|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111302874|NCT01686165|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111302875|NCT01686165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111302876|NCT01686165|Immunologic Factors|immunologic factors|mesh-ancestor
111302877|NCT01686165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111302878|NCT01686165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111302879|NCT01686165|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111302880|NCT01686165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111302881|NCT01686165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111302882|NCT00123643|Rosiglitazone|rosiglitazone|mesh-list
111302883|NCT00123643|Glyburide|glyburide|mesh-list
111302884|NCT00123643|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111302885|NCT00123643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111302886|NCT00235573|Vitamin B 12|vitamin b 12|mesh-list
111302887|NCT00235573|Hydroxocobalamin|hydroxocobalamin|mesh-list
111302888|NCT00235573|Vitamins|vitamins|mesh-ancestor
111302889|NCT00235573|Micronutrients|micronutrients|mesh-ancestor
111302890|NCT00235573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111302891|NCT00235573|Vitamin B Complex|vitamin b complex|mesh-ancestor
111302892|NCT00235573|Hematinics|hematinics|mesh-ancestor
111302893|NCT01687179|Sirolimus|sirolimus|mesh-list
111302894|NCT01687179|Hydroxychloroquine|hydroxychloroquine|mesh-list
111302895|NCT01687179|Temsirolimus|temsirolimus|mesh-list
111302896|NCT01687179|MTOR Inhibitors|mtor inhibitors|mesh-list
111302897|NCT01687179|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111302898|NCT01687179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111302899|NCT01687179|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111302900|NCT01687179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111302901|NCT01687179|Antifungal Agents|antifungal agents|mesh-ancestor
111302902|NCT01687179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111302903|NCT01687179|Immunologic Factors|immunologic factors|mesh-ancestor
111302904|NCT01687179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111302905|NCT01687179|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111302906|NCT01687179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111302907|NCT01687179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111302908|NCT01687179|Antimalarials|antimalarials|mesh-ancestor
111302909|NCT01687179|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111302910|NCT01687179|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111302911|NCT01687179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111302912|NCT00124579|Thalidomide|thalidomide|mesh-list
111302913|NCT00124579|Dexamethasone|dexamethasone|mesh-list
111302914|NCT00124579|Bortezomib|bortezomib|mesh-list
111302915|NCT00124579|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111302916|NCT00124579|Antiemetics|antiemetics|mesh-ancestor
111302917|NCT00124579|Autonomic Agents|autonomic agents|mesh-ancestor
111302918|NCT00124579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111302919|NCT00124579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111302920|NCT00124579|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111302921|NCT00124579|Glucocorticoids|glucocorticoids|mesh-ancestor
111302922|NCT00124579|Hormones|hormones|mesh-ancestor
111302923|NCT00124579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111302924|NCT00124579|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111302925|NCT00124579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111302926|NCT00124579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111302927|NCT00124579|Immunologic Factors|immunologic factors|mesh-ancestor
111302928|NCT00124579|Leprostatic Agents|leprostatic agents|mesh-ancestor
111302929|NCT00124579|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111302930|NCT00124579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111302931|NCT00124579|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111302932|NCT00124579|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111302933|NCT00124579|Growth Substances|growth substances|mesh-ancestor
111302934|NCT00124579|Growth Inhibitors|growth inhibitors|mesh-ancestor
111302935|NCT05550090|Immunomodulating Agents|immunomodulating agents|mesh-list
111302936|NCT05550090|Immunologic Factors|immunologic factors|mesh-ancestor
111302937|NCT05550090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111027341|NCT04427618|Hemostatics|hemostatics|mesh-ancestor
111302938|NCT00124735|Rocuronium|rocuronium|mesh-list
111302939|NCT00124735|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
111302940|NCT00124735|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
111302941|NCT00124735|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111302942|NCT00124735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111302943|NCT00124735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111302944|NCT05340309|Atezolizumab|atezolizumab|mesh-list
111302945|NCT05340309|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111302946|NCT05340309|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111302947|NCT05340309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111302948|NCT05340309|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111302949|NCT05340309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111302950|NCT05340309|Immunologic Factors|immunologic factors|mesh-ancestor
111302951|NCT05340309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111302952|NCT00125515|Naltrexone|naltrexone|mesh-list
111302953|NCT00125515|Memantine|memantine|mesh-list
111302954|NCT00125515|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111302955|NCT00125515|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111302956|NCT00125515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111302957|NCT00125515|Sensory System Agents|sensory system agents|mesh-ancestor
111302958|NCT00125515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111302959|NCT00125515|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111302960|NCT00125515|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111302961|NCT00125515|Dopamine Agents|dopamine agents|mesh-ancestor
111302962|NCT00125515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111302963|NCT00125515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111302964|NCT00125515|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111302965|NCT00125515|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111302966|NCT00125593|Simvastatin|simvastatin|mesh-list
111302967|NCT00125593|Ezetimibe|ezetimibe|mesh-list
111302968|NCT00125593|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111302969|NCT00125593|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111302970|NCT00125593|Antimetabolites|antimetabolites|mesh-ancestor
111302971|NCT00125593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111302972|NCT00125593|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111302973|NCT00125593|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111302974|NCT00125593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111302975|NCT01689441|Calcitriol|calcitriol|mesh-list
111302976|NCT01689441|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111302977|NCT01689441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111302978|NCT01689441|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
111302979|NCT01689441|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111302980|NCT01689441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111302981|NCT01689441|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111302982|NCT01689441|Vitamins|vitamins|mesh-ancestor
111302983|NCT01689441|Micronutrients|micronutrients|mesh-ancestor
111302984|NCT01689441|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111302985|NCT00236977|Iron|iron|mesh-list
111302986|NCT00236977|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
111302987|NCT00236977|Trace Elements|trace elements|mesh-ancestor
111302988|NCT00236977|Micronutrients|micronutrients|mesh-ancestor
111302989|NCT00236977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111302990|NCT00236977|Hematinics|hematinics|mesh-ancestor
111302991|NCT04753177|Paclitaxel|paclitaxel|mesh-list
111302992|NCT04753177|Cyclophosphamide|cyclophosphamide|mesh-list
111302993|NCT04753177|Doxorubicin|doxorubicin|mesh-list
111302994|NCT04753177|Fulvestrant|fulvestrant|mesh-list
111302995|NCT04753177|Triptorelin Pamoate|triptorelin pamoate|mesh-list
111302996|NCT04753177|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111302997|NCT04753177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111302998|NCT04753177|Tubulin Modulators|tubulin modulators|mesh-ancestor
111302999|NCT04753177|Antimitotic Agents|antimitotic agents|mesh-ancestor
111303000|NCT04753177|Mitosis Modulators|mitosis modulators|mesh-ancestor
111303001|NCT04753177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111303002|NCT04753177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111303003|NCT04753177|Immunologic Factors|immunologic factors|mesh-ancestor
111303004|NCT04753177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111303005|NCT04753177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111303006|NCT04753177|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111303007|NCT04753177|Alkylating Agents|alkylating agents|mesh-ancestor
111303008|NCT04753177|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111303009|NCT04753177|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111303010|NCT04753177|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111303011|NCT04753177|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111303012|NCT04753177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111303013|NCT04753177|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111303014|NCT04753177|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
111303015|NCT04753177|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111303016|NCT04753177|Hormone Antagonists|hormone antagonists|mesh-ancestor
111303017|NCT04753177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111303018|NCT04753177|Luteolytic Agents|luteolytic agents|mesh-ancestor
111303019|NCT04753177|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111303020|NCT04753177|Contraceptive Agents|contraceptive agents|mesh-ancestor
111303021|NCT04753177|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111303022|NCT04753177|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111303023|NCT01691313|Vanoxerine|vanoxerine|mesh-list
111303024|NCT01691313|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111303025|NCT01691313|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111303026|NCT01691313|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111303027|NCT01691313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111303028|NCT01691313|Dopamine Agents|dopamine agents|mesh-ancestor
111303029|NCT01691313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111303030|NCT01691313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111303031|NCT00079001|Vitamin D|vitamin d|mesh-list
111303032|NCT00079001|Zoledronic Acid|zoledronic acid|mesh-list
111303033|NCT00079001|Calcium|calcium|mesh-list
111303034|NCT00079001|Androgens|androgens|mesh-list
111303035|NCT00079001|Vitamins|vitamins|mesh-ancestor
111303036|NCT00079001|Micronutrients|micronutrients|mesh-ancestor
111303037|NCT00079001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111303038|NCT00079001|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111303039|NCT00079001|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111303040|NCT00079001|Hormones|hormones|mesh-ancestor
111303041|NCT00079001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111303042|NCT05234307|Nivolumab|nivolumab|mesh-list
111303043|NCT05234307|Adenosine|adenosine|mesh-list
111303044|NCT05234307|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-list
111303045|NCT05234307|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111303046|NCT05234307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111303047|NCT05234307|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111303048|NCT05234307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111303049|NCT05234307|Analgesics|analgesics|mesh-ancestor
111303050|NCT05234307|Sensory System Agents|sensory system agents|mesh-ancestor
111303051|NCT05234307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111303052|NCT05234307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111303053|NCT05234307|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111303054|NCT05234307|Vasodilator Agents|vasodilator agents|mesh-ancestor
111303055|NCT05234307|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
111303056|NCT05234307|Purinergic Agonists|purinergic agonists|mesh-ancestor
111303057|NCT05234307|Purinergic Agents|purinergic agents|mesh-ancestor
111303058|NCT05234307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111303059|NCT05234307|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
111303060|NCT05234307|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111303061|NCT00238615|Carboplatin|carboplatin|mesh-list
111303062|NCT00238615|Docetaxel|docetaxel|mesh-list
111303063|NCT00238615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111303064|NCT00238615|Tubulin Modulators|tubulin modulators|mesh-ancestor
111303065|NCT00238615|Antimitotic Agents|antimitotic agents|mesh-ancestor
111303066|NCT00238615|Mitosis Modulators|mitosis modulators|mesh-ancestor
111303067|NCT00238615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111303068|NCT02243943|Neostigmine|neostigmine|mesh-list
111303069|NCT02243943|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111303070|NCT02243943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111303071|NCT02243943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111303072|NCT02243943|Cholinergic Agents|cholinergic agents|mesh-ancestor
111303073|NCT02243943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111303074|NCT02243943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111303075|NCT02243943|Parasympathomimetics|parasympathomimetics|mesh-ancestor
111303076|NCT02243943|Autonomic Agents|autonomic agents|mesh-ancestor
111303077|NCT02243943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111303078|NCT03088631|Metformin|metformin|mesh-list
111303079|NCT03088631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111303080|NCT03088631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111303081|NCT00131677|Tenofovir|tenofovir|mesh-list
111303082|NCT00131677|Antiviral Agents|antiviral agents|mesh-ancestor
111303083|NCT00131677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111303084|NCT00131677|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111303085|NCT00131677|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111303086|NCT00131677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111303087|NCT00131677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111303088|NCT00131677|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111303089|NCT00131677|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111303090|NCT00240487|Nitric Oxide|nitric oxide|mesh-list
111303091|NCT00240487|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111303092|NCT00240487|Autonomic Agents|autonomic agents|mesh-ancestor
111303093|NCT00240487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111303094|NCT00240487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111303095|NCT00240487|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111303096|NCT00240487|Respiratory System Agents|respiratory system agents|mesh-ancestor
111303097|NCT00240487|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111303098|NCT00240487|Antioxidants|antioxidants|mesh-ancestor
111303099|NCT00240487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111303100|NCT00240487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111303101|NCT00240487|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
111303102|NCT00240487|Vasodilator Agents|vasodilator agents|mesh-ancestor
111303103|NCT00240487|Gasotransmitters|gasotransmitters|mesh-ancestor
111303104|NCT00240487|Protective Agents|protective agents|mesh-ancestor
111303105|NCT02126917|Ethanol|ethanol|mesh-list
111303106|NCT02126917|Hydrocodone|hydrocodone|mesh-list
111303107|NCT02126917|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111303108|NCT02126917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111303109|NCT02126917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111303110|NCT02126917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111303111|NCT02126917|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111303112|NCT02126917|Narcotics|narcotics|mesh-ancestor
111303113|NCT02126917|Analgesics|analgesics|mesh-ancestor
111303114|NCT02126917|Sensory System Agents|sensory system agents|mesh-ancestor
111303115|NCT02126917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111303116|NCT02126917|Antitussive Agents|antitussive agents|mesh-ancestor
111303117|NCT02126917|Respiratory System Agents|respiratory system agents|mesh-ancestor
111303118|NCT01895075|Budesonide|budesonide|mesh-list
111303119|NCT01895075|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111303120|NCT01895075|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111303121|NCT01895075|Autonomic Agents|autonomic agents|mesh-ancestor
111303122|NCT01895075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111303123|NCT01895075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111303124|NCT01895075|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111303125|NCT01895075|Respiratory System Agents|respiratory system agents|mesh-ancestor
111303126|NCT01895075|Glucocorticoids|glucocorticoids|mesh-ancestor
111303127|NCT01895075|Hormones|hormones|mesh-ancestor
111303128|NCT01895075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111303129|NCT03088709|Mycophenolic Acid|mycophenolic acid|mesh-list
111303130|NCT03088709|Cyclophosphamide|cyclophosphamide|mesh-list
111303131|NCT03088709|Tacrolimus|tacrolimus|mesh-list
111303132|NCT03088709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111303133|NCT03088709|Immunologic Factors|immunologic factors|mesh-ancestor
111303134|NCT03088709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111303135|NCT03088709|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111303136|NCT03088709|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111303137|NCT03088709|Alkylating Agents|alkylating agents|mesh-ancestor
111303138|NCT03088709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111303139|NCT03088709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111303140|NCT03088709|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111303141|NCT03088709|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111303142|NCT03088709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111303143|NCT03088709|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111303144|NCT03088709|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111303145|NCT03088709|Antitubercular Agents|antitubercular agents|mesh-ancestor
111303146|NCT03088709|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111303147|NCT03088709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111303148|NCT03139305|Glucagon|glucagon|mesh-list
111303149|NCT03139305|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
111303150|NCT03139305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111303151|NCT03139305|Hormones|hormones|mesh-ancestor
111303152|NCT03139305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111303153|NCT03139305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111303154|NCT03139305|Incretins|incretins|mesh-ancestor
111303155|NCT00084149|Ritonavir|ritonavir|mesh-list
111303156|NCT00084149|Lopinavir|lopinavir|mesh-list
111303157|NCT00084149|Lamivudine|lamivudine|mesh-list
111303158|NCT00084149|Zidovudine|zidovudine|mesh-list
111303159|NCT00084149|Abacavir|abacavir|mesh-list
111303160|NCT00084149|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111303161|NCT00084149|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111303162|NCT00084149|Protease Inhibitors|protease inhibitors|mesh-ancestor
111303163|NCT00084149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111303164|NCT00084149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111303165|NCT00084149|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111303166|NCT00084149|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111303167|NCT00084149|Antiviral Agents|antiviral agents|mesh-ancestor
111303168|NCT00084149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111303169|NCT00084149|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111303170|NCT00084149|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111303171|NCT00084149|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111303172|NCT00084149|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111303173|NCT00084149|Antimetabolites|antimetabolites|mesh-ancestor
111303174|NCT02959905|Cyclophosphamide|cyclophosphamide|mesh-list
111303175|NCT02959905|Fludarabine|fludarabine|mesh-list
111303176|NCT02959905|Fludarabine phosphate|fludarabine phosphate|mesh-list
111303177|NCT02959905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111303178|NCT02959905|Immunologic Factors|immunologic factors|mesh-ancestor
111303179|NCT02959905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111303180|NCT02959905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111303181|NCT02959905|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111303182|NCT02959905|Alkylating Agents|alkylating agents|mesh-ancestor
111303183|NCT02959905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111303184|NCT02959905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111303185|NCT02959905|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111303186|NCT02959905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111303187|NCT02959905|Antimetabolites|antimetabolites|mesh-ancestor
111303188|NCT00134017|Cyclophosphamide|cyclophosphamide|mesh-list
111303189|NCT00134017|Busulfan|busulfan|mesh-list
111303190|NCT00134017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111303191|NCT00134017|Immunologic Factors|immunologic factors|mesh-ancestor
111303192|NCT00134017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111303193|NCT00134017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111303194|NCT00134017|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111303195|NCT00134017|Alkylating Agents|alkylating agents|mesh-ancestor
111303196|NCT00134017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111303197|NCT00134017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111303198|NCT00134017|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111303199|NCT04783051|Pyrimethamine|pyrimethamine|mesh-list
111303200|NCT04783051|Sulfadoxine|sulfadoxine|mesh-list
111303201|NCT04783051|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
111303202|NCT04783051|Pyronaridine tetraphosphate, artesunate drug combination|pyronaridine tetraphosphate, artesunate drug combination|mesh-list
111303203|NCT04783051|Antimalarials|antimalarials|mesh-ancestor
111303204|NCT04783051|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111303205|NCT04783051|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111303206|NCT04783051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111303207|NCT04783051|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111303208|NCT04783051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111303209|NCT04783051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111303210|NCT04783051|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111303211|NCT04783051|Antiviral Agents|antiviral agents|mesh-ancestor
111303212|NCT00243061|Cediranib|cediranib|mesh-list
111303213|NCT00243061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111303214|NCT00243061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111303215|NCT00243061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111303216|NCT00243061|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111303217|NCT00245557|Sertraline|sertraline|mesh-list
111303218|NCT00245557|Antidepressive Agents|antidepressive agents|mesh-ancestor
111303219|NCT00245557|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111303220|NCT00245557|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111303221|NCT00245557|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111303222|NCT00245557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111303223|NCT00245557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111303224|NCT00245557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111303225|NCT00245557|Serotonin Agents|serotonin agents|mesh-ancestor
111303226|NCT00245557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111303227|NCT00245635|Fluoxetine|fluoxetine|mesh-list
111303228|NCT00245635|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111303229|NCT00245635|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111303230|NCT00245635|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111303231|NCT00245635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111303232|NCT00245635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111303233|NCT00245635|Serotonin Agents|serotonin agents|mesh-ancestor
111303234|NCT00245635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111303235|NCT00245635|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111303236|NCT00245635|Antidepressive Agents|antidepressive agents|mesh-ancestor
111303237|NCT00245635|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111303238|NCT00245635|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111303239|NCT00245635|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111303240|NCT00245635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111303241|NCT00141115|Levetiracetam|levetiracetam|mesh-list
111303242|NCT00141115|Anticonvulsants|anticonvulsants|mesh-ancestor
111303243|NCT00141115|Nootropic Agents|nootropic agents|mesh-ancestor
111303244|NCT00249379|Acamprosate|acamprosate|mesh-list
111303245|NCT00249379|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111303246|NCT00141739|Etanercept|etanercept|mesh-list
111303247|NCT00141739|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111303248|NCT00141739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111303249|NCT00141739|Analgesics|analgesics|mesh-ancestor
111303250|NCT00141739|Sensory System Agents|sensory system agents|mesh-ancestor
111303251|NCT00141739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111303252|NCT00141739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111303253|NCT00141739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111303254|NCT00141739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111303255|NCT00141739|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111303256|NCT00141739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111303257|NCT00141739|Immunologic Factors|immunologic factors|mesh-ancestor
111303258|NCT00143845|Immunosuppressive Agents|immunosuppressive agents|mesh-list
111303259|NCT00143845|Immunologic Factors|immunologic factors|mesh-ancestor
111303260|NCT00143845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111303261|NCT00086957|Docetaxel|docetaxel|mesh-list
111303262|NCT00086957|Trastuzumab|trastuzumab|mesh-list
111303263|NCT00086957|Gefitinib|gefitinib|mesh-list
111303264|NCT00086957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111303265|NCT00086957|Tubulin Modulators|tubulin modulators|mesh-ancestor
111303266|NCT00086957|Antimitotic Agents|antimitotic agents|mesh-ancestor
111303267|NCT00086957|Mitosis Modulators|mitosis modulators|mesh-ancestor
111303268|NCT00086957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111303269|NCT00086957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111303270|NCT00086957|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111303271|NCT00086957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111303272|NCT00144391|Testosterone|testosterone|mesh-list
111303273|NCT00144391|Androgens|androgens|mesh-ancestor
111303274|NCT00144391|Hormones|hormones|mesh-ancestor
111303275|NCT00144391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111303276|NCT00144391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111303277|NCT00145249|Fluconazole|fluconazole|mesh-list
111303278|NCT00145249|Amphotericin B|amphotericin b|mesh-list
111303279|NCT00145249|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
111303280|NCT00145249|Antifungal Agents|antifungal agents|mesh-ancestor
111303281|NCT00145249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111303282|NCT00145249|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111303283|NCT00145249|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111303284|NCT00145249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111303285|NCT00145249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111303286|NCT00145249|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111303287|NCT00145249|Hormone Antagonists|hormone antagonists|mesh-ancestor
111303288|NCT00145249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111303289|NCT00145249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111303290|NCT00145249|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111303291|NCT00145249|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111303292|NCT00145249|Amebicides|amebicides|mesh-ancestor
111303293|NCT00145249|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111303294|NCT00145249|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111303295|NCT00145249|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111303296|NCT00153803|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111303297|NCT00153803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111303298|NCT00153803|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111303299|NCT00153803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111303300|NCT00153803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111303301|NCT00252967|Atorvastatin|atorvastatin|mesh-list
111303302|NCT00252967|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111303303|NCT00252967|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111303304|NCT00252967|Antimetabolites|antimetabolites|mesh-ancestor
110755840|NCT01108848|Complement C1s|complement c1s|mesh-list
111303305|NCT00252967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111303306|NCT00252967|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111303307|NCT00252967|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111303308|NCT00252967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111303309|NCT00088985|Trastuzumab|trastuzumab|mesh-list
111303310|NCT00088985|Vinorelbine|vinorelbine|mesh-list
111303311|NCT00088985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111303312|NCT00088985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111027715|NCT03056924|Vaccines|vaccines|mesh-list
111303313|NCT00088985|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111303314|NCT00088985|Tubulin Modulators|tubulin modulators|mesh-ancestor
111303315|NCT00088985|Antimitotic Agents|antimitotic agents|mesh-ancestor
111303316|NCT00088985|Mitosis Modulators|mitosis modulators|mesh-ancestor
111303317|NCT00088985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111303318|NCT00156923|Naltrexone|naltrexone|mesh-list
111303319|NCT00156923|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111303320|NCT00156923|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111303321|NCT00156923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111303322|NCT00156923|Sensory System Agents|sensory system agents|mesh-ancestor
111303323|NCT00156923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111303324|NCT00093041|Zalutumumab|zalutumumab|mesh-list
111303325|NCT00093041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111303326|NCT00093041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111303327|NCT00158249|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
111303328|NCT00158249|Nootropic Agents|nootropic agents|mesh-ancestor
111303329|NCT01769885|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
111303330|NCT01769885|Tivozanib|tivozanib|mesh-list
111303331|NCT01769885|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111303332|NCT01769885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111303333|NCT01769885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111303334|NCT01895231|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
111303335|NCT01895231|Hematinics|hematinics|mesh-ancestor
111303336|NCT04745663|Iodine|iodine|mesh-list
111303337|NCT04745663|Cadexomer iodine|cadexomer iodine|mesh-list
111303338|NCT04745663|Povidone-Iodine|povidone-iodine|mesh-list
111303339|NCT04745663|Povidone|povidone|mesh-list
111303340|NCT04745663|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111303341|NCT04745663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111303342|NCT04745663|Trace Elements|trace elements|mesh-ancestor
111303343|NCT04745663|Micronutrients|micronutrients|mesh-ancestor
111303344|NCT04745663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111303345|NCT04745663|Plasma Substitutes|plasma substitutes|mesh-ancestor
111303346|NCT04745663|Blood Substitutes|blood substitutes|mesh-ancestor
111303347|NCT01747577|Solifenacin Succinate|solifenacin succinate|mesh-list
111303348|NCT01747577|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111303349|NCT01747577|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111303350|NCT01747577|Cholinergic Agents|cholinergic agents|mesh-ancestor
111303351|NCT01747577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111303352|NCT01747577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111303353|NCT01747577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111303354|NCT01747577|Urological Agents|urological agents|mesh-ancestor
111303355|NCT00159263|Budesonide|budesonide|mesh-list
111303356|NCT00159263|Formoterol Fumarate|formoterol fumarate|mesh-list
111303357|NCT00159263|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111303358|NCT00159263|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111303359|NCT00159263|Autonomic Agents|autonomic agents|mesh-ancestor
111303360|NCT00159263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111303361|NCT00159263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111303362|NCT00159263|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111303363|NCT00159263|Respiratory System Agents|respiratory system agents|mesh-ancestor
111303364|NCT00159263|Glucocorticoids|glucocorticoids|mesh-ancestor
111303365|NCT00159263|Hormones|hormones|mesh-ancestor
111303366|NCT00159263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111303367|NCT00159263|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111303368|NCT00159263|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111303369|NCT00159263|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111303370|NCT00159263|Adrenergic Agents|adrenergic agents|mesh-ancestor
111303371|NCT00159263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110979812|NCT03234296|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111303372|NCT00159263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111303373|NCT00159419|Alendronate|alendronate|mesh-list
111303374|NCT00159419|Pamidronate|pamidronate|mesh-list
111303375|NCT00159419|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111303376|NCT00159419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111303377|NCT00159965|Sertraline|sertraline|mesh-list
111303378|NCT00159965|Antidepressive Agents|antidepressive agents|mesh-ancestor
111303379|NCT00159965|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111303380|NCT00159965|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111303381|NCT00159965|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111303382|NCT00159965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111303383|NCT00159965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111303384|NCT00159965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111303385|NCT00159965|Serotonin Agents|serotonin agents|mesh-ancestor
111303386|NCT00159965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111303387|NCT02926833|Cyclophosphamide|cyclophosphamide|mesh-list
111303388|NCT02926833|Fludarabine|fludarabine|mesh-list
111303389|NCT02926833|Atezolizumab|atezolizumab|mesh-list
111303390|NCT02926833|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
111303391|NCT02926833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111303392|NCT02926833|Immunologic Factors|immunologic factors|mesh-ancestor
111303393|NCT02926833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111303394|NCT02926833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111303395|NCT02926833|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111303396|NCT02926833|Alkylating Agents|alkylating agents|mesh-ancestor
111303397|NCT02926833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111303398|NCT02926833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111303399|NCT02926833|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111303400|NCT02926833|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111303401|NCT02926833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111303402|NCT00096161|Cyclosporine|cyclosporine|mesh-list
111303403|NCT00096161|Mycophenolic Acid|mycophenolic acid|mesh-list
111303404|NCT00096161|Vidarabine|vidarabine|mesh-list
111303405|NCT00096161|Pentostatin|pentostatin|mesh-list
111303406|NCT00096161|Cyclosporins|cyclosporins|mesh-list
111303407|NCT00096161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111303408|NCT00096161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111303409|NCT00096161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111303410|NCT00096161|Immunologic Factors|immunologic factors|mesh-ancestor
111303411|NCT00096161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111303412|NCT00096161|Antifungal Agents|antifungal agents|mesh-ancestor
111303413|NCT00096161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111303414|NCT00096161|Dermatologic Agents|dermatologic agents|mesh-ancestor
111303415|NCT00096161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111303416|NCT00096161|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111303417|NCT00096161|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111303418|NCT00096161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111303419|NCT00096161|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111303420|NCT00096161|Antitubercular Agents|antitubercular agents|mesh-ancestor
111303421|NCT00096161|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111303422|NCT00096161|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
111303423|NCT00096161|Antimetabolites|antimetabolites|mesh-ancestor
111303424|NCT00096161|Antiviral Agents|antiviral agents|mesh-ancestor
111303425|NCT00097253|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
111303426|NCT00097253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111303427|NCT01898039|Cyclophosphamide|cyclophosphamide|mesh-list
111303428|NCT01898039|Vaccines|vaccines|mesh-list
111303429|NCT01898039|Immunologic Factors|immunologic factors|mesh-ancestor
111303430|NCT01898039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111303431|NCT01898039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111303432|NCT01898039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111303433|NCT01898039|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111303434|NCT01898039|Alkylating Agents|alkylating agents|mesh-ancestor
111303435|NCT01898039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111303436|NCT01898039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111303437|NCT01898039|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111303438|NCT00099047|Celecoxib|celecoxib|mesh-list
111303439|NCT00099047|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111303440|NCT00099047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111303441|NCT00099047|Analgesics|analgesics|mesh-ancestor
111303442|NCT00099047|Sensory System Agents|sensory system agents|mesh-ancestor
111303443|NCT00099047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110979818|NCT03228368|Atezolizumab|atezolizumab|mesh-list
111303444|NCT00099047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111303445|NCT00099047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111303446|NCT00099047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111303447|NCT00099047|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111303448|NCT00099047|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111303449|NCT00099047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111303450|NCT00099047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111303451|NCT02851797|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
111303452|NCT02851797|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111303453|NCT02851797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111303454|NCT02851797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111303455|NCT00253435|Carboplatin|carboplatin|mesh-list
111303456|NCT00253435|Etoposide|etoposide|mesh-list
111303457|NCT00253435|Melphalan|melphalan|mesh-list
111303458|NCT00253435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111303459|NCT00253435|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111303460|NCT00253435|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111303461|NCT00253435|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111303462|NCT00253435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111303463|NCT00253435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111303464|NCT00253435|Immunologic Factors|immunologic factors|mesh-ancestor
111303465|NCT00253435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111303466|NCT00253435|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111303467|NCT00253435|Alkylating Agents|alkylating agents|mesh-ancestor
111303468|NCT00253435|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111303469|NCT00253435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111303471|NCT00253513|Treosulfan|treosulfan|mesh-list
111303472|NCT00253513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111303473|NCT00253513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111303474|NCT00253513|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111303475|NCT00253513|Alkylating Agents|alkylating agents|mesh-ancestor
111303476|NCT05033847|Vaccines|vaccines|mesh-list
111303477|NCT05033847|Immunologic Factors|immunologic factors|mesh-ancestor
111303478|NCT05033847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111303479|NCT04963725|Ustekinumab|ustekinumab|mesh-list
111303480|NCT04963725|Dermatologic Agents|dermatologic agents|mesh-ancestor
111303481|NCT02098993|Heparin|heparin|mesh-list
111303482|NCT02098993|Calcium heparin|calcium heparin|mesh-list
111303483|NCT02098993|Anticoagulants|anticoagulants|mesh-ancestor
111303484|NCT02098993|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111303485|NCT02098993|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111303486|NCT02098993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111303487|NCT04930107|Fluconazole|fluconazole|mesh-list
111303488|NCT04930107|Antifungal Agents|antifungal agents|mesh-ancestor
111303489|NCT04930107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111303490|NCT04930107|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111303491|NCT04930107|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111303492|NCT04930107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111303493|NCT04930107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111303494|NCT04930107|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111303495|NCT04930107|Hormone Antagonists|hormone antagonists|mesh-ancestor
111303496|NCT04930107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111303497|NCT04930107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111303498|NCT04930107|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111303499|NCT04930107|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111303500|NCT00100841|Leucovorin|leucovorin|mesh-list
111303501|NCT00100841|Bevacizumab|bevacizumab|mesh-list
111303502|NCT00100841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111303503|NCT00100841|Cetuximab|cetuximab|mesh-list
111303504|NCT00100841|Fluorouracil|fluorouracil|mesh-list
111303505|NCT00100841|Oxaliplatin|oxaliplatin|mesh-list
111303506|NCT00100841|Antibodies|antibodies|mesh-list
111303507|NCT00100841|Immunoglobulins|immunoglobulins|mesh-list
111303508|NCT00100841|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111303509|NCT00100841|Levoleucovorin|levoleucovorin|mesh-list
111303510|NCT00100841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111303511|NCT00100841|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111303512|NCT00100841|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111303513|NCT00100841|Growth Substances|growth substances|mesh-ancestor
111303514|NCT00100841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111303515|NCT00100841|Growth Inhibitors|growth inhibitors|mesh-ancestor
111303516|NCT00100841|Immunologic Factors|immunologic factors|mesh-ancestor
111303517|NCT00100841|Antimetabolites|antimetabolites|mesh-ancestor
111303518|NCT00100841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111303519|NCT00100841|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111303520|NCT00100841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111303521|NCT00100841|Antidotes|antidotes|mesh-ancestor
111303522|NCT00100841|Protective Agents|protective agents|mesh-ancestor
111303523|NCT00100841|Vitamin B Complex|vitamin b complex|mesh-ancestor
111303524|NCT00100841|Vitamins|vitamins|mesh-ancestor
111303525|NCT00100841|Micronutrients|micronutrients|mesh-ancestor
111303526|NCT00147199|Treprostinil|treprostinil|mesh-list
111303527|NCT00147199|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111303528|NCT05709171|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
111303529|NCT05709171|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111303530|NCT05709171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111303531|NCT00149227|Valsartan|valsartan|mesh-list
111303532|NCT00149227|Antihypertensive Agents|antihypertensive agents|mesh-list
111303533|NCT00149227|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111303534|NCT00149227|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111303535|NCT00149227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111303536|NCT00445965|Antibodies|antibodies|mesh-list
111303537|NCT00445965|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111303538|NCT00445965|Immunologic Factors|immunologic factors|mesh-ancestor
111303539|NCT00445965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111303540|NCT02096081|Botulinum Toxins|botulinum toxins|mesh-list
111303541|NCT02096081|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111303542|NCT02096081|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111303543|NCT02096081|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
111303544|NCT02096081|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111303545|NCT02096081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111303546|NCT02096081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111303547|NCT02096081|Cholinergic Agents|cholinergic agents|mesh-ancestor
111303548|NCT02096081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111303549|NCT02096081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111303550|NCT02096081|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111303551|NCT02096081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111303552|NCT05708235|Inavolisib|inavolisib|mesh-list
111303553|NCT05708235|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
111303554|NCT05708235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111303555|NCT05708235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111303556|NCT02240589|Memantine|memantine|mesh-list
111303557|NCT02240589|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111303558|NCT02240589|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111303559|NCT02240589|Dopamine Agents|dopamine agents|mesh-ancestor
111303560|NCT02240589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111303561|NCT02240589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111303562|NCT02240589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111303563|NCT02240589|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111303564|NCT02240589|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111303565|NCT00258349|Trastuzumab|trastuzumab|mesh-list
111303566|NCT00258349|Vorinostat|vorinostat|mesh-list
111303567|NCT00258349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111303568|NCT00258349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111303569|NCT00258349|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111303570|NCT00258349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111303571|NCT00258349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111303572|NCT01713621|Artefenomel|artefenomel|mesh-list
111303573|NCT01713621|Antimalarials|antimalarials|mesh-ancestor
111303574|NCT01713621|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111303575|NCT01713621|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111303576|NCT01713621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111303577|NCT05165485|Tiotropium Bromide|tiotropium bromide|mesh-list
111303578|NCT05165485|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111303579|NCT05165485|Autonomic Agents|autonomic agents|mesh-ancestor
111303580|NCT05165485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111303581|NCT05165485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111303582|NCT05165485|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111303583|NCT05165485|Respiratory System Agents|respiratory system agents|mesh-ancestor
111303584|NCT05165485|Parasympatholytics|parasympatholytics|mesh-ancestor
111303585|NCT05165485|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111303586|NCT05165485|Cholinergic Agents|cholinergic agents|mesh-ancestor
111303587|NCT05165485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111303588|NCT05165485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111303589|NCT00258817|Vaccines|vaccines|mesh-list
111303590|NCT00258817|Immunologic Factors|immunologic factors|mesh-ancestor
111303591|NCT00258817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111303592|NCT00259285|Pemetrexed|pemetrexed|mesh-list
111303593|NCT00259285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111303594|NCT00259285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111303595|NCT00259285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111303596|NCT00259285|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111303597|NCT00259285|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111303598|NCT01716039|Adalimumab|adalimumab|mesh-list
111303599|NCT01716039|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111303600|NCT01716039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111303601|NCT01716039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111303602|NCT01716195|Paclitaxel|paclitaxel|mesh-list
111303603|NCT01716195|Carboplatin|carboplatin|mesh-list
111303604|NCT01716195|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111303605|NCT01716195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111303606|NCT01716195|Tubulin Modulators|tubulin modulators|mesh-ancestor
111303607|NCT01716195|Antimitotic Agents|antimitotic agents|mesh-ancestor
111303608|NCT01716195|Mitosis Modulators|mitosis modulators|mesh-ancestor
111303609|NCT01716195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111303610|NCT02249481|Bupivacaine|bupivacaine|mesh-list
111303611|NCT02249481|Anesthetics, Local|anesthetics, local|mesh-ancestor
111303612|NCT02249481|Anesthetics|anesthetics|mesh-ancestor
111303613|NCT02249481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111303614|NCT02249481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111303615|NCT02249481|Sensory System Agents|sensory system agents|mesh-ancestor
111303616|NCT02249481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111303618|NCT01717053|Abiraterone Acetate|abiraterone acetate|mesh-list
111303619|NCT01717053|Androgens|androgens|mesh-list
111303620|NCT01717053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111303621|NCT01717053|Glucocorticoids|glucocorticoids|mesh-ancestor
111303622|NCT01717053|Hormones|hormones|mesh-ancestor
111303623|NCT01717053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111303624|NCT01717053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111303625|NCT01717053|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111303626|NCT01717053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111303627|NCT01717053|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111303628|NCT01717053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111303629|NCT01717053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111303630|NCT01717053|Hormone Antagonists|hormone antagonists|mesh-ancestor
111303631|NCT01717053|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111303632|NCT01666314|Prednisone|prednisone|mesh-list
111303633|NCT01666314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111303634|NCT01666314|Glucocorticoids|glucocorticoids|mesh-ancestor
111303635|NCT01666314|Hormones|hormones|mesh-ancestor
111303636|NCT01666314|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111303637|NCT01666314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111303638|NCT01666314|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111303639|NCT01666314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111303640|NCT01717209|Epoprostenol|epoprostenol|mesh-list
111303641|NCT01717209|Nitric Oxide|nitric oxide|mesh-list
111303642|NCT01717209|Tezosentan|tezosentan|mesh-list
111303643|NCT01717209|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111303644|NCT01717209|Autonomic Agents|autonomic agents|mesh-ancestor
111303645|NCT01717209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111303646|NCT01717209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111303647|NCT01717209|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111303648|NCT01717209|Respiratory System Agents|respiratory system agents|mesh-ancestor
111303649|NCT01717209|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111303650|NCT01717209|Antioxidants|antioxidants|mesh-ancestor
111303651|NCT01717209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111303652|NCT01717209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111303653|NCT01717209|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
111303654|NCT01717209|Vasodilator Agents|vasodilator agents|mesh-ancestor
111303655|NCT01717209|Gasotransmitters|gasotransmitters|mesh-ancestor
111303656|NCT01717209|Protective Agents|protective agents|mesh-ancestor
111303657|NCT01717209|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111303658|NCT01717209|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111303659|NCT00260689|Cyclosporine|cyclosporine|mesh-list
111303660|NCT00260689|Alemtuzumab|alemtuzumab|mesh-list
111303661|NCT00260689|Cyclosporins|cyclosporins|mesh-list
111303662|NCT00260689|Antilymphocyte Serum|antilymphocyte serum|mesh-list
111303663|NCT00260689|Thymoglobulin|thymoglobulin|mesh-list
111303664|NCT00260689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111303665|NCT00260689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111303666|NCT00260689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111303667|NCT00260689|Immunologic Factors|immunologic factors|mesh-ancestor
111303668|NCT00260689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111303669|NCT00260689|Antifungal Agents|antifungal agents|mesh-ancestor
111303670|NCT00260689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111303671|NCT00260689|Dermatologic Agents|dermatologic agents|mesh-ancestor
111303672|NCT00260689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111303673|NCT00260689|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111303674|NCT00260689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111303675|NCT00260689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111303676|NCT00262639|Gabapentin|gabapentin|mesh-list
111303677|NCT00262639|Flumazenil|flumazenil|mesh-list
111303678|NCT00262639|Analgesics|analgesics|mesh-ancestor
111303679|NCT00262639|Sensory System Agents|sensory system agents|mesh-ancestor
111303680|NCT00262639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111303681|NCT00262639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111303682|NCT00262639|Anticonvulsants|anticonvulsants|mesh-ancestor
111303683|NCT00262639|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111303684|NCT00262639|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111303685|NCT00262639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111303686|NCT00262639|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111303687|NCT00262639|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111303688|NCT00262639|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111303689|NCT00262639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111303690|NCT00262639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111303691|NCT00262639|Antimanic Agents|antimanic agents|mesh-ancestor
111303692|NCT00262639|Antidotes|antidotes|mesh-ancestor
111303693|NCT00262639|Protective Agents|protective agents|mesh-ancestor
111303694|NCT00262639|GABA Modulators|gaba modulators|mesh-ancestor
111303695|NCT00262639|GABA Agents|gaba agents|mesh-ancestor
111303696|NCT01062451|Candesartan|candesartan|mesh-list
111303697|NCT01062451|Candesartan cilexetil|candesartan cilexetil|mesh-list
111303698|NCT01062451|Perindopril|perindopril|mesh-list
111303699|NCT01062451|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111303700|NCT01062451|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111303701|NCT01062451|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111303702|NCT01062451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111303703|NCT01062451|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
111303704|NCT01062451|Protease Inhibitors|protease inhibitors|mesh-ancestor
111303705|NCT01062451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111303706|NCT04639843|Doxorubicin|doxorubicin|mesh-list
111303708|NCT04639843|Azacitidine|azacitidine|mesh-list
111303709|NCT04639843|Cc-486|cc-486|mesh-list
111303710|NCT04639843|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111303711|NCT04639843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111303712|NCT04639843|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111303713|NCT04639843|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111303714|NCT04639843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111303715|NCT04639843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111303716|NCT04639843|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111303717|NCT04639843|Antimetabolites|antimetabolites|mesh-ancestor
111303718|NCT04639843|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111303719|NCT01718691|Rituximab|rituximab|mesh-list
111303720|NCT01718691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111303721|NCT01718691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111303722|NCT01718691|Immunologic Factors|immunologic factors|mesh-ancestor
111303723|NCT01718691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111303724|NCT01718691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111303725|NCT05699148|Ivacaftor|ivacaftor|mesh-list
111303726|NCT05699148|Elexacaftor|elexacaftor|mesh-list
111303727|NCT05699148|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
111303728|NCT05699148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111303729|NCT05699148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111303730|NCT04638517|Danazol|danazol|mesh-list
111303731|NCT04638517|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111303732|NCT04638517|Hormone Antagonists|hormone antagonists|mesh-ancestor
111303733|NCT04638517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111303734|NCT04638517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111303735|NCT04425642|Methamphetamine|methamphetamine|mesh-list
111303736|NCT04425642|SMOFlipid|smoflipid|mesh-list
111303737|NCT04425642|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111303738|NCT04425642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111303739|NCT04425642|Sympathomimetics|sympathomimetics|mesh-ancestor
111303740|NCT04425642|Autonomic Agents|autonomic agents|mesh-ancestor
111303741|NCT04425642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111303742|NCT04425642|Dopamine Agents|dopamine agents|mesh-ancestor
111303743|NCT04425642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111303744|NCT04425642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111303745|NCT04425642|Adrenergic Agents|adrenergic agents|mesh-ancestor
111303746|NCT04425642|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111303747|NCT04425642|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111303748|NCT04425642|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111303749|NCT04425642|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111303750|NCT04425642|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
111303751|NCT04425642|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
111303752|NCT04425642|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111303753|NCT00266851|Azithromycin|azithromycin|mesh-list
111303754|NCT00266851|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111303755|NCT00266851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111303756|NCT00015847|Interferons|interferons|mesh-list
111303757|NCT00015847|Interferon-alpha|interferon-alpha|mesh-list
111303758|NCT00015847|Imatinib Mesylate|imatinib mesylate|mesh-list
111303759|NCT00015847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111303760|NCT00015847|Antiviral Agents|antiviral agents|mesh-ancestor
111303761|NCT00015847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111303762|NCT00015847|Immunologic Factors|immunologic factors|mesh-ancestor
111303763|NCT00015847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111303764|NCT00015847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111303765|NCT00015847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111303766|NCT00015847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111303767|NCT01665768|Rituximab|rituximab|mesh-list
111303768|NCT01665768|Everolimus|everolimus|mesh-list
111303769|NCT01665768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111303770|NCT01665768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111303771|NCT01665768|Immunologic Factors|immunologic factors|mesh-ancestor
111303772|NCT01665768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111303773|NCT01665768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111303774|NCT01665768|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111303775|NCT01665768|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111303776|NCT01665768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111303777|NCT01665768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111303778|NCT01665768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111303779|NCT01720173|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
111303780|NCT01720173|Immunologic Factors|immunologic factors|mesh-ancestor
111303781|NCT01720173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111303782|NCT04617457|Leucovorin|leucovorin|mesh-list
111303783|NCT04617457|Folic Acid|folic acid|mesh-list
111303784|NCT04617457|Oxaliplatin|oxaliplatin|mesh-list
111303785|NCT04617457|Irinotecan|irinotecan|mesh-list
111303786|NCT04617457|Fluorouracil|fluorouracil|mesh-list
111303787|NCT04617457|Levoleucovorin|levoleucovorin|mesh-list
111303788|NCT04617457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111303789|NCT04617457|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111303790|NCT04617457|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111303791|NCT04617457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111303792|NCT04617457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111303793|NCT04617457|Antidotes|antidotes|mesh-ancestor
111303794|NCT04617457|Protective Agents|protective agents|mesh-ancestor
111303795|NCT04617457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111303796|NCT04617457|Vitamin B Complex|vitamin b complex|mesh-ancestor
111303797|NCT04617457|Vitamins|vitamins|mesh-ancestor
111303798|NCT04617457|Micronutrients|micronutrients|mesh-ancestor
111303799|NCT04617457|Hematinics|hematinics|mesh-ancestor
111303800|NCT04617457|Antimetabolites|antimetabolites|mesh-ancestor
111303801|NCT04617457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111303802|NCT04617457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111303803|NCT04617457|Immunologic Factors|immunologic factors|mesh-ancestor
111303804|NCT00017563|Docetaxel|docetaxel|mesh-list
111303805|NCT00017563|Mitoxantrone|mitoxantrone|mesh-list
111303806|NCT00017563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111303807|NCT00017563|Tubulin Modulators|tubulin modulators|mesh-ancestor
111303808|NCT00017563|Antimitotic Agents|antimitotic agents|mesh-ancestor
111303809|NCT00017563|Mitosis Modulators|mitosis modulators|mesh-ancestor
111303810|NCT00017563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111303811|NCT00017563|Analgesics|analgesics|mesh-ancestor
111303812|NCT00017563|Sensory System Agents|sensory system agents|mesh-ancestor
111303813|NCT00017563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111303814|NCT00017563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111303815|NCT00017563|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111303816|NCT00017563|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111303817|NCT00017563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111303818|NCT00018031|Ribavirin|ribavirin|mesh-list
111303819|NCT00018031|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
111303820|NCT00018031|Interferon-alpha|interferon-alpha|mesh-list
111303821|NCT00018031|Antimetabolites|antimetabolites|mesh-ancestor
111303822|NCT00018031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111303823|NCT00018031|Antiviral Agents|antiviral agents|mesh-ancestor
111303824|NCT00018031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111303825|NCT00018031|Immunologic Factors|immunologic factors|mesh-ancestor
111303826|NCT00018031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111303827|NCT04734210|Betamethasone|betamethasone|mesh-list
111303828|NCT04734210|Betamethasone Valerate|betamethasone valerate|mesh-list
111303829|NCT04734210|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
111303830|NCT04734210|Betamethasone benzoate|betamethasone benzoate|mesh-list
111303831|NCT04734210|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
111303832|NCT04734210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111303833|NCT04734210|Glucocorticoids|glucocorticoids|mesh-ancestor
111303834|NCT04734210|Hormones|hormones|mesh-ancestor
111303835|NCT04734210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111303836|NCT04734210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111303837|NCT04734210|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111303838|NCT04734210|Respiratory System Agents|respiratory system agents|mesh-ancestor
111303839|NCT00267085|Imatinib Mesylate|imatinib mesylate|mesh-list
111303841|NCT00267085|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111303842|NCT00267085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111303843|NCT00267085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111303844|NCT04476511|Cholecalciferol|cholecalciferol|mesh-list
111303845|NCT04476511|Vitamin D|vitamin d|mesh-list
111303846|NCT04476511|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111303847|NCT04476511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111303848|NCT04476511|Vitamins|vitamins|mesh-ancestor
111303849|NCT04476511|Micronutrients|micronutrients|mesh-ancestor
111303850|NCT04476511|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111303851|NCT00026221|Interferons|interferons|mesh-list
111303852|NCT00026221|Interferon-alpha|interferon-alpha|mesh-list
111303853|NCT00026221|Bevacizumab|bevacizumab|mesh-list
111303854|NCT00026221|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111303855|NCT00026221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111303856|NCT00026221|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111303857|NCT00026221|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111303858|NCT00026221|Growth Substances|growth substances|mesh-ancestor
111303859|NCT00026221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111303860|NCT00026221|Growth Inhibitors|growth inhibitors|mesh-ancestor
111303861|NCT00026221|Antiviral Agents|antiviral agents|mesh-ancestor
111303862|NCT00026221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111303863|NCT00026221|Immunologic Factors|immunologic factors|mesh-ancestor
111303864|NCT00028093|Ribavirin|ribavirin|mesh-list
111303865|NCT00028093|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
111303866|NCT00028093|Interferon-alpha|interferon-alpha|mesh-list
111303867|NCT00028093|Antimetabolites|antimetabolites|mesh-ancestor
111303868|NCT00028093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111303869|NCT00028093|Antiviral Agents|antiviral agents|mesh-ancestor
111303870|NCT00028093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111303871|NCT00028093|Immunologic Factors|immunologic factors|mesh-ancestor
111303872|NCT00028093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111303873|NCT01721967|Ranolazine|ranolazine|mesh-list
111303874|NCT01721967|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111303875|NCT01721967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111303876|NCT01721967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111303877|NCT04026451|Propofol|propofol|mesh-list
111303878|NCT04026451|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111303879|NCT04026451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111303880|NCT04026451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111303881|NCT04026451|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111303882|NCT04026451|Anesthetics, General|anesthetics, general|mesh-ancestor
111303883|NCT04026451|Anesthetics|anesthetics|mesh-ancestor
111303884|NCT01722435|Opiate Alkaloids|opiate alkaloids|mesh-list
111303885|NCT01722435|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111303886|NCT01722435|Narcotics|narcotics|mesh-ancestor
111303887|NCT01722435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111303888|NCT01722435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111303889|NCT01722435|Analgesics|analgesics|mesh-ancestor
111303890|NCT01722435|Sensory System Agents|sensory system agents|mesh-ancestor
111303891|NCT01722435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111303892|NCT00029107|Rituximab|rituximab|mesh-list
111303893|NCT00029107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111303894|NCT00029107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111303895|NCT00029107|Immunologic Factors|immunologic factors|mesh-ancestor
111303896|NCT00029107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111303897|NCT00029107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111303898|NCT04389229|Aldesleukin|aldesleukin|mesh-list
111303899|NCT04389229|Cyclophosphamide|cyclophosphamide|mesh-list
111303900|NCT04389229|Fludarabine|fludarabine|mesh-list
111303901|NCT04389229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111303902|NCT04389229|Immunologic Factors|immunologic factors|mesh-ancestor
111303903|NCT04389229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111303904|NCT04389229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111303905|NCT04389229|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111303906|NCT04389229|Alkylating Agents|alkylating agents|mesh-ancestor
111303907|NCT04389229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111303908|NCT04389229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111303909|NCT04389229|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111303910|NCT04389229|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111303911|NCT04389229|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111303912|NCT04389229|Antiviral Agents|antiviral agents|mesh-ancestor
111303913|NCT04389229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111303914|NCT03723252|Dapagliflozin|dapagliflozin|mesh-list
111028313|NCT03208101|Vaccines|vaccines|mesh-list
111303915|NCT03723252|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111303916|NCT03723252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111303917|NCT03723252|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111303918|NCT03723252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111303919|NCT05538702|Menthol|menthol|mesh-list
111303920|NCT05538702|Antipruritics|antipruritics|mesh-ancestor
111303921|NCT05538702|Dermatologic Agents|dermatologic agents|mesh-ancestor
111303922|NCT00271219|Buprenorphine|buprenorphine|mesh-list
111303923|NCT00271219|Methadone|methadone|mesh-list
111303924|NCT00271219|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111303925|NCT00271219|Narcotics|narcotics|mesh-ancestor
111303926|NCT00271219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111303927|NCT00271219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111303928|NCT00271219|Analgesics|analgesics|mesh-ancestor
111303929|NCT00271219|Sensory System Agents|sensory system agents|mesh-ancestor
111303930|NCT00271219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111303931|NCT00271219|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111303932|NCT00271219|Antitussive Agents|antitussive agents|mesh-ancestor
111303933|NCT00271219|Respiratory System Agents|respiratory system agents|mesh-ancestor
111303934|NCT02240667|Vitamin K|vitamin k|mesh-list
111303935|NCT02240667|Dabigatran|dabigatran|mesh-list
111303936|NCT02240667|Phenprocoumon|phenprocoumon|mesh-list
111303937|NCT02240667|Vitamins|vitamins|mesh-ancestor
111303938|NCT02240667|Micronutrients|micronutrients|mesh-ancestor
111303939|NCT02240667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111303940|NCT02240667|Antithrombins|antithrombins|mesh-ancestor
111303941|NCT02240667|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111303942|NCT02240667|Protease Inhibitors|protease inhibitors|mesh-ancestor
111303943|NCT02240667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111303944|NCT02240667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111303945|NCT02240667|Anticoagulants|anticoagulants|mesh-ancestor
111303946|NCT02240667|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111303947|NCT02240667|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111303948|NCT02240667|Hemostatics|hemostatics|mesh-ancestor
111303949|NCT02240667|Coagulants|coagulants|mesh-ancestor
111303950|NCT00272311|Aspirin|aspirin|mesh-list
111303951|NCT00272311|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111303952|NCT00272311|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111303953|NCT00272311|Analgesics|analgesics|mesh-ancestor
111303954|NCT00272311|Sensory System Agents|sensory system agents|mesh-ancestor
111303955|NCT00272311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111303956|NCT00272311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111303957|NCT00272311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111303958|NCT00272311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111303959|NCT00272311|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111303960|NCT00272311|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111303961|NCT00272311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111303962|NCT00272311|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111303963|NCT00272311|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111303964|NCT00272311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111303965|NCT00272311|Antipyretics|antipyretics|mesh-ancestor
111303966|NCT00038857|Fludarabine|fludarabine|mesh-list
111303967|NCT00038857|Fludarabine phosphate|fludarabine phosphate|mesh-list
111303968|NCT00038857|Melphalan|melphalan|mesh-list
111303969|NCT00038857|Thiotepa|thiotepa|mesh-list
111303970|NCT00038857|Thymoglobulin|thymoglobulin|mesh-list
111303971|NCT00038857|Antilymphocyte Serum|antilymphocyte serum|mesh-list
111303972|NCT00038857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111303973|NCT00038857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111303974|NCT00038857|Antimetabolites|antimetabolites|mesh-ancestor
111303975|NCT00038857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111303976|NCT00038857|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111303977|NCT00038857|Immunologic Factors|immunologic factors|mesh-ancestor
111303978|NCT00038857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111303979|NCT00038857|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111303980|NCT00038857|Alkylating Agents|alkylating agents|mesh-ancestor
111303981|NCT00038857|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111303982|NCT03097068|Ranibizumab|ranibizumab|mesh-list
111303983|NCT03097068|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111303984|NCT03097068|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111303985|NCT03097068|Growth Substances|growth substances|mesh-ancestor
111303986|NCT03097068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111303987|NCT03097068|Growth Inhibitors|growth inhibitors|mesh-ancestor
111303988|NCT03097068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111303989|NCT01729845|Cytarabine|cytarabine|mesh-list
111303990|NCT01729845|Etoposide|etoposide|mesh-list
111303991|NCT01729845|Podophyllotoxin|podophyllotoxin|mesh-list
111303992|NCT01729845|Mitoxantrone|mitoxantrone|mesh-list
111303993|NCT01729845|Etoposide phosphate|etoposide phosphate|mesh-list
111303995|NCT01729845|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111303996|NCT01729845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111303997|NCT01729845|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111303998|NCT01729845|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111303999|NCT01729845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111304000|NCT01729845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111304001|NCT01729845|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111304002|NCT01729845|Antimetabolites|antimetabolites|mesh-ancestor
111304003|NCT01729845|Antiviral Agents|antiviral agents|mesh-ancestor
111304004|NCT01729845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111304005|NCT01729845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111304006|NCT01729845|Immunologic Factors|immunologic factors|mesh-ancestor
111304007|NCT01729845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111304008|NCT01729845|Analgesics|analgesics|mesh-ancestor
111304009|NCT01729845|Sensory System Agents|sensory system agents|mesh-ancestor
111304010|NCT01729845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111304011|NCT01729845|Keratolytic Agents|keratolytic agents|mesh-ancestor
111304012|NCT01729845|Dermatologic Agents|dermatologic agents|mesh-ancestor
111304013|NCT01729845|Tubulin Modulators|tubulin modulators|mesh-ancestor
111304014|NCT01729845|Antimitotic Agents|antimitotic agents|mesh-ancestor
111304015|NCT01729845|Mitosis Modulators|mitosis modulators|mesh-ancestor
111304016|NCT01729923|Celecoxib|celecoxib|mesh-list
111304017|NCT01729923|Capecitabine|capecitabine|mesh-list
111304018|NCT01729923|Benzenesulfonamide|benzenesulfonamide|mesh-list
111304019|NCT01729923|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111304020|NCT01729923|Antimetabolites|antimetabolites|mesh-ancestor
111304021|NCT01729923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111304022|NCT01729923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111304023|NCT01729923|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111304024|NCT01729923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111304025|NCT01729923|Analgesics|analgesics|mesh-ancestor
111304026|NCT01729923|Sensory System Agents|sensory system agents|mesh-ancestor
111304027|NCT01729923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111304028|NCT01729923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111304029|NCT01729923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111304030|NCT01729923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111304031|NCT01729923|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111304032|NCT01729923|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111304033|NCT01729923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111304034|NCT01729923|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
111304035|NCT02584452|Dexamethasone|dexamethasone|mesh-list
111304036|NCT02584452|Fentanyl|fentanyl|mesh-list
111304037|NCT02584452|Bupivacaine|bupivacaine|mesh-list
111304038|NCT02584452|Ropivacaine|ropivacaine|mesh-list
111304039|NCT02584452|Mepivacaine|mepivacaine|mesh-list
111304040|NCT02584452|Propofol|propofol|mesh-list
111304041|NCT02584452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111304042|NCT02584452|Antiemetics|antiemetics|mesh-ancestor
111304043|NCT02584452|Autonomic Agents|autonomic agents|mesh-ancestor
111304044|NCT02584452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111304045|NCT02584452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111304046|NCT02584452|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111304047|NCT02584452|Glucocorticoids|glucocorticoids|mesh-ancestor
111304048|NCT02584452|Hormones|hormones|mesh-ancestor
111304049|NCT02584452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111304050|NCT02584452|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111304051|NCT02584452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111304052|NCT02584452|Anesthetics, Local|anesthetics, local|mesh-ancestor
111304053|NCT02584452|Anesthetics|anesthetics|mesh-ancestor
111304054|NCT02584452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111304055|NCT02584452|Sensory System Agents|sensory system agents|mesh-ancestor
111304056|NCT02584452|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111304057|NCT02584452|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111304058|NCT02584452|Anesthetics, General|anesthetics, general|mesh-ancestor
111304059|NCT02584452|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111304060|NCT02584452|Narcotics|narcotics|mesh-ancestor
111304061|NCT02584452|Analgesics|analgesics|mesh-ancestor
111304062|NCT02584452|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111304063|NCT02502006|Celecoxib|celecoxib|mesh-list
111304064|NCT02502006|Naproxen|naproxen|mesh-list
111304065|NCT02502006|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111304066|NCT02502006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111304067|NCT02502006|Analgesics|analgesics|mesh-ancestor
111304068|NCT02502006|Sensory System Agents|sensory system agents|mesh-ancestor
111304069|NCT02502006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111304070|NCT02502006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111304071|NCT02502006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111304072|NCT02502006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111304073|NCT02502006|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111304074|NCT02502006|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111304075|NCT02502006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111304076|NCT02502006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111304077|NCT02502006|Gout Suppressants|gout suppressants|mesh-ancestor
111304079|NCT05679102|Atorvastatin|atorvastatin|mesh-list
111304080|NCT05679102|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111304081|NCT05679102|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111304082|NCT05679102|Antimetabolites|antimetabolites|mesh-ancestor
111304083|NCT05679102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111304084|NCT05679102|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111304085|NCT05679102|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111304086|NCT05679102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111304087|NCT05679102|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111304088|NCT05679102|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111304089|NCT05679102|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111304090|NCT05679102|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111304091|NCT05679102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111304092|NCT05679102|Vasodilator Agents|vasodilator agents|mesh-ancestor
111304093|NCT03520491|Nivolumab|nivolumab|mesh-list
111304094|NCT03520491|Ipilimumab|ipilimumab|mesh-list
111304095|NCT03520491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111304096|NCT03520491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111304097|NCT03520491|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111304098|NCT03520491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111304099|NCT05588934|Caffeine|caffeine|mesh-list
111304100|NCT05588934|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111304101|NCT05588934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111304102|NCT05588934|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111304103|NCT05588934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111304104|NCT05588934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111304105|NCT05588934|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
111304106|NCT05588934|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111304107|NCT05588934|Purinergic Agents|purinergic agents|mesh-ancestor
111304108|NCT05588934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111304109|NCT02243007|Paclitaxel|paclitaxel|mesh-list
111304110|NCT02243007|Gemcitabine|gemcitabine|mesh-list
111304111|NCT02243007|Capecitabine|capecitabine|mesh-list
111304112|NCT02243007|Folfirinox|folfirinox|mesh-list
111304113|NCT02243007|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111304114|NCT02243007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111304115|NCT02243007|Tubulin Modulators|tubulin modulators|mesh-ancestor
111304116|NCT02243007|Antimitotic Agents|antimitotic agents|mesh-ancestor
111304117|NCT02243007|Mitosis Modulators|mitosis modulators|mesh-ancestor
111304118|NCT02243007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111304119|NCT02243007|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111304120|NCT02243007|Antimetabolites|antimetabolites|mesh-ancestor
111304121|NCT05536596|Hydroxocobalamin|hydroxocobalamin|mesh-list
111304122|NCT05536596|Vitamin B 12|vitamin b 12|mesh-list
111304123|NCT05536596|Melatonin|melatonin|mesh-list
111304124|NCT05536596|Antioxidants|antioxidants|mesh-ancestor
111304125|NCT05536596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111304126|NCT05536596|Protective Agents|protective agents|mesh-ancestor
111304127|NCT05536596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111304128|NCT05536596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111304129|NCT05536596|Hematinics|hematinics|mesh-ancestor
111304130|NCT05536596|Vitamin B Complex|vitamin b complex|mesh-ancestor
111304131|NCT05536596|Vitamins|vitamins|mesh-ancestor
111304132|NCT05536596|Micronutrients|micronutrients|mesh-ancestor
111304133|NCT03469011|Imatinib Mesylate|imatinib mesylate|mesh-list
111304134|NCT03469011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111304135|NCT03469011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111304136|NCT03469011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111304137|NCT03469011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111304138|NCT03430791|Nivolumab|nivolumab|mesh-list
111304139|NCT03430791|Ipilimumab|ipilimumab|mesh-list
111304140|NCT03430791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111304141|NCT03430791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111304142|NCT03430791|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111304143|NCT03430791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111304144|NCT05536128|Fulvestrant|fulvestrant|mesh-list
111304145|NCT05536128|Olaparib|olaparib|mesh-list
111304146|NCT05536128|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111304147|NCT05536128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111304148|NCT05536128|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
111304149|NCT05536128|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111304150|NCT05536128|Hormone Antagonists|hormone antagonists|mesh-ancestor
111304151|NCT05536128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111304152|NCT05536128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111304153|NCT05536128|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111304154|NCT05536128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111304155|NCT05536128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111304156|NCT04790175|Tolvaptan|tolvaptan|mesh-list
111304157|NCT04790175|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
111304158|NCT04790175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111304159|NCT04790175|Natriuretic Agents|natriuretic agents|mesh-ancestor
111304160|NCT04790175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111304161|NCT05316675|Isotretinoin|isotretinoin|mesh-list
111304162|NCT05316675|Dermatologic Agents|dermatologic agents|mesh-ancestor
111304163|NCT02582814|Dapagliflozin|dapagliflozin|mesh-list
111304164|NCT02582814|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111304165|NCT02582814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111304166|NCT02582814|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111304167|NCT02582814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111304168|NCT01736865|Cholecalciferol|cholecalciferol|mesh-list
111304169|NCT01736865|Vitamin D|vitamin d|mesh-list
111304170|NCT01736865|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111304171|NCT01736865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111304172|NCT01736865|Vitamins|vitamins|mesh-ancestor
111304173|NCT01736865|Micronutrients|micronutrients|mesh-ancestor
111304174|NCT01736865|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111304175|NCT01736943|Doxorubicin|doxorubicin|mesh-list
111304176|NCT01736943|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111304177|NCT01736943|Bortezomib|bortezomib|mesh-list
111304178|NCT01736943|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111304179|NCT01736943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111304180|NCT01736943|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111304181|NCT01736943|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111304182|NCT01736943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111304183|NCT01736943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111304184|NCT01739361|Acetaminophen|acetaminophen|mesh-list
111304185|NCT01739361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111304186|NCT01739361|Analgesics|analgesics|mesh-ancestor
111304187|NCT01739361|Sensory System Agents|sensory system agents|mesh-ancestor
111304188|NCT01739361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111304189|NCT01739361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111304190|NCT01739361|Antipyretics|antipyretics|mesh-ancestor
111304191|NCT01743729|Lifitegrast|lifitegrast|mesh-list
111304192|NCT01743729|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
111304193|NCT01743729|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111304194|NCT01744353|Oxaliplatin|oxaliplatin|mesh-list
111304195|NCT01744353|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111304196|NCT01744353|Paclitaxel|paclitaxel|mesh-list
111304197|NCT01744353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111304198|NCT01744353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111304199|NCT01744353|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111304200|NCT01744353|Tubulin Modulators|tubulin modulators|mesh-ancestor
111304201|NCT01744353|Antimitotic Agents|antimitotic agents|mesh-ancestor
111304202|NCT01744353|Mitosis Modulators|mitosis modulators|mesh-ancestor
111304203|NCT01744821|Vitamin D|vitamin d|mesh-list
111304204|NCT01744821|Cholecalciferol|cholecalciferol|mesh-list
111304205|NCT01744821|Vitamins|vitamins|mesh-ancestor
111304206|NCT01744821|Micronutrients|micronutrients|mesh-ancestor
111304207|NCT01744821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111304208|NCT01744821|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111304209|NCT01744821|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111304210|NCT04369365|Azithromycin|azithromycin|mesh-list
111304211|NCT04369365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111304212|NCT04369365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111304213|NCT01745055|Methotrexate|methotrexate|mesh-list
111304214|NCT01745055|Tofacitinib|tofacitinib|mesh-list
111304215|NCT01745055|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111304216|NCT01745055|Abortifacient Agents|abortifacient agents|mesh-ancestor
111304217|NCT01745055|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111304218|NCT01745055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111304219|NCT01745055|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111304220|NCT01745055|Antimetabolites|antimetabolites|mesh-ancestor
111304221|NCT01745055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111304222|NCT01745055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111304223|NCT01745055|Dermatologic Agents|dermatologic agents|mesh-ancestor
111304224|NCT01745055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111304225|NCT01745055|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111304226|NCT01745055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111304227|NCT01745055|Immunologic Factors|immunologic factors|mesh-ancestor
111304228|NCT01745055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111304229|NCT01745055|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111304230|NCT01745055|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
111304231|NCT01745055|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111304232|NCT01745133|Calcitriol|calcitriol|mesh-list
111304233|NCT01745133|Clobetasol|clobetasol|mesh-list
111304234|NCT01745133|Calcipotriene|calcipotriene|mesh-list
111304235|NCT01745133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111304236|NCT01745133|Glucocorticoids|glucocorticoids|mesh-ancestor
111304237|NCT01745133|Hormones|hormones|mesh-ancestor
111304238|NCT01745133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111304239|NCT01745133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111304240|NCT01745133|Dermatologic Agents|dermatologic agents|mesh-ancestor
111304241|NCT01745133|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111304242|NCT01745133|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
111304243|NCT01745133|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111304244|NCT01745133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111304245|NCT01745133|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111304246|NCT01745133|Vitamins|vitamins|mesh-ancestor
111304247|NCT01745133|Micronutrients|micronutrients|mesh-ancestor
111304248|NCT01745133|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111304249|NCT05302011|Carboplatin|carboplatin|mesh-list
111304250|NCT05302011|Docetaxel|docetaxel|mesh-list
111304251|NCT05302011|Pembrolizumab|pembrolizumab|mesh-list
111304252|NCT05302011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111304253|NCT05302011|Tubulin Modulators|tubulin modulators|mesh-ancestor
111304254|NCT05302011|Antimitotic Agents|antimitotic agents|mesh-ancestor
111304255|NCT05302011|Mitosis Modulators|mitosis modulators|mesh-ancestor
111304256|NCT05302011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111304257|NCT05302011|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111304258|NCT05302011|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111304259|NCT04769271|Tea Tree Oil|tea tree oil|mesh-list
111304260|NCT04769271|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111304261|NCT04769271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111304262|NCT04246359|Interferons|interferons|mesh-list
111304263|NCT04246359|Rituximab|rituximab|mesh-list
111304264|NCT04246359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111304265|NCT04246359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111304266|NCT04246359|Immunologic Factors|immunologic factors|mesh-ancestor
111304267|NCT04246359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111304268|NCT04246359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111304269|NCT04246359|Antiviral Agents|antiviral agents|mesh-ancestor
111304270|NCT04246359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111304271|NCT05213169|Apomorphine|apomorphine|mesh-list
111304272|NCT05213169|Emetics|emetics|mesh-ancestor
111304273|NCT05213169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111304274|NCT05213169|Autonomic Agents|autonomic agents|mesh-ancestor
111304275|NCT05213169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111304276|NCT05213169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111304277|NCT05213169|Dopamine Agonists|dopamine agonists|mesh-ancestor
111304278|NCT05213169|Dopamine Agents|dopamine agents|mesh-ancestor
111304279|NCT05213169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111304280|NCT05213169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111304281|NCT05192265|Artesunate|artesunate|mesh-list
111304282|NCT05192265|Lumefantrine|lumefantrine|mesh-list
111304283|NCT05192265|Artemether|artemether|mesh-list
111304284|NCT05192265|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
111304285|NCT05192265|Pyronaridine|pyronaridine|mesh-list
111304286|NCT05192265|Antimalarials|antimalarials|mesh-list
111304287|NCT05192265|Pyronaridine tetraphosphate, artesunate drug combination|pyronaridine tetraphosphate, artesunate drug combination|mesh-list
111304288|NCT05192265|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111304289|NCT05192265|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111304290|NCT05192265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111304291|NCT05192265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111304292|NCT05192265|Antiviral Agents|antiviral agents|mesh-ancestor
111304293|NCT05192265|Schistosomicides|schistosomicides|mesh-ancestor
111304294|NCT05192265|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
111028703|NCT03203967|Morphine|morphine|mesh-list
111304295|NCT05192265|Anthelmintics|anthelmintics|mesh-ancestor
111304296|NCT01748643|Glycopyrrolate|glycopyrrolate|mesh-list
111304297|NCT01748643|Rocuronium|rocuronium|mesh-list
111304298|NCT01748643|Neostigmine|neostigmine|mesh-list
111304299|NCT01748643|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
111304300|NCT01748643|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
111304301|NCT01748643|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111304302|NCT01748643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111304303|NCT01748643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111304304|NCT01748643|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111304305|NCT01748643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111304306|NCT01748643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111304307|NCT01748643|Cholinergic Agents|cholinergic agents|mesh-ancestor
111304308|NCT01748643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111304309|NCT01748643|Parasympathomimetics|parasympathomimetics|mesh-ancestor
111304310|NCT01748643|Autonomic Agents|autonomic agents|mesh-ancestor
111304311|NCT01748643|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111304312|NCT01748643|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111304313|NCT01748643|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111304314|NCT00106535|Methotrexate|methotrexate|mesh-list
111304315|NCT00106535|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111304316|NCT00106535|Abortifacient Agents|abortifacient agents|mesh-ancestor
111304317|NCT00106535|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111304318|NCT00106535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111304319|NCT00106535|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111304320|NCT00106535|Antimetabolites|antimetabolites|mesh-ancestor
111304321|NCT00106535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111304322|NCT00106535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111304323|NCT00106535|Dermatologic Agents|dermatologic agents|mesh-ancestor
111304324|NCT00106535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111304325|NCT00106535|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111304326|NCT00106535|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111304327|NCT00106535|Immunologic Factors|immunologic factors|mesh-ancestor
111304328|NCT00106535|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111304329|NCT00106535|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111304330|NCT01748799|Ethanol|ethanol|mesh-list
111304331|NCT01748799|Nabiximols|nabiximols|mesh-list
111304332|NCT01748799|Dronabinol|dronabinol|mesh-list
111304333|NCT01748799|Cannabidiol|cannabidiol|mesh-list
111304334|NCT01748799|Peppermint oil|peppermint oil|mesh-list
111304335|NCT01748799|Anticonvulsants|anticonvulsants|mesh-ancestor
111304336|NCT01748799|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111304337|NCT01748799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111304338|NCT01748799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111304339|NCT01748799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111304340|NCT01748799|Analgesics|analgesics|mesh-ancestor
111304341|NCT01748799|Sensory System Agents|sensory system agents|mesh-ancestor
111304342|NCT01748799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111304343|NCT01748799|Hallucinogens|hallucinogens|mesh-ancestor
111304344|NCT01748799|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111304345|NCT01748799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111304346|NCT01748799|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
111304347|NCT01748799|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
111304348|NCT01748799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111304349|NCT01748799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111304350|NCT01748799|Hormones|hormones|mesh-ancestor
111304351|NCT01748799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111304352|NCT01748799|Antiemetics|antiemetics|mesh-ancestor
111304353|NCT01748799|Autonomic Agents|autonomic agents|mesh-ancestor
111304354|NCT01748799|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111304355|NCT01748799|Parasympatholytics|parasympatholytics|mesh-ancestor
111304356|NCT04107051|Nalmefene|nalmefene|mesh-list
111304357|NCT04107051|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111304358|NCT04107051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111304359|NCT04107051|Sensory System Agents|sensory system agents|mesh-ancestor
111304360|NCT04107051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111304361|NCT05696886|Meperidine|meperidine|mesh-list
111304362|NCT05696886|Tramadol|tramadol|mesh-list
111304363|NCT05696886|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111304364|NCT05696886|Narcotics|narcotics|mesh-ancestor
111304365|NCT05696886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111304366|NCT05696886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111304367|NCT05696886|Analgesics|analgesics|mesh-ancestor
111304368|NCT05696886|Sensory System Agents|sensory system agents|mesh-ancestor
111304369|NCT05696886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111304370|NCT05696886|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111304371|NCT01748955|Bupropion|bupropion|mesh-list
111304372|NCT01748955|Paroxetine|paroxetine|mesh-list
111304373|NCT01748955|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111304374|NCT01748955|Antidepressive Agents|antidepressive agents|mesh-ancestor
111304375|NCT01748955|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111304376|NCT01748955|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111304377|NCT01748955|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111304378|NCT01748955|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111304379|NCT01748955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111304380|NCT01748955|Dopamine Agents|dopamine agents|mesh-ancestor
111304381|NCT01748955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111304382|NCT01748955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111304383|NCT01748955|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111304384|NCT01748955|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111304385|NCT01748955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111304386|NCT01748955|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111304387|NCT01748955|Serotonin Agents|serotonin agents|mesh-ancestor
111304388|NCT05687448|Warfarin|warfarin|mesh-list
111304389|NCT05687448|Apixaban|apixaban|mesh-list
111304390|NCT05687448|Anticoagulants|anticoagulants|mesh-ancestor
111304391|NCT05687448|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111304392|NCT05687448|Antithrombins|antithrombins|mesh-ancestor
111304393|NCT05687448|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111304394|NCT05687448|Protease Inhibitors|protease inhibitors|mesh-ancestor
111304395|NCT05687448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111304396|NCT05687448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111304397|NCT01749501|Rocuronium|rocuronium|mesh-list
111304398|NCT01749501|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
111304399|NCT01749501|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
111304400|NCT01749501|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111304401|NCT01749501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111304402|NCT01749501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111304403|NCT02255175|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
111304404|NCT02255175|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
111304405|NCT02255175|Estradiol|estradiol|mesh-list
111304406|NCT02255175|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
111304407|NCT02255175|Progesterone|progesterone|mesh-list
111304408|NCT02255175|Estrogens|estrogens|mesh-ancestor
111304409|NCT02255175|Hormones|hormones|mesh-ancestor
111304410|NCT02255175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111304411|NCT02255175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111304412|NCT02255175|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111304413|NCT02255175|Contraceptive Agents|contraceptive agents|mesh-ancestor
111304414|NCT02255175|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111304415|NCT02255175|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111304416|NCT02255175|Progestins|progestins|mesh-ancestor
111304417|NCT02585778|Hypoglycemic Agents|hypoglycemic agents|mesh-list
111304418|NCT02585778|Alirocumab|alirocumab|mesh-list
111304419|NCT02585778|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
111304420|NCT02585778|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111304421|NCT02585778|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111304422|NCT02585778|Antimetabolites|antimetabolites|mesh-ancestor
111304423|NCT02585778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111304424|NCT02585778|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111304425|NCT02585778|Protease Inhibitors|protease inhibitors|mesh-ancestor
111304426|NCT02585778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111304427|NCT02585778|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111304428|NCT02585778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111304429|NCT03899103|Mycophenolic Acid|mycophenolic acid|mesh-list
111304430|NCT03899103|Rituximab|rituximab|mesh-list
111304431|NCT03899103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111304432|NCT03899103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111304433|NCT03899103|Immunologic Factors|immunologic factors|mesh-ancestor
111304434|NCT03899103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111304435|NCT03899103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111304436|NCT03899103|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111304437|NCT03899103|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111304438|NCT03899103|Antitubercular Agents|antitubercular agents|mesh-ancestor
111304439|NCT03899103|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111304440|NCT03899103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111304441|NCT03899103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111304442|NCT03899103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111304443|NCT01751451|Abiraterone Acetate|abiraterone acetate|mesh-list
111304444|NCT01751451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111304445|NCT01751451|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111304446|NCT01751451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111304447|NCT01751451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111304448|NCT01751451|Hormone Antagonists|hormone antagonists|mesh-ancestor
111304449|NCT01751451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111304450|NCT01751451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111304451|NCT01751451|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111304452|NCT01438424|Lamivudine|lamivudine|mesh-list
111304453|NCT01438424|Entecavir|entecavir|mesh-list
111304454|NCT01438424|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111304455|NCT01438424|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111304456|NCT01438424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111304457|NCT01438424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111304458|NCT01438424|Antiviral Agents|antiviral agents|mesh-ancestor
111304459|NCT01438424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111304460|NCT01438424|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111304461|NCT01438424|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111304462|NCT02580240|Hydrocortisone|hydrocortisone|mesh-list
111304463|NCT02580240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111304464|NCT01465958|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111304465|NCT01465958|gamma-Globulins|gamma-globulins|mesh-list
111304466|NCT01465958|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
111304467|NCT01465958|Immunoglobulin G|immunoglobulin g|mesh-list
111304468|NCT01465958|Immunologic Factors|immunologic factors|mesh-ancestor
111304469|NCT01465958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111304470|NCT05299866|Ketamine|ketamine|mesh-list
111304471|NCT05299866|Esketamine|esketamine|mesh-list
111304472|NCT05299866|Analgesics|analgesics|mesh-ancestor
111304473|NCT05299866|Sensory System Agents|sensory system agents|mesh-ancestor
111304474|NCT05299866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111304475|NCT05299866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111304476|NCT05299866|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111304477|NCT05299866|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111304478|NCT05299866|Anesthetics, General|anesthetics, general|mesh-ancestor
111304479|NCT05299866|Anesthetics|anesthetics|mesh-ancestor
111304480|NCT05299866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111304481|NCT05299866|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111304482|NCT05299866|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111304483|NCT05299866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111304484|NCT05299866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111304485|NCT05299866|Antidepressive Agents|antidepressive agents|mesh-ancestor
111304486|NCT05299866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111304487|NCT04133376|Nicotine|nicotine|mesh-list
111304488|NCT04133376|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111304489|NCT04133376|Autonomic Agents|autonomic agents|mesh-ancestor
111304490|NCT04133376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111304491|NCT04133376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111304492|NCT04133376|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111304493|NCT04133376|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111304494|NCT04133376|Cholinergic Agents|cholinergic agents|mesh-ancestor
111304495|NCT04133376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111304496|NCT04133376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111304497|NCT01753557|Interferon alpha-2|interferon alpha-2|mesh-list
111304498|NCT01753557|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
111304499|NCT01753557|Antiviral Agents|antiviral agents|mesh-ancestor
111304500|NCT01753557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111304501|NCT01753557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111304502|NCT05267886|Dobutamine|dobutamine|mesh-list
111304503|NCT05267886|Milrinone|milrinone|mesh-list
111304504|NCT05267886|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111304505|NCT05267886|Sympathomimetics|sympathomimetics|mesh-ancestor
111304506|NCT05267886|Autonomic Agents|autonomic agents|mesh-ancestor
111304507|NCT05267886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111304508|NCT05267886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111304509|NCT05267886|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
111304510|NCT05267886|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111304511|NCT05267886|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111304512|NCT05267886|Adrenergic Agents|adrenergic agents|mesh-ancestor
111304513|NCT05267886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111304514|NCT05267886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111304515|NCT05267886|Protective Agents|protective agents|mesh-ancestor
111304516|NCT05267886|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111304517|NCT05267886|Vasodilator Agents|vasodilator agents|mesh-ancestor
111304518|NCT05267886|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
111304519|NCT05267886|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111304520|NCT05267886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111304522|NCT02250807|Simeprevir|simeprevir|mesh-list
111304523|NCT02250807|Antiviral Agents|antiviral agents|mesh-ancestor
111304524|NCT02250807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111304525|NCT02250807|Protease Inhibitors|protease inhibitors|mesh-ancestor
111304526|NCT02250807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111304527|NCT02250807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111304528|NCT05694936|Cetuximab|cetuximab|mesh-list
111304529|NCT05694936|Panitumumab|panitumumab|mesh-list
111304530|NCT05694936|Valproic Acid|valproic acid|mesh-list
111304531|NCT05694936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111304532|NCT05694936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111304533|NCT05694936|Anticonvulsants|anticonvulsants|mesh-ancestor
111304534|NCT05694936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111304535|NCT05694936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111304536|NCT05694936|GABA Agents|gaba agents|mesh-ancestor
111304537|NCT05694936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111304538|NCT05694936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111304539|NCT05694936|Antimanic Agents|antimanic agents|mesh-ancestor
111304540|NCT05694936|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111304541|NCT05694936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111304542|NCT05694936|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111304543|NCT00168389|Dexamethasone|dexamethasone|mesh-list
111304544|NCT00168389|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111304545|NCT00168389|Antiemetics|antiemetics|mesh-ancestor
111304546|NCT00168389|Autonomic Agents|autonomic agents|mesh-ancestor
111304547|NCT00168389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111304548|NCT00168389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111304549|NCT00168389|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111304550|NCT00168389|Glucocorticoids|glucocorticoids|mesh-ancestor
111304551|NCT00168389|Hormones|hormones|mesh-ancestor
111304552|NCT00168389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111304553|NCT00168389|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111304554|NCT00168389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111304555|NCT02252445|Propofol|propofol|mesh-list
111304556|NCT02252445|Sevoflurane|sevoflurane|mesh-list
111304557|NCT02252445|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111304558|NCT02252445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111304559|NCT02252445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111304560|NCT02252445|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111304561|NCT02252445|Anesthetics, General|anesthetics, general|mesh-ancestor
111304562|NCT02252445|Anesthetics|anesthetics|mesh-ancestor
111304563|NCT02252445|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111304564|NCT02252445|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111304565|NCT04592952|Calcitonin|calcitonin|mesh-list
111304566|NCT04592952|Salmon calcitonin|salmon calcitonin|mesh-list
111304567|NCT04592952|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
111304568|NCT04592952|Erenumab|erenumab|mesh-list
111304569|NCT04592952|Katacalcin|katacalcin|mesh-list
111304570|NCT04592952|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
111304571|NCT04592952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111304572|NCT04592952|Analgesics|analgesics|mesh-ancestor
111304573|NCT04592952|Sensory System Agents|sensory system agents|mesh-ancestor
111304574|NCT04592952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111304575|NCT04592952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111304576|NCT04592952|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111304577|NCT04592952|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111304578|NCT04592952|Vasodilator Agents|vasodilator agents|mesh-ancestor
111304579|NCT00176423|Galantamine|galantamine|mesh-list
111304580|NCT00176423|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111304581|NCT00176423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111304582|NCT00176423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111304583|NCT00176423|Cholinergic Agents|cholinergic agents|mesh-ancestor
111304584|NCT00176423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111304585|NCT00176423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111304586|NCT00176423|Parasympathomimetics|parasympathomimetics|mesh-ancestor
111304587|NCT00176423|Autonomic Agents|autonomic agents|mesh-ancestor
111304588|NCT00176423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111304589|NCT00176423|Nootropic Agents|nootropic agents|mesh-ancestor
111304590|NCT02094443|Ribavirin|ribavirin|mesh-list
111304591|NCT02094443|Antimetabolites|antimetabolites|mesh-ancestor
111304592|NCT02094443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111304593|NCT02094443|Antiviral Agents|antiviral agents|mesh-ancestor
111304594|NCT02094443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111304595|NCT00110513|Antithrombins|antithrombins|mesh-list
111304596|NCT00110513|Antithrombin III|antithrombin iii|mesh-list
111304597|NCT00110513|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111304598|NCT00110513|Protease Inhibitors|protease inhibitors|mesh-ancestor
111304599|NCT00110513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111304600|NCT00110513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111304601|NCT00110513|Anticoagulants|anticoagulants|mesh-ancestor
111304602|NCT05691426|Nitric Oxide|nitric oxide|mesh-list
111304603|NCT05691426|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111304604|NCT05691426|Autonomic Agents|autonomic agents|mesh-ancestor
111304605|NCT05691426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111304606|NCT05691426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111304607|NCT05691426|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111304608|NCT05691426|Respiratory System Agents|respiratory system agents|mesh-ancestor
111304609|NCT05691426|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111304610|NCT05691426|Antioxidants|antioxidants|mesh-ancestor
111304611|NCT05691426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111304612|NCT05691426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111304613|NCT05691426|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
111304614|NCT05691426|Vasodilator Agents|vasodilator agents|mesh-ancestor
111304615|NCT05691426|Gasotransmitters|gasotransmitters|mesh-ancestor
111304616|NCT05691426|Protective Agents|protective agents|mesh-ancestor
111304617|NCT05696574|Misoprostol|misoprostol|mesh-list
111304618|NCT05696574|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111304619|NCT05696574|Abortifacient Agents|abortifacient agents|mesh-ancestor
111304620|NCT05696574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111304621|NCT05696574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111304622|NCT05696574|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111304623|NCT05696574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111304624|NCT05696574|Oxytocics|oxytocics|mesh-ancestor
111304625|NCT00112151|Methyltestosterone|methyltestosterone|mesh-list
111304626|NCT00112151|Testosterone|testosterone|mesh-list
111304627|NCT00112151|Testosterone undecanoate|testosterone undecanoate|mesh-list
111304628|NCT00112151|Testosterone enanthate|testosterone enanthate|mesh-list
110979845|NCT03235700|Vitamins|vitamins|mesh-ancestor
111304629|NCT00112151|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
111304630|NCT00112151|Androgens|androgens|mesh-ancestor
111304632|NCT00112151|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111304633|NCT00112151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111304634|NCT00112151|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111304635|NCT00112151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111304636|NCT00112151|Anabolic Agents|anabolic agents|mesh-ancestor
111304637|NCT05162742|Colchicine|colchicine|mesh-list
111304638|NCT05162742|Gout Suppressants|gout suppressants|mesh-ancestor
111304639|NCT05162742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111304640|NCT05162742|Tubulin Modulators|tubulin modulators|mesh-ancestor
111304641|NCT05162742|Antimitotic Agents|antimitotic agents|mesh-ancestor
111304642|NCT05162742|Mitosis Modulators|mitosis modulators|mesh-ancestor
111304643|NCT05162742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111304644|NCT05162742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111304645|NCT04303026|Zoledronic Acid|zoledronic acid|mesh-list
111304646|NCT04303026|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111304647|NCT04303026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111304648|NCT00113321|Decitabine|decitabine|mesh-list
111304649|NCT00113321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111304650|NCT00113321|Antimetabolites|antimetabolites|mesh-ancestor
111304651|NCT00113321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111304652|NCT00113321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111304653|NCT00113321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111304654|NCT05669742|Empagliflozin|empagliflozin|mesh-list
111304655|NCT05669742|Olanzapine|olanzapine|mesh-list
111304656|NCT05669742|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111304657|NCT05669742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111304658|NCT05669742|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111304659|NCT05669742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111304660|NCT05669742|Antiemetics|antiemetics|mesh-ancestor
111304661|NCT05669742|Autonomic Agents|autonomic agents|mesh-ancestor
111304662|NCT05669742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111304663|NCT05669742|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111304664|NCT05669742|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111304665|NCT05669742|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111304666|NCT05669742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111304667|NCT05669742|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111304668|NCT05669742|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111304669|NCT05669742|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111304670|NCT05669742|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111304671|NCT05669742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111304672|NCT05669742|Serotonin Agents|serotonin agents|mesh-ancestor
111304673|NCT00177047|Cyclophosphamide|cyclophosphamide|mesh-list
111304674|NCT00177047|Melphalan|melphalan|mesh-list
111304675|NCT00177047|Lenograstim|lenograstim|mesh-list
111304676|NCT00177047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111304677|NCT00177047|Immunologic Factors|immunologic factors|mesh-ancestor
111304678|NCT00177047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111304679|NCT00177047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111304680|NCT00177047|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111304681|NCT00177047|Alkylating Agents|alkylating agents|mesh-ancestor
111304682|NCT00177047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111304683|NCT00177047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111304684|NCT00177047|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111304685|NCT00177047|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111304686|NCT03573921|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111304687|NCT00178841|Rosiglitazone|rosiglitazone|mesh-list
111304688|NCT00178841|Bexarotene|bexarotene|mesh-list
111304689|NCT00178841|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111304690|NCT00178841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111304691|NCT00178841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111304692|NCT01756209|Acetaminophen|acetaminophen|mesh-list
111304693|NCT01756209|Ibuprofen|ibuprofen|mesh-list
111304694|NCT01756209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111304695|NCT01756209|Analgesics|analgesics|mesh-ancestor
111304696|NCT01756209|Sensory System Agents|sensory system agents|mesh-ancestor
111304697|NCT01756209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111304698|NCT01756209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111304699|NCT01756209|Antipyretics|antipyretics|mesh-ancestor
111304700|NCT01756209|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111304701|NCT01756209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111304702|NCT01756209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111304703|NCT01756209|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111304704|NCT01756209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111304705|NCT01756209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111304706|NCT00116207|Niacinamide|niacinamide|mesh-list
111304707|NCT00116207|Allopurinol|allopurinol|mesh-list
111304708|NCT00116207|Antioxidants|antioxidants|mesh-list
111304709|NCT00116207|Antimetabolites|antimetabolites|mesh-ancestor
111304710|NCT00116207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111304711|NCT00116207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111304712|NCT00116207|Gout Suppressants|gout suppressants|mesh-ancestor
111304713|NCT00116207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111304714|NCT00116207|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111304715|NCT00116207|Protective Agents|protective agents|mesh-ancestor
111304716|NCT00116207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111304717|NCT00116207|Vitamin B Complex|vitamin b complex|mesh-ancestor
111304718|NCT00116207|Vitamins|vitamins|mesh-ancestor
111304719|NCT00116207|Micronutrients|micronutrients|mesh-ancestor
111304720|NCT04129398|Letermovir|letermovir|mesh-list
111304721|NCT04129398|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111304722|NCT04129398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111304723|NCT04129398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111304724|NCT04129398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111304725|NCT04129398|Antiviral Agents|antiviral agents|mesh-ancestor
111304726|NCT04129398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111304727|NCT00178919|Trimethaphan|trimethaphan|mesh-list
111304728|NCT00178919|Trimethaphan camsylate|trimethaphan camsylate|mesh-list
111304729|NCT00178919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111304730|NCT00178919|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111304731|NCT00178919|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111304732|NCT00178919|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
111304733|NCT00178919|Autonomic Agents|autonomic agents|mesh-ancestor
111304734|NCT00178919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111304735|NCT00178919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111304736|NCT00178919|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
111304737|NCT00178919|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111304738|NCT00178919|Cholinergic Agents|cholinergic agents|mesh-ancestor
111304739|NCT00178919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111304740|NCT00178919|Vasodilator Agents|vasodilator agents|mesh-ancestor
111304741|NCT05609682|Gabapentin|gabapentin|mesh-list
111304742|NCT05609682|Analgesics|analgesics|mesh-ancestor
111304743|NCT05609682|Sensory System Agents|sensory system agents|mesh-ancestor
111304744|NCT05609682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111304745|NCT05609682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111304746|NCT05609682|Anticonvulsants|anticonvulsants|mesh-ancestor
111304747|NCT05609682|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111304749|NCT05609682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111304750|NCT05609682|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111304751|NCT05609682|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111304752|NCT05609682|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111304753|NCT05609682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111304754|NCT05609682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111304755|NCT05609682|Antimanic Agents|antimanic agents|mesh-ancestor
111304756|NCT04284839|Warfarin|warfarin|mesh-list
111304757|NCT04284839|Rivaroxaban|rivaroxaban|mesh-list
111304758|NCT04284839|Dabigatran|dabigatran|mesh-list
111304759|NCT04284839|Apixaban|apixaban|mesh-list
111304760|NCT04284839|Edoxaban|edoxaban|mesh-list
111304761|NCT04284839|Anticoagulants|anticoagulants|mesh-ancestor
111304762|NCT04284839|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111304763|NCT04284839|Antithrombins|antithrombins|mesh-ancestor
111304764|NCT04284839|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111304765|NCT04284839|Protease Inhibitors|protease inhibitors|mesh-ancestor
111304766|NCT04284839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111304767|NCT04284839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111304768|NCT05577000|Cyclophosphamide|cyclophosphamide|mesh-list
111304769|NCT05577000|Fludarabine|fludarabine|mesh-list
111304770|NCT05577000|Idecabtagene vicleucel|idecabtagene vicleucel|mesh-list
111304771|NCT05577000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111304772|NCT05577000|Immunologic Factors|immunologic factors|mesh-ancestor
111304773|NCT05577000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111304774|NCT05577000|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111304775|NCT05577000|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111304776|NCT05577000|Alkylating Agents|alkylating agents|mesh-ancestor
111304777|NCT05577000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111304778|NCT05577000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111304779|NCT05577000|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111304780|NCT05577000|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111304781|NCT00122369|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
111304782|NCT00122369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111304783|NCT00122369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111304784|NCT00122447|Aspirin|aspirin|mesh-list
111304785|NCT00122447|Thioctic Acid|thioctic acid|mesh-list
111304786|NCT00122447|Olmesartan|olmesartan|mesh-list
111304787|NCT00122447|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111304788|NCT00122447|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111304789|NCT00122447|Analgesics|analgesics|mesh-ancestor
111304790|NCT00122447|Sensory System Agents|sensory system agents|mesh-ancestor
111304791|NCT00122447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111304792|NCT00122447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111304793|NCT00122447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111304794|NCT00122447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111304795|NCT00122447|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111304796|NCT00122447|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111304797|NCT00122447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111304798|NCT00122447|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111304799|NCT00122447|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111304800|NCT00122447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111304801|NCT00122447|Antipyretics|antipyretics|mesh-ancestor
111304802|NCT00122447|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111304803|NCT00122447|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111304804|NCT00122447|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111304805|NCT00122447|Antioxidants|antioxidants|mesh-ancestor
111304806|NCT00122447|Protective Agents|protective agents|mesh-ancestor
111304807|NCT00122447|Vitamin B Complex|vitamin b complex|mesh-ancestor
111304808|NCT00122447|Vitamins|vitamins|mesh-ancestor
111304809|NCT00122447|Micronutrients|micronutrients|mesh-ancestor
111304810|NCT00125957|Bupropion|bupropion|mesh-list
111304811|NCT00125957|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111304812|NCT00125957|Antidepressive Agents|antidepressive agents|mesh-ancestor
111304813|NCT00125957|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111304814|NCT00125957|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111304815|NCT00125957|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111304816|NCT00125957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111304817|NCT00125957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111304818|NCT00125957|Dopamine Agents|dopamine agents|mesh-ancestor
111304819|NCT00125957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111304820|NCT00125957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111304821|NCT00125957|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111304822|NCT00125957|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111304824|NCT00183443|Valproic Acid|valproic acid|mesh-list
111304825|NCT00183443|Quetiapine Fumarate|quetiapine fumarate|mesh-list
111304826|NCT00183443|Antidepressive Agents|antidepressive agents|mesh-ancestor
111304827|NCT00183443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111304828|NCT00183443|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111304829|NCT00183443|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111304830|NCT00183443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111304831|NCT00183443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111304832|NCT00183443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111304833|NCT00183443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111304834|NCT00183443|Antimanic Agents|antimanic agents|mesh-ancestor
111304835|NCT00183443|Anticonvulsants|anticonvulsants|mesh-ancestor
111304836|NCT00183443|GABA Agents|gaba agents|mesh-ancestor
111304837|NCT00183443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111304838|NCT02579928|Midazolam|midazolam|mesh-list
111304839|NCT02579928|Ketamine|ketamine|mesh-list
111304840|NCT02579928|Analgesics|analgesics|mesh-ancestor
111304841|NCT02579928|Sensory System Agents|sensory system agents|mesh-ancestor
111304842|NCT02579928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111304843|NCT02579928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111304844|NCT02579928|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111304845|NCT02579928|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111304846|NCT02579928|Anesthetics, General|anesthetics, general|mesh-ancestor
111304847|NCT02579928|Anesthetics|anesthetics|mesh-ancestor
111304848|NCT02579928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111304849|NCT02579928|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111304850|NCT02579928|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111304851|NCT02579928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111304852|NCT02579928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111304853|NCT02579928|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111304854|NCT02579928|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111304855|NCT02579928|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111304856|NCT02579928|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111304857|NCT02579928|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111304858|NCT02579928|GABA Modulators|gaba modulators|mesh-ancestor
111304859|NCT02579928|GABA Agents|gaba agents|mesh-ancestor
111304860|NCT00183677|Escitalopram|escitalopram|mesh-list
111304861|NCT00183677|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111304862|NCT00183677|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111304863|NCT00183677|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111304864|NCT00183677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111304865|NCT00183677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111304866|NCT00183677|Serotonin Agents|serotonin agents|mesh-ancestor
111304867|NCT00183677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111304868|NCT00186017|Olanzapine|olanzapine|mesh-list
111304869|NCT00186017|Antiemetics|antiemetics|mesh-ancestor
111304870|NCT00186017|Autonomic Agents|autonomic agents|mesh-ancestor
111304871|NCT00186017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111304872|NCT00186017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111304873|NCT00186017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111304874|NCT00186017|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111304875|NCT00186017|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111304876|NCT00186017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111304877|NCT00186017|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111304878|NCT00186017|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111304879|NCT00186017|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111304880|NCT00186017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111304881|NCT00186017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111304882|NCT00186017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111304883|NCT00186017|Serotonin Agents|serotonin agents|mesh-ancestor
111304884|NCT00041119|Paclitaxel|paclitaxel|mesh-list
111304885|NCT00041119|Cyclophosphamide|cyclophosphamide|mesh-list
111304886|NCT00041119|Doxorubicin|doxorubicin|mesh-list
111304887|NCT00041119|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111304888|NCT00041119|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111304889|NCT00041119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111304890|NCT00041119|Tubulin Modulators|tubulin modulators|mesh-ancestor
111304891|NCT00041119|Antimitotic Agents|antimitotic agents|mesh-ancestor
111304892|NCT00041119|Mitosis Modulators|mitosis modulators|mesh-ancestor
111304893|NCT00041119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111304894|NCT00041119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111304895|NCT00041119|Immunologic Factors|immunologic factors|mesh-ancestor
111304896|NCT00041119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111304897|NCT00041119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111304898|NCT00041119|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111304899|NCT00041119|Alkylating Agents|alkylating agents|mesh-ancestor
111304900|NCT00041119|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111304901|NCT00041119|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111304902|NCT00041119|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111304903|NCT00041119|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111304904|NCT00041119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111304905|NCT00186875|Cytarabine|cytarabine|mesh-list
111304906|NCT00186875|Dexamethasone|dexamethasone|mesh-list
111304907|NCT00186875|Dexamethasone acetate|dexamethasone acetate|mesh-list
111304908|NCT00186875|Cyclophosphamide|cyclophosphamide|mesh-list
111304909|NCT00186875|Methotrexate|methotrexate|mesh-list
111304910|NCT00186875|Etoposide|etoposide|mesh-list
111304911|NCT00186875|Etoposide phosphate|etoposide phosphate|mesh-list
111304912|NCT00186875|Vincristine|vincristine|mesh-list
111304913|NCT00186875|Asparaginase|asparaginase|mesh-list
111304914|NCT00186875|Mitoxantrone|mitoxantrone|mesh-list
111304915|NCT00186875|Mercaptopurine|mercaptopurine|mesh-list
111304916|NCT00186875|Vinblastine|vinblastine|mesh-list
111304917|NCT00186875|Pegaspargase|pegaspargase|mesh-list
111304918|NCT00186875|Teniposide|teniposide|mesh-list
111304919|NCT00186875|BB 1101|bb 1101|mesh-list
111304920|NCT00186875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111304921|NCT00186875|Immunologic Factors|immunologic factors|mesh-ancestor
111304922|NCT00186875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111304923|NCT00186875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111304924|NCT00186875|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111304925|NCT00186875|Alkylating Agents|alkylating agents|mesh-ancestor
111304926|NCT00186875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111304927|NCT00186875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111304928|NCT00186875|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111304929|NCT00186875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111304930|NCT00186875|Antiemetics|antiemetics|mesh-ancestor
111304931|NCT00186875|Autonomic Agents|autonomic agents|mesh-ancestor
111304932|NCT00186875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111304933|NCT00186875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111304934|NCT00186875|Glucocorticoids|glucocorticoids|mesh-ancestor
111304935|NCT00186875|Hormones|hormones|mesh-ancestor
111304936|NCT00186875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111304937|NCT00186875|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111304938|NCT00186875|Protease Inhibitors|protease inhibitors|mesh-ancestor
111304939|NCT00186875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111304940|NCT00186875|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111304941|NCT00186875|Abortifacient Agents|abortifacient agents|mesh-ancestor
111304942|NCT00186875|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111304943|NCT00186875|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111304944|NCT00186875|Antimetabolites|antimetabolites|mesh-ancestor
111304945|NCT00186875|Dermatologic Agents|dermatologic agents|mesh-ancestor
111304946|NCT00186875|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111304947|NCT00186875|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111304948|NCT00186875|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111304949|NCT00186875|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111304950|NCT00186875|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111304951|NCT00186875|Antiviral Agents|antiviral agents|mesh-ancestor
111304952|NCT00186875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111304953|NCT00186875|Tubulin Modulators|tubulin modulators|mesh-ancestor
111304954|NCT00186875|Antimitotic Agents|antimitotic agents|mesh-ancestor
111304955|NCT00186875|Mitosis Modulators|mitosis modulators|mesh-ancestor
111304956|NCT00186875|Analgesics|analgesics|mesh-ancestor
111304957|NCT00186875|Sensory System Agents|sensory system agents|mesh-ancestor
111304958|NCT00551460|Methotrexate|methotrexate|mesh-list
111304959|NCT00551460|Mercaptopurine|mercaptopurine|mesh-list
111304960|NCT00551460|Arsenic Trioxide|arsenic trioxide|mesh-list
111304961|NCT00551460|Tretinoin|tretinoin|mesh-list
111304962|NCT00551460|Gemtuzumab|gemtuzumab|mesh-list
111304963|NCT00551460|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111304964|NCT00551460|Abortifacient Agents|abortifacient agents|mesh-ancestor
111304965|NCT00551460|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111304966|NCT00551460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111304967|NCT00551460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111304968|NCT00551460|Antimetabolites|antimetabolites|mesh-ancestor
111304969|NCT00551460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111304970|NCT00551460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111304971|NCT00551460|Dermatologic Agents|dermatologic agents|mesh-ancestor
111304972|NCT00551460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111304973|NCT00551460|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111304974|NCT00551460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111304975|NCT00551460|Immunologic Factors|immunologic factors|mesh-ancestor
111304976|NCT00551460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111304977|NCT00551460|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111304978|NCT00551460|Keratolytic Agents|keratolytic agents|mesh-ancestor
111304979|NCT00551460|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111304980|NCT00551460|Immunotoxins|immunotoxins|mesh-ancestor
111304981|NCT00551460|Immunoconjugates|immunoconjugates|mesh-ancestor
111304982|NCT04751227|Modafinil|modafinil|mesh-list
111304983|NCT04751227|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111304984|NCT04751227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111304985|NCT04751227|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
111304986|NCT04751227|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111304987|NCT04751227|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111304988|NCT04751227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111304989|NCT02579772|Acetylcysteine|acetylcysteine|mesh-list
111304990|NCT02579772|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111304991|NCT02579772|Antiviral Agents|antiviral agents|mesh-ancestor
111304992|NCT02579772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111304993|NCT02579772|Expectorants|expectorants|mesh-ancestor
111304994|NCT02579772|Respiratory System Agents|respiratory system agents|mesh-ancestor
111304995|NCT02579772|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111304996|NCT02579772|Antioxidants|antioxidants|mesh-ancestor
111304997|NCT02579772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111304998|NCT02579772|Protective Agents|protective agents|mesh-ancestor
111304999|NCT02579772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111305000|NCT02579772|Antidotes|antidotes|mesh-ancestor
111305001|NCT05535036|Dexamethasone|dexamethasone|mesh-list
111305002|NCT05535036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111305003|NCT05535036|Antiemetics|antiemetics|mesh-ancestor
111305004|NCT05535036|Autonomic Agents|autonomic agents|mesh-ancestor
111305005|NCT05535036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111305006|NCT05535036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111305007|NCT05535036|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111305008|NCT05535036|Glucocorticoids|glucocorticoids|mesh-ancestor
111305009|NCT05535036|Hormones|hormones|mesh-ancestor
111305010|NCT05535036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111305011|NCT05535036|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111305012|NCT05535036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111305013|NCT00044005|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
111305014|NCT00044005|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111305015|NCT00044005|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111305016|NCT00044005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111305017|NCT00044005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111305018|NCT00044005|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111305019|NCT00044005|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
111305020|NCT00044005|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111305021|NCT00044005|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111305022|NCT00044005|Adrenergic Agents|adrenergic agents|mesh-ancestor
111305023|NCT00044005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111305024|NCT00044005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111305025|NCT00044005|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111305026|NCT00044005|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111305027|NCT00044005|Serotonin Agents|serotonin agents|mesh-ancestor
111305028|NCT00044005|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111305029|NCT00044005|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111305030|NCT00044005|Dopamine Agents|dopamine agents|mesh-ancestor
111305031|NCT02989701|Plerixafor|plerixafor|mesh-list
111305032|NCT02989701|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111305033|NCT02989701|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111305034|NCT02989701|Antiviral Agents|antiviral agents|mesh-ancestor
111305035|NCT02989701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111305036|NCT01790737|Cyclophosphamide|cyclophosphamide|mesh-list
111305037|NCT01790737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111305038|NCT01790737|Immunologic Factors|immunologic factors|mesh-ancestor
111305039|NCT01790737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111305040|NCT01790737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111305041|NCT01790737|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111305042|NCT01790737|Alkylating Agents|alkylating agents|mesh-ancestor
111305043|NCT01790737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111305044|NCT01790737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111305045|NCT01790737|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111305046|NCT04953156|Nitroglycerin|nitroglycerin|mesh-list
111305047|NCT04953156|Dexmedetomidine|dexmedetomidine|mesh-list
111305048|NCT04953156|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111305049|NCT04953156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111305050|NCT04953156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111305051|NCT04953156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111305052|NCT04953156|Analgesics|analgesics|mesh-ancestor
111305053|NCT04953156|Sensory System Agents|sensory system agents|mesh-ancestor
111305054|NCT04953156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111305055|NCT04953156|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111305056|NCT04953156|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111305057|NCT04953156|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111305058|NCT04953156|Adrenergic Agents|adrenergic agents|mesh-ancestor
111305059|NCT04953156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111305060|NCT04953156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111305061|NCT04953156|Vasodilator Agents|vasodilator agents|mesh-ancestor
111305062|NCT01761747|Ponatinib|ponatinib|mesh-list
111305063|NCT01761747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111305064|NCT01761747|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111305065|NCT01761747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111305066|NCT01761747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111305067|NCT00045487|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111305068|NCT00045487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111305069|NCT00045487|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111305070|NCT00045487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111305071|NCT00045487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111305072|NCT00278863|Capecitabine|capecitabine|mesh-list
111305073|NCT00278863|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111305074|NCT00278863|Antimetabolites|antimetabolites|mesh-ancestor
111305075|NCT00278863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111305076|NCT00278863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111305077|NCT01762059|Pancrelipase|pancrelipase|mesh-list
111305078|NCT01762059|Pancreatin|pancreatin|mesh-list
111305079|NCT01762059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111305080|NCT01808547|Bromfenac|bromfenac|mesh-list
111305081|NCT01808547|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111305082|NCT01808547|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111305083|NCT01808547|Analgesics|analgesics|mesh-ancestor
111305084|NCT01808547|Sensory System Agents|sensory system agents|mesh-ancestor
111305085|NCT01808547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111305086|NCT01808547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111305087|NCT01808547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111305088|NCT01808547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111305089|NCT00187655|Cefotaxime|cefotaxime|mesh-list
111305090|NCT00187655|Cefoxitin|cefoxitin|mesh-list
111305091|NCT00187655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111305092|NCT00187655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111305093|NCT02991651|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111305094|NCT02991651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111305095|NCT02991651|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111305096|NCT02991651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111305097|NCT02991651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111305098|NCT02579616|Lenvatinib|lenvatinib|mesh-list
111305099|NCT02579616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111305100|NCT02579616|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111305101|NCT02579616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111305102|NCT02579616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111305103|NCT00131885|Levonorgestrel|levonorgestrel|mesh-list
111305104|NCT00131885|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111305105|NCT00131885|Contraceptive Agents|contraceptive agents|mesh-ancestor
111305106|NCT00131885|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111305107|NCT00131885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111305108|NCT00131885|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111305109|NCT00131885|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111305110|NCT00131885|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111305111|NCT05534802|Urinastatin|urinastatin|mesh-list
111305112|NCT05534802|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
111305113|NCT05534802|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111305114|NCT05534802|Protease Inhibitors|protease inhibitors|mesh-ancestor
111305115|NCT05534802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111305116|NCT05534802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111305117|NCT01899703|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
111305118|NCT01899703|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
111305119|NCT01899703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111305120|NCT01899781|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111305121|NCT01899781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111305122|NCT01790893|Aflibercept|aflibercept|mesh-list
111305123|NCT01790893|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111305124|NCT01790893|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111305125|NCT01790893|Growth Substances|growth substances|mesh-ancestor
111305126|NCT01790893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111305127|NCT01790893|Growth Inhibitors|growth inhibitors|mesh-ancestor
111305128|NCT01790893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111305129|NCT02256111|Androgens|androgens|mesh-list
111305130|NCT02256111|Hormones|hormones|mesh-ancestor
111305131|NCT02256111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111305132|NCT02256111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111305133|NCT01790971|Morphine|morphine|mesh-list
111305134|NCT01790971|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111305135|NCT01790971|Narcotics|narcotics|mesh-ancestor
111305136|NCT01790971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111305137|NCT01790971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111305138|NCT01790971|Analgesics|analgesics|mesh-ancestor
111305139|NCT01790971|Sensory System Agents|sensory system agents|mesh-ancestor
111305140|NCT01790971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111305141|NCT00189137|Gemcitabine|gemcitabine|mesh-list
111305142|NCT00189137|Docetaxel|docetaxel|mesh-list
111305143|NCT00189137|Doxorubicin|doxorubicin|mesh-list
111305144|NCT00189137|Ifosfamide|ifosfamide|mesh-list
111305145|NCT00189137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111305146|NCT00189137|Antimetabolites|antimetabolites|mesh-ancestor
111305147|NCT00189137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111305148|NCT00189137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111305149|NCT00189137|Tubulin Modulators|tubulin modulators|mesh-ancestor
111305150|NCT00189137|Antimitotic Agents|antimitotic agents|mesh-ancestor
111305151|NCT00189137|Mitosis Modulators|mitosis modulators|mesh-ancestor
111305152|NCT00189137|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111305153|NCT00189137|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111305154|NCT00189137|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111305155|NCT00189137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111305156|NCT00189137|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111305157|NCT00189137|Alkylating Agents|alkylating agents|mesh-ancestor
111305158|NCT02099461|Denosumab|denosumab|mesh-list
111305159|NCT02099461|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111305160|NCT02099461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111305161|NCT02256189|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111305162|NCT02256189|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111305163|NCT02256189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111305164|NCT02256189|Incretins|incretins|mesh-ancestor
111305165|NCT02256189|Hormones|hormones|mesh-ancestor
111305166|NCT02256189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111305167|NCT02256189|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111305168|NCT02256189|Protease Inhibitors|protease inhibitors|mesh-ancestor
111305169|NCT02256189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111305170|NCT02256189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111305171|NCT00193037|Docetaxel|docetaxel|mesh-list
111305172|NCT00193037|Doxorubicin|doxorubicin|mesh-list
111305173|NCT00193037|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111305174|NCT00193037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111305175|NCT00193037|Tubulin Modulators|tubulin modulators|mesh-ancestor
111305176|NCT00193037|Antimitotic Agents|antimitotic agents|mesh-ancestor
111305177|NCT00193037|Mitosis Modulators|mitosis modulators|mesh-ancestor
111305178|NCT00193037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111305179|NCT00193037|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111305180|NCT00193037|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111305181|NCT00193037|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111305182|NCT00193037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111305183|NCT02100007|Topotecan|topotecan|mesh-list
111305184|NCT02100007|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111305185|NCT02100007|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111305186|NCT02100007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111305187|NCT02100007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111305188|NCT02100007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111305189|NCT05392764|Empagliflozin|empagliflozin|mesh-list
111305190|NCT05392764|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111305191|NCT05392764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111305192|NCT05392764|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111305193|NCT05392764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111305194|NCT01809639|Progesterone|progesterone|mesh-list
111305195|NCT01809639|Progestins|progestins|mesh-ancestor
111305196|NCT01809639|Hormones|hormones|mesh-ancestor
111305197|NCT01809639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111305198|NCT01809639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111305199|NCT05391750|Venetoclax|venetoclax|mesh-list
111305200|NCT05391750|Immunoglobulins|immunoglobulins|mesh-list
111305201|NCT05391750|Immunoglobulin G|immunoglobulin g|mesh-list
111305202|NCT05391750|Immunologic Factors|immunologic factors|mesh-ancestor
111305203|NCT05391750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111305204|NCT05391750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111305205|NCT01763931|Digoxin|digoxin|mesh-list
111305206|NCT01763931|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111305207|NCT01763931|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111305208|NCT01763931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111305209|NCT01763931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111305210|NCT01763931|Protective Agents|protective agents|mesh-ancestor
111305211|NCT01763931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111305212|NCT02822625|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
111305213|NCT02822625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111305214|NCT02822625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111305215|NCT04677114|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111305216|NCT04677114|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
111305217|NCT04677114|Buprenorphine|buprenorphine|mesh-list
111305218|NCT04677114|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
111305219|NCT04677114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111305220|NCT04677114|Antitubercular Agents|antitubercular agents|mesh-ancestor
111305221|NCT04677114|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111305222|NCT04677114|Narcotics|narcotics|mesh-ancestor
111305223|NCT04677114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111305224|NCT04677114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111305225|NCT04677114|Analgesics|analgesics|mesh-ancestor
111305226|NCT04677114|Sensory System Agents|sensory system agents|mesh-ancestor
111305227|NCT04677114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111305228|NCT04677114|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111305229|NCT02783859|Amoxicillin|amoxicillin|mesh-list
111305230|NCT02783859|Clavulanic Acids|clavulanic acids|mesh-list
111305231|NCT02783859|Clavulanic Acid|clavulanic acid|mesh-list
111305232|NCT02783859|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
111305233|NCT02783859|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111305234|NCT02783859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111305235|NCT02783859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111305236|NCT02783859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111305237|NCT02783859|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
111305238|NCT01765803|Thioridazine|thioridazine|mesh-list
111305239|NCT01765803|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111305240|NCT01765803|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111305241|NCT01765803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111305242|NCT01765803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111305243|NCT01765803|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111305244|NCT01765803|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111305245|NCT01765803|Dopamine Agents|dopamine agents|mesh-ancestor
111305246|NCT01765803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111305247|NCT01765803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111305248|NCT02566395|Cyclophosphamide|cyclophosphamide|mesh-list
111305249|NCT02566395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111305250|NCT02566395|Immunologic Factors|immunologic factors|mesh-ancestor
111305251|NCT02566395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111305252|NCT02566395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111305253|NCT02566395|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111305254|NCT02566395|Alkylating Agents|alkylating agents|mesh-ancestor
111305255|NCT02566395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111305256|NCT02566395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111305257|NCT02566395|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111305258|NCT01811355|Mexiletine|mexiletine|mesh-list
111305259|NCT01811355|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111305260|NCT01811355|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111305261|NCT01811355|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111305262|NCT01811355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111305263|NCT01811355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111305264|NCT05534334|Hydrocortisone|hydrocortisone|mesh-list
111305265|NCT05534334|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
111305266|NCT05534334|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
111305267|NCT05534334|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
111305268|NCT05534334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111305269|NCT01767285|Etonogestrel|etonogestrel|mesh-list
111305270|NCT01767285|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111305271|NCT01767285|Contraceptive Agents|contraceptive agents|mesh-ancestor
111305272|NCT01767285|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111305273|NCT01767285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111305274|NCT01767285|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111305275|NCT02100891|Immunomodulating Agents|immunomodulating agents|mesh-list
111305276|NCT02100891|Immunologic Factors|immunologic factors|mesh-ancestor
111305277|NCT02100891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111305279|NCT01465802|Alclometasone dipropionate|alclometasone dipropionate|mesh-list
111305280|NCT01465802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111305281|NCT01465802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111305282|NCT01465802|Antimalarials|antimalarials|mesh-ancestor
111305283|NCT01465802|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111305284|NCT01465802|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111305285|NCT01465802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111305286|NCT01465802|Glucocorticoids|glucocorticoids|mesh-ancestor
111305287|NCT01465802|Hormones|hormones|mesh-ancestor
111305288|NCT01465802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111305289|NCT01465802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111305290|NCT01813149|Clonidine|clonidine|mesh-list
111305291|NCT01813149|Phenylephrine|phenylephrine|mesh-list
111305292|NCT01813149|Oxymetazoline|oxymetazoline|mesh-list
111305293|NCT01813149|Anesthetics|anesthetics|mesh-list
111305294|NCT01813149|Anesthetics, Local|anesthetics, local|mesh-list
111305295|NCT01813149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111305296|NCT01813149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111305297|NCT01813149|Sensory System Agents|sensory system agents|mesh-ancestor
111305298|NCT01813149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111305299|NCT01813149|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111305300|NCT01813149|Mydriatics|mydriatics|mesh-ancestor
111305301|NCT01813149|Autonomic Agents|autonomic agents|mesh-ancestor
111305302|NCT01813149|Sympathomimetics|sympathomimetics|mesh-ancestor
111305303|NCT01813149|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111305304|NCT01813149|Nasal Decongestants|nasal decongestants|mesh-ancestor
111305305|NCT01813149|Respiratory System Agents|respiratory system agents|mesh-ancestor
111305306|NCT01813149|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111305307|NCT01813149|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111305308|NCT01813149|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111305309|NCT01813149|Adrenergic Agents|adrenergic agents|mesh-ancestor
111305310|NCT01813149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111305311|NCT01813149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111305312|NCT01813149|Protective Agents|protective agents|mesh-ancestor
111305313|NCT01813149|Analgesics|analgesics|mesh-ancestor
111305314|NCT01813149|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111305315|NCT01813149|Sympatholytics|sympatholytics|mesh-ancestor
111305316|NCT01813149|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111305317|NCT00137969|Acetaminophen|acetaminophen|mesh-list
111305318|NCT00137969|Diphenhydramine|diphenhydramine|mesh-list
111305319|NCT00137969|Promethazine|promethazine|mesh-list
111305320|NCT00137969|Prednisone|prednisone|mesh-list
111305321|NCT00137969|Rituximab|rituximab|mesh-list
111305322|NCT00137969|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111305323|NCT00137969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111305324|NCT00137969|Immunologic Factors|immunologic factors|mesh-ancestor
111305325|NCT00137969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111305326|NCT00137969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111305327|NCT00137969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111305328|NCT00137969|Glucocorticoids|glucocorticoids|mesh-ancestor
111305329|NCT00137969|Hormones|hormones|mesh-ancestor
111305330|NCT00137969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111305331|NCT00137969|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111305332|NCT00137969|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111305333|NCT00137969|Analgesics|analgesics|mesh-ancestor
111305334|NCT00137969|Sensory System Agents|sensory system agents|mesh-ancestor
111305335|NCT00137969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111305336|NCT00137969|Antipyretics|antipyretics|mesh-ancestor
111305337|NCT00137969|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111305338|NCT00137969|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111305339|NCT00137969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111305340|NCT00137969|Anesthetics, Local|anesthetics, local|mesh-ancestor
111305341|NCT00137969|Anesthetics|anesthetics|mesh-ancestor
111305342|NCT00137969|Antiemetics|antiemetics|mesh-ancestor
111305343|NCT00137969|Autonomic Agents|autonomic agents|mesh-ancestor
111305344|NCT00137969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111305345|NCT00137969|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111305346|NCT00137969|Histamine Antagonists|histamine antagonists|mesh-ancestor
111305347|NCT00137969|Histamine Agents|histamine agents|mesh-ancestor
111305348|NCT00137969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111305349|NCT00137969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111305350|NCT00137969|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111305351|NCT00137969|Antipruritics|antipruritics|mesh-ancestor
111305352|NCT00137969|Dermatologic Agents|dermatologic agents|mesh-ancestor
111305353|NCT01437878|Iloprost|iloprost|mesh-list
111305354|NCT01437878|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111305355|NCT01437878|Vasodilator Agents|vasodilator agents|mesh-ancestor
111305356|NCT04767308|Cyclophosphamide|cyclophosphamide|mesh-list
111305357|NCT04767308|Fludarabine|fludarabine|mesh-list
111305358|NCT04767308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111305359|NCT04767308|Immunologic Factors|immunologic factors|mesh-ancestor
111305360|NCT04767308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111305361|NCT04767308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111305362|NCT04767308|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110979865|NCT05702879|Glucocorticoids|glucocorticoids|mesh-ancestor
111305363|NCT04767308|Alkylating Agents|alkylating agents|mesh-ancestor
111305364|NCT04767308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111305365|NCT04767308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111305366|NCT04767308|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111305367|NCT00138125|Trastuzumab|trastuzumab|mesh-list
111305368|NCT00138125|Fulvestrant|fulvestrant|mesh-list
111305369|NCT00138125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111305370|NCT00138125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111305371|NCT00138125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111305372|NCT00138125|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
111305373|NCT00138125|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111305374|NCT00138125|Hormone Antagonists|hormone antagonists|mesh-ancestor
111305375|NCT00138125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111305376|NCT00138125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111305377|NCT01815333|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
111305378|NCT01815333|Hematinics|hematinics|mesh-ancestor
111305379|NCT01815333|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
111305380|NCT01815333|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111305381|NCT01465178|Cholecalciferol|cholecalciferol|mesh-list
111305382|NCT01465178|Vitamin D|vitamin d|mesh-list
111305383|NCT01465178|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111305384|NCT01465178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111305385|NCT01465178|Vitamins|vitamins|mesh-ancestor
111305386|NCT01465178|Micronutrients|micronutrients|mesh-ancestor
111305387|NCT01465178|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111305388|NCT00138203|Vorinostat|vorinostat|mesh-list
111305389|NCT00138203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111305390|NCT00138203|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111305391|NCT00138203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111305392|NCT00138203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111305393|NCT01732809|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111305394|NCT01732809|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111305395|NCT01732809|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111305396|NCT01732809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111305397|NCT01732809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111305398|NCT01732809|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111305399|NCT01732809|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111305400|NCT01732809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111305401|NCT01732809|Cholinergic Agents|cholinergic agents|mesh-ancestor
111305402|NCT01732809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111305403|NCT00194129|Valproic Acid|valproic acid|mesh-list
111305404|NCT00194129|Lithium Carbonate|lithium carbonate|mesh-list
111305405|NCT00194129|Antidepressive Agents|antidepressive agents|mesh-ancestor
111305406|NCT00194129|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111305407|NCT00194129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111305408|NCT00194129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111305409|NCT00194129|Antimanic Agents|antimanic agents|mesh-ancestor
111305410|NCT00194129|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111305411|NCT00194129|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111305412|NCT00194129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111305413|NCT00194129|Anticonvulsants|anticonvulsants|mesh-ancestor
111305414|NCT00194129|GABA Agents|gaba agents|mesh-ancestor
111305415|NCT00194129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111305416|NCT01817907|Trazodone|trazodone|mesh-list
111305417|NCT01817907|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111305418|NCT01817907|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111305419|NCT01817907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111305420|NCT01817907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111305421|NCT01817907|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111305422|NCT01817907|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111305423|NCT01817907|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111305424|NCT01817907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111305425|NCT01817907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111305427|NCT01817907|Serotonin Agents|serotonin agents|mesh-ancestor
111305428|NCT01817907|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111305429|NCT01817907|Antidepressive Agents|antidepressive agents|mesh-ancestor
111305430|NCT01445678|Metronidazole|metronidazole|mesh-list
111305431|NCT01445678|Meropenem|meropenem|mesh-list
111305432|NCT01445678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111305433|NCT01445678|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111305434|NCT01445678|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111305435|NCT01445678|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111305436|NCT01818063|Paclitaxel|paclitaxel|mesh-list
111305437|NCT01818063|Cyclophosphamide|cyclophosphamide|mesh-list
111305438|NCT01818063|Carboplatin|carboplatin|mesh-list
111305439|NCT01818063|Doxorubicin|doxorubicin|mesh-list
111305440|NCT01818063|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111305441|NCT01818063|Veliparib|veliparib|mesh-list
111305442|NCT01818063|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111305443|NCT01818063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111305444|NCT01818063|Tubulin Modulators|tubulin modulators|mesh-ancestor
111305445|NCT01818063|Antimitotic Agents|antimitotic agents|mesh-ancestor
111305446|NCT01818063|Mitosis Modulators|mitosis modulators|mesh-ancestor
111305447|NCT01818063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111305448|NCT01818063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111305449|NCT01818063|Immunologic Factors|immunologic factors|mesh-ancestor
111305450|NCT01818063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111305451|NCT01818063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111305452|NCT01818063|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111305453|NCT01818063|Alkylating Agents|alkylating agents|mesh-ancestor
111305454|NCT01818063|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111305455|NCT01818063|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111305456|NCT01818063|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111305457|NCT01818063|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111305458|NCT01818063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111305459|NCT01818063|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111305460|NCT01465022|Estrogens|estrogens|mesh-list
111305461|NCT01465022|Progestins|progestins|mesh-list
111305462|NCT01465022|Hormones|hormones|mesh-ancestor
111305463|NCT01465022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111305464|NCT01465022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111305465|NCT02258217|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
111305466|NCT02258217|Hormones|hormones|mesh-ancestor
111305467|NCT02258217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111305468|NCT02258217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111305469|NCT01464788|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
111305470|NCT01464788|Argatroban|argatroban|mesh-list
111305471|NCT01464788|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111305472|NCT01464788|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111305473|NCT01464788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111305474|NCT01464788|Antithrombins|antithrombins|mesh-ancestor
111305475|NCT01464788|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111305476|NCT01464788|Protease Inhibitors|protease inhibitors|mesh-ancestor
111305477|NCT01464788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111305478|NCT01464788|Anticoagulants|anticoagulants|mesh-ancestor
111305479|NCT01464788|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111305480|NCT01444898|Exenatide|exenatide|mesh-list
111305481|NCT01444898|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111305482|NCT01444898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111305483|NCT01444898|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111305484|NCT01444898|Incretins|incretins|mesh-ancestor
111305485|NCT01444898|Hormones|hormones|mesh-ancestor
111305486|NCT01444898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111305487|NCT00201773|Celecoxib|celecoxib|mesh-list
111305488|NCT00201773|Exemestane|exemestane|mesh-list
111305489|NCT00201773|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111305490|NCT00201773|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111305491|NCT00201773|Analgesics|analgesics|mesh-ancestor
111305492|NCT00201773|Sensory System Agents|sensory system agents|mesh-ancestor
111305493|NCT00201773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111305494|NCT00201773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111305495|NCT00201773|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111029911|NCT04898270|Flupenthixol|flupenthixol|mesh-list
111305496|NCT00201773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111305497|NCT00201773|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111305498|NCT00201773|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111305499|NCT00201773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111305500|NCT00201773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111305501|NCT00201773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111305502|NCT00201773|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111305503|NCT00201773|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111305504|NCT00201773|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111305505|NCT00201773|Hormone Antagonists|hormone antagonists|mesh-ancestor
111305506|NCT00201773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111305507|NCT00256217|Anastrozole|anastrozole|mesh-list
111305508|NCT00256217|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111305509|NCT00256217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111305510|NCT00256217|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111305511|NCT00256217|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111305512|NCT00256217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111305513|NCT00256217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111305514|NCT00256217|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111305515|NCT00256217|Hormone Antagonists|hormone antagonists|mesh-ancestor
111305516|NCT00256217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111305517|NCT00256217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111305518|NCT05643066|Ketamine|ketamine|mesh-list
111305519|NCT05643066|Propofol|propofol|mesh-list
111305520|NCT05643066|Esketamine|esketamine|mesh-list
111305521|NCT05643066|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111305522|NCT05643066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111305523|NCT05643066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111305524|NCT05643066|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111305525|NCT05643066|Anesthetics, General|anesthetics, general|mesh-ancestor
111305526|NCT05643066|Anesthetics|anesthetics|mesh-ancestor
111305527|NCT05643066|Analgesics|analgesics|mesh-ancestor
111305528|NCT05643066|Sensory System Agents|sensory system agents|mesh-ancestor
111305529|NCT05643066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111305530|NCT05643066|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111305531|NCT05643066|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111305532|NCT05643066|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111305533|NCT05643066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111305534|NCT05643066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111305535|NCT05643066|Antidepressive Agents|antidepressive agents|mesh-ancestor
111305536|NCT05643066|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111305537|NCT00256451|Ethanol|ethanol|mesh-list
111305538|NCT00256451|Naltrexone|naltrexone|mesh-list
111305539|NCT00256451|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111305540|NCT00256451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111305541|NCT00256451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111305542|NCT00256451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111305543|NCT00256451|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111305544|NCT00256451|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111305545|NCT00256451|Sensory System Agents|sensory system agents|mesh-ancestor
111305546|NCT00256451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111305547|NCT03582618|Sorafenib|sorafenib|mesh-list
111305548|NCT03582618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111305549|NCT03582618|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111305550|NCT03582618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111305551|NCT03582618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111305552|NCT00257309|Tenecteplase|tenecteplase|mesh-list
111305553|NCT00257309|Clopidogrel|clopidogrel|mesh-list
111305554|NCT00257309|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111305555|NCT00257309|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111305556|NCT00257309|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111305557|NCT00257309|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111305558|NCT00257309|Purinergic Agents|purinergic agents|mesh-ancestor
111305559|NCT00257309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111305560|NCT00257309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111305561|NCT00257309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111305562|NCT00257309|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111305563|NCT00257309|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111305564|NCT01444742|Cytarabine|cytarabine|mesh-list
111305565|NCT01444742|Clofarabine|clofarabine|mesh-list
110979870|NCT05702879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111305566|NCT01444742|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111305567|NCT01444742|Antimetabolites|antimetabolites|mesh-ancestor
111305568|NCT01444742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111029993|NCT04883996|Miotics|miotics|mesh-ancestor
111305569|NCT01444742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111305571|NCT01444742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111305572|NCT01444742|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111305573|NCT01444742|Immunologic Factors|immunologic factors|mesh-ancestor
111305574|NCT01444742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111305575|NCT01770483|Interferons|interferons|mesh-list
111305576|NCT01770483|Ribavirin|ribavirin|mesh-list
111305577|NCT01770483|Interferon-alpha|interferon-alpha|mesh-list
111305578|NCT01770483|Nitazoxanide|nitazoxanide|mesh-list
111305579|NCT01770483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111305580|NCT01770483|Antiviral Agents|antiviral agents|mesh-ancestor
111305581|NCT01770483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111305582|NCT01770483|Antimetabolites|antimetabolites|mesh-ancestor
111305583|NCT01770483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111305584|NCT01770483|Immunologic Factors|immunologic factors|mesh-ancestor
111305585|NCT01770483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111305586|NCT01770483|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111305587|NCT00257933|Prednisolone|prednisolone|mesh-list
111305588|NCT00257933|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111305589|NCT00257933|Methylprednisolone|methylprednisolone|mesh-list
111305590|NCT00257933|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111305591|NCT00257933|Prednisolone acetate|prednisolone acetate|mesh-list
111305592|NCT00257933|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111305593|NCT00257933|Prednisolone phosphate|prednisolone phosphate|mesh-list
111305594|NCT00257933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111305595|NCT00257933|Glucocorticoids|glucocorticoids|mesh-ancestor
111305596|NCT00257933|Hormones|hormones|mesh-ancestor
111305597|NCT00257933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111305598|NCT00257933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111305599|NCT00257933|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111305600|NCT00257933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111305601|NCT00257933|Antiemetics|antiemetics|mesh-ancestor
111305602|NCT00257933|Autonomic Agents|autonomic agents|mesh-ancestor
111305603|NCT00257933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111305604|NCT00257933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111305605|NCT00257933|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111305606|NCT00257933|Protective Agents|protective agents|mesh-ancestor
111305607|NCT01734525|Anidulafungin|anidulafungin|mesh-list
111305608|NCT01734525|Antifungal Agents|antifungal agents|mesh-ancestor
111305609|NCT01734525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111305610|NCT01819935|Vancomycin|vancomycin|mesh-list
111305611|NCT01819935|Linezolid|linezolid|mesh-list
111305612|NCT01819935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111305613|NCT01819935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111305614|NCT01819935|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111305615|NCT01819935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111305616|NCT01819935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111305617|NCT01821105|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
111305618|NCT01821105|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111305619|NCT01821105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111305620|NCT00264641|Insulin|insulin|mesh-list
111305621|NCT00264641|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111305622|NCT00264641|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111305623|NCT00264641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111305624|NCT01735617|Hydrocortisone|hydrocortisone|mesh-list
111305625|NCT01735617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111305626|NCT00208091|Botulinum Toxins|botulinum toxins|mesh-list
111305627|NCT00208091|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111305628|NCT00208091|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111305629|NCT00208091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111305630|NCT00208091|Cholinergic Agents|cholinergic agents|mesh-ancestor
111305631|NCT00208091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111305632|NCT00208091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111305633|NCT00266279|Capecitabine|capecitabine|mesh-list
111305634|NCT00266279|Oxaliplatin|oxaliplatin|mesh-list
111305635|NCT00266279|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111305636|NCT00266279|Antimetabolites|antimetabolites|mesh-ancestor
111305637|NCT00266279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111305638|NCT00266279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111305639|NCT01736085|Nicotine|nicotine|mesh-list
110979886|NCT03235778|Analgesics|analgesics|mesh-ancestor
111305640|NCT01736085|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111305641|NCT01736085|Autonomic Agents|autonomic agents|mesh-ancestor
111305642|NCT01736085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111305643|NCT01736085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111305644|NCT01736085|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111305645|NCT01736085|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111305646|NCT01736085|Cholinergic Agents|cholinergic agents|mesh-ancestor
111305647|NCT01736085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111305648|NCT01736085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111305650|NCT00210353|Chlorambucil|chlorambucil|mesh-list
111305651|NCT00210353|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111305652|NCT00210353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111305653|NCT00210353|Immunologic Factors|immunologic factors|mesh-ancestor
111305654|NCT00210353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111305655|NCT00210353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111305656|NCT00210353|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111305657|NCT00210353|Alkylating Agents|alkylating agents|mesh-ancestor
111305658|NCT00210353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111305659|NCT00267059|Lenalidomide|lenalidomide|mesh-list
111305660|NCT00267059|Immunologic Factors|immunologic factors|mesh-ancestor
111305661|NCT00267059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111305662|NCT00267059|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111305663|NCT00267059|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111305664|NCT00267059|Growth Substances|growth substances|mesh-ancestor
111305665|NCT00267059|Growth Inhibitors|growth inhibitors|mesh-ancestor
111305666|NCT00267059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111305667|NCT00213239|Remifentanil|remifentanil|mesh-list
111305668|NCT00213239|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111305669|NCT00213239|Narcotics|narcotics|mesh-ancestor
111305670|NCT00213239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111305671|NCT00213239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111305672|NCT00213239|Analgesics|analgesics|mesh-ancestor
111305673|NCT00213239|Sensory System Agents|sensory system agents|mesh-ancestor
111305674|NCT00213239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111305675|NCT01444430|Budesonide|budesonide|mesh-list
111305676|NCT01444430|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
111305677|NCT01444430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111305678|NCT01444430|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111305679|NCT01444430|Autonomic Agents|autonomic agents|mesh-ancestor
111305680|NCT01444430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111305681|NCT01444430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111305682|NCT01444430|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111305683|NCT01444430|Respiratory System Agents|respiratory system agents|mesh-ancestor
111305684|NCT01444430|Glucocorticoids|glucocorticoids|mesh-ancestor
111305685|NCT01444430|Hormones|hormones|mesh-ancestor
111305686|NCT01444430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111305687|NCT01774149|Diazepam|diazepam|mesh-list
111305688|NCT01774149|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111305689|NCT01774149|Anticonvulsants|anticonvulsants|mesh-ancestor
111305690|NCT01774149|Antiemetics|antiemetics|mesh-ancestor
111305691|NCT01774149|Autonomic Agents|autonomic agents|mesh-ancestor
111305692|NCT01774149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111305693|NCT01774149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111305694|NCT01774149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111305695|NCT01774149|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111305696|NCT01774149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111305697|NCT01774149|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
111305698|NCT01774149|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111305699|NCT01774149|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111305700|NCT01774149|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111305701|NCT01774149|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111305702|NCT01774149|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111305703|NCT01774149|Anesthetics, General|anesthetics, general|mesh-ancestor
111305704|NCT01774149|Anesthetics|anesthetics|mesh-ancestor
111305705|NCT01774149|GABA Modulators|gaba modulators|mesh-ancestor
111305706|NCT01774149|GABA Agents|gaba agents|mesh-ancestor
111305707|NCT01774149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111305708|NCT01774149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111305709|NCT01898507|Nicotine|nicotine|mesh-list
111305710|NCT01898507|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111305711|NCT01898507|Autonomic Agents|autonomic agents|mesh-ancestor
111305712|NCT01898507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111305713|NCT01898507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111305714|NCT01898507|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111305715|NCT01898507|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111305716|NCT01898507|Cholinergic Agents|cholinergic agents|mesh-ancestor
111305717|NCT01898507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111305718|NCT01898507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111030137|NCT03154580|Antidotes|antidotes|mesh-ancestor
111305719|NCT00267293|Acetaminophen|acetaminophen|mesh-list
111305720|NCT00267293|Ibuprofen|ibuprofen|mesh-list
111305721|NCT00267293|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111305722|NCT00267293|Analgesics|analgesics|mesh-ancestor
111305723|NCT00267293|Sensory System Agents|sensory system agents|mesh-ancestor
111305724|NCT00267293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111305725|NCT00267293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111305726|NCT00267293|Antipyretics|antipyretics|mesh-ancestor
111305727|NCT00267293|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111305728|NCT00267293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111305729|NCT00267293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111305730|NCT00267293|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111305731|NCT00267293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111305732|NCT00267293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111305733|NCT01436162|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
111305734|NCT01436162|Antidepressive Agents|antidepressive agents|mesh-list
111305735|NCT01436162|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111305736|NCT01436162|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111305737|NCT01436162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111305738|NCT01436162|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111305739|NCT01436162|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111305740|NCT01436162|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111305741|NCT01436162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111305742|NCT01436162|Dopamine Agents|dopamine agents|mesh-ancestor
111305743|NCT01436162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111305744|NCT02579382|Vesatolimod|vesatolimod|mesh-list
111305745|NCT02579382|Antiviral Agents|antiviral agents|mesh-ancestor
111305746|NCT02579382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111305747|NCT01774851|Paclitaxel|paclitaxel|mesh-list
111305748|NCT01774851|Trastuzumab|trastuzumab|mesh-list
111305749|NCT01774851|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111305750|NCT01774851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111305751|NCT01774851|Tubulin Modulators|tubulin modulators|mesh-ancestor
111305752|NCT01774851|Antimitotic Agents|antimitotic agents|mesh-ancestor
111305753|NCT01774851|Mitosis Modulators|mitosis modulators|mesh-ancestor
111305754|NCT01774851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111305755|NCT01774851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111305756|NCT02990013|Chlorhexidine|chlorhexidine|mesh-list
111305757|NCT02990013|Povidone-Iodine|povidone-iodine|mesh-list
111305758|NCT02990013|Povidone|povidone|mesh-list
111305759|NCT02990013|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111305760|NCT02990013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111305761|NCT02990013|Disinfectants|disinfectants|mesh-ancestor
111305762|NCT02990013|Plasma Substitutes|plasma substitutes|mesh-ancestor
111305763|NCT02990013|Blood Substitutes|blood substitutes|mesh-ancestor
111305764|NCT03440112|Clarithromycin|clarithromycin|mesh-list
111305765|NCT03440112|Flumazenil|flumazenil|mesh-list
111305766|NCT03440112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111305767|NCT03440112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111305768|NCT03440112|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111305769|NCT03440112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111305770|NCT03440112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111305771|NCT03440112|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111305772|NCT03440112|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111305773|NCT03440112|Antidotes|antidotes|mesh-ancestor
111305774|NCT03440112|Protective Agents|protective agents|mesh-ancestor
111305775|NCT03440112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111305776|NCT03440112|GABA Modulators|gaba modulators|mesh-ancestor
111305777|NCT03440112|GABA Agents|gaba agents|mesh-ancestor
111305778|NCT03440112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111305779|NCT01775865|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
111305780|NCT01775865|Sodium Salicylate|sodium salicylate|mesh-list
111305781|NCT01775865|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111305782|NCT01775865|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111305783|NCT01775865|Analgesics|analgesics|mesh-ancestor
111305784|NCT01775865|Sensory System Agents|sensory system agents|mesh-ancestor
111305785|NCT01775865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111305786|NCT01775865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111305787|NCT01775865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111305788|NCT01775865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111305789|NCT01775865|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111305790|NCT01775865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111305791|NCT01775865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111305792|NCT01419236|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111305793|NCT01419236|Testosterone|testosterone|mesh-list
111305795|NCT01419236|Hormones|hormones|mesh-ancestor
111305796|NCT01419236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111305797|NCT01419236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111305798|NCT03323658|Bexarotene|bexarotene|mesh-list
111305799|NCT03323658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111305800|NCT01443026|Lycopene|lycopene|mesh-list
111305801|NCT01443026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111305802|NCT01443026|Antioxidants|antioxidants|mesh-ancestor
111305803|NCT01443026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111305804|NCT01443026|Protective Agents|protective agents|mesh-ancestor
111305805|NCT01443026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111305806|NCT01443026|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111305807|NCT01443026|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
111305808|NCT01443026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111305809|NCT01879371|Ibuprofen|ibuprofen|mesh-list
111305810|NCT01879371|Caffeine|caffeine|mesh-list
111305811|NCT01879371|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111305812|NCT01879371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111305813|NCT01879371|Analgesics|analgesics|mesh-ancestor
111305814|NCT01879371|Sensory System Agents|sensory system agents|mesh-ancestor
111305815|NCT01879371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111305816|NCT01879371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111305817|NCT01879371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111305818|NCT01879371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111305819|NCT01879371|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111305820|NCT01879371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111305821|NCT01879371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111305822|NCT01879371|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111305823|NCT01879371|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111305824|NCT01879371|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
111305825|NCT01879371|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111305826|NCT01879371|Purinergic Agents|purinergic agents|mesh-ancestor
111305827|NCT01879371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111305828|NCT01733745|Vitamins|vitamins|mesh-list
111305829|NCT01733745|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111305830|NCT01733745|Micronutrients|micronutrients|mesh-ancestor
111305831|NCT01733745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111305832|NCT01733745|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111305833|NCT03276468|Atezolizumab|atezolizumab|mesh-list
111305834|NCT03276468|Venetoclax|venetoclax|mesh-list
111305835|NCT03276468|Obinutuzumab|obinutuzumab|mesh-list
111305836|NCT03276468|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111305837|NCT03276468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111305838|NCT03276468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111305839|NCT03276468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111305840|NCT01442714|Lenalidomide|lenalidomide|mesh-list
111305841|NCT01442714|Azacitidine|azacitidine|mesh-list
111305842|NCT01442714|Immunologic Factors|immunologic factors|mesh-ancestor
111305843|NCT01442714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111305844|NCT01442714|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111305845|NCT01442714|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111305846|NCT01442714|Growth Substances|growth substances|mesh-ancestor
111305847|NCT01442714|Growth Inhibitors|growth inhibitors|mesh-ancestor
111305848|NCT01442714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111305849|NCT01442714|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111305850|NCT01442714|Antimetabolites|antimetabolites|mesh-ancestor
111305851|NCT01442714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111305852|NCT01442714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111305853|NCT05328921|Antihypertensive Agents|antihypertensive agents|mesh-list
111305854|NCT05532852|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
111305855|NCT05532852|Antiviral Agents|antiviral agents|mesh-ancestor
111305856|NCT05532852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111305857|NCT05501574|Tacrolimus|tacrolimus|mesh-list
111305858|NCT05501574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111305859|NCT05501574|Immunologic Factors|immunologic factors|mesh-ancestor
111305860|NCT05501574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111305861|NCT05501574|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111305862|NCT05501574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111305863|NCT05501574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111305864|NCT01435928|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
111305865|NCT01435928|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111305866|NCT01435928|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111305867|NCT01435928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111305868|NCT01435928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111305869|NCT01435928|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111305870|NCT01435928|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
111305871|NCT01435928|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111305872|NCT01435928|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111305873|NCT01435928|Adrenergic Agents|adrenergic agents|mesh-ancestor
111305874|NCT01435928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111305875|NCT01435928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111305876|NCT01435928|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111305877|NCT01435928|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111305878|NCT01435928|Serotonin Agents|serotonin agents|mesh-ancestor
111305879|NCT01435928|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111305880|NCT01435928|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111305881|NCT01435928|Dopamine Agents|dopamine agents|mesh-ancestor
111305882|NCT01828515|Hydrocortisone|hydrocortisone|mesh-list
111305883|NCT01828515|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
111305884|NCT01828515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111305885|NCT01828515|Antidepressive Agents|antidepressive agents|mesh-ancestor
111305886|NCT01828515|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111305887|NCT01828515|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111305888|NCT01828515|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111305889|NCT01828515|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111305890|NCT01828515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111305891|NCT01828515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111305892|NCT01828515|Serotonin Agents|serotonin agents|mesh-ancestor
111305893|NCT01828515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111305894|NCT01828515|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111305895|NCT01828515|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111305896|NCT01828593|Immunoglobulins|immunoglobulins|mesh-list
111305897|NCT01828593|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111305898|NCT01828593|Antibodies|antibodies|mesh-list
111305899|NCT01828593|Immunologic Factors|immunologic factors|mesh-ancestor
111305900|NCT01828593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111305901|NCT01781169|Vitamin D|vitamin d|mesh-list
111305902|NCT01781169|Vitamins|vitamins|mesh-ancestor
111305903|NCT01781169|Micronutrients|micronutrients|mesh-ancestor
111305904|NCT01781169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111305905|NCT01781169|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111305906|NCT00216125|Docetaxel|docetaxel|mesh-list
111305907|NCT00216125|Etoposide|etoposide|mesh-list
111305908|NCT00216125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111305909|NCT00216125|Tubulin Modulators|tubulin modulators|mesh-ancestor
111305910|NCT00216125|Antimitotic Agents|antimitotic agents|mesh-ancestor
111305911|NCT00216125|Mitosis Modulators|mitosis modulators|mesh-ancestor
111305912|NCT00216125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111305913|NCT00216125|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111305914|NCT00216125|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111305915|NCT00216125|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111305916|NCT00216125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111305917|NCT01781403|Capecitabine|capecitabine|mesh-list
111305918|NCT01781403|Temozolomide|temozolomide|mesh-list
111305919|NCT01781403|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111305920|NCT01781403|Antimetabolites|antimetabolites|mesh-ancestor
111305921|NCT01781403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111305922|NCT01781403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111305923|NCT01781403|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111305924|NCT01781403|Alkylating Agents|alkylating agents|mesh-ancestor
111305925|NCT00218387|Modafinil|modafinil|mesh-list
111305926|NCT00218387|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111305927|NCT00218387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111305928|NCT00218387|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
111305929|NCT00218387|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111305930|NCT00218387|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111305931|NCT00218387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111305932|NCT00218465|Glycine|glycine|mesh-list
111305933|NCT00218465|Glycine Agents|glycine agents|mesh-ancestor
111305934|NCT00218465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111305935|NCT00218465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111305936|NCT00218465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111305937|NCT01898585|Vemurafenib|vemurafenib|mesh-list
111305938|NCT01898585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111305939|NCT01898585|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111305940|NCT01898585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111305941|NCT01898585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111305942|NCT00220961|Pioglitazone|pioglitazone|mesh-list
111305943|NCT00220961|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111305944|NCT00220961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111305945|NCT00222131|Esomeprazole|esomeprazole|mesh-list
111305946|NCT00222131|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111305947|NCT00222131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111305948|NCT00222131|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111305949|NCT00222131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111305950|NCT00222131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111305951|NCT00225017|Atazanavir Sulfate|atazanavir sulfate|mesh-list
111305952|NCT00225017|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
111305953|NCT00225017|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111305954|NCT00225017|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111305955|NCT00225017|Protease Inhibitors|protease inhibitors|mesh-ancestor
111305956|NCT00225017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111305957|NCT00225017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111305958|NCT00225017|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111305959|NCT00225017|Antiviral Agents|antiviral agents|mesh-ancestor
111305960|NCT00225017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111305961|NCT01782963|Dexamethasone|dexamethasone|mesh-list
111305962|NCT01782963|Lenalidomide|lenalidomide|mesh-list
111305963|NCT01782963|Bortezomib|bortezomib|mesh-list
111305964|NCT01782963|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111305965|NCT01782963|Antiemetics|antiemetics|mesh-ancestor
111305966|NCT01782963|Autonomic Agents|autonomic agents|mesh-ancestor
111305967|NCT01782963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111305968|NCT01782963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111305969|NCT01782963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111305970|NCT01782963|Glucocorticoids|glucocorticoids|mesh-ancestor
111305971|NCT01782963|Hormones|hormones|mesh-ancestor
111305972|NCT01782963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111305973|NCT01782963|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111305974|NCT01782963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111305975|NCT01782963|Immunologic Factors|immunologic factors|mesh-ancestor
111305976|NCT01782963|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111305977|NCT01782963|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111305978|NCT01782963|Growth Substances|growth substances|mesh-ancestor
111305979|NCT01782963|Growth Inhibitors|growth inhibitors|mesh-ancestor
111305980|NCT01829217|Sunitinib|sunitinib|mesh-list
111305981|NCT01829217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111305982|NCT01829217|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111305983|NCT01829217|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111305984|NCT01829217|Growth Substances|growth substances|mesh-ancestor
111305985|NCT01829217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111305986|NCT01829217|Growth Inhibitors|growth inhibitors|mesh-ancestor
111305987|NCT01829217|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111305988|NCT01829217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111305989|NCT01829217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111305990|NCT05327751|Celecoxib|celecoxib|mesh-list
111305991|NCT05327751|Capecitabine|capecitabine|mesh-list
111305992|NCT05327751|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111305993|NCT05327751|Antimetabolites|antimetabolites|mesh-ancestor
111305994|NCT05327751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111305995|NCT05327751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111305996|NCT05327751|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111305997|NCT05327751|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111305998|NCT05327751|Analgesics|analgesics|mesh-ancestor
111305999|NCT05327751|Sensory System Agents|sensory system agents|mesh-ancestor
111306000|NCT05327751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111306001|NCT05327751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111306002|NCT05327751|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111306003|NCT05327751|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111306004|NCT05327751|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111306005|NCT05327751|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111306006|NCT05327751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111306007|NCT02096861|Infliximab|infliximab|mesh-list
111306008|NCT02096861|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111306009|NCT02096861|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111306010|NCT02096861|Dermatologic Agents|dermatologic agents|mesh-ancestor
111306011|NCT02096861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111306012|NCT02096861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111306013|NCT01829919|Paroxetine|paroxetine|mesh-list
111306014|NCT01829919|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111306015|NCT01829919|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111306016|NCT01829919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111306017|NCT01829919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111306018|NCT01829919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111306019|NCT01829919|Serotonin Agents|serotonin agents|mesh-ancestor
111306020|NCT01829919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111306021|NCT01829919|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111306022|NCT01829919|Antidepressive Agents|antidepressive agents|mesh-ancestor
111306023|NCT01829919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111306024|NCT01829919|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111306025|NCT01829919|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111306026|NCT01829919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111306027|NCT02097641|Plasma-lyte 148|plasma-lyte 148|mesh-list
111306028|NCT02097641|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
111306029|NCT02097641|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111306030|NCT00274781|Arsenic Trioxide|arsenic trioxide|mesh-list
111306031|NCT00274781|Gemtuzumab|gemtuzumab|mesh-list
111306032|NCT00274781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111306033|NCT00274781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111306034|NCT00274781|Immunotoxins|immunotoxins|mesh-ancestor
111306035|NCT00274781|Immunoconjugates|immunoconjugates|mesh-ancestor
111306036|NCT00274781|Immunologic Factors|immunologic factors|mesh-ancestor
111306037|NCT00274781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111306038|NCT00226577|Gemcitabine|gemcitabine|mesh-list
111306039|NCT00226577|Pemetrexed|pemetrexed|mesh-list
111306040|NCT00226577|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111306041|NCT00226577|Antimetabolites|antimetabolites|mesh-ancestor
111306042|NCT00226577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111306043|NCT00226577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111306044|NCT00226577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111306045|NCT00226577|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111306046|NCT00226577|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111306047|NCT01830699|Triamcinolone|triamcinolone|mesh-list
111306048|NCT01830699|Rilonacept|rilonacept|mesh-list
111306049|NCT01830699|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111306050|NCT01830699|Glucocorticoids|glucocorticoids|mesh-ancestor
111306051|NCT01830699|Hormones|hormones|mesh-ancestor
111306052|NCT01830699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111306053|NCT01830699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111306054|NCT00280241|Cyclophosphamide|cyclophosphamide|mesh-list
111306055|NCT00280241|Rituximab|rituximab|mesh-list
111306056|NCT00280241|Fludarabine|fludarabine|mesh-list
111306057|NCT00280241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111306058|NCT00280241|Immunologic Factors|immunologic factors|mesh-ancestor
111306059|NCT00280241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111306060|NCT00280241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111306061|NCT00280241|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111306062|NCT00280241|Alkylating Agents|alkylating agents|mesh-ancestor
111306063|NCT00280241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111306064|NCT00280241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111306065|NCT00280241|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111306066|NCT00280241|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111306067|NCT01899755|Adalimumab|adalimumab|mesh-list
111306068|NCT01899755|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111306069|NCT01899755|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111306070|NCT01899755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111306071|NCT01899755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111306072|NCT01899833|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
111306073|NCT01899833|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111306074|NCT01899833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111306075|NCT00229619|Rituximab|rituximab|mesh-list
111306076|NCT00229619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111306077|NCT00229619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111306078|NCT00229619|Immunologic Factors|immunologic factors|mesh-ancestor
111306079|NCT00229619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111306080|NCT00229619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111306081|NCT00281021|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111306082|NCT00281021|Digoxin|digoxin|mesh-list
111306083|NCT00281021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111306084|NCT00281021|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111306085|NCT00281021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111306086|NCT00281021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111306087|NCT00281021|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111306088|NCT00281021|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111306089|NCT00281021|Protective Agents|protective agents|mesh-ancestor
111030525|NCT02086019|Ramipril|ramipril|mesh-list
111306090|NCT00281021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111306092|NCT01786161|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111306093|NCT01786161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111306094|NCT01786239|Risperidone|risperidone|mesh-list
111306095|NCT01786239|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111306096|NCT01786239|Serotonin Agents|serotonin agents|mesh-ancestor
111306097|NCT01786239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111306098|NCT01786239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111306099|NCT01786239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111306100|NCT01786239|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111306101|NCT01786239|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111306102|NCT01786239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111306103|NCT01786239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111306104|NCT01786239|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111306105|NCT01786239|Dopamine Agents|dopamine agents|mesh-ancestor
111306106|NCT01832961|Bronchodilator Agents|bronchodilator agents|mesh-list
111306107|NCT01832961|Autonomic Agents|autonomic agents|mesh-ancestor
111306108|NCT01832961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111306109|NCT01832961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111306110|NCT01832961|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111306111|NCT01832961|Respiratory System Agents|respiratory system agents|mesh-ancestor
111306112|NCT01833741|Bimatoprost|bimatoprost|mesh-list
111306113|NCT01833741|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111306114|NCT02261727|Prednisone|prednisone|mesh-list
111306115|NCT02261727|Cortisone|cortisone|mesh-list
111306116|NCT02261727|Theophylline|theophylline|mesh-list
111306117|NCT02261727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111306118|NCT02261727|Glucocorticoids|glucocorticoids|mesh-ancestor
111306119|NCT02261727|Hormones|hormones|mesh-ancestor
111306120|NCT02261727|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111306121|NCT02261727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111306122|NCT02261727|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111306123|NCT02261727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111306124|NCT02261727|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111306125|NCT02261727|Autonomic Agents|autonomic agents|mesh-ancestor
111306126|NCT02261727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111306127|NCT02261727|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111306128|NCT02261727|Respiratory System Agents|respiratory system agents|mesh-ancestor
111306129|NCT02261727|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111306130|NCT02261727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111306131|NCT02261727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111306132|NCT02261727|Vasodilator Agents|vasodilator agents|mesh-ancestor
111306133|NCT02261727|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
111306134|NCT02261727|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111306135|NCT02261727|Purinergic Agents|purinergic agents|mesh-ancestor
111306136|NCT02261727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111306137|NCT02261805|Doxorubicin|doxorubicin|mesh-list
111306138|NCT02261805|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111306139|NCT02261805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111306140|NCT02261805|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111306141|NCT02261805|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111306142|NCT02261805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111306143|NCT02261805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111306144|NCT05300841|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
111306145|NCT05300841|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
111306146|NCT05300841|Estradiol|estradiol|mesh-list
111306147|NCT05300841|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
111306148|NCT05300841|Dydrogesterone|dydrogesterone|mesh-list
111306149|NCT05300841|Estrogens|estrogens|mesh-ancestor
111306150|NCT05300841|Hormones|hormones|mesh-ancestor
111306151|NCT05300841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111306152|NCT05300841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111306153|NCT05300841|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111306154|NCT05300841|Contraceptive Agents|contraceptive agents|mesh-ancestor
110979892|NCT04439513|Hemostatics|hemostatics|mesh-list
111306155|NCT05300841|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111306156|NCT05300841|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111306157|NCT05300841|Progestins|progestins|mesh-ancestor
111306158|NCT00232505|Carboplatin|carboplatin|mesh-list
111306159|NCT00232505|Cetuximab|cetuximab|mesh-list
111306160|NCT00232505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111306161|NCT00232505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111306162|NCT00232583|Metformin|metformin|mesh-list
111306163|NCT00232583|Pioglitazone|pioglitazone|mesh-list
111306164|NCT00232583|Glyburide|glyburide|mesh-list
111306165|NCT00232583|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111306166|NCT00232583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111306167|NCT00232739|Sirolimus|sirolimus|mesh-list
111306168|NCT00232739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111306169|NCT00232739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111306170|NCT00232739|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111306171|NCT00232739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111306172|NCT00232739|Antifungal Agents|antifungal agents|mesh-ancestor
111306173|NCT00232739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111306174|NCT00232739|Immunologic Factors|immunologic factors|mesh-ancestor
111306175|NCT00232739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111306176|NCT01789905|Tigecycline|tigecycline|mesh-list
111306177|NCT01789905|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111306178|NCT01789905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111306179|NCT01789905|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111306180|NCT01789905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111306181|NCT01789905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111306182|NCT01790685|Dexamethasone|dexamethasone|mesh-list
111306183|NCT01790685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111306184|NCT01790685|Antiemetics|antiemetics|mesh-ancestor
111306185|NCT01790685|Autonomic Agents|autonomic agents|mesh-ancestor
111306186|NCT01790685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111306187|NCT01790685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111306188|NCT01790685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111306189|NCT01790685|Glucocorticoids|glucocorticoids|mesh-ancestor
111306190|NCT01790685|Hormones|hormones|mesh-ancestor
111306191|NCT01790685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111306192|NCT01790685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111306193|NCT01790685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111306194|NCT01838655|Nitisinone|nitisinone|mesh-list
111306195|NCT01838655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111306196|NCT01838655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111306197|NCT00050089|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
111306198|NCT00050089|Antiviral Agents|antiviral agents|mesh-ancestor
111306199|NCT00050089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111306200|NCT00282971|Insulin|insulin|mesh-list
111306201|NCT00282971|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111306202|NCT00282971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111306203|NCT01791465|Exenatide|exenatide|mesh-list
111306204|NCT01791465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111306205|NCT01791465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111306206|NCT01791465|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111306207|NCT01791465|Incretins|incretins|mesh-ancestor
111306208|NCT01791465|Hormones|hormones|mesh-ancestor
111306209|NCT01791465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111306210|NCT04484701|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
111306211|NCT04484701|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111306212|NCT04484701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111306213|NCT00285467|Vitamin D|vitamin d|mesh-list
111306214|NCT00285467|Cholecalciferol|cholecalciferol|mesh-list
111306215|NCT00285467|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
111306216|NCT00285467|Vitamins|vitamins|mesh-ancestor
111306217|NCT00285467|Micronutrients|micronutrients|mesh-ancestor
111306218|NCT00285467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111306219|NCT00285467|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111306220|NCT00285467|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111306221|NCT00281671|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
111306222|NCT00281671|Natriuretic Agents|natriuretic agents|mesh-ancestor
111306223|NCT00281671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111306224|NCT05261321|Dronabinol|dronabinol|mesh-list
111306225|NCT05261321|Hallucinogens|hallucinogens|mesh-ancestor
111306226|NCT05261321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111306227|NCT05261321|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111306228|NCT05261321|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111306229|NCT05261321|Analgesics|analgesics|mesh-ancestor
111306230|NCT05261321|Sensory System Agents|sensory system agents|mesh-ancestor
111306231|NCT05261321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111306232|NCT05261321|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
111306233|NCT05261321|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
111306234|NCT05261321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111306235|NCT05261321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111306236|NCT05261321|Hormones|hormones|mesh-ancestor
111306237|NCT05261321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111306238|NCT01676753|Pembrolizumab|pembrolizumab|mesh-list
111306239|NCT01676753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111306240|NCT01676753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111306241|NCT01676753|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111306242|NCT01676753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111306243|NCT01794039|Dexamethasone|dexamethasone|mesh-list
111306244|NCT01794039|Dexamethasone acetate|dexamethasone acetate|mesh-list
111306245|NCT01794039|Lenalidomide|lenalidomide|mesh-list
111306246|NCT01794039|Pomalidomide|pomalidomide|mesh-list
111306247|NCT01794039|Ichthammol|ichthammol|mesh-list
111306248|NCT01794039|BB 1101|bb 1101|mesh-list
111306249|NCT01794039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111306250|NCT01794039|Antiemetics|antiemetics|mesh-ancestor
111306251|NCT01794039|Autonomic Agents|autonomic agents|mesh-ancestor
111306252|NCT01794039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111306253|NCT01794039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111306254|NCT01794039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111306255|NCT01794039|Glucocorticoids|glucocorticoids|mesh-ancestor
111306256|NCT01794039|Hormones|hormones|mesh-ancestor
111306257|NCT01794039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111306258|NCT01794039|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111306259|NCT01794039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111306260|NCT01794039|Immunologic Factors|immunologic factors|mesh-ancestor
111306261|NCT01794039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111306262|NCT01794039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111306263|NCT01794039|Growth Substances|growth substances|mesh-ancestor
111306264|NCT01794039|Growth Inhibitors|growth inhibitors|mesh-ancestor
111306265|NCT01794039|Protease Inhibitors|protease inhibitors|mesh-ancestor
111306266|NCT01794039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111306267|NCT01794039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111306268|NCT01794039|Dermatologic Agents|dermatologic agents|mesh-ancestor
111306269|NCT00281827|Thalidomide|thalidomide|mesh-list
111306270|NCT00281827|Carboplatin|carboplatin|mesh-list
111306271|NCT00281827|Gemcitabine|gemcitabine|mesh-list
111306272|NCT00281827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111306273|NCT00281827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111306274|NCT00281827|Antimetabolites|antimetabolites|mesh-ancestor
111306275|NCT00281827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111306276|NCT00281827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111306277|NCT00281827|Immunologic Factors|immunologic factors|mesh-ancestor
111306278|NCT00281827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111306279|NCT00281827|Leprostatic Agents|leprostatic agents|mesh-ancestor
111306280|NCT00281827|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111306281|NCT00281827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111306282|NCT00281827|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111306283|NCT00281827|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111306284|NCT00281827|Growth Substances|growth substances|mesh-ancestor
111306285|NCT00281827|Growth Inhibitors|growth inhibitors|mesh-ancestor
111306286|NCT01898819|Dexmedetomidine|dexmedetomidine|mesh-list
111306287|NCT01898819|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111306288|NCT01898819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111306289|NCT01898819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111306290|NCT01898819|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111306291|NCT01898819|Analgesics|analgesics|mesh-ancestor
111306292|NCT01898819|Sensory System Agents|sensory system agents|mesh-ancestor
111306293|NCT01898819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111306294|NCT01898819|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111306295|NCT01898819|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111306296|NCT01898819|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111306297|NCT01898819|Adrenergic Agents|adrenergic agents|mesh-ancestor
111306298|NCT01898819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111306299|NCT01898819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111306300|NCT01794741|Fluticasone|fluticasone|mesh-list
111306301|NCT01794741|Xhance|xhance|mesh-list
111306302|NCT01794741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111306303|NCT01794741|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111306304|NCT01794741|Autonomic Agents|autonomic agents|mesh-ancestor
111306305|NCT01794741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111306306|NCT01794741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111306307|NCT01794741|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111306308|NCT01794741|Respiratory System Agents|respiratory system agents|mesh-ancestor
111306309|NCT01794741|Dermatologic Agents|dermatologic agents|mesh-ancestor
111306310|NCT01794741|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111306311|NCT04446871|Methylene Blue|methylene blue|mesh-list
111306312|NCT04446871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111306313|NCT04446871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111306314|NCT04085419|Zoledronic Acid|zoledronic acid|mesh-list
111306315|NCT04085419|Denosumab|denosumab|mesh-list
111306316|NCT04085419|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111306317|NCT04085419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111306319|NCT02989623|Trace Elements|trace elements|mesh-ancestor
111306320|NCT02989623|Micronutrients|micronutrients|mesh-ancestor
111306321|NCT02989623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111306322|NCT00052429|Fluorouracil|fluorouracil|mesh-list
111306323|NCT00052429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111306324|NCT00052429|Antimetabolites|antimetabolites|mesh-ancestor
111306325|NCT00052429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111306326|NCT00052429|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111306327|NCT00052429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111306328|NCT00052429|Immunologic Factors|immunologic factors|mesh-ancestor
111306329|NCT00052429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111306330|NCT01435616|Insulin Glargine|insulin glargine|mesh-list
111306331|NCT01435616|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111306332|NCT01435616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111306333|NCT03972397|Bupivacaine|bupivacaine|mesh-list
111306334|NCT03972397|Anesthetics, Local|anesthetics, local|mesh-ancestor
111306335|NCT03972397|Anesthetics|anesthetics|mesh-ancestor
111306336|NCT03972397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111306337|NCT03972397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111306338|NCT03972397|Sensory System Agents|sensory system agents|mesh-ancestor
111306339|NCT03972397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111306340|NCT00287053|Valproic Acid|valproic acid|mesh-list
111306341|NCT00287053|Anticonvulsants|anticonvulsants|mesh-ancestor
111306342|NCT00287053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111306343|NCT00287053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111306344|NCT00287053|GABA Agents|gaba agents|mesh-ancestor
111306345|NCT00287053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111306346|NCT00287053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111306347|NCT00287053|Antimanic Agents|antimanic agents|mesh-ancestor
111306348|NCT00287053|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111306349|NCT00287053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111306350|NCT00287053|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111306351|NCT01435460|Loteprednol Etabonate|loteprednol etabonate|mesh-list
111306352|NCT01435460|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
111306353|NCT01435460|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111306354|NCT01435460|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111306355|NCT01435460|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111306356|NCT01435460|Analgesics|analgesics|mesh-ancestor
111306357|NCT01435460|Sensory System Agents|sensory system agents|mesh-ancestor
111306358|NCT01435460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111306359|NCT01435460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111306360|NCT01435460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111306361|NCT01435460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111306362|NCT01435460|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
111306363|NCT01435460|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111306364|NCT01435460|Histamine Antagonists|histamine antagonists|mesh-ancestor
111306365|NCT01435460|Histamine Agents|histamine agents|mesh-ancestor
111306366|NCT01435460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111306367|NCT01435460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111306368|NCT00236951|Epoetin Alfa|epoetin alfa|mesh-list
111306369|NCT00236951|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
111306370|NCT00236951|Hematinics|hematinics|mesh-ancestor
111306371|NCT00287287|Lenalidomide|lenalidomide|mesh-list
111306372|NCT00287287|Immunologic Factors|immunologic factors|mesh-ancestor
111306373|NCT00287287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111306374|NCT00287287|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111306375|NCT00287287|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111306376|NCT00287287|Growth Substances|growth substances|mesh-ancestor
111306377|NCT00287287|Growth Inhibitors|growth inhibitors|mesh-ancestor
111306378|NCT00287287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111306379|NCT04871061|Fentanyl|fentanyl|mesh-list
110758921|NCT01225302|Paclitaxel|paclitaxel|mesh-list
111306380|NCT04871061|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111306381|NCT04871061|Narcotics|narcotics|mesh-ancestor
111306382|NCT04871061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111306383|NCT04871061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111306384|NCT04871061|Analgesics|analgesics|mesh-ancestor
111306385|NCT04871061|Sensory System Agents|sensory system agents|mesh-ancestor
111306386|NCT04871061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111306387|NCT04871061|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111306388|NCT04871061|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111306389|NCT04871061|Anesthetics, General|anesthetics, general|mesh-ancestor
111306390|NCT04871061|Anesthetics|anesthetics|mesh-ancestor
111306391|NCT00287989|Paclitaxel|paclitaxel|mesh-list
111306392|NCT00287989|Carboplatin|carboplatin|mesh-list
111306393|NCT00287989|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111306394|NCT00287989|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111306395|NCT00287989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111306396|NCT00287989|Tubulin Modulators|tubulin modulators|mesh-ancestor
111306397|NCT00287989|Antimitotic Agents|antimitotic agents|mesh-ancestor
111306398|NCT00287989|Mitosis Modulators|mitosis modulators|mesh-ancestor
111306399|NCT00287989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111306400|NCT00287989|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111306401|NCT00287989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111306402|NCT00288067|Rituximab|rituximab|mesh-list
111306403|NCT00288067|Fenretinide|fenretinide|mesh-list
111306404|NCT00288067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111306405|NCT00288067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111306406|NCT00288067|Immunologic Factors|immunologic factors|mesh-ancestor
111306407|NCT00288067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111306408|NCT00288067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111306409|NCT00288067|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
111306410|NCT00288067|Protective Agents|protective agents|mesh-ancestor
111306411|NCT00285779|Etanercept|etanercept|mesh-list
111306412|NCT00285779|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111306413|NCT00285779|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111306414|NCT00285779|Analgesics|analgesics|mesh-ancestor
111306415|NCT00285779|Sensory System Agents|sensory system agents|mesh-ancestor
111306416|NCT00285779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111306417|NCT00285779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111306418|NCT00285779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111306419|NCT00285779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111306420|NCT00285779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111306421|NCT00285779|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111306422|NCT00285779|Immunologic Factors|immunologic factors|mesh-ancestor
111306423|NCT04827537|Metronidazole|metronidazole|mesh-list
111306424|NCT04827537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111306425|NCT04827537|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111306426|NCT04827537|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111306427|NCT04827537|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111306428|NCT01435382|Bococizumab|bococizumab|mesh-list
111306429|NCT01435382|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111306430|NCT01435382|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111306431|NCT01435382|Antimetabolites|antimetabolites|mesh-ancestor
111306432|NCT01435382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111306433|NCT01435382|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111306434|NCT01801449|Rilonacept|rilonacept|mesh-list
111306435|NCT01801449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111306436|NCT00286325|Rituximab|rituximab|mesh-list
111306437|NCT00286325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111306438|NCT00286325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111306439|NCT00286325|Immunologic Factors|immunologic factors|mesh-ancestor
111306440|NCT00286325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111306441|NCT00286325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111306442|NCT00238355|Voriconazole|voriconazole|mesh-list
111306443|NCT00238355|Caspofungin|caspofungin|mesh-list
111306444|NCT00238355|Antifungal Agents|antifungal agents|mesh-ancestor
111306445|NCT00238355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111306446|NCT00238355|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111306447|NCT00238355|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111306448|NCT00238355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111306449|NCT00238355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111306450|NCT00238355|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111306451|NCT00238355|Hormone Antagonists|hormone antagonists|mesh-ancestor
110979896|NCT02452970|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111306452|NCT00238355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111306453|NCT00238355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111306454|NCT00238355|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111306455|NCT01791439|Lidocaine|lidocaine|mesh-list
111306456|NCT01791439|Anesthetics, Local|anesthetics, local|mesh-ancestor
111306457|NCT01791439|Anesthetics|anesthetics|mesh-ancestor
111306458|NCT01791439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111306459|NCT01791439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111306460|NCT01791439|Sensory System Agents|sensory system agents|mesh-ancestor
111306461|NCT01791439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111306462|NCT01791439|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111306463|NCT01791439|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111306464|NCT01791439|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111306465|NCT01791439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111306466|NCT01791439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111306467|NCT00290329|Vaccines|vaccines|mesh-list
111306468|NCT00290329|Immunologic Factors|immunologic factors|mesh-ancestor
111306469|NCT00290329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111306470|NCT04058678|Danazol|danazol|mesh-list
111306471|NCT04058678|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111306472|NCT04058678|Hormone Antagonists|hormone antagonists|mesh-ancestor
111306473|NCT04058678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111306474|NCT04058678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111306475|NCT00286949|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
111306476|NCT00286949|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111306477|NCT00286949|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111306478|NCT00286949|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111306479|NCT00286949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111306480|NCT00286949|Adrenergic Agents|adrenergic agents|mesh-ancestor
111306481|NCT00286949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111306482|NCT00286949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111306483|NCT00287339|Esomeprazole|esomeprazole|mesh-list
111306484|NCT00287339|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111306485|NCT00287339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111306486|NCT00287339|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111306487|NCT00287339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111306488|NCT00287339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111306489|NCT00291655|Levetiracetam|levetiracetam|mesh-list
111306490|NCT00291655|Anticonvulsants|anticonvulsants|mesh-ancestor
111306491|NCT00291655|Nootropic Agents|nootropic agents|mesh-ancestor
111306492|NCT01846455|Promethazine|promethazine|mesh-list
111306493|NCT01846455|Diphenhydramine|diphenhydramine|mesh-list
111306494|NCT01846455|Buprenorphine|buprenorphine|mesh-list
111306495|NCT01846455|Naloxone|naloxone|mesh-list
111306496|NCT01846455|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111306497|NCT01846455|Narcotics|narcotics|mesh-ancestor
111306498|NCT01846455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111306499|NCT01846455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111306500|NCT01846455|Analgesics|analgesics|mesh-ancestor
111306501|NCT01846455|Sensory System Agents|sensory system agents|mesh-ancestor
111306502|NCT01846455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111306503|NCT01846455|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111306504|NCT01846455|Antipruritics|antipruritics|mesh-ancestor
111306505|NCT01846455|Dermatologic Agents|dermatologic agents|mesh-ancestor
111306506|NCT01846455|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111306507|NCT01846455|Histamine Antagonists|histamine antagonists|mesh-ancestor
111306508|NCT01846455|Histamine Agents|histamine agents|mesh-ancestor
111306509|NCT01846455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111306510|NCT01846455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111306511|NCT01846455|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111306512|NCT01846455|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111306513|NCT01846455|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111306514|NCT01846455|Anesthetics, Local|anesthetics, local|mesh-ancestor
111306515|NCT01846455|Anesthetics|anesthetics|mesh-ancestor
111306516|NCT01846455|Antiemetics|antiemetics|mesh-ancestor
111306517|NCT01846455|Autonomic Agents|autonomic agents|mesh-ancestor
111306518|NCT01846455|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111306519|NCT03366415|Cisplatin|cisplatin|mesh-list
111306520|NCT03366415|Gemcitabine|gemcitabine|mesh-list
111306521|NCT03366415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111306522|NCT03366415|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111306523|NCT03366415|Antimetabolites|antimetabolites|mesh-ancestor
111306524|NCT03366415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111306525|NCT00292591|Vitamin D|vitamin d|mesh-list
111306526|NCT00292591|Ergocalciferols|ergocalciferols|mesh-list
111306527|NCT00292591|Cholecalciferol|cholecalciferol|mesh-list
111306528|NCT00292591|Vitamins|vitamins|mesh-list
111306529|NCT00292591|Micronutrients|micronutrients|mesh-ancestor
111306530|NCT00292591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111306531|NCT00292591|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111306532|NCT00292591|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111306533|NCT01847001|Paclitaxel|paclitaxel|mesh-list
111306534|NCT01847001|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111306535|NCT01847001|Cyclophosphamide|cyclophosphamide|mesh-list
111306536|NCT01847001|Doxorubicin|doxorubicin|mesh-list
111306537|NCT01847001|Trastuzumab|trastuzumab|mesh-list
111306538|NCT01847001|Pertuzumab|pertuzumab|mesh-list
111306539|NCT01847001|Propranolol|propranolol|mesh-list
111306540|NCT01847001|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111306541|NCT01847001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111306542|NCT01847001|Tubulin Modulators|tubulin modulators|mesh-ancestor
111306543|NCT01847001|Antimitotic Agents|antimitotic agents|mesh-ancestor
111306544|NCT01847001|Mitosis Modulators|mitosis modulators|mesh-ancestor
111306545|NCT01847001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111306546|NCT01847001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111306547|NCT01847001|Immunologic Factors|immunologic factors|mesh-ancestor
111306548|NCT01847001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111306549|NCT01847001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111306550|NCT01847001|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111306551|NCT01847001|Alkylating Agents|alkylating agents|mesh-ancestor
111306552|NCT01847001|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111306553|NCT01847001|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111306554|NCT01847001|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111306555|NCT01847001|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111306556|NCT01847001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111306557|NCT01847001|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111306558|NCT01847001|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111306559|NCT01847001|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111306560|NCT01847001|Adrenergic Agents|adrenergic agents|mesh-ancestor
111306561|NCT01847001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111306562|NCT01847001|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111306563|NCT01847001|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111306564|NCT01847001|Vasodilator Agents|vasodilator agents|mesh-ancestor
111306566|NCT01847469|Anticonvulsants|anticonvulsants|mesh-ancestor
111306567|NCT01847469|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111306568|NCT01847469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111306569|NCT01847469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111306570|NCT01847469|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111306571|NCT01847469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111306572|NCT01804101|Cytarabine|cytarabine|mesh-list
111306573|NCT01804101|Daunorubicin|daunorubicin|mesh-list
111306574|NCT01804101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111306575|NCT01804101|Antimetabolites|antimetabolites|mesh-ancestor
111306576|NCT01804101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111306577|NCT01804101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111306578|NCT01804101|Antiviral Agents|antiviral agents|mesh-ancestor
111306579|NCT01804101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111306580|NCT01804101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111306581|NCT01804101|Immunologic Factors|immunologic factors|mesh-ancestor
111306582|NCT01804101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111306583|NCT01804101|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111306584|NCT01804101|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111306585|NCT01804101|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111306586|NCT01804101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111306587|NCT00287729|Pirfenidone|pirfenidone|mesh-list
111306588|NCT00287729|Analgesics|analgesics|mesh-ancestor
111306589|NCT00287729|Sensory System Agents|sensory system agents|mesh-ancestor
111306590|NCT00287729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111306591|NCT00287729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111306592|NCT00287729|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111306593|NCT00287729|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111306594|NCT00287729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111306595|NCT00287729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111306596|NCT00287729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111306597|NCT01433978|Maleic acid|maleic acid|mesh-list
111306598|NCT01433978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110979899|NCT03227900|Lidocaine|lidocaine|mesh-list
111306599|NCT01433978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111306600|NCT00289211|Complement C1s|complement c1s|mesh-list
111306601|NCT00289211|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
111306602|NCT00289211|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
111306603|NCT00289211|Immunologic Factors|immunologic factors|mesh-ancestor
111306604|NCT00289211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111306605|NCT00289211|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
111306606|NCT00289211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111306607|NCT01619111|Lapatinib|lapatinib|mesh-list
111306608|NCT01619111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111306609|NCT01619111|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111306610|NCT01619111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111306611|NCT01619111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111306612|NCT01727193|Azathioprine|azathioprine|mesh-list
111306613|NCT01727193|Leflunomide|leflunomide|mesh-list
111306614|NCT01727193|Antimetabolites|antimetabolites|mesh-ancestor
111306615|NCT01727193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111306616|NCT01727193|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111031046|NCT02337946|Antimetabolites|antimetabolites|mesh-ancestor
111306617|NCT01727193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111306618|NCT01727193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111306619|NCT01727193|Immunologic Factors|immunologic factors|mesh-ancestor
111306620|NCT01727193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111306621|NCT01727193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111306622|NCT01727193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111306623|NCT00181701|Paclitaxel|paclitaxel|mesh-list
111306624|NCT00181701|Carboplatin|carboplatin|mesh-list
111306625|NCT00181701|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111306626|NCT00181701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111306627|NCT00181701|Tubulin Modulators|tubulin modulators|mesh-ancestor
111306628|NCT00181701|Antimitotic Agents|antimitotic agents|mesh-ancestor
111306629|NCT00181701|Mitosis Modulators|mitosis modulators|mesh-ancestor
111306630|NCT00181701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111306631|NCT01849419|Oxytocin|oxytocin|mesh-list
111306632|NCT01849419|Oxytocics|oxytocics|mesh-ancestor
111306633|NCT01849419|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111306634|NCT01849419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111306635|NCT00295867|Zoledronic Acid|zoledronic acid|mesh-list
111306636|NCT00295867|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111306637|NCT00295867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111306638|NCT05098067|Ondansetron|ondansetron|mesh-list
111306639|NCT05098067|Metoclopramide|metoclopramide|mesh-list
111306640|NCT05098067|Capsaicin|capsaicin|mesh-list
111306641|NCT05098067|Antiemetics|antiemetics|mesh-ancestor
111306642|NCT05098067|Autonomic Agents|autonomic agents|mesh-ancestor
111306643|NCT05098067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111306644|NCT05098067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111306645|NCT05098067|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111306646|NCT05098067|Antipruritics|antipruritics|mesh-ancestor
111306647|NCT05098067|Dermatologic Agents|dermatologic agents|mesh-ancestor
111306648|NCT05098067|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111306649|NCT05098067|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111306650|NCT05098067|Serotonin Agents|serotonin agents|mesh-ancestor
111306651|NCT05098067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111306652|NCT05098067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111306653|NCT05098067|Sensory System Agents|sensory system agents|mesh-ancestor
111306654|NCT05098067|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111306655|NCT05098067|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111306656|NCT05098067|Dopamine Agents|dopamine agents|mesh-ancestor
111306657|NCT01852383|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
111306658|NCT01852383|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111306659|NCT01852383|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111306660|NCT01852383|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111306661|NCT01852383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111306662|NCT01852383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111306663|NCT01852383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111306664|NCT01852383|Analgesics|analgesics|mesh-ancestor
111306665|NCT01852383|Sensory System Agents|sensory system agents|mesh-ancestor
111306666|NCT01852383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111306667|NCT01852383|Antidepressive Agents|antidepressive agents|mesh-ancestor
111306668|NCT01852383|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111306669|NCT01852383|Dopamine Agents|dopamine agents|mesh-ancestor
111306670|NCT04272333|Nivolumab|nivolumab|mesh-list
111306671|NCT04272333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111306672|NCT04272333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111306673|NCT04272333|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111306674|NCT04272333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111306675|NCT02273115|Oxytocin|oxytocin|mesh-list
111306676|NCT02273115|Oxytocics|oxytocics|mesh-ancestor
111306677|NCT02273115|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111306678|NCT02273115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111306679|NCT01853085|Bimatoprost|bimatoprost|mesh-list
111306680|NCT01853085|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111306681|NCT01853085|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111306682|NCT01853085|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111306683|NCT02989467|Aprepitant|aprepitant|mesh-list
111306684|NCT02989467|Antiemetics|antiemetics|mesh-ancestor
111306685|NCT02989467|Autonomic Agents|autonomic agents|mesh-ancestor
111306686|NCT02989467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111306687|NCT02989467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111306688|NCT02989467|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111306689|NCT02989467|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
111306690|NCT02989467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111306691|NCT02989467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111306693|NCT01853553|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
111306694|NCT01853553|Hormone Antagonists|hormone antagonists|mesh-ancestor
111306695|NCT01853553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111306696|NCT01853553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111306697|NCT01853553|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
111306698|NCT01853553|Diuretics|diuretics|mesh-ancestor
111306699|NCT01853553|Natriuretic Agents|natriuretic agents|mesh-ancestor
111306700|NCT05748561|Methylprednisolone|methylprednisolone|mesh-list
111306701|NCT05748561|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111306702|NCT05748561|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111306703|NCT05748561|Prednisolone|prednisolone|mesh-list
111306704|NCT05748561|Prednisolone acetate|prednisolone acetate|mesh-list
111306705|NCT05748561|Epoetin Alfa|epoetin alfa|mesh-list
111306706|NCT05748561|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111306707|NCT05748561|Prednisolone phosphate|prednisolone phosphate|mesh-list
111306708|NCT05748561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111306709|NCT05748561|Antiemetics|antiemetics|mesh-ancestor
111306710|NCT05748561|Autonomic Agents|autonomic agents|mesh-ancestor
111306711|NCT05748561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111306712|NCT05748561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111306713|NCT05748561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111306714|NCT05748561|Glucocorticoids|glucocorticoids|mesh-ancestor
111306715|NCT05748561|Hormones|hormones|mesh-ancestor
111306716|NCT05748561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111306717|NCT05748561|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111306718|NCT05748561|Protective Agents|protective agents|mesh-ancestor
111306719|NCT05748561|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111306720|NCT05748561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111306721|NCT05748561|Hematinics|hematinics|mesh-ancestor
111306722|NCT00290537|Paclitaxel|paclitaxel|mesh-list
111306723|NCT00290537|Carboplatin|carboplatin|mesh-list
111306724|NCT00290537|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111306725|NCT00290537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111306726|NCT00290537|Tubulin Modulators|tubulin modulators|mesh-ancestor
111306727|NCT00290537|Antimitotic Agents|antimitotic agents|mesh-ancestor
111306728|NCT00290537|Mitosis Modulators|mitosis modulators|mesh-ancestor
111306729|NCT00290537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111306730|NCT00290615|Bevacizumab|bevacizumab|mesh-list
111306731|NCT00290615|Cetuximab|cetuximab|mesh-list
111306732|NCT00290615|Capecitabine|capecitabine|mesh-list
111306733|NCT00290615|Oxaliplatin|oxaliplatin|mesh-list
111306734|NCT00290615|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111306735|NCT00290615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111306736|NCT00290615|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111306737|NCT00290615|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111306738|NCT00290615|Growth Substances|growth substances|mesh-ancestor
111306739|NCT00290615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111306740|NCT00290615|Growth Inhibitors|growth inhibitors|mesh-ancestor
111306741|NCT00290615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111306742|NCT00290615|Antimetabolites|antimetabolites|mesh-ancestor
111306743|NCT00290615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111306744|NCT01854177|Aprepitant|aprepitant|mesh-list
111306745|NCT01854177|Fosaprepitant|fosaprepitant|mesh-list
111306746|NCT01854177|Antiemetics|antiemetics|mesh-ancestor
111306747|NCT01854177|Autonomic Agents|autonomic agents|mesh-ancestor
111306748|NCT01854177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111306749|NCT01854177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111306750|NCT01854177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111306751|NCT01854177|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
111306752|NCT01854177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111306753|NCT01854177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111306754|NCT00243191|Imatinib Mesylate|imatinib mesylate|mesh-list
111306755|NCT00243191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111306756|NCT00243191|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111306757|NCT00243191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111306758|NCT00243191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111306759|NCT00299221|Mycophenolic Acid|mycophenolic acid|mesh-list
111306760|NCT00299221|Tacrolimus|tacrolimus|mesh-list
111306761|NCT00299221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111306762|NCT00299221|Immunologic Factors|immunologic factors|mesh-ancestor
111306763|NCT00299221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111306764|NCT00299221|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111306765|NCT00299221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111031194|NCT02097407|Anesthetics|anesthetics|mesh-ancestor
111306766|NCT00299221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111306767|NCT00299221|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111306768|NCT00299221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111306769|NCT00299221|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111306770|NCT00299221|Antitubercular Agents|antitubercular agents|mesh-ancestor
111306771|NCT00299221|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111306772|NCT00299221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111306773|NCT03799731|Trifluridine|trifluridine|mesh-list
111306774|NCT03799731|Antimetabolites|antimetabolites|mesh-ancestor
111306775|NCT03799731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111306776|NCT03799731|Antiviral Agents|antiviral agents|mesh-ancestor
111306777|NCT03799731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111306778|NCT00299689|Denileukin diftitox|denileukin diftitox|mesh-list
111306779|NCT00299689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111306780|NCT00244985|Rituximab|rituximab|mesh-list
111306781|NCT00244985|Doxorubicin|doxorubicin|mesh-list
111306782|NCT00244985|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111306783|NCT00244985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111306784|NCT00244985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111306785|NCT00244985|Immunologic Factors|immunologic factors|mesh-ancestor
111306786|NCT00244985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111306787|NCT00244985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111306788|NCT00244985|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111306789|NCT00244985|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111306790|NCT00244985|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111306791|NCT00244985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111306792|NCT00244985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111306793|NCT01857297|Vaccines|vaccines|mesh-list
111306794|NCT01857297|Immunologic Factors|immunologic factors|mesh-ancestor
111306795|NCT01857297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111306796|NCT00300391|Haloperidol|haloperidol|mesh-list
111306797|NCT00300391|Haloperidol decanoate|haloperidol decanoate|mesh-list
111306798|NCT00300391|Antiemetics|antiemetics|mesh-ancestor
111306799|NCT00300391|Autonomic Agents|autonomic agents|mesh-ancestor
111306800|NCT00300391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111306801|NCT00300391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111306802|NCT00300391|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111306803|NCT00300391|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111306804|NCT00300391|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111306805|NCT00300391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111306806|NCT00300391|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111306807|NCT00300391|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111306808|NCT00300391|Dopamine Agents|dopamine agents|mesh-ancestor
111306809|NCT00300391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111306810|NCT00300391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111306811|NCT00300391|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111306812|NCT01859013|Topiramate|topiramate|mesh-list
111306813|NCT01859013|Anticonvulsants|anticonvulsants|mesh-ancestor
111306814|NCT01859013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111306815|NCT01859013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111306816|NCT00294515|Valganciclovir|valganciclovir|mesh-list
111306817|NCT00294515|Antiviral Agents|antiviral agents|mesh-ancestor
111306818|NCT00294515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111306819|NCT00300469|Atorvastatin|atorvastatin|mesh-list
111306820|NCT00300469|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111306821|NCT00300469|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111306822|NCT00300469|Antimetabolites|antimetabolites|mesh-ancestor
111306823|NCT00300469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111306824|NCT00300469|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111306825|NCT00300469|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111306826|NCT00300469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111306827|NCT01859637|Lenograstim|lenograstim|mesh-list
111306828|NCT01859637|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111306829|NCT01859637|Immunologic Factors|immunologic factors|mesh-ancestor
111306830|NCT01859637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111306831|NCT00295061|Protease Inhibitors|protease inhibitors|mesh-list
111306832|NCT00295061|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
111306833|NCT00295061|Protein C Inhibitor|protein c inhibitor|mesh-list
111306834|NCT00295061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111306835|NCT00295061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111306836|NCT00295061|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
111306837|NCT00295061|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111306838|NCT02117141|Hydrocodone|hydrocodone|mesh-list
111306839|NCT02117141|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111306840|NCT02117141|Narcotics|narcotics|mesh-ancestor
111306841|NCT02117141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111306842|NCT02117141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111306844|NCT02117141|Sensory System Agents|sensory system agents|mesh-ancestor
111306845|NCT02117141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111306846|NCT02117141|Antitussive Agents|antitussive agents|mesh-ancestor
111306847|NCT02117141|Respiratory System Agents|respiratory system agents|mesh-ancestor
111306848|NCT00299741|Sunitinib|sunitinib|mesh-list
111306849|NCT00299741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111306850|NCT00299741|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111306851|NCT00299741|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111306852|NCT00299741|Growth Substances|growth substances|mesh-ancestor
111306853|NCT00299741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111306854|NCT00299741|Growth Inhibitors|growth inhibitors|mesh-ancestor
111306855|NCT00299741|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111306856|NCT00299741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111306857|NCT00299741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111306858|NCT00328861|Aldesleukin|aldesleukin|mesh-list
111306859|NCT00328861|Cyclophosphamide|cyclophosphamide|mesh-list
111306860|NCT00328861|Fludarabine|fludarabine|mesh-list
111306861|NCT00328861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111306862|NCT00328861|Immunologic Factors|immunologic factors|mesh-ancestor
111306863|NCT00328861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111306864|NCT00328861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111306865|NCT00328861|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111306866|NCT00328861|Alkylating Agents|alkylating agents|mesh-ancestor
111306867|NCT00328861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111306868|NCT00328861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111306869|NCT00328861|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111306870|NCT00328861|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111306871|NCT00328861|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111306872|NCT00328861|Antiviral Agents|antiviral agents|mesh-ancestor
111306873|NCT00328861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111306874|NCT00248807|Enalaprilat|enalaprilat|mesh-list
111306875|NCT00248807|Enalapril|enalapril|mesh-list
111306876|NCT00248807|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
111306877|NCT00248807|Protease Inhibitors|protease inhibitors|mesh-ancestor
111306878|NCT00248807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111306879|NCT00248807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111306880|NCT00248807|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111306881|NCT01860807|Ibudilast|ibudilast|mesh-list
111306882|NCT01860807|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111306883|NCT01860807|Autonomic Agents|autonomic agents|mesh-ancestor
111306884|NCT01860807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111306885|NCT01860807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111306886|NCT01860807|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111306887|NCT01860807|Respiratory System Agents|respiratory system agents|mesh-ancestor
111306888|NCT01860807|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111306889|NCT01860807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111306890|NCT01860807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111306891|NCT01860807|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111306892|NCT01860807|Vasodilator Agents|vasodilator agents|mesh-ancestor
111306893|NCT00330421|Sorafenib|sorafenib|mesh-list
111306894|NCT00330421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111306895|NCT00330421|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111306896|NCT00330421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111306897|NCT00330421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111306898|NCT04350645|Tranexamic Acid|tranexamic acid|mesh-list
111306899|NCT04350645|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111306900|NCT04350645|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111306901|NCT04350645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111306902|NCT04350645|Hemostatics|hemostatics|mesh-ancestor
111306903|NCT04350645|Coagulants|coagulants|mesh-ancestor
111306904|NCT00330733|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
111306905|NCT00330733|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111306906|NCT00330733|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111306907|NCT00330733|Analgesics|analgesics|mesh-ancestor
111306908|NCT00330733|Sensory System Agents|sensory system agents|mesh-ancestor
111306909|NCT00330733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111306910|NCT00330733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111306911|NCT00330733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111306912|NCT00330733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111306913|NCT05192369|Moxifloxacin|moxifloxacin|mesh-list
111306914|NCT05192369|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111306915|NCT05192369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111306916|NCT05192369|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111306917|NCT05192369|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111306918|NCT05192369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111306919|NCT05192369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111306920|NCT05192369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111306921|NCT05185973|Micronutrients|micronutrients|mesh-list
111306922|NCT05185973|Trace Elements|trace elements|mesh-list
111306923|NCT05185973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111306924|NCT00301873|Zoledronic Acid|zoledronic acid|mesh-list
111306925|NCT00301873|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111306926|NCT00301873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111306927|NCT01892839|Dialysis Solutions|dialysis solutions|mesh-list
111306928|NCT01892839|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111306929|NCT00251225|Docetaxel|docetaxel|mesh-list
111306930|NCT00251225|Imatinib Mesylate|imatinib mesylate|mesh-list
111306931|NCT00251225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111306932|NCT00251225|Tubulin Modulators|tubulin modulators|mesh-ancestor
111306933|NCT00251225|Antimitotic Agents|antimitotic agents|mesh-ancestor
111306934|NCT00251225|Mitosis Modulators|mitosis modulators|mesh-ancestor
111306935|NCT00251225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111306936|NCT00251225|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111306937|NCT00251225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111306938|NCT02979327|Adderall|adderall|mesh-list
111306939|NCT02979327|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111306940|NCT02979327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111306941|NCT05951075|Vitamins|vitamins|mesh-list
111306942|NCT05951075|Micronutrients|micronutrients|mesh-ancestor
111306943|NCT05951075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111306944|NCT05951062|Antihypertensive Agents|antihypertensive agents|mesh-list
111306945|NCT05951023|Eszopiclone|eszopiclone|mesh-list
111306946|NCT05951023|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111306947|NCT05951023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111306948|NCT05951023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111306949|NCT05950997|Obinutuzumab|obinutuzumab|mesh-list
111306950|NCT05950997|Acalabrutinib|acalabrutinib|mesh-list
111306951|NCT05950997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111306952|NCT05950997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111306953|NCT05950971|Amiodarone|amiodarone|mesh-list
111306954|NCT05950971|Diltiazem|diltiazem|mesh-list
111306955|NCT05950971|Esmolol|esmolol|mesh-list
111306956|NCT05950971|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111306957|NCT05950971|Vasodilator Agents|vasodilator agents|mesh-ancestor
111306958|NCT05950971|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
111306959|NCT05950971|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111306960|NCT05950971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111306961|NCT05950971|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111306962|NCT05950971|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111306963|NCT05950971|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111306964|NCT05950971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111306965|NCT05950971|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111306966|NCT05950971|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111306967|NCT05950971|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111306968|NCT05950971|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111306969|NCT05950971|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111306970|NCT05950971|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111306971|NCT05950971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111306972|NCT05950971|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
111306973|NCT05950971|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111306974|NCT05950971|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111306975|NCT05950971|Adrenergic Agents|adrenergic agents|mesh-ancestor
111306976|NCT05950971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111306977|NCT05950945|Trastuzumab|trastuzumab|mesh-list
111306978|NCT05950945|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
111306979|NCT05950945|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111306980|NCT05950945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111306981|NCT05950945|Immunoconjugates|immunoconjugates|mesh-ancestor
111306982|NCT05950945|Immunologic Factors|immunologic factors|mesh-ancestor
111306983|NCT05950945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111306984|NCT05950841|Locust bean gum|locust bean gum|mesh-list
111306985|NCT05950841|Antidiarrheals|antidiarrheals|mesh-ancestor
111306986|NCT05950841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111306987|NCT05950711|Ketamine|ketamine|mesh-list
111306988|NCT05950711|Analgesics|analgesics|mesh-ancestor
111306989|NCT05950711|Sensory System Agents|sensory system agents|mesh-ancestor
111306990|NCT05950711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111306991|NCT05950711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111306992|NCT05950711|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111306993|NCT05950711|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111306994|NCT05950711|Anesthetics, General|anesthetics, general|mesh-ancestor
111306995|NCT05950711|Anesthetics|anesthetics|mesh-ancestor
111306996|NCT05950711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111306997|NCT05950711|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111306998|NCT05950711|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111306999|NCT05950711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111307000|NCT05950711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111307001|NCT05950555|Dexmedetomidine|dexmedetomidine|mesh-list
111307002|NCT05950555|Ketamine|ketamine|mesh-list
111307003|NCT05950555|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111307004|NCT05950555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111307005|NCT05950555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111307006|NCT05950555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111307007|NCT05950555|Analgesics|analgesics|mesh-ancestor
111307008|NCT05950555|Sensory System Agents|sensory system agents|mesh-ancestor
111307009|NCT05950555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111307010|NCT05950555|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111307011|NCT05950555|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111307012|NCT05950555|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111307013|NCT05950555|Adrenergic Agents|adrenergic agents|mesh-ancestor
111307014|NCT05950555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111307015|NCT05950555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111307016|NCT05950555|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111307017|NCT05950555|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111307018|NCT05950555|Anesthetics, General|anesthetics, general|mesh-ancestor
111307019|NCT05950555|Anesthetics|anesthetics|mesh-ancestor
111307020|NCT05950555|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111307021|NCT05950555|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111307022|NCT05950529|Sorbitol|sorbitol|mesh-list
111307023|NCT05950529|Cathartics|cathartics|mesh-ancestor
111307024|NCT05950529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111307025|NCT05950490|Methotrexate|methotrexate|mesh-list
111307026|NCT05950490|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111307027|NCT05950490|Abortifacient Agents|abortifacient agents|mesh-ancestor
111307028|NCT05950490|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111307029|NCT05950490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111307030|NCT05950490|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111307031|NCT05950490|Antimetabolites|antimetabolites|mesh-ancestor
111307032|NCT05950490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111307033|NCT05950490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111307034|NCT05950490|Dermatologic Agents|dermatologic agents|mesh-ancestor
111307035|NCT05950490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111307036|NCT05950490|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111307037|NCT05950490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111307038|NCT05950490|Immunologic Factors|immunologic factors|mesh-ancestor
111307039|NCT05950490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111307040|NCT05950490|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111307041|NCT05950334|Cyclophosphamide|cyclophosphamide|mesh-list
111307042|NCT05950334|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
111307043|NCT05950334|Rituximab|rituximab|mesh-list
111307044|NCT05950334|Fludarabine|fludarabine|mesh-list
111307045|NCT05950334|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111307046|NCT05950334|Immunologic Factors|immunologic factors|mesh-ancestor
111307047|NCT05950334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111307048|NCT05950334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111307049|NCT05950334|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111307050|NCT05950334|Alkylating Agents|alkylating agents|mesh-ancestor
111307051|NCT05950334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111307052|NCT05950334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111307053|NCT05950334|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111307054|NCT05950334|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111307055|NCT05950204|Calcium, Dietary|calcium, dietary|mesh-list
111307056|NCT05950204|Vitamin D|vitamin d|mesh-list
111307057|NCT05950204|Ergocalciferols|ergocalciferols|mesh-list
111307058|NCT05950204|Cholecalciferol|cholecalciferol|mesh-list
111307059|NCT05950204|Vitamins|vitamins|mesh-list
111307060|NCT05950204|Calcium Carbonate|calcium carbonate|mesh-list
111307061|NCT05950204|Calcium|calcium|mesh-list
111307062|NCT05950204|Micronutrients|micronutrients|mesh-ancestor
111307063|NCT05950204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111307064|NCT05950204|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111307065|NCT05950204|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111307067|NCT05950204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111307068|NCT05950204|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111307069|NCT05950152|Meloxicam|meloxicam|mesh-list
111307070|NCT05950152|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111307071|NCT05950152|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111307072|NCT05950152|Analgesics|analgesics|mesh-ancestor
111307073|NCT05950152|Sensory System Agents|sensory system agents|mesh-ancestor
111307074|NCT05950152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111307075|NCT05950152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111307076|NCT05950152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111307077|NCT05950152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111307078|NCT05950152|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111307079|NCT05950152|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111307080|NCT05950152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111307081|NCT05950152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111307082|NCT05950113|Deoxyglucose|deoxyglucose|mesh-list
111307083|NCT05950113|Cyclophosphamide|cyclophosphamide|mesh-list
111307084|NCT05950113|Fludarabine|fludarabine|mesh-list
111307085|NCT05950113|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
111307086|NCT05950113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111307087|NCT05950113|Immunologic Factors|immunologic factors|mesh-ancestor
111307088|NCT05950113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111307089|NCT05950113|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111307090|NCT05950113|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111307091|NCT05950113|Alkylating Agents|alkylating agents|mesh-ancestor
111307092|NCT05950113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111307093|NCT05950113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111307094|NCT05950113|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111307095|NCT05950113|Antimetabolites|antimetabolites|mesh-ancestor
111307096|NCT05950113|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111307097|NCT05950113|Antiviral Agents|antiviral agents|mesh-ancestor
111307098|NCT05950113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111307099|NCT05950061|Dexetimide|dexetimide|mesh-list
111307100|NCT05950061|Citalopram|citalopram|mesh-list
111307101|NCT05950061|Sertraline|sertraline|mesh-list
111307102|NCT05950061|Escitalopram|escitalopram|mesh-list
111307103|NCT05950061|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111307104|NCT05950061|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111307105|NCT05950061|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111307106|NCT05950061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111307107|NCT05950061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111307108|NCT05950061|Serotonin Agents|serotonin agents|mesh-ancestor
111307109|NCT05950061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111307110|NCT05950061|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111307111|NCT05950061|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111307112|NCT05950061|Parasympatholytics|parasympatholytics|mesh-ancestor
111307113|NCT05950061|Autonomic Agents|autonomic agents|mesh-ancestor
111307114|NCT05950061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111307115|NCT05950061|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111307116|NCT05950061|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111307117|NCT05950061|Cholinergic Agents|cholinergic agents|mesh-ancestor
111307118|NCT05950061|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111307119|NCT05950061|Antidepressive Agents|antidepressive agents|mesh-ancestor
111307120|NCT05950061|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111307121|NCT05949762|Azacitidine|azacitidine|mesh-list
111307122|NCT05949762|Venetoclax|venetoclax|mesh-list
111307123|NCT05949762|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111307124|NCT05949762|Antimetabolites|antimetabolites|mesh-ancestor
111307125|NCT05949762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111307126|NCT05949762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111307127|NCT05949762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111307128|NCT05949658|Sirolimus|sirolimus|mesh-list
111307129|NCT05949658|Everolimus|everolimus|mesh-list
111307130|NCT05949658|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111307131|NCT05949658|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111307132|NCT05949658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111307133|NCT05949658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111307134|NCT05949658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111307135|NCT05949658|Immunologic Factors|immunologic factors|mesh-ancestor
111307136|NCT05949658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111307137|NCT05949658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111307138|NCT05949658|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111307139|NCT05949658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111031577|NCT02109965|Anesthetics|anesthetics|mesh-ancestor
111307140|NCT05949658|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111307141|NCT05949658|Antifungal Agents|antifungal agents|mesh-ancestor
111307142|NCT05949554|Ketamine|ketamine|mesh-list
111307143|NCT05949554|Analgesics|analgesics|mesh-ancestor
111307144|NCT05949554|Sensory System Agents|sensory system agents|mesh-ancestor
111307145|NCT05949554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111307146|NCT05949554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111307147|NCT05949554|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111307148|NCT05949554|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111307149|NCT05949554|Anesthetics, General|anesthetics, general|mesh-ancestor
111307150|NCT05949554|Anesthetics|anesthetics|mesh-ancestor
111307151|NCT05949554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111307152|NCT05949554|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111307153|NCT05949554|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111307154|NCT05949554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111307155|NCT05949554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111307156|NCT05949541|Everolimus|everolimus|mesh-list
111307157|NCT05949541|Fulvestrant|fulvestrant|mesh-list
111307158|NCT05949541|Aromatase Inhibitors|aromatase inhibitors|mesh-list
111307159|NCT05949541|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111307160|NCT05949541|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111307161|NCT05949541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111307162|NCT05949541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111307163|NCT05949541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111307164|NCT05949541|Immunologic Factors|immunologic factors|mesh-ancestor
111307165|NCT05949541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111307166|NCT05949541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111307167|NCT05949541|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111307168|NCT05949541|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
111307169|NCT05949541|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111307170|NCT05949541|Hormone Antagonists|hormone antagonists|mesh-ancestor
111307171|NCT05949541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111307172|NCT05949541|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111307173|NCT05949424|Sunitinib|sunitinib|mesh-list
111307174|NCT05949424|Lenvatinib|lenvatinib|mesh-list
111307175|NCT05949424|Olaparib|olaparib|mesh-list
111307176|NCT05949424|Palbociclib|palbociclib|mesh-list
111307177|NCT05949424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111307178|NCT05949424|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111307179|NCT05949424|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111307180|NCT05949424|Growth Substances|growth substances|mesh-ancestor
111307181|NCT05949424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111307182|NCT05949424|Growth Inhibitors|growth inhibitors|mesh-ancestor
110979914|NCT03120182|Analgesics|analgesics|mesh-ancestor
111307183|NCT05949424|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111307184|NCT05949424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111307185|NCT05949424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111307186|NCT05949424|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111307187|NCT05949411|Lactulose|lactulose|mesh-list
111307188|NCT05949411|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111307189|NCT05949385|Itraconazole|itraconazole|mesh-list
111307190|NCT05949385|Antifungal Agents|antifungal agents|mesh-ancestor
111307191|NCT05949385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111307192|NCT05949385|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111307193|NCT05949385|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111307194|NCT05949385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111307195|NCT05949385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111307196|NCT05949385|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111307197|NCT05949385|Hormone Antagonists|hormone antagonists|mesh-ancestor
111307198|NCT05949385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111307199|NCT05949385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111307200|NCT05949385|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111307201|NCT05944965|Oxybutynin|oxybutynin|mesh-list
111307202|NCT05944965|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
111307203|NCT05944965|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111307204|NCT05944965|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111307205|NCT05944965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111307206|NCT05944965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111307207|NCT05944965|Adrenergic Agents|adrenergic agents|mesh-ancestor
111307208|NCT05944965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111307209|NCT05944965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111307210|NCT05944965|Parasympatholytics|parasympatholytics|mesh-ancestor
111307211|NCT05944965|Autonomic Agents|autonomic agents|mesh-ancestor
111307212|NCT05944965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111307213|NCT05944965|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111307214|NCT05944965|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111307215|NCT05944965|Cholinergic Agents|cholinergic agents|mesh-ancestor
111307216|NCT05944965|Urological Agents|urological agents|mesh-ancestor
111307217|NCT05930028|Atorvastatin|atorvastatin|mesh-list
111307218|NCT05930028|Ezetimibe|ezetimibe|mesh-list
111307219|NCT05930028|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111307220|NCT05930028|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111307221|NCT05930028|Antimetabolites|antimetabolites|mesh-ancestor
111307222|NCT05930028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111307223|NCT05930028|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111307224|NCT05930028|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111307225|NCT05930028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111307226|NCT05915442|Quemliclustat|quemliclustat|mesh-list
111307227|NCT05915442|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111307228|NCT05915442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111307229|NCT05915442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111307230|NCT05915442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111307231|NCT05765487|Sildenafil Citrate|sildenafil citrate|mesh-list
111307232|NCT05765487|Vasodilator Agents|vasodilator agents|mesh-ancestor
111307233|NCT05765487|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111307234|NCT05765487|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111307235|NCT05765487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111307236|NCT05765487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111307237|NCT05765487|Urological Agents|urological agents|mesh-ancestor
111307238|NCT05718297|Durvalumab|durvalumab|mesh-list
111307239|NCT05718297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111307240|NCT05718297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111307241|NCT05701956|Tenecteplase|tenecteplase|mesh-list
111307242|NCT05701956|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111307243|NCT05701956|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111307244|NCT05701956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111307245|NCT05662228|Lorazepam|lorazepam|mesh-list
111307246|NCT05662228|Immunoglobulins|immunoglobulins|mesh-list
111307247|NCT05662228|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111307248|NCT05662228|Antibodies|antibodies|mesh-list
111307249|NCT05662228|gamma-Globulins|gamma-globulins|mesh-list
111307250|NCT05662228|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
111307251|NCT05662228|Tofacitinib|tofacitinib|mesh-list
111307252|NCT05662228|Immunologic Factors|immunologic factors|mesh-ancestor
111307253|NCT05662228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111307254|NCT05662228|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
111307255|NCT05662228|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111307256|NCT05662228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111307257|NCT05662228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111307258|NCT05662228|Anticonvulsants|anticonvulsants|mesh-ancestor
111307259|NCT05662228|Antiemetics|antiemetics|mesh-ancestor
111307260|NCT05662228|Autonomic Agents|autonomic agents|mesh-ancestor
111307261|NCT05662228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111307262|NCT05662228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111307263|NCT05662228|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111307264|NCT05662228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111307265|NCT05662228|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111307266|NCT05662228|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111307267|NCT05662228|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111307268|NCT05662228|GABA Modulators|gaba modulators|mesh-ancestor
111307269|NCT05662228|GABA Agents|gaba agents|mesh-ancestor
111307270|NCT05662228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111307271|NCT05656235|Pembrolizumab|pembrolizumab|mesh-list
111307272|NCT05656235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111307273|NCT05656235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111307274|NCT05656235|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111307275|NCT05656235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111307276|NCT05593627|Lithium Carbonate|lithium carbonate|mesh-list
111307277|NCT05593627|Calcium Carbonate|calcium carbonate|mesh-list
111307278|NCT05593627|Calcium|calcium|mesh-list
111307279|NCT05593627|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111307280|NCT05593627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111307281|NCT05593627|Antidepressive Agents|antidepressive agents|mesh-ancestor
111307282|NCT05593627|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111307283|NCT05593627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111307284|NCT05593627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111307285|NCT05593627|Antimanic Agents|antimanic agents|mesh-ancestor
111307286|NCT05593627|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111307287|NCT05593627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111307289|NCT05593627|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111307290|NCT05582096|Tirzepatide|tirzepatide|mesh-list
111307291|NCT05582096|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111307292|NCT05582096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111307293|NCT05582096|Incretins|incretins|mesh-ancestor
111307294|NCT05582096|Hormones|hormones|mesh-ancestor
111307295|NCT05582096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111307296|NCT05577715|Farletuzumab|farletuzumab|mesh-list
111307297|NCT05577715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111307298|NCT05563961|Acetaminophen|acetaminophen|mesh-list
111307299|NCT05563961|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111307300|NCT05563961|Analgesics|analgesics|mesh-ancestor
111307301|NCT05563961|Sensory System Agents|sensory system agents|mesh-ancestor
111307302|NCT05563961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111307303|NCT05563961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111307304|NCT05563961|Antipyretics|antipyretics|mesh-ancestor
111307305|NCT05527834|Ceftibuten|ceftibuten|mesh-list
111307306|NCT05527834|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111307307|NCT05527834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111307308|NCT05522660|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
111307309|NCT05522660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111307310|NCT05522660|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111307311|NCT05522660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111307312|NCT05507658|Capecitabine|capecitabine|mesh-list
111307313|NCT05507658|Oxaliplatin|oxaliplatin|mesh-list
111307314|NCT05507658|Tislelizumab|tislelizumab|mesh-list
111307315|NCT05507658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111307316|NCT05507658|Antimetabolites|antimetabolites|mesh-ancestor
111307317|NCT05507658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111307318|NCT05507658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111307319|NCT05507658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111307320|NCT05502250|Gemcitabine|gemcitabine|mesh-list
111307321|NCT05502250|Tislelizumab|tislelizumab|mesh-list
111307322|NCT05502250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111307323|NCT05502250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111307324|NCT05502250|Antimetabolites|antimetabolites|mesh-ancestor
111307325|NCT05502250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111307326|NCT05502250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111307327|NCT05488678|Ceftibuten|ceftibuten|mesh-list
111307328|NCT05488678|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111307329|NCT05488678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111307330|NCT05457868|Albuterol|albuterol|mesh-list
111307331|NCT05457868|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111307332|NCT05457868|Autonomic Agents|autonomic agents|mesh-ancestor
111307333|NCT05457868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111307334|NCT05457868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111307335|NCT05457868|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111307336|NCT05457868|Respiratory System Agents|respiratory system agents|mesh-ancestor
111307337|NCT05457868|Tocolytic Agents|tocolytic agents|mesh-ancestor
111307338|NCT05457868|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111307339|NCT05457868|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111307340|NCT05457868|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111307341|NCT05457868|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111307342|NCT05457868|Adrenergic Agents|adrenergic agents|mesh-ancestor
111307343|NCT05457868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111307344|NCT05457868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111307345|NCT05434065|Celecoxib|celecoxib|mesh-list
111307346|NCT05434065|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111307347|NCT05434065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111307348|NCT05434065|Analgesics|analgesics|mesh-ancestor
111307349|NCT05434065|Sensory System Agents|sensory system agents|mesh-ancestor
111307350|NCT05434065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111307351|NCT05434065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111307352|NCT05434065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111307353|NCT05434065|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111307354|NCT05434065|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111307355|NCT05434065|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111307356|NCT05434065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111307357|NCT05434065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111307358|NCT05425979|Bupivacaine|bupivacaine|mesh-list
111307359|NCT05425979|Mepivacaine|mepivacaine|mesh-list
111307360|NCT05425979|Anesthetics, Local|anesthetics, local|mesh-ancestor
111307361|NCT05425979|Anesthetics|anesthetics|mesh-ancestor
111307362|NCT05425979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111307363|NCT05425979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111307364|NCT05425979|Sensory System Agents|sensory system agents|mesh-ancestor
111307365|NCT05425979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111307366|NCT05398757|Midazolam|midazolam|mesh-list
111307367|NCT05398757|Dexmedetomidine|dexmedetomidine|mesh-list
111307368|NCT05398757|Propofol|propofol|mesh-list
111307369|NCT05398757|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111307370|NCT05398757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111307371|NCT05398757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111307372|NCT05398757|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111307373|NCT05398757|Anesthetics, General|anesthetics, general|mesh-ancestor
111307374|NCT05398757|Anesthetics|anesthetics|mesh-ancestor
111307375|NCT05398757|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111307376|NCT05398757|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111307377|NCT05398757|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111307378|NCT05398757|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111307379|NCT05398757|GABA Modulators|gaba modulators|mesh-ancestor
111307380|NCT05398757|GABA Agents|gaba agents|mesh-ancestor
111307381|NCT05398757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111307382|NCT05398757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111307383|NCT05398757|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111307384|NCT05398757|Analgesics|analgesics|mesh-ancestor
111307385|NCT05398757|Sensory System Agents|sensory system agents|mesh-ancestor
111307386|NCT05398757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111307387|NCT05398757|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111307388|NCT05398757|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111307389|NCT05398757|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111307390|NCT05398757|Adrenergic Agents|adrenergic agents|mesh-ancestor
111307391|NCT05378269|Tamoxifen|tamoxifen|mesh-list
111307392|NCT05378269|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111307393|NCT05378269|Hormone Antagonists|hormone antagonists|mesh-ancestor
111307394|NCT05378269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111307395|NCT05378269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111307396|NCT05378269|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111307397|NCT05378269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111307398|NCT05378269|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111307399|NCT05378269|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111307400|NCT05378269|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111307401|NCT05323552|Curare|curare|mesh-list
111307402|NCT05323552|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
111307403|NCT05323552|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
111307404|NCT05323552|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111307405|NCT05323552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111307406|NCT05323552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111307407|NCT05323552|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
111307408|NCT05323552|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111307409|NCT05323552|Cholinergic Agents|cholinergic agents|mesh-ancestor
111307410|NCT05323552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111307411|NCT05323552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111307412|NCT05322954|Psilocybin|psilocybin|mesh-list
111307413|NCT05322954|Hallucinogens|hallucinogens|mesh-ancestor
111307414|NCT05322954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111307415|NCT05322954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111307416|NCT05310253|Fludrocortisone|fludrocortisone|mesh-list
111307417|NCT05310253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111307418|NCT05291039|Adalimumab|adalimumab|mesh-list
111307419|NCT05291039|Infliximab|infliximab|mesh-list
111307420|NCT05291039|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111307421|NCT05291039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111307422|NCT05291039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111307423|NCT05291039|Dermatologic Agents|dermatologic agents|mesh-ancestor
111307424|NCT05291039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111307425|NCT05274633|Ravulizumab|ravulizumab|mesh-list
111307426|NCT05274633|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
111307427|NCT05274633|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111307428|NCT05274633|Immunologic Factors|immunologic factors|mesh-ancestor
111307429|NCT05274633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111307430|NCT05249101|Capecitabine|capecitabine|mesh-list
111307431|NCT05249101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111307432|NCT05249101|Antimetabolites|antimetabolites|mesh-ancestor
111307433|NCT05249101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111307434|NCT05249101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111307435|NCT05224089|Dexamethasone|dexamethasone|mesh-list
111307436|NCT05224089|Epinephrine|epinephrine|mesh-list
111307437|NCT05224089|Bupivacaine|bupivacaine|mesh-list
111307438|NCT05224089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111307439|NCT05224089|Antiemetics|antiemetics|mesh-ancestor
111307440|NCT05224089|Autonomic Agents|autonomic agents|mesh-ancestor
111307441|NCT05224089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111307442|NCT05224089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111307443|NCT05224089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111307444|NCT05224089|Glucocorticoids|glucocorticoids|mesh-ancestor
111307445|NCT05224089|Hormones|hormones|mesh-ancestor
111307446|NCT05224089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111307447|NCT05224089|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111307448|NCT05224089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111307449|NCT05224089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111307450|NCT05224089|Anesthetics, Local|anesthetics, local|mesh-ancestor
111307451|NCT05224089|Anesthetics|anesthetics|mesh-ancestor
111307452|NCT05224089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111307453|NCT05224089|Sensory System Agents|sensory system agents|mesh-ancestor
111307454|NCT05224089|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111307455|NCT05224089|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111307456|NCT05224089|Adrenergic Agents|adrenergic agents|mesh-ancestor
111307457|NCT05224089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111307458|NCT05224089|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111307459|NCT05224089|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111307460|NCT05224089|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111307461|NCT05224089|Respiratory System Agents|respiratory system agents|mesh-ancestor
111307462|NCT05224089|Mydriatics|mydriatics|mesh-ancestor
111307463|NCT05224089|Sympathomimetics|sympathomimetics|mesh-ancestor
111307464|NCT05224089|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111307465|NCT05205252|Dexamethasone|dexamethasone|mesh-list
111307466|NCT05205252|Lenalidomide|lenalidomide|mesh-list
111307467|NCT05205252|Daratumumab|daratumumab|mesh-list
111307468|NCT05205252|Pomalidomide|pomalidomide|mesh-list
111307469|NCT05205252|Acalabrutinib|acalabrutinib|mesh-list
111307470|NCT05205252|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111307471|NCT05205252|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
111307472|NCT05205252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111307473|NCT05205252|Antiemetics|antiemetics|mesh-ancestor
111307474|NCT05205252|Autonomic Agents|autonomic agents|mesh-ancestor
111307475|NCT05205252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111307476|NCT05205252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111307477|NCT05205252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111307478|NCT05205252|Glucocorticoids|glucocorticoids|mesh-ancestor
111307479|NCT05205252|Hormones|hormones|mesh-ancestor
111307480|NCT05205252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111307481|NCT05205252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111307482|NCT05205252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111307483|NCT05205252|Immunologic Factors|immunologic factors|mesh-ancestor
111307484|NCT05205252|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111307485|NCT05205252|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111307486|NCT05205252|Growth Substances|growth substances|mesh-ancestor
111307487|NCT05205252|Growth Inhibitors|growth inhibitors|mesh-ancestor
111307488|NCT05205252|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111307489|NCT05205252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111307490|NCT05205252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111307491|NCT05125237|Amiloride|amiloride|mesh-list
111307492|NCT05125237|Triamterene|triamterene|mesh-list
111307493|NCT05125237|Diuretics|diuretics|mesh-ancestor
111307494|NCT05125237|Natriuretic Agents|natriuretic agents|mesh-ancestor
111307495|NCT05125237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111307496|NCT05125237|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
111307497|NCT05125237|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111307498|NCT05125237|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111307499|NCT05125237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111307500|NCT05125237|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
111307501|NCT05125237|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
111307502|NCT05125224|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
111307503|NCT05125224|Calcium Channel Blockers|calcium channel blockers|mesh-list
111307504|NCT05125224|1,4-dihydropyridine|1,4-dihydropyridine|mesh-list
111307505|NCT05125224|Calcium|calcium|mesh-list
111307506|NCT05125224|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111307507|NCT05125224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111307508|NCT05125224|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111307509|NCT05125224|Diuretics|diuretics|mesh-ancestor
111307510|NCT05125224|Natriuretic Agents|natriuretic agents|mesh-ancestor
111307511|NCT05125224|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
111307512|NCT05125224|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111031958|NCT04854668|Bevacizumab|bevacizumab|mesh-list
111307513|NCT05125224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111307515|NCT05016947|Venetoclax|venetoclax|mesh-list
111307516|NCT05016947|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
111307517|NCT05016947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111307518|NCT05016947|Antiemetics|antiemetics|mesh-ancestor
111307519|NCT05016947|Autonomic Agents|autonomic agents|mesh-ancestor
111307520|NCT05016947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111307521|NCT05016947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111307522|NCT05016947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111307523|NCT05016947|Glucocorticoids|glucocorticoids|mesh-ancestor
111307524|NCT05016947|Hormones|hormones|mesh-ancestor
111307525|NCT05016947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111307526|NCT05016947|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111307527|NCT05016947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111307528|NCT05016947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111307529|NCT05016947|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111307530|NCT05016947|Immunotoxins|immunotoxins|mesh-ancestor
111307531|NCT05016947|Immunoconjugates|immunoconjugates|mesh-ancestor
111307532|NCT05016947|Immunologic Factors|immunologic factors|mesh-ancestor
111307533|NCT04989816|Trastuzumab|trastuzumab|mesh-list
111307534|NCT04989816|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
111307535|NCT04989816|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111307536|NCT04989816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111307537|NCT04989816|Immunoconjugates|immunoconjugates|mesh-ancestor
111307538|NCT04989816|Immunologic Factors|immunologic factors|mesh-ancestor
111307539|NCT04989816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111307540|NCT04963712|Thymalfasin|thymalfasin|mesh-list
111307541|NCT04963712|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111307542|NCT04963712|Immunologic Factors|immunologic factors|mesh-ancestor
111307543|NCT04963712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111307544|NCT04754399|Cannabidiol|cannabidiol|mesh-list
111307545|NCT04754399|Anticonvulsants|anticonvulsants|mesh-ancestor
111307546|NCT04750616|Niacinamide|niacinamide|mesh-list
111307547|NCT04750616|Niacin|niacin|mesh-list
111307548|NCT04750616|Nicotinic Acids|nicotinic acids|mesh-list
111307549|NCT04750616|Vitamin B Complex|vitamin b complex|mesh-ancestor
111307550|NCT04750616|Vitamins|vitamins|mesh-ancestor
111307551|NCT04750616|Micronutrients|micronutrients|mesh-ancestor
111307552|NCT04750616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111307553|NCT04750616|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111307554|NCT04750616|Antimetabolites|antimetabolites|mesh-ancestor
111307555|NCT04750616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111307556|NCT04750616|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111307557|NCT04750616|Vasodilator Agents|vasodilator agents|mesh-ancestor
111307558|NCT04734652|Tenofovir|tenofovir|mesh-list
111307559|NCT04734652|Lamivudine|lamivudine|mesh-list
111307560|NCT04734652|Dolutegravir|dolutegravir|mesh-list
111307561|NCT04734652|Antiviral Agents|antiviral agents|mesh-ancestor
111307562|NCT04734652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111307563|NCT04734652|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111307564|NCT04734652|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111307565|NCT04734652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111307566|NCT04734652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111307567|NCT04734652|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111307568|NCT04734652|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111307569|NCT04734652|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111307570|NCT04734652|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111307571|NCT04697576|Pembrolizumab|pembrolizumab|mesh-list
111307572|NCT04697576|Nivolumab|nivolumab|mesh-list
111307573|NCT04697576|Ipilimumab|ipilimumab|mesh-list
111307574|NCT04697576|Relatlimab|relatlimab|mesh-list
111307575|NCT04697576|Vaccines|vaccines|mesh-list
111307576|NCT04697576|Immunologic Factors|immunologic factors|mesh-ancestor
111307577|NCT04697576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111307578|NCT04697576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111307579|NCT04697576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111307580|NCT04697576|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111307581|NCT04697576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111307582|NCT04673422|Montelukast|montelukast|mesh-list
111307583|NCT04673422|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111307584|NCT04673422|Respiratory System Agents|respiratory system agents|mesh-ancestor
111307585|NCT04673422|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
111032025|NCT02434029|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111307586|NCT04673422|Hormone Antagonists|hormone antagonists|mesh-ancestor
111307587|NCT04673422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111307588|NCT04673422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111307589|NCT04673422|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
111307590|NCT04673422|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111307591|NCT04673422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111307592|NCT04646356|Tacrolimus|tacrolimus|mesh-list
111307593|NCT04646356|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111307594|NCT04646356|Immunologic Factors|immunologic factors|mesh-ancestor
111307595|NCT04646356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111307596|NCT04646356|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111307597|NCT04646356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111307598|NCT04646356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111307599|NCT04618016|Vitamins|vitamins|mesh-list
111307600|NCT04618016|Vitamin E|vitamin e|mesh-list
111307601|NCT04618016|Tocopherols|tocopherols|mesh-list
111307602|NCT04618016|Tocotrienols|tocotrienols|mesh-list
111307603|NCT04618016|alpha-Tocopherol|alpha-tocopherol|mesh-list
111307604|NCT04618016|Micronutrients|micronutrients|mesh-ancestor
111307605|NCT04618016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111307606|NCT04618016|Antioxidants|antioxidants|mesh-ancestor
111307607|NCT04618016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111307608|NCT04618016|Protective Agents|protective agents|mesh-ancestor
111307609|NCT04515472|Hormones|hormones|mesh-list
111307610|NCT04515472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111307611|NCT04515472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111307612|NCT04508023|Rivaroxaban|rivaroxaban|mesh-list
111307613|NCT04508023|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111307614|NCT04508023|Antithrombins|antithrombins|mesh-ancestor
111307615|NCT04508023|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111307616|NCT04508023|Protease Inhibitors|protease inhibitors|mesh-ancestor
111307617|NCT04508023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111307618|NCT04508023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111307619|NCT04508023|Anticoagulants|anticoagulants|mesh-ancestor
111307620|NCT04505098|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
111307621|NCT04505098|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111307622|NCT04505098|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111307623|NCT04489732|Interferons|interferons|mesh-list
111307624|NCT04489732|Interferon-gamma|interferon-gamma|mesh-list
111307625|NCT04489732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111307626|NCT04489732|Antiviral Agents|antiviral agents|mesh-ancestor
111307627|NCT04489732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111307628|NCT04451746|Contraceptive Agents|contraceptive agents|mesh-list
111307629|NCT04451746|Contraceptives, Oral|contraceptives, oral|mesh-list
111307630|NCT04451746|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
111307631|NCT04451746|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111307632|NCT04451746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111307633|NCT04451746|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111307634|NCT04429542|Pembrolizumab|pembrolizumab|mesh-list
111307635|NCT04429542|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111307636|NCT04429542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111307637|NCT04429542|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111307638|NCT04429542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111307639|NCT04425018|Paclitaxel|paclitaxel|mesh-list
111307640|NCT04425018|Trastuzumab|trastuzumab|mesh-list
111307641|NCT04425018|Pertuzumab|pertuzumab|mesh-list
111307642|NCT04425018|Margetuximab|margetuximab|mesh-list
111307643|NCT04425018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111307644|NCT04425018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111307645|NCT04425018|Tubulin Modulators|tubulin modulators|mesh-ancestor
111307646|NCT04425018|Antimitotic Agents|antimitotic agents|mesh-ancestor
111307647|NCT04425018|Mitosis Modulators|mitosis modulators|mesh-ancestor
111307648|NCT04425018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111307649|NCT04425018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111307650|NCT04300595|Anesthetics|anesthetics|mesh-list
111307651|NCT04300595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111307652|NCT04300595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111307653|NCT04212026|Nivolumab|nivolumab|mesh-list
111307654|NCT04212026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111307655|NCT04212026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111307656|NCT04212026|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111307657|NCT04212026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111307658|NCT04187144|Nitrofurantoin|nitrofurantoin|mesh-list
111307659|NCT04187144|Gepotidacin|gepotidacin|mesh-list
111307660|NCT04187144|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111307661|NCT04187144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111307662|NCT04187144|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111307663|NCT04187144|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111307664|NCT04187144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111307665|NCT04187144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111307666|NCT04187144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111307667|NCT04096638|Atezolizumab|atezolizumab|mesh-list
111307668|NCT04096638|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111307669|NCT04096638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111307670|NCT04096638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111307671|NCT04096638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111307672|NCT04027946|Pembrolizumab|pembrolizumab|mesh-list
111307673|NCT04027946|LMB-100|lmb-100|mesh-list
111307674|NCT04027946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111307675|NCT04027946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111307676|NCT04027946|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111307677|NCT04027946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111307678|NCT04027946|Immunoconjugates|immunoconjugates|mesh-ancestor
111307679|NCT04027946|Immunologic Factors|immunologic factors|mesh-ancestor
111307680|NCT04027946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111307681|NCT04017468|Vancomycin|vancomycin|mesh-list
111307682|NCT04017468|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111307683|NCT04017468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111307684|NCT03976310|Benralizumab|benralizumab|mesh-list
111307685|NCT03976310|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111307686|NCT03976310|Respiratory System Agents|respiratory system agents|mesh-ancestor
111307687|NCT03950570|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111307688|NCT03950570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111307689|NCT03949764|Sofosbuvir|sofosbuvir|mesh-list
111307690|NCT03949764|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
111307691|NCT03949764|Velpatasvir|velpatasvir|mesh-list
111307692|NCT03949764|Antiviral Agents|antiviral agents|mesh-ancestor
111307693|NCT03949764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111307694|NCT03944954|Dronabinol|dronabinol|mesh-list
111307695|NCT03944954|Hallucinogens|hallucinogens|mesh-ancestor
111307696|NCT03944954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111307697|NCT03944954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111307698|NCT03944954|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111307699|NCT03944954|Analgesics|analgesics|mesh-ancestor
111307700|NCT03944954|Sensory System Agents|sensory system agents|mesh-ancestor
111307701|NCT03944954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111307702|NCT03944954|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
111307703|NCT03944954|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
111307704|NCT03944954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111307705|NCT03944954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111307706|NCT03944954|Hormones|hormones|mesh-ancestor
111307707|NCT03944954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111307708|NCT03930212|Progesterone|progesterone|mesh-list
111307709|NCT03930212|Progestins|progestins|mesh-ancestor
111307710|NCT03930212|Hormones|hormones|mesh-ancestor
111307711|NCT03930212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111307712|NCT03930212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111307713|NCT03901339|Gemcitabine|gemcitabine|mesh-list
111307714|NCT03901339|Capecitabine|capecitabine|mesh-list
111307715|NCT03901339|Vinorelbine|vinorelbine|mesh-list
111307716|NCT03901339|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
111307717|NCT03901339|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111307718|NCT03901339|Antimetabolites|antimetabolites|mesh-ancestor
111307719|NCT03901339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111307720|NCT03901339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111307721|NCT03901339|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111307722|NCT03901339|Tubulin Modulators|tubulin modulators|mesh-ancestor
111307723|NCT03901339|Antimitotic Agents|antimitotic agents|mesh-ancestor
111307724|NCT03901339|Mitosis Modulators|mitosis modulators|mesh-ancestor
111307725|NCT03901339|Immunoconjugates|immunoconjugates|mesh-ancestor
111307726|NCT03901339|Immunologic Factors|immunologic factors|mesh-ancestor
111307727|NCT03901339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111307728|NCT03893617|Propranolol|propranolol|mesh-list
111307729|NCT03893617|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111307730|NCT03893617|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111307731|NCT03893617|Adrenergic Agents|adrenergic agents|mesh-ancestor
111307732|NCT03893617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111307733|NCT03893617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111307734|NCT03893617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111307735|NCT03893617|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111307736|NCT03893617|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111307737|NCT03893617|Vasodilator Agents|vasodilator agents|mesh-ancestor
111307738|NCT03856047|Liraglutide|liraglutide|mesh-list
111307739|NCT03856047|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111307740|NCT03856047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111307741|NCT03856047|Incretins|incretins|mesh-ancestor
111307742|NCT03856047|Hormones|hormones|mesh-ancestor
111307743|NCT03856047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111307744|NCT03850782|Bimatoprost|bimatoprost|mesh-list
111307745|NCT03850782|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111307746|NCT03810742|Irinotecan|irinotecan|mesh-list
111307747|NCT03810742|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111307748|NCT03810742|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111307749|NCT03810742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111307750|NCT03810742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111307751|NCT03810742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111307752|NCT03797014|Tenofovir|tenofovir|mesh-list
111307753|NCT03797014|Emtricitabine|emtricitabine|mesh-list
111307754|NCT03797014|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
111307755|NCT03797014|Antiviral Agents|antiviral agents|mesh-ancestor
111307756|NCT03797014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111307757|NCT03797014|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111307758|NCT03797014|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111307759|NCT03797014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111307760|NCT03797014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111307761|NCT03797014|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111307762|NCT03797014|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111307763|NCT03787628|Cannabidiol|cannabidiol|mesh-list
111307764|NCT03787628|Anticonvulsants|anticonvulsants|mesh-ancestor
111307765|NCT03752684|Calcium|calcium|mesh-list
111307766|NCT03752684|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111307767|NCT03752684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111307768|NCT03751709|Blinatumomab|blinatumomab|mesh-list
111307769|NCT03751709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111307770|NCT03737136|Bortezomib|bortezomib|mesh-list
111307771|NCT03737136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111307772|NCT03691376|Aldesleukin|aldesleukin|mesh-list
111307773|NCT03691376|Melphalan|melphalan|mesh-list
111307774|NCT03691376|Mechlorethamine|mechlorethamine|mesh-list
111307775|NCT03691376|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
111307776|NCT03691376|Interleukin-2|interleukin-2|mesh-list
111307777|NCT03691376|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111307778|NCT03691376|Alkylating Agents|alkylating agents|mesh-ancestor
111307779|NCT03691376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111307780|NCT03691376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111307781|NCT03691376|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111307782|NCT03691376|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111307783|NCT03691376|Immunologic Factors|immunologic factors|mesh-ancestor
111307784|NCT03691376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111307785|NCT03691376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111307786|NCT03691376|Analgesics|analgesics|mesh-ancestor
111307787|NCT03691376|Sensory System Agents|sensory system agents|mesh-ancestor
111307788|NCT03691376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111307789|NCT03691376|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111307790|NCT03691376|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111307791|NCT03691376|Antiviral Agents|antiviral agents|mesh-ancestor
111307792|NCT03691376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111307793|NCT03647163|Pembrolizumab|pembrolizumab|mesh-list
111307794|NCT03647163|Nivolumab|nivolumab|mesh-list
111307795|NCT03647163|Ipilimumab|ipilimumab|mesh-list
111307796|NCT03647163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111307797|NCT03647163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111307798|NCT03647163|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111307799|NCT03647163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111307800|NCT03635749|Atorvastatin|atorvastatin|mesh-list
111307801|NCT03635749|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
111307802|NCT03635749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111307803|NCT03635749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111307804|NCT03635749|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111307805|NCT03635749|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111307806|NCT03635749|Antimetabolites|antimetabolites|mesh-ancestor
111307807|NCT03635749|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111307808|NCT03599453|Interferons|interferons|mesh-list
111307809|NCT03599453|Interferon-alpha|interferon-alpha|mesh-list
111307810|NCT03599453|Interferon alpha-2|interferon alpha-2|mesh-list
111307811|NCT03599453|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
111307812|NCT03599453|Poly I-C|poly i-c|mesh-list
111307813|NCT03599453|Celecoxib|celecoxib|mesh-list
111307814|NCT03599453|Pembrolizumab|pembrolizumab|mesh-list
111307815|NCT03599453|Immunoglobulins|immunoglobulins|mesh-list
111307816|NCT03599453|Immunoglobulin G|immunoglobulin g|mesh-list
111307817|NCT03599453|Benzenesulfonamide|benzenesulfonamide|mesh-list
111307818|NCT03599453|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111307819|NCT03599453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111307820|NCT03599453|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111307821|NCT03599453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111307822|NCT03599453|Antiviral Agents|antiviral agents|mesh-ancestor
111307823|NCT03599453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111307824|NCT03599453|Immunologic Factors|immunologic factors|mesh-ancestor
111307825|NCT03599453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111307826|NCT03599453|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111307827|NCT03599453|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111307828|NCT03599453|Analgesics|analgesics|mesh-ancestor
111307829|NCT03599453|Sensory System Agents|sensory system agents|mesh-ancestor
111307830|NCT03599453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111307831|NCT03599453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111307832|NCT03599453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111307833|NCT03599453|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111307834|NCT03599453|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111307835|NCT03599453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111307836|NCT03599453|Interferon Inducers|interferon inducers|mesh-ancestor
111307837|NCT03599453|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
111307838|NCT03573960|Lenvatinib|lenvatinib|mesh-list
111307839|NCT03573960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111307840|NCT03573960|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111307841|NCT03573960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111307842|NCT03573960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111307843|NCT03554291|Famotidine|famotidine|mesh-list
111307844|NCT03554291|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111307845|NCT03554291|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111307846|NCT03554291|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
111307847|NCT03554291|Histamine Antagonists|histamine antagonists|mesh-ancestor
111307848|NCT03554291|Histamine Agents|histamine agents|mesh-ancestor
111307849|NCT03554291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111307850|NCT03554291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111307851|NCT03554291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111307852|NCT03524235|Rituximab|rituximab|mesh-list
111307853|NCT03524235|Fludarabine|fludarabine|mesh-list
111307854|NCT03524235|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
111307855|NCT03524235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111307856|NCT03524235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111307857|NCT03524235|Immunologic Factors|immunologic factors|mesh-ancestor
111307858|NCT03524235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111307859|NCT03524235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111307860|NCT03524235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111307861|NCT03524235|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111307862|NCT03524235|Alkylating Agents|alkylating agents|mesh-ancestor
111307863|NCT03464461|Ketorolac|ketorolac|mesh-list
111307864|NCT03464461|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
111307865|NCT03464461|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111307866|NCT03464461|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111307867|NCT03464461|Analgesics|analgesics|mesh-ancestor
111307868|NCT03464461|Sensory System Agents|sensory system agents|mesh-ancestor
111307869|NCT03464461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111307870|NCT03464461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111307871|NCT03464461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111307872|NCT03464461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111307873|NCT03464461|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111307874|NCT03464461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111307875|NCT03464461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111307876|NCT03440437|Paclitaxel|paclitaxel|mesh-list
111307877|NCT03440437|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111307878|NCT03440437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111307879|NCT03440437|Tubulin Modulators|tubulin modulators|mesh-ancestor
111307880|NCT03440437|Antimitotic Agents|antimitotic agents|mesh-ancestor
111307881|NCT03440437|Mitosis Modulators|mitosis modulators|mesh-ancestor
111307882|NCT03440437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111307883|NCT03392246|Osimertinib|osimertinib|mesh-list
111307884|NCT03392246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111307885|NCT03392246|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111307886|NCT03392246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111307887|NCT03392246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111307888|NCT03374956|Liraglutide|liraglutide|mesh-list
111307889|NCT03374956|Topiramate|topiramate|mesh-list
111307890|NCT03374956|Phentermine|phentermine|mesh-list
111307892|NCT03374956|Bupropion|bupropion|mesh-list
111307893|NCT03374956|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111307894|NCT03374956|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111307895|NCT03374956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111307896|NCT03374956|Sensory System Agents|sensory system agents|mesh-ancestor
111307897|NCT03374956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111307898|NCT03374956|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111307899|NCT03374956|Incretins|incretins|mesh-ancestor
111307900|NCT03374956|Hormones|hormones|mesh-ancestor
111307901|NCT03374956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111307902|NCT03374956|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111307903|NCT03374956|Antidepressive Agents|antidepressive agents|mesh-ancestor
111307904|NCT03374956|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111307905|NCT03374956|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111307906|NCT03374956|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111307907|NCT03374956|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111307908|NCT03374956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111307909|NCT03374956|Dopamine Agents|dopamine agents|mesh-ancestor
111307910|NCT03374956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111307911|NCT03374956|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111307912|NCT03374956|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111307913|NCT03374956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111307914|NCT03374956|Anticonvulsants|anticonvulsants|mesh-ancestor
111307915|NCT03374956|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111307916|NCT03374956|Appetite Depressants|appetite depressants|mesh-ancestor
111307917|NCT03374956|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111307918|NCT03374956|Sympathomimetics|sympathomimetics|mesh-ancestor
111307919|NCT03374956|Autonomic Agents|autonomic agents|mesh-ancestor
111307920|NCT03374956|Adrenergic Agents|adrenergic agents|mesh-ancestor
111307921|NCT03334682|Doxycycline|doxycycline|mesh-list
111307922|NCT03334682|Spironolactone|spironolactone|mesh-list
111307923|NCT03334682|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111307924|NCT03334682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111307925|NCT03334682|Antimalarials|antimalarials|mesh-ancestor
111307926|NCT03334682|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111307927|NCT03334682|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111307928|NCT03334682|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
111307929|NCT03334682|Hormone Antagonists|hormone antagonists|mesh-ancestor
111307930|NCT03334682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111307931|NCT03334682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111307932|NCT03334682|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
111307933|NCT03334682|Diuretics|diuretics|mesh-ancestor
111307934|NCT03334682|Natriuretic Agents|natriuretic agents|mesh-ancestor
111307935|NCT03211416|Pembrolizumab|pembrolizumab|mesh-list
111307936|NCT03211416|Sorafenib|sorafenib|mesh-list
111307937|NCT03211416|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111307938|NCT03211416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111307939|NCT03211416|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111307940|NCT03211416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111307941|NCT03211416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111307942|NCT03211416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111307943|NCT03112603|Mycophenolic Acid|mycophenolic acid|mesh-list
111307944|NCT03112603|Sirolimus|sirolimus|mesh-list
111307945|NCT03112603|Infliximab|infliximab|mesh-list
111307946|NCT03112603|Rituximab|rituximab|mesh-list
111307947|NCT03112603|Methotrexate|methotrexate|mesh-list
111307948|NCT03112603|Everolimus|everolimus|mesh-list
111307949|NCT03112603|Imatinib Mesylate|imatinib mesylate|mesh-list
111307950|NCT03112603|Pentostatin|pentostatin|mesh-list
111307951|NCT03112603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111307952|NCT03112603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111307953|NCT03112603|Immunologic Factors|immunologic factors|mesh-ancestor
111307954|NCT03112603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111307955|NCT03112603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111307956|NCT03112603|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111307957|NCT03112603|Abortifacient Agents|abortifacient agents|mesh-ancestor
111307958|NCT03112603|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111307959|NCT03112603|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111307960|NCT03112603|Antimetabolites|antimetabolites|mesh-ancestor
111307961|NCT03112603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111307962|NCT03112603|Dermatologic Agents|dermatologic agents|mesh-ancestor
111307963|NCT03112603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111307964|NCT03112603|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111307965|NCT03112603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111307966|NCT03112603|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111307967|NCT03112603|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111307968|NCT03112603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111307969|NCT03112603|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111307970|NCT03112603|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111307971|NCT03112603|Antitubercular Agents|antitubercular agents|mesh-ancestor
111307972|NCT03112603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111307973|NCT03112603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111307974|NCT03112603|Antifungal Agents|antifungal agents|mesh-ancestor
111307975|NCT03112603|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111307976|NCT03112603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111307977|NCT03112603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111307978|NCT03112603|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
111307979|NCT03073317|Mitogens|mitogens|mesh-list
111307980|NCT03073317|Mitosis Modulators|mitosis modulators|mesh-ancestor
111307981|NCT03073317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111307982|NCT03056001|Doxorubicin|doxorubicin|mesh-list
111307983|NCT03056001|Pembrolizumab|pembrolizumab|mesh-list
111307984|NCT03056001|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111307985|NCT03056001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111307986|NCT03056001|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111307987|NCT03056001|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111307988|NCT03056001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111307989|NCT03056001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111307990|NCT03056001|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111307991|NCT03056001|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111307992|NCT02736266|Pembrolizumab|pembrolizumab|mesh-list
111307993|NCT02736266|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111307994|NCT02736266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111307995|NCT02736266|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111307996|NCT02736266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111307997|NCT02627963|Sorafenib|sorafenib|mesh-list
111307998|NCT02627963|Tivozanib|tivozanib|mesh-list
111307999|NCT02627963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111308000|NCT02627963|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111308001|NCT02627963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111308002|NCT02627963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111308003|NCT02589691|Rocuronium|rocuronium|mesh-list
111308004|NCT02589691|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
111308005|NCT02589691|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
111308006|NCT02589691|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111308007|NCT02589691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111308008|NCT02589691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111308009|NCT02585258|Prednisolone|prednisolone|mesh-list
111308010|NCT02585258|Glucocorticoids|glucocorticoids|mesh-list
111308011|NCT02585258|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111308012|NCT02585258|Hormones|hormones|mesh-ancestor
111308013|NCT02585258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111308014|NCT02585258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111308015|NCT02585258|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111308016|NCT02585258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111308017|NCT02491099|Afatinib|afatinib|mesh-list
111308018|NCT02491099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111308019|NCT02491099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111308020|NCT02491099|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111308021|NCT02491099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111308022|NCT02320435|Trastuzumab|trastuzumab|mesh-list
111308023|NCT02320435|Pertuzumab|pertuzumab|mesh-list
111308024|NCT02320435|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111308025|NCT02320435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111308026|NCT02320292|Rituximab|rituximab|mesh-list
111308027|NCT02320292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111308028|NCT02320292|Antibodies|antibodies|mesh-list
111308029|NCT02320292|Immunoglobulins|immunoglobulins|mesh-list
111308030|NCT02320292|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111308031|NCT02320292|Immunologic Factors|immunologic factors|mesh-ancestor
111308032|NCT02320292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111308033|NCT02320292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111308034|NCT02320292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111308035|NCT02213107|Finasteride|finasteride|mesh-list
111308036|NCT02213107|Dutasteride|dutasteride|mesh-list
111308037|NCT02213107|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
111308038|NCT02213107|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111308039|NCT02213107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111032478|NCT03038516|Vitamin D|vitamin d|mesh-list
111308040|NCT02213107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111308042|NCT02213107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111308043|NCT02213107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111308044|NCT02213107|Urological Agents|urological agents|mesh-ancestor
111308045|NCT02203604|Aldesleukin|aldesleukin|mesh-list
111308046|NCT02203604|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111308047|NCT02203604|Ipilimumab|ipilimumab|mesh-list
111308048|NCT02203604|Interleukin-2|interleukin-2|mesh-list
111308049|NCT02203604|Antibodies|antibodies|mesh-list
111308050|NCT02203604|Immunoglobulins|immunoglobulins|mesh-list
111308051|NCT02203604|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111308052|NCT02203604|Immunologic Factors|immunologic factors|mesh-ancestor
111308053|NCT02203604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111308054|NCT02203604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111308055|NCT02203604|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111308056|NCT02203604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111308057|NCT02203604|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111308058|NCT02203604|Analgesics|analgesics|mesh-ancestor
111308059|NCT02203604|Sensory System Agents|sensory system agents|mesh-ancestor
111308060|NCT02203604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111308061|NCT02203604|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111308062|NCT02203604|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111308063|NCT02203604|Antiviral Agents|antiviral agents|mesh-ancestor
111308064|NCT02203604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111308065|NCT02188745|Letrozole|letrozole|mesh-list
111308066|NCT02188745|Anastrozole|anastrozole|mesh-list
111308067|NCT02188745|Exemestane|exemestane|mesh-list
111308068|NCT02188745|Estradiol|estradiol|mesh-list
111308069|NCT02188745|Aromatase Inhibitors|aromatase inhibitors|mesh-list
111308070|NCT02188745|Estrogens|estrogens|mesh-ancestor
111308071|NCT02188745|Hormones|hormones|mesh-ancestor
111308072|NCT02188745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111308073|NCT02188745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111308074|NCT02188745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111308075|NCT02188745|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111308076|NCT02188745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111308077|NCT02188745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111308078|NCT02188745|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111308079|NCT02188745|Hormone Antagonists|hormone antagonists|mesh-ancestor
111308080|NCT02188745|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111308081|NCT01874353|Olaparib|olaparib|mesh-list
111308082|NCT01874353|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111308083|NCT01874353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111308084|NCT01874353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111308085|NCT01874353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111308086|NCT01228240|Metformin|metformin|mesh-list
111308087|NCT01228240|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111308088|NCT01228240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111308089|NCT00701220|Atorvastatin|atorvastatin|mesh-list
111308090|NCT00701220|Calcium|calcium|mesh-list
111308091|NCT00701220|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111308092|NCT00701220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111308093|NCT00701220|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111308094|NCT00701220|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111308095|NCT00701220|Antimetabolites|antimetabolites|mesh-ancestor
111308096|NCT00701220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111308097|NCT00701220|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111308098|NCT00701220|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111308099|NCT00701220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111308100|NCT00677924|Zalutumumab|zalutumumab|mesh-list
111308101|NCT00677924|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111308102|NCT00677924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111308103|NCT00251303|Riluzole|riluzole|mesh-list
111308104|NCT00251303|Anticonvulsants|anticonvulsants|mesh-ancestor
111308105|NCT00251303|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111308106|NCT00251303|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111308107|NCT00251303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111308108|NCT00251303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111308109|NCT00251303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111308110|NCT00251303|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111308111|NCT00251303|Protective Agents|protective agents|mesh-ancestor
111308112|NCT00303823|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
111308113|NCT00303823|Antioxidants|antioxidants|mesh-ancestor
111308114|NCT00303823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111308115|NCT00303823|Protective Agents|protective agents|mesh-ancestor
111308116|NCT00303823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111308117|NCT00303823|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
111308118|NCT00303823|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
111308119|NCT00303823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111308120|NCT00303823|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111308121|NCT00300677|Voriconazole|voriconazole|mesh-list
111308122|NCT00300677|Antifungal Agents|antifungal agents|mesh-ancestor
111308123|NCT00300677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111308124|NCT00300677|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111308125|NCT00300677|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111308126|NCT00300677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111308127|NCT00300677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111308128|NCT00300677|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111308129|NCT00300677|Hormone Antagonists|hormone antagonists|mesh-ancestor
111308130|NCT00300677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111308131|NCT00300677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111308132|NCT00300677|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111308134|NCT00559845|Cyclophosphamide|cyclophosphamide|mesh-list
111308135|NCT00559845|Bevacizumab|bevacizumab|mesh-list
111308136|NCT00559845|Fluorouracil|fluorouracil|mesh-list
111308137|NCT00559845|Epirubicin|epirubicin|mesh-list
111308138|NCT00559845|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111308139|NCT00559845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111308140|NCT00559845|Tubulin Modulators|tubulin modulators|mesh-ancestor
111308141|NCT00559845|Antimitotic Agents|antimitotic agents|mesh-ancestor
111308142|NCT00559845|Mitosis Modulators|mitosis modulators|mesh-ancestor
111308143|NCT00559845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111308144|NCT00559845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111308145|NCT00559845|Immunologic Factors|immunologic factors|mesh-ancestor
111308146|NCT00559845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111308147|NCT00559845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111308148|NCT00559845|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111308149|NCT00559845|Alkylating Agents|alkylating agents|mesh-ancestor
111308150|NCT00559845|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111308151|NCT00559845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111308152|NCT00559845|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111308153|NCT00559845|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111308154|NCT00559845|Growth Substances|growth substances|mesh-ancestor
111308155|NCT00559845|Growth Inhibitors|growth inhibitors|mesh-ancestor
111308156|NCT00559845|Antimetabolites|antimetabolites|mesh-ancestor
111308157|NCT00559845|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111308158|NCT00559845|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111308159|NCT00559845|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111308160|NCT00559845|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111308161|NCT00559845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111308162|NCT00304187|Erythromycin|erythromycin|mesh-list
111308163|NCT00304187|Erythromycin Estolate|erythromycin estolate|mesh-list
111308164|NCT00304187|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
111308165|NCT00304187|Erythromycin stearate|erythromycin stearate|mesh-list
111308166|NCT00304187|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111308167|NCT00304187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111308168|NCT00304187|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111308169|NCT00304187|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111308170|NCT00304187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111308171|NCT00304187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111308172|NCT00334633|Metronidazole|metronidazole|mesh-list
111308173|NCT00334633|Tinidazole|tinidazole|mesh-list
111308174|NCT00334633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111308175|NCT00334633|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111308176|NCT00334633|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111308177|NCT00334633|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111308178|NCT00334633|Alkylating Agents|alkylating agents|mesh-ancestor
111308179|NCT00334633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111308180|NCT00334633|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
111308181|NCT01393964|Dexamethasone|dexamethasone|mesh-list
111308182|NCT01393964|Dexamethasone acetate|dexamethasone acetate|mesh-list
111308183|NCT01393964|Lenalidomide|lenalidomide|mesh-list
111308184|NCT01393964|Elotuzumab|elotuzumab|mesh-list
111308185|NCT01393964|BB 1101|bb 1101|mesh-list
111308186|NCT01393964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111308187|NCT01393964|Antiemetics|antiemetics|mesh-ancestor
111032631|NCT03037736|Bevacizumab|bevacizumab|mesh-list
111308189|NCT01393964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111308190|NCT01393964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111308191|NCT01393964|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111308192|NCT01393964|Glucocorticoids|glucocorticoids|mesh-ancestor
111308193|NCT01393964|Hormones|hormones|mesh-ancestor
111308194|NCT01393964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111308195|NCT01393964|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111308196|NCT01393964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111308197|NCT01393964|Protease Inhibitors|protease inhibitors|mesh-ancestor
111308198|NCT01393964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111308199|NCT01393964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111308200|NCT01393964|Immunologic Factors|immunologic factors|mesh-ancestor
111308201|NCT01393964|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111308202|NCT01393964|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111308203|NCT01393964|Growth Substances|growth substances|mesh-ancestor
111308204|NCT01393964|Growth Inhibitors|growth inhibitors|mesh-ancestor
111308205|NCT01790555|Diazepam|diazepam|mesh-list
111308206|NCT01790555|Dronabinol|dronabinol|mesh-list
111308207|NCT01790555|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111308208|NCT01790555|Anticonvulsants|anticonvulsants|mesh-ancestor
111308209|NCT01790555|Antiemetics|antiemetics|mesh-ancestor
111308210|NCT01790555|Autonomic Agents|autonomic agents|mesh-ancestor
111308211|NCT01790555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111308212|NCT01790555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111308213|NCT01790555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111308214|NCT01790555|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111308215|NCT01790555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111308216|NCT01790555|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
111308217|NCT01790555|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111308218|NCT01790555|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111308219|NCT01790555|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111308220|NCT01790555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111308221|NCT01790555|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111308222|NCT01790555|Anesthetics, General|anesthetics, general|mesh-ancestor
111308223|NCT01790555|Anesthetics|anesthetics|mesh-ancestor
111308224|NCT01790555|GABA Modulators|gaba modulators|mesh-ancestor
111308225|NCT01790555|GABA Agents|gaba agents|mesh-ancestor
111308226|NCT01790555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111308227|NCT01790555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111308228|NCT01790555|Hallucinogens|hallucinogens|mesh-ancestor
111308229|NCT01790555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111308230|NCT01790555|Analgesics|analgesics|mesh-ancestor
111308231|NCT01790555|Sensory System Agents|sensory system agents|mesh-ancestor
111308232|NCT01790555|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
111308233|NCT01790555|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
111308234|NCT01790555|Hormones|hormones|mesh-ancestor
111308235|NCT01790555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111308236|NCT00335725|Hormones|hormones|mesh-list
111308237|NCT00335725|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
111308238|NCT00335725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111308239|NCT00335725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111308240|NCT01393730|Prednisone|prednisone|mesh-list
111308241|NCT01393730|Abiraterone Acetate|abiraterone acetate|mesh-list
111308242|NCT01393730|Dutasteride|dutasteride|mesh-list
111308243|NCT01393730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111308244|NCT01393730|Glucocorticoids|glucocorticoids|mesh-ancestor
111308245|NCT01393730|Hormones|hormones|mesh-ancestor
111308246|NCT01393730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111308247|NCT01393730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111308248|NCT01393730|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111308249|NCT01393730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111308250|NCT01393730|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111308251|NCT01393730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111308252|NCT01393730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111308253|NCT01393730|Hormone Antagonists|hormone antagonists|mesh-ancestor
111308254|NCT01393730|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111308255|NCT01393730|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
111308256|NCT00336817|Mycophenolic Acid|mycophenolic acid|mesh-list
111308257|NCT00336817|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111308258|NCT00336817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111308259|NCT00336817|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111308260|NCT00336817|Antitubercular Agents|antitubercular agents|mesh-ancestor
111032709|NCT04841096|Metformin|metformin|mesh-list
111308261|NCT00336817|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111308262|NCT00336817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111308263|NCT00336817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111308264|NCT00336817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111308265|NCT00337987|Prednisone|prednisone|mesh-list
111308266|NCT00337987|Cyclophosphamide|cyclophosphamide|mesh-list
111308267|NCT00337987|Vincristine|vincristine|mesh-list
111308268|NCT00337987|Doxorubicin|doxorubicin|mesh-list
111308269|NCT00337987|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111308270|NCT00337987|Denileukin diftitox|denileukin diftitox|mesh-list
111308271|NCT00337987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111308272|NCT00337987|Immunologic Factors|immunologic factors|mesh-ancestor
111308273|NCT00337987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111308274|NCT00337987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111308275|NCT00337987|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111308276|NCT00337987|Alkylating Agents|alkylating agents|mesh-ancestor
111308277|NCT00337987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111308278|NCT00337987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111308279|NCT00337987|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111308280|NCT00337987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111308281|NCT00337987|Glucocorticoids|glucocorticoids|mesh-ancestor
111308282|NCT00337987|Hormones|hormones|mesh-ancestor
111308283|NCT00337987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111308284|NCT00337987|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111308285|NCT00337987|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111308286|NCT00337987|Tubulin Modulators|tubulin modulators|mesh-ancestor
111308287|NCT00337987|Antimitotic Agents|antimitotic agents|mesh-ancestor
111308288|NCT00337987|Mitosis Modulators|mitosis modulators|mesh-ancestor
111308289|NCT00337987|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111308290|NCT00337987|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111308291|NCT00337987|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111308292|NCT00337987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111308293|NCT01393106|Idelalisib|idelalisib|mesh-list
111308294|NCT01393106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111308295|NCT01393106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111308296|NCT01393106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111308297|NCT00553059|Dexamethasone|dexamethasone|mesh-list
111308298|NCT00553059|Dronabinol|dronabinol|mesh-list
111308299|NCT00553059|Palonosetron|palonosetron|mesh-list
111308300|NCT00553059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111308301|NCT00553059|Antiemetics|antiemetics|mesh-ancestor
111308302|NCT00553059|Autonomic Agents|autonomic agents|mesh-ancestor
111308303|NCT00553059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111308304|NCT00553059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111308305|NCT00553059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111308306|NCT00553059|Glucocorticoids|glucocorticoids|mesh-ancestor
111308307|NCT00553059|Hormones|hormones|mesh-ancestor
111308308|NCT00553059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111308309|NCT00553059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111308310|NCT00553059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111308311|NCT00553059|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111308312|NCT00553059|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111308313|NCT00553059|Serotonin Agents|serotonin agents|mesh-ancestor
111308314|NCT00553059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111308315|NCT00553059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111308316|NCT00553059|Hallucinogens|hallucinogens|mesh-ancestor
111308317|NCT00553059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111308318|NCT00553059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111308319|NCT00553059|Analgesics|analgesics|mesh-ancestor
111308320|NCT00553059|Sensory System Agents|sensory system agents|mesh-ancestor
111308321|NCT00553059|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
111308322|NCT00553059|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
111308323|NCT02989311|Iron|iron|mesh-list
111308324|NCT02989311|Trace Elements|trace elements|mesh-ancestor
111308325|NCT02989311|Micronutrients|micronutrients|mesh-ancestor
111308326|NCT02989311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111308327|NCT00325403|Treprostinil|treprostinil|mesh-list
111308328|NCT00325403|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111308329|NCT02015611|Vitamin D|vitamin d|mesh-list
111308330|NCT02015611|Vitamins|vitamins|mesh-ancestor
111308331|NCT02015611|Micronutrients|micronutrients|mesh-ancestor
111308332|NCT02015611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111308333|NCT02015611|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111308334|NCT01872819|Antineoplastic Agents|antineoplastic agents|mesh-list
111308335|NCT01413542|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111308336|NCT01413542|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
111308337|NCT01413542|Enalaprilat|enalaprilat|mesh-list
111308338|NCT01413542|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
111308339|NCT01413542|Bradykinin|bradykinin|mesh-list
111308340|NCT01413542|Glucagon|glucagon|mesh-list
111308341|NCT01413542|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
111308342|NCT01413542|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
111308343|NCT01413542|Substance P|substance p|mesh-list
111308344|NCT01413542|Neurokinin A|neurokinin a|mesh-list
111308345|NCT01413542|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111308346|NCT01413542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111308347|NCT01413542|Incretins|incretins|mesh-ancestor
111308348|NCT01413542|Hormones|hormones|mesh-ancestor
111308349|NCT01413542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111308350|NCT01413542|Protease Inhibitors|protease inhibitors|mesh-ancestor
111308351|NCT01413542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111308352|NCT01413542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111308353|NCT01413542|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111308354|NCT01413542|Natriuretic Agents|natriuretic agents|mesh-ancestor
111308355|NCT01413542|Vasodilator Agents|vasodilator agents|mesh-ancestor
111308356|NCT01413542|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111308357|NCT01413542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111308358|NCT01873989|Testosterone|testosterone|mesh-list
111308359|NCT01873989|Androgens|androgens|mesh-ancestor
111308360|NCT01873989|Hormones|hormones|mesh-ancestor
111308361|NCT01873989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111308362|NCT01873989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111308363|NCT01875159|Caffeine|caffeine|mesh-list
111308364|NCT01875159|Caffeine citrate|caffeine citrate|mesh-list
111308365|NCT01875159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111308366|NCT01875159|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111308367|NCT01875159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111308368|NCT01875159|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111308369|NCT01875159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111308370|NCT01875159|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
111308371|NCT01875159|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111308372|NCT01875159|Purinergic Agents|purinergic agents|mesh-ancestor
111308373|NCT01875159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111308374|NCT01432574|Vaccines|vaccines|mesh-list
111308375|NCT01432574|Immunologic Factors|immunologic factors|mesh-ancestor
111308376|NCT01432574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111308377|NCT00339079|Fluoxetine|fluoxetine|mesh-list
111308378|NCT00339079|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111308379|NCT00339079|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111308380|NCT00339079|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111308381|NCT00339079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111308382|NCT00339079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111308383|NCT00339079|Serotonin Agents|serotonin agents|mesh-ancestor
111308384|NCT00339079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111308385|NCT00339079|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111308386|NCT00339079|Antidepressive Agents|antidepressive agents|mesh-ancestor
111308387|NCT00339079|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111308388|NCT00339079|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111308389|NCT00339079|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111308390|NCT00339079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111308391|NCT01392560|Empagliflozin|empagliflozin|mesh-list
111308392|NCT01392560|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110979970|NCT01750281|Docetaxel|docetaxel|mesh-list
111308393|NCT01392560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111308394|NCT01392560|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111308395|NCT01392560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111308396|NCT00342355|Ritonavir|ritonavir|mesh-list
111308397|NCT00342355|Lopinavir|lopinavir|mesh-list
111308398|NCT00342355|Lamivudine|lamivudine|mesh-list
111308399|NCT00342355|Zidovudine|zidovudine|mesh-list
111308400|NCT00342355|Stavudine|stavudine|mesh-list
111308401|NCT00342355|Didanosine|didanosine|mesh-list
111308402|NCT00342355|Efavirenz|efavirenz|mesh-list
111308403|NCT00342355|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111308404|NCT00342355|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111308405|NCT00342355|Protease Inhibitors|protease inhibitors|mesh-ancestor
111308406|NCT00342355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111308407|NCT00342355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111308408|NCT00342355|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111308409|NCT00342355|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111032852|NCT03180255|Hormones|hormones|mesh-ancestor
111308410|NCT00342355|Antiviral Agents|antiviral agents|mesh-ancestor
111308411|NCT00342355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111308412|NCT00342355|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111308413|NCT00342355|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111308414|NCT00342355|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111308415|NCT00342355|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111308416|NCT00342355|Antimetabolites|antimetabolites|mesh-ancestor
111308417|NCT00342355|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111308418|NCT00342355|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111308419|NCT00342355|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111308420|NCT00342355|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111308421|NCT00342355|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111308422|NCT00306163|Fluticasone|fluticasone|mesh-list
111308423|NCT00306163|Ciclesonide|ciclesonide|mesh-list
111308424|NCT00306163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111308425|NCT00306163|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111308426|NCT00306163|Autonomic Agents|autonomic agents|mesh-ancestor
111308427|NCT00306163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111308428|NCT00306163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111308429|NCT00306163|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111308430|NCT00306163|Respiratory System Agents|respiratory system agents|mesh-ancestor
111308431|NCT00306163|Dermatologic Agents|dermatologic agents|mesh-ancestor
111308432|NCT00306163|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111308433|NCT00306163|Glucocorticoids|glucocorticoids|mesh-ancestor
111308434|NCT00306163|Hormones|hormones|mesh-ancestor
111308435|NCT00306163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111308436|NCT01861665|Bupivacaine|bupivacaine|mesh-list
111308437|NCT01861665|Anesthetics, Local|anesthetics, local|mesh-ancestor
111308438|NCT01861665|Anesthetics|anesthetics|mesh-ancestor
111308439|NCT01861665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111308440|NCT01861665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111308441|NCT01861665|Sensory System Agents|sensory system agents|mesh-ancestor
111308442|NCT01861665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111308443|NCT00330161|Vorinostat|vorinostat|mesh-list
111308444|NCT00330161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111308445|NCT00330161|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111308446|NCT00330161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111308447|NCT00330161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111308448|NCT00552279|Vaccines|vaccines|mesh-list
111308449|NCT00552279|Immunologic Factors|immunologic factors|mesh-ancestor
111308450|NCT00552279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111308451|NCT00309751|Atorvastatin|atorvastatin|mesh-list
111308452|NCT00309751|Pitavastatin|pitavastatin|mesh-list
111308453|NCT00309751|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111308454|NCT00309751|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111308455|NCT00309751|Antimetabolites|antimetabolites|mesh-ancestor
111308456|NCT00309751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111308457|NCT00309751|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111308458|NCT00309751|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111308459|NCT00309751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111308460|NCT04346095|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
111308461|NCT04346095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111308462|NCT04346095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111308463|NCT02988999|Erythritol|erythritol|mesh-list
111308464|NCT02988999|Vasodilator Agents|vasodilator agents|mesh-ancestor
111308465|NCT00313729|Temozolomide|temozolomide|mesh-list
111308466|NCT00313729|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111308467|NCT00313729|Alkylating Agents|alkylating agents|mesh-ancestor
111308468|NCT00313729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111308469|NCT00313729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111308470|NCT00559377|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
111308471|NCT00559377|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111308472|NCT00559377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111308473|NCT05266651|Tadalafil|tadalafil|mesh-list
111308474|NCT05266651|Vasodilator Agents|vasodilator agents|mesh-ancestor
111308475|NCT05266651|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111308476|NCT05266651|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111308477|NCT05266651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111308478|NCT05266651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111308479|NCT05266651|Urological Agents|urological agents|mesh-ancestor
111308480|NCT05746689|Sirolimus|sirolimus|mesh-list
111308481|NCT05746689|Prednisone|prednisone|mesh-list
111308482|NCT05746689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111308483|NCT05746689|Glucocorticoids|glucocorticoids|mesh-ancestor
111308484|NCT05746689|Hormones|hormones|mesh-ancestor
111032937|NCT02426463|Oxycodone|oxycodone|mesh-list
111308485|NCT05746689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111308486|NCT05746689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111308487|NCT05746689|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111308488|NCT05746689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111308489|NCT05746689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111308490|NCT05746689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111308491|NCT05746689|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111308492|NCT05746689|Antifungal Agents|antifungal agents|mesh-ancestor
111308493|NCT05746689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111308494|NCT05746689|Immunologic Factors|immunologic factors|mesh-ancestor
111308495|NCT01412060|Cariprazine|cariprazine|mesh-list
111308496|NCT01412060|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111308497|NCT01412060|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111308498|NCT01412060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111308499|NCT01412060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111308500|NCT01412060|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111308501|NCT00345865|Cytarabine|cytarabine|mesh-list
111308502|NCT00345865|Cyclophosphamide|cyclophosphamide|mesh-list
111308503|NCT00345865|Carmustine|carmustine|mesh-list
111308504|NCT00345865|Etoposide|etoposide|mesh-list
111308505|NCT00345865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111308506|NCT00345865|Immunologic Factors|immunologic factors|mesh-ancestor
111308507|NCT00345865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111308508|NCT00345865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111308509|NCT00345865|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111308510|NCT00345865|Alkylating Agents|alkylating agents|mesh-ancestor
111308511|NCT00345865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111308512|NCT00345865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111308513|NCT00345865|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111308514|NCT00345865|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111308515|NCT00345865|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111308516|NCT00345865|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111308517|NCT00345865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111308518|NCT00345865|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111308519|NCT00345865|Antimetabolites|antimetabolites|mesh-ancestor
111308520|NCT00345865|Antiviral Agents|antiviral agents|mesh-ancestor
111308521|NCT00345865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111308522|NCT00551421|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111308523|NCT00551421|Cetuximab|cetuximab|mesh-list
111308524|NCT00551421|Pertuzumab|pertuzumab|mesh-list
111308525|NCT00551421|Irinotecan|irinotecan|mesh-list
111308526|NCT00551421|Antibodies|antibodies|mesh-list
111308527|NCT00551421|Immunoglobulins|immunoglobulins|mesh-list
111308528|NCT00551421|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111308529|NCT00551421|Immunologic Factors|immunologic factors|mesh-ancestor
111308530|NCT00551421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111308531|NCT00551421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111308532|NCT00551421|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111308533|NCT00551421|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111308534|NCT00551421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111308535|NCT00551421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111308536|NCT01791751|Clomiphene|clomiphene|mesh-list
111308537|NCT01791751|Enclomiphene|enclomiphene|mesh-list
111308538|NCT01791751|Zuclomiphene|zuclomiphene|mesh-list
111308539|NCT01791751|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111308540|NCT01791751|Hormone Antagonists|hormone antagonists|mesh-ancestor
111308541|NCT01791751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111308542|NCT01791751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111308543|NCT01791751|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111308544|NCT01791751|Fertility Agents|fertility agents|mesh-ancestor
111308545|NCT01791751|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111308546|NCT01791751|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111308547|NCT01791751|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111308548|NCT05266261|Cholecalciferol|cholecalciferol|mesh-list
111308549|NCT05266261|Ibandronic Acid|ibandronic acid|mesh-list
111308550|NCT05266261|Calcium Carbonate|calcium carbonate|mesh-list
111308551|NCT05266261|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111308552|NCT05266261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111308553|NCT05266261|Vitamins|vitamins|mesh-ancestor
111308554|NCT05266261|Micronutrients|micronutrients|mesh-ancestor
111308555|NCT05266261|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111308556|NCT05266261|Antacids|antacids|mesh-ancestor
111308557|NCT05266261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111308558|NCT05266261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111308559|NCT05266105|Palbociclib|palbociclib|mesh-list
111308560|NCT05266105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111308561|NCT05266105|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111308562|NCT05266105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111308563|NCT05266105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111308564|NCT01891643|Dexamethasone|dexamethasone|mesh-list
111308565|NCT01891643|Dexamethasone acetate|dexamethasone acetate|mesh-list
111308566|NCT01891643|Lenalidomide|lenalidomide|mesh-list
111308567|NCT01891643|Elotuzumab|elotuzumab|mesh-list
111308568|NCT01891643|BB 1101|bb 1101|mesh-list
111308569|NCT01891643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111308570|NCT01891643|Antiemetics|antiemetics|mesh-ancestor
111308571|NCT01891643|Autonomic Agents|autonomic agents|mesh-ancestor
111308572|NCT01891643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111308573|NCT01891643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111308574|NCT01891643|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111308575|NCT01891643|Glucocorticoids|glucocorticoids|mesh-ancestor
111308576|NCT01891643|Hormones|hormones|mesh-ancestor
111308577|NCT01891643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111308578|NCT01891643|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111308579|NCT01891643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111308580|NCT01891643|Protease Inhibitors|protease inhibitors|mesh-ancestor
111308581|NCT01891643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111308582|NCT01891643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111308583|NCT01891643|Immunologic Factors|immunologic factors|mesh-ancestor
111308584|NCT01891643|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111308585|NCT01891643|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111308586|NCT01891643|Growth Substances|growth substances|mesh-ancestor
111308587|NCT01891643|Growth Inhibitors|growth inhibitors|mesh-ancestor
111308588|NCT05265793|Apatinib|apatinib|mesh-list
111308589|NCT05265793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111308590|NCT05265793|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111308591|NCT05265793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111308592|NCT05265793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111308593|NCT04005599|Magnesium Sulfate|magnesium sulfate|mesh-list
111308594|NCT04005599|Remifentanil|remifentanil|mesh-list
111308595|NCT04005599|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111308596|NCT04005599|Narcotics|narcotics|mesh-ancestor
111308597|NCT04005599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111308598|NCT04005599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111308599|NCT04005599|Analgesics|analgesics|mesh-ancestor
111308600|NCT04005599|Sensory System Agents|sensory system agents|mesh-ancestor
111308601|NCT04005599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111308602|NCT04005599|Anesthetics|anesthetics|mesh-ancestor
111308603|NCT04005599|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111308604|NCT04005599|Anticonvulsants|anticonvulsants|mesh-ancestor
111308605|NCT04005599|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111308606|NCT04005599|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111308607|NCT04005599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111308608|NCT04005599|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111308609|NCT04005599|Tocolytic Agents|tocolytic agents|mesh-ancestor
111308610|NCT04005599|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111308611|NCT00330863|Olanzapine|olanzapine|mesh-list
111308612|NCT00330863|Risperidone|risperidone|mesh-list
111308613|NCT00330863|Aripiprazole|aripiprazole|mesh-list
111308614|NCT00330863|Quetiapine Fumarate|quetiapine fumarate|mesh-list
111308615|NCT00330863|Paliperidone Palmitate|paliperidone palmitate|mesh-list
111308616|NCT00330863|Ziprasidone|ziprasidone|mesh-list
111308617|NCT00330863|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111308618|NCT00330863|Serotonin Agents|serotonin agents|mesh-ancestor
111308619|NCT00330863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111308620|NCT00330863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111308621|NCT00330863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111308622|NCT00330863|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111308623|NCT00330863|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111308624|NCT00330863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111308625|NCT00330863|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111308626|NCT00330863|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111308627|NCT00330863|Dopamine Agents|dopamine agents|mesh-ancestor
111308628|NCT00330863|Antiemetics|antiemetics|mesh-ancestor
111308629|NCT00330863|Autonomic Agents|autonomic agents|mesh-ancestor
111308630|NCT00330863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111308631|NCT00330863|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111308632|NCT00330863|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111308633|NCT00330863|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111308634|NCT00330863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111308635|NCT00330863|Antidepressive Agents|antidepressive agents|mesh-ancestor
111308636|NCT00330863|Dopamine Agonists|dopamine agonists|mesh-ancestor
111308637|NCT00330863|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111308638|NCT00330863|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111308639|NCT00330863|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111308640|NCT00330863|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111308641|NCT01899521|Zinc Sulfate|zinc sulfate|mesh-list
111308642|NCT01899521|Astringents|astringents|mesh-ancestor
111308643|NCT01899521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111308644|NCT01899521|Dermatologic Agents|dermatologic agents|mesh-ancestor
111308645|NCT01790009|Acetaminophen|acetaminophen|mesh-list
111308646|NCT01790009|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111308647|NCT01790009|Analgesics|analgesics|mesh-ancestor
111308648|NCT01790009|Sensory System Agents|sensory system agents|mesh-ancestor
111308649|NCT01790009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111308650|NCT01790009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111308651|NCT01790009|Antipyretics|antipyretics|mesh-ancestor
111308652|NCT05737329|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
111308653|NCT05737329|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
111308654|NCT05737329|Estradiol|estradiol|mesh-list
111308655|NCT05737329|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
111308656|NCT05737329|Estrogens|estrogens|mesh-ancestor
111308657|NCT05737329|Hormones|hormones|mesh-ancestor
111308658|NCT05737329|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111308659|NCT05737329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111308660|NCT05737329|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111308661|NCT05737329|Contraceptive Agents|contraceptive agents|mesh-ancestor
111308662|NCT05737329|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111308663|NCT05737329|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111308664|NCT00317941|Interferon beta-1b|interferon beta-1b|mesh-list
111308665|NCT00317941|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111308666|NCT00317941|Immunologic Factors|immunologic factors|mesh-ancestor
111308667|NCT00317941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111308668|NCT01790087|Moxifloxacin|moxifloxacin|mesh-list
111308669|NCT01790087|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111308670|NCT01790087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111308671|NCT01790087|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111308672|NCT01790087|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111308673|NCT01790087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111308674|NCT01790087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111308675|NCT01790087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111308676|NCT00332579|Naltrexone|naltrexone|mesh-list
111308677|NCT00332579|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111308678|NCT00332579|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111308679|NCT00332579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111308680|NCT00332579|Sensory System Agents|sensory system agents|mesh-ancestor
111308681|NCT00332579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111308682|NCT00318409|Bupropion|bupropion|mesh-list
111308683|NCT00318409|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111308684|NCT00318409|Antidepressive Agents|antidepressive agents|mesh-ancestor
111308685|NCT00318409|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111308686|NCT00318409|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111308687|NCT00318409|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111308688|NCT00318409|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111308689|NCT00318409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111308690|NCT00318409|Dopamine Agents|dopamine agents|mesh-ancestor
111308691|NCT00318409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111308692|NCT00318409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111308693|NCT00318409|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111308694|NCT00318409|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111308695|NCT00318409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111308696|NCT00333437|Mycophenolic Acid|mycophenolic acid|mesh-list
111308697|NCT00333437|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111308698|NCT00333437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111308699|NCT00333437|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111308700|NCT00333437|Antitubercular Agents|antitubercular agents|mesh-ancestor
111308701|NCT00333437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111308702|NCT00333437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111308703|NCT00333437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111308704|NCT00333437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111308705|NCT04129619|Ether|ether|mesh-list
111308706|NCT04129619|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111308707|NCT04129619|Anesthetics, General|anesthetics, general|mesh-ancestor
111308708|NCT04129619|Anesthetics|anesthetics|mesh-ancestor
111308709|NCT04129619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111308710|NCT04129619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111308712|NCT00353119|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111308713|NCT00353119|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111308714|NCT00353119|Analgesics|analgesics|mesh-ancestor
111308715|NCT00353119|Sensory System Agents|sensory system agents|mesh-ancestor
111308716|NCT00353119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111308717|NCT00353119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111308718|NCT00353119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111308719|NCT00353119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111308720|NCT00353119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111308721|NCT00353119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111308722|NCT00353119|Immunologic Factors|immunologic factors|mesh-ancestor
111308723|NCT00353431|Insulin Aspart|insulin aspart|mesh-list
111308724|NCT00353431|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111308725|NCT00353431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111308726|NCT00353977|Vaccines|vaccines|mesh-list
111308727|NCT00353977|Immunologic Factors|immunologic factors|mesh-ancestor
111308728|NCT00353977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111308729|NCT00320281|Botulinum Toxins|botulinum toxins|mesh-list
111308730|NCT00320281|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111308731|NCT00320281|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111308732|NCT00320281|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111308733|NCT00320281|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111308734|NCT00320281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111308735|NCT00320281|Cholinergic Agents|cholinergic agents|mesh-ancestor
111308736|NCT00320281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111308737|NCT00320281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110761370|NCT04908956|Osimertinib|osimertinib|mesh-list
111308738|NCT00320281|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111308739|NCT00320281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111308740|NCT01792375|Dinoprostone|dinoprostone|mesh-list
111308741|NCT01792375|Oxytocics|oxytocics|mesh-ancestor
111308742|NCT01792375|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111308743|NCT01792375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111308744|NCT01392326|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111308745|NCT01392326|Immunologic Factors|immunologic factors|mesh-ancestor
111308746|NCT01392326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111308747|NCT00320671|Risperidone|risperidone|mesh-list
111308748|NCT00320671|Aripiprazole|aripiprazole|mesh-list
111308749|NCT00320671|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111308750|NCT00320671|Serotonin Agents|serotonin agents|mesh-ancestor
111308751|NCT00320671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111308752|NCT00320671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111308753|NCT00320671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111308754|NCT00320671|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111308755|NCT00320671|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111308756|NCT00320671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111308757|NCT00320671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111308758|NCT00320671|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111308759|NCT00320671|Dopamine Agents|dopamine agents|mesh-ancestor
111308760|NCT00320671|Antidepressive Agents|antidepressive agents|mesh-ancestor
111308761|NCT00320671|Dopamine Agonists|dopamine agonists|mesh-ancestor
111308762|NCT00320671|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111308763|NCT00320671|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111308764|NCT00320671|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111308765|NCT00320671|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111308766|NCT00320749|Gemcitabine|gemcitabine|mesh-list
111308767|NCT00320749|Capecitabine|capecitabine|mesh-list
111308768|NCT00320749|Docetaxel|docetaxel|mesh-list
111308769|NCT00320749|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111308770|NCT00320749|Antimetabolites|antimetabolites|mesh-ancestor
111308771|NCT00320749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111308772|NCT00320749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111308773|NCT00320749|Tubulin Modulators|tubulin modulators|mesh-ancestor
111308774|NCT00320749|Antimitotic Agents|antimitotic agents|mesh-ancestor
111308775|NCT00320749|Mitosis Modulators|mitosis modulators|mesh-ancestor
111308776|NCT00354913|Imatinib Mesylate|imatinib mesylate|mesh-list
111308777|NCT00354913|Hydroxyurea|hydroxyurea|mesh-list
111308778|NCT00354913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111308779|NCT00354913|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111308780|NCT00354913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111308781|NCT00354913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111308782|NCT00354913|Antisickling Agents|antisickling agents|mesh-ancestor
111308783|NCT00354913|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111308784|NCT01432262|Vaccines|vaccines|mesh-list
111033229|NCT05618912|Dermatologic Agents|dermatologic agents|mesh-ancestor
111308785|NCT01432262|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
111308786|NCT01432262|Immunologic Factors|immunologic factors|mesh-ancestor
111308787|NCT01432262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111308788|NCT00322309|Mirtazapine|mirtazapine|mesh-list
111308789|NCT00322309|Antidepressive Agents|antidepressive agents|mesh-ancestor
111308790|NCT00322309|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111308791|NCT00322309|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111308792|NCT00322309|Histamine Antagonists|histamine antagonists|mesh-ancestor
111308793|NCT00322309|Histamine Agents|histamine agents|mesh-ancestor
111308794|NCT00322309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111308795|NCT00322309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111308796|NCT00322309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111308797|NCT00322309|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111308798|NCT00322309|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111308799|NCT00322309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111308800|NCT00322309|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
111308801|NCT00322309|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111308802|NCT00322309|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111308803|NCT00322309|Adrenergic Agents|adrenergic agents|mesh-ancestor
111308804|NCT00322309|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111308805|NCT00322309|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111308806|NCT00322309|Serotonin Agents|serotonin agents|mesh-ancestor
111308807|NCT00322309|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111308808|NCT04046744|Lidocaine|lidocaine|mesh-list
111308809|NCT04046744|Analgesics|analgesics|mesh-list
111308810|NCT04046744|Ropivacaine|ropivacaine|mesh-list
111308811|NCT04046744|Anesthetics, Local|anesthetics, local|mesh-list
111308812|NCT04046744|Anesthetics|anesthetics|mesh-list
111308813|NCT04046744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111308814|NCT04046744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111308815|NCT04046744|Sensory System Agents|sensory system agents|mesh-ancestor
111308816|NCT04046744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111308817|NCT04046744|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111308818|NCT04046744|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111308819|NCT04046744|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111308820|NCT04046744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111308821|NCT04046744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111308822|NCT01431950|Fluticasone|fluticasone|mesh-list
111308823|NCT01431950|Xhance|xhance|mesh-list
111308824|NCT01431950|Albuterol|albuterol|mesh-list
111308825|NCT01431950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111308826|NCT01431950|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111308827|NCT01431950|Autonomic Agents|autonomic agents|mesh-ancestor
111308828|NCT01431950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111308829|NCT01431950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111308830|NCT01431950|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111308831|NCT01431950|Respiratory System Agents|respiratory system agents|mesh-ancestor
111308832|NCT01431950|Dermatologic Agents|dermatologic agents|mesh-ancestor
111308833|NCT01431950|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111308834|NCT01431950|Tocolytic Agents|tocolytic agents|mesh-ancestor
111308835|NCT01431950|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111308836|NCT01431950|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111308837|NCT01431950|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111308838|NCT01431950|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111308839|NCT01431950|Adrenergic Agents|adrenergic agents|mesh-ancestor
111308840|NCT01431950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111308841|NCT01431950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111308842|NCT00551031|Vaccines|vaccines|mesh-list
111308843|NCT00551031|Immunologic Factors|immunologic factors|mesh-ancestor
111308844|NCT00551031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111308845|NCT01431716|Epoprostenol|epoprostenol|mesh-list
111308846|NCT01431716|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111308847|NCT01431716|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111308848|NCT00550953|Amlodipine|amlodipine|mesh-list
111308849|NCT00550953|Telmisartan|telmisartan|mesh-list
111308850|NCT00550953|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
111308851|NCT00550953|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111308852|NCT00550953|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111308853|NCT00550953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111308854|NCT00550953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111308855|NCT00550953|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111308856|NCT00550953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111308857|NCT00550953|Vasodilator Agents|vasodilator agents|mesh-ancestor
111308858|NCT00550953|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111308859|NCT00550953|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111308860|NCT00322465|Azithromycin|azithromycin|mesh-list
111308861|NCT00322465|Doxycycline|doxycycline|mesh-list
111308862|NCT00322465|Tinidazole|tinidazole|mesh-list
111308863|NCT00322465|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111308864|NCT00322465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111308865|NCT00322465|Antimalarials|antimalarials|mesh-ancestor
111308866|NCT00322465|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111308867|NCT00322465|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111308868|NCT00322465|Alkylating Agents|alkylating agents|mesh-ancestor
111308869|NCT00322465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111308870|NCT00322465|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
111308871|NCT00558831|Benzoyl Peroxide|benzoyl peroxide|mesh-list
111308872|NCT00558831|Dermatologic Agents|dermatologic agents|mesh-ancestor
111308873|NCT03021993|Nivolumab|nivolumab|mesh-list
111308874|NCT03021993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111308875|NCT03021993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111308876|NCT03021993|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111308877|NCT03021993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111308878|NCT01392170|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
111308879|NCT01392170|Antiviral Agents|antiviral agents|mesh-ancestor
111308880|NCT01392170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111308881|NCT00558753|Pregabalin|pregabalin|mesh-list
111308882|NCT00558753|Analgesics|analgesics|mesh-ancestor
111308883|NCT00558753|Sensory System Agents|sensory system agents|mesh-ancestor
111308884|NCT00558753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111308885|NCT00558753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111308886|NCT00558753|Anticonvulsants|anticonvulsants|mesh-ancestor
111308887|NCT00558753|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111308888|NCT00558753|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111308889|NCT00558753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111308890|NCT00558753|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111308891|NCT00558753|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111308892|NCT00558753|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111308893|NCT00558753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111308894|NCT00558753|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111308895|NCT00324259|Estradiol|estradiol|mesh-list
111308896|NCT00324259|Estrogens|estrogens|mesh-ancestor
111308897|NCT00324259|Hormones|hormones|mesh-ancestor
111308898|NCT00324259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111308899|NCT00324259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111308900|NCT04600141|Heparin|heparin|mesh-list
111308901|NCT04600141|Calcium heparin|calcium heparin|mesh-list
111308902|NCT04600141|Anticoagulants|anticoagulants|mesh-ancestor
111308903|NCT04600141|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111308904|NCT04600141|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111308905|NCT04600141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111308906|NCT00324415|Fluorouracil|fluorouracil|mesh-list
111308907|NCT00324415|Cetuximab|cetuximab|mesh-list
111308908|NCT00324415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111308909|NCT00324415|Antimetabolites|antimetabolites|mesh-ancestor
111308910|NCT00324415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111308911|NCT00324415|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111308912|NCT00324415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111308913|NCT00324415|Immunologic Factors|immunologic factors|mesh-ancestor
111308914|NCT00324415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111308915|NCT00324415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111308916|NCT00390559|Nicotine|nicotine|mesh-list
111308917|NCT00390559|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111308918|NCT00390559|Autonomic Agents|autonomic agents|mesh-ancestor
111308919|NCT00390559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111308920|NCT00390559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111308921|NCT00390559|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111308922|NCT00390559|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111308923|NCT00390559|Cholinergic Agents|cholinergic agents|mesh-ancestor
111308924|NCT00390559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111308925|NCT00390559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111308926|NCT02107339|Methadone|methadone|mesh-list
111308927|NCT02107339|Hydromorphone|hydromorphone|mesh-list
111308928|NCT02107339|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111308929|NCT02107339|Narcotics|narcotics|mesh-ancestor
111308930|NCT02107339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111308931|NCT02107339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111308932|NCT02107339|Analgesics|analgesics|mesh-ancestor
111308933|NCT02107339|Sensory System Agents|sensory system agents|mesh-ancestor
111308934|NCT02107339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111308935|NCT02107339|Antitussive Agents|antitussive agents|mesh-ancestor
111308936|NCT02107339|Respiratory System Agents|respiratory system agents|mesh-ancestor
111308937|NCT00392041|Eszopiclone|eszopiclone|mesh-list
111308938|NCT00392041|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111308939|NCT00392041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111308940|NCT00392041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111308941|NCT01390844|Ribavirin|ribavirin|mesh-list
111308942|NCT01390844|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
111308943|NCT01390844|Antimetabolites|antimetabolites|mesh-ancestor
111308944|NCT01390844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111308945|NCT01390844|Antiviral Agents|antiviral agents|mesh-ancestor
111308946|NCT01390844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111308947|NCT04035278|Vaccines|vaccines|mesh-list
111308948|NCT04035278|Immunologic Factors|immunologic factors|mesh-ancestor
111308949|NCT04035278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111308950|NCT00395161|Selenium|selenium|mesh-list
111308951|NCT00395161|Metoclopramide|metoclopramide|mesh-list
111308952|NCT00395161|Antioxidants|antioxidants|mesh-ancestor
111308953|NCT00395161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111308954|NCT00395161|Protective Agents|protective agents|mesh-ancestor
111308955|NCT00395161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111308956|NCT00395161|Trace Elements|trace elements|mesh-ancestor
111308957|NCT00395161|Micronutrients|micronutrients|mesh-ancestor
111308958|NCT00395161|Antiemetics|antiemetics|mesh-ancestor
111308959|NCT00395161|Autonomic Agents|autonomic agents|mesh-ancestor
111308960|NCT00395161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111308961|NCT00395161|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111308962|NCT00395161|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111308963|NCT00395161|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111308964|NCT00395161|Dopamine Agents|dopamine agents|mesh-ancestor
111308965|NCT00395161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111308966|NCT01409564|Cilostazol|cilostazol|mesh-list
111308967|NCT01409564|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111308968|NCT01409564|Autonomic Agents|autonomic agents|mesh-ancestor
111308969|NCT01409564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111308970|NCT01409564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111308971|NCT01409564|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111308972|NCT01409564|Respiratory System Agents|respiratory system agents|mesh-ancestor
111308973|NCT01409564|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111308974|NCT01409564|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111308975|NCT01409564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111308976|NCT01409564|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111308977|NCT01409564|Vasodilator Agents|vasodilator agents|mesh-ancestor
111308978|NCT01409564|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111308979|NCT01409564|Protective Agents|protective agents|mesh-ancestor
111308980|NCT01409564|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
111308981|NCT01409564|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111308982|NCT01409564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111308983|NCT02009449|Leucovorin|leucovorin|mesh-list
111308984|NCT02009449|Paclitaxel|paclitaxel|mesh-list
111308985|NCT02009449|Docetaxel|docetaxel|mesh-list
111308986|NCT02009449|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111308987|NCT02009449|Carboplatin|carboplatin|mesh-list
111308988|NCT02009449|Gemcitabine|gemcitabine|mesh-list
111308989|NCT02009449|Pembrolizumab|pembrolizumab|mesh-list
111308990|NCT02009449|Fluorouracil|fluorouracil|mesh-list
111308991|NCT02009449|Capecitabine|capecitabine|mesh-list
111308992|NCT02009449|Oxaliplatin|oxaliplatin|mesh-list
111308993|NCT02009449|Nivolumab|nivolumab|mesh-list
111308994|NCT02009449|Levoleucovorin|levoleucovorin|mesh-list
111308995|NCT02009449|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111308996|NCT02009449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111308997|NCT02009449|Tubulin Modulators|tubulin modulators|mesh-ancestor
111308998|NCT02009449|Antimitotic Agents|antimitotic agents|mesh-ancestor
111308999|NCT02009449|Mitosis Modulators|mitosis modulators|mesh-ancestor
111309000|NCT02009449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111309001|NCT02009449|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111309002|NCT02009449|Antimetabolites|antimetabolites|mesh-ancestor
111309003|NCT02009449|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111309004|NCT02009449|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111309005|NCT02009449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111309006|NCT02009449|Immunologic Factors|immunologic factors|mesh-ancestor
111309007|NCT02009449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111309008|NCT02009449|Antidotes|antidotes|mesh-ancestor
111309009|NCT02009449|Protective Agents|protective agents|mesh-ancestor
111309010|NCT02009449|Vitamin B Complex|vitamin b complex|mesh-ancestor
111309011|NCT02009449|Vitamins|vitamins|mesh-ancestor
111309012|NCT02009449|Micronutrients|micronutrients|mesh-ancestor
111309013|NCT01794091|Eplerenone|eplerenone|mesh-list
111309014|NCT01794091|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
111309015|NCT01794091|Hormone Antagonists|hormone antagonists|mesh-ancestor
111309016|NCT01794091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111309017|NCT01794091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111309018|NCT01794091|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
111309019|NCT01794091|Diuretics|diuretics|mesh-ancestor
111309020|NCT01794091|Natriuretic Agents|natriuretic agents|mesh-ancestor
111309021|NCT01794091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111309022|NCT01794169|Cytarabine|cytarabine|mesh-list
111309023|NCT01794169|Azacitidine|azacitidine|mesh-list
111309024|NCT01794169|Daunorubicin|daunorubicin|mesh-list
111309025|NCT01794169|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111309026|NCT01794169|Antimetabolites|antimetabolites|mesh-ancestor
111309027|NCT01794169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111309028|NCT01794169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111309029|NCT01794169|Antiviral Agents|antiviral agents|mesh-ancestor
111309030|NCT01794169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111309031|NCT01794169|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111309032|NCT01794169|Immunologic Factors|immunologic factors|mesh-ancestor
111309033|NCT01794169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111309034|NCT01794169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111309035|NCT01794169|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111309036|NCT01794169|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111309037|NCT01794169|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111309038|NCT00396019|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
111309039|NCT00396019|Antiviral Agents|antiviral agents|mesh-ancestor
111309040|NCT00396019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111309041|NCT01390220|Midazolam|midazolam|mesh-list
111309042|NCT01390220|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111309043|NCT01390220|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111309044|NCT01390220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111309045|NCT01390220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111309046|NCT01390220|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111309047|NCT01390220|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111309048|NCT01390220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111309049|NCT01390220|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111309050|NCT01390220|Anesthetics, General|anesthetics, general|mesh-ancestor
111309051|NCT01390220|Anesthetics|anesthetics|mesh-ancestor
111309052|NCT01390220|GABA Modulators|gaba modulators|mesh-ancestor
111309053|NCT01390220|GABA Agents|gaba agents|mesh-ancestor
111309054|NCT01390220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111309055|NCT01390220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111309056|NCT00357331|Potassium Citrate|potassium citrate|mesh-list
111309057|NCT00357331|Diuretics|diuretics|mesh-ancestor
111309058|NCT00357331|Natriuretic Agents|natriuretic agents|mesh-ancestor
111309059|NCT00357331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111309060|NCT00357331|Expectorants|expectorants|mesh-ancestor
111309061|NCT00357331|Respiratory System Agents|respiratory system agents|mesh-ancestor
111309062|NCT00550173|Pemetrexed|pemetrexed|mesh-list
111309063|NCT00550173|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111309064|NCT00550173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111309065|NCT00550173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111309066|NCT00550173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111309067|NCT00550173|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111309068|NCT00550173|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111309069|NCT00550173|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111309070|NCT04163107|Hydroxychloroquine|hydroxychloroquine|mesh-list
111309071|NCT04163107|Dexamethasone|dexamethasone|mesh-list
111309072|NCT04163107|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111309073|NCT04163107|Antiemetics|antiemetics|mesh-ancestor
111309074|NCT04163107|Autonomic Agents|autonomic agents|mesh-ancestor
111309075|NCT04163107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111309076|NCT04163107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111309077|NCT04163107|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111309078|NCT04163107|Glucocorticoids|glucocorticoids|mesh-ancestor
111309079|NCT04163107|Hormones|hormones|mesh-ancestor
111309080|NCT04163107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111309081|NCT04163107|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111309082|NCT04163107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111309083|NCT04163107|Antimalarials|antimalarials|mesh-ancestor
111309084|NCT04163107|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111309085|NCT04163107|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111309086|NCT04163107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111309087|NCT04163107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111309088|NCT04163107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111309089|NCT04163107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111309090|NCT01429298|Hydromorphone|hydromorphone|mesh-list
111309091|NCT01429298|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111309092|NCT01429298|Narcotics|narcotics|mesh-ancestor
111309093|NCT01429298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111309094|NCT01429298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111309095|NCT01429298|Analgesics|analgesics|mesh-ancestor
111309096|NCT01429298|Sensory System Agents|sensory system agents|mesh-ancestor
111309097|NCT01429298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111309098|NCT01408628|Insulin|insulin|mesh-list
111309099|NCT01408628|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111309100|NCT01408628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111309101|NCT01389752|Charcoal|charcoal|mesh-list
111309102|NCT01389752|Antidotes|antidotes|mesh-ancestor
111309103|NCT01389752|Protective Agents|protective agents|mesh-ancestor
111309104|NCT01389752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111309105|NCT01428128|Arsenic Trioxide|arsenic trioxide|mesh-list
111309106|NCT01428128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111309107|NCT00358501|Defibrotide|defibrotide|mesh-list
111309108|NCT00358501|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111309109|NCT00358501|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111309110|NCT00358501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111309111|NCT00358501|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111309112|NCT01427972|Eplerenone|eplerenone|mesh-list
111309113|NCT01427972|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
111309114|NCT01427972|Hormone Antagonists|hormone antagonists|mesh-ancestor
111309115|NCT01427972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111309116|NCT01427972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111309117|NCT01427972|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
111309118|NCT01427972|Diuretics|diuretics|mesh-ancestor
111309119|NCT01427972|Natriuretic Agents|natriuretic agents|mesh-ancestor
111309120|NCT01427972|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111309121|NCT00336323|Bevacizumab|bevacizumab|mesh-list
111309122|NCT00336323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111309123|NCT00336323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111309124|NCT00336323|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111309125|NCT00336323|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111309126|NCT00336323|Growth Substances|growth substances|mesh-ancestor
111309127|NCT00336323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111309128|NCT00336323|Growth Inhibitors|growth inhibitors|mesh-ancestor
111309129|NCT01427738|Nystatin|nystatin|mesh-list
111309130|NCT01427738|Gentian Violet|gentian violet|mesh-list
111309131|NCT01427738|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111309132|NCT01427738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111309133|NCT01427738|Antifungal Agents|antifungal agents|mesh-ancestor
111309134|NCT01427738|Ionophores|ionophores|mesh-ancestor
111309135|NCT01427738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111309136|NCT01427738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111309137|NCT01427738|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111309138|NCT01426958|Ritonavir|ritonavir|mesh-list
111309139|NCT01426958|Afatinib|afatinib|mesh-list
111309140|NCT01426958|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111309141|NCT01426958|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111309142|NCT01426958|Protease Inhibitors|protease inhibitors|mesh-ancestor
111309143|NCT01426958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111309144|NCT01426958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111309145|NCT01426958|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111309146|NCT01426958|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111309147|NCT01426958|Antiviral Agents|antiviral agents|mesh-ancestor
111309148|NCT01426958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111309149|NCT01426958|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111309150|NCT01426958|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111309151|NCT01426958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111309152|NCT01426958|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111309153|NCT00397813|Cyclosporine|cyclosporine|mesh-list
111309154|NCT00397813|Mycophenolic Acid|mycophenolic acid|mesh-list
111309155|NCT00397813|Fludarabine|fludarabine|mesh-list
111309156|NCT00397813|Fludarabine phosphate|fludarabine phosphate|mesh-list
111309157|NCT00397813|Cyclosporins|cyclosporins|mesh-list
111309158|NCT00397813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111309159|NCT00397813|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111309160|NCT00397813|Antimetabolites|antimetabolites|mesh-ancestor
111309161|NCT00397813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111309162|NCT00397813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111309163|NCT00397813|Immunologic Factors|immunologic factors|mesh-ancestor
111309164|NCT00397813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111309165|NCT00397813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111309166|NCT00397813|Antifungal Agents|antifungal agents|mesh-ancestor
111309167|NCT00397813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111309168|NCT00397813|Dermatologic Agents|dermatologic agents|mesh-ancestor
111309169|NCT00397813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111309170|NCT00397813|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111309171|NCT00397813|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111309172|NCT00397813|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111309173|NCT00397813|Antitubercular Agents|antitubercular agents|mesh-ancestor
111309174|NCT00397813|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111309175|NCT00398983|Decitabine|decitabine|mesh-list
111309176|NCT00398983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111309177|NCT00398983|Antimetabolites|antimetabolites|mesh-ancestor
111309178|NCT00398983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111309179|NCT00398983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111309180|NCT00398983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111309181|NCT00358579|Vasopressins|vasopressins|mesh-list
111309182|NCT00358579|Arginine Vasopressin|arginine vasopressin|mesh-list
111309183|NCT00358579|Epinephrine|epinephrine|mesh-list
111309184|NCT00358579|Racepinephrine|racepinephrine|mesh-list
111309185|NCT00358579|Epinephryl borate|epinephryl borate|mesh-list
111309186|NCT00358579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111309187|NCT00358579|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111309188|NCT00358579|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111309189|NCT00358579|Adrenergic Agents|adrenergic agents|mesh-ancestor
111309190|NCT00358579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111309191|NCT00358579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111309192|NCT00358579|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111309193|NCT00358579|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111309194|NCT00358579|Autonomic Agents|autonomic agents|mesh-ancestor
111309195|NCT00358579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111309196|NCT00358579|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111309197|NCT00358579|Respiratory System Agents|respiratory system agents|mesh-ancestor
111309198|NCT00358579|Mydriatics|mydriatics|mesh-ancestor
111309199|NCT00358579|Sympathomimetics|sympathomimetics|mesh-ancestor
111309200|NCT00358579|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111309201|NCT00358579|Hemostatics|hemostatics|mesh-ancestor
111309202|NCT00358579|Coagulants|coagulants|mesh-ancestor
111309203|NCT00358579|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
111309204|NCT00358579|Natriuretic Agents|natriuretic agents|mesh-ancestor
111309205|NCT00338039|Gemcitabine|gemcitabine|mesh-list
111309206|NCT00338039|Capecitabine|capecitabine|mesh-list
111309207|NCT00338039|Oxaliplatin|oxaliplatin|mesh-list
111309208|NCT00338039|Cetuximab|cetuximab|mesh-list
111309209|NCT00338039|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111309210|NCT00338039|Antimetabolites|antimetabolites|mesh-ancestor
111309211|NCT00338039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111309212|NCT00338039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111309213|NCT00338039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111309214|NCT00358657|Mycophenolic Acid|mycophenolic acid|mesh-list
111309215|NCT00358657|Sirolimus|sirolimus|mesh-list
111309216|NCT00358657|Cyclophosphamide|cyclophosphamide|mesh-list
111309217|NCT00358657|Fludarabine|fludarabine|mesh-list
111309218|NCT00358657|Fludarabine phosphate|fludarabine phosphate|mesh-list
111309219|NCT00358657|Tacrolimus|tacrolimus|mesh-list
111309220|NCT00358657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111309221|NCT00358657|Immunologic Factors|immunologic factors|mesh-ancestor
111309222|NCT00358657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111309223|NCT00358657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111309224|NCT00358657|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111309225|NCT00358657|Alkylating Agents|alkylating agents|mesh-ancestor
111309226|NCT00358657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111309227|NCT00358657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111309228|NCT00358657|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111309229|NCT00358657|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111309230|NCT00358657|Antimetabolites|antimetabolites|mesh-ancestor
111309231|NCT00358657|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111309232|NCT00358657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111309233|NCT00358657|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111309234|NCT00358657|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111309235|NCT00358657|Antitubercular Agents|antitubercular agents|mesh-ancestor
111309236|NCT00358657|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111309237|NCT00358657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111309238|NCT00358657|Antifungal Agents|antifungal agents|mesh-ancestor
111309239|NCT00340379|Haloperidol|haloperidol|mesh-list
111309240|NCT00340379|Haloperidol decanoate|haloperidol decanoate|mesh-list
111309241|NCT00340379|Ziprasidone|ziprasidone|mesh-list
111309242|NCT00340379|Sertraline|sertraline|mesh-list
111309243|NCT00340379|Antidepressive Agents|antidepressive agents|mesh-ancestor
111309244|NCT00340379|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111309245|NCT00340379|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111309246|NCT00340379|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111309247|NCT00340379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111309248|NCT00340379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111309249|NCT00340379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111309250|NCT00340379|Serotonin Agents|serotonin agents|mesh-ancestor
111309251|NCT00340379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111309252|NCT00340379|Antiemetics|antiemetics|mesh-ancestor
111309253|NCT00340379|Autonomic Agents|autonomic agents|mesh-ancestor
111309254|NCT00340379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111309255|NCT00340379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111309256|NCT00340379|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111309257|NCT00340379|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111309258|NCT00340379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111309259|NCT00340379|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111309260|NCT00340379|Dopamine Agents|dopamine agents|mesh-ancestor
111309261|NCT00340379|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111309262|NCT00340379|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111309263|NCT00342563|Mecamylamine|mecamylamine|mesh-list
111309264|NCT00342563|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111309265|NCT00342563|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
111309266|NCT00342563|Autonomic Agents|autonomic agents|mesh-ancestor
111309267|NCT00342563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111309268|NCT00342563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111309269|NCT00342563|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
111309270|NCT00342563|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111309271|NCT00342563|Cholinergic Agents|cholinergic agents|mesh-ancestor
111309272|NCT00342563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111309273|NCT00342563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111309274|NCT00358735|Enoxaparin|enoxaparin|mesh-list
111309275|NCT00358735|Anticoagulants|anticoagulants|mesh-ancestor
111309276|NCT00358735|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111309277|NCT00358735|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111309278|NCT00358735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111309279|NCT01793519|Adalimumab|adalimumab|mesh-list
111309280|NCT01793519|Infliximab|infliximab|mesh-list
111309281|NCT01793519|Etanercept|etanercept|mesh-list
111309282|NCT01793519|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111309283|NCT01793519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111309284|NCT01793519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111309285|NCT01793519|Dermatologic Agents|dermatologic agents|mesh-ancestor
111309286|NCT01793519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111309287|NCT01793519|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111309288|NCT01793519|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111309289|NCT01793519|Analgesics|analgesics|mesh-ancestor
111309290|NCT01793519|Sensory System Agents|sensory system agents|mesh-ancestor
111309291|NCT01793519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111309292|NCT01793519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111309293|NCT01793519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111309294|NCT01793519|Immunologic Factors|immunologic factors|mesh-ancestor
111309295|NCT00345371|Topiramate|topiramate|mesh-list
111309296|NCT00345371|Anticonvulsants|anticonvulsants|mesh-ancestor
111309297|NCT00345371|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111309298|NCT00345371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111309299|NCT03006276|Celecoxib|celecoxib|mesh-list
111309300|NCT03006276|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111309301|NCT03006276|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111309302|NCT03006276|Analgesics|analgesics|mesh-ancestor
111309303|NCT03006276|Sensory System Agents|sensory system agents|mesh-ancestor
111309304|NCT03006276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111309305|NCT03006276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111309306|NCT03006276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111309307|NCT03006276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111309308|NCT03006276|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111309309|NCT03006276|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111309310|NCT03006276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111309311|NCT03006276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111309312|NCT00350363|Gatifloxacin|gatifloxacin|mesh-list
111309313|NCT00350363|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111309314|NCT00350363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111309315|NCT00350363|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
111309316|NCT00350363|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111309317|NCT00350363|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111309318|NCT00350363|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111309319|NCT00350363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111309320|NCT00350363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111309321|NCT00350363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111309322|NCT00351299|Dexmedetomidine|dexmedetomidine|mesh-list
111309323|NCT00351299|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111309324|NCT00351299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111309325|NCT00351299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111309326|NCT00351299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111309327|NCT00351299|Analgesics|analgesics|mesh-ancestor
111309328|NCT00351299|Sensory System Agents|sensory system agents|mesh-ancestor
111309329|NCT00351299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111309330|NCT00351299|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111309331|NCT00351299|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111309332|NCT00351299|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111309333|NCT00351299|Adrenergic Agents|adrenergic agents|mesh-ancestor
111309334|NCT00351299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111309335|NCT00351299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111309336|NCT00352001|Lenalidomide|lenalidomide|mesh-list
111309337|NCT00352001|Azacitidine|azacitidine|mesh-list
111309338|NCT00352001|Immunologic Factors|immunologic factors|mesh-ancestor
111309339|NCT00352001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111309340|NCT00352001|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111309341|NCT00352001|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111309342|NCT00352001|Growth Substances|growth substances|mesh-ancestor
111309343|NCT00352001|Growth Inhibitors|growth inhibitors|mesh-ancestor
111309344|NCT00352001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111309345|NCT00352001|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111309346|NCT00352001|Antimetabolites|antimetabolites|mesh-ancestor
111309347|NCT00352001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111309348|NCT00352001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111309349|NCT00401401|Zalutumumab|zalutumumab|mesh-list
111309350|NCT00401401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111309351|NCT00401401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111309352|NCT00352781|Nicotine|nicotine|mesh-list
111309353|NCT00352781|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111309354|NCT00352781|Autonomic Agents|autonomic agents|mesh-ancestor
111309355|NCT00352781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111309356|NCT00352781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111309357|NCT00352781|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111309358|NCT00352781|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111309359|NCT00352781|Cholinergic Agents|cholinergic agents|mesh-ancestor
111309360|NCT00352781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111309361|NCT00352781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111309362|NCT02812524|Ipilimumab|ipilimumab|mesh-list
111309363|NCT02812524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111309364|NCT02812524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111309365|NCT02812524|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111309366|NCT02812524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111309367|NCT01793753|Propofol|propofol|mesh-list
111309368|NCT01793753|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111309369|NCT01793753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111309370|NCT01793753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111309371|NCT01793753|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111309372|NCT01793753|Anesthetics, General|anesthetics, general|mesh-ancestor
111309373|NCT01793753|Anesthetics|anesthetics|mesh-ancestor
111309374|NCT00360685|Mycophenolic Acid|mycophenolic acid|mesh-list
111309375|NCT00360685|Methotrexate|methotrexate|mesh-list
111309376|NCT00360685|Tacrolimus|tacrolimus|mesh-list
111309377|NCT00360685|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111309378|NCT00360685|Abortifacient Agents|abortifacient agents|mesh-ancestor
111309379|NCT00360685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111309380|NCT00360685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111309381|NCT00360685|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111309382|NCT00360685|Antimetabolites|antimetabolites|mesh-ancestor
111309383|NCT00360685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111309384|NCT00360685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111309385|NCT00360685|Dermatologic Agents|dermatologic agents|mesh-ancestor
111309386|NCT00360685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111309387|NCT00360685|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111309388|NCT00360685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111309389|NCT00360685|Immunologic Factors|immunologic factors|mesh-ancestor
111309390|NCT00360685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111309391|NCT00360685|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111033832|NCT02125565|Sensory System Agents|sensory system agents|mesh-ancestor
111309392|NCT00360685|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111309393|NCT00360685|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111309394|NCT00360685|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111309395|NCT00360685|Antitubercular Agents|antitubercular agents|mesh-ancestor
111309396|NCT00360685|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111309397|NCT00360685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111309399|NCT05487456|Nicotine|nicotine|mesh-list
111309400|NCT05487456|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111309401|NCT05487456|Autonomic Agents|autonomic agents|mesh-ancestor
111309402|NCT05487456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111309403|NCT05487456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111309404|NCT05487456|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111309405|NCT05487456|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111309406|NCT05487456|Cholinergic Agents|cholinergic agents|mesh-ancestor
111309407|NCT05487456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111309408|NCT05487456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111309409|NCT05487456|Antipruritics|antipruritics|mesh-ancestor
111309410|NCT05487456|Dermatologic Agents|dermatologic agents|mesh-ancestor
111309411|NCT00558519|Cytarabine|cytarabine|mesh-list
111309412|NCT00558519|Dexamethasone|dexamethasone|mesh-list
111309413|NCT00558519|Cyclophosphamide|cyclophosphamide|mesh-list
111309414|NCT00558519|Doxorubicin|doxorubicin|mesh-list
111309415|NCT00558519|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111309416|NCT00558519|Methotrexate|methotrexate|mesh-list
111309417|NCT00558519|Vincristine|vincristine|mesh-list
111309418|NCT00558519|Daunorubicin|daunorubicin|mesh-list
111309419|NCT00558519|Mercaptopurine|mercaptopurine|mesh-list
111309420|NCT00558519|Pegaspargase|pegaspargase|mesh-list
111309421|NCT00558519|Thioguanine|thioguanine|mesh-list
111309422|NCT00558519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111309423|NCT00558519|Immunologic Factors|immunologic factors|mesh-ancestor
111309424|NCT00558519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111309425|NCT00558519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111309426|NCT00558519|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111309427|NCT00558519|Alkylating Agents|alkylating agents|mesh-ancestor
111309428|NCT00558519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111309429|NCT00558519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111309430|NCT00558519|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111309431|NCT00558519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111309432|NCT00558519|Antiemetics|antiemetics|mesh-ancestor
111309433|NCT00558519|Autonomic Agents|autonomic agents|mesh-ancestor
111309434|NCT00558519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111309435|NCT00558519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111309436|NCT00558519|Glucocorticoids|glucocorticoids|mesh-ancestor
111309437|NCT00558519|Hormones|hormones|mesh-ancestor
111309438|NCT00558519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111309439|NCT00558519|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111309440|NCT00558519|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111309441|NCT00558519|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111309442|NCT00558519|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111309443|NCT00558519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111309444|NCT00558519|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111309445|NCT00558519|Abortifacient Agents|abortifacient agents|mesh-ancestor
111309446|NCT00558519|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111309447|NCT00558519|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111309448|NCT00558519|Antimetabolites|antimetabolites|mesh-ancestor
111309449|NCT00558519|Dermatologic Agents|dermatologic agents|mesh-ancestor
111309450|NCT00558519|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111309451|NCT00558519|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111309452|NCT00558519|Antiviral Agents|antiviral agents|mesh-ancestor
111309453|NCT00558519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111309454|NCT00558519|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111309455|NCT00558519|Tubulin Modulators|tubulin modulators|mesh-ancestor
111309456|NCT00558519|Antimitotic Agents|antimitotic agents|mesh-ancestor
111309457|NCT00558519|Mitosis Modulators|mitosis modulators|mesh-ancestor
111309458|NCT00403117|Naltrexone|naltrexone|mesh-list
111309459|NCT00403117|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111309460|NCT00403117|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111309461|NCT00403117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111309462|NCT00403117|Sensory System Agents|sensory system agents|mesh-ancestor
111309463|NCT00403117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111309464|NCT00558285|Glycopyrrolate|glycopyrrolate|mesh-list
111309465|NCT00558285|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111309466|NCT00558285|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111309467|NCT00558285|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111309468|NCT00558285|Cholinergic Agents|cholinergic agents|mesh-ancestor
111309470|NCT00558285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111309471|NCT00558285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111309472|NCT01389596|Pregabalin|pregabalin|mesh-list
111309473|NCT01389596|Analgesics|analgesics|mesh-ancestor
111309474|NCT01389596|Sensory System Agents|sensory system agents|mesh-ancestor
111309475|NCT01389596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111309476|NCT01389596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111309477|NCT01389596|Anticonvulsants|anticonvulsants|mesh-ancestor
111309478|NCT01389596|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111309479|NCT01389596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111309480|NCT01389596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111309481|NCT01389596|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111309482|NCT01389596|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111309483|NCT01389596|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111309484|NCT01389596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111309485|NCT01389596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111309486|NCT00558207|Gemcitabine|gemcitabine|mesh-list
111309487|NCT00558207|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111309488|NCT00558207|Antimetabolites|antimetabolites|mesh-ancestor
111309489|NCT00558207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111309490|NCT00558207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111309491|NCT00407485|Aflibercept|aflibercept|mesh-list
111309492|NCT00407485|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111309493|NCT00407485|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111309494|NCT00407485|Growth Substances|growth substances|mesh-ancestor
111309495|NCT00407485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111309496|NCT00407485|Growth Inhibitors|growth inhibitors|mesh-ancestor
111309497|NCT00407485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111309498|NCT00354887|Capecitabine|capecitabine|mesh-list
111309499|NCT00354887|Oxaliplatin|oxaliplatin|mesh-list
111309500|NCT00354887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111309501|NCT00354887|Antimetabolites|antimetabolites|mesh-ancestor
111309502|NCT00354887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111309503|NCT00354887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111309504|NCT02111863|Aldesleukin|aldesleukin|mesh-list
111309505|NCT02111863|Cyclophosphamide|cyclophosphamide|mesh-list
111309506|NCT02111863|Fludarabine|fludarabine|mesh-list
111309507|NCT02111863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111309508|NCT02111863|Immunologic Factors|immunologic factors|mesh-ancestor
111309509|NCT02111863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111309510|NCT02111863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111309511|NCT02111863|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111309512|NCT02111863|Alkylating Agents|alkylating agents|mesh-ancestor
111309513|NCT02111863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111309514|NCT02111863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111309515|NCT02111863|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111309516|NCT02111863|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111309517|NCT02111863|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111309518|NCT02111863|Antiviral Agents|antiviral agents|mesh-ancestor
111309519|NCT02111863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111309520|NCT02660411|Propofol|propofol|mesh-list
111309521|NCT02660411|Sevoflurane|sevoflurane|mesh-list
111309522|NCT02660411|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111309523|NCT02660411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111309524|NCT02660411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111309525|NCT02660411|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111309526|NCT02660411|Anesthetics, General|anesthetics, general|mesh-ancestor
111309527|NCT02660411|Anesthetics|anesthetics|mesh-ancestor
111309528|NCT02660411|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111309529|NCT02660411|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111309530|NCT02078492|Ketorolac|ketorolac|mesh-list
111309531|NCT02078492|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
111309532|NCT02078492|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111309533|NCT02078492|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111309534|NCT02078492|Analgesics|analgesics|mesh-ancestor
111309535|NCT02078492|Sensory System Agents|sensory system agents|mesh-ancestor
111309536|NCT02078492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111309537|NCT02078492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111309538|NCT02078492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111309539|NCT02078492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111309540|NCT02078492|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111309541|NCT02078492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111033980|NCT02126267|Disinfectants|disinfectants|mesh-ancestor
110980017|NCT03226340|Antimetabolites|antimetabolites|mesh-ancestor
111309542|NCT02078492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111309544|NCT02988921|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111309545|NCT02988921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111309546|NCT02988921|Tubulin Modulators|tubulin modulators|mesh-ancestor
111309547|NCT02988921|Antimitotic Agents|antimitotic agents|mesh-ancestor
111309548|NCT02988921|Mitosis Modulators|mitosis modulators|mesh-ancestor
111309549|NCT02988921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111309550|NCT04528563|Ketorolac|ketorolac|mesh-list
111309551|NCT04528563|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
111309552|NCT04528563|Morphine|morphine|mesh-list
111309553|NCT04528563|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111309554|NCT04528563|Narcotics|narcotics|mesh-ancestor
111309555|NCT04528563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111309556|NCT04528563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111309557|NCT04528563|Analgesics|analgesics|mesh-ancestor
111309558|NCT04528563|Sensory System Agents|sensory system agents|mesh-ancestor
111309559|NCT04528563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111309560|NCT04528563|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111309561|NCT04528563|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111309562|NCT04528563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111309563|NCT04528563|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111309564|NCT04528563|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111309565|NCT04528563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111309566|NCT04528563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111309567|NCT00355199|Rituximab|rituximab|mesh-list
111309568|NCT00355199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111309569|NCT00355199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111309570|NCT00355199|Immunologic Factors|immunologic factors|mesh-ancestor
111309571|NCT00355199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111309572|NCT00355199|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111309573|NCT01791647|Inositol|inositol|mesh-list
111309574|NCT01791647|Metformin|metformin|mesh-list
111309575|NCT01791647|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111309576|NCT01791647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111309577|NCT01791647|Vitamin B Complex|vitamin b complex|mesh-ancestor
111309578|NCT01791647|Vitamins|vitamins|mesh-ancestor
111309579|NCT01791647|Micronutrients|micronutrients|mesh-ancestor
111309580|NCT00363883|Vorinostat|vorinostat|mesh-list
111309581|NCT00363883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111309582|NCT00363883|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111309583|NCT00363883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111309584|NCT00363883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111309585|NCT00364819|Rituximab|rituximab|mesh-list
111309586|NCT00364819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111309587|NCT00364819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111309588|NCT00364819|Immunologic Factors|immunologic factors|mesh-ancestor
111309589|NCT00364819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111309590|NCT00364819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111309591|NCT04524351|Phenserine|phenserine|mesh-list
111309592|NCT04524351|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111309593|NCT04524351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111309594|NCT04524351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111309595|NCT04524351|Cholinergic Agents|cholinergic agents|mesh-ancestor
111309596|NCT04524351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111309597|NCT04524351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111309598|NCT04523961|Lidocaine|lidocaine|mesh-list
111309599|NCT04523961|Tetracaine|tetracaine|mesh-list
111309600|NCT04523961|Prilocaine|prilocaine|mesh-list
111309601|NCT04523961|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
111309602|NCT04523961|Anesthetics, Local|anesthetics, local|mesh-ancestor
111309603|NCT04523961|Anesthetics|anesthetics|mesh-ancestor
111309604|NCT04523961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111309605|NCT04523961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111309606|NCT04523961|Sensory System Agents|sensory system agents|mesh-ancestor
111309607|NCT04523961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111309608|NCT04523961|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111309609|NCT04523961|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111309610|NCT04523961|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111309611|NCT04523961|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111309612|NCT04523961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111309613|NCT04523961|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
111309614|NCT01792505|Imiquimod|imiquimod|mesh-list
111309615|NCT01792505|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111309616|NCT01792505|Immunologic Factors|immunologic factors|mesh-ancestor
111309617|NCT01792505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111309618|NCT01792505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111309619|NCT01792505|Interferon Inducers|interferon inducers|mesh-ancestor
111309620|NCT00365053|Belinostat|belinostat|mesh-list
111309621|NCT00365053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111309622|NCT00365053|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111309623|NCT00365053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111309624|NCT00365053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111309625|NCT00555789|Tacrolimus|tacrolimus|mesh-list
111309626|NCT00555789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111309627|NCT00555789|Immunologic Factors|immunologic factors|mesh-ancestor
111309628|NCT00555789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111309629|NCT00555789|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111309630|NCT00555789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111309631|NCT00555789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111309632|NCT04288895|Vortioxetine|vortioxetine|mesh-list
111309633|NCT04288895|Antidepressive Agents|antidepressive agents|mesh-ancestor
111309634|NCT04288895|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111309635|NCT04288895|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111309636|NCT04288895|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111309637|NCT04288895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111309638|NCT04288895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111309639|NCT04288895|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111309640|NCT04288895|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111309641|NCT04288895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111309642|NCT04288895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111309643|NCT04288895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111309644|NCT04288895|Serotonin Agents|serotonin agents|mesh-ancestor
111309645|NCT04288895|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111309646|NCT04288895|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111309647|NCT04288895|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111309648|NCT04288895|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111309649|NCT00365209|Curcumin|curcumin|mesh-list
111309650|NCT00365209|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111309651|NCT00365209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111309652|NCT00365209|Analgesics|analgesics|mesh-ancestor
111309653|NCT00365209|Sensory System Agents|sensory system agents|mesh-ancestor
111309654|NCT00365209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111309655|NCT00365209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111309656|NCT00365209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111309657|NCT00365209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111309658|NCT00365209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111309659|NCT00365209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111309660|NCT00365209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111309661|NCT00409825|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
111309662|NCT00409825|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
111309663|NCT00409825|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111309664|NCT00409825|Hormone Antagonists|hormone antagonists|mesh-ancestor
111309665|NCT00409825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111309666|NCT00409825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111309667|NCT00409825|Progestins|progestins|mesh-ancestor
111309668|NCT00409825|Hormones|hormones|mesh-ancestor
111309669|NCT00410059|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111309670|NCT00410059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111309671|NCT00410059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111309672|NCT00410059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111309673|NCT00410059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111309674|NCT04749069|Remifentanil|remifentanil|mesh-list
111309675|NCT04749069|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111309676|NCT04749069|Narcotics|narcotics|mesh-ancestor
111309677|NCT04749069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111309678|NCT04749069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111309679|NCT04749069|Analgesics|analgesics|mesh-ancestor
111309680|NCT04749069|Sensory System Agents|sensory system agents|mesh-ancestor
111309681|NCT04749069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111309682|NCT00411463|Quetiapine Fumarate|quetiapine fumarate|mesh-list
111309683|NCT00411463|Antidepressive Agents|antidepressive agents|mesh-ancestor
111309684|NCT00411463|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111309685|NCT00411463|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111309686|NCT00411463|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111309687|NCT00411463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111309688|NCT00411463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111309689|NCT03239015|Trastuzumab|trastuzumab|mesh-list
111309690|NCT03239015|Everolimus|everolimus|mesh-list
111309691|NCT03239015|Olaparib|olaparib|mesh-list
111309692|NCT03239015|Palbociclib|palbociclib|mesh-list
111309693|NCT03239015|Gefitinib|gefitinib|mesh-list
111309694|NCT03239015|Afatinib|afatinib|mesh-list
111309695|NCT03239015|Vemurafenib|vemurafenib|mesh-list
111309696|NCT03239015|Dabrafenib|dabrafenib|mesh-list
111309697|NCT03239015|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
111309698|NCT03239015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111309699|NCT03239015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111309700|NCT03239015|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111309701|NCT03239015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111309702|NCT03239015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111309703|NCT03239015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111309704|NCT03239015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111309705|NCT03239015|Immunologic Factors|immunologic factors|mesh-ancestor
111309706|NCT03239015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111309707|NCT03239015|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111309708|NCT03239015|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111309709|NCT03239015|Growth Substances|growth substances|mesh-ancestor
111309710|NCT03239015|Growth Inhibitors|growth inhibitors|mesh-ancestor
111309711|NCT00356993|Nicotine|nicotine|mesh-list
111309712|NCT00356993|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111309713|NCT00356993|Autonomic Agents|autonomic agents|mesh-ancestor
111309714|NCT00356993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111309715|NCT00356993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111309716|NCT00356993|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111309717|NCT00356993|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111309718|NCT00356993|Cholinergic Agents|cholinergic agents|mesh-ancestor
111309719|NCT00356993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111309720|NCT00356993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111309721|NCT01793077|Leuprolide|leuprolide|mesh-list
111309722|NCT01793077|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111309723|NCT01793077|Fertility Agents|fertility agents|mesh-ancestor
111309724|NCT01793077|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111309725|NCT01793077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111309726|NCT01793077|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111309727|NCT01793077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111309728|NCT00555477|Anastrozole|anastrozole|mesh-list
111309729|NCT00555477|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111309730|NCT00555477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111309731|NCT00555477|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111309732|NCT00555477|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111309733|NCT00555477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111309734|NCT00555477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111309735|NCT00555477|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111309736|NCT00555477|Hormone Antagonists|hormone antagonists|mesh-ancestor
111309737|NCT00555477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111309738|NCT00555477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111309739|NCT00365599|Tamoxifen|tamoxifen|mesh-list
111309740|NCT00365599|Vorinostat|vorinostat|mesh-list
111309741|NCT00365599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111309742|NCT00365599|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111309743|NCT00365599|Hormone Antagonists|hormone antagonists|mesh-ancestor
111309744|NCT00365599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111309745|NCT00365599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111309746|NCT00365599|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111309747|NCT00365599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111309748|NCT00365599|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111309749|NCT00365599|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111309750|NCT00365599|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111309751|NCT00365599|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111309752|NCT00365599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111309753|NCT00554619|Ambrisentan|ambrisentan|mesh-list
111309754|NCT00554619|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111309755|NCT02104739|Exenatide|exenatide|mesh-list
111309756|NCT02104739|Saxagliptin|saxagliptin|mesh-list
111309757|NCT02104739|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111309758|NCT02104739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111309759|NCT02104739|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111309760|NCT02104739|Incretins|incretins|mesh-ancestor
111309761|NCT02104739|Hormones|hormones|mesh-ancestor
111309762|NCT02104739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111034200|NCT03549923|Esmolol|esmolol|mesh-list
111309763|NCT02104739|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111309764|NCT02104739|Protease Inhibitors|protease inhibitors|mesh-ancestor
111309765|NCT02104739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111309766|NCT02104739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111309767|NCT00411619|Everolimus|everolimus|mesh-list
111309768|NCT00411619|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111309769|NCT00411619|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111309770|NCT00411619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111309771|NCT00411619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111309772|NCT00411619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111309773|NCT00411619|Immunologic Factors|immunologic factors|mesh-ancestor
111309774|NCT00411619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111309775|NCT00411619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111309776|NCT00412087|Vitamin D|vitamin d|mesh-list
111309777|NCT00412087|Ergocalciferols|ergocalciferols|mesh-list
111309778|NCT00412087|Cholecalciferol|cholecalciferol|mesh-list
111309779|NCT00412087|Vitamins|vitamins|mesh-list
111309780|NCT00412087|Micronutrients|micronutrients|mesh-ancestor
111309781|NCT00412087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111309782|NCT00412087|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111309783|NCT00412087|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111309784|NCT00312923|Policosanol|policosanol|mesh-list
111309785|NCT00312923|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111309786|NCT00312923|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111309787|NCT00312923|Antimetabolites|antimetabolites|mesh-ancestor
111309788|NCT00312923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111309789|NCT00312923|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111309790|NCT00312923|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111309791|NCT00412243|Cyclophosphamide|cyclophosphamide|mesh-list
111309792|NCT00412243|Clofarabine|clofarabine|mesh-list
111309793|NCT00412243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111309794|NCT00412243|Immunologic Factors|immunologic factors|mesh-ancestor
111309795|NCT00412243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111309796|NCT00412243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111309797|NCT00412243|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111309798|NCT00412243|Alkylating Agents|alkylating agents|mesh-ancestor
111309799|NCT00412243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111309800|NCT00412243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111309801|NCT00412243|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111309802|NCT00412243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111309803|NCT00412243|Antimetabolites|antimetabolites|mesh-ancestor
111309804|NCT01426412|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111309805|NCT01426412|Immunologic Factors|immunologic factors|mesh-ancestor
111309806|NCT01426412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111309807|NCT00315341|Buprenorphine|buprenorphine|mesh-list
111309808|NCT00315341|Methadone|methadone|mesh-list
111309809|NCT00315341|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
111309810|NCT00315341|Naloxone|naloxone|mesh-list
111309811|NCT00315341|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111309812|NCT00315341|Narcotics|narcotics|mesh-ancestor
111309813|NCT00315341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111309814|NCT00315341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111309815|NCT00315341|Analgesics|analgesics|mesh-ancestor
111309816|NCT00315341|Sensory System Agents|sensory system agents|mesh-ancestor
111309817|NCT00315341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111309818|NCT00315341|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111309819|NCT00315341|Antitussive Agents|antitussive agents|mesh-ancestor
111309820|NCT00315341|Respiratory System Agents|respiratory system agents|mesh-ancestor
111309821|NCT02277249|Digoxin|digoxin|mesh-list
111309822|NCT02277249|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111309823|NCT02277249|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111309824|NCT02277249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111309825|NCT02277249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111309826|NCT02277249|Protective Agents|protective agents|mesh-ancestor
111309827|NCT02277249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111309828|NCT04767542|Acetaminophen|acetaminophen|mesh-list
111309829|NCT04767542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111309830|NCT04767542|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111309831|NCT04767542|Analgesics|analgesics|mesh-ancestor
111309832|NCT04767542|Sensory System Agents|sensory system agents|mesh-ancestor
111309833|NCT04767542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111309834|NCT04767542|Antipyretics|antipyretics|mesh-ancestor
111309835|NCT01794533|Lidocaine|lidocaine|mesh-list
111309836|NCT01794533|Epinephrine|epinephrine|mesh-list
111309837|NCT01794533|Racepinephrine|racepinephrine|mesh-list
111309838|NCT01794533|Fentanyl|fentanyl|mesh-list
111309839|NCT01794533|Epinephryl borate|epinephryl borate|mesh-list
111309840|NCT01794533|Anesthetics, Local|anesthetics, local|mesh-ancestor
111309842|NCT01794533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111309843|NCT01794533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111309844|NCT01794533|Sensory System Agents|sensory system agents|mesh-ancestor
111309845|NCT01794533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111309846|NCT01794533|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111309847|NCT01794533|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111309848|NCT01794533|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111309849|NCT01794533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111309850|NCT01794533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111309851|NCT01794533|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111309852|NCT01794533|Narcotics|narcotics|mesh-ancestor
111309853|NCT01794533|Analgesics|analgesics|mesh-ancestor
111309854|NCT01794533|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111309855|NCT01794533|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111309856|NCT01794533|Anesthetics, General|anesthetics, general|mesh-ancestor
111309857|NCT01794533|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111309858|NCT01794533|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111309859|NCT01794533|Adrenergic Agents|adrenergic agents|mesh-ancestor
111309860|NCT01794533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111309861|NCT01794533|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111309862|NCT01794533|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111309863|NCT01794533|Autonomic Agents|autonomic agents|mesh-ancestor
111309864|NCT01794533|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111309865|NCT01794533|Respiratory System Agents|respiratory system agents|mesh-ancestor
111309866|NCT01794533|Mydriatics|mydriatics|mesh-ancestor
111309867|NCT01794533|Sympathomimetics|sympathomimetics|mesh-ancestor
111309868|NCT01794533|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111309869|NCT00412867|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
111309870|NCT00412867|Plasminogen|plasminogen|mesh-list
111309871|NCT00412867|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111309872|NCT00412867|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111309873|NCT00412867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111309874|NCT01730833|Paclitaxel|paclitaxel|mesh-list
111309875|NCT01730833|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111309876|NCT01730833|Trastuzumab|trastuzumab|mesh-list
111309877|NCT01730833|Pertuzumab|pertuzumab|mesh-list
111309878|NCT01730833|Antibodies|antibodies|mesh-list
111309879|NCT01730833|Immunoglobulins|immunoglobulins|mesh-list
111309880|NCT01730833|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111309881|NCT01730833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111309882|NCT01730833|Tubulin Modulators|tubulin modulators|mesh-ancestor
111309883|NCT01730833|Antimitotic Agents|antimitotic agents|mesh-ancestor
111309884|NCT01730833|Mitosis Modulators|mitosis modulators|mesh-ancestor
111309885|NCT01730833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111309886|NCT01730833|Immunologic Factors|immunologic factors|mesh-ancestor
111309887|NCT01730833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111309888|NCT01730833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111309889|NCT00413335|Rosiglitazone|rosiglitazone|mesh-list
111309890|NCT00413335|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111309891|NCT00413335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111309892|NCT00414271|Docetaxel|docetaxel|mesh-list
111309893|NCT00414271|Capecitabine|capecitabine|mesh-list
111309894|NCT00414271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111309895|NCT00414271|Tubulin Modulators|tubulin modulators|mesh-ancestor
111309896|NCT00414271|Antimitotic Agents|antimitotic agents|mesh-ancestor
111309897|NCT00414271|Mitosis Modulators|mitosis modulators|mesh-ancestor
111309898|NCT00414271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111309899|NCT00414271|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111309900|NCT00414271|Antimetabolites|antimetabolites|mesh-ancestor
111309901|NCT00360971|Cisplatin|cisplatin|mesh-list
111309902|NCT00360971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111309903|NCT01791881|Botulinum Toxins|botulinum toxins|mesh-list
111309904|NCT01791881|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111309905|NCT01791881|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111309906|NCT01791881|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111309907|NCT01791881|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111309908|NCT01791881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111309909|NCT01791881|Cholinergic Agents|cholinergic agents|mesh-ancestor
111309910|NCT01791881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111309911|NCT01791881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111309912|NCT01791881|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111309913|NCT01791881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111309914|NCT03636503|Rituximab|rituximab|mesh-list
111034349|NCT02133677|Temozolomide|temozolomide|mesh-list
111309915|NCT03636503|Avelumab|avelumab|mesh-list
111309916|NCT03636503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111309917|NCT03636503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111309918|NCT03636503|Immunologic Factors|immunologic factors|mesh-ancestor
111309919|NCT03636503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111309920|NCT03636503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111309921|NCT03448159|Fluoxetine|fluoxetine|mesh-list
111309922|NCT03448159|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111309923|NCT03448159|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111309924|NCT03448159|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111309925|NCT03448159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111309926|NCT03448159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111309927|NCT03448159|Serotonin Agents|serotonin agents|mesh-ancestor
111309928|NCT03448159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111309929|NCT03448159|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111309930|NCT03448159|Antidepressive Agents|antidepressive agents|mesh-ancestor
111309931|NCT03448159|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111309932|NCT03448159|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111309933|NCT03448159|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111309934|NCT03448159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111309935|NCT00361439|Mometasone Furoate|mometasone furoate|mesh-list
111309936|NCT00361439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111309937|NCT00361439|Dermatologic Agents|dermatologic agents|mesh-ancestor
111309938|NCT00361439|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111309939|NCT00361595|Zoledronic Acid|zoledronic acid|mesh-list
111309940|NCT00361595|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111309941|NCT00361595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111309942|NCT03438487|Vaccines|vaccines|mesh-list
111309943|NCT03438487|Immunologic Factors|immunologic factors|mesh-ancestor
111309944|NCT03438487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111309945|NCT03458117|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
111309946|NCT03458117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111309947|NCT03458117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111309948|NCT01792037|Methylprednisolone|methylprednisolone|mesh-list
111309949|NCT01792037|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111309950|NCT01792037|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111309951|NCT01792037|Prednisolone|prednisolone|mesh-list
111309952|NCT01792037|Prednisolone acetate|prednisolone acetate|mesh-list
111309953|NCT01792037|Midazolam|midazolam|mesh-list
111309954|NCT01792037|Etomidate|etomidate|mesh-list
111309955|NCT01792037|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111309956|NCT01792037|Prednisolone phosphate|prednisolone phosphate|mesh-list
111309957|NCT01792037|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111309958|NCT01792037|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111309959|NCT01792037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111309960|NCT01792037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111309961|NCT01792037|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111309962|NCT01792037|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111309963|NCT01792037|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111309964|NCT01792037|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111309965|NCT01792037|Anesthetics, General|anesthetics, general|mesh-ancestor
111309966|NCT01792037|Anesthetics|anesthetics|mesh-ancestor
111309967|NCT01792037|GABA Modulators|gaba modulators|mesh-ancestor
111309968|NCT01792037|GABA Agents|gaba agents|mesh-ancestor
111309969|NCT01792037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111309970|NCT01792037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111309971|NCT01792037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111309972|NCT01792037|Antiemetics|antiemetics|mesh-ancestor
111309973|NCT01792037|Autonomic Agents|autonomic agents|mesh-ancestor
111309974|NCT01792037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111309975|NCT01792037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111309976|NCT01792037|Glucocorticoids|glucocorticoids|mesh-ancestor
111309977|NCT01792037|Hormones|hormones|mesh-ancestor
110980026|NCT03221504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111309978|NCT01792037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111309979|NCT01792037|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111309980|NCT01792037|Protective Agents|protective agents|mesh-ancestor
111309981|NCT01792037|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111309982|NCT01792037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111309983|NCT00373399|Dronabinol|dronabinol|mesh-list
111309984|NCT00373399|Hallucinogens|hallucinogens|mesh-ancestor
111309985|NCT00373399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111309986|NCT00373399|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111309987|NCT00373399|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111309988|NCT00373399|Analgesics|analgesics|mesh-ancestor
111309989|NCT00373399|Sensory System Agents|sensory system agents|mesh-ancestor
111309990|NCT00373399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111309991|NCT00373399|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
111309992|NCT00373399|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
111309993|NCT00373399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111309994|NCT00373399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111309995|NCT00373399|Hormones|hormones|mesh-ancestor
111309996|NCT00373399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111309997|NCT00318929|Valproic Acid|valproic acid|mesh-list
111309998|NCT00318929|Anticonvulsants|anticonvulsants|mesh-ancestor
111309999|NCT00318929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111310000|NCT00318929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111310001|NCT00318929|GABA Agents|gaba agents|mesh-ancestor
111310002|NCT00318929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111310003|NCT00318929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111310004|NCT00318929|Antimanic Agents|antimanic agents|mesh-ancestor
111310005|NCT00318929|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111310006|NCT00318929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111310007|NCT00318929|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111310008|NCT00418093|Bevacizumab|bevacizumab|mesh-list
111310009|NCT00418093|Gemcitabine|gemcitabine|mesh-list
111310010|NCT00418093|Oxaliplatin|oxaliplatin|mesh-list
111310011|NCT00418093|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111310012|NCT00418093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111310013|NCT00418093|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111310014|NCT00418093|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111310015|NCT00418093|Growth Substances|growth substances|mesh-ancestor
111310016|NCT00418093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111310017|NCT00418093|Growth Inhibitors|growth inhibitors|mesh-ancestor
111310018|NCT00418093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111310019|NCT00418093|Antimetabolites|antimetabolites|mesh-ancestor
111310020|NCT00418093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111310021|NCT03855371|Decitabine|decitabine|mesh-list
111310022|NCT03855371|Arsenic Trioxide|arsenic trioxide|mesh-list
111310023|NCT03855371|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111310024|NCT03855371|Antimetabolites|antimetabolites|mesh-ancestor
111310025|NCT03855371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111310026|NCT03855371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111310027|NCT03855371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111310028|NCT03284723|Letrozole|letrozole|mesh-list
111310029|NCT03284723|Palbociclib|palbociclib|mesh-list
111310030|NCT03284723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111310031|NCT03284723|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111310032|NCT03284723|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111310033|NCT03284723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111310034|NCT03284723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111310035|NCT03284723|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111310036|NCT03284723|Hormone Antagonists|hormone antagonists|mesh-ancestor
111310037|NCT03284723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111310038|NCT03284723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111310039|NCT03284723|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111310040|NCT00374803|Mycophenolic Acid|mycophenolic acid|mesh-list
111310041|NCT00374803|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111310042|NCT00374803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111310043|NCT00374803|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111310044|NCT00374803|Antitubercular Agents|antitubercular agents|mesh-ancestor
111310045|NCT00374803|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111310046|NCT00374803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111310047|NCT00374803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111310048|NCT00374803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111310049|NCT00418951|Voriconazole|voriconazole|mesh-list
111310050|NCT00418951|Amphotericin B|amphotericin b|mesh-list
111310051|NCT00418951|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
111310052|NCT00418951|Antifungal Agents|antifungal agents|mesh-ancestor
111310053|NCT00418951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111310054|NCT00418951|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111310055|NCT00418951|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111310056|NCT00418951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111310057|NCT00418951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111310058|NCT00418951|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111310059|NCT00418951|Hormone Antagonists|hormone antagonists|mesh-ancestor
111310060|NCT00418951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111310061|NCT00418951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111310062|NCT00418951|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111310063|NCT00418951|Amebicides|amebicides|mesh-ancestor
111310064|NCT00418951|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111310065|NCT00418951|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111310066|NCT00418951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111310067|NCT00363077|Vaccines|vaccines|mesh-list
111310068|NCT00363077|Immunologic Factors|immunologic factors|mesh-ancestor
111310069|NCT00363077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111310070|NCT00375973|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
111310071|NCT00375973|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111310072|NCT00375973|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111310073|NCT00375973|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111310074|NCT00375973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111310075|NCT00375973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111310076|NCT00375973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111310077|NCT00375973|Analgesics|analgesics|mesh-ancestor
111310078|NCT00375973|Sensory System Agents|sensory system agents|mesh-ancestor
111310079|NCT00375973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111310080|NCT00375973|Antidepressive Agents|antidepressive agents|mesh-ancestor
111310081|NCT00375973|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111310082|NCT00375973|Dopamine Agents|dopamine agents|mesh-ancestor
111310083|NCT00421603|Topiramate|topiramate|mesh-list
111310084|NCT00421603|Adderall|adderall|mesh-list
111310085|NCT00421603|Anticonvulsants|anticonvulsants|mesh-ancestor
111310086|NCT00421603|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111310087|NCT00421603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111310088|NCT00421603|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111310089|NCT00363779|Cyclosporine|cyclosporine|mesh-list
111310090|NCT00363779|Cyclosporins|cyclosporins|mesh-list
111310091|NCT00363779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111310092|NCT00363779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111310093|NCT00363779|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111310094|NCT00363779|Immunologic Factors|immunologic factors|mesh-ancestor
111310095|NCT00363779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111310096|NCT00363779|Antifungal Agents|antifungal agents|mesh-ancestor
111310097|NCT00363779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111310098|NCT00363779|Dermatologic Agents|dermatologic agents|mesh-ancestor
111310099|NCT00363779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111310100|NCT00363779|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111310101|NCT01405820|Natalizumab|natalizumab|mesh-list
111310102|NCT01405820|Immunologic Factors|immunologic factors|mesh-ancestor
111310103|NCT01405820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111310104|NCT01405742|Factor VIII|factor viii|mesh-list
111310105|NCT01405742|Coagulants|coagulants|mesh-ancestor
111310106|NCT01794767|Heparin|heparin|mesh-list
111310107|NCT01794767|Calcium heparin|calcium heparin|mesh-list
111310108|NCT01794767|Anticoagulants|anticoagulants|mesh-ancestor
111310109|NCT01794767|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111310110|NCT01794767|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111310111|NCT01794767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111310112|NCT01425632|Bepotastine besilate|bepotastine besilate|mesh-list
111310113|NCT01425632|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111310114|NCT02076152|Bevacizumab|bevacizumab|mesh-list
111310115|NCT02076152|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111310116|NCT02076152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111310117|NCT02076152|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111310118|NCT02076152|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111310119|NCT02076152|Growth Substances|growth substances|mesh-ancestor
111310120|NCT02076152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111310121|NCT02076152|Growth Inhibitors|growth inhibitors|mesh-ancestor
111310122|NCT03025958|Nimotuzumab|nimotuzumab|mesh-list
111310123|NCT03025958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111310124|NCT03025958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111310125|NCT00380029|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111310126|NCT00380029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111310127|NCT00380029|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111310128|NCT00380029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111310129|NCT00380029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111310130|NCT01405508|Brivaracetam|brivaracetam|mesh-list
111310131|NCT01405508|Anticonvulsants|anticonvulsants|mesh-ancestor
111310132|NCT00426283|Fluticasone|fluticasone|mesh-list
111310133|NCT00426283|Xhance|xhance|mesh-list
111310134|NCT00426283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111310135|NCT00426283|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111310136|NCT00426283|Autonomic Agents|autonomic agents|mesh-ancestor
111310137|NCT00426283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111034578|NCT04791332|Aticaprant|aticaprant|mesh-list
111310138|NCT00426283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111310139|NCT00426283|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111310140|NCT00426283|Respiratory System Agents|respiratory system agents|mesh-ancestor
111310141|NCT00426283|Dermatologic Agents|dermatologic agents|mesh-ancestor
111310142|NCT00426283|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111310143|NCT00322439|Etanercept|etanercept|mesh-list
111310144|NCT00322439|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111310145|NCT00322439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111310146|NCT00322439|Analgesics|analgesics|mesh-ancestor
111310147|NCT00322439|Sensory System Agents|sensory system agents|mesh-ancestor
111310148|NCT00322439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111310149|NCT00322439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111310150|NCT00322439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111310151|NCT00322439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111310152|NCT00322439|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111310153|NCT00322439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111310154|NCT00322439|Immunologic Factors|immunologic factors|mesh-ancestor
111310155|NCT01795027|Oxaliplatin|oxaliplatin|mesh-list
111310156|NCT01795027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111310157|NCT00365261|Eszopiclone|eszopiclone|mesh-list
111310158|NCT00365261|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111310159|NCT00365261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111310160|NCT00365261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111310161|NCT00426517|Sirolimus|sirolimus|mesh-list
111310162|NCT00426517|Busulfan|busulfan|mesh-list
111310163|NCT00426517|Alemtuzumab|alemtuzumab|mesh-list
111310164|NCT00426517|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111310165|NCT00426517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111310166|NCT00426517|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111310167|NCT00426517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111310168|NCT00426517|Antifungal Agents|antifungal agents|mesh-ancestor
111310169|NCT00426517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111310170|NCT00426517|Immunologic Factors|immunologic factors|mesh-ancestor
111310171|NCT00426517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111310172|NCT00426517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111310173|NCT00426517|Alkylating Agents|alkylating agents|mesh-ancestor
111310174|NCT00426517|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111310175|NCT00426517|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111310176|NCT00426517|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111310177|NCT00365417|Cyclophosphamide|cyclophosphamide|mesh-list
111310178|NCT00365417|Bevacizumab|bevacizumab|mesh-list
111310179|NCT00365417|Docetaxel|docetaxel|mesh-list
111310180|NCT00365417|Doxorubicin|doxorubicin|mesh-list
111310181|NCT00365417|Capecitabine|capecitabine|mesh-list
111310182|NCT00365417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111310183|NCT00365417|Immunologic Factors|immunologic factors|mesh-ancestor
111310184|NCT00365417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111310185|NCT00365417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111310186|NCT00365417|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111310187|NCT00365417|Alkylating Agents|alkylating agents|mesh-ancestor
111310188|NCT00365417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111310189|NCT00365417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111310190|NCT00365417|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111310191|NCT00365417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111310192|NCT00365417|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111310193|NCT00365417|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111310194|NCT00365417|Growth Substances|growth substances|mesh-ancestor
111310195|NCT00365417|Growth Inhibitors|growth inhibitors|mesh-ancestor
111310196|NCT00365417|Tubulin Modulators|tubulin modulators|mesh-ancestor
111310197|NCT00365417|Antimitotic Agents|antimitotic agents|mesh-ancestor
111310198|NCT00365417|Mitosis Modulators|mitosis modulators|mesh-ancestor
111310199|NCT00365417|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111310200|NCT00365417|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111310201|NCT00365417|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111310202|NCT00365417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111310203|NCT00365417|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111310204|NCT00365417|Antimetabolites|antimetabolites|mesh-ancestor
111310205|NCT00427297|Ritonavir|ritonavir|mesh-list
111310206|NCT00427297|Lopinavir|lopinavir|mesh-list
111310207|NCT00427297|Tenofovir|tenofovir|mesh-list
111310208|NCT00427297|Lamivudine|lamivudine|mesh-list
111310209|NCT00427297|Zidovudine|zidovudine|mesh-list
111310210|NCT00427297|Nevirapine|nevirapine|mesh-list
111034651|NCT02072486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111310211|NCT00427297|Abacavir|abacavir|mesh-list
111310212|NCT00427297|Stavudine|stavudine|mesh-list
111310213|NCT00427297|Didanosine|didanosine|mesh-list
111310214|NCT00427297|Efavirenz|efavirenz|mesh-list
111310215|NCT00427297|Dideoxynucleosides|dideoxynucleosides|mesh-list
111310216|NCT00427297|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111310217|NCT00427297|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111310218|NCT00427297|Protease Inhibitors|protease inhibitors|mesh-ancestor
111310219|NCT00427297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111310220|NCT00427297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111310221|NCT00427297|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111310222|NCT00427297|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111310223|NCT00427297|Antiviral Agents|antiviral agents|mesh-ancestor
111310224|NCT00427297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111310225|NCT00427297|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111310226|NCT00427297|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111310227|NCT00427297|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111310228|NCT00427297|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111310229|NCT00427297|Antimetabolites|antimetabolites|mesh-ancestor
111310230|NCT00427297|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111310231|NCT00427297|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111310232|NCT00427297|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111310233|NCT00427297|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111310234|NCT00427297|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111310235|NCT00427765|Melphalan|melphalan|mesh-list
111310236|NCT00427765|Busulfan|busulfan|mesh-list
111310237|NCT00427765|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111310238|NCT00427765|Alkylating Agents|alkylating agents|mesh-ancestor
111310239|NCT00427765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111310240|NCT00427765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111310241|NCT00427765|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111310242|NCT00427765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111310243|NCT00427765|Immunologic Factors|immunologic factors|mesh-ancestor
111310244|NCT00427765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111310245|NCT04346017|Complement System Proteins|complement system proteins|mesh-list
111310246|NCT04346017|Immunologic Factors|immunologic factors|mesh-ancestor
111310247|NCT04346017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111310248|NCT00384865|Aspirin|aspirin|mesh-list
111310249|NCT00384865|Simvastatin|simvastatin|mesh-list
111310250|NCT00384865|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111310251|NCT00384865|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111310252|NCT00384865|Analgesics|analgesics|mesh-ancestor
111310253|NCT00384865|Sensory System Agents|sensory system agents|mesh-ancestor
111310254|NCT00384865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111310255|NCT00384865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111310256|NCT00384865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111310257|NCT00384865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111310258|NCT00384865|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111310259|NCT00384865|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111310260|NCT00384865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111310261|NCT00384865|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111310262|NCT00384865|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111310263|NCT00384865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111310264|NCT00384865|Antipyretics|antipyretics|mesh-ancestor
111310265|NCT00384865|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111310266|NCT00384865|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111310267|NCT00384865|Antimetabolites|antimetabolites|mesh-ancestor
111310268|NCT00384865|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111310269|NCT00384865|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111310270|NCT00367601|Bevacizumab|bevacizumab|mesh-list
111310271|NCT00367601|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111310272|NCT00367601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111310273|NCT00367601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111310274|NCT00367601|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111310275|NCT00367601|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111310276|NCT00367601|Growth Substances|growth substances|mesh-ancestor
111310277|NCT00367601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111310278|NCT00367601|Growth Inhibitors|growth inhibitors|mesh-ancestor
111310279|NCT00367601|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111310280|NCT00367601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111310281|NCT00367601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111310282|NCT00385801|Risperidone|risperidone|mesh-list
111310283|NCT00385801|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111310284|NCT00385801|Serotonin Agents|serotonin agents|mesh-ancestor
111310285|NCT00385801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111310286|NCT00385801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111310287|NCT00385801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111034721|NCT02139761|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111310288|NCT00385801|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111310289|NCT00385801|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111310290|NCT00385801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111310291|NCT00385801|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111310292|NCT00385801|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111310293|NCT00385801|Dopamine Agents|dopamine agents|mesh-ancestor
111310294|NCT00429403|Goserelin|goserelin|mesh-list
111310295|NCT00429403|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111310296|NCT00429403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111310297|NCT05286931|Ciprofloxacin|ciprofloxacin|mesh-list
111310298|NCT05286931|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111310299|NCT05286931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111310300|NCT05286931|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111310301|NCT05286931|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111310302|NCT05286931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111310303|NCT05286931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111310304|NCT05286931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111310305|NCT05286931|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111310306|NCT05286931|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111310307|NCT00368459|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
111310308|NCT00368459|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111310309|NCT00368459|Hormone Antagonists|hormone antagonists|mesh-ancestor
111310310|NCT00368459|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111310311|NCT00368459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111310312|NCT00368459|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111310313|NCT00368459|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111310314|NCT00368459|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111310315|NCT00429949|Dasatinib|dasatinib|mesh-list
111310316|NCT00429949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111310317|NCT00429949|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111310318|NCT00429949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111310319|NCT00429949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111310320|NCT02078726|Glucagon|glucagon|mesh-list
111310321|NCT02078726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111310322|NCT02078726|Hormones|hormones|mesh-ancestor
111310323|NCT02078726|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111310324|NCT02078726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111310325|NCT00431041|Solifenacin Succinate|solifenacin succinate|mesh-list
111310326|NCT00431041|Oxybutynin|oxybutynin|mesh-list
111310327|NCT00431041|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111310328|NCT00431041|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111310329|NCT00431041|Cholinergic Agents|cholinergic agents|mesh-ancestor
111310330|NCT00431041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111310331|NCT00431041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111310332|NCT00431041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111310333|NCT00431041|Urological Agents|urological agents|mesh-ancestor
111310334|NCT00431041|Parasympatholytics|parasympatholytics|mesh-ancestor
111310335|NCT00431041|Autonomic Agents|autonomic agents|mesh-ancestor
111310336|NCT00431041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111310337|NCT00390611|Paclitaxel|paclitaxel|mesh-list
111310338|NCT00390611|Carboplatin|carboplatin|mesh-list
111310339|NCT00390611|Sorafenib|sorafenib|mesh-list
111310340|NCT00390611|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111310341|NCT00390611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111310342|NCT00390611|Tubulin Modulators|tubulin modulators|mesh-ancestor
111310343|NCT00390611|Antimitotic Agents|antimitotic agents|mesh-ancestor
111310344|NCT00390611|Mitosis Modulators|mitosis modulators|mesh-ancestor
111310345|NCT00390611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111310346|NCT00390611|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111310347|NCT00390611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111310348|NCT00391079|Nabiximols|nabiximols|mesh-list
111310349|NCT00391079|Analgesics|analgesics|mesh-ancestor
111310350|NCT00391079|Sensory System Agents|sensory system agents|mesh-ancestor
111310351|NCT00391079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111310352|NCT00391079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111310353|NCT00387751|Bevacizumab|bevacizumab|mesh-list
111310354|NCT00387751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111310355|NCT00387751|Sorafenib|sorafenib|mesh-list
111310356|NCT00387751|Endothelial Growth Factors|endothelial growth factors|mesh-list
111310357|NCT00387751|Antibodies|antibodies|mesh-list
111310358|NCT00387751|Immunoglobulins|immunoglobulins|mesh-list
111310359|NCT00387751|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111310360|NCT00387751|Immunoglobulin G|immunoglobulin g|mesh-list
111310361|NCT00387751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111310362|NCT00387751|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111310363|NCT00387751|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111310364|NCT00387751|Growth Substances|growth substances|mesh-ancestor
111310365|NCT00387751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111310366|NCT00387751|Growth Inhibitors|growth inhibitors|mesh-ancestor
111310367|NCT00387751|Immunologic Factors|immunologic factors|mesh-ancestor
111310368|NCT00387751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111310369|NCT00387751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111310370|NCT00387751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111310371|NCT01795235|Atenolol|atenolol|mesh-list
111310372|NCT01795235|Glucagon|glucagon|mesh-list
111310373|NCT01795235|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
111310374|NCT01795235|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111310375|NCT01795235|Hormones|hormones|mesh-ancestor
111310376|NCT01795235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111310377|NCT01795235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111310378|NCT01795235|Incretins|incretins|mesh-ancestor
111310379|NCT01795235|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111310380|NCT01795235|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111310381|NCT01795235|Sympatholytics|sympatholytics|mesh-ancestor
111310382|NCT01795235|Autonomic Agents|autonomic agents|mesh-ancestor
111310383|NCT01795235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111310384|NCT01795235|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
111310385|NCT01795235|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111310386|NCT01795235|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111310387|NCT01795235|Adrenergic Agents|adrenergic agents|mesh-ancestor
111310388|NCT01795235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111310389|NCT01795235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111310390|NCT00387829|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
111310391|NCT00387829|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
111310392|NCT00387829|Estradiol|estradiol|mesh-list
111310393|NCT00387829|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
111310394|NCT00387829|Estrogens|estrogens|mesh-ancestor
111310395|NCT00387829|Hormones|hormones|mesh-ancestor
111310396|NCT00387829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111310397|NCT00387829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111310398|NCT00387829|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111310399|NCT00387829|Contraceptive Agents|contraceptive agents|mesh-ancestor
111310400|NCT00387829|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111310401|NCT00387829|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111310402|NCT01512407|Ethiodized Oil|ethiodized oil|mesh-list
111310403|NCT01512407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111310404|NCT00392951|Sirolimus|sirolimus|mesh-list
111310405|NCT00392951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111310406|NCT00392951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111310407|NCT00392951|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111310408|NCT00392951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111310409|NCT00392951|Antifungal Agents|antifungal agents|mesh-ancestor
111310410|NCT00392951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111310411|NCT00392951|Immunologic Factors|immunologic factors|mesh-ancestor
111310412|NCT00392951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111310413|NCT01424930|Prednisone|prednisone|mesh-list
111310414|NCT01424930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111310415|NCT01424930|Glucocorticoids|glucocorticoids|mesh-ancestor
111310416|NCT01424930|Hormones|hormones|mesh-ancestor
111310417|NCT01424930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111310418|NCT01424930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111310419|NCT01424930|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111310420|NCT01424930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111310421|NCT00389857|Vaccines|vaccines|mesh-list
111310422|NCT00389857|Immunologic Factors|immunologic factors|mesh-ancestor
111310423|NCT00389857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111310424|NCT01795183|Amisulpride|amisulpride|mesh-list
111310425|NCT01795183|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111310426|NCT01795183|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111310427|NCT01795183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111310428|NCT01795183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111310429|NCT01795183|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111310430|NCT01795183|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111310431|NCT01795183|Dopamine Agents|dopamine agents|mesh-ancestor
111310432|NCT01795183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111310433|NCT01795183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111310434|NCT01795183|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111310435|NCT01795183|Antidepressive Agents|antidepressive agents|mesh-ancestor
111310436|NCT01424228|Prucalopride|prucalopride|mesh-list
111310437|NCT01424228|Laxatives|laxatives|mesh-ancestor
111310438|NCT01424228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111310439|NCT01424228|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
111310440|NCT01424228|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111310441|NCT01424228|Serotonin Agents|serotonin agents|mesh-ancestor
111310442|NCT01424228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111310443|NCT01424228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111310444|NCT01424228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111310445|NCT03562975|Ocrelizumab|ocrelizumab|mesh-list
111310446|NCT03562975|Immunologic Factors|immunologic factors|mesh-ancestor
111310447|NCT03562975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111310448|NCT04750603|Fluticasone|fluticasone|mesh-list
111310449|NCT04750603|Xhance|xhance|mesh-list
111310450|NCT04750603|Albuterol|albuterol|mesh-list
111310451|NCT04750603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111310452|NCT04750603|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111310453|NCT04750603|Autonomic Agents|autonomic agents|mesh-ancestor
111310454|NCT04750603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111310455|NCT04750603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111310456|NCT04750603|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111310457|NCT04750603|Respiratory System Agents|respiratory system agents|mesh-ancestor
111310458|NCT04750603|Dermatologic Agents|dermatologic agents|mesh-ancestor
111310459|NCT04750603|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111310460|NCT04750603|Tocolytic Agents|tocolytic agents|mesh-ancestor
111310461|NCT04750603|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111310462|NCT04750603|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111310463|NCT04750603|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111310464|NCT04750603|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111310465|NCT04750603|Adrenergic Agents|adrenergic agents|mesh-ancestor
111310466|NCT04750603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111310467|NCT04750603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111310468|NCT01423916|Moxifloxacin|moxifloxacin|mesh-list
111310469|NCT01423916|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111310470|NCT01423916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111310471|NCT01423916|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111310472|NCT01423916|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111310473|NCT01423916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111310474|NCT01423916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111310475|NCT01423916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111310476|NCT00436969|Hyaluronic Acid|hyaluronic acid|mesh-list
111310477|NCT00436969|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111310478|NCT00436969|Immunologic Factors|immunologic factors|mesh-ancestor
111310479|NCT00436969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111310480|NCT00436969|Viscosupplements|viscosupplements|mesh-ancestor
111310481|NCT00436969|Protective Agents|protective agents|mesh-ancestor
111310482|NCT00455689|Leuprolide|leuprolide|mesh-list
111310483|NCT00455689|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111310484|NCT00455689|Fertility Agents|fertility agents|mesh-ancestor
111310485|NCT00455689|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111310486|NCT00455689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111310487|NCT00455689|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111310488|NCT00455689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111310489|NCT00394277|Ribavirin|ribavirin|mesh-list
111310490|NCT00394277|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
111310491|NCT00394277|Interferon-alpha|interferon-alpha|mesh-list
111310492|NCT00394277|Antimetabolites|antimetabolites|mesh-ancestor
111310493|NCT00394277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111310494|NCT00394277|Antiviral Agents|antiviral agents|mesh-ancestor
111310495|NCT00394277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111310496|NCT00394277|Immunologic Factors|immunologic factors|mesh-ancestor
111310497|NCT00394277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111310498|NCT00395057|Ranibizumab|ranibizumab|mesh-list
111310499|NCT00395057|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111310500|NCT00395057|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111310501|NCT00395057|Growth Substances|growth substances|mesh-ancestor
111310502|NCT00395057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111310503|NCT00395057|Growth Inhibitors|growth inhibitors|mesh-ancestor
111310504|NCT00395057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111310505|NCT00438451|Lamotrigine|lamotrigine|mesh-list
111310506|NCT00438451|Carbamazepine|carbamazepine|mesh-list
111310507|NCT00438451|Levetiracetam|levetiracetam|mesh-list
111310508|NCT00438451|Anticonvulsants|anticonvulsants|mesh-ancestor
111310509|NCT00438451|Nootropic Agents|nootropic agents|mesh-ancestor
111310510|NCT00438451|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111310511|NCT00438451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111310512|NCT00438451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111310513|NCT00438451|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111310514|NCT00438451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111310515|NCT00438451|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111310516|NCT00438451|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111310517|NCT00438451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111310518|NCT00438451|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111310519|NCT00438451|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111310520|NCT00438451|Antimanic Agents|antimanic agents|mesh-ancestor
111310521|NCT00438451|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111310522|NCT00438451|Analgesics|analgesics|mesh-ancestor
111310523|NCT00438451|Sensory System Agents|sensory system agents|mesh-ancestor
111310524|NCT00438451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111310525|NCT00438451|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111310526|NCT00438451|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111310527|NCT00456625|Vaccines|vaccines|mesh-list
111310528|NCT00456625|Immunologic Factors|immunologic factors|mesh-ancestor
111310529|NCT00456625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111310530|NCT00457795|Brimonidine Tartrate|brimonidine tartrate|mesh-list
111310531|NCT00457795|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111310532|NCT00457795|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111310533|NCT00457795|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111310534|NCT00457795|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111310535|NCT00457795|Adrenergic Agents|adrenergic agents|mesh-ancestor
111310536|NCT00457795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111310537|NCT00457795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111310538|NCT00457795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111310539|NCT04749979|Triptorelin Pamoate|triptorelin pamoate|mesh-list
111310540|NCT04749979|Luteolytic Agents|luteolytic agents|mesh-ancestor
111310541|NCT04749979|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111310542|NCT04749979|Contraceptive Agents|contraceptive agents|mesh-ancestor
111310543|NCT04749979|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111310544|NCT04749979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111310545|NCT04749979|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111310546|NCT04749979|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111310547|NCT04749979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111310548|NCT01423604|Capecitabine|capecitabine|mesh-list
111310549|NCT01423604|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111310550|NCT01423604|Antimetabolites|antimetabolites|mesh-ancestor
111310551|NCT01423604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111310552|NCT01423604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111310553|NCT01402544|Ranibizumab|ranibizumab|mesh-list
111310554|NCT01402544|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111310555|NCT01402544|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111310556|NCT01402544|Growth Substances|growth substances|mesh-ancestor
111310557|NCT01402544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111310558|NCT01402544|Growth Inhibitors|growth inhibitors|mesh-ancestor
110980038|NCT03232034|Calcium|calcium|mesh-list
111310559|NCT01402544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111310560|NCT00460993|Eszopiclone|eszopiclone|mesh-list
111310561|NCT00460993|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111310562|NCT00460993|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111310563|NCT00460993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111310564|NCT00441883|Latanoprost|latanoprost|mesh-list
111310565|NCT00441883|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
111310566|NCT00441883|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111310567|NCT00461773|Bevacizumab|bevacizumab|mesh-list
111310568|NCT00461773|Letrozole|letrozole|mesh-list
111310569|NCT00461773|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111310570|NCT00461773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111310571|NCT00461773|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111310572|NCT00461773|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111310573|NCT00461773|Growth Substances|growth substances|mesh-ancestor
111310574|NCT00461773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111310575|NCT00461773|Growth Inhibitors|growth inhibitors|mesh-ancestor
111310576|NCT00461773|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111310577|NCT00461773|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111310578|NCT00461773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111310579|NCT00461773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111310580|NCT00461773|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111310581|NCT00461773|Hormone Antagonists|hormone antagonists|mesh-ancestor
111310582|NCT00461773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111310583|NCT00461851|Carboplatin|carboplatin|mesh-list
111310584|NCT00461851|Gemcitabine|gemcitabine|mesh-list
111310585|NCT00461851|Sorafenib|sorafenib|mesh-list
111310586|NCT00461851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111310587|NCT00461851|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111310588|NCT00461851|Antimetabolites|antimetabolites|mesh-ancestor
111310589|NCT00461851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111310590|NCT00461851|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111310591|NCT00461851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111310592|NCT00442507|Bevacizumab|bevacizumab|mesh-list
111310593|NCT00442507|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111310594|NCT00442507|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111310595|NCT00442507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111310596|NCT00442507|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111310597|NCT00442507|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111310598|NCT00442507|Growth Substances|growth substances|mesh-ancestor
111310599|NCT00442507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111310600|NCT00442507|Growth Inhibitors|growth inhibitors|mesh-ancestor
111310601|NCT00442507|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111310602|NCT00442507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111310603|NCT00442507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111310604|NCT01401530|Denileukin diftitox|denileukin diftitox|mesh-list
111310605|NCT01401530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111310606|NCT01387022|Tenofovir|tenofovir|mesh-list
111310607|NCT01387022|Lamivudine|lamivudine|mesh-list
111310608|NCT01387022|Efavirenz|efavirenz|mesh-list
111310609|NCT01387022|Antiviral Agents|antiviral agents|mesh-ancestor
111310610|NCT01387022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111310611|NCT01387022|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111310612|NCT01387022|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111310613|NCT01387022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111310614|NCT01387022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111310615|NCT01387022|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111310616|NCT01387022|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111310617|NCT01387022|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111310618|NCT01387022|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111310619|NCT01387022|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111310620|NCT01387022|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111310621|NCT01387022|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111310622|NCT01387022|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111310623|NCT00374231|Mycophenolic Acid|mycophenolic acid|mesh-list
111310624|NCT00374231|Prednisone|prednisone|mesh-list
111310625|NCT00374231|Tacrolimus|tacrolimus|mesh-list
111310626|NCT00374231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111310627|NCT00374231|Glucocorticoids|glucocorticoids|mesh-ancestor
111310628|NCT00374231|Hormones|hormones|mesh-ancestor
111310629|NCT00374231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110980041|NCT03225950|Antibodies|antibodies|mesh-list
111310630|NCT00374231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111310631|NCT00374231|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111310632|NCT00374231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111310633|NCT00374231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111310634|NCT00374231|Immunologic Factors|immunologic factors|mesh-ancestor
111310635|NCT00374231|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111310636|NCT00374231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111310637|NCT00374231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111310638|NCT00374231|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111310639|NCT00374231|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111310640|NCT00374231|Antitubercular Agents|antitubercular agents|mesh-ancestor
111310641|NCT00374231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111310642|NCT00374231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111310643|NCT00400205|Docetaxel|docetaxel|mesh-list
111310644|NCT00400205|Fluorouracil|fluorouracil|mesh-list
111310645|NCT00400205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111310646|NCT00400205|Tubulin Modulators|tubulin modulators|mesh-ancestor
111310647|NCT00400205|Antimitotic Agents|antimitotic agents|mesh-ancestor
111310648|NCT00400205|Mitosis Modulators|mitosis modulators|mesh-ancestor
111310649|NCT00400205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111310650|NCT00400205|Antimetabolites|antimetabolites|mesh-ancestor
111310651|NCT00400205|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111310652|NCT00400205|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111310653|NCT00400205|Immunologic Factors|immunologic factors|mesh-ancestor
111310654|NCT00400205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111310655|NCT01386554|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
111310656|NCT01386554|Hormones|hormones|mesh-ancestor
111310657|NCT01386554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111310658|NCT01386554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111310659|NCT00400439|Dalcetrapib|dalcetrapib|mesh-list
111310660|NCT00400439|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111035100|NCT05556122|Betamethasone|betamethasone|mesh-list
111310661|NCT00400439|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111310662|NCT00400439|Antimetabolites|antimetabolites|mesh-ancestor
111310663|NCT00400439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111310664|NCT00400439|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111310665|NCT00448201|Methotrexate|methotrexate|mesh-list
111310666|NCT00448201|Fludarabine phosphate|fludarabine phosphate|mesh-list
111310667|NCT00448201|Fludarabine|fludarabine|mesh-list
111310668|NCT00448201|Busulfan|busulfan|mesh-list
111310669|NCT00448201|Tacrolimus|tacrolimus|mesh-list
111310670|NCT00448201|Antilymphocyte Serum|antilymphocyte serum|mesh-list
111310671|NCT00448201|Sargramostim|sargramostim|mesh-list
111310672|NCT00448201|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111310673|NCT00448201|Abortifacient Agents|abortifacient agents|mesh-ancestor
111310674|NCT00448201|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111310675|NCT00448201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111310676|NCT00448201|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111310677|NCT00448201|Antimetabolites|antimetabolites|mesh-ancestor
111310678|NCT00448201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111310679|NCT00448201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111310680|NCT00448201|Dermatologic Agents|dermatologic agents|mesh-ancestor
111310681|NCT00448201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111310682|NCT00448201|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111310683|NCT00448201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111310684|NCT00448201|Immunologic Factors|immunologic factors|mesh-ancestor
111310685|NCT00448201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111310686|NCT00448201|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111310687|NCT00448201|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111310688|NCT00448201|Alkylating Agents|alkylating agents|mesh-ancestor
111310689|NCT00448201|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111310690|NCT00448201|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111310691|NCT05287607|Bilirubin|bilirubin|mesh-list
111310692|NCT05287607|Antioxidants|antioxidants|mesh-ancestor
111310693|NCT05287607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111310694|NCT05287607|Protective Agents|protective agents|mesh-ancestor
111310695|NCT05287607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111310696|NCT00375713|Cetirizine|cetirizine|mesh-list
111310697|NCT00375713|Hydrocortisone|hydrocortisone|mesh-list
111310698|NCT00375713|Levocetirizine|levocetirizine|mesh-list
111310699|NCT00375713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111310700|NCT00375713|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110980042|NCT03225950|Immunologic Factors|immunologic factors|mesh-ancestor
111310701|NCT00375713|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
111310702|NCT00375713|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111310703|NCT00375713|Histamine Antagonists|histamine antagonists|mesh-ancestor
111310704|NCT00375713|Histamine Agents|histamine agents|mesh-ancestor
111310705|NCT00375713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111310706|NCT00375713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111310707|NCT00375713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111310708|NCT00465595|Psilocybin|psilocybin|mesh-list
111310709|NCT00465595|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
111310710|NCT00465595|Hallucinogens|hallucinogens|mesh-ancestor
111310711|NCT00465595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111310712|NCT00465595|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111310713|NCT00465595|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111310714|NCT00465595|Serotonin Agents|serotonin agents|mesh-ancestor
111310715|NCT00465595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111310716|NCT00465595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111310717|NCT00465595|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111310718|NCT00376805|Cyclophosphamide|cyclophosphamide|mesh-list
111310719|NCT00376805|Fludarabine|fludarabine|mesh-list
111310720|NCT00376805|Interleukin-2|interleukin-2|mesh-list
111310721|NCT00376805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111310722|NCT00376805|Immunologic Factors|immunologic factors|mesh-ancestor
111310723|NCT00376805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111310724|NCT00376805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111310725|NCT00376805|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111310726|NCT00376805|Alkylating Agents|alkylating agents|mesh-ancestor
111310727|NCT00376805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111310728|NCT00376805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111310729|NCT00376805|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111310730|NCT00376805|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111310731|NCT00376805|Analgesics|analgesics|mesh-ancestor
111310732|NCT00376805|Sensory System Agents|sensory system agents|mesh-ancestor
111310733|NCT00376805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111310734|NCT00448357|Methotrexate|methotrexate|mesh-list
111310735|NCT00448357|Fludarabine phosphate|fludarabine phosphate|mesh-list
111310736|NCT00448357|Fludarabine|fludarabine|mesh-list
111310737|NCT00448357|Busulfan|busulfan|mesh-list
111310738|NCT00448357|Tacrolimus|tacrolimus|mesh-list
111310739|NCT00448357|Antilymphocyte Serum|antilymphocyte serum|mesh-list
111310740|NCT00448357|Thymoglobulin|thymoglobulin|mesh-list
111310741|NCT00448357|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111310742|NCT00448357|Abortifacient Agents|abortifacient agents|mesh-ancestor
111310743|NCT00448357|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111310744|NCT00448357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111310745|NCT00448357|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111310746|NCT00448357|Antimetabolites|antimetabolites|mesh-ancestor
111310747|NCT00448357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111310748|NCT00448357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111310749|NCT00448357|Dermatologic Agents|dermatologic agents|mesh-ancestor
111310750|NCT00448357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111310751|NCT00448357|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111310752|NCT00448357|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111310753|NCT00448357|Immunologic Factors|immunologic factors|mesh-ancestor
111310754|NCT00448357|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111310755|NCT00448357|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111310756|NCT00448357|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111310757|NCT00448357|Alkylating Agents|alkylating agents|mesh-ancestor
111310758|NCT00448357|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111310759|NCT00448357|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111310760|NCT00450073|Vitamin D|vitamin d|mesh-list
111310761|NCT00450073|Ergocalciferols|ergocalciferols|mesh-list
111310762|NCT00450073|Cholecalciferol|cholecalciferol|mesh-list
111310763|NCT00450073|Vitamins|vitamins|mesh-list
111310764|NCT00450073|Micronutrients|micronutrients|mesh-ancestor
111310765|NCT00450073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111310766|NCT00450073|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111310767|NCT00450073|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111310768|NCT00467077|Interferons|interferons|mesh-list
111310769|NCT00467077|Interferon-alpha|interferon-alpha|mesh-list
111310770|NCT00467077|Interferon alpha-2|interferon alpha-2|mesh-list
111310771|NCT00467077|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
111310772|NCT00467077|Gefitinib|gefitinib|mesh-list
111310773|NCT00467077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111310774|NCT00467077|Antiviral Agents|antiviral agents|mesh-ancestor
111310775|NCT00467077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111310776|NCT00467077|Immunologic Factors|immunologic factors|mesh-ancestor
111310777|NCT00467077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111310778|NCT00467077|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111310779|NCT00467077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111310780|NCT00467077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111310781|NCT00467389|Donepezil|donepezil|mesh-list
111310782|NCT00467389|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111310783|NCT00467389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111310784|NCT00467389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111310785|NCT00467389|Cholinergic Agents|cholinergic agents|mesh-ancestor
111310786|NCT00467389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111310787|NCT00467389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111310788|NCT00467389|Nootropic Agents|nootropic agents|mesh-ancestor
111310789|NCT00377741|Valganciclovir|valganciclovir|mesh-list
111310790|NCT00377741|Antiviral Agents|antiviral agents|mesh-ancestor
111310791|NCT00377741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111310792|NCT00379145|Trabectedin|trabectedin|mesh-list
111310793|NCT00379145|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111310794|NCT00379145|Alkylating Agents|alkylating agents|mesh-ancestor
111310795|NCT00379145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111310796|NCT00379145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111310797|NCT00382031|Zalutumumab|zalutumumab|mesh-list
111310798|NCT00382031|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111310799|NCT00382031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111310800|NCT00382031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111310801|NCT00382031|Immunologic Factors|immunologic factors|mesh-ancestor
111310802|NCT00382031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111310803|NCT00382265|Tamsulosin|tamsulosin|mesh-list
111310804|NCT00382265|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111310805|NCT00382265|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111310806|NCT00382265|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111310807|NCT00382265|Adrenergic Agents|adrenergic agents|mesh-ancestor
111310808|NCT00382265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111310809|NCT00382265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111310810|NCT00382265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111310811|NCT00382265|Urological Agents|urological agents|mesh-ancestor
111310812|NCT00383747|Nicotine|nicotine|mesh-list
111310814|NCT00383747|Autonomic Agents|autonomic agents|mesh-ancestor
111310815|NCT00383747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111310816|NCT00383747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111310817|NCT00383747|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111310818|NCT00383747|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111310819|NCT00383747|Cholinergic Agents|cholinergic agents|mesh-ancestor
111310820|NCT00383747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111310821|NCT00383747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111310822|NCT01421342|Aripiprazole|aripiprazole|mesh-list
111310823|NCT01421342|Bupropion|bupropion|mesh-list
111310824|NCT01421342|Antidepressive Agents|antidepressive agents|mesh-list
111310825|NCT01421342|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111310826|NCT01421342|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111310827|NCT01421342|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111310828|NCT01421342|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111310829|NCT01421342|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111310830|NCT01421342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111310831|NCT01421342|Dopamine Agents|dopamine agents|mesh-ancestor
111310832|NCT01421342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111310833|NCT01421342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111310834|NCT01421342|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111310835|NCT01421342|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111310836|NCT01421342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111310837|NCT01421342|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111310838|NCT01421342|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111310839|NCT01421342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111310840|NCT01421342|Dopamine Agonists|dopamine agonists|mesh-ancestor
111310841|NCT01421342|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111310842|NCT01421342|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111310843|NCT01421342|Serotonin Agents|serotonin agents|mesh-ancestor
111310844|NCT01421342|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111310845|NCT01421342|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111310846|NCT01421342|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111310847|NCT01421342|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111310848|NCT00403403|Bevacizumab|bevacizumab|mesh-list
111310849|NCT00403403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111310850|NCT00403403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111310851|NCT00403403|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111310852|NCT00403403|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111310853|NCT00403403|Growth Substances|growth substances|mesh-ancestor
111310854|NCT00403403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111310855|NCT00403403|Growth Inhibitors|growth inhibitors|mesh-ancestor
111310856|NCT00405353|Methyltestosterone|methyltestosterone|mesh-list
111310857|NCT00405353|Testosterone|testosterone|mesh-list
111310858|NCT00405353|Testosterone undecanoate|testosterone undecanoate|mesh-list
111310859|NCT00405353|Testosterone enanthate|testosterone enanthate|mesh-list
111310860|NCT00405353|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
111310861|NCT00405353|Androgens|androgens|mesh-ancestor
111310862|NCT00405353|Hormones|hormones|mesh-ancestor
111310863|NCT00405353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111310864|NCT00405353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111310865|NCT00405353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111310866|NCT00405353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111310867|NCT00405353|Anabolic Agents|anabolic agents|mesh-ancestor
111310868|NCT01384292|Naloxegol|naloxegol|mesh-list
111310869|NCT01384292|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111310870|NCT01384292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111310871|NCT01384292|Sensory System Agents|sensory system agents|mesh-ancestor
111310872|NCT01384292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111310873|NCT00450463|Metronidazole|metronidazole|mesh-list
111310874|NCT00450463|Molgramostim|molgramostim|mesh-list
111310875|NCT00450463|Flutamide|flutamide|mesh-list
111310876|NCT00450463|Sargramostim|sargramostim|mesh-list
111310877|NCT00450463|Immunologic Factors|immunologic factors|mesh-ancestor
111310878|NCT00450463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111310879|NCT00450463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111310880|NCT00450463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111310881|NCT00450463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111310882|NCT00450463|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111310883|NCT00450463|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111310884|NCT00450463|Androgen Antagonists|androgen antagonists|mesh-ancestor
111310885|NCT00450463|Hormone Antagonists|hormone antagonists|mesh-ancestor
111035328|NCT02160301|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111310886|NCT00450463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111310887|NCT00450463|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111310889|NCT00407381|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111310890|NCT00407381|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111310891|NCT00407381|Growth Substances|growth substances|mesh-ancestor
111310892|NCT00407381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111310893|NCT00407381|Growth Inhibitors|growth inhibitors|mesh-ancestor
111310894|NCT00407381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111310895|NCT00384449|Ranibizumab|ranibizumab|mesh-list
111310896|NCT00384449|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111310897|NCT00384449|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111310898|NCT00384449|Growth Substances|growth substances|mesh-ancestor
111310899|NCT00384449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111310900|NCT00384449|Growth Inhibitors|growth inhibitors|mesh-ancestor
111310901|NCT00384449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111310902|NCT00452335|Lubiprostone|lubiprostone|mesh-list
111310903|NCT00452335|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
111310904|NCT00452335|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111310905|NCT00452335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111310906|NCT00386243|Analgesics, Opioid|analgesics, opioid|mesh-list
111310907|NCT00386243|Analgesics|analgesics|mesh-list
111310908|NCT00386243|Narcotics|narcotics|mesh-ancestor
111310909|NCT00386243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111310910|NCT00386243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111310911|NCT00386243|Sensory System Agents|sensory system agents|mesh-ancestor
111310912|NCT00386243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111310913|NCT01400516|Vitamin D|vitamin d|mesh-list
111310914|NCT01400516|Teriparatide|teriparatide|mesh-list
111310915|NCT01400516|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
111310916|NCT01400516|Calcium|calcium|mesh-list
111310917|NCT01400516|Vitamins|vitamins|mesh-ancestor
111310918|NCT01400516|Micronutrients|micronutrients|mesh-ancestor
111310919|NCT01400516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111310920|NCT01400516|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111310921|NCT01400516|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111310922|NCT01400516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111310923|NCT01383356|Metformin|metformin|mesh-list
111310924|NCT01383356|Linagliptin|linagliptin|mesh-list
111310925|NCT01383356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111310926|NCT01383356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111310927|NCT01383356|Incretins|incretins|mesh-ancestor
111310928|NCT01383356|Hormones|hormones|mesh-ancestor
111310929|NCT01383356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111310930|NCT01383356|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111310931|NCT01383356|Protease Inhibitors|protease inhibitors|mesh-ancestor
111310932|NCT01383356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111310933|NCT01383356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111310934|NCT02111447|Propofol|propofol|mesh-list
111310935|NCT02111447|Sevoflurane|sevoflurane|mesh-list
111310936|NCT02111447|Isoflurane|isoflurane|mesh-list
111310937|NCT02111447|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111310938|NCT02111447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111310939|NCT02111447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111310940|NCT02111447|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111310941|NCT02111447|Anesthetics, General|anesthetics, general|mesh-ancestor
111310942|NCT02111447|Anesthetics|anesthetics|mesh-ancestor
111310943|NCT02111447|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111310944|NCT02111447|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111310945|NCT05966454|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111310946|NCT05966454|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
111310947|NCT05966454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111310948|NCT05966454|Antitubercular Agents|antitubercular agents|mesh-ancestor
111310949|NCT05966441|Curcumin|curcumin|mesh-list
111310950|NCT05966441|Paclitaxel|paclitaxel|mesh-list
111310951|NCT05966441|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111310952|NCT05966441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111310953|NCT05966441|Tubulin Modulators|tubulin modulators|mesh-ancestor
111310954|NCT05966441|Antimitotic Agents|antimitotic agents|mesh-ancestor
111310955|NCT05966441|Mitosis Modulators|mitosis modulators|mesh-ancestor
111310956|NCT05966441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111310957|NCT05966441|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111310958|NCT05966441|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111310959|NCT05966441|Analgesics|analgesics|mesh-ancestor
111310960|NCT05966441|Sensory System Agents|sensory system agents|mesh-ancestor
111310961|NCT05966441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111310962|NCT05966441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111310963|NCT05966441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111310964|NCT05966441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111310965|NCT05966441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111310966|NCT05966064|Denosumab|denosumab|mesh-list
111310967|NCT05966064|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111310968|NCT05966064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111310969|NCT05966012|Tranexamic Acid|tranexamic acid|mesh-list
111310970|NCT05966012|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111310971|NCT05966012|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111310972|NCT05966012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111310973|NCT05966012|Hemostatics|hemostatics|mesh-ancestor
111310974|NCT05966012|Coagulants|coagulants|mesh-ancestor
111310975|NCT05965934|Dapagliflozin|dapagliflozin|mesh-list
111310976|NCT05965934|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
111310977|NCT05965934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111310978|NCT05965934|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111310979|NCT05965934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111310980|NCT05965531|Trifluridine|trifluridine|mesh-list
111310981|NCT05965531|Antimetabolites|antimetabolites|mesh-ancestor
111310982|NCT05965531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111310983|NCT05965531|Antiviral Agents|antiviral agents|mesh-ancestor
111310984|NCT05965531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111310985|NCT05965479|Trastuzumab|trastuzumab|mesh-list
111310986|NCT05965479|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
111310987|NCT05965479|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111310988|NCT05965479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111310989|NCT05965479|Immunoconjugates|immunoconjugates|mesh-ancestor
111310990|NCT05965479|Immunologic Factors|immunologic factors|mesh-ancestor
111310991|NCT05965479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111310992|NCT05965388|Interferons|interferons|mesh-list
111310993|NCT05965388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111310994|NCT05965388|Antiviral Agents|antiviral agents|mesh-ancestor
111310995|NCT05965388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111310996|NCT05965284|Azathioprine|azathioprine|mesh-list
111310997|NCT05965284|Antimetabolites|antimetabolites|mesh-ancestor
111310998|NCT05965284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111310999|NCT05965284|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111311000|NCT05965284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111311001|NCT05965284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111311002|NCT05965284|Immunologic Factors|immunologic factors|mesh-ancestor
111311003|NCT05965284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111311004|NCT05965284|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111311005|NCT05965167|Teriparatide|teriparatide|mesh-list
111311006|NCT05965167|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111311007|NCT05965167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111311008|NCT05965167|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111311009|NCT05965154|Bevacizumab|bevacizumab|mesh-list
111311010|NCT05965154|Capecitabine|capecitabine|mesh-list
111311011|NCT05965154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111311012|NCT05965154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111311013|NCT05965154|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111311014|NCT05965154|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111311015|NCT05965154|Growth Substances|growth substances|mesh-ancestor
111311016|NCT05965154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111311017|NCT05965154|Growth Inhibitors|growth inhibitors|mesh-ancestor
111311018|NCT05965154|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111311019|NCT05965154|Antimetabolites|antimetabolites|mesh-ancestor
111311020|NCT05965154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111311021|NCT05965141|Bevacizumab|bevacizumab|mesh-list
111311022|NCT05965141|Carboplatin|carboplatin|mesh-list
111311023|NCT05965141|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111311024|NCT05965141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111311025|NCT05965141|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111311026|NCT05965141|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111311027|NCT05965141|Growth Substances|growth substances|mesh-ancestor
111311028|NCT05965141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111311029|NCT05965141|Growth Inhibitors|growth inhibitors|mesh-ancestor
111311030|NCT05965076|Glycine|glycine|mesh-list
111311031|NCT05965076|Glycine Agents|glycine agents|mesh-ancestor
111311032|NCT05965076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111311033|NCT05965076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111311034|NCT05965076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111311035|NCT05964985|Lidocaine|lidocaine|mesh-list
111311036|NCT05964985|Ropivacaine|ropivacaine|mesh-list
111311037|NCT05964985|Esketamine|esketamine|mesh-list
111311038|NCT05964985|Anesthetics, Local|anesthetics, local|mesh-ancestor
111311039|NCT05964985|Anesthetics|anesthetics|mesh-ancestor
111311040|NCT05964985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111311041|NCT05964985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111311042|NCT05964985|Sensory System Agents|sensory system agents|mesh-ancestor
111311043|NCT05964985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111311044|NCT05964985|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111311045|NCT05964985|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111311046|NCT05964985|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111311047|NCT05964985|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111311048|NCT05964985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111311049|NCT05964985|Antidepressive Agents|antidepressive agents|mesh-ancestor
111311050|NCT05964985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111311051|NCT05964920|Methyltestosterone|methyltestosterone|mesh-list
111311052|NCT05964920|Testosterone|testosterone|mesh-list
111311053|NCT05964920|Testosterone undecanoate|testosterone undecanoate|mesh-list
111311054|NCT05964920|Testosterone enanthate|testosterone enanthate|mesh-list
111311055|NCT05964920|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
111311056|NCT05964920|Androgens|androgens|mesh-ancestor
111311057|NCT05964920|Hormones|hormones|mesh-ancestor
111311058|NCT05964920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111311059|NCT05964920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111311060|NCT05964920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111311061|NCT05964920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111311062|NCT05964920|Anabolic Agents|anabolic agents|mesh-ancestor
111311063|NCT05964738|Diuretics|diuretics|mesh-list
111311064|NCT05964738|Natriuretic Agents|natriuretic agents|mesh-ancestor
111311065|NCT05964738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111311066|NCT05964686|Edetic Acid|edetic acid|mesh-list
111311067|NCT05964686|Pentetic Acid|pentetic acid|mesh-list
111311068|NCT05964686|Anticoagulants|anticoagulants|mesh-ancestor
111311069|NCT05964686|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
111311070|NCT05964686|Chelating Agents|chelating agents|mesh-ancestor
111311071|NCT05964686|Sequestering Agents|sequestering agents|mesh-ancestor
111311072|NCT05964686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111311073|NCT05964686|Antidotes|antidotes|mesh-ancestor
111311074|NCT05964686|Protective Agents|protective agents|mesh-ancestor
111311075|NCT05964686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111311076|NCT05964686|Iron Chelating Agents|iron chelating agents|mesh-ancestor
111311077|NCT05964543|Capecitabine|capecitabine|mesh-list
111311078|NCT05964543|Oxaliplatin|oxaliplatin|mesh-list
111311079|NCT05964543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111311080|NCT05964543|Antimetabolites|antimetabolites|mesh-ancestor
111311081|NCT05964543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111311082|NCT05964543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111311083|NCT05961644|Cladribine|cladribine|mesh-list
111311084|NCT05961644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111311085|NCT05961644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111311086|NCT05961644|Immunologic Factors|immunologic factors|mesh-ancestor
111311087|NCT05961644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111311088|NCT05961059|Detox adjuvant|detox adjuvant|mesh-list
111311089|NCT05961059|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111311090|NCT05961059|Immunologic Factors|immunologic factors|mesh-ancestor
111311091|NCT05961059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111311092|NCT05939245|Furosemide|furosemide|mesh-list
111311093|NCT05939245|Diuretics|diuretics|mesh-ancestor
111311094|NCT05939245|Natriuretic Agents|natriuretic agents|mesh-ancestor
111311095|NCT05939245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111311096|NCT05939245|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
111311097|NCT05939245|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111311098|NCT05939245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111311099|NCT05899933|Erythritol|erythritol|mesh-list
111311100|NCT05899933|Vasodilator Agents|vasodilator agents|mesh-ancestor
111311101|NCT05870579|Fulvestrant|fulvestrant|mesh-list
111311102|NCT05870579|Goserelin|goserelin|mesh-list
111311103|NCT05870579|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111311104|NCT05870579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111311105|NCT05870579|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
111311106|NCT05870579|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111311107|NCT05870579|Hormone Antagonists|hormone antagonists|mesh-ancestor
111311108|NCT05870579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111311109|NCT05870579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111311110|NCT05838768|Irinotecan|irinotecan|mesh-list
111311111|NCT05838768|Tislelizumab|tislelizumab|mesh-list
111311112|NCT05838768|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111311113|NCT05838768|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111311114|NCT05838768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111311115|NCT05838768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111311116|NCT05838768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111311117|NCT05838768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111311118|NCT05783921|Paclitaxel|paclitaxel|mesh-list
111311119|NCT05783921|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111311120|NCT05783921|Cisplatin|cisplatin|mesh-list
111311121|NCT05783921|Carboplatin|carboplatin|mesh-list
111311122|NCT05783921|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111311123|NCT05783921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111311124|NCT05783921|Tubulin Modulators|tubulin modulators|mesh-ancestor
111311125|NCT05783921|Antimitotic Agents|antimitotic agents|mesh-ancestor
111311126|NCT05783921|Mitosis Modulators|mitosis modulators|mesh-ancestor
111311127|NCT05783921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111311128|NCT05754073|Oxytocin|oxytocin|mesh-list
111311129|NCT05754073|Oxytocics|oxytocics|mesh-ancestor
111311130|NCT05754073|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111311131|NCT05754073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111311132|NCT05741372|Metformin|metformin|mesh-list
111311133|NCT05741372|Digoxin|digoxin|mesh-list
111311134|NCT05741372|Furosemide|furosemide|mesh-list
111311135|NCT05741372|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111311136|NCT05741372|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111311137|NCT05741372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111311138|NCT05741372|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111311139|NCT05741372|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111311140|NCT05741372|Antimetabolites|antimetabolites|mesh-ancestor
111311141|NCT05741372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111311142|NCT05741372|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111311143|NCT05741372|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111311144|NCT05741372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111311145|NCT05741372|Diuretics|diuretics|mesh-ancestor
111311146|NCT05741372|Natriuretic Agents|natriuretic agents|mesh-ancestor
111311147|NCT05741372|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
111311148|NCT05741372|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111311149|NCT05741372|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111311150|NCT05741372|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111311151|NCT05741372|Protective Agents|protective agents|mesh-ancestor
111311152|NCT05740098|Nicotine|nicotine|mesh-list
111311153|NCT05740098|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111311154|NCT05740098|Autonomic Agents|autonomic agents|mesh-ancestor
111311155|NCT05740098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111311156|NCT05740098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111311157|NCT05740098|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111311158|NCT05740098|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111311159|NCT05740098|Cholinergic Agents|cholinergic agents|mesh-ancestor
111311160|NCT05740098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111311161|NCT05740098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111311162|NCT05730413|Bisoprolol|bisoprolol|mesh-list
111311163|NCT05730413|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111311164|NCT05730413|Sympatholytics|sympatholytics|mesh-ancestor
111311165|NCT05730413|Autonomic Agents|autonomic agents|mesh-ancestor
111311166|NCT05730413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111311167|NCT05730413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111311168|NCT05730413|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
111311169|NCT05730413|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111311170|NCT05730413|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111311171|NCT05730413|Adrenergic Agents|adrenergic agents|mesh-ancestor
111311172|NCT05730413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111311173|NCT05730413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111311174|NCT05725213|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
111311175|NCT05725213|Aminolevulinic Acid|aminolevulinic acid|mesh-list
111311176|NCT05725213|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111311177|NCT05725213|Dermatologic Agents|dermatologic agents|mesh-ancestor
111311178|NCT05720455|Fexofenadine|fexofenadine|mesh-list
111311179|NCT05720455|Pseudoephedrine|pseudoephedrine|mesh-list
111311180|NCT05720455|Ephedrine|ephedrine|mesh-list
111311181|NCT05720455|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111311182|NCT05720455|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
111311183|NCT05720455|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111311184|NCT05720455|Histamine Antagonists|histamine antagonists|mesh-ancestor
111035628|NCT05699720|Sensory System Agents|sensory system agents|mesh-ancestor
111311185|NCT05720455|Histamine Agents|histamine agents|mesh-ancestor
111311186|NCT05720455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111311187|NCT05720455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111311188|NCT05720455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111311189|NCT05720455|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111311190|NCT05720455|Autonomic Agents|autonomic agents|mesh-ancestor
111311191|NCT05720455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111311192|NCT05720455|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111311193|NCT05720455|Respiratory System Agents|respiratory system agents|mesh-ancestor
111311194|NCT05720455|Nasal Decongestants|nasal decongestants|mesh-ancestor
111311195|NCT05720455|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111311196|NCT05720455|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111311197|NCT05720455|Sympathomimetics|sympathomimetics|mesh-ancestor
111311198|NCT05720455|Adrenergic Agents|adrenergic agents|mesh-ancestor
111311199|NCT05647265|Nivolumab|nivolumab|mesh-list
111311200|NCT05647265|Ipilimumab|ipilimumab|mesh-list
111311201|NCT05647265|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111311202|NCT05647265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111311203|NCT05647265|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111311204|NCT05647265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111311205|NCT05641753|Atorvastatin|atorvastatin|mesh-list
111311206|NCT05641753|Ezetimibe|ezetimibe|mesh-list
111311207|NCT05641753|Evolocumab|evolocumab|mesh-list
111311208|NCT05641753|Calcium|calcium|mesh-list
111311209|NCT05641753|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111311210|NCT05641753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111311211|NCT05641753|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111311212|NCT05641753|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111311213|NCT05641753|Antimetabolites|antimetabolites|mesh-ancestor
111311214|NCT05641753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111311215|NCT05641753|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111311216|NCT05641753|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111311217|NCT05641753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111311218|NCT05641753|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
111311219|NCT05641753|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111311220|NCT05641753|Protease Inhibitors|protease inhibitors|mesh-ancestor
111311221|NCT05626621|Mometasone Furoate|mometasone furoate|mesh-list
111311222|NCT05626621|Azelastine|azelastine|mesh-list
111311223|NCT05626621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111311224|NCT05626621|Dermatologic Agents|dermatologic agents|mesh-ancestor
111311225|NCT05626621|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111311226|NCT05626621|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111311227|NCT05626621|Autonomic Agents|autonomic agents|mesh-ancestor
111311228|NCT05626621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111311229|NCT05626621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111311230|NCT05626621|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111311231|NCT05626621|Respiratory System Agents|respiratory system agents|mesh-ancestor
111311232|NCT05626621|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
111311233|NCT05626621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111311234|NCT05626621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111311235|NCT05626621|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
111311236|NCT05626621|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111311237|NCT05626621|Histamine Antagonists|histamine antagonists|mesh-ancestor
111311238|NCT05626621|Histamine Agents|histamine agents|mesh-ancestor
111311239|NCT05626621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111311240|NCT05593094|Trastuzumab|trastuzumab|mesh-list
111311241|NCT05593094|Pertuzumab|pertuzumab|mesh-list
111311242|NCT05593094|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
111311243|NCT05593094|Maytansine|maytansine|mesh-list
111311244|NCT05593094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111311245|NCT05593094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111311246|NCT05593094|Immunotoxins|immunotoxins|mesh-ancestor
111311247|NCT05593094|Immunoconjugates|immunoconjugates|mesh-ancestor
111311248|NCT05593094|Immunologic Factors|immunologic factors|mesh-ancestor
111311249|NCT05593094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111311250|NCT05593094|Tubulin Modulators|tubulin modulators|mesh-ancestor
111311251|NCT05593094|Antimitotic Agents|antimitotic agents|mesh-ancestor
111311252|NCT05593094|Mitosis Modulators|mitosis modulators|mesh-ancestor
111311253|NCT05593094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111311254|NCT05593094|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111311255|NCT05591677|Cycloserine|cycloserine|mesh-list
111311256|NCT05591677|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111311257|NCT05591677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111311258|NCT05591677|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111311259|NCT05591677|Antitubercular Agents|antitubercular agents|mesh-ancestor
111311260|NCT05591677|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111311261|NCT05591677|Antimetabolites|antimetabolites|mesh-ancestor
111311262|NCT05591677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111311263|NCT05591118|Anticoagulants|anticoagulants|mesh-list
111311264|NCT05588609|Abiraterone Acetate|abiraterone acetate|mesh-list
111311265|NCT05588609|Afatinib|afatinib|mesh-list
111311266|NCT05588609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111311267|NCT05588609|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111311268|NCT05588609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111311269|NCT05588609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111311270|NCT05588609|Hormone Antagonists|hormone antagonists|mesh-ancestor
111311271|NCT05588609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111311272|NCT05588609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111311273|NCT05588609|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111311274|NCT05588609|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111311275|NCT05567601|Doxorubicin|doxorubicin|mesh-list
111311276|NCT05567601|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111311277|NCT05567601|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111311278|NCT05567601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111311279|NCT05567601|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111311280|NCT05567601|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111311281|NCT05567601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111311282|NCT05567601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111311283|NCT05541276|Melatonin|melatonin|mesh-list
111311284|NCT05541276|Antioxidants|antioxidants|mesh-ancestor
111311285|NCT05541276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111311286|NCT05541276|Protective Agents|protective agents|mesh-ancestor
111311287|NCT05541276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111311288|NCT05541276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111311289|NCT05517174|Vaccines|vaccines|mesh-list
111311290|NCT05517174|Immunologic Factors|immunologic factors|mesh-ancestor
111311291|NCT05517174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111311292|NCT05493761|Denosumab|denosumab|mesh-list
111311293|NCT05493761|Alendronate|alendronate|mesh-list
111311294|NCT05493761|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111311295|NCT05493761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111311296|NCT05492994|Carbon Monoxide|carbon monoxide|mesh-list
111311297|NCT05492994|Antimetabolites|antimetabolites|mesh-ancestor
111311298|NCT05492994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111311299|NCT05492994|Gasotransmitters|gasotransmitters|mesh-ancestor
111311300|NCT05492994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111311301|NCT05492994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111311302|NCT05434663|Granisetron|granisetron|mesh-list
111311303|NCT05434663|Antiemetics|antiemetics|mesh-ancestor
111311304|NCT05434663|Autonomic Agents|autonomic agents|mesh-ancestor
111311305|NCT05434663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111311306|NCT05434663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111311307|NCT05434663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111311308|NCT05434663|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111311309|NCT05434663|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111311310|NCT05434663|Serotonin Agents|serotonin agents|mesh-ancestor
111311311|NCT05434663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111311312|NCT05434663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111311313|NCT05434351|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
111311314|NCT05434351|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111311315|NCT05434351|Immunologic Factors|immunologic factors|mesh-ancestor
111311316|NCT05434351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111311317|NCT05405257|Oxytocin|oxytocin|mesh-list
111311318|NCT05405257|Oxytocics|oxytocics|mesh-ancestor
111311319|NCT05405257|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111311320|NCT05405257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111311321|NCT05401292|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
111311322|NCT05401292|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111311323|NCT05401292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111311324|NCT05401292|Dermatologic Agents|dermatologic agents|mesh-ancestor
111311325|NCT05375630|Vitamin K|vitamin k|mesh-list
111311326|NCT05375630|Vitamin K 2|vitamin k 2|mesh-list
111311327|NCT05375630|Vitamins|vitamins|mesh-ancestor
111311328|NCT05375630|Micronutrients|micronutrients|mesh-ancestor
111311329|NCT05375630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111311330|NCT05375630|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111311331|NCT05375630|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111311332|NCT05375630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111311333|NCT05375630|Hemostatics|hemostatics|mesh-ancestor
111311334|NCT05375630|Coagulants|coagulants|mesh-ancestor
111311335|NCT05358535|Propofol|propofol|mesh-list
111311337|NCT05358535|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111311338|NCT05358535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111311339|NCT05358535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111311340|NCT05358535|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111311341|NCT05358535|Anesthetics, General|anesthetics, general|mesh-ancestor
111311342|NCT05358535|Anesthetics|anesthetics|mesh-ancestor
111311343|NCT05349188|Melatonin|melatonin|mesh-list
111311344|NCT05349188|Antioxidants|antioxidants|mesh-ancestor
111311345|NCT05349188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111311346|NCT05349188|Protective Agents|protective agents|mesh-ancestor
111311347|NCT05349188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111311348|NCT05349188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111311349|NCT05307627|Naltrexone|naltrexone|mesh-list
111311350|NCT05307627|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111311351|NCT05307627|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111311352|NCT05307627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111311353|NCT05307627|Sensory System Agents|sensory system agents|mesh-ancestor
111311354|NCT05307627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111311355|NCT05303792|Cytarabine|cytarabine|mesh-list
111311356|NCT05303792|Dexamethasone|dexamethasone|mesh-list
111311357|NCT05303792|Prednisone|prednisone|mesh-list
111311358|NCT05303792|Methylprednisolone|methylprednisolone|mesh-list
111311359|NCT05303792|Cyclophosphamide|cyclophosphamide|mesh-list
111311360|NCT05303792|Rituximab|rituximab|mesh-list
111311361|NCT05303792|Doxorubicin|doxorubicin|mesh-list
111311362|NCT05303792|Methotrexate|methotrexate|mesh-list
111311363|NCT05303792|Vincristine|vincristine|mesh-list
111311364|NCT05303792|Mercaptopurine|mercaptopurine|mesh-list
111311365|NCT05303792|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
111311366|NCT05303792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111311367|NCT05303792|Immunologic Factors|immunologic factors|mesh-ancestor
111311368|NCT05303792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111311369|NCT05303792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111311370|NCT05303792|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111311371|NCT05303792|Alkylating Agents|alkylating agents|mesh-ancestor
111311372|NCT05303792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111311373|NCT05303792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111311374|NCT05303792|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111311375|NCT05303792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111311376|NCT05303792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111311377|NCT05303792|Antiemetics|antiemetics|mesh-ancestor
111311378|NCT05303792|Autonomic Agents|autonomic agents|mesh-ancestor
111311379|NCT05303792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111311380|NCT05303792|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111311381|NCT05303792|Glucocorticoids|glucocorticoids|mesh-ancestor
111311382|NCT05303792|Hormones|hormones|mesh-ancestor
111311383|NCT05303792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111311384|NCT05303792|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111311385|NCT05303792|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111311386|NCT05303792|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111311387|NCT05303792|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111311388|NCT05303792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111311389|NCT05303792|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111311390|NCT05303792|Abortifacient Agents|abortifacient agents|mesh-ancestor
111311391|NCT05303792|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111311392|NCT05303792|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111311393|NCT05303792|Antimetabolites|antimetabolites|mesh-ancestor
111311394|NCT05303792|Dermatologic Agents|dermatologic agents|mesh-ancestor
111311395|NCT05303792|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111311396|NCT05303792|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111311397|NCT05303792|Antiviral Agents|antiviral agents|mesh-ancestor
111311398|NCT05303792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111311399|NCT05303792|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111311400|NCT05303792|Tubulin Modulators|tubulin modulators|mesh-ancestor
111311401|NCT05303792|Antimitotic Agents|antimitotic agents|mesh-ancestor
111311402|NCT05303792|Mitosis Modulators|mitosis modulators|mesh-ancestor
111311403|NCT05303792|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111311404|NCT05303792|Protective Agents|protective agents|mesh-ancestor
111311405|NCT05303792|Immunotoxins|immunotoxins|mesh-ancestor
111311406|NCT05303792|Immunoconjugates|immunoconjugates|mesh-ancestor
111311407|NCT05291338|Doxorubicin|doxorubicin|mesh-list
111311408|NCT05291338|Ethiodized Oil|ethiodized oil|mesh-list
111311409|NCT05291338|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111311410|NCT05291338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111311411|NCT05291338|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111311412|NCT05291338|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111311413|NCT05291338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111311414|NCT05291338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111311415|NCT05268237|Liraglutide|liraglutide|mesh-list
111311416|NCT05268237|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111311417|NCT05268237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111311418|NCT05268237|Incretins|incretins|mesh-ancestor
111311419|NCT05268237|Hormones|hormones|mesh-ancestor
111311420|NCT05268237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111311421|NCT05177796|Paclitaxel|paclitaxel|mesh-list
111311422|NCT05177796|Cyclophosphamide|cyclophosphamide|mesh-list
111311423|NCT05177796|Carboplatin|carboplatin|mesh-list
111311424|NCT05177796|Doxorubicin|doxorubicin|mesh-list
111311425|NCT05177796|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111311426|NCT05177796|Pembrolizumab|pembrolizumab|mesh-list
111311427|NCT05177796|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111311428|NCT05177796|Daunorubicin|daunorubicin|mesh-list
111311429|NCT05177796|Panitumumab|panitumumab|mesh-list
111311430|NCT05177796|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111311431|NCT05177796|Antibodies|antibodies|mesh-list
111311432|NCT05177796|Immunoglobulins|immunoglobulins|mesh-list
111311433|NCT05177796|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111311434|NCT05177796|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111311435|NCT05177796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111311436|NCT05177796|Tubulin Modulators|tubulin modulators|mesh-ancestor
111311437|NCT05177796|Antimitotic Agents|antimitotic agents|mesh-ancestor
111311438|NCT05177796|Mitosis Modulators|mitosis modulators|mesh-ancestor
110980059|NCT03000569|Antiparkinson Agents|antiparkinson agents|mesh-list
111311439|NCT05177796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111311440|NCT05177796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111311441|NCT05177796|Immunologic Factors|immunologic factors|mesh-ancestor
111311442|NCT05177796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111311443|NCT05177796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111311444|NCT05177796|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111311445|NCT05177796|Alkylating Agents|alkylating agents|mesh-ancestor
111311446|NCT05177796|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111311447|NCT05177796|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111311448|NCT05177796|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111311449|NCT05177796|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111311450|NCT05177796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111311451|NCT05177796|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111311452|NCT05106127|Pembrolizumab|pembrolizumab|mesh-list
111311453|NCT05106127|Lenvatinib|lenvatinib|mesh-list
111311454|NCT05106127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111311455|NCT05106127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111311456|NCT05106127|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111311457|NCT05106127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111311458|NCT05106127|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111311459|NCT05106127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111311460|NCT05077215|Pembrolizumab|pembrolizumab|mesh-list
111311461|NCT05077215|Lenvatinib|lenvatinib|mesh-list
111311462|NCT05077215|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111311463|NCT05077215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111311464|NCT05077215|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111311465|NCT05077215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111311466|NCT05077215|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111311467|NCT05077215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111311468|NCT05028829|Atorvastatin|atorvastatin|mesh-list
111311469|NCT05028829|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111311470|NCT05028829|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111311471|NCT05028829|Antimetabolites|antimetabolites|mesh-ancestor
111311472|NCT05028829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111311473|NCT05028829|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111311474|NCT05028829|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111311475|NCT05028829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111311476|NCT04925479|Niacinamide|niacinamide|mesh-list
111311477|NCT04925479|Vitamin B Complex|vitamin b complex|mesh-ancestor
111311478|NCT04925479|Vitamins|vitamins|mesh-ancestor
111311479|NCT04925479|Micronutrients|micronutrients|mesh-ancestor
111311480|NCT04925479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111311481|NCT04912505|Aspirin|aspirin|mesh-list
111311482|NCT04912505|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111311483|NCT04912505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111311484|NCT04912505|Analgesics|analgesics|mesh-ancestor
111311485|NCT04912505|Sensory System Agents|sensory system agents|mesh-ancestor
111311486|NCT04912505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111311487|NCT04912505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111035927|NCT03174561|Choline|choline|mesh-list
111311488|NCT04912505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111311489|NCT04912505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111311490|NCT04912505|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111311491|NCT04912505|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111311492|NCT04912505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111311493|NCT04912505|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111311494|NCT04912505|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111311495|NCT04912505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111311496|NCT04912505|Antipyretics|antipyretics|mesh-ancestor
111311497|NCT04882813|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111311498|NCT04882813|Dapagliflozin|dapagliflozin|mesh-list
111311499|NCT04882813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111311500|NCT04882813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111311501|NCT04882813|Incretins|incretins|mesh-ancestor
111311502|NCT04882813|Hormones|hormones|mesh-ancestor
111311503|NCT04882813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111311504|NCT04882813|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111311505|NCT04882813|Protease Inhibitors|protease inhibitors|mesh-ancestor
111311506|NCT04882813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111311507|NCT04882813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111311508|NCT04882813|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111311509|NCT04879407|Warfarin|warfarin|mesh-list
111311510|NCT04879407|Rivaroxaban|rivaroxaban|mesh-list
111311511|NCT04879407|Anticoagulants|anticoagulants|mesh-ancestor
111311512|NCT04879407|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111311513|NCT04879407|Antithrombins|antithrombins|mesh-ancestor
111311514|NCT04879407|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111311515|NCT04879407|Protease Inhibitors|protease inhibitors|mesh-ancestor
111311516|NCT04879407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111311517|NCT04879407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111311518|NCT04843566|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111311519|NCT04843566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111311520|NCT04839692|Hyaluronic Acid|hyaluronic acid|mesh-list
111311521|NCT04839692|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111311522|NCT04839692|Immunologic Factors|immunologic factors|mesh-ancestor
111311523|NCT04839692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111311524|NCT04839692|Viscosupplements|viscosupplements|mesh-ancestor
111311525|NCT04839692|Protective Agents|protective agents|mesh-ancestor
111311526|NCT04745910|Rasburicase|rasburicase|mesh-list
111311527|NCT04745910|Uric Acid|uric acid|mesh-list
111311528|NCT04745910|Gout Suppressants|gout suppressants|mesh-ancestor
111311529|NCT04745910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111311530|NCT04745910|Antioxidants|antioxidants|mesh-ancestor
111311531|NCT04745910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111311532|NCT04745910|Protective Agents|protective agents|mesh-ancestor
111311533|NCT04745910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111311534|NCT04736420|Warfarin|warfarin|mesh-list
111311535|NCT04736420|Rivaroxaban|rivaroxaban|mesh-list
111311536|NCT04736420|Anticoagulants|anticoagulants|mesh-ancestor
111311537|NCT04736420|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111311538|NCT04736420|Antithrombins|antithrombins|mesh-ancestor
111311539|NCT04736420|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111311540|NCT04736420|Protease Inhibitors|protease inhibitors|mesh-ancestor
111311541|NCT04736420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111311542|NCT04736420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111311543|NCT04715646|Brivaracetam|brivaracetam|mesh-list
111311544|NCT04715646|Anticonvulsants|anticonvulsants|mesh-ancestor
111311545|NCT04691817|Atezolizumab|atezolizumab|mesh-list
111311546|NCT04691817|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111311547|NCT04691817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111311548|NCT04691817|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111311549|NCT04691817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111311550|NCT04673942|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
111311551|NCT04673942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111311552|NCT04673942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111311553|NCT04673942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111311554|NCT04641351|Triamcinolone|triamcinolone|mesh-list
111311555|NCT04641351|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
111311556|NCT04641351|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
111311557|NCT04641351|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
111311558|NCT04641351|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111311559|NCT04641351|Glucocorticoids|glucocorticoids|mesh-ancestor
111311560|NCT04641351|Hormones|hormones|mesh-ancestor
111311561|NCT04641351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111311562|NCT04641351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111311563|NCT04641351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111311564|NCT04641351|Immunologic Factors|immunologic factors|mesh-ancestor
111311565|NCT04641351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111311566|NCT04641351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111311567|NCT04606264|Dexamethasone|dexamethasone|mesh-list
111311568|NCT04606264|Morphine|morphine|mesh-list
111311569|NCT04606264|Hydromorphone|hydromorphone|mesh-list
111311570|NCT04606264|Ondansetron|ondansetron|mesh-list
111311571|NCT04606264|Aprepitant|aprepitant|mesh-list
111311572|NCT04606264|Dimenhydrinate|dimenhydrinate|mesh-list
111311573|NCT04606264|Perphenazine|perphenazine|mesh-list
111311574|NCT04606264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111311575|NCT04606264|Antiemetics|antiemetics|mesh-ancestor
111311576|NCT04606264|Autonomic Agents|autonomic agents|mesh-ancestor
111311577|NCT04606264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111311578|NCT04606264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111311579|NCT04606264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111311580|NCT04606264|Glucocorticoids|glucocorticoids|mesh-ancestor
111311581|NCT04606264|Hormones|hormones|mesh-ancestor
111311582|NCT04606264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111311583|NCT04606264|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111311584|NCT04606264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111311585|NCT04606264|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111311586|NCT04606264|Narcotics|narcotics|mesh-ancestor
111311587|NCT04606264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111311588|NCT04606264|Analgesics|analgesics|mesh-ancestor
111311589|NCT04606264|Sensory System Agents|sensory system agents|mesh-ancestor
111311590|NCT04606264|Antipruritics|antipruritics|mesh-ancestor
111311591|NCT04606264|Dermatologic Agents|dermatologic agents|mesh-ancestor
111311592|NCT04606264|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111311593|NCT04606264|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111311594|NCT04606264|Serotonin Agents|serotonin agents|mesh-ancestor
111311595|NCT04606264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111311596|NCT04606264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111311597|NCT04606264|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
111311598|NCT04606264|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111311599|NCT04606264|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111311600|NCT04606264|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111311601|NCT04606264|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111311602|NCT04606264|Dopamine Agents|dopamine agents|mesh-ancestor
111311603|NCT04606264|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111311604|NCT04606264|Histamine Antagonists|histamine antagonists|mesh-ancestor
111311605|NCT04606264|Histamine Agents|histamine agents|mesh-ancestor
111311606|NCT04594811|Nivolumab|nivolumab|mesh-list
111311607|NCT04594811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111311608|NCT04594811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111311609|NCT04594811|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111311610|NCT04594811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111311611|NCT04593056|Warfarin|warfarin|mesh-list
111311612|NCT04593056|Rivaroxaban|rivaroxaban|mesh-list
111311613|NCT04593056|Anticoagulants|anticoagulants|mesh-ancestor
111311614|NCT04593056|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111311615|NCT04593056|Antithrombins|antithrombins|mesh-ancestor
111311616|NCT04593056|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111311617|NCT04593056|Protease Inhibitors|protease inhibitors|mesh-ancestor
111311618|NCT04593056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111311619|NCT04593056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111311620|NCT04566380|Bevacizumab|bevacizumab|mesh-list
111311621|NCT04566380|Nivolumab|nivolumab|mesh-list
111311622|NCT04566380|Capecitabine|capecitabine|mesh-list
111311623|NCT04566380|Oxaliplatin|oxaliplatin|mesh-list
111311624|NCT04566380|Temozolomide|temozolomide|mesh-list
111311625|NCT04566380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111311626|NCT04566380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111311627|NCT04566380|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111311628|NCT04566380|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111311629|NCT04566380|Growth Substances|growth substances|mesh-ancestor
111311630|NCT04566380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111311631|NCT04566380|Growth Inhibitors|growth inhibitors|mesh-ancestor
111311632|NCT04566380|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111311633|NCT04566380|Antimetabolites|antimetabolites|mesh-ancestor
111311634|NCT04566380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111311635|NCT04566380|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111311636|NCT04566380|Alkylating Agents|alkylating agents|mesh-ancestor
111311637|NCT04566380|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111311638|NCT04561180|Dexamethasone|dexamethasone|mesh-list
111311639|NCT04561180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111311640|NCT04561180|Antiemetics|antiemetics|mesh-ancestor
111311641|NCT04561180|Autonomic Agents|autonomic agents|mesh-ancestor
111311642|NCT04561180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111311643|NCT04561180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111311644|NCT04561180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111311645|NCT04561180|Glucocorticoids|glucocorticoids|mesh-ancestor
111311646|NCT04561180|Hormones|hormones|mesh-ancestor
111311647|NCT04561180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111311648|NCT04561180|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111311649|NCT04561180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111311650|NCT04552288|Benralizumab|benralizumab|mesh-list
111311651|NCT04552288|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111311652|NCT04552288|Respiratory System Agents|respiratory system agents|mesh-ancestor
111311653|NCT04500665|Colchicine|colchicine|mesh-list
111311654|NCT04500665|Gout Suppressants|gout suppressants|mesh-ancestor
111311655|NCT04500665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111311656|NCT04500665|Tubulin Modulators|tubulin modulators|mesh-ancestor
111311657|NCT04500665|Antimitotic Agents|antimitotic agents|mesh-ancestor
111311658|NCT04500665|Mitosis Modulators|mitosis modulators|mesh-ancestor
111311659|NCT04500665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111311660|NCT04500665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111311661|NCT04495881|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111311662|NCT04495881|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111311663|NCT04495881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111311664|NCT04495881|Incretins|incretins|mesh-ancestor
111311665|NCT04495881|Hormones|hormones|mesh-ancestor
111311666|NCT04495881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111311667|NCT04495881|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111311668|NCT04495881|Protease Inhibitors|protease inhibitors|mesh-ancestor
111311669|NCT04495881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111311670|NCT04495881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111311671|NCT04486625|Aztreonam|aztreonam|mesh-list
111311672|NCT04486625|Avibactam|avibactam|mesh-list
111311673|NCT04486625|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111311674|NCT04486625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111311675|NCT04486625|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
111311676|NCT04486625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111311677|NCT04486625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111311678|NCT04401904|Dapagliflozin|dapagliflozin|mesh-list
111311679|NCT04401904|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111311680|NCT04401904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111311681|NCT04401904|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111311682|NCT04401904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111311683|NCT04384107|Vaccines|vaccines|mesh-list
111311684|NCT04384107|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
111311685|NCT04384107|Immunologic Factors|immunologic factors|mesh-ancestor
111311686|NCT04384107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111311687|NCT04329728|Dexamethasone|dexamethasone|mesh-list
111311688|NCT04329728|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
111311689|NCT04329728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111311690|NCT04329728|Antiemetics|antiemetics|mesh-ancestor
111311691|NCT04329728|Autonomic Agents|autonomic agents|mesh-ancestor
111311692|NCT04329728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111311693|NCT04329728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111311694|NCT04329728|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111311695|NCT04329728|Glucocorticoids|glucocorticoids|mesh-ancestor
111311696|NCT04329728|Hormones|hormones|mesh-ancestor
111311697|NCT04329728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111311698|NCT04329728|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111311699|NCT04329728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111311700|NCT04298697|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
111311701|NCT04298697|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111311702|NCT04298697|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111311703|NCT04298697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111311704|NCT04298697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111311705|NCT04298697|Antiviral Agents|antiviral agents|mesh-ancestor
111311706|NCT04298697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111311707|NCT04298697|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111311708|NCT04298697|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111311709|NCT04280848|Temozolomide|temozolomide|mesh-list
111311710|NCT04280848|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111311711|NCT04280848|Alkylating Agents|alkylating agents|mesh-ancestor
111311712|NCT04280848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111311713|NCT04280848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111311714|NCT04262154|Prednisone|prednisone|mesh-list
111311715|NCT04262154|Atezolizumab|atezolizumab|mesh-list
111311716|NCT04262154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111311717|NCT04262154|Glucocorticoids|glucocorticoids|mesh-ancestor
111311718|NCT04262154|Hormones|hormones|mesh-ancestor
111311719|NCT04262154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111311720|NCT04262154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111311721|NCT04262154|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111311722|NCT04262154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111311723|NCT04262154|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111311724|NCT04262154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111311725|NCT04262154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111311726|NCT04241601|Aldesleukin|aldesleukin|mesh-list
111311727|NCT04241601|Interleukin-2|interleukin-2|mesh-list
111311728|NCT04241601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111311729|NCT04241601|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111311730|NCT04241601|Analgesics|analgesics|mesh-ancestor
111311731|NCT04241601|Sensory System Agents|sensory system agents|mesh-ancestor
111311732|NCT04241601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111311733|NCT04241601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111311734|NCT04241601|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111311735|NCT04241601|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111311736|NCT04241601|Antiviral Agents|antiviral agents|mesh-ancestor
111311737|NCT04241601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111311738|NCT04214288|Fulvestrant|fulvestrant|mesh-list
111311739|NCT04214288|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111311740|NCT04214288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111311741|NCT04214288|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
111311742|NCT04214288|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111311743|NCT04214288|Hormone Antagonists|hormone antagonists|mesh-ancestor
111311744|NCT04214288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111311745|NCT04214288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111311746|NCT04206787|Afatinib|afatinib|mesh-list
111311747|NCT04206787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111311748|NCT04206787|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111311749|NCT04206787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111311750|NCT04206787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111311751|NCT04200651|Dexamethasone|dexamethasone|mesh-list
111311752|NCT04200651|Prednisolone|prednisolone|mesh-list
111311753|NCT04200651|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111311754|NCT04200651|Methylprednisolone|methylprednisolone|mesh-list
111311755|NCT04200651|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111311756|NCT04200651|Prednisolone acetate|prednisolone acetate|mesh-list
111311757|NCT04200651|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111311758|NCT04200651|Prednisolone phosphate|prednisolone phosphate|mesh-list
111311759|NCT04200651|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111311760|NCT04200651|Antiemetics|antiemetics|mesh-ancestor
111311761|NCT04200651|Autonomic Agents|autonomic agents|mesh-ancestor
111311762|NCT04200651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111311763|NCT04200651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111311764|NCT04200651|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111311765|NCT04200651|Glucocorticoids|glucocorticoids|mesh-ancestor
111311766|NCT04200651|Hormones|hormones|mesh-ancestor
111311767|NCT04200651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111311768|NCT04200651|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111311769|NCT04200651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111311770|NCT04200651|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111311771|NCT04200651|Protective Agents|protective agents|mesh-ancestor
111311772|NCT04170153|Niraparib|niraparib|mesh-list
111311773|NCT04170153|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111311774|NCT04170153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111311775|NCT04170153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111311776|NCT04170153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111311777|NCT04162015|Carboplatin|carboplatin|mesh-list
111311778|NCT04162015|Nivolumab|nivolumab|mesh-list
111311779|NCT04162015|Pemetrexed|pemetrexed|mesh-list
111311780|NCT04162015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111311781|NCT04162015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111311782|NCT04162015|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111311783|NCT04162015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111311784|NCT04162015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111311785|NCT04162015|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111311786|NCT04162015|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111311787|NCT04150965|Thalidomide|thalidomide|mesh-list
111311789|NCT04150965|Dexamethasone acetate|dexamethasone acetate|mesh-list
111311790|NCT04150965|Pomalidomide|pomalidomide|mesh-list
111311791|NCT04150965|Relatlimab|relatlimab|mesh-list
111311792|NCT04150965|Elotuzumab|elotuzumab|mesh-list
111311793|NCT04150965|BB 1101|bb 1101|mesh-list
111311794|NCT04150965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111311795|NCT04150965|Antiemetics|antiemetics|mesh-ancestor
111311796|NCT04150965|Autonomic Agents|autonomic agents|mesh-ancestor
111311797|NCT04150965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111311798|NCT04150965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111311799|NCT04150965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111311800|NCT04150965|Glucocorticoids|glucocorticoids|mesh-ancestor
111311801|NCT04150965|Hormones|hormones|mesh-ancestor
111311802|NCT04150965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111311803|NCT04150965|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111311804|NCT04150965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111311805|NCT04150965|Protease Inhibitors|protease inhibitors|mesh-ancestor
111311806|NCT04150965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111311807|NCT04150965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111311808|NCT04150965|Immunologic Factors|immunologic factors|mesh-ancestor
111311809|NCT04150965|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111311810|NCT04150965|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111311811|NCT04150965|Growth Substances|growth substances|mesh-ancestor
111311812|NCT04150965|Growth Inhibitors|growth inhibitors|mesh-ancestor
111311813|NCT04150965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111311814|NCT04150965|Leprostatic Agents|leprostatic agents|mesh-ancestor
111311815|NCT04150965|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111311816|NCT04150965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111311817|NCT04150965|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111311818|NCT04150965|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111311819|NCT04136353|Hormones|hormones|mesh-list
111311820|NCT04136353|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
111311821|NCT04136353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111311822|NCT04136353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111311823|NCT04072822|Prednisone|prednisone|mesh-list
111311824|NCT04072822|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
111311825|NCT04072822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111311826|NCT04072822|Glucocorticoids|glucocorticoids|mesh-ancestor
111311827|NCT04072822|Hormones|hormones|mesh-ancestor
111311828|NCT04072822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111311829|NCT04072822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111311830|NCT04072822|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111311831|NCT04072822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111311832|NCT04072822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111311833|NCT04058756|Spartalizumab|spartalizumab|mesh-list
111311834|NCT04058756|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111311835|NCT04058756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111311836|NCT04058756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111311837|NCT04058756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111311838|NCT04031846|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
111311839|NCT04031846|Immunologic Factors|immunologic factors|mesh-ancestor
111311840|NCT04031846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111311841|NCT03893448|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
111311842|NCT03893448|Immunologic Factors|immunologic factors|mesh-ancestor
111311843|NCT03893448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111311844|NCT03692871|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
111311845|NCT03692871|Immunologic Factors|immunologic factors|mesh-ancestor
111311846|NCT03692871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111311847|NCT03667846|Topiramate|topiramate|mesh-list
111311848|NCT03667846|Anticonvulsants|anticonvulsants|mesh-ancestor
111311849|NCT03667846|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111311850|NCT03667846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111311851|NCT03658447|Pembrolizumab|pembrolizumab|mesh-list
111311852|NCT03658447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111311853|NCT03658447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111311854|NCT03658447|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111311855|NCT03658447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111311856|NCT03649880|Misonidazole|misonidazole|mesh-list
111311857|NCT03649880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111311858|NCT03649880|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111311859|NCT03649880|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111311860|NCT03649880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111311861|NCT03565900|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
111311862|NCT03565900|Immunologic Factors|immunologic factors|mesh-ancestor
111311863|NCT03565900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111311864|NCT03531762|Tepotinib|tepotinib|mesh-list
111311865|NCT03531762|Omeprazole|omeprazole|mesh-list
111311866|NCT03531762|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111311867|NCT03531762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111311868|NCT03531762|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111311869|NCT03531762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111311870|NCT03531762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111311871|NCT03531762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111311872|NCT03464045|Empagliflozin|empagliflozin|mesh-list
111311873|NCT03464045|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
111311874|NCT03464045|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
111311875|NCT03464045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111311876|NCT03464045|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111311877|NCT03464045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111311878|NCT03464045|Protease Inhibitors|protease inhibitors|mesh-ancestor
111311879|NCT03464045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111311880|NCT03462459|Vancomycin|vancomycin|mesh-list
111311881|NCT03462459|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111311882|NCT03462459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111311883|NCT03443869|Valganciclovir|valganciclovir|mesh-list
111311884|NCT03443869|Acyclovir|acyclovir|mesh-list
111311885|NCT03443869|Letermovir|letermovir|mesh-list
111311886|NCT03443869|Antiviral Agents|antiviral agents|mesh-ancestor
111311887|NCT03443869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111311888|NCT03443869|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111311889|NCT03443869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111311890|NCT03443869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111311891|NCT03443869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111311892|NCT03321630|Pembrolizumab|pembrolizumab|mesh-list
111311893|NCT03321630|Lenvatinib|lenvatinib|mesh-list
111311894|NCT03321630|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111311895|NCT03321630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111311896|NCT03321630|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111311897|NCT03321630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111311898|NCT03321630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111311899|NCT03321630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111311900|NCT03253796|Golimumab|golimumab|mesh-list
111311901|NCT03253796|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111311902|NCT03253796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111311903|NCT03253796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111311904|NCT03253796|Immunologic Factors|immunologic factors|mesh-ancestor
111311905|NCT03253796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111311906|NCT03241940|Cyclophosphamide|cyclophosphamide|mesh-list
111311907|NCT03241940|Fludarabine|fludarabine|mesh-list
111311908|NCT03241940|Fludarabine phosphate|fludarabine phosphate|mesh-list
111311909|NCT03241940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111311910|NCT03241940|Immunologic Factors|immunologic factors|mesh-ancestor
111311911|NCT03241940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111311912|NCT03241940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111311913|NCT03241940|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111311914|NCT03241940|Alkylating Agents|alkylating agents|mesh-ancestor
111311915|NCT03241940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111311916|NCT03241940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111311917|NCT03241940|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111311918|NCT03241940|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111311919|NCT03241940|Antimetabolites|antimetabolites|mesh-ancestor
111311920|NCT03233854|Cyclophosphamide|cyclophosphamide|mesh-list
111311921|NCT03233854|Fludarabine|fludarabine|mesh-list
110764586|NCT03099538|Ixekizumab|ixekizumab|mesh-list
111311922|NCT03233854|Fludarabine phosphate|fludarabine phosphate|mesh-list
111311923|NCT03233854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111311924|NCT03233854|Immunologic Factors|immunologic factors|mesh-ancestor
111311925|NCT03233854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111311926|NCT03233854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111311927|NCT03233854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111311928|NCT03233854|Alkylating Agents|alkylating agents|mesh-ancestor
111311929|NCT03233854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111311930|NCT03233854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111311931|NCT03233854|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111311932|NCT03233854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111311933|NCT03233854|Antimetabolites|antimetabolites|mesh-ancestor
111311934|NCT03132116|Gentamicins|gentamicins|mesh-list
111036383|NCT03173235|Vitamin D|vitamin d|mesh-list
111311935|NCT03132116|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111311936|NCT03132116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111311937|NCT03132116|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111311938|NCT03132116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111311939|NCT03132116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111311940|NCT03029143|Vedolizumab|vedolizumab|mesh-list
111311941|NCT03029143|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111311942|NCT02959164|Gemcitabine|gemcitabine|mesh-list
111311943|NCT02959164|Decitabine|decitabine|mesh-list
111311944|NCT02959164|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111311945|NCT02959164|Antimetabolites|antimetabolites|mesh-ancestor
111311946|NCT02959164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111311947|NCT02959164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111311948|NCT02959164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111311949|NCT02803502|Thrombin|thrombin|mesh-list
111311950|NCT02803502|Hemostatics|hemostatics|mesh-ancestor
111311951|NCT02803502|Coagulants|coagulants|mesh-ancestor
111311952|NCT02763579|Carboplatin|carboplatin|mesh-list
111311953|NCT02763579|Etoposide|etoposide|mesh-list
111311954|NCT02763579|Atezolizumab|atezolizumab|mesh-list
111311955|NCT02763579|Antibodies|antibodies|mesh-list
111311956|NCT02763579|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111311957|NCT02763579|Immunologic Factors|immunologic factors|mesh-ancestor
111311958|NCT02763579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111311959|NCT02763579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111311960|NCT02763579|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111311961|NCT02763579|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111311962|NCT02763579|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111311963|NCT02763579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111311964|NCT02763579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111311965|NCT02763579|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111311966|NCT02763579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111311967|NCT02618577|Edoxaban|edoxaban|mesh-list
111311968|NCT02618577|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111311969|NCT02618577|Antithrombins|antithrombins|mesh-ancestor
111311970|NCT02618577|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111311971|NCT02618577|Protease Inhibitors|protease inhibitors|mesh-ancestor
111311972|NCT02618577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111311973|NCT02618577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111311974|NCT02618577|Anticoagulants|anticoagulants|mesh-ancestor
111311975|NCT02607722|Nintedanib|nintedanib|mesh-list
111311976|NCT02607722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111311977|NCT02607722|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111311978|NCT02607722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111311979|NCT02607722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111311980|NCT02572791|Chlorhexidine|chlorhexidine|mesh-list
111311981|NCT02572791|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
111311982|NCT02572791|Mupirocin|mupirocin|mesh-list
111311983|NCT02572791|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111311984|NCT02572791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111311985|NCT02572791|Disinfectants|disinfectants|mesh-ancestor
111311986|NCT02572791|Dermatologic Agents|dermatologic agents|mesh-ancestor
111311987|NCT02572791|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111311988|NCT02572791|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111311989|NCT02572791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111311990|NCT02572791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111311991|NCT02550652|Mycophenolic Acid|mycophenolic acid|mesh-list
111311992|NCT02550652|Prednisone|prednisone|mesh-list
111311993|NCT02550652|Methylprednisolone|methylprednisolone|mesh-list
111311994|NCT02550652|Obinutuzumab|obinutuzumab|mesh-list
111311995|NCT02550652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111311996|NCT02550652|Glucocorticoids|glucocorticoids|mesh-ancestor
111311997|NCT02550652|Hormones|hormones|mesh-ancestor
111311998|NCT02550652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111311999|NCT02550652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111312000|NCT02550652|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111312001|NCT02550652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111312002|NCT02550652|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111312003|NCT02550652|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111312004|NCT02550652|Antitubercular Agents|antitubercular agents|mesh-ancestor
111312005|NCT02550652|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111312006|NCT02550652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111312007|NCT02550652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111312008|NCT02550652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111312009|NCT02550652|Antiemetics|antiemetics|mesh-ancestor
111312010|NCT02550652|Autonomic Agents|autonomic agents|mesh-ancestor
111036463|NCT02167633|Hormones|hormones|mesh-ancestor
111312011|NCT02550652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111312012|NCT02550652|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111312013|NCT02550652|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111312014|NCT02550652|Protective Agents|protective agents|mesh-ancestor
111312015|NCT02550652|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111312016|NCT02281084|Azacitidine|azacitidine|mesh-list
111312017|NCT02281084|Durvalumab|durvalumab|mesh-list
111312018|NCT02281084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111312019|NCT02281084|Antimetabolites|antimetabolites|mesh-ancestor
111312020|NCT02281084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111312021|NCT02281084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111312022|NCT02281084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111312023|NCT02281084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111312024|NCT01966120|Aminolevulinic Acid|aminolevulinic acid|mesh-list
111312025|NCT01966120|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111312026|NCT01966120|Dermatologic Agents|dermatologic agents|mesh-ancestor
111312027|NCT00840944|Triptorelin Pamoate|triptorelin pamoate|mesh-list
111312028|NCT00840944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111312029|NCT00840944|Luteolytic Agents|luteolytic agents|mesh-ancestor
111312030|NCT00840944|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111312031|NCT00840944|Contraceptive Agents|contraceptive agents|mesh-ancestor
111312032|NCT00840944|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111312033|NCT00840944|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111312034|NCT00840944|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111312035|NCT00840944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111312036|NCT00097474|Hydrocortisone|hydrocortisone|mesh-list
111312037|NCT00097474|Melatonin|melatonin|mesh-list
111312038|NCT00097474|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111312039|NCT00097474|Antioxidants|antioxidants|mesh-ancestor
111312040|NCT00097474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111312041|NCT00097474|Protective Agents|protective agents|mesh-ancestor
111312042|NCT00097474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111312043|NCT00097474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111312044|NCT00386477|Povidone-Iodine|povidone-iodine|mesh-list
111312045|NCT00386477|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111312046|NCT00386477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111312047|NCT00453193|Alemtuzumab|alemtuzumab|mesh-list
111312048|NCT00453193|Pentostatin|pentostatin|mesh-list
111312049|NCT00453193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111312050|NCT00453193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111312051|NCT00453193|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
111312052|NCT00453193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111312053|NCT00453193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111312054|NCT00387023|Rituximab|rituximab|mesh-list
111312055|NCT00387023|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111312056|NCT00387023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111312057|NCT00387023|Immunologic Factors|immunologic factors|mesh-ancestor
111312058|NCT00387023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111312059|NCT00387023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111312060|NCT00472849|Cytarabine|cytarabine|mesh-list
111312061|NCT00472849|Rituximab|rituximab|mesh-list
111312062|NCT00472849|Oxaliplatin|oxaliplatin|mesh-list
111312063|NCT00472849|Fludarabine|fludarabine|mesh-list
111312064|NCT00472849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111312065|NCT00472849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111312066|NCT00472849|Immunologic Factors|immunologic factors|mesh-ancestor
111312067|NCT00472849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111312068|NCT00472849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111312069|NCT00472849|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111312070|NCT00472849|Antimetabolites|antimetabolites|mesh-ancestor
111312071|NCT00472849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111312072|NCT00472849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111312073|NCT00472849|Antiviral Agents|antiviral agents|mesh-ancestor
111312074|NCT00472849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111312075|NCT00453895|Sunitinib|sunitinib|mesh-list
111312076|NCT00453895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111312077|NCT00453895|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111312078|NCT00453895|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111312079|NCT00453895|Growth Substances|growth substances|mesh-ancestor
111312080|NCT00453895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111312081|NCT00453895|Growth Inhibitors|growth inhibitors|mesh-ancestor
111312082|NCT00453895|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111312083|NCT00453895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111312084|NCT00453895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111312085|NCT00528541|Botulinum Toxins|botulinum toxins|mesh-list
111312086|NCT00528541|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111312087|NCT00528541|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111312088|NCT00528541|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111312089|NCT00528541|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111312090|NCT00528541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111312091|NCT00528541|Cholinergic Agents|cholinergic agents|mesh-ancestor
111312092|NCT00528541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111312093|NCT00528541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111312094|NCT00528541|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111312095|NCT00528541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111312096|NCT00409565|Bevacizumab|bevacizumab|mesh-list
111312097|NCT00409565|Cetuximab|cetuximab|mesh-list
111312098|NCT00409565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111312099|NCT00409565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111312100|NCT00409565|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111312101|NCT00409565|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111312102|NCT00409565|Growth Substances|growth substances|mesh-ancestor
111312103|NCT00409565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111312104|NCT00409565|Growth Inhibitors|growth inhibitors|mesh-ancestor
111312105|NCT00475501|Methyltestosterone|methyltestosterone|mesh-list
111312106|NCT00475501|Finasteride|finasteride|mesh-list
111312107|NCT00475501|Testosterone|testosterone|mesh-list
111312108|NCT00475501|Testosterone undecanoate|testosterone undecanoate|mesh-list
111312109|NCT00475501|Testosterone enanthate|testosterone enanthate|mesh-list
111312110|NCT00475501|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
111312111|NCT00475501|Androgens|androgens|mesh-ancestor
111312112|NCT00475501|Hormones|hormones|mesh-ancestor
111312113|NCT00475501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111312114|NCT00475501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111312115|NCT00475501|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111312116|NCT00475501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111312117|NCT00475501|Anabolic Agents|anabolic agents|mesh-ancestor
111312118|NCT00475501|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
111312119|NCT00475501|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111312120|NCT00475501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111312121|NCT00475501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111312122|NCT00475501|Hormone Antagonists|hormone antagonists|mesh-ancestor
111312123|NCT00475501|Urological Agents|urological agents|mesh-ancestor
111312124|NCT00529555|Minocycline|minocycline|mesh-list
111312125|NCT00529555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111312126|NCT00529555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111312127|NCT00387335|Sunitinib|sunitinib|mesh-list
111312128|NCT00387335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111312129|NCT00387335|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111312130|NCT00387335|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111312131|NCT00387335|Growth Substances|growth substances|mesh-ancestor
111312132|NCT00387335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111312133|NCT00387335|Growth Inhibitors|growth inhibitors|mesh-ancestor
111312134|NCT00387335|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111312135|NCT00387335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111312136|NCT00387335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111312137|NCT01797757|Orlistat|orlistat|mesh-list
111312138|NCT01797757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111312139|NCT01797757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111312140|NCT01797757|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111312141|NCT01797757|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111312142|NCT01796899|Brivaracetam|brivaracetam|mesh-list
111312143|NCT01796899|Anticonvulsants|anticonvulsants|mesh-ancestor
111312144|NCT00477451|Alprazolam|alprazolam|mesh-list
111312145|NCT00477451|Doxapram|doxapram|mesh-list
111312146|NCT00477451|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111312147|NCT00477451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111312148|NCT00477451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111312149|NCT00477451|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111312150|NCT00477451|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111312151|NCT00477451|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111312152|NCT00477451|GABA Modulators|gaba modulators|mesh-ancestor
111312153|NCT00477451|GABA Agents|gaba agents|mesh-ancestor
111312154|NCT00477451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111312155|NCT00477451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111312156|NCT00477451|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111312157|NCT00477451|Respiratory System Agents|respiratory system agents|mesh-ancestor
111312158|NCT00530803|Lidocaine|lidocaine|mesh-list
111312159|NCT00530803|Tetracaine|tetracaine|mesh-list
111312160|NCT00530803|Prilocaine|prilocaine|mesh-list
111036614|NCT03172065|Analgesics|analgesics|mesh-ancestor
111312161|NCT00530803|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
111312162|NCT00530803|Anesthetics, Local|anesthetics, local|mesh-ancestor
111312163|NCT00530803|Anesthetics|anesthetics|mesh-ancestor
111312164|NCT00530803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111312165|NCT00530803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111312166|NCT00530803|Sensory System Agents|sensory system agents|mesh-ancestor
111312167|NCT00530803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111312168|NCT00530803|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111312169|NCT00530803|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111312170|NCT00530803|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111312171|NCT00530803|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111312172|NCT00530803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111312173|NCT00530803|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
111312174|NCT04372927|Cisplatin|cisplatin|mesh-list
111312175|NCT04372927|Etoposide|etoposide|mesh-list
111312176|NCT04372927|Pemetrexed|pemetrexed|mesh-list
111312177|NCT04372927|Etoposide phosphate|etoposide phosphate|mesh-list
111312178|NCT04372927|Durvalumab|durvalumab|mesh-list
111312179|NCT04372927|Podophyllotoxin|podophyllotoxin|mesh-list
111312180|NCT04372927|Immunoglobulins|immunoglobulins|mesh-list
111312181|NCT04372927|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111312182|NCT04372927|Immunoglobulin G|immunoglobulin g|mesh-list
111312183|NCT04372927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111312184|NCT04372927|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111312185|NCT04372927|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111312186|NCT04372927|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111312187|NCT04372927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111312188|NCT04372927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111312189|NCT04372927|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111312190|NCT04372927|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111312191|NCT04372927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111312192|NCT04372927|Immunologic Factors|immunologic factors|mesh-ancestor
111312193|NCT04372927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111312194|NCT04372927|Keratolytic Agents|keratolytic agents|mesh-ancestor
111312195|NCT04372927|Dermatologic Agents|dermatologic agents|mesh-ancestor
111312196|NCT04372927|Tubulin Modulators|tubulin modulators|mesh-ancestor
111312197|NCT04372927|Antimitotic Agents|antimitotic agents|mesh-ancestor
111312198|NCT04372927|Mitosis Modulators|mitosis modulators|mesh-ancestor
111312199|NCT01381874|Prednisone|prednisone|mesh-list
111312200|NCT01381874|Prednisolone|prednisolone|mesh-list
111312201|NCT01381874|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111312202|NCT01381874|Methylprednisolone|methylprednisolone|mesh-list
111312203|NCT01381874|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111312204|NCT01381874|Prednisolone acetate|prednisolone acetate|mesh-list
111312205|NCT01381874|Exemestane|exemestane|mesh-list
111312206|NCT01381874|Abiraterone Acetate|abiraterone acetate|mesh-list
111312207|NCT01381874|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111312208|NCT01381874|Prednisolone phosphate|prednisolone phosphate|mesh-list
111312209|NCT01381874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111312210|NCT01381874|Glucocorticoids|glucocorticoids|mesh-ancestor
111312211|NCT01381874|Hormones|hormones|mesh-ancestor
111312212|NCT01381874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110980103|NCT03220880|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111312213|NCT01381874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111312214|NCT01381874|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111312215|NCT01381874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111312216|NCT01381874|Antiemetics|antiemetics|mesh-ancestor
111312217|NCT01381874|Autonomic Agents|autonomic agents|mesh-ancestor
111312218|NCT01381874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111312219|NCT01381874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111312220|NCT01381874|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111312221|NCT01381874|Protective Agents|protective agents|mesh-ancestor
111312222|NCT01381874|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111312223|NCT01381874|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111312224|NCT01381874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111312225|NCT01381874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111312226|NCT01381874|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111312227|NCT01381874|Hormone Antagonists|hormone antagonists|mesh-ancestor
111312228|NCT01381874|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111312229|NCT01399190|Bevacizumab|bevacizumab|mesh-list
111312230|NCT01399190|Capecitabine|capecitabine|mesh-list
111312231|NCT01399190|Oxaliplatin|oxaliplatin|mesh-list
111312232|NCT01399190|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111312233|NCT01399190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111312234|NCT01399190|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111312235|NCT01399190|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111312236|NCT01399190|Growth Substances|growth substances|mesh-ancestor
111312237|NCT01399190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111312238|NCT01399190|Growth Inhibitors|growth inhibitors|mesh-ancestor
111312239|NCT01399190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111312240|NCT01399190|Antimetabolites|antimetabolites|mesh-ancestor
111312241|NCT01399190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111312242|NCT01381718|Modafinil|modafinil|mesh-list
111312243|NCT01381718|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111312244|NCT01381718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111312245|NCT01381718|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
111312246|NCT01381718|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111312247|NCT01381718|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111312248|NCT01381718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111312249|NCT05365178|Fulvestrant|fulvestrant|mesh-list
111312250|NCT05365178|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111312251|NCT05365178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111312252|NCT05365178|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
111312253|NCT05365178|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111312254|NCT05365178|Hormone Antagonists|hormone antagonists|mesh-ancestor
111312255|NCT05365178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111312256|NCT05365178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111312257|NCT00479089|Dexamethasone|dexamethasone|mesh-list
111312258|NCT00479089|Docetaxel|docetaxel|mesh-list
111312259|NCT00479089|Gefitinib|gefitinib|mesh-list
111312260|NCT00479089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111312261|NCT00479089|Antiemetics|antiemetics|mesh-ancestor
111312262|NCT00479089|Autonomic Agents|autonomic agents|mesh-ancestor
111312263|NCT00479089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111312264|NCT00479089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111312265|NCT00479089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111312266|NCT00479089|Glucocorticoids|glucocorticoids|mesh-ancestor
111312267|NCT00479089|Hormones|hormones|mesh-ancestor
111312268|NCT00479089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111312269|NCT00479089|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111312270|NCT00479089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111312271|NCT00479089|Tubulin Modulators|tubulin modulators|mesh-ancestor
111312272|NCT00479089|Antimitotic Agents|antimitotic agents|mesh-ancestor
111312273|NCT00479089|Mitosis Modulators|mitosis modulators|mesh-ancestor
111312274|NCT00479089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111312275|NCT00479089|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111312276|NCT00479089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111312277|NCT01398956|Levetiracetam|levetiracetam|mesh-list
111312278|NCT01398956|Anticonvulsants|anticonvulsants|mesh-ancestor
111312279|NCT01398956|Nootropic Agents|nootropic agents|mesh-ancestor
111312280|NCT00410423|Cytarabine|cytarabine|mesh-list
111312281|NCT00410423|Etoposide|etoposide|mesh-list
111312282|NCT00410423|Mitoxantrone|mitoxantrone|mesh-list
111312283|NCT00410423|Bortezomib|bortezomib|mesh-list
111312284|NCT00410423|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111312285|NCT00410423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111312286|NCT00410423|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111312287|NCT00410423|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111312288|NCT00410423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111312289|NCT00410423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111312290|NCT00410423|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111312291|NCT00410423|Antimetabolites|antimetabolites|mesh-ancestor
111312292|NCT00410423|Antiviral Agents|antiviral agents|mesh-ancestor
111312293|NCT00410423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111312294|NCT00410423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111312295|NCT00410423|Immunologic Factors|immunologic factors|mesh-ancestor
111312296|NCT00410423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111312297|NCT00410423|Analgesics|analgesics|mesh-ancestor
111312298|NCT00410423|Sensory System Agents|sensory system agents|mesh-ancestor
111312299|NCT00410423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111312300|NCT00387959|Cyclosporine|cyclosporine|mesh-list
111312301|NCT00387959|Mycophenolic Acid|mycophenolic acid|mesh-list
111312302|NCT00387959|Cyclophosphamide|cyclophosphamide|mesh-list
111312303|NCT00387959|Rituximab|rituximab|mesh-list
111312304|NCT00387959|Fludarabine|fludarabine|mesh-list
111312305|NCT00387959|Fludarabine phosphate|fludarabine phosphate|mesh-list
111312306|NCT00387959|Cyclosporins|cyclosporins|mesh-list
111312307|NCT00387959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111312308|NCT00387959|Immunologic Factors|immunologic factors|mesh-ancestor
111312309|NCT00387959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111312310|NCT00387959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111312311|NCT00387959|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111312312|NCT00387959|Alkylating Agents|alkylating agents|mesh-ancestor
111312313|NCT00387959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111312314|NCT00387959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111312315|NCT00387959|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111312316|NCT00387959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111312317|NCT00387959|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111312318|NCT00387959|Antimetabolites|antimetabolites|mesh-ancestor
111312319|NCT00387959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111312320|NCT00387959|Antifungal Agents|antifungal agents|mesh-ancestor
111312321|NCT00387959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111312322|NCT00387959|Dermatologic Agents|dermatologic agents|mesh-ancestor
111312323|NCT00387959|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111312324|NCT00387959|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111312325|NCT00387959|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111312326|NCT00387959|Antitubercular Agents|antitubercular agents|mesh-ancestor
111312327|NCT00387959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111312328|NCT00410891|Gatifloxacin|gatifloxacin|mesh-list
111312329|NCT00410891|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111312330|NCT00410891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111312331|NCT00410891|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
111312332|NCT00410891|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111312333|NCT00410891|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111312334|NCT00410891|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111312335|NCT00410891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111312336|NCT00410891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111312337|NCT00410891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111312338|NCT01381562|Meropenem|meropenem|mesh-list
111312339|NCT01381562|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111312340|NCT01381562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111312341|NCT01381016|Hormones|hormones|mesh-list
111312342|NCT01381016|Estradiol|estradiol|mesh-list
111312343|NCT01381016|Progesterone|progesterone|mesh-list
111312344|NCT01381016|Estrogens|estrogens|mesh-list
111312345|NCT01381016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111312346|NCT01381016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111312347|NCT01381016|Progestins|progestins|mesh-ancestor
111312348|NCT00412451|Plasminogen|plasminogen|mesh-list
111312349|NCT00412451|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111312350|NCT00412451|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111312351|NCT00412451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111312352|NCT01398410|Rabeprazole|rabeprazole|mesh-list
111312353|NCT01398410|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111312354|NCT01398410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111312355|NCT01398410|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111312356|NCT01398410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111312357|NCT01398410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111312358|NCT00412529|Entecavir|entecavir|mesh-list
111312359|NCT00412529|Telbivudine|telbivudine|mesh-list
111312360|NCT00412529|Antiviral Agents|antiviral agents|mesh-ancestor
111312361|NCT00412529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110980106|NCT03220880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111312362|NCT00412529|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111312363|NCT00412529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111312364|NCT00412529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111312365|NCT00412841|Atorvastatin|atorvastatin|mesh-list
111312366|NCT00412841|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111312367|NCT00412841|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111312368|NCT00412841|Antimetabolites|antimetabolites|mesh-ancestor
111312369|NCT00412841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111312370|NCT00412841|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111312371|NCT00412841|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111312372|NCT00412841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111312373|NCT01796483|Clonidine|clonidine|mesh-list
111312374|NCT01796483|Analgesics|analgesics|mesh-ancestor
111312375|NCT01796483|Sensory System Agents|sensory system agents|mesh-ancestor
111312376|NCT01796483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111312377|NCT01796483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111312378|NCT01796483|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111312379|NCT01796483|Sympatholytics|sympatholytics|mesh-ancestor
111312380|NCT01796483|Autonomic Agents|autonomic agents|mesh-ancestor
111312381|NCT01796483|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111312382|NCT01796483|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111312383|NCT01796483|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111312384|NCT01796483|Adrenergic Agents|adrenergic agents|mesh-ancestor
111312385|NCT01796483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111312386|NCT01796483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111312387|NCT00414167|Bupropion|bupropion|mesh-list
111312388|NCT00414167|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111312389|NCT00414167|Antidepressive Agents|antidepressive agents|mesh-ancestor
111312390|NCT00414167|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111312391|NCT00414167|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111312392|NCT00414167|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111312393|NCT00414167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111312394|NCT00414167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111312395|NCT00414167|Dopamine Agents|dopamine agents|mesh-ancestor
111312396|NCT00414167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111312397|NCT00414167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111312398|NCT00414167|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111312399|NCT00414167|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111312400|NCT00414167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111312401|NCT01380782|Nintedanib|nintedanib|mesh-list
111312402|NCT01380782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111312403|NCT01380782|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111312404|NCT01380782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111312405|NCT01380782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111312406|NCT00534001|Bupropion|bupropion|mesh-list
111312407|NCT00534001|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111312408|NCT00534001|Antidepressive Agents|antidepressive agents|mesh-ancestor
111312409|NCT00534001|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111312410|NCT00534001|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111312411|NCT00534001|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111312412|NCT00534001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111312413|NCT00534001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111312414|NCT00534001|Dopamine Agents|dopamine agents|mesh-ancestor
111312415|NCT00534001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111312416|NCT00534001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111312417|NCT00534001|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111312418|NCT00534001|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111312419|NCT00534001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111312420|NCT00481351|Simvastatin|simvastatin|mesh-list
111312421|NCT00481351|Ezetimibe|ezetimibe|mesh-list
111312422|NCT00481351|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111312423|NCT00481351|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111312424|NCT00481351|Antimetabolites|antimetabolites|mesh-ancestor
111312425|NCT00481351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111312426|NCT00481351|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111312427|NCT00481351|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111312428|NCT00481351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111312429|NCT00455975|Bevacizumab|bevacizumab|mesh-list
111312430|NCT00455975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111312431|NCT00455975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111312432|NCT00455975|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111312433|NCT00455975|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111312434|NCT00455975|Growth Substances|growth substances|mesh-ancestor
111312435|NCT00455975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111312436|NCT00455975|Growth Inhibitors|growth inhibitors|mesh-ancestor
111312437|NCT05366192|Ritonavir|ritonavir|mesh-list
111312438|NCT05366192|Nirmatrelvir|nirmatrelvir|mesh-list
111312439|NCT05366192|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111312440|NCT05366192|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111312441|NCT05366192|Protease Inhibitors|protease inhibitors|mesh-ancestor
111312442|NCT05366192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111312443|NCT05366192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111312444|NCT05366192|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111312445|NCT05366192|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111312446|NCT05366192|Antiviral Agents|antiviral agents|mesh-ancestor
111312447|NCT05366192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111312448|NCT05366192|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111312449|NCT05366192|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111312450|NCT04013672|Pembrolizumab|pembrolizumab|mesh-list
111312451|NCT04013672|Sargramostim|sargramostim|mesh-list
111312452|NCT04013672|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
111312453|NCT04013672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111312454|NCT04013672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111312455|NCT04013672|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111312456|NCT04013672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111312457|NCT04013672|Immunologic Factors|immunologic factors|mesh-ancestor
111312458|NCT04013672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111312459|NCT04013672|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111312460|NCT02078882|Abatacept|abatacept|mesh-list
111312461|NCT02078882|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111312462|NCT02078882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111312463|NCT02078882|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111312464|NCT02078882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111312465|NCT02078882|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111312466|NCT02078882|Immunologic Factors|immunologic factors|mesh-ancestor
111312467|NCT02078882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111312468|NCT02078882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111312469|NCT00458237|Trastuzumab|trastuzumab|mesh-list
111312470|NCT00458237|Everolimus|everolimus|mesh-list
111312471|NCT00458237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111312472|NCT00458237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111312473|NCT00458237|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111312474|NCT00458237|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111312475|NCT00458237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111312476|NCT00458237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111312477|NCT00458237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111312478|NCT00458237|Immunologic Factors|immunologic factors|mesh-ancestor
111312479|NCT00458237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111312480|NCT00418457|Anesthetics|anesthetics|mesh-list
111312481|NCT00418457|Propofol|propofol|mesh-list
111312482|NCT00418457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111312483|NCT00418457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111312484|NCT00418457|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111312485|NCT00418457|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111312486|NCT00418457|Anesthetics, General|anesthetics, general|mesh-ancestor
111312487|NCT01397552|Dexamethasone|dexamethasone|mesh-list
111312488|NCT01397552|Methylprednisolone|methylprednisolone|mesh-list
111312489|NCT01397552|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111312490|NCT01397552|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111312491|NCT01397552|Prednisolone|prednisolone|mesh-list
111312492|NCT01397552|Prednisolone acetate|prednisolone acetate|mesh-list
111312493|NCT01397552|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111312494|NCT01397552|Prednisolone phosphate|prednisolone phosphate|mesh-list
111312495|NCT01397552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111312496|NCT01397552|Antiemetics|antiemetics|mesh-ancestor
111312497|NCT01397552|Autonomic Agents|autonomic agents|mesh-ancestor
111312498|NCT01397552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111312499|NCT01397552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111312500|NCT01397552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111312501|NCT01397552|Glucocorticoids|glucocorticoids|mesh-ancestor
111312502|NCT01397552|Hormones|hormones|mesh-ancestor
111312503|NCT01397552|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110980108|NCT02929589|Ibuprofen|ibuprofen|mesh-list
111312504|NCT01397552|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111312505|NCT01397552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111312506|NCT01397552|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111312507|NCT01397552|Protective Agents|protective agents|mesh-ancestor
111312508|NCT00482911|Cyclophosphamide|cyclophosphamide|mesh-list
111312509|NCT00482911|Lenalidomide|lenalidomide|mesh-list
111312510|NCT00482911|Sunitinib|sunitinib|mesh-list
111312511|NCT00482911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111312512|NCT00482911|Immunologic Factors|immunologic factors|mesh-ancestor
111312513|NCT00482911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111312514|NCT00482911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111312515|NCT00482911|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111312516|NCT00482911|Alkylating Agents|alkylating agents|mesh-ancestor
111312517|NCT00482911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111312518|NCT00482911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111312519|NCT00482911|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111312520|NCT00482911|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111312521|NCT00482911|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111312522|NCT00482911|Growth Substances|growth substances|mesh-ancestor
111312523|NCT00482911|Growth Inhibitors|growth inhibitors|mesh-ancestor
111312524|NCT00482911|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111312525|NCT00482911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111312526|NCT01397162|Fluticasone|fluticasone|mesh-list
111312527|NCT01397162|Xhance|xhance|mesh-list
111312528|NCT01397162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111312529|NCT01397162|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111312530|NCT01397162|Autonomic Agents|autonomic agents|mesh-ancestor
111312531|NCT01397162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111312532|NCT01397162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111312533|NCT01397162|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111312534|NCT01397162|Respiratory System Agents|respiratory system agents|mesh-ancestor
111312535|NCT01397162|Dermatologic Agents|dermatologic agents|mesh-ancestor
111312536|NCT01397162|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111312537|NCT05362916|Letermovir|letermovir|mesh-list
111312538|NCT05362916|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111312539|NCT05362916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111312540|NCT05362916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111312541|NCT05362916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111312542|NCT05362916|Antiviral Agents|antiviral agents|mesh-ancestor
111312543|NCT05362916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111312544|NCT00483223|Carboplatin|carboplatin|mesh-list
111312545|NCT00483223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111312546|NCT01397084|Esomeprazole|esomeprazole|mesh-list
111312547|NCT01397084|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111312548|NCT01397084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111312549|NCT01397084|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111312550|NCT01397084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111312551|NCT01397084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111312552|NCT00420017|Amiodarone|amiodarone|mesh-list
111312553|NCT00420017|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111312554|NCT00420017|Vasodilator Agents|vasodilator agents|mesh-ancestor
111312555|NCT00420017|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
111312556|NCT00420017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111312557|NCT00420017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111312558|NCT00420017|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111312559|NCT00420017|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111312560|NCT00420017|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111312561|NCT00420017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111312562|NCT00420017|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111312563|NCT00420017|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111312564|NCT00420017|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111312565|NCT00484393|Tetracaine|tetracaine|mesh-list
111312566|NCT00484393|Anesthetics, Local|anesthetics, local|mesh-ancestor
111312567|NCT00484393|Anesthetics|anesthetics|mesh-ancestor
111312568|NCT00484393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111312569|NCT00484393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111312570|NCT00484393|Sensory System Agents|sensory system agents|mesh-ancestor
111312571|NCT00484393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111312572|NCT00485485|Docetaxel|docetaxel|mesh-list
111312573|NCT00485485|Imatinib Mesylate|imatinib mesylate|mesh-list
111312574|NCT00485485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111312575|NCT00485485|Tubulin Modulators|tubulin modulators|mesh-ancestor
111312576|NCT00485485|Antimitotic Agents|antimitotic agents|mesh-ancestor
111312577|NCT00485485|Mitosis Modulators|mitosis modulators|mesh-ancestor
111312578|NCT00485485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111312579|NCT00485485|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111312580|NCT00485485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111312581|NCT00422201|Mifepristone|mifepristone|mesh-list
111312582|NCT00422201|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
111312583|NCT00422201|Abortifacient Agents|abortifacient agents|mesh-ancestor
111312584|NCT00422201|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111312585|NCT00422201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111312586|NCT00422201|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111312587|NCT00422201|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111312588|NCT00422201|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111312589|NCT00422201|Contraceptive Agents|contraceptive agents|mesh-ancestor
111312590|NCT00422201|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
111312591|NCT00422201|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
111312592|NCT00422201|Hormone Antagonists|hormone antagonists|mesh-ancestor
111312593|NCT00422201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111312594|NCT00422201|Luteolytic Agents|luteolytic agents|mesh-ancestor
111312595|NCT00422201|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111312596|NCT00422201|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
111312597|NCT01396148|Sunitinib|sunitinib|mesh-list
111312598|NCT01396148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111312599|NCT01396148|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111312600|NCT01396148|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111312601|NCT01396148|Growth Substances|growth substances|mesh-ancestor
111312602|NCT01396148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111312603|NCT01396148|Growth Inhibitors|growth inhibitors|mesh-ancestor
111312604|NCT01396148|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111312605|NCT01396148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111312606|NCT01396148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111312607|NCT00485953|Risedronic Acid|risedronic acid|mesh-list
111037062|NCT05678036|Analgesics|analgesics|mesh-ancestor
111312609|NCT00485953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111312610|NCT00485953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111312611|NCT00485953|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111312612|NCT00485953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111312613|NCT00485953|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111312614|NCT00486031|Balsalazide|balsalazide|mesh-list
111312615|NCT00486031|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111312616|NCT00486031|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111312617|NCT00486031|Analgesics|analgesics|mesh-ancestor
111312618|NCT00486031|Sensory System Agents|sensory system agents|mesh-ancestor
111312619|NCT00486031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111312620|NCT00486031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111312621|NCT00486031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111312622|NCT00486031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111312623|NCT00486031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111312624|NCT04019834|Bupivacaine|bupivacaine|mesh-list
111312625|NCT04019834|Anesthetics, Local|anesthetics, local|mesh-ancestor
111312626|NCT04019834|Anesthetics|anesthetics|mesh-ancestor
111312627|NCT04019834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111312628|NCT04019834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111312629|NCT04019834|Sensory System Agents|sensory system agents|mesh-ancestor
111312630|NCT04019834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111312631|NCT04017962|Letermovir|letermovir|mesh-list
111312632|NCT04017962|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111312633|NCT04017962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111312634|NCT04017962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111312635|NCT04017962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111312636|NCT04017962|Antiviral Agents|antiviral agents|mesh-ancestor
111312637|NCT04017962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110765328|NCT03913884|Mitogens|mitogens|mesh-list
111312638|NCT01396070|Brentuximab Vedotin|brentuximab vedotin|mesh-list
111312639|NCT01396070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111312640|NCT01396070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111312641|NCT01396070|Immunotoxins|immunotoxins|mesh-ancestor
111312642|NCT01396070|Immunoconjugates|immunoconjugates|mesh-ancestor
111312643|NCT01396070|Immunologic Factors|immunologic factors|mesh-ancestor
111312644|NCT01396070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111312645|NCT02108171|Dexmedetomidine|dexmedetomidine|mesh-list
111312646|NCT02108171|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111312647|NCT02108171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111312648|NCT02108171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111312649|NCT02108171|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111312650|NCT02108171|Analgesics|analgesics|mesh-ancestor
111312651|NCT02108171|Sensory System Agents|sensory system agents|mesh-ancestor
111312652|NCT02108171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111312653|NCT02108171|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111312654|NCT02108171|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111312655|NCT02108171|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111312656|NCT02108171|Adrenergic Agents|adrenergic agents|mesh-ancestor
111312657|NCT02108171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111312658|NCT02108171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111312659|NCT03940807|Estradiol|estradiol|mesh-list
111312660|NCT03940807|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
111312661|NCT03940807|Estrogens|estrogens|mesh-ancestor
111312662|NCT03940807|Hormones|hormones|mesh-ancestor
111312663|NCT03940807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111312664|NCT03940807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111312665|NCT00535873|Lenalidomide|lenalidomide|mesh-list
111312666|NCT00535873|Immunologic Factors|immunologic factors|mesh-ancestor
111312667|NCT00535873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111312668|NCT00535873|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111312669|NCT00535873|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111312670|NCT00535873|Growth Substances|growth substances|mesh-ancestor
111312671|NCT00535873|Growth Inhibitors|growth inhibitors|mesh-ancestor
111312672|NCT00535873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111312673|NCT00487669|Paclitaxel|paclitaxel|mesh-list
111312674|NCT00487669|Pemetrexed|pemetrexed|mesh-list
111312675|NCT00487669|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
111312676|NCT00487669|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111312677|NCT00487669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111312678|NCT00487669|Tubulin Modulators|tubulin modulators|mesh-ancestor
111312679|NCT00487669|Antimitotic Agents|antimitotic agents|mesh-ancestor
111312680|NCT00487669|Mitosis Modulators|mitosis modulators|mesh-ancestor
111312681|NCT00487669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111312682|NCT00487669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111312683|NCT00487669|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111312684|NCT00487669|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111312686|NCT00488059|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-list
111312687|NCT00488059|Integrase Inhibitors|integrase inhibitors|mesh-list
111312688|NCT00488059|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
111312689|NCT00488059|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
111312690|NCT00488059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111312691|NCT00488059|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111312692|NCT00488059|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111312693|NCT00488059|Antiviral Agents|antiviral agents|mesh-ancestor
111312694|NCT00488059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111312695|NCT00488059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111312696|NCT00536341|Rituximab|rituximab|mesh-list
111312697|NCT00536341|Fludarabine|fludarabine|mesh-list
111312698|NCT00536341|Lenalidomide|lenalidomide|mesh-list
111312699|NCT00536341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111312700|NCT00536341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111312701|NCT00536341|Immunologic Factors|immunologic factors|mesh-ancestor
111312702|NCT00536341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111312703|NCT00536341|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111312704|NCT00536341|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111312705|NCT00536341|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111312706|NCT00536341|Growth Substances|growth substances|mesh-ancestor
111312707|NCT00536341|Growth Inhibitors|growth inhibitors|mesh-ancestor
111312708|NCT02122471|Plecanatide|plecanatide|mesh-list
111312709|NCT02122471|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
111312710|NCT02122471|Enzyme Activators|enzyme activators|mesh-ancestor
111312711|NCT02122471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111312712|NCT02122471|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111312713|NCT00461591|Apaziquone|apaziquone|mesh-list
111312714|NCT00461591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111312715|NCT00533117|Fluoxetine|fluoxetine|mesh-list
111312716|NCT00533117|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111312717|NCT00533117|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111312718|NCT00533117|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111312719|NCT00533117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111312720|NCT00533117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111312721|NCT00533117|Serotonin Agents|serotonin agents|mesh-ancestor
111312722|NCT00533117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111312723|NCT00533117|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111312724|NCT00533117|Antidepressive Agents|antidepressive agents|mesh-ancestor
111312725|NCT00533117|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111312726|NCT00533117|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111312727|NCT00533117|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111312728|NCT00533117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111312729|NCT00423683|PENTA|penta|mesh-list
111312730|NCT00423683|Fondaparinux|fondaparinux|mesh-list
111312731|NCT00423683|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111312732|NCT00423683|Antithrombins|antithrombins|mesh-ancestor
111312733|NCT00423683|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111312734|NCT00423683|Protease Inhibitors|protease inhibitors|mesh-ancestor
111312735|NCT00423683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111312736|NCT00423683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111312737|NCT00423683|Anticoagulants|anticoagulants|mesh-ancestor
111312738|NCT00423683|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111312739|NCT00423683|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111312740|NCT00424619|Vitamin D|vitamin d|mesh-list
111312741|NCT00424619|Ergocalciferols|ergocalciferols|mesh-list
111312742|NCT00424619|Cholecalciferol|cholecalciferol|mesh-list
111312743|NCT00424619|Vitamins|vitamins|mesh-list
111312744|NCT00424619|Micronutrients|micronutrients|mesh-ancestor
111312745|NCT00424619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111312746|NCT00424619|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111312747|NCT00424619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111312748|NCT00425477|Bexarotene|bexarotene|mesh-list
111312749|NCT00425477|Sargramostim|sargramostim|mesh-list
111312750|NCT00425477|Immunologic Factors|immunologic factors|mesh-ancestor
111312751|NCT00425477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111312752|NCT00425477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111312753|NCT00427037|Vitamin D|vitamin d|mesh-list
111037215|NCT02168959|Anesthetics|anesthetics|mesh-ancestor
111312754|NCT00427037|Cholecalciferol|cholecalciferol|mesh-list
111312755|NCT00427037|Vitamins|vitamins|mesh-ancestor
111312756|NCT00427037|Micronutrients|micronutrients|mesh-ancestor
111312757|NCT00427037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111312758|NCT00427037|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111312759|NCT00427037|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111312760|NCT02113241|Dapagliflozin|dapagliflozin|mesh-list
111312761|NCT02113241|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111312762|NCT02113241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111312763|NCT02113241|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111312764|NCT02113241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111312765|NCT00427661|Cyclosporine|cyclosporine|mesh-list
111312766|NCT00427661|Fludarabine|fludarabine|mesh-list
111312767|NCT00427661|Busulfan|busulfan|mesh-list
111312768|NCT00427661|Cyclosporins|cyclosporins|mesh-list
111312769|NCT00427661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111312770|NCT00427661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111312771|NCT00427661|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111312772|NCT00427661|Immunologic Factors|immunologic factors|mesh-ancestor
111312773|NCT00427661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111312774|NCT00427661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111312775|NCT00427661|Antifungal Agents|antifungal agents|mesh-ancestor
111312776|NCT00427661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111312777|NCT00427661|Dermatologic Agents|dermatologic agents|mesh-ancestor
111312778|NCT00427661|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111312779|NCT00427661|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111312780|NCT00427661|Alkylating Agents|alkylating agents|mesh-ancestor
111312781|NCT00427661|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111312782|NCT00427661|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111312783|NCT00427973|Cediranib|cediranib|mesh-list
111312784|NCT00427973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111312785|NCT00427973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111312786|NCT00427973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111312787|NCT00427973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111312788|NCT01795703|Prednisolone|prednisolone|mesh-list
111312789|NCT01795703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111312790|NCT01795703|Glucocorticoids|glucocorticoids|mesh-ancestor
111312791|NCT01795703|Hormones|hormones|mesh-ancestor
111312792|NCT01795703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111312793|NCT01795703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111312794|NCT01795703|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111312795|NCT01795703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111312796|NCT00429143|Mycophenolic Acid|mycophenolic acid|mesh-list
111312797|NCT00429143|Cyclophosphamide|cyclophosphamide|mesh-list
111312798|NCT00429143|Tacrolimus|tacrolimus|mesh-list
111312799|NCT00429143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111312800|NCT00429143|Immunologic Factors|immunologic factors|mesh-ancestor
111312801|NCT00429143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111312802|NCT00429143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111312803|NCT00429143|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111312804|NCT00429143|Alkylating Agents|alkylating agents|mesh-ancestor
111312805|NCT00429143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111312806|NCT00429143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111312807|NCT00429143|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111312808|NCT00429143|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111312809|NCT00429143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111312810|NCT00429143|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111312811|NCT00429143|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111312812|NCT00429143|Antitubercular Agents|antitubercular agents|mesh-ancestor
111312813|NCT00429143|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111312814|NCT00429143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111312815|NCT00432341|Botulinum Toxins|botulinum toxins|mesh-list
111312816|NCT00432341|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111312817|NCT00432341|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111312818|NCT00432341|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111312819|NCT00432341|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111312820|NCT00432341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111312821|NCT00432341|Cholinergic Agents|cholinergic agents|mesh-ancestor
111312822|NCT00432341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111312823|NCT00432341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111312824|NCT00432341|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111312825|NCT00432341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111312826|NCT00433745|Vaccines|vaccines|mesh-list
111312827|NCT00433745|Immunologic Factors|immunologic factors|mesh-ancestor
111312828|NCT00433745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111312829|NCT01395758|Gemcitabine|gemcitabine|mesh-list
111312831|NCT01395758|Pemetrexed|pemetrexed|mesh-list
111312832|NCT01395758|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111312833|NCT01395758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111312834|NCT01395758|Antimetabolites|antimetabolites|mesh-ancestor
111312835|NCT01395758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111312836|NCT01395758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111312837|NCT01395758|Tubulin Modulators|tubulin modulators|mesh-ancestor
111312838|NCT01395758|Antimitotic Agents|antimitotic agents|mesh-ancestor
111312839|NCT01395758|Mitosis Modulators|mitosis modulators|mesh-ancestor
111312840|NCT01395758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111312841|NCT01395758|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111312842|NCT01395758|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111312843|NCT01395758|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111312844|NCT00462605|Entinostat|entinostat|mesh-list
111312845|NCT00462605|Sargramostim|sargramostim|mesh-list
111312846|NCT00462605|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
111312847|NCT00462605|Immunologic Factors|immunologic factors|mesh-ancestor
111312848|NCT00462605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111312849|NCT00462605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111312850|NCT00462605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111312851|NCT00462605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111312852|NCT02120287|Bevacizumab|bevacizumab|mesh-list
111312853|NCT02120287|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111312854|NCT02120287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111312855|NCT02120287|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111312856|NCT02120287|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111312857|NCT02120287|Growth Substances|growth substances|mesh-ancestor
111312858|NCT02120287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111312859|NCT02120287|Growth Inhibitors|growth inhibitors|mesh-ancestor
111312860|NCT00534833|Vaccines|vaccines|mesh-list
111312861|NCT00534833|Immunologic Factors|immunologic factors|mesh-ancestor
111312862|NCT00534833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111312863|NCT00434993|Albuterol|albuterol|mesh-list
111312864|NCT00434993|Dimercaprol|dimercaprol|mesh-list
111312865|NCT00434993|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111312866|NCT00434993|Autonomic Agents|autonomic agents|mesh-ancestor
111312867|NCT00434993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111312868|NCT00434993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111312869|NCT00434993|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111312870|NCT00434993|Respiratory System Agents|respiratory system agents|mesh-ancestor
111312871|NCT00434993|Tocolytic Agents|tocolytic agents|mesh-ancestor
111312872|NCT00434993|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111312873|NCT00434993|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111312874|NCT00434993|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111312875|NCT00434993|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111312876|NCT00434993|Adrenergic Agents|adrenergic agents|mesh-ancestor
111312877|NCT00434993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111312878|NCT00434993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111312879|NCT00434993|Chelating Agents|chelating agents|mesh-ancestor
111312880|NCT00434993|Sequestering Agents|sequestering agents|mesh-ancestor
111312881|NCT01395524|Naloxegol|naloxegol|mesh-list
111312882|NCT01395524|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111312883|NCT01395524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111312884|NCT01395524|Sensory System Agents|sensory system agents|mesh-ancestor
111312885|NCT01395524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111312886|NCT04338698|Azithromycin|azithromycin|mesh-list
111312887|NCT04338698|Hydroxychloroquine|hydroxychloroquine|mesh-list
111312888|NCT04338698|Oseltamivir|oseltamivir|mesh-list
111312889|NCT04338698|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111312890|NCT04338698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111312891|NCT04338698|Antimalarials|antimalarials|mesh-ancestor
111312892|NCT04338698|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111312893|NCT04338698|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111312894|NCT04338698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111312895|NCT04338698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111312896|NCT04338698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111312897|NCT04338698|Antiviral Agents|antiviral agents|mesh-ancestor
111312898|NCT00435539|Plasminogen|plasminogen|mesh-list
111312899|NCT00435539|Fibrinolysin|fibrinolysin|mesh-list
111312900|NCT00435539|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111312901|NCT00435539|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111312902|NCT00435539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111312903|NCT00464711|Escitalopram|escitalopram|mesh-list
111037363|NCT05142319|Vaccines|vaccines|mesh-list
111312904|NCT00464711|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111312905|NCT00464711|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111312906|NCT00464711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111312907|NCT00464711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111312908|NCT00464711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111312909|NCT00464711|Serotonin Agents|serotonin agents|mesh-ancestor
111312910|NCT00464711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111312911|NCT02078180|Bupropion|bupropion|mesh-list
111312912|NCT02078180|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111312913|NCT02078180|Antidepressive Agents|antidepressive agents|mesh-ancestor
111312914|NCT02078180|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111312915|NCT02078180|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111312916|NCT02078180|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111312917|NCT02078180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111312918|NCT02078180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111312919|NCT02078180|Dopamine Agents|dopamine agents|mesh-ancestor
111312920|NCT02078180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111312921|NCT02078180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111312922|NCT02078180|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111312923|NCT02078180|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111312924|NCT02078180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111312925|NCT00535613|Propofol|propofol|mesh-list
111312926|NCT00535613|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111312927|NCT00535613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111312928|NCT00535613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111312929|NCT00535613|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111312930|NCT00535613|Anesthetics, General|anesthetics, general|mesh-ancestor
111312931|NCT00535613|Anesthetics|anesthetics|mesh-ancestor
111312932|NCT00466661|Acamprosate|acamprosate|mesh-list
111312933|NCT00466661|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111312934|NCT05360576|Ethinyl Estradiol|ethinyl estradiol|mesh-list
111312935|NCT05360576|Etonogestrel|etonogestrel|mesh-list
111312936|NCT05360576|NuvaRing|nuvaring|mesh-list
111312937|NCT05360576|Estradiol|estradiol|mesh-list
111312938|NCT05360576|Estrogens|estrogens|mesh-ancestor
111312939|NCT05360576|Hormones|hormones|mesh-ancestor
111312940|NCT05360576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111312941|NCT05360576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111312942|NCT05360576|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111312943|NCT05360576|Contraceptive Agents|contraceptive agents|mesh-ancestor
111312944|NCT05360576|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111312945|NCT05360576|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111312946|NCT05360576|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111312947|NCT05360576|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111312948|NCT00535925|Aspirin|aspirin|mesh-list
111312949|NCT00535925|Atenolol|atenolol|mesh-list
111312950|NCT00535925|Amlodipine|amlodipine|mesh-list
111312951|NCT00535925|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
111312952|NCT00535925|Clonidine|clonidine|mesh-list
111312953|NCT00535925|Ramipril|ramipril|mesh-list
111312954|NCT00535925|Irbesartan|irbesartan|mesh-list
111312955|NCT00535925|Doxazosin|doxazosin|mesh-list
111312956|NCT00535925|Furosemide|furosemide|mesh-list
111312957|NCT00535925|Epoetin Alfa|epoetin alfa|mesh-list
111312958|NCT00535925|Simvastatin|simvastatin|mesh-list
111312959|NCT00535925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111312960|NCT00535925|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111312961|NCT00535925|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111312962|NCT00535925|Analgesics|analgesics|mesh-ancestor
111312963|NCT00535925|Sensory System Agents|sensory system agents|mesh-ancestor
111312964|NCT00535925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111312965|NCT00535925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111312966|NCT00535925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111312967|NCT00535925|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111312968|NCT00535925|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111312969|NCT00535925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111312970|NCT00535925|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111312971|NCT00535925|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111312972|NCT00535925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111312973|NCT00535925|Antipyretics|antipyretics|mesh-ancestor
111312974|NCT00535925|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111312975|NCT00535925|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111312976|NCT00535925|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111312977|NCT00535925|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111312978|NCT00535925|Vasodilator Agents|vasodilator agents|mesh-ancestor
111312979|NCT00535925|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111312980|NCT00535925|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111312981|NCT00535925|Antimetabolites|antimetabolites|mesh-ancestor
111312982|NCT00535925|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111312983|NCT00535925|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111312985|NCT00535925|Natriuretic Agents|natriuretic agents|mesh-ancestor
111312986|NCT00535925|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
111312987|NCT00535925|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
111312988|NCT00535925|Sympatholytics|sympatholytics|mesh-ancestor
111312989|NCT00535925|Autonomic Agents|autonomic agents|mesh-ancestor
111312990|NCT00535925|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111312991|NCT00535925|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111312992|NCT00535925|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111312993|NCT00535925|Adrenergic Agents|adrenergic agents|mesh-ancestor
111312994|NCT00535925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111312995|NCT00535925|Hematinics|hematinics|mesh-ancestor
111312996|NCT00535925|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
111312997|NCT00535925|Protease Inhibitors|protease inhibitors|mesh-ancestor
111312998|NCT00535925|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111312999|NCT00535925|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111313000|NCT00535925|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111313001|NCT00535925|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
111313002|NCT00535925|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111313003|NCT00535925|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111313004|NCT00535925|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111313005|NCT00535925|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111313006|NCT00211172|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
111313007|NCT00211172|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111313008|NCT00211172|Adrenergic Agents|adrenergic agents|mesh-ancestor
111313009|NCT00211172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111313010|NCT00211172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111313011|NCT00211172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111313012|NCT01796093|Digoxin|digoxin|mesh-list
111313013|NCT01796093|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111313014|NCT01796093|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111313015|NCT01796093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111313016|NCT01796093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111313017|NCT01796093|Protective Agents|protective agents|mesh-ancestor
111313018|NCT01796093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111313019|NCT00537511|Etoposide|etoposide|mesh-list
111313020|NCT00537511|Etoposide phosphate|etoposide phosphate|mesh-list
111313021|NCT00537511|Pomalidomide|pomalidomide|mesh-list
111313022|NCT00537511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111313023|NCT00537511|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111313024|NCT00537511|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111313025|NCT00537511|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111313026|NCT00537511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111313027|NCT00537511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111313028|NCT00537511|Immunologic Factors|immunologic factors|mesh-ancestor
111313029|NCT00537511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111313030|NCT00537511|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111313031|NCT00537511|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111313032|NCT00537511|Growth Substances|growth substances|mesh-ancestor
111313033|NCT00537511|Growth Inhibitors|growth inhibitors|mesh-ancestor
111313034|NCT00435929|Ritonavir|ritonavir|mesh-list
111313035|NCT00435929|Saquinavir|saquinavir|mesh-list
111313036|NCT00435929|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111313037|NCT00435929|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111313038|NCT00435929|Protease Inhibitors|protease inhibitors|mesh-ancestor
111313039|NCT00435929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111313040|NCT00435929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111313041|NCT00435929|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111313042|NCT00435929|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111313043|NCT00435929|Antiviral Agents|antiviral agents|mesh-ancestor
111313044|NCT00435929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111313045|NCT00435929|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111313046|NCT00435929|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111313047|NCT00436475|Calcium, Dietary|calcium, dietary|mesh-list
111313048|NCT00436475|Vitamin D|vitamin d|mesh-list
111313049|NCT00436475|Ergocalciferols|ergocalciferols|mesh-list
111313050|NCT00436475|Cholecalciferol|cholecalciferol|mesh-list
111313051|NCT00436475|Vitamins|vitamins|mesh-list
111313052|NCT00436475|Calcium Carbonate|calcium carbonate|mesh-list
111313053|NCT00436475|Calcium|calcium|mesh-list
111313054|NCT00436475|Micronutrients|micronutrients|mesh-ancestor
111313055|NCT00436475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111313056|NCT00436475|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111313057|NCT00436475|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111313058|NCT00436475|Antacids|antacids|mesh-ancestor
111313059|NCT00436475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111313060|NCT00436475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111313061|NCT00210626|Epoetin Alfa|epoetin alfa|mesh-list
111313062|NCT00210626|Hematinics|hematinics|mesh-ancestor
111313063|NCT03595514|Dexamethasone|dexamethasone|mesh-list
111313064|NCT03595514|Lidocaine|lidocaine|mesh-list
111313065|NCT03595514|Epinephrine|epinephrine|mesh-list
111313066|NCT03595514|Bupivacaine|bupivacaine|mesh-list
111313067|NCT03595514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111313068|NCT03595514|Antiemetics|antiemetics|mesh-ancestor
111313069|NCT03595514|Autonomic Agents|autonomic agents|mesh-ancestor
111313070|NCT03595514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111313071|NCT03595514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111313072|NCT03595514|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111313073|NCT03595514|Glucocorticoids|glucocorticoids|mesh-ancestor
111313074|NCT03595514|Hormones|hormones|mesh-ancestor
111313075|NCT03595514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111313076|NCT03595514|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111313077|NCT03595514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111313078|NCT03595514|Anesthetics, Local|anesthetics, local|mesh-ancestor
111313079|NCT03595514|Anesthetics|anesthetics|mesh-ancestor
111313080|NCT03595514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111313081|NCT03595514|Sensory System Agents|sensory system agents|mesh-ancestor
111313082|NCT03595514|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111313083|NCT03595514|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111313084|NCT03595514|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111313085|NCT03595514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111313086|NCT03595514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111313087|NCT03595514|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111313088|NCT03595514|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111313089|NCT03595514|Adrenergic Agents|adrenergic agents|mesh-ancestor
111313090|NCT03595514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111313091|NCT03595514|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111313092|NCT03595514|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111313093|NCT03595514|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111313094|NCT03595514|Respiratory System Agents|respiratory system agents|mesh-ancestor
111313095|NCT03595514|Mydriatics|mydriatics|mesh-ancestor
111313096|NCT03595514|Sympathomimetics|sympathomimetics|mesh-ancestor
111313097|NCT03595514|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111313098|NCT00215852|Interferon-alpha|interferon-alpha|mesh-list
111313099|NCT00215852|Antiviral Agents|antiviral agents|mesh-ancestor
111313100|NCT00215852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111313101|NCT00215852|Immunologic Factors|immunologic factors|mesh-ancestor
111313102|NCT00215852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111313103|NCT03595046|Dexamethasone|dexamethasone|mesh-list
111313104|NCT03595046|Dexamethasone acetate|dexamethasone acetate|mesh-list
111313105|NCT03595046|Ropivacaine|ropivacaine|mesh-list
111313106|NCT03595046|BB 1101|bb 1101|mesh-list
111313107|NCT03595046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111313108|NCT03595046|Antiemetics|antiemetics|mesh-ancestor
111313109|NCT03595046|Autonomic Agents|autonomic agents|mesh-ancestor
111313110|NCT03595046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111313111|NCT03595046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111313112|NCT03595046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111313113|NCT03595046|Glucocorticoids|glucocorticoids|mesh-ancestor
111313114|NCT03595046|Hormones|hormones|mesh-ancestor
111313115|NCT03595046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111313116|NCT03595046|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111313117|NCT03595046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111313118|NCT03595046|Protease Inhibitors|protease inhibitors|mesh-ancestor
111313119|NCT03595046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111313120|NCT03595046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111313121|NCT03595046|Anesthetics, Local|anesthetics, local|mesh-ancestor
111313122|NCT03595046|Anesthetics|anesthetics|mesh-ancestor
111313123|NCT03595046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111313124|NCT03595046|Sensory System Agents|sensory system agents|mesh-ancestor
111313125|NCT00217022|Budesonide|budesonide|mesh-list
111313126|NCT00217022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111313127|NCT00217022|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111313128|NCT00217022|Autonomic Agents|autonomic agents|mesh-ancestor
111313129|NCT00217022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111313130|NCT00217022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111313131|NCT00217022|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111313132|NCT00217022|Respiratory System Agents|respiratory system agents|mesh-ancestor
111313133|NCT00217022|Glucocorticoids|glucocorticoids|mesh-ancestor
111313134|NCT00217022|Hormones|hormones|mesh-ancestor
111313135|NCT00217022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111313136|NCT03594968|Progesterone|progesterone|mesh-list
111313137|NCT03594968|Progestins|progestins|mesh-ancestor
111313138|NCT03594968|Hormones|hormones|mesh-ancestor
111313139|NCT03594968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111313140|NCT03594968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111313141|NCT00538915|Immunoglobulins|immunoglobulins|mesh-list
111313142|NCT00538915|Antibodies|antibodies|mesh-list
111313143|NCT00538915|gamma-Globulins|gamma-globulins|mesh-list
111313144|NCT00538915|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111313145|NCT00538915|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
111313146|NCT00538915|Immunologic Factors|immunologic factors|mesh-ancestor
111313147|NCT00538915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111313148|NCT00490009|Acetaminophen|acetaminophen|mesh-list
111313149|NCT00490009|Iodine|iodine|mesh-list
111313150|NCT00490009|Diphenhydramine|diphenhydramine|mesh-list
111313151|NCT00490009|Promethazine|promethazine|mesh-list
111313152|NCT00490009|Cadexomer iodine|cadexomer iodine|mesh-list
111313153|NCT00490009|Tositumomab I-131|tositumomab i-131|mesh-list
111313154|NCT00490009|Lugol's solution|lugol's solution|mesh-list
111313155|NCT00490009|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111313156|NCT00490009|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111313157|NCT00490009|Analgesics|analgesics|mesh-ancestor
111313158|NCT00490009|Sensory System Agents|sensory system agents|mesh-ancestor
111313159|NCT00490009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111313160|NCT00490009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111313161|NCT00490009|Antipyretics|antipyretics|mesh-ancestor
111313162|NCT00490009|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111313163|NCT00490009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111313164|NCT00490009|Trace Elements|trace elements|mesh-ancestor
111313165|NCT00490009|Micronutrients|micronutrients|mesh-ancestor
111313166|NCT00490009|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111313167|NCT00490009|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111313168|NCT00490009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111313169|NCT00490009|Anesthetics, Local|anesthetics, local|mesh-ancestor
111313170|NCT00490009|Anesthetics|anesthetics|mesh-ancestor
111313171|NCT00490009|Antiemetics|antiemetics|mesh-ancestor
111313172|NCT00490009|Autonomic Agents|autonomic agents|mesh-ancestor
111313173|NCT00490009|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111313174|NCT00490009|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111313175|NCT00490009|Histamine Antagonists|histamine antagonists|mesh-ancestor
111313176|NCT00490009|Histamine Agents|histamine agents|mesh-ancestor
111313177|NCT00490009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111313178|NCT00490009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111313179|NCT00490009|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111313180|NCT00490009|Antipruritics|antipruritics|mesh-ancestor
111313181|NCT00490009|Dermatologic Agents|dermatologic agents|mesh-ancestor
111313182|NCT00490009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111313183|NCT00490009|Hemostatics|hemostatics|mesh-ancestor
111313184|NCT00490009|Coagulants|coagulants|mesh-ancestor
111313185|NCT03769532|Pembrolizumab|pembrolizumab|mesh-list
111313186|NCT03769532|Azacitidine|azacitidine|mesh-list
111313187|NCT03769532|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111313188|NCT03769532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111313189|NCT03769532|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111313190|NCT03769532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111313191|NCT03769532|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111313192|NCT03769532|Antimetabolites|antimetabolites|mesh-ancestor
111313193|NCT03769532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111313194|NCT00490477|Polymyxins|polymyxins|mesh-list
111313195|NCT00490477|Polymyxin B|polymyxin b|mesh-list
111313196|NCT00490477|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111313197|NCT00490477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111313198|NCT00492973|Cefuroxime|cefuroxime|mesh-list
111313199|NCT00492973|Methylprednisolone|methylprednisolone|mesh-list
111313200|NCT00492973|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111313201|NCT00492973|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111313202|NCT00492973|Prednisolone|prednisolone|mesh-list
111313203|NCT00492973|Prednisolone acetate|prednisolone acetate|mesh-list
111313204|NCT00492973|Clonidine|clonidine|mesh-list
111313205|NCT00492973|Epinephrine|epinephrine|mesh-list
111313206|NCT00492973|Morphine|morphine|mesh-list
111313207|NCT00492973|Bupivacaine|bupivacaine|mesh-list
111313208|NCT00492973|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111313209|NCT00492973|Prednisolone phosphate|prednisolone phosphate|mesh-list
111313210|NCT00492973|Anesthetics, Local|anesthetics, local|mesh-ancestor
111313211|NCT00492973|Anesthetics|anesthetics|mesh-ancestor
111313212|NCT00492973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111313213|NCT00492973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111313214|NCT00492973|Sensory System Agents|sensory system agents|mesh-ancestor
111313215|NCT00492973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111313216|NCT00492973|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111313217|NCT00492973|Narcotics|narcotics|mesh-ancestor
111313218|NCT00492973|Analgesics|analgesics|mesh-ancestor
111313219|NCT00492973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111313220|NCT00492973|Antiemetics|antiemetics|mesh-ancestor
111313221|NCT00492973|Autonomic Agents|autonomic agents|mesh-ancestor
111313222|NCT00492973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111313223|NCT00492973|Glucocorticoids|glucocorticoids|mesh-ancestor
111313224|NCT00492973|Hormones|hormones|mesh-ancestor
111313225|NCT00492973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111313226|NCT00492973|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111313227|NCT00492973|Protective Agents|protective agents|mesh-ancestor
111313228|NCT00492973|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111313229|NCT00492973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111313230|NCT00492973|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111313231|NCT00492973|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111313232|NCT00492973|Adrenergic Agents|adrenergic agents|mesh-ancestor
111313233|NCT00492973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111313234|NCT00492973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111313235|NCT00492973|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111313236|NCT00492973|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111313237|NCT00492973|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111313238|NCT00492973|Respiratory System Agents|respiratory system agents|mesh-ancestor
111313239|NCT00492973|Mydriatics|mydriatics|mesh-ancestor
111313240|NCT00492973|Sympathomimetics|sympathomimetics|mesh-ancestor
111313241|NCT00492973|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111313242|NCT00492973|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111313243|NCT00492973|Sympatholytics|sympatholytics|mesh-ancestor
111313244|NCT00492973|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111313245|NCT00492973|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111313246|NCT00492973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111313247|NCT05630534|Minocycline|minocycline|mesh-list
111313248|NCT05630534|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111313249|NCT05630534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111313250|NCT00495079|Vincristine|vincristine|mesh-list
111313251|NCT00495079|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111313252|NCT00495079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111313253|NCT00495079|Tubulin Modulators|tubulin modulators|mesh-ancestor
111313254|NCT00495079|Antimitotic Agents|antimitotic agents|mesh-ancestor
111313255|NCT00495079|Mitosis Modulators|mitosis modulators|mesh-ancestor
111313256|NCT00495079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111313257|NCT03594188|Anesthetics|anesthetics|mesh-list
111313258|NCT03594188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111313259|NCT03594188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111313260|NCT00539695|Aldesleukin|aldesleukin|mesh-list
111313261|NCT00539695|Interleukin-2|interleukin-2|mesh-list
111313262|NCT00539695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111313263|NCT00539695|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111313264|NCT00539695|Analgesics|analgesics|mesh-ancestor
111313265|NCT00539695|Sensory System Agents|sensory system agents|mesh-ancestor
111313266|NCT00539695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111313267|NCT00539695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111313268|NCT00539695|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111313269|NCT00539695|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111313270|NCT00539695|Antiviral Agents|antiviral agents|mesh-ancestor
111313271|NCT00539695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111313272|NCT03593954|Ritonavir|ritonavir|mesh-list
111313273|NCT03593954|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111313274|NCT03593954|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111313275|NCT03593954|Protease Inhibitors|protease inhibitors|mesh-ancestor
111313276|NCT03593954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111313277|NCT03593954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111313278|NCT03593954|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111313279|NCT03593954|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111313280|NCT03593954|Antiviral Agents|antiviral agents|mesh-ancestor
111313281|NCT03593954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111313282|NCT03593954|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111313283|NCT03593954|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111313284|NCT03590210|Nivolumab|nivolumab|mesh-list
111313285|NCT03590210|Trabectedin|trabectedin|mesh-list
111313286|NCT03590210|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111313287|NCT03590210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111313288|NCT03590210|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111313289|NCT03590210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111313290|NCT03590210|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111313291|NCT03590210|Alkylating Agents|alkylating agents|mesh-ancestor
111313292|NCT05632328|Paclitaxel|paclitaxel|mesh-list
111313293|NCT05632328|Gemcitabine|gemcitabine|mesh-list
111313294|NCT05632328|Antibodies, Bispecific|antibodies, bispecific|mesh-list
111313295|NCT05632328|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111313296|NCT05632328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111313297|NCT05632328|Tubulin Modulators|tubulin modulators|mesh-ancestor
111313298|NCT05632328|Antimitotic Agents|antimitotic agents|mesh-ancestor
111313299|NCT05632328|Mitosis Modulators|mitosis modulators|mesh-ancestor
111313300|NCT05632328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111313301|NCT05632328|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111313302|NCT05632328|Antimetabolites|antimetabolites|mesh-ancestor
111313303|NCT05632328|Immunologic Factors|immunologic factors|mesh-ancestor
111313304|NCT05632328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111313305|NCT03599726|Donepezil|donepezil|mesh-list
111313306|NCT03599726|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111313307|NCT03599726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111313308|NCT03599726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111313309|NCT03599726|Cholinergic Agents|cholinergic agents|mesh-ancestor
111313310|NCT03599726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111313311|NCT03599726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111313312|NCT03599726|Nootropic Agents|nootropic agents|mesh-ancestor
111313313|NCT00466817|Valganciclovir|valganciclovir|mesh-list
111313314|NCT00466817|Antiviral Agents|antiviral agents|mesh-ancestor
111313315|NCT00466817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111313316|NCT04406870|Sirolimus|sirolimus|mesh-list
111313317|NCT04406870|Propranolol|propranolol|mesh-list
111313318|NCT04406870|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111313319|NCT04406870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111313320|NCT04406870|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111313321|NCT04406870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111313322|NCT04406870|Antifungal Agents|antifungal agents|mesh-ancestor
111313323|NCT04406870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111313324|NCT04406870|Immunologic Factors|immunologic factors|mesh-ancestor
111313325|NCT04406870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111313326|NCT04406870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111313327|NCT04406870|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111313328|NCT04406870|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111313329|NCT04406870|Adrenergic Agents|adrenergic agents|mesh-ancestor
111313330|NCT04406870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111313331|NCT04406870|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111313332|NCT04406870|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111313333|NCT04406870|Vasodilator Agents|vasodilator agents|mesh-ancestor
111313334|NCT03985514|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111313335|NCT03985514|Ciprofloxacin|ciprofloxacin|mesh-list
111313336|NCT03985514|Tazobactam|tazobactam|mesh-list
111313337|NCT03985514|Piperacillin|piperacillin|mesh-list
111313338|NCT03985514|Metronidazole|metronidazole|mesh-list
111313339|NCT03985514|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
111313340|NCT03985514|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
111313341|NCT03985514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111313342|NCT03985514|Antitubercular Agents|antitubercular agents|mesh-ancestor
111313343|NCT03985514|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111313344|NCT03985514|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111313345|NCT03985514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111313346|NCT03985514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111313347|NCT03985514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111313348|NCT03985514|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111313349|NCT03985514|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111313350|NCT03985514|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
111313351|NCT03985514|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111313352|NCT03985514|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111313353|NCT00540007|Lenalidomide|lenalidomide|mesh-list
111313354|NCT00540007|Immunologic Factors|immunologic factors|mesh-ancestor
111313355|NCT00540007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111313356|NCT00540007|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111313357|NCT00540007|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111313358|NCT00540007|Growth Substances|growth substances|mesh-ancestor
111313359|NCT00540007|Growth Inhibitors|growth inhibitors|mesh-ancestor
111313360|NCT00540007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111037810|NCT00109967|Antifungal Agents|antifungal agents|mesh-ancestor
111313361|NCT02982889|Bupivacaine|bupivacaine|mesh-list
111313362|NCT02982889|Hyaluronic Acid|hyaluronic acid|mesh-list
111313363|NCT02982889|Anesthetics, Local|anesthetics, local|mesh-ancestor
111313364|NCT02982889|Anesthetics|anesthetics|mesh-ancestor
111313365|NCT02982889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111313366|NCT02982889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111313367|NCT02982889|Sensory System Agents|sensory system agents|mesh-ancestor
111313368|NCT02982889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111313369|NCT02982889|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111313370|NCT02982889|Immunologic Factors|immunologic factors|mesh-ancestor
111313371|NCT02982889|Viscosupplements|viscosupplements|mesh-ancestor
111313372|NCT02982889|Protective Agents|protective agents|mesh-ancestor
111313373|NCT03592082|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111313374|NCT03592082|Bismuth|bismuth|mesh-list
111313375|NCT03592082|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
111313376|NCT03592082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111313377|NCT03592082|Antacids|antacids|mesh-ancestor
111313378|NCT03592082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111313379|NCT03592082|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111313380|NCT03592082|Antidiarrheals|antidiarrheals|mesh-ancestor
111313381|NCT03598868|Vortioxetine|vortioxetine|mesh-list
111313382|NCT03598868|Antidepressive Agents|antidepressive agents|mesh-ancestor
111313383|NCT03598868|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111313384|NCT03598868|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111313385|NCT03598868|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111313386|NCT03598868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111313387|NCT03598868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111313388|NCT03598868|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111313389|NCT03598868|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111313390|NCT03598868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111313391|NCT03598868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111313392|NCT03598868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111313393|NCT03598868|Serotonin Agents|serotonin agents|mesh-ancestor
111313394|NCT03598868|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111313395|NCT03598868|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111313396|NCT03598868|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111313397|NCT03598868|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111313398|NCT00501631|Naltrexone|naltrexone|mesh-list
111313399|NCT00501631|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111313400|NCT00501631|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111313401|NCT00501631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111313402|NCT00501631|Sensory System Agents|sensory system agents|mesh-ancestor
111313403|NCT00501631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111313404|NCT05631704|Midazolam|midazolam|mesh-list
111313405|NCT05631704|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111313406|NCT05631704|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111313407|NCT05631704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111313408|NCT05631704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111313409|NCT05631704|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111313410|NCT05631704|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111313411|NCT05631704|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111313412|NCT05631704|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111313413|NCT05631704|Anesthetics, General|anesthetics, general|mesh-ancestor
111313414|NCT05631704|Anesthetics|anesthetics|mesh-ancestor
111313415|NCT05631704|GABA Modulators|gaba modulators|mesh-ancestor
111313416|NCT05631704|GABA Agents|gaba agents|mesh-ancestor
111313417|NCT05631704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111313418|NCT05631704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111313419|NCT03591536|Pentoxifylline|pentoxifylline|mesh-list
111313420|NCT03591536|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111313421|NCT03591536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111313422|NCT03591536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111313423|NCT03591536|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111313424|NCT03591536|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111313425|NCT03591536|Protective Agents|protective agents|mesh-ancestor
111313426|NCT03591536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111313427|NCT03591536|Vasodilator Agents|vasodilator agents|mesh-ancestor
111313428|NCT03591536|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111313429|NCT03591536|Antioxidants|antioxidants|mesh-ancestor
111313430|NCT00501943|Interferons|interferons|mesh-list
111313431|NCT00501943|Interferon-beta|interferon-beta|mesh-list
111313432|NCT00501943|Interferon beta-1a|interferon beta-1a|mesh-list
111313433|NCT00501943|Riluzole|riluzole|mesh-list
111037894|NCT05532332|Fluoxetine|fluoxetine|mesh-list
111313434|NCT00501943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111313435|NCT00501943|Antiviral Agents|antiviral agents|mesh-ancestor
111313436|NCT00501943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111313437|NCT00501943|Immunologic Factors|immunologic factors|mesh-ancestor
111313438|NCT00501943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111313439|NCT00501943|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111313440|NCT00501943|Anticonvulsants|anticonvulsants|mesh-ancestor
111313441|NCT00501943|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111313442|NCT00501943|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111313443|NCT00501943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111313444|NCT00501943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111313445|NCT00501943|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111313446|NCT00501943|Protective Agents|protective agents|mesh-ancestor
111313447|NCT03598634|Riboflavin|riboflavin|mesh-list
111313448|NCT03598634|Vitamin B Complex|vitamin b complex|mesh-ancestor
111313449|NCT03598634|Vitamins|vitamins|mesh-ancestor
111313450|NCT03598634|Micronutrients|micronutrients|mesh-ancestor
111313451|NCT03598634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111313452|NCT03598634|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111313453|NCT03598634|Dermatologic Agents|dermatologic agents|mesh-ancestor
111313454|NCT03598556|Vitamin D|vitamin d|mesh-list
111313455|NCT03598556|Cholecalciferol|cholecalciferol|mesh-list
111313456|NCT03598556|Vitamins|vitamins|mesh-ancestor
111313457|NCT03598556|Micronutrients|micronutrients|mesh-ancestor
111313458|NCT03598556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111313459|NCT03598556|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111313460|NCT03598556|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111313461|NCT03024476|Olmesartan|olmesartan|mesh-list
111313462|NCT03024476|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111313463|NCT03024476|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111313464|NCT03024476|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111313465|NCT03024476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111313466|NCT03590912|Mometasone Furoate|mometasone furoate|mesh-list
111313467|NCT03590912|Cetirizine|cetirizine|mesh-list
111313468|NCT03590912|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111313469|NCT03590912|Cefpodoxime|cefpodoxime|mesh-list
111313470|NCT03590912|Prednisolone|prednisolone|mesh-list
111313471|NCT03590912|Phenylephrine|phenylephrine|mesh-list
111313472|NCT03590912|Oxymetazoline|oxymetazoline|mesh-list
111313473|NCT03590912|Nasal Decongestants|nasal decongestants|mesh-list
111313474|NCT03590912|Levocetirizine|levocetirizine|mesh-list
111313475|NCT03590912|Histamine Antagonists|histamine antagonists|mesh-list
111313476|NCT03590912|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
111313477|NCT03590912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111313478|NCT03590912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111313479|NCT03590912|Glucocorticoids|glucocorticoids|mesh-ancestor
111313480|NCT03590912|Hormones|hormones|mesh-ancestor
111313481|NCT03590912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111313482|NCT03590912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111313483|NCT03590912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111313484|NCT03590912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111313485|NCT03590912|Autonomic Agents|autonomic agents|mesh-ancestor
111313486|NCT03590912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111313487|NCT03590912|Protective Agents|protective agents|mesh-ancestor
111313488|NCT03590912|Dermatologic Agents|dermatologic agents|mesh-ancestor
111313489|NCT03590912|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111313490|NCT03590912|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
111313491|NCT03590912|Histamine Agents|histamine agents|mesh-ancestor
111313492|NCT03590912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111313493|NCT03590912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111313494|NCT03590912|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111313495|NCT03590912|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111313496|NCT03590912|Adrenergic Agents|adrenergic agents|mesh-ancestor
111313497|NCT03590912|Sympathomimetics|sympathomimetics|mesh-ancestor
111313498|NCT03590912|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111313499|NCT03590912|Respiratory System Agents|respiratory system agents|mesh-ancestor
111313500|NCT03590912|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111313501|NCT03590912|Mydriatics|mydriatics|mesh-ancestor
111313502|NCT03590912|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111313503|NCT00503113|Alendronate|alendronate|mesh-list
111313504|NCT00503113|Ibandronic Acid|ibandronic acid|mesh-list
111313505|NCT00503113|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111313506|NCT00503113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111313507|NCT00542971|Cytarabine|cytarabine|mesh-list
111313508|NCT00542971|Sorafenib|sorafenib|mesh-list
111313509|NCT00542971|Idarubicin|idarubicin|mesh-list
111313510|NCT00542971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111313511|NCT00542971|Antimetabolites|antimetabolites|mesh-ancestor
111313512|NCT00542971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111313513|NCT00542971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111313515|NCT00542971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111313516|NCT00542971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111313517|NCT00542971|Immunologic Factors|immunologic factors|mesh-ancestor
111313518|NCT00542971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111313519|NCT00542971|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111313520|NCT00542971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111313521|NCT00542971|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111313522|NCT00542971|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111313523|NCT00542971|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111313524|NCT00504751|Dexamethasone|dexamethasone|mesh-list
111313525|NCT00504751|Rituximab|rituximab|mesh-list
111313526|NCT00504751|Etoposide|etoposide|mesh-list
111313527|NCT00504751|Bortezomib|bortezomib|mesh-list
111313528|NCT00504751|Ifosfamide|ifosfamide|mesh-list
111313529|NCT00504751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111313530|NCT00504751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111313531|NCT00504751|Immunologic Factors|immunologic factors|mesh-ancestor
110980138|NCT04472481|Ergocalciferols|ergocalciferols|mesh-list
111313532|NCT00504751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111313533|NCT00504751|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111313534|NCT00504751|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111313535|NCT00504751|Antiemetics|antiemetics|mesh-ancestor
111313536|NCT00504751|Autonomic Agents|autonomic agents|mesh-ancestor
111313537|NCT00504751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111313538|NCT00504751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111313539|NCT00504751|Glucocorticoids|glucocorticoids|mesh-ancestor
111313540|NCT00504751|Hormones|hormones|mesh-ancestor
111313541|NCT00504751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111313542|NCT00504751|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111313543|NCT00504751|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111313544|NCT00504751|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111313545|NCT00504751|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111313546|NCT00504751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111313547|NCT00504751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111313548|NCT00504751|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111313549|NCT00504751|Alkylating Agents|alkylating agents|mesh-ancestor
111313550|NCT01013779|Carboplatin|carboplatin|mesh-list
111313551|NCT01013779|Etoposide|etoposide|mesh-list
111313552|NCT01013779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111313553|NCT01013779|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111313554|NCT01013779|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111313555|NCT01013779|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111313556|NCT01013779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111313557|NCT01013779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111313558|NCT05630846|Vaccines|vaccines|mesh-list
111313559|NCT05630846|Immunologic Factors|immunologic factors|mesh-ancestor
111313560|NCT05630846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111313561|NCT05630768|Vitamin D|vitamin d|mesh-list
111313562|NCT05630768|Risedronic Acid|risedronic acid|mesh-list
111313563|NCT05630768|Calcium|calcium|mesh-list
111313564|NCT05630768|Vitamins|vitamins|mesh-ancestor
111313565|NCT05630768|Micronutrients|micronutrients|mesh-ancestor
111313566|NCT05630768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111313567|NCT05630768|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111313568|NCT05630768|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111313569|NCT05630768|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111313570|NCT05630768|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111313571|NCT05630768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111313572|NCT00506155|Bevacizumab|bevacizumab|mesh-list
111313573|NCT00506155|Cisplatin|cisplatin|mesh-list
111313574|NCT00506155|Doxorubicin|doxorubicin|mesh-list
111313575|NCT00506155|Methotrexate|methotrexate|mesh-list
111313576|NCT00506155|Vinblastine|vinblastine|mesh-list
111313577|NCT00506155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111313578|NCT00506155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111313579|NCT00506155|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111313580|NCT00506155|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111313581|NCT00506155|Growth Substances|growth substances|mesh-ancestor
111313582|NCT00506155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111313583|NCT00506155|Growth Inhibitors|growth inhibitors|mesh-ancestor
111313584|NCT00506155|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111313585|NCT00506155|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111313586|NCT00506155|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111313587|NCT00506155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111038033|NCT02254577|Hormones|hormones|mesh-ancestor
111313588|NCT00506155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111313589|NCT00506155|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111313590|NCT00506155|Abortifacient Agents|abortifacient agents|mesh-ancestor
111313591|NCT00506155|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111313592|NCT00506155|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111313593|NCT00506155|Antimetabolites|antimetabolites|mesh-ancestor
111313594|NCT00506155|Dermatologic Agents|dermatologic agents|mesh-ancestor
111313595|NCT00506155|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111313596|NCT00506155|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111313597|NCT00506155|Immunologic Factors|immunologic factors|mesh-ancestor
111313598|NCT00506155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111313599|NCT00506155|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111313600|NCT00506155|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111313601|NCT00506155|Tubulin Modulators|tubulin modulators|mesh-ancestor
111313602|NCT00506155|Antimitotic Agents|antimitotic agents|mesh-ancestor
111313603|NCT00506155|Mitosis Modulators|mitosis modulators|mesh-ancestor
111313604|NCT03590444|Ranibizumab|ranibizumab|mesh-list
111313605|NCT03590444|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111313606|NCT03590444|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111313607|NCT03590444|Growth Substances|growth substances|mesh-ancestor
111313608|NCT03590444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111313609|NCT03590444|Growth Inhibitors|growth inhibitors|mesh-ancestor
111313610|NCT03590444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111313611|NCT00506857|Fludarabine|fludarabine|mesh-list
111313612|NCT00506857|Fludarabine phosphate|fludarabine phosphate|mesh-list
111313613|NCT00506857|Busulfan|busulfan|mesh-list
111313614|NCT00506857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111313615|NCT00506857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111313616|NCT00506857|Antimetabolites|antimetabolites|mesh-ancestor
111313617|NCT00506857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111313618|NCT00506857|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111313619|NCT00506857|Immunologic Factors|immunologic factors|mesh-ancestor
111313620|NCT00506857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111313621|NCT00506857|Alkylating Agents|alkylating agents|mesh-ancestor
111313622|NCT00506857|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111313623|NCT00506857|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111313624|NCT04005170|Paclitaxel|paclitaxel|mesh-list
111313625|NCT04005170|Cisplatin|cisplatin|mesh-list
111313626|NCT04005170|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111313627|NCT04005170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111313628|NCT04005170|Tubulin Modulators|tubulin modulators|mesh-ancestor
111313629|NCT04005170|Antimitotic Agents|antimitotic agents|mesh-ancestor
111313630|NCT04005170|Mitosis Modulators|mitosis modulators|mesh-ancestor
111313631|NCT04005170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111313632|NCT03597308|Acetaminophen|acetaminophen|mesh-list
111313633|NCT03597308|Ibuprofen|ibuprofen|mesh-list
111313634|NCT03597308|Oxycodone|oxycodone|mesh-list
111313635|NCT03597308|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111313636|NCT03597308|Analgesics|analgesics|mesh-ancestor
111313637|NCT03597308|Sensory System Agents|sensory system agents|mesh-ancestor
111313638|NCT03597308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111313639|NCT03597308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111313640|NCT03597308|Antipyretics|antipyretics|mesh-ancestor
111313641|NCT03597308|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111313642|NCT03597308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111313643|NCT03597308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111313644|NCT03597308|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111313645|NCT03597308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111313646|NCT03597308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111313647|NCT03597308|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111313648|NCT03597308|Narcotics|narcotics|mesh-ancestor
111313649|NCT03597308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111313650|NCT04750135|Metformin|metformin|mesh-list
111313651|NCT04750135|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111313652|NCT04750135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111313653|NCT04003922|Adalimumab|adalimumab|mesh-list
111313654|NCT04003922|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111313655|NCT04003922|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111313656|NCT04003922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111313657|NCT00558571|Empagliflozin|empagliflozin|mesh-list
111313658|NCT00558571|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111313659|NCT00558571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111313660|NCT00558571|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111313661|NCT00558571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111038109|NCT06009900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111313663|NCT03970382|Nivolumab|nivolumab|mesh-list
111313664|NCT03970382|Interleukin-2|interleukin-2|mesh-list
111313665|NCT03970382|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111313666|NCT03970382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111313667|NCT03970382|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111313668|NCT03970382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111313669|NCT03970382|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111313670|NCT03970382|Analgesics|analgesics|mesh-ancestor
111313671|NCT03970382|Sensory System Agents|sensory system agents|mesh-ancestor
111313672|NCT03970382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111313673|NCT03970382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111313674|NCT03970382|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111313675|NCT03970382|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111313676|NCT03970382|Antiviral Agents|antiviral agents|mesh-ancestor
111313677|NCT03970382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111313678|NCT01797133|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111313679|NCT01797133|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
111313680|NCT01797133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111313681|NCT01797133|Antitubercular Agents|antitubercular agents|mesh-ancestor
111313682|NCT01797913|Gemcitabine|gemcitabine|mesh-list
111313683|NCT01797913|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111313684|NCT01797913|Antimetabolites|antimetabolites|mesh-ancestor
111313685|NCT01797913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111313686|NCT01797913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111313687|NCT03596294|Rifampin|rifampin|mesh-list
111313688|NCT03596294|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111313689|NCT03596294|Antitubercular Agents|antitubercular agents|mesh-ancestor
111313690|NCT03596294|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111313691|NCT03596294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111313692|NCT03596294|Leprostatic Agents|leprostatic agents|mesh-ancestor
111313693|NCT03596294|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111313694|NCT03596294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111313695|NCT03596294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111313696|NCT03596294|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111313697|NCT03596294|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111313698|NCT03596294|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
111313699|NCT03596294|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
111313700|NCT03596294|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
111313701|NCT03596294|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111313702|NCT00537407|Ribavirin|ribavirin|mesh-list
111313703|NCT00537407|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
111313704|NCT00537407|Antimetabolites|antimetabolites|mesh-ancestor
111313705|NCT00537407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111313706|NCT00537407|Antiviral Agents|antiviral agents|mesh-ancestor
111313707|NCT00537407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111313708|NCT00214916|Insulin|insulin|mesh-list
111313709|NCT00214916|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111313710|NCT00214916|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111313711|NCT00214916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111313712|NCT00438971|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
111313713|NCT00438971|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111313714|NCT00438971|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111313715|NCT00438971|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111313716|NCT00438971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111313717|NCT00438971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111313718|NCT00438971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111313719|NCT00438971|Analgesics|analgesics|mesh-ancestor
111313720|NCT00438971|Sensory System Agents|sensory system agents|mesh-ancestor
111313721|NCT00438971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111313722|NCT00438971|Antidepressive Agents|antidepressive agents|mesh-ancestor
111313723|NCT00438971|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111313724|NCT00438971|Dopamine Agents|dopamine agents|mesh-ancestor
111313725|NCT00219284|Levodopa|levodopa|mesh-list
111313726|NCT00219284|Carbidopa|carbidopa|mesh-list
111313727|NCT00219284|Entacapone|entacapone|mesh-list
111313728|NCT00219284|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
111313729|NCT00219284|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111313730|NCT00219284|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111313731|NCT00219284|Dopamine Agents|dopamine agents|mesh-ancestor
111313732|NCT00219284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111313733|NCT00219284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111313734|NCT00219284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111313735|NCT00219284|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
111313736|NCT00219284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111313737|NCT00219284|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
111313738|NCT00219284|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111313739|NCT00219284|Immunologic Factors|immunologic factors|mesh-ancestor
111313740|NCT00219284|Dopamine Agonists|dopamine agonists|mesh-ancestor
111313741|NCT00509041|Dasatinib|dasatinib|mesh-list
111313742|NCT00509041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111313743|NCT00509041|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111313744|NCT00509041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111313745|NCT00509041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111313746|NCT03781700|Prednisolone|prednisolone|mesh-list
111313747|NCT03781700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111313748|NCT03781700|Glucocorticoids|glucocorticoids|mesh-ancestor
111313749|NCT03781700|Hormones|hormones|mesh-ancestor
111313750|NCT03781700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111313751|NCT03781700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111313752|NCT03781700|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111313753|NCT03781700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111313754|NCT00439673|Azacitidine|azacitidine|mesh-list
111313755|NCT00439673|Valproic Acid|valproic acid|mesh-list
111313756|NCT00439673|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111313757|NCT00439673|Antimetabolites|antimetabolites|mesh-ancestor
111313758|NCT00439673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111313759|NCT00439673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111313760|NCT00439673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111313761|NCT00439673|Anticonvulsants|anticonvulsants|mesh-ancestor
111313762|NCT00439673|GABA Agents|gaba agents|mesh-ancestor
111313763|NCT00439673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111313764|NCT00439673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111313765|NCT00439673|Antimanic Agents|antimanic agents|mesh-ancestor
111313766|NCT00439673|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111313767|NCT00439673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111313768|NCT00439673|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111313769|NCT03596060|Fentanyl|fentanyl|mesh-list
111313770|NCT03596060|Morphine|morphine|mesh-list
111313771|NCT03596060|Propofol|propofol|mesh-list
111313772|NCT03596060|Rocuronium|rocuronium|mesh-list
111313773|NCT03596060|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111313774|NCT03596060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111313775|NCT03596060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111313776|NCT03596060|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111313777|NCT03596060|Anesthetics, General|anesthetics, general|mesh-ancestor
111313778|NCT03596060|Anesthetics|anesthetics|mesh-ancestor
111313779|NCT03596060|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111313780|NCT03596060|Narcotics|narcotics|mesh-ancestor
111313781|NCT03596060|Analgesics|analgesics|mesh-ancestor
111313782|NCT03596060|Sensory System Agents|sensory system agents|mesh-ancestor
111313783|NCT03596060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111313784|NCT03596060|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111313785|NCT03596060|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
111313786|NCT03596060|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
111313787|NCT03596060|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111313788|NCT00473837|Chloroquine|chloroquine|mesh-list
111313789|NCT00473837|Amebicides|amebicides|mesh-ancestor
111313790|NCT00473837|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111313791|NCT00473837|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111313792|NCT00473837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111313793|NCT00473837|Antimalarials|antimalarials|mesh-ancestor
111313794|NCT00473837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111313795|NCT04198922|Acalabrutinib|acalabrutinib|mesh-list
111313796|NCT04198922|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
111313797|NCT04198922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111313798|NCT04198922|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111313799|NCT04198922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111313800|NCT04198922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111313801|NCT00509197|Fluticasone|fluticasone|mesh-list
111313802|NCT00509197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111313803|NCT00509197|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111313804|NCT00509197|Autonomic Agents|autonomic agents|mesh-ancestor
111313805|NCT00509197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111313806|NCT00509197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111313807|NCT00509197|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111313808|NCT00509197|Respiratory System Agents|respiratory system agents|mesh-ancestor
111313809|NCT00509197|Dermatologic Agents|dermatologic agents|mesh-ancestor
111313810|NCT00509197|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111313811|NCT00442013|Lansoprazole|lansoprazole|mesh-list
111313813|NCT00442013|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111313814|NCT00442013|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111313815|NCT00442013|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111313816|NCT00442013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111313817|NCT00442013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111313818|NCT02121067|Levonorgestrel|levonorgestrel|mesh-list
111313819|NCT02121067|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111313820|NCT02121067|Contraceptive Agents|contraceptive agents|mesh-ancestor
111313821|NCT02121067|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111313822|NCT02121067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111313823|NCT02121067|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111313824|NCT02121067|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111313825|NCT02121067|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111313826|NCT00509665|Gemcitabine|gemcitabine|mesh-list
111313827|NCT00509665|Doxorubicin|doxorubicin|mesh-list
111313828|NCT00509665|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111313829|NCT00509665|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111313830|NCT00509665|Antimetabolites|antimetabolites|mesh-ancestor
111313831|NCT00509665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111313832|NCT00509665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111313833|NCT00509665|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111313834|NCT00509665|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111313835|NCT00509665|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111313836|NCT00509665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111313837|NCT00513799|Chlorhexidine|chlorhexidine|mesh-list
111313838|NCT00513799|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
111313839|NCT00513799|Mupirocin|mupirocin|mesh-list
111313840|NCT00513799|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111313841|NCT00513799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111313842|NCT00513799|Disinfectants|disinfectants|mesh-ancestor
111313843|NCT00513799|Dermatologic Agents|dermatologic agents|mesh-ancestor
111313844|NCT00513799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111313845|NCT00513799|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111313846|NCT00513799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111313847|NCT00513799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111313848|NCT00442169|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111313849|NCT00216476|Risperidone|risperidone|mesh-list
111313850|NCT00216476|Aripiprazole|aripiprazole|mesh-list
111313851|NCT00216476|Quetiapine Fumarate|quetiapine fumarate|mesh-list
111313852|NCT00216476|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111313853|NCT00216476|Serotonin Agents|serotonin agents|mesh-ancestor
111313854|NCT00216476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111313855|NCT00216476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111313856|NCT00216476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111313857|NCT00216476|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111313858|NCT00216476|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111313859|NCT00216476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111313860|NCT00216476|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111313861|NCT00216476|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111313862|NCT00216476|Dopamine Agents|dopamine agents|mesh-ancestor
111313863|NCT00216476|Antidepressive Agents|antidepressive agents|mesh-ancestor
111313864|NCT00216476|Dopamine Agonists|dopamine agonists|mesh-ancestor
111313865|NCT00216476|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111313866|NCT00216476|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111313867|NCT00216476|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111313868|NCT00216476|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111313869|NCT00515437|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
111313870|NCT00515437|Botulinum Toxins|botulinum toxins|mesh-list
111313871|NCT00515437|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111313872|NCT00515437|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111313873|NCT00515437|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111313874|NCT00515437|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111313875|NCT00515437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111313876|NCT00515437|Cholinergic Agents|cholinergic agents|mesh-ancestor
111313877|NCT00515437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111313878|NCT00515437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111313879|NCT00515437|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111313880|NCT00515437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111313881|NCT00515437|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111313882|NCT00216086|Capecitabine|capecitabine|mesh-list
111313883|NCT00216086|Irinotecan|irinotecan|mesh-list
111313884|NCT00216086|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111313885|NCT00216086|Antimetabolites|antimetabolites|mesh-ancestor
111313886|NCT00216086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111313887|NCT00216086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111313888|NCT00216086|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111313889|NCT00216086|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111313890|NCT00216086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111313891|NCT00474851|Norethindrone|norethindrone|mesh-list
111313892|NCT00474851|Norethindrone Acetate|norethindrone acetate|mesh-list
111313893|NCT00474851|Estrogens|estrogens|mesh-list
111313894|NCT00474851|Hormones|hormones|mesh-ancestor
111313895|NCT00474851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111313896|NCT00474851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111313897|NCT00474851|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111313898|NCT00474851|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111313899|NCT00474851|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111313900|NCT00474851|Contraceptive Agents|contraceptive agents|mesh-ancestor
111313901|NCT00474851|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111313902|NCT00474851|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111313903|NCT00474851|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111313904|NCT00215150|Ziprasidone|ziprasidone|mesh-list
111313905|NCT00215150|Sertraline|sertraline|mesh-list
111313906|NCT00215150|Antidepressive Agents|antidepressive agents|mesh-ancestor
111313907|NCT00215150|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111313908|NCT00215150|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111313909|NCT00215150|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111313910|NCT00215150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111313911|NCT00215150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111313912|NCT00215150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111313913|NCT00215150|Serotonin Agents|serotonin agents|mesh-ancestor
111313914|NCT00215150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111313915|NCT00215150|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111313916|NCT00215150|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111313917|NCT00215150|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111313918|NCT00215150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111313919|NCT00215150|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111313920|NCT00215150|Dopamine Agents|dopamine agents|mesh-ancestor
111313921|NCT04192994|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111313922|NCT04192994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111313923|NCT04198844|Warfarin|warfarin|mesh-list
111313924|NCT04198844|Apixaban|apixaban|mesh-list
111313925|NCT04198844|Anticoagulants|anticoagulants|mesh-ancestor
111313926|NCT04198844|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111313927|NCT04198844|Antithrombins|antithrombins|mesh-ancestor
111313928|NCT04198844|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111313929|NCT04198844|Protease Inhibitors|protease inhibitors|mesh-ancestor
111313930|NCT04198844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111313931|NCT04198844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111313932|NCT03023852|Oseltamivir|oseltamivir|mesh-list
111313933|NCT03023852|Antiviral Agents|antiviral agents|mesh-ancestor
111313934|NCT03023852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111313935|NCT03023852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111313936|NCT03023852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111313937|NCT00213980|Zoledronic Acid|zoledronic acid|mesh-list
111313938|NCT00213980|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111313939|NCT00213980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111313940|NCT00516217|Galiximab|galiximab|mesh-list
111313941|NCT00516217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111313942|NCT00516217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111313943|NCT04001504|Vaccines|vaccines|mesh-list
111313944|NCT04001504|Immunologic Factors|immunologic factors|mesh-ancestor
111313945|NCT04001504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111313946|NCT00516919|Orlistat|orlistat|mesh-list
111313947|NCT00516919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111313948|NCT00516919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111313949|NCT00516919|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111313950|NCT00516919|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110980167|NCT00580125|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111313951|NCT00547105|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111313952|NCT00547105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111313953|NCT00547105|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111313954|NCT00547105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111313955|NCT00547105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111313956|NCT04195100|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111313957|NCT04195100|Pilocarpine|pilocarpine|mesh-list
111313958|NCT04195100|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111313959|NCT04195100|Miotics|miotics|mesh-ancestor
111313960|NCT04195100|Autonomic Agents|autonomic agents|mesh-ancestor
111038412|NCT05846698|Tibolone|tibolone|mesh-list
111313961|NCT04195100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111313962|NCT04195100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111313964|NCT04195100|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111313965|NCT04195100|Cholinergic Agents|cholinergic agents|mesh-ancestor
111313966|NCT04195100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111313967|NCT04195100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111313968|NCT04193774|Anesthetics|anesthetics|mesh-list
111313969|NCT04193774|Benoxinate|benoxinate|mesh-list
111313970|NCT04193774|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111313971|NCT04193774|Lubricant Eye Drops|lubricant eye drops|mesh-list
111313972|NCT04193774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111313973|NCT04193774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111313974|NCT04193774|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111313975|NCT04193774|Anesthetics, Local|anesthetics, local|mesh-ancestor
111313976|NCT04193774|Sensory System Agents|sensory system agents|mesh-ancestor
111313977|NCT04193774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111313978|NCT00518089|Gatifloxacin|gatifloxacin|mesh-list
111313979|NCT00518089|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111313980|NCT00518089|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111313981|NCT00518089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111313982|NCT00518089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111313983|NCT00518089|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111313984|NCT00518089|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111313985|NCT00518089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111313986|NCT00518089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111313987|NCT00518089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111313988|NCT02985242|Empagliflozin|empagliflozin|mesh-list
111313989|NCT02985242|Glimepiride|glimepiride|mesh-list
111313990|NCT02985242|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111313991|NCT02985242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111313992|NCT02985242|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111313993|NCT02985242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111313994|NCT02985242|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111313995|NCT02985242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111313996|NCT02985242|Immunologic Factors|immunologic factors|mesh-ancestor
111313997|NCT03023774|Lenograstim|lenograstim|mesh-list
111313998|NCT03023774|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111313999|NCT03023774|Immunologic Factors|immunologic factors|mesh-ancestor
111314000|NCT03023774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111314001|NCT04196426|Calcium|calcium|mesh-list
111314002|NCT04196426|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111314003|NCT04196426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111314004|NCT00518713|Clobazam|clobazam|mesh-list
111314005|NCT00518713|Anticonvulsants|anticonvulsants|mesh-ancestor
111314006|NCT00518713|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111314007|NCT00518713|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111314008|NCT00518713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111314009|NCT00518713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111314010|NCT00518713|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111314011|NCT00518713|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
111314012|NCT00518713|GABA Agonists|gaba agonists|mesh-ancestor
111314013|NCT00518713|GABA Agents|gaba agents|mesh-ancestor
111314014|NCT00518713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111314015|NCT00518713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111314016|NCT03948464|Morphine|morphine|mesh-list
111314017|NCT03948464|Methadone|methadone|mesh-list
111314018|NCT03948464|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111314019|NCT03948464|Narcotics|narcotics|mesh-ancestor
111314020|NCT03948464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111314021|NCT03948464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111314022|NCT03948464|Analgesics|analgesics|mesh-ancestor
111314023|NCT03948464|Sensory System Agents|sensory system agents|mesh-ancestor
111314024|NCT03948464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111314025|NCT03948464|Antitussive Agents|antitussive agents|mesh-ancestor
111314026|NCT03948464|Respiratory System Agents|respiratory system agents|mesh-ancestor
111314027|NCT04196270|Ropivacaine|ropivacaine|mesh-list
111314028|NCT04196270|Anesthetics, Local|anesthetics, local|mesh-ancestor
111314029|NCT04196270|Anesthetics|anesthetics|mesh-ancestor
111314030|NCT04196270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111314031|NCT04196270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111314032|NCT04196270|Sensory System Agents|sensory system agents|mesh-ancestor
111314033|NCT04196270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111314034|NCT04020380|Azithromycin|azithromycin|mesh-list
111314035|NCT04020380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111314036|NCT04020380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111314037|NCT00521989|Prednisolone|prednisolone|mesh-list
111314038|NCT00521989|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111314039|NCT00521989|Methylprednisolone|methylprednisolone|mesh-list
111314040|NCT00521989|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111314041|NCT00521989|Prednisolone acetate|prednisolone acetate|mesh-list
111314042|NCT00521989|Dipyridamole|dipyridamole|mesh-list
111314043|NCT00521989|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111314044|NCT00521989|Prednisolone phosphate|prednisolone phosphate|mesh-list
111314045|NCT00521989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111314046|NCT00521989|Glucocorticoids|glucocorticoids|mesh-ancestor
111314048|NCT00521989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111314049|NCT00521989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111314050|NCT00521989|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111314051|NCT00521989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111314052|NCT00521989|Antiemetics|antiemetics|mesh-ancestor
111314053|NCT00521989|Autonomic Agents|autonomic agents|mesh-ancestor
111314054|NCT00521989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111314055|NCT00521989|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111314056|NCT00521989|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111314057|NCT00521989|Protective Agents|protective agents|mesh-ancestor
111314058|NCT00521989|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111314059|NCT00521989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111314060|NCT00521989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111314061|NCT00521989|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111314062|NCT00521989|Vasodilator Agents|vasodilator agents|mesh-ancestor
111314063|NCT04029350|Osimertinib|osimertinib|mesh-list
111314064|NCT04029350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111314065|NCT04029350|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111314066|NCT04029350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111314067|NCT04029350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111314068|NCT00548197|Bevacizumab|bevacizumab|mesh-list
111314069|NCT00548197|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111314070|NCT00548197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111314071|NCT00548197|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111314072|NCT00548197|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111314073|NCT00548197|Growth Substances|growth substances|mesh-ancestor
111314074|NCT00548197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111314075|NCT00548197|Growth Inhibitors|growth inhibitors|mesh-ancestor
111314076|NCT04029272|Metformin|metformin|mesh-list
111314077|NCT04029272|Exenatide|exenatide|mesh-list
111314078|NCT04029272|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111314079|NCT04029272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111314080|NCT04029272|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111314081|NCT04029272|Incretins|incretins|mesh-ancestor
111314082|NCT04029272|Hormones|hormones|mesh-ancestor
111314083|NCT04029272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111314084|NCT00548431|Mercaptopurine|mercaptopurine|mesh-list
111314085|NCT00548431|Antimetabolites|antimetabolites|mesh-ancestor
111314086|NCT00548431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111314087|NCT00548431|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111314088|NCT00548431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111314089|NCT00548431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111314090|NCT00548431|Immunologic Factors|immunologic factors|mesh-ancestor
111314091|NCT00548431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111314092|NCT00548431|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111314093|NCT00548431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111314094|NCT04028804|Deoxyglucose|deoxyglucose|mesh-list
111314095|NCT04028804|Fluorides|fluorides|mesh-list
111314096|NCT04028804|Cariostatic Agents|cariostatic agents|mesh-ancestor
111314097|NCT04028804|Protective Agents|protective agents|mesh-ancestor
110980171|NCT00580125|Dopamine Agents|dopamine agents|mesh-ancestor
111314098|NCT04028804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111314099|NCT04028804|Antimetabolites|antimetabolites|mesh-ancestor
111314100|NCT04028804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111314101|NCT04028804|Antiviral Agents|antiviral agents|mesh-ancestor
111314102|NCT04028804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111314103|NCT00524017|Cetuximab|cetuximab|mesh-list
111314104|NCT00524017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111314105|NCT00524017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111314106|NCT02985554|Nivolumab|nivolumab|mesh-list
111314107|NCT02985554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111314108|NCT02985554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111314109|NCT02985554|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111038567|NCT05579964|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111314110|NCT02985554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111314111|NCT05560165|Listerine|listerine|mesh-list
111314112|NCT05560165|Anesthetics|anesthetics|mesh-list
111314113|NCT05560165|Anesthetics, Local|anesthetics, local|mesh-list
111314114|NCT05560165|Fluorides|fluorides|mesh-list
111314115|NCT05560165|Sodium Fluoride|sodium fluoride|mesh-list
111314116|NCT05560165|Cariostatic Agents|cariostatic agents|mesh-ancestor
111314117|NCT05560165|Protective Agents|protective agents|mesh-ancestor
111314118|NCT05560165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111314119|NCT05560165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111314120|NCT05560165|Sensory System Agents|sensory system agents|mesh-ancestor
111314121|NCT05560165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111314122|NCT05560165|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111314123|NCT05560165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111314124|NCT00525421|Curcumin|curcumin|mesh-list
111314125|NCT00525421|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111314126|NCT00525421|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111314127|NCT00525421|Analgesics|analgesics|mesh-ancestor
111314128|NCT00525421|Sensory System Agents|sensory system agents|mesh-ancestor
111314129|NCT00525421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111314130|NCT00525421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111314131|NCT00525421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111314132|NCT00525421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111314133|NCT00525421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111314134|NCT00525421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111314135|NCT00525421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111314136|NCT04023110|Carvedilol|carvedilol|mesh-list
111314137|NCT04023110|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111314138|NCT04023110|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111314139|NCT04023110|Adrenergic Agents|adrenergic agents|mesh-ancestor
111314140|NCT04023110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111314141|NCT04023110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111314142|NCT04023110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111314143|NCT04023110|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111314144|NCT04023110|Antioxidants|antioxidants|mesh-ancestor
111314145|NCT04023110|Protective Agents|protective agents|mesh-ancestor
111314146|NCT04023110|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111314147|NCT04023110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111314148|NCT04023110|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111314149|NCT04023110|Vasodilator Agents|vasodilator agents|mesh-ancestor
111314150|NCT04023110|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111314151|NCT04023110|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111314152|NCT00525733|Ritonavir|ritonavir|mesh-list
111314153|NCT00525733|Darunavir|darunavir|mesh-list
111314154|NCT00525733|Raltegravir Potassium|raltegravir potassium|mesh-list
111314155|NCT00525733|Maraviroc|maraviroc|mesh-list
111314156|NCT00525733|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111314157|NCT00525733|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111314158|NCT00525733|Protease Inhibitors|protease inhibitors|mesh-ancestor
111314159|NCT00525733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111314160|NCT00525733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111314161|NCT00525733|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111314162|NCT00525733|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111314163|NCT00525733|Antiviral Agents|antiviral agents|mesh-ancestor
111314164|NCT00525733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111314165|NCT00525733|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111314166|NCT00525733|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111314167|NCT00525733|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111314168|NCT00525733|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111314169|NCT00525733|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
111314170|NCT00525733|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
111314171|NCT00525733|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
111314172|NCT04028024|Urinastatin|urinastatin|mesh-list
111314173|NCT04028024|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
111314174|NCT04028024|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111314175|NCT04028024|Protease Inhibitors|protease inhibitors|mesh-ancestor
111314176|NCT04028024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111314177|NCT04028024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111314178|NCT00526591|Everolimus|everolimus|mesh-list
111314179|NCT00526591|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111314180|NCT00526591|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111314181|NCT00526591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111314182|NCT00526591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111314183|NCT00526591|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111314184|NCT00526591|Immunologic Factors|immunologic factors|mesh-ancestor
111314185|NCT00526591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111314186|NCT00526591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111314187|NCT05559619|Calcium, Dietary|calcium, dietary|mesh-list
111314188|NCT05559619|Vitamin D|vitamin d|mesh-list
111314189|NCT05559619|Cholecalciferol|cholecalciferol|mesh-list
111314190|NCT05559619|Calcium Carbonate|calcium carbonate|mesh-list
111314191|NCT05559619|Calcium|calcium|mesh-list
111314192|NCT05559619|Vitamins|vitamins|mesh-ancestor
111314193|NCT05559619|Micronutrients|micronutrients|mesh-ancestor
111314194|NCT05559619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111314195|NCT05559619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111314196|NCT05559619|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111314197|NCT05559619|Antacids|antacids|mesh-ancestor
111314198|NCT05559619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111314199|NCT05559619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111314200|NCT04194086|Posaconazole|posaconazole|mesh-list
111314201|NCT04194086|Antifungal Agents|antifungal agents|mesh-ancestor
111314202|NCT04194086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111314203|NCT04194086|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
111314204|NCT04194086|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111314205|NCT04194086|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111314206|NCT04194086|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111314207|NCT04194086|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111314208|NCT04194086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111314209|NCT04194086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111314210|NCT04194086|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111314211|NCT04194086|Hormone Antagonists|hormone antagonists|mesh-ancestor
111314212|NCT04194086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111314213|NCT04194086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111314214|NCT04023266|Acetylcysteine|acetylcysteine|mesh-list
111314215|NCT04023266|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111314216|NCT04023266|Antiviral Agents|antiviral agents|mesh-ancestor
111314217|NCT04023266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111314218|NCT04023266|Expectorants|expectorants|mesh-ancestor
111314219|NCT04023266|Respiratory System Agents|respiratory system agents|mesh-ancestor
111314220|NCT04023266|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111314221|NCT04023266|Antioxidants|antioxidants|mesh-ancestor
111314222|NCT04023266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111314223|NCT04023266|Protective Agents|protective agents|mesh-ancestor
111314224|NCT04023266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111314225|NCT04023266|Antidotes|antidotes|mesh-ancestor
111314226|NCT00475085|Dexamethasone|dexamethasone|mesh-list
111314227|NCT00475085|Aprepitant|aprepitant|mesh-list
111314228|NCT00475085|Palonosetron|palonosetron|mesh-list
111314229|NCT00475085|Granisetron|granisetron|mesh-list
111314230|NCT00475085|Prochlorperazine|prochlorperazine|mesh-list
111314231|NCT00475085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111314232|NCT00475085|Antiemetics|antiemetics|mesh-ancestor
111314233|NCT00475085|Autonomic Agents|autonomic agents|mesh-ancestor
111314234|NCT00475085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111314235|NCT00475085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111314236|NCT00475085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111314237|NCT00475085|Glucocorticoids|glucocorticoids|mesh-ancestor
111314238|NCT00475085|Hormones|hormones|mesh-ancestor
111314239|NCT00475085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111314240|NCT00475085|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111314241|NCT00475085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111314242|NCT00475085|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
111314243|NCT00475085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111314244|NCT00475085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111314245|NCT00475085|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111314246|NCT00475085|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111314247|NCT00475085|Serotonin Agents|serotonin agents|mesh-ancestor
111314248|NCT00475085|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111314249|NCT00475085|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111314250|NCT00475085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111314251|NCT00475085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111314252|NCT00475085|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111314253|NCT00475085|Dopamine Agents|dopamine agents|mesh-ancestor
111314254|NCT00551707|Prednisolone|prednisolone|mesh-list
111314255|NCT00551707|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111314256|NCT00551707|Methylprednisolone|methylprednisolone|mesh-list
111038714|NCT05020236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111038715|NCT05020236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111038716|NCT05020236|Glucocorticoids|glucocorticoids|mesh-ancestor
111038717|NCT05020236|Hormones|hormones|mesh-ancestor
111314257|NCT00551707|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111314258|NCT00551707|Prednisolone acetate|prednisolone acetate|mesh-list
111314259|NCT00551707|Dipyridamole|dipyridamole|mesh-list
111314260|NCT00551707|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111314261|NCT00551707|Prednisolone phosphate|prednisolone phosphate|mesh-list
111314262|NCT00551707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111314263|NCT00551707|Glucocorticoids|glucocorticoids|mesh-ancestor
111314264|NCT00551707|Hormones|hormones|mesh-ancestor
111314265|NCT00551707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111314266|NCT00551707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111314267|NCT00551707|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111314268|NCT00551707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111314269|NCT00551707|Antiemetics|antiemetics|mesh-ancestor
111314270|NCT00551707|Autonomic Agents|autonomic agents|mesh-ancestor
111314271|NCT00551707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111314272|NCT00551707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111314273|NCT00551707|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111314274|NCT00551707|Protective Agents|protective agents|mesh-ancestor
111314275|NCT00551707|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111314276|NCT00551707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111314277|NCT00551707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111314278|NCT00551707|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111314279|NCT00551707|Vasodilator Agents|vasodilator agents|mesh-ancestor
111314280|NCT04193930|Letrozole|letrozole|mesh-list
111314281|NCT04193930|Menotropins|menotropins|mesh-list
111314282|NCT04193930|Hormones|hormones|mesh-list
111314283|NCT04193930|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
111314284|NCT04193930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111314285|NCT04193930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111314286|NCT04193930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111314287|NCT04193930|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111314288|NCT04193930|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111314289|NCT04193930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111314290|NCT04193930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111314291|NCT04193930|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111314292|NCT04193930|Hormone Antagonists|hormone antagonists|mesh-ancestor
111314293|NCT04193930|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111314294|NCT04193930|Fertility Agents|fertility agents|mesh-ancestor
111314295|NCT04193930|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111314296|NCT00445211|Heparin|heparin|mesh-list
111314297|NCT00445211|Calcium heparin|calcium heparin|mesh-list
111314298|NCT00445211|Anticoagulants|anticoagulants|mesh-ancestor
111314299|NCT00445211|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111314300|NCT00445211|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111314301|NCT00445211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111314302|NCT04193852|Dienogest|dienogest|mesh-list
111314303|NCT04193852|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
111314304|NCT04193852|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
111314305|NCT04193852|Ethinyl Estradiol|ethinyl estradiol|mesh-list
111314306|NCT04193852|Estradiol|estradiol|mesh-list
111314307|NCT04193852|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
111314308|NCT04193852|Nandrolone|nandrolone|mesh-list
111314309|NCT04193852|Estrogens|estrogens|mesh-ancestor
111314310|NCT04193852|Hormones|hormones|mesh-ancestor
111314311|NCT04193852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111314312|NCT04193852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111314313|NCT04193852|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111314314|NCT04193852|Contraceptive Agents|contraceptive agents|mesh-ancestor
111314315|NCT04193852|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111314316|NCT04193852|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111314317|NCT04193852|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111314318|NCT04193852|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111314319|NCT04193852|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
111314320|NCT04193852|Hormone Antagonists|hormone antagonists|mesh-ancestor
111314321|NCT04193852|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111314322|NCT04193852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111314323|NCT04193852|Androgens|androgens|mesh-ancestor
111314324|NCT04193852|Anabolic Agents|anabolic agents|mesh-ancestor
111314325|NCT00552409|Cholecalciferol|cholecalciferol|mesh-list
111314326|NCT00552409|Vitamin D|vitamin d|mesh-list
111314327|NCT00552409|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111314328|NCT00552409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111314329|NCT00552409|Vitamins|vitamins|mesh-ancestor
111314330|NCT00552409|Micronutrients|micronutrients|mesh-ancestor
111314331|NCT00552409|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111038794|NCT04701307|Niraparib|niraparib|mesh-list
111314333|NCT03830918|Atezolizumab|atezolizumab|mesh-list
111314334|NCT03830918|Niraparib|niraparib|mesh-list
111314335|NCT03830918|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111314336|NCT03830918|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111314337|NCT03830918|Alkylating Agents|alkylating agents|mesh-ancestor
111314338|NCT03830918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111314339|NCT03830918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111314340|NCT03830918|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111314341|NCT03830918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111314342|NCT03830918|Immunologic Factors|immunologic factors|mesh-ancestor
111314343|NCT03830918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111314344|NCT03830918|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111314345|NCT03830918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111314346|NCT00553735|Cyclosporine|cyclosporine|mesh-list
111314347|NCT00553735|Lubricant Eye Drops|lubricant eye drops|mesh-list
111314348|NCT00553735|Cyclosporins|cyclosporins|mesh-list
111314349|NCT00553735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111314350|NCT00553735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111314351|NCT00553735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111314352|NCT00553735|Immunologic Factors|immunologic factors|mesh-ancestor
111314353|NCT00553735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111314354|NCT00553735|Antifungal Agents|antifungal agents|mesh-ancestor
111314355|NCT00553735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111314356|NCT00553735|Dermatologic Agents|dermatologic agents|mesh-ancestor
111314357|NCT00553735|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111314358|NCT00553735|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111314359|NCT00553735|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
111314360|NCT00553735|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111314361|NCT00523237|Raltegravir Potassium|raltegravir potassium|mesh-list
111314362|NCT00523237|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111314363|NCT00523237|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111314364|NCT00523237|Antiviral Agents|antiviral agents|mesh-ancestor
111314365|NCT00523237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111314366|NCT00523237|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111314367|NCT00523237|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111314368|NCT00523237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111314369|NCT00523237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111314370|NCT04027166|Methadone|methadone|mesh-list
111314371|NCT04027166|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111314372|NCT04027166|Narcotics|narcotics|mesh-ancestor
111314373|NCT04027166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111314374|NCT04027166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111314375|NCT04027166|Analgesics|analgesics|mesh-ancestor
111314376|NCT04027166|Sensory System Agents|sensory system agents|mesh-ancestor
111314377|NCT04027166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111314378|NCT04027166|Antitussive Agents|antitussive agents|mesh-ancestor
111314379|NCT04027166|Respiratory System Agents|respiratory system agents|mesh-ancestor
111314380|NCT00543101|Darunavir|darunavir|mesh-list
111314381|NCT00543101|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111314382|NCT00543101|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111314383|NCT00543101|Protease Inhibitors|protease inhibitors|mesh-ancestor
111314384|NCT00543101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111314385|NCT00543101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111314386|NCT00543101|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111314387|NCT00543101|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111314388|NCT00543101|Antiviral Agents|antiviral agents|mesh-ancestor
111314389|NCT00543101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111314390|NCT00553969|Carvedilol|carvedilol|mesh-list
111314391|NCT00553969|Lisinopril|lisinopril|mesh-list
111314392|NCT00553969|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111314393|NCT00553969|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111314394|NCT00553969|Adrenergic Agents|adrenergic agents|mesh-ancestor
111314395|NCT00553969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111314396|NCT00553969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111314397|NCT00553969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111314398|NCT00553969|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111314399|NCT00553969|Antioxidants|antioxidants|mesh-ancestor
111314400|NCT00553969|Protective Agents|protective agents|mesh-ancestor
111314401|NCT00553969|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111314402|NCT00553969|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111314403|NCT00553969|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111314404|NCT00553969|Vasodilator Agents|vasodilator agents|mesh-ancestor
111314405|NCT00553969|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111314406|NCT00553969|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111314407|NCT00553969|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
111314408|NCT00553969|Protease Inhibitors|protease inhibitors|mesh-ancestor
111314409|NCT00553969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111314410|NCT00553969|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111314411|NCT05533567|Sufentanil|sufentanil|mesh-list
111314412|NCT05533567|Dsuvia|dsuvia|mesh-list
111314413|NCT05533567|Propofol|propofol|mesh-list
111314414|NCT05533567|Cisatracurium|cisatracurium|mesh-list
111314415|NCT05533567|Atracurium|atracurium|mesh-list
111314416|NCT05533567|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111314417|NCT05533567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111314418|NCT05533567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111314419|NCT05533567|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111314420|NCT05533567|Anesthetics, General|anesthetics, general|mesh-ancestor
111314421|NCT05533567|Anesthetics|anesthetics|mesh-ancestor
111314422|NCT05533567|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111314423|NCT05533567|Narcotics|narcotics|mesh-ancestor
111314424|NCT05533567|Analgesics|analgesics|mesh-ancestor
111314425|NCT05533567|Sensory System Agents|sensory system agents|mesh-ancestor
111314426|NCT05533567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111314427|NCT05533567|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111314428|NCT05533567|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
111314429|NCT05533567|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111314430|NCT05533567|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
111314431|NCT05533567|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
111314432|NCT05533567|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111314433|NCT05533567|Cholinergic Agents|cholinergic agents|mesh-ancestor
111314434|NCT05533567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111314435|NCT05533567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111314436|NCT04026464|Acetaminophen|acetaminophen|mesh-list
111314437|NCT04026464|Ibuprofen|ibuprofen|mesh-list
111314438|NCT04026464|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111314439|NCT04026464|Analgesics|analgesics|mesh-ancestor
111314440|NCT04026464|Sensory System Agents|sensory system agents|mesh-ancestor
111314441|NCT04026464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111314442|NCT04026464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111314443|NCT04026464|Antipyretics|antipyretics|mesh-ancestor
111314444|NCT04026464|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111314445|NCT04026464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111314446|NCT04026464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111314447|NCT04026464|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111314448|NCT04026464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111314449|NCT04026464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111314450|NCT04192916|Rivaroxaban|rivaroxaban|mesh-list
111314451|NCT04192916|Apixaban|apixaban|mesh-list
111314452|NCT04192916|Edoxaban|edoxaban|mesh-list
111314453|NCT04192916|Dabigatran|dabigatran|mesh-list
111314454|NCT04192916|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111314455|NCT04192916|Antithrombins|antithrombins|mesh-ancestor
111314456|NCT04192916|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111314457|NCT04192916|Protease Inhibitors|protease inhibitors|mesh-ancestor
111314458|NCT04192916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111314459|NCT04192916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111314460|NCT04192916|Anticoagulants|anticoagulants|mesh-ancestor
111314461|NCT01797991|Dexamethasone|dexamethasone|mesh-list
111314462|NCT01797991|Dexamethasone acetate|dexamethasone acetate|mesh-list
111314463|NCT01797991|BB 1101|bb 1101|mesh-list
111314464|NCT01797991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111314465|NCT01797991|Antiemetics|antiemetics|mesh-ancestor
111314466|NCT01797991|Autonomic Agents|autonomic agents|mesh-ancestor
111314467|NCT01797991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111314468|NCT01797991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111314469|NCT01797991|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111314470|NCT01797991|Glucocorticoids|glucocorticoids|mesh-ancestor
111314471|NCT01797991|Hormones|hormones|mesh-ancestor
111314472|NCT01797991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111314473|NCT01797991|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111314474|NCT01797991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111314475|NCT01797991|Protease Inhibitors|protease inhibitors|mesh-ancestor
111314476|NCT01797991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111314477|NCT01797991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111314478|NCT00475319|Rebamipide|rebamipide|mesh-list
111314479|NCT00475319|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111314480|NCT00475319|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111314481|NCT00475319|Antioxidants|antioxidants|mesh-ancestor
111314482|NCT00475319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111314483|NCT00475319|Protective Agents|protective agents|mesh-ancestor
111038944|NCT04169763|Nelfinavir|nelfinavir|mesh-list
111314484|NCT00475319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111314485|NCT00475319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111314486|NCT04026074|Clonidine|clonidine|mesh-list
111314487|NCT04026074|Fentanyl|fentanyl|mesh-list
111314488|NCT04026074|Remifentanil|remifentanil|mesh-list
111314489|NCT04026074|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
111314490|NCT04026074|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111314491|NCT04026074|Narcotics|narcotics|mesh-ancestor
111314492|NCT04026074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111314493|NCT04026074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111314494|NCT04026074|Analgesics|analgesics|mesh-ancestor
111314495|NCT04026074|Sensory System Agents|sensory system agents|mesh-ancestor
111314496|NCT04026074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111314497|NCT04026074|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111314498|NCT04026074|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111314499|NCT04026074|Anesthetics, General|anesthetics, general|mesh-ancestor
111314500|NCT04026074|Anesthetics|anesthetics|mesh-ancestor
111314501|NCT04026074|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111314502|NCT04026074|Sympatholytics|sympatholytics|mesh-ancestor
111314503|NCT04026074|Autonomic Agents|autonomic agents|mesh-ancestor
111314504|NCT04026074|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111314505|NCT04026074|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111314506|NCT04026074|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111314507|NCT04026074|Adrenergic Agents|adrenergic agents|mesh-ancestor
111314508|NCT04026074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111314509|NCT04026074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111314510|NCT04026074|Anesthetics, Local|anesthetics, local|mesh-ancestor
111314511|NCT04026074|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
111314512|NCT00555997|Ziprasidone|ziprasidone|mesh-list
111314513|NCT00555997|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111314514|NCT00555997|Serotonin Agents|serotonin agents|mesh-ancestor
111314515|NCT00555997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111314516|NCT00555997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111314517|NCT00555997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111314518|NCT00555997|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111314519|NCT00555997|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111314520|NCT00555997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111314521|NCT00555997|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111314522|NCT00555997|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111314523|NCT00555997|Dopamine Agents|dopamine agents|mesh-ancestor
111314524|NCT00446147|Pyridoxine|pyridoxine|mesh-list
111314525|NCT00446147|Vitamin B Complex|vitamin b complex|mesh-ancestor
111314526|NCT00446147|Vitamins|vitamins|mesh-ancestor
111314527|NCT00446147|Micronutrients|micronutrients|mesh-ancestor
111314528|NCT00446147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111314529|NCT04345471|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
111314530|NCT04345471|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111314531|NCT04345471|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111314532|NCT04345471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111314533|NCT04345471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111314534|NCT04345471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111314535|NCT04345471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111314536|NCT04345471|Antidepressive Agents|antidepressive agents|mesh-ancestor
111314537|NCT04345471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111314538|NCT00476021|Levonorgestrel|levonorgestrel|mesh-list
111314539|NCT00476021|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111314540|NCT00476021|Contraceptive Agents|contraceptive agents|mesh-ancestor
111314541|NCT00476021|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111314542|NCT00476021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111314543|NCT00476021|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111314544|NCT00476021|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111314545|NCT00476021|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111314546|NCT04192292|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111314547|NCT04192292|Gliclazide|gliclazide|mesh-list
111314548|NCT04192292|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
111314549|NCT04192292|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111314550|NCT04192292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111314551|NCT04192292|Incretins|incretins|mesh-ancestor
111314552|NCT04192292|Hormones|hormones|mesh-ancestor
111314553|NCT04192292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111314554|NCT04192292|Protease Inhibitors|protease inhibitors|mesh-ancestor
111314555|NCT04192292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111314556|NCT04192292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111314557|NCT00448175|Tolterodine Tartrate|tolterodine tartrate|mesh-list
111314558|NCT00448175|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111314559|NCT00448175|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111314560|NCT00448175|Cholinergic Agents|cholinergic agents|mesh-ancestor
111314561|NCT00448175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111314562|NCT00448175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111314563|NCT00448175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111314564|NCT00448175|Urological Agents|urological agents|mesh-ancestor
111314565|NCT04176835|Oxytocin|oxytocin|mesh-list
111314566|NCT04176835|Oxytocics|oxytocics|mesh-ancestor
111314567|NCT04176835|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111314568|NCT04176835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111314569|NCT00476645|Fulvestrant|fulvestrant|mesh-list
111314570|NCT00476645|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111314571|NCT00476645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111314572|NCT00476645|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
111314573|NCT00476645|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111314574|NCT00476645|Hormone Antagonists|hormone antagonists|mesh-ancestor
111314575|NCT00476645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111314576|NCT00476645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111314577|NCT00477191|Etanercept|etanercept|mesh-list
111314578|NCT00477191|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111314579|NCT00477191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111314580|NCT00477191|Analgesics|analgesics|mesh-ancestor
111314581|NCT00477191|Sensory System Agents|sensory system agents|mesh-ancestor
111314582|NCT00477191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111314583|NCT00477191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111314584|NCT00477191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111314585|NCT00477191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111314586|NCT00477191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111314587|NCT00477191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111314588|NCT00477191|Immunologic Factors|immunologic factors|mesh-ancestor
111314589|NCT04025918|Phenylephrine|phenylephrine|mesh-list
111314590|NCT04025918|Oxymetazoline|oxymetazoline|mesh-list
111314591|NCT04025918|Ephedrine|ephedrine|mesh-list
111314592|NCT04025918|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
111314593|NCT04025918|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111314594|NCT04025918|Mydriatics|mydriatics|mesh-ancestor
111314595|NCT04025918|Autonomic Agents|autonomic agents|mesh-ancestor
111314596|NCT04025918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111314597|NCT04025918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111314598|NCT04025918|Sympathomimetics|sympathomimetics|mesh-ancestor
111314599|NCT04025918|Nasal Decongestants|nasal decongestants|mesh-ancestor
111314600|NCT04025918|Respiratory System Agents|respiratory system agents|mesh-ancestor
111314601|NCT04025918|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111314602|NCT04025918|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111314603|NCT04025918|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111314604|NCT04025918|Adrenergic Agents|adrenergic agents|mesh-ancestor
111314605|NCT04025918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111314606|NCT04025918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111314607|NCT04025918|Protective Agents|protective agents|mesh-ancestor
111314608|NCT04025918|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111314609|NCT04406246|Nitazoxanide|nitazoxanide|mesh-list
111314610|NCT04406246|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111314611|NCT04406246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111314612|NCT02115347|Ertugliflozin|ertugliflozin|mesh-list
111314613|NCT02115347|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111314614|NCT02115347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111314615|NCT02115347|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111314616|NCT02115347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111314617|NCT02115581|Ubiquinone|ubiquinone|mesh-list
111314618|NCT02115581|Coenzyme Q10|coenzyme q10|mesh-list
111314619|NCT02115581|Micronutrients|micronutrients|mesh-ancestor
111314620|NCT02115581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111314621|NCT02115581|Vitamins|vitamins|mesh-ancestor
111314622|NCT00477659|Donepezil|donepezil|mesh-list
111314623|NCT00477659|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111314624|NCT00477659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111314625|NCT00477659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111314626|NCT00477659|Cholinergic Agents|cholinergic agents|mesh-ancestor
111314627|NCT00477659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111314628|NCT00477659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111314629|NCT00477659|Nootropic Agents|nootropic agents|mesh-ancestor
111314630|NCT04191278|Varenicline|varenicline|mesh-list
111314631|NCT04191278|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111314632|NCT04191278|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111314633|NCT04191278|Cholinergic Agents|cholinergic agents|mesh-ancestor
111314634|NCT04191278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111314635|NCT04191278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111314636|NCT04191278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111314637|NCT04148534|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-list
111314638|NCT04148534|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
111314639|NCT04148534|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111314640|NCT04148534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111314641|NCT04148534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111314642|NCT03988387|Tenofovir|tenofovir|mesh-list
111314643|NCT03988387|Emtricitabine|emtricitabine|mesh-list
111314644|NCT03988387|Antiviral Agents|antiviral agents|mesh-ancestor
111314645|NCT03988387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111314646|NCT03988387|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111314647|NCT03988387|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111314648|NCT03988387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111314649|NCT03988387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111314650|NCT03988387|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111314651|NCT03988387|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111314652|NCT03748082|Nitric Oxide|nitric oxide|mesh-list
111314653|NCT03748082|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111314654|NCT03748082|Autonomic Agents|autonomic agents|mesh-ancestor
111314655|NCT03748082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111314656|NCT03748082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111314657|NCT03748082|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111314658|NCT03748082|Respiratory System Agents|respiratory system agents|mesh-ancestor
111314659|NCT03748082|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111314660|NCT03748082|Antioxidants|antioxidants|mesh-ancestor
111314661|NCT03748082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111314662|NCT03748082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111314663|NCT03748082|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
111314664|NCT03748082|Vasodilator Agents|vasodilator agents|mesh-ancestor
111314665|NCT03748082|Gasotransmitters|gasotransmitters|mesh-ancestor
111314666|NCT03748082|Protective Agents|protective agents|mesh-ancestor
111314667|NCT00478361|Paclitaxel|paclitaxel|mesh-list
111314668|NCT00478361|Gemcitabine|gemcitabine|mesh-list
111314669|NCT00478361|Doxorubicin|doxorubicin|mesh-list
111314670|NCT00478361|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111314671|NCT00478361|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111314672|NCT00478361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111314673|NCT00478361|Tubulin Modulators|tubulin modulators|mesh-ancestor
111314674|NCT00478361|Antimitotic Agents|antimitotic agents|mesh-ancestor
111314675|NCT00478361|Mitosis Modulators|mitosis modulators|mesh-ancestor
111314676|NCT00478361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111314677|NCT00478361|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111314678|NCT00478361|Antimetabolites|antimetabolites|mesh-ancestor
111314679|NCT00478361|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111314680|NCT00478361|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111314681|NCT00478361|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111314682|NCT00478361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111314683|NCT02129725|Sildenafil Citrate|sildenafil citrate|mesh-list
111314684|NCT02129725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111314685|NCT02129725|Vasodilator Agents|vasodilator agents|mesh-ancestor
111314686|NCT02129725|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111314687|NCT02129725|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111314688|NCT02129725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111314689|NCT02129725|Urological Agents|urological agents|mesh-ancestor
111314690|NCT00483509|Doxorubicin|doxorubicin|mesh-list
111314691|NCT00483509|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111314692|NCT00483509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111314693|NCT00483509|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111314694|NCT00483509|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111314695|NCT00483509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111314696|NCT00483509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111314697|NCT03864211|Immunomodulating Agents|immunomodulating agents|mesh-list
111314698|NCT03864211|Immunologic Factors|immunologic factors|mesh-ancestor
111314699|NCT03864211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111314700|NCT03840200|Rucaparib|rucaparib|mesh-list
111314701|NCT03840200|Ipatasertib|ipatasertib|mesh-list
111314702|NCT03840200|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111314703|NCT03840200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111314704|NCT03840200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111314705|NCT03840200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111314706|NCT03840200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111314707|NCT03842839|Albuterol|albuterol|mesh-list
111039168|NCT02762266|Ethiodized Oil|ethiodized oil|mesh-list
111314708|NCT03842839|Tiotropium Bromide|tiotropium bromide|mesh-list
111314709|NCT03842839|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111314710|NCT03842839|Autonomic Agents|autonomic agents|mesh-ancestor
111314711|NCT03842839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111314712|NCT03842839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111314713|NCT03842839|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111314714|NCT03842839|Respiratory System Agents|respiratory system agents|mesh-ancestor
111314715|NCT03842839|Parasympatholytics|parasympatholytics|mesh-ancestor
111314716|NCT03842839|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111314717|NCT03842839|Cholinergic Agents|cholinergic agents|mesh-ancestor
111314718|NCT03842839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111314719|NCT03842839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111314720|NCT03842839|Tocolytic Agents|tocolytic agents|mesh-ancestor
111314721|NCT03842839|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111314722|NCT03842839|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111314723|NCT03842839|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111314724|NCT03842839|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111314725|NCT03842839|Adrenergic Agents|adrenergic agents|mesh-ancestor
111314726|NCT00450983|Methotrexate|methotrexate|mesh-list
111314727|NCT00450983|Fludarabine phosphate|fludarabine phosphate|mesh-list
111314728|NCT00450983|Fludarabine|fludarabine|mesh-list
111314729|NCT00450983|Thiotepa|thiotepa|mesh-list
111314730|NCT00450983|Muromonab-CD3|muromonab-cd3|mesh-list
111314731|NCT00450983|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111314732|NCT00450983|Abortifacient Agents|abortifacient agents|mesh-ancestor
111314733|NCT00450983|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111314734|NCT00450983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111314735|NCT00450983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111314736|NCT00450983|Antimetabolites|antimetabolites|mesh-ancestor
111314737|NCT00450983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111314738|NCT00450983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111314739|NCT00450983|Dermatologic Agents|dermatologic agents|mesh-ancestor
111314740|NCT00450983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111314741|NCT00450983|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111314742|NCT00450983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111314743|NCT00450983|Immunologic Factors|immunologic factors|mesh-ancestor
111314744|NCT00450983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111314745|NCT00450983|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111314746|NCT00450983|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111314747|NCT00450983|Alkylating Agents|alkylating agents|mesh-ancestor
111314748|NCT00450983|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111314749|NCT01796405|Clofarabine|clofarabine|mesh-list
111314750|NCT01796405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111314751|NCT01796405|Antimetabolites|antimetabolites|mesh-ancestor
111314752|NCT01796405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111314753|NCT01796405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111314754|NCT03649321|Paclitaxel|paclitaxel|mesh-list
111314755|NCT03649321|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111314756|NCT03649321|Gemcitabine|gemcitabine|mesh-list
111314757|NCT03649321|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111314758|NCT03649321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111314759|NCT03649321|Tubulin Modulators|tubulin modulators|mesh-ancestor
111314760|NCT03649321|Antimitotic Agents|antimitotic agents|mesh-ancestor
111314761|NCT03649321|Mitosis Modulators|mitosis modulators|mesh-ancestor
111314762|NCT03649321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111314763|NCT03649321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111314764|NCT03649321|Antimetabolites|antimetabolites|mesh-ancestor
111314765|NCT04149938|Lidocaine|lidocaine|mesh-list
111314766|NCT04149938|Anesthetics, Local|anesthetics, local|mesh-ancestor
111314767|NCT04149938|Anesthetics|anesthetics|mesh-ancestor
111314768|NCT04149938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111314769|NCT04149938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111314770|NCT04149938|Sensory System Agents|sensory system agents|mesh-ancestor
111314771|NCT04149938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111314772|NCT04149938|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111314773|NCT04149938|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111314774|NCT04149938|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111314775|NCT04149938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111314776|NCT04149938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111314777|NCT01797601|Insulin|insulin|mesh-list
111314778|NCT01797601|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111314779|NCT01797601|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111314780|NCT01797601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111314781|NCT02984930|Esomeprazole|esomeprazole|mesh-list
111039242|NCT00381641|Sunitinib|sunitinib|mesh-list
111314782|NCT02984930|Mosapride|mosapride|mesh-list
111314783|NCT02984930|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111314784|NCT02984930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111314785|NCT02984930|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111314786|NCT02984930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111314787|NCT02984930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111314788|NCT02984930|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111314789|NCT02984930|Serotonin Agents|serotonin agents|mesh-ancestor
111314790|NCT02984930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111314791|NCT02984930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111314792|NCT02123017|Lactulose|lactulose|mesh-list
111314793|NCT02123017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111314794|NCT04149626|Midazolam|midazolam|mesh-list
111314795|NCT04149626|Dexmedetomidine|dexmedetomidine|mesh-list
111314796|NCT04149626|Remifentanil|remifentanil|mesh-list
111314797|NCT04149626|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111314798|NCT04149626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111314799|NCT04149626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111314800|NCT04149626|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111314801|NCT04149626|Analgesics|analgesics|mesh-ancestor
111314802|NCT04149626|Sensory System Agents|sensory system agents|mesh-ancestor
111314803|NCT04149626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111314804|NCT04149626|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111314805|NCT04149626|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111314806|NCT04149626|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111314807|NCT04149626|Adrenergic Agents|adrenergic agents|mesh-ancestor
111314808|NCT04149626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111314809|NCT04149626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111314810|NCT04149626|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111314811|NCT04149626|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111314812|NCT04149626|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110980190|NCT00667953|Temozolomide|temozolomide|mesh-list
111314813|NCT04149626|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111314814|NCT04149626|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111314815|NCT04149626|Anesthetics, General|anesthetics, general|mesh-ancestor
111314816|NCT04149626|Anesthetics|anesthetics|mesh-ancestor
111314817|NCT04149626|GABA Modulators|gaba modulators|mesh-ancestor
111314818|NCT04149626|GABA Agents|gaba agents|mesh-ancestor
111314819|NCT04149626|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111314820|NCT04149626|Narcotics|narcotics|mesh-ancestor
111314821|NCT00486863|Praziquantel|praziquantel|mesh-list
111314822|NCT00486863|Anthelmintics|anthelmintics|mesh-ancestor
111314823|NCT00486863|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111314824|NCT00486863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111314825|NCT04023344|Insulin Lispro|insulin lispro|mesh-list
111314826|NCT04023344|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111314827|NCT04023344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111314828|NCT00452387|Prednisone|prednisone|mesh-list
111314829|NCT00452387|Sorafenib|sorafenib|mesh-list
111314830|NCT00452387|Mitoxantrone|mitoxantrone|mesh-list
111314831|NCT00452387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111314832|NCT00452387|Glucocorticoids|glucocorticoids|mesh-ancestor
111314833|NCT00452387|Hormones|hormones|mesh-ancestor
111314834|NCT00452387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111314835|NCT00452387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111314836|NCT00452387|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111314837|NCT00452387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111314838|NCT00452387|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111314839|NCT00452387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111314840|NCT00452387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111314841|NCT00452387|Analgesics|analgesics|mesh-ancestor
111314842|NCT00452387|Sensory System Agents|sensory system agents|mesh-ancestor
111314843|NCT00452387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111314844|NCT00452387|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111314845|NCT00452387|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111314846|NCT00452543|Acamprosate|acamprosate|mesh-list
111314847|NCT00452543|Dexetimide|dexetimide|mesh-list
111314848|NCT00452543|Citalopram|citalopram|mesh-list
111314849|NCT00452543|Escitalopram|escitalopram|mesh-list
111314850|NCT00452543|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111314851|NCT00452543|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111314852|NCT00452543|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111314853|NCT00452543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111039318|NCT05450432|Ketamine|ketamine|mesh-list
111314854|NCT00452543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111314855|NCT00452543|Serotonin Agents|serotonin agents|mesh-ancestor
111314856|NCT00452543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111314857|NCT00452543|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111314859|NCT00452543|Parasympatholytics|parasympatholytics|mesh-ancestor
111314860|NCT00452543|Autonomic Agents|autonomic agents|mesh-ancestor
111314861|NCT00452543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111314862|NCT00452543|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111314863|NCT00452543|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111314864|NCT00452543|Cholinergic Agents|cholinergic agents|mesh-ancestor
111314865|NCT00452543|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111314866|NCT00452543|Antidepressive Agents|antidepressive agents|mesh-ancestor
111314867|NCT00452543|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111314868|NCT00452543|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111314869|NCT04961359|Vaccines|vaccines|mesh-list
111314870|NCT04961359|Immunologic Factors|immunologic factors|mesh-ancestor
111314871|NCT04961359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111314872|NCT05621707|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
111314873|NCT05621707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111314874|NCT05621707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111314875|NCT05621707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111314876|NCT04765904|Fluorides|fluorides|mesh-list
111314877|NCT04765904|Cariostatic Agents|cariostatic agents|mesh-ancestor
111314878|NCT04765904|Protective Agents|protective agents|mesh-ancestor
111314879|NCT04765904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111314880|NCT05621551|Dapagliflozin|dapagliflozin|mesh-list
111314881|NCT05621551|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111314882|NCT05621551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111314883|NCT05621551|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111314884|NCT05621551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111314885|NCT00565669|Cyclosporine|cyclosporine|mesh-list
111314886|NCT00565669|Cyclosporins|cyclosporins|mesh-list
111314887|NCT00565669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111314888|NCT00565669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111314889|NCT00565669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111314890|NCT00565669|Immunologic Factors|immunologic factors|mesh-ancestor
111314891|NCT00565669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111314892|NCT00565669|Antifungal Agents|antifungal agents|mesh-ancestor
111314893|NCT00565669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111314894|NCT00565669|Dermatologic Agents|dermatologic agents|mesh-ancestor
111314895|NCT00565669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111314896|NCT00565669|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111314897|NCT04165135|Factor VIII|factor viii|mesh-list
111314898|NCT04165135|Coagulants|coagulants|mesh-ancestor
111314899|NCT02132533|Nifedipine|nifedipine|mesh-list
111314900|NCT02132533|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111314901|NCT02132533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111314902|NCT02132533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111314903|NCT02132533|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111314904|NCT02132533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111314905|NCT02132533|Vasodilator Agents|vasodilator agents|mesh-ancestor
111314906|NCT02132533|Tocolytic Agents|tocolytic agents|mesh-ancestor
111314907|NCT02132533|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111314908|NCT03926702|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
111314909|NCT03926702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111314910|NCT00567229|Rituximab|rituximab|mesh-list
111314911|NCT00567229|Lenalidomide|lenalidomide|mesh-list
111314912|NCT00567229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111314913|NCT00567229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111314914|NCT00567229|Immunologic Factors|immunologic factors|mesh-ancestor
111314915|NCT00567229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111314916|NCT00567229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111314917|NCT00567229|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111314918|NCT00567229|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111314919|NCT00567229|Growth Substances|growth substances|mesh-ancestor
111314920|NCT00567229|Growth Inhibitors|growth inhibitors|mesh-ancestor
111314921|NCT04148846|Dexamethasone|dexamethasone|mesh-list
111314922|NCT04148846|Ketoprofen|ketoprofen|mesh-list
111314923|NCT04148846|Theophylline|theophylline|mesh-list
111314924|NCT04148846|Gabapentin|gabapentin|mesh-list
111314925|NCT04148846|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111314926|NCT04148846|Antiemetics|antiemetics|mesh-ancestor
111314927|NCT04148846|Autonomic Agents|autonomic agents|mesh-ancestor
111314928|NCT04148846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111314929|NCT04148846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111314930|NCT04148846|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111314931|NCT04148846|Glucocorticoids|glucocorticoids|mesh-ancestor
111314932|NCT04148846|Hormones|hormones|mesh-ancestor
111314933|NCT04148846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111314934|NCT04148846|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111314936|NCT04148846|Analgesics|analgesics|mesh-ancestor
111314937|NCT04148846|Sensory System Agents|sensory system agents|mesh-ancestor
111314938|NCT04148846|Anticonvulsants|anticonvulsants|mesh-ancestor
111314939|NCT04148846|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111314940|NCT04148846|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111314941|NCT04148846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111314942|NCT04148846|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111314943|NCT04148846|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111314944|NCT04148846|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111314945|NCT04148846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111314946|NCT04148846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111314947|NCT04148846|Antimanic Agents|antimanic agents|mesh-ancestor
111314948|NCT04148846|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111314949|NCT04148846|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111314950|NCT04148846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111314951|NCT04148846|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111314952|NCT04148846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111314953|NCT04148846|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111314954|NCT04148846|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111314955|NCT04148846|Respiratory System Agents|respiratory system agents|mesh-ancestor
111314956|NCT04148846|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111314957|NCT04148846|Vasodilator Agents|vasodilator agents|mesh-ancestor
111314958|NCT04148846|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
111314959|NCT04148846|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111314960|NCT04148846|Purinergic Agents|purinergic agents|mesh-ancestor
111314961|NCT00568087|Acetylcysteine|acetylcysteine|mesh-list
111314962|NCT00568087|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111314963|NCT00568087|Antiviral Agents|antiviral agents|mesh-ancestor
111314964|NCT00568087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111314965|NCT00568087|Expectorants|expectorants|mesh-ancestor
111314966|NCT00568087|Respiratory System Agents|respiratory system agents|mesh-ancestor
111314967|NCT00568087|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111314968|NCT00568087|Antioxidants|antioxidants|mesh-ancestor
111314969|NCT00568087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111314970|NCT00568087|Protective Agents|protective agents|mesh-ancestor
111314971|NCT00568087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111314972|NCT00568087|Antidotes|antidotes|mesh-ancestor
111314973|NCT00487721|Silymarin|silymarin|mesh-list
111314974|NCT00487721|Antioxidants|antioxidants|mesh-ancestor
111314975|NCT00487721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111314976|NCT00487721|Protective Agents|protective agents|mesh-ancestor
111314977|NCT00487721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111314978|NCT00568633|Cyclosporine|cyclosporine|mesh-list
111314979|NCT00568633|Mycophenolic Acid|mycophenolic acid|mesh-list
111314980|NCT00568633|Methylprednisolone|methylprednisolone|mesh-list
111314981|NCT00568633|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111314982|NCT00568633|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111314983|NCT00568633|Prednisolone|prednisolone|mesh-list
111314984|NCT00568633|Prednisolone acetate|prednisolone acetate|mesh-list
111314985|NCT00568633|Cyclosporins|cyclosporins|mesh-list
111314986|NCT00568633|Thymoglobulin|thymoglobulin|mesh-list
111314987|NCT00568633|Antilymphocyte Serum|antilymphocyte serum|mesh-list
111314988|NCT00568633|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111314989|NCT00568633|Prednisolone phosphate|prednisolone phosphate|mesh-list
111314990|NCT00568633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111314991|NCT00568633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111314992|NCT00568633|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111314993|NCT00568633|Immunologic Factors|immunologic factors|mesh-ancestor
111314994|NCT00568633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111314995|NCT00568633|Antifungal Agents|antifungal agents|mesh-ancestor
111314996|NCT00568633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111314997|NCT00568633|Dermatologic Agents|dermatologic agents|mesh-ancestor
111314998|NCT00568633|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111314999|NCT00568633|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111315000|NCT00568633|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111315001|NCT00568633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111315002|NCT00568633|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111315003|NCT00568633|Antitubercular Agents|antitubercular agents|mesh-ancestor
111315004|NCT00568633|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111315005|NCT00568633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111315006|NCT00568633|Antiemetics|antiemetics|mesh-ancestor
111315007|NCT00568633|Autonomic Agents|autonomic agents|mesh-ancestor
111315008|NCT00568633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111315009|NCT00568633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111315010|NCT00568633|Glucocorticoids|glucocorticoids|mesh-ancestor
111315011|NCT00568633|Hormones|hormones|mesh-ancestor
111315012|NCT00568633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111315013|NCT00568633|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111315014|NCT00568633|Protective Agents|protective agents|mesh-ancestor
111315015|NCT00568633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111315016|NCT03022838|Caffeine|caffeine|mesh-list
111315017|NCT03022838|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111315018|NCT03022838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111315019|NCT03022838|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111315020|NCT03022838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111315021|NCT03022838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111315022|NCT03022838|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
111315023|NCT03022838|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111315024|NCT03022838|Purinergic Agents|purinergic agents|mesh-ancestor
111315025|NCT03022838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111315026|NCT05363449|Naftifine|naftifine|mesh-list
111315027|NCT05363449|Antifungal Agents|antifungal agents|mesh-ancestor
111315028|NCT05363449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111315029|NCT00489281|Mycophenolic Acid|mycophenolic acid|mesh-list
111315030|NCT00489281|Sirolimus|sirolimus|mesh-list
111315031|NCT00489281|Cyclophosphamide|cyclophosphamide|mesh-list
111315032|NCT00489281|Fludarabine|fludarabine|mesh-list
111315033|NCT00489281|Levetiracetam|levetiracetam|mesh-list
111315034|NCT00489281|Thymoglobulin|thymoglobulin|mesh-list
111315035|NCT00489281|Antilymphocyte Serum|antilymphocyte serum|mesh-list
111315036|NCT00489281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111315037|NCT00489281|Immunologic Factors|immunologic factors|mesh-ancestor
111315038|NCT00489281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111315039|NCT00489281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111315040|NCT00489281|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111315041|NCT00489281|Alkylating Agents|alkylating agents|mesh-ancestor
111315042|NCT00489281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111315043|NCT00489281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111315044|NCT00489281|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111315045|NCT00489281|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111315046|NCT00489281|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111315047|NCT00489281|Antitubercular Agents|antitubercular agents|mesh-ancestor
111315048|NCT00489281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111315049|NCT00489281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111315050|NCT00489281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111315051|NCT00489281|Antifungal Agents|antifungal agents|mesh-ancestor
111315052|NCT00489281|Anticonvulsants|anticonvulsants|mesh-ancestor
111315053|NCT00489281|Nootropic Agents|nootropic agents|mesh-ancestor
111315054|NCT05362513|Ivermectin|ivermectin|mesh-list
111315055|NCT05362513|Permethrin|permethrin|mesh-list
111315056|NCT05362513|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111315057|NCT05362513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111315058|NCT05362513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111315059|NCT05362513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111315060|NCT04457297|Trifluridine|trifluridine|mesh-list
111315061|NCT04457297|Antimetabolites|antimetabolites|mesh-ancestor
111315062|NCT04457297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111315063|NCT04457297|Antiviral Agents|antiviral agents|mesh-ancestor
111315064|NCT04457297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111315065|NCT04146116|Povidone-Iodine|povidone-iodine|mesh-list
111315066|NCT04146116|Povidone|povidone|mesh-list
111315067|NCT04146116|Plasma Substitutes|plasma substitutes|mesh-ancestor
111315068|NCT04146116|Blood Substitutes|blood substitutes|mesh-ancestor
111315069|NCT04146116|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111315070|NCT04146116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111315071|NCT04145804|Insulin|insulin|mesh-list
111315072|NCT04145804|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111315073|NCT04145804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111315074|NCT02120261|Triamcinolone|triamcinolone|mesh-list
111315075|NCT02120261|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
111315076|NCT02120261|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
111315077|NCT02120261|Lidocaine|lidocaine|mesh-list
111315078|NCT02120261|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
111315079|NCT02120261|Anesthetics, Local|anesthetics, local|mesh-ancestor
111315080|NCT02120261|Anesthetics|anesthetics|mesh-ancestor
111315081|NCT02120261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111315082|NCT02120261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111315083|NCT02120261|Sensory System Agents|sensory system agents|mesh-ancestor
111315084|NCT02120261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111315085|NCT02120261|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111315086|NCT02120261|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111315087|NCT02120261|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111315088|NCT02120261|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111315089|NCT02120261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111315090|NCT02120261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111315091|NCT02120261|Glucocorticoids|glucocorticoids|mesh-ancestor
111315093|NCT02120261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111315094|NCT02120261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111315095|NCT02120261|Immunologic Factors|immunologic factors|mesh-ancestor
111315096|NCT02120261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111315097|NCT03840421|Cisplatin|cisplatin|mesh-list
111315098|NCT03840421|Gemcitabine|gemcitabine|mesh-list
111315099|NCT03840421|Fluorouracil|fluorouracil|mesh-list
111315100|NCT03840421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111315101|NCT03840421|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111315102|NCT03840421|Antimetabolites|antimetabolites|mesh-ancestor
111315103|NCT03840421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111315104|NCT03840421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111315105|NCT03840421|Immunologic Factors|immunologic factors|mesh-ancestor
111315106|NCT03840421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111315107|NCT00492089|Bevacizumab|bevacizumab|mesh-list
111315108|NCT00492089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111315109|NCT00492089|Antibodies|antibodies|mesh-list
111315110|NCT00492089|Immunoglobulins|immunoglobulins|mesh-list
111315111|NCT00492089|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111315112|NCT00492089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111315113|NCT00492089|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111315114|NCT00492089|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111315115|NCT00492089|Growth Substances|growth substances|mesh-ancestor
111315116|NCT00492089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111315117|NCT00492089|Growth Inhibitors|growth inhibitors|mesh-ancestor
111315118|NCT00492089|Immunologic Factors|immunologic factors|mesh-ancestor
111315119|NCT01798537|Vancomycin|vancomycin|mesh-list
111315120|NCT01798537|Colistin|colistin|mesh-list
111315121|NCT01798537|Neomycin|neomycin|mesh-list
111315122|NCT01798537|Nystatin|nystatin|mesh-list
111315123|NCT01798537|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111315124|NCT01798537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111315125|NCT01798537|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111315126|NCT01798537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111315127|NCT01798537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111315128|NCT01798537|Antifungal Agents|antifungal agents|mesh-ancestor
111315129|NCT01798537|Ionophores|ionophores|mesh-ancestor
111315130|NCT01798537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111315131|NCT04315181|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
111315132|NCT04315181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111315133|NCT04315181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111315134|NCT03805477|Nintedanib|nintedanib|mesh-list
111315135|NCT03805477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111315136|NCT03805477|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111315137|NCT03805477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111315138|NCT03805477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111315139|NCT04140422|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111315140|NCT04140422|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111315141|NCT01797341|Tacrolimus|tacrolimus|mesh-list
111315142|NCT01797341|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111315143|NCT01797341|Immunologic Factors|immunologic factors|mesh-ancestor
111315144|NCT01797341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111315145|NCT01797341|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111315146|NCT01797341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111315147|NCT01797341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111315148|NCT04145570|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111315149|NCT04145570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111315150|NCT04145570|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111315151|NCT04145570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111315152|NCT04145570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111315153|NCT04145492|Vitamin D|vitamin d|mesh-list
111315154|NCT04145492|Cholecalciferol|cholecalciferol|mesh-list
111315155|NCT04145492|Calcifediol|calcifediol|mesh-list
111315156|NCT04145492|Vitamins|vitamins|mesh-list
111315157|NCT04145492|Vitamin K|vitamin k|mesh-list
111315158|NCT04145492|Vitamin K 2|vitamin k 2|mesh-list
111315159|NCT04145492|Micronutrients|micronutrients|mesh-ancestor
111315160|NCT04145492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111315161|NCT04145492|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111315162|NCT04145492|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111315163|NCT04145492|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111315164|NCT04145492|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111315165|NCT04145492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111315166|NCT04145492|Hemostatics|hemostatics|mesh-ancestor
111315167|NCT04145492|Coagulants|coagulants|mesh-ancestor
111315168|NCT04147754|Morphine|morphine|mesh-list
111315169|NCT04147754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111315170|NCT04147754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111315171|NCT04147754|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111315172|NCT04147754|Narcotics|narcotics|mesh-ancestor
111315173|NCT04147754|Analgesics|analgesics|mesh-ancestor
111315174|NCT04147754|Sensory System Agents|sensory system agents|mesh-ancestor
111315175|NCT04147754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111315176|NCT00492401|Decitabine|decitabine|mesh-list
111315177|NCT00492401|Azacitidine|azacitidine|mesh-list
111315178|NCT00492401|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111315179|NCT00492401|Antimetabolites|antimetabolites|mesh-ancestor
111315180|NCT00492401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111315181|NCT00492401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111315182|NCT00492401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111315183|NCT03674827|Immunomodulating Agents|immunomodulating agents|mesh-list
111315184|NCT03674827|Immunologic Factors|immunologic factors|mesh-ancestor
111315185|NCT03674827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111315186|NCT04147286|Atorvastatin|atorvastatin|mesh-list
111315187|NCT04147286|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111315188|NCT04147286|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111315189|NCT04147286|Antimetabolites|antimetabolites|mesh-ancestor
111315190|NCT04147286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111315191|NCT04147286|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111315192|NCT04147286|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111315193|NCT04147286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111315194|NCT00493181|Oprelvekin|oprelvekin|mesh-list
111315195|NCT00493181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111315196|NCT04143659|Levonorgestrel|levonorgestrel|mesh-list
111315197|NCT04143659|Levonorgestrel butanoate|levonorgestrel butanoate|mesh-list
111315198|NCT04143659|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111315199|NCT04143659|Contraceptive Agents|contraceptive agents|mesh-ancestor
111315200|NCT04143659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111315201|NCT04143659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111315202|NCT04143659|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111315203|NCT04143659|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111315204|NCT04143659|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111315205|NCT04143659|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111315206|NCT00493805|Interferons|interferons|mesh-list
111315207|NCT00493805|Ribavirin|ribavirin|mesh-list
111315208|NCT00493805|Interferon-alpha|interferon-alpha|mesh-list
111315209|NCT00493805|Interferon alpha-2|interferon alpha-2|mesh-list
111315210|NCT00493805|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
111315211|NCT00493805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111315212|NCT00493805|Antiviral Agents|antiviral agents|mesh-ancestor
111315213|NCT00493805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111315214|NCT00493805|Antimetabolites|antimetabolites|mesh-ancestor
111315215|NCT00493805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111315216|NCT00493805|Immunologic Factors|immunologic factors|mesh-ancestor
111315217|NCT00493805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111315218|NCT04145102|Propolis|propolis|mesh-list
111315219|NCT04145102|Fluorides|fluorides|mesh-list
111315220|NCT04145102|Cariostatic Agents|cariostatic agents|mesh-ancestor
111315221|NCT04145102|Protective Agents|protective agents|mesh-ancestor
111315222|NCT04145102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111315223|NCT04145102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111315224|NCT03558373|Immunosuppressive Agents|immunosuppressive agents|mesh-list
111315225|NCT03558373|Immunologic Factors|immunologic factors|mesh-ancestor
111315226|NCT03558373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111315227|NCT05183191|Hypoglycemic Agents|hypoglycemic agents|mesh-list
111315228|NCT05183191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111315229|NCT03588494|Endostar protein|endostar protein|mesh-list
111315230|NCT03588494|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111315231|NCT03588494|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111315232|NCT03588494|Growth Substances|growth substances|mesh-ancestor
111315233|NCT03588494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111039672|NCT05522270|Mitogens|mitogens|mesh-list
111315234|NCT03588494|Growth Inhibitors|growth inhibitors|mesh-ancestor
111315235|NCT03588494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111315237|NCT00550277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111315238|NCT00550277|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111315239|NCT00550277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111315240|NCT00550277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111315241|NCT00550589|Cidofovir|cidofovir|mesh-list
111315242|NCT00550589|Antiviral Agents|antiviral agents|mesh-ancestor
111315243|NCT00550589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111315244|NCT00550589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111315245|NCT00550589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111315246|NCT04144712|Caffeine|caffeine|mesh-list
111315247|NCT04144712|Caffeine citrate|caffeine citrate|mesh-list
111315248|NCT04144712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111315249|NCT04144712|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111315250|NCT04144712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111315251|NCT04144712|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111315252|NCT04144712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111315253|NCT04144712|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
111315254|NCT04144712|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111315255|NCT04144712|Purinergic Agents|purinergic agents|mesh-ancestor
111315256|NCT04144712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111315257|NCT03588338|Acetaminophen|acetaminophen|mesh-list
111315258|NCT03588338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111315259|NCT03588338|Analgesics|analgesics|mesh-ancestor
111315260|NCT03588338|Sensory System Agents|sensory system agents|mesh-ancestor
111315261|NCT03588338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111315262|NCT03588338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111315263|NCT03588338|Antipyretics|antipyretics|mesh-ancestor
111315264|NCT05099185|Trace Elements|trace elements|mesh-list
111315265|NCT05099185|Micronutrients|micronutrients|mesh-list
111315266|NCT05099185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111315267|NCT05068609|Nivolumab|nivolumab|mesh-list
111315268|NCT05068609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111315269|NCT05068609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111315270|NCT05068609|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111315271|NCT05068609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111315272|NCT00496379|Epothilones|epothilones|mesh-list
111315273|NCT00496379|Sagopilone|sagopilone|mesh-list
111315274|NCT00496379|Tubulin Modulators|tubulin modulators|mesh-ancestor
111315275|NCT00496379|Antimitotic Agents|antimitotic agents|mesh-ancestor
111315276|NCT00496379|Mitosis Modulators|mitosis modulators|mesh-ancestor
111315277|NCT00496379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111315278|NCT00496379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111315279|NCT00497081|Mirtazapine|mirtazapine|mesh-list
111315280|NCT00497081|Antidepressive Agents|antidepressive agents|mesh-ancestor
111315281|NCT00497081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111315282|NCT00497081|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111315283|NCT00497081|Histamine Antagonists|histamine antagonists|mesh-ancestor
111315284|NCT00497081|Histamine Agents|histamine agents|mesh-ancestor
111315285|NCT00497081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111315286|NCT00497081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111315287|NCT00497081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111315288|NCT00497081|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111315289|NCT00497081|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111315290|NCT00497081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111315291|NCT00497081|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
111315292|NCT00497081|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111315293|NCT00497081|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111315294|NCT00497081|Adrenergic Agents|adrenergic agents|mesh-ancestor
111315295|NCT00497081|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111315296|NCT00497081|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111315297|NCT00497081|Serotonin Agents|serotonin agents|mesh-ancestor
111315298|NCT00497081|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111315299|NCT01796951|Aspirin|aspirin|mesh-list
111315300|NCT01796951|Celecoxib|celecoxib|mesh-list
111315301|NCT01796951|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111315302|NCT01796951|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111315303|NCT01796951|Analgesics|analgesics|mesh-ancestor
111315304|NCT01796951|Sensory System Agents|sensory system agents|mesh-ancestor
111315305|NCT01796951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111315306|NCT01796951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111315307|NCT01796951|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111315308|NCT01796951|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111315309|NCT01796951|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111315310|NCT01796951|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111315311|NCT01796951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111315312|NCT01796951|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111315313|NCT01796951|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111315315|NCT01796951|Antipyretics|antipyretics|mesh-ancestor
111315316|NCT01796951|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111315317|NCT04838041|Imatinib Mesylate|imatinib mesylate|mesh-list
111315318|NCT04838041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111315319|NCT04838041|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111315320|NCT04838041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111315321|NCT04838041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111315322|NCT03895502|Edoxaban|edoxaban|mesh-list
111315323|NCT03895502|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111315324|NCT03895502|Antithrombins|antithrombins|mesh-ancestor
111315325|NCT03895502|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111315326|NCT03895502|Protease Inhibitors|protease inhibitors|mesh-ancestor
111315327|NCT03895502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111315328|NCT03895502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111315329|NCT03895502|Anticoagulants|anticoagulants|mesh-ancestor
111315330|NCT04143854|Botulinum Toxins|botulinum toxins|mesh-list
111315331|NCT04143854|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111315332|NCT04143854|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111315333|NCT04143854|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111315334|NCT04143854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111315335|NCT04143854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111315336|NCT04143854|Cholinergic Agents|cholinergic agents|mesh-ancestor
111315337|NCT04143854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111315338|NCT04143854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111315339|NCT04143854|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111315340|NCT04143854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111315341|NCT03587558|Flecainide|flecainide|mesh-list
111315342|NCT03587558|Carvedilol|carvedilol|mesh-list
111315343|NCT03587558|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111315344|NCT03587558|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111315345|NCT03587558|Adrenergic Agents|adrenergic agents|mesh-ancestor
111315346|NCT03587558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111315347|NCT03587558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111315348|NCT03587558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111315349|NCT03587558|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111315350|NCT03587558|Antioxidants|antioxidants|mesh-ancestor
111315351|NCT03587558|Protective Agents|protective agents|mesh-ancestor
111315352|NCT03587558|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111315353|NCT03587558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111315354|NCT03587558|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111315355|NCT03587558|Vasodilator Agents|vasodilator agents|mesh-ancestor
111315356|NCT03587558|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111315357|NCT03587558|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111315358|NCT03587558|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111315359|NCT03587558|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111315360|NCT03587558|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111315361|NCT04415905|Propofol|propofol|mesh-list
111315362|NCT04415905|Sevoflurane|sevoflurane|mesh-list
111315363|NCT04415905|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111315364|NCT04415905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111315365|NCT04415905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111315366|NCT04415905|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111315367|NCT04415905|Anesthetics, General|anesthetics, general|mesh-ancestor
111315368|NCT04415905|Anesthetics|anesthetics|mesh-ancestor
111315369|NCT04415905|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111315370|NCT04415905|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111315371|NCT02979704|Atorvastatin|atorvastatin|mesh-list
111315372|NCT02979704|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111315373|NCT02979704|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111315374|NCT02979704|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111315375|NCT02979704|Antimetabolites|antimetabolites|mesh-ancestor
111315376|NCT02979704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111315377|NCT02979704|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111315378|NCT02979704|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111315379|NCT02979704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111315380|NCT03587324|Clopidogrel|clopidogrel|mesh-list
111039823|NCT05075876|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111315381|NCT03587324|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111315382|NCT03587324|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111315383|NCT03587324|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111315384|NCT03587324|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111315385|NCT03587324|Purinergic Agents|purinergic agents|mesh-ancestor
111315386|NCT03587324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111315387|NCT03587324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111315388|NCT03587324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111315390|NCT01798459|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111315391|NCT01798459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111315392|NCT01798459|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111315393|NCT01798459|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111315394|NCT01798459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111315395|NCT01798459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111315396|NCT01798459|Dopamine Agents|dopamine agents|mesh-ancestor
111315397|NCT01798459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111315398|NCT00555321|Mycophenolic Acid|mycophenolic acid|mesh-list
111315399|NCT00555321|Abatacept|abatacept|mesh-list
111315400|NCT00555321|Tacrolimus|tacrolimus|mesh-list
111315401|NCT00555321|Basiliximab|basiliximab|mesh-list
111315402|NCT00555321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111315403|NCT00555321|Immunologic Factors|immunologic factors|mesh-ancestor
111315404|NCT00555321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111315405|NCT00555321|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111315406|NCT00555321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111315407|NCT00555321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111315408|NCT00555321|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111315409|NCT00555321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111315410|NCT00555321|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111315411|NCT00555321|Antitubercular Agents|antitubercular agents|mesh-ancestor
111315412|NCT00555321|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111315413|NCT00555321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111315414|NCT00555321|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111315415|NCT00555321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111315416|NCT00555321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111315417|NCT05583266|Pentoxifylline|pentoxifylline|mesh-list
111315418|NCT05583266|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111315419|NCT05583266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111315420|NCT05583266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111315421|NCT05583266|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111315422|NCT05583266|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111315423|NCT05583266|Protective Agents|protective agents|mesh-ancestor
111315424|NCT05583266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111315425|NCT05583266|Vasodilator Agents|vasodilator agents|mesh-ancestor
111315426|NCT05583266|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111315427|NCT05583266|Antioxidants|antioxidants|mesh-ancestor
111315428|NCT04142840|Dexmedetomidine|dexmedetomidine|mesh-list
111315429|NCT04142840|Propofol|propofol|mesh-list
111315430|NCT04142840|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111315431|NCT04142840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111315432|NCT04142840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111315433|NCT04142840|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111315434|NCT04142840|Analgesics|analgesics|mesh-ancestor
111315435|NCT04142840|Sensory System Agents|sensory system agents|mesh-ancestor
111315436|NCT04142840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111315437|NCT04142840|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111315438|NCT04142840|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111315439|NCT04142840|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111315440|NCT04142840|Adrenergic Agents|adrenergic agents|mesh-ancestor
111315441|NCT04142840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111315442|NCT04142840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111315443|NCT04142840|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111315444|NCT04142840|Anesthetics, General|anesthetics, general|mesh-ancestor
111315445|NCT04142840|Anesthetics|anesthetics|mesh-ancestor
111315446|NCT04142762|Itraconazole|itraconazole|mesh-list
111315447|NCT04142762|Rifampin|rifampin|mesh-list
111315448|NCT04142762|Midazolam|midazolam|mesh-list
111315449|NCT04142762|Esomeprazole|esomeprazole|mesh-list
111315450|NCT04142762|Levonorgestrel|levonorgestrel|mesh-list
111315451|NCT04142762|Ethinyl Estradiol|ethinyl estradiol|mesh-list
111315452|NCT04142762|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
111315453|NCT04142762|Contraceptive Agents|contraceptive agents|mesh-list
111315454|NCT04142762|Contraceptives, Oral|contraceptives, oral|mesh-list
111315455|NCT04142762|Estradiol|estradiol|mesh-list
111315456|NCT04142762|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111315457|NCT04142762|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111315458|NCT04142762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111315459|NCT04142762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111315460|NCT04142762|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111315461|NCT04142762|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111315462|NCT04142762|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111315463|NCT04142762|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111315464|NCT04142762|Anesthetics, General|anesthetics, general|mesh-ancestor
111315465|NCT04142762|Anesthetics|anesthetics|mesh-ancestor
111315466|NCT04142762|GABA Modulators|gaba modulators|mesh-ancestor
111315467|NCT04142762|GABA Agents|gaba agents|mesh-ancestor
111315468|NCT04142762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111315469|NCT04142762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111315470|NCT04142762|Estrogens|estrogens|mesh-ancestor
111315471|NCT04142762|Hormones|hormones|mesh-ancestor
111315472|NCT04142762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111315473|NCT04142762|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111315474|NCT04142762|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111315475|NCT04142762|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111315476|NCT04142762|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111315477|NCT04142762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111315478|NCT04142762|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111315479|NCT04142762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111315480|NCT04142762|Antifungal Agents|antifungal agents|mesh-ancestor
111315481|NCT04142762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111315482|NCT04142762|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111315483|NCT04142762|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111315484|NCT04142762|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111315485|NCT04142762|Hormone Antagonists|hormone antagonists|mesh-ancestor
111315486|NCT04142762|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111315487|NCT04142762|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111315488|NCT04142762|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111315489|NCT04142762|Antitubercular Agents|antitubercular agents|mesh-ancestor
111315490|NCT04142762|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111315491|NCT04142762|Leprostatic Agents|leprostatic agents|mesh-ancestor
111315492|NCT04142762|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111315493|NCT04142762|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111315494|NCT04142762|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111315495|NCT04142762|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
111315496|NCT04142762|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
111315497|NCT04142762|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
111315498|NCT04142762|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111315499|NCT04142762|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111315500|NCT04142762|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
111315501|NCT02139007|Alendronate|alendronate|mesh-list
111315502|NCT02139007|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111315503|NCT02139007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111315504|NCT01590277|Ethanol|ethanol|mesh-list
111315505|NCT01590277|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111315506|NCT01590277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111315507|NCT01590277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111315508|NCT01590277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111315509|NCT03586466|Buprenorphine|buprenorphine|mesh-list
111315510|NCT03586466|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
111315511|NCT03586466|Naloxone|naloxone|mesh-list
111315512|NCT03586466|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111315513|NCT03586466|Narcotics|narcotics|mesh-ancestor
111315514|NCT03586466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111315515|NCT03586466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111315516|NCT03586466|Analgesics|analgesics|mesh-ancestor
111315517|NCT03586466|Sensory System Agents|sensory system agents|mesh-ancestor
111315518|NCT03586466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111315519|NCT03586466|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111315520|NCT00570349|Nitric Oxide|nitric oxide|mesh-list
111315521|NCT00570349|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111315522|NCT00570349|Autonomic Agents|autonomic agents|mesh-ancestor
111315523|NCT00570349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111315524|NCT00570349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111315525|NCT00570349|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111315526|NCT00570349|Respiratory System Agents|respiratory system agents|mesh-ancestor
111315527|NCT00570349|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111315528|NCT00570349|Antioxidants|antioxidants|mesh-ancestor
111315529|NCT00570349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111315530|NCT00570349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111315531|NCT00570349|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
111315532|NCT00570349|Vasodilator Agents|vasodilator agents|mesh-ancestor
111315533|NCT00570349|Gasotransmitters|gasotransmitters|mesh-ancestor
111315534|NCT00570349|Protective Agents|protective agents|mesh-ancestor
111315535|NCT03586388|Immunomodulating Agents|immunomodulating agents|mesh-list
111315536|NCT03586388|Immunologic Factors|immunologic factors|mesh-ancestor
111315537|NCT03586388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111315539|NCT02985086|Misoprostol|misoprostol|mesh-list
111315540|NCT02985086|Oxytocin|oxytocin|mesh-list
111315541|NCT02985086|Oxytocics|oxytocics|mesh-ancestor
111315542|NCT02985086|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111315543|NCT02985086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111315544|NCT02985086|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111315545|NCT02985086|Abortifacient Agents|abortifacient agents|mesh-ancestor
111315546|NCT02985086|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111315547|NCT02985086|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111315548|NCT02985086|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111315549|NCT02985086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111315550|NCT04157985|Pembrolizumab|pembrolizumab|mesh-list
111315551|NCT04157985|Nivolumab|nivolumab|mesh-list
111315552|NCT04157985|Ipilimumab|ipilimumab|mesh-list
111315553|NCT04157985|Atezolizumab|atezolizumab|mesh-list
111315554|NCT04157985|Cemiplimab|cemiplimab|mesh-list
111315555|NCT04157985|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
111315556|NCT04157985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111315557|NCT04157985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111315558|NCT04157985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111315559|NCT00609739|Cytarabine|cytarabine|mesh-list
111315560|NCT00609739|Cyclosporine|cyclosporine|mesh-list
111315561|NCT00609739|Methylprednisolone|methylprednisolone|mesh-list
111315562|NCT00609739|Methotrexate|methotrexate|mesh-list
111315563|NCT00609739|Mitoxantrone|mitoxantrone|mesh-list
111315564|NCT00609739|Tretinoin|tretinoin|mesh-list
111315565|NCT00609739|Isotretinoin|isotretinoin|mesh-list
111315566|NCT00609739|Cyclosporins|cyclosporins|mesh-list
111315567|NCT00609739|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111315568|NCT00609739|Abortifacient Agents|abortifacient agents|mesh-ancestor
111315569|NCT00609739|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111315570|NCT00609739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111315571|NCT00609739|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111315572|NCT00609739|Antimetabolites|antimetabolites|mesh-ancestor
111315573|NCT00609739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111315574|NCT00609739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111315575|NCT00609739|Dermatologic Agents|dermatologic agents|mesh-ancestor
111315576|NCT00609739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111315577|NCT00609739|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111315578|NCT00609739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111315579|NCT00609739|Immunologic Factors|immunologic factors|mesh-ancestor
111315580|NCT00609739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111315581|NCT00609739|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111315582|NCT00609739|Antiviral Agents|antiviral agents|mesh-ancestor
111315583|NCT00609739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111315584|NCT00609739|Antifungal Agents|antifungal agents|mesh-ancestor
111315585|NCT00609739|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111315586|NCT00609739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111315587|NCT00609739|Antiemetics|antiemetics|mesh-ancestor
111315588|NCT00609739|Autonomic Agents|autonomic agents|mesh-ancestor
111315589|NCT00609739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111315590|NCT00609739|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111315591|NCT00609739|Glucocorticoids|glucocorticoids|mesh-ancestor
111315592|NCT00609739|Hormones|hormones|mesh-ancestor
111315593|NCT00609739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111315594|NCT00609739|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111315595|NCT00609739|Protective Agents|protective agents|mesh-ancestor
111315596|NCT00609739|Analgesics|analgesics|mesh-ancestor
111315597|NCT00609739|Sensory System Agents|sensory system agents|mesh-ancestor
111315598|NCT00609739|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111315599|NCT00609739|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111315600|NCT00609739|Keratolytic Agents|keratolytic agents|mesh-ancestor
111315601|NCT00610987|Cefazolin|cefazolin|mesh-list
111315602|NCT00610987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111315603|NCT00610987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111315604|NCT04140578|Ertapenem|ertapenem|mesh-list
111315605|NCT04140578|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111315606|NCT04140578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111315607|NCT00574171|Capecitabine|capecitabine|mesh-list
111315608|NCT00574171|Lapatinib|lapatinib|mesh-list
111315609|NCT00574171|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111315610|NCT00574171|Antimetabolites|antimetabolites|mesh-ancestor
111315611|NCT00574171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111315612|NCT00574171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111315613|NCT00574171|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111315614|NCT00574171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111315615|NCT03585998|Cisplatin|cisplatin|mesh-list
111315616|NCT03585998|Etoposide|etoposide|mesh-list
111315617|NCT03585998|Durvalumab|durvalumab|mesh-list
111315618|NCT03585998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111315619|NCT03585998|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111315620|NCT03585998|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111315621|NCT03585998|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111315622|NCT03585998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111315623|NCT03585998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111315624|NCT03585998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111315625|NCT00612235|Lamotrigine|lamotrigine|mesh-list
111315626|NCT00612235|Carbamazepine|carbamazepine|mesh-list
111315627|NCT00612235|Levetiracetam|levetiracetam|mesh-list
111315628|NCT00612235|Anticonvulsants|anticonvulsants|mesh-ancestor
111315629|NCT00612235|Nootropic Agents|nootropic agents|mesh-ancestor
111315630|NCT00612235|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111315631|NCT00612235|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111315632|NCT00612235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111315633|NCT00612235|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111315634|NCT00612235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111315635|NCT00612235|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111315636|NCT00612235|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111315637|NCT00612235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111315638|NCT00612235|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111315639|NCT00612235|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111315640|NCT00612235|Antimanic Agents|antimanic agents|mesh-ancestor
111315641|NCT00612235|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111315642|NCT00612235|Analgesics|analgesics|mesh-ancestor
111315643|NCT00612235|Sensory System Agents|sensory system agents|mesh-ancestor
111315644|NCT00612235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111315645|NCT00612235|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111315646|NCT00612235|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111315647|NCT00575029|Megestrol|megestrol|mesh-list
111315648|NCT00575029|Megestrol Acetate|megestrol acetate|mesh-list
111315649|NCT00575029|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111315650|NCT00575029|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111315651|NCT00575029|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111315652|NCT00575029|Contraceptive Agents|contraceptive agents|mesh-ancestor
111315653|NCT00575029|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111315654|NCT00575029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111315655|NCT00575029|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111315656|NCT00575029|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111315657|NCT00575029|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111315658|NCT00575029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111315659|NCT00575029|Appetite Stimulants|appetite stimulants|mesh-ancestor
111315660|NCT00575029|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111315661|NCT00499109|Carboplatin|carboplatin|mesh-list
111315662|NCT00499109|Gemcitabine|gemcitabine|mesh-list
111315663|NCT00499109|Docetaxel|docetaxel|mesh-list
111315664|NCT00499109|Vinorelbine|vinorelbine|mesh-list
111315665|NCT00499109|Antineoplastic Agents|antineoplastic agents|mesh-list
111315666|NCT00499109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111315667|NCT00499109|Antimetabolites|antimetabolites|mesh-ancestor
111315668|NCT00499109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111315669|NCT00499109|Tubulin Modulators|tubulin modulators|mesh-ancestor
111315670|NCT00499109|Antimitotic Agents|antimitotic agents|mesh-ancestor
111315671|NCT00499109|Mitosis Modulators|mitosis modulators|mesh-ancestor
111315672|NCT00499109|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111315673|NCT03585530|Raltitrexed|raltitrexed|mesh-list
111315674|NCT03585530|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111315675|NCT03585530|Antimetabolites|antimetabolites|mesh-ancestor
111315676|NCT03585530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111315677|NCT03585530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111315678|NCT03585530|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111315679|NCT03585530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111315680|NCT03021590|Amoxicillin|amoxicillin|mesh-list
111315681|NCT03021590|Clarithromycin|clarithromycin|mesh-list
111315682|NCT03021590|Levofloxacin|levofloxacin|mesh-list
111315683|NCT03021590|Tinidazole|tinidazole|mesh-list
111315684|NCT03021590|Esomeprazole|esomeprazole|mesh-list
111315685|NCT03021590|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111315686|NCT03021590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111315687|NCT03021590|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111315688|NCT03021590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111315689|NCT03021590|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111315690|NCT03021590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111315691|NCT03021590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111315692|NCT03021590|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111315693|NCT03021590|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111315694|NCT03021590|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111315695|NCT03021590|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111315696|NCT03021590|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111315697|NCT03021590|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111315698|NCT03021590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111315699|NCT03021590|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111315700|NCT03021590|Alkylating Agents|alkylating agents|mesh-ancestor
111315701|NCT03021590|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
111315702|NCT03021590|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111315703|NCT03021590|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111315704|NCT02125721|Penicillamine|penicillamine|mesh-list
111315705|NCT02125721|Antidotes|antidotes|mesh-ancestor
111315706|NCT02125721|Protective Agents|protective agents|mesh-ancestor
111315707|NCT02125721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111315708|NCT02125721|Chelating Agents|chelating agents|mesh-ancestor
111315709|NCT02125721|Sequestering Agents|sequestering agents|mesh-ancestor
111315710|NCT02125721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111315711|NCT02125721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111315712|NCT00552695|Lidocaine|lidocaine|mesh-list
111315713|NCT00552695|Tetracaine|tetracaine|mesh-list
111315714|NCT00552695|Anesthetics, Local|anesthetics, local|mesh-ancestor
111315715|NCT00552695|Anesthetics|anesthetics|mesh-ancestor
111315716|NCT00552695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111315717|NCT00552695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111315718|NCT00552695|Sensory System Agents|sensory system agents|mesh-ancestor
111315719|NCT00552695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111315720|NCT00552695|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111315721|NCT00552695|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111315722|NCT00552695|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111315723|NCT00552695|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111315724|NCT00552695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111315725|NCT00615433|Olanzapine|olanzapine|mesh-list
111315726|NCT00615433|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
111315727|NCT00615433|Antiemetics|antiemetics|mesh-ancestor
111315728|NCT00615433|Autonomic Agents|autonomic agents|mesh-ancestor
111315729|NCT00615433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111315730|NCT00615433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111315731|NCT00615433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111315732|NCT00615433|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111315733|NCT00615433|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111315734|NCT00615433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111315735|NCT00615433|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111315736|NCT00615433|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111315737|NCT00615433|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111315738|NCT00615433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111315739|NCT00615433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111315740|NCT00615433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111315741|NCT00615433|Serotonin Agents|serotonin agents|mesh-ancestor
111315742|NCT00615433|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
111315743|NCT00615433|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111315744|NCT00615433|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111315745|NCT00615433|Adrenergic Agents|adrenergic agents|mesh-ancestor
111315746|NCT00615433|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111315747|NCT00615433|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111315748|NCT00615433|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111315749|NCT00615433|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111315750|NCT00615433|Dopamine Agents|dopamine agents|mesh-ancestor
111315751|NCT03899402|Dapagliflozin|dapagliflozin|mesh-list
111315752|NCT03899402|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111315753|NCT03899402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111315754|NCT03899402|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111040195|NCT04411862|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111315755|NCT03899402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111315756|NCT03585374|Acetaminophen|acetaminophen|mesh-list
111315757|NCT03585374|Ketoprofen|ketoprofen|mesh-list
111315758|NCT03585374|Morphine|morphine|mesh-list
111315759|NCT03585374|Methoxyflurane|methoxyflurane|mesh-list
111315760|NCT03585374|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111315761|NCT03585374|Narcotics|narcotics|mesh-ancestor
111315762|NCT03585374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111315763|NCT03585374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111315764|NCT03585374|Analgesics|analgesics|mesh-ancestor
111315765|NCT03585374|Sensory System Agents|sensory system agents|mesh-ancestor
111315766|NCT03585374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111315767|NCT03585374|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111315768|NCT03585374|Antipyretics|antipyretics|mesh-ancestor
111315769|NCT03585374|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111315770|NCT03585374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111315771|NCT03585374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111315772|NCT03585374|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111315773|NCT03585374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111315774|NCT03585374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111315775|NCT03585374|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111315776|NCT03585374|Anesthetics, General|anesthetics, general|mesh-ancestor
111315777|NCT03585374|Anesthetics|anesthetics|mesh-ancestor
111315778|NCT00499343|Rituximab|rituximab|mesh-list
111315779|NCT00499343|Etoposide|etoposide|mesh-list
111315780|NCT00499343|Ifosfamide|ifosfamide|mesh-list
111315781|NCT00499343|Isophosphamide mustard|isophosphamide mustard|mesh-list
111315782|NCT00499343|Sargramostim|sargramostim|mesh-list
111315783|NCT00499343|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111315784|NCT00499343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111315785|NCT00499343|Immunologic Factors|immunologic factors|mesh-ancestor
111315786|NCT00499343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111315787|NCT00499343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111315788|NCT00499343|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111315789|NCT00499343|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111315790|NCT00499343|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111315791|NCT00499343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111315792|NCT00499343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111315793|NCT00499343|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111315794|NCT00499343|Alkylating Agents|alkylating agents|mesh-ancestor
111315795|NCT00615589|Fludarabine|fludarabine|mesh-list
111315796|NCT00615589|Busulfan|busulfan|mesh-list
111315797|NCT00615589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111315798|NCT00615589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111315799|NCT00615589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111315800|NCT00615589|Immunologic Factors|immunologic factors|mesh-ancestor
111315801|NCT00615589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111315802|NCT00615589|Alkylating Agents|alkylating agents|mesh-ancestor
111315803|NCT00615589|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111315804|NCT00615589|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111315805|NCT00499655|Celecoxib|celecoxib|mesh-list
111315806|NCT00499655|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111315807|NCT00499655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111315808|NCT00499655|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111315809|NCT00499655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111315810|NCT00499655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111315811|NCT00499655|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111315812|NCT00499655|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111315813|NCT00499655|Analgesics|analgesics|mesh-ancestor
111315814|NCT00499655|Sensory System Agents|sensory system agents|mesh-ancestor
111315815|NCT00499655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111315816|NCT00499655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111315817|NCT00499655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111315818|NCT00499655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111315819|NCT00499655|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111315820|NCT00499655|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111315821|NCT03585140|Doxycycline|doxycycline|mesh-list
111315822|NCT03585140|Adapalene|adapalene|mesh-list
111315823|NCT03585140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111315824|NCT03585140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111315825|NCT03585140|Antimalarials|antimalarials|mesh-ancestor
111315826|NCT03585140|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111315827|NCT03585140|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111315828|NCT03585140|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111315829|NCT03585140|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111315830|NCT03585140|Analgesics|analgesics|mesh-ancestor
111315831|NCT03585140|Sensory System Agents|sensory system agents|mesh-ancestor
111315832|NCT03585140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111315833|NCT03585140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111315834|NCT03585140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111315835|NCT03585140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111315836|NCT03585140|Dermatologic Agents|dermatologic agents|mesh-ancestor
111315837|NCT03584984|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
111315838|NCT03584984|Hemostatics|hemostatics|mesh-ancestor
111315839|NCT03584984|Coagulants|coagulants|mesh-ancestor
111315840|NCT00575887|Temozolomide|temozolomide|mesh-list
111315841|NCT00575887|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111315842|NCT00575887|Alkylating Agents|alkylating agents|mesh-ancestor
111315843|NCT00575887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111315844|NCT00575887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111315845|NCT00575965|Simvastatin|simvastatin|mesh-list
111315846|NCT00575965|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111315847|NCT00575965|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111315848|NCT00575965|Antimetabolites|antimetabolites|mesh-ancestor
111315849|NCT00575965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111315850|NCT00575965|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111315851|NCT00575965|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111315852|NCT00575965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111315853|NCT03217097|Oxaliplatin|oxaliplatin|mesh-list
111315854|NCT03217097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111315855|NCT03623828|Apomorphine|apomorphine|mesh-list
111315856|NCT03623828|Emetics|emetics|mesh-ancestor
111315857|NCT03623828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111315858|NCT03623828|Autonomic Agents|autonomic agents|mesh-ancestor
111315859|NCT03623828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111315860|NCT03623828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111315861|NCT03623828|Dopamine Agonists|dopamine agonists|mesh-ancestor
111315862|NCT03623828|Dopamine Agents|dopamine agents|mesh-ancestor
111315863|NCT03623828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111315864|NCT03623828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111315865|NCT00501995|Cyclophosphamide|cyclophosphamide|mesh-list
111315866|NCT00501995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111315867|NCT00501995|Immunologic Factors|immunologic factors|mesh-ancestor
111315868|NCT00501995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111315869|NCT00501995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111315870|NCT00501995|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111315871|NCT00501995|Alkylating Agents|alkylating agents|mesh-ancestor
111315872|NCT00501995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111315873|NCT00501995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111315874|NCT00501995|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111315875|NCT03589898|Gabapentin|gabapentin|mesh-list
111315876|NCT03589898|Analgesics|analgesics|mesh-ancestor
111315877|NCT03589898|Sensory System Agents|sensory system agents|mesh-ancestor
111315878|NCT03589898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111315879|NCT03589898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111315880|NCT03589898|Anticonvulsants|anticonvulsants|mesh-ancestor
111315881|NCT03589898|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111315882|NCT03589898|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111315883|NCT03589898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111315884|NCT03589898|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111315885|NCT03589898|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111315886|NCT03589898|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111315887|NCT03589898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111315888|NCT03589898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111315889|NCT03589898|Antimanic Agents|antimanic agents|mesh-ancestor
111315890|NCT00577135|Furosemide|furosemide|mesh-list
111315891|NCT00577135|Diuretics|diuretics|mesh-list
111315892|NCT00577135|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
111315893|NCT00577135|Natriuretic Agents|natriuretic agents|mesh-ancestor
111315894|NCT00577135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111315895|NCT00577135|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111315896|NCT00577135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111315897|NCT00502853|Rituximab|rituximab|mesh-list
111315898|NCT00502853|Methotrexate|methotrexate|mesh-list
111315899|NCT00502853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111315900|NCT00502853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111315901|NCT00502853|Immunologic Factors|immunologic factors|mesh-ancestor
111315902|NCT00502853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111315903|NCT00502853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111315904|NCT00502853|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111315905|NCT00502853|Abortifacient Agents|abortifacient agents|mesh-ancestor
111315906|NCT00502853|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111315907|NCT00502853|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111315908|NCT00502853|Antimetabolites|antimetabolites|mesh-ancestor
111315909|NCT00502853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111315910|NCT00502853|Dermatologic Agents|dermatologic agents|mesh-ancestor
111315911|NCT00502853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111315912|NCT00502853|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111315913|NCT00502853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111315914|NCT00502853|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111315915|NCT00617539|Irinotecan|irinotecan|mesh-list
111315916|NCT00617539|Temozolomide|temozolomide|mesh-list
111315917|NCT00617539|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111315918|NCT00617539|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111315919|NCT00617539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111315920|NCT00617539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111315921|NCT00617539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111315922|NCT00617539|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111315923|NCT00617539|Alkylating Agents|alkylating agents|mesh-ancestor
111315924|NCT03620123|Docetaxel|docetaxel|mesh-list
111315925|NCT03620123|Nivolumab|nivolumab|mesh-list
111315926|NCT03620123|Ipilimumab|ipilimumab|mesh-list
111315927|NCT03620123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111315928|NCT03620123|Tubulin Modulators|tubulin modulators|mesh-ancestor
111315929|NCT03620123|Antimitotic Agents|antimitotic agents|mesh-ancestor
111315930|NCT03620123|Mitosis Modulators|mitosis modulators|mesh-ancestor
111315931|NCT03620123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111315932|NCT03620123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111315933|NCT03620123|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111315934|NCT00578071|Capecitabine|capecitabine|mesh-list
111315935|NCT00578071|Oxaliplatin|oxaliplatin|mesh-list
111315936|NCT00578071|Panitumumab|panitumumab|mesh-list
111315937|NCT00578071|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111315938|NCT00578071|Antimetabolites|antimetabolites|mesh-ancestor
111315939|NCT00578071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111315940|NCT00578071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111315941|NCT00578071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111315942|NCT00555581|Imatinib Mesylate|imatinib mesylate|mesh-list
111315943|NCT00555581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111315944|NCT00555581|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111315945|NCT00555581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111315946|NCT00555581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111315947|NCT00504023|Imiquimod|imiquimod|mesh-list
111315948|NCT00504023|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111315949|NCT00504023|Immunologic Factors|immunologic factors|mesh-ancestor
111315950|NCT00504023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111315951|NCT00504023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111315952|NCT00504023|Interferon Inducers|interferon inducers|mesh-ancestor
111315953|NCT03589430|Protein C|protein c|mesh-list
111315954|NCT03589430|Antithrombins|antithrombins|mesh-list
111315955|NCT03589430|Antithrombin III|antithrombin iii|mesh-list
111315956|NCT03589430|Protein S|protein s|mesh-list
111315957|NCT03589430|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111315958|NCT03589430|Protease Inhibitors|protease inhibitors|mesh-ancestor
111315959|NCT03589430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111315960|NCT03589430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111315961|NCT03589430|Anticoagulants|anticoagulants|mesh-ancestor
111315962|NCT03589430|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111315963|NCT03589430|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111315964|NCT05702762|Gentamicins|gentamicins|mesh-list
111315965|NCT05702762|Cephalexin|cephalexin|mesh-list
111315966|NCT05702762|Nitrofurantoin|nitrofurantoin|mesh-list
111315967|NCT05702762|Cefdinir|cefdinir|mesh-list
111315968|NCT05702762|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
111315969|NCT05702762|Trimethoprim|trimethoprim|mesh-list
111315970|NCT05702762|Sulfamethoxazole|sulfamethoxazole|mesh-list
111315971|NCT05702762|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111315972|NCT05702762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111315973|NCT05702762|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111315974|NCT05702762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111315975|NCT05702762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111315976|NCT05702762|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111040423|NCT02188225|Fluoxetine|fluoxetine|mesh-list
111315977|NCT05702762|Antimalarials|antimalarials|mesh-ancestor
111315978|NCT05702762|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111315979|NCT05702762|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111315980|NCT05702762|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111315981|NCT05702762|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111315982|NCT05702762|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
111315983|NCT05702762|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111315984|NCT03580694|Cemiplimab|cemiplimab|mesh-list
111315985|NCT03580694|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111315986|NCT03580694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111315987|NCT03583892|Gabapentin|gabapentin|mesh-list
111315988|NCT03583892|Analgesics|analgesics|mesh-ancestor
111315989|NCT03583892|Sensory System Agents|sensory system agents|mesh-ancestor
111315990|NCT03583892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111315991|NCT03583892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111315992|NCT03583892|Anticonvulsants|anticonvulsants|mesh-ancestor
111315993|NCT03583892|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111315994|NCT03583892|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111315995|NCT03583892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111315996|NCT03583892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111315997|NCT03583892|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111315998|NCT03583892|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111315999|NCT03583892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111316000|NCT03583892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111316001|NCT03583892|Antimanic Agents|antimanic agents|mesh-ancestor
111316002|NCT03589040|Darunavir|darunavir|mesh-list
111316003|NCT03589040|Rilpivirine|rilpivirine|mesh-list
111316004|NCT03589040|Etonogestrel|etonogestrel|mesh-list
111316005|NCT03589040|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111316006|NCT03589040|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111316007|NCT03589040|Protease Inhibitors|protease inhibitors|mesh-ancestor
111316008|NCT03589040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111316009|NCT03589040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111316010|NCT03589040|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111316011|NCT03589040|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111316012|NCT03589040|Antiviral Agents|antiviral agents|mesh-ancestor
111316013|NCT03589040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111316014|NCT03589040|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111316015|NCT03589040|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111316016|NCT03589040|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111316017|NCT03589040|Contraceptive Agents|contraceptive agents|mesh-ancestor
111316018|NCT03589040|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111316019|NCT03589040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111316020|NCT03589040|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111316021|NCT03583424|Cytarabine|cytarabine|mesh-list
111316022|NCT03583424|Etoposide|etoposide|mesh-list
111316023|NCT03583424|Podophyllotoxin|podophyllotoxin|mesh-list
111316024|NCT03583424|Etoposide phosphate|etoposide phosphate|mesh-list
111316025|NCT03583424|Melphalan|melphalan|mesh-list
111316026|NCT03583424|Venetoclax|venetoclax|mesh-list
111316027|NCT03583424|Mechlorethamine|mechlorethamine|mesh-list
111316028|NCT03583424|Carmustine|carmustine|mesh-list
111316029|NCT03583424|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
111316030|NCT03583424|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111316031|NCT03583424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111316032|NCT03583424|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111316033|NCT03583424|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111316034|NCT03583424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111316035|NCT03583424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111316036|NCT03583424|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111316037|NCT03583424|Antimetabolites|antimetabolites|mesh-ancestor
111316038|NCT03583424|Antiviral Agents|antiviral agents|mesh-ancestor
111316039|NCT03583424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111316040|NCT03583424|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111316041|NCT03583424|Immunologic Factors|immunologic factors|mesh-ancestor
111316042|NCT03583424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111316043|NCT03583424|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111316044|NCT03583424|Alkylating Agents|alkylating agents|mesh-ancestor
111316045|NCT03583424|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111316046|NCT03583424|Keratolytic Agents|keratolytic agents|mesh-ancestor
111316047|NCT03583424|Dermatologic Agents|dermatologic agents|mesh-ancestor
111316048|NCT03583424|Tubulin Modulators|tubulin modulators|mesh-ancestor
111316049|NCT03583424|Antimitotic Agents|antimitotic agents|mesh-ancestor
111316050|NCT03583424|Mitosis Modulators|mitosis modulators|mesh-ancestor
111316051|NCT00578305|Folic Acid|folic acid|mesh-list
111316052|NCT00578305|Methylprednisolone|methylprednisolone|mesh-list
111316053|NCT00578305|Rituximab|rituximab|mesh-list
111316054|NCT00578305|Methotrexate|methotrexate|mesh-list
111316055|NCT00578305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111316056|NCT00578305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111316057|NCT00578305|Immunologic Factors|immunologic factors|mesh-ancestor
111316058|NCT00578305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111316059|NCT00578305|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111316060|NCT00578305|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111316061|NCT00578305|Abortifacient Agents|abortifacient agents|mesh-ancestor
111316062|NCT00578305|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111316063|NCT00578305|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111316064|NCT00578305|Antimetabolites|antimetabolites|mesh-ancestor
111316065|NCT00578305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111316066|NCT00578305|Dermatologic Agents|dermatologic agents|mesh-ancestor
111316067|NCT00578305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111316068|NCT00578305|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111316069|NCT00578305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111316070|NCT00578305|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111316071|NCT00578305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111316072|NCT00578305|Antiemetics|antiemetics|mesh-ancestor
111316073|NCT00578305|Autonomic Agents|autonomic agents|mesh-ancestor
111316074|NCT00578305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111316075|NCT00578305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111316076|NCT00578305|Glucocorticoids|glucocorticoids|mesh-ancestor
111316077|NCT00578305|Hormones|hormones|mesh-ancestor
111316078|NCT00578305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111316079|NCT00578305|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111316080|NCT00578305|Protective Agents|protective agents|mesh-ancestor
111316081|NCT00578305|Hematinics|hematinics|mesh-ancestor
111316082|NCT00578305|Vitamin B Complex|vitamin b complex|mesh-ancestor
111316083|NCT00578305|Vitamins|vitamins|mesh-ancestor
111316084|NCT00578305|Micronutrients|micronutrients|mesh-ancestor
111316085|NCT00578461|Cytarabine|cytarabine|mesh-list
111316086|NCT00578461|Cyclophosphamide|cyclophosphamide|mesh-list
111316087|NCT00578461|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111316088|NCT00578461|Immunologic Factors|immunologic factors|mesh-ancestor
111316089|NCT00578461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111316090|NCT00578461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111316091|NCT00578461|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111316092|NCT00578461|Alkylating Agents|alkylating agents|mesh-ancestor
111316093|NCT00578461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111316094|NCT00578461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111316095|NCT00578461|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111316096|NCT00578461|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111316097|NCT00578461|Antimetabolites|antimetabolites|mesh-ancestor
111316098|NCT00578461|Antiviral Agents|antiviral agents|mesh-ancestor
111316099|NCT00578461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111316100|NCT03580070|Immunomodulating Agents|immunomodulating agents|mesh-list
111316101|NCT03580070|Immunologic Factors|immunologic factors|mesh-ancestor
111316102|NCT03580070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111316103|NCT03156296|Dexmedetomidine|dexmedetomidine|mesh-list
111316104|NCT03156296|Bupivacaine|bupivacaine|mesh-list
111316105|NCT03156296|Anesthetics, Local|anesthetics, local|mesh-ancestor
111316106|NCT03156296|Anesthetics|anesthetics|mesh-ancestor
111316107|NCT03156296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111316108|NCT03156296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111316109|NCT03156296|Sensory System Agents|sensory system agents|mesh-ancestor
111316110|NCT03156296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111316111|NCT03156296|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111316112|NCT03156296|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111316113|NCT03156296|Analgesics|analgesics|mesh-ancestor
111316114|NCT03156296|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111316115|NCT03156296|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111316116|NCT03156296|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111316117|NCT03156296|Adrenergic Agents|adrenergic agents|mesh-ancestor
111316118|NCT03156296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111316119|NCT03156296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111316120|NCT00578539|Cytarabine|cytarabine|mesh-list
111316121|NCT00578539|Cyclophosphamide|cyclophosphamide|mesh-list
111316122|NCT00578539|Alemtuzumab|alemtuzumab|mesh-list
111316123|NCT00578539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111316124|NCT00578539|Immunologic Factors|immunologic factors|mesh-ancestor
111316125|NCT00578539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111316126|NCT00578539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111316127|NCT00578539|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111316128|NCT00578539|Alkylating Agents|alkylating agents|mesh-ancestor
111316129|NCT00578539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111316130|NCT00578539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111316131|NCT00578539|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111316132|NCT00578539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110768819|NCT05833958|Metformin|metformin|mesh-list
111316133|NCT00578539|Antimetabolites|antimetabolites|mesh-ancestor
111316134|NCT00578539|Antiviral Agents|antiviral agents|mesh-ancestor
111316135|NCT00578539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111316136|NCT00578539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111316137|NCT00578617|Amiodarone|amiodarone|mesh-list
111316138|NCT00578617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111316139|NCT00578617|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111316140|NCT00578617|Vasodilator Agents|vasodilator agents|mesh-ancestor
111316141|NCT00578617|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
111316142|NCT00578617|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111316143|NCT00578617|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111316144|NCT00578617|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111316145|NCT00578617|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111316146|NCT00578617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111316147|NCT00578617|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111316148|NCT00578617|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111316149|NCT00578617|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111316150|NCT00505895|Rituximab|rituximab|mesh-list
111316151|NCT00505895|Fludarabine|fludarabine|mesh-list
111316152|NCT00505895|Fludarabine phosphate|fludarabine phosphate|mesh-list
111316153|NCT00505895|Melphalan|melphalan|mesh-list
111316154|NCT00505895|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111316155|NCT00505895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111316156|NCT00505895|Immunologic Factors|immunologic factors|mesh-ancestor
111316157|NCT00505895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111316158|NCT00505895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111316159|NCT00505895|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111316160|NCT00505895|Antimetabolites|antimetabolites|mesh-ancestor
111316161|NCT00505895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111316162|NCT00505895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111316163|NCT00505895|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111316164|NCT00505895|Alkylating Agents|alkylating agents|mesh-ancestor
111316165|NCT00505895|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111316166|NCT03582332|Indomethacin|indomethacin|mesh-list
111316167|NCT03582332|Etoricoxib|etoricoxib|mesh-list
111316168|NCT03582332|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111316169|NCT03582332|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111316170|NCT03582332|Analgesics|analgesics|mesh-ancestor
111316171|NCT03582332|Sensory System Agents|sensory system agents|mesh-ancestor
111316172|NCT03582332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111316173|NCT03582332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111316174|NCT03582332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111316175|NCT03582332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111316176|NCT03582332|Gout Suppressants|gout suppressants|mesh-ancestor
111316177|NCT03582332|Tocolytic Agents|tocolytic agents|mesh-ancestor
111316178|NCT03582332|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111316179|NCT03582332|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111316180|NCT03582332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111316181|NCT03582332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111316182|NCT03582332|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111316183|NCT00619723|Choline|choline|mesh-list
111316184|NCT00619723|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
111316185|NCT00619723|Lipotropic Agents|lipotropic agents|mesh-ancestor
111316186|NCT00619723|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111316187|NCT00619723|Antimetabolites|antimetabolites|mesh-ancestor
111316188|NCT00619723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111316189|NCT00619723|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111316190|NCT00619723|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111316191|NCT00619723|Nootropic Agents|nootropic agents|mesh-ancestor
111316192|NCT03582098|Rituximab|rituximab|mesh-list
111316193|NCT03582098|Idelalisib|idelalisib|mesh-list
111316194|NCT03582098|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111316195|NCT03582098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111316196|NCT03582098|Immunologic Factors|immunologic factors|mesh-ancestor
111316197|NCT03582098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111316198|NCT03582098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111316199|NCT03582098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111316200|NCT03582098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111316201|NCT00555893|Oseltamivir|oseltamivir|mesh-list
111316202|NCT00555893|Antiviral Agents|antiviral agents|mesh-ancestor
111316203|NCT00555893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111316204|NCT00555893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111316205|NCT00555893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111316206|NCT00578929|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
111316207|NCT00578929|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111316208|NCT00578929|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111316209|NCT00578929|Analgesics|analgesics|mesh-ancestor
111316210|NCT00578929|Sensory System Agents|sensory system agents|mesh-ancestor
111316211|NCT00578929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111316212|NCT00578929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111316213|NCT00578929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111316214|NCT00578929|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111316215|NCT00578929|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111316216|NCT00578929|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
111316217|NCT00578929|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111316218|NCT00578929|Histamine Antagonists|histamine antagonists|mesh-ancestor
111316219|NCT00578929|Histamine Agents|histamine agents|mesh-ancestor
111316220|NCT00578929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111316221|NCT00578929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111316222|NCT00556049|Gemcitabine|gemcitabine|mesh-list
111316223|NCT00556049|Sunitinib|sunitinib|mesh-list
111316224|NCT00556049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111316225|NCT00556049|Antimetabolites|antimetabolites|mesh-ancestor
111316226|NCT00556049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111316227|NCT00556049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111316228|NCT00556049|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111316229|NCT00556049|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111316230|NCT00556049|Growth Substances|growth substances|mesh-ancestor
111316231|NCT00556049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111316232|NCT00556049|Growth Inhibitors|growth inhibitors|mesh-ancestor
111316233|NCT00556049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111316234|NCT00556049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111316235|NCT01797107|Azithromycin|azithromycin|mesh-list
111316236|NCT01797107|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111316237|NCT01797107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111316238|NCT03155984|Antibodies|antibodies|mesh-list
111316239|NCT03155984|Immunologic Factors|immunologic factors|mesh-ancestor
111316240|NCT03155984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111316241|NCT00620191|Metformin|metformin|mesh-list
111316242|NCT00620191|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111316243|NCT00620191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111316244|NCT00506597|Asparaginase|asparaginase|mesh-list
111316245|NCT00506597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111316246|NCT03589976|Sirolimus|sirolimus|mesh-list
111316247|NCT03589976|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111316248|NCT03589976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111316249|NCT03589976|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111316250|NCT03589976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111316251|NCT03589976|Antifungal Agents|antifungal agents|mesh-ancestor
111316252|NCT03589976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111316253|NCT03589976|Immunologic Factors|immunologic factors|mesh-ancestor
111316254|NCT03589976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111316255|NCT03581630|Naltrexone|naltrexone|mesh-list
111316256|NCT03581630|Bupropion|bupropion|mesh-list
111316257|NCT03581630|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111316258|NCT03581630|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111316259|NCT03581630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111316260|NCT03581630|Sensory System Agents|sensory system agents|mesh-ancestor
111316261|NCT03581630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111316262|NCT03581630|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111316263|NCT03581630|Antidepressive Agents|antidepressive agents|mesh-ancestor
111316264|NCT03581630|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111316265|NCT03581630|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111316266|NCT03581630|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111316267|NCT03581630|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111316268|NCT03581630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111316269|NCT03581630|Dopamine Agents|dopamine agents|mesh-ancestor
111316270|NCT03581630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111316271|NCT03581630|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111316272|NCT03581630|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111316273|NCT03581630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111316274|NCT00506675|Atropine|atropine|mesh-list
111316275|NCT00506675|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111316276|NCT00506675|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111316277|NCT00506675|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111316278|NCT00506675|Autonomic Agents|autonomic agents|mesh-ancestor
111316279|NCT00506675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111316280|NCT00506675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111316281|NCT00506675|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111316282|NCT00506675|Respiratory System Agents|respiratory system agents|mesh-ancestor
111316283|NCT00506675|Mydriatics|mydriatics|mesh-ancestor
111316284|NCT00506675|Parasympatholytics|parasympatholytics|mesh-ancestor
111316285|NCT00506675|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111316286|NCT00506675|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111316287|NCT00506675|Cholinergic Agents|cholinergic agents|mesh-ancestor
111316288|NCT00506675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111316289|NCT00506675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111316290|NCT00507767|Dasatinib|dasatinib|mesh-list
111316291|NCT00507767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111316292|NCT00507767|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111316293|NCT00507767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111316294|NCT00507767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111316295|NCT00621049|Bevacizumab|bevacizumab|mesh-list
111316296|NCT00621049|Carboplatin|carboplatin|mesh-list
111316297|NCT00621049|Docetaxel|docetaxel|mesh-list
111316298|NCT00621049|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111316299|NCT00621049|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111316300|NCT00621049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111316301|NCT00621049|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111316302|NCT00621049|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111316303|NCT00621049|Growth Substances|growth substances|mesh-ancestor
111316304|NCT00621049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111316305|NCT00621049|Growth Inhibitors|growth inhibitors|mesh-ancestor
111316306|NCT00621049|Tubulin Modulators|tubulin modulators|mesh-ancestor
111316307|NCT00621049|Antimitotic Agents|antimitotic agents|mesh-ancestor
111316308|NCT00621049|Mitosis Modulators|mitosis modulators|mesh-ancestor
111316309|NCT00621049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111316310|NCT00621049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111316311|NCT00621049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111316312|NCT00508469|Timolol|timolol|mesh-list
111316313|NCT00508469|Travoprost|travoprost|mesh-list
111316314|NCT00508469|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111316315|NCT00508469|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111316316|NCT00508469|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111316317|NCT00508469|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111316318|NCT00508469|Adrenergic Agents|adrenergic agents|mesh-ancestor
111316319|NCT00508469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111316320|NCT00508469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111316321|NCT00508469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111316322|NCT00508469|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111316323|NCT00508469|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111316324|NCT05702996|Eculizumab|eculizumab|mesh-list
111316325|NCT05702996|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
111316326|NCT05702996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111316327|NCT05702996|Immunologic Factors|immunologic factors|mesh-ancestor
111316328|NCT05702996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111316329|NCT00580333|Paclitaxel|paclitaxel|mesh-list
111316330|NCT00580333|Cyclophosphamide|cyclophosphamide|mesh-list
111316331|NCT00580333|Bevacizumab|bevacizumab|mesh-list
111316332|NCT00580333|Doxorubicin|doxorubicin|mesh-list
111316333|NCT00580333|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111316334|NCT00580333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111316335|NCT00580333|Tubulin Modulators|tubulin modulators|mesh-ancestor
111316336|NCT00580333|Antimitotic Agents|antimitotic agents|mesh-ancestor
111316337|NCT00580333|Mitosis Modulators|mitosis modulators|mesh-ancestor
111316338|NCT00580333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111316339|NCT00580333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111316340|NCT00580333|Immunologic Factors|immunologic factors|mesh-ancestor
111316341|NCT00580333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111316342|NCT00580333|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111316343|NCT00580333|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111316344|NCT00580333|Alkylating Agents|alkylating agents|mesh-ancestor
111316345|NCT00580333|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111316346|NCT00580333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111316347|NCT00580333|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110980237|NCT02424851|Glucocorticoids|glucocorticoids|mesh-ancestor
111316348|NCT00580333|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111316349|NCT00580333|Growth Substances|growth substances|mesh-ancestor
111316350|NCT00580333|Growth Inhibitors|growth inhibitors|mesh-ancestor
111316351|NCT00580333|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111316352|NCT00580333|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111316353|NCT00580333|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111316354|NCT00580333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111316355|NCT00580645|Varenicline|varenicline|mesh-list
111316356|NCT00580645|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111040792|NCT02195557|Hylan|hylan|mesh-list
111316357|NCT00580645|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111316358|NCT00580645|Cholinergic Agents|cholinergic agents|mesh-ancestor
111316359|NCT00580645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111316360|NCT00580645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111316361|NCT00580645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111316362|NCT00580957|Trimethaphan|trimethaphan|mesh-list
111316363|NCT00580957|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111316364|NCT00580957|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111316365|NCT00580957|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
111316366|NCT00580957|Autonomic Agents|autonomic agents|mesh-ancestor
111316367|NCT00580957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111316368|NCT00580957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111316369|NCT00580957|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
111316370|NCT00580957|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111316371|NCT00580957|Cholinergic Agents|cholinergic agents|mesh-ancestor
111316372|NCT00580957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111316373|NCT00580957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111316374|NCT00509249|Aflibercept|aflibercept|mesh-list
111316375|NCT00509249|Endothelial Growth Factors|endothelial growth factors|mesh-list
111316376|NCT00509249|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111316377|NCT00509249|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111316378|NCT00509249|Growth Substances|growth substances|mesh-ancestor
111316379|NCT00509249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111316380|NCT00509249|Growth Inhibitors|growth inhibitors|mesh-ancestor
111316381|NCT00509249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111316382|NCT00624013|Sertraline|sertraline|mesh-list
111316383|NCT00624013|Antidepressive Agents|antidepressive agents|mesh-ancestor
111316384|NCT00624013|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111316385|NCT00624013|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111316386|NCT00624013|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111316387|NCT00624013|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111316388|NCT00624013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111316389|NCT00624013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111316390|NCT00624013|Serotonin Agents|serotonin agents|mesh-ancestor
111316391|NCT00624013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111316392|NCT02121041|Losartan|losartan|mesh-list
111316393|NCT02121041|Amlodipine|amlodipine|mesh-list
111316394|NCT02121041|Chlorthalidone|chlorthalidone|mesh-list
111316395|NCT02121041|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111316396|NCT02121041|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111316397|NCT02121041|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111316398|NCT02121041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111316399|NCT02121041|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111316400|NCT02121041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111316401|NCT02121041|Vasodilator Agents|vasodilator agents|mesh-ancestor
111316402|NCT02121041|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111316403|NCT02121041|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111316404|NCT02121041|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111316405|NCT02121041|Diuretics|diuretics|mesh-ancestor
111316406|NCT02121041|Natriuretic Agents|natriuretic agents|mesh-ancestor
111316407|NCT02121041|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
111316408|NCT00509873|Gatifloxacin|gatifloxacin|mesh-list
111316409|NCT00509873|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111316410|NCT00509873|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111316411|NCT00509873|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111316412|NCT00509873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111316413|NCT00509873|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111316414|NCT00509873|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111316415|NCT00509873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111316416|NCT00509873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111316417|NCT00509873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111316418|NCT02133781|Vaccines|vaccines|mesh-list
111316419|NCT02133781|Immunologic Factors|immunologic factors|mesh-ancestor
111316420|NCT02133781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111316421|NCT01855451|Cetuximab|cetuximab|mesh-list
111316422|NCT01855451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111316423|NCT01855451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111316424|NCT02134951|Ketamine|ketamine|mesh-list
111316425|NCT02134951|Analgesics|analgesics|mesh-ancestor
111316426|NCT02134951|Sensory System Agents|sensory system agents|mesh-ancestor
111316427|NCT02134951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111316428|NCT02134951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111316429|NCT02134951|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111316430|NCT02134951|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111316431|NCT02134951|Anesthetics, General|anesthetics, general|mesh-ancestor
111316432|NCT02134951|Anesthetics|anesthetics|mesh-ancestor
111316433|NCT02134951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111316434|NCT02134951|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111316435|NCT02134951|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111316436|NCT02134951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111316437|NCT02134951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111316438|NCT03029780|Nivolumab|nivolumab|mesh-list
111316439|NCT03029780|Ipilimumab|ipilimumab|mesh-list
111316440|NCT03029780|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111316441|NCT03029780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111316442|NCT03029780|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111316443|NCT03029780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111316444|NCT00624559|Celecoxib|celecoxib|mesh-list
111316445|NCT00624559|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111316446|NCT00624559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111316447|NCT00624559|Analgesics|analgesics|mesh-ancestor
111316448|NCT00624559|Sensory System Agents|sensory system agents|mesh-ancestor
111316449|NCT00624559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111316450|NCT00624559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111316451|NCT00624559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111316452|NCT00624559|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111316453|NCT00624559|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111316454|NCT00624559|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111316455|NCT00624559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111316456|NCT00624559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111316457|NCT00510809|Ethanol|ethanol|mesh-list
111316458|NCT00510809|Policosanol|policosanol|mesh-list
111316459|NCT00510809|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
111316460|NCT00510809|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111316461|NCT00510809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111316462|NCT00510809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111316463|NCT00510809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111316464|NCT00510809|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111316465|NCT00510809|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111316466|NCT00510809|Antimetabolites|antimetabolites|mesh-ancestor
111316467|NCT00510809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111316468|NCT00510809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111316469|NCT00510809|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111316470|NCT00510809|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111316471|NCT00625729|Aldesleukin|aldesleukin|mesh-list
111316472|NCT00625729|Cyclophosphamide|cyclophosphamide|mesh-list
111316473|NCT00625729|Rituximab|rituximab|mesh-list
111316474|NCT00625729|Fludarabine|fludarabine|mesh-list
111316475|NCT00625729|Fludarabine phosphate|fludarabine phosphate|mesh-list
111316476|NCT00625729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111316477|NCT00625729|Immunologic Factors|immunologic factors|mesh-ancestor
111316478|NCT00625729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111316479|NCT00625729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111316480|NCT00625729|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111316481|NCT00625729|Alkylating Agents|alkylating agents|mesh-ancestor
111316482|NCT00625729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111316483|NCT00625729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111316484|NCT00625729|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111316485|NCT00625729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111316486|NCT00625729|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111316487|NCT00625729|Antimetabolites|antimetabolites|mesh-ancestor
111316488|NCT00625729|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111316489|NCT00625729|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111316490|NCT00625729|Antiviral Agents|antiviral agents|mesh-ancestor
111316491|NCT00625729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111316492|NCT00581971|Celecoxib|celecoxib|mesh-list
111316493|NCT00581971|Paclitaxel|paclitaxel|mesh-list
111316494|NCT00581971|Carboplatin|carboplatin|mesh-list
111316495|NCT00581971|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111316496|NCT00581971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111316497|NCT00581971|Tubulin Modulators|tubulin modulators|mesh-ancestor
111316498|NCT00581971|Antimitotic Agents|antimitotic agents|mesh-ancestor
111316499|NCT00581971|Mitosis Modulators|mitosis modulators|mesh-ancestor
111316500|NCT00581971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111316501|NCT00581971|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111316502|NCT00581971|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111316503|NCT00581971|Analgesics|analgesics|mesh-ancestor
111316504|NCT00581971|Sensory System Agents|sensory system agents|mesh-ancestor
111316505|NCT00581971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111316506|NCT00581971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111316507|NCT00581971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111316508|NCT00581971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111316509|NCT00581971|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111316510|NCT00581971|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111316511|NCT00581971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111316512|NCT03029234|Dexamethasone|dexamethasone|mesh-list
111316513|NCT03029234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111316514|NCT03029234|Antiemetics|antiemetics|mesh-ancestor
111316515|NCT03029234|Autonomic Agents|autonomic agents|mesh-ancestor
111316516|NCT03029234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111316517|NCT03029234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111316518|NCT03029234|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111316519|NCT03029234|Glucocorticoids|glucocorticoids|mesh-ancestor
111316520|NCT03029234|Hormones|hormones|mesh-ancestor
111316521|NCT03029234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111316522|NCT03029234|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111316523|NCT03029234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111316524|NCT01670318|Chromium|chromium|mesh-list
111316525|NCT01670318|Everolimus|everolimus|mesh-list
111316526|NCT01670318|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111316527|NCT01670318|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111316528|NCT01670318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111316529|NCT01670318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111316530|NCT01670318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111316531|NCT01670318|Immunologic Factors|immunologic factors|mesh-ancestor
111316532|NCT01670318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111316533|NCT01670318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111316534|NCT01670318|Trace Elements|trace elements|mesh-ancestor
111316535|NCT01670318|Micronutrients|micronutrients|mesh-ancestor
111316536|NCT03155204|Tiotropium Bromide|tiotropium bromide|mesh-list
111316537|NCT03155204|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111316538|NCT03155204|Autonomic Agents|autonomic agents|mesh-ancestor
111316539|NCT03155204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111316540|NCT03155204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111316541|NCT03155204|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111316542|NCT03155204|Respiratory System Agents|respiratory system agents|mesh-ancestor
111316543|NCT03155204|Parasympatholytics|parasympatholytics|mesh-ancestor
111316544|NCT03155204|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111316545|NCT03155204|Cholinergic Agents|cholinergic agents|mesh-ancestor
111316546|NCT03155204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111316547|NCT03155204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111316548|NCT03111992|Spartalizumab|spartalizumab|mesh-list
111316549|NCT03111992|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111316550|NCT03111992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111316551|NCT03111992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111316552|NCT03111992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111316553|NCT00626431|Leuprolide|leuprolide|mesh-list
111316554|NCT00626431|Hormones|hormones|mesh-list
111316555|NCT00626431|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
110980243|NCT02424851|Alkylating Agents|alkylating agents|mesh-ancestor
111316556|NCT00626431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111316557|NCT00626431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111316558|NCT00626431|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111316559|NCT00626431|Fertility Agents|fertility agents|mesh-ancestor
111316560|NCT00626431|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111316561|NCT00626431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111316562|NCT00626431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111316563|NCT01670474|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
111316564|NCT01670474|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111316565|NCT01670474|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111316566|NCT01670474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111316567|NCT00582205|Paclitaxel|paclitaxel|mesh-list
111316568|NCT00582205|Cisplatin|cisplatin|mesh-list
111316569|NCT00582205|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111316570|NCT00582205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111316571|NCT00582205|Tubulin Modulators|tubulin modulators|mesh-ancestor
111316572|NCT00582205|Antimitotic Agents|antimitotic agents|mesh-ancestor
111316573|NCT00582205|Mitosis Modulators|mitosis modulators|mesh-ancestor
111316574|NCT00582205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111316575|NCT00626743|Amlodipine|amlodipine|mesh-list
111316576|NCT00626743|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111316577|NCT00626743|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111316578|NCT00626743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111316579|NCT00626743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111316580|NCT00626743|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111316581|NCT00626743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111316582|NCT00626743|Vasodilator Agents|vasodilator agents|mesh-ancestor
111316584|NCT03155048|Estrogens|estrogens|mesh-list
111316585|NCT03155048|Hormones|hormones|mesh-ancestor
111316586|NCT03155048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111316587|NCT03155048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111316588|NCT00627367|Hydromorphone|hydromorphone|mesh-list
111316589|NCT00627367|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111316590|NCT00627367|Narcotics|narcotics|mesh-ancestor
111316591|NCT00627367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111316592|NCT00627367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111316593|NCT00627367|Analgesics|analgesics|mesh-ancestor
111316594|NCT00627367|Sensory System Agents|sensory system agents|mesh-ancestor
111316595|NCT00627367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111316596|NCT00627679|Budesonide|budesonide|mesh-list
111316597|NCT00627679|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111316598|NCT00627679|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111316599|NCT00627679|Autonomic Agents|autonomic agents|mesh-ancestor
111316600|NCT00627679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111316601|NCT00627679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111316602|NCT00627679|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111316603|NCT00627679|Respiratory System Agents|respiratory system agents|mesh-ancestor
111316604|NCT00627679|Glucocorticoids|glucocorticoids|mesh-ancestor
111316605|NCT00627679|Hormones|hormones|mesh-ancestor
111316606|NCT00627679|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111316607|NCT00514709|Vaccines|vaccines|mesh-list
111316608|NCT00514709|Immunologic Factors|immunologic factors|mesh-ancestor
111316609|NCT00514709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111316610|NCT03154814|Urinastatin|urinastatin|mesh-list
111316611|NCT03154814|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
111316612|NCT03154814|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111316613|NCT03154814|Protease Inhibitors|protease inhibitors|mesh-ancestor
111316614|NCT03154814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111316615|NCT03154814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111316616|NCT00515021|Eplerenone|eplerenone|mesh-list
111316617|NCT00515021|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
111316618|NCT00515021|Hormone Antagonists|hormone antagonists|mesh-ancestor
111316619|NCT00515021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111316620|NCT00515021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111316621|NCT00515021|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
111316622|NCT00515021|Diuretics|diuretics|mesh-ancestor
111316623|NCT00515021|Natriuretic Agents|natriuretic agents|mesh-ancestor
111316624|NCT00515021|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111316625|NCT00515177|Eszopiclone|eszopiclone|mesh-list
111316626|NCT00515177|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111316627|NCT00515177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111316628|NCT00515177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111316629|NCT01671410|Morphine|morphine|mesh-list
111316630|NCT01671410|Buprenorphine|buprenorphine|mesh-list
111316631|NCT01671410|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111316632|NCT01671410|Narcotics|narcotics|mesh-ancestor
111316633|NCT01671410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111316634|NCT01671410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111316635|NCT01671410|Analgesics|analgesics|mesh-ancestor
111316636|NCT01671410|Sensory System Agents|sensory system agents|mesh-ancestor
111316637|NCT01671410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111316638|NCT01671410|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111316639|NCT00630253|Cyclosporine|cyclosporine|mesh-list
111316640|NCT00630253|Mycophenolic Acid|mycophenolic acid|mesh-list
111316641|NCT00630253|Methylprednisolone|methylprednisolone|mesh-list
111316642|NCT00630253|Cyclophosphamide|cyclophosphamide|mesh-list
111316643|NCT00630253|Fludarabine|fludarabine|mesh-list
111316644|NCT00630253|Cyclosporins|cyclosporins|mesh-list
111316645|NCT00630253|Antilymphocyte Serum|antilymphocyte serum|mesh-list
111316646|NCT00630253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111316647|NCT00630253|Immunologic Factors|immunologic factors|mesh-ancestor
111316648|NCT00630253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111316649|NCT00630253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111316650|NCT00630253|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111316651|NCT00630253|Alkylating Agents|alkylating agents|mesh-ancestor
111041090|NCT05976737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111316652|NCT00630253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111316653|NCT00630253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111316654|NCT00630253|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111316655|NCT00630253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111316656|NCT00630253|Antifungal Agents|antifungal agents|mesh-ancestor
111316657|NCT00630253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111316658|NCT00630253|Dermatologic Agents|dermatologic agents|mesh-ancestor
111316659|NCT00630253|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111316660|NCT00630253|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111316661|NCT00630253|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111316662|NCT00630253|Antitubercular Agents|antitubercular agents|mesh-ancestor
111316663|NCT00630253|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111316664|NCT00630253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111316665|NCT00630253|Antiemetics|antiemetics|mesh-ancestor
111316666|NCT00630253|Autonomic Agents|autonomic agents|mesh-ancestor
111316667|NCT00630253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111316668|NCT00630253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111316669|NCT00630253|Glucocorticoids|glucocorticoids|mesh-ancestor
111316670|NCT00630253|Hormones|hormones|mesh-ancestor
111316671|NCT00630253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111316672|NCT00630253|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111316673|NCT00630253|Protective Agents|protective agents|mesh-ancestor
111316674|NCT01671722|Montelukast|montelukast|mesh-list
111316675|NCT01671722|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111316676|NCT01671722|Respiratory System Agents|respiratory system agents|mesh-ancestor
111316677|NCT01671722|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
111316678|NCT01671722|Hormone Antagonists|hormone antagonists|mesh-ancestor
111316679|NCT01671722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111316680|NCT01671722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111316681|NCT01671722|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
111316682|NCT01671722|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111316683|NCT01671722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111316684|NCT00584701|Risperidone|risperidone|mesh-list
111316685|NCT00584701|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111316686|NCT00584701|Serotonin Agents|serotonin agents|mesh-ancestor
111316687|NCT00584701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111316688|NCT00584701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111316689|NCT00584701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111316690|NCT00584701|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111316691|NCT00584701|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111316692|NCT00584701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111316693|NCT00584701|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111316694|NCT00584701|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111316695|NCT00584701|Dopamine Agents|dopamine agents|mesh-ancestor
111316696|NCT00630409|Gemcitabine|gemcitabine|mesh-list
111316697|NCT00630409|Doxorubicin|doxorubicin|mesh-list
111316698|NCT00630409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111316699|NCT00630409|Antimetabolites|antimetabolites|mesh-ancestor
111316700|NCT00630409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111316701|NCT00630409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111316702|NCT00630409|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111316703|NCT00630409|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111316704|NCT00630409|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111316705|NCT00630409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111316706|NCT00630955|Memantine|memantine|mesh-list
111316707|NCT00630955|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111316708|NCT00630955|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111316709|NCT00630955|Dopamine Agents|dopamine agents|mesh-ancestor
111316710|NCT00630955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111316711|NCT00630955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111316712|NCT00630955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111316713|NCT00630955|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111316714|NCT00630955|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111316715|NCT00584857|Paclitaxel|paclitaxel|mesh-list
111316716|NCT00584857|Carboplatin|carboplatin|mesh-list
111316717|NCT00584857|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111316718|NCT00584857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111316719|NCT00584857|Tubulin Modulators|tubulin modulators|mesh-ancestor
111316720|NCT00584857|Antimitotic Agents|antimitotic agents|mesh-ancestor
111316721|NCT00584857|Mitosis Modulators|mitosis modulators|mesh-ancestor
111316722|NCT00584857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111316723|NCT00585013|Nitric Oxide|nitric oxide|mesh-list
111316724|NCT00585013|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111316725|NCT00585013|Autonomic Agents|autonomic agents|mesh-ancestor
111316726|NCT00585013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111316727|NCT00585013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111316728|NCT00585013|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111316729|NCT00585013|Respiratory System Agents|respiratory system agents|mesh-ancestor
111316730|NCT00585013|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111316731|NCT00585013|Antioxidants|antioxidants|mesh-ancestor
111316732|NCT00585013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111316733|NCT00585013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111316734|NCT00585013|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
111316735|NCT00585013|Vasodilator Agents|vasodilator agents|mesh-ancestor
111316736|NCT00585013|Gasotransmitters|gasotransmitters|mesh-ancestor
111316737|NCT00585013|Protective Agents|protective agents|mesh-ancestor
111316738|NCT01672112|Oxycodone|oxycodone|mesh-list
111316739|NCT01672112|Codeine|codeine|mesh-list
111316740|NCT01672112|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111316741|NCT01672112|Narcotics|narcotics|mesh-ancestor
111316742|NCT01672112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111316743|NCT01672112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111316744|NCT01672112|Analgesics|analgesics|mesh-ancestor
111316745|NCT01672112|Sensory System Agents|sensory system agents|mesh-ancestor
111316746|NCT01672112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111316747|NCT01672112|Antitussive Agents|antitussive agents|mesh-ancestor
111316748|NCT01672112|Respiratory System Agents|respiratory system agents|mesh-ancestor
111316749|NCT00585637|Vitamin D|vitamin d|mesh-list
111316750|NCT00585637|Vitamins|vitamins|mesh-ancestor
111316751|NCT00585637|Micronutrients|micronutrients|mesh-ancestor
111316752|NCT00585637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111316753|NCT00585637|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111316754|NCT03158792|Enoxaparin|enoxaparin|mesh-list
111316755|NCT03158792|Enoxaparin sodium|enoxaparin sodium|mesh-list
111316756|NCT03158792|Anticoagulants|anticoagulants|mesh-ancestor
111316757|NCT03158792|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111316758|NCT03158792|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111316759|NCT03158792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111316760|NCT01798771|Aminolevulinic Acid|aminolevulinic acid|mesh-list
111316761|NCT01798771|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111316762|NCT01798771|Dermatologic Agents|dermatologic agents|mesh-ancestor
111316763|NCT03158480|Immunomodulating Agents|immunomodulating agents|mesh-list
111316764|NCT03158480|Immunologic Factors|immunologic factors|mesh-ancestor
111316765|NCT03158480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111316766|NCT00633919|Prednisone|prednisone|mesh-list
111316767|NCT00633919|Budesonide|budesonide|mesh-list
111316768|NCT00633919|Albuterol|albuterol|mesh-list
111316769|NCT00633919|Formoterol Fumarate|formoterol fumarate|mesh-list
111316770|NCT00633919|Desloratadine|desloratadine|mesh-list
111316771|NCT00633919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111316772|NCT00633919|Glucocorticoids|glucocorticoids|mesh-ancestor
111316773|NCT00633919|Hormones|hormones|mesh-ancestor
111316774|NCT00633919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111316775|NCT00633919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111316776|NCT00633919|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111316777|NCT00633919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111316778|NCT00633919|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111316779|NCT00633919|Autonomic Agents|autonomic agents|mesh-ancestor
111316780|NCT00633919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111316781|NCT00633919|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111316782|NCT00633919|Respiratory System Agents|respiratory system agents|mesh-ancestor
111316783|NCT00633919|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111316784|NCT00633919|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111316785|NCT00633919|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111316786|NCT00633919|Adrenergic Agents|adrenergic agents|mesh-ancestor
111316787|NCT00633919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111316788|NCT00633919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111316789|NCT00633919|Tocolytic Agents|tocolytic agents|mesh-ancestor
111316790|NCT00633919|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111316791|NCT00633919|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111316792|NCT00633919|Cholinergic Agents|cholinergic agents|mesh-ancestor
111316793|NCT00633919|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
111316794|NCT00633919|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111316795|NCT00633919|Histamine Antagonists|histamine antagonists|mesh-ancestor
111316796|NCT00633919|Histamine Agents|histamine agents|mesh-ancestor
111316797|NCT03158246|Vitamin D|vitamin d|mesh-list
111316798|NCT03158246|Zoledronic Acid|zoledronic acid|mesh-list
111316799|NCT03158246|Calcium|calcium|mesh-list
111316800|NCT03158246|Vitamins|vitamins|mesh-ancestor
111316801|NCT03158246|Micronutrients|micronutrients|mesh-ancestor
111316802|NCT03158246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111316803|NCT03158246|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111316804|NCT03158246|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111316806|NCT00515411|Cisplatin|cisplatin|mesh-list
111316807|NCT00515411|Docetaxel|docetaxel|mesh-list
111316808|NCT00515411|Fluorouracil|fluorouracil|mesh-list
111316809|NCT00515411|Trastuzumab|trastuzumab|mesh-list
111316810|NCT00515411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111316811|NCT00515411|Tubulin Modulators|tubulin modulators|mesh-ancestor
111316812|NCT00515411|Antimitotic Agents|antimitotic agents|mesh-ancestor
111316813|NCT00515411|Mitosis Modulators|mitosis modulators|mesh-ancestor
111316814|NCT00515411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111316815|NCT00515411|Antimetabolites|antimetabolites|mesh-ancestor
111316816|NCT00515411|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111316817|NCT00515411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111316818|NCT00515411|Immunologic Factors|immunologic factors|mesh-ancestor
111316819|NCT00515411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111316820|NCT00515411|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111316821|NCT00515411|Antidotes|antidotes|mesh-ancestor
111316822|NCT00515411|Protective Agents|protective agents|mesh-ancestor
111316823|NCT00515411|Vitamin B Complex|vitamin b complex|mesh-ancestor
111316824|NCT00515411|Vitamins|vitamins|mesh-ancestor
111316825|NCT00515411|Micronutrients|micronutrients|mesh-ancestor
111316826|NCT00586261|Pioglitazone|pioglitazone|mesh-list
111316827|NCT00586261|Nitroglycerin|nitroglycerin|mesh-list
111316828|NCT00586261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111316829|NCT00586261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111316830|NCT00586261|Vasodilator Agents|vasodilator agents|mesh-ancestor
111316831|NCT00515723|Olanzapine|olanzapine|mesh-list
111316832|NCT00515723|Risperidone|risperidone|mesh-list
111316833|NCT00515723|Quetiapine Fumarate|quetiapine fumarate|mesh-list
111316834|NCT00515723|Ziprasidone|ziprasidone|mesh-list
111316835|NCT00515723|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111316836|NCT00515723|Serotonin Agents|serotonin agents|mesh-ancestor
111316837|NCT00515723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111316838|NCT00515723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111316839|NCT00515723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111316840|NCT00515723|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111316841|NCT00515723|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111316842|NCT00515723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111316843|NCT00515723|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111316844|NCT00515723|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111316845|NCT00515723|Dopamine Agents|dopamine agents|mesh-ancestor
111316846|NCT00515723|Antiemetics|antiemetics|mesh-ancestor
111316847|NCT00515723|Autonomic Agents|autonomic agents|mesh-ancestor
111316848|NCT00515723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111316849|NCT00515723|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111316850|NCT00515723|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111316851|NCT00515723|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111316852|NCT00515723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111316853|NCT00515723|Antidepressive Agents|antidepressive agents|mesh-ancestor
111316854|NCT04405154|Cisplatin|cisplatin|mesh-list
111316855|NCT04405154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111316856|NCT00586573|Memantine|memantine|mesh-list
111316857|NCT00586573|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111316858|NCT00586573|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111316859|NCT00586573|Dopamine Agents|dopamine agents|mesh-ancestor
111316860|NCT00586573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111316861|NCT00586573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111316862|NCT00586573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111316863|NCT00586573|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111316864|NCT00586573|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111316865|NCT01799005|Micronutrients|micronutrients|mesh-list
111316866|NCT01799005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111316867|NCT00515879|Cycloserine|cycloserine|mesh-list
111316868|NCT00515879|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111316869|NCT00515879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111316870|NCT00515879|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111316871|NCT00515879|Antitubercular Agents|antitubercular agents|mesh-ancestor
111316872|NCT00515879|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111316873|NCT00515879|Antimetabolites|antimetabolites|mesh-ancestor
111316874|NCT00515879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111316875|NCT03152942|Aminophylline|aminophylline|mesh-list
111316876|NCT03152942|Progesterone|progesterone|mesh-list
111316877|NCT03152942|Progestins|progestins|mesh-ancestor
111041315|NCT05627635|Calcium|calcium|mesh-list
111316878|NCT03152942|Hormones|hormones|mesh-ancestor
111316879|NCT03152942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111316880|NCT03152942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111316881|NCT03152942|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111316882|NCT03152942|Autonomic Agents|autonomic agents|mesh-ancestor
111316883|NCT03152942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111316884|NCT03152942|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111316885|NCT03152942|Respiratory System Agents|respiratory system agents|mesh-ancestor
111316886|NCT03152942|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111316887|NCT03152942|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111316888|NCT03152942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111316889|NCT03152942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111316890|NCT03152942|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
111316891|NCT03152942|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111316892|NCT03152942|Purinergic Agents|purinergic agents|mesh-ancestor
111316893|NCT03152942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111316894|NCT03152942|Protective Agents|protective agents|mesh-ancestor
111316895|NCT00586729|Mafenide|mafenide|mesh-list
111316896|NCT00586729|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111316897|NCT00586729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111316898|NCT00586729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111316899|NCT00586729|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
111316900|NCT00586729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111316901|NCT00586729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111316902|NCT01672346|Adenosine|adenosine|mesh-list
111316903|NCT01672346|Analgesics|analgesics|mesh-ancestor
111316904|NCT01672346|Sensory System Agents|sensory system agents|mesh-ancestor
111316905|NCT01672346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111316906|NCT01672346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111316907|NCT01672346|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111316908|NCT01672346|Vasodilator Agents|vasodilator agents|mesh-ancestor
111316909|NCT01672346|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
111316910|NCT01672346|Purinergic Agonists|purinergic agonists|mesh-ancestor
111316911|NCT01672346|Purinergic Agents|purinergic agents|mesh-ancestor
111316912|NCT01672346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111316913|NCT01672346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111316914|NCT00516503|Ketamine|ketamine|mesh-list
111316915|NCT00516503|Amitriptyline|amitriptyline|mesh-list
111316916|NCT00516503|Baclofen|baclofen|mesh-list
111316917|NCT00516503|Analgesics|analgesics|mesh-ancestor
111316918|NCT00516503|Sensory System Agents|sensory system agents|mesh-ancestor
111316919|NCT00516503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111316920|NCT00516503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111316921|NCT00516503|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111316922|NCT00516503|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111316923|NCT00516503|Anesthetics, General|anesthetics, general|mesh-ancestor
111316924|NCT00516503|Anesthetics|anesthetics|mesh-ancestor
111316925|NCT00516503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111316926|NCT00516503|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111316927|NCT00516503|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111316928|NCT00516503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111316929|NCT00516503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111316930|NCT00516503|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
111316931|NCT00516503|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111316932|NCT00516503|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
111316933|NCT00516503|GABA Agonists|gaba agonists|mesh-ancestor
111316934|NCT00516503|GABA Agents|gaba agents|mesh-ancestor
111316935|NCT00516503|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
111316936|NCT00516503|Antidepressive Agents|antidepressive agents|mesh-ancestor
111316937|NCT00516503|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111316938|NCT00516503|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111316939|NCT00516503|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111316940|NCT00516503|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111316941|NCT00516503|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111316942|NCT00516503|Adrenergic Agents|adrenergic agents|mesh-ancestor
111316943|NCT03157310|Gefitinib|gefitinib|mesh-list
111316944|NCT03157310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111316945|NCT03157310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111316946|NCT03157310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111316947|NCT03157310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111316948|NCT03157388|Vancomycin|vancomycin|mesh-list
111316949|NCT03157388|Gentamicins|gentamicins|mesh-list
111316950|NCT03157388|Meropenem|meropenem|mesh-list
111316951|NCT03157388|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111316952|NCT03157388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111316953|NCT03157388|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111316954|NCT03157388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111316955|NCT03157388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111316956|NCT03156920|Sumatriptan|sumatriptan|mesh-list
111316957|NCT03156920|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111316958|NCT03156920|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111316959|NCT03156920|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111316960|NCT03156920|Serotonin Agents|serotonin agents|mesh-ancestor
111316961|NCT03156920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111316962|NCT03156920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111316963|NCT03156920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111316964|NCT05247385|Ticagrelor|ticagrelor|mesh-list
111316965|NCT05247385|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
111316966|NCT05247385|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111316967|NCT05247385|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111316968|NCT05247385|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111316969|NCT05247385|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111316970|NCT05247385|Purinergic Agents|purinergic agents|mesh-ancestor
111316971|NCT05247385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111316972|NCT05247385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111316973|NCT05247385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111316974|NCT03156842|Amlodipine|amlodipine|mesh-list
111316975|NCT03156842|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111316976|NCT03156842|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111316977|NCT03156842|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111316978|NCT03156842|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111316979|NCT03156842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111316980|NCT03156842|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111316981|NCT03156842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111316982|NCT03156842|Vasodilator Agents|vasodilator agents|mesh-ancestor
111316983|NCT03156842|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111316984|NCT03156842|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111316985|NCT03156842|Antimetabolites|antimetabolites|mesh-ancestor
111316986|NCT03156842|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111316987|NCT03156842|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111316988|NCT03156842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111316989|NCT01672580|Vitamins|vitamins|mesh-list
111316990|NCT01672580|Micronutrients|micronutrients|mesh-ancestor
111316991|NCT01672580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111316992|NCT00636649|Escitalopram|escitalopram|mesh-list
111316993|NCT00636649|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111316994|NCT00636649|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111316995|NCT00636649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111316996|NCT00636649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111316997|NCT00636649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111316998|NCT00636649|Serotonin Agents|serotonin agents|mesh-ancestor
111316999|NCT00636649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111317000|NCT05061524|Omalizumab|omalizumab|mesh-list
111317001|NCT05061524|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111317002|NCT05061524|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111317003|NCT05061524|Respiratory System Agents|respiratory system agents|mesh-ancestor
111317004|NCT00636805|Dexamethasone|dexamethasone|mesh-list
111317005|NCT00636805|Palonosetron|palonosetron|mesh-list
111317006|NCT00636805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111317007|NCT00636805|Antiemetics|antiemetics|mesh-ancestor
111317008|NCT00636805|Autonomic Agents|autonomic agents|mesh-ancestor
111317009|NCT00636805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111317010|NCT00636805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111317011|NCT00636805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111317012|NCT00636805|Glucocorticoids|glucocorticoids|mesh-ancestor
111317013|NCT00636805|Hormones|hormones|mesh-ancestor
111317014|NCT00636805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111317015|NCT00636805|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111317016|NCT00636805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111317017|NCT00636805|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111317018|NCT00636805|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111317019|NCT00636805|Serotonin Agents|serotonin agents|mesh-ancestor
111317020|NCT00636805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111317021|NCT00636805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111317022|NCT05247151|Oxytocin|oxytocin|mesh-list
111317023|NCT05247151|Oxytocics|oxytocics|mesh-ancestor
111317024|NCT05247151|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111317025|NCT05247151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111317026|NCT01676246|Flupirtine|flupirtine|mesh-list
111041466|NCT05169567|Fulvestrant|fulvestrant|mesh-list
111317027|NCT01676246|Analgesics|analgesics|mesh-ancestor
111317028|NCT01676246|Sensory System Agents|sensory system agents|mesh-ancestor
111317029|NCT01676246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111317030|NCT01676246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111317031|NCT00517595|Bevacizumab|bevacizumab|mesh-list
111317032|NCT00517595|Gemcitabine|gemcitabine|mesh-list
111317033|NCT00517595|Pemetrexed|pemetrexed|mesh-list
111317034|NCT00517595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111317035|NCT00517595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111317036|NCT00517595|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111317037|NCT00517595|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111317038|NCT00517595|Growth Substances|growth substances|mesh-ancestor
111317039|NCT00517595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111317040|NCT00517595|Growth Inhibitors|growth inhibitors|mesh-ancestor
111317041|NCT00517595|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111317042|NCT00517595|Antimetabolites|antimetabolites|mesh-ancestor
111317043|NCT00517595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111317044|NCT00517595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111317045|NCT00517595|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111317046|NCT00517595|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111317047|NCT01672814|Riboflavin|riboflavin|mesh-list
111317048|NCT01672814|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111317049|NCT01672814|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111317050|NCT01672814|Vitamin B Complex|vitamin b complex|mesh-ancestor
111317051|NCT01672814|Vitamins|vitamins|mesh-ancestor
111317052|NCT01672814|Micronutrients|micronutrients|mesh-ancestor
111317053|NCT01672814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111317054|NCT01672814|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111317055|NCT01672814|Dermatologic Agents|dermatologic agents|mesh-ancestor
111317056|NCT00524225|Oprelvekin|oprelvekin|mesh-list
111317057|NCT00524225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111317058|NCT00669019|Saracatinib|saracatinib|mesh-list
111317059|NCT00669019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111317060|NCT00669019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111317061|NCT00669019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111317062|NCT05560373|Huperzine A|huperzine a|mesh-list
111317063|NCT05560373|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111317064|NCT05560373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111317065|NCT05560373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111317066|NCT05560373|Cholinergic Agents|cholinergic agents|mesh-ancestor
111317067|NCT05560373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111317068|NCT05560373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111317069|NCT05560373|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111317070|NCT05560373|Protective Agents|protective agents|mesh-ancestor
111317071|NCT00670267|Nadolol|nadolol|mesh-list
111317072|NCT00670267|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111317073|NCT00670267|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111317074|NCT00670267|Adrenergic Agents|adrenergic agents|mesh-ancestor
111317075|NCT00670267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111317076|NCT00670267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111317077|NCT00670267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111317078|NCT00670267|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111317079|NCT00670267|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111317080|NCT00670267|Sympatholytics|sympatholytics|mesh-ancestor
111317081|NCT00670267|Autonomic Agents|autonomic agents|mesh-ancestor
111317082|NCT00670267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111317083|NCT05621915|Nadroparin|nadroparin|mesh-list
111317084|NCT05621915|Anticoagulants|anticoagulants|mesh-ancestor
111317085|NCT05621915|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111317086|NCT05621915|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111317087|NCT05621915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111317088|NCT01673204|Calcitriol|calcitriol|mesh-list
111317089|NCT01673204|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111317090|NCT01673204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111317091|NCT01673204|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
111317092|NCT01673204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111317093|NCT01673204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111317094|NCT01673204|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111317095|NCT01673204|Vitamins|vitamins|mesh-ancestor
111317096|NCT01673204|Micronutrients|micronutrients|mesh-ancestor
111317097|NCT01673204|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111317098|NCT00641563|Midazolam|midazolam|mesh-list
111317099|NCT00641563|Dexmedetomidine|dexmedetomidine|mesh-list
111317100|NCT00641563|Remifentanil|remifentanil|mesh-list
111317101|NCT00641563|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111317102|NCT00641563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111317103|NCT00641563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111317104|NCT00641563|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111317106|NCT00641563|Sensory System Agents|sensory system agents|mesh-ancestor
111317107|NCT00641563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111317108|NCT00641563|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111317109|NCT00641563|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111317110|NCT00641563|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111317111|NCT00641563|Adrenergic Agents|adrenergic agents|mesh-ancestor
111317112|NCT00641563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111317113|NCT00641563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111317114|NCT00641563|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111317115|NCT00641563|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111317116|NCT00641563|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111317117|NCT00641563|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111317118|NCT00641563|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111317119|NCT00641563|Anesthetics, General|anesthetics, general|mesh-ancestor
111317120|NCT00641563|Anesthetics|anesthetics|mesh-ancestor
111317121|NCT00641563|GABA Modulators|gaba modulators|mesh-ancestor
111317122|NCT00641563|GABA Agents|gaba agents|mesh-ancestor
111317123|NCT00641563|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111317124|NCT00641563|Narcotics|narcotics|mesh-ancestor
111317125|NCT05621759|Cyclophosphamide|cyclophosphamide|mesh-list
111317126|NCT05621759|Abatacept|abatacept|mesh-list
111317127|NCT05621759|Tacrolimus|tacrolimus|mesh-list
111317128|NCT05621759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111317129|NCT05621759|Immunologic Factors|immunologic factors|mesh-ancestor
111317130|NCT05621759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111317131|NCT05621759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111317132|NCT05621759|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111317133|NCT05621759|Alkylating Agents|alkylating agents|mesh-ancestor
111317134|NCT05621759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111317135|NCT05621759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111317136|NCT05621759|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111317137|NCT05621759|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111317138|NCT05621759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111317139|NCT05621759|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111317140|NCT05621759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111317141|NCT02251262|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
111317142|NCT02251262|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111317143|NCT02251262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111317144|NCT00641641|Tenofovir|tenofovir|mesh-list
111317145|NCT00641641|Emtricitabine|emtricitabine|mesh-list
111317146|NCT00641641|Raltegravir Potassium|raltegravir potassium|mesh-list
111317147|NCT00641641|Antiviral Agents|antiviral agents|mesh-ancestor
111317148|NCT00641641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111317149|NCT00641641|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111317150|NCT00641641|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111317151|NCT00641641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111317152|NCT00641641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111317153|NCT00641641|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111317154|NCT00641641|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111317155|NCT00641641|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111317156|NCT00641641|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111317157|NCT03152474|Vitamin A|vitamin a|mesh-list
111317158|NCT03152474|Methylprednisolone|methylprednisolone|mesh-list
111317159|NCT03152474|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111317160|NCT03152474|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111317161|NCT03152474|Prednisolone|prednisolone|mesh-list
111317162|NCT03152474|Prednisolone acetate|prednisolone acetate|mesh-list
111317163|NCT03152474|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111317164|NCT03152474|Prednisolone phosphate|prednisolone phosphate|mesh-list
111317165|NCT03152474|Vitamins|vitamins|mesh-ancestor
111317166|NCT03152474|Micronutrients|micronutrients|mesh-ancestor
111317167|NCT03152474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111317168|NCT03152474|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111317169|NCT03152474|Antiemetics|antiemetics|mesh-ancestor
111317170|NCT03152474|Autonomic Agents|autonomic agents|mesh-ancestor
111317171|NCT03152474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111317172|NCT03152474|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111317173|NCT03152474|Glucocorticoids|glucocorticoids|mesh-ancestor
111317174|NCT03152474|Hormones|hormones|mesh-ancestor
111317175|NCT03152474|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111317176|NCT03152474|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111317177|NCT03152474|Protective Agents|protective agents|mesh-ancestor
111317178|NCT03152474|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111317179|NCT03152474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111317180|NCT00641797|Diphenhydramine|diphenhydramine|mesh-list
111317181|NCT00641797|Promethazine|promethazine|mesh-list
111317182|NCT00641797|Meclizine|meclizine|mesh-list
111317183|NCT00641797|Lorazepam|lorazepam|mesh-list
111317184|NCT00641797|Ondansetron|ondansetron|mesh-list
111317185|NCT00641797|Antiemetics|antiemetics|mesh-ancestor
111317186|NCT00641797|Autonomic Agents|autonomic agents|mesh-ancestor
111317187|NCT00641797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111317188|NCT00641797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111317189|NCT00641797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111317190|NCT00641797|Antipruritics|antipruritics|mesh-ancestor
111317191|NCT00641797|Dermatologic Agents|dermatologic agents|mesh-ancestor
111317192|NCT00641797|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111317193|NCT00641797|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111317194|NCT00641797|Serotonin Agents|serotonin agents|mesh-ancestor
111317195|NCT00641797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111317196|NCT00641797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111317197|NCT00641797|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111317198|NCT00641797|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111317199|NCT00641797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111317200|NCT00641797|Anesthetics, Local|anesthetics, local|mesh-ancestor
111317201|NCT00641797|Anesthetics|anesthetics|mesh-ancestor
111317202|NCT00641797|Sensory System Agents|sensory system agents|mesh-ancestor
111317203|NCT00641797|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111317204|NCT00641797|Histamine Antagonists|histamine antagonists|mesh-ancestor
111317205|NCT00641797|Histamine Agents|histamine agents|mesh-ancestor
111317206|NCT00641797|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111317207|NCT00641797|Anticonvulsants|anticonvulsants|mesh-ancestor
111317208|NCT00641797|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111317209|NCT00641797|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111317210|NCT00641797|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111317211|NCT00641797|GABA Modulators|gaba modulators|mesh-ancestor
111317212|NCT00641797|GABA Agents|gaba agents|mesh-ancestor
111317213|NCT00641797|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111317214|NCT00641797|Cholinergic Agents|cholinergic agents|mesh-ancestor
111317215|NCT04333459|Vaccines|vaccines|mesh-list
111317216|NCT04333459|Immunologic Factors|immunologic factors|mesh-ancestor
111317217|NCT04333459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111317218|NCT00671515|Pioglitazone|pioglitazone|mesh-list
111317219|NCT00671515|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111317220|NCT00671515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111317221|NCT01893320|Decitabine|decitabine|mesh-list
111317222|NCT01893320|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111317223|NCT01893320|Antimetabolites|antimetabolites|mesh-ancestor
111317224|NCT01893320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111317225|NCT01893320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111317226|NCT01893320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111317227|NCT04120766|Nicorandil|nicorandil|mesh-list
111317228|NCT04120766|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111317229|NCT04120766|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111317230|NCT04120766|Vasodilator Agents|vasodilator agents|mesh-ancestor
111317231|NCT04120766|Vitamin B Complex|vitamin b complex|mesh-ancestor
111317232|NCT04120766|Vitamins|vitamins|mesh-ancestor
111317233|NCT04120766|Micronutrients|micronutrients|mesh-ancestor
111317234|NCT04120766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111317235|NCT00673075|Carvedilol|carvedilol|mesh-list
111317236|NCT00673075|Nebivolol|nebivolol|mesh-list
111317237|NCT00673075|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111317238|NCT00673075|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111317239|NCT00673075|Adrenergic Agents|adrenergic agents|mesh-ancestor
111317240|NCT00673075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111317241|NCT00673075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111317242|NCT00673075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111317243|NCT00673075|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111317244|NCT00673075|Antioxidants|antioxidants|mesh-ancestor
111317245|NCT00673075|Protective Agents|protective agents|mesh-ancestor
111317246|NCT00673075|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111317247|NCT00673075|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111317248|NCT00673075|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111317249|NCT00673075|Vasodilator Agents|vasodilator agents|mesh-ancestor
111317250|NCT00673075|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111317251|NCT00673075|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111317252|NCT00673075|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
111317253|NCT00673075|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111317254|NCT00673075|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111317255|NCT02250014|Sargramostim|sargramostim|mesh-list
111317256|NCT02250014|Immunologic Factors|immunologic factors|mesh-ancestor
111317257|NCT02250014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111317258|NCT04022096|Lansoprazole|lansoprazole|mesh-list
111317259|NCT04022096|Dexlansoprazole|dexlansoprazole|mesh-list
111317260|NCT04022096|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111317261|NCT04022096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111317262|NCT04022096|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111317263|NCT04022096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111317264|NCT04022096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111317265|NCT00673153|Vorinostat|vorinostat|mesh-list
111317266|NCT00673153|Gemtuzumab|gemtuzumab|mesh-list
111317267|NCT00673153|Calicheamicins|calicheamicins|mesh-list
111317268|NCT00673153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111317269|NCT00673153|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111317270|NCT00673153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111317271|NCT00673153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111317272|NCT00673153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111317273|NCT00673153|Immunotoxins|immunotoxins|mesh-ancestor
111317274|NCT00673153|Immunoconjugates|immunoconjugates|mesh-ancestor
111317275|NCT00673153|Immunologic Factors|immunologic factors|mesh-ancestor
111317276|NCT00673153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111317277|NCT00673153|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111317278|NCT00673855|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111317279|NCT00673855|Lubricant Eye Drops|lubricant eye drops|mesh-list
111317280|NCT00673855|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111317281|NCT00654511|Fentanyl|fentanyl|mesh-list
111317282|NCT00654511|Dexmedetomidine|dexmedetomidine|mesh-list
111317283|NCT00654511|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111317284|NCT00654511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111317285|NCT00654511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111317286|NCT00654511|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111317287|NCT00654511|Analgesics|analgesics|mesh-ancestor
111317288|NCT00654511|Sensory System Agents|sensory system agents|mesh-ancestor
111317289|NCT00654511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111317290|NCT00654511|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111317291|NCT00654511|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111317292|NCT00654511|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111317293|NCT00654511|Adrenergic Agents|adrenergic agents|mesh-ancestor
111317294|NCT00654511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111317295|NCT00654511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111317296|NCT00654511|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111317297|NCT00654511|Narcotics|narcotics|mesh-ancestor
111317298|NCT00654511|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111317299|NCT00654511|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111317300|NCT00654511|Anesthetics, General|anesthetics, general|mesh-ancestor
111317301|NCT00654511|Anesthetics|anesthetics|mesh-ancestor
111317302|NCT01670084|Leucovorin|leucovorin|mesh-list
111317303|NCT01670084|Cytarabine|cytarabine|mesh-list
111317304|NCT01670084|Dexamethasone|dexamethasone|mesh-list
111317305|NCT01670084|Prednisone|prednisone|mesh-list
111317306|NCT01670084|Cyclophosphamide|cyclophosphamide|mesh-list
111317307|NCT01670084|Rituximab|rituximab|mesh-list
111317308|NCT01670084|Doxorubicin|doxorubicin|mesh-list
111317309|NCT01670084|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111317310|NCT01670084|Methotrexate|methotrexate|mesh-list
111317311|NCT01670084|Vincristine|vincristine|mesh-list
111317312|NCT01670084|Levoleucovorin|levoleucovorin|mesh-list
111317313|NCT01670084|Mesna|mesna|mesh-list
111317314|NCT01670084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111317315|NCT01670084|Immunologic Factors|immunologic factors|mesh-ancestor
111317316|NCT01670084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111317317|NCT01670084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111317318|NCT01670084|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111317319|NCT01670084|Alkylating Agents|alkylating agents|mesh-ancestor
111317320|NCT01670084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111317321|NCT01670084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111317322|NCT01670084|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111317323|NCT01670084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111317324|NCT01670084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111317325|NCT01670084|Antiemetics|antiemetics|mesh-ancestor
111317326|NCT01670084|Autonomic Agents|autonomic agents|mesh-ancestor
111317327|NCT01670084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111317328|NCT01670084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111317329|NCT01670084|Glucocorticoids|glucocorticoids|mesh-ancestor
111317330|NCT01670084|Hormones|hormones|mesh-ancestor
110770020|NCT01168440|Sunitinib|sunitinib|mesh-list
111317331|NCT01670084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111317332|NCT01670084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111317333|NCT01670084|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111317334|NCT01670084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111317335|NCT01670084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111317336|NCT01670084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111317337|NCT01670084|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111317338|NCT01670084|Abortifacient Agents|abortifacient agents|mesh-ancestor
111317339|NCT01670084|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111317340|NCT01670084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111317341|NCT01670084|Antimetabolites|antimetabolites|mesh-ancestor
111317342|NCT01670084|Dermatologic Agents|dermatologic agents|mesh-ancestor
111317343|NCT01670084|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111317344|NCT01670084|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111317345|NCT01670084|Antiviral Agents|antiviral agents|mesh-ancestor
111317346|NCT01670084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111317347|NCT01670084|Antidotes|antidotes|mesh-ancestor
111317348|NCT01670084|Protective Agents|protective agents|mesh-ancestor
111317349|NCT01670084|Vitamin B Complex|vitamin b complex|mesh-ancestor
111317350|NCT01670084|Vitamins|vitamins|mesh-ancestor
111317351|NCT01670084|Micronutrients|micronutrients|mesh-ancestor
111317352|NCT01670084|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111317353|NCT01670084|Tubulin Modulators|tubulin modulators|mesh-ancestor
111317354|NCT01670084|Antimitotic Agents|antimitotic agents|mesh-ancestor
111317355|NCT01670084|Mitosis Modulators|mitosis modulators|mesh-ancestor
111317356|NCT01670162|Aflibercept|aflibercept|mesh-list
111317357|NCT01670162|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111317358|NCT01670162|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111317359|NCT01670162|Growth Substances|growth substances|mesh-ancestor
111317360|NCT01670162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111317361|NCT01670162|Growth Inhibitors|growth inhibitors|mesh-ancestor
111317362|NCT01670162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111317363|NCT04345783|Apatinib|apatinib|mesh-list
111317364|NCT04345783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111317365|NCT04345783|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111317366|NCT04345783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111317367|NCT04345783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111317368|NCT00675259|Paclitaxel|paclitaxel|mesh-list
111317369|NCT00675259|Bevacizumab|bevacizumab|mesh-list
111317370|NCT00675259|Carboplatin|carboplatin|mesh-list
111317371|NCT00675259|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111317372|NCT00675259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111317373|NCT00675259|Tubulin Modulators|tubulin modulators|mesh-ancestor
111317374|NCT00675259|Antimitotic Agents|antimitotic agents|mesh-ancestor
111317375|NCT00675259|Mitosis Modulators|mitosis modulators|mesh-ancestor
111317376|NCT00675259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111317377|NCT00675259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111317378|NCT00675259|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111317379|NCT00675259|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111317380|NCT00675259|Growth Substances|growth substances|mesh-ancestor
111317381|NCT00675259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111317382|NCT00675259|Growth Inhibitors|growth inhibitors|mesh-ancestor
111317383|NCT01674218|Moxifloxacin|moxifloxacin|mesh-list
111317384|NCT01674218|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111317385|NCT01674218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111317386|NCT01674218|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111317387|NCT01674218|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111317388|NCT01674218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111317389|NCT01674218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111317390|NCT01674218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111317391|NCT01670240|Adalimumab|adalimumab|mesh-list
111317392|NCT01670240|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111317393|NCT01670240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111317394|NCT01670240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111317395|NCT04404686|Indomethacin|indomethacin|mesh-list
111317396|NCT04404686|Nifedipine|nifedipine|mesh-list
111317397|NCT04404686|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111317398|NCT04404686|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111317399|NCT04404686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111317400|NCT04404686|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111317401|NCT04404686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111317402|NCT04404686|Vasodilator Agents|vasodilator agents|mesh-ancestor
111317403|NCT04404686|Tocolytic Agents|tocolytic agents|mesh-ancestor
111317404|NCT04404686|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111317405|NCT04404686|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111317406|NCT04404686|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111317407|NCT04404686|Analgesics|analgesics|mesh-ancestor
111317408|NCT04404686|Sensory System Agents|sensory system agents|mesh-ancestor
111317409|NCT04404686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111317410|NCT04404686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111317411|NCT04404686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111317412|NCT04404686|Gout Suppressants|gout suppressants|mesh-ancestor
111317413|NCT04404686|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111317414|NCT04404686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111317415|NCT00676585|Hydrocortisone|hydrocortisone|mesh-list
111317416|NCT00676585|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111317417|NCT00658411|Deferoxamine|deferoxamine|mesh-list
111317418|NCT00658411|Siderophores|siderophores|mesh-ancestor
111317419|NCT00658411|Iron Chelating Agents|iron chelating agents|mesh-ancestor
111317420|NCT00658411|Chelating Agents|chelating agents|mesh-ancestor
111317421|NCT00658411|Sequestering Agents|sequestering agents|mesh-ancestor
111317422|NCT00658411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111317423|NCT01674530|Lubiprostone|lubiprostone|mesh-list
111317424|NCT01674530|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
111317425|NCT01674530|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111317426|NCT01674530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111317427|NCT00676897|Simvastatin|simvastatin|mesh-list
111317428|NCT00676897|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111317429|NCT00676897|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111317430|NCT00676897|Antimetabolites|antimetabolites|mesh-ancestor
111317431|NCT00676897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111317432|NCT00676897|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111317433|NCT00676897|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111317434|NCT00676897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111317435|NCT02115074|Celecoxib|celecoxib|mesh-list
111317436|NCT02115074|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111317437|NCT02115074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111317438|NCT02115074|Analgesics|analgesics|mesh-ancestor
111317439|NCT02115074|Sensory System Agents|sensory system agents|mesh-ancestor
111317440|NCT02115074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111317441|NCT02115074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111317442|NCT02115074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111317443|NCT02115074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111317444|NCT02115074|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111317445|NCT02115074|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111317446|NCT02115074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111317447|NCT02115074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111317448|NCT01674686|Sarpogrelate|sarpogrelate|mesh-list
111317449|NCT01674686|Atorvastatin|atorvastatin|mesh-list
111317450|NCT01674686|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111317451|NCT01674686|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111317452|NCT01674686|Antimetabolites|antimetabolites|mesh-ancestor
111317453|NCT01674686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111317454|NCT01674686|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111317455|NCT01674686|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111317456|NCT01674686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111317457|NCT01674686|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111317458|NCT01674686|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111317459|NCT01674686|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111317460|NCT01674686|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111317461|NCT01674686|Serotonin Agents|serotonin agents|mesh-ancestor
111317462|NCT01674686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111317463|NCT01674686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111317464|NCT02082392|Escitalopram|escitalopram|mesh-list
111317465|NCT02082392|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111317466|NCT02082392|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111317467|NCT02082392|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111317468|NCT02082392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111317469|NCT02082392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111317470|NCT02082392|Serotonin Agents|serotonin agents|mesh-ancestor
111317471|NCT02082392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111317472|NCT01674842|Cisplatin|cisplatin|mesh-list
111317473|NCT01674842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111317474|NCT03845894|Bupivacaine|bupivacaine|mesh-list
111317475|NCT03845894|Anesthetics, Local|anesthetics, local|mesh-ancestor
111317476|NCT03845894|Anesthetics|anesthetics|mesh-ancestor
111317477|NCT03845894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111317478|NCT03845894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111317479|NCT03845894|Sensory System Agents|sensory system agents|mesh-ancestor
111317480|NCT03845894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111317481|NCT03161132|Doxorubicin|doxorubicin|mesh-list
111317482|NCT03161132|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111317483|NCT03161132|Olaparib|olaparib|mesh-list
111317484|NCT03161132|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111317485|NCT03161132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111317486|NCT03161132|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111317487|NCT03161132|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111317488|NCT03161132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111317489|NCT03161132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111317490|NCT03161132|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111317492|NCT03844256|Nivolumab|nivolumab|mesh-list
111317493|NCT03844256|Ipilimumab|ipilimumab|mesh-list
111317494|NCT03844256|Mitomycins|mitomycins|mesh-list
111317495|NCT03844256|Mitomycin|mitomycin|mesh-list
111317496|NCT03844256|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111317497|NCT03844256|Antimetabolites|antimetabolites|mesh-ancestor
111317498|NCT03844256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111317499|NCT03844256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111317500|NCT03844256|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111317501|NCT03844256|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111317502|NCT03844256|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111317503|NCT03844256|Alkylating Agents|alkylating agents|mesh-ancestor
111317504|NCT03844256|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111317505|NCT03844256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111317506|NCT01675076|Rivaroxaban|rivaroxaban|mesh-list
111317507|NCT01675076|Apixaban|apixaban|mesh-list
111317508|NCT01675076|Dabigatran|dabigatran|mesh-list
111317509|NCT01675076|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111317510|NCT01675076|Antithrombins|antithrombins|mesh-ancestor
111317511|NCT01675076|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111317512|NCT01675076|Protease Inhibitors|protease inhibitors|mesh-ancestor
111317513|NCT01675076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111317514|NCT01675076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111317515|NCT01675076|Anticoagulants|anticoagulants|mesh-ancestor
111317516|NCT03838796|Lenvatinib|lenvatinib|mesh-list
111317517|NCT03838796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111317518|NCT03838796|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111317519|NCT03838796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111317520|NCT03838796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111317521|NCT03719690|Tipifarnib|tipifarnib|mesh-list
111317522|NCT03719690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111317523|NCT01675466|Anesthetics|anesthetics|mesh-list
111317524|NCT01675466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111317525|NCT01675466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111317526|NCT01675700|Nitroglycerin|nitroglycerin|mesh-list
111317527|NCT01675700|Vasodilator Agents|vasodilator agents|mesh-ancestor
111317528|NCT01676558|Rituximab|rituximab|mesh-list
111317529|NCT01676558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111317530|NCT01676558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111317531|NCT01676558|Immunologic Factors|immunologic factors|mesh-ancestor
111317532|NCT01676558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111317533|NCT01676558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111317534|NCT02510300|Sofosbuvir|sofosbuvir|mesh-list
111317535|NCT02510300|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
111317536|NCT02510300|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
111317537|NCT02510300|Ledipasvir|ledipasvir|mesh-list
111317538|NCT02510300|Velpatasvir|velpatasvir|mesh-list
111317539|NCT02510300|Antiviral Agents|antiviral agents|mesh-ancestor
111317540|NCT02510300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111317541|NCT00678535|Capecitabine|capecitabine|mesh-list
111317542|NCT00678535|Cetuximab|cetuximab|mesh-list
111317543|NCT00678535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111317544|NCT00678535|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111317545|NCT00678535|Antimetabolites|antimetabolites|mesh-ancestor
111317546|NCT00678535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111317547|NCT00678535|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111317548|NCT00659737|Scopolamine|scopolamine|mesh-list
111317549|NCT00659737|Aprepitant|aprepitant|mesh-list
111317550|NCT00659737|Fosaprepitant|fosaprepitant|mesh-list
111317551|NCT00659737|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
111317552|NCT00659737|Antiemetics|antiemetics|mesh-ancestor
111317553|NCT00659737|Autonomic Agents|autonomic agents|mesh-ancestor
111317554|NCT00659737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111317555|NCT00659737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111317556|NCT00659737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111317557|NCT00659737|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
111317558|NCT00659737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111317559|NCT00659737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111317561|NCT00659737|Mydriatics|mydriatics|mesh-ancestor
111317562|NCT00659737|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111317563|NCT00659737|Cholinergic Agents|cholinergic agents|mesh-ancestor
111317564|NCT00659737|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111317565|NCT00659737|Parasympatholytics|parasympatholytics|mesh-ancestor
111317566|NCT04763876|Ketorolac|ketorolac|mesh-list
111317567|NCT04763876|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
111317568|NCT04763876|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111317569|NCT04763876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111317570|NCT04763876|Analgesics|analgesics|mesh-ancestor
111317571|NCT04763876|Sensory System Agents|sensory system agents|mesh-ancestor
111317572|NCT04763876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111317573|NCT04763876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111317574|NCT04763876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111317575|NCT04763876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111317576|NCT04763876|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111317577|NCT04763876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111317578|NCT04763876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111317579|NCT00680797|Testosterone|testosterone|mesh-list
111317580|NCT00680797|Estrogens|estrogens|mesh-list
111317581|NCT00680797|Androgens|androgens|mesh-ancestor
111317582|NCT00680797|Hormones|hormones|mesh-ancestor
111317583|NCT00680797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111317584|NCT00680797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111317585|NCT02984852|Tenofovir|tenofovir|mesh-list
111317586|NCT02984852|Emtricitabine|emtricitabine|mesh-list
111317587|NCT02984852|Darunavir|darunavir|mesh-list
111317588|NCT02984852|Cobicistat|cobicistat|mesh-list
111317589|NCT02984852|Antiviral Agents|antiviral agents|mesh-ancestor
111317590|NCT02984852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111317591|NCT02984852|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111317592|NCT02984852|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111317593|NCT02984852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111317594|NCT02984852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111317595|NCT02984852|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111317596|NCT02984852|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111317597|NCT02984852|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111317598|NCT02984852|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111317599|NCT02984852|Protease Inhibitors|protease inhibitors|mesh-ancestor
111317600|NCT02984852|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111317601|NCT02984852|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111317602|NCT00660517|Fluticasone|fluticasone|mesh-list
111317603|NCT00660517|Xhance|xhance|mesh-list
111317604|NCT00660517|Azelastine|azelastine|mesh-list
111317605|NCT00660517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111317606|NCT00660517|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111317607|NCT00660517|Autonomic Agents|autonomic agents|mesh-ancestor
111317608|NCT00660517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111317609|NCT00660517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111317610|NCT00660517|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111317611|NCT00660517|Respiratory System Agents|respiratory system agents|mesh-ancestor
111317612|NCT00660517|Dermatologic Agents|dermatologic agents|mesh-ancestor
111317613|NCT00660517|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111317614|NCT00660517|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
111317615|NCT00660517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111317616|NCT00660517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111317617|NCT00660517|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
111317618|NCT00660517|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111317619|NCT00660517|Histamine Antagonists|histamine antagonists|mesh-ancestor
111317620|NCT00660517|Histamine Agents|histamine agents|mesh-ancestor
111317621|NCT00660517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111317622|NCT02141581|Vaccines|vaccines|mesh-list
111317623|NCT02141581|Immunologic Factors|immunologic factors|mesh-ancestor
110980312|NCT02549092|Levodopa|levodopa|mesh-list
111317624|NCT02141581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111317625|NCT03991299|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111317626|NCT03991299|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111317627|NCT03991299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111317628|NCT03991299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111317629|NCT03991299|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111317630|NCT03991299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111317631|NCT03991299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111317632|NCT03991299|Cholinergic Agents|cholinergic agents|mesh-ancestor
111317633|NCT03991299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111317634|NCT03819530|Micronutrients|micronutrients|mesh-list
111317635|NCT03819530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111317636|NCT02279667|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
111317637|NCT02279667|Anticonvulsants|anticonvulsants|mesh-ancestor
111317638|NCT02279667|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111317639|NCT02279667|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111317640|NCT02279667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111317641|NCT02279667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111317642|NCT03818672|Rifaximin|rifaximin|mesh-list
111317643|NCT03818672|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111317644|NCT03818672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111317645|NCT03818672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111317646|NCT03749018|Prednisone|prednisone|mesh-list
111317647|NCT03749018|Cortisone|cortisone|mesh-list
111317648|NCT03749018|Cyclophosphamide|cyclophosphamide|mesh-list
111317649|NCT03749018|Rituximab|rituximab|mesh-list
111317650|NCT03749018|Doxorubicin|doxorubicin|mesh-list
111317651|NCT03749018|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111317652|NCT03749018|Nivolumab|nivolumab|mesh-list
111317653|NCT03749018|Etoposide|etoposide|mesh-list
111317654|NCT03749018|Vincristine|vincristine|mesh-list
111317655|NCT03749018|Etoposide phosphate|etoposide phosphate|mesh-list
111317656|NCT03749018|Podophyllotoxin|podophyllotoxin|mesh-list
111317657|NCT03749018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111317658|NCT03749018|Antibodies|antibodies|mesh-list
111317659|NCT03749018|Immunoglobulins|immunoglobulins|mesh-list
111317660|NCT03749018|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111317661|NCT03749018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111317662|NCT03749018|Immunologic Factors|immunologic factors|mesh-ancestor
111317663|NCT03749018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111317664|NCT03749018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111317665|NCT03749018|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111317666|NCT03749018|Alkylating Agents|alkylating agents|mesh-ancestor
111317667|NCT03749018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111317668|NCT03749018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111317669|NCT03749018|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111317670|NCT03749018|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111317671|NCT03749018|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111317672|NCT03749018|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111317673|NCT03749018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111317674|NCT03749018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111317675|NCT03749018|Glucocorticoids|glucocorticoids|mesh-ancestor
111317676|NCT03749018|Hormones|hormones|mesh-ancestor
111317677|NCT03749018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111317678|NCT03749018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111317679|NCT03749018|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111317680|NCT03749018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111317681|NCT03749018|Tubulin Modulators|tubulin modulators|mesh-ancestor
111317682|NCT03749018|Antimitotic Agents|antimitotic agents|mesh-ancestor
111317683|NCT03749018|Mitosis Modulators|mitosis modulators|mesh-ancestor
111317684|NCT03749018|Keratolytic Agents|keratolytic agents|mesh-ancestor
111317685|NCT03749018|Dermatologic Agents|dermatologic agents|mesh-ancestor
111317686|NCT01931163|Everolimus|everolimus|mesh-list
111317687|NCT01931163|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111317688|NCT01931163|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111317689|NCT01931163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111317690|NCT01931163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111317691|NCT01931163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111317692|NCT01931163|Immunologic Factors|immunologic factors|mesh-ancestor
111317693|NCT01931163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111317694|NCT01931163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111317695|NCT04763486|Cefazolin|cefazolin|mesh-list
111317696|NCT04763486|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111317697|NCT04763486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111317698|NCT02988063|Polidocanol|polidocanol|mesh-list
111317699|NCT02988063|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
111317700|NCT02988063|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111317701|NCT03025269|Ocrelizumab|ocrelizumab|mesh-list
111317702|NCT03025269|Immunologic Factors|immunologic factors|mesh-ancestor
111317703|NCT03025269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111317704|NCT03744026|Carboplatin|carboplatin|mesh-list
111317705|NCT03744026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111317706|NCT03869450|Lidocaine|lidocaine|mesh-list
111317707|NCT03869450|Hyaluronic Acid|hyaluronic acid|mesh-list
111317708|NCT03869450|Anesthetics, Local|anesthetics, local|mesh-ancestor
111317709|NCT03869450|Anesthetics|anesthetics|mesh-ancestor
111317710|NCT03869450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111317711|NCT03869450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111042144|NCT02734771|Cyclophosphamide|cyclophosphamide|mesh-list
111317712|NCT03869450|Sensory System Agents|sensory system agents|mesh-ancestor
111317713|NCT03869450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111317714|NCT03869450|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111317715|NCT03869450|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111317716|NCT03869450|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111317717|NCT03869450|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111317718|NCT03869450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111317719|NCT03869450|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111317720|NCT03869450|Immunologic Factors|immunologic factors|mesh-ancestor
111317721|NCT03869450|Viscosupplements|viscosupplements|mesh-ancestor
111317722|NCT03869450|Protective Agents|protective agents|mesh-ancestor
111317723|NCT03799874|Carbon Monoxide|carbon monoxide|mesh-list
111317724|NCT03799874|Antimetabolites|antimetabolites|mesh-ancestor
111317725|NCT03799874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111317726|NCT03799874|Gasotransmitters|gasotransmitters|mesh-ancestor
111317727|NCT03799874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111317728|NCT03799874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111317729|NCT03736928|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111317730|NCT03736928|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111317731|NCT03736928|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111317732|NCT03736928|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111317733|NCT03736928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111317734|NCT03736928|Cholinergic Agents|cholinergic agents|mesh-ancestor
111317735|NCT03736928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111317736|NCT03736928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111317737|NCT03736928|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111317738|NCT03736928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111317739|NCT01101464|Asenapine|asenapine|mesh-list
111317740|NCT01101464|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111317741|NCT01101464|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111317742|NCT01101464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111317743|NCT01101464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111317744|NCT01101464|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111317745|NCT03736538|Nitrous Oxide|nitrous oxide|mesh-list
111317746|NCT03736538|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111317747|NCT03736538|Anesthetics, General|anesthetics, general|mesh-ancestor
111317748|NCT03736538|Anesthetics|anesthetics|mesh-ancestor
111317749|NCT03736538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111317750|NCT03736538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111317751|NCT03736538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111317752|NCT03736538|Analgesics|analgesics|mesh-ancestor
111317753|NCT03736538|Sensory System Agents|sensory system agents|mesh-ancestor
111317754|NCT03736538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111317755|NCT01676948|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111317756|NCT01676948|Immunologic Factors|immunologic factors|mesh-ancestor
111317757|NCT01676948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111317758|NCT03725930|Clonidine|clonidine|mesh-list
111317759|NCT03725930|Analgesics|analgesics|mesh-ancestor
111317760|NCT03725930|Sensory System Agents|sensory system agents|mesh-ancestor
111317761|NCT03725930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111317762|NCT03725930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111317763|NCT03725930|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111317764|NCT03725930|Sympatholytics|sympatholytics|mesh-ancestor
111317765|NCT03725930|Autonomic Agents|autonomic agents|mesh-ancestor
111317766|NCT03725930|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111317767|NCT03725930|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111317768|NCT03725930|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111317769|NCT03725930|Adrenergic Agents|adrenergic agents|mesh-ancestor
111317770|NCT03725930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111317771|NCT03725930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111317772|NCT03781388|Bupivacaine|bupivacaine|mesh-list
111317773|NCT03781388|Anesthetics, Local|anesthetics, local|mesh-ancestor
111317774|NCT03781388|Anesthetics|anesthetics|mesh-ancestor
111317775|NCT03781388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111317776|NCT03781388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111317777|NCT03781388|Sensory System Agents|sensory system agents|mesh-ancestor
111317778|NCT03781388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111317779|NCT03779048|Phentermine|phentermine|mesh-list
111317780|NCT03779048|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111317781|NCT03779048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111317782|NCT03779048|Appetite Depressants|appetite depressants|mesh-ancestor
111317783|NCT03779048|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111317784|NCT03779048|Sympathomimetics|sympathomimetics|mesh-ancestor
111317785|NCT03779048|Autonomic Agents|autonomic agents|mesh-ancestor
111317786|NCT03779048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111317788|NCT03779048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111317789|NCT03779048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111317790|NCT03778580|Pyridoxamine|pyridoxamine|mesh-list
111317791|NCT03778580|Vitamin B Complex|vitamin b complex|mesh-ancestor
111317792|NCT03778580|Vitamins|vitamins|mesh-ancestor
111317793|NCT03778580|Micronutrients|micronutrients|mesh-ancestor
111317794|NCT03778580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111317795|NCT03722342|Pembrolizumab|pembrolizumab|mesh-list
111317796|NCT03722342|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111317797|NCT03722342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111317798|NCT03722342|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111317799|NCT03722342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111317800|NCT03722108|Irinotecan|irinotecan|mesh-list
111317801|NCT03722108|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111317802|NCT03722108|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111317803|NCT03722108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111317804|NCT03722108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111317805|NCT03722108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111317806|NCT03775070|Simvastatin|simvastatin|mesh-list
111317807|NCT03775070|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111317808|NCT03775070|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111317809|NCT03775070|Antimetabolites|antimetabolites|mesh-ancestor
111317810|NCT03775070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111317811|NCT03775070|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111317812|NCT03775070|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111317813|NCT03775070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111317814|NCT02083406|Artefenomel|artefenomel|mesh-list
111317815|NCT02083406|Antimalarials|antimalarials|mesh-ancestor
111317816|NCT02083406|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111317817|NCT02083406|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111317818|NCT02083406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111317819|NCT03773666|Durvalumab|durvalumab|mesh-list
111317820|NCT03773666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111317821|NCT03773666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111317822|NCT04762784|Glucocorticoids|glucocorticoids|mesh-list
111317823|NCT04762784|Hormones|hormones|mesh-ancestor
111317824|NCT04762784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111317825|NCT04762784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111317826|NCT00003644|Paclitaxel|paclitaxel|mesh-list
111317827|NCT00003644|Carboplatin|carboplatin|mesh-list
111317828|NCT00003644|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111317829|NCT00003644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111317830|NCT00003644|Tubulin Modulators|tubulin modulators|mesh-ancestor
111317831|NCT00003644|Antimitotic Agents|antimitotic agents|mesh-ancestor
111317832|NCT00003644|Mitosis Modulators|mitosis modulators|mesh-ancestor
111317833|NCT00003644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111317834|NCT02142049|Lenalidomide|lenalidomide|mesh-list
111317835|NCT02142049|Immunologic Factors|immunologic factors|mesh-ancestor
111317836|NCT02142049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111317837|NCT02142049|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111317838|NCT02142049|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111317839|NCT02142049|Growth Substances|growth substances|mesh-ancestor
111317840|NCT02142049|Growth Inhibitors|growth inhibitors|mesh-ancestor
111317841|NCT02142049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111317842|NCT03715244|Anesthetics|anesthetics|mesh-list
111317843|NCT03715244|Anesthetics, Local|anesthetics, local|mesh-list
111317844|NCT03715244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111317845|NCT03715244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111317846|NCT03715244|Sensory System Agents|sensory system agents|mesh-ancestor
111317847|NCT03715244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111317848|NCT03714620|Ketamine|ketamine|mesh-list
111317849|NCT03714620|Analgesics|analgesics|mesh-ancestor
111317850|NCT03714620|Sensory System Agents|sensory system agents|mesh-ancestor
111317851|NCT03714620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111317852|NCT03714620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111317853|NCT03714620|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111317854|NCT03714620|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111317855|NCT03714620|Anesthetics, General|anesthetics, general|mesh-ancestor
111317856|NCT03714620|Anesthetics|anesthetics|mesh-ancestor
111317857|NCT03714620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111317858|NCT03714620|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111317859|NCT03714620|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111317860|NCT03714620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111317861|NCT03714620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111317862|NCT03629288|Azithromycin|azithromycin|mesh-list
111317863|NCT03629288|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111317864|NCT03629288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111317865|NCT04763096|Tacrolimus|tacrolimus|mesh-list
111317866|NCT04763096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111317867|NCT04763096|Immunologic Factors|immunologic factors|mesh-ancestor
111317868|NCT04763096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111317869|NCT04763096|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111317870|NCT04763096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111317871|NCT04763096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111317872|NCT00680953|Denosumab|denosumab|mesh-list
111317873|NCT00680953|Alendronate|alendronate|mesh-list
111317874|NCT00680953|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111317875|NCT00680953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111317876|NCT00660985|Adapalene|adapalene|mesh-list
111317877|NCT00660985|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111317878|NCT00660985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111317879|NCT00660985|Analgesics|analgesics|mesh-ancestor
111317880|NCT00660985|Sensory System Agents|sensory system agents|mesh-ancestor
111317881|NCT00660985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111317882|NCT00660985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111317883|NCT00660985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111317884|NCT00660985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111317885|NCT00660985|Dermatologic Agents|dermatologic agents|mesh-ancestor
111317886|NCT03551522|Seladelpar|seladelpar|mesh-list
111317887|NCT03551522|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111317888|NCT03551522|Antimetabolites|antimetabolites|mesh-ancestor
111317889|NCT03551522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111317890|NCT03551522|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111317891|NCT03704714|Prednisone|prednisone|mesh-list
111317892|NCT03704714|Cortisone|cortisone|mesh-list
111317893|NCT03704714|Cyclophosphamide|cyclophosphamide|mesh-list
111317894|NCT03704714|Rituximab|rituximab|mesh-list
111317895|NCT03704714|Doxorubicin|doxorubicin|mesh-list
111317896|NCT03704714|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111317897|NCT03704714|Nivolumab|nivolumab|mesh-list
111317898|NCT03704714|Vincristine|vincristine|mesh-list
111317899|NCT03704714|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111317900|NCT03704714|Antibodies|antibodies|mesh-list
111317901|NCT03704714|Immunoglobulins|immunoglobulins|mesh-list
111317902|NCT03704714|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111317903|NCT03704714|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111317904|NCT03704714|Immunologic Factors|immunologic factors|mesh-ancestor
111317905|NCT03704714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111317906|NCT03704714|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111317907|NCT03704714|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111317908|NCT03704714|Alkylating Agents|alkylating agents|mesh-ancestor
111317909|NCT03704714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111317910|NCT03704714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111317911|NCT03704714|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111317912|NCT03704714|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111317913|NCT03704714|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111317914|NCT03704714|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111317915|NCT03704714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111317916|NCT03704714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111317917|NCT03704714|Glucocorticoids|glucocorticoids|mesh-ancestor
111317918|NCT03704714|Hormones|hormones|mesh-ancestor
111317919|NCT03704714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111317920|NCT03704714|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111317921|NCT03704714|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111317922|NCT03704714|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111317923|NCT03704714|Tubulin Modulators|tubulin modulators|mesh-ancestor
111317924|NCT03704714|Antimitotic Agents|antimitotic agents|mesh-ancestor
111317925|NCT03704714|Mitosis Modulators|mitosis modulators|mesh-ancestor
111317926|NCT00661141|Ethanol|ethanol|mesh-list
111317927|NCT00661141|Fomepizole|fomepizole|mesh-list
111317928|NCT00661141|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111317929|NCT00661141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111317930|NCT00661141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111317931|NCT00661141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111317932|NCT00661141|Antidotes|antidotes|mesh-ancestor
111317933|NCT00661141|Protective Agents|protective agents|mesh-ancestor
111317934|NCT00661141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111317935|NCT00661141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111317936|NCT03616574|Trifluridine|trifluridine|mesh-list
111317937|NCT03616574|Antimetabolites|antimetabolites|mesh-ancestor
111317938|NCT03616574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111317939|NCT03616574|Antiviral Agents|antiviral agents|mesh-ancestor
111317940|NCT03616574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111317941|NCT00681265|Glycerol|glycerol|mesh-list
111317942|NCT00681265|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
111317943|NCT00681265|Protective Agents|protective agents|mesh-ancestor
111317944|NCT00681265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111317945|NCT01677104|Liraglutide|liraglutide|mesh-list
111317946|NCT01677104|Exenatide|exenatide|mesh-list
111317947|NCT01677104|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
111317948|NCT01677104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111317949|NCT01677104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111317950|NCT01677104|Incretins|incretins|mesh-ancestor
111317951|NCT01677104|Hormones|hormones|mesh-ancestor
111317952|NCT01677104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111317953|NCT01677104|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111317954|NCT00661453|Valproic Acid|valproic acid|mesh-list
111317955|NCT00661453|Anticonvulsants|anticonvulsants|mesh-ancestor
111317956|NCT00661453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111317957|NCT00661453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111317958|NCT00661453|GABA Agents|gaba agents|mesh-ancestor
111317959|NCT00661453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111317960|NCT00661453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111317961|NCT00661453|Antimanic Agents|antimanic agents|mesh-ancestor
111317962|NCT00661453|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111317963|NCT00661453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111317964|NCT00661453|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111317965|NCT03547622|Galantamine|galantamine|mesh-list
111317966|NCT03547622|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111317967|NCT03547622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111317968|NCT03547622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111317969|NCT03547622|Cholinergic Agents|cholinergic agents|mesh-ancestor
111317970|NCT03547622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111317971|NCT03547622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111317972|NCT03547622|Parasympathomimetics|parasympathomimetics|mesh-ancestor
111317973|NCT03547622|Autonomic Agents|autonomic agents|mesh-ancestor
111317974|NCT03547622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111317975|NCT03547622|Nootropic Agents|nootropic agents|mesh-ancestor
111317976|NCT00681889|Ranibizumab|ranibizumab|mesh-list
111317977|NCT00681889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111317978|NCT00681889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111317979|NCT00681889|Growth Substances|growth substances|mesh-ancestor
111317980|NCT00681889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111317981|NCT00681889|Growth Inhibitors|growth inhibitors|mesh-ancestor
111317982|NCT00681889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111317983|NCT00682357|Methylprednisolone|methylprednisolone|mesh-list
111317984|NCT00682357|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111317985|NCT00682357|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111317986|NCT00682357|Prednisolone|prednisolone|mesh-list
111317987|NCT00682357|Prednisolone acetate|prednisolone acetate|mesh-list
111317988|NCT00682357|Lidocaine|lidocaine|mesh-list
111317989|NCT00682357|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111317990|NCT00682357|Prednisolone phosphate|prednisolone phosphate|mesh-list
111317991|NCT00682357|Anesthetics, Local|anesthetics, local|mesh-ancestor
111317992|NCT00682357|Anesthetics|anesthetics|mesh-ancestor
111317993|NCT00682357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111317994|NCT00682357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111317995|NCT00682357|Sensory System Agents|sensory system agents|mesh-ancestor
111317996|NCT00682357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111317997|NCT00682357|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111317998|NCT00682357|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111317999|NCT00682357|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111318000|NCT00682357|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111318001|NCT00682357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111318002|NCT00682357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111318003|NCT00682357|Antiemetics|antiemetics|mesh-ancestor
111318004|NCT00682357|Autonomic Agents|autonomic agents|mesh-ancestor
111318005|NCT00682357|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111318006|NCT00682357|Glucocorticoids|glucocorticoids|mesh-ancestor
111318007|NCT00682357|Hormones|hormones|mesh-ancestor
111318008|NCT00682357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111318009|NCT00682357|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111318010|NCT00682357|Protective Agents|protective agents|mesh-ancestor
111318011|NCT00682357|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111318012|NCT00682357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111318013|NCT00662155|Zolpidem|zolpidem|mesh-list
111318014|NCT00662155|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111318015|NCT00662155|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111318016|NCT00662155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111318017|NCT00662155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111318018|NCT00662155|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
111318019|NCT00662155|GABA Agonists|gaba agonists|mesh-ancestor
111318020|NCT00662155|GABA Agents|gaba agents|mesh-ancestor
111318021|NCT00662155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111318022|NCT00662155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111318023|NCT03546608|Tepotinib|tepotinib|mesh-list
111318024|NCT03546608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111318025|NCT00662545|Tenofovir|tenofovir|mesh-list
111318026|NCT00662545|Lamivudine|lamivudine|mesh-list
111318027|NCT00662545|Emtricitabine|emtricitabine|mesh-list
111318028|NCT00662545|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
111318029|NCT00662545|Entecavir|entecavir|mesh-list
111318030|NCT00662545|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
111318031|NCT00662545|Antiviral Agents|antiviral agents|mesh-ancestor
111318032|NCT00662545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111318033|NCT00662545|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111318034|NCT00662545|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111318035|NCT00662545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111318036|NCT00662545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111318037|NCT00662545|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111318038|NCT03539198|Nivolumab|nivolumab|mesh-list
111318039|NCT03539198|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111318040|NCT03539198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111318041|NCT03539198|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111318042|NCT03539198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111318043|NCT00663169|Dexamethasone|dexamethasone|mesh-list
111318044|NCT00663169|Dexamethasone acetate|dexamethasone acetate|mesh-list
111318045|NCT00663169|BB 1101|bb 1101|mesh-list
111318046|NCT00663169|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111318047|NCT00663169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111318048|NCT00663169|Antiemetics|antiemetics|mesh-ancestor
111318049|NCT00663169|Autonomic Agents|autonomic agents|mesh-ancestor
111318050|NCT00663169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111318051|NCT00663169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111318052|NCT00663169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111318053|NCT00663169|Glucocorticoids|glucocorticoids|mesh-ancestor
111318054|NCT00663169|Hormones|hormones|mesh-ancestor
111318055|NCT00663169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111318056|NCT00663169|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111318057|NCT00663169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111318058|NCT00663169|Protease Inhibitors|protease inhibitors|mesh-ancestor
111318059|NCT00663169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111318060|NCT00663169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111318061|NCT00663169|Immunologic Factors|immunologic factors|mesh-ancestor
111318062|NCT00663403|Daptomycin|daptomycin|mesh-list
111318063|NCT00663403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111318064|NCT00663403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111318065|NCT00663793|Methyltestosterone|methyltestosterone|mesh-list
111318066|NCT00663793|Finasteride|finasteride|mesh-list
111318067|NCT00663793|Testosterone|testosterone|mesh-list
111318068|NCT00663793|Testosterone undecanoate|testosterone undecanoate|mesh-list
111318069|NCT00663793|Testosterone enanthate|testosterone enanthate|mesh-list
111318070|NCT00663793|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
111318071|NCT00663793|Acyline|acyline|mesh-list
111318072|NCT00663793|Androgens|androgens|mesh-ancestor
111318073|NCT00663793|Hormones|hormones|mesh-ancestor
111318074|NCT00663793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111318075|NCT00663793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111318076|NCT00663793|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111318077|NCT00663793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111318078|NCT00663793|Anabolic Agents|anabolic agents|mesh-ancestor
111318079|NCT00663793|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
111318080|NCT00663793|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111318081|NCT00663793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111318082|NCT00663793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111318083|NCT00663793|Hormone Antagonists|hormone antagonists|mesh-ancestor
111318084|NCT00663793|Urological Agents|urological agents|mesh-ancestor
111318085|NCT03690986|Nivolumab|nivolumab|mesh-list
111318086|NCT03690986|Ipilimumab|ipilimumab|mesh-list
111318087|NCT03690986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111318088|NCT03690986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111318089|NCT03690986|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111318090|NCT03690986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111318091|NCT03605654|Mycophenolic Acid|mycophenolic acid|mesh-list
111318092|NCT03605654|Tacrolimus|tacrolimus|mesh-list
111318093|NCT03605654|Immunosuppressive Agents|immunosuppressive agents|mesh-list
111318094|NCT03605654|Immunologic Factors|immunologic factors|mesh-ancestor
111318095|NCT03605654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111318096|NCT03605654|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111318097|NCT03605654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111318098|NCT03605654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111318099|NCT03605654|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111318100|NCT03605654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111318101|NCT03605654|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111318102|NCT03605654|Antitubercular Agents|antitubercular agents|mesh-ancestor
111318103|NCT03605654|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111318104|NCT03605654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111318105|NCT02336438|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
111318106|NCT02336438|Cathartics|cathartics|mesh-ancestor
111318107|NCT02336438|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111318108|NCT00667615|Prednisone|prednisone|mesh-list
111318109|NCT00667615|Cyclophosphamide|cyclophosphamide|mesh-list
111318110|NCT00667615|Rituximab|rituximab|mesh-list
111318111|NCT00667615|Etoposide|etoposide|mesh-list
111318112|NCT00667615|Vorinostat|vorinostat|mesh-list
111318113|NCT00667615|Lenograstim|lenograstim|mesh-list
111318114|NCT00667615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111318115|NCT00667615|Immunologic Factors|immunologic factors|mesh-ancestor
111318116|NCT00667615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111318117|NCT00667615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111318118|NCT00667615|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111318119|NCT00667615|Alkylating Agents|alkylating agents|mesh-ancestor
111318120|NCT00667615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111318121|NCT00667615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111318122|NCT00667615|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111318123|NCT00667615|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111318124|NCT00667615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111318125|NCT00667615|Glucocorticoids|glucocorticoids|mesh-ancestor
111318126|NCT00667615|Hormones|hormones|mesh-ancestor
111318127|NCT00667615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111318128|NCT00667615|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111318129|NCT00667615|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111318130|NCT00667615|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111318131|NCT00667615|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111318132|NCT00667615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111318133|NCT00667615|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111318134|NCT00667615|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111318135|NCT03683810|Lactoferrin|lactoferrin|mesh-list
111318136|NCT03683810|Epoetin Alfa|epoetin alfa|mesh-list
111318137|NCT03683810|Hematinics|hematinics|mesh-ancestor
111318138|NCT03683810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111318139|NCT01587235|Simvastatin|simvastatin|mesh-list
111318140|NCT01587235|Ezetimibe|ezetimibe|mesh-list
111318141|NCT01587235|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
111318142|NCT01587235|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111318143|NCT01587235|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111318144|NCT01587235|Antimetabolites|antimetabolites|mesh-ancestor
111318145|NCT01587235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111318146|NCT01587235|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111318147|NCT01587235|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111318148|NCT01587235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111318149|NCT00705133|Treprostinil|treprostinil|mesh-list
111318150|NCT00705133|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111318151|NCT00652717|Simvastatin|simvastatin|mesh-list
111318152|NCT00652717|Ezetimibe|ezetimibe|mesh-list
111318153|NCT00652717|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111318154|NCT00652717|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111318155|NCT00652717|Antimetabolites|antimetabolites|mesh-ancestor
111318156|NCT00652717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111318157|NCT00652717|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111318158|NCT00652717|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111318159|NCT00652717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111318160|NCT00553891|Mometasone Furoate|mometasone furoate|mesh-list
111318161|NCT00553891|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111318162|NCT00553891|Dermatologic Agents|dermatologic agents|mesh-ancestor
111318163|NCT00553891|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111318164|NCT00684775|Naltrexone|naltrexone|mesh-list
111318165|NCT00684775|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111318166|NCT00684775|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111318167|NCT00684775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111318168|NCT00684775|Sensory System Agents|sensory system agents|mesh-ancestor
111318169|NCT00684775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111318170|NCT00395473|Ezetimibe|ezetimibe|mesh-list
111318171|NCT00395473|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111318172|NCT00395473|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111318173|NCT00395473|Antimetabolites|antimetabolites|mesh-ancestor
111318174|NCT00395473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111318175|NCT00395473|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111318176|NCT00393211|Etoricoxib|etoricoxib|mesh-list
111318177|NCT00393211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111318178|NCT00393211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111318179|NCT00393211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111318180|NCT00393211|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111318181|NCT00393211|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111318182|NCT00393211|Analgesics|analgesics|mesh-ancestor
111318183|NCT00393211|Sensory System Agents|sensory system agents|mesh-ancestor
111318184|NCT00393211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111318185|NCT00393211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111318186|NCT00393211|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111318187|NCT00393211|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111318188|NCT00393211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111318189|NCT03676556|Lidocaine|lidocaine|mesh-list
111318190|NCT03676556|Anesthetics, Local|anesthetics, local|mesh-ancestor
111318191|NCT03676556|Anesthetics|anesthetics|mesh-ancestor
111318192|NCT03676556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111318193|NCT03676556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111318194|NCT03676556|Sensory System Agents|sensory system agents|mesh-ancestor
111318195|NCT03676556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111318196|NCT03676556|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111318197|NCT03676556|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111318198|NCT03676556|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111318199|NCT03676556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111318200|NCT03676556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111318201|NCT02144233|Salicylic Acid|salicylic acid|mesh-list
111318202|NCT02144233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111318203|NCT02144233|Antifungal Agents|antifungal agents|mesh-ancestor
111318204|NCT02144233|Keratolytic Agents|keratolytic agents|mesh-ancestor
111318205|NCT02144233|Dermatologic Agents|dermatologic agents|mesh-ancestor
111318206|NCT03592472|Abexinostat|abexinostat|mesh-list
111318207|NCT03592472|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111318208|NCT03592472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111318209|NCT03592472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111318210|NCT00269191|Ibuprofen|ibuprofen|mesh-list
111318211|NCT00269191|Etoricoxib|etoricoxib|mesh-list
111318212|NCT00269191|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111318213|NCT00269191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111318214|NCT00269191|Analgesics|analgesics|mesh-ancestor
111318215|NCT00269191|Sensory System Agents|sensory system agents|mesh-ancestor
111318216|NCT00269191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111318217|NCT00269191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111318218|NCT00269191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111318219|NCT00269191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111318220|NCT00269191|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111318221|NCT00269191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111318222|NCT00269191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111318223|NCT00269191|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111318224|NCT00690235|Pramlintide|pramlintide|mesh-list
111318225|NCT00690235|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111318226|NCT00690235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111318227|NCT00092833|Ezetimibe|ezetimibe|mesh-list
111318228|NCT00092833|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111318229|NCT00092833|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111318230|NCT00092833|Antimetabolites|antimetabolites|mesh-ancestor
111318231|NCT00092833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111318232|NCT00092833|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111318233|NCT01799083|Decitabine|decitabine|mesh-list
111318234|NCT01799083|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111318235|NCT01799083|Antimetabolites|antimetabolites|mesh-ancestor
111318236|NCT01799083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111318237|NCT01799083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111318238|NCT01799083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111318239|NCT01799161|Theophylline|theophylline|mesh-list
111318240|NCT01799161|Vaccines|vaccines|mesh-list
111318241|NCT01799161|Immunologic Factors|immunologic factors|mesh-ancestor
111318242|NCT01799161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111318243|NCT01799161|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111318244|NCT01799161|Autonomic Agents|autonomic agents|mesh-ancestor
111318245|NCT01799161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111318246|NCT01799161|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111318247|NCT01799161|Respiratory System Agents|respiratory system agents|mesh-ancestor
111318248|NCT01799161|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111318249|NCT01799161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111318250|NCT01799161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111318251|NCT01799161|Vasodilator Agents|vasodilator agents|mesh-ancestor
111318252|NCT01799161|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
111318253|NCT01799161|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111318254|NCT01799161|Purinergic Agents|purinergic agents|mesh-ancestor
111318255|NCT01799161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111318256|NCT00006110|Paclitaxel|paclitaxel|mesh-list
111318257|NCT00006110|Cyclophosphamide|cyclophosphamide|mesh-list
111318258|NCT00006110|Doxorubicin|doxorubicin|mesh-list
111318259|NCT00006110|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111318260|NCT00006110|Trastuzumab|trastuzumab|mesh-list
111318261|NCT00006110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111318262|NCT00006110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111318263|NCT00006110|Tubulin Modulators|tubulin modulators|mesh-ancestor
111318264|NCT00006110|Antimitotic Agents|antimitotic agents|mesh-ancestor
111318265|NCT00006110|Mitosis Modulators|mitosis modulators|mesh-ancestor
111318266|NCT00006110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111318267|NCT00006110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111318268|NCT00006110|Immunologic Factors|immunologic factors|mesh-ancestor
111318269|NCT00006110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111318270|NCT00006110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111318271|NCT00006110|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111318272|NCT00006110|Alkylating Agents|alkylating agents|mesh-ancestor
111318273|NCT00006110|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111318274|NCT00006110|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111318275|NCT00006110|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111318276|NCT00006110|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111318277|NCT00006110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111318278|NCT00006110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111318279|NCT00692185|Olanzapine|olanzapine|mesh-list
111318280|NCT00692185|Antiemetics|antiemetics|mesh-ancestor
111318281|NCT00692185|Autonomic Agents|autonomic agents|mesh-ancestor
111318282|NCT00692185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111318283|NCT00692185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111318284|NCT00692185|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111318285|NCT00692185|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111318286|NCT00692185|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111318287|NCT00692185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111318288|NCT00692185|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111318289|NCT00692185|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111318290|NCT00692185|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111318291|NCT00692185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111318292|NCT00692185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111318293|NCT00692185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111318294|NCT00692185|Serotonin Agents|serotonin agents|mesh-ancestor
111318295|NCT04270279|Nitroglycerin|nitroglycerin|mesh-list
111318296|NCT04270279|Vasodilator Agents|vasodilator agents|mesh-ancestor
111318297|NCT00692341|Axitinib|axitinib|mesh-list
111318298|NCT00692341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111318299|NCT00692341|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111318300|NCT00692341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111318301|NCT00692341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111318302|NCT00694603|Cetuximab|cetuximab|mesh-list
111318303|NCT00694603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111318304|NCT00694603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111318305|NCT00590161|Pentoxifylline|pentoxifylline|mesh-list
111318306|NCT00590161|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111318307|NCT00590161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111318308|NCT00590161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111318309|NCT00590161|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111318310|NCT00590161|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111318311|NCT00590161|Protective Agents|protective agents|mesh-ancestor
111318312|NCT00590161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111318313|NCT00590161|Vasodilator Agents|vasodilator agents|mesh-ancestor
111318314|NCT00590161|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111318315|NCT00590161|Antioxidants|antioxidants|mesh-ancestor
111318316|NCT00590395|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
111318317|NCT00590395|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
111318318|NCT00590395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111318319|NCT00006170|Bupropion|bupropion|mesh-list
111318320|NCT00006170|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111318321|NCT00006170|Antidepressive Agents|antidepressive agents|mesh-ancestor
111318322|NCT00006170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111318323|NCT00006170|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111318324|NCT00006170|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111318325|NCT00006170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111318326|NCT00006170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111318327|NCT00006170|Dopamine Agents|dopamine agents|mesh-ancestor
111318328|NCT00006170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111318329|NCT00006170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111318330|NCT00006170|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111318331|NCT00006170|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111318332|NCT00006170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111318333|NCT02123849|Aspirin|aspirin|mesh-list
111318334|NCT02123849|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111318335|NCT02123849|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111318336|NCT02123849|Analgesics|analgesics|mesh-ancestor
111318337|NCT02123849|Sensory System Agents|sensory system agents|mesh-ancestor
111318338|NCT02123849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111318339|NCT02123849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111318340|NCT02123849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111318341|NCT02123849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111318342|NCT02123849|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111318343|NCT02123849|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111318344|NCT02123849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111318345|NCT02123849|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111318346|NCT02123849|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111318347|NCT02123849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111318348|NCT02123849|Antipyretics|antipyretics|mesh-ancestor
111318349|NCT05347160|Calcium|calcium|mesh-list
111318350|NCT05347160|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111318351|NCT05347160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111318352|NCT00671528|Gentamicins|gentamicins|mesh-list
111318353|NCT00671528|Clotrimazole|clotrimazole|mesh-list
111318354|NCT00671528|Miconazole|miconazole|mesh-list
111318355|NCT00671528|Betamethasone|betamethasone|mesh-list
111318356|NCT00671528|Betamethasone Valerate|betamethasone valerate|mesh-list
111318357|NCT00671528|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
111318358|NCT00671528|Betamethasone benzoate|betamethasone benzoate|mesh-list
111318359|NCT00671528|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
111318360|NCT00671528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111318361|NCT00671528|Glucocorticoids|glucocorticoids|mesh-ancestor
111318362|NCT00671528|Hormones|hormones|mesh-ancestor
111318363|NCT00671528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111318364|NCT00671528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111318365|NCT00671528|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111318366|NCT00671528|Respiratory System Agents|respiratory system agents|mesh-ancestor
111318367|NCT00671528|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111318368|NCT00671528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111318369|NCT00671528|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111318370|NCT00671528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111318371|NCT00671528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111318372|NCT00671528|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111318373|NCT00671528|Antifungal Agents|antifungal agents|mesh-ancestor
111318374|NCT00671528|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111318375|NCT00671528|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111318376|NCT00671528|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111318377|NCT00671528|Hormone Antagonists|hormone antagonists|mesh-ancestor
111318378|NCT00671528|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111318379|NCT00671528|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111318380|NCT00590863|Dexetimide|dexetimide|mesh-list
111318381|NCT00590863|Mirtazapine|mirtazapine|mesh-list
111318382|NCT00590863|Citalopram|citalopram|mesh-list
111318383|NCT00590863|Bupropion|bupropion|mesh-list
111318384|NCT00590863|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
111318385|NCT00590863|Escitalopram|escitalopram|mesh-list
111318386|NCT00590863|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111318387|NCT00590863|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111318388|NCT00590863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111318389|NCT00590863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111318390|NCT00590863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111318391|NCT00590863|Serotonin Agents|serotonin agents|mesh-ancestor
111318392|NCT00590863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111318393|NCT00590863|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111318394|NCT00590863|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111318395|NCT00590863|Parasympatholytics|parasympatholytics|mesh-ancestor
111318396|NCT00590863|Autonomic Agents|autonomic agents|mesh-ancestor
111318397|NCT00590863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111318398|NCT00590863|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111318399|NCT00590863|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111318400|NCT00590863|Cholinergic Agents|cholinergic agents|mesh-ancestor
111318401|NCT00590863|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111318402|NCT00590863|Antidepressive Agents|antidepressive agents|mesh-ancestor
111318403|NCT00590863|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111318404|NCT00590863|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111318405|NCT00590863|Dopamine Agents|dopamine agents|mesh-ancestor
111318406|NCT00590863|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111318407|NCT00590863|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111318408|NCT00590863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111318409|NCT00590863|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111318410|NCT00590863|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111318411|NCT00590863|Histamine Antagonists|histamine antagonists|mesh-ancestor
111318412|NCT00590863|Histamine Agents|histamine agents|mesh-ancestor
111318413|NCT00590863|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111318414|NCT00590863|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111318415|NCT00590863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111318416|NCT00590863|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
111318417|NCT00590863|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111318418|NCT00590863|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111318419|NCT00590863|Adrenergic Agents|adrenergic agents|mesh-ancestor
111318420|NCT00590863|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111318421|NCT00590863|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111318422|NCT00590863|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111318423|NCT00591019|Modafinil|modafinil|mesh-list
111318424|NCT00591019|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111318425|NCT00591019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111318426|NCT00591019|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
111318427|NCT00591019|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111318428|NCT00591019|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111318429|NCT00591019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111318430|NCT02996695|Artesunate|artesunate|mesh-list
111318431|NCT02996695|Chloroquine|chloroquine|mesh-list
111318432|NCT02996695|Antimalarials|antimalarials|mesh-ancestor
111318433|NCT02996695|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111318434|NCT02996695|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111318435|NCT02996695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111318436|NCT02996695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111318437|NCT02996695|Antiviral Agents|antiviral agents|mesh-ancestor
111318438|NCT02996695|Schistosomicides|schistosomicides|mesh-ancestor
111318439|NCT02996695|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
111318440|NCT02996695|Anthelmintics|anthelmintics|mesh-ancestor
111318441|NCT02996695|Amebicides|amebicides|mesh-ancestor
111318442|NCT02996695|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111318443|NCT00359138|Cetirizine|cetirizine|mesh-list
111318444|NCT00359138|Loratadine|loratadine|mesh-list
111318445|NCT00359138|Levocetirizine|levocetirizine|mesh-list
111318446|NCT00359138|Desloratadine|desloratadine|mesh-list
111318447|NCT00359138|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
111318448|NCT00359138|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111318449|NCT00359138|Histamine Antagonists|histamine antagonists|mesh-ancestor
111318450|NCT00359138|Histamine Agents|histamine agents|mesh-ancestor
111318451|NCT00359138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111318452|NCT00359138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111318453|NCT00359138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111318454|NCT00359138|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111318455|NCT00359138|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111318456|NCT00359138|Cholinergic Agents|cholinergic agents|mesh-ancestor
111318457|NCT00359138|Antipruritics|antipruritics|mesh-ancestor
111318458|NCT00359138|Dermatologic Agents|dermatologic agents|mesh-ancestor
111318459|NCT05503979|Sofosbuvir|sofosbuvir|mesh-list
111318460|NCT05503979|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
111318461|NCT05503979|Velpatasvir|velpatasvir|mesh-list
111318462|NCT05503979|Antiviral Agents|antiviral agents|mesh-ancestor
111318463|NCT05503979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111318464|NCT02996227|Bupivacaine|bupivacaine|mesh-list
111318465|NCT02996227|Anesthetics, Local|anesthetics, local|mesh-ancestor
111318466|NCT02996227|Anesthetics|anesthetics|mesh-ancestor
111318467|NCT02996227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111318468|NCT02996227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111318469|NCT02996227|Sensory System Agents|sensory system agents|mesh-ancestor
111318470|NCT02996227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111318471|NCT00698035|Methyltestosterone|methyltestosterone|mesh-list
111318472|NCT00698035|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
111318473|NCT00698035|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
111318474|NCT00698035|Testosterone|testosterone|mesh-list
111318475|NCT00698035|Testosterone undecanoate|testosterone undecanoate|mesh-list
111318476|NCT00698035|Testosterone enanthate|testosterone enanthate|mesh-list
111318477|NCT00698035|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
111318478|NCT00698035|Estradiol|estradiol|mesh-list
111318479|NCT00698035|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
111318480|NCT00698035|Androgens|androgens|mesh-ancestor
111318481|NCT00698035|Hormones|hormones|mesh-ancestor
111318482|NCT00698035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111318483|NCT00698035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111318484|NCT00698035|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111318485|NCT00698035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111318486|NCT00698035|Anabolic Agents|anabolic agents|mesh-ancestor
111318487|NCT00698035|Estrogens|estrogens|mesh-ancestor
111318488|NCT00698035|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111318489|NCT00698035|Contraceptive Agents|contraceptive agents|mesh-ancestor
111318490|NCT00698035|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111318491|NCT00698035|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111318492|NCT02129075|Poly I-C|poly i-c|mesh-list
111318493|NCT02129075|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
111318494|NCT02129075|Poly ICLC|poly iclc|mesh-list
111318495|NCT02129075|Flt3 ligand protein|flt3 ligand protein|mesh-list
111318496|NCT02129075|Interferon Inducers|interferon inducers|mesh-ancestor
111318497|NCT02129075|Immunologic Factors|immunologic factors|mesh-ancestor
111318498|NCT02129075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111318499|NCT02129075|Laxatives|laxatives|mesh-ancestor
111318500|NCT02129075|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111318501|NCT02129075|Antiviral Agents|antiviral agents|mesh-ancestor
111318502|NCT02129075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111318503|NCT02129075|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111318504|NCT02129075|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111318505|NCT02129075|Protective Agents|protective agents|mesh-ancestor
111318506|NCT02775903|Azacitidine|azacitidine|mesh-list
111318507|NCT02775903|Durvalumab|durvalumab|mesh-list
111318508|NCT02775903|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111318509|NCT02775903|Antimetabolites|antimetabolites|mesh-ancestor
111318510|NCT02775903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111318511|NCT02775903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111318512|NCT02775903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111318513|NCT02775903|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111318514|NCT01933425|Rocuronium|rocuronium|mesh-list
111318515|NCT01933425|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
111318516|NCT01933425|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
111318517|NCT01933425|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111318518|NCT01933425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111318519|NCT01933425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111318520|NCT04239599|Leuprolide|leuprolide|mesh-list
111318521|NCT04239599|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111318522|NCT04239599|Fertility Agents|fertility agents|mesh-ancestor
111318523|NCT04239599|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111318524|NCT04239599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111318525|NCT04239599|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111318526|NCT04239599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111318527|NCT03487016|Paclitaxel|paclitaxel|mesh-list
111318528|NCT03487016|Gemcitabine|gemcitabine|mesh-list
111318529|NCT03487016|Oxaliplatin|oxaliplatin|mesh-list
111318530|NCT03487016|Irinotecan|irinotecan|mesh-list
111318531|NCT03487016|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111318532|NCT03487016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111318533|NCT03487016|Tubulin Modulators|tubulin modulators|mesh-ancestor
111318534|NCT03487016|Antimitotic Agents|antimitotic agents|mesh-ancestor
111318535|NCT03487016|Mitosis Modulators|mitosis modulators|mesh-ancestor
111318536|NCT03487016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111318537|NCT03487016|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111318538|NCT03487016|Antimetabolites|antimetabolites|mesh-ancestor
111318539|NCT03487016|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111318540|NCT03487016|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111318541|NCT03487016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111318542|NCT05346926|Calpastatin|calpastatin|mesh-list
111318543|NCT05346926|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
111318544|NCT05346926|Protease Inhibitors|protease inhibitors|mesh-ancestor
111318545|NCT05346926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111318546|NCT05346926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111318547|NCT05292209|Riluzole|riluzole|mesh-list
111318548|NCT05292209|Anticonvulsants|anticonvulsants|mesh-ancestor
111318549|NCT05292209|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111318550|NCT05292209|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111318551|NCT05292209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111318552|NCT05292209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111318553|NCT05292209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111318554|NCT05292209|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111318555|NCT05292209|Protective Agents|protective agents|mesh-ancestor
111318556|NCT03023319|Pemetrexed|pemetrexed|mesh-list
111318557|NCT03023319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111318558|NCT03023319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111318559|NCT03023319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111318560|NCT03023319|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111318561|NCT03023319|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111318562|NCT02980653|Megestrol|megestrol|mesh-list
111318563|NCT02980653|Megestrol Acetate|megestrol acetate|mesh-list
111318564|NCT02980653|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111318565|NCT02980653|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111318566|NCT02980653|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111318567|NCT02980653|Contraceptive Agents|contraceptive agents|mesh-ancestor
111318568|NCT02980653|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111318569|NCT02980653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111318570|NCT02980653|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111318571|NCT02980653|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111318572|NCT02980653|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111318573|NCT02980653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111318574|NCT02980653|Appetite Stimulants|appetite stimulants|mesh-ancestor
111318575|NCT02980653|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111318576|NCT05265065|Vaccines|vaccines|mesh-list
111318577|NCT05265065|Immunologic Factors|immunologic factors|mesh-ancestor
111318578|NCT05265065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111318579|NCT01677338|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
111318580|NCT01677338|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111318581|NCT01677338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111318582|NCT03088280|Thymoglobulin|thymoglobulin|mesh-list
111318583|NCT03088280|Immunologic Factors|immunologic factors|mesh-ancestor
111318584|NCT03088280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111318585|NCT03088280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111318586|NCT03087968|Prednisolone|prednisolone|mesh-list
111318587|NCT03087968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111318588|NCT03087968|Glucocorticoids|glucocorticoids|mesh-ancestor
111318589|NCT03087968|Hormones|hormones|mesh-ancestor
111318590|NCT03087968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111318591|NCT03087968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111318592|NCT03087968|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111318593|NCT03087968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111318594|NCT03845049|Aflibercept|aflibercept|mesh-list
111318595|NCT03845049|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111318596|NCT03845049|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111318597|NCT03845049|Growth Substances|growth substances|mesh-ancestor
111318598|NCT03845049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111318599|NCT03845049|Growth Inhibitors|growth inhibitors|mesh-ancestor
111318600|NCT03845049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111318601|NCT03790839|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111318602|NCT03790839|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111318603|NCT03790839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111318604|NCT03790839|Incretins|incretins|mesh-ancestor
111318605|NCT03790839|Hormones|hormones|mesh-ancestor
111318606|NCT03790839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111318607|NCT03790839|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111318608|NCT03790839|Protease Inhibitors|protease inhibitors|mesh-ancestor
111318609|NCT03790839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111318610|NCT03790839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111318611|NCT03088046|Progesterone|progesterone|mesh-list
111318612|NCT03088046|Progestins|progestins|mesh-ancestor
111318613|NCT03088046|Hormones|hormones|mesh-ancestor
111318614|NCT03088046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111318615|NCT03088046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111318616|NCT01677884|Bevacizumab|bevacizumab|mesh-list
111318617|NCT01677884|Capecitabine|capecitabine|mesh-list
111318618|NCT01677884|Irinotecan|irinotecan|mesh-list
111318619|NCT01677884|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111318620|NCT01677884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111318621|NCT01677884|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111318622|NCT01677884|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111318623|NCT01677884|Growth Substances|growth substances|mesh-ancestor
111318624|NCT01677884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111318625|NCT01677884|Growth Inhibitors|growth inhibitors|mesh-ancestor
111318626|NCT01677884|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111318627|NCT01677884|Antimetabolites|antimetabolites|mesh-ancestor
111318628|NCT01677884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111318629|NCT01677884|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111318630|NCT01677884|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111318631|NCT01677884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111318632|NCT02124083|Vorinostat|vorinostat|mesh-list
111318633|NCT02124083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111318634|NCT02124083|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111318635|NCT02124083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111318636|NCT02124083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111318637|NCT02405078|Deoxyglucose|deoxyglucose|mesh-list
111318638|NCT02405078|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
111318639|NCT02405078|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111318640|NCT02405078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111318641|NCT02405078|Antimetabolites|antimetabolites|mesh-ancestor
111318642|NCT02405078|Antiviral Agents|antiviral agents|mesh-ancestor
111318643|NCT02405078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111318644|NCT00701389|Sumatriptan|sumatriptan|mesh-list
111318645|NCT00701389|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111318646|NCT00701389|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111318647|NCT00701389|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111318648|NCT00701389|Serotonin Agents|serotonin agents|mesh-ancestor
111318649|NCT00701389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111318650|NCT00701389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111318651|NCT00701389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111318652|NCT02336594|Verinurad|verinurad|mesh-list
111318653|NCT02336594|Gout Suppressants|gout suppressants|mesh-ancestor
111318654|NCT02336594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111318655|NCT01799317|Vitamin D|vitamin d|mesh-list
111318656|NCT01799317|Ergocalciferols|ergocalciferols|mesh-list
111318657|NCT01799317|Vitamins|vitamins|mesh-ancestor
111318658|NCT01799317|Micronutrients|micronutrients|mesh-ancestor
111318659|NCT01799317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111318660|NCT01799317|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111318661|NCT01799317|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111318662|NCT01677962|Poly ICLC|poly iclc|mesh-list
111318663|NCT01677962|Interferon Inducers|interferon inducers|mesh-ancestor
111318664|NCT01677962|Immunologic Factors|immunologic factors|mesh-ancestor
111318665|NCT01677962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111318666|NCT00595153|Budesonide|budesonide|mesh-list
111318667|NCT00595153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111318668|NCT00595153|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111318669|NCT00595153|Autonomic Agents|autonomic agents|mesh-ancestor
111318670|NCT00595153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111318671|NCT00595153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111318672|NCT00595153|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111318673|NCT00595153|Respiratory System Agents|respiratory system agents|mesh-ancestor
111318674|NCT00595153|Glucocorticoids|glucocorticoids|mesh-ancestor
111318675|NCT00595153|Hormones|hormones|mesh-ancestor
111318676|NCT00595153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111318677|NCT02995291|Phentolamine|phentolamine|mesh-list
111318678|NCT02995291|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111318679|NCT02995291|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111318680|NCT02995291|Adrenergic Agents|adrenergic agents|mesh-ancestor
111318681|NCT02995291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111318682|NCT02995291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111318683|NCT02995291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111318684|NCT02995291|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111318685|NCT00595231|Rufinamide|rufinamide|mesh-list
111318686|NCT00595231|Anticonvulsants|anticonvulsants|mesh-ancestor
111318688|NCT00595231|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111318689|NCT00595231|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111318690|NCT00595231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111318691|NCT02995057|Nickel|nickel|mesh-list
111318692|NCT02995057|Trace Elements|trace elements|mesh-ancestor
111318693|NCT02995057|Micronutrients|micronutrients|mesh-ancestor
111318694|NCT02995057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111318695|NCT02474173|Paclitaxel|paclitaxel|mesh-list
111318696|NCT02474173|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111318697|NCT02474173|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111318698|NCT02474173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111318699|NCT02474173|Tubulin Modulators|tubulin modulators|mesh-ancestor
111318700|NCT02474173|Antimitotic Agents|antimitotic agents|mesh-ancestor
111318701|NCT02474173|Mitosis Modulators|mitosis modulators|mesh-ancestor
111318702|NCT02474173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111318703|NCT03482102|Durvalumab|durvalumab|mesh-list
111318704|NCT03482102|Tremelimumab|tremelimumab|mesh-list
111318705|NCT03482102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111318706|NCT03482102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111318707|NCT02402270|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
111318708|NCT02402270|Laxatives|laxatives|mesh-ancestor
111318709|NCT02402270|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111318710|NCT00701935|Exenatide|exenatide|mesh-list
111318711|NCT00701935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111318712|NCT00701935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111318713|NCT00701935|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111318714|NCT00701935|Incretins|incretins|mesh-ancestor
111318715|NCT00701935|Hormones|hormones|mesh-ancestor
111318716|NCT00701935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111318717|NCT02984696|Estradiol|estradiol|mesh-list
111318718|NCT02984696|Estrogens|estrogens|mesh-ancestor
111318719|NCT02984696|Hormones|hormones|mesh-ancestor
111318720|NCT02984696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111318721|NCT02984696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111318722|NCT03277313|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111318723|NCT03277313|Immunologic Factors|immunologic factors|mesh-ancestor
111318724|NCT03277313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111318725|NCT00596167|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111318726|NCT00596167|Vancomycin|vancomycin|mesh-list
111318727|NCT00596167|Levofloxacin|levofloxacin|mesh-list
111318728|NCT00596167|Gentamicins|gentamicins|mesh-list
111318729|NCT00596167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111318730|NCT00596167|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111318731|NCT00596167|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111318732|NCT00596167|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111318733|NCT00596167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111318734|NCT00596167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111318735|NCT00596167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111318736|NCT00596167|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111318737|NCT00596167|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111318738|NCT00596167|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111318739|NCT03087032|Insulin Glargine|insulin glargine|mesh-list
111318740|NCT03087032|Liraglutide|liraglutide|mesh-list
111318741|NCT03087032|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111318742|NCT03087032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111318743|NCT03087032|Incretins|incretins|mesh-ancestor
111318744|NCT03087032|Hormones|hormones|mesh-ancestor
111318745|NCT03087032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111318746|NCT02994745|Atorvastatin|atorvastatin|mesh-list
111318747|NCT02994745|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111318748|NCT02994745|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111318749|NCT02994745|Antimetabolites|antimetabolites|mesh-ancestor
111318750|NCT02994745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111318751|NCT02994745|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111318752|NCT02994745|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111318753|NCT02994745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111318754|NCT00703261|Atorvastatin|atorvastatin|mesh-list
111318755|NCT00703261|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111318756|NCT00703261|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111318757|NCT00703261|Antimetabolites|antimetabolites|mesh-ancestor
111318758|NCT00703261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111318759|NCT00703261|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111043183|NCT02205931|Topiramate|topiramate|mesh-list
111318760|NCT00703261|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111318761|NCT00703261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111318763|NCT04912115|Ketamine|ketamine|mesh-list
111318764|NCT04912115|Analgesics|analgesics|mesh-ancestor
111318765|NCT04912115|Sensory System Agents|sensory system agents|mesh-ancestor
111318766|NCT04912115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111318767|NCT04912115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111318768|NCT04912115|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111318769|NCT04912115|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111318770|NCT04912115|Anesthetics, General|anesthetics, general|mesh-ancestor
111318771|NCT04912115|Anesthetics|anesthetics|mesh-ancestor
111318772|NCT04912115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111318773|NCT04912115|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111318774|NCT04912115|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111318775|NCT04912115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111318776|NCT04912115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111318777|NCT04912115|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111318778|NCT04912115|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111318779|NCT04912115|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111318780|NCT04912115|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111318781|NCT04912115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111318782|NCT04912115|GABA Modulators|gaba modulators|mesh-ancestor
111318783|NCT04912115|GABA Agents|gaba agents|mesh-ancestor
111318784|NCT04346147|Imatinib Mesylate|imatinib mesylate|mesh-list
111318785|NCT04346147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111318786|NCT04346147|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111318787|NCT04346147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111318788|NCT04346147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111318789|NCT03478358|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
111318790|NCT03478358|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
111318791|NCT03478358|(177)Lu-DOTA-EB-TATE|(177)lu-dota-eb-tate|mesh-list
111318792|NCT03478358|Chelating Agents|chelating agents|mesh-ancestor
111318793|NCT03478358|Sequestering Agents|sequestering agents|mesh-ancestor
111318794|NCT03478358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111318795|NCT03478358|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111318796|NCT04200833|Golimumab|golimumab|mesh-list
111318797|NCT04200833|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111318798|NCT04200833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111318799|NCT04200833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111318800|NCT04200833|Immunologic Factors|immunologic factors|mesh-ancestor
111318801|NCT04200833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111318802|NCT01678352|Imiquimod|imiquimod|mesh-list
111318803|NCT01678352|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111318804|NCT01678352|Immunologic Factors|immunologic factors|mesh-ancestor
111318805|NCT01678352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111318806|NCT01678352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111318807|NCT01678352|Interferon Inducers|interferon inducers|mesh-ancestor
111318808|NCT01678430|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
111318809|NCT01678430|Chlorambucil|chlorambucil|mesh-list
111318810|NCT01678430|Ofatumumab|ofatumumab|mesh-list
111318811|NCT01678430|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111318812|NCT01678430|Alkylating Agents|alkylating agents|mesh-ancestor
111318813|NCT01678430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111318814|NCT01678430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111318815|NCT01678664|Doxorubicin|doxorubicin|mesh-list
111318816|NCT01678664|Everolimus|everolimus|mesh-list
111318817|NCT01678664|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111318818|NCT01678664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111318819|NCT01678664|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111318820|NCT01678664|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111318821|NCT01678664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111318822|NCT01678664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111318823|NCT01678664|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111318824|NCT01678664|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111318825|NCT01678664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111318826|NCT01678664|Immunologic Factors|immunologic factors|mesh-ancestor
111318827|NCT01678664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111318828|NCT00597493|Temozolomide|temozolomide|mesh-list
111318829|NCT00597493|Sorafenib|sorafenib|mesh-list
111318830|NCT00597493|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111318831|NCT00597493|Alkylating Agents|alkylating agents|mesh-ancestor
111318832|NCT00597493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111043253|NCT02206165|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111318833|NCT00597493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111318834|NCT00597493|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111318835|NCT00597493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111318836|NCT03086954|Immunomodulating Agents|immunomodulating agents|mesh-list
111318837|NCT03086954|Immunologic Factors|immunologic factors|mesh-ancestor
111318838|NCT03086954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111318839|NCT03086720|Sodium Hypochlorite|sodium hypochlorite|mesh-list
111318840|NCT03086720|Eusol|eusol|mesh-list
111318841|NCT03086720|Disinfectants|disinfectants|mesh-ancestor
111318842|NCT03086720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111318843|NCT04402112|Pitavastatin|pitavastatin|mesh-list
111318844|NCT04402112|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111318845|NCT04402112|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111318846|NCT04402112|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111318847|NCT04402112|Antimetabolites|antimetabolites|mesh-ancestor
111318848|NCT04402112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111318849|NCT04402112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111318850|NCT04402112|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111318851|NCT00597727|Glycerol|glycerol|mesh-list
111318852|NCT00597727|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
111318853|NCT00597727|Protective Agents|protective agents|mesh-ancestor
111318854|NCT00597727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111318855|NCT03474770|Huperzine A|huperzine a|mesh-list
111318856|NCT03474770|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111318857|NCT03474770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111318858|NCT03474770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111318859|NCT03474770|Cholinergic Agents|cholinergic agents|mesh-ancestor
111318860|NCT03474770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111318861|NCT03474770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111318862|NCT03474770|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111318863|NCT03474770|Protective Agents|protective agents|mesh-ancestor
111318864|NCT02998645|Cyclosporine|cyclosporine|mesh-list
111318865|NCT02998645|Cyclosporins|cyclosporins|mesh-list
111318866|NCT02998645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111318867|NCT02998645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111318868|NCT02998645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111318869|NCT02998645|Immunologic Factors|immunologic factors|mesh-ancestor
111318870|NCT02998645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111318871|NCT02998645|Antifungal Agents|antifungal agents|mesh-ancestor
111318872|NCT02998645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111318873|NCT02998645|Dermatologic Agents|dermatologic agents|mesh-ancestor
111318874|NCT02998645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111318875|NCT02998645|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111318876|NCT00707863|Escitalopram|escitalopram|mesh-list
111318877|NCT00707863|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111318878|NCT00707863|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111318879|NCT00707863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111318880|NCT00707863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111318881|NCT00707863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111318882|NCT00707863|Serotonin Agents|serotonin agents|mesh-ancestor
111318883|NCT00707863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111318884|NCT00565643|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
111318885|NCT00565643|Hyaluronic Acid|hyaluronic acid|mesh-list
111318886|NCT00565643|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111318887|NCT00565643|Immunologic Factors|immunologic factors|mesh-ancestor
111318888|NCT00565643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111318889|NCT00565643|Viscosupplements|viscosupplements|mesh-ancestor
111318890|NCT00565643|Protective Agents|protective agents|mesh-ancestor
111318891|NCT00565643|Laxatives|laxatives|mesh-ancestor
111318892|NCT00565643|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111318893|NCT01798277|Amiodarone|amiodarone|mesh-list
111318894|NCT01798277|Sotalol|sotalol|mesh-list
111318895|NCT01798277|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111318896|NCT01798277|Vasodilator Agents|vasodilator agents|mesh-ancestor
111318897|NCT01798277|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
111318898|NCT01798277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111318899|NCT01798277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111318900|NCT01798277|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111318901|NCT01798277|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111318902|NCT01798277|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111318903|NCT01798277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111318904|NCT01798277|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111318905|NCT01798277|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111318906|NCT01798277|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111318907|NCT01798277|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111318908|NCT01798277|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111318909|NCT01798277|Adrenergic Agents|adrenergic agents|mesh-ancestor
111318910|NCT01798277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111318911|NCT01798277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111318912|NCT01798277|Sympatholytics|sympatholytics|mesh-ancestor
111318913|NCT01798277|Autonomic Agents|autonomic agents|mesh-ancestor
111318914|NCT01798277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111318915|NCT00598507|Sagopilone|sagopilone|mesh-list
111318916|NCT00598507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111318917|NCT00566813|Exenatide|exenatide|mesh-list
111318918|NCT00566813|Etanercept|etanercept|mesh-list
111318919|NCT00566813|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111318920|NCT00566813|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111318921|NCT00566813|Analgesics|analgesics|mesh-ancestor
111318922|NCT00566813|Sensory System Agents|sensory system agents|mesh-ancestor
111318923|NCT00566813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111318924|NCT00566813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111318925|NCT00566813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111318926|NCT00566813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111318927|NCT00566813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111318928|NCT00566813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111318929|NCT00566813|Immunologic Factors|immunologic factors|mesh-ancestor
111318930|NCT00566813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111318931|NCT00566813|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111318932|NCT00566813|Incretins|incretins|mesh-ancestor
111318933|NCT00566813|Hormones|hormones|mesh-ancestor
111318934|NCT00566813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111318935|NCT00088166|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
111318936|NCT00088166|Hormones|hormones|mesh-ancestor
111318937|NCT00088166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111318938|NCT00088166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111318939|NCT00566969|Carvedilol|carvedilol|mesh-list
111318940|NCT00566969|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111318941|NCT00566969|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111318942|NCT00566969|Adrenergic Agents|adrenergic agents|mesh-ancestor
111318943|NCT00566969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111318944|NCT00566969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111318945|NCT00566969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111318946|NCT00566969|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111318947|NCT00566969|Antioxidants|antioxidants|mesh-ancestor
111318948|NCT00566969|Protective Agents|protective agents|mesh-ancestor
111318949|NCT00566969|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111318950|NCT00566969|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111318951|NCT00566969|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111318952|NCT00566969|Vasodilator Agents|vasodilator agents|mesh-ancestor
111318953|NCT00566969|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111318954|NCT00566969|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111318955|NCT03086564|Chlorotrianisene|chlorotrianisene|mesh-list
111318956|NCT03086564|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
111318957|NCT03086564|Estrogens|estrogens|mesh-ancestor
111318958|NCT03086564|Hormones|hormones|mesh-ancestor
111318959|NCT03086564|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111318960|NCT03086564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111318961|NCT03086564|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111318962|NCT03086564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111318963|NCT00598663|Insulin|insulin|mesh-list
111318964|NCT00598663|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111318965|NCT00598663|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111318966|NCT00598663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111318967|NCT00704353|Ferric gluconate|ferric gluconate|mesh-list
111318968|NCT00704353|Iron-Dextran Complex|iron-dextran complex|mesh-list
111318969|NCT00704353|Hematinics|hematinics|mesh-ancestor
111318970|NCT00087698|Pemetrexed|pemetrexed|mesh-list
111318971|NCT00087698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111318972|NCT00087698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111318973|NCT00087698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111318974|NCT00087698|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111318975|NCT00087698|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111318976|NCT03755739|Pembrolizumab|pembrolizumab|mesh-list
111318977|NCT03755739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111318978|NCT03755739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111318979|NCT03755739|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111318980|NCT03755739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111318981|NCT05245721|Nalbuphine|nalbuphine|mesh-list
111318982|NCT05245721|Bupivacaine|bupivacaine|mesh-list
111318983|NCT05245721|Anesthetics, Local|anesthetics, local|mesh-ancestor
111318984|NCT05245721|Anesthetics|anesthetics|mesh-ancestor
111318985|NCT05245721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111318986|NCT05245721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111318987|NCT05245721|Sensory System Agents|sensory system agents|mesh-ancestor
111318988|NCT05245721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111318989|NCT05245721|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111318990|NCT05245721|Narcotics|narcotics|mesh-ancestor
111318991|NCT05245721|Analgesics|analgesics|mesh-ancestor
111318992|NCT04402892|Lithium Carbonate|lithium carbonate|mesh-list
111318993|NCT04402892|Antidepressive Agents|antidepressive agents|mesh-ancestor
111318994|NCT04402892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111318995|NCT04402892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111318996|NCT04402892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111318997|NCT04402892|Antimanic Agents|antimanic agents|mesh-ancestor
111318998|NCT04402892|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111318999|NCT04402892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111319000|NCT04402892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111319002|NCT03472586|Ipilimumab|ipilimumab|mesh-list
111319003|NCT03472586|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111319004|NCT03472586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111319005|NCT03472586|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111319006|NCT03472586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111319007|NCT02987985|Acetaminophen|acetaminophen|mesh-list
111319008|NCT02987985|Dexamethasone|dexamethasone|mesh-list
111319009|NCT02987985|Lidocaine|lidocaine|mesh-list
111319010|NCT02987985|Fentanyl|fentanyl|mesh-list
111319011|NCT02987985|Dexmedetomidine|dexmedetomidine|mesh-list
111319012|NCT02987985|Ketamine|ketamine|mesh-list
111319013|NCT02987985|Gabapentin|gabapentin|mesh-list
111319014|NCT02987985|Analgesics, Opioid|analgesics, opioid|mesh-list
111319015|NCT02987985|Ondansetron|ondansetron|mesh-list
111319016|NCT02987985|Sevoflurane|sevoflurane|mesh-list
111319017|NCT02987985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111319018|NCT02987985|Antiemetics|antiemetics|mesh-ancestor
111319019|NCT02987985|Autonomic Agents|autonomic agents|mesh-ancestor
111319020|NCT02987985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111319021|NCT02987985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111319022|NCT02987985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111319023|NCT02987985|Glucocorticoids|glucocorticoids|mesh-ancestor
111319024|NCT02987985|Hormones|hormones|mesh-ancestor
111319025|NCT02987985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111319026|NCT02987985|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111319027|NCT02987985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111319028|NCT02987985|Anesthetics, Local|anesthetics, local|mesh-ancestor
111319029|NCT02987985|Anesthetics|anesthetics|mesh-ancestor
111319030|NCT02987985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111319031|NCT02987985|Sensory System Agents|sensory system agents|mesh-ancestor
111319032|NCT02987985|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111319033|NCT02987985|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111319034|NCT02987985|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111319035|NCT02987985|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111319036|NCT02987985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111319037|NCT02987985|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111319038|NCT02987985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111319039|NCT02987985|Analgesics|analgesics|mesh-ancestor
111319040|NCT02987985|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111319041|NCT02987985|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111319042|NCT02987985|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111319043|NCT02987985|Adrenergic Agents|adrenergic agents|mesh-ancestor
111319044|NCT02987985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111319045|NCT02987985|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111319046|NCT02987985|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111319047|NCT02987985|Anesthetics, General|anesthetics, general|mesh-ancestor
111319048|NCT02987985|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111319049|NCT02987985|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111319050|NCT02987985|Narcotics|narcotics|mesh-ancestor
111319051|NCT02987985|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111319052|NCT02987985|Antipyretics|antipyretics|mesh-ancestor
111319053|NCT02987985|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111319054|NCT02987985|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111043483|NCT02221765|Hormones|hormones|mesh-ancestor
111319055|NCT02987985|Anticonvulsants|anticonvulsants|mesh-ancestor
111319056|NCT02987985|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111319057|NCT02987985|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111319059|NCT02987985|Antimanic Agents|antimanic agents|mesh-ancestor
111319060|NCT02987985|Antipruritics|antipruritics|mesh-ancestor
111319061|NCT02987985|Dermatologic Agents|dermatologic agents|mesh-ancestor
111319062|NCT02987985|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111319063|NCT02987985|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111319064|NCT02987985|Serotonin Agents|serotonin agents|mesh-ancestor
111319065|NCT00708721|Clofarabine|clofarabine|mesh-list
111319066|NCT00708721|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111319067|NCT00708721|Antimetabolites|antimetabolites|mesh-ancestor
111319068|NCT00708721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111319069|NCT00708721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111319070|NCT00087152|Capecitabine|capecitabine|mesh-list
111319071|NCT00087152|Imatinib Mesylate|imatinib mesylate|mesh-list
111319072|NCT00087152|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111319073|NCT00087152|Antimetabolites|antimetabolites|mesh-ancestor
111319074|NCT00087152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111319075|NCT00087152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111319076|NCT00087152|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111319077|NCT00087152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111319078|NCT05362799|Metformin|metformin|mesh-list
111319079|NCT05362799|Letrozole|letrozole|mesh-list
111319080|NCT05362799|Lactitol|lactitol|mesh-list
111319081|NCT05362799|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111319082|NCT05362799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111319083|NCT05362799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111319084|NCT05362799|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111319085|NCT05362799|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111319086|NCT05362799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111319087|NCT05362799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111319088|NCT05362799|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111319089|NCT05362799|Hormone Antagonists|hormone antagonists|mesh-ancestor
111319090|NCT05362799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111319091|NCT05362799|Cathartics|cathartics|mesh-ancestor
111319092|NCT05362799|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111319093|NCT01940523|Tranexamic Acid|tranexamic acid|mesh-list
111319094|NCT01940523|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111319095|NCT01940523|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111319096|NCT01940523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111319097|NCT01940523|Hemostatics|hemostatics|mesh-ancestor
111319098|NCT01940523|Coagulants|coagulants|mesh-ancestor
111319099|NCT04403282|Eflornithine|eflornithine|mesh-list
111319100|NCT04403282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111319101|NCT04403282|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
111319102|NCT04403282|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111319103|NCT04403282|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111319104|NCT04403282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111319105|NCT04403282|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
111319106|NCT04403282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111319107|NCT04403282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111319108|NCT02994433|Nitrous Oxide|nitrous oxide|mesh-list
111319109|NCT02994433|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111319110|NCT02994433|Anesthetics, General|anesthetics, general|mesh-ancestor
111319111|NCT02994433|Anesthetics|anesthetics|mesh-ancestor
111319112|NCT02994433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111319113|NCT02994433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111319114|NCT02994433|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111319115|NCT02994433|Analgesics|analgesics|mesh-ancestor
111319116|NCT02994433|Sensory System Agents|sensory system agents|mesh-ancestor
111319117|NCT02994433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111319118|NCT04388189|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
111319119|NCT04388189|Bupropion|bupropion|mesh-list
111319120|NCT04388189|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111319121|NCT04388189|Antidepressive Agents|antidepressive agents|mesh-ancestor
111319122|NCT04388189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111319123|NCT04388189|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111319124|NCT04388189|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111319125|NCT04388189|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111319126|NCT04388189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111319127|NCT04388189|Dopamine Agents|dopamine agents|mesh-ancestor
111319128|NCT04388189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111319129|NCT04388189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111319130|NCT04388189|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111043548|NCT02231905|Dopamine Agonists|dopamine agonists|mesh-ancestor
111319131|NCT04388189|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111319132|NCT04388189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111319133|NCT04388189|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111319134|NCT04388189|Analgesics|analgesics|mesh-ancestor
111319135|NCT04388189|Sensory System Agents|sensory system agents|mesh-ancestor
111319136|NCT04388189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111319137|NCT00599053|Azithromycin|azithromycin|mesh-list
111319138|NCT00599053|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111319139|NCT00599053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111319140|NCT01941927|Trametinib|trametinib|mesh-list
111319141|NCT01941927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111319142|NCT01941927|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111319143|NCT01941927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111319144|NCT01941927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111319145|NCT05220917|Insulin|insulin|mesh-list
111319146|NCT05220917|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111319147|NCT05220917|Metformin|metformin|mesh-list
111319148|NCT05220917|Insulin Glargine|insulin glargine|mesh-list
111319149|NCT05220917|Pioglitazone|pioglitazone|mesh-list
111319150|NCT05220917|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111319151|NCT05220917|Dapagliflozin|dapagliflozin|mesh-list
111319152|NCT05220917|Liraglutide|liraglutide|mesh-list
111319153|NCT05220917|Empagliflozin|empagliflozin|mesh-list
111319154|NCT05220917|Exenatide|exenatide|mesh-list
111319155|NCT05220917|Glimepiride|glimepiride|mesh-list
111319156|NCT05220917|Linagliptin|linagliptin|mesh-list
111319157|NCT05220917|Rosiglitazone|rosiglitazone|mesh-list
111319158|NCT05220917|Canagliflozin|canagliflozin|mesh-list
111319159|NCT05220917|Saxagliptin|saxagliptin|mesh-list
111319160|NCT05220917|Alogliptin|alogliptin|mesh-list
111319161|NCT05220917|Dulaglutide|dulaglutide|mesh-list
111319162|NCT05220917|Glyburide|glyburide|mesh-list
111319163|NCT05220917|Ertugliflozin|ertugliflozin|mesh-list
111319164|NCT05220917|Lixisenatide|lixisenatide|mesh-list
111319165|NCT05220917|Glipizide|glipizide|mesh-list
111319166|NCT05220917|Xultophy|xultophy|mesh-list
111319167|NCT05220917|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
111319168|NCT05220917|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
111319169|NCT05220917|Simvastatin|simvastatin|mesh-list
111319170|NCT05220917|rGLP-1 protein|rglp-1 protein|mesh-list
111319171|NCT05220917|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111319172|NCT05220917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111319173|NCT05220917|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111319174|NCT05220917|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111319175|NCT05220917|Antimetabolites|antimetabolites|mesh-ancestor
111319176|NCT05220917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111319177|NCT05220917|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111319178|NCT05220917|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111319179|NCT05220917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111319180|NCT05220917|Incretins|incretins|mesh-ancestor
111319181|NCT05220917|Hormones|hormones|mesh-ancestor
111319182|NCT05220917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111319183|NCT05220917|Protease Inhibitors|protease inhibitors|mesh-ancestor
111319184|NCT05220917|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111319185|NCT05220917|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111319186|NCT05220917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111319187|NCT05220917|Immunologic Factors|immunologic factors|mesh-ancestor
111319188|NCT00086996|Fluorouracil|fluorouracil|mesh-list
111319189|NCT00086996|Oxaliplatin|oxaliplatin|mesh-list
111319190|NCT00086996|Antimetabolites|antimetabolites|mesh-ancestor
111319191|NCT00086996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111319192|NCT00086996|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111319193|NCT00086996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111319194|NCT00086996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111319195|NCT00086996|Immunologic Factors|immunologic factors|mesh-ancestor
111319196|NCT00086996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111319197|NCT01943565|Hydromorphone|hydromorphone|mesh-list
111319198|NCT01943565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111319199|NCT01943565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111319200|NCT01943565|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111319201|NCT01943565|Narcotics|narcotics|mesh-ancestor
111319202|NCT01943565|Analgesics|analgesics|mesh-ancestor
111319203|NCT01943565|Sensory System Agents|sensory system agents|mesh-ancestor
111319204|NCT01943565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111319205|NCT03316859|Naloxegol|naloxegol|mesh-list
111319206|NCT03316859|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111319207|NCT03316859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111319208|NCT03316859|Sensory System Agents|sensory system agents|mesh-ancestor
111319209|NCT03316859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111319210|NCT04401878|Lidocaine|lidocaine|mesh-list
111319211|NCT04401878|Anesthetics, Local|anesthetics, local|mesh-ancestor
111319212|NCT04401878|Anesthetics|anesthetics|mesh-ancestor
111319213|NCT04401878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111319214|NCT04401878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111319215|NCT04401878|Sensory System Agents|sensory system agents|mesh-ancestor
111319216|NCT04401878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111319217|NCT04401878|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111319218|NCT04401878|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111319219|NCT04401878|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111319220|NCT04401878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111319221|NCT04401878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111319222|NCT05362019|Norethindrone|norethindrone|mesh-list
111319223|NCT05362019|Norethindrone enanthate|norethindrone enanthate|mesh-list
111319224|NCT05362019|Norethindrone Acetate|norethindrone acetate|mesh-list
111319225|NCT05362019|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111319226|NCT05362019|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111319227|NCT05362019|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111319228|NCT05362019|Contraceptive Agents|contraceptive agents|mesh-ancestor
111319229|NCT05362019|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111319230|NCT05362019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111319231|NCT05362019|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111319232|NCT05362019|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111319233|NCT03654105|Aspirin|aspirin|mesh-list
111319234|NCT03654105|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111319235|NCT03654105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111319236|NCT03654105|Analgesics|analgesics|mesh-ancestor
111319237|NCT03654105|Sensory System Agents|sensory system agents|mesh-ancestor
111319238|NCT03654105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111319239|NCT03654105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111319240|NCT03654105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111319241|NCT03654105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111319242|NCT03654105|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111319243|NCT03654105|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111319244|NCT03654105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111319245|NCT03654105|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111319246|NCT03654105|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111319247|NCT03654105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111319248|NCT03654105|Antipyretics|antipyretics|mesh-ancestor
111319249|NCT04388111|Morphine|morphine|mesh-list
111319250|NCT04388111|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111319251|NCT04388111|Narcotics|narcotics|mesh-ancestor
111319252|NCT04388111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111319253|NCT04388111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111319254|NCT04388111|Analgesics|analgesics|mesh-ancestor
111319255|NCT04388111|Sensory System Agents|sensory system agents|mesh-ancestor
111319256|NCT04388111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111319257|NCT03309137|Chlorhexidine|chlorhexidine|mesh-list
111319258|NCT03309137|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111319259|NCT03309137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111319260|NCT03309137|Disinfectants|disinfectants|mesh-ancestor
111319261|NCT01881087|Levobupivacaine|levobupivacaine|mesh-list
111319262|NCT01881087|Anesthetics, Local|anesthetics, local|mesh-ancestor
111319263|NCT01881087|Anesthetics|anesthetics|mesh-ancestor
111319264|NCT01881087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111319265|NCT01881087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111319266|NCT01881087|Sensory System Agents|sensory system agents|mesh-ancestor
111319267|NCT01881087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111319268|NCT01944423|Cycloserine|cycloserine|mesh-list
111319269|NCT01944423|Nicotine|nicotine|mesh-list
111319270|NCT01944423|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111319271|NCT01944423|Autonomic Agents|autonomic agents|mesh-ancestor
111319272|NCT01944423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111319273|NCT01944423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111319274|NCT01944423|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111319275|NCT01944423|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111319276|NCT01944423|Cholinergic Agents|cholinergic agents|mesh-ancestor
111319277|NCT01944423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111319278|NCT01944423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111319279|NCT01944423|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111319280|NCT01944423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111319281|NCT01944423|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111319282|NCT01944423|Antitubercular Agents|antitubercular agents|mesh-ancestor
111319283|NCT01944423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111319284|NCT01944423|Antimetabolites|antimetabolites|mesh-ancestor
111319285|NCT05305313|Propofol|propofol|mesh-list
111319286|NCT05305313|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111319287|NCT05305313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111319288|NCT05305313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111319289|NCT05305313|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111319290|NCT05305313|Anesthetics, General|anesthetics, general|mesh-ancestor
111319291|NCT05305313|Anesthetics|anesthetics|mesh-ancestor
111319292|NCT00600925|Gentamicins|gentamicins|mesh-list
111319293|NCT00600925|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111319294|NCT00600925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111319295|NCT00600925|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111319296|NCT00600925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111319297|NCT00600925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111319298|NCT02338973|Interferons|interferons|mesh-list
111319299|NCT02338973|Interferon-gamma|interferon-gamma|mesh-list
111319300|NCT02338973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111319301|NCT02338973|Antiviral Agents|antiviral agents|mesh-ancestor
111319302|NCT02338973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111319303|NCT00601627|Gemcitabine|gemcitabine|mesh-list
111319304|NCT00601627|Fluorouracil|fluorouracil|mesh-list
111319305|NCT00601627|Capecitabine|capecitabine|mesh-list
111319306|NCT00601627|Panitumumab|panitumumab|mesh-list
111319307|NCT00601627|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111319308|NCT00601627|Antimetabolites|antimetabolites|mesh-ancestor
111319309|NCT00601627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111319310|NCT00601627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111319311|NCT00601627|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111319312|NCT00601627|Immunologic Factors|immunologic factors|mesh-ancestor
111319313|NCT00601627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111319314|NCT00601627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111319315|NCT01947153|Metformin|metformin|mesh-list
111319316|NCT01947153|Linagliptin|linagliptin|mesh-list
111319317|NCT01947153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111319318|NCT01947153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111319319|NCT01947153|Incretins|incretins|mesh-ancestor
111319320|NCT01947153|Hormones|hormones|mesh-ancestor
111319321|NCT01947153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111319322|NCT01947153|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111319323|NCT01947153|Protease Inhibitors|protease inhibitors|mesh-ancestor
111319324|NCT01947153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111319325|NCT01947153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111319326|NCT02476409|Tolvaptan|tolvaptan|mesh-list
111319327|NCT02476409|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
111319328|NCT02476409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111319329|NCT02476409|Natriuretic Agents|natriuretic agents|mesh-ancestor
111319330|NCT02476409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111319331|NCT01269853|Bevacizumab|bevacizumab|mesh-list
111319332|NCT01269853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111319333|NCT01269853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111319334|NCT01269853|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111319335|NCT01269853|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111319336|NCT01269853|Growth Substances|growth substances|mesh-ancestor
111319337|NCT01269853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111319338|NCT01269853|Growth Inhibitors|growth inhibitors|mesh-ancestor
111319339|NCT02993575|Floxacillin|floxacillin|mesh-list
111319340|NCT02993575|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111319341|NCT02993575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111319342|NCT00603187|Acyline|acyline|mesh-list
111319343|NCT00603187|Hormone Antagonists|hormone antagonists|mesh-ancestor
111319344|NCT00603187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111319345|NCT00603187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111319346|NCT01886937|Phentermine|phentermine|mesh-list
111319347|NCT01886937|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111319348|NCT01886937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111319349|NCT01886937|Appetite Depressants|appetite depressants|mesh-ancestor
111319350|NCT01886937|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111319351|NCT01886937|Sympathomimetics|sympathomimetics|mesh-ancestor
111319352|NCT01886937|Autonomic Agents|autonomic agents|mesh-ancestor
111319353|NCT01886937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111319354|NCT01886937|Adrenergic Agents|adrenergic agents|mesh-ancestor
111319355|NCT01886937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111319356|NCT01886937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111319357|NCT02993341|Tranexamic Acid|tranexamic acid|mesh-list
111043771|NCT03543683|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111319358|NCT02993341|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111319359|NCT02993341|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111319360|NCT02993341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111319361|NCT02993341|Hemostatics|hemostatics|mesh-ancestor
111319362|NCT02993341|Coagulants|coagulants|mesh-ancestor
111319363|NCT01219075|Phytoestrogens|phytoestrogens|mesh-list
111319364|NCT01219075|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
111319365|NCT01219075|Estrogens|estrogens|mesh-ancestor
111319366|NCT01219075|Hormones|hormones|mesh-ancestor
111319367|NCT01219075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111319368|NCT01219075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111319369|NCT00086684|Pentosan Sulfuric Polyester|pentosan sulfuric polyester|mesh-list
111319370|NCT00086684|Anticoagulants|anticoagulants|mesh-ancestor
111319371|NCT02987907|Dexamethasone|dexamethasone|mesh-list
111319372|NCT02987907|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111319373|NCT02987907|Antiemetics|antiemetics|mesh-ancestor
111319374|NCT02987907|Autonomic Agents|autonomic agents|mesh-ancestor
111319375|NCT02987907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111319376|NCT02987907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111319377|NCT02987907|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111319378|NCT02987907|Glucocorticoids|glucocorticoids|mesh-ancestor
111319379|NCT02987907|Hormones|hormones|mesh-ancestor
111319380|NCT02987907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111319381|NCT02987907|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111319382|NCT02987907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111319383|NCT01887171|Tacrolimus|tacrolimus|mesh-list
111319384|NCT01887171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111319385|NCT01887171|Immunologic Factors|immunologic factors|mesh-ancestor
111319386|NCT01887171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111319387|NCT01887171|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111319388|NCT01887171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111319389|NCT01887171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111319390|NCT00713479|Varenicline|varenicline|mesh-list
111319391|NCT00713479|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111319392|NCT00713479|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111319393|NCT00713479|Cholinergic Agents|cholinergic agents|mesh-ancestor
111319394|NCT00713479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111319395|NCT00713479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111319396|NCT00713479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111319397|NCT04402580|Mycophenolic Acid|mycophenolic acid|mesh-list
111319398|NCT04402580|Rituximab|rituximab|mesh-list
111319399|NCT04402580|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111319400|NCT04402580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111319401|NCT04402580|Immunologic Factors|immunologic factors|mesh-ancestor
111319402|NCT04402580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111319403|NCT04402580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111319404|NCT04402580|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111319405|NCT04402580|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111319406|NCT04402580|Antitubercular Agents|antitubercular agents|mesh-ancestor
111319407|NCT04402580|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111319408|NCT04402580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111319409|NCT04402580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111319410|NCT04402580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111319411|NCT01887327|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
111319412|NCT01887327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111319413|NCT01887327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111319414|NCT02987751|Insulin|insulin|mesh-list
111319415|NCT02987751|Insulin Glargine|insulin glargine|mesh-list
111319416|NCT02987751|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111319417|NCT02987751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111319418|NCT04385719|Remdesivir|remdesivir|mesh-list
111319419|NCT04385719|Antimetabolites|antimetabolites|mesh-ancestor
111319420|NCT04385719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111319421|NCT04385719|Antiviral Agents|antiviral agents|mesh-ancestor
111319422|NCT04385719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111319423|NCT00082628|Hormones|hormones|mesh-list
111319424|NCT00082628|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111319425|NCT00082628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111319426|NCT01275859|Letrozole|letrozole|mesh-list
111319427|NCT01275859|Lapatinib|lapatinib|mesh-list
111319428|NCT01275859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111319429|NCT01275859|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111319430|NCT01275859|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111319431|NCT01275859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111319432|NCT01275859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111319433|NCT01275859|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111319435|NCT01275859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111319436|NCT01275859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111319437|NCT01275859|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111319438|NCT01950039|Betaine|betaine|mesh-list
111319439|NCT01950039|Glycine|glycine|mesh-list
111319440|NCT01950039|Glycine Agents|glycine agents|mesh-ancestor
111319441|NCT01950039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111319442|NCT01950039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111319443|NCT01950039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111319444|NCT01950039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111319445|NCT01950039|Lipotropic Agents|lipotropic agents|mesh-ancestor
111319446|NCT01950039|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111319447|NCT01950039|Antimetabolites|antimetabolites|mesh-ancestor
111319448|NCT01950039|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111319449|NCT01275937|Esomeprazole|esomeprazole|mesh-list
111319450|NCT01275937|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111319451|NCT01275937|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111319452|NCT01275937|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111319453|NCT01275937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111319454|NCT01275937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111319455|NCT02990455|Nicotine|nicotine|mesh-list
111319456|NCT02990455|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111319457|NCT02990455|Autonomic Agents|autonomic agents|mesh-ancestor
111319458|NCT02990455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111319459|NCT02990455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111319460|NCT02990455|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111319461|NCT02990455|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111319462|NCT02990455|Cholinergic Agents|cholinergic agents|mesh-ancestor
111319463|NCT02990455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111319464|NCT02990455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111319465|NCT01889667|Insulin|insulin|mesh-list
111319466|NCT01889667|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111319467|NCT01889667|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111319468|NCT01889667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111319469|NCT01276015|Botulinum Toxins|botulinum toxins|mesh-list
111319470|NCT01276015|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111319471|NCT01276015|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111319472|NCT01276015|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111319473|NCT01276015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111319474|NCT01276015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111319475|NCT01276015|Cholinergic Agents|cholinergic agents|mesh-ancestor
111319476|NCT01276015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111319477|NCT01276015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111319478|NCT01276015|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111319479|NCT01276015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111319480|NCT02130635|Nemiralisib|nemiralisib|mesh-list
111319481|NCT02130635|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111319482|NCT02130635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111319483|NCT02130635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111319484|NCT01276093|Amiodarone|amiodarone|mesh-list
111319485|NCT01276093|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111319486|NCT01276093|Vasodilator Agents|vasodilator agents|mesh-ancestor
111319487|NCT01276093|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
111319488|NCT01276093|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111319489|NCT01276093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111319490|NCT01276093|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111319491|NCT01276093|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111319492|NCT01276093|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111319493|NCT01276093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111319494|NCT01276093|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111319495|NCT01276093|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111319496|NCT01276093|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111319497|NCT00557973|Arbaclofen placarbil|arbaclofen placarbil|mesh-list
111319498|NCT00557973|Baclofen|baclofen|mesh-list
111319499|NCT00557973|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
111319500|NCT00557973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111319501|NCT00557973|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111319502|NCT00557973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111319503|NCT00557973|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
111319504|NCT00557973|GABA Agonists|gaba agonists|mesh-ancestor
111319505|NCT00557973|GABA Agents|gaba agents|mesh-ancestor
111043919|NCT02142569|Tocotrienols|tocotrienols|mesh-list
111319506|NCT00557973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111319507|NCT00557973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111319508|NCT00726739|Aldesleukin|aldesleukin|mesh-list
111319509|NCT00726739|Interleukin-2|interleukin-2|mesh-list
111319510|NCT00726739|Vaccines|vaccines|mesh-list
111319511|NCT00726739|Immunologic Factors|immunologic factors|mesh-ancestor
111319512|NCT00726739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111319513|NCT00726739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111319514|NCT00726739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111319515|NCT00726739|Analgesics|analgesics|mesh-ancestor
111319516|NCT00726739|Sensory System Agents|sensory system agents|mesh-ancestor
111319517|NCT00726739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111319518|NCT00726739|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111319519|NCT00726739|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111319520|NCT00726739|Antiviral Agents|antiviral agents|mesh-ancestor
111319521|NCT00726739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111319522|NCT00569309|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
111319523|NCT00569309|Immunologic Factors|immunologic factors|mesh-ancestor
111319524|NCT00569309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111319525|NCT00569855|Phenoxybenzamine|phenoxybenzamine|mesh-list
111319526|NCT00569855|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111319527|NCT00569855|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111319528|NCT00569855|Adrenergic Agents|adrenergic agents|mesh-ancestor
111319529|NCT00569855|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111319530|NCT00569855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111319531|NCT00569855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111319532|NCT00569855|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111319533|NCT00569855|Vasodilator Agents|vasodilator agents|mesh-ancestor
111319534|NCT02991781|Varenicline|varenicline|mesh-list
111319535|NCT02991781|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111319536|NCT02991781|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111319537|NCT02991781|Cholinergic Agents|cholinergic agents|mesh-ancestor
111319538|NCT02991781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111319539|NCT02991781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111319540|NCT02991781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111319541|NCT01893801|Paclitaxel|paclitaxel|mesh-list
111319542|NCT01893801|Cisplatin|cisplatin|mesh-list
111319543|NCT01893801|Gemcitabine|gemcitabine|mesh-list
111319544|NCT01893801|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111319545|NCT01893801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111319546|NCT01893801|Tubulin Modulators|tubulin modulators|mesh-ancestor
111319547|NCT01893801|Antimitotic Agents|antimitotic agents|mesh-ancestor
111319548|NCT01893801|Mitosis Modulators|mitosis modulators|mesh-ancestor
111319549|NCT01893801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111319550|NCT01893801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111319551|NCT01893801|Antimetabolites|antimetabolites|mesh-ancestor
111319552|NCT00570089|Ranolazine|ranolazine|mesh-list
111319553|NCT00570089|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111319554|NCT00570089|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111319555|NCT00570089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111319556|NCT00727597|Efavirenz|efavirenz|mesh-list
111319557|NCT00727597|Fosamprenavir|fosamprenavir|mesh-list
111319558|NCT00727597|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111319559|NCT00727597|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111319560|NCT00727597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111319561|NCT00727597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111319562|NCT00727597|Antiviral Agents|antiviral agents|mesh-ancestor
111319563|NCT00727597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111319564|NCT00727597|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111319565|NCT00727597|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111319566|NCT00727597|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111319567|NCT00727597|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111319568|NCT00727597|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111319569|NCT00727597|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111319570|NCT00727597|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111319571|NCT00727597|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111319572|NCT00727597|Protease Inhibitors|protease inhibitors|mesh-ancestor
111319573|NCT00727597|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111319574|NCT00727597|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111319575|NCT00571259|Gentamicins|gentamicins|mesh-list
111319576|NCT00571259|Heparin|heparin|mesh-list
111319577|NCT00571259|Citric Acid|citric acid|mesh-list
111043999|NCT02146547|Dopamine Agents|dopamine agents|mesh-ancestor
111319578|NCT00571259|Sodium Citrate|sodium citrate|mesh-list
111319579|NCT00571259|Anticoagulants|anticoagulants|mesh-ancestor
111319580|NCT00571259|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
111319581|NCT00571259|Chelating Agents|chelating agents|mesh-ancestor
111319582|NCT00571259|Sequestering Agents|sequestering agents|mesh-ancestor
111319583|NCT00571259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111319584|NCT00571259|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111319585|NCT00571259|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111319586|NCT00571259|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111319587|NCT00571259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111319588|NCT00571259|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111319589|NCT00571259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111319590|NCT01893879|Ketoprofen|ketoprofen|mesh-list
111319591|NCT01893879|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111319592|NCT01893879|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111319593|NCT01893879|Analgesics|analgesics|mesh-ancestor
111319594|NCT01893879|Sensory System Agents|sensory system agents|mesh-ancestor
111319595|NCT01893879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111319596|NCT01893879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111319597|NCT01893879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111319598|NCT01893879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111319599|NCT01893879|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111319600|NCT01893879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111319601|NCT01893879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111319602|NCT01894503|Mometasone Furoate|mometasone furoate|mesh-list
111319603|NCT01894503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111319604|NCT01894503|Dermatologic Agents|dermatologic agents|mesh-ancestor
111319605|NCT01894503|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111319606|NCT00571961|Ritonavir|ritonavir|mesh-list
111319607|NCT00571961|Lopinavir|lopinavir|mesh-list
111319608|NCT00571961|Buprenorphine|buprenorphine|mesh-list
111319609|NCT00571961|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111319610|NCT00571961|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111319611|NCT00571961|Protease Inhibitors|protease inhibitors|mesh-ancestor
111319612|NCT00571961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111319613|NCT00571961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111319614|NCT00571961|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111319615|NCT00571961|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111319616|NCT00571961|Antiviral Agents|antiviral agents|mesh-ancestor
111319617|NCT00571961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111319618|NCT00571961|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111319619|NCT00571961|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111319620|NCT00571961|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111319621|NCT00571961|Narcotics|narcotics|mesh-ancestor
111319622|NCT00571961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111319623|NCT00571961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111319624|NCT00571961|Analgesics|analgesics|mesh-ancestor
111319625|NCT00571961|Sensory System Agents|sensory system agents|mesh-ancestor
111319626|NCT00571961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111319627|NCT00571961|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111319628|NCT00572117|Topiramate|topiramate|mesh-list
111319629|NCT00572117|Anticonvulsants|anticonvulsants|mesh-ancestor
111319630|NCT00572117|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111319631|NCT00572117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111319632|NCT01895127|Immunoglobulins|immunoglobulins|mesh-list
111319633|NCT01895127|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111319634|NCT01895127|Antibodies|antibodies|mesh-list
111319635|NCT01895127|Eculizumab|eculizumab|mesh-list
111319636|NCT01895127|Immunologic Factors|immunologic factors|mesh-ancestor
111319637|NCT01895127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111319638|NCT01895127|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
111319639|NCT01895127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111319640|NCT01953081|Metoclopramide|metoclopramide|mesh-list
111319641|NCT01953081|Antiemetics|antiemetics|mesh-ancestor
111319642|NCT01953081|Autonomic Agents|autonomic agents|mesh-ancestor
111319643|NCT01953081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111319644|NCT01953081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111319645|NCT01953081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111319646|NCT01953081|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111319647|NCT01953081|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111319648|NCT01953081|Dopamine Agents|dopamine agents|mesh-ancestor
111319649|NCT01953081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111319650|NCT01953081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111319651|NCT00572897|Fludarabine|fludarabine|mesh-list
111319652|NCT00572897|Melphalan|melphalan|mesh-list
111319653|NCT00572897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111319654|NCT00572897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111319655|NCT00572897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111319656|NCT00572897|Immunologic Factors|immunologic factors|mesh-ancestor
111319657|NCT00572897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111319658|NCT00572897|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111319659|NCT00572897|Alkylating Agents|alkylating agents|mesh-ancestor
111319660|NCT00572897|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111319662|NCT01276717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111319663|NCT01276717|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111319664|NCT01276717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111319665|NCT01276717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111319666|NCT02991157|Nimodipine|nimodipine|mesh-list
111319667|NCT02991157|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111319668|NCT02991157|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111319669|NCT02991157|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111319670|NCT02991157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111319671|NCT02991157|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111319672|NCT02991157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111319673|NCT02991157|Vasodilator Agents|vasodilator agents|mesh-ancestor
111319674|NCT04386499|Folic Acid|folic acid|mesh-list
111319675|NCT04386499|Resveratrol|resveratrol|mesh-list
111319676|NCT04386499|Hematinics|hematinics|mesh-ancestor
111319677|NCT04386499|Vitamin B Complex|vitamin b complex|mesh-ancestor
111319678|NCT04386499|Vitamins|vitamins|mesh-ancestor
111319679|NCT04386499|Micronutrients|micronutrients|mesh-ancestor
111319680|NCT04386499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111319681|NCT04386499|Antioxidants|antioxidants|mesh-ancestor
111319682|NCT04386499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111319683|NCT04386499|Protective Agents|protective agents|mesh-ancestor
111319684|NCT04386499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111319685|NCT04386499|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111319686|NCT00573287|Risperidone|risperidone|mesh-list
111319687|NCT00573287|Clozapine|clozapine|mesh-list
111319688|NCT00573287|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111319689|NCT00573287|Serotonin Agents|serotonin agents|mesh-ancestor
111319690|NCT00573287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111319691|NCT00573287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111319692|NCT00573287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111319693|NCT00573287|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111319694|NCT00573287|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111319695|NCT00573287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111319696|NCT00573287|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111319697|NCT00573287|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111319698|NCT00573287|Dopamine Agents|dopamine agents|mesh-ancestor
111319699|NCT00573287|GABA Antagonists|gaba antagonists|mesh-ancestor
111319700|NCT00573287|GABA Agents|gaba agents|mesh-ancestor
111319701|NCT01896921|Raltegravir Potassium|raltegravir potassium|mesh-list
111319702|NCT01896921|Dolutegravir|dolutegravir|mesh-list
111319703|NCT01896921|Maraviroc|maraviroc|mesh-list
111319704|NCT01896921|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111319705|NCT01896921|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111319706|NCT01896921|Antiviral Agents|antiviral agents|mesh-ancestor
111319707|NCT01896921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111319708|NCT01896921|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111319709|NCT01896921|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111319710|NCT01896921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111319711|NCT01896921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111319712|NCT01896921|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
111319713|NCT01896921|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
111319714|NCT01896921|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
111319715|NCT00749749|Bupivacaine|bupivacaine|mesh-list
111319716|NCT00749749|Anesthetics, Local|anesthetics, local|mesh-ancestor
111319717|NCT00749749|Anesthetics|anesthetics|mesh-ancestor
111319718|NCT00749749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111319719|NCT00749749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111319720|NCT00749749|Sensory System Agents|sensory system agents|mesh-ancestor
111319721|NCT00749749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111319722|NCT02991937|Tazobactam|tazobactam|mesh-list
111319723|NCT02991937|Piperacillin|piperacillin|mesh-list
111319724|NCT02991937|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
111319725|NCT02991937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111319726|NCT02991937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111319727|NCT02991937|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
111319728|NCT02991937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111319729|NCT02991937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111319730|NCT00420667|Enoxaparin|enoxaparin|mesh-list
111044137|NCT02146937|Bicalutamide|bicalutamide|mesh-list
111319731|NCT00420667|Anticoagulants|anticoagulants|mesh-ancestor
111319732|NCT00420667|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111319733|NCT00420667|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111319734|NCT00420667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111319736|NCT01277107|Anticonvulsants|anticonvulsants|mesh-ancestor
111319737|NCT01277107|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111319738|NCT01277107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111319739|NCT01277107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111319740|NCT01277107|GABA Modulators|gaba modulators|mesh-ancestor
111319741|NCT01277107|GABA Agents|gaba agents|mesh-ancestor
111319742|NCT01277107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111319743|NCT01277107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111319744|NCT01277185|Calcium, Dietary|calcium, dietary|mesh-list
111319745|NCT01277185|Calcium|calcium|mesh-list
111319746|NCT01277185|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111319747|NCT01277185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111319748|NCT01277185|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111319749|NCT01274533|Lenalidomide|lenalidomide|mesh-list
111319750|NCT01274533|Immunologic Factors|immunologic factors|mesh-ancestor
111319751|NCT01274533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111319752|NCT01274533|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111319753|NCT01274533|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111319754|NCT01274533|Growth Substances|growth substances|mesh-ancestor
111319755|NCT01274533|Growth Inhibitors|growth inhibitors|mesh-ancestor
111319756|NCT01274533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111319757|NCT01277497|Calcium|calcium|mesh-list
111319758|NCT01277497|Sevelamer|sevelamer|mesh-list
111319759|NCT01277497|Calcium acetate|calcium acetate|mesh-list
111319760|NCT01277497|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111319761|NCT01277497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111319762|NCT01277497|Chelating Agents|chelating agents|mesh-ancestor
111319763|NCT01277497|Sequestering Agents|sequestering agents|mesh-ancestor
111319764|NCT01277497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111319765|NCT01270087|Adalimumab|adalimumab|mesh-list
111319766|NCT01270087|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111319767|NCT01270087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111319768|NCT01270087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111319769|NCT01958073|Estradiol|estradiol|mesh-list
111319770|NCT01958073|Estrogens|estrogens|mesh-list
111319771|NCT01958073|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
111319772|NCT01958073|Hormones|hormones|mesh-ancestor
111319773|NCT01958073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111319774|NCT01958073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111319775|NCT01270165|Telbivudine|telbivudine|mesh-list
111319776|NCT01270165|Antiviral Agents|antiviral agents|mesh-ancestor
111319777|NCT01270165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111319778|NCT01270165|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111319779|NCT01270165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111319780|NCT01270165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111319781|NCT05740215|Lenvatinib|lenvatinib|mesh-list
111319782|NCT05740215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111319783|NCT05740215|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111319784|NCT05740215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111319785|NCT05740215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111319786|NCT01277731|Methylprednisolone|methylprednisolone|mesh-list
111319787|NCT01277731|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111319788|NCT01277731|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111319789|NCT01277731|Prednisolone|prednisolone|mesh-list
111319790|NCT01277731|Prednisolone acetate|prednisolone acetate|mesh-list
111319791|NCT01277731|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111319792|NCT01277731|Prednisolone phosphate|prednisolone phosphate|mesh-list
111319793|NCT01277731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111319794|NCT01277731|Antiemetics|antiemetics|mesh-ancestor
111319795|NCT01277731|Autonomic Agents|autonomic agents|mesh-ancestor
111319796|NCT01277731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111319797|NCT01277731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111319798|NCT01277731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111319799|NCT01277731|Glucocorticoids|glucocorticoids|mesh-ancestor
111319800|NCT01277731|Hormones|hormones|mesh-ancestor
111319801|NCT01277731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111319802|NCT01277731|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111319803|NCT01277731|Protective Agents|protective agents|mesh-ancestor
111319804|NCT01277731|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111044213|NCT03166605|Simethicone|simethicone|mesh-list
111319806|NCT01898403|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111319807|NCT00751777|Vaccines|vaccines|mesh-list
111319808|NCT00751777|Immunologic Factors|immunologic factors|mesh-ancestor
111319809|NCT00751777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111319810|NCT01902459|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
111319811|NCT01902459|Hemostatics|hemostatics|mesh-ancestor
111319812|NCT01902459|Coagulants|coagulants|mesh-ancestor
111319813|NCT01274611|Botulinum Toxins|botulinum toxins|mesh-list
111319814|NCT01274611|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111319815|NCT01274611|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111319816|NCT01274611|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111319817|NCT01274611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111319818|NCT01274611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111319819|NCT01274611|Cholinergic Agents|cholinergic agents|mesh-ancestor
111319820|NCT01274611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111319821|NCT01274611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111319822|NCT01274611|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111319823|NCT01274611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111319824|NCT05735145|Paclitaxel|paclitaxel|mesh-list
111319825|NCT05735145|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111319826|NCT05735145|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111319827|NCT05735145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111319828|NCT05735145|Tubulin Modulators|tubulin modulators|mesh-ancestor
111319829|NCT05735145|Antimitotic Agents|antimitotic agents|mesh-ancestor
111319830|NCT05735145|Mitosis Modulators|mitosis modulators|mesh-ancestor
111319831|NCT05735145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111319832|NCT01903005|Buprenorphine|buprenorphine|mesh-list
111319833|NCT01903005|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
111319834|NCT01903005|Naloxone|naloxone|mesh-list
111319835|NCT01903005|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111319836|NCT01903005|Narcotics|narcotics|mesh-ancestor
111319837|NCT01903005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111319838|NCT01903005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111319839|NCT01903005|Analgesics|analgesics|mesh-ancestor
111319840|NCT01903005|Sensory System Agents|sensory system agents|mesh-ancestor
111319841|NCT01903005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111319842|NCT01903005|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111319843|NCT00614029|Sumatriptan|sumatriptan|mesh-list
111319844|NCT00614029|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111319845|NCT00614029|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111319846|NCT00614029|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111319847|NCT00614029|Serotonin Agents|serotonin agents|mesh-ancestor
111319848|NCT00614029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111319849|NCT00614029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111319850|NCT00614029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111319851|NCT01905423|Albendazole|albendazole|mesh-list
111319852|NCT01905423|Diethylcarbamazine|diethylcarbamazine|mesh-list
111319853|NCT01905423|Piperazine|piperazine|mesh-list
111319854|NCT01905423|Mebendazole|mebendazole|mesh-list
111319855|NCT01905423|Piperazine citrate|piperazine citrate|mesh-list
111319856|NCT01905423|Citric Acid|citric acid|mesh-list
111319857|NCT01905423|Sodium Citrate|sodium citrate|mesh-list
111319858|NCT01905423|DMP 777|dmp 777|mesh-list
111319859|NCT01905423|Anticoagulants|anticoagulants|mesh-ancestor
111319860|NCT01905423|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
111319861|NCT01905423|Chelating Agents|chelating agents|mesh-ancestor
111319862|NCT01905423|Sequestering Agents|sequestering agents|mesh-ancestor
111319863|NCT01905423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111319864|NCT01905423|Anthelmintics|anthelmintics|mesh-ancestor
111319865|NCT01905423|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111319866|NCT01905423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111319867|NCT01905423|Anticestodal Agents|anticestodal agents|mesh-ancestor
111319868|NCT01905423|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
111319869|NCT01905423|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111319870|NCT01905423|Tubulin Modulators|tubulin modulators|mesh-ancestor
111319871|NCT01905423|Antimitotic Agents|antimitotic agents|mesh-ancestor
111319872|NCT01905423|Mitosis Modulators|mitosis modulators|mesh-ancestor
111319873|NCT01905423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111319874|NCT01905423|Filaricides|filaricides|mesh-ancestor
111319875|NCT01905423|Antinematodal Agents|antinematodal agents|mesh-ancestor
111319876|NCT01905423|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
111319877|NCT01905423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111044291|NCT02255045|Analgesics|analgesics|mesh-ancestor
111319878|NCT05734911|Niraparib|niraparib|mesh-list
111319879|NCT05734911|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111319880|NCT05734911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111319881|NCT05734911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111319882|NCT05734911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111319883|NCT01906515|Chrysarobin|chrysarobin|mesh-list
111319884|NCT01906515|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111319885|NCT01906515|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111319886|NCT01906515|Analgesics|analgesics|mesh-ancestor
111319887|NCT01906515|Sensory System Agents|sensory system agents|mesh-ancestor
111319888|NCT01906515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111319889|NCT01906515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111319890|NCT01906515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111319891|NCT01906515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111319892|NCT00730483|Doxorubicin|doxorubicin|mesh-list
111319893|NCT00730483|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111319894|NCT00730483|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111319895|NCT00730483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111319896|NCT00730483|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111319897|NCT00730483|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111319898|NCT00730483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111319899|NCT00730483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111319900|NCT01907607|Palbociclib|palbociclib|mesh-list
111319901|NCT01907607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111319902|NCT01907607|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111319903|NCT01907607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111319904|NCT01907607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111319905|NCT00753337|Cobalt|cobalt|mesh-list
111319906|NCT00753337|Trace Elements|trace elements|mesh-ancestor
111319907|NCT00753337|Micronutrients|micronutrients|mesh-ancestor
111319908|NCT00753337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111319909|NCT01911351|Nitrous Oxide|nitrous oxide|mesh-list
111319910|NCT01911351|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111319911|NCT01911351|Anesthetics, General|anesthetics, general|mesh-ancestor
111319912|NCT01911351|Anesthetics|anesthetics|mesh-ancestor
111319913|NCT01911351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111319914|NCT01911351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111319915|NCT01911351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111319916|NCT01911351|Analgesics|analgesics|mesh-ancestor
111319917|NCT01911351|Sensory System Agents|sensory system agents|mesh-ancestor
111319918|NCT01911351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111319919|NCT04385407|Ribavirin|ribavirin|mesh-list
111319920|NCT04385407|Sofosbuvir|sofosbuvir|mesh-list
111319921|NCT04385407|Simeprevir|simeprevir|mesh-list
111319922|NCT04385407|Antimetabolites|antimetabolites|mesh-ancestor
111319923|NCT04385407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111319924|NCT04385407|Antiviral Agents|antiviral agents|mesh-ancestor
111319925|NCT04385407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111319926|NCT04385407|Protease Inhibitors|protease inhibitors|mesh-ancestor
111319927|NCT04385407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111319928|NCT00573989|Pemetrexed|pemetrexed|mesh-list
111319929|NCT00573989|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111319930|NCT00573989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111319931|NCT00573989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111319932|NCT00573989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111319933|NCT00573989|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111319934|NCT00573989|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111319935|NCT00573989|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111319936|NCT02286921|Methyltestosterone|methyltestosterone|mesh-list
111319937|NCT02286921|Testosterone|testosterone|mesh-list
111319938|NCT02286921|Testosterone undecanoate|testosterone undecanoate|mesh-list
111319939|NCT02286921|Testosterone enanthate|testosterone enanthate|mesh-list
111319940|NCT02286921|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
111319941|NCT02286921|Androgens|androgens|mesh-ancestor
111319942|NCT02286921|Hormones|hormones|mesh-ancestor
111319943|NCT02286921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111319944|NCT02286921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111319945|NCT02286921|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111319946|NCT02286921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111319947|NCT02286921|Anabolic Agents|anabolic agents|mesh-ancestor
111319948|NCT00574067|Buprenorphine|buprenorphine|mesh-list
111319949|NCT00574067|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
111319950|NCT00574067|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111319951|NCT00574067|Narcotics|narcotics|mesh-ancestor
111319952|NCT00574067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111319953|NCT00574067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111319954|NCT00574067|Analgesics|analgesics|mesh-ancestor
111319955|NCT00574067|Sensory System Agents|sensory system agents|mesh-ancestor
111319956|NCT00574067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111319957|NCT00574067|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111319958|NCT01913535|Aticaprant|aticaprant|mesh-list
111319959|NCT01913535|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111319960|NCT01913535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111319961|NCT01913535|Sensory System Agents|sensory system agents|mesh-ancestor
111319962|NCT01913535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111319963|NCT01914159|Ranibizumab|ranibizumab|mesh-list
111319964|NCT01914159|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111319965|NCT01914159|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111319966|NCT01914159|Growth Substances|growth substances|mesh-ancestor
111319967|NCT01914159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111319968|NCT01914159|Growth Inhibitors|growth inhibitors|mesh-ancestor
111319969|NCT01914159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111319970|NCT00576251|Tobramycin|tobramycin|mesh-list
111319971|NCT00576251|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
111319972|NCT00576251|Dexamethasone|dexamethasone|mesh-list
111319973|NCT00576251|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111319974|NCT00576251|Antiemetics|antiemetics|mesh-ancestor
111319975|NCT00576251|Autonomic Agents|autonomic agents|mesh-ancestor
111319976|NCT00576251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111319977|NCT00576251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111319978|NCT00576251|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111319979|NCT00576251|Glucocorticoids|glucocorticoids|mesh-ancestor
111319980|NCT00576251|Hormones|hormones|mesh-ancestor
111319981|NCT00576251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111319982|NCT00576251|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111319983|NCT00576251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111319984|NCT00576251|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111319985|NCT00576251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111319986|NCT00576251|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
111319987|NCT00576251|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111319988|NCT00578279|Ethanol|ethanol|mesh-list
111319989|NCT00578279|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111319990|NCT00578279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111319991|NCT00578279|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111319992|NCT00578279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111319993|NCT00578669|Fluoxetine|fluoxetine|mesh-list
111319994|NCT00578669|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111319995|NCT00578669|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111319996|NCT00578669|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111319997|NCT00578669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111319998|NCT00578669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111319999|NCT00578669|Serotonin Agents|serotonin agents|mesh-ancestor
111320000|NCT00578669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111320001|NCT00578669|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111320002|NCT00578669|Antidepressive Agents|antidepressive agents|mesh-ancestor
111320003|NCT00578669|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111320004|NCT00578669|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111320005|NCT00578669|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111320006|NCT00578669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111320007|NCT00578903|Cyclophosphamide|cyclophosphamide|mesh-list
111320008|NCT00578903|Methotrexate|methotrexate|mesh-list
111320009|NCT00578903|Alemtuzumab|alemtuzumab|mesh-list
111320010|NCT00578903|Tacrolimus|tacrolimus|mesh-list
111320011|NCT00578903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111320012|NCT00578903|Immunologic Factors|immunologic factors|mesh-ancestor
111320013|NCT00578903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111320014|NCT00578903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111320015|NCT00578903|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111320016|NCT00578903|Alkylating Agents|alkylating agents|mesh-ancestor
111320017|NCT00578903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111320018|NCT00578903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111320019|NCT00578903|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111320020|NCT00578903|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111320021|NCT00578903|Abortifacient Agents|abortifacient agents|mesh-ancestor
111320022|NCT00578903|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111320023|NCT00578903|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111320024|NCT00578903|Antimetabolites|antimetabolites|mesh-ancestor
111320025|NCT00578903|Dermatologic Agents|dermatologic agents|mesh-ancestor
111320026|NCT00578903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111320027|NCT00578903|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111320028|NCT00578903|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111320029|NCT00578903|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111320030|NCT00578903|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111320031|NCT01918761|Pemetrexed|pemetrexed|mesh-list
111320032|NCT01918761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111320033|NCT01918761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111320034|NCT01918761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111320035|NCT01918761|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111320036|NCT01918761|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111320037|NCT00579137|Fludarabine|fludarabine|mesh-list
111320038|NCT00579137|Alemtuzumab|alemtuzumab|mesh-list
111320039|NCT00579137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111320040|NCT00579137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111320041|NCT00580073|Leucovorin|leucovorin|mesh-list
111320042|NCT00580073|Fluorouracil|fluorouracil|mesh-list
111320043|NCT00580073|Oxaliplatin|oxaliplatin|mesh-list
111320044|NCT00580073|Cetuximab|cetuximab|mesh-list
111320045|NCT00580073|Antimetabolites|antimetabolites|mesh-ancestor
111320046|NCT00580073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111320047|NCT00580073|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111320048|NCT00580073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111320049|NCT00580073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111320050|NCT00580073|Immunologic Factors|immunologic factors|mesh-ancestor
111320051|NCT00580073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111320052|NCT00580073|Antidotes|antidotes|mesh-ancestor
111320053|NCT00580073|Protective Agents|protective agents|mesh-ancestor
111320054|NCT00580073|Vitamin B Complex|vitamin b complex|mesh-ancestor
111320055|NCT00580073|Vitamins|vitamins|mesh-ancestor
111320056|NCT00580073|Micronutrients|micronutrients|mesh-ancestor
111320057|NCT00580073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111320058|NCT00580151|Clonidine|clonidine|mesh-list
111320059|NCT00580151|Analgesics|analgesics|mesh-ancestor
111320060|NCT00580151|Sensory System Agents|sensory system agents|mesh-ancestor
111320061|NCT00580151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111320062|NCT00580151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111320063|NCT00580151|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111320064|NCT00580151|Sympatholytics|sympatholytics|mesh-ancestor
111320065|NCT00580151|Autonomic Agents|autonomic agents|mesh-ancestor
111320066|NCT00580151|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111320067|NCT00580151|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111320068|NCT00580151|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111320069|NCT00580151|Adrenergic Agents|adrenergic agents|mesh-ancestor
111320070|NCT00580151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111320071|NCT00580151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111320072|NCT01919697|Plecanatide|plecanatide|mesh-list
111320073|NCT01919697|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
111320074|NCT01919697|Enzyme Activators|enzyme activators|mesh-ancestor
111320075|NCT01919697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111320076|NCT01919697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111320077|NCT00580229|Prednisone|prednisone|mesh-list
111320078|NCT00580229|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111320079|NCT00580229|Glucocorticoids|glucocorticoids|mesh-ancestor
111320080|NCT00580229|Hormones|hormones|mesh-ancestor
111320081|NCT00580229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111320082|NCT00580229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111320083|NCT00580229|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111320084|NCT00580229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111320085|NCT00580853|Bupropion|bupropion|mesh-list
111320086|NCT00580853|Varenicline|varenicline|mesh-list
111320087|NCT00580853|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111320088|NCT00580853|Antidepressive Agents|antidepressive agents|mesh-ancestor
111320089|NCT00580853|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111320090|NCT00580853|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111320091|NCT00580853|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111320092|NCT00580853|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111320093|NCT00580853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111320094|NCT00580853|Dopamine Agents|dopamine agents|mesh-ancestor
111320095|NCT00580853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111320096|NCT00580853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111320097|NCT00580853|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111320098|NCT00580853|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111320099|NCT00580853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111320100|NCT00580853|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111320101|NCT00580853|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111320102|NCT00580853|Cholinergic Agents|cholinergic agents|mesh-ancestor
111320103|NCT05739045|Nivolumab|nivolumab|mesh-list
111320104|NCT05739045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111320105|NCT05739045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111320107|NCT05739045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111320108|NCT00604019|Dopamine|dopamine|mesh-list
111320109|NCT00604019|Norepinephrine|norepinephrine|mesh-list
111320110|NCT00604019|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111320111|NCT00604019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111320112|NCT00604019|Adrenergic Agents|adrenergic agents|mesh-ancestor
111320113|NCT00604019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111320114|NCT00604019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111320115|NCT00604019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111320116|NCT00604019|Sympathomimetics|sympathomimetics|mesh-ancestor
111320117|NCT00604019|Autonomic Agents|autonomic agents|mesh-ancestor
111320118|NCT00604019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111320119|NCT00604019|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111320120|NCT00604019|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111320121|NCT00604019|Dopamine Agents|dopamine agents|mesh-ancestor
111320122|NCT00604019|Protective Agents|protective agents|mesh-ancestor
111320123|NCT01922115|Trospium chloride|trospium chloride|mesh-list
111320124|NCT01922115|Parasympatholytics|parasympatholytics|mesh-ancestor
111320125|NCT01922115|Autonomic Agents|autonomic agents|mesh-ancestor
111320126|NCT01922115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111320127|NCT01922115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111320128|NCT01922115|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111320129|NCT01922115|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111320130|NCT01922115|Cholinergic Agents|cholinergic agents|mesh-ancestor
111320131|NCT01922115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111320132|NCT01922115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111320133|NCT01922115|Urological Agents|urological agents|mesh-ancestor
111320134|NCT00081770|Ribavirin|ribavirin|mesh-list
111320135|NCT00081770|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
111320136|NCT00081770|Interferon-alpha|interferon-alpha|mesh-list
111320137|NCT00081770|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
111320138|NCT00081770|Antimetabolites|antimetabolites|mesh-ancestor
111320139|NCT00081770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111320140|NCT00081770|Antiviral Agents|antiviral agents|mesh-ancestor
111320141|NCT00081770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111320142|NCT00081770|Immunologic Factors|immunologic factors|mesh-ancestor
111320143|NCT00081770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111320144|NCT00605423|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
111320145|NCT00605423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111320146|NCT00605423|Glucocorticoids|glucocorticoids|mesh-ancestor
111320147|NCT00605423|Hormones|hormones|mesh-ancestor
111320148|NCT00605423|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111320149|NCT00605423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111320150|NCT01923129|Prazosin|prazosin|mesh-list
111320151|NCT01923129|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111320152|NCT01923129|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111320153|NCT01923129|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111320154|NCT01923129|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111320155|NCT01923129|Adrenergic Agents|adrenergic agents|mesh-ancestor
111320156|NCT01923129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111320157|NCT01923129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111320158|NCT01923129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111320159|NCT00581867|Insulin|insulin|mesh-list
111320160|NCT00581867|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111320161|NCT00581867|Insulin Aspart|insulin aspart|mesh-list
111320162|NCT00581867|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111320163|NCT00581867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111320164|NCT01925469|Benzocaine|benzocaine|mesh-list
111320165|NCT01925469|Anesthetics, Local|anesthetics, local|mesh-ancestor
111320166|NCT01925469|Anesthetics|anesthetics|mesh-ancestor
111320167|NCT01925469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111320168|NCT01925469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111320169|NCT01925469|Sensory System Agents|sensory system agents|mesh-ancestor
111320170|NCT01925469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111320171|NCT01925781|Nicotine|nicotine|mesh-list
111320172|NCT01925781|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111320173|NCT01925781|Autonomic Agents|autonomic agents|mesh-ancestor
111320174|NCT01925781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111320175|NCT01925781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111320176|NCT01925781|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111320177|NCT01925781|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111320178|NCT01925781|Cholinergic Agents|cholinergic agents|mesh-ancestor
111320179|NCT01925781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111044594|NCT02688933|Insulin|insulin|mesh-list
111320180|NCT01925781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111320182|NCT01927887|Hematinics|hematinics|mesh-ancestor
111320183|NCT01927887|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
111320184|NCT01927887|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111320185|NCT00081458|Teduglutide|teduglutide|mesh-list
111320186|NCT00081458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111320187|NCT00081458|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111320188|NCT00081458|Protective Agents|protective agents|mesh-ancestor
111320189|NCT00081458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111320190|NCT00610727|Prochlorperazine|prochlorperazine|mesh-list
111320191|NCT00610727|Antiemetics|antiemetics|mesh-ancestor
111320192|NCT00610727|Autonomic Agents|autonomic agents|mesh-ancestor
111320193|NCT00610727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111320194|NCT00610727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111320195|NCT00610727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111320196|NCT00610727|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111320197|NCT00610727|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111320198|NCT00610727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111320199|NCT00610727|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111320200|NCT00610727|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111320201|NCT00610727|Dopamine Agents|dopamine agents|mesh-ancestor
111320202|NCT00610727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111320203|NCT00610727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111320204|NCT01929291|Vaccines|vaccines|mesh-list
111320205|NCT01929291|Immunologic Factors|immunologic factors|mesh-ancestor
111320206|NCT01929291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111320207|NCT01929759|Tenofovir|tenofovir|mesh-list
111320208|NCT01929759|Emtricitabine|emtricitabine|mesh-list
111320209|NCT01929759|Cobicistat|cobicistat|mesh-list
111320210|NCT01929759|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
111320211|NCT01929759|Elvitegravir|elvitegravir|mesh-list
111320212|NCT01929759|Antiviral Agents|antiviral agents|mesh-ancestor
111320213|NCT01929759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111320214|NCT01929759|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111320215|NCT01929759|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111320216|NCT01929759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111320217|NCT01929759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111320218|NCT01929759|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111320219|NCT01929759|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111320220|NCT01929759|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111320221|NCT01929759|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111320222|NCT01929759|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111320223|NCT03437330|Insulin Glargine|insulin glargine|mesh-list
111320224|NCT03437330|Empagliflozin|empagliflozin|mesh-list
111320225|NCT03437330|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111320226|NCT03437330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111320227|NCT03437330|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111320228|NCT03437330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111320229|NCT01271803|Vemurafenib|vemurafenib|mesh-list
111320230|NCT01271803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111320231|NCT01271803|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111320232|NCT01271803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111320233|NCT01271803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111320234|NCT00585377|Bevacizumab|bevacizumab|mesh-list
111320235|NCT00585377|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111320236|NCT00585377|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111320237|NCT00585377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111320238|NCT00585377|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111320239|NCT00585377|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111320240|NCT00585377|Growth Substances|growth substances|mesh-ancestor
111320241|NCT00585377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111320242|NCT00585377|Growth Inhibitors|growth inhibitors|mesh-ancestor
111320243|NCT00585377|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111320244|NCT00585377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111320245|NCT00585377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111320246|NCT00080288|Modafinil|modafinil|mesh-list
111320247|NCT00080288|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111320248|NCT00080288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111320249|NCT00080288|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
111320250|NCT00080288|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111320251|NCT00080288|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111320252|NCT00080288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111320253|NCT03084380|Cyclophosphamide|cyclophosphamide|mesh-list
111320254|NCT03084380|Fludarabine|fludarabine|mesh-list
111320255|NCT03084380|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111320256|NCT03084380|Immunologic Factors|immunologic factors|mesh-ancestor
111320257|NCT03084380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111320258|NCT03084380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111320259|NCT03084380|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111320260|NCT03084380|Alkylating Agents|alkylating agents|mesh-ancestor
111320261|NCT03084380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111320262|NCT03084380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111320263|NCT03084380|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111320264|NCT00084344|Afimoxifene|afimoxifene|mesh-list
111320265|NCT00084344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111320266|NCT00084344|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111320267|NCT00084344|Hormone Antagonists|hormone antagonists|mesh-ancestor
111320268|NCT00084344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111320269|NCT00084344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111320270|NCT00084344|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111320271|NCT00084344|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111320272|NCT00611351|Mycophenolic Acid|mycophenolic acid|mesh-list
111320273|NCT00611351|Cyclophosphamide|cyclophosphamide|mesh-list
111320274|NCT00611351|Busulfan|busulfan|mesh-list
111320275|NCT00611351|Tacrolimus|tacrolimus|mesh-list
111320276|NCT00611351|Antilymphocyte Serum|antilymphocyte serum|mesh-list
111320277|NCT00611351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111320278|NCT00611351|Immunologic Factors|immunologic factors|mesh-ancestor
111320279|NCT00611351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111320280|NCT00611351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111320281|NCT00611351|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111320282|NCT00611351|Alkylating Agents|alkylating agents|mesh-ancestor
111320283|NCT00611351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111320284|NCT00611351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111320285|NCT00611351|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111320286|NCT00611351|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111320287|NCT00611351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111320288|NCT00611351|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111320289|NCT00611351|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111320290|NCT00611351|Antitubercular Agents|antitubercular agents|mesh-ancestor
111320291|NCT00611351|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111320292|NCT00611351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111320293|NCT00611897|Acetylcysteine|acetylcysteine|mesh-list
111320294|NCT00611897|Ketamine|ketamine|mesh-list
111320295|NCT00611897|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111320296|NCT00611897|Analgesics|analgesics|mesh-ancestor
111320297|NCT00611897|Sensory System Agents|sensory system agents|mesh-ancestor
111320298|NCT00611897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111320299|NCT00611897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111320300|NCT00611897|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111320301|NCT00611897|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111320302|NCT00611897|Anesthetics, General|anesthetics, general|mesh-ancestor
111320303|NCT00611897|Anesthetics|anesthetics|mesh-ancestor
111320304|NCT00611897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111320305|NCT00611897|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111320306|NCT00611897|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111320307|NCT00611897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111320308|NCT00611897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111320309|NCT00611897|Antiviral Agents|antiviral agents|mesh-ancestor
111320310|NCT00611897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111320311|NCT00611897|Expectorants|expectorants|mesh-ancestor
111320312|NCT00611897|Respiratory System Agents|respiratory system agents|mesh-ancestor
111320313|NCT00611897|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111320314|NCT00611897|Antioxidants|antioxidants|mesh-ancestor
111320315|NCT00611897|Protective Agents|protective agents|mesh-ancestor
111320316|NCT00611897|Antidotes|antidotes|mesh-ancestor
111320317|NCT05711823|Dexamethasone|dexamethasone|mesh-list
111320318|NCT05711823|Dexamethasone acetate|dexamethasone acetate|mesh-list
111320319|NCT05711823|Aprepitant|aprepitant|mesh-list
111320320|NCT05711823|Granisetron|granisetron|mesh-list
111320321|NCT05711823|BB 1101|bb 1101|mesh-list
111320322|NCT05711823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111320323|NCT05711823|Antiemetics|antiemetics|mesh-ancestor
111320324|NCT05711823|Autonomic Agents|autonomic agents|mesh-ancestor
111320325|NCT05711823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111320326|NCT05711823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111044735|NCT05491460|Apixaban|apixaban|mesh-list
111320327|NCT05711823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111320328|NCT05711823|Glucocorticoids|glucocorticoids|mesh-ancestor
111320329|NCT05711823|Hormones|hormones|mesh-ancestor
111320330|NCT05711823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111320331|NCT05711823|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111320332|NCT05711823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111320333|NCT05711823|Protease Inhibitors|protease inhibitors|mesh-ancestor
111320334|NCT05711823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111320335|NCT05711823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111320336|NCT05711823|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
111320337|NCT05711823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111320338|NCT05711823|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111320339|NCT05711823|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111320340|NCT05711823|Serotonin Agents|serotonin agents|mesh-ancestor
111320341|NCT03080324|Fentanyl|fentanyl|mesh-list
111320342|NCT03080324|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111320343|NCT03080324|Narcotics|narcotics|mesh-ancestor
111320344|NCT03080324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111320345|NCT03080324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111320346|NCT03080324|Analgesics|analgesics|mesh-ancestor
111320347|NCT03080324|Sensory System Agents|sensory system agents|mesh-ancestor
111320348|NCT03080324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111320349|NCT03080324|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111320350|NCT03080324|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111320351|NCT03080324|Anesthetics, General|anesthetics, general|mesh-ancestor
111320352|NCT03080324|Anesthetics|anesthetics|mesh-ancestor
111320353|NCT03083834|Cosyntropin|cosyntropin|mesh-list
111320354|NCT03083834|Hormones|hormones|mesh-ancestor
111320355|NCT03083834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111320356|NCT03083834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111320357|NCT02780609|Dexamethasone|dexamethasone|mesh-list
111320358|NCT02780609|Melphalan|melphalan|mesh-list
111320359|NCT02780609|Fosaprepitant|fosaprepitant|mesh-list
111320360|NCT02780609|Aprepitant|aprepitant|mesh-list
111320361|NCT02780609|Antiemetics|antiemetics|mesh-list
111320362|NCT02780609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111320363|NCT02780609|Autonomic Agents|autonomic agents|mesh-ancestor
111320364|NCT02780609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111320365|NCT02780609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111320366|NCT02780609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111320367|NCT02780609|Glucocorticoids|glucocorticoids|mesh-ancestor
111320368|NCT02780609|Hormones|hormones|mesh-ancestor
111320369|NCT02780609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111320370|NCT02780609|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111320371|NCT02780609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111320372|NCT02780609|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111320373|NCT02780609|Alkylating Agents|alkylating agents|mesh-ancestor
111320374|NCT02780609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111320375|NCT02780609|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111320376|NCT02780609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111320377|NCT02780609|Immunologic Factors|immunologic factors|mesh-ancestor
111320378|NCT02780609|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
111320379|NCT02780609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111320380|NCT03086096|Irinotecan|irinotecan|mesh-list
111320381|NCT03086096|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111320382|NCT03086096|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111320383|NCT03086096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111320384|NCT03086096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111320385|NCT03086096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111320386|NCT03402152|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
111320387|NCT03402152|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111320388|NCT03402152|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111320389|NCT03402152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111320390|NCT03402152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111320391|NCT03402152|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111320392|NCT03402152|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
111320393|NCT03402152|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111320394|NCT03402152|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111320395|NCT03402152|Adrenergic Agents|adrenergic agents|mesh-ancestor
111320396|NCT03402152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111320397|NCT03402152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111320398|NCT03402152|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111320399|NCT03402152|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111320400|NCT03402152|Serotonin Agents|serotonin agents|mesh-ancestor
111320401|NCT03402152|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111320402|NCT03402152|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111320403|NCT03402152|Dopamine Agents|dopamine agents|mesh-ancestor
111320405|NCT05346146|Gemcitabine|gemcitabine|mesh-list
111320406|NCT05346146|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111320407|NCT05346146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111320408|NCT05346146|Tubulin Modulators|tubulin modulators|mesh-ancestor
111320409|NCT05346146|Antimitotic Agents|antimitotic agents|mesh-ancestor
111320410|NCT05346146|Mitosis Modulators|mitosis modulators|mesh-ancestor
111320411|NCT05346146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111320412|NCT05346146|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111320413|NCT05346146|Antimetabolites|antimetabolites|mesh-ancestor
111320414|NCT00613379|Leronlimab|leronlimab|mesh-list
111320415|NCT00613379|HIV Antibodies|hiv antibodies|mesh-list
111320416|NCT00613379|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
111320417|NCT00613379|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
111320418|NCT00613379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111320419|NCT00613379|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111320420|NCT00613379|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111320421|NCT00613379|Antiviral Agents|antiviral agents|mesh-ancestor
111320422|NCT00613379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111320423|NCT00613379|Immunologic Factors|immunologic factors|mesh-ancestor
111320424|NCT00613379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111320425|NCT01271725|Paclitaxel|paclitaxel|mesh-list
111320426|NCT01271725|Vinorelbine|vinorelbine|mesh-list
111320427|NCT01271725|Afatinib|afatinib|mesh-list
111320428|NCT01271725|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111320429|NCT01271725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111320430|NCT01271725|Tubulin Modulators|tubulin modulators|mesh-ancestor
111320431|NCT01271725|Antimitotic Agents|antimitotic agents|mesh-ancestor
111320432|NCT01271725|Mitosis Modulators|mitosis modulators|mesh-ancestor
111320433|NCT01271725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111320434|NCT01271725|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111320435|NCT01271725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111320436|NCT00587483|Lidocaine|lidocaine|mesh-list
111320437|NCT00587483|Amiodarone|amiodarone|mesh-list
111320438|NCT00587483|Anesthetics, Local|anesthetics, local|mesh-ancestor
111320439|NCT00587483|Anesthetics|anesthetics|mesh-ancestor
111320440|NCT00587483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111320441|NCT00587483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111320442|NCT00587483|Sensory System Agents|sensory system agents|mesh-ancestor
111320443|NCT00587483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111320444|NCT00587483|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111320445|NCT00587483|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111320446|NCT00587483|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111320447|NCT00587483|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111320448|NCT00587483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111320449|NCT00587483|Vasodilator Agents|vasodilator agents|mesh-ancestor
111320450|NCT00587483|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
111320451|NCT00587483|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111320452|NCT00587483|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111320453|NCT00587483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111320454|NCT00587483|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111320455|NCT00587483|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111320456|NCT00587483|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111320457|NCT03401060|Denosumab|denosumab|mesh-list
111320458|NCT03401060|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111320459|NCT03401060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111320460|NCT01270321|Everolimus|everolimus|mesh-list
111320461|NCT01270321|Pasireotide|pasireotide|mesh-list
111320462|NCT01270321|Somatostatin|somatostatin|mesh-list
111320463|NCT01270321|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111320464|NCT01270321|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111320465|NCT01270321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111044877|NCT02234869|Interferon-beta|interferon-beta|mesh-list
111044878|NCT02234869|Interferon beta-1a|interferon beta-1a|mesh-list
111044879|NCT02234869|Interferon beta-1b|interferon beta-1b|mesh-list
111044880|NCT02234869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111044881|NCT02234869|Antiviral Agents|antiviral agents|mesh-ancestor
111044882|NCT02234869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111044883|NCT02234869|Immunologic Factors|immunologic factors|mesh-ancestor
111044884|NCT02234869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111044885|NCT02234869|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111044886|NCT05499026|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
111320466|NCT01270321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111320467|NCT01270321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111320468|NCT01270321|Immunologic Factors|immunologic factors|mesh-ancestor
111320469|NCT01270321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111320470|NCT01270321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111320471|NCT01270321|Hormones|hormones|mesh-ancestor
111320472|NCT01270321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111320473|NCT01271023|Insulin|insulin|mesh-list
111320474|NCT01271023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111320475|NCT01271023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111320476|NCT03086486|Linezolid|linezolid|mesh-list
111320477|NCT03086486|Bedaquiline|bedaquiline|mesh-list
111320478|NCT03086486|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111320479|NCT03086486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111320480|NCT03086486|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111320481|NCT03086486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111320482|NCT03086486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111320483|NCT03086486|Antitubercular Agents|antitubercular agents|mesh-ancestor
111320484|NCT02287779|Volixibat|volixibat|mesh-list
111320485|NCT02287779|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111320486|NCT00732901|Escitalopram|escitalopram|mesh-list
111320487|NCT00732901|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111320488|NCT00732901|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111320489|NCT00732901|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111320490|NCT00732901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111320491|NCT00732901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111320492|NCT00732901|Serotonin Agents|serotonin agents|mesh-ancestor
111320493|NCT00732901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111320494|NCT03083210|Lanreotide|lanreotide|mesh-list
111320495|NCT03083210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111320496|NCT00616109|Sunitinib|sunitinib|mesh-list
111320497|NCT00616109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111320498|NCT00616109|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111320499|NCT00616109|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111320500|NCT00616109|Growth Substances|growth substances|mesh-ancestor
111320501|NCT00616109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111320502|NCT00616109|Growth Inhibitors|growth inhibitors|mesh-ancestor
111320503|NCT00616109|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111320504|NCT00616109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111320505|NCT00616109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111320506|NCT04401488|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
111320507|NCT04401488|Immunologic Factors|immunologic factors|mesh-ancestor
111320508|NCT04401488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111320509|NCT00249769|Vaccines|vaccines|mesh-list
111320510|NCT00249769|Immunologic Factors|immunologic factors|mesh-ancestor
111320511|NCT00249769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111320512|NCT03434678|Fentanyl|fentanyl|mesh-list
111320513|NCT03434678|Bupivacaine|bupivacaine|mesh-list
111320514|NCT03434678|Propofol|propofol|mesh-list
111320515|NCT03434678|Rocuronium|rocuronium|mesh-list
111320516|NCT03434678|Anesthetics, Local|anesthetics, local|mesh-ancestor
111320517|NCT03434678|Anesthetics|anesthetics|mesh-ancestor
111320518|NCT03434678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111320519|NCT03434678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111320520|NCT03434678|Sensory System Agents|sensory system agents|mesh-ancestor
111320521|NCT03434678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111320522|NCT03434678|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111320523|NCT03434678|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111320524|NCT03434678|Anesthetics, General|anesthetics, general|mesh-ancestor
111320525|NCT03434678|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111320526|NCT03434678|Narcotics|narcotics|mesh-ancestor
111320527|NCT03434678|Analgesics|analgesics|mesh-ancestor
111320528|NCT03434678|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111320529|NCT03434678|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
111320530|NCT03434678|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
111320531|NCT03434678|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111320532|NCT05445921|Mepivacaine|mepivacaine|mesh-list
111320533|NCT05445921|Anesthetics, Local|anesthetics, local|mesh-ancestor
111320534|NCT05445921|Anesthetics|anesthetics|mesh-ancestor
111320535|NCT05445921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111320536|NCT05445921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111320537|NCT05445921|Sensory System Agents|sensory system agents|mesh-ancestor
111320538|NCT05445921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111320539|NCT03837873|Cytarabine|cytarabine|mesh-list
111044953|NCT04424420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111320540|NCT03837873|Dexamethasone|dexamethasone|mesh-list
111320541|NCT03837873|Cyclophosphamide|cyclophosphamide|mesh-list
111320542|NCT03837873|Rituximab|rituximab|mesh-list
111320543|NCT03837873|Doxorubicin|doxorubicin|mesh-list
111320544|NCT03837873|Etoposide|etoposide|mesh-list
111320545|NCT03837873|Vincristine|vincristine|mesh-list
111320546|NCT03837873|Lenalidomide|lenalidomide|mesh-list
111320547|NCT03837873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111320548|NCT03837873|Immunologic Factors|immunologic factors|mesh-ancestor
111320549|NCT03837873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111320550|NCT03837873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111320551|NCT03837873|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111320552|NCT03837873|Alkylating Agents|alkylating agents|mesh-ancestor
111320553|NCT03837873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111320554|NCT03837873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111320555|NCT03837873|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111320556|NCT03837873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111320557|NCT03837873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111320558|NCT03837873|Antiemetics|antiemetics|mesh-ancestor
111320559|NCT03837873|Autonomic Agents|autonomic agents|mesh-ancestor
111320560|NCT03837873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111320561|NCT03837873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111320562|NCT03837873|Glucocorticoids|glucocorticoids|mesh-ancestor
111320563|NCT03837873|Hormones|hormones|mesh-ancestor
111320564|NCT03837873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111320565|NCT03837873|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111320566|NCT03837873|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111320567|NCT03837873|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111320568|NCT03837873|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111320569|NCT03837873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111320570|NCT03837873|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111320571|NCT03837873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111320572|NCT03837873|Antimetabolites|antimetabolites|mesh-ancestor
111320573|NCT03837873|Antiviral Agents|antiviral agents|mesh-ancestor
111320574|NCT03837873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111320575|NCT03837873|Tubulin Modulators|tubulin modulators|mesh-ancestor
111320576|NCT03837873|Antimitotic Agents|antimitotic agents|mesh-ancestor
111320577|NCT03837873|Mitosis Modulators|mitosis modulators|mesh-ancestor
111320578|NCT03837873|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111320579|NCT03837873|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111320580|NCT03837873|Growth Substances|growth substances|mesh-ancestor
111320581|NCT03837873|Growth Inhibitors|growth inhibitors|mesh-ancestor
111320582|NCT03082742|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
111320583|NCT03082742|Furosemide|furosemide|mesh-list
111320584|NCT03082742|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111320585|NCT03082742|Diuretics|diuretics|mesh-ancestor
111320586|NCT03082742|Natriuretic Agents|natriuretic agents|mesh-ancestor
111320587|NCT03082742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111320588|NCT03082742|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
111320589|NCT03082742|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111320590|NCT03082742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111320591|NCT03082742|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
111320592|NCT05434533|Tranexamic Acid|tranexamic acid|mesh-list
111320593|NCT05434533|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111320594|NCT05434533|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111320595|NCT05434533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111320596|NCT05434533|Hemostatics|hemostatics|mesh-ancestor
111320597|NCT05434533|Coagulants|coagulants|mesh-ancestor
111320598|NCT03432650|Dexamethasone|dexamethasone|mesh-list
111320599|NCT03432650|Bupivacaine|bupivacaine|mesh-list
111320600|NCT03432650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111320601|NCT03432650|Antiemetics|antiemetics|mesh-ancestor
111320602|NCT03432650|Autonomic Agents|autonomic agents|mesh-ancestor
111320603|NCT03432650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111320604|NCT03432650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111320605|NCT03432650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111320606|NCT03432650|Glucocorticoids|glucocorticoids|mesh-ancestor
111320607|NCT03432650|Hormones|hormones|mesh-ancestor
111320608|NCT03432650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111320609|NCT03432650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111320610|NCT03432650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111320611|NCT03432650|Anesthetics, Local|anesthetics, local|mesh-ancestor
111320612|NCT03432650|Anesthetics|anesthetics|mesh-ancestor
111320613|NCT03432650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111320614|NCT03432650|Sensory System Agents|sensory system agents|mesh-ancestor
111045011|NCT02559206|Linaclotide|linaclotide|mesh-list
111320615|NCT00248833|Vaccines|vaccines|mesh-list
111320616|NCT00248833|Immunologic Factors|immunologic factors|mesh-ancestor
111320617|NCT00248833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111320619|NCT00668525|Citalopram|citalopram|mesh-list
111320620|NCT00668525|Escitalopram|escitalopram|mesh-list
111320621|NCT00668525|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111320622|NCT00668525|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111320623|NCT00668525|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111320624|NCT00668525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111320625|NCT00668525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111320626|NCT00668525|Serotonin Agents|serotonin agents|mesh-ancestor
111320627|NCT00668525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111320628|NCT00668525|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111320629|NCT00668525|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111320630|NCT00668525|Parasympatholytics|parasympatholytics|mesh-ancestor
111320631|NCT00668525|Autonomic Agents|autonomic agents|mesh-ancestor
111320632|NCT00668525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111320633|NCT00668525|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111320634|NCT00668525|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111320635|NCT00668525|Cholinergic Agents|cholinergic agents|mesh-ancestor
111320636|NCT00668525|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111320637|NCT00668525|Antidepressive Agents|antidepressive agents|mesh-ancestor
111320638|NCT00668525|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111320639|NCT05736549|Dexamethasone|dexamethasone|mesh-list
111320640|NCT05736549|Methylprednisolone|methylprednisolone|mesh-list
111320641|NCT05736549|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111320642|NCT05736549|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111320643|NCT05736549|Prednisolone|prednisolone|mesh-list
111320644|NCT05736549|Prednisolone acetate|prednisolone acetate|mesh-list
111320645|NCT05736549|Dexamethasone acetate|dexamethasone acetate|mesh-list
111320646|NCT05736549|Bupivacaine|bupivacaine|mesh-list
111320647|NCT05736549|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111320648|NCT05736549|Prednisolone phosphate|prednisolone phosphate|mesh-list
111320649|NCT05736549|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
111320650|NCT05736549|BB 1101|bb 1101|mesh-list
111320651|NCT05736549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111320652|NCT05736549|Antiemetics|antiemetics|mesh-ancestor
111320653|NCT05736549|Autonomic Agents|autonomic agents|mesh-ancestor
111320654|NCT05736549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111320655|NCT05736549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111320656|NCT05736549|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111320657|NCT05736549|Glucocorticoids|glucocorticoids|mesh-ancestor
111320658|NCT05736549|Hormones|hormones|mesh-ancestor
111320659|NCT05736549|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110773385|NCT02722668|Sirolimus|sirolimus|mesh-list
111320774|NCT02285283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111320775|NCT02285283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111320776|NCT02285283|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111320777|NCT03429140|Hyaluronic Acid|hyaluronic acid|mesh-list
111141328|NCT05472259|Leucovorin|leucovorin|mesh-list
111320778|NCT03429140|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111320779|NCT03429140|Immunologic Factors|immunologic factors|mesh-ancestor
111320780|NCT03429140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111320781|NCT03429140|Viscosupplements|viscosupplements|mesh-ancestor
111320782|NCT03429140|Protective Agents|protective agents|mesh-ancestor
111320783|NCT03081494|Spartalizumab|spartalizumab|mesh-list
111320784|NCT03081494|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111320785|NCT03081494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111320786|NCT03081494|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111320787|NCT03081494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111320788|NCT03081728|Acetaminophen|acetaminophen|mesh-list
111320789|NCT03081728|Diclofenac|diclofenac|mesh-list
111320790|NCT03081728|Ropivacaine|ropivacaine|mesh-list
111320791|NCT03081728|Anesthetics, Local|anesthetics, local|mesh-ancestor
111320792|NCT03081728|Anesthetics|anesthetics|mesh-ancestor
111320793|NCT03081728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111320794|NCT03081728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111320795|NCT03081728|Sensory System Agents|sensory system agents|mesh-ancestor
111320796|NCT03081728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111320797|NCT03081728|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111320798|NCT03081728|Analgesics|analgesics|mesh-ancestor
111320799|NCT03081728|Antipyretics|antipyretics|mesh-ancestor
111320800|NCT03081728|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111320801|NCT03081728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111320802|NCT03081728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111320803|NCT03081728|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111141684|NCT02717507|Antioxidants|antioxidants|mesh-ancestor
111320804|NCT03081728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111320805|NCT03081728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111320806|NCT05651217|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111320807|NCT05651217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111320808|NCT00618917|Manganese|manganese|mesh-list
111320809|NCT00618917|Paclitaxel|paclitaxel|mesh-list
111320810|NCT00618917|Carboplatin|carboplatin|mesh-list
111320811|NCT00618917|Superoxide Dismutase|superoxide dismutase|mesh-list
111320812|NCT00618917|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111320813|NCT00618917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111320814|NCT00618917|Tubulin Modulators|tubulin modulators|mesh-ancestor
111320815|NCT00618917|Antimitotic Agents|antimitotic agents|mesh-ancestor
111320816|NCT00618917|Mitosis Modulators|mitosis modulators|mesh-ancestor
111320817|NCT00618917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111320818|NCT00618917|Trace Elements|trace elements|mesh-ancestor
111320819|NCT00618917|Micronutrients|micronutrients|mesh-ancestor
111320820|NCT00618917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111320821|NCT00618917|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111320822|NCT00618917|Antioxidants|antioxidants|mesh-ancestor
111320823|NCT00618917|Protective Agents|protective agents|mesh-ancestor
111320824|NCT05736081|Dexamethasone|dexamethasone|mesh-list
111320825|NCT05736081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111320826|NCT05736081|Antiemetics|antiemetics|mesh-ancestor
111320827|NCT05736081|Autonomic Agents|autonomic agents|mesh-ancestor
111320828|NCT05736081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111320829|NCT05736081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111142031|NCT05485259|Vitamins|vitamins|mesh-ancestor
111320830|NCT05736081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111320831|NCT05736081|Glucocorticoids|glucocorticoids|mesh-ancestor
111320832|NCT05736081|Hormones|hormones|mesh-ancestor
111320833|NCT05736081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111320834|NCT05736081|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111142192|NCT04051619|Oxytocin|oxytocin|mesh-list
111320835|NCT05736081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111320836|NCT00619073|Aspirin|aspirin|mesh-list
111320837|NCT00619073|Clopidogrel|clopidogrel|mesh-list
111320838|NCT00619073|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111142261|NCT05486819|Anesthetics|anesthetics|mesh-ancestor
111320839|NCT00619073|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111320840|NCT00619073|Analgesics|analgesics|mesh-ancestor
111320841|NCT00619073|Sensory System Agents|sensory system agents|mesh-ancestor
111320842|NCT00619073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111365060|NCT01585207|GABA Agents|gaba agents|mesh-ancestor
111320843|NCT00619073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111320844|NCT00619073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111320845|NCT00619073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111320846|NCT00619073|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111320847|NCT00619073|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111320848|NCT00619073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111320849|NCT00619073|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111320850|NCT00619073|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111320851|NCT00619073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111320852|NCT00619073|Antipyretics|antipyretics|mesh-ancestor
111320853|NCT00619073|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111320854|NCT00619073|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111320855|NCT00619073|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111320856|NCT00619073|Purinergic Agents|purinergic agents|mesh-ancestor
111320857|NCT00619073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111320858|NCT00670241|Betamethasone|betamethasone|mesh-list
111320859|NCT00670241|1 alpha,24-dihydroxyvitamin D3|1 alpha,24-dihydroxyvitamin d3|mesh-list
111320860|NCT00670241|Calcipotriene|calcipotriene|mesh-list
111320861|NCT00670241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111320862|NCT00670241|Glucocorticoids|glucocorticoids|mesh-ancestor
111320863|NCT00670241|Hormones|hormones|mesh-ancestor
111320864|NCT00670241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111320865|NCT00670241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111320866|NCT00670241|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111320867|NCT00670241|Respiratory System Agents|respiratory system agents|mesh-ancestor
111320868|NCT00670241|Dermatologic Agents|dermatologic agents|mesh-ancestor
111320869|NCT03088670|Metformin|metformin|mesh-list
111320870|NCT03088670|Vildagliptin|vildagliptin|mesh-list
111320871|NCT03088670|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111320872|NCT03088670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111320873|NCT03088670|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111320874|NCT03088670|Protease Inhibitors|protease inhibitors|mesh-ancestor
111320875|NCT03088670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111320876|NCT03088670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111320877|NCT03088358|Enoxaparin|enoxaparin|mesh-list
111320878|NCT03088358|Anticoagulants|anticoagulants|mesh-ancestor
111320879|NCT03088358|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111320880|NCT03088358|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111320881|NCT03088358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111320882|NCT03396068|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
111320883|NCT03396068|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111320884|NCT03396068|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111320885|NCT03396068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111320886|NCT03396068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111320887|NCT03396068|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111320888|NCT03396068|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
111320889|NCT03396068|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111320890|NCT03396068|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111320891|NCT03396068|Adrenergic Agents|adrenergic agents|mesh-ancestor
111320892|NCT03396068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111320893|NCT03396068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111320894|NCT03396068|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111320895|NCT03396068|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111320896|NCT03396068|Serotonin Agents|serotonin agents|mesh-ancestor
111320897|NCT03396068|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111320898|NCT03396068|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111320899|NCT03396068|Dopamine Agents|dopamine agents|mesh-ancestor
111320900|NCT00620945|Phenoxybenzamine|phenoxybenzamine|mesh-list
111320901|NCT00620945|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111142724|NCT02363283|Immunotoxins|immunotoxins|mesh-list
111320902|NCT00620945|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111320903|NCT00620945|Adrenergic Agents|adrenergic agents|mesh-ancestor
111320904|NCT00620945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111142782|NCT02293395|Analgesics|analgesics|mesh-ancestor
111320905|NCT00620945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111320906|NCT00620945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111320907|NCT00620945|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111320908|NCT00620945|Vasodilator Agents|vasodilator agents|mesh-ancestor
111320909|NCT00621179|Leuprolide|leuprolide|mesh-list
111320910|NCT00621179|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111320911|NCT00621179|Fertility Agents|fertility agents|mesh-ancestor
111320912|NCT00621179|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111320913|NCT00621179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111320914|NCT00621179|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111320915|NCT00621179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111320916|NCT00247273|Risedronic Acid|risedronic acid|mesh-list
111320918|NCT00247273|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111320919|NCT00247273|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111320920|NCT00247273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111320921|NCT00247273|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111320922|NCT00247273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111320923|NCT00247273|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111320924|NCT05056233|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111320925|NCT05056233|Lubricant Eye Drops|lubricant eye drops|mesh-list
111320926|NCT05056233|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111320927|NCT03382106|Sildenafil Citrate|sildenafil citrate|mesh-list
111320928|NCT03382106|Vasodilator Agents|vasodilator agents|mesh-ancestor
111320929|NCT03382106|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111320930|NCT03382106|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111320931|NCT03382106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111320932|NCT03382106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111320933|NCT03382106|Urological Agents|urological agents|mesh-ancestor
111320934|NCT00622895|Mycophenolic Acid|mycophenolic acid|mesh-list
111320935|NCT00622895|Fludarabine|fludarabine|mesh-list
111320936|NCT00622895|Fludarabine phosphate|fludarabine phosphate|mesh-list
111320937|NCT00622895|Tacrolimus|tacrolimus|mesh-list
111320938|NCT00622895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111320939|NCT00622895|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111320940|NCT00622895|Antimetabolites|antimetabolites|mesh-ancestor
111320941|NCT00622895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111320942|NCT00622895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111320943|NCT00622895|Immunologic Factors|immunologic factors|mesh-ancestor
111320944|NCT00622895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111320945|NCT00622895|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111143273|NCT05334277|Pemetrexed|pemetrexed|mesh-list
111320946|NCT00622895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111320947|NCT00622895|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111320948|NCT00622895|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111320949|NCT00622895|Antitubercular Agents|antitubercular agents|mesh-ancestor
111320950|NCT00622895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111320951|NCT00622895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111143334|NCT05347069|Aspirin|aspirin|mesh-list
111320952|NCT00672737|Remifentanil|remifentanil|mesh-list
111320953|NCT00672737|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111320954|NCT00672737|Narcotics|narcotics|mesh-ancestor
111320955|NCT00672737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111320956|NCT00672737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111143403|NCT05291845|Vaccines|vaccines|mesh-list
111320957|NCT00672737|Analgesics|analgesics|mesh-ancestor
111320958|NCT00672737|Sensory System Agents|sensory system agents|mesh-ancestor
111320959|NCT00672737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111320960|NCT00673127|Ketoconazole|ketoconazole|mesh-list
111320961|NCT00673127|Hydrocortisone|hydrocortisone|mesh-list
111320962|NCT00673127|Dutasteride|dutasteride|mesh-list
111320963|NCT00673127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111320964|NCT00673127|Antifungal Agents|antifungal agents|mesh-ancestor
111320965|NCT00673127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111320966|NCT00673127|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111320967|NCT00673127|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111320968|NCT00673127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111320969|NCT00673127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111320970|NCT00673127|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111320971|NCT00673127|Hormone Antagonists|hormone antagonists|mesh-ancestor
111320972|NCT00673127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111320973|NCT00673127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111320974|NCT00673127|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111320975|NCT00673127|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
111320976|NCT00246259|Risperidone|risperidone|mesh-list
111320977|NCT00246259|Antipsychotic Agents|antipsychotic agents|mesh-list
111320978|NCT00246259|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111320979|NCT00246259|Serotonin Agents|serotonin agents|mesh-ancestor
111320980|NCT00246259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111320981|NCT00246259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111320982|NCT00246259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111320983|NCT00246259|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111320984|NCT00246259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111320985|NCT00246259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111045388|NCT02233621|Hormones|hormones|mesh-ancestor
111320987|NCT00246259|Dopamine Agents|dopamine agents|mesh-ancestor
111320988|NCT00673439|PENTA|penta|mesh-list
111320989|NCT00673439|Warfarin|warfarin|mesh-list
111320990|NCT00673439|Fondaparinux|fondaparinux|mesh-list
111320991|NCT00673439|Anticoagulants|anticoagulants|mesh-ancestor
111320992|NCT00673439|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111320993|NCT00673439|Antithrombins|antithrombins|mesh-ancestor
111320994|NCT00673439|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111320995|NCT00673439|Protease Inhibitors|protease inhibitors|mesh-ancestor
111320996|NCT00673439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111320997|NCT00673439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111320998|NCT00673439|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111320999|NCT00673439|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111321000|NCT03316118|Bupivacaine|bupivacaine|mesh-list
111321001|NCT03316118|Anesthetics, Local|anesthetics, local|mesh-ancestor
111321002|NCT03316118|Anesthetics|anesthetics|mesh-ancestor
111143801|NCT05133817|Norepinephrine|norepinephrine|mesh-list
111321003|NCT03316118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111321004|NCT03316118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111321005|NCT03316118|Sensory System Agents|sensory system agents|mesh-ancestor
111321006|NCT03316118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111321007|NCT03029013|Apatinib|apatinib|mesh-list
111321008|NCT03029013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111321009|NCT03029013|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111321010|NCT03029013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111321011|NCT03029013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111321012|NCT00674219|Memantine|memantine|mesh-list
111143941|NCT05054881|Iodine|iodine|mesh-list
111321013|NCT00674219|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111321014|NCT00674219|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111321015|NCT00674219|Dopamine Agents|dopamine agents|mesh-ancestor
111321016|NCT00674219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111321017|NCT00674219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111321018|NCT00674219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111321019|NCT00674219|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111321020|NCT00674219|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111321021|NCT00246025|Dabigatran|dabigatran|mesh-list
111321022|NCT00246025|Antithrombins|antithrombins|mesh-ancestor
111321023|NCT00246025|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111321024|NCT00246025|Protease Inhibitors|protease inhibitors|mesh-ancestor
111321025|NCT00246025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111321026|NCT00246025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111321027|NCT00246025|Anticoagulants|anticoagulants|mesh-ancestor
111321028|NCT03311594|Ethanol|ethanol|mesh-list
111321029|NCT03311594|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111144150|NCT04979065|Vitamin D|vitamin d|mesh-list
111321030|NCT03311594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111321031|NCT03311594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111321032|NCT03311594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111321033|NCT05069051|Belimumab|belimumab|mesh-list
111321034|NCT05069051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111321035|NCT05069051|Immunologic Factors|immunologic factors|mesh-ancestor
111321036|NCT05069051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111321037|NCT00624923|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
111321038|NCT00624923|Sodium Salicylate|sodium salicylate|mesh-list
111321039|NCT00624923|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111321040|NCT00624923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111321041|NCT00624923|Analgesics|analgesics|mesh-ancestor
111321042|NCT00624923|Sensory System Agents|sensory system agents|mesh-ancestor
111321043|NCT00624923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111321044|NCT00624923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111321045|NCT00624923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111321046|NCT00624923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111321047|NCT00624923|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111321048|NCT00624923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111321049|NCT00624923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111321050|NCT05593653|Suvorexant|suvorexant|mesh-list
111321051|NCT05593653|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111144356|NCT02284893|Hormones|hormones|mesh-ancestor
111321052|NCT05593653|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111321053|NCT05593653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111321054|NCT05593653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111321055|NCT05593653|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
111321056|NCT05593653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111321057|NCT05593653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111321058|NCT00735787|Adalimumab|adalimumab|mesh-list
111321059|NCT00735787|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111045525|NCT05491928|Tempol|tempol|mesh-list
111321060|NCT00735787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111321061|NCT00735787|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111321062|NCT00628589|Loxapine|loxapine|mesh-list
111321063|NCT00628589|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111321064|NCT00628589|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111321065|NCT00628589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111321066|NCT00628589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111321067|NCT00628589|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111321068|NCT00628589|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111321069|NCT00628589|Dopamine Agents|dopamine agents|mesh-ancestor
111321070|NCT00628589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111321071|NCT00628589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111321072|NCT01271569|Fospropofol|fospropofol|mesh-list
111321073|NCT01271569|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111321074|NCT01271569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111321075|NCT01271569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111321076|NCT05686772|Dopamine|dopamine|mesh-list
111321077|NCT05686772|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111321078|NCT05686772|Sympathomimetics|sympathomimetics|mesh-ancestor
111321079|NCT05686772|Autonomic Agents|autonomic agents|mesh-ancestor
111321080|NCT05686772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111321081|NCT05686772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111321082|NCT05686772|Dopamine Agents|dopamine agents|mesh-ancestor
111321083|NCT05686772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111321084|NCT05686772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111321085|NCT05686772|Protective Agents|protective agents|mesh-ancestor
111321086|NCT04771871|Paclitaxel|paclitaxel|mesh-list
111321087|NCT04771871|Cyclophosphamide|cyclophosphamide|mesh-list
111321088|NCT04771871|Carboplatin|carboplatin|mesh-list
111321089|NCT04771871|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111321090|NCT04771871|Epirubicin|epirubicin|mesh-list
111321091|NCT04771871|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111321092|NCT04771871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111321093|NCT04771871|Tubulin Modulators|tubulin modulators|mesh-ancestor
111321094|NCT04771871|Antimitotic Agents|antimitotic agents|mesh-ancestor
111321095|NCT04771871|Mitosis Modulators|mitosis modulators|mesh-ancestor
111321096|NCT04771871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111321097|NCT04771871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111321098|NCT04771871|Immunologic Factors|immunologic factors|mesh-ancestor
111321099|NCT04771871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111321100|NCT04771871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111321101|NCT04771871|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111321102|NCT04771871|Alkylating Agents|alkylating agents|mesh-ancestor
111321103|NCT04771871|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111321104|NCT04771871|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111321105|NCT04771871|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111321106|NCT04771871|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111321107|NCT04771871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111321108|NCT04386577|Vitamin D|vitamin d|mesh-list
111321109|NCT04386577|Cholecalciferol|cholecalciferol|mesh-list
111321110|NCT04386577|Vitamins|vitamins|mesh-ancestor
111321111|NCT04386577|Micronutrients|micronutrients|mesh-ancestor
111321112|NCT04386577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111321113|NCT04386577|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111321114|NCT04386577|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111321115|NCT04270669|RC28-E protein|rc28-e protein|mesh-list
111321116|NCT04270669|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111321117|NCT04270669|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111321118|NCT04270669|Growth Substances|growth substances|mesh-ancestor
111321119|NCT04270669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111321120|NCT04270669|Growth Inhibitors|growth inhibitors|mesh-ancestor
111321121|NCT04270669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111321122|NCT05680454|Vaccines|vaccines|mesh-list
111321123|NCT05680454|Immunologic Factors|immunologic factors|mesh-ancestor
111321124|NCT05680454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111321125|NCT04928703|Ketamine|ketamine|mesh-list
111321126|NCT04928703|Analgesics|analgesics|mesh-ancestor
111321127|NCT04928703|Sensory System Agents|sensory system agents|mesh-ancestor
111321128|NCT04928703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111321129|NCT04928703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111321130|NCT04928703|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111321131|NCT04928703|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111321132|NCT04928703|Anesthetics, General|anesthetics, general|mesh-ancestor
111321133|NCT04928703|Anesthetics|anesthetics|mesh-ancestor
111321134|NCT04928703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111321135|NCT04928703|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111321136|NCT04928703|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111321137|NCT04928703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111321138|NCT04928703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111321139|NCT04278950|Povidone-Iodine|povidone-iodine|mesh-list
111321140|NCT04278950|Povidone|povidone|mesh-list
111321141|NCT04278950|Plasma Substitutes|plasma substitutes|mesh-ancestor
111321142|NCT04278950|Blood Substitutes|blood substitutes|mesh-ancestor
111321143|NCT04278950|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111321144|NCT04278950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111321145|NCT00755755|Iron|iron|mesh-list
111321146|NCT00755755|Ulipristal acetate|ulipristal acetate|mesh-list
111321147|NCT00755755|Trace Elements|trace elements|mesh-ancestor
111321148|NCT00755755|Micronutrients|micronutrients|mesh-ancestor
111321149|NCT00755755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111321150|NCT00755755|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111321151|NCT00755755|Contraceptive Agents|contraceptive agents|mesh-ancestor
111321152|NCT00755755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111321153|NCT00755755|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111321154|NCT05686616|Dapagliflozin|dapagliflozin|mesh-list
111321155|NCT05686616|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111321156|NCT05686616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111321157|NCT05686616|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111321158|NCT05686616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111321159|NCT00674765|Quetiapine Fumarate|quetiapine fumarate|mesh-list
111321160|NCT00674765|Antidepressive Agents|antidepressive agents|mesh-ancestor
111321161|NCT00674765|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111321162|NCT00674765|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111321163|NCT00674765|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111321164|NCT00674765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111321165|NCT00674765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111321166|NCT00755911|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
111321167|NCT00755911|Hemostatics|hemostatics|mesh-ancestor
111321168|NCT00755911|Coagulants|coagulants|mesh-ancestor
111321169|NCT00737737|Morphine|morphine|mesh-list
111321170|NCT00737737|Oxycodone|oxycodone|mesh-list
111321171|NCT00737737|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111321172|NCT00737737|Narcotics|narcotics|mesh-ancestor
111321173|NCT00737737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111321174|NCT00737737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111321175|NCT00737737|Analgesics|analgesics|mesh-ancestor
111321176|NCT00737737|Sensory System Agents|sensory system agents|mesh-ancestor
111321177|NCT00737737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111321178|NCT05199051|Cytarabine|cytarabine|mesh-list
111321179|NCT05199051|Gemtuzumab|gemtuzumab|mesh-list
111321180|NCT05199051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111321181|NCT05199051|Antimetabolites|antimetabolites|mesh-ancestor
111321182|NCT05199051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111321183|NCT05199051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111321184|NCT05199051|Antiviral Agents|antiviral agents|mesh-ancestor
111321185|NCT05199051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111321186|NCT05199051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111321187|NCT05199051|Immunologic Factors|immunologic factors|mesh-ancestor
111321188|NCT05199051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111145114|NCT02440789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111321189|NCT05199051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111321190|NCT05199051|Immunotoxins|immunotoxins|mesh-ancestor
111321191|NCT05199051|Immunoconjugates|immunoconjugates|mesh-ancestor
111321192|NCT00245011|Ifosfamide|ifosfamide|mesh-list
111321193|NCT00245011|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
111321194|NCT00245011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111321195|NCT00245011|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111321196|NCT00245011|Alkylating Agents|alkylating agents|mesh-ancestor
111321197|NCT00245011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111321198|NCT00245011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111321199|NCT00245011|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111145256|NCT02460991|Sorafenib|sorafenib|mesh-list
111321200|NCT00245011|Analgesics|analgesics|mesh-ancestor
111321201|NCT00245011|Sensory System Agents|sensory system agents|mesh-ancestor
111321202|NCT00245011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111321203|NCT05539053|Acetylcysteine|acetylcysteine|mesh-list
111321204|NCT05539053|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111321205|NCT05539053|Antiviral Agents|antiviral agents|mesh-ancestor
111321206|NCT05539053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111321207|NCT05539053|Expectorants|expectorants|mesh-ancestor
111321208|NCT05539053|Respiratory System Agents|respiratory system agents|mesh-ancestor
111045609|NCT02264119|Pantoprazole|pantoprazole|mesh-list
111321209|NCT05539053|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111321210|NCT05539053|Antioxidants|antioxidants|mesh-ancestor
111321211|NCT05539053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111321212|NCT05539053|Protective Agents|protective agents|mesh-ancestor
111321213|NCT05539053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111321215|NCT00629525|Everolimus|everolimus|mesh-list
111321216|NCT00629525|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111321217|NCT00629525|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111321218|NCT00629525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111321219|NCT00629525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111321220|NCT00629525|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111145337|NCT02260791|Adalimumab|adalimumab|mesh-list
111321221|NCT00629525|Immunologic Factors|immunologic factors|mesh-ancestor
111321222|NCT00629525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111321223|NCT00629525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111321224|NCT00244855|Dexamethasone|dexamethasone|mesh-list
111321225|NCT00244855|Rituximab|rituximab|mesh-list
111321226|NCT00244855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111321227|NCT00244855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111321228|NCT00244855|Immunologic Factors|immunologic factors|mesh-ancestor
111321229|NCT00244855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111321230|NCT00244855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111321231|NCT00244855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111321232|NCT00244855|Antiemetics|antiemetics|mesh-ancestor
111321233|NCT00244855|Autonomic Agents|autonomic agents|mesh-ancestor
111321234|NCT00244855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111321235|NCT00244855|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111321236|NCT00244855|Glucocorticoids|glucocorticoids|mesh-ancestor
111321237|NCT00244855|Hormones|hormones|mesh-ancestor
111321238|NCT00244855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111321239|NCT00244855|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111321240|NCT00737893|Epoetin Alfa|epoetin alfa|mesh-list
111321241|NCT00737893|Hematinics|hematinics|mesh-ancestor
111321242|NCT00631319|Hydromorphone|hydromorphone|mesh-list
111321243|NCT00631319|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111321244|NCT00631319|Narcotics|narcotics|mesh-ancestor
111321245|NCT00631319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111321246|NCT00631319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111321247|NCT00631319|Analgesics|analgesics|mesh-ancestor
111321248|NCT00631319|Sensory System Agents|sensory system agents|mesh-ancestor
111321249|NCT00631319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111321250|NCT00244621|Candesartan|candesartan|mesh-list
111321251|NCT00244621|Candesartan cilexetil|candesartan cilexetil|mesh-list
111321252|NCT00244621|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111321253|NCT00244621|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111321254|NCT00244621|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111321255|NCT00244621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111321256|NCT00680225|Ranibizumab|ranibizumab|mesh-list
111321257|NCT00680225|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111321258|NCT00680225|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111321259|NCT00680225|Growth Substances|growth substances|mesh-ancestor
111321260|NCT00680225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111321261|NCT00680225|Growth Inhibitors|growth inhibitors|mesh-ancestor
111321262|NCT00680225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111321263|NCT04603391|Cannabidiol|cannabidiol|mesh-list
111321264|NCT04603391|Methylphenidate|methylphenidate|mesh-list
111321265|NCT04603391|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111321266|NCT04603391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111145459|NCT02254551|Bortezomib|bortezomib|mesh-list
111321267|NCT04603391|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111321268|NCT04603391|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111321269|NCT04603391|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111365061|NCT01585207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111321270|NCT04603391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111321271|NCT04603391|Dopamine Agents|dopamine agents|mesh-ancestor
111321272|NCT04603391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111321273|NCT04603391|Anticonvulsants|anticonvulsants|mesh-ancestor
111321274|NCT00738049|Darusentan|darusentan|mesh-list
111321275|NCT00738049|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
111321276|NCT00738049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111321277|NCT02291133|Bleomycin|bleomycin|mesh-list
111321278|NCT02291133|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111321279|NCT02291133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111321280|NCT00680459|Ethanol|ethanol|mesh-list
111321281|NCT00680459|Heparin|heparin|mesh-list
111321282|NCT00680459|Anticoagulants|anticoagulants|mesh-list
111321283|NCT00680459|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111321284|NCT00680459|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111321285|NCT00680459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111321286|NCT00680459|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111321288|NCT00680459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111321289|NCT00680459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111321290|NCT00632411|Nicotine|nicotine|mesh-list
111321291|NCT00632411|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111321292|NCT00632411|Autonomic Agents|autonomic agents|mesh-ancestor
111321293|NCT00632411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111321294|NCT00632411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111321295|NCT00632411|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111321296|NCT00632411|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111321297|NCT00632411|Cholinergic Agents|cholinergic agents|mesh-ancestor
111321298|NCT00632411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111321299|NCT00632411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111321300|NCT05685836|Bevacizumab|bevacizumab|mesh-list
111321301|NCT05685836|89Zr-bevacizumab|89zr-bevacizumab|mesh-list
111321302|NCT05685836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111321303|NCT05685836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111321304|NCT05685836|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111321305|NCT05685836|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111321306|NCT05685836|Growth Substances|growth substances|mesh-ancestor
111321307|NCT05685836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111321308|NCT05685836|Growth Inhibitors|growth inhibitors|mesh-ancestor
111321309|NCT05685836|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111321310|NCT05685836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111321311|NCT00632489|Capecitabine|capecitabine|mesh-list
111321312|NCT00632489|Lapatinib|lapatinib|mesh-list
111321313|NCT00632489|Panobinostat|panobinostat|mesh-list
111321314|NCT00632489|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111321315|NCT00632489|Antimetabolites|antimetabolites|mesh-ancestor
111321316|NCT00632489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111321317|NCT00632489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111321318|NCT00632489|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111321319|NCT00632489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111321320|NCT00632489|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111321321|NCT05074875|Carbon Monoxide|carbon monoxide|mesh-list
111321322|NCT05074875|Antimetabolites|antimetabolites|mesh-ancestor
111321323|NCT05074875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111321324|NCT05074875|Gasotransmitters|gasotransmitters|mesh-ancestor
111321325|NCT05074875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111321326|NCT05074875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111321327|NCT01798979|Midazolam|midazolam|mesh-list
111321328|NCT01798979|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111321329|NCT01798979|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111321330|NCT01798979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111321331|NCT01798979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111321332|NCT01798979|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111321333|NCT01798979|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111321334|NCT01798979|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111321335|NCT01798979|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111321336|NCT01798979|Anesthetics, General|anesthetics, general|mesh-ancestor
111321337|NCT01798979|Anesthetics|anesthetics|mesh-ancestor
111321338|NCT01798979|GABA Modulators|gaba modulators|mesh-ancestor
111321339|NCT01798979|GABA Agents|gaba agents|mesh-ancestor
111146100|NCT03560349|Lidocaine|lidocaine|mesh-list
111321340|NCT01798979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111321341|NCT01798979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111321342|NCT00738361|Paclitaxel|paclitaxel|mesh-list
111321343|NCT00738361|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111321344|NCT00738361|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111321345|NCT00738361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111321346|NCT00738361|Tubulin Modulators|tubulin modulators|mesh-ancestor
111321347|NCT00738361|Antimitotic Agents|antimitotic agents|mesh-ancestor
111321348|NCT00738361|Mitosis Modulators|mitosis modulators|mesh-ancestor
111321349|NCT00738361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111321350|NCT01279213|Paliperidone Palmitate|paliperidone palmitate|mesh-list
111321351|NCT01279213|Clozapine|clozapine|mesh-list
111321352|NCT01279213|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111321353|NCT01279213|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111321354|NCT01279213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111321355|NCT01279213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111321356|NCT01279213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111321357|NCT01279213|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111321358|NCT01279213|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111321359|NCT01279213|Serotonin Agents|serotonin agents|mesh-ancestor
111321360|NCT01279213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111321361|NCT01279213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111321362|NCT01279213|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111321363|NCT01279213|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111321365|NCT01279213|GABA Antagonists|gaba antagonists|mesh-ancestor
111321366|NCT01279213|GABA Agents|gaba agents|mesh-ancestor
111321367|NCT00634283|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
111321368|NCT00634283|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111321369|NCT00634283|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111321370|NCT00634283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111321371|NCT00634283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111146282|NCT02236611|Glycopyrrolate|glycopyrrolate|mesh-list
111321372|NCT00634283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111321373|NCT00634283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111321374|NCT00634283|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111321375|NCT00634283|Antidepressive Agents|antidepressive agents|mesh-ancestor
111321376|NCT00634283|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111321377|NCT01279291|Paclitaxel|paclitaxel|mesh-list
111321378|NCT01279291|Carboplatin|carboplatin|mesh-list
111321379|NCT01279291|Gemcitabine|gemcitabine|mesh-list
111321380|NCT01279291|Doxorubicin|doxorubicin|mesh-list
111321381|NCT01279291|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111321382|NCT01279291|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111321383|NCT01279291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111321384|NCT01279291|Tubulin Modulators|tubulin modulators|mesh-ancestor
111321385|NCT01279291|Antimitotic Agents|antimitotic agents|mesh-ancestor
111321386|NCT01279291|Mitosis Modulators|mitosis modulators|mesh-ancestor
111321387|NCT01279291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111146414|NCT02202837|Sensory System Agents|sensory system agents|mesh-ancestor
111321388|NCT01279291|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111321389|NCT01279291|Antimetabolites|antimetabolites|mesh-ancestor
111321390|NCT01279291|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111321391|NCT01279291|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111321392|NCT01279291|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111321393|NCT01279291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111321394|NCT04367883|Amantadine|amantadine|mesh-list
111321395|NCT04367883|Histamine Antagonists|histamine antagonists|mesh-list
111321396|NCT04367883|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
111321397|NCT04367883|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111321398|NCT04367883|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111321399|NCT04367883|Antiviral Agents|antiviral agents|mesh-ancestor
111321400|NCT04367883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111321401|NCT04367883|Dopamine Agents|dopamine agents|mesh-ancestor
111321402|NCT04367883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111321403|NCT04367883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111321404|NCT04367883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111321405|NCT04367883|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111321406|NCT04367883|Analgesics|analgesics|mesh-ancestor
111321407|NCT04367883|Sensory System Agents|sensory system agents|mesh-ancestor
111321408|NCT04367883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111321409|NCT04367883|Histamine Agents|histamine agents|mesh-ancestor
111321410|NCT04329039|Somatostatin|somatostatin|mesh-list
111321411|NCT04329039|Hormones|hormones|mesh-ancestor
111321412|NCT04329039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111321413|NCT04329039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111321414|NCT00635609|Doxycycline|doxycycline|mesh-list
111321415|NCT00635609|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111321416|NCT00635609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111321417|NCT00635609|Antimalarials|antimalarials|mesh-ancestor
111321418|NCT00635609|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111321419|NCT00635609|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111321420|NCT04347902|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
111321421|NCT04347902|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
111321422|NCT04347902|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111321423|NCT03298802|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
111321424|NCT03298802|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111321425|NCT03298802|Diuretics|diuretics|mesh-ancestor
111321426|NCT03298802|Natriuretic Agents|natriuretic agents|mesh-ancestor
111321427|NCT03298802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111321428|NCT03298802|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
111321429|NCT03298802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111321430|NCT03298802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111321431|NCT03066843|Aminolevulinic Acid|aminolevulinic acid|mesh-list
111321432|NCT03066843|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111321433|NCT03066843|Dermatologic Agents|dermatologic agents|mesh-ancestor
111321434|NCT05315336|Antibodies|antibodies|mesh-list
111321435|NCT05315336|Immunologic Factors|immunologic factors|mesh-ancestor
111321436|NCT05315336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111321437|NCT04746495|Eplerenone|eplerenone|mesh-list
111321438|NCT04746495|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
111321439|NCT04746495|Hormone Antagonists|hormone antagonists|mesh-ancestor
111321440|NCT04746495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111146809|NCT02384395|Lamivudine|lamivudine|mesh-list
111321441|NCT04746495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111321442|NCT04746495|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
111321443|NCT04746495|Diuretics|diuretics|mesh-ancestor
111321444|NCT04746495|Natriuretic Agents|natriuretic agents|mesh-ancestor
111321445|NCT04746495|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111321446|NCT03347786|Verapamil|verapamil|mesh-list
111321447|NCT03347786|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111321448|NCT03347786|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111321449|NCT03347786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111365062|NCT01585207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111321450|NCT03347786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111321451|NCT03347786|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111321452|NCT03347786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111321453|NCT03347786|Vasodilator Agents|vasodilator agents|mesh-ancestor
111321454|NCT03288974|Pomalidomide|pomalidomide|mesh-list
111321455|NCT03288974|Immunologic Factors|immunologic factors|mesh-ancestor
111321456|NCT03288974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111321457|NCT03288974|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111321458|NCT03288974|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111321459|NCT03288974|Growth Substances|growth substances|mesh-ancestor
111321460|NCT03288974|Growth Inhibitors|growth inhibitors|mesh-ancestor
111321461|NCT03288974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111321462|NCT03286634|Cytarabine|cytarabine|mesh-list
111321463|NCT03286634|Prednisolone|prednisolone|mesh-list
111321464|NCT03286634|Hydrocortisone|hydrocortisone|mesh-list
111321465|NCT03286634|Cyclophosphamide|cyclophosphamide|mesh-list
111321466|NCT03286634|Methotrexate|methotrexate|mesh-list
111321467|NCT03286634|Vincristine|vincristine|mesh-list
111321468|NCT03286634|Daunorubicin|daunorubicin|mesh-list
111321469|NCT03286634|Asparaginase|asparaginase|mesh-list
111321470|NCT03286634|Epirubicin|epirubicin|mesh-list
111321471|NCT03286634|Mercaptopurine|mercaptopurine|mesh-list
111321472|NCT03286634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111321473|NCT03286634|Immunologic Factors|immunologic factors|mesh-ancestor
111321474|NCT03286634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111321475|NCT03286634|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111321476|NCT03286634|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111321477|NCT03286634|Alkylating Agents|alkylating agents|mesh-ancestor
111321478|NCT03286634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111321479|NCT03286634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111321480|NCT03286634|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111365063|NCT03007303|Olanzapine|olanzapine|mesh-list
111321481|NCT03286634|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111321482|NCT03286634|Abortifacient Agents|abortifacient agents|mesh-ancestor
111321483|NCT03286634|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111321484|NCT03286634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111321485|NCT03286634|Antimetabolites|antimetabolites|mesh-ancestor
111321486|NCT03286634|Dermatologic Agents|dermatologic agents|mesh-ancestor
111321487|NCT03286634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111321488|NCT03286634|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111321489|NCT03286634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111321490|NCT03286634|Antiviral Agents|antiviral agents|mesh-ancestor
111321491|NCT03286634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111365064|NCT03007303|Risperidone|risperidone|mesh-list
111321492|NCT03286634|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111321493|NCT03286634|Tubulin Modulators|tubulin modulators|mesh-ancestor
111321494|NCT03286634|Antimitotic Agents|antimitotic agents|mesh-ancestor
111321495|NCT03286634|Mitosis Modulators|mitosis modulators|mesh-ancestor
111321496|NCT03286634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111321497|NCT03286634|Glucocorticoids|glucocorticoids|mesh-ancestor
111321498|NCT03286634|Hormones|hormones|mesh-ancestor
111365065|NCT03007303|Quetiapine Fumarate|quetiapine fumarate|mesh-list
111321499|NCT03286634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111321500|NCT03286634|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111321501|NCT03286634|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111321502|NCT03286634|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111321503|NCT03286634|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111321504|NCT00637247|Gemcitabine|gemcitabine|mesh-list
111321505|NCT00637247|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111321506|NCT00637247|Antimetabolites|antimetabolites|mesh-ancestor
111321507|NCT00637247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111321508|NCT00637247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111045929|NCT05478044|Vitamins|vitamins|mesh-ancestor
111321509|NCT04998032|Metformin|metformin|mesh-list
111321511|NCT04998032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111321512|NCT04388033|Temozolomide|temozolomide|mesh-list
111321513|NCT04388033|Interleukin-12|interleukin-12|mesh-list
111321514|NCT04388033|Vaccines|vaccines|mesh-list
111321515|NCT04388033|Immunologic Factors|immunologic factors|mesh-ancestor
111321516|NCT04388033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111321517|NCT04388033|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111321518|NCT04388033|Alkylating Agents|alkylating agents|mesh-ancestor
111365066|NCT03007303|Ziprasidone|ziprasidone|mesh-list
111321519|NCT04388033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111321520|NCT04388033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111321521|NCT04388033|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111321522|NCT04388033|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111321523|NCT04388033|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111321524|NCT04388033|Growth Substances|growth substances|mesh-ancestor
111321525|NCT04388033|Growth Inhibitors|growth inhibitors|mesh-ancestor
111321526|NCT02980731|Venetoclax|venetoclax|mesh-list
111321527|NCT02980731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111321528|NCT05564390|Cytarabine|cytarabine|mesh-list
111321529|NCT05564390|Azacitidine|azacitidine|mesh-list
111321530|NCT05564390|Daunorubicin|daunorubicin|mesh-list
111321531|NCT05564390|Venetoclax|venetoclax|mesh-list
111321532|NCT05564390|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111321533|NCT05564390|Antimetabolites|antimetabolites|mesh-ancestor
111147924|NCT04422275|Glucocorticoids|glucocorticoids|mesh-ancestor
111321534|NCT05564390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111321535|NCT05564390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111321536|NCT05564390|Antiviral Agents|antiviral agents|mesh-ancestor
111321537|NCT05564390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111321538|NCT05564390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111321539|NCT05564390|Immunologic Factors|immunologic factors|mesh-ancestor
111321540|NCT05564390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111321541|NCT05564390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111321542|NCT05564390|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111321543|NCT05564390|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111321544|NCT05564390|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111321545|NCT04725591|Insulin|insulin|mesh-list
111321546|NCT04725591|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111321547|NCT04725591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111321548|NCT02980497|Ethanol|ethanol|mesh-list
111321549|NCT02980497|Listerine|listerine|mesh-list
111321550|NCT02980497|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
111321551|NCT02980497|Sodium Fluoride|sodium fluoride|mesh-list
111321552|NCT02980497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111321553|NCT02980497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111321554|NCT02980497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111321555|NCT02980497|Cariostatic Agents|cariostatic agents|mesh-ancestor
111321556|NCT02980497|Protective Agents|protective agents|mesh-ancestor
111321557|NCT02652429|Nitric Oxide|nitric oxide|mesh-list
111321558|NCT02652429|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111321559|NCT02652429|Autonomic Agents|autonomic agents|mesh-ancestor
111365067|NCT03007303|Antipsychotic Agents|antipsychotic agents|mesh-list
111321560|NCT02652429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111321561|NCT02652429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111321562|NCT02652429|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111321563|NCT02652429|Respiratory System Agents|respiratory system agents|mesh-ancestor
111321564|NCT02652429|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111321565|NCT02652429|Antioxidants|antioxidants|mesh-ancestor
111321566|NCT02652429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111321567|NCT02652429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111321568|NCT02652429|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
111321569|NCT02652429|Vasodilator Agents|vasodilator agents|mesh-ancestor
111321570|NCT02652429|Gasotransmitters|gasotransmitters|mesh-ancestor
111321571|NCT02652429|Protective Agents|protective agents|mesh-ancestor
111321572|NCT02294253|Buprenorphine|buprenorphine|mesh-list
111148341|NCT02118597|Antimetabolites|antimetabolites|mesh-ancestor
111321573|NCT02294253|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
111321574|NCT02294253|Naloxone|naloxone|mesh-list
111321575|NCT02294253|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111321576|NCT02294253|Narcotics|narcotics|mesh-ancestor
111321577|NCT02294253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111321578|NCT02294253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111321579|NCT02294253|Analgesics|analgesics|mesh-ancestor
111321580|NCT02294253|Sensory System Agents|sensory system agents|mesh-ancestor
111321581|NCT02294253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111321582|NCT02294253|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111045982|NCT03646604|Upadacitinib|upadacitinib|mesh-list
111321583|NCT00684983|Capecitabine|capecitabine|mesh-list
111321584|NCT00684983|Lapatinib|lapatinib|mesh-list
111321585|NCT00684983|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111321586|NCT00684983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111321587|NCT00684983|Antimetabolites|antimetabolites|mesh-ancestor
111321588|NCT00684983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111321589|NCT00684983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111148555|NCT02152371|Metformin|metformin|mesh-list
111321590|NCT00684983|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111321591|NCT00684983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111321592|NCT00684983|Immunologic Factors|immunologic factors|mesh-ancestor
111148615|NCT02300311|Micronutrients|micronutrients|mesh-ancestor
111321593|NCT00684983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111321594|NCT00638651|Imiquimod|imiquimod|mesh-list
111321595|NCT00638651|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111321596|NCT00638651|Immunologic Factors|immunologic factors|mesh-ancestor
111321597|NCT00638651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111321598|NCT00638651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111321599|NCT00638651|Interferon Inducers|interferon inducers|mesh-ancestor
111321600|NCT02584647|Sirolimus|sirolimus|mesh-list
111321601|NCT02584647|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111321602|NCT02584647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111321603|NCT02584647|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111321604|NCT02584647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111148869|NCT05046431|Golimumab|golimumab|mesh-list
111321605|NCT02584647|Antifungal Agents|antifungal agents|mesh-ancestor
111321606|NCT02584647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111321607|NCT02584647|Immunologic Factors|immunologic factors|mesh-ancestor
111321608|NCT02584647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111321609|NCT00685139|Zonisamide|zonisamide|mesh-list
111321610|NCT00685139|Anticonvulsants|anticonvulsants|mesh-ancestor
111321611|NCT00685139|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111321612|NCT00685139|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111321613|NCT00685139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111321614|NCT00685139|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111148968|NCT02106351|Cholinergic Agents|cholinergic agents|mesh-ancestor
111321615|NCT00685139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111321616|NCT00685295|Fentanyl|fentanyl|mesh-list
111321617|NCT00685295|Oxycodone|oxycodone|mesh-list
111321618|NCT00685295|Lansoprazole|lansoprazole|mesh-list
111321619|NCT00685295|Dexlansoprazole|dexlansoprazole|mesh-list
111321620|NCT00685295|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111321621|NCT00685295|Narcotics|narcotics|mesh-ancestor
111321622|NCT00685295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111149112|NCT02519777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111321623|NCT00685295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111321624|NCT00685295|Analgesics|analgesics|mesh-ancestor
111321625|NCT00685295|Sensory System Agents|sensory system agents|mesh-ancestor
111321626|NCT00685295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111321627|NCT00685295|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111321628|NCT00685295|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111321629|NCT00685295|Anesthetics, General|anesthetics, general|mesh-ancestor
111321630|NCT00685295|Anesthetics|anesthetics|mesh-ancestor
111321631|NCT00685295|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111321632|NCT00685295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111321633|NCT00685295|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111321634|NCT00685295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111321635|NCT00685295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111321636|NCT00686231|Lidocaine|lidocaine|mesh-list
111321637|NCT00686231|Nitroglycerin|nitroglycerin|mesh-list
111321638|NCT00686231|Anesthetics, Local|anesthetics, local|mesh-ancestor
111321639|NCT00686231|Anesthetics|anesthetics|mesh-ancestor
111321640|NCT00686231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111321641|NCT00686231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111321642|NCT00686231|Sensory System Agents|sensory system agents|mesh-ancestor
111321643|NCT00686231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111321644|NCT00686231|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111321645|NCT00686231|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111321646|NCT00686231|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111321647|NCT00686231|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111321648|NCT00686231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111321649|NCT00686231|Vasodilator Agents|vasodilator agents|mesh-ancestor
111321650|NCT05278208|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
111321651|NCT05278208|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111321652|NCT05278208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111321653|NCT03335774|Hydrocortisone|hydrocortisone|mesh-list
111321654|NCT03335774|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
111321655|NCT03335774|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
111321656|NCT03335774|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
111149372|NCT02502149|Factor VIII|factor viii|mesh-list
111321657|NCT03335774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111321658|NCT03335540|Nivolumab|nivolumab|mesh-list
111321659|NCT03335540|Ipilimumab|ipilimumab|mesh-list
111321660|NCT03335540|Relatlimab|relatlimab|mesh-list
111321661|NCT03335540|Linrodostat|linrodostat|mesh-list
111321662|NCT03335540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111321663|NCT03335540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111321664|NCT03335540|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111321665|NCT03335540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111321666|NCT03335540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111321667|NCT00643097|Temozolomide|temozolomide|mesh-list
111321668|NCT00643097|Sargramostim|sargramostim|mesh-list
111321669|NCT00643097|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111321670|NCT00643097|Alkylating Agents|alkylating agents|mesh-ancestor
111321671|NCT00643097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111321672|NCT00643097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111321673|NCT00643097|Immunologic Factors|immunologic factors|mesh-ancestor
111321674|NCT00643097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111321676|NCT03333668|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
111321677|NCT03333668|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111321678|NCT03333668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111321679|NCT03333668|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111321680|NCT03333668|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111321681|NCT03333668|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111321682|NCT03333668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111321683|NCT03333668|Dopamine Agents|dopamine agents|mesh-ancestor
111321684|NCT03333668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111321685|NCT03333668|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111321686|NCT03333668|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111321687|NCT03333668|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111321688|NCT03333668|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111321689|NCT03333668|Adrenergic Agents|adrenergic agents|mesh-ancestor
111321690|NCT03280160|Ofatumumab|ofatumumab|mesh-list
111321691|NCT03280160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111321692|NCT04683315|Paclitaxel|paclitaxel|mesh-list
111321693|NCT04683315|Gemcitabine|gemcitabine|mesh-list
111321694|NCT04683315|Fluorouracil|fluorouracil|mesh-list
111321695|NCT04683315|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111321696|NCT04683315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111149637|NCT02500901|Niraparib|niraparib|mesh-list
111321697|NCT04683315|Tubulin Modulators|tubulin modulators|mesh-ancestor
111321698|NCT04683315|Antimitotic Agents|antimitotic agents|mesh-ancestor
111321699|NCT04683315|Mitosis Modulators|mitosis modulators|mesh-ancestor
111321700|NCT04683315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111321701|NCT04683315|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111321702|NCT04683315|Antimetabolites|antimetabolites|mesh-ancestor
111321703|NCT04683315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111321704|NCT04683315|Immunologic Factors|immunologic factors|mesh-ancestor
111149769|NCT01872910|Analgesics|analgesics|mesh-ancestor
111321705|NCT04683315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111321706|NCT05502146|Norepinephrine|norepinephrine|mesh-list
111321707|NCT05502146|Bupivacaine|bupivacaine|mesh-list
111321708|NCT05502146|Anesthetics, Local|anesthetics, local|mesh-ancestor
111321709|NCT05502146|Anesthetics|anesthetics|mesh-ancestor
111321710|NCT05502146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111321711|NCT05502146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111321712|NCT05502146|Sensory System Agents|sensory system agents|mesh-ancestor
111321713|NCT05502146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111321714|NCT05502146|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111321715|NCT05502146|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111321716|NCT05502146|Adrenergic Agents|adrenergic agents|mesh-ancestor
111321717|NCT05502146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111321718|NCT05502146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111321719|NCT05502146|Sympathomimetics|sympathomimetics|mesh-ancestor
111321720|NCT05502146|Autonomic Agents|autonomic agents|mesh-ancestor
111321721|NCT05502146|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111321722|NCT04027361|Amphetamine|amphetamine|mesh-list
111321723|NCT04027361|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111149897|NCT02476175|Adrenergic Agents|adrenergic agents|mesh-ancestor
111321724|NCT04027361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111321725|NCT04027361|Sympathomimetics|sympathomimetics|mesh-ancestor
111321726|NCT04027361|Autonomic Agents|autonomic agents|mesh-ancestor
111321727|NCT04027361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111321728|NCT04027361|Dopamine Agents|dopamine agents|mesh-ancestor
111321729|NCT04027361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111321730|NCT04027361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111321731|NCT04027361|Adrenergic Agents|adrenergic agents|mesh-ancestor
111321732|NCT04027361|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111321733|NCT04027361|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111150036|NCT01901146|Paclitaxel|paclitaxel|mesh-list
111321734|NCT04027361|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111321736|NCT04682847|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
111321737|NCT04682847|Hematinics|hematinics|mesh-ancestor
111321738|NCT04682847|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
111150107|NCT01646827|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111321739|NCT04682847|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111321740|NCT04011839|Levobupivacaine|levobupivacaine|mesh-list
111321741|NCT04011839|Anesthetics, Local|anesthetics, local|mesh-ancestor
111321742|NCT04011839|Anesthetics|anesthetics|mesh-ancestor
111321743|NCT04011839|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111150178|NCT02359435|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111321744|NCT04011839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111321745|NCT04011839|Sensory System Agents|sensory system agents|mesh-ancestor
111321746|NCT04011839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111321747|NCT03793439|Prednisone|prednisone|mesh-list
111321748|NCT03793439|Tofacitinib|tofacitinib|mesh-list
111321749|NCT03793439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111321750|NCT03793439|Glucocorticoids|glucocorticoids|mesh-ancestor
111321751|NCT03793439|Hormones|hormones|mesh-ancestor
111321752|NCT03793439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111321753|NCT03793439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111321754|NCT03793439|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111321755|NCT03793439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111321756|NCT03793439|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
111321757|NCT03793439|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111321758|NCT03793439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111321759|NCT03793439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111321760|NCT00687167|Zonisamide|zonisamide|mesh-list
111321761|NCT00687167|Anticonvulsants|anticonvulsants|mesh-ancestor
111321762|NCT00687167|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111321763|NCT00687167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111321764|NCT00687167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111321765|NCT00687167|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111321766|NCT00687167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111321767|NCT00687713|Bupropion|bupropion|mesh-list
111321768|NCT00687713|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111150530|NCT01896232|Cinacalcet|cinacalcet|mesh-list
111321769|NCT00687713|Antidepressive Agents|antidepressive agents|mesh-ancestor
111321770|NCT00687713|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111321771|NCT00687713|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111321772|NCT00687713|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111150595|NCT01857622|Edoxaban|edoxaban|mesh-list
111321773|NCT00687713|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111321774|NCT00687713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111321775|NCT00687713|Dopamine Agents|dopamine agents|mesh-ancestor
111321776|NCT00687713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111321777|NCT00687713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111150669|NCT04204967|Anesthetics, General|anesthetics, general|mesh-ancestor
111321778|NCT00687713|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111321779|NCT00687713|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111321780|NCT00687713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111321781|NCT02304159|Ribavirin|ribavirin|mesh-list
111321782|NCT02304159|Sofosbuvir|sofosbuvir|mesh-list
111321783|NCT02304159|Antimetabolites|antimetabolites|mesh-ancestor
111321784|NCT02304159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111321785|NCT02304159|Antiviral Agents|antiviral agents|mesh-ancestor
111321786|NCT02304159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111321787|NCT02143973|Nalbuphine|nalbuphine|mesh-list
111321788|NCT02143973|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111321789|NCT02143973|Narcotics|narcotics|mesh-ancestor
111321790|NCT02143973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111321791|NCT02143973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111321792|NCT02143973|Analgesics|analgesics|mesh-ancestor
111321793|NCT02143973|Sensory System Agents|sensory system agents|mesh-ancestor
111321794|NCT02143973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111321795|NCT03028701|Budesonide|budesonide|mesh-list
111321796|NCT03028701|Formoterol Fumarate|formoterol fumarate|mesh-list
111321797|NCT03028701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111321798|NCT03028701|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111321799|NCT03028701|Autonomic Agents|autonomic agents|mesh-ancestor
111321800|NCT03028701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111321801|NCT03028701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111321802|NCT03028701|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111321803|NCT03028701|Respiratory System Agents|respiratory system agents|mesh-ancestor
111321804|NCT03028701|Glucocorticoids|glucocorticoids|mesh-ancestor
111321805|NCT03028701|Hormones|hormones|mesh-ancestor
111321806|NCT03028701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111046210|NCT02159573|Dermatologic Agents|dermatologic agents|mesh-ancestor
111321807|NCT03028701|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111321808|NCT03028701|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111321809|NCT03028701|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111321810|NCT03028701|Adrenergic Agents|adrenergic agents|mesh-ancestor
111321811|NCT03028701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111321812|NCT03028701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111321813|NCT03686696|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
111321814|NCT03686696|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
111321815|NCT03686696|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
111321816|NCT03686696|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111321817|NCT03686696|Adrenergic Agents|adrenergic agents|mesh-ancestor
111321818|NCT03686696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111321819|NCT03686696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111321820|NCT03686696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111321821|NCT03686696|Protease Inhibitors|protease inhibitors|mesh-ancestor
111321822|NCT03686696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111321823|NCT02267655|Nitric Oxide|nitric oxide|mesh-list
111321824|NCT02267655|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111321825|NCT02267655|Autonomic Agents|autonomic agents|mesh-ancestor
111321826|NCT02267655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111321827|NCT02267655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111321828|NCT02267655|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111321829|NCT02267655|Respiratory System Agents|respiratory system agents|mesh-ancestor
111321830|NCT02267655|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111321831|NCT02267655|Antioxidants|antioxidants|mesh-ancestor
111321832|NCT02267655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111321833|NCT02267655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111321834|NCT02267655|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
111321835|NCT02267655|Vasodilator Agents|vasodilator agents|mesh-ancestor
111321836|NCT02267655|Gasotransmitters|gasotransmitters|mesh-ancestor
111321837|NCT02267655|Protective Agents|protective agents|mesh-ancestor
111321838|NCT04858958|Aflutinib|aflutinib|mesh-list
111321839|NCT04858958|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111321840|NCT04858958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111321841|NCT04858958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111321842|NCT00690833|Desonide|desonide|mesh-list
111321843|NCT00690833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111321844|NCT03686306|Sildenafil Citrate|sildenafil citrate|mesh-list
111321845|NCT03686306|Vasodilator Agents|vasodilator agents|mesh-ancestor
111321846|NCT03686306|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111321847|NCT03686306|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111321848|NCT03686306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111321849|NCT03686306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111321850|NCT03686306|Urological Agents|urological agents|mesh-ancestor
111321851|NCT04078269|Immunomodulating Agents|immunomodulating agents|mesh-list
111321852|NCT04078269|Immunologic Factors|immunologic factors|mesh-ancestor
111321853|NCT04078269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111321854|NCT00644657|Clopidogrel|clopidogrel|mesh-list
111321855|NCT00644657|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111321856|NCT00644657|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111321857|NCT00644657|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111321858|NCT00644657|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111321859|NCT00644657|Purinergic Agents|purinergic agents|mesh-ancestor
111321860|NCT00644657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111321861|NCT00644657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111321862|NCT00644657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111321863|NCT04613024|Topiramate|topiramate|mesh-list
111321864|NCT04613024|Gabapentin|gabapentin|mesh-list
111321865|NCT04613024|Analgesics|analgesics|mesh-ancestor
111321866|NCT04613024|Sensory System Agents|sensory system agents|mesh-ancestor
111321867|NCT04613024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111321868|NCT04613024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111321869|NCT04613024|Anticonvulsants|anticonvulsants|mesh-ancestor
111321870|NCT04613024|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111321871|NCT04613024|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111321872|NCT04613024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111321873|NCT04613024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111321874|NCT04613024|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111321875|NCT04613024|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111321876|NCT04613024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111321877|NCT04613024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111321878|NCT04613024|Antimanic Agents|antimanic agents|mesh-ancestor
111321879|NCT04613024|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111321880|NCT01933815|Bevacizumab|bevacizumab|mesh-list
111321881|NCT01933815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111321882|NCT01933815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111321883|NCT01933815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111321884|NCT01933815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111321885|NCT01933815|Growth Substances|growth substances|mesh-ancestor
111321886|NCT01933815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111321887|NCT01933815|Growth Inhibitors|growth inhibitors|mesh-ancestor
111321888|NCT04606316|Nivolumab|nivolumab|mesh-list
111321889|NCT04606316|Ipilimumab|ipilimumab|mesh-list
111321890|NCT04606316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111321891|NCT04606316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111321892|NCT04606316|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111321893|NCT04606316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111321894|NCT03480971|Tempol|tempol|mesh-list
111321895|NCT03480971|TEMPO|tempo|mesh-list
111321896|NCT03480971|Antioxidants|antioxidants|mesh-ancestor
111321897|NCT03480971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111321898|NCT03480971|Protective Agents|protective agents|mesh-ancestor
111321899|NCT03480971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111321900|NCT03480971|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111321901|NCT03480971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111321902|NCT03480971|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111321903|NCT03480971|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111321904|NCT00646763|Lenograstim|lenograstim|mesh-list
111321905|NCT00646763|Sargramostim|sargramostim|mesh-list
111321906|NCT00646763|Mitogens|mitogens|mesh-list
111321907|NCT00646763|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111321908|NCT00646763|Immunologic Factors|immunologic factors|mesh-ancestor
111321909|NCT00646763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111321910|NCT00646763|Mitosis Modulators|mitosis modulators|mesh-ancestor
111321911|NCT00646763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111321912|NCT03237572|Pembrolizumab|pembrolizumab|mesh-list
111321913|NCT03237572|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111151438|NCT05565235|Nalbuphine|nalbuphine|mesh-list
111321914|NCT03237572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111321915|NCT03237572|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111321916|NCT03237572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111321917|NCT02986347|Epinephrine|epinephrine|mesh-list
111321918|NCT02986347|Racepinephrine|racepinephrine|mesh-list
111321919|NCT02986347|Anesthetics|anesthetics|mesh-list
111321920|NCT02986347|Epinephryl borate|epinephryl borate|mesh-list
111321921|NCT02986347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111321922|NCT02986347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111321923|NCT02986347|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111321924|NCT02986347|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111321925|NCT02986347|Adrenergic Agents|adrenergic agents|mesh-ancestor
111321926|NCT02986347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111321927|NCT02986347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111321928|NCT02986347|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111321929|NCT02986347|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111321930|NCT02986347|Autonomic Agents|autonomic agents|mesh-ancestor
111321931|NCT02986347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111321932|NCT02986347|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111321933|NCT02986347|Respiratory System Agents|respiratory system agents|mesh-ancestor
111321934|NCT02986347|Mydriatics|mydriatics|mesh-ancestor
111321935|NCT02986347|Sympathomimetics|sympathomimetics|mesh-ancestor
111321936|NCT02986347|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111321937|NCT00649961|Melatonin|melatonin|mesh-list
111321938|NCT00649961|Antioxidants|antioxidants|mesh-ancestor
111321939|NCT00649961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111321940|NCT00649961|Protective Agents|protective agents|mesh-ancestor
111321941|NCT00649961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111321942|NCT00649961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111321943|NCT03235232|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111321944|NCT03235232|Brimonidine Tartrate, Timolol Maleate Drug Combination|brimonidine tartrate, timolol maleate drug combination|mesh-list
111321945|NCT03235232|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111321946|NCT03235232|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111321947|NCT03235232|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111321948|NCT03235232|Adrenergic Agents|adrenergic agents|mesh-ancestor
111321949|NCT03235232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111321950|NCT03235232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111321951|NCT03235232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111321952|NCT03235232|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111046360|NCT02156843|Pyridoxamine|pyridoxamine|mesh-list
111321953|NCT03235232|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111321955|NCT01781637|Omalizumab|omalizumab|mesh-list
111321956|NCT01781637|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111321957|NCT01781637|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111321958|NCT01781637|Respiratory System Agents|respiratory system agents|mesh-ancestor
111321959|NCT00652145|Mesalamine|mesalamine|mesh-list
111321960|NCT00652145|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111151682|NCT02323334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111321961|NCT00652145|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111321962|NCT00652145|Analgesics|analgesics|mesh-ancestor
111321963|NCT00652145|Sensory System Agents|sensory system agents|mesh-ancestor
111321964|NCT00652145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111321965|NCT00652145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111321966|NCT00652145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111321967|NCT00652145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111321968|NCT03231722|Leucovorin|leucovorin|mesh-list
111321969|NCT03231722|Fluorouracil|fluorouracil|mesh-list
111321970|NCT03231722|Oxaliplatin|oxaliplatin|mesh-list
111321971|NCT03231722|Irinotecan|irinotecan|mesh-list
111321972|NCT03231722|Panitumumab|panitumumab|mesh-list
111321973|NCT03231722|Levoleucovorin|levoleucovorin|mesh-list
111321974|NCT03231722|Antimetabolites|antimetabolites|mesh-ancestor
111321975|NCT03231722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111321976|NCT03231722|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111321977|NCT03231722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111321978|NCT03231722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111321979|NCT03231722|Immunologic Factors|immunologic factors|mesh-ancestor
111321980|NCT03231722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111321981|NCT03231722|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111321982|NCT03231722|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111321983|NCT03231722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111321984|NCT03231722|Antidotes|antidotes|mesh-ancestor
111321985|NCT03231722|Protective Agents|protective agents|mesh-ancestor
111321986|NCT03231722|Vitamin B Complex|vitamin b complex|mesh-ancestor
111321987|NCT03231722|Vitamins|vitamins|mesh-ancestor
111321988|NCT03231722|Micronutrients|micronutrients|mesh-ancestor
111321989|NCT03231722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111321990|NCT02298933|Eculizumab|eculizumab|mesh-list
111321991|NCT02298933|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
111321992|NCT02298933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111321993|NCT02298933|Immunologic Factors|immunologic factors|mesh-ancestor
111321994|NCT02298933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111321995|NCT02959775|Vaccines|vaccines|mesh-list
111321996|NCT02959775|Immunologic Factors|immunologic factors|mesh-ancestor
111321997|NCT02959775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111321998|NCT04761848|Cilostazol|cilostazol|mesh-list
111321999|NCT04761848|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111322000|NCT04761848|Autonomic Agents|autonomic agents|mesh-ancestor
111322001|NCT04761848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111322002|NCT04761848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111322003|NCT04761848|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111322004|NCT04761848|Respiratory System Agents|respiratory system agents|mesh-ancestor
111322005|NCT04761848|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111322006|NCT04761848|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111322007|NCT04761848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111152182|NCT04709211|Bupivacaine|bupivacaine|mesh-list
111322008|NCT04761848|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111322009|NCT04761848|Vasodilator Agents|vasodilator agents|mesh-ancestor
111322010|NCT04761848|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111322011|NCT04761848|Protective Agents|protective agents|mesh-ancestor
111322012|NCT04761848|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
111322013|NCT04761848|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111322014|NCT04761848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111322015|NCT04278248|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
111322016|NCT04278248|Immunologic Factors|immunologic factors|mesh-ancestor
111322017|NCT04278248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111322018|NCT04056962|Tacrolimus|tacrolimus|mesh-list
111322019|NCT04056962|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111322020|NCT04056962|Immunologic Factors|immunologic factors|mesh-ancestor
111322021|NCT04056962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111322022|NCT04056962|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111322023|NCT04056962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111322024|NCT04056962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111322025|NCT00693485|Brimonidine Tartrate|brimonidine tartrate|mesh-list
111322026|NCT00693485|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111322027|NCT00693485|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111046437|NCT02157311|Tenofovir|tenofovir|mesh-list
111322028|NCT00693485|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111322029|NCT00693485|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111322030|NCT00693485|Adrenergic Agents|adrenergic agents|mesh-ancestor
111322031|NCT00693485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111322032|NCT00693485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111322033|NCT00693485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110869704|NCT03169504|Xhance|xhance|mesh-list
111322034|NCT00693719|Irinotecan|irinotecan|mesh-list
111322035|NCT00693719|Etoposide|etoposide|mesh-list
111322036|NCT00693719|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111322037|NCT00693719|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111322038|NCT00693719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111322039|NCT00693719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111322040|NCT00693719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111322041|NCT00693719|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111322042|NCT00693719|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111322043|NCT00653861|Lidocaine|lidocaine|mesh-list
111322044|NCT00653861|Anesthetics, Local|anesthetics, local|mesh-ancestor
111322045|NCT00653861|Anesthetics|anesthetics|mesh-ancestor
111322046|NCT00653861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111322047|NCT00653861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111322048|NCT00653861|Sensory System Agents|sensory system agents|mesh-ancestor
111322049|NCT00653861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111322050|NCT00653861|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111322051|NCT00653861|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111322052|NCT00653861|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111322053|NCT00653861|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111322054|NCT00653861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111322055|NCT00654329|Fentanyl|fentanyl|mesh-list
111322056|NCT00654329|Dexmedetomidine|dexmedetomidine|mesh-list
111322057|NCT00654329|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111322058|NCT00654329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111322059|NCT00654329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111322060|NCT00654329|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111322061|NCT00654329|Analgesics|analgesics|mesh-ancestor
111322062|NCT00654329|Sensory System Agents|sensory system agents|mesh-ancestor
111152777|NCT02387957|Growth Substances|growth substances|mesh-ancestor
111322063|NCT00654329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111322064|NCT00654329|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111322065|NCT00654329|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111322066|NCT00654329|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111322067|NCT00654329|Adrenergic Agents|adrenergic agents|mesh-ancestor
111322068|NCT00654329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111322069|NCT00654329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111322070|NCT00654329|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111322071|NCT00654329|Narcotics|narcotics|mesh-ancestor
111322072|NCT00654329|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111322073|NCT00654329|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111322074|NCT00654329|Anesthetics, General|anesthetics, general|mesh-ancestor
111322075|NCT00654329|Anesthetics|anesthetics|mesh-ancestor
111322076|NCT00695435|Tobramycin|tobramycin|mesh-list
111322077|NCT00695435|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
111322078|NCT00695435|Dexamethasone|dexamethasone|mesh-list
111322079|NCT00695435|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111322080|NCT00695435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111322081|NCT00695435|Antiemetics|antiemetics|mesh-ancestor
111322082|NCT00695435|Autonomic Agents|autonomic agents|mesh-ancestor
111322083|NCT00695435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111322084|NCT00695435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111322085|NCT00695435|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111322086|NCT00695435|Glucocorticoids|glucocorticoids|mesh-ancestor
111322087|NCT00695435|Hormones|hormones|mesh-ancestor
111322088|NCT00695435|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111322089|NCT00695435|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111322090|NCT00695435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111322091|NCT00695435|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111322092|NCT00695435|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111322093|NCT00695435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111322094|NCT00654953|Gabapentin|gabapentin|mesh-list
111322095|NCT00654953|Sertraline|sertraline|mesh-list
111322096|NCT00654953|Analgesics|analgesics|mesh-ancestor
111322097|NCT00654953|Sensory System Agents|sensory system agents|mesh-ancestor
111322098|NCT00654953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111322099|NCT00654953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111322100|NCT00654953|Anticonvulsants|anticonvulsants|mesh-ancestor
111322101|NCT00654953|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111046510|NCT02538614|Idelalisib|idelalisib|mesh-list
111322102|NCT00654953|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111322103|NCT00654953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111322104|NCT00654953|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111322105|NCT00654953|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111322106|NCT00654953|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111322107|NCT00654953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111322108|NCT00654953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111322109|NCT00654953|Antimanic Agents|antimanic agents|mesh-ancestor
111322110|NCT00654953|Antidepressive Agents|antidepressive agents|mesh-ancestor
111322111|NCT00654953|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111322112|NCT00654953|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111322113|NCT00654953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111322114|NCT00654953|Serotonin Agents|serotonin agents|mesh-ancestor
111322115|NCT01790165|Terbinafine|terbinafine|mesh-list
111322116|NCT01790165|Antifungal Agents|antifungal agents|mesh-ancestor
111322117|NCT01790165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111322118|NCT01790165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111322119|NCT01790165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111322120|NCT02299089|Octreotide|octreotide|mesh-list
111322121|NCT02299089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111322122|NCT02299089|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111322123|NCT02299089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111322124|NCT00655811|Capsaicin|capsaicin|mesh-list
111322125|NCT00655811|Antipruritics|antipruritics|mesh-ancestor
111322126|NCT00655811|Dermatologic Agents|dermatologic agents|mesh-ancestor
111322127|NCT00655811|Sensory System Agents|sensory system agents|mesh-ancestor
111322128|NCT00655811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111322129|NCT00655811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111322130|NCT03931551|Trastuzumab|trastuzumab|mesh-list
111322131|NCT03931551|Olaparib|olaparib|mesh-list
111322132|NCT03931551|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111322133|NCT03931551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111322134|NCT03931551|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111322135|NCT03931551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111322136|NCT03931551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111322137|NCT00696293|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
111322138|NCT00696293|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111322139|NCT00696293|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111322140|NCT00696293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111322141|NCT00696293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111322142|NCT00696293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111322143|NCT00696293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111322144|NCT00696293|Analgesics|analgesics|mesh-ancestor
111322145|NCT00696293|Sensory System Agents|sensory system agents|mesh-ancestor
111322146|NCT00696293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111322147|NCT00696293|Antidepressive Agents|antidepressive agents|mesh-ancestor
111322148|NCT00696293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111322149|NCT00696293|Dopamine Agents|dopamine agents|mesh-ancestor
111322150|NCT00696449|Adapalene|adapalene|mesh-list
111153739|NCT01766050|Dextromethorphan|dextromethorphan|mesh-list
111322151|NCT00696449|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111322152|NCT00696449|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111322153|NCT00696449|Analgesics|analgesics|mesh-ancestor
111322154|NCT00696449|Sensory System Agents|sensory system agents|mesh-ancestor
111322155|NCT00696449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111322156|NCT00696449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111322157|NCT00696449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111322158|NCT00696449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111322159|NCT00696449|Dermatologic Agents|dermatologic agents|mesh-ancestor
111322160|NCT00696761|Alfuzosin|alfuzosin|mesh-list
111322161|NCT00696761|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111322162|NCT00696761|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111322163|NCT00696761|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111322164|NCT00696761|Adrenergic Agents|adrenergic agents|mesh-ancestor
111322165|NCT00696761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111153802|NCT01734772|Protease Inhibitors|protease inhibitors|mesh-ancestor
111322166|NCT00696761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111322167|NCT00696761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111322168|NCT00696761|Urological Agents|urological agents|mesh-ancestor
111322169|NCT00656201|Progesterone|progesterone|mesh-list
111322170|NCT00656201|Progestins|progestins|mesh-ancestor
111322171|NCT00656201|Hormones|hormones|mesh-ancestor
111153865|NCT01608724|Saxagliptin|saxagliptin|mesh-list
111322172|NCT00656201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111322173|NCT00656201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111322174|NCT00759291|Acipimox|acipimox|mesh-list
111322175|NCT00759291|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111322176|NCT00759291|Antimetabolites|antimetabolites|mesh-ancestor
111322177|NCT00759291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111153930|NCT01765582|Antimetabolites|antimetabolites|mesh-ancestor
111322178|NCT00759291|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111322180|NCT00756405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111322181|NCT00756405|Protective Agents|protective agents|mesh-ancestor
111322182|NCT00756405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111322183|NCT00697541|Brimonidine Tartrate|brimonidine tartrate|mesh-list
111322184|NCT00697541|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111322185|NCT00697541|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111322186|NCT00697541|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111322187|NCT00697541|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111322188|NCT00697541|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111322189|NCT00697541|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111322190|NCT00697541|Adrenergic Agents|adrenergic agents|mesh-ancestor
111322191|NCT00697541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111322192|NCT00697541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111322193|NCT00697541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111322194|NCT03889275|Durvalumab|durvalumab|mesh-list
111322195|NCT03889275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111322196|NCT03889275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111322197|NCT00657917|Gentamicins|gentamicins|mesh-list
111322198|NCT00657917|Paromomycin|paromomycin|mesh-list
111322199|NCT00657917|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111322200|NCT00657917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111322201|NCT00657917|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111322202|NCT00657917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111322203|NCT00657917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111322204|NCT00657917|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111322205|NCT00657917|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111322206|NCT01959945|Hemagglutinins|hemagglutinins|mesh-list
111322207|NCT01959945|Vaccines|vaccines|mesh-list
111322208|NCT01959945|Immunologic Factors|immunologic factors|mesh-ancestor
111322209|NCT01959945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111322210|NCT01959945|Agglutinins|agglutinins|mesh-ancestor
111322211|NCT01959945|Coagulants|coagulants|mesh-ancestor
111322212|NCT00700661|Montelukast|montelukast|mesh-list
111322213|NCT00700661|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111322214|NCT00700661|Respiratory System Agents|respiratory system agents|mesh-ancestor
111322215|NCT00700661|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
111322216|NCT00700661|Hormone Antagonists|hormone antagonists|mesh-ancestor
111154413|NCT05302297|Cemiplimab|cemiplimab|mesh-list
111322217|NCT00700661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111322218|NCT00700661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111322219|NCT00700661|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
111322220|NCT00700661|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111322221|NCT00700661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111322222|NCT00652847|Ezetimibe|ezetimibe|mesh-list
111322223|NCT00652847|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111322224|NCT00652847|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111322225|NCT00652847|Antimetabolites|antimetabolites|mesh-ancestor
111322226|NCT00652847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111322227|NCT00652847|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111322228|NCT00652301|Simvastatin|simvastatin|mesh-list
111322229|NCT00652301|Ezetimibe|ezetimibe|mesh-list
111322230|NCT00652301|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111322231|NCT00652301|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111322232|NCT00652301|Antimetabolites|antimetabolites|mesh-ancestor
111322233|NCT00652301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111322234|NCT00652301|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111154696|NCT02003391|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111322235|NCT00652301|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111322236|NCT00652301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111322237|NCT01961271|Buprenorphine|buprenorphine|mesh-list
111322238|NCT01961271|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111322239|NCT01961271|Narcotics|narcotics|mesh-ancestor
111154768|NCT02001987|Abortifacient Agents|abortifacient agents|mesh-ancestor
111322240|NCT01961271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111322241|NCT01961271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111322242|NCT01961271|Analgesics|analgesics|mesh-ancestor
111322243|NCT01961271|Sensory System Agents|sensory system agents|mesh-ancestor
111322244|NCT01961271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111322245|NCT01961271|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111322246|NCT01963143|gamma-Globulins|gamma-globulins|mesh-list
111322247|NCT01963143|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111322248|NCT01963143|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
111322249|NCT01963143|Immunologic Factors|immunologic factors|mesh-ancestor
111322250|NCT01963143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111322252|NCT03822351|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111322253|NCT03822351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111322254|NCT03822351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111322255|NCT03822351|Immunologic Factors|immunologic factors|mesh-ancestor
111322256|NCT03822351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111322257|NCT01963845|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111322258|NCT01963845|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111322259|NCT01963845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111322260|NCT01963845|Incretins|incretins|mesh-ancestor
111322261|NCT01963845|Hormones|hormones|mesh-ancestor
111322262|NCT01963845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111322263|NCT01963845|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111322264|NCT01963845|Protease Inhibitors|protease inhibitors|mesh-ancestor
111322265|NCT01963845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111322266|NCT01963845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111322267|NCT00658619|Brimonidine Tartrate|brimonidine tartrate|mesh-list
111322268|NCT00658619|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111322269|NCT00658619|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111322270|NCT00658619|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111322271|NCT00658619|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111322272|NCT00658619|Adrenergic Agents|adrenergic agents|mesh-ancestor
111155109|NCT04792567|Siponimod|siponimod|mesh-list
111322273|NCT00658619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111322274|NCT00658619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111322275|NCT00658619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111322276|NCT01966419|Phenylacetic acid|phenylacetic acid|mesh-list
111322277|NCT01966419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111322278|NCT01966419|Antimetabolites|antimetabolites|mesh-ancestor
111322279|NCT01966419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111322280|NCT01966419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111155248|NCT05813951|Linezolid|linezolid|mesh-list
111322281|NCT01966809|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
111322282|NCT01966809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111322283|NCT01966809|Dermatologic Agents|dermatologic agents|mesh-ancestor
111155321|NCT05813249|Vitamins|vitamins|mesh-ancestor
111322284|NCT01966809|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111322285|NCT04575584|Molnupiravir|molnupiravir|mesh-list
111322286|NCT04575584|Antiviral Agents|antiviral agents|mesh-ancestor
111322287|NCT04575584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111322288|NCT04277702|Montelukast|montelukast|mesh-list
111322289|NCT04277702|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111322290|NCT04277702|Respiratory System Agents|respiratory system agents|mesh-ancestor
111155467|NCT05552196|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111322291|NCT04277702|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
111322292|NCT04277702|Hormone Antagonists|hormone antagonists|mesh-ancestor
111322293|NCT04277702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111322294|NCT04277702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111322295|NCT04277702|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
111155535|NCT05287568|Venetoclax|venetoclax|mesh-list
111322296|NCT04277702|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111322297|NCT04277702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111322298|NCT00699491|Sirolimus|sirolimus|mesh-list
111322299|NCT00699491|Temsirolimus|temsirolimus|mesh-list
111322300|NCT00699491|MTOR Inhibitors|mtor inhibitors|mesh-list
111322301|NCT00699491|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111322302|NCT00699491|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111322303|NCT00699491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111322304|NCT00699491|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111322305|NCT00699491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111322306|NCT00699491|Antifungal Agents|antifungal agents|mesh-ancestor
111322307|NCT00699491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111322308|NCT00699491|Immunologic Factors|immunologic factors|mesh-ancestor
111322309|NCT00699491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111322310|NCT00699491|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111322311|NCT00699491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111322312|NCT00699491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111322313|NCT04493216|Dolutegravir|dolutegravir|mesh-list
111322314|NCT04493216|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111322315|NCT04493216|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111322316|NCT04493216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111322317|NCT04493216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111322318|NCT04493216|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111322319|NCT04493216|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111322320|NCT04493216|Antiviral Agents|antiviral agents|mesh-ancestor
111046733|NCT03738683|Tazobactam|tazobactam|mesh-list
111322321|NCT04493216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111322322|NCT03721965|Prednisone|prednisone|mesh-list
111322323|NCT03721965|Methylprednisolone|methylprednisolone|mesh-list
111322324|NCT03721965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111322325|NCT03721965|Glucocorticoids|glucocorticoids|mesh-ancestor
111322326|NCT03721965|Hormones|hormones|mesh-ancestor
111322327|NCT03721965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111322328|NCT03721965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111322329|NCT03721965|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111322330|NCT03721965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111322331|NCT03721965|Antiemetics|antiemetics|mesh-ancestor
111322332|NCT03721965|Autonomic Agents|autonomic agents|mesh-ancestor
111322333|NCT03721965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111322334|NCT03721965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111322335|NCT03721965|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111322336|NCT03721965|Protective Agents|protective agents|mesh-ancestor
111322337|NCT04399148|Ketotifen|ketotifen|mesh-list
111322338|NCT04399148|Aprepitant|aprepitant|mesh-list
111322339|NCT04399148|Desloratadine|desloratadine|mesh-list
111322340|NCT04399148|Antiemetics|antiemetics|mesh-ancestor
111322341|NCT04399148|Autonomic Agents|autonomic agents|mesh-ancestor
111322342|NCT04399148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111322343|NCT04399148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111322344|NCT04399148|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111322345|NCT04399148|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
111322346|NCT04399148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111365068|NCT03007303|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111322347|NCT04399148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111322348|NCT04399148|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111322349|NCT04399148|Cholinergic Agents|cholinergic agents|mesh-ancestor
111322350|NCT04399148|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
111322351|NCT04399148|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111322352|NCT04399148|Histamine Antagonists|histamine antagonists|mesh-ancestor
111322353|NCT04399148|Histamine Agents|histamine agents|mesh-ancestor
111322354|NCT04399148|Antipruritics|antipruritics|mesh-ancestor
111322355|NCT04399148|Dermatologic Agents|dermatologic agents|mesh-ancestor
111322356|NCT04399148|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111322357|NCT04672382|Morphine|morphine|mesh-list
111322358|NCT04672382|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111322359|NCT04672382|Narcotics|narcotics|mesh-ancestor
111322360|NCT04672382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111322361|NCT04672382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111322362|NCT04672382|Analgesics|analgesics|mesh-ancestor
111322363|NCT04672382|Sensory System Agents|sensory system agents|mesh-ancestor
111322364|NCT04672382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111322365|NCT00699803|Prednisone|prednisone|mesh-list
111322366|NCT00699803|Prednisolone acetate|prednisolone acetate|mesh-list
111322367|NCT00699803|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111322368|NCT00699803|Methylprednisolone|methylprednisolone|mesh-list
111322369|NCT00699803|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111322370|NCT00699803|Prednisolone|prednisolone|mesh-list
111322371|NCT00699803|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111322372|NCT00699803|Prednisolone phosphate|prednisolone phosphate|mesh-list
111322373|NCT00699803|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111322374|NCT00699803|Glucocorticoids|glucocorticoids|mesh-ancestor
111322375|NCT00699803|Hormones|hormones|mesh-ancestor
111322376|NCT00699803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111322377|NCT00699803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111322378|NCT00699803|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111322379|NCT00699803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111322380|NCT00699803|Antiemetics|antiemetics|mesh-ancestor
111322381|NCT00699803|Autonomic Agents|autonomic agents|mesh-ancestor
111322382|NCT00699803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111156055|NCT02782949|Curcumin|curcumin|mesh-list
111322383|NCT00699803|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111322384|NCT00699803|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111322385|NCT00699803|Protective Agents|protective agents|mesh-ancestor
111322386|NCT01967433|Diphenhydramine|diphenhydramine|mesh-list
111322387|NCT01967433|Promethazine|promethazine|mesh-list
111322388|NCT01967433|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111322389|NCT01967433|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111322390|NCT01967433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111322391|NCT01967433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111322392|NCT01967433|Anesthetics, Local|anesthetics, local|mesh-ancestor
111322393|NCT01967433|Anesthetics|anesthetics|mesh-ancestor
111322394|NCT01967433|Sensory System Agents|sensory system agents|mesh-ancestor
111322395|NCT01967433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111046817|NCT03923959|Tranexamic Acid|tranexamic acid|mesh-list
111322396|NCT01967433|Antiemetics|antiemetics|mesh-ancestor
111322397|NCT01967433|Autonomic Agents|autonomic agents|mesh-ancestor
111322398|NCT01967433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111322399|NCT01967433|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111322400|NCT01967433|Histamine Antagonists|histamine antagonists|mesh-ancestor
111322401|NCT01967433|Histamine Agents|histamine agents|mesh-ancestor
111322402|NCT01967433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111322403|NCT01967433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111322404|NCT01967433|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111322405|NCT01967433|Antipruritics|antipruritics|mesh-ancestor
111322406|NCT01967433|Dermatologic Agents|dermatologic agents|mesh-ancestor
111322407|NCT00551447|Simvastatin|simvastatin|mesh-list
111322408|NCT00551447|Ezetimibe|ezetimibe|mesh-list
111156500|NCT01774786|Pertuzumab|pertuzumab|mesh-list
111322409|NCT00551447|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111322410|NCT00551447|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111322411|NCT00551447|Antimetabolites|antimetabolites|mesh-ancestor
111322412|NCT00551447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111322413|NCT00551447|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111322414|NCT00551447|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111322415|NCT00551447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111322416|NCT01968057|Cyclosporine|cyclosporine|mesh-list
111322417|NCT01968057|Cyclosporins|cyclosporins|mesh-list
111322418|NCT01968057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111322419|NCT01968057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111322420|NCT01968057|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111322421|NCT01968057|Immunologic Factors|immunologic factors|mesh-ancestor
111322422|NCT01968057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111322423|NCT01968057|Antifungal Agents|antifungal agents|mesh-ancestor
111322424|NCT01968057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111322425|NCT01968057|Dermatologic Agents|dermatologic agents|mesh-ancestor
111322426|NCT01968057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111322427|NCT01968057|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111322428|NCT01968135|Contraceptive Agents|contraceptive agents|mesh-list
111322429|NCT01968135|Contraceptives, Oral|contraceptives, oral|mesh-list
111322430|NCT01968135|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
111156855|NCT01726270|Tamsulosin|tamsulosin|mesh-list
111322431|NCT01968135|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111322432|NCT01968135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111322433|NCT01968135|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111322434|NCT00658697|Bevacizumab|bevacizumab|mesh-list
111322435|NCT00658697|Docetaxel|docetaxel|mesh-list
111322436|NCT00658697|Bicalutamide|bicalutamide|mesh-list
111322437|NCT00658697|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111322438|NCT00658697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111322439|NCT00658697|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111322440|NCT00658697|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111322441|NCT00658697|Growth Substances|growth substances|mesh-ancestor
111322442|NCT00658697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111322443|NCT00658697|Growth Inhibitors|growth inhibitors|mesh-ancestor
111156928|NCT01545271|Xenon|xenon|mesh-list
111322444|NCT00658697|Tubulin Modulators|tubulin modulators|mesh-ancestor
111322445|NCT00658697|Antimitotic Agents|antimitotic agents|mesh-ancestor
111322446|NCT00658697|Mitosis Modulators|mitosis modulators|mesh-ancestor
111322447|NCT00658697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111157022|NCT04630821|Eusol|eusol|mesh-list
111322448|NCT00658697|Androgen Antagonists|androgen antagonists|mesh-ancestor
111322449|NCT00658697|Hormone Antagonists|hormone antagonists|mesh-ancestor
111322450|NCT00658697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111322451|NCT03873116|Berotralstat|berotralstat|mesh-list
111322452|NCT03873116|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111322453|NCT03873116|Protease Inhibitors|protease inhibitors|mesh-ancestor
111322454|NCT03873116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111322455|NCT03873116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111322456|NCT04399226|Dexmedetomidine|dexmedetomidine|mesh-list
111322457|NCT04399226|Ketamine|ketamine|mesh-list
111322458|NCT04399226|Propofol|propofol|mesh-list
111322459|NCT04399226|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111322460|NCT04399226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111322461|NCT04399226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111322462|NCT04399226|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111322463|NCT04399226|Analgesics|analgesics|mesh-ancestor
111322464|NCT04399226|Sensory System Agents|sensory system agents|mesh-ancestor
111322465|NCT04399226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111322466|NCT04399226|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111322467|NCT04399226|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111322468|NCT04399226|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111322469|NCT04399226|Adrenergic Agents|adrenergic agents|mesh-ancestor
111322470|NCT04399226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111322471|NCT04399226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111322472|NCT04399226|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111322473|NCT04399226|Anesthetics, General|anesthetics, general|mesh-ancestor
111322474|NCT04399226|Anesthetics|anesthetics|mesh-ancestor
111322475|NCT04399226|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111322476|NCT04399226|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111322477|NCT04399226|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111322479|NCT00659165|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111322480|NCT00659165|Insulin Glargine|insulin glargine|mesh-list
111322481|NCT00659165|Insulin Detemir|insulin detemir|mesh-list
111322482|NCT00659165|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111365069|NCT03007303|Serotonin Agents|serotonin agents|mesh-ancestor
111322483|NCT00659165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111322484|NCT00542087|Diclofenac|diclofenac|mesh-list
111322485|NCT00542087|Etoricoxib|etoricoxib|mesh-list
111322486|NCT00542087|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111322487|NCT00542087|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111322488|NCT00542087|Analgesics|analgesics|mesh-ancestor
111322489|NCT00542087|Sensory System Agents|sensory system agents|mesh-ancestor
111322490|NCT00542087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111322491|NCT00542087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111322492|NCT00542087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111322493|NCT00542087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111322494|NCT00542087|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111322495|NCT00542087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111322496|NCT00542087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111322497|NCT00542087|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111322498|NCT00541697|Atorvastatin|atorvastatin|mesh-list
111322499|NCT00541697|Simvastatin|simvastatin|mesh-list
111322500|NCT00541697|Ezetimibe|ezetimibe|mesh-list
111322501|NCT00541697|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111322502|NCT00541697|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111322503|NCT00541697|Antimetabolites|antimetabolites|mesh-ancestor
111322504|NCT00541697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111322505|NCT00541697|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111322506|NCT00541697|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111322507|NCT00541697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111322508|NCT03223376|Paclitaxel|paclitaxel|mesh-list
111322509|NCT03223376|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111322510|NCT03223376|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111322511|NCT03223376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111322512|NCT03223376|Tubulin Modulators|tubulin modulators|mesh-ancestor
111157511|NCT02304302|Dopamine Agents|dopamine agents|mesh-ancestor
111322513|NCT03223376|Antimitotic Agents|antimitotic agents|mesh-ancestor
111322514|NCT03223376|Mitosis Modulators|mitosis modulators|mesh-ancestor
111322515|NCT03223376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111322516|NCT00395603|Atorvastatin|atorvastatin|mesh-list
111322517|NCT00395603|Simvastatin|simvastatin|mesh-list
111322518|NCT00395603|Ezetimibe|ezetimibe|mesh-list
111322519|NCT00395603|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111322520|NCT00395603|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111322521|NCT00395603|Antimetabolites|antimetabolites|mesh-ancestor
111322522|NCT00395603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111322523|NCT00395603|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111322524|NCT00395603|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111322525|NCT00395603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111322526|NCT00659633|Lidocaine|lidocaine|mesh-list
111322527|NCT00659633|Anesthetics, Local|anesthetics, local|mesh-ancestor
111322528|NCT00659633|Anesthetics|anesthetics|mesh-ancestor
111322529|NCT00659633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111322530|NCT00659633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111322531|NCT00659633|Sensory System Agents|sensory system agents|mesh-ancestor
111322532|NCT00659633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111322533|NCT00659633|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111322534|NCT00659633|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111322535|NCT00659633|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111322536|NCT00659633|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111322537|NCT00659633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111322538|NCT00328523|Ezetimibe|ezetimibe|mesh-list
111322539|NCT00328523|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111322540|NCT00328523|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111322541|NCT00328523|Antimetabolites|antimetabolites|mesh-ancestor
111322542|NCT00328523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111322543|NCT00328523|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111322544|NCT00701675|Sertraline|sertraline|mesh-list
111322545|NCT00701675|Antidepressive Agents|antidepressive agents|mesh-ancestor
111322546|NCT00701675|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111365070|NCT03007303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111322547|NCT00701675|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111322548|NCT00701675|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111322549|NCT00701675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111322550|NCT00701675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111157905|NCT02296892|Midazolam|midazolam|mesh-list
111322551|NCT00701675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111322552|NCT00701675|Serotonin Agents|serotonin agents|mesh-ancestor
111322553|NCT00701675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111322554|NCT04639310|Ezogabine|ezogabine|mesh-list
111322555|NCT04639310|Anticonvulsants|anticonvulsants|mesh-ancestor
111322556|NCT04639310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111322557|NCT04639310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111322558|NCT02300727|Curcumin|curcumin|mesh-list
111322559|NCT02300727|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111322560|NCT02300727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111322561|NCT02300727|Analgesics|analgesics|mesh-ancestor
111322562|NCT02300727|Sensory System Agents|sensory system agents|mesh-ancestor
111322563|NCT02300727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111322564|NCT02300727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111322565|NCT02300727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111322566|NCT02300727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111322567|NCT02300727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111322568|NCT02300727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111322569|NCT02300727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111322570|NCT00250445|Diclofenac|diclofenac|mesh-list
111322571|NCT00250445|Etoricoxib|etoricoxib|mesh-list
111158180|NCT01925703|Ferric gluconate|ferric gluconate|mesh-list
111322572|NCT00250445|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111322573|NCT00250445|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111322574|NCT00250445|Analgesics|analgesics|mesh-ancestor
111322575|NCT00250445|Sensory System Agents|sensory system agents|mesh-ancestor
111322576|NCT00250445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111322577|NCT00250445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111322578|NCT00250445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111322579|NCT00250445|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111322580|NCT00250445|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111322581|NCT00250445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111322582|NCT00250445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111322583|NCT00250445|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111322584|NCT00242489|Diclofenac|diclofenac|mesh-list
111322585|NCT00242489|Etoricoxib|etoricoxib|mesh-list
111322586|NCT00242489|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111158305|NCT04865237|Antiviral Agents|antiviral agents|mesh-ancestor
111322587|NCT00242489|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111322588|NCT00242489|Analgesics|analgesics|mesh-ancestor
111322589|NCT00242489|Sensory System Agents|sensory system agents|mesh-ancestor
111322590|NCT00242489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111322591|NCT00242489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111322592|NCT00242489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111322593|NCT00242489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111322594|NCT00242489|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111322595|NCT00242489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111322596|NCT00242489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111322597|NCT00242489|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111322598|NCT00659945|Ondansetron|ondansetron|mesh-list
111322599|NCT00659945|Aprepitant|aprepitant|mesh-list
111322600|NCT00659945|Antiemetics|antiemetics|mesh-ancestor
111322601|NCT00659945|Autonomic Agents|autonomic agents|mesh-ancestor
111322602|NCT00659945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111322603|NCT00659945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111322604|NCT00659945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111322605|NCT00659945|Antipruritics|antipruritics|mesh-ancestor
111322606|NCT00659945|Dermatologic Agents|dermatologic agents|mesh-ancestor
111322607|NCT00659945|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111322608|NCT00659945|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111322609|NCT00659945|Serotonin Agents|serotonin agents|mesh-ancestor
111322610|NCT00659945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111322611|NCT00659945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111322612|NCT00659945|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
111322613|NCT04387565|Vanadium|vanadium|mesh-list
111322614|NCT04387565|Trace Elements|trace elements|mesh-ancestor
111322615|NCT04387565|Micronutrients|micronutrients|mesh-ancestor
111322616|NCT04387565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111322617|NCT02141555|Misoprostol|misoprostol|mesh-list
111322618|NCT02141555|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111322619|NCT02141555|Abortifacient Agents|abortifacient agents|mesh-ancestor
111322620|NCT02141555|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110841229|NCT02890992|Niacin|niacin|mesh-list
111322621|NCT02141555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111322622|NCT02141555|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111322623|NCT02141555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111322624|NCT02141555|Oxytocics|oxytocics|mesh-ancestor
111322626|NCT01799057|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111322627|NCT01799057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111322628|NCT00588965|Propranolol|propranolol|mesh-list
111322629|NCT00588965|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111322630|NCT00588965|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111322631|NCT00588965|Adrenergic Agents|adrenergic agents|mesh-ancestor
111322632|NCT00588965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111322633|NCT00588965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111322634|NCT00588965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111322635|NCT00588965|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111322636|NCT00588965|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111322637|NCT00588965|Vasodilator Agents|vasodilator agents|mesh-ancestor
111322638|NCT00702299|Paclitaxel|paclitaxel|mesh-list
111322639|NCT00702299|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111322640|NCT00702299|Cisplatin|cisplatin|mesh-list
111322641|NCT00702299|Pemetrexed|pemetrexed|mesh-list
111322642|NCT00702299|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111322643|NCT00702299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111322644|NCT00702299|Tubulin Modulators|tubulin modulators|mesh-ancestor
111322645|NCT00702299|Antimitotic Agents|antimitotic agents|mesh-ancestor
111322646|NCT00702299|Mitosis Modulators|mitosis modulators|mesh-ancestor
111322647|NCT00702299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111322648|NCT00702299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111322649|NCT00702299|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111322650|NCT00702299|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111322651|NCT00661583|Ranibizumab|ranibizumab|mesh-list
111322652|NCT00661583|Mitomycins|mitomycins|mesh-list
111322653|NCT00661583|Mitomycin|mitomycin|mesh-list
111322654|NCT00661583|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111322655|NCT00661583|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111322656|NCT00661583|Growth Substances|growth substances|mesh-ancestor
111322657|NCT00661583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111322658|NCT00661583|Growth Inhibitors|growth inhibitors|mesh-ancestor
111322659|NCT00661583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111322660|NCT00661583|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111322661|NCT00661583|Alkylating Agents|alkylating agents|mesh-ancestor
111322662|NCT00661583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111322663|NCT00661583|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111322664|NCT00661583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111322665|NCT00661895|Metoprolol|metoprolol|mesh-list
111322666|NCT00661895|Atenolol|atenolol|mesh-list
111322667|NCT00661895|Amlodipine|amlodipine|mesh-list
111322668|NCT00661895|Valsartan|valsartan|mesh-list
111322669|NCT00661895|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
111322670|NCT00661895|Clonidine|clonidine|mesh-list
111322671|NCT00661895|Lisinopril|lisinopril|mesh-list
111322672|NCT00661895|Doxazosin|doxazosin|mesh-list
111322673|NCT00661895|Hydralazine|hydralazine|mesh-list
111322674|NCT00661895|Nifedipine|nifedipine|mesh-list
111322675|NCT00661895|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111322676|NCT00661895|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111322677|NCT00661895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111322678|NCT00661895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111322679|NCT00661895|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111322680|NCT00661895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111322681|NCT00661895|Vasodilator Agents|vasodilator agents|mesh-ancestor
111322682|NCT00661895|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111322683|NCT00661895|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111322684|NCT00661895|Diuretics|diuretics|mesh-ancestor
111322685|NCT00661895|Natriuretic Agents|natriuretic agents|mesh-ancestor
111322686|NCT00661895|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
111322687|NCT00661895|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111322688|NCT00661895|Sympatholytics|sympatholytics|mesh-ancestor
111322689|NCT00661895|Autonomic Agents|autonomic agents|mesh-ancestor
111322690|NCT00661895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111322691|NCT00661895|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
111158896|NCT04835870|Hormones|hormones|mesh-ancestor
111322692|NCT00661895|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111047115|NCT05454709|Glucagon|glucagon|mesh-list
111322693|NCT00661895|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111322694|NCT00661895|Adrenergic Agents|adrenergic agents|mesh-ancestor
111322695|NCT00661895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111322696|NCT00661895|Analgesics|analgesics|mesh-ancestor
111322697|NCT00661895|Sensory System Agents|sensory system agents|mesh-ancestor
111322698|NCT00661895|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111322699|NCT00661895|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111158955|NCT05345678|Durvalumab|durvalumab|mesh-list
111322700|NCT00661895|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111322701|NCT00661895|Tocolytic Agents|tocolytic agents|mesh-ancestor
111322702|NCT00661895|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111322703|NCT00661895|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
111322704|NCT00661895|Protease Inhibitors|protease inhibitors|mesh-ancestor
111322705|NCT00661895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111322706|NCT00661895|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111322707|NCT00661895|Protective Agents|protective agents|mesh-ancestor
111322708|NCT00661895|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111322709|NCT00661895|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111322710|NCT02301039|Pembrolizumab|pembrolizumab|mesh-list
111322711|NCT02301039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111322712|NCT02301039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111322713|NCT02301039|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111322714|NCT02301039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111322715|NCT00662675|Pancrelipase|pancrelipase|mesh-list
111322716|NCT00662675|Pancreatin|pancreatin|mesh-list
111322717|NCT00662675|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111322718|NCT00591305|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
111322719|NCT00591305|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
111322720|NCT00591305|Protective Agents|protective agents|mesh-ancestor
111322721|NCT00591305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111322722|NCT00591305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111322723|NCT01799603|Simeprevir|simeprevir|mesh-list
111322724|NCT01799603|Antiviral Agents|antiviral agents|mesh-ancestor
111322725|NCT01799603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111322726|NCT01799603|Protease Inhibitors|protease inhibitors|mesh-ancestor
111322727|NCT01799603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111159016|NCT02164513|Bromides|bromides|mesh-list
111322728|NCT01799603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111322729|NCT00666029|Atorvastatin|atorvastatin|mesh-list
111322730|NCT00666029|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111322731|NCT00666029|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111322732|NCT00666029|Antimetabolites|antimetabolites|mesh-ancestor
111322733|NCT00666029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111322734|NCT00666029|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111159065|NCT01713946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111322735|NCT00666029|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111322736|NCT00666029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111322737|NCT04372940|Tranexamic Acid|tranexamic acid|mesh-list
111322738|NCT04372940|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111322739|NCT04372940|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111322740|NCT04372940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111322741|NCT04372940|Hemostatics|hemostatics|mesh-ancestor
111322742|NCT04372940|Coagulants|coagulants|mesh-ancestor
111322743|NCT00592475|Conivaptan|conivaptan|mesh-list
111322744|NCT00592475|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
111322745|NCT00592475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111322746|NCT00592475|Natriuretic Agents|natriuretic agents|mesh-ancestor
111322747|NCT00592475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111322748|NCT01989195|Manganese|manganese|mesh-list
111322749|NCT01989195|Trace Elements|trace elements|mesh-ancestor
111322750|NCT01989195|Micronutrients|micronutrients|mesh-ancestor
111322751|NCT01989195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111322752|NCT00592943|Modafinil|modafinil|mesh-list
111322753|NCT00592943|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111322754|NCT00592943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111322755|NCT00592943|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
111322756|NCT00592943|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111322757|NCT00592943|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111322758|NCT00592943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111322759|NCT01973205|Aspirin|aspirin|mesh-list
111322760|NCT01973205|Acetaminophen|acetaminophen|mesh-list
111322761|NCT01973205|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111322762|NCT01973205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111322763|NCT01973205|Analgesics|analgesics|mesh-ancestor
111322764|NCT01973205|Sensory System Agents|sensory system agents|mesh-ancestor
111322765|NCT01973205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111322766|NCT01973205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111322767|NCT01973205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111322768|NCT01973205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111322769|NCT01973205|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111322770|NCT01973205|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111322771|NCT01973205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111322772|NCT01973205|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111322773|NCT01973205|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111322774|NCT01973205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111322776|NCT01990677|Eplerenone|eplerenone|mesh-list
111322777|NCT01990677|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
111322778|NCT01990677|Hormone Antagonists|hormone antagonists|mesh-ancestor
111322779|NCT01990677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111322780|NCT01990677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111322781|NCT01990677|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
111322782|NCT01990677|Diuretics|diuretics|mesh-ancestor
111322783|NCT01990677|Natriuretic Agents|natriuretic agents|mesh-ancestor
111322784|NCT01990677|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111322785|NCT00593645|Cytarabine|cytarabine|mesh-list
111322786|NCT00593645|Clofarabine|clofarabine|mesh-list
111322787|NCT00593645|Thymoglobulin|thymoglobulin|mesh-list
111322788|NCT00593645|Antilymphocyte Serum|antilymphocyte serum|mesh-list
111322789|NCT00593645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111322790|NCT00593645|Antimetabolites|antimetabolites|mesh-ancestor
111322791|NCT00593645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111322792|NCT00593645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111322793|NCT00593645|Antiviral Agents|antiviral agents|mesh-ancestor
111322794|NCT00593645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111322795|NCT00593645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111322796|NCT00593645|Immunologic Factors|immunologic factors|mesh-ancestor
111322797|NCT00593645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111322798|NCT03194126|Misoprostol|misoprostol|mesh-list
111322799|NCT03194126|Mifepristone|mifepristone|mesh-list
111322800|NCT03194126|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111322801|NCT03194126|Abortifacient Agents|abortifacient agents|mesh-ancestor
111322802|NCT03194126|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111322803|NCT03194126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111322804|NCT03194126|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111322805|NCT03194126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111322806|NCT03194126|Oxytocics|oxytocics|mesh-ancestor
111322807|NCT03194126|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
111322808|NCT03194126|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111322809|NCT03194126|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111322810|NCT03194126|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111322811|NCT03194126|Contraceptive Agents|contraceptive agents|mesh-ancestor
111322812|NCT03194126|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
111322813|NCT03194126|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
111322814|NCT03194126|Hormone Antagonists|hormone antagonists|mesh-ancestor
111322815|NCT03194126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111322816|NCT03194126|Luteolytic Agents|luteolytic agents|mesh-ancestor
111159645|NCT04274894|Androgens|androgens|mesh-ancestor
111322817|NCT03194126|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111322818|NCT03194126|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
111322819|NCT03219086|Bupivacaine|bupivacaine|mesh-list
111322820|NCT03219086|Prilocaine|prilocaine|mesh-list
111322821|NCT03219086|Anesthetics|anesthetics|mesh-list
111322822|NCT03219086|Anesthetics, Local|anesthetics, local|mesh-ancestor
111322823|NCT03219086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111322824|NCT03219086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111322825|NCT03219086|Sensory System Agents|sensory system agents|mesh-ancestor
111322826|NCT03219086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111322827|NCT04398290|Nitric Oxide|nitric oxide|mesh-list
111322828|NCT04398290|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111322829|NCT04398290|Autonomic Agents|autonomic agents|mesh-ancestor
111322830|NCT04398290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111322831|NCT04398290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111322832|NCT04398290|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111322833|NCT04398290|Respiratory System Agents|respiratory system agents|mesh-ancestor
111322834|NCT04398290|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111322835|NCT04398290|Antioxidants|antioxidants|mesh-ancestor
111322836|NCT04398290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111322837|NCT04398290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111322838|NCT04398290|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
111322839|NCT04398290|Vasodilator Agents|vasodilator agents|mesh-ancestor
111322840|NCT04398290|Gasotransmitters|gasotransmitters|mesh-ancestor
111322841|NCT04398290|Protective Agents|protective agents|mesh-ancestor
111322842|NCT04397510|Heparin|heparin|mesh-list
111322843|NCT04397510|Anticoagulants|anticoagulants|mesh-ancestor
111047262|NCT02155205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111159848|NCT00119366|Iodine|iodine|mesh-list
111322845|NCT04397510|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111322846|NCT04397510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111322847|NCT00704717|Ribavirin|ribavirin|mesh-list
111322848|NCT00704717|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
111322849|NCT00704717|Interferon-alpha|interferon-alpha|mesh-list
111322850|NCT00704717|Antimetabolites|antimetabolites|mesh-ancestor
111322851|NCT00704717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111322852|NCT00704717|Antiviral Agents|antiviral agents|mesh-ancestor
111322853|NCT00704717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111322854|NCT00704717|Immunologic Factors|immunologic factors|mesh-ancestor
111322855|NCT00704717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111322856|NCT03708224|Atezolizumab|atezolizumab|mesh-list
111322857|NCT03708224|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111322858|NCT03708224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111322859|NCT03708224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111322860|NCT03708224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111322861|NCT03632642|Floxacillin|floxacillin|mesh-list
111322862|NCT03632642|Penicillin G|penicillin g|mesh-list
111322863|NCT03632642|Penicillin G Benzathine|penicillin g benzathine|mesh-list
111322864|NCT03632642|Penicillin G Procaine|penicillin g procaine|mesh-list
111322865|NCT03632642|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111322866|NCT03632642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111322867|NCT00594425|Aminolevulinic Acid|aminolevulinic acid|mesh-list
111322868|NCT00594425|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
111322869|NCT00594425|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111322870|NCT00594425|Dermatologic Agents|dermatologic agents|mesh-ancestor
111322871|NCT04317404|Triamcinolone|triamcinolone|mesh-list
111322872|NCT04317404|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
111322873|NCT04317404|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
111322874|NCT04317404|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
111322875|NCT04317404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111322876|NCT04317404|Glucocorticoids|glucocorticoids|mesh-ancestor
111322877|NCT04317404|Hormones|hormones|mesh-ancestor
111322878|NCT04317404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111322879|NCT04317404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111322880|NCT04317404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111322881|NCT04317404|Immunologic Factors|immunologic factors|mesh-ancestor
111322882|NCT04317404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111322883|NCT04317404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111322884|NCT04399070|Ketamine|ketamine|mesh-list
111322885|NCT04399070|Esketamine|esketamine|mesh-list
111322886|NCT04399070|Analgesics|analgesics|mesh-ancestor
111322887|NCT04399070|Sensory System Agents|sensory system agents|mesh-ancestor
111322888|NCT04399070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111322889|NCT04399070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111322890|NCT04399070|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111322891|NCT04399070|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111322892|NCT04399070|Anesthetics, General|anesthetics, general|mesh-ancestor
111322893|NCT04399070|Anesthetics|anesthetics|mesh-ancestor
111322894|NCT04399070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111322895|NCT04399070|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111322896|NCT04399070|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111322897|NCT04399070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111322898|NCT04399070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111322899|NCT04399070|Antidepressive Agents|antidepressive agents|mesh-ancestor
111322900|NCT04399070|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111322901|NCT00667589|Fluocinonide|fluocinonide|mesh-list
111322902|NCT00667589|Tazarotene|tazarotene|mesh-list
111322903|NCT00667589|Emollients|emollients|mesh-list
111322904|NCT00667589|Dermatologic Agents|dermatologic agents|mesh-ancestor
111322905|NCT00667589|Keratolytic Agents|keratolytic agents|mesh-ancestor
111322906|NCT00667589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111322907|NCT00667589|Glucocorticoids|glucocorticoids|mesh-ancestor
111322908|NCT00667589|Hormones|hormones|mesh-ancestor
111322909|NCT00667589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111322910|NCT00667589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111322911|NCT00667589|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111322912|NCT00667745|Lithium Carbonate|lithium carbonate|mesh-list
111322913|NCT00667745|Antidepressive Agents|antidepressive agents|mesh-ancestor
111322914|NCT00667745|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111322915|NCT00667745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111322916|NCT00667745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111322917|NCT00667745|Antimanic Agents|antimanic agents|mesh-ancestor
111322918|NCT00667745|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111322919|NCT00667745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111322920|NCT00667745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111322922|NCT03173612|Etoposide|etoposide|mesh-list
111322923|NCT03173612|Mitoxantrone|mitoxantrone|mesh-list
111322924|NCT03173612|Idarubicin|idarubicin|mesh-list
111322925|NCT03173612|Dasatinib|dasatinib|mesh-list
111322926|NCT03173612|Aclacinomycins|aclacinomycins|mesh-list
111322927|NCT03173612|Lenograstim|lenograstim|mesh-list
111322928|NCT03173612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111322929|NCT03173612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111160235|NCT02182999|Ropivacaine|ropivacaine|mesh-list
111322930|NCT03173612|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111322931|NCT03173612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111322932|NCT03173612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111322933|NCT03173612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111322934|NCT03173612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111322935|NCT03173612|Antimetabolites|antimetabolites|mesh-ancestor
111322936|NCT03173612|Antiviral Agents|antiviral agents|mesh-ancestor
111322937|NCT03173612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111322938|NCT03173612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111322939|NCT03173612|Immunologic Factors|immunologic factors|mesh-ancestor
111322940|NCT03173612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111322941|NCT03173612|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111322942|NCT03173612|Analgesics|analgesics|mesh-ancestor
111322943|NCT03173612|Sensory System Agents|sensory system agents|mesh-ancestor
111322944|NCT03173612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111322945|NCT03173612|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111322946|NCT03173612|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111322947|NCT00595361|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
111322948|NCT00595361|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111160348|NCT02179177|Apixaban|apixaban|mesh-list
111322949|NCT00595361|Autonomic Agents|autonomic agents|mesh-ancestor
111322950|NCT00595361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111322951|NCT00595361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111322952|NCT00595361|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111322953|NCT00595361|Respiratory System Agents|respiratory system agents|mesh-ancestor
111322954|NCT00595361|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111160484|NCT01687270|Sofosbuvir|sofosbuvir|mesh-list
111322955|NCT00595361|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111322956|NCT00595361|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111322957|NCT00595361|Adrenergic Agents|adrenergic agents|mesh-ancestor
111322958|NCT00595361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111322959|NCT00595361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111322960|NCT00596453|Ciprofloxacin|ciprofloxacin|mesh-list
111322961|NCT00596453|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111322962|NCT00596453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111322963|NCT00596453|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111322964|NCT00596453|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111322965|NCT00596453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111322966|NCT00596453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111160591|NCT01568866|Bortezomib|bortezomib|mesh-list
111322967|NCT00596453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111322968|NCT00596453|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111322969|NCT00596453|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111322970|NCT00705107|Ribavirin|ribavirin|mesh-list
111322971|NCT00705107|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
111322972|NCT00705107|Interferon-alpha|interferon-alpha|mesh-list
111322973|NCT00705107|Antimetabolites|antimetabolites|mesh-ancestor
111365084|NCT03007303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111322974|NCT00705107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111322975|NCT00705107|Antiviral Agents|antiviral agents|mesh-ancestor
111322976|NCT00705107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111322977|NCT00705107|Immunologic Factors|immunologic factors|mesh-ancestor
111322978|NCT00705107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111322979|NCT00240331|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111322980|NCT00240331|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111322981|NCT00240331|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111322982|NCT00240331|Antimetabolites|antimetabolites|mesh-ancestor
111322983|NCT00240331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111322984|NCT00240331|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111322985|NCT00240331|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111322986|NCT00240331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111322987|NCT00240097|Carboplatin|carboplatin|mesh-list
111322988|NCT00240097|Oxaliplatin|oxaliplatin|mesh-list
111322989|NCT00240097|Irinotecan|irinotecan|mesh-list
111322990|NCT00240097|Etoposide|etoposide|mesh-list
111322991|NCT00240097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111322992|NCT00240097|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111047412|NCT02166593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111322993|NCT00240097|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111160966|NCT02253992|Nivolumab|nivolumab|mesh-list
111322994|NCT00240097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111322995|NCT00240097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111322996|NCT00240097|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111322997|NCT00240097|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111322998|NCT04270487|Octylonium|octylonium|mesh-list
111322999|NCT04270487|Bromides|bromides|mesh-list
111323000|NCT04270487|Anticonvulsants|anticonvulsants|mesh-ancestor
111323001|NCT04270487|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111161035|NCT02196506|Dopamine Agonists|dopamine agonists|mesh-ancestor
111323002|NCT04270487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111323003|NCT04270487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111323004|NCT04270487|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111323005|NCT04270487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111323006|NCT04270487|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111323007|NCT04270487|Parasympatholytics|parasympatholytics|mesh-ancestor
111323008|NCT04270487|Autonomic Agents|autonomic agents|mesh-ancestor
111323009|NCT04270487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111323010|NCT04270487|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111323011|NCT04270487|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111323012|NCT04270487|Cholinergic Agents|cholinergic agents|mesh-ancestor
111323013|NCT04270487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111323014|NCT00739999|Atorvastatin|atorvastatin|mesh-list
111323015|NCT00739999|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111323016|NCT00739999|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111323017|NCT00739999|Antimetabolites|antimetabolites|mesh-ancestor
111323018|NCT00739999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111323019|NCT00739999|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111323020|NCT00739999|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111323021|NCT00739999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111323022|NCT02997995|Durvalumab|durvalumab|mesh-list
111323023|NCT02997995|Tremelimumab|tremelimumab|mesh-list
111323024|NCT02997995|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111323025|NCT02997995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111323026|NCT03620162|Vaccines|vaccines|mesh-list
111323027|NCT03620162|Immunologic Factors|immunologic factors|mesh-ancestor
111323028|NCT03620162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111323029|NCT00742573|Antidepressive Agents|antidepressive agents|mesh-list
111323030|NCT00742573|Bupropion|bupropion|mesh-list
111323031|NCT00742573|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111323032|NCT00742573|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111323033|NCT00742573|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111323034|NCT00742573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111323035|NCT00742573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111323036|NCT00742573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111323037|NCT00742573|Dopamine Agents|dopamine agents|mesh-ancestor
111323038|NCT00742573|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111161102|NCT04659317|Sensory System Agents|sensory system agents|mesh-ancestor
111323039|NCT00742573|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111323040|NCT00742573|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111323041|NCT00742573|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111323042|NCT00742573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111323043|NCT03809923|Lidocaine|lidocaine|mesh-list
111323044|NCT03809923|Dexmedetomidine|dexmedetomidine|mesh-list
111323045|NCT03809923|Anesthetics, Local|anesthetics, local|mesh-ancestor
111323046|NCT03809923|Anesthetics|anesthetics|mesh-ancestor
111323047|NCT03809923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111323048|NCT03809923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111323049|NCT03809923|Sensory System Agents|sensory system agents|mesh-ancestor
111161208|NCT02170064|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
111323050|NCT03809923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111323051|NCT03809923|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111323052|NCT03809923|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111323053|NCT03809923|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111323054|NCT03809923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111323055|NCT03809923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111323056|NCT03809923|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111323057|NCT03809923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111323058|NCT03809923|Analgesics|analgesics|mesh-ancestor
111323059|NCT03809923|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111323060|NCT03809923|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111323061|NCT03809923|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111323062|NCT03809923|Adrenergic Agents|adrenergic agents|mesh-ancestor
111323063|NCT03809923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111323064|NCT00719329|Chlorhexidine|chlorhexidine|mesh-list
111323065|NCT00719329|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111323066|NCT00719329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111323067|NCT00719329|Disinfectants|disinfectants|mesh-ancestor
111323069|NCT00602225|Clofarabine|clofarabine|mesh-list
111323070|NCT00602225|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111323071|NCT00602225|Antimetabolites|antimetabolites|mesh-ancestor
111323072|NCT00602225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111323073|NCT00602225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111323074|NCT00602225|Antiviral Agents|antiviral agents|mesh-ancestor
111323075|NCT00602225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111323076|NCT00602225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111323077|NCT00602225|Immunologic Factors|immunologic factors|mesh-ancestor
111323078|NCT00602225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111323079|NCT00602771|Etoposide|etoposide|mesh-list
111323080|NCT00602771|Etoposide phosphate|etoposide phosphate|mesh-list
111323081|NCT00602771|Tipifarnib|tipifarnib|mesh-list
111323082|NCT00602771|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111323083|NCT00602771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111323084|NCT00602771|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111323085|NCT00602771|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111323086|NCT00602771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111323087|NCT00602771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111323088|NCT00744211|Sitaxsentan|sitaxsentan|mesh-list
111323089|NCT00744211|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
111323090|NCT00744211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111323091|NCT02997371|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
111323092|NCT02997371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111323093|NCT04248998|Metformin|metformin|mesh-list
111323094|NCT04248998|Paclitaxel|paclitaxel|mesh-list
111323095|NCT04248998|Cyclophosphamide|cyclophosphamide|mesh-list
111323096|NCT04248998|Doxorubicin|doxorubicin|mesh-list
111161544|NCT02164916|Cetuximab|cetuximab|mesh-list
111323097|NCT04248998|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111323098|NCT04248998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111323099|NCT04248998|Tubulin Modulators|tubulin modulators|mesh-ancestor
111323100|NCT04248998|Antimitotic Agents|antimitotic agents|mesh-ancestor
111323101|NCT04248998|Mitosis Modulators|mitosis modulators|mesh-ancestor
111323102|NCT04248998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111323103|NCT04248998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111323104|NCT04248998|Immunologic Factors|immunologic factors|mesh-ancestor
111323105|NCT04248998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111323106|NCT04248998|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111161681|NCT04790279|Tocolytic Agents|tocolytic agents|mesh-ancestor
111323107|NCT04248998|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111323108|NCT04248998|Alkylating Agents|alkylating agents|mesh-ancestor
111323109|NCT04248998|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111323110|NCT04248998|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111323111|NCT04248998|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111323112|NCT04248998|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111323113|NCT04248998|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111323114|NCT04248998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111323115|NCT00714233|Metformin|metformin|mesh-list
111323116|NCT00714233|Contraceptive Agents|contraceptive agents|mesh-list
111323117|NCT00714233|Contraceptives, Oral|contraceptives, oral|mesh-list
111323118|NCT00714233|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
111323119|NCT00714233|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
111323120|NCT00714233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111323121|NCT00714233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111323122|NCT00714233|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111323123|NCT00714233|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111323124|NCT00746395|Lubiprostone|lubiprostone|mesh-list
111323125|NCT00746395|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
111323126|NCT00746395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111323127|NCT00746395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111323128|NCT04205786|Vitamin B 12|vitamin b 12|mesh-list
111323129|NCT04205786|Hydroxocobalamin|hydroxocobalamin|mesh-list
111323130|NCT04205786|Aromatase Inhibitors|aromatase inhibitors|mesh-list
111323131|NCT04205786|Vitamins|vitamins|mesh-ancestor
111323132|NCT04205786|Micronutrients|micronutrients|mesh-ancestor
111323133|NCT04205786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111323134|NCT04205786|Vitamin B Complex|vitamin b complex|mesh-ancestor
111323135|NCT04205786|Hematinics|hematinics|mesh-ancestor
111323136|NCT04205786|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111323137|NCT04205786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111323138|NCT04205786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111323139|NCT04205786|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111047564|NCT02171507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111323140|NCT04205786|Hormone Antagonists|hormone antagonists|mesh-ancestor
111323141|NCT04205786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111323142|NCT00719966|Letrozole|letrozole|mesh-list
111323143|NCT00719966|Anastrozole|anastrozole|mesh-list
111323144|NCT00719966|Exemestane|exemestane|mesh-list
111323145|NCT00719966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111323146|NCT00719966|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111323147|NCT00719966|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111323148|NCT00719966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111323149|NCT00719966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111323150|NCT00719966|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111323151|NCT00719966|Hormone Antagonists|hormone antagonists|mesh-ancestor
111323152|NCT00719966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111323153|NCT00719966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111323154|NCT00719966|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111323155|NCT01276067|Donepezil|donepezil|mesh-list
111323156|NCT01276067|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111323157|NCT01276067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111323158|NCT01276067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111323159|NCT01276067|Cholinergic Agents|cholinergic agents|mesh-ancestor
111323160|NCT01276067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111323161|NCT01276067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111323162|NCT01276067|Nootropic Agents|nootropic agents|mesh-ancestor
111323163|NCT04183868|Empagliflozin|empagliflozin|mesh-list
111323164|NCT04183868|Glimepiride|glimepiride|mesh-list
111323165|NCT04183868|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111323166|NCT04183868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111323167|NCT04183868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111323168|NCT04183868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111323169|NCT04183868|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111323170|NCT04183868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111323171|NCT04183868|Immunologic Factors|immunologic factors|mesh-ancestor
111323172|NCT02997215|Lidocaine|lidocaine|mesh-list
111323173|NCT02997215|Anesthetics, Local|anesthetics, local|mesh-ancestor
111323174|NCT02997215|Anesthetics|anesthetics|mesh-ancestor
111323175|NCT02997215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111323176|NCT02997215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111323177|NCT02997215|Sensory System Agents|sensory system agents|mesh-ancestor
111323178|NCT02997215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111323179|NCT02997215|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111323180|NCT02997215|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111323181|NCT02997215|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111323182|NCT02997215|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111323183|NCT02997215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111323184|NCT02990507|Methyltestosterone|methyltestosterone|mesh-list
111323185|NCT02990507|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
111323186|NCT02990507|Testosterone|testosterone|mesh-list
111162126|NCT01559116|Tiotropium Bromide|tiotropium bromide|mesh-list
111323187|NCT02990507|Testosterone undecanoate|testosterone undecanoate|mesh-list
111323188|NCT02990507|Testosterone enanthate|testosterone enanthate|mesh-list
111323189|NCT02990507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111323190|NCT02990507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111323191|NCT02990507|Anabolic Agents|anabolic agents|mesh-ancestor
111323192|NCT02990507|Hormones|hormones|mesh-ancestor
111323193|NCT02990507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111323194|NCT02990507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111323195|NCT02990507|Androgens|androgens|mesh-ancestor
111323196|NCT03331484|Rivaroxaban|rivaroxaban|mesh-list
111323197|NCT03331484|Ticagrelor|ticagrelor|mesh-list
111323198|NCT03331484|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111323199|NCT03331484|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111323200|NCT03331484|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111323201|NCT03331484|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111323202|NCT03331484|Purinergic Agents|purinergic agents|mesh-ancestor
111323203|NCT03331484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111323204|NCT03331484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111323205|NCT03331484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111323206|NCT03331484|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111323207|NCT03331484|Antithrombins|antithrombins|mesh-ancestor
111323208|NCT03331484|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111323209|NCT03331484|Protease Inhibitors|protease inhibitors|mesh-ancestor
111323210|NCT03331484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111323211|NCT03331484|Anticoagulants|anticoagulants|mesh-ancestor
111047637|NCT00835705|Clavulanic Acids|clavulanic acids|mesh-list
111323213|NCT00721513|Fluorouracil|fluorouracil|mesh-list
111323214|NCT00721513|Cetuximab|cetuximab|mesh-list
111323215|NCT00721513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111323216|NCT00721513|Tubulin Modulators|tubulin modulators|mesh-ancestor
111323217|NCT00721513|Antimitotic Agents|antimitotic agents|mesh-ancestor
111323218|NCT00721513|Mitosis Modulators|mitosis modulators|mesh-ancestor
111323219|NCT00721513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111323220|NCT00721513|Antimetabolites|antimetabolites|mesh-ancestor
111323221|NCT00721513|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111323222|NCT00721513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111323223|NCT00721513|Immunologic Factors|immunologic factors|mesh-ancestor
111323224|NCT00721513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111323225|NCT00721513|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111323226|NCT00706121|Vitamins|vitamins|mesh-list
111323227|NCT00706121|Vitamin E|vitamin e|mesh-list
111323228|NCT00706121|Tocopherols|tocopherols|mesh-list
111323229|NCT00706121|Tocotrienols|tocotrienols|mesh-list
111323230|NCT00706121|alpha-Tocopherol|alpha-tocopherol|mesh-list
111323231|NCT00706121|Selenium|selenium|mesh-list
111323232|NCT00706121|Micronutrients|micronutrients|mesh-ancestor
111323233|NCT00706121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111323234|NCT00706121|Antioxidants|antioxidants|mesh-ancestor
111323235|NCT00706121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111323236|NCT00706121|Protective Agents|protective agents|mesh-ancestor
111323237|NCT00706121|Trace Elements|trace elements|mesh-ancestor
111323238|NCT00746863|Bupivacaine|bupivacaine|mesh-list
111323239|NCT00746863|Anesthetics, Local|anesthetics, local|mesh-ancestor
111323240|NCT00746863|Anesthetics|anesthetics|mesh-ancestor
111323241|NCT00746863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111323242|NCT00746863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111323243|NCT00746863|Sensory System Agents|sensory system agents|mesh-ancestor
111323244|NCT00746863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111323245|NCT04385563|Docetaxel|docetaxel|mesh-list
111323246|NCT04385563|Trastuzumab|trastuzumab|mesh-list
111323247|NCT04385563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111323248|NCT04385563|Tubulin Modulators|tubulin modulators|mesh-ancestor
111323249|NCT04385563|Antimitotic Agents|antimitotic agents|mesh-ancestor
111162814|NCT01950741|Aflibercept|aflibercept|mesh-list
111323250|NCT04385563|Mitosis Modulators|mitosis modulators|mesh-ancestor
111323251|NCT04385563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111323252|NCT04385563|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111323253|NCT03568838|Enoxaparin|enoxaparin|mesh-list
111323254|NCT03568838|Anticoagulants|anticoagulants|mesh-ancestor
111323255|NCT03568838|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111323256|NCT03568838|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111323257|NCT03568838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111323258|NCT00726713|Vitamin B 12|vitamin b 12|mesh-list
111323259|NCT00726713|Vitamin B Complex|vitamin b complex|mesh-ancestor
111323260|NCT00726713|Vitamins|vitamins|mesh-ancestor
111323261|NCT00726713|Micronutrients|micronutrients|mesh-ancestor
111162882|NCT01545388|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111323262|NCT00726713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111323263|NCT00759187|Chlorhexidine|chlorhexidine|mesh-list
111323264|NCT00759187|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
111323265|NCT00759187|Triclosan|triclosan|mesh-list
111323266|NCT00759187|Fluorides|fluorides|mesh-list
111323267|NCT00759187|Sodium Fluoride|sodium fluoride|mesh-list
111323268|NCT00759187|Fluorophosphate|fluorophosphate|mesh-list
111323269|NCT00759187|Cariostatic Agents|cariostatic agents|mesh-ancestor
111323270|NCT00759187|Protective Agents|protective agents|mesh-ancestor
111323271|NCT00759187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111323272|NCT00759187|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111323273|NCT00759187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111323274|NCT00759187|Disinfectants|disinfectants|mesh-ancestor
111323275|NCT00759187|Dermatologic Agents|dermatologic agents|mesh-ancestor
111323276|NCT00759187|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
111323277|NCT00759187|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111323278|NCT00759187|Antimetabolites|antimetabolites|mesh-ancestor
111323279|NCT00759187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111323280|NCT00759187|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111323281|NCT03085940|Hydroxychloroquine|hydroxychloroquine|mesh-list
111323282|NCT03085940|Antimalarials|antimalarials|mesh-ancestor
111323283|NCT03085940|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111323284|NCT03085940|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111323285|NCT03085940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111323286|NCT03085940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111323287|NCT03085940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111323288|NCT03085940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111323289|NCT01279915|Linaclotide|linaclotide|mesh-list
111047717|NCT03539003|Propofol|propofol|mesh-list
111323290|NCT01279915|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
111323291|NCT01279915|Enzyme Activators|enzyme activators|mesh-ancestor
111323292|NCT01279915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111323293|NCT01279915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111323294|NCT03809455|Fentanyl|fentanyl|mesh-list
111323295|NCT03809455|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111323296|NCT03809455|Narcotics|narcotics|mesh-ancestor
111323297|NCT03809455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111323298|NCT03809455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111323299|NCT03809455|Analgesics|analgesics|mesh-ancestor
111323300|NCT03809455|Sensory System Agents|sensory system agents|mesh-ancestor
111323301|NCT03809455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111323302|NCT03809455|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111323303|NCT03809455|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111323304|NCT03809455|Anesthetics, General|anesthetics, general|mesh-ancestor
111323305|NCT03809455|Anesthetics|anesthetics|mesh-ancestor
111323306|NCT03618134|Durvalumab|durvalumab|mesh-list
111323307|NCT03618134|Ipilimumab|ipilimumab|mesh-list
111323308|NCT03618134|Tremelimumab|tremelimumab|mesh-list
111323309|NCT03618134|Immunoglobulins|immunoglobulins|mesh-list
111323310|NCT03618134|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111323311|NCT03618134|Immunoglobulin G|immunoglobulin g|mesh-list
111323312|NCT03618134|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111323313|NCT03618134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111323314|NCT03618134|Immunologic Factors|immunologic factors|mesh-ancestor
111323315|NCT03618134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111323316|NCT03618134|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110880658|NCT05330273|Efavirenz|efavirenz|mesh-list
111323317|NCT03618134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111323318|NCT02997059|Fluconazole|fluconazole|mesh-list
111323319|NCT02997059|Antifungal Agents|antifungal agents|mesh-ancestor
111323320|NCT02997059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111323321|NCT02997059|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111323322|NCT02997059|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111323323|NCT02997059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111323324|NCT02997059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111323325|NCT02997059|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111323326|NCT02997059|Hormone Antagonists|hormone antagonists|mesh-ancestor
111323327|NCT02997059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111323328|NCT02997059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111323329|NCT02997059|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111163650|NCT02073656|Sofosbuvir|sofosbuvir|mesh-list
111323330|NCT02997059|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111323331|NCT00759811|Methotrexate|methotrexate|mesh-list
111323332|NCT00759811|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111323333|NCT00759811|Abortifacient Agents|abortifacient agents|mesh-ancestor
111323334|NCT00759811|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111323335|NCT00759811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111323336|NCT00759811|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111323337|NCT00759811|Antimetabolites|antimetabolites|mesh-ancestor
111323338|NCT00759811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111323339|NCT00759811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111323340|NCT00759811|Dermatologic Agents|dermatologic agents|mesh-ancestor
111323341|NCT00759811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111323342|NCT00759811|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111323343|NCT00759811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111323344|NCT00759811|Immunologic Factors|immunologic factors|mesh-ancestor
111323345|NCT00759811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111163854|NCT02069366|Hormones|hormones|mesh-ancestor
111323346|NCT00759811|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111323347|NCT03085628|Oxytocin|oxytocin|mesh-list
111323348|NCT03085628|Oxytocics|oxytocics|mesh-ancestor
111323349|NCT03085628|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111323350|NCT03085628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111323351|NCT01276613|Gemcitabine|gemcitabine|mesh-list
111323352|NCT01276613|Losartan|losartan|mesh-list
111323353|NCT01276613|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111323354|NCT01276613|Antimetabolites|antimetabolites|mesh-ancestor
111323355|NCT01276613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111323356|NCT01276613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111163917|NCT01896531|Antidotes|antidotes|mesh-ancestor
111323357|NCT01276613|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111323358|NCT01276613|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111323359|NCT01276613|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111323360|NCT01276613|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111323361|NCT02428205|Propranolol|propranolol|mesh-list
111323362|NCT02428205|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111323363|NCT02428205|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111323365|NCT02428205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111163982|NCT02203331|Anastrozole|anastrozole|mesh-list
111323366|NCT02428205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111323367|NCT02428205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111323368|NCT02428205|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111323369|NCT02428205|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111323370|NCT02428205|Vasodilator Agents|vasodilator agents|mesh-ancestor
111323371|NCT01276691|Aspirin|aspirin|mesh-list
111323372|NCT01276691|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111323373|NCT01276691|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111323374|NCT01276691|Analgesics|analgesics|mesh-ancestor
111323375|NCT01276691|Sensory System Agents|sensory system agents|mesh-ancestor
111323376|NCT01276691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111164052|NCT02202551|Analgesics|analgesics|mesh-ancestor
111323377|NCT01276691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111323378|NCT01276691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111323379|NCT01276691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111323380|NCT01276691|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111164120|NCT02137837|Fulvestrant|fulvestrant|mesh-list
111323381|NCT01276691|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111323382|NCT01276691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111323383|NCT01276691|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111323384|NCT01276691|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111323385|NCT01276691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111323386|NCT01276691|Antipyretics|antipyretics|mesh-ancestor
111323387|NCT03081416|Diphenhydramine|diphenhydramine|mesh-list
111323388|NCT03081416|Dexamethasone|dexamethasone|mesh-list
111323389|NCT03081416|Ketorolac|ketorolac|mesh-list
111323390|NCT03081416|Ketamine|ketamine|mesh-list
111323391|NCT03081416|Metoclopramide|metoclopramide|mesh-list
111323392|NCT03081416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111323393|NCT03081416|Antiemetics|antiemetics|mesh-ancestor
111323394|NCT03081416|Autonomic Agents|autonomic agents|mesh-ancestor
111323395|NCT03081416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111323396|NCT03081416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111323397|NCT03081416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111323398|NCT03081416|Glucocorticoids|glucocorticoids|mesh-ancestor
111323399|NCT03081416|Hormones|hormones|mesh-ancestor
111323400|NCT03081416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111164313|NCT01461538|Immunoconjugates|immunoconjugates|mesh-ancestor
111323401|NCT03081416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111323402|NCT03081416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111323403|NCT03081416|Analgesics|analgesics|mesh-ancestor
111323404|NCT03081416|Sensory System Agents|sensory system agents|mesh-ancestor
111323405|NCT03081416|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111323406|NCT03081416|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111323407|NCT03081416|Anesthetics, General|anesthetics, general|mesh-ancestor
111323408|NCT03081416|Anesthetics|anesthetics|mesh-ancestor
111323409|NCT03081416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111323410|NCT03081416|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111323411|NCT03081416|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111323412|NCT03081416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111164459|NCT02201771|Aspirin|aspirin|mesh-list
111323413|NCT03081416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111323414|NCT03081416|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111323415|NCT03081416|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111164524|NCT01458574|Tofacitinib|tofacitinib|mesh-list
111323416|NCT03081416|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111323417|NCT03081416|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111323418|NCT03081416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111323419|NCT03081416|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111323420|NCT03081416|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111323421|NCT03081416|Dopamine Agents|dopamine agents|mesh-ancestor
111323422|NCT03081416|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111323423|NCT03081416|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111323424|NCT03081416|Anesthetics, Local|anesthetics, local|mesh-ancestor
111323425|NCT03081416|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111323426|NCT03081416|Histamine Antagonists|histamine antagonists|mesh-ancestor
111323427|NCT03081416|Histamine Agents|histamine agents|mesh-ancestor
111323428|NCT03081416|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111323429|NCT00706589|Aripiprazole|aripiprazole|mesh-list
111323430|NCT00706589|Antidepressive Agents|antidepressive agents|mesh-ancestor
111164748|NCT02219087|Bupivacaine|bupivacaine|mesh-list
111323431|NCT00706589|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111323432|NCT00706589|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111323433|NCT00706589|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111323434|NCT00706589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111323435|NCT00706589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111323436|NCT00706589|Dopamine Agonists|dopamine agonists|mesh-ancestor
111047865|NCT00694135|Hormones|hormones|mesh-ancestor
111323437|NCT00706589|Dopamine Agents|dopamine agents|mesh-ancestor
111323439|NCT00706589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111323440|NCT00706589|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111323441|NCT00706589|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111323442|NCT00706589|Serotonin Agents|serotonin agents|mesh-ancestor
111323443|NCT00706589|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111323444|NCT00706589|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111323445|NCT00706589|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111323446|NCT00706589|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111323447|NCT01276769|Paclitaxel|paclitaxel|mesh-list
111323448|NCT01276769|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111323449|NCT01276769|Carboplatin|carboplatin|mesh-list
111323450|NCT01276769|Epirubicin|epirubicin|mesh-list
111323451|NCT01276769|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111323452|NCT01276769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111323453|NCT01276769|Tubulin Modulators|tubulin modulators|mesh-ancestor
111323454|NCT01276769|Antimitotic Agents|antimitotic agents|mesh-ancestor
111323455|NCT01276769|Mitosis Modulators|mitosis modulators|mesh-ancestor
111323456|NCT01276769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111323457|NCT01276769|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111323458|NCT01276769|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111323459|NCT01276769|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111323460|NCT01276769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111323461|NCT01279681|Leucovorin|leucovorin|mesh-list
111323462|NCT01279681|Bevacizumab|bevacizumab|mesh-list
111323463|NCT01279681|Fluorouracil|fluorouracil|mesh-list
111323464|NCT01279681|Capecitabine|capecitabine|mesh-list
111323465|NCT01279681|Oxaliplatin|oxaliplatin|mesh-list
111323466|NCT01279681|Calcium|calcium|mesh-list
111323467|NCT01279681|Levoleucovorin|levoleucovorin|mesh-list
111323468|NCT01279681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111323469|NCT01279681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111323470|NCT01279681|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111323471|NCT01279681|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111165074|NCT02116309|Indomethacin|indomethacin|mesh-list
111323472|NCT01279681|Growth Substances|growth substances|mesh-ancestor
111323473|NCT01279681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111323474|NCT01279681|Growth Inhibitors|growth inhibitors|mesh-ancestor
111165137|NCT02070991|Macitentan|macitentan|mesh-list
111323475|NCT01279681|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111323476|NCT01279681|Antimetabolites|antimetabolites|mesh-ancestor
111323477|NCT01279681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111323478|NCT01279681|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111323479|NCT01279681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111323480|NCT01279681|Immunologic Factors|immunologic factors|mesh-ancestor
111323481|NCT01279681|Antidotes|antidotes|mesh-ancestor
111323482|NCT01279681|Protective Agents|protective agents|mesh-ancestor
111323483|NCT01279681|Vitamin B Complex|vitamin b complex|mesh-ancestor
111323484|NCT01279681|Vitamins|vitamins|mesh-ancestor
111323485|NCT01279681|Micronutrients|micronutrients|mesh-ancestor
111323486|NCT01276925|Bupivacaine|bupivacaine|mesh-list
111323487|NCT01276925|Ropivacaine|ropivacaine|mesh-list
111323488|NCT01276925|Anesthetics, Local|anesthetics, local|mesh-ancestor
111323489|NCT01276925|Anesthetics|anesthetics|mesh-ancestor
111323490|NCT01276925|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111323491|NCT01276925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111323492|NCT01276925|Sensory System Agents|sensory system agents|mesh-ancestor
111323493|NCT01276925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111323494|NCT00728507|Moxifloxacin|moxifloxacin|mesh-list
111323495|NCT00728507|Rifampin|rifampin|mesh-list
111323496|NCT00728507|Isoniazid|isoniazid|mesh-list
111323497|NCT00728507|Pyrazinamide|pyrazinamide|mesh-list
111323498|NCT00728507|Ethambutol|ethambutol|mesh-list
111323499|NCT00728507|Rifapentine|rifapentine|mesh-list
111323500|NCT00728507|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111323501|NCT00728507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111323502|NCT00728507|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111323503|NCT00728507|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111323504|NCT00728507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111323505|NCT00728507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111323506|NCT00728507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111323507|NCT00728507|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111323508|NCT00728507|Antitubercular Agents|antitubercular agents|mesh-ancestor
111323509|NCT00728507|Leprostatic Agents|leprostatic agents|mesh-ancestor
111323510|NCT00728507|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111323511|NCT00728507|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111323512|NCT00728507|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111323513|NCT00728507|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
111323514|NCT00728507|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
111323515|NCT00728507|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
111323516|NCT00728507|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111323517|NCT00728507|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
111323518|NCT00728507|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111323519|NCT00728507|Antimetabolites|antimetabolites|mesh-ancestor
111323520|NCT00728507|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111323521|NCT01279057|Fluticasone|fluticasone|mesh-list
111323522|NCT01279057|Xhance|xhance|mesh-list
111323523|NCT01279057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111323524|NCT01279057|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111323525|NCT01279057|Autonomic Agents|autonomic agents|mesh-ancestor
111323526|NCT01279057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111323527|NCT01279057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111323528|NCT01279057|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111323529|NCT01279057|Respiratory System Agents|respiratory system agents|mesh-ancestor
111323530|NCT01279057|Dermatologic Agents|dermatologic agents|mesh-ancestor
111323531|NCT01279057|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111323532|NCT04384783|Hormones|hormones|mesh-list
111323533|NCT04384783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111323534|NCT04384783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111323535|NCT03186326|Bevacizumab|bevacizumab|mesh-list
111323536|NCT03186326|Cetuximab|cetuximab|mesh-list
111323537|NCT03186326|Avelumab|avelumab|mesh-list
111323538|NCT03186326|Panitumumab|panitumumab|mesh-list
111323539|NCT03186326|Aflibercept|aflibercept|mesh-list
111323540|NCT03186326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111323541|NCT03186326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111323542|NCT03186326|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111323543|NCT03186326|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111323544|NCT03186326|Growth Substances|growth substances|mesh-ancestor
111323545|NCT03186326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111323546|NCT03186326|Growth Inhibitors|growth inhibitors|mesh-ancestor
111323547|NCT02999633|Acetaminophen|acetaminophen|mesh-list
111323548|NCT02999633|Diphenhydramine|diphenhydramine|mesh-list
111323549|NCT02999633|Promethazine|promethazine|mesh-list
111323550|NCT02999633|Dexamethasone|dexamethasone|mesh-list
111323551|NCT02999633|Dexamethasone acetate|dexamethasone acetate|mesh-list
111323552|NCT02999633|Ranitidine|ranitidine|mesh-list
111323553|NCT02999633|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
111323554|NCT02999633|BB 1101|bb 1101|mesh-list
111323555|NCT02999633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111323556|NCT02999633|Antiemetics|antiemetics|mesh-ancestor
111323557|NCT02999633|Autonomic Agents|autonomic agents|mesh-ancestor
111323558|NCT02999633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111323559|NCT02999633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111323560|NCT02999633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111323561|NCT02999633|Glucocorticoids|glucocorticoids|mesh-ancestor
111323562|NCT02999633|Hormones|hormones|mesh-ancestor
111323563|NCT02999633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111323564|NCT02999633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111323565|NCT02999633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111323566|NCT02999633|Protease Inhibitors|protease inhibitors|mesh-ancestor
111323567|NCT02999633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111165372|NCT01857063|Montelukast|montelukast|mesh-list
111323568|NCT02999633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111323569|NCT02999633|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111323570|NCT02999633|Analgesics|analgesics|mesh-ancestor
111323571|NCT02999633|Sensory System Agents|sensory system agents|mesh-ancestor
111323572|NCT02999633|Antipyretics|antipyretics|mesh-ancestor
111323573|NCT02999633|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111323574|NCT02999633|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111323575|NCT02999633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111323576|NCT02999633|Anesthetics, Local|anesthetics, local|mesh-ancestor
111323577|NCT02999633|Anesthetics|anesthetics|mesh-ancestor
111323578|NCT02999633|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111323579|NCT02999633|Histamine Antagonists|histamine antagonists|mesh-ancestor
111323580|NCT02999633|Histamine Agents|histamine agents|mesh-ancestor
111323581|NCT02999633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111323582|NCT02999633|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111323583|NCT02999633|Antipruritics|antipruritics|mesh-ancestor
111323584|NCT02999633|Dermatologic Agents|dermatologic agents|mesh-ancestor
111323585|NCT02999633|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111323586|NCT02999633|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
111323587|NCT02991599|Vaccines|vaccines|mesh-list
111165484|NCT02162771|Hormones|hormones|mesh-ancestor
111323588|NCT02991599|Immunologic Factors|immunologic factors|mesh-ancestor
111323589|NCT02991599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111323590|NCT02996513|Vitamin A|vitamin a|mesh-list
111323591|NCT02996513|Vitamins|vitamins|mesh-ancestor
111323592|NCT02996513|Micronutrients|micronutrients|mesh-ancestor
111323593|NCT02996513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111323594|NCT04276688|Interferons|interferons|mesh-list
111323595|NCT04276688|Ritonavir|ritonavir|mesh-list
111323596|NCT04276688|Ribavirin|ribavirin|mesh-list
111323597|NCT04276688|Lopinavir|lopinavir|mesh-list
111323598|NCT04276688|Interferon-beta|interferon-beta|mesh-list
111323599|NCT04276688|Interferon beta-1b|interferon beta-1b|mesh-list
111323600|NCT04276688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111323601|NCT04276688|Antiviral Agents|antiviral agents|mesh-ancestor
111323602|NCT04276688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111323603|NCT04276688|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111323604|NCT04276688|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111323605|NCT04276688|Protease Inhibitors|protease inhibitors|mesh-ancestor
111323606|NCT04276688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111323607|NCT04276688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111165683|NCT01625611|Naltrexone|naltrexone|mesh-list
111323608|NCT04276688|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111323609|NCT04276688|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111323610|NCT04276688|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111323611|NCT04276688|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111323612|NCT04276688|Antimetabolites|antimetabolites|mesh-ancestor
111323613|NCT04276688|Immunologic Factors|immunologic factors|mesh-ancestor
111323614|NCT04276688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111323615|NCT04276688|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111323616|NCT01277627|Efavirenz|efavirenz|mesh-list
111323617|NCT01277627|Nevirapine|nevirapine|mesh-list
111323618|NCT01277627|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
111323619|NCT01277627|Protease Inhibitors|protease inhibitors|mesh-list
111323620|NCT01277627|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111323621|NCT01277627|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111323622|NCT01277627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111323623|NCT01277627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111323624|NCT01277627|Antiviral Agents|antiviral agents|mesh-ancestor
111323625|NCT01277627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111323626|NCT01277627|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111323627|NCT01277627|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111323628|NCT01277627|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111323629|NCT01277627|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111323630|NCT01277627|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111323631|NCT01277627|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111323632|NCT01277627|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111323633|NCT01277627|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111323634|NCT01277627|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111323635|NCT05241470|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111323636|NCT05241470|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111323637|NCT01270451|Insulin|insulin|mesh-list
111323638|NCT01270451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111323639|NCT01270451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111323640|NCT00706979|Nicotine|nicotine|mesh-list
111323641|NCT00706979|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111323642|NCT00706979|Autonomic Agents|autonomic agents|mesh-ancestor
111323643|NCT00706979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111323644|NCT00706979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111323645|NCT00706979|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111323646|NCT00706979|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111323647|NCT00706979|Cholinergic Agents|cholinergic agents|mesh-ancestor
111323648|NCT00706979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111323649|NCT00706979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111323650|NCT01278017|Ceftriaxone|ceftriaxone|mesh-list
111165937|NCT01854645|Parasympatholytics|parasympatholytics|mesh-ancestor
111323651|NCT01278017|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111323652|NCT01278017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111323653|NCT00716963|Fluticasone|fluticasone|mesh-list
111323654|NCT00716963|Xhance|xhance|mesh-list
111323655|NCT00716963|Budesonide|budesonide|mesh-list
111323656|NCT00716963|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111323657|NCT00716963|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111323658|NCT00716963|Autonomic Agents|autonomic agents|mesh-ancestor
111323659|NCT00716963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111323660|NCT00716963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111323661|NCT00716963|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111323662|NCT00716963|Respiratory System Agents|respiratory system agents|mesh-ancestor
111323663|NCT00716963|Dermatologic Agents|dermatologic agents|mesh-ancestor
111323664|NCT00716963|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111323665|NCT00716963|Glucocorticoids|glucocorticoids|mesh-ancestor
111048093|NCT03607539|Pemetrexed|pemetrexed|mesh-list
111323666|NCT00716963|Hormones|hormones|mesh-ancestor
111323667|NCT00716963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111323668|NCT01270997|Etanercept|etanercept|mesh-list
111323669|NCT01270997|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111323670|NCT01270997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111323671|NCT01270997|Analgesics|analgesics|mesh-ancestor
111323672|NCT01270997|Sensory System Agents|sensory system agents|mesh-ancestor
111323673|NCT01270997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111323674|NCT01270997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111323675|NCT01270997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111323676|NCT01270997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111323677|NCT01270997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111323678|NCT01270997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111323679|NCT01270997|Immunologic Factors|immunologic factors|mesh-ancestor
111323680|NCT01278745|Rituximab|rituximab|mesh-list
111323681|NCT01278745|Tacrolimus|tacrolimus|mesh-list
111323682|NCT01278745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111323683|NCT01278745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111323684|NCT01278745|Immunologic Factors|immunologic factors|mesh-ancestor
111323685|NCT01278745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111323686|NCT01278745|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111323687|NCT01278745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111323688|NCT01278745|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111323689|NCT01278745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111323690|NCT01278745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111323691|NCT02995655|Azacitidine|azacitidine|mesh-list
111323692|NCT02995655|Heparin|heparin|mesh-list
111323693|NCT02995655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111323694|NCT02995655|Antimetabolites|antimetabolites|mesh-ancestor
111323695|NCT02995655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111323696|NCT02995655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111323697|NCT02995655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111323698|NCT02995655|Anticoagulants|anticoagulants|mesh-ancestor
111323699|NCT02995655|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111323700|NCT02995655|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111323701|NCT01271153|Dobutamine|dobutamine|mesh-list
111323702|NCT01271153|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111323703|NCT01271153|Sympathomimetics|sympathomimetics|mesh-ancestor
111323704|NCT01271153|Autonomic Agents|autonomic agents|mesh-ancestor
111323705|NCT01271153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111323706|NCT01271153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111323707|NCT01271153|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
111166325|NCT02118896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111323708|NCT01271153|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111323709|NCT01271153|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111323710|NCT01271153|Adrenergic Agents|adrenergic agents|mesh-ancestor
111323711|NCT01271153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111323712|NCT01271153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111323713|NCT01271153|Protective Agents|protective agents|mesh-ancestor
111323714|NCT03809065|Labetalol|labetalol|mesh-list
111323715|NCT03809065|Nitroglycerin|nitroglycerin|mesh-list
111323716|NCT03809065|Vasodilator Agents|vasodilator agents|mesh-ancestor
111323717|NCT03809065|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111323718|NCT03809065|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111323719|NCT03809065|Adrenergic Agents|adrenergic agents|mesh-ancestor
111323720|NCT03809065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111323721|NCT03809065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111323722|NCT03809065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111323723|NCT03809065|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111323724|NCT03809065|Sympathomimetics|sympathomimetics|mesh-ancestor
111323725|NCT03809065|Autonomic Agents|autonomic agents|mesh-ancestor
111323726|NCT03809065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111323727|NCT03809065|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111323728|NCT03809065|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111323729|NCT03006926|Pembrolizumab|pembrolizumab|mesh-list
111323730|NCT03006926|Lenvatinib|lenvatinib|mesh-list
111323731|NCT03006926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111323732|NCT03006926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111323733|NCT03006926|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111323734|NCT03006926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111323735|NCT03006926|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111323736|NCT03006926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111323737|NCT02995187|Apatinib|apatinib|mesh-list
111323738|NCT02995187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111323739|NCT02995187|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111323740|NCT02995187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111323741|NCT02995187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111323742|NCT01272089|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
111048163|NCT04472689|Lidocaine|lidocaine|mesh-list
111323744|NCT01272089|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111323745|NCT01272089|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111323746|NCT01272089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111323747|NCT01272089|Analgesics|analgesics|mesh-ancestor
111323748|NCT01272089|Sensory System Agents|sensory system agents|mesh-ancestor
111323749|NCT01272089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111323750|NCT01272089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111323751|NCT01272089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111323752|NCT01272089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111323753|NCT01272089|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111323754|NCT01272089|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
111323755|NCT01272089|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111323756|NCT01272089|Histamine Antagonists|histamine antagonists|mesh-ancestor
111323757|NCT01272089|Histamine Agents|histamine agents|mesh-ancestor
111323758|NCT01272089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111365085|NCT03007303|Antidepressive Agents|antidepressive agents|mesh-ancestor
111323759|NCT01272089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111323760|NCT00748657|Bevacizumab|bevacizumab|mesh-list
111323761|NCT00748657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111323762|NCT00748657|Endothelial Growth Factors|endothelial growth factors|mesh-list
111323763|NCT00748657|Antibodies|antibodies|mesh-list
111323764|NCT00748657|Immunoglobulins|immunoglobulins|mesh-list
111323765|NCT00748657|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111323766|NCT00748657|Immunoglobulin G|immunoglobulin g|mesh-list
111323767|NCT00748657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110883860|NCT03240575|Xhance|xhance|mesh-list
111323768|NCT00748657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111323769|NCT00748657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111323770|NCT00748657|Growth Substances|growth substances|mesh-ancestor
111166859|NCT02044094|Naloxone|naloxone|mesh-list
111323771|NCT00748657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111323772|NCT00748657|Growth Inhibitors|growth inhibitors|mesh-ancestor
111323773|NCT00748657|Immunologic Factors|immunologic factors|mesh-ancestor
111323774|NCT02994953|Avelumab|avelumab|mesh-list
111323775|NCT02994953|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111323776|NCT02994953|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111323777|NCT02994953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111323778|NCT02994953|Immunologic Factors|immunologic factors|mesh-ancestor
111323779|NCT02994953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111323780|NCT01273051|Capecitabine|capecitabine|mesh-list
111323781|NCT01273051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111323782|NCT01273051|Antimetabolites|antimetabolites|mesh-ancestor
111323783|NCT01273051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111323784|NCT01273051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111323785|NCT02994875|Acetylcysteine|acetylcysteine|mesh-list
111323786|NCT02994875|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111323787|NCT02994875|Antiviral Agents|antiviral agents|mesh-ancestor
111323788|NCT02994875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111323789|NCT02994875|Expectorants|expectorants|mesh-ancestor
111323790|NCT02994875|Respiratory System Agents|respiratory system agents|mesh-ancestor
111323791|NCT02994875|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111323792|NCT02994875|Antioxidants|antioxidants|mesh-ancestor
111323793|NCT02994875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111323794|NCT02994875|Protective Agents|protective agents|mesh-ancestor
111323795|NCT02994875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111323796|NCT02994875|Antidotes|antidotes|mesh-ancestor
111323797|NCT03809143|Buprenorphine|buprenorphine|mesh-list
111323798|NCT03809143|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111323799|NCT03809143|Narcotics|narcotics|mesh-ancestor
111323800|NCT03809143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111323801|NCT03809143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111323802|NCT03809143|Analgesics|analgesics|mesh-ancestor
111323803|NCT03809143|Sensory System Agents|sensory system agents|mesh-ancestor
111323804|NCT03809143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111323805|NCT03809143|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111323806|NCT02390960|Sildenafil Citrate|sildenafil citrate|mesh-list
111323807|NCT02390960|Vasodilator Agents|vasodilator agents|mesh-ancestor
111323808|NCT02390960|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111323809|NCT02390960|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111323810|NCT02390960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111323811|NCT02390960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111323812|NCT02390960|Urological Agents|urological agents|mesh-ancestor
111323813|NCT00720473|Lamotrigine|lamotrigine|mesh-list
111323814|NCT00720473|Anticonvulsants|anticonvulsants|mesh-ancestor
111323815|NCT00720473|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111048242|NCT02173457|Incretins|incretins|mesh-ancestor
111365086|NCT01585441|Finasteride|finasteride|mesh-list
111323816|NCT00720473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111323817|NCT00720473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111323818|NCT00720473|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111323819|NCT00720473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111323820|NCT00720473|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111323821|NCT00720473|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111323822|NCT00720473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111323823|NCT00720473|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111323824|NCT00720473|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111323825|NCT00637832|Prednisolone|prednisolone|mesh-list
111323826|NCT00637832|Cyclophosphamide|cyclophosphamide|mesh-list
111323827|NCT00637832|Rituximab|rituximab|mesh-list
111323828|NCT00637832|Doxorubicin|doxorubicin|mesh-list
111323829|NCT00637832|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111323830|NCT00637832|Vincristine|vincristine|mesh-list
111323831|NCT00637832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111323832|NCT00637832|Immunologic Factors|immunologic factors|mesh-ancestor
111323833|NCT00637832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111323834|NCT00637832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111323835|NCT00637832|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111323836|NCT00637832|Alkylating Agents|alkylating agents|mesh-ancestor
111323837|NCT00637832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111323838|NCT00637832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111323839|NCT00637832|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111323840|NCT00637832|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111323841|NCT00637832|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111323842|NCT00637832|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111323843|NCT00637832|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111323844|NCT00637832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111323845|NCT00637832|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111323846|NCT00637832|Tubulin Modulators|tubulin modulators|mesh-ancestor
111323847|NCT00637832|Antimitotic Agents|antimitotic agents|mesh-ancestor
111323848|NCT00637832|Mitosis Modulators|mitosis modulators|mesh-ancestor
111323849|NCT00637832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111323850|NCT00637832|Glucocorticoids|glucocorticoids|mesh-ancestor
111323851|NCT00637832|Hormones|hormones|mesh-ancestor
111167205|NCT05882643|Iodine|iodine|mesh-list
111323852|NCT00637832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111323853|NCT00637832|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111323854|NCT00720629|Methotrexate|methotrexate|mesh-list
111323855|NCT00720629|Tacrolimus|tacrolimus|mesh-list
111323856|NCT00720629|Thymoglobulin|thymoglobulin|mesh-list
111323857|NCT00720629|Antilymphocyte Serum|antilymphocyte serum|mesh-list
111323858|NCT00720629|Visilizumab|visilizumab|mesh-list
111323859|NCT00720629|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111323860|NCT00720629|Abortifacient Agents|abortifacient agents|mesh-ancestor
111323861|NCT00720629|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111323862|NCT00720629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111323863|NCT00720629|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111323864|NCT00720629|Antimetabolites|antimetabolites|mesh-ancestor
111167225|NCT05802056|Levoleucovorin|levoleucovorin|mesh-list
111323865|NCT00720629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111323866|NCT00720629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111323867|NCT00720629|Dermatologic Agents|dermatologic agents|mesh-ancestor
111323868|NCT00720629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111323869|NCT00720629|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111323870|NCT00720629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111323871|NCT00720629|Immunologic Factors|immunologic factors|mesh-ancestor
111323872|NCT00720629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111323873|NCT00720629|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111323874|NCT00720629|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111323875|NCT01276327|Pioglitazone|pioglitazone|mesh-list
111323876|NCT01276327|Linagliptin|linagliptin|mesh-list
111323877|NCT01276327|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111323878|NCT01276327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111323879|NCT01276327|Incretins|incretins|mesh-ancestor
111323880|NCT01276327|Hormones|hormones|mesh-ancestor
111323881|NCT01276327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111323882|NCT01276327|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111323883|NCT01276327|Protease Inhibitors|protease inhibitors|mesh-ancestor
111323884|NCT01276327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111323885|NCT01276327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111323886|NCT05245760|Paclitaxel|paclitaxel|mesh-list
111323887|NCT05245760|Carboplatin|carboplatin|mesh-list
111323888|NCT05245760|Tislelizumab|tislelizumab|mesh-list
111323889|NCT05245760|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111323890|NCT05245760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111323891|NCT05245760|Tubulin Modulators|tubulin modulators|mesh-ancestor
111323892|NCT05245760|Antimitotic Agents|antimitotic agents|mesh-ancestor
111323893|NCT05245760|Mitosis Modulators|mitosis modulators|mesh-ancestor
111167289|NCT05769478|Amifampridine|amifampridine|mesh-list
111323894|NCT05245760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111323895|NCT05245760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111323896|NCT02674958|Aspirin|aspirin|mesh-list
111323897|NCT02674958|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111323898|NCT02674958|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111323899|NCT02674958|Analgesics|analgesics|mesh-ancestor
111323900|NCT02674958|Sensory System Agents|sensory system agents|mesh-ancestor
111323901|NCT02674958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111323902|NCT02674958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111323903|NCT02674958|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111323904|NCT02674958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111323905|NCT02674958|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111323906|NCT02674958|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111323907|NCT02674958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111323908|NCT02674958|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111323909|NCT02674958|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111323910|NCT02674958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111323911|NCT02674958|Antipyretics|antipyretics|mesh-ancestor
111323912|NCT00760435|Infliximab|infliximab|mesh-list
111167330|NCT05741086|Protease Inhibitors|protease inhibitors|mesh-ancestor
111323913|NCT00760435|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111323914|NCT00760435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111323915|NCT00760435|Dermatologic Agents|dermatologic agents|mesh-ancestor
111323916|NCT00760435|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111323917|NCT00760435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111323918|NCT03808129|Lidocaine|lidocaine|mesh-list
111323919|NCT03808129|Bupivacaine|bupivacaine|mesh-list
111323920|NCT03808129|Anesthetics, Local|anesthetics, local|mesh-ancestor
111323921|NCT03808129|Anesthetics|anesthetics|mesh-ancestor
111323922|NCT03808129|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111323923|NCT03808129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111323924|NCT03808129|Sensory System Agents|sensory system agents|mesh-ancestor
111323925|NCT03808129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111323926|NCT03808129|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111323927|NCT03808129|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111323928|NCT03808129|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111323929|NCT03808129|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111323930|NCT03808129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111323931|NCT00749125|Escitalopram|escitalopram|mesh-list
111323932|NCT00749125|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111323933|NCT00749125|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111167525|NCT05351489|Analgesics|analgesics|mesh-ancestor
111323934|NCT00749125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111323935|NCT00749125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111323936|NCT00749125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111323937|NCT00749125|Serotonin Agents|serotonin agents|mesh-ancestor
111323938|NCT00749125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111323939|NCT02144675|Cytarabine|cytarabine|mesh-list
111323940|NCT02144675|Choline magnesium trisalicylate|choline magnesium trisalicylate|mesh-list
111323941|NCT02144675|Salicylates|salicylates|mesh-list
111323942|NCT02144675|Idarubicin|idarubicin|mesh-list
111323943|NCT02144675|Choline|choline|mesh-list
111323944|NCT02144675|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111323945|NCT02144675|Antimetabolites|antimetabolites|mesh-ancestor
111323946|NCT02144675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111323947|NCT02144675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111323948|NCT02144675|Antiviral Agents|antiviral agents|mesh-ancestor
111323949|NCT02144675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111323950|NCT02144675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111323951|NCT02144675|Immunologic Factors|immunologic factors|mesh-ancestor
111323952|NCT02144675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111323953|NCT02144675|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111323954|NCT02144675|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111323955|NCT02144675|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111323956|NCT02144675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111323957|NCT02144675|Lipotropic Agents|lipotropic agents|mesh-ancestor
111323958|NCT02144675|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111323959|NCT02144675|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111323960|NCT02144675|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111323961|NCT02144675|Nootropic Agents|nootropic agents|mesh-ancestor
111323962|NCT02144675|Analgesics|analgesics|mesh-ancestor
111323963|NCT02144675|Sensory System Agents|sensory system agents|mesh-ancestor
111323964|NCT02144675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111048386|NCT00485563|Interferons|interferons|mesh-list
111323965|NCT02144675|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111323966|NCT02144675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111323967|NCT02144675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111323968|NCT02144675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111323969|NCT02144675|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111323970|NCT00749515|Deferasirox|deferasirox|mesh-list
111323971|NCT00749515|Deferoxamine|deferoxamine|mesh-list
111323972|NCT00749515|Iron Chelating Agents|iron chelating agents|mesh-ancestor
111323973|NCT00749515|Chelating Agents|chelating agents|mesh-ancestor
111323974|NCT00749515|Sequestering Agents|sequestering agents|mesh-ancestor
111167589|NCT05145296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111323975|NCT00749515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111323976|NCT00749515|Siderophores|siderophores|mesh-ancestor
111323977|NCT01272557|Doxorubicin|doxorubicin|mesh-list
111323978|NCT01272557|Sorafenib|sorafenib|mesh-list
111323979|NCT01272557|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111323980|NCT01272557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111323981|NCT01272557|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111323982|NCT01272557|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111323983|NCT01272557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111323984|NCT01272557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111323985|NCT01272557|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111323986|NCT00639002|Dexamethasone|dexamethasone|mesh-list
111323987|NCT00639002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111323988|NCT00639002|Antiemetics|antiemetics|mesh-ancestor
111323989|NCT00639002|Autonomic Agents|autonomic agents|mesh-ancestor
111323990|NCT00639002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111323991|NCT00639002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111323992|NCT00639002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111323993|NCT00639002|Glucocorticoids|glucocorticoids|mesh-ancestor
111323994|NCT00639002|Hormones|hormones|mesh-ancestor
111323995|NCT00639002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111323996|NCT00639002|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111323997|NCT00639002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111323998|NCT00761137|Tropicamide|tropicamide|mesh-list
111323999|NCT00761137|Mydriatics|mydriatics|mesh-ancestor
111324000|NCT00761137|Autonomic Agents|autonomic agents|mesh-ancestor
111324001|NCT00761137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111324002|NCT00761137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111324003|NCT00761137|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111324004|NCT00761137|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111324005|NCT00761137|Cholinergic Agents|cholinergic agents|mesh-ancestor
111324006|NCT00761137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111324007|NCT00761137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111324008|NCT02145247|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
111324009|NCT02145247|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111324010|NCT02145247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111324011|NCT01273493|Dexamethasone|dexamethasone|mesh-list
111324012|NCT01273493|Trabectedin|trabectedin|mesh-list
111324013|NCT01273493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111324014|NCT01273493|Antiemetics|antiemetics|mesh-ancestor
111324015|NCT01273493|Autonomic Agents|autonomic agents|mesh-ancestor
111324016|NCT01273493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111324017|NCT01273493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111324018|NCT01273493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111324019|NCT01273493|Glucocorticoids|glucocorticoids|mesh-ancestor
111324020|NCT01273493|Hormones|hormones|mesh-ancestor
111324021|NCT01273493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111324022|NCT01273493|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111324023|NCT01273493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111324024|NCT01273493|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111324025|NCT01273493|Alkylating Agents|alkylating agents|mesh-ancestor
111324026|NCT01273493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111324027|NCT00638456|Budesonide|budesonide|mesh-list
111324028|NCT00638456|Lansoprazole|lansoprazole|mesh-list
111324029|NCT00638456|Dexlansoprazole|dexlansoprazole|mesh-list
111324030|NCT00638456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111324031|NCT00638456|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111324032|NCT00638456|Autonomic Agents|autonomic agents|mesh-ancestor
111324033|NCT00638456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111324034|NCT00638456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111324035|NCT00638456|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111324036|NCT00638456|Respiratory System Agents|respiratory system agents|mesh-ancestor
111324037|NCT00638456|Glucocorticoids|glucocorticoids|mesh-ancestor
111324038|NCT00638456|Hormones|hormones|mesh-ancestor
111168397|NCT01822821|Acetaminophen|acetaminophen|mesh-list
111324039|NCT00638456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111324040|NCT00638456|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111324041|NCT00638456|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111324042|NCT00638456|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111168461|NCT01820637|Paclitaxel|paclitaxel|mesh-list
111324043|NCT00638456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111324044|NCT00638456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111324045|NCT01273571|Metformin|metformin|mesh-list
111168528|NCT01847313|Glucagon|glucagon|mesh-list
111324046|NCT01273571|Canagliflozin|canagliflozin|mesh-list
111324047|NCT01273571|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111168602|NCT01846221|Clonidine|clonidine|mesh-list
111324048|NCT01273571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111324049|NCT01273571|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111324050|NCT01273571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111324051|NCT02147899|Secnidazole|secnidazole|mesh-list
111324052|NCT02147899|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111324053|NCT02147899|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111324054|NCT02147899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111324055|NCT02565992|Pembrolizumab|pembrolizumab|mesh-list
111324056|NCT02565992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111324057|NCT02565992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111324058|NCT02565992|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111168834|NCT02018042|Abatacept|abatacept|mesh-list
111324059|NCT02565992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111324060|NCT00762619|Triclosan|triclosan|mesh-list
111324061|NCT00762619|Fluorides|fluorides|mesh-list
111324062|NCT00762619|Cariostatic Agents|cariostatic agents|mesh-ancestor
111324063|NCT00762619|Protective Agents|protective agents|mesh-ancestor
111324064|NCT00762619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111168883|NCT02017015|Gemcitabine|gemcitabine|mesh-list
111324065|NCT00762619|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111324066|NCT00762619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111168952|NCT02027311|Midazolam|midazolam|mesh-list
111324067|NCT00762619|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
111324068|NCT00762619|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111324069|NCT00762619|Antimetabolites|antimetabolites|mesh-ancestor
111324070|NCT00762619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111324071|NCT00762619|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111324072|NCT00735449|Timolol|timolol|mesh-list
111324073|NCT00735449|Brimonidine Tartrate|brimonidine tartrate|mesh-list
111324074|NCT00735449|Latanoprost|latanoprost|mesh-list
111324075|NCT00735449|Maleic acid|maleic acid|mesh-list
111324076|NCT00735449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111324077|NCT00735449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111324078|NCT00735449|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111324079|NCT00735449|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111324080|NCT00735449|Adrenergic Agents|adrenergic agents|mesh-ancestor
111324081|NCT00735449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111324082|NCT00735449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111324083|NCT00735449|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111324084|NCT00735449|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111324085|NCT00735449|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
111324086|NCT00735449|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111324087|NCT00735449|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111324088|NCT00735449|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111324089|NCT00735449|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111324090|NCT01273831|Cisatracurium|cisatracurium|mesh-list
111324091|NCT01273831|Atracurium|atracurium|mesh-list
111324092|NCT01273831|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
111324093|NCT01273831|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111324094|NCT01273831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111324095|NCT01273831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111324096|NCT01273831|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
111169225|NCT02038010|Immunotoxins|immunotoxins|mesh-ancestor
111324097|NCT01273831|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
111324098|NCT01273831|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111324099|NCT01273831|Cholinergic Agents|cholinergic agents|mesh-ancestor
111324100|NCT01273831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111324101|NCT01273831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111324102|NCT00735917|Saracatinib|saracatinib|mesh-list
111324103|NCT00735917|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
111324104|NCT00735917|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111324105|NCT00735917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111324106|NCT00735917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111324107|NCT00735917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111324108|NCT00736073|Aprepitant|aprepitant|mesh-list
111324109|NCT00736073|Antiemetics|antiemetics|mesh-ancestor
111324110|NCT00736073|Autonomic Agents|autonomic agents|mesh-ancestor
111324111|NCT00736073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111324112|NCT00736073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111324113|NCT00736073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111048550|NCT02175017|Nivolumab|nivolumab|mesh-list
111324114|NCT00736073|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
111324115|NCT00736073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111324116|NCT00736073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111324117|NCT00736229|Exenatide|exenatide|mesh-list
111324118|NCT00736229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111324119|NCT00736229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111324120|NCT00736229|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111324121|NCT00736229|Incretins|incretins|mesh-ancestor
111324122|NCT00736229|Hormones|hormones|mesh-ancestor
111324123|NCT00736229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111324124|NCT00737243|Paclitaxel|paclitaxel|mesh-list
111324125|NCT00737243|Bevacizumab|bevacizumab|mesh-list
111324126|NCT00737243|Carboplatin|carboplatin|mesh-list
111324127|NCT00737243|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111324128|NCT00737243|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111324129|NCT00737243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111324130|NCT00737243|Tubulin Modulators|tubulin modulators|mesh-ancestor
111324131|NCT00737243|Antimitotic Agents|antimitotic agents|mesh-ancestor
111324132|NCT00737243|Mitosis Modulators|mitosis modulators|mesh-ancestor
111324133|NCT00737243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111324134|NCT00737243|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111324135|NCT00737243|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111324136|NCT00737243|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111324137|NCT00737243|Growth Substances|growth substances|mesh-ancestor
111324138|NCT00737243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111324139|NCT00737243|Growth Inhibitors|growth inhibitors|mesh-ancestor
111324140|NCT00737243|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111324141|NCT00737243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111324142|NCT00707759|Mycophenolic Acid|mycophenolic acid|mesh-list
111324143|NCT00707759|Prednisone|prednisone|mesh-list
111324144|NCT00707759|Prednisolone|prednisolone|mesh-list
111324145|NCT00707759|Tacrolimus|tacrolimus|mesh-list
111324146|NCT00707759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111324147|NCT00707759|Glucocorticoids|glucocorticoids|mesh-ancestor
111324148|NCT00707759|Hormones|hormones|mesh-ancestor
111324149|NCT00707759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111169625|NCT01984424|Ezetimibe|ezetimibe|mesh-list
111324150|NCT00707759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111324151|NCT00707759|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111324152|NCT00707759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111324153|NCT00707759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111324154|NCT00707759|Immunologic Factors|immunologic factors|mesh-ancestor
111324155|NCT00707759|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111324156|NCT00707759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111324157|NCT00707759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111324158|NCT00707759|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111324159|NCT00707759|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111324160|NCT00707759|Antitubercular Agents|antitubercular agents|mesh-ancestor
111324161|NCT00707759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111324162|NCT00707759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111324163|NCT01273727|Dexamethasone|dexamethasone|mesh-list
111324164|NCT01273727|Dexamethasone acetate|dexamethasone acetate|mesh-list
111324165|NCT01273727|BB 1101|bb 1101|mesh-list
111324166|NCT01273727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111324167|NCT01273727|Antiemetics|antiemetics|mesh-ancestor
111324168|NCT01273727|Autonomic Agents|autonomic agents|mesh-ancestor
111324169|NCT01273727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111324170|NCT01273727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111324171|NCT01273727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111324172|NCT01273727|Glucocorticoids|glucocorticoids|mesh-ancestor
111324173|NCT01273727|Hormones|hormones|mesh-ancestor
111324174|NCT01273727|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111324175|NCT01273727|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111324176|NCT01273727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111324177|NCT01273727|Protease Inhibitors|protease inhibitors|mesh-ancestor
111324178|NCT01273727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111324179|NCT01273727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111324180|NCT00708071|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
111324181|NCT00708071|Thrombin|thrombin|mesh-list
111324182|NCT00708071|Aprotinin|aprotinin|mesh-list
111324183|NCT00708071|Hemostatics|hemostatics|mesh-ancestor
111324184|NCT00708071|Coagulants|coagulants|mesh-ancestor
111324185|NCT00708071|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
111324186|NCT00708071|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111324187|NCT00708071|Protease Inhibitors|protease inhibitors|mesh-ancestor
111324188|NCT00708071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111324189|NCT00708071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111324190|NCT02994485|Simvastatin|simvastatin|mesh-list
111324191|NCT02994485|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111324192|NCT02994485|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111324193|NCT02994485|Antimetabolites|antimetabolites|mesh-ancestor
111324194|NCT02994485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111324195|NCT02994485|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111324196|NCT02994485|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111324197|NCT02994485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111324198|NCT02994173|Ketamine|ketamine|mesh-list
111324199|NCT02994173|Oxycodone|oxycodone|mesh-list
111324200|NCT02994173|Esketamine|esketamine|mesh-list
111324201|NCT02994173|Analgesics|analgesics|mesh-ancestor
111324202|NCT02994173|Sensory System Agents|sensory system agents|mesh-ancestor
111324203|NCT02994173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111324204|NCT02994173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111324205|NCT02994173|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111324206|NCT02994173|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111324207|NCT02994173|Anesthetics, General|anesthetics, general|mesh-ancestor
111324208|NCT02994173|Anesthetics|anesthetics|mesh-ancestor
111324209|NCT02994173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111324210|NCT02994173|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111324211|NCT02994173|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111324212|NCT02994173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111324213|NCT02994173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111324214|NCT02994173|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111324215|NCT02994173|Narcotics|narcotics|mesh-ancestor
111324216|NCT02994173|Antidepressive Agents|antidepressive agents|mesh-ancestor
111324217|NCT02994173|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111324218|NCT00723749|Buprenorphine|buprenorphine|mesh-list
111324219|NCT00723749|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
111324220|NCT00723749|Naloxone|naloxone|mesh-list
111324221|NCT00723749|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111324222|NCT00723749|Narcotics|narcotics|mesh-ancestor
111324223|NCT00723749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111324224|NCT00723749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111324225|NCT00723749|Analgesics|analgesics|mesh-ancestor
111324226|NCT00723749|Sensory System Agents|sensory system agents|mesh-ancestor
111324227|NCT00723749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111324228|NCT00723749|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111324229|NCT00723827|Temozolomide|temozolomide|mesh-list
111324230|NCT00723827|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111324231|NCT00723827|Alkylating Agents|alkylating agents|mesh-ancestor
111324232|NCT00723827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111324233|NCT00723827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111324234|NCT02993861|Anticonvulsants|anticonvulsants|mesh-list
111324235|NCT00779311|Bevacizumab|bevacizumab|mesh-list
111324236|NCT00779311|Sorafenib|sorafenib|mesh-list
111324237|NCT00779311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111324238|NCT00779311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111324239|NCT00779311|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111324240|NCT00779311|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111324241|NCT00779311|Growth Substances|growth substances|mesh-ancestor
111324242|NCT00779311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111324243|NCT00779311|Growth Inhibitors|growth inhibitors|mesh-ancestor
111324244|NCT00779311|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111324245|NCT00779311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111324246|NCT00779311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111324247|NCT01274039|Acetazolamide|acetazolamide|mesh-list
111324248|NCT01274039|Anticonvulsants|anticonvulsants|mesh-ancestor
111324249|NCT01274039|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
111324250|NCT01274039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111324251|NCT01274039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111324252|NCT01274039|Diuretics|diuretics|mesh-ancestor
111324253|NCT01274039|Natriuretic Agents|natriuretic agents|mesh-ancestor
111170115|NCT02097719|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111324254|NCT01274039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111324255|NCT01274195|Busulfan|busulfan|mesh-list
111324256|NCT01274195|Alkylating Agents|alkylating agents|mesh-ancestor
111324257|NCT01274195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111324258|NCT01274195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111324259|NCT01274195|Immunologic Factors|immunologic factors|mesh-ancestor
111324260|NCT01274195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111324261|NCT01274195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111324262|NCT01274195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111324263|NCT01274195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111048684|NCT04575779|Dermatologic Agents|dermatologic agents|mesh-ancestor
111324264|NCT00779701|Insulin|insulin|mesh-list
111324265|NCT00779701|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111324266|NCT00779701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111324267|NCT00738023|Rosiglitazone|rosiglitazone|mesh-list
111324268|NCT00738023|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
111324269|NCT00738023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111324270|NCT00738023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111324271|NCT00738023|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
111324272|NCT00738023|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
111324273|NCT00738023|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111324274|NCT03809221|Triptorelin Pamoate|triptorelin pamoate|mesh-list
111324275|NCT03809221|Hormones|hormones|mesh-list
111324276|NCT03809221|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
111324277|NCT03809221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111324278|NCT03809221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111324279|NCT03809221|Luteolytic Agents|luteolytic agents|mesh-ancestor
111324280|NCT03809221|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111324281|NCT03809221|Contraceptive Agents|contraceptive agents|mesh-ancestor
111324282|NCT03809221|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111324283|NCT03809221|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111324284|NCT03809221|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111324285|NCT03809221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111324286|NCT02993159|Tamoxifen|tamoxifen|mesh-list
111324287|NCT02993159|Afimoxifene|afimoxifene|mesh-list
111324288|NCT02993159|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111324289|NCT02993159|Hormone Antagonists|hormone antagonists|mesh-ancestor
111324290|NCT02993159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111324291|NCT02993159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111324292|NCT02993159|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111324293|NCT02993159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111324294|NCT02993159|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111324295|NCT02993159|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111324296|NCT02993159|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111324297|NCT00723931|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
111324298|NCT00723931|Antiviral Agents|antiviral agents|mesh-ancestor
111324299|NCT00723931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111324300|NCT00740129|Zoledronic Acid|zoledronic acid|mesh-list
111324301|NCT00740129|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111324302|NCT00740129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111324303|NCT00762853|Triclosan|triclosan|mesh-list
111324304|NCT00762853|Fluorides|fluorides|mesh-list
111324305|NCT00762853|Cariostatic Agents|cariostatic agents|mesh-ancestor
111324306|NCT00762853|Protective Agents|protective agents|mesh-ancestor
111324307|NCT00762853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111324308|NCT00762853|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111324309|NCT00762853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111324310|NCT00762853|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
111324311|NCT00762853|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111324312|NCT00762853|Antimetabolites|antimetabolites|mesh-ancestor
111324313|NCT00762853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111324314|NCT00762853|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111324315|NCT00724009|Clofarabine|clofarabine|mesh-list
111324316|NCT00724009|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111324317|NCT00724009|Antimetabolites|antimetabolites|mesh-ancestor
111324318|NCT00724009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111324319|NCT00724009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111324320|NCT01279499|Remifentanil|remifentanil|mesh-list
111324321|NCT01279499|Propofol|propofol|mesh-list
111324322|NCT01279499|Sevoflurane|sevoflurane|mesh-list
111324323|NCT01279499|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111324324|NCT01279499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111324325|NCT01279499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111324326|NCT01279499|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111324327|NCT01279499|Anesthetics, General|anesthetics, general|mesh-ancestor
111324328|NCT01279499|Anesthetics|anesthetics|mesh-ancestor
111324329|NCT01279499|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111324330|NCT01279499|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111324331|NCT01279499|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111324332|NCT01279499|Narcotics|narcotics|mesh-ancestor
111324333|NCT01279499|Analgesics|analgesics|mesh-ancestor
111324334|NCT01279499|Sensory System Agents|sensory system agents|mesh-ancestor
111324335|NCT01279499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111324336|NCT02992925|Vaccines|vaccines|mesh-list
111324337|NCT02992925|Immunologic Factors|immunologic factors|mesh-ancestor
111324338|NCT02992925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111324340|NCT00780715|Pioglitazone|pioglitazone|mesh-list
111324341|NCT00780715|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111324342|NCT00780715|Gliclazide|gliclazide|mesh-list
111324343|NCT00780715|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111324344|NCT00780715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111324345|NCT00780715|Incretins|incretins|mesh-ancestor
111324346|NCT00780715|Hormones|hormones|mesh-ancestor
111365087|NCT01585441|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
111324347|NCT00780715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111324348|NCT00780715|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111324349|NCT00780715|Protease Inhibitors|protease inhibitors|mesh-ancestor
111324350|NCT00780715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111324351|NCT00780715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111324352|NCT05318443|Paclitaxel|paclitaxel|mesh-list
111324353|NCT05318443|Carboplatin|carboplatin|mesh-list
111324354|NCT05318443|Bevacizumab|bevacizumab|mesh-list
111324355|NCT05318443|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111324356|NCT05318443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111324357|NCT05318443|Tubulin Modulators|tubulin modulators|mesh-ancestor
111324358|NCT05318443|Antimitotic Agents|antimitotic agents|mesh-ancestor
111324359|NCT05318443|Mitosis Modulators|mitosis modulators|mesh-ancestor
111324360|NCT05318443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111170829|NCT04176055|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111324361|NCT05318443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111324362|NCT05318443|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111324363|NCT05318443|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111324364|NCT05318443|Growth Substances|growth substances|mesh-ancestor
111324365|NCT05318443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111170922|NCT01441414|Axitinib|axitinib|mesh-list
111324366|NCT05318443|Growth Inhibitors|growth inhibitors|mesh-ancestor
111324367|NCT00740831|Leuprolide|leuprolide|mesh-list
111324368|NCT00740831|Ulipristal acetate|ulipristal acetate|mesh-list
111324369|NCT00740831|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111324370|NCT00740831|Fertility Agents|fertility agents|mesh-ancestor
111324371|NCT00740831|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111324372|NCT00740831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111324373|NCT00740831|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111324374|NCT00740831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111324375|NCT00740831|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111324376|NCT00740831|Contraceptive Agents|contraceptive agents|mesh-ancestor
111324377|NCT00740831|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111324378|NCT01275287|Eculizumab|eculizumab|mesh-list
111324379|NCT01275287|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
111324380|NCT01275287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111324381|NCT01275287|Immunologic Factors|immunologic factors|mesh-ancestor
111324382|NCT01275287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111324383|NCT01275443|Rilpivirine|rilpivirine|mesh-list
111324384|NCT01275443|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111324385|NCT01275443|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111324386|NCT01275443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111324387|NCT01275443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111324388|NCT01275443|Antiviral Agents|antiviral agents|mesh-ancestor
111324389|NCT01275443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111324390|NCT01275443|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111324391|NCT01275443|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111324392|NCT01274221|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
111324393|NCT01274221|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111324394|NCT01274221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111324395|NCT01274221|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111324396|NCT01274221|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111324397|NCT01274221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111324398|NCT01274221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111324399|NCT01274221|Dopamine Agents|dopamine agents|mesh-ancestor
111324400|NCT01274221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111324401|NCT00741455|Cyclosporine|cyclosporine|mesh-list
111324402|NCT00741455|Cyclophosphamide|cyclophosphamide|mesh-list
111324403|NCT00741455|Methotrexate|methotrexate|mesh-list
111324404|NCT00741455|Fludarabine|fludarabine|mesh-list
111324405|NCT00741455|Cyclosporins|cyclosporins|mesh-list
111324406|NCT00741455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111324407|NCT00741455|Immunologic Factors|immunologic factors|mesh-ancestor
111324408|NCT00741455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111324409|NCT00741455|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111324410|NCT00741455|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111324411|NCT00741455|Alkylating Agents|alkylating agents|mesh-ancestor
111324412|NCT00741455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111324413|NCT00741455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111171238|NCT04683965|Bevacizumab|bevacizumab|mesh-list
111324414|NCT00741455|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111324415|NCT00741455|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111324416|NCT00741455|Abortifacient Agents|abortifacient agents|mesh-ancestor
111324417|NCT00741455|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111171293|NCT02013791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111324418|NCT00741455|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111324419|NCT00741455|Antimetabolites|antimetabolites|mesh-ancestor
111324420|NCT00741455|Dermatologic Agents|dermatologic agents|mesh-ancestor
111324421|NCT00741455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111324422|NCT00741455|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111324423|NCT00741455|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111324424|NCT00741455|Antifungal Agents|antifungal agents|mesh-ancestor
111324425|NCT00741455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111324426|NCT00741455|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111324428|NCT00742313|Coagulants|coagulants|mesh-ancestor
111324429|NCT00742469|Rifaximin|rifaximin|mesh-list
111324430|NCT00742469|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111324431|NCT00742469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111324432|NCT00742469|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111324433|NCT01275599|Buprenorphine|buprenorphine|mesh-list
111324434|NCT01275599|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
111324435|NCT01275599|Naloxone|naloxone|mesh-list
111324436|NCT01275599|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111324437|NCT01275599|Narcotics|narcotics|mesh-ancestor
111171495|NCT01977625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111324438|NCT01275599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111324439|NCT01275599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111324440|NCT01275599|Analgesics|analgesics|mesh-ancestor
111324441|NCT01275599|Sensory System Agents|sensory system agents|mesh-ancestor
111324442|NCT01275599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111324443|NCT01275599|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111324444|NCT00782821|Rituximab|rituximab|mesh-list
111324445|NCT00782821|Bortezomib|bortezomib|mesh-list
111324446|NCT00782821|Thymoglobulin|thymoglobulin|mesh-list
111324447|NCT00782821|Antilymphocyte Serum|antilymphocyte serum|mesh-list
111324448|NCT00782821|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111324449|NCT00782821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111324450|NCT00782821|Immunologic Factors|immunologic factors|mesh-ancestor
111171711|NCT01467466|Antidotes|antidotes|mesh-ancestor
111324451|NCT00782821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111324452|NCT00782821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111324453|NCT00782821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111324454|NCT00743093|Acetaminophen|acetaminophen|mesh-list
111324455|NCT00743093|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111324456|NCT00743093|Analgesics|analgesics|mesh-ancestor
111324457|NCT00743093|Sensory System Agents|sensory system agents|mesh-ancestor
111324458|NCT00743093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111324459|NCT00743093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111324460|NCT00743093|Antipyretics|antipyretics|mesh-ancestor
111324461|NCT03805945|Dexmedetomidine|dexmedetomidine|mesh-list
111324462|NCT03805945|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111324463|NCT03805945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111324464|NCT03805945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111324465|NCT03805945|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111324466|NCT03805945|Analgesics|analgesics|mesh-ancestor
111324467|NCT03805945|Sensory System Agents|sensory system agents|mesh-ancestor
111324468|NCT03805945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111324469|NCT03805945|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111324470|NCT03805945|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111171915|NCT04767178|Acetaminophen|acetaminophen|mesh-list
111324471|NCT03805945|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111324472|NCT03805945|Adrenergic Agents|adrenergic agents|mesh-ancestor
111324473|NCT03805945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111324474|NCT03805945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111324475|NCT04270019|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
111324476|NCT04270019|Laxatives|laxatives|mesh-ancestor
111324477|NCT04270019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111324478|NCT02992301|Alirocumab|alirocumab|mesh-list
111172058|NCT04053712|Glucagon|glucagon|mesh-list
111324479|NCT02992301|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
111324480|NCT02992301|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111324481|NCT02992301|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111324482|NCT02992301|Antimetabolites|antimetabolites|mesh-ancestor
111324483|NCT02992301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111324484|NCT02992301|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111324485|NCT02992301|Protease Inhibitors|protease inhibitors|mesh-ancestor
111172122|NCT01765179|Hormones|hormones|mesh-ancestor
111324486|NCT02992301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111324487|NCT02992301|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111324488|NCT00743717|Cobalt|cobalt|mesh-list
111324489|NCT00743717|Trace Elements|trace elements|mesh-ancestor
111324490|NCT00743717|Micronutrients|micronutrients|mesh-ancestor
111324491|NCT00743717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111324492|NCT00744965|Glyburide|glyburide|mesh-list
111324493|NCT00744965|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111324494|NCT00744965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111324495|NCT00763867|Sildenafil Citrate|sildenafil citrate|mesh-list
111324496|NCT00763867|Vasodilator Agents|vasodilator agents|mesh-ancestor
111324497|NCT00763867|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111172255|NCT01411774|Antitubercular Agents|antitubercular agents|mesh-ancestor
111324498|NCT00763867|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111324499|NCT00763867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111324500|NCT00763867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111324501|NCT00763867|Urological Agents|urological agents|mesh-ancestor
111324502|NCT00711347|Hyaluronic Acid|hyaluronic acid|mesh-list
111172326|NCT01942993|Vemurafenib|vemurafenib|mesh-list
111324503|NCT00711347|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111324504|NCT00711347|Immunologic Factors|immunologic factors|mesh-ancestor
111324505|NCT00711347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111324506|NCT00711347|Viscosupplements|viscosupplements|mesh-ancestor
111324507|NCT00711347|Protective Agents|protective agents|mesh-ancestor
111324508|NCT01276223|Fluprednisolone|fluprednisolone|mesh-list
111324509|NCT01276223|Difluprednate|difluprednate|mesh-list
111324510|NCT01276223|Glucocorticoids|glucocorticoids|mesh-ancestor
111324511|NCT01276223|Hormones|hormones|mesh-ancestor
111324512|NCT01276223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111324513|NCT01276223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111324514|NCT01276223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111324515|NCT00784225|Vitamins|vitamins|mesh-list
111324516|NCT00784225|Vitamin E|vitamin e|mesh-list
111324517|NCT00784225|Tocopherols|tocopherols|mesh-list
111324518|NCT00784225|Tocotrienols|tocotrienols|mesh-list
111324519|NCT00784225|alpha-Tocopherol|alpha-tocopherol|mesh-list
111324520|NCT00784225|Selenium|selenium|mesh-list
111324521|NCT00784225|Micronutrients|micronutrients|mesh-ancestor
111324522|NCT00784225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111324523|NCT00784225|Antioxidants|antioxidants|mesh-ancestor
111324524|NCT00784225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111324525|NCT00784225|Protective Agents|protective agents|mesh-ancestor
111324526|NCT00784225|Trace Elements|trace elements|mesh-ancestor
111324527|NCT02991911|MEDI3726|medi3726|mesh-list
111324528|NCT02991911|Immunoconjugates|immunoconjugates|mesh-ancestor
111324529|NCT02991911|Immunologic Factors|immunologic factors|mesh-ancestor
111324530|NCT02991911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111324531|NCT01275131|Insulin Aspart|insulin aspart|mesh-list
111324532|NCT01275131|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111324533|NCT01275131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111324534|NCT01273805|Hydroxychloroquine|hydroxychloroquine|mesh-list
111324535|NCT01273805|Antimalarials|antimalarials|mesh-ancestor
111324536|NCT01273805|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111324537|NCT01273805|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111324538|NCT01273805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111324539|NCT01273805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111324540|NCT01273805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111324541|NCT01273805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111324542|NCT01273181|Aldesleukin|aldesleukin|mesh-list
111324543|NCT01273181|Cyclophosphamide|cyclophosphamide|mesh-list
111324544|NCT01273181|Fludarabine|fludarabine|mesh-list
111324545|NCT01273181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111324546|NCT01273181|Immunologic Factors|immunologic factors|mesh-ancestor
111324547|NCT01273181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111324548|NCT01273181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111324549|NCT01273181|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111324550|NCT01273181|Alkylating Agents|alkylating agents|mesh-ancestor
111324551|NCT01273181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111324552|NCT01273181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111172876|NCT01754493|Analgesics|analgesics|mesh-ancestor
111324553|NCT01273181|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111324554|NCT01273181|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111324555|NCT01273181|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111324556|NCT01273181|Antiviral Agents|antiviral agents|mesh-ancestor
111324557|NCT01273181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111324558|NCT01272947|Diclofenac|diclofenac|mesh-list
111324559|NCT01272947|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111173012|NCT01426438|Aspirin|aspirin|mesh-list
111324560|NCT01272947|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111324561|NCT01272947|Analgesics|analgesics|mesh-ancestor
111324562|NCT01272947|Sensory System Agents|sensory system agents|mesh-ancestor
111324563|NCT01272947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111324564|NCT01272947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111324565|NCT01272947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111324566|NCT01272947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111324567|NCT01272947|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111324568|NCT01272947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111324569|NCT01272947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111324570|NCT01279343|Misoprostol|misoprostol|mesh-list
111324571|NCT01279343|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111324572|NCT01279343|Abortifacient Agents|abortifacient agents|mesh-ancestor
111324573|NCT01279343|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111324574|NCT01279343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111324575|NCT01279343|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111324576|NCT01279343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111324577|NCT01279343|Oxytocics|oxytocics|mesh-ancestor
111324578|NCT01278797|Amlodipine|amlodipine|mesh-list
111324579|NCT01278797|Telmisartan|telmisartan|mesh-list
111324580|NCT01278797|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
111324581|NCT01278797|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111324582|NCT01278797|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111324583|NCT01278797|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111324584|NCT01278797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111324585|NCT01278797|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111324586|NCT01278797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111324587|NCT01278797|Vasodilator Agents|vasodilator agents|mesh-ancestor
111324588|NCT01278797|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111324589|NCT01278797|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111324590|NCT01272635|Azithromycin|azithromycin|mesh-list
111324591|NCT01272635|Prednisolone|prednisolone|mesh-list
111324592|NCT01272635|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111324593|NCT01272635|Methylprednisolone|methylprednisolone|mesh-list
111173277|NCT01421134|Dopamine Agents|dopamine agents|mesh-ancestor
111324594|NCT01272635|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111324595|NCT01272635|Prednisolone acetate|prednisolone acetate|mesh-list
111324596|NCT01272635|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111324597|NCT01272635|Prednisolone phosphate|prednisolone phosphate|mesh-list
111324598|NCT01272635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111324599|NCT01272635|Glucocorticoids|glucocorticoids|mesh-ancestor
111324600|NCT01272635|Hormones|hormones|mesh-ancestor
111324601|NCT01272635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111324602|NCT01272635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111324603|NCT01272635|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111324604|NCT01272635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111324605|NCT01272635|Antiemetics|antiemetics|mesh-ancestor
111324606|NCT01272635|Autonomic Agents|autonomic agents|mesh-ancestor
111324607|NCT01272635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111324608|NCT01272635|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111324609|NCT01272635|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111173481|NCT01775475|Prednisone|prednisone|mesh-list
111324610|NCT01272635|Protective Agents|protective agents|mesh-ancestor
111324611|NCT01272635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111324612|NCT01272635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111173552|NCT01736475|BAX 855|bax 855|mesh-list
111324613|NCT04387097|Remifentanil|remifentanil|mesh-list
111324614|NCT04387097|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111324615|NCT04387097|Narcotics|narcotics|mesh-ancestor
111324616|NCT04387097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111324617|NCT04387097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111324618|NCT04387097|Analgesics|analgesics|mesh-ancestor
111324619|NCT04387097|Sensory System Agents|sensory system agents|mesh-ancestor
111324620|NCT04387097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111324621|NCT01270841|Enclomiphene|enclomiphene|mesh-list
111324622|NCT01270841|Clomiphene|clomiphene|mesh-list
111324623|NCT01270841|Zuclomiphene|zuclomiphene|mesh-list
111324624|NCT01270841|Testosterone|testosterone|mesh-list
111324625|NCT01270841|Androgens|androgens|mesh-ancestor
111324626|NCT01270841|Hormones|hormones|mesh-ancestor
111324627|NCT01270841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111324628|NCT01270841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111324629|NCT01270841|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111324630|NCT01270841|Hormone Antagonists|hormone antagonists|mesh-ancestor
111324631|NCT01270841|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111324632|NCT01270841|Fertility Agents|fertility agents|mesh-ancestor
111324633|NCT01270841|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111324634|NCT01270841|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111324635|NCT01270841|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111324636|NCT01278407|Donepezil|donepezil|mesh-list
111324637|NCT01278407|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111324638|NCT01278407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111324639|NCT01278407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111324640|NCT01278407|Cholinergic Agents|cholinergic agents|mesh-ancestor
111324641|NCT01278407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111173898|NCT05600686|Rituximab|rituximab|mesh-list
111324642|NCT01278407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111324643|NCT01278407|Nootropic Agents|nootropic agents|mesh-ancestor
111324645|NCT01278173|Anticonvulsants|anticonvulsants|mesh-ancestor
111324646|NCT01278173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111324647|NCT01278173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111324648|NCT01278173|GABA Agents|gaba agents|mesh-ancestor
111324649|NCT01278173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111324650|NCT01278173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111324651|NCT00784303|Lenvatinib|lenvatinib|mesh-list
111324652|NCT00784303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111174065|NCT05205486|Cefazolin|cefazolin|mesh-list
111324653|NCT00784303|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111324654|NCT00784303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111324655|NCT00784303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111324656|NCT00750815|Dexamethasone|dexamethasone|mesh-list
111324657|NCT00750815|Cyclophosphamide|cyclophosphamide|mesh-list
111324658|NCT00750815|Doxorubicin|doxorubicin|mesh-list
111324659|NCT00750815|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111324660|NCT00750815|Bortezomib|bortezomib|mesh-list
111324661|NCT00750815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111324662|NCT00750815|Immunologic Factors|immunologic factors|mesh-ancestor
111174255|NCT04439149|GSK2636771|gsk2636771|mesh-list
111324663|NCT00750815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111324664|NCT00750815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111174323|NCT04085172|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
111324665|NCT00750815|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111324666|NCT00750815|Alkylating Agents|alkylating agents|mesh-ancestor
111324667|NCT00750815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111324668|NCT00750815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111324669|NCT00750815|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111324670|NCT00750815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111324671|NCT00750815|Antiemetics|antiemetics|mesh-ancestor
111324672|NCT00750815|Autonomic Agents|autonomic agents|mesh-ancestor
111324673|NCT00750815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111324674|NCT00750815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111324675|NCT00750815|Glucocorticoids|glucocorticoids|mesh-ancestor
111324676|NCT00750815|Hormones|hormones|mesh-ancestor
111324677|NCT00750815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111324678|NCT00750815|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111324679|NCT00750815|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111324680|NCT00750815|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111324681|NCT00750815|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111324682|NCT00750815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111324683|NCT00784849|Methylene Blue|methylene blue|mesh-list
111324684|NCT00784849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111324685|NCT00784849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111324686|NCT01277861|Fentanyl|fentanyl|mesh-list
111324687|NCT01277861|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111324688|NCT01277861|Narcotics|narcotics|mesh-ancestor
111324689|NCT01277861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111324690|NCT01277861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111324691|NCT01277861|Analgesics|analgesics|mesh-ancestor
111324692|NCT01277861|Sensory System Agents|sensory system agents|mesh-ancestor
111324693|NCT01277861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111324694|NCT01277861|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111324695|NCT01277861|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111324696|NCT01277861|Anesthetics, General|anesthetics, general|mesh-ancestor
111324697|NCT01277861|Anesthetics|anesthetics|mesh-ancestor
111324698|NCT00786487|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
111324699|NCT00786487|Glycerol|glycerol|mesh-list
111324700|NCT00786487|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
111324701|NCT00786487|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
111324702|NCT00786487|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111324703|NCT00786487|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
111324704|NCT00786487|Protective Agents|protective agents|mesh-ancestor
111324705|NCT00786487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111324706|NCT03805633|Pancrelipase|pancrelipase|mesh-list
111324707|NCT03805633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111324708|NCT01276847|Etanercept|etanercept|mesh-list
111324709|NCT01276847|Ustekinumab|ustekinumab|mesh-list
111324710|NCT01276847|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111324711|NCT01276847|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111324712|NCT01276847|Analgesics|analgesics|mesh-ancestor
111324713|NCT01276847|Sensory System Agents|sensory system agents|mesh-ancestor
111324714|NCT01276847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111324715|NCT01276847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111324716|NCT01276847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111324717|NCT01276847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111324718|NCT01276847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111324719|NCT01276847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111324720|NCT01276847|Immunologic Factors|immunologic factors|mesh-ancestor
111324721|NCT01276847|Dermatologic Agents|dermatologic agents|mesh-ancestor
111324722|NCT00945269|Aldesleukin|aldesleukin|mesh-list
111324723|NCT00945269|Interleukin-2|interleukin-2|mesh-list
111324724|NCT00945269|Denileukin diftitox|denileukin diftitox|mesh-list
111324725|NCT00945269|Immunotoxins|immunotoxins|mesh-list
111174948|NCT01744197|Lidocaine|lidocaine|mesh-list
111324726|NCT00945269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111324727|NCT00945269|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111324728|NCT00945269|Analgesics|analgesics|mesh-ancestor
111324729|NCT00945269|Sensory System Agents|sensory system agents|mesh-ancestor
111175016|NCT01380184|Sirolimus|sirolimus|mesh-list
111324730|NCT00945269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111324731|NCT00945269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111324732|NCT00945269|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111324733|NCT00945269|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111324734|NCT00945269|Antiviral Agents|antiviral agents|mesh-ancestor
111175089|NCT01834274|Incretins|incretins|mesh-ancestor
111324735|NCT00945269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111324736|NCT00945269|Immunoconjugates|immunoconjugates|mesh-ancestor
111324737|NCT00945269|Immunologic Factors|immunologic factors|mesh-ancestor
111324738|NCT01272791|Gemcitabine|gemcitabine|mesh-list
111324739|NCT01272791|Bavituximab|bavituximab|mesh-list
111324740|NCT01272791|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111324741|NCT01272791|Antimetabolites|antimetabolites|mesh-ancestor
111324742|NCT01272791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111324743|NCT01272791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111324744|NCT01272791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111324745|NCT00765661|Tacrolimus|tacrolimus|mesh-list
111324746|NCT00765661|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111324747|NCT00765661|Immunologic Factors|immunologic factors|mesh-ancestor
111324748|NCT00765661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111324749|NCT00765661|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111324750|NCT00765661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111324751|NCT00765661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111324752|NCT00765895|Nortriptyline|nortriptyline|mesh-list
111324753|NCT00765895|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
111324754|NCT00765895|Antidepressive Agents|antidepressive agents|mesh-ancestor
111324755|NCT00765895|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111324756|NCT00765895|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111324757|NCT00765895|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111324758|NCT00765895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111324759|NCT00765895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111324760|NCT00765895|Adrenergic Agents|adrenergic agents|mesh-ancestor
111324761|NCT00765895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111324762|NCT00765895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111324763|NCT01276457|Cyclosporine|cyclosporine|mesh-list
111324764|NCT01276457|Everolimus|everolimus|mesh-list
111324765|NCT01276457|Cyclosporins|cyclosporins|mesh-list
111324766|NCT01276457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111324767|NCT01276457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111324768|NCT01276457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111324769|NCT01276457|Immunologic Factors|immunologic factors|mesh-ancestor
111324770|NCT01276457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111324771|NCT01276457|Antifungal Agents|antifungal agents|mesh-ancestor
111324772|NCT01276457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111324773|NCT01276457|Dermatologic Agents|dermatologic agents|mesh-ancestor
111324774|NCT01276457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111175720|NCT03598816|Durvalumab|durvalumab|mesh-list
111324775|NCT01276457|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111324776|NCT01276457|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111324777|NCT01276457|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111324778|NCT01276457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111324779|NCT03804931|Aminosalicylic Acid|aminosalicylic acid|mesh-list
111324780|NCT03804931|Prednisone|prednisone|mesh-list
111324781|NCT03804931|Mesalamine|mesalamine|mesh-list
111324782|NCT03804931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111324783|NCT03804931|Glucocorticoids|glucocorticoids|mesh-ancestor
111324784|NCT03804931|Hormones|hormones|mesh-ancestor
111365088|NCT01585441|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111324785|NCT03804931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111324786|NCT03804931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111324787|NCT03804931|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111324788|NCT03804931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111324789|NCT03804931|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111324790|NCT03804931|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111324791|NCT03804931|Analgesics|analgesics|mesh-ancestor
111324792|NCT03804931|Sensory System Agents|sensory system agents|mesh-ancestor
111324793|NCT03804931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111324794|NCT03804931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111324795|NCT03804931|Antitubercular Agents|antitubercular agents|mesh-ancestor
111324796|NCT03804931|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111324797|NCT03804931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111324799|NCT02991131|Tedizolid|tedizolid|mesh-list
111324800|NCT02991131|Tedizolid phosphate|tedizolid phosphate|mesh-list
111324801|NCT02991131|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111324802|NCT02991131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111176077|NCT04194658|Letrozole|letrozole|mesh-list
111324803|NCT02991131|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111324804|NCT02991131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111324805|NCT02991131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111324806|NCT00748865|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111324807|NCT00748865|Lubricant Eye Drops|lubricant eye drops|mesh-list
111176145|NCT03828292|Bortezomib|bortezomib|mesh-list
111324808|NCT00748865|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111324809|NCT00766753|Vaccines|vaccines|mesh-list
111324810|NCT00766753|Immunologic Factors|immunologic factors|mesh-ancestor
111324811|NCT00766753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111324812|NCT00767767|Thiopental|thiopental|mesh-list
111324813|NCT00767767|Propofol|propofol|mesh-list
111324814|NCT00767767|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111324815|NCT00767767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111324816|NCT00767767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111324817|NCT00767767|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111324818|NCT00767767|Anesthetics, General|anesthetics, general|mesh-ancestor
111324819|NCT00767767|Anesthetics|anesthetics|mesh-ancestor
111324820|NCT00767767|Anticonvulsants|anticonvulsants|mesh-ancestor
111324821|NCT00767767|GABA Modulators|gaba modulators|mesh-ancestor
111324822|NCT00767767|GABA Agents|gaba agents|mesh-ancestor
111324823|NCT00767767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111324824|NCT00767767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111324825|NCT00761345|Gemcitabine|gemcitabine|mesh-list
111324826|NCT00761345|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111324827|NCT00761345|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111324828|NCT00761345|Antimetabolites|antimetabolites|mesh-ancestor
111324829|NCT00761345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111176496|NCT01710657|Lacosamide|lacosamide|mesh-list
111324830|NCT00761345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111324831|NCT00761345|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111324832|NCT00761345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111324833|NCT00762515|Triclosan|triclosan|mesh-list
111324834|NCT00762515|Fluorides|fluorides|mesh-list
111324835|NCT00762515|Cariostatic Agents|cariostatic agents|mesh-ancestor
111324836|NCT00762515|Protective Agents|protective agents|mesh-ancestor
111365089|NCT01585441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111324837|NCT00762515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111324838|NCT00762515|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111324839|NCT00762515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111324840|NCT00762515|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
111324841|NCT00762515|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111324842|NCT00762515|Antimetabolites|antimetabolites|mesh-ancestor
111324843|NCT00762515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111324844|NCT00762515|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111324845|NCT03806933|Botulinum Toxins|botulinum toxins|mesh-list
111324846|NCT03806933|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111324847|NCT03806933|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111324848|NCT03806933|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
111324849|NCT03806933|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111324850|NCT03806933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111324851|NCT03806933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111324852|NCT03806933|Cholinergic Agents|cholinergic agents|mesh-ancestor
111324853|NCT03806933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111324854|NCT03806933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111324855|NCT03806933|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111324856|NCT03806933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111324857|NCT00753935|Aspirin|aspirin|mesh-list
111324858|NCT00753935|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111324859|NCT00753935|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111324860|NCT00753935|Analgesics|analgesics|mesh-ancestor
111176691|NCT01822496|Paclitaxel|paclitaxel|mesh-list
111324861|NCT00753935|Sensory System Agents|sensory system agents|mesh-ancestor
111324862|NCT00753935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111324863|NCT00753935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111176762|NCT01709721|Analgesics|analgesics|mesh-ancestor
111324864|NCT00753935|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111324865|NCT00753935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111324866|NCT00753935|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111324867|NCT00753935|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111324868|NCT00753935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111324869|NCT00753935|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111324870|NCT00753935|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111324871|NCT00753935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111324872|NCT00753935|Antipyretics|antipyretics|mesh-ancestor
111324873|NCT00779285|Doxorubicin|doxorubicin|mesh-list
111324874|NCT00779285|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111324875|NCT00779285|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111324876|NCT00779285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111324877|NCT00779285|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111324878|NCT00779285|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111324879|NCT00779285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111324880|NCT00779285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111324881|NCT00786643|Leucovorin|leucovorin|mesh-list
111324882|NCT00786643|Interferons|interferons|mesh-list
111324883|NCT00786643|Interferon-gamma|interferon-gamma|mesh-list
111324884|NCT00786643|Bevacizumab|bevacizumab|mesh-list
111324885|NCT00786643|Fluorouracil|fluorouracil|mesh-list
111324886|NCT00786643|Levoleucovorin|levoleucovorin|mesh-list
111177048|NCT03584074|Anticonvulsants|anticonvulsants|mesh-ancestor
111324887|NCT00786643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111324888|NCT00786643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111324889|NCT00786643|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111324890|NCT00786643|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111324891|NCT00786643|Growth Substances|growth substances|mesh-ancestor
111324892|NCT00786643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111324893|NCT00786643|Growth Inhibitors|growth inhibitors|mesh-ancestor
111324894|NCT00786643|Antimetabolites|antimetabolites|mesh-ancestor
111177126|NCT03582280|Calcium|calcium|mesh-list
111324895|NCT00786643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111324896|NCT00786643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111324897|NCT00786643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111324898|NCT00786643|Immunologic Factors|immunologic factors|mesh-ancestor
111324899|NCT00786643|Antiviral Agents|antiviral agents|mesh-ancestor
111324900|NCT00786643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111324901|NCT00786643|Antidotes|antidotes|mesh-ancestor
111324902|NCT00786643|Protective Agents|protective agents|mesh-ancestor
111324903|NCT00786643|Vitamin B Complex|vitamin b complex|mesh-ancestor
111324904|NCT00786643|Vitamins|vitamins|mesh-ancestor
111324905|NCT00786643|Micronutrients|micronutrients|mesh-ancestor
111324906|NCT01276379|Leucovorin|leucovorin|mesh-list
111324907|NCT01276379|Folic Acid|folic acid|mesh-list
111324908|NCT01276379|Fluorouracil|fluorouracil|mesh-list
111324909|NCT01276379|Oxaliplatin|oxaliplatin|mesh-list
111324910|NCT01276379|Irinotecan|irinotecan|mesh-list
111324911|NCT01276379|Cetuximab|cetuximab|mesh-list
111324912|NCT01276379|Levoleucovorin|levoleucovorin|mesh-list
111324913|NCT01276379|Antimetabolites|antimetabolites|mesh-ancestor
111324914|NCT01276379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111324915|NCT01276379|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111324916|NCT01276379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111324917|NCT01276379|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111324918|NCT01276379|Immunologic Factors|immunologic factors|mesh-ancestor
111324919|NCT01276379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111324920|NCT01276379|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111324921|NCT01276379|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111324922|NCT01276379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111324923|NCT01276379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111324924|NCT01276379|Antidotes|antidotes|mesh-ancestor
111324925|NCT01276379|Protective Agents|protective agents|mesh-ancestor
111324926|NCT01276379|Vitamin B Complex|vitamin b complex|mesh-ancestor
111324927|NCT01276379|Vitamins|vitamins|mesh-ancestor
111324928|NCT01276379|Micronutrients|micronutrients|mesh-ancestor
111324929|NCT01276379|Hematinics|hematinics|mesh-ancestor
111324930|NCT01275547|Midazolam|midazolam|mesh-list
111324931|NCT01275547|Ketamine|ketamine|mesh-list
111324932|NCT01275547|Morphine|morphine|mesh-list
111324933|NCT01275547|Esketamine|esketamine|mesh-list
111324934|NCT01275547|Analgesics|analgesics|mesh-ancestor
111324935|NCT01275547|Sensory System Agents|sensory system agents|mesh-ancestor
111324936|NCT01275547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111324937|NCT01275547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111324938|NCT01275547|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111324939|NCT01275547|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111324940|NCT01275547|Anesthetics, General|anesthetics, general|mesh-ancestor
111324941|NCT01275547|Anesthetics|anesthetics|mesh-ancestor
111049358|NCT02184299|Nevirapine|nevirapine|mesh-list
111177666|NCT03883828|Mupirocin|mupirocin|mesh-list
111324942|NCT01275547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111324943|NCT01275547|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111324944|NCT01275547|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111324945|NCT01275547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111177737|NCT01675804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111324946|NCT01275547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111324947|NCT01275547|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111324948|NCT01275547|Narcotics|narcotics|mesh-ancestor
111324950|NCT01275547|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111324951|NCT01275547|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111324952|NCT01275547|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111324953|NCT01275547|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111324954|NCT01275547|GABA Modulators|gaba modulators|mesh-ancestor
111324955|NCT01275547|GABA Agents|gaba agents|mesh-ancestor
111324956|NCT01275547|Antidepressive Agents|antidepressive agents|mesh-ancestor
111324957|NCT00789685|Interferons|interferons|mesh-list
111324958|NCT00789685|Interferon-beta|interferon-beta|mesh-list
111324959|NCT00789685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111324960|NCT00789685|Antiviral Agents|antiviral agents|mesh-ancestor
111324961|NCT00789685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111324962|NCT00789685|Immunologic Factors|immunologic factors|mesh-ancestor
111324963|NCT00789685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111324964|NCT03804229|3-n-butylphthalide|3-n-butylphthalide|mesh-list
111324965|NCT03804229|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111324966|NCT03804229|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111324967|NCT03804229|Protective Agents|protective agents|mesh-ancestor
111324968|NCT03804229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111324969|NCT02149303|Dabigatran|dabigatran|mesh-list
111324970|NCT02149303|Antithrombins|antithrombins|mesh-ancestor
111324971|NCT02149303|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111324972|NCT02149303|Protease Inhibitors|protease inhibitors|mesh-ancestor
111324973|NCT02149303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111324974|NCT02149303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111324975|NCT02149303|Anticoagulants|anticoagulants|mesh-ancestor
111324976|NCT03803449|Fentanyl|fentanyl|mesh-list
111324977|NCT03803449|Midazolam|midazolam|mesh-list
111324978|NCT03803449|Propofol|propofol|mesh-list
111324979|NCT03803449|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111178011|NCT03806530|Dopamine Agents|dopamine agents|mesh-ancestor
111324980|NCT03803449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111324981|NCT03803449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111324982|NCT03803449|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111324983|NCT03803449|Anesthetics, General|anesthetics, general|mesh-ancestor
111324984|NCT03803449|Anesthetics|anesthetics|mesh-ancestor
111324985|NCT03803449|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111324986|NCT03803449|Narcotics|narcotics|mesh-ancestor
111324987|NCT03803449|Analgesics|analgesics|mesh-ancestor
111324988|NCT03803449|Sensory System Agents|sensory system agents|mesh-ancestor
111324989|NCT03803449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111324990|NCT03803449|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111324991|NCT03803449|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111324992|NCT03803449|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111324993|NCT03803449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111324994|NCT03803449|GABA Modulators|gaba modulators|mesh-ancestor
111324995|NCT03803449|GABA Agents|gaba agents|mesh-ancestor
111324996|NCT03803449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111324997|NCT03803449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111324998|NCT03803839|Clodronic Acid|clodronic acid|mesh-list
111324999|NCT03803839|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111325000|NCT03803839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111325001|NCT00789997|Levofloxacin|levofloxacin|mesh-list
111325002|NCT00789997|Prednisone|prednisone|mesh-list
111325003|NCT00789997|Etanercept|etanercept|mesh-list
111325004|NCT00789997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111325005|NCT00789997|Glucocorticoids|glucocorticoids|mesh-ancestor
111325006|NCT00789997|Hormones|hormones|mesh-ancestor
111325007|NCT00789997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111325008|NCT00789997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111325009|NCT00789997|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111325010|NCT00789997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111325011|NCT00789997|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111325012|NCT00789997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111325013|NCT00789997|Analgesics|analgesics|mesh-ancestor
111325014|NCT00789997|Sensory System Agents|sensory system agents|mesh-ancestor
111325015|NCT00789997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111325016|NCT00789997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111325017|NCT00789997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111325018|NCT00789997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111325019|NCT00789997|Immunologic Factors|immunologic factors|mesh-ancestor
111325020|NCT00789997|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111325021|NCT00789997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111325022|NCT00789997|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111178435|NCT03088306|Narcotics|narcotics|mesh-ancestor
111325023|NCT00789997|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111325024|NCT00789997|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111325025|NCT00789997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111325026|NCT00789997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111325027|NCT00789997|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111325028|NCT00789997|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111325029|NCT00771745|Thymoglobulin|thymoglobulin|mesh-list
111325030|NCT00771745|Antilymphocyte Serum|antilymphocyte serum|mesh-list
111325031|NCT00771745|Immunologic Factors|immunologic factors|mesh-ancestor
111325032|NCT00771745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111325033|NCT00771745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111178573|NCT01689363|Histamine|histamine|mesh-list
111325034|NCT03803215|Theophylline|theophylline|mesh-list
111325035|NCT03803215|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111325036|NCT03803215|Autonomic Agents|autonomic agents|mesh-ancestor
111325037|NCT03803215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111325038|NCT03803215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111325039|NCT03803215|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111325040|NCT03803215|Respiratory System Agents|respiratory system agents|mesh-ancestor
111325041|NCT03803215|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111325042|NCT03803215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111325043|NCT03803215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111325044|NCT03803215|Vasodilator Agents|vasodilator agents|mesh-ancestor
111325045|NCT03803215|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
111325046|NCT03803215|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111325047|NCT03803215|Purinergic Agents|purinergic agents|mesh-ancestor
111325048|NCT03803215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111325049|NCT00790855|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
111325050|NCT00790855|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111325051|NCT00790855|Alkylating Agents|alkylating agents|mesh-ancestor
111325052|NCT00790855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111325053|NCT00790855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111325054|NCT03802747|Durvalumab|durvalumab|mesh-list
111325055|NCT03802747|Tremelimumab|tremelimumab|mesh-list
111325056|NCT03802747|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111325057|NCT03802747|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111325058|NCT03802747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111325059|NCT03802747|Immunologic Factors|immunologic factors|mesh-ancestor
111325060|NCT03802747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111325061|NCT00791323|Ketorolac|ketorolac|mesh-list
111325062|NCT00791323|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111325063|NCT00791323|Lubricant Eye Drops|lubricant eye drops|mesh-list
111325064|NCT00791323|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111325065|NCT00791323|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111325066|NCT00791323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111325067|NCT00791323|Analgesics|analgesics|mesh-ancestor
111325068|NCT00791323|Sensory System Agents|sensory system agents|mesh-ancestor
111325069|NCT00791323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111325070|NCT00791323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111178833|NCT01688037|Tetrabenazine|tetrabenazine|mesh-list
111325071|NCT00791323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111325072|NCT00791323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111325073|NCT00791323|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111178926|NCT03082300|Naquotinib|naquotinib|mesh-list
111325074|NCT00791323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111325075|NCT00791323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111325076|NCT00772915|Dexamethasone|dexamethasone|mesh-list
111325077|NCT00772915|Lenalidomide|lenalidomide|mesh-list
111325078|NCT00772915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111325079|NCT00772915|Antiemetics|antiemetics|mesh-ancestor
111325080|NCT00772915|Autonomic Agents|autonomic agents|mesh-ancestor
111325081|NCT00772915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111325082|NCT00772915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111325083|NCT00772915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111325084|NCT00772915|Glucocorticoids|glucocorticoids|mesh-ancestor
111325085|NCT00772915|Hormones|hormones|mesh-ancestor
111325086|NCT00772915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111325087|NCT00772915|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111325088|NCT00772915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111325089|NCT00772915|Immunologic Factors|immunologic factors|mesh-ancestor
111325090|NCT00772915|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111325091|NCT00772915|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111325092|NCT00772915|Growth Substances|growth substances|mesh-ancestor
111325093|NCT00772915|Growth Inhibitors|growth inhibitors|mesh-ancestor
111325094|NCT05497453|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
111325095|NCT05497453|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
111325096|NCT05497453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111325097|NCT05497453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111325098|NCT05497453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111325099|NCT05497453|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111325100|NCT05497453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111325101|NCT03801733|Sulfasalazine|sulfasalazine|mesh-list
111325102|NCT03801733|Atorvastatin|atorvastatin|mesh-list
111325103|NCT03801733|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111325104|NCT03801733|Simvastatin|simvastatin|mesh-list
111325105|NCT03801733|Pravastatin|pravastatin|mesh-list
111325106|NCT03801733|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111325107|NCT03801733|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111325108|NCT03801733|Antimetabolites|antimetabolites|mesh-ancestor
111325109|NCT03801733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111325110|NCT03801733|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111325111|NCT03801733|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111325112|NCT03801733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111325113|NCT03801733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111325114|NCT03801733|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111325115|NCT03801733|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111325116|NCT03801733|Analgesics|analgesics|mesh-ancestor
111325117|NCT03801733|Sensory System Agents|sensory system agents|mesh-ancestor
111179307|NCT01811732|Vancomycin|vancomycin|mesh-list
111325118|NCT03801733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111325119|NCT03801733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111325120|NCT03801733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111325121|NCT03801733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111325122|NCT03801733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111325123|NCT00775411|Dexamethasone|dexamethasone|mesh-list
111325124|NCT00775411|Ranibizumab|ranibizumab|mesh-list
111325125|NCT00775411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111325126|NCT00775411|Antiemetics|antiemetics|mesh-ancestor
111325127|NCT00775411|Autonomic Agents|autonomic agents|mesh-ancestor
111325128|NCT00775411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111325129|NCT00775411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111325130|NCT00775411|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111325131|NCT00775411|Glucocorticoids|glucocorticoids|mesh-ancestor
111325132|NCT00775411|Hormones|hormones|mesh-ancestor
111325133|NCT00775411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111325134|NCT00775411|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111325135|NCT00775411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111325136|NCT00775411|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111325137|NCT00775411|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111325138|NCT00775411|Growth Substances|growth substances|mesh-ancestor
111325139|NCT00775411|Growth Inhibitors|growth inhibitors|mesh-ancestor
111325140|NCT03801499|Lenvatinib|lenvatinib|mesh-list
111325141|NCT03801499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111325142|NCT03801499|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111325143|NCT03801499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111325144|NCT03801499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111325145|NCT00808405|Acyclovir|acyclovir|mesh-list
111325146|NCT00808405|Antiviral Agents|antiviral agents|mesh-ancestor
111325147|NCT00808405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111325148|NCT00775645|Acetylcarnitine|acetylcarnitine|mesh-list
111325149|NCT00775645|Vitamin B Complex|vitamin b complex|mesh-ancestor
111325150|NCT00775645|Vitamins|vitamins|mesh-ancestor
111325151|NCT00775645|Micronutrients|micronutrients|mesh-ancestor
111325152|NCT00775645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111325153|NCT00775645|Nootropic Agents|nootropic agents|mesh-ancestor
111325154|NCT01974687|Itraconazole|itraconazole|mesh-list
111325155|NCT01974687|Uprifosbuvir|uprifosbuvir|mesh-list
111325156|NCT01974687|Antifungal Agents|antifungal agents|mesh-ancestor
111179646|NCT03568708|Contraceptive Agents|contraceptive agents|mesh-ancestor
111325157|NCT01974687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111325158|NCT01974687|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111325159|NCT01974687|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111325160|NCT01974687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111325161|NCT01974687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111325162|NCT01974687|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111325163|NCT01974687|Hormone Antagonists|hormone antagonists|mesh-ancestor
111325164|NCT01974687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111325165|NCT01974687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111325166|NCT01974687|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111325167|NCT01974687|Antiviral Agents|antiviral agents|mesh-ancestor
111325168|NCT00795145|Moxifloxacin|moxifloxacin|mesh-list
111325169|NCT00795145|Linezolid|linezolid|mesh-list
111325170|NCT00795145|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111325171|NCT00795145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111325172|NCT00795145|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111325173|NCT00795145|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111325174|NCT00795145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111325175|NCT00795145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111325176|NCT00795145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111325177|NCT00795145|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111325178|NCT03801187|Chlorhexidine|chlorhexidine|mesh-list
111325179|NCT03801187|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111325180|NCT03801187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111325181|NCT03801187|Disinfectants|disinfectants|mesh-ancestor
111325182|NCT00809185|Everolimus|everolimus|mesh-list
111325183|NCT00809185|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111325184|NCT00809185|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111325185|NCT00809185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111325186|NCT00809185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111325187|NCT00809185|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111325188|NCT00809185|Immunologic Factors|immunologic factors|mesh-ancestor
111325189|NCT00809185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111325190|NCT00809185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111325191|NCT03800953|Avelumab|avelumab|mesh-list
111179786|NCT01687413|Cisplatin|cisplatin|mesh-list
111325192|NCT03800953|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111325193|NCT03800953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111325194|NCT00795769|Ondansetron|ondansetron|mesh-list
111325195|NCT00795769|Antiemetics|antiemetics|mesh-ancestor
111325196|NCT00795769|Autonomic Agents|autonomic agents|mesh-ancestor
111325197|NCT00795769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111325198|NCT00795769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111179892|NCT01929343|Lidocaine|lidocaine|mesh-list
111325199|NCT00795769|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111325200|NCT00795769|Antipruritics|antipruritics|mesh-ancestor
111179965|NCT01575561|Serotonin Agents|serotonin agents|mesh-ancestor
111325201|NCT00795769|Dermatologic Agents|dermatologic agents|mesh-ancestor
111325202|NCT00795769|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111325203|NCT00795769|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111325204|NCT00795769|Serotonin Agents|serotonin agents|mesh-ancestor
111325205|NCT00795769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111325206|NCT00795769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111325207|NCT01975935|Amlexanox|amlexanox|mesh-list
111325208|NCT01975935|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111325209|NCT02305017|Acetaminophen|acetaminophen|mesh-list
111325210|NCT02305017|Opicapone|opicapone|mesh-list
111325211|NCT02305017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111325212|NCT02305017|Analgesics|analgesics|mesh-ancestor
111325213|NCT02305017|Sensory System Agents|sensory system agents|mesh-ancestor
111325214|NCT02305017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111325215|NCT02305017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111325216|NCT02305017|Antipyretics|antipyretics|mesh-ancestor
111180174|NCT05929664|Cemiplimab|cemiplimab|mesh-list
111325217|NCT02305017|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
111325218|NCT02305017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111325219|NCT02305017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111325220|NCT02305017|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111325221|NCT02305017|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111325222|NCT01976871|Rotigotine|rotigotine|mesh-list
111325223|NCT01976871|Dopamine Agonists|dopamine agonists|mesh-ancestor
111325224|NCT01976871|Dopamine Agents|dopamine agents|mesh-ancestor
111325225|NCT01976871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111325226|NCT01976871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111325227|NCT01976871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111325228|NCT03602781|Nitric Oxide|nitric oxide|mesh-list
111325229|NCT03602781|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111325230|NCT03602781|Autonomic Agents|autonomic agents|mesh-ancestor
111325231|NCT03602781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111325232|NCT03602781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111325233|NCT03602781|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111325234|NCT03602781|Respiratory System Agents|respiratory system agents|mesh-ancestor
111325235|NCT03602781|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111325236|NCT03602781|Antioxidants|antioxidants|mesh-ancestor
111325237|NCT03602781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111325238|NCT03602781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111325239|NCT03602781|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
111325240|NCT03602781|Vasodilator Agents|vasodilator agents|mesh-ancestor
111325241|NCT03602781|Gasotransmitters|gasotransmitters|mesh-ancestor
111325242|NCT03602781|Protective Agents|protective agents|mesh-ancestor
111325243|NCT02280239|Acetaminophen|acetaminophen|mesh-list
111325244|NCT02280239|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111325245|NCT02280239|Analgesics|analgesics|mesh-ancestor
111325246|NCT02280239|Sensory System Agents|sensory system agents|mesh-ancestor
111325247|NCT02280239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111325248|NCT02280239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111325249|NCT02280239|Antipyretics|antipyretics|mesh-ancestor
111325250|NCT01993875|Lubiprostone|lubiprostone|mesh-list
111325251|NCT01993875|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
111325252|NCT01993875|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111325253|NCT01993875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111325254|NCT00796705|Adalimumab|adalimumab|mesh-list
111325255|NCT00796705|Etanercept|etanercept|mesh-list
111325256|NCT00796705|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111325257|NCT00796705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111325258|NCT00796705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111325259|NCT00796705|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111325260|NCT00796705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111325261|NCT00796705|Analgesics|analgesics|mesh-ancestor
111325262|NCT00796705|Sensory System Agents|sensory system agents|mesh-ancestor
111325263|NCT00796705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111325264|NCT00796705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111325265|NCT00796705|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111325266|NCT00796705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111325267|NCT00796705|Immunologic Factors|immunologic factors|mesh-ancestor
111325268|NCT00809809|Zinc|zinc|mesh-list
111325269|NCT00809809|Trace Elements|trace elements|mesh-ancestor
111325270|NCT00809809|Micronutrients|micronutrients|mesh-ancestor
111325271|NCT00809809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111325272|NCT00248651|Amitriptyline|amitriptyline|mesh-list
111325273|NCT00248651|Escitalopram|escitalopram|mesh-list
111325274|NCT00248651|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111325275|NCT00248651|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111325276|NCT00248651|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111180573|NCT04973566|Analgesics|analgesics|mesh-ancestor
111325277|NCT00248651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111325278|NCT00248651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111325279|NCT00248651|Serotonin Agents|serotonin agents|mesh-ancestor
111325280|NCT00248651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111325281|NCT00248651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111325282|NCT00248651|Antidepressive Agents|antidepressive agents|mesh-ancestor
111325283|NCT00248651|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111325284|NCT00248651|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
111325285|NCT00248651|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111325286|NCT00248651|Analgesics|analgesics|mesh-ancestor
111325287|NCT00248651|Sensory System Agents|sensory system agents|mesh-ancestor
111325288|NCT00248651|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111180649|NCT04563507|Letrozole|letrozole|mesh-list
111325289|NCT00248651|Adrenergic Agents|adrenergic agents|mesh-ancestor
111325290|NCT03800797|Loxoprofen|loxoprofen|mesh-list
111325291|NCT03800797|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111325292|NCT03800797|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111325293|NCT03800797|Analgesics|analgesics|mesh-ancestor
111325294|NCT03800797|Sensory System Agents|sensory system agents|mesh-ancestor
111325295|NCT03800797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111325296|NCT03800797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111325297|NCT03800797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111325298|NCT03800797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111325299|NCT04383067|Aldesleukin|aldesleukin|mesh-list
111325300|NCT04383067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111325301|NCT04383067|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111325302|NCT04383067|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111325303|NCT04383067|Antiviral Agents|antiviral agents|mesh-ancestor
111325304|NCT04383067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111325305|NCT01994109|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
111325306|NCT01994109|Botulinum Toxins|botulinum toxins|mesh-list
111325307|NCT01994109|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111325308|NCT01994109|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111325309|NCT01994109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111325310|NCT01994109|Cholinergic Agents|cholinergic agents|mesh-ancestor
111325311|NCT01994109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111325312|NCT01994109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111325313|NCT01994109|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111325314|NCT00248495|Pemetrexed|pemetrexed|mesh-list
111325315|NCT00248495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111325316|NCT00248495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111325317|NCT00248495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111325318|NCT00248495|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111325319|NCT00248495|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111325320|NCT04739371|Insulin|insulin|mesh-list
111325321|NCT04739371|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111325322|NCT04739371|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111325323|NCT04739371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111325324|NCT03809767|Antibodies|antibodies|mesh-list
111325325|NCT03809767|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111325327|NCT03809767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111325328|NCT03800641|Dexmedetomidine|dexmedetomidine|mesh-list
111325329|NCT03800641|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111325330|NCT03800641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111325331|NCT03800641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111180963|NCT03585465|Cyclophosphamide|cyclophosphamide|mesh-list
111325332|NCT03800641|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111325333|NCT03800641|Analgesics|analgesics|mesh-ancestor
111325334|NCT03800641|Sensory System Agents|sensory system agents|mesh-ancestor
111325335|NCT03800641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111325336|NCT03800641|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111325337|NCT03800641|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111181036|NCT03404778|Histamine Agents|histamine agents|mesh-ancestor
111325338|NCT03800641|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111325339|NCT03800641|Adrenergic Agents|adrenergic agents|mesh-ancestor
111325340|NCT03800641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111325341|NCT03800641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111325342|NCT03807011|Fentanyl|fentanyl|mesh-list
111325343|NCT03807011|Remifentanil|remifentanil|mesh-list
111325344|NCT03807011|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111325345|NCT03807011|Narcotics|narcotics|mesh-ancestor
111325346|NCT03807011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111325347|NCT03807011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111325348|NCT03807011|Analgesics|analgesics|mesh-ancestor
111325349|NCT03807011|Sensory System Agents|sensory system agents|mesh-ancestor
111325350|NCT03807011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111325351|NCT03807011|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111181183|NCT03086343|Abatacept|abatacept|mesh-list
111325352|NCT03807011|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111325353|NCT03807011|Anesthetics, General|anesthetics, general|mesh-ancestor
111325354|NCT03807011|Anesthetics|anesthetics|mesh-ancestor
111325355|NCT02986503|Cisplatin|cisplatin|mesh-list
111325356|NCT02986503|Doxorubicin|doxorubicin|mesh-list
111325357|NCT02986503|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111325358|NCT02986503|Methotrexate|methotrexate|mesh-list
111325359|NCT02986503|Ifosfamide|ifosfamide|mesh-list
111325360|NCT02986503|Isophosphamide mustard|isophosphamide mustard|mesh-list
111325361|NCT02986503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111325362|NCT02986503|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111325363|NCT02986503|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111325364|NCT02986503|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111325365|NCT02986503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111325366|NCT02986503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111325367|NCT02986503|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111325368|NCT02986503|Abortifacient Agents|abortifacient agents|mesh-ancestor
111325369|NCT02986503|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111325370|NCT02986503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111325371|NCT02986503|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111325372|NCT02986503|Antimetabolites|antimetabolites|mesh-ancestor
111325373|NCT02986503|Dermatologic Agents|dermatologic agents|mesh-ancestor
111325374|NCT02986503|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111325375|NCT02986503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111325376|NCT02986503|Immunologic Factors|immunologic factors|mesh-ancestor
111325377|NCT02986503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111325378|NCT02986503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111325379|NCT02986503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111325380|NCT02986503|Alkylating Agents|alkylating agents|mesh-ancestor
111325381|NCT01978743|Raltegravir Potassium|raltegravir potassium|mesh-list
111325382|NCT01978743|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111325383|NCT01978743|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111325384|NCT01978743|Antiviral Agents|antiviral agents|mesh-ancestor
111325385|NCT01978743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111325386|NCT01978743|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111325387|NCT01978743|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111325388|NCT01978743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111325389|NCT01978743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111325390|NCT00763061|Timolol|timolol|mesh-list
111325391|NCT00763061|Travoprost|travoprost|mesh-list
111325392|NCT00763061|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111325393|NCT00763061|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111325394|NCT00763061|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111325395|NCT00763061|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111325396|NCT00763061|Adrenergic Agents|adrenergic agents|mesh-ancestor
111325397|NCT00763061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111325398|NCT00763061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111325399|NCT00763061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111325400|NCT00763061|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111325401|NCT00763061|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111325402|NCT03806335|Anesthetics|anesthetics|mesh-list
111325403|NCT03806335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111325404|NCT03806335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111325405|NCT03806777|Dexmedetomidine|dexmedetomidine|mesh-list
111325406|NCT03806777|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111325407|NCT03806777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111325408|NCT03806777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111325409|NCT03806777|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111325410|NCT03806777|Analgesics|analgesics|mesh-ancestor
111325411|NCT03806777|Sensory System Agents|sensory system agents|mesh-ancestor
111325412|NCT03806777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111325413|NCT03806777|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111325414|NCT03806777|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111325415|NCT03806777|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111325416|NCT03806777|Adrenergic Agents|adrenergic agents|mesh-ancestor
111325417|NCT03806777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111325418|NCT03806777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111325419|NCT00754247|Vitamin E|vitamin e|mesh-list
111325420|NCT00754247|Hydrocortisone|hydrocortisone|mesh-list
111325421|NCT00754247|Vitamins|vitamins|mesh-ancestor
111325422|NCT00754247|Micronutrients|micronutrients|mesh-ancestor
111325423|NCT00754247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111325424|NCT00754247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111325425|NCT00754247|Antioxidants|antioxidants|mesh-ancestor
111325426|NCT00754247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111325427|NCT00754247|Protective Agents|protective agents|mesh-ancestor
111325428|NCT02305329|Opicapone|opicapone|mesh-list
111325429|NCT02305329|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
111325430|NCT02305329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111325431|NCT02305329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111325432|NCT02305329|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111325433|NCT02305329|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111325434|NCT01979445|Clopidogrel|clopidogrel|mesh-list
111325435|NCT01979445|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
111325436|NCT01979445|Cangrelor|cangrelor|mesh-list
111325437|NCT01979445|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111325438|NCT01979445|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111181548|NCT00635050|Growth Substances|growth substances|mesh-ancestor
111325439|NCT01979445|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111325440|NCT01979445|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111325441|NCT01979445|Purinergic Agents|purinergic agents|mesh-ancestor
111325442|NCT01979445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111325443|NCT01979445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111325444|NCT01979445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111325445|NCT03802565|Tolperisone|tolperisone|mesh-list
111325446|NCT03802565|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
111325447|NCT03802565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111325448|NCT03802565|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111325449|NCT03802565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111325450|NCT04382443|Colchicine|colchicine|mesh-list
111325451|NCT04382443|Gout Suppressants|gout suppressants|mesh-ancestor
111325452|NCT04382443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111325453|NCT04382443|Tubulin Modulators|tubulin modulators|mesh-ancestor
111325454|NCT04382443|Antimitotic Agents|antimitotic agents|mesh-ancestor
111325455|NCT04382443|Mitosis Modulators|mitosis modulators|mesh-ancestor
111325456|NCT04382443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111325457|NCT04382443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111325458|NCT04633213|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111325459|NCT04633213|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111325460|NCT01981863|Aminocaproic Acid|aminocaproic acid|mesh-list
111325461|NCT01981863|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111325462|NCT01981863|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111325463|NCT01981863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111325464|NCT01981863|Hemostatics|hemostatics|mesh-ancestor
111325465|NCT01981863|Coagulants|coagulants|mesh-ancestor
111325466|NCT00245765|Certolizumab Pegol|certolizumab pegol|mesh-list
111325467|NCT00245765|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111325468|NCT00245765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111325469|NCT00245765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111325470|NCT00245765|Immunologic Factors|immunologic factors|mesh-ancestor
111325471|NCT00245765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111181658|NCT01924234|Analgesics|analgesics|mesh-ancestor
111325472|NCT00245765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111325473|NCT01995045|Triamcinolone|triamcinolone|mesh-list
111325474|NCT01995045|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
111325475|NCT01995045|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
111325476|NCT01995045|Bupivacaine|bupivacaine|mesh-list
111325477|NCT01995045|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
111325478|NCT01995045|Anesthetics, Local|anesthetics, local|mesh-ancestor
111325479|NCT01995045|Anesthetics|anesthetics|mesh-ancestor
111325480|NCT01995045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111325481|NCT01995045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111181792|NCT01920334|GABA Agonists|gaba agonists|mesh-ancestor
111325482|NCT01995045|Sensory System Agents|sensory system agents|mesh-ancestor
111325483|NCT01995045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111325484|NCT01995045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111325485|NCT01995045|Glucocorticoids|glucocorticoids|mesh-ancestor
111325486|NCT01995045|Hormones|hormones|mesh-ancestor
111325487|NCT01995045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111325488|NCT01995045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111325489|NCT01995045|Immunologic Factors|immunologic factors|mesh-ancestor
111325490|NCT01995045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111325491|NCT01995045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111325492|NCT01982643|Naltrexone|naltrexone|mesh-list
111325493|NCT01982643|Bupropion|bupropion|mesh-list
111325494|NCT01982643|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111325495|NCT01982643|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111325496|NCT01982643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111325497|NCT01982643|Sensory System Agents|sensory system agents|mesh-ancestor
111325498|NCT01982643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111325499|NCT01982643|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111325500|NCT01982643|Antidepressive Agents|antidepressive agents|mesh-ancestor
111325501|NCT01982643|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111325502|NCT01982643|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111325503|NCT01982643|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111325504|NCT01982643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111325505|NCT01982643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111325506|NCT01982643|Dopamine Agents|dopamine agents|mesh-ancestor
111325507|NCT01982643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111325508|NCT01982643|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111325509|NCT01982643|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111325510|NCT01982643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111325511|NCT01996839|Loteprednol Etabonate|loteprednol etabonate|mesh-list
111325512|NCT01996839|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111325513|NCT00797797|Milnacipran|milnacipran|mesh-list
111325514|NCT00797797|Levomilnacipran|levomilnacipran|mesh-list
111325515|NCT00797797|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111325516|NCT00797797|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111325517|NCT00797797|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111325518|NCT00797797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111181865|NCT00985738|Dutasteride|dutasteride|mesh-list
111325519|NCT00797797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111325520|NCT00797797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111325521|NCT00797797|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111325522|NCT00797797|Analgesics|analgesics|mesh-ancestor
111325523|NCT00797797|Sensory System Agents|sensory system agents|mesh-ancestor
111325524|NCT00797797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111325525|NCT00797797|Antidepressive Agents|antidepressive agents|mesh-ancestor
111325526|NCT00797797|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111325527|NCT03496233|Grazoprevir|grazoprevir|mesh-list
111325528|NCT03496233|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
111325529|NCT03496233|Antiviral Agents|antiviral agents|mesh-ancestor
111325530|NCT03496233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111325531|NCT04482673|Vitamin D|vitamin d|mesh-list
111325532|NCT04482673|Ergocalciferols|ergocalciferols|mesh-list
111325533|NCT04482673|Cholecalciferol|cholecalciferol|mesh-list
111325534|NCT04482673|Vitamins|vitamins|mesh-list
111325535|NCT04482673|Micronutrients|micronutrients|mesh-ancestor
111325536|NCT04482673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111325537|NCT04482673|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111325538|NCT04482673|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111325539|NCT00245063|Cediranib|cediranib|mesh-list
111325540|NCT00245063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111325541|NCT00245063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111325542|NCT00245063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111325543|NCT00245063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111325544|NCT02151487|Dexamethasone|dexamethasone|mesh-list
111325545|NCT02151487|Dexamethasone acetate|dexamethasone acetate|mesh-list
111325546|NCT02151487|Clonidine|clonidine|mesh-list
111325547|NCT02151487|Ropivacaine|ropivacaine|mesh-list
111325548|NCT02151487|BB 1101|bb 1101|mesh-list
111049947|NCT02186483|Antimetabolites|antimetabolites|mesh-ancestor
111325549|NCT02151487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111325550|NCT02151487|Antiemetics|antiemetics|mesh-ancestor
111325551|NCT02151487|Autonomic Agents|autonomic agents|mesh-ancestor
111325552|NCT02151487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111325553|NCT02151487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111325554|NCT02151487|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111325555|NCT02151487|Glucocorticoids|glucocorticoids|mesh-ancestor
111325556|NCT02151487|Hormones|hormones|mesh-ancestor
111325557|NCT02151487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111325558|NCT02151487|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111325559|NCT02151487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111325560|NCT02151487|Protease Inhibitors|protease inhibitors|mesh-ancestor
111325561|NCT02151487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111325562|NCT02151487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111325563|NCT02151487|Anesthetics, Local|anesthetics, local|mesh-ancestor
111325564|NCT02151487|Anesthetics|anesthetics|mesh-ancestor
111325565|NCT02151487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111325566|NCT02151487|Sensory System Agents|sensory system agents|mesh-ancestor
111325567|NCT02151487|Analgesics|analgesics|mesh-ancestor
111325568|NCT02151487|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111325569|NCT02151487|Sympatholytics|sympatholytics|mesh-ancestor
111325570|NCT02151487|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111325571|NCT02151487|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111325572|NCT02151487|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111325573|NCT02151487|Adrenergic Agents|adrenergic agents|mesh-ancestor
111325574|NCT02151487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111325575|NCT05318339|Trastuzumab|trastuzumab|mesh-list
111325576|NCT05318339|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111325577|NCT05318339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111325578|NCT04703335|Anti-Infective Agents|anti-infective agents|mesh-list
111325579|NCT04703335|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111325580|NCT00764309|Dasatinib|dasatinib|mesh-list
111325581|NCT00764309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111325582|NCT00764309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111325583|NCT00764309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111325584|NCT00764309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111325585|NCT02151877|Nitric Oxide|nitric oxide|mesh-list
111325586|NCT02151877|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111325587|NCT02151877|Autonomic Agents|autonomic agents|mesh-ancestor
111325588|NCT02151877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111325589|NCT02151877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111325590|NCT02151877|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111325591|NCT02151877|Respiratory System Agents|respiratory system agents|mesh-ancestor
111325592|NCT02151877|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111325593|NCT02151877|Antioxidants|antioxidants|mesh-ancestor
111325594|NCT02151877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111325595|NCT02151877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111325596|NCT02151877|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
111325597|NCT02151877|Vasodilator Agents|vasodilator agents|mesh-ancestor
111325598|NCT02151877|Gasotransmitters|gasotransmitters|mesh-ancestor
111325599|NCT02151877|Protective Agents|protective agents|mesh-ancestor
111325600|NCT00798577|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111325601|NCT00798577|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111325602|NCT00799435|Exenatide|exenatide|mesh-list
111325603|NCT00799435|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111325604|NCT00799435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111325605|NCT00799435|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111325606|NCT00799435|Incretins|incretins|mesh-ancestor
111325607|NCT00799435|Hormones|hormones|mesh-ancestor
111325608|NCT00799435|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111182135|NCT01903837|Naltrexone|naltrexone|mesh-list
111325609|NCT04329091|Dexmedetomidine|dexmedetomidine|mesh-list
111325610|NCT04329091|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111325611|NCT04329091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111325612|NCT04329091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111325613|NCT04329091|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111325614|NCT04329091|Analgesics|analgesics|mesh-ancestor
111325615|NCT04329091|Sensory System Agents|sensory system agents|mesh-ancestor
111325616|NCT04329091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111325617|NCT04329091|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111325618|NCT04329091|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111325619|NCT04329091|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111325620|NCT04329091|Adrenergic Agents|adrenergic agents|mesh-ancestor
111325621|NCT04329091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111325622|NCT04329091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111325623|NCT04382209|Meperidine|meperidine|mesh-list
111325624|NCT04382209|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111325625|NCT04382209|Narcotics|narcotics|mesh-ancestor
111325626|NCT04382209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111325627|NCT04382209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111325628|NCT04382209|Analgesics|analgesics|mesh-ancestor
111325629|NCT04382209|Sensory System Agents|sensory system agents|mesh-ancestor
111325630|NCT04382209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111325631|NCT04382209|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111325632|NCT04634071|Bupropion|bupropion|mesh-list
111325633|NCT04634071|Nicotine|nicotine|mesh-list
111325634|NCT04634071|Varenicline|varenicline|mesh-list
111325635|NCT04634071|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111325636|NCT04634071|Autonomic Agents|autonomic agents|mesh-ancestor
111325637|NCT04634071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111325638|NCT04634071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111325639|NCT04634071|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111325640|NCT04634071|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111325641|NCT04634071|Cholinergic Agents|cholinergic agents|mesh-ancestor
111325642|NCT04634071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111325643|NCT04634071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111325644|NCT04634071|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111325645|NCT04634071|Antidepressive Agents|antidepressive agents|mesh-ancestor
111325646|NCT04634071|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111325647|NCT04634071|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111325648|NCT04634071|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111325649|NCT04634071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111325650|NCT04634071|Dopamine Agents|dopamine agents|mesh-ancestor
111325651|NCT04634071|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111182455|NCT03043924|Estradiol|estradiol|mesh-list
111325652|NCT04634071|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111325653|NCT04634071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111325654|NCT03417921|Paclitaxel|paclitaxel|mesh-list
111325655|NCT03417921|Gemcitabine|gemcitabine|mesh-list
111325656|NCT03417921|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111182522|NCT03823846|Narcotics|narcotics|mesh-ancestor
111325657|NCT03417921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111182600|NCT02983084|Copper|copper|mesh-list
111325658|NCT03417921|Tubulin Modulators|tubulin modulators|mesh-ancestor
111325659|NCT03417921|Antimitotic Agents|antimitotic agents|mesh-ancestor
111325660|NCT03417921|Mitosis Modulators|mitosis modulators|mesh-ancestor
111325661|NCT03417921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111325662|NCT03417921|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111325663|NCT03417921|Antimetabolites|antimetabolites|mesh-ancestor
111325664|NCT03378297|Aspirin|aspirin|mesh-list
111325665|NCT03378297|Metformin|metformin|mesh-list
111325666|NCT03378297|Letrozole|letrozole|mesh-list
111325667|NCT03378297|Olaparib|olaparib|mesh-list
111325668|NCT03378297|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111325669|NCT03378297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111325670|NCT03378297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111325671|NCT03378297|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111325672|NCT03378297|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111325673|NCT03378297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111325674|NCT03378297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111182722|NCT04390984|Apatinib|apatinib|mesh-list
111325675|NCT03378297|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111325676|NCT03378297|Hormone Antagonists|hormone antagonists|mesh-ancestor
111325677|NCT03378297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111325678|NCT03378297|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111325679|NCT03378297|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111325680|NCT03378297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111182829|NCT02798536|Paclitaxel|paclitaxel|mesh-list
111325681|NCT03378297|Analgesics|analgesics|mesh-ancestor
111325682|NCT03378297|Sensory System Agents|sensory system agents|mesh-ancestor
111325683|NCT03378297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111325684|NCT03378297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111325685|NCT03378297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111325686|NCT03378297|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111325687|NCT03378297|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111325688|NCT03378297|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111325689|NCT03378297|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111325690|NCT03378297|Antipyretics|antipyretics|mesh-ancestor
111325691|NCT03367689|Olaparib|olaparib|mesh-list
111325692|NCT03367689|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111182862|NCT01901185|Etanercept|etanercept|mesh-list
111325693|NCT03367689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111325694|NCT03367689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111325695|NCT03367689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111325696|NCT00243659|Factor VIII|factor viii|mesh-list
111325697|NCT00243659|Coagulants|coagulants|mesh-ancestor
111325698|NCT00814177|Warfarin|warfarin|mesh-list
111050098|NCT02298868|GABA Agents|gaba agents|mesh-ancestor
111325699|NCT00814177|Anticoagulants|anticoagulants|mesh-ancestor
111325701|NCT00243347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111325702|NCT00243347|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111325703|NCT00243347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111325704|NCT00243347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111325705|NCT03364491|Tranexamic Acid|tranexamic acid|mesh-list
111325706|NCT03364491|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111325707|NCT03364491|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111325708|NCT03364491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111325709|NCT03364491|Hemostatics|hemostatics|mesh-ancestor
111325710|NCT03364491|Coagulants|coagulants|mesh-ancestor
111325711|NCT04294069|Azithromycin|azithromycin|mesh-list
111325712|NCT04294069|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111325713|NCT04294069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111325714|NCT01997229|Eculizumab|eculizumab|mesh-list
111325715|NCT01997229|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
111325716|NCT01997229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111325717|NCT01997229|Immunologic Factors|immunologic factors|mesh-ancestor
111325718|NCT01997229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111325719|NCT00800839|Cyclophosphamide|cyclophosphamide|mesh-list
111325720|NCT00800839|Busulfan|busulfan|mesh-list
111325721|NCT00800839|Fludarabine|fludarabine|mesh-list
111325722|NCT00800839|Fludarabine phosphate|fludarabine phosphate|mesh-list
111325723|NCT00800839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111183124|NCT02315872|Hormones|hormones|mesh-ancestor
111325724|NCT00800839|Immunologic Factors|immunologic factors|mesh-ancestor
111325725|NCT00800839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111325726|NCT00800839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111325727|NCT00800839|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111325728|NCT00800839|Alkylating Agents|alkylating agents|mesh-ancestor
111325729|NCT00800839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111325730|NCT00800839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111325731|NCT00800839|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111325732|NCT00800839|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111325733|NCT00800839|Antimetabolites|antimetabolites|mesh-ancestor
111325734|NCT00814255|Adalimumab|adalimumab|mesh-list
111325735|NCT00814255|Losartan|losartan|mesh-list
111325736|NCT00814255|Lisinopril|lisinopril|mesh-list
111325737|NCT00814255|Atorvastatin|atorvastatin|mesh-list
111325738|NCT00814255|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111325739|NCT00814255|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111325740|NCT00814255|Antimetabolites|antimetabolites|mesh-ancestor
111325741|NCT00814255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111325742|NCT00814255|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111325743|NCT00814255|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111325744|NCT00814255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111325745|NCT00814255|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111325746|NCT00814255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111325747|NCT00814255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111325748|NCT00814255|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111325749|NCT00814255|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111325750|NCT00814255|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111325751|NCT00814255|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111325752|NCT00814255|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
111325753|NCT00814255|Protease Inhibitors|protease inhibitors|mesh-ancestor
111325754|NCT00814255|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111325755|NCT00814255|Protective Agents|protective agents|mesh-ancestor
111325756|NCT00814255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111325757|NCT02000973|Lidocaine|lidocaine|mesh-list
111325758|NCT02000973|Bupivacaine|bupivacaine|mesh-list
111325759|NCT02000973|Ropivacaine|ropivacaine|mesh-list
111325760|NCT02000973|Anesthetics, Local|anesthetics, local|mesh-ancestor
111325761|NCT02000973|Anesthetics|anesthetics|mesh-ancestor
111325762|NCT02000973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111325763|NCT02000973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111325764|NCT02000973|Sensory System Agents|sensory system agents|mesh-ancestor
111325765|NCT02000973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111325766|NCT02000973|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111325767|NCT02000973|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111325768|NCT02000973|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111325769|NCT02000973|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111325770|NCT02000973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111050167|NCT02296840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111325771|NCT02002767|Velpatasvir|velpatasvir|mesh-list
111325772|NCT02002767|Antiviral Agents|antiviral agents|mesh-ancestor
111325773|NCT02002767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111325774|NCT01985685|Thiamine|thiamine|mesh-list
111325775|NCT01985685|Vitamin B Complex|vitamin b complex|mesh-ancestor
111325776|NCT01985685|Vitamins|vitamins|mesh-ancestor
111325777|NCT01985685|Micronutrients|micronutrients|mesh-ancestor
111325778|NCT01985685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111325779|NCT00815347|Bosentan|bosentan|mesh-list
111325780|NCT00815347|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111325781|NCT00815347|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
111325782|NCT00815347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111325783|NCT01985763|Genistein|genistein|mesh-list
111325784|NCT01985763|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
111325785|NCT01985763|Protective Agents|protective agents|mesh-ancestor
111325786|NCT01985763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111325787|NCT01985763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111325788|NCT01985763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111325789|NCT01985763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111325790|NCT01985763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111325791|NCT01985763|Phytoestrogens|phytoestrogens|mesh-ancestor
111325792|NCT01985763|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
111325793|NCT01985763|Estrogens|estrogens|mesh-ancestor
111325794|NCT01985763|Hormones|hormones|mesh-ancestor
111325795|NCT01985763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111325796|NCT02061969|Insulin Glargine|insulin glargine|mesh-list
111325797|NCT02061969|Linagliptin|linagliptin|mesh-list
111325798|NCT02061969|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111325799|NCT02061969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111325800|NCT02061969|Incretins|incretins|mesh-ancestor
111325801|NCT02061969|Hormones|hormones|mesh-ancestor
111325802|NCT02061969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111325803|NCT02061969|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111325804|NCT02061969|Protease Inhibitors|protease inhibitors|mesh-ancestor
111183956|NCT02543944|Clonidine|clonidine|mesh-list
111325805|NCT02061969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111325806|NCT02061969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111325807|NCT02003625|Meloxicam|meloxicam|mesh-list
111325808|NCT02003625|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111325809|NCT02003625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111325810|NCT02003625|Analgesics|analgesics|mesh-ancestor
111325811|NCT02003625|Sensory System Agents|sensory system agents|mesh-ancestor
111325812|NCT02003625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111325813|NCT02003625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111325814|NCT02003625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111325815|NCT02003625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111325816|NCT02003625|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111325817|NCT02003625|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111325818|NCT02003625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111325819|NCT02003625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111325820|NCT04037683|Misoprostol|misoprostol|mesh-list
111325821|NCT04037683|Oxytocin|oxytocin|mesh-list
111325822|NCT04037683|Oxytocics|oxytocics|mesh-ancestor
111325823|NCT04037683|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111325824|NCT04037683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111325825|NCT04037683|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111325826|NCT04037683|Abortifacient Agents|abortifacient agents|mesh-ancestor
111325827|NCT04037683|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111325828|NCT04037683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111325829|NCT04251247|Fibrin fragment D|fibrin fragment d|mesh-list
111325830|NCT04251247|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111325831|NCT04251247|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111325832|NCT04251247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111325833|NCT04251247|Hemostatics|hemostatics|mesh-ancestor
111325834|NCT04251247|Coagulants|coagulants|mesh-ancestor
111325835|NCT02396511|Bevacizumab|bevacizumab|mesh-list
111325836|NCT02396511|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111325837|NCT02396511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111325838|NCT02396511|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111325839|NCT02396511|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111325840|NCT02396511|Growth Substances|growth substances|mesh-ancestor
111325841|NCT02396511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111325842|NCT02396511|Growth Inhibitors|growth inhibitors|mesh-ancestor
111325843|NCT00816829|Fenofibrate|fenofibrate|mesh-list
111325844|NCT00816829|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111325845|NCT00816829|Antimetabolites|antimetabolites|mesh-ancestor
111325846|NCT00816829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111325847|NCT00816829|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111325848|NCT02062359|Aldesleukin|aldesleukin|mesh-list
111325849|NCT02062359|Cyclophosphamide|cyclophosphamide|mesh-list
111325850|NCT02062359|Fludarabine|fludarabine|mesh-list
111325851|NCT02062359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111325852|NCT02062359|Immunologic Factors|immunologic factors|mesh-ancestor
111325853|NCT02062359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111325854|NCT02062359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111325855|NCT02062359|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111325856|NCT02062359|Alkylating Agents|alkylating agents|mesh-ancestor
111325857|NCT02062359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111325858|NCT02062359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111325859|NCT02062359|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111325860|NCT02062359|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111325861|NCT02062359|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111325862|NCT02062359|Antiviral Agents|antiviral agents|mesh-ancestor
111325863|NCT02062359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111325864|NCT02397291|Inositol|inositol|mesh-list
111325865|NCT02397291|Vitamin B Complex|vitamin b complex|mesh-ancestor
111325866|NCT02397291|Vitamins|vitamins|mesh-ancestor
111325867|NCT02397291|Micronutrients|micronutrients|mesh-ancestor
111325868|NCT02397291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111325869|NCT00816907|Metformin|metformin|mesh-list
111325870|NCT00816907|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111325871|NCT00816907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111325872|NCT00817219|Betamethasone|betamethasone|mesh-list
111325873|NCT00817219|Betamethasone Valerate|betamethasone valerate|mesh-list
111325874|NCT00817219|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
111325875|NCT00817219|Betamethasone benzoate|betamethasone benzoate|mesh-list
111325876|NCT00817219|Calcipotriene|calcipotriene|mesh-list
111325877|NCT00817219|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
111184926|NCT04161664|Paclitaxel|paclitaxel|mesh-list
111325878|NCT00817219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111325879|NCT00817219|Glucocorticoids|glucocorticoids|mesh-ancestor
111325880|NCT00817219|Hormones|hormones|mesh-ancestor
111325881|NCT00817219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111325882|NCT00817219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111325883|NCT00817219|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111325884|NCT00817219|Respiratory System Agents|respiratory system agents|mesh-ancestor
111325885|NCT00817219|Dermatologic Agents|dermatologic agents|mesh-ancestor
111325886|NCT00817843|Simvastatin|simvastatin|mesh-list
111325887|NCT00817843|Ezetimibe|ezetimibe|mesh-list
111325888|NCT00817843|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111325889|NCT00817843|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111325890|NCT00817843|Antimetabolites|antimetabolites|mesh-ancestor
111325891|NCT00817843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111325892|NCT00817843|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111325893|NCT00817843|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111325894|NCT00817843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111325895|NCT00817999|Clopidogrel|clopidogrel|mesh-list
111325896|NCT00817999|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111325897|NCT00817999|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111325898|NCT00817999|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111325899|NCT00817999|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111325900|NCT00817999|Purinergic Agents|purinergic agents|mesh-ancestor
111325901|NCT00817999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111325902|NCT00817999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111325903|NCT00817999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111325904|NCT03839485|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111325905|NCT03839485|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
111185141|NCT04782310|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111325906|NCT03839485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111325907|NCT03839485|Antitubercular Agents|antitubercular agents|mesh-ancestor
111325908|NCT02008617|Bupivacaine|bupivacaine|mesh-list
111325909|NCT02008617|Anesthetics, Local|anesthetics, local|mesh-ancestor
111325910|NCT02008617|Anesthetics|anesthetics|mesh-ancestor
111325911|NCT02008617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111325912|NCT02008617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111325913|NCT02008617|Sensory System Agents|sensory system agents|mesh-ancestor
111325914|NCT02008617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111325915|NCT03839251|Aripiprazole|aripiprazole|mesh-list
111325916|NCT03839251|Antidepressive Agents|antidepressive agents|mesh-ancestor
111325917|NCT03839251|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111325918|NCT03839251|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111325919|NCT03839251|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111185276|NCT04779892|Infliximab|infliximab|mesh-list
111325920|NCT03839251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111325921|NCT03839251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111050315|NCT00317395|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111325922|NCT03839251|Dopamine Agonists|dopamine agonists|mesh-ancestor
111185344|NCT04769908|Lenvatinib|lenvatinib|mesh-list
111325923|NCT03839251|Dopamine Agents|dopamine agents|mesh-ancestor
111325924|NCT03839251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111325925|NCT03839251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111325926|NCT03839251|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111325927|NCT03839251|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111325928|NCT03839251|Serotonin Agents|serotonin agents|mesh-ancestor
111325929|NCT03839251|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111325930|NCT03839251|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111325931|NCT03839251|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111325932|NCT03839251|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111325933|NCT00819403|Simvastatin|simvastatin|mesh-list
111325934|NCT00819403|Ezetimibe|ezetimibe|mesh-list
111325935|NCT00819403|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
111325936|NCT00819403|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111325937|NCT00819403|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111325938|NCT00819403|Antimetabolites|antimetabolites|mesh-ancestor
111325939|NCT00819403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111325940|NCT00819403|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111325941|NCT00819403|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111325942|NCT00819403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111325943|NCT02010021|Letrozole|letrozole|mesh-list
111325944|NCT02010021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111325945|NCT02010021|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111325946|NCT02010021|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111325947|NCT02010021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111325948|NCT02010021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111325949|NCT02010021|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111325950|NCT02010021|Hormone Antagonists|hormone antagonists|mesh-ancestor
111325951|NCT02010021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111325952|NCT02010021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111325953|NCT02062905|Dexamethasone|dexamethasone|mesh-list
111325954|NCT02062905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111325955|NCT02062905|Antiemetics|antiemetics|mesh-ancestor
111325956|NCT02062905|Autonomic Agents|autonomic agents|mesh-ancestor
111325957|NCT02062905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111325958|NCT02062905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111325959|NCT02062905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111325960|NCT02062905|Glucocorticoids|glucocorticoids|mesh-ancestor
111325961|NCT02062905|Hormones|hormones|mesh-ancestor
111325962|NCT02062905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111325963|NCT02062905|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111325964|NCT02062905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111325965|NCT00820573|Metformin|metformin|mesh-list
111325966|NCT00820573|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111325967|NCT00820573|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111325968|NCT00820573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111325969|NCT00820573|Incretins|incretins|mesh-ancestor
111325970|NCT00820573|Hormones|hormones|mesh-ancestor
111325971|NCT00820573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111325972|NCT00820573|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111325973|NCT00820573|Protease Inhibitors|protease inhibitors|mesh-ancestor
111325974|NCT00820573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111325975|NCT00820573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111325976|NCT05217355|Botulinum Toxins|botulinum toxins|mesh-list
111325977|NCT05217355|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111325978|NCT05217355|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111325979|NCT05217355|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111325980|NCT05217355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111325981|NCT05217355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111325982|NCT05217355|Cholinergic Agents|cholinergic agents|mesh-ancestor
111325983|NCT05217355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111325984|NCT05217355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111325985|NCT05217355|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111325986|NCT05217355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111325987|NCT02010645|Decitabine|decitabine|mesh-list
111325988|NCT02010645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111325989|NCT02010645|Antimetabolites|antimetabolites|mesh-ancestor
111325990|NCT02010645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111325991|NCT02010645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111325992|NCT02010645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111325993|NCT02065479|Ticagrelor|ticagrelor|mesh-list
111325994|NCT02065479|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
111325995|NCT02065479|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111325996|NCT02065479|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111325997|NCT02065479|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111325998|NCT02065479|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111326000|NCT02065479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111326001|NCT02065479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111326002|NCT02065479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111326003|NCT05236621|Dexamethasone|dexamethasone|mesh-list
111326004|NCT05236621|Pomalidomide|pomalidomide|mesh-list
111326005|NCT05236621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111326006|NCT05236621|Antiemetics|antiemetics|mesh-ancestor
111326007|NCT05236621|Autonomic Agents|autonomic agents|mesh-ancestor
111185568|NCT00074308|Imatinib Mesylate|imatinib mesylate|mesh-list
111326008|NCT05236621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111326009|NCT05236621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111326010|NCT05236621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111326011|NCT05236621|Glucocorticoids|glucocorticoids|mesh-ancestor
111326012|NCT05236621|Hormones|hormones|mesh-ancestor
111326013|NCT05236621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111326014|NCT05236621|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111326015|NCT05236621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111326016|NCT05236621|Immunologic Factors|immunologic factors|mesh-ancestor
111326017|NCT05236621|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111326018|NCT05236621|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111326019|NCT05236621|Growth Substances|growth substances|mesh-ancestor
111326020|NCT05236621|Growth Inhibitors|growth inhibitors|mesh-ancestor
111326021|NCT02066727|Dexmedetomidine|dexmedetomidine|mesh-list
111326022|NCT02066727|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111326023|NCT02066727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111326024|NCT02066727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111326025|NCT02066727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111326026|NCT02066727|Analgesics|analgesics|mesh-ancestor
111326027|NCT02066727|Sensory System Agents|sensory system agents|mesh-ancestor
111326028|NCT02066727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111326029|NCT02066727|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111326030|NCT02066727|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111326031|NCT02066727|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111326032|NCT02066727|Adrenergic Agents|adrenergic agents|mesh-ancestor
111326033|NCT02066727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111326034|NCT02066727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111326035|NCT04349241|Favipiravir|favipiravir|mesh-list
111326036|NCT04349241|Antiviral Agents|antiviral agents|mesh-ancestor
111326037|NCT04349241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111326038|NCT02812615|Micronutrients|micronutrients|mesh-list
111326039|NCT02812615|Trace Elements|trace elements|mesh-list
111326040|NCT02812615|Albendazole|albendazole|mesh-list
111326041|NCT02812615|Pyrantel|pyrantel|mesh-list
111326042|NCT02812615|Pyrantel Pamoate|pyrantel pamoate|mesh-list
111326043|NCT02812615|Anthelmintics|anthelmintics|mesh-ancestor
111326044|NCT02812615|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111326045|NCT02812615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111326046|NCT02812615|Anticestodal Agents|anticestodal agents|mesh-ancestor
111326047|NCT02812615|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
111326048|NCT02812615|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111326049|NCT02812615|Tubulin Modulators|tubulin modulators|mesh-ancestor
111326050|NCT02812615|Antimitotic Agents|antimitotic agents|mesh-ancestor
111326051|NCT02812615|Mitosis Modulators|mitosis modulators|mesh-ancestor
111326052|NCT02812615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111326053|NCT02812615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111326054|NCT02812615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111326055|NCT02812615|Antinematodal Agents|antinematodal agents|mesh-ancestor
111326056|NCT02812615|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
111326057|NCT02812615|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
111326058|NCT02812615|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111326059|NCT02812615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111326060|NCT02151253|Modafinil|modafinil|mesh-list
111186194|NCT00194896|Glyburide|glyburide|mesh-list
111326061|NCT02151253|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111186251|NCT00201448|Vaccines|vaccines|mesh-list
111326062|NCT02151253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111326063|NCT02151253|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
111326064|NCT02151253|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111326065|NCT02151253|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111326066|NCT02151253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111326067|NCT02069847|Budesonide|budesonide|mesh-list
111050494|NCT03535415|Hormones|hormones|mesh-list
111326068|NCT02069847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111326069|NCT02069847|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111326070|NCT02069847|Autonomic Agents|autonomic agents|mesh-ancestor
111326071|NCT02069847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111326072|NCT02069847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111326073|NCT02069847|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111326074|NCT02069847|Respiratory System Agents|respiratory system agents|mesh-ancestor
111326075|NCT02069847|Glucocorticoids|glucocorticoids|mesh-ancestor
111326076|NCT02069847|Hormones|hormones|mesh-ancestor
111326077|NCT02069847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111326078|NCT02070237|Enoxaparin|enoxaparin|mesh-list
111326079|NCT02070237|Anticoagulants|anticoagulants|mesh-ancestor
111326080|NCT02070237|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111326081|NCT02070237|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111326082|NCT02070237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111326083|NCT02071095|Poly I-C|poly i-c|mesh-list
111326084|NCT02071095|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
111326085|NCT02071095|Poly ICLC|poly iclc|mesh-list
111326086|NCT02071095|Interferon Inducers|interferon inducers|mesh-ancestor
111326087|NCT02071095|Immunologic Factors|immunologic factors|mesh-ancestor
111326088|NCT02071095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111326089|NCT02071095|Laxatives|laxatives|mesh-ancestor
111326090|NCT02071095|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111326091|NCT02071095|Antiviral Agents|antiviral agents|mesh-ancestor
111326092|NCT02071095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111326093|NCT02348359|Ranibizumab|ranibizumab|mesh-list
111326094|NCT02348359|Aflibercept|aflibercept|mesh-list
111326095|NCT02348359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111326096|NCT02348359|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111326097|NCT02348359|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111326098|NCT02348359|Growth Substances|growth substances|mesh-ancestor
111326099|NCT02348359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111326100|NCT02348359|Growth Inhibitors|growth inhibitors|mesh-ancestor
111326101|NCT02406885|Apixaban|apixaban|mesh-list
111326102|NCT02406885|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111326103|NCT02406885|Antithrombins|antithrombins|mesh-ancestor
111326104|NCT02406885|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111326105|NCT02406885|Protease Inhibitors|protease inhibitors|mesh-ancestor
111326106|NCT02406885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111326107|NCT02406885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111326108|NCT02406885|Anticoagulants|anticoagulants|mesh-ancestor
111326109|NCT02408445|Methyltestosterone|methyltestosterone|mesh-list
111326110|NCT02408445|Testosterone|testosterone|mesh-list
111326111|NCT02408445|Testosterone undecanoate|testosterone undecanoate|mesh-list
111326112|NCT02408445|Testosterone enanthate|testosterone enanthate|mesh-list
111326113|NCT02408445|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
111326114|NCT02408445|Androgens|androgens|mesh-ancestor
111326115|NCT02408445|Hormones|hormones|mesh-ancestor
111326116|NCT02408445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111326117|NCT02408445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111326118|NCT02408445|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111326119|NCT02408445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111326120|NCT02408445|Anabolic Agents|anabolic agents|mesh-ancestor
111326121|NCT00388921|Vitamin A|vitamin a|mesh-list
111326122|NCT00388921|Vitamins|vitamins|mesh-ancestor
111326123|NCT00388921|Micronutrients|micronutrients|mesh-ancestor
111326124|NCT00388921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111326125|NCT02016885|Glycopyrrolate|glycopyrrolate|mesh-list
111326126|NCT02016885|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111326127|NCT02016885|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111326128|NCT02016885|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111326129|NCT02016885|Cholinergic Agents|cholinergic agents|mesh-ancestor
111326130|NCT02016885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111326131|NCT02016885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111186993|NCT05389722|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111326132|NCT02016885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111326133|NCT00142285|Zinc Sulfate|zinc sulfate|mesh-list
111326134|NCT00142285|Astringents|astringents|mesh-ancestor
111326135|NCT00142285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111187067|NCT05180357|Benralizumab|benralizumab|mesh-list
111326136|NCT00142285|Dermatologic Agents|dermatologic agents|mesh-ancestor
111326137|NCT02342379|Bevacizumab|bevacizumab|mesh-list
111326138|NCT02342379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111326139|NCT02342379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111326140|NCT02342379|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111326141|NCT02342379|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111326142|NCT02342379|Growth Substances|growth substances|mesh-ancestor
111326143|NCT02342379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111326144|NCT02342379|Growth Inhibitors|growth inhibitors|mesh-ancestor
111326145|NCT02019069|Cytarabine|cytarabine|mesh-list
111326146|NCT02019069|Daunorubicin|daunorubicin|mesh-list
111326147|NCT02019069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111326148|NCT02019069|Antimetabolites|antimetabolites|mesh-ancestor
111326149|NCT02019069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111326150|NCT02019069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111326151|NCT02019069|Antiviral Agents|antiviral agents|mesh-ancestor
111326152|NCT02019069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111326153|NCT02019069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111187283|NCT04792385|Diuretics|diuretics|mesh-ancestor
111326154|NCT02019069|Immunologic Factors|immunologic factors|mesh-ancestor
111326155|NCT02019069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111187345|NCT04604067|Acalabrutinib|acalabrutinib|mesh-list
111326156|NCT02019069|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111326157|NCT02019069|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111326158|NCT02019069|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111326159|NCT02019069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111326160|NCT00821821|Edaravone|edaravone|mesh-list
111326161|NCT00821821|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111326162|NCT00821821|Antioxidants|antioxidants|mesh-ancestor
111326163|NCT00821821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111326164|NCT00821821|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111326165|NCT00821821|Protective Agents|protective agents|mesh-ancestor
111326166|NCT00821821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111326167|NCT00816751|Lidocaine|lidocaine|mesh-list
111326168|NCT00816751|Vasopressins|vasopressins|mesh-list
111326169|NCT00816751|Arginine Vasopressin|arginine vasopressin|mesh-list
111326170|NCT00816751|Anesthetics, Local|anesthetics, local|mesh-ancestor
111326171|NCT00816751|Anesthetics|anesthetics|mesh-ancestor
111187629|NCT03935958|Curcumin|curcumin|mesh-list
111326172|NCT00816751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111187699|NCT03841097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111326173|NCT00816751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111326174|NCT00816751|Sensory System Agents|sensory system agents|mesh-ancestor
111326175|NCT00816751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111187774|NCT03699631|Methotrexate|methotrexate|mesh-list
111326176|NCT00816751|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111326177|NCT00816751|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111326178|NCT00816751|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111326179|NCT00816751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111187844|NCT03530124|Vaccines|vaccines|mesh-list
111326180|NCT00816751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111326181|NCT00816751|Hemostatics|hemostatics|mesh-ancestor
111326182|NCT00816751|Coagulants|coagulants|mesh-ancestor
111326183|NCT00816751|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111326184|NCT00816751|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
111326185|NCT00816751|Natriuretic Agents|natriuretic agents|mesh-ancestor
111326186|NCT00822523|Botulinum Toxins|botulinum toxins|mesh-list
111326187|NCT00822523|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111326188|NCT00822523|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111326189|NCT00822523|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111326190|NCT00822523|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111326191|NCT00822523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111326192|NCT00822523|Cholinergic Agents|cholinergic agents|mesh-ancestor
111326193|NCT00822523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111326194|NCT00822523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111326195|NCT00822523|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111326196|NCT00822523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111326197|NCT02410707|Nitrous Oxide|nitrous oxide|mesh-list
111326198|NCT02410707|Propofol|propofol|mesh-list
111326199|NCT02410707|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111326200|NCT02410707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111326201|NCT02410707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111187981|NCT03060434|Acetaminophen|acetaminophen|mesh-list
111326202|NCT02410707|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111326203|NCT02410707|Anesthetics, General|anesthetics, general|mesh-ancestor
111326204|NCT02410707|Anesthetics|anesthetics|mesh-ancestor
111326205|NCT02410707|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111326206|NCT02410707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111326207|NCT02410707|Analgesics|analgesics|mesh-ancestor
111326208|NCT02410707|Sensory System Agents|sensory system agents|mesh-ancestor
111326209|NCT02410707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111326210|NCT02343081|Temozolomide|temozolomide|mesh-list
111326211|NCT02343081|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111326212|NCT02343081|Alkylating Agents|alkylating agents|mesh-ancestor
111326213|NCT02343081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111326214|NCT02343081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111326215|NCT00823303|Calcitriol|calcitriol|mesh-list
111326216|NCT00823303|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111326217|NCT00823303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111326218|NCT00823303|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
111326219|NCT00823303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111050618|NCT00004231|Antimetabolites|antimetabolites|mesh-ancestor
111188113|NCT02444429|Hormones|hormones|mesh-ancestor
111326220|NCT00823303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111326222|NCT00823303|Vitamins|vitamins|mesh-ancestor
111326223|NCT00823303|Micronutrients|micronutrients|mesh-ancestor
111326224|NCT00823303|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111326225|NCT00823459|Everolimus|everolimus|mesh-list
111326226|NCT00823459|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111188173|NCT06018337|Antimetabolites|antimetabolites|mesh-ancestor
111326227|NCT00823459|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111326228|NCT00823459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111326229|NCT00823459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111326230|NCT00823459|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111326231|NCT00823459|Immunologic Factors|immunologic factors|mesh-ancestor
111188241|NCT06017284|Antimetabolites|antimetabolites|mesh-ancestor
111326232|NCT00823459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111326233|NCT00823459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111326234|NCT00825565|Allantoin|allantoin|mesh-list
111326235|NCT00825565|Dermatologic Agents|dermatologic agents|mesh-ancestor
111326236|NCT00803647|Leucovorin|leucovorin|mesh-list
111326237|NCT00803647|Fluorouracil|fluorouracil|mesh-list
111326238|NCT00803647|Oxaliplatin|oxaliplatin|mesh-list
111326239|NCT00803647|Cetuximab|cetuximab|mesh-list
111326240|NCT00803647|Antimetabolites|antimetabolites|mesh-ancestor
111326241|NCT00803647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111188384|NCT05936086|Cyclosporine|cyclosporine|mesh-list
111326242|NCT00803647|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111326243|NCT00803647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111326244|NCT00803647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111326245|NCT00803647|Immunologic Factors|immunologic factors|mesh-ancestor
111326246|NCT00803647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111326247|NCT00803647|Antidotes|antidotes|mesh-ancestor
111188454|NCT05873712|Fludarabine|fludarabine|mesh-list
111326248|NCT00803647|Protective Agents|protective agents|mesh-ancestor
111326249|NCT00803647|Vitamin B Complex|vitamin b complex|mesh-ancestor
111326250|NCT00803647|Vitamins|vitamins|mesh-ancestor
111326251|NCT00803647|Micronutrients|micronutrients|mesh-ancestor
111326252|NCT00803647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111326253|NCT00827983|Progesterone|progesterone|mesh-list
111326254|NCT00827983|Progestins|progestins|mesh-ancestor
111326255|NCT00827983|Hormones|hormones|mesh-ancestor
111326256|NCT00827983|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111326257|NCT00827983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111326258|NCT02346903|Capsaicin|capsaicin|mesh-list
111326259|NCT02346903|Antipruritics|antipruritics|mesh-ancestor
111326260|NCT02346903|Dermatologic Agents|dermatologic agents|mesh-ancestor
111326261|NCT02346903|Sensory System Agents|sensory system agents|mesh-ancestor
111326262|NCT02346903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111326263|NCT02346903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111326264|NCT02347605|Nicotine|nicotine|mesh-list
111326265|NCT02347605|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111326266|NCT02347605|Autonomic Agents|autonomic agents|mesh-ancestor
111326267|NCT02347605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111326268|NCT02347605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111326269|NCT02347605|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111326270|NCT02347605|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111326271|NCT02347605|Cholinergic Agents|cholinergic agents|mesh-ancestor
111326272|NCT02347605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111326273|NCT02347605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111326274|NCT02153671|Vaccines|vaccines|mesh-list
111326275|NCT02153671|Immunologic Factors|immunologic factors|mesh-ancestor
111326276|NCT02153671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111326277|NCT02413203|Celecoxib|celecoxib|mesh-list
111326278|NCT02413203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111326279|NCT02413203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111326280|NCT02413203|Analgesics|analgesics|mesh-ancestor
111326281|NCT02413203|Sensory System Agents|sensory system agents|mesh-ancestor
111326282|NCT02413203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111326283|NCT02413203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111326284|NCT02413203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111326285|NCT02413203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111326286|NCT02413203|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111326287|NCT02413203|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111326288|NCT02413203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111326289|NCT02413203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111326290|NCT02153983|Colchicine|colchicine|mesh-list
111326291|NCT02153983|Gout Suppressants|gout suppressants|mesh-ancestor
111188800|NCT05421065|Hallucinogens|hallucinogens|mesh-ancestor
111326292|NCT02153983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111326293|NCT02153983|Tubulin Modulators|tubulin modulators|mesh-ancestor
111326294|NCT02153983|Antimitotic Agents|antimitotic agents|mesh-ancestor
111326295|NCT02153983|Mitosis Modulators|mitosis modulators|mesh-ancestor
111326296|NCT02153983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111326297|NCT02153983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111326298|NCT02348775|Acetylcysteine|acetylcysteine|mesh-list
111326299|NCT02348775|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111326300|NCT02348775|Glycine|glycine|mesh-list
111326301|NCT02348775|Antiviral Agents|antiviral agents|mesh-ancestor
111326302|NCT02348775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111326303|NCT02348775|Expectorants|expectorants|mesh-ancestor
111326304|NCT02348775|Respiratory System Agents|respiratory system agents|mesh-ancestor
111326305|NCT02348775|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111326306|NCT02348775|Antioxidants|antioxidants|mesh-ancestor
111326307|NCT02348775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111326308|NCT02348775|Protective Agents|protective agents|mesh-ancestor
111326309|NCT02348775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111326310|NCT02348775|Antidotes|antidotes|mesh-ancestor
111326311|NCT02348775|Glycine Agents|glycine agents|mesh-ancestor
111326312|NCT02348775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111326313|NCT00828061|Prednisone|prednisone|mesh-list
111326314|NCT00828061|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111326315|NCT00828061|Glucocorticoids|glucocorticoids|mesh-ancestor
111326316|NCT00828061|Hormones|hormones|mesh-ancestor
111326317|NCT00828061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111326318|NCT00828061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111326319|NCT00828061|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111326320|NCT00828061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111326321|NCT00849121|Vaccines|vaccines|mesh-list
111326322|NCT00849121|Immunologic Factors|immunologic factors|mesh-ancestor
111326323|NCT00849121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111326324|NCT02023125|Esomeprazole|esomeprazole|mesh-list
111326325|NCT02023125|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111326326|NCT02023125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111326327|NCT02023125|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111326328|NCT02023125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111326329|NCT02023125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111326330|NCT02349477|Gabapentin|gabapentin|mesh-list
111326331|NCT02349477|Analgesics|analgesics|mesh-ancestor
111326332|NCT02349477|Sensory System Agents|sensory system agents|mesh-ancestor
111326333|NCT02349477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111326334|NCT02349477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111326335|NCT02349477|Anticonvulsants|anticonvulsants|mesh-ancestor
111326336|NCT02349477|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111326337|NCT02349477|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111326338|NCT02349477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111326339|NCT02349477|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111326340|NCT02349477|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111326341|NCT02349477|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111326342|NCT02349477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111326343|NCT02349477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111326344|NCT02349477|Antimanic Agents|antimanic agents|mesh-ancestor
111326345|NCT00828295|Palonosetron|palonosetron|mesh-list
111326346|NCT00828295|Antiemetics|antiemetics|mesh-ancestor
111326347|NCT00828295|Autonomic Agents|autonomic agents|mesh-ancestor
111326348|NCT00828295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111326349|NCT00828295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111326350|NCT00828295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111326351|NCT00828295|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111326352|NCT00828295|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111326353|NCT00828295|Serotonin Agents|serotonin agents|mesh-ancestor
111326354|NCT00828295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111326355|NCT00828295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111326356|NCT02350569|Sofosbuvir|sofosbuvir|mesh-list
111326357|NCT02350569|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
111326358|NCT02350569|Ledipasvir|ledipasvir|mesh-list
111326359|NCT02350569|Antiviral Agents|antiviral agents|mesh-ancestor
111326360|NCT02350569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111326361|NCT02351115|Alprazolam|alprazolam|mesh-list
111326362|NCT02351115|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111326363|NCT02351115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111326364|NCT02351115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111326365|NCT02351115|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111326366|NCT02351115|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111326367|NCT02351115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111326368|NCT02351115|GABA Modulators|gaba modulators|mesh-ancestor
111326369|NCT02351115|GABA Agents|gaba agents|mesh-ancestor
111326370|NCT02351115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111326371|NCT02351115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111326373|NCT02025075|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
111326374|NCT02025075|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
111326375|NCT02025075|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111326376|NCT02025075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111326377|NCT02025075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111326378|NCT00242567|Zoledronic Acid|zoledronic acid|mesh-list
111326379|NCT00242567|Androgens|androgens|mesh-list
111326380|NCT00242567|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111326381|NCT00242567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111326382|NCT00242567|Hormones|hormones|mesh-ancestor
111189292|NCT04318678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111326383|NCT00242567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111326384|NCT00241631|Fluticasone|fluticasone|mesh-list
111326385|NCT00241631|Xhance|xhance|mesh-list
111326386|NCT00241631|Theophylline|theophylline|mesh-list
111326387|NCT00241631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111326388|NCT00241631|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111326389|NCT00241631|Autonomic Agents|autonomic agents|mesh-ancestor
111326390|NCT00241631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111326391|NCT00241631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111326392|NCT00241631|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111326393|NCT00241631|Respiratory System Agents|respiratory system agents|mesh-ancestor
111326394|NCT00241631|Dermatologic Agents|dermatologic agents|mesh-ancestor
111326395|NCT00241631|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111326396|NCT00241631|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111326397|NCT00241631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111326398|NCT00241631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111326399|NCT00241631|Vasodilator Agents|vasodilator agents|mesh-ancestor
111326400|NCT00241631|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
111326401|NCT00241631|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111326402|NCT00241631|Purinergic Agents|purinergic agents|mesh-ancestor
111326403|NCT00241631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111326404|NCT02351739|Pembrolizumab|pembrolizumab|mesh-list
111326405|NCT02351739|Acalabrutinib|acalabrutinib|mesh-list
111326406|NCT02351739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111326407|NCT02351739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111326408|NCT02351739|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111326409|NCT02351739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111326410|NCT00240071|Tamoxifen|tamoxifen|mesh-list
111326411|NCT00240071|Bevacizumab|bevacizumab|mesh-list
111326412|NCT00240071|Letrozole|letrozole|mesh-list
111326413|NCT00240071|Exemestane|exemestane|mesh-list
111326414|NCT00240071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111326415|NCT00240071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111189708|NCT03012321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111326416|NCT00240071|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111326417|NCT00240071|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111189781|NCT02227199|Immunotoxins|immunotoxins|mesh-ancestor
111326418|NCT00240071|Growth Substances|growth substances|mesh-ancestor
111326419|NCT00240071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111326420|NCT00240071|Growth Inhibitors|growth inhibitors|mesh-ancestor
111326421|NCT00240071|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111326422|NCT00240071|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111326423|NCT00240071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111326424|NCT00240071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111326425|NCT00240071|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111326426|NCT00240071|Hormone Antagonists|hormone antagonists|mesh-ancestor
111326427|NCT00240071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111326428|NCT00240071|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111326429|NCT00240071|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111326430|NCT00240071|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111326431|NCT00240071|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111326432|NCT02352363|Levodopa|levodopa|mesh-list
111326433|NCT02352363|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111326434|NCT02352363|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111326435|NCT02352363|Dopamine Agents|dopamine agents|mesh-ancestor
111326436|NCT02352363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111326437|NCT02352363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111326438|NCT02352363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111326439|NCT00765947|Amlodipine|amlodipine|mesh-list
111326440|NCT00765947|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
111326441|NCT00765947|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111189922|NCT00679042|Antifungal Agents|antifungal agents|mesh-ancestor
111326442|NCT00765947|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111326443|NCT00765947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111326444|NCT00765947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111326445|NCT00765947|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111326446|NCT00765947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111326447|NCT00765947|Vasodilator Agents|vasodilator agents|mesh-ancestor
111326448|NCT00765947|Diuretics|diuretics|mesh-ancestor
111326449|NCT00765947|Natriuretic Agents|natriuretic agents|mesh-ancestor
111326450|NCT00765947|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
111326451|NCT05743907|Dapagliflozin|dapagliflozin|mesh-list
111326452|NCT05743907|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111326453|NCT05743907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111326454|NCT05743907|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111326455|NCT05743907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111326456|NCT00766649|Sirolimus|sirolimus|mesh-list
111326457|NCT00766649|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111326458|NCT00766649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111326459|NCT00766649|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111326460|NCT00766649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111326461|NCT00766649|Antifungal Agents|antifungal agents|mesh-ancestor
111326462|NCT00766649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111326463|NCT00766649|Immunologic Factors|immunologic factors|mesh-ancestor
111326464|NCT00766649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111326465|NCT02352831|Capecitabine|capecitabine|mesh-list
111326466|NCT02352831|Tosedostat|tosedostat|mesh-list
111326467|NCT02352831|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111326468|NCT02352831|Antimetabolites|antimetabolites|mesh-ancestor
111326469|NCT02352831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111326470|NCT02352831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111326471|NCT02352831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111326472|NCT02353299|Zolpidem|zolpidem|mesh-list
111326473|NCT02353299|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111326474|NCT02353299|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111326475|NCT02353299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111326476|NCT02353299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111326477|NCT02353299|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
111326478|NCT02353299|GABA Agonists|gaba agonists|mesh-ancestor
111326479|NCT02353299|GABA Agents|gaba agents|mesh-ancestor
111326480|NCT02353299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111326481|NCT02353299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111326482|NCT00756977|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
111326483|NCT00756977|Laxatives|laxatives|mesh-ancestor
111326484|NCT00756977|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111326485|NCT03808961|Vitamins|vitamins|mesh-list
111326486|NCT03808961|Niacin|niacin|mesh-list
111326487|NCT03808961|Niacinamide|niacinamide|mesh-list
111326488|NCT03808961|Nicotinic Acids|nicotinic acids|mesh-list
111326489|NCT03808961|Vitamin B Complex|vitamin b complex|mesh-list
111326490|NCT03808961|Micronutrients|micronutrients|mesh-ancestor
111326491|NCT03808961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111326492|NCT03808961|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111326493|NCT03808961|Antimetabolites|antimetabolites|mesh-ancestor
111326494|NCT03808961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111326495|NCT03808961|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111326496|NCT03808961|Vasodilator Agents|vasodilator agents|mesh-ancestor
111326497|NCT00783965|Tazarotene|tazarotene|mesh-list
111326498|NCT00783965|Dermatologic Agents|dermatologic agents|mesh-ancestor
111326499|NCT00783965|Keratolytic Agents|keratolytic agents|mesh-ancestor
111326500|NCT02354859|Gallium nitrate|gallium nitrate|mesh-list
111326501|NCT02354859|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111326502|NCT02354859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111326503|NCT02354859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111326504|NCT00421551|Ritonavir|ritonavir|mesh-list
111326505|NCT00421551|Darunavir|darunavir|mesh-list
111326506|NCT00421551|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111326507|NCT00421551|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111326508|NCT00421551|Protease Inhibitors|protease inhibitors|mesh-ancestor
111326509|NCT00421551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111326510|NCT00421551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111326511|NCT00421551|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111326512|NCT00421551|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111326513|NCT00421551|Antiviral Agents|antiviral agents|mesh-ancestor
111326514|NCT00421551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111326515|NCT00421551|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111326516|NCT00421551|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111326517|NCT02356107|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
111326518|NCT02356107|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111326519|NCT02356107|Antidepressive Agents|antidepressive agents|mesh-ancestor
111326520|NCT02356107|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111326521|NCT00767507|Cangrelor|cangrelor|mesh-list
111326522|NCT00767507|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111326523|NCT00767507|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111326524|NCT00767507|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111326525|NCT00767507|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111326526|NCT00767507|Purinergic Agents|purinergic agents|mesh-ancestor
111326527|NCT00767507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111326528|NCT00767507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111326529|NCT00767507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111326530|NCT02029755|Anesthetics|anesthetics|mesh-list
111326531|NCT02029755|Anesthetics, Local|anesthetics, local|mesh-list
111326532|NCT02029755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111326533|NCT02029755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111326534|NCT02029755|Sensory System Agents|sensory system agents|mesh-ancestor
111326535|NCT02029755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111326536|NCT03804749|Suramin|suramin|mesh-list
111326537|NCT03804749|Antinematodal Agents|antinematodal agents|mesh-ancestor
111326538|NCT03804749|Anthelmintics|anthelmintics|mesh-ancestor
111326539|NCT03804749|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111326540|NCT03804749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111326541|NCT03804749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111326542|NCT03804749|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
111326543|NCT03804749|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111326544|NCT02312739|Ketorolac|ketorolac|mesh-list
111191178|NCT02100826|Cephalexin|cephalexin|mesh-list
111326545|NCT02312739|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
111326546|NCT02312739|Nitrous Oxide|nitrous oxide|mesh-list
111326547|NCT02312739|Analgesics|analgesics|mesh-list
111326548|NCT02312739|Lorazepam|lorazepam|mesh-list
111326549|NCT02312739|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111326550|NCT02312739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111191245|NCT05267392|Durvalumab|durvalumab|mesh-list
111326551|NCT02312739|Sensory System Agents|sensory system agents|mesh-ancestor
111326552|NCT02312739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111326553|NCT02312739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111326554|NCT02312739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111326555|NCT02312739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111326556|NCT02312739|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111326557|NCT02312739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111326558|NCT02312739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111326559|NCT02312739|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111326560|NCT02312739|Anesthetics, General|anesthetics, general|mesh-ancestor
111326561|NCT02312739|Anesthetics|anesthetics|mesh-ancestor
111326562|NCT02312739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111326563|NCT02312739|Anticonvulsants|anticonvulsants|mesh-ancestor
111326564|NCT02312739|Antiemetics|antiemetics|mesh-ancestor
111326565|NCT02312739|Autonomic Agents|autonomic agents|mesh-ancestor
111326566|NCT02312739|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111326567|NCT02312739|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111326568|NCT02312739|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111326569|NCT02312739|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111326570|NCT02312739|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111326571|NCT02312739|GABA Modulators|gaba modulators|mesh-ancestor
111326572|NCT02312739|GABA Agents|gaba agents|mesh-ancestor
111326573|NCT02312739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111326574|NCT02351037|Azacitidine|azacitidine|mesh-list
111326575|NCT02351037|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111326576|NCT02351037|Antimetabolites|antimetabolites|mesh-ancestor
111326577|NCT02351037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111326578|NCT02351037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111326579|NCT02351037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111326580|NCT05718609|Amoxicillin|amoxicillin|mesh-list
111326581|NCT05718609|Clarithromycin|clarithromycin|mesh-list
111326582|NCT05718609|Furazolidone|furazolidone|mesh-list
111326583|NCT05718609|Rabeprazole|rabeprazole|mesh-list
111326584|NCT05718609|Bismuth|bismuth|mesh-list
111326585|NCT05718609|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111326586|NCT05718609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111326587|NCT05718609|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111326588|NCT05718609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111326589|NCT05718609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111326590|NCT05718609|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111326591|NCT05718609|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111326592|NCT05718609|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111326593|NCT05718609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111050994|NCT05724745|Albuterol|albuterol|mesh-list
111050995|NCT05724745|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111050996|NCT05724745|Autonomic Agents|autonomic agents|mesh-ancestor
111050999|NCT05724745|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111326594|NCT05718609|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111326595|NCT05718609|Antacids|antacids|mesh-ancestor
111326596|NCT05718609|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111326597|NCT05718609|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111326598|NCT05718609|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
111326599|NCT05718609|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111326600|NCT05718609|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111326601|NCT05718609|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
111326602|NCT02359305|Acetaminophen|acetaminophen|mesh-list
111326603|NCT02359305|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111326604|NCT02359305|Analgesics|analgesics|mesh-ancestor
111326605|NCT02359305|Sensory System Agents|sensory system agents|mesh-ancestor
111326606|NCT02359305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111326607|NCT02359305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111326608|NCT02359305|Antipyretics|antipyretics|mesh-ancestor
111326609|NCT02360319|Aripiprazole|aripiprazole|mesh-list
111326610|NCT02360319|Antipsychotic Agents|antipsychotic agents|mesh-list
111326611|NCT02360319|Antidepressive Agents|antidepressive agents|mesh-ancestor
111326612|NCT02360319|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111326613|NCT02360319|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111326614|NCT02360319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111326615|NCT02360319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111326616|NCT02360319|Dopamine Agonists|dopamine agonists|mesh-ancestor
111326617|NCT02360319|Dopamine Agents|dopamine agents|mesh-ancestor
111326618|NCT02360319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110908692|NCT02916927|Ketamine|ketamine|mesh-list
111326619|NCT02360319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111326620|NCT02360319|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111326621|NCT02360319|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111326622|NCT02360319|Serotonin Agents|serotonin agents|mesh-ancestor
111326623|NCT02360319|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111326624|NCT02360319|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111326625|NCT02360319|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111326626|NCT02360319|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111326627|NCT05718531|Aspirin|aspirin|mesh-list
111326628|NCT05718531|Rivaroxaban|rivaroxaban|mesh-list
111326629|NCT05718531|Clopidogrel|clopidogrel|mesh-list
111326630|NCT05718531|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111326631|NCT05718531|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111326632|NCT05718531|Analgesics|analgesics|mesh-ancestor
111326633|NCT05718531|Sensory System Agents|sensory system agents|mesh-ancestor
111191597|NCT01466673|Moxifloxacin|moxifloxacin|mesh-list
111326634|NCT05718531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111326635|NCT05718531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111326636|NCT05718531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111326637|NCT05718531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111326638|NCT05718531|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111326639|NCT05718531|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111326640|NCT05718531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111326641|NCT05718531|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111326642|NCT05718531|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111326643|NCT05718531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111326644|NCT05718531|Antipyretics|antipyretics|mesh-ancestor
111326645|NCT05718531|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111326646|NCT05718531|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111326647|NCT05718531|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111326648|NCT05718531|Purinergic Agents|purinergic agents|mesh-ancestor
111326649|NCT05718531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111326650|NCT05718531|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111326651|NCT05718531|Antithrombins|antithrombins|mesh-ancestor
111326652|NCT05718531|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111326653|NCT05718531|Protease Inhibitors|protease inhibitors|mesh-ancestor
111326654|NCT05718531|Anticoagulants|anticoagulants|mesh-ancestor
111326655|NCT02360631|Varenicline|varenicline|mesh-list
111326656|NCT02360631|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111326657|NCT02360631|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111326658|NCT02360631|Cholinergic Agents|cholinergic agents|mesh-ancestor
111326659|NCT02360631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111326660|NCT02360631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111191790|NCT01752842|Fenofibrate|fenofibrate|mesh-list
111326661|NCT02360631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111326662|NCT00355095|Epoetin Alfa|epoetin alfa|mesh-list
111326663|NCT00355095|Hematinics|hematinics|mesh-ancestor
111326664|NCT02366871|Enoxaparin|enoxaparin|mesh-list
111326665|NCT02366871|Apixaban|apixaban|mesh-list
111326666|NCT02366871|Anticoagulants|anticoagulants|mesh-ancestor
111191856|NCT00318136|Paclitaxel|paclitaxel|mesh-list
111326667|NCT02366871|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111326668|NCT02366871|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111326669|NCT02366871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111326670|NCT02366871|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111326671|NCT02366871|Antithrombins|antithrombins|mesh-ancestor
111191932|NCT00352612|Cephalexin|cephalexin|mesh-list
111326672|NCT02366871|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111326673|NCT02366871|Protease Inhibitors|protease inhibitors|mesh-ancestor
111326674|NCT02366871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111326675|NCT02368431|Zonisamide|zonisamide|mesh-list
111326676|NCT02368431|Anticonvulsants|anticonvulsants|mesh-ancestor
111326677|NCT02368431|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111326678|NCT02368431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111326679|NCT02368431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111326680|NCT02368431|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111326681|NCT02368431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111326682|NCT03836651|Antioxidants|antioxidants|mesh-list
111326683|NCT03836651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111326684|NCT03836651|Protective Agents|protective agents|mesh-ancestor
111326685|NCT03836651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111326686|NCT02037555|Antithrombins|antithrombins|mesh-list
111326687|NCT02037555|Antithrombin III|antithrombin iii|mesh-list
111326688|NCT02037555|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111326689|NCT02037555|Protease Inhibitors|protease inhibitors|mesh-ancestor
111191993|NCT00392704|Paclitaxel|paclitaxel|mesh-list
111326690|NCT02037555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111326691|NCT02037555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111326692|NCT02037555|Anticoagulants|anticoagulants|mesh-ancestor
111326693|NCT03804359|Rituximab|rituximab|mesh-list
111326694|NCT03804359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111326695|NCT03804359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111326696|NCT03804359|Immunologic Factors|immunologic factors|mesh-ancestor
111326697|NCT03804359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111326698|NCT03804359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111326699|NCT02369211|Acetaminophen|acetaminophen|mesh-list
111326700|NCT02369211|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111326701|NCT02369211|Analgesics|analgesics|mesh-ancestor
111326702|NCT02369211|Sensory System Agents|sensory system agents|mesh-ancestor
111326703|NCT02369211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111326704|NCT02369211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111326705|NCT02369211|Antipyretics|antipyretics|mesh-ancestor
111326706|NCT02038023|Iron|iron|mesh-list
111326707|NCT02038023|Dextrans|dextrans|mesh-list
111326708|NCT02038023|Iron-Dextran Complex|iron-dextran complex|mesh-list
111326709|NCT02038023|Trace Elements|trace elements|mesh-ancestor
111326710|NCT02038023|Micronutrients|micronutrients|mesh-ancestor
111326711|NCT02038023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111326712|NCT02038023|Anticoagulants|anticoagulants|mesh-ancestor
111326713|NCT02038023|Plasma Substitutes|plasma substitutes|mesh-ancestor
111326714|NCT02038023|Blood Substitutes|blood substitutes|mesh-ancestor
111326715|NCT02038023|Hematinics|hematinics|mesh-ancestor
111326716|NCT04384133|Nitric Oxide|nitric oxide|mesh-list
111326717|NCT04384133|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111326718|NCT04384133|Autonomic Agents|autonomic agents|mesh-ancestor
111326719|NCT04384133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111326720|NCT04384133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111326721|NCT04384133|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111326722|NCT04384133|Respiratory System Agents|respiratory system agents|mesh-ancestor
111326723|NCT04384133|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111326724|NCT04384133|Antioxidants|antioxidants|mesh-ancestor
111326725|NCT04384133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111326726|NCT04384133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111326727|NCT04384133|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
111326728|NCT04384133|Vasodilator Agents|vasodilator agents|mesh-ancestor
111326729|NCT04384133|Gasotransmitters|gasotransmitters|mesh-ancestor
111326730|NCT04384133|Protective Agents|protective agents|mesh-ancestor
111326731|NCT02038179|Allopurinol|allopurinol|mesh-list
111326732|NCT02038179|Antimetabolites|antimetabolites|mesh-ancestor
111326733|NCT02038179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111326734|NCT02038179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111326735|NCT02038179|Gout Suppressants|gout suppressants|mesh-ancestor
111326736|NCT02038179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111326737|NCT02038179|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111326738|NCT02038179|Antioxidants|antioxidants|mesh-ancestor
111326739|NCT02038179|Protective Agents|protective agents|mesh-ancestor
111326740|NCT02038179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111326741|NCT02369835|Sodium Hypochlorite|sodium hypochlorite|mesh-list
111326742|NCT02369835|Eusol|eusol|mesh-list
111326743|NCT02369835|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111326744|NCT02369835|Disinfectants|disinfectants|mesh-ancestor
111051149|NCT04547049|Cytarabine|cytarabine|mesh-list
111326745|NCT02369835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111326746|NCT00768521|Tolterodine Tartrate|tolterodine tartrate|mesh-list
111326747|NCT00768521|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111326748|NCT00768521|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111192292|NCT01416441|Aripiprazole|aripiprazole|mesh-list
111326749|NCT00768521|Cholinergic Agents|cholinergic agents|mesh-ancestor
111192370|NCT01793272|Antioxidants|antioxidants|mesh-ancestor
111326750|NCT00768521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111326751|NCT00768521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111192442|NCT04749940|Laxatives|laxatives|mesh-ancestor
111326752|NCT00768521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111326753|NCT00768521|Urological Agents|urological agents|mesh-ancestor
111326754|NCT00768599|Econazole|econazole|mesh-list
111326755|NCT00768599|Antifungal Agents|antifungal agents|mesh-ancestor
111326756|NCT00768599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111326757|NCT00768599|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111326758|NCT00768599|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111326759|NCT00768599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111326760|NCT00768599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111326761|NCT00768599|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111326762|NCT00768599|Hormone Antagonists|hormone antagonists|mesh-ancestor
111326763|NCT00768599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111326764|NCT00768599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111326765|NCT02370693|Mycophenolic Acid|mycophenolic acid|mesh-list
111326766|NCT02370693|Bortezomib|bortezomib|mesh-list
111326767|NCT02370693|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111326768|NCT02370693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111326769|NCT02370693|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111326770|NCT02370693|Antitubercular Agents|antitubercular agents|mesh-ancestor
111326771|NCT02370693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111326772|NCT02370693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111326773|NCT02370693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111326774|NCT02370693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111326775|NCT02039115|Prednisone|prednisone|mesh-list
111326776|NCT02039115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111326777|NCT02039115|Glucocorticoids|glucocorticoids|mesh-ancestor
111326778|NCT02039115|Hormones|hormones|mesh-ancestor
111192508|NCT02112370|Epinephrine|epinephrine|mesh-list
111326779|NCT02039115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111192556|NCT00428584|Interferon-beta|interferon-beta|mesh-list
111326780|NCT02039115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111326781|NCT02039115|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111326782|NCT02039115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111326783|NCT00759473|Cycloserine|cycloserine|mesh-list
111326784|NCT00759473|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111326785|NCT00759473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111326786|NCT00759473|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111326787|NCT00759473|Antitubercular Agents|antitubercular agents|mesh-ancestor
111326788|NCT00759473|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111326789|NCT00759473|Antimetabolites|antimetabolites|mesh-ancestor
111326790|NCT00759473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111326791|NCT00759707|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
111326792|NCT00759707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111326793|NCT00759707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111326794|NCT03809273|Trimetazidine|trimetazidine|mesh-list
111326795|NCT03809273|Vasodilator Agents|vasodilator agents|mesh-ancestor
111326796|NCT04384991|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111326797|NCT04384991|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111326798|NCT00354627|Etravirine|etravirine|mesh-list
111326799|NCT00354627|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111326800|NCT00354627|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111326801|NCT00354627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111326802|NCT00354627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111326803|NCT00354627|Antiviral Agents|antiviral agents|mesh-ancestor
111326804|NCT00354627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111326805|NCT00770861|Nebivolol|nebivolol|mesh-list
111326806|NCT00770861|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111326807|NCT00770861|Vasodilator Agents|vasodilator agents|mesh-ancestor
111326808|NCT00770861|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
111326809|NCT00770861|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111326810|NCT00770861|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111326811|NCT00770861|Adrenergic Agents|adrenergic agents|mesh-ancestor
111326812|NCT00770861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111326813|NCT00770861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111326814|NCT00770861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111326815|NCT03808805|Aprepitant|aprepitant|mesh-list
111326816|NCT03808805|Fosaprepitant|fosaprepitant|mesh-list
111326817|NCT03808805|Hydroxyzine|hydroxyzine|mesh-list
111326818|NCT03808805|Antiemetics|antiemetics|mesh-ancestor
111326819|NCT03808805|Autonomic Agents|autonomic agents|mesh-ancestor
111326820|NCT03808805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111326821|NCT03808805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111326822|NCT03808805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111326823|NCT03808805|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
111326824|NCT03808805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111326825|NCT03808805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111326826|NCT03808805|Antipruritics|antipruritics|mesh-ancestor
111326827|NCT03808805|Dermatologic Agents|dermatologic agents|mesh-ancestor
111326828|NCT03808805|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111326829|NCT03808805|Histamine Antagonists|histamine antagonists|mesh-ancestor
111326830|NCT03808805|Histamine Agents|histamine agents|mesh-ancestor
111326831|NCT03803267|Fentanyl|fentanyl|mesh-list
111326832|NCT03803267|Propofol|propofol|mesh-list
111326833|NCT03803267|Atracurium|atracurium|mesh-list
111326834|NCT03803267|Anesthetics|anesthetics|mesh-ancestor
111326835|NCT03803267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111326836|NCT03803267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111326837|NCT03803267|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111326838|NCT03803267|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111326839|NCT03803267|Anesthetics, General|anesthetics, general|mesh-ancestor
111326840|NCT03803267|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111326841|NCT03803267|Narcotics|narcotics|mesh-ancestor
111326842|NCT03803267|Analgesics|analgesics|mesh-ancestor
111326843|NCT03803267|Sensory System Agents|sensory system agents|mesh-ancestor
111326844|NCT03803267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111326845|NCT03803267|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111192949|NCT00445744|Alkylating Agents|alkylating agents|mesh-ancestor
111326846|NCT03803267|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
111326847|NCT03803267|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
111326848|NCT03803267|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111326849|NCT03803267|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
111326850|NCT03803267|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111326851|NCT03803267|Cholinergic Agents|cholinergic agents|mesh-ancestor
111326852|NCT03803267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111326853|NCT03803267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111326854|NCT00787943|Benzoyl Peroxide|benzoyl peroxide|mesh-list
111326855|NCT00787943|Dermatologic Agents|dermatologic agents|mesh-ancestor
111326856|NCT03808649|Mannitol|mannitol|mesh-list
111326857|NCT03808649|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
111326858|NCT03808649|Diuretics|diuretics|mesh-ancestor
111326859|NCT03808649|Natriuretic Agents|natriuretic agents|mesh-ancestor
111326860|NCT03808649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111326861|NCT00788255|Oxytocin|oxytocin|mesh-list
111326862|NCT00788255|Oxytocics|oxytocics|mesh-ancestor
111326863|NCT00788255|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111326864|NCT00788255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111326865|NCT02379195|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
111326866|NCT02379195|Cyclophosphamide|cyclophosphamide|mesh-list
111326867|NCT02379195|Fludarabine|fludarabine|mesh-list
111326868|NCT02379195|Interleukin-2|interleukin-2|mesh-list
111326869|NCT02379195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111326870|NCT02379195|Immunologic Factors|immunologic factors|mesh-ancestor
111326871|NCT02379195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111326872|NCT02379195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111326873|NCT02379195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111326874|NCT02379195|Alkylating Agents|alkylating agents|mesh-ancestor
111326875|NCT02379195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111326876|NCT02379195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111326877|NCT02379195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111326878|NCT02379195|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111326879|NCT02379195|Analgesics|analgesics|mesh-ancestor
111193225|NCT01795222|Anesthetics|anesthetics|mesh-ancestor
111326880|NCT02379195|Sensory System Agents|sensory system agents|mesh-ancestor
111326881|NCT02379195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111326882|NCT02379195|Antiviral Agents|antiviral agents|mesh-ancestor
111326883|NCT02379195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111193294|NCT01453023|Xhance|xhance|mesh-list
111326884|NCT00771875|Acetaminophen|acetaminophen|mesh-list
111326885|NCT00771875|Diphenhydramine|diphenhydramine|mesh-list
111326886|NCT00771875|Methylprednisolone|methylprednisolone|mesh-list
111326887|NCT00771875|Rituximab|rituximab|mesh-list
111326888|NCT00771875|Bortezomib|bortezomib|mesh-list
111326889|NCT00771875|Thymoglobulin|thymoglobulin|mesh-list
111326890|NCT00771875|Antilymphocyte Serum|antilymphocyte serum|mesh-list
111326891|NCT00771875|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
111326892|NCT00771875|Histamine Antagonists|histamine antagonists|mesh-list
111326893|NCT00771875|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111326894|NCT00771875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111326895|NCT00771875|Immunologic Factors|immunologic factors|mesh-ancestor
111326896|NCT00771875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111326897|NCT00771875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111326898|NCT00771875|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111326899|NCT00771875|Analgesics|analgesics|mesh-ancestor
111326900|NCT00771875|Sensory System Agents|sensory system agents|mesh-ancestor
111326901|NCT00771875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111326902|NCT00771875|Antipyretics|antipyretics|mesh-ancestor
111326903|NCT00771875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111326904|NCT00771875|Antiemetics|antiemetics|mesh-ancestor
111326905|NCT00771875|Autonomic Agents|autonomic agents|mesh-ancestor
111326906|NCT00771875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111326907|NCT00771875|Glucocorticoids|glucocorticoids|mesh-ancestor
111326908|NCT00771875|Hormones|hormones|mesh-ancestor
111326909|NCT00771875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111326910|NCT00771875|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111326911|NCT00771875|Protective Agents|protective agents|mesh-ancestor
111326912|NCT00771875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111326913|NCT00771875|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111326914|NCT00771875|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111326915|NCT00771875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111326916|NCT00771875|Anesthetics, Local|anesthetics, local|mesh-ancestor
111326917|NCT00771875|Anesthetics|anesthetics|mesh-ancestor
111326918|NCT00771875|Histamine Agents|histamine agents|mesh-ancestor
111326919|NCT00771875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111326920|NCT00771875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111326921|NCT00771875|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111326922|NCT00760019|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
111193618|NCT03145558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111326923|NCT00760019|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111326924|NCT00760019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111326925|NCT00760019|Analgesics|analgesics|mesh-ancestor
111326926|NCT00760019|Sensory System Agents|sensory system agents|mesh-ancestor
111326927|NCT00760019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111193693|NCT00500656|Icatibant|icatibant|mesh-list
111326928|NCT00760019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111326929|NCT00760019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111326930|NCT00760019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111326931|NCT00789113|Lamotrigine|lamotrigine|mesh-list
111326932|NCT00789113|Anticonvulsants|anticonvulsants|mesh-ancestor
111326933|NCT00789113|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111326934|NCT00789113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111326935|NCT00789113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111326936|NCT00789113|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111326937|NCT00789113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111326938|NCT00789113|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111326939|NCT00789113|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111326940|NCT00789113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111326941|NCT00789113|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111326942|NCT00789113|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111326943|NCT03808259|Ketamine|ketamine|mesh-list
111326944|NCT03808259|Esketamine|esketamine|mesh-list
111326945|NCT03808259|Analgesics|analgesics|mesh-ancestor
111326946|NCT03808259|Sensory System Agents|sensory system agents|mesh-ancestor
111326947|NCT03808259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111326948|NCT03808259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111326949|NCT03808259|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111326950|NCT03808259|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111326951|NCT03808259|Anesthetics, General|anesthetics, general|mesh-ancestor
111326952|NCT03808259|Anesthetics|anesthetics|mesh-ancestor
111326953|NCT03808259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111326954|NCT03808259|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111326955|NCT03808259|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111193967|NCT00559468|Bromides|bromides|mesh-list
111326956|NCT03808259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111326957|NCT03808259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111326958|NCT03808259|Antidepressive Agents|antidepressive agents|mesh-ancestor
111326959|NCT03808259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111326960|NCT02051595|Vancomycin|vancomycin|mesh-list
111326961|NCT02051595|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111326962|NCT02051595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111326963|NCT05742503|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
111326964|NCT05742503|Medroxyprogesterone|medroxyprogesterone|mesh-list
111326965|NCT05742503|Etonogestrel|etonogestrel|mesh-list
111326966|NCT05742503|Norgestrel|norgestrel|mesh-list
111326967|NCT05742503|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111326968|NCT05742503|Contraceptive Agents|contraceptive agents|mesh-ancestor
111326969|NCT05742503|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111326970|NCT05742503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111326971|NCT05742503|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111326972|NCT05742503|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111051375|NCT04594915|Edoxaban|edoxaban|mesh-list
111326973|NCT05742503|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111194166|NCT01426347|Vitamin D|vitamin d|mesh-list
111326974|NCT05742503|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
111326975|NCT05742503|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111326976|NCT05742503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111326977|NCT05742503|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111326978|NCT02388321|Fentanyl|fentanyl|mesh-list
111326979|NCT02388321|Ketamine|ketamine|mesh-list
111326980|NCT02388321|Analgesics|analgesics|mesh-ancestor
111326981|NCT02388321|Sensory System Agents|sensory system agents|mesh-ancestor
111326982|NCT02388321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111326983|NCT02388321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111326984|NCT02388321|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111326985|NCT02388321|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111326986|NCT02388321|Anesthetics, General|anesthetics, general|mesh-ancestor
111326987|NCT02388321|Anesthetics|anesthetics|mesh-ancestor
111326988|NCT02388321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111326989|NCT02388321|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111326990|NCT02388321|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111326991|NCT02388321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111194386|NCT01391793|Hormones|hormones|mesh-ancestor
111326992|NCT02388321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111326993|NCT02388321|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111326994|NCT02388321|Narcotics|narcotics|mesh-ancestor
111326995|NCT02388321|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111326996|NCT05742425|Bevacizumab|bevacizumab|mesh-list
111326997|NCT05742425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111194508|NCT01390389|Vitamins|vitamins|mesh-ancestor
111326998|NCT05742425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111326999|NCT05742425|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111327000|NCT05742425|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111327001|NCT05742425|Growth Substances|growth substances|mesh-ancestor
111327002|NCT05742425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111327003|NCT05742425|Growth Inhibitors|growth inhibitors|mesh-ancestor
111327004|NCT02313675|Acetaminophen|acetaminophen|mesh-list
111327005|NCT02313675|Ketorolac|ketorolac|mesh-list
111327006|NCT02313675|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
111327007|NCT02313675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111327008|NCT02313675|Analgesics|analgesics|mesh-ancestor
111327009|NCT02313675|Sensory System Agents|sensory system agents|mesh-ancestor
111327010|NCT02313675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111327011|NCT02313675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111327012|NCT02313675|Antipyretics|antipyretics|mesh-ancestor
111327013|NCT02313675|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111194834|NCT01396395|Nicorandil|nicorandil|mesh-list
111327014|NCT02313675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111327015|NCT02313675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111327016|NCT02313675|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111327017|NCT02313675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111327018|NCT02313675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111327019|NCT05568797|Vaccines|vaccines|mesh-list
111327020|NCT05568797|Immunologic Factors|immunologic factors|mesh-ancestor
111327021|NCT05568797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111327022|NCT03801629|Morphine|morphine|mesh-list
111327023|NCT03801629|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111327024|NCT03801629|Narcotics|narcotics|mesh-ancestor
111327025|NCT03801629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111327026|NCT03801629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111327027|NCT03801629|Analgesics|analgesics|mesh-ancestor
111327028|NCT03801629|Sensory System Agents|sensory system agents|mesh-ancestor
111327029|NCT03801629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111327030|NCT05741021|Paclitaxel|paclitaxel|mesh-list
111327031|NCT05741021|Carboplatin|carboplatin|mesh-list
111327032|NCT05741021|Pemetrexed|pemetrexed|mesh-list
111327033|NCT05741021|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111327034|NCT05741021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111327035|NCT05741021|Tubulin Modulators|tubulin modulators|mesh-ancestor
111327036|NCT05741021|Antimitotic Agents|antimitotic agents|mesh-ancestor
111327037|NCT05741021|Mitosis Modulators|mitosis modulators|mesh-ancestor
111327038|NCT05741021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111327039|NCT05741021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111327040|NCT05741021|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111195000|NCT00211185|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111327041|NCT05741021|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111327042|NCT04383977|Etoposide|etoposide|mesh-list
111327043|NCT04383977|Apatinib|apatinib|mesh-list
111327044|NCT04383977|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111327045|NCT04383977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111327046|NCT04383977|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111195071|NCT03592407|Pembrolizumab|pembrolizumab|mesh-list
111327047|NCT04383977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111327048|NCT04383977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111327049|NCT04383977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111327050|NCT04383977|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111327051|NCT02389959|Bevacizumab|bevacizumab|mesh-list
111327052|NCT02389959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111327053|NCT02389959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111327054|NCT02389959|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111327055|NCT02389959|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111327056|NCT02389959|Growth Substances|growth substances|mesh-ancestor
111327057|NCT02389959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111327058|NCT02389959|Growth Inhibitors|growth inhibitors|mesh-ancestor
111327059|NCT00775931|Cyclophosphamide|cyclophosphamide|mesh-list
111327060|NCT00775931|Busulfan|busulfan|mesh-list
111327061|NCT00775931|Fludarabine|fludarabine|mesh-list
111327062|NCT00775931|Fludarabine phosphate|fludarabine phosphate|mesh-list
111327063|NCT00775931|Alemtuzumab|alemtuzumab|mesh-list
111327064|NCT00775931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111327065|NCT00775931|Immunologic Factors|immunologic factors|mesh-ancestor
111327066|NCT00775931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111327067|NCT00775931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111327068|NCT00775931|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111327069|NCT00775931|Alkylating Agents|alkylating agents|mesh-ancestor
111327070|NCT00775931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111327071|NCT00775931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111327072|NCT00775931|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111327073|NCT00775931|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111327074|NCT00775931|Antimetabolites|antimetabolites|mesh-ancestor
111327075|NCT00775931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111195345|NCT01855789|Methotrexate|methotrexate|mesh-list
111327076|NCT02052141|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
111195415|NCT01876381|Natriuretic Agents|natriuretic agents|mesh-ancestor
111327077|NCT02052141|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
111327078|NCT02052141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111327079|NCT02052141|Immunologic Factors|immunologic factors|mesh-ancestor
111327080|NCT02052141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111327081|NCT05734235|Vitamins|vitamins|mesh-list
111327082|NCT05734235|Vitamin E|vitamin e|mesh-list
111327083|NCT05734235|Micronutrients|micronutrients|mesh-ancestor
111195521|NCT03597867|Diclofenac|diclofenac|mesh-list
111327084|NCT05734235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111327085|NCT05734235|Antioxidants|antioxidants|mesh-ancestor
111195556|NCT04193319|Fluzoparib|fluzoparib|mesh-list
111327086|NCT05734235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111327087|NCT05734235|Protective Agents|protective agents|mesh-ancestor
111327088|NCT05732129|Irinotecan|irinotecan|mesh-list
111327089|NCT05732129|Fluzoparib|fluzoparib|mesh-list
111327090|NCT05732129|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111327091|NCT05732129|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111327092|NCT05732129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111327093|NCT05732129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111327094|NCT05732129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111327095|NCT05732129|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111327096|NCT02394951|Pregabalin|pregabalin|mesh-list
111327097|NCT02394951|Analgesics|analgesics|mesh-ancestor
111327098|NCT02394951|Sensory System Agents|sensory system agents|mesh-ancestor
111327099|NCT02394951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111327100|NCT02394951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111327101|NCT02394951|Anticonvulsants|anticonvulsants|mesh-ancestor
111327102|NCT02394951|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111327103|NCT02394951|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111327104|NCT02394951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111327105|NCT02394951|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111327106|NCT02394951|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111327107|NCT02394951|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111327108|NCT02394951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111327109|NCT02394951|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111327110|NCT03838367|Leronlimab|leronlimab|mesh-list
111327111|NCT03838367|Carboplatin|carboplatin|mesh-list
111327112|NCT03838367|HIV Antibodies|hiv antibodies|mesh-list
111327113|NCT03838367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111327114|NCT03838367|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
111327115|NCT03838367|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
111327116|NCT03838367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111327117|NCT03838367|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111327118|NCT03838367|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111327119|NCT03838367|Antiviral Agents|antiviral agents|mesh-ancestor
111327120|NCT03838367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111327121|NCT03838367|Immunologic Factors|immunologic factors|mesh-ancestor
111327122|NCT03838367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111327123|NCT00354861|Aluminum sulfate|aluminum sulfate|mesh-list
111327124|NCT00354861|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111327125|NCT00354861|Immunologic Factors|immunologic factors|mesh-ancestor
111327126|NCT00354861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111327127|NCT04345445|Methylprednisolone|methylprednisolone|mesh-list
111327128|NCT04345445|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111327129|NCT04345445|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111327130|NCT04345445|Prednisolone|prednisolone|mesh-list
111327131|NCT04345445|Prednisolone acetate|prednisolone acetate|mesh-list
111327132|NCT04345445|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111327133|NCT04345445|Prednisolone phosphate|prednisolone phosphate|mesh-list
111327134|NCT04345445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111327135|NCT04345445|Antiemetics|antiemetics|mesh-ancestor
111327136|NCT04345445|Autonomic Agents|autonomic agents|mesh-ancestor
111327137|NCT04345445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111327138|NCT04345445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111327139|NCT04345445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111327140|NCT04345445|Glucocorticoids|glucocorticoids|mesh-ancestor
111327141|NCT04345445|Hormones|hormones|mesh-ancestor
111327142|NCT04345445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111327143|NCT04345445|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111327144|NCT04345445|Protective Agents|protective agents|mesh-ancestor
111196110|NCT06057675|Coagulants|coagulants|mesh-ancestor
111327145|NCT04345445|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111327146|NCT04345445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111327147|NCT00354939|Insulin Glargine|insulin glargine|mesh-list
111327148|NCT00354939|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111327149|NCT00354939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111327150|NCT05713877|Melatonin|melatonin|mesh-list
111327151|NCT05713877|Antioxidants|antioxidants|mesh-ancestor
111196169|NCT06057103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111327152|NCT05713877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111327153|NCT05713877|Protective Agents|protective agents|mesh-ancestor
111327154|NCT05713877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111327155|NCT05713877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111327156|NCT00795275|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111327157|NCT00795275|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111327158|NCT00795275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111327159|NCT00795275|Incretins|incretins|mesh-ancestor
111327160|NCT00795275|Hormones|hormones|mesh-ancestor
111327161|NCT00795275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111327162|NCT00795275|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111327163|NCT00795275|Protease Inhibitors|protease inhibitors|mesh-ancestor
111327164|NCT00795275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111196387|NCT06055608|Antifungal Agents|antifungal agents|mesh-ancestor
111327165|NCT00795275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111327166|NCT00777335|Panobinostat|panobinostat|mesh-list
111327167|NCT00777335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111327168|NCT00777335|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111327169|NCT00777335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111327170|NCT00777335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111327171|NCT04896645|Albuterol|albuterol|mesh-list
111327172|NCT04896645|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111327173|NCT04896645|Autonomic Agents|autonomic agents|mesh-ancestor
111327174|NCT04896645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111327175|NCT04896645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111327176|NCT04896645|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111327177|NCT04896645|Respiratory System Agents|respiratory system agents|mesh-ancestor
111327178|NCT04896645|Tocolytic Agents|tocolytic agents|mesh-ancestor
111327179|NCT04896645|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111327180|NCT04896645|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111327181|NCT04896645|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111327182|NCT04896645|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111327183|NCT04896645|Adrenergic Agents|adrenergic agents|mesh-ancestor
111327184|NCT04896645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111327185|NCT04896645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111327186|NCT05644587|Buprenorphine|buprenorphine|mesh-list
111327187|NCT05644587|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
111327188|NCT05644587|Naloxone|naloxone|mesh-list
111327189|NCT05644587|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111327190|NCT05644587|Narcotics|narcotics|mesh-ancestor
111196656|NCT06036511|Ketamine|ketamine|mesh-list
111327191|NCT05644587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111327192|NCT05644587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111327193|NCT05644587|Analgesics|analgesics|mesh-ancestor
111327194|NCT05644587|Sensory System Agents|sensory system agents|mesh-ancestor
111327195|NCT05644587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111327196|NCT05644587|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111051603|NCT05530421|Hormones|hormones|mesh-ancestor
111327197|NCT00355407|Darbepoetin alfa|darbepoetin alfa|mesh-list
111327198|NCT00355407|Hematinics|hematinics|mesh-ancestor
111327199|NCT00355251|Atorvastatin|atorvastatin|mesh-list
111327200|NCT00355251|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111327201|NCT00355251|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111327202|NCT00355251|Antimetabolites|antimetabolites|mesh-ancestor
111327203|NCT00355251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111327204|NCT00355251|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111327205|NCT00355251|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111327206|NCT00355251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111327207|NCT03832127|Fludarabine|fludarabine|mesh-list
111327208|NCT03832127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111327209|NCT04876131|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111327210|NCT04876131|Gentamicins|gentamicins|mesh-list
111327212|NCT04876131|Penicillin G|penicillin g|mesh-list
111327213|NCT04876131|Penicillin G Benzathine|penicillin g benzathine|mesh-list
111327214|NCT04876131|Penicillin G Procaine|penicillin g procaine|mesh-list
111327215|NCT04876131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111327216|NCT04876131|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111327217|NCT04876131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111327218|NCT04876131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111327219|NCT04825275|Posaconazole|posaconazole|mesh-list
111327220|NCT04825275|Antifungal Agents|antifungal agents|mesh-ancestor
111327221|NCT04825275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111327222|NCT04825275|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
111327223|NCT04825275|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111327224|NCT04825275|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111327225|NCT04825275|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111327226|NCT04825275|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111327227|NCT04825275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111327228|NCT04825275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111327229|NCT04825275|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111327230|NCT04825275|Hormone Antagonists|hormone antagonists|mesh-ancestor
111327231|NCT04825275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111327232|NCT04825275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111327233|NCT00791219|Itraconazole|itraconazole|mesh-list
111196930|NCT05981118|Hormones|hormones|mesh-ancestor
111327234|NCT00791219|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
111327235|NCT00791219|Antifungal Agents|antifungal agents|mesh-ancestor
111327236|NCT00791219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111327237|NCT00791219|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111196979|NCT05965492|Acetaminophen|acetaminophen|mesh-list
111327238|NCT00791219|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111327239|NCT00791219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111327240|NCT00791219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111197055|NCT05940324|Anesthetics|anesthetics|mesh-ancestor
111197124|NCT05904028|Faricimab|faricimab|mesh-list
111327241|NCT00791219|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111197197|NCT05866471|Hallucinogens|hallucinogens|mesh-ancestor
111327242|NCT00791219|Hormone Antagonists|hormone antagonists|mesh-ancestor
111327243|NCT00791219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111327244|NCT00791219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111327245|NCT00791219|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111327246|NCT00797459|Hyaluronic Acid|hyaluronic acid|mesh-list
111327247|NCT00797459|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111327248|NCT00797459|Immunologic Factors|immunologic factors|mesh-ancestor
111327249|NCT00797459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111327250|NCT00797459|Viscosupplements|viscosupplements|mesh-ancestor
111327251|NCT00797459|Protective Agents|protective agents|mesh-ancestor
111327252|NCT04807101|Midazolam|midazolam|mesh-list
111327253|NCT04807101|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111327254|NCT04807101|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111197418|NCT05743400|Thymoglobulin|thymoglobulin|mesh-list
111327255|NCT04807101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111327256|NCT04807101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111327257|NCT04807101|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111327258|NCT04807101|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111197487|NCT05723588|Nicotine|nicotine|mesh-list
111327259|NCT04807101|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111327260|NCT04807101|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111327261|NCT04807101|Anesthetics, General|anesthetics, general|mesh-ancestor
111327262|NCT04807101|Anesthetics|anesthetics|mesh-ancestor
111327263|NCT04807101|GABA Modulators|gaba modulators|mesh-ancestor
111327264|NCT04807101|GABA Agents|gaba agents|mesh-ancestor
111327265|NCT04807101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111327266|NCT04807101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111327267|NCT00355953|Genistein|genistein|mesh-list
111327268|NCT00355953|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
111197645|NCT05673200|Paclitaxel|paclitaxel|mesh-list
111327269|NCT00355953|Protective Agents|protective agents|mesh-ancestor
111327270|NCT00355953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111327271|NCT00355953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111327272|NCT00355953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111327273|NCT00355953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111327274|NCT00355953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111327275|NCT00355953|Phytoestrogens|phytoestrogens|mesh-ancestor
111327276|NCT00355953|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
111327277|NCT00355953|Estrogens|estrogens|mesh-ancestor
111327278|NCT00355953|Hormones|hormones|mesh-ancestor
111327279|NCT00355953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111327280|NCT05419193|Propranolol|propranolol|mesh-list
111327281|NCT05419193|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111327282|NCT05419193|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111327283|NCT05419193|Adrenergic Agents|adrenergic agents|mesh-ancestor
111327284|NCT05419193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111327285|NCT05419193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111327286|NCT05419193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111327287|NCT05419193|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111327288|NCT05419193|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111327289|NCT05419193|Vasodilator Agents|vasodilator agents|mesh-ancestor
111327290|NCT05416073|Sufentanil|sufentanil|mesh-list
111327291|NCT05416073|Esketamine|esketamine|mesh-list
111327292|NCT05416073|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111327293|NCT05416073|Narcotics|narcotics|mesh-ancestor
111327294|NCT05416073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111327295|NCT05416073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111327296|NCT05416073|Analgesics|analgesics|mesh-ancestor
111327297|NCT05416073|Sensory System Agents|sensory system agents|mesh-ancestor
111327298|NCT05416073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111327299|NCT05416073|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111327300|NCT05416073|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111327301|NCT05416073|Anesthetics, General|anesthetics, general|mesh-ancestor
111327302|NCT05416073|Anesthetics|anesthetics|mesh-ancestor
111327303|NCT05416073|Antidepressive Agents|antidepressive agents|mesh-ancestor
111327304|NCT05416073|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111327305|NCT05664971|Paclitaxel|paclitaxel|mesh-list
111327306|NCT05664971|Etoposide|etoposide|mesh-list
111327307|NCT05664971|Docetaxel|docetaxel|mesh-list
111327308|NCT05664971|Carboplatin|carboplatin|mesh-list
111327309|NCT05664971|Pemetrexed|pemetrexed|mesh-list
111327310|NCT05664971|Antibodies|antibodies|mesh-list
111327311|NCT05664971|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111327312|NCT05664971|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111327313|NCT05664971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111327314|NCT05664971|Tubulin Modulators|tubulin modulators|mesh-ancestor
111327315|NCT05664971|Antimitotic Agents|antimitotic agents|mesh-ancestor
111327316|NCT05664971|Mitosis Modulators|mitosis modulators|mesh-ancestor
111327317|NCT05664971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111327318|NCT05664971|Immunologic Factors|immunologic factors|mesh-ancestor
111327319|NCT05664971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111327320|NCT05664971|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111327321|NCT05664971|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111327322|NCT05664971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111327323|NCT05664971|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111327324|NCT05664971|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111198409|NCT05353439|Pembrolizumab|pembrolizumab|mesh-list
111327325|NCT05590299|Immunomodulating Agents|immunomodulating agents|mesh-list
111327326|NCT05590299|Immunologic Factors|immunologic factors|mesh-list
111327327|NCT05590299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111327328|NCT04812509|Denosumab|denosumab|mesh-list
111327329|NCT04812509|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111327330|NCT04812509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111327331|NCT05446623|Sufentanil|sufentanil|mesh-list
111327332|NCT05446623|Dexmedetomidine|dexmedetomidine|mesh-list
111327333|NCT05446623|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111198475|NCT05308446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111198542|NCT05292664|Immunologic Factors|immunologic factors|mesh-ancestor
111327334|NCT05446623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111327335|NCT05446623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111327336|NCT05446623|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111327337|NCT05446623|Analgesics|analgesics|mesh-ancestor
111327338|NCT05446623|Sensory System Agents|sensory system agents|mesh-ancestor
111327339|NCT05446623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111327340|NCT05446623|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111327341|NCT05446623|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111327342|NCT05446623|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111327343|NCT05446623|Adrenergic Agents|adrenergic agents|mesh-ancestor
111327344|NCT05446623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111327345|NCT05446623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111327346|NCT05446623|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111051752|NCT04861064|Sirolimus|sirolimus|mesh-list
111327347|NCT05446623|Narcotics|narcotics|mesh-ancestor
111327348|NCT05446623|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111327349|NCT05446623|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111327350|NCT05446623|Anesthetics, General|anesthetics, general|mesh-ancestor
111327351|NCT05446623|Anesthetics|anesthetics|mesh-ancestor
111327352|NCT00792077|Lenalidomide|lenalidomide|mesh-list
111327353|NCT00792077|Immunologic Factors|immunologic factors|mesh-ancestor
111327354|NCT00792077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111327355|NCT00792077|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111327356|NCT00792077|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111327357|NCT00792077|Growth Substances|growth substances|mesh-ancestor
111327358|NCT00792077|Growth Inhibitors|growth inhibitors|mesh-ancestor
111327359|NCT00792077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111327360|NCT02979015|Alirocumab|alirocumab|mesh-list
111327361|NCT02979015|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
111327362|NCT02979015|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111327363|NCT02979015|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111327364|NCT02979015|Antimetabolites|antimetabolites|mesh-ancestor
111327365|NCT02979015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111327366|NCT02979015|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111327367|NCT02979015|Protease Inhibitors|protease inhibitors|mesh-ancestor
111327368|NCT02979015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111327369|NCT02979015|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111327370|NCT00799643|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
111327371|NCT00799643|Sodium Salicylate|sodium salicylate|mesh-list
111327372|NCT00799643|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111327373|NCT00799643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111327374|NCT00799643|Analgesics|analgesics|mesh-ancestor
111327375|NCT00799643|Sensory System Agents|sensory system agents|mesh-ancestor
111327376|NCT00799643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111327377|NCT00799643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111327378|NCT00799643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111198963|NCT05053971|Entinostat|entinostat|mesh-list
111327379|NCT00799643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111327380|NCT00799643|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111327381|NCT00799643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111327382|NCT00799643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111327383|NCT03835013|Exenatide|exenatide|mesh-list
111327384|NCT03835013|Glucagon|glucagon|mesh-list
111327385|NCT03835013|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
111327386|NCT03835013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111327387|NCT03835013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111327388|NCT03835013|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111327389|NCT03835013|Incretins|incretins|mesh-ancestor
111327390|NCT03835013|Hormones|hormones|mesh-ancestor
111327391|NCT03835013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111327392|NCT03835013|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111327393|NCT00800345|Topotecan|topotecan|mesh-list
111327394|NCT00800345|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111327395|NCT00800345|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111327396|NCT00800345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111199314|NCT04898894|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111327397|NCT00800345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111327398|NCT00800345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111327399|NCT03806751|Acetazolamide|acetazolamide|mesh-list
111327400|NCT03806751|Anticonvulsants|anticonvulsants|mesh-ancestor
111327401|NCT03806751|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
111327402|NCT03806751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111327403|NCT03806751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111327404|NCT03806751|Diuretics|diuretics|mesh-ancestor
111327405|NCT03806751|Natriuretic Agents|natriuretic agents|mesh-ancestor
111327406|NCT03806751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111327407|NCT04383275|Capecitabine|capecitabine|mesh-list
111327408|NCT04383275|Trastuzumab|trastuzumab|mesh-list
111327409|NCT04383275|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111327410|NCT04383275|Antimetabolites|antimetabolites|mesh-ancestor
111327411|NCT04383275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111327412|NCT04383275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111199458|NCT04799275|Antibodies|antibodies|mesh-list
111327413|NCT04383275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111327414|NCT03973229|Estradiol|estradiol|mesh-list
111327415|NCT03973229|Estrogens|estrogens|mesh-ancestor
111327416|NCT03973229|Hormones|hormones|mesh-ancestor
111327417|NCT03973229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111327418|NCT03973229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111327419|NCT03782103|Ethanol|ethanol|mesh-list
111327420|NCT03782103|Chlorhexidine|chlorhexidine|mesh-list
111327421|NCT03782103|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
111327422|NCT03782103|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111327423|NCT03782103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111327424|NCT03782103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111327425|NCT03782103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111327427|NCT03782103|Dermatologic Agents|dermatologic agents|mesh-ancestor
111327428|NCT05319015|Pembrolizumab|pembrolizumab|mesh-list
111327429|NCT05319015|Lenvatinib|lenvatinib|mesh-list
111199671|NCT04704661|Trastuzumab|trastuzumab|mesh-list
111327430|NCT05319015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111327431|NCT05319015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111199742|NCT04633252|Prednisone|prednisone|mesh-list
111327432|NCT05319015|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111327433|NCT05319015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111327434|NCT05319015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111327435|NCT05319015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111327436|NCT00810719|Gemcitabine|gemcitabine|mesh-list
111327437|NCT00810719|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111327438|NCT00810719|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111327439|NCT00810719|Antimetabolites|antimetabolites|mesh-ancestor
111327440|NCT00810719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111327441|NCT00810719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111327442|NCT00810719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111327443|NCT00810719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111327444|NCT03761277|Morphine|morphine|mesh-list
111327445|NCT03761277|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111327446|NCT03761277|Narcotics|narcotics|mesh-ancestor
111327447|NCT03761277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111199874|NCT04576117|Mitosis Modulators|mitosis modulators|mesh-ancestor
111327448|NCT03761277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111327449|NCT03761277|Analgesics|analgesics|mesh-ancestor
111327450|NCT03761277|Sensory System Agents|sensory system agents|mesh-ancestor
111327451|NCT03761277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111327452|NCT00810797|Exemestane|exemestane|mesh-list
111327453|NCT00810797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111327454|NCT00810797|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111199946|NCT04553692|Vitamins|vitamins|mesh-ancestor
111327455|NCT00810797|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111327456|NCT00810797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111327457|NCT00810797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111327458|NCT00810797|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111327459|NCT00810797|Hormone Antagonists|hormone antagonists|mesh-ancestor
111327460|NCT00810797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111327461|NCT00810797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111327462|NCT04340505|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
111327463|NCT04340505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111327464|NCT04340505|Glucocorticoids|glucocorticoids|mesh-ancestor
111327465|NCT04340505|Hormones|hormones|mesh-ancestor
111327466|NCT04340505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111327467|NCT04340505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111327468|NCT04724447|Valganciclovir|valganciclovir|mesh-list
111327469|NCT04724447|Antiviral Agents|antiviral agents|mesh-ancestor
111200157|NCT04370054|Factor VIII|factor viii|mesh-list
111327470|NCT04724447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111327471|NCT00355641|Ropinirole|ropinirole|mesh-list
111327472|NCT00355641|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111327473|NCT00355641|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111327474|NCT00355641|Dopamine Agonists|dopamine agonists|mesh-ancestor
111327475|NCT00355641|Dopamine Agents|dopamine agents|mesh-ancestor
111327476|NCT00355641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111327477|NCT00355641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111327478|NCT00355641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111327479|NCT00356733|Epoetin Alfa|epoetin alfa|mesh-list
111327480|NCT00356733|Hematinics|hematinics|mesh-ancestor
111327481|NCT04591925|Insulin|insulin|mesh-list
111327482|NCT04591925|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111327483|NCT04591925|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111327484|NCT04591925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111327485|NCT04542473|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
111327486|NCT04542473|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
111327487|NCT04542473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111327488|NCT04290689|Botulinum Toxins|botulinum toxins|mesh-list
111327489|NCT04290689|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111327490|NCT04290689|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111327491|NCT04290689|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111327492|NCT04290689|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111327493|NCT04290689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111327494|NCT04290689|Cholinergic Agents|cholinergic agents|mesh-ancestor
111327495|NCT04290689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111327496|NCT04290689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111327497|NCT04290689|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111327498|NCT04290689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111327499|NCT00801827|Fallypride|fallypride|mesh-list
111327500|NCT00801827|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111327501|NCT00801827|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111327502|NCT00801827|Dopamine Agents|dopamine agents|mesh-ancestor
111327503|NCT00801827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111327504|NCT00801827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111327505|NCT00801827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111327506|NCT00802685|Ibuprofen|ibuprofen|mesh-list
111327507|NCT00802685|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111327508|NCT00802685|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111327509|NCT00802685|Analgesics|analgesics|mesh-ancestor
111327510|NCT00802685|Sensory System Agents|sensory system agents|mesh-ancestor
111327511|NCT00802685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111327512|NCT00802685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111327513|NCT00802685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111327514|NCT00802685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111200487|NCT04214262|Atezolizumab|atezolizumab|mesh-list
111327515|NCT00802685|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111327516|NCT00802685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111327517|NCT00802685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111327518|NCT03496623|Treprostinil|treprostinil|mesh-list
111327519|NCT03496623|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111327520|NCT03496623|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111327521|NCT00802919|Varenicline|varenicline|mesh-list
111327522|NCT00802919|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111327523|NCT00802919|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111327524|NCT00802919|Cholinergic Agents|cholinergic agents|mesh-ancestor
111327525|NCT00802919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111327526|NCT00802919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111327527|NCT00802919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111327528|NCT04467905|Etripamil|etripamil|mesh-list
111327529|NCT04467905|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111327530|NCT04467905|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111327531|NCT04467905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111327532|NCT04467905|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111327533|NCT04467905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111327534|NCT00803543|Valacyclovir|valacyclovir|mesh-list
111327535|NCT00803543|Antiviral Agents|antiviral agents|mesh-ancestor
111327536|NCT00803543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111327537|NCT04099641|Pembrolizumab|pembrolizumab|mesh-list
111327538|NCT04099641|Bavituximab|bavituximab|mesh-list
111327539|NCT04099641|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111200684|NCT04092283|Carboplatin|carboplatin|mesh-list
111327540|NCT04099641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111327541|NCT04099641|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111327542|NCT04099641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111327543|NCT05051735|Acetaminophen|acetaminophen|mesh-list
111327544|NCT05051735|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111327545|NCT05051735|Analgesics|analgesics|mesh-ancestor
111327546|NCT05051735|Sensory System Agents|sensory system agents|mesh-ancestor
111327547|NCT05051735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111327548|NCT05051735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111327549|NCT05051735|Antipyretics|antipyretics|mesh-ancestor
111327550|NCT04098237|Pancrelipase|pancrelipase|mesh-list
111327551|NCT04098237|Pancreatin|pancreatin|mesh-list
111327552|NCT04098237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111327553|NCT04095221|Irinotecan|irinotecan|mesh-list
111327554|NCT04095221|Prexasertib|prexasertib|mesh-list
111327555|NCT04095221|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111327556|NCT04095221|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111327557|NCT04095221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111200818|NCT04033107|Micronutrients|micronutrients|mesh-ancestor
111327558|NCT04095221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111327559|NCT04095221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111327560|NCT04095221|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111327561|NCT03357627|Venetoclax|venetoclax|mesh-list
111327562|NCT03357627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111327563|NCT04923113|Amoxicillin|amoxicillin|mesh-list
111327564|NCT04923113|Minocycline|minocycline|mesh-list
111327565|NCT04923113|Rabeprazole|rabeprazole|mesh-list
111327566|NCT04923113|Bismuth|bismuth|mesh-list
111327567|NCT04923113|Antibodies|antibodies|mesh-list
111327568|NCT04923113|Immunologic Factors|immunologic factors|mesh-ancestor
111327569|NCT04923113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111327570|NCT04923113|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111327571|NCT04923113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111327572|NCT04923113|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111327573|NCT04923113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111327574|NCT04923113|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111327575|NCT04923113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111327576|NCT04923113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111327577|NCT04923113|Antacids|antacids|mesh-ancestor
111327578|NCT03250923|Acemannan|acemannan|mesh-list
111327579|NCT03250923|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111327580|NCT03250923|Immunologic Factors|immunologic factors|mesh-ancestor
111327581|NCT03250923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111327582|NCT03250923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111327583|NCT03250923|Antiviral Agents|antiviral agents|mesh-ancestor
111327584|NCT03250923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111327585|NCT03250923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111327586|NCT00805493|Riluzole|riluzole|mesh-list
111327587|NCT00805493|Anticonvulsants|anticonvulsants|mesh-ancestor
111327588|NCT00805493|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111327589|NCT00805493|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111327590|NCT00805493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111327591|NCT00805493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111327592|NCT00805493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111327593|NCT00805493|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111327594|NCT00805493|Protective Agents|protective agents|mesh-ancestor
111327595|NCT03236649|Sorafenib|sorafenib|mesh-list
111327596|NCT03236649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111327597|NCT03236649|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111327598|NCT03236649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111327599|NCT03236649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111327600|NCT00807209|Fentanyl|fentanyl|mesh-list
111327601|NCT00807209|Bupivacaine|bupivacaine|mesh-list
111327602|NCT00807209|Anesthetics, Local|anesthetics, local|mesh-ancestor
111327603|NCT00807209|Anesthetics|anesthetics|mesh-ancestor
111327604|NCT00807209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111327605|NCT00807209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111327606|NCT00807209|Sensory System Agents|sensory system agents|mesh-ancestor
111327607|NCT00807209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111327608|NCT00807209|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111327609|NCT00807209|Narcotics|narcotics|mesh-ancestor
111327610|NCT00807209|Analgesics|analgesics|mesh-ancestor
111201456|NCT03761225|Prednisone|prednisone|mesh-list
111327611|NCT00807209|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111327612|NCT00807209|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111327613|NCT00807209|Anesthetics, General|anesthetics, general|mesh-ancestor
111327614|NCT00807989|Lamotrigine|lamotrigine|mesh-list
111327615|NCT00807989|Carbamazepine|carbamazepine|mesh-list
111327616|NCT00807989|Valproic Acid|valproic acid|mesh-list
111327617|NCT00807989|Anticonvulsants|anticonvulsants|mesh-ancestor
111327618|NCT00807989|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111327619|NCT00807989|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111327620|NCT00807989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111327621|NCT00807989|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111327622|NCT00807989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111327623|NCT00807989|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111327624|NCT00807989|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111327625|NCT00807989|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111327626|NCT00807989|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111327627|NCT00807989|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111327628|NCT00807989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111327629|NCT00807989|GABA Agents|gaba agents|mesh-ancestor
111327630|NCT00807989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111327631|NCT00807989|Antimanic Agents|antimanic agents|mesh-ancestor
111327632|NCT00807989|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111327633|NCT00807989|Analgesics|analgesics|mesh-ancestor
111327634|NCT00807989|Sensory System Agents|sensory system agents|mesh-ancestor
111327635|NCT00807989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111327636|NCT00807989|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111327637|NCT00807989|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111327638|NCT05111392|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111327639|NCT00843713|Raltegravir Potassium|raltegravir potassium|mesh-list
111327640|NCT00843713|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111327641|NCT00843713|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111327642|NCT00843713|Antiviral Agents|antiviral agents|mesh-ancestor
111327643|NCT00843713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111327644|NCT00843713|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111327645|NCT00843713|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111327646|NCT00843713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111327647|NCT00843713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111327648|NCT04845490|Mitomycins|mitomycins|mesh-list
111052044|NCT02401139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111327649|NCT04845490|Mitomycin|mitomycin|mesh-list
111327650|NCT04845490|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111327651|NCT04845490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111327652|NCT04845490|Alkylating Agents|alkylating agents|mesh-ancestor
111327653|NCT04845490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111327654|NCT04845490|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111327655|NCT04845490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111327656|NCT00357045|Paroxetine|paroxetine|mesh-list
111327657|NCT00357045|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111327658|NCT00357045|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111327659|NCT00357045|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111327660|NCT00357045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111327661|NCT00357045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111327662|NCT00357045|Serotonin Agents|serotonin agents|mesh-ancestor
111327663|NCT00357045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111327664|NCT00357045|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111327665|NCT00357045|Antidepressive Agents|antidepressive agents|mesh-ancestor
111327666|NCT00357045|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111327667|NCT00357045|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111327668|NCT00357045|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111327669|NCT00357045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111327670|NCT04819360|Solifenacin Succinate|solifenacin succinate|mesh-list
111327671|NCT04819360|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111327672|NCT04819360|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111327673|NCT04819360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111201778|NCT03539731|Piperazine|piperazine|mesh-list
111327674|NCT04819360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111327675|NCT04819360|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111327676|NCT04819360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111327677|NCT04819360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111327678|NCT04819360|Cholinergic Agents|cholinergic agents|mesh-ancestor
111327679|NCT04819360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111327680|NCT04819360|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111327681|NCT04819360|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111327682|NCT04819360|Urological Agents|urological agents|mesh-ancestor
111327683|NCT00357123|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111327684|NCT00357123|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111327685|NCT00357123|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111327686|NCT00357123|Antimetabolites|antimetabolites|mesh-ancestor
111327687|NCT00357123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111327688|NCT00357123|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111327689|NCT00357123|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111201986|NCT03412877|Aldesleukin|aldesleukin|mesh-list
111327690|NCT00357123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111327691|NCT04436458|Niclosamide|niclosamide|mesh-list
111327692|NCT04436458|Anticestodal Agents|anticestodal agents|mesh-ancestor
111202054|NCT03377361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111327693|NCT04436458|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
111327694|NCT04436458|Anthelmintics|anthelmintics|mesh-ancestor
111327695|NCT04436458|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111327696|NCT04436458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111327697|NCT04436458|Antinematodal Agents|antinematodal agents|mesh-ancestor
111327698|NCT03834753|Bevacizumab|bevacizumab|mesh-list
111327699|NCT03834753|Ranibizumab|ranibizumab|mesh-list
111327700|NCT03834753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111327701|NCT03834753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111327702|NCT03834753|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111327703|NCT03834753|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111327704|NCT03834753|Growth Substances|growth substances|mesh-ancestor
111327705|NCT03834753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111327706|NCT03834753|Growth Inhibitors|growth inhibitors|mesh-ancestor
111327707|NCT00845039|Irinotecan|irinotecan|mesh-list
111327708|NCT00845039|Cetuximab|cetuximab|mesh-list
111327709|NCT00845039|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111327710|NCT00845039|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111327711|NCT00845039|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111327712|NCT00845039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111327713|NCT00845039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111327714|NCT00845039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111327715|NCT00845039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111327716|NCT00845039|Immunologic Factors|immunologic factors|mesh-ancestor
111327717|NCT00845039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111327718|NCT00845195|Azelastine|azelastine|mesh-list
111327719|NCT00845195|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
111327720|NCT00845195|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111052121|NCT01709136|Sirolimus|sirolimus|mesh-list
111327721|NCT00845195|Autonomic Agents|autonomic agents|mesh-ancestor
111327722|NCT00845195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111327723|NCT00845195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111327724|NCT00845195|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111327725|NCT00845195|Respiratory System Agents|respiratory system agents|mesh-ancestor
111327726|NCT00845195|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
111327727|NCT00845195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111327728|NCT00845195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111327729|NCT00845195|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111202476|NCT02883049|Prednisone|prednisone|mesh-list
111327730|NCT00845195|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
111327731|NCT00845195|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111327732|NCT00845195|Histamine Antagonists|histamine antagonists|mesh-ancestor
111327733|NCT00845195|Histamine Agents|histamine agents|mesh-ancestor
111327734|NCT00845195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111327735|NCT00845195|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111327736|NCT00845195|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111327737|NCT00845195|Analgesics|analgesics|mesh-ancestor
111327738|NCT00845195|Sensory System Agents|sensory system agents|mesh-ancestor
111327739|NCT00845195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111327740|NCT00845195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111327741|NCT00845507|Exenatide|exenatide|mesh-list
111327742|NCT00845507|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111327743|NCT00845507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111327744|NCT00845507|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111327745|NCT00845507|Incretins|incretins|mesh-ancestor
111327746|NCT00845507|Hormones|hormones|mesh-ancestor
111327747|NCT00845507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111327748|NCT03761914|Pembrolizumab|pembrolizumab|mesh-list
111327749|NCT03761914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111327750|NCT03761914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111202760|NCT02565914|Ivacaftor|ivacaftor|mesh-list
111327751|NCT03761914|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111327752|NCT03761914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111327753|NCT00845663|Certolizumab Pegol|certolizumab pegol|mesh-list
111327754|NCT00845663|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111327755|NCT00845663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111327756|NCT00845663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111327757|NCT00845663|Immunologic Factors|immunologic factors|mesh-ancestor
111327758|NCT00845663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111327759|NCT00845663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111327760|NCT03500380|Capecitabine|capecitabine|mesh-list
111327761|NCT03500380|Lapatinib|lapatinib|mesh-list
111202984|NCT02017717|Bevacizumab|bevacizumab|mesh-list
111327762|NCT03500380|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111327763|NCT03500380|Antimetabolites|antimetabolites|mesh-ancestor
111327764|NCT03500380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111327765|NCT03500380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111327766|NCT03500380|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111327767|NCT03500380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111327768|NCT00534430|Cyclosporine|cyclosporine|mesh-list
111327769|NCT00534430|Mycophenolic Acid|mycophenolic acid|mesh-list
111327770|NCT00534430|Etoposide|etoposide|mesh-list
111327771|NCT00534430|Busulfan|busulfan|mesh-list
111327772|NCT00534430|Cyclosporins|cyclosporins|mesh-list
111327773|NCT00534430|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111327774|NCT00534430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110920093|NCT02134002|Disulfiram|disulfiram|mesh-list
111327775|NCT00534430|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111327776|NCT00534430|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111327777|NCT00534430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111327778|NCT00534430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111327779|NCT00534430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111327780|NCT00534430|Immunologic Factors|immunologic factors|mesh-ancestor
111327781|NCT00534430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111327782|NCT00534430|Antifungal Agents|antifungal agents|mesh-ancestor
111327783|NCT00534430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111327784|NCT00534430|Dermatologic Agents|dermatologic agents|mesh-ancestor
111327785|NCT00534430|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111327786|NCT00534430|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111327787|NCT00534430|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111327788|NCT00534430|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111327789|NCT00534430|Antitubercular Agents|antitubercular agents|mesh-ancestor
111327790|NCT00534430|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111327791|NCT00534430|Alkylating Agents|alkylating agents|mesh-ancestor
111327792|NCT00534430|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111327793|NCT00534430|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111327794|NCT03092895|Apatinib|apatinib|mesh-list
111327795|NCT03092895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111327796|NCT03092895|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111327797|NCT03092895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111327798|NCT03092895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111327799|NCT03839771|Ivosidenib|ivosidenib|mesh-list
111327800|NCT03839771|Glycine|glycine|mesh-list
111327801|NCT03839771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111327802|NCT03839771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111327803|NCT03839771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111327804|NCT03839771|Glycine Agents|glycine agents|mesh-ancestor
111327805|NCT03839771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111327806|NCT03839771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111327807|NCT02593396|Bupropion|bupropion|mesh-list
111327808|NCT02593396|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111327809|NCT02593396|Antidepressive Agents|antidepressive agents|mesh-ancestor
111327810|NCT02593396|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111327811|NCT02593396|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111327812|NCT02593396|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111327813|NCT02593396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111327814|NCT02593396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110937310|NCT04755218|Misoprostol|misoprostol|mesh-list
111327815|NCT02593396|Dopamine Agents|dopamine agents|mesh-ancestor
111327816|NCT02593396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111327817|NCT02593396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111327818|NCT02593396|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111327819|NCT02593396|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111327820|NCT02593396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111327821|NCT00848783|Capecitabine|capecitabine|mesh-list
111327822|NCT00848783|Irinotecan|irinotecan|mesh-list
111327823|NCT00848783|Floxuridine|floxuridine|mesh-list
111327824|NCT00848783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111327825|NCT00848783|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111327826|NCT00848783|Antimetabolites|antimetabolites|mesh-ancestor
111327827|NCT00848783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111327828|NCT00848783|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111327829|NCT00848783|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111327830|NCT00848783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111327831|NCT05372536|Cytarabine|cytarabine|mesh-list
111327832|NCT05372536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111327833|NCT05372536|Antimetabolites|antimetabolites|mesh-ancestor
111327834|NCT05372536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111327835|NCT05372536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111327836|NCT05372536|Antiviral Agents|antiviral agents|mesh-ancestor
111327837|NCT05372536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111327838|NCT05372536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111327839|NCT05372536|Immunologic Factors|immunologic factors|mesh-ancestor
111327840|NCT05372536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111327841|NCT00849251|Dexamethasone|dexamethasone|mesh-list
111327842|NCT00849251|Cyclophosphamide|cyclophosphamide|mesh-list
111327843|NCT00849251|Doxorubicin|doxorubicin|mesh-list
111327844|NCT00849251|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111327845|NCT00849251|Bortezomib|bortezomib|mesh-list
111327846|NCT00849251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111327847|NCT00849251|Immunologic Factors|immunologic factors|mesh-ancestor
111327848|NCT00849251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111327849|NCT00849251|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111327850|NCT00849251|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111327851|NCT00849251|Alkylating Agents|alkylating agents|mesh-ancestor
111327852|NCT00849251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111327853|NCT00849251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111327854|NCT00849251|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111327855|NCT00849251|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111327856|NCT00849251|Antiemetics|antiemetics|mesh-ancestor
111327857|NCT00849251|Autonomic Agents|autonomic agents|mesh-ancestor
111327858|NCT00849251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111327859|NCT00849251|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111327860|NCT00849251|Glucocorticoids|glucocorticoids|mesh-ancestor
111327861|NCT00849251|Hormones|hormones|mesh-ancestor
111327862|NCT00849251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111327863|NCT00849251|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111327864|NCT00849251|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111327865|NCT00849251|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111327866|NCT00849251|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111327867|NCT00849251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111327868|NCT00850889|Lidocaine|lidocaine|mesh-list
111052270|NCT03528421|Alkylating Agents|alkylating agents|mesh-ancestor
111327869|NCT00850889|Hyaluronic Acid|hyaluronic acid|mesh-list
111327870|NCT00850889|Anesthetics, Local|anesthetics, local|mesh-ancestor
111327872|NCT00850889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111327873|NCT00850889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111327874|NCT00850889|Sensory System Agents|sensory system agents|mesh-ancestor
111327875|NCT00850889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111327876|NCT00850889|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110773678|NCT01379482|Cisplatin|cisplatin|mesh-list
111327877|NCT00850889|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111327878|NCT00850889|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111327879|NCT00850889|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111327880|NCT00850889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111327881|NCT00850889|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111327882|NCT00850889|Immunologic Factors|immunologic factors|mesh-ancestor
111327883|NCT00850889|Viscosupplements|viscosupplements|mesh-ancestor
111327884|NCT00850889|Protective Agents|protective agents|mesh-ancestor
111327885|NCT05254288|Chlorhexidine|chlorhexidine|mesh-list
111327886|NCT05254288|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111327887|NCT05254288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111327888|NCT05254288|Disinfectants|disinfectants|mesh-ancestor
111327889|NCT00851357|Nicotine|nicotine|mesh-list
111327890|NCT00851357|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111327891|NCT00851357|Autonomic Agents|autonomic agents|mesh-ancestor
111327892|NCT00851357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111327893|NCT00851357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111327894|NCT00851357|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111327895|NCT00851357|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111327896|NCT00851357|Cholinergic Agents|cholinergic agents|mesh-ancestor
111327897|NCT00851357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111327898|NCT00851357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111327899|NCT05105074|Morphine|morphine|mesh-list
111327900|NCT05105074|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111327901|NCT05105074|Narcotics|narcotics|mesh-ancestor
111327902|NCT05105074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111327903|NCT05105074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111327904|NCT05105074|Analgesics|analgesics|mesh-ancestor
111327905|NCT05105074|Sensory System Agents|sensory system agents|mesh-ancestor
111327906|NCT05105074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111327907|NCT00364702|Methylphenidate|methylphenidate|mesh-list
111327908|NCT00364702|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111327909|NCT00364702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111327910|NCT00364702|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111327911|NCT00364702|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111327912|NCT00364702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111327913|NCT00364702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111327914|NCT00364702|Dopamine Agents|dopamine agents|mesh-ancestor
111327915|NCT00364702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111327916|NCT00852761|Clobetasol|clobetasol|mesh-list
111327917|NCT00852761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111327918|NCT00852761|Glucocorticoids|glucocorticoids|mesh-ancestor
111327919|NCT00852761|Hormones|hormones|mesh-ancestor
111327920|NCT00852761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111327921|NCT00852761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111327922|NCT03839537|Nitric Oxide|nitric oxide|mesh-list
111327923|NCT03839537|Carbon Monoxide|carbon monoxide|mesh-list
111327924|NCT03839537|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111327925|NCT03839537|Autonomic Agents|autonomic agents|mesh-ancestor
111327926|NCT03839537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111327927|NCT03839537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111327928|NCT03839537|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111327929|NCT03839537|Respiratory System Agents|respiratory system agents|mesh-ancestor
111327930|NCT03839537|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111327931|NCT03839537|Antioxidants|antioxidants|mesh-ancestor
111327932|NCT03839537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111327933|NCT03839537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111327934|NCT03839537|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
111327935|NCT03839537|Vasodilator Agents|vasodilator agents|mesh-ancestor
111327936|NCT03839537|Gasotransmitters|gasotransmitters|mesh-ancestor
111327937|NCT03839537|Protective Agents|protective agents|mesh-ancestor
111327938|NCT03839537|Antimetabolites|antimetabolites|mesh-ancestor
111327939|NCT04082806|Trazodone|trazodone|mesh-list
111327940|NCT04082806|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111327941|NCT04082806|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111327942|NCT04082806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111052346|NCT02207855|Chloroprocaine|chloroprocaine|mesh-list
111327943|NCT04082806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111327944|NCT04082806|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111327945|NCT04082806|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110773780|NCT03077698|Hormones|hormones|mesh-ancestor
111327946|NCT04082806|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111327947|NCT04082806|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111327948|NCT04082806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111327949|NCT04082806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111327950|NCT04082806|Serotonin Agents|serotonin agents|mesh-ancestor
111327951|NCT04082806|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111327952|NCT04082806|Antidepressive Agents|antidepressive agents|mesh-ancestor
111327953|NCT05635786|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
111327954|NCT05635786|Tenecteplase|tenecteplase|mesh-list
111327955|NCT05635786|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111327956|NCT05635786|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111327957|NCT05635786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111327958|NCT00365950|Warfarin|warfarin|mesh-list
111327959|NCT00365950|Anticoagulants|anticoagulants|mesh-ancestor
111327960|NCT02487797|Oxytocin|oxytocin|mesh-list
111327961|NCT02487797|Oxytocics|oxytocics|mesh-ancestor
111327962|NCT02487797|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111327963|NCT02487797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111327964|NCT01733693|Buprenorphine|buprenorphine|mesh-list
111327965|NCT01733693|Methadone|methadone|mesh-list
111327966|NCT01733693|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111327967|NCT01733693|Narcotics|narcotics|mesh-ancestor
111327968|NCT01733693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111327969|NCT01733693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111327970|NCT01733693|Analgesics|analgesics|mesh-ancestor
111327971|NCT01733693|Sensory System Agents|sensory system agents|mesh-ancestor
111327972|NCT01733693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111327973|NCT01733693|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111327974|NCT01733693|Antitussive Agents|antitussive agents|mesh-ancestor
111327975|NCT01733693|Respiratory System Agents|respiratory system agents|mesh-ancestor
111327976|NCT00855413|Ritonavir|ritonavir|mesh-list
111327977|NCT00855413|Darunavir|darunavir|mesh-list
111327978|NCT00855413|Etravirine|etravirine|mesh-list
111327979|NCT00855413|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111327980|NCT00855413|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111327981|NCT00855413|Protease Inhibitors|protease inhibitors|mesh-ancestor
111327982|NCT00855413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111327983|NCT00855413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111327984|NCT00855413|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111327985|NCT00855413|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111327986|NCT00855413|Antiviral Agents|antiviral agents|mesh-ancestor
111327987|NCT00855413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111327988|NCT00855413|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111327989|NCT00855413|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111327990|NCT00855413|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111327991|NCT00855413|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111327992|NCT00816101|Anti-Infective Agents|anti-infective agents|mesh-list
111327993|NCT00816101|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111327994|NCT00366262|Naproxen|naproxen|mesh-list
111327995|NCT00366262|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111327996|NCT00366262|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111327997|NCT00366262|Analgesics|analgesics|mesh-ancestor
111327998|NCT00366262|Sensory System Agents|sensory system agents|mesh-ancestor
111327999|NCT00366262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111328000|NCT00366262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111328001|NCT00366262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111328002|NCT00366262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111328003|NCT00366262|Gout Suppressants|gout suppressants|mesh-ancestor
111328004|NCT00366262|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111328005|NCT00366262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111328006|NCT00366262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111328007|NCT00818363|Bupivacaine|bupivacaine|mesh-list
111328008|NCT00818363|Anesthetics, Local|anesthetics, local|mesh-ancestor
111328009|NCT00818363|Anesthetics|anesthetics|mesh-ancestor
111328010|NCT00818363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111328011|NCT00818363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111328012|NCT00818363|Sensory System Agents|sensory system agents|mesh-ancestor
111328013|NCT00818363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111328014|NCT00828841|Paclitaxel|paclitaxel|mesh-list
111328015|NCT00828841|Carboplatin|carboplatin|mesh-list
111328016|NCT00828841|Gemcitabine|gemcitabine|mesh-list
111328017|NCT00828841|Cetuximab|cetuximab|mesh-list
111052422|NCT02324842|Liraglutide|liraglutide|mesh-list
111328018|NCT00828841|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111328019|NCT00828841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111328020|NCT00828841|Tubulin Modulators|tubulin modulators|mesh-ancestor
111328021|NCT00828841|Antimitotic Agents|antimitotic agents|mesh-ancestor
111328022|NCT00828841|Mitosis Modulators|mitosis modulators|mesh-ancestor
111328023|NCT00828841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111328024|NCT00828841|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111328025|NCT00828841|Antimetabolites|antimetabolites|mesh-ancestor
111328026|NCT00828841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111328027|NCT05445310|Aflutinib|aflutinib|mesh-list
111328028|NCT05445310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111328029|NCT05445310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111328030|NCT05445310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111328031|NCT00858689|Minocycline|minocycline|mesh-list
111328032|NCT00858689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110773919|NCT04436224|Anesthetics|anesthetics|mesh-ancestor
111328033|NCT00858689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111328034|NCT00821795|Insulin|insulin|mesh-list
111328035|NCT00821795|Insulin Aspart|insulin aspart|mesh-list
111328036|NCT00821795|Protamines|protamines|mesh-list
111328037|NCT00821795|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111328038|NCT00821795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111328039|NCT00821795|Heparin Antagonists|heparin antagonists|mesh-ancestor
111328040|NCT00821795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111328041|NCT00821795|Coagulants|coagulants|mesh-ancestor
111328042|NCT00833365|Ibuprofen|ibuprofen|mesh-list
111328043|NCT00833365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111328044|NCT00833365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111328045|NCT00833365|Analgesics|analgesics|mesh-ancestor
111328046|NCT00833365|Sensory System Agents|sensory system agents|mesh-ancestor
111328047|NCT00833365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111328048|NCT00833365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111328049|NCT00833365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111328050|NCT00833365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111328051|NCT00833365|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111328052|NCT00833365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111328053|NCT00833365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111328054|NCT00821951|Vorinostat|vorinostat|mesh-list
111328055|NCT00821951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111328056|NCT00821951|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111328057|NCT00821951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111328058|NCT00821951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111328059|NCT00852631|Quetiapine Fumarate|quetiapine fumarate|mesh-list
111328060|NCT00852631|Antidepressive Agents|antidepressive agents|mesh-ancestor
111328061|NCT00852631|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111328062|NCT00852631|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111328063|NCT00852631|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111328064|NCT00852631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111328065|NCT00852631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111328066|NCT00860015|Gemcitabine|gemcitabine|mesh-list
111328067|NCT00860015|Pemetrexed|pemetrexed|mesh-list
111328068|NCT00860015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111328069|NCT00860015|Antimetabolites|antimetabolites|mesh-ancestor
111328070|NCT00860015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111328071|NCT00860015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111328072|NCT00860015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111328073|NCT00860015|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111328074|NCT00860015|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111328075|NCT00853333|Midazolam|midazolam|mesh-list
111328076|NCT00853333|Dexmedetomidine|dexmedetomidine|mesh-list
111328077|NCT00853333|Propofol|propofol|mesh-list
111328078|NCT00853333|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111328079|NCT00853333|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111328080|NCT00853333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111328081|NCT00853333|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111328082|NCT00853333|Analgesics|analgesics|mesh-ancestor
111328083|NCT00853333|Sensory System Agents|sensory system agents|mesh-ancestor
111328084|NCT00853333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111328085|NCT00853333|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111328086|NCT00853333|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111328087|NCT00853333|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111328088|NCT00853333|Adrenergic Agents|adrenergic agents|mesh-ancestor
111328089|NCT00853333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110773996|NCT04108234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111328090|NCT00853333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111328091|NCT00853333|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111328093|NCT00853333|Anesthetics|anesthetics|mesh-ancestor
111328094|NCT00853333|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111328095|NCT00853333|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111328096|NCT00853333|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111328097|NCT00853333|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111328098|NCT00853333|GABA Modulators|gaba modulators|mesh-ancestor
111328099|NCT00853333|GABA Agents|gaba agents|mesh-ancestor
111328100|NCT00822107|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
111328101|NCT00822107|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111328102|NCT00822107|Diuretics|diuretics|mesh-ancestor
111328103|NCT00822107|Natriuretic Agents|natriuretic agents|mesh-ancestor
111328104|NCT00822107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111328105|NCT00822107|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
111328106|NCT00822107|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111328107|NCT00822107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111328108|NCT05236907|Midazolam|midazolam|mesh-list
111328109|NCT05236907|Melatonin|melatonin|mesh-list
111328110|NCT05236907|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111328111|NCT05236907|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111328112|NCT05236907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111328113|NCT05236907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111328114|NCT05236907|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111328115|NCT05236907|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111328116|NCT05236907|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111328117|NCT05236907|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111328118|NCT05236907|Anesthetics, General|anesthetics, general|mesh-ancestor
111328119|NCT05236907|Anesthetics|anesthetics|mesh-ancestor
111328120|NCT05236907|GABA Modulators|gaba modulators|mesh-ancestor
111328121|NCT05236907|GABA Agents|gaba agents|mesh-ancestor
111328122|NCT05236907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111328123|NCT05236907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111328124|NCT05236907|Antioxidants|antioxidants|mesh-ancestor
111328125|NCT05236907|Protective Agents|protective agents|mesh-ancestor
111328126|NCT05217706|Ketamine|ketamine|mesh-list
111328127|NCT05217706|Analgesics|analgesics|mesh-ancestor
111328128|NCT05217706|Sensory System Agents|sensory system agents|mesh-ancestor
111328129|NCT05217706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111328130|NCT05217706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111328131|NCT05217706|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111328132|NCT05217706|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111328133|NCT05217706|Anesthetics, General|anesthetics, general|mesh-ancestor
111328134|NCT05217706|Anesthetics|anesthetics|mesh-ancestor
111328135|NCT05217706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111328136|NCT05217706|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111328137|NCT05217706|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111328138|NCT05217706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111328139|NCT05217706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111328140|NCT00833443|Bupropion|bupropion|mesh-list
111328141|NCT00833443|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111328142|NCT00833443|Antidepressive Agents|antidepressive agents|mesh-ancestor
111328143|NCT00833443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111328144|NCT00833443|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111328145|NCT00833443|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111328146|NCT00833443|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111328147|NCT00833443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111328148|NCT00833443|Dopamine Agents|dopamine agents|mesh-ancestor
111328149|NCT00833443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111328150|NCT00833443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111328151|NCT00833443|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111328152|NCT00833443|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111328153|NCT00833443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111328154|NCT05207722|Aldesleukin|aldesleukin|mesh-list
111328155|NCT05207722|Cyclophosphamide|cyclophosphamide|mesh-list
111328156|NCT05207722|Pembrolizumab|pembrolizumab|mesh-list
111328157|NCT05207722|Trastuzumab|trastuzumab|mesh-list
111328158|NCT05207722|Fludarabine|fludarabine|mesh-list
111328159|NCT05207722|Interleukin-2|interleukin-2|mesh-list
111328160|NCT05207722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111328161|NCT05207722|Immunologic Factors|immunologic factors|mesh-ancestor
111328162|NCT05207722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111328163|NCT05207722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111328164|NCT05207722|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111328165|NCT05207722|Alkylating Agents|alkylating agents|mesh-ancestor
111052568|NCT02220647|Hormones|hormones|mesh-ancestor
111328166|NCT05207722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111328167|NCT05207722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111328168|NCT05207722|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111328169|NCT05207722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111328170|NCT05207722|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111328171|NCT05207722|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111328172|NCT05207722|Analgesics|analgesics|mesh-ancestor
111328173|NCT05207722|Sensory System Agents|sensory system agents|mesh-ancestor
111328174|NCT05207722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111328175|NCT05207722|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111328176|NCT05207722|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111328177|NCT05207722|Antiviral Agents|antiviral agents|mesh-ancestor
111328178|NCT05207722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111328179|NCT00860171|Iodine|iodine|mesh-list
111328180|NCT00860171|Cadexomer iodine|cadexomer iodine|mesh-list
111328181|NCT00860171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111328182|NCT00860171|Antibodies|antibodies|mesh-list
111328183|NCT00860171|Immunoglobulins|immunoglobulins|mesh-list
111328184|NCT00860171|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111328185|NCT00860171|Immunologic Factors|immunologic factors|mesh-ancestor
111328186|NCT00860171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111328187|NCT00860171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111328188|NCT00860171|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111328189|NCT00860171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111328190|NCT00860171|Trace Elements|trace elements|mesh-ancestor
111328191|NCT00860171|Micronutrients|micronutrients|mesh-ancestor
111328192|NCT00366418|Rituximab|rituximab|mesh-list
111328193|NCT00366418|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111328194|NCT00366418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111328195|NCT00366418|Immunologic Factors|immunologic factors|mesh-ancestor
111328196|NCT00366418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111328197|NCT00366418|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111328198|NCT00823043|Timolol|timolol|mesh-list
111328199|NCT00823043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111328200|NCT00823043|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111328201|NCT00823043|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111328202|NCT00823043|Adrenergic Agents|adrenergic agents|mesh-ancestor
111328203|NCT00823043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111328204|NCT00823043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111328205|NCT00823043|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111328206|NCT00823043|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111328207|NCT00862745|Fesoterodine|fesoterodine|mesh-list
111328208|NCT00862745|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111328209|NCT00862745|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111328210|NCT00862745|Cholinergic Agents|cholinergic agents|mesh-ancestor
111328211|NCT00862745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111328212|NCT00862745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111328213|NCT00862745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111328214|NCT00862745|Urological Agents|urological agents|mesh-ancestor
111328215|NCT02150759|Fentanyl|fentanyl|mesh-list
111328216|NCT02150759|Dexmedetomidine|dexmedetomidine|mesh-list
111328217|NCT02150759|Ketamine|ketamine|mesh-list
111328218|NCT02150759|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111328219|NCT02150759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111328220|NCT02150759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111328221|NCT02150759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111328222|NCT02150759|Analgesics|analgesics|mesh-ancestor
111328223|NCT02150759|Sensory System Agents|sensory system agents|mesh-ancestor
111328224|NCT02150759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111328225|NCT02150759|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111328226|NCT02150759|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111328227|NCT02150759|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111328228|NCT02150759|Adrenergic Agents|adrenergic agents|mesh-ancestor
111328229|NCT02150759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111328230|NCT02150759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111328231|NCT02150759|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111328232|NCT02150759|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111328233|NCT02150759|Anesthetics, General|anesthetics, general|mesh-ancestor
111328234|NCT02150759|Anesthetics|anesthetics|mesh-ancestor
111328235|NCT02150759|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111328236|NCT02150759|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111328237|NCT02150759|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111328238|NCT02150759|Narcotics|narcotics|mesh-ancestor
111328239|NCT02150759|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111328240|NCT04991350|Bevacizumab|bevacizumab|mesh-list
111328241|NCT04991350|Ranibizumab|ranibizumab|mesh-list
111328242|NCT04991350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111328243|NCT04991350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111328244|NCT04991350|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111328245|NCT04991350|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111328246|NCT04991350|Growth Substances|growth substances|mesh-ancestor
111328247|NCT04991350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111328248|NCT04991350|Growth Inhibitors|growth inhibitors|mesh-ancestor
111328249|NCT00857545|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
111328250|NCT00857545|Immunologic Factors|immunologic factors|mesh-ancestor
111328251|NCT00857545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111328252|NCT04952194|Levodopa|levodopa|mesh-list
111328253|NCT04952194|Carbidopa|carbidopa|mesh-list
111328254|NCT04952194|Entacapone|entacapone|mesh-list
111328255|NCT04952194|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111328256|NCT04952194|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111328257|NCT04952194|Dopamine Agents|dopamine agents|mesh-ancestor
111328258|NCT04952194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111328259|NCT04952194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111328260|NCT04952194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111328261|NCT04952194|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
111328262|NCT04952194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111328263|NCT04952194|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
111328264|NCT00835159|Rivastigmine|rivastigmine|mesh-list
111328265|NCT00835159|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111328266|NCT00835159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111328267|NCT00835159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111328268|NCT00835159|Cholinergic Agents|cholinergic agents|mesh-ancestor
111328269|NCT00835159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111328270|NCT00835159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111328271|NCT00835159|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111328272|NCT00835159|Protective Agents|protective agents|mesh-ancestor
111328273|NCT04860856|Ropivacaine|ropivacaine|mesh-list
111328274|NCT04860856|Anesthetics, Local|anesthetics, local|mesh-ancestor
111328275|NCT04860856|Anesthetics|anesthetics|mesh-ancestor
111328276|NCT04860856|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111328277|NCT04860856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111328278|NCT04860856|Sensory System Agents|sensory system agents|mesh-ancestor
111328279|NCT04860856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111328280|NCT00827099|Mycophenolic Acid|mycophenolic acid|mesh-list
111328281|NCT00827099|Fludarabine|fludarabine|mesh-list
111328282|NCT00827099|Fludarabine phosphate|fludarabine phosphate|mesh-list
111328283|NCT00827099|Melphalan|melphalan|mesh-list
111328284|NCT00827099|Tacrolimus|tacrolimus|mesh-list
111328285|NCT00827099|Antilymphocyte Serum|antilymphocyte serum|mesh-list
111328286|NCT00827099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111328287|NCT00827099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111328288|NCT00827099|Antimetabolites|antimetabolites|mesh-ancestor
111328289|NCT00827099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111328290|NCT00827099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111328291|NCT00827099|Immunologic Factors|immunologic factors|mesh-ancestor
111328292|NCT00827099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111328293|NCT00827099|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111328294|NCT00827099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111328295|NCT00827099|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111328296|NCT00827099|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111328297|NCT00827099|Antitubercular Agents|antitubercular agents|mesh-ancestor
111328298|NCT00827099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111328299|NCT00827099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111328300|NCT00827099|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111328301|NCT00827099|Alkylating Agents|alkylating agents|mesh-ancestor
111328302|NCT00827099|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111328303|NCT00366652|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
111328304|NCT00366652|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
111328305|NCT00366652|Desipramine|desipramine|mesh-list
111328306|NCT00366652|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111328307|NCT00366652|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111328308|NCT00366652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111328309|NCT00366652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111328310|NCT00366652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111328311|NCT00366652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111328312|NCT00366652|Analgesics|analgesics|mesh-ancestor
111328313|NCT00366652|Sensory System Agents|sensory system agents|mesh-ancestor
111328314|NCT00366652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111052737|NCT04467931|Sympathomimetics|sympathomimetics|mesh-ancestor
111328315|NCT00366652|Antidepressive Agents|antidepressive agents|mesh-ancestor
111328316|NCT00366652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111328317|NCT00366652|Dopamine Agents|dopamine agents|mesh-ancestor
111328318|NCT00366652|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
111328319|NCT00366652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111328320|NCT00366652|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111328321|NCT00366652|Adrenergic Agents|adrenergic agents|mesh-ancestor
111328322|NCT00366730|Nitazoxanide|nitazoxanide|mesh-list
111328323|NCT00366730|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111328324|NCT00366730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111328325|NCT02617888|Bismuth|bismuth|mesh-list
111328326|NCT02617888|Antacids|antacids|mesh-ancestor
111328327|NCT02617888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111328328|NCT02617888|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111328329|NCT02625298|Pemetrexed|pemetrexed|mesh-list
111328330|NCT02625298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111328331|NCT02625298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111328332|NCT02625298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111328333|NCT02625298|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111328334|NCT02625298|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111328335|NCT00858013|Glimepiride|glimepiride|mesh-list
111328336|NCT00858013|Nateglinide|nateglinide|mesh-list
111328337|NCT00858013|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111328338|NCT00858013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111328339|NCT00858013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111328340|NCT00858013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111328341|NCT00858013|Immunologic Factors|immunologic factors|mesh-ancestor
111328342|NCT02626156|Methyl salicylate|methyl salicylate|mesh-list
111328343|NCT02626156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111328344|NCT00835861|Insulin|insulin|mesh-list
111328345|NCT00835861|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111328346|NCT00835861|Metformin|metformin|mesh-list
111328347|NCT00835861|Insulin, Isophane|insulin, isophane|mesh-list
111328348|NCT00835861|Isophane Insulin, Human|isophane insulin, human|mesh-list
111328349|NCT00835861|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111328350|NCT00835861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111328351|NCT00804973|Sumatriptan|sumatriptan|mesh-list
111328352|NCT00804973|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111328353|NCT00804973|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111328354|NCT00804973|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111328355|NCT00804973|Serotonin Agents|serotonin agents|mesh-ancestor
111328356|NCT00804973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111328357|NCT00804973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111328358|NCT00804973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111328359|NCT02628106|Alprostadil|alprostadil|mesh-list
111328360|NCT02628106|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111328361|NCT02628106|Vasodilator Agents|vasodilator agents|mesh-ancestor
111328362|NCT02628106|Urological Agents|urological agents|mesh-ancestor
111328363|NCT02629354|Ibuprofen|ibuprofen|mesh-list
111328364|NCT02629354|Caffeine|caffeine|mesh-list
111328365|NCT02629354|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111328366|NCT02629354|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111328367|NCT02629354|Analgesics|analgesics|mesh-ancestor
111328368|NCT02629354|Sensory System Agents|sensory system agents|mesh-ancestor
111328369|NCT02629354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111328370|NCT02629354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110774414|NCT03779100|Lenvatinib|lenvatinib|mesh-list
111328371|NCT02629354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111328372|NCT02629354|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111328373|NCT02629354|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111328374|NCT02629354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111328375|NCT02629354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111328376|NCT02629354|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111328377|NCT02629354|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111328378|NCT02629354|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
111328379|NCT02629354|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111328380|NCT02629354|Purinergic Agents|purinergic agents|mesh-ancestor
111328381|NCT02629354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111328382|NCT02834247|Nivolumab|nivolumab|mesh-list
111328383|NCT02834247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111328384|NCT02834247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111328385|NCT02834247|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111328386|NCT02834247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111328387|NCT00859027|Risedronic Acid|risedronic acid|mesh-list
111052819|NCT05373433|Ritonavir|ritonavir|mesh-list
111328388|NCT00859027|Etidronic Acid|etidronic acid|mesh-list
111328389|NCT00859027|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111328390|NCT00859027|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111328391|NCT00859027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111328392|NCT00859027|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111328393|NCT00859027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111328394|NCT00859027|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111328395|NCT02630992|Amoxicillin|amoxicillin|mesh-list
111328396|NCT02630992|Clavulanic Acid|clavulanic acid|mesh-list
111328397|NCT02630992|Clavulanic Acids|clavulanic acids|mesh-list
111328398|NCT02630992|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
111328399|NCT02630992|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111328400|NCT02630992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111328401|NCT02630992|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
111328402|NCT02630992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111328403|NCT02630992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111328404|NCT00836407|Ipilimumab|ipilimumab|mesh-list
111328405|NCT00836407|Vaccines|vaccines|mesh-list
111328406|NCT00836407|Immunologic Factors|immunologic factors|mesh-ancestor
111328407|NCT00836407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111328408|NCT00836407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111328409|NCT00836407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111328410|NCT00836407|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111328411|NCT00836407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111328412|NCT02631772|Ribavirin|ribavirin|mesh-list
111328413|NCT02631772|Sofosbuvir|sofosbuvir|mesh-list
111328414|NCT02631772|Ledipasvir|ledipasvir|mesh-list
111328415|NCT02631772|Antimetabolites|antimetabolites|mesh-ancestor
111328416|NCT02631772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111328417|NCT02631772|Antiviral Agents|antiviral agents|mesh-ancestor
111328418|NCT02631772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111328419|NCT02633488|Metformin|metformin|mesh-list
111328420|NCT02633488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111328421|NCT02633488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111328422|NCT00859339|Gemcitabine|gemcitabine|mesh-list
111328423|NCT00859339|Sunitinib|sunitinib|mesh-list
111328424|NCT00859339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111328425|NCT00859339|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111328426|NCT00859339|Antimetabolites|antimetabolites|mesh-ancestor
111328427|NCT00859339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111328428|NCT00859339|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111328429|NCT00859339|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111328430|NCT00859339|Growth Substances|growth substances|mesh-ancestor
111328431|NCT00859339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111328432|NCT00859339|Growth Inhibitors|growth inhibitors|mesh-ancestor
111328433|NCT00859339|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111328434|NCT00859339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111328435|NCT00859495|Doxorubicin|doxorubicin|mesh-list
111328436|NCT00859495|Pemetrexed|pemetrexed|mesh-list
111328437|NCT00859495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111328438|NCT00859495|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111328439|NCT00859495|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111328440|NCT00859495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111328441|NCT00859495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111328442|NCT00859495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111328443|NCT00859495|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111328444|NCT00859495|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111328445|NCT00355719|Ritonavir|ritonavir|mesh-list
111328446|NCT00355719|Atazanavir Sulfate|atazanavir sulfate|mesh-list
111328447|NCT00355719|Nevirapine|nevirapine|mesh-list
111328448|NCT00355719|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111328449|NCT00355719|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111328450|NCT00355719|Protease Inhibitors|protease inhibitors|mesh-ancestor
111328451|NCT00355719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111328452|NCT00355719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111328453|NCT00355719|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111328454|NCT00355719|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111328455|NCT00355719|Antiviral Agents|antiviral agents|mesh-ancestor
111328456|NCT00355719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111328457|NCT00355719|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111328458|NCT00355719|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111328459|NCT00355719|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111328460|NCT00355719|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111328461|NCT00355719|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111328462|NCT00355719|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111328463|NCT00859651|Vitamin D|vitamin d|mesh-list
111328464|NCT00859651|Cholecalciferol|cholecalciferol|mesh-list
111328465|NCT00859651|Vitamins|vitamins|mesh-ancestor
111328466|NCT00859651|Micronutrients|micronutrients|mesh-ancestor
111328467|NCT00859651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111328468|NCT00859651|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111328469|NCT00859651|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111328470|NCT02633956|Atorvastatin|atorvastatin|mesh-list
111328471|NCT02633956|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111328472|NCT02633956|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111328473|NCT02633956|Antimetabolites|antimetabolites|mesh-ancestor
111328474|NCT02633956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111328475|NCT02633956|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111328476|NCT02633956|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111328477|NCT02633956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111328478|NCT00836641|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
111328479|NCT00836641|Immunologic Factors|immunologic factors|mesh-ancestor
111328480|NCT00836641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111328481|NCT00806221|Emollients|emollients|mesh-list
111328482|NCT00806221|Dermatologic Agents|dermatologic agents|mesh-ancestor
111328483|NCT02635828|Promethazine|promethazine|mesh-list
111328484|NCT02635828|Diphenhydramine|diphenhydramine|mesh-list
111328485|NCT02635828|Dexamethasone|dexamethasone|mesh-list
111328486|NCT02635828|Palonosetron|palonosetron|mesh-list
111328487|NCT02635828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111328488|NCT02635828|Antiemetics|antiemetics|mesh-ancestor
111328489|NCT02635828|Autonomic Agents|autonomic agents|mesh-ancestor
111328490|NCT02635828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111328491|NCT02635828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111328492|NCT02635828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111328493|NCT02635828|Glucocorticoids|glucocorticoids|mesh-ancestor
111328494|NCT02635828|Hormones|hormones|mesh-ancestor
111328495|NCT02635828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111328496|NCT02635828|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111328497|NCT02635828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111328498|NCT02635828|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111328499|NCT02635828|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111328500|NCT02635828|Serotonin Agents|serotonin agents|mesh-ancestor
111328501|NCT02635828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111328502|NCT02635828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111328503|NCT02635828|Antipruritics|antipruritics|mesh-ancestor
111328504|NCT02635828|Dermatologic Agents|dermatologic agents|mesh-ancestor
111328505|NCT02635828|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111328506|NCT02635828|Histamine Antagonists|histamine antagonists|mesh-ancestor
111328507|NCT02635828|Histamine Agents|histamine agents|mesh-ancestor
111328508|NCT02635828|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111328509|NCT02635828|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111328510|NCT02635828|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111328511|NCT02635828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111328512|NCT02635828|Anesthetics, Local|anesthetics, local|mesh-ancestor
111328513|NCT02635828|Anesthetics|anesthetics|mesh-ancestor
111328514|NCT02635828|Sensory System Agents|sensory system agents|mesh-ancestor
111328515|NCT02638168|Methylphenidate|methylphenidate|mesh-list
111328516|NCT02638168|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111328517|NCT02638168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111328518|NCT02638168|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111328519|NCT02638168|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111328520|NCT02638168|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111328521|NCT02638168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111328522|NCT02638168|Dopamine Agents|dopamine agents|mesh-ancestor
111328523|NCT02638168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111328524|NCT00837031|Gemcitabine|gemcitabine|mesh-list
111328525|NCT00837031|Lenalidomide|lenalidomide|mesh-list
111328526|NCT00837031|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111328527|NCT00837031|Antimetabolites|antimetabolites|mesh-ancestor
111328528|NCT00837031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111328529|NCT00837031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111328530|NCT00837031|Immunologic Factors|immunologic factors|mesh-ancestor
111328531|NCT00837031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111328532|NCT00837031|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111328533|NCT00837031|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111328534|NCT00837031|Growth Substances|growth substances|mesh-ancestor
111328535|NCT00837031|Growth Inhibitors|growth inhibitors|mesh-ancestor
111328536|NCT02973880|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111328537|NCT02973880|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111328538|NCT04344483|Lidocaine|lidocaine|mesh-list
111328539|NCT04344483|Epinephrine|epinephrine|mesh-list
111328540|NCT04344483|Racepinephrine|racepinephrine|mesh-list
111328541|NCT04344483|Epinephryl borate|epinephryl borate|mesh-list
111328542|NCT04344483|Anesthetics, Local|anesthetics, local|mesh-ancestor
111328543|NCT04344483|Anesthetics|anesthetics|mesh-ancestor
111328544|NCT04344483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111328545|NCT04344483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111328546|NCT04344483|Sensory System Agents|sensory system agents|mesh-ancestor
111328547|NCT04344483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111328548|NCT04344483|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111328549|NCT04344483|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111328550|NCT04344483|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111328551|NCT04344483|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111328552|NCT04344483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111328553|NCT04344483|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111328554|NCT04344483|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111328555|NCT04344483|Adrenergic Agents|adrenergic agents|mesh-ancestor
111328556|NCT04344483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111328557|NCT04344483|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111328558|NCT04344483|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111328559|NCT04344483|Autonomic Agents|autonomic agents|mesh-ancestor
111328560|NCT04344483|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111328561|NCT04344483|Respiratory System Agents|respiratory system agents|mesh-ancestor
111328562|NCT04344483|Mydriatics|mydriatics|mesh-ancestor
111328563|NCT04344483|Sympathomimetics|sympathomimetics|mesh-ancestor
111328564|NCT04344483|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111328565|NCT02154763|Ropivacaine|ropivacaine|mesh-list
111328566|NCT02154763|Anesthetics, Local|anesthetics, local|mesh-ancestor
111328567|NCT02154763|Anesthetics|anesthetics|mesh-ancestor
111328568|NCT02154763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111328569|NCT02154763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111328570|NCT02154763|Sensory System Agents|sensory system agents|mesh-ancestor
111328571|NCT02154763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111328572|NCT02641522|Siltuximab|siltuximab|mesh-list
111328573|NCT02641522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111328574|NCT04964427|Methylphenidate|methylphenidate|mesh-list
111328575|NCT04964427|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111328576|NCT04964427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111328577|NCT04964427|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111328578|NCT04964427|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111328579|NCT04964427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111328580|NCT04964427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111328581|NCT04964427|Dopamine Agents|dopamine agents|mesh-ancestor
111328582|NCT04964427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111328583|NCT00357669|Brivaracetam|brivaracetam|mesh-list
111328584|NCT00357669|Anticonvulsants|anticonvulsants|mesh-ancestor
111328585|NCT00863551|Trospium chloride|trospium chloride|mesh-list
111328586|NCT00863551|Parasympatholytics|parasympatholytics|mesh-ancestor
111328587|NCT00863551|Autonomic Agents|autonomic agents|mesh-ancestor
111328588|NCT00863551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111328589|NCT00863551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111328590|NCT00863551|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111328591|NCT00863551|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111328592|NCT00863551|Cholinergic Agents|cholinergic agents|mesh-ancestor
111328593|NCT00863551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111328594|NCT00863551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111328595|NCT00863551|Urological Agents|urological agents|mesh-ancestor
111328596|NCT03838575|Chlorhexidine|chlorhexidine|mesh-list
111328597|NCT03838575|Gentamicins|gentamicins|mesh-list
111328598|NCT03838575|Anti-Infective Agents|anti-infective agents|mesh-list
111328599|NCT03838575|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111328600|NCT03838575|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111328601|NCT03838575|Disinfectants|disinfectants|mesh-ancestor
111328602|NCT03838575|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111328603|NCT03838575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111328604|NCT03838575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111328605|NCT02620774|Tazobactam|tazobactam|mesh-list
111328606|NCT02620774|Ceftolozane|ceftolozane|mesh-list
111328607|NCT02620774|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
111328608|NCT02620774|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111328609|NCT02620774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111328610|NCT02620774|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
111328611|NCT02620774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111328612|NCT02620774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111053037|NCT03596281|Growth Substances|growth substances|mesh-ancestor
111328613|NCT02620774|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111328615|NCT03540355|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111328616|NCT03540355|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111328617|NCT03540355|Antimetabolites|antimetabolites|mesh-ancestor
111328618|NCT03540355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111328619|NCT03540355|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111328620|NCT03540355|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111328621|NCT03540355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111328622|NCT04339816|Azithromycin|azithromycin|mesh-list
111328623|NCT04339816|Hydroxychloroquine|hydroxychloroquine|mesh-list
111328624|NCT04339816|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111328625|NCT04339816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111328626|NCT04339816|Antimalarials|antimalarials|mesh-ancestor
111328627|NCT04339816|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111328628|NCT04339816|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111328629|NCT04339816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111328630|NCT04339816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111328631|NCT04339816|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111328632|NCT05588908|Betamethasone|betamethasone|mesh-list
111328633|NCT05588908|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111328634|NCT05588908|Antibodies|antibodies|mesh-list
111328635|NCT05588908|Immunoglobulins|immunoglobulins|mesh-list
111328636|NCT05588908|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111328637|NCT05588908|Immunologic Factors|immunologic factors|mesh-ancestor
111328638|NCT05588908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111328639|NCT05588908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111328640|NCT05588908|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111328641|NCT05588908|Glucocorticoids|glucocorticoids|mesh-ancestor
111328642|NCT05588908|Hormones|hormones|mesh-ancestor
111328643|NCT05588908|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111328644|NCT05588908|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111328645|NCT05588908|Respiratory System Agents|respiratory system agents|mesh-ancestor
111328646|NCT05588830|Belimumab|belimumab|mesh-list
111328647|NCT05588830|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111328648|NCT05588830|Immunologic Factors|immunologic factors|mesh-ancestor
111328649|NCT05588830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111328650|NCT04740190|Carboplatin|carboplatin|mesh-list
111328651|NCT04740190|Talazoparib|talazoparib|mesh-list
111328652|NCT04740190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111328653|NCT04740190|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111328654|NCT04740190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111328655|NCT04740190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111328656|NCT00865969|Belinostat|belinostat|mesh-list
111328657|NCT00865969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111328658|NCT00865969|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111328659|NCT00865969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111328660|NCT00865969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111328661|NCT05588518|Propolis|propolis|mesh-list
111328662|NCT05588518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111328663|NCT00866749|Cytarabine|cytarabine|mesh-list
111328664|NCT00866749|Cyclophosphamide|cyclophosphamide|mesh-list
111328665|NCT00866749|Doxorubicin|doxorubicin|mesh-list
111328666|NCT00866749|Methotrexate|methotrexate|mesh-list
111328667|NCT00866749|Vincristine|vincristine|mesh-list
111328668|NCT00866749|Daunorubicin|daunorubicin|mesh-list
111328669|NCT00866749|Asparaginase|asparaginase|mesh-list
111328670|NCT00866749|Mercaptopurine|mercaptopurine|mesh-list
111328671|NCT00866749|Thioguanine|thioguanine|mesh-list
111328672|NCT00866749|Pegaspargase|pegaspargase|mesh-list
111328673|NCT00866749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111328674|NCT00866749|Immunologic Factors|immunologic factors|mesh-ancestor
111328675|NCT00866749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111328676|NCT00866749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111328677|NCT00866749|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111328678|NCT00866749|Alkylating Agents|alkylating agents|mesh-ancestor
111328679|NCT00866749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111328680|NCT00866749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111328681|NCT00866749|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110774912|NCT05223010|Protective Agents|protective agents|mesh-ancestor
111328682|NCT00866749|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111328683|NCT00866749|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111328684|NCT00866749|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111328685|NCT00866749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111328686|NCT00866749|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111328687|NCT00866749|Abortifacient Agents|abortifacient agents|mesh-ancestor
111328688|NCT00866749|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111328689|NCT00866749|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111328690|NCT00866749|Antimetabolites|antimetabolites|mesh-ancestor
111328691|NCT00866749|Dermatologic Agents|dermatologic agents|mesh-ancestor
111328692|NCT00866749|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111328693|NCT00866749|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111328694|NCT00866749|Antiviral Agents|antiviral agents|mesh-ancestor
111328695|NCT00866749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111328696|NCT00866749|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111328697|NCT00866749|Tubulin Modulators|tubulin modulators|mesh-ancestor
111328698|NCT00866749|Antimitotic Agents|antimitotic agents|mesh-ancestor
111328699|NCT00866749|Mitosis Modulators|mitosis modulators|mesh-ancestor
111328700|NCT00866905|Cyclophosphamide|cyclophosphamide|mesh-list
111328701|NCT00866905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111328702|NCT00866905|Immunologic Factors|immunologic factors|mesh-ancestor
111328703|NCT00866905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111328704|NCT00866905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111328705|NCT00866905|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111328706|NCT00866905|Alkylating Agents|alkylating agents|mesh-ancestor
111328707|NCT00866905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111328708|NCT00866905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111328709|NCT00866905|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111328711|NCT05587426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111328712|NCT00867139|Oseltamivir|oseltamivir|mesh-list
111328713|NCT00867139|Ribavirin|ribavirin|mesh-list
111328714|NCT00867139|Zanamivir|zanamivir|mesh-list
111328715|NCT00867139|Amantadine|amantadine|mesh-list
111328716|NCT00867139|Thiazole-4-carboxamide adenine dinucleotide|thiazole-4-carboxamide adenine dinucleotide|mesh-list
111328717|NCT00867139|Antiviral Agents|antiviral agents|mesh-ancestor
111328718|NCT00867139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111328719|NCT00867139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111328720|NCT00867139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111328721|NCT00867139|Antimetabolites|antimetabolites|mesh-ancestor
111328722|NCT00867139|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111328723|NCT00867139|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111328724|NCT00867139|Dopamine Agents|dopamine agents|mesh-ancestor
111328725|NCT00867139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111328726|NCT00867139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111328727|NCT00867139|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111328728|NCT00867139|Analgesics|analgesics|mesh-ancestor
111328729|NCT00867139|Sensory System Agents|sensory system agents|mesh-ancestor
111328730|NCT00867139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111328731|NCT05342818|Ondansetron|ondansetron|mesh-list
111328732|NCT05342818|Metoclopramide|metoclopramide|mesh-list
111328733|NCT05342818|Neostigmine|neostigmine|mesh-list
111328734|NCT05342818|Antiemetics|antiemetics|mesh-ancestor
111328735|NCT05342818|Autonomic Agents|autonomic agents|mesh-ancestor
111328736|NCT05342818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111328737|NCT05342818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111328738|NCT05342818|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111328739|NCT05342818|Antipruritics|antipruritics|mesh-ancestor
111328740|NCT05342818|Dermatologic Agents|dermatologic agents|mesh-ancestor
111328741|NCT05342818|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111328742|NCT05342818|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111328743|NCT05342818|Serotonin Agents|serotonin agents|mesh-ancestor
111328744|NCT05342818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111328745|NCT05342818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111328746|NCT05342818|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111328747|NCT05342818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111328748|NCT05342818|Cholinergic Agents|cholinergic agents|mesh-ancestor
111328749|NCT05342818|Parasympathomimetics|parasympathomimetics|mesh-ancestor
111328750|NCT05342818|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111328751|NCT05342818|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111328752|NCT05342818|Dopamine Agents|dopamine agents|mesh-ancestor
111328753|NCT00867217|Vitamin D|vitamin d|mesh-list
111328754|NCT00867217|Ergocalciferols|ergocalciferols|mesh-list
111328755|NCT00867217|Cholecalciferol|cholecalciferol|mesh-list
111328756|NCT00867217|Vitamins|vitamins|mesh-list
111328757|NCT00867217|Letrozole|letrozole|mesh-list
111328758|NCT00867217|Micronutrients|micronutrients|mesh-ancestor
111328759|NCT00867217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111328760|NCT00867217|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111328761|NCT00867217|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111328762|NCT00867217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111053184|NCT02372487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111328763|NCT00867217|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111328764|NCT00867217|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111328766|NCT00867217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111328767|NCT00867217|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111328768|NCT00867217|Hormone Antagonists|hormone antagonists|mesh-ancestor
111328769|NCT00867217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111328770|NCT00867451|Melatonin|melatonin|mesh-list
111328771|NCT00867451|Antioxidants|antioxidants|mesh-ancestor
111328772|NCT00867451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111328773|NCT00867451|Protective Agents|protective agents|mesh-ancestor
111328774|NCT00867451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111328775|NCT00867451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111328776|NCT00867529|Rituximab|rituximab|mesh-list
111328777|NCT00867529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111328778|NCT00867529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111328779|NCT00867529|Immunologic Factors|immunologic factors|mesh-ancestor
111328780|NCT00867529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111328781|NCT00867529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111328782|NCT05197270|Aflibercept|aflibercept|mesh-list
111328783|NCT05197270|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111328784|NCT05197270|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111328785|NCT05197270|Growth Substances|growth substances|mesh-ancestor
111328786|NCT05197270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111328787|NCT05197270|Growth Inhibitors|growth inhibitors|mesh-ancestor
111328788|NCT05197270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111328789|NCT05028946|Muromonab-CD3|muromonab-cd3|mesh-list
111328790|NCT05028946|Immunologic Factors|immunologic factors|mesh-ancestor
111328791|NCT05028946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111328792|NCT05028946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111328793|NCT00889915|Methylphenidate|methylphenidate|mesh-list
111328794|NCT00889915|Amphetamine|amphetamine|mesh-list
111328795|NCT00889915|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
111328796|NCT00889915|Adderall|adderall|mesh-list
111328797|NCT00889915|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111328798|NCT00889915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111328799|NCT00889915|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111328800|NCT00889915|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111328801|NCT00889915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111328802|NCT00889915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111328803|NCT00889915|Dopamine Agents|dopamine agents|mesh-ancestor
111328804|NCT00889915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111328805|NCT00889915|Sympathomimetics|sympathomimetics|mesh-ancestor
111328806|NCT00889915|Autonomic Agents|autonomic agents|mesh-ancestor
111328807|NCT00889915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111328808|NCT00889915|Adrenergic Agents|adrenergic agents|mesh-ancestor
111328809|NCT00889915|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111328810|NCT00841087|Insulin|insulin|mesh-list
111328811|NCT00841087|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111328812|NCT00841087|Insulin Aspart|insulin aspart|mesh-list
111328813|NCT00841087|Insulin Detemir|insulin detemir|mesh-list
111328814|NCT00841087|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111328815|NCT00841087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111328816|NCT02685436|Domperidone|domperidone|mesh-list
111328817|NCT02685436|Omeprazole|omeprazole|mesh-list
111328818|NCT02685436|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111328819|NCT02685436|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111328820|NCT02685436|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111328821|NCT02685436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111328822|NCT02685436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111328823|NCT02685436|Antiemetics|antiemetics|mesh-ancestor
111328824|NCT02685436|Autonomic Agents|autonomic agents|mesh-ancestor
111328825|NCT02685436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111328826|NCT02685436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111328827|NCT02685436|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111328828|NCT02685436|Dopamine Agents|dopamine agents|mesh-ancestor
111328829|NCT02685436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111328830|NCT00841555|Temozolomide|temozolomide|mesh-list
111328831|NCT00841555|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111328832|NCT00841555|Alkylating Agents|alkylating agents|mesh-ancestor
111328833|NCT00841555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111328834|NCT00841555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111328835|NCT00842023|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
110775146|NCT05692804|Protein S|protein s|mesh-list
111328836|NCT00842023|Nitroglycerin|nitroglycerin|mesh-list
111053263|NCT02360007|Buprenorphine|buprenorphine|mesh-list
111328837|NCT00842023|Vasodilator Agents|vasodilator agents|mesh-ancestor
111328838|NCT00842023|Natriuretic Agents|natriuretic agents|mesh-ancestor
111328839|NCT00842023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111328841|NCT00868309|Immunologic Factors|immunologic factors|mesh-ancestor
111328842|NCT00868309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111328843|NCT00368134|Vildagliptin|vildagliptin|mesh-list
111328844|NCT00368134|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111328845|NCT00368134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111328846|NCT00368134|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111328847|NCT00368134|Protease Inhibitors|protease inhibitors|mesh-ancestor
111328848|NCT00368134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111328849|NCT00368134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111328850|NCT02697292|Immunoglobulins|immunoglobulins|mesh-list
111328851|NCT02697292|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111328852|NCT02697292|Antibodies|antibodies|mesh-list
111328853|NCT02697292|gamma-Globulins|gamma-globulins|mesh-list
111328854|NCT02697292|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
111328855|NCT02697292|Immunologic Factors|immunologic factors|mesh-ancestor
111328856|NCT02697292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111328857|NCT02700334|Dapagliflozin|dapagliflozin|mesh-list
111328858|NCT02700334|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111328859|NCT02700334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111328860|NCT02700334|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111328861|NCT02700334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111328862|NCT00868699|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
111328863|NCT00868699|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111328864|NCT00868699|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111328865|NCT00868699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111328866|NCT00868699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111328867|NCT00868699|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111328868|NCT00868699|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
111328869|NCT00868699|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111328870|NCT00868699|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111328871|NCT00868699|Adrenergic Agents|adrenergic agents|mesh-ancestor
111328872|NCT00868699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110775192|NCT04650542|Serotonin Agents|serotonin agents|mesh-ancestor
111328873|NCT00868699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111328874|NCT00868699|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111328875|NCT00868699|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111328876|NCT00868699|Serotonin Agents|serotonin agents|mesh-ancestor
111328877|NCT00868699|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111328878|NCT00868699|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111328879|NCT00868699|Dopamine Agents|dopamine agents|mesh-ancestor
111328880|NCT02701582|Phenylephrine|phenylephrine|mesh-list
111328881|NCT02701582|Epinephrine|epinephrine|mesh-list
111328882|NCT02701582|Oxymetazoline|oxymetazoline|mesh-list
111328883|NCT02701582|Synephrine|synephrine|mesh-list
111328884|NCT02701582|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111328885|NCT02701582|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111328886|NCT02701582|Adrenergic Agents|adrenergic agents|mesh-ancestor
111328887|NCT02701582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111328888|NCT02701582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111328889|NCT02701582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111328890|NCT02701582|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111328891|NCT02701582|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111328892|NCT02701582|Autonomic Agents|autonomic agents|mesh-ancestor
111328893|NCT02701582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111328894|NCT02701582|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111328895|NCT02701582|Respiratory System Agents|respiratory system agents|mesh-ancestor
111328896|NCT02701582|Mydriatics|mydriatics|mesh-ancestor
111328897|NCT02701582|Sympathomimetics|sympathomimetics|mesh-ancestor
111328898|NCT02701582|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111328899|NCT02701582|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111328900|NCT02701582|Nasal Decongestants|nasal decongestants|mesh-ancestor
111328901|NCT02701582|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111328902|NCT02701582|Protective Agents|protective agents|mesh-ancestor
111328903|NCT00869791|Levodopa|levodopa|mesh-list
111328904|NCT00869791|Carbidopa|carbidopa|mesh-list
111328905|NCT00869791|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
111328906|NCT00869791|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111328907|NCT00869791|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111328908|NCT00869791|Dopamine Agents|dopamine agents|mesh-ancestor
111328909|NCT00869791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111328910|NCT00869791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111328911|NCT00869791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111328912|NCT00869791|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
111328913|NCT00869791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111328914|NCT00869791|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111328915|NCT00869791|Immunologic Factors|immunologic factors|mesh-ancestor
111328916|NCT00869791|Dopamine Agonists|dopamine agonists|mesh-ancestor
111328917|NCT02704702|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111328918|NCT02704702|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111328919|NCT02704702|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111328920|NCT02704702|Antimetabolites|antimetabolites|mesh-ancestor
111328921|NCT02704702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111328922|NCT02704702|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111328923|NCT02704702|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111328924|NCT02704702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111328925|NCT00895531|Morphine|morphine|mesh-list
111328926|NCT00895531|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111328927|NCT00895531|Narcotics|narcotics|mesh-ancestor
111328928|NCT00895531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111328929|NCT00895531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111328930|NCT00895531|Analgesics|analgesics|mesh-ancestor
111328931|NCT00895531|Sensory System Agents|sensory system agents|mesh-ancestor
111328932|NCT00895531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111328933|NCT03215875|Torsemide|torsemide|mesh-list
111328934|NCT03215875|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111328935|NCT03215875|Diuretics|diuretics|mesh-ancestor
111328936|NCT03215875|Natriuretic Agents|natriuretic agents|mesh-ancestor
111328937|NCT03215875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111328938|NCT03215875|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
111328939|NCT03215875|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111328940|NCT03215875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111328941|NCT02710630|Dabigatran|dabigatran|mesh-list
111328942|NCT02710630|Antithrombins|antithrombins|mesh-ancestor
111328943|NCT02710630|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111328944|NCT02710630|Protease Inhibitors|protease inhibitors|mesh-ancestor
111328945|NCT02710630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111328946|NCT02710630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111328947|NCT02710630|Anticoagulants|anticoagulants|mesh-ancestor
111328948|NCT02715700|Methadone|methadone|mesh-list
111328949|NCT02715700|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111328950|NCT02715700|Narcotics|narcotics|mesh-ancestor
111328951|NCT02715700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111328952|NCT02715700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111328953|NCT02715700|Analgesics|analgesics|mesh-ancestor
111328954|NCT02715700|Sensory System Agents|sensory system agents|mesh-ancestor
111328955|NCT02715700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111328956|NCT02715700|Antitussive Agents|antitussive agents|mesh-ancestor
111328957|NCT02715700|Respiratory System Agents|respiratory system agents|mesh-ancestor
111328958|NCT00895921|Olanzapine|olanzapine|mesh-list
111328959|NCT00895921|Aripiprazole|aripiprazole|mesh-list
111328960|NCT00895921|Antiemetics|antiemetics|mesh-ancestor
111328961|NCT00895921|Autonomic Agents|autonomic agents|mesh-ancestor
111328962|NCT00895921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111328963|NCT00895921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111328964|NCT00895921|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111328965|NCT00895921|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111328966|NCT00895921|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111328967|NCT00895921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111328968|NCT00895921|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111328969|NCT00895921|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111328970|NCT00895921|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111328971|NCT00895921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111328972|NCT00895921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111328973|NCT00895921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111328974|NCT00895921|Serotonin Agents|serotonin agents|mesh-ancestor
111328975|NCT00895921|Antidepressive Agents|antidepressive agents|mesh-ancestor
111328976|NCT00895921|Dopamine Agonists|dopamine agonists|mesh-ancestor
111328977|NCT00895921|Dopamine Agents|dopamine agents|mesh-ancestor
111328978|NCT00895921|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111328979|NCT00895921|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111328980|NCT00895921|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111328981|NCT00895921|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111328982|NCT00895921|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111328983|NCT00895921|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111328984|NCT00883675|Carboplatin|carboplatin|mesh-list
111328985|NCT00883675|Docetaxel|docetaxel|mesh-list
111328986|NCT00883675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111328987|NCT00883675|Tubulin Modulators|tubulin modulators|mesh-ancestor
111328988|NCT00883675|Antimitotic Agents|antimitotic agents|mesh-ancestor
111328989|NCT00883675|Mitosis Modulators|mitosis modulators|mesh-ancestor
111328990|NCT00883675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111328991|NCT03215407|Betamethasone|betamethasone|mesh-list
111328992|NCT03215407|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111328993|NCT03215407|Glucocorticoids|glucocorticoids|mesh-ancestor
111328994|NCT03215407|Hormones|hormones|mesh-ancestor
111328995|NCT03215407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111328996|NCT03215407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111328997|NCT03215407|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111328998|NCT03215407|Respiratory System Agents|respiratory system agents|mesh-ancestor
111328999|NCT05310331|Paclitaxel|paclitaxel|mesh-list
111329000|NCT05310331|Antibodies|antibodies|mesh-list
111329001|NCT05310331|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111329002|NCT05310331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111329003|NCT05310331|Tubulin Modulators|tubulin modulators|mesh-ancestor
111329004|NCT05310331|Antimitotic Agents|antimitotic agents|mesh-ancestor
111329005|NCT05310331|Mitosis Modulators|mitosis modulators|mesh-ancestor
111329006|NCT05310331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111329007|NCT05310331|Immunologic Factors|immunologic factors|mesh-ancestor
111329008|NCT05310331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111329009|NCT00885079|Rebamipide|rebamipide|mesh-list
111329010|NCT00885079|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111329011|NCT00885079|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111329012|NCT00885079|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111329013|NCT00885079|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111329014|NCT00885079|Antioxidants|antioxidants|mesh-ancestor
111329015|NCT00885079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111329016|NCT00885079|Protective Agents|protective agents|mesh-ancestor
111329017|NCT00885079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111329018|NCT00885079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111329019|NCT00896779|Ranibizumab|ranibizumab|mesh-list
111329020|NCT00896779|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111329021|NCT00896779|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111329022|NCT00896779|Growth Substances|growth substances|mesh-ancestor
111329023|NCT00896779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111329024|NCT00896779|Growth Inhibitors|growth inhibitors|mesh-ancestor
111329025|NCT00896779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111329026|NCT03214939|Immunomodulating Agents|immunomodulating agents|mesh-list
111329027|NCT03214939|Immunologic Factors|immunologic factors|mesh-ancestor
111329028|NCT03214939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111329029|NCT03376477|Lenalidomide|lenalidomide|mesh-list
111329030|NCT03376477|Molgramostim|molgramostim|mesh-list
111329031|NCT03376477|Vaccines|vaccines|mesh-list
111329032|NCT03376477|Sargramostim|sargramostim|mesh-list
111329033|NCT03376477|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
111329034|NCT03376477|Immunologic Factors|immunologic factors|mesh-ancestor
111329035|NCT03376477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111329036|NCT03376477|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111329037|NCT03376477|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111329038|NCT03376477|Growth Substances|growth substances|mesh-ancestor
111329039|NCT03376477|Growth Inhibitors|growth inhibitors|mesh-ancestor
111329040|NCT03376477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111329041|NCT02726620|Lidocaine|lidocaine|mesh-list
111329042|NCT02726620|Atropine|atropine|mesh-list
111329043|NCT02726620|Terlipressin|terlipressin|mesh-list
111329044|NCT02726620|Phenylephrine|phenylephrine|mesh-list
111329045|NCT02726620|Dobutamine|dobutamine|mesh-list
111329046|NCT02726620|Dopamine|dopamine|mesh-list
111329047|NCT02726620|Milrinone|milrinone|mesh-list
111329048|NCT02726620|Isoproterenol|isoproterenol|mesh-list
111329049|NCT02726620|Vasopressins|vasopressins|mesh-list
111329050|NCT02726620|Epinephrine|epinephrine|mesh-list
111329051|NCT02726620|Norepinephrine|norepinephrine|mesh-list
111329052|NCT02726620|Ephedrine|ephedrine|mesh-list
111329053|NCT02726620|Glycopyrrolate|glycopyrrolate|mesh-list
111329054|NCT02726620|Bupivacaine|bupivacaine|mesh-list
111329055|NCT02726620|Ropivacaine|ropivacaine|mesh-list
111329056|NCT02726620|Levobupivacaine|levobupivacaine|mesh-list
111329057|NCT02726620|Tetracaine|tetracaine|mesh-list
111329058|NCT02726620|Prilocaine|prilocaine|mesh-list
111329059|NCT02726620|Mepivacaine|mepivacaine|mesh-list
111329060|NCT02726620|Benzocaine|benzocaine|mesh-list
111329061|NCT02726620|Chloroprocaine|chloroprocaine|mesh-list
111329062|NCT02726620|Procaine|procaine|mesh-list
111329063|NCT02726620|Anesthetics|anesthetics|mesh-list
111329064|NCT02726620|Propofol|propofol|mesh-list
111329065|NCT02726620|Sevoflurane|sevoflurane|mesh-list
111329066|NCT02726620|Desflurane|desflurane|mesh-list
111329067|NCT02726620|Isoflurane|isoflurane|mesh-list
111329068|NCT02726620|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111329069|NCT02726620|Plasma-lyte 148|plasma-lyte 148|mesh-list
111329070|NCT02726620|Anesthetics, Local|anesthetics, local|mesh-ancestor
111329071|NCT02726620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111329072|NCT02726620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111329073|NCT02726620|Sensory System Agents|sensory system agents|mesh-ancestor
111329074|NCT02726620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111329075|NCT02726620|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111329076|NCT02726620|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111329077|NCT02726620|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111329078|NCT02726620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111329079|NCT02726620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111329080|NCT02726620|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111329081|NCT02726620|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111329082|NCT02726620|Anesthetics, General|anesthetics, general|mesh-ancestor
111329083|NCT02726620|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111329084|NCT02726620|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111329085|NCT02726620|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111329086|NCT02726620|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111329087|NCT02726620|Adrenergic Agents|adrenergic agents|mesh-ancestor
111329088|NCT02726620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111329089|NCT02726620|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111329090|NCT02726620|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111329091|NCT02726620|Autonomic Agents|autonomic agents|mesh-ancestor
111329092|NCT02726620|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111329093|NCT02726620|Respiratory System Agents|respiratory system agents|mesh-ancestor
111329094|NCT02726620|Mydriatics|mydriatics|mesh-ancestor
111329095|NCT02726620|Sympathomimetics|sympathomimetics|mesh-ancestor
111329096|NCT02726620|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111329097|NCT02726620|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111329098|NCT02726620|Nasal Decongestants|nasal decongestants|mesh-ancestor
111329099|NCT02726620|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111329100|NCT02726620|Protective Agents|protective agents|mesh-ancestor
111329101|NCT02726620|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111329102|NCT02726620|Parasympatholytics|parasympatholytics|mesh-ancestor
111329103|NCT02726620|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111329104|NCT02726620|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111329105|NCT02726620|Cholinergic Agents|cholinergic agents|mesh-ancestor
111329106|NCT02726620|Hemostatics|hemostatics|mesh-ancestor
111329107|NCT02726620|Coagulants|coagulants|mesh-ancestor
111329108|NCT02726620|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
111329109|NCT02726620|Natriuretic Agents|natriuretic agents|mesh-ancestor
111329110|NCT02726620|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
111329111|NCT02726620|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111329112|NCT02726620|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111329113|NCT02726620|Dopamine Agents|dopamine agents|mesh-ancestor
111329114|NCT02726620|Vasodilator Agents|vasodilator agents|mesh-ancestor
111329115|NCT02726620|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
111329116|NCT02726620|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111329117|NCT02726620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111329118|NCT02726620|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
111329119|NCT00887575|Paclitaxel|paclitaxel|mesh-list
111329120|NCT00887575|Carboplatin|carboplatin|mesh-list
111329121|NCT00887575|Sunitinib|sunitinib|mesh-list
111329122|NCT00887575|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111329123|NCT00887575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111329124|NCT00887575|Tubulin Modulators|tubulin modulators|mesh-ancestor
111329125|NCT00887575|Antimitotic Agents|antimitotic agents|mesh-ancestor
111329126|NCT00887575|Mitosis Modulators|mitosis modulators|mesh-ancestor
111329127|NCT00887575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111329128|NCT00887575|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111329129|NCT00887575|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111329130|NCT00887575|Growth Substances|growth substances|mesh-ancestor
110775545|NCT04219358|Protective Agents|protective agents|mesh-ancestor
111329131|NCT00887575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111329132|NCT00887575|Growth Inhibitors|growth inhibitors|mesh-ancestor
111329133|NCT00887575|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111329134|NCT00887575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111329135|NCT03352843|Primaquine|primaquine|mesh-list
111329136|NCT03352843|Antimalarials|antimalarials|mesh-ancestor
111329137|NCT03352843|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111329138|NCT03352843|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111329139|NCT03352843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111329140|NCT03238027|Durvalumab|durvalumab|mesh-list
111329141|NCT03238027|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111329142|NCT03238027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111053551|NCT02352285|Tolvaptan|tolvaptan|mesh-list
111329143|NCT00887653|Raltegravir Potassium|raltegravir potassium|mesh-list
111329144|NCT00887653|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111329145|NCT00887653|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111329146|NCT00887653|Antiviral Agents|antiviral agents|mesh-ancestor
111329147|NCT00887653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111329148|NCT00887653|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111329149|NCT00887653|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111329150|NCT00887653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111329151|NCT00887653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111329152|NCT00887965|Denosumab|denosumab|mesh-list
111329153|NCT00887965|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111329154|NCT00887965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111329155|NCT02729038|Gepotidacin|gepotidacin|mesh-list
111329156|NCT02729038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111329157|NCT02729038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111329158|NCT02729038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111329159|NCT02729038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111329160|NCT05311813|Hydroxychloroquine|hydroxychloroquine|mesh-list
111329161|NCT05311813|Enoxaparin|enoxaparin|mesh-list
111329162|NCT05311813|Antimalarials|antimalarials|mesh-ancestor
111329163|NCT05311813|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111329164|NCT05311813|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111329165|NCT05311813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111329166|NCT05311813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111329167|NCT05311813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111329168|NCT05311813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111329169|NCT05311813|Anticoagulants|anticoagulants|mesh-ancestor
111329170|NCT05311813|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111329171|NCT05311813|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111329172|NCT03214627|Iron|iron|mesh-list
111329173|NCT03214627|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
111329174|NCT03214627|Hematinics|hematinics|mesh-list
111329175|NCT03214627|Trace Elements|trace elements|mesh-ancestor
111329176|NCT03214627|Micronutrients|micronutrients|mesh-ancestor
111329177|NCT03214627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111329178|NCT00888511|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111329179|NCT00888511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111329180|NCT00888511|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111329181|NCT00888511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111329182|NCT00888511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111329183|NCT03214393|Antibodies|antibodies|mesh-list
111329184|NCT03214393|Immunologic Factors|immunologic factors|mesh-ancestor
111329185|NCT03214393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111329186|NCT00888979|Nicotine|nicotine|mesh-list
111329187|NCT00888979|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111329188|NCT00888979|Autonomic Agents|autonomic agents|mesh-ancestor
111329189|NCT00888979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111329190|NCT00888979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111329191|NCT00888979|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111329192|NCT00888979|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111329193|NCT00888979|Cholinergic Agents|cholinergic agents|mesh-ancestor
111329194|NCT00888979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111329195|NCT00888979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111329196|NCT03214159|Ritonavir|ritonavir|mesh-list
111329197|NCT03214159|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111329198|NCT03214159|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111329199|NCT03214159|Protease Inhibitors|protease inhibitors|mesh-ancestor
111329200|NCT03214159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111329201|NCT03214159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111329202|NCT03214159|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111329203|NCT03214159|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111329204|NCT03214159|Antiviral Agents|antiviral agents|mesh-ancestor
111329205|NCT03214159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111329206|NCT03214159|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111329207|NCT03214159|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111329208|NCT02737072|Durvalumab|durvalumab|mesh-list
111329209|NCT02737072|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111329210|NCT02737072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111329211|NCT05446480|Desloratadine|desloratadine|mesh-list
111329212|NCT05446480|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111329213|NCT05446480|Cholinergic Agents|cholinergic agents|mesh-ancestor
111329214|NCT05446480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111329215|NCT05446480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111329216|NCT05446480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111329217|NCT05446480|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
111329218|NCT05446480|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111329219|NCT05446480|Histamine Antagonists|histamine antagonists|mesh-ancestor
111329220|NCT05446480|Histamine Agents|histamine agents|mesh-ancestor
111329221|NCT03213145|Rifampin|rifampin|mesh-list
111329222|NCT03213145|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111329223|NCT03213145|Antitubercular Agents|antitubercular agents|mesh-ancestor
111329224|NCT03213145|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111329225|NCT03213145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111329226|NCT03213145|Leprostatic Agents|leprostatic agents|mesh-ancestor
111329227|NCT03213145|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111329228|NCT03213145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111329229|NCT03213145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111329230|NCT03213145|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111329231|NCT03213145|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111329232|NCT03213145|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
111329233|NCT03213145|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
111329234|NCT03213145|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
111329235|NCT03213145|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111329236|NCT02722564|Ethanol|ethanol|mesh-list
111329237|NCT02722564|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111329238|NCT02722564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111329239|NCT02722564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111329240|NCT02722564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111329241|NCT05446090|Nitric Oxide|nitric oxide|mesh-list
111329242|NCT05446090|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111329243|NCT05446090|Autonomic Agents|autonomic agents|mesh-ancestor
111329244|NCT05446090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111329245|NCT05446090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111329246|NCT05446090|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111329247|NCT05446090|Respiratory System Agents|respiratory system agents|mesh-ancestor
111329248|NCT05446090|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111329249|NCT05446090|Antioxidants|antioxidants|mesh-ancestor
111329250|NCT05446090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111329251|NCT05446090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111329252|NCT05446090|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
111329253|NCT05446090|Vasodilator Agents|vasodilator agents|mesh-ancestor
111329254|NCT05446090|Gasotransmitters|gasotransmitters|mesh-ancestor
111329255|NCT05446090|Protective Agents|protective agents|mesh-ancestor
111329256|NCT05444998|Paclitaxel|paclitaxel|mesh-list
111329257|NCT05444998|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111329258|NCT05444998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111329259|NCT05444998|Tubulin Modulators|tubulin modulators|mesh-ancestor
111329260|NCT05444998|Antimitotic Agents|antimitotic agents|mesh-ancestor
111329261|NCT05444998|Mitosis Modulators|mitosis modulators|mesh-ancestor
111329262|NCT05444998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111329263|NCT05444842|Insulin|insulin|mesh-list
111329264|NCT05444842|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111329265|NCT05444842|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111329266|NCT05444842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111329267|NCT04381741|Antibodies|antibodies|mesh-list
111329268|NCT04381741|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111329269|NCT04381741|Immunologic Factors|immunologic factors|mesh-ancestor
111329270|NCT04381741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111329271|NCT05444452|Sirolimus|sirolimus|mesh-list
111329272|NCT05444452|Everolimus|everolimus|mesh-list
111329273|NCT05444452|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111329274|NCT05444452|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111329275|NCT05444452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111329276|NCT05444452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111329277|NCT05444452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111329278|NCT05444452|Immunologic Factors|immunologic factors|mesh-ancestor
111329279|NCT05444452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111329280|NCT05444452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111329281|NCT05444452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111329282|NCT05444452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111329283|NCT05444452|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111329284|NCT05444452|Antifungal Agents|antifungal agents|mesh-ancestor
111329285|NCT05444374|Bevacizumab|bevacizumab|mesh-list
111329286|NCT05444374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111329287|NCT05444374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111329288|NCT05444374|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111329289|NCT05444374|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111329290|NCT05444374|Growth Substances|growth substances|mesh-ancestor
111329291|NCT05444374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111329292|NCT05444374|Growth Inhibitors|growth inhibitors|mesh-ancestor
111329293|NCT05444218|Amoxicillin|amoxicillin|mesh-list
111329294|NCT05444218|Metronidazole|metronidazole|mesh-list
111329295|NCT05444218|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111329296|NCT05444218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111329297|NCT05444218|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111329298|NCT05444218|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111329299|NCT01830361|Midostaurin|midostaurin|mesh-list
111329300|NCT01830361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111329301|NCT01830361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111329302|NCT01830361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111329303|NCT01830361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111329304|NCT01830517|Losartan|losartan|mesh-list
111329305|NCT01830517|Amlodipine|amlodipine|mesh-list
111329306|NCT01830517|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111329307|NCT01830517|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111329308|NCT01830517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111329309|NCT01830517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111329310|NCT01830517|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111329311|NCT01830517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111329312|NCT01830517|Vasodilator Agents|vasodilator agents|mesh-ancestor
111329313|NCT01830517|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110775952|NCT05280626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111329314|NCT01830517|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111329315|NCT01830517|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111329316|NCT03212833|Insulin|insulin|mesh-list
111329317|NCT03212833|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111329318|NCT03212833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111329319|NCT05443360|Calcium, Dietary|calcium, dietary|mesh-list
111329320|NCT05443360|Calcium Carbonate|calcium carbonate|mesh-list
111329321|NCT05443360|Calcium|calcium|mesh-list
111329322|NCT05443360|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111329323|NCT05443360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111329324|NCT05443360|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111329325|NCT05443360|Antacids|antacids|mesh-ancestor
111329326|NCT05443360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111329327|NCT05443360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111329328|NCT05443282|Hormones|hormones|mesh-list
111329329|NCT05443282|Estradiol|estradiol|mesh-list
111329330|NCT05443282|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
111329331|NCT05443282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111329332|NCT05443282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111329333|NCT05443282|Estrogens|estrogens|mesh-ancestor
111329334|NCT00904345|Cetuximab|cetuximab|mesh-list
111329335|NCT00904345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111329336|NCT00904345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111329337|NCT05442736|Ciprofloxacin|ciprofloxacin|mesh-list
111329338|NCT05442736|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111329339|NCT05442736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111329340|NCT05442736|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111329341|NCT05442736|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111329342|NCT05442736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111329343|NCT05442736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111329344|NCT05442736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111329345|NCT05442736|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111329346|NCT05442736|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111329347|NCT01830829|Tamsulosin|tamsulosin|mesh-list
111329348|NCT01830829|Dutasteride|dutasteride|mesh-list
111329349|NCT01830829|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111329350|NCT01830829|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111329351|NCT01830829|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111329352|NCT01830829|Adrenergic Agents|adrenergic agents|mesh-ancestor
111329353|NCT01830829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111329354|NCT01830829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111329355|NCT01830829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111329356|NCT01830829|Urological Agents|urological agents|mesh-ancestor
111329357|NCT01830829|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
111329358|NCT01830829|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111329359|NCT01830829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111329360|NCT01830829|Hormone Antagonists|hormone antagonists|mesh-ancestor
111329361|NCT01830829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111329362|NCT03212755|Immunoglobulins|immunoglobulins|mesh-list
111329363|NCT03212755|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111329364|NCT03212755|Antibodies|antibodies|mesh-list
111329365|NCT03212755|Immunoglobulin G|immunoglobulin g|mesh-list
111329366|NCT03212755|Immunologic Factors|immunologic factors|mesh-ancestor
111329367|NCT03212755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111329368|NCT05437822|Tranexamic Acid|tranexamic acid|mesh-list
111053785|NCT02227823|Bromides|bromides|mesh-list
111329369|NCT05437822|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111329370|NCT05437822|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111329371|NCT05437822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111329372|NCT05437822|Hemostatics|hemostatics|mesh-ancestor
111329373|NCT05437822|Coagulants|coagulants|mesh-ancestor
111329374|NCT03212599|Disulfiram|disulfiram|mesh-list
111329375|NCT03212599|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111329376|NCT03212599|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
111329377|NCT03212599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111329378|NCT03212599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111329379|NCT03212053|Hemostatics|hemostatics|mesh-list
111329380|NCT03212053|Coagulants|coagulants|mesh-ancestor
111329381|NCT05311189|Trastuzumab|trastuzumab|mesh-list
111329382|NCT05311189|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111329383|NCT05311189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111329384|NCT00369772|Darbepoetin alfa|darbepoetin alfa|mesh-list
111329385|NCT00369772|Hematinics|hematinics|mesh-ancestor
111329386|NCT03211897|Midazolam|midazolam|mesh-list
111329387|NCT03211897|Haloperidol|haloperidol|mesh-list
111329388|NCT03211897|Olanzapine|olanzapine|mesh-list
111329389|NCT03211897|Haloperidol decanoate|haloperidol decanoate|mesh-list
111329390|NCT03211897|Ziprasidone|ziprasidone|mesh-list
111329391|NCT03211897|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111329392|NCT03211897|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111329393|NCT03211897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111329394|NCT03211897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111329395|NCT03211897|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111329396|NCT03211897|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111329397|NCT03211897|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111329398|NCT03211897|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111329399|NCT03211897|Anesthetics, General|anesthetics, general|mesh-ancestor
111329400|NCT03211897|Anesthetics|anesthetics|mesh-ancestor
111329401|NCT03211897|GABA Modulators|gaba modulators|mesh-ancestor
111329402|NCT03211897|GABA Agents|gaba agents|mesh-ancestor
111329403|NCT03211897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111329404|NCT03211897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111329405|NCT03211897|Antiemetics|antiemetics|mesh-ancestor
111329406|NCT03211897|Autonomic Agents|autonomic agents|mesh-ancestor
111329407|NCT03211897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111329408|NCT03211897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111329409|NCT03211897|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111329410|NCT03211897|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111329411|NCT03211897|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111329412|NCT03211897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111329413|NCT03211897|Serotonin Agents|serotonin agents|mesh-ancestor
111329414|NCT03211897|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111329415|NCT03211897|Dopamine Agents|dopamine agents|mesh-ancestor
111329416|NCT03211897|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111329417|NCT03211897|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111329418|NCT01831687|Etodolac|etodolac|mesh-list
111329419|NCT01831687|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111329420|NCT01831687|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111329421|NCT01831687|Analgesics|analgesics|mesh-ancestor
111329422|NCT01831687|Sensory System Agents|sensory system agents|mesh-ancestor
111329423|NCT01831687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111329424|NCT01831687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111329425|NCT01831687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111329426|NCT01831687|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111329427|NCT01831687|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111329428|NCT01831687|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111329429|NCT01831687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111329430|NCT01831687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111329431|NCT05441254|Paclitaxel|paclitaxel|mesh-list
111329432|NCT05441254|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111329433|NCT05441254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111329434|NCT05441254|Tubulin Modulators|tubulin modulators|mesh-ancestor
111329435|NCT05441254|Antimitotic Agents|antimitotic agents|mesh-ancestor
111329436|NCT05441254|Mitosis Modulators|mitosis modulators|mesh-ancestor
111329437|NCT05441254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111329438|NCT00369148|Nateglinide|nateglinide|mesh-list
111329439|NCT00369148|Mitiglinide|mitiglinide|mesh-list
111329440|NCT00369148|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111329441|NCT00369148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111329442|NCT01832467|Cetuximab|cetuximab|mesh-list
111329443|NCT01832467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111329444|NCT01832467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111329445|NCT03211351|Dextrans|dextrans|mesh-list
111329446|NCT03211351|Anticoagulants|anticoagulants|mesh-ancestor
111329447|NCT03211351|Plasma Substitutes|plasma substitutes|mesh-ancestor
111329448|NCT03211351|Blood Substitutes|blood substitutes|mesh-ancestor
111329449|NCT01832623|Vitamin D|vitamin d|mesh-list
111329450|NCT01832623|Vitamins|vitamins|mesh-ancestor
111329451|NCT01832623|Micronutrients|micronutrients|mesh-ancestor
111329452|NCT01832623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111329453|NCT01832623|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111329454|NCT03211195|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
111329455|NCT03211195|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111329456|NCT03211195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111329457|NCT03211195|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111329458|NCT03211195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111329459|NCT02470390|Fentanyl|fentanyl|mesh-list
111329460|NCT02470390|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111329461|NCT02470390|Narcotics|narcotics|mesh-ancestor
111329462|NCT02470390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111329463|NCT02470390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111329464|NCT02470390|Analgesics|analgesics|mesh-ancestor
111329465|NCT02470390|Sensory System Agents|sensory system agents|mesh-ancestor
111329466|NCT02470390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111329467|NCT02470390|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111329468|NCT02470390|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111329469|NCT02470390|Anesthetics, General|anesthetics, general|mesh-ancestor
111329470|NCT02470390|Anesthetics|anesthetics|mesh-ancestor
111329471|NCT00363532|Calcitonin|calcitonin|mesh-list
111329472|NCT00363532|Salmon calcitonin|salmon calcitonin|mesh-list
111329473|NCT00363532|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
111329474|NCT00363532|Katacalcin|katacalcin|mesh-list
111329475|NCT00363532|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111329476|NCT00363532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111329477|NCT00363532|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111329478|NCT00363532|Vasodilator Agents|vasodilator agents|mesh-ancestor
111329479|NCT00363610|Pegaspargase|pegaspargase|mesh-list
111329480|NCT00363610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111329481|NCT00363688|Penicillins|penicillins|mesh-list
111329482|NCT00363688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111329483|NCT00363688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111329484|NCT01832935|Insulin|insulin|mesh-list
111329485|NCT01832935|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111329486|NCT01832935|Insulin Glargine|insulin glargine|mesh-list
111329487|NCT01832935|Isophane Insulin, Human|isophane insulin, human|mesh-list
111329488|NCT01832935|Insulin, Isophane|insulin, isophane|mesh-list
111329489|NCT01832935|Isophane insulin, beef|isophane insulin, beef|mesh-list
111329490|NCT01832935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111329491|NCT01832935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111329492|NCT03216733|Sirolimus|sirolimus|mesh-list
111329493|NCT03216733|Temsirolimus|temsirolimus|mesh-list
111329494|NCT03216733|MTOR Inhibitors|mtor inhibitors|mesh-list
111329495|NCT03216733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111329496|NCT03216733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111329497|NCT03216733|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111329498|NCT03216733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111329499|NCT03216733|Antifungal Agents|antifungal agents|mesh-ancestor
111329500|NCT03216733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111329501|NCT03216733|Immunologic Factors|immunologic factors|mesh-ancestor
111329502|NCT03216733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111329503|NCT03216733|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111329504|NCT03216733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111329505|NCT03216733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111329506|NCT04380181|Milrinone|milrinone|mesh-list
111329507|NCT04380181|Epinephrine|epinephrine|mesh-list
111329508|NCT04380181|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111329509|NCT04380181|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111329510|NCT04380181|Adrenergic Agents|adrenergic agents|mesh-ancestor
111329511|NCT04380181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110776358|NCT04347954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111329512|NCT04380181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111329513|NCT04380181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111329514|NCT04380181|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111329515|NCT04380181|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111329516|NCT04380181|Autonomic Agents|autonomic agents|mesh-ancestor
111329517|NCT04380181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111329518|NCT04380181|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111329519|NCT04380181|Respiratory System Agents|respiratory system agents|mesh-ancestor
111329520|NCT04380181|Mydriatics|mydriatics|mesh-ancestor
111329521|NCT04380181|Sympathomimetics|sympathomimetics|mesh-ancestor
111329522|NCT04380181|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111329523|NCT04380181|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111329524|NCT04380181|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111329525|NCT04380181|Vasodilator Agents|vasodilator agents|mesh-ancestor
111329526|NCT04380181|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
111329527|NCT04380181|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111329528|NCT04380181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111329529|NCT04380181|Protective Agents|protective agents|mesh-ancestor
111329530|NCT01833559|Insulin|insulin|mesh-list
111329531|NCT01833559|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111329532|NCT01833559|Isophane Insulin, Human|isophane insulin, human|mesh-list
111329533|NCT01833559|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111329534|NCT01833559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111329535|NCT05394142|Metformin|metformin|mesh-list
111329536|NCT05394142|Pioglitazone|pioglitazone|mesh-list
111329537|NCT05394142|Spironolactone|spironolactone|mesh-list
111329538|NCT05394142|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111329539|NCT05394142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111329540|NCT05394142|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
111329541|NCT05394142|Hormone Antagonists|hormone antagonists|mesh-ancestor
111329542|NCT05394142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111329543|NCT05394142|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
111329544|NCT05394142|Diuretics|diuretics|mesh-ancestor
111329545|NCT05394142|Natriuretic Agents|natriuretic agents|mesh-ancestor
111329546|NCT00901225|Plerixafor|plerixafor|mesh-list
111329547|NCT00901225|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111329548|NCT00901225|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111329549|NCT00901225|Antiviral Agents|antiviral agents|mesh-ancestor
111329550|NCT00901225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111329551|NCT05393050|Methotrexate|methotrexate|mesh-list
111329552|NCT05393050|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111329553|NCT05393050|Abortifacient Agents|abortifacient agents|mesh-ancestor
111329554|NCT05393050|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111329555|NCT05393050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111329556|NCT05393050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111329557|NCT05393050|Antimetabolites|antimetabolites|mesh-ancestor
111329558|NCT05393050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111329559|NCT05393050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111329560|NCT05393050|Dermatologic Agents|dermatologic agents|mesh-ancestor
111329561|NCT05393050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111329562|NCT05393050|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111329563|NCT05393050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111329564|NCT05393050|Immunologic Factors|immunologic factors|mesh-ancestor
111329565|NCT05393050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110776406|NCT03579160|Petrolatum|petrolatum|mesh-list
111329566|NCT05393050|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111329567|NCT03166228|Glycine|glycine|mesh-list
111329568|NCT03166228|Glycine Agents|glycine agents|mesh-ancestor
111329569|NCT03166228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111329570|NCT03166228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111329571|NCT03166228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111329572|NCT01833793|Levonorgestrel|levonorgestrel|mesh-list
111329573|NCT01833793|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111329574|NCT01833793|Contraceptive Agents|contraceptive agents|mesh-ancestor
110776431|NCT03745664|Prednisolone phosphate|prednisolone phosphate|mesh-list
111329575|NCT01833793|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111329576|NCT01833793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111329577|NCT01833793|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111329578|NCT01833793|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111329579|NCT01833793|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111329580|NCT03154996|Topotecan|topotecan|mesh-list
111329581|NCT03154996|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111329582|NCT03154996|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110776498|NCT02414750|Vemurafenib|vemurafenib|mesh-list
111329583|NCT03154996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111329584|NCT03154996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111329585|NCT03154996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111329586|NCT02475070|Dapagliflozin|dapagliflozin|mesh-list
111329587|NCT02475070|Vildagliptin|vildagliptin|mesh-list
111329588|NCT02475070|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111329589|NCT02475070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111329590|NCT02475070|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111329591|NCT02475070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111329592|NCT02475070|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111329593|NCT02475070|Protease Inhibitors|protease inhibitors|mesh-ancestor
111329594|NCT02475070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111329595|NCT00902161|Propranolol|propranolol|mesh-list
111054007|NCT02347839|Gefitinib|gefitinib|mesh-list
111329596|NCT00902161|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111329597|NCT00902161|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111329598|NCT00902161|Adrenergic Agents|adrenergic agents|mesh-ancestor
111329599|NCT00902161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111329600|NCT00902161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111329601|NCT00902161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111329602|NCT00902161|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111329603|NCT00902161|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111329604|NCT00902161|Vasodilator Agents|vasodilator agents|mesh-ancestor
111329605|NCT01834183|Gemcitabine|gemcitabine|mesh-list
111329606|NCT01834183|Tivozanib|tivozanib|mesh-list
111329607|NCT01834183|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111329608|NCT01834183|Antimetabolites|antimetabolites|mesh-ancestor
111329609|NCT01834183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111329610|NCT01834183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111329611|NCT01834183|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111329612|NCT01834183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111329613|NCT02478580|Modafinil|modafinil|mesh-list
111329614|NCT02478580|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111329615|NCT02478580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111329616|NCT02478580|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
111329617|NCT02478580|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111329618|NCT02478580|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111329619|NCT02478580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110776570|NCT00826462|Glucocorticoids|glucocorticoids|mesh-ancestor
111329620|NCT03210493|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
111329621|NCT03210493|Antiviral Agents|antiviral agents|mesh-ancestor
111329622|NCT03210493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111329623|NCT03210025|Methyldopa|methyldopa|mesh-list
111329624|NCT03210025|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111329625|NCT03210025|Sympatholytics|sympatholytics|mesh-ancestor
111329626|NCT03210025|Autonomic Agents|autonomic agents|mesh-ancestor
111329627|NCT03210025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111329628|NCT03210025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111329629|NCT03210025|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111329630|NCT03210025|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111329631|NCT03210025|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111329632|NCT03210025|Adrenergic Agents|adrenergic agents|mesh-ancestor
111329633|NCT03210025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111329634|NCT03210025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111329635|NCT03219853|Selenium|selenium|mesh-list
111329636|NCT03219853|Antioxidants|antioxidants|mesh-ancestor
111329637|NCT03219853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111329638|NCT03219853|Protective Agents|protective agents|mesh-ancestor
111329639|NCT03219853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111329640|NCT03219853|Trace Elements|trace elements|mesh-ancestor
111329641|NCT03219853|Micronutrients|micronutrients|mesh-ancestor
111329642|NCT05330884|BCG Vaccine|bcg vaccine|mesh-list
111329643|NCT05330884|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111329644|NCT05330884|Immunologic Factors|immunologic factors|mesh-ancestor
111329645|NCT05330884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111329646|NCT02480998|Vaccines|vaccines|mesh-list
111329647|NCT02480998|Immunologic Factors|immunologic factors|mesh-ancestor
111329648|NCT02480998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111329649|NCT03215797|Phenylephrine|phenylephrine|mesh-list
111329650|NCT03215797|Oxymetazoline|oxymetazoline|mesh-list
111329651|NCT03215797|Norepinephrine|norepinephrine|mesh-list
111329652|NCT03215797|Adrenergic Agonists|adrenergic agonists|mesh-list
111329653|NCT03215797|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111329654|NCT03215797|Mydriatics|mydriatics|mesh-ancestor
111329655|NCT03215797|Autonomic Agents|autonomic agents|mesh-ancestor
111329656|NCT03215797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111329657|NCT03215797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111329658|NCT03215797|Sympathomimetics|sympathomimetics|mesh-ancestor
111329659|NCT03215797|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111329660|NCT03215797|Nasal Decongestants|nasal decongestants|mesh-ancestor
111329661|NCT03215797|Respiratory System Agents|respiratory system agents|mesh-ancestor
111329662|NCT03215797|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111329663|NCT03215797|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111329664|NCT03215797|Adrenergic Agents|adrenergic agents|mesh-ancestor
111329665|NCT03215797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111329666|NCT03215797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111329667|NCT03215797|Protective Agents|protective agents|mesh-ancestor
111329668|NCT02485834|Docetaxel|docetaxel|mesh-list
111329669|NCT02485834|Capecitabine|capecitabine|mesh-list
111329670|NCT02485834|Irinotecan|irinotecan|mesh-list
111054075|NCT03542669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111329671|NCT02485834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111329672|NCT02485834|Tubulin Modulators|tubulin modulators|mesh-ancestor
111329673|NCT02485834|Antimitotic Agents|antimitotic agents|mesh-ancestor
111329674|NCT02485834|Mitosis Modulators|mitosis modulators|mesh-ancestor
111329675|NCT02485834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111329676|NCT02485834|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111329677|NCT02485834|Antimetabolites|antimetabolites|mesh-ancestor
111329678|NCT02485834|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111329679|NCT02485834|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111329680|NCT02485834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111329681|NCT01834885|Fluticasone|fluticasone|mesh-list
111329682|NCT01834885|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110776650|NCT04368910|Pyronaridine|pyronaridine|mesh-list
111329683|NCT01834885|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
111329684|NCT01834885|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111329685|NCT01834885|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111329686|NCT01834885|Autonomic Agents|autonomic agents|mesh-ancestor
111329687|NCT01834885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111329688|NCT01834885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111329689|NCT01834885|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111329690|NCT01834885|Respiratory System Agents|respiratory system agents|mesh-ancestor
111329691|NCT01834885|Dermatologic Agents|dermatologic agents|mesh-ancestor
111329692|NCT01834885|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111329693|NCT01834885|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111329694|NCT01834885|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111329695|NCT01834885|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111329696|NCT01834885|Adrenergic Agents|adrenergic agents|mesh-ancestor
111329697|NCT01834885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111329698|NCT01834885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111329699|NCT01834885|Glucocorticoids|glucocorticoids|mesh-ancestor
111329701|NCT01834885|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111329702|NCT01834885|Sympathomimetics|sympathomimetics|mesh-ancestor
111329703|NCT01834963|Interferons|interferons|mesh-list
111329704|NCT01834963|Interferon-alpha|interferon-alpha|mesh-list
111329705|NCT01834963|Cisplatin|cisplatin|mesh-list
111329706|NCT01834963|Fluorouracil|fluorouracil|mesh-list
111329707|NCT01834963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111329708|NCT01834963|Antimetabolites|antimetabolites|mesh-ancestor
111329709|NCT01834963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111329710|NCT01834963|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111329711|NCT01834963|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111329712|NCT01834963|Immunologic Factors|immunologic factors|mesh-ancestor
111329713|NCT01834963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111329714|NCT01834963|Antiviral Agents|antiviral agents|mesh-ancestor
111329715|NCT01834963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111329716|NCT04380103|Bevacizumab|bevacizumab|mesh-list
111329717|NCT04380103|Capecitabine|capecitabine|mesh-list
111329718|NCT04380103|Oxaliplatin|oxaliplatin|mesh-list
111329719|NCT04380103|Irinotecan|irinotecan|mesh-list
111329720|NCT04380103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111329721|NCT04380103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111329722|NCT04380103|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111329723|NCT04380103|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111329724|NCT04380103|Growth Substances|growth substances|mesh-ancestor
111329725|NCT04380103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111329726|NCT04380103|Growth Inhibitors|growth inhibitors|mesh-ancestor
111329727|NCT04380103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111329728|NCT04380103|Antimetabolites|antimetabolites|mesh-ancestor
111329729|NCT04380103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111329730|NCT04380103|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111329731|NCT04380103|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111329732|NCT04380103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111329733|NCT01954966|Progesterone|progesterone|mesh-list
111329734|NCT01954966|Progestins|progestins|mesh-ancestor
111329735|NCT01954966|Hormones|hormones|mesh-ancestor
111329736|NCT01954966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111329737|NCT01954966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111329738|NCT01835353|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
111329739|NCT01835353|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111329740|NCT03836599|Allopurinol|allopurinol|mesh-list
111329741|NCT03836599|Verinurad|verinurad|mesh-list
111329742|NCT03836599|Antimetabolites|antimetabolites|mesh-ancestor
111329743|NCT03836599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111329744|NCT03836599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111329745|NCT03836599|Gout Suppressants|gout suppressants|mesh-ancestor
111329746|NCT03836599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111329747|NCT03836599|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111329748|NCT03836599|Antioxidants|antioxidants|mesh-ancestor
111329749|NCT03836599|Protective Agents|protective agents|mesh-ancestor
111329750|NCT03836599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111329751|NCT01839097|Prednisone|prednisone|mesh-list
111329752|NCT01839097|Cyclophosphamide|cyclophosphamide|mesh-list
111329753|NCT01839097|Doxorubicin|doxorubicin|mesh-list
111329754|NCT01839097|Vincristine|vincristine|mesh-list
111329755|NCT01839097|Belinostat|belinostat|mesh-list
111329756|NCT01839097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111329757|NCT01839097|Immunologic Factors|immunologic factors|mesh-ancestor
111329758|NCT01839097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111329759|NCT01839097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111329760|NCT01839097|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111329761|NCT01839097|Alkylating Agents|alkylating agents|mesh-ancestor
111329762|NCT01839097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111329763|NCT01839097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111329764|NCT01839097|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111329765|NCT01839097|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111329766|NCT01839097|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111329767|NCT01839097|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111329768|NCT01839097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111329769|NCT01839097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111329770|NCT01839097|Glucocorticoids|glucocorticoids|mesh-ancestor
111329771|NCT01839097|Hormones|hormones|mesh-ancestor
111329772|NCT01839097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111329773|NCT01839097|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111329774|NCT01839097|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111329775|NCT01839097|Tubulin Modulators|tubulin modulators|mesh-ancestor
111329776|NCT01839097|Antimitotic Agents|antimitotic agents|mesh-ancestor
111329777|NCT01839097|Mitosis Modulators|mitosis modulators|mesh-ancestor
111329778|NCT01839097|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111329779|NCT01835665|Nimodipine|nimodipine|mesh-list
111329780|NCT01835665|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111329781|NCT01835665|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111329782|NCT01835665|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111329783|NCT01835665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111329784|NCT01835665|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111329785|NCT01835665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111329786|NCT01835665|Vasodilator Agents|vasodilator agents|mesh-ancestor
111329787|NCT01839175|Vaccines|vaccines|mesh-list
110776757|NCT04331704|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111329788|NCT01839175|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
111329789|NCT01839175|Immunologic Factors|immunologic factors|mesh-ancestor
111329790|NCT01839175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111329791|NCT01839253|Atenolol|atenolol|mesh-list
111329792|NCT01839253|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
111329793|NCT01839253|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111329794|NCT01839253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111329795|NCT01839253|Sympatholytics|sympatholytics|mesh-ancestor
111329796|NCT01839253|Autonomic Agents|autonomic agents|mesh-ancestor
111329797|NCT01839253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111329798|NCT01839253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111329799|NCT01839253|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
111329800|NCT01839253|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111329801|NCT01839253|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111329802|NCT01839253|Adrenergic Agents|adrenergic agents|mesh-ancestor
111329803|NCT01839253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111329804|NCT01839253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111329805|NCT01839253|Protease Inhibitors|protease inhibitors|mesh-ancestor
111329806|NCT01839253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111329807|NCT01836289|Cyclophosphamide|cyclophosphamide|mesh-list
111329808|NCT01836289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111329809|NCT01836289|Immunologic Factors|immunologic factors|mesh-ancestor
111329810|NCT01836289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111329811|NCT01836289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111329812|NCT01836289|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111329813|NCT01836289|Alkylating Agents|alkylating agents|mesh-ancestor
111329814|NCT01836289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111329815|NCT01836289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111329816|NCT01836289|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111329817|NCT01839643|Meloxicam|meloxicam|mesh-list
111329818|NCT01839643|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111054232|NCT02298205|Beclomethasone|beclomethasone|mesh-list
111329819|NCT01839643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111329820|NCT01839643|Analgesics|analgesics|mesh-ancestor
111329821|NCT01839643|Sensory System Agents|sensory system agents|mesh-ancestor
111329822|NCT01839643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111329823|NCT01839643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111329824|NCT01839643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111329825|NCT01839643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111329826|NCT01839643|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111329827|NCT01839643|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111329828|NCT01839643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111329829|NCT01839643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111329830|NCT04380025|Pycnogenols|pycnogenols|mesh-list
111329831|NCT04380025|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111329832|NCT04380025|Immunologic Factors|immunologic factors|mesh-ancestor
111329833|NCT04380025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111329834|NCT04380025|Antioxidants|antioxidants|mesh-ancestor
111329835|NCT04380025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111329836|NCT04380025|Protective Agents|protective agents|mesh-ancestor
111329837|NCT04380025|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111329838|NCT01836679|Paclitaxel|paclitaxel|mesh-list
111329839|NCT01836679|Carboplatin|carboplatin|mesh-list
111329840|NCT01836679|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111329841|NCT01836679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111329842|NCT01836679|Tubulin Modulators|tubulin modulators|mesh-ancestor
111329843|NCT01836679|Antimitotic Agents|antimitotic agents|mesh-ancestor
111329844|NCT01836679|Mitosis Modulators|mitosis modulators|mesh-ancestor
111329845|NCT01836679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111329846|NCT00369538|Losartan|losartan|mesh-list
111329847|NCT00369538|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
111329848|NCT00369538|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111329849|NCT00369538|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111329850|NCT00369538|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111329851|NCT00369538|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111329852|NCT00369538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111329853|NCT00369538|Diuretics|diuretics|mesh-ancestor
111329854|NCT00369538|Natriuretic Agents|natriuretic agents|mesh-ancestor
111329855|NCT00369538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111329856|NCT00369538|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
111329857|NCT00369538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111329858|NCT02489734|Sevoflurane|sevoflurane|mesh-list
111329859|NCT02489734|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111329860|NCT02489734|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111329861|NCT02489734|Anesthetics, General|anesthetics, general|mesh-ancestor
111329862|NCT02489734|Anesthetics|anesthetics|mesh-ancestor
111329863|NCT02489734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111329864|NCT02489734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111329865|NCT02490670|Cephalexin|cephalexin|mesh-list
111329866|NCT02490670|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111329867|NCT02490670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111329868|NCT01836757|Dimethyl sulfone|dimethyl sulfone|mesh-list
111329869|NCT01836757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111329870|NCT05451472|Calcium|calcium|mesh-list
111329871|NCT05451472|Parathyroid Hormone|parathyroid hormone|mesh-list
111329872|NCT05451472|Hormones|hormones|mesh-list
111329873|NCT05451472|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111329874|NCT05451472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111329875|NCT05451472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111329876|NCT03218059|Methotrexate|methotrexate|mesh-list
111329877|NCT03218059|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111329878|NCT03218059|Abortifacient Agents|abortifacient agents|mesh-ancestor
111329879|NCT03218059|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111329880|NCT03218059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111329881|NCT03218059|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111329882|NCT03218059|Antimetabolites|antimetabolites|mesh-ancestor
111329883|NCT03218059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111329884|NCT03218059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111329885|NCT03218059|Dermatologic Agents|dermatologic agents|mesh-ancestor
111329886|NCT03218059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111329887|NCT03218059|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111329888|NCT03218059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111329889|NCT03218059|Immunologic Factors|immunologic factors|mesh-ancestor
110776913|NCT03771586|Ketamine|ketamine|mesh-list
111329890|NCT03218059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111329891|NCT03218059|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111329892|NCT01839955|Quinacrine|quinacrine|mesh-list
111329893|NCT01839955|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111329894|NCT01839955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111329895|NCT01839955|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111329896|NCT01839955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111329897|NCT01839955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111329898|NCT01839955|Anticestodal Agents|anticestodal agents|mesh-ancestor
111329899|NCT01839955|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
111329900|NCT01839955|Anthelmintics|anthelmintics|mesh-ancestor
111329901|NCT01839955|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111329902|NCT01839955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111329903|NCT01839955|Antimalarials|antimalarials|mesh-ancestor
111329904|NCT01839955|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111329905|NCT01839955|Antinematodal Agents|antinematodal agents|mesh-ancestor
111329906|NCT02494102|Modafinil|modafinil|mesh-list
111329907|NCT02494102|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111329908|NCT02494102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111329909|NCT02494102|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
111329910|NCT02494102|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111329911|NCT02494102|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111329912|NCT02494102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111329913|NCT00894517|Botulinum Toxins|botulinum toxins|mesh-list
110776943|NCT02335060|Analgesics|analgesics|mesh-ancestor
111329914|NCT00894517|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111329915|NCT00894517|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111329916|NCT00894517|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111329917|NCT00894517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111329918|NCT00894517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111329919|NCT00894517|Cholinergic Agents|cholinergic agents|mesh-ancestor
111329920|NCT00894517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111329921|NCT00894517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111329922|NCT00894517|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111329923|NCT00894517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111329924|NCT01838395|Cytarabine|cytarabine|mesh-list
111329925|NCT01838395|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111329926|NCT01838395|Antimetabolites|antimetabolites|mesh-ancestor
111329927|NCT01838395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111329928|NCT01838395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111329929|NCT01838395|Antiviral Agents|antiviral agents|mesh-ancestor
111329930|NCT01838395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111329931|NCT01838395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111329932|NCT01838395|Immunologic Factors|immunologic factors|mesh-ancestor
111329933|NCT01838395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111329934|NCT00422578|Tadalafil|tadalafil|mesh-list
111329935|NCT00422578|Vasodilator Agents|vasodilator agents|mesh-ancestor
111329936|NCT00422578|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111329937|NCT00422578|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111329938|NCT00422578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111329939|NCT00422578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111329940|NCT00422578|Urological Agents|urological agents|mesh-ancestor
111329941|NCT02494180|Fentanyl|fentanyl|mesh-list
111329942|NCT02494180|Midazolam|midazolam|mesh-list
111329943|NCT02494180|Diazepam|diazepam|mesh-list
111329944|NCT02494180|Meperidine|meperidine|mesh-list
111329945|NCT02494180|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111329946|NCT02494180|Narcotics|narcotics|mesh-ancestor
111329947|NCT02494180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111329948|NCT02494180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111329949|NCT02494180|Analgesics|analgesics|mesh-ancestor
111329950|NCT02494180|Sensory System Agents|sensory system agents|mesh-ancestor
111329951|NCT02494180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111329952|NCT02494180|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111329953|NCT02494180|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111329954|NCT02494180|Anesthetics, General|anesthetics, general|mesh-ancestor
111329955|NCT02494180|Anesthetics|anesthetics|mesh-ancestor
111329956|NCT02494180|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111329957|NCT02494180|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111329958|NCT02494180|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111329959|NCT02494180|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111329960|NCT02494180|GABA Modulators|gaba modulators|mesh-ancestor
111329961|NCT02494180|GABA Agents|gaba agents|mesh-ancestor
111329962|NCT02494180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111329963|NCT02494180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111329964|NCT02494180|Anticonvulsants|anticonvulsants|mesh-ancestor
111329965|NCT02494180|Antiemetics|antiemetics|mesh-ancestor
111329966|NCT02494180|Autonomic Agents|autonomic agents|mesh-ancestor
111329967|NCT02494180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111329968|NCT02494180|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
111329970|NCT02494336|Ropivacaine|ropivacaine|mesh-list
111329971|NCT02494336|Anesthetics, Local|anesthetics, local|mesh-ancestor
111329972|NCT02494336|Anesthetics|anesthetics|mesh-ancestor
111329973|NCT02494336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111329974|NCT02494336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111329975|NCT02494336|Sensory System Agents|sensory system agents|mesh-ancestor
111329976|NCT02494336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111329977|NCT02495038|Rocuronium|rocuronium|mesh-list
111329978|NCT02495038|Atracurium|atracurium|mesh-list
111329979|NCT02495038|Cisatracurium|cisatracurium|mesh-list
111329980|NCT02495038|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
111329981|NCT02495038|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
111329982|NCT02495038|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111329983|NCT02495038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111329984|NCT02495038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111329985|NCT02495038|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
111329986|NCT02495038|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111329987|NCT02495038|Cholinergic Agents|cholinergic agents|mesh-ancestor
111329988|NCT02495038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111329989|NCT02495038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111329990|NCT04956484|Belimumab|belimumab|mesh-list
111329991|NCT04956484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111329992|NCT04956484|Immunologic Factors|immunologic factors|mesh-ancestor
111329993|NCT04956484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111329994|NCT05450458|Sorbitol|sorbitol|mesh-list
111329995|NCT05450458|Hyaluronic Acid|hyaluronic acid|mesh-list
111329996|NCT05450458|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111329997|NCT05450458|Immunologic Factors|immunologic factors|mesh-ancestor
111329998|NCT05450458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111329999|NCT05450458|Viscosupplements|viscosupplements|mesh-ancestor
111330000|NCT05450458|Protective Agents|protective agents|mesh-ancestor
111330001|NCT05450458|Cathartics|cathartics|mesh-ancestor
111330002|NCT05450458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111330003|NCT01720615|Remifentanil|remifentanil|mesh-list
111330004|NCT01720615|Propofol|propofol|mesh-list
111330005|NCT01720615|Sevoflurane|sevoflurane|mesh-list
111330006|NCT01720615|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111330007|NCT01720615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111330008|NCT01720615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111330009|NCT01720615|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111330010|NCT01720615|Anesthetics, General|anesthetics, general|mesh-ancestor
111330011|NCT01720615|Anesthetics|anesthetics|mesh-ancestor
111330012|NCT01720615|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111330013|NCT01720615|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111330014|NCT01720615|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111330015|NCT01720615|Narcotics|narcotics|mesh-ancestor
111330016|NCT01720615|Analgesics|analgesics|mesh-ancestor
111330017|NCT01720615|Sensory System Agents|sensory system agents|mesh-ancestor
111330018|NCT01720615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111330019|NCT01837927|Glycopyrrolate|glycopyrrolate|mesh-list
111330020|NCT01837927|Tiotropium Bromide|tiotropium bromide|mesh-list
111330021|NCT01837927|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111330022|NCT01837927|Autonomic Agents|autonomic agents|mesh-ancestor
111330023|NCT01837927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111330024|NCT01837927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111330025|NCT01837927|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111330026|NCT01837927|Respiratory System Agents|respiratory system agents|mesh-ancestor
111330027|NCT01837927|Parasympatholytics|parasympatholytics|mesh-ancestor
111330028|NCT01837927|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111330029|NCT01837927|Cholinergic Agents|cholinergic agents|mesh-ancestor
111330030|NCT01837927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111330031|NCT01837927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111330032|NCT01837927|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111330033|NCT01837927|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111330034|NCT01838083|Insulin Glargine|insulin glargine|mesh-list
111330035|NCT01838083|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111330036|NCT01838083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111330037|NCT02504554|Vancomycin|vancomycin|mesh-list
111330038|NCT02504554|Omeprazole|omeprazole|mesh-list
111330039|NCT02504554|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111330040|NCT02504554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111330041|NCT02504554|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111330042|NCT02504554|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111054451|NCT02298985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111330043|NCT02504554|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111330044|NCT02504554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111330045|NCT02504554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111330046|NCT01838473|Lobeline|lobeline|mesh-list
111330047|NCT01838473|Nicotine|nicotine|mesh-list
111330048|NCT01838473|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111330049|NCT01838473|Autonomic Agents|autonomic agents|mesh-ancestor
111330050|NCT01838473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111330051|NCT01838473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111330052|NCT01838473|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111330053|NCT01838473|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111330054|NCT01838473|Cholinergic Agents|cholinergic agents|mesh-ancestor
111330055|NCT01838473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111330056|NCT01838473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111330057|NCT01838473|Respiratory System Agents|respiratory system agents|mesh-ancestor
111330058|NCT04937452|Rotigotine|rotigotine|mesh-list
111330059|NCT04937452|Dopamine Agonists|dopamine agonists|mesh-ancestor
111330060|NCT04937452|Dopamine Agents|dopamine agents|mesh-ancestor
111330061|NCT04937452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111330062|NCT04937452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111330063|NCT04937452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111330064|NCT01838707|Fentanyl|fentanyl|mesh-list
111330065|NCT01838707|Morphine|morphine|mesh-list
111330066|NCT01838707|Bupivacaine|bupivacaine|mesh-list
111330067|NCT01838707|Anesthetics, Local|anesthetics, local|mesh-ancestor
111330068|NCT01838707|Anesthetics|anesthetics|mesh-ancestor
111330069|NCT01838707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111330070|NCT01838707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111330071|NCT01838707|Sensory System Agents|sensory system agents|mesh-ancestor
111330072|NCT01838707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111330073|NCT01838707|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111330074|NCT01838707|Narcotics|narcotics|mesh-ancestor
111330075|NCT01838707|Analgesics|analgesics|mesh-ancestor
111330076|NCT01838707|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111330077|NCT01838707|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111330078|NCT01838707|Anesthetics, General|anesthetics, general|mesh-ancestor
111330079|NCT02506114|Ipilimumab|ipilimumab|mesh-list
111330080|NCT02506114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111330081|NCT02506114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111330082|NCT02506114|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111330083|NCT02506114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111330084|NCT04920994|Bupivacaine|bupivacaine|mesh-list
111330085|NCT04920994|Anesthetics, Local|anesthetics, local|mesh-ancestor
111330086|NCT04920994|Anesthetics|anesthetics|mesh-ancestor
111330087|NCT04920994|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111330088|NCT04920994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111330089|NCT04920994|Sensory System Agents|sensory system agents|mesh-ancestor
110777287|NCT04369950|Narcotics|narcotics|mesh-ancestor
111330090|NCT04920994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111330091|NCT02506660|Dexamethasone|dexamethasone|mesh-list
111330092|NCT02506660|Dexamethasone acetate|dexamethasone acetate|mesh-list
111330093|NCT02506660|Bupivacaine|bupivacaine|mesh-list
111330094|NCT02506660|BB 1101|bb 1101|mesh-list
111330095|NCT02506660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111330096|NCT02506660|Antiemetics|antiemetics|mesh-ancestor
111330097|NCT02506660|Autonomic Agents|autonomic agents|mesh-ancestor
111330098|NCT02506660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111330099|NCT02506660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111330100|NCT02506660|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111330101|NCT02506660|Glucocorticoids|glucocorticoids|mesh-ancestor
111330102|NCT02506660|Hormones|hormones|mesh-ancestor
111330103|NCT02506660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111330104|NCT02506660|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111330105|NCT02506660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111330106|NCT02506660|Protease Inhibitors|protease inhibitors|mesh-ancestor
111330107|NCT02506660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111330108|NCT02506660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111330109|NCT02506660|Anesthetics, Local|anesthetics, local|mesh-ancestor
111330110|NCT02506660|Anesthetics|anesthetics|mesh-ancestor
111330111|NCT02506660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111330112|NCT02506660|Sensory System Agents|sensory system agents|mesh-ancestor
111330113|NCT02509624|Selonsertib|selonsertib|mesh-list
111330114|NCT02509624|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111330115|NCT02509624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111330116|NCT02509624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111330117|NCT01726075|Brimonidine Tartrate|brimonidine tartrate|mesh-list
111330118|NCT01726075|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111330119|NCT01726075|Somatostatin|somatostatin|mesh-list
111330120|NCT01726075|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111330121|NCT01726075|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111330122|NCT01726075|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111330123|NCT01726075|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111330124|NCT01726075|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111330125|NCT01726075|Adrenergic Agents|adrenergic agents|mesh-ancestor
111330126|NCT01726075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111330127|NCT01726075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111330128|NCT01726075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111330129|NCT01726075|Hormones|hormones|mesh-ancestor
111330130|NCT01726075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111330131|NCT00369694|Terlipressin|terlipressin|mesh-list
111330132|NCT00369694|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111330133|NCT00369694|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111330134|NCT01721707|Latanoprost|latanoprost|mesh-list
111330135|NCT01721707|Brinzolamide|brinzolamide|mesh-list
111330136|NCT01721707|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
111330137|NCT01721707|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111330138|NCT01721707|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
111330139|NCT01721707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111330140|NCT01721707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111330141|NCT05448586|Analgesics, Opioid|analgesics, opioid|mesh-list
111330142|NCT05448586|Narcotics|narcotics|mesh-ancestor
111330143|NCT05448586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111330144|NCT05448586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111330145|NCT05448586|Analgesics|analgesics|mesh-ancestor
111330146|NCT05448586|Sensory System Agents|sensory system agents|mesh-ancestor
111330147|NCT05448586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111330148|NCT01726465|Acetylcysteine|acetylcysteine|mesh-list
111330149|NCT01726465|Methylprednisolone|methylprednisolone|mesh-list
111330150|NCT01726465|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111330151|NCT01726465|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111330152|NCT01726465|Prednisolone|prednisolone|mesh-list
111330153|NCT01726465|Prednisolone acetate|prednisolone acetate|mesh-list
111330154|NCT01726465|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111330155|NCT01726465|Prednisolone phosphate|prednisolone phosphate|mesh-list
111330156|NCT01726465|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111330157|NCT01726465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111330158|NCT01726465|Antiemetics|antiemetics|mesh-ancestor
111330159|NCT01726465|Autonomic Agents|autonomic agents|mesh-ancestor
111330160|NCT01726465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111330161|NCT01726465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111330162|NCT01726465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111330163|NCT01726465|Glucocorticoids|glucocorticoids|mesh-ancestor
111330164|NCT01726465|Hormones|hormones|mesh-ancestor
111330165|NCT01726465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111330166|NCT01726465|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111330167|NCT01726465|Protective Agents|protective agents|mesh-ancestor
111330168|NCT01726465|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111330169|NCT01726465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111330170|NCT01726465|Antiviral Agents|antiviral agents|mesh-ancestor
111330171|NCT01726465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111330172|NCT01726465|Expectorants|expectorants|mesh-ancestor
111330173|NCT01726465|Respiratory System Agents|respiratory system agents|mesh-ancestor
111330174|NCT01726465|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111330175|NCT01726465|Antioxidants|antioxidants|mesh-ancestor
111330176|NCT01726465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111330177|NCT01726465|Antidotes|antidotes|mesh-ancestor
111330178|NCT01720303|Insulin|insulin|mesh-list
111330179|NCT01720303|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111330180|NCT01720303|Repaglinide|repaglinide|mesh-list
111054602|NCT04083183|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111330181|NCT01720303|Isophane Insulin, Human|isophane insulin, human|mesh-list
111054603|NCT04083183|Alkylating Agents|alkylating agents|mesh-ancestor
111054604|NCT04083183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111054605|NCT04083183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111054606|NCT04083183|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111054607|NCT04083183|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111054608|NCT04083183|Antimetabolites|antimetabolites|mesh-ancestor
111054609|NCT04083183|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111054610|NCT04083183|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111054611|NCT04083183|Antitubercular Agents|antitubercular agents|mesh-ancestor
111054612|NCT04083183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111054613|NCT04083183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111330182|NCT01720303|Insulin, Isophane|insulin, isophane|mesh-list
111330183|NCT01720303|Isophane insulin, beef|isophane insulin, beef|mesh-list
111330184|NCT01720303|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111330185|NCT01720303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111330186|NCT02733042|Rituximab|rituximab|mesh-list
111330187|NCT02733042|Durvalumab|durvalumab|mesh-list
111330188|NCT02733042|Lenalidomide|lenalidomide|mesh-list
111330189|NCT02733042|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
111330190|NCT02733042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111330191|NCT02733042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111330192|NCT02733042|Immunologic Factors|immunologic factors|mesh-ancestor
111330193|NCT02733042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111330194|NCT02733042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111330195|NCT02733042|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111330196|NCT02733042|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111330197|NCT02733042|Growth Substances|growth substances|mesh-ancestor
111330198|NCT02733042|Growth Inhibitors|growth inhibitors|mesh-ancestor
111330199|NCT02733042|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111330200|NCT02733042|Alkylating Agents|alkylating agents|mesh-ancestor
111330201|NCT02733042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111330202|NCT00912301|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
111330203|NCT00912301|Cathartics|cathartics|mesh-ancestor
111330204|NCT00912301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111330205|NCT04850638|Furosemide|furosemide|mesh-list
111330206|NCT04850638|Diuretics|diuretics|mesh-ancestor
111330207|NCT04850638|Natriuretic Agents|natriuretic agents|mesh-ancestor
111330208|NCT04850638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111330209|NCT04850638|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
111330210|NCT04850638|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111330211|NCT04850638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111330212|NCT01726777|Vitamin D|vitamin d|mesh-list
111330213|NCT01726777|Ergocalciferols|ergocalciferols|mesh-list
111330214|NCT01726777|Cholecalciferol|cholecalciferol|mesh-list
111330215|NCT01726777|Vitamins|vitamins|mesh-list
111330216|NCT01726777|Micronutrients|micronutrients|mesh-ancestor
111330217|NCT01726777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110777482|NCT04052204|Avelumab|avelumab|mesh-list
111330218|NCT01726777|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111330219|NCT01726777|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111330220|NCT05532306|Ribavirin|ribavirin|mesh-list
111330221|NCT05532306|Antimetabolites|antimetabolites|mesh-ancestor
111330222|NCT05532306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111330223|NCT05532306|Antiviral Agents|antiviral agents|mesh-ancestor
111330224|NCT05532306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111330225|NCT05602038|Morphine|morphine|mesh-list
111330226|NCT05602038|Bupivacaine|bupivacaine|mesh-list
111330227|NCT05602038|Anesthetics, Local|anesthetics, local|mesh-ancestor
111330228|NCT05602038|Anesthetics|anesthetics|mesh-ancestor
111330229|NCT05602038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111330230|NCT05602038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111330231|NCT05602038|Sensory System Agents|sensory system agents|mesh-ancestor
111330232|NCT05602038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111330233|NCT05602038|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111330234|NCT05602038|Narcotics|narcotics|mesh-ancestor
111330235|NCT05602038|Analgesics|analgesics|mesh-ancestor
111330236|NCT01722409|Dexmedetomidine|dexmedetomidine|mesh-list
111330237|NCT01722409|Sevoflurane|sevoflurane|mesh-list
111330238|NCT01722409|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111330239|NCT01722409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111330240|NCT01722409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111330241|NCT01722409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111330242|NCT01722409|Analgesics|analgesics|mesh-ancestor
111330243|NCT01722409|Sensory System Agents|sensory system agents|mesh-ancestor
111330244|NCT01722409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111330245|NCT01722409|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111330246|NCT01722409|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111330247|NCT01722409|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111330248|NCT01722409|Adrenergic Agents|adrenergic agents|mesh-ancestor
111330249|NCT01722409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111330250|NCT01722409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111330251|NCT01722409|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111330252|NCT01722409|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111330253|NCT01722409|Anesthetics, General|anesthetics, general|mesh-ancestor
111330254|NCT01722409|Anesthetics|anesthetics|mesh-ancestor
111330255|NCT01726933|Dimethyl Fumarate|dimethyl fumarate|mesh-list
111330256|NCT01726933|Dermatologic Agents|dermatologic agents|mesh-ancestor
111330257|NCT01726933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111330258|NCT01726933|Immunologic Factors|immunologic factors|mesh-ancestor
111330259|NCT01726933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111330260|NCT01727401|PENTA|penta|mesh-list
111330261|NCT01727401|Fondaparinux|fondaparinux|mesh-list
111330262|NCT01727401|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111330263|NCT01727401|Antithrombins|antithrombins|mesh-ancestor
111330264|NCT01727401|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111330265|NCT01727401|Protease Inhibitors|protease inhibitors|mesh-ancestor
111330266|NCT01727401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111330267|NCT01727401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111330268|NCT01727401|Anticoagulants|anticoagulants|mesh-ancestor
111330269|NCT01727401|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111330270|NCT01727401|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111330271|NCT02513212|Fluorides|fluorides|mesh-list
111330272|NCT02513212|Tin Fluorides|tin fluorides|mesh-list
111330273|NCT02513212|Cariostatic Agents|cariostatic agents|mesh-ancestor
111330274|NCT02513212|Protective Agents|protective agents|mesh-ancestor
111330275|NCT02513212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111330276|NCT02513446|Itraconazole|itraconazole|mesh-list
111330277|NCT02513446|Antifungal Agents|antifungal agents|mesh-ancestor
111330278|NCT02513446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111330279|NCT02513446|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111330280|NCT02513446|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111330281|NCT02513446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111330282|NCT02513446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111330283|NCT02513446|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111330284|NCT02513446|Hormone Antagonists|hormone antagonists|mesh-ancestor
111330285|NCT02513446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111330286|NCT02513446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111330287|NCT02513446|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111330288|NCT00363844|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111330289|NCT00363844|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110777563|NCT03629054|Metformin|metformin|mesh-list
111330290|NCT00363844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111330291|NCT00363844|Incretins|incretins|mesh-ancestor
111330292|NCT00363844|Hormones|hormones|mesh-ancestor
111330293|NCT00363844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111330294|NCT00363844|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111330295|NCT00363844|Protease Inhibitors|protease inhibitors|mesh-ancestor
111330296|NCT00363844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111330297|NCT00363844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111330298|NCT04687800|Dexamethasone|dexamethasone|mesh-list
111330299|NCT04687800|Difluprednate|difluprednate|mesh-list
111330300|NCT04687800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111330301|NCT04687800|Antiemetics|antiemetics|mesh-ancestor
111330302|NCT04687800|Autonomic Agents|autonomic agents|mesh-ancestor
111330303|NCT04687800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111330304|NCT04687800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111330305|NCT04687800|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111330306|NCT04687800|Glucocorticoids|glucocorticoids|mesh-ancestor
111330307|NCT04687800|Hormones|hormones|mesh-ancestor
111330308|NCT04687800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111330309|NCT04687800|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111330310|NCT04687800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111330311|NCT00864383|Moxifloxacin|moxifloxacin|mesh-list
111330312|NCT00864383|Rifampin|rifampin|mesh-list
111330313|NCT00864383|Isoniazid|isoniazid|mesh-list
111330314|NCT00864383|Pyrazinamide|pyrazinamide|mesh-list
111330315|NCT00864383|Ethambutol|ethambutol|mesh-list
111330316|NCT00864383|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111330317|NCT00864383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111330318|NCT00864383|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111330319|NCT00864383|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111330320|NCT00864383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111330321|NCT00864383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111330322|NCT00864383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111330323|NCT00864383|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111330324|NCT00864383|Antitubercular Agents|antitubercular agents|mesh-ancestor
111330325|NCT00864383|Leprostatic Agents|leprostatic agents|mesh-ancestor
111330326|NCT00864383|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111330327|NCT00864383|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111330328|NCT00864383|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111330329|NCT00864383|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
111330330|NCT00864383|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
111330331|NCT00864383|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
111330332|NCT00864383|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111330333|NCT00864383|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
111330334|NCT00864383|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111330335|NCT00864383|Antimetabolites|antimetabolites|mesh-ancestor
111330336|NCT00864383|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111330337|NCT05532072|Sirolimus|sirolimus|mesh-list
111330338|NCT05532072|Methylprednisolone|methylprednisolone|mesh-list
111330339|NCT05532072|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111330340|NCT05532072|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111330341|NCT05532072|Prednisolone|prednisolone|mesh-list
111330342|NCT05532072|Prednisolone acetate|prednisolone acetate|mesh-list
111330343|NCT05532072|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111330344|NCT05532072|Prednisolone phosphate|prednisolone phosphate|mesh-list
110777588|NCT02573896|Lenalidomide|lenalidomide|mesh-list
111330345|NCT05532072|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111330346|NCT05532072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111330347|NCT05532072|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111330348|NCT05532072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111330349|NCT05532072|Antifungal Agents|antifungal agents|mesh-ancestor
111330350|NCT05532072|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111330351|NCT05532072|Immunologic Factors|immunologic factors|mesh-ancestor
111330352|NCT05532072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111330353|NCT05532072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111330354|NCT05532072|Antiemetics|antiemetics|mesh-ancestor
111330355|NCT05532072|Autonomic Agents|autonomic agents|mesh-ancestor
111330356|NCT05532072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111330357|NCT05532072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111330358|NCT05532072|Glucocorticoids|glucocorticoids|mesh-ancestor
111330359|NCT05532072|Hormones|hormones|mesh-ancestor
111330360|NCT05532072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111330361|NCT05532072|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111330362|NCT05532072|Protective Agents|protective agents|mesh-ancestor
110777605|NCT02154490|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111330363|NCT05532072|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111330364|NCT00864539|Vitamin D|vitamin d|mesh-list
111330365|NCT00864539|Calcium|calcium|mesh-list
111330366|NCT00864539|Vitamins|vitamins|mesh-ancestor
111330367|NCT00864539|Micronutrients|micronutrients|mesh-ancestor
111330368|NCT00864539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111330369|NCT00864539|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111330370|NCT00864539|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111330371|NCT00827255|Cyclosporine|cyclosporine|mesh-list
111330372|NCT00827255|Cyclosporins|cyclosporins|mesh-list
111330373|NCT00827255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111330374|NCT00827255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111330375|NCT00827255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111330376|NCT00827255|Immunologic Factors|immunologic factors|mesh-ancestor
111330377|NCT00827255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110777675|NCT00972478|Hormones|hormones|mesh-ancestor
111330378|NCT00827255|Antifungal Agents|antifungal agents|mesh-ancestor
111330379|NCT00827255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111330380|NCT00827255|Dermatologic Agents|dermatologic agents|mesh-ancestor
111330381|NCT00827255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111330382|NCT00827255|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111330383|NCT02153489|Bromides|bromides|mesh-list
111330384|NCT02153489|Anticonvulsants|anticonvulsants|mesh-ancestor
111330385|NCT04627012|Pembrolizumab|pembrolizumab|mesh-list
111330386|NCT04627012|Tislelizumab|tislelizumab|mesh-list
111330387|NCT04627012|Lenvatinib|lenvatinib|mesh-list
111330388|NCT04627012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111330389|NCT04627012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111330390|NCT04627012|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111330391|NCT04627012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111330392|NCT04627012|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111330393|NCT04627012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111330394|NCT00866879|Sirolimus|sirolimus|mesh-list
111330395|NCT00866879|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111330396|NCT00866879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111330397|NCT00866879|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111330398|NCT00866879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111330399|NCT00866879|Antifungal Agents|antifungal agents|mesh-ancestor
111330400|NCT00866879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111330401|NCT00866879|Immunologic Factors|immunologic factors|mesh-ancestor
111330402|NCT00866879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111330403|NCT02311920|Nivolumab|nivolumab|mesh-list
111330404|NCT02311920|Ipilimumab|ipilimumab|mesh-list
111330405|NCT02311920|Temozolomide|temozolomide|mesh-list
111330406|NCT02311920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111330407|NCT02311920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111330408|NCT02311920|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111330409|NCT02311920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111330410|NCT02311920|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111330411|NCT02311920|Alkylating Agents|alkylating agents|mesh-ancestor
111330412|NCT02153723|Glatiramer Acetate|glatiramer acetate|mesh-list
111330414|NCT02153723|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111330415|NCT02153723|Immunologic Factors|immunologic factors|mesh-ancestor
110777725|NCT01089855|Analgesics|analgesics|mesh-ancestor
111330416|NCT02153723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111330417|NCT02153723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111330418|NCT02153723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111330419|NCT00828191|Progesterone|progesterone|mesh-list
111330420|NCT00828191|Progestins|progestins|mesh-ancestor
111330421|NCT00828191|Hormones|hormones|mesh-ancestor
111330422|NCT00828191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111330423|NCT00828191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111330424|NCT00867659|Cetrorelix|cetrorelix|mesh-list
111330425|NCT00867659|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111330426|NCT00867659|Fertility Agents|fertility agents|mesh-ancestor
111330427|NCT00867659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111330428|NCT00867659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111330429|NCT00867659|Hormone Antagonists|hormone antagonists|mesh-ancestor
111330430|NCT00867659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111330431|NCT05531058|Vaccines|vaccines|mesh-list
111330432|NCT05531058|Immunologic Factors|immunologic factors|mesh-ancestor
110777765|NCT03243838|Apatinib|apatinib|mesh-list
111330433|NCT05531058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111330434|NCT00828347|Alfacalcidol|alfacalcidol|mesh-list
111330435|NCT00828347|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
111330436|NCT00828347|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111330437|NCT00828347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111330438|NCT00828347|Vitamins|vitamins|mesh-ancestor
111330439|NCT00828347|Micronutrients|micronutrients|mesh-ancestor
111330440|NCT02939872|Aspirin|aspirin|mesh-list
111330441|NCT02939872|Clopidogrel|clopidogrel|mesh-list
111330442|NCT02939872|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111330443|NCT02939872|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111330444|NCT02939872|Analgesics|analgesics|mesh-ancestor
111330445|NCT02939872|Sensory System Agents|sensory system agents|mesh-ancestor
111330446|NCT02939872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111330447|NCT02939872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111330448|NCT02939872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111330449|NCT02939872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111330450|NCT02939872|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111330451|NCT02939872|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111330452|NCT02939872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111330453|NCT02939872|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111330454|NCT02939872|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111330455|NCT02939872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111330456|NCT02939872|Antipyretics|antipyretics|mesh-ancestor
111330457|NCT02939872|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111330458|NCT02939872|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111330459|NCT02939872|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111330460|NCT02939872|Purinergic Agents|purinergic agents|mesh-ancestor
111330461|NCT02939872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111330462|NCT00829049|Adapalene|adapalene|mesh-list
111330463|NCT00829049|Tazarotene|tazarotene|mesh-list
111330464|NCT00829049|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111330465|NCT00829049|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111330466|NCT00829049|Analgesics|analgesics|mesh-ancestor
111330467|NCT00829049|Sensory System Agents|sensory system agents|mesh-ancestor
111330468|NCT00829049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111330469|NCT00829049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111330470|NCT00829049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111330471|NCT00829049|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111330472|NCT00829049|Dermatologic Agents|dermatologic agents|mesh-ancestor
111330473|NCT00829049|Keratolytic Agents|keratolytic agents|mesh-ancestor
111330474|NCT02859064|Lanreotide|lanreotide|mesh-list
111330475|NCT02859064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111330476|NCT04303702|Oxytocin|oxytocin|mesh-list
111330477|NCT04303702|Oxytocics|oxytocics|mesh-ancestor
111330478|NCT04303702|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111330479|NCT04303702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111330480|NCT01727557|Anesthetics|anesthetics|mesh-list
111330481|NCT01727557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111330482|NCT01727557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111330483|NCT04529044|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
111330484|NCT04529044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111330485|NCT04529044|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111330486|NCT00913003|Lidocaine|lidocaine|mesh-list
111330488|NCT00913003|Anesthetics|anesthetics|mesh-ancestor
111330489|NCT00913003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111330490|NCT00913003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111330491|NCT00913003|Sensory System Agents|sensory system agents|mesh-ancestor
111330492|NCT00913003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111330493|NCT00913003|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111330494|NCT00913003|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111330495|NCT00913003|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111330496|NCT00913003|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111330497|NCT00913003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111330498|NCT00869141|Timolol|timolol|mesh-list
111330499|NCT00869141|Brimonidine Tartrate|brimonidine tartrate|mesh-list
111330500|NCT00869141|Dorzolamide|dorzolamide|mesh-list
111330501|NCT00869141|Brinzolamide|brinzolamide|mesh-list
111330502|NCT00869141|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111330503|NCT00869141|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111330504|NCT00869141|Adrenergic Agents|adrenergic agents|mesh-ancestor
111330505|NCT00869141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111330506|NCT00869141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111330507|NCT00869141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111330508|NCT00869141|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111330509|NCT00869141|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111330510|NCT00869141|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111330511|NCT00869141|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111330512|NCT00869141|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111330513|NCT00869141|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110777920|NCT00745108|Hormones|hormones|mesh-ancestor
111330514|NCT00869141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111330515|NCT01722799|Paclitaxel|paclitaxel|mesh-list
111330516|NCT01722799|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111330517|NCT01722799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111330518|NCT01722799|Tubulin Modulators|tubulin modulators|mesh-ancestor
111330519|NCT01722799|Antimitotic Agents|antimitotic agents|mesh-ancestor
111330520|NCT01722799|Mitosis Modulators|mitosis modulators|mesh-ancestor
111330521|NCT01722799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111330522|NCT04260022|Blinatumomab|blinatumomab|mesh-list
111330523|NCT04260022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111330524|NCT01606176|Nabiximols|nabiximols|mesh-list
111330525|NCT01606176|Analgesics|analgesics|mesh-ancestor
111330526|NCT01606176|Sensory System Agents|sensory system agents|mesh-ancestor
111330527|NCT01606176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111330528|NCT01606176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111330529|NCT00913081|Quercetin|quercetin|mesh-list
111330530|NCT00913081|Antioxidants|antioxidants|mesh-ancestor
111330531|NCT00913081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111330532|NCT00913081|Protective Agents|protective agents|mesh-ancestor
111330533|NCT00913081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111330534|NCT04077424|Hemagglutinins|hemagglutinins|mesh-list
111330535|NCT04077424|Vaccines|vaccines|mesh-list
111330536|NCT04077424|Immunologic Factors|immunologic factors|mesh-ancestor
111330537|NCT04077424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111330538|NCT04077424|Agglutinins|agglutinins|mesh-ancestor
111330539|NCT04077424|Coagulants|coagulants|mesh-ancestor
111330540|NCT01727869|Cetuximab|cetuximab|mesh-list
111330541|NCT01727869|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111330542|NCT01727869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111330543|NCT01727869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111330544|NCT01727869|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111330545|NCT01727869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111330546|NCT01727869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111330547|NCT00371020|Heparin|heparin|mesh-list
111330548|NCT00371020|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
111330549|NCT00371020|Tinzaparin|tinzaparin|mesh-list
111330550|NCT00371020|Dalteparin|dalteparin|mesh-list
111330551|NCT00371020|Anticoagulants|anticoagulants|mesh-ancestor
111330552|NCT00371020|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111330553|NCT00371020|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111330554|NCT00371020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111330555|NCT04476628|Budesonide|budesonide|mesh-list
111330556|NCT04476628|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111330557|NCT04476628|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111330558|NCT04476628|Autonomic Agents|autonomic agents|mesh-ancestor
111330559|NCT04476628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111330560|NCT04476628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111330561|NCT04476628|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111330562|NCT04476628|Respiratory System Agents|respiratory system agents|mesh-ancestor
111330563|NCT04476628|Glucocorticoids|glucocorticoids|mesh-ancestor
111330564|NCT04476628|Hormones|hormones|mesh-ancestor
111330565|NCT04476628|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111330566|NCT01728181|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111330567|NCT01728181|Tivozanib|tivozanib|mesh-list
111330568|NCT01728181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111330569|NCT01728181|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111330570|NCT01728181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111330571|NCT01728181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111330572|NCT04378231|Amoxicillin|amoxicillin|mesh-list
111330573|NCT04378231|Clavulanic Acid|clavulanic acid|mesh-list
111330574|NCT04378231|Clavulanic Acids|clavulanic acids|mesh-list
111330575|NCT04378231|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
111330576|NCT04378231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111330577|NCT04378231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110778012|NCT00090142|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111330578|NCT04378231|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
111330579|NCT04378231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111330580|NCT04378231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111330581|NCT04475302|BCG Vaccine|bcg vaccine|mesh-list
111330582|NCT04475302|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111330583|NCT04475302|Immunologic Factors|immunologic factors|mesh-ancestor
111330584|NCT04475302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111330585|NCT01728571|Vitamin D|vitamin d|mesh-list
111330586|NCT01728571|Ergocalciferols|ergocalciferols|mesh-list
111330587|NCT01728571|Cholecalciferol|cholecalciferol|mesh-list
111330588|NCT01728571|Vitamins|vitamins|mesh-list
111330589|NCT01728571|Micronutrients|micronutrients|mesh-ancestor
111330590|NCT01728571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111330591|NCT01728571|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111330592|NCT01728571|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111330593|NCT00832637|Gemcitabine|gemcitabine|mesh-list
111330594|NCT00832637|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111330595|NCT00832637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111330596|NCT00832637|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111330597|NCT00832637|Antimetabolites|antimetabolites|mesh-ancestor
111330598|NCT00832637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111330599|NCT00832637|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111330600|NCT00832637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111330601|NCT03408457|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111330602|NCT03408457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111330603|NCT00370240|Ropivacaine|ropivacaine|mesh-list
111330604|NCT00370240|Anesthetics, Local|anesthetics, local|mesh-ancestor
111330605|NCT00370240|Anesthetics|anesthetics|mesh-ancestor
111330606|NCT00370240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111330607|NCT00370240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111330608|NCT00370240|Sensory System Agents|sensory system agents|mesh-ancestor
111330609|NCT00370240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111330610|NCT03408145|Hyaluronic Acid|hyaluronic acid|mesh-list
111330611|NCT03408145|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111330612|NCT03408145|Immunologic Factors|immunologic factors|mesh-ancestor
111330613|NCT03408145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111330614|NCT03408145|Viscosupplements|viscosupplements|mesh-ancestor
110778114|NCT00071799|Antiviral Agents|antiviral agents|mesh-ancestor
111330615|NCT03408145|Protective Agents|protective agents|mesh-ancestor
111330616|NCT02475772|Cisplatin|cisplatin|mesh-list
111330617|NCT02475772|Doxorubicin|doxorubicin|mesh-list
111330618|NCT02475772|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111330619|NCT02475772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111330620|NCT02475772|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111330621|NCT02475772|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111330622|NCT02475772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111330623|NCT02475772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111330624|NCT02475772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111330625|NCT00915655|Ritonavir|ritonavir|mesh-list
111330626|NCT00915655|Darunavir|darunavir|mesh-list
111330627|NCT00915655|Lamivudine|lamivudine|mesh-list
111330628|NCT00915655|Zidovudine|zidovudine|mesh-list
111330629|NCT00915655|Abacavir|abacavir|mesh-list
111330630|NCT00915655|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111330631|NCT00915655|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111330632|NCT00915655|Protease Inhibitors|protease inhibitors|mesh-ancestor
111330633|NCT00915655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111330634|NCT00915655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111330635|NCT00915655|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111330636|NCT00915655|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111330637|NCT00915655|Antiviral Agents|antiviral agents|mesh-ancestor
111330638|NCT00915655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111330639|NCT00915655|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111330640|NCT00915655|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111330641|NCT00915655|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111330642|NCT00915655|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111330643|NCT00915655|Antimetabolites|antimetabolites|mesh-ancestor
111330644|NCT03835507|Epoetin Alfa|epoetin alfa|mesh-list
111330645|NCT03835507|Hematinics|hematinics|mesh-ancestor
111330646|NCT05524974|Paclitaxel|paclitaxel|mesh-list
111330647|NCT05524974|Oxaliplatin|oxaliplatin|mesh-list
111330648|NCT05524974|Apatinib|apatinib|mesh-list
111330649|NCT05524974|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111330650|NCT05524974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111330651|NCT05524974|Tubulin Modulators|tubulin modulators|mesh-ancestor
111330652|NCT05524974|Antimitotic Agents|antimitotic agents|mesh-ancestor
111330653|NCT05524974|Mitosis Modulators|mitosis modulators|mesh-ancestor
111330654|NCT05524974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111330655|NCT05524974|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111330656|NCT05524974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111330657|NCT00870467|Adalimumab|adalimumab|mesh-list
111330658|NCT00870467|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111330659|NCT00870467|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111330660|NCT00870467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111330661|NCT00370318|Acetaminophen|acetaminophen|mesh-list
111330662|NCT00370318|Vaccines|vaccines|mesh-list
111330663|NCT00370318|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
111330664|NCT00370318|Immunologic Factors|immunologic factors|mesh-ancestor
111330665|NCT00370318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111330666|NCT00370318|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111330667|NCT00370318|Analgesics|analgesics|mesh-ancestor
111330668|NCT00370318|Sensory System Agents|sensory system agents|mesh-ancestor
111330669|NCT00370318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111330670|NCT00370318|Antipyretics|antipyretics|mesh-ancestor
111330671|NCT01728961|Lumefantrine|lumefantrine|mesh-list
111330672|NCT01728961|Artemether|artemether|mesh-list
111330673|NCT01728961|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
111330674|NCT01728961|Antimalarials|antimalarials|mesh-ancestor
111330675|NCT01728961|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111330676|NCT01728961|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111330677|NCT01728961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111330678|NCT01723501|Chlorhexidine|chlorhexidine|mesh-list
111330679|NCT01723501|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111330680|NCT01723501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111330681|NCT01723501|Disinfectants|disinfectants|mesh-ancestor
111330682|NCT00872027|Escitalopram|escitalopram|mesh-list
111330683|NCT00872027|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111330684|NCT00872027|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111330685|NCT00872027|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111330686|NCT00872027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111330687|NCT00872027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111330688|NCT00872027|Serotonin Agents|serotonin agents|mesh-ancestor
111330689|NCT00872027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111330690|NCT01854814|Mycophenolic Acid|mycophenolic acid|mesh-list
111330691|NCT01854814|Losartan|losartan|mesh-list
111330692|NCT01854814|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111330693|NCT01854814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111330694|NCT01854814|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111330695|NCT01854814|Antitubercular Agents|antitubercular agents|mesh-ancestor
111330696|NCT01854814|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111330697|NCT01854814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111330698|NCT01854814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111330699|NCT01854814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111330700|NCT01854814|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111330701|NCT01854814|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111330702|NCT01854814|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111330703|NCT01854814|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111330704|NCT01723657|Gemtuzumab|gemtuzumab|mesh-list
111330705|NCT01723657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111330706|NCT01723657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111330707|NCT01723657|Immunotoxins|immunotoxins|mesh-ancestor
111330708|NCT01723657|Immunoconjugates|immunoconjugates|mesh-ancestor
111330709|NCT01723657|Immunologic Factors|immunologic factors|mesh-ancestor
111330710|NCT01723657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111330711|NCT02576652|Tetracycline|tetracycline|mesh-list
111330712|NCT02576652|Demeclocycline|demeclocycline|mesh-list
111330713|NCT02576652|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111330714|NCT02576652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111330715|NCT02576652|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111330716|NCT02576652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111330717|NCT02576652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111330718|NCT01743742|Vitamins|vitamins|mesh-list
111330719|NCT01743742|Vitamin E|vitamin e|mesh-list
111330720|NCT01743742|Micronutrients|micronutrients|mesh-ancestor
111330721|NCT01743742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111330722|NCT01743742|Antioxidants|antioxidants|mesh-ancestor
111330723|NCT01743742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111330724|NCT01743742|Protective Agents|protective agents|mesh-ancestor
111330725|NCT01723735|Ezetimibe|ezetimibe|mesh-list
111330726|NCT01723735|Alirocumab|alirocumab|mesh-list
111330727|NCT01723735|Fenofibrate|fenofibrate|mesh-list
111330728|NCT01723735|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111330729|NCT01723735|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111330730|NCT01723735|Antimetabolites|antimetabolites|mesh-ancestor
111330731|NCT01723735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111330732|NCT01723735|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111330733|NCT01723735|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
111330734|NCT01723735|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111330735|NCT01723735|Protease Inhibitors|protease inhibitors|mesh-ancestor
111330736|NCT01723735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111330737|NCT00872729|Cysteamine|cysteamine|mesh-list
111330738|NCT00872729|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
111330739|NCT00872729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111330740|NCT04640376|Acetaminophen|acetaminophen|mesh-list
110778307|NCT03730766|Antacids|antacids|mesh-ancestor
111330741|NCT04640376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111330742|NCT04640376|Analgesics|analgesics|mesh-ancestor
111330743|NCT04640376|Sensory System Agents|sensory system agents|mesh-ancestor
111330744|NCT04640376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111330745|NCT04640376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111330746|NCT04640376|Antipyretics|antipyretics|mesh-ancestor
111330747|NCT00832871|Mifepristone|mifepristone|mesh-list
111330748|NCT00832871|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
111330749|NCT00832871|Abortifacient Agents|abortifacient agents|mesh-ancestor
111330750|NCT00832871|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111330751|NCT00832871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111330752|NCT00832871|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111330753|NCT00832871|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111330754|NCT00832871|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111330755|NCT00832871|Contraceptive Agents|contraceptive agents|mesh-ancestor
111330756|NCT00832871|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
111330757|NCT00832871|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
111330758|NCT00832871|Hormone Antagonists|hormone antagonists|mesh-ancestor
111330759|NCT00832871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111330760|NCT00832871|Luteolytic Agents|luteolytic agents|mesh-ancestor
111330761|NCT00832871|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111330762|NCT00832871|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
111330763|NCT05530200|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
111330764|NCT05530200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111330765|NCT05530200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111330766|NCT05530200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111330767|NCT01729663|Interferons|interferons|mesh-list
111330768|NCT01729663|Interferon-alpha|interferon-alpha|mesh-list
111330769|NCT01729663|Interferon alpha-2|interferon alpha-2|mesh-list
111330770|NCT01729663|Molgramostim|molgramostim|mesh-list
111330771|NCT01729663|Sargramostim|sargramostim|mesh-list
111330772|NCT01729663|BCG Vaccine|bcg vaccine|mesh-list
111330773|NCT01729663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111330774|NCT01729663|Antiviral Agents|antiviral agents|mesh-ancestor
111330775|NCT01729663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111330776|NCT01729663|Immunologic Factors|immunologic factors|mesh-ancestor
111330777|NCT01729663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111330778|NCT01729663|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111330779|NCT05530122|Adalimumab|adalimumab|mesh-list
111330780|NCT05530122|Infliximab|infliximab|mesh-list
111330781|NCT05530122|Golimumab|golimumab|mesh-list
111330782|NCT05530122|Ustekinumab|ustekinumab|mesh-list
111330783|NCT05530122|Vedolizumab|vedolizumab|mesh-list
110778341|NCT03588572|Antidepressive Agents|antidepressive agents|mesh-ancestor
111330784|NCT05530122|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111330785|NCT05530122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111330786|NCT05530122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111330787|NCT05530122|Dermatologic Agents|dermatologic agents|mesh-ancestor
111330788|NCT05530122|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111330789|NCT05530122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111330790|NCT05530122|Immunologic Factors|immunologic factors|mesh-ancestor
111330791|NCT05530122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111330792|NCT05208840|Ocrelizumab|ocrelizumab|mesh-list
111330793|NCT05208840|Immunologic Factors|immunologic factors|mesh-ancestor
111330794|NCT05208840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111330795|NCT03407599|Insulin Aspart|insulin aspart|mesh-list
111330796|NCT03407599|Insulin, Long-Acting|insulin, long-acting|mesh-list
111330797|NCT03407599|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
111330798|NCT03407599|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111330799|NCT03407599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111330800|NCT05529888|Isotretinoin|isotretinoin|mesh-list
111330801|NCT05529888|Dermatologic Agents|dermatologic agents|mesh-ancestor
111330802|NCT05518578|Huperzine A|huperzine a|mesh-list
111330803|NCT05518578|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111330804|NCT05518578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111330805|NCT05518578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111330806|NCT05518578|Cholinergic Agents|cholinergic agents|mesh-ancestor
111330807|NCT05518578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111330808|NCT05518578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111330809|NCT05518578|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111330810|NCT05518578|Protective Agents|protective agents|mesh-ancestor
111330811|NCT05518500|Vaccines|vaccines|mesh-list
111330812|NCT05518500|Immunologic Factors|immunologic factors|mesh-ancestor
111330813|NCT05518500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111330814|NCT03058978|Etonogestrel|etonogestrel|mesh-list
111330815|NCT03058978|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111330816|NCT03058978|Contraceptive Agents|contraceptive agents|mesh-ancestor
111330817|NCT03058978|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111330818|NCT03058978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111330819|NCT03058978|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111330820|NCT00212134|Dipivefrin|dipivefrin|mesh-list
111330821|NCT00212134|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111330822|NCT00212134|Adrenergic Agents|adrenergic agents|mesh-ancestor
111330823|NCT00212134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111330824|NCT00212134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111330825|NCT00212134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111330826|NCT00913627|Ibuprofen|ibuprofen|mesh-list
111330827|NCT00913627|Naproxen|naproxen|mesh-list
111330828|NCT00913627|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111330829|NCT00913627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111330830|NCT00913627|Analgesics|analgesics|mesh-ancestor
111330831|NCT00913627|Sensory System Agents|sensory system agents|mesh-ancestor
111330832|NCT00913627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111330833|NCT00913627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111330834|NCT00913627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111330835|NCT00913627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111330836|NCT00913627|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111330837|NCT00913627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111330838|NCT00913627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110778485|NCT03589768|Antacids|antacids|mesh-ancestor
111330839|NCT00913627|Gout Suppressants|gout suppressants|mesh-ancestor
111330840|NCT04297176|Vancomycin|vancomycin|mesh-list
111330841|NCT04297176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111330842|NCT04297176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111330843|NCT02425306|Cyclophosphamide|cyclophosphamide|mesh-list
111330844|NCT02425306|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
111330845|NCT02425306|Poly ICLC|poly iclc|mesh-list
111330846|NCT02425306|Immunologic Factors|immunologic factors|mesh-ancestor
111330847|NCT02425306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111330848|NCT02425306|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111330849|NCT02425306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111330850|NCT02425306|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111330851|NCT02425306|Alkylating Agents|alkylating agents|mesh-ancestor
111330852|NCT02425306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111330853|NCT02425306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111330854|NCT02425306|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111330855|NCT02425306|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111330856|NCT02425306|Interferon Inducers|interferon inducers|mesh-ancestor
111330857|NCT04052698|Factor VIII|factor viii|mesh-list
111330858|NCT04052698|Coagulants|coagulants|mesh-ancestor
111330859|NCT05523102|Acetaminophen|acetaminophen|mesh-list
111330860|NCT05523102|Ketorolac|ketorolac|mesh-list
111330861|NCT05523102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111330862|NCT05523102|Analgesics|analgesics|mesh-ancestor
111330863|NCT05523102|Sensory System Agents|sensory system agents|mesh-ancestor
111330864|NCT05523102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111330865|NCT05523102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111330866|NCT05523102|Antipyretics|antipyretics|mesh-ancestor
111330867|NCT05523102|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111330868|NCT05523102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111330869|NCT05523102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111330870|NCT05523102|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111330871|NCT05523102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111330872|NCT05523102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111330873|NCT03407209|Anesthetics|anesthetics|mesh-list
111330874|NCT03407209|Anesthetics, Local|anesthetics, local|mesh-list
111330875|NCT03407209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111330876|NCT03407209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111330877|NCT03407209|Sensory System Agents|sensory system agents|mesh-ancestor
111330878|NCT03407209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111330879|NCT03999268|Insulin|insulin|mesh-list
111330880|NCT03999268|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111330881|NCT03999268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111330882|NCT05517330|Tislelizumab|tislelizumab|mesh-list
111330883|NCT05517330|Afatinib|afatinib|mesh-list
111330884|NCT05517330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111330885|NCT05517330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111330886|NCT05517330|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111330887|NCT05517330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111330888|NCT05517330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111330889|NCT01729897|Fentanyl|fentanyl|mesh-list
111330890|NCT01729897|Propofol|propofol|mesh-list
111330891|NCT01729897|Etomidate|etomidate|mesh-list
111330892|NCT01729897|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111330893|NCT01729897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111330894|NCT01729897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111330895|NCT01729897|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111330896|NCT01729897|Anesthetics, General|anesthetics, general|mesh-ancestor
111330897|NCT01729897|Anesthetics|anesthetics|mesh-ancestor
111330898|NCT01729897|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111330899|NCT01729897|Narcotics|narcotics|mesh-ancestor
111330900|NCT01729897|Analgesics|analgesics|mesh-ancestor
111330901|NCT01729897|Sensory System Agents|sensory system agents|mesh-ancestor
111330902|NCT01729897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111330903|NCT01729897|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111330904|NCT01048177|Lidocaine|lidocaine|mesh-list
111330905|NCT01048177|Heparin|heparin|mesh-list
111330906|NCT01048177|Anesthetics, Local|anesthetics, local|mesh-ancestor
111330907|NCT01048177|Anesthetics|anesthetics|mesh-ancestor
111330908|NCT01048177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111330909|NCT01048177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111330910|NCT01048177|Sensory System Agents|sensory system agents|mesh-ancestor
111330911|NCT01048177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111330912|NCT01048177|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111330913|NCT01048177|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111330914|NCT01048177|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111330915|NCT01048177|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111330916|NCT01048177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111330917|NCT01048177|Anticoagulants|anticoagulants|mesh-ancestor
110778623|NCT03727646|Niacin|niacin|mesh-list
111330918|NCT01048177|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111330919|NCT01048177|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111330920|NCT02740582|Tolcapone|tolcapone|mesh-list
111330921|NCT02740582|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111330922|NCT02740582|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111330923|NCT02740582|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
111330924|NCT02740582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111330925|NCT02740582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111330926|NCT05453266|Tranexamic Acid|tranexamic acid|mesh-list
111330927|NCT05453266|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111330928|NCT05453266|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111330929|NCT05453266|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111330930|NCT05453266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111330931|NCT05453266|Hemostatics|hemostatics|mesh-ancestor
111330932|NCT05453266|Coagulants|coagulants|mesh-ancestor
111330933|NCT02740660|Caffeine|caffeine|mesh-list
111330934|NCT02740660|Albuterol|albuterol|mesh-list
111330935|NCT02740660|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111330936|NCT02740660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111330937|NCT02740660|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111330938|NCT02740660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111330939|NCT02740660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111330940|NCT02740660|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
111330941|NCT02740660|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111055363|NCT02331927|Aflibercept|aflibercept|mesh-list
111330942|NCT02740660|Purinergic Agents|purinergic agents|mesh-ancestor
111330943|NCT02740660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111330944|NCT02740660|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111330945|NCT02740660|Autonomic Agents|autonomic agents|mesh-ancestor
111330946|NCT02740660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111330947|NCT02740660|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111330948|NCT02740660|Respiratory System Agents|respiratory system agents|mesh-ancestor
111330949|NCT02740660|Tocolytic Agents|tocolytic agents|mesh-ancestor
111330950|NCT02740660|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111330951|NCT02740660|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111330952|NCT02740660|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111330953|NCT02740660|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111330954|NCT02740660|Adrenergic Agents|adrenergic agents|mesh-ancestor
111330955|NCT05516862|Camphor|camphor|mesh-list
111330956|NCT05516862|Salicylates|salicylates|mesh-list
111330957|NCT05516862|Methyl salicylate|methyl salicylate|mesh-list
111330958|NCT05516862|Menthol|menthol|mesh-list
111330959|NCT05516862|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111330960|NCT05516862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111330961|NCT05516862|Antipruritics|antipruritics|mesh-ancestor
111330962|NCT05516862|Dermatologic Agents|dermatologic agents|mesh-ancestor
111330963|NCT05516862|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111330964|NCT05516862|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111330965|NCT05516862|Analgesics|analgesics|mesh-ancestor
111330966|NCT05516862|Sensory System Agents|sensory system agents|mesh-ancestor
111330967|NCT05516862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111330968|NCT05516862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111330969|NCT05516862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111330970|NCT05516862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111330971|NCT05516862|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111330972|NCT05516862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111330973|NCT05516862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111330974|NCT03929068|Levodopa|levodopa|mesh-list
111330975|NCT03929068|Carbidopa|carbidopa|mesh-list
111330976|NCT03929068|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
111330977|NCT03929068|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111330978|NCT03929068|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111330979|NCT03929068|Dopamine Agents|dopamine agents|mesh-ancestor
111330980|NCT03929068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111330981|NCT03929068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111330982|NCT03929068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111330983|NCT03929068|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
111330984|NCT03929068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111330985|NCT03929068|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111330986|NCT03929068|Immunologic Factors|immunologic factors|mesh-ancestor
111330987|NCT03929068|Dopamine Agonists|dopamine agonists|mesh-ancestor
111330988|NCT05516784|Clopidogrel|clopidogrel|mesh-list
111330989|NCT05516784|Ticagrelor|ticagrelor|mesh-list
111330990|NCT05516784|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111330991|NCT05516784|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111330992|NCT05516784|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111330993|NCT05516784|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111330994|NCT05516784|Purinergic Agents|purinergic agents|mesh-ancestor
111330995|NCT05516784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111330996|NCT05516784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111330997|NCT05516784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111330998|NCT02571972|Timolol|timolol|mesh-list
111330999|NCT02571972|Dorzolamide|dorzolamide|mesh-list
111331000|NCT02571972|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111331001|NCT02571972|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111331002|NCT02571972|Adrenergic Agents|adrenergic agents|mesh-ancestor
111331003|NCT02571972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111331004|NCT02571972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111331005|NCT02571972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111331006|NCT02571972|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111331007|NCT02571972|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111331008|NCT02571972|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
111331009|NCT02571972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111331010|NCT04996134|Domperidone|domperidone|mesh-list
111331011|NCT04996134|Antiemetics|antiemetics|mesh-ancestor
111331012|NCT04996134|Autonomic Agents|autonomic agents|mesh-ancestor
111331013|NCT04996134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111331014|NCT04996134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111331015|NCT04996134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111331016|NCT04996134|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111331018|NCT04996134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111331019|NCT04996134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111331020|NCT00371332|Minocycline|minocycline|mesh-list
111331021|NCT00371332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111331022|NCT00371332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111331023|NCT00842075|Pramlintide|pramlintide|mesh-list
111331024|NCT00842075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111331025|NCT00842075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111331026|NCT00879359|Paclitaxel|paclitaxel|mesh-list
111331027|NCT00879359|Bevacizumab|bevacizumab|mesh-list
111331028|NCT00879359|Carboplatin|carboplatin|mesh-list
111331029|NCT00879359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111331030|NCT00879359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111331031|NCT00879359|Tubulin Modulators|tubulin modulators|mesh-ancestor
111331032|NCT00879359|Antimitotic Agents|antimitotic agents|mesh-ancestor
111331033|NCT00879359|Mitosis Modulators|mitosis modulators|mesh-ancestor
111331034|NCT00879359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111331035|NCT00879359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111331036|NCT00879359|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111331037|NCT00879359|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111331038|NCT00879359|Growth Substances|growth substances|mesh-ancestor
111331039|NCT00879359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111331040|NCT00879359|Growth Inhibitors|growth inhibitors|mesh-ancestor
111331041|NCT00880919|Quetiapine Fumarate|quetiapine fumarate|mesh-list
111331042|NCT00880919|Antidepressive Agents|antidepressive agents|mesh-ancestor
111331043|NCT00880919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111331044|NCT00880919|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111331045|NCT00880919|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111331046|NCT00880919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111331047|NCT00880919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111331048|NCT00880997|Doxazosin|doxazosin|mesh-list
111331049|NCT00880997|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111331050|NCT00880997|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111331051|NCT00880997|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111331052|NCT00880997|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111331053|NCT00880997|Adrenergic Agents|adrenergic agents|mesh-ancestor
111331054|NCT00880997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111331055|NCT00880997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111331056|NCT00880997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111331057|NCT00883103|Lidocaine|lidocaine|mesh-list
111331058|NCT00883103|Anesthetics, Local|anesthetics, local|mesh-ancestor
111331059|NCT00883103|Anesthetics|anesthetics|mesh-ancestor
111331060|NCT00883103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110779449|NCT01094457|Antipyretics|antipyretics|mesh-ancestor
111331061|NCT00883103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111331062|NCT00883103|Sensory System Agents|sensory system agents|mesh-ancestor
111331063|NCT00883103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111331064|NCT00883103|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111331065|NCT00883103|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111331066|NCT00883103|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111331067|NCT00883103|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111331068|NCT00883103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111331069|NCT02742532|Oxytocin|oxytocin|mesh-list
111331070|NCT02742532|Oxytocics|oxytocics|mesh-ancestor
111331071|NCT02742532|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111331072|NCT02742532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111331073|NCT05521386|Caffeine|caffeine|mesh-list
111331074|NCT05521386|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111331075|NCT05521386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110779606|NCT03479216|Analgesics|analgesics|mesh-ancestor
111331076|NCT05521386|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111331077|NCT05521386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111331078|NCT05521386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111331079|NCT05521386|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
111331080|NCT05521386|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111331081|NCT05521386|Purinergic Agents|purinergic agents|mesh-ancestor
111331082|NCT05521386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111331083|NCT00370630|Triamcinolone|triamcinolone|mesh-list
111331084|NCT00370630|Bevacizumab|bevacizumab|mesh-list
111331085|NCT00370630|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111331086|NCT00370630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111331087|NCT00370630|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111331088|NCT00370630|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111331089|NCT00370630|Growth Substances|growth substances|mesh-ancestor
111331091|NCT00370630|Growth Inhibitors|growth inhibitors|mesh-ancestor
111331092|NCT00370630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111331093|NCT00370630|Glucocorticoids|glucocorticoids|mesh-ancestor
111331094|NCT00370630|Hormones|hormones|mesh-ancestor
111331095|NCT00370630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111331096|NCT04984980|Bevacizumab|bevacizumab|mesh-list
111331097|NCT04984980|Gemcitabine|gemcitabine|mesh-list
111331098|NCT04984980|Oxaliplatin|oxaliplatin|mesh-list
111331099|NCT04984980|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111331100|NCT04984980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111331101|NCT04984980|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111331102|NCT04984980|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111331103|NCT04984980|Growth Substances|growth substances|mesh-ancestor
111331104|NCT04984980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111331105|NCT04984980|Growth Inhibitors|growth inhibitors|mesh-ancestor
111331106|NCT04984980|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111331107|NCT04984980|Antimetabolites|antimetabolites|mesh-ancestor
111331108|NCT04984980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111331109|NCT00370786|Bevacizumab|bevacizumab|mesh-list
111331110|NCT00370786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111331111|NCT00370786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111331112|NCT00370786|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111331113|NCT00370786|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111331114|NCT00370786|Growth Substances|growth substances|mesh-ancestor
111331115|NCT00370786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111331116|NCT00370786|Growth Inhibitors|growth inhibitors|mesh-ancestor
111331117|NCT03437356|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
111331118|NCT03387670|Simvastatin|simvastatin|mesh-list
111331119|NCT03387670|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111331120|NCT03387670|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111331121|NCT03387670|Antimetabolites|antimetabolites|mesh-ancestor
111331122|NCT03387670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111331123|NCT03387670|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111331124|NCT03387670|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111331125|NCT03387670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111331126|NCT04979832|Metronidazole|metronidazole|mesh-list
111331127|NCT04979832|Fosfomycin|fosfomycin|mesh-list
111331128|NCT04979832|Molgramostim|molgramostim|mesh-list
111331129|NCT04979832|Sargramostim|sargramostim|mesh-list
111331130|NCT04979832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111331131|NCT04979832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111331132|NCT04979832|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111331133|NCT04979832|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111331134|NCT04979832|Immunologic Factors|immunologic factors|mesh-ancestor
111331135|NCT04979832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111331136|NCT04979832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111331137|NCT05521152|Norepinephrine|norepinephrine|mesh-list
111331138|NCT05521152|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111331139|NCT05521152|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111331140|NCT05521152|Adrenergic Agents|adrenergic agents|mesh-ancestor
111331141|NCT05521152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111331142|NCT05521152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111331143|NCT05521152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111331144|NCT05521152|Sympathomimetics|sympathomimetics|mesh-ancestor
111331145|NCT05521152|Autonomic Agents|autonomic agents|mesh-ancestor
111331146|NCT05521152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111331147|NCT05521152|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111331148|NCT02740114|Oxycodone|oxycodone|mesh-list
111331149|NCT02740114|Bupivacaine|bupivacaine|mesh-list
111331150|NCT02740114|Anesthetics, Local|anesthetics, local|mesh-ancestor
111331151|NCT02740114|Anesthetics|anesthetics|mesh-ancestor
111331152|NCT02740114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111331153|NCT02740114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111331154|NCT02740114|Sensory System Agents|sensory system agents|mesh-ancestor
111331155|NCT02740114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111331156|NCT02740114|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111331157|NCT02740114|Narcotics|narcotics|mesh-ancestor
111331158|NCT02740114|Analgesics|analgesics|mesh-ancestor
111331159|NCT00371410|Triamcinolone|triamcinolone|mesh-list
111331160|NCT00371410|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
111331161|NCT00371410|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
111331162|NCT00371410|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
111331163|NCT00371410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111331164|NCT00371410|Glucocorticoids|glucocorticoids|mesh-ancestor
111331165|NCT00371410|Hormones|hormones|mesh-ancestor
111331166|NCT00371410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111331167|NCT00371410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111331168|NCT00371410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111331169|NCT00371410|Immunologic Factors|immunologic factors|mesh-ancestor
111331170|NCT00371410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111331171|NCT00371410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111331173|NCT04295850|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111331174|NCT04295850|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111331175|NCT04295850|Analgesics|analgesics|mesh-ancestor
111331176|NCT04295850|Sensory System Agents|sensory system agents|mesh-ancestor
111331177|NCT04295850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111331178|NCT04295850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111331179|NCT04295850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111331180|NCT04295850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111331181|NCT04295850|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111331182|NCT04295850|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111331183|NCT04295850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111331184|NCT04295850|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111331185|NCT04295850|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111331186|NCT04295850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111331187|NCT04295850|Antipyretics|antipyretics|mesh-ancestor
111331188|NCT02166905|Poly I-C|poly i-c|mesh-list
111331189|NCT02166905|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
111331190|NCT02166905|Poly ICLC|poly iclc|mesh-list
111331191|NCT02166905|Interferon Inducers|interferon inducers|mesh-ancestor
111331192|NCT02166905|Immunologic Factors|immunologic factors|mesh-ancestor
111331193|NCT02166905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111331194|NCT02166905|Laxatives|laxatives|mesh-ancestor
111331195|NCT02166905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111331196|NCT02166905|Antiviral Agents|antiviral agents|mesh-ancestor
111331197|NCT02166905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111331198|NCT02743078|Bevacizumab|bevacizumab|mesh-list
111331199|NCT02743078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111331200|NCT02743078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111331201|NCT02743078|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111331202|NCT02743078|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111331203|NCT02743078|Growth Substances|growth substances|mesh-ancestor
111331204|NCT02743078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111331205|NCT02743078|Growth Inhibitors|growth inhibitors|mesh-ancestor
111331206|NCT03323398|Durvalumab|durvalumab|mesh-list
111331207|NCT03323398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111331208|NCT03323398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111331209|NCT00890981|Denosumab|denosumab|mesh-list
111331210|NCT00890981|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111331211|NCT00890981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111331212|NCT05515770|Cabotegravir|cabotegravir|mesh-list
111331213|NCT05515770|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110497637|NCT04031703|Paclitaxel|paclitaxel|mesh-list
111331214|NCT05515770|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111331215|NCT05515770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111331216|NCT05515770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111331217|NCT05515770|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111331218|NCT05515770|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111331219|NCT05515770|Antiviral Agents|antiviral agents|mesh-ancestor
111331220|NCT05515770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111331221|NCT04480138|Interferons|interferons|mesh-list
111331222|NCT04480138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111331223|NCT04480138|Antiviral Agents|antiviral agents|mesh-ancestor
111331224|NCT04480138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111331225|NCT00371488|Lapatinib|lapatinib|mesh-list
111331226|NCT00371488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111331227|NCT00371488|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111331228|NCT00371488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111331229|NCT00371488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111331230|NCT00883415|Darbepoetin alfa|darbepoetin alfa|mesh-list
111331231|NCT00883415|Hematinics|hematinics|mesh-ancestor
111331232|NCT04337632|Paclitaxel|paclitaxel|mesh-list
111331233|NCT04337632|Carboplatin|carboplatin|mesh-list
111331234|NCT04337632|Doxorubicin|doxorubicin|mesh-list
111331235|NCT04337632|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111331236|NCT04337632|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111331237|NCT04337632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111331238|NCT04337632|Tubulin Modulators|tubulin modulators|mesh-ancestor
111055661|NCT02316535|Antimetabolites|antimetabolites|mesh-ancestor
111331239|NCT04337632|Antimitotic Agents|antimitotic agents|mesh-ancestor
111331240|NCT04337632|Mitosis Modulators|mitosis modulators|mesh-ancestor
111331241|NCT04337632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111331242|NCT04337632|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111331243|NCT04337632|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111331245|NCT04337632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111331246|NCT05349058|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
111331247|NCT05349058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111331248|NCT05349058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111331249|NCT05349058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111331250|NCT05348980|Phenylephrine|phenylephrine|mesh-list
111331251|NCT05348980|Oxymetazoline|oxymetazoline|mesh-list
111331252|NCT05348980|Synephrine|synephrine|mesh-list
111331253|NCT05348980|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111331254|NCT05348980|Mydriatics|mydriatics|mesh-ancestor
111331255|NCT05348980|Autonomic Agents|autonomic agents|mesh-ancestor
111331256|NCT05348980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111331257|NCT05348980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111331258|NCT05348980|Sympathomimetics|sympathomimetics|mesh-ancestor
110780111|NCT03953001|Lidocaine|lidocaine|mesh-list
111331259|NCT05348980|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111331260|NCT05348980|Nasal Decongestants|nasal decongestants|mesh-ancestor
111331261|NCT05348980|Respiratory System Agents|respiratory system agents|mesh-ancestor
111331262|NCT05348980|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111331263|NCT05348980|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111331264|NCT05348980|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111331265|NCT05348980|Adrenergic Agents|adrenergic agents|mesh-ancestor
111331266|NCT05348980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111331267|NCT05348980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111331268|NCT05348980|Protective Agents|protective agents|mesh-ancestor
111331269|NCT00884585|Cyclosporine|cyclosporine|mesh-list
111331270|NCT00884585|Cyclosporins|cyclosporins|mesh-list
111331271|NCT00884585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111331272|NCT00884585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111331273|NCT00884585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111331274|NCT00884585|Immunologic Factors|immunologic factors|mesh-ancestor
111331275|NCT00884585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111331276|NCT00884585|Antifungal Agents|antifungal agents|mesh-ancestor
111331277|NCT00884585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111331278|NCT00884585|Dermatologic Agents|dermatologic agents|mesh-ancestor
111331279|NCT00884585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111331280|NCT00884585|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111331281|NCT00884897|Oxytocin|oxytocin|mesh-list
111331282|NCT00884897|Oxytocics|oxytocics|mesh-ancestor
111331283|NCT00884897|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111331284|NCT00884897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111331285|NCT03216473|Botulinum Toxins|botulinum toxins|mesh-list
111331286|NCT03216473|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111331287|NCT03216473|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111331288|NCT03216473|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111331289|NCT03216473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111331290|NCT03216473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111331291|NCT03216473|Cholinergic Agents|cholinergic agents|mesh-ancestor
111331292|NCT03216473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110780161|NCT03692416|Hormones|hormones|mesh-ancestor
111331293|NCT03216473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111331294|NCT03216473|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111331295|NCT03216473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111331296|NCT03384563|Dexmedetomidine|dexmedetomidine|mesh-list
111331297|NCT03384563|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111331298|NCT03384563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111331299|NCT03384563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111331300|NCT03384563|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111331301|NCT03384563|Analgesics|analgesics|mesh-ancestor
111331302|NCT03384563|Sensory System Agents|sensory system agents|mesh-ancestor
111331303|NCT03384563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111331304|NCT03384563|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111331305|NCT03384563|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111331306|NCT03384563|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111331307|NCT03384563|Adrenergic Agents|adrenergic agents|mesh-ancestor
111331308|NCT03384563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111331309|NCT03384563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111331310|NCT04946526|Mechlorethamine|mechlorethamine|mesh-list
111331311|NCT04946526|Alkylating Agents|alkylating agents|mesh-ancestor
111331312|NCT04946526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111055734|NCT02332941|Rituximab|rituximab|mesh-list
111331313|NCT04946526|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111331314|NCT04946526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111331315|NCT02748070|Fluticasone|fluticasone|mesh-list
111331316|NCT02748070|Prednisone|prednisone|mesh-list
111331317|NCT02748070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111331318|NCT02748070|Glucocorticoids|glucocorticoids|mesh-ancestor
111331319|NCT02748070|Hormones|hormones|mesh-ancestor
111331320|NCT02748070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111331321|NCT02748070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111331322|NCT02748070|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111331323|NCT02748070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111331324|NCT02748070|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111331325|NCT02748070|Autonomic Agents|autonomic agents|mesh-ancestor
111331326|NCT02748070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111331327|NCT02748070|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111331328|NCT02748070|Respiratory System Agents|respiratory system agents|mesh-ancestor
111331329|NCT02748070|Dermatologic Agents|dermatologic agents|mesh-ancestor
111331330|NCT02748070|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111331331|NCT05311709|Sotorasib|sotorasib|mesh-list
111331332|NCT05311709|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111331333|NCT05311709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111331334|NCT05311709|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111331335|NCT05311709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111331336|NCT05310383|Tislelizumab|tislelizumab|mesh-list
111331337|NCT05310383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111331338|NCT05310383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111331339|NCT05310305|Antibodies|antibodies|mesh-list
111331340|NCT05310305|Immunologic Factors|immunologic factors|mesh-ancestor
111331341|NCT05310305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111331342|NCT05149638|Cosyntropin|cosyntropin|mesh-list
111331343|NCT05149638|Hormones|hormones|mesh-ancestor
110780309|NCT03029650|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111331344|NCT05149638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111331345|NCT05149638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111331346|NCT05519670|Niraparib|niraparib|mesh-list
111331347|NCT05519670|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111331348|NCT05519670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111331349|NCT05519670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111331350|NCT05519670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111331351|NCT05519592|Ropivacaine|ropivacaine|mesh-list
111331352|NCT05519592|Anesthetics, Local|anesthetics, local|mesh-ancestor
111331353|NCT05519592|Anesthetics|anesthetics|mesh-ancestor
111331354|NCT05519592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111331355|NCT05519592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111331356|NCT05519592|Sensory System Agents|sensory system agents|mesh-ancestor
111331357|NCT05519592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111331358|NCT05519514|Budesonide|budesonide|mesh-list
110780436|NCT03730740|Lenalidomide|lenalidomide|mesh-list
111331359|NCT05519514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111331360|NCT05519514|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111331361|NCT05519514|Autonomic Agents|autonomic agents|mesh-ancestor
111331362|NCT05519514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111331363|NCT05519514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111331364|NCT05519514|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111331365|NCT05519514|Respiratory System Agents|respiratory system agents|mesh-ancestor
111331366|NCT05519514|Glucocorticoids|glucocorticoids|mesh-ancestor
111331367|NCT05519514|Hormones|hormones|mesh-ancestor
111331368|NCT05519514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111331369|NCT02756572|Cytarabine|cytarabine|mesh-list
111331370|NCT02756572|Cyclosporine|cyclosporine|mesh-list
111331371|NCT02756572|Mycophenolic Acid|mycophenolic acid|mesh-list
111331372|NCT02756572|Sirolimus|sirolimus|mesh-list
111331373|NCT02756572|Fludarabine|fludarabine|mesh-list
111331374|NCT02756572|Fludarabine phosphate|fludarabine phosphate|mesh-list
111331375|NCT02756572|Melphalan|melphalan|mesh-list
111331376|NCT02756572|Mechlorethamine|mechlorethamine|mesh-list
111331377|NCT02756572|Mitoxantrone|mitoxantrone|mesh-list
111331378|NCT02756572|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
111331379|NCT02756572|Cladribine|cladribine|mesh-list
111331380|NCT02756572|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
111331381|NCT02756572|Cyclosporins|cyclosporins|mesh-list
111331382|NCT02756572|Lenograstim|lenograstim|mesh-list
111331383|NCT02756572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111331384|NCT02756572|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111331385|NCT02756572|Antimetabolites|antimetabolites|mesh-ancestor
111331386|NCT02756572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111331387|NCT02756572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111331388|NCT02756572|Immunologic Factors|immunologic factors|mesh-ancestor
111055810|NCT01959633|Interferons|interferons|mesh-list
111331389|NCT02756572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111331390|NCT02756572|Antiviral Agents|antiviral agents|mesh-ancestor
111331391|NCT02756572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111331392|NCT02756572|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111331393|NCT02756572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111331394|NCT02756572|Antifungal Agents|antifungal agents|mesh-ancestor
111331395|NCT02756572|Dermatologic Agents|dermatologic agents|mesh-ancestor
111331396|NCT02756572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111331397|NCT02756572|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111331398|NCT02756572|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111331399|NCT02756572|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111331400|NCT02756572|Antitubercular Agents|antitubercular agents|mesh-ancestor
111331401|NCT02756572|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111331402|NCT02756572|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111331403|NCT02756572|Alkylating Agents|alkylating agents|mesh-ancestor
111331404|NCT02756572|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111331405|NCT02756572|Analgesics|analgesics|mesh-ancestor
111331406|NCT02756572|Sensory System Agents|sensory system agents|mesh-ancestor
111331407|NCT02756572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111331408|NCT02756572|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111331409|NCT02756572|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111331410|NCT01049035|Vaccines|vaccines|mesh-list
111331411|NCT01049035|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
111331412|NCT01049035|Immunologic Factors|immunologic factors|mesh-ancestor
111331413|NCT01049035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111331414|NCT05131698|Lenvatinib|lenvatinib|mesh-list
111331415|NCT05131698|Tislelizumab|tislelizumab|mesh-list
111331416|NCT05131698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111331417|NCT05131698|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111331418|NCT05131698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111331419|NCT05131698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111331420|NCT05131698|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111331421|NCT01724983|Fentanyl|fentanyl|mesh-list
111331422|NCT01724983|Ketamine|ketamine|mesh-list
111331423|NCT01724983|Analgesics|analgesics|mesh-ancestor
111331424|NCT01724983|Sensory System Agents|sensory system agents|mesh-ancestor
111331425|NCT01724983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111331426|NCT01724983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111331427|NCT01724983|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111331428|NCT01724983|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111331429|NCT01724983|Anesthetics, General|anesthetics, general|mesh-ancestor
111331430|NCT01724983|Anesthetics|anesthetics|mesh-ancestor
111331431|NCT01724983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111331432|NCT01724983|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111331433|NCT01724983|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111331434|NCT01724983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111331435|NCT01724983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111331436|NCT01724983|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111331437|NCT01724983|Narcotics|narcotics|mesh-ancestor
111331438|NCT01724983|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111331439|NCT02973958|Acetaminophen|acetaminophen|mesh-list
111331440|NCT02973958|Ibuprofen|ibuprofen|mesh-list
111331441|NCT02973958|Ketorolac|ketorolac|mesh-list
111331442|NCT02973958|Bupivacaine|bupivacaine|mesh-list
111331443|NCT02973958|Sevoflurane|sevoflurane|mesh-list
111331444|NCT02973958|Anesthetics, Local|anesthetics, local|mesh-ancestor
111331445|NCT02973958|Anesthetics|anesthetics|mesh-ancestor
111331446|NCT02973958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111331447|NCT02973958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111331448|NCT02973958|Sensory System Agents|sensory system agents|mesh-ancestor
111331449|NCT02973958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111331450|NCT02973958|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111331451|NCT02973958|Analgesics|analgesics|mesh-ancestor
111331452|NCT02973958|Antipyretics|antipyretics|mesh-ancestor
111331453|NCT02973958|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111331454|NCT02973958|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110780876|NCT03518112|Vitamins|vitamins|mesh-ancestor
111331455|NCT02973958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111331456|NCT02973958|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111331457|NCT02973958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111331458|NCT02973958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111331459|NCT02973958|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111331460|NCT02973958|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111331461|NCT02973958|Anesthetics, General|anesthetics, general|mesh-ancestor
111331462|NCT01048333|Formoterol Fumarate|formoterol fumarate|mesh-list
111331463|NCT01048333|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
111331464|NCT01048333|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111331466|NCT01048333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111331467|NCT01048333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111331468|NCT01048333|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111331469|NCT01048333|Respiratory System Agents|respiratory system agents|mesh-ancestor
111331470|NCT01048333|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111331471|NCT01048333|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111331472|NCT01048333|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111331473|NCT01048333|Adrenergic Agents|adrenergic agents|mesh-ancestor
111331474|NCT01048333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111331475|NCT01048333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111331476|NCT05513976|Febuxostat|febuxostat|mesh-list
111331477|NCT05513976|Gout Suppressants|gout suppressants|mesh-ancestor
111331478|NCT05513976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110780934|NCT03444298|Vitamin E|vitamin e|mesh-list
111331479|NCT04335526|Cholestyramine Resin|cholestyramine resin|mesh-list
111331480|NCT04335526|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111331481|NCT04335526|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111331482|NCT04335526|Antimetabolites|antimetabolites|mesh-ancestor
111331483|NCT04335526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111331484|NCT04335526|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111331485|NCT05348434|Ether|ether|mesh-list
111331486|NCT05348434|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111331487|NCT05348434|Anesthetics, General|anesthetics, general|mesh-ancestor
111331488|NCT05348434|Anesthetics|anesthetics|mesh-ancestor
111331489|NCT05348434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111331490|NCT05348434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111331491|NCT05519202|Oxaliplatin|oxaliplatin|mesh-list
111331492|NCT05519202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111331493|NCT02281383|BCG Vaccine|bcg vaccine|mesh-list
111331494|NCT02281383|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111331495|NCT02281383|Immunologic Factors|immunologic factors|mesh-ancestor
111331496|NCT02281383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111331497|NCT01047553|Formoterol Fumarate|formoterol fumarate|mesh-list
111331498|NCT01047553|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111331499|NCT01047553|Autonomic Agents|autonomic agents|mesh-ancestor
111331500|NCT01047553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111331501|NCT01047553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111331502|NCT01047553|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111331503|NCT01047553|Respiratory System Agents|respiratory system agents|mesh-ancestor
111331504|NCT01047553|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111331505|NCT01047553|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111331506|NCT01047553|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111331507|NCT01047553|Adrenergic Agents|adrenergic agents|mesh-ancestor
111331508|NCT01047553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111331509|NCT01047553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111331510|NCT02760862|Hydrocortisone|hydrocortisone|mesh-list
111331511|NCT02760862|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
111331512|NCT02760862|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
111331513|NCT02760862|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
111331514|NCT02760862|Mannitol|mannitol|mesh-list
111331515|NCT02760862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111331516|NCT02760862|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
111331517|NCT02760862|Diuretics|diuretics|mesh-ancestor
111331518|NCT02760862|Natriuretic Agents|natriuretic agents|mesh-ancestor
111331519|NCT02760862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111331520|NCT05720637|Serotonin|serotonin|mesh-list
111331521|NCT05720637|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111331522|NCT05720637|Serotonin Agents|serotonin agents|mesh-ancestor
111331523|NCT05720637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111331524|NCT05720637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111331525|NCT05720637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111331526|NCT05720559|Folic Acid|folic acid|mesh-list
111331527|NCT05720559|Vitamin A|vitamin a|mesh-list
111331528|NCT05720559|Metronidazole|metronidazole|mesh-list
111331529|NCT05720559|Capecitabine|capecitabine|mesh-list
111331530|NCT05720559|Oxaliplatin|oxaliplatin|mesh-list
111331531|NCT05720559|Cetuximab|cetuximab|mesh-list
111331532|NCT05720559|Vitamins|vitamins|mesh-ancestor
111331533|NCT05720559|Micronutrients|micronutrients|mesh-ancestor
111331534|NCT05720559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110781392|NCT03023722|Antimitotic Agents|antimitotic agents|mesh-ancestor
111331535|NCT05720559|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111331536|NCT05720559|Antimetabolites|antimetabolites|mesh-ancestor
111331537|NCT05720559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111331538|NCT05720559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111331539|NCT05720559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111055960|NCT02305927|Vitamins|vitamins|mesh-ancestor
111331540|NCT05720559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111331541|NCT05720559|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111331542|NCT05720559|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111331543|NCT05720559|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111331544|NCT05720559|Hematinics|hematinics|mesh-ancestor
111331545|NCT05720559|Vitamin B Complex|vitamin b complex|mesh-ancestor
111331546|NCT02761252|Montelukast|montelukast|mesh-list
111331547|NCT02761252|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111331548|NCT02761252|Respiratory System Agents|respiratory system agents|mesh-ancestor
111331549|NCT02761252|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
111331550|NCT02761252|Hormone Antagonists|hormone antagonists|mesh-ancestor
111331551|NCT02761252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111331552|NCT02761252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111331553|NCT02761252|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110781538|NCT03668860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111331554|NCT02761252|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111331555|NCT02761252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111331556|NCT05714475|Pancrelipase|pancrelipase|mesh-list
111331557|NCT05714475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111331558|NCT05443984|Esomeprazole|esomeprazole|mesh-list
111331559|NCT05443984|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111331560|NCT05443984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111331561|NCT05443984|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111331562|NCT05443984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111331563|NCT05443984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111331564|NCT01725607|Dexmedetomidine|dexmedetomidine|mesh-list
111331565|NCT01725607|Anesthetics|anesthetics|mesh-list
111331566|NCT01725607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111331567|NCT01725607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111331568|NCT01725607|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111331569|NCT01725607|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111331570|NCT01725607|Analgesics|analgesics|mesh-ancestor
111331571|NCT01725607|Sensory System Agents|sensory system agents|mesh-ancestor
111331572|NCT01725607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110781654|NCT00031551|Analgesics|analgesics|mesh-ancestor
111331573|NCT01725607|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111331574|NCT01725607|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111331575|NCT01725607|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111331576|NCT01725607|Adrenergic Agents|adrenergic agents|mesh-ancestor
111331577|NCT01725607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111331578|NCT01725607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111331579|NCT03304379|Celecoxib|celecoxib|mesh-list
111331580|NCT03304379|Diclofenac|diclofenac|mesh-list
111331581|NCT03304379|Fasinumab|fasinumab|mesh-list
111331582|NCT03304379|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111331583|NCT03304379|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111331584|NCT03304379|Analgesics|analgesics|mesh-ancestor
111331585|NCT03304379|Sensory System Agents|sensory system agents|mesh-ancestor
111331586|NCT03304379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111331587|NCT03304379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111331588|NCT03304379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110781791|NCT01093365|Varenicline|varenicline|mesh-list
111331589|NCT03304379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111331590|NCT03304379|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111331591|NCT03304379|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111331592|NCT03304379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111331593|NCT03304379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111331594|NCT00915967|Vancomycin|vancomycin|mesh-list
111331595|NCT00915967|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111331596|NCT00915967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111331597|NCT02766244|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111331598|NCT02766244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111331599|NCT05031078|Lidocaine|lidocaine|mesh-list
111331600|NCT05031078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111331601|NCT05031078|Anesthetics, Local|anesthetics, local|mesh-ancestor
111331602|NCT05031078|Anesthetics|anesthetics|mesh-ancestor
111331603|NCT05031078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111331604|NCT05031078|Sensory System Agents|sensory system agents|mesh-ancestor
111331605|NCT05031078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111331606|NCT05031078|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111331607|NCT05031078|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111331608|NCT05031078|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111331609|NCT05031078|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111331610|NCT05031078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111331611|NCT05513664|Osimertinib|osimertinib|mesh-list
111331612|NCT05513664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111331613|NCT05513664|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111331614|NCT05513664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111331615|NCT05513664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111331616|NCT03216395|Epinephrine|epinephrine|mesh-list
111331617|NCT03216395|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111331618|NCT03216395|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111331619|NCT03216395|Adrenergic Agents|adrenergic agents|mesh-ancestor
111331620|NCT03216395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111331621|NCT03216395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111331622|NCT03216395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111331623|NCT03216395|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110781922|NCT00021255|Docetaxel|docetaxel|mesh-list
111331624|NCT03216395|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111331625|NCT03216395|Autonomic Agents|autonomic agents|mesh-ancestor
111331626|NCT03216395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110781976|NCT04052932|Antioxidants|antioxidants|mesh-ancestor
111331627|NCT03216395|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111331628|NCT03216395|Respiratory System Agents|respiratory system agents|mesh-ancestor
111331629|NCT03216395|Mydriatics|mydriatics|mesh-ancestor
111331630|NCT03216395|Sympathomimetics|sympathomimetics|mesh-ancestor
111331631|NCT03216395|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111331632|NCT02767492|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
111331633|NCT02767492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111331634|NCT02767492|Glucocorticoids|glucocorticoids|mesh-ancestor
111331635|NCT02767492|Hormones|hormones|mesh-ancestor
110782121|NCT02912650|Acetaminophen|acetaminophen|mesh-list
111331636|NCT02767492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111331637|NCT02767492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111331638|NCT02767492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111331639|NCT02767492|Immunologic Factors|immunologic factors|mesh-ancestor
111331640|NCT01044433|Capecitabine|capecitabine|mesh-list
111331641|NCT01044433|Lapatinib|lapatinib|mesh-list
111331642|NCT01044433|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111331643|NCT01044433|Antimetabolites|antimetabolites|mesh-ancestor
111331644|NCT01044433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111331645|NCT01044433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111331646|NCT01044433|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111331647|NCT01044433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111331648|NCT03400969|Glycerol|glycerol|mesh-list
111331649|NCT03400969|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
111331650|NCT03400969|Protective Agents|protective agents|mesh-ancestor
111331651|NCT03400969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111331652|NCT04633278|Pembrolizumab|pembrolizumab|mesh-list
111331653|NCT04633278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111331654|NCT04633278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111331655|NCT04633278|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110782190|NCT03487666|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111331656|NCT04633278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111331657|NCT05518812|Carboprost|carboprost|mesh-list
111331658|NCT05518812|Carboprost tromethamine|carboprost tromethamine|mesh-list
111331659|NCT05518812|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111331660|NCT05518812|Abortifacient Agents|abortifacient agents|mesh-ancestor
111331661|NCT05518812|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111331662|NCT05518812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111331663|NCT05518812|Oxytocics|oxytocics|mesh-ancestor
111331664|NCT04334512|Vitamin D|vitamin d|mesh-list
111331665|NCT04334512|Vitamins|vitamins|mesh-list
111331666|NCT04334512|Azithromycin|azithromycin|mesh-list
111331667|NCT04334512|Hydroxychloroquine|hydroxychloroquine|mesh-list
111331668|NCT04334512|Micronutrients|micronutrients|mesh-ancestor
111331669|NCT04334512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111331670|NCT04334512|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111331671|NCT04334512|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111331672|NCT04334512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111331673|NCT04334512|Antimalarials|antimalarials|mesh-ancestor
111331674|NCT04334512|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111331675|NCT04334512|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111331676|NCT04334512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111331677|NCT04334512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111331678|NCT04334512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111331679|NCT01043185|Lesogaberan|lesogaberan|mesh-list
111331680|NCT01043185|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111331681|NCT01043185|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
111331682|NCT01043185|GABA Agonists|gaba agonists|mesh-ancestor
111331683|NCT01043185|GABA Agents|gaba agents|mesh-ancestor
111331684|NCT01043185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111331685|NCT01043185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111331686|NCT01043185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111331687|NCT01042093|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
111331688|NCT01042093|Clonidine|clonidine|mesh-list
111331689|NCT01042093|Epinephrine|epinephrine|mesh-list
111331690|NCT01042093|Ropivacaine|ropivacaine|mesh-list
111331691|NCT01042093|Anesthetics, Local|anesthetics, local|mesh-ancestor
111331692|NCT01042093|Anesthetics|anesthetics|mesh-ancestor
111331693|NCT01042093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111331694|NCT01042093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111331695|NCT01042093|Sensory System Agents|sensory system agents|mesh-ancestor
111331696|NCT01042093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111331697|NCT01042093|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111331698|NCT01042093|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111331699|NCT01042093|Adrenergic Agents|adrenergic agents|mesh-ancestor
111331700|NCT01042093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111331701|NCT01042093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111331702|NCT01042093|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111331703|NCT01042093|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111331704|NCT01042093|Autonomic Agents|autonomic agents|mesh-ancestor
111331705|NCT01042093|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111331706|NCT01042093|Respiratory System Agents|respiratory system agents|mesh-ancestor
111331707|NCT01042093|Mydriatics|mydriatics|mesh-ancestor
111331708|NCT01042093|Sympathomimetics|sympathomimetics|mesh-ancestor
111331709|NCT01042093|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111331710|NCT01042093|Analgesics|analgesics|mesh-ancestor
110782643|NCT05974501|Analgesics|analgesics|mesh-ancestor
111331711|NCT01042093|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111331712|NCT01042093|Sympatholytics|sympatholytics|mesh-ancestor
111331713|NCT01042093|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111331714|NCT01042093|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111331715|NCT01042093|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111331716|NCT01042093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111331717|NCT01042093|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111331718|NCT01042093|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111331719|NCT01042093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111331720|NCT03400735|Cefdinir|cefdinir|mesh-list
111331721|NCT03400735|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111331722|NCT03400735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111331723|NCT04737928|Latanoprost|latanoprost|mesh-list
111331724|NCT04737928|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
111331725|NCT04737928|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111331726|NCT01041859|Tapentadol|tapentadol|mesh-list
111331727|NCT01041859|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111331728|NCT01041859|Narcotics|narcotics|mesh-ancestor
111331729|NCT01041859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111331730|NCT01041859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111331731|NCT01041859|Analgesics|analgesics|mesh-ancestor
111331732|NCT01041859|Sensory System Agents|sensory system agents|mesh-ancestor
111331733|NCT01041859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111331734|NCT01041859|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111331735|NCT01041859|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111331736|NCT01041859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111331737|NCT01041859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110782848|NCT05688371|Morphine|morphine|mesh-list
111331738|NCT01041859|Adrenergic Agents|adrenergic agents|mesh-ancestor
111331739|NCT01041859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111331740|NCT03405805|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
111331741|NCT03405805|Immunologic Factors|immunologic factors|mesh-ancestor
111331742|NCT03405805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111331743|NCT00371878|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
111331744|NCT00371878|Immunologic Factors|immunologic factors|mesh-ancestor
111331745|NCT00371878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111331746|NCT03400423|Caffeine|caffeine|mesh-list
111331747|NCT03400423|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111331748|NCT03400423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111331749|NCT03400423|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111331750|NCT03400423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111331751|NCT03400423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111331752|NCT03400423|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
111331753|NCT03400423|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111331754|NCT03400423|Purinergic Agents|purinergic agents|mesh-ancestor
111331755|NCT03400423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111331756|NCT01040845|Colchicine|colchicine|mesh-list
111331757|NCT01040845|Ethinyl Estradiol|ethinyl estradiol|mesh-list
111331758|NCT01040845|Norethindrone|norethindrone|mesh-list
111331759|NCT01040845|Norethindrone Acetate|norethindrone acetate|mesh-list
111331760|NCT01040845|Estradiol|estradiol|mesh-list
111331761|NCT01040845|Estrogens|estrogens|mesh-ancestor
111331762|NCT01040845|Hormones|hormones|mesh-ancestor
111056197|NCT03498703|Azathioprine|azathioprine|mesh-list
110782977|NCT05110742|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111331763|NCT01040845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111331764|NCT01040845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111331765|NCT01040845|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111331766|NCT01040845|Contraceptive Agents|contraceptive agents|mesh-ancestor
111331767|NCT01040845|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110783116|NCT04733092|Ethiodized Oil|ethiodized oil|mesh-list
111331768|NCT01040845|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111331769|NCT01040845|Gout Suppressants|gout suppressants|mesh-ancestor
111331770|NCT01040845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111331771|NCT01040845|Tubulin Modulators|tubulin modulators|mesh-ancestor
111331772|NCT01040845|Antimitotic Agents|antimitotic agents|mesh-ancestor
111331773|NCT01040845|Mitosis Modulators|mitosis modulators|mesh-ancestor
111331774|NCT01040845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111331775|NCT01040845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111331776|NCT01040845|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111331777|NCT01040845|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111331778|NCT01040845|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111331779|NCT00371956|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
111331780|NCT00371956|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111331781|NCT00371956|Hormone Antagonists|hormone antagonists|mesh-ancestor
111331782|NCT00371956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111331783|NCT00371956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111331784|NCT00371956|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111331785|NCT00371956|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111331786|NCT00371956|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111331787|NCT01040689|Tiotropium Bromide|tiotropium bromide|mesh-list
111331788|NCT01040689|Olodaterol|olodaterol|mesh-list
111331789|NCT01040689|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111331790|NCT01040689|Autonomic Agents|autonomic agents|mesh-ancestor
111331791|NCT01040689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111331792|NCT01040689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111331793|NCT01040689|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111331794|NCT01040689|Respiratory System Agents|respiratory system agents|mesh-ancestor
111331795|NCT01040689|Parasympatholytics|parasympatholytics|mesh-ancestor
111331796|NCT01040689|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111331797|NCT01040689|Cholinergic Agents|cholinergic agents|mesh-ancestor
111331798|NCT01040689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111331799|NCT01040689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111331800|NCT00372658|Lidocaine|lidocaine|mesh-list
111331801|NCT00372658|Anesthetics, Local|anesthetics, local|mesh-ancestor
111331802|NCT00372658|Anesthetics|anesthetics|mesh-ancestor
111331803|NCT00372658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111331804|NCT00372658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111331805|NCT00372658|Sensory System Agents|sensory system agents|mesh-ancestor
111331806|NCT00372658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111331807|NCT00372658|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111331808|NCT00372658|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111331809|NCT00372658|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111331810|NCT00372658|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111331811|NCT00372658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111331812|NCT03400189|Sulthiame|sulthiame|mesh-list
111331813|NCT03400189|Anticonvulsants|anticonvulsants|mesh-ancestor
111331814|NCT01043029|Pioglitazone|pioglitazone|mesh-list
110783519|NCT02753283|Micronutrients|micronutrients|mesh-ancestor
111331815|NCT01043029|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111331816|NCT01043029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111331817|NCT04282954|Esomeprazole|esomeprazole|mesh-list
111331818|NCT04282954|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111331819|NCT04282954|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111331820|NCT04282954|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111331821|NCT04282954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111331822|NCT04282954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111331823|NCT05337436|Calcium|calcium|mesh-list
111331824|NCT05337436|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111331825|NCT05337436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111331826|NCT04755712|Sufentanil|sufentanil|mesh-list
111331827|NCT04755712|Morphine|morphine|mesh-list
111331828|NCT04755712|Bupivacaine|bupivacaine|mesh-list
111331829|NCT04755712|Anesthetics, Local|anesthetics, local|mesh-ancestor
111331830|NCT04755712|Anesthetics|anesthetics|mesh-ancestor
111331831|NCT04755712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111331832|NCT04755712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111331833|NCT04755712|Sensory System Agents|sensory system agents|mesh-ancestor
111331834|NCT04755712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111331835|NCT04755712|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111331836|NCT04755712|Narcotics|narcotics|mesh-ancestor
111331837|NCT04755712|Analgesics|analgesics|mesh-ancestor
111331838|NCT04755712|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111331839|NCT04755712|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111331840|NCT04755712|Anesthetics, General|anesthetics, general|mesh-ancestor
111331841|NCT02415712|Fomepizole|fomepizole|mesh-list
111331842|NCT02415712|Antidotes|antidotes|mesh-ancestor
111331843|NCT02415712|Protective Agents|protective agents|mesh-ancestor
111331844|NCT02415712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111331845|NCT02415712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111331846|NCT02415712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111331847|NCT05456698|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
111331848|NCT05456698|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111331849|NCT05456698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111331850|NCT05456698|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111331851|NCT05456698|Immunotoxins|immunotoxins|mesh-ancestor
111331852|NCT05456698|Immunoconjugates|immunoconjugates|mesh-ancestor
110783948|NCT02682004|Serotonin|serotonin|mesh-list
111331853|NCT05456698|Immunologic Factors|immunologic factors|mesh-ancestor
111331854|NCT05456698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111331855|NCT02973724|Remifentanil|remifentanil|mesh-list
111331856|NCT02973724|Propofol|propofol|mesh-list
111331857|NCT02973724|Anesthetics|anesthetics|mesh-ancestor
111331858|NCT02973724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110783984|NCT02908516|Coagulants|coagulants|mesh-ancestor
111331859|NCT02973724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111331860|NCT02973724|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111331861|NCT02973724|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111331862|NCT02973724|Anesthetics, General|anesthetics, general|mesh-ancestor
111331863|NCT02973724|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111331864|NCT02973724|Narcotics|narcotics|mesh-ancestor
111331865|NCT02973724|Analgesics|analgesics|mesh-ancestor
111331866|NCT02973724|Sensory System Agents|sensory system agents|mesh-ancestor
111331867|NCT02973724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111331868|NCT05456542|Dexamethasone|dexamethasone|mesh-list
111331869|NCT05456542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111331870|NCT05456542|Antiemetics|antiemetics|mesh-ancestor
111331871|NCT05456542|Autonomic Agents|autonomic agents|mesh-ancestor
111331872|NCT05456542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111331873|NCT05456542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111331874|NCT05456542|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111331875|NCT05456542|Glucocorticoids|glucocorticoids|mesh-ancestor
111331876|NCT05456542|Hormones|hormones|mesh-ancestor
111331877|NCT05456542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111331878|NCT05456542|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111331879|NCT05456542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111331880|NCT05455918|Paclitaxel|paclitaxel|mesh-list
111331881|NCT05455918|Ifosfamide|ifosfamide|mesh-list
111331882|NCT05455918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111331883|NCT05455918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111331884|NCT05455918|Tubulin Modulators|tubulin modulators|mesh-ancestor
111331885|NCT05455918|Antimitotic Agents|antimitotic agents|mesh-ancestor
111331886|NCT05455918|Mitosis Modulators|mitosis modulators|mesh-ancestor
111331887|NCT05455918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111331888|NCT05455918|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111331889|NCT05455918|Alkylating Agents|alkylating agents|mesh-ancestor
111331890|NCT00889187|Capecitabine|capecitabine|mesh-list
111331891|NCT00889187|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111331892|NCT00889187|Antimetabolites|antimetabolites|mesh-ancestor
111331893|NCT00889187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111331894|NCT00889187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111331895|NCT04334824|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
111331896|NCT04334824|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
111331897|NCT04334824|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111331898|NCT04334824|Diuretics|diuretics|mesh-ancestor
111331899|NCT04334824|Natriuretic Agents|natriuretic agents|mesh-ancestor
111331900|NCT04334824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111331901|NCT04334824|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
111331902|NCT04334824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111331903|NCT04334824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111331904|NCT04334824|Protease Inhibitors|protease inhibitors|mesh-ancestor
111331905|NCT04334824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111331906|NCT05314127|Fluorouracil|fluorouracil|mesh-list
111331907|NCT05314127|Imiquimod|imiquimod|mesh-list
111331908|NCT05314127|Tazarotene|tazarotene|mesh-list
111331909|NCT05314127|Petrolatum|petrolatum|mesh-list
111331910|NCT05314127|Antimetabolites|antimetabolites|mesh-ancestor
111331911|NCT05314127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111331912|NCT05314127|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110784532|NCT01102335|Telbivudine|telbivudine|mesh-list
111331913|NCT05314127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111331915|NCT05314127|Immunologic Factors|immunologic factors|mesh-ancestor
111331916|NCT05314127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111331917|NCT05314127|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111331918|NCT05314127|Interferon Inducers|interferon inducers|mesh-ancestor
111331919|NCT05314127|Dermatologic Agents|dermatologic agents|mesh-ancestor
111331920|NCT05314127|Keratolytic Agents|keratolytic agents|mesh-ancestor
111331921|NCT05314127|Emollients|emollients|mesh-ancestor
111331922|NCT03130127|Terlipressin|terlipressin|mesh-list
111331923|NCT03130127|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111331924|NCT03130127|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111331925|NCT04225078|Moxifloxacin|moxifloxacin|mesh-list
111331926|NCT04225078|Loperamide|loperamide|mesh-list
111331927|NCT04225078|Antidiarrheals|antidiarrheals|mesh-list
111331928|NCT04225078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111331929|NCT04225078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110784831|NCT01106547|Hormones|hormones|mesh-ancestor
111331930|NCT04225078|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111331931|NCT04225078|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111331932|NCT04225078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111331933|NCT04225078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111331934|NCT04225078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111331935|NCT04225078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111331936|NCT00373048|Mefloquine|mefloquine|mesh-list
111331937|NCT00373048|Antimalarials|antimalarials|mesh-ancestor
111331938|NCT00373048|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111331939|NCT00373048|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111331940|NCT00373048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111331941|NCT00372892|Rituximab|rituximab|mesh-list
111331942|NCT00372892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111331943|NCT00372892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111331944|NCT00372892|Immunologic Factors|immunologic factors|mesh-ancestor
111331945|NCT00372892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111331946|NCT00372892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111331947|NCT00895817|Fluticasone|fluticasone|mesh-list
111331948|NCT00895817|Esomeprazole|esomeprazole|mesh-list
111331949|NCT00895817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111331950|NCT00895817|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111331951|NCT00895817|Autonomic Agents|autonomic agents|mesh-ancestor
111331952|NCT00895817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110784893|NCT00127335|Atorvastatin|atorvastatin|mesh-list
111331953|NCT00895817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111331954|NCT00895817|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111331955|NCT00895817|Respiratory System Agents|respiratory system agents|mesh-ancestor
111331956|NCT00895817|Dermatologic Agents|dermatologic agents|mesh-ancestor
111331957|NCT00895817|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111331958|NCT00895817|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111331959|NCT00895817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111331960|NCT00895817|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111331961|NCT00895817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111331962|NCT00895817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111331963|NCT03020303|Spironolactone|spironolactone|mesh-list
111331964|NCT03020303|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
111331965|NCT03020303|Hormone Antagonists|hormone antagonists|mesh-ancestor
111331966|NCT03020303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111331967|NCT03020303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111331968|NCT03020303|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
111331969|NCT03020303|Diuretics|diuretics|mesh-ancestor
111331970|NCT03020303|Natriuretic Agents|natriuretic agents|mesh-ancestor
111331971|NCT04825522|Vancomycin|vancomycin|mesh-list
111331972|NCT04825522|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111331973|NCT04825522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111331974|NCT00373204|Motexafin gadolinium|motexafin gadolinium|mesh-list
111331975|NCT00373204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111331976|NCT00373204|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111331977|NCT00373204|Dermatologic Agents|dermatologic agents|mesh-ancestor
111331978|NCT00373282|Triamcinolone|triamcinolone|mesh-list
111331979|NCT00373282|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
111331980|NCT00373282|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
111331981|NCT00373282|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
111331982|NCT00373282|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111331983|NCT00373282|Glucocorticoids|glucocorticoids|mesh-ancestor
111331984|NCT00373282|Hormones|hormones|mesh-ancestor
111331985|NCT00373282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111331986|NCT00373282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111331987|NCT00373282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111331988|NCT00373282|Immunologic Factors|immunologic factors|mesh-ancestor
111331989|NCT00373282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111331990|NCT00373282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111331991|NCT04382027|Vitamins|vitamins|mesh-list
111331992|NCT04382027|Vitamin K|vitamin k|mesh-list
111331993|NCT04382027|Vitamin K 2|vitamin k 2|mesh-list
111331994|NCT04382027|Micronutrients|micronutrients|mesh-ancestor
111331995|NCT04382027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111331996|NCT04382027|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111331997|NCT04382027|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111331998|NCT04382027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111331999|NCT04382027|Hemostatics|hemostatics|mesh-ancestor
111332000|NCT04382027|Coagulants|coagulants|mesh-ancestor
111332001|NCT00896441|Citalopram|citalopram|mesh-list
111332002|NCT00896441|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111332003|NCT00896441|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111332004|NCT00896441|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111332005|NCT00896441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111332006|NCT00896441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111332007|NCT00896441|Serotonin Agents|serotonin agents|mesh-ancestor
111332008|NCT00896441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111332009|NCT00896441|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111332010|NCT00896441|Antidepressive Agents|antidepressive agents|mesh-ancestor
111332011|NCT00896441|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111332012|NCT02790515|Sirolimus|sirolimus|mesh-list
111332013|NCT02790515|Cyclophosphamide|cyclophosphamide|mesh-list
111332014|NCT02790515|Melphalan|melphalan|mesh-list
111332015|NCT02790515|Mechlorethamine|mechlorethamine|mesh-list
111332016|NCT02790515|Thiotepa|thiotepa|mesh-list
111332017|NCT02790515|Rituximab|rituximab|mesh-list
111332018|NCT02790515|Fludarabine|fludarabine|mesh-list
111332019|NCT02790515|Blinatumomab|blinatumomab|mesh-list
111332020|NCT02790515|Tacrolimus|tacrolimus|mesh-list
111332021|NCT02790515|Thymoglobulin|thymoglobulin|mesh-list
111332022|NCT02790515|Antilymphocyte Serum|antilymphocyte serum|mesh-list
111332023|NCT02790515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111332024|NCT02790515|Immunologic Factors|immunologic factors|mesh-ancestor
111332025|NCT02790515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111332026|NCT02790515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111332027|NCT02790515|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111332028|NCT02790515|Alkylating Agents|alkylating agents|mesh-ancestor
111332029|NCT02790515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111332030|NCT02790515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111332031|NCT02790515|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111332032|NCT02790515|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111332033|NCT02790515|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111332034|NCT02790515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111332035|NCT02790515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111332036|NCT02790515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111332037|NCT02790515|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111332038|NCT02790515|Antifungal Agents|antifungal agents|mesh-ancestor
111332039|NCT03400111|Acetaminophen|acetaminophen|mesh-list
111332040|NCT03400111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111332041|NCT03400111|Analgesics|analgesics|mesh-ancestor
111332042|NCT03400111|Sensory System Agents|sensory system agents|mesh-ancestor
111332043|NCT03400111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111332044|NCT03400111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111332045|NCT03400111|Antipyretics|antipyretics|mesh-ancestor
111332046|NCT03404791|Gemcitabine|gemcitabine|mesh-list
111332047|NCT03404791|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111332048|NCT03404791|Antimetabolites|antimetabolites|mesh-ancestor
111332049|NCT03404791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111332050|NCT03404791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111332051|NCT00918931|Obatoclax|obatoclax|mesh-list
111332052|NCT00918931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111332053|NCT00918931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111332054|NCT03404011|Glycerol|glycerol|mesh-list
111332055|NCT03404011|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
111332056|NCT03404011|Protective Agents|protective agents|mesh-ancestor
111332057|NCT03404011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111332058|NCT01830491|Aspirin|aspirin|mesh-list
111332059|NCT01830491|Clopidogrel|clopidogrel|mesh-list
111332060|NCT01830491|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111332061|NCT01830491|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111332062|NCT01830491|Analgesics|analgesics|mesh-ancestor
111332063|NCT01830491|Sensory System Agents|sensory system agents|mesh-ancestor
111056484|NCT03490279|Lactoferrin|lactoferrin|mesh-list
111332064|NCT01830491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111332065|NCT01830491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111332066|NCT01830491|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110785593|NCT01120119|Vitamins|vitamins|mesh-ancestor
111332067|NCT01830491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111332068|NCT01830491|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111332069|NCT01830491|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111332070|NCT01830491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111332071|NCT01830491|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111332072|NCT01830491|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111332073|NCT01830491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111332074|NCT01830491|Antipyretics|antipyretics|mesh-ancestor
111332075|NCT01830491|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111332076|NCT01830491|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111332077|NCT01830491|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111332078|NCT01830491|Purinergic Agents|purinergic agents|mesh-ancestor
111332079|NCT01830491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111332080|NCT02778880|Fentanyl|fentanyl|mesh-list
111332081|NCT02778880|Ketamine|ketamine|mesh-list
110785753|NCT01219569|Propofol|propofol|mesh-list
111332082|NCT02778880|Analgesics|analgesics|mesh-ancestor
111332083|NCT02778880|Sensory System Agents|sensory system agents|mesh-ancestor
111332084|NCT02778880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111332085|NCT02778880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111332086|NCT02778880|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111332087|NCT02778880|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111332088|NCT02778880|Anesthetics, General|anesthetics, general|mesh-ancestor
111332089|NCT02778880|Anesthetics|anesthetics|mesh-ancestor
111332090|NCT02778880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111332091|NCT02778880|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111332092|NCT02778880|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111332093|NCT02778880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111332094|NCT02778880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111332095|NCT02778880|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111332096|NCT02778880|Narcotics|narcotics|mesh-ancestor
111332097|NCT02778880|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111332098|NCT05310929|Labetalol|labetalol|mesh-list
111332099|NCT05310929|Nitroglycerin|nitroglycerin|mesh-list
111332100|NCT05310929|Vasodilator Agents|vasodilator agents|mesh-ancestor
111332101|NCT05310929|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111332102|NCT05310929|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111332103|NCT05310929|Adrenergic Agents|adrenergic agents|mesh-ancestor
111332104|NCT05310929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111332105|NCT05310929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111332106|NCT05310929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111332107|NCT05310929|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111332108|NCT05310929|Sympathomimetics|sympathomimetics|mesh-ancestor
111332109|NCT05310929|Autonomic Agents|autonomic agents|mesh-ancestor
111332110|NCT05310929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111332111|NCT05310929|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111332112|NCT05310929|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111332113|NCT00891995|Insulin|insulin|mesh-list
111332114|NCT00891995|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111332115|NCT00891995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111332116|NCT02781454|Mexiletine|mexiletine|mesh-list
111332117|NCT02781454|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111332118|NCT02781454|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111332119|NCT02781454|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111332120|NCT02781454|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111332121|NCT02781454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111332122|NCT00892697|Ribavirin|ribavirin|mesh-list
111332123|NCT00892697|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
111332124|NCT00892697|Antimetabolites|antimetabolites|mesh-ancestor
110785912|NCT01222611|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111332125|NCT00892697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111332126|NCT00892697|Antiviral Agents|antiviral agents|mesh-ancestor
111332127|NCT00892697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111332128|NCT02155465|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111332129|NCT02155465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111332130|NCT02155465|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111332131|NCT02155465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111332132|NCT02155465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111332133|NCT01831193|Curcumin|curcumin|mesh-list
111332134|NCT01831193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111332135|NCT01831193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111332136|NCT01831193|Analgesics|analgesics|mesh-ancestor
111332137|NCT01831193|Sensory System Agents|sensory system agents|mesh-ancestor
111332138|NCT01831193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111332139|NCT01831193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111332140|NCT01831193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111332141|NCT01831193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110786041|NCT05284942|Glucocorticoids|glucocorticoids|mesh-ancestor
111332142|NCT01831193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111332143|NCT01831193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111332144|NCT01831193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111332145|NCT01831505|Prednisolone|prednisolone|mesh-list
111332146|NCT01831505|Rituximab|rituximab|mesh-list
111332147|NCT01831505|Doxorubicin|doxorubicin|mesh-list
111332148|NCT01831505|Vincristine|vincristine|mesh-list
111332149|NCT01831505|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
111332150|NCT01831505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111332151|NCT01831505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111332152|NCT01831505|Immunologic Factors|immunologic factors|mesh-ancestor
111332153|NCT01831505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111332154|NCT01831505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111332155|NCT01831505|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111332156|NCT01831505|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111332157|NCT01831505|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111332158|NCT01831505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111332159|NCT01831505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111332160|NCT01831505|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111332161|NCT01831505|Tubulin Modulators|tubulin modulators|mesh-ancestor
111332162|NCT01831505|Antimitotic Agents|antimitotic agents|mesh-ancestor
111332163|NCT01831505|Mitosis Modulators|mitosis modulators|mesh-ancestor
111332164|NCT01831505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111332165|NCT01831505|Glucocorticoids|glucocorticoids|mesh-ancestor
111332166|NCT01831505|Hormones|hormones|mesh-ancestor
111332167|NCT01831505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111332168|NCT01831505|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111332169|NCT01831505|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111332170|NCT01831505|Alkylating Agents|alkylating agents|mesh-ancestor
111332171|NCT02781610|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111332172|NCT02781610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111332173|NCT03214055|Mannitol|mannitol|mesh-list
111332174|NCT03214055|Diuretics|diuretics|mesh-list
111332175|NCT03214055|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
111332176|NCT03214055|Natriuretic Agents|natriuretic agents|mesh-ancestor
111332177|NCT03214055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111332178|NCT03405337|Factor VIII|factor viii|mesh-list
111332179|NCT03405337|Coagulants|coagulants|mesh-ancestor
111332180|NCT01831661|Metformin|metformin|mesh-list
111332181|NCT01831661|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111332182|NCT01831661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111332183|NCT05311085|Nicotine|nicotine|mesh-list
111332184|NCT05311085|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111332185|NCT05311085|Autonomic Agents|autonomic agents|mesh-ancestor
111332186|NCT05311085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111332187|NCT05311085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111332188|NCT05311085|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111332189|NCT05311085|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111332190|NCT05311085|Cholinergic Agents|cholinergic agents|mesh-ancestor
111332191|NCT05311085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111332192|NCT05311085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111332193|NCT03400267|Acetaminophen|acetaminophen|mesh-list
111332194|NCT03400267|Fentanyl|fentanyl|mesh-list
111332195|NCT03400267|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111332196|NCT03400267|Narcotics|narcotics|mesh-ancestor
111332197|NCT03400267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111332198|NCT03400267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111332199|NCT03400267|Analgesics|analgesics|mesh-ancestor
111332200|NCT03400267|Sensory System Agents|sensory system agents|mesh-ancestor
111332201|NCT03400267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111332202|NCT03400267|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111332203|NCT03400267|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111332204|NCT03400267|Anesthetics, General|anesthetics, general|mesh-ancestor
111332205|NCT03400267|Anesthetics|anesthetics|mesh-ancestor
111332206|NCT03400267|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111332207|NCT03400267|Antipyretics|antipyretics|mesh-ancestor
111332208|NCT01832051|Trastuzumab|trastuzumab|mesh-list
111332209|NCT01832051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111332210|NCT01832051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111332211|NCT01832129|Vitamins|vitamins|mesh-list
111332212|NCT01832129|Hydroxocobalamin|hydroxocobalamin|mesh-list
111332213|NCT01832129|Vitamin B 12|vitamin b 12|mesh-list
111332214|NCT01832129|Vitamin B Complex|vitamin b complex|mesh-list
111332215|NCT01832129|Micronutrients|micronutrients|mesh-ancestor
111332216|NCT01832129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111332217|NCT01832129|Hematinics|hematinics|mesh-ancestor
111332218|NCT03219359|Methylprednisolone|methylprednisolone|mesh-list
111332219|NCT03219359|Cyclophosphamide|cyclophosphamide|mesh-list
111332220|NCT03219359|Vedolizumab|vedolizumab|mesh-list
111332221|NCT03219359|Thymoglobulin|thymoglobulin|mesh-list
111332222|NCT03219359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111332223|NCT03219359|Immunologic Factors|immunologic factors|mesh-ancestor
111332224|NCT03219359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111332225|NCT03219359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111332226|NCT03219359|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111332227|NCT03219359|Alkylating Agents|alkylating agents|mesh-ancestor
110786406|NCT01585623|Metoprolol|metoprolol|mesh-list
111332228|NCT03219359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111332229|NCT03219359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111332230|NCT03219359|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111332231|NCT03219359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111332232|NCT03219359|Antiemetics|antiemetics|mesh-ancestor
111332233|NCT03219359|Autonomic Agents|autonomic agents|mesh-ancestor
111332234|NCT03219359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111332235|NCT03219359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111332236|NCT03219359|Glucocorticoids|glucocorticoids|mesh-ancestor
111332237|NCT03219359|Hormones|hormones|mesh-ancestor
111332238|NCT03219359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111332239|NCT03219359|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111332240|NCT03219359|Protective Agents|protective agents|mesh-ancestor
111332241|NCT02903446|Denosumab|denosumab|mesh-list
111332242|NCT02903446|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110786480|NCT03740295|Protective Agents|protective agents|mesh-ancestor
111332243|NCT02903446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111332244|NCT01832285|Fluvoxamine|fluvoxamine|mesh-list
111332245|NCT01832285|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111332246|NCT01832285|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111332247|NCT01832285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111332248|NCT01832285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111332249|NCT01832285|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111332250|NCT01832285|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111332251|NCT01832285|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111332252|NCT01832285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111332253|NCT01832285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111332254|NCT01832285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111332255|NCT01832285|Serotonin Agents|serotonin agents|mesh-ancestor
111332256|NCT01832285|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111332257|NCT01832285|Antidepressive Agents|antidepressive agents|mesh-ancestor
111332258|NCT01832285|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110786541|NCT01131429|Cisplatin|cisplatin|mesh-list
111332259|NCT01832285|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111332260|NCT01832285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111332261|NCT01832285|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111332263|NCT01832363|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111332264|NCT01832363|Anesthetics, General|anesthetics, general|mesh-ancestor
111332265|NCT01832363|Anesthetics|anesthetics|mesh-ancestor
111332266|NCT01832363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111332267|NCT01832363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111332268|NCT02903836|Moxifloxacin|moxifloxacin|mesh-list
111332269|NCT02903836|Nafithromycin|nafithromycin|mesh-list
110786664|NCT03925233|Vinorelbine|vinorelbine|mesh-list
111332270|NCT02903836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111332271|NCT02903836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110786738|NCT01345162|Ketorolac|ketorolac|mesh-list
111332272|NCT02903836|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111332273|NCT02903836|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111332274|NCT02903836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111332275|NCT02903836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111332276|NCT02903836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111332277|NCT02903836|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111332278|NCT00014911|Sirolimus|sirolimus|mesh-list
111332279|NCT00014911|Pentamidine|pentamidine|mesh-list
111332280|NCT00014911|Trimethoprim|trimethoprim|mesh-list
111332281|NCT00014911|Sulfamethoxazole|sulfamethoxazole|mesh-list
111332282|NCT00014911|Ganciclovir|ganciclovir|mesh-list
111332283|NCT00014911|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
111332284|NCT00014911|Tacrolimus|tacrolimus|mesh-list
111332285|NCT00014911|Daclizumab|daclizumab|mesh-list
111332286|NCT00014911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111332287|NCT00014911|Immunologic Factors|immunologic factors|mesh-ancestor
111332288|NCT00014911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111332289|NCT00014911|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111332290|NCT00014911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111332291|NCT00014911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111332292|NCT00014911|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111332293|NCT00014911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111332294|NCT00014911|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110786955|NCT01132677|Methylprednisolone|methylprednisolone|mesh-list
111332295|NCT00014911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111332296|NCT00014911|Antifungal Agents|antifungal agents|mesh-ancestor
111332297|NCT00014911|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111332298|NCT00014911|Antimalarials|antimalarials|mesh-ancestor
111332299|NCT00014911|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111332300|NCT00014911|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111332301|NCT00014911|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111332302|NCT00014911|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111332303|NCT00014911|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
111332304|NCT00014911|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111332305|NCT00014911|Antiviral Agents|antiviral agents|mesh-ancestor
111332306|NCT00014911|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110787086|NCT03920475|Sertraline|sertraline|mesh-list
111332307|NCT00014911|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
111332308|NCT01832675|Bupivacaine|bupivacaine|mesh-list
111332309|NCT01832675|Anesthetics, Local|anesthetics, local|mesh-ancestor
111332310|NCT01832675|Anesthetics|anesthetics|mesh-ancestor
111332311|NCT01832675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111332312|NCT01832675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111332313|NCT01832675|Sensory System Agents|sensory system agents|mesh-ancestor
111332314|NCT01832675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111332315|NCT03213587|Apatinib|apatinib|mesh-list
111332316|NCT03213587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110787222|NCT02960854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111332317|NCT03213587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111332318|NCT03213587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111332319|NCT03213587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111332320|NCT00013897|Lamivudine|lamivudine|mesh-list
111332321|NCT00013897|Zidovudine|zidovudine|mesh-list
111332322|NCT00013897|Efavirenz|efavirenz|mesh-list
111332323|NCT00013897|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
111332324|NCT00013897|Atazanavir Sulfate|atazanavir sulfate|mesh-list
111332325|NCT00013897|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111332326|NCT00013897|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110787373|NCT01135953|Cycloserine|cycloserine|mesh-list
111332327|NCT00013897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111332328|NCT00013897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111332329|NCT00013897|Antiviral Agents|antiviral agents|mesh-ancestor
111332330|NCT00013897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111332331|NCT00013897|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111332332|NCT00013897|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111332333|NCT00013897|Antimetabolites|antimetabolites|mesh-ancestor
111332334|NCT00013897|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110787502|NCT01136421|Anesthetics|anesthetics|mesh-ancestor
111332335|NCT00013897|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111332336|NCT00013897|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111332337|NCT00013897|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111332338|NCT00013897|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111332339|NCT00013897|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111332340|NCT00013897|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110787643|NCT01234935|Gemcitabine|gemcitabine|mesh-list
111332341|NCT00013897|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111332342|NCT00013897|Protease Inhibitors|protease inhibitors|mesh-ancestor
111332343|NCT03219983|Bupivacaine|bupivacaine|mesh-list
111332344|NCT03219983|Ropivacaine|ropivacaine|mesh-list
111332345|NCT03219983|Anesthetics, Local|anesthetics, local|mesh-ancestor
111332346|NCT03219983|Anesthetics|anesthetics|mesh-ancestor
111332347|NCT03219983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111332348|NCT03219983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111332349|NCT03219983|Sensory System Agents|sensory system agents|mesh-ancestor
111332350|NCT03219983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111332351|NCT04347577|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
111332352|NCT04347577|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111332353|NCT04347577|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111332354|NCT04347577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111332355|NCT04347577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111332356|NCT04347577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111332357|NCT04347577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111332358|NCT04347577|Analgesics|analgesics|mesh-ancestor
111332359|NCT04347577|Sensory System Agents|sensory system agents|mesh-ancestor
110787853|NCT02872012|Lidocaine|lidocaine|mesh-list
111332360|NCT04347577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111332361|NCT04347577|Antidepressive Agents|antidepressive agents|mesh-ancestor
111332362|NCT04347577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111332363|NCT04347577|Dopamine Agents|dopamine agents|mesh-ancestor
111332364|NCT02240017|Carboplatin|carboplatin|mesh-list
111332365|NCT02240017|Gemcitabine|gemcitabine|mesh-list
111332366|NCT02240017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111332367|NCT02240017|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111332368|NCT02240017|Antimetabolites|antimetabolites|mesh-ancestor
111332369|NCT02240017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111332370|NCT00899717|Salicylic Acid|salicylic acid|mesh-list
111332371|NCT00899717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111332372|NCT00899717|Antifungal Agents|antifungal agents|mesh-ancestor
111332373|NCT00899717|Keratolytic Agents|keratolytic agents|mesh-ancestor
111332374|NCT00899717|Dermatologic Agents|dermatologic agents|mesh-ancestor
111332375|NCT03219593|Apatinib|apatinib|mesh-list
111332376|NCT03219593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111332377|NCT03219593|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111332378|NCT03219593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111332379|NCT03219593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111332380|NCT04375267|Olaparib|olaparib|mesh-list
111332381|NCT04375267|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
111332382|NCT04375267|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111332383|NCT04375267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111332384|NCT04375267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111332385|NCT04375267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111332386|NCT04375267|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111332387|NCT03836807|Ketoprofen|ketoprofen|mesh-list
111332388|NCT03836807|Ketoprofen lysine|ketoprofen lysine|mesh-list
111332389|NCT03836807|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111332390|NCT03836807|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111332391|NCT03836807|Analgesics|analgesics|mesh-ancestor
110788271|NCT01347866|Irinotecan|irinotecan|mesh-list
111332392|NCT03836807|Sensory System Agents|sensory system agents|mesh-ancestor
111332393|NCT03836807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111332394|NCT03836807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111332395|NCT03836807|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111332396|NCT03836807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111332397|NCT03836807|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111332398|NCT03836807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111332399|NCT03836807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111332400|NCT02240173|Haloperidol|haloperidol|mesh-list
111332401|NCT02240173|Haloperidol decanoate|haloperidol decanoate|mesh-list
111332402|NCT02240173|Antiemetics|antiemetics|mesh-ancestor
111332403|NCT02240173|Autonomic Agents|autonomic agents|mesh-ancestor
111332404|NCT02240173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111332405|NCT02240173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111332406|NCT02240173|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111332407|NCT02240173|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111332408|NCT02240173|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111332409|NCT02240173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111332410|NCT02240173|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111332411|NCT02240173|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111332412|NCT02240173|Dopamine Agents|dopamine agents|mesh-ancestor
111332413|NCT02240173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111332414|NCT02240173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111332415|NCT02240173|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111332416|NCT02240641|Antihypertensive Agents|antihypertensive agents|mesh-list
111332417|NCT02240641|Lacidipine|lacidipine|mesh-list
111332418|NCT02240641|Diuretics|diuretics|mesh-list
111332419|NCT02240641|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
111332420|NCT02240641|Enzyme Inhibitors|enzyme inhibitors|mesh-list
110788691|NCT04125550|Anesthetics|anesthetics|mesh-ancestor
111332421|NCT02240641|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
111332422|NCT02240641|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
111332423|NCT02240641|Natriuretic Agents|natriuretic agents|mesh-ancestor
111332424|NCT02240641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110788830|NCT02852434|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111332425|NCT02240641|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111332426|NCT02240641|Adrenergic Agents|adrenergic agents|mesh-ancestor
111332427|NCT02240641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111332428|NCT02240641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111332429|NCT02240641|Protease Inhibitors|protease inhibitors|mesh-ancestor
111332430|NCT02240641|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110788912|NCT03601624|Hormones|hormones|mesh-ancestor
111332431|NCT02240641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111332432|NCT02240641|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111332433|NCT03219671|Nivolumab|nivolumab|mesh-list
111332434|NCT03219671|Ipilimumab|ipilimumab|mesh-list
111332435|NCT03219671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110788974|NCT02238184|Autonomic Agents|autonomic agents|mesh-ancestor
111332436|NCT03219671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111332437|NCT03219671|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111332438|NCT03219671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111332439|NCT03404635|Rivaroxaban|rivaroxaban|mesh-list
111332440|NCT03404635|Apixaban|apixaban|mesh-list
111056867|NCT01516073|Xhance|xhance|mesh-list
110789048|NCT03334448|Insulin Lispro|insulin lispro|mesh-list
111332441|NCT03404635|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111332442|NCT03404635|Antithrombins|antithrombins|mesh-ancestor
111332443|NCT03404635|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111332444|NCT03404635|Protease Inhibitors|protease inhibitors|mesh-ancestor
111332445|NCT03404635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111332446|NCT03404635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111332447|NCT03404635|Anticoagulants|anticoagulants|mesh-ancestor
111332449|NCT01832987|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
111332450|NCT01832987|Sulfamethoxazole|sulfamethoxazole|mesh-list
111332451|NCT01832987|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111332452|NCT01832987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111332453|NCT01832987|Antimalarials|antimalarials|mesh-ancestor
111332454|NCT01832987|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111332455|NCT01832987|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110789181|NCT02646982|Candesartan|candesartan|mesh-list
111332456|NCT01832987|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111332457|NCT01832987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111332458|NCT01832987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111332459|NCT01832987|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111332460|NCT01832987|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
111332461|NCT01832987|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111332462|NCT01832987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111332463|NCT03404479|Celecoxib|celecoxib|mesh-list
111332464|NCT03404479|Diacerein|diacerein|mesh-list
111332465|NCT03404479|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110789400|NCT03369704|Omalizumab|omalizumab|mesh-list
111332466|NCT03404479|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111332467|NCT03404479|Analgesics|analgesics|mesh-ancestor
111332468|NCT03404479|Sensory System Agents|sensory system agents|mesh-ancestor
111332469|NCT03404479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111332470|NCT03404479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111332471|NCT03404479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111332472|NCT03404479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111332473|NCT03404479|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111332474|NCT03404479|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111332475|NCT03404479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111332476|NCT03404479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111332477|NCT04380467|Vitamin D|vitamin d|mesh-list
111332478|NCT04380467|Cholecalciferol|cholecalciferol|mesh-list
111332479|NCT04380467|Vitamins|vitamins|mesh-ancestor
111332480|NCT04380467|Micronutrients|micronutrients|mesh-ancestor
111332481|NCT04380467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111332482|NCT04380467|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111332483|NCT04380467|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111332484|NCT03218657|Cyclosporine|cyclosporine|mesh-list
111332485|NCT03218657|Levamisole|levamisole|mesh-list
111332486|NCT03218657|Cyclosporins|cyclosporins|mesh-list
111332487|NCT03218657|Androgens|androgens|mesh-list
111332488|NCT03218657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110789524|NCT03708926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111332489|NCT03218657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111332490|NCT03218657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111332491|NCT03218657|Immunologic Factors|immunologic factors|mesh-ancestor
111332492|NCT03218657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110789592|NCT03710330|Hemostatics|hemostatics|mesh-ancestor
111332493|NCT03218657|Antifungal Agents|antifungal agents|mesh-ancestor
111332494|NCT03218657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111332495|NCT03218657|Dermatologic Agents|dermatologic agents|mesh-ancestor
111332496|NCT03218657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111332497|NCT03218657|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111332498|NCT03218657|Hormones|hormones|mesh-ancestor
111332499|NCT03218657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111332500|NCT03218657|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111332501|NCT03218657|Antinematodal Agents|antinematodal agents|mesh-ancestor
111332502|NCT03218657|Anthelmintics|anthelmintics|mesh-ancestor
111332503|NCT03218657|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111332504|NCT02240719|Everolimus|everolimus|mesh-list
111332505|NCT02240719|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
111332506|NCT02240719|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110789813|NCT05625555|Midazolam|midazolam|mesh-list
111332507|NCT02240719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111332508|NCT02240719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111332509|NCT02240719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111332510|NCT02240719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111332511|NCT02240719|Immunologic Factors|immunologic factors|mesh-ancestor
111332512|NCT02240719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111332513|NCT02240719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111056936|NCT01470131|Hormones|hormones|mesh-ancestor
111332514|NCT02240719|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111332516|NCT01833299|Sorafenib|sorafenib|mesh-list
111332517|NCT01833299|Chlorotrianisene|chlorotrianisene|mesh-list
110789948|NCT04865835|Metformin|metformin|mesh-list
110790015|NCT01147029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111332518|NCT01833299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111332519|NCT01833299|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111332520|NCT01833299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111332521|NCT01833299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111332522|NCT01833299|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
111332523|NCT01833299|Estrogens|estrogens|mesh-ancestor
111332524|NCT01833299|Hormones|hormones|mesh-ancestor
111365071|NCT03007303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111332525|NCT01833299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111332526|NCT01833299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111332527|NCT01833299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111332528|NCT03213041|Carboplatin|carboplatin|mesh-list
111332529|NCT03213041|Pembrolizumab|pembrolizumab|mesh-list
111332530|NCT03213041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111332531|NCT03213041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111332532|NCT03213041|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111332533|NCT03213041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111332534|NCT02240875|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
111332535|NCT02240875|Antiviral Agents|antiviral agents|mesh-ancestor
111332536|NCT02240875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111332537|NCT01833611|Entecavir|entecavir|mesh-list
111332538|NCT01833611|Antiviral Agents|antiviral agents|mesh-ancestor
111332539|NCT01833611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111332540|NCT02240953|Warfarin|warfarin|mesh-list
111332541|NCT02240953|Anticoagulants|anticoagulants|mesh-ancestor
111332542|NCT03212729|Anti-Infective Agents|anti-infective agents|mesh-list
111332543|NCT03212729|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111332544|NCT02241031|Oprelvekin|oprelvekin|mesh-list
111332545|NCT02241031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111332546|NCT03212807|Lenalidomide|lenalidomide|mesh-list
111332547|NCT03212807|Durvalumab|durvalumab|mesh-list
111332548|NCT03212807|Immunologic Factors|immunologic factors|mesh-ancestor
111332549|NCT03212807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111332550|NCT03212807|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111332551|NCT03212807|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111332552|NCT03212807|Growth Substances|growth substances|mesh-ancestor
111332553|NCT03212807|Growth Inhibitors|growth inhibitors|mesh-ancestor
111332554|NCT03212807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111332555|NCT03212807|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111332556|NCT01833767|Cyclophosphamide|cyclophosphamide|mesh-list
111332557|NCT01833767|Interleukin-2|interleukin-2|mesh-list
111332558|NCT01833767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111332559|NCT01833767|Immunologic Factors|immunologic factors|mesh-ancestor
110790654|NCT03892161|Protease Inhibitors|protease inhibitors|mesh-ancestor
111332560|NCT01833767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111332561|NCT01833767|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111332562|NCT01833767|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111332563|NCT01833767|Alkylating Agents|alkylating agents|mesh-ancestor
111365072|NCT03007303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111332564|NCT01833767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111332565|NCT01833767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111332566|NCT01833767|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111332567|NCT01833767|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111332568|NCT01833767|Analgesics|analgesics|mesh-ancestor
111332569|NCT01833767|Sensory System Agents|sensory system agents|mesh-ancestor
111332570|NCT01833767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111332571|NCT03213353|Acetaminophen|acetaminophen|mesh-list
111332572|NCT03213353|Phenylpropanolamine|phenylpropanolamine|mesh-list
111332573|NCT03213353|Phenylephrine|phenylephrine|mesh-list
111332574|NCT03213353|Oxymetazoline|oxymetazoline|mesh-list
111332575|NCT03213353|Guaifenesin|guaifenesin|mesh-list
110790936|NCT01259817|Antipyretics|antipyretics|mesh-ancestor
111332576|NCT03213353|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
110445937|NCT00943917|Hormones|hormones|mesh-ancestor
111332577|NCT03213353|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111332578|NCT03213353|Analgesics|analgesics|mesh-ancestor
111332579|NCT03213353|Sensory System Agents|sensory system agents|mesh-ancestor
111332580|NCT03213353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111332581|NCT03213353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111332582|NCT03213353|Antipyretics|antipyretics|mesh-ancestor
111332583|NCT03213353|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111332584|NCT03213353|Mydriatics|mydriatics|mesh-ancestor
111332585|NCT03213353|Autonomic Agents|autonomic agents|mesh-ancestor
111332586|NCT03213353|Sympathomimetics|sympathomimetics|mesh-ancestor
111332587|NCT03213353|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111332588|NCT03213353|Nasal Decongestants|nasal decongestants|mesh-ancestor
111332589|NCT03213353|Respiratory System Agents|respiratory system agents|mesh-ancestor
111057009|NCT01660022|Piperaquine|piperaquine|mesh-list
111332590|NCT03213353|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111332591|NCT03213353|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111332592|NCT03213353|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111332593|NCT03213353|Adrenergic Agents|adrenergic agents|mesh-ancestor
111332594|NCT03213353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111332595|NCT03213353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111332596|NCT03213353|Protective Agents|protective agents|mesh-ancestor
111332598|NCT03213353|Appetite Depressants|appetite depressants|mesh-ancestor
111332599|NCT03213353|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111332600|NCT01834235|Paclitaxel|paclitaxel|mesh-list
111332601|NCT01834235|Gemcitabine|gemcitabine|mesh-list
111332602|NCT01834235|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111332603|NCT01834235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111332604|NCT01834235|Tubulin Modulators|tubulin modulators|mesh-ancestor
111332605|NCT01834235|Antimitotic Agents|antimitotic agents|mesh-ancestor
111332606|NCT01834235|Mitosis Modulators|mitosis modulators|mesh-ancestor
111365073|NCT03007303|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110791433|NCT01159275|Protease Inhibitors|protease inhibitors|mesh-ancestor
111332607|NCT01834235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111332608|NCT01834235|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111332609|NCT01834235|Antimetabolites|antimetabolites|mesh-ancestor
111332610|NCT03211871|Dexmedetomidine|dexmedetomidine|mesh-list
111332611|NCT03211871|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111332612|NCT03211871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111332613|NCT03211871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111332614|NCT03211871|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111332615|NCT03211871|Analgesics|analgesics|mesh-ancestor
111332616|NCT03211871|Sensory System Agents|sensory system agents|mesh-ancestor
111332617|NCT03211871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111332618|NCT03211871|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111332619|NCT03211871|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111332620|NCT03211871|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111332621|NCT03211871|Adrenergic Agents|adrenergic agents|mesh-ancestor
111332622|NCT03211871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111332623|NCT03211871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111332624|NCT03838133|Bupivacaine|bupivacaine|mesh-list
111332625|NCT03838133|Ropivacaine|ropivacaine|mesh-list
111332626|NCT03838133|Anesthetics, Local|anesthetics, local|mesh-ancestor
111332627|NCT03838133|Anesthetics|anesthetics|mesh-ancestor
111332628|NCT03838133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111332629|NCT03838133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111332630|NCT03838133|Sensory System Agents|sensory system agents|mesh-ancestor
111332631|NCT03838133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111332632|NCT03217409|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111332633|NCT03217409|Ezetimibe|ezetimibe|mesh-list
111332634|NCT03217409|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110791807|NCT03882255|Propranolol|propranolol|mesh-list
111332635|NCT03217409|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111332636|NCT03217409|Antimetabolites|antimetabolites|mesh-ancestor
111332637|NCT03217409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111332638|NCT03217409|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111332639|NCT03217409|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111332640|NCT03217409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111332641|NCT00895193|Aspirin|aspirin|mesh-list
111332642|NCT00895193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111332643|NCT00895193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111332644|NCT00895193|Analgesics|analgesics|mesh-ancestor
111332645|NCT00895193|Sensory System Agents|sensory system agents|mesh-ancestor
111332646|NCT00895193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111332647|NCT00895193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111332648|NCT00895193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111332649|NCT00895193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111332650|NCT00895193|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111332651|NCT00895193|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111332652|NCT00895193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111332653|NCT00895193|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111332654|NCT00895193|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111332655|NCT00895193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111332656|NCT00895193|Antipyretics|antipyretics|mesh-ancestor
111332657|NCT01834547|Caffeine|caffeine|mesh-list
111332658|NCT01834547|Methylphenidate|methylphenidate|mesh-list
111332659|NCT01834547|Modafinil|modafinil|mesh-list
111332660|NCT01834547|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111332661|NCT01834547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111332662|NCT01834547|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111332663|NCT01834547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110792130|NCT01164267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111332664|NCT01834547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111332665|NCT01834547|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
111332666|NCT01834547|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111332667|NCT01834547|Purinergic Agents|purinergic agents|mesh-ancestor
111332668|NCT01834547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111332669|NCT01834547|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111332670|NCT01834547|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111332671|NCT01834547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111332672|NCT01834547|Dopamine Agents|dopamine agents|mesh-ancestor
111332673|NCT01834547|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
111332674|NCT01834547|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111332675|NCT01834547|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111332676|NCT03216941|Ketamine|ketamine|mesh-list
111332677|NCT03216941|Olanzapine|olanzapine|mesh-list
111332678|NCT03216941|Analgesics|analgesics|mesh-ancestor
111332679|NCT03216941|Sensory System Agents|sensory system agents|mesh-ancestor
111332680|NCT03216941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111332681|NCT03216941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111332682|NCT03216941|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111332683|NCT03216941|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111332684|NCT03216941|Anesthetics, General|anesthetics, general|mesh-ancestor
111332685|NCT03216941|Anesthetics|anesthetics|mesh-ancestor
111332686|NCT03216941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111332687|NCT03216941|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111332688|NCT03216941|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111332689|NCT03216941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111332690|NCT03216941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111332691|NCT03216941|Antiemetics|antiemetics|mesh-ancestor
111332692|NCT03216941|Autonomic Agents|autonomic agents|mesh-ancestor
111332693|NCT03216941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111332694|NCT03216941|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111332695|NCT03216941|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111332696|NCT03216941|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111332697|NCT03216941|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111332698|NCT03216941|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111332699|NCT03216941|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111332700|NCT03216941|Serotonin Agents|serotonin agents|mesh-ancestor
111332701|NCT03216707|Capsaicin|capsaicin|mesh-list
111332702|NCT03216707|Antipruritics|antipruritics|mesh-ancestor
111332703|NCT03216707|Dermatologic Agents|dermatologic agents|mesh-ancestor
111332704|NCT03216707|Sensory System Agents|sensory system agents|mesh-ancestor
111332705|NCT03216707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111332706|NCT03216707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111332707|NCT01838993|Lidocaine|lidocaine|mesh-list
111332708|NCT01838993|Anesthetics, Local|anesthetics, local|mesh-ancestor
111332709|NCT01838993|Anesthetics|anesthetics|mesh-ancestor
111332710|NCT01838993|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111332711|NCT01838993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111332712|NCT01838993|Sensory System Agents|sensory system agents|mesh-ancestor
111332713|NCT01838993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111332714|NCT01838993|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111332715|NCT01838993|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111332716|NCT01838993|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111332717|NCT01838993|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111332718|NCT01838993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111332719|NCT03211013|Oxytocin|oxytocin|mesh-list
111332720|NCT03211013|Oxytocics|oxytocics|mesh-ancestor
111332721|NCT03211013|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111332722|NCT03211013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111332723|NCT01835561|Thalidomide|thalidomide|mesh-list
111332724|NCT01835561|Pomalidomide|pomalidomide|mesh-list
111332725|NCT01835561|Immunologic Factors|immunologic factors|mesh-ancestor
111332726|NCT01835561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111332727|NCT01835561|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111332728|NCT01835561|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111332729|NCT01835561|Growth Substances|growth substances|mesh-ancestor
111332730|NCT01835561|Growth Inhibitors|growth inhibitors|mesh-ancestor
111332731|NCT01835561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111332732|NCT01835561|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111332733|NCT01835561|Leprostatic Agents|leprostatic agents|mesh-ancestor
111332734|NCT01835561|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110792667|NCT01173003|Misoprostol|misoprostol|mesh-list
111332735|NCT01835561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111332736|NCT01835639|Vitamin D|vitamin d|mesh-list
111332737|NCT01835639|Cholecalciferol|cholecalciferol|mesh-list
111332738|NCT01835639|Vitamins|vitamins|mesh-ancestor
111332740|NCT01835639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110792747|NCT01172223|Paclitaxel|paclitaxel|mesh-list
111332741|NCT01835639|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111332742|NCT01835639|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111332743|NCT01839149|Oxytocin|oxytocin|mesh-list
111332744|NCT01839149|Oxytocics|oxytocics|mesh-ancestor
111332745|NCT01839149|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111332746|NCT01839149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111332747|NCT01839383|Dialysis Solutions|dialysis solutions|mesh-list
111332748|NCT01839383|Calcium|calcium|mesh-list
111332749|NCT01839383|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111332750|NCT01839383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111332751|NCT01839383|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111332752|NCT00901199|Deferasirox|deferasirox|mesh-list
111332753|NCT00901199|Deferoxamine|deferoxamine|mesh-list
111332754|NCT00901199|Iron Chelating Agents|iron chelating agents|mesh-ancestor
111332755|NCT00901199|Chelating Agents|chelating agents|mesh-ancestor
111332756|NCT00901199|Sequestering Agents|sequestering agents|mesh-ancestor
111332757|NCT00901199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111332758|NCT00901199|Siderophores|siderophores|mesh-ancestor
111332759|NCT01836341|Carboplatin|carboplatin|mesh-list
111332760|NCT01836341|Pemetrexed|pemetrexed|mesh-list
111332761|NCT01836341|Afatinib|afatinib|mesh-list
111332762|NCT01836341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111332763|NCT01836341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111332764|NCT01836341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111332765|NCT01836341|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111332766|NCT01836341|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111332767|NCT01836341|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111332768|NCT00906503|Dexamethasone|dexamethasone|mesh-list
111332769|NCT00906503|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
111332770|NCT00906503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111332771|NCT00906503|Antiemetics|antiemetics|mesh-ancestor
111332772|NCT00906503|Autonomic Agents|autonomic agents|mesh-ancestor
111332773|NCT00906503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111332774|NCT00906503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111332775|NCT00906503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111332776|NCT00906503|Glucocorticoids|glucocorticoids|mesh-ancestor
111332777|NCT00906503|Hormones|hormones|mesh-ancestor
111332778|NCT00906503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111332779|NCT00906503|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111332780|NCT00906503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111332781|NCT00906503|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111332782|NCT00906503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111332783|NCT01836575|Carboplatin|carboplatin|mesh-list
111332784|NCT01836575|Pemetrexed|pemetrexed|mesh-list
111332785|NCT01836575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111332786|NCT01836575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111332787|NCT01836575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110793127|NCT01178151|Everolimus|everolimus|mesh-list
111332788|NCT01836575|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111332789|NCT01836575|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111332790|NCT01836653|Bevacizumab|bevacizumab|mesh-list
111332791|NCT01836653|Cetuximab|cetuximab|mesh-list
111332792|NCT01836653|Fluorouracil|fluorouracil|mesh-list
111332793|NCT01836653|Oxaliplatin|oxaliplatin|mesh-list
111332794|NCT01836653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111332795|NCT01836653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111332796|NCT01836653|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111332797|NCT01836653|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111332798|NCT01836653|Growth Substances|growth substances|mesh-ancestor
111332799|NCT01836653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111332800|NCT01836653|Growth Inhibitors|growth inhibitors|mesh-ancestor
111332801|NCT01836653|Antimetabolites|antimetabolites|mesh-ancestor
111332802|NCT01836653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111332803|NCT01836653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111332804|NCT01836653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111332805|NCT01836653|Immunologic Factors|immunologic factors|mesh-ancestor
111332806|NCT03836885|Apremilast|apremilast|mesh-list
111332807|NCT03836885|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111332808|NCT03836885|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111332809|NCT03836885|Analgesics|analgesics|mesh-ancestor
111332810|NCT03836885|Sensory System Agents|sensory system agents|mesh-ancestor
111057240|NCT01329419|Antiviral Agents|antiviral agents|mesh-ancestor
111332811|NCT03836885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111332812|NCT03836885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111332813|NCT03836885|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111332814|NCT03836885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111332815|NCT03836885|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
111332816|NCT03836885|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111332817|NCT03836885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111332818|NCT03836885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111332819|NCT01837043|Cyclosporine|cyclosporine|mesh-list
111332821|NCT01837043|Tacrolimus|tacrolimus|mesh-list
111332822|NCT01837043|Cyclosporins|cyclosporins|mesh-list
111332823|NCT01837043|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
111332824|NCT01837043|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111332825|NCT01837043|Immunologic Factors|immunologic factors|mesh-ancestor
111332826|NCT01837043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111332827|NCT01837043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111332828|NCT01837043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111332829|NCT01837043|Antifungal Agents|antifungal agents|mesh-ancestor
111332830|NCT01837043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111332831|NCT01837043|Dermatologic Agents|dermatologic agents|mesh-ancestor
111332832|NCT01837043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111332833|NCT01837043|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110793337|NCT01287741|Obinutuzumab|obinutuzumab|mesh-list
111332834|NCT01837043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111332835|NCT01837043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111332836|NCT01839773|Paclitaxel|paclitaxel|mesh-list
111332837|NCT01839773|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111332838|NCT01839773|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111332839|NCT01839773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111332840|NCT01839773|Tubulin Modulators|tubulin modulators|mesh-ancestor
111332841|NCT01839773|Antimitotic Agents|antimitotic agents|mesh-ancestor
111332842|NCT01839773|Mitosis Modulators|mitosis modulators|mesh-ancestor
111332843|NCT01839773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111332844|NCT00909155|Fluoxetine|fluoxetine|mesh-list
111332845|NCT00909155|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
111332846|NCT00909155|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111332847|NCT00909155|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111332848|NCT00909155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111332849|NCT00909155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110793522|NCT06008223|Vitamin B 6|vitamin b 6|mesh-list
111332850|NCT00909155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111332851|NCT00909155|Serotonin Agents|serotonin agents|mesh-ancestor
111332852|NCT00909155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111332853|NCT00909155|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111332854|NCT00909155|Antidepressive Agents|antidepressive agents|mesh-ancestor
111332855|NCT00909155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110793636|NCT06006663|Ciprofloxacin|ciprofloxacin|mesh-list
111332856|NCT00909155|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111332857|NCT00909155|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111332858|NCT00909155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111332859|NCT00909155|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111332860|NCT01839851|Glucocorticoids|glucocorticoids|mesh-list
111332861|NCT01839851|Hormones|hormones|mesh-ancestor
111332862|NCT01839851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111332863|NCT01839851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111332864|NCT01839929|Tacrolimus|tacrolimus|mesh-list
111332865|NCT01839929|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111332866|NCT01839929|Immunologic Factors|immunologic factors|mesh-ancestor
111332867|NCT01839929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111332868|NCT01839929|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111332869|NCT01839929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111332870|NCT01839929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111332871|NCT04373083|Cemiplimab|cemiplimab|mesh-list
111332872|NCT04373083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111332873|NCT04373083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111332874|NCT03210545|Betamethasone|betamethasone|mesh-list
111332875|NCT03210545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111332876|NCT03210545|Glucocorticoids|glucocorticoids|mesh-ancestor
111332877|NCT03210545|Hormones|hormones|mesh-ancestor
111332878|NCT03210545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111332879|NCT03210545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111332880|NCT03210545|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111332881|NCT03210545|Respiratory System Agents|respiratory system agents|mesh-ancestor
111332882|NCT04372849|Insulin|insulin|mesh-list
111332883|NCT04372849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111332884|NCT04372849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111332885|NCT03403777|Avelumab|avelumab|mesh-list
111332886|NCT03403777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110793854|NCT05962957|Levodopa|levodopa|mesh-list
111332888|NCT02241421|Amoxicillin|amoxicillin|mesh-list
111332889|NCT02241421|Vancomycin|vancomycin|mesh-list
111332890|NCT02241421|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111332891|NCT02241421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111332892|NCT01837199|Amoxicillin|amoxicillin|mesh-list
111332893|NCT01837199|Metronidazole|metronidazole|mesh-list
111332894|NCT01837199|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111332895|NCT01837199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111332896|NCT01837199|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111332897|NCT01837199|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111332898|NCT00926185|Lifitegrast|lifitegrast|mesh-list
111332899|NCT00926185|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
111332900|NCT00926185|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111332901|NCT02241499|Fluorouracil|fluorouracil|mesh-list
111332902|NCT02241499|Oxaliplatin|oxaliplatin|mesh-list
111332903|NCT02241499|Antimetabolites|antimetabolites|mesh-ancestor
111332904|NCT02241499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111332905|NCT02241499|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111332906|NCT02241499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111332907|NCT02241499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111332908|NCT02241499|Immunologic Factors|immunologic factors|mesh-ancestor
111332909|NCT02241499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111332910|NCT01837667|Docetaxel|docetaxel|mesh-list
111332911|NCT01837667|LB100|lb100|mesh-list
111332912|NCT01837667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111332913|NCT01837667|Tubulin Modulators|tubulin modulators|mesh-ancestor
111332914|NCT01837667|Antimitotic Agents|antimitotic agents|mesh-ancestor
111332915|NCT01837667|Mitosis Modulators|mitosis modulators|mesh-ancestor
111332916|NCT01837667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111332917|NCT01837667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111332918|NCT03833947|Dexamethasone|dexamethasone|mesh-list
111332919|NCT03833947|Lidocaine|lidocaine|mesh-list
111332920|NCT03833947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111332921|NCT03833947|Antiemetics|antiemetics|mesh-ancestor
111332922|NCT03833947|Autonomic Agents|autonomic agents|mesh-ancestor
111332923|NCT03833947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111332924|NCT03833947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111332925|NCT03833947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111332926|NCT03833947|Glucocorticoids|glucocorticoids|mesh-ancestor
111332927|NCT03833947|Hormones|hormones|mesh-ancestor
111332928|NCT03833947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111332929|NCT03833947|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111332930|NCT03833947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111332931|NCT03833947|Anesthetics, Local|anesthetics, local|mesh-ancestor
111332932|NCT03833947|Anesthetics|anesthetics|mesh-ancestor
111332933|NCT03833947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111332934|NCT03833947|Sensory System Agents|sensory system agents|mesh-ancestor
111332935|NCT03833947|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111332936|NCT03833947|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111332937|NCT03833947|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111332938|NCT03833947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111332939|NCT03833947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111332940|NCT03219437|Methotrexate|methotrexate|mesh-list
111332941|NCT03219437|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111332942|NCT03219437|Abortifacient Agents|abortifacient agents|mesh-ancestor
111332943|NCT03219437|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111332944|NCT03219437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111332945|NCT03219437|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110794266|NCT04795336|Melatonin|melatonin|mesh-list
111332946|NCT03219437|Antimetabolites|antimetabolites|mesh-ancestor
111332947|NCT03219437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111332948|NCT03219437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111332949|NCT03219437|Dermatologic Agents|dermatologic agents|mesh-ancestor
111332950|NCT03219437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111332951|NCT03219437|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111332952|NCT03219437|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111332953|NCT03219437|Immunologic Factors|immunologic factors|mesh-ancestor
111332954|NCT03219437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111332955|NCT03219437|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111332956|NCT03212963|Clobetasol|clobetasol|mesh-list
111332957|NCT03212963|Halobetasol|halobetasol|mesh-list
111332958|NCT03212963|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111332959|NCT03212963|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111332960|NCT03212963|Glucocorticoids|glucocorticoids|mesh-ancestor
111332961|NCT03212963|Hormones|hormones|mesh-ancestor
111332962|NCT03212963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111332963|NCT03212963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111332964|NCT03218969|Ecopipam|ecopipam|mesh-list
111332965|NCT03218969|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111332966|NCT03218969|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111332967|NCT03218969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111332968|NCT03218969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111332969|NCT03218969|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111332970|NCT03218969|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111332971|NCT03218969|Dopamine Agents|dopamine agents|mesh-ancestor
111332972|NCT03218969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111365074|NCT03007303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111332973|NCT03218969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111332974|NCT01830101|Temozolomide|temozolomide|mesh-list
111332975|NCT01830101|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111332976|NCT01830101|Alkylating Agents|alkylating agents|mesh-ancestor
111332977|NCT01830101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111332978|NCT01830101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111332979|NCT01830335|Indomethacin|indomethacin|mesh-list
111332980|NCT01830335|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111332981|NCT01830335|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111332982|NCT01830335|Analgesics|analgesics|mesh-ancestor
111332983|NCT01830335|Sensory System Agents|sensory system agents|mesh-ancestor
111332984|NCT01830335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111332985|NCT01830335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111332986|NCT01830335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111332987|NCT01830335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111332988|NCT01830335|Gout Suppressants|gout suppressants|mesh-ancestor
111332989|NCT01830335|Tocolytic Agents|tocolytic agents|mesh-ancestor
111332990|NCT01830335|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111332991|NCT01830335|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111332992|NCT01830335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111332993|NCT01830335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111332994|NCT00926263|Moxifloxacin|moxifloxacin|mesh-list
111332995|NCT00926263|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111332996|NCT00926263|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111332997|NCT00926263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111332998|NCT00926263|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111332999|NCT00926263|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111333000|NCT00926263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111333001|NCT00926263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111333002|NCT00926263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111333003|NCT00926263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111333004|NCT00926263|Immunologic Factors|immunologic factors|mesh-ancestor
111333005|NCT02242279|Tiotropium Bromide|tiotropium bromide|mesh-list
111333006|NCT02242279|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111333007|NCT02242279|Autonomic Agents|autonomic agents|mesh-ancestor
111333008|NCT02242279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111333009|NCT02242279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111333010|NCT02242279|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111333011|NCT02242279|Respiratory System Agents|respiratory system agents|mesh-ancestor
111333012|NCT02242279|Parasympatholytics|parasympatholytics|mesh-ancestor
111333013|NCT02242279|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111333014|NCT02242279|Cholinergic Agents|cholinergic agents|mesh-ancestor
111333015|NCT02242279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111333016|NCT02242279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111333017|NCT04371757|Doxazosin|doxazosin|mesh-list
111333018|NCT04371757|Adrenergic Agents|adrenergic agents|mesh-list
111333019|NCT04371757|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111333020|NCT04371757|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111333021|NCT04371757|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111333022|NCT04371757|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111333023|NCT04371757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111333024|NCT04371757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111333025|NCT04371757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111333026|NCT04371601|Oseltamivir|oseltamivir|mesh-list
111333027|NCT04371601|Hormones|hormones|mesh-list
111333028|NCT04371601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111333029|NCT04371601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111333030|NCT04371601|Antiviral Agents|antiviral agents|mesh-ancestor
111333031|NCT04371601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110794890|NCT00233662|Alefacept|alefacept|mesh-list
111333032|NCT04371601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111333033|NCT04371601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111333034|NCT04371523|Hydroxychloroquine|hydroxychloroquine|mesh-list
111333035|NCT04371523|Antimalarials|antimalarials|mesh-ancestor
111333036|NCT04371523|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111333037|NCT04371523|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111333038|NCT04371523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111333039|NCT04371523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111333040|NCT04371523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111333041|NCT04371523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111333042|NCT02242357|Telmisartan|telmisartan|mesh-list
111333043|NCT02242357|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111333044|NCT02242357|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111333045|NCT02242357|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111333046|NCT02242357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111333047|NCT03409835|Ramosetron|ramosetron|mesh-list
111333048|NCT03409835|Antiemetics|antiemetics|mesh-ancestor
111333049|NCT03409835|Autonomic Agents|autonomic agents|mesh-ancestor
111333050|NCT03409835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111333051|NCT03409835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111333052|NCT03409835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111333053|NCT03409835|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111333054|NCT03409835|Serotonin Agents|serotonin agents|mesh-ancestor
111333055|NCT03409835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111333056|NCT03409835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111333057|NCT02242513|Lidocaine|lidocaine|mesh-list
111333058|NCT02242513|Anesthetics, Local|anesthetics, local|mesh-ancestor
111333059|NCT02242513|Anesthetics|anesthetics|mesh-ancestor
111333060|NCT02242513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111333061|NCT02242513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111333062|NCT02242513|Sensory System Agents|sensory system agents|mesh-ancestor
111333063|NCT02242513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111333064|NCT02242513|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111333065|NCT02242513|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111333066|NCT02242513|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111333067|NCT02242513|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111333068|NCT02242513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111333069|NCT03409679|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111333070|NCT03409679|Murepavadin|murepavadin|mesh-list
111333071|NCT03409679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111333072|NCT04371367|Avdoralimab|avdoralimab|mesh-list
111333073|NCT04371367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111333074|NCT04371367|Antiviral Agents|antiviral agents|mesh-ancestor
111333075|NCT04371367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111333076|NCT02242591|Ropivacaine|ropivacaine|mesh-list
111333077|NCT02242591|Anesthetics, Local|anesthetics, local|mesh-ancestor
111333078|NCT02242591|Anesthetics|anesthetics|mesh-ancestor
111333079|NCT02242591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111333080|NCT02242591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111333081|NCT02242591|Sensory System Agents|sensory system agents|mesh-ancestor
111333082|NCT02242591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111333083|NCT02982577|Pilocarpine|pilocarpine|mesh-list
111333084|NCT02982577|Miotics|miotics|mesh-ancestor
111333085|NCT02982577|Autonomic Agents|autonomic agents|mesh-ancestor
111333086|NCT02982577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111333087|NCT02982577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111333088|NCT02982577|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
111333089|NCT02982577|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111333090|NCT02982577|Cholinergic Agents|cholinergic agents|mesh-ancestor
111333091|NCT02982577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111333092|NCT02982577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111333093|NCT01726205|Pregabalin|pregabalin|mesh-list
111333094|NCT01726205|Ropivacaine|ropivacaine|mesh-list
111333095|NCT01726205|Anesthetics, Local|anesthetics, local|mesh-ancestor
111333096|NCT01726205|Anesthetics|anesthetics|mesh-ancestor
111333097|NCT01726205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111333098|NCT01726205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111333099|NCT01726205|Sensory System Agents|sensory system agents|mesh-ancestor
111333100|NCT01726205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111333101|NCT01726205|Analgesics|analgesics|mesh-ancestor
111333102|NCT01726205|Anticonvulsants|anticonvulsants|mesh-ancestor
111333103|NCT01726205|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111333104|NCT01726205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111365075|NCT03007303|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111333105|NCT01726205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111333106|NCT01726205|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111333107|NCT01726205|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111333108|NCT01726205|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111333109|NCT01726205|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111333110|NCT02242825|Telmisartan|telmisartan|mesh-list
111333111|NCT02242825|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
111333112|NCT02242825|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111333113|NCT02242825|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111333114|NCT02242825|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111333115|NCT02242825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111333116|NCT02242825|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
111333117|NCT02242825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111333118|NCT02242825|Diuretics|diuretics|mesh-ancestor
111333119|NCT02242825|Natriuretic Agents|natriuretic agents|mesh-ancestor
111333120|NCT02242825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111333121|NCT04370977|Artesunate|artesunate|mesh-list
111333122|NCT04370977|Lumefantrine|lumefantrine|mesh-list
111333123|NCT04370977|Artemether|artemether|mesh-list
111333124|NCT04370977|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
111333125|NCT04370977|Amodiaquine|amodiaquine|mesh-list
111333126|NCT04370977|Antimalarials|antimalarials|mesh-ancestor
111333127|NCT04370977|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111333128|NCT04370977|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111333129|NCT04370977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111333130|NCT04370977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111333131|NCT04370977|Antiviral Agents|antiviral agents|mesh-ancestor
111333132|NCT04370977|Schistosomicides|schistosomicides|mesh-ancestor
110795414|NCT01293747|Hormones|hormones|mesh-ancestor
111333133|NCT04370977|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
111333134|NCT04370977|Anthelmintics|anthelmintics|mesh-ancestor
111333135|NCT01726283|Riboflavin|riboflavin|mesh-list
111333136|NCT01726283|Vitamin B Complex|vitamin b complex|mesh-ancestor
111333137|NCT01726283|Vitamins|vitamins|mesh-ancestor
111333138|NCT01726283|Micronutrients|micronutrients|mesh-ancestor
111333139|NCT01726283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110795490|NCT03847155|Nicotine|nicotine|mesh-list
111333140|NCT01726283|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111333141|NCT01726283|Dermatologic Agents|dermatologic agents|mesh-ancestor
111333142|NCT04370431|Edaravone|edaravone|mesh-list
111333143|NCT04370431|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111333144|NCT04370431|Antioxidants|antioxidants|mesh-ancestor
111333145|NCT04370431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111333146|NCT04370431|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111333147|NCT04370431|Protective Agents|protective agents|mesh-ancestor
111333148|NCT04370431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111333149|NCT02245165|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
111333150|NCT02245165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111333151|NCT02245165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111333152|NCT03835871|Beclomethasone|beclomethasone|mesh-list
111333153|NCT03835871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111333154|NCT03835871|Glucocorticoids|glucocorticoids|mesh-ancestor
111333155|NCT03835871|Hormones|hormones|mesh-ancestor
111333156|NCT03835871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111333157|NCT03835871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111333158|NCT03835871|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110795706|NCT01292343|Listerine|listerine|mesh-list
111333159|NCT03835871|Respiratory System Agents|respiratory system agents|mesh-ancestor
111333160|NCT03402295|Thalidomide|thalidomide|mesh-list
111333161|NCT03402295|Dexamethasone|dexamethasone|mesh-list
111333162|NCT03402295|Cyclophosphamide|cyclophosphamide|mesh-list
111333163|NCT03402295|Bortezomib|bortezomib|mesh-list
111333164|NCT03402295|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111333165|NCT03402295|Immunologic Factors|immunologic factors|mesh-ancestor
111333166|NCT03402295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111333167|NCT03402295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111333168|NCT03402295|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111333169|NCT03402295|Alkylating Agents|alkylating agents|mesh-ancestor
111333170|NCT03402295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111333171|NCT03402295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111333172|NCT03402295|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111333173|NCT03402295|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111333174|NCT03402295|Antiemetics|antiemetics|mesh-ancestor
111333175|NCT03402295|Autonomic Agents|autonomic agents|mesh-ancestor
111333176|NCT03402295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110796047|NCT01198353|Ziprasidone|ziprasidone|mesh-list
111333177|NCT03402295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111333178|NCT03402295|Glucocorticoids|glucocorticoids|mesh-ancestor
111333179|NCT03402295|Hormones|hormones|mesh-ancestor
111333180|NCT03402295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111333181|NCT03402295|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111333182|NCT03402295|Leprostatic Agents|leprostatic agents|mesh-ancestor
111333183|NCT03402295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111333184|NCT03402295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111333185|NCT03402295|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110796279|NCT03074240|Anesthetics|anesthetics|mesh-list
111333186|NCT03402295|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111333187|NCT03402295|Growth Substances|growth substances|mesh-ancestor
111333188|NCT03402295|Growth Inhibitors|growth inhibitors|mesh-ancestor
111333189|NCT02243839|Fibrinolytic Agents|fibrinolytic agents|mesh-list
111333190|NCT02243839|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110796393|NCT03838029|Analgesics|analgesics|mesh-ancestor
111333191|NCT02243839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111333192|NCT02244073|Insulin|insulin|mesh-list
111333193|NCT02244073|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111333194|NCT02244073|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111333195|NCT02244073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111333196|NCT02244151|Triptorelin Pamoate|triptorelin pamoate|mesh-list
111333197|NCT02244151|Luteolytic Agents|luteolytic agents|mesh-ancestor
111333198|NCT02244151|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111333199|NCT02244151|Contraceptive Agents|contraceptive agents|mesh-ancestor
111333200|NCT02244151|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111333201|NCT02244151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111365076|NCT03007303|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111333202|NCT02244151|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111333203|NCT02244151|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111333204|NCT02244151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111333205|NCT03401827|Paclitaxel|paclitaxel|mesh-list
111333206|NCT03401827|Gemcitabine|gemcitabine|mesh-list
111333207|NCT03401827|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111333208|NCT03401827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111333209|NCT03401827|Tubulin Modulators|tubulin modulators|mesh-ancestor
111333210|NCT03401827|Antimitotic Agents|antimitotic agents|mesh-ancestor
111333211|NCT03401827|Mitosis Modulators|mitosis modulators|mesh-ancestor
111333212|NCT03401827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111365078|NCT03007303|Antiemetics|antiemetics|mesh-ancestor
111333213|NCT03401827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111333214|NCT03401827|Antimetabolites|antimetabolites|mesh-ancestor
111333215|NCT00909545|Isradipine|isradipine|mesh-list
111333216|NCT00909545|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111333217|NCT00909545|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111333218|NCT00909545|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111333219|NCT00909545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111365079|NCT03007303|Autonomic Agents|autonomic agents|mesh-ancestor
111333220|NCT00909545|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111333221|NCT00909545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111333222|NCT00909545|Vasodilator Agents|vasodilator agents|mesh-ancestor
111333223|NCT02244229|Tamsulosin|tamsulosin|mesh-list
111333224|NCT02244229|Finasteride|finasteride|mesh-list
111333225|NCT02244229|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111333226|NCT02244229|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111333227|NCT02244229|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111333228|NCT02244229|Adrenergic Agents|adrenergic agents|mesh-ancestor
111333229|NCT02244229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111333230|NCT02244229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111333231|NCT02244229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111333232|NCT02244229|Urological Agents|urological agents|mesh-ancestor
111333233|NCT02244229|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
111333234|NCT02244229|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111333235|NCT02244229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111333236|NCT02244229|Hormone Antagonists|hormone antagonists|mesh-ancestor
111333237|NCT02244229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111333238|NCT02157103|Bevacizumab|bevacizumab|mesh-list
111333239|NCT02157103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111333240|NCT02157103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111333241|NCT02157103|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111333242|NCT02157103|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111333243|NCT02157103|Growth Substances|growth substances|mesh-ancestor
111333244|NCT02157103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111333245|NCT02157103|Growth Inhibitors|growth inhibitors|mesh-ancestor
111333246|NCT00924001|Aldesleukin|aldesleukin|mesh-list
111333247|NCT00924001|Cyclophosphamide|cyclophosphamide|mesh-list
111333248|NCT00924001|Fludarabine|fludarabine|mesh-list
111333249|NCT00924001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111333250|NCT00924001|Immunologic Factors|immunologic factors|mesh-ancestor
110796869|NCT01300377|Anesthetics|anesthetics|mesh-ancestor
111333251|NCT00924001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111333252|NCT00924001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111333253|NCT00924001|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111333254|NCT00924001|Alkylating Agents|alkylating agents|mesh-ancestor
110796916|NCT03813927|Vitamins|vitamins|mesh-ancestor
111333255|NCT00924001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111333256|NCT00924001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111333257|NCT00924001|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111333258|NCT00924001|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111333259|NCT00924001|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111333260|NCT00924001|Antiviral Agents|antiviral agents|mesh-ancestor
111333261|NCT00924001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111333262|NCT02244307|Adrenergic Agents|adrenergic agents|mesh-list
111333263|NCT02244307|Adrenergic Antagonists|adrenergic antagonists|mesh-list
111333264|NCT02244307|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
110797069|NCT05577117|Fentanyl|fentanyl|mesh-list
111333265|NCT02244307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111333266|NCT02244307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111333267|NCT02244307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111333268|NCT03401593|Fentanyl|fentanyl|mesh-list
111333269|NCT03401593|Midazolam|midazolam|mesh-list
111333270|NCT03401593|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111333271|NCT03401593|Narcotics|narcotics|mesh-ancestor
111333272|NCT03401593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111333273|NCT03401593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111333274|NCT03401593|Analgesics|analgesics|mesh-ancestor
111333275|NCT03401593|Sensory System Agents|sensory system agents|mesh-ancestor
111333276|NCT03401593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111333277|NCT03401593|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111333278|NCT03401593|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111333279|NCT03401593|Anesthetics, General|anesthetics, general|mesh-ancestor
111333280|NCT03401593|Anesthetics|anesthetics|mesh-ancestor
111333281|NCT03401593|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111333282|NCT03401593|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111333283|NCT03401593|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111333284|NCT03401593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111333285|NCT03401593|GABA Modulators|gaba modulators|mesh-ancestor
111333286|NCT03401593|GABA Agents|gaba agents|mesh-ancestor
111333287|NCT03401593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111333288|NCT03401593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111333289|NCT03401515|Propranolol|propranolol|mesh-list
111333290|NCT03401515|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111333291|NCT03401515|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111333292|NCT03401515|Adrenergic Agents|adrenergic agents|mesh-ancestor
111333293|NCT03401515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111333294|NCT03401515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111333295|NCT03401515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111333296|NCT03401515|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111333297|NCT03401515|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111333298|NCT03401515|Vasodilator Agents|vasodilator agents|mesh-ancestor
111333299|NCT01726829|Pancrelipase|pancrelipase|mesh-list
111333300|NCT01726829|Pancreatin|pancreatin|mesh-list
111333301|NCT01726829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111333302|NCT03834233|Nivolumab|nivolumab|mesh-list
111333303|NCT03834233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111333304|NCT03834233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110797195|NCT02047552|Oxandrolone|oxandrolone|mesh-list
111333305|NCT03834233|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111333306|NCT03834233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111333307|NCT04367155|Tranexamic Acid|tranexamic acid|mesh-list
111333308|NCT04367155|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111333309|NCT04367155|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111333310|NCT04367155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111333311|NCT04367155|Hemostatics|hemostatics|mesh-ancestor
111333312|NCT04367155|Coagulants|coagulants|mesh-ancestor
111333313|NCT01727453|Warfarin|warfarin|mesh-list
111333314|NCT01727453|Anticoagulants|anticoagulants|mesh-ancestor
111333315|NCT01727531|Chloroquine|chloroquine|mesh-list
110797326|NCT02940860|Iron|iron|mesh-list
111333316|NCT01727531|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
111333317|NCT01727531|Amebicides|amebicides|mesh-ancestor
111333318|NCT01727531|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111333319|NCT01727531|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111333320|NCT01727531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111333321|NCT01727531|Antimalarials|antimalarials|mesh-ancestor
111333322|NCT01727531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111333323|NCT01727531|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111333324|NCT01727531|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111333325|NCT01727531|Analgesics|analgesics|mesh-ancestor
111333326|NCT01727531|Sensory System Agents|sensory system agents|mesh-ancestor
111333327|NCT01727531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110797463|NCT02051842|Metadoxine|metadoxine|mesh-list
111333328|NCT01727531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111333329|NCT01727531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111333330|NCT01727531|Filaricides|filaricides|mesh-ancestor
111333331|NCT01727531|Antinematodal Agents|antinematodal agents|mesh-ancestor
111333332|NCT01727531|Anthelmintics|anthelmintics|mesh-ancestor
111333333|NCT01721135|Moxifloxacin|moxifloxacin|mesh-list
111333334|NCT01721135|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
111333336|NCT01721135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111333337|NCT01721135|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111333338|NCT01721135|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111333339|NCT01721135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111333340|NCT01721135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111333341|NCT01721135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111333342|NCT01721135|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111333343|NCT01721135|Contraceptive Agents|contraceptive agents|mesh-ancestor
111333344|NCT01721135|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111333345|NCT01721135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111333346|NCT01721135|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
111333347|NCT01721135|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111333348|NCT01721135|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111333349|NCT00929071|Lidocaine|lidocaine|mesh-list
111333350|NCT00929071|Anesthetics, Local|anesthetics, local|mesh-list
111333351|NCT00929071|Anesthetics|anesthetics|mesh-list
111333352|NCT00929071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111333353|NCT00929071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111333354|NCT00929071|Sensory System Agents|sensory system agents|mesh-ancestor
111333355|NCT00929071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110797586|NCT01303029|Gemcitabine|gemcitabine|mesh-list
111333356|NCT00929071|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111333357|NCT00929071|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111333358|NCT00929071|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111333359|NCT00929071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111333360|NCT00929071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111333361|NCT01721525|Ribavirin|ribavirin|mesh-list
111333362|NCT01721525|Paclitaxel|paclitaxel|mesh-list
111333363|NCT01721525|Carboplatin|carboplatin|mesh-list
111333364|NCT01721525|Afatinib|afatinib|mesh-list
111333365|NCT01721525|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111333366|NCT01721525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111333367|NCT01721525|Tubulin Modulators|tubulin modulators|mesh-ancestor
111333368|NCT01721525|Antimitotic Agents|antimitotic agents|mesh-ancestor
111333369|NCT01721525|Mitosis Modulators|mitosis modulators|mesh-ancestor
111333370|NCT01721525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111333371|NCT01721525|Antimetabolites|antimetabolites|mesh-ancestor
111333372|NCT01721525|Antiviral Agents|antiviral agents|mesh-ancestor
111333373|NCT01721525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111333374|NCT01721525|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111333375|NCT01721525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111333376|NCT01727843|Tranexamic Acid|tranexamic acid|mesh-list
110797860|NCT03792321|Anabolic Agents|anabolic agents|mesh-ancestor
111333377|NCT01727843|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111333378|NCT01727843|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111333379|NCT01727843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111333380|NCT01727843|Hemostatics|hemostatics|mesh-ancestor
111333381|NCT01727843|Coagulants|coagulants|mesh-ancestor
111333382|NCT01721915|Vitamin D|vitamin d|mesh-list
111333383|NCT01721915|Vitamins|vitamins|mesh-ancestor
111333384|NCT01721915|Micronutrients|micronutrients|mesh-ancestor
110798005|NCT04753515|Analgesics|analgesics|mesh-ancestor
111333385|NCT01721915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111333386|NCT01721915|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111333387|NCT04357483|Thrombin|thrombin|mesh-list
111333388|NCT04357483|Hemostatics|hemostatics|mesh-ancestor
111333389|NCT04357483|Coagulants|coagulants|mesh-ancestor
111333390|NCT01721993|Zoledronic Acid|zoledronic acid|mesh-list
111333391|NCT01721993|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110798076|NCT05590689|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111333392|NCT01721993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111333393|NCT04366609|Methylphenidate|methylphenidate|mesh-list
111333394|NCT04366609|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111333395|NCT04366609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111333396|NCT04366609|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111333397|NCT04366609|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111333398|NCT04366609|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111333399|NCT04366609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111333400|NCT04366609|Dopamine Agents|dopamine agents|mesh-ancestor
111333401|NCT04366609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111333402|NCT03407105|Ipilimumab|ipilimumab|mesh-list
110798147|NCT01307865|Mannitol|mannitol|mesh-list
111333403|NCT03407105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111333404|NCT03407105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111333405|NCT03407105|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110798212|NCT03781869|Cisplatin|cisplatin|mesh-list
111333406|NCT03407105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111333407|NCT01722227|Liraglutide|liraglutide|mesh-list
111333408|NCT01722227|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111333409|NCT01722227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111333411|NCT01722227|Hormones|hormones|mesh-ancestor
111333412|NCT01722227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111333413|NCT01722305|Dexamethasone|dexamethasone|mesh-list
111333414|NCT01722305|Dexamethasone acetate|dexamethasone acetate|mesh-list
111333415|NCT01722305|Pomalidomide|pomalidomide|mesh-list
111333416|NCT01722305|Ichthammol|ichthammol|mesh-list
111333417|NCT01722305|BB 1101|bb 1101|mesh-list
111333418|NCT01722305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111333419|NCT01722305|Antiemetics|antiemetics|mesh-ancestor
111333420|NCT01722305|Autonomic Agents|autonomic agents|mesh-ancestor
111333421|NCT01722305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111333422|NCT01722305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111333423|NCT01722305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111333424|NCT01722305|Glucocorticoids|glucocorticoids|mesh-ancestor
111333425|NCT01722305|Hormones|hormones|mesh-ancestor
111333426|NCT01722305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111333427|NCT01722305|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111333428|NCT01722305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111333429|NCT01722305|Protease Inhibitors|protease inhibitors|mesh-ancestor
111333430|NCT01722305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111333431|NCT01722305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111333432|NCT01722305|Immunologic Factors|immunologic factors|mesh-ancestor
111333433|NCT01722305|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111333434|NCT01722305|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111333435|NCT01722305|Growth Substances|growth substances|mesh-ancestor
111333436|NCT01722305|Growth Inhibitors|growth inhibitors|mesh-ancestor
111333437|NCT01722305|Dermatologic Agents|dermatologic agents|mesh-ancestor
111333438|NCT04365517|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111333439|NCT04365517|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111333440|NCT04365517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111333441|NCT04365517|Incretins|incretins|mesh-ancestor
111333442|NCT04365517|Hormones|hormones|mesh-ancestor
111333443|NCT04365517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111333444|NCT04365517|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111333445|NCT04365517|Protease Inhibitors|protease inhibitors|mesh-ancestor
111333446|NCT04365517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110798402|NCT03784443|Growth Inhibitors|growth inhibitors|mesh-ancestor
111333447|NCT04365517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111333448|NCT03406871|Nivolumab|nivolumab|mesh-list
111333449|NCT03406871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111333450|NCT03406871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111333451|NCT03406871|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111333452|NCT03406871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111333453|NCT04357093|Listerine|listerine|mesh-list
111333454|NCT04357093|Grape Seed Extract|grape seed extract|mesh-list
111333455|NCT04357093|Fluorides|fluorides|mesh-list
111333456|NCT04357093|Sodium Fluoride|sodium fluoride|mesh-list
111333457|NCT04357093|Cariostatic Agents|cariostatic agents|mesh-ancestor
111333458|NCT04357093|Protective Agents|protective agents|mesh-ancestor
111333459|NCT04357093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111333460|NCT04357093|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111333461|NCT04357093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111333462|NCT04357093|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111333463|NCT04357093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111333464|NCT04357093|Antioxidants|antioxidants|mesh-ancestor
111333465|NCT04357093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111333466|NCT03406793|Iron|iron|mesh-list
111333467|NCT03406793|Zinc|zinc|mesh-list
111333468|NCT03406793|Trace Elements|trace elements|mesh-ancestor
111333469|NCT03406793|Micronutrients|micronutrients|mesh-ancestor
111333470|NCT03406793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110798613|NCT03778593|Vitamins|vitamins|mesh-ancestor
111333471|NCT04365127|Progesterone|progesterone|mesh-list
111333472|NCT04365127|Progestins|progestins|mesh-ancestor
111333473|NCT04365127|Hormones|hormones|mesh-ancestor
110798678|NCT05654662|Listerine|listerine|mesh-list
111333474|NCT04365127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111333475|NCT04365127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111333476|NCT00929383|Hemostatics|hemostatics|mesh-list
111333477|NCT00929383|Coagulants|coagulants|mesh-ancestor
111333478|NCT01722539|Pyrimethamine|pyrimethamine|mesh-list
111333479|NCT01722539|Piperaquine|piperaquine|mesh-list
111333480|NCT01722539|Sulfadoxine|sulfadoxine|mesh-list
111333481|NCT01722539|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
111333482|NCT01722539|Albendazole|albendazole|mesh-list
111333483|NCT01722539|Praziquantel|praziquantel|mesh-list
111333484|NCT01722539|Antimalarials|antimalarials|mesh-ancestor
111333485|NCT01722539|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111333486|NCT01722539|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111333487|NCT01722539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111333488|NCT01722539|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111333489|NCT01722539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111333490|NCT01722539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111333491|NCT01722539|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111333492|NCT01722539|Anthelmintics|anthelmintics|mesh-ancestor
111333493|NCT01722539|Anticestodal Agents|anticestodal agents|mesh-ancestor
111333494|NCT01722539|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
111333495|NCT01722539|Tubulin Modulators|tubulin modulators|mesh-ancestor
111333496|NCT01722539|Antimitotic Agents|antimitotic agents|mesh-ancestor
111333497|NCT01722539|Mitosis Modulators|mitosis modulators|mesh-ancestor
111333498|NCT01722539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111333499|NCT03406403|Anesthetics|anesthetics|mesh-list
111333500|NCT03406403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111333501|NCT03406403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111333502|NCT03406169|Sildenafil Citrate|sildenafil citrate|mesh-list
111333503|NCT03406169|Pentoxifylline|pentoxifylline|mesh-list
111333504|NCT03406169|Vasodilator Agents|vasodilator agents|mesh-ancestor
111333505|NCT03406169|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111333506|NCT03406169|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111333507|NCT03406169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111333508|NCT03406169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111333509|NCT03406169|Urological Agents|urological agents|mesh-ancestor
111333510|NCT03406169|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111333511|NCT03406169|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111333512|NCT03406169|Protective Agents|protective agents|mesh-ancestor
111333513|NCT03406169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111333514|NCT03406169|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111333515|NCT03406169|Antioxidants|antioxidants|mesh-ancestor
111333516|NCT04357015|Tranexamic Acid|tranexamic acid|mesh-list
111333517|NCT04357015|Carbetocin|carbetocin|mesh-list
111333518|NCT04357015|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111333519|NCT04357015|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111333520|NCT04357015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111333521|NCT04357015|Hemostatics|hemostatics|mesh-ancestor
111333522|NCT04357015|Coagulants|coagulants|mesh-ancestor
111333523|NCT04357015|Oxytocics|oxytocics|mesh-ancestor
111333524|NCT04357015|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111333525|NCT04357015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111333526|NCT04364893|Enzyme Inhibitors|enzyme inhibitors|mesh-list
111333527|NCT04364893|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
111333528|NCT04364893|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
111333529|NCT04364893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111333530|NCT04364893|Protease Inhibitors|protease inhibitors|mesh-ancestor
111333531|NCT03406091|Plerixafor|plerixafor|mesh-list
111333532|NCT03406091|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111333533|NCT03406091|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111333534|NCT03406091|Antiviral Agents|antiviral agents|mesh-ancestor
111333535|NCT03406091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111333536|NCT04364815|Hydroxychloroquine|hydroxychloroquine|mesh-list
111333537|NCT04364815|Antimalarials|antimalarials|mesh-ancestor
111333538|NCT04364815|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111333539|NCT04364815|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111333540|NCT04364815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111333541|NCT04364815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111333542|NCT04364815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111333543|NCT04364815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111333544|NCT04673383|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
111333545|NCT04673383|Hallucinogens|hallucinogens|mesh-ancestor
111333546|NCT04673383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111333547|NCT04673383|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111333548|NCT04673383|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111333549|NCT04673383|Serotonin Agents|serotonin agents|mesh-ancestor
111333550|NCT04673383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111333551|NCT04673383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111333552|NCT04673383|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111333553|NCT02245243|Delafloxacin|delafloxacin|mesh-list
111333554|NCT02245243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111057989|NCT01646320|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111057990|NCT01646320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111057991|NCT01646320|Incretins|incretins|mesh-ancestor
111057992|NCT01646320|Hormones|hormones|mesh-ancestor
111057993|NCT01646320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111058010|NCT05327426|Vaccines|vaccines|mesh-list
111333555|NCT01728935|Tenofovir|tenofovir|mesh-list
111333556|NCT01728935|Antiviral Agents|antiviral agents|mesh-ancestor
111333557|NCT01728935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111333558|NCT01728935|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111333559|NCT01728935|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111333560|NCT01728935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111333561|NCT01728935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111333562|NCT01728935|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111333563|NCT01728935|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111333564|NCT03833999|Ondansetron|ondansetron|mesh-list
111333565|NCT03833999|Lactulose|lactulose|mesh-list
111333566|NCT03833999|Antiemetics|antiemetics|mesh-ancestor
111333567|NCT03833999|Autonomic Agents|autonomic agents|mesh-ancestor
111333568|NCT03833999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111333569|NCT03833999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111333570|NCT03833999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111333571|NCT03833999|Antipruritics|antipruritics|mesh-ancestor
111333572|NCT03833999|Dermatologic Agents|dermatologic agents|mesh-ancestor
111333573|NCT03833999|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111333574|NCT03833999|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111333575|NCT03833999|Serotonin Agents|serotonin agents|mesh-ancestor
111333576|NCT03833999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111333577|NCT03833999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111333578|NCT04379219|Methotrexate|methotrexate|mesh-list
111333579|NCT04379219|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111333580|NCT04379219|Abortifacient Agents|abortifacient agents|mesh-ancestor
111333581|NCT04379219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111333582|NCT04379219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111333583|NCT04379219|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111333584|NCT04379219|Antimetabolites|antimetabolites|mesh-ancestor
111333585|NCT04379219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111333586|NCT04379219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111333587|NCT04379219|Dermatologic Agents|dermatologic agents|mesh-ancestor
111333588|NCT04379219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111333589|NCT04379219|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111333590|NCT04379219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111333591|NCT04379219|Immunologic Factors|immunologic factors|mesh-ancestor
111333592|NCT04379219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111333593|NCT04379219|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111333594|NCT04347031|Azithromycin|azithromycin|mesh-list
111333595|NCT04347031|Hydroxychloroquine|hydroxychloroquine|mesh-list
111333596|NCT04347031|Mefloquine|mefloquine|mesh-list
111333597|NCT04347031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111333598|NCT04347031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111333599|NCT04347031|Antimalarials|antimalarials|mesh-ancestor
111333600|NCT04347031|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111333601|NCT04347031|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111333602|NCT04347031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111333603|NCT04347031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111333604|NCT04347031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111333605|NCT02906566|Vitamin A|vitamin a|mesh-list
111333606|NCT02906566|Vitamins|vitamins|mesh-ancestor
111333607|NCT02906566|Micronutrients|micronutrients|mesh-ancestor
111333608|NCT02906566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111333609|NCT00913133|Desirudin|desirudin|mesh-list
111333610|NCT00913133|Anticoagulants|anticoagulants|mesh-ancestor
111333611|NCT00913133|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111333612|NCT00913133|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111333613|NCT00913133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111333614|NCT00373126|Nicotine|nicotine|mesh-list
111333615|NCT00373126|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111333616|NCT00373126|Autonomic Agents|autonomic agents|mesh-ancestor
111333617|NCT00373126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111333618|NCT00373126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111333619|NCT00373126|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111333620|NCT00373126|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111333621|NCT00373126|Cholinergic Agents|cholinergic agents|mesh-ancestor
111333622|NCT00373126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111333623|NCT00373126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111333624|NCT04378283|Lidocaine|lidocaine|mesh-list
111333625|NCT04378283|Epinephrine|epinephrine|mesh-list
111333626|NCT04378283|Tetracaine|tetracaine|mesh-list
111333627|NCT04378283|Anesthetics|anesthetics|mesh-list
111333628|NCT04378283|Anesthetics, Local|anesthetics, local|mesh-ancestor
111333629|NCT04378283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111333630|NCT04378283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111333631|NCT04378283|Sensory System Agents|sensory system agents|mesh-ancestor
111333632|NCT04378283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110799128|NCT03560362|Sympathomimetics|sympathomimetics|mesh-ancestor
111333633|NCT04378283|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111333634|NCT04378283|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111333635|NCT04378283|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111333636|NCT04378283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111333637|NCT04378283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111333638|NCT04378283|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111333639|NCT04378283|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111333640|NCT04378283|Adrenergic Agents|adrenergic agents|mesh-ancestor
111333641|NCT04378283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111333642|NCT04378283|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111333643|NCT04378283|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111333644|NCT04378283|Autonomic Agents|autonomic agents|mesh-ancestor
111333645|NCT04378283|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111333646|NCT04378283|Respiratory System Agents|respiratory system agents|mesh-ancestor
111333647|NCT04378283|Mydriatics|mydriatics|mesh-ancestor
111333648|NCT04378283|Sympathomimetics|sympathomimetics|mesh-ancestor
111333649|NCT04378283|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111333650|NCT04355845|Sumatriptan|sumatriptan|mesh-list
111333651|NCT04355845|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111333652|NCT04355845|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111333653|NCT04355845|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111333654|NCT04355845|Serotonin Agents|serotonin agents|mesh-ancestor
111333655|NCT04355845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111333656|NCT04355845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111333657|NCT04355845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111333658|NCT02789410|Morphine|morphine|mesh-list
111333659|NCT02789410|Hydromorphone|hydromorphone|mesh-list
111333660|NCT02789410|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111333661|NCT02789410|Narcotics|narcotics|mesh-ancestor
111333662|NCT02789410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111333663|NCT02789410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111333664|NCT02789410|Analgesics|analgesics|mesh-ancestor
111333665|NCT02789410|Sensory System Agents|sensory system agents|mesh-ancestor
111333666|NCT02789410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111333667|NCT01729481|Leucovorin|leucovorin|mesh-list
111333668|NCT01729481|Folic Acid|folic acid|mesh-list
111333669|NCT01729481|Gemcitabine|gemcitabine|mesh-list
111333670|NCT01729481|Oxaliplatin|oxaliplatin|mesh-list
111333671|NCT01729481|Irinotecan|irinotecan|mesh-list
111333672|NCT01729481|Levoleucovorin|levoleucovorin|mesh-list
111333673|NCT01729481|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111333674|NCT01729481|Antimetabolites|antimetabolites|mesh-ancestor
111365080|NCT03007303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111333675|NCT01729481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111333676|NCT01729481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111333677|NCT01729481|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111333678|NCT01729481|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111333679|NCT01729481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111333680|NCT01729481|Antidotes|antidotes|mesh-ancestor
111333681|NCT01729481|Protective Agents|protective agents|mesh-ancestor
111333682|NCT01729481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111333683|NCT01729481|Vitamin B Complex|vitamin b complex|mesh-ancestor
111333684|NCT01729481|Vitamins|vitamins|mesh-ancestor
111333685|NCT01729481|Micronutrients|micronutrients|mesh-ancestor
111333686|NCT01729481|Hematinics|hematinics|mesh-ancestor
111333687|NCT00939211|Tiotropium Bromide|tiotropium bromide|mesh-list
111333688|NCT00939211|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111333689|NCT00939211|Autonomic Agents|autonomic agents|mesh-ancestor
110799664|NCT03758079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111333690|NCT00939211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111333691|NCT00939211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111333692|NCT00939211|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111333693|NCT00939211|Respiratory System Agents|respiratory system agents|mesh-ancestor
111333694|NCT00939211|Parasympatholytics|parasympatholytics|mesh-ancestor
111333695|NCT00939211|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111333696|NCT00939211|Cholinergic Agents|cholinergic agents|mesh-ancestor
111333697|NCT00939211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111333698|NCT00939211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111333699|NCT02793154|Exenatide|exenatide|mesh-list
111333700|NCT02793154|rGLP-1 protein|rglp-1 protein|mesh-list
111333701|NCT02793154|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111333702|NCT02793154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111333703|NCT02793154|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111058137|NCT03144843|Apatinib|apatinib|mesh-list
111333704|NCT02793154|Incretins|incretins|mesh-ancestor
111333705|NCT02793154|Hormones|hormones|mesh-ancestor
111333706|NCT02793154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111333707|NCT01723553|Corticosterone|corticosterone|mesh-list
111333708|NCT01723553|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111333709|NCT02907268|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111333710|NCT02907268|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111333711|NCT02907268|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111333712|NCT02907268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111333713|NCT02907268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111333714|NCT02907268|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111333715|NCT02907268|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111333716|NCT02907268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111333717|NCT02907268|Cholinergic Agents|cholinergic agents|mesh-ancestor
111333718|NCT02907268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111333719|NCT02909140|Lidocaine|lidocaine|mesh-list
111333720|NCT02909140|Phenylephrine|phenylephrine|mesh-list
111333721|NCT02909140|Epinephrine|epinephrine|mesh-list
111333722|NCT02909140|Oxymetazoline|oxymetazoline|mesh-list
111333723|NCT02909140|Cyclopentolate|cyclopentolate|mesh-list
111333724|NCT02909140|Anesthetics, Local|anesthetics, local|mesh-ancestor
111333725|NCT02909140|Anesthetics|anesthetics|mesh-ancestor
111333726|NCT02909140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111333727|NCT02909140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111333728|NCT02909140|Sensory System Agents|sensory system agents|mesh-ancestor
111333729|NCT02909140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111333730|NCT02909140|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111333731|NCT02909140|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111333732|NCT02909140|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111333733|NCT02909140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111333734|NCT02909140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111333735|NCT02909140|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111333736|NCT02909140|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111333737|NCT02909140|Adrenergic Agents|adrenergic agents|mesh-ancestor
111333738|NCT02909140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111333739|NCT02909140|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111333740|NCT02909140|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111333741|NCT02909140|Autonomic Agents|autonomic agents|mesh-ancestor
111333742|NCT02909140|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111333743|NCT02909140|Respiratory System Agents|respiratory system agents|mesh-ancestor
111333744|NCT02909140|Mydriatics|mydriatics|mesh-ancestor
111333745|NCT02909140|Sympathomimetics|sympathomimetics|mesh-ancestor
111333746|NCT02909140|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111333747|NCT02909140|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111333748|NCT02909140|Nasal Decongestants|nasal decongestants|mesh-ancestor
111333749|NCT02909140|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111333750|NCT02909140|Protective Agents|protective agents|mesh-ancestor
111333751|NCT02909140|Parasympatholytics|parasympatholytics|mesh-ancestor
111333752|NCT02909140|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110800224|NCT03753867|Acitretin|acitretin|mesh-list
111333753|NCT02909140|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111333754|NCT02909140|Cholinergic Agents|cholinergic agents|mesh-ancestor
111333755|NCT01724879|Dasatinib|dasatinib|mesh-list
111333756|NCT01724879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111333757|NCT01724879|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111333758|NCT01724879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110800314|NCT02072746|Zinc|zinc|mesh-list
111333759|NCT01724879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111333760|NCT02793856|Cyclophosphamide|cyclophosphamide|mesh-list
111333761|NCT02793856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111333762|NCT02793856|Immunologic Factors|immunologic factors|mesh-ancestor
111333763|NCT02793856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111333764|NCT02793856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110800427|NCT02084446|Everolimus|everolimus|mesh-list
111333765|NCT02793856|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111333766|NCT02793856|Alkylating Agents|alkylating agents|mesh-ancestor
111333767|NCT02793856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111333768|NCT02793856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111333769|NCT02793856|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111333770|NCT03403985|Calcium|calcium|mesh-list
111333771|NCT03403985|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111333772|NCT03403985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111333773|NCT04364425|Triamcinolone|triamcinolone|mesh-list
111333774|NCT04364425|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
111333775|NCT04364425|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
111333776|NCT04364425|Lidocaine|lidocaine|mesh-list
111333777|NCT04364425|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
111333778|NCT04364425|Anesthetics, Local|anesthetics, local|mesh-ancestor
111333779|NCT04364425|Anesthetics|anesthetics|mesh-ancestor
111333780|NCT04364425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111333781|NCT04364425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111333782|NCT04364425|Sensory System Agents|sensory system agents|mesh-ancestor
111333783|NCT04364425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111333784|NCT04364425|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111333785|NCT04364425|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111333786|NCT04364425|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111333787|NCT04364425|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111333788|NCT04364425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111333789|NCT04364425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111333790|NCT04364425|Glucocorticoids|glucocorticoids|mesh-ancestor
111333791|NCT04364425|Hormones|hormones|mesh-ancestor
111333792|NCT04364425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110800780|NCT02086942|Hormones|hormones|mesh-ancestor
111333793|NCT04364425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111333794|NCT04364425|Immunologic Factors|immunologic factors|mesh-ancestor
111333795|NCT04364425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111333796|NCT02911324|Nabilone|nabilone|mesh-list
111333797|NCT02911324|Antiemetics|antiemetics|mesh-ancestor
111333798|NCT02911324|Autonomic Agents|autonomic agents|mesh-ancestor
111333799|NCT02911324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110800916|NCT04596033|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111333800|NCT02911324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111333801|NCT02911324|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111333802|NCT02911324|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111333803|NCT02911324|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111333804|NCT02911324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111333805|NCT02911324|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111333806|NCT01729403|Metformin|metformin|mesh-list
111333807|NCT01729403|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111333808|NCT01729403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111333809|NCT04281667|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111333810|NCT04281667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111333811|NCT04355455|Citalopram|citalopram|mesh-list
111333812|NCT04355455|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111333813|NCT04355455|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111333814|NCT04355455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110801129|NCT02096068|Dexmedetomidine|dexmedetomidine|mesh-list
111333815|NCT04355455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111333816|NCT04355455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111333817|NCT04355455|Serotonin Agents|serotonin agents|mesh-ancestor
111333818|NCT04355455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111333819|NCT04355455|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110801206|NCT02094274|Xhance|xhance|mesh-list
111333820|NCT04355455|Antidepressive Agents|antidepressive agents|mesh-ancestor
111333821|NCT04355455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111333822|NCT00913913|Bevacizumab|bevacizumab|mesh-list
111333823|NCT00913913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111333824|NCT00913913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111333825|NCT00913913|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111333826|NCT00913913|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111333827|NCT00913913|Growth Substances|growth substances|mesh-ancestor
111333828|NCT00913913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111333829|NCT00913913|Growth Inhibitors|growth inhibitors|mesh-ancestor
111333830|NCT00373594|Rituximab|rituximab|mesh-list
111333831|NCT00373594|Fludarabine|fludarabine|mesh-list
111333832|NCT00373594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111333833|NCT00373594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111333834|NCT00373594|Immunologic Factors|immunologic factors|mesh-ancestor
111333835|NCT00373594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111333836|NCT00373594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111333837|NCT03403829|Gemcitabine|gemcitabine|mesh-list
111333838|NCT03403829|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111333839|NCT03403829|Antimetabolites|antimetabolites|mesh-ancestor
111333840|NCT03403829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111333841|NCT03403829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111333842|NCT04364113|Benzocaine|benzocaine|mesh-list
111333843|NCT04364113|Anesthetics, Local|anesthetics, local|mesh-ancestor
111333844|NCT04364113|Anesthetics|anesthetics|mesh-ancestor
110801619|NCT02104648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111333845|NCT04364113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111333846|NCT04364113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110519247|NCT05905757|Anesthetics|anesthetics|mesh-ancestor
111333847|NCT04364113|Sensory System Agents|sensory system agents|mesh-ancestor
111333848|NCT04364113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111333849|NCT03403595|177Lu-EB-PSMA-617|177lu-eb-psma-617|mesh-list
111333850|NCT03403595|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111333851|NCT03403595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111333852|NCT03197194|Aspirin|aspirin|mesh-list
111333853|NCT03197194|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
111333854|NCT03197194|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111333855|NCT03197194|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111333856|NCT03197194|Analgesics|analgesics|mesh-ancestor
111333857|NCT03197194|Sensory System Agents|sensory system agents|mesh-ancestor
111333858|NCT03197194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111333859|NCT03197194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111333860|NCT03197194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111333861|NCT03197194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111333862|NCT03197194|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111333863|NCT03197194|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111333864|NCT03197194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111333865|NCT03197194|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111333866|NCT03197194|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111333867|NCT03197194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111333868|NCT03197194|Antipyretics|antipyretics|mesh-ancestor
111333869|NCT03834935|Pimecrolimus|pimecrolimus|mesh-list
111333870|NCT03834935|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111333871|NCT03834935|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111333872|NCT03834935|Analgesics|analgesics|mesh-ancestor
111333873|NCT03834935|Sensory System Agents|sensory system agents|mesh-ancestor
111333874|NCT03834935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111333875|NCT03834935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111333876|NCT03834935|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111333877|NCT03834935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111333878|NCT03834935|Dermatologic Agents|dermatologic agents|mesh-ancestor
111333879|NCT03834935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111333880|NCT03834935|Immunologic Factors|immunologic factors|mesh-ancestor
111333881|NCT03834935|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110802182|NCT03743649|Lorazepam|lorazepam|mesh-list
111333882|NCT03834935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111333883|NCT03834935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111333884|NCT02796352|Interleukin-2|interleukin-2|mesh-list
111333885|NCT02796352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111333886|NCT02796352|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111333887|NCT02796352|Analgesics|analgesics|mesh-ancestor
111333888|NCT02796352|Sensory System Agents|sensory system agents|mesh-ancestor
111333889|NCT02796352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111333890|NCT02796352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111333891|NCT00939367|Zolpidem|zolpidem|mesh-list
111333892|NCT00939367|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111333893|NCT00939367|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110802394|NCT00177671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111333894|NCT00939367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111333895|NCT00939367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111333896|NCT00939367|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
111333897|NCT00939367|GABA Agonists|gaba agonists|mesh-ancestor
111333898|NCT00939367|GABA Agents|gaba agents|mesh-ancestor
110802468|NCT02117362|Ipilimumab|ipilimumab|mesh-list
111333899|NCT00939367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111333900|NCT00939367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111333901|NCT03168880|Paclitaxel|paclitaxel|mesh-list
111333902|NCT03168880|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111333903|NCT03168880|Carboplatin|carboplatin|mesh-list
111333904|NCT03168880|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111333905|NCT03168880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111333906|NCT03168880|Tubulin Modulators|tubulin modulators|mesh-ancestor
111333907|NCT03168880|Antimitotic Agents|antimitotic agents|mesh-ancestor
111333908|NCT03168880|Mitosis Modulators|mitosis modulators|mesh-ancestor
111333909|NCT03168880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111333910|NCT04347187|Anticoagulants|anticoagulants|mesh-list
111333911|NCT00920075|Alendronate|alendronate|mesh-list
111333912|NCT00920075|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111333913|NCT00920075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111333914|NCT04364035|Vesatolimod|vesatolimod|mesh-list
111333915|NCT04364035|Antiviral Agents|antiviral agents|mesh-ancestor
110802601|NCT02118376|Exenatide|exenatide|mesh-list
111333916|NCT04364035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111333917|NCT03403439|Itraconazole|itraconazole|mesh-list
111333918|NCT03403439|Antifungal Agents|antifungal agents|mesh-ancestor
111333919|NCT03403439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111333920|NCT03403439|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111333921|NCT03403439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111333922|NCT03403439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111333923|NCT03403439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110802678|NCT02124226|Dermatologic Agents|dermatologic agents|mesh-ancestor
111333924|NCT03403439|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111333925|NCT03403439|Hormone Antagonists|hormone antagonists|mesh-ancestor
111333926|NCT03403439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111333927|NCT03403439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111333928|NCT03403439|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111333929|NCT04346797|Eculizumab|eculizumab|mesh-list
111333930|NCT04346797|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
111333931|NCT04346797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110802894|NCT02126332|Analgesics|analgesics|mesh-ancestor
111333932|NCT04346797|Immunologic Factors|immunologic factors|mesh-ancestor
111333933|NCT04346797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111333934|NCT04364581|Letrozole|letrozole|mesh-list
111333935|NCT04364581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111333936|NCT04364581|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111333937|NCT04364581|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110802963|NCT02252614|Antipyretics|antipyretics|mesh-ancestor
111333938|NCT04364581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111333939|NCT04364581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111333940|NCT04364581|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111333941|NCT04364581|Hormone Antagonists|hormone antagonists|mesh-ancestor
110803035|NCT01074905|Artesunate|artesunate|mesh-list
111333942|NCT04364581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111333943|NCT04364581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111333944|NCT01049009|Metoprolol|metoprolol|mesh-list
111333945|NCT01049009|Nebivolol|nebivolol|mesh-list
111333946|NCT01049009|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111333947|NCT01049009|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111333948|NCT01049009|Sympatholytics|sympatholytics|mesh-ancestor
111333949|NCT01049009|Autonomic Agents|autonomic agents|mesh-ancestor
111333950|NCT01049009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111333951|NCT01049009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111333952|NCT01049009|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
111333953|NCT01049009|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111333954|NCT01049009|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111333955|NCT01049009|Adrenergic Agents|adrenergic agents|mesh-ancestor
111333956|NCT01049009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111333957|NCT01049009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111333958|NCT01049009|Vasodilator Agents|vasodilator agents|mesh-ancestor
111333959|NCT01049009|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
111333960|NCT01049009|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111333961|NCT01049009|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111333962|NCT02850874|Gemcitabine|gemcitabine|mesh-list
111333963|NCT02850874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111333964|NCT02850874|Antimetabolites|antimetabolites|mesh-ancestor
111333965|NCT02850874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110803314|NCT00137111|Hormones|hormones|mesh-ancestor
111333966|NCT02850874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111333967|NCT01047683|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
111333968|NCT01047683|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111333969|NCT01047683|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111333970|NCT02920918|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111333971|NCT02920918|Canagliflozin|canagliflozin|mesh-list
111333972|NCT02920918|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111333973|NCT02920918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111333974|NCT02920918|Incretins|incretins|mesh-ancestor
111333975|NCT02920918|Hormones|hormones|mesh-ancestor
111333976|NCT02920918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111333977|NCT02920918|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111333978|NCT02920918|Protease Inhibitors|protease inhibitors|mesh-ancestor
111333979|NCT02920918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111333980|NCT02920918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111333981|NCT02920918|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111333982|NCT03403049|Gemcitabine|gemcitabine|mesh-list
111333983|NCT03403049|Capecitabine|capecitabine|mesh-list
111333984|NCT03403049|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111333985|NCT03403049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111333986|NCT03403049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111333987|NCT03403049|Antimetabolites|antimetabolites|mesh-ancestor
111333988|NCT03403049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111333989|NCT03403049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111333990|NCT03403049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111333991|NCT00944047|Paclitaxel|paclitaxel|mesh-list
111333992|NCT00944047|Cyclophosphamide|cyclophosphamide|mesh-list
111333993|NCT00944047|Doxorubicin|doxorubicin|mesh-list
111333994|NCT00944047|Trastuzumab|trastuzumab|mesh-list
111333995|NCT00944047|Mitogens|mitogens|mesh-list
111333996|NCT00944047|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111333997|NCT00944047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111333998|NCT00944047|Tubulin Modulators|tubulin modulators|mesh-ancestor
111333999|NCT00944047|Antimitotic Agents|antimitotic agents|mesh-ancestor
111334000|NCT00944047|Mitosis Modulators|mitosis modulators|mesh-ancestor
111334001|NCT00944047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111334002|NCT00944047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111334003|NCT00944047|Immunologic Factors|immunologic factors|mesh-ancestor
111334004|NCT00944047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111334005|NCT00944047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111334006|NCT00944047|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111334007|NCT00944047|Alkylating Agents|alkylating agents|mesh-ancestor
111334008|NCT00944047|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111334009|NCT00944047|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111334010|NCT00944047|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111334011|NCT00944047|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111334012|NCT00944047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110803641|NCT03549832|Antimetabolites|antimetabolites|mesh-ancestor
111334013|NCT00944047|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111334014|NCT02921386|Methyltestosterone|methyltestosterone|mesh-list
111334015|NCT02921386|Testosterone|testosterone|mesh-list
111334016|NCT02921386|Testosterone undecanoate|testosterone undecanoate|mesh-list
111334017|NCT02921386|Testosterone enanthate|testosterone enanthate|mesh-list
111334018|NCT02921386|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
111334019|NCT02921386|Androgens|androgens|mesh-ancestor
111334020|NCT02921386|Hormones|hormones|mesh-ancestor
111334021|NCT02921386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111334022|NCT02921386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111334023|NCT02921386|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111334024|NCT02921386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111334025|NCT02921386|Anabolic Agents|anabolic agents|mesh-ancestor
111334026|NCT03402815|Maraviroc|maraviroc|mesh-list
111334027|NCT03402815|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110803780|NCT05203432|Atropine|atropine|mesh-list
111334028|NCT03402815|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
111334029|NCT03402815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111334030|NCT03402815|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111334031|NCT03402815|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111334032|NCT03402815|Antiviral Agents|antiviral agents|mesh-ancestor
111334033|NCT03402815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111334034|NCT03402815|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
111334035|NCT02245555|Tamsulosin|tamsulosin|mesh-list
111334036|NCT02245555|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111334037|NCT02245555|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111334038|NCT02245555|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111334039|NCT02245555|Adrenergic Agents|adrenergic agents|mesh-ancestor
111334040|NCT02245555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111334041|NCT02245555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111334042|NCT02245555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111334043|NCT02245555|Urological Agents|urological agents|mesh-ancestor
110804006|NCT03704584|Hormones|hormones|mesh-ancestor
111334044|NCT04354441|Hydroxychloroquine|hydroxychloroquine|mesh-list
111334045|NCT04354441|Antimalarials|antimalarials|mesh-ancestor
111334046|NCT04354441|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111334047|NCT04354441|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111334048|NCT04354441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111334049|NCT04354441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111334050|NCT04354441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111334051|NCT04354441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111334052|NCT02802514|Exenatide|exenatide|mesh-list
111334053|NCT02802514|rGLP-1 protein|rglp-1 protein|mesh-list
111334054|NCT02802514|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
111334055|NCT02802514|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111334056|NCT02802514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111334057|NCT02802514|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111334058|NCT02802514|Incretins|incretins|mesh-ancestor
111334059|NCT02802514|Hormones|hormones|mesh-ancestor
111334060|NCT02802514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111334061|NCT00944671|Calcium, Dietary|calcium, dietary|mesh-list
111334062|NCT00944671|Calcium Carbonate|calcium carbonate|mesh-list
111334063|NCT00944671|Magnesium Hydroxide|magnesium hydroxide|mesh-list
111334064|NCT00944671|Famotidine|famotidine|mesh-list
111334065|NCT00944671|Calcium|calcium|mesh-list
111334066|NCT00944671|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111334067|NCT00944671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111334068|NCT00944671|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111334069|NCT00944671|Antacids|antacids|mesh-ancestor
110804217|NCT02911792|Metformin|metformin|mesh-list
111334070|NCT00944671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111334071|NCT00944671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111334072|NCT00944671|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111334073|NCT00944671|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
111334074|NCT00944671|Histamine Antagonists|histamine antagonists|mesh-ancestor
111334075|NCT00944671|Histamine Agents|histamine agents|mesh-ancestor
111058514|NCT03692715|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110804257|NCT02140840|Trametinib|trametinib|mesh-list
111334076|NCT00944671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111334077|NCT00944749|Cyclosporine|cyclosporine|mesh-list
111334078|NCT00944749|Cyclosporins|cyclosporins|mesh-list
111334079|NCT00944749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111334080|NCT00944749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111334081|NCT00944749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111334082|NCT00944749|Immunologic Factors|immunologic factors|mesh-ancestor
111334083|NCT00944749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111334084|NCT00944749|Antifungal Agents|antifungal agents|mesh-ancestor
111334085|NCT00944749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111334086|NCT00944749|Dermatologic Agents|dermatologic agents|mesh-ancestor
111334087|NCT00944749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111334088|NCT00944749|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111334089|NCT01047293|Leucovorin|leucovorin|mesh-list
111334090|NCT01047293|Bevacizumab|bevacizumab|mesh-list
111334091|NCT01047293|Oxaliplatin|oxaliplatin|mesh-list
111334092|NCT01047293|Everolimus|everolimus|mesh-list
111334093|NCT01047293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111334094|NCT01047293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111334095|NCT01047293|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111334096|NCT01047293|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111334097|NCT01047293|Growth Substances|growth substances|mesh-ancestor
111334098|NCT01047293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111334099|NCT01047293|Growth Inhibitors|growth inhibitors|mesh-ancestor
111334100|NCT01047293|Antidotes|antidotes|mesh-ancestor
111334101|NCT01047293|Protective Agents|protective agents|mesh-ancestor
110804457|NCT02145520|Tocolytic Agents|tocolytic agents|mesh-ancestor
111334102|NCT01047293|Vitamin B Complex|vitamin b complex|mesh-ancestor
111334103|NCT01047293|Vitamins|vitamins|mesh-ancestor
111334104|NCT01047293|Micronutrients|micronutrients|mesh-ancestor
111334105|NCT01047293|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111334106|NCT01047293|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110804526|NCT02152228|Hormones|hormones|mesh-list
111334107|NCT01047293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111334108|NCT01047293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111334109|NCT01047293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111334110|NCT01047293|Immunologic Factors|immunologic factors|mesh-ancestor
111334111|NCT01045967|Lansoprazole|lansoprazole|mesh-list
111334112|NCT01045967|Dexlansoprazole|dexlansoprazole|mesh-list
111334113|NCT01045967|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111334114|NCT01045967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111334115|NCT01045967|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111334116|NCT01045967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111365081|NCT03007303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111334117|NCT01045967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111334118|NCT02808052|Minocycline|minocycline|mesh-list
111334119|NCT02808052|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111334120|NCT02808052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111334121|NCT02924350|Fluorides|fluorides|mesh-list
111334122|NCT02924350|Tin Fluorides|tin fluorides|mesh-list
111334123|NCT02924350|Fluorophosphate|fluorophosphate|mesh-list
111334124|NCT02924350|Cariostatic Agents|cariostatic agents|mesh-ancestor
111334125|NCT02924350|Protective Agents|protective agents|mesh-ancestor
111334126|NCT02924350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111334127|NCT02344498|Tenofovir|tenofovir|mesh-list
111334128|NCT02344498|Antiviral Agents|antiviral agents|mesh-ancestor
111334129|NCT02344498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111334130|NCT02344498|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111334131|NCT02344498|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111334132|NCT02344498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111334133|NCT02344498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111334134|NCT02344498|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111334135|NCT02344498|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111334136|NCT00945139|Bevacizumab|bevacizumab|mesh-list
111334137|NCT00945139|Doxorubicin|doxorubicin|mesh-list
111334138|NCT00945139|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111334139|NCT00945139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111334140|NCT00945139|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111334141|NCT00945139|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111334142|NCT00945139|Growth Substances|growth substances|mesh-ancestor
111334143|NCT00945139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111334144|NCT00945139|Growth Inhibitors|growth inhibitors|mesh-ancestor
111334145|NCT00945139|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111334146|NCT00945139|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111334147|NCT00945139|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111334148|NCT00945139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111334149|NCT00945139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111334150|NCT02812342|Tofacitinib|tofacitinib|mesh-list
111334151|NCT02812342|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
111058627|NCT01657760|Citalopram|citalopram|mesh-list
111334152|NCT02812342|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111334153|NCT02812342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111334154|NCT02812342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111334155|NCT03871465|Triamcinolone|triamcinolone|mesh-list
111334156|NCT03871465|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
111334157|NCT03871465|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
111334158|NCT03871465|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
111334159|NCT03871465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111334160|NCT03871465|Glucocorticoids|glucocorticoids|mesh-ancestor
111334161|NCT03871465|Hormones|hormones|mesh-ancestor
111334162|NCT03871465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111334163|NCT03871465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111334164|NCT03871465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111334165|NCT03871465|Immunologic Factors|immunologic factors|mesh-ancestor
111334166|NCT03871465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111334167|NCT03871465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111334168|NCT00931489|Ranibizumab|ranibizumab|mesh-list
111334169|NCT00931489|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111334170|NCT00931489|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111334171|NCT00931489|Growth Substances|growth substances|mesh-ancestor
111334172|NCT00931489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110805146|NCT04804696|Cisplatin|cisplatin|mesh-list
111334173|NCT00931489|Growth Inhibitors|growth inhibitors|mesh-ancestor
111334174|NCT00931489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111334175|NCT04363255|Cisplatin|cisplatin|mesh-list
111334176|NCT04363255|Carboplatin|carboplatin|mesh-list
111334177|NCT04363255|Etoposide|etoposide|mesh-list
111334178|NCT04363255|Etoposide phosphate|etoposide phosphate|mesh-list
111334179|NCT04363255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111334180|NCT04363255|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111334181|NCT04363255|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111334182|NCT04363255|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111334183|NCT04363255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111334184|NCT04363255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111334185|NCT00945295|Botulinum Toxins|botulinum toxins|mesh-list
111334186|NCT00945295|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111334187|NCT00945295|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111334188|NCT00945295|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111334189|NCT00945295|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111334190|NCT00945295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111334191|NCT00945295|Cholinergic Agents|cholinergic agents|mesh-ancestor
111334192|NCT00945295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111334193|NCT00945295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111334194|NCT00945295|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111334195|NCT00945295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111334196|NCT03490825|Melatonin|melatonin|mesh-list
111334197|NCT03490825|Antioxidants|antioxidants|mesh-ancestor
111334198|NCT03490825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111334199|NCT03490825|Protective Agents|protective agents|mesh-ancestor
111334200|NCT03490825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111334201|NCT03490825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111334202|NCT04362943|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
111334203|NCT04362943|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111334204|NCT03317899|Lenograstim|lenograstim|mesh-list
111334205|NCT03317899|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111334206|NCT03317899|Immunologic Factors|immunologic factors|mesh-ancestor
111334207|NCT03317899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110805400|NCT03220178|Letrozole|letrozole|mesh-list
111334208|NCT04353505|Dexamethasone|dexamethasone|mesh-list
111334209|NCT04353505|Ketorolac|ketorolac|mesh-list
111334210|NCT04353505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111334211|NCT04353505|Antiemetics|antiemetics|mesh-ancestor
111334212|NCT04353505|Autonomic Agents|autonomic agents|mesh-ancestor
111334213|NCT04353505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111334214|NCT04353505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111334215|NCT04353505|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111334216|NCT04353505|Glucocorticoids|glucocorticoids|mesh-ancestor
111334217|NCT04353505|Hormones|hormones|mesh-ancestor
111334218|NCT04353505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111334219|NCT04353505|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111334220|NCT04353505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111334221|NCT04353505|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111334222|NCT04353505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111334223|NCT04353505|Analgesics|analgesics|mesh-ancestor
110805526|NCT03183908|Vaccines|vaccines|mesh-list
111334224|NCT04353505|Sensory System Agents|sensory system agents|mesh-ancestor
111334225|NCT04353505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111334226|NCT04353505|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111334227|NCT04353505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111334228|NCT04353505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111334229|NCT02929927|Sodium Hypochlorite|sodium hypochlorite|mesh-list
111334230|NCT02929927|Eusol|eusol|mesh-list
111334231|NCT02929927|Disinfectants|disinfectants|mesh-ancestor
111334232|NCT02929927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111334233|NCT02427451|Venetoclax|venetoclax|mesh-list
111334234|NCT02427451|Obinutuzumab|obinutuzumab|mesh-list
111334235|NCT02427451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111334236|NCT02427451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111334237|NCT04362241|Prednisolone|prednisolone|mesh-list
111334238|NCT04362241|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111334239|NCT04362241|Methylprednisolone|methylprednisolone|mesh-list
111334240|NCT04362241|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111334241|NCT04362241|Prednisolone acetate|prednisolone acetate|mesh-list
111334242|NCT04362241|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111334243|NCT04362241|Prednisolone phosphate|prednisolone phosphate|mesh-list
111334244|NCT04362241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111334245|NCT04362241|Glucocorticoids|glucocorticoids|mesh-ancestor
111334246|NCT04362241|Hormones|hormones|mesh-ancestor
111334247|NCT04362241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111334248|NCT04362241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110805799|NCT03726099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111334249|NCT04362241|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111334250|NCT04362241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111334251|NCT04362241|Antiemetics|antiemetics|mesh-ancestor
111334252|NCT04362241|Autonomic Agents|autonomic agents|mesh-ancestor
111334253|NCT04362241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111334254|NCT04362241|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111334255|NCT04362241|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110805942|NCT03521193|Antipyretics|antipyretics|mesh-ancestor
111334256|NCT04362241|Protective Agents|protective agents|mesh-ancestor
111334257|NCT01384513|Mycophenolic Acid|mycophenolic acid|mesh-list
111334258|NCT01384513|Cyclophosphamide|cyclophosphamide|mesh-list
111334259|NCT01384513|Busulfan|busulfan|mesh-list
111334260|NCT01384513|Fludarabine|fludarabine|mesh-list
111334261|NCT01384513|Fludarabine phosphate|fludarabine phosphate|mesh-list
111334262|NCT01384513|Tacrolimus|tacrolimus|mesh-list
111334263|NCT01384513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111334264|NCT01384513|Immunologic Factors|immunologic factors|mesh-ancestor
111334265|NCT01384513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111334266|NCT01384513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111334267|NCT01384513|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111334268|NCT01384513|Alkylating Agents|alkylating agents|mesh-ancestor
111334269|NCT01384513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111334270|NCT01384513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111334271|NCT01384513|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111334272|NCT01384513|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111334273|NCT01384513|Antimetabolites|antimetabolites|mesh-ancestor
111334274|NCT01384513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111334275|NCT01384513|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111334276|NCT01384513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111334277|NCT01384513|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111334278|NCT01384513|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111334279|NCT01384513|Antitubercular Agents|antitubercular agents|mesh-ancestor
111334280|NCT01384513|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111334281|NCT03035617|Bupivacaine|bupivacaine|mesh-list
111334282|NCT03035617|Anesthetics, Local|anesthetics, local|mesh-ancestor
111334283|NCT03035617|Anesthetics|anesthetics|mesh-ancestor
111334284|NCT03035617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111334285|NCT03035617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111334286|NCT03035617|Sensory System Agents|sensory system agents|mesh-ancestor
111334287|NCT03035617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111334288|NCT02933320|Rituximab|rituximab|mesh-list
111334289|NCT02933320|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111334290|NCT02933320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111334291|NCT02933320|Immunologic Factors|immunologic factors|mesh-ancestor
111334292|NCT02933320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111334293|NCT02933320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111334294|NCT05563675|Cholinergic Agents|cholinergic agents|mesh-list
111334295|NCT05563675|Muscarinic Antagonists|muscarinic antagonists|mesh-list
111334296|NCT05563675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111334297|NCT05563675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111334298|NCT05563675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111334299|NCT05563675|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111334300|NCT05555251|Trastuzumab|trastuzumab|mesh-list
111334301|NCT05555251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111334302|NCT05555251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111334303|NCT03035305|Pyrimethamine|pyrimethamine|mesh-list
111334304|NCT03035305|Sulfadoxine|sulfadoxine|mesh-list
111334305|NCT03035305|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
111058738|NCT05456165|Ipilimumab|ipilimumab|mesh-list
110806427|NCT02255734|Acyclovir|acyclovir|mesh-list
111334306|NCT03035305|Amodiaquine|amodiaquine|mesh-list
111334307|NCT03035305|Antimalarials|antimalarials|mesh-ancestor
111334308|NCT03035305|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111334309|NCT03035305|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111334310|NCT03035305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111334311|NCT03035305|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111334312|NCT03035305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111334313|NCT03035305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111334314|NCT03035305|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111334315|NCT03034759|Insulin|insulin|mesh-list
111334316|NCT03034759|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111334317|NCT03034759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111334318|NCT02158273|Fenofibrate|fenofibrate|mesh-list
111334319|NCT02158273|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111334320|NCT02158273|Antimetabolites|antimetabolites|mesh-ancestor
111334321|NCT02158273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111334322|NCT02158273|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111334323|NCT02819284|Loteprednol Etabonate|loteprednol etabonate|mesh-list
111334324|NCT02819284|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111334325|NCT04361461|Azithromycin|azithromycin|mesh-list
111334326|NCT04361461|Hydroxychloroquine|hydroxychloroquine|mesh-list
111334327|NCT04361461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111334328|NCT04361461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111334329|NCT04361461|Antimalarials|antimalarials|mesh-ancestor
111334330|NCT04361461|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111334331|NCT04361461|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111334332|NCT04361461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111334333|NCT04361461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111334334|NCT04361461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111334335|NCT03002506|Tazobactam|tazobactam|mesh-list
111334336|NCT03002506|Ceftolozane|ceftolozane|mesh-list
111334337|NCT03002506|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
111334338|NCT03002506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111334339|NCT03002506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111334340|NCT03002506|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
111334341|NCT03002506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111334342|NCT03002506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111334343|NCT03002506|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111334344|NCT02822950|Ceftazidime|ceftazidime|mesh-list
111334345|NCT02822950|Avibactam|avibactam|mesh-list
111334346|NCT02822950|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
111334347|NCT02822950|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111334348|NCT02822950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111334349|NCT02822950|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
111334350|NCT02822950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111334351|NCT02822950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111334352|NCT02935738|Prednisolone|prednisolone|mesh-list
111334353|NCT02935738|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111334354|NCT02935738|Glucocorticoids|glucocorticoids|mesh-ancestor
111334355|NCT02935738|Hormones|hormones|mesh-ancestor
111334356|NCT02935738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111334357|NCT02935738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111334358|NCT02935738|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111334359|NCT02935738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111334360|NCT00939991|Bevacizumab|bevacizumab|mesh-list
111334361|NCT00939991|Temozolomide|temozolomide|mesh-list
111334362|NCT00939991|Vorinostat|vorinostat|mesh-list
111334363|NCT00939991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111334364|NCT00939991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111334365|NCT00939991|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111334366|NCT00939991|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111334367|NCT00939991|Growth Substances|growth substances|mesh-ancestor
110806746|NCT02177422|Diuretics|diuretics|mesh-ancestor
111334368|NCT00939991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111334369|NCT00939991|Growth Inhibitors|growth inhibitors|mesh-ancestor
111334370|NCT00939991|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111334371|NCT00939991|Alkylating Agents|alkylating agents|mesh-ancestor
111334372|NCT00939991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111334373|NCT00939991|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111334374|NCT00939991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111334375|NCT04361305|Tadalafil|tadalafil|mesh-list
111334376|NCT04361305|Vasodilator Agents|vasodilator agents|mesh-ancestor
111334377|NCT04361305|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111334378|NCT04361305|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111334379|NCT04361305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110806877|NCT02183428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111334380|NCT04361305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111334381|NCT04361305|Urological Agents|urological agents|mesh-ancestor
111334382|NCT02245321|Ferrous gluconate|ferrous gluconate|mesh-list
111334383|NCT02245321|Hematinics|hematinics|mesh-ancestor
111334384|NCT04361149|Capsaicin|capsaicin|mesh-list
111334385|NCT04361149|Antipruritics|antipruritics|mesh-ancestor
111334386|NCT04361149|Dermatologic Agents|dermatologic agents|mesh-ancestor
111334387|NCT04361149|Sensory System Agents|sensory system agents|mesh-ancestor
111334388|NCT04361149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111334389|NCT04361149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111334390|NCT05332483|Megestrol|megestrol|mesh-list
111334391|NCT05332483|Megestrol Acetate|megestrol acetate|mesh-list
111334392|NCT05332483|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111334393|NCT05332483|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111334394|NCT05332483|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111334395|NCT05332483|Contraceptive Agents|contraceptive agents|mesh-ancestor
111334396|NCT05332483|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111334397|NCT05332483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111334398|NCT05332483|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111334399|NCT05332483|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111334400|NCT05332483|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111334401|NCT05332483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111334402|NCT05332483|Appetite Stimulants|appetite stimulants|mesh-ancestor
111334403|NCT05332483|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111334404|NCT03033589|Bupivacaine|bupivacaine|mesh-list
111334405|NCT03033589|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111334406|NCT03033589|Anesthetics, Local|anesthetics, local|mesh-ancestor
111334407|NCT03033589|Anesthetics|anesthetics|mesh-ancestor
111334408|NCT03033589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111334409|NCT03033589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111334410|NCT03033589|Sensory System Agents|sensory system agents|mesh-ancestor
111334411|NCT03033589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111334412|NCT00947167|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111334413|NCT00947167|Pertuzumab|pertuzumab|mesh-list
110807084|NCT03536806|Diuretics|diuretics|mesh-ancestor
111334414|NCT00947167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111334415|NCT00947167|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111334416|NCT00947167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111334417|NCT00947167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111334418|NCT00947167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111334419|NCT04360759|Hydroxychloroquine|hydroxychloroquine|mesh-list
111334420|NCT04360759|Chloroquine|chloroquine|mesh-list
111334421|NCT04360759|Antimalarials|antimalarials|mesh-ancestor
111334422|NCT04360759|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111334423|NCT04360759|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111334424|NCT04360759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111334425|NCT04360759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110807275|NCT02185300|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111334426|NCT04360759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111334427|NCT04360759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111334428|NCT04360759|Amebicides|amebicides|mesh-ancestor
111334429|NCT00940771|Atazanavir Sulfate|atazanavir sulfate|mesh-list
111334430|NCT00940771|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111334431|NCT00940771|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111334432|NCT00940771|Protease Inhibitors|protease inhibitors|mesh-ancestor
111334433|NCT00940771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111334434|NCT00940771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111334435|NCT00940771|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111334436|NCT00940771|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111334437|NCT00940771|Antiviral Agents|antiviral agents|mesh-ancestor
111334438|NCT00940771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111334439|NCT03033355|Botulinum Toxins|botulinum toxins|mesh-list
111334440|NCT03033355|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111334441|NCT03033355|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110807347|NCT02191228|Protease Inhibitors|protease inhibitors|mesh-ancestor
111334442|NCT03033355|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111334443|NCT03033355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111334444|NCT03033355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111334445|NCT03033355|Cholinergic Agents|cholinergic agents|mesh-ancestor
111334446|NCT03033355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111334447|NCT03033355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111334448|NCT03033355|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111334449|NCT03033355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111334450|NCT03033121|Hormones|hormones|mesh-list
111334451|NCT03033121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111334452|NCT03033121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111334453|NCT03033199|Dexamethasone|dexamethasone|mesh-list
111334454|NCT03033199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111334455|NCT03033199|Antiemetics|antiemetics|mesh-ancestor
111334456|NCT03033199|Autonomic Agents|autonomic agents|mesh-ancestor
111334457|NCT03033199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111334458|NCT03033199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110807466|NCT02187874|Oxytocics|oxytocics|mesh-ancestor
111334459|NCT03033199|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111334460|NCT03033199|Glucocorticoids|glucocorticoids|mesh-ancestor
111334461|NCT03033199|Hormones|hormones|mesh-ancestor
111334462|NCT03033199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111334463|NCT03033199|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111334464|NCT03033199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111334465|NCT00940927|Albuterol|albuterol|mesh-list
111334466|NCT00940927|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111334467|NCT00940927|Autonomic Agents|autonomic agents|mesh-ancestor
111334468|NCT00940927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111334469|NCT00940927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111334470|NCT00940927|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111334471|NCT00940927|Respiratory System Agents|respiratory system agents|mesh-ancestor
111334472|NCT00940927|Tocolytic Agents|tocolytic agents|mesh-ancestor
111334473|NCT00940927|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111334474|NCT00940927|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111334475|NCT00940927|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111334476|NCT00940927|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111334477|NCT00940927|Adrenergic Agents|adrenergic agents|mesh-ancestor
110807752|NCT02031016|Anesthetics|anesthetics|mesh-ancestor
111334478|NCT00940927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111334479|NCT00940927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111334480|NCT00934375|Donepezil|donepezil|mesh-list
111334481|NCT00934375|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111334482|NCT00934375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111334483|NCT00934375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111334484|NCT00934375|Cholinergic Agents|cholinergic agents|mesh-ancestor
111334485|NCT00934375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111334486|NCT00934375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111334487|NCT00934375|Nootropic Agents|nootropic agents|mesh-ancestor
111334488|NCT03002974|Triamcinolone|triamcinolone|mesh-list
111334489|NCT03002974|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
111334490|NCT03002974|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110807819|NCT02198404|Anesthetics, General|anesthetics, general|mesh-ancestor
111334491|NCT03002974|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
111334492|NCT03002974|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
111334493|NCT03002974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111334494|NCT03002974|Glucocorticoids|glucocorticoids|mesh-ancestor
111334495|NCT03002974|Hormones|hormones|mesh-ancestor
111334496|NCT03002974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111334497|NCT03002974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111334498|NCT03002974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111334499|NCT03002974|Immunologic Factors|immunologic factors|mesh-ancestor
111334500|NCT03002974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111334501|NCT03002974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111334502|NCT03002974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111334503|NCT02245477|Mitogens|mitogens|mesh-list
111334504|NCT02245477|Endothelial Growth Factors|endothelial growth factors|mesh-list
111334505|NCT02245477|Mitosis Modulators|mitosis modulators|mesh-ancestor
111334506|NCT02245477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111334507|NCT02245477|Growth Substances|growth substances|mesh-ancestor
111334508|NCT02245477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111334509|NCT02825212|Sofosbuvir|sofosbuvir|mesh-list
111334510|NCT02825212|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
111334511|NCT02825212|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
111334512|NCT02825212|Ledipasvir|ledipasvir|mesh-list
111334513|NCT02825212|Velpatasvir|velpatasvir|mesh-list
111334514|NCT02825212|Antiviral Agents|antiviral agents|mesh-ancestor
111334515|NCT02825212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111334516|NCT00373672|Modafinil|modafinil|mesh-list
111334517|NCT00373672|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111334518|NCT00373672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111334519|NCT00373672|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
111334520|NCT00373672|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111334521|NCT00373672|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111334522|NCT00373672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111334523|NCT04941703|Magnesium citrate|magnesium citrate|mesh-list
111334524|NCT04941703|Cathartics|cathartics|mesh-ancestor
111334525|NCT04941703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111334526|NCT04359823|Lovastatin|lovastatin|mesh-list
111334527|NCT04359823|L 647318|l 647318|mesh-list
111334528|NCT04359823|Dihydromevinolin|dihydromevinolin|mesh-list
111334529|NCT04359823|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111334530|NCT04359823|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111334532|NCT04359823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111334533|NCT04359823|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111334534|NCT04359823|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111334535|NCT04359823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111334536|NCT03008590|Naltrexone|naltrexone|mesh-list
111334537|NCT03008590|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111334538|NCT03008590|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111334539|NCT03008590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111334540|NCT03008590|Sensory System Agents|sensory system agents|mesh-ancestor
111334541|NCT03008590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111334542|NCT04359511|Prednisone|prednisone|mesh-list
111334543|NCT04359511|Hydrocortisone|hydrocortisone|mesh-list
111334544|NCT04359511|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111334545|NCT04359511|Glucocorticoids|glucocorticoids|mesh-ancestor
111334546|NCT04359511|Hormones|hormones|mesh-ancestor
111334547|NCT04359511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111334548|NCT04359511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111334549|NCT04359511|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111334550|NCT04359511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111334551|NCT03032419|Vaccines|vaccines|mesh-list
111334552|NCT03032419|Immunologic Factors|immunologic factors|mesh-ancestor
111334553|NCT03032419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111334554|NCT00373906|Bortezomib|bortezomib|mesh-list
111334555|NCT00373906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111334556|NCT00955513|Diclofenac|diclofenac|mesh-list
110807914|NCT03533062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111334557|NCT00955513|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111334558|NCT00955513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111334559|NCT00955513|Analgesics|analgesics|mesh-ancestor
111334560|NCT00955513|Sensory System Agents|sensory system agents|mesh-ancestor
111334561|NCT00955513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111334562|NCT00955513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111334563|NCT00955513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111334564|NCT00955513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111334565|NCT00955513|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111334566|NCT00955513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111334567|NCT00955513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111334568|NCT00935311|Acetaminophen|acetaminophen|mesh-list
111334569|NCT00935311|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
111334570|NCT00935311|Hydrocodone|hydrocodone|mesh-list
111334571|NCT00935311|Oxycodone|oxycodone|mesh-list
111334572|NCT00935311|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111334573|NCT00935311|Analgesics|analgesics|mesh-ancestor
111334574|NCT00935311|Sensory System Agents|sensory system agents|mesh-ancestor
111334575|NCT00935311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111334576|NCT00935311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111334577|NCT00935311|Antipyretics|antipyretics|mesh-ancestor
111334578|NCT00935311|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111334579|NCT00935311|Narcotics|narcotics|mesh-ancestor
111334580|NCT00935311|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111334581|NCT00935311|Antitussive Agents|antitussive agents|mesh-ancestor
111334582|NCT00935311|Respiratory System Agents|respiratory system agents|mesh-ancestor
111334583|NCT00935311|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111334584|NCT00935311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111334585|NCT00935311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111334586|NCT02946034|Ribavirin|ribavirin|mesh-list
111334587|NCT02946034|Antimetabolites|antimetabolites|mesh-ancestor
110808094|NCT02221102|Protease Inhibitors|protease inhibitors|mesh-ancestor
111334588|NCT02946034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111334589|NCT02946034|Antiviral Agents|antiviral agents|mesh-ancestor
111334590|NCT02946034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111334591|NCT00955747|Tagatose|tagatose|mesh-list
111334592|NCT00955747|Iron Chelating Agents|iron chelating agents|mesh-ancestor
111334593|NCT00955747|Chelating Agents|chelating agents|mesh-ancestor
111334594|NCT00955747|Sequestering Agents|sequestering agents|mesh-ancestor
111334595|NCT00955747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111334596|NCT02946892|Carvedilol|carvedilol|mesh-list
111334597|NCT02946892|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111334598|NCT02946892|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111334599|NCT02946892|Adrenergic Agents|adrenergic agents|mesh-ancestor
111334600|NCT02946892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111334601|NCT02946892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111334602|NCT02946892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111334603|NCT02946892|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111334604|NCT02946892|Antioxidants|antioxidants|mesh-ancestor
111334605|NCT02946892|Protective Agents|protective agents|mesh-ancestor
111334606|NCT02946892|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111334607|NCT02946892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110808225|NCT02220088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111334608|NCT02946892|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111334609|NCT02946892|Vasodilator Agents|vasodilator agents|mesh-ancestor
111334610|NCT02946892|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111334611|NCT02946892|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111334612|NCT03402191|Sildenafil Citrate|sildenafil citrate|mesh-list
111334613|NCT03402191|Vasodilator Agents|vasodilator agents|mesh-ancestor
111334614|NCT03402191|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111334615|NCT03402191|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111334616|NCT03402191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111334617|NCT03402191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111334618|NCT03402191|Urological Agents|urological agents|mesh-ancestor
111334619|NCT03402113|Midazolam|midazolam|mesh-list
111334620|NCT03402113|Dexmedetomidine|dexmedetomidine|mesh-list
111334621|NCT03402113|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111334622|NCT03402113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111334623|NCT03402113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111334624|NCT03402113|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111334625|NCT03402113|Analgesics|analgesics|mesh-ancestor
111334626|NCT03402113|Sensory System Agents|sensory system agents|mesh-ancestor
111334627|NCT03402113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111334628|NCT03402113|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111334629|NCT03402113|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111334630|NCT03402113|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111334631|NCT03402113|Adrenergic Agents|adrenergic agents|mesh-ancestor
111334632|NCT03402113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111334633|NCT03402113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111334634|NCT03402113|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111334635|NCT03402113|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111334636|NCT03402113|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111334637|NCT03402113|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111334638|NCT03402113|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111334639|NCT03402113|Anesthetics, General|anesthetics, general|mesh-ancestor
111334640|NCT03402113|Anesthetics|anesthetics|mesh-ancestor
111334641|NCT03402113|GABA Modulators|gaba modulators|mesh-ancestor
111334642|NCT03402113|GABA Agents|gaba agents|mesh-ancestor
111334643|NCT01725113|Calcitriol|calcitriol|mesh-list
111334644|NCT01725113|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111334645|NCT01725113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111334646|NCT01725113|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
111334647|NCT01725113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111334648|NCT01725113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111334649|NCT01725113|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111334650|NCT01725113|Vitamins|vitamins|mesh-ancestor
111334651|NCT01725113|Micronutrients|micronutrients|mesh-ancestor
111334652|NCT01725113|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111334653|NCT03031405|Oxytocin|oxytocin|mesh-list
111334654|NCT03031405|Oxytocics|oxytocics|mesh-ancestor
111334655|NCT03031405|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111334656|NCT03031405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111334657|NCT03031249|Cytarabine|cytarabine|mesh-list
111334658|NCT03031249|Tretinoin|tretinoin|mesh-list
111334659|NCT03031249|Arsenic Trioxide|arsenic trioxide|mesh-list
111334660|NCT03031249|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111334661|NCT03031249|Antimetabolites|antimetabolites|mesh-ancestor
111334662|NCT03031249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111334663|NCT03031249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111334664|NCT03031249|Antiviral Agents|antiviral agents|mesh-ancestor
111334665|NCT03031249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111334666|NCT03031249|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111334667|NCT03031249|Immunologic Factors|immunologic factors|mesh-ancestor
111334668|NCT03031249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111334669|NCT03031249|Keratolytic Agents|keratolytic agents|mesh-ancestor
111334670|NCT03031249|Dermatologic Agents|dermatologic agents|mesh-ancestor
111334671|NCT02980315|Immunomodulating Agents|immunomodulating agents|mesh-list
111334672|NCT02980315|Immunologic Factors|immunologic factors|mesh-ancestor
111334673|NCT02980315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111334674|NCT01042535|Tryptophan|tryptophan|mesh-list
111334675|NCT01042535|Vaccines|vaccines|mesh-list
111334676|NCT01042535|Immunologic Factors|immunologic factors|mesh-ancestor
111334677|NCT01042535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111334678|NCT01042535|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111334679|NCT01042535|Antidepressive Agents|antidepressive agents|mesh-ancestor
111334681|NCT03031327|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111334682|NCT03031327|Hyaluronic Acid|hyaluronic acid|mesh-list
111334683|NCT03031327|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111334684|NCT03031327|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111334685|NCT03031327|Immunologic Factors|immunologic factors|mesh-ancestor
111334686|NCT03031327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111334687|NCT03031327|Viscosupplements|viscosupplements|mesh-ancestor
111334688|NCT03031327|Protective Agents|protective agents|mesh-ancestor
111334689|NCT03401957|Cetuximab|cetuximab|mesh-list
111334690|NCT03401957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111334691|NCT03401957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111334692|NCT04358965|Misoprostol|misoprostol|mesh-list
111334693|NCT04358965|Tranexamic Acid|tranexamic acid|mesh-list
111334694|NCT04358965|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111334695|NCT04358965|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111334696|NCT04358965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111334697|NCT04358965|Hemostatics|hemostatics|mesh-ancestor
111334698|NCT04358965|Coagulants|coagulants|mesh-ancestor
111334699|NCT04358965|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111334700|NCT04358965|Abortifacient Agents|abortifacient agents|mesh-ancestor
111334701|NCT04358965|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111334702|NCT04358965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111334703|NCT04358965|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111334704|NCT04358965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111334705|NCT04358965|Oxytocics|oxytocics|mesh-ancestor
111334706|NCT01041287|Metoprolol|metoprolol|mesh-list
111334707|NCT01041287|Nebivolol|nebivolol|mesh-list
111334708|NCT01041287|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111334709|NCT01041287|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111334710|NCT01041287|Sympatholytics|sympatholytics|mesh-ancestor
111334711|NCT01041287|Autonomic Agents|autonomic agents|mesh-ancestor
111334712|NCT01041287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111334713|NCT01041287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111334714|NCT01041287|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
111334715|NCT01041287|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111334716|NCT01041287|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111334717|NCT01041287|Adrenergic Agents|adrenergic agents|mesh-ancestor
111334718|NCT01041287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111334719|NCT01041287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111334720|NCT01041287|Vasodilator Agents|vasodilator agents|mesh-ancestor
111334721|NCT01041287|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
111334722|NCT01041287|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111334723|NCT01041287|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111334724|NCT03016741|Prednisone|prednisone|mesh-list
111334725|NCT03016741|Abiraterone Acetate|abiraterone acetate|mesh-list
111334726|NCT03016741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111334727|NCT03016741|Glucocorticoids|glucocorticoids|mesh-ancestor
111334728|NCT03016741|Hormones|hormones|mesh-ancestor
111334729|NCT03016741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111334730|NCT03016741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111334731|NCT03016741|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111334732|NCT03016741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111334733|NCT03016741|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111334734|NCT03016741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111334735|NCT03016741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111334736|NCT03016741|Hormone Antagonists|hormone antagonists|mesh-ancestor
111334737|NCT03016741|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111334738|NCT01042925|Paclitaxel|paclitaxel|mesh-list
111334739|NCT01042925|Trastuzumab|trastuzumab|mesh-list
111334740|NCT01042925|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111334741|NCT01042925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111334742|NCT01042925|Tubulin Modulators|tubulin modulators|mesh-ancestor
111334743|NCT01042925|Antimitotic Agents|antimitotic agents|mesh-ancestor
111334744|NCT01042925|Mitosis Modulators|mitosis modulators|mesh-ancestor
111334745|NCT01042925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111334746|NCT01042925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111334747|NCT03400709|Acetylcysteine|acetylcysteine|mesh-list
111334748|NCT03400709|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111334749|NCT03400709|Antiviral Agents|antiviral agents|mesh-ancestor
111334750|NCT03400709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111334751|NCT03400709|Expectorants|expectorants|mesh-ancestor
111334752|NCT03400709|Respiratory System Agents|respiratory system agents|mesh-ancestor
111334753|NCT03400709|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111334754|NCT03400709|Antioxidants|antioxidants|mesh-ancestor
111334755|NCT03400709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111334757|NCT03400709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111334758|NCT03400709|Antidotes|antidotes|mesh-ancestor
111334759|NCT02049957|Fulvestrant|fulvestrant|mesh-list
111334760|NCT02049957|Exemestane|exemestane|mesh-list
111334761|NCT02049957|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111334762|NCT02049957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111334763|NCT02049957|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
111334764|NCT02049957|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111334765|NCT02049957|Hormone Antagonists|hormone antagonists|mesh-ancestor
111334766|NCT02049957|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111334767|NCT02049957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111334768|NCT02049957|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111334769|NCT02049957|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111334770|NCT02049957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111334771|NCT02049957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111334772|NCT03030937|Irinotecan|irinotecan|mesh-list
111334773|NCT03030937|Apatinib|apatinib|mesh-list
110809112|NCT04981678|Narcotics|narcotics|mesh-ancestor
111334774|NCT03030937|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111334775|NCT03030937|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111334776|NCT03030937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111334777|NCT03030937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111334778|NCT03030937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111334779|NCT03030937|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111334780|NCT00950365|Pemetrexed|pemetrexed|mesh-list
111334781|NCT00950365|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111334782|NCT00950365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111334783|NCT00950365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111334784|NCT00950365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111334785|NCT00950365|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111334786|NCT00950365|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111334787|NCT00950365|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111334788|NCT01908465|Ebastine|ebastine|mesh-list
111334789|NCT01908465|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111334790|NCT01908465|Histamine Antagonists|histamine antagonists|mesh-ancestor
111334791|NCT01908465|Histamine Agents|histamine agents|mesh-ancestor
111334792|NCT01908465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111334793|NCT01908465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111334794|NCT01908465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111334795|NCT00950833|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
111334796|NCT00950833|Immunologic Factors|immunologic factors|mesh-ancestor
111334797|NCT00950833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111334798|NCT02246023|Propofol|propofol|mesh-list
111334799|NCT02246023|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111334800|NCT02246023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111334801|NCT02246023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111334802|NCT02246023|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111334803|NCT02246023|Anesthetics, General|anesthetics, general|mesh-ancestor
111334804|NCT02246023|Anesthetics|anesthetics|mesh-ancestor
111334805|NCT00924053|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
111334806|NCT00924053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111334807|NCT00924053|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111334808|NCT00924053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111334809|NCT00357825|Reboxetine|reboxetine|mesh-list
111334810|NCT00357825|Antidepressive Agents|antidepressive agents|mesh-ancestor
111334811|NCT00357825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111334812|NCT00357825|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111334813|NCT00357825|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111334814|NCT00357825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111334815|NCT00357825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111334816|NCT00357825|Adrenergic Agents|adrenergic agents|mesh-ancestor
111334817|NCT00357825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111334818|NCT00357825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111334819|NCT03400241|Bromides|bromides|mesh-list
111334820|NCT03400241|Tiotropium Bromide|tiotropium bromide|mesh-list
111334821|NCT03400241|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111334822|NCT03400241|Autonomic Agents|autonomic agents|mesh-ancestor
111334823|NCT03400241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111334824|NCT03400241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111334825|NCT03400241|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111059263|NCT05191472|Pembrolizumab|pembrolizumab|mesh-list
111334826|NCT03400241|Respiratory System Agents|respiratory system agents|mesh-ancestor
111334827|NCT03400241|Parasympatholytics|parasympatholytics|mesh-ancestor
111334828|NCT03400241|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111334829|NCT03400241|Cholinergic Agents|cholinergic agents|mesh-ancestor
111334830|NCT03400241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111334831|NCT03400241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111334832|NCT03400241|Anticonvulsants|anticonvulsants|mesh-ancestor
111334833|NCT05706987|Lidocaine|lidocaine|mesh-list
111334834|NCT05706987|Anesthetics, Local|anesthetics, local|mesh-ancestor
111334835|NCT05706987|Anesthetics|anesthetics|mesh-ancestor
110809432|NCT01095185|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111334836|NCT05706987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111334837|NCT05706987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111334838|NCT05706987|Sensory System Agents|sensory system agents|mesh-ancestor
111334839|NCT05706987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111334840|NCT05706987|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111334841|NCT05706987|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111334842|NCT05706987|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111334843|NCT05706987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111334844|NCT05706987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111334845|NCT00729573|Tenofovir|tenofovir|mesh-list
111334846|NCT00729573|Emtricitabine|emtricitabine|mesh-list
111334847|NCT00729573|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
111334848|NCT00729573|Antiviral Agents|antiviral agents|mesh-ancestor
111334849|NCT00729573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110809491|NCT00051311|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111334850|NCT00729573|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111334851|NCT00729573|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111334852|NCT00729573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111334853|NCT00729573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111334854|NCT00729573|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111334855|NCT00729573|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111334856|NCT02951182|Ivacaftor|ivacaftor|mesh-list
111334857|NCT02951182|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
111334858|NCT02951182|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111334859|NCT02951182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111334860|NCT02959359|Ribavirin|ribavirin|mesh-list
111334861|NCT02959359|Sofosbuvir|sofosbuvir|mesh-list
111334862|NCT02959359|Ledipasvir|ledipasvir|mesh-list
111334863|NCT02959359|Antimetabolites|antimetabolites|mesh-ancestor
111334864|NCT02959359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111334865|NCT02959359|Antiviral Agents|antiviral agents|mesh-ancestor
111334866|NCT02959359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111334867|NCT02829034|Ranolazine|ranolazine|mesh-list
111334868|NCT02829034|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110809550|NCT00048347|Antiviral Agents|antiviral agents|mesh-ancestor
111334869|NCT02829034|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111334870|NCT02829034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111334871|NCT00924209|Bevacizumab|bevacizumab|mesh-list
111334872|NCT00924209|Gemcitabine|gemcitabine|mesh-list
111334873|NCT00924209|Etoposide|etoposide|mesh-list
111334874|NCT00924209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111334875|NCT00924209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111334876|NCT00924209|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111334877|NCT00924209|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111334878|NCT00924209|Growth Substances|growth substances|mesh-ancestor
111334879|NCT00924209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111334880|NCT00924209|Growth Inhibitors|growth inhibitors|mesh-ancestor
111334881|NCT00924209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111334882|NCT00924209|Antimetabolites|antimetabolites|mesh-ancestor
110809609|NCT01095809|Bevacizumab|bevacizumab|mesh-list
111334883|NCT00924209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111334884|NCT00924209|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111334885|NCT00924209|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110809674|NCT00064337|Hormones|hormones|mesh-ancestor
111334886|NCT00924209|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111334887|NCT00924209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111334888|NCT05719467|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
111334889|NCT05719467|Parasympatholytics|parasympatholytics|mesh-ancestor
111334890|NCT05719467|Autonomic Agents|autonomic agents|mesh-ancestor
111334891|NCT05719467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111334892|NCT05719467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111334893|NCT05719467|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111334894|NCT05719467|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111334895|NCT05719467|Cholinergic Agents|cholinergic agents|mesh-ancestor
111334896|NCT05719467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111334897|NCT05719467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111334898|NCT03408119|Vitamin D|vitamin d|mesh-list
111334900|NCT03408119|Vitamins|vitamins|mesh-ancestor
111334901|NCT03408119|Micronutrients|micronutrients|mesh-ancestor
111334902|NCT03408119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111334903|NCT03408119|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111334904|NCT03408119|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111334905|NCT03405155|Nivolumab|nivolumab|mesh-list
111334906|NCT03405155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111334907|NCT03405155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111334908|NCT03405155|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110810019|NCT01527916|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111334909|NCT03405155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111334910|NCT04374929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
111334911|NCT04374929|Glucocorticoids|glucocorticoids|mesh-list
111334912|NCT04374929|Hormones|hormones|mesh-ancestor
111334913|NCT04374929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111334914|NCT04374929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111334915|NCT05717361|Lidocaine|lidocaine|mesh-list
111334916|NCT05717361|Ketamine|ketamine|mesh-list
111334917|NCT05717361|Remifentanil|remifentanil|mesh-list
110810092|NCT01357642|Epinephrine|epinephrine|mesh-list
111334918|NCT05717361|Anesthetics, Local|anesthetics, local|mesh-ancestor
111334919|NCT05717361|Anesthetics|anesthetics|mesh-ancestor
111334920|NCT05717361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111334921|NCT05717361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111334922|NCT05717361|Sensory System Agents|sensory system agents|mesh-ancestor
111334923|NCT05717361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111334924|NCT05717361|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111334925|NCT05717361|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111334926|NCT05717361|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111334927|NCT05717361|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111334928|NCT05717361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111334929|NCT05717361|Analgesics|analgesics|mesh-ancestor
111334930|NCT05717361|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111334931|NCT05717361|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111334932|NCT05717361|Anesthetics, General|anesthetics, general|mesh-ancestor
111334933|NCT05717361|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111334934|NCT05717361|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111334935|NCT05717361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111334936|NCT05717361|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111334937|NCT05717361|Narcotics|narcotics|mesh-ancestor
111334938|NCT02951884|Bupivacaine|bupivacaine|mesh-list
111334939|NCT02951884|Anesthetics, Local|anesthetics, local|mesh-ancestor
111334940|NCT02951884|Anesthetics|anesthetics|mesh-ancestor
111334941|NCT02951884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111334942|NCT02951884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111334943|NCT02951884|Sensory System Agents|sensory system agents|mesh-ancestor
111334944|NCT02951884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111334945|NCT05574387|Metformin|metformin|mesh-list
111334946|NCT05574387|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111334947|NCT05574387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111334948|NCT02978001|Glycerol|glycerol|mesh-list
111334949|NCT02978001|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
111334950|NCT02978001|Protective Agents|protective agents|mesh-ancestor
111334951|NCT02978001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111334952|NCT02978313|Cetuximab|cetuximab|mesh-list
111334953|NCT02978313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111334954|NCT02978313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111334955|NCT00014495|Cytarabine|cytarabine|mesh-list
111334956|NCT00014495|Bismuth|bismuth|mesh-list
111334957|NCT00014495|Antibodies|antibodies|mesh-list
111334958|NCT00014495|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111334959|NCT00014495|Immunologic Factors|immunologic factors|mesh-ancestor
111334960|NCT00014495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111334961|NCT00014495|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111334962|NCT00014495|Antimetabolites|antimetabolites|mesh-ancestor
111334963|NCT00014495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111334964|NCT00014495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110810433|NCT01174732|Albuterol|albuterol|mesh-list
111334965|NCT00014495|Antiviral Agents|antiviral agents|mesh-ancestor
111334966|NCT00014495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111334967|NCT00014495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111334968|NCT00014495|Antacids|antacids|mesh-ancestor
111334969|NCT00014495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111334970|NCT05566041|Carboplatin|carboplatin|mesh-list
111334971|NCT05566041|Etoposide|etoposide|mesh-list
111334972|NCT05566041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111334973|NCT05566041|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111059405|NCT05096390|Pembrolizumab|pembrolizumab|mesh-list
111334974|NCT05566041|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111334975|NCT05566041|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111334976|NCT05566041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111334977|NCT05566041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111334978|NCT04374071|Methylprednisolone|methylprednisolone|mesh-list
111334979|NCT04374071|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111334980|NCT04374071|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111334982|NCT04374071|Prednisolone acetate|prednisolone acetate|mesh-list
111334983|NCT04374071|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111334984|NCT04374071|Prednisolone phosphate|prednisolone phosphate|mesh-list
111334985|NCT04374071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111334986|NCT04374071|Antiemetics|antiemetics|mesh-ancestor
111334987|NCT04374071|Autonomic Agents|autonomic agents|mesh-ancestor
111334988|NCT04374071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111334989|NCT04374071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111334990|NCT04374071|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111334991|NCT04374071|Glucocorticoids|glucocorticoids|mesh-ancestor
111334992|NCT04374071|Hormones|hormones|mesh-ancestor
111334993|NCT04374071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111334994|NCT04374071|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111334995|NCT04374071|Protective Agents|protective agents|mesh-ancestor
111334996|NCT04374071|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111334997|NCT04374071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111334998|NCT00357981|Contraceptive Agents|contraceptive agents|mesh-list
111334999|NCT00357981|Ortho Evra|ortho evra|mesh-list
111335000|NCT00357981|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111335001|NCT00357981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111335002|NCT00357981|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111335003|NCT03030703|Inositol|inositol|mesh-list
111335004|NCT03030703|Vitamin B Complex|vitamin b complex|mesh-ancestor
111335005|NCT03030703|Vitamins|vitamins|mesh-ancestor
111335006|NCT03030703|Micronutrients|micronutrients|mesh-ancestor
111335007|NCT03030703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111335008|NCT02157623|Aminolevulinic Acid|aminolevulinic acid|mesh-list
111335009|NCT02157623|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111335010|NCT02157623|Dermatologic Agents|dermatologic agents|mesh-ancestor
111335011|NCT03030469|Analgesics, Opioid|analgesics, opioid|mesh-list
111335012|NCT03030469|Analgesics|analgesics|mesh-list
111335013|NCT03030469|Narcotics|narcotics|mesh-ancestor
111335014|NCT03030469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111335015|NCT03030469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111335016|NCT03030469|Sensory System Agents|sensory system agents|mesh-ancestor
111335017|NCT03030469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111335018|NCT00952081|Clevidipine|clevidipine|mesh-list
111335019|NCT00952081|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111335020|NCT00952081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111335021|NCT00952081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111335022|NCT00952081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111335023|NCT00952081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111335024|NCT05716347|Vaccines|vaccines|mesh-list
111335025|NCT05716347|Immunologic Factors|immunologic factors|mesh-ancestor
111335026|NCT05716347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111335027|NCT02959840|Ondansetron|ondansetron|mesh-list
111335028|NCT02959840|Metoclopramide|metoclopramide|mesh-list
111335029|NCT02959840|Antiemetics|antiemetics|mesh-ancestor
111335030|NCT02959840|Autonomic Agents|autonomic agents|mesh-ancestor
110810597|NCT05613400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111335031|NCT02959840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111335032|NCT02959840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111335033|NCT02959840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111335034|NCT02959840|Antipruritics|antipruritics|mesh-ancestor
111335035|NCT02959840|Dermatologic Agents|dermatologic agents|mesh-ancestor
111335036|NCT02959840|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111335037|NCT02959840|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111335038|NCT02959840|Serotonin Agents|serotonin agents|mesh-ancestor
111335039|NCT02959840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111335040|NCT02959840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111335041|NCT02959840|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111335042|NCT02959840|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111335043|NCT02959840|Dopamine Agents|dopamine agents|mesh-ancestor
111335044|NCT04358341|Doxorubicin|doxorubicin|mesh-list
111335045|NCT04358341|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111335046|NCT04358341|Fluorouracil|fluorouracil|mesh-list
111335047|NCT04358341|Irinotecan|irinotecan|mesh-list
111335048|NCT04358341|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111335049|NCT04358341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111335050|NCT04358341|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111335051|NCT04358341|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111335052|NCT04358341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111335053|NCT04358341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111335054|NCT04358341|Antimetabolites|antimetabolites|mesh-ancestor
111335055|NCT04358341|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111335056|NCT04358341|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111335057|NCT04358341|Immunologic Factors|immunologic factors|mesh-ancestor
111335058|NCT04358341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111335059|NCT04358341|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111335060|NCT02978547|Metformin|metformin|mesh-list
111335061|NCT02978547|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111335062|NCT02978547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111335063|NCT02959996|Bupivacaine|bupivacaine|mesh-list
111335064|NCT02959996|Anesthetics, Local|anesthetics, local|mesh-ancestor
111335065|NCT02959996|Anesthetics|anesthetics|mesh-ancestor
111335066|NCT02959996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110810779|NCT05628610|Paclitaxel|paclitaxel|mesh-list
111335067|NCT02959996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111335068|NCT02959996|Sensory System Agents|sensory system agents|mesh-ancestor
111335069|NCT02959996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111335070|NCT00929981|Methylprednisolone|methylprednisolone|mesh-list
111335071|NCT00929981|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111335072|NCT00929981|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111335073|NCT00929981|Prednisolone|prednisolone|mesh-list
111335074|NCT00929981|Prednisolone acetate|prednisolone acetate|mesh-list
111335075|NCT00929981|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111335076|NCT00929981|Prednisolone phosphate|prednisolone phosphate|mesh-list
111335077|NCT00929981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111335078|NCT00929981|Antiemetics|antiemetics|mesh-ancestor
111335079|NCT00929981|Autonomic Agents|autonomic agents|mesh-ancestor
111335080|NCT00929981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111335081|NCT00929981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111335082|NCT00929981|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111335083|NCT00929981|Glucocorticoids|glucocorticoids|mesh-ancestor
111335084|NCT00929981|Hormones|hormones|mesh-ancestor
111335085|NCT00929981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111335086|NCT00929981|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111335087|NCT00929981|Protective Agents|protective agents|mesh-ancestor
111335088|NCT00929981|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111335089|NCT00929981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111335090|NCT00961441|Levetiracetam|levetiracetam|mesh-list
111335091|NCT00961441|Anticonvulsants|anticonvulsants|mesh-ancestor
111335092|NCT00961441|Nootropic Agents|nootropic agents|mesh-ancestor
111335093|NCT02961946|Nitroglycerin|nitroglycerin|mesh-list
111335094|NCT02961946|Vasodilator Agents|vasodilator agents|mesh-ancestor
111335095|NCT02240459|Fesoterodine|fesoterodine|mesh-list
111335096|NCT02240459|Oxybutynin|oxybutynin|mesh-list
111335097|NCT02240459|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111335098|NCT02240459|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111335099|NCT02240459|Cholinergic Agents|cholinergic agents|mesh-ancestor
111335100|NCT02240459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111335101|NCT02240459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111335102|NCT02240459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111335103|NCT02240459|Urological Agents|urological agents|mesh-ancestor
111335104|NCT02240459|Parasympatholytics|parasympatholytics|mesh-ancestor
111335105|NCT02240459|Autonomic Agents|autonomic agents|mesh-ancestor
111335106|NCT02240459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111335107|NCT02240537|Sargramostim|sargramostim|mesh-list
111335108|NCT02240537|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
111335109|NCT02240537|Immunologic Factors|immunologic factors|mesh-ancestor
111335110|NCT02240537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111335111|NCT02240537|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111335112|NCT00962065|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
111335113|NCT00962065|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111335114|NCT00962065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111335115|NCT00962065|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111335116|NCT00962065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111335117|NCT02240927|Enoxaparin|enoxaparin|mesh-list
111335118|NCT02240927|Warfarin|warfarin|mesh-list
111335119|NCT02240927|Enoxaparin sodium|enoxaparin sodium|mesh-list
111335120|NCT02240927|Anticoagulants|anticoagulants|mesh-ancestor
110811315|NCT00077207|Carboplatin|carboplatin|mesh-list
111335121|NCT02240927|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111335122|NCT02240927|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111335123|NCT02240927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111335124|NCT03038308|Ropinirole|ropinirole|mesh-list
111335125|NCT03038308|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110811389|NCT00914602|Levodopa|levodopa|mesh-list
111335126|NCT03038308|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111335127|NCT03038308|Dopamine Agonists|dopamine agonists|mesh-ancestor
111335128|NCT03038308|Dopamine Agents|dopamine agents|mesh-ancestor
111335129|NCT03038308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110811453|NCT00838630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111335130|NCT03038308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111335131|NCT03038308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111335132|NCT04358497|Ibuprofen|ibuprofen|mesh-list
111335133|NCT04358497|Polidocanol|polidocanol|mesh-list
111335134|NCT04358497|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111335135|NCT04358497|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111335136|NCT04358497|Analgesics|analgesics|mesh-ancestor
111335137|NCT04358497|Sensory System Agents|sensory system agents|mesh-ancestor
111335138|NCT04358497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111335139|NCT04358497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111335140|NCT04358497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111335141|NCT04358497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111335142|NCT04358497|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111335143|NCT04358497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111335144|NCT04358497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111335145|NCT04358497|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
111335146|NCT04358497|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111335147|NCT02851108|Primaquine|primaquine|mesh-list
111335148|NCT02851108|Phenothiazine|phenothiazine|mesh-list
111335149|NCT02851108|Methylene Blue|methylene blue|mesh-list
111335150|NCT02851108|Antimalarials|antimalarials|mesh-ancestor
111335151|NCT02851108|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111335152|NCT02851108|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111335153|NCT02851108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111335154|NCT02851108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111335155|NCT02851108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111335156|NCT00930293|Dexetimide|dexetimide|mesh-list
111335157|NCT00930293|Citalopram|citalopram|mesh-list
111335158|NCT00930293|Escitalopram|escitalopram|mesh-list
111335159|NCT00930293|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111335160|NCT00930293|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111335161|NCT00930293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111335162|NCT00930293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111335163|NCT00930293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111335164|NCT00930293|Serotonin Agents|serotonin agents|mesh-ancestor
110811860|NCT01315262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111335165|NCT00930293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111335166|NCT00930293|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111335167|NCT00930293|Antidepressive Agents|antidepressive agents|mesh-ancestor
111335168|NCT00930293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111335169|NCT00930293|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111335170|NCT00930293|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111335171|NCT00930293|Parasympatholytics|parasympatholytics|mesh-ancestor
111335172|NCT00930293|Autonomic Agents|autonomic agents|mesh-ancestor
111335173|NCT00930293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111335174|NCT00930293|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111335175|NCT00930293|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111335176|NCT00930293|Cholinergic Agents|cholinergic agents|mesh-ancestor
111335177|NCT02855086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111335178|NCT02855086|Cetuximab|cetuximab|mesh-list
111335179|NCT02855086|Antibodies|antibodies|mesh-list
111335180|NCT02855086|Immunoglobulins|immunoglobulins|mesh-list
111335181|NCT02855086|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110812077|NCT01103401|Hormones|hormones|mesh-ancestor
111335182|NCT02855086|Immunologic Factors|immunologic factors|mesh-ancestor
111335183|NCT02855086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111335184|NCT02855086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111335185|NCT05368857|Afamelanotide|afamelanotide|mesh-list
111335186|NCT05368857|Dermatologic Agents|dermatologic agents|mesh-ancestor
111335187|NCT04347005|Allopurinol|allopurinol|mesh-list
111335188|NCT04347005|Febuxostat|febuxostat|mesh-list
111335189|NCT04347005|Antimetabolites|antimetabolites|mesh-ancestor
111335190|NCT04347005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111335191|NCT04347005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111335192|NCT04347005|Gout Suppressants|gout suppressants|mesh-ancestor
111335193|NCT04347005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111335194|NCT04347005|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111335195|NCT04347005|Antioxidants|antioxidants|mesh-ancestor
111335196|NCT04347005|Protective Agents|protective agents|mesh-ancestor
111335197|NCT04347005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111335198|NCT00358293|Tizanidine|tizanidine|mesh-list
111335199|NCT00358293|Analgesics|analgesics|mesh-ancestor
111335200|NCT00358293|Sensory System Agents|sensory system agents|mesh-ancestor
111335201|NCT00358293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111335202|NCT00358293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111335204|NCT00358293|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
111335205|NCT00358293|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111335206|NCT00358293|Parasympatholytics|parasympatholytics|mesh-ancestor
111335207|NCT00358293|Autonomic Agents|autonomic agents|mesh-ancestor
111335208|NCT00358293|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111335209|NCT00358293|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111335210|NCT00358293|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111335211|NCT00358293|Adrenergic Agents|adrenergic agents|mesh-ancestor
111335212|NCT00358293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111335213|NCT00358293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111335214|NCT02241083|Dopamine|dopamine|mesh-list
111335215|NCT02241083|Norepinephrine|norepinephrine|mesh-list
110812572|NCT01337804|Omeprazole|omeprazole|mesh-list
111335216|NCT02241083|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111335217|NCT02241083|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111335218|NCT02241083|Adrenergic Agents|adrenergic agents|mesh-ancestor
111335219|NCT02241083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111335220|NCT02241083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111335221|NCT02241083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111335222|NCT02241083|Sympathomimetics|sympathomimetics|mesh-ancestor
111335223|NCT02241083|Autonomic Agents|autonomic agents|mesh-ancestor
111335224|NCT02241083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111335225|NCT02241083|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111335226|NCT02241083|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111335227|NCT02241083|Dopamine Agents|dopamine agents|mesh-ancestor
111335228|NCT02241083|Protective Agents|protective agents|mesh-ancestor
111335229|NCT04372589|Heparin|heparin|mesh-list
111335230|NCT04372589|Anticoagulants|anticoagulants|mesh-ancestor
111335231|NCT04372589|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111335232|NCT04372589|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111335233|NCT04372589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111335234|NCT04364399|Vaccines|vaccines|mesh-list
111335235|NCT04364399|Immunologic Factors|immunologic factors|mesh-ancestor
111335236|NCT04364399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111335237|NCT02982551|Insulin|insulin|mesh-list
111335238|NCT02982551|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111335239|NCT02982551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111335240|NCT02965924|Phenylephrine|phenylephrine|mesh-list
111335241|NCT02965924|Oxymetazoline|oxymetazoline|mesh-list
111335242|NCT02965924|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111335243|NCT02965924|Mydriatics|mydriatics|mesh-ancestor
111335244|NCT02965924|Autonomic Agents|autonomic agents|mesh-ancestor
111335245|NCT02965924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111335246|NCT02965924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111335247|NCT02965924|Sympathomimetics|sympathomimetics|mesh-ancestor
111335248|NCT02965924|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111335249|NCT02965924|Nasal Decongestants|nasal decongestants|mesh-ancestor
111335250|NCT02965924|Respiratory System Agents|respiratory system agents|mesh-ancestor
110812772|NCT00749632|Oxybutynin|oxybutynin|mesh-list
111335251|NCT02965924|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111335252|NCT02965924|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111335253|NCT02965924|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111335254|NCT02965924|Adrenergic Agents|adrenergic agents|mesh-ancestor
111335255|NCT02965924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111335256|NCT02965924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111335257|NCT02965924|Protective Agents|protective agents|mesh-ancestor
111335258|NCT04364321|Diazepam|diazepam|mesh-list
111335259|NCT04364321|Clonazepam|clonazepam|mesh-list
111335260|NCT04364321|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111335261|NCT04364321|Anticonvulsants|anticonvulsants|mesh-ancestor
111335262|NCT04364321|Antiemetics|antiemetics|mesh-ancestor
111335263|NCT04364321|Autonomic Agents|autonomic agents|mesh-ancestor
111335264|NCT04364321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111335265|NCT04364321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111335266|NCT04364321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111335267|NCT04364321|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110813042|NCT01111591|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111335268|NCT04364321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111335269|NCT04364321|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
111335270|NCT04364321|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111335271|NCT04364321|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111335272|NCT04364321|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111335273|NCT04364321|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111335274|NCT04364321|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111335275|NCT04364321|Anesthetics, General|anesthetics, general|mesh-ancestor
111335276|NCT04364321|Anesthetics|anesthetics|mesh-ancestor
111335277|NCT04364321|GABA Modulators|gaba modulators|mesh-ancestor
111335278|NCT04364321|GABA Agents|gaba agents|mesh-ancestor
111335279|NCT04364321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111335280|NCT04364321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111335281|NCT03039088|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
111335282|NCT03039088|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111335283|NCT03039088|Adrenergic Agents|adrenergic agents|mesh-ancestor
110813190|NCT02282098|Colchicine|colchicine|mesh-list
111335284|NCT03039088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111335285|NCT03039088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111335286|NCT03039088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111335287|NCT05528913|Benralizumab|benralizumab|mesh-list
111335288|NCT05528913|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111335289|NCT05528913|Respiratory System Agents|respiratory system agents|mesh-ancestor
111335290|NCT04364009|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
111335291|NCT04364009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111335292|NCT04371965|Povidone-Iodine|povidone-iodine|mesh-list
111335293|NCT04371965|Povidone|povidone|mesh-list
111335294|NCT04371965|Plasma Substitutes|plasma substitutes|mesh-ancestor
111335295|NCT04371965|Blood Substitutes|blood substitutes|mesh-ancestor
111335296|NCT04371965|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111335297|NCT04371965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111335298|NCT02959125|Micronutrients|micronutrients|mesh-list
111335299|NCT02959125|Trace Elements|trace elements|mesh-list
111335300|NCT02959125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111335301|NCT02972554|Propranolol|propranolol|mesh-list
111335302|NCT02972554|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111335303|NCT02972554|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111335304|NCT02972554|Adrenergic Agents|adrenergic agents|mesh-ancestor
110813460|NCT01339286|Adrenergic Agents|adrenergic agents|mesh-ancestor
111335305|NCT02972554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111335306|NCT02972554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111335307|NCT02972554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111335308|NCT02972554|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111335309|NCT02972554|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111335310|NCT02972554|Vasodilator Agents|vasodilator agents|mesh-ancestor
111335311|NCT02241941|Daptomycin|daptomycin|mesh-list
111335312|NCT02241941|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111335313|NCT02241941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111335314|NCT00359151|Celecoxib|celecoxib|mesh-list
111335315|NCT00359151|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111335316|NCT00359151|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111335317|NCT00359151|Analgesics|analgesics|mesh-ancestor
111335318|NCT00359151|Sensory System Agents|sensory system agents|mesh-ancestor
111335319|NCT00359151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111335320|NCT00359151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111335321|NCT00359151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111335322|NCT00359151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111335323|NCT00359151|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111335324|NCT00359151|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111335325|NCT00359151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111335326|NCT00359151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111335327|NCT02242097|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
111335328|NCT02242097|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111335329|NCT02242097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111335330|NCT02242097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111335331|NCT00374686|Valganciclovir|valganciclovir|mesh-list
111335332|NCT00374686|Antiviral Agents|antiviral agents|mesh-ancestor
111335333|NCT00374686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111335334|NCT04371575|Carbamazepine|carbamazepine|mesh-list
111335335|NCT04371575|Oxcarbazepine|oxcarbazepine|mesh-list
111335336|NCT04371575|Anticonvulsants|anticonvulsants|mesh-ancestor
111335337|NCT04371575|Antimanic Agents|antimanic agents|mesh-ancestor
111335338|NCT04371575|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111335339|NCT04371575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111335340|NCT04371575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110813800|NCT00523042|Insulin|insulin|mesh-list
111335341|NCT04371575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111335342|NCT04371575|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111335343|NCT04371575|Analgesics|analgesics|mesh-ancestor
111335344|NCT04371575|Sensory System Agents|sensory system agents|mesh-ancestor
111335345|NCT04371575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111335346|NCT04371575|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110813870|NCT05982470|Progesterone|progesterone|mesh-list
111335347|NCT04371575|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111335348|NCT04371575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111335349|NCT04371575|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111335350|NCT04371575|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111335351|NCT04371575|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111335352|NCT00359229|Zolpidem|zolpidem|mesh-list
111335353|NCT00359229|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111335354|NCT00359229|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111335355|NCT00359229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111335356|NCT00359229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111335357|NCT00359229|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
111335358|NCT00359229|GABA Agonists|gaba agonists|mesh-ancestor
111335359|NCT00359229|GABA Agents|gaba agents|mesh-ancestor
111335360|NCT00359229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111335361|NCT00359229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111335362|NCT04371341|Bupivacaine|bupivacaine|mesh-list
111335363|NCT04371341|Anesthetics, Local|anesthetics, local|mesh-ancestor
111335364|NCT04371341|Anesthetics|anesthetics|mesh-ancestor
111335365|NCT04371341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111335366|NCT04371341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110814102|NCT05979389|Bicalutamide|bicalutamide|mesh-list
111335367|NCT04371341|Sensory System Agents|sensory system agents|mesh-ancestor
111335368|NCT04371341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111335369|NCT00374764|Risperidone|risperidone|mesh-list
111335370|NCT00374764|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111335371|NCT00374764|Serotonin Agents|serotonin agents|mesh-ancestor
111335372|NCT00374764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111335373|NCT00374764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111335374|NCT00374764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111335375|NCT00374764|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111335376|NCT00374764|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111335377|NCT00374764|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111335378|NCT00374764|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111335379|NCT00374764|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111335380|NCT00374764|Dopamine Agents|dopamine agents|mesh-ancestor
111335381|NCT04371185|Ustekinumab|ustekinumab|mesh-list
111335382|NCT04371185|Dermatologic Agents|dermatologic agents|mesh-ancestor
111335383|NCT01005355|Ramucirumab|ramucirumab|mesh-list
111335384|NCT01005355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111335385|NCT02242253|Tiotropium Bromide|tiotropium bromide|mesh-list
111335386|NCT02242253|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
111335387|NCT02242253|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111335388|NCT02242253|Autonomic Agents|autonomic agents|mesh-ancestor
111335389|NCT02242253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111335390|NCT02242253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111335391|NCT02242253|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111335392|NCT02242253|Respiratory System Agents|respiratory system agents|mesh-ancestor
111335393|NCT02242253|Parasympatholytics|parasympatholytics|mesh-ancestor
111335394|NCT02242253|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111335395|NCT02242253|Cholinergic Agents|cholinergic agents|mesh-ancestor
111335396|NCT02242253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111335397|NCT02242253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111335398|NCT02242253|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111335399|NCT02242253|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111335400|NCT02242253|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111335401|NCT02242253|Adrenergic Agents|adrenergic agents|mesh-ancestor
111335402|NCT05285943|Betamethasone|betamethasone|mesh-list
111335403|NCT05285943|Betamethasone Valerate|betamethasone valerate|mesh-list
111335404|NCT05285943|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
111335405|NCT05285943|Betamethasone benzoate|betamethasone benzoate|mesh-list
111335406|NCT05285943|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
111335407|NCT05285943|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111335408|NCT05285943|Glucocorticoids|glucocorticoids|mesh-ancestor
111335409|NCT05285943|Hormones|hormones|mesh-ancestor
110814664|NCT05116189|Growth Substances|growth substances|mesh-ancestor
111335410|NCT05285943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111335411|NCT05285943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111335412|NCT05285943|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111335413|NCT05285943|Respiratory System Agents|respiratory system agents|mesh-ancestor
111335414|NCT03030001|Antibodies|antibodies|mesh-list
110814752|NCT04941872|FAPI-46|fapi-46|mesh-list
111335415|NCT03030001|Immunologic Factors|immunologic factors|mesh-ancestor
111335416|NCT03030001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111335417|NCT02242331|Telmisartan|telmisartan|mesh-list
111335418|NCT02242331|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111335419|NCT02242331|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111335420|NCT02242331|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111335421|NCT02242331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111335422|NCT05495061|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111335423|NCT05495061|Latanoprost|latanoprost|mesh-list
111335424|NCT05495061|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111335425|NCT03030157|Pirarubicin|pirarubicin|mesh-list
111335426|NCT03030157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111335427|NCT00359385|Alendronate|alendronate|mesh-list
111335428|NCT00359385|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110814878|NCT04663347|Antiemetics|antiemetics|mesh-ancestor
111335429|NCT00359385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111335430|NCT03029455|Ivacaftor|ivacaftor|mesh-list
111335431|NCT03029455|VX-659|vx-659|mesh-list
110814938|NCT04601402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111335432|NCT03029455|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
111335433|NCT03029455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111335434|NCT03029455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111335435|NCT02245789|Remifentanil|remifentanil|mesh-list
111335436|NCT02245789|Propofol|propofol|mesh-list
111335437|NCT02245789|Anesthetics|anesthetics|mesh-ancestor
110815011|NCT04520178|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111335438|NCT02245789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111335439|NCT02245789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111335440|NCT02245789|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111335441|NCT02245789|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111335442|NCT02245789|Anesthetics, General|anesthetics, general|mesh-ancestor
111335443|NCT02245789|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111335444|NCT02245789|Narcotics|narcotics|mesh-ancestor
111335445|NCT02245789|Analgesics|analgesics|mesh-ancestor
111335446|NCT02245789|Sensory System Agents|sensory system agents|mesh-ancestor
111335447|NCT02245789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111335448|NCT04370015|Hydroxychloroquine|hydroxychloroquine|mesh-list
111335449|NCT04370015|Antimalarials|antimalarials|mesh-ancestor
111335450|NCT04370015|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111335451|NCT04370015|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111335452|NCT04370015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111335453|NCT04370015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111335454|NCT04370015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111335455|NCT04370015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111335456|NCT01006369|Hydroxychloroquine|hydroxychloroquine|mesh-list
111335457|NCT01006369|Antimalarials|antimalarials|mesh-ancestor
111335458|NCT01006369|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111335459|NCT01006369|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111335460|NCT01006369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111335461|NCT01006369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111335462|NCT01006369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111335463|NCT01006369|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111335464|NCT02242877|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
111335465|NCT02242877|Telmisartan|telmisartan|mesh-list
111335466|NCT02242877|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111335467|NCT02242877|Diuretics|diuretics|mesh-ancestor
111335468|NCT02242877|Natriuretic Agents|natriuretic agents|mesh-ancestor
111335469|NCT02242877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111335470|NCT02242877|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
111335471|NCT02242877|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111335472|NCT02242877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111335473|NCT02242877|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111335474|NCT02242877|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111335475|NCT01007071|Hormones|hormones|mesh-list
111335476|NCT01007071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111335477|NCT01007071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111335478|NCT05475639|Diclofenac|diclofenac|mesh-list
111335479|NCT05475639|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111335480|NCT05475639|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111335481|NCT05475639|Analgesics|analgesics|mesh-ancestor
111335482|NCT05475639|Sensory System Agents|sensory system agents|mesh-ancestor
111335483|NCT05475639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111335484|NCT05475639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111335485|NCT05475639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111335486|NCT05475639|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111335487|NCT05475639|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111335488|NCT05475639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111335489|NCT05475639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111335490|NCT02242955|Diazepam|diazepam|mesh-list
111335491|NCT02242955|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111335492|NCT02242955|Anticonvulsants|anticonvulsants|mesh-ancestor
111335493|NCT02242955|Antiemetics|antiemetics|mesh-ancestor
111335494|NCT02242955|Autonomic Agents|autonomic agents|mesh-ancestor
111335495|NCT02242955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111335496|NCT02242955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111335497|NCT02242955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111335498|NCT02242955|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111335499|NCT02242955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111335500|NCT02242955|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
111335501|NCT02242955|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111335502|NCT02242955|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111335503|NCT02242955|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111335504|NCT02242955|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111335505|NCT02242955|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111335506|NCT02242955|Anesthetics, General|anesthetics, general|mesh-ancestor
111335507|NCT02242955|Anesthetics|anesthetics|mesh-ancestor
111335508|NCT02242955|GABA Modulators|gaba modulators|mesh-ancestor
111335509|NCT02242955|GABA Agents|gaba agents|mesh-ancestor
111335510|NCT02242955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111335511|NCT02242955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111335512|NCT02984644|Dapagliflozin|dapagliflozin|mesh-list
111335513|NCT02984644|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111335514|NCT02984644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111335515|NCT02984644|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111335516|NCT02984644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111335517|NCT01008319|Citric Acid|citric acid|mesh-list
110815925|NCT00292396|Antibodies|antibodies|mesh-list
111335518|NCT01008319|Sodium Citrate|sodium citrate|mesh-list
111335519|NCT01008319|Clomiphene|clomiphene|mesh-list
111335520|NCT01008319|Enclomiphene|enclomiphene|mesh-list
111335521|NCT01008319|Zuclomiphene|zuclomiphene|mesh-list
111335522|NCT01008319|Anticoagulants|anticoagulants|mesh-ancestor
111335523|NCT01008319|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
111335524|NCT01008319|Chelating Agents|chelating agents|mesh-ancestor
111335525|NCT01008319|Sequestering Agents|sequestering agents|mesh-ancestor
111335526|NCT01008319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111335527|NCT01008319|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111335528|NCT01008319|Hormone Antagonists|hormone antagonists|mesh-ancestor
111335529|NCT01008319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111335530|NCT01008319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111335531|NCT01008319|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111335532|NCT01008319|Fertility Agents|fertility agents|mesh-ancestor
111335533|NCT01008319|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110816117|NCT03147248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111335534|NCT01008319|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111335535|NCT01008319|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111335536|NCT04369391|Moxifloxacin|moxifloxacin|mesh-list
111335537|NCT04369391|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111335538|NCT04369391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111335539|NCT04369391|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111335540|NCT04369391|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111335541|NCT04369391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111335542|NCT04369391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111335543|NCT04369391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111335544|NCT00358683|Certolizumab Pegol|certolizumab pegol|mesh-list
111335545|NCT00358683|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111335546|NCT00358683|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111335547|NCT00358683|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111335548|NCT00358683|Immunologic Factors|immunologic factors|mesh-ancestor
111335549|NCT00358683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111335550|NCT00358683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111335551|NCT00967369|Carboplatin|carboplatin|mesh-list
111335552|NCT00967369|Etoposide|etoposide|mesh-list
111335553|NCT00967369|Etoposide phosphate|etoposide phosphate|mesh-list
111335554|NCT00967369|Bortezomib|bortezomib|mesh-list
111335555|NCT00967369|Ifosfamide|ifosfamide|mesh-list
111335556|NCT00967369|Isophosphamide mustard|isophosphamide mustard|mesh-list
111335557|NCT00967369|Podophyllotoxin|podophyllotoxin|mesh-list
111335558|NCT00967369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111335559|NCT00967369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111335560|NCT00967369|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111335561|NCT00967369|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111335562|NCT00967369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111335563|NCT00967369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111335564|NCT00967369|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111335565|NCT00967369|Alkylating Agents|alkylating agents|mesh-ancestor
111335566|NCT00967369|Keratolytic Agents|keratolytic agents|mesh-ancestor
111335567|NCT00967369|Dermatologic Agents|dermatologic agents|mesh-ancestor
111335568|NCT00967369|Tubulin Modulators|tubulin modulators|mesh-ancestor
111335569|NCT00967369|Antimitotic Agents|antimitotic agents|mesh-ancestor
111335570|NCT00967369|Mitosis Modulators|mitosis modulators|mesh-ancestor
111335571|NCT02245295|Anesthetics|anesthetics|mesh-list
111335572|NCT02245295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111335573|NCT02245295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111335574|NCT02880514|Mometasone Furoate|mometasone furoate|mesh-list
111335575|NCT02880514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111335576|NCT02880514|Dermatologic Agents|dermatologic agents|mesh-ancestor
111335577|NCT02880514|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111335578|NCT00968071|Decitabine|decitabine|mesh-list
111059997|NCT03382925|Triamcinolone|triamcinolone|mesh-list
111335580|NCT00968071|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111335581|NCT00968071|Antimetabolites|antimetabolites|mesh-ancestor
111335582|NCT00968071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111335583|NCT00968071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111335584|NCT00968071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111335585|NCT00968071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111335586|NCT00968071|Immunotoxins|immunotoxins|mesh-ancestor
111335587|NCT00968071|Immunoconjugates|immunoconjugates|mesh-ancestor
111335588|NCT00968071|Immunologic Factors|immunologic factors|mesh-ancestor
111335589|NCT00968071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111335590|NCT00971737|Cyclophosphamide|cyclophosphamide|mesh-list
111335591|NCT00971737|Trastuzumab|trastuzumab|mesh-list
111335592|NCT00971737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111335593|NCT00971737|Immunologic Factors|immunologic factors|mesh-ancestor
111335594|NCT00971737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111335595|NCT00971737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111335596|NCT00971737|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111335597|NCT00971737|Alkylating Agents|alkylating agents|mesh-ancestor
111335598|NCT00971737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111335599|NCT00971737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111335600|NCT00971737|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111335601|NCT00971737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111335602|NCT04368377|Aspirin|aspirin|mesh-list
111335603|NCT04368377|PENTA|penta|mesh-list
111335604|NCT04368377|Tirofiban|tirofiban|mesh-list
111335605|NCT04368377|Fondaparinux|fondaparinux|mesh-list
111335606|NCT04368377|Clopidogrel|clopidogrel|mesh-list
111335607|NCT04368377|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111335608|NCT04368377|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111335609|NCT04368377|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111335610|NCT04368377|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110816733|NCT01122199|Everolimus|everolimus|mesh-list
111335611|NCT04368377|Purinergic Agents|purinergic agents|mesh-ancestor
111335612|NCT04368377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111335613|NCT04368377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111335614|NCT04368377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110816784|NCT03935815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111335615|NCT04368377|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111335616|NCT04368377|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111335617|NCT04368377|Analgesics|analgesics|mesh-ancestor
111335618|NCT04368377|Sensory System Agents|sensory system agents|mesh-ancestor
111335619|NCT04368377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110816855|NCT01116193|Antiemetics|antiemetics|mesh-ancestor
111335620|NCT04368377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111335621|NCT04368377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111335622|NCT04368377|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111335623|NCT04368377|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110816922|NCT03935347|Aldesleukin|aldesleukin|mesh-list
111335624|NCT04368377|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111335625|NCT04368377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111335626|NCT04368377|Antipyretics|antipyretics|mesh-ancestor
111335627|NCT04368377|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111335628|NCT04368377|Antithrombins|antithrombins|mesh-ancestor
111335629|NCT04368377|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111335630|NCT04368377|Protease Inhibitors|protease inhibitors|mesh-ancestor
111335631|NCT04368377|Anticoagulants|anticoagulants|mesh-ancestor
111335632|NCT04361513|Triamcinolone|triamcinolone|mesh-list
111335633|NCT04361513|Bupivacaine|bupivacaine|mesh-list
111335634|NCT04361513|Anesthetics, Local|anesthetics, local|mesh-ancestor
111335635|NCT04361513|Anesthetics|anesthetics|mesh-ancestor
111335636|NCT04361513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111335637|NCT04361513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111335638|NCT04361513|Sensory System Agents|sensory system agents|mesh-ancestor
111335639|NCT04361513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111335640|NCT04361513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111335641|NCT04361513|Glucocorticoids|glucocorticoids|mesh-ancestor
111335642|NCT04361513|Hormones|hormones|mesh-ancestor
111335643|NCT04361513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111335644|NCT05595993|Cilostazol|cilostazol|mesh-list
111335645|NCT05595993|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111335646|NCT05595993|Autonomic Agents|autonomic agents|mesh-ancestor
111335647|NCT05595993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111335648|NCT05595993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111335649|NCT05595993|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111335650|NCT05595993|Respiratory System Agents|respiratory system agents|mesh-ancestor
111335651|NCT05595993|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111335652|NCT05595993|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110817271|NCT04674020|Analgesics|analgesics|mesh-ancestor
111335653|NCT05595993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111335654|NCT05595993|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111335655|NCT05595993|Vasodilator Agents|vasodilator agents|mesh-ancestor
111335656|NCT05595993|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111335657|NCT05595993|Protective Agents|protective agents|mesh-ancestor
111335658|NCT05595993|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
111335659|NCT05595993|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111335660|NCT05595993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111335661|NCT00972205|Paclitaxel|paclitaxel|mesh-list
111335662|NCT00972205|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
111335663|NCT00972205|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111335664|NCT00972205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111335665|NCT00972205|Tubulin Modulators|tubulin modulators|mesh-ancestor
111335666|NCT00972205|Antimitotic Agents|antimitotic agents|mesh-ancestor
111335667|NCT00972205|Mitosis Modulators|mitosis modulators|mesh-ancestor
111335668|NCT00972205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111335669|NCT00972205|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111335670|NCT00928421|Polidocanol|polidocanol|mesh-list
111335671|NCT00928421|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
111335672|NCT00928421|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111335673|NCT03051256|Methadone|methadone|mesh-list
111335674|NCT03051256|D-methadone|d-methadone|mesh-list
111335675|NCT03051256|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111335676|NCT03051256|Narcotics|narcotics|mesh-ancestor
111335677|NCT03051256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111335678|NCT03051256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111335679|NCT03051256|Analgesics|analgesics|mesh-ancestor
111335680|NCT03051256|Sensory System Agents|sensory system agents|mesh-ancestor
111335681|NCT03051256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111335682|NCT03051256|Antitussive Agents|antitussive agents|mesh-ancestor
111335683|NCT03051256|Respiratory System Agents|respiratory system agents|mesh-ancestor
111335684|NCT03051256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111335685|NCT00932321|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
111335686|NCT00932321|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
111335687|NCT00932321|Ethinyl Estradiol|ethinyl estradiol|mesh-list
111335688|NCT00932321|Norethindrone|norethindrone|mesh-list
111335689|NCT00932321|Norethindrone Acetate|norethindrone acetate|mesh-list
111335690|NCT00932321|Estradiol|estradiol|mesh-list
111335691|NCT00932321|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
111335692|NCT00932321|Estrogens|estrogens|mesh-ancestor
111335693|NCT00932321|Hormones|hormones|mesh-ancestor
111335694|NCT00932321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111335695|NCT00932321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111335696|NCT00932321|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111335697|NCT00932321|Contraceptive Agents|contraceptive agents|mesh-ancestor
111335698|NCT00932321|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110817753|NCT03931135|Narcotics|narcotics|mesh-ancestor
111335699|NCT00932321|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111335700|NCT00932321|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111335701|NCT00932321|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111335702|NCT00932321|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111335703|NCT01011829|Varenicline|varenicline|mesh-list
111335704|NCT01011829|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111335705|NCT01011829|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111335706|NCT01011829|Cholinergic Agents|cholinergic agents|mesh-ancestor
111335707|NCT01011829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111335708|NCT01011829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111335709|NCT01011829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111335710|NCT00932477|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
111335711|NCT00932477|Lubricant Eye Drops|lubricant eye drops|mesh-list
111335712|NCT00932477|Glycerol|glycerol|mesh-list
111335713|NCT00932477|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
111335714|NCT00932477|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111335715|NCT00932477|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
111335716|NCT00932477|Protective Agents|protective agents|mesh-ancestor
111335717|NCT00932477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111335718|NCT00932477|Laxatives|laxatives|mesh-ancestor
111335719|NCT00932477|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111335720|NCT00972439|Contraceptive Agents|contraceptive agents|mesh-list
111335721|NCT00972439|Norinyl|norinyl|mesh-list
111335722|NCT00972439|Contraceptives, Oral|contraceptives, oral|mesh-list
111335723|NCT00972439|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111335724|NCT00972439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111335725|NCT00972439|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111335726|NCT00972439|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
111335727|NCT00972439|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111335728|NCT00972439|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111335729|NCT00358371|Floxacillin|floxacillin|mesh-list
111335730|NCT00358371|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111335731|NCT00358371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111335733|NCT02989714|Interleukin-2|interleukin-2|mesh-list
111335734|NCT02989714|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111335735|NCT02989714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111335736|NCT02989714|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110818285|NCT04933058|Antipyretics|antipyretics|mesh-ancestor
111335737|NCT02989714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111335738|NCT02989714|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111335739|NCT02989714|Analgesics|analgesics|mesh-ancestor
111335740|NCT02989714|Sensory System Agents|sensory system agents|mesh-ancestor
111335741|NCT02989714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111335742|NCT02989714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111335743|NCT04361279|Rituximab|rituximab|mesh-list
111335744|NCT04361279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111335745|NCT04361279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111335746|NCT04361279|Immunologic Factors|immunologic factors|mesh-ancestor
111335747|NCT04361279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111335748|NCT04361279|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111335749|NCT05582499|Paclitaxel|paclitaxel|mesh-list
111335750|NCT05582499|Cyclophosphamide|cyclophosphamide|mesh-list
111335751|NCT05582499|Carboplatin|carboplatin|mesh-list
111335752|NCT05582499|Trastuzumab|trastuzumab|mesh-list
111335753|NCT05582499|Letrozole|letrozole|mesh-list
111335754|NCT05582499|Epirubicin|epirubicin|mesh-list
111335755|NCT05582499|Pertuzumab|pertuzumab|mesh-list
111335756|NCT05582499|Goserelin|goserelin|mesh-list
111335757|NCT05582499|Fluzoparib|fluzoparib|mesh-list
111335758|NCT05582499|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111335759|NCT05582499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111335760|NCT05582499|Tubulin Modulators|tubulin modulators|mesh-ancestor
111335761|NCT05582499|Antimitotic Agents|antimitotic agents|mesh-ancestor
111335762|NCT05582499|Mitosis Modulators|mitosis modulators|mesh-ancestor
111335763|NCT05582499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111335764|NCT05582499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111335765|NCT05582499|Immunologic Factors|immunologic factors|mesh-ancestor
111335766|NCT05582499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111335767|NCT05582499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111335768|NCT05582499|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111335769|NCT05582499|Alkylating Agents|alkylating agents|mesh-ancestor
111335770|NCT05582499|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111335771|NCT05582499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111335772|NCT05582499|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111335773|NCT05582499|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111335774|NCT05582499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111335775|NCT05582499|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111335776|NCT05582499|Hormone Antagonists|hormone antagonists|mesh-ancestor
111335777|NCT05582499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111335778|NCT05582499|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111335779|NCT05582499|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111335780|NCT05582499|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111335781|NCT05582499|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111335782|NCT05582499|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111335783|NCT02881996|Acetaminophen|acetaminophen|mesh-list
111335784|NCT02881996|Ketorolac|ketorolac|mesh-list
111335785|NCT02881996|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111335786|NCT02881996|Analgesics|analgesics|mesh-ancestor
111335787|NCT02881996|Sensory System Agents|sensory system agents|mesh-ancestor
110818717|NCT03289351|Tazobactam|tazobactam|mesh-list
111335788|NCT02881996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111335789|NCT02881996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111335790|NCT02881996|Antipyretics|antipyretics|mesh-ancestor
111335791|NCT02881996|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111335792|NCT02881996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111335793|NCT02881996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111335794|NCT02881996|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110818763|NCT03108690|Ampicillin|ampicillin|mesh-list
111335795|NCT02881996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111335796|NCT02881996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111335797|NCT04367831|Heparin|heparin|mesh-list
111335798|NCT04367831|Calcium heparin|calcium heparin|mesh-list
111335799|NCT04367831|Enoxaparin|enoxaparin|mesh-list
111335800|NCT04367831|Enoxaparin sodium|enoxaparin sodium|mesh-list
111335801|NCT04367831|Anticoagulants|anticoagulants|mesh-ancestor
111335802|NCT04367831|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111335803|NCT04367831|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111335804|NCT04367831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111335805|NCT03051646|Aspirin|aspirin|mesh-list
111335806|NCT03051646|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111335807|NCT03051646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111335808|NCT03051646|Analgesics|analgesics|mesh-ancestor
111335809|NCT03051646|Sensory System Agents|sensory system agents|mesh-ancestor
111335810|NCT03051646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111335811|NCT03051646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111335812|NCT03051646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111335813|NCT03051646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111335814|NCT03051646|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111335815|NCT03051646|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111335816|NCT03051646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111335817|NCT03051646|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111335818|NCT03051646|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111335819|NCT03051646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111335820|NCT03051646|Antipyretics|antipyretics|mesh-ancestor
111335821|NCT04344405|Vitamin D|vitamin d|mesh-list
111335822|NCT04344405|Vitamins|vitamins|mesh-ancestor
111335823|NCT04344405|Micronutrients|micronutrients|mesh-ancestor
111335824|NCT04344405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110818956|NCT04481672|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111335825|NCT04344405|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111335826|NCT05187429|Nivolumab|nivolumab|mesh-list
111335827|NCT05187429|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111335828|NCT05187429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111335829|NCT05187429|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111335830|NCT05187429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111335831|NCT02993302|Alfacalcidol|alfacalcidol|mesh-list
111335832|NCT02993302|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
110819028|NCT02291536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111335833|NCT02993302|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111335834|NCT02993302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111335835|NCT02993302|Vitamins|vitamins|mesh-ancestor
111335836|NCT02993302|Micronutrients|micronutrients|mesh-ancestor
111335837|NCT00359853|Norfloxacin|norfloxacin|mesh-list
111335838|NCT00359853|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111335839|NCT00359853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111335840|NCT00359853|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111335841|NCT00359853|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110819175|NCT01354262|Vitamin D|vitamin d|mesh-list
111335842|NCT00359853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111335843|NCT00359853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111335844|NCT00359853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111335845|NCT00359853|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111335846|NCT00359853|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111335847|NCT05168709|Vaccines|vaccines|mesh-list
111335848|NCT05168709|Immunologic Factors|immunologic factors|mesh-ancestor
111335849|NCT05168709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111335850|NCT04367051|Spironolactone|spironolactone|mesh-list
111335851|NCT04367051|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
111335852|NCT04367051|Hormone Antagonists|hormone antagonists|mesh-ancestor
111335853|NCT04367051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111335854|NCT04367051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111335855|NCT04367051|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
111335856|NCT04367051|Diuretics|diuretics|mesh-ancestor
111335857|NCT04367051|Natriuretic Agents|natriuretic agents|mesh-ancestor
111335858|NCT03111316|Dinoprostone|dinoprostone|mesh-list
111335859|NCT03111316|Oxytocics|oxytocics|mesh-ancestor
111335860|NCT03111316|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111335861|NCT03111316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111335862|NCT03054844|Lidocaine|lidocaine|mesh-list
111335863|NCT03054844|Midazolam|midazolam|mesh-list
111335864|NCT03054844|Anesthetics, Local|anesthetics, local|mesh-ancestor
111335865|NCT03054844|Anesthetics|anesthetics|mesh-ancestor
111335866|NCT03054844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111335867|NCT03054844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111335868|NCT03054844|Sensory System Agents|sensory system agents|mesh-ancestor
110819448|NCT02294656|Glucocorticoids|glucocorticoids|mesh-ancestor
111335869|NCT03054844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111335870|NCT03054844|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111335871|NCT03054844|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111335872|NCT03054844|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111335873|NCT03054844|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110819516|NCT03517618|Leucovorin|leucovorin|mesh-list
111335874|NCT03054844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111335875|NCT03054844|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111335876|NCT03054844|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111335877|NCT03054844|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111335878|NCT03054844|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111335879|NCT03054844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111335880|NCT03054844|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111335881|NCT03054844|Anesthetics, General|anesthetics, general|mesh-ancestor
111335882|NCT03054844|GABA Modulators|gaba modulators|mesh-ancestor
111335884|NCT03054844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111335885|NCT05405595|Pembrolizumab|pembrolizumab|mesh-list
111335886|NCT05405595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111335887|NCT05405595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111335888|NCT05405595|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111335889|NCT05405595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111335890|NCT00359697|Mannitol|mannitol|mesh-list
111335891|NCT00359697|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
111335892|NCT00359697|Diuretics|diuretics|mesh-ancestor
111335893|NCT00359697|Natriuretic Agents|natriuretic agents|mesh-ancestor
110819713|NCT01132183|Valproic Acid|valproic acid|mesh-list
111335894|NCT00359697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111335895|NCT03111628|Omalizumab|omalizumab|mesh-list
111335896|NCT03111628|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111335897|NCT03111628|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111335898|NCT03111628|Respiratory System Agents|respiratory system agents|mesh-ancestor
111335899|NCT05120505|Metformin|metformin|mesh-list
111335900|NCT05120505|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111335901|NCT05120505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111335902|NCT02977533|Acyclovir|acyclovir|mesh-list
111335903|NCT02977533|Antiviral Agents|antiviral agents|mesh-ancestor
111335904|NCT02977533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111335905|NCT01012297|Bevacizumab|bevacizumab|mesh-list
111335906|NCT01012297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111335907|NCT01012297|Gemcitabine|gemcitabine|mesh-list
111335908|NCT01012297|Docetaxel|docetaxel|mesh-list
111335909|NCT01012297|Endothelial Growth Factors|endothelial growth factors|mesh-list
111335910|NCT01012297|Antibodies|antibodies|mesh-list
111335911|NCT01012297|Immunoglobulins|immunoglobulins|mesh-list
111335912|NCT01012297|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111335913|NCT01012297|Lenograstim|lenograstim|mesh-list
111335914|NCT01012297|Immunoglobulin G|immunoglobulin g|mesh-list
111335915|NCT01012297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111335916|NCT01012297|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111335917|NCT01012297|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111335918|NCT01012297|Growth Substances|growth substances|mesh-ancestor
111335919|NCT01012297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111335920|NCT01012297|Growth Inhibitors|growth inhibitors|mesh-ancestor
111335921|NCT01012297|Immunologic Factors|immunologic factors|mesh-ancestor
111335922|NCT01012297|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111335923|NCT01012297|Antimetabolites|antimetabolites|mesh-ancestor
111335924|NCT01012297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111335925|NCT01012297|Tubulin Modulators|tubulin modulators|mesh-ancestor
111335926|NCT01012297|Antimitotic Agents|antimitotic agents|mesh-ancestor
111335927|NCT01012297|Mitosis Modulators|mitosis modulators|mesh-ancestor
111335928|NCT01012297|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111335929|NCT00923117|Sunitinib|sunitinib|mesh-list
111335930|NCT00923117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111335931|NCT00923117|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111335932|NCT00923117|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111335933|NCT00923117|Growth Substances|growth substances|mesh-ancestor
111335934|NCT00923117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111335935|NCT00923117|Growth Inhibitors|growth inhibitors|mesh-ancestor
111335936|NCT00923117|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111335937|NCT00923117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110820113|NCT02302456|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111335938|NCT00923117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111335939|NCT03054922|Plasma-lyte 148|plasma-lyte 148|mesh-list
111335940|NCT03054922|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
111335941|NCT03054922|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111335942|NCT02977611|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
111335943|NCT02977611|Hematinics|hematinics|mesh-ancestor
111335944|NCT04360655|Antibodies|antibodies|mesh-list
111335945|NCT04360655|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111335946|NCT04360655|Immunologic Factors|immunologic factors|mesh-ancestor
111335947|NCT04360655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111335948|NCT00375232|Montelukast|montelukast|mesh-list
111335949|NCT00375232|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111335950|NCT00375232|Respiratory System Agents|respiratory system agents|mesh-ancestor
110820263|NCT02302768|Protective Agents|protective agents|mesh-ancestor
111335951|NCT00375232|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
111335952|NCT00375232|Hormone Antagonists|hormone antagonists|mesh-ancestor
111335953|NCT00375232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111335954|NCT00375232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111335955|NCT00375232|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
111335956|NCT00375232|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111335957|NCT00375232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111335958|NCT00975637|Brodalumab|brodalumab|mesh-list
111335959|NCT00975637|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111335960|NCT00975637|Dermatologic Agents|dermatologic agents|mesh-ancestor
111335961|NCT00975637|Immunologic Factors|immunologic factors|mesh-ancestor
111335962|NCT00975637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111335963|NCT02244437|Acetaminophen|acetaminophen|mesh-list
111335964|NCT02244437|Ibuprofen|ibuprofen|mesh-list
111335965|NCT02244437|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111335966|NCT02244437|Analgesics|analgesics|mesh-ancestor
111335967|NCT02244437|Sensory System Agents|sensory system agents|mesh-ancestor
111335968|NCT02244437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111335969|NCT02244437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111335970|NCT02244437|Antipyretics|antipyretics|mesh-ancestor
111335971|NCT02244437|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111335972|NCT02244437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111335973|NCT02244437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111335974|NCT02244437|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111335975|NCT02244437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111335976|NCT02244437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111335977|NCT03023527|Dexamethasone|dexamethasone|mesh-list
111335978|NCT03023527|Nivolumab|nivolumab|mesh-list
111335979|NCT03023527|Pomalidomide|pomalidomide|mesh-list
111335980|NCT03023527|Elotuzumab|elotuzumab|mesh-list
111335981|NCT03023527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111335982|NCT03023527|Antiemetics|antiemetics|mesh-ancestor
111335983|NCT03023527|Autonomic Agents|autonomic agents|mesh-ancestor
111335984|NCT03023527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111335985|NCT03023527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111335986|NCT03023527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111335987|NCT03023527|Glucocorticoids|glucocorticoids|mesh-ancestor
111335988|NCT03023527|Hormones|hormones|mesh-ancestor
111335989|NCT03023527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111335990|NCT03023527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111335991|NCT03023527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111335992|NCT03023527|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111335993|NCT03023527|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111335994|NCT03023527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111335995|NCT03023527|Immunologic Factors|immunologic factors|mesh-ancestor
111335996|NCT03023527|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111335997|NCT03023527|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111335998|NCT03023527|Growth Substances|growth substances|mesh-ancestor
111335999|NCT03023527|Growth Inhibitors|growth inhibitors|mesh-ancestor
111336000|NCT04878627|Cannabidiol|cannabidiol|mesh-list
111336001|NCT04878627|Anticonvulsants|anticonvulsants|mesh-ancestor
111336002|NCT02244515|Dexmedetomidine|dexmedetomidine|mesh-list
111336003|NCT02244515|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111336004|NCT02244515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111336005|NCT02244515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111336006|NCT02244515|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111336007|NCT02244515|Analgesics|analgesics|mesh-ancestor
111336008|NCT02244515|Sensory System Agents|sensory system agents|mesh-ancestor
111336009|NCT02244515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111336010|NCT02244515|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110820389|NCT03918265|Immunologic Factors|immunologic factors|mesh-ancestor
111336011|NCT02244515|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111336012|NCT02244515|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111336013|NCT02244515|Adrenergic Agents|adrenergic agents|mesh-ancestor
111336014|NCT02244515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111336015|NCT02244515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111336016|NCT04360031|Mycophenolic Acid|mycophenolic acid|mesh-list
111336017|NCT04360031|Tacrolimus|tacrolimus|mesh-list
111336018|NCT04360031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111336019|NCT04360031|Immunologic Factors|immunologic factors|mesh-ancestor
111336020|NCT04360031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111336021|NCT04360031|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111336022|NCT04360031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111336023|NCT04360031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111336024|NCT04360031|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111336025|NCT04360031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111336026|NCT04360031|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111336027|NCT04360031|Antitubercular Agents|antitubercular agents|mesh-ancestor
111336028|NCT04360031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111336029|NCT04360031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111336030|NCT04366739|Chlorpromazine|chlorpromazine|mesh-list
111336031|NCT04366739|Antiemetics|antiemetics|mesh-ancestor
111336032|NCT04366739|Autonomic Agents|autonomic agents|mesh-ancestor
111336033|NCT04366739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111336034|NCT04366739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111336035|NCT04366739|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111336036|NCT04366739|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111336037|NCT04366739|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111336038|NCT04366739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111336039|NCT04366739|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111336040|NCT04366739|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111336041|NCT04366739|Dopamine Agents|dopamine agents|mesh-ancestor
111336042|NCT04366739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111336043|NCT04366739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111336045|NCT03023059|Carbidopa|carbidopa|mesh-list
111336046|NCT03023059|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
111336047|NCT03023059|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111336048|NCT03023059|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111336049|NCT03023059|Dopamine Agents|dopamine agents|mesh-ancestor
111336050|NCT03023059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110820473|NCT01131949|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111336051|NCT03023059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111336052|NCT03023059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111336053|NCT03023059|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
111336054|NCT03023059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111336055|NCT03023059|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111336056|NCT03023059|Immunologic Factors|immunologic factors|mesh-ancestor
111336057|NCT03023059|Dopamine Agonists|dopamine agonists|mesh-ancestor
111336058|NCT02244827|Levonadifloxacin|levonadifloxacin|mesh-list
111336059|NCT02244827|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
111336060|NCT02244827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111336061|NCT02244827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111336062|NCT02244827|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111336063|NCT02244827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111336064|NCT04359485|Glycolic acid|glycolic acid|mesh-list
111336065|NCT04359485|Keratolytic Agents|keratolytic agents|mesh-ancestor
111336066|NCT04359485|Dermatologic Agents|dermatologic agents|mesh-ancestor
111336067|NCT02976987|Cidofovir|cidofovir|mesh-list
111336068|NCT02976987|Antiviral Agents|antiviral agents|mesh-ancestor
111336069|NCT02976987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111336070|NCT02976987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111336071|NCT02976987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111336072|NCT02244281|Tamsulosin|tamsulosin|mesh-list
111336073|NCT02244281|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111336074|NCT02244281|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111336075|NCT02244281|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111336076|NCT02244281|Adrenergic Agents|adrenergic agents|mesh-ancestor
111336077|NCT02244281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111336078|NCT02244281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111336079|NCT02244281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111336080|NCT02244281|Urological Agents|urological agents|mesh-ancestor
111336081|NCT00361413|Alefacept|alefacept|mesh-list
111336082|NCT00361413|Dermatologic Agents|dermatologic agents|mesh-ancestor
111336083|NCT00361413|Immunologic Factors|immunologic factors|mesh-ancestor
111336084|NCT00361413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111336085|NCT03062488|Acetaminophen|acetaminophen|mesh-list
111336086|NCT03062488|Fentanyl|fentanyl|mesh-list
111336087|NCT03062488|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111336088|NCT03062488|Narcotics|narcotics|mesh-ancestor
111336089|NCT03062488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111336090|NCT03062488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111336091|NCT03062488|Analgesics|analgesics|mesh-ancestor
111336092|NCT03062488|Sensory System Agents|sensory system agents|mesh-ancestor
111336093|NCT03062488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111336094|NCT03062488|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111336095|NCT03062488|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111336096|NCT03062488|Anesthetics, General|anesthetics, general|mesh-ancestor
111336097|NCT03062488|Anesthetics|anesthetics|mesh-ancestor
111336098|NCT03062488|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111336099|NCT03062488|Antipyretics|antipyretics|mesh-ancestor
111336100|NCT00936299|Bupropion|bupropion|mesh-list
111336101|NCT00936299|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111336102|NCT00936299|Antidepressive Agents|antidepressive agents|mesh-ancestor
111336103|NCT00936299|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111336104|NCT00936299|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111336105|NCT00936299|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111336106|NCT00936299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111336107|NCT00936299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111336108|NCT00936299|Dopamine Agents|dopamine agents|mesh-ancestor
111336109|NCT00936299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111336110|NCT00936299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111336111|NCT00936299|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111336112|NCT00936299|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111336113|NCT00936299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111336114|NCT04375943|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
111336115|NCT04375943|Hypoglycemic Agents|hypoglycemic agents|mesh-list
111336116|NCT04375943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111336117|NCT04375943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111336118|NCT03117634|Aflibercept|aflibercept|mesh-list
111336119|NCT03117634|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111336120|NCT03117634|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111336121|NCT03117634|Growth Substances|growth substances|mesh-ancestor
111336122|NCT03117634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111336123|NCT03117634|Growth Inhibitors|growth inhibitors|mesh-ancestor
111336124|NCT03117634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111336125|NCT00937235|Varenicline|varenicline|mesh-list
111336126|NCT00937235|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111336127|NCT00937235|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111336128|NCT00937235|Cholinergic Agents|cholinergic agents|mesh-ancestor
110820801|NCT01233505|Veliparib|veliparib|mesh-list
111336129|NCT00937235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111336130|NCT00937235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111336131|NCT00937235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111336132|NCT01014403|Enoxaparin|enoxaparin|mesh-list
111336133|NCT01014403|Anticoagulants|anticoagulants|mesh-ancestor
111336134|NCT01014403|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111336135|NCT01014403|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111336136|NCT01014403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111336137|NCT05405608|Ondansetron|ondansetron|mesh-list
111336138|NCT05405608|Antiemetics|antiemetics|mesh-ancestor
111336139|NCT05405608|Autonomic Agents|autonomic agents|mesh-ancestor
111336140|NCT05405608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111336141|NCT05405608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111336142|NCT05405608|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111336143|NCT05405608|Antipruritics|antipruritics|mesh-ancestor
111336144|NCT05405608|Dermatologic Agents|dermatologic agents|mesh-ancestor
111336145|NCT05405608|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111336146|NCT05405608|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111336147|NCT05405608|Serotonin Agents|serotonin agents|mesh-ancestor
111336148|NCT05405608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111336149|NCT05405608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111336150|NCT01014871|Botulinum Toxins|botulinum toxins|mesh-list
111336151|NCT01014871|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111336152|NCT01014871|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111336153|NCT01014871|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111336154|NCT01014871|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111336155|NCT01014871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110820893|NCT02304094|Glucocorticoids|glucocorticoids|mesh-ancestor
111336156|NCT01014871|Cholinergic Agents|cholinergic agents|mesh-ancestor
111336157|NCT01014871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111336158|NCT01014871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111336159|NCT01014871|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111336160|NCT01014871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111336161|NCT00375466|Tranexamic Acid|tranexamic acid|mesh-list
111336162|NCT00375466|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111336163|NCT00375466|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111336164|NCT00375466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111336165|NCT00375466|Hemostatics|hemostatics|mesh-ancestor
111336166|NCT00375466|Coagulants|coagulants|mesh-ancestor
111336167|NCT00976183|Vorinostat|vorinostat|mesh-list
111336168|NCT00976183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111336169|NCT00976183|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111336170|NCT00976183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111336171|NCT00976183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111336172|NCT04357535|Angiotensin II|angiotensin ii|mesh-list
111336173|NCT04357535|Giapreza|giapreza|mesh-list
111336174|NCT04357535|Enzyme Inhibitors|enzyme inhibitors|mesh-list
111336175|NCT04357535|Angiotensinogen|angiotensinogen|mesh-list
111336176|NCT04357535|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
111336177|NCT04357535|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
110821016|NCT01136863|Vasodilator Agents|vasodilator agents|mesh-ancestor
111336178|NCT04357535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111060593|NCT00734435|Antiemetics|antiemetics|mesh-ancestor
111336179|NCT04357535|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111336180|NCT04357535|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111336181|NCT04357535|Protease Inhibitors|protease inhibitors|mesh-ancestor
111336182|NCT01015807|Clonidine|clonidine|mesh-list
111336183|NCT01015807|Bupivacaine|bupivacaine|mesh-list
111336184|NCT01015807|Anesthetics, Local|anesthetics, local|mesh-ancestor
111336185|NCT01015807|Anesthetics|anesthetics|mesh-ancestor
111336186|NCT01015807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111336187|NCT01015807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111336188|NCT01015807|Sensory System Agents|sensory system agents|mesh-ancestor
111336189|NCT01015807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111336190|NCT01015807|Analgesics|analgesics|mesh-ancestor
111336191|NCT01015807|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111336192|NCT01015807|Sympatholytics|sympatholytics|mesh-ancestor
111336193|NCT01015807|Autonomic Agents|autonomic agents|mesh-ancestor
111336194|NCT01015807|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111336195|NCT01015807|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111336196|NCT01015807|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111336197|NCT01015807|Adrenergic Agents|adrenergic agents|mesh-ancestor
111336198|NCT01015807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111336199|NCT01015807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111336200|NCT01575925|Thalidomide|thalidomide|mesh-list
111336201|NCT01575925|Dexamethasone|dexamethasone|mesh-list
111336202|NCT01575925|Dexamethasone acetate|dexamethasone acetate|mesh-list
111336203|NCT01575925|Pomalidomide|pomalidomide|mesh-list
111336204|NCT01575925|BB 1101|bb 1101|mesh-list
111336205|NCT01575925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111336206|NCT01575925|Antiemetics|antiemetics|mesh-ancestor
111336207|NCT01575925|Autonomic Agents|autonomic agents|mesh-ancestor
111336208|NCT01575925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111336209|NCT01575925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111336210|NCT01575925|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111336211|NCT01575925|Glucocorticoids|glucocorticoids|mesh-ancestor
111336212|NCT01575925|Hormones|hormones|mesh-ancestor
111336213|NCT01575925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111336214|NCT01575925|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111336215|NCT01575925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111336216|NCT01575925|Protease Inhibitors|protease inhibitors|mesh-ancestor
111336217|NCT01575925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111336218|NCT01575925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111336219|NCT01575925|Immunologic Factors|immunologic factors|mesh-ancestor
111336220|NCT01575925|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111336221|NCT01575925|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111336222|NCT01575925|Growth Substances|growth substances|mesh-ancestor
111336223|NCT01575925|Growth Inhibitors|growth inhibitors|mesh-ancestor
110821136|NCT01231165|Antipyretics|antipyretics|mesh-ancestor
111336224|NCT01575925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111336225|NCT01575925|Leprostatic Agents|leprostatic agents|mesh-ancestor
111336226|NCT01575925|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111336227|NCT01575925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111336228|NCT00936377|Dexmedetomidine|dexmedetomidine|mesh-list
111336229|NCT00936377|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111336230|NCT00936377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111336231|NCT00936377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111336232|NCT00936377|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111336233|NCT00936377|Analgesics|analgesics|mesh-ancestor
111336234|NCT00936377|Sensory System Agents|sensory system agents|mesh-ancestor
111336235|NCT00936377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111336236|NCT00936377|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111336237|NCT00936377|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111336238|NCT00936377|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111336239|NCT00936377|Adrenergic Agents|adrenergic agents|mesh-ancestor
111336240|NCT00936377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110821179|NCT05221645|Alkylating Agents|alkylating agents|mesh-ancestor
111336241|NCT00936377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111336242|NCT04471233|Pregabalin|pregabalin|mesh-list
111336243|NCT04471233|Analgesics|analgesics|mesh-ancestor
111336244|NCT04471233|Sensory System Agents|sensory system agents|mesh-ancestor
111336245|NCT04471233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111336246|NCT04471233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111336247|NCT04471233|Anticonvulsants|anticonvulsants|mesh-ancestor
111336248|NCT04471233|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111336249|NCT04471233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111336250|NCT04471233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111336251|NCT04471233|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111336252|NCT04471233|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111336253|NCT04471233|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111336254|NCT04471233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111336255|NCT04471233|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111336256|NCT04359095|Tenofovir|tenofovir|mesh-list
111336257|NCT04359095|Emtricitabine|emtricitabine|mesh-list
111336258|NCT04359095|Colchicine|colchicine|mesh-list
111336259|NCT04359095|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111336260|NCT04359095|Antiviral Agents|antiviral agents|mesh-ancestor
111336261|NCT04359095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111336262|NCT04359095|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111336263|NCT04359095|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111336264|NCT04359095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111336265|NCT04359095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111336266|NCT04359095|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111336267|NCT04359095|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111336268|NCT04359095|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111336269|NCT04359095|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111336270|NCT04359095|Antimetabolites|antimetabolites|mesh-ancestor
111336271|NCT04359095|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111336272|NCT04359095|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111336273|NCT04359095|Gout Suppressants|gout suppressants|mesh-ancestor
111336274|NCT04359095|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111336275|NCT04359095|Tubulin Modulators|tubulin modulators|mesh-ancestor
111336276|NCT04359095|Antimitotic Agents|antimitotic agents|mesh-ancestor
111336277|NCT04359095|Mitosis Modulators|mitosis modulators|mesh-ancestor
111336278|NCT04359095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111336279|NCT02163421|Vedolizumab|vedolizumab|mesh-list
111336280|NCT02163421|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111336281|NCT02982395|Ethanol|ethanol|mesh-list
111336282|NCT02982395|Docetaxel|docetaxel|mesh-list
111336283|NCT02982395|Mitomycins|mitomycins|mesh-list
111336284|NCT02982395|Mitomycin|mitomycin|mesh-list
111336285|NCT02982395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111336286|NCT02982395|Tubulin Modulators|tubulin modulators|mesh-ancestor
111336287|NCT02982395|Antimitotic Agents|antimitotic agents|mesh-ancestor
111336288|NCT02982395|Mitosis Modulators|mitosis modulators|mesh-ancestor
111336289|NCT02982395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111336290|NCT02982395|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111336291|NCT02982395|Alkylating Agents|alkylating agents|mesh-ancestor
111336292|NCT02982395|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111336293|NCT02982395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111336294|NCT02982395|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111336295|NCT02982395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111336296|NCT02982395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111336297|NCT02982395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111336298|NCT02982005|Brodalumab|brodalumab|mesh-list
111336299|NCT02982005|Dermatologic Agents|dermatologic agents|mesh-ancestor
111336300|NCT04736836|Rifaximin|rifaximin|mesh-list
111336301|NCT04736836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111336302|NCT04736836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111336303|NCT04736836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111336304|NCT03126370|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
111336305|NCT03126370|Emtricitabine|emtricitabine|mesh-list
111336306|NCT03126370|Tenofovir|tenofovir|mesh-list
111336307|NCT03126370|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
111336308|NCT03126370|Protease Inhibitors|protease inhibitors|mesh-list
110821402|NCT02313922|Dermatologic Agents|dermatologic agents|mesh-ancestor
111336309|NCT03126370|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111336310|NCT03126370|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111336311|NCT03126370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111336312|NCT03126370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111336313|NCT03126370|Antiviral Agents|antiviral agents|mesh-ancestor
111336314|NCT03126370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111336315|NCT03126370|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111336316|NCT03126370|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111336317|NCT03126370|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111336318|NCT04467801|Ipatasertib|ipatasertib|mesh-list
111336319|NCT04467801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111336320|NCT04467801|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111336321|NCT04467801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111336322|NCT04467801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111336323|NCT01019707|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
111336324|NCT01019707|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111336325|NCT01019707|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111336326|NCT01019707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111336327|NCT01019707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111336328|NCT01019707|Adrenergic Agents|adrenergic agents|mesh-ancestor
111336329|NCT01019707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111336331|NCT00979615|Azelastine|azelastine|mesh-list
111336332|NCT00979615|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
111336333|NCT00979615|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111336334|NCT00979615|Autonomic Agents|autonomic agents|mesh-ancestor
111336335|NCT00979615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110821531|NCT01141153|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111336336|NCT00979615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111336337|NCT00979615|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111336338|NCT00979615|Respiratory System Agents|respiratory system agents|mesh-ancestor
111336339|NCT00979615|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
111336340|NCT00979615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111336341|NCT00979615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111336342|NCT00979615|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111336343|NCT00979615|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
111336344|NCT00979615|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111336345|NCT00979615|Histamine Antagonists|histamine antagonists|mesh-ancestor
111336346|NCT00979615|Histamine Agents|histamine agents|mesh-ancestor
111336347|NCT00979615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111336348|NCT00979615|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111336349|NCT00979615|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111336350|NCT00979615|Analgesics|analgesics|mesh-ancestor
111336351|NCT00979615|Sensory System Agents|sensory system agents|mesh-ancestor
111336352|NCT00979615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111336353|NCT00979615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111336354|NCT03126682|Bupropion|bupropion|mesh-list
111336355|NCT03126682|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111336356|NCT03126682|Antidepressive Agents|antidepressive agents|mesh-ancestor
111336357|NCT03126682|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111336358|NCT03126682|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111336359|NCT03126682|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111336360|NCT03126682|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111336361|NCT03126682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111336362|NCT03126682|Dopamine Agents|dopamine agents|mesh-ancestor
111336363|NCT03126682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111336364|NCT03126682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111336365|NCT03126682|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111336366|NCT03126682|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111336367|NCT03126682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111336368|NCT05236738|Atazanavir Sulfate|atazanavir sulfate|mesh-list
111336369|NCT05236738|Cobicistat|cobicistat|mesh-list
111336370|NCT05236738|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111336371|NCT05236738|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111336372|NCT05236738|Protease Inhibitors|protease inhibitors|mesh-ancestor
111336373|NCT05236738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111336374|NCT05236738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111336375|NCT05236738|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111336376|NCT05236738|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111336377|NCT05236738|Antiviral Agents|antiviral agents|mesh-ancestor
111336378|NCT05236738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111336379|NCT05236738|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111336380|NCT05236738|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111336381|NCT00980395|Rituximab|rituximab|mesh-list
111336382|NCT00980395|Bortezomib|bortezomib|mesh-list
111336383|NCT00980395|Cladribine|cladribine|mesh-list
111336384|NCT00980395|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111336385|NCT00980395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111336386|NCT00980395|Immunologic Factors|immunologic factors|mesh-ancestor
111336387|NCT00980395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111336388|NCT00980395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111336389|NCT00980395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111336390|NCT02976597|Morphine|morphine|mesh-list
111336391|NCT02976597|Bupivacaine|bupivacaine|mesh-list
111336392|NCT02976597|Anesthetics, Local|anesthetics, local|mesh-ancestor
111336393|NCT02976597|Anesthetics|anesthetics|mesh-ancestor
111336394|NCT02976597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111336395|NCT02976597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111336396|NCT02976597|Sensory System Agents|sensory system agents|mesh-ancestor
111336397|NCT02976597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111336398|NCT02976597|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111336399|NCT02976597|Narcotics|narcotics|mesh-ancestor
111336400|NCT02976597|Analgesics|analgesics|mesh-ancestor
111336401|NCT03020329|Paclitaxel|paclitaxel|mesh-list
111336402|NCT03020329|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111336403|NCT03020329|Cisplatin|cisplatin|mesh-list
111336404|NCT03020329|Fluorouracil|fluorouracil|mesh-list
111336405|NCT03020329|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111336407|NCT03020329|Tubulin Modulators|tubulin modulators|mesh-ancestor
111336408|NCT03020329|Antimitotic Agents|antimitotic agents|mesh-ancestor
111336409|NCT03020329|Mitosis Modulators|mitosis modulators|mesh-ancestor
111336410|NCT03020329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111336411|NCT03020329|Antimetabolites|antimetabolites|mesh-ancestor
111336412|NCT03020329|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111336413|NCT03020329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111336414|NCT03020329|Immunologic Factors|immunologic factors|mesh-ancestor
111336415|NCT03020329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111336416|NCT04791579|Ciprofloxacin|ciprofloxacin|mesh-list
111336417|NCT04791579|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111336418|NCT04791579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111336419|NCT04791579|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111336420|NCT04791579|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111336421|NCT04791579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111336422|NCT04791579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111336423|NCT04791579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111336424|NCT04791579|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111336425|NCT04791579|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111336426|NCT00980785|Ramipril|ramipril|mesh-list
111336427|NCT00980785|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
111336428|NCT00980785|Protease Inhibitors|protease inhibitors|mesh-ancestor
111336429|NCT00980785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111336430|NCT00980785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111336431|NCT00980785|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111336432|NCT04772547|Vigabatrin|vigabatrin|mesh-list
111336433|NCT04772547|Anticonvulsants|anticonvulsants|mesh-ancestor
111336434|NCT04772547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111336435|NCT04772547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111336436|NCT04772547|GABA Agents|gaba agents|mesh-ancestor
111336437|NCT04772547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111336438|NCT04772547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111336439|NCT05028153|Azithromycin|azithromycin|mesh-list
111336440|NCT05028153|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111336441|NCT05028153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111336442|NCT03126760|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
111336443|NCT03126760|Hormones|hormones|mesh-ancestor
111336444|NCT03126760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111336445|NCT03126760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111336446|NCT05026905|Leucovorin|leucovorin|mesh-list
111336447|NCT05026905|Paclitaxel|paclitaxel|mesh-list
111336448|NCT05026905|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111336449|NCT05026905|Gemcitabine|gemcitabine|mesh-list
111336450|NCT05026905|Oxaliplatin|oxaliplatin|mesh-list
111336451|NCT05026905|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111336452|NCT05026905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111336453|NCT05026905|Tubulin Modulators|tubulin modulators|mesh-ancestor
111336454|NCT05026905|Antimitotic Agents|antimitotic agents|mesh-ancestor
111336455|NCT05026905|Mitosis Modulators|mitosis modulators|mesh-ancestor
111336456|NCT05026905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111336457|NCT05026905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111336458|NCT05026905|Antimetabolites|antimetabolites|mesh-ancestor
111336459|NCT05026905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111336460|NCT05026905|Antidotes|antidotes|mesh-ancestor
111336461|NCT05026905|Protective Agents|protective agents|mesh-ancestor
111336462|NCT05026905|Vitamin B Complex|vitamin b complex|mesh-ancestor
111336463|NCT05026905|Vitamins|vitamins|mesh-ancestor
111336464|NCT05026905|Micronutrients|micronutrients|mesh-ancestor
111336465|NCT00982189|Lisinopril|lisinopril|mesh-list
111336466|NCT00982189|Pravastatin|pravastatin|mesh-list
111336467|NCT00982189|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111336468|NCT00982189|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111336469|NCT00982189|Antimetabolites|antimetabolites|mesh-ancestor
111336470|NCT00982189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111336471|NCT00982189|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111336472|NCT00982189|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111336473|NCT00982189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111336474|NCT00982189|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
111336475|NCT00982189|Protease Inhibitors|protease inhibitors|mesh-ancestor
111336476|NCT00982189|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111336477|NCT00982189|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111336478|NCT00982189|Protective Agents|protective agents|mesh-ancestor
111336479|NCT00982189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111336480|NCT05017545|Abatacept|abatacept|mesh-list
111336481|NCT05017545|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111336482|NCT05017545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111336483|NCT05017545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111336484|NCT05017545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111336485|NCT05017545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111336486|NCT05017545|Immunologic Factors|immunologic factors|mesh-ancestor
111336487|NCT05017545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111336488|NCT05017545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111336489|NCT03128008|Paclitaxel|paclitaxel|mesh-list
111336490|NCT03128008|Carboplatin|carboplatin|mesh-list
111336491|NCT03128008|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111336492|NCT03128008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111336493|NCT03128008|Tubulin Modulators|tubulin modulators|mesh-ancestor
111336494|NCT03128008|Antimitotic Agents|antimitotic agents|mesh-ancestor
111336495|NCT03128008|Mitosis Modulators|mitosis modulators|mesh-ancestor
111336496|NCT03128008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111336497|NCT05017311|Escitalopram|escitalopram|mesh-list
111336498|NCT05017311|Brexpiprazole|brexpiprazole|mesh-list
111336499|NCT05017311|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111336500|NCT05017311|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111336501|NCT05017311|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111336502|NCT05017311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111336503|NCT05017311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111336504|NCT05017311|Serotonin Agents|serotonin agents|mesh-ancestor
111336505|NCT05017311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111336506|NCT05017311|Dopamine Agonists|dopamine agonists|mesh-ancestor
111336507|NCT05017311|Dopamine Agents|dopamine agents|mesh-ancestor
111336508|NCT00360087|Bosentan|bosentan|mesh-list
111336509|NCT00360087|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111336510|NCT00360087|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
111336511|NCT00360087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111336512|NCT00982423|Furosemide|furosemide|mesh-list
111336513|NCT00982423|Diuretics|diuretics|mesh-ancestor
111336514|NCT00982423|Natriuretic Agents|natriuretic agents|mesh-ancestor
111336515|NCT00982423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111336516|NCT00982423|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
111336517|NCT00982423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111336518|NCT00982423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111336519|NCT04719819|Anesthetics|anesthetics|mesh-list
111336520|NCT04719819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111336521|NCT04719819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111336522|NCT02981719|Gemcitabine|gemcitabine|mesh-list
111336523|NCT02981719|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111336524|NCT02981719|Antimetabolites|antimetabolites|mesh-ancestor
111336525|NCT02981719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111336526|NCT02981719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111336527|NCT03073876|Donepezil|donepezil|mesh-list
111336528|NCT03073876|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111336529|NCT03073876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111336530|NCT03073876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111336531|NCT03073876|Cholinergic Agents|cholinergic agents|mesh-ancestor
111336532|NCT03073876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111336533|NCT03073876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111336534|NCT03073876|Nootropic Agents|nootropic agents|mesh-ancestor
111336535|NCT04718961|Volixibat|volixibat|mesh-list
111336536|NCT04718961|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111336537|NCT03130738|Miconazole|miconazole|mesh-list
111336538|NCT03130738|Clotrimazole|clotrimazole|mesh-list
111336539|NCT03130738|Antifungal Agents|antifungal agents|mesh-ancestor
111336540|NCT03130738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111336541|NCT03130738|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111336542|NCT03130738|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111336543|NCT03130738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111336544|NCT03130738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111336545|NCT03130738|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111336546|NCT03130738|Hormone Antagonists|hormone antagonists|mesh-ancestor
111336547|NCT03130738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111336548|NCT03130738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111336549|NCT03130738|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110822212|NCT01236859|Gabapentin|gabapentin|mesh-list
111336550|NCT03130738|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111336551|NCT03130738|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111336552|NCT00984139|Vaccines|vaccines|mesh-list
111336553|NCT00984139|Immunologic Factors|immunologic factors|mesh-ancestor
111336554|NCT00984139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111336555|NCT04672395|Vaccines|vaccines|mesh-list
111336556|NCT04672395|1018 oligonucleotide|1018 oligonucleotide|mesh-list
111336557|NCT04672395|Immunologic Factors|immunologic factors|mesh-ancestor
111336558|NCT04672395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111336559|NCT04672395|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111336560|NCT00985543|Ritonavir|ritonavir|mesh-list
111336561|NCT00985543|Lopinavir|lopinavir|mesh-list
111336562|NCT00985543|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111336563|NCT00985543|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111336564|NCT00985543|Protease Inhibitors|protease inhibitors|mesh-ancestor
111336565|NCT00985543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111336566|NCT00985543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111336567|NCT00985543|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110822274|NCT04722952|Antimetabolites|antimetabolites|mesh-ancestor
111336568|NCT00985543|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111336569|NCT00985543|Antiviral Agents|antiviral agents|mesh-ancestor
111336570|NCT00985543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111336571|NCT00985543|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111336572|NCT00985543|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111336573|NCT05394415|Paclitaxel|paclitaxel|mesh-list
111336574|NCT05394415|Carboplatin|carboplatin|mesh-list
111336575|NCT05394415|Tislelizumab|tislelizumab|mesh-list
111336576|NCT05394415|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111336577|NCT05394415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111336578|NCT05394415|Tubulin Modulators|tubulin modulators|mesh-ancestor
111336579|NCT05394415|Antimitotic Agents|antimitotic agents|mesh-ancestor
111336580|NCT05394415|Mitosis Modulators|mitosis modulators|mesh-ancestor
111336581|NCT05394415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111336582|NCT05394415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111336583|NCT04352959|Betadex|betadex|mesh-list
111336584|NCT04352959|Sequestering Agents|sequestering agents|mesh-ancestor
111336585|NCT04352959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111336586|NCT00360945|Temozolomide|temozolomide|mesh-list
111336587|NCT00360945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111336588|NCT00360945|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111336589|NCT00360945|Alkylating Agents|alkylating agents|mesh-ancestor
111336590|NCT00360945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111336591|NCT03019237|Omalizumab|omalizumab|mesh-list
111336592|NCT03019237|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111336593|NCT03019237|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111336594|NCT03019237|Respiratory System Agents|respiratory system agents|mesh-ancestor
111336595|NCT00361023|Losartan|losartan|mesh-list
111336596|NCT00361023|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111336597|NCT00361023|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111336598|NCT00361023|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111336599|NCT00361023|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111336600|NCT00361023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111336601|NCT03019081|Isoproterenol|isoproterenol|mesh-list
111336602|NCT03019081|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111336603|NCT03019081|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111336604|NCT03019081|Adrenergic Agents|adrenergic agents|mesh-ancestor
111336605|NCT03019081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111336606|NCT03019081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111336607|NCT03019081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111336608|NCT03019081|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111336609|NCT03019081|Autonomic Agents|autonomic agents|mesh-ancestor
111336610|NCT03019081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111336611|NCT03019081|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111336612|NCT03019081|Respiratory System Agents|respiratory system agents|mesh-ancestor
111336613|NCT03019081|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111336614|NCT03019081|Sympathomimetics|sympathomimetics|mesh-ancestor
111336615|NCT03019081|Protective Agents|protective agents|mesh-ancestor
111336616|NCT00986401|Metformin|metformin|mesh-list
111336617|NCT00986401|Trospium chloride|trospium chloride|mesh-list
111336618|NCT00986401|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111336619|NCT00986401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111336620|NCT00986401|Parasympatholytics|parasympatholytics|mesh-ancestor
111336621|NCT00986401|Autonomic Agents|autonomic agents|mesh-ancestor
111336622|NCT00986401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111336623|NCT00986401|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111336624|NCT00986401|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111336625|NCT00986401|Cholinergic Agents|cholinergic agents|mesh-ancestor
111336626|NCT00986401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111336627|NCT00986401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111336628|NCT00986401|Urological Agents|urological agents|mesh-ancestor
111336629|NCT00375076|Enoxaparin|enoxaparin|mesh-list
111336630|NCT00375076|Anticoagulants|anticoagulants|mesh-ancestor
111336631|NCT00375076|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111336632|NCT00375076|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111336633|NCT00375076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111336634|NCT00987415|Allopurinol|allopurinol|mesh-list
111336635|NCT00987415|Antimetabolites|antimetabolites|mesh-ancestor
111336636|NCT00987415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111336637|NCT00987415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111336638|NCT00987415|Gout Suppressants|gout suppressants|mesh-ancestor
111336639|NCT00987415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111336640|NCT00987415|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111336641|NCT00987415|Antioxidants|antioxidants|mesh-ancestor
111336642|NCT00987415|Protective Agents|protective agents|mesh-ancestor
111336643|NCT00987415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111336644|NCT04807504|Ropivacaine|ropivacaine|mesh-list
111336645|NCT04807504|Anesthetics, Local|anesthetics, local|mesh-ancestor
111336646|NCT04807504|Anesthetics|anesthetics|mesh-ancestor
111336647|NCT04807504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111336648|NCT04807504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111336649|NCT04807504|Sensory System Agents|sensory system agents|mesh-ancestor
111336650|NCT04807504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111336651|NCT04771156|Ketorolac|ketorolac|mesh-list
111336652|NCT04771156|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111336653|NCT04771156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111336654|NCT04771156|Analgesics|analgesics|mesh-ancestor
111336655|NCT04771156|Sensory System Agents|sensory system agents|mesh-ancestor
111336656|NCT04771156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111336657|NCT04771156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111336658|NCT04771156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111336659|NCT04771156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111336660|NCT04771156|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111336661|NCT04771156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111336662|NCT04771156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111336663|NCT04707118|Paclitaxel|paclitaxel|mesh-list
111336664|NCT04707118|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111336665|NCT04707118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111336666|NCT04707118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111336667|NCT04707118|Tubulin Modulators|tubulin modulators|mesh-ancestor
111336668|NCT04707118|Antimitotic Agents|antimitotic agents|mesh-ancestor
111336669|NCT04707118|Mitosis Modulators|mitosis modulators|mesh-ancestor
111336670|NCT04707118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111336671|NCT03086356|Dabigatran|dabigatran|mesh-list
111336672|NCT03086356|Antithrombins|antithrombins|mesh-ancestor
111336673|NCT03086356|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111336674|NCT03086356|Protease Inhibitors|protease inhibitors|mesh-ancestor
111336675|NCT03086356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110822912|NCT03496870|Levodopa|levodopa|mesh-list
111336676|NCT03086356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111336677|NCT03086356|Anticoagulants|anticoagulants|mesh-ancestor
111336678|NCT03140254|Chlorhexidine|chlorhexidine|mesh-list
111336679|NCT03140254|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
111336680|NCT03140254|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111336681|NCT03140254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111336682|NCT03140254|Disinfectants|disinfectants|mesh-ancestor
111336683|NCT03140254|Dermatologic Agents|dermatologic agents|mesh-ancestor
111336684|NCT03140722|Epoetin Alfa|epoetin alfa|mesh-list
111336685|NCT03140722|Hematinics|hematinics|mesh-ancestor
111336686|NCT00982345|Quetiapine Fumarate|quetiapine fumarate|mesh-list
111336687|NCT00982345|Antidepressive Agents|antidepressive agents|mesh-ancestor
111336688|NCT00982345|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111336689|NCT00982345|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111336690|NCT00982345|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111336691|NCT00982345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111336692|NCT00982345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110469936|NCT02815449|Iron|iron|mesh-list
111336693|NCT00375622|Tamoxifen|tamoxifen|mesh-list
111336694|NCT00375622|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111336695|NCT00375622|Hormone Antagonists|hormone antagonists|mesh-ancestor
111336696|NCT00375622|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111336697|NCT00375622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111336698|NCT00375622|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111336699|NCT00375622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111336700|NCT00375622|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111336701|NCT00375622|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111336702|NCT00375622|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111336703|NCT03087604|Lidocaine|lidocaine|mesh-list
111336704|NCT03087604|Epinephrine|epinephrine|mesh-list
111336705|NCT03087604|Anesthetics, Local|anesthetics, local|mesh-ancestor
111336706|NCT03087604|Anesthetics|anesthetics|mesh-ancestor
111336707|NCT03087604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111336708|NCT03087604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111336709|NCT03087604|Sensory System Agents|sensory system agents|mesh-ancestor
111336710|NCT03087604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110823074|NCT02017964|Carboplatin|carboplatin|mesh-list
111336711|NCT03087604|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111336712|NCT03087604|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111336713|NCT03087604|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111336714|NCT03087604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111336715|NCT03087604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111336716|NCT03087604|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111336717|NCT03087604|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111336718|NCT03087604|Adrenergic Agents|adrenergic agents|mesh-ancestor
111336719|NCT03087604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111336720|NCT03087604|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111336721|NCT03087604|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111336722|NCT03087604|Autonomic Agents|autonomic agents|mesh-ancestor
111336723|NCT03087604|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111336724|NCT03087604|Respiratory System Agents|respiratory system agents|mesh-ancestor
111336725|NCT03087604|Mydriatics|mydriatics|mesh-ancestor
111336726|NCT03087604|Sympathomimetics|sympathomimetics|mesh-ancestor
111336727|NCT03087604|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111336728|NCT00987727|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
111336729|NCT00987727|Hyaluronic Acid|hyaluronic acid|mesh-list
111336730|NCT00987727|Glycerol|glycerol|mesh-list
111336731|NCT00987727|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111336732|NCT00987727|Immunologic Factors|immunologic factors|mesh-ancestor
111336733|NCT00987727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111336734|NCT00987727|Viscosupplements|viscosupplements|mesh-ancestor
111336735|NCT00987727|Protective Agents|protective agents|mesh-ancestor
111336736|NCT00987727|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
111336737|NCT00987727|Laxatives|laxatives|mesh-ancestor
111336738|NCT00987727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111336739|NCT02160535|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111336740|NCT02160535|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111336741|NCT02160535|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111336742|NCT02160535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111336743|NCT02160535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111336744|NCT02160535|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111336745|NCT02160535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111336746|NCT02160535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111336747|NCT02160535|Cholinergic Agents|cholinergic agents|mesh-ancestor
111336748|NCT02160535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111336749|NCT04913337|Pembrolizumab|pembrolizumab|mesh-list
110823483|NCT01367756|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111336750|NCT04913337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111336751|NCT04913337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110823550|NCT01367912|Hormones|hormones|mesh-ancestor
111336752|NCT04913337|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111336753|NCT04913337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111336754|NCT05386459|Interferons|interferons|mesh-list
111061202|NCT05403476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111061203|NCT05403476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111061204|NCT05394350|Pembrolizumab|pembrolizumab|mesh-list
111061205|NCT05394350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111061206|NCT05394350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111061207|NCT05394350|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111061208|NCT05394350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111061232|NCT05346224|Pertuzumab|pertuzumab|mesh-list
111061233|NCT05346224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111061234|NCT05346224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111061235|NCT05335941|Pemetrexed|pemetrexed|mesh-list
111061236|NCT05335941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111061237|NCT05335941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111061238|NCT05335941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111061239|NCT05335941|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111061240|NCT05335941|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111061241|NCT05326776|Oxytocin|oxytocin|mesh-list
111061242|NCT05326776|Oxytocics|oxytocics|mesh-ancestor
111061243|NCT05326776|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111061245|NCT05302804|Menthol|menthol|mesh-list
111336755|NCT05386459|Interferon-gamma|interferon-gamma|mesh-list
111336756|NCT05386459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111336757|NCT05386459|Antiviral Agents|antiviral agents|mesh-ancestor
111336758|NCT05386459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111336759|NCT03018535|Methylprednisolone|methylprednisolone|mesh-list
111336760|NCT03018535|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111336761|NCT03018535|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111336762|NCT03018535|Prednisolone|prednisolone|mesh-list
111336763|NCT03018535|Prednisolone acetate|prednisolone acetate|mesh-list
111336764|NCT03018535|Cyclophosphamide|cyclophosphamide|mesh-list
111336765|NCT03018535|Rituximab|rituximab|mesh-list
111336766|NCT03018535|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111336767|NCT03018535|Prednisolone phosphate|prednisolone phosphate|mesh-list
111336768|NCT03018535|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111336769|NCT03018535|Immunologic Factors|immunologic factors|mesh-ancestor
111336770|NCT03018535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111336771|NCT03018535|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111336772|NCT03018535|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111336773|NCT03018535|Alkylating Agents|alkylating agents|mesh-ancestor
111336774|NCT03018535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111336775|NCT03018535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111336776|NCT03018535|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111336777|NCT03018535|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111336778|NCT03018535|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111336779|NCT03018535|Antiemetics|antiemetics|mesh-ancestor
111336780|NCT03018535|Autonomic Agents|autonomic agents|mesh-ancestor
111336781|NCT03018535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111336782|NCT03018535|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111336783|NCT03018535|Glucocorticoids|glucocorticoids|mesh-ancestor
111336784|NCT03018535|Hormones|hormones|mesh-ancestor
111336785|NCT03018535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111336786|NCT03018535|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111336787|NCT03018535|Protective Agents|protective agents|mesh-ancestor
111336788|NCT03018535|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110824178|NCT05759546|Fluzoparib|fluzoparib|mesh-list
111336789|NCT04890873|Magnesium Hydroxide|magnesium hydroxide|mesh-list
111336790|NCT04890873|Antacids|antacids|mesh-ancestor
111336791|NCT04890873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111336792|NCT04890873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111336793|NCT04889547|Dexamethasone|dexamethasone|mesh-list
111336794|NCT04889547|Dexamethasone acetate|dexamethasone acetate|mesh-list
111336795|NCT04889547|BB 1101|bb 1101|mesh-list
111336796|NCT04889547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111336797|NCT04889547|Antiemetics|antiemetics|mesh-ancestor
111336798|NCT04889547|Autonomic Agents|autonomic agents|mesh-ancestor
111336799|NCT04889547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111336800|NCT04889547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111336801|NCT04889547|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111336802|NCT04889547|Glucocorticoids|glucocorticoids|mesh-ancestor
111336803|NCT04889547|Hormones|hormones|mesh-ancestor
111336804|NCT04889547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111336805|NCT04889547|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111336806|NCT04889547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111336807|NCT04889547|Protease Inhibitors|protease inhibitors|mesh-ancestor
111336808|NCT04889547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111336809|NCT04889547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111336810|NCT00989911|Bosentan|bosentan|mesh-list
111336811|NCT00989911|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111336812|NCT00989911|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
111336813|NCT00989911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111336814|NCT02977065|Atorvastatin|atorvastatin|mesh-list
111336815|NCT02977065|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111336816|NCT02977065|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111336817|NCT02977065|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111336818|NCT02977065|Antimetabolites|antimetabolites|mesh-ancestor
111336819|NCT02977065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111336820|NCT02977065|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111336821|NCT02977065|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111336822|NCT02977065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111336823|NCT03146806|Ketamine|ketamine|mesh-list
111336824|NCT03146806|Analgesics|analgesics|mesh-ancestor
111336825|NCT03146806|Sensory System Agents|sensory system agents|mesh-ancestor
111336826|NCT03146806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110824678|NCT02348203|Aspirin|aspirin|mesh-list
111336827|NCT03146806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111336828|NCT03146806|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111336829|NCT03146806|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111336830|NCT03146806|Anesthetics, General|anesthetics, general|mesh-ancestor
111336831|NCT03146806|Anesthetics|anesthetics|mesh-ancestor
111336832|NCT03146806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111336833|NCT03146806|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111336834|NCT03146806|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111336835|NCT03146806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111336836|NCT03146806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111336837|NCT04706806|Acetic Acid|acetic acid|mesh-list
111336838|NCT04706806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111336839|NCT04706806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111336840|NCT02975583|Vorapaxar|vorapaxar|mesh-list
111336841|NCT02975583|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111336842|NCT03095638|Dolutegravir|dolutegravir|mesh-list
111336843|NCT03095638|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111336844|NCT03095638|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111336845|NCT03095638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111336846|NCT03095638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111336847|NCT03095638|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111336848|NCT03095638|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111336849|NCT03095638|Antiviral Agents|antiviral agents|mesh-ancestor
111336850|NCT03095638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111336851|NCT04458688|Ocrelizumab|ocrelizumab|mesh-list
111336852|NCT04458688|Immunologic Factors|immunologic factors|mesh-ancestor
111336853|NCT04458688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111336854|NCT04450108|Nitric Oxide|nitric oxide|mesh-list
111336855|NCT04450108|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111336856|NCT04450108|Autonomic Agents|autonomic agents|mesh-ancestor
111336857|NCT04450108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110542510|NCT00648986|Tazarotene|tazarotene|mesh-list
111336858|NCT04450108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111336859|NCT04450108|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111336860|NCT04450108|Respiratory System Agents|respiratory system agents|mesh-ancestor
111336861|NCT04450108|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111336862|NCT04450108|Antioxidants|antioxidants|mesh-ancestor
111336863|NCT04450108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111336864|NCT04450108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111336865|NCT04450108|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
111336866|NCT04450108|Vasodilator Agents|vasodilator agents|mesh-ancestor
111336867|NCT04450108|Gasotransmitters|gasotransmitters|mesh-ancestor
111336868|NCT04450108|Protective Agents|protective agents|mesh-ancestor
111336869|NCT03891849|Octreotide|octreotide|mesh-list
111336870|NCT03891849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111336871|NCT03891849|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111336872|NCT03891849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111336873|NCT04341831|Teicoplanin|teicoplanin|mesh-list
111336874|NCT04341831|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111336875|NCT04341831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111336876|NCT00361959|Fluticasone|fluticasone|mesh-list
111336877|NCT00361959|Xhance|xhance|mesh-list
111336878|NCT00361959|Bromides|bromides|mesh-list
111336879|NCT00361959|Tiotropium Bromide|tiotropium bromide|mesh-list
111336880|NCT00361959|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
111336881|NCT00361959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111336882|NCT00361959|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111336883|NCT00361959|Autonomic Agents|autonomic agents|mesh-ancestor
111336884|NCT00361959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111336885|NCT00361959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111336886|NCT00361959|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111336887|NCT00361959|Respiratory System Agents|respiratory system agents|mesh-ancestor
111336888|NCT00361959|Dermatologic Agents|dermatologic agents|mesh-ancestor
111336889|NCT00361959|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111336890|NCT00361959|Parasympatholytics|parasympatholytics|mesh-ancestor
111336891|NCT00361959|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111336892|NCT00361959|Cholinergic Agents|cholinergic agents|mesh-ancestor
111336893|NCT00361959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111336894|NCT00361959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111336895|NCT00361959|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111336896|NCT00361959|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111336897|NCT00361959|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111336898|NCT00361959|Adrenergic Agents|adrenergic agents|mesh-ancestor
111336899|NCT00361959|Anticonvulsants|anticonvulsants|mesh-ancestor
111336900|NCT03158116|Aztreonam|aztreonam|mesh-list
111336901|NCT03158116|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111336902|NCT03158116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111336903|NCT03096730|Sufentanil|sufentanil|mesh-list
111336904|NCT03096730|Dexmedetomidine|dexmedetomidine|mesh-list
111336905|NCT03096730|Remifentanil|remifentanil|mesh-list
111336906|NCT03096730|Dsuvia|dsuvia|mesh-list
111336907|NCT03096730|Nalmefene|nalmefene|mesh-list
111336908|NCT03096730|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111336909|NCT03096730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111336910|NCT03096730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111336911|NCT03096730|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111336912|NCT03096730|Analgesics|analgesics|mesh-ancestor
111336913|NCT03096730|Sensory System Agents|sensory system agents|mesh-ancestor
111336914|NCT03096730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111336915|NCT03096730|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111336916|NCT03096730|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110825319|NCT02527993|Acarbose|acarbose|mesh-list
111336917|NCT03096730|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111336918|NCT03096730|Adrenergic Agents|adrenergic agents|mesh-ancestor
111336919|NCT03096730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111336920|NCT03096730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111336921|NCT03096730|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111336922|NCT03096730|Narcotics|narcotics|mesh-ancestor
111336923|NCT03096730|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110825391|NCT03894007|Epirubicin|epirubicin|mesh-list
111336924|NCT03096730|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111336925|NCT03096730|Anesthetics, General|anesthetics, general|mesh-ancestor
111336926|NCT03096730|Anesthetics|anesthetics|mesh-ancestor
111336927|NCT03096730|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111336928|NCT00362037|Irbesartan|irbesartan|mesh-list
110825453|NCT01586299|Ibuprofen|ibuprofen|mesh-list
111336929|NCT00362037|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111336930|NCT00362037|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111336931|NCT00362037|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111336932|NCT00362037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111336933|NCT03161158|Diuretics|diuretics|mesh-list
111336934|NCT03161158|Natriuretic Agents|natriuretic agents|mesh-ancestor
111336935|NCT03161158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111336936|NCT03161938|Dexamethasone|dexamethasone|mesh-list
111336937|NCT03161938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111336938|NCT03161938|Antiemetics|antiemetics|mesh-ancestor
111336939|NCT03161938|Autonomic Agents|autonomic agents|mesh-ancestor
111336940|NCT03161938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111336941|NCT03161938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111336942|NCT03161938|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111336943|NCT03161938|Glucocorticoids|glucocorticoids|mesh-ancestor
111336944|NCT03161938|Hormones|hormones|mesh-ancestor
110825521|NCT05505409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111336945|NCT03161938|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111336946|NCT03161938|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111336947|NCT03161938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111336948|NCT03321045|Trastuzumab|trastuzumab|mesh-list
111336949|NCT03321045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111336950|NCT03321045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111336951|NCT00989989|Ranibizumab|ranibizumab|mesh-list
111336952|NCT00989989|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111336953|NCT00989989|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111336954|NCT00989989|Growth Substances|growth substances|mesh-ancestor
111336955|NCT00989989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111336956|NCT00989989|Growth Inhibitors|growth inhibitors|mesh-ancestor
111336957|NCT00989989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111336958|NCT03802773|Cyclophosphamide|cyclophosphamide|mesh-list
111336959|NCT03802773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111336960|NCT03802773|Immunologic Factors|immunologic factors|mesh-ancestor
111336961|NCT03802773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111336962|NCT03802773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111336963|NCT03802773|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111336964|NCT03802773|Alkylating Agents|alkylating agents|mesh-ancestor
111336965|NCT03802773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111336966|NCT03802773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111336967|NCT03802773|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111336968|NCT03018301|Ketamine|ketamine|mesh-list
111336969|NCT03018301|Analgesics|analgesics|mesh-ancestor
111336970|NCT03018301|Sensory System Agents|sensory system agents|mesh-ancestor
111336971|NCT03018301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111336972|NCT03018301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111061426|NCT04883281|Paclitaxel|paclitaxel|mesh-list
111061427|NCT04883281|Carboplatin|carboplatin|mesh-list
111061428|NCT04883281|Cetuximab|cetuximab|mesh-list
111061429|NCT04883281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111336973|NCT03018301|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111061430|NCT04883281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111061431|NCT04883281|Tubulin Modulators|tubulin modulators|mesh-ancestor
111061432|NCT04883281|Antimitotic Agents|antimitotic agents|mesh-ancestor
111061433|NCT04883281|Mitosis Modulators|mitosis modulators|mesh-ancestor
111061436|NCT04877522|Niacinamide|niacinamide|mesh-list
111336974|NCT03018301|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111336975|NCT03018301|Anesthetics, General|anesthetics, general|mesh-ancestor
111336976|NCT03018301|Anesthetics|anesthetics|mesh-ancestor
111336977|NCT03018301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111336978|NCT03018301|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111336979|NCT03018301|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111336980|NCT03018301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110825843|NCT01260415|Oxaliplatin|oxaliplatin|mesh-list
111336981|NCT03018301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111336982|NCT00990769|Anesthetics|anesthetics|mesh-list
111336983|NCT00990769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110825928|NCT01154569|Azithromycin|azithromycin|mesh-list
111336984|NCT00990769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111336985|NCT00991081|Bupropion|bupropion|mesh-list
111336986|NCT00991081|Nicotine|nicotine|mesh-list
111336987|NCT00991081|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110825997|NCT01152931|Vitamins|vitamins|mesh-list
111336988|NCT00991081|Autonomic Agents|autonomic agents|mesh-ancestor
111336989|NCT00991081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111336990|NCT00991081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111336991|NCT00991081|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111336992|NCT00991081|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111336993|NCT00991081|Cholinergic Agents|cholinergic agents|mesh-ancestor
111336994|NCT00991081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111336995|NCT00991081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111336996|NCT00991081|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111336997|NCT00991081|Antidepressive Agents|antidepressive agents|mesh-ancestor
111336998|NCT00991081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111336999|NCT00991081|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111337000|NCT00991081|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111337001|NCT00991081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111337002|NCT00991081|Dopamine Agents|dopamine agents|mesh-ancestor
111337003|NCT00991081|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111337004|NCT00991081|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111337005|NCT00991081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111337006|NCT03168022|Amitriptyline|amitriptyline|mesh-list
111337007|NCT03168022|Cyclobenzaprine|cyclobenzaprine|mesh-list
111337008|NCT03168022|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
111337009|NCT03168022|Antidepressive Agents|antidepressive agents|mesh-ancestor
111337010|NCT03168022|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111337011|NCT03168022|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
111337012|NCT03168022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110826110|NCT03456960|Analgesics|analgesics|mesh-ancestor
111337013|NCT03168022|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111337014|NCT03168022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111337015|NCT03168022|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111337016|NCT03168022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111337017|NCT03168022|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111337018|NCT03168022|Analgesics|analgesics|mesh-ancestor
111337019|NCT03168022|Sensory System Agents|sensory system agents|mesh-ancestor
111337020|NCT03168022|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111337021|NCT03168022|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111337022|NCT03168022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111337023|NCT03168022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111337024|NCT03168022|Adrenergic Agents|adrenergic agents|mesh-ancestor
111337025|NCT03168022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111337026|NCT03102190|Verapamil|verapamil|mesh-list
111337027|NCT03102190|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111337028|NCT03102190|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111337029|NCT03102190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111337030|NCT03102190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111337031|NCT03102190|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111337032|NCT03102190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111337033|NCT03102190|Vasodilator Agents|vasodilator agents|mesh-ancestor
111337034|NCT03254667|Brodalumab|brodalumab|mesh-list
111337035|NCT03254667|Dermatologic Agents|dermatologic agents|mesh-ancestor
111337036|NCT03102736|Nitroprusside|nitroprusside|mesh-list
111337037|NCT03102736|Ketamine|ketamine|mesh-list
111337038|NCT03102736|Analgesics|analgesics|mesh-ancestor
110826243|NCT01154959|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111337039|NCT03102736|Sensory System Agents|sensory system agents|mesh-ancestor
111337040|NCT03102736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111337041|NCT03102736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111337042|NCT03102736|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111337043|NCT03102736|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111337044|NCT03102736|Anesthetics, General|anesthetics, general|mesh-ancestor
111337045|NCT03102736|Anesthetics|anesthetics|mesh-ancestor
111061500|NCT04673617|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111337046|NCT03102736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111337047|NCT03102736|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111337048|NCT03102736|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111337050|NCT03102736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111337051|NCT03102736|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111337052|NCT03102736|Vasodilator Agents|vasodilator agents|mesh-ancestor
111337053|NCT03102736|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
111337054|NCT03743103|Nitroprusside|nitroprusside|mesh-list
111337055|NCT03743103|Esmolol|esmolol|mesh-list
111337056|NCT03743103|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111337057|NCT03743103|Vasodilator Agents|vasodilator agents|mesh-ancestor
111337058|NCT03743103|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
111337059|NCT03743103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111337060|NCT03743103|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
111337061|NCT03743103|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111337062|NCT03743103|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111337063|NCT03743103|Adrenergic Agents|adrenergic agents|mesh-ancestor
111337064|NCT03743103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111337065|NCT03743103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111337066|NCT04049266|Aflibercept|aflibercept|mesh-list
111337067|NCT04049266|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111337068|NCT04049266|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111337069|NCT04049266|Growth Substances|growth substances|mesh-ancestor
110826359|NCT03424044|Glucagon|glucagon|mesh-list
111337070|NCT04049266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111337071|NCT04049266|Growth Inhibitors|growth inhibitors|mesh-ancestor
111337072|NCT04049266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111337073|NCT01502917|Antibodies|antibodies|mesh-list
111337074|NCT01502917|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111337075|NCT01502917|Immunologic Factors|immunologic factors|mesh-ancestor
111337076|NCT01502917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111337077|NCT00362505|Clevudine|clevudine|mesh-list
111337078|NCT00362505|Antiviral Agents|antiviral agents|mesh-ancestor
111337079|NCT00362505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111337080|NCT00993187|Metformin|metformin|mesh-list
111337081|NCT00993187|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111337082|NCT00993187|Glimepiride|glimepiride|mesh-list
111337083|NCT00993187|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111337084|NCT00993187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111337085|NCT00993187|Incretins|incretins|mesh-ancestor
111337086|NCT00993187|Hormones|hormones|mesh-ancestor
110826560|NCT00075725|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111337087|NCT00993187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111337088|NCT00993187|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111337089|NCT00993187|Protease Inhibitors|protease inhibitors|mesh-ancestor
111337090|NCT00993187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111337091|NCT00993187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111337092|NCT00993187|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111337093|NCT00993187|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111337094|NCT00993187|Immunologic Factors|immunologic factors|mesh-ancestor
111337095|NCT03173170|Itraconazole|itraconazole|mesh-list
111337096|NCT03173170|Antifungal Agents|antifungal agents|mesh-ancestor
111337097|NCT03173170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111337098|NCT03173170|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111337099|NCT03173170|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111337100|NCT03173170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111337101|NCT03173170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111337102|NCT03173170|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111337103|NCT03173170|Hormone Antagonists|hormone antagonists|mesh-ancestor
111337104|NCT03173170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111337105|NCT03173170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111337106|NCT03173170|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111337107|NCT03106870|Insulin|insulin|mesh-list
111337108|NCT03106870|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111337109|NCT03106870|Metformin|metformin|mesh-list
111337110|NCT03106870|Insulin, pork; isophane insulin, pork drug combination 30:70|insulin, pork; isophane insulin, pork drug combination 30:70|mesh-list
111337111|NCT03106870|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111337112|NCT03106870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111337113|NCT00375310|Gemcitabine|gemcitabine|mesh-list
111337114|NCT00375310|Sorafenib|sorafenib|mesh-list
111337115|NCT00375310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111337116|NCT00375310|Antimetabolites|antimetabolites|mesh-ancestor
111337117|NCT00375310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111337118|NCT00375310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111337119|NCT00375310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111337120|NCT00375310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111337121|NCT03670953|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
111337122|NCT03670953|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111337123|NCT03670953|Immunologic Factors|immunologic factors|mesh-ancestor
111337124|NCT03670953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111337125|NCT03670953|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111337126|NCT03670953|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111337127|NCT03670953|Dopamine Agonists|dopamine agonists|mesh-ancestor
111337128|NCT03670953|Dopamine Agents|dopamine agents|mesh-ancestor
111337129|NCT03670953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111337130|NCT03670953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111337131|NCT04736914|Zanubrutinib|zanubrutinib|mesh-list
111337132|NCT04736914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111337133|NCT04736914|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111337134|NCT04736914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111337135|NCT04736914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111337136|NCT00362583|Fentanyl|fentanyl|mesh-list
111337137|NCT00362583|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111337138|NCT00362583|Narcotics|narcotics|mesh-ancestor
111337139|NCT00362583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111337140|NCT00362583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111337141|NCT00362583|Analgesics|analgesics|mesh-ancestor
111337142|NCT00362583|Sensory System Agents|sensory system agents|mesh-ancestor
111337143|NCT00362583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110485781|NCT04065529|Zinc|zinc|mesh-list
111337144|NCT00362583|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111337145|NCT00362583|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111337146|NCT00362583|Anesthetics, General|anesthetics, general|mesh-ancestor
111337147|NCT00362583|Anesthetics|anesthetics|mesh-ancestor
111337148|NCT00657241|Valsartan|valsartan|mesh-list
111337149|NCT00657241|Carvedilol|carvedilol|mesh-list
111337150|NCT00657241|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111337151|NCT00657241|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111337152|NCT00657241|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111337153|NCT00657241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111337154|NCT00657241|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111337155|NCT00657241|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111337156|NCT00657241|Adrenergic Agents|adrenergic agents|mesh-ancestor
111337157|NCT00657241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111337158|NCT00657241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111337159|NCT00657241|Antioxidants|antioxidants|mesh-ancestor
111337160|NCT00657241|Protective Agents|protective agents|mesh-ancestor
111337161|NCT00657241|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111337162|NCT00657241|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111337163|NCT00657241|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111337164|NCT00657241|Vasodilator Agents|vasodilator agents|mesh-ancestor
111337165|NCT00657241|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110827200|NCT03872011|Thiamine|thiamine|mesh-list
111337166|NCT00657241|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111337167|NCT04342065|Celecoxib|celecoxib|mesh-list
111337168|NCT04342065|Pregabalin|pregabalin|mesh-list
110827271|NCT03388164|Dexetimide|dexetimide|mesh-list
111337169|NCT04342065|Analgesics|analgesics|mesh-ancestor
111337170|NCT04342065|Sensory System Agents|sensory system agents|mesh-ancestor
111337171|NCT04342065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111337172|NCT04342065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111337173|NCT04342065|Anticonvulsants|anticonvulsants|mesh-ancestor
111337174|NCT04342065|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110827334|NCT03387462|Tenofovir|tenofovir|mesh-list
111337175|NCT04342065|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111337176|NCT04342065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111337177|NCT04342065|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111337178|NCT04342065|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111337179|NCT04342065|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111337180|NCT04342065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111337181|NCT04342065|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111337182|NCT04342065|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111337183|NCT04342065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111337184|NCT04342065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111337185|NCT04342065|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111337186|NCT04342065|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111337187|NCT04342065|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111337188|NCT04342065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111337189|NCT03179410|Avelumab|avelumab|mesh-list
111337190|NCT03179410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111337191|NCT03179410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111061654|NCT04240626|Cyclobenzaprine|cyclobenzaprine|mesh-list
111337192|NCT00478465|Valganciclovir|valganciclovir|mesh-list
111337193|NCT00478465|Antiviral Agents|antiviral agents|mesh-ancestor
110827394|NCT03386448|Cholinergic Agents|cholinergic agents|mesh-ancestor
111337194|NCT00478465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111337195|NCT00421785|Acetylcysteine|acetylcysteine|mesh-list
111337196|NCT00421785|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111337197|NCT00421785|Antiviral Agents|antiviral agents|mesh-ancestor
111337198|NCT00421785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111337199|NCT00421785|Expectorants|expectorants|mesh-ancestor
111337200|NCT00421785|Respiratory System Agents|respiratory system agents|mesh-ancestor
111337201|NCT00421785|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111337202|NCT00421785|Antioxidants|antioxidants|mesh-ancestor
111337203|NCT00421785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111337204|NCT00421785|Protective Agents|protective agents|mesh-ancestor
111337205|NCT00421785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111337206|NCT00421785|Antidotes|antidotes|mesh-ancestor
111337207|NCT02519348|Bevacizumab|bevacizumab|mesh-list
111337208|NCT02519348|Durvalumab|durvalumab|mesh-list
111337209|NCT02519348|Tremelimumab|tremelimumab|mesh-list
111337210|NCT02519348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111337211|NCT02519348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111337212|NCT02519348|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111337213|NCT02519348|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111337214|NCT02519348|Growth Substances|growth substances|mesh-ancestor
111337215|NCT02519348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111337216|NCT02519348|Growth Inhibitors|growth inhibitors|mesh-ancestor
111337217|NCT00421863|Amlodipine|amlodipine|mesh-list
111337218|NCT00421863|Telmisartan|telmisartan|mesh-list
111337219|NCT00421863|Clonidine|clonidine|mesh-list
111337220|NCT00421863|Ramipril|ramipril|mesh-list
111337221|NCT00421863|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111337222|NCT00421863|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111337223|NCT00421863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111337224|NCT00421863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111337225|NCT00421863|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111337226|NCT00421863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111337227|NCT00421863|Vasodilator Agents|vasodilator agents|mesh-ancestor
111337228|NCT00421863|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111337229|NCT00421863|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111337230|NCT00421863|Analgesics|analgesics|mesh-ancestor
111337231|NCT00421863|Sensory System Agents|sensory system agents|mesh-ancestor
111337232|NCT00421863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111337233|NCT00421863|Sympatholytics|sympatholytics|mesh-ancestor
111337234|NCT00421863|Autonomic Agents|autonomic agents|mesh-ancestor
111337235|NCT00421863|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111337236|NCT00421863|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111337237|NCT00421863|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111337238|NCT00421863|Adrenergic Agents|adrenergic agents|mesh-ancestor
111337239|NCT00421863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111337240|NCT00421863|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
111337241|NCT00421863|Protease Inhibitors|protease inhibitors|mesh-ancestor
111337242|NCT00421863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111337243|NCT00636818|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
111337244|NCT00636818|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111337245|NCT00636818|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111337246|NCT00636818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111337247|NCT00636818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111337248|NCT00636818|Adrenergic Agents|adrenergic agents|mesh-ancestor
111337249|NCT00636818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111337250|NCT00636818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111337251|NCT05363722|Bevacizumab|bevacizumab|mesh-list
111337252|NCT05363722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111337253|NCT05363722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111337254|NCT05363722|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111337255|NCT05363722|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111337256|NCT05363722|Growth Substances|growth substances|mesh-ancestor
110504810|NCT02740985|Docetaxel|docetaxel|mesh-list
111337257|NCT05363722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111337258|NCT05363722|Growth Inhibitors|growth inhibitors|mesh-ancestor
111337259|NCT01922492|Hypoglycemic Agents|hypoglycemic agents|mesh-list
111337260|NCT01922492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111337261|NCT03127137|Triamcinolone|triamcinolone|mesh-list
111337262|NCT03127137|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
111337263|NCT03127137|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
111337264|NCT03127137|Lidocaine|lidocaine|mesh-list
111337265|NCT03127137|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
111337266|NCT03127137|Anesthetics, Local|anesthetics, local|mesh-ancestor
111337267|NCT03127137|Anesthetics|anesthetics|mesh-ancestor
111337268|NCT03127137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111337270|NCT03127137|Sensory System Agents|sensory system agents|mesh-ancestor
111337271|NCT03127137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111337272|NCT03127137|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111337273|NCT03127137|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111337274|NCT03127137|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111337275|NCT03127137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111337276|NCT03127137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111337277|NCT03127137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111337278|NCT03127137|Glucocorticoids|glucocorticoids|mesh-ancestor
111337279|NCT03127137|Hormones|hormones|mesh-ancestor
111337280|NCT03127137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111337281|NCT03127137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111337282|NCT03127137|Immunologic Factors|immunologic factors|mesh-ancestor
111337283|NCT03127137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111337284|NCT03122847|Methylprednisolone|methylprednisolone|mesh-list
111337285|NCT03122847|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111337286|NCT03122847|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111337287|NCT03122847|Prednisolone|prednisolone|mesh-list
111337288|NCT03122847|Prednisolone acetate|prednisolone acetate|mesh-list
111337289|NCT03122847|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111337290|NCT03122847|Prednisolone phosphate|prednisolone phosphate|mesh-list
111337291|NCT03122847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111337292|NCT03122847|Antiemetics|antiemetics|mesh-ancestor
111337293|NCT03122847|Autonomic Agents|autonomic agents|mesh-ancestor
111337294|NCT03122847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111337295|NCT03122847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111337296|NCT03122847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111337297|NCT03122847|Glucocorticoids|glucocorticoids|mesh-ancestor
111337298|NCT03122847|Hormones|hormones|mesh-ancestor
111337299|NCT03122847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111337300|NCT03122847|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111337301|NCT03122847|Protective Agents|protective agents|mesh-ancestor
111337302|NCT03122847|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111337303|NCT03122847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111337304|NCT04342221|Hydroxychloroquine|hydroxychloroquine|mesh-list
111337305|NCT04342221|Antimalarials|antimalarials|mesh-ancestor
111337306|NCT04342221|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111337307|NCT04342221|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111337308|NCT04342221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111337309|NCT04342221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110827535|NCT01281553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111337310|NCT04342221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111337311|NCT04342221|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111337312|NCT03525028|Metformin|metformin|mesh-list
111337313|NCT03525028|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111337314|NCT03525028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111337315|NCT00636194|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111337316|NCT00754312|Entinostat|entinostat|mesh-list
111337317|NCT00754312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111337318|NCT00754312|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111337319|NCT00754312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111337320|NCT00754312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111337321|NCT03623373|Cytarabine|cytarabine|mesh-list
111337322|NCT03623373|Rituximab|rituximab|mesh-list
111337323|NCT03623373|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
111337324|NCT03623373|Acalabrutinib|acalabrutinib|mesh-list
111337325|NCT03623373|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111337326|NCT03623373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111337327|NCT03623373|Immunologic Factors|immunologic factors|mesh-ancestor
111337328|NCT03623373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111337329|NCT03623373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111337330|NCT03623373|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111337331|NCT03623373|Antimetabolites|antimetabolites|mesh-ancestor
111337332|NCT03623373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111337333|NCT03623373|Antiviral Agents|antiviral agents|mesh-ancestor
111337334|NCT03623373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111337335|NCT03623373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111337336|NCT03623373|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111337337|NCT03623373|Alkylating Agents|alkylating agents|mesh-ancestor
111337338|NCT04736524|Antibodies|antibodies|mesh-list
111337339|NCT04736524|Immunologic Factors|immunologic factors|mesh-ancestor
111337340|NCT04736524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111337341|NCT00362661|Hydrocortisone|hydrocortisone|mesh-list
110827623|NCT01168063|Amoxicillin|amoxicillin|mesh-list
111337342|NCT00362661|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
111337343|NCT00362661|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
111337344|NCT00362661|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
111337345|NCT00362661|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111337346|NCT03410446|Ketamine|ketamine|mesh-list
110517876|NCT04877093|Clonidine|clonidine|mesh-list
111337347|NCT03410446|Analgesics|analgesics|mesh-ancestor
111337348|NCT03410446|Sensory System Agents|sensory system agents|mesh-ancestor
111337349|NCT03410446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111337350|NCT03410446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111337351|NCT03410446|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111337352|NCT03410446|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111337353|NCT03410446|Anesthetics, General|anesthetics, general|mesh-ancestor
111337354|NCT03410446|Anesthetics|anesthetics|mesh-ancestor
111337355|NCT03410446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111337356|NCT03410446|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111337357|NCT03410446|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111337358|NCT03410446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111337359|NCT03410446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111337360|NCT00375388|Metformin|metformin|mesh-list
111337361|NCT00375388|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111337362|NCT00375388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111337363|NCT00375778|Memantine|memantine|mesh-list
111337364|NCT00375778|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111337365|NCT00375778|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111337366|NCT00375778|Dopamine Agents|dopamine agents|mesh-ancestor
111337367|NCT00375778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111337368|NCT00375778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111337369|NCT00375778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111337370|NCT00375778|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111337371|NCT00375778|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111337372|NCT00994123|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111337373|NCT00994123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111337374|NCT00994123|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111337375|NCT00994123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111337376|NCT00994123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111337377|NCT03001726|Docetaxel|docetaxel|mesh-list
111337378|NCT03001726|Oxaliplatin|oxaliplatin|mesh-list
111337379|NCT03001726|Tegafur|tegafur|mesh-list
111337380|NCT03001726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111337381|NCT03001726|Tubulin Modulators|tubulin modulators|mesh-ancestor
111337382|NCT03001726|Antimitotic Agents|antimitotic agents|mesh-ancestor
111337383|NCT03001726|Mitosis Modulators|mitosis modulators|mesh-ancestor
111337384|NCT03001726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111337385|NCT03001726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111337386|NCT03001726|Antimetabolites|antimetabolites|mesh-ancestor
110522109|NCT00770679|Atorvastatin|atorvastatin|mesh-list
111337387|NCT04697329|Levobupivacaine|levobupivacaine|mesh-list
111337388|NCT04697329|Anesthetics, Local|anesthetics, local|mesh-ancestor
111337389|NCT04697329|Anesthetics|anesthetics|mesh-ancestor
111337390|NCT04697329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111337391|NCT04697329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111337392|NCT04697329|Sensory System Agents|sensory system agents|mesh-ancestor
111337393|NCT04697329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111337394|NCT04444843|Mycophenolic Acid|mycophenolic acid|mesh-list
111337395|NCT04444843|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111337396|NCT04444843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111337397|NCT04444843|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111337398|NCT04444843|Antitubercular Agents|antitubercular agents|mesh-ancestor
111337399|NCT04444843|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111337400|NCT04444843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111337401|NCT04444843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111337402|NCT04444843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111337403|NCT04353193|Octreotide|octreotide|mesh-list
111337404|NCT04353193|Terlipressin|terlipressin|mesh-list
111337405|NCT04353193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111337406|NCT04353193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111337407|NCT04353193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111337408|NCT04353193|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111337409|NCT04353193|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111337410|NCT01023841|Bimatoprost|bimatoprost|mesh-list
111337411|NCT01023841|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111337412|NCT01023841|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111337413|NCT01023841|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111337414|NCT00635648|Caspofungin|caspofungin|mesh-list
111337415|NCT00635648|Antifungal Agents|antifungal agents|mesh-ancestor
111337416|NCT00635648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111337417|NCT00635648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111337418|NCT00635648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111337419|NCT05240456|Solifenacin Succinate|solifenacin succinate|mesh-list
111337420|NCT05240456|Cholinergic Antagonists|cholinergic antagonists|mesh-list
111337421|NCT05240456|Adrenergic Agents|adrenergic agents|mesh-list
111337422|NCT05240456|Adrenergic Agonists|adrenergic agonists|mesh-list
111337423|NCT05240456|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-list
111337424|NCT05240456|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111337425|NCT05240456|Cholinergic Agents|cholinergic agents|mesh-ancestor
111337426|NCT05240456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111337427|NCT05240456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111337428|NCT05240456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111337429|NCT05240456|Urological Agents|urological agents|mesh-ancestor
111337430|NCT05240456|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111337431|NCT03574779|Paclitaxel|paclitaxel|mesh-list
111337432|NCT03574779|Bevacizumab|bevacizumab|mesh-list
111337433|NCT03574779|Carboplatin|carboplatin|mesh-list
111337434|NCT03574779|Niraparib|niraparib|mesh-list
111337435|NCT03574779|Dostarlimab|dostarlimab|mesh-list
111337436|NCT03574779|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111337437|NCT03574779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111337438|NCT03574779|Tubulin Modulators|tubulin modulators|mesh-ancestor
111337439|NCT03574779|Antimitotic Agents|antimitotic agents|mesh-ancestor
111337440|NCT03574779|Mitosis Modulators|mitosis modulators|mesh-ancestor
111337441|NCT03574779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111337442|NCT03574779|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111337443|NCT03574779|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111337444|NCT03574779|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111337445|NCT03574779|Growth Substances|growth substances|mesh-ancestor
111337446|NCT03574779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111337447|NCT03574779|Growth Inhibitors|growth inhibitors|mesh-ancestor
111337448|NCT03574779|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111337449|NCT03574779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111337450|NCT04341883|Paclitaxel|paclitaxel|mesh-list
111337451|NCT04341883|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111337452|NCT04341883|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111337453|NCT04341883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111337454|NCT04341883|Tubulin Modulators|tubulin modulators|mesh-ancestor
111337455|NCT04341883|Antimitotic Agents|antimitotic agents|mesh-ancestor
111337456|NCT04341883|Mitosis Modulators|mitosis modulators|mesh-ancestor
111337457|NCT04341883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111337458|NCT00995761|Cisplatin|cisplatin|mesh-list
111337459|NCT00995761|Docetaxel|docetaxel|mesh-list
111337460|NCT00995761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111337461|NCT00995761|Tubulin Modulators|tubulin modulators|mesh-ancestor
111337462|NCT00995761|Antimitotic Agents|antimitotic agents|mesh-ancestor
110532774|NCT00903617|Niacin|niacin|mesh-list
111337463|NCT00995761|Mitosis Modulators|mitosis modulators|mesh-ancestor
111337464|NCT00995761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111337465|NCT00362271|Aripiprazole|aripiprazole|mesh-list
111337466|NCT00362271|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
111337467|NCT00362271|Antidepressive Agents|antidepressive agents|mesh-ancestor
111337468|NCT00362271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111337469|NCT00362271|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111337470|NCT00362271|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111337471|NCT00362271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111337472|NCT00362271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111337473|NCT00362271|Dopamine Agonists|dopamine agonists|mesh-ancestor
111337474|NCT00362271|Dopamine Agents|dopamine agents|mesh-ancestor
111337475|NCT00362271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111337476|NCT00362271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111337477|NCT00362271|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111337478|NCT00362271|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111337479|NCT00362271|Serotonin Agents|serotonin agents|mesh-ancestor
111337480|NCT00362271|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111337481|NCT00362271|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111337482|NCT00362271|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111337483|NCT00362271|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111337484|NCT00362271|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111337485|NCT00362271|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111337486|NCT00362271|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111337487|NCT00362271|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111337488|NCT00635102|Cycloserine|cycloserine|mesh-list
111337489|NCT00635102|Glycine|glycine|mesh-list
110779107|NCT02926690|OTS167|ots167|mesh-list
111337490|NCT00635102|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111337492|NCT00635102|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111337493|NCT00635102|Antitubercular Agents|antitubercular agents|mesh-ancestor
111337494|NCT00635102|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111337495|NCT00635102|Antimetabolites|antimetabolites|mesh-ancestor
111337496|NCT00635102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111337497|NCT00635102|Glycine Agents|glycine agents|mesh-ancestor
111337498|NCT00635102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111337499|NCT00635102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111337500|NCT03041883|Riboflavin|riboflavin|mesh-list
111337501|NCT03041883|Vitamin B Complex|vitamin b complex|mesh-ancestor
111337502|NCT03041883|Vitamins|vitamins|mesh-ancestor
111337503|NCT03041883|Micronutrients|micronutrients|mesh-ancestor
111337504|NCT03041883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111337505|NCT03041883|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111337506|NCT03041883|Dermatologic Agents|dermatologic agents|mesh-ancestor
111337507|NCT03034005|Budesonide|budesonide|mesh-list
111337508|NCT03034005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111337509|NCT03034005|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111337510|NCT03034005|Autonomic Agents|autonomic agents|mesh-ancestor
111337511|NCT03034005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111337512|NCT03034005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111337513|NCT03034005|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111337514|NCT03034005|Respiratory System Agents|respiratory system agents|mesh-ancestor
111337515|NCT03034005|Glucocorticoids|glucocorticoids|mesh-ancestor
111337516|NCT03034005|Hormones|hormones|mesh-ancestor
111337517|NCT03034005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111337518|NCT04296916|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111337519|NCT04296916|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111337520|NCT00635024|Melphalan|melphalan|mesh-list
111337521|NCT00635024|Antilymphocyte Serum|antilymphocyte serum|mesh-list
111337522|NCT00635024|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111337523|NCT00635024|Alkylating Agents|alkylating agents|mesh-ancestor
111337524|NCT00635024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111337525|NCT00635024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111337526|NCT00635024|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111337527|NCT00635024|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111337528|NCT00635024|Immunologic Factors|immunologic factors|mesh-ancestor
110677134|NCT02687958|Everolimus|everolimus|mesh-list
111337529|NCT00635024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111337530|NCT03182920|Lasmiditan|lasmiditan|mesh-list
111337531|NCT03182920|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111337532|NCT03182920|Serotonin Agents|serotonin agents|mesh-ancestor
111337533|NCT03182920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111337534|NCT03182920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111337535|NCT03182920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111337536|NCT03485547|Venetoclax|venetoclax|mesh-list
111337537|NCT03485547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111337538|NCT03187678|Selexipag|selexipag|mesh-list
111337539|NCT03187678|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111337540|NCT03192826|Brimonidine Tartrate|brimonidine tartrate|mesh-list
111337541|NCT03192826|Lubricant Eye Drops|lubricant eye drops|mesh-list
111337542|NCT03192826|Dipivefrin|dipivefrin|mesh-list
111337543|NCT03192826|Brinzolamide|brinzolamide|mesh-list
111337544|NCT03192826|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111337545|NCT03192826|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111337546|NCT03192826|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111337547|NCT03192826|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111337548|NCT03192826|Adrenergic Agents|adrenergic agents|mesh-ancestor
110677227|NCT02166463|Prednisone|prednisone|mesh-list
111337549|NCT03192826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111337550|NCT03192826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111337551|NCT03192826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111337552|NCT03192826|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
111337553|NCT03192826|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111337554|NCT03192826|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
111337555|NCT03192826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111337556|NCT03287674|Cyclophosphamide|cyclophosphamide|mesh-list
111337557|NCT03287674|Nivolumab|nivolumab|mesh-list
111337558|NCT03287674|Fludarabine|fludarabine|mesh-list
111337559|NCT03287674|Fludarabine phosphate|fludarabine phosphate|mesh-list
111337560|NCT03287674|Ipilimumab|ipilimumab|mesh-list
111337561|NCT03287674|Interleukin-2|interleukin-2|mesh-list
111337562|NCT03287674|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111337563|NCT03287674|Immunologic Factors|immunologic factors|mesh-ancestor
111337564|NCT03287674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111337565|NCT03287674|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111337566|NCT03287674|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111337567|NCT03287674|Alkylating Agents|alkylating agents|mesh-ancestor
111337568|NCT03287674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111337569|NCT03287674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111337570|NCT03287674|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111337571|NCT03287674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111337572|NCT03287674|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111337573|NCT03287674|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111337574|NCT03287674|Antimetabolites|antimetabolites|mesh-ancestor
111337575|NCT03287674|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111337576|NCT03287674|Analgesics|analgesics|mesh-ancestor
111337577|NCT03287674|Sensory System Agents|sensory system agents|mesh-ancestor
110677331|NCT01517451|Hormones|hormones|mesh-ancestor
111337578|NCT03287674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111337579|NCT00634244|Cytarabine|cytarabine|mesh-list
111337580|NCT00634244|Sirolimus|sirolimus|mesh-list
111337581|NCT00634244|Carboplatin|carboplatin|mesh-list
111337582|NCT00634244|Etoposide|etoposide|mesh-list
111337583|NCT00634244|Etoposide phosphate|etoposide phosphate|mesh-list
111337584|NCT00634244|Topotecan|topotecan|mesh-list
111337585|NCT00634244|Mitoxantrone|mitoxantrone|mesh-list
111337586|NCT00634244|Alvocidib|alvocidib|mesh-list
111337587|NCT00634244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110677435|NCT00696111|Leuprolide|leuprolide|mesh-list
111337588|NCT00634244|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111337589|NCT00634244|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110677487|NCT00882947|Iloprost|iloprost|mesh-list
111337590|NCT00634244|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111337591|NCT00634244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111337592|NCT00634244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111337593|NCT00634244|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111337594|NCT00634244|Antimetabolites|antimetabolites|mesh-ancestor
111337595|NCT00634244|Antiviral Agents|antiviral agents|mesh-ancestor
111337596|NCT00634244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111337597|NCT00634244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111337598|NCT00634244|Immunologic Factors|immunologic factors|mesh-ancestor
111337599|NCT00634244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111337600|NCT00634244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111337601|NCT00634244|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111337602|NCT00634244|Antifungal Agents|antifungal agents|mesh-ancestor
111337603|NCT00634244|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111337604|NCT00634244|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111337605|NCT00634244|Analgesics|analgesics|mesh-ancestor
111337606|NCT00634244|Sensory System Agents|sensory system agents|mesh-ancestor
111337607|NCT00634244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111337608|NCT00634244|Growth Inhibitors|growth inhibitors|mesh-ancestor
111337609|NCT00634244|Growth Substances|growth substances|mesh-ancestor
111337610|NCT01922804|Vitamins|vitamins|mesh-list
111337611|NCT01922804|Micronutrients|micronutrients|mesh-ancestor
111337612|NCT01922804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111337613|NCT03289858|Bupivacaine|bupivacaine|mesh-list
111337614|NCT03289858|Anesthetics, Local|anesthetics, local|mesh-ancestor
111337615|NCT03289858|Anesthetics|anesthetics|mesh-ancestor
111337616|NCT03289858|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111337617|NCT03289858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111337618|NCT03289858|Sensory System Agents|sensory system agents|mesh-ancestor
111337619|NCT03289858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111337620|NCT03418714|Salvinorin A|salvinorin a|mesh-list
111337621|NCT03418714|Hallucinogens|hallucinogens|mesh-ancestor
111337622|NCT03418714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111337623|NCT03418714|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111337624|NCT03421210|Nicotine|nicotine|mesh-list
111337625|NCT03421210|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111337626|NCT03421210|Autonomic Agents|autonomic agents|mesh-ancestor
111337627|NCT03421210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111337628|NCT03421210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111337629|NCT03421210|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111337630|NCT03421210|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111337631|NCT03421210|Cholinergic Agents|cholinergic agents|mesh-ancestor
111337632|NCT03421210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111337633|NCT03421210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111337634|NCT03294850|Cholic Acids|cholic acids|mesh-list
111337635|NCT03294850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111337636|NCT00996931|Lenalidomide|lenalidomide|mesh-list
111337637|NCT00996931|Immunologic Factors|immunologic factors|mesh-ancestor
111337638|NCT00996931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111337639|NCT00996931|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111337640|NCT00996931|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111337641|NCT00996931|Growth Substances|growth substances|mesh-ancestor
111337642|NCT00996931|Growth Inhibitors|growth inhibitors|mesh-ancestor
111337643|NCT00996931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111337644|NCT00634088|Capecitabine|capecitabine|mesh-list
111337645|NCT00634088|Lapatinib|lapatinib|mesh-list
111337646|NCT00634088|Epothilones|epothilones|mesh-list
111337647|NCT00634088|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111337648|NCT00634088|Antimetabolites|antimetabolites|mesh-ancestor
111337649|NCT00634088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111337650|NCT00634088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111337651|NCT00634088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111337652|NCT00634088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111337653|NCT00634088|Tubulin Modulators|tubulin modulators|mesh-ancestor
111337654|NCT00634088|Antimitotic Agents|antimitotic agents|mesh-ancestor
111337655|NCT00634088|Mitosis Modulators|mitosis modulators|mesh-ancestor
111337656|NCT03428230|Acetaminophen|acetaminophen|mesh-list
111337657|NCT03428230|Chloroprocaine|chloroprocaine|mesh-list
111337658|NCT03428230|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111337659|NCT03428230|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111337660|NCT03428230|Analgesics|analgesics|mesh-ancestor
111337661|NCT03428230|Sensory System Agents|sensory system agents|mesh-ancestor
111337662|NCT03428230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110677722|NCT00614393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111337663|NCT03428230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111337664|NCT03428230|Antipyretics|antipyretics|mesh-ancestor
111337665|NCT03428230|Anesthetics, Local|anesthetics, local|mesh-ancestor
111337666|NCT03428230|Anesthetics|anesthetics|mesh-ancestor
111337667|NCT03428230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111337668|NCT03296800|Bexagliflozin|bexagliflozin|mesh-list
111337669|NCT03296800|Rifampin|rifampin|mesh-list
111337670|NCT03296800|Probenecid|probenecid|mesh-list
111337671|NCT03296800|Verapamil|verapamil|mesh-list
111337672|NCT03296800|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111337673|NCT03296800|Antitubercular Agents|antitubercular agents|mesh-ancestor
111337674|NCT03296800|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111337675|NCT03296800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111337676|NCT03296800|Leprostatic Agents|leprostatic agents|mesh-ancestor
111337677|NCT03296800|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111337678|NCT03296800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111337679|NCT03296800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111337680|NCT03296800|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111337681|NCT03296800|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111337682|NCT03296800|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
111337683|NCT03296800|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
111337684|NCT03296800|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
111337685|NCT03296800|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111337686|NCT03296800|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111337687|NCT03296800|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111337688|NCT03296800|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111337689|NCT03296800|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111337690|NCT03296800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111337691|NCT03296800|Vasodilator Agents|vasodilator agents|mesh-ancestor
111337692|NCT03296800|Uricosuric Agents|uricosuric agents|mesh-ancestor
111337693|NCT03296800|Gout Suppressants|gout suppressants|mesh-ancestor
111337694|NCT03296800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111337695|NCT03296800|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111337696|NCT00634010|Morphine|morphine|mesh-list
111337697|NCT00634010|Methadone|methadone|mesh-list
111337698|NCT00634010|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111337699|NCT00634010|Narcotics|narcotics|mesh-ancestor
111337700|NCT00634010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111337701|NCT00634010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111337702|NCT00634010|Analgesics|analgesics|mesh-ancestor
111337703|NCT00634010|Sensory System Agents|sensory system agents|mesh-ancestor
111337704|NCT00634010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111337705|NCT00634010|Antitussive Agents|antitussive agents|mesh-ancestor
111337706|NCT00634010|Respiratory System Agents|respiratory system agents|mesh-ancestor
111337707|NCT00633932|Esomeprazole|esomeprazole|mesh-list
111337708|NCT00633932|Omeprazole|omeprazole|mesh-list
111337709|NCT00633932|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111337710|NCT00633932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111337711|NCT00633932|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111337712|NCT00633932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110677972|NCT00888797|Analgesics|analgesics|mesh-ancestor
111337713|NCT00633932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111337714|NCT01028677|Oxytocin|oxytocin|mesh-list
111337715|NCT01028677|Oxytocics|oxytocics|mesh-ancestor
111337716|NCT01028677|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111337717|NCT01028677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111337718|NCT03302416|Hydrocortisone|hydrocortisone|mesh-list
111337719|NCT03302416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111337720|NCT01000285|Raltegravir Potassium|raltegravir potassium|mesh-list
111337721|NCT01000285|Prednisone|prednisone|mesh-list
111337722|NCT01000285|Cyclophosphamide|cyclophosphamide|mesh-list
111337723|NCT01000285|Doxorubicin|doxorubicin|mesh-list
111337724|NCT01000285|Etoposide|etoposide|mesh-list
111337725|NCT01000285|Vincristine|vincristine|mesh-list
111337726|NCT01000285|Bortezomib|bortezomib|mesh-list
111337727|NCT01000285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111337728|NCT01000285|Immunologic Factors|immunologic factors|mesh-ancestor
111337729|NCT01000285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111337730|NCT01000285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111337731|NCT01000285|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111337732|NCT01000285|Alkylating Agents|alkylating agents|mesh-ancestor
111337733|NCT01000285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111337734|NCT01000285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111337735|NCT01000285|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111337736|NCT01000285|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111337737|NCT01000285|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111337738|NCT01000285|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111337739|NCT01000285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111337740|NCT01000285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111337741|NCT01000285|Glucocorticoids|glucocorticoids|mesh-ancestor
111337742|NCT01000285|Hormones|hormones|mesh-ancestor
111337743|NCT01000285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111337744|NCT01000285|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111337745|NCT01000285|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111337746|NCT01000285|Tubulin Modulators|tubulin modulators|mesh-ancestor
111337747|NCT01000285|Antimitotic Agents|antimitotic agents|mesh-ancestor
111337748|NCT01000285|Mitosis Modulators|mitosis modulators|mesh-ancestor
111337749|NCT01000285|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111337750|NCT01000285|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111337751|NCT01000285|Antiviral Agents|antiviral agents|mesh-ancestor
111337752|NCT01000285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111337753|NCT01000285|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111337754|NCT01000285|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111337755|NCT01000987|Varenicline|varenicline|mesh-list
111337756|NCT01000987|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111337757|NCT01000987|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111337758|NCT01000987|Cholinergic Agents|cholinergic agents|mesh-ancestor
111337759|NCT01000987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111337760|NCT01000987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111337761|NCT01000987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111337762|NCT00633464|Cetuximab|cetuximab|mesh-list
111337763|NCT00633464|Epothilones|epothilones|mesh-list
111337764|NCT00633464|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111337765|NCT00633464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111337766|NCT00633464|Tubulin Modulators|tubulin modulators|mesh-ancestor
111337767|NCT00633464|Antimitotic Agents|antimitotic agents|mesh-ancestor
111337768|NCT00633464|Mitosis Modulators|mitosis modulators|mesh-ancestor
111337769|NCT00633464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111337770|NCT03437044|Clopidogrel|clopidogrel|mesh-list
111337771|NCT03437044|Ticagrelor|ticagrelor|mesh-list
111337772|NCT03437044|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111337773|NCT03437044|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111337774|NCT03437044|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111337775|NCT03437044|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111337776|NCT03437044|Purinergic Agents|purinergic agents|mesh-ancestor
111337777|NCT03437044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111337778|NCT03437044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110678520|NCT02631759|Levetiracetam|levetiracetam|mesh-list
111337779|NCT03437044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111337780|NCT01923194|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
111337781|NCT01923194|Hormones|hormones|mesh-ancestor
111337782|NCT01923194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111337783|NCT01923194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111337784|NCT03303196|Pancrelipase|pancrelipase|mesh-list
111337785|NCT03303196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111337786|NCT00633152|Linezolid|linezolid|mesh-list
111337787|NCT00633152|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
111337788|NCT00633152|Cephalosporins|cephalosporins|mesh-list
111337789|NCT00633152|Aztreonam|aztreonam|mesh-list
110678661|NCT06050941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111337790|NCT00633152|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111337791|NCT00633152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111337792|NCT00633152|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111337793|NCT00633152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111337794|NCT00633152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111062261|NCT02356588|Analgesics|analgesics|mesh-ancestor
111337796|NCT01030783|Tivozanib|tivozanib|mesh-list
111337797|NCT01030783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111337798|NCT01030783|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111337799|NCT01030783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111337800|NCT01030783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111337801|NCT00633074|Vaccines|vaccines|mesh-list
111337802|NCT00633074|Immunologic Factors|immunologic factors|mesh-ancestor
111337803|NCT00633074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111337804|NCT03304054|Amifampridine|amifampridine|mesh-list
111337805|NCT03304054|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111337806|NCT03304054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111337807|NCT03304054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111337808|NCT03304054|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
111337809|NCT03304054|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111337810|NCT03304054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111337811|NCT01929278|Clindamycin|clindamycin|mesh-list
110678740|NCT06049940|Vaccines|vaccines|mesh-list
111337812|NCT01929278|Clindamycin palmitate|clindamycin palmitate|mesh-list
111337813|NCT01929278|Clindamycin phosphate|clindamycin phosphate|mesh-list
111337814|NCT01929278|Tretinoin|tretinoin|mesh-list
111337815|NCT01929278|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111337816|NCT01929278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111337817|NCT01929278|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111337818|NCT01929278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111337819|NCT01929278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111337820|NCT01929278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111337821|NCT01929278|Keratolytic Agents|keratolytic agents|mesh-ancestor
111337822|NCT01929278|Dermatologic Agents|dermatologic agents|mesh-ancestor
111337823|NCT03210376|Neostigmine|neostigmine|mesh-list
111337824|NCT03210376|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111337825|NCT03210376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111337826|NCT03210376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111337827|NCT03210376|Cholinergic Agents|cholinergic agents|mesh-ancestor
111337828|NCT03210376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111337829|NCT03210376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111337830|NCT03210376|Parasympathomimetics|parasympathomimetics|mesh-ancestor
111337831|NCT03210376|Autonomic Agents|autonomic agents|mesh-ancestor
111337832|NCT03210376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111337833|NCT01929512|Metformin|metformin|mesh-list
111337834|NCT01929512|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111337835|NCT01929512|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111337836|NCT01929512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111337837|NCT01929512|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111337838|NCT01929512|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111337839|NCT01929512|Antimetabolites|antimetabolites|mesh-ancestor
111337840|NCT01929512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111337841|NCT01929512|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111337842|NCT01929512|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111337843|NCT01929512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111337844|NCT03211234|Ranibizumab|ranibizumab|mesh-list
111337845|NCT03211234|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111337846|NCT03211234|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111337847|NCT03211234|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111337848|NCT03211234|Growth Substances|growth substances|mesh-ancestor
111337849|NCT03211234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111337850|NCT03211234|Growth Inhibitors|growth inhibitors|mesh-ancestor
111337851|NCT03211234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111337852|NCT03105518|Acetaminophen|acetaminophen|mesh-list
111337853|NCT03105518|Fentanyl|fentanyl|mesh-list
111337854|NCT03105518|Oxycodone|oxycodone|mesh-list
111337855|NCT03105518|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111337856|NCT03105518|Narcotics|narcotics|mesh-ancestor
111337857|NCT03105518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111337858|NCT03105518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111337859|NCT03105518|Analgesics|analgesics|mesh-ancestor
111337860|NCT03105518|Sensory System Agents|sensory system agents|mesh-ancestor
111337861|NCT03105518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111337862|NCT03105518|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111337863|NCT03105518|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111337864|NCT03105518|Anesthetics, General|anesthetics, general|mesh-ancestor
111337865|NCT03105518|Anesthetics|anesthetics|mesh-ancestor
111337866|NCT03105518|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111337867|NCT03105518|Antipyretics|antipyretics|mesh-ancestor
111337868|NCT01929668|Ascorbic Acid|ascorbic acid|mesh-list
111337869|NCT01929668|Antioxidants|antioxidants|mesh-ancestor
111062340|NCT04179019|Amlodipine|amlodipine|mesh-list
111337870|NCT01929668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111337871|NCT01929668|Protective Agents|protective agents|mesh-ancestor
111337872|NCT01929668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111337873|NCT01929668|Vitamins|vitamins|mesh-ancestor
111337874|NCT01929668|Micronutrients|micronutrients|mesh-ancestor
111337875|NCT01929746|Daclizumab|daclizumab|mesh-list
111337876|NCT01929746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111337877|NCT01929746|Immunologic Factors|immunologic factors|mesh-ancestor
111337878|NCT01929746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111337879|NCT03506048|Lenvatinib|lenvatinib|mesh-list
111337880|NCT03506048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111337881|NCT03506048|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111337882|NCT03506048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111337883|NCT03506048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111337884|NCT02161705|Ropivacaine|ropivacaine|mesh-list
111337885|NCT02161705|Anesthetics, Local|anesthetics, local|mesh-ancestor
111337886|NCT02161705|Anesthetics|anesthetics|mesh-ancestor
111337887|NCT02161705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111337888|NCT02161705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111337889|NCT02161705|Sensory System Agents|sensory system agents|mesh-ancestor
111337890|NCT02161705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111337891|NCT01929824|Nitric Oxide|nitric oxide|mesh-list
111337892|NCT01929824|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111337893|NCT01929824|Autonomic Agents|autonomic agents|mesh-ancestor
111337894|NCT01929824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111337895|NCT01929824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111337896|NCT01929824|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111337897|NCT01929824|Respiratory System Agents|respiratory system agents|mesh-ancestor
111337898|NCT01929824|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111337899|NCT01929824|Antioxidants|antioxidants|mesh-ancestor
111337900|NCT01929824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111337901|NCT01929824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111337902|NCT01929824|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
111337903|NCT01929824|Vasodilator Agents|vasodilator agents|mesh-ancestor
111337904|NCT01929824|Gasotransmitters|gasotransmitters|mesh-ancestor
111337905|NCT01929824|Protective Agents|protective agents|mesh-ancestor
111337906|NCT01031953|Fosaprepitant|fosaprepitant|mesh-list
111337907|NCT01031953|Aprepitant|aprepitant|mesh-list
111337908|NCT01031953|Antiemetics|antiemetics|mesh-ancestor
111337909|NCT01031953|Autonomic Agents|autonomic agents|mesh-ancestor
110679079|NCT05932303|Analgesics|analgesics|mesh-ancestor
111337910|NCT01031953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111337911|NCT01031953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111337912|NCT01031953|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110683010|NCT00904631|Analgesics|analgesics|mesh-ancestor
111337913|NCT01031953|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
111337914|NCT01031953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111337915|NCT01031953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111337916|NCT01923584|Ubiquinone|ubiquinone|mesh-list
111337917|NCT01923584|Micronutrients|micronutrients|mesh-ancestor
111337918|NCT01923584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111337919|NCT00630344|Everolimus|everolimus|mesh-list
111337920|NCT00630344|Bicalutamide|bicalutamide|mesh-list
111337921|NCT00630344|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111337922|NCT00630344|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111337923|NCT00630344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111337924|NCT00630344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111337925|NCT00630344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111337926|NCT00630344|Immunologic Factors|immunologic factors|mesh-ancestor
111337927|NCT00630344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111337928|NCT00630344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111337929|NCT00630344|Androgen Antagonists|androgen antagonists|mesh-ancestor
111337930|NCT00630344|Hormone Antagonists|hormone antagonists|mesh-ancestor
111337931|NCT00630344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111337932|NCT01923818|Aspirin|aspirin|mesh-list
111337933|NCT01923818|Rivaroxaban|rivaroxaban|mesh-list
111337934|NCT01923818|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111337935|NCT01923818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111337936|NCT01923818|Analgesics|analgesics|mesh-ancestor
111337937|NCT01923818|Sensory System Agents|sensory system agents|mesh-ancestor
111337938|NCT01923818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111337939|NCT01923818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111337940|NCT01923818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111337941|NCT01923818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111337942|NCT01923818|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111337943|NCT01923818|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111337944|NCT01923818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111337945|NCT01923818|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111337946|NCT01923818|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111337947|NCT01923818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111337948|NCT01923818|Antipyretics|antipyretics|mesh-ancestor
111337949|NCT01923818|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111337950|NCT01923818|Antithrombins|antithrombins|mesh-ancestor
111337951|NCT01923818|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111337952|NCT01923818|Protease Inhibitors|protease inhibitors|mesh-ancestor
111337953|NCT01923818|Anticoagulants|anticoagulants|mesh-ancestor
111337954|NCT02169115|Omalizumab|omalizumab|mesh-list
111337955|NCT02169115|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111337956|NCT02169115|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111337957|NCT02169115|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111337958|NCT02169115|Respiratory System Agents|respiratory system agents|mesh-ancestor
111337959|NCT02169115|Immunologic Factors|immunologic factors|mesh-ancestor
111337960|NCT02169115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111337961|NCT00376792|Docetaxel|docetaxel|mesh-list
110679466|NCT05512949|Antiviral Agents|antiviral agents|mesh-ancestor
111337962|NCT00376792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111337963|NCT00376792|Tubulin Modulators|tubulin modulators|mesh-ancestor
111337964|NCT00376792|Antimitotic Agents|antimitotic agents|mesh-ancestor
111337965|NCT00376792|Mitosis Modulators|mitosis modulators|mesh-ancestor
111337966|NCT00376792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111337967|NCT00635882|Mometasone Furoate|mometasone furoate|mesh-list
111337968|NCT00635882|Formoterol Fumarate|formoterol fumarate|mesh-list
111337969|NCT00635882|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111337970|NCT00635882|Autonomic Agents|autonomic agents|mesh-ancestor
111337971|NCT00635882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111337972|NCT00635882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111337973|NCT00635882|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111337974|NCT00635882|Respiratory System Agents|respiratory system agents|mesh-ancestor
111337975|NCT00635882|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110679619|NCT05267600|Hormones|hormones|mesh-ancestor
111337976|NCT00635882|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111337977|NCT00635882|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111337978|NCT00635882|Adrenergic Agents|adrenergic agents|mesh-ancestor
111337979|NCT00635882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111337980|NCT00635882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111337981|NCT00635882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111337982|NCT00635882|Dermatologic Agents|dermatologic agents|mesh-ancestor
111337983|NCT00635882|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111337984|NCT03316378|Ropivacaine|ropivacaine|mesh-list
111337985|NCT03316378|Anesthetics, Local|anesthetics, local|mesh-ancestor
111337986|NCT03316378|Anesthetics|anesthetics|mesh-ancestor
111337987|NCT03316378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111337988|NCT03316378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110326963|NCT00440661|Diacerein|diacerein|mesh-list
111337989|NCT03316378|Sensory System Agents|sensory system agents|mesh-ancestor
111337990|NCT03316378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111337991|NCT00637130|Travoprost|travoprost|mesh-list
110679938|NCT04762498|Immunologic Factors|immunologic factors|mesh-ancestor
111337992|NCT00637130|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111337993|NCT00637130|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111337994|NCT00637130|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111337995|NCT02847559|Bevacizumab|bevacizumab|mesh-list
110680010|NCT04644068|Tubulin Modulators|tubulin modulators|mesh-ancestor
111337996|NCT02847559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111337997|NCT02847559|Endothelial Growth Factors|endothelial growth factors|mesh-list
111337998|NCT02847559|Antibodies|antibodies|mesh-list
111337999|NCT02847559|Immunoglobulins|immunoglobulins|mesh-list
111338000|NCT02847559|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111338001|NCT02847559|Immunoglobulin G|immunoglobulin g|mesh-list
111338002|NCT02847559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111338003|NCT02847559|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111338004|NCT02847559|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111338005|NCT02847559|Growth Substances|growth substances|mesh-ancestor
111338006|NCT02847559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111338007|NCT02847559|Growth Inhibitors|growth inhibitors|mesh-ancestor
111338008|NCT02847559|Immunologic Factors|immunologic factors|mesh-ancestor
111338009|NCT00637052|Filanesib|filanesib|mesh-list
111338010|NCT00637052|Antimitotic Agents|antimitotic agents|mesh-ancestor
111338011|NCT00637052|Mitosis Modulators|mitosis modulators|mesh-ancestor
110680240|NCT04388839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111338012|NCT00637052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111338013|NCT00637052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111338014|NCT01921868|Acetylcarnitine|acetylcarnitine|mesh-list
111338015|NCT01921868|Vitamin B Complex|vitamin b complex|mesh-ancestor
111338016|NCT01921868|Vitamins|vitamins|mesh-ancestor
111338017|NCT01921868|Micronutrients|micronutrients|mesh-ancestor
110680322|NCT04278404|Antimetabolites|antimetabolites|mesh-ancestor
111338018|NCT01921868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111062517|NCT02258074|Niacin|niacin|mesh-list
111338019|NCT01921868|Nootropic Agents|nootropic agents|mesh-ancestor
111338020|NCT02150785|Streptokinase|streptokinase|mesh-list
111338021|NCT02150785|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111338022|NCT02150785|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111338023|NCT02150785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111338024|NCT01926158|Denosumab|denosumab|mesh-list
111338025|NCT01926158|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111338026|NCT01926158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111338027|NCT03445390|Acetaminophen|acetaminophen|mesh-list
111338028|NCT03445390|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111338029|NCT03445390|Analgesics|analgesics|mesh-ancestor
111338030|NCT03445390|Sensory System Agents|sensory system agents|mesh-ancestor
111338031|NCT03445390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111338032|NCT03445390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111338033|NCT03445390|Antipyretics|antipyretics|mesh-ancestor
111338034|NCT00981890|Sunitinib|sunitinib|mesh-list
111338035|NCT00981890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110680557|NCT03807765|Nivolumab|nivolumab|mesh-list
111338036|NCT00981890|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111338037|NCT00981890|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111338038|NCT00981890|Growth Substances|growth substances|mesh-ancestor
111338039|NCT00981890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111338040|NCT00981890|Growth Inhibitors|growth inhibitors|mesh-ancestor
111338041|NCT00981890|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111338042|NCT00981890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111338043|NCT00981890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111338044|NCT03221764|Amiodarone|amiodarone|mesh-list
111338045|NCT03221764|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110680753|NCT03299088|Pembrolizumab|pembrolizumab|mesh-list
111338046|NCT03221764|Vasodilator Agents|vasodilator agents|mesh-ancestor
111338047|NCT03221764|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
111338048|NCT03221764|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110680816|NCT03177291|Analgesics|analgesics|mesh-ancestor
111338049|NCT03221764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111338050|NCT03221764|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111338051|NCT03221764|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111338052|NCT03221764|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111338053|NCT03221764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111338054|NCT03221764|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111338055|NCT03221764|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111338056|NCT03221764|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111338057|NCT03122444|Imipramine|imipramine|mesh-list
111338058|NCT03122444|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
111338059|NCT03122444|Antidepressive Agents|antidepressive agents|mesh-ancestor
111338060|NCT03122444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111338061|NCT03122444|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111338062|NCT03122444|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111338063|NCT03122444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111338064|NCT03122444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111338065|NCT03122444|Adrenergic Agents|adrenergic agents|mesh-ancestor
111338066|NCT03122444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111338067|NCT03122444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111338068|NCT02169427|Opicapone|opicapone|mesh-list
111338069|NCT02169427|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
111338070|NCT02169427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111338071|NCT02169427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111338072|NCT02169427|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111338073|NCT02169427|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111338074|NCT03454048|Pyrimethamine|pyrimethamine|mesh-list
111338075|NCT03454048|Piperaquine|piperaquine|mesh-list
111338076|NCT03454048|Sulfadoxine|sulfadoxine|mesh-list
111338077|NCT03454048|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
111338078|NCT03454048|Atovaquone|atovaquone|mesh-list
111338079|NCT03454048|Proguanil|proguanil|mesh-list
111338080|NCT03454048|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
111338081|NCT03454048|Antimalarials|antimalarials|mesh-ancestor
111338082|NCT03454048|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111338083|NCT03454048|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111338084|NCT03454048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111338085|NCT03454048|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111338086|NCT03454048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111338087|NCT03454048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110681112|NCT01107522|Alkylating Agents|alkylating agents|mesh-ancestor
111338088|NCT03454048|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111338089|NCT03454048|Antimetabolites|antimetabolites|mesh-ancestor
111338090|NCT04396184|Aminolevulinic Acid|aminolevulinic acid|mesh-list
111338091|NCT04396184|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111338092|NCT04396184|Dermatologic Agents|dermatologic agents|mesh-ancestor
111338093|NCT01924286|Prednisone|prednisone|mesh-list
111338094|NCT01924286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111338095|NCT01924286|Glucocorticoids|glucocorticoids|mesh-ancestor
111338097|NCT01924286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111338098|NCT01924286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111338099|NCT01924286|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111338100|NCT01924286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111338101|NCT03455218|Nitric Oxide|nitric oxide|mesh-list
111338102|NCT03455218|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111338103|NCT03455218|Autonomic Agents|autonomic agents|mesh-ancestor
111338104|NCT03455218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111338105|NCT03455218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111338106|NCT03455218|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111338107|NCT03455218|Respiratory System Agents|respiratory system agents|mesh-ancestor
111338108|NCT03455218|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111338109|NCT03455218|Antioxidants|antioxidants|mesh-ancestor
111338110|NCT03455218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111338111|NCT03455218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111338112|NCT03455218|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
111338113|NCT03455218|Vasodilator Agents|vasodilator agents|mesh-ancestor
111338114|NCT03455218|Gasotransmitters|gasotransmitters|mesh-ancestor
111338115|NCT03455218|Protective Agents|protective agents|mesh-ancestor
111338116|NCT01050907|Miltefosine|miltefosine|mesh-list
111338117|NCT01050907|Antifungal Agents|antifungal agents|mesh-ancestor
111338118|NCT01050907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111338119|NCT01050907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111338120|NCT01050907|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111338121|NCT01050907|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111338122|NCT01924520|Quetiapine Fumarate|quetiapine fumarate|mesh-list
111338123|NCT01924520|Antidepressive Agents|antidepressive agents|mesh-ancestor
111338124|NCT01924520|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111338125|NCT01924520|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111338126|NCT01924520|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111338127|NCT01924520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111338128|NCT01924520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111338129|NCT04433845|Psilocybin|psilocybin|mesh-list
111338130|NCT04433845|Hallucinogens|hallucinogens|mesh-ancestor
111338131|NCT04433845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111338132|NCT04433845|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111338133|NCT01920386|Acetaminophen|acetaminophen|mesh-list
111338134|NCT01920386|Tramadol|tramadol|mesh-list
111338135|NCT01920386|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111338136|NCT01920386|Analgesics|analgesics|mesh-ancestor
111338137|NCT01920386|Sensory System Agents|sensory system agents|mesh-ancestor
111338138|NCT01920386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111338139|NCT01920386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111338140|NCT01920386|Antipyretics|antipyretics|mesh-ancestor
111338141|NCT01920386|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111338142|NCT01920386|Narcotics|narcotics|mesh-ancestor
111338143|NCT01920386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111338144|NCT03460990|Ivacaftor|ivacaftor|mesh-list
111338145|NCT03460990|VX-659|vx-659|mesh-list
111338146|NCT03460990|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
111338147|NCT03460990|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111338148|NCT03460990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111338149|NCT01924832|Dimethyl Fumarate|dimethyl fumarate|mesh-list
111338150|NCT01924832|Dermatologic Agents|dermatologic agents|mesh-ancestor
111338151|NCT01924832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111338152|NCT01924832|Immunologic Factors|immunologic factors|mesh-ancestor
111338153|NCT01924832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111338154|NCT01920542|Dexmedetomidine|dexmedetomidine|mesh-list
111338155|NCT01920542|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111338156|NCT01920542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111338157|NCT01920542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111338158|NCT01920542|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111338159|NCT01920542|Analgesics|analgesics|mesh-ancestor
111338160|NCT01920542|Sensory System Agents|sensory system agents|mesh-ancestor
111338161|NCT01920542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111338162|NCT01920542|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110681270|NCT00346216|Ibuprofen|ibuprofen|mesh-list
111338163|NCT01920542|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111338164|NCT01920542|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111338165|NCT01920542|Adrenergic Agents|adrenergic agents|mesh-ancestor
111338166|NCT01920542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111338167|NCT01920542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111338168|NCT03319810|gamma-Globulins|gamma-globulins|mesh-list
111338169|NCT03319810|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111338170|NCT03319810|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
111338171|NCT03319810|Immunologic Factors|immunologic factors|mesh-ancestor
111338172|NCT03319810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111338173|NCT01052701|Ribavirin|ribavirin|mesh-list
111338174|NCT01052701|Abacavir|abacavir|mesh-list
111338175|NCT01052701|Antimetabolites|antimetabolites|mesh-ancestor
111338176|NCT01052701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111338177|NCT01052701|Antiviral Agents|antiviral agents|mesh-ancestor
111338178|NCT01052701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111338179|NCT01052701|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111338180|NCT01052701|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111338181|NCT01052701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111338182|NCT01052701|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111338183|NCT01052701|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111338184|NCT01921010|Niacin|niacin|mesh-list
111338185|NCT01921010|Nicotinic Acids|nicotinic acids|mesh-list
111338186|NCT01921010|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111338187|NCT01921010|Antimetabolites|antimetabolites|mesh-ancestor
111338188|NCT01921010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111338189|NCT01921010|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111338190|NCT01921010|Vasodilator Agents|vasodilator agents|mesh-ancestor
111338191|NCT01921010|Vitamin B Complex|vitamin b complex|mesh-ancestor
111338192|NCT01921010|Vitamins|vitamins|mesh-ancestor
111338193|NCT01921010|Micronutrients|micronutrients|mesh-ancestor
111338194|NCT01921010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111338195|NCT03325816|Nivolumab|nivolumab|mesh-list
111338196|NCT03325816|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
111338197|NCT03325816|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111338198|NCT03325816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111338199|NCT03325816|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111338200|NCT03325816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111338201|NCT03325816|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111338202|NCT00986570|Botulinum Toxins|botulinum toxins|mesh-list
111338203|NCT00986570|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111338204|NCT00986570|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111338205|NCT00986570|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111338206|NCT00986570|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111338207|NCT00986570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111338208|NCT00986570|Cholinergic Agents|cholinergic agents|mesh-ancestor
111338209|NCT00986570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110681757|NCT00345046|Prednisolone|prednisolone|mesh-list
111338210|NCT00986570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111338211|NCT00986570|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111338212|NCT00986570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111338213|NCT00986258|Tapentadol|tapentadol|mesh-list
111338214|NCT00986258|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111338215|NCT00986258|Narcotics|narcotics|mesh-ancestor
111338216|NCT00986258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111338217|NCT00986258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111338218|NCT00986258|Analgesics|analgesics|mesh-ancestor
111338219|NCT00986258|Sensory System Agents|sensory system agents|mesh-ancestor
111338220|NCT00986258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111338221|NCT00986258|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111338222|NCT00986258|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111338223|NCT00986258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111338224|NCT00986258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111338225|NCT00986258|Adrenergic Agents|adrenergic agents|mesh-ancestor
111338226|NCT00986258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111338227|NCT00986180|Oxycodone|oxycodone|mesh-list
111338228|NCT00986180|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111338229|NCT00986180|Narcotics|narcotics|mesh-ancestor
111338230|NCT00986180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111338231|NCT00986180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111338232|NCT00986180|Analgesics|analgesics|mesh-ancestor
111338233|NCT00986180|Sensory System Agents|sensory system agents|mesh-ancestor
111338234|NCT00986180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111338235|NCT01056601|Bortezomib|bortezomib|mesh-list
111338236|NCT01056601|Panobinostat|panobinostat|mesh-list
111338237|NCT01056601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111338238|NCT01056601|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111338239|NCT01056601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111338240|NCT01056601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111338241|NCT03014947|Adalimumab|adalimumab|mesh-list
110316950|NCT00344994|Pramipexole|pramipexole|mesh-list
111338242|NCT03014947|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111338243|NCT03014947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111338244|NCT03014947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111338245|NCT01057225|Thalidomide|thalidomide|mesh-list
111338246|NCT01057225|Dexamethasone|dexamethasone|mesh-list
111338247|NCT01057225|Cyclophosphamide|cyclophosphamide|mesh-list
111338248|NCT01057225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111338249|NCT01057225|Immunologic Factors|immunologic factors|mesh-ancestor
111338250|NCT01057225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111338251|NCT01057225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111338252|NCT01057225|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111338253|NCT01057225|Alkylating Agents|alkylating agents|mesh-ancestor
111338254|NCT01057225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111338255|NCT01057225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111338256|NCT01057225|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111338257|NCT01057225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111338258|NCT01057225|Antiemetics|antiemetics|mesh-ancestor
111338259|NCT01057225|Autonomic Agents|autonomic agents|mesh-ancestor
111338260|NCT01057225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111338261|NCT01057225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111338262|NCT01057225|Glucocorticoids|glucocorticoids|mesh-ancestor
111338263|NCT01057225|Hormones|hormones|mesh-ancestor
110682164|NCT00609245|Valproic Acid|valproic acid|mesh-list
111338264|NCT01057225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111338265|NCT01057225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111338266|NCT01057225|Leprostatic Agents|leprostatic agents|mesh-ancestor
111338267|NCT01057225|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111338268|NCT01057225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111338269|NCT01057225|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111338270|NCT01057225|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111338271|NCT01057225|Growth Substances|growth substances|mesh-ancestor
111338272|NCT01057225|Growth Inhibitors|growth inhibitors|mesh-ancestor
111338273|NCT01057381|Dexmedetomidine|dexmedetomidine|mesh-list
111338274|NCT01057381|Morphine|morphine|mesh-list
111338275|NCT01057381|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110682293|NCT00606281|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111338276|NCT01057381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111338277|NCT01057381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111338278|NCT01057381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111338279|NCT01057381|Analgesics|analgesics|mesh-ancestor
111338280|NCT01057381|Sensory System Agents|sensory system agents|mesh-ancestor
111338281|NCT01057381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110682377|NCT01012830|Huperzine A|huperzine a|mesh-list
111338282|NCT01057381|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111338283|NCT01057381|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111338284|NCT01057381|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111338285|NCT01057381|Adrenergic Agents|adrenergic agents|mesh-ancestor
111338286|NCT01057381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111338287|NCT01057381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111338288|NCT01057381|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111338289|NCT01057381|Narcotics|narcotics|mesh-ancestor
111338290|NCT00986102|Doripenem|doripenem|mesh-list
111338291|NCT00986102|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111338292|NCT00986102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111338293|NCT01058239|Rituximab|rituximab|mesh-list
111338294|NCT01058239|Bortezomib|bortezomib|mesh-list
111338295|NCT01058239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111338296|NCT01058239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111338297|NCT01058239|Immunologic Factors|immunologic factors|mesh-ancestor
110682572|NCT00892307|Purinergic Agents|purinergic agents|mesh-ancestor
111338298|NCT01058239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111338299|NCT01058239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111338300|NCT01058941|Thioctic Acid|thioctic acid|mesh-list
111338301|NCT01058941|Antioxidants|antioxidants|mesh-ancestor
111338302|NCT01058941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111338303|NCT01058941|Protective Agents|protective agents|mesh-ancestor
111338304|NCT01058941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111338305|NCT01058941|Vitamin B Complex|vitamin b complex|mesh-ancestor
111338306|NCT01058941|Vitamins|vitamins|mesh-ancestor
111338307|NCT01058941|Micronutrients|micronutrients|mesh-ancestor
111338308|NCT00985946|Panobinostat|panobinostat|mesh-list
111338309|NCT00985946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111338310|NCT00985946|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111338311|NCT00985946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111338312|NCT00985946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111338313|NCT02170519|Iloprost|iloprost|mesh-list
111338314|NCT02170519|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111338315|NCT02170519|Vasodilator Agents|vasodilator agents|mesh-ancestor
111338316|NCT00985712|Insulin Lispro|insulin lispro|mesh-list
111338317|NCT00985712|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111338318|NCT00985712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111338319|NCT04275284|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110682648|NCT05278637|Aspirin|aspirin|mesh-list
111338320|NCT04275284|Immunologic Factors|immunologic factors|mesh-ancestor
111338321|NCT04275284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111338322|NCT01924910|Vitamin D|vitamin d|mesh-list
111338323|NCT01924910|Cholecalciferol|cholecalciferol|mesh-list
111338324|NCT01924910|Vitamins|vitamins|mesh-ancestor
111338325|NCT01924910|Micronutrients|micronutrients|mesh-ancestor
110682697|NCT00895115|Vitamin E|vitamin e|mesh-list
111338326|NCT01924910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111338327|NCT01924910|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111338328|NCT01924910|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111338329|NCT04395638|Vitamin D|vitamin d|mesh-list
111338330|NCT04395638|Ergocalciferols|ergocalciferols|mesh-list
111338331|NCT04395638|Cholecalciferol|cholecalciferol|mesh-list
111338332|NCT04395638|Vitamins|vitamins|mesh-list
111338333|NCT04395638|Micronutrients|micronutrients|mesh-ancestor
111338334|NCT04395638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111338335|NCT04395638|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111338336|NCT04395638|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111338337|NCT04347980|Hydroxychloroquine|hydroxychloroquine|mesh-list
111338338|NCT04347980|Dexamethasone|dexamethasone|mesh-list
111338339|NCT04347980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111338340|NCT04347980|Antiemetics|antiemetics|mesh-ancestor
111338341|NCT04347980|Autonomic Agents|autonomic agents|mesh-ancestor
111338342|NCT04347980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111338343|NCT04347980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111338344|NCT04347980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111338345|NCT04347980|Glucocorticoids|glucocorticoids|mesh-ancestor
111338346|NCT04347980|Hormones|hormones|mesh-ancestor
111338347|NCT04347980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111338348|NCT04347980|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111338349|NCT04347980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111338350|NCT04347980|Antimalarials|antimalarials|mesh-ancestor
111338351|NCT04347980|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111338352|NCT04347980|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111338353|NCT04347980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111338354|NCT04347980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111338355|NCT04347980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111338356|NCT04347980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111338357|NCT01925300|Bisoprolol|bisoprolol|mesh-list
111338358|NCT01925300|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111338359|NCT01925300|Calcium|calcium|mesh-list
111338360|NCT01925300|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111338361|NCT01925300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111338362|NCT01925300|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111338363|NCT01925300|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111338364|NCT01925300|Antimetabolites|antimetabolites|mesh-ancestor
111338365|NCT01925300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111338366|NCT01925300|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111338367|NCT01925300|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111338368|NCT01925300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111338369|NCT01925300|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111338370|NCT01925300|Sympatholytics|sympatholytics|mesh-ancestor
111338371|NCT01925300|Autonomic Agents|autonomic agents|mesh-ancestor
111338372|NCT01925300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111338373|NCT01925300|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
111338374|NCT01925300|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111338375|NCT01925300|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111338376|NCT01925300|Adrenergic Agents|adrenergic agents|mesh-ancestor
111338377|NCT01925300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111338378|NCT01921946|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111338379|NCT01921946|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111338380|NCT01921946|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111338381|NCT01921946|Antimetabolites|antimetabolites|mesh-ancestor
111338382|NCT01921946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111338383|NCT01921946|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111338384|NCT01921946|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111338385|NCT01921946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111338386|NCT01925378|Nelfinavir|nelfinavir|mesh-list
111338387|NCT01925378|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111338388|NCT01925378|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111338389|NCT01925378|Protease Inhibitors|protease inhibitors|mesh-ancestor
111338390|NCT01925378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111338391|NCT01925378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111338392|NCT01925378|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111338393|NCT01925378|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111338394|NCT01925378|Antiviral Agents|antiviral agents|mesh-ancestor
111338395|NCT01925378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111338396|NCT01925456|Fesoterodine|fesoterodine|mesh-list
111338397|NCT01925456|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111338398|NCT01925456|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111338399|NCT01925456|Cholinergic Agents|cholinergic agents|mesh-ancestor
111338400|NCT01925456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111338401|NCT01925456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111338402|NCT01925456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111338403|NCT01925456|Urological Agents|urological agents|mesh-ancestor
111338404|NCT02226159|Dexamethasone|dexamethasone|mesh-list
111338405|NCT02226159|Dexamethasone acetate|dexamethasone acetate|mesh-list
111338406|NCT02226159|Lidocaine|lidocaine|mesh-list
111338407|NCT02226159|BB 1101|bb 1101|mesh-list
110687779|NCT00299182|Autonomic Agents|autonomic agents|mesh-ancestor
111338408|NCT02226159|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111338409|NCT02226159|Antiemetics|antiemetics|mesh-ancestor
111338410|NCT02226159|Autonomic Agents|autonomic agents|mesh-ancestor
111338411|NCT02226159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111338412|NCT02226159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111338413|NCT02226159|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111338414|NCT02226159|Glucocorticoids|glucocorticoids|mesh-ancestor
111338415|NCT02226159|Hormones|hormones|mesh-ancestor
111338416|NCT02226159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111338417|NCT02226159|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111338418|NCT02226159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111338419|NCT02226159|Protease Inhibitors|protease inhibitors|mesh-ancestor
111338420|NCT02226159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111338421|NCT02226159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111338422|NCT02226159|Anesthetics, Local|anesthetics, local|mesh-ancestor
111338423|NCT02226159|Anesthetics|anesthetics|mesh-ancestor
111338424|NCT02226159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111338425|NCT02226159|Sensory System Agents|sensory system agents|mesh-ancestor
110687864|NCT01060696|Mefenamic Acid|mefenamic acid|mesh-list
111338426|NCT02226159|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111338427|NCT02226159|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111338428|NCT02226159|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111338429|NCT02226159|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111338430|NCT03241030|Acetaminophen|acetaminophen|mesh-list
111338431|NCT03241030|Ibuprofen|ibuprofen|mesh-list
111338432|NCT03241030|Sucralfate|sucralfate|mesh-list
111338433|NCT03241030|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111338434|NCT03241030|Analgesics|analgesics|mesh-ancestor
111338435|NCT03241030|Sensory System Agents|sensory system agents|mesh-ancestor
111338436|NCT03241030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110687999|NCT00507416|Thalidomide|thalidomide|mesh-list
111338437|NCT03241030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111338438|NCT03241030|Antipyretics|antipyretics|mesh-ancestor
111338439|NCT03241030|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111338440|NCT03241030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111338441|NCT03241030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111338442|NCT03241030|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111338443|NCT03241030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111338444|NCT03241030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111338445|NCT03241030|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111338446|NCT03241030|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111338447|NCT03241810|Fulvestrant|fulvestrant|mesh-list
111338448|NCT03241810|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111338449|NCT03241810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111338450|NCT03241810|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110688175|NCT00548249|Iron|iron|mesh-list
111338451|NCT03241810|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111338452|NCT03241810|Hormone Antagonists|hormone antagonists|mesh-ancestor
111338453|NCT03241810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111338454|NCT03241810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111338455|NCT02129751|Bupropion|bupropion|mesh-list
111338456|NCT02129751|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111338457|NCT02129751|Antidepressive Agents|antidepressive agents|mesh-ancestor
111338458|NCT02129751|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111338459|NCT02129751|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111338460|NCT02129751|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111338461|NCT02129751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111338462|NCT02129751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111338463|NCT02129751|Dopamine Agents|dopamine agents|mesh-ancestor
111338464|NCT02129751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111338465|NCT02129751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111338466|NCT02129751|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111338467|NCT02129751|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111338468|NCT02129751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111338469|NCT03242590|Methyltestosterone|methyltestosterone|mesh-list
111338470|NCT03242590|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
111338471|NCT03242590|Testosterone|testosterone|mesh-list
111338472|NCT03242590|Testosterone undecanoate|testosterone undecanoate|mesh-list
111338473|NCT03242590|Testosterone enanthate|testosterone enanthate|mesh-list
111338474|NCT03242590|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110688344|NCT01022736|Anticonvulsants|anticonvulsants|mesh-ancestor
111338475|NCT03242590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111338476|NCT03242590|Anabolic Agents|anabolic agents|mesh-ancestor
111338477|NCT03242590|Hormones|hormones|mesh-ancestor
111338478|NCT03242590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111338479|NCT03242590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111338480|NCT03242590|Androgens|androgens|mesh-ancestor
111338481|NCT03247738|Cangrelor|cangrelor|mesh-list
111338482|NCT03247738|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111338483|NCT03247738|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111338484|NCT03247738|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111338485|NCT03247738|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111338486|NCT03247738|Purinergic Agents|purinergic agents|mesh-ancestor
111338487|NCT03247738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111338488|NCT03247738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111338489|NCT03247738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111338490|NCT03345160|Immunomodulating Agents|immunomodulating agents|mesh-list
111338491|NCT03345160|Immunologic Factors|immunologic factors|mesh-ancestor
111338492|NCT03345160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111338493|NCT01567605|Lidocaine|lidocaine|mesh-list
111338494|NCT01567605|Anesthetics, Local|anesthetics, local|mesh-ancestor
111338495|NCT01567605|Anesthetics|anesthetics|mesh-ancestor
111338496|NCT01567605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111338497|NCT01567605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111338498|NCT01567605|Sensory System Agents|sensory system agents|mesh-ancestor
111338499|NCT01567605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111338500|NCT01567605|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111338501|NCT01567605|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111338502|NCT01567605|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111338503|NCT01567605|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111338504|NCT01567605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111338505|NCT02604537|Ketorolac|ketorolac|mesh-list
111338506|NCT02604537|Betamethasone|betamethasone|mesh-list
111338507|NCT02604537|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111338508|NCT02604537|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111338509|NCT02604537|Analgesics|analgesics|mesh-ancestor
111338510|NCT02604537|Sensory System Agents|sensory system agents|mesh-ancestor
111338511|NCT02604537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111338512|NCT02604537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111338513|NCT02604537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111338514|NCT02604537|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111338515|NCT02604537|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111338516|NCT02604537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111338517|NCT02604537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111338518|NCT02604537|Glucocorticoids|glucocorticoids|mesh-ancestor
111338519|NCT02604537|Hormones|hormones|mesh-ancestor
111338520|NCT02604537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111338521|NCT02604537|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111338522|NCT02604537|Respiratory System Agents|respiratory system agents|mesh-ancestor
111338523|NCT01384773|Riboflavin|riboflavin|mesh-list
111338524|NCT01384773|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111338525|NCT01384773|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111338526|NCT01384773|Vitamin B Complex|vitamin b complex|mesh-ancestor
111338527|NCT01384773|Vitamins|vitamins|mesh-ancestor
111338528|NCT01384773|Micronutrients|micronutrients|mesh-ancestor
111338529|NCT01384773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111338530|NCT01384773|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111338531|NCT01384773|Dermatologic Agents|dermatologic agents|mesh-ancestor
111338532|NCT01063075|Carboplatin|carboplatin|mesh-list
111338533|NCT01063075|Cetuximab|cetuximab|mesh-list
111338534|NCT01063075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111338535|NCT01063075|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111338536|NCT01341405|Celecoxib|celecoxib|mesh-list
111338537|NCT01341405|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111338538|NCT01341405|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111338539|NCT01341405|Analgesics|analgesics|mesh-ancestor
111338540|NCT01341405|Sensory System Agents|sensory system agents|mesh-ancestor
111338541|NCT01341405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110688743|NCT00547703|Adrenergic Agents|adrenergic agents|mesh-ancestor
111338542|NCT01341405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111338543|NCT01341405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111338544|NCT01341405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111338545|NCT01341405|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111338546|NCT01341405|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111338547|NCT01341405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111338548|NCT01341405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111338549|NCT05136157|Insulin|insulin|mesh-list
111338550|NCT05136157|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111338551|NCT05136157|Insulin, Short-Acting|insulin, short-acting|mesh-list
111338552|NCT05136157|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111338553|NCT05136157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111338554|NCT01921790|Dexamethasone|dexamethasone|mesh-list
111338555|NCT01921790|Gemcitabine|gemcitabine|mesh-list
111338556|NCT01921790|Oxaliplatin|oxaliplatin|mesh-list
111338557|NCT01921790|Bevacizumab|bevacizumab|mesh-list
111338558|NCT01921790|Pegaspargase|pegaspargase|mesh-list
111338559|NCT01921790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111338560|NCT01921790|Antiemetics|antiemetics|mesh-ancestor
111338561|NCT01921790|Autonomic Agents|autonomic agents|mesh-ancestor
111338562|NCT01921790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111338563|NCT01921790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111338564|NCT01921790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111338565|NCT01921790|Glucocorticoids|glucocorticoids|mesh-ancestor
111338566|NCT01921790|Hormones|hormones|mesh-ancestor
111338567|NCT01921790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111338568|NCT01921790|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111338569|NCT01921790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111338570|NCT01921790|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111338571|NCT01921790|Antimetabolites|antimetabolites|mesh-ancestor
111338572|NCT01921790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111338573|NCT01921790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111338574|NCT01921790|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111338575|NCT01921790|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111338576|NCT01921790|Growth Substances|growth substances|mesh-ancestor
111338577|NCT01921790|Growth Inhibitors|growth inhibitors|mesh-ancestor
111338578|NCT02153541|Antipyrine|antipyrine|mesh-list
111338579|NCT02153541|Benzocaine|benzocaine|mesh-list
111338580|NCT02153541|Glycerol|glycerol|mesh-list
111338581|NCT02153541|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
111338582|NCT02153541|Protective Agents|protective agents|mesh-ancestor
111338583|NCT02153541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111338584|NCT02153541|Anesthetics, Local|anesthetics, local|mesh-ancestor
111338585|NCT02153541|Anesthetics|anesthetics|mesh-ancestor
111338586|NCT02153541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111338587|NCT02153541|Sensory System Agents|sensory system agents|mesh-ancestor
111338588|NCT02153541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111338589|NCT02153541|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111338590|NCT02153541|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111338591|NCT02153541|Analgesics|analgesics|mesh-ancestor
111338592|NCT02153541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111338593|NCT02153541|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111338594|NCT03487276|Vilobelimab|vilobelimab|mesh-list
111338595|NCT03487276|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
111338596|NCT03487276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111338597|NCT03487276|Immunologic Factors|immunologic factors|mesh-ancestor
111338598|NCT03487276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111338599|NCT03489850|Ibudilast|ibudilast|mesh-list
111338600|NCT03489850|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111338601|NCT03489850|Autonomic Agents|autonomic agents|mesh-ancestor
111338602|NCT03489850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111338603|NCT03489850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111338604|NCT03489850|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111338605|NCT03489850|Respiratory System Agents|respiratory system agents|mesh-ancestor
111338606|NCT03489850|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111338607|NCT03489850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111338608|NCT03489850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111338609|NCT03489850|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111338610|NCT03489850|Vasodilator Agents|vasodilator agents|mesh-ancestor
111338611|NCT03490942|Glucagon|glucagon|mesh-list
111338612|NCT03490942|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
111338613|NCT03490942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111338614|NCT03490942|Hormones|hormones|mesh-ancestor
111338615|NCT03490942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111338616|NCT03490942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111338617|NCT03490942|Incretins|incretins|mesh-ancestor
111063076|NCT05374291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111063077|NCT05374291|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111063078|NCT05374291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111338618|NCT00376870|Pioglitazone|pioglitazone|mesh-list
111338619|NCT00376870|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111338620|NCT00376870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111338621|NCT03015025|Acenocoumarol|acenocoumarol|mesh-list
111338622|NCT03015025|Anticoagulants|anticoagulants|mesh-ancestor
111338623|NCT03256162|Midazolam|midazolam|mesh-list
111338624|NCT03256162|Ketamine|ketamine|mesh-list
111338625|NCT03256162|Analgesics|analgesics|mesh-ancestor
111338626|NCT03256162|Sensory System Agents|sensory system agents|mesh-ancestor
111338627|NCT03256162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111338628|NCT03256162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111338629|NCT03256162|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111338630|NCT03256162|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111338631|NCT03256162|Anesthetics, General|anesthetics, general|mesh-ancestor
111338632|NCT03256162|Anesthetics|anesthetics|mesh-ancestor
111338633|NCT03256162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111338634|NCT03256162|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111338635|NCT03256162|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111338636|NCT03256162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111338637|NCT03256162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111338638|NCT03256162|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111338639|NCT03256162|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111338640|NCT03256162|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111338641|NCT03256162|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111338642|NCT03256162|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111338643|NCT03256162|GABA Modulators|gaba modulators|mesh-ancestor
111338644|NCT03256162|GABA Agents|gaba agents|mesh-ancestor
111338645|NCT03493828|Bupivacaine|bupivacaine|mesh-list
111338646|NCT03493828|Anesthetics, Local|anesthetics, local|mesh-ancestor
111338647|NCT03493828|Anesthetics|anesthetics|mesh-ancestor
111338648|NCT03493828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111338649|NCT03493828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111338650|NCT03493828|Sensory System Agents|sensory system agents|mesh-ancestor
111338651|NCT03493828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111338652|NCT03496324|Ibuprofen|ibuprofen|mesh-list
111338653|NCT03496324|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111338654|NCT03496324|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111338655|NCT03496324|Analgesics|analgesics|mesh-ancestor
111338656|NCT03496324|Sensory System Agents|sensory system agents|mesh-ancestor
111338657|NCT03496324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111338658|NCT03496324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111338659|NCT03496324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111338660|NCT03496324|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111338661|NCT03496324|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111338662|NCT03496324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111338663|NCT03496324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111338664|NCT03354598|Ciprofloxacin|ciprofloxacin|mesh-list
111338665|NCT03354598|Probenecid|probenecid|mesh-list
111338666|NCT03354598|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111338667|NCT03354598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111338668|NCT03354598|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111338669|NCT03354598|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111338670|NCT03354598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111338671|NCT03354598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111338672|NCT03354598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111338673|NCT03354598|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111338674|NCT03354598|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111338675|NCT03354598|Uricosuric Agents|uricosuric agents|mesh-ancestor
111338676|NCT03354598|Gout Suppressants|gout suppressants|mesh-ancestor
111338677|NCT03354598|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111338678|NCT02169895|Opicapone|opicapone|mesh-list
111338679|NCT02169895|Benserazide, levodopa drug combination|benserazide, levodopa drug combination|mesh-list
111338680|NCT02169895|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
111338681|NCT02169895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111338682|NCT02169895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111338683|NCT02169895|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111338684|NCT02169895|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111338685|NCT02169895|Dopamine Agents|dopamine agents|mesh-ancestor
111338686|NCT02169895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111338687|NCT02169895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111338688|NCT01072669|Ambrisentan|ambrisentan|mesh-list
111338689|NCT01072669|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111338690|NCT03014713|Flurbiprofen|flurbiprofen|mesh-list
111338691|NCT03014713|Dexmedetomidine|dexmedetomidine|mesh-list
111338692|NCT03014713|Dezocine|dezocine|mesh-list
111338693|NCT03014713|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111338694|NCT03014713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111338695|NCT03014713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111338696|NCT03014713|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111338698|NCT03014713|Sensory System Agents|sensory system agents|mesh-ancestor
111338699|NCT03014713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111338700|NCT03014713|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111338701|NCT03014713|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111338702|NCT03014713|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111338703|NCT03014713|Adrenergic Agents|adrenergic agents|mesh-ancestor
111338704|NCT03014713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111338705|NCT03014713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111338706|NCT03014713|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111338707|NCT03014713|Narcotics|narcotics|mesh-ancestor
111338708|NCT03014713|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111338709|NCT03014713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111338710|NCT03014713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111338711|NCT03014713|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111338712|NCT03014713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111338713|NCT01074463|Pramipexole|pramipexole|mesh-list
111338714|NCT01074463|Antioxidants|antioxidants|mesh-ancestor
111338715|NCT01074463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111338716|NCT01074463|Protective Agents|protective agents|mesh-ancestor
111338717|NCT01074463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111338718|NCT01074463|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111338719|NCT01074463|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111338720|NCT01074463|Dopamine Agonists|dopamine agonists|mesh-ancestor
111338721|NCT01074463|Dopamine Agents|dopamine agents|mesh-ancestor
111338722|NCT01074463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111338723|NCT01075087|Ropivacaine|ropivacaine|mesh-list
111338724|NCT01075087|Anesthetics, Local|anesthetics, local|mesh-ancestor
111338725|NCT01075087|Anesthetics|anesthetics|mesh-ancestor
111338726|NCT01075087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111338727|NCT01075087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111338728|NCT01075087|Sensory System Agents|sensory system agents|mesh-ancestor
111338729|NCT01075087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111338730|NCT01075399|Imidazole|imidazole|mesh-list
111338731|NCT01075399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111338732|NCT01075399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111338733|NCT03835819|Pembrolizumab|pembrolizumab|mesh-list
111338734|NCT03835819|Mirvetuximab soravtansine|mirvetuximab soravtansine|mesh-list
111338735|NCT03835819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111338736|NCT03835819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111338737|NCT03835819|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111338738|NCT03835819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111338739|NCT03835819|Immunoconjugates|immunoconjugates|mesh-ancestor
111338740|NCT03835819|Immunologic Factors|immunologic factors|mesh-ancestor
111338741|NCT03835819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111338742|NCT03358576|Amoxicillin|amoxicillin|mesh-list
111338743|NCT03358576|Metronidazole|metronidazole|mesh-list
111338744|NCT03358576|Ciprofloxacin|ciprofloxacin|mesh-list
111338745|NCT03358576|Clavulanic Acid|clavulanic acid|mesh-list
111338746|NCT03358576|Clavulanic Acids|clavulanic acids|mesh-list
111338747|NCT03358576|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
111338748|NCT03358576|Ertapenem|ertapenem|mesh-list
111338749|NCT03358576|Lactams|lactams|mesh-list
111338750|NCT03358576|Probenecid|probenecid|mesh-list
111338751|NCT03358576|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111338752|NCT03358576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111338753|NCT03358576|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111338754|NCT03358576|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111338755|NCT03358576|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111338756|NCT03358576|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111338757|NCT03358576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111338758|NCT03358576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111338759|NCT03358576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111338760|NCT03358576|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111338761|NCT03358576|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111338762|NCT03358576|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
111338763|NCT03358576|Uricosuric Agents|uricosuric agents|mesh-ancestor
111338764|NCT03358576|Gout Suppressants|gout suppressants|mesh-ancestor
111338765|NCT03358576|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111338766|NCT03822013|Miglustat|miglustat|mesh-list
111338767|NCT03822013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111063226|NCT05006079|GABA Agents|gaba agents|mesh-ancestor
111338768|NCT03822013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111338769|NCT03822013|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111338770|NCT03822013|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111338771|NCT03822013|Antiviral Agents|antiviral agents|mesh-ancestor
111338772|NCT03822013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111338773|NCT03822013|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
111338774|NCT03822013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111338775|NCT03822013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111338777|NCT00376324|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111338778|NCT00376324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111338779|NCT00376324|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111338780|NCT00376324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111338781|NCT00376324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111338782|NCT00376480|Methylprednisolone|methylprednisolone|mesh-list
111338783|NCT00376480|Fludarabine|fludarabine|mesh-list
111338784|NCT00376480|Fludarabine phosphate|fludarabine phosphate|mesh-list
111338785|NCT00376480|Thiotepa|thiotepa|mesh-list
111338786|NCT00376480|Antilymphocyte Serum|antilymphocyte serum|mesh-list
111338787|NCT00376480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111338788|NCT00376480|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111338789|NCT00376480|Antimetabolites|antimetabolites|mesh-ancestor
111338790|NCT00376480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111338791|NCT00376480|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111338792|NCT00376480|Immunologic Factors|immunologic factors|mesh-ancestor
111338793|NCT00376480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111338794|NCT00376480|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111338795|NCT00376480|Antiemetics|antiemetics|mesh-ancestor
111338796|NCT00376480|Autonomic Agents|autonomic agents|mesh-ancestor
111338797|NCT00376480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111338798|NCT00376480|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111338799|NCT00376480|Glucocorticoids|glucocorticoids|mesh-ancestor
111338800|NCT00376480|Hormones|hormones|mesh-ancestor
111338801|NCT00376480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111338802|NCT00376480|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111338803|NCT00376480|Protective Agents|protective agents|mesh-ancestor
111338804|NCT00376480|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111338805|NCT00376480|Alkylating Agents|alkylating agents|mesh-ancestor
111338806|NCT00376480|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111338807|NCT03016039|Curcumin|curcumin|mesh-list
111338808|NCT03016039|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111338809|NCT03016039|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111338810|NCT03016039|Analgesics|analgesics|mesh-ancestor
111338811|NCT03016039|Sensory System Agents|sensory system agents|mesh-ancestor
111338812|NCT03016039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111338813|NCT03016039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111338814|NCT03016039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111338815|NCT03016039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111338816|NCT03016039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111338817|NCT03016039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111338818|NCT03016039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111338819|NCT03753919|Durvalumab|durvalumab|mesh-list
111338820|NCT03753919|Tremelimumab|tremelimumab|mesh-list
111338821|NCT03753919|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111338822|NCT03753919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111338823|NCT03498196|Avelumab|avelumab|mesh-list
111338824|NCT03498196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111338825|NCT03498196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111338826|NCT03500302|Evolocumab|evolocumab|mesh-list
111338827|NCT03500302|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
111338828|NCT03500302|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111338829|NCT03500302|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111338830|NCT03500302|Antimetabolites|antimetabolites|mesh-ancestor
111338831|NCT03500302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111338832|NCT03500302|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111338833|NCT03500302|Protease Inhibitors|protease inhibitors|mesh-ancestor
111063301|NCT04827953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111063302|NCT04827953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111063303|NCT04827953|Tubulin Modulators|tubulin modulators|mesh-ancestor
111063304|NCT04827953|Antimitotic Agents|antimitotic agents|mesh-ancestor
111063305|NCT04827953|Mitosis Modulators|mitosis modulators|mesh-ancestor
110689646|NCT00972101|Antimetabolites|antimetabolites|mesh-ancestor
111063306|NCT04827953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111063307|NCT04827953|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111063308|NCT04827953|Antimetabolites|antimetabolites|mesh-ancestor
111338834|NCT03500302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111338835|NCT03500302|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111338836|NCT03501550|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
111338837|NCT03501550|Antiviral Agents|antiviral agents|mesh-ancestor
111338838|NCT03501550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111338839|NCT03503578|Ketamine|ketamine|mesh-list
111338840|NCT03503578|Sevoflurane|sevoflurane|mesh-list
111338841|NCT03503578|Analgesics|analgesics|mesh-ancestor
110689685|NCT00311584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111338842|NCT03503578|Sensory System Agents|sensory system agents|mesh-ancestor
111338843|NCT03503578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111338844|NCT03503578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111338845|NCT03503578|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111338846|NCT03503578|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111338847|NCT03503578|Anesthetics, General|anesthetics, general|mesh-ancestor
111338848|NCT03503578|Anesthetics|anesthetics|mesh-ancestor
111338849|NCT03503578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111338850|NCT03503578|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111338851|NCT03503578|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111338852|NCT03503578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111338853|NCT03503578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111338854|NCT03503578|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111338855|NCT03503578|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111338856|NCT03270514|Bupivacaine|bupivacaine|mesh-list
111338857|NCT03270514|Anesthetics, Local|anesthetics, local|mesh-ancestor
111338858|NCT03270514|Anesthetics|anesthetics|mesh-ancestor
111338859|NCT03270514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111338860|NCT03270514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111338861|NCT03270514|Sensory System Agents|sensory system agents|mesh-ancestor
111338862|NCT03270514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111338863|NCT02178241|Gemcitabine|gemcitabine|mesh-list
111338864|NCT02178241|Halichondrin B|halichondrin b|mesh-list
111338865|NCT02178241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111338866|NCT02178241|Antimetabolites|antimetabolites|mesh-ancestor
111338867|NCT02178241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111338868|NCT02178241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111338869|NCT02178241|Tubulin Modulators|tubulin modulators|mesh-ancestor
111338870|NCT02178241|Antimitotic Agents|antimitotic agents|mesh-ancestor
111338871|NCT02178241|Mitosis Modulators|mitosis modulators|mesh-ancestor
111338872|NCT03015727|Docetaxel|docetaxel|mesh-list
111338873|NCT03015727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111338874|NCT03015727|Tubulin Modulators|tubulin modulators|mesh-ancestor
111338875|NCT03015727|Antimitotic Agents|antimitotic agents|mesh-ancestor
111338876|NCT03015727|Mitosis Modulators|mitosis modulators|mesh-ancestor
111338877|NCT03015727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111338878|NCT01077973|Ibuprofen|ibuprofen|mesh-list
111338879|NCT01077973|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111338880|NCT01077973|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111338881|NCT01077973|Analgesics|analgesics|mesh-ancestor
111338882|NCT01077973|Sensory System Agents|sensory system agents|mesh-ancestor
110689799|NCT00974441|GABA Agents|gaba agents|mesh-ancestor
111338883|NCT01077973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111338884|NCT01077973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111338885|NCT01077973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111338886|NCT01077973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111338887|NCT01077973|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111338888|NCT01077973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111338889|NCT01077973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111338890|NCT02973646|Tenofovir|tenofovir|mesh-list
111338891|NCT02973646|Entecavir|entecavir|mesh-list
111338892|NCT02973646|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
111338893|NCT02973646|Antiviral Agents|antiviral agents|mesh-ancestor
111338894|NCT02973646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111338895|NCT02973646|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111338896|NCT02973646|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111338897|NCT02973646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111338898|NCT02973646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111338899|NCT02973646|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111338900|NCT02973646|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111338901|NCT01078363|Ramipril|ramipril|mesh-list
111338902|NCT01078363|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
111338903|NCT01078363|Protease Inhibitors|protease inhibitors|mesh-ancestor
111338904|NCT01078363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111338905|NCT01078363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111338906|NCT01078363|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111338907|NCT03371836|Clobazam|clobazam|mesh-list
111338908|NCT03371836|Anticonvulsants|anticonvulsants|mesh-ancestor
111338909|NCT03371836|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111338910|NCT03371836|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111338911|NCT03371836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111338912|NCT03371836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111338913|NCT03371836|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111338914|NCT03371836|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
111338915|NCT03371836|GABA Agonists|gaba agonists|mesh-ancestor
111338916|NCT03371836|GABA Agents|gaba agents|mesh-ancestor
111338917|NCT03371836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111338918|NCT03371836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111338919|NCT01078753|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
111338920|NCT01078753|Hemostatics|hemostatics|mesh-ancestor
111338921|NCT01078753|Coagulants|coagulants|mesh-ancestor
111338922|NCT01078753|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
111338923|NCT01078753|Natriuretic Agents|natriuretic agents|mesh-ancestor
111338924|NCT01078753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111338925|NCT03372382|Acetaminophen|acetaminophen|mesh-list
111338926|NCT03372382|Ibuprofen|ibuprofen|mesh-list
111338927|NCT03372382|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111338928|NCT03372382|Analgesics|analgesics|mesh-ancestor
111338929|NCT03372382|Sensory System Agents|sensory system agents|mesh-ancestor
111338930|NCT03372382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111338931|NCT03372382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111338932|NCT03372382|Antipyretics|antipyretics|mesh-ancestor
110689967|NCT00365547|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111338933|NCT03372382|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111338934|NCT03372382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111338935|NCT03372382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111338936|NCT03372382|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111338937|NCT03372382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111338938|NCT03372382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111338939|NCT03373162|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111338940|NCT03373162|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111338941|NCT03373162|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111338942|NCT03373162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111338943|NCT03373162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111338944|NCT03373162|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111338945|NCT03373162|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111338946|NCT03373162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111338947|NCT03373162|Cholinergic Agents|cholinergic agents|mesh-ancestor
111338948|NCT03373162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111338949|NCT03374176|Amoxicillin|amoxicillin|mesh-list
111338950|NCT03374176|Metronidazole|metronidazole|mesh-list
111338951|NCT03374176|Clindamycin|clindamycin|mesh-list
111338952|NCT03374176|Clindamycin palmitate|clindamycin palmitate|mesh-list
111338953|NCT03374176|Clindamycin phosphate|clindamycin phosphate|mesh-list
111338954|NCT03374176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111338955|NCT03374176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111338956|NCT03374176|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111338957|NCT03374176|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111338958|NCT03374176|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111338959|NCT03374176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111338960|NCT03374176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111338961|NCT03281200|Nintedanib|nintedanib|mesh-list
111338962|NCT03281200|Antineoplastic Agents|antineoplastic agents|mesh-list
111338963|NCT03281200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-list
111338964|NCT03281200|Immunomodulating Agents|immunomodulating agents|mesh-list
111338965|NCT03281200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111338966|NCT03281200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111338967|NCT03281200|Immunologic Factors|immunologic factors|mesh-ancestor
111338968|NCT03281200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111338969|NCT03378076|Triamcinolone|triamcinolone|mesh-list
111338970|NCT03378076|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
111338971|NCT03378076|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
111338973|NCT03378076|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
111338974|NCT03378076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111338975|NCT03378076|Glucocorticoids|glucocorticoids|mesh-ancestor
111338976|NCT03378076|Hormones|hormones|mesh-ancestor
111338977|NCT03378076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111338978|NCT03378076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111338979|NCT03378076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111338980|NCT03378076|Immunologic Factors|immunologic factors|mesh-ancestor
111338981|NCT03378076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111338982|NCT03378076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111338983|NCT03520348|Pantothenic Acid|pantothenic acid|mesh-list
111338984|NCT03520348|Vitamin B Complex|vitamin b complex|mesh-ancestor
111338986|NCT03520348|Micronutrients|micronutrients|mesh-ancestor
111338987|NCT03520348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111338988|NCT03380026|Triamcinolone|triamcinolone|mesh-list
111338989|NCT03380026|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
111338990|NCT03380026|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
111338991|NCT03380026|Mechlorethamine|mechlorethamine|mesh-list
111338992|NCT03380026|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
111338993|NCT03380026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111338994|NCT03380026|Glucocorticoids|glucocorticoids|mesh-ancestor
111338995|NCT03380026|Hormones|hormones|mesh-ancestor
111338996|NCT03380026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111338997|NCT03380026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111338998|NCT03380026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111338999|NCT03380026|Immunologic Factors|immunologic factors|mesh-ancestor
111339000|NCT03380026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111339001|NCT03380026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111339002|NCT03380026|Alkylating Agents|alkylating agents|mesh-ancestor
111339003|NCT03380026|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111339004|NCT03380026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111339005|NCT01079143|Cyclosporine|cyclosporine|mesh-list
111339006|NCT01079143|Mycophenolic Acid|mycophenolic acid|mesh-list
111339007|NCT01079143|Everolimus|everolimus|mesh-list
111339008|NCT01079143|Cyclosporins|cyclosporins|mesh-list
111339009|NCT01079143|Basiliximab|basiliximab|mesh-list
111339010|NCT01079143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111339011|NCT01079143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111339012|NCT01079143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111339013|NCT01079143|Immunologic Factors|immunologic factors|mesh-ancestor
111339014|NCT01079143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111339015|NCT01079143|Antifungal Agents|antifungal agents|mesh-ancestor
111339016|NCT01079143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111339017|NCT01079143|Dermatologic Agents|dermatologic agents|mesh-ancestor
111339018|NCT01079143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111339019|NCT01079143|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111339020|NCT01079143|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111339021|NCT01079143|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111339022|NCT01079143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111339023|NCT01079143|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111339024|NCT01079143|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111339025|NCT01079143|Antitubercular Agents|antitubercular agents|mesh-ancestor
111339026|NCT01079143|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111339027|NCT03381742|Clopidogrel|clopidogrel|mesh-list
111339028|NCT03381742|Ticagrelor|ticagrelor|mesh-list
111339029|NCT03381742|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111339030|NCT03381742|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111339031|NCT03381742|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111339032|NCT03381742|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111339033|NCT03381742|Purinergic Agents|purinergic agents|mesh-ancestor
111339034|NCT03381742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111339035|NCT03381742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111339036|NCT03381742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111339037|NCT04735042|Dapagliflozin|dapagliflozin|mesh-list
111339038|NCT04735042|Empagliflozin|empagliflozin|mesh-list
111339039|NCT04735042|Linagliptin|linagliptin|mesh-list
111339040|NCT04735042|Saxagliptin|saxagliptin|mesh-list
111339041|NCT04735042|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111339042|NCT04735042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111339043|NCT04735042|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111339044|NCT04735042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111339045|NCT04735042|Incretins|incretins|mesh-ancestor
111339046|NCT04735042|Hormones|hormones|mesh-ancestor
111339047|NCT04735042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111339048|NCT04735042|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111339049|NCT04735042|Protease Inhibitors|protease inhibitors|mesh-ancestor
111339050|NCT04735042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111339051|NCT04681339|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111339052|NCT04681339|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
111339053|NCT04681339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111339054|NCT04681339|Antitubercular Agents|antitubercular agents|mesh-ancestor
111339055|NCT00376012|Rifampin|rifampin|mesh-list
111339056|NCT00376012|Isoniazid|isoniazid|mesh-list
111339057|NCT00376012|Pyrazinamide|pyrazinamide|mesh-list
111339058|NCT00376012|Ethambutol|ethambutol|mesh-list
111339059|NCT00376012|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111339060|NCT00376012|Antitubercular Agents|antitubercular agents|mesh-ancestor
111339061|NCT00376012|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111339062|NCT00376012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111339063|NCT00376012|Leprostatic Agents|leprostatic agents|mesh-ancestor
111339064|NCT00376012|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111339065|NCT00376012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111339066|NCT00376012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111339067|NCT00376012|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111339068|NCT00376012|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111339069|NCT00376012|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
111339070|NCT00376012|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
111339071|NCT00376012|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
111339072|NCT00376012|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111339073|NCT00376012|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
111339074|NCT00376012|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111339075|NCT00376012|Antimetabolites|antimetabolites|mesh-ancestor
111339076|NCT00376012|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111339077|NCT02171611|Dabigatran|dabigatran|mesh-list
111339078|NCT02171611|Antithrombins|antithrombins|mesh-ancestor
111339079|NCT02171611|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111339080|NCT02171611|Protease Inhibitors|protease inhibitors|mesh-ancestor
111339081|NCT02171611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111339082|NCT02171611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111339083|NCT02171611|Anticoagulants|anticoagulants|mesh-ancestor
111339084|NCT01083667|Pyrimethamine|pyrimethamine|mesh-list
111339085|NCT01083667|Antimalarials|antimalarials|mesh-ancestor
111339086|NCT01083667|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111339087|NCT01083667|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111339088|NCT01083667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111339089|NCT01083667|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111339090|NCT01083667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111339091|NCT01083667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111339092|NCT00942305|Brincidofovir|brincidofovir|mesh-list
111339093|NCT00942305|Antiviral Agents|antiviral agents|mesh-ancestor
111339094|NCT00942305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111339095|NCT01084759|Etoposide|etoposide|mesh-list
111339096|NCT01084759|Methyltestosterone|methyltestosterone|mesh-list
111339097|NCT01084759|Testosterone|testosterone|mesh-list
111339098|NCT01084759|Testosterone undecanoate|testosterone undecanoate|mesh-list
111339099|NCT01084759|Testosterone enanthate|testosterone enanthate|mesh-list
111339100|NCT01084759|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
111339101|NCT01084759|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111339102|NCT01084759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111339103|NCT01084759|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111339104|NCT01084759|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111339105|NCT01084759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111339106|NCT01084759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111339107|NCT01084759|Androgens|androgens|mesh-ancestor
111339108|NCT01084759|Hormones|hormones|mesh-ancestor
111339109|NCT01084759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111339110|NCT01084759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111339111|NCT01084759|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111339112|NCT01084759|Anabolic Agents|anabolic agents|mesh-ancestor
111339113|NCT01110187|Lacosamide|lacosamide|mesh-list
111339114|NCT01110187|Fosphenytoin|fosphenytoin|mesh-list
111339115|NCT01110187|Anticonvulsants|anticonvulsants|mesh-ancestor
111339116|NCT01110187|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111339117|NCT01110187|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111339118|NCT01110187|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111339119|NCT01110187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111339120|NCT04357301|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
111339121|NCT01110421|Amoxicillin|amoxicillin|mesh-list
111339122|NCT01110421|Clavulanic Acid|clavulanic acid|mesh-list
111339123|NCT01110421|Clavulanic Acids|clavulanic acids|mesh-list
111339124|NCT01110421|Cefepime|cefepime|mesh-list
111339125|NCT01110421|Doripenem|doripenem|mesh-list
111339126|NCT01110421|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
111339127|NCT01110421|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111339128|NCT01110421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111339129|NCT01110421|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
111339130|NCT01110421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111339131|NCT01110421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111063611|NCT03677141|Glucocorticoids|glucocorticoids|mesh-ancestor
111339132|NCT04358627|Dexmedetomidine|dexmedetomidine|mesh-list
111339133|NCT04358627|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111339134|NCT04358627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111339135|NCT04358627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111339136|NCT04358627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111339137|NCT04358627|Analgesics|analgesics|mesh-ancestor
111339138|NCT04358627|Sensory System Agents|sensory system agents|mesh-ancestor
111339139|NCT04358627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111339140|NCT04358627|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111339141|NCT04358627|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111339142|NCT04358627|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111339143|NCT04358627|Adrenergic Agents|adrenergic agents|mesh-ancestor
111339144|NCT04358627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111339145|NCT04358627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111339146|NCT04356677|Ribavirin|ribavirin|mesh-list
111339147|NCT04356677|Antimetabolites|antimetabolites|mesh-ancestor
111339148|NCT04356677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111339149|NCT04356677|Antiviral Agents|antiviral agents|mesh-ancestor
111339150|NCT04356677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111339151|NCT04356833|Plasminogen|plasminogen|mesh-list
111339152|NCT04356833|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
111339153|NCT04356833|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111339154|NCT04356833|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110690585|NCT03975166|Xhance|xhance|mesh-list
111339155|NCT04356833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111339156|NCT05620277|Tocopherols|tocopherols|mesh-list
111339157|NCT05620277|Vitamin E|vitamin e|mesh-list
111339158|NCT05620277|alpha-Tocopherol|alpha-tocopherol|mesh-list
111339159|NCT05620277|Antioxidants|antioxidants|mesh-ancestor
111339160|NCT05620277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111339161|NCT05620277|Protective Agents|protective agents|mesh-ancestor
111339162|NCT05620277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111339163|NCT05620277|Vitamins|vitamins|mesh-ancestor
111339164|NCT05620277|Micronutrients|micronutrients|mesh-ancestor
111339165|NCT01110499|Bimatoprost|bimatoprost|mesh-list
110690640|NCT02535039|Hormones|hormones|mesh-ancestor
111339166|NCT01110499|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111339167|NCT01110499|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111339168|NCT01110499|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111339169|NCT02174419|Nalbuphine|nalbuphine|mesh-list
111339170|NCT02174419|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111339171|NCT02174419|Narcotics|narcotics|mesh-ancestor
111339172|NCT02174419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111339173|NCT02174419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111339174|NCT02174419|Analgesics|analgesics|mesh-ancestor
111339175|NCT02174419|Sensory System Agents|sensory system agents|mesh-ancestor
111339176|NCT02174419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111339177|NCT05620589|Amoxicillin|amoxicillin|mesh-list
111339178|NCT05620589|Tetracycline|tetracycline|mesh-list
111339179|NCT05620589|Esomeprazole|esomeprazole|mesh-list
111339180|NCT05620589|Bismuth|bismuth|mesh-list
111339181|NCT05620589|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111339182|NCT05620589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111339183|NCT05620589|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111339184|NCT05620589|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111339185|NCT05620589|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111339186|NCT05620589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111339187|NCT05620589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111339188|NCT05620589|Antacids|antacids|mesh-ancestor
111339189|NCT05620589|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111339190|NCT01086475|Cycloserine|cycloserine|mesh-list
111339191|NCT01086475|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111339192|NCT01086475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111339193|NCT01086475|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111339194|NCT01086475|Antitubercular Agents|antitubercular agents|mesh-ancestor
111339195|NCT01086475|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111339196|NCT01086475|Antimetabolites|antimetabolites|mesh-ancestor
111339197|NCT01086475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111339198|NCT01112683|Memantine|memantine|mesh-list
111339199|NCT01112683|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111339200|NCT01112683|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111339201|NCT01112683|Dopamine Agents|dopamine agents|mesh-ancestor
111339202|NCT01112683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111339203|NCT01112683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111339204|NCT01112683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111339205|NCT01112683|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111339206|NCT01112683|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111339207|NCT02245373|Antidepressive Agents|antidepressive agents|mesh-list
111339208|NCT02245373|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111063681|NCT03287908|Dexamethasone|dexamethasone|mesh-list
111339209|NCT04355273|Heparin|heparin|mesh-list
111339210|NCT04355273|Calcium heparin|calcium heparin|mesh-list
111339211|NCT04355273|Anticoagulants|anticoagulants|mesh-ancestor
111339212|NCT04355273|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111339213|NCT04355273|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111339214|NCT04355273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111339215|NCT04355429|Captopril|captopril|mesh-list
111339216|NCT04355429|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
111339217|NCT04355429|Protease Inhibitors|protease inhibitors|mesh-ancestor
111339218|NCT04355429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111339219|NCT04355429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111339220|NCT04355429|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111339221|NCT01114555|Bevacizumab|bevacizumab|mesh-list
111339222|NCT01114555|Irinotecan|irinotecan|mesh-list
111339223|NCT01114555|Temozolomide|temozolomide|mesh-list
111339224|NCT01114555|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111339225|NCT01114555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111339226|NCT01114555|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111339227|NCT01114555|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111339228|NCT01114555|Growth Substances|growth substances|mesh-ancestor
111339229|NCT01114555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111339230|NCT01114555|Growth Inhibitors|growth inhibitors|mesh-ancestor
111339231|NCT01114555|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111339232|NCT01114555|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111339233|NCT01114555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111339234|NCT01114555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111339235|NCT01114555|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111339236|NCT01114555|Alkylating Agents|alkylating agents|mesh-ancestor
111339237|NCT02673931|Exenatide|exenatide|mesh-list
111339238|NCT02673931|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111339239|NCT02673931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111339240|NCT02673931|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111339241|NCT02673931|Incretins|incretins|mesh-ancestor
111339242|NCT02673931|Hormones|hormones|mesh-ancestor
111339243|NCT02673931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111339244|NCT01115101|Pirinitramide|pirinitramide|mesh-list
111339245|NCT01115101|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111339246|NCT01115101|Narcotics|narcotics|mesh-ancestor
111339247|NCT01115101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111339248|NCT01115101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111339249|NCT01115101|Analgesics|analgesics|mesh-ancestor
111339250|NCT01115101|Sensory System Agents|sensory system agents|mesh-ancestor
111339251|NCT01115101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111339252|NCT02245529|Tamsulosin|tamsulosin|mesh-list
111339253|NCT02245529|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111339254|NCT02245529|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111339255|NCT02245529|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111339256|NCT02245529|Adrenergic Agents|adrenergic agents|mesh-ancestor
111339257|NCT02245529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111339258|NCT02245529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111339259|NCT02245529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111339260|NCT02245529|Urological Agents|urological agents|mesh-ancestor
111339261|NCT00947765|Prednisolone|prednisolone|mesh-list
111339262|NCT00947765|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111339263|NCT00947765|Methylprednisolone|methylprednisolone|mesh-list
111339264|NCT00947765|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111339265|NCT00947765|Prednisolone acetate|prednisolone acetate|mesh-list
111339266|NCT00947765|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111339267|NCT00947765|Prednisolone phosphate|prednisolone phosphate|mesh-list
111339268|NCT00947765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111339269|NCT00947765|Glucocorticoids|glucocorticoids|mesh-ancestor
111339270|NCT00947765|Hormones|hormones|mesh-ancestor
111339271|NCT00947765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111339272|NCT00947765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111339273|NCT00947765|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111339274|NCT00947765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111339275|NCT00947765|Antiemetics|antiemetics|mesh-ancestor
111339276|NCT00947765|Autonomic Agents|autonomic agents|mesh-ancestor
111339277|NCT00947765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111339278|NCT00947765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111339279|NCT00947765|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111339280|NCT00947765|Protective Agents|protective agents|mesh-ancestor
111339281|NCT01089517|Ranibizumab|ranibizumab|mesh-list
111339282|NCT01089517|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111339283|NCT01089517|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111339284|NCT01089517|Growth Substances|growth substances|mesh-ancestor
111339285|NCT01089517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111339286|NCT01089517|Growth Inhibitors|growth inhibitors|mesh-ancestor
111339287|NCT01089517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111339288|NCT04311515|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
111339289|NCT04311515|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111339290|NCT04311515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111339291|NCT01089595|Imatinib Mesylate|imatinib mesylate|mesh-list
111339292|NCT01089595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110690965|NCT01011920|Antimetabolites|antimetabolites|mesh-ancestor
111339293|NCT01089595|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111339294|NCT01089595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111339295|NCT01089595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111339296|NCT04354961|Paclitaxel|paclitaxel|mesh-list
111339297|NCT04354961|Carboplatin|carboplatin|mesh-list
111339298|NCT04354961|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111339299|NCT04354961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111339300|NCT04354961|Tubulin Modulators|tubulin modulators|mesh-ancestor
111339301|NCT04354961|Antimitotic Agents|antimitotic agents|mesh-ancestor
111339302|NCT04354961|Mitosis Modulators|mitosis modulators|mesh-ancestor
111339303|NCT04354961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111339304|NCT01089751|Trospium chloride|trospium chloride|mesh-list
111339305|NCT01089751|Parasympatholytics|parasympatholytics|mesh-ancestor
111339306|NCT01089751|Autonomic Agents|autonomic agents|mesh-ancestor
111339307|NCT01089751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111339308|NCT01089751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111339309|NCT01089751|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111339310|NCT01089751|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111339311|NCT01089751|Cholinergic Agents|cholinergic agents|mesh-ancestor
111339312|NCT01089751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111339313|NCT01089751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111339314|NCT01089751|Urological Agents|urological agents|mesh-ancestor
111339315|NCT03032315|Amlodipine|amlodipine|mesh-list
111339316|NCT03032315|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
111339317|NCT03032315|Telmisartan|telmisartan|mesh-list
111339318|NCT03032315|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
111339319|NCT03032315|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111339320|NCT03032315|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111339321|NCT03032315|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111339322|NCT03032315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111339323|NCT03032315|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111339324|NCT03032315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111339325|NCT03032315|Vasodilator Agents|vasodilator agents|mesh-ancestor
111339326|NCT03032315|Diuretics|diuretics|mesh-ancestor
111339327|NCT03032315|Natriuretic Agents|natriuretic agents|mesh-ancestor
111339328|NCT03032315|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
111339329|NCT03032315|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111339330|NCT03032315|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111339331|NCT01090921|Bortezomib|bortezomib|mesh-list
111339332|NCT01090921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111339333|NCT03537274|Interferons|interferons|mesh-list
111339334|NCT03537274|Interferon-alpha|interferon-alpha|mesh-list
111339335|NCT03537274|Interferon alpha-2|interferon alpha-2|mesh-list
111339336|NCT03537274|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110691091|NCT00377637|Antimetabolites|antimetabolites|mesh-ancestor
111339337|NCT03537274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111339338|NCT03537274|Antiviral Agents|antiviral agents|mesh-ancestor
111339339|NCT03537274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111339340|NCT03537274|Immunologic Factors|immunologic factors|mesh-ancestor
111339341|NCT03537274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111339342|NCT00939653|Cytarabine|cytarabine|mesh-list
111339343|NCT00939653|Cyclophosphamide|cyclophosphamide|mesh-list
111339344|NCT00939653|Etoposide|etoposide|mesh-list
111339345|NCT00939653|Clofarabine|clofarabine|mesh-list
111339346|NCT00939653|Lenograstim|lenograstim|mesh-list
111339347|NCT00939653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111339348|NCT00939653|Immunologic Factors|immunologic factors|mesh-ancestor
111339349|NCT00939653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111339350|NCT00939653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111339351|NCT00939653|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111339352|NCT00939653|Alkylating Agents|alkylating agents|mesh-ancestor
111339353|NCT00939653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111339354|NCT00939653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111339355|NCT00939653|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111339356|NCT00939653|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111339357|NCT00939653|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111339358|NCT00939653|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111339359|NCT00939653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111339360|NCT00939653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111339361|NCT00939653|Antimetabolites|antimetabolites|mesh-ancestor
111339362|NCT00939653|Antiviral Agents|antiviral agents|mesh-ancestor
111339363|NCT00939653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111339364|NCT00939653|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111339365|NCT04355039|Dexamethasone|dexamethasone|mesh-list
111339366|NCT04355039|Pomalidomide|pomalidomide|mesh-list
111339367|NCT04355039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111339368|NCT04355039|Antiemetics|antiemetics|mesh-ancestor
111339369|NCT04355039|Autonomic Agents|autonomic agents|mesh-ancestor
111339370|NCT04355039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111339371|NCT04355039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110691130|NCT00292942|Artesunate|artesunate|mesh-list
111339372|NCT04355039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111339373|NCT04355039|Glucocorticoids|glucocorticoids|mesh-ancestor
111339374|NCT04355039|Hormones|hormones|mesh-ancestor
111339375|NCT04355039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111339376|NCT04355039|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111339377|NCT04355039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111339378|NCT04355039|Immunologic Factors|immunologic factors|mesh-ancestor
111339379|NCT04355039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111339380|NCT04355039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111339381|NCT04355039|Growth Substances|growth substances|mesh-ancestor
111339382|NCT04355039|Growth Inhibitors|growth inhibitors|mesh-ancestor
111339383|NCT02524405|Corticosterone|corticosterone|mesh-list
111339384|NCT02524405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111339385|NCT03014323|Galantamine|galantamine|mesh-list
111339386|NCT03014323|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111339387|NCT03014323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111339388|NCT03014323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111339389|NCT03014323|Cholinergic Agents|cholinergic agents|mesh-ancestor
111339390|NCT03014323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111339391|NCT03014323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111339392|NCT03014323|Parasympathomimetics|parasympathomimetics|mesh-ancestor
111339393|NCT03014323|Autonomic Agents|autonomic agents|mesh-ancestor
111339394|NCT03014323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111339395|NCT03014323|Nootropic Agents|nootropic agents|mesh-ancestor
111339396|NCT03393208|Metformin|metformin|mesh-list
111339397|NCT03393208|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111339398|NCT03393208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111339399|NCT01092559|Nitric Oxide|nitric oxide|mesh-list
111339400|NCT01092559|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111339401|NCT01092559|Autonomic Agents|autonomic agents|mesh-ancestor
111339402|NCT01092559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111339403|NCT01092559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111339404|NCT01092559|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111339405|NCT01092559|Respiratory System Agents|respiratory system agents|mesh-ancestor
111339406|NCT01092559|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111339407|NCT01092559|Antioxidants|antioxidants|mesh-ancestor
111339408|NCT01092559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111339409|NCT01092559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111339410|NCT01092559|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
111339411|NCT01092559|Vasodilator Agents|vasodilator agents|mesh-ancestor
111339412|NCT01092559|Gasotransmitters|gasotransmitters|mesh-ancestor
111339413|NCT01092559|Protective Agents|protective agents|mesh-ancestor
111339414|NCT03587428|Zinc|zinc|mesh-list
111339415|NCT03587428|Trace Elements|trace elements|mesh-ancestor
111339416|NCT03587428|Micronutrients|micronutrients|mesh-ancestor
111339417|NCT03587428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111339418|NCT03398278|Oxycodone|oxycodone|mesh-list
111339419|NCT03398278|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111339420|NCT03398278|Narcotics|narcotics|mesh-ancestor
111339421|NCT03398278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111339422|NCT03398278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111339423|NCT03398278|Analgesics|analgesics|mesh-ancestor
111339424|NCT03398278|Sensory System Agents|sensory system agents|mesh-ancestor
111339425|NCT03398278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111339426|NCT03593902|Methylprednisolone|methylprednisolone|mesh-list
111339427|NCT03593902|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111339428|NCT03593902|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111339429|NCT03593902|Prednisolone|prednisolone|mesh-list
111339430|NCT03593902|Prednisolone acetate|prednisolone acetate|mesh-list
111339431|NCT03593902|Cyclophosphamide|cyclophosphamide|mesh-list
111339432|NCT03593902|Rituximab|rituximab|mesh-list
111339433|NCT03593902|Fludarabine|fludarabine|mesh-list
111339434|NCT03593902|Thymoglobulin|thymoglobulin|mesh-list
111339435|NCT03593902|Antilymphocyte Serum|antilymphocyte serum|mesh-list
111339436|NCT03593902|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111339437|NCT03593902|Prednisolone phosphate|prednisolone phosphate|mesh-list
111339438|NCT03593902|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111339439|NCT03593902|Immunologic Factors|immunologic factors|mesh-ancestor
111339440|NCT03593902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111339441|NCT03593902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111339442|NCT03593902|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111339443|NCT03593902|Alkylating Agents|alkylating agents|mesh-ancestor
111339444|NCT03593902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111339445|NCT03593902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111339446|NCT03593902|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111339447|NCT03593902|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111339448|NCT03593902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111339449|NCT03593902|Antiemetics|antiemetics|mesh-ancestor
111339450|NCT03593902|Autonomic Agents|autonomic agents|mesh-ancestor
111339451|NCT03593902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111339452|NCT03593902|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111339453|NCT03593902|Glucocorticoids|glucocorticoids|mesh-ancestor
111339454|NCT03593902|Hormones|hormones|mesh-ancestor
111339455|NCT03593902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111339456|NCT03593902|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111339457|NCT03593902|Protective Agents|protective agents|mesh-ancestor
111339458|NCT03593902|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111339459|NCT00948935|Gemcitabine|gemcitabine|mesh-list
111339460|NCT00948935|Irinotecan|irinotecan|mesh-list
111339461|NCT00948935|Panitumumab|panitumumab|mesh-list
111339462|NCT00948935|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111339463|NCT00948935|Antimetabolites|antimetabolites|mesh-ancestor
111339464|NCT00948935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111339465|NCT00948935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111339466|NCT00948935|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111339467|NCT00948935|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111339468|NCT00948935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111339469|NCT00948935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111339470|NCT04354805|Chlorpromazine|chlorpromazine|mesh-list
111339471|NCT04354805|Antiemetics|antiemetics|mesh-ancestor
111339472|NCT04354805|Autonomic Agents|autonomic agents|mesh-ancestor
111339473|NCT04354805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111339474|NCT04354805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111339475|NCT04354805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111339476|NCT04354805|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111339477|NCT04354805|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110691204|NCT00369681|Doxorubicin|doxorubicin|mesh-list
111339478|NCT04354805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111339479|NCT04354805|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111339480|NCT04354805|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111339481|NCT04354805|Dopamine Agents|dopamine agents|mesh-ancestor
111339482|NCT04354805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111339483|NCT04354805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111339484|NCT03944681|Droperidol|droperidol|mesh-list
111339485|NCT03944681|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111339486|NCT03944681|Antiemetics|antiemetics|mesh-ancestor
111339487|NCT03944681|Autonomic Agents|autonomic agents|mesh-ancestor
111339488|NCT03944681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111339489|NCT03944681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111339490|NCT03944681|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111339491|NCT03944681|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111339492|NCT03944681|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111339493|NCT03944681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111339494|NCT03944681|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111339495|NCT03944681|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111339496|NCT03944681|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111339497|NCT03944681|Dopamine Agents|dopamine agents|mesh-ancestor
111339498|NCT03944681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111339499|NCT03944681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111339500|NCT03935555|9H-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-N-(1-methylethyl)-|9h-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-n-(1-methylethyl)-|mesh-list
111339501|NCT03935555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111339502|NCT03031691|Trifluridine|trifluridine|mesh-list
111339503|NCT03031691|Antimetabolites|antimetabolites|mesh-ancestor
111339504|NCT03031691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111339505|NCT03031691|Antiviral Agents|antiviral agents|mesh-ancestor
111339506|NCT03031691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111339507|NCT02430103|Goserelin|goserelin|mesh-list
111339508|NCT02430103|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111339509|NCT02430103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111339510|NCT03031535|Octreotide|octreotide|mesh-list
111339511|NCT03031535|Hormones|hormones|mesh-list
111339512|NCT03031535|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
111339513|NCT03031535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111339514|NCT03031535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111339515|NCT03031535|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111339516|NCT03031535|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111339517|NCT03031535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111339518|NCT01093417|Vitamin D|vitamin d|mesh-list
111339519|NCT01093417|Vitamins|vitamins|mesh-ancestor
111339520|NCT01093417|Micronutrients|micronutrients|mesh-ancestor
111339521|NCT01093417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111339522|NCT01093417|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111339523|NCT01093651|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111339524|NCT01093651|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111339525|NCT01093651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111339526|NCT01093651|Incretins|incretins|mesh-ancestor
111339527|NCT01093651|Hormones|hormones|mesh-ancestor
111339528|NCT01093651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111339529|NCT01093651|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111339530|NCT01093651|Protease Inhibitors|protease inhibitors|mesh-ancestor
111339531|NCT01093651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111339532|NCT01093651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111339533|NCT00362895|Tobramycin|tobramycin|mesh-list
111339534|NCT00362895|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
111339535|NCT00362895|Dexamethasone|dexamethasone|mesh-list
111339536|NCT00362895|Dexamethasone acetate|dexamethasone acetate|mesh-list
111339537|NCT00362895|BB 1101|bb 1101|mesh-list
111339538|NCT00362895|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111339539|NCT00362895|Antiemetics|antiemetics|mesh-ancestor
111339540|NCT00362895|Autonomic Agents|autonomic agents|mesh-ancestor
111339541|NCT00362895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111339542|NCT00362895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110691344|NCT01019798|Docetaxel|docetaxel|mesh-list
111339543|NCT00362895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111339544|NCT00362895|Glucocorticoids|glucocorticoids|mesh-ancestor
111339545|NCT00362895|Hormones|hormones|mesh-ancestor
111339546|NCT00362895|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111339547|NCT00362895|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111339548|NCT00362895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111339549|NCT00362895|Protease Inhibitors|protease inhibitors|mesh-ancestor
111339550|NCT00362895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111339551|NCT00362895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111339552|NCT00362895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111339553|NCT00362895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111339554|NCT00362895|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
111339555|NCT00362895|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111339556|NCT04744623|Mycophenolic Acid|mycophenolic acid|mesh-list
111339557|NCT04744623|Dapsone|dapsone|mesh-list
111339558|NCT04744623|Prednisolone|prednisolone|mesh-list
111339559|NCT04744623|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111339560|NCT04744623|Methylprednisolone|methylprednisolone|mesh-list
111339561|NCT04744623|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111339562|NCT04744623|Prednisolone acetate|prednisolone acetate|mesh-list
111339563|NCT04744623|Triamcinolone|triamcinolone|mesh-list
111339564|NCT04744623|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
111339565|NCT04744623|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
111339566|NCT04744623|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
111339567|NCT04744623|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111339568|NCT04744623|Prednisolone phosphate|prednisolone phosphate|mesh-list
111339569|NCT04744623|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111339570|NCT04744623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111339571|NCT04744623|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111339572|NCT04744623|Antitubercular Agents|antitubercular agents|mesh-ancestor
111339573|NCT04744623|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111339574|NCT04744623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111339575|NCT04744623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111339576|NCT04744623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111339577|NCT04744623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111339578|NCT04744623|Glucocorticoids|glucocorticoids|mesh-ancestor
111339579|NCT04744623|Hormones|hormones|mesh-ancestor
111339580|NCT04744623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111339581|NCT04744623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111339582|NCT04744623|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111339583|NCT04744623|Antiemetics|antiemetics|mesh-ancestor
111339584|NCT04744623|Autonomic Agents|autonomic agents|mesh-ancestor
111339585|NCT04744623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111339587|NCT04744623|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111339588|NCT04744623|Protective Agents|protective agents|mesh-ancestor
111339589|NCT04744623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111339590|NCT04744623|Immunologic Factors|immunologic factors|mesh-ancestor
111339591|NCT04744623|Antimalarials|antimalarials|mesh-ancestor
111339592|NCT04744623|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111339593|NCT04744623|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111339594|NCT04744623|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111339595|NCT04744623|Leprostatic Agents|leprostatic agents|mesh-ancestor
111339596|NCT00939731|Crizotinib|crizotinib|mesh-list
111339597|NCT00939731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111339598|NCT00939731|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111339599|NCT00939731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111339600|NCT00939731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111339601|NCT00633945|Lenalidomide|lenalidomide|mesh-list
111339602|NCT00633945|Immunologic Factors|immunologic factors|mesh-ancestor
111339603|NCT00633945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111339604|NCT00633945|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111339605|NCT00633945|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111339606|NCT00633945|Growth Substances|growth substances|mesh-ancestor
111339607|NCT00633945|Growth Inhibitors|growth inhibitors|mesh-ancestor
111339608|NCT00633945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111339609|NCT03609047|Paclitaxel|paclitaxel|mesh-list
111339610|NCT03609047|Docetaxel|docetaxel|mesh-list
111339611|NCT03609047|Cyclophosphamide|cyclophosphamide|mesh-list
111339612|NCT03609047|Doxorubicin|doxorubicin|mesh-list
111339613|NCT03609047|Epirubicin|epirubicin|mesh-list
111339614|NCT03609047|Palbociclib|palbociclib|mesh-list
111339615|NCT03609047|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110691785|NCT04377503|Antiemetics|antiemetics|mesh-ancestor
111339616|NCT03609047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111339617|NCT03609047|Tubulin Modulators|tubulin modulators|mesh-ancestor
111339618|NCT03609047|Antimitotic Agents|antimitotic agents|mesh-ancestor
111339619|NCT03609047|Mitosis Modulators|mitosis modulators|mesh-ancestor
111339620|NCT03609047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111339621|NCT03609047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111339622|NCT03609047|Immunologic Factors|immunologic factors|mesh-ancestor
111339623|NCT03609047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111339624|NCT03609047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111339625|NCT03609047|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111339626|NCT03609047|Alkylating Agents|alkylating agents|mesh-ancestor
111339627|NCT03609047|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111339628|NCT03609047|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111339629|NCT03609047|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111339630|NCT03609047|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111339631|NCT03609047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111339632|NCT03609047|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111339633|NCT01118845|Rituximab|rituximab|mesh-list
111339634|NCT01118845|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
111339635|NCT01118845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111339636|NCT01118845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111339637|NCT01118845|Immunologic Factors|immunologic factors|mesh-ancestor
111339638|NCT01118845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111339639|NCT01118845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111339640|NCT01118845|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111339641|NCT01118845|Alkylating Agents|alkylating agents|mesh-ancestor
111339642|NCT01118845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111339643|NCT01130077|Poly ICLC|poly iclc|mesh-list
111339644|NCT01130077|Interferon Inducers|interferon inducers|mesh-ancestor
111339645|NCT01130077|Immunologic Factors|immunologic factors|mesh-ancestor
111339646|NCT01130077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111339647|NCT03162731|Nivolumab|nivolumab|mesh-list
111339648|NCT03162731|Ipilimumab|ipilimumab|mesh-list
111339649|NCT03162731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111339650|NCT03162731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111339651|NCT03162731|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111339652|NCT03162731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111339653|NCT03030911|Fentanyl|fentanyl|mesh-list
111339654|NCT03030911|Midazolam|midazolam|mesh-list
111339655|NCT03030911|Dexmedetomidine|dexmedetomidine|mesh-list
111339656|NCT03030911|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111339657|NCT03030911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111339658|NCT03030911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111339659|NCT03030911|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111339660|NCT03030911|Analgesics|analgesics|mesh-ancestor
111339661|NCT03030911|Sensory System Agents|sensory system agents|mesh-ancestor
111339662|NCT03030911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111339663|NCT03030911|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111339664|NCT03030911|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111339665|NCT03030911|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111339666|NCT03030911|Adrenergic Agents|adrenergic agents|mesh-ancestor
111339667|NCT03030911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111339668|NCT03030911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111339669|NCT03030911|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111339670|NCT03030911|Narcotics|narcotics|mesh-ancestor
111339671|NCT03030911|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111339672|NCT03030911|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111339673|NCT03030911|Anesthetics, General|anesthetics, general|mesh-ancestor
111339674|NCT03030911|Anesthetics|anesthetics|mesh-ancestor
111339675|NCT03030911|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111339676|NCT03030911|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111339677|NCT03030911|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111339678|NCT03030911|GABA Modulators|gaba modulators|mesh-ancestor
111339679|NCT03030911|GABA Agents|gaba agents|mesh-ancestor
111339680|NCT01120405|Sevoflurane|sevoflurane|mesh-list
111339681|NCT01120405|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111339682|NCT01120405|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111339683|NCT01120405|Anesthetics, General|anesthetics, general|mesh-ancestor
111339684|NCT01120405|Anesthetics|anesthetics|mesh-ancestor
111339685|NCT01120405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111339686|NCT01120405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111339687|NCT03013387|Octreotide|octreotide|mesh-list
111339688|NCT03013387|Edotreotide|edotreotide|mesh-list
111339689|NCT03013387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111339690|NCT03013387|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111339691|NCT03013387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111339692|NCT03013387|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111339693|NCT03013387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111339694|NCT01782989|Doxycycline|doxycycline|mesh-list
111339695|NCT01782989|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111339696|NCT01782989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111339697|NCT01782989|Antimalarials|antimalarials|mesh-ancestor
111339698|NCT01782989|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111339699|NCT01782989|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111339700|NCT01120639|Temozolomide|temozolomide|mesh-list
111339701|NCT01120639|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111339702|NCT01120639|Alkylating Agents|alkylating agents|mesh-ancestor
111339703|NCT01120639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111339704|NCT01120639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111339705|NCT01095757|Plerixafor|plerixafor|mesh-list
111339706|NCT01095757|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111339707|NCT01095757|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111339708|NCT01095757|Antiviral Agents|antiviral agents|mesh-ancestor
111339709|NCT01095757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111339710|NCT03549598|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
111339711|NCT03549598|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111339712|NCT03549598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111339713|NCT02245451|Ritonavir|ritonavir|mesh-list
111339714|NCT02245451|Tipranavir|tipranavir|mesh-list
111339715|NCT02245451|Methadone|methadone|mesh-list
111339716|NCT02245451|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111339717|NCT02245451|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111339718|NCT02245451|Protease Inhibitors|protease inhibitors|mesh-ancestor
111339719|NCT02245451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110692282|NCT02534337|Vitamins|vitamins|mesh-ancestor
111339720|NCT02245451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111339721|NCT02245451|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111339722|NCT02245451|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111339723|NCT02245451|Antiviral Agents|antiviral agents|mesh-ancestor
111339724|NCT02245451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111339725|NCT02245451|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111339726|NCT02245451|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111339727|NCT02245451|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111339728|NCT02245451|Narcotics|narcotics|mesh-ancestor
111339729|NCT02245451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111339730|NCT02245451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111339731|NCT02245451|Analgesics|analgesics|mesh-ancestor
111339732|NCT02245451|Sensory System Agents|sensory system agents|mesh-ancestor
111339733|NCT02245451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111339734|NCT02245451|Antitussive Agents|antitussive agents|mesh-ancestor
110781350|NCT03673384|Xhance|xhance|mesh-list
110692491|NCT01051011|Hormones|hormones|mesh-ancestor
111339735|NCT02245451|Respiratory System Agents|respiratory system agents|mesh-ancestor
111339736|NCT01096771|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
111339737|NCT01096771|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
111339738|NCT01096771|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
111339739|NCT01096771|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111339740|NCT00951899|Metformin|metformin|mesh-list
111339741|NCT00951899|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
111339742|NCT00951899|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111339743|NCT00951899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111339744|NCT00951899|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111339745|NCT00951899|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111339746|NCT00951899|Antimetabolites|antimetabolites|mesh-ancestor
111339747|NCT00951899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111339748|NCT00951899|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111339749|NCT01097395|Ribavirin|ribavirin|mesh-list
111339750|NCT01097395|Antimetabolites|antimetabolites|mesh-ancestor
111339751|NCT01097395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111339752|NCT01097395|Antiviral Agents|antiviral agents|mesh-ancestor
111339753|NCT01097395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111339754|NCT00467987|Testosterone|testosterone|mesh-list
111339755|NCT00467987|Androgens|androgens|mesh-ancestor
111339756|NCT00467987|Hormones|hormones|mesh-ancestor
111339757|NCT00467987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111339758|NCT00467987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111339759|NCT00433589|Tamoxifen|tamoxifen|mesh-list
111339760|NCT00433589|Docetaxel|docetaxel|mesh-list
111339761|NCT00433589|Capecitabine|capecitabine|mesh-list
111339762|NCT00433589|Letrozole|letrozole|mesh-list
111339763|NCT00433589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111339764|NCT00433589|Tubulin Modulators|tubulin modulators|mesh-ancestor
111339765|NCT00433589|Antimitotic Agents|antimitotic agents|mesh-ancestor
111339766|NCT00433589|Mitosis Modulators|mitosis modulators|mesh-ancestor
111339767|NCT00433589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110692684|NCT00991133|Clofarabine|clofarabine|mesh-list
111339768|NCT00433589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111339769|NCT00433589|Antimetabolites|antimetabolites|mesh-ancestor
111339770|NCT00433589|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111339771|NCT00433589|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111339772|NCT00433589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111339773|NCT00433589|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111339774|NCT00433589|Hormone Antagonists|hormone antagonists|mesh-ancestor
111339775|NCT00433589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111339776|NCT00433589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111339777|NCT00433589|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111339778|NCT00433589|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111339779|NCT00433589|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111339780|NCT00433589|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111339781|NCT03013075|Morphine|morphine|mesh-list
111339782|NCT03013075|Bupivacaine|bupivacaine|mesh-list
111339783|NCT03013075|Anesthetics|anesthetics|mesh-list
111339784|NCT03013075|Anesthetics, General|anesthetics, general|mesh-list
111339785|NCT03013075|Anesthetics, Local|anesthetics, local|mesh-ancestor
111339786|NCT03013075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111339787|NCT03013075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111339788|NCT03013075|Sensory System Agents|sensory system agents|mesh-ancestor
111339789|NCT03013075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111339790|NCT03013075|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111339791|NCT03013075|Narcotics|narcotics|mesh-ancestor
111339792|NCT03013075|Analgesics|analgesics|mesh-ancestor
111339793|NCT03030677|Lidocaine|lidocaine|mesh-list
111339794|NCT03030677|Anesthetics, Local|anesthetics, local|mesh-ancestor
111339795|NCT03030677|Anesthetics|anesthetics|mesh-ancestor
111339796|NCT03030677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111339797|NCT03030677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111339798|NCT03030677|Sensory System Agents|sensory system agents|mesh-ancestor
111339799|NCT03030677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111339800|NCT03030677|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111339801|NCT03030677|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111339802|NCT03030677|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111339803|NCT03030677|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111339804|NCT03030677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111339805|NCT01122901|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
111339806|NCT01122901|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
111339807|NCT01122901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111339808|NCT01122901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111339809|NCT01097785|Simvastatin|simvastatin|mesh-list
111064275|NCT02283359|Irinotecan|irinotecan|mesh-list
111339810|NCT01097785|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111339811|NCT01097785|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111339812|NCT01097785|Antimetabolites|antimetabolites|mesh-ancestor
111339813|NCT01097785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111339814|NCT01097785|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111339815|NCT01097785|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111339816|NCT01097785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111339817|NCT03030287|Paclitaxel|paclitaxel|mesh-list
111339818|NCT03030287|Antibodies, Bispecific|antibodies, bispecific|mesh-list
111339819|NCT03030287|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111339820|NCT03030287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111339821|NCT03030287|Tubulin Modulators|tubulin modulators|mesh-ancestor
111339822|NCT03030287|Antimitotic Agents|antimitotic agents|mesh-ancestor
111339823|NCT03030287|Mitosis Modulators|mitosis modulators|mesh-ancestor
111339824|NCT03030287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111339825|NCT03030287|Immunologic Factors|immunologic factors|mesh-ancestor
111339826|NCT03030287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111339827|NCT03035357|Daratumumab|daratumumab|mesh-list
111339828|NCT03035357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111339829|NCT00940589|Melatonin|melatonin|mesh-list
111339830|NCT00940589|Antioxidants|antioxidants|mesh-ancestor
111339831|NCT00940589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111339832|NCT00940589|Protective Agents|protective agents|mesh-ancestor
111339833|NCT00940589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111339834|NCT00940589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111339835|NCT02574078|Paclitaxel|paclitaxel|mesh-list
111339836|NCT02574078|Docetaxel|docetaxel|mesh-list
111339837|NCT02574078|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111339838|NCT02574078|Bevacizumab|bevacizumab|mesh-list
111339839|NCT02574078|Carboplatin|carboplatin|mesh-list
111339840|NCT02574078|Gemcitabine|gemcitabine|mesh-list
111339841|NCT02574078|Nivolumab|nivolumab|mesh-list
111339842|NCT02574078|Pemetrexed|pemetrexed|mesh-list
111339843|NCT02574078|Crizotinib|crizotinib|mesh-list
111339844|NCT02574078|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111339845|NCT02574078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111339846|NCT02574078|Tubulin Modulators|tubulin modulators|mesh-ancestor
111339847|NCT02574078|Antimitotic Agents|antimitotic agents|mesh-ancestor
111339848|NCT02574078|Mitosis Modulators|mitosis modulators|mesh-ancestor
110693006|NCT04941443|Ibuprofen|ibuprofen|mesh-list
111339849|NCT02574078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111339850|NCT02574078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111339851|NCT02574078|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110693048|NCT00536939|Growth Inhibitors|growth inhibitors|mesh-ancestor
111339852|NCT02574078|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111339853|NCT02574078|Growth Substances|growth substances|mesh-ancestor
111339854|NCT02574078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111339855|NCT02574078|Growth Inhibitors|growth inhibitors|mesh-ancestor
111339856|NCT02574078|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111339857|NCT02574078|Antimetabolites|antimetabolites|mesh-ancestor
111339858|NCT02574078|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111339859|NCT02574078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111339860|NCT02574078|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111339861|NCT02574078|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111339862|NCT02574078|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111339863|NCT03605914|Acetaminophen|acetaminophen|mesh-list
111339864|NCT03605914|Diclofenac|diclofenac|mesh-list
111339865|NCT03605914|Hydrocodone|hydrocodone|mesh-list
111339866|NCT03605914|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111339867|NCT03605914|Analgesics|analgesics|mesh-ancestor
111339868|NCT03605914|Sensory System Agents|sensory system agents|mesh-ancestor
111339869|NCT03605914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111339870|NCT03605914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111339871|NCT03605914|Antipyretics|antipyretics|mesh-ancestor
111339872|NCT03605914|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111339873|NCT03605914|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111339874|NCT03605914|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111339875|NCT03605914|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111339876|NCT03605914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111339877|NCT03605914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111339878|NCT03605914|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111339879|NCT03605914|Narcotics|narcotics|mesh-ancestor
111339880|NCT03605914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111339881|NCT03605914|Antitussive Agents|antitussive agents|mesh-ancestor
111339882|NCT03605914|Respiratory System Agents|respiratory system agents|mesh-ancestor
111339883|NCT04353479|Decitabine|decitabine|mesh-list
111339884|NCT04353479|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
111339885|NCT04353479|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111339886|NCT04353479|Antimetabolites|antimetabolites|mesh-ancestor
111339887|NCT04353479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111339888|NCT04353479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111339889|NCT04353479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111339890|NCT04353479|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111339891|NCT03608488|Vitamin D|vitamin d|mesh-list
111339892|NCT03608488|Vitamins|vitamins|mesh-ancestor
111339893|NCT03608488|Micronutrients|micronutrients|mesh-ancestor
111339894|NCT03608488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111339895|NCT03608488|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111339896|NCT03035045|Acetaminophen|acetaminophen|mesh-list
111339897|NCT03035045|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111339898|NCT03035045|Analgesics|analgesics|mesh-ancestor
111339899|NCT03035045|Sensory System Agents|sensory system agents|mesh-ancestor
111339900|NCT03035045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111339901|NCT03035045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111339902|NCT03035045|Antipyretics|antipyretics|mesh-ancestor
111339903|NCT03034733|Dexamethasone|dexamethasone|mesh-list
110693524|NCT00535847|Ribavirin|ribavirin|mesh-list
111339904|NCT03034733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111339905|NCT03034733|Antiemetics|antiemetics|mesh-ancestor
111339906|NCT03034733|Autonomic Agents|autonomic agents|mesh-ancestor
111339907|NCT03034733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111339908|NCT03034733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111339909|NCT03034733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111339910|NCT03034733|Glucocorticoids|glucocorticoids|mesh-ancestor
111339911|NCT03034733|Hormones|hormones|mesh-ancestor
111339912|NCT03034733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111339913|NCT03034733|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111339914|NCT03034733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111339915|NCT05512416|Letrozole|letrozole|mesh-list
111339916|NCT05512416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111339917|NCT05512416|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110693730|NCT00992849|Growth Inhibitors|growth inhibitors|mesh-ancestor
111339918|NCT05512416|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111339919|NCT05512416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111339920|NCT05512416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111339921|NCT05512416|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111339922|NCT05512416|Hormone Antagonists|hormone antagonists|mesh-ancestor
111339923|NCT05512416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111339924|NCT05512416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111339925|NCT04290624|Listerine|listerine|mesh-list
111339926|NCT04290624|Fluorides|fluorides|mesh-list
111339927|NCT04290624|Sodium Fluoride|sodium fluoride|mesh-list
111339928|NCT04290624|Tin Fluorides|tin fluorides|mesh-list
111339929|NCT04290624|Cariostatic Agents|cariostatic agents|mesh-ancestor
111339930|NCT04290624|Protective Agents|protective agents|mesh-ancestor
111339931|NCT04290624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111339932|NCT04290624|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111339933|NCT04290624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111339934|NCT03403504|Oxycodone|oxycodone|mesh-list
111339935|NCT03403504|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111339936|NCT03403504|Narcotics|narcotics|mesh-ancestor
111339937|NCT03403504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111339938|NCT03403504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111339939|NCT03403504|Analgesics|analgesics|mesh-ancestor
111339940|NCT03403504|Sensory System Agents|sensory system agents|mesh-ancestor
111339941|NCT03403504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111339942|NCT05512728|Midazolam|midazolam|mesh-list
111339943|NCT05512728|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111339944|NCT05512728|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111339945|NCT05512728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111339946|NCT05512728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111339947|NCT05512728|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111339948|NCT05512728|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111339949|NCT05512728|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111339950|NCT05512728|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111339951|NCT05512728|Anesthetics, General|anesthetics, general|mesh-ancestor
111339952|NCT05512728|Anesthetics|anesthetics|mesh-ancestor
111339953|NCT05512728|GABA Modulators|gaba modulators|mesh-ancestor
111339954|NCT05512728|GABA Agents|gaba agents|mesh-ancestor
111339955|NCT05512728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111339956|NCT05512728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111339957|NCT02565810|Adalimumab|adalimumab|mesh-list
111339958|NCT02565810|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111339959|NCT02565810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111339960|NCT02565810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111339961|NCT00940901|Sildenafil Citrate|sildenafil citrate|mesh-list
111339962|NCT00940901|Vasodilator Agents|vasodilator agents|mesh-ancestor
111339963|NCT00940901|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111339964|NCT00940901|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111339965|NCT00940901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111339966|NCT00940901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111339967|NCT00940901|Urological Agents|urological agents|mesh-ancestor
111339968|NCT04353713|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
111339969|NCT04353713|Laxatives|laxatives|mesh-ancestor
111339970|NCT04353713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111339971|NCT03565666|Insulin|insulin|mesh-list
111339972|NCT03565666|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111339973|NCT03565666|Insulin Lispro|insulin lispro|mesh-list
111339974|NCT03565666|Insulin Aspart|insulin aspart|mesh-list
111339975|NCT03565666|Pancrelipase|pancrelipase|mesh-list
111339976|NCT03565666|Pancreatin|pancreatin|mesh-list
111339977|NCT03565666|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111339978|NCT03565666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111339979|NCT03565666|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111339980|NCT03620890|Protamines|protamines|mesh-list
111339981|NCT03620890|Heparin Antagonists|heparin antagonists|mesh-ancestor
111339982|NCT03620890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111339983|NCT03620890|Coagulants|coagulants|mesh-ancestor
111339984|NCT05507112|Capecitabine|capecitabine|mesh-list
111339985|NCT05507112|Tislelizumab|tislelizumab|mesh-list
111339986|NCT05507112|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
111339987|NCT05507112|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111339988|NCT05507112|Antimetabolites|antimetabolites|mesh-ancestor
111339989|NCT05507112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111339990|NCT05507112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111339991|NCT05507112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111339992|NCT05511948|Hydroquinone|hydroquinone|mesh-list
111339993|NCT05511948|Antioxidants|antioxidants|mesh-ancestor
111339994|NCT05511948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111339995|NCT05511948|Protective Agents|protective agents|mesh-ancestor
111339996|NCT05511948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111339997|NCT05511948|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111339998|NCT00952133|Dexamethasone|dexamethasone|mesh-list
111339999|NCT00952133|Dexamethasone acetate|dexamethasone acetate|mesh-list
111340000|NCT00952133|Palonosetron|palonosetron|mesh-list
111340001|NCT00952133|BB 1101|bb 1101|mesh-list
111340002|NCT00952133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111340003|NCT00952133|Antiemetics|antiemetics|mesh-ancestor
111340004|NCT00952133|Autonomic Agents|autonomic agents|mesh-ancestor
111340005|NCT00952133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111340006|NCT00952133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111340007|NCT00952133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111340008|NCT00952133|Glucocorticoids|glucocorticoids|mesh-ancestor
111340009|NCT00952133|Hormones|hormones|mesh-ancestor
110694121|NCT01055301|Thalidomide|thalidomide|mesh-list
111340010|NCT00952133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111340011|NCT00952133|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111340012|NCT00952133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111340013|NCT00952133|Protease Inhibitors|protease inhibitors|mesh-ancestor
111340014|NCT00952133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111340015|NCT00952133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111340016|NCT00952133|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111340017|NCT00952133|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111340018|NCT00952133|Serotonin Agents|serotonin agents|mesh-ancestor
111340019|NCT00952133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111340020|NCT05042375|Pembrolizumab|pembrolizumab|mesh-list
111340021|NCT05042375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111340022|NCT05042375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111340023|NCT05042375|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110694168|NCT03988101|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111340024|NCT05042375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111340025|NCT03023189|Tranexamic Acid|tranexamic acid|mesh-list
111340026|NCT03023189|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111340027|NCT03023189|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111340028|NCT03023189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111340029|NCT03023189|Hemostatics|hemostatics|mesh-ancestor
111340030|NCT03023189|Coagulants|coagulants|mesh-ancestor
111340031|NCT02561832|Cyclophosphamide|cyclophosphamide|mesh-list
111340032|NCT02561832|Carboplatin|carboplatin|mesh-list
111340033|NCT02561832|Olaparib|olaparib|mesh-list
111340034|NCT02561832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111340035|NCT02561832|Immunologic Factors|immunologic factors|mesh-ancestor
111340036|NCT02561832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111340037|NCT02561832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111340038|NCT02561832|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111340039|NCT02561832|Alkylating Agents|alkylating agents|mesh-ancestor
111340040|NCT02561832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111340041|NCT02561832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111340042|NCT02561832|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111340043|NCT02561832|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111340044|NCT02561832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111340045|NCT02982161|Celecoxib|celecoxib|mesh-list
111340046|NCT02982161|Tramadol|tramadol|mesh-list
111340047|NCT02982161|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111340048|NCT02982161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111340049|NCT02982161|Analgesics|analgesics|mesh-ancestor
111340050|NCT02982161|Sensory System Agents|sensory system agents|mesh-ancestor
111340051|NCT02982161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111340052|NCT02982161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111340053|NCT02982161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111340054|NCT02982161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111340055|NCT02982161|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111340056|NCT02982161|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111340057|NCT02982161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111340058|NCT02982161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111340059|NCT02982161|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111340060|NCT02982161|Narcotics|narcotics|mesh-ancestor
111340061|NCT02982161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111340062|NCT05506488|Dasatinib|dasatinib|mesh-list
111340063|NCT05506488|Quercetin|quercetin|mesh-list
111340064|NCT05506488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111340065|NCT05506488|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111340066|NCT05506488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111340067|NCT05506488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111340068|NCT05506488|Antioxidants|antioxidants|mesh-ancestor
111340069|NCT05506488|Protective Agents|protective agents|mesh-ancestor
111340070|NCT05506488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111340071|NCT00942149|Daptomycin|daptomycin|mesh-list
111340072|NCT00942149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111340073|NCT00942149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111340074|NCT03023111|Miltefosine|miltefosine|mesh-list
111340075|NCT03023111|Meglumine Antimoniate|meglumine antimoniate|mesh-list
111340076|NCT03023111|Molgramostim|molgramostim|mesh-list
111340077|NCT03023111|Sargramostim|sargramostim|mesh-list
111340078|NCT03023111|Immunologic Factors|immunologic factors|mesh-ancestor
111340079|NCT03023111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111340080|NCT03023111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111340081|NCT03023111|Antifungal Agents|antifungal agents|mesh-ancestor
111340082|NCT03023111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111340083|NCT03023111|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111340084|NCT03023111|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111340085|NCT03022253|Acetaminophen|acetaminophen|mesh-list
111340086|NCT03022253|Ibuprofen|ibuprofen|mesh-list
111340087|NCT03022253|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111340088|NCT03022253|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111340089|NCT03022253|Analgesics|analgesics|mesh-ancestor
111340090|NCT03022253|Sensory System Agents|sensory system agents|mesh-ancestor
111340091|NCT03022253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110694394|NCT01005641|Exemestane|exemestane|mesh-list
111340092|NCT03022253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111340093|NCT03022253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111340094|NCT03022253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111340095|NCT03022253|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111340096|NCT03022253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111340097|NCT03022253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111340098|NCT03022253|Antipyretics|antipyretics|mesh-ancestor
111340099|NCT01037881|Pimecrolimus|pimecrolimus|mesh-list
111340100|NCT01037881|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111340101|NCT01037881|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111340102|NCT01037881|Analgesics|analgesics|mesh-ancestor
111340103|NCT01037881|Sensory System Agents|sensory system agents|mesh-ancestor
111340104|NCT01037881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111340105|NCT01037881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111340106|NCT01037881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111340107|NCT01037881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111340108|NCT01037881|Dermatologic Agents|dermatologic agents|mesh-ancestor
111340109|NCT01037881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111340110|NCT01037881|Immunologic Factors|immunologic factors|mesh-ancestor
111340111|NCT01037881|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111340112|NCT01037881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111340113|NCT01037881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111064598|NCT00394199|Xhance|xhance|mesh-list
111340115|NCT03017807|Immunologic Factors|immunologic factors|mesh-ancestor
111340116|NCT03017807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111340117|NCT03017729|Botulinum Toxins|botulinum toxins|mesh-list
111340118|NCT03017729|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111340119|NCT03017729|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111340120|NCT03017729|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111340121|NCT03017729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111340122|NCT03017729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111340123|NCT03017729|Cholinergic Agents|cholinergic agents|mesh-ancestor
111340124|NCT03017729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111340125|NCT03017729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111340126|NCT03017729|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111340127|NCT03017729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111340128|NCT03017495|Midazolam|midazolam|mesh-list
111340129|NCT03017495|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111340130|NCT03017495|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111340131|NCT03017495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111340132|NCT03017495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111340133|NCT03017495|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111340134|NCT03017495|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111340135|NCT03017495|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111340136|NCT03017495|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111340137|NCT03017495|Anesthetics, General|anesthetics, general|mesh-ancestor
111340138|NCT03017495|Anesthetics|anesthetics|mesh-ancestor
111340139|NCT03017495|GABA Modulators|gaba modulators|mesh-ancestor
111340140|NCT03017495|GABA Agents|gaba agents|mesh-ancestor
111340141|NCT03017495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111340142|NCT03017495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111340143|NCT01039207|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111340144|NCT01039207|Rilotumumab|rilotumumab|mesh-list
111340145|NCT01039207|Antibodies|antibodies|mesh-list
111340146|NCT01039207|Immunoglobulins|immunoglobulins|mesh-list
111340147|NCT01039207|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111340148|NCT01039207|Immunologic Factors|immunologic factors|mesh-ancestor
111340149|NCT01039207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111340150|NCT01039207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111340151|NCT02981615|Levofloxacin|levofloxacin|mesh-list
111340152|NCT02981615|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111340153|NCT02981615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111340154|NCT02981615|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111340155|NCT02981615|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111340156|NCT02981615|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111340157|NCT02981615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111340158|NCT02981615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111340159|NCT02981615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111340160|NCT02981615|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111340161|NCT02981615|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111340162|NCT01125163|Iron|iron|mesh-list
111340163|NCT01125163|Trace Elements|trace elements|mesh-ancestor
111340164|NCT01125163|Micronutrients|micronutrients|mesh-ancestor
111340165|NCT01125163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111340166|NCT03019991|Ritonavir|ritonavir|mesh-list
111340167|NCT03019991|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111340168|NCT03019991|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111340169|NCT03019991|Protease Inhibitors|protease inhibitors|mesh-ancestor
111340170|NCT03019991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111340171|NCT03019991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111340172|NCT03019991|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110694687|NCT01021358|Navitoclax|navitoclax|mesh-list
111340173|NCT03019991|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111340174|NCT03019991|Antiviral Agents|antiviral agents|mesh-ancestor
111340175|NCT03019991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111340176|NCT03019991|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111340177|NCT03019991|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111340178|NCT05307835|Molgramostim|molgramostim|mesh-list
111340179|NCT05307835|Sargramostim|sargramostim|mesh-list
111340180|NCT05307835|Immunologic Factors|immunologic factors|mesh-ancestor
111340181|NCT05307835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111340182|NCT05307835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111340183|NCT00947297|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
111340184|NCT00947297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111340185|NCT03019835|Neostigmine|neostigmine|mesh-list
111340186|NCT03019835|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111340187|NCT03019835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111340188|NCT03019835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111340189|NCT03019835|Cholinergic Agents|cholinergic agents|mesh-ancestor
111340190|NCT03019835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111340191|NCT03019835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111340192|NCT03019835|Parasympathomimetics|parasympathomimetics|mesh-ancestor
111340193|NCT03019835|Autonomic Agents|autonomic agents|mesh-ancestor
111340194|NCT03019835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111340195|NCT00955877|Morphine|morphine|mesh-list
111340196|NCT00955877|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111340197|NCT00955877|Narcotics|narcotics|mesh-ancestor
111340198|NCT00955877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111340199|NCT00955877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111340200|NCT00955877|Analgesics|analgesics|mesh-ancestor
110694880|NCT01025102|Analgesics|analgesics|mesh-ancestor
111340201|NCT00955877|Sensory System Agents|sensory system agents|mesh-ancestor
111340202|NCT00955877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111340203|NCT03960658|Ketamine|ketamine|mesh-list
111340204|NCT03960658|Analgesics|analgesics|mesh-ancestor
111340205|NCT03960658|Sensory System Agents|sensory system agents|mesh-ancestor
111340206|NCT03960658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111340207|NCT03960658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111340208|NCT03960658|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111340209|NCT03960658|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111340210|NCT03960658|Anesthetics, General|anesthetics, general|mesh-ancestor
111340211|NCT03960658|Anesthetics|anesthetics|mesh-ancestor
111340212|NCT03960658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111340213|NCT03960658|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111340214|NCT03960658|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111340215|NCT03960658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111340216|NCT03960658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111340217|NCT01005407|Vaccines|vaccines|mesh-list
111340218|NCT01005407|Immunologic Factors|immunologic factors|mesh-ancestor
111340219|NCT01005407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111340220|NCT03633448|Phenylpropanolamine|phenylpropanolamine|mesh-list
111340221|NCT03633448|Guaifenesin|guaifenesin|mesh-list
111340222|NCT03633448|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
111340223|NCT03633448|Expectorants|expectorants|mesh-ancestor
111340224|NCT03633448|Respiratory System Agents|respiratory system agents|mesh-ancestor
111340225|NCT03633448|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111340226|NCT03633448|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111340227|NCT03633448|Adrenergic Agents|adrenergic agents|mesh-ancestor
110695028|NCT00461630|Niacin|niacin|mesh-list
111340228|NCT03633448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111340229|NCT03633448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111340230|NCT03633448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111340231|NCT03633448|Appetite Depressants|appetite depressants|mesh-ancestor
111340232|NCT03633448|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111340233|NCT03633448|Sympathomimetics|sympathomimetics|mesh-ancestor
111340234|NCT03633448|Autonomic Agents|autonomic agents|mesh-ancestor
111340235|NCT03633448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111340236|NCT03633448|Nasal Decongestants|nasal decongestants|mesh-ancestor
111340237|NCT03633448|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111340238|NCT05313958|Cytarabine|cytarabine|mesh-list
111340239|NCT05313958|Sorafenib|sorafenib|mesh-list
111340240|NCT05313958|Mitoxantrone|mitoxantrone|mesh-list
111340241|NCT05313958|Idarubicin|idarubicin|mesh-list
111340242|NCT05313958|Cladribine|cladribine|mesh-list
111340243|NCT05313958|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111340244|NCT05313958|Antimetabolites|antimetabolites|mesh-ancestor
111340245|NCT05313958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111340246|NCT05313958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111340247|NCT05313958|Antiviral Agents|antiviral agents|mesh-ancestor
111340248|NCT05313958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111340249|NCT05313958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111340250|NCT05313958|Immunologic Factors|immunologic factors|mesh-ancestor
111340251|NCT05313958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111340252|NCT05313958|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111340253|NCT05313958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111340254|NCT05313958|Analgesics|analgesics|mesh-ancestor
111340255|NCT05313958|Sensory System Agents|sensory system agents|mesh-ancestor
111340256|NCT05313958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111340257|NCT05313958|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111340258|NCT05313958|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111340259|NCT05313958|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111340260|NCT01006655|Beclomethasone|beclomethasone|mesh-list
111340261|NCT01006655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111340262|NCT01006655|Glucocorticoids|glucocorticoids|mesh-ancestor
111340263|NCT01006655|Hormones|hormones|mesh-ancestor
110695129|NCT01063647|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111340264|NCT01006655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111340265|NCT01006655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111340266|NCT01006655|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111340267|NCT01006655|Respiratory System Agents|respiratory system agents|mesh-ancestor
111340268|NCT03633526|Ivacaftor|ivacaftor|mesh-list
111340269|NCT03633526|VX-659|vx-659|mesh-list
110695189|NCT00433290|Analgesics|analgesics|mesh-ancestor
111340270|NCT03633526|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
111340271|NCT03633526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111340272|NCT03633526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111340273|NCT01007591|Hydrocortisone|hydrocortisone|mesh-list
111340274|NCT01007591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111340275|NCT03019523|Caffeine|caffeine|mesh-list
111340276|NCT03019523|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111340277|NCT03019523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111340278|NCT03019523|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111340279|NCT03019523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111340280|NCT03019523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111340281|NCT03019523|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
111340282|NCT03019523|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111340283|NCT03019523|Purinergic Agents|purinergic agents|mesh-ancestor
111340284|NCT03019523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111340285|NCT01008059|Alfentanil|alfentanil|mesh-list
111340286|NCT01008059|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111340287|NCT01008059|Narcotics|narcotics|mesh-ancestor
111340288|NCT01008059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111340289|NCT01008059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111340290|NCT01008059|Analgesics|analgesics|mesh-ancestor
111340291|NCT01008059|Sensory System Agents|sensory system agents|mesh-ancestor
111340292|NCT01008059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111340293|NCT01008059|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111340294|NCT01008059|Anesthetics, General|anesthetics, general|mesh-ancestor
111340295|NCT01008059|Anesthetics|anesthetics|mesh-ancestor
111340296|NCT01009619|Azithromycin|azithromycin|mesh-list
111340297|NCT01009619|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111340298|NCT01009619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111340299|NCT01010009|Resveratrol|resveratrol|mesh-list
111340300|NCT01010009|Antioxidants|antioxidants|mesh-ancestor
111340301|NCT01010009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111340302|NCT01010009|Protective Agents|protective agents|mesh-ancestor
111340303|NCT01010009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111340304|NCT01010009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111340305|NCT01010009|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111340306|NCT04467424|Lidocaine|lidocaine|mesh-list
111340307|NCT04467424|Ketamine|ketamine|mesh-list
111340308|NCT04467424|Propofol|propofol|mesh-list
111340309|NCT04467424|Anesthetics, Local|anesthetics, local|mesh-ancestor
111340310|NCT04467424|Anesthetics|anesthetics|mesh-ancestor
111340311|NCT04467424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111340312|NCT04467424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111340313|NCT04467424|Sensory System Agents|sensory system agents|mesh-ancestor
111340314|NCT04467424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111340315|NCT04467424|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111340316|NCT04467424|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111340317|NCT04467424|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111340318|NCT04467424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110695507|NCT01027520|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111340319|NCT04467424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111340320|NCT04467424|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111340321|NCT04467424|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111340322|NCT04467424|Anesthetics, General|anesthetics, general|mesh-ancestor
111340323|NCT04467424|Analgesics|analgesics|mesh-ancestor
111340324|NCT04467424|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111340325|NCT04467424|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111340326|NCT04467424|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111340327|NCT04467424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111340328|NCT03016715|Sirolimus|sirolimus|mesh-list
111340329|NCT03016715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111340330|NCT03016715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111340331|NCT03016715|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111340332|NCT03016715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111340333|NCT03016715|Antifungal Agents|antifungal agents|mesh-ancestor
111340334|NCT03016715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111340335|NCT03016715|Immunologic Factors|immunologic factors|mesh-ancestor
111340336|NCT03016715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111340337|NCT00377104|Alvocidib|alvocidib|mesh-list
111340338|NCT00377104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111340339|NCT00377104|Growth Inhibitors|growth inhibitors|mesh-ancestor
111340340|NCT00377104|Growth Substances|growth substances|mesh-ancestor
111340341|NCT00377104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111340342|NCT00377104|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111340343|NCT00377104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111340344|NCT00377104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111340345|NCT03016793|Puerarin|puerarin|mesh-list
111340346|NCT03016793|Vasodilator Agents|vasodilator agents|mesh-ancestor
111340347|NCT03928522|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111340348|NCT03928522|Vancomycin|vancomycin|mesh-list
111340349|NCT03928522|Tobramycin|tobramycin|mesh-list
111340350|NCT03928522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111340351|NCT01010399|Ritonavir|ritonavir|mesh-list
111340352|NCT01010399|Fosamprenavir|fosamprenavir|mesh-list
111340353|NCT01010399|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111340354|NCT01010399|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111340355|NCT01010399|Protease Inhibitors|protease inhibitors|mesh-ancestor
111340356|NCT01010399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111340357|NCT01010399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111340358|NCT01010399|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111340359|NCT01010399|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111340360|NCT01010399|Antiviral Agents|antiviral agents|mesh-ancestor
111340361|NCT01010399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111340362|NCT01010399|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111340363|NCT01010399|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111340364|NCT03638908|Fluoxetine|fluoxetine|mesh-list
111340365|NCT03638908|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111340366|NCT03638908|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111340367|NCT03638908|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111340368|NCT03638908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111340369|NCT03638908|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111340370|NCT03638908|Serotonin Agents|serotonin agents|mesh-ancestor
111340371|NCT03638908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111340372|NCT03638908|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111340373|NCT03638908|Antidepressive Agents|antidepressive agents|mesh-ancestor
111340374|NCT03638908|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111340375|NCT03638908|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111340376|NCT03638908|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111340377|NCT03638908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111340378|NCT01041781|Celecoxib|celecoxib|mesh-list
111340379|NCT01041781|Carboplatin|carboplatin|mesh-list
111340380|NCT01041781|Gemcitabine|gemcitabine|mesh-list
111340381|NCT01041781|Pemetrexed|pemetrexed|mesh-list
111340382|NCT01041781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111340383|NCT01041781|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111340384|NCT01041781|Antimetabolites|antimetabolites|mesh-ancestor
111340385|NCT01041781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111340386|NCT01041781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111340387|NCT01041781|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111340388|NCT01041781|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111340389|NCT01041781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111340390|NCT01041781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111340391|NCT01041781|Analgesics|analgesics|mesh-ancestor
111340392|NCT01041781|Sensory System Agents|sensory system agents|mesh-ancestor
111340393|NCT01041781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111340394|NCT01041781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111340395|NCT01041781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111340396|NCT01041781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111340397|NCT01041781|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110695749|NCT01023464|Emollients|emollients|mesh-list
111340398|NCT01041781|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111340399|NCT01010477|Nicotine|nicotine|mesh-list
111340400|NCT01010477|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111340401|NCT01010477|Autonomic Agents|autonomic agents|mesh-ancestor
111340402|NCT01010477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111340403|NCT01010477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111340404|NCT01010477|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111340405|NCT01010477|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111340406|NCT01010477|Cholinergic Agents|cholinergic agents|mesh-ancestor
111340407|NCT01010477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111340408|NCT01010477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111340409|NCT03921190|Anesthetics|anesthetics|mesh-list
111340410|NCT03921190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111340411|NCT03921190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111340412|NCT00953849|Calcitriol|calcitriol|mesh-list
111340413|NCT00953849|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
111340414|NCT00953849|Vitamin D|vitamin d|mesh-list
111340415|NCT00953849|Celecoxib|celecoxib|mesh-list
111340416|NCT00953849|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111340417|NCT00953849|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111340419|NCT00953849|Sensory System Agents|sensory system agents|mesh-ancestor
111340420|NCT00953849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110695795|NCT00430716|Sildenafil Citrate|sildenafil citrate|mesh-list
111340421|NCT00953849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111340422|NCT00953849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111340423|NCT00953849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111340424|NCT00953849|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111340425|NCT00953849|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111340426|NCT00953849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111340427|NCT00953849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111340428|NCT00953849|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111340429|NCT00953849|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
111340430|NCT00953849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111340431|NCT00953849|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111340432|NCT00953849|Vitamins|vitamins|mesh-ancestor
111340433|NCT00953849|Micronutrients|micronutrients|mesh-ancestor
111340434|NCT00953849|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111340435|NCT04425850|Ivermectin|ivermectin|mesh-list
111340436|NCT04425850|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111340437|NCT04425850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111340438|NCT03639766|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111340439|NCT03639766|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111340440|NCT03639766|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111340441|NCT03639766|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111340442|NCT03639766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111340443|NCT03639766|Cholinergic Agents|cholinergic agents|mesh-ancestor
111340444|NCT03639766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111340445|NCT03639766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111340446|NCT03639766|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110695905|NCT01024322|Autonomic Agents|autonomic agents|mesh-ancestor
111340447|NCT03639766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111340448|NCT01042795|Sunitinib|sunitinib|mesh-list
111340449|NCT01042795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111340450|NCT01042795|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111340451|NCT01042795|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111340452|NCT01042795|Growth Substances|growth substances|mesh-ancestor
111340453|NCT01042795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111340454|NCT01042795|Growth Inhibitors|growth inhibitors|mesh-ancestor
111340455|NCT01042795|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111340456|NCT01042795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111340457|NCT01042795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111340458|NCT03644212|Vitamin D|vitamin d|mesh-list
111340459|NCT03644212|Cholecalciferol|cholecalciferol|mesh-list
111340460|NCT03644212|Vitamins|vitamins|mesh-list
111340461|NCT03644212|Micronutrients|micronutrients|mesh-ancestor
111340462|NCT03644212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111340463|NCT03644212|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111340464|NCT03644212|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111340465|NCT03906448|Temozolomide|temozolomide|mesh-list
111340466|NCT03906448|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111340467|NCT03906448|Alkylating Agents|alkylating agents|mesh-ancestor
111340468|NCT03906448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110696101|NCT01039740|Mirtazapine|mirtazapine|mesh-list
111340469|NCT03906448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111340470|NCT01011413|Efavirenz|efavirenz|mesh-list
111340471|NCT01011413|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110696174|NCT00440726|Antimetabolites|antimetabolites|mesh-ancestor
111340472|NCT01011413|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111340473|NCT01011413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111340474|NCT01011413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110696243|NCT00405756|Aspirin|aspirin|mesh-list
111340475|NCT01011413|Antiviral Agents|antiviral agents|mesh-ancestor
111340476|NCT01011413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111340477|NCT01011413|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110696313|NCT00446030|Immunologic Factors|immunologic factors|mesh-ancestor
111340478|NCT01011413|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111340479|NCT01011413|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111340480|NCT01011413|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111340481|NCT01011413|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111340482|NCT01011413|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111340483|NCT03889444|Dexamethasone|dexamethasone|mesh-list
111340484|NCT03889444|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111340485|NCT03889444|Antiemetics|antiemetics|mesh-ancestor
111340486|NCT03889444|Autonomic Agents|autonomic agents|mesh-ancestor
111340487|NCT03889444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111340488|NCT03889444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111340489|NCT03889444|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111340490|NCT03889444|Glucocorticoids|glucocorticoids|mesh-ancestor
111340491|NCT03889444|Hormones|hormones|mesh-ancestor
111340492|NCT03889444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111340493|NCT03889444|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111340494|NCT03889444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111340495|NCT01104025|Dexamethasone|dexamethasone|mesh-list
111340496|NCT01104025|Hydrocortisone|hydrocortisone|mesh-list
111340497|NCT01104025|Methotrexate|methotrexate|mesh-list
111340498|NCT01104025|Etoposide|etoposide|mesh-list
111340499|NCT01104025|Thymoglobulin|thymoglobulin|mesh-list
111340500|NCT01104025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111340501|NCT01104025|Antiemetics|antiemetics|mesh-ancestor
111340502|NCT01104025|Autonomic Agents|autonomic agents|mesh-ancestor
111340503|NCT01104025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111340504|NCT01104025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111340505|NCT01104025|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111340506|NCT01104025|Glucocorticoids|glucocorticoids|mesh-ancestor
111340507|NCT01104025|Hormones|hormones|mesh-ancestor
111340508|NCT01104025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111340509|NCT01104025|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111340510|NCT01104025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111340511|NCT01104025|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111340512|NCT01104025|Abortifacient Agents|abortifacient agents|mesh-ancestor
111340513|NCT01104025|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111340514|NCT01104025|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111340515|NCT01104025|Antimetabolites|antimetabolites|mesh-ancestor
111340516|NCT01104025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111340517|NCT01104025|Dermatologic Agents|dermatologic agents|mesh-ancestor
111340518|NCT01104025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111340519|NCT01104025|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111340520|NCT01104025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111340521|NCT01104025|Immunologic Factors|immunologic factors|mesh-ancestor
111340522|NCT01104025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110696588|NCT01033760|Ritonavir|ritonavir|mesh-list
111340523|NCT01104025|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111340524|NCT01104025|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111340525|NCT01104025|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111340526|NCT01104025|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111340527|NCT03649750|Guaifenesin|guaifenesin|mesh-list
111340528|NCT03649750|Expectorants|expectorants|mesh-ancestor
111340529|NCT03649750|Respiratory System Agents|respiratory system agents|mesh-ancestor
111340530|NCT04343092|Ivermectin|ivermectin|mesh-list
111340531|NCT04343092|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111340532|NCT04343092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111340533|NCT01105117|Epoprostenol|epoprostenol|mesh-list
111340534|NCT01105117|Tezosentan|tezosentan|mesh-list
111340535|NCT01105117|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111340536|NCT01105117|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111340537|NCT01105117|Vasodilator Agents|vasodilator agents|mesh-ancestor
111340538|NCT03885154|Dihydroergotamine|dihydroergotamine|mesh-list
111340539|NCT03885154|Valproic Acid|valproic acid|mesh-list
111340540|NCT03885154|Anticonvulsants|anticonvulsants|mesh-ancestor
111340541|NCT03885154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111340542|NCT03885154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111340543|NCT03885154|GABA Agents|gaba agents|mesh-ancestor
111340544|NCT03885154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111340545|NCT03885154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111340546|NCT03885154|Antimanic Agents|antimanic agents|mesh-ancestor
111340547|NCT03885154|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111340548|NCT03885154|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111340549|NCT03885154|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111340550|NCT03885154|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111340551|NCT03885154|Dopamine Agonists|dopamine agonists|mesh-ancestor
111340552|NCT03885154|Dopamine Agents|dopamine agents|mesh-ancestor
111340553|NCT03885154|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111340554|NCT03885154|Analgesics|analgesics|mesh-ancestor
111340555|NCT03885154|Sensory System Agents|sensory system agents|mesh-ancestor
111340556|NCT03885154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111340557|NCT01106833|Sirolimus|sirolimus|mesh-list
111340558|NCT01106833|Prednisone|prednisone|mesh-list
111340559|NCT01106833|Temsirolimus|temsirolimus|mesh-list
110697067|NCT00239590|Testosterone|testosterone|mesh-list
111340560|NCT01106833|MTOR Inhibitors|mtor inhibitors|mesh-list
111340561|NCT01106833|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
111340562|NCT01106833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111340563|NCT01106833|Glucocorticoids|glucocorticoids|mesh-ancestor
111340564|NCT01106833|Hormones|hormones|mesh-ancestor
111479310|NCT05012631|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111340565|NCT01106833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111340566|NCT01106833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111340567|NCT01106833|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111340568|NCT01106833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111340569|NCT01106833|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111340570|NCT01106833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111340571|NCT01106833|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111340572|NCT01106833|Antifungal Agents|antifungal agents|mesh-ancestor
111340573|NCT01106833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111340574|NCT01106833|Immunologic Factors|immunologic factors|mesh-ancestor
111340575|NCT01106833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111340576|NCT01106833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111340577|NCT01106833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111340578|NCT00957047|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
111340579|NCT00957047|Anticonvulsants|anticonvulsants|mesh-ancestor
111340580|NCT00957047|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111340581|NCT00957047|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111340582|NCT00957047|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111340583|NCT00957047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111340584|NCT00957359|Niacin|niacin|mesh-list
111340585|NCT00957359|Psilocybin|psilocybin|mesh-list
111340586|NCT00957359|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
110697347|NCT00408408|Bevacizumab|bevacizumab|mesh-list
111340587|NCT00957359|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111340588|NCT00957359|Antimetabolites|antimetabolites|mesh-ancestor
111340589|NCT00957359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111340590|NCT00957359|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110697406|NCT01044186|Deferasirox|deferasirox|mesh-list
111340591|NCT00957359|Vasodilator Agents|vasodilator agents|mesh-ancestor
111340592|NCT00957359|Vitamin B Complex|vitamin b complex|mesh-ancestor
111340593|NCT00957359|Vitamins|vitamins|mesh-ancestor
111340594|NCT00957359|Micronutrients|micronutrients|mesh-ancestor
111340595|NCT00957359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110697474|NCT03972982|Insulin|insulin|mesh-list
111340596|NCT00957359|Hallucinogens|hallucinogens|mesh-ancestor
111340597|NCT00957359|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111340598|NCT00957359|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111340599|NCT00957359|Serotonin Agents|serotonin agents|mesh-ancestor
111340600|NCT00957359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111340601|NCT00957359|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111340602|NCT00957593|Oxytocin|oxytocin|mesh-list
111340603|NCT00957593|Oxytocics|oxytocics|mesh-ancestor
111340604|NCT00957593|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111340605|NCT00957593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111340606|NCT00957671|Hormones|hormones|mesh-list
111340607|NCT00957671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111340608|NCT00957671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111340609|NCT04322968|Ketorolac|ketorolac|mesh-list
111340610|NCT04322968|Ketamine|ketamine|mesh-list
111340611|NCT04322968|Analgesics|analgesics|mesh-ancestor
111340612|NCT04322968|Sensory System Agents|sensory system agents|mesh-ancestor
111340613|NCT04322968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111340614|NCT04322968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111340615|NCT04322968|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111340616|NCT04322968|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111340617|NCT04322968|Anesthetics, General|anesthetics, general|mesh-ancestor
111340618|NCT04322968|Anesthetics|anesthetics|mesh-ancestor
111340619|NCT04322968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111340620|NCT04322968|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111340621|NCT04322968|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111340622|NCT04322968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111340623|NCT04322968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111340624|NCT04322968|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111340625|NCT04322968|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111340626|NCT04322968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111340627|NCT04322968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111340628|NCT04322968|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111340629|NCT04322968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111340630|NCT03018899|Anesthetics|anesthetics|mesh-list
111340631|NCT03018899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111340632|NCT03018899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111340633|NCT00958919|Naloxone|naloxone|mesh-list
111340634|NCT00958919|Endorphins|endorphins|mesh-list
111340635|NCT00958919|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111340636|NCT00958919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111340637|NCT00958919|Sensory System Agents|sensory system agents|mesh-ancestor
111340638|NCT00958919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111340639|NCT00958919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111340640|NCT00958919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111340641|NCT04323592|Methylprednisolone|methylprednisolone|mesh-list
111340642|NCT04323592|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111340643|NCT04323592|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111340644|NCT04323592|Prednisolone|prednisolone|mesh-list
111340645|NCT04323592|Prednisolone acetate|prednisolone acetate|mesh-list
111340646|NCT04323592|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111340647|NCT04323592|Prednisolone phosphate|prednisolone phosphate|mesh-list
111340648|NCT04323592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111340649|NCT04323592|Antiemetics|antiemetics|mesh-ancestor
111340650|NCT04323592|Autonomic Agents|autonomic agents|mesh-ancestor
111340651|NCT04323592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111340652|NCT04323592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111340653|NCT04323592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111340654|NCT04323592|Glucocorticoids|glucocorticoids|mesh-ancestor
111340655|NCT04323592|Hormones|hormones|mesh-ancestor
111340656|NCT04323592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111340657|NCT04323592|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111340658|NCT04323592|Protective Agents|protective agents|mesh-ancestor
111340659|NCT04323592|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111340660|NCT04323592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111340661|NCT01047241|Sufentanil|sufentanil|mesh-list
111340662|NCT01047241|Ketamine|ketamine|mesh-list
111340663|NCT01047241|Analgesics|analgesics|mesh-ancestor
111340664|NCT01047241|Sensory System Agents|sensory system agents|mesh-ancestor
111340665|NCT01047241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111340666|NCT01047241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111340667|NCT01047241|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111340668|NCT01047241|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111340669|NCT01047241|Anesthetics, General|anesthetics, general|mesh-ancestor
111340670|NCT01047241|Anesthetics|anesthetics|mesh-ancestor
111340671|NCT01047241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111340672|NCT01047241|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111340673|NCT01047241|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111340674|NCT01047241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111340675|NCT01047241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111340676|NCT01047241|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111340677|NCT01047241|Narcotics|narcotics|mesh-ancestor
111340678|NCT01047241|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111340679|NCT01012661|Lidocaine|lidocaine|mesh-list
111340680|NCT01012661|Anesthetics, Local|anesthetics, local|mesh-ancestor
111340681|NCT01012661|Anesthetics|anesthetics|mesh-ancestor
111340682|NCT01012661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111340683|NCT01012661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111340684|NCT01012661|Sensory System Agents|sensory system agents|mesh-ancestor
111340685|NCT01012661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111340686|NCT01012661|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111340687|NCT01012661|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111340688|NCT01012661|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111340689|NCT01012661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111340690|NCT01012661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111340691|NCT03655444|Nivolumab|nivolumab|mesh-list
111340692|NCT03655444|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111340693|NCT03655444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111340694|NCT03655444|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111340695|NCT03655444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111340696|NCT03018977|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
111340697|NCT03018977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111340698|NCT03018977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111340699|NCT03018821|Tenofovir|tenofovir|mesh-list
111340700|NCT03018821|Entecavir|entecavir|mesh-list
111340701|NCT03018821|Antiviral Agents|antiviral agents|mesh-ancestor
111340702|NCT03018821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111340703|NCT03018821|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111340704|NCT03018821|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111340705|NCT03018821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111340706|NCT03018821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111340707|NCT03018821|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111340708|NCT03018821|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111340709|NCT03866434|Anagrelide|anagrelide|mesh-list
111340710|NCT03866434|Omeprazole|omeprazole|mesh-list
111340711|NCT03866434|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111340712|NCT03866434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111340713|NCT03866434|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111340714|NCT03866434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111340715|NCT03866434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111340716|NCT03866434|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111340717|NCT03866434|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110697942|NCT00290511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111340718|NCT03866434|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111340719|NCT00962039|Citalopram|citalopram|mesh-list
111340720|NCT00962039|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110698016|NCT00374868|Pemetrexed|pemetrexed|mesh-list
111340721|NCT00962039|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111340722|NCT00962039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111340723|NCT00962039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111340724|NCT00962039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111340725|NCT00962039|Serotonin Agents|serotonin agents|mesh-ancestor
110698086|NCT00288639|Analgesics|analgesics|mesh-ancestor
111340726|NCT00962039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111340727|NCT00962039|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111340728|NCT00962039|Antidepressive Agents|antidepressive agents|mesh-ancestor
111340729|NCT00962039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111340730|NCT03375385|Dexmedetomidine|dexmedetomidine|mesh-list
111340731|NCT03375385|Propofol|propofol|mesh-list
111340732|NCT03375385|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111340733|NCT03375385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111340734|NCT03375385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111340735|NCT03375385|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111340736|NCT03375385|Analgesics|analgesics|mesh-ancestor
111340737|NCT03375385|Sensory System Agents|sensory system agents|mesh-ancestor
111340738|NCT03375385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110698231|NCT00388362|Sirolimus|sirolimus|mesh-list
111340739|NCT03375385|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111340740|NCT03375385|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111340741|NCT03375385|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111340742|NCT03375385|Adrenergic Agents|adrenergic agents|mesh-ancestor
110698285|NCT00387348|Dexetimide|dexetimide|mesh-list
111340743|NCT03375385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111340744|NCT03375385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111340745|NCT03375385|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111340746|NCT03375385|Anesthetics, General|anesthetics, general|mesh-ancestor
111340747|NCT03375385|Anesthetics|anesthetics|mesh-ancestor
111340748|NCT03018665|Metformin|metformin|mesh-list
111340749|NCT03018665|Exenatide|exenatide|mesh-list
110698341|NCT00430352|Rituximab|rituximab|mesh-list
111340750|NCT03018665|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111340751|NCT03018665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110698423|NCT00429026|Melphalan|melphalan|mesh-list
111340752|NCT03018665|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111340753|NCT03018665|Incretins|incretins|mesh-ancestor
111340754|NCT03018665|Hormones|hormones|mesh-ancestor
111340755|NCT03018665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111340756|NCT03012763|Acetaminophen|acetaminophen|mesh-list
111340757|NCT03012763|Fexofenadine|fexofenadine|mesh-list
111340758|NCT03012763|Sulfasalazine|sulfasalazine|mesh-list
111340759|NCT03012763|Valsartan|valsartan|mesh-list
111340760|NCT03012763|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111340761|NCT03012763|Analgesics|analgesics|mesh-ancestor
111340762|NCT03012763|Sensory System Agents|sensory system agents|mesh-ancestor
111340763|NCT03012763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111340764|NCT03012763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111340765|NCT03012763|Antipyretics|antipyretics|mesh-ancestor
111340766|NCT03012763|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111340767|NCT03012763|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111340768|NCT03012763|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111340769|NCT03012763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110698540|NCT00386100|Metformin|metformin|mesh-list
111340770|NCT03012763|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111340771|NCT03012763|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
111340772|NCT03012763|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111340773|NCT03012763|Histamine Antagonists|histamine antagonists|mesh-ancestor
111340774|NCT03012763|Histamine Agents|histamine agents|mesh-ancestor
111340775|NCT03012763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111340776|NCT03012763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111340777|NCT03012763|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111340778|NCT03012763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111340779|NCT03012763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111340780|NCT03012763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111340781|NCT03012607|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
111340782|NCT03012607|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111340783|NCT03012607|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111340784|NCT03012607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111065249|NCT01601626|Pyridoxine|pyridoxine|mesh-list
111340785|NCT03012607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111340786|NCT03012607|Antiviral Agents|antiviral agents|mesh-ancestor
111340787|NCT03012607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111340788|NCT03012607|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111340789|NCT03012607|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111340790|NCT01048879|Oseltamivir|oseltamivir|mesh-list
111340791|NCT01048879|Dialysis Solutions|dialysis solutions|mesh-list
111340792|NCT01048879|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111340793|NCT01048879|Antiviral Agents|antiviral agents|mesh-ancestor
110698896|NCT00232180|Eplerenone|eplerenone|mesh-list
111340794|NCT01048879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111340795|NCT01048879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111340796|NCT01048879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111340797|NCT04290676|Dexamethasone|dexamethasone|mesh-list
110698949|NCT00269919|Dopamine Agents|dopamine agents|mesh-ancestor
111340798|NCT04290676|Dexamethasone acetate|dexamethasone acetate|mesh-list
111340799|NCT04290676|BB 1101|bb 1101|mesh-list
111340800|NCT04290676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111340801|NCT04290676|Antiemetics|antiemetics|mesh-ancestor
111340802|NCT04290676|Autonomic Agents|autonomic agents|mesh-ancestor
111340803|NCT04290676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111340804|NCT04290676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111340805|NCT04290676|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111340806|NCT04290676|Glucocorticoids|glucocorticoids|mesh-ancestor
111340807|NCT04290676|Hormones|hormones|mesh-ancestor
111340808|NCT04290676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111340809|NCT04290676|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111340810|NCT04290676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111340811|NCT04290676|Protease Inhibitors|protease inhibitors|mesh-ancestor
111340812|NCT04290676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111340813|NCT04290676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111340814|NCT03112993|Neostigmine|neostigmine|mesh-list
111340815|NCT03112993|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111340816|NCT03112993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111340817|NCT03112993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111340818|NCT03112993|Cholinergic Agents|cholinergic agents|mesh-ancestor
111340819|NCT03112993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111340820|NCT03112993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110699092|NCT00423332|Cediranib|cediranib|mesh-list
111340821|NCT03112993|Parasympathomimetics|parasympathomimetics|mesh-ancestor
111340822|NCT03112993|Autonomic Agents|autonomic agents|mesh-ancestor
111340823|NCT03112993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111340824|NCT03670030|Sirolimus|sirolimus|mesh-list
110699143|NCT00423098|Hormones|hormones|mesh-ancestor
111340825|NCT03670030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111340826|NCT03670030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110699210|NCT01046838|Urological Agents|urological agents|mesh-ancestor
111340827|NCT03670030|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111340828|NCT03670030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111340829|NCT03670030|Antifungal Agents|antifungal agents|mesh-ancestor
111340830|NCT03670030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111340831|NCT03670030|Immunologic Factors|immunologic factors|mesh-ancestor
111340832|NCT03670030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111340833|NCT03859960|Insulin|insulin|mesh-list
111340834|NCT03859960|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111340835|NCT03859960|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111340836|NCT03859960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111340837|NCT03857230|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
111340838|NCT03857230|Hormones|hormones|mesh-ancestor
111340839|NCT03857230|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111340840|NCT03857230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111340841|NCT02181127|Glucagon|glucagon|mesh-list
111340842|NCT02181127|Pancrelipase|pancrelipase|mesh-list
111340843|NCT02181127|Pancreatin|pancreatin|mesh-list
111340844|NCT02181127|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111340845|NCT02181127|Hormones|hormones|mesh-ancestor
111340846|NCT02181127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111340847|NCT02181127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111340848|NCT04332094|Azithromycin|azithromycin|mesh-list
111340849|NCT04332094|Hydroxychloroquine|hydroxychloroquine|mesh-list
111340850|NCT04332094|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111340851|NCT04332094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111340852|NCT04332094|Antimalarials|antimalarials|mesh-ancestor
111340853|NCT04332094|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111340854|NCT04332094|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111340855|NCT04332094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111340856|NCT04332094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111340857|NCT04332094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111340858|NCT05314270|Copper|copper|mesh-list
111340859|NCT05314270|Trace Elements|trace elements|mesh-ancestor
111065330|NCT05641480|Nootropic Agents|nootropic agents|mesh-ancestor
111340860|NCT05314270|Micronutrients|micronutrients|mesh-ancestor
111340861|NCT05314270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111340862|NCT01167829|Testosterone|testosterone|mesh-list
111340863|NCT01167829|Acyline|acyline|mesh-list
111340864|NCT01167829|Androgens|androgens|mesh-ancestor
111340865|NCT01167829|Hormones|hormones|mesh-ancestor
111340866|NCT01167829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111340867|NCT01167829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111340868|NCT01167829|Hormone Antagonists|hormone antagonists|mesh-ancestor
111340869|NCT02066623|Everolimus|everolimus|mesh-list
111340870|NCT02066623|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111340871|NCT02066623|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111340872|NCT02066623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111340873|NCT02066623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111340874|NCT02066623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111340875|NCT02066623|Immunologic Factors|immunologic factors|mesh-ancestor
111340876|NCT02066623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111340877|NCT02066623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111340878|NCT04974151|Folic Acid|folic acid|mesh-list
111340879|NCT04974151|Amlodipine|amlodipine|mesh-list
111340880|NCT04974151|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111340881|NCT04974151|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111340882|NCT04974151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110699447|NCT00280059|Lamotrigine|lamotrigine|mesh-list
111340883|NCT04974151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111340884|NCT04974151|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111340885|NCT04974151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111340886|NCT04974151|Vasodilator Agents|vasodilator agents|mesh-ancestor
111340887|NCT04974151|Hematinics|hematinics|mesh-ancestor
111340888|NCT04974151|Vitamin B Complex|vitamin b complex|mesh-ancestor
111340889|NCT04974151|Vitamins|vitamins|mesh-ancestor
111340890|NCT04974151|Micronutrients|micronutrients|mesh-ancestor
111340891|NCT01924819|Leucovorin|leucovorin|mesh-list
111340892|NCT01924819|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
111340893|NCT01924819|Cisplatin|cisplatin|mesh-list
111340894|NCT01924819|Docetaxel|docetaxel|mesh-list
111340895|NCT01924819|Fluorouracil|fluorouracil|mesh-list
111340896|NCT01924819|Capecitabine|capecitabine|mesh-list
111340897|NCT01924819|Oxaliplatin|oxaliplatin|mesh-list
111340898|NCT01924819|Epirubicin|epirubicin|mesh-list
111340899|NCT01924819|Levoleucovorin|levoleucovorin|mesh-list
111340900|NCT01924819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111340901|NCT01924819|Tubulin Modulators|tubulin modulators|mesh-ancestor
111340902|NCT01924819|Antimitotic Agents|antimitotic agents|mesh-ancestor
111340903|NCT01924819|Mitosis Modulators|mitosis modulators|mesh-ancestor
110699644|NCT00411554|Vitamins|vitamins|mesh-ancestor
111340904|NCT01924819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111340905|NCT01924819|Antimetabolites|antimetabolites|mesh-ancestor
111340906|NCT01924819|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111340907|NCT01924819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111340908|NCT01924819|Immunologic Factors|immunologic factors|mesh-ancestor
111340909|NCT01924819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111340910|NCT01924819|Antidotes|antidotes|mesh-ancestor
111340911|NCT01924819|Protective Agents|protective agents|mesh-ancestor
111340912|NCT01924819|Vitamin B Complex|vitamin b complex|mesh-ancestor
111340913|NCT01924819|Vitamins|vitamins|mesh-ancestor
111340914|NCT01924819|Micronutrients|micronutrients|mesh-ancestor
111340915|NCT01924819|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111340916|NCT01924819|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111340917|NCT01924819|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111340918|NCT01924819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111340919|NCT01168687|Levetiracetam|levetiracetam|mesh-list
111340920|NCT01168687|Anticonvulsants|anticonvulsants|mesh-ancestor
111340921|NCT01168687|Nootropic Agents|nootropic agents|mesh-ancestor
111340922|NCT03685396|Hemostatics|hemostatics|mesh-list
111340923|NCT03685396|Coagulants|coagulants|mesh-ancestor
111340924|NCT01126255|Clobetasol|clobetasol|mesh-list
111340925|NCT01126255|Progesterone|progesterone|mesh-list
111340926|NCT01126255|Progestins|progestins|mesh-ancestor
111340927|NCT01126255|Hormones|hormones|mesh-ancestor
111340928|NCT01126255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111340929|NCT01126255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111340930|NCT01126255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111340931|NCT01126255|Glucocorticoids|glucocorticoids|mesh-ancestor
111340932|NCT04198948|Gliclazide|gliclazide|mesh-list
111340933|NCT04198948|Omeprazole|omeprazole|mesh-list
111340934|NCT04198948|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111340935|NCT04198948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111340936|NCT04198948|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111340937|NCT04198948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111340938|NCT04198948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111340939|NCT04198948|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111340940|NCT04198948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110699817|NCT00410384|Belimumab|belimumab|mesh-list
111340941|NCT01169467|Dexmedetomidine|dexmedetomidine|mesh-list
111340942|NCT01169467|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111340943|NCT01169467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111340944|NCT01169467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111340945|NCT01169467|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111340946|NCT01169467|Analgesics|analgesics|mesh-ancestor
111340947|NCT01169467|Sensory System Agents|sensory system agents|mesh-ancestor
111340948|NCT01169467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111340949|NCT01169467|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111340950|NCT01169467|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111340951|NCT01169467|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111340952|NCT01169467|Adrenergic Agents|adrenergic agents|mesh-ancestor
111340953|NCT01169467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111340954|NCT01169467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111340955|NCT04822363|Aspirin|aspirin|mesh-list
111340956|NCT04822363|Clopidogrel|clopidogrel|mesh-list
111340957|NCT04822363|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111340958|NCT04822363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111340959|NCT04822363|Analgesics|analgesics|mesh-ancestor
111340960|NCT04822363|Sensory System Agents|sensory system agents|mesh-ancestor
111340961|NCT04822363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111340962|NCT04822363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111340963|NCT04822363|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111340964|NCT04822363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111340965|NCT04822363|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111340966|NCT04822363|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111340967|NCT04822363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110700189|NCT00200356|Ozagrel|ozagrel|mesh-list
111340968|NCT04822363|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111340969|NCT04822363|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111340970|NCT04822363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111340971|NCT04822363|Antipyretics|antipyretics|mesh-ancestor
111340972|NCT04822363|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111340973|NCT04822363|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111340974|NCT04822363|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111340975|NCT04822363|Purinergic Agents|purinergic agents|mesh-ancestor
111340976|NCT04822363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111340977|NCT01170247|Ketamine|ketamine|mesh-list
111340978|NCT01170247|Analgesics|analgesics|mesh-ancestor
111340979|NCT01170247|Sensory System Agents|sensory system agents|mesh-ancestor
111340980|NCT01170247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111340981|NCT01170247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111340982|NCT01170247|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111340983|NCT01170247|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111340984|NCT01170247|Anesthetics, General|anesthetics, general|mesh-ancestor
111340985|NCT01170247|Anesthetics|anesthetics|mesh-ancestor
111340986|NCT01170247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111340987|NCT01170247|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111340988|NCT01170247|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111340989|NCT01170247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111340990|NCT01170247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111340991|NCT01126099|Prazosin|prazosin|mesh-list
111340992|NCT01126099|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111340993|NCT01126099|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111340994|NCT01126099|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111340995|NCT01126099|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111340996|NCT01126099|Adrenergic Agents|adrenergic agents|mesh-ancestor
111340997|NCT01126099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111340998|NCT01126099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111340999|NCT01126099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111341000|NCT01170715|Etanercept|etanercept|mesh-list
110700599|NCT00363480|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111341001|NCT01170715|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111341002|NCT01170715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111341003|NCT01170715|Analgesics|analgesics|mesh-ancestor
111341004|NCT01170715|Sensory System Agents|sensory system agents|mesh-ancestor
111341005|NCT01170715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111341006|NCT01170715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111341007|NCT01170715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111341008|NCT01170715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111341009|NCT01170715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111341010|NCT01170715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111341011|NCT01170715|Immunologic Factors|immunologic factors|mesh-ancestor
111341012|NCT03809182|Fentanyl|fentanyl|mesh-list
111341013|NCT03809182|Dexmedetomidine|dexmedetomidine|mesh-list
111341014|NCT03809182|Morphine|morphine|mesh-list
111341015|NCT03809182|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111341016|NCT03809182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110700891|NCT01048632|Oxandrolone|oxandrolone|mesh-list
111341017|NCT03809182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111341018|NCT03809182|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111341019|NCT03809182|Analgesics|analgesics|mesh-ancestor
111341020|NCT03809182|Sensory System Agents|sensory system agents|mesh-ancestor
111341021|NCT03809182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111341022|NCT03809182|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111341023|NCT03809182|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111341024|NCT03809182|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111341025|NCT03809182|Adrenergic Agents|adrenergic agents|mesh-ancestor
111341026|NCT03809182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111341027|NCT03809182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111341028|NCT03809182|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111341029|NCT03809182|Narcotics|narcotics|mesh-ancestor
111341030|NCT03809182|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111341031|NCT03809182|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111341032|NCT03809182|Anesthetics, General|anesthetics, general|mesh-ancestor
111341033|NCT03809182|Anesthetics|anesthetics|mesh-ancestor
111341034|NCT01170949|Miltefosine|miltefosine|mesh-list
111341035|NCT01170949|Antifungal Agents|antifungal agents|mesh-ancestor
111341036|NCT01170949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111341037|NCT01170949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111341038|NCT01170949|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111341039|NCT01170949|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111341040|NCT03805672|Enoxaparin|enoxaparin|mesh-list
111341041|NCT03805672|Enoxaparin sodium|enoxaparin sodium|mesh-list
111341042|NCT03805672|Anticoagulants|anticoagulants|mesh-ancestor
111341043|NCT03805672|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111341044|NCT03805672|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111341045|NCT03805672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111341046|NCT03802864|Bupivacaine|bupivacaine|mesh-list
111341047|NCT03802864|Anesthetics, Local|anesthetics, local|mesh-ancestor
111341048|NCT03802864|Anesthetics|anesthetics|mesh-ancestor
111341049|NCT03802864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111341050|NCT03802864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111341051|NCT03802864|Sensory System Agents|sensory system agents|mesh-ancestor
111341052|NCT03802864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111341053|NCT03797872|Sulfasalazine|sulfasalazine|mesh-list
111341054|NCT03797872|Methylprednisolone|methylprednisolone|mesh-list
111341055|NCT03797872|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111341056|NCT03797872|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111341057|NCT03797872|Prednisolone|prednisolone|mesh-list
111341058|NCT03797872|Prednisolone acetate|prednisolone acetate|mesh-list
111341059|NCT03797872|Triamcinolone|triamcinolone|mesh-list
111341060|NCT03797872|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
111341061|NCT03797872|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
111341062|NCT03797872|Methotrexate|methotrexate|mesh-list
111341063|NCT03797872|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
111341064|NCT03797872|Leflunomide|leflunomide|mesh-list
111341065|NCT03797872|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111341066|NCT03797872|Prednisolone phosphate|prednisolone phosphate|mesh-list
111341067|NCT03797872|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111341068|NCT03797872|Abortifacient Agents|abortifacient agents|mesh-ancestor
111341069|NCT03797872|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111341070|NCT03797872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111341071|NCT03797872|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111341072|NCT03797872|Antimetabolites|antimetabolites|mesh-ancestor
111341073|NCT03797872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111341074|NCT03797872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111341075|NCT03797872|Dermatologic Agents|dermatologic agents|mesh-ancestor
111341076|NCT03797872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111341077|NCT03797872|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111341078|NCT03797872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111341079|NCT03797872|Immunologic Factors|immunologic factors|mesh-ancestor
111341080|NCT03797872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111341081|NCT03797872|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111341082|NCT03797872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111341083|NCT03797872|Antiemetics|antiemetics|mesh-ancestor
111341084|NCT03797872|Autonomic Agents|autonomic agents|mesh-ancestor
111341085|NCT03797872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111341086|NCT03797872|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111341087|NCT03797872|Glucocorticoids|glucocorticoids|mesh-ancestor
111341088|NCT03797872|Hormones|hormones|mesh-ancestor
111341089|NCT03797872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111341090|NCT03797872|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111341091|NCT03797872|Protective Agents|protective agents|mesh-ancestor
111341092|NCT03797872|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111341093|NCT03797872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111341094|NCT03797872|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111341095|NCT03797872|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111341096|NCT03797872|Analgesics|analgesics|mesh-ancestor
111341097|NCT03797872|Sensory System Agents|sensory system agents|mesh-ancestor
111341098|NCT01127581|Dinoprostone|dinoprostone|mesh-list
111341099|NCT01127581|Oxytocics|oxytocics|mesh-ancestor
110701254|NCT00183430|Adrenergic Agents|adrenergic agents|mesh-ancestor
111341100|NCT01127581|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111341101|NCT01127581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111341102|NCT00377728|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|mesh-list
111341103|NCT00377728|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
111341104|NCT00377728|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111341105|NCT00377728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111341106|NCT00377728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111341107|NCT04498351|Magnesium Sulfate|magnesium sulfate|mesh-list
111341108|NCT04498351|Dexmedetomidine|dexmedetomidine|mesh-list
111341109|NCT04498351|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111341110|NCT04498351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111341111|NCT04498351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111341112|NCT04498351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111341113|NCT04498351|Analgesics|analgesics|mesh-ancestor
111341114|NCT04498351|Sensory System Agents|sensory system agents|mesh-ancestor
111341115|NCT04498351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111341116|NCT04498351|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111341117|NCT04498351|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111341118|NCT04498351|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111341119|NCT04498351|Adrenergic Agents|adrenergic agents|mesh-ancestor
111341120|NCT04498351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111341121|NCT04498351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111341122|NCT04498351|Anesthetics|anesthetics|mesh-ancestor
111341123|NCT04498351|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111341124|NCT04498351|Anticonvulsants|anticonvulsants|mesh-ancestor
111341125|NCT04498351|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111341126|NCT04498351|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111341127|NCT04498351|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111341128|NCT04498351|Tocolytic Agents|tocolytic agents|mesh-ancestor
111341129|NCT04498351|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111341130|NCT02186665|Calcitriol|calcitriol|mesh-list
111341131|NCT02186665|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111341132|NCT02186665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111341133|NCT02186665|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
111341134|NCT02186665|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111341135|NCT02186665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111341136|NCT02186665|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111341137|NCT02186665|Vitamins|vitamins|mesh-ancestor
111341138|NCT02186665|Micronutrients|micronutrients|mesh-ancestor
111341139|NCT02186665|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111341140|NCT01172197|Ropivacaine|ropivacaine|mesh-list
111341141|NCT01172197|Levobupivacaine|levobupivacaine|mesh-list
111341142|NCT01172197|Anesthetics, Local|anesthetics, local|mesh-ancestor
111341143|NCT01172197|Anesthetics|anesthetics|mesh-ancestor
111341144|NCT01172197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111341145|NCT01172197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111341146|NCT01172197|Sensory System Agents|sensory system agents|mesh-ancestor
111341147|NCT01172197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111341148|NCT04141930|Baloxavir|baloxavir|mesh-list
111341149|NCT04141930|Antiviral Agents|antiviral agents|mesh-ancestor
111341150|NCT04141930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111341151|NCT04141930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111341152|NCT04141930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111341153|NCT04138498|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
111341154|NCT04138498|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111341155|NCT04138498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111341156|NCT04138498|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111341157|NCT04138498|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111341158|NCT04138498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111341159|NCT04138498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111341160|NCT04138498|Dopamine Agents|dopamine agents|mesh-ancestor
111341161|NCT04138498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111341162|NCT03746002|Metolazone|metolazone|mesh-list
111341163|NCT03746002|Furosemide|furosemide|mesh-list
111341164|NCT03746002|Diuretics|diuretics|mesh-ancestor
111341165|NCT03746002|Natriuretic Agents|natriuretic agents|mesh-ancestor
111341166|NCT03746002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111341167|NCT03746002|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
111341168|NCT03746002|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111341169|NCT03746002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111341170|NCT03746002|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111341171|NCT03746002|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
111341172|NCT04089982|Varenicline|varenicline|mesh-list
111341173|NCT04089982|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111341174|NCT04089982|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111341175|NCT04089982|Cholinergic Agents|cholinergic agents|mesh-ancestor
111341176|NCT04089982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111341177|NCT04089982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111341178|NCT04089982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111341179|NCT03783130|Aluminum Hydroxide|aluminum hydroxide|mesh-list
111341180|NCT03783130|Aluminum sulfate|aluminum sulfate|mesh-list
111341181|NCT03783130|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111341182|NCT03783130|Immunologic Factors|immunologic factors|mesh-ancestor
111341183|NCT03783130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111341184|NCT03783130|Antacids|antacids|mesh-ancestor
111341185|NCT03783130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111341186|NCT03783130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111341187|NCT00984542|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
111341188|NCT00984542|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111341189|NCT00984542|Alkylating Agents|alkylating agents|mesh-ancestor
111341190|NCT00984542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111341191|NCT00984542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111341192|NCT00983918|Propofol|propofol|mesh-list
111341193|NCT00983918|Sevoflurane|sevoflurane|mesh-list
111341194|NCT00983918|Desflurane|desflurane|mesh-list
111341195|NCT00983918|Isoflurane|isoflurane|mesh-list
111341196|NCT00983918|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111341197|NCT00983918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111341198|NCT00983918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111341199|NCT00983918|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111341200|NCT00983918|Anesthetics, General|anesthetics, general|mesh-ancestor
111341201|NCT00983918|Anesthetics|anesthetics|mesh-ancestor
111341202|NCT00983918|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111341203|NCT00983918|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111341204|NCT01926236|Leucovorin|leucovorin|mesh-list
111341205|NCT01926236|Folic Acid|folic acid|mesh-list
111341206|NCT01926236|Fluorouracil|fluorouracil|mesh-list
111341207|NCT01926236|Oxaliplatin|oxaliplatin|mesh-list
111341208|NCT01926236|Levoleucovorin|levoleucovorin|mesh-list
111341209|NCT01926236|Antimetabolites|antimetabolites|mesh-ancestor
111341210|NCT01926236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111341211|NCT01926236|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111341212|NCT01926236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111341213|NCT01926236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111341214|NCT01926236|Immunologic Factors|immunologic factors|mesh-ancestor
111341215|NCT01926236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111341216|NCT01926236|Antidotes|antidotes|mesh-ancestor
111341217|NCT01926236|Protective Agents|protective agents|mesh-ancestor
111341218|NCT01926236|Vitamin B Complex|vitamin b complex|mesh-ancestor
111341219|NCT01926236|Vitamins|vitamins|mesh-ancestor
111341220|NCT01926236|Micronutrients|micronutrients|mesh-ancestor
111341221|NCT01926236|Hematinics|hematinics|mesh-ancestor
111341222|NCT00983528|Alemtuzumab|alemtuzumab|mesh-list
111341223|NCT00983528|Clofarabine|clofarabine|mesh-list
111341224|NCT00983528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111341225|NCT00983528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111341226|NCT00983528|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110701616|NCT00417482|Risperidone|risperidone|mesh-list
111341227|NCT00983528|Antimetabolites|antimetabolites|mesh-ancestor
111341228|NCT00983528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111341229|NCT00983372|Colchicine|colchicine|mesh-list
111341230|NCT00983372|Diltiazem|diltiazem|mesh-list
111341231|NCT00983372|Gout Suppressants|gout suppressants|mesh-ancestor
111341232|NCT00983372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111341233|NCT00983372|Tubulin Modulators|tubulin modulators|mesh-ancestor
111341234|NCT00983372|Antimitotic Agents|antimitotic agents|mesh-ancestor
111341235|NCT00983372|Mitosis Modulators|mitosis modulators|mesh-ancestor
111341236|NCT00983372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111341237|NCT00983372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111341238|NCT00983372|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111341239|NCT00983372|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111341240|NCT00983372|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111341241|NCT00983372|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111341242|NCT00983372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111341243|NCT00983372|Vasodilator Agents|vasodilator agents|mesh-ancestor
111341244|NCT01173211|Vaccines|vaccines|mesh-list
111341245|NCT01173211|Immunologic Factors|immunologic factors|mesh-ancestor
111341246|NCT01173211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111341247|NCT00983294|Azithromycin|azithromycin|mesh-list
111341248|NCT00983294|Colchicine|colchicine|mesh-list
111341249|NCT00983294|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111341250|NCT00983294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111341251|NCT00983294|Gout Suppressants|gout suppressants|mesh-ancestor
111341252|NCT00983294|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111341253|NCT00983294|Tubulin Modulators|tubulin modulators|mesh-ancestor
111341254|NCT00983294|Antimitotic Agents|antimitotic agents|mesh-ancestor
111341255|NCT00983294|Mitosis Modulators|mitosis modulators|mesh-ancestor
111341256|NCT00983294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111341257|NCT00983294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111341258|NCT01926392|Sulfadiazine|sulfadiazine|mesh-list
111341259|NCT01926392|Silver Sulfadiazine|silver sulfadiazine|mesh-list
111341260|NCT01926392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111341261|NCT01926392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111341262|NCT01926392|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111341263|NCT01926392|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111341264|NCT01926392|Coccidiostats|coccidiostats|mesh-ancestor
111341265|NCT01926392|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111341266|NCT05601830|Cytarabine|cytarabine|mesh-list
111341267|NCT05601830|Cyclophosphamide|cyclophosphamide|mesh-list
111341268|NCT05601830|Fludarabine|fludarabine|mesh-list
111341269|NCT05601830|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111341270|NCT05601830|Immunologic Factors|immunologic factors|mesh-ancestor
111341271|NCT05601830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111341272|NCT05601830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111341273|NCT05601830|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111341274|NCT05601830|Alkylating Agents|alkylating agents|mesh-ancestor
111341275|NCT05601830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111341276|NCT05601830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111341277|NCT05601830|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111341278|NCT05601830|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111341279|NCT05601830|Antimetabolites|antimetabolites|mesh-ancestor
111341280|NCT05601830|Antiviral Agents|antiviral agents|mesh-ancestor
111341281|NCT05601830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111341282|NCT00982280|Tapentadol|tapentadol|mesh-list
111341283|NCT00982280|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111341284|NCT00982280|Narcotics|narcotics|mesh-ancestor
111341285|NCT00982280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111341286|NCT00982280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111341287|NCT00982280|Analgesics|analgesics|mesh-ancestor
111341288|NCT00982280|Sensory System Agents|sensory system agents|mesh-ancestor
111341289|NCT00982280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111341290|NCT00982280|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111341291|NCT00982280|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111341292|NCT00982280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111341293|NCT00982280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111341294|NCT00982280|Adrenergic Agents|adrenergic agents|mesh-ancestor
111341295|NCT00982280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111341296|NCT01175395|Triamcinolone|triamcinolone|mesh-list
111341297|NCT01175395|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
111341298|NCT01175395|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
111341299|NCT01175395|Ranibizumab|ranibizumab|mesh-list
111341300|NCT01175395|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
111341301|NCT01175395|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111341302|NCT01175395|Glucocorticoids|glucocorticoids|mesh-ancestor
111341303|NCT01175395|Hormones|hormones|mesh-ancestor
111341304|NCT01175395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111341305|NCT01175395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111341306|NCT01175395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111341307|NCT01175395|Immunologic Factors|immunologic factors|mesh-ancestor
111341308|NCT01175395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111341309|NCT01175395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111341310|NCT01175395|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111341311|NCT01175395|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111065781|NCT04468685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111341312|NCT01175395|Growth Substances|growth substances|mesh-ancestor
111341313|NCT01175395|Growth Inhibitors|growth inhibitors|mesh-ancestor
111341314|NCT01175395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111341315|NCT03011905|Acetaminophen|acetaminophen|mesh-list
111341316|NCT03011905|Dexamethasone|dexamethasone|mesh-list
111341317|NCT03011905|Etoricoxib|etoricoxib|mesh-list
111341318|NCT03011905|Oxycodone|oxycodone|mesh-list
111341319|NCT03011905|Ropivacaine|ropivacaine|mesh-list
111341320|NCT03011905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111341321|NCT03011905|Antiemetics|antiemetics|mesh-ancestor
111341322|NCT03011905|Autonomic Agents|autonomic agents|mesh-ancestor
111341323|NCT03011905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111341324|NCT03011905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111341325|NCT03011905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111341326|NCT03011905|Glucocorticoids|glucocorticoids|mesh-ancestor
111341327|NCT03011905|Hormones|hormones|mesh-ancestor
111341328|NCT03011905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111341329|NCT03011905|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111341330|NCT03011905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111341331|NCT03011905|Anesthetics, Local|anesthetics, local|mesh-ancestor
111341332|NCT03011905|Anesthetics|anesthetics|mesh-ancestor
111341333|NCT03011905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111341334|NCT03011905|Sensory System Agents|sensory system agents|mesh-ancestor
111341335|NCT03011905|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111341336|NCT03011905|Analgesics|analgesics|mesh-ancestor
111341337|NCT03011905|Antipyretics|antipyretics|mesh-ancestor
111341338|NCT03011905|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111341339|NCT03011905|Narcotics|narcotics|mesh-ancestor
111341340|NCT03011905|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111341341|NCT03011905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111341342|NCT03011905|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111341343|NCT03011905|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111341344|NCT03011905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111341345|NCT03011905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111341346|NCT01926548|Imatinib Mesylate|imatinib mesylate|mesh-list
111341347|NCT01926548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111341348|NCT01926548|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111341349|NCT01926548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111341350|NCT01926548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111341351|NCT01176955|Benzoyl Peroxide|benzoyl peroxide|mesh-list
111341352|NCT01176955|Dermatologic Agents|dermatologic agents|mesh-ancestor
111341353|NCT00980798|Hydromorphone|hydromorphone|mesh-list
111341354|NCT00980798|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111341355|NCT00980798|Narcotics|narcotics|mesh-ancestor
111341356|NCT00980798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111341357|NCT00980798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111341358|NCT00980798|Analgesics|analgesics|mesh-ancestor
111341359|NCT00980798|Sensory System Agents|sensory system agents|mesh-ancestor
111341360|NCT00980798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111341361|NCT01177189|Thioctic Acid|thioctic acid|mesh-list
111341362|NCT01177189|Vitamins|vitamins|mesh-ancestor
111341363|NCT01177189|Micronutrients|micronutrients|mesh-ancestor
110702043|NCT03971019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111341364|NCT01177189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111341365|NCT01177189|Antioxidants|antioxidants|mesh-ancestor
111341366|NCT01177189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111341367|NCT01177189|Protective Agents|protective agents|mesh-ancestor
111341368|NCT01177189|Vitamin B Complex|vitamin b complex|mesh-ancestor
111341369|NCT01926860|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
111341370|NCT01926860|Immunologic Factors|immunologic factors|mesh-ancestor
111341371|NCT01926860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111341372|NCT01177735|Pomalidomide|pomalidomide|mesh-list
111341373|NCT01177735|Immunologic Factors|immunologic factors|mesh-ancestor
111341374|NCT01177735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111341375|NCT01177735|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111341376|NCT01177735|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111341377|NCT01177735|Growth Substances|growth substances|mesh-ancestor
111341378|NCT01177735|Growth Inhibitors|growth inhibitors|mesh-ancestor
111341379|NCT01177735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111341380|NCT01135069|Tretinoin|tretinoin|mesh-list
111341381|NCT01135069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111341382|NCT01135069|Keratolytic Agents|keratolytic agents|mesh-ancestor
111341383|NCT01135069|Dermatologic Agents|dermatologic agents|mesh-ancestor
111341384|NCT01178281|Thalidomide|thalidomide|mesh-list
111341385|NCT01178281|Pomalidomide|pomalidomide|mesh-list
111341386|NCT01178281|Immunologic Factors|immunologic factors|mesh-ancestor
111065857|NCT04939649|Midazolam|midazolam|mesh-list
111341387|NCT01178281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111341388|NCT01178281|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111341389|NCT01178281|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111341390|NCT01178281|Growth Substances|growth substances|mesh-ancestor
111341391|NCT01178281|Growth Inhibitors|growth inhibitors|mesh-ancestor
111341392|NCT01178281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111341393|NCT01178281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111341394|NCT01178281|Leprostatic Agents|leprostatic agents|mesh-ancestor
111341395|NCT01178281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111341396|NCT01178281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111341397|NCT01178827|Mandelic Acids|mandelic acids|mesh-list
111341398|NCT01178827|Oxybutynin|oxybutynin|mesh-list
111341399|NCT01178827|Trospium chloride|trospium chloride|mesh-list
111341400|NCT01178827|Parasympatholytics|parasympatholytics|mesh-ancestor
111341401|NCT01178827|Autonomic Agents|autonomic agents|mesh-ancestor
111341402|NCT01178827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110702102|NCT03970239|Fluorides|fluorides|mesh-list
111341403|NCT01178827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111341404|NCT01178827|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111341405|NCT01178827|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111341406|NCT01178827|Cholinergic Agents|cholinergic agents|mesh-ancestor
111341407|NCT01178827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111341408|NCT01178827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111341409|NCT01178827|Urological Agents|urological agents|mesh-ancestor
111341410|NCT01178827|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111341411|NCT01178827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111341412|NCT01135537|Thymoglobulin|thymoglobulin|mesh-list
111341413|NCT01135537|Antilymphocyte Serum|antilymphocyte serum|mesh-list
111341414|NCT01135537|Immunologic Factors|immunologic factors|mesh-ancestor
111341415|NCT01135537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111341416|NCT01135537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111341417|NCT02181517|Ranibizumab|ranibizumab|mesh-list
111341418|NCT02181517|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111341419|NCT02181517|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111341420|NCT02181517|Growth Substances|growth substances|mesh-ancestor
111341421|NCT02181517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111341422|NCT02181517|Growth Inhibitors|growth inhibitors|mesh-ancestor
111341423|NCT02181517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111341424|NCT03010267|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
111341425|NCT03010267|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111341426|NCT03010267|Hormone Antagonists|hormone antagonists|mesh-ancestor
111341427|NCT03010267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111341428|NCT03010267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111341429|NCT03010267|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111341430|NCT03010267|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111341431|NCT03010267|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111341432|NCT01181323|Vaccines|vaccines|mesh-list
111341433|NCT01181323|Immunologic Factors|immunologic factors|mesh-ancestor
111341434|NCT01181323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111341435|NCT03872947|Leucovorin|leucovorin|mesh-list
111341436|NCT03872947|Bevacizumab|bevacizumab|mesh-list
111341437|NCT03872947|Carboplatin|carboplatin|mesh-list
111341438|NCT03872947|Gemcitabine|gemcitabine|mesh-list
111341439|NCT03872947|Pembrolizumab|pembrolizumab|mesh-list
111341440|NCT03872947|Nivolumab|nivolumab|mesh-list
111341441|NCT03872947|Irinotecan|irinotecan|mesh-list
111341442|NCT03872947|Topotecan|topotecan|mesh-list
111341443|NCT03872947|Imiquimod|imiquimod|mesh-list
111341444|NCT03872947|Ramucirumab|ramucirumab|mesh-list
111341445|NCT03872947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111341446|NCT03872947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111341447|NCT03872947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111341448|NCT03872947|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111341449|NCT03872947|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111341450|NCT03872947|Growth Substances|growth substances|mesh-ancestor
111341451|NCT03872947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111341452|NCT03872947|Growth Inhibitors|growth inhibitors|mesh-ancestor
111341453|NCT03872947|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111341454|NCT03872947|Antimetabolites|antimetabolites|mesh-ancestor
111341455|NCT03872947|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111341456|NCT03872947|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111341457|NCT03872947|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111341458|NCT03872947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111341459|NCT03872947|Antidotes|antidotes|mesh-ancestor
111341460|NCT03872947|Protective Agents|protective agents|mesh-ancestor
111341461|NCT03872947|Vitamin B Complex|vitamin b complex|mesh-ancestor
111341462|NCT03872947|Vitamins|vitamins|mesh-ancestor
111341463|NCT03872947|Micronutrients|micronutrients|mesh-ancestor
111341464|NCT03872947|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111341465|NCT03872947|Immunologic Factors|immunologic factors|mesh-ancestor
111341466|NCT03872947|Interferon Inducers|interferon inducers|mesh-ancestor
111341467|NCT02246881|Factor VIII|factor viii|mesh-list
111341468|NCT02246881|Coagulants|coagulants|mesh-ancestor
111341469|NCT00980330|Ribavirin|ribavirin|mesh-list
111341470|NCT00980330|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
111341471|NCT00980330|Interferon alpha-2|interferon alpha-2|mesh-list
111341472|NCT00980330|Simeprevir|simeprevir|mesh-list
111341473|NCT00980330|Antimetabolites|antimetabolites|mesh-ancestor
111341474|NCT00980330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111341475|NCT00980330|Antiviral Agents|antiviral agents|mesh-ancestor
111341476|NCT00980330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111341477|NCT00980330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111341478|NCT00980330|Protease Inhibitors|protease inhibitors|mesh-ancestor
111341479|NCT00980330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111341480|NCT01138735|Adapalene|adapalene|mesh-list
111341481|NCT01138735|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
111341482|NCT01138735|Benzoyl Peroxide|benzoyl peroxide|mesh-list
111341483|NCT01138735|Dermatologic Agents|dermatologic agents|mesh-ancestor
111341484|NCT01138735|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111341485|NCT01138735|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111341486|NCT01138735|Analgesics|analgesics|mesh-ancestor
111341487|NCT01138735|Sensory System Agents|sensory system agents|mesh-ancestor
111341488|NCT01138735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111341489|NCT01138735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111341490|NCT01138735|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111341491|NCT01138735|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111341492|NCT00980174|Denosumab|denosumab|mesh-list
111341493|NCT00980174|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111341494|NCT00980174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111341495|NCT01138969|Esomeprazole|esomeprazole|mesh-list
111341496|NCT01138969|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111341497|NCT01138969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111341498|NCT01138969|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111341499|NCT01138969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111341500|NCT01138969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111341501|NCT01139515|Eletriptan|eletriptan|mesh-list
111341502|NCT01139515|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111341503|NCT01139515|Serotonin Agents|serotonin agents|mesh-ancestor
111341504|NCT01139515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111341505|NCT01139515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111341506|NCT01139515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111341507|NCT00987272|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
111341508|NCT00987272|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111341509|NCT00987272|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111341510|NCT00987272|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111341511|NCT00987272|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111341512|NCT00987272|Analgesics|analgesics|mesh-ancestor
111341513|NCT00987272|Sensory System Agents|sensory system agents|mesh-ancestor
111341514|NCT00987272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111341515|NCT00987272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111341516|NCT00987272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111341517|NCT00987272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111341518|NCT00987272|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111341519|NCT00987272|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
111341520|NCT00987272|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111341521|NCT00987272|Histamine Antagonists|histamine antagonists|mesh-ancestor
111341522|NCT00987272|Histamine Agents|histamine agents|mesh-ancestor
111341523|NCT00987272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111341524|NCT00987272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111341525|NCT03709459|Doxycycline|doxycycline|mesh-list
111341526|NCT03709459|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111341527|NCT03709459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111341528|NCT03709459|Antimalarials|antimalarials|mesh-ancestor
111341529|NCT03709459|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111341530|NCT03709459|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111341531|NCT00986882|Ibuprofen|ibuprofen|mesh-list
111341532|NCT00986882|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111341533|NCT00986882|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111341534|NCT00986882|Analgesics|analgesics|mesh-ancestor
111341535|NCT00986882|Sensory System Agents|sensory system agents|mesh-ancestor
111341536|NCT00986882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111341537|NCT00986882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111341538|NCT00986882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111341539|NCT00986882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111341540|NCT00986882|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111341541|NCT00986882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111479311|NCT05012631|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111066017|NCT04969276|Vaccines|vaccines|mesh-list
111341542|NCT00986882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111341543|NCT04395170|Immunoglobulins|immunoglobulins|mesh-list
111341544|NCT04395170|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111341545|NCT04395170|Antibodies|antibodies|mesh-list
111341546|NCT04395170|Immunologic Factors|immunologic factors|mesh-ancestor
111341547|NCT04395170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111341548|NCT01927328|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
111341549|NCT01927328|Hematinics|hematinics|mesh-ancestor
111341550|NCT04552808|Yimitasvir|yimitasvir|mesh-list
111341551|NCT04552808|Antiviral Agents|antiviral agents|mesh-ancestor
111341552|NCT04552808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111341553|NCT01927406|Timolol|timolol|mesh-list
111341554|NCT01927406|Bimatoprost|bimatoprost|mesh-list
111341555|NCT01927406|Travoprost|travoprost|mesh-list
111341556|NCT01927406|Latanoprost|latanoprost|mesh-list
111341557|NCT01927406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111341558|NCT01927406|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111341559|NCT01927406|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111341560|NCT01927406|Adrenergic Agents|adrenergic agents|mesh-ancestor
111341561|NCT01927406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111341562|NCT01927406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111341563|NCT01927406|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111341564|NCT01927406|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111341565|NCT01927406|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
111341566|NCT01927406|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111341567|NCT01182493|Insulin|insulin|mesh-list
111341568|NCT01182493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111341569|NCT01182493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111341570|NCT01927484|Methotrexate|methotrexate|mesh-list
111341571|NCT01927484|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111341572|NCT01927484|Abortifacient Agents|abortifacient agents|mesh-ancestor
111341573|NCT01927484|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111341574|NCT01927484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111341575|NCT01927484|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111341576|NCT01927484|Antimetabolites|antimetabolites|mesh-ancestor
111341577|NCT01927484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111341578|NCT01927484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111341579|NCT01927484|Dermatologic Agents|dermatologic agents|mesh-ancestor
111341580|NCT01927484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111341581|NCT01927484|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111341582|NCT01927484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111341583|NCT01927484|Immunologic Factors|immunologic factors|mesh-ancestor
111341584|NCT01927484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111341585|NCT01927484|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111341586|NCT05607446|Montelukast|montelukast|mesh-list
111341587|NCT05607446|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111341588|NCT05607446|Respiratory System Agents|respiratory system agents|mesh-ancestor
111341589|NCT05607446|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
111341590|NCT05607446|Hormone Antagonists|hormone antagonists|mesh-ancestor
111341591|NCT05607446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111341592|NCT05607446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111341593|NCT05607446|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
111341594|NCT05607446|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111341595|NCT05607446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111341596|NCT02185339|Rocuronium|rocuronium|mesh-list
111341597|NCT02185339|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
111341598|NCT02185339|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
111341599|NCT02185339|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111341600|NCT02185339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111341601|NCT02185339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111341602|NCT03831464|Metformin|metformin|mesh-list
111341603|NCT03831464|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111341604|NCT03831464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111341605|NCT01928498|Paclitaxel|paclitaxel|mesh-list
111341606|NCT01928498|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111341607|NCT01928498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111341608|NCT01928498|Tubulin Modulators|tubulin modulators|mesh-ancestor
111341609|NCT01928498|Antimitotic Agents|antimitotic agents|mesh-ancestor
111341610|NCT01928498|Mitosis Modulators|mitosis modulators|mesh-ancestor
111341611|NCT01928498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111341612|NCT04558502|Amoxicillin|amoxicillin|mesh-list
111341613|NCT04558502|Clarithromycin|clarithromycin|mesh-list
111341614|NCT04558502|Minocycline|minocycline|mesh-list
111341615|NCT04558502|Esomeprazole|esomeprazole|mesh-list
111341616|NCT04558502|Bismuth|bismuth|mesh-list
111066074|NCT04810156|Glucocorticoids|glucocorticoids|mesh-ancestor
111341617|NCT04558502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111341618|NCT04558502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111341619|NCT04558502|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111341620|NCT04558502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111341621|NCT04558502|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111341622|NCT04558502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111341623|NCT04558502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111341624|NCT04558502|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111341625|NCT04558502|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111341626|NCT04558502|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111341627|NCT04558502|Antacids|antacids|mesh-ancestor
111341628|NCT01218997|Naltrexone|naltrexone|mesh-list
111341629|NCT01218997|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111341630|NCT01218997|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111341631|NCT01218997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111341632|NCT01218997|Sensory System Agents|sensory system agents|mesh-ancestor
111341633|NCT01218997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111341634|NCT01219777|Paclitaxel|paclitaxel|mesh-list
111341635|NCT01219777|Bevacizumab|bevacizumab|mesh-list
111341636|NCT01219777|Carboplatin|carboplatin|mesh-list
111341637|NCT01219777|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111341638|NCT01219777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111341639|NCT01219777|Tubulin Modulators|tubulin modulators|mesh-ancestor
111341640|NCT01219777|Antimitotic Agents|antimitotic agents|mesh-ancestor
111341641|NCT01219777|Mitosis Modulators|mitosis modulators|mesh-ancestor
111341642|NCT01219777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111341643|NCT01219777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111341644|NCT01219777|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111341645|NCT01219777|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111341646|NCT01219777|Growth Substances|growth substances|mesh-ancestor
111341647|NCT01219777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111341648|NCT01219777|Growth Inhibitors|growth inhibitors|mesh-ancestor
111341649|NCT05603156|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
111341650|NCT05603156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111341651|NCT05603156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111341652|NCT05603156|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111341653|NCT05603156|Immunotoxins|immunotoxins|mesh-ancestor
111341654|NCT05603156|Immunoconjugates|immunoconjugates|mesh-ancestor
111341655|NCT05603156|Immunologic Factors|immunologic factors|mesh-ancestor
111341656|NCT05603156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111341657|NCT04759742|Ropivacaine|ropivacaine|mesh-list
111341658|NCT04759742|Anesthetics, Local|anesthetics, local|mesh-ancestor
111341659|NCT04759742|Anesthetics|anesthetics|mesh-ancestor
111341660|NCT04759742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111341661|NCT04759742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111341662|NCT04759742|Sensory System Agents|sensory system agents|mesh-ancestor
111341663|NCT04759742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111341664|NCT01928888|Famotidine|famotidine|mesh-list
111341665|NCT01928888|Hydrotalcite|hydrotalcite|mesh-list
111341666|NCT01928888|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111341667|NCT01928888|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111341668|NCT01928888|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
111341669|NCT01928888|Histamine Antagonists|histamine antagonists|mesh-ancestor
111341670|NCT01928888|Histamine Agents|histamine agents|mesh-ancestor
111341671|NCT01928888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111341672|NCT01928888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111341673|NCT01928888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111341674|NCT01928888|Antacids|antacids|mesh-ancestor
111341675|NCT04556084|Blinatumomab|blinatumomab|mesh-list
111341676|NCT04556084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111341677|NCT04394234|Warfarin|warfarin|mesh-list
111341678|NCT04394234|Anticoagulants|anticoagulants|mesh-list
111341679|NCT02569710|Simeprevir|simeprevir|mesh-list
111341680|NCT02569710|Odalasvir|odalasvir|mesh-list
111341681|NCT02569710|Antiviral Agents|antiviral agents|mesh-ancestor
111341682|NCT02569710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111341683|NCT02569710|Protease Inhibitors|protease inhibitors|mesh-ancestor
111341684|NCT02569710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111341685|NCT02569710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111341686|NCT04550624|Pembrolizumab|pembrolizumab|mesh-list
111341687|NCT04550624|Lenvatinib|lenvatinib|mesh-list
111341688|NCT04550624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110702437|NCT03966040|Vaccines|vaccines|mesh-list
111341689|NCT04550624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111341690|NCT04550624|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111341691|NCT04550624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111341692|NCT04550624|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111341693|NCT04550624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111341694|NCT04550546|Nystatin|nystatin|mesh-list
111341695|NCT04550546|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111341696|NCT04550546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111341697|NCT04550546|Antifungal Agents|antifungal agents|mesh-ancestor
111341698|NCT04550546|Ionophores|ionophores|mesh-ancestor
111341699|NCT04550546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111341700|NCT04550546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111341701|NCT02984072|Menthol|menthol|mesh-list
110443593|NCT02794792|Metformin|metformin|mesh-list
111341702|NCT02984072|Antipruritics|antipruritics|mesh-ancestor
111341703|NCT02984072|Dermatologic Agents|dermatologic agents|mesh-ancestor
111341704|NCT04589832|Entrectinib|entrectinib|mesh-list
111341705|NCT04589832|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111341706|NCT04589832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111341707|NCT04589832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111341708|NCT05506410|Cytarabine|cytarabine|mesh-list
111341709|NCT05506410|Prednisone|prednisone|mesh-list
111341710|NCT05506410|Rituximab|rituximab|mesh-list
111341711|NCT05506410|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
111341712|NCT05506410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111341713|NCT05506410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111341714|NCT05506410|Immunologic Factors|immunologic factors|mesh-ancestor
111341715|NCT05506410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111341716|NCT05506410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111341717|NCT05506410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111341718|NCT05506410|Glucocorticoids|glucocorticoids|mesh-ancestor
111341719|NCT05506410|Hormones|hormones|mesh-ancestor
111341720|NCT05506410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111341721|NCT05506410|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111341722|NCT05506410|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111341723|NCT05506410|Antimetabolites|antimetabolites|mesh-ancestor
111341724|NCT05506410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111341725|NCT05506410|Antiviral Agents|antiviral agents|mesh-ancestor
111341726|NCT05506410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111341727|NCT05506410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111341728|NCT05506410|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111341729|NCT05506410|Alkylating Agents|alkylating agents|mesh-ancestor
111341730|NCT05506332|Venetoclax|venetoclax|mesh-list
111341731|NCT05506332|Mercaptopurine|mercaptopurine|mesh-list
111341732|NCT05506332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110702719|NCT01076140|Lisinopril|lisinopril|mesh-list
111341733|NCT05506332|Antimetabolites|antimetabolites|mesh-ancestor
111341734|NCT05506332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111341735|NCT05506332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111341736|NCT05506332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111341737|NCT05506332|Immunologic Factors|immunologic factors|mesh-ancestor
110702788|NCT00203307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111341738|NCT05506332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111341739|NCT05506332|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111341740|NCT05506332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111341741|NCT01927874|Bupivacaine|bupivacaine|mesh-list
111341742|NCT01927874|Anesthetics, Local|anesthetics, local|mesh-ancestor
111341743|NCT01927874|Anesthetics|anesthetics|mesh-ancestor
110702922|NCT00337662|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111341744|NCT01927874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111341745|NCT01927874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111341746|NCT01927874|Sensory System Agents|sensory system agents|mesh-ancestor
111341747|NCT01927874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111341748|NCT05604638|Tenecteplase|tenecteplase|mesh-list
111341749|NCT05604638|Tirofiban|tirofiban|mesh-list
111341750|NCT05604638|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111341751|NCT05604638|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111341752|NCT05604638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111341753|NCT05604638|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111341754|NCT03033758|Budesonide|budesonide|mesh-list
111341755|NCT03033758|Formoterol Fumarate|formoterol fumarate|mesh-list
111341756|NCT03033758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111341757|NCT03033758|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111341758|NCT03033758|Autonomic Agents|autonomic agents|mesh-ancestor
111341759|NCT03033758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111341760|NCT03033758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111341761|NCT03033758|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111341762|NCT03033758|Respiratory System Agents|respiratory system agents|mesh-ancestor
111341763|NCT03033758|Glucocorticoids|glucocorticoids|mesh-ancestor
111341764|NCT03033758|Hormones|hormones|mesh-ancestor
111341765|NCT03033758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111341766|NCT03033758|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111341767|NCT03033758|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110703206|NCT00527111|Cetuximab|cetuximab|mesh-list
111341768|NCT03033758|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111341769|NCT03033758|Adrenergic Agents|adrenergic agents|mesh-ancestor
111341770|NCT03033758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111341771|NCT03033758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111341773|NCT01016483|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111341774|NCT01016483|Antimetabolites|antimetabolites|mesh-ancestor
111341775|NCT01016483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110703278|NCT03992066|Epoetin Alfa|epoetin alfa|mesh-list
111341776|NCT01016483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111341777|NCT02569476|Obinutuzumab|obinutuzumab|mesh-list
111341778|NCT02569476|Zanubrutinib|zanubrutinib|mesh-list
111341779|NCT02569476|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111341780|NCT02569476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111341781|NCT02569476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111341782|NCT02569476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111341783|NCT02569476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111341784|NCT00955253|Guanfacine|guanfacine|mesh-list
111341785|NCT00955253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111341786|NCT00955253|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111341787|NCT00955253|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111341788|NCT00955253|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111341789|NCT00955253|Adrenergic Agents|adrenergic agents|mesh-ancestor
111341790|NCT00955253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111341791|NCT00955253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110703410|NCT00524459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111341792|NCT00955253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111341793|NCT04394390|Vitamin D|vitamin d|mesh-list
111341794|NCT04394390|Ergocalciferols|ergocalciferols|mesh-list
111341795|NCT04394390|Cholecalciferol|cholecalciferol|mesh-list
111341796|NCT04394390|Vitamins|vitamins|mesh-list
111341797|NCT04394390|Micronutrients|micronutrients|mesh-ancestor
111341798|NCT04394390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111341799|NCT04394390|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111341800|NCT04394390|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111341801|NCT04120454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111341802|NCT04120454|Pembrolizumab|pembrolizumab|mesh-list
111341803|NCT04120454|Ramucirumab|ramucirumab|mesh-list
111341804|NCT04120454|Antibodies|antibodies|mesh-list
111341805|NCT04120454|Immunoglobulins|immunoglobulins|mesh-list
111341806|NCT04120454|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111341807|NCT04120454|Lexatumumab|lexatumumab|mesh-list
111341808|NCT04120454|Immunologic Factors|immunologic factors|mesh-ancestor
111341809|NCT04120454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111341810|NCT04120454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111341811|NCT04120454|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111341812|NCT04120454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111341813|NCT01017653|Irinotecan|irinotecan|mesh-list
111341814|NCT01017653|Panitumumab|panitumumab|mesh-list
111341815|NCT01017653|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111341816|NCT01017653|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111341817|NCT01017653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111341818|NCT01017653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111341819|NCT01017653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111341820|NCT01017653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111341821|NCT00966641|Naproxen|naproxen|mesh-list
111341822|NCT00966641|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111341823|NCT00966641|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111341824|NCT00966641|Analgesics|analgesics|mesh-ancestor
111341825|NCT00966641|Sensory System Agents|sensory system agents|mesh-ancestor
111341826|NCT00966641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111341827|NCT00966641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111341828|NCT00966641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111341829|NCT00966641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111341830|NCT00966641|Gout Suppressants|gout suppressants|mesh-ancestor
111341831|NCT00966641|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111341832|NCT00966641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111341833|NCT00966641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111341834|NCT00970073|Mycophenolic Acid|mycophenolic acid|mesh-list
111341835|NCT00970073|Tacrolimus|tacrolimus|mesh-list
111341836|NCT00970073|Thymoglobulin|thymoglobulin|mesh-list
111341837|NCT00970073|Antilymphocyte Serum|antilymphocyte serum|mesh-list
111341838|NCT00970073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111341839|NCT00970073|Immunologic Factors|immunologic factors|mesh-ancestor
111341840|NCT00970073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111341841|NCT00970073|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111066316|NCT02502734|Xhance|xhance|mesh-list
111341842|NCT00970073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110703720|NCT03741621|Cathartics|cathartics|mesh-ancestor
111341843|NCT00970073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111341844|NCT00970073|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111341845|NCT00970073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111341846|NCT00970073|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111341847|NCT00970073|Antitubercular Agents|antitubercular agents|mesh-ancestor
111341848|NCT00970073|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111341849|NCT00970073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111341850|NCT00971633|Ondansetron|ondansetron|mesh-list
111341851|NCT00971633|Antiemetics|antiemetics|mesh-ancestor
111341852|NCT00971633|Autonomic Agents|autonomic agents|mesh-ancestor
111341853|NCT00971633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110703858|NCT00185211|Interferons|interferons|mesh-list
111341854|NCT00971633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111341855|NCT00971633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111341856|NCT00971633|Antipruritics|antipruritics|mesh-ancestor
111341857|NCT00971633|Dermatologic Agents|dermatologic agents|mesh-ancestor
111341858|NCT00971633|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111341859|NCT00971633|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111341860|NCT00971633|Serotonin Agents|serotonin agents|mesh-ancestor
111341861|NCT00971633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110703932|NCT00522275|Lacosamide|lacosamide|mesh-list
111341862|NCT00971633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111341863|NCT05511246|Ethanol|ethanol|mesh-list
111341864|NCT05511246|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111341865|NCT05511246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110703998|NCT01076842|Insulin Detemir|insulin detemir|mesh-list
111341866|NCT05511246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111341867|NCT05511246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111341868|NCT00971789|Sirolimus|sirolimus|mesh-list
111341869|NCT00971789|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
111341870|NCT00971789|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111341871|NCT00971789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111341872|NCT00971789|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111341873|NCT00971789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111341874|NCT00971789|Antifungal Agents|antifungal agents|mesh-ancestor
111341875|NCT00971789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111341876|NCT00971789|Immunologic Factors|immunologic factors|mesh-ancestor
111341877|NCT00971789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110704068|NCT00122278|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111341878|NCT00971789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111341879|NCT00971789|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111341880|NCT05510778|Charcoal|charcoal|mesh-list
111341881|NCT05510778|Antidotes|antidotes|mesh-ancestor
111341882|NCT05510778|Protective Agents|protective agents|mesh-ancestor
111341883|NCT05510778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111341884|NCT00972335|Bevacizumab|bevacizumab|mesh-list
111341885|NCT00972335|Everolimus|everolimus|mesh-list
111341886|NCT00972335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111341887|NCT00972335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111341888|NCT00972335|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111341889|NCT00972335|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111341890|NCT00972335|Growth Substances|growth substances|mesh-ancestor
111341891|NCT00972335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111341892|NCT00972335|Growth Inhibitors|growth inhibitors|mesh-ancestor
111341893|NCT00972335|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111341894|NCT00972335|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111341895|NCT00972335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111341896|NCT00972335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111341897|NCT00972335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111341898|NCT00972335|Immunologic Factors|immunologic factors|mesh-ancestor
111341899|NCT02337530|Carboplatin|carboplatin|mesh-list
111341900|NCT02337530|Pemetrexed|pemetrexed|mesh-list
111341901|NCT02337530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111341902|NCT02337530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111341903|NCT02337530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111341904|NCT02337530|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111341905|NCT02337530|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111341906|NCT03341156|Thrombin|thrombin|mesh-list
111341907|NCT03341156|Hemostatics|hemostatics|mesh-ancestor
111341908|NCT03341156|Coagulants|coagulants|mesh-ancestor
111341909|NCT04122560|Fluconazole|fluconazole|mesh-list
111341910|NCT04122560|Antifungal Agents|antifungal agents|mesh-ancestor
111341911|NCT04122560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111341912|NCT04122560|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111341913|NCT04122560|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111341914|NCT04122560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110704467|NCT03330821|Antiviral Agents|antiviral agents|mesh-ancestor
111341915|NCT04122560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111341916|NCT04122560|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111341917|NCT04122560|Hormone Antagonists|hormone antagonists|mesh-ancestor
111341918|NCT04122560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111341919|NCT04122560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110704608|NCT01083784|Clonazepam|clonazepam|mesh-list
111341920|NCT04122560|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110704679|NCT00384176|Antidotes|antidotes|mesh-ancestor
111341921|NCT04122560|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111341923|NCT02569242|Docetaxel|docetaxel|mesh-list
111341924|NCT02569242|Nivolumab|nivolumab|mesh-list
111341925|NCT02569242|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111341926|NCT02569242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111341927|NCT02569242|Tubulin Modulators|tubulin modulators|mesh-ancestor
111341928|NCT02569242|Antimitotic Agents|antimitotic agents|mesh-ancestor
111341929|NCT02569242|Mitosis Modulators|mitosis modulators|mesh-ancestor
110704771|NCT01009697|Codeine|codeine|mesh-list
111341930|NCT02569242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111341931|NCT02569242|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111341932|NCT02569242|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111341933|NCT04124588|Hemostatics|hemostatics|mesh-list
111341934|NCT04124588|Coagulants|coagulants|mesh-ancestor
111341935|NCT05501340|Molgramostim|molgramostim|mesh-list
111341936|NCT05501340|Sargramostim|sargramostim|mesh-list
111341937|NCT05501340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110704890|NCT00383240|Mometasone Furoate|mometasone furoate|mesh-list
111341938|NCT05501340|Immunologic Factors|immunologic factors|mesh-ancestor
111341939|NCT05501340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111341940|NCT00972725|Chloroquine|chloroquine|mesh-list
111341941|NCT00972725|Amebicides|amebicides|mesh-ancestor
111341942|NCT00972725|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111341943|NCT00972725|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111341944|NCT00972725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111341945|NCT00972725|Antimalarials|antimalarials|mesh-ancestor
111341946|NCT00972725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111341947|NCT05600660|Rituximab|rituximab|mesh-list
111341948|NCT05600660|Methotrexate|methotrexate|mesh-list
110705061|NCT00098722|Maraviroc|maraviroc|mesh-list
111341949|NCT05600660|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111341950|NCT05600660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111341951|NCT05600660|Immunologic Factors|immunologic factors|mesh-ancestor
111341952|NCT05600660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111341953|NCT05600660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111341954|NCT05600660|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111341955|NCT05600660|Abortifacient Agents|abortifacient agents|mesh-ancestor
111341956|NCT05600660|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111341957|NCT05600660|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111341958|NCT05600660|Antimetabolites|antimetabolites|mesh-ancestor
110705198|NCT01050374|Anthelmintics|anthelmintics|mesh-ancestor
111341959|NCT05600660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111341960|NCT05600660|Dermatologic Agents|dermatologic agents|mesh-ancestor
111341961|NCT05600660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111341962|NCT05600660|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111341963|NCT05600660|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111341964|NCT05600660|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111341965|NCT00972959|Zoledronic Acid|zoledronic acid|mesh-list
111341966|NCT00972959|Dexamethasone|dexamethasone|mesh-list
111341967|NCT00972959|Bortezomib|bortezomib|mesh-list
111341968|NCT00972959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111341969|NCT00972959|Antiemetics|antiemetics|mesh-ancestor
111341970|NCT00972959|Autonomic Agents|autonomic agents|mesh-ancestor
111341971|NCT00972959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111341972|NCT00972959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111341973|NCT00972959|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111341974|NCT00972959|Glucocorticoids|glucocorticoids|mesh-ancestor
111341975|NCT00972959|Hormones|hormones|mesh-ancestor
111341976|NCT00972959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111341977|NCT00972959|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111341978|NCT00972959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111341979|NCT00972959|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111341980|NCT00973739|Lapatinib|lapatinib|mesh-list
111341981|NCT00973739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111341982|NCT00973739|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111341983|NCT00973739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111341984|NCT00973739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111341985|NCT00974051|Insulin|insulin|mesh-list
111341986|NCT00974051|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111341987|NCT00974051|Terbutaline|terbutaline|mesh-list
111341988|NCT00974051|Adrenergic Agonists|adrenergic agonists|mesh-list
111341989|NCT00974051|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111341990|NCT00974051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111341991|NCT00974051|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111341992|NCT00974051|Autonomic Agents|autonomic agents|mesh-ancestor
111341993|NCT00974051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111341994|NCT00974051|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111341995|NCT00974051|Respiratory System Agents|respiratory system agents|mesh-ancestor
111341996|NCT00974051|Sympathomimetics|sympathomimetics|mesh-ancestor
111341997|NCT00974051|Tocolytic Agents|tocolytic agents|mesh-ancestor
111341998|NCT00974051|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111341999|NCT00974051|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111342000|NCT00974051|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111342001|NCT00974051|Adrenergic Agents|adrenergic agents|mesh-ancestor
111342002|NCT00974051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111342003|NCT00974051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111342004|NCT03017963|Sodium thiosulfate|sodium thiosulfate|mesh-list
111342005|NCT03017963|Antidotes|antidotes|mesh-ancestor
111342006|NCT03017963|Protective Agents|protective agents|mesh-ancestor
111342007|NCT03017963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111342008|NCT03017963|Antioxidants|antioxidants|mesh-ancestor
111342009|NCT03017963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111342010|NCT03017963|Antitubercular Agents|antitubercular agents|mesh-ancestor
111342011|NCT03017963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111342012|NCT03017963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111342013|NCT03017963|Chelating Agents|chelating agents|mesh-ancestor
111342014|NCT03017963|Sequestering Agents|sequestering agents|mesh-ancestor
111342015|NCT03018353|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
111342016|NCT03018353|Antiviral Agents|antiviral agents|mesh-ancestor
111342017|NCT03018353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111342018|NCT00977171|Droxidopa|droxidopa|mesh-list
111342019|NCT00977171|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111342020|NCT00977171|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111342021|NCT04129424|Insulin|insulin|mesh-list
111342022|NCT04129424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110705742|NCT01016093|Zoledronic Acid|zoledronic acid|mesh-list
111342023|NCT04129424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111342024|NCT00955487|Nitric Oxide|nitric oxide|mesh-list
111342025|NCT00955487|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111342026|NCT00955487|Autonomic Agents|autonomic agents|mesh-ancestor
111342027|NCT00955487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111342028|NCT00955487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111342029|NCT00955487|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111342030|NCT00955487|Respiratory System Agents|respiratory system agents|mesh-ancestor
111342031|NCT00955487|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111342032|NCT00955487|Antioxidants|antioxidants|mesh-ancestor
111342033|NCT00955487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111342034|NCT00955487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111342035|NCT00955487|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
111342036|NCT00955487|Vasodilator Agents|vasodilator agents|mesh-ancestor
111342037|NCT00955487|Gasotransmitters|gasotransmitters|mesh-ancestor
111342038|NCT00955487|Protective Agents|protective agents|mesh-ancestor
111342039|NCT04120922|Calcium Carbonate|calcium carbonate|mesh-list
111342040|NCT04120922|Calcium|calcium|mesh-list
111342041|NCT04120922|Sevelamer|sevelamer|mesh-list
111342042|NCT04120922|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111342043|NCT04120922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111342044|NCT04120922|Antacids|antacids|mesh-ancestor
110443729|NCT02793544|Mycophenolic Acid|mycophenolic acid|mesh-list
111342045|NCT04120922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111342046|NCT04120922|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111342047|NCT04120922|Chelating Agents|chelating agents|mesh-ancestor
111342048|NCT04120922|Sequestering Agents|sequestering agents|mesh-ancestor
111342049|NCT01663740|Valganciclovir|valganciclovir|mesh-list
111342050|NCT01663740|Antiviral Agents|antiviral agents|mesh-ancestor
111342051|NCT01663740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111342052|NCT02984228|Hyaluronic Acid|hyaluronic acid|mesh-list
111342053|NCT02984228|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111342054|NCT02984228|Immunologic Factors|immunologic factors|mesh-ancestor
111342055|NCT02984228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111342056|NCT02984228|Viscosupplements|viscosupplements|mesh-ancestor
111342057|NCT02984228|Protective Agents|protective agents|mesh-ancestor
111342058|NCT00979121|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111342059|NCT00979121|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111342060|NCT00979121|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111342061|NCT00979121|Antimetabolites|antimetabolites|mesh-ancestor
111342062|NCT00979121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111342063|NCT00979121|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111342064|NCT00979121|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111342065|NCT00979121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111342066|NCT03828032|Mannitol|mannitol|mesh-list
111342067|NCT03828032|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
111342068|NCT03828032|Diuretics|diuretics|mesh-ancestor
111342069|NCT03828032|Natriuretic Agents|natriuretic agents|mesh-ancestor
111342070|NCT03828032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111342071|NCT03827876|Calcitriol|calcitriol|mesh-list
111342072|NCT03827876|Betamethasone|betamethasone|mesh-list
111342073|NCT03827876|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
111342074|NCT03827876|Calcipotriene|calcipotriene|mesh-list
111342075|NCT03827876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111342076|NCT03827876|Glucocorticoids|glucocorticoids|mesh-ancestor
111342077|NCT03827876|Hormones|hormones|mesh-ancestor
111342078|NCT03827876|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111342079|NCT03827876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111342080|NCT03827876|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111342081|NCT03827876|Respiratory System Agents|respiratory system agents|mesh-ancestor
111342082|NCT03827876|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111342083|NCT03827876|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
111342084|NCT03827876|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110706271|NCT03991442|Vasodilator Agents|vasodilator agents|mesh-ancestor
111342085|NCT03827876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111342086|NCT03827876|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111342087|NCT03827876|Vitamins|vitamins|mesh-ancestor
111342088|NCT03827876|Micronutrients|micronutrients|mesh-ancestor
111342089|NCT03827876|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111342090|NCT03827876|Dermatologic Agents|dermatologic agents|mesh-ancestor
111342091|NCT03898934|Vitamin D|vitamin d|mesh-list
111342092|NCT03898934|Vitamins|vitamins|mesh-ancestor
111342093|NCT03898934|Micronutrients|micronutrients|mesh-ancestor
111342094|NCT03898934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111342095|NCT03898934|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111342096|NCT04128800|Apatinib|apatinib|mesh-list
111342097|NCT04128800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111342098|NCT04128800|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111342099|NCT04128800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111342100|NCT04128800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111342101|NCT04129112|Propofol|propofol|mesh-list
111342102|NCT04129112|Anesthetics|anesthetics|mesh-ancestor
111342103|NCT04129112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111342104|NCT04129112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111342105|NCT04129112|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111342106|NCT04129112|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111342107|NCT04129112|Anesthetics, General|anesthetics, general|mesh-ancestor
111342108|NCT01608893|Metoprolol|metoprolol|mesh-list
111342109|NCT01608893|Carvedilol|carvedilol|mesh-list
111342110|NCT01608893|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111342111|NCT01608893|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111342112|NCT01608893|Sympatholytics|sympatholytics|mesh-ancestor
111342113|NCT01608893|Autonomic Agents|autonomic agents|mesh-ancestor
111342114|NCT01608893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111342115|NCT01608893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111342116|NCT01608893|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
111342117|NCT01608893|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111342118|NCT01608893|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111342119|NCT01608893|Adrenergic Agents|adrenergic agents|mesh-ancestor
111342120|NCT01608893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111342121|NCT01608893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111342122|NCT01608893|Antioxidants|antioxidants|mesh-ancestor
111342123|NCT01608893|Protective Agents|protective agents|mesh-ancestor
111342124|NCT01608893|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111342125|NCT01608893|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111342126|NCT01608893|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111342127|NCT01608893|Vasodilator Agents|vasodilator agents|mesh-ancestor
111342128|NCT01608893|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111342129|NCT01608893|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111342130|NCT04128878|Sotalol|sotalol|mesh-list
111342131|NCT04128878|Dofetilide|dofetilide|mesh-list
111342132|NCT04128878|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111342133|NCT04128878|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111342134|NCT04128878|Adrenergic Agents|adrenergic agents|mesh-ancestor
111342135|NCT04128878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111342136|NCT04128878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111342137|NCT04128878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111342138|NCT04128878|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111342139|NCT04128878|Sympatholytics|sympatholytics|mesh-ancestor
111066571|NCT05235256|Hormones|hormones|mesh-ancestor
111342140|NCT04128878|Autonomic Agents|autonomic agents|mesh-ancestor
111342141|NCT04128878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111342142|NCT04128878|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
111342144|NCT00979745|Afamelanotide|afamelanotide|mesh-list
111342145|NCT00979745|Dermatologic Agents|dermatologic agents|mesh-ancestor
111342146|NCT00042341|Clofarabine|clofarabine|mesh-list
111342147|NCT00042341|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111342148|NCT00042341|Antimetabolites|antimetabolites|mesh-ancestor
111342149|NCT00042341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111342150|NCT00042341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111342151|NCT00980681|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
111342152|NCT00980681|Chelating Agents|chelating agents|mesh-ancestor
111342153|NCT00980681|Sequestering Agents|sequestering agents|mesh-ancestor
111342154|NCT00980681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111342155|NCT04759196|Topiramate|topiramate|mesh-list
111342156|NCT04759196|Levetiracetam|levetiracetam|mesh-list
111342157|NCT04759196|Anticonvulsants|anticonvulsants|mesh-ancestor
111342158|NCT04759196|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111342159|NCT04759196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111342160|NCT04759196|Nootropic Agents|nootropic agents|mesh-ancestor
111342161|NCT04128254|Apixaban|apixaban|mesh-list
111342162|NCT04128254|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111342163|NCT04128254|Antithrombins|antithrombins|mesh-ancestor
111342164|NCT04128254|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111342165|NCT04128254|Protease Inhibitors|protease inhibitors|mesh-ancestor
111342166|NCT04128254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111342167|NCT04128254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110706348|NCT00482729|Hormones|hormones|mesh-ancestor
111342168|NCT04128254|Anticoagulants|anticoagulants|mesh-ancestor
111342169|NCT04128020|Nivolumab|nivolumab|mesh-list
111342170|NCT04128020|Azacitidine|azacitidine|mesh-list
111342171|NCT04128020|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111342172|NCT04128020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111342173|NCT04128020|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111342174|NCT04128020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111342175|NCT04128020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111342176|NCT04128020|Antimetabolites|antimetabolites|mesh-ancestor
111342177|NCT04128020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111342178|NCT03827642|Naloxone|naloxone|mesh-list
111342179|NCT03827642|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111342180|NCT03827642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111342181|NCT03827642|Sensory System Agents|sensory system agents|mesh-ancestor
111342182|NCT03827642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111342183|NCT05510310|Oxytocin|oxytocin|mesh-list
111342184|NCT05510310|Oxytocics|oxytocics|mesh-ancestor
111342185|NCT05510310|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111342186|NCT05510310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111342187|NCT00981227|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
111342188|NCT00981227|Anticonvulsants|anticonvulsants|mesh-ancestor
111342189|NCT00981227|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111342190|NCT00981227|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111342191|NCT00981227|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111342192|NCT00981227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111342193|NCT01022567|Ertapenem|ertapenem|mesh-list
111342194|NCT01022567|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111342195|NCT01022567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111342196|NCT04411524|Capecitabine|capecitabine|mesh-list
111342197|NCT04411524|Irinotecan|irinotecan|mesh-list
111342198|NCT04411524|Antibodies|antibodies|mesh-list
111342199|NCT04411524|Immunologic Factors|immunologic factors|mesh-ancestor
111342200|NCT04411524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110706613|NCT01051934|Paclitaxel|paclitaxel|mesh-list
111342201|NCT04411524|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111342202|NCT04411524|Antimetabolites|antimetabolites|mesh-ancestor
111342203|NCT04411524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110706678|NCT01056614|Methotrexate|methotrexate|mesh-list
111342204|NCT04411524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111342205|NCT04411524|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111342206|NCT04411524|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111342207|NCT04411524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111342208|NCT04127396|Sorafenib|sorafenib|mesh-list
111342209|NCT04127396|Lenvatinib|lenvatinib|mesh-list
110336534|NCT00502541|Hormones|hormones|mesh-ancestor
111342210|NCT04127396|Chlorotrianisene|chlorotrianisene|mesh-list
111342211|NCT04127396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111342212|NCT04127396|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111342213|NCT04127396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111342214|NCT04127396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111342215|NCT04127396|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
111342216|NCT04127396|Estrogens|estrogens|mesh-ancestor
111342217|NCT04127396|Hormones|hormones|mesh-ancestor
111342218|NCT04127396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111342219|NCT04127396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111342220|NCT04127396|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111342221|NCT04120064|Cholecalciferol|cholecalciferol|mesh-list
111342222|NCT04120064|Vitamin D|vitamin d|mesh-list
111342223|NCT04120064|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111342224|NCT04120064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111342225|NCT04120064|Vitamins|vitamins|mesh-ancestor
111342226|NCT04120064|Micronutrients|micronutrients|mesh-ancestor
111342227|NCT04120064|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111342228|NCT00982007|Ferric Compounds|ferric compounds|mesh-list
111342229|NCT00982007|Hematinics|hematinics|mesh-ancestor
111342230|NCT04814940|Menotropins|menotropins|mesh-list
111342231|NCT04814940|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111342232|NCT04814940|Fertility Agents|fertility agents|mesh-ancestor
111342233|NCT04814940|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111342234|NCT04814940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111342235|NCT05042934|Irinotecan|irinotecan|mesh-list
111342236|NCT05042934|Camptothecin|camptothecin|mesh-list
111342237|NCT05042934|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111342238|NCT05042934|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111342239|NCT05042934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111342240|NCT05042934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111342241|NCT05042934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111342242|NCT05042934|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111342243|NCT05505006|Folic Acid|folic acid|mesh-list
111342244|NCT05505006|Vitamin B 12|vitamin b 12|mesh-list
110707155|NCT00324038|Codeine|codeine|mesh-list
111342245|NCT05505006|Hematinics|hematinics|mesh-ancestor
111342246|NCT05505006|Vitamin B Complex|vitamin b complex|mesh-ancestor
111342247|NCT05505006|Vitamins|vitamins|mesh-ancestor
110707244|NCT00312858|Vaccines|vaccines|mesh-list
111342248|NCT05505006|Micronutrients|micronutrients|mesh-ancestor
111342249|NCT05505006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111342250|NCT03826706|Pyrithione zinc|pyrithione zinc|mesh-list
111342251|NCT03826706|Keratolytic Agents|keratolytic agents|mesh-ancestor
111342252|NCT03826706|Dermatologic Agents|dermatologic agents|mesh-ancestor
111342253|NCT02979548|Ondansetron|ondansetron|mesh-list
111342254|NCT02979548|Aprepitant|aprepitant|mesh-list
110707306|NCT01077609|Xhance|xhance|mesh-list
111342255|NCT02979548|Metoclopramide|metoclopramide|mesh-list
111342256|NCT02979548|Antiemetics|antiemetics|mesh-ancestor
111342257|NCT02979548|Autonomic Agents|autonomic agents|mesh-ancestor
111342258|NCT02979548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111342259|NCT02979548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111342260|NCT02979548|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111342261|NCT02979548|Antipruritics|antipruritics|mesh-ancestor
111342262|NCT02979548|Dermatologic Agents|dermatologic agents|mesh-ancestor
110707367|NCT00323492|Antiviral Agents|antiviral agents|mesh-ancestor
111342263|NCT02979548|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111342264|NCT02979548|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111342265|NCT02979548|Serotonin Agents|serotonin agents|mesh-ancestor
111342266|NCT02979548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111342267|NCT02979548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111342268|NCT02979548|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
111342269|NCT02979548|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111342270|NCT02979548|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111342271|NCT02979548|Dopamine Agents|dopamine agents|mesh-ancestor
111342272|NCT03821246|Atezolizumab|atezolizumab|mesh-list
111342273|NCT03821246|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111342274|NCT03821246|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111342275|NCT03821246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111342276|NCT03821246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111342277|NCT03821246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111342278|NCT03821246|Immunologic Factors|immunologic factors|mesh-ancestor
111342279|NCT03821246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111342280|NCT03826316|Nalbuphine|nalbuphine|mesh-list
111342281|NCT03826316|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111342282|NCT03826316|Narcotics|narcotics|mesh-ancestor
111342283|NCT03826316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111342284|NCT03826316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111342285|NCT03826316|Analgesics|analgesics|mesh-ancestor
110707503|NCT00329108|Olanzapine|olanzapine|mesh-list
111342286|NCT03826316|Sensory System Agents|sensory system agents|mesh-ancestor
111342287|NCT03826316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111342288|NCT04393610|Lidocaine|lidocaine|mesh-list
111342289|NCT04393610|Magnesium Sulfate|magnesium sulfate|mesh-list
111342290|NCT04393610|Fentanyl|fentanyl|mesh-list
111342291|NCT04393610|Anesthetics, Local|anesthetics, local|mesh-ancestor
111342292|NCT04393610|Anesthetics|anesthetics|mesh-ancestor
111342293|NCT04393610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111342294|NCT04393610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111342295|NCT04393610|Sensory System Agents|sensory system agents|mesh-ancestor
111342296|NCT04393610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111342297|NCT04393610|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111342298|NCT04393610|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111342299|NCT04393610|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111342300|NCT04393610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111342301|NCT04393610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111342302|NCT04393610|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111342303|NCT04393610|Narcotics|narcotics|mesh-ancestor
111342304|NCT04393610|Analgesics|analgesics|mesh-ancestor
111342305|NCT04393610|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111342306|NCT04393610|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111342307|NCT04393610|Anesthetics, General|anesthetics, general|mesh-ancestor
111342308|NCT04393610|Anticonvulsants|anticonvulsants|mesh-ancestor
111342309|NCT04393610|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111342310|NCT04393610|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110707696|NCT03982862|Hormones|hormones|mesh-ancestor
111342311|NCT04393610|Tocolytic Agents|tocolytic agents|mesh-ancestor
111342312|NCT04393610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111342313|NCT03820466|Aspirin|aspirin|mesh-list
111342314|NCT03820466|Atorvastatin|atorvastatin|mesh-list
111342315|NCT03820466|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111342316|NCT03820466|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111342317|NCT03820466|Analgesics|analgesics|mesh-ancestor
111342318|NCT03820466|Sensory System Agents|sensory system agents|mesh-ancestor
111342319|NCT03820466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111342320|NCT03820466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111342321|NCT03820466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111342322|NCT03820466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111342323|NCT03820466|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111342324|NCT03820466|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110707831|NCT03985982|Botulinum Toxins|botulinum toxins|mesh-list
111342325|NCT03820466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111342326|NCT03820466|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111342327|NCT03820466|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111342328|NCT03820466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111342329|NCT03820466|Antipyretics|antipyretics|mesh-ancestor
111342330|NCT03820466|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111342331|NCT03820466|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111342332|NCT03820466|Antimetabolites|antimetabolites|mesh-ancestor
110707898|NCT00489359|Carboplatin|carboplatin|mesh-list
111342333|NCT03820466|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111342334|NCT03820466|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111342335|NCT03826004|Clemastine|clemastine|mesh-list
111342336|NCT03826004|Antipruritics|antipruritics|mesh-ancestor
111342337|NCT03826004|Dermatologic Agents|dermatologic agents|mesh-ancestor
111342338|NCT03826004|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111342339|NCT03826004|Histamine Antagonists|histamine antagonists|mesh-ancestor
111342340|NCT03826004|Histamine Agents|histamine agents|mesh-ancestor
111342341|NCT03826004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111342342|NCT03826004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111342343|NCT03826004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111342344|NCT03826004|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111342345|NCT02338076|Petrolatum|petrolatum|mesh-list
111342346|NCT02338076|Emollients|emollients|mesh-ancestor
111342347|NCT02338076|Dermatologic Agents|dermatologic agents|mesh-ancestor
111342348|NCT02978534|Quetiapine Fumarate|quetiapine fumarate|mesh-list
111342349|NCT02978534|Antidepressive Agents|antidepressive agents|mesh-ancestor
111342350|NCT02978534|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111342351|NCT02978534|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110708106|NCT01064180|Antioxidants|antioxidants|mesh-ancestor
111342352|NCT02978534|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111342353|NCT02978534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111342354|NCT02978534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111342355|NCT01222117|Plasminogen|plasminogen|mesh-list
111342356|NCT01222117|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
111342357|NCT01222117|Fibrinolysin|fibrinolysin|mesh-list
111342358|NCT01222117|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111342359|NCT01222117|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111342360|NCT01222117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111342361|NCT03825380|Bimatoprost|bimatoprost|mesh-list
111342362|NCT03825380|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111342363|NCT01222195|Lenalidomide|lenalidomide|mesh-list
111342364|NCT01222195|Darbepoetin alfa|darbepoetin alfa|mesh-list
111342365|NCT01222195|Immunologic Factors|immunologic factors|mesh-ancestor
111342366|NCT01222195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111342367|NCT01222195|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111342368|NCT01222195|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111342369|NCT01222195|Growth Substances|growth substances|mesh-ancestor
111066798|NCT02462720|Polidocanol|polidocanol|mesh-list
111342370|NCT01222195|Growth Inhibitors|growth inhibitors|mesh-ancestor
110708169|NCT01069770|Sunitinib|sunitinib|mesh-list
111342371|NCT01222195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111342372|NCT01222195|Hematinics|hematinics|mesh-ancestor
111342373|NCT01222273|Vitamin D|vitamin d|mesh-list
111342374|NCT01222273|Cholecalciferol|cholecalciferol|mesh-list
111342375|NCT01222273|Vitamins|vitamins|mesh-ancestor
111342376|NCT01222273|Micronutrients|micronutrients|mesh-ancestor
111342377|NCT01222273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111342378|NCT01222273|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111342379|NCT01222273|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111342380|NCT03161912|Aflibercept|aflibercept|mesh-list
111342381|NCT03161912|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111342382|NCT03161912|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111342383|NCT03161912|Growth Substances|growth substances|mesh-ancestor
111342384|NCT03161912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111342385|NCT03161912|Growth Inhibitors|growth inhibitors|mesh-ancestor
111342386|NCT03161912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111342387|NCT01222585|Metronidazole|metronidazole|mesh-list
111342388|NCT01222585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111342389|NCT01222585|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111342390|NCT01222585|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111342391|NCT01222585|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111342392|NCT04126382|Pulmonary Surfactants|pulmonary surfactants|mesh-list
111342393|NCT04126382|Respiratory System Agents|respiratory system agents|mesh-ancestor
111342394|NCT03829592|Misoprostol|misoprostol|mesh-list
111342395|NCT03829592|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111342396|NCT03829592|Abortifacient Agents|abortifacient agents|mesh-ancestor
111342397|NCT03829592|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111342398|NCT03829592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111342399|NCT03829592|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111342400|NCT03829592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111342401|NCT03829592|Oxytocics|oxytocics|mesh-ancestor
111342402|NCT01142323|Fenofibrate|fenofibrate|mesh-list
111342403|NCT01142323|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111342404|NCT01142323|Antimetabolites|antimetabolites|mesh-ancestor
111342405|NCT01142323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111342406|NCT01142323|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111342407|NCT01142947|Beclomethasone|beclomethasone|mesh-list
111342408|NCT01142947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111342409|NCT01142947|Glucocorticoids|glucocorticoids|mesh-ancestor
111342410|NCT01142947|Hormones|hormones|mesh-ancestor
111342411|NCT01142947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111342412|NCT01142947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111342413|NCT01142947|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110708427|NCT00319046|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111342414|NCT01142947|Respiratory System Agents|respiratory system agents|mesh-ancestor
111342415|NCT02972294|Iron|iron|mesh-list
111342416|NCT02972294|Tranexamic Acid|tranexamic acid|mesh-list
111342417|NCT02972294|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
111342418|NCT02972294|Ferric Compounds|ferric compounds|mesh-list
111342419|NCT02972294|Trace Elements|trace elements|mesh-ancestor
111342420|NCT02972294|Micronutrients|micronutrients|mesh-ancestor
111342421|NCT02972294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111342422|NCT02972294|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111342423|NCT02972294|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111342424|NCT02972294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111342425|NCT02972294|Hemostatics|hemostatics|mesh-ancestor
111342426|NCT02972294|Coagulants|coagulants|mesh-ancestor
111342427|NCT02972294|Hematinics|hematinics|mesh-ancestor
111342428|NCT02983214|Cilostazol|cilostazol|mesh-list
111342429|NCT02983214|Clopidogrel|clopidogrel|mesh-list
111342430|NCT02983214|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111342431|NCT02983214|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111342432|NCT02983214|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111342433|NCT02983214|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111342434|NCT02983214|Purinergic Agents|purinergic agents|mesh-ancestor
111342435|NCT02983214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111342436|NCT02983214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111342437|NCT02983214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111342438|NCT02983214|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111342439|NCT02983214|Autonomic Agents|autonomic agents|mesh-ancestor
111342440|NCT02983214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111342441|NCT02983214|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111342442|NCT02983214|Respiratory System Agents|respiratory system agents|mesh-ancestor
111342443|NCT02983214|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111342444|NCT02983214|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111342445|NCT02983214|Vasodilator Agents|vasodilator agents|mesh-ancestor
111342446|NCT02983214|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111342447|NCT02983214|Protective Agents|protective agents|mesh-ancestor
111342448|NCT02983214|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
111342449|NCT02983214|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111342450|NCT02983214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111342451|NCT03825068|Anesthetics|anesthetics|mesh-list
111342452|NCT03825068|Anesthetics, General|anesthetics, general|mesh-list
111342453|NCT03825068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111342454|NCT03825068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111342455|NCT03824834|Morphine|morphine|mesh-list
111342456|NCT03824834|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111342457|NCT03824834|Narcotics|narcotics|mesh-ancestor
111342458|NCT03824834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111342459|NCT03824834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111342460|NCT03824834|Analgesics|analgesics|mesh-ancestor
111342461|NCT03824834|Sensory System Agents|sensory system agents|mesh-ancestor
111342462|NCT03824834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111342463|NCT03829124|Ketamine|ketamine|mesh-list
111342464|NCT03829124|Propofol|propofol|mesh-list
111342465|NCT03829124|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111342466|NCT03829124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111342467|NCT03829124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111342468|NCT03829124|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111342469|NCT03829124|Anesthetics, General|anesthetics, general|mesh-ancestor
111342470|NCT03829124|Anesthetics|anesthetics|mesh-ancestor
111342471|NCT03829124|Analgesics|analgesics|mesh-ancestor
111342472|NCT03829124|Sensory System Agents|sensory system agents|mesh-ancestor
111342473|NCT03829124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111342474|NCT03829124|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111342475|NCT03829124|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111342476|NCT03829124|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111342477|NCT03829124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111342478|NCT03829124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111342479|NCT02965976|Botulinum Toxins|botulinum toxins|mesh-list
111342480|NCT02965976|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111342481|NCT02965976|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111342482|NCT02965976|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
111342483|NCT02965976|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111342484|NCT02965976|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111342485|NCT02965976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111342486|NCT02965976|Cholinergic Agents|cholinergic agents|mesh-ancestor
111342487|NCT02965976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111342488|NCT02965976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111342489|NCT02965976|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111342490|NCT02965976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111342491|NCT04393220|Bevacizumab|bevacizumab|mesh-list
111342492|NCT04393220|Nivolumab|nivolumab|mesh-list
111342493|NCT04393220|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111342494|NCT04393220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111342495|NCT04393220|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111342496|NCT04393220|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111342497|NCT04393220|Growth Substances|growth substances|mesh-ancestor
111342498|NCT04393220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111342499|NCT04393220|Growth Inhibitors|growth inhibitors|mesh-ancestor
111342500|NCT04393220|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111342501|NCT04393220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111342502|NCT01025453|Sirolimus|sirolimus|mesh-list
111342503|NCT01025453|Sorafenib|sorafenib|mesh-list
111342504|NCT01025453|Temsirolimus|temsirolimus|mesh-list
111342505|NCT01025453|MTOR Inhibitors|mtor inhibitors|mesh-list
111342506|NCT01025453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111342507|NCT01025453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111342508|NCT01025453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111342509|NCT01025453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111342510|NCT01025453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111342511|NCT01025453|Immunologic Factors|immunologic factors|mesh-ancestor
111342512|NCT01025453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111342513|NCT01025453|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111342514|NCT01025453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111342515|NCT01025453|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111342516|NCT01025453|Antifungal Agents|antifungal agents|mesh-ancestor
111342517|NCT05394233|Bevacizumab|bevacizumab|mesh-list
111342518|NCT05394233|Tislelizumab|tislelizumab|mesh-list
111342519|NCT05394233|Pemetrexed|pemetrexed|mesh-list
111342520|NCT05394233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111342521|NCT05394233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111342522|NCT05394233|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111342523|NCT05394233|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111342524|NCT05394233|Growth Substances|growth substances|mesh-ancestor
111342525|NCT05394233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110708827|NCT01020539|Gemtuzumab|gemtuzumab|mesh-list
111342526|NCT05394233|Growth Inhibitors|growth inhibitors|mesh-ancestor
111342527|NCT05394233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111342528|NCT05394233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111342529|NCT05394233|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111342530|NCT05394233|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111342531|NCT03823976|Anesthetics|anesthetics|mesh-list
111342532|NCT03823976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111342533|NCT03823976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111342534|NCT00982553|Ribavirin|ribavirin|mesh-list
111342535|NCT00982553|Raltegravir Potassium|raltegravir potassium|mesh-list
111342536|NCT00982553|Antimetabolites|antimetabolites|mesh-ancestor
111342537|NCT00982553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111342538|NCT00982553|Antiviral Agents|antiviral agents|mesh-ancestor
111342539|NCT00982553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111342540|NCT00982553|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111342541|NCT00982553|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111342542|NCT00982553|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111342543|NCT00982553|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111342544|NCT00982553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111342545|NCT02943590|Atorvastatin|atorvastatin|mesh-list
111342546|NCT02943590|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111342547|NCT02943590|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111342548|NCT02943590|Antimetabolites|antimetabolites|mesh-ancestor
111342549|NCT02943590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111342550|NCT02943590|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111342551|NCT02943590|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111342552|NCT02943590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111342553|NCT02939300|Nivolumab|nivolumab|mesh-list
111342554|NCT02939300|Ipilimumab|ipilimumab|mesh-list
111342555|NCT02939300|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111342556|NCT02939300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111342557|NCT02939300|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111342558|NCT02939300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111342559|NCT04392128|Azithromycin|azithromycin|mesh-list
111342560|NCT04392128|Hydroxychloroquine|hydroxychloroquine|mesh-list
111342561|NCT04392128|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111342562|NCT04392128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111342563|NCT04392128|Antimalarials|antimalarials|mesh-ancestor
111342564|NCT04392128|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111342565|NCT04392128|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111342566|NCT04392128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111342567|NCT04392128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111342568|NCT04392128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111342569|NCT02565186|Lasmiditan|lasmiditan|mesh-list
111342570|NCT02565186|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111342571|NCT02565186|Serotonin Agents|serotonin agents|mesh-ancestor
111342572|NCT02565186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111342573|NCT02565186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111342574|NCT02565186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111342575|NCT04694586|Rifampin|rifampin|mesh-list
111342576|NCT04694586|Isoniazid|isoniazid|mesh-list
111342577|NCT04694586|Pyrazinamide|pyrazinamide|mesh-list
111342578|NCT04694586|Ethambutol|ethambutol|mesh-list
111342579|NCT04694586|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111342580|NCT04694586|Antitubercular Agents|antitubercular agents|mesh-ancestor
111342581|NCT04694586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111342582|NCT04694586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111342583|NCT04694586|Leprostatic Agents|leprostatic agents|mesh-ancestor
111342584|NCT04694586|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111342585|NCT04694586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111342586|NCT04694586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111342587|NCT04694586|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111342588|NCT04694586|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111342589|NCT04694586|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
111342590|NCT04694586|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
111342591|NCT04694586|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
111342592|NCT04694586|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111342593|NCT04694586|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
111342594|NCT04694586|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111342595|NCT04694586|Antimetabolites|antimetabolites|mesh-ancestor
111342596|NCT04694586|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111342597|NCT04274816|Tremelimumab|tremelimumab|mesh-list
111342598|NCT04274816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111342599|NCT05509374|Dexamethasone|dexamethasone|mesh-list
111342600|NCT05509374|Pomalidomide|pomalidomide|mesh-list
111342601|NCT05509374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111342602|NCT05509374|Antiemetics|antiemetics|mesh-ancestor
111342603|NCT05509374|Autonomic Agents|autonomic agents|mesh-ancestor
111342604|NCT05509374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111342605|NCT05509374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111342606|NCT05509374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111342607|NCT05509374|Glucocorticoids|glucocorticoids|mesh-ancestor
111342608|NCT05509374|Hormones|hormones|mesh-ancestor
111342609|NCT05509374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111342610|NCT05509374|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111342611|NCT05509374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111342612|NCT05509374|Immunologic Factors|immunologic factors|mesh-ancestor
111342613|NCT05509374|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111342614|NCT05509374|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111342615|NCT05509374|Growth Substances|growth substances|mesh-ancestor
111342616|NCT05509374|Growth Inhibitors|growth inhibitors|mesh-ancestor
111342617|NCT04124822|Prednisolone|prednisolone|mesh-list
111342618|NCT04124822|Piroxicam|piroxicam|mesh-list
111342619|NCT04124822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111342620|NCT04124822|Glucocorticoids|glucocorticoids|mesh-ancestor
111342621|NCT04124822|Hormones|hormones|mesh-ancestor
111342622|NCT04124822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111342623|NCT04124822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111342624|NCT04124822|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111342625|NCT04124822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111342626|NCT04124822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111342627|NCT04124822|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111342628|NCT04124822|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111342629|NCT04124822|Analgesics|analgesics|mesh-ancestor
111342630|NCT04124822|Sensory System Agents|sensory system agents|mesh-ancestor
111342631|NCT04124822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111342632|NCT04124822|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111342633|NCT04124822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111342634|NCT04124822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111342635|NCT05504694|Ofatumumab|ofatumumab|mesh-list
111342636|NCT05504694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111342637|NCT02854670|Capsaicin|capsaicin|mesh-list
111342638|NCT02854670|Antipruritics|antipruritics|mesh-ancestor
111342639|NCT02854670|Dermatologic Agents|dermatologic agents|mesh-ancestor
111342640|NCT02854670|Sensory System Agents|sensory system agents|mesh-ancestor
111342641|NCT02854670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111342642|NCT02854670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111342643|NCT02937272|Paclitaxel|paclitaxel|mesh-list
111342644|NCT02937272|Gemcitabine|gemcitabine|mesh-list
110709092|NCT01065038|Hydroxyurea|hydroxyurea|mesh-list
111342645|NCT02937272|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111342646|NCT02937272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111342647|NCT02937272|Tubulin Modulators|tubulin modulators|mesh-ancestor
111342648|NCT02937272|Antimitotic Agents|antimitotic agents|mesh-ancestor
111342649|NCT02937272|Mitosis Modulators|mitosis modulators|mesh-ancestor
111342650|NCT02937272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111342651|NCT02937272|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111342652|NCT02937272|Antimetabolites|antimetabolites|mesh-ancestor
111342653|NCT03519308|Paclitaxel|paclitaxel|mesh-list
111342654|NCT03519308|Gemcitabine|gemcitabine|mesh-list
111342655|NCT03519308|Nivolumab|nivolumab|mesh-list
111342656|NCT03519308|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111342657|NCT03519308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111342658|NCT03519308|Tubulin Modulators|tubulin modulators|mesh-ancestor
111342659|NCT03519308|Antimitotic Agents|antimitotic agents|mesh-ancestor
111342660|NCT03519308|Mitosis Modulators|mitosis modulators|mesh-ancestor
111342661|NCT03519308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111342662|NCT03519308|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111342663|NCT03519308|Antimetabolites|antimetabolites|mesh-ancestor
111342664|NCT03519308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111342665|NCT03519308|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111342666|NCT03821714|Vitamins|vitamins|mesh-list
111342667|NCT03821714|Hydrocortisone|hydrocortisone|mesh-list
111342668|NCT03821714|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
111342669|NCT03821714|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
111342670|NCT03821714|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
111342671|NCT03821714|Glucocorticoids|glucocorticoids|mesh-list
111342672|NCT03821714|Micronutrients|micronutrients|mesh-ancestor
111342673|NCT03821714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111342674|NCT03821714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111342676|NCT03821714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111342677|NCT02565108|Cannabidiol|cannabidiol|mesh-list
111342678|NCT02565108|Clobazam|clobazam|mesh-list
111342679|NCT02565108|Anticonvulsants|anticonvulsants|mesh-ancestor
111342680|NCT02565108|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111342681|NCT02565108|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111342682|NCT02565108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111342683|NCT02565108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111342684|NCT02565108|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111342685|NCT02565108|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
111342686|NCT02565108|GABA Agonists|gaba agonists|mesh-ancestor
111342687|NCT02565108|GABA Agents|gaba agents|mesh-ancestor
111342688|NCT02565108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111342689|NCT02565108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111342690|NCT03821168|Bevacizumab|bevacizumab|mesh-list
111342691|NCT03821168|Epoetin Alfa|epoetin alfa|mesh-list
111342692|NCT03821168|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110709154|NCT00294554|Memantine|memantine|mesh-list
111342693|NCT03821168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111342694|NCT03821168|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111342695|NCT03821168|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111342696|NCT03821168|Growth Substances|growth substances|mesh-ancestor
111342697|NCT03821168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111342698|NCT03821168|Growth Inhibitors|growth inhibitors|mesh-ancestor
111342699|NCT03821168|Hematinics|hematinics|mesh-ancestor
111342700|NCT01454180|Leucovorin|leucovorin|mesh-list
111342701|NCT01454180|Gemcitabine|gemcitabine|mesh-list
111342702|NCT01454180|Capecitabine|capecitabine|mesh-list
111342703|NCT01454180|Fluorouracil|fluorouracil|mesh-list
111342704|NCT01454180|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111342705|NCT01454180|Oxaliplatin|oxaliplatin|mesh-list
111342706|NCT01454180|Folfirinox|folfirinox|mesh-list
111342707|NCT01454180|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111342708|NCT01454180|Antimetabolites|antimetabolites|mesh-ancestor
111342709|NCT01454180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111342710|NCT01454180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111342711|NCT01454180|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111342712|NCT01454180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111342713|NCT01454180|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111342714|NCT01454180|Immunologic Factors|immunologic factors|mesh-ancestor
111342715|NCT01454180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111342716|NCT01454180|Antidotes|antidotes|mesh-ancestor
111342717|NCT01454180|Protective Agents|protective agents|mesh-ancestor
111342718|NCT01454180|Vitamin B Complex|vitamin b complex|mesh-ancestor
111342719|NCT01454180|Vitamins|vitamins|mesh-ancestor
111342720|NCT01454180|Micronutrients|micronutrients|mesh-ancestor
111342721|NCT02564952|Cannabidiol|cannabidiol|mesh-list
111342722|NCT02564952|Clobazam|clobazam|mesh-list
111342723|NCT02564952|Anticonvulsants|anticonvulsants|mesh-ancestor
111342724|NCT02564952|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111342725|NCT02564952|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111342726|NCT02564952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111342727|NCT02564952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111342728|NCT02564952|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111342729|NCT02564952|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
111342730|NCT02564952|GABA Agonists|gaba agonists|mesh-ancestor
111342731|NCT02564952|GABA Agents|gaba agents|mesh-ancestor
111342732|NCT02564952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111342733|NCT02564952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111342734|NCT05564286|Dexamethasone|dexamethasone|mesh-list
111342735|NCT05564286|Fosaprepitant|fosaprepitant|mesh-list
111342736|NCT05564286|Aprepitant|aprepitant|mesh-list
111342737|NCT05564286|Tropisetron|tropisetron|mesh-list
111342738|NCT05564286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111342739|NCT05564286|Antiemetics|antiemetics|mesh-ancestor
111342740|NCT05564286|Autonomic Agents|autonomic agents|mesh-ancestor
111342741|NCT05564286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111342742|NCT05564286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111342743|NCT05564286|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111342744|NCT05564286|Glucocorticoids|glucocorticoids|mesh-ancestor
111342745|NCT05564286|Hormones|hormones|mesh-ancestor
111342746|NCT05564286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111342747|NCT05564286|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111342748|NCT05564286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111342749|NCT05564286|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
111342750|NCT05564286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111342751|NCT05564286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111342752|NCT05564286|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110709225|NCT01582230|Vildagliptin|vildagliptin|mesh-list
111342753|NCT05564286|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111342754|NCT05564286|Serotonin Agents|serotonin agents|mesh-ancestor
111342755|NCT01454804|Trastuzumab|trastuzumab|mesh-list
111342757|NCT01454804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111342758|NCT01454804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111342759|NCT01454804|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111342760|NCT01454804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111342761|NCT01454804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111342762|NCT03820622|Paclitaxel|paclitaxel|mesh-list
111342763|NCT03820622|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111342764|NCT03820622|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111342765|NCT03820622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111342766|NCT03820622|Tubulin Modulators|tubulin modulators|mesh-ancestor
111342767|NCT03820622|Antimitotic Agents|antimitotic agents|mesh-ancestor
111342768|NCT03820622|Mitosis Modulators|mitosis modulators|mesh-ancestor
111342769|NCT03820622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111342770|NCT05504382|Naproxen|naproxen|mesh-list
111342771|NCT05504382|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111342772|NCT05504382|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111342773|NCT05504382|Analgesics|analgesics|mesh-ancestor
111342774|NCT05504382|Sensory System Agents|sensory system agents|mesh-ancestor
111342775|NCT05504382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111342776|NCT05504382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111342777|NCT05504382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111342778|NCT05504382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111342779|NCT05504382|Gout Suppressants|gout suppressants|mesh-ancestor
111342780|NCT05504382|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111342781|NCT05504382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111342782|NCT05504382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111342783|NCT03823040|Oxiconazole|oxiconazole|mesh-list
111342784|NCT03823040|Antifungal Agents|antifungal agents|mesh-ancestor
111342785|NCT03823040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111342786|NCT02566902|Albuterol|albuterol|mesh-list
111342787|NCT02566902|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111342788|NCT02566902|Autonomic Agents|autonomic agents|mesh-ancestor
111342789|NCT02566902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111342790|NCT02566902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111342791|NCT02566902|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111342792|NCT02566902|Respiratory System Agents|respiratory system agents|mesh-ancestor
111342793|NCT02566902|Tocolytic Agents|tocolytic agents|mesh-ancestor
111342794|NCT02566902|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111342795|NCT02566902|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111342796|NCT02566902|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111342797|NCT02566902|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111342798|NCT02566902|Adrenergic Agents|adrenergic agents|mesh-ancestor
111342799|NCT02566902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111342800|NCT02566902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111342801|NCT05508516|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
111342802|NCT05508516|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110709525|NCT00293384|Glucocorticoids|glucocorticoids|mesh-ancestor
111342803|NCT05508516|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111342804|NCT05508516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111342805|NCT05508516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111342806|NCT05508516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110709600|NCT01084720|V0034CR|v0034cr|mesh-list
111342807|NCT05508516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111342808|NCT05508516|Analgesics|analgesics|mesh-ancestor
111342809|NCT05508516|Sensory System Agents|sensory system agents|mesh-ancestor
111342810|NCT05508516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111342811|NCT05508516|Antidepressive Agents|antidepressive agents|mesh-ancestor
111342812|NCT05508516|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111342813|NCT05508516|Dopamine Agents|dopamine agents|mesh-ancestor
111342814|NCT01455506|Fludarabine|fludarabine|mesh-list
111342815|NCT01455506|Busulfan|busulfan|mesh-list
111342816|NCT01455506|Decitabine|decitabine|mesh-list
111342817|NCT01455506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111342818|NCT01455506|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111342819|NCT01455506|Antimetabolites|antimetabolites|mesh-ancestor
111342820|NCT01455506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111342821|NCT01455506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111342822|NCT01455506|Immunologic Factors|immunologic factors|mesh-ancestor
110709735|NCT00469859|Antimetabolites|antimetabolites|mesh-ancestor
111342823|NCT01455506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111342824|NCT01455506|Alkylating Agents|alkylating agents|mesh-ancestor
111342825|NCT01455506|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111342826|NCT01455506|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111342827|NCT01455506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111342828|NCT02564796|Iron|iron|mesh-list
111342829|NCT02564796|Epoetin Alfa|epoetin alfa|mesh-list
111342830|NCT02564796|Trace Elements|trace elements|mesh-ancestor
111342831|NCT02564796|Micronutrients|micronutrients|mesh-ancestor
111342832|NCT02564796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111342833|NCT02564796|Hematinics|hematinics|mesh-ancestor
111342834|NCT05563350|Midazolam|midazolam|mesh-list
111342835|NCT05563350|Omeprazole|omeprazole|mesh-list
111342836|NCT05563350|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111342837|NCT05563350|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111342838|NCT05563350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111342839|NCT05563350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111342840|NCT05563350|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111342841|NCT05563350|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111342842|NCT05563350|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111342843|NCT05563350|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111342844|NCT05563350|Anesthetics, General|anesthetics, general|mesh-ancestor
111342845|NCT05563350|Anesthetics|anesthetics|mesh-ancestor
111342846|NCT05563350|GABA Modulators|gaba modulators|mesh-ancestor
111342847|NCT05563350|GABA Agents|gaba agents|mesh-ancestor
111342848|NCT05563350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111342849|NCT05563350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111342850|NCT05563350|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111342851|NCT05563350|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111342852|NCT05563350|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111342853|NCT05563350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111342854|NCT04273100|Lenvatinib|lenvatinib|mesh-list
111342855|NCT04273100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111342856|NCT04273100|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111342857|NCT04273100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111342858|NCT04273100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111342859|NCT02564718|Rivaroxaban|rivaroxaban|mesh-list
111342860|NCT02564718|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111342861|NCT02564718|Antithrombins|antithrombins|mesh-ancestor
111342862|NCT02564718|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111342863|NCT02564718|Protease Inhibitors|protease inhibitors|mesh-ancestor
111342864|NCT02564718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111342865|NCT02564718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111342866|NCT02564718|Anticoagulants|anticoagulants|mesh-ancestor
111342867|NCT01453946|Budesonide|budesonide|mesh-list
111342868|NCT01453946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111342869|NCT01453946|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111342870|NCT01453946|Autonomic Agents|autonomic agents|mesh-ancestor
111342871|NCT01453946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111342872|NCT01453946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111342873|NCT01453946|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111342874|NCT01453946|Respiratory System Agents|respiratory system agents|mesh-ancestor
111342875|NCT01453946|Glucocorticoids|glucocorticoids|mesh-ancestor
111342876|NCT01453946|Hormones|hormones|mesh-ancestor
111342877|NCT01453946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111342878|NCT01455896|Exenatide|exenatide|mesh-list
111342879|NCT01455896|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111342880|NCT01455896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111342881|NCT01455896|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111342882|NCT01455896|Incretins|incretins|mesh-ancestor
111342883|NCT01455896|Hormones|hormones|mesh-ancestor
111342884|NCT01455896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111342885|NCT05562882|Daratumumab|daratumumab|mesh-list
111342886|NCT05562882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111342887|NCT05560542|Dexamethasone|dexamethasone|mesh-list
111342888|NCT05560542|Atropine|atropine|mesh-list
111342889|NCT05560542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111342890|NCT05560542|Antiemetics|antiemetics|mesh-ancestor
111342891|NCT05560542|Autonomic Agents|autonomic agents|mesh-ancestor
111342892|NCT05560542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111342893|NCT05560542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111342894|NCT05560542|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111342895|NCT05560542|Glucocorticoids|glucocorticoids|mesh-ancestor
111342896|NCT05560542|Hormones|hormones|mesh-ancestor
111342897|NCT05560542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111067340|NCT02293187|Vitamin D|vitamin d|mesh-list
110710257|NCT01086046|Heparin|heparin|mesh-list
111342898|NCT05560542|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111342899|NCT05560542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111342900|NCT05560542|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111342901|NCT05560542|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111342902|NCT05560542|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111342903|NCT05560542|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111342904|NCT05560542|Respiratory System Agents|respiratory system agents|mesh-ancestor
111342905|NCT05560542|Mydriatics|mydriatics|mesh-ancestor
111342906|NCT05560542|Parasympatholytics|parasympatholytics|mesh-ancestor
111342907|NCT05560542|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111342908|NCT05560542|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111342909|NCT05560542|Cholinergic Agents|cholinergic agents|mesh-ancestor
111342910|NCT05560542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111342911|NCT05560542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111342912|NCT01455974|Dialysis Solutions|dialysis solutions|mesh-list
111342913|NCT01455974|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111342914|NCT05560308|Trastuzumab|trastuzumab|mesh-list
111342915|NCT05560308|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
111342916|NCT05560308|Maytansine|maytansine|mesh-list
111342917|NCT05560308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111342918|NCT05560308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111342919|NCT05560308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111342920|NCT05560308|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111342921|NCT05560308|Tubulin Modulators|tubulin modulators|mesh-ancestor
111342922|NCT05560308|Antimitotic Agents|antimitotic agents|mesh-ancestor
111342923|NCT05560308|Mitosis Modulators|mitosis modulators|mesh-ancestor
111342924|NCT05560308|Immunotoxins|immunotoxins|mesh-ancestor
111342925|NCT05560308|Immunoconjugates|immunoconjugates|mesh-ancestor
111342926|NCT05560308|Immunologic Factors|immunologic factors|mesh-ancestor
111342927|NCT05560308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111342928|NCT01456208|Norepinephrine|norepinephrine|mesh-list
111342929|NCT01456208|Angiotensin II|angiotensin ii|mesh-list
111342930|NCT01456208|Giapreza|giapreza|mesh-list
111342931|NCT01456208|Angiotensinogen|angiotensinogen|mesh-list
111342932|NCT01456208|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111342933|NCT01456208|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111342934|NCT01456208|Adrenergic Agents|adrenergic agents|mesh-ancestor
111342935|NCT01456208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110710684|NCT01070030|Diuretics|diuretics|mesh-ancestor
111342936|NCT01456208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111342937|NCT01456208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111342938|NCT01456208|Sympathomimetics|sympathomimetics|mesh-ancestor
111342939|NCT01456208|Autonomic Agents|autonomic agents|mesh-ancestor
111342940|NCT01456208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111342941|NCT01456208|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111342942|NCT01456208|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111342943|NCT01456208|Protease Inhibitors|protease inhibitors|mesh-ancestor
111342944|NCT01456208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111342945|NCT05436522|Propofol|propofol|mesh-list
111342946|NCT05436522|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111342947|NCT05436522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111342948|NCT05436522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111342949|NCT05436522|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111342950|NCT05436522|Anesthetics, General|anesthetics, general|mesh-ancestor
111342951|NCT05436522|Anesthetics|anesthetics|mesh-ancestor
111342952|NCT03780010|Paclitaxel|paclitaxel|mesh-list
111342953|NCT03780010|Carboplatin|carboplatin|mesh-list
111342954|NCT03780010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111342955|NCT03780010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111342956|NCT03780010|Tubulin Modulators|tubulin modulators|mesh-ancestor
111342957|NCT03780010|Antimitotic Agents|antimitotic agents|mesh-ancestor
111342958|NCT03780010|Mitosis Modulators|mitosis modulators|mesh-ancestor
110710957|NCT03956212|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111342959|NCT03780010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111342960|NCT03826550|Diclofenac|diclofenac|mesh-list
111342961|NCT03826550|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110340861|NCT02939547|Betadex|betadex|mesh-list
111342962|NCT03826550|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111342963|NCT03826550|Analgesics|analgesics|mesh-ancestor
111342964|NCT03826550|Sensory System Agents|sensory system agents|mesh-ancestor
111342965|NCT03826550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111342966|NCT03826550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111342967|NCT03826550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111342968|NCT03826550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111342969|NCT03826550|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111342970|NCT03826550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111342971|NCT03826550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111342972|NCT03827018|Prednisone|prednisone|mesh-list
111342973|NCT03827018|Mavrilimumab|mavrilimumab|mesh-list
111342974|NCT03827018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111342975|NCT03827018|Glucocorticoids|glucocorticoids|mesh-ancestor
111342976|NCT03827018|Hormones|hormones|mesh-ancestor
111342977|NCT03827018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111342978|NCT03827018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111342979|NCT03827018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111342980|NCT03827018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111342981|NCT03827018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111342982|NCT05325762|Dexmedetomidine|dexmedetomidine|mesh-list
111342983|NCT05325762|Propofol|propofol|mesh-list
111342984|NCT05325762|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111342985|NCT05325762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110711159|NCT00064792|Simvastatin|simvastatin|mesh-list
111342986|NCT05325762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111342987|NCT05325762|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111342988|NCT05325762|Analgesics|analgesics|mesh-ancestor
111342989|NCT05325762|Sensory System Agents|sensory system agents|mesh-ancestor
111342990|NCT05325762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110711224|NCT00063934|Docetaxel|docetaxel|mesh-list
111342991|NCT05325762|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111342992|NCT05325762|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111342993|NCT05325762|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111342994|NCT05325762|Adrenergic Agents|adrenergic agents|mesh-ancestor
111342995|NCT05325762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111342996|NCT05325762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111342997|NCT05325762|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111342998|NCT05325762|Anesthetics, General|anesthetics, general|mesh-ancestor
111342999|NCT05325762|Anesthetics|anesthetics|mesh-ancestor
111343000|NCT04391582|Sulfadiazine|sulfadiazine|mesh-list
111343001|NCT04391582|Silver Sulfadiazine|silver sulfadiazine|mesh-list
111343002|NCT04391582|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111343003|NCT04391582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111343004|NCT04391582|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111343005|NCT04391582|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111343006|NCT04391582|Coccidiostats|coccidiostats|mesh-ancestor
111343007|NCT04391582|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111343008|NCT05498064|Ensartinib|ensartinib|mesh-list
111343009|NCT05498064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111343010|NCT05498064|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111343011|NCT05498064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111343012|NCT05498064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111343013|NCT03767062|Topiramate|topiramate|mesh-list
111343014|NCT03767062|Anticonvulsants|anticonvulsants|mesh-ancestor
111343015|NCT03767062|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111343016|NCT03767062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111343017|NCT01456364|Ticagrelor|ticagrelor|mesh-list
111343018|NCT01456364|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
111343019|NCT01456364|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111343020|NCT01456364|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111343021|NCT01456364|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111343022|NCT01456364|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111343023|NCT01456364|Purinergic Agents|purinergic agents|mesh-ancestor
111343024|NCT01456364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111343025|NCT01456364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111343026|NCT01456364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111343027|NCT04281420|Niacin|niacin|mesh-list
111343028|NCT04281420|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111343029|NCT04281420|Antimetabolites|antimetabolites|mesh-ancestor
111343030|NCT04281420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111343031|NCT04281420|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111343032|NCT04281420|Vasodilator Agents|vasodilator agents|mesh-ancestor
111343033|NCT04281420|Vitamin B Complex|vitamin b complex|mesh-ancestor
111343034|NCT04281420|Vitamins|vitamins|mesh-ancestor
111343035|NCT04281420|Micronutrients|micronutrients|mesh-ancestor
111343036|NCT04281420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111343037|NCT03765502|Glucagon|glucagon|mesh-list
111343038|NCT03765502|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
111343039|NCT03765502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111343040|NCT03765502|Hormones|hormones|mesh-ancestor
111343041|NCT03765502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111343042|NCT03765502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111343043|NCT03765502|Incretins|incretins|mesh-ancestor
111343044|NCT05285124|Melatonin|melatonin|mesh-list
111343045|NCT05285124|Antioxidants|antioxidants|mesh-ancestor
111343046|NCT05285124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111343047|NCT05285124|Protective Agents|protective agents|mesh-ancestor
111343048|NCT05285124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111343049|NCT05285124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111343050|NCT01450046|Vitamin E|vitamin e|mesh-list
111067469|NCT02299115|Glucocorticoids|glucocorticoids|mesh-ancestor
111343052|NCT01450046|Tocotrienols|tocotrienols|mesh-list
111343053|NCT01450046|Vitamins|vitamins|mesh-ancestor
111343054|NCT01450046|Micronutrients|micronutrients|mesh-ancestor
111343055|NCT01450046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111343056|NCT01450046|Antioxidants|antioxidants|mesh-ancestor
111343057|NCT01450046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111343058|NCT01450046|Protective Agents|protective agents|mesh-ancestor
111343059|NCT01450124|Boswellic acid|boswellic acid|mesh-list
111343060|NCT01450124|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111343061|NCT01450124|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111343062|NCT01450124|Analgesics|analgesics|mesh-ancestor
111343063|NCT01450124|Sensory System Agents|sensory system agents|mesh-ancestor
111343064|NCT01450124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111343065|NCT01450124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111343066|NCT01450124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111343067|NCT01450124|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111343068|NCT03751124|Norethindrone|norethindrone|mesh-list
111343069|NCT03751124|Norethindrone Acetate|norethindrone acetate|mesh-list
111343070|NCT03751124|Estradiol|estradiol|mesh-list
111343071|NCT03751124|Relugolix|relugolix|mesh-list
111343072|NCT03751124|Estrogens|estrogens|mesh-ancestor
111343073|NCT03751124|Hormones|hormones|mesh-ancestor
111343074|NCT03751124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111343075|NCT03751124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110712111|NCT03953716|Progestins|progestins|mesh-ancestor
111343076|NCT03751124|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111343077|NCT03751124|Contraceptive Agents|contraceptive agents|mesh-ancestor
111343078|NCT03751124|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111343079|NCT03751124|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111343080|NCT03751124|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111343081|NCT03751124|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111343082|NCT03751124|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111343083|NCT03751124|Androgen Antagonists|androgen antagonists|mesh-ancestor
111343084|NCT03751124|Hormone Antagonists|hormone antagonists|mesh-ancestor
111343085|NCT02563548|Pembrolizumab|pembrolizumab|mesh-list
111343086|NCT02563548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111343087|NCT02563548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111343088|NCT02563548|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111343089|NCT02563548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111343090|NCT01450358|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111343091|NCT01450358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111343092|NCT04081324|Lasmiditan|lasmiditan|mesh-list
110712328|NCT00221403|GABA Agents|gaba agents|mesh-ancestor
111343093|NCT04081324|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111343094|NCT04081324|Serotonin Agents|serotonin agents|mesh-ancestor
111343095|NCT04081324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111343096|NCT04081324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111343097|NCT04081324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111343098|NCT04042324|Heparin|heparin|mesh-list
110712395|NCT03965871|Esketamine|esketamine|mesh-list
111343099|NCT04042324|Calcium heparin|calcium heparin|mesh-list
111343100|NCT04042324|Anticoagulants|anticoagulants|mesh-ancestor
111343101|NCT04042324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111343102|NCT04042324|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111343103|NCT04042324|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111343104|NCT04391660|Ethanol|ethanol|mesh-list
111343105|NCT04391660|Sodium Hypochlorite|sodium hypochlorite|mesh-list
111343106|NCT04391660|Eusol|eusol|mesh-list
110712534|NCT00205712|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111343107|NCT04391660|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111343108|NCT04391660|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111343109|NCT04391660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110712598|NCT00234494|Growth Inhibitors|growth inhibitors|mesh-ancestor
111343110|NCT04391660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111343111|NCT04391660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111343112|NCT04391660|Disinfectants|disinfectants|mesh-ancestor
111343113|NCT04842422|Imiquimod|imiquimod|mesh-list
111343114|NCT04842422|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111343115|NCT04842422|Immunologic Factors|immunologic factors|mesh-ancestor
110712673|NCT01097278|Vitamin D|vitamin d|mesh-list
111343116|NCT04842422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111343117|NCT04842422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111343118|NCT04842422|Interferon Inducers|interferon inducers|mesh-ancestor
111343119|NCT04066426|Acetaminophen|acetaminophen|mesh-list
111343120|NCT04066426|Dexamethasone|dexamethasone|mesh-list
111343121|NCT04066426|Naproxen|naproxen|mesh-list
111343122|NCT04066426|Codeine|codeine|mesh-list
111343123|NCT04066426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111343124|NCT04066426|Antiemetics|antiemetics|mesh-ancestor
111343125|NCT04066426|Autonomic Agents|autonomic agents|mesh-ancestor
111343126|NCT04066426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111067546|NCT02834403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111343127|NCT04066426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111343128|NCT04066426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111343129|NCT04066426|Glucocorticoids|glucocorticoids|mesh-ancestor
111343131|NCT04066426|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111343132|NCT04066426|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111343133|NCT04066426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111343134|NCT04066426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111343135|NCT04066426|Analgesics|analgesics|mesh-ancestor
111343136|NCT04066426|Sensory System Agents|sensory system agents|mesh-ancestor
111343137|NCT04066426|Antipyretics|antipyretics|mesh-ancestor
111343138|NCT04066426|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111343139|NCT04066426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111343140|NCT04066426|Gout Suppressants|gout suppressants|mesh-ancestor
111343141|NCT04066426|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111343142|NCT04066426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111343143|NCT04066426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111343144|NCT04066426|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111343145|NCT04066426|Narcotics|narcotics|mesh-ancestor
111343146|NCT04066426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111343147|NCT04066426|Antitussive Agents|antitussive agents|mesh-ancestor
111343148|NCT04066426|Respiratory System Agents|respiratory system agents|mesh-ancestor
111343149|NCT01450514|Pipamperone|pipamperone|mesh-list
111343150|NCT01450514|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111343151|NCT01450514|Serotonin Agents|serotonin agents|mesh-ancestor
111343152|NCT01450514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111343153|NCT01450514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111343154|NCT01450514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111343155|NCT01450514|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111343156|NCT01450514|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111343157|NCT01450514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111343158|NCT01450514|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111343159|NCT04758728|Epinephrine|epinephrine|mesh-list
111343160|NCT04758728|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111343161|NCT04758728|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111343162|NCT04758728|Adrenergic Agents|adrenergic agents|mesh-ancestor
111343163|NCT04758728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110713080|NCT01097980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111343164|NCT04758728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111343165|NCT04758728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111343166|NCT04758728|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110713147|NCT01029743|Protease Inhibitors|protease inhibitors|mesh-ancestor
111343167|NCT04758728|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111343168|NCT04758728|Autonomic Agents|autonomic agents|mesh-ancestor
111343169|NCT04758728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111343170|NCT04758728|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111343171|NCT04758728|Respiratory System Agents|respiratory system agents|mesh-ancestor
111343172|NCT04758728|Mydriatics|mydriatics|mesh-ancestor
111343173|NCT04758728|Sympathomimetics|sympathomimetics|mesh-ancestor
111343174|NCT04758728|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111343175|NCT02559570|Linaclotide|linaclotide|mesh-list
111343176|NCT02559570|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
111343177|NCT02559570|Enzyme Activators|enzyme activators|mesh-ancestor
111343178|NCT02559570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110713297|NCT01030601|BB 1101|bb 1101|mesh-list
111343179|NCT02559570|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111343180|NCT04051684|Ropivacaine|ropivacaine|mesh-list
111343181|NCT04051684|Anesthetics, Local|anesthetics, local|mesh-ancestor
111343182|NCT04051684|Anesthetics|anesthetics|mesh-ancestor
111343183|NCT04051684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111343184|NCT04051684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111343185|NCT04051684|Sensory System Agents|sensory system agents|mesh-ancestor
111343186|NCT04051684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111343187|NCT04840862|Rifabutin|rifabutin|mesh-list
111343188|NCT04840862|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110713434|NCT00428441|Warfarin|warfarin|mesh-list
111343189|NCT04840862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111343190|NCT04840862|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111343191|NCT04840862|Antitubercular Agents|antitubercular agents|mesh-ancestor
111343192|NCT04840238|Cholecalciferol|cholecalciferol|mesh-list
111343193|NCT04840238|Vitamin D|vitamin d|mesh-list
111343194|NCT04840238|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111343195|NCT04840238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111343196|NCT04840238|Vitamins|vitamins|mesh-ancestor
111343197|NCT04840238|Micronutrients|micronutrients|mesh-ancestor
111343198|NCT04840238|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111343199|NCT03829618|Lidocaine|lidocaine|mesh-list
111343200|NCT03829618|Anesthetics, Local|anesthetics, local|mesh-ancestor
111343201|NCT03829618|Anesthetics|anesthetics|mesh-ancestor
111343202|NCT03829618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111343203|NCT03829618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111343204|NCT03829618|Sensory System Agents|sensory system agents|mesh-ancestor
111343205|NCT03829618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111343206|NCT03829618|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111343207|NCT03829618|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111343208|NCT03829618|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111343209|NCT03829618|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111343210|NCT03829618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111343212|NCT04272788|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111343213|NCT04272788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111343214|NCT04272788|Dermatologic Agents|dermatologic agents|mesh-ancestor
111343215|NCT04272788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111343216|NCT04272788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111343217|NCT01457690|Tocopherols|tocopherols|mesh-list
111343218|NCT01457690|Vitamin E|vitamin e|mesh-list
111343219|NCT01457690|Tocotrienols|tocotrienols|mesh-list
110713654|NCT00031486|Valacyclovir|valacyclovir|mesh-list
111343220|NCT01457690|alpha-Tocopherol|alpha-tocopherol|mesh-list
111343221|NCT01457690|Antioxidants|antioxidants|mesh-ancestor
111343222|NCT01457690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111343223|NCT01457690|Protective Agents|protective agents|mesh-ancestor
111343224|NCT01457690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111343225|NCT01457690|Vitamins|vitamins|mesh-ancestor
111343226|NCT01457690|Micronutrients|micronutrients|mesh-ancestor
111343227|NCT05497206|Metronidazole|metronidazole|mesh-list
111343228|NCT05497206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111343229|NCT05497206|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111343230|NCT05497206|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111343231|NCT05497206|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111343232|NCT01451060|Ephedrine|ephedrine|mesh-list
111343233|NCT01451060|Metaraminol|metaraminol|mesh-list
111343234|NCT01451060|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110713784|NCT00219141|Losartan|losartan|mesh-list
111343235|NCT01451060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111343236|NCT01451060|Sympathomimetics|sympathomimetics|mesh-ancestor
111343237|NCT01451060|Autonomic Agents|autonomic agents|mesh-ancestor
111343238|NCT01451060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111343239|NCT01451060|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111343240|NCT01451060|Adrenergic Agents|adrenergic agents|mesh-ancestor
111343241|NCT01451060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111343242|NCT01451060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111343243|NCT01451060|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111343244|NCT01451060|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111343245|NCT01451060|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111343246|NCT04904562|Angiotensin II|angiotensin ii|mesh-list
111343247|NCT04904562|Giapreza|giapreza|mesh-list
111343248|NCT04904562|Angiotensinogen|angiotensinogen|mesh-list
111343249|NCT04904562|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111343250|NCT04904562|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111343251|NCT04904562|Protease Inhibitors|protease inhibitors|mesh-ancestor
111343252|NCT04904562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111343253|NCT04904562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111343254|NCT01143181|Brincidofovir|brincidofovir|mesh-list
111343255|NCT01143181|Antiviral Agents|antiviral agents|mesh-ancestor
111343256|NCT01143181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111343257|NCT01451294|Phenylephrine|phenylephrine|mesh-list
111343258|NCT01451294|Oxymetazoline|oxymetazoline|mesh-list
111343259|NCT01451294|Ephedrine|ephedrine|mesh-list
111343260|NCT01451294|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111343261|NCT01451294|Mydriatics|mydriatics|mesh-ancestor
111343262|NCT01451294|Autonomic Agents|autonomic agents|mesh-ancestor
111343263|NCT01451294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111343264|NCT01451294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111343265|NCT01451294|Sympathomimetics|sympathomimetics|mesh-ancestor
111343266|NCT01451294|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111343267|NCT01451294|Nasal Decongestants|nasal decongestants|mesh-ancestor
111343268|NCT01451294|Respiratory System Agents|respiratory system agents|mesh-ancestor
111343269|NCT01451294|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111343270|NCT01451294|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111343271|NCT01451294|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111343272|NCT01451294|Adrenergic Agents|adrenergic agents|mesh-ancestor
111343273|NCT01451294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111343274|NCT01451294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111343275|NCT01451294|Protective Agents|protective agents|mesh-ancestor
111343276|NCT01451294|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111343277|NCT01187017|Cyclophosphamide|cyclophosphamide|mesh-list
111343279|NCT01187017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111343280|NCT01187017|Immunologic Factors|immunologic factors|mesh-ancestor
110714175|NCT00181844|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111343281|NCT01187017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111343282|NCT01187017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111343283|NCT01187017|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111343284|NCT01187017|Alkylating Agents|alkylating agents|mesh-ancestor
111343285|NCT01187017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111343286|NCT01187017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111343287|NCT01187017|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111343288|NCT00378118|Antibodies|antibodies|mesh-list
111343289|NCT00378118|Immunoglobulins|immunoglobulins|mesh-list
111343290|NCT00378118|HIV Antibodies|hiv antibodies|mesh-list
111343291|NCT00378118|Immunologic Factors|immunologic factors|mesh-ancestor
111343292|NCT00378118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111343293|NCT01224145|Bupivacaine|bupivacaine|mesh-list
111343294|NCT01224145|Anesthetics, Local|anesthetics, local|mesh-ancestor
111343295|NCT01224145|Anesthetics|anesthetics|mesh-ancestor
111343296|NCT01224145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110714321|NCT01103518|Ethinyl Estradiol|ethinyl estradiol|mesh-list
111343297|NCT01224145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111343298|NCT01224145|Sensory System Agents|sensory system agents|mesh-ancestor
111343299|NCT01224145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111343300|NCT01451840|Lidocaine|lidocaine|mesh-list
111343301|NCT01451840|Remifentanil|remifentanil|mesh-list
111343302|NCT01451840|Anesthetics, Local|anesthetics, local|mesh-ancestor
111343303|NCT01451840|Anesthetics|anesthetics|mesh-ancestor
111343304|NCT01451840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111343305|NCT01451840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111343306|NCT01451840|Sensory System Agents|sensory system agents|mesh-ancestor
111343307|NCT01451840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111343308|NCT01451840|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111343309|NCT01451840|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111343310|NCT01451840|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111343311|NCT01451840|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111343312|NCT01451840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111343313|NCT01451840|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111343314|NCT01451840|Narcotics|narcotics|mesh-ancestor
111343315|NCT01451840|Analgesics|analgesics|mesh-ancestor
111343316|NCT01451918|Resveratrol|resveratrol|mesh-list
111343317|NCT01451918|Antioxidants|antioxidants|mesh-ancestor
111343318|NCT01451918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111343319|NCT01451918|Protective Agents|protective agents|mesh-ancestor
111343320|NCT01451918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111343321|NCT01451918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111343322|NCT01451918|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111343323|NCT00378196|Ranibizumab|ranibizumab|mesh-list
111343324|NCT00378196|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111343325|NCT00378196|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111343326|NCT00378196|Growth Substances|growth substances|mesh-ancestor
111343327|NCT00378196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111343328|NCT00378196|Growth Inhibitors|growth inhibitors|mesh-ancestor
111343329|NCT00378196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111343330|NCT01188109|Gemcitabine|gemcitabine|mesh-list
111343331|NCT01188109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111343332|NCT01188109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111343333|NCT01188109|Antimetabolites|antimetabolites|mesh-ancestor
111343334|NCT01188109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111343335|NCT01458236|Beraprost|beraprost|mesh-list
110714504|NCT00072280|Mesna|mesna|mesh-list
111343336|NCT01458236|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111343337|NCT01458236|Vasodilator Agents|vasodilator agents|mesh-ancestor
111343338|NCT01146457|Morphine|morphine|mesh-list
111343339|NCT01146457|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111343340|NCT01146457|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111343341|NCT01146457|Narcotics|narcotics|mesh-ancestor
111343342|NCT01146457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111343343|NCT01146457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111343344|NCT01146457|Analgesics|analgesics|mesh-ancestor
111343345|NCT01146457|Sensory System Agents|sensory system agents|mesh-ancestor
111343346|NCT01146457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111343347|NCT05495958|Vitamin D|vitamin d|mesh-list
111343348|NCT05495958|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111343349|NCT05495958|Vitamins|vitamins|mesh-ancestor
111343350|NCT05495958|Micronutrients|micronutrients|mesh-ancestor
111343351|NCT05495958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111067770|NCT02322099|Antacids|antacids|mesh-ancestor
111343352|NCT05495958|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111343353|NCT05495958|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111343354|NCT04011592|Ketamine|ketamine|mesh-list
111343355|NCT04011592|Analgesics|analgesics|mesh-ancestor
111343356|NCT04011592|Sensory System Agents|sensory system agents|mesh-ancestor
111343357|NCT04011592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111343358|NCT04011592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111343359|NCT04011592|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111343360|NCT04011592|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111343361|NCT04011592|Anesthetics, General|anesthetics, general|mesh-ancestor
111343362|NCT04011592|Anesthetics|anesthetics|mesh-ancestor
111343363|NCT04011592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111343364|NCT04011592|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111343365|NCT04011592|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111343366|NCT04011592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111343367|NCT04011592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111343368|NCT01458470|Memantine|memantine|mesh-list
111343369|NCT01458470|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111343370|NCT01458470|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111343371|NCT01458470|Dopamine Agents|dopamine agents|mesh-ancestor
111343372|NCT01458470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111343373|NCT01458470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111343374|NCT01458470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111343375|NCT01458470|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111343376|NCT01458470|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111343377|NCT05025488|Poly ICLC|poly iclc|mesh-list
111343378|NCT05025488|Interferon Inducers|interferon inducers|mesh-ancestor
111343379|NCT05025488|Immunologic Factors|immunologic factors|mesh-ancestor
111343380|NCT05025488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111343381|NCT01452542|Eliglustat|eliglustat|mesh-list
111343382|NCT01452542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110714755|NCT01108042|Docetaxel|docetaxel|mesh-list
111343383|NCT01452542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111343384|NCT01458548|Rituximab|rituximab|mesh-list
111343385|NCT01458548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111343386|NCT01458548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111343387|NCT01458548|Immunologic Factors|immunologic factors|mesh-ancestor
111343388|NCT01458548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111343389|NCT01458548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111343390|NCT05027204|Docetaxel|docetaxel|mesh-list
111343391|NCT05027204|Nivolumab|nivolumab|mesh-list
111343392|NCT05027204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111343393|NCT05027204|Tubulin Modulators|tubulin modulators|mesh-ancestor
111343394|NCT05027204|Antimitotic Agents|antimitotic agents|mesh-ancestor
111343395|NCT05027204|Mitosis Modulators|mitosis modulators|mesh-ancestor
111343396|NCT05027204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111343397|NCT05027204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111343398|NCT05027204|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111343399|NCT01458626|Mirtazapine|mirtazapine|mesh-list
111343400|NCT01458626|Paroxetine|paroxetine|mesh-list
111343401|NCT01458626|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111343402|NCT01458626|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111343403|NCT01458626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111343404|NCT01458626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111343405|NCT01458626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111343406|NCT01458626|Serotonin Agents|serotonin agents|mesh-ancestor
111343407|NCT01458626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111343408|NCT01458626|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111343409|NCT01458626|Antidepressive Agents|antidepressive agents|mesh-ancestor
111343410|NCT01458626|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111343411|NCT01458626|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110715029|NCT01112644|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111343412|NCT01458626|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111343413|NCT01458626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111343414|NCT01458626|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111343415|NCT01458626|Histamine Antagonists|histamine antagonists|mesh-ancestor
111343416|NCT01458626|Histamine Agents|histamine agents|mesh-ancestor
111343417|NCT01458626|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111343418|NCT01458626|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111343419|NCT01458626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111343420|NCT01458626|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
111343421|NCT01458626|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111343422|NCT01458626|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111343423|NCT01458626|Adrenergic Agents|adrenergic agents|mesh-ancestor
110715098|NCT01112878|Gabapentin|gabapentin|mesh-list
111343424|NCT01458626|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111343425|NCT01458626|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111343426|NCT01458626|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111343427|NCT00377806|Diclofenac|diclofenac|mesh-list
111343428|NCT00377806|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111343429|NCT00377806|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111343430|NCT00377806|Analgesics|analgesics|mesh-ancestor
111343431|NCT00377806|Sensory System Agents|sensory system agents|mesh-ancestor
111343432|NCT00377806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111343433|NCT00377806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111343434|NCT00377806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111343435|NCT00377806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111343436|NCT00377806|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111343437|NCT00377806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111343438|NCT00377806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111343439|NCT05495724|Tislelizumab|tislelizumab|mesh-list
111343440|NCT05495724|Disitamab vedotin|disitamab vedotin|mesh-list
111343441|NCT05495724|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111343442|NCT05495724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111343443|NCT05495724|Immunoconjugates|immunoconjugates|mesh-ancestor
110715360|NCT01117636|Aspirin|aspirin|mesh-list
111343444|NCT05495724|Immunologic Factors|immunologic factors|mesh-ancestor
111343445|NCT05495724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111343446|NCT02559414|Aspirin|aspirin|mesh-list
111343447|NCT02559414|Clopidogrel|clopidogrel|mesh-list
111343448|NCT02559414|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111343449|NCT02559414|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111343450|NCT02559414|Analgesics|analgesics|mesh-ancestor
111343451|NCT02559414|Sensory System Agents|sensory system agents|mesh-ancestor
111343452|NCT02559414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111343453|NCT02559414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111343454|NCT02559414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111343455|NCT02559414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111343456|NCT02559414|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111343457|NCT02559414|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111343458|NCT02559414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111343459|NCT02559414|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111343460|NCT02559414|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111343461|NCT02559414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111343462|NCT02559414|Antipyretics|antipyretics|mesh-ancestor
111343463|NCT02559414|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111343464|NCT02559414|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111343465|NCT02559414|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111343466|NCT02559414|Purinergic Agents|purinergic agents|mesh-ancestor
111343467|NCT02559414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111343468|NCT03527264|Nivolumab|nivolumab|mesh-list
111343469|NCT03527264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111343470|NCT03527264|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111343471|NCT03527264|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111343472|NCT03527264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111343473|NCT04713904|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
111343474|NCT04713904|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
111343475|NCT04713904|Ethinyl Estradiol|ethinyl estradiol|mesh-list
111343476|NCT04713904|Estradiol|estradiol|mesh-list
111343477|NCT04713904|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
111343478|NCT04713904|Estrogens|estrogens|mesh-ancestor
111343479|NCT04713904|Hormones|hormones|mesh-ancestor
111343480|NCT04713904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111343481|NCT04713904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111343482|NCT04713904|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111343483|NCT04713904|Contraceptive Agents|contraceptive agents|mesh-ancestor
111343484|NCT04713904|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110715622|NCT01217086|Infliximab|infliximab|mesh-list
111343485|NCT04713904|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111343486|NCT04713904|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111343487|NCT04713904|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111343488|NCT03995680|Mebendazole|mebendazole|mesh-list
111343489|NCT03995680|Piperazine|piperazine|mesh-list
111343490|NCT03995680|Piperazine citrate|piperazine citrate|mesh-list
111343491|NCT03995680|DMP 777|dmp 777|mesh-list
111343492|NCT03995680|Antinematodal Agents|antinematodal agents|mesh-ancestor
111343493|NCT03995680|Anthelmintics|anthelmintics|mesh-ancestor
111343494|NCT03995680|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111343495|NCT03995680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111343496|NCT03995680|Tubulin Modulators|tubulin modulators|mesh-ancestor
111343497|NCT03995680|Antimitotic Agents|antimitotic agents|mesh-ancestor
111343498|NCT03995680|Mitosis Modulators|mitosis modulators|mesh-ancestor
111343499|NCT03995680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111067925|NCT03135795|Parecoxib|parecoxib|mesh-list
111343500|NCT03995680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111343501|NCT03995680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111343502|NCT01452698|Lansoprazole|lansoprazole|mesh-list
111343503|NCT01452698|Dexlansoprazole|dexlansoprazole|mesh-list
111343504|NCT01452698|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111343505|NCT01452698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111343506|NCT01452698|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111343507|NCT01452698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111343508|NCT01452698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111343509|NCT05029856|Vaccines|vaccines|mesh-list
111343510|NCT05029856|Immunologic Factors|immunologic factors|mesh-ancestor
111343511|NCT05029856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111343512|NCT05490342|Antibodies|antibodies|mesh-list
111343513|NCT05490342|Myeloma Proteins|myeloma proteins|mesh-list
111343514|NCT05490342|Paraproteins|paraproteins|mesh-list
111343515|NCT05490342|Immunologic Factors|immunologic factors|mesh-ancestor
111343516|NCT05490342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111343517|NCT05495100|Azacitidine|azacitidine|mesh-list
111343518|NCT05495100|Mitoxantrone|mitoxantrone|mesh-list
111343519|NCT05495100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111343520|NCT05495100|Antimetabolites|antimetabolites|mesh-ancestor
111343521|NCT05495100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111343522|NCT05495100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111343523|NCT05495100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111343524|NCT05495100|Analgesics|analgesics|mesh-ancestor
111343525|NCT05495100|Sensory System Agents|sensory system agents|mesh-ancestor
111343526|NCT05495100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111343527|NCT05495100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111343528|NCT05495100|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111343529|NCT05495100|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111343530|NCT03325114|Chlorthalidone|chlorthalidone|mesh-list
111343531|NCT03325114|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111343532|NCT03325114|Diuretics|diuretics|mesh-ancestor
111343533|NCT03325114|Natriuretic Agents|natriuretic agents|mesh-ancestor
111343534|NCT03325114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111343535|NCT03325114|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
111343536|NCT03325114|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111343537|NCT03325114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111343538|NCT01453400|Aspirin|aspirin|mesh-list
111343539|NCT01453400|Acetaminophen|acetaminophen|mesh-list
111343540|NCT01453400|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111343541|NCT01453400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111343542|NCT01453400|Analgesics|analgesics|mesh-ancestor
111343543|NCT01453400|Sensory System Agents|sensory system agents|mesh-ancestor
111343544|NCT01453400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111343545|NCT01453400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111343546|NCT01453400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111343547|NCT01453400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111343548|NCT01453400|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111343549|NCT01453400|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111343550|NCT01453400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111343551|NCT01453400|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111343552|NCT01453400|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111343553|NCT01453400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111343554|NCT01453400|Antipyretics|antipyretics|mesh-ancestor
111343555|NCT05025644|Dobutamine|dobutamine|mesh-list
111343556|NCT05025644|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111343557|NCT05025644|Sympathomimetics|sympathomimetics|mesh-ancestor
111343558|NCT05025644|Autonomic Agents|autonomic agents|mesh-ancestor
111343559|NCT05025644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111343560|NCT05025644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111343561|NCT05025644|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
111343562|NCT05025644|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111343563|NCT05025644|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111343564|NCT05025644|Adrenergic Agents|adrenergic agents|mesh-ancestor
111343565|NCT05025644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110716215|NCT00224120|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111343566|NCT05025644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111343567|NCT05025644|Protective Agents|protective agents|mesh-ancestor
111343568|NCT05494710|Bleomycin|bleomycin|mesh-list
111343569|NCT05494710|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111343570|NCT05494710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111343571|NCT03810066|Osimertinib|osimertinib|mesh-list
111343572|NCT03810066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110716322|NCT03967964|Hormones|hormones|mesh-ancestor
111343573|NCT03810066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111343574|NCT03810066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111067997|NCT03508817|Mydriatics|mydriatics|mesh-ancestor
111343575|NCT03810066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111343576|NCT03992482|Immunoglobulins|immunoglobulins|mesh-list
111343577|NCT03992482|Antibodies|antibodies|mesh-list
111343578|NCT03992482|gamma-Globulins|gamma-globulins|mesh-list
111343579|NCT03992482|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111343580|NCT03992482|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
111343581|NCT03992482|Immunologic Factors|immunologic factors|mesh-ancestor
111343582|NCT03992482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111343583|NCT00377494|Vaccines|vaccines|mesh-list
111343584|NCT00377494|Immunologic Factors|immunologic factors|mesh-ancestor
111343585|NCT00377494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111343586|NCT01459250|Agomelatine|agomelatine|mesh-list
111343587|NCT01459250|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111343588|NCT01459250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111343589|NCT01459250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111343590|NCT04303156|Islatravir|islatravir|mesh-list
111343591|NCT04303156|Antiviral Agents|antiviral agents|mesh-ancestor
111343592|NCT04303156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111343593|NCT04303156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111343594|NCT04303156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111343595|NCT04303156|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110716631|NCT01132768|Autonomic Agents|autonomic agents|mesh-ancestor
111343596|NCT04303156|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111343597|NCT04303156|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111343598|NCT04390334|Efavirenz|efavirenz|mesh-list
111343599|NCT04390334|Famotidine|famotidine|mesh-list
111343600|NCT04390334|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111343601|NCT04390334|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111343602|NCT04390334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111343603|NCT04390334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111343604|NCT04390334|Antiviral Agents|antiviral agents|mesh-ancestor
111343605|NCT04390334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111343606|NCT04390334|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111343607|NCT04390334|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111343608|NCT04390334|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110716780|NCT01134718|Simeprevir|simeprevir|mesh-list
111343609|NCT04390334|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111343610|NCT04390334|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111343611|NCT04390334|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111343612|NCT04390334|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110716842|NCT03769090|Glucocorticoids|glucocorticoids|mesh-ancestor
111343613|NCT04390334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111343614|NCT04390334|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
111343615|NCT04390334|Histamine Antagonists|histamine antagonists|mesh-ancestor
111343616|NCT04390334|Histamine Agents|histamine agents|mesh-ancestor
111343617|NCT04390334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111343618|NCT04390334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111343619|NCT02880020|Nivolumab|nivolumab|mesh-list
111343620|NCT02880020|Ipilimumab|ipilimumab|mesh-list
110716983|NCT01137994|Antimitotic Agents|antimitotic agents|mesh-ancestor
111343621|NCT02880020|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111343622|NCT02880020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111343623|NCT02880020|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111343624|NCT02880020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111343625|NCT03150160|Brimonidine Tartrate|brimonidine tartrate|mesh-list
111343626|NCT03150160|Travoprost|travoprost|mesh-list
111343627|NCT03150160|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111343628|NCT03150160|Brinzolamide|brinzolamide|mesh-list
111343629|NCT03150160|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111343630|NCT03150160|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111343631|NCT03150160|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111343632|NCT03150160|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111343633|NCT03150160|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111343634|NCT03150160|Adrenergic Agents|adrenergic agents|mesh-ancestor
111343635|NCT03150160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111343636|NCT03150160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111343637|NCT03150160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111343638|NCT03150160|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
111343639|NCT03150160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111343640|NCT01459406|Levan|levan|mesh-list
111343641|NCT01459406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111343642|NCT05489952|Iron|iron|mesh-list
111343643|NCT05489952|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
111343644|NCT05489952|Trace Elements|trace elements|mesh-ancestor
111343645|NCT05489952|Micronutrients|micronutrients|mesh-ancestor
111343646|NCT05489952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111343647|NCT05489952|Hematinics|hematinics|mesh-ancestor
111343648|NCT01459640|Hyaluronic Acid|hyaluronic acid|mesh-list
111343649|NCT01459640|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111343650|NCT01459640|Immunologic Factors|immunologic factors|mesh-ancestor
111343651|NCT01459640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111343652|NCT01459640|Viscosupplements|viscosupplements|mesh-ancestor
111343653|NCT01459640|Protective Agents|protective agents|mesh-ancestor
111343654|NCT04257396|Carbon Fiber|carbon fiber|mesh-list
111343655|NCT04257396|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111343656|NCT04257396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111343657|NCT01500772|Ribavirin|ribavirin|mesh-list
111343658|NCT01500772|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
111343659|NCT01500772|Antimetabolites|antimetabolites|mesh-ancestor
111343660|NCT01500772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111343661|NCT01500772|Antiviral Agents|antiviral agents|mesh-ancestor
111343662|NCT01500772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111343663|NCT04272476|Fluoxetine|fluoxetine|mesh-list
111343664|NCT04272476|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111343665|NCT04272476|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111343666|NCT04272476|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111343667|NCT04272476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111343668|NCT04272476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111343669|NCT04272476|Serotonin Agents|serotonin agents|mesh-ancestor
111343670|NCT04272476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111343671|NCT04272476|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111343672|NCT04272476|Antidepressive Agents|antidepressive agents|mesh-ancestor
111343673|NCT04272476|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111343674|NCT04272476|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111343675|NCT04272476|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111343676|NCT04272476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111343677|NCT03984838|Dolutegravir|dolutegravir|mesh-list
111343678|NCT03984838|Rilpivirine|rilpivirine|mesh-list
111343679|NCT03984838|Dolutegravir, rilpivirine drug combination|dolutegravir, rilpivirine drug combination|mesh-list
111343680|NCT03984838|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111343681|NCT03984838|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111343682|NCT03984838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111343683|NCT03984838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111343684|NCT03984838|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110717445|NCT00113373|Lapatinib|lapatinib|mesh-list
111343685|NCT03984838|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111343686|NCT03984838|Antiviral Agents|antiviral agents|mesh-ancestor
111343687|NCT03984838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111343688|NCT03984838|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111343689|NCT03984838|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111343690|NCT01890902|Ketoprofen|ketoprofen|mesh-list
111343691|NCT01890902|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111343692|NCT01890902|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111343693|NCT01890902|Analgesics|analgesics|mesh-ancestor
110717586|NCT01141894|Phenylephrine|phenylephrine|mesh-list
111343694|NCT01890902|Sensory System Agents|sensory system agents|mesh-ancestor
111343695|NCT01890902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111343696|NCT01890902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111343697|NCT01890902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111343698|NCT01890902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111343699|NCT01890902|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111343700|NCT01890902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111343701|NCT01890902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111343702|NCT04423926|Prednisolone|prednisolone|mesh-list
111343703|NCT04423926|Cyclophosphamide|cyclophosphamide|mesh-list
111343704|NCT04423926|Doxorubicin|doxorubicin|mesh-list
111343705|NCT04423926|Vincristine|vincristine|mesh-list
111343706|NCT04423926|Lenalidomide|lenalidomide|mesh-list
111343707|NCT04423926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111343708|NCT04423926|Immunologic Factors|immunologic factors|mesh-ancestor
111343709|NCT04423926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111343710|NCT04423926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111343711|NCT04423926|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111343712|NCT04423926|Alkylating Agents|alkylating agents|mesh-ancestor
111343713|NCT04423926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111343714|NCT04423926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111343715|NCT04423926|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111343716|NCT04423926|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111343717|NCT04423926|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111343718|NCT04423926|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111343719|NCT04423926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111343720|NCT04423926|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111343721|NCT04423926|Tubulin Modulators|tubulin modulators|mesh-ancestor
111343722|NCT04423926|Antimitotic Agents|antimitotic agents|mesh-ancestor
111068149|NCT02301221|Vancomycin|vancomycin|mesh-list
111343723|NCT04423926|Mitosis Modulators|mitosis modulators|mesh-ancestor
111343724|NCT04423926|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111343725|NCT04423926|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111343726|NCT04423926|Growth Substances|growth substances|mesh-ancestor
111343727|NCT04423926|Growth Inhibitors|growth inhibitors|mesh-ancestor
111343728|NCT04423926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111343730|NCT04423926|Hormones|hormones|mesh-ancestor
111343731|NCT04423926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111343732|NCT04423926|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111343733|NCT03979066|Atezolizumab|atezolizumab|mesh-list
111343734|NCT03979066|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111343735|NCT03979066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111343736|NCT03979066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111343737|NCT03979066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111343738|NCT03968848|Acalabrutinib|acalabrutinib|mesh-list
111343739|NCT03968848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111343740|NCT05489406|Dolutegravir|dolutegravir|mesh-list
111343741|NCT05489406|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111343742|NCT05489406|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111343743|NCT05489406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110718074|NCT03916432|Sirolimus|sirolimus|mesh-list
111343744|NCT05489406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111343745|NCT05489406|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111343746|NCT05489406|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111343747|NCT05489406|Antiviral Agents|antiviral agents|mesh-ancestor
111343748|NCT05489406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111343749|NCT01479010|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
111343750|NCT01479010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111343751|NCT01472692|Febuxostat|febuxostat|mesh-list
111343752|NCT01472692|Gout Suppressants|gout suppressants|mesh-ancestor
111343753|NCT01472692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111343754|NCT00378820|Caseins|caseins|mesh-list
111343755|NCT00378820|Chelating Agents|chelating agents|mesh-ancestor
111343756|NCT00378820|Sequestering Agents|sequestering agents|mesh-ancestor
111343757|NCT00378820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111343758|NCT02558400|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111343759|NCT02558400|Latanoprost|latanoprost|mesh-list
111343760|NCT02558400|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111343761|NCT04758260|Antioxidants|antioxidants|mesh-list
111343762|NCT04758260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111343763|NCT04758260|Protective Agents|protective agents|mesh-ancestor
111343764|NCT04758260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111343765|NCT01446250|Ribavirin|ribavirin|mesh-list
111343766|NCT01446250|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
111343767|NCT01446250|Antimetabolites|antimetabolites|mesh-ancestor
111343768|NCT01446250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111343769|NCT01446250|Antiviral Agents|antiviral agents|mesh-ancestor
111343770|NCT01446250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111343771|NCT05493618|Dexamethasone|dexamethasone|mesh-list
111343772|NCT05493618|Pembrolizumab|pembrolizumab|mesh-list
111343773|NCT05493618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111343774|NCT05493618|Antiemetics|antiemetics|mesh-ancestor
111343775|NCT05493618|Autonomic Agents|autonomic agents|mesh-ancestor
111343776|NCT05493618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111343777|NCT05493618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111343778|NCT05493618|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111343779|NCT05493618|Glucocorticoids|glucocorticoids|mesh-ancestor
111343780|NCT05493618|Hormones|hormones|mesh-ancestor
111343781|NCT05493618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111343782|NCT05493618|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111343783|NCT05493618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111343784|NCT05493618|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111343785|NCT05493618|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111343786|NCT05493618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111343787|NCT00379600|Rosiglitazone|rosiglitazone|mesh-list
111343788|NCT00379600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111343789|NCT00379600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111343790|NCT05020574|Cephalexin|cephalexin|mesh-list
111343791|NCT05020574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110718780|NCT03894280|Hormones|hormones|mesh-ancestor
111343792|NCT05020574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111343793|NCT02936206|Tamoxifen|tamoxifen|mesh-list
111343794|NCT02936206|Fulvestrant|fulvestrant|mesh-list
111343795|NCT02936206|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111343796|NCT02936206|Hormone Antagonists|hormone antagonists|mesh-ancestor
111343797|NCT02936206|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110718836|NCT03899038|Anesthetics|anesthetics|mesh-list
111343798|NCT02936206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111343799|NCT02936206|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111343800|NCT02936206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111343801|NCT02936206|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111343802|NCT02936206|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111343803|NCT02936206|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111343804|NCT02936206|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
111343806|NCT01891526|Alitretinoin|alitretinoin|mesh-list
111343807|NCT01891526|Isotretinoin|isotretinoin|mesh-list
111343808|NCT01891526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111343809|NCT01891526|Keratolytic Agents|keratolytic agents|mesh-ancestor
111343810|NCT01891526|Dermatologic Agents|dermatologic agents|mesh-ancestor
111343811|NCT01406860|Diphenhydramine|diphenhydramine|mesh-list
111343812|NCT01406860|Promethazine|promethazine|mesh-list
111343813|NCT01406860|Droperidol|droperidol|mesh-list
111343814|NCT01406860|Metoclopramide|metoclopramide|mesh-list
111343815|NCT01406860|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110719054|NCT00186186|Valproic Acid|valproic acid|mesh-list
111343816|NCT01406860|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111343817|NCT01406860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111343818|NCT01406860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111343819|NCT01406860|Anesthetics, Local|anesthetics, local|mesh-ancestor
111343820|NCT01406860|Anesthetics|anesthetics|mesh-ancestor
111343821|NCT01406860|Sensory System Agents|sensory system agents|mesh-ancestor
110719116|NCT01260610|Antiviral Agents|antiviral agents|mesh-ancestor
111343822|NCT01406860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111343823|NCT01406860|Antiemetics|antiemetics|mesh-ancestor
111343824|NCT01406860|Autonomic Agents|autonomic agents|mesh-ancestor
111343825|NCT01406860|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111343826|NCT01406860|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111343827|NCT01406860|Histamine Antagonists|histamine antagonists|mesh-ancestor
111343828|NCT01406860|Histamine Agents|histamine agents|mesh-ancestor
111343829|NCT01406860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110719257|NCT01586494|Narcotics|narcotics|mesh-ancestor
111343830|NCT01406860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111343831|NCT01406860|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111343832|NCT01406860|Antipruritics|antipruritics|mesh-ancestor
111343833|NCT01406860|Dermatologic Agents|dermatologic agents|mesh-ancestor
111343834|NCT01406860|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111343835|NCT01406860|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111343836|NCT01406860|Dopamine Agents|dopamine agents|mesh-ancestor
111343837|NCT01406860|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111343838|NCT01406860|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111343839|NCT01406860|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111343840|NCT01406860|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111343841|NCT04138212|Paclitaxel|paclitaxel|mesh-list
111343842|NCT04138212|Cisplatin|cisplatin|mesh-list
111343843|NCT04138212|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111343844|NCT04138212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111343845|NCT04138212|Tubulin Modulators|tubulin modulators|mesh-ancestor
111343846|NCT04138212|Antimitotic Agents|antimitotic agents|mesh-ancestor
111343847|NCT04138212|Mitosis Modulators|mitosis modulators|mesh-ancestor
111343848|NCT04138212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111343849|NCT02773576|Risperidone|risperidone|mesh-list
111343850|NCT02773576|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111343851|NCT02773576|Serotonin Agents|serotonin agents|mesh-ancestor
111343852|NCT02773576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111343853|NCT02773576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111343854|NCT02773576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110719541|NCT00224484|Vaccines|vaccines|mesh-list
111343855|NCT02773576|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111343856|NCT02773576|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111343857|NCT02773576|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111343858|NCT02773576|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111343859|NCT02773576|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111343860|NCT02773576|Dopamine Agents|dopamine agents|mesh-ancestor
111343861|NCT05022758|Warfarin|warfarin|mesh-list
111343862|NCT05022758|Rivaroxaban|rivaroxaban|mesh-list
111343863|NCT05022758|Anticoagulants|anticoagulants|mesh-ancestor
111343864|NCT05022758|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111343865|NCT05022758|Antithrombins|antithrombins|mesh-ancestor
111343866|NCT05022758|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111343867|NCT05022758|Protease Inhibitors|protease inhibitors|mesh-ancestor
111343868|NCT05022758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111343869|NCT05022758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111343870|NCT05021978|Pramoxine|pramoxine|mesh-list
111343871|NCT05021978|Anesthetics, Local|anesthetics, local|mesh-ancestor
111343872|NCT05021978|Anesthetics|anesthetics|mesh-ancestor
111343873|NCT05021978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111343874|NCT05021978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111343876|NCT05021978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111343877|NCT04280406|Azithromycin|azithromycin|mesh-list
111343878|NCT04280406|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111343879|NCT04280406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111343880|NCT05599828|Sotorasib|sotorasib|mesh-list
111343881|NCT05599828|Omeprazole|omeprazole|mesh-list
111343882|NCT05599828|Famotidine|famotidine|mesh-list
111343883|NCT05599828|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111343884|NCT05599828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111343885|NCT05599828|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111343886|NCT05599828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111343887|NCT05599828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111343888|NCT05599828|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
111343889|NCT05599828|Histamine Antagonists|histamine antagonists|mesh-ancestor
111343890|NCT05599828|Histamine Agents|histamine agents|mesh-ancestor
111343891|NCT05599828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111343892|NCT05599828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111343893|NCT05599828|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111343894|NCT05599828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111343895|NCT05599828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111343896|NCT01350232|Cytarabine|cytarabine|mesh-list
111343897|NCT01350232|Cyclophosphamide|cyclophosphamide|mesh-list
111343898|NCT01350232|Rituximab|rituximab|mesh-list
111343899|NCT01350232|Fludarabine|fludarabine|mesh-list
111343900|NCT01350232|Bortezomib|bortezomib|mesh-list
111343901|NCT01350232|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111343902|NCT01350232|Immunologic Factors|immunologic factors|mesh-ancestor
111343903|NCT01350232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111343904|NCT01350232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111343905|NCT01350232|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111343906|NCT01350232|Alkylating Agents|alkylating agents|mesh-ancestor
111343907|NCT01350232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111343908|NCT01350232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111343909|NCT01350232|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111343910|NCT01350232|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111343911|NCT01350232|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111343912|NCT01350232|Antimetabolites|antimetabolites|mesh-ancestor
111343913|NCT01350232|Antiviral Agents|antiviral agents|mesh-ancestor
111343914|NCT01350232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111343915|NCT05493228|Dexmedetomidine|dexmedetomidine|mesh-list
111343916|NCT05493228|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111343917|NCT05493228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111343918|NCT05493228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110719945|NCT03871972|Sirolimus|sirolimus|mesh-list
111343919|NCT05493228|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111343920|NCT05493228|Analgesics|analgesics|mesh-ancestor
111343921|NCT05493228|Sensory System Agents|sensory system agents|mesh-ancestor
111343922|NCT05493228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111343923|NCT05493228|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111343924|NCT05493228|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111343925|NCT05493228|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111343926|NCT05493228|Adrenergic Agents|adrenergic agents|mesh-ancestor
111343927|NCT05493228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111343928|NCT05493228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111343929|NCT02758132|Denosumab|denosumab|mesh-list
111343930|NCT02758132|Prednisone|prednisone|mesh-list
111343931|NCT02758132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111343932|NCT02758132|Glucocorticoids|glucocorticoids|mesh-ancestor
111343933|NCT02758132|Hormones|hormones|mesh-ancestor
111343934|NCT02758132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111343935|NCT02758132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111343936|NCT02758132|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111343937|NCT02758132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111343938|NCT02758132|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111343939|NCT01891916|Caseins|caseins|mesh-list
111343940|NCT01891916|Chelating Agents|chelating agents|mesh-ancestor
111343941|NCT01891916|Sequestering Agents|sequestering agents|mesh-ancestor
111343942|NCT01891916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111343943|NCT01313416|Gemcitabine|gemcitabine|mesh-list
111343944|NCT01313416|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111343945|NCT01313416|Antimetabolites|antimetabolites|mesh-ancestor
111343946|NCT01313416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111343947|NCT01313416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111343948|NCT05599360|Gemtuzumab|gemtuzumab|mesh-list
111068369|NCT02311439|Folfirinox|folfirinox|mesh-list
111343949|NCT05599360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111343950|NCT05599360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111343951|NCT05599360|Immunotoxins|immunotoxins|mesh-ancestor
111343952|NCT05599360|Immunoconjugates|immunoconjugates|mesh-ancestor
111343953|NCT05599360|Immunologic Factors|immunologic factors|mesh-ancestor
111343954|NCT05599360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111343955|NCT05499234|Acetaminophen|acetaminophen|mesh-list
111343957|NCT05499234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111343958|NCT05499234|Analgesics|analgesics|mesh-ancestor
111343959|NCT05499234|Sensory System Agents|sensory system agents|mesh-ancestor
111343960|NCT05499234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111343961|NCT05499234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111343962|NCT05499234|Antipyretics|antipyretics|mesh-ancestor
111343963|NCT05499234|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111343964|NCT05499234|Narcotics|narcotics|mesh-ancestor
111343965|NCT05499234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111343966|NCT05499234|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111343967|NCT01269034|Insulin|insulin|mesh-list
111343968|NCT01269034|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111343969|NCT01269034|Exenatide|exenatide|mesh-list
111343970|NCT01269034|Insulin Glargine|insulin glargine|mesh-list
111343971|NCT01269034|Insulin Detemir|insulin detemir|mesh-list
111343972|NCT01269034|Insulin, Long-Acting|insulin, long-acting|mesh-list
111343973|NCT01269034|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111343974|NCT01269034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111343975|NCT01269034|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111343976|NCT01269034|Incretins|incretins|mesh-ancestor
111343977|NCT01269034|Hormones|hormones|mesh-ancestor
111343978|NCT01269034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111343979|NCT05599126|Lorazepam|lorazepam|mesh-list
111343980|NCT05599126|Mianserin|mianserin|mesh-list
111343981|NCT05599126|Anticonvulsants|anticonvulsants|mesh-ancestor
111343982|NCT05599126|Antiemetics|antiemetics|mesh-ancestor
111343983|NCT05599126|Autonomic Agents|autonomic agents|mesh-ancestor
111343984|NCT05599126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111343985|NCT05599126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111343986|NCT05599126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111343987|NCT05599126|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111343988|NCT05599126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111343989|NCT05599126|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111343990|NCT05599126|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111343991|NCT05599126|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111343992|NCT05599126|GABA Modulators|gaba modulators|mesh-ancestor
111343993|NCT05599126|GABA Agents|gaba agents|mesh-ancestor
111343994|NCT05599126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111343995|NCT05599126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111343996|NCT05599126|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111343997|NCT05599126|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111343998|NCT05599126|Adrenergic Agents|adrenergic agents|mesh-ancestor
111343999|NCT05599126|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111344000|NCT05599126|Histamine Antagonists|histamine antagonists|mesh-ancestor
110720347|NCT01168804|Bortezomib|bortezomib|mesh-list
111344001|NCT05599126|Histamine Agents|histamine agents|mesh-ancestor
111344002|NCT05599126|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111344003|NCT05599126|Serotonin Agents|serotonin agents|mesh-ancestor
111344004|NCT05599126|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111344005|NCT05599126|Antidepressive Agents|antidepressive agents|mesh-ancestor
111344006|NCT01892150|Sunscreening Agents|sunscreening agents|mesh-list
111344007|NCT01892150|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111344008|NCT01892150|Protective Agents|protective agents|mesh-ancestor
111344009|NCT01892150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111344010|NCT01892150|Dermatologic Agents|dermatologic agents|mesh-ancestor
111344011|NCT02663752|Deferasirox|deferasirox|mesh-list
111344012|NCT02663752|Iron Chelating Agents|iron chelating agents|mesh-ancestor
111344013|NCT02663752|Chelating Agents|chelating agents|mesh-ancestor
111344014|NCT02663752|Sequestering Agents|sequestering agents|mesh-ancestor
111344015|NCT02663752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111344016|NCT01253668|Antibodies|antibodies|mesh-list
111344017|NCT01253668|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111344018|NCT01253668|Immunologic Factors|immunologic factors|mesh-ancestor
111344019|NCT01253668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111344020|NCT01890200|Ribavirin|ribavirin|mesh-list
111344021|NCT01890200|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
111344022|NCT01890200|Antimetabolites|antimetabolites|mesh-ancestor
111344023|NCT01890200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111344024|NCT01890200|Antiviral Agents|antiviral agents|mesh-ancestor
111344025|NCT01890200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111344026|NCT01662648|Paliperidone Palmitate|paliperidone palmitate|mesh-list
111344028|NCT01662648|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111344029|NCT01662648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110720492|NCT01170130|Lidocaine|lidocaine|mesh-list
111344030|NCT01662648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111344031|NCT01662648|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111344032|NCT01662648|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111344033|NCT01662648|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111344034|NCT01662648|Serotonin Agents|serotonin agents|mesh-ancestor
111344035|NCT01662648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111344036|NCT01662648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111344037|NCT01662648|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111344038|NCT01662648|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111344039|NCT01662648|Dopamine Agents|dopamine agents|mesh-ancestor
111344040|NCT05586620|Mitomycins|mitomycins|mesh-list
111344041|NCT05586620|Mitomycin|mitomycin|mesh-list
110720636|NCT03868306|Chrysarobin|chrysarobin|mesh-list
111344042|NCT05586620|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111344043|NCT05586620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111344044|NCT05586620|Alkylating Agents|alkylating agents|mesh-ancestor
111344045|NCT05586620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111344046|NCT05586620|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111344047|NCT05586620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111344048|NCT01893788|Eplerenone|eplerenone|mesh-list
111344049|NCT01893788|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
111344050|NCT01893788|Hormone Antagonists|hormone antagonists|mesh-ancestor
111344051|NCT01893788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111344052|NCT01893788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111344053|NCT01893788|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
111344054|NCT01893788|Diuretics|diuretics|mesh-ancestor
111344055|NCT01893788|Natriuretic Agents|natriuretic agents|mesh-ancestor
111344056|NCT01893788|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111344057|NCT01231750|Capsaicin|capsaicin|mesh-list
111344058|NCT01231750|Antipruritics|antipruritics|mesh-ancestor
111344059|NCT01231750|Dermatologic Agents|dermatologic agents|mesh-ancestor
111344060|NCT01231750|Sensory System Agents|sensory system agents|mesh-ancestor
111344061|NCT01231750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111344062|NCT01231750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111344063|NCT05488860|Triamcinolone|triamcinolone|mesh-list
111344064|NCT05488860|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
111344065|NCT05488860|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
111344066|NCT05488860|Aminolevulinic Acid|aminolevulinic acid|mesh-list
111344067|NCT05488860|Photosensitizing Agents|photosensitizing agents|mesh-list
111344068|NCT05488860|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
111344069|NCT05488860|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111344070|NCT05488860|Glucocorticoids|glucocorticoids|mesh-ancestor
111344071|NCT05488860|Hormones|hormones|mesh-ancestor
111344072|NCT05488860|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111344073|NCT05488860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111344074|NCT05488860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111344075|NCT05488860|Immunologic Factors|immunologic factors|mesh-ancestor
111344076|NCT05488860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111344077|NCT05488860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111344078|NCT05488860|Dermatologic Agents|dermatologic agents|mesh-ancestor
111344079|NCT02549716|Acetaminophen|acetaminophen|mesh-list
111344080|NCT02549716|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111344081|NCT02549716|Analgesics|analgesics|mesh-ancestor
111344082|NCT02549716|Sensory System Agents|sensory system agents|mesh-ancestor
111344083|NCT02549716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111344084|NCT02549716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111344085|NCT02549716|Antipyretics|antipyretics|mesh-ancestor
111344086|NCT01207726|Azacitidine|azacitidine|mesh-list
111344087|NCT01207726|Entinostat|entinostat|mesh-list
111344088|NCT01207726|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
111344089|NCT01207726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111344090|NCT01207726|Antimetabolites|antimetabolites|mesh-ancestor
111344091|NCT01207726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111344092|NCT01207726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111344093|NCT01207726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111344094|NCT02534038|Quinidine|quinidine|mesh-list
111344095|NCT02534038|Dextromethorphan|dextromethorphan|mesh-list
111344096|NCT02534038|Antitussive Agents|antitussive agents|mesh-ancestor
111344097|NCT02534038|Respiratory System Agents|respiratory system agents|mesh-ancestor
110720958|NCT01177852|Sympathomimetics|sympathomimetics|mesh-ancestor
111344098|NCT02534038|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111344099|NCT02534038|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111344100|NCT02534038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111344101|NCT02534038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111344102|NCT02534038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111344103|NCT02534038|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111344104|NCT02534038|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111344105|NCT02534038|Adrenergic Agents|adrenergic agents|mesh-ancestor
111344106|NCT02534038|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111344107|NCT02534038|Antimalarials|antimalarials|mesh-ancestor
111344108|NCT02534038|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111344109|NCT02534038|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111344110|NCT02534038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111344111|NCT02534038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111344112|NCT02534038|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111344113|NCT02534038|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111344114|NCT02534038|Cholinergic Agents|cholinergic agents|mesh-ancestor
111344115|NCT02534038|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111344116|NCT02534038|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111344117|NCT02534038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111344118|NCT02534038|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111344119|NCT02534038|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111344120|NCT01202110|Propranolol|propranolol|mesh-list
111344121|NCT01202110|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111344122|NCT01202110|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111344123|NCT01202110|Adrenergic Agents|adrenergic agents|mesh-ancestor
111344124|NCT01202110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111344125|NCT01202110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111344126|NCT01202110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111344127|NCT01202110|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111344128|NCT01202110|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111344129|NCT01202110|Vasodilator Agents|vasodilator agents|mesh-ancestor
111344130|NCT02556918|Insulin|insulin|mesh-list
111344131|NCT02556918|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111344132|NCT02556918|Insulin Glargine|insulin glargine|mesh-list
111344133|NCT02556918|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111344134|NCT02556918|Insulin Aspart|insulin aspart|mesh-list
111344135|NCT02556918|Insulin Lispro|insulin lispro|mesh-list
111344136|NCT02556918|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111344137|NCT02556918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111344138|NCT02556918|Incretins|incretins|mesh-ancestor
111344139|NCT02556918|Hormones|hormones|mesh-ancestor
111344140|NCT02556918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111344141|NCT02556918|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111344142|NCT02556918|Protease Inhibitors|protease inhibitors|mesh-ancestor
111344143|NCT02556918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111344144|NCT02556918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111344145|NCT00379756|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
111344146|NCT00379756|Vasodilator Agents|vasodilator agents|mesh-ancestor
111344147|NCT00379756|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111344148|NCT00379756|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111344149|NCT00379756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111344150|NCT00379756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111344151|NCT00379756|Urological Agents|urological agents|mesh-ancestor
111344152|NCT02518750|Cytarabine|cytarabine|mesh-list
111344153|NCT02518750|Dexamethasone|dexamethasone|mesh-list
111344154|NCT02518750|Hydrocortisone|hydrocortisone|mesh-list
111344155|NCT02518750|Cyclophosphamide|cyclophosphamide|mesh-list
111344156|NCT02518750|Methotrexate|methotrexate|mesh-list
111344157|NCT02518750|Etoposide|etoposide|mesh-list
111344158|NCT02518750|Vincristine|vincristine|mesh-list
111344159|NCT02518750|Bortezomib|bortezomib|mesh-list
111344160|NCT02518750|Asparaginase|asparaginase|mesh-list
111344161|NCT02518750|Mitoxantrone|mitoxantrone|mesh-list
111344162|NCT02518750|Mercaptopurine|mercaptopurine|mesh-list
111344163|NCT02518750|Clofarabine|clofarabine|mesh-list
111344164|NCT02518750|Panobinostat|panobinostat|mesh-list
111344165|NCT02518750|Pegaspargase|pegaspargase|mesh-list
111344166|NCT02518750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111344167|NCT02518750|Immunologic Factors|immunologic factors|mesh-ancestor
111344168|NCT02518750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111344169|NCT02518750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111344170|NCT02518750|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111344171|NCT02518750|Alkylating Agents|alkylating agents|mesh-ancestor
111344172|NCT02518750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111344173|NCT02518750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111344174|NCT02518750|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111344175|NCT02518750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111344176|NCT02518750|Antiemetics|antiemetics|mesh-ancestor
111344177|NCT02518750|Autonomic Agents|autonomic agents|mesh-ancestor
111344178|NCT02518750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111344180|NCT02518750|Glucocorticoids|glucocorticoids|mesh-ancestor
111344181|NCT02518750|Hormones|hormones|mesh-ancestor
110721645|NCT03861598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111344182|NCT02518750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111344183|NCT02518750|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111344184|NCT02518750|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111344185|NCT02518750|Abortifacient Agents|abortifacient agents|mesh-ancestor
111344186|NCT02518750|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111344187|NCT02518750|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111344188|NCT02518750|Antimetabolites|antimetabolites|mesh-ancestor
111344189|NCT02518750|Dermatologic Agents|dermatologic agents|mesh-ancestor
111344190|NCT02518750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111344191|NCT02518750|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111344192|NCT02518750|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111344193|NCT02518750|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111344194|NCT02518750|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111344195|NCT02518750|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111344196|NCT02518750|Antiviral Agents|antiviral agents|mesh-ancestor
111344197|NCT02518750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111344198|NCT02518750|Tubulin Modulators|tubulin modulators|mesh-ancestor
111344199|NCT02518750|Antimitotic Agents|antimitotic agents|mesh-ancestor
111344200|NCT02518750|Mitosis Modulators|mitosis modulators|mesh-ancestor
111344201|NCT02518750|Analgesics|analgesics|mesh-ancestor
111344202|NCT02518750|Sensory System Agents|sensory system agents|mesh-ancestor
111344203|NCT02518750|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111344204|NCT01194856|Ritonavir|ritonavir|mesh-list
111344205|NCT01194856|Atazanavir Sulfate|atazanavir sulfate|mesh-list
111344206|NCT01194856|Efavirenz|efavirenz|mesh-list
111344207|NCT01194856|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111344208|NCT01194856|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111344209|NCT01194856|Protease Inhibitors|protease inhibitors|mesh-ancestor
111344210|NCT01194856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111344211|NCT01194856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111344212|NCT01194856|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111344213|NCT01194856|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111344214|NCT01194856|Antiviral Agents|antiviral agents|mesh-ancestor
111344215|NCT01194856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111344216|NCT01194856|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111344217|NCT01194856|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111344218|NCT01194856|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111344219|NCT01194856|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111344220|NCT01194856|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111344221|NCT01194856|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111344222|NCT01194856|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111344223|NCT01194856|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111344224|NCT01194856|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111344225|NCT01182610|Paclitaxel|paclitaxel|mesh-list
111344226|NCT01182610|Carboplatin|carboplatin|mesh-list
111344227|NCT01182610|Fluorouracil|fluorouracil|mesh-list
111344228|NCT01182610|Panitumumab|panitumumab|mesh-list
111344229|NCT01182610|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111344230|NCT01182610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111344231|NCT01182610|Tubulin Modulators|tubulin modulators|mesh-ancestor
111344232|NCT01182610|Antimitotic Agents|antimitotic agents|mesh-ancestor
111344233|NCT01182610|Mitosis Modulators|mitosis modulators|mesh-ancestor
111344234|NCT01182610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111344235|NCT01182610|Antimetabolites|antimetabolites|mesh-ancestor
111344236|NCT01182610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111344237|NCT01182610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111344238|NCT01182610|Immunologic Factors|immunologic factors|mesh-ancestor
111344239|NCT01182610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111344240|NCT01182610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111344241|NCT05491902|Flutemetamol|flutemetamol|mesh-list
111344242|NCT05491902|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111344243|NCT05491902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111344244|NCT05485896|Pembrolizumab|pembrolizumab|mesh-list
111344245|NCT05485896|Lenvatinib|lenvatinib|mesh-list
111344246|NCT05485896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111344247|NCT05485896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111344248|NCT05485896|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111344249|NCT05485896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111068665|NCT05094375|Misoprostol|misoprostol|mesh-list
111344250|NCT05485896|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111344251|NCT05485896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111344253|NCT05507398|Atorvastatin|atorvastatin|mesh-list
111344254|NCT05507398|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111344255|NCT05507398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111344256|NCT05507398|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111344257|NCT05507398|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111344258|NCT05507398|Antimetabolites|antimetabolites|mesh-ancestor
111344259|NCT05507398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111344260|NCT05507398|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111344261|NCT05507398|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111344262|NCT05507398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111344263|NCT05487300|Levodopa|levodopa|mesh-list
111344264|NCT05487300|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111344265|NCT05487300|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111344266|NCT05487300|Dopamine Agents|dopamine agents|mesh-ancestor
111344267|NCT05487300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111344268|NCT05487300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111344269|NCT05487300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111344270|NCT01147042|Interferons|interferons|mesh-list
111344271|NCT01147042|Interferon-gamma|interferon-gamma|mesh-list
111344272|NCT01147042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111344273|NCT01147042|Antiviral Agents|antiviral agents|mesh-ancestor
111344274|NCT01147042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111344275|NCT05485272|Fluorides|fluorides|mesh-list
111344276|NCT05485272|Cariostatic Agents|cariostatic agents|mesh-ancestor
111344277|NCT05485272|Protective Agents|protective agents|mesh-ancestor
111344278|NCT05485272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111344279|NCT01108666|Nelfinavir|nelfinavir|mesh-list
111344280|NCT01108666|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111344281|NCT01108666|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111344282|NCT01108666|Protease Inhibitors|protease inhibitors|mesh-ancestor
111344283|NCT01108666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111344284|NCT01108666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111344285|NCT01108666|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111344286|NCT01108666|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111344287|NCT01108666|Antiviral Agents|antiviral agents|mesh-ancestor
111344288|NCT01108666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111344289|NCT02317276|Triamcinolone|triamcinolone|mesh-list
111344290|NCT02317276|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
111344291|NCT02317276|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
111344292|NCT02317276|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
111344293|NCT02317276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111344294|NCT02317276|Glucocorticoids|glucocorticoids|mesh-ancestor
111344295|NCT02317276|Hormones|hormones|mesh-ancestor
110722275|NCT01295086|Antimetabolites|antimetabolites|mesh-ancestor
111344296|NCT02317276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111344297|NCT02317276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111344298|NCT02317276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111344299|NCT02317276|Immunologic Factors|immunologic factors|mesh-ancestor
111344300|NCT02317276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111344301|NCT02317276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111344302|NCT01662492|Botulinum Toxins|botulinum toxins|mesh-list
111344303|NCT01662492|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111344304|NCT01662492|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110722413|NCT01192984|Mogamulizumab|mogamulizumab|mesh-list
111344305|NCT01662492|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111344306|NCT01662492|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111344307|NCT01662492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111344308|NCT01662492|Cholinergic Agents|cholinergic agents|mesh-ancestor
111344309|NCT01662492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111344310|NCT01662492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111344311|NCT01662492|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111344312|NCT01662492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111344313|NCT00378976|Valacyclovir|valacyclovir|mesh-list
111344314|NCT00378976|Antiviral Agents|antiviral agents|mesh-ancestor
111344315|NCT00378976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111344316|NCT05342974|Misoprostol|misoprostol|mesh-list
111344317|NCT05342974|Atorvastatin|atorvastatin|mesh-list
111344318|NCT05342974|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111344319|NCT05342974|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111344320|NCT05342974|Antimetabolites|antimetabolites|mesh-ancestor
110722550|NCT01588522|Calcitriol|calcitriol|mesh-list
111344321|NCT05342974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111344322|NCT05342974|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111344323|NCT05342974|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111344324|NCT05342974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111344325|NCT05342974|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111344326|NCT05342974|Abortifacient Agents|abortifacient agents|mesh-ancestor
111344327|NCT05342974|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111344328|NCT05342974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111344329|NCT05342974|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111344330|NCT05342974|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111344332|NCT02297230|Paclitaxel|paclitaxel|mesh-list
111344333|NCT02297230|Capecitabine|capecitabine|mesh-list
111344334|NCT02297230|Trastuzumab|trastuzumab|mesh-list
111344335|NCT02297230|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111344336|NCT02297230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111344337|NCT02297230|Tubulin Modulators|tubulin modulators|mesh-ancestor
111344338|NCT02297230|Antimitotic Agents|antimitotic agents|mesh-ancestor
111344339|NCT02297230|Mitosis Modulators|mitosis modulators|mesh-ancestor
111344340|NCT02297230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111344341|NCT02297230|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111344342|NCT02297230|Antimetabolites|antimetabolites|mesh-ancestor
111344343|NCT02297230|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111344344|NCT02282332|Ticagrelor|ticagrelor|mesh-list
111344345|NCT02282332|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111344346|NCT02282332|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111344347|NCT02282332|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111344348|NCT02282332|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111344349|NCT02282332|Purinergic Agents|purinergic agents|mesh-ancestor
111344350|NCT02282332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111344351|NCT02282332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111344352|NCT02282332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111344353|NCT02287636|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
111344354|NCT02287636|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111344355|NCT02287636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111344356|NCT05486988|Antineoplastic Agents|antineoplastic agents|mesh-list
111344357|NCT02253394|Ambrisentan|ambrisentan|mesh-list
111344358|NCT02253394|Spironolactone|spironolactone|mesh-list
111344359|NCT02253394|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
111344360|NCT02253394|Hormone Antagonists|hormone antagonists|mesh-ancestor
111344361|NCT02253394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111344362|NCT02253394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111344363|NCT02253394|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
111344364|NCT02253394|Diuretics|diuretics|mesh-ancestor
111344365|NCT02253394|Natriuretic Agents|natriuretic agents|mesh-ancestor
111344366|NCT02253394|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111344367|NCT05479032|Amantadine|amantadine|mesh-list
111344368|NCT05479032|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110722799|NCT05084248|Vitamin D|vitamin d|mesh-list
111344369|NCT05479032|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111344370|NCT05479032|Antiviral Agents|antiviral agents|mesh-ancestor
111344371|NCT05479032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111344372|NCT05479032|Dopamine Agents|dopamine agents|mesh-ancestor
111344373|NCT05479032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111344374|NCT05479032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111344375|NCT05479032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111344376|NCT05479032|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111344377|NCT05479032|Analgesics|analgesics|mesh-ancestor
111344378|NCT05479032|Sensory System Agents|sensory system agents|mesh-ancestor
111344379|NCT05479032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111344380|NCT02236546|Deoxyglucose|deoxyglucose|mesh-list
111344381|NCT02236546|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
111344382|NCT02236546|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111344383|NCT02236546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111344384|NCT02236546|Antimetabolites|antimetabolites|mesh-ancestor
111344385|NCT02236546|Antiviral Agents|antiviral agents|mesh-ancestor
111344386|NCT02236546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111344387|NCT05484648|Dexamethasone|dexamethasone|mesh-list
111344388|NCT05484648|Dexmedetomidine|dexmedetomidine|mesh-list
110723009|NCT02428270|Trametinib|trametinib|mesh-list
111344389|NCT05484648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111344390|NCT05484648|Antiemetics|antiemetics|mesh-ancestor
111344391|NCT05484648|Autonomic Agents|autonomic agents|mesh-ancestor
111344392|NCT05484648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111344393|NCT05484648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111344394|NCT05484648|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111344395|NCT05484648|Glucocorticoids|glucocorticoids|mesh-ancestor
111344396|NCT05484648|Hormones|hormones|mesh-ancestor
111344397|NCT05484648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111344398|NCT05484648|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111344399|NCT05484648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111344400|NCT05484648|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111344401|NCT05484648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111344402|NCT05484648|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111344404|NCT05484648|Sensory System Agents|sensory system agents|mesh-ancestor
111344405|NCT05484648|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111344406|NCT05484648|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111344407|NCT05484648|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111344408|NCT05484648|Adrenergic Agents|adrenergic agents|mesh-ancestor
111344409|NCT05484648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110723065|NCT01203358|Beractant|beractant|mesh-list
111344410|NCT05484648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111344411|NCT05478954|Pyrimethamine|pyrimethamine|mesh-list
111344412|NCT05478954|Sulfadoxine|sulfadoxine|mesh-list
111344413|NCT05478954|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
111344414|NCT05478954|Amodiaquine|amodiaquine|mesh-list
111344415|NCT05478954|Antimalarials|antimalarials|mesh-ancestor
111344416|NCT05478954|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111344417|NCT05478954|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111344418|NCT05478954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111344419|NCT05478954|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111344420|NCT05478954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110723186|NCT05667220|Protease Inhibitors|protease inhibitors|mesh-ancestor
111344421|NCT05478954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111344422|NCT05478954|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111344423|NCT02137096|Carboplatin|carboplatin|mesh-list
111344424|NCT02137096|Etoposide|etoposide|mesh-list
111344425|NCT02137096|Ifosfamide|ifosfamide|mesh-list
111344426|NCT02137096|Etoposide phosphate|etoposide phosphate|mesh-list
111344427|NCT02137096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111344428|NCT02137096|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111344429|NCT02137096|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111344430|NCT02137096|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111344431|NCT02137096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111344432|NCT02137096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111344433|NCT02137096|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111344434|NCT02137096|Alkylating Agents|alkylating agents|mesh-ancestor
111344435|NCT02130622|Promethazine|promethazine|mesh-list
111344436|NCT02130622|Diphenhydramine|diphenhydramine|mesh-list
111344437|NCT02130622|Antipruritics|antipruritics|mesh-ancestor
111344438|NCT02130622|Dermatologic Agents|dermatologic agents|mesh-ancestor
111344439|NCT02130622|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111344440|NCT02130622|Histamine Antagonists|histamine antagonists|mesh-ancestor
111344441|NCT02130622|Histamine Agents|histamine agents|mesh-ancestor
111344442|NCT02130622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111344443|NCT02130622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111344444|NCT02130622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111344445|NCT02130622|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111344446|NCT02130622|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111344447|NCT02130622|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111344448|NCT02130622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111344449|NCT02130622|Anesthetics, Local|anesthetics, local|mesh-ancestor
111344450|NCT02130622|Anesthetics|anesthetics|mesh-ancestor
111344451|NCT02130622|Sensory System Agents|sensory system agents|mesh-ancestor
111344452|NCT02130622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111344453|NCT02130622|Antiemetics|antiemetics|mesh-ancestor
111344454|NCT02130622|Autonomic Agents|autonomic agents|mesh-ancestor
111344455|NCT02130622|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111344456|NCT02134912|Pemetrexed|pemetrexed|mesh-list
111344457|NCT02134912|Crizotinib|crizotinib|mesh-list
111344458|NCT02134912|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
111344459|NCT02134912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111344460|NCT02134912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111344461|NCT02134912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111344462|NCT02134912|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110723602|NCT01075802|Tamoxifen|tamoxifen|mesh-list
111344463|NCT02134912|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111344464|NCT02134912|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111344465|NCT02094352|Ketamine|ketamine|mesh-list
111344466|NCT02094352|Analgesics|analgesics|mesh-ancestor
111344467|NCT02094352|Sensory System Agents|sensory system agents|mesh-ancestor
111344468|NCT02094352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111344469|NCT02094352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111344470|NCT02094352|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111344471|NCT02094352|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111344472|NCT02094352|Anesthetics, General|anesthetics, general|mesh-ancestor
111344473|NCT02094352|Anesthetics|anesthetics|mesh-ancestor
111344474|NCT02094352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111344475|NCT02094352|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111344476|NCT02094352|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111344477|NCT02094352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111344478|NCT02094352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111344479|NCT05478876|Immunomodulating Agents|immunomodulating agents|mesh-list
111344480|NCT05478876|Immunologic Factors|immunologic factors|mesh-ancestor
111344481|NCT05478876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111344483|NCT01188421|Buprenorphine|buprenorphine|mesh-list
111344484|NCT01188421|Tramadol|tramadol|mesh-list
111344485|NCT01188421|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
111344486|NCT01188421|Naloxone|naloxone|mesh-list
111344487|NCT01188421|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111344488|NCT01188421|Narcotics|narcotics|mesh-ancestor
111344489|NCT01188421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111344490|NCT01188421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111344491|NCT01188421|Analgesics|analgesics|mesh-ancestor
111344492|NCT01188421|Sensory System Agents|sensory system agents|mesh-ancestor
111344493|NCT01188421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111344494|NCT01188421|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111344495|NCT01188421|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111344496|NCT01188421|Sympatholytics|sympatholytics|mesh-ancestor
111344497|NCT01188421|Autonomic Agents|autonomic agents|mesh-ancestor
111344498|NCT01188421|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111344499|NCT01188421|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111344500|NCT01188421|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111344501|NCT01188421|Adrenergic Agents|adrenergic agents|mesh-ancestor
111344502|NCT01188421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111344503|NCT01188421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111344504|NCT01006018|Pioglitazone|pioglitazone|mesh-list
111344505|NCT01006018|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111344506|NCT01006018|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111344507|NCT01006018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111344508|NCT01006018|Incretins|incretins|mesh-ancestor
111344509|NCT01006018|Hormones|hormones|mesh-ancestor
111344510|NCT01006018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111344511|NCT01006018|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111344512|NCT01006018|Protease Inhibitors|protease inhibitors|mesh-ancestor
111344513|NCT01006018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111344514|NCT01006018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111344515|NCT00996502|Prednisone|prednisone|mesh-list
111344516|NCT00996502|Bevacizumab|bevacizumab|mesh-list
111344517|NCT00996502|Docetaxel|docetaxel|mesh-list
111344518|NCT00996502|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111344519|NCT00996502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111344520|NCT00996502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111344521|NCT00996502|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111344522|NCT00996502|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111344523|NCT00996502|Growth Substances|growth substances|mesh-ancestor
111344524|NCT00996502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111344525|NCT00996502|Growth Inhibitors|growth inhibitors|mesh-ancestor
111344526|NCT00996502|Tubulin Modulators|tubulin modulators|mesh-ancestor
111344527|NCT00996502|Antimitotic Agents|antimitotic agents|mesh-ancestor
111344528|NCT00996502|Mitosis Modulators|mitosis modulators|mesh-ancestor
111344529|NCT00996502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111344530|NCT00996502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111344531|NCT00996502|Glucocorticoids|glucocorticoids|mesh-ancestor
111344532|NCT00996502|Hormones|hormones|mesh-ancestor
111344533|NCT00996502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111344534|NCT00996502|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111344535|NCT00996502|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111344536|NCT00996502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111344537|NCT00984490|Metformin|metformin|mesh-list
111344538|NCT00984490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111344539|NCT00984490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111344540|NCT05484024|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
111344541|NCT05484024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111344542|NCT05484024|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111344543|NCT05484024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111344544|NCT02027272|Dexamethasone|dexamethasone|mesh-list
111344545|NCT02027272|Glucocorticoids|glucocorticoids|mesh-list
111344546|NCT02027272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111344547|NCT02027272|Antiemetics|antiemetics|mesh-ancestor
111344548|NCT02027272|Autonomic Agents|autonomic agents|mesh-ancestor
111344549|NCT02027272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111344550|NCT02027272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111344551|NCT02027272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111344552|NCT02027272|Hormones|hormones|mesh-ancestor
111344553|NCT02027272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111344554|NCT02027272|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111344555|NCT02027272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111344556|NCT05475444|Ciprofloxacin|ciprofloxacin|mesh-list
111344557|NCT05475444|Chitosan|chitosan|mesh-list
111344558|NCT05475444|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111344559|NCT05475444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111344560|NCT05475444|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111344561|NCT05475444|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111344562|NCT05475444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111344563|NCT05475444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111344564|NCT05475444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111344565|NCT05475444|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111344566|NCT05475444|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111344567|NCT05475444|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111344568|NCT05475444|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111344569|NCT05475444|Antimetabolites|antimetabolites|mesh-ancestor
111344570|NCT05475444|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111344571|NCT05475444|Chelating Agents|chelating agents|mesh-ancestor
111344572|NCT05475444|Sequestering Agents|sequestering agents|mesh-ancestor
111344573|NCT05475444|Hemostatics|hemostatics|mesh-ancestor
111344574|NCT05475444|Coagulants|coagulants|mesh-ancestor
111344575|NCT03472092|Amitriptyline|amitriptyline|mesh-list
111344576|NCT03472092|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
111344577|NCT03472092|Antidepressive Agents|antidepressive agents|mesh-ancestor
111344578|NCT03472092|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111344579|NCT03472092|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111344580|NCT03472092|Analgesics|analgesics|mesh-ancestor
111344581|NCT03472092|Sensory System Agents|sensory system agents|mesh-ancestor
111344582|NCT03472092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111344583|NCT03472092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111344584|NCT03472092|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111344585|NCT03472092|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111344586|NCT03472092|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111344587|NCT03472092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111344588|NCT03472092|Adrenergic Agents|adrenergic agents|mesh-ancestor
111344589|NCT03472092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111344590|NCT01996852|Sildenafil Citrate|sildenafil citrate|mesh-list
111344591|NCT01996852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111344592|NCT01996852|Vasodilator Agents|vasodilator agents|mesh-ancestor
111344593|NCT01996852|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111344594|NCT01996852|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111344595|NCT01996852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111344596|NCT01996852|Urological Agents|urological agents|mesh-ancestor
111344597|NCT05478330|Flutamide|flutamide|mesh-list
111344598|NCT05478330|Androgen Antagonists|androgen antagonists|mesh-ancestor
111344599|NCT05478330|Hormone Antagonists|hormone antagonists|mesh-ancestor
111344600|NCT05478330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111344601|NCT05478330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111344602|NCT05478330|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111344603|NCT05478330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111344604|NCT00978874|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
111344605|NCT00978874|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110723922|NCT01300312|Anticonvulsants|anticonvulsants|mesh-ancestor
111344606|NCT00978874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111344607|NCT04331626|Gemcitabine|gemcitabine|mesh-list
111344608|NCT04331626|Nivolumab|nivolumab|mesh-list
111344609|NCT04331626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111344610|NCT04331626|Antimetabolites|antimetabolites|mesh-ancestor
111344611|NCT04331626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111344612|NCT04331626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111344613|NCT04331626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111344614|NCT04331626|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111344615|NCT03699540|Ethanol|ethanol|mesh-list
111344616|NCT03699540|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111344617|NCT03699540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110724036|NCT04246762|Caffeine|caffeine|mesh-list
111344618|NCT03699540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111344619|NCT03699540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111344620|NCT00970606|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111344622|NCT00970606|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111344623|NCT00970606|Antimetabolites|antimetabolites|mesh-ancestor
111344624|NCT00970606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111344625|NCT00970606|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111344626|NCT00970606|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111344627|NCT00970606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111344628|NCT01973062|Rituximab|rituximab|mesh-list
111344629|NCT01973062|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111344630|NCT01973062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111344631|NCT01973062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111344632|NCT01973062|Immunologic Factors|immunologic factors|mesh-ancestor
111344633|NCT01973062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111344634|NCT01973062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111344635|NCT03661320|Gemcitabine|gemcitabine|mesh-list
111344636|NCT03661320|Nivolumab|nivolumab|mesh-list
111344637|NCT03661320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110724174|NCT03799900|Anesthetics|anesthetics|mesh-ancestor
111344638|NCT03661320|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111344639|NCT03661320|Antimetabolites|antimetabolites|mesh-ancestor
111344640|NCT03661320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111344641|NCT03661320|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111344642|NCT03661320|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111344643|NCT00981370|Deferasirox|deferasirox|mesh-list
111344644|NCT00981370|Iron Chelating Agents|iron chelating agents|mesh-ancestor
111344645|NCT00981370|Chelating Agents|chelating agents|mesh-ancestor
111344646|NCT00981370|Sequestering Agents|sequestering agents|mesh-ancestor
111344647|NCT00981370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111344648|NCT00979810|Alovudine|alovudine|mesh-list
111344649|NCT00979810|Antiviral Agents|antiviral agents|mesh-ancestor
111344650|NCT00979810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111344651|NCT00947284|Nalbuphine|nalbuphine|mesh-list
111344652|NCT00947284|Naloxone|naloxone|mesh-list
111344653|NCT00947284|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111344654|NCT00947284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111344655|NCT00947284|Sensory System Agents|sensory system agents|mesh-ancestor
111344656|NCT00947284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111344657|NCT00947284|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111344658|NCT00947284|Narcotics|narcotics|mesh-ancestor
111344659|NCT00947284|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111344660|NCT00947284|Analgesics|analgesics|mesh-ancestor
111344661|NCT00932152|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111344662|NCT00932152|Bevacizumab|bevacizumab|mesh-list
111344663|NCT00932152|Fulvestrant|fulvestrant|mesh-list
111344664|NCT00932152|Anastrozole|anastrozole|mesh-list
111344665|NCT00932152|Analgesics|analgesics|mesh-list
111344666|NCT00932152|Antiemetics|antiemetics|mesh-list
111344667|NCT00932152|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111344668|NCT00932152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111344669|NCT00932152|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111344670|NCT00932152|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111344671|NCT00932152|Growth Substances|growth substances|mesh-ancestor
111344672|NCT00932152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111344673|NCT00932152|Growth Inhibitors|growth inhibitors|mesh-ancestor
111344674|NCT00932152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111344675|NCT00932152|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111344676|NCT00932152|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
111344677|NCT00932152|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111344678|NCT00932152|Hormone Antagonists|hormone antagonists|mesh-ancestor
111344679|NCT00932152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111344680|NCT00932152|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111344681|NCT00932152|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111344682|NCT00932152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111344683|NCT00932152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111344684|NCT00932152|Sensory System Agents|sensory system agents|mesh-ancestor
111344685|NCT00932152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111344686|NCT00932152|Autonomic Agents|autonomic agents|mesh-ancestor
111344687|NCT00932152|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111344688|NCT01916590|Bupivacaine|bupivacaine|mesh-list
111344689|NCT01916590|Anesthetics, Local|anesthetics, local|mesh-ancestor
111344690|NCT01916590|Anesthetics|anesthetics|mesh-ancestor
110724367|NCT05669092|Capecitabine|capecitabine|mesh-list
111344691|NCT01916590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111344692|NCT01916590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111344693|NCT01916590|Sensory System Agents|sensory system agents|mesh-ancestor
111344694|NCT01916590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111344695|NCT01890694|Tolvaptan|tolvaptan|mesh-list
111344696|NCT01890694|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
111344697|NCT01890694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111344698|NCT01890694|Natriuretic Agents|natriuretic agents|mesh-ancestor
111344699|NCT01890694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111344700|NCT05474898|Magnesium Sulfate|magnesium sulfate|mesh-list
111344701|NCT05474898|Analgesics|analgesics|mesh-ancestor
111344702|NCT05474898|Sensory System Agents|sensory system agents|mesh-ancestor
111344703|NCT05474898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111344704|NCT05474898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111344705|NCT05474898|Anesthetics|anesthetics|mesh-ancestor
111344706|NCT05474898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111344707|NCT05474898|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111344708|NCT05474898|Anticonvulsants|anticonvulsants|mesh-ancestor
111344709|NCT05474898|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111344710|NCT05474898|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111344711|NCT05474898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110724542|NCT03790540|Sensory System Agents|sensory system agents|mesh-ancestor
111344712|NCT05474898|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111344713|NCT05474898|Tocolytic Agents|tocolytic agents|mesh-ancestor
111344714|NCT05474898|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111344715|NCT03428958|Leucovorin|leucovorin|mesh-list
111344716|NCT03428958|Bevacizumab|bevacizumab|mesh-list
111344717|NCT03428958|Cetuximab|cetuximab|mesh-list
111344718|NCT03428958|Panitumumab|panitumumab|mesh-list
110724624|NCT01304836|Hormones|hormones|mesh-ancestor
111344719|NCT03428958|Oxaliplatin|oxaliplatin|mesh-list
111344720|NCT03428958|Irinotecan|irinotecan|mesh-list
111344721|NCT03428958|Levoleucovorin|levoleucovorin|mesh-list
111344722|NCT03428958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111344723|NCT03428958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111344724|NCT03428958|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111344725|NCT03428958|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111344726|NCT03428958|Growth Substances|growth substances|mesh-ancestor
110724681|NCT00139776|Celecoxib|celecoxib|mesh-list
111344727|NCT03428958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111344728|NCT03428958|Growth Inhibitors|growth inhibitors|mesh-ancestor
111344729|NCT03428958|Antidotes|antidotes|mesh-ancestor
111344730|NCT03428958|Protective Agents|protective agents|mesh-ancestor
111344731|NCT03428958|Vitamin B Complex|vitamin b complex|mesh-ancestor
111344732|NCT03428958|Vitamins|vitamins|mesh-ancestor
111344733|NCT03428958|Micronutrients|micronutrients|mesh-ancestor
111344734|NCT03428958|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111344735|NCT03428958|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111344736|NCT03428958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111344737|NCT03428958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111344738|NCT01844206|Morphine|morphine|mesh-list
111344739|NCT01844206|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111344740|NCT01844206|Narcotics|narcotics|mesh-ancestor
111344741|NCT01844206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110724816|NCT01308346|Everolimus|everolimus|mesh-list
111344742|NCT01844206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111344743|NCT01844206|Analgesics|analgesics|mesh-ancestor
111344744|NCT01844206|Sensory System Agents|sensory system agents|mesh-ancestor
111344745|NCT01844206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111344746|NCT03626454|Norepinephrine|norepinephrine|mesh-list
111344747|NCT03626454|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111344748|NCT03626454|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110724887|NCT01312402|Brinzolamide|brinzolamide|mesh-list
111344749|NCT03626454|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111344750|NCT03626454|Adrenergic Agents|adrenergic agents|mesh-ancestor
111344751|NCT03626454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111344752|NCT03626454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111344753|NCT03626454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111344754|NCT03626454|Sympathomimetics|sympathomimetics|mesh-ancestor
111344755|NCT03626454|Autonomic Agents|autonomic agents|mesh-ancestor
111344756|NCT03626454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111344757|NCT03626454|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111344758|NCT01830790|Sildenafil Citrate|sildenafil citrate|mesh-list
111344759|NCT01830790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111344760|NCT01830790|Vasodilator Agents|vasodilator agents|mesh-ancestor
111344761|NCT01830790|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111344762|NCT01830790|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111344763|NCT01830790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111344764|NCT01830790|Urological Agents|urological agents|mesh-ancestor
111344765|NCT01662102|Rituximab|rituximab|mesh-list
111344766|NCT01662102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111344767|NCT01662102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111344768|NCT01662102|Immunologic Factors|immunologic factors|mesh-ancestor
111344769|NCT01662102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111344770|NCT01662102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111344771|NCT03950076|Edoxaban|edoxaban|mesh-list
111344772|NCT03950076|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110725236|NCT03775876|Propofol|propofol|mesh-list
111344773|NCT03950076|Antithrombins|antithrombins|mesh-ancestor
111344774|NCT03950076|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111344775|NCT03950076|Protease Inhibitors|protease inhibitors|mesh-ancestor
111344776|NCT03950076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110725320|NCT01321138|Morphine|morphine|mesh-list
111344777|NCT03950076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111344778|NCT03950076|Anticoagulants|anticoagulants|mesh-ancestor
111344779|NCT05292976|Albuterol|albuterol|mesh-list
111344780|NCT05292976|Methacholine Chloride|methacholine chloride|mesh-list
111344781|NCT05292976|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111344782|NCT05292976|Autonomic Agents|autonomic agents|mesh-ancestor
111344783|NCT05292976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111344784|NCT05292976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111344785|NCT05292976|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111344786|NCT05292976|Respiratory System Agents|respiratory system agents|mesh-ancestor
110725442|NCT03774706|Oxytocics|oxytocics|mesh-ancestor
111344787|NCT05292976|Tocolytic Agents|tocolytic agents|mesh-ancestor
111344788|NCT05292976|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111344789|NCT05292976|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111344790|NCT05292976|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111344791|NCT05292976|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111344792|NCT05292976|Adrenergic Agents|adrenergic agents|mesh-ancestor
111344793|NCT05292976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111344794|NCT05292976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111344795|NCT05292976|Miotics|miotics|mesh-ancestor
111344796|NCT05292976|Parasympathomimetics|parasympathomimetics|mesh-ancestor
111344797|NCT05292976|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
111344798|NCT05292976|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
110725537|NCT00411671|Sorafenib|sorafenib|mesh-list
111344799|NCT05292976|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111344800|NCT05292976|Cholinergic Agents|cholinergic agents|mesh-ancestor
111344801|NCT00850720|Hydrocortisone|hydrocortisone|mesh-list
111344802|NCT00850720|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
111344803|NCT00850720|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
111344804|NCT00850720|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
111344805|NCT00850720|Vasopressins|vasopressins|mesh-list
111344806|NCT00850720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111344807|NCT00850720|Hemostatics|hemostatics|mesh-ancestor
111344808|NCT00850720|Coagulants|coagulants|mesh-ancestor
111344809|NCT00850720|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111344810|NCT00850720|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
111344811|NCT00850720|Natriuretic Agents|natriuretic agents|mesh-ancestor
111344812|NCT00850720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111344813|NCT00843310|Dexamethasone|dexamethasone|mesh-list
111344814|NCT00843310|Lenalidomide|lenalidomide|mesh-list
111344815|NCT00843310|Melphalan|melphalan|mesh-list
111344816|NCT00843310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111344817|NCT00843310|Antiemetics|antiemetics|mesh-ancestor
111344818|NCT00843310|Autonomic Agents|autonomic agents|mesh-ancestor
111344819|NCT00843310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111344820|NCT00843310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111344821|NCT00843310|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111344822|NCT00843310|Glucocorticoids|glucocorticoids|mesh-ancestor
111344823|NCT00843310|Hormones|hormones|mesh-ancestor
111344824|NCT00843310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111344825|NCT00843310|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111344826|NCT00843310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111344827|NCT00843310|Immunologic Factors|immunologic factors|mesh-ancestor
111344828|NCT00843310|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111344829|NCT00843310|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111344830|NCT00843310|Growth Substances|growth substances|mesh-ancestor
111344831|NCT00843310|Growth Inhibitors|growth inhibitors|mesh-ancestor
111344832|NCT00843310|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111344833|NCT00843310|Alkylating Agents|alkylating agents|mesh-ancestor
111344834|NCT00843310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111344835|NCT00843310|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111344836|NCT00843310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111344837|NCT00809458|Vitamin E|vitamin e|mesh-list
111344838|NCT00809458|Tocopherols|tocopherols|mesh-list
111344839|NCT00809458|Tocotrienols|tocotrienols|mesh-list
111344840|NCT00809458|alpha-Tocopherol|alpha-tocopherol|mesh-list
111344841|NCT00809458|Vitamins|vitamins|mesh-ancestor
110725849|NCT01589159|Capecitabine|capecitabine|mesh-list
111344842|NCT00809458|Micronutrients|micronutrients|mesh-ancestor
111344843|NCT00809458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111344844|NCT00809458|Antioxidants|antioxidants|mesh-ancestor
111344845|NCT00809458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111344846|NCT00809458|Protective Agents|protective agents|mesh-ancestor
111344847|NCT01701622|Febuxostat|febuxostat|mesh-list
111344848|NCT01701622|Gout Suppressants|gout suppressants|mesh-ancestor
111069271|NCT02813655|Cosyntropin|cosyntropin|mesh-list
111344849|NCT01701622|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111344850|NCT01675960|Gabapentin|gabapentin|mesh-list
111344851|NCT01675960|Analgesics|analgesics|mesh-ancestor
111344852|NCT01675960|Sensory System Agents|sensory system agents|mesh-ancestor
111344853|NCT01675960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111344854|NCT01675960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111344855|NCT01675960|Anticonvulsants|anticonvulsants|mesh-ancestor
111344856|NCT01675960|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111344857|NCT01675960|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111344858|NCT01675960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111344859|NCT01675960|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111344860|NCT01675960|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111344861|NCT01675960|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111344862|NCT01675960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111344863|NCT01675960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111344864|NCT01675960|Antimanic Agents|antimanic agents|mesh-ancestor
111344865|NCT01607320|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
111344866|NCT01607320|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
111344867|NCT01607320|Clomiphene|clomiphene|mesh-list
111344868|NCT01607320|Medroxyprogesterone|medroxyprogesterone|mesh-list
111344869|NCT01607320|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111344870|NCT01607320|Hormone Antagonists|hormone antagonists|mesh-ancestor
111344871|NCT01607320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111344872|NCT01607320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111344873|NCT01607320|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111344874|NCT01607320|Fertility Agents|fertility agents|mesh-ancestor
111344875|NCT01607320|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111344876|NCT01607320|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111344877|NCT01607320|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110726030|NCT01028716|Immunologic Factors|immunologic factors|mesh-ancestor
111344878|NCT01607320|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111344879|NCT01607320|Contraceptive Agents|contraceptive agents|mesh-ancestor
111344880|NCT01607320|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111344881|NCT01607320|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
111344882|NCT01607320|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111344883|NCT01607320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110726102|NCT01322308|Pioglitazone|pioglitazone|mesh-list
111344884|NCT01607320|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111344885|NCT01607320|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111344886|NCT01607320|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111344887|NCT01607320|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111344888|NCT01606150|Lidocaine|lidocaine|mesh-list
111344889|NCT01606150|Anesthetics, Local|anesthetics, local|mesh-ancestor
111344890|NCT01606150|Anesthetics|anesthetics|mesh-ancestor
110726173|NCT00134082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111344891|NCT01606150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111344892|NCT01606150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111344893|NCT01606150|Sensory System Agents|sensory system agents|mesh-ancestor
111344894|NCT01606150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110726246|NCT00101400|Sorafenib|sorafenib|mesh-list
111344895|NCT01606150|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111344896|NCT01606150|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111344897|NCT01606150|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111344898|NCT01606150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111344899|NCT01606150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111344900|NCT01602016|Leucovorin|leucovorin|mesh-list
111344901|NCT01602016|Folic Acid|folic acid|mesh-list
111344902|NCT01602016|Levoleucovorin|levoleucovorin|mesh-list
111344903|NCT01602016|Antidotes|antidotes|mesh-ancestor
111344904|NCT01602016|Protective Agents|protective agents|mesh-ancestor
111344905|NCT01602016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111344906|NCT01602016|Vitamin B Complex|vitamin b complex|mesh-ancestor
111344907|NCT01602016|Vitamins|vitamins|mesh-ancestor
111344908|NCT01602016|Micronutrients|micronutrients|mesh-ancestor
111344909|NCT01602016|Hematinics|hematinics|mesh-ancestor
111344910|NCT00731770|Fluticasone|fluticasone|mesh-list
111344911|NCT00731770|Xhance|xhance|mesh-list
111344912|NCT00731770|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
111344913|NCT00731770|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
111344914|NCT00731770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111344915|NCT00731770|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111344916|NCT00731770|Autonomic Agents|autonomic agents|mesh-ancestor
111344917|NCT00731770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111344918|NCT00731770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111344919|NCT00731770|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111344920|NCT00731770|Respiratory System Agents|respiratory system agents|mesh-ancestor
111344921|NCT00731770|Dermatologic Agents|dermatologic agents|mesh-ancestor
111344922|NCT00731770|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111069343|NCT03502343|Paclitaxel|paclitaxel|mesh-list
111344923|NCT00731770|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111344924|NCT00731770|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111344925|NCT00731770|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111344926|NCT00731770|Adrenergic Agents|adrenergic agents|mesh-ancestor
111344927|NCT00731770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111344928|NCT00731770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111344929|NCT00731770|Glucocorticoids|glucocorticoids|mesh-ancestor
111344930|NCT00731770|Hormones|hormones|mesh-ancestor
110726588|NCT04980040|Incretins|incretins|mesh-ancestor
111344931|NCT00731770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111344932|NCT00731770|Sympathomimetics|sympathomimetics|mesh-ancestor
111344933|NCT00719914|Eptifibatide|eptifibatide|mesh-list
111344934|NCT00719914|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111344935|NCT01566370|Zonisamide|zonisamide|mesh-list
111344936|NCT01566370|Anticonvulsants|anticonvulsants|mesh-ancestor
111344937|NCT01566370|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111344938|NCT01566370|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111344939|NCT01566370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111344940|NCT01566370|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111344941|NCT01566370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111344942|NCT03414684|Carboplatin|carboplatin|mesh-list
111344943|NCT03414684|Nivolumab|nivolumab|mesh-list
111344944|NCT03414684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111344945|NCT03414684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111344946|NCT03414684|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111344947|NCT03414684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111344948|NCT01558492|Paclitaxel|paclitaxel|mesh-list
111344949|NCT01558492|Carboplatin|carboplatin|mesh-list
111344950|NCT01558492|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111344951|NCT01558492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111344952|NCT01558492|Tubulin Modulators|tubulin modulators|mesh-ancestor
111344953|NCT01558492|Antimitotic Agents|antimitotic agents|mesh-ancestor
111344954|NCT01558492|Mitosis Modulators|mitosis modulators|mesh-ancestor
111344955|NCT01558492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111344956|NCT03579472|Halichondrin B|halichondrin b|mesh-list
111344957|NCT03579472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111344958|NCT03579472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111344959|NCT03579472|Tubulin Modulators|tubulin modulators|mesh-ancestor
111344960|NCT03579472|Antimitotic Agents|antimitotic agents|mesh-ancestor
111344961|NCT03579472|Mitosis Modulators|mitosis modulators|mesh-ancestor
111344962|NCT05286190|Bupivacaine|bupivacaine|mesh-list
111344963|NCT05286190|Anesthetics, Local|anesthetics, local|mesh-ancestor
111344964|NCT05286190|Anesthetics|anesthetics|mesh-ancestor
111344965|NCT05286190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111344966|NCT05286190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111344967|NCT05286190|Sensory System Agents|sensory system agents|mesh-ancestor
111344968|NCT05286190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111344969|NCT03399552|Avelumab|avelumab|mesh-list
111344970|NCT03399552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111344971|NCT03399552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111344972|NCT00691444|Melatonin|melatonin|mesh-list
111344973|NCT00691444|Antioxidants|antioxidants|mesh-ancestor
111344974|NCT00691444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111344975|NCT00691444|Protective Agents|protective agents|mesh-ancestor
111344976|NCT00691444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111344977|NCT00691444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111344978|NCT05482464|Caseins|caseins|mesh-list
111344979|NCT05482464|Chelating Agents|chelating agents|mesh-ancestor
111344980|NCT05482464|Sequestering Agents|sequestering agents|mesh-ancestor
110726908|NCT03965208|Antithrombins|antithrombins|mesh-ancestor
111344981|NCT05482464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111344982|NCT01530880|Acetaminophen|acetaminophen|mesh-list
111344983|NCT01530880|Ibuprofen|ibuprofen|mesh-list
111344984|NCT01530880|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111344985|NCT01530880|Analgesics|analgesics|mesh-ancestor
111344986|NCT01530880|Sensory System Agents|sensory system agents|mesh-ancestor
111344987|NCT01530880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111344988|NCT01530880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111344989|NCT01530880|Antipyretics|antipyretics|mesh-ancestor
111344990|NCT01530880|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110727057|NCT04790812|Celecoxib|celecoxib|mesh-list
111344991|NCT01530880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111344992|NCT01530880|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111344993|NCT01530880|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111344994|NCT01530880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111344995|NCT01530880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111344996|NCT05482074|Olaparib|olaparib|mesh-list
111344997|NCT05482074|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111344998|NCT05482074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111344999|NCT05482074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111345000|NCT05482074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110727192|NCT01322776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111345002|NCT00678574|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111345003|NCT00678574|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111345004|NCT00678574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111345005|NCT00678574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111345006|NCT00678574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111345007|NCT00678574|Serotonin Agents|serotonin agents|mesh-ancestor
111345008|NCT00678574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111345009|NCT00678574|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111345010|NCT00678574|Antidepressive Agents|antidepressive agents|mesh-ancestor
111345011|NCT00678574|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111345012|NCT00678574|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111345013|NCT00678574|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111345014|NCT00678574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111345015|NCT01475500|Dimercaprol|dimercaprol|mesh-list
111345016|NCT01475500|Chelating Agents|chelating agents|mesh-ancestor
111345017|NCT01475500|Sequestering Agents|sequestering agents|mesh-ancestor
111345018|NCT01475500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111345019|NCT02551692|Nicotine|nicotine|mesh-list
111345020|NCT02551692|Varenicline|varenicline|mesh-list
111345021|NCT02551692|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111345022|NCT02551692|Autonomic Agents|autonomic agents|mesh-ancestor
111345023|NCT02551692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111345024|NCT02551692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111345025|NCT02551692|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111345026|NCT02551692|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111345027|NCT02551692|Cholinergic Agents|cholinergic agents|mesh-ancestor
111345028|NCT02551692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111345029|NCT02551692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111345030|NCT00542542|Fentanyl|fentanyl|mesh-list
111345031|NCT00542542|Midazolam|midazolam|mesh-list
111345032|NCT00542542|Propofol|propofol|mesh-list
111345033|NCT00542542|Ropivacaine|ropivacaine|mesh-list
111345034|NCT00542542|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111345035|NCT00542542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111345036|NCT00542542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111345037|NCT00542542|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111345038|NCT00542542|Anesthetics, General|anesthetics, general|mesh-ancestor
111345039|NCT00542542|Anesthetics|anesthetics|mesh-ancestor
111345040|NCT00542542|Anesthetics, Local|anesthetics, local|mesh-ancestor
111345041|NCT00542542|Sensory System Agents|sensory system agents|mesh-ancestor
111345042|NCT00542542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111345043|NCT00542542|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111345044|NCT00542542|Narcotics|narcotics|mesh-ancestor
110727545|NCT00125138|Metylperon|metylperon|mesh-list
111345045|NCT00542542|Analgesics|analgesics|mesh-ancestor
111345046|NCT00542542|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111345047|NCT00542542|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111345048|NCT00542542|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111345049|NCT00542542|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111345050|NCT00542542|GABA Modulators|gaba modulators|mesh-ancestor
111345051|NCT00542542|GABA Agents|gaba agents|mesh-ancestor
111345052|NCT00542542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111345053|NCT00542542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111345054|NCT05471544|Pyrimethamine|pyrimethamine|mesh-list
111345055|NCT05471544|Sulfadoxine|sulfadoxine|mesh-list
111345056|NCT05471544|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
111345057|NCT05471544|Amodiaquine|amodiaquine|mesh-list
111345058|NCT05471544|Antimalarials|antimalarials|mesh-ancestor
111345059|NCT05471544|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111345060|NCT05471544|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111345061|NCT05471544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111345062|NCT05471544|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111345063|NCT05471544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111345064|NCT05471544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111345065|NCT05471544|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111345066|NCT03333486|Cyclophosphamide|cyclophosphamide|mesh-list
111345067|NCT03333486|Fludarabine|fludarabine|mesh-list
111345068|NCT03333486|Fludarabine phosphate|fludarabine phosphate|mesh-list
110727730|NCT01083290|Spironolactone|spironolactone|mesh-list
111345069|NCT03333486|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111345070|NCT03333486|Immunologic Factors|immunologic factors|mesh-ancestor
111345071|NCT03333486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111345072|NCT03333486|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111345073|NCT03333486|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111345074|NCT03333486|Alkylating Agents|alkylating agents|mesh-ancestor
111345075|NCT03333486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111345076|NCT03333486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111345077|NCT03333486|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111345078|NCT03333486|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111345079|NCT03333486|Antimetabolites|antimetabolites|mesh-ancestor
111345080|NCT02598778|Chlorhexidine|chlorhexidine|mesh-list
111345081|NCT02598778|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
111345083|NCT02598778|Fluorides|fluorides|mesh-list
111345084|NCT02598778|Sodium Fluoride|sodium fluoride|mesh-list
111345085|NCT02598778|Cariostatic Agents|cariostatic agents|mesh-ancestor
111345086|NCT02598778|Protective Agents|protective agents|mesh-ancestor
111345087|NCT02598778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111345088|NCT02598778|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111345089|NCT02598778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111345090|NCT02598778|Disinfectants|disinfectants|mesh-ancestor
111345091|NCT02598778|Dermatologic Agents|dermatologic agents|mesh-ancestor
111345092|NCT00642382|Hyaluronic Acid|hyaluronic acid|mesh-list
111345093|NCT00642382|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111345094|NCT00642382|Immunologic Factors|immunologic factors|mesh-ancestor
110727861|NCT04018612|Acetaminophen|acetaminophen|mesh-list
111345095|NCT00642382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111345096|NCT00642382|Viscosupplements|viscosupplements|mesh-ancestor
111345097|NCT00642382|Protective Agents|protective agents|mesh-ancestor
111345098|NCT05476380|Paclitaxel|paclitaxel|mesh-list
111345099|NCT05476380|Cisplatin|cisplatin|mesh-list
111345100|NCT05476380|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111345101|NCT05476380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111345102|NCT05476380|Tubulin Modulators|tubulin modulators|mesh-ancestor
111345103|NCT05476380|Antimitotic Agents|antimitotic agents|mesh-ancestor
111345104|NCT05476380|Mitosis Modulators|mitosis modulators|mesh-ancestor
111345105|NCT05476380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111345106|NCT00634972|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
111345107|NCT00634972|Ketorolac|ketorolac|mesh-list
111345108|NCT00634972|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111345109|NCT00634972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111345110|NCT00634972|Analgesics|analgesics|mesh-ancestor
111345111|NCT00634972|Sensory System Agents|sensory system agents|mesh-ancestor
111345112|NCT00634972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111345113|NCT00634972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111345114|NCT00634972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111345115|NCT00634972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111345116|NCT00634972|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111345117|NCT00634972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111345118|NCT00634972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111345119|NCT00529282|Vancomycin|vancomycin|mesh-list
111345120|NCT00529282|Cefepime|cefepime|mesh-list
111345121|NCT00529282|Ceftobiprole|ceftobiprole|mesh-list
111345122|NCT00529282|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
111345123|NCT00529282|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111345124|NCT00529282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111345125|NCT00623974|Teriparatide|teriparatide|mesh-list
111345126|NCT00623974|Calcitriol|calcitriol|mesh-list
111345127|NCT00623974|Calcium|calcium|mesh-list
111345128|NCT00623974|Parathyroid Hormone|parathyroid hormone|mesh-list
111345129|NCT00623974|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111345130|NCT00623974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110728130|NCT00405275|Etanercept|etanercept|mesh-list
111345131|NCT00623974|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111345132|NCT00623974|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
111345133|NCT00623974|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111345134|NCT00623974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111345135|NCT00623974|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111345136|NCT00623974|Vitamins|vitamins|mesh-ancestor
111345137|NCT00623974|Micronutrients|micronutrients|mesh-ancestor
111345138|NCT02550288|Atorvastatin|atorvastatin|mesh-list
111345139|NCT02550288|Ezetimibe|ezetimibe|mesh-list
111345140|NCT02550288|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111345141|NCT02550288|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111345142|NCT02550288|Antimetabolites|antimetabolites|mesh-ancestor
111345143|NCT02550288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111345144|NCT02550288|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111345145|NCT02550288|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111345146|NCT02550288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111345147|NCT00380146|Pyrimethamine|pyrimethamine|mesh-list
111345148|NCT00380146|Sulfadoxine|sulfadoxine|mesh-list
111345149|NCT00380146|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
111345150|NCT00380146|Antimalarials|antimalarials|mesh-ancestor
111345151|NCT00380146|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111345152|NCT00380146|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111345153|NCT00380146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111345154|NCT00380146|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111345155|NCT00380146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111345156|NCT00380146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110728260|NCT01083992|Vitamin D|vitamin d|mesh-list
111345157|NCT00380146|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111345158|NCT00500890|Cyclophosphamide|cyclophosphamide|mesh-list
111345160|NCT00500890|Etoposide|etoposide|mesh-list
111345161|NCT00500890|Vincristine|vincristine|mesh-list
111345162|NCT00500890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111345163|NCT00500890|Immunologic Factors|immunologic factors|mesh-ancestor
111345164|NCT00500890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111345165|NCT00500890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111345166|NCT00500890|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111345167|NCT00500890|Alkylating Agents|alkylating agents|mesh-ancestor
111345168|NCT00500890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110728324|NCT00094328|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111345169|NCT00500890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111345170|NCT00500890|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111345171|NCT00500890|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111345172|NCT00500890|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110728393|NCT00094458|Antimetabolites|antimetabolites|mesh-ancestor
111345173|NCT00500890|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111345174|NCT00500890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111345175|NCT00500890|Tubulin Modulators|tubulin modulators|mesh-ancestor
111345176|NCT00500890|Antimitotic Agents|antimitotic agents|mesh-ancestor
111345177|NCT00500890|Mitosis Modulators|mitosis modulators|mesh-ancestor
111345178|NCT00000736|Zidovudine|zidovudine|mesh-list
110728462|NCT00403559|Ketoconazole|ketoconazole|mesh-list
111345179|NCT00000736|Antimetabolites|antimetabolites|mesh-ancestor
111345180|NCT00000736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111345181|NCT00000736|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111345182|NCT00000736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111345183|NCT00000736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111345184|NCT00000736|Antiviral Agents|antiviral agents|mesh-ancestor
111345185|NCT00000736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111345186|NCT00000736|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111345187|NCT00000736|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111345188|NCT00379522|Vasopressins|vasopressins|mesh-list
111345189|NCT00379522|Arginine Vasopressin|arginine vasopressin|mesh-list
111345190|NCT00379522|Hemostatics|hemostatics|mesh-ancestor
111345191|NCT00379522|Coagulants|coagulants|mesh-ancestor
111345192|NCT00379522|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111345193|NCT00379522|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
111345194|NCT00379522|Natriuretic Agents|natriuretic agents|mesh-ancestor
111345195|NCT00379522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111345196|NCT00421954|Ziprasidone|ziprasidone|mesh-list
111345197|NCT00421954|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111345198|NCT00421954|Serotonin Agents|serotonin agents|mesh-ancestor
111345199|NCT00421954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111345200|NCT00421954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111345201|NCT00421954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111345202|NCT00421954|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110728748|NCT01044485|Docetaxel|docetaxel|mesh-list
111345203|NCT00421954|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111345204|NCT00421954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111345205|NCT00421954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111345206|NCT00421954|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111345207|NCT00421954|Dopamine Agents|dopamine agents|mesh-ancestor
111345208|NCT01662336|Ritonavir|ritonavir|mesh-list
111345209|NCT01662336|Lopinavir|lopinavir|mesh-list
110728834|NCT01085552|Epoetin Alfa|epoetin alfa|mesh-list
111345210|NCT01662336|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111345211|NCT01662336|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111345212|NCT01662336|Protease Inhibitors|protease inhibitors|mesh-ancestor
111345213|NCT01662336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111345214|NCT01662336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111345215|NCT01662336|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111345216|NCT01662336|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111345217|NCT01662336|Antiviral Agents|antiviral agents|mesh-ancestor
111345218|NCT01662336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111345219|NCT01662336|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111345220|NCT01662336|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111345221|NCT00000766|Ganciclovir|ganciclovir|mesh-list
111345222|NCT00000766|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
111345223|NCT00000766|Foscarnet|foscarnet|mesh-list
111345224|NCT00000766|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
111345225|NCT00000766|Antiviral Agents|antiviral agents|mesh-ancestor
111345226|NCT00000766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111345227|NCT00000766|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111345228|NCT00000766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111345229|NCT00000766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111345230|NCT00000766|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111345231|NCT00000772|Ribavirin|ribavirin|mesh-list
111345232|NCT00000772|Didanosine|didanosine|mesh-list
111345233|NCT00000772|Antimetabolites|antimetabolites|mesh-ancestor
111345234|NCT00000772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111345235|NCT00000772|Antiviral Agents|antiviral agents|mesh-ancestor
111345236|NCT00000772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111345237|NCT00000772|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111345238|NCT00000772|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111345239|NCT00000772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111345240|NCT00000772|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111345241|NCT00000772|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111345242|NCT00572260|Daptomycin|daptomycin|mesh-list
111345243|NCT00572260|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111345244|NCT00572260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111345245|NCT00000778|Pyridoxine|pyridoxine|mesh-list
111345246|NCT00000778|Vitamin B 6|vitamin b 6|mesh-list
111345247|NCT00000778|Levofloxacin|levofloxacin|mesh-list
111345248|NCT00000778|Isoniazid|isoniazid|mesh-list
111345249|NCT00000778|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111345250|NCT00000778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111345251|NCT00000778|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111345252|NCT00000778|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111345253|NCT00000778|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111345254|NCT00000778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111345255|NCT00000778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111345256|NCT00000778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110729513|NCT00098774|Antimetabolites|antimetabolites|mesh-ancestor
111345257|NCT00000778|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111345258|NCT00000778|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111345259|NCT00000778|Antitubercular Agents|antitubercular agents|mesh-ancestor
111345260|NCT00000778|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
111345261|NCT00000778|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111345262|NCT00000778|Antimetabolites|antimetabolites|mesh-ancestor
111345263|NCT00000778|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111345264|NCT00000778|Vitamin B Complex|vitamin b complex|mesh-ancestor
111345265|NCT00000778|Vitamins|vitamins|mesh-ancestor
111345266|NCT00000778|Micronutrients|micronutrients|mesh-ancestor
111345267|NCT00000778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111345268|NCT00000796|Pyridoxine|pyridoxine|mesh-list
111345269|NCT00000796|Vitamin B 6|vitamin b 6|mesh-list
111345270|NCT00000796|Levofloxacin|levofloxacin|mesh-list
111345271|NCT00000796|Cycloserine|cycloserine|mesh-list
111345272|NCT00000796|Rifampin|rifampin|mesh-list
111345273|NCT00000796|Isoniazid|isoniazid|mesh-list
111345274|NCT00000796|Amikacin|amikacin|mesh-list
111345275|NCT00000796|Pyrazinamide|pyrazinamide|mesh-list
111345276|NCT00000796|Ethambutol|ethambutol|mesh-list
111345277|NCT00000796|Clofazimine|clofazimine|mesh-list
111345278|NCT00000796|Aminosalicylic Acid|aminosalicylic acid|mesh-list
111345279|NCT00000796|Streptomycin|streptomycin|mesh-list
111345280|NCT00000796|Ethionamide|ethionamide|mesh-list
111345281|NCT00000796|Capreomycin|capreomycin|mesh-list
111345282|NCT00000796|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111345283|NCT00000796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111345284|NCT00000796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111345285|NCT00000796|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111345286|NCT00000796|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111345287|NCT00000796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111345288|NCT00000796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111345289|NCT00000796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110729718|NCT00372593|Cytarabine|cytarabine|mesh-list
111345290|NCT00000796|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111345291|NCT00000796|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111345292|NCT00000796|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111345293|NCT00000796|Antitubercular Agents|antitubercular agents|mesh-ancestor
111345294|NCT00000796|Leprostatic Agents|leprostatic agents|mesh-ancestor
111345295|NCT00000796|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111345296|NCT00000796|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111345297|NCT00000796|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111345298|NCT00000796|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
111345299|NCT00000796|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
111345300|NCT00000796|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
111345301|NCT00000796|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111345302|NCT00000796|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
111345303|NCT00000796|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111345305|NCT00000796|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111345306|NCT00000796|Vitamin B Complex|vitamin b complex|mesh-ancestor
111345307|NCT00000796|Vitamins|vitamins|mesh-ancestor
111345308|NCT00000796|Micronutrients|micronutrients|mesh-ancestor
111345309|NCT00000796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111345310|NCT00000796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111345311|NCT00000796|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111345312|NCT00000802|Dapsone|dapsone|mesh-list
111345313|NCT00000802|Atovaquone|atovaquone|mesh-list
111345314|NCT00000802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111345315|NCT00000802|Antimalarials|antimalarials|mesh-ancestor
111345316|NCT00000802|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111345317|NCT00000802|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111345318|NCT00000802|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111345319|NCT00000802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111345320|NCT00000802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111345321|NCT00000802|Leprostatic Agents|leprostatic agents|mesh-ancestor
111345322|NCT00000802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111345323|NCT02389946|Sirolimus|sirolimus|mesh-list
111345324|NCT02389946|Everolimus|everolimus|mesh-list
111345325|NCT02389946|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111345326|NCT02389946|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111345327|NCT02389946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111345328|NCT02389946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111345329|NCT02389946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111345330|NCT02389946|Immunologic Factors|immunologic factors|mesh-ancestor
111345331|NCT02389946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111345332|NCT02389946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111345333|NCT02389946|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111345334|NCT02389946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111345335|NCT02389946|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111345336|NCT02389946|Antifungal Agents|antifungal agents|mesh-ancestor
111345337|NCT00245128|Imatinib Mesylate|imatinib mesylate|mesh-list
111345338|NCT00245128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111345339|NCT00245128|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111345340|NCT00245128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111345341|NCT00245128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111345342|NCT00268450|Paclitaxel|paclitaxel|mesh-list
111345343|NCT00268450|Bevacizumab|bevacizumab|mesh-list
111345344|NCT00268450|Gemcitabine|gemcitabine|mesh-list
111345345|NCT00268450|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111345346|NCT00268450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111345347|NCT00268450|Tubulin Modulators|tubulin modulators|mesh-ancestor
111345348|NCT00268450|Antimitotic Agents|antimitotic agents|mesh-ancestor
111345349|NCT00268450|Mitosis Modulators|mitosis modulators|mesh-ancestor
111345350|NCT00268450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111345351|NCT00268450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111345352|NCT00268450|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111345353|NCT00268450|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111345354|NCT00268450|Growth Substances|growth substances|mesh-ancestor
111345355|NCT00268450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111345356|NCT00268450|Growth Inhibitors|growth inhibitors|mesh-ancestor
111345357|NCT00268450|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111345358|NCT00268450|Antimetabolites|antimetabolites|mesh-ancestor
111345359|NCT00000808|Nevirapine|nevirapine|mesh-list
111345360|NCT00000808|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110730264|NCT03571516|Protective Agents|protective agents|mesh-ancestor
111345361|NCT00000808|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111345362|NCT00000808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111345363|NCT00000808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111345364|NCT00000808|Antiviral Agents|antiviral agents|mesh-ancestor
111345365|NCT00000808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111345366|NCT00000808|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111345367|NCT00000808|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111345368|NCT00000808|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111345369|NCT00000808|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111345370|NCT01892384|BI 409306|bi 409306|mesh-list
111345371|NCT01892384|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111345372|NCT01892384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111345373|NCT01892384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111345374|NCT00000814|Zidovudine|zidovudine|mesh-list
111345375|NCT00000814|Nevirapine|nevirapine|mesh-list
111345376|NCT00000814|Didanosine|didanosine|mesh-list
111345377|NCT00000814|Antimetabolites|antimetabolites|mesh-ancestor
111345378|NCT00000814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111345379|NCT00000814|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111345380|NCT00000814|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111345381|NCT00000814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111345383|NCT00000814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111345384|NCT00000814|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111345385|NCT00000814|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111345386|NCT00000814|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111345387|NCT00000814|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111345388|NCT02661932|Letrozole|letrozole|mesh-list
111345389|NCT02661932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111345390|NCT02661932|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110360464|NCT04640324|Vitamin D|vitamin d|mesh-list
111345391|NCT02661932|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111345392|NCT02661932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111345393|NCT02661932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111345394|NCT02661932|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111345395|NCT02661932|Hormone Antagonists|hormone antagonists|mesh-ancestor
111345396|NCT02661932|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111345397|NCT02661932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111345398|NCT00177970|Immunoglobulins|immunoglobulins|mesh-list
110730803|NCT01081353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111345399|NCT00177970|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111345400|NCT00177970|Antibodies|antibodies|mesh-list
111345401|NCT00177970|Immunoglobulin G|immunoglobulin g|mesh-list
111345402|NCT00177970|gamma-Globulins|gamma-globulins|mesh-list
111345403|NCT00177970|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
111345404|NCT00177970|Immunologic Factors|immunologic factors|mesh-ancestor
111345405|NCT00177970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111345406|NCT01892618|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
111345407|NCT01892618|Immunologic Factors|immunologic factors|mesh-ancestor
111345408|NCT01892618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111345409|NCT00088972|Celecoxib|celecoxib|mesh-list
111345410|NCT00088972|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111345411|NCT00088972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111345412|NCT00088972|Analgesics|analgesics|mesh-ancestor
111345413|NCT00088972|Sensory System Agents|sensory system agents|mesh-ancestor
111345414|NCT00088972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111345415|NCT00088972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111345416|NCT00088972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111345417|NCT00088972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111345418|NCT00088972|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110731011|NCT03721900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111345419|NCT00088972|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111345420|NCT00088972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111345421|NCT00088972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111345422|NCT00089128|Gemcitabine|gemcitabine|mesh-list
111345423|NCT00089128|Irinotecan|irinotecan|mesh-list
111345424|NCT00089128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111345425|NCT00089128|Antimetabolites|antimetabolites|mesh-ancestor
111345426|NCT00089128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111345427|NCT00089128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111345428|NCT00089128|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111345429|NCT00089128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111345430|NCT00089128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111345431|NCT00000838|Lamivudine|lamivudine|mesh-list
111345432|NCT00000838|Zidovudine|zidovudine|mesh-list
111345433|NCT00000838|Stavudine|stavudine|mesh-list
111345434|NCT00000838|Didanosine|didanosine|mesh-list
111345435|NCT00000838|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111345436|NCT00000838|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111345437|NCT00000838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111345438|NCT00000838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111345439|NCT00000838|Antiviral Agents|antiviral agents|mesh-ancestor
111345440|NCT00000838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111345441|NCT00000838|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111345442|NCT00000838|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111345443|NCT00000838|Antimetabolites|antimetabolites|mesh-ancestor
111345444|NCT00001768|Immunoglobulins|immunoglobulins|mesh-list
111345445|NCT00001768|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111345446|NCT00001768|Antibodies|antibodies|mesh-list
111345447|NCT00001768|gamma-Globulins|gamma-globulins|mesh-list
111345448|NCT00001768|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
111345449|NCT00001768|Immunologic Factors|immunologic factors|mesh-ancestor
111345450|NCT00001768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111345451|NCT00000844|Interferons|interferons|mesh-list
111345452|NCT00000844|Interferon-alpha|interferon-alpha|mesh-list
111345453|NCT00000844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111345454|NCT00000844|Antiviral Agents|antiviral agents|mesh-ancestor
111345455|NCT00000844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111345456|NCT00000844|Immunologic Factors|immunologic factors|mesh-ancestor
111345457|NCT00000844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111345458|NCT00014560|Antibodies|antibodies|mesh-list
111345459|NCT00014560|Sargramostim|sargramostim|mesh-list
111345460|NCT00014560|Antibodies, Bispecific|antibodies, bispecific|mesh-list
111345461|NCT00014560|Immunologic Factors|immunologic factors|mesh-ancestor
111345462|NCT00014560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111345463|NCT00020722|Cyclophosphamide|cyclophosphamide|mesh-list
111345464|NCT00020722|Ifosfamide|ifosfamide|mesh-list
111345465|NCT00020722|Thiotepa|thiotepa|mesh-list
111345466|NCT00020722|Carboplatin|carboplatin|mesh-list
111345467|NCT00020722|Etoposide|etoposide|mesh-list
111345468|NCT00020722|Etoposide phosphate|etoposide phosphate|mesh-list
111345469|NCT00020722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111345470|NCT00020722|Immunologic Factors|immunologic factors|mesh-ancestor
111345471|NCT00020722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111345472|NCT00020722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111345473|NCT00020722|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111345474|NCT00020722|Alkylating Agents|alkylating agents|mesh-ancestor
111345475|NCT00020722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111345476|NCT00020722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111345477|NCT00020722|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111345478|NCT00020722|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111345479|NCT00020722|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111345480|NCT00020722|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111345481|NCT00020722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111345482|NCT02649764|Cytarabine|cytarabine|mesh-list
111345483|NCT02649764|Fludarabine|fludarabine|mesh-list
111345484|NCT02649764|Fludarabine phosphate|fludarabine phosphate|mesh-list
111345485|NCT02649764|Prexasertib|prexasertib|mesh-list
111345486|NCT02649764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111345487|NCT02649764|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111345488|NCT02649764|Antimetabolites|antimetabolites|mesh-ancestor
110731406|NCT05178550|Heparin|heparin|mesh-list
111345489|NCT02649764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111345490|NCT02649764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111345491|NCT02649764|Immunologic Factors|immunologic factors|mesh-ancestor
111345492|NCT02649764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111345493|NCT02649764|Antiviral Agents|antiviral agents|mesh-ancestor
110731461|NCT04704921|Growth Substances|growth substances|mesh-ancestor
111345494|NCT02649764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111345495|NCT02649764|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111345496|NCT02649764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111345497|NCT04051996|Decitabine|decitabine|mesh-list
111345498|NCT04051996|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111345499|NCT04051996|Antimetabolites|antimetabolites|mesh-ancestor
111345500|NCT04051996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111345501|NCT04051996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111345502|NCT04051996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111345503|NCT02126878|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
111345504|NCT02126878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111345505|NCT02126878|Glucocorticoids|glucocorticoids|mesh-ancestor
111345506|NCT02126878|Hormones|hormones|mesh-ancestor
111345507|NCT02126878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111345508|NCT02126878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111345509|NCT02126878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111345510|NCT02126878|Immunologic Factors|immunologic factors|mesh-ancestor
111345511|NCT02634008|Ritonavir|ritonavir|mesh-list
111345512|NCT02634008|Ribavirin|ribavirin|mesh-list
111345513|NCT02634008|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111345514|NCT02634008|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111345515|NCT02634008|Protease Inhibitors|protease inhibitors|mesh-ancestor
111345516|NCT02634008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111345517|NCT02634008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111345518|NCT02634008|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111345519|NCT02634008|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111345520|NCT02634008|Antiviral Agents|antiviral agents|mesh-ancestor
111345521|NCT02634008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111345522|NCT02634008|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111345523|NCT02634008|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111345524|NCT02634008|Antimetabolites|antimetabolites|mesh-ancestor
111345525|NCT00000850|Indinavir|indinavir|mesh-list
111345526|NCT00000850|Sargramostim|sargramostim|mesh-list
111345527|NCT00000850|Immunologic Factors|immunologic factors|mesh-ancestor
111345528|NCT00000850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111345529|NCT00000850|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111345530|NCT00000850|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111345531|NCT00000850|Protease Inhibitors|protease inhibitors|mesh-ancestor
111345532|NCT00000850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111345533|NCT00000850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111345534|NCT00000850|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111345535|NCT00000850|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111345536|NCT00000850|Antiviral Agents|antiviral agents|mesh-ancestor
111345537|NCT00000850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111345538|NCT00000856|Ganciclovir|ganciclovir|mesh-list
111345539|NCT00000856|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
111345540|NCT00000856|Foscarnet|foscarnet|mesh-list
111345541|NCT00000856|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
111345542|NCT00000856|Antiviral Agents|antiviral agents|mesh-ancestor
111345543|NCT00000856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111345544|NCT00000856|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111345545|NCT00000856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111345546|NCT00000856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111345547|NCT00000856|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111345548|NCT00001810|Voriconazole|voriconazole|mesh-list
111345549|NCT00001810|Antifungal Agents|antifungal agents|mesh-ancestor
111345550|NCT00001810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111345551|NCT00001810|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110732126|NCT00227617|Immunologic Factors|immunologic factors|mesh-ancestor
111345552|NCT00001810|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111345553|NCT00001810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111345554|NCT00001810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111345555|NCT00001810|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111345556|NCT00001810|Hormone Antagonists|hormone antagonists|mesh-ancestor
111345557|NCT00001810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111345558|NCT00001810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111345559|NCT00001810|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111345560|NCT00000862|Zidovudine|zidovudine|mesh-list
111345561|NCT00000862|Antimetabolites|antimetabolites|mesh-ancestor
111345562|NCT00000862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111345563|NCT00000862|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111345564|NCT00000862|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111345565|NCT00000862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111345566|NCT00000862|Antiviral Agents|antiviral agents|mesh-ancestor
111345567|NCT00000862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111345568|NCT00000862|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111345569|NCT00000862|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111345570|NCT02344472|Paclitaxel|paclitaxel|mesh-list
111345571|NCT02344472|Vinorelbine|vinorelbine|mesh-list
111345572|NCT02344472|Docetaxel|docetaxel|mesh-list
111345573|NCT02344472|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111345574|NCT02344472|Capecitabine|capecitabine|mesh-list
111345575|NCT02344472|Trastuzumab|trastuzumab|mesh-list
111345576|NCT02344472|Letrozole|letrozole|mesh-list
111345577|NCT02344472|Fulvestrant|fulvestrant|mesh-list
111345578|NCT02344472|Pertuzumab|pertuzumab|mesh-list
111345579|NCT02344472|Anastrozole|anastrozole|mesh-list
111345580|NCT02344472|Exemestane|exemestane|mesh-list
111345581|NCT02344472|Goserelin|goserelin|mesh-list
111345582|NCT02344472|Leuprolide|leuprolide|mesh-list
111345583|NCT02344472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110732208|NCT05568615|Edaravone|edaravone|mesh-list
111345584|NCT02344472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111345585|NCT02344472|Tubulin Modulators|tubulin modulators|mesh-ancestor
111345586|NCT02344472|Antimitotic Agents|antimitotic agents|mesh-ancestor
111345587|NCT02344472|Mitosis Modulators|mitosis modulators|mesh-ancestor
111345588|NCT02344472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111345589|NCT02344472|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111345590|NCT02344472|Antimetabolites|antimetabolites|mesh-ancestor
111345591|NCT02344472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111345592|NCT02344472|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111345593|NCT02344472|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111345594|NCT02344472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111345595|NCT02344472|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111345596|NCT02344472|Hormone Antagonists|hormone antagonists|mesh-ancestor
111345597|NCT02344472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111345598|NCT02344472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111345599|NCT02344472|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111345600|NCT02344472|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
111345601|NCT02344472|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111345602|NCT02344472|Fertility Agents|fertility agents|mesh-ancestor
111345603|NCT02344472|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111345604|NCT02338232|Telmisartan|telmisartan|mesh-list
111345605|NCT02338232|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111345606|NCT02338232|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111345607|NCT02338232|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111345608|NCT02338232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111345609|NCT01780636|Botulinum Toxins|botulinum toxins|mesh-list
110732248|NCT05532358|Serotonin Agents|serotonin agents|mesh-ancestor
111345610|NCT01780636|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111345611|NCT01780636|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111345612|NCT01780636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111345613|NCT01780636|Cholinergic Agents|cholinergic agents|mesh-ancestor
111345614|NCT01780636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111345615|NCT01780636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111345616|NCT00000868|Aluminum Hydroxide|aluminum hydroxide|mesh-list
111345617|NCT00000868|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111345618|NCT00000868|Immunologic Factors|immunologic factors|mesh-ancestor
111345619|NCT00000868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111345620|NCT00000868|Antacids|antacids|mesh-ancestor
111345621|NCT00000868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111345622|NCT00000868|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111345623|NCT05586464|Bismuth|bismuth|mesh-list
111345624|NCT05586464|Antacids|antacids|mesh-ancestor
111345625|NCT05586464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111345626|NCT05586464|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111345627|NCT01561378|Insulin Aspart|insulin aspart|mesh-list
111345628|NCT01561378|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111345629|NCT01561378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111345630|NCT02608268|Decitabine|decitabine|mesh-list
111345631|NCT02608268|Spartalizumab|spartalizumab|mesh-list
111345632|NCT02608268|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111345633|NCT02608268|Antimetabolites|antimetabolites|mesh-ancestor
111345634|NCT02608268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111345635|NCT02608268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111345636|NCT02608268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111345637|NCT02608268|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111345638|NCT02608268|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111345639|NCT00000880|Cyclosporine|cyclosporine|mesh-list
111345640|NCT00000880|Cyclosporins|cyclosporins|mesh-list
111345641|NCT00000880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111345642|NCT00000880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111345643|NCT00000880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111345644|NCT00000880|Immunologic Factors|immunologic factors|mesh-ancestor
111345645|NCT00000880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111345646|NCT00000880|Antifungal Agents|antifungal agents|mesh-ancestor
111345647|NCT00000880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111345648|NCT00000880|Dermatologic Agents|dermatologic agents|mesh-ancestor
111345649|NCT00000880|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111345650|NCT00000880|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111345651|NCT02308280|Bortezomib|bortezomib|mesh-list
111345652|NCT02308280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111345653|NCT02279654|Lenalidomide|lenalidomide|mesh-list
111345654|NCT02279654|Immunologic Factors|immunologic factors|mesh-ancestor
111345655|NCT02279654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111345656|NCT02279654|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111345657|NCT02279654|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111345658|NCT02279654|Growth Substances|growth substances|mesh-ancestor
111345659|NCT02279654|Growth Inhibitors|growth inhibitors|mesh-ancestor
111345660|NCT02279654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111345661|NCT02780024|Metformin|metformin|mesh-list
111345662|NCT02780024|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111345663|NCT02780024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111345664|NCT02268656|Propofol|propofol|mesh-list
111345665|NCT02268656|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111345666|NCT02268656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111345667|NCT02268656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111345668|NCT02268656|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111345669|NCT02268656|Anesthetics, General|anesthetics, general|mesh-ancestor
111345670|NCT02268656|Anesthetics|anesthetics|mesh-ancestor
111345671|NCT02564978|Minocycline|minocycline|mesh-list
111345672|NCT02564978|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111345673|NCT02564978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111345674|NCT02554890|Valsartan|valsartan|mesh-list
111345675|NCT02554890|Enalapril|enalapril|mesh-list
111345676|NCT02554890|Enalaprilat|enalaprilat|mesh-list
111345677|NCT02554890|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
111345678|NCT02554890|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111345679|NCT02554890|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111345680|NCT02554890|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111345681|NCT02554890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111345682|NCT02554890|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
111345683|NCT02554890|Protease Inhibitors|protease inhibitors|mesh-ancestor
111345684|NCT02554890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111345685|NCT00001864|Atropine|atropine|mesh-list
111345686|NCT00001864|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111345687|NCT00001864|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111345688|NCT00001864|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111345689|NCT00001864|Autonomic Agents|autonomic agents|mesh-ancestor
111345690|NCT00001864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111345691|NCT00001864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111345692|NCT00001864|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111345693|NCT00001864|Respiratory System Agents|respiratory system agents|mesh-ancestor
111345694|NCT00001864|Mydriatics|mydriatics|mesh-ancestor
111345695|NCT00001864|Parasympatholytics|parasympatholytics|mesh-ancestor
111345696|NCT00001864|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111345697|NCT00001864|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111345698|NCT00001864|Cholinergic Agents|cholinergic agents|mesh-ancestor
111345699|NCT00001864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111345700|NCT00001864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111345701|NCT02229656|Olaparib|olaparib|mesh-list
111345702|NCT02229656|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111345703|NCT02229656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111345704|NCT02229656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111345705|NCT02229656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111345706|NCT00001870|Acetylcholine|acetylcholine|mesh-list
111345707|NCT00001870|Vasodilator Agents|vasodilator agents|mesh-ancestor
111345708|NCT00001870|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111345709|NCT00001870|Cholinergic Agents|cholinergic agents|mesh-ancestor
111345710|NCT00001870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111345711|NCT00001870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111345712|NCT00001870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111345713|NCT03252600|Dexamethasone|dexamethasone|mesh-list
111345714|NCT03252600|Dexamethasone acetate|dexamethasone acetate|mesh-list
111345715|NCT03252600|Cyclophosphamide|cyclophosphamide|mesh-list
111345716|NCT03252600|Lenalidomide|lenalidomide|mesh-list
111345717|NCT03252600|Elotuzumab|elotuzumab|mesh-list
111345718|NCT03252600|Ichthammol|ichthammol|mesh-list
111345719|NCT03252600|BB 1101|bb 1101|mesh-list
111345720|NCT03252600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111345721|NCT03252600|Immunologic Factors|immunologic factors|mesh-ancestor
111345722|NCT03252600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111345723|NCT03252600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111345724|NCT03252600|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111345725|NCT03252600|Alkylating Agents|alkylating agents|mesh-ancestor
110732400|NCT05097209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111345726|NCT03252600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111345727|NCT03252600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111345728|NCT03252600|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111345729|NCT03252600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111345730|NCT03252600|Antiemetics|antiemetics|mesh-ancestor
111345731|NCT03252600|Autonomic Agents|autonomic agents|mesh-ancestor
111345732|NCT03252600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111345733|NCT03252600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111345734|NCT03252600|Glucocorticoids|glucocorticoids|mesh-ancestor
111345735|NCT03252600|Hormones|hormones|mesh-ancestor
111345736|NCT03252600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111345737|NCT03252600|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111345738|NCT03252600|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111345739|NCT03252600|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111345740|NCT03252600|Growth Substances|growth substances|mesh-ancestor
111345741|NCT03252600|Growth Inhibitors|growth inhibitors|mesh-ancestor
111345742|NCT03252600|Protease Inhibitors|protease inhibitors|mesh-ancestor
111345743|NCT03252600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111345744|NCT03252600|Dermatologic Agents|dermatologic agents|mesh-ancestor
111345745|NCT02749526|Tegafur|tegafur|mesh-list
111345746|NCT02749526|Endostar protein|endostar protein|mesh-list
111345747|NCT02749526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111345748|NCT02749526|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111345749|NCT02749526|Antimetabolites|antimetabolites|mesh-ancestor
111345750|NCT02749526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111345751|NCT02749526|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111345752|NCT02749526|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111345753|NCT02749526|Growth Substances|growth substances|mesh-ancestor
111345754|NCT02749526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111345755|NCT02749526|Growth Inhibitors|growth inhibitors|mesh-ancestor
111345756|NCT00000916|Lamivudine|lamivudine|mesh-list
111345757|NCT00000916|Zidovudine|zidovudine|mesh-list
111345758|NCT00000916|Stavudine|stavudine|mesh-list
111345759|NCT00000916|Didanosine|didanosine|mesh-list
111345760|NCT00000916|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
111345761|NCT00000916|Indinavir|indinavir|mesh-list
111345762|NCT00000916|Hydroxyurea|hydroxyurea|mesh-list
111345763|NCT00000916|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111345764|NCT00000916|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111345765|NCT00000916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111345766|NCT00000916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111345767|NCT00000916|Antiviral Agents|antiviral agents|mesh-ancestor
111345768|NCT00000916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111345769|NCT00000916|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111345770|NCT00000916|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111345771|NCT00000916|Antimetabolites|antimetabolites|mesh-ancestor
111345772|NCT00000916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111345773|NCT00000916|Antisickling Agents|antisickling agents|mesh-ancestor
111345774|NCT00000916|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111345775|NCT00000916|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111345776|NCT00000916|Protease Inhibitors|protease inhibitors|mesh-ancestor
111345777|NCT02548364|Vitamin D|vitamin d|mesh-list
111345778|NCT02548364|Calcifediol|calcifediol|mesh-list
111345779|NCT02548364|Vitamins|vitamins|mesh-ancestor
111345780|NCT02548364|Micronutrients|micronutrients|mesh-ancestor
111345781|NCT02548364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111345782|NCT02548364|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111345783|NCT00000130|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111345784|NCT00000130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111345785|NCT02221310|Gemtuzumab|gemtuzumab|mesh-list
111345786|NCT02221310|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111345787|NCT02221310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111345788|NCT02221310|Immunotoxins|immunotoxins|mesh-ancestor
111345789|NCT02221310|Immunoconjugates|immunoconjugates|mesh-ancestor
111345790|NCT02221310|Immunologic Factors|immunologic factors|mesh-ancestor
111345791|NCT02221310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111345793|NCT00000160|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111345794|NCT00000160|Anesthetics, General|anesthetics, general|mesh-ancestor
111345795|NCT00000160|Anesthetics|anesthetics|mesh-ancestor
111345796|NCT00000160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111345797|NCT00000160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111345798|NCT00000178|Prednisone|prednisone|mesh-list
111345799|NCT00000178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111345800|NCT00000178|Glucocorticoids|glucocorticoids|mesh-ancestor
111345801|NCT00000178|Hormones|hormones|mesh-ancestor
111345802|NCT00000178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111345803|NCT00000178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111345804|NCT00000178|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111345805|NCT00000178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111345806|NCT05480280|Leucovorin|leucovorin|mesh-list
111345807|NCT05480280|Fluorouracil|fluorouracil|mesh-list
111345808|NCT05480280|Oxaliplatin|oxaliplatin|mesh-list
111345809|NCT05480280|Calcium|calcium|mesh-list
111345810|NCT05480280|Levoleucovorin|levoleucovorin|mesh-list
111345811|NCT05480280|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111345812|NCT05480280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111345813|NCT05480280|Antimetabolites|antimetabolites|mesh-ancestor
111345814|NCT05480280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111345815|NCT05480280|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111345816|NCT05480280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111345817|NCT05480280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111345818|NCT05480280|Immunologic Factors|immunologic factors|mesh-ancestor
111345819|NCT05480280|Antidotes|antidotes|mesh-ancestor
111345820|NCT05480280|Protective Agents|protective agents|mesh-ancestor
111345821|NCT05480280|Vitamin B Complex|vitamin b complex|mesh-ancestor
111345822|NCT05480280|Vitamins|vitamins|mesh-ancestor
111345823|NCT05480280|Micronutrients|micronutrients|mesh-ancestor
111345824|NCT00001906|Interleukin-12|interleukin-12|mesh-list
111345825|NCT00001906|Aluminum Hydroxide|aluminum hydroxide|mesh-list
111345826|NCT00001906|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111345827|NCT00001906|Immunologic Factors|immunologic factors|mesh-ancestor
111345828|NCT00001906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111345829|NCT00001906|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111345830|NCT00001906|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111070244|NCT00846430|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111345831|NCT00001906|Growth Substances|growth substances|mesh-ancestor
111345832|NCT00001906|Growth Inhibitors|growth inhibitors|mesh-ancestor
111345833|NCT00001906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111345835|NCT00001906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111345836|NCT00001906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111345837|NCT00000196|Naltrexone|naltrexone|mesh-list
111345838|NCT00000196|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111345839|NCT00000196|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111345840|NCT00000196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111345841|NCT00000196|Sensory System Agents|sensory system agents|mesh-ancestor
111345842|NCT00000196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111345843|NCT00000946|polysaccharide-K|polysaccharide-k|mesh-list
111345844|NCT00000946|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111345845|NCT00000946|Immunologic Factors|immunologic factors|mesh-ancestor
111345846|NCT00000946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111345847|NCT00000946|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111345848|NCT00000946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111345849|NCT00000946|Antiviral Agents|antiviral agents|mesh-ancestor
111345850|NCT00000946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111345851|NCT00000946|Interferon Inducers|interferon inducers|mesh-ancestor
111345852|NCT00000946|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111345853|NCT00000946|Protective Agents|protective agents|mesh-ancestor
111345854|NCT02543346|Cetirizine|cetirizine|mesh-list
111345855|NCT02543346|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111345856|NCT02543346|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
111345857|NCT02543346|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111345858|NCT02543346|Histamine Antagonists|histamine antagonists|mesh-ancestor
111345859|NCT02543346|Histamine Agents|histamine agents|mesh-ancestor
111345860|NCT02543346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111345861|NCT02543346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111345862|NCT02543346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111345863|NCT04390100|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
111345864|NCT04390100|Hyaluronic Acid|hyaluronic acid|mesh-list
111345865|NCT04390100|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111345866|NCT04390100|Immunologic Factors|immunologic factors|mesh-ancestor
111345867|NCT04390100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111345868|NCT04390100|Viscosupplements|viscosupplements|mesh-ancestor
111345869|NCT04390100|Protective Agents|protective agents|mesh-ancestor
111345870|NCT04390100|Hemostatics|hemostatics|mesh-ancestor
111345871|NCT04390100|Coagulants|coagulants|mesh-ancestor
111345872|NCT00000202|Buprenorphine|buprenorphine|mesh-list
111345873|NCT00000202|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111345874|NCT00000202|Narcotics|narcotics|mesh-ancestor
111345875|NCT00000202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111345876|NCT00000202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111345877|NCT00000202|Analgesics|analgesics|mesh-ancestor
111345878|NCT00000202|Sensory System Agents|sensory system agents|mesh-ancestor
111345879|NCT00000202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111345880|NCT00000202|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111345881|NCT00000208|Buprenorphine|buprenorphine|mesh-list
111345882|NCT00000208|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111345883|NCT00000208|Narcotics|narcotics|mesh-ancestor
111345884|NCT00000208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111345885|NCT00000208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111345886|NCT00000208|Analgesics|analgesics|mesh-ancestor
111345887|NCT00000208|Sensory System Agents|sensory system agents|mesh-ancestor
111345888|NCT00000208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111345889|NCT00000208|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111345890|NCT00001930|Amantadine|amantadine|mesh-list
111345891|NCT00001930|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111345892|NCT00001930|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111345893|NCT00001930|Antiviral Agents|antiviral agents|mesh-ancestor
111345894|NCT00001930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111345895|NCT00001930|Dopamine Agents|dopamine agents|mesh-ancestor
111345896|NCT00001930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111345897|NCT00001930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110732454|NCT04915248|BB 1101|bb 1101|mesh-list
111345898|NCT00001930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111345899|NCT00001930|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111345900|NCT00001930|Analgesics|analgesics|mesh-ancestor
111345901|NCT00001930|Sensory System Agents|sensory system agents|mesh-ancestor
111345902|NCT00001930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111345903|NCT00000964|Foscarnet|foscarnet|mesh-list
111345904|NCT00000964|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
111345905|NCT00000964|Ranitidine|ranitidine|mesh-list
111345906|NCT00000964|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
111345907|NCT00000964|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111345908|NCT00000964|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111345909|NCT00000964|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
111345910|NCT00000964|Histamine Antagonists|histamine antagonists|mesh-ancestor
111345911|NCT00000964|Histamine Agents|histamine agents|mesh-ancestor
111345912|NCT00000964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111345913|NCT00000964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111345914|NCT00000964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111345915|NCT00000964|Antiviral Agents|antiviral agents|mesh-ancestor
111345916|NCT00000964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111345917|NCT00000964|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111345918|NCT00000964|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111345919|NCT00000964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111345920|NCT00000976|Zidovudine|zidovudine|mesh-list
111345921|NCT00000976|CD4 Immunoadhesins|cd4 immunoadhesins|mesh-list
111345922|NCT00000976|Antimetabolites|antimetabolites|mesh-ancestor
111345923|NCT00000976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111345924|NCT00000976|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111345925|NCT00000976|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111345926|NCT00000976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111345927|NCT00000976|Antiviral Agents|antiviral agents|mesh-ancestor
111345928|NCT00000976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111345929|NCT00000976|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111345930|NCT00000976|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111345931|NCT00000976|Immunologic Factors|immunologic factors|mesh-ancestor
111345932|NCT00000976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111345933|NCT00000226|Buprenorphine|buprenorphine|mesh-list
111345934|NCT00000226|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111345935|NCT00000226|Narcotics|narcotics|mesh-ancestor
111345936|NCT00000226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111345937|NCT00000226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111345938|NCT00000226|Analgesics|analgesics|mesh-ancestor
111345939|NCT00000226|Sensory System Agents|sensory system agents|mesh-ancestor
111345940|NCT00000226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111345941|NCT00000226|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111345942|NCT00000982|Zidovudine|zidovudine|mesh-list
111345943|NCT00000982|Didanosine|didanosine|mesh-list
111345944|NCT00000982|Antimetabolites|antimetabolites|mesh-ancestor
111345945|NCT00000982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111345946|NCT00000982|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111345947|NCT00000982|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111345948|NCT00000982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111345949|NCT00000982|Antiviral Agents|antiviral agents|mesh-ancestor
111345950|NCT00000982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111345951|NCT00000982|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111345952|NCT00000982|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111345953|NCT02549196|Donepezil|donepezil|mesh-list
111345954|NCT02549196|Solifenacin Succinate|solifenacin succinate|mesh-list
111345955|NCT02549196|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111345956|NCT02549196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111345957|NCT02549196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111345958|NCT02549196|Cholinergic Agents|cholinergic agents|mesh-ancestor
111345959|NCT02549196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111345960|NCT02549196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111345961|NCT02549196|Nootropic Agents|nootropic agents|mesh-ancestor
111345962|NCT02549196|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111345963|NCT02549196|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111345964|NCT02549196|Urological Agents|urological agents|mesh-ancestor
111345965|NCT00000988|Stavudine|stavudine|mesh-list
111345966|NCT00000988|Antimetabolites|antimetabolites|mesh-ancestor
111345967|NCT00000988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111345968|NCT00000988|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111345969|NCT00000988|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111345970|NCT00000988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111345971|NCT00000988|Antiviral Agents|antiviral agents|mesh-ancestor
111345972|NCT00000988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111345973|NCT00000988|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111345974|NCT00000988|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111345975|NCT00000232|Buprenorphine|buprenorphine|mesh-list
111345976|NCT00000232|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111345977|NCT00000232|Narcotics|narcotics|mesh-ancestor
111345978|NCT00000232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111345979|NCT00000232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111345980|NCT00000232|Analgesics|analgesics|mesh-ancestor
111345981|NCT00000232|Sensory System Agents|sensory system agents|mesh-ancestor
111345982|NCT00000232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111345983|NCT00000232|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111345984|NCT00000238|Buprenorphine|buprenorphine|mesh-list
111345985|NCT00000238|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111345986|NCT00000238|Narcotics|narcotics|mesh-ancestor
111345987|NCT00000238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111345988|NCT00000238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111345990|NCT00000238|Sensory System Agents|sensory system agents|mesh-ancestor
111345991|NCT00000238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111345992|NCT00000238|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111345993|NCT00000244|Dynorphins|dynorphins|mesh-list
111345994|NCT00000244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111345995|NCT00000244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111345996|NCT00000244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111345997|NCT00000994|Zidovudine|zidovudine|mesh-list
111345998|NCT00000994|Antimetabolites|antimetabolites|mesh-ancestor
111345999|NCT00000994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111346000|NCT00000994|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111346001|NCT00000994|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111346002|NCT00000994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111346003|NCT00000994|Antiviral Agents|antiviral agents|mesh-ancestor
111346004|NCT00000994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111346005|NCT00000994|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111346006|NCT00000994|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111346007|NCT00001006|Ammonium trichloro(dioxoethylene-O,O'-)tellurate|ammonium trichloro(dioxoethylene-o,o'-)tellurate|mesh-list
111346008|NCT00001006|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111346009|NCT00001006|Immunologic Factors|immunologic factors|mesh-ancestor
111346010|NCT00001006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111346011|NCT00001006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111346012|NCT00001006|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111346013|NCT00001006|Protective Agents|protective agents|mesh-ancestor
111346014|NCT00001006|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111346015|NCT00001006|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111346016|NCT00001006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111346017|NCT00001006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111346018|NCT00001006|Antiviral Agents|antiviral agents|mesh-ancestor
111346019|NCT00001006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111346020|NCT00001954|Etanercept|etanercept|mesh-list
111346021|NCT00001954|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111346022|NCT00001954|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111346023|NCT00001954|Analgesics|analgesics|mesh-ancestor
111346024|NCT00001954|Sensory System Agents|sensory system agents|mesh-ancestor
111346025|NCT00001954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111346026|NCT00001954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111346027|NCT00001954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111346028|NCT00001954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111346029|NCT00001954|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110732577|NCT04447183|Iodine|iodine|mesh-list
111346030|NCT00001954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111346031|NCT00001954|Immunologic Factors|immunologic factors|mesh-ancestor
111346032|NCT02904954|Durvalumab|durvalumab|mesh-list
111346033|NCT02904954|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111346034|NCT02904954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111346035|NCT02904954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111346036|NCT02904954|Immunologic Factors|immunologic factors|mesh-ancestor
111346037|NCT02904954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111346038|NCT00000250|Nitrous Oxide|nitrous oxide|mesh-list
110732712|NCT05933213|Serotonin Agents|serotonin agents|mesh-ancestor
111346039|NCT00000250|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111346040|NCT00000250|Anesthetics, General|anesthetics, general|mesh-ancestor
111346041|NCT00000250|Anesthetics|anesthetics|mesh-ancestor
111346042|NCT00000250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111346043|NCT00000250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110732790|NCT05932316|Albuterol|albuterol|mesh-list
111346044|NCT00000250|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111346045|NCT00000250|Analgesics|analgesics|mesh-ancestor
111346046|NCT00000250|Sensory System Agents|sensory system agents|mesh-ancestor
111346047|NCT00000250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111346048|NCT03244020|Aspirin|aspirin|mesh-list
111346049|NCT03244020|Enoxaparin|enoxaparin|mesh-list
111346050|NCT03244020|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110732855|NCT05932264|Apatinib|apatinib|mesh-list
111346051|NCT03244020|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111346052|NCT03244020|Analgesics|analgesics|mesh-ancestor
111346053|NCT03244020|Sensory System Agents|sensory system agents|mesh-ancestor
111346054|NCT03244020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111346055|NCT03244020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111346056|NCT03244020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110732920|NCT05931328|Thiotepa|thiotepa|mesh-list
111346057|NCT03244020|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111346058|NCT03244020|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111346059|NCT03244020|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111070469|NCT03130153|Analgesics|analgesics|mesh-ancestor
111346060|NCT03244020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111346061|NCT03244020|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111346062|NCT03244020|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111346063|NCT03244020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111346064|NCT03244020|Antipyretics|antipyretics|mesh-ancestor
111346065|NCT03244020|Anticoagulants|anticoagulants|mesh-ancestor
111346066|NCT00000262|Nitrous Oxide|nitrous oxide|mesh-list
111346067|NCT00000262|Sevoflurane|sevoflurane|mesh-list
111346068|NCT00000262|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111346069|NCT00000262|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111346070|NCT00000262|Anesthetics, General|anesthetics, general|mesh-ancestor
111346071|NCT00000262|Anesthetics|anesthetics|mesh-ancestor
111346072|NCT00000262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110733057|NCT05930171|Sensory System Agents|sensory system agents|mesh-ancestor
111346073|NCT00000262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111346074|NCT00000262|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111346075|NCT00000262|Analgesics|analgesics|mesh-ancestor
111346076|NCT00000262|Sensory System Agents|sensory system agents|mesh-ancestor
111346077|NCT00000262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111346078|NCT00001024|Zidovudine|zidovudine|mesh-list
111346079|NCT00001024|Didanosine|didanosine|mesh-list
111346080|NCT00001024|Antimetabolites|antimetabolites|mesh-ancestor
111346081|NCT00001024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111346082|NCT00001024|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111346083|NCT00001024|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111346084|NCT00001024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111346085|NCT00001024|Antiviral Agents|antiviral agents|mesh-ancestor
111346086|NCT00001024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111346087|NCT00001024|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111346088|NCT00001024|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111346089|NCT00000268|Bupropion|bupropion|mesh-list
111346090|NCT00000268|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111346091|NCT00000268|Antidepressive Agents|antidepressive agents|mesh-ancestor
111346092|NCT00000268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111346093|NCT00000268|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111346094|NCT00000268|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111346095|NCT00000268|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111346096|NCT00000268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111346097|NCT00000268|Dopamine Agents|dopamine agents|mesh-ancestor
111346098|NCT00000268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111346099|NCT00000268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111346100|NCT00000268|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111346101|NCT00000268|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111346102|NCT00000268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111346103|NCT02847624|Tolvaptan|tolvaptan|mesh-list
110733446|NCT05627557|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111346104|NCT02847624|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
111346105|NCT02847624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111346106|NCT02847624|Natriuretic Agents|natriuretic agents|mesh-ancestor
110451271|NCT00930579|Metformin|metformin|mesh-list
111346107|NCT02847624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111346108|NCT00001042|Aluminum Hydroxide|aluminum hydroxide|mesh-list
111346109|NCT00001042|MF59 oil emulsion|mf59 oil emulsion|mesh-list
111346110|NCT00001042|Acetylmuramyl-Alanyl-Isoglutamine|acetylmuramyl-alanyl-isoglutamine|mesh-list
111346111|NCT00001042|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111346112|NCT00001042|Immunologic Factors|immunologic factors|mesh-ancestor
111346113|NCT00001042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111346114|NCT00001042|Antacids|antacids|mesh-ancestor
110733592|NCT05444543|Hormones|hormones|mesh-ancestor
110733594|NCT05443971|Durvalumab|durvalumab|mesh-list
111346115|NCT00001042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111346116|NCT00001042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111346117|NCT00982865|Niacinamide|niacinamide|mesh-list
111346118|NCT00982865|Vitamin B Complex|vitamin b complex|mesh-ancestor
111346119|NCT00982865|Vitamins|vitamins|mesh-ancestor
111346120|NCT00982865|Micronutrients|micronutrients|mesh-ancestor
111346121|NCT00982865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111346122|NCT00001054|Valacyclovir|valacyclovir|mesh-list
111346123|NCT00001054|Antiviral Agents|antiviral agents|mesh-ancestor
111346124|NCT00001054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111346125|NCT02521844|Pembrolizumab|pembrolizumab|mesh-list
111346126|NCT02521844|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111346127|NCT02521844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111346128|NCT02521844|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111346129|NCT02521844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111346130|NCT01226719|Leucovorin|leucovorin|mesh-list
111346131|NCT01226719|Fluorouracil|fluorouracil|mesh-list
111070549|NCT03491969|Vitamins|vitamins|mesh-ancestor
111346132|NCT01226719|Oxaliplatin|oxaliplatin|mesh-list
111346133|NCT01226719|Irinotecan|irinotecan|mesh-list
111346134|NCT01226719|Panitumumab|panitumumab|mesh-list
111346135|NCT01226719|Antimetabolites|antimetabolites|mesh-ancestor
111346136|NCT01226719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110733798|NCT05143281|Dexamethasone|dexamethasone|mesh-list
111346137|NCT01226719|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111346138|NCT01226719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111346139|NCT01226719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111346140|NCT01226719|Immunologic Factors|immunologic factors|mesh-ancestor
111346141|NCT01226719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111346142|NCT01226719|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111346143|NCT01226719|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111346144|NCT01226719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111346145|NCT01226719|Antidotes|antidotes|mesh-ancestor
111346146|NCT01226719|Protective Agents|protective agents|mesh-ancestor
110733954|NCT05021913|Lidocaine|lidocaine|mesh-list
111346147|NCT01226719|Vitamin B Complex|vitamin b complex|mesh-ancestor
111346148|NCT01226719|Vitamins|vitamins|mesh-ancestor
111346149|NCT01226719|Micronutrients|micronutrients|mesh-ancestor
111346150|NCT01226719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111346151|NCT00001072|polysaccharide-K|polysaccharide-k|mesh-list
111346152|NCT00001072|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111346153|NCT00001072|Immunologic Factors|immunologic factors|mesh-ancestor
111346154|NCT00001072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111346155|NCT00001072|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111346156|NCT00001072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111346157|NCT00001072|Antiviral Agents|antiviral agents|mesh-ancestor
111346158|NCT00001072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111346159|NCT00001072|Interferon Inducers|interferon inducers|mesh-ancestor
111346160|NCT00001072|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111346161|NCT00001072|Protective Agents|protective agents|mesh-ancestor
111346162|NCT04331470|Ritonavir|ritonavir|mesh-list
111346163|NCT04331470|Lopinavir|lopinavir|mesh-list
111346164|NCT04331470|Chloroquine|chloroquine|mesh-list
111346165|NCT04331470|Levamisole|levamisole|mesh-list
111346166|NCT04331470|Hydroxychloroquine|hydroxychloroquine|mesh-list
111346167|NCT04331470|Budesonide|budesonide|mesh-list
111346168|NCT04331470|Formoterol Fumarate|formoterol fumarate|mesh-list
111346169|NCT04331470|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110734147|NCT04663750|Aflibercept|aflibercept|mesh-list
111346170|NCT04331470|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111346171|NCT04331470|Protease Inhibitors|protease inhibitors|mesh-ancestor
111346172|NCT04331470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111346173|NCT04331470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111346174|NCT04331470|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111346175|NCT04331470|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111346176|NCT04331470|Antiviral Agents|antiviral agents|mesh-ancestor
111346177|NCT04331470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111346178|NCT04331470|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110734303|NCT04310995|Nicorandil|nicorandil|mesh-list
111346179|NCT04331470|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111346180|NCT04331470|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111346181|NCT04331470|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111346182|NCT04331470|Autonomic Agents|autonomic agents|mesh-ancestor
111346183|NCT04331470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111346184|NCT04331470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111346185|NCT04331470|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111346186|NCT04331470|Respiratory System Agents|respiratory system agents|mesh-ancestor
111346187|NCT04331470|Glucocorticoids|glucocorticoids|mesh-ancestor
111346188|NCT04331470|Hormones|hormones|mesh-ancestor
111346189|NCT04331470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111346190|NCT04331470|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111346191|NCT04331470|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111346192|NCT04331470|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111346193|NCT04331470|Adrenergic Agents|adrenergic agents|mesh-ancestor
111346194|NCT04331470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111346195|NCT04331470|Amebicides|amebicides|mesh-ancestor
111346196|NCT04331470|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111346197|NCT04331470|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111346198|NCT04331470|Antimalarials|antimalarials|mesh-ancestor
111346199|NCT04331470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111346200|NCT04331470|Antinematodal Agents|antinematodal agents|mesh-ancestor
111346201|NCT04331470|Anthelmintics|anthelmintics|mesh-ancestor
111346202|NCT04331470|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111346203|NCT04331470|Immunologic Factors|immunologic factors|mesh-ancestor
111346204|NCT00001090|Sargramostim|sargramostim|mesh-list
111346205|NCT00001090|Immunologic Factors|immunologic factors|mesh-ancestor
111346206|NCT00001090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111346207|NCT01147627|Insulin|insulin|mesh-list
111346208|NCT01147627|Pioglitazone|pioglitazone|mesh-list
111346209|NCT01147627|Exenatide|exenatide|mesh-list
111346210|NCT01147627|Insulin Lispro|insulin lispro|mesh-list
111346211|NCT01147627|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111346212|NCT01147627|Protamines|protamines|mesh-list
111346213|NCT01147627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111346214|NCT01147627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111346215|NCT01147627|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111346216|NCT01147627|Incretins|incretins|mesh-ancestor
111346217|NCT01147627|Hormones|hormones|mesh-ancestor
111346218|NCT01147627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111346219|NCT01147627|Heparin Antagonists|heparin antagonists|mesh-ancestor
111346220|NCT01147627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111346221|NCT01147627|Coagulants|coagulants|mesh-ancestor
111346222|NCT02548962|Dexamethasone|dexamethasone|mesh-list
111346223|NCT02548962|Pomalidomide|pomalidomide|mesh-list
111346224|NCT02548962|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111346225|NCT02548962|Antiemetics|antiemetics|mesh-ancestor
111346226|NCT02548962|Autonomic Agents|autonomic agents|mesh-ancestor
111346227|NCT02548962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111346228|NCT02548962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111346229|NCT02548962|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111346230|NCT02548962|Glucocorticoids|glucocorticoids|mesh-ancestor
111346231|NCT02548962|Hormones|hormones|mesh-ancestor
111346232|NCT02548962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111346233|NCT02548962|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111346234|NCT02548962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111346235|NCT02548962|Immunologic Factors|immunologic factors|mesh-ancestor
111346236|NCT02548962|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111346237|NCT02548962|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111346238|NCT02548962|Growth Substances|growth substances|mesh-ancestor
111346239|NCT02548962|Growth Inhibitors|growth inhibitors|mesh-ancestor
111346240|NCT00000274|Flupenthixol|flupenthixol|mesh-list
111346241|NCT00000274|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
111346242|NCT00000274|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111346243|NCT00000274|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111346244|NCT00000274|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111346245|NCT00000274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111346246|NCT00000274|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111346247|NCT00000274|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111346248|NCT00000274|Dopamine Agents|dopamine agents|mesh-ancestor
111346249|NCT00000274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111346250|NCT00000274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111346251|NCT02743598|Liraglutide|liraglutide|mesh-list
111346252|NCT02743598|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111346253|NCT02743598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111346254|NCT02743598|Incretins|incretins|mesh-ancestor
111346255|NCT02743598|Hormones|hormones|mesh-ancestor
111346256|NCT02743598|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111346257|NCT00000280|Nimodipine|nimodipine|mesh-list
111346258|NCT00000280|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111346259|NCT00000280|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111346260|NCT00000280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111346261|NCT00000280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111346262|NCT00000280|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111346263|NCT00000280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111346264|NCT00000280|Vasodilator Agents|vasodilator agents|mesh-ancestor
111346265|NCT00000286|Nefazodone|nefazodone|mesh-list
111346266|NCT00000286|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111346267|NCT00000286|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111346268|NCT00000286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111346269|NCT00000286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111346270|NCT00000286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111346271|NCT00000286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111346272|NCT00000286|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111346273|NCT00000286|Antidepressive Agents|antidepressive agents|mesh-ancestor
111346274|NCT00000286|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111346275|NCT00000286|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110734510|NCT04059562|Irinotecan|irinotecan|mesh-list
111346276|NCT00000286|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111346277|NCT00000286|Serotonin Agents|serotonin agents|mesh-ancestor
111346278|NCT01188577|Epinephrine|epinephrine|mesh-list
111346279|NCT01188577|Racepinephrine|racepinephrine|mesh-list
111346280|NCT01188577|Epinephryl borate|epinephryl borate|mesh-list
111346281|NCT01188577|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111346282|NCT01188577|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111346283|NCT01188577|Adrenergic Agents|adrenergic agents|mesh-ancestor
110452326|NCT01095653|Metformin|metformin|mesh-list
111346284|NCT01188577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111346285|NCT01188577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111346286|NCT01188577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111346287|NCT01188577|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111346288|NCT01188577|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111346290|NCT01188577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111346291|NCT01188577|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111346292|NCT01188577|Respiratory System Agents|respiratory system agents|mesh-ancestor
111346293|NCT01188577|Mydriatics|mydriatics|mesh-ancestor
111346294|NCT01188577|Sympathomimetics|sympathomimetics|mesh-ancestor
111346295|NCT01188577|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111346296|NCT02507336|Thalidomide|thalidomide|mesh-list
111346297|NCT02507336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111346298|NCT02507336|Immunologic Factors|immunologic factors|mesh-ancestor
111346299|NCT02507336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111346300|NCT02507336|Leprostatic Agents|leprostatic agents|mesh-ancestor
111346301|NCT02507336|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111346302|NCT02507336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111346303|NCT02507336|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111346304|NCT02507336|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111346305|NCT02507336|Growth Substances|growth substances|mesh-ancestor
111346306|NCT02507336|Growth Inhibitors|growth inhibitors|mesh-ancestor
110734786|NCT03412773|Sorafenib|sorafenib|mesh-list
111346307|NCT02507336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111346308|NCT00000292|Cocaine|cocaine|mesh-list
111346309|NCT00000292|Anesthetics, Local|anesthetics, local|mesh-ancestor
111346310|NCT00000292|Anesthetics|anesthetics|mesh-ancestor
111346311|NCT00000292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111346312|NCT00000292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110734852|NCT03290950|Dexamethasone|dexamethasone|mesh-list
111346313|NCT00000292|Sensory System Agents|sensory system agents|mesh-ancestor
111346314|NCT00000292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111346315|NCT00000292|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111346316|NCT00000292|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111346317|NCT00000292|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111346318|NCT00000292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111346319|NCT00000292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111346320|NCT00000292|Dopamine Agents|dopamine agents|mesh-ancestor
111346321|NCT00000292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111346322|NCT00000298|Buprenorphine|buprenorphine|mesh-list
111346323|NCT00000298|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
111346324|NCT00000298|Naloxone|naloxone|mesh-list
111346325|NCT00000298|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111346326|NCT00000298|Narcotics|narcotics|mesh-ancestor
111346327|NCT00000298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111346328|NCT00000298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111346329|NCT00000298|Analgesics|analgesics|mesh-ancestor
111346330|NCT00000298|Sensory System Agents|sensory system agents|mesh-ancestor
111346331|NCT00000298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111346332|NCT00000298|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111346333|NCT00000304|Amphetamine|amphetamine|mesh-list
111346334|NCT00000304|Dextroamphetamine|dextroamphetamine|mesh-list
111346335|NCT00000304|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111346336|NCT00000304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111346337|NCT00000304|Sympathomimetics|sympathomimetics|mesh-ancestor
111346338|NCT00000304|Autonomic Agents|autonomic agents|mesh-ancestor
111346339|NCT00000304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111346340|NCT00000304|Dopamine Agents|dopamine agents|mesh-ancestor
111346341|NCT00000304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111346342|NCT00000304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111346343|NCT00000304|Adrenergic Agents|adrenergic agents|mesh-ancestor
111346344|NCT00000304|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111346345|NCT00000304|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111346346|NCT00000304|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111346347|NCT00000304|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111346348|NCT02548650|Aspirin|aspirin|mesh-list
111346349|NCT02548650|Clopidogrel|clopidogrel|mesh-list
111346350|NCT02548650|Vorapaxar|vorapaxar|mesh-list
111346351|NCT02548650|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111346352|NCT02548650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111346353|NCT02548650|Analgesics|analgesics|mesh-ancestor
111346354|NCT02548650|Sensory System Agents|sensory system agents|mesh-ancestor
111346355|NCT02548650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111346356|NCT02548650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111346357|NCT02548650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111346358|NCT02548650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111070767|NCT04006769|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111346359|NCT02548650|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111346360|NCT02548650|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111346361|NCT02548650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111346362|NCT02548650|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111346363|NCT02548650|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110735117|NCT02804594|Antidotes|antidotes|mesh-ancestor
111346364|NCT02548650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111346365|NCT02548650|Antipyretics|antipyretics|mesh-ancestor
111346366|NCT02548650|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111346367|NCT02548650|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111346368|NCT02548650|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111346369|NCT02548650|Purinergic Agents|purinergic agents|mesh-ancestor
111346370|NCT02548650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111346371|NCT00000310|Risperidone|risperidone|mesh-list
111346372|NCT00000310|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111346373|NCT00000310|Serotonin Agents|serotonin agents|mesh-ancestor
111346374|NCT00000310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111346375|NCT00000310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111346376|NCT00000310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111346377|NCT00000310|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111346378|NCT00000310|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110735365|NCT01504815|Cisplatin|cisplatin|mesh-list
111346379|NCT00000310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111346380|NCT00000310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111346381|NCT00000310|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111346382|NCT00000310|Dopamine Agents|dopamine agents|mesh-ancestor
111346383|NCT02734004|Bevacizumab|bevacizumab|mesh-list
111346384|NCT02734004|Durvalumab|durvalumab|mesh-list
111346385|NCT02734004|Olaparib|olaparib|mesh-list
111346386|NCT02734004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111346387|NCT02734004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111346388|NCT02734004|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111346389|NCT02734004|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111346390|NCT02734004|Growth Substances|growth substances|mesh-ancestor
111346391|NCT02734004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111346392|NCT02734004|Growth Inhibitors|growth inhibitors|mesh-ancestor
111346393|NCT02734004|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111346394|NCT02734004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111346395|NCT02734004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111346396|NCT01227655|Levodopa|levodopa|mesh-list
111346397|NCT01227655|Carbidopa|carbidopa|mesh-list
111346398|NCT01227655|Opicapone|opicapone|mesh-list
111346399|NCT01227655|Benserazide|benserazide|mesh-list
111346400|NCT01227655|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111346401|NCT01227655|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111346402|NCT01227655|Dopamine Agents|dopamine agents|mesh-ancestor
111346403|NCT01227655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111346404|NCT01227655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111346405|NCT01227655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111346406|NCT01227655|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
111346407|NCT01227655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111346408|NCT01227655|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
111346409|NCT00000316|Cocaine|cocaine|mesh-list
111346410|NCT00000316|Anesthetics, Local|anesthetics, local|mesh-ancestor
111346411|NCT00000316|Anesthetics|anesthetics|mesh-ancestor
111346412|NCT00000316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111346413|NCT00000316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111346414|NCT00000316|Sensory System Agents|sensory system agents|mesh-ancestor
111346415|NCT00000316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111346416|NCT00000316|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111346417|NCT00000316|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111346418|NCT00000316|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110735708|NCT00046930|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111346419|NCT00000316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111346420|NCT00000316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111346421|NCT00000316|Dopamine Agents|dopamine agents|mesh-ancestor
111346422|NCT00000316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111346423|NCT05459532|Molnupiravir|molnupiravir|mesh-list
111346424|NCT05459532|Antiviral Agents|antiviral agents|mesh-ancestor
111346425|NCT05459532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111346426|NCT00001990|Atovaquone|atovaquone|mesh-list
111346427|NCT00001990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111346428|NCT00001990|Antimalarials|antimalarials|mesh-ancestor
111346429|NCT00001990|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111346430|NCT00001990|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111346431|NCT00001990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111070837|NCT03417479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111346432|NCT00001990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111346433|NCT01026623|Sirolimus|sirolimus|mesh-list
111346434|NCT01026623|Temsirolimus|temsirolimus|mesh-list
111346435|NCT01026623|MTOR Inhibitors|mtor inhibitors|mesh-list
111346436|NCT01026623|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111346437|NCT01026623|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111346438|NCT01026623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110735918|NCT04090710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111346439|NCT01026623|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111346440|NCT01026623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111346441|NCT01026623|Antifungal Agents|antifungal agents|mesh-ancestor
111346442|NCT01026623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111346443|NCT01026623|Immunologic Factors|immunologic factors|mesh-ancestor
111346444|NCT01026623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110735997|NCT03711474|Hormones|hormones|mesh-ancestor
111346445|NCT01026623|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111346446|NCT01026623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111346447|NCT01026623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111346448|NCT00001996|Atovaquone|atovaquone|mesh-list
111346449|NCT00001996|Pentamidine|pentamidine|mesh-list
111346450|NCT00001996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111346451|NCT00001996|Antimalarials|antimalarials|mesh-ancestor
111346452|NCT00001996|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111346453|NCT00001996|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111346454|NCT00001996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111346455|NCT00001996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111346456|NCT00001996|Antifungal Agents|antifungal agents|mesh-ancestor
111346457|NCT00001996|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
111346458|NCT02725424|Docetaxel|docetaxel|mesh-list
111346459|NCT02725424|Oxaliplatin|oxaliplatin|mesh-list
111346460|NCT02725424|Trastuzumab|trastuzumab|mesh-list
111346461|NCT02725424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111346462|NCT02725424|Tubulin Modulators|tubulin modulators|mesh-ancestor
111346463|NCT02725424|Antimitotic Agents|antimitotic agents|mesh-ancestor
111346464|NCT02725424|Mitosis Modulators|mitosis modulators|mesh-ancestor
111346465|NCT02725424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111346466|NCT02725424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111346467|NCT01189279|Bimatoprost|bimatoprost|mesh-list
111346468|NCT01189279|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111346469|NCT00001108|Ritonavir|ritonavir|mesh-list
111346470|NCT00001108|Nelfinavir|nelfinavir|mesh-list
111346471|NCT00001108|Saquinavir|saquinavir|mesh-list
111346472|NCT00001108|Lamivudine|lamivudine|mesh-list
111346473|NCT00001108|Nevirapine|nevirapine|mesh-list
111346474|NCT00001108|Stavudine|stavudine|mesh-list
111346475|NCT00001108|Didanosine|didanosine|mesh-list
111346476|NCT00001108|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111346477|NCT00001108|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111346478|NCT00001108|Protease Inhibitors|protease inhibitors|mesh-ancestor
111346479|NCT00001108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111346480|NCT00001108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111346481|NCT00001108|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111346482|NCT00001108|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111346483|NCT00001108|Antiviral Agents|antiviral agents|mesh-ancestor
111346484|NCT00001108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111346485|NCT00001108|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111346486|NCT00001108|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111346487|NCT00001108|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111346488|NCT00001108|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111346489|NCT00001108|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111346490|NCT00001108|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111346491|NCT00001108|Antimetabolites|antimetabolites|mesh-ancestor
111346492|NCT00000328|Analgesics, Opioid|analgesics, opioid|mesh-list
111346493|NCT00000328|Narcotics|narcotics|mesh-ancestor
111346494|NCT00000328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111346495|NCT00000328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111346496|NCT00000328|Analgesics|analgesics|mesh-ancestor
111346497|NCT00000328|Sensory System Agents|sensory system agents|mesh-ancestor
111346498|NCT00000328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111346499|NCT00380224|Olanzapine|olanzapine|mesh-list
111346500|NCT00380224|Antiemetics|antiemetics|mesh-ancestor
111346501|NCT00380224|Autonomic Agents|autonomic agents|mesh-ancestor
111346502|NCT00380224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111346503|NCT00380224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111346504|NCT00380224|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111346505|NCT00380224|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111346506|NCT00380224|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111346507|NCT00380224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111346508|NCT00380224|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111346509|NCT00380224|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111346510|NCT00380224|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111346511|NCT00380224|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111346512|NCT00380224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111346513|NCT00380224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111346514|NCT00380224|Serotonin Agents|serotonin agents|mesh-ancestor
111346515|NCT00002002|Leucovorin|leucovorin|mesh-list
111346516|NCT00002002|Trimethoprim|trimethoprim|mesh-list
111346517|NCT00002002|Sulfamethoxazole|sulfamethoxazole|mesh-list
111346518|NCT00002002|Calcium|calcium|mesh-list
111346519|NCT00002002|Levoleucovorin|levoleucovorin|mesh-list
111346520|NCT00002002|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110736687|NCT02530424|Pertuzumab|pertuzumab|mesh-list
111346521|NCT00002002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111346522|NCT00002002|Antidotes|antidotes|mesh-ancestor
111346523|NCT00002002|Protective Agents|protective agents|mesh-ancestor
111346524|NCT00002002|Vitamin B Complex|vitamin b complex|mesh-ancestor
111346525|NCT00002002|Vitamins|vitamins|mesh-ancestor
111346526|NCT00002002|Micronutrients|micronutrients|mesh-ancestor
111346527|NCT00002002|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111346528|NCT00002002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111346529|NCT00002002|Antimalarials|antimalarials|mesh-ancestor
111346530|NCT00002002|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111346531|NCT00002002|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111346532|NCT00002002|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111346533|NCT00002002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111346534|NCT00002002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111346535|NCT00002002|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111346536|NCT00002002|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
111346537|NCT00002002|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111346538|NCT02535000|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
111346539|NCT02535000|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111346540|NCT02535000|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111346541|NCT02535000|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111346542|NCT02535000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111346543|NCT02535000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111346544|NCT02535000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111346545|NCT02535000|Analgesics|analgesics|mesh-ancestor
111346546|NCT02535000|Sensory System Agents|sensory system agents|mesh-ancestor
111346547|NCT02535000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110736862|NCT01311076|Insulin|insulin|mesh-list
111346548|NCT02535000|Antidepressive Agents|antidepressive agents|mesh-ancestor
111346549|NCT02535000|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111346550|NCT02535000|Dopamine Agents|dopamine agents|mesh-ancestor
111346551|NCT00380380|Vildagliptin|vildagliptin|mesh-list
111346552|NCT00380380|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111346553|NCT00380380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111346554|NCT00380380|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111346555|NCT00380380|Protease Inhibitors|protease inhibitors|mesh-ancestor
111346556|NCT00380380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111346557|NCT00380380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111346558|NCT01228903|Allopurinol|allopurinol|mesh-list
111346559|NCT01228903|Antimetabolites|antimetabolites|mesh-ancestor
111346560|NCT01228903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111346561|NCT01228903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111346562|NCT01228903|Gout Suppressants|gout suppressants|mesh-ancestor
111346563|NCT01228903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111346564|NCT01228903|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111346565|NCT01228903|Antioxidants|antioxidants|mesh-ancestor
111346566|NCT01228903|Protective Agents|protective agents|mesh-ancestor
111346567|NCT01228903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111346568|NCT01189747|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111346569|NCT01189747|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111346570|NCT01189747|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111346571|NCT01189747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111346572|NCT01189747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111346573|NCT01189747|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111346574|NCT01189747|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111346575|NCT01189747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111346576|NCT01189747|Cholinergic Agents|cholinergic agents|mesh-ancestor
111346577|NCT01189747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111346578|NCT00001126|Cidofovir|cidofovir|mesh-list
110737301|NCT03716596|Antibodies|antibodies|mesh-list
111346579|NCT00001126|Antiviral Agents|antiviral agents|mesh-ancestor
111346580|NCT00001126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111346581|NCT00001126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110737346|NCT01310842|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111346582|NCT00001126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111346583|NCT00002008|Sargramostim|sargramostim|mesh-list
111346584|NCT00002008|Immunologic Factors|immunologic factors|mesh-ancestor
111346585|NCT00002008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111346587|NCT00001132|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111346588|NCT00001132|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111346589|NCT00001132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111346590|NCT00001132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111346591|NCT00001132|Antiviral Agents|antiviral agents|mesh-ancestor
111346592|NCT00001132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111346593|NCT00001132|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111346594|NCT00001132|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111346595|NCT01149733|Tamsulosin|tamsulosin|mesh-list
111346596|NCT01149733|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111346597|NCT01149733|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111346598|NCT01149733|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111346599|NCT01149733|Adrenergic Agents|adrenergic agents|mesh-ancestor
111346600|NCT01149733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111346601|NCT01149733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111346602|NCT01149733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111346603|NCT01149733|Urological Agents|urological agents|mesh-ancestor
111346604|NCT00002014|Zidovudine|zidovudine|mesh-list
111346605|NCT00002014|Didanosine|didanosine|mesh-list
111346606|NCT00002014|Antimetabolites|antimetabolites|mesh-ancestor
111346607|NCT00002014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111346608|NCT00002014|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111346609|NCT00002014|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111346610|NCT00002014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111346611|NCT00002014|Antiviral Agents|antiviral agents|mesh-ancestor
111346612|NCT00002014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111346613|NCT00002014|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111346614|NCT00002014|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111346615|NCT00000334|Buprenorphine|buprenorphine|mesh-list
111346616|NCT00000334|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111346617|NCT00000334|Narcotics|narcotics|mesh-ancestor
111346618|NCT00000334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111346619|NCT00000334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111346620|NCT00000334|Analgesics|analgesics|mesh-ancestor
111346621|NCT00000334|Sensory System Agents|sensory system agents|mesh-ancestor
110737554|NCT00378209|Growth Substances|growth substances|mesh-ancestor
111346622|NCT00000334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111346623|NCT00000334|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111346624|NCT00000340|Pemoline|pemoline|mesh-list
111346625|NCT00000340|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111346626|NCT00000340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111346627|NCT00002020|Zidovudine|zidovudine|mesh-list
111346628|NCT00002020|Antimetabolites|antimetabolites|mesh-ancestor
111346629|NCT00002020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110737680|NCT01049633|Antipyretics|antipyretics|mesh-ancestor
111346630|NCT00002020|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111346631|NCT00002020|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111346632|NCT00002020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111346633|NCT00002020|Antiviral Agents|antiviral agents|mesh-ancestor
111346634|NCT00002020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111346635|NCT00002020|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111346636|NCT00002020|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111346637|NCT00002026|Acyclovir|acyclovir|mesh-list
111346638|NCT00002026|Antiviral Agents|antiviral agents|mesh-ancestor
111346639|NCT00002026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111346640|NCT00000352|Dextromethorphan|dextromethorphan|mesh-list
111346641|NCT00000352|Antitussive Agents|antitussive agents|mesh-ancestor
111346642|NCT00000352|Respiratory System Agents|respiratory system agents|mesh-ancestor
110737759|NCT00005906|Octreotide|octreotide|mesh-list
111346643|NCT00000352|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111346644|NCT00000352|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111346645|NCT00000352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111346646|NCT00000352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110737814|NCT03409276|Vaccines|vaccines|mesh-list
111346647|NCT00000352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111346648|NCT00002032|Rifabutin|rifabutin|mesh-list
111346649|NCT00002032|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111346650|NCT00002032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111346651|NCT00002032|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111346652|NCT00002032|Antitubercular Agents|antitubercular agents|mesh-ancestor
111346653|NCT01229527|Meperidine|meperidine|mesh-list
111346654|NCT01229527|Remifentanil|remifentanil|mesh-list
111346655|NCT01229527|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111346656|NCT01229527|Narcotics|narcotics|mesh-ancestor
111346657|NCT01229527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111346658|NCT01229527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111346659|NCT01229527|Analgesics|analgesics|mesh-ancestor
111346660|NCT01229527|Sensory System Agents|sensory system agents|mesh-ancestor
110737876|NCT00003896|Doxorubicin|doxorubicin|mesh-list
111346661|NCT01229527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111346662|NCT01229527|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111346663|NCT02723162|Acetylcysteine|acetylcysteine|mesh-list
111346664|NCT02723162|Varenicline|varenicline|mesh-list
111346665|NCT02723162|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111346666|NCT02723162|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111346667|NCT02723162|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111346668|NCT02723162|Cholinergic Agents|cholinergic agents|mesh-ancestor
111346669|NCT02723162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111346670|NCT02723162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111346671|NCT02723162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111346672|NCT02723162|Antiviral Agents|antiviral agents|mesh-ancestor
111346673|NCT02723162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111346674|NCT02723162|Expectorants|expectorants|mesh-ancestor
111346675|NCT02723162|Respiratory System Agents|respiratory system agents|mesh-ancestor
111346676|NCT02723162|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111346677|NCT02723162|Antioxidants|antioxidants|mesh-ancestor
111346678|NCT02723162|Protective Agents|protective agents|mesh-ancestor
111346679|NCT02723162|Antidotes|antidotes|mesh-ancestor
111346680|NCT00000358|Lofexidine|lofexidine|mesh-list
111346681|NCT00000358|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111346682|NCT00000358|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111346683|NCT00000358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111346684|NCT00000358|Sensory System Agents|sensory system agents|mesh-ancestor
111346685|NCT00000358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110737998|NCT03416374|Glucocorticoids|glucocorticoids|mesh-ancestor
111346686|NCT00000358|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111346687|NCT00000358|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111346688|NCT00000358|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111346689|NCT00000358|Adrenergic Agents|adrenergic agents|mesh-ancestor
111346690|NCT00000358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111346691|NCT00000358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111346692|NCT00000376|Desipramine|desipramine|mesh-list
111346693|NCT00000376|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
111346694|NCT00000376|Antidepressive Agents|antidepressive agents|mesh-ancestor
111346695|NCT00000376|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111346696|NCT00000376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111346697|NCT00000376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111346698|NCT00000376|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111346699|NCT00000376|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111346700|NCT00000376|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111346701|NCT00000376|Adrenergic Agents|adrenergic agents|mesh-ancestor
111346702|NCT00000376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111346703|NCT00000376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111346704|NCT02143388|Cisplatin|cisplatin|mesh-list
111346705|NCT02143388|Capecitabine|capecitabine|mesh-list
111346706|NCT02143388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111346707|NCT02143388|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111346708|NCT02143388|Antimetabolites|antimetabolites|mesh-ancestor
111346709|NCT02143388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111346710|NCT00001228|Interferons|interferons|mesh-list
111346711|NCT00001228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111346712|NCT00001228|Antiviral Agents|antiviral agents|mesh-ancestor
111346713|NCT00001228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111346714|NCT02483936|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
111346715|NCT02483936|Olmesartan|olmesartan|mesh-list
111346716|NCT02483936|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
111346717|NCT02483936|Chlorthalidone|chlorthalidone|mesh-list
111346718|NCT02483936|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111346719|NCT02483936|Diuretics|diuretics|mesh-ancestor
111346720|NCT02483936|Natriuretic Agents|natriuretic agents|mesh-ancestor
111346721|NCT02483936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111346722|NCT02483936|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
111346723|NCT02483936|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111346724|NCT02483936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111346725|NCT02483936|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111346726|NCT02483936|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111346727|NCT00002038|Fluconazole|fluconazole|mesh-list
111346728|NCT00002038|Antifungal Agents|antifungal agents|mesh-ancestor
111346729|NCT00002038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111346730|NCT00002038|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111346731|NCT00002038|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111346732|NCT00002038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111346733|NCT00002038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111346734|NCT00002038|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111346735|NCT00002038|Hormone Antagonists|hormone antagonists|mesh-ancestor
111346736|NCT00002038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111346737|NCT00002038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111346738|NCT00002038|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111346739|NCT00002038|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111346741|NCT01894334|Tranexamic Acid|tranexamic acid|mesh-list
111346742|NCT01894334|Urinastatin|urinastatin|mesh-list
111346743|NCT01894334|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111346744|NCT01894334|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111346745|NCT01894334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111346746|NCT01894334|Hemostatics|hemostatics|mesh-ancestor
111346747|NCT01894334|Coagulants|coagulants|mesh-ancestor
111346748|NCT01894334|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111346749|NCT01894334|Antioxidants|antioxidants|mesh-ancestor
111346750|NCT01894334|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111346751|NCT01894334|Protective Agents|protective agents|mesh-ancestor
111346752|NCT01894334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111346753|NCT01894334|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
111346754|NCT01894334|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111346755|NCT01894334|Protease Inhibitors|protease inhibitors|mesh-ancestor
111346756|NCT01894334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111346757|NCT00002044|Zidovudine|zidovudine|mesh-list
111346758|NCT00002044|Antimetabolites|antimetabolites|mesh-ancestor
111346759|NCT00002044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111346760|NCT00002044|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111346761|NCT00002044|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111346762|NCT00002044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111346763|NCT00002044|Antiviral Agents|antiviral agents|mesh-ancestor
111346764|NCT00002044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111346765|NCT00002044|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111346766|NCT00002044|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111346767|NCT00001282|Zidovudine|zidovudine|mesh-list
111346768|NCT00001282|Interleukin-2|interleukin-2|mesh-list
111346769|NCT00001282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111346770|NCT00001282|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111346771|NCT00001282|Analgesics|analgesics|mesh-ancestor
111346772|NCT00001282|Sensory System Agents|sensory system agents|mesh-ancestor
111346773|NCT00001282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111346774|NCT00001282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111346775|NCT00001282|Antimetabolites|antimetabolites|mesh-ancestor
111346776|NCT00001282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111346777|NCT00001282|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111346778|NCT00001282|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111346779|NCT00001282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111346780|NCT00001282|Antiviral Agents|antiviral agents|mesh-ancestor
111346781|NCT00001282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111346782|NCT00001282|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111346783|NCT00001282|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111346784|NCT01150981|Rosiglitazone|rosiglitazone|mesh-list
111346785|NCT01150981|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111346786|NCT01150981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111346787|NCT00001300|Doxorubicin|doxorubicin|mesh-list
111346788|NCT00001300|Ifosfamide|ifosfamide|mesh-list
111346789|NCT00001300|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111346790|NCT00001300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111346791|NCT00001300|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111346792|NCT00001300|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111346793|NCT00001300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111346794|NCT00001300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111346795|NCT00001300|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111346796|NCT00001300|Alkylating Agents|alkylating agents|mesh-ancestor
111346797|NCT00000400|Alendronate|alendronate|mesh-list
111346798|NCT00000400|Teriparatide|teriparatide|mesh-list
111346799|NCT00000400|Hormones|hormones|mesh-list
111346800|NCT00000400|Parathyroid Hormone|parathyroid hormone|mesh-list
111346801|NCT00000400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111346802|NCT00000400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111346803|NCT00000400|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111346804|NCT00000400|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111346805|NCT01195597|Nicotine|nicotine|mesh-list
111346806|NCT01195597|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111346807|NCT01195597|Autonomic Agents|autonomic agents|mesh-ancestor
111346808|NCT01195597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111071211|NCT03474263|Antibodies|antibodies|mesh-list
111346809|NCT01195597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111346810|NCT01195597|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110738776|NCT04283500|Naloxone|naloxone|mesh-list
111346811|NCT01195597|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111346812|NCT01195597|Cholinergic Agents|cholinergic agents|mesh-ancestor
111346813|NCT01195597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111346814|NCT01195597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111346815|NCT00002050|Thymopentin|thymopentin|mesh-list
111346816|NCT00002050|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111346817|NCT00002050|Immunologic Factors|immunologic factors|mesh-ancestor
111346818|NCT00002050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111346819|NCT04389866|Hyaluronic Acid|hyaluronic acid|mesh-list
111346820|NCT04389866|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111346821|NCT04389866|Immunologic Factors|immunologic factors|mesh-ancestor
111346822|NCT04389866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111346823|NCT04389866|Viscosupplements|viscosupplements|mesh-ancestor
111346824|NCT04389866|Protective Agents|protective agents|mesh-ancestor
111346825|NCT00000412|Alendronate|alendronate|mesh-list
111346826|NCT00000412|Calcitriol|calcitriol|mesh-list
111346827|NCT00000412|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111346828|NCT00000412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111346829|NCT00000412|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111346830|NCT00000412|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
111346831|NCT00000412|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111346832|NCT00000412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111346833|NCT00000412|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111346834|NCT00000412|Vitamins|vitamins|mesh-ancestor
111346835|NCT00000412|Micronutrients|micronutrients|mesh-ancestor
111346836|NCT00002056|Pentamidine|pentamidine|mesh-list
111346837|NCT00002056|Antifungal Agents|antifungal agents|mesh-ancestor
111346838|NCT00002056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111346839|NCT00002056|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111346840|NCT00002056|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111346841|NCT00002056|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
111346842|NCT03110562|Dexamethasone|dexamethasone|mesh-list
111346843|NCT03110562|Bortezomib|bortezomib|mesh-list
111346844|NCT03110562|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111346845|NCT03110562|Antiemetics|antiemetics|mesh-ancestor
111346846|NCT03110562|Autonomic Agents|autonomic agents|mesh-ancestor
111346847|NCT03110562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111346848|NCT03110562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111346849|NCT03110562|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111346850|NCT03110562|Glucocorticoids|glucocorticoids|mesh-ancestor
111346851|NCT03110562|Hormones|hormones|mesh-ancestor
111346852|NCT03110562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111346853|NCT03110562|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111346854|NCT03110562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111346855|NCT00380614|Lamivudine|lamivudine|mesh-list
111346856|NCT00380614|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111346857|NCT00380614|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111346858|NCT00380614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111346859|NCT00380614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111346860|NCT00380614|Antiviral Agents|antiviral agents|mesh-ancestor
111346861|NCT00380614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111346862|NCT00380614|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111346863|NCT00380614|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111346864|NCT00000430|Alendronate|alendronate|mesh-list
111346865|NCT00000430|Estrogens|estrogens|mesh-list
111346866|NCT00000430|Progestins|progestins|mesh-list
111346867|NCT00000430|Hormones|hormones|mesh-ancestor
111346868|NCT00000430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111346869|NCT00000430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111346870|NCT00000430|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111346871|NCT00380770|Lamivudine|lamivudine|mesh-list
111346872|NCT00380770|Stavudine|stavudine|mesh-list
111346873|NCT00380770|Stavudine, lamivudine, nevirapine drug combination|stavudine, lamivudine, nevirapine drug combination|mesh-list
111346874|NCT00380770|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111346875|NCT00380770|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111346876|NCT00380770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111346877|NCT00380770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111346878|NCT00380770|Antiviral Agents|antiviral agents|mesh-ancestor
111346879|NCT00380770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110739486|NCT00076752|Hormones|hormones|mesh-ancestor
111346880|NCT00380770|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111346881|NCT00380770|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111346882|NCT00380770|Antimetabolites|antimetabolites|mesh-ancestor
111346883|NCT01231399|Calcium, Dietary|calcium, dietary|mesh-list
111071277|NCT04418128|Nafamostat|nafamostat|mesh-list
111346884|NCT01231399|Leucovorin|leucovorin|mesh-list
111346885|NCT01231399|Fluorouracil|fluorouracil|mesh-list
111346886|NCT01231399|Oxaliplatin|oxaliplatin|mesh-list
111346887|NCT01231399|Everolimus|everolimus|mesh-list
111346888|NCT01231399|Calcium|calcium|mesh-list
111346889|NCT01231399|Levoleucovorin|levoleucovorin|mesh-list
111346890|NCT01231399|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111346891|NCT01231399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111346892|NCT01231399|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111346893|NCT01231399|Antimetabolites|antimetabolites|mesh-ancestor
111346894|NCT01231399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111346895|NCT01231399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111346896|NCT01231399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111346897|NCT01231399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111346898|NCT01231399|Immunologic Factors|immunologic factors|mesh-ancestor
111346899|NCT01231399|Antidotes|antidotes|mesh-ancestor
111346900|NCT01231399|Protective Agents|protective agents|mesh-ancestor
111346901|NCT01231399|Vitamin B Complex|vitamin b complex|mesh-ancestor
111346902|NCT01231399|Vitamins|vitamins|mesh-ancestor
111346903|NCT01231399|Micronutrients|micronutrients|mesh-ancestor
111346904|NCT01231399|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111346905|NCT01231399|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111346906|NCT01231399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111346907|NCT00002062|Spiramycin|spiramycin|mesh-list
111346908|NCT00002062|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111346909|NCT00002062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111346910|NCT00002062|Coccidiostats|coccidiostats|mesh-ancestor
111346911|NCT00002062|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111346912|NCT00002062|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111346913|NCT01231633|Dexamethasone|dexamethasone|mesh-list
111346914|NCT01231633|Bevacizumab|bevacizumab|mesh-list
111346915|NCT01231633|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111346916|NCT01231633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111346917|NCT01231633|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111346918|NCT01231633|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111346919|NCT01231633|Growth Substances|growth substances|mesh-ancestor
111346920|NCT01231633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111346921|NCT01231633|Growth Inhibitors|growth inhibitors|mesh-ancestor
111346922|NCT01231633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111346923|NCT01231633|Antiemetics|antiemetics|mesh-ancestor
111346924|NCT01231633|Autonomic Agents|autonomic agents|mesh-ancestor
111346925|NCT01231633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111346926|NCT01231633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111346927|NCT01231633|Glucocorticoids|glucocorticoids|mesh-ancestor
111346928|NCT01231633|Hormones|hormones|mesh-ancestor
111346929|NCT01231633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111346930|NCT01231633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111346931|NCT00000442|Naltrexone|naltrexone|mesh-list
111346932|NCT00000442|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111346933|NCT00000442|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111346934|NCT00000442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111346935|NCT00000442|Sensory System Agents|sensory system agents|mesh-ancestor
111346936|NCT00000442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111346937|NCT00002068|Fluconazole|fluconazole|mesh-list
111346938|NCT00002068|Amphotericin B|amphotericin b|mesh-list
111346939|NCT00002068|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
110740085|NCT03946826|Halometasone|halometasone|mesh-list
111346940|NCT00002068|Antifungal Agents|antifungal agents|mesh-ancestor
111346941|NCT00002068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111346942|NCT00002068|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111346943|NCT00002068|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111346944|NCT00002068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111346945|NCT00002068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111346946|NCT00002068|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111346947|NCT00002068|Hormone Antagonists|hormone antagonists|mesh-ancestor
111346948|NCT00002068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111346949|NCT00002068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110740227|NCT01209416|Acipimox|acipimox|mesh-list
111346950|NCT00002068|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111346951|NCT00002068|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111346952|NCT00002068|Amebicides|amebicides|mesh-ancestor
111346953|NCT00002068|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111346954|NCT00002068|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111346955|NCT00002068|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111346956|NCT00000448|Naltrexone|naltrexone|mesh-list
111346957|NCT00000448|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111346958|NCT00000448|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111346959|NCT00000448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111346960|NCT00000448|Sensory System Agents|sensory system agents|mesh-ancestor
111346961|NCT00000448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111346962|NCT00001318|Interferons|interferons|mesh-list
111346963|NCT00001318|Interferon-gamma|interferon-gamma|mesh-list
111346964|NCT00001318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110740362|NCT00346775|Hormones|hormones|mesh-ancestor
111346965|NCT00001318|Antiviral Agents|antiviral agents|mesh-ancestor
111346966|NCT00001318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111346967|NCT00002074|Fluconazole|fluconazole|mesh-list
111346968|NCT00002074|Amphotericin B|amphotericin b|mesh-list
111346969|NCT00002074|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
110740430|NCT00346151|Hormones|hormones|mesh-ancestor
111346970|NCT00002074|Antifungal Agents|antifungal agents|mesh-ancestor
111346971|NCT00002074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111346972|NCT00002074|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111346973|NCT00002074|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111346974|NCT00002074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111346975|NCT00002074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110740523|NCT01209806|TEMPO|tempo|mesh-list
111346976|NCT00002074|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111346977|NCT00002074|Hormone Antagonists|hormone antagonists|mesh-ancestor
110740565|NCT01057511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111346978|NCT00002074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111346979|NCT00002074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111346980|NCT00002074|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111346981|NCT00002074|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111346982|NCT00002074|Amebicides|amebicides|mesh-ancestor
111346983|NCT00002074|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111346984|NCT00002074|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111346985|NCT00002074|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111346986|NCT00001354|Zidovudine|zidovudine|mesh-list
111346987|NCT00001354|Interleukin-2|interleukin-2|mesh-list
111346988|NCT00001354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111346989|NCT00001354|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111346990|NCT00001354|Analgesics|analgesics|mesh-ancestor
111346991|NCT00001354|Sensory System Agents|sensory system agents|mesh-ancestor
111346992|NCT00001354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111346993|NCT00001354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111346994|NCT00001354|Antimetabolites|antimetabolites|mesh-ancestor
111346995|NCT00001354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111346996|NCT00001354|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111346997|NCT00001354|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111346998|NCT00001354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111346999|NCT00001354|Antiviral Agents|antiviral agents|mesh-ancestor
111347000|NCT00001354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111347001|NCT00001354|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111347002|NCT00001354|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111347003|NCT00000454|Nicotine|nicotine|mesh-list
111347004|NCT00000454|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111347005|NCT00000454|Autonomic Agents|autonomic agents|mesh-ancestor
111347006|NCT00000454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111347007|NCT00000454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111347008|NCT00000454|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111347009|NCT00000454|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111347010|NCT00000454|Cholinergic Agents|cholinergic agents|mesh-ancestor
111347011|NCT00000454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111347012|NCT00000454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111347013|NCT00002080|Rifabutin|rifabutin|mesh-list
111347014|NCT00002080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111347015|NCT00002080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111347016|NCT00002080|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111347017|NCT00002080|Antitubercular Agents|antitubercular agents|mesh-ancestor
111347018|NCT00000484|Chlorothiazide|chlorothiazide|mesh-list
111347019|NCT00000484|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111347020|NCT00000484|Diuretics|diuretics|mesh-ancestor
111347021|NCT00000484|Natriuretic Agents|natriuretic agents|mesh-ancestor
111347022|NCT00000484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111347023|NCT00000484|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
111347024|NCT00000484|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111347025|NCT00000484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111347026|NCT00000496|Aspirin|aspirin|mesh-list
111347027|NCT00000496|Dipyridamole|dipyridamole|mesh-list
111347028|NCT00000496|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111347029|NCT00000496|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111347030|NCT00000496|Analgesics|analgesics|mesh-ancestor
111347031|NCT00000496|Sensory System Agents|sensory system agents|mesh-ancestor
111347032|NCT00000496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111347033|NCT00000496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111347034|NCT00000496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111347035|NCT00000496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111347036|NCT00000496|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111347037|NCT00000496|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111347038|NCT00000496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111347039|NCT00000496|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111347040|NCT00000496|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111347041|NCT00000496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111347043|NCT00000496|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111347044|NCT00000496|Vasodilator Agents|vasodilator agents|mesh-ancestor
111347045|NCT00002086|Interferons|interferons|mesh-list
111347046|NCT00002086|Interferon-alpha|interferon-alpha|mesh-list
111347047|NCT00002086|Zidovudine|zidovudine|mesh-list
111347048|NCT00002086|Zalcitabine|zalcitabine|mesh-list
111347049|NCT00002086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111347050|NCT00002086|Antiviral Agents|antiviral agents|mesh-ancestor
111347051|NCT00002086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111347052|NCT00002086|Immunologic Factors|immunologic factors|mesh-ancestor
111347053|NCT00002086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111347054|NCT00002086|Antimetabolites|antimetabolites|mesh-ancestor
111347055|NCT00002086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111347056|NCT00002086|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111347057|NCT00002086|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111347058|NCT00002086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111347059|NCT00002086|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111347060|NCT00002086|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111347061|NCT01151449|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
111347062|NCT01151449|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
111347063|NCT01151449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111347064|NCT01151449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111347065|NCT00001384|Paclitaxel|paclitaxel|mesh-list
111347066|NCT00001384|Cyclophosphamide|cyclophosphamide|mesh-list
111347067|NCT00001384|Doxorubicin|doxorubicin|mesh-list
111347068|NCT00001384|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111347069|NCT00001384|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111347070|NCT00001384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111347071|NCT00001384|Tubulin Modulators|tubulin modulators|mesh-ancestor
111347072|NCT00001384|Antimitotic Agents|antimitotic agents|mesh-ancestor
111347073|NCT00001384|Mitosis Modulators|mitosis modulators|mesh-ancestor
111347074|NCT00001384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111347075|NCT00001384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111347076|NCT00001384|Immunologic Factors|immunologic factors|mesh-ancestor
111347077|NCT00001384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111347078|NCT00001384|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111347079|NCT00001384|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111347080|NCT00001384|Alkylating Agents|alkylating agents|mesh-ancestor
111347081|NCT00001384|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111347082|NCT00001384|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111347083|NCT00001384|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111347084|NCT00001384|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111347085|NCT00001384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111347086|NCT01151761|Cisplatin|cisplatin|mesh-list
111347087|NCT01151761|Carboplatin|carboplatin|mesh-list
111347088|NCT01151761|Gemcitabine|gemcitabine|mesh-list
111347089|NCT01151761|Fluorouracil|fluorouracil|mesh-list
111347090|NCT01151761|Capecitabine|capecitabine|mesh-list
111347091|NCT01151761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111347092|NCT01151761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111347093|NCT01151761|Antimetabolites|antimetabolites|mesh-ancestor
111347094|NCT01151761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110741129|NCT03987893|Lactulose|lactulose|mesh-list
111347095|NCT01151761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111347096|NCT01151761|Immunologic Factors|immunologic factors|mesh-ancestor
111347097|NCT01151761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111347098|NCT00002092|Cimetidine|cimetidine|mesh-list
111347099|NCT00002092|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111347100|NCT00002092|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111347101|NCT00002092|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
111347102|NCT00002092|Histamine Antagonists|histamine antagonists|mesh-ancestor
111347103|NCT00002092|Histamine Agents|histamine agents|mesh-ancestor
111347104|NCT00002092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111347105|NCT00002092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111347106|NCT00002092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111347107|NCT00002092|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111347108|NCT00002092|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111347109|NCT00002092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111347110|NCT00002098|Didanosine|didanosine|mesh-list
111347111|NCT00002098|Lentinan|lentinan|mesh-list
111347112|NCT00002098|Antimetabolites|antimetabolites|mesh-ancestor
111347113|NCT00002098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111347114|NCT00002098|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111347115|NCT00002098|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111347116|NCT00002098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111347117|NCT00002098|Antiviral Agents|antiviral agents|mesh-ancestor
111347118|NCT00002098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111347119|NCT00002098|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111347120|NCT00002098|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111347121|NCT00002098|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111347122|NCT00002098|Immunologic Factors|immunologic factors|mesh-ancestor
111347123|NCT00002098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111347124|NCT00002098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111347125|NCT01196377|Albuterol|albuterol|mesh-list
111347126|NCT01196377|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111347127|NCT01196377|Autonomic Agents|autonomic agents|mesh-ancestor
111347128|NCT01196377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111347129|NCT01196377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111347130|NCT01196377|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111347131|NCT01196377|Respiratory System Agents|respiratory system agents|mesh-ancestor
111347132|NCT01196377|Tocolytic Agents|tocolytic agents|mesh-ancestor
111347133|NCT01196377|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111347134|NCT01196377|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111347135|NCT01196377|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111347136|NCT01196377|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111347137|NCT01196377|Adrenergic Agents|adrenergic agents|mesh-ancestor
111347138|NCT01196377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111347139|NCT01196377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111347140|NCT00001426|Paclitaxel|paclitaxel|mesh-list
111347141|NCT00001426|Cyclophosphamide|cyclophosphamide|mesh-list
111347142|NCT00001426|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111347143|NCT00001426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111347144|NCT00001426|Tubulin Modulators|tubulin modulators|mesh-ancestor
111347145|NCT00001426|Antimitotic Agents|antimitotic agents|mesh-ancestor
111347146|NCT00001426|Mitosis Modulators|mitosis modulators|mesh-ancestor
111347147|NCT00001426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111347148|NCT00001426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111347149|NCT00001426|Immunologic Factors|immunologic factors|mesh-ancestor
111347150|NCT00001426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111347151|NCT00001426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111347152|NCT00001426|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111347153|NCT00001426|Alkylating Agents|alkylating agents|mesh-ancestor
111347154|NCT00001426|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111347155|NCT00002104|Thalidomide|thalidomide|mesh-list
111347156|NCT00002104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111347157|NCT00002104|Immunologic Factors|immunologic factors|mesh-ancestor
111347158|NCT00002104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111347159|NCT00002104|Leprostatic Agents|leprostatic agents|mesh-ancestor
111347160|NCT00002104|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111347161|NCT00002104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111347162|NCT00002104|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110741449|NCT01124630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111347163|NCT00002104|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111347164|NCT00002104|Growth Substances|growth substances|mesh-ancestor
111347165|NCT00002104|Growth Inhibitors|growth inhibitors|mesh-ancestor
111347166|NCT00002104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111347167|NCT00001438|Interferon alpha-2|interferon alpha-2|mesh-list
111347168|NCT00001438|Tretinoin|tretinoin|mesh-list
111347169|NCT00001438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111347170|NCT00001438|Keratolytic Agents|keratolytic agents|mesh-ancestor
111347171|NCT00001438|Dermatologic Agents|dermatologic agents|mesh-ancestor
111347172|NCT00001438|Antiviral Agents|antiviral agents|mesh-ancestor
111347173|NCT00001438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111347174|NCT00001444|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
111347175|NCT00001444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111347176|NCT00001444|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111347177|NCT00001444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111347178|NCT00001444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111347179|NCT00000574|Ibuprofen|ibuprofen|mesh-list
111347180|NCT00000574|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111347181|NCT00000574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111347182|NCT00000574|Analgesics|analgesics|mesh-ancestor
111347183|NCT00000574|Sensory System Agents|sensory system agents|mesh-ancestor
111347184|NCT00000574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111347185|NCT00000574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111347186|NCT00000574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111347187|NCT00000574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111347188|NCT00000574|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111347189|NCT00000574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111347190|NCT00000574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111347191|NCT00002110|Zidovudine|zidovudine|mesh-list
111347192|NCT00002110|Cysteamine|cysteamine|mesh-list
111347193|NCT00002110|Antimetabolites|antimetabolites|mesh-ancestor
111347194|NCT00002110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111347195|NCT00002110|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111347196|NCT00002110|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111347197|NCT00002110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111347198|NCT00002110|Antiviral Agents|antiviral agents|mesh-ancestor
111347199|NCT00002110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111347200|NCT00002110|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111347201|NCT00002110|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111347202|NCT00002110|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
111347203|NCT00001450|Paclitaxel|paclitaxel|mesh-list
111347204|NCT00001450|Cisplatin|cisplatin|mesh-list
111347205|NCT00001450|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110741499|NCT01214408|Pantoprazole|pantoprazole|mesh-list
111347206|NCT00001450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111347207|NCT00001450|Tubulin Modulators|tubulin modulators|mesh-ancestor
111347208|NCT00001450|Antimitotic Agents|antimitotic agents|mesh-ancestor
111347209|NCT00001450|Mitosis Modulators|mitosis modulators|mesh-ancestor
111347210|NCT00001450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111347211|NCT00000580|Immunoglobulins|immunoglobulins|mesh-list
111347212|NCT00000580|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111347213|NCT00000580|Antibodies|antibodies|mesh-list
111347214|NCT00000580|gamma-Globulins|gamma-globulins|mesh-list
111347215|NCT00000580|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
111347216|NCT00000580|Immunologic Factors|immunologic factors|mesh-ancestor
111347217|NCT00000580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111347218|NCT00002116|Cidofovir|cidofovir|mesh-list
111347219|NCT00002116|Antiviral Agents|antiviral agents|mesh-ancestor
111347220|NCT00002116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111347221|NCT00002116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111347222|NCT00002116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111347223|NCT00001498|Leucovorin|leucovorin|mesh-list
111347224|NCT00001498|Paclitaxel|paclitaxel|mesh-list
111347225|NCT00001498|Cyclophosphamide|cyclophosphamide|mesh-list
111347226|NCT00001498|Doxorubicin|doxorubicin|mesh-list
111347227|NCT00001498|Fluorouracil|fluorouracil|mesh-list
111347228|NCT00001498|Methotrexate|methotrexate|mesh-list
111347229|NCT00001498|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111347230|NCT00001498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111347231|NCT00001498|Tubulin Modulators|tubulin modulators|mesh-ancestor
111347232|NCT00001498|Antimitotic Agents|antimitotic agents|mesh-ancestor
111347233|NCT00001498|Mitosis Modulators|mitosis modulators|mesh-ancestor
111347234|NCT00001498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111347235|NCT00001498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111347236|NCT00001498|Immunologic Factors|immunologic factors|mesh-ancestor
111347237|NCT00001498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111347238|NCT00001498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111347239|NCT00001498|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111347240|NCT00001498|Alkylating Agents|alkylating agents|mesh-ancestor
111347241|NCT00001498|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111347242|NCT00001498|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111347243|NCT00001498|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111347244|NCT00001498|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111347245|NCT00001498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111347246|NCT00001498|Antimetabolites|antimetabolites|mesh-ancestor
111347247|NCT00001498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111347248|NCT00001498|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111347249|NCT00001498|Abortifacient Agents|abortifacient agents|mesh-ancestor
111347250|NCT00001498|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111347251|NCT00001498|Dermatologic Agents|dermatologic agents|mesh-ancestor
111347252|NCT00001498|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111347253|NCT00001498|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111347254|NCT00001498|Antidotes|antidotes|mesh-ancestor
111347255|NCT00001498|Protective Agents|protective agents|mesh-ancestor
111347256|NCT00001498|Vitamin B Complex|vitamin b complex|mesh-ancestor
111347257|NCT00001498|Vitamins|vitamins|mesh-ancestor
111347258|NCT00001498|Micronutrients|micronutrients|mesh-ancestor
111347259|NCT00001504|Tretinoin|tretinoin|mesh-list
111347260|NCT00001504|Alitretinoin|alitretinoin|mesh-list
111071665|NCT03465085|Heparin|heparin|mesh-list
111347261|NCT00001504|Isotretinoin|isotretinoin|mesh-list
111347262|NCT00001504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111347263|NCT00001504|Keratolytic Agents|keratolytic agents|mesh-ancestor
111347264|NCT00001504|Dermatologic Agents|dermatologic agents|mesh-ancestor
111347265|NCT02688140|Cytarabine|cytarabine|mesh-list
111347266|NCT02688140|Methotrexate|methotrexate|mesh-list
111347267|NCT02688140|Mercaptopurine|mercaptopurine|mesh-list
111347268|NCT02688140|Mitoxantrone|mitoxantrone|mesh-list
111347269|NCT02688140|Idarubicin|idarubicin|mesh-list
111347270|NCT02688140|Tretinoin|tretinoin|mesh-list
111347271|NCT02688140|Arsenic Trioxide|arsenic trioxide|mesh-list
111347272|NCT02688140|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111347273|NCT02688140|Abortifacient Agents|abortifacient agents|mesh-ancestor
111347274|NCT02688140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111347275|NCT02688140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111347276|NCT02688140|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111347277|NCT02688140|Antimetabolites|antimetabolites|mesh-ancestor
111347278|NCT02688140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111347279|NCT02688140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111347280|NCT02688140|Dermatologic Agents|dermatologic agents|mesh-ancestor
111347281|NCT02688140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111347282|NCT02688140|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111347283|NCT02688140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111347284|NCT02688140|Immunologic Factors|immunologic factors|mesh-ancestor
111347285|NCT02688140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111347286|NCT02688140|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111347287|NCT02688140|Antiviral Agents|antiviral agents|mesh-ancestor
111347288|NCT02688140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111347289|NCT02688140|Analgesics|analgesics|mesh-ancestor
111347290|NCT02688140|Sensory System Agents|sensory system agents|mesh-ancestor
111347291|NCT02688140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111347292|NCT02688140|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111347293|NCT02688140|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111347294|NCT02688140|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111347295|NCT02688140|Keratolytic Agents|keratolytic agents|mesh-ancestor
111347296|NCT00002122|Azithromycin|azithromycin|mesh-list
111347297|NCT00002122|Rifabutin|rifabutin|mesh-list
111347298|NCT00002122|Fluconazole|fluconazole|mesh-list
111347299|NCT00002122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110741581|NCT03710356|Danazol|danazol|mesh-list
111347300|NCT00002122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111347301|NCT00002122|Antifungal Agents|antifungal agents|mesh-ancestor
111347302|NCT00002122|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111347303|NCT00002122|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111347304|NCT00002122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111347305|NCT00002122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111347306|NCT00002122|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111347307|NCT00002122|Hormone Antagonists|hormone antagonists|mesh-ancestor
111347308|NCT00002122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111347309|NCT00002122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111347310|NCT00002122|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111347311|NCT00002122|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111347312|NCT00002122|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111347313|NCT00002122|Antitubercular Agents|antitubercular agents|mesh-ancestor
111347314|NCT05456334|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
111347315|NCT05456334|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111347316|NCT05456334|Dermatologic Agents|dermatologic agents|mesh-ancestor
111347317|NCT00001534|Losartan|losartan|mesh-list
111347318|NCT00001534|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111347319|NCT00001534|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110741588|NCT01217294|Narcotics|narcotics|mesh-ancestor
111347320|NCT00001534|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111347321|NCT00001534|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111347322|NCT00001534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111347323|NCT01027559|Sertraline|sertraline|mesh-list
111347324|NCT01027559|Antidepressive Agents|antidepressive agents|mesh-ancestor
111347325|NCT01027559|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111347326|NCT01027559|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111347327|NCT01027559|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111347328|NCT01027559|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111347329|NCT01027559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111347330|NCT01027559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111347331|NCT01027559|Serotonin Agents|serotonin agents|mesh-ancestor
111347332|NCT01027559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111347333|NCT00002128|Adefovir|adefovir|mesh-list
111347334|NCT00002128|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
111347335|NCT00002128|Antiviral Agents|antiviral agents|mesh-ancestor
111347336|NCT00002128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111347337|NCT00002128|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111347338|NCT00002128|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111347339|NCT00002128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111347340|NCT00002128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111347341|NCT00001570|Vinblastine|vinblastine|mesh-list
111347342|NCT00001570|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111347343|NCT00001570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111347344|NCT00001570|Tubulin Modulators|tubulin modulators|mesh-ancestor
111347345|NCT00001570|Antimitotic Agents|antimitotic agents|mesh-ancestor
111347346|NCT00001570|Mitosis Modulators|mitosis modulators|mesh-ancestor
111347347|NCT00001570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111347349|NCT00000628|L-697661|l-697661|mesh-list
111347350|NCT00000628|Antimetabolites|antimetabolites|mesh-ancestor
111347351|NCT00000628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111347352|NCT00000628|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111347353|NCT00000628|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111347354|NCT00000628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111347355|NCT00000628|Antiviral Agents|antiviral agents|mesh-ancestor
111347356|NCT00000628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111347357|NCT00000628|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111347358|NCT00000628|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111347359|NCT00000634|Nevirapine|nevirapine|mesh-list
111347360|NCT00000634|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111347361|NCT00000634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111347362|NCT00000634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111347363|NCT00000634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111347364|NCT00000634|Antiviral Agents|antiviral agents|mesh-ancestor
111347365|NCT00000634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111347366|NCT00000634|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111347367|NCT00000634|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111347368|NCT00000634|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111347369|NCT00000634|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111347370|NCT01661790|Bevacizumab|bevacizumab|mesh-list
111347371|NCT01661790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111347372|NCT01661790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111347373|NCT01661790|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111347374|NCT01661790|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111347375|NCT01661790|Growth Substances|growth substances|mesh-ancestor
111347376|NCT01661790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111347377|NCT01661790|Growth Inhibitors|growth inhibitors|mesh-ancestor
111347378|NCT00002134|Ganciclovir|ganciclovir|mesh-list
111347379|NCT00002134|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
111347380|NCT00002134|Antiviral Agents|antiviral agents|mesh-ancestor
111347381|NCT00002134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111347382|NCT00002134|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111347383|NCT00002134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111347384|NCT00002134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111347385|NCT00985907|Bortezomib|bortezomib|mesh-list
111347386|NCT00985907|Melphalan|melphalan|mesh-list
111347387|NCT00985907|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111347388|NCT00985907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111347389|NCT00985907|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111347390|NCT00985907|Alkylating Agents|alkylating agents|mesh-ancestor
111347391|NCT00985907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111347392|NCT00985907|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111347393|NCT00985907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111347394|NCT00985907|Immunologic Factors|immunologic factors|mesh-ancestor
111347395|NCT00985907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111347396|NCT00985907|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111347397|NCT00002140|Azithromycin|azithromycin|mesh-list
111347398|NCT00002140|Clarithromycin|clarithromycin|mesh-list
111347399|NCT00002140|Ethambutol|ethambutol|mesh-list
111347400|NCT00002140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111347401|NCT00002140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111347402|NCT00002140|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111347403|NCT00002140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111347404|NCT00002140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111347405|NCT00002140|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111347406|NCT00002140|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111347407|NCT00002140|Antitubercular Agents|antitubercular agents|mesh-ancestor
111347408|NCT00000658|Leucovorin|leucovorin|mesh-list
111347409|NCT00000658|Cytarabine|cytarabine|mesh-list
111347410|NCT00000658|Dexamethasone|dexamethasone|mesh-list
111347412|NCT00000658|Doxorubicin|doxorubicin|mesh-list
111347413|NCT00000658|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111347414|NCT00000658|Methotrexate|methotrexate|mesh-list
111347415|NCT00000658|Vincristine|vincristine|mesh-list
111347416|NCT00000658|Bleomycin|bleomycin|mesh-list
111347417|NCT00000658|Allopurinol|allopurinol|mesh-list
111347418|NCT00000658|Sargramostim|sargramostim|mesh-list
111347419|NCT00000658|Levoleucovorin|levoleucovorin|mesh-list
111347420|NCT00000658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111347421|NCT00000658|Immunologic Factors|immunologic factors|mesh-ancestor
111347422|NCT00000658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111347423|NCT00000658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111347424|NCT00000658|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111347425|NCT00000658|Alkylating Agents|alkylating agents|mesh-ancestor
111347426|NCT00000658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111347427|NCT00000658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111347428|NCT00000658|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111347429|NCT00000658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111347430|NCT00000658|Antiemetics|antiemetics|mesh-ancestor
111347431|NCT00000658|Autonomic Agents|autonomic agents|mesh-ancestor
111347432|NCT00000658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111347433|NCT00000658|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111347434|NCT00000658|Glucocorticoids|glucocorticoids|mesh-ancestor
111347435|NCT00000658|Hormones|hormones|mesh-ancestor
111347436|NCT00000658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111347437|NCT00000658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111347438|NCT00000658|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111347439|NCT00000658|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111347440|NCT00000658|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111347441|NCT00000658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111347442|NCT00000658|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111347443|NCT00000658|Abortifacient Agents|abortifacient agents|mesh-ancestor
111347444|NCT00000658|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111347445|NCT00000658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111347446|NCT00000658|Antimetabolites|antimetabolites|mesh-ancestor
111347447|NCT00000658|Dermatologic Agents|dermatologic agents|mesh-ancestor
111347448|NCT00000658|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111347449|NCT00000658|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111347450|NCT00000658|Antiviral Agents|antiviral agents|mesh-ancestor
110741701|NCT01219712|Simendan|simendan|mesh-list
111347451|NCT00000658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111347452|NCT00000658|Antidotes|antidotes|mesh-ancestor
111347453|NCT00000658|Protective Agents|protective agents|mesh-ancestor
111347454|NCT00000658|Vitamin B Complex|vitamin b complex|mesh-ancestor
111347455|NCT00000658|Vitamins|vitamins|mesh-ancestor
111347456|NCT00000658|Micronutrients|micronutrients|mesh-ancestor
111347457|NCT00000658|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111347458|NCT00000658|Tubulin Modulators|tubulin modulators|mesh-ancestor
111347459|NCT00000658|Antimitotic Agents|antimitotic agents|mesh-ancestor
111347460|NCT00000658|Mitosis Modulators|mitosis modulators|mesh-ancestor
111347461|NCT00000658|Gout Suppressants|gout suppressants|mesh-ancestor
111347462|NCT00000658|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111347463|NCT00000658|Antioxidants|antioxidants|mesh-ancestor
111347464|NCT01027793|Tretinoin|tretinoin|mesh-list
111347465|NCT01027793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111347466|NCT01027793|Keratolytic Agents|keratolytic agents|mesh-ancestor
111347467|NCT01027793|Dermatologic Agents|dermatologic agents|mesh-ancestor
111347468|NCT00002146|Foscarnet|foscarnet|mesh-list
111347469|NCT00002146|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
111347470|NCT00002146|Magnesium Sulfate|magnesium sulfate|mesh-list
111347471|NCT00002146|Analgesics|analgesics|mesh-ancestor
111347472|NCT00002146|Sensory System Agents|sensory system agents|mesh-ancestor
111347473|NCT00002146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111347474|NCT00002146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111347475|NCT00002146|Anesthetics|anesthetics|mesh-ancestor
111347476|NCT00002146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111347477|NCT00002146|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111347478|NCT00002146|Anticonvulsants|anticonvulsants|mesh-ancestor
111347479|NCT00002146|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111347480|NCT00002146|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111347481|NCT00002146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111347482|NCT00002146|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111347483|NCT00002146|Tocolytic Agents|tocolytic agents|mesh-ancestor
111347484|NCT00002146|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111347485|NCT00002146|Antiviral Agents|antiviral agents|mesh-ancestor
111347486|NCT00002146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111347487|NCT00002146|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111347488|NCT00002146|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111347489|NCT00002146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111347491|NCT04389554|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111347492|NCT04389554|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111347493|NCT04389554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111347494|NCT04389554|Hemostatics|hemostatics|mesh-ancestor
111347495|NCT04389554|Coagulants|coagulants|mesh-ancestor
111347496|NCT03051516|Vaccines|vaccines|mesh-list
111347497|NCT03051516|Immunologic Factors|immunologic factors|mesh-ancestor
111347498|NCT03051516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111347499|NCT01029587|Eculizumab|eculizumab|mesh-list
111347500|NCT01029587|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
111347501|NCT01029587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111347502|NCT01029587|Immunologic Factors|immunologic factors|mesh-ancestor
111347503|NCT01029587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111347504|NCT00000664|Zidovudine|zidovudine|mesh-list
111347505|NCT00000664|Interleukin-2|interleukin-2|mesh-list
111347506|NCT00000664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111347507|NCT00000664|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111347508|NCT00000664|Analgesics|analgesics|mesh-ancestor
111347509|NCT00000664|Sensory System Agents|sensory system agents|mesh-ancestor
111347510|NCT00000664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111347511|NCT00000664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111347512|NCT00000664|Antimetabolites|antimetabolites|mesh-ancestor
111347513|NCT00000664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111347514|NCT00000664|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111347515|NCT00000664|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111347516|NCT00000664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111347517|NCT00000664|Antiviral Agents|antiviral agents|mesh-ancestor
111347518|NCT00000664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111347519|NCT00000664|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111347520|NCT00000664|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111347521|NCT00000670|Zidovudine|zidovudine|mesh-list
111347522|NCT00000670|Probenecid|probenecid|mesh-list
111347523|NCT00000670|Antimetabolites|antimetabolites|mesh-ancestor
111347524|NCT00000670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111347525|NCT00000670|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111347526|NCT00000670|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111347527|NCT00000670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111347528|NCT00000670|Antiviral Agents|antiviral agents|mesh-ancestor
111347529|NCT00000670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111347530|NCT00000670|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111347531|NCT00000670|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111347532|NCT00000670|Uricosuric Agents|uricosuric agents|mesh-ancestor
111347533|NCT00000670|Gout Suppressants|gout suppressants|mesh-ancestor
111347534|NCT00000670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111347535|NCT00002158|Nitazoxanide|nitazoxanide|mesh-list
111347536|NCT00002158|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111347537|NCT00002158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111347538|NCT00000694|Interferons|interferons|mesh-list
111347539|NCT00000694|Interferon-alpha|interferon-alpha|mesh-list
111347540|NCT00000694|Interferon alpha-2|interferon alpha-2|mesh-list
111347541|NCT00000694|Zidovudine|zidovudine|mesh-list
111347542|NCT00000694|Sargramostim|sargramostim|mesh-list
111347543|NCT00000694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111347544|NCT00000694|Antiviral Agents|antiviral agents|mesh-ancestor
111347545|NCT00000694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111347546|NCT00000694|Immunologic Factors|immunologic factors|mesh-ancestor
111347547|NCT00000694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111347548|NCT00000694|Antimetabolites|antimetabolites|mesh-ancestor
111347549|NCT00000694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111347550|NCT00000694|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111347551|NCT00000694|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111347552|NCT00000694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111347553|NCT00000694|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111347554|NCT00000694|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111347555|NCT01894412|Etanercept|etanercept|mesh-list
111347556|NCT01894412|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111347557|NCT01894412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111347558|NCT01894412|Analgesics|analgesics|mesh-ancestor
111347559|NCT01894412|Sensory System Agents|sensory system agents|mesh-ancestor
111347560|NCT01894412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111347561|NCT01894412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111347562|NCT01894412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111347563|NCT01894412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111071974|NCT05579249|Topiramate|topiramate|mesh-list
111347564|NCT01894412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111347565|NCT01894412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111347566|NCT01894412|Immunologic Factors|immunologic factors|mesh-ancestor
111347567|NCT00000700|Zidovudine|zidovudine|mesh-list
111347568|NCT00000700|Antimetabolites|antimetabolites|mesh-ancestor
111347569|NCT00000700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111347570|NCT00000700|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111347571|NCT00000700|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111347572|NCT00000700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111347573|NCT00000700|Antiviral Agents|antiviral agents|mesh-ancestor
111347574|NCT00000700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111347575|NCT00000700|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111347576|NCT00000700|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111347577|NCT00002164|Nelfinavir|nelfinavir|mesh-list
111347578|NCT00002164|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111347579|NCT00002164|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111347580|NCT00002164|Protease Inhibitors|protease inhibitors|mesh-ancestor
111347581|NCT00002164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111347582|NCT00002164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111347583|NCT00002164|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111347584|NCT00002164|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111347585|NCT00002164|Antiviral Agents|antiviral agents|mesh-ancestor
111347586|NCT00002164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111347587|NCT00000706|Zidovudine|zidovudine|mesh-list
111347588|NCT00000706|Quinine|quinine|mesh-list
111347589|NCT00000706|Probenecid|probenecid|mesh-list
111347590|NCT00000706|Antimetabolites|antimetabolites|mesh-ancestor
111347591|NCT00000706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111347592|NCT00000706|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111347593|NCT00000706|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111347594|NCT00000706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111347595|NCT00000706|Antiviral Agents|antiviral agents|mesh-ancestor
111347596|NCT00000706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111347597|NCT00000706|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111347598|NCT00000706|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111347599|NCT00000706|Antimalarials|antimalarials|mesh-ancestor
111347600|NCT00000706|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111347601|NCT00000706|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111347602|NCT00000706|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
111347603|NCT00000706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111347604|NCT00000706|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111347605|NCT00000706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111347606|NCT00000706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111347607|NCT00000706|Analgesics|analgesics|mesh-ancestor
111347608|NCT00000706|Sensory System Agents|sensory system agents|mesh-ancestor
111347609|NCT00000706|Uricosuric Agents|uricosuric agents|mesh-ancestor
111347610|NCT00000706|Gout Suppressants|gout suppressants|mesh-ancestor
111347611|NCT00000706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111347612|NCT00988325|Oseltamivir|oseltamivir|mesh-list
111347613|NCT00988325|Antiviral Agents|antiviral agents|mesh-ancestor
111347614|NCT00988325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111347615|NCT00988325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111347616|NCT00988325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111347617|NCT00002296|Inosine Pranobex|inosine pranobex|mesh-list
111347618|NCT00002296|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111347619|NCT00002296|Immunologic Factors|immunologic factors|mesh-ancestor
111347620|NCT00002296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111347621|NCT00002296|Antiviral Agents|antiviral agents|mesh-ancestor
111347622|NCT00002296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111347623|NCT00002302|Epoetin Alfa|epoetin alfa|mesh-list
111347624|NCT00002302|Hematinics|hematinics|mesh-ancestor
111347625|NCT00002170|Nelfinavir|nelfinavir|mesh-list
111347626|NCT00002170|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111347627|NCT00002170|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111347628|NCT00002170|Protease Inhibitors|protease inhibitors|mesh-ancestor
111347629|NCT00002170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111347630|NCT00002170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111347631|NCT00002170|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111347632|NCT00002170|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111347633|NCT00002170|Antiviral Agents|antiviral agents|mesh-ancestor
111347634|NCT00002170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111347635|NCT00002308|Stavudine|stavudine|mesh-list
111347636|NCT00002308|Antimetabolites|antimetabolites|mesh-ancestor
111347637|NCT00002308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111347638|NCT00002308|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111347639|NCT00002308|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110741942|NCT03932864|Plerixafor|plerixafor|mesh-list
111347640|NCT00002308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111347641|NCT00002308|Antiviral Agents|antiviral agents|mesh-ancestor
111347642|NCT00002308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111347643|NCT00002308|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111347644|NCT00002308|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111347645|NCT00000724|Leucovorin|leucovorin|mesh-list
111347646|NCT00000724|Trimetrexate|trimetrexate|mesh-list
111347647|NCT00000724|Calcium|calcium|mesh-list
111347648|NCT00000724|Levoleucovorin|levoleucovorin|mesh-list
111347649|NCT00000724|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111347650|NCT00000724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111347651|NCT00000724|Antidotes|antidotes|mesh-ancestor
111347652|NCT00000724|Protective Agents|protective agents|mesh-ancestor
111347653|NCT00000724|Vitamin B Complex|vitamin b complex|mesh-ancestor
111347654|NCT00000724|Vitamins|vitamins|mesh-ancestor
111347655|NCT00000724|Micronutrients|micronutrients|mesh-ancestor
111347656|NCT00000724|Antifungal Agents|antifungal agents|mesh-ancestor
111347657|NCT00000724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111347658|NCT00000724|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111347659|NCT00000724|Antimetabolites|antimetabolites|mesh-ancestor
111347660|NCT00000724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111347661|NCT00000724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111347662|NCT00000724|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111347663|NCT00000724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111347664|NCT00000730|Leucovorin|leucovorin|mesh-list
111347665|NCT00000730|Trimethoprim|trimethoprim|mesh-list
111347666|NCT00000730|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
111347667|NCT00000730|Sulfamethoxazole|sulfamethoxazole|mesh-list
111347668|NCT00000730|Pentamidine|pentamidine|mesh-list
111347669|NCT00000730|Trimetrexate|trimetrexate|mesh-list
111347670|NCT00000730|Methylprednisolone|methylprednisolone|mesh-list
111347671|NCT00000730|Levoleucovorin|levoleucovorin|mesh-list
111347672|NCT00000730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111347673|NCT00000730|Antidotes|antidotes|mesh-ancestor
111347674|NCT00000730|Protective Agents|protective agents|mesh-ancestor
111347675|NCT00000730|Vitamin B Complex|vitamin b complex|mesh-ancestor
111347676|NCT00000730|Vitamins|vitamins|mesh-ancestor
111347677|NCT00000730|Micronutrients|micronutrients|mesh-ancestor
111347678|NCT00000730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111347679|NCT00000730|Antiemetics|antiemetics|mesh-ancestor
111347680|NCT00000730|Autonomic Agents|autonomic agents|mesh-ancestor
111347681|NCT00000730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111347682|NCT00000730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111347683|NCT00000730|Glucocorticoids|glucocorticoids|mesh-ancestor
111347684|NCT00000730|Hormones|hormones|mesh-ancestor
111347685|NCT00000730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111347686|NCT00000730|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111347687|NCT00000730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111347688|NCT00000730|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111347689|NCT00000730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111347690|NCT00000730|Antimalarials|antimalarials|mesh-ancestor
111347691|NCT00000730|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111347692|NCT00000730|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111347693|NCT00000730|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111347694|NCT00000730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111347695|NCT00000730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111347696|NCT00000730|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111347697|NCT00000730|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
111347698|NCT00000730|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111347699|NCT00000730|Antifungal Agents|antifungal agents|mesh-ancestor
111347700|NCT00000730|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
111347701|NCT00000730|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111347702|NCT00000730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111347703|NCT00000730|Antimetabolites|antimetabolites|mesh-ancestor
111347704|NCT00002176|Nelfinavir|nelfinavir|mesh-list
111347705|NCT00002176|Stavudine|stavudine|mesh-list
111347706|NCT00002176|Didanosine|didanosine|mesh-list
111347707|NCT00002176|Hydroxyurea|hydroxyurea|mesh-list
111347708|NCT00002176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111347709|NCT00002176|Antisickling Agents|antisickling agents|mesh-ancestor
111347710|NCT00002176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111347711|NCT00002176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111347712|NCT00002176|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111347713|NCT00002176|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111347714|NCT00002176|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111347715|NCT00002176|Protease Inhibitors|protease inhibitors|mesh-ancestor
111347716|NCT00002176|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111347717|NCT00002176|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111347718|NCT00002176|Antiviral Agents|antiviral agents|mesh-ancestor
111347719|NCT00002176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111347721|NCT00002176|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111347722|NCT00381316|Technetium tc-99m tetrofosmin|technetium tc-99m tetrofosmin|mesh-list
111347723|NCT00381316|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111347724|NCT00381316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111347725|NCT00002182|Megestrol|megestrol|mesh-list
111347726|NCT00002182|Megestrol Acetate|megestrol acetate|mesh-list
111347727|NCT00002182|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111347728|NCT00002182|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111347729|NCT00002182|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111347730|NCT00002182|Contraceptive Agents|contraceptive agents|mesh-ancestor
111347731|NCT00002182|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111347732|NCT00002182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111347733|NCT00002182|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111347734|NCT00002182|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111347735|NCT00002182|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111347736|NCT00002182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111347737|NCT00002182|Appetite Stimulants|appetite stimulants|mesh-ancestor
111347738|NCT00002182|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111347739|NCT00002320|Lamivudine|lamivudine|mesh-list
111347740|NCT00002320|Zidovudine|zidovudine|mesh-list
111347741|NCT00002320|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111347742|NCT00002320|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111347743|NCT00002320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111347744|NCT00002320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111347745|NCT00002320|Antiviral Agents|antiviral agents|mesh-ancestor
111347746|NCT00002320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111347747|NCT00002320|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111347748|NCT00002320|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111347749|NCT00002320|Antimetabolites|antimetabolites|mesh-ancestor
111347750|NCT02167217|Prednisolone|prednisolone|mesh-list
111347751|NCT02167217|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111347752|NCT02167217|Methylprednisolone|methylprednisolone|mesh-list
111347753|NCT02167217|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111347754|NCT02167217|Prednisolone acetate|prednisolone acetate|mesh-list
111347755|NCT02167217|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111347756|NCT02167217|Prednisolone phosphate|prednisolone phosphate|mesh-list
111347757|NCT02167217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111347758|NCT02167217|Glucocorticoids|glucocorticoids|mesh-ancestor
111347759|NCT02167217|Hormones|hormones|mesh-ancestor
111347760|NCT02167217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111347761|NCT02167217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111347762|NCT02167217|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111347763|NCT02167217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111347764|NCT02167217|Antiemetics|antiemetics|mesh-ancestor
111347765|NCT02167217|Autonomic Agents|autonomic agents|mesh-ancestor
111347766|NCT02167217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111347767|NCT02167217|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111347768|NCT02167217|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111347769|NCT02167217|Protective Agents|protective agents|mesh-ancestor
111347770|NCT00002326|Zidovudine|zidovudine|mesh-list
111347771|NCT00002326|Adefovir|adefovir|mesh-list
111347772|NCT00002326|Antimetabolites|antimetabolites|mesh-ancestor
111347773|NCT00002326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111347774|NCT00002326|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111347775|NCT00002326|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111347776|NCT00002326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111347777|NCT00002326|Antiviral Agents|antiviral agents|mesh-ancestor
111347778|NCT00002326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111347779|NCT00002326|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111347780|NCT00002326|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111347781|NCT01152697|Haloperidol|haloperidol|mesh-list
111347782|NCT01152697|Haloperidol decanoate|haloperidol decanoate|mesh-list
111347783|NCT01152697|Antiemetics|antiemetics|mesh-ancestor
111347784|NCT01152697|Autonomic Agents|autonomic agents|mesh-ancestor
111347785|NCT01152697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111347786|NCT01152697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111347787|NCT01152697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111347788|NCT01152697|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111347789|NCT01152697|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111347790|NCT01152697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111347791|NCT01152697|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111347792|NCT01152697|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111347793|NCT01152697|Dopamine Agents|dopamine agents|mesh-ancestor
111347794|NCT01152697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111347795|NCT01152697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111347796|NCT01152697|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111347797|NCT00002188|Alitretinoin|alitretinoin|mesh-list
111347798|NCT00002188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111347799|NCT00002188|Dermatologic Agents|dermatologic agents|mesh-ancestor
111347800|NCT00002332|Thymopentin|thymopentin|mesh-list
111347801|NCT00002332|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111347802|NCT00002332|Immunologic Factors|immunologic factors|mesh-ancestor
111347803|NCT00002332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111347804|NCT05571644|Leucovorin|leucovorin|mesh-list
111347805|NCT05571644|Fluorouracil|fluorouracil|mesh-list
111347806|NCT05571644|Oxaliplatin|oxaliplatin|mesh-list
111347807|NCT05571644|Irinotecan|irinotecan|mesh-list
111347808|NCT05571644|Levoleucovorin|levoleucovorin|mesh-list
111347809|NCT05571644|Antimetabolites|antimetabolites|mesh-ancestor
111347810|NCT05571644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111347811|NCT05571644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111347812|NCT05571644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111347813|NCT05571644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111347814|NCT05571644|Immunologic Factors|immunologic factors|mesh-ancestor
111347815|NCT05571644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111347816|NCT05571644|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111347817|NCT05571644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111347818|NCT05571644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111347819|NCT05571644|Antidotes|antidotes|mesh-ancestor
111347820|NCT05571644|Protective Agents|protective agents|mesh-ancestor
111347821|NCT05571644|Vitamin B Complex|vitamin b complex|mesh-ancestor
111347822|NCT05571644|Vitamins|vitamins|mesh-ancestor
111347823|NCT05571644|Micronutrients|micronutrients|mesh-ancestor
111347824|NCT03011281|Tofacitinib|tofacitinib|mesh-list
111347825|NCT03011281|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
111347826|NCT03011281|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111347827|NCT03011281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111347828|NCT03011281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111347829|NCT00002194|Clarithromycin|clarithromycin|mesh-list
111347830|NCT00002194|Erythromycin|erythromycin|mesh-list
111347831|NCT00002194|Erythromycin Estolate|erythromycin estolate|mesh-list
111347832|NCT00002194|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
111347833|NCT00002194|Erythromycin stearate|erythromycin stearate|mesh-list
111347834|NCT00002194|Nevirapine|nevirapine|mesh-list
111347835|NCT00002194|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111347836|NCT00002194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111347837|NCT00002194|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111347838|NCT00002194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110742418|NCT01225874|Antiviral Agents|antiviral agents|mesh-ancestor
111347839|NCT00002194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111347840|NCT00002194|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111347841|NCT00002194|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111347842|NCT00002194|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111347843|NCT00002194|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111347844|NCT00002194|Antiviral Agents|antiviral agents|mesh-ancestor
111347845|NCT00002194|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111347846|NCT00002194|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111347847|NCT00002194|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111347848|NCT00002194|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111347849|NCT00002194|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111347850|NCT04756622|Acetylcysteine|acetylcysteine|mesh-list
111347851|NCT04756622|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111347852|NCT04756622|Antiviral Agents|antiviral agents|mesh-ancestor
111347853|NCT04756622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111347854|NCT04756622|Expectorants|expectorants|mesh-ancestor
111347855|NCT04756622|Respiratory System Agents|respiratory system agents|mesh-ancestor
111347856|NCT04756622|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111347857|NCT04756622|Antioxidants|antioxidants|mesh-ancestor
111347858|NCT04756622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111347859|NCT04756622|Protective Agents|protective agents|mesh-ancestor
111347860|NCT04756622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111347861|NCT04756622|Antidotes|antidotes|mesh-ancestor
111347862|NCT00002344|Azithromycin|azithromycin|mesh-list
111347863|NCT00002344|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111347864|NCT00002344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111347865|NCT01198327|Ranibizumab|ranibizumab|mesh-list
111347866|NCT01198327|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111347867|NCT01198327|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111347868|NCT01198327|Growth Substances|growth substances|mesh-ancestor
111347869|NCT01198327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111347870|NCT01198327|Growth Inhibitors|growth inhibitors|mesh-ancestor
111347871|NCT01198327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111347872|NCT00002200|Abacavir|abacavir|mesh-list
110742478|NCT00321737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111347873|NCT00002200|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111347874|NCT00002200|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111347875|NCT00002200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111347876|NCT00002200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111347877|NCT00002200|Antiviral Agents|antiviral agents|mesh-ancestor
111347878|NCT00002200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111347879|NCT00002200|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111347880|NCT00002200|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111347881|NCT00002356|Fomivirsen|fomivirsen|mesh-list
111347882|NCT00002356|Antiviral Agents|antiviral agents|mesh-ancestor
111347883|NCT00002356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111347884|NCT00994175|Pioglitazone|pioglitazone|mesh-list
111347885|NCT00994175|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111347886|NCT00994175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111347887|NCT00002206|Adefovir|adefovir|mesh-list
111347888|NCT00002206|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
111347889|NCT00002206|Antiviral Agents|antiviral agents|mesh-ancestor
111347890|NCT00002206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111347891|NCT00002206|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111347892|NCT00002206|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111347893|NCT00002206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111347894|NCT00002206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111347895|NCT02403986|Lidocaine|lidocaine|mesh-list
111347896|NCT02403986|Anesthetics, Local|anesthetics, local|mesh-ancestor
111347897|NCT02403986|Anesthetics|anesthetics|mesh-ancestor
111347898|NCT02403986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111347899|NCT02403986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111347900|NCT02403986|Sensory System Agents|sensory system agents|mesh-ancestor
111347901|NCT02403986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111347902|NCT02403986|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111347903|NCT02403986|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111347904|NCT02403986|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111347905|NCT02403986|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111347906|NCT02403986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111347907|NCT00002212|Bexarotene|bexarotene|mesh-list
111347908|NCT00002212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111347909|NCT00002362|Emtricitabine|emtricitabine|mesh-list
111347910|NCT00002362|Efavirenz|efavirenz|mesh-list
111347911|NCT00002362|Abacavir|abacavir|mesh-list
111347912|NCT00002362|Stavudine|stavudine|mesh-list
111347913|NCT00002362|Antiviral Agents|antiviral agents|mesh-ancestor
111347914|NCT00002362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111347915|NCT00002362|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111347916|NCT00002362|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111347917|NCT00002362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111347918|NCT00002362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111347919|NCT00002362|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111347920|NCT00002362|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111347921|NCT00002362|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111347922|NCT00002362|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111347923|NCT00002362|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111347924|NCT00002362|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111347925|NCT00002362|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111347926|NCT00002362|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111347927|NCT00002362|Antimetabolites|antimetabolites|mesh-ancestor
111347928|NCT02168309|Labetalol|labetalol|mesh-list
111347929|NCT02168309|Nifedipine|nifedipine|mesh-list
111347930|NCT02168309|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111347931|NCT02168309|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111347932|NCT02168309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111347933|NCT02168309|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111347934|NCT02168309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111347935|NCT02168309|Vasodilator Agents|vasodilator agents|mesh-ancestor
111347936|NCT02168309|Tocolytic Agents|tocolytic agents|mesh-ancestor
111347937|NCT02168309|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111347938|NCT02168309|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111347939|NCT02168309|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111347940|NCT02168309|Adrenergic Agents|adrenergic agents|mesh-ancestor
111347941|NCT02168309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111347942|NCT02168309|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111347943|NCT02168309|Sympathomimetics|sympathomimetics|mesh-ancestor
111347944|NCT02168309|Autonomic Agents|autonomic agents|mesh-ancestor
111347945|NCT02168309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111072350|NCT05174845|Vitamins|vitamins|mesh-ancestor
111347946|NCT02168309|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111347947|NCT02168309|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111347949|NCT00002368|Nevirapine|nevirapine|mesh-list
111347950|NCT00002368|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111347951|NCT00002368|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111347952|NCT00002368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111347953|NCT00002368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111347954|NCT00002368|Antiviral Agents|antiviral agents|mesh-ancestor
111347955|NCT00002368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111347956|NCT00002368|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111347957|NCT00002368|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111347958|NCT00002368|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111347959|NCT00002368|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111347960|NCT01199965|Dihydroergotamine|dihydroergotamine|mesh-list
111347961|NCT01199965|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111347962|NCT01199965|Dopamine Agonists|dopamine agonists|mesh-ancestor
111347963|NCT01199965|Dopamine Agents|dopamine agents|mesh-ancestor
111347964|NCT01199965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111347965|NCT01199965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111347966|NCT01199965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111347967|NCT01199965|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111347968|NCT01199965|Analgesics|analgesics|mesh-ancestor
111347969|NCT01199965|Sensory System Agents|sensory system agents|mesh-ancestor
111347970|NCT01199965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111347971|NCT00995501|Insulin|insulin|mesh-list
111347972|NCT00995501|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111347973|NCT00995501|Dexamethasone|dexamethasone|mesh-list
111347974|NCT00995501|Dexamethasone acetate|dexamethasone acetate|mesh-list
111347975|NCT00995501|Anesthetics|anesthetics|mesh-list
111347976|NCT00995501|Sodium sulfate|sodium sulfate|mesh-list
111347977|NCT00995501|BB 1101|bb 1101|mesh-list
111347978|NCT00995501|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111347979|NCT00995501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111347980|NCT00995501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111347981|NCT00995501|Antiemetics|antiemetics|mesh-ancestor
111347982|NCT00995501|Autonomic Agents|autonomic agents|mesh-ancestor
111347983|NCT00995501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111347984|NCT00995501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111347985|NCT00995501|Glucocorticoids|glucocorticoids|mesh-ancestor
111347986|NCT00995501|Hormones|hormones|mesh-ancestor
111347987|NCT00995501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111347988|NCT00995501|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111347989|NCT00995501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111347990|NCT00995501|Protease Inhibitors|protease inhibitors|mesh-ancestor
111347991|NCT00995501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111347992|NCT00995501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111347993|NCT00995501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111347994|NCT00995501|Cathartics|cathartics|mesh-ancestor
111347995|NCT00002374|Ritonavir|ritonavir|mesh-list
111347996|NCT00002374|Nelfinavir|nelfinavir|mesh-list
111347997|NCT00002374|Saquinavir|saquinavir|mesh-list
111347998|NCT00002374|Stavudine|stavudine|mesh-list
111347999|NCT00002374|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111348000|NCT00002374|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111348001|NCT00002374|Protease Inhibitors|protease inhibitors|mesh-ancestor
111348002|NCT00002374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111348003|NCT00002374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111348004|NCT00002374|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111348005|NCT00002374|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111348006|NCT00002374|Antiviral Agents|antiviral agents|mesh-ancestor
111348007|NCT00002374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111348008|NCT00002374|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111348009|NCT00002374|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111348010|NCT00002374|Antimetabolites|antimetabolites|mesh-ancestor
111348011|NCT00002374|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111348012|NCT00002374|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111348013|NCT00002380|Nelfinavir|nelfinavir|mesh-list
111348014|NCT00002380|Saquinavir|saquinavir|mesh-list
111348015|NCT00002380|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111348016|NCT00002380|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111348017|NCT00002380|Protease Inhibitors|protease inhibitors|mesh-ancestor
111348018|NCT00002380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111348019|NCT00002380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111072413|NCT03445897|Antifungal Agents|antifungal agents|mesh-ancestor
111348020|NCT00002380|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111348021|NCT00002380|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111348022|NCT00002380|Antiviral Agents|antiviral agents|mesh-ancestor
111348023|NCT00002380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111348024|NCT00002380|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111348025|NCT00002380|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111348026|NCT00002386|Lamivudine|lamivudine|mesh-list
111348027|NCT00002386|Zidovudine|zidovudine|mesh-list
111348028|NCT00002386|Stavudine|stavudine|mesh-list
111348029|NCT00002386|Didanosine|didanosine|mesh-list
111348030|NCT00002386|Zalcitabine|zalcitabine|mesh-list
111348031|NCT00002386|Indinavir|indinavir|mesh-list
111348032|NCT00002386|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111348033|NCT00002386|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111348034|NCT00002386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111348035|NCT00002386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111348036|NCT00002386|Antiviral Agents|antiviral agents|mesh-ancestor
111348037|NCT00002386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111348038|NCT00002386|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111348039|NCT00002386|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111348040|NCT00002386|Antimetabolites|antimetabolites|mesh-ancestor
111348041|NCT00002386|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111348042|NCT00002386|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111348043|NCT00002386|Protease Inhibitors|protease inhibitors|mesh-ancestor
111348044|NCT01942694|Vitamin D|vitamin d|mesh-list
111348045|NCT01942694|Cholecalciferol|cholecalciferol|mesh-list
111348046|NCT01942694|Vitamins|vitamins|mesh-ancestor
111348047|NCT01942694|Micronutrients|micronutrients|mesh-ancestor
111348048|NCT01942694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111348049|NCT01942694|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111348050|NCT01942694|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111348051|NCT01153711|Ketoconazole|ketoconazole|mesh-list
111348052|NCT01153711|Antifungal Agents|antifungal agents|mesh-ancestor
111348053|NCT01153711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111348054|NCT01153711|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111348055|NCT01153711|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111348056|NCT01153711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111348057|NCT01153711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111348058|NCT01153711|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111348059|NCT01153711|Hormone Antagonists|hormone antagonists|mesh-ancestor
111348060|NCT01153711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111348061|NCT01153711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111348062|NCT01153711|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111348063|NCT02168855|Nicotine|nicotine|mesh-list
111348064|NCT02168855|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111348065|NCT02168855|Autonomic Agents|autonomic agents|mesh-ancestor
111348066|NCT02168855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111348067|NCT02168855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111348068|NCT02168855|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111348069|NCT02168855|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111348070|NCT02168855|Cholinergic Agents|cholinergic agents|mesh-ancestor
111348071|NCT02168855|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111348072|NCT02168855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111348073|NCT05751850|Leucovorin|leucovorin|mesh-list
111348074|NCT05751850|Paclitaxel|paclitaxel|mesh-list
111348075|NCT05751850|Gemcitabine|gemcitabine|mesh-list
111348076|NCT05751850|Fluorouracil|fluorouracil|mesh-list
111348077|NCT05751850|Oxaliplatin|oxaliplatin|mesh-list
111348078|NCT05751850|Calcium|calcium|mesh-list
111348079|NCT05751850|Levoleucovorin|levoleucovorin|mesh-list
111348080|NCT05751850|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111348081|NCT05751850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111348082|NCT05751850|Tubulin Modulators|tubulin modulators|mesh-ancestor
111348083|NCT05751850|Antimitotic Agents|antimitotic agents|mesh-ancestor
111348084|NCT05751850|Mitosis Modulators|mitosis modulators|mesh-ancestor
111348085|NCT05751850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111348086|NCT05751850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111348087|NCT05751850|Antimetabolites|antimetabolites|mesh-ancestor
111348088|NCT05751850|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111348089|NCT05751850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111348090|NCT05751850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111348091|NCT05751850|Immunologic Factors|immunologic factors|mesh-ancestor
111348092|NCT05751850|Antidotes|antidotes|mesh-ancestor
111348093|NCT05751850|Protective Agents|protective agents|mesh-ancestor
111348094|NCT05751850|Vitamin B Complex|vitamin b complex|mesh-ancestor
111348095|NCT05751850|Vitamins|vitamins|mesh-ancestor
111348096|NCT05751850|Micronutrients|micronutrients|mesh-ancestor
111348097|NCT01938248|Aspirin|aspirin|mesh-list
111348099|NCT01938248|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111348100|NCT01938248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111348101|NCT01938248|Analgesics|analgesics|mesh-ancestor
111348102|NCT01938248|Sensory System Agents|sensory system agents|mesh-ancestor
111348103|NCT01938248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111348104|NCT01938248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111348105|NCT01938248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111348106|NCT01938248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111348107|NCT01938248|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111348108|NCT01938248|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111348109|NCT01938248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111348110|NCT01938248|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111348111|NCT01938248|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111348112|NCT01938248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111348113|NCT01938248|Antipyretics|antipyretics|mesh-ancestor
111348114|NCT01938248|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111348115|NCT01938248|Antithrombins|antithrombins|mesh-ancestor
111348116|NCT01938248|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111348117|NCT01938248|Protease Inhibitors|protease inhibitors|mesh-ancestor
111348118|NCT01938248|Anticoagulants|anticoagulants|mesh-ancestor
111348119|NCT00002230|Efavirenz|efavirenz|mesh-list
111348120|NCT00002230|Stavudine|stavudine|mesh-list
111348121|NCT00002230|Didanosine|didanosine|mesh-list
111348122|NCT00002230|Hydroxyurea|hydroxyurea|mesh-list
111348123|NCT00002230|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111348124|NCT00002230|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111348125|NCT00002230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111348126|NCT00002230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111348127|NCT00002230|Antiviral Agents|antiviral agents|mesh-ancestor
111348128|NCT00002230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111348129|NCT00002230|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111348130|NCT00002230|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111348131|NCT00002230|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111348132|NCT00002230|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111348133|NCT00002230|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111348134|NCT00002230|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111348135|NCT00002230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111348136|NCT00002230|Antisickling Agents|antisickling agents|mesh-ancestor
111348137|NCT00002230|Antimetabolites|antimetabolites|mesh-ancestor
111348138|NCT00002230|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111348139|NCT00002230|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111348140|NCT03009877|Fentanyl|fentanyl|mesh-list
111348141|NCT03009877|Midazolam|midazolam|mesh-list
111348142|NCT03009877|Propofol|propofol|mesh-list
111348143|NCT03009877|Rocuronium|rocuronium|mesh-list
111348144|NCT03009877|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111348145|NCT03009877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111348146|NCT03009877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111348147|NCT03009877|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111348148|NCT03009877|Anesthetics, General|anesthetics, general|mesh-ancestor
111348149|NCT03009877|Anesthetics|anesthetics|mesh-ancestor
111348150|NCT03009877|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111348151|NCT03009877|Narcotics|narcotics|mesh-ancestor
111348152|NCT03009877|Analgesics|analgesics|mesh-ancestor
111348153|NCT03009877|Sensory System Agents|sensory system agents|mesh-ancestor
111348154|NCT03009877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111348155|NCT03009877|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111348156|NCT03009877|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111348157|NCT03009877|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111348158|NCT03009877|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111348159|NCT03009877|GABA Modulators|gaba modulators|mesh-ancestor
111348160|NCT03009877|GABA Agents|gaba agents|mesh-ancestor
111348161|NCT03009877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111348162|NCT03009877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111348163|NCT03009877|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
111348164|NCT03009877|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
111348165|NCT03009877|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111348166|NCT00002392|Thalidomide|thalidomide|mesh-list
111348167|NCT00002392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110742845|NCT01227590|Ritonavir|ritonavir|mesh-list
111348168|NCT00002392|Immunologic Factors|immunologic factors|mesh-ancestor
111348169|NCT00002392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111348170|NCT00002392|Leprostatic Agents|leprostatic agents|mesh-ancestor
111348171|NCT00002392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111348172|NCT00002392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111348173|NCT00002392|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111348174|NCT00002392|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111348175|NCT00002392|Growth Substances|growth substances|mesh-ancestor
111348176|NCT00002392|Growth Inhibitors|growth inhibitors|mesh-ancestor
111348177|NCT00002392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111348178|NCT00002398|Adefovir|adefovir|mesh-list
111348179|NCT00002398|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
111348180|NCT00002398|Antiviral Agents|antiviral agents|mesh-ancestor
111348181|NCT00002398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111348182|NCT00002398|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111348183|NCT00002398|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111348184|NCT00002398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111348185|NCT00002398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111348186|NCT00997139|Polymyxins|polymyxins|mesh-list
111348187|NCT00997139|Neomycin|neomycin|mesh-list
111348188|NCT00997139|Bacitracin|bacitracin|mesh-list
111348189|NCT00997139|Polymyxin B|polymyxin b|mesh-list
111348190|NCT00997139|Bacitracin zinc, neomycin sulfate, polymyxin B, drug combination|bacitracin zinc, neomycin sulfate, polymyxin b, drug combination|mesh-list
111348191|NCT00997139|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111348192|NCT00997139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111348193|NCT00997139|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111348194|NCT00997139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111348195|NCT00997139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111348196|NCT00997139|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111348197|NCT00002236|Zidovudine|zidovudine|mesh-list
111348198|NCT00002236|Delavirdine|delavirdine|mesh-list
111348199|NCT00002236|Indinavir|indinavir|mesh-list
111348200|NCT00002236|Antimetabolites|antimetabolites|mesh-ancestor
110742897|NCT01131806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111348201|NCT00002236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111348202|NCT00002236|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111348203|NCT00002236|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111348204|NCT00002236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111348205|NCT00002236|Antiviral Agents|antiviral agents|mesh-ancestor
111348206|NCT00002236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111348207|NCT00002236|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111348208|NCT00002236|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111348209|NCT00002236|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111348210|NCT00002236|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111348211|NCT00002236|Protease Inhibitors|protease inhibitors|mesh-ancestor
111348212|NCT01241539|Dabigatran|dabigatran|mesh-list
111348213|NCT01241539|Antithrombins|antithrombins|mesh-ancestor
111348214|NCT01241539|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111348215|NCT01241539|Protease Inhibitors|protease inhibitors|mesh-ancestor
111348216|NCT01241539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111348217|NCT01241539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111348218|NCT01241539|Anticoagulants|anticoagulants|mesh-ancestor
111348219|NCT00002404|Valacyclovir|valacyclovir|mesh-list
111348220|NCT00002404|Antiviral Agents|antiviral agents|mesh-ancestor
111348221|NCT00002404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111348222|NCT01242241|Propofol|propofol|mesh-list
111348223|NCT01242241|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111348224|NCT01242241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111348225|NCT01242241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111348226|NCT01242241|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111348227|NCT01242241|Anesthetics, General|anesthetics, general|mesh-ancestor
111348228|NCT01242241|Anesthetics|anesthetics|mesh-ancestor
111348229|NCT02393690|Iodine|iodine|mesh-list
111348230|NCT02393690|Cadexomer iodine|cadexomer iodine|mesh-list
111348231|NCT02393690|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111348232|NCT02393690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111348233|NCT02393690|Trace Elements|trace elements|mesh-ancestor
111348234|NCT02393690|Micronutrients|micronutrients|mesh-ancestor
111348235|NCT02393690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111348236|NCT01200433|Dexmedetomidine|dexmedetomidine|mesh-list
111348237|NCT01200433|Propofol|propofol|mesh-list
111348238|NCT01200433|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111348239|NCT01200433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111348240|NCT01200433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111348241|NCT01200433|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111348242|NCT01200433|Analgesics|analgesics|mesh-ancestor
111348243|NCT01200433|Sensory System Agents|sensory system agents|mesh-ancestor
111348244|NCT01200433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111348245|NCT01200433|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111348246|NCT01200433|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111348247|NCT01200433|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111348248|NCT01200433|Adrenergic Agents|adrenergic agents|mesh-ancestor
111072637|NCT03463967|Lycopene|lycopene|mesh-list
111348249|NCT01200433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111348250|NCT01200433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111348251|NCT01200433|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111348252|NCT01200433|Anesthetics, General|anesthetics, general|mesh-ancestor
111348253|NCT01200433|Anesthetics|anesthetics|mesh-ancestor
111348254|NCT00002410|Lamivudine|lamivudine|mesh-list
111348255|NCT00002410|Zidovudine|zidovudine|mesh-list
111348256|NCT00002410|Indinavir|indinavir|mesh-list
111348257|NCT00002410|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111348258|NCT00002410|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111348259|NCT00002410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111348260|NCT00002410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111348261|NCT00002410|Antiviral Agents|antiviral agents|mesh-ancestor
111348262|NCT00002410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111348263|NCT00002410|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111348264|NCT00002410|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111348265|NCT00002410|Antimetabolites|antimetabolites|mesh-ancestor
111348266|NCT00002410|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111348267|NCT00002410|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111348268|NCT00002410|Protease Inhibitors|protease inhibitors|mesh-ancestor
111348269|NCT01243333|Deoxyglucose|deoxyglucose|mesh-list
111348270|NCT01243333|Alovudine|alovudine|mesh-list
111348271|NCT01243333|Dideoxynucleosides|dideoxynucleosides|mesh-list
110742978|NCT01231802|Leucovorin|leucovorin|mesh-list
111348272|NCT01243333|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
111348273|NCT01243333|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111348274|NCT01243333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111348275|NCT01243333|Antimetabolites|antimetabolites|mesh-ancestor
111348276|NCT01243333|Antiviral Agents|antiviral agents|mesh-ancestor
111348277|NCT01243333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111348278|NCT01243333|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111348279|NCT01243333|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111348280|NCT01243333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111348281|NCT01924052|Calcitonin|calcitonin|mesh-list
111348282|NCT01924052|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
111348283|NCT01924052|Katacalcin|katacalcin|mesh-list
111348284|NCT01924052|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111348285|NCT01924052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111348286|NCT01924052|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111348287|NCT01924052|Vasodilator Agents|vasodilator agents|mesh-ancestor
111348288|NCT00002416|Lamivudine|lamivudine|mesh-list
111348289|NCT00002416|Emtricitabine|emtricitabine|mesh-list
111348290|NCT00002416|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111348291|NCT00002416|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111348292|NCT00002416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111348293|NCT00002416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111348294|NCT00002416|Antiviral Agents|antiviral agents|mesh-ancestor
111348295|NCT00002416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111348296|NCT00002416|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111348297|NCT00002416|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111348298|NCT00002254|Alovudine|alovudine|mesh-list
111348299|NCT00002254|Antiviral Agents|antiviral agents|mesh-ancestor
111348300|NCT00002254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111348301|NCT01897454|Calcium, Dietary|calcium, dietary|mesh-list
111348302|NCT01897454|Leucovorin|leucovorin|mesh-list
111348303|NCT01897454|Folic Acid|folic acid|mesh-list
111348304|NCT01897454|Gemcitabine|gemcitabine|mesh-list
111348305|NCT01897454|Fluorouracil|fluorouracil|mesh-list
111348306|NCT01897454|Oxaliplatin|oxaliplatin|mesh-list
111348307|NCT01897454|Irinotecan|irinotecan|mesh-list
111348308|NCT01897454|Camptothecin|camptothecin|mesh-list
111348309|NCT01897454|Calcium|calcium|mesh-list
111348310|NCT01897454|Levoleucovorin|levoleucovorin|mesh-list
111348311|NCT01897454|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111348312|NCT01897454|Antimetabolites|antimetabolites|mesh-ancestor
111348313|NCT01897454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111348314|NCT01897454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111348315|NCT01897454|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111348316|NCT01897454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111348317|NCT01897454|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111348318|NCT01897454|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111348319|NCT01897454|Immunologic Factors|immunologic factors|mesh-ancestor
111348320|NCT01897454|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111348321|NCT01897454|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111348322|NCT01897454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111348323|NCT01897454|Antidotes|antidotes|mesh-ancestor
111348324|NCT01897454|Protective Agents|protective agents|mesh-ancestor
111348325|NCT01897454|Vitamin B Complex|vitamin b complex|mesh-ancestor
111348326|NCT01897454|Vitamins|vitamins|mesh-ancestor
111348327|NCT01897454|Micronutrients|micronutrients|mesh-ancestor
111348328|NCT01897454|Hematinics|hematinics|mesh-ancestor
111348329|NCT01897454|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111348331|NCT01243567|Bimatoprost|bimatoprost|mesh-list
111348332|NCT01243567|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111348333|NCT01243567|Latanoprost|latanoprost|mesh-list
111348334|NCT01243567|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111348335|NCT01243567|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111348336|NCT01243567|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111348337|NCT01243567|Adrenergic Agents|adrenergic agents|mesh-ancestor
111348338|NCT01243567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111348339|NCT01243567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111348340|NCT01243567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111348341|NCT01243567|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111348342|NCT01243567|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111348343|NCT01001195|Bimatoprost|bimatoprost|mesh-list
111348344|NCT01001195|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111348345|NCT01001195|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111348346|NCT01001195|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111348347|NCT00381472|Ropinirole|ropinirole|mesh-list
111348348|NCT00381472|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111348349|NCT00381472|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111348350|NCT00381472|Dopamine Agonists|dopamine agonists|mesh-ancestor
111348351|NCT00381472|Dopamine Agents|dopamine agents|mesh-ancestor
111348352|NCT00381472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111348353|NCT00381472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111348354|NCT00381472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111348355|NCT02185729|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
111348356|NCT02185729|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
111348357|NCT02185729|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
111348358|NCT02185729|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111348359|NCT01460654|Alendronate|alendronate|mesh-list
111348360|NCT01460654|Methyltestosterone|methyltestosterone|mesh-list
111348361|NCT01460654|Testosterone|testosterone|mesh-list
111348362|NCT01460654|Testosterone undecanoate|testosterone undecanoate|mesh-list
111348363|NCT01460654|Testosterone enanthate|testosterone enanthate|mesh-list
111348364|NCT01460654|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
111348365|NCT01460654|Androgens|androgens|mesh-ancestor
111348366|NCT01460654|Hormones|hormones|mesh-ancestor
111348367|NCT01460654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111348368|NCT01460654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111348369|NCT01460654|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111348370|NCT01460654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111348371|NCT01460654|Anabolic Agents|anabolic agents|mesh-ancestor
111348372|NCT01460654|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111348373|NCT01001975|Sunscreening Agents|sunscreening agents|mesh-list
111348374|NCT01001975|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111348375|NCT01001975|Protective Agents|protective agents|mesh-ancestor
111348376|NCT01001975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111348377|NCT01001975|Dermatologic Agents|dermatologic agents|mesh-ancestor
111348378|NCT01459484|Cisplatin|cisplatin|mesh-list
111348379|NCT01459484|Doxorubicin|doxorubicin|mesh-list
111348380|NCT01459484|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111348381|NCT01459484|Methotrexate|methotrexate|mesh-list
111348382|NCT01459484|Ifosfamide|ifosfamide|mesh-list
111348383|NCT01459484|Mifamurtide|mifamurtide|mesh-list
111348384|NCT01459484|Acetylmuramyl-Alanyl-Isoglutamine|acetylmuramyl-alanyl-isoglutamine|mesh-list
111348385|NCT01459484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111348386|NCT01459484|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111348387|NCT01459484|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111348388|NCT01459484|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111348389|NCT01459484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111348390|NCT01459484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111348391|NCT01459484|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111348392|NCT01459484|Abortifacient Agents|abortifacient agents|mesh-ancestor
111348393|NCT01459484|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111348394|NCT01459484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111348395|NCT01459484|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111348396|NCT01459484|Antimetabolites|antimetabolites|mesh-ancestor
111348397|NCT01459484|Dermatologic Agents|dermatologic agents|mesh-ancestor
111348398|NCT01459484|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111348399|NCT01459484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111348400|NCT01459484|Immunologic Factors|immunologic factors|mesh-ancestor
111348401|NCT01459484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111348402|NCT01459484|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111348403|NCT01459484|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111348404|NCT01459484|Alkylating Agents|alkylating agents|mesh-ancestor
111348405|NCT01459484|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111348406|NCT00002260|Alovudine|alovudine|mesh-list
111348407|NCT00002260|Antiviral Agents|antiviral agents|mesh-ancestor
111348408|NCT00002260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111348409|NCT01444040|Travoprost|travoprost|mesh-list
111348410|NCT01444040|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111348411|NCT00002266|Ammonium trichloro(dioxoethylene-O,O'-)tellurate|ammonium trichloro(dioxoethylene-o,o'-)tellurate|mesh-list
111348412|NCT00002266|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111348413|NCT00002266|Immunologic Factors|immunologic factors|mesh-ancestor
111348414|NCT00002266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111348415|NCT00002266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111348416|NCT00002266|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111348417|NCT00002266|Protective Agents|protective agents|mesh-ancestor
111348418|NCT00002266|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111348419|NCT00002266|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111348420|NCT00002266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111348421|NCT00002266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111348422|NCT00002266|Antiviral Agents|antiviral agents|mesh-ancestor
111348423|NCT00002266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111348424|NCT05751304|Dexmedetomidine|dexmedetomidine|mesh-list
111348425|NCT05751304|Ketamine|ketamine|mesh-list
111348426|NCT05751304|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110743439|NCT01231490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111348427|NCT05751304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111348428|NCT05751304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111348429|NCT05751304|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111348430|NCT05751304|Analgesics|analgesics|mesh-ancestor
111348431|NCT05751304|Sensory System Agents|sensory system agents|mesh-ancestor
111348432|NCT05751304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111348433|NCT05751304|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111348434|NCT05751304|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111348435|NCT05751304|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111348436|NCT05751304|Adrenergic Agents|adrenergic agents|mesh-ancestor
111348437|NCT05751304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111348438|NCT05751304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111348439|NCT05751304|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111348440|NCT05751304|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111348441|NCT05751304|Anesthetics, General|anesthetics, general|mesh-ancestor
111348442|NCT05751304|Anesthetics|anesthetics|mesh-ancestor
111348443|NCT05751304|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111348444|NCT05751304|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111348445|NCT01202071|Rabeprazole|rabeprazole|mesh-list
111348446|NCT01202071|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111348447|NCT01202071|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111348448|NCT01202071|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111348449|NCT01202071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111348450|NCT01202071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111348451|NCT00002428|Vaccines|vaccines|mesh-list
111348452|NCT00002428|Immunologic Factors|immunologic factors|mesh-ancestor
111348453|NCT00002428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111348454|NCT01422746|Metformin|metformin|mesh-list
111348455|NCT01422746|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111348456|NCT01422746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111348457|NCT00002272|Foscarnet|foscarnet|mesh-list
111348458|NCT00002272|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
111348459|NCT00002272|Antiviral Agents|antiviral agents|mesh-ancestor
111348460|NCT00002272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111348461|NCT00002272|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111348462|NCT00002272|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111348463|NCT00002272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111348464|NCT00002272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111348465|NCT01002755|Lenalidomide|lenalidomide|mesh-list
111348466|NCT01002755|Ofatumumab|ofatumumab|mesh-list
111348467|NCT01002755|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111348468|NCT01002755|Immunologic Factors|immunologic factors|mesh-ancestor
111348469|NCT01002755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111348470|NCT01002755|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111348471|NCT01002755|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111348472|NCT01002755|Growth Substances|growth substances|mesh-ancestor
111348473|NCT01002755|Growth Inhibitors|growth inhibitors|mesh-ancestor
111348474|NCT01002755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111348475|NCT00002434|Leucovorin|leucovorin|mesh-list
111348476|NCT00002434|Trimetrexate|trimetrexate|mesh-list
111348477|NCT00002434|Calcium|calcium|mesh-list
111348478|NCT00002434|Levoleucovorin|levoleucovorin|mesh-list
111348479|NCT00002434|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110743540|NCT01139840|Vitamin D|vitamin d|mesh-list
111348480|NCT00002434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111348481|NCT00002434|Antidotes|antidotes|mesh-ancestor
111348482|NCT00002434|Protective Agents|protective agents|mesh-ancestor
111348483|NCT00002434|Vitamin B Complex|vitamin b complex|mesh-ancestor
111348485|NCT00002434|Micronutrients|micronutrients|mesh-ancestor
111348486|NCT00002434|Antifungal Agents|antifungal agents|mesh-ancestor
111348487|NCT00002434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111348488|NCT00002434|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111348489|NCT00002434|Antimetabolites|antimetabolites|mesh-ancestor
111348490|NCT00002434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111348491|NCT00002434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111348492|NCT00002434|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111348493|NCT00002434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111348494|NCT00002278|Diclazuril|diclazuril|mesh-list
111348495|NCT00002278|Coccidiostats|coccidiostats|mesh-ancestor
111348496|NCT00002278|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111348497|NCT00002278|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111348498|NCT00002278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111348499|NCT01885130|Dimenhydrinate|dimenhydrinate|mesh-list
111348500|NCT01885130|Antiemetics|antiemetics|mesh-ancestor
111348501|NCT01885130|Autonomic Agents|autonomic agents|mesh-ancestor
111348502|NCT01885130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111348503|NCT01885130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111348504|NCT01885130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111348505|NCT01885130|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111348506|NCT01885130|Histamine Antagonists|histamine antagonists|mesh-ancestor
111348507|NCT01885130|Histamine Agents|histamine agents|mesh-ancestor
111348508|NCT01885130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111348509|NCT01885130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111348510|NCT01003301|Omalizumab|omalizumab|mesh-list
111348511|NCT01003301|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111348512|NCT01003301|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111348513|NCT01003301|Respiratory System Agents|respiratory system agents|mesh-ancestor
111348514|NCT00002440|Ritonavir|ritonavir|mesh-list
111348515|NCT00002440|Nelfinavir|nelfinavir|mesh-list
111348516|NCT00002440|Indinavir|indinavir|mesh-list
111348517|NCT00002440|Saquinavir|saquinavir|mesh-list
111348518|NCT00002440|Amprenavir|amprenavir|mesh-list
111348519|NCT00002440|Abacavir|abacavir|mesh-list
111348520|NCT00002440|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111348521|NCT00002440|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111348522|NCT00002440|Protease Inhibitors|protease inhibitors|mesh-ancestor
111348523|NCT00002440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111348524|NCT00002440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111348525|NCT00002440|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111348526|NCT00002440|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111348527|NCT00002440|Antiviral Agents|antiviral agents|mesh-ancestor
111348528|NCT00002440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111348529|NCT00002440|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111348530|NCT00002440|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111348531|NCT00002440|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111348532|NCT00002440|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111348533|NCT00002440|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111348534|NCT00002440|Antitubercular Agents|antitubercular agents|mesh-ancestor
111348535|NCT00002440|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111348536|NCT01421810|Dexamethasone|dexamethasone|mesh-list
111348537|NCT01421810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111348538|NCT01421810|Antiemetics|antiemetics|mesh-ancestor
111348539|NCT01421810|Autonomic Agents|autonomic agents|mesh-ancestor
111348540|NCT01421810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111348541|NCT01421810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111348542|NCT01421810|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111348543|NCT01421810|Glucocorticoids|glucocorticoids|mesh-ancestor
111348544|NCT01421810|Hormones|hormones|mesh-ancestor
111348545|NCT01421810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111348546|NCT01421810|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111348547|NCT01421810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111348548|NCT00002284|Zidovudine|zidovudine|mesh-list
111348549|NCT00002284|Antimetabolites|antimetabolites|mesh-ancestor
111348550|NCT00002284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111348551|NCT00002284|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111348552|NCT00002284|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111348553|NCT00002284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111348554|NCT00002284|Antiviral Agents|antiviral agents|mesh-ancestor
111348555|NCT00002284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111348556|NCT00002284|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111348557|NCT00002284|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111348558|NCT01243957|Fluoxetine|fluoxetine|mesh-list
111348559|NCT01243957|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111348560|NCT01243957|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111348561|NCT01243957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111348562|NCT01243957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111348563|NCT01243957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111348564|NCT01243957|Serotonin Agents|serotonin agents|mesh-ancestor
111348565|NCT01243957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111348566|NCT01243957|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111348567|NCT01243957|Antidepressive Agents|antidepressive agents|mesh-ancestor
111348568|NCT01243957|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111348569|NCT01243957|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111348570|NCT01243957|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111348571|NCT01243957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111348572|NCT00002446|Fluconazole|fluconazole|mesh-list
111348573|NCT00002446|Posaconazole|posaconazole|mesh-list
111348574|NCT00002446|Antifungal Agents|antifungal agents|mesh-ancestor
111348575|NCT00002446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111348576|NCT00002446|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111348577|NCT00002446|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111348578|NCT00002446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111348579|NCT00002446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111348580|NCT00002446|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111348581|NCT00002446|Hormone Antagonists|hormone antagonists|mesh-ancestor
111348582|NCT00002446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111348583|NCT00002446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111348584|NCT00002446|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111348585|NCT00002446|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111348586|NCT00002446|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
111348587|NCT00002446|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111348588|NCT00002446|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111348589|NCT01884740|Bevacizumab|bevacizumab|mesh-list
111348590|NCT01884740|Cetuximab|cetuximab|mesh-list
111348591|NCT01884740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111348592|NCT01884740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111348593|NCT01884740|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111348594|NCT01884740|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110743802|NCT01143584|Dopamine|dopamine|mesh-list
111348595|NCT01884740|Growth Substances|growth substances|mesh-ancestor
111348596|NCT01884740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111348597|NCT01884740|Growth Inhibitors|growth inhibitors|mesh-ancestor
111348598|NCT00002290|Zidovudine|zidovudine|mesh-list
111348599|NCT00002290|Acyclovir|acyclovir|mesh-list
111348600|NCT00002290|Antimetabolites|antimetabolites|mesh-ancestor
111348601|NCT00002290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111348602|NCT00002290|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111348603|NCT00002290|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111348604|NCT00002290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111348605|NCT00002290|Antiviral Agents|antiviral agents|mesh-ancestor
111348606|NCT00002290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111348607|NCT00002290|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111348608|NCT00002290|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111348609|NCT01003769|Acetic Acid|acetic acid|mesh-list
111348610|NCT01003769|Lenalidomide|lenalidomide|mesh-list
111348611|NCT01003769|Retinol acetate|retinol acetate|mesh-list
111348612|NCT01003769|Gossypol acetic acid|gossypol acetic acid|mesh-list
111348613|NCT01003769|Gossypol|gossypol|mesh-list
111348614|NCT01003769|Immunologic Factors|immunologic factors|mesh-ancestor
111348615|NCT01003769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111348616|NCT01003769|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110743910|NCT04705480|Gabapentin|gabapentin|mesh-list
111348617|NCT01003769|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111348618|NCT01003769|Growth Substances|growth substances|mesh-ancestor
111348619|NCT01003769|Growth Inhibitors|growth inhibitors|mesh-ancestor
111348620|NCT01003769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111348621|NCT01003769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111348622|NCT01003769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111348623|NCT01003769|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111348624|NCT01003769|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
111348625|NCT01003769|Protective Agents|protective agents|mesh-ancestor
111348626|NCT01003769|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
111348627|NCT01003769|Contraceptive Agents|contraceptive agents|mesh-ancestor
111348628|NCT01003769|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111348629|NCT01003769|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110743974|NCT01048229|Rasagiline|rasagiline|mesh-list
111348630|NCT01003769|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111348632|NCT01003769|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
111348633|NCT00002452|Indinavir|indinavir|mesh-list
111348634|NCT00002452|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111348635|NCT00002452|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111348636|NCT00002452|Protease Inhibitors|protease inhibitors|mesh-ancestor
111348637|NCT00002452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111348638|NCT00002452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111348639|NCT00002452|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111348640|NCT00002452|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111348641|NCT00002452|Antiviral Agents|antiviral agents|mesh-ancestor
110744126|NCT01143974|Pemetrexed|pemetrexed|mesh-list
111348642|NCT00002452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111348643|NCT01004393|Bromides|bromides|mesh-list
111348644|NCT01004393|Methylnaltrexone|methylnaltrexone|mesh-list
111348645|NCT01004393|Anticonvulsants|anticonvulsants|mesh-ancestor
111348646|NCT01004393|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111348647|NCT01004393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111348648|NCT01004393|Sensory System Agents|sensory system agents|mesh-ancestor
111348649|NCT01004393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111348650|NCT00002458|Antibodies|antibodies|mesh-list
111348651|NCT00002458|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111348652|NCT00002458|Immunologic Factors|immunologic factors|mesh-ancestor
111348653|NCT00002458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111348654|NCT00002470|Interferons|interferons|mesh-list
111348655|NCT00002470|Interferon-alpha|interferon-alpha|mesh-list
111348656|NCT00002470|Fluorouracil|fluorouracil|mesh-list
111348657|NCT00002470|Antimetabolites|antimetabolites|mesh-ancestor
111348658|NCT00002470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111348659|NCT00002470|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111348660|NCT00002470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111348661|NCT00002470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111348662|NCT00002470|Immunologic Factors|immunologic factors|mesh-ancestor
110744328|NCT03912974|Serotonin Agents|serotonin agents|mesh-ancestor
111348663|NCT00002470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111348664|NCT00002470|Antiviral Agents|antiviral agents|mesh-ancestor
111348665|NCT00002470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111348666|NCT00002476|Leucovorin|leucovorin|mesh-list
111348667|NCT00002476|Cobalt|cobalt|mesh-list
111348668|NCT00002476|Fluorouracil|fluorouracil|mesh-list
111348669|NCT00002476|Methotrexate|methotrexate|mesh-list
111348670|NCT00002476|Vincristine|vincristine|mesh-list
111348671|NCT00002476|Bleomycin|bleomycin|mesh-list
111348672|NCT00002476|Calcium|calcium|mesh-list
111348673|NCT00002476|Levoleucovorin|levoleucovorin|mesh-list
111348674|NCT00002476|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111348675|NCT00002476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111348676|NCT00002476|Antimetabolites|antimetabolites|mesh-ancestor
111348677|NCT00002476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111348678|NCT00002476|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111348679|NCT00002476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111348680|NCT00002476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111348681|NCT00002476|Immunologic Factors|immunologic factors|mesh-ancestor
111348682|NCT00002476|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111348683|NCT00002476|Abortifacient Agents|abortifacient agents|mesh-ancestor
111348684|NCT00002476|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111348685|NCT00002476|Dermatologic Agents|dermatologic agents|mesh-ancestor
111348686|NCT00002476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110744596|NCT03914534|Valproic Acid|valproic acid|mesh-list
111348687|NCT00002476|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111348688|NCT00002476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111348689|NCT00002476|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111348690|NCT00002476|Antidotes|antidotes|mesh-ancestor
111348691|NCT00002476|Protective Agents|protective agents|mesh-ancestor
111348692|NCT00002476|Vitamin B Complex|vitamin b complex|mesh-ancestor
111348693|NCT00002476|Vitamins|vitamins|mesh-ancestor
111348694|NCT00002476|Micronutrients|micronutrients|mesh-ancestor
111348695|NCT00002476|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111348696|NCT00002476|Tubulin Modulators|tubulin modulators|mesh-ancestor
111348697|NCT00002476|Antimitotic Agents|antimitotic agents|mesh-ancestor
111348698|NCT00002476|Mitosis Modulators|mitosis modulators|mesh-ancestor
111348699|NCT00002476|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111348700|NCT00002476|Trace Elements|trace elements|mesh-ancestor
111348701|NCT01876628|Clindamycin|clindamycin|mesh-list
111348702|NCT01876628|Clindamycin palmitate|clindamycin palmitate|mesh-list
111348703|NCT01876628|Clindamycin phosphate|clindamycin phosphate|mesh-list
111348704|NCT01876628|Floxacillin|floxacillin|mesh-list
111348705|NCT01876628|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111348706|NCT01876628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111348707|NCT01876628|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111348708|NCT01876628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111348709|NCT01876628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111348710|NCT01004705|Aspirin|aspirin|mesh-list
111348711|NCT01004705|Ramipril|ramipril|mesh-list
111348712|NCT01004705|Simvastatin|simvastatin|mesh-list
111348713|NCT01004705|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111348714|NCT01004705|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111348715|NCT01004705|Antimetabolites|antimetabolites|mesh-ancestor
110745028|NCT03905486|Pregabalin|pregabalin|mesh-list
111348716|NCT01004705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111348717|NCT01004705|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111348718|NCT01004705|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111348719|NCT01004705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111348720|NCT01004705|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111348721|NCT01004705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111348722|NCT01004705|Analgesics|analgesics|mesh-ancestor
111348723|NCT01004705|Sensory System Agents|sensory system agents|mesh-ancestor
111348724|NCT01004705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111348725|NCT01004705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111348726|NCT01004705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111348727|NCT01004705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111348728|NCT01004705|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111348729|NCT01004705|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111348730|NCT01004705|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111348731|NCT01004705|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111348732|NCT01004705|Antipyretics|antipyretics|mesh-ancestor
111348733|NCT01004705|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
111348734|NCT01004705|Protease Inhibitors|protease inhibitors|mesh-ancestor
110745170|NCT03894800|Anesthetics|anesthetics|mesh-ancestor
111348735|NCT01004705|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111348736|NCT00002482|Cyclophosphamide|cyclophosphamide|mesh-list
111348737|NCT00002482|Muromonab-CD3|muromonab-cd3|mesh-list
111348738|NCT00002482|Antibodies|antibodies|mesh-list
111348739|NCT00002482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111348740|NCT00002482|Immunologic Factors|immunologic factors|mesh-ancestor
111348741|NCT00002482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111348742|NCT00002482|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111348743|NCT00002482|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111348744|NCT00002482|Alkylating Agents|alkylating agents|mesh-ancestor
111348745|NCT00002482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111348746|NCT00002482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111348747|NCT00002482|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111348748|NCT01004939|PENTA|penta|mesh-list
111348749|NCT01004939|Fondaparinux|fondaparinux|mesh-list
111348750|NCT01004939|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111348751|NCT01004939|Antithrombins|antithrombins|mesh-ancestor
111348752|NCT01004939|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111348753|NCT01004939|Protease Inhibitors|protease inhibitors|mesh-ancestor
111348754|NCT01004939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110745301|NCT01258634|Antidotes|antidotes|mesh-ancestor
111348755|NCT01004939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111348756|NCT01004939|Anticoagulants|anticoagulants|mesh-ancestor
111348757|NCT01004939|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111348758|NCT01004939|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111348759|NCT05750758|Rivaroxaban|rivaroxaban|mesh-list
111348760|NCT05750758|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111348761|NCT05750758|Antithrombins|antithrombins|mesh-ancestor
111348762|NCT05750758|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111348763|NCT05750758|Protease Inhibitors|protease inhibitors|mesh-ancestor
111348764|NCT05750758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111348765|NCT05750758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111348766|NCT05750758|Anticoagulants|anticoagulants|mesh-ancestor
111348767|NCT00002488|Cyclophosphamide|cyclophosphamide|mesh-list
111348768|NCT00002488|Etoposide|etoposide|mesh-list
110745517|NCT01153802|Sympathomimetics|sympathomimetics|mesh-ancestor
111348769|NCT00002488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111348770|NCT00002488|Immunologic Factors|immunologic factors|mesh-ancestor
111348771|NCT00002488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111348772|NCT00002488|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111348773|NCT00002488|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111348774|NCT00002488|Alkylating Agents|alkylating agents|mesh-ancestor
111348775|NCT00002488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111348776|NCT00002488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111348777|NCT00002488|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111348778|NCT00002488|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111348779|NCT00002488|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111348780|NCT00002488|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111348781|NCT00002488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111348782|NCT01245595|Aminophylline|aminophylline|mesh-list
111348783|NCT01245595|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111073158|NCT05283161|Hormones|hormones|mesh-ancestor
111348784|NCT01245595|Autonomic Agents|autonomic agents|mesh-ancestor
111348785|NCT01245595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111348786|NCT01245595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111348787|NCT01245595|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111348788|NCT01245595|Respiratory System Agents|respiratory system agents|mesh-ancestor
111348789|NCT01245595|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111348790|NCT01245595|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111348791|NCT01245595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111348792|NCT01245595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111348793|NCT01245595|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
111348794|NCT01245595|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111348795|NCT01245595|Purinergic Agents|purinergic agents|mesh-ancestor
111348796|NCT01245595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111348797|NCT01245595|Protective Agents|protective agents|mesh-ancestor
111348798|NCT01864772|Cetuximab|cetuximab|mesh-list
111348799|NCT01864772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111348800|NCT01864772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111348801|NCT00002494|Leucovorin|leucovorin|mesh-list
111348802|NCT00002494|Cobalt|cobalt|mesh-list
111348803|NCT00002494|Cytarabine|cytarabine|mesh-list
111348804|NCT00002494|Dexamethasone|dexamethasone|mesh-list
111348805|NCT00002494|Prednisone|prednisone|mesh-list
111348806|NCT00002494|Hydrocortisone|hydrocortisone|mesh-list
111348807|NCT00002494|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
111348808|NCT00002494|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
111348809|NCT00002494|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
111348810|NCT00002494|Cyclophosphamide|cyclophosphamide|mesh-list
111348811|NCT00002494|Ifosfamide|ifosfamide|mesh-list
111348812|NCT00002494|Doxorubicin|doxorubicin|mesh-list
111348813|NCT00002494|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111348814|NCT00002494|Methotrexate|methotrexate|mesh-list
111348815|NCT00002494|Etoposide|etoposide|mesh-list
111348816|NCT00002494|Vincristine|vincristine|mesh-list
111348817|NCT00002494|Levoleucovorin|levoleucovorin|mesh-list
111348818|NCT00002494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111348819|NCT00002494|Immunologic Factors|immunologic factors|mesh-ancestor
111348820|NCT00002494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111348821|NCT00002494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111348822|NCT00002494|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111348823|NCT00002494|Alkylating Agents|alkylating agents|mesh-ancestor
111348824|NCT00002494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111348825|NCT00002494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111348826|NCT00002494|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111348827|NCT00002494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111348828|NCT00002494|Antiemetics|antiemetics|mesh-ancestor
111348829|NCT00002494|Autonomic Agents|autonomic agents|mesh-ancestor
111348830|NCT00002494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111348831|NCT00002494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111348832|NCT00002494|Glucocorticoids|glucocorticoids|mesh-ancestor
111348833|NCT00002494|Hormones|hormones|mesh-ancestor
111348834|NCT00002494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111348835|NCT00002494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111348836|NCT00002494|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111348837|NCT00002494|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111348838|NCT00002494|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111348839|NCT00002494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110746046|NCT01159652|GABA Modulators|gaba modulators|mesh-ancestor
111348840|NCT00002494|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111348841|NCT00002494|Abortifacient Agents|abortifacient agents|mesh-ancestor
111348842|NCT00002494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111348843|NCT00002494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111348844|NCT00002494|Antimetabolites|antimetabolites|mesh-ancestor
111348845|NCT00002494|Dermatologic Agents|dermatologic agents|mesh-ancestor
111348846|NCT00002494|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111348847|NCT00002494|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111348848|NCT00002494|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111348849|NCT00002494|Antiviral Agents|antiviral agents|mesh-ancestor
111348850|NCT00002494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111348851|NCT00002494|Antidotes|antidotes|mesh-ancestor
111348852|NCT00002494|Protective Agents|protective agents|mesh-ancestor
111348853|NCT00002494|Vitamin B Complex|vitamin b complex|mesh-ancestor
111348854|NCT00002494|Vitamins|vitamins|mesh-ancestor
111348855|NCT00002494|Micronutrients|micronutrients|mesh-ancestor
111348856|NCT00002494|Tubulin Modulators|tubulin modulators|mesh-ancestor
111348857|NCT00002494|Antimitotic Agents|antimitotic agents|mesh-ancestor
111348858|NCT00002494|Mitosis Modulators|mitosis modulators|mesh-ancestor
111348859|NCT00002494|Trace Elements|trace elements|mesh-ancestor
111348860|NCT00002506|Interferons|interferons|mesh-list
111348861|NCT00002506|Interferon-alpha|interferon-alpha|mesh-list
111348862|NCT00002506|Isotretinoin|isotretinoin|mesh-list
111348863|NCT00002506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111348864|NCT00002506|Antiviral Agents|antiviral agents|mesh-ancestor
110746246|NCT01267058|Vaccines|vaccines|mesh-list
111348865|NCT00002506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111348866|NCT00002506|Immunologic Factors|immunologic factors|mesh-ancestor
111348867|NCT00002506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111348868|NCT00002506|Dermatologic Agents|dermatologic agents|mesh-ancestor
111348869|NCT01895894|Mycophenolic Acid|mycophenolic acid|mesh-list
111348870|NCT01895894|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111348871|NCT01895894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111348872|NCT01895894|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111348873|NCT01895894|Antitubercular Agents|antitubercular agents|mesh-ancestor
111348874|NCT01895894|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111348875|NCT01895894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111348876|NCT01895894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111348877|NCT01895894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111348878|NCT02165111|Botulinum Toxins|botulinum toxins|mesh-list
111348879|NCT02165111|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111348880|NCT02165111|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110071444|NCT01559480|Hormones|hormones|mesh-ancestor
111348881|NCT02165111|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111348882|NCT02165111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111348883|NCT02165111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111348884|NCT02165111|Cholinergic Agents|cholinergic agents|mesh-ancestor
111348885|NCT02165111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111348886|NCT02165111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111348887|NCT02165111|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110746449|NCT03874364|Lidocaine|lidocaine|mesh-list
111348888|NCT02165111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111348889|NCT05750446|Riociguat|riociguat|mesh-list
111348890|NCT05750446|Enzyme Activators|enzyme activators|mesh-ancestor
111348891|NCT05750446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111348892|NCT05750290|Irinotecan|irinotecan|mesh-list
111348893|NCT05750290|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111348894|NCT05750290|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111348895|NCT05750290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111348896|NCT05750290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111348897|NCT05750290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111348898|NCT03845621|Salicylic Acid|salicylic acid|mesh-list
111348899|NCT03845621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111348900|NCT03845621|Antifungal Agents|antifungal agents|mesh-ancestor
111348901|NCT03845621|Keratolytic Agents|keratolytic agents|mesh-ancestor
111348902|NCT03845621|Dermatologic Agents|dermatologic agents|mesh-ancestor
111348903|NCT04456517|Ranolazine|ranolazine|mesh-list
111348904|NCT04456517|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111348905|NCT04456517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111348906|NCT04456517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111348907|NCT01840046|Interleukin-2|interleukin-2|mesh-list
111348908|NCT01840046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111348909|NCT01840046|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111348910|NCT01840046|Analgesics|analgesics|mesh-ancestor
111348911|NCT01840046|Sensory System Agents|sensory system agents|mesh-ancestor
111348912|NCT01840046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111348913|NCT01840046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111348914|NCT00437216|Clobetasol|clobetasol|mesh-list
111348915|NCT00437216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111348916|NCT00437216|Glucocorticoids|glucocorticoids|mesh-ancestor
111348917|NCT00437216|Hormones|hormones|mesh-ancestor
111348918|NCT00437216|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111348919|NCT00437216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111348920|NCT00002524|Leucovorin|leucovorin|mesh-list
111348921|NCT00002524|Cytarabine|cytarabine|mesh-list
111348922|NCT00002524|Zidovudine|zidovudine|mesh-list
111348923|NCT00002524|Trimethoprim|trimethoprim|mesh-list
111348924|NCT00002524|Sulfamethoxazole|sulfamethoxazole|mesh-list
110746627|NCT01167764|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111348925|NCT00002524|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
111348926|NCT00002524|Pentamidine|pentamidine|mesh-list
111348927|NCT00002524|Prednisone|prednisone|mesh-list
111348928|NCT00002524|Methylprednisolone|methylprednisolone|mesh-list
111348929|NCT00002524|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111348930|NCT00002524|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111348931|NCT00002524|Prednisolone|prednisolone|mesh-list
111348932|NCT00002524|Prednisolone acetate|prednisolone acetate|mesh-list
111348933|NCT00002524|Cyclophosphamide|cyclophosphamide|mesh-list
111348934|NCT00002524|Ifosfamide|ifosfamide|mesh-list
111348935|NCT00002524|Doxorubicin|doxorubicin|mesh-list
111348936|NCT00002524|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111348937|NCT00002524|Fluorouracil|fluorouracil|mesh-list
111348938|NCT00002524|Methotrexate|methotrexate|mesh-list
111348939|NCT00002524|Etoposide|etoposide|mesh-list
111348940|NCT00002524|Vincristine|vincristine|mesh-list
111348941|NCT00002524|Bleomycin|bleomycin|mesh-list
111348942|NCT00002524|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111348943|NCT00002524|Prednisolone phosphate|prednisolone phosphate|mesh-list
111348944|NCT00002524|Levoleucovorin|levoleucovorin|mesh-list
111348945|NCT00002524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111348946|NCT00002524|Immunologic Factors|immunologic factors|mesh-ancestor
111348947|NCT00002524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111348948|NCT00002524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111348949|NCT00002524|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111348950|NCT00002524|Alkylating Agents|alkylating agents|mesh-ancestor
111348951|NCT00002524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111348952|NCT00002524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111348953|NCT00002524|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110746900|NCT01172912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111348954|NCT00002524|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111348955|NCT00002524|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111348956|NCT00002524|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111348957|NCT00002524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111348958|NCT00002524|Antimetabolites|antimetabolites|mesh-ancestor
111348959|NCT00002524|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111348960|NCT00002524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111348961|NCT00002524|Glucocorticoids|glucocorticoids|mesh-ancestor
111348962|NCT00002524|Hormones|hormones|mesh-ancestor
111348963|NCT00002524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111348964|NCT00002524|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110746970|NCT01284764|Serotonin Agents|serotonin agents|mesh-ancestor
111348965|NCT00002524|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111348966|NCT00002524|Abortifacient Agents|abortifacient agents|mesh-ancestor
111348967|NCT00002524|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111348968|NCT00002524|Dermatologic Agents|dermatologic agents|mesh-ancestor
111348969|NCT00002524|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111348970|NCT00002524|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111348971|NCT00002524|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111348972|NCT00002524|Antiviral Agents|antiviral agents|mesh-ancestor
111348973|NCT00002524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111348974|NCT00002524|Antidotes|antidotes|mesh-ancestor
111348975|NCT00002524|Protective Agents|protective agents|mesh-ancestor
111348976|NCT00002524|Vitamin B Complex|vitamin b complex|mesh-ancestor
111348977|NCT00002524|Vitamins|vitamins|mesh-ancestor
111348978|NCT00002524|Micronutrients|micronutrients|mesh-ancestor
111348979|NCT00002524|Tubulin Modulators|tubulin modulators|mesh-ancestor
111348980|NCT00002524|Antimitotic Agents|antimitotic agents|mesh-ancestor
111348981|NCT00002524|Mitosis Modulators|mitosis modulators|mesh-ancestor
111348982|NCT00002524|Antiemetics|antiemetics|mesh-ancestor
111348983|NCT00002524|Autonomic Agents|autonomic agents|mesh-ancestor
111348984|NCT00002524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111348985|NCT00002524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111348986|NCT00002524|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111348987|NCT00002524|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111348988|NCT00002524|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111348989|NCT00002524|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111348990|NCT00002524|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111348991|NCT00002524|Antimalarials|antimalarials|mesh-ancestor
111348992|NCT00002524|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111348993|NCT00002524|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111348994|NCT00002524|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111348995|NCT00002524|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
110747104|NCT02987530|Cobicistat|cobicistat|mesh-list
111348996|NCT00002524|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111348997|NCT00002524|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111348998|NCT00002524|Antifungal Agents|antifungal agents|mesh-ancestor
111348999|NCT00002524|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
111349000|NCT00002536|Vincristine|vincristine|mesh-list
111349001|NCT00002536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111349002|NCT00002536|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111349003|NCT00002536|Tubulin Modulators|tubulin modulators|mesh-ancestor
111349004|NCT00002536|Antimitotic Agents|antimitotic agents|mesh-ancestor
111349005|NCT00002536|Mitosis Modulators|mitosis modulators|mesh-ancestor
111349006|NCT00002536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111349007|NCT01203319|Vaccines|vaccines|mesh-list
111349008|NCT01203319|Immunologic Factors|immunologic factors|mesh-ancestor
111349009|NCT01203319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111349010|NCT01344200|Celecoxib|celecoxib|mesh-list
111349011|NCT01344200|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111349012|NCT01344200|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111349013|NCT01344200|Analgesics|analgesics|mesh-ancestor
111349014|NCT01344200|Sensory System Agents|sensory system agents|mesh-ancestor
111349015|NCT01344200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111349016|NCT01344200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111349017|NCT01344200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111349018|NCT01344200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111349019|NCT01344200|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111349020|NCT01344200|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111349021|NCT01344200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111349022|NCT01344200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111349023|NCT01204255|Diphenhydramine|diphenhydramine|mesh-list
111349024|NCT01204255|Promethazine|promethazine|mesh-list
111349025|NCT01204255|Lorazepam|lorazepam|mesh-list
111349026|NCT01204255|Haloperidol|haloperidol|mesh-list
111349027|NCT01204255|Haloperidol decanoate|haloperidol decanoate|mesh-list
111349028|NCT01204255|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111349029|NCT01204255|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111349030|NCT01204255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111349031|NCT01204255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111349032|NCT01204255|Anesthetics, Local|anesthetics, local|mesh-ancestor
111349033|NCT01204255|Anesthetics|anesthetics|mesh-ancestor
111349034|NCT01204255|Sensory System Agents|sensory system agents|mesh-ancestor
111349035|NCT01204255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111349036|NCT01204255|Antiemetics|antiemetics|mesh-ancestor
111349037|NCT01204255|Autonomic Agents|autonomic agents|mesh-ancestor
111349038|NCT01204255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111349039|NCT01204255|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111349040|NCT01204255|Histamine Antagonists|histamine antagonists|mesh-ancestor
111349041|NCT01204255|Histamine Agents|histamine agents|mesh-ancestor
111349042|NCT01204255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111349043|NCT01204255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111349044|NCT01204255|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111349045|NCT01204255|Antipruritics|antipruritics|mesh-ancestor
110747557|NCT01172444|Analgesics|analgesics|mesh-ancestor
111349046|NCT01204255|Dermatologic Agents|dermatologic agents|mesh-ancestor
111349047|NCT01204255|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111349048|NCT01204255|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111349049|NCT01204255|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111349050|NCT01204255|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111349051|NCT01204255|Dopamine Agents|dopamine agents|mesh-ancestor
111349052|NCT01204255|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110747645|NCT03088826|Morphine|morphine|mesh-list
111349053|NCT01204255|Anticonvulsants|anticonvulsants|mesh-ancestor
111349054|NCT01204255|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111349055|NCT01204255|GABA Modulators|gaba modulators|mesh-ancestor
111349056|NCT01204255|GABA Agents|gaba agents|mesh-ancestor
111349057|NCT00002542|Tamoxifen|tamoxifen|mesh-list
111349058|NCT00002542|Cyclophosphamide|cyclophosphamide|mesh-list
111349059|NCT00002542|Doxorubicin|doxorubicin|mesh-list
111349060|NCT00002542|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111349061|NCT00002542|Fluorouracil|fluorouracil|mesh-list
111349062|NCT00002542|Methotrexate|methotrexate|mesh-list
111349063|NCT00002542|Epirubicin|epirubicin|mesh-list
111349064|NCT00002542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111349065|NCT00002542|Immunologic Factors|immunologic factors|mesh-ancestor
111349066|NCT00002542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111349067|NCT00002542|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111349068|NCT00002542|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111349069|NCT00002542|Alkylating Agents|alkylating agents|mesh-ancestor
111349070|NCT00002542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111349071|NCT00002542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111349072|NCT00002542|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111349073|NCT00002542|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111349074|NCT00002542|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111349075|NCT00002542|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111349076|NCT00002542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111349077|NCT00002542|Antimetabolites|antimetabolites|mesh-ancestor
110747764|NCT01093092|Vitamins|vitamins|mesh-ancestor
111349078|NCT00002542|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111349079|NCT00002542|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111349080|NCT00002542|Abortifacient Agents|abortifacient agents|mesh-ancestor
111349081|NCT00002542|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111349082|NCT00002542|Dermatologic Agents|dermatologic agents|mesh-ancestor
111349083|NCT00002542|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111349084|NCT00002542|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110747821|NCT01287260|Nifedipine|nifedipine|mesh-list
111349085|NCT00002542|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111349086|NCT00002542|Hormone Antagonists|hormone antagonists|mesh-ancestor
111349087|NCT00002542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111349088|NCT00002542|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111349089|NCT00002542|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110747888|NCT01587638|Metoprolol|metoprolol|mesh-list
111349090|NCT00002542|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111349091|NCT00002542|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111349092|NCT01156597|Pioglitazone|pioglitazone|mesh-list
111349093|NCT01156597|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111349094|NCT01156597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111349095|NCT01823198|Aldesleukin|aldesleukin|mesh-list
111349096|NCT01823198|Fludarabine|fludarabine|mesh-list
111349097|NCT01823198|Fludarabine phosphate|fludarabine phosphate|mesh-list
111349098|NCT01823198|Busulfan|busulfan|mesh-list
111349099|NCT01823198|Interleukin-2|interleukin-2|mesh-list
111349100|NCT01823198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111349101|NCT01823198|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111349102|NCT01823198|Antimetabolites|antimetabolites|mesh-ancestor
111349103|NCT01823198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111349104|NCT01823198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111349105|NCT01823198|Immunologic Factors|immunologic factors|mesh-ancestor
111349106|NCT01823198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111349107|NCT01823198|Alkylating Agents|alkylating agents|mesh-ancestor
111349108|NCT01823198|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111349109|NCT01823198|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111349110|NCT01823198|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111349111|NCT01823198|Analgesics|analgesics|mesh-ancestor
111349112|NCT01823198|Sensory System Agents|sensory system agents|mesh-ancestor
111349113|NCT01823198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111349114|NCT01823198|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111349115|NCT01823198|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111349116|NCT01823198|Antiviral Agents|antiviral agents|mesh-ancestor
111349117|NCT01823198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111349118|NCT05750056|Lidocaine|lidocaine|mesh-list
111349119|NCT05750056|Sufentanil|sufentanil|mesh-list
111349120|NCT05750056|Dsuvia|dsuvia|mesh-list
111349121|NCT05750056|Propofol|propofol|mesh-list
111349122|NCT05750056|Anesthetics, Local|anesthetics, local|mesh-ancestor
111349123|NCT05750056|Anesthetics|anesthetics|mesh-ancestor
111349124|NCT05750056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111349125|NCT05750056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111349126|NCT05750056|Sensory System Agents|sensory system agents|mesh-ancestor
111349127|NCT05750056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111349128|NCT05750056|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111349129|NCT05750056|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111349130|NCT05750056|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111349131|NCT05750056|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111349132|NCT05750056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111349133|NCT05750056|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111349134|NCT05750056|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111349135|NCT05750056|Anesthetics, General|anesthetics, general|mesh-ancestor
111349136|NCT05750056|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111349137|NCT05750056|Narcotics|narcotics|mesh-ancestor
111349138|NCT05750056|Analgesics|analgesics|mesh-ancestor
111349139|NCT05750056|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111349140|NCT03011125|Dexlansoprazole|dexlansoprazole|mesh-list
111349141|NCT03011125|Lansoprazole|lansoprazole|mesh-list
111349142|NCT03011125|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111349143|NCT03011125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111349144|NCT03011125|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111349145|NCT03011125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111349146|NCT03011125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111349147|NCT05749900|Gemcitabine|gemcitabine|mesh-list
111349148|NCT05749900|Nivolumab|nivolumab|mesh-list
111349149|NCT05749900|Trastuzumab|trastuzumab|mesh-list
111349150|NCT05749900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111349151|NCT05749900|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111349152|NCT05749900|Antimetabolites|antimetabolites|mesh-ancestor
110748120|NCT01185158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111349153|NCT05749900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111349154|NCT05749900|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111349155|NCT05749900|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111349156|NCT03442751|Riboflavin|riboflavin|mesh-list
111349157|NCT03442751|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111349158|NCT03442751|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111349159|NCT03442751|Vitamin B Complex|vitamin b complex|mesh-ancestor
111349160|NCT03442751|Vitamins|vitamins|mesh-ancestor
111349161|NCT03442751|Micronutrients|micronutrients|mesh-ancestor
111349162|NCT03442751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111349163|NCT03442751|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111349164|NCT03442751|Dermatologic Agents|dermatologic agents|mesh-ancestor
111349165|NCT05749666|Prednisolone|prednisolone|mesh-list
111349166|NCT05749666|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111349167|NCT05749666|Methylprednisolone|methylprednisolone|mesh-list
111349168|NCT05749666|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111349169|NCT05749666|Prednisolone acetate|prednisolone acetate|mesh-list
111349170|NCT05749666|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111349171|NCT05749666|Prednisolone phosphate|prednisolone phosphate|mesh-list
111349172|NCT05749666|Tofacitinib|tofacitinib|mesh-list
111349173|NCT05749666|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111349174|NCT05749666|Glucocorticoids|glucocorticoids|mesh-ancestor
111349175|NCT05749666|Hormones|hormones|mesh-ancestor
111349176|NCT05749666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111349177|NCT05749666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111349178|NCT05749666|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111349179|NCT05749666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111349180|NCT05749666|Antiemetics|antiemetics|mesh-ancestor
111349181|NCT05749666|Autonomic Agents|autonomic agents|mesh-ancestor
111349182|NCT05749666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111349183|NCT05749666|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111349184|NCT05749666|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111349185|NCT05749666|Protective Agents|protective agents|mesh-ancestor
111349186|NCT05749666|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
111349187|NCT05749666|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110748425|NCT01093638|Insulin|insulin|mesh-list
111349188|NCT05749666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111349189|NCT05749666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111349190|NCT05449535|Omalizumab|omalizumab|mesh-list
111349191|NCT05449535|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111349192|NCT05449535|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111349193|NCT05449535|Respiratory System Agents|respiratory system agents|mesh-ancestor
111349194|NCT05749276|Daratumumab|daratumumab|mesh-list
111349195|NCT05749276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111349196|NCT05749042|Cisplatin|cisplatin|mesh-list
111349197|NCT05749042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111349198|NCT02940509|Magnesium Sulfate|magnesium sulfate|mesh-list
111349199|NCT02940509|Ketamine|ketamine|mesh-list
111349200|NCT02940509|Analgesics|analgesics|mesh-ancestor
111349201|NCT02940509|Sensory System Agents|sensory system agents|mesh-ancestor
111349202|NCT02940509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111349203|NCT02940509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111349204|NCT02940509|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111349205|NCT02940509|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111349206|NCT02940509|Anesthetics, General|anesthetics, general|mesh-ancestor
111349207|NCT02940509|Anesthetics|anesthetics|mesh-ancestor
111349208|NCT02940509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111349209|NCT02940509|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111349210|NCT02940509|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111349211|NCT02940509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111349212|NCT02940509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111349213|NCT02940509|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111349214|NCT02940509|Anticonvulsants|anticonvulsants|mesh-ancestor
111349215|NCT02940509|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111349216|NCT02940509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111349217|NCT02940509|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111349218|NCT02940509|Tocolytic Agents|tocolytic agents|mesh-ancestor
111349219|NCT02940509|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111349220|NCT02530697|Miltefosine|miltefosine|mesh-list
111349221|NCT02530697|Meglumine Antimoniate|meglumine antimoniate|mesh-list
111349222|NCT02530697|Pentoxifylline|pentoxifylline|mesh-list
111349223|NCT02530697|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111349224|NCT02530697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111349225|NCT02530697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110748734|NCT01293734|Autonomic Agents|autonomic agents|mesh-ancestor
111349226|NCT02530697|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111349227|NCT02530697|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111349228|NCT02530697|Protective Agents|protective agents|mesh-ancestor
111349229|NCT02530697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111349230|NCT02530697|Vasodilator Agents|vasodilator agents|mesh-ancestor
111349231|NCT02530697|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111349232|NCT02530697|Antioxidants|antioxidants|mesh-ancestor
111349233|NCT02530697|Antifungal Agents|antifungal agents|mesh-ancestor
111349234|NCT02530697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111349235|NCT02530697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111349236|NCT02530697|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111349237|NCT02530697|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111349238|NCT02170649|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
111349239|NCT02170649|Anticonvulsants|anticonvulsants|mesh-ancestor
111349240|NCT02170649|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110748881|NCT01294826|Cetuximab|cetuximab|mesh-list
111349241|NCT02170649|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111349242|NCT02170649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111349243|NCT02170649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111349244|NCT04094207|Pentoxifylline|pentoxifylline|mesh-list
111349245|NCT04094207|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111349246|NCT04094207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111349247|NCT04094207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111349248|NCT04094207|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111349249|NCT04094207|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111349250|NCT04094207|Protective Agents|protective agents|mesh-ancestor
111349251|NCT04094207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111349252|NCT04094207|Vasodilator Agents|vasodilator agents|mesh-ancestor
111349253|NCT04094207|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111349255|NCT02144831|Aspirin|aspirin|mesh-list
111349256|NCT02144831|Clopidogrel|clopidogrel|mesh-list
111349257|NCT02144831|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111349258|NCT02144831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111349259|NCT02144831|Analgesics|analgesics|mesh-ancestor
111349260|NCT02144831|Sensory System Agents|sensory system agents|mesh-ancestor
111349261|NCT02144831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111349262|NCT02144831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111349263|NCT02144831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111349264|NCT02144831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110749081|NCT01191710|Progesterone|progesterone|mesh-list
111349265|NCT02144831|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111349266|NCT02144831|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111349267|NCT02144831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111349268|NCT02144831|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111349269|NCT02144831|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111349270|NCT02144831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111349271|NCT02144831|Antipyretics|antipyretics|mesh-ancestor
111349272|NCT02144831|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111349273|NCT02144831|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111349274|NCT02144831|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111349275|NCT02144831|Purinergic Agents|purinergic agents|mesh-ancestor
111349276|NCT02144831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111349277|NCT05232461|Ciprofloxacin|ciprofloxacin|mesh-list
111349278|NCT05232461|Celecoxib|celecoxib|mesh-list
111349279|NCT05232461|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111349280|NCT05232461|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111349281|NCT05232461|Analgesics|analgesics|mesh-ancestor
111349282|NCT05232461|Sensory System Agents|sensory system agents|mesh-ancestor
111349283|NCT05232461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111349284|NCT05232461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111349285|NCT05232461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111349286|NCT05232461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111349287|NCT05232461|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111349288|NCT05232461|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111349289|NCT05232461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111349290|NCT05232461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111349291|NCT05232461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111349292|NCT05232461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111349293|NCT05232461|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111349294|NCT05232461|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111349295|NCT05232461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111349296|NCT05232461|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111349297|NCT05232461|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111349298|NCT01804790|Capecitabine|capecitabine|mesh-list
111349299|NCT01804790|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111349300|NCT01804790|Antimetabolites|antimetabolites|mesh-ancestor
111349301|NCT01804790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111349302|NCT01804790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111349303|NCT01313702|Atenolol|atenolol|mesh-list
111349304|NCT01313702|Lisinopril|lisinopril|mesh-list
111349305|NCT01313702|Simvastatin|simvastatin|mesh-list
111349306|NCT01313702|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111349307|NCT01313702|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111349308|NCT01313702|Antimetabolites|antimetabolites|mesh-ancestor
111349309|NCT01313702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111349310|NCT01313702|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111349311|NCT01313702|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111349312|NCT01313702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111349313|NCT01313702|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
111349314|NCT01313702|Protease Inhibitors|protease inhibitors|mesh-ancestor
111349315|NCT01313702|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111349316|NCT01313702|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111349317|NCT01313702|Protective Agents|protective agents|mesh-ancestor
111349318|NCT01313702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111349320|NCT01313702|Sympatholytics|sympatholytics|mesh-ancestor
111349321|NCT01313702|Autonomic Agents|autonomic agents|mesh-ancestor
111349322|NCT01313702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111349323|NCT01313702|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
111349324|NCT01313702|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111349325|NCT01313702|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111349326|NCT01313702|Adrenergic Agents|adrenergic agents|mesh-ancestor
111349327|NCT01313702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111349328|NCT04868708|Paclitaxel|paclitaxel|mesh-list
111349329|NCT04868708|Bevacizumab|bevacizumab|mesh-list
111349330|NCT04868708|Carboplatin|carboplatin|mesh-list
111349331|NCT04868708|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111349332|NCT04868708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111349333|NCT04868708|Tubulin Modulators|tubulin modulators|mesh-ancestor
111349334|NCT04868708|Antimitotic Agents|antimitotic agents|mesh-ancestor
111349335|NCT04868708|Mitosis Modulators|mitosis modulators|mesh-ancestor
111349336|NCT04868708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111349337|NCT04868708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111349338|NCT04868708|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111349339|NCT04868708|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111349340|NCT04868708|Growth Substances|growth substances|mesh-ancestor
111349341|NCT04868708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111349342|NCT04868708|Growth Inhibitors|growth inhibitors|mesh-ancestor
111349343|NCT05732272|Bupropion|bupropion|mesh-list
111349344|NCT05732272|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111349345|NCT05732272|Antidepressive Agents|antidepressive agents|mesh-ancestor
111349346|NCT05732272|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111349347|NCT05732272|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111349348|NCT05732272|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111349349|NCT05732272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111349350|NCT05732272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111349351|NCT05732272|Dopamine Agents|dopamine agents|mesh-ancestor
111349352|NCT05732272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110749595|NCT01347112|Varenicline|varenicline|mesh-list
111349353|NCT05732272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111349354|NCT05732272|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111349355|NCT05732272|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111349356|NCT05732272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111349357|NCT05513872|Nicotine|nicotine|mesh-list
110749673|NCT01066169|Lactitol|lactitol|mesh-list
111349358|NCT05513872|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111349359|NCT05513872|Autonomic Agents|autonomic agents|mesh-ancestor
111349360|NCT05513872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111349361|NCT05513872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111349362|NCT05513872|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111349363|NCT05513872|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111349364|NCT05513872|Cholinergic Agents|cholinergic agents|mesh-ancestor
111349365|NCT05513872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111349366|NCT05513872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111349367|NCT05445856|Fentanyl|fentanyl|mesh-list
111349368|NCT05445856|Methadone|methadone|mesh-list
111349369|NCT05445856|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111349370|NCT05445856|Narcotics|narcotics|mesh-ancestor
111349371|NCT05445856|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111349372|NCT05445856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111349373|NCT05445856|Analgesics|analgesics|mesh-ancestor
111349374|NCT05445856|Sensory System Agents|sensory system agents|mesh-ancestor
111349375|NCT05445856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111349376|NCT05445856|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111349377|NCT05445856|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111349378|NCT05445856|Anesthetics, General|anesthetics, general|mesh-ancestor
111349379|NCT05445856|Anesthetics|anesthetics|mesh-ancestor
111349380|NCT05445856|Antitussive Agents|antitussive agents|mesh-ancestor
111349381|NCT05445856|Respiratory System Agents|respiratory system agents|mesh-ancestor
111349382|NCT00382330|Ciclopirox|ciclopirox|mesh-list
111349383|NCT00382330|Antifungal Agents|antifungal agents|mesh-ancestor
111349384|NCT00382330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111349385|NCT05520892|Immunoglobulins|immunoglobulins|mesh-list
111349386|NCT05520892|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111349387|NCT05520892|Antibodies|antibodies|mesh-list
111349388|NCT05520892|gamma-Globulins|gamma-globulins|mesh-list
111349389|NCT05520892|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
111349390|NCT05520892|Immunologic Factors|immunologic factors|mesh-ancestor
111349391|NCT05520892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111349392|NCT05397964|Calcium|calcium|mesh-list
111349393|NCT05397964|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111349394|NCT05397964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111349395|NCT00002548|Interferons|interferons|mesh-list
111349396|NCT00002548|Interferon-alpha|interferon-alpha|mesh-list
111349397|NCT00002548|Dexamethasone|dexamethasone|mesh-list
111349398|NCT00002548|Prednisone|prednisone|mesh-list
111349399|NCT00002548|Cyclophosphamide|cyclophosphamide|mesh-list
111349400|NCT00002548|Melphalan|melphalan|mesh-list
111349401|NCT00002548|Carmustine|carmustine|mesh-list
111349402|NCT00002548|Doxorubicin|doxorubicin|mesh-list
111349403|NCT00002548|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111349404|NCT00002548|Vincristine|vincristine|mesh-list
111349405|NCT00002548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111349406|NCT00002548|Immunologic Factors|immunologic factors|mesh-ancestor
111349407|NCT00002548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111349408|NCT00002548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111349409|NCT00002548|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111349410|NCT00002548|Alkylating Agents|alkylating agents|mesh-ancestor
111349411|NCT00002548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111349412|NCT00002548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111349413|NCT00002548|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111349414|NCT00002548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111349415|NCT00002548|Antiemetics|antiemetics|mesh-ancestor
111349416|NCT00002548|Autonomic Agents|autonomic agents|mesh-ancestor
111349417|NCT00002548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111349418|NCT00002548|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111349419|NCT00002548|Glucocorticoids|glucocorticoids|mesh-ancestor
111349420|NCT00002548|Hormones|hormones|mesh-ancestor
111349421|NCT00002548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111349422|NCT00002548|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111349423|NCT00002548|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111349424|NCT00002548|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111349425|NCT00002548|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111349426|NCT00002548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111349427|NCT00002548|Antiviral Agents|antiviral agents|mesh-ancestor
111349428|NCT00002548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111349429|NCT00002548|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111349430|NCT00002548|Tubulin Modulators|tubulin modulators|mesh-ancestor
111349431|NCT00002548|Antimitotic Agents|antimitotic agents|mesh-ancestor
111349432|NCT00002548|Mitosis Modulators|mitosis modulators|mesh-ancestor
111349433|NCT02087306|Brincidofovir|brincidofovir|mesh-list
111349434|NCT02087306|Antiviral Agents|antiviral agents|mesh-ancestor
111349435|NCT02087306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111349436|NCT00002554|Cyclophosphamide|cyclophosphamide|mesh-list
111349437|NCT00002554|Busulfan|busulfan|mesh-list
111349438|NCT00002554|Methotrexate|methotrexate|mesh-list
111349439|NCT00002554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111349440|NCT00002554|Immunologic Factors|immunologic factors|mesh-ancestor
111349441|NCT00002554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111349442|NCT00002554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111349443|NCT00002554|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111349444|NCT00002554|Alkylating Agents|alkylating agents|mesh-ancestor
111349445|NCT00002554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111349446|NCT00002554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111349447|NCT00002554|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111349448|NCT00002554|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111349449|NCT00002554|Abortifacient Agents|abortifacient agents|mesh-ancestor
111349450|NCT00002554|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111349451|NCT00002554|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111349452|NCT00002554|Antimetabolites|antimetabolites|mesh-ancestor
111349453|NCT00002554|Dermatologic Agents|dermatologic agents|mesh-ancestor
111349454|NCT00002554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111349455|NCT00002554|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111349456|NCT00002554|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111349457|NCT00002560|Antibodies|antibodies|mesh-list
111349458|NCT00002560|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111349459|NCT00002560|Sargramostim|sargramostim|mesh-list
111349460|NCT00002560|Immunologic Factors|immunologic factors|mesh-ancestor
111349461|NCT00002560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111349462|NCT00002566|Cyclophosphamide|cyclophosphamide|mesh-list
111349463|NCT00002566|Ifosfamide|ifosfamide|mesh-list
111349464|NCT00002566|Carboplatin|carboplatin|mesh-list
111349465|NCT00002566|Etoposide|etoposide|mesh-list
111349466|NCT00002566|Vinblastine|vinblastine|mesh-list
111349467|NCT00002566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111349468|NCT00002566|Immunologic Factors|immunologic factors|mesh-ancestor
111349469|NCT00002566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111349470|NCT00002566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111349471|NCT00002566|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111349472|NCT00002566|Alkylating Agents|alkylating agents|mesh-ancestor
111349473|NCT00002566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111349474|NCT00002566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111349475|NCT00002566|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111349476|NCT00002566|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111349477|NCT00002566|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111349478|NCT00002566|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111349479|NCT00002566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111349480|NCT00002566|Tubulin Modulators|tubulin modulators|mesh-ancestor
111349481|NCT00002566|Antimitotic Agents|antimitotic agents|mesh-ancestor
111349482|NCT00002566|Mitosis Modulators|mitosis modulators|mesh-ancestor
111349483|NCT00002572|Aldesleukin|aldesleukin|mesh-list
111349484|NCT00002572|Muromonab-CD3|muromonab-cd3|mesh-list
111349485|NCT00002572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111349486|NCT00002572|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111349487|NCT00002572|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111349488|NCT00002572|Antiviral Agents|antiviral agents|mesh-ancestor
111349489|NCT00002572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111349490|NCT00002572|Immunologic Factors|immunologic factors|mesh-ancestor
111349491|NCT00002572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111349492|NCT00002572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111349493|NCT00002578|Leucovorin|leucovorin|mesh-list
111349494|NCT00002578|Cytarabine|cytarabine|mesh-list
111349495|NCT00002578|Methotrexate|methotrexate|mesh-list
111349496|NCT00002578|Gallium nitrate|gallium nitrate|mesh-list
111349497|NCT00002578|Calcium|calcium|mesh-list
111349498|NCT00002578|Levoleucovorin|levoleucovorin|mesh-list
111349499|NCT00002578|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110750810|NCT00303329|Deferasirox|deferasirox|mesh-list
111349500|NCT00002578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111349501|NCT00002578|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111349502|NCT00002578|Abortifacient Agents|abortifacient agents|mesh-ancestor
111349503|NCT00002578|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111349504|NCT00002578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111349505|NCT00002578|Antimetabolites|antimetabolites|mesh-ancestor
111349506|NCT00002578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111349507|NCT00002578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111349508|NCT00002578|Dermatologic Agents|dermatologic agents|mesh-ancestor
111349509|NCT00002578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111349510|NCT00002578|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111349511|NCT00002578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111349512|NCT00002578|Immunologic Factors|immunologic factors|mesh-ancestor
111349513|NCT00002578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111349514|NCT00002578|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111349515|NCT00002578|Antiviral Agents|antiviral agents|mesh-ancestor
111349516|NCT00002578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111349517|NCT00002578|Antidotes|antidotes|mesh-ancestor
111349518|NCT00002578|Protective Agents|protective agents|mesh-ancestor
111349519|NCT00002578|Vitamin B Complex|vitamin b complex|mesh-ancestor
111349520|NCT00002578|Vitamins|vitamins|mesh-ancestor
111349521|NCT00002578|Micronutrients|micronutrients|mesh-ancestor
111349522|NCT00002590|Leucovorin|leucovorin|mesh-list
111349523|NCT00002590|Cytarabine|cytarabine|mesh-list
111349524|NCT00002590|Prednisone|prednisone|mesh-list
111349525|NCT00002590|Cyclophosphamide|cyclophosphamide|mesh-list
111349526|NCT00002590|Doxorubicin|doxorubicin|mesh-list
111349527|NCT00002590|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111349528|NCT00002590|Methotrexate|methotrexate|mesh-list
111349529|NCT00002590|Etoposide|etoposide|mesh-list
111349530|NCT00002590|Vincristine|vincristine|mesh-list
111349531|NCT00002590|Daunorubicin|daunorubicin|mesh-list
111349532|NCT00002590|Asparaginase|asparaginase|mesh-list
111349533|NCT00002590|Pegaspargase|pegaspargase|mesh-list
111349534|NCT00002590|Thioguanine|thioguanine|mesh-list
111349535|NCT00002590|Levoleucovorin|levoleucovorin|mesh-list
111349536|NCT00002590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111349537|NCT00002590|Immunologic Factors|immunologic factors|mesh-ancestor
111349538|NCT00002590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111349539|NCT00002590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110750994|NCT01097382|Zolpidem|zolpidem|mesh-list
111349540|NCT00002590|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111349541|NCT00002590|Alkylating Agents|alkylating agents|mesh-ancestor
111349542|NCT00002590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111349543|NCT00002590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110751056|NCT00300365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111349544|NCT00002590|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111349545|NCT00002590|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111349546|NCT00002590|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111349547|NCT00002590|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111349548|NCT00002590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111349549|NCT00002590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111349550|NCT00002590|Glucocorticoids|glucocorticoids|mesh-ancestor
111349551|NCT00002590|Hormones|hormones|mesh-ancestor
111349552|NCT00002590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111349553|NCT00002590|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111349554|NCT00002590|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110751191|NCT03979469|Ketamine|ketamine|mesh-list
111349555|NCT00002590|Abortifacient Agents|abortifacient agents|mesh-ancestor
111349556|NCT00002590|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111349557|NCT00002590|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111349558|NCT00002590|Antimetabolites|antimetabolites|mesh-ancestor
111349559|NCT00002590|Dermatologic Agents|dermatologic agents|mesh-ancestor
111349560|NCT00002590|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111349561|NCT00002590|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111349562|NCT00002590|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111349563|NCT00002590|Antiviral Agents|antiviral agents|mesh-ancestor
111349564|NCT00002590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111349565|NCT00002590|Antidotes|antidotes|mesh-ancestor
111349566|NCT00002590|Protective Agents|protective agents|mesh-ancestor
111349567|NCT00002590|Vitamin B Complex|vitamin b complex|mesh-ancestor
111349568|NCT00002590|Vitamins|vitamins|mesh-ancestor
111349569|NCT00002590|Micronutrients|micronutrients|mesh-ancestor
111349570|NCT00002590|Tubulin Modulators|tubulin modulators|mesh-ancestor
111349571|NCT00002590|Antimitotic Agents|antimitotic agents|mesh-ancestor
111349572|NCT00002590|Mitosis Modulators|mitosis modulators|mesh-ancestor
111349573|NCT00002596|Cyclophosphamide|cyclophosphamide|mesh-list
111349574|NCT00002596|Carboplatin|carboplatin|mesh-list
111349575|NCT00002596|Etoposide|etoposide|mesh-list
111349576|NCT00002596|Bleomycin|bleomycin|mesh-list
111349577|NCT00002596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111349578|NCT00002596|Immunologic Factors|immunologic factors|mesh-ancestor
110751322|NCT02379520|Fludarabine|fludarabine|mesh-list
111349579|NCT00002596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111349580|NCT00002596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111349581|NCT00002596|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111349582|NCT00002596|Alkylating Agents|alkylating agents|mesh-ancestor
111349583|NCT00002596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111349584|NCT00002596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111349585|NCT00002596|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111349586|NCT00002596|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111349587|NCT00002596|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111349588|NCT00002596|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111349589|NCT00002596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111349590|NCT00002596|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111349591|NCT00199082|Cytarabine|cytarabine|mesh-list
111349592|NCT00199082|Dexamethasone|dexamethasone|mesh-list
111349593|NCT00199082|Prednisolone|prednisolone|mesh-list
111349594|NCT00199082|Cyclophosphamide|cyclophosphamide|mesh-list
111349595|NCT00199082|Ifosfamide|ifosfamide|mesh-list
111349596|NCT00199082|Rituximab|rituximab|mesh-list
111349597|NCT00199082|Methotrexate|methotrexate|mesh-list
111349598|NCT00199082|Vincristine|vincristine|mesh-list
111349599|NCT00199082|Doxorubicin|doxorubicin|mesh-list
111349600|NCT00199082|Vindesine|vindesine|mesh-list
111349601|NCT00199082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111349602|NCT00199082|Immunologic Factors|immunologic factors|mesh-ancestor
111349603|NCT00199082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111349604|NCT00199082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111349605|NCT00199082|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110751459|NCT00120952|Cobalt|cobalt|mesh-list
111349606|NCT00199082|Alkylating Agents|alkylating agents|mesh-ancestor
111349607|NCT00199082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111349608|NCT00199082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111349609|NCT00199082|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111349610|NCT00199082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111349611|NCT00199082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111349612|NCT00199082|Antiemetics|antiemetics|mesh-ancestor
111349613|NCT00199082|Autonomic Agents|autonomic agents|mesh-ancestor
111349614|NCT00199082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111349615|NCT00199082|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111349616|NCT00199082|Glucocorticoids|glucocorticoids|mesh-ancestor
111349617|NCT00199082|Hormones|hormones|mesh-ancestor
110751579|NCT01333696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111349618|NCT00199082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111349619|NCT00199082|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111349620|NCT00199082|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111349621|NCT00199082|Abortifacient Agents|abortifacient agents|mesh-ancestor
111349622|NCT00199082|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111349623|NCT00199082|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111349624|NCT00199082|Antimetabolites|antimetabolites|mesh-ancestor
111349625|NCT00199082|Dermatologic Agents|dermatologic agents|mesh-ancestor
111349626|NCT00199082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110751715|NCT03175120|Liraglutide|liraglutide|mesh-list
111349627|NCT00199082|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111349628|NCT00199082|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111349630|NCT00199082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111349631|NCT00199082|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111349632|NCT00199082|Tubulin Modulators|tubulin modulators|mesh-ancestor
111349633|NCT00199082|Antimitotic Agents|antimitotic agents|mesh-ancestor
111349634|NCT00199082|Mitosis Modulators|mitosis modulators|mesh-ancestor
111349635|NCT00199082|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111349636|NCT00199082|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111349637|NCT00199082|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111349638|NCT00194090|Celecoxib|celecoxib|mesh-list
110751790|NCT01320280|Afatinib|afatinib|mesh-list
110751847|NCT01332370|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111349639|NCT00194090|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111349640|NCT00194090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111349641|NCT00194090|Analgesics|analgesics|mesh-ancestor
111349642|NCT00194090|Sensory System Agents|sensory system agents|mesh-ancestor
111349643|NCT00194090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111349644|NCT00194090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111349645|NCT00194090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111349646|NCT00194090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111349647|NCT00194090|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111349648|NCT00194090|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111349649|NCT00194090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111349650|NCT00194090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111349651|NCT00002608|Tamoxifen|tamoxifen|mesh-list
111349652|NCT00002608|Doxorubicin|doxorubicin|mesh-list
111349653|NCT00002608|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110752006|NCT01340248|Carvedilol|carvedilol|mesh-list
111349654|NCT00002608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111349655|NCT00002608|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111349656|NCT00002608|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111349657|NCT00002608|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111349658|NCT00002608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111349659|NCT00002608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111349660|NCT00002608|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111349661|NCT00002608|Hormone Antagonists|hormone antagonists|mesh-ancestor
111349662|NCT00002608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111349663|NCT00002608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111349664|NCT00002608|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111349665|NCT00002608|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111349666|NCT00002608|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110752133|NCT01341496|Analgesics|analgesics|mesh-ancestor
111349667|NCT00002608|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111349668|NCT00002620|Cobalt|cobalt|mesh-list
111349669|NCT00002620|Carmustine|carmustine|mesh-list
111349670|NCT00002620|Mitolactol|mitolactol|mesh-list
111349671|NCT00002620|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111349672|NCT00002620|Alkylating Agents|alkylating agents|mesh-ancestor
111349673|NCT00002620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111349674|NCT00002620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111349675|NCT00002620|Trace Elements|trace elements|mesh-ancestor
111349676|NCT00002620|Micronutrients|micronutrients|mesh-ancestor
110752194|NCT01342198|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111349677|NCT00002620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111349678|NCT04160000|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
111349679|NCT00002638|Cytarabine|cytarabine|mesh-list
111349680|NCT00002638|Cyclophosphamide|cyclophosphamide|mesh-list
111349681|NCT00002638|Carmustine|carmustine|mesh-list
111349682|NCT00002638|Etoposide|etoposide|mesh-list
111349683|NCT00002638|Sargramostim|sargramostim|mesh-list
111349684|NCT00002638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111349685|NCT00002638|Immunologic Factors|immunologic factors|mesh-ancestor
111349686|NCT00002638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111349687|NCT00002638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111349688|NCT00002638|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111349689|NCT00002638|Alkylating Agents|alkylating agents|mesh-ancestor
111349690|NCT00002638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111349691|NCT00002638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110752260|NCT03635398|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111349692|NCT00002638|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111349693|NCT00002638|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111349694|NCT00002638|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111349695|NCT00002638|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111349696|NCT00002638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111349697|NCT00002638|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111349698|NCT00002638|Antimetabolites|antimetabolites|mesh-ancestor
111349699|NCT00002638|Antiviral Agents|antiviral agents|mesh-ancestor
111349700|NCT00002638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111349701|NCT05120362|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
111349702|NCT05120362|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111349703|NCT05120362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111349704|NCT05120362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111349705|NCT01896440|Ondansetron|ondansetron|mesh-list
111349706|NCT01896440|Antiemetics|antiemetics|mesh-ancestor
111349707|NCT01896440|Autonomic Agents|autonomic agents|mesh-ancestor
111349708|NCT01896440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111349709|NCT01896440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111349710|NCT01896440|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111349711|NCT01896440|Antipruritics|antipruritics|mesh-ancestor
111349712|NCT01896440|Dermatologic Agents|dermatologic agents|mesh-ancestor
110752454|NCT00281957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111349713|NCT01896440|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111349714|NCT01896440|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111349715|NCT01896440|Serotonin Agents|serotonin agents|mesh-ancestor
111349716|NCT01896440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111349717|NCT01896440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111349718|NCT00002656|NSC 366140|nsc 366140|mesh-list
111349719|NCT00002656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111349720|NCT00002662|Paclitaxel|paclitaxel|mesh-list
111349721|NCT00002662|Docetaxel|docetaxel|mesh-list
111349722|NCT00002662|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111349723|NCT00002662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111349724|NCT00002662|Tubulin Modulators|tubulin modulators|mesh-ancestor
111349725|NCT00002662|Antimitotic Agents|antimitotic agents|mesh-ancestor
111349726|NCT00002662|Mitosis Modulators|mitosis modulators|mesh-ancestor
111349727|NCT00002662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111349728|NCT00054314|IDN 5109|idn 5109|mesh-list
111349729|NCT00054314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111349730|NCT01743950|Bevacizumab|bevacizumab|mesh-list
111349731|NCT01743950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111349732|NCT01743950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111349733|NCT01743950|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111349734|NCT01743950|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111349735|NCT01743950|Growth Substances|growth substances|mesh-ancestor
111349736|NCT01743950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111349737|NCT01743950|Growth Inhibitors|growth inhibitors|mesh-ancestor
111349738|NCT00002674|Cytarabine|cytarabine|mesh-list
111349739|NCT00002674|Etoposide|etoposide|mesh-list
111349740|NCT00002674|Mitoxantrone|mitoxantrone|mesh-list
111349741|NCT00002674|Hydroxyurea|hydroxyurea|mesh-list
111349742|NCT00002674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111349743|NCT00002674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111349744|NCT00002674|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111349745|NCT00002674|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111349746|NCT00002674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111349747|NCT00002674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111349748|NCT00002674|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111349749|NCT00002674|Antimetabolites|antimetabolites|mesh-ancestor
111349750|NCT00002674|Antiviral Agents|antiviral agents|mesh-ancestor
111349751|NCT00002674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111349752|NCT00002674|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111349753|NCT00002674|Immunologic Factors|immunologic factors|mesh-ancestor
111349754|NCT00002674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111349755|NCT00002674|Analgesics|analgesics|mesh-ancestor
111349756|NCT00002674|Sensory System Agents|sensory system agents|mesh-ancestor
110752650|NCT03974867|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111349757|NCT00002674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111349758|NCT00002674|Antisickling Agents|antisickling agents|mesh-ancestor
111349759|NCT00002674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111349760|NCT01743872|Dextrans|dextrans|mesh-list
111349761|NCT01743872|Anticoagulants|anticoagulants|mesh-ancestor
111349762|NCT01743872|Plasma Substitutes|plasma substitutes|mesh-ancestor
111349763|NCT01743872|Blood Substitutes|blood substitutes|mesh-ancestor
111349764|NCT00002680|Tamoxifen|tamoxifen|mesh-list
111349765|NCT00002680|Cyclophosphamide|cyclophosphamide|mesh-list
111349766|NCT00002680|Melphalan|melphalan|mesh-list
111349767|NCT00002680|Thiotepa|thiotepa|mesh-list
111349768|NCT00002680|Megestrol|megestrol|mesh-list
111349769|NCT00002680|Megestrol Acetate|megestrol acetate|mesh-list
111349770|NCT00002680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111349771|NCT00002680|Immunologic Factors|immunologic factors|mesh-ancestor
111349772|NCT00002680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111349773|NCT00002680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111349774|NCT00002680|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111349775|NCT00002680|Alkylating Agents|alkylating agents|mesh-ancestor
111074134|NCT02022059|Sensory System Agents|sensory system agents|mesh-ancestor
111349776|NCT00002680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111349777|NCT00002680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111349778|NCT00002680|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111349779|NCT00002680|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110752710|NCT03798392|Anesthetics|anesthetics|mesh-list
111349780|NCT00002680|Hormone Antagonists|hormone antagonists|mesh-ancestor
111349781|NCT00002680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111349782|NCT00002680|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111349783|NCT00002680|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111349784|NCT00002680|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111349785|NCT00002680|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111349786|NCT00002680|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111349787|NCT00002680|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111349788|NCT00002680|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111349789|NCT00002680|Contraceptive Agents|contraceptive agents|mesh-ancestor
111349790|NCT00002680|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111349791|NCT00002680|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111349792|NCT00002680|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111349793|NCT00002680|Appetite Stimulants|appetite stimulants|mesh-ancestor
111349794|NCT00002680|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111349795|NCT00002692|Leucovorin|leucovorin|mesh-list
111349796|NCT00002692|Fluorouracil|fluorouracil|mesh-list
111349797|NCT00002692|Calcium|calcium|mesh-list
111349798|NCT00002692|Levoleucovorin|levoleucovorin|mesh-list
111349799|NCT00002692|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111349800|NCT00002692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111349801|NCT00002692|Antimetabolites|antimetabolites|mesh-ancestor
111349802|NCT00002692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111349803|NCT00002692|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111349804|NCT00002692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111349805|NCT00002692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111349806|NCT00002692|Immunologic Factors|immunologic factors|mesh-ancestor
111349807|NCT00002692|Antidotes|antidotes|mesh-ancestor
111349808|NCT00002692|Protective Agents|protective agents|mesh-ancestor
111349809|NCT00002692|Vitamin B Complex|vitamin b complex|mesh-ancestor
111349810|NCT00002692|Vitamins|vitamins|mesh-ancestor
111349811|NCT00002692|Micronutrients|micronutrients|mesh-ancestor
111349812|NCT05293210|Dexamethasone|dexamethasone|mesh-list
111349813|NCT05293210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111349814|NCT05293210|Antiemetics|antiemetics|mesh-ancestor
111349815|NCT05293210|Autonomic Agents|autonomic agents|mesh-ancestor
111349816|NCT05293210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111349817|NCT05293210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111349818|NCT05293210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111349819|NCT05293210|Glucocorticoids|glucocorticoids|mesh-ancestor
111349820|NCT05293210|Hormones|hormones|mesh-ancestor
111349821|NCT05293210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111349822|NCT05293210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111349823|NCT05293210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111349824|NCT01895348|Dexmedetomidine|dexmedetomidine|mesh-list
111349825|NCT01895348|Remifentanil|remifentanil|mesh-list
111349826|NCT01895348|Propofol|propofol|mesh-list
111349827|NCT01895348|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111349828|NCT01895348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111349829|NCT01895348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111349830|NCT01895348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111349831|NCT01895348|Analgesics|analgesics|mesh-ancestor
111349832|NCT01895348|Sensory System Agents|sensory system agents|mesh-ancestor
111349833|NCT01895348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111349834|NCT01895348|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111349835|NCT01895348|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111349836|NCT01895348|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111349837|NCT01895348|Adrenergic Agents|adrenergic agents|mesh-ancestor
111349838|NCT01895348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111349839|NCT01895348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111349840|NCT01895348|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111349841|NCT01895348|Anesthetics, General|anesthetics, general|mesh-ancestor
111349842|NCT01895348|Anesthetics|anesthetics|mesh-ancestor
111349843|NCT01895348|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111349844|NCT01895348|Narcotics|narcotics|mesh-ancestor
111349845|NCT05073718|Aspirin|aspirin|mesh-list
111349846|NCT05073718|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111349847|NCT05073718|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111349848|NCT05073718|Analgesics|analgesics|mesh-ancestor
111349849|NCT05073718|Sensory System Agents|sensory system agents|mesh-ancestor
111349850|NCT05073718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111349851|NCT05073718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111349852|NCT05073718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111349853|NCT05073718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111349854|NCT05073718|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111349855|NCT05073718|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111349856|NCT05073718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111349857|NCT05073718|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111349858|NCT05073718|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111349859|NCT05073718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111349860|NCT05073718|Antipyretics|antipyretics|mesh-ancestor
111349861|NCT04784000|Carbamazepine|carbamazepine|mesh-list
111349862|NCT04784000|Anticonvulsants|anticonvulsants|mesh-ancestor
111349863|NCT04784000|Antimanic Agents|antimanic agents|mesh-ancestor
111349864|NCT04784000|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111349865|NCT04784000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111349866|NCT04784000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111349867|NCT04784000|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111349868|NCT04784000|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111349869|NCT04784000|Analgesics|analgesics|mesh-ancestor
111349870|NCT04784000|Sensory System Agents|sensory system agents|mesh-ancestor
111349871|NCT04784000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111349872|NCT04784000|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111349873|NCT04784000|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111349874|NCT04784000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111349875|NCT04784000|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111349876|NCT04784000|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111349878|NCT05271292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111349879|NCT05271292|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111349880|NCT05271292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111349881|NCT05271292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111349882|NCT01113476|Paclitaxel|paclitaxel|mesh-list
111349883|NCT01113476|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111349884|NCT01113476|Bevacizumab|bevacizumab|mesh-list
111349885|NCT01113476|Gemcitabine|gemcitabine|mesh-list
111349886|NCT01113476|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111349887|NCT01113476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111349888|NCT01113476|Tubulin Modulators|tubulin modulators|mesh-ancestor
111349889|NCT01113476|Antimitotic Agents|antimitotic agents|mesh-ancestor
110753255|NCT05694416|Etoposide|etoposide|mesh-list
111349890|NCT01113476|Mitosis Modulators|mitosis modulators|mesh-ancestor
111349891|NCT01113476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111349892|NCT01113476|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111349893|NCT01113476|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111349894|NCT01113476|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111349895|NCT01113476|Growth Substances|growth substances|mesh-ancestor
111349896|NCT01113476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111349897|NCT01113476|Growth Inhibitors|growth inhibitors|mesh-ancestor
111349898|NCT01113476|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111349899|NCT01113476|Antimetabolites|antimetabolites|mesh-ancestor
111349900|NCT01107236|Naproxen|naproxen|mesh-list
111349901|NCT01107236|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111349902|NCT01107236|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111349903|NCT01107236|Analgesics|analgesics|mesh-ancestor
111349904|NCT01107236|Sensory System Agents|sensory system agents|mesh-ancestor
111349905|NCT01107236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111349906|NCT01107236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111349907|NCT01107236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111349908|NCT01107236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111349909|NCT01107236|Gout Suppressants|gout suppressants|mesh-ancestor
111349910|NCT01107236|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111349911|NCT01107236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111349912|NCT01107236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111349913|NCT00002704|Leucovorin|leucovorin|mesh-list
111349914|NCT00002704|Cytarabine|cytarabine|mesh-list
111349915|NCT00002704|Dexamethasone|dexamethasone|mesh-list
111349916|NCT00002704|Hydrocortisone|hydrocortisone|mesh-list
111349917|NCT00002704|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
111349918|NCT00002704|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
111349919|NCT00002704|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
111349920|NCT00002704|Cyclophosphamide|cyclophosphamide|mesh-list
111349921|NCT00002704|Thiotepa|thiotepa|mesh-list
111349922|NCT00002704|Methotrexate|methotrexate|mesh-list
111349923|NCT00002704|Etoposide|etoposide|mesh-list
111349924|NCT00002704|Vincristine|vincristine|mesh-list
111349925|NCT00002704|Daunorubicin|daunorubicin|mesh-list
111074284|NCT02692339|Growth Substances|growth substances|mesh-ancestor
111349926|NCT00002704|Asparaginase|asparaginase|mesh-list
111349927|NCT00002704|Mercaptopurine|mercaptopurine|mesh-list
111349928|NCT00002704|Levoleucovorin|levoleucovorin|mesh-list
111349929|NCT00002704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111349930|NCT00002704|Immunologic Factors|immunologic factors|mesh-ancestor
111349931|NCT00002704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111349932|NCT00002704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111349933|NCT00002704|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111349934|NCT00002704|Alkylating Agents|alkylating agents|mesh-ancestor
111349935|NCT00002704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111349936|NCT00002704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111349937|NCT00002704|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111349938|NCT00002704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111349939|NCT00002704|Antiemetics|antiemetics|mesh-ancestor
111349940|NCT00002704|Autonomic Agents|autonomic agents|mesh-ancestor
111349941|NCT00002704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111349942|NCT00002704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111349943|NCT00002704|Glucocorticoids|glucocorticoids|mesh-ancestor
111349944|NCT00002704|Hormones|hormones|mesh-ancestor
111349945|NCT00002704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111349946|NCT00002704|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111349947|NCT00002704|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111349948|NCT00002704|Abortifacient Agents|abortifacient agents|mesh-ancestor
111349949|NCT00002704|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111349950|NCT00002704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111349951|NCT00002704|Antimetabolites|antimetabolites|mesh-ancestor
111349952|NCT00002704|Dermatologic Agents|dermatologic agents|mesh-ancestor
111349953|NCT00002704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111349954|NCT00002704|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111349955|NCT00002704|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111349956|NCT00002704|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111349957|NCT00002704|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111349958|NCT00002704|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111349959|NCT00002704|Antiviral Agents|antiviral agents|mesh-ancestor
111349960|NCT00002704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111349961|NCT00002704|Antidotes|antidotes|mesh-ancestor
111349962|NCT00002704|Protective Agents|protective agents|mesh-ancestor
111349963|NCT00002704|Vitamin B Complex|vitamin b complex|mesh-ancestor
111349964|NCT00002704|Vitamins|vitamins|mesh-ancestor
111349965|NCT00002704|Micronutrients|micronutrients|mesh-ancestor
111349966|NCT00002704|Tubulin Modulators|tubulin modulators|mesh-ancestor
111349967|NCT00002704|Antimitotic Agents|antimitotic agents|mesh-ancestor
111349968|NCT00002704|Mitosis Modulators|mitosis modulators|mesh-ancestor
111349969|NCT00002704|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111349970|NCT00002716|Leucovorin|leucovorin|mesh-list
111349971|NCT00002716|Dexamethasone|dexamethasone|mesh-list
111349972|NCT00002716|Fluorouracil|fluorouracil|mesh-list
111349973|NCT00002716|Floxuridine|floxuridine|mesh-list
111349974|NCT00002716|Calcium|calcium|mesh-list
111349975|NCT00002716|Levoleucovorin|levoleucovorin|mesh-list
111349976|NCT00002716|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111349977|NCT00002716|Antiemetics|antiemetics|mesh-ancestor
111349978|NCT00002716|Autonomic Agents|autonomic agents|mesh-ancestor
111349979|NCT00002716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111349980|NCT00002716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111349981|NCT00002716|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111349982|NCT00002716|Glucocorticoids|glucocorticoids|mesh-ancestor
111349983|NCT00002716|Hormones|hormones|mesh-ancestor
111349984|NCT00002716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111349985|NCT00002716|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111349986|NCT00002716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111349987|NCT00002716|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111349988|NCT00002716|Antimetabolites|antimetabolites|mesh-ancestor
111349989|NCT00002716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111349990|NCT00002716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111349991|NCT00002716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111349992|NCT00002716|Immunologic Factors|immunologic factors|mesh-ancestor
111349993|NCT00002716|Antidotes|antidotes|mesh-ancestor
111349994|NCT00002716|Protective Agents|protective agents|mesh-ancestor
111349995|NCT00002716|Vitamin B Complex|vitamin b complex|mesh-ancestor
111349996|NCT00002716|Vitamins|vitamins|mesh-ancestor
111349997|NCT00002716|Micronutrients|micronutrients|mesh-ancestor
111349998|NCT02533674|Gemcitabine|gemcitabine|mesh-list
111349999|NCT02533674|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111350000|NCT02533674|Antimetabolites|antimetabolites|mesh-ancestor
111350001|NCT02533674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110753778|NCT03779360|Hormones|hormones|mesh-ancestor
111350002|NCT02533674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111350003|NCT00002722|Leucovorin|leucovorin|mesh-list
111350004|NCT00002722|Fluorouracil|fluorouracil|mesh-list
111350005|NCT00002722|Calcium|calcium|mesh-list
111350006|NCT00002722|Levoleucovorin|levoleucovorin|mesh-list
111350007|NCT00002722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111350008|NCT00002722|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111350009|NCT00002722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111350010|NCT00002722|Antimetabolites|antimetabolites|mesh-ancestor
111350011|NCT00002722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111350012|NCT00002722|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111350013|NCT00002722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111350014|NCT00002722|Immunologic Factors|immunologic factors|mesh-ancestor
111350015|NCT00002722|Antidotes|antidotes|mesh-ancestor
111350016|NCT00002722|Protective Agents|protective agents|mesh-ancestor
111350017|NCT00002722|Vitamin B Complex|vitamin b complex|mesh-ancestor
111350018|NCT00002722|Vitamins|vitamins|mesh-ancestor
111350019|NCT00002722|Micronutrients|micronutrients|mesh-ancestor
111350020|NCT00002734|Interferons|interferons|mesh-list
111350021|NCT00002734|Interferon-alpha|interferon-alpha|mesh-list
111350022|NCT00002734|Paclitaxel|paclitaxel|mesh-list
111350023|NCT00002734|Topotecan|topotecan|mesh-list
111350024|NCT00002734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111350025|NCT00002734|Antibodies|antibodies|mesh-list
111350026|NCT00002734|Immunoglobulins|immunoglobulins|mesh-list
111350027|NCT00002734|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111350028|NCT00002734|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111350029|NCT00002734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111350030|NCT00002734|Tubulin Modulators|tubulin modulators|mesh-ancestor
111350031|NCT00002734|Antimitotic Agents|antimitotic agents|mesh-ancestor
111350032|NCT00002734|Mitosis Modulators|mitosis modulators|mesh-ancestor
111350033|NCT00002734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111350034|NCT00002734|Immunologic Factors|immunologic factors|mesh-ancestor
111350035|NCT00002734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111350036|NCT00002734|Antiviral Agents|antiviral agents|mesh-ancestor
111350037|NCT00002734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111350038|NCT00002734|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111350039|NCT00002734|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111350040|NCT00002734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111350041|NCT04783610|Ethanol|ethanol|mesh-list
111350042|NCT04783610|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111350043|NCT04783610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111350044|NCT04783610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111350045|NCT04783610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111350047|NCT00002740|Cyclophosphamide|cyclophosphamide|mesh-list
111350048|NCT00002740|Carboplatin|carboplatin|mesh-list
111350049|NCT00002740|Doxorubicin|doxorubicin|mesh-list
111350050|NCT00002740|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111350051|NCT00002740|Etoposide|etoposide|mesh-list
111350052|NCT00002740|Vincristine|vincristine|mesh-list
111350053|NCT00002740|Lenograstim|lenograstim|mesh-list
111350054|NCT00002740|Mesna|mesna|mesh-list
111350055|NCT00002740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111350056|NCT00002740|Immunologic Factors|immunologic factors|mesh-ancestor
111350057|NCT00002740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111350058|NCT00002740|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111350059|NCT00002740|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111350060|NCT00002740|Alkylating Agents|alkylating agents|mesh-ancestor
111350061|NCT00002740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111350062|NCT00002740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111350063|NCT00002740|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111350064|NCT00002740|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111350065|NCT00002740|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111350066|NCT00002740|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111350067|NCT00002740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111350068|NCT00002740|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110754100|NCT04345666|Hormones|hormones|mesh-ancestor
111350069|NCT00002740|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111350070|NCT00002740|Tubulin Modulators|tubulin modulators|mesh-ancestor
111350071|NCT00002740|Antimitotic Agents|antimitotic agents|mesh-ancestor
111350072|NCT00002740|Mitosis Modulators|mitosis modulators|mesh-ancestor
111350073|NCT00002740|Protective Agents|protective agents|mesh-ancestor
111350074|NCT00002740|Trace Elements|trace elements|mesh-ancestor
111350075|NCT00002740|Micronutrients|micronutrients|mesh-ancestor
111350076|NCT00002746|Aldesleukin|aldesleukin|mesh-list
111074441|NCT03432793|Serotonin Agents|serotonin agents|mesh-ancestor
111350077|NCT00002746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111350078|NCT00002746|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111350079|NCT00002746|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111350080|NCT00002746|Antiviral Agents|antiviral agents|mesh-ancestor
111350081|NCT00002746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111350082|NCT01049945|Dexamethasone|dexamethasone|mesh-list
111350083|NCT01049945|Lenalidomide|lenalidomide|mesh-list
111350084|NCT01049945|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
111350085|NCT01049945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111350086|NCT01049945|Antiemetics|antiemetics|mesh-ancestor
111350087|NCT01049945|Autonomic Agents|autonomic agents|mesh-ancestor
111350088|NCT01049945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111350089|NCT01049945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111350090|NCT01049945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111350091|NCT01049945|Glucocorticoids|glucocorticoids|mesh-ancestor
111350092|NCT01049945|Hormones|hormones|mesh-ancestor
111350093|NCT01049945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111350094|NCT01049945|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110754348|NCT01347814|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111350095|NCT01049945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111350096|NCT01049945|Immunologic Factors|immunologic factors|mesh-ancestor
111350097|NCT01049945|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111350098|NCT01049945|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111350099|NCT01049945|Growth Substances|growth substances|mesh-ancestor
111350100|NCT01049945|Growth Inhibitors|growth inhibitors|mesh-ancestor
111350101|NCT01049945|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111350102|NCT01049945|Alkylating Agents|alkylating agents|mesh-ancestor
111350103|NCT01049945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111350104|NCT00002752|Antibodies|antibodies|mesh-list
111350105|NCT00002752|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111350106|NCT00002752|Immunologic Factors|immunologic factors|mesh-ancestor
111350107|NCT00002752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111350108|NCT01050647|Castor Oil|castor oil|mesh-list
111350109|NCT01050647|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
111350110|NCT01050647|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
111350111|NCT01050647|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111350112|NCT01050647|Hormone Antagonists|hormone antagonists|mesh-ancestor
111350113|NCT01050647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111350114|NCT01050647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111350115|NCT01050647|Progestins|progestins|mesh-ancestor
111350116|NCT01050647|Hormones|hormones|mesh-ancestor
111350117|NCT01050647|Cathartics|cathartics|mesh-ancestor
111350118|NCT01050647|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111350119|NCT04825678|Erenumab|erenumab|mesh-list
111350120|NCT04825678|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
111350121|NCT04825678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111350122|NCT04825678|Analgesics|analgesics|mesh-ancestor
111350123|NCT04825678|Sensory System Agents|sensory system agents|mesh-ancestor
111350124|NCT04825678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111350125|NCT04825678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111350126|NCT00002764|Doxorubicin|doxorubicin|mesh-list
111350127|NCT00002764|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111350128|NCT00002764|Ifosfamide|ifosfamide|mesh-list
111350129|NCT00002764|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111350130|NCT00002764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110754646|NCT04737278|Niacin|niacin|mesh-list
111350131|NCT00002764|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111350132|NCT00002764|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111350133|NCT00002764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111350134|NCT00002764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111350135|NCT00002764|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111350136|NCT00002764|Alkylating Agents|alkylating agents|mesh-ancestor
111350137|NCT05167175|Prednisone|prednisone|mesh-list
111350138|NCT05167175|Olaparib|olaparib|mesh-list
111350139|NCT05167175|Abiraterone Acetate|abiraterone acetate|mesh-list
111350140|NCT05167175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111350141|NCT05167175|Glucocorticoids|glucocorticoids|mesh-ancestor
111350142|NCT05167175|Hormones|hormones|mesh-ancestor
111350143|NCT05167175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111350144|NCT05167175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110754754|NCT04386616|Astegolimab|astegolimab|mesh-list
111350145|NCT05167175|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111350146|NCT05167175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111350147|NCT05167175|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111350148|NCT05167175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111350149|NCT05167175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111350150|NCT05167175|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111350151|NCT05167175|Hormone Antagonists|hormone antagonists|mesh-ancestor
111350152|NCT05167175|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111350153|NCT00002788|Dexamethasone|dexamethasone|mesh-list
111350154|NCT00002788|Cyclophosphamide|cyclophosphamide|mesh-list
111350155|NCT00002788|Etoposide|etoposide|mesh-list
111350156|NCT00002788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111350157|NCT00002788|Immunologic Factors|immunologic factors|mesh-ancestor
110754897|NCT00031590|Lomustine|lomustine|mesh-list
111350158|NCT00002788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111350159|NCT00002788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111350160|NCT00002788|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111350161|NCT00002788|Alkylating Agents|alkylating agents|mesh-ancestor
111350162|NCT00002788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111350163|NCT00002788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111350164|NCT00002788|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111350165|NCT00002788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111350166|NCT00002788|Antiemetics|antiemetics|mesh-ancestor
111350167|NCT00002788|Autonomic Agents|autonomic agents|mesh-ancestor
111350168|NCT00002788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111350169|NCT00002788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111350170|NCT00002788|Glucocorticoids|glucocorticoids|mesh-ancestor
111350171|NCT00002788|Hormones|hormones|mesh-ancestor
111350172|NCT00002788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111350173|NCT00002788|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111350174|NCT00002788|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111350175|NCT00002788|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111350176|NCT00002788|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111350177|NCT00002788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111350178|NCT04352933|Hydroxychloroquine|hydroxychloroquine|mesh-list
111350179|NCT04352933|Antimalarials|antimalarials|mesh-ancestor
111350180|NCT04352933|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111350181|NCT04352933|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111350182|NCT04352933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111350183|NCT04352933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111350184|NCT04352933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111350185|NCT04352933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111350186|NCT04783792|Ascorbic Acid|ascorbic acid|mesh-list
111350187|NCT04783792|Antioxidants|antioxidants|mesh-ancestor
111350188|NCT04783792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111350189|NCT04783792|Protective Agents|protective agents|mesh-ancestor
111350190|NCT04783792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111350191|NCT04783792|Vitamins|vitamins|mesh-ancestor
111350192|NCT04783792|Micronutrients|micronutrients|mesh-ancestor
111350193|NCT05002816|Elotuzumab|elotuzumab|mesh-list
111350194|NCT05002816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111350195|NCT01676402|Vaccines|vaccines|mesh-list
111350196|NCT01676402|Immunologic Factors|immunologic factors|mesh-ancestor
111350197|NCT01676402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111350198|NCT01052831|Naltrexone|naltrexone|mesh-list
111350199|NCT01052831|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111350200|NCT01052831|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111350201|NCT01052831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111350202|NCT01052831|Sensory System Agents|sensory system agents|mesh-ancestor
111350203|NCT01052831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111350204|NCT04330300|Losartan|losartan|mesh-list
111350205|NCT04330300|Verapamil|verapamil|mesh-list
111350206|NCT04330300|Felodipine|felodipine|mesh-list
111350207|NCT04330300|Amlodipine|amlodipine|mesh-list
111350208|NCT04330300|Valsartan|valsartan|mesh-list
111350209|NCT04330300|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
111350210|NCT04330300|Telmisartan|telmisartan|mesh-list
111350211|NCT04330300|Candesartan|candesartan|mesh-list
111350212|NCT04330300|Ramipril|ramipril|mesh-list
111350213|NCT04330300|Olmesartan|olmesartan|mesh-list
111350214|NCT04330300|Enalapril|enalapril|mesh-list
111350215|NCT04330300|Lisinopril|lisinopril|mesh-list
111350216|NCT04330300|Irbesartan|irbesartan|mesh-list
111350217|NCT04330300|Chlorthalidone|chlorthalidone|mesh-list
111350218|NCT04330300|Perindopril|perindopril|mesh-list
111350219|NCT04330300|Diltiazem|diltiazem|mesh-list
111350220|NCT04330300|Benazepril|benazepril|mesh-list
111350221|NCT04330300|Captopril|captopril|mesh-list
111350222|NCT04330300|Indapamide|indapamide|mesh-list
111350223|NCT04330300|Nicardipine|nicardipine|mesh-list
111350224|NCT04330300|Nimodipine|nimodipine|mesh-list
111350225|NCT04330300|Quinapril|quinapril|mesh-list
111350226|NCT04330300|Metolazone|metolazone|mesh-list
111350227|NCT04330300|Trandolapril|trandolapril|mesh-list
111350228|NCT04330300|Fosinopril|fosinopril|mesh-list
111350229|NCT04330300|Eprosartan|eprosartan|mesh-list
111350230|NCT04330300|Nitrendipine|nitrendipine|mesh-list
111350231|NCT04330300|Bendroflumethiazide|bendroflumethiazide|mesh-list
111350232|NCT04330300|Chlorothiazide|chlorothiazide|mesh-list
111350233|NCT04330300|Nifedipine|nifedipine|mesh-list
111350234|NCT04330300|Calcium Channel Blockers|calcium channel blockers|mesh-list
111350235|NCT04330300|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
111350236|NCT04330300|Diuretics|diuretics|mesh-list
111350237|NCT04330300|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
111350238|NCT04330300|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111350239|NCT04330300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111350240|NCT04330300|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111350241|NCT04330300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111350242|NCT04330300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111350243|NCT04330300|Vasodilator Agents|vasodilator agents|mesh-ancestor
111350244|NCT04330300|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111350245|NCT04330300|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111350246|NCT04330300|Natriuretic Agents|natriuretic agents|mesh-ancestor
111350247|NCT04330300|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
111350248|NCT04330300|Protease Inhibitors|protease inhibitors|mesh-ancestor
111350249|NCT04330300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111350250|NCT04330300|Tocolytic Agents|tocolytic agents|mesh-ancestor
111350251|NCT04330300|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111350252|NCT04330300|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111350253|NCT04330300|Protective Agents|protective agents|mesh-ancestor
111350254|NCT04330300|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
111350255|NCT04352855|Tazobactam|tazobactam|mesh-list
111350256|NCT04352855|Ceftolozane|ceftolozane|mesh-list
111350257|NCT04352855|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
111350258|NCT04352855|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111350259|NCT04352855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111350260|NCT04352855|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
111350261|NCT04352855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111350262|NCT04352855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111350263|NCT04352855|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111350264|NCT04782128|RC28-E protein|rc28-e protein|mesh-list
111350265|NCT04782128|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110755255|NCT00003102|Antibodies|antibodies|mesh-list
111350266|NCT04782128|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111350267|NCT04782128|Growth Substances|growth substances|mesh-ancestor
111350268|NCT04782128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111350269|NCT04782128|Growth Inhibitors|growth inhibitors|mesh-ancestor
111350270|NCT04782128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111350271|NCT00995150|Levonorgestrel|levonorgestrel|mesh-list
111350272|NCT00995150|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111350273|NCT00995150|Contraceptive Agents|contraceptive agents|mesh-ancestor
111350274|NCT00995150|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111350275|NCT00995150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110755304|NCT04234906|Vasodilator Agents|vasodilator agents|mesh-ancestor
111350276|NCT00995150|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111350277|NCT00995150|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111350278|NCT00995150|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111350279|NCT00382642|Ondansetron|ondansetron|mesh-list
111350280|NCT00382642|Antiemetics|antiemetics|mesh-ancestor
111350281|NCT00382642|Autonomic Agents|autonomic agents|mesh-ancestor
110755369|NCT01355614|Infliximab|infliximab|mesh-list
111350282|NCT00382642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111350283|NCT00382642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111350284|NCT00382642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111350285|NCT00382642|Antipruritics|antipruritics|mesh-ancestor
111350286|NCT00382642|Dermatologic Agents|dermatologic agents|mesh-ancestor
111350287|NCT00382642|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111350288|NCT00382642|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111350289|NCT00382642|Serotonin Agents|serotonin agents|mesh-ancestor
111350290|NCT00382642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111350291|NCT00382642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111350292|NCT01054079|Cinacalcet|cinacalcet|mesh-list
111350293|NCT01054079|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111350294|NCT01054079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111350295|NCT01054079|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
111350296|NCT01054079|Hormone Antagonists|hormone antagonists|mesh-ancestor
111350297|NCT01054079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111350298|NCT02544750|Cannabidiol|cannabidiol|mesh-list
111350299|NCT02544750|Anticonvulsants|anticonvulsants|mesh-ancestor
111350300|NCT01662050|Cytarabine|cytarabine|mesh-list
111350301|NCT01662050|Rituximab|rituximab|mesh-list
111350302|NCT01662050|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
111350303|NCT01662050|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111350304|NCT01662050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111350305|NCT01662050|Immunologic Factors|immunologic factors|mesh-ancestor
111350306|NCT01662050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111350307|NCT01662050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111350308|NCT01662050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111350309|NCT01662050|Antimetabolites|antimetabolites|mesh-ancestor
111350310|NCT01662050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111350311|NCT01662050|Antiviral Agents|antiviral agents|mesh-ancestor
111350312|NCT01662050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111350313|NCT01662050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111350314|NCT01662050|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111350315|NCT01662050|Alkylating Agents|alkylating agents|mesh-ancestor
111350316|NCT04748848|Azacitidine|azacitidine|mesh-list
111350317|NCT04748848|Venetoclax|venetoclax|mesh-list
111350318|NCT04748848|Pulrodemstat besilate|pulrodemstat besilate|mesh-list
111350319|NCT04748848|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111350320|NCT04748848|Antimetabolites|antimetabolites|mesh-ancestor
111350321|NCT04748848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111350322|NCT04748848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111350323|NCT04748848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111350324|NCT02171195|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
111350325|NCT02171195|Anticonvulsants|anticonvulsants|mesh-ancestor
111350326|NCT02171195|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111350327|NCT02171195|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111350328|NCT02171195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111350329|NCT02171195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111350330|NCT01620788|Losartan|losartan|mesh-list
111350331|NCT01620788|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
111350332|NCT01620788|Indapamide|indapamide|mesh-list
111350333|NCT01620788|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111350334|NCT01620788|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111350335|NCT01620788|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111350336|NCT01620788|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110755773|NCT05626140|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111350337|NCT01620788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111350338|NCT01620788|Diuretics|diuretics|mesh-ancestor
111350339|NCT01620788|Natriuretic Agents|natriuretic agents|mesh-ancestor
111350340|NCT01620788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111350341|NCT01620788|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
111350342|NCT01620788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111350343|NCT03014843|Bromides|bromides|mesh-list
111350344|NCT03014843|Naloxone|naloxone|mesh-list
111350345|NCT03014843|Methylnaltrexone|methylnaltrexone|mesh-list
111350346|NCT03014843|Anticonvulsants|anticonvulsants|mesh-ancestor
111350347|NCT03014843|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110755902|NCT01073111|Immunologic Factors|immunologic factors|mesh-ancestor
111350348|NCT03014843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111350349|NCT03014843|Sensory System Agents|sensory system agents|mesh-ancestor
111350350|NCT03014843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111350351|NCT05081375|Enoxaparin|enoxaparin|mesh-list
111350352|NCT05081375|Anticoagulants|anticoagulants|mesh-ancestor
111350353|NCT05081375|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111350354|NCT05081375|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111350355|NCT05081375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111350356|NCT04755062|Micronutrients|micronutrients|mesh-list
111350357|NCT04755062|Trace Elements|trace elements|mesh-list
111350358|NCT04755062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111350359|NCT03852797|Ketamine|ketamine|mesh-list
111350360|NCT03852797|Propofol|propofol|mesh-list
111350361|NCT03852797|Etomidate|etomidate|mesh-list
111350362|NCT03852797|Oxytocin|oxytocin|mesh-list
111350363|NCT03852797|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111350364|NCT03852797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111350365|NCT03852797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111350366|NCT03852797|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111350367|NCT03852797|Anesthetics, General|anesthetics, general|mesh-ancestor
111350368|NCT03852797|Anesthetics|anesthetics|mesh-ancestor
111350369|NCT03852797|Analgesics|analgesics|mesh-ancestor
111350370|NCT03852797|Sensory System Agents|sensory system agents|mesh-ancestor
111350371|NCT03852797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111350372|NCT03852797|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111350373|NCT03852797|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111350374|NCT03852797|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111350375|NCT03852797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111350376|NCT03852797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111350377|NCT03852797|Oxytocics|oxytocics|mesh-ancestor
111350378|NCT03852797|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111350379|NCT01055171|Propranolol|propranolol|mesh-list
111350380|NCT01055171|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111350381|NCT01055171|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111350382|NCT01055171|Adrenergic Agents|adrenergic agents|mesh-ancestor
111350383|NCT01055171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111350384|NCT01055171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111350385|NCT01055171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111350386|NCT01055171|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111350387|NCT01055171|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111350388|NCT01055171|Vasodilator Agents|vasodilator agents|mesh-ancestor
111350389|NCT01057277|Everolimus|everolimus|mesh-list
111350390|NCT01057277|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110756100|NCT01364974|Peficitinib|peficitinib|mesh-list
111350391|NCT01057277|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111350392|NCT01057277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111350393|NCT01057277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111350394|NCT01057277|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111350395|NCT01057277|Immunologic Factors|immunologic factors|mesh-ancestor
111350396|NCT01057277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111350397|NCT01057277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111350398|NCT00866840|Riluzole|riluzole|mesh-list
111350399|NCT00866840|Anticonvulsants|anticonvulsants|mesh-ancestor
111350400|NCT00866840|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111350401|NCT00866840|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111350402|NCT00866840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111350403|NCT00866840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111350404|NCT00866840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111350405|NCT00866840|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111350406|NCT00866840|Protective Agents|protective agents|mesh-ancestor
111350407|NCT04349722|Scopolamine|scopolamine|mesh-list
111350408|NCT04349722|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
111350409|NCT04349722|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111350410|NCT04349722|Antiemetics|antiemetics|mesh-ancestor
111350411|NCT04349722|Autonomic Agents|autonomic agents|mesh-ancestor
111350412|NCT04349722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111350413|NCT04349722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111350414|NCT04349722|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111350415|NCT04349722|Mydriatics|mydriatics|mesh-ancestor
111350416|NCT04349722|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111350417|NCT04349722|Cholinergic Agents|cholinergic agents|mesh-ancestor
111350418|NCT04349722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111350419|NCT04349722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111350420|NCT04349722|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111350421|NCT04349722|Parasympatholytics|parasympatholytics|mesh-ancestor
111350422|NCT01058993|Plerixafor|plerixafor|mesh-list
111350423|NCT01058993|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111350424|NCT01058993|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111350425|NCT01058993|Antiviral Agents|antiviral agents|mesh-ancestor
111350426|NCT01058993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111350427|NCT04652518|Pirfenidone|pirfenidone|mesh-list
111350428|NCT04652518|Analgesics|analgesics|mesh-ancestor
111350429|NCT04652518|Sensory System Agents|sensory system agents|mesh-ancestor
111350430|NCT04652518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111350431|NCT04652518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111350432|NCT04652518|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111350433|NCT04652518|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111350434|NCT04652518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111350435|NCT04652518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111350436|NCT04652518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111350437|NCT01059305|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111350438|NCT01059305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111350439|NCT01059305|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111350440|NCT01059305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111350441|NCT01059305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111350442|NCT04650490|Immunomodulating Agents|immunomodulating agents|mesh-list
111350443|NCT04650490|Immunologic Factors|immunologic factors|mesh-ancestor
111350444|NCT04650490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111350445|NCT03014687|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111350446|NCT03014687|Cefdinir|cefdinir|mesh-list
111350447|NCT03014687|Cephalosporins|cephalosporins|mesh-list
111350448|NCT03014687|Trimethoprim|trimethoprim|mesh-list
111350449|NCT03014687|Sulfamethoxazole|sulfamethoxazole|mesh-list
111350450|NCT03014687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111350451|NCT03014687|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111350452|NCT03014687|Antimalarials|antimalarials|mesh-ancestor
111350453|NCT03014687|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111350454|NCT03014687|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111350455|NCT03014687|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111350456|NCT03014687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111350457|NCT03014687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111350458|NCT03014687|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111350459|NCT03014687|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
111350460|NCT03014687|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111350461|NCT04199572|Acetaminophen|acetaminophen|mesh-list
111350462|NCT04199572|Diclofenac|diclofenac|mesh-list
111350463|NCT04199572|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111074804|NCT03128203|Oxytocics|oxytocics|mesh-ancestor
111350464|NCT04199572|Analgesics|analgesics|mesh-ancestor
111350465|NCT04199572|Sensory System Agents|sensory system agents|mesh-ancestor
111350466|NCT04199572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111350467|NCT04199572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111350468|NCT04199572|Antipyretics|antipyretics|mesh-ancestor
111350469|NCT04199572|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111350470|NCT04199572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111350471|NCT04199572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111350472|NCT04199572|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111350473|NCT04199572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111350474|NCT04199572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111350475|NCT00383032|Mifepristone|mifepristone|mesh-list
111350476|NCT00383032|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
111350477|NCT00383032|Abortifacient Agents|abortifacient agents|mesh-ancestor
111350478|NCT00383032|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111350479|NCT00383032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111350480|NCT00383032|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111350481|NCT00383032|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111350482|NCT00383032|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111350483|NCT00383032|Contraceptive Agents|contraceptive agents|mesh-ancestor
111350484|NCT00383032|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
111350485|NCT00383032|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
111350486|NCT00383032|Hormone Antagonists|hormone antagonists|mesh-ancestor
111350487|NCT00383032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111350488|NCT00383032|Luteolytic Agents|luteolytic agents|mesh-ancestor
111350489|NCT00383032|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111350490|NCT00383032|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
111350491|NCT02169479|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
111350492|NCT02169479|Opicapone|opicapone|mesh-list
110756991|NCT03942354|Clofazimine|clofazimine|mesh-list
111350493|NCT02169479|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111350494|NCT02169479|Immunologic Factors|immunologic factors|mesh-ancestor
111350495|NCT02169479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111350496|NCT02169479|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111350497|NCT02169479|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111350498|NCT02169479|Dopamine Agonists|dopamine agonists|mesh-ancestor
111350499|NCT02169479|Dopamine Agents|dopamine agents|mesh-ancestor
111350500|NCT02169479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111350501|NCT02169479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111350502|NCT02169479|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
111350503|NCT02169479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111350504|NCT04302454|Leuprolide|leuprolide|mesh-list
111350505|NCT04302454|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111350506|NCT04302454|Fertility Agents|fertility agents|mesh-ancestor
111350507|NCT04302454|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111350508|NCT04302454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111350509|NCT04302454|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111350510|NCT04302454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111350511|NCT01059851|Suvorexant|suvorexant|mesh-list
111350512|NCT01059851|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111350513|NCT01059851|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110757117|NCT02529540|Adrenergic Agents|adrenergic agents|mesh-ancestor
111350514|NCT01059851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111350515|NCT01059851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111350516|NCT01059851|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
111350517|NCT01059851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111350518|NCT01059851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111350519|NCT02169869|Levonorgestrel|levonorgestrel|mesh-list
111350520|NCT02169869|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111350521|NCT02169869|Contraceptive Agents|contraceptive agents|mesh-ancestor
111350522|NCT02169869|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111350523|NCT02169869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110757185|NCT01372306|Parasympathomimetics|parasympathomimetics|mesh-ancestor
111350524|NCT02169869|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111350525|NCT02169869|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111350526|NCT02169869|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111350527|NCT01059929|Fentanyl|fentanyl|mesh-list
111350528|NCT01059929|Midazolam|midazolam|mesh-list
111350529|NCT01059929|Dexmedetomidine|dexmedetomidine|mesh-list
111350530|NCT01059929|Propofol|propofol|mesh-list
111350531|NCT01059929|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111350532|NCT01059929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110757260|NCT01372540|Filanesib|filanesib|mesh-list
111350533|NCT01059929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111350534|NCT01059929|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111350535|NCT01059929|Analgesics|analgesics|mesh-ancestor
111350536|NCT01059929|Sensory System Agents|sensory system agents|mesh-ancestor
111074879|NCT01004029|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
111350537|NCT01059929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111350538|NCT01059929|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111350539|NCT01059929|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111350540|NCT01059929|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111350541|NCT01059929|Adrenergic Agents|adrenergic agents|mesh-ancestor
111350542|NCT01059929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111350543|NCT01059929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111350544|NCT01059929|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111350545|NCT01059929|Anesthetics, General|anesthetics, general|mesh-ancestor
111350546|NCT01059929|Anesthetics|anesthetics|mesh-ancestor
111350547|NCT01059929|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111350548|NCT01059929|Narcotics|narcotics|mesh-ancestor
111350549|NCT01059929|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111350550|NCT01059929|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111350551|NCT01059929|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111350552|NCT01059929|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111350553|NCT01059929|GABA Modulators|gaba modulators|mesh-ancestor
111350554|NCT01059929|GABA Agents|gaba agents|mesh-ancestor
111350555|NCT04162522|Escitalopram|escitalopram|mesh-list
111350556|NCT04162522|Brexpiprazole|brexpiprazole|mesh-list
111350557|NCT04162522|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111350558|NCT04162522|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111350559|NCT04162522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110757594|NCT01119534|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111350560|NCT04162522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111350561|NCT04162522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111350562|NCT04162522|Serotonin Agents|serotonin agents|mesh-ancestor
111350563|NCT04162522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111350564|NCT04162522|Dopamine Agonists|dopamine agonists|mesh-ancestor
111350565|NCT04162522|Dopamine Agents|dopamine agents|mesh-ancestor
111350566|NCT04896658|Dexamethasone|dexamethasone|mesh-list
111350567|NCT04896658|Cyclophosphamide|cyclophosphamide|mesh-list
111350568|NCT04896658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111350569|NCT04896658|Immunologic Factors|immunologic factors|mesh-ancestor
111350570|NCT04896658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111350571|NCT04896658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111350572|NCT04896658|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111350573|NCT04896658|Alkylating Agents|alkylating agents|mesh-ancestor
111350574|NCT04896658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111350575|NCT04896658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111350576|NCT04896658|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111350577|NCT04896658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111350578|NCT04896658|Antiemetics|antiemetics|mesh-ancestor
111350579|NCT04896658|Autonomic Agents|autonomic agents|mesh-ancestor
111350580|NCT04896658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111350581|NCT04896658|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111350582|NCT04896658|Glucocorticoids|glucocorticoids|mesh-ancestor
111350584|NCT04896658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111350585|NCT04896658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111350586|NCT01062269|Cholestyramine Resin|cholestyramine resin|mesh-list
111350587|NCT01062269|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111350588|NCT01062269|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111350589|NCT01062269|Antimetabolites|antimetabolites|mesh-ancestor
111350590|NCT01062269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111350591|NCT01062269|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111350592|NCT04156828|Dexamethasone|dexamethasone|mesh-list
111350593|NCT04156828|Dexamethasone acetate|dexamethasone acetate|mesh-list
111350594|NCT04156828|Rituximab|rituximab|mesh-list
111350595|NCT04156828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111350596|NCT04156828|Carboplatin|carboplatin|mesh-list
111350597|NCT04156828|Gemcitabine|gemcitabine|mesh-list
111350598|NCT04156828|Antibodies|antibodies|mesh-list
111350599|NCT04156828|Immunoglobulins|immunoglobulins|mesh-list
111350600|NCT04156828|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111350601|NCT04156828|Lenograstim|lenograstim|mesh-list
111350602|NCT04156828|BB 1101|bb 1101|mesh-list
111350603|NCT04156828|Immunologic Factors|immunologic factors|mesh-ancestor
111350604|NCT04156828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111350605|NCT04156828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111350606|NCT04156828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111350607|NCT04156828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111350608|NCT04156828|Antiemetics|antiemetics|mesh-ancestor
111350609|NCT04156828|Autonomic Agents|autonomic agents|mesh-ancestor
111350610|NCT04156828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111350611|NCT04156828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111350612|NCT04156828|Glucocorticoids|glucocorticoids|mesh-ancestor
111350613|NCT04156828|Hormones|hormones|mesh-ancestor
111350614|NCT04156828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111350615|NCT04156828|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111350616|NCT04156828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111350618|NCT04156828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111350619|NCT04156828|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111350620|NCT04156828|Protease Inhibitors|protease inhibitors|mesh-ancestor
111350621|NCT04156828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111350622|NCT01063049|Bisacodyl|bisacodyl|mesh-list
111350623|NCT01063049|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
111350624|NCT01063049|Cathartics|cathartics|mesh-ancestor
111350625|NCT01063049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111350626|NCT01063049|Laxatives|laxatives|mesh-ancestor
111350627|NCT04883242|Dexamethasone|dexamethasone|mesh-list
111350628|NCT04883242|Dexamethasone acetate|dexamethasone acetate|mesh-list
111350629|NCT04883242|Pomalidomide|pomalidomide|mesh-list
111350630|NCT04883242|Ichthammol|ichthammol|mesh-list
111350631|NCT04883242|BB 1101|bb 1101|mesh-list
111350632|NCT04883242|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111350633|NCT04883242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111350634|NCT04883242|Antiemetics|antiemetics|mesh-ancestor
111350635|NCT04883242|Autonomic Agents|autonomic agents|mesh-ancestor
110758141|NCT03117010|Dexamethasone|dexamethasone|mesh-list
111350636|NCT04883242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111350637|NCT04883242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111350638|NCT04883242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111350639|NCT04883242|Glucocorticoids|glucocorticoids|mesh-ancestor
111350640|NCT04883242|Hormones|hormones|mesh-ancestor
111350641|NCT04883242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110758200|NCT01375972|Antimetabolites|antimetabolites|mesh-ancestor
111350642|NCT04883242|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111350643|NCT04883242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111350644|NCT04883242|Protease Inhibitors|protease inhibitors|mesh-ancestor
111350645|NCT04883242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111350646|NCT04883242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111350647|NCT04883242|Immunologic Factors|immunologic factors|mesh-ancestor
111350648|NCT04883242|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111350649|NCT04883242|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111350650|NCT04883242|Growth Substances|growth substances|mesh-ancestor
111350651|NCT04883242|Growth Inhibitors|growth inhibitors|mesh-ancestor
111350652|NCT04883242|Dermatologic Agents|dermatologic agents|mesh-ancestor
111350653|NCT04104178|Clindamycin|clindamycin|mesh-list
111350654|NCT04104178|Clindamycin palmitate|clindamycin palmitate|mesh-list
111350655|NCT04104178|Clindamycin phosphate|clindamycin phosphate|mesh-list
111350656|NCT04104178|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111350657|NCT04104178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111350658|NCT04104178|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111350659|NCT04104178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111350660|NCT04104178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111350661|NCT03661138|Upadacitinib|upadacitinib|mesh-list
111350662|NCT03661138|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
111350663|NCT03661138|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111350664|NCT03661138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111350665|NCT03661138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111350666|NCT03661138|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111350667|NCT04588792|Furosemide|furosemide|mesh-list
111350668|NCT04588792|Diuretics|diuretics|mesh-ancestor
111350669|NCT04588792|Natriuretic Agents|natriuretic agents|mesh-ancestor
111350670|NCT04588792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111350671|NCT04588792|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
111350672|NCT04588792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111350673|NCT04588792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111350674|NCT04081792|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111350675|NCT04081792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111350676|NCT04038970|Methotrexate|methotrexate|mesh-list
111350677|NCT04038970|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111350678|NCT04038970|Abortifacient Agents|abortifacient agents|mesh-ancestor
111350679|NCT04038970|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111350680|NCT04038970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111350681|NCT04038970|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111350682|NCT04038970|Antimetabolites|antimetabolites|mesh-ancestor
111350683|NCT04038970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111350684|NCT04038970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111350685|NCT04038970|Dermatologic Agents|dermatologic agents|mesh-ancestor
111350686|NCT04038970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111350687|NCT04038970|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111350688|NCT04038970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111350690|NCT04038970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111350691|NCT04038970|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111350692|NCT02181738|Doxorubicin|doxorubicin|mesh-list
111350693|NCT02181738|Nivolumab|nivolumab|mesh-list
111350694|NCT02181738|Dacarbazine|dacarbazine|mesh-list
111350695|NCT02181738|Vinblastine|vinblastine|mesh-list
111350696|NCT02181738|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111350697|NCT02181738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111350698|NCT02181738|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111350699|NCT02181738|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111350700|NCT02181738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110758580|NCT01127724|Hematinics|hematinics|mesh-ancestor
111350701|NCT02181738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110758652|NCT01129830|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
111350702|NCT02181738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111350703|NCT02181738|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111350704|NCT02181738|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111350705|NCT02181738|Alkylating Agents|alkylating agents|mesh-ancestor
111350706|NCT02181738|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111350707|NCT02181738|Tubulin Modulators|tubulin modulators|mesh-ancestor
111350708|NCT02181738|Antimitotic Agents|antimitotic agents|mesh-ancestor
111350709|NCT02181738|Mitosis Modulators|mitosis modulators|mesh-ancestor
111350710|NCT05426304|Agomelatine|agomelatine|mesh-list
111350711|NCT05426304|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111350712|NCT05426304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111350713|NCT05426304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111350714|NCT03955198|Durvalumab|durvalumab|mesh-list
111350715|NCT03955198|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111350716|NCT03955198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111350717|NCT04494958|Palbociclib|palbociclib|mesh-list
111350718|NCT04494958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110758790|NCT05370820|Tranexamic Acid|tranexamic acid|mesh-list
111350719|NCT04494958|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111350720|NCT04494958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111350721|NCT04494958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111350722|NCT00382954|Bortezomib|bortezomib|mesh-list
111350723|NCT00382954|Idarubicin|idarubicin|mesh-list
111350724|NCT00382954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111350725|NCT00382954|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111350726|NCT00382954|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111350727|NCT00382954|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111350728|NCT00382954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111350729|NCT00382954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111350730|NCT01246063|Dexamethasone|dexamethasone|mesh-list
111350731|NCT01246063|Doxorubicin|doxorubicin|mesh-list
111350732|NCT01246063|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111350733|NCT01246063|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111350734|NCT01246063|Antiemetics|antiemetics|mesh-ancestor
111350735|NCT01246063|Autonomic Agents|autonomic agents|mesh-ancestor
111350736|NCT01246063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111350737|NCT01246063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111350738|NCT01246063|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111350739|NCT01246063|Glucocorticoids|glucocorticoids|mesh-ancestor
111350740|NCT01246063|Hormones|hormones|mesh-ancestor
111350741|NCT01246063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111350742|NCT01246063|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111350743|NCT01246063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111350744|NCT01246063|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111350745|NCT01246063|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111350746|NCT01246063|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111350747|NCT01246063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111350748|NCT01246063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111350749|NCT03836014|Dexamethasone|dexamethasone|mesh-list
111350750|NCT03836014|Dexamethasone acetate|dexamethasone acetate|mesh-list
111350751|NCT03836014|Lenalidomide|lenalidomide|mesh-list
111350752|NCT03836014|Daratumumab|daratumumab|mesh-list
111350753|NCT03836014|BB 1101|bb 1101|mesh-list
111350754|NCT03836014|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111350755|NCT03836014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111350756|NCT03836014|Antiemetics|antiemetics|mesh-ancestor
111350757|NCT03836014|Autonomic Agents|autonomic agents|mesh-ancestor
111350758|NCT03836014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111350759|NCT03836014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111350760|NCT03836014|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111350761|NCT03836014|Glucocorticoids|glucocorticoids|mesh-ancestor
111350762|NCT03836014|Hormones|hormones|mesh-ancestor
111075109|NCT01239797|Elotuzumab|elotuzumab|mesh-list
111350763|NCT03836014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111350764|NCT03836014|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111350765|NCT03836014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111350766|NCT03836014|Protease Inhibitors|protease inhibitors|mesh-ancestor
111350767|NCT03836014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111350768|NCT03836014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111350769|NCT03836014|Immunologic Factors|immunologic factors|mesh-ancestor
111350770|NCT03836014|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110759120|NCT03919812|Vitamins|vitamins|mesh-ancestor
111350771|NCT03836014|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111350772|NCT03836014|Growth Substances|growth substances|mesh-ancestor
111350773|NCT03836014|Growth Inhibitors|growth inhibitors|mesh-ancestor
111350774|NCT01205503|Cyclophosphamide|cyclophosphamide|mesh-list
111350776|NCT01205503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111350777|NCT01205503|Immunologic Factors|immunologic factors|mesh-ancestor
111350778|NCT01205503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111350779|NCT01205503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110759177|NCT05402124|Analgesics|analgesics|mesh-ancestor
111350780|NCT01205503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111350781|NCT01205503|Alkylating Agents|alkylating agents|mesh-ancestor
111350782|NCT01205503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111350783|NCT01205503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111350784|NCT01205503|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111350785|NCT01205503|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111350786|NCT01205503|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111350787|NCT01205503|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111350788|NCT01205503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111350789|NCT03187834|Amoxicillin|amoxicillin|mesh-list
111350790|NCT03187834|Azithromycin|azithromycin|mesh-list
111350791|NCT03187834|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
111350792|NCT03187834|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110759311|NCT01135290|Petrolatum|petrolatum|mesh-list
111350793|NCT03187834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111350794|NCT03187834|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111350795|NCT03187834|Antimalarials|antimalarials|mesh-ancestor
111350796|NCT03187834|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111350797|NCT03187834|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111350798|NCT01206595|Bupivacaine|bupivacaine|mesh-list
111350799|NCT01206595|Anesthetics, Local|anesthetics, local|mesh-ancestor
111350800|NCT01206595|Anesthetics|anesthetics|mesh-ancestor
110759378|NCT01138956|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111350801|NCT01206595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111350802|NCT01206595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111350803|NCT01206595|Sensory System Agents|sensory system agents|mesh-ancestor
111350804|NCT01206595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111350805|NCT04385992|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
111350806|NCT04385992|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111350807|NCT04385992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111350808|NCT01158703|Aspirin|aspirin|mesh-list
111350809|NCT01158703|Clopidogrel|clopidogrel|mesh-list
111350810|NCT01158703|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111350811|NCT01158703|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111350812|NCT01158703|Analgesics|analgesics|mesh-ancestor
111350813|NCT01158703|Sensory System Agents|sensory system agents|mesh-ancestor
111350814|NCT01158703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111350815|NCT01158703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111350816|NCT01158703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111350817|NCT01158703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110759529|NCT03917394|Iron|iron|mesh-list
111350818|NCT01158703|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111350819|NCT01158703|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111350820|NCT01158703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111350821|NCT01158703|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110759581|NCT01234272|Anesthetics|anesthetics|mesh-ancestor
111350822|NCT01158703|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111350823|NCT01158703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111350824|NCT01158703|Antipyretics|antipyretics|mesh-ancestor
111350825|NCT01158703|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111350826|NCT01158703|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111350827|NCT01158703|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111350828|NCT01158703|Purinergic Agents|purinergic agents|mesh-ancestor
111350829|NCT01158703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111350830|NCT03009643|Nitric Oxide|nitric oxide|mesh-list
111350831|NCT03009643|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111350832|NCT03009643|Autonomic Agents|autonomic agents|mesh-ancestor
111350833|NCT03009643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111350834|NCT03009643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111075181|NCT03420911|Analgesics|analgesics|mesh-ancestor
111350835|NCT03009643|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111350836|NCT03009643|Respiratory System Agents|respiratory system agents|mesh-ancestor
111350837|NCT03009643|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111350838|NCT03009643|Antioxidants|antioxidants|mesh-ancestor
111350839|NCT03009643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111350840|NCT03009643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111350841|NCT03009643|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
111350842|NCT03009643|Vasodilator Agents|vasodilator agents|mesh-ancestor
111350843|NCT03009643|Gasotransmitters|gasotransmitters|mesh-ancestor
111350844|NCT03009643|Protective Agents|protective agents|mesh-ancestor
111350845|NCT04275232|Plasminogen|plasminogen|mesh-list
111350846|NCT04275232|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111350847|NCT04275232|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111350848|NCT04275232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111350849|NCT01207765|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111350850|NCT01207765|Immunologic Factors|immunologic factors|mesh-ancestor
110759932|NCT05848505|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111350851|NCT01207765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111350852|NCT03786796|Olaparib|olaparib|mesh-list
111350853|NCT03786796|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111350854|NCT03786796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111350855|NCT03786796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111350856|NCT03786796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111350857|NCT03089866|Midazolam|midazolam|mesh-list
111350858|NCT03089866|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111350859|NCT03089866|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111350860|NCT03089866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111350861|NCT03089866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111350862|NCT03089866|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111350863|NCT03089866|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111350864|NCT03089866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110760190|NCT05843162|Losartan|losartan|mesh-list
111350865|NCT03089866|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111350866|NCT03089866|Anesthetics, General|anesthetics, general|mesh-ancestor
111350867|NCT03089866|Anesthetics|anesthetics|mesh-ancestor
111350868|NCT03089866|GABA Modulators|gaba modulators|mesh-ancestor
111350869|NCT03089866|GABA Agents|gaba agents|mesh-ancestor
111350870|NCT03089866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111350871|NCT03089866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111350872|NCT00002890|Lintuzumab|lintuzumab|mesh-list
111350873|NCT00002890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111350874|NCT00002890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111350875|NCT00002896|Leucovorin|leucovorin|mesh-list
111350877|NCT00002896|Fluorouracil|fluorouracil|mesh-list
111350878|NCT00002896|Calcium|calcium|mesh-list
111350879|NCT00002896|Levoleucovorin|levoleucovorin|mesh-list
111350880|NCT00002896|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111350881|NCT00002896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111350882|NCT00002896|Antimetabolites|antimetabolites|mesh-ancestor
111350883|NCT00002896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111350884|NCT00002896|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111350885|NCT00002896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111350886|NCT00002896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111350887|NCT00002896|Immunologic Factors|immunologic factors|mesh-ancestor
111350888|NCT00002896|Antidotes|antidotes|mesh-ancestor
111350889|NCT00002896|Protective Agents|protective agents|mesh-ancestor
111350890|NCT00002896|Vitamin B Complex|vitamin b complex|mesh-ancestor
111350891|NCT00002896|Vitamins|vitamins|mesh-ancestor
111350892|NCT00002896|Micronutrients|micronutrients|mesh-ancestor
111350893|NCT00002896|Trace Elements|trace elements|mesh-ancestor
111350894|NCT01249027|Everolimus|everolimus|mesh-list
111350895|NCT01249027|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111350896|NCT01249027|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111350897|NCT01249027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111350898|NCT01249027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111350899|NCT01249027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111350900|NCT01249027|Immunologic Factors|immunologic factors|mesh-ancestor
111350901|NCT01249027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110760263|NCT05840562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111350902|NCT01249027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111350903|NCT00002902|Irinotecan|irinotecan|mesh-list
111350904|NCT00002902|Raltitrexed|raltitrexed|mesh-list
111350905|NCT00002902|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111350906|NCT00002902|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111350907|NCT00002902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111350908|NCT00002902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111350909|NCT00002902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111350910|NCT00002902|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111350911|NCT00002902|Antimetabolites|antimetabolites|mesh-ancestor
111350912|NCT00002902|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111350913|NCT02992756|Mitogens|mitogens|mesh-list
111350914|NCT02992756|Mitosis Modulators|mitosis modulators|mesh-ancestor
111350915|NCT02992756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111350916|NCT01250899|Vitamin D|vitamin d|mesh-list
111350917|NCT01250899|Vitamins|vitamins|mesh-ancestor
111350918|NCT01250899|Micronutrients|micronutrients|mesh-ancestor
111350919|NCT01250899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111350920|NCT01250899|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111350921|NCT01212445|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
111350922|NCT01212445|Laxatives|laxatives|mesh-list
110760309|NCT05825573|Vitamin K|vitamin k|mesh-list
111350923|NCT01212445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111350924|NCT00002908|Vincristine|vincristine|mesh-list
111350925|NCT00002908|Bryostatin 1|bryostatin 1|mesh-list
111350926|NCT00002908|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111350927|NCT00002908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111350928|NCT00002908|Tubulin Modulators|tubulin modulators|mesh-ancestor
111350929|NCT00002908|Antimitotic Agents|antimitotic agents|mesh-ancestor
111350930|NCT00002908|Mitosis Modulators|mitosis modulators|mesh-ancestor
111350931|NCT00002908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111350932|NCT00002908|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111350933|NCT00002908|Immunologic Factors|immunologic factors|mesh-ancestor
111350934|NCT00002908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111350935|NCT00002920|Tamoxifen|tamoxifen|mesh-list
111350936|NCT00002920|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
111350937|NCT00002920|Medroxyprogesterone|medroxyprogesterone|mesh-list
111350938|NCT00002920|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111350939|NCT00002920|Hormone Antagonists|hormone antagonists|mesh-ancestor
111350940|NCT00002920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111350941|NCT00002920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111350942|NCT00002920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111350943|NCT00002920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111350944|NCT00002920|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111350945|NCT00002920|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111350946|NCT00002920|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111350947|NCT00002920|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111350948|NCT00002920|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111350949|NCT00002920|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111350950|NCT00002920|Contraceptive Agents|contraceptive agents|mesh-ancestor
111350951|NCT00002920|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111350952|NCT00002920|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111350953|NCT00002920|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111350954|NCT00002920|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
111350955|NCT01250977|Donepezil|donepezil|mesh-list
111350956|NCT01250977|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111350957|NCT01250977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111350958|NCT01250977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111350959|NCT01250977|Cholinergic Agents|cholinergic agents|mesh-ancestor
111350960|NCT01250977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111350961|NCT01250977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111350962|NCT01250977|Nootropic Agents|nootropic agents|mesh-ancestor
111350963|NCT01161121|Adenosine|adenosine|mesh-list
111350964|NCT01161121|Regadenoson|regadenoson|mesh-list
111350965|NCT01161121|Analgesics|analgesics|mesh-ancestor
111350966|NCT01161121|Sensory System Agents|sensory system agents|mesh-ancestor
111350967|NCT01161121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111350968|NCT01161121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111350969|NCT01161121|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111350970|NCT01161121|Vasodilator Agents|vasodilator agents|mesh-ancestor
111350971|NCT01161121|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
111350972|NCT01161121|Purinergic Agonists|purinergic agonists|mesh-ancestor
111350973|NCT01161121|Purinergic Agents|purinergic agents|mesh-ancestor
111350974|NCT01161121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110760635|NCT05654818|Vitamin D|vitamin d|mesh-list
111350975|NCT01161121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111350976|NCT01161121|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
111350977|NCT03010579|Epoetin Alfa|epoetin alfa|mesh-list
111350978|NCT03010579|Ferrous succinate|ferrous succinate|mesh-list
111350979|NCT03010579|Hematinics|hematinics|mesh-list
111350980|NCT01214083|Acetylcysteine|acetylcysteine|mesh-list
111350981|NCT01214083|Naltrexone|naltrexone|mesh-list
111350982|NCT01214083|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111350983|NCT01214083|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111350984|NCT01214083|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111350985|NCT01214083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111350986|NCT01214083|Sensory System Agents|sensory system agents|mesh-ancestor
111350987|NCT01214083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111350988|NCT01214083|Antiviral Agents|antiviral agents|mesh-ancestor
111350989|NCT01214083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111350990|NCT01214083|Expectorants|expectorants|mesh-ancestor
111350991|NCT01214083|Respiratory System Agents|respiratory system agents|mesh-ancestor
111350992|NCT01214083|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110760809|NCT05383521|Tinidazole|tinidazole|mesh-list
111350993|NCT01214083|Antioxidants|antioxidants|mesh-ancestor
111350994|NCT01214083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111350995|NCT01214083|Protective Agents|protective agents|mesh-ancestor
111350996|NCT01214083|Antidotes|antidotes|mesh-ancestor
111350997|NCT01254877|Ondansetron|ondansetron|mesh-list
111350998|NCT01254877|Antiemetics|antiemetics|mesh-ancestor
111350999|NCT01254877|Autonomic Agents|autonomic agents|mesh-ancestor
111351000|NCT01254877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111351001|NCT01254877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111351002|NCT01254877|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111351003|NCT01254877|Antipruritics|antipruritics|mesh-ancestor
111351004|NCT01254877|Dermatologic Agents|dermatologic agents|mesh-ancestor
111351005|NCT01254877|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111351006|NCT01254877|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111351007|NCT01254877|Serotonin Agents|serotonin agents|mesh-ancestor
111351008|NCT01254877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111351009|NCT01254877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111351010|NCT02189317|Bupivacaine|bupivacaine|mesh-list
111351011|NCT02189317|Anesthetics, Local|anesthetics, local|mesh-ancestor
111351012|NCT02189317|Anesthetics|anesthetics|mesh-ancestor
111351013|NCT02189317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111351014|NCT02189317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111351015|NCT02189317|Sensory System Agents|sensory system agents|mesh-ancestor
110761050|NCT05121324|GABA Modulators|gaba modulators|mesh-ancestor
111351016|NCT02189317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111351017|NCT03713944|Bevacizumab|bevacizumab|mesh-list
111351018|NCT03713944|Atezolizumab|atezolizumab|mesh-list
111351019|NCT03713944|Carboplatin|carboplatin|mesh-list
111351020|NCT03713944|Pemetrexed|pemetrexed|mesh-list
111351021|NCT03713944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111351022|NCT03713944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111351023|NCT03713944|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111351024|NCT03713944|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111351025|NCT03713944|Growth Substances|growth substances|mesh-ancestor
111351026|NCT03713944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111351027|NCT03713944|Growth Inhibitors|growth inhibitors|mesh-ancestor
111351028|NCT03713944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111351029|NCT03713944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111351030|NCT03713944|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111351031|NCT03713944|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111351032|NCT03713944|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111351033|NCT01214161|Lidocaine|lidocaine|mesh-list
111351034|NCT01214161|Anesthetics, Local|anesthetics, local|mesh-ancestor
111351035|NCT01214161|Anesthetics|anesthetics|mesh-ancestor
111351036|NCT01214161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110761183|NCT05074992|Ipilimumab|ipilimumab|mesh-list
111351037|NCT01214161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111351038|NCT01214161|Sensory System Agents|sensory system agents|mesh-ancestor
111351039|NCT01214161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111351040|NCT01214161|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111351041|NCT01214161|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110761268|NCT05006599|Insulin|insulin|mesh-list
111351042|NCT01214161|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111351043|NCT01214161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111351044|NCT01214161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111351045|NCT02981329|Metformin|metformin|mesh-list
111351046|NCT02981329|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111351047|NCT02981329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111351048|NCT00383656|Hormones|hormones|mesh-list
111351049|NCT00383656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111351050|NCT00383656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111351051|NCT01214317|Mitoxantrone|mitoxantrone|mesh-list
111351052|NCT01214317|Analgesics|analgesics|mesh-ancestor
111351053|NCT01214317|Sensory System Agents|sensory system agents|mesh-ancestor
111351054|NCT01214317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111351055|NCT01214317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111351056|NCT01214317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111351057|NCT01214317|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111351058|NCT01214317|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111351059|NCT01214317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111351060|NCT01214317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111351061|NCT00383812|Bevacizumab|bevacizumab|mesh-list
111351062|NCT00383812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111351063|NCT00383812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111351064|NCT00383812|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111351065|NCT00383812|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111351066|NCT00383812|Growth Substances|growth substances|mesh-ancestor
111351067|NCT00383812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111351068|NCT00383812|Growth Inhibitors|growth inhibitors|mesh-ancestor
111351069|NCT02189629|Trifarotene|trifarotene|mesh-list
111351070|NCT02189629|Dermatologic Agents|dermatologic agents|mesh-ancestor
111351071|NCT00002926|Cytarabine|cytarabine|mesh-list
111351072|NCT00002926|Etoposide|etoposide|mesh-list
111351073|NCT00002926|Idarubicin|idarubicin|mesh-list
111351074|NCT00002926|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111351075|NCT00002926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111351076|NCT00002926|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111351077|NCT00002926|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111351078|NCT00002926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111351079|NCT00002926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111351080|NCT00002926|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111351081|NCT00002926|Antimetabolites|antimetabolites|mesh-ancestor
111351082|NCT00002926|Antiviral Agents|antiviral agents|mesh-ancestor
111351083|NCT00002926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111351084|NCT00002926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111351085|NCT00002926|Immunologic Factors|immunologic factors|mesh-ancestor
111351086|NCT00002926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111351087|NCT00002926|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111351088|NCT01281007|Acyclovir|acyclovir|mesh-list
111351089|NCT01281007|Famciclovir|famciclovir|mesh-list
111351090|NCT01281007|Antiviral Agents|antiviral agents|mesh-ancestor
111351091|NCT01281007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111351092|NCT01281007|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111351093|NCT01281007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111351094|NCT01281007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111351095|NCT02898610|Colchicine|colchicine|mesh-list
111351096|NCT02898610|Gout Suppressants|gout suppressants|mesh-ancestor
111351097|NCT02898610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111351098|NCT02898610|Tubulin Modulators|tubulin modulators|mesh-ancestor
111351099|NCT02898610|Antimitotic Agents|antimitotic agents|mesh-ancestor
111351100|NCT02898610|Mitosis Modulators|mitosis modulators|mesh-ancestor
111351101|NCT02898610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111351102|NCT02898610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111351103|NCT01281475|Levodopa|levodopa|mesh-list
111351104|NCT01281475|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111351105|NCT01281475|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111351106|NCT01281475|Dopamine Agents|dopamine agents|mesh-ancestor
111351107|NCT01281475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111351108|NCT01281475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111351109|NCT01281475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111351110|NCT00002932|Cisplatin|cisplatin|mesh-list
111351111|NCT00002932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111351112|NCT01572662|Methotrexate|methotrexate|mesh-list
111351113|NCT01572662|Fludarabine phosphate|fludarabine phosphate|mesh-list
111351114|NCT01572662|Fludarabine|fludarabine|mesh-list
111351115|NCT01572662|Busulfan|busulfan|mesh-list
111351116|NCT01572662|Tacrolimus|tacrolimus|mesh-list
111351117|NCT01572662|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111351118|NCT01572662|Abortifacient Agents|abortifacient agents|mesh-ancestor
111351119|NCT01572662|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110761729|NCT04579120|Corticosterone|corticosterone|mesh-list
111351120|NCT01572662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111351121|NCT01572662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111351122|NCT01572662|Antimetabolites|antimetabolites|mesh-ancestor
111351123|NCT01572662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111351124|NCT01572662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110761804|NCT04456439|Antiemetics|antiemetics|mesh-ancestor
111351125|NCT01572662|Dermatologic Agents|dermatologic agents|mesh-ancestor
111351126|NCT01572662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111351127|NCT01572662|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111351128|NCT01572662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111351129|NCT01572662|Immunologic Factors|immunologic factors|mesh-ancestor
111351130|NCT01572662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111351131|NCT01572662|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111351132|NCT01572662|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111351133|NCT01572662|Alkylating Agents|alkylating agents|mesh-ancestor
111351134|NCT01572662|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111351135|NCT01572662|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111351136|NCT01258153|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111351137|NCT01258153|MEN 11420|men 11420|mesh-list
111351138|NCT01258153|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111351139|NCT01258153|Autonomic Agents|autonomic agents|mesh-ancestor
111351140|NCT01258153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111351141|NCT01258153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111351142|NCT01258153|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111351143|NCT01258153|Respiratory System Agents|respiratory system agents|mesh-ancestor
111351145|NCT01555268|Trebananib|trebananib|mesh-list
110762146|NCT03948035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111351146|NCT01555268|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111351147|NCT01555268|Antimetabolites|antimetabolites|mesh-ancestor
111351148|NCT01555268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111351149|NCT01555268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111351150|NCT01555268|Antiviral Agents|antiviral agents|mesh-ancestor
111351151|NCT01555268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111351152|NCT01555268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111351153|NCT01555268|Immunologic Factors|immunologic factors|mesh-ancestor
111351154|NCT01555268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110762291|NCT03715972|Hydroxyurea|hydroxyurea|mesh-list
111351155|NCT01555268|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111351156|NCT01555268|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111351157|NCT01555268|Growth Substances|growth substances|mesh-ancestor
111351158|NCT01555268|Growth Inhibitors|growth inhibitors|mesh-ancestor
111351159|NCT04781270|Bevacizumab|bevacizumab|mesh-list
111351160|NCT04781270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111351161|NCT04781270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111351162|NCT04781270|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111351163|NCT04781270|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111351164|NCT04781270|Growth Substances|growth substances|mesh-ancestor
111351165|NCT04781270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111351166|NCT04781270|Growth Inhibitors|growth inhibitors|mesh-ancestor
111351167|NCT00003394|Paclitaxel|paclitaxel|mesh-list
111351168|NCT00003394|Carboplatin|carboplatin|mesh-list
111351169|NCT00003394|Leuprolide|leuprolide|mesh-list
111351170|NCT00003394|Goserelin|goserelin|mesh-list
111351171|NCT00003394|Estramustine|estramustine|mesh-list
111351172|NCT00003394|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111351173|NCT00003394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111351174|NCT00003394|Tubulin Modulators|tubulin modulators|mesh-ancestor
111351175|NCT00003394|Antimitotic Agents|antimitotic agents|mesh-ancestor
111351176|NCT00003394|Mitosis Modulators|mitosis modulators|mesh-ancestor
111351177|NCT00003394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111351178|NCT00003394|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111351179|NCT00003394|Fertility Agents|fertility agents|mesh-ancestor
111351180|NCT00003394|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111351181|NCT00003394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111351182|NCT00003394|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111351183|NCT00003394|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111351184|NCT00003394|Alkylating Agents|alkylating agents|mesh-ancestor
111351185|NCT00003400|Melphalan|melphalan|mesh-list
111351186|NCT00003400|Vinorelbine|vinorelbine|mesh-list
111351187|NCT00003400|Carmustine|carmustine|mesh-list
111351188|NCT00003400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111351189|NCT00003400|Immunologic Factors|immunologic factors|mesh-ancestor
111351190|NCT00003400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111351191|NCT00003400|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111351192|NCT00003400|Alkylating Agents|alkylating agents|mesh-ancestor
111351193|NCT00003400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111351194|NCT00003400|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111351195|NCT00003400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111351196|NCT00003400|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111351197|NCT00003400|Tubulin Modulators|tubulin modulators|mesh-ancestor
111351198|NCT00003400|Antimitotic Agents|antimitotic agents|mesh-ancestor
111351199|NCT00003400|Mitosis Modulators|mitosis modulators|mesh-ancestor
111351200|NCT04348370|Vaccines|vaccines|mesh-list
111351201|NCT04348370|BCG Vaccine|bcg vaccine|mesh-list
111351202|NCT04348370|Immunologic Factors|immunologic factors|mesh-ancestor
111351203|NCT04348370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111351204|NCT04348370|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111351205|NCT00002944|Carboplatin|carboplatin|mesh-list
111351206|NCT00002944|Vincristine|vincristine|mesh-list
111351207|NCT00002944|Thioguanine|thioguanine|mesh-list
111351208|NCT00002944|Lomustine|lomustine|mesh-list
111351209|NCT00002944|Procarbazine|procarbazine|mesh-list
111351210|NCT00002944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111351211|NCT00002944|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111351212|NCT00002944|Tubulin Modulators|tubulin modulators|mesh-ancestor
111075557|NCT04260477|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111351213|NCT00002944|Antimitotic Agents|antimitotic agents|mesh-ancestor
111351214|NCT00002944|Mitosis Modulators|mitosis modulators|mesh-ancestor
111351215|NCT00002944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111351216|NCT00002944|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111351217|NCT00002944|Antimetabolites|antimetabolites|mesh-ancestor
111351218|NCT00002944|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111351219|NCT00002944|Alkylating Agents|alkylating agents|mesh-ancestor
111351220|NCT04778072|Iron|iron|mesh-list
111351221|NCT04778072|Trace Elements|trace elements|mesh-ancestor
111351222|NCT04778072|Micronutrients|micronutrients|mesh-ancestor
111351223|NCT04778072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111351224|NCT00002950|Topotecan|topotecan|mesh-list
111351225|NCT00002950|Sargramostim|sargramostim|mesh-list
111351226|NCT00002950|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111351227|NCT00002950|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111351228|NCT00002950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111351229|NCT00002950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111351230|NCT00002950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111351231|NCT00002950|Immunologic Factors|immunologic factors|mesh-ancestor
111351232|NCT00002950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111351233|NCT00777140|Deferoxamine|deferoxamine|mesh-list
111351234|NCT00777140|Siderophores|siderophores|mesh-ancestor
111351235|NCT00777140|Iron Chelating Agents|iron chelating agents|mesh-ancestor
111351236|NCT00777140|Chelating Agents|chelating agents|mesh-ancestor
111351237|NCT00777140|Sequestering Agents|sequestering agents|mesh-ancestor
111351238|NCT00777140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111351239|NCT00003406|Carboplatin|carboplatin|mesh-list
111351240|NCT00003406|Docetaxel|docetaxel|mesh-list
111351241|NCT00003406|Ifosfamide|ifosfamide|mesh-list
111351242|NCT00003406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111351243|NCT00003406|Tubulin Modulators|tubulin modulators|mesh-ancestor
111351244|NCT00003406|Antimitotic Agents|antimitotic agents|mesh-ancestor
111351245|NCT00003406|Mitosis Modulators|mitosis modulators|mesh-ancestor
111351246|NCT00003406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111351247|NCT00003406|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111351248|NCT00003406|Alkylating Agents|alkylating agents|mesh-ancestor
111351249|NCT00003412|Interleukin-12|interleukin-12|mesh-list
111351250|NCT00003412|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111351251|NCT00003412|Immunologic Factors|immunologic factors|mesh-ancestor
111351252|NCT00003412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111351253|NCT00003412|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111351254|NCT00003412|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111351255|NCT00003412|Growth Substances|growth substances|mesh-ancestor
111351256|NCT00003412|Growth Inhibitors|growth inhibitors|mesh-ancestor
111351257|NCT00003412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111351258|NCT04780958|Vitamin A|vitamin a|mesh-list
111351259|NCT04780958|Vitamins|vitamins|mesh-ancestor
111351260|NCT04780958|Micronutrients|micronutrients|mesh-ancestor
111351261|NCT04780958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111351262|NCT00002968|Edrecolomab|edrecolomab|mesh-list
111351263|NCT00002968|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111351264|NCT00002968|Immunologic Factors|immunologic factors|mesh-ancestor
111351265|NCT00002968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110763089|NCT02339922|Rituximab|rituximab|mesh-list
111351266|NCT04780412|Alprostadil|alprostadil|mesh-list
111351267|NCT04780412|Misoprostol|misoprostol|mesh-list
111351268|NCT04780412|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111351269|NCT04780412|Abortifacient Agents|abortifacient agents|mesh-ancestor
111351270|NCT04780412|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111351271|NCT04780412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111351272|NCT04780412|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110763165|NCT02297139|Dasatinib|dasatinib|mesh-list
111351273|NCT04780412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111351274|NCT04780412|Oxytocics|oxytocics|mesh-ancestor
111351275|NCT04780412|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111351276|NCT04780412|Vasodilator Agents|vasodilator agents|mesh-ancestor
111351277|NCT04780412|Urological Agents|urological agents|mesh-ancestor
111479252|NCT05133258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111479253|NCT05133258|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111479254|NCT05133258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111479255|NCT05133258|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111479256|NCT05133258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111479257|NCT05133258|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111479258|NCT05133258|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111479259|NCT05133258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111479260|NCT05133258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111479261|NCT05133258|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111479262|NCT05133258|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111479263|NCT05091346|Pembrolizumab|pembrolizumab|mesh-list
111351278|NCT00002974|Carboplatin|carboplatin|mesh-list
111351279|NCT00002974|Etoposide|etoposide|mesh-list
111351280|NCT00002974|Ifosfamide|ifosfamide|mesh-list
111351281|NCT00002974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111351282|NCT00002974|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111351283|NCT00002974|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111351284|NCT00002974|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111351285|NCT00002974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111351286|NCT00002974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111351287|NCT00002974|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111351288|NCT00002974|Alkylating Agents|alkylating agents|mesh-ancestor
111351289|NCT00754364|Carboplatin|carboplatin|mesh-list
111351290|NCT00754364|Gemcitabine|gemcitabine|mesh-list
111351291|NCT00754364|Pemetrexed|pemetrexed|mesh-list
111351292|NCT00754364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111351293|NCT00754364|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111351294|NCT00754364|Antimetabolites|antimetabolites|mesh-ancestor
111351295|NCT00754364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111351296|NCT00754364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111351297|NCT00754364|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111351298|NCT00754364|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111351299|NCT02612896|Praziquantel|praziquantel|mesh-list
111351300|NCT02612896|Anthelmintics|anthelmintics|mesh-ancestor
111351301|NCT02612896|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111351302|NCT02612896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111351303|NCT00002980|Decitabine|decitabine|mesh-list
111351304|NCT00002980|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111351305|NCT00002980|Antimetabolites|antimetabolites|mesh-ancestor
111351306|NCT00002980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111351307|NCT00002980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111351308|NCT00002980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111351309|NCT00002986|Topotecan|topotecan|mesh-list
111351310|NCT00002986|Carmustine|carmustine|mesh-list
110445533|NCT01192178|Hormones|hormones|mesh-ancestor
111351311|NCT00002986|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111351312|NCT00002986|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111351313|NCT00002986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111351314|NCT00002986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111351315|NCT00002986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111351316|NCT00002986|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111351317|NCT00002986|Alkylating Agents|alkylating agents|mesh-ancestor
111351318|NCT00003418|Tamoxifen|tamoxifen|mesh-list
111351319|NCT00003418|Exemestane|exemestane|mesh-list
111351320|NCT00003418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111351321|NCT00003418|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111351322|NCT00003418|Hormone Antagonists|hormone antagonists|mesh-ancestor
111351323|NCT00003418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111351324|NCT00003418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111351325|NCT00003418|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111351326|NCT00003418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111351327|NCT00003418|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111351328|NCT00003418|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111351329|NCT00003418|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111351330|NCT00003418|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111351331|NCT00003418|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111351332|NCT00003418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111351333|NCT04777838|Amitriptyline|amitriptyline|mesh-list
111351334|NCT04777838|Citalopram|citalopram|mesh-list
111351335|NCT04777838|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111351336|NCT04777838|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111351337|NCT04777838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111351338|NCT04777838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111351339|NCT04777838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111351340|NCT04777838|Serotonin Agents|serotonin agents|mesh-ancestor
111351341|NCT04777838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110763906|NCT04349124|Tocolytic Agents|tocolytic agents|mesh-ancestor
111351342|NCT04777838|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111351343|NCT04777838|Antidepressive Agents|antidepressive agents|mesh-ancestor
111351344|NCT04777838|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111351345|NCT04777838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111351346|NCT04777838|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
111351347|NCT04777838|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111351348|NCT04777838|Analgesics|analgesics|mesh-ancestor
111351349|NCT04777838|Sensory System Agents|sensory system agents|mesh-ancestor
111351350|NCT04777838|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111351351|NCT04777838|Adrenergic Agents|adrenergic agents|mesh-ancestor
111351352|NCT00003424|Tamoxifen|tamoxifen|mesh-list
111351353|NCT00003424|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111351354|NCT00003424|Hormone Antagonists|hormone antagonists|mesh-ancestor
111351355|NCT00003424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110763976|NCT03897439|Bupropion|bupropion|mesh-list
111351356|NCT00003424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111351357|NCT00003424|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111351358|NCT00003424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111351359|NCT00003424|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111351360|NCT00003424|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111351361|NCT00003424|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111351362|NCT00002998|Gemcitabine|gemcitabine|mesh-list
111351363|NCT00002998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111351364|NCT00002998|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111351365|NCT00002998|Antimetabolites|antimetabolites|mesh-ancestor
111351366|NCT00002998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111351367|NCT00003004|Paclitaxel|paclitaxel|mesh-list
111351368|NCT00003004|Alvocidib|alvocidib|mesh-list
111351369|NCT00003004|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111351370|NCT00003004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111351371|NCT00003004|Tubulin Modulators|tubulin modulators|mesh-ancestor
111351372|NCT00003004|Antimitotic Agents|antimitotic agents|mesh-ancestor
111351373|NCT00003004|Mitosis Modulators|mitosis modulators|mesh-ancestor
111351374|NCT00003004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111351375|NCT00003004|Growth Inhibitors|growth inhibitors|mesh-ancestor
110764172|NCT01345175|Metronidazole|metronidazole|mesh-list
111351376|NCT00003004|Growth Substances|growth substances|mesh-ancestor
111351377|NCT00003004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111351378|NCT00003004|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111351379|NCT00003004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111351380|NCT04776512|Bupivacaine|bupivacaine|mesh-list
111351381|NCT04776512|Anesthetics, Local|anesthetics, local|mesh-ancestor
111351382|NCT04776512|Anesthetics|anesthetics|mesh-ancestor
111351383|NCT04776512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111351384|NCT04776512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111351385|NCT04776512|Sensory System Agents|sensory system agents|mesh-ancestor
111351386|NCT04776512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111351387|NCT04776590|Tislelizumab|tislelizumab|mesh-list
111351388|NCT04776590|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111351389|NCT04776590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111351390|NCT00003436|Cytarabine|cytarabine|mesh-list
111351391|NCT00003436|Hydrocortisone|hydrocortisone|mesh-list
111351392|NCT00003436|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
111351393|NCT00003436|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
111351394|NCT00003436|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
111351395|NCT00003436|Methotrexate|methotrexate|mesh-list
111351396|NCT00003436|Etoposide|etoposide|mesh-list
111351397|NCT00003436|Daunorubicin|daunorubicin|mesh-list
111351398|NCT00003436|Asparaginase|asparaginase|mesh-list
111351399|NCT00003436|Mitoxantrone|mitoxantrone|mesh-list
111351400|NCT00003436|Amsacrine|amsacrine|mesh-list
111351401|NCT00003436|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111351402|NCT00003436|Abortifacient Agents|abortifacient agents|mesh-ancestor
111351403|NCT00003436|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111351404|NCT00003436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111351405|NCT00003436|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111351406|NCT00003436|Antimetabolites|antimetabolites|mesh-ancestor
111351407|NCT00003436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111351408|NCT00003436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111351409|NCT00003436|Dermatologic Agents|dermatologic agents|mesh-ancestor
111351410|NCT00003436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111351411|NCT00003436|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111351412|NCT00003436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111351413|NCT00003436|Immunologic Factors|immunologic factors|mesh-ancestor
111351414|NCT00003436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111351415|NCT00003436|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111351416|NCT00003436|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111351417|NCT00003436|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111351418|NCT00003436|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111351419|NCT00003436|Antiviral Agents|antiviral agents|mesh-ancestor
111351420|NCT00003436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111351421|NCT00003436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111351422|NCT00003436|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111351423|NCT00003436|Analgesics|analgesics|mesh-ancestor
111351424|NCT00003436|Sensory System Agents|sensory system agents|mesh-ancestor
111351425|NCT00003436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111075787|NCT03424291|Apatinib|apatinib|mesh-list
111351426|NCT02432378|Celecoxib|celecoxib|mesh-list
111351427|NCT02432378|Cisplatin|cisplatin|mesh-list
111351428|NCT02432378|Vaccines|vaccines|mesh-list
111351429|NCT02432378|Immunologic Factors|immunologic factors|mesh-ancestor
111351430|NCT02432378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111351431|NCT02432378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111351432|NCT02432378|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111351433|NCT02432378|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111351434|NCT02432378|Analgesics|analgesics|mesh-ancestor
111351435|NCT02432378|Sensory System Agents|sensory system agents|mesh-ancestor
111351436|NCT02432378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111351437|NCT02432378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111351438|NCT02432378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111351439|NCT02432378|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110764551|NCT00203021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111351440|NCT02432378|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111351441|NCT02432378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111351442|NCT02432378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111351443|NCT00003466|Temozolomide|temozolomide|mesh-list
111351444|NCT00003466|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111351445|NCT00003466|Alkylating Agents|alkylating agents|mesh-ancestor
111351446|NCT00003466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111351447|NCT00003466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111351448|NCT00003478|Antibodies|antibodies|mesh-list
111351449|NCT00003478|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111351450|NCT00003478|Immunologic Factors|immunologic factors|mesh-ancestor
111351451|NCT00003478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111351452|NCT00003016|Tamoxifen|tamoxifen|mesh-list
111351453|NCT00003016|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111351454|NCT00003016|Hormone Antagonists|hormone antagonists|mesh-ancestor
111351455|NCT00003016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111351456|NCT00003016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111351457|NCT00003016|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111351458|NCT00003016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111351459|NCT00003016|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111351460|NCT00003016|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111351461|NCT00003016|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111351462|NCT00003022|Antibodies|antibodies|mesh-list
111351463|NCT00003022|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111351464|NCT00003022|Immunologic Factors|immunologic factors|mesh-ancestor
111351465|NCT00003022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111351466|NCT01258387|Mitogens|mitogens|mesh-list
111351467|NCT01258387|Mitosis Modulators|mitosis modulators|mesh-ancestor
111351468|NCT01258387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111351469|NCT00003484|Irinotecan|irinotecan|mesh-list
111351470|NCT00003484|Carmustine|carmustine|mesh-list
111351471|NCT00003484|Antibodies|antibodies|mesh-list
111351472|NCT00003484|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111351473|NCT00003484|Immunologic Factors|immunologic factors|mesh-ancestor
111351474|NCT00003484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111351475|NCT00003484|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111351476|NCT00003484|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111351477|NCT00003484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111351478|NCT00003484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111351479|NCT00003484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110764737|NCT00468130|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111351480|NCT00003484|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111351481|NCT00003484|Alkylating Agents|alkylating agents|mesh-ancestor
111351482|NCT00003490|Prednisone|prednisone|mesh-list
111351483|NCT00003490|Cyclophosphamide|cyclophosphamide|mesh-list
111351484|NCT00003490|Vincristine|vincristine|mesh-list
111351485|NCT00003490|Sargramostim|sargramostim|mesh-list
111351486|NCT00003490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111351487|NCT00003490|Immunologic Factors|immunologic factors|mesh-ancestor
111351488|NCT00003490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111351489|NCT00003490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111351490|NCT00003490|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111351491|NCT00003490|Alkylating Agents|alkylating agents|mesh-ancestor
111351492|NCT00003490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111351493|NCT00003490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111351494|NCT00003490|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111351495|NCT00003490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111351496|NCT00003490|Glucocorticoids|glucocorticoids|mesh-ancestor
111351497|NCT00003490|Hormones|hormones|mesh-ancestor
111351498|NCT00003490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111075862|NCT05170217|Cannabidiol|cannabidiol|mesh-list
111351499|NCT00003490|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111351500|NCT00003490|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111351501|NCT00003490|Tubulin Modulators|tubulin modulators|mesh-ancestor
111351502|NCT00003490|Antimitotic Agents|antimitotic agents|mesh-ancestor
111351503|NCT00003490|Mitosis Modulators|mitosis modulators|mesh-ancestor
111351504|NCT00003034|Doxorubicin|doxorubicin|mesh-list
111351505|NCT00003034|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111351506|NCT00003034|Ranpirnase|ranpirnase|mesh-list
111351507|NCT00003034|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111351508|NCT00003034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111351509|NCT00003034|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111351510|NCT00003034|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111351511|NCT00003034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111351512|NCT00003034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111351513|NCT00003034|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111351514|NCT00383890|Dexmedetomidine|dexmedetomidine|mesh-list
111351515|NCT00383890|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111351516|NCT00383890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111351517|NCT00383890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111351518|NCT00383890|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111351519|NCT00383890|Analgesics|analgesics|mesh-ancestor
111351520|NCT00383890|Sensory System Agents|sensory system agents|mesh-ancestor
111351521|NCT00383890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111351522|NCT00383890|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111351523|NCT00383890|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111351524|NCT00383890|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111351525|NCT00383890|Adrenergic Agents|adrenergic agents|mesh-ancestor
111351526|NCT00383890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111351527|NCT00383890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111351528|NCT00003046|Interleukin-12|interleukin-12|mesh-list
111351529|NCT00003046|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111351530|NCT00003046|Immunologic Factors|immunologic factors|mesh-ancestor
111351531|NCT00003046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111351532|NCT00003046|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111351533|NCT00003046|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111351534|NCT00003046|Growth Substances|growth substances|mesh-ancestor
111351535|NCT00003046|Growth Inhibitors|growth inhibitors|mesh-ancestor
111351536|NCT00003046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111351537|NCT00003052|Doxorubicin|doxorubicin|mesh-list
111351538|NCT00003052|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111351539|NCT00003052|Etoposide|etoposide|mesh-list
111351540|NCT00003052|Ifosfamide|ifosfamide|mesh-list
111351541|NCT00003052|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111351542|NCT00003052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111351543|NCT00003052|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111351544|NCT00003052|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111351545|NCT00003052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111351546|NCT00003052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111351547|NCT00003052|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110765206|NCT01148472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111351548|NCT00003052|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111351549|NCT00003052|Alkylating Agents|alkylating agents|mesh-ancestor
111351550|NCT00003058|Troglitazone|troglitazone|mesh-list
111351551|NCT00003058|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111351552|NCT00003058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111351553|NCT04775732|Infliximab|infliximab|mesh-list
111351554|NCT04775732|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111351555|NCT04775732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111351556|NCT04775732|Dermatologic Agents|dermatologic agents|mesh-ancestor
111351557|NCT04775732|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111351558|NCT04775732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111351559|NCT04754750|Paliperidone Palmitate|paliperidone palmitate|mesh-list
111351560|NCT04754750|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111351561|NCT04754750|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111351562|NCT04754750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111351563|NCT04754750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111351564|NCT04754750|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111351565|NCT04754750|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111351566|NCT04754750|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111351567|NCT04754750|Serotonin Agents|serotonin agents|mesh-ancestor
111351568|NCT04754750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111351569|NCT04754750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110765555|NCT03898128|Immunoconjugates|immunoconjugates|mesh-ancestor
111351570|NCT04754750|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111351571|NCT04754750|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111351572|NCT04754750|Dopamine Agents|dopamine agents|mesh-ancestor
111351573|NCT00003064|Paclitaxel|paclitaxel|mesh-list
111075953|NCT03394105|Docetaxel|docetaxel|mesh-list
111351574|NCT00003064|Etoposide|etoposide|mesh-list
111351575|NCT00003064|Carboplatin|carboplatin|mesh-list
111351576|NCT00003064|Topotecan|topotecan|mesh-list
111351577|NCT00003064|Thiotepa|thiotepa|mesh-list
111351578|NCT00003064|Etoposide phosphate|etoposide phosphate|mesh-list
111351579|NCT00003064|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111351580|NCT00003064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111351581|NCT00003064|Tubulin Modulators|tubulin modulators|mesh-ancestor
111351582|NCT00003064|Antimitotic Agents|antimitotic agents|mesh-ancestor
111351583|NCT00003064|Mitosis Modulators|mitosis modulators|mesh-ancestor
111351584|NCT00003064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111351585|NCT00003064|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111351586|NCT00003064|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111351587|NCT00003064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111351588|NCT00003064|Immunologic Factors|immunologic factors|mesh-ancestor
111351589|NCT00003064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111351590|NCT00003064|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111351591|NCT00003064|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111351592|NCT00003064|Alkylating Agents|alkylating agents|mesh-ancestor
111351593|NCT00003064|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111351594|NCT00003064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111351595|NCT00003544|Irinotecan|irinotecan|mesh-list
111351596|NCT00003544|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111351597|NCT00003544|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111351598|NCT00003544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111351599|NCT00003544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111351600|NCT00003544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111351601|NCT03475394|Chlorhexidine|chlorhexidine|mesh-list
111351602|NCT03475394|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111351603|NCT03475394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111351604|NCT03475394|Disinfectants|disinfectants|mesh-ancestor
111351605|NCT01269424|Temozolomide|temozolomide|mesh-list
111351606|NCT01269424|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
111351607|NCT01269424|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111351608|NCT01269424|Alkylating Agents|alkylating agents|mesh-ancestor
111351609|NCT01269424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111351610|NCT01269424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111351611|NCT01269424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111351612|NCT03395912|Anesthetics|anesthetics|mesh-list
111351613|NCT03395912|Anesthetics, Local|anesthetics, local|mesh-list
111351614|NCT03395912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111351615|NCT03395912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111351616|NCT03395912|Sensory System Agents|sensory system agents|mesh-ancestor
111351617|NCT03395912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111351618|NCT00384436|Escitalopram|escitalopram|mesh-list
111351619|NCT00384436|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111351620|NCT00384436|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110765878|NCT05941585|Analgesics|analgesics|mesh-ancestor
111351621|NCT00384436|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111351622|NCT00384436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111351623|NCT00384436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111351624|NCT00384436|Serotonin Agents|serotonin agents|mesh-ancestor
111351625|NCT00384436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111351626|NCT00003562|Carboplatin|carboplatin|mesh-list
111351627|NCT00003562|Docetaxel|docetaxel|mesh-list
110766022|NCT05903859|Probenecid|probenecid|mesh-list
111351628|NCT00003562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111351629|NCT00003562|Tubulin Modulators|tubulin modulators|mesh-ancestor
111351630|NCT00003562|Antimitotic Agents|antimitotic agents|mesh-ancestor
111351631|NCT00003562|Mitosis Modulators|mitosis modulators|mesh-ancestor
111351632|NCT00003562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111351633|NCT04775576|Anesthetics|anesthetics|mesh-list
111351634|NCT04775576|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111351635|NCT04775576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111351636|NCT00003568|Aldesleukin|aldesleukin|mesh-list
111351637|NCT00003568|Freund's Adjuvant|freund's adjuvant|mesh-list
111351638|NCT00003568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111351639|NCT00003568|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111351640|NCT00003568|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111351641|NCT00003568|Antiviral Agents|antiviral agents|mesh-ancestor
111351642|NCT00003568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111351643|NCT00003568|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111351644|NCT00003568|Immunologic Factors|immunologic factors|mesh-ancestor
111351645|NCT00003568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111351646|NCT00003070|Enalapril|enalapril|mesh-list
111351647|NCT00003070|Enalaprilat|enalaprilat|mesh-list
111351648|NCT00003070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111479264|NCT05091346|Lenvatinib|lenvatinib|mesh-list
111351649|NCT00003070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111351650|NCT00003070|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
111351651|NCT00003070|Protease Inhibitors|protease inhibitors|mesh-ancestor
111351652|NCT00003070|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111351653|NCT00003076|Eflornithine|eflornithine|mesh-list
111351654|NCT00003076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111351655|NCT00003076|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
111351656|NCT00003076|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111351657|NCT00003076|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111351658|NCT00003076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110766450|NCT04631510|Anticonvulsants|anticonvulsants|mesh-ancestor
111351659|NCT00003076|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
111351660|NCT00003076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111351661|NCT00003076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111351662|NCT01896518|Nicotine|nicotine|mesh-list
111351663|NCT01896518|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111351664|NCT01896518|Autonomic Agents|autonomic agents|mesh-ancestor
111351665|NCT01896518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111351666|NCT01896518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111351667|NCT01896518|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111351668|NCT01896518|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111351669|NCT01896518|Cholinergic Agents|cholinergic agents|mesh-ancestor
111351670|NCT01896518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111351671|NCT01896518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111351672|NCT00003082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111351673|NCT00003082|Antibodies|antibodies|mesh-list
111351674|NCT00003082|Immunoglobulins|immunoglobulins|mesh-list
111351675|NCT00003082|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111351676|NCT00003082|Immunologic Factors|immunologic factors|mesh-ancestor
111351677|NCT00003082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111351678|NCT00003082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111351679|NCT00003088|Paclitaxel|paclitaxel|mesh-list
111351680|NCT00003088|Cyclophosphamide|cyclophosphamide|mesh-list
111351681|NCT00003088|Doxorubicin|doxorubicin|mesh-list
111351682|NCT00003088|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111351683|NCT00003088|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111351684|NCT00003088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111351685|NCT00003088|Tubulin Modulators|tubulin modulators|mesh-ancestor
111351686|NCT00003088|Antimitotic Agents|antimitotic agents|mesh-ancestor
111351687|NCT00003088|Mitosis Modulators|mitosis modulators|mesh-ancestor
111351688|NCT00003088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111351689|NCT00003088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111351690|NCT00003088|Immunologic Factors|immunologic factors|mesh-ancestor
111351691|NCT00003088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111351692|NCT00003088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111351693|NCT00003088|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111351694|NCT00003088|Alkylating Agents|alkylating agents|mesh-ancestor
111351695|NCT00003088|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111351696|NCT00003088|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111351697|NCT00003088|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111351698|NCT00003088|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111351699|NCT00003088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111351700|NCT04775030|Salicylic Acid|salicylic acid|mesh-list
111351701|NCT04775030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111351702|NCT04775030|Antifungal Agents|antifungal agents|mesh-ancestor
111351703|NCT04775030|Keratolytic Agents|keratolytic agents|mesh-ancestor
111351704|NCT04775030|Dermatologic Agents|dermatologic agents|mesh-ancestor
111351705|NCT05423210|Atezolizumab|atezolizumab|mesh-list
111351706|NCT05423210|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111351707|NCT05423210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111351708|NCT05423210|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111351709|NCT05423210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111351710|NCT00755560|Albendazole|albendazole|mesh-list
111351711|NCT00755560|Anthelmintics|anthelmintics|mesh-ancestor
111351712|NCT00755560|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111351713|NCT00755560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111351714|NCT00755560|Anticestodal Agents|anticestodal agents|mesh-ancestor
111351715|NCT00755560|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
111351716|NCT00755560|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111351717|NCT00755560|Tubulin Modulators|tubulin modulators|mesh-ancestor
111351718|NCT00755560|Antimitotic Agents|antimitotic agents|mesh-ancestor
111351719|NCT00755560|Mitosis Modulators|mitosis modulators|mesh-ancestor
111351720|NCT00755560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111351721|NCT00755560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111351722|NCT05405894|Zoledronic Acid|zoledronic acid|mesh-list
111351723|NCT05405894|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111351724|NCT05405894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111351725|NCT00003118|Fluorouracil|fluorouracil|mesh-list
111351726|NCT00003118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111351727|NCT00003118|Antimetabolites|antimetabolites|mesh-ancestor
111351728|NCT00003118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111351729|NCT00003118|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111351730|NCT00003118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111351731|NCT00003118|Immunologic Factors|immunologic factors|mesh-ancestor
111351732|NCT00003118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111351733|NCT00003124|Leuprolide|leuprolide|mesh-list
111351734|NCT00003124|Flutamide|flutamide|mesh-list
111351735|NCT00003124|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111351736|NCT00003124|Fertility Agents|fertility agents|mesh-ancestor
111351737|NCT00003124|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111351738|NCT00003124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111351739|NCT00003124|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111351740|NCT00003124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111351741|NCT00003124|Androgen Antagonists|androgen antagonists|mesh-ancestor
111351742|NCT00003124|Hormone Antagonists|hormone antagonists|mesh-ancestor
111351743|NCT00003124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111351744|NCT00003580|Amifostine|amifostine|mesh-list
111351745|NCT00003580|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111351746|NCT00003580|Protective Agents|protective agents|mesh-ancestor
111351747|NCT00003580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111351748|NCT00056498|Risperidone|risperidone|mesh-list
111351749|NCT00056498|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111351750|NCT00056498|Serotonin Agents|serotonin agents|mesh-ancestor
111351751|NCT00056498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111351752|NCT00056498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111351753|NCT00056498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111351754|NCT00056498|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111351755|NCT00056498|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111351756|NCT00056498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111351757|NCT00056498|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111351758|NCT00056498|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111351759|NCT00056498|Dopamine Agents|dopamine agents|mesh-ancestor
111351760|NCT04330144|Hydroxychloroquine|hydroxychloroquine|mesh-list
111351761|NCT04330144|Antimalarials|antimalarials|mesh-ancestor
111351762|NCT04330144|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111351763|NCT04330144|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111351764|NCT04330144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111351765|NCT04330144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111351766|NCT04330144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111351767|NCT04330144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111351768|NCT00003130|Paclitaxel|paclitaxel|mesh-list
110766960|NCT02427568|Hallucinogens|hallucinogens|mesh-ancestor
111351769|NCT00003130|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111351770|NCT00003130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111351771|NCT00003130|Tubulin Modulators|tubulin modulators|mesh-ancestor
111351772|NCT00003130|Antimitotic Agents|antimitotic agents|mesh-ancestor
111351773|NCT00003130|Mitosis Modulators|mitosis modulators|mesh-ancestor
111351774|NCT00003130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111351775|NCT00058370|Vincristine|vincristine|mesh-list
111351776|NCT00058370|Lomustine|lomustine|mesh-list
111351777|NCT00058370|Antibodies|antibodies|mesh-list
111351778|NCT00058370|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111351779|NCT00058370|Immunologic Factors|immunologic factors|mesh-ancestor
111351780|NCT00058370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111351781|NCT00058370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110767017|NCT01951339|Immunologic Factors|immunologic factors|mesh-ancestor
111351782|NCT00058370|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111351783|NCT00058370|Tubulin Modulators|tubulin modulators|mesh-ancestor
111351784|NCT00058370|Antimitotic Agents|antimitotic agents|mesh-ancestor
111351785|NCT00058370|Mitosis Modulators|mitosis modulators|mesh-ancestor
111351786|NCT00058370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111351787|NCT00058370|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111351788|NCT00058370|Alkylating Agents|alkylating agents|mesh-ancestor
111351789|NCT00059228|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
111351790|NCT00059228|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
111351791|NCT00059228|Estradiol|estradiol|mesh-list
111351792|NCT00059228|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
111351793|NCT00059228|Estrogens|estrogens|mesh-ancestor
111351794|NCT00059228|Hormones|hormones|mesh-ancestor
111351795|NCT00059228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111351796|NCT00059228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111351797|NCT00059228|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111076158|NCT03399487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111351798|NCT00059228|Contraceptive Agents|contraceptive agents|mesh-ancestor
110767080|NCT01793610|Hallucinogens|hallucinogens|mesh-ancestor
111351799|NCT00059228|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111351800|NCT00059228|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111351801|NCT00060008|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
111351802|NCT00060008|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111351803|NCT00060008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111351804|NCT00062738|Paroxetine|paroxetine|mesh-list
111351805|NCT00062738|Nortriptyline|nortriptyline|mesh-list
111351806|NCT00062738|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111351807|NCT00062738|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111351808|NCT00062738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111351809|NCT00062738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111351810|NCT00062738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111351811|NCT00062738|Serotonin Agents|serotonin agents|mesh-ancestor
111351812|NCT00062738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111351813|NCT00062738|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111351814|NCT00062738|Antidepressive Agents|antidepressive agents|mesh-ancestor
111351815|NCT00062738|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111351816|NCT00062738|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111351817|NCT00062738|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111351818|NCT00062738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111351819|NCT00062738|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
111351820|NCT00062738|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111351821|NCT00062738|Adrenergic Agents|adrenergic agents|mesh-ancestor
111351822|NCT00063362|Lamotrigine|lamotrigine|mesh-list
111351823|NCT00063362|Valproic Acid|valproic acid|mesh-list
111351824|NCT00063362|Lithium Carbonate|lithium carbonate|mesh-list
111351825|NCT00063362|Antidepressive Agents|antidepressive agents|mesh-ancestor
111351826|NCT00063362|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111351827|NCT00063362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111351828|NCT00063362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111351829|NCT00063362|Antimanic Agents|antimanic agents|mesh-ancestor
111351830|NCT00063362|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111351831|NCT00063362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111351832|NCT00063362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111351833|NCT00063362|Anticonvulsants|anticonvulsants|mesh-ancestor
111351834|NCT00063362|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111351835|NCT00063362|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111351836|NCT00063362|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111351837|NCT00063362|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111351838|NCT00063362|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111351839|NCT00063362|GABA Agents|gaba agents|mesh-ancestor
111351840|NCT00063362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111351841|NCT00064844|Nicotine|nicotine|mesh-list
111351842|NCT00064844|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111351843|NCT00064844|Autonomic Agents|autonomic agents|mesh-ancestor
111351844|NCT00064844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111351845|NCT00064844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111351846|NCT00064844|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111351847|NCT00064844|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111351848|NCT00064844|Cholinergic Agents|cholinergic agents|mesh-ancestor
111351849|NCT00064844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111351850|NCT00064844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111351851|NCT02668562|Ticagrelor|ticagrelor|mesh-list
111351852|NCT02668562|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111351853|NCT02668562|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111351854|NCT02668562|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111351855|NCT02668562|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111351856|NCT02668562|Purinergic Agents|purinergic agents|mesh-ancestor
111351857|NCT02668562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111351858|NCT02668562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110767470|NCT01589562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111351859|NCT02668562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111351860|NCT00067028|Cytarabine|cytarabine|mesh-list
111351861|NCT00067028|Clofarabine|clofarabine|mesh-list
111351862|NCT00067028|Idarubicin|idarubicin|mesh-list
111351863|NCT00067028|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111351864|NCT00067028|Antimetabolites|antimetabolites|mesh-ancestor
110767536|NCT01153854|Antidiarrheals|antidiarrheals|mesh-ancestor
111351865|NCT00067028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111351866|NCT00067028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111351867|NCT00067028|Antiviral Agents|antiviral agents|mesh-ancestor
111351868|NCT00067028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111351869|NCT00067028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110959202|NCT01025505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111351870|NCT00067028|Immunologic Factors|immunologic factors|mesh-ancestor
111351871|NCT00067028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111351872|NCT00067028|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111351873|NCT00067028|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111351874|NCT00067028|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111351875|NCT00067028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111351876|NCT00067808|Decitabine|decitabine|mesh-list
111351877|NCT00067808|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111351878|NCT00067808|Antimetabolites|antimetabolites|mesh-ancestor
111351879|NCT00067808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111351880|NCT00067808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111351881|NCT00067808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111351882|NCT05174312|Diuretics|diuretics|mesh-list
111351883|NCT05174312|Natriuretic Agents|natriuretic agents|mesh-ancestor
111351884|NCT05174312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111351885|NCT00493870|Cyclophosphamide|cyclophosphamide|mesh-list
111351886|NCT00493870|Docetaxel|docetaxel|mesh-list
111351887|NCT00493870|Doxorubicin|doxorubicin|mesh-list
111351888|NCT00493870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111351889|NCT00493870|Immunologic Factors|immunologic factors|mesh-ancestor
111351890|NCT00493870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111351891|NCT00493870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111351892|NCT00493870|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111351893|NCT00493870|Alkylating Agents|alkylating agents|mesh-ancestor
111351894|NCT00493870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111351895|NCT00493870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111351896|NCT00493870|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111351897|NCT00493870|Tubulin Modulators|tubulin modulators|mesh-ancestor
111351898|NCT00493870|Antimitotic Agents|antimitotic agents|mesh-ancestor
111351899|NCT00493870|Mitosis Modulators|mitosis modulators|mesh-ancestor
111351900|NCT00493870|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111351901|NCT00493870|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111351902|NCT00493870|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111351903|NCT00493870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111351904|NCT03287336|Tranexamic Acid|tranexamic acid|mesh-list
111351905|NCT03287336|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111351906|NCT03287336|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111351907|NCT03287336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111351908|NCT03287336|Hemostatics|hemostatics|mesh-ancestor
111351909|NCT03287336|Coagulants|coagulants|mesh-ancestor
111351910|NCT00003136|Cyclophosphamide|cyclophosphamide|mesh-list
111351911|NCT00003136|Carboplatin|carboplatin|mesh-list
111351912|NCT00003136|Amifostine|amifostine|mesh-list
111351913|NCT00003136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111351914|NCT00003136|Immunologic Factors|immunologic factors|mesh-ancestor
111351915|NCT00003136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111351916|NCT00003136|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110767935|NCT03880968|Etanercept|etanercept|mesh-list
111351917|NCT00003136|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111351918|NCT00003136|Alkylating Agents|alkylating agents|mesh-ancestor
111351919|NCT00003136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111351920|NCT00003136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111351921|NCT00003136|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111351922|NCT00003136|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111351923|NCT00003136|Protective Agents|protective agents|mesh-ancestor
111351924|NCT00003598|Tretinoin|tretinoin|mesh-list
111351925|NCT00003598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111351926|NCT00003598|Keratolytic Agents|keratolytic agents|mesh-ancestor
111351927|NCT00003598|Dermatologic Agents|dermatologic agents|mesh-ancestor
111351928|NCT00003604|Aldesleukin|aldesleukin|mesh-list
111351929|NCT00003604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111351930|NCT00003604|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111351931|NCT00003604|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111351932|NCT00003604|Antiviral Agents|antiviral agents|mesh-ancestor
111351933|NCT00003604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111351934|NCT00002794|Carboplatin|carboplatin|mesh-list
111351935|NCT00002794|Vincristine|vincristine|mesh-list
111351936|NCT00002794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111351937|NCT00002794|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111351938|NCT00002794|Tubulin Modulators|tubulin modulators|mesh-ancestor
111351939|NCT00002794|Antimitotic Agents|antimitotic agents|mesh-ancestor
111351940|NCT00002794|Mitosis Modulators|mitosis modulators|mesh-ancestor
111351941|NCT00002794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111351942|NCT00003610|Capsaicin|capsaicin|mesh-list
111351943|NCT00003610|Antipruritics|antipruritics|mesh-ancestor
111351944|NCT00003610|Dermatologic Agents|dermatologic agents|mesh-ancestor
111351945|NCT00003610|Sensory System Agents|sensory system agents|mesh-ancestor
111351946|NCT00003610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110768053|NCT03878784|Sumatriptan|sumatriptan|mesh-list
111351947|NCT00003610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111351948|NCT00003616|Irinotecan|irinotecan|mesh-list
111351949|NCT00003616|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111351950|NCT00003616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111351951|NCT00003616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111351952|NCT00003616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111351953|NCT00003616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111351954|NCT01063829|Letermovir|letermovir|mesh-list
111351955|NCT01063829|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111351956|NCT01063829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111351957|NCT01063829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111351958|NCT01063829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111351959|NCT01063829|Antiviral Agents|antiviral agents|mesh-ancestor
111351960|NCT01063829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111351961|NCT00072566|Cyclophosphamide|cyclophosphamide|mesh-list
111351962|NCT00072566|Bevacizumab|bevacizumab|mesh-list
111351963|NCT00072566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111351964|NCT00072566|Antibodies|antibodies|mesh-list
111351965|NCT00072566|Immunoglobulins|immunoglobulins|mesh-list
111351966|NCT00072566|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111351967|NCT00072566|Immunoglobulin G|immunoglobulin g|mesh-list
111351968|NCT00072566|Endothelial Growth Factors|endothelial growth factors|mesh-list
111351969|NCT00072566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111351970|NCT00072566|Immunologic Factors|immunologic factors|mesh-ancestor
111351971|NCT00072566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111351972|NCT00072566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111351973|NCT00072566|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111351974|NCT00072566|Alkylating Agents|alkylating agents|mesh-ancestor
111351975|NCT00072566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111351976|NCT00072566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111351977|NCT00072566|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111351978|NCT00072566|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111351979|NCT00072566|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111351980|NCT00072566|Growth Substances|growth substances|mesh-ancestor
111351981|NCT00072566|Growth Inhibitors|growth inhibitors|mesh-ancestor
111351982|NCT00003622|Paclitaxel|paclitaxel|mesh-list
111351983|NCT00003622|Vinorelbine|vinorelbine|mesh-list
111351984|NCT00003622|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111351985|NCT00003622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111351986|NCT00003622|Tubulin Modulators|tubulin modulators|mesh-ancestor
111351987|NCT00003622|Antimitotic Agents|antimitotic agents|mesh-ancestor
111351988|NCT00003622|Mitosis Modulators|mitosis modulators|mesh-ancestor
111351989|NCT00003622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111351990|NCT00003148|Aldesleukin|aldesleukin|mesh-list
111351991|NCT00003148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111351992|NCT00003148|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111351993|NCT00003148|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111351994|NCT00003148|Antiviral Agents|antiviral agents|mesh-ancestor
111351995|NCT00003148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111351996|NCT00384046|Testosterone|testosterone|mesh-list
111351997|NCT00384046|Androgens|androgens|mesh-ancestor
111351998|NCT00384046|Hormones|hormones|mesh-ancestor
111351999|NCT00384046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111352000|NCT00384046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111352001|NCT00002800|Cytarabine|cytarabine|mesh-list
111352002|NCT00002800|Etoposide|etoposide|mesh-list
111352003|NCT00002800|Idarubicin|idarubicin|mesh-list
111352004|NCT00002800|Lintuzumab|lintuzumab|mesh-list
111352005|NCT00002800|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111352006|NCT00002800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111352007|NCT00002800|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111352008|NCT00002800|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111352009|NCT00002800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111352010|NCT00002800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111352011|NCT00002800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111352012|NCT00002800|Antimetabolites|antimetabolites|mesh-ancestor
111352013|NCT00002800|Antiviral Agents|antiviral agents|mesh-ancestor
111352014|NCT00002800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111352015|NCT00002800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111352016|NCT00002800|Immunologic Factors|immunologic factors|mesh-ancestor
111352017|NCT00002800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111352018|NCT00002800|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111352019|NCT00002800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111352020|NCT05061992|Lactulose|lactulose|mesh-list
111352021|NCT05061992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111352022|NCT00002806|Vincristine|vincristine|mesh-list
111352023|NCT00002806|Lomustine|lomustine|mesh-list
111352024|NCT00002806|Procarbazine|procarbazine|mesh-list
111352025|NCT00002806|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111352026|NCT00002806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111352027|NCT00002806|Tubulin Modulators|tubulin modulators|mesh-ancestor
111352028|NCT00002806|Antimitotic Agents|antimitotic agents|mesh-ancestor
111352029|NCT00002806|Mitosis Modulators|mitosis modulators|mesh-ancestor
111352030|NCT00002806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111352031|NCT00002806|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111352032|NCT00002806|Alkylating Agents|alkylating agents|mesh-ancestor
111352033|NCT00003160|Paclitaxel|paclitaxel|mesh-list
111352034|NCT00003160|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111352035|NCT00003160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111352036|NCT00003160|Tubulin Modulators|tubulin modulators|mesh-ancestor
111352037|NCT00003160|Antimitotic Agents|antimitotic agents|mesh-ancestor
111352038|NCT00003160|Mitosis Modulators|mitosis modulators|mesh-ancestor
111352039|NCT00003160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111352040|NCT00002812|Cytarabine|cytarabine|mesh-list
111352041|NCT00002812|Dexamethasone|dexamethasone|mesh-list
111352042|NCT00002812|Prednisone|prednisone|mesh-list
111352043|NCT00002812|Cyclophosphamide|cyclophosphamide|mesh-list
111352044|NCT00002812|Doxorubicin|doxorubicin|mesh-list
111352045|NCT00002812|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111352046|NCT00002812|Methotrexate|methotrexate|mesh-list
111352047|NCT00002812|Vincristine|vincristine|mesh-list
111352048|NCT00002812|Daunorubicin|daunorubicin|mesh-list
111352049|NCT00002812|Asparaginase|asparaginase|mesh-list
111352050|NCT00002812|Mercaptopurine|mercaptopurine|mesh-list
111352051|NCT00002812|Idarubicin|idarubicin|mesh-list
111352052|NCT00002812|Pegaspargase|pegaspargase|mesh-list
111352053|NCT00002812|Thioguanine|thioguanine|mesh-list
111352054|NCT00002812|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111352055|NCT00002812|Immunologic Factors|immunologic factors|mesh-ancestor
111352056|NCT00002812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111352057|NCT00002812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111352058|NCT00002812|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111352059|NCT00002812|Alkylating Agents|alkylating agents|mesh-ancestor
111352060|NCT00002812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111352061|NCT00002812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111352062|NCT00002812|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111352063|NCT00002812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111352064|NCT00002812|Antiemetics|antiemetics|mesh-ancestor
111352065|NCT00002812|Autonomic Agents|autonomic agents|mesh-ancestor
111352066|NCT00002812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111352067|NCT00002812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111352068|NCT00002812|Glucocorticoids|glucocorticoids|mesh-ancestor
111352069|NCT00002812|Hormones|hormones|mesh-ancestor
111352070|NCT00002812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111352071|NCT00002812|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111352072|NCT00002812|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111352073|NCT00002812|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111352074|NCT00002812|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111352075|NCT00002812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111352076|NCT00002812|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111352077|NCT00002812|Abortifacient Agents|abortifacient agents|mesh-ancestor
111352078|NCT00002812|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111352079|NCT00002812|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111352080|NCT00002812|Antimetabolites|antimetabolites|mesh-ancestor
111352081|NCT00002812|Dermatologic Agents|dermatologic agents|mesh-ancestor
111352082|NCT00002812|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111352083|NCT00002812|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111352084|NCT00002812|Antiviral Agents|antiviral agents|mesh-ancestor
111352085|NCT00002812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111352086|NCT00002812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111352087|NCT00002812|Tubulin Modulators|tubulin modulators|mesh-ancestor
111352088|NCT00002812|Antimitotic Agents|antimitotic agents|mesh-ancestor
111352089|NCT00002812|Mitosis Modulators|mitosis modulators|mesh-ancestor
111352090|NCT01258855|Aldesleukin|aldesleukin|mesh-list
111352091|NCT01258855|Aflibercept|aflibercept|mesh-list
111352092|NCT01258855|Interleukin-2|interleukin-2|mesh-list
111352093|NCT01258855|Endothelial Growth Factors|endothelial growth factors|mesh-list
111352094|NCT01258855|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111352095|NCT01258855|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111352096|NCT01258855|Growth Substances|growth substances|mesh-ancestor
111352097|NCT01258855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111352098|NCT01258855|Growth Inhibitors|growth inhibitors|mesh-ancestor
111352099|NCT01258855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111352100|NCT01258855|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111352101|NCT01258855|Analgesics|analgesics|mesh-ancestor
111352103|NCT01258855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111352104|NCT01258855|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111352105|NCT01258855|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111352106|NCT01258855|Antiviral Agents|antiviral agents|mesh-ancestor
111352107|NCT01258855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111352108|NCT00003166|Vincristine|vincristine|mesh-list
111352109|NCT00003166|Bryostatin 1|bryostatin 1|mesh-list
111352110|NCT00003166|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111352111|NCT00003166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111352112|NCT00003166|Tubulin Modulators|tubulin modulators|mesh-ancestor
111352113|NCT00003166|Antimitotic Agents|antimitotic agents|mesh-ancestor
111352114|NCT00003166|Mitosis Modulators|mitosis modulators|mesh-ancestor
111352115|NCT00003166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111352116|NCT00003166|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111352117|NCT00003166|Immunologic Factors|immunologic factors|mesh-ancestor
111352118|NCT00003166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111352119|NCT00003172|Interferons|interferons|mesh-list
111352120|NCT00003172|Interferon-alpha|interferon-alpha|mesh-list
111352121|NCT00003172|Docetaxel|docetaxel|mesh-list
111352122|NCT00003172|Doxorubicin|doxorubicin|mesh-list
111352123|NCT00003172|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111352124|NCT00003172|Fluorouracil|fluorouracil|mesh-list
111352125|NCT00003172|Hydroxyurea|hydroxyurea|mesh-list
111352126|NCT00003172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110768492|NCT01280526|Romidepsin|romidepsin|mesh-list
111352127|NCT00003172|Tubulin Modulators|tubulin modulators|mesh-ancestor
111352128|NCT00003172|Antimitotic Agents|antimitotic agents|mesh-ancestor
111352129|NCT00003172|Mitosis Modulators|mitosis modulators|mesh-ancestor
111352130|NCT00003172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111352131|NCT00003172|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111352132|NCT00003172|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111352133|NCT00003172|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111352134|NCT00003172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111352135|NCT00003172|Antimetabolites|antimetabolites|mesh-ancestor
111352136|NCT00003172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111352137|NCT00003172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111352138|NCT00003172|Immunologic Factors|immunologic factors|mesh-ancestor
111352139|NCT00003172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111352140|NCT00003172|Antiviral Agents|antiviral agents|mesh-ancestor
111352141|NCT00003172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111352142|NCT00003172|Antisickling Agents|antisickling agents|mesh-ancestor
111352143|NCT00003172|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111352144|NCT00003634|Oregovomab|oregovomab|mesh-list
111352145|NCT00003634|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111352146|NCT00003634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111352147|NCT02191033|Nicotine|nicotine|mesh-list
111352148|NCT02191033|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111352149|NCT02191033|Autonomic Agents|autonomic agents|mesh-ancestor
111352150|NCT02191033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111352151|NCT02191033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111352152|NCT02191033|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111352153|NCT02191033|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111352154|NCT02191033|Cholinergic Agents|cholinergic agents|mesh-ancestor
111352155|NCT02191033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111352156|NCT02191033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111352157|NCT00002818|Cytarabine|cytarabine|mesh-list
110768599|NCT01270776|Disinfectants|disinfectants|mesh-ancestor
111352158|NCT00002818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111352159|NCT00002818|Antimetabolites|antimetabolites|mesh-ancestor
111352160|NCT00002818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111352161|NCT00002818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111352162|NCT00002818|Antiviral Agents|antiviral agents|mesh-ancestor
111352163|NCT00002818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111352164|NCT00002818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111352165|NCT00002818|Immunologic Factors|immunologic factors|mesh-ancestor
111352166|NCT00002818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111352167|NCT00003640|Doxorubicin|doxorubicin|mesh-list
111352168|NCT00003640|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111352169|NCT00003640|Methotrexate|methotrexate|mesh-list
111352170|NCT00003640|Vinblastine|vinblastine|mesh-list
111352171|NCT00003640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111352172|NCT00003640|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111352173|NCT00003640|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111352174|NCT00003640|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111352175|NCT00003640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110959203|NCT02582632|Ritonavir|ritonavir|mesh-list
110768739|NCT05834543|Paclitaxel|paclitaxel|mesh-list
111352176|NCT00003640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111352177|NCT00003640|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111352178|NCT00003640|Abortifacient Agents|abortifacient agents|mesh-ancestor
111352179|NCT00003640|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111352180|NCT00003640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111352181|NCT00003640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111352182|NCT00003640|Antimetabolites|antimetabolites|mesh-ancestor
111352183|NCT00003640|Dermatologic Agents|dermatologic agents|mesh-ancestor
111352184|NCT00003640|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111352185|NCT00003640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111352186|NCT00003640|Immunologic Factors|immunologic factors|mesh-ancestor
111352187|NCT00003640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111352188|NCT00003640|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111352189|NCT00003640|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111352190|NCT00003640|Tubulin Modulators|tubulin modulators|mesh-ancestor
111352191|NCT00003640|Antimitotic Agents|antimitotic agents|mesh-ancestor
111352192|NCT00003640|Mitosis Modulators|mitosis modulators|mesh-ancestor
111352193|NCT00002824|Ganciclovir|ganciclovir|mesh-list
111352194|NCT00002824|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
111352195|NCT00002824|Antiviral Agents|antiviral agents|mesh-ancestor
111352196|NCT00002824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111352197|NCT00002824|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110768859|NCT05819918|Calcifediol|calcifediol|mesh-list
111352198|NCT00002824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111352199|NCT00002824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111352200|NCT00003178|Idarubicin|idarubicin|mesh-list
111352201|NCT00003178|Cladribine|cladribine|mesh-list
111352202|NCT00003178|Lenograstim|lenograstim|mesh-list
110768926|NCT05699811|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111352203|NCT00003178|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111352204|NCT00003178|Immunologic Factors|immunologic factors|mesh-ancestor
111352205|NCT00003178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111352206|NCT00003178|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111352207|NCT00003178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111352208|NCT00003178|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111352209|NCT00003178|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111352210|NCT00003178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111352211|NCT00003178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111352212|NCT00003178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111352213|NCT01260649|Ketamine|ketamine|mesh-list
111352214|NCT01260649|Anesthetics|anesthetics|mesh-list
111352215|NCT01260649|Analgesics|analgesics|mesh-ancestor
111352216|NCT01260649|Sensory System Agents|sensory system agents|mesh-ancestor
111352217|NCT01260649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111352218|NCT01260649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111352219|NCT01260649|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111352220|NCT01260649|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111352221|NCT01260649|Anesthetics, General|anesthetics, general|mesh-ancestor
111352222|NCT01260649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111352223|NCT01260649|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111352224|NCT01260649|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111352225|NCT01260649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111352226|NCT01260649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111352227|NCT01260883|Ketorolac|ketorolac|mesh-list
111352228|NCT01260883|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
111352229|NCT01260883|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111352230|NCT01260883|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111352231|NCT01260883|Analgesics|analgesics|mesh-ancestor
111352232|NCT01260883|Sensory System Agents|sensory system agents|mesh-ancestor
111352233|NCT01260883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111352234|NCT01260883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111352235|NCT01260883|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111352236|NCT01260883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111352237|NCT01260883|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111352238|NCT01260883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111352239|NCT01260883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111352240|NCT00076622|Antidepressive Agents|antidepressive agents|mesh-list
111352241|NCT00076622|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111352242|NCT00423202|Ambrisentan|ambrisentan|mesh-list
111352243|NCT00423202|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111352244|NCT00003184|Vaccines|vaccines|mesh-list
111352245|NCT00003184|Sargramostim|sargramostim|mesh-list
111352246|NCT00003184|BCG Vaccine|bcg vaccine|mesh-list
111352247|NCT00003184|Immunologic Factors|immunologic factors|mesh-ancestor
111352248|NCT00003184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111352249|NCT00003184|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111352250|NCT00003190|Cytarabine|cytarabine|mesh-list
111352251|NCT00003190|Etoposide|etoposide|mesh-list
111352252|NCT00003190|Daunorubicin|daunorubicin|mesh-list
111352253|NCT00003190|Etoposide phosphate|etoposide phosphate|mesh-list
111352254|NCT00003190|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111352255|NCT00003190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111352256|NCT00003190|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111352257|NCT00003190|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111352258|NCT00003190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111352259|NCT00003190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111352260|NCT00003190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111352261|NCT00003190|Antimetabolites|antimetabolites|mesh-ancestor
111352262|NCT00003190|Antiviral Agents|antiviral agents|mesh-ancestor
110769094|NCT05284552|Tinzaparin|tinzaparin|mesh-list
111352263|NCT00003190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111352264|NCT00003190|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111352265|NCT00003190|Immunologic Factors|immunologic factors|mesh-ancestor
111352266|NCT00003190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111352267|NCT00003190|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111352268|NCT00003652|Fluorouracil|fluorouracil|mesh-list
111352269|NCT00003652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111352270|NCT00003652|Antimetabolites|antimetabolites|mesh-ancestor
110769159|NCT04869501|Atezolizumab|atezolizumab|mesh-list
111352271|NCT00003652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111352272|NCT00003652|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111352273|NCT00003652|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110769226|NCT04348006|Bortezomib|bortezomib|mesh-list
111352274|NCT00003652|Immunologic Factors|immunologic factors|mesh-ancestor
111352275|NCT00003652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111352276|NCT04773236|Lidocaine|lidocaine|mesh-list
111352277|NCT04773236|Anesthetics, Local|anesthetics, local|mesh-ancestor
111352278|NCT04773236|Anesthetics|anesthetics|mesh-ancestor
111352279|NCT04773236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111352280|NCT04773236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111352281|NCT04773236|Sensory System Agents|sensory system agents|mesh-ancestor
111352282|NCT04773236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111352283|NCT04773236|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111352284|NCT04773236|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111352285|NCT04773236|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111352286|NCT04773236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111352287|NCT04773236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111352288|NCT00003658|Cyclophosphamide|cyclophosphamide|mesh-list
111352289|NCT00003658|Rituximab|rituximab|mesh-list
111352290|NCT00003658|Pentostatin|pentostatin|mesh-list
111352291|NCT00003658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111352292|NCT00003658|Immunologic Factors|immunologic factors|mesh-ancestor
111352293|NCT00003658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111352294|NCT00003658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111352295|NCT00003658|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111352296|NCT00003658|Alkylating Agents|alkylating agents|mesh-ancestor
111352297|NCT00003658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111352298|NCT00003658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111352299|NCT00003658|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111352300|NCT00003658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111352301|NCT00003658|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
111352302|NCT00003658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111352303|NCT00002836|Cyclophosphamide|cyclophosphamide|mesh-list
111352304|NCT00002836|Thiotepa|thiotepa|mesh-list
111352305|NCT00002836|Carmustine|carmustine|mesh-list
111352306|NCT00002836|Cisplatin|cisplatin|mesh-list
111352307|NCT00002836|Etoposide|etoposide|mesh-list
111352308|NCT00002836|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111352309|NCT00002836|Immunologic Factors|immunologic factors|mesh-ancestor
111352310|NCT00002836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111352311|NCT00002836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111352312|NCT00002836|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111352313|NCT00002836|Alkylating Agents|alkylating agents|mesh-ancestor
111352314|NCT00002836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111352315|NCT00002836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111352316|NCT00002836|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111352317|NCT00002836|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111352318|NCT00002836|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111352319|NCT00002836|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111352320|NCT00002836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111352321|NCT00003664|Interferons|interferons|mesh-list
111352322|NCT00003664|Interferon-alpha|interferon-alpha|mesh-list
111352323|NCT00003664|Aldesleukin|aldesleukin|mesh-list
111352324|NCT00003664|Gemcitabine|gemcitabine|mesh-list
111352325|NCT00003664|Fluorouracil|fluorouracil|mesh-list
111352326|NCT00003664|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111352327|NCT00003664|Antimetabolites|antimetabolites|mesh-ancestor
111352328|NCT00003664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111352329|NCT00003664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111352330|NCT00003664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111352331|NCT00003664|Immunologic Factors|immunologic factors|mesh-ancestor
111352332|NCT00003664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111352333|NCT00003664|Antiviral Agents|antiviral agents|mesh-ancestor
111352334|NCT00003664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111352335|NCT00003664|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111352336|NCT00003664|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111352337|NCT00003196|Cyclosporine|cyclosporine|mesh-list
111352338|NCT00003196|Mycophenolic Acid|mycophenolic acid|mesh-list
111352339|NCT00003196|Cyclosporins|cyclosporins|mesh-list
111352340|NCT00003196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111352341|NCT00003196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111352342|NCT00003196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111352343|NCT00003196|Immunologic Factors|immunologic factors|mesh-ancestor
111352344|NCT00003196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111352345|NCT00003196|Antifungal Agents|antifungal agents|mesh-ancestor
111352346|NCT00003196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111352347|NCT00003196|Dermatologic Agents|dermatologic agents|mesh-ancestor
111352348|NCT00003196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111352349|NCT00003196|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111352350|NCT00003196|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111352351|NCT00003196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111352352|NCT00003196|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111352353|NCT00003196|Antitubercular Agents|antitubercular agents|mesh-ancestor
111352354|NCT00003196|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111352355|NCT00003202|Gemcitabine|gemcitabine|mesh-list
111352356|NCT00003202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111352357|NCT00003202|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111352358|NCT00003202|Antimetabolites|antimetabolites|mesh-ancestor
111352359|NCT00003202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111352360|NCT00002854|Paclitaxel|paclitaxel|mesh-list
111352361|NCT00002854|Etoposide|etoposide|mesh-list
111352362|NCT00002854|Cyclophosphamide|cyclophosphamide|mesh-list
111352363|NCT00002854|Carboplatin|carboplatin|mesh-list
111352364|NCT00002854|Ifosfamide|ifosfamide|mesh-list
111352365|NCT00002854|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111352366|NCT00002854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111352367|NCT00002854|Tubulin Modulators|tubulin modulators|mesh-ancestor
111352368|NCT00002854|Antimitotic Agents|antimitotic agents|mesh-ancestor
111352369|NCT00002854|Mitosis Modulators|mitosis modulators|mesh-ancestor
111352370|NCT00002854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111352371|NCT00002854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111352372|NCT00002854|Immunologic Factors|immunologic factors|mesh-ancestor
111352373|NCT00002854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111352374|NCT00002854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111352375|NCT00002854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111352376|NCT00002854|Alkylating Agents|alkylating agents|mesh-ancestor
111352377|NCT00002854|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111352378|NCT00002854|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111352379|NCT00002854|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111352380|NCT00002854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111352381|NCT02308202|Perindopril|perindopril|mesh-list
111352382|NCT02308202|Doxazosin|doxazosin|mesh-list
111352383|NCT02308202|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
111352384|NCT02308202|Protease Inhibitors|protease inhibitors|mesh-ancestor
111352385|NCT02308202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111352386|NCT02308202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111352387|NCT02308202|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111352388|NCT02308202|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111352389|NCT02308202|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111352390|NCT02308202|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111352391|NCT02308202|Adrenergic Agents|adrenergic agents|mesh-ancestor
111352392|NCT02308202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111352393|NCT02308202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111352394|NCT00003214|Paclitaxel|paclitaxel|mesh-list
111352395|NCT00003214|Cyclophosphamide|cyclophosphamide|mesh-list
111352396|NCT00003214|Carboplatin|carboplatin|mesh-list
111352397|NCT00003214|Doxorubicin|doxorubicin|mesh-list
111352398|NCT00003214|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110769748|NCT02213913|Hormones|hormones|mesh-ancestor
111352399|NCT00003214|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111352400|NCT00003214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111352401|NCT00003214|Tubulin Modulators|tubulin modulators|mesh-ancestor
111352402|NCT00003214|Antimitotic Agents|antimitotic agents|mesh-ancestor
111352403|NCT00003214|Mitosis Modulators|mitosis modulators|mesh-ancestor
111352404|NCT00003214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111352405|NCT00003214|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111352406|NCT00003214|Immunologic Factors|immunologic factors|mesh-ancestor
111352407|NCT00003214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111352408|NCT00003214|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111352409|NCT00003214|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111352410|NCT00003214|Alkylating Agents|alkylating agents|mesh-ancestor
111352411|NCT00003214|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111352412|NCT00003214|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111352413|NCT00003214|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111352414|NCT00003214|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111352415|NCT00003214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111352416|NCT00384592|Esomeprazole|esomeprazole|mesh-list
111352417|NCT00384592|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111352418|NCT00384592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111352419|NCT00384592|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111352420|NCT00384592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111352421|NCT00384592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111352422|NCT00003220|Bryostatin 1|bryostatin 1|mesh-list
111352423|NCT00003220|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111352424|NCT00003220|Immunologic Factors|immunologic factors|mesh-ancestor
111352425|NCT00003220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111352426|NCT00003220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111352427|NCT00002866|Docetaxel|docetaxel|mesh-list
111352428|NCT00002866|Epirubicin|epirubicin|mesh-list
111352429|NCT00002866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111352430|NCT00002866|Tubulin Modulators|tubulin modulators|mesh-ancestor
111352431|NCT00002866|Antimitotic Agents|antimitotic agents|mesh-ancestor
111352432|NCT00002866|Mitosis Modulators|mitosis modulators|mesh-ancestor
111352433|NCT00002866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111352434|NCT00002866|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111352435|NCT00002866|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111352436|NCT00002866|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111352437|NCT00002866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111352438|NCT00003232|Clodronic Acid|clodronic acid|mesh-list
111352439|NCT00003232|Prednisone|prednisone|mesh-list
111352440|NCT00003232|Mitoxantrone|mitoxantrone|mesh-list
111352441|NCT00003232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111352442|NCT00003232|Glucocorticoids|glucocorticoids|mesh-ancestor
111352443|NCT00003232|Hormones|hormones|mesh-ancestor
111352444|NCT00003232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111352445|NCT00003232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111352446|NCT00003232|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111352447|NCT00003232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111352448|NCT00003232|Analgesics|analgesics|mesh-ancestor
111352449|NCT00003232|Sensory System Agents|sensory system agents|mesh-ancestor
111352450|NCT00003232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111352451|NCT00003232|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111352452|NCT00003232|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111352453|NCT00003232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111352454|NCT00003232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111352455|NCT00003232|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111352456|NCT00003238|Perillyl alcohol|perillyl alcohol|mesh-list
111352457|NCT00003238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111352458|NCT00003238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111352459|NCT00003238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111352460|NCT00002884|Fluorouracil|fluorouracil|mesh-list
111352461|NCT00002884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111352462|NCT00002884|Antimetabolites|antimetabolites|mesh-ancestor
111352463|NCT00002884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111352464|NCT00002884|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111352465|NCT00002884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111352466|NCT00002884|Immunologic Factors|immunologic factors|mesh-ancestor
111352467|NCT00002884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111352468|NCT00003682|Methylprednisolone|methylprednisolone|mesh-list
111352469|NCT00003682|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111352470|NCT00003682|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111352471|NCT00003682|Prednisolone|prednisolone|mesh-list
111352472|NCT00003682|Prednisolone acetate|prednisolone acetate|mesh-list
111352473|NCT00003682|Doxorubicin|doxorubicin|mesh-list
111352474|NCT00003682|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111352475|NCT00003682|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111352476|NCT00003682|Prednisolone phosphate|prednisolone phosphate|mesh-list
111352477|NCT00003682|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111352478|NCT00003682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111352479|NCT00003682|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111352480|NCT00003682|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111352481|NCT00003682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110769943|NCT01167738|Epirubicin|epirubicin|mesh-list
111352482|NCT00003682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111352483|NCT00003682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111352485|NCT00003682|Autonomic Agents|autonomic agents|mesh-ancestor
111352486|NCT00003682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111352487|NCT00003682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111352488|NCT00003682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111352489|NCT00003682|Glucocorticoids|glucocorticoids|mesh-ancestor
111352490|NCT00003682|Hormones|hormones|mesh-ancestor
111352491|NCT00003682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111352492|NCT00003682|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111352493|NCT00003682|Protective Agents|protective agents|mesh-ancestor
111352494|NCT00003682|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111352495|NCT00003688|Dactinomycin|dactinomycin|mesh-list
111352496|NCT00003688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111352497|NCT00003688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111352498|NCT00003688|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111352499|NCT00003688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111352500|NCT00003688|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111352501|NCT00003688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111352502|NCT00003688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111352503|NCT00003688|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111352504|NCT00003934|Cytarabine|cytarabine|mesh-list
111352505|NCT00003934|Methotrexate|methotrexate|mesh-list
111352506|NCT00003934|Mercaptopurine|mercaptopurine|mesh-list
111352507|NCT00003934|Daunorubicin|daunorubicin|mesh-list
111352508|NCT00003934|Arsenic Trioxide|arsenic trioxide|mesh-list
111352509|NCT00003934|Tretinoin|tretinoin|mesh-list
111352510|NCT00003934|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111352511|NCT00003934|Abortifacient Agents|abortifacient agents|mesh-ancestor
111352512|NCT00003934|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111352513|NCT00003934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111352514|NCT00003934|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111352515|NCT00003934|Antimetabolites|antimetabolites|mesh-ancestor
111352516|NCT00003934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111352517|NCT00003934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111352518|NCT00003934|Dermatologic Agents|dermatologic agents|mesh-ancestor
111352519|NCT00003934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111352520|NCT00003934|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111352521|NCT00003934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111352522|NCT00003934|Immunologic Factors|immunologic factors|mesh-ancestor
111352523|NCT00003934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111352524|NCT00003934|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111352525|NCT00003934|Antiviral Agents|antiviral agents|mesh-ancestor
111352526|NCT00003934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111352527|NCT00003934|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111352528|NCT00003934|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111352529|NCT00003934|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111352530|NCT00003934|Keratolytic Agents|keratolytic agents|mesh-ancestor
111352531|NCT00003694|Cytarabine|cytarabine|mesh-list
111352532|NCT00003694|Homoharringtonine|homoharringtonine|mesh-list
111352533|NCT00003694|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111352534|NCT00003694|Antimetabolites|antimetabolites|mesh-ancestor
111352535|NCT00003694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111352536|NCT00003694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111352537|NCT00003694|Antiviral Agents|antiviral agents|mesh-ancestor
111352538|NCT00003694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111352539|NCT00003694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111352540|NCT00003694|Immunologic Factors|immunologic factors|mesh-ancestor
111352541|NCT00003694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111352542|NCT00003694|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111352543|NCT00003694|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111352544|NCT00003694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111352545|NCT00003250|Fenretinide|fenretinide|mesh-list
111352546|NCT00003250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111352547|NCT00003250|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
111352548|NCT00003250|Protective Agents|protective agents|mesh-ancestor
111352549|NCT00003250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111352550|NCT00003256|Alvocidib|alvocidib|mesh-list
111352551|NCT00003256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111352552|NCT00003256|Growth Inhibitors|growth inhibitors|mesh-ancestor
111076907|NCT03858049|Dydrogesterone|dydrogesterone|mesh-list
111352553|NCT00003256|Growth Substances|growth substances|mesh-ancestor
111352554|NCT00003256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111352555|NCT00003256|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111352556|NCT00003256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111352557|NCT00003256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111352558|NCT00003946|Danazol|danazol|mesh-list
111352559|NCT00003946|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111352560|NCT00003946|Hormone Antagonists|hormone antagonists|mesh-ancestor
111352561|NCT00003946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111352562|NCT00003946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111352563|NCT04679480|Cemiplimab|cemiplimab|mesh-list
111352564|NCT04679480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111352565|NCT04679480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111352566|NCT00003262|Prednisone|prednisone|mesh-list
111352567|NCT00003262|Doxorubicin|doxorubicin|mesh-list
111352568|NCT00003262|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111352569|NCT00003262|Epirubicin|epirubicin|mesh-list
111352570|NCT00003262|Bleomycin|bleomycin|mesh-list
111352571|NCT00003262|Etoposide|etoposide|mesh-list
111352572|NCT00003262|Vincristine|vincristine|mesh-list
111352573|NCT00003262|Vinblastine|vinblastine|mesh-list
111352574|NCT00003262|Mechlorethamine|mechlorethamine|mesh-list
111352575|NCT00003262|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111352576|NCT00003262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111352577|NCT00003262|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111352578|NCT00003262|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111352579|NCT00003262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111352580|NCT00003262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111352581|NCT00003262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111352582|NCT00003262|Glucocorticoids|glucocorticoids|mesh-ancestor
111352583|NCT00003262|Hormones|hormones|mesh-ancestor
111352584|NCT00003262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111352585|NCT00003262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111352586|NCT00003262|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111352587|NCT00003262|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111352588|NCT00003262|Tubulin Modulators|tubulin modulators|mesh-ancestor
111352589|NCT00003262|Antimitotic Agents|antimitotic agents|mesh-ancestor
111352590|NCT00003262|Mitosis Modulators|mitosis modulators|mesh-ancestor
111352591|NCT00003262|Alkylating Agents|alkylating agents|mesh-ancestor
111352592|NCT00003262|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111352593|NCT00003700|Leucovorin|leucovorin|mesh-list
111352594|NCT00003700|Cytarabine|cytarabine|mesh-list
111352595|NCT00003700|Prednisone|prednisone|mesh-list
111352596|NCT00003700|Cyclophosphamide|cyclophosphamide|mesh-list
111352597|NCT00003700|Methotrexate|methotrexate|mesh-list
111352598|NCT00003700|Vincristine|vincristine|mesh-list
111352599|NCT00003700|Daunorubicin|daunorubicin|mesh-list
111352600|NCT00003700|Asparaginase|asparaginase|mesh-list
111352601|NCT00003700|Mercaptopurine|mercaptopurine|mesh-list
111352602|NCT00003700|Allopurinol|allopurinol|mesh-list
111352603|NCT00003700|Levoleucovorin|levoleucovorin|mesh-list
111352604|NCT00003700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111352605|NCT00003700|Immunologic Factors|immunologic factors|mesh-ancestor
111352606|NCT00003700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111352607|NCT00003700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111352608|NCT00003700|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111352609|NCT00003700|Alkylating Agents|alkylating agents|mesh-ancestor
111352610|NCT00003700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111352611|NCT00003700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111352612|NCT00003700|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111352613|NCT00003700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111352614|NCT00003700|Glucocorticoids|glucocorticoids|mesh-ancestor
111352615|NCT00003700|Hormones|hormones|mesh-ancestor
111352616|NCT00003700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111352617|NCT00003700|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111352618|NCT00003700|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111352619|NCT00003700|Abortifacient Agents|abortifacient agents|mesh-ancestor
111352620|NCT00003700|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111352621|NCT00003700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111352622|NCT00003700|Antimetabolites|antimetabolites|mesh-ancestor
111352623|NCT00003700|Dermatologic Agents|dermatologic agents|mesh-ancestor
111352624|NCT00003700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111352625|NCT00003700|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111352626|NCT00003700|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111352627|NCT00003700|Antiviral Agents|antiviral agents|mesh-ancestor
111352628|NCT00003700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111076985|NCT03386591|Naloxone|naloxone|mesh-list
111352629|NCT00003700|Antidotes|antidotes|mesh-ancestor
111352630|NCT00003700|Protective Agents|protective agents|mesh-ancestor
111352631|NCT00003700|Vitamin B Complex|vitamin b complex|mesh-ancestor
111352632|NCT00003700|Vitamins|vitamins|mesh-ancestor
111352633|NCT00003700|Micronutrients|micronutrients|mesh-ancestor
111352634|NCT00003700|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111352635|NCT00003700|Tubulin Modulators|tubulin modulators|mesh-ancestor
111352636|NCT00003700|Antimitotic Agents|antimitotic agents|mesh-ancestor
111352637|NCT00003700|Mitosis Modulators|mitosis modulators|mesh-ancestor
111352638|NCT00003700|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111352639|NCT00003700|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111352640|NCT00003700|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111352641|NCT00003700|Gout Suppressants|gout suppressants|mesh-ancestor
111352642|NCT00003700|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111352643|NCT00003700|Antioxidants|antioxidants|mesh-ancestor
111352644|NCT00003706|Pemetrexed|pemetrexed|mesh-list
111352645|NCT00003706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111352646|NCT00003706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111352647|NCT00003706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111352648|NCT00003706|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111352649|NCT00003706|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111352650|NCT00003958|Dactinomycin|dactinomycin|mesh-list
111352651|NCT00003958|Cactinomycin|cactinomycin|mesh-list
111352652|NCT00003958|Cyclophosphamide|cyclophosphamide|mesh-list
111352653|NCT00003958|Vincristine|vincristine|mesh-list
111352654|NCT00003958|Topotecan|topotecan|mesh-list
111352655|NCT00003958|Sargramostim|sargramostim|mesh-list
111352656|NCT00003958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111352657|NCT00003958|Immunologic Factors|immunologic factors|mesh-ancestor
111352658|NCT00003958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111352659|NCT00003958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111352660|NCT00003958|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111352661|NCT00003958|Alkylating Agents|alkylating agents|mesh-ancestor
111352662|NCT00003958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111352663|NCT00003958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111352664|NCT00003958|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111352665|NCT00003958|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111352666|NCT00003958|Tubulin Modulators|tubulin modulators|mesh-ancestor
111352667|NCT00003958|Antimitotic Agents|antimitotic agents|mesh-ancestor
111352668|NCT00003958|Mitosis Modulators|mitosis modulators|mesh-ancestor
111352669|NCT00003958|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111352670|NCT00003958|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111352671|NCT00003958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111352672|NCT00003958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111352673|NCT00003958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111352674|NCT00003958|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111352675|NCT00003958|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111352676|NCT00003958|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111352677|NCT00003712|Sirolimus|sirolimus|mesh-list
111352678|NCT00003712|Temsirolimus|temsirolimus|mesh-list
111352679|NCT00003712|MTOR Inhibitors|mtor inhibitors|mesh-list
111352680|NCT00003712|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111352681|NCT00003712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111352682|NCT00003712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111352683|NCT00003712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111352684|NCT00003712|Immunologic Factors|immunologic factors|mesh-ancestor
111352685|NCT00003712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111352686|NCT00003712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111352687|NCT00003712|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111352688|NCT00003712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111352689|NCT00003712|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111352690|NCT00003712|Antifungal Agents|antifungal agents|mesh-ancestor
111352691|NCT00003268|Cytarabine|cytarabine|mesh-list
111352692|NCT00003268|Idarubicin|idarubicin|mesh-list
111352693|NCT00003268|Amifostine|amifostine|mesh-list
111352694|NCT00003268|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111352695|NCT00003268|Antimetabolites|antimetabolites|mesh-ancestor
111352696|NCT00003268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111352697|NCT00003268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111352698|NCT00003268|Antiviral Agents|antiviral agents|mesh-ancestor
111352699|NCT00003268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111352700|NCT00003268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111352701|NCT00003268|Immunologic Factors|immunologic factors|mesh-ancestor
111352702|NCT00003268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111352703|NCT00003268|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111352704|NCT00003268|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111077070|NCT02520245|Cemiplimab|cemiplimab|mesh-list
111352705|NCT00003268|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111352707|NCT00003268|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111352708|NCT00003268|Protective Agents|protective agents|mesh-ancestor
111352709|NCT00083720|Cetuximab|cetuximab|mesh-list
111352710|NCT00083720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111352711|NCT00083720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111352712|NCT00003274|Sargramostim|sargramostim|mesh-list
111352713|NCT00003274|Freund's Adjuvant|freund's adjuvant|mesh-list
111352714|NCT00003274|Immunologic Factors|immunologic factors|mesh-ancestor
111352715|NCT00003274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111352716|NCT00003274|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111352717|NCT00003280|Rituximab|rituximab|mesh-list
111352718|NCT00003280|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111352719|NCT00003280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111352720|NCT00003280|Immunologic Factors|immunologic factors|mesh-ancestor
111352721|NCT00003280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111352722|NCT00003280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111352723|NCT00384124|Imiquimod|imiquimod|mesh-list
111352724|NCT00384124|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111352725|NCT00384124|Immunologic Factors|immunologic factors|mesh-ancestor
111352726|NCT00384124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111352727|NCT00384124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111352728|NCT00384124|Interferon Inducers|interferon inducers|mesh-ancestor
111352729|NCT00003718|Temozolomide|temozolomide|mesh-list
111352730|NCT00003718|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111352731|NCT00003718|Alkylating Agents|alkylating agents|mesh-ancestor
111352732|NCT00003718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111352733|NCT00003718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111352734|NCT00003970|Irinotecan|irinotecan|mesh-list
111352735|NCT00003970|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111352736|NCT00003970|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111352737|NCT00003970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111352738|NCT00003970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111352739|NCT00003970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111352740|NCT00085436|Interferons|interferons|mesh-list
111352741|NCT00085436|Interferon-alpha|interferon-alpha|mesh-list
110771348|NCT01183962|Vitamin D|vitamin d|mesh-list
111352742|NCT00085436|Interferon alpha-2|interferon alpha-2|mesh-list
111352743|NCT00085436|Aldesleukin|aldesleukin|mesh-list
111352744|NCT00085436|Vaccines|vaccines|mesh-list
111352745|NCT00085436|Immunologic Factors|immunologic factors|mesh-ancestor
111352746|NCT00085436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111352747|NCT00085436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111352748|NCT00085436|Antiviral Agents|antiviral agents|mesh-ancestor
111352749|NCT00085436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111352750|NCT00085436|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111352751|NCT00085436|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111352752|NCT00384202|Tacrolimus|tacrolimus|mesh-list
111352753|NCT00384202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111352754|NCT00384202|Immunologic Factors|immunologic factors|mesh-ancestor
111352755|NCT00384202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111352756|NCT00384202|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111352757|NCT00384202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111352758|NCT00384202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111352759|NCT00086138|Sertraline|sertraline|mesh-list
111352760|NCT00086138|Antidepressive Agents|antidepressive agents|mesh-ancestor
111352761|NCT00086138|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111352762|NCT00086138|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111352763|NCT00086138|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111352764|NCT00086138|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111352765|NCT00086138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111352766|NCT00086138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111352767|NCT00086138|Serotonin Agents|serotonin agents|mesh-ancestor
111352768|NCT00086138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111352769|NCT04329130|Lenalidomide|lenalidomide|mesh-list
111352770|NCT04329130|Immunologic Factors|immunologic factors|mesh-ancestor
111352771|NCT04329130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111352772|NCT04329130|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111352773|NCT04329130|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111352774|NCT04329130|Growth Substances|growth substances|mesh-ancestor
111352775|NCT04329130|Growth Inhibitors|growth inhibitors|mesh-ancestor
111352776|NCT04329130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111352777|NCT00384280|Rifampin|rifampin|mesh-list
111352778|NCT00384280|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111352779|NCT00384280|Antitubercular Agents|antitubercular agents|mesh-ancestor
111077142|NCT04448717|Antibodies|antibodies|mesh-list
111352780|NCT00384280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111352781|NCT00384280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111352782|NCT00384280|Leprostatic Agents|leprostatic agents|mesh-ancestor
111352783|NCT00384280|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111352784|NCT00384280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111352785|NCT00384280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111352786|NCT00384280|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111352787|NCT00384280|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111352788|NCT00384280|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
111352789|NCT00384280|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
111352790|NCT00384280|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
111352791|NCT00384280|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111352792|NCT00003976|N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|mesh-list
111352793|NCT00003976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111352794|NCT00003976|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
111352795|NCT00003976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111352796|NCT00003976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111352797|NCT00003730|Fluorouracil|fluorouracil|mesh-list
111352798|NCT00003730|Vinorelbine|vinorelbine|mesh-list
111352799|NCT00003730|Antimetabolites|antimetabolites|mesh-ancestor
111352800|NCT00003730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111352801|NCT00003730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111352802|NCT00003730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111352803|NCT00003730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111352804|NCT00003730|Immunologic Factors|immunologic factors|mesh-ancestor
111352805|NCT00003730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111352806|NCT00003730|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111352807|NCT00003730|Tubulin Modulators|tubulin modulators|mesh-ancestor
111352808|NCT00003730|Antimitotic Agents|antimitotic agents|mesh-ancestor
111352809|NCT00003730|Mitosis Modulators|mitosis modulators|mesh-ancestor
111352810|NCT01881308|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
111352811|NCT01881308|Antirheumatic Agents|antirheumatic agents|mesh-list
111352812|NCT01881308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111352813|NCT00003292|Ifosfamide|ifosfamide|mesh-list
111352814|NCT00003292|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110771557|NCT01194336|Huperzine A|huperzine a|mesh-list
111352815|NCT00003292|Alkylating Agents|alkylating agents|mesh-ancestor
111352816|NCT00003292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111352817|NCT00003292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111352818|NCT00088634|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
111352819|NCT00088634|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111352820|NCT00088634|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111352821|NCT00088634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111352822|NCT00088634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111352823|NCT00088634|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111352824|NCT00088634|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
111352825|NCT00088634|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111352826|NCT00088634|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111352827|NCT00088634|Adrenergic Agents|adrenergic agents|mesh-ancestor
111352828|NCT00088634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111352829|NCT00088634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111352830|NCT00088634|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111352831|NCT00088634|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111352832|NCT00088634|Serotonin Agents|serotonin agents|mesh-ancestor
111352833|NCT00088634|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111352834|NCT00088634|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111352835|NCT00088634|Dopamine Agents|dopamine agents|mesh-ancestor
111352836|NCT00003736|Motexafin gadolinium|motexafin gadolinium|mesh-list
111352837|NCT00003736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111352838|NCT00003736|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111352839|NCT00003736|Dermatologic Agents|dermatologic agents|mesh-ancestor
111352840|NCT00003994|Carboplatin|carboplatin|mesh-list
111352841|NCT00003994|Fluorouracil|fluorouracil|mesh-list
111352842|NCT00003994|Vincristine|vincristine|mesh-list
111352843|NCT00003994|Amifostine|amifostine|mesh-list
111352844|NCT00003994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111352845|NCT00003994|Antimetabolites|antimetabolites|mesh-ancestor
111352846|NCT00003994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111352847|NCT00003994|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111352848|NCT00003994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111352849|NCT00003994|Immunologic Factors|immunologic factors|mesh-ancestor
111352850|NCT00003994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111352851|NCT00003994|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111352852|NCT00003994|Tubulin Modulators|tubulin modulators|mesh-ancestor
111352853|NCT00003994|Antimitotic Agents|antimitotic agents|mesh-ancestor
111352854|NCT00003994|Mitosis Modulators|mitosis modulators|mesh-ancestor
111352855|NCT00003994|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111352856|NCT00003994|Protective Agents|protective agents|mesh-ancestor
111352858|NCT00003742|Irinotecan|irinotecan|mesh-list
111352859|NCT00003742|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111352860|NCT00003742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111352861|NCT00003742|Tubulin Modulators|tubulin modulators|mesh-ancestor
111352862|NCT00003742|Antimitotic Agents|antimitotic agents|mesh-ancestor
111352863|NCT00003742|Mitosis Modulators|mitosis modulators|mesh-ancestor
111352864|NCT00003742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111352865|NCT00003742|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111352866|NCT00003742|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111352867|NCT00003742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111352868|NCT00003304|Temozolomide|temozolomide|mesh-list
111352869|NCT00003304|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111352870|NCT00003304|Alkylating Agents|alkylating agents|mesh-ancestor
111352871|NCT00003304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111352872|NCT00003304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111352873|NCT00004006|Cyclophosphamide|cyclophosphamide|mesh-list
111352874|NCT00004006|Carboplatin|carboplatin|mesh-list
111352875|NCT00004006|Doxorubicin|doxorubicin|mesh-list
111352876|NCT00004006|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111352877|NCT00004006|Etoposide|etoposide|mesh-list
111352878|NCT00004006|Topotecan|topotecan|mesh-list
111352879|NCT00004006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111352880|NCT00004006|Immunologic Factors|immunologic factors|mesh-ancestor
111352881|NCT00004006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111352882|NCT00004006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111352883|NCT00004006|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111352884|NCT00004006|Alkylating Agents|alkylating agents|mesh-ancestor
111352885|NCT00004006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111352886|NCT00004006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111352887|NCT00004006|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111352888|NCT00004006|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111352889|NCT00004006|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111352890|NCT00004006|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111352891|NCT00004006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111352892|NCT00004006|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111352893|NCT00004006|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111352894|NCT00003316|Gemcitabine|gemcitabine|mesh-list
111352895|NCT00003316|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111352896|NCT00003316|Antimetabolites|antimetabolites|mesh-ancestor
110771798|NCT01295502|Antimitotic Agents|antimitotic agents|mesh-ancestor
111352897|NCT00003316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111352898|NCT00003316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111352899|NCT00003322|Paclitaxel|paclitaxel|mesh-list
111352900|NCT00003322|Cisplatin|cisplatin|mesh-list
111352901|NCT00003322|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111352902|NCT00003322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111352903|NCT00003322|Tubulin Modulators|tubulin modulators|mesh-ancestor
111352904|NCT00003322|Antimitotic Agents|antimitotic agents|mesh-ancestor
111352905|NCT00003322|Mitosis Modulators|mitosis modulators|mesh-ancestor
111352906|NCT00003322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111352907|NCT00519818|Hydrocortisone|hydrocortisone|mesh-list
111352908|NCT00519818|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
111352909|NCT00519818|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
111352910|NCT00519818|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
111352911|NCT00519818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111352912|NCT00003748|Irinotecan|irinotecan|mesh-list
111352913|NCT00003748|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111352914|NCT00003748|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111352915|NCT00003748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111352916|NCT00003748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111352917|NCT00003748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111352918|NCT00089102|Gemcitabine|gemcitabine|mesh-list
111352919|NCT00089102|Irinotecan|irinotecan|mesh-list
111352920|NCT00089102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111352921|NCT00089102|Antimetabolites|antimetabolites|mesh-ancestor
111352922|NCT00089102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111352923|NCT00089102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111352924|NCT00089102|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111352925|NCT00089102|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111077299|NCT03383237|Apatinib|apatinib|mesh-list
111352926|NCT00089102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111352927|NCT00004012|Capecitabine|capecitabine|mesh-list
111352928|NCT00004012|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111352929|NCT00004012|Antimetabolites|antimetabolites|mesh-ancestor
111352930|NCT00004012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111352931|NCT00004012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111352932|NCT00003754|Thalidomide|thalidomide|mesh-list
111352933|NCT00003754|Cyclophosphamide|cyclophosphamide|mesh-list
111352934|NCT00003754|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111352935|NCT00003754|Immunologic Factors|immunologic factors|mesh-ancestor
111352936|NCT00003754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111352937|NCT00003754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111352938|NCT00003754|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111352939|NCT00003754|Alkylating Agents|alkylating agents|mesh-ancestor
111352940|NCT00003754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111352941|NCT00003754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111352942|NCT00003754|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111352943|NCT00003754|Leprostatic Agents|leprostatic agents|mesh-ancestor
111352944|NCT00003754|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111352945|NCT00003754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111352946|NCT00003754|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111352947|NCT00003754|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111352948|NCT00003754|Growth Substances|growth substances|mesh-ancestor
111352949|NCT00003754|Growth Inhibitors|growth inhibitors|mesh-ancestor
111352950|NCT00003328|Porfiromycin|porfiromycin|mesh-list
111352951|NCT00003328|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111352952|NCT00003328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111352953|NCT00004024|Aldesleukin|aldesleukin|mesh-list
111352954|NCT00004024|Sargramostim|sargramostim|mesh-list
111352955|NCT00004024|Muromonab-CD3|muromonab-cd3|mesh-list
111352956|NCT00004024|Immunologic Factors|immunologic factors|mesh-ancestor
111352957|NCT00004024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111352958|NCT00004024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111352959|NCT00004024|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111352960|NCT00004024|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111352961|NCT00004024|Antiviral Agents|antiviral agents|mesh-ancestor
111352962|NCT00004024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111352963|NCT00004024|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111352964|NCT00003334|Paclitaxel|paclitaxel|mesh-list
111352965|NCT00003334|Doxorubicin|doxorubicin|mesh-list
111352966|NCT00003334|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111352967|NCT00003334|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111352968|NCT00003334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111352969|NCT00003334|Tubulin Modulators|tubulin modulators|mesh-ancestor
111352970|NCT00003334|Antimitotic Agents|antimitotic agents|mesh-ancestor
111352971|NCT00003334|Mitosis Modulators|mitosis modulators|mesh-ancestor
111352972|NCT00003334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111352973|NCT00003334|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111352974|NCT00003334|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111352975|NCT00003334|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111352976|NCT00003334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111352977|NCT00093782|Sirolimus|sirolimus|mesh-list
111352978|NCT00093782|Temsirolimus|temsirolimus|mesh-list
111352979|NCT00093782|MTOR Inhibitors|mtor inhibitors|mesh-list
111352980|NCT00093782|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111352981|NCT00093782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111352982|NCT00093782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111352983|NCT00093782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111352984|NCT00093782|Immunologic Factors|immunologic factors|mesh-ancestor
111352985|NCT00093782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111352986|NCT00093782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111352987|NCT00093782|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111352988|NCT00093782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111352989|NCT00093782|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111352990|NCT00093782|Antifungal Agents|antifungal agents|mesh-ancestor
111352991|NCT00003760|Irofulven|irofulven|mesh-list
111352992|NCT00003760|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111352993|NCT00003760|Alkylating Agents|alkylating agents|mesh-ancestor
111352994|NCT00003760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111352995|NCT00003760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111352996|NCT04771754|Dolutegravir|dolutegravir|mesh-list
111352997|NCT04771754|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111352998|NCT04771754|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111352999|NCT04771754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111353000|NCT04771754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111353001|NCT04771754|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111353002|NCT04771754|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111353003|NCT04771754|Antiviral Agents|antiviral agents|mesh-ancestor
111353004|NCT04771754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111353005|NCT00003766|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
111353006|NCT00003766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111353007|NCT00003766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111353008|NCT00003766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111353009|NCT00004030|Doxorubicin|doxorubicin|mesh-list
111353010|NCT00004030|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111353011|NCT00004030|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111353012|NCT00004030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111353013|NCT00004030|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111353014|NCT00004030|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111353015|NCT00004030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111353016|NCT00004030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111353017|NCT04389320|Hydroxychloroquine|hydroxychloroquine|mesh-list
111353018|NCT04389320|Antimalarials|antimalarials|mesh-ancestor
111353019|NCT04389320|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111353020|NCT04389320|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111353021|NCT04389320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111353022|NCT04389320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111353023|NCT04389320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111353024|NCT04389320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111353025|NCT00003340|Cyclophosphamide|cyclophosphamide|mesh-list
111353027|NCT00003340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111353028|NCT00003340|Immunologic Factors|immunologic factors|mesh-ancestor
111353029|NCT00003340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111353030|NCT00003340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111353031|NCT00003340|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111353032|NCT00003340|Alkylating Agents|alkylating agents|mesh-ancestor
111353033|NCT00003340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111353034|NCT00003340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111353035|NCT00003340|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111353036|NCT00003340|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111353037|NCT00003340|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111353038|NCT00003340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111353039|NCT00004036|Cyclophosphamide|cyclophosphamide|mesh-list
111353040|NCT00004036|Carboplatin|carboplatin|mesh-list
111353041|NCT00004036|Sargramostim|sargramostim|mesh-list
111353042|NCT00004036|Amifostine|amifostine|mesh-list
111353043|NCT00004036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111353044|NCT00004036|Immunologic Factors|immunologic factors|mesh-ancestor
111353045|NCT00004036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111353046|NCT00004036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111353047|NCT00004036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111353048|NCT00004036|Alkylating Agents|alkylating agents|mesh-ancestor
111353049|NCT00004036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111353050|NCT00004036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111353051|NCT00004036|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111353052|NCT00004036|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111353053|NCT00004036|Protective Agents|protective agents|mesh-ancestor
111353054|NCT00003346|Acetaminophen|acetaminophen|mesh-list
111353055|NCT00003346|Acetylcysteine|acetylcysteine|mesh-list
111353056|NCT00003346|Carmustine|carmustine|mesh-list
111353057|NCT00003346|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111353058|NCT00003346|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111353059|NCT00003346|Analgesics|analgesics|mesh-ancestor
111353060|NCT00003346|Sensory System Agents|sensory system agents|mesh-ancestor
111353061|NCT00003346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111353062|NCT00003346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111353063|NCT00003346|Antipyretics|antipyretics|mesh-ancestor
111353064|NCT00003346|Antiviral Agents|antiviral agents|mesh-ancestor
111353065|NCT00003346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111353066|NCT00003346|Expectorants|expectorants|mesh-ancestor
111353067|NCT00003346|Respiratory System Agents|respiratory system agents|mesh-ancestor
111353068|NCT00003346|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111353069|NCT00003346|Antioxidants|antioxidants|mesh-ancestor
111353070|NCT00003346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111353071|NCT00003346|Protective Agents|protective agents|mesh-ancestor
111353072|NCT00003346|Antidotes|antidotes|mesh-ancestor
111353073|NCT00003346|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111353074|NCT00003346|Alkylating Agents|alkylating agents|mesh-ancestor
111353075|NCT00003346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111353076|NCT00096122|Cytarabine|cytarabine|mesh-list
111353077|NCT00096122|Idarubicin|idarubicin|mesh-list
111353078|NCT00096122|Tipifarnib|tipifarnib|mesh-list
111353079|NCT00096122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111353081|NCT00096122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111353082|NCT00096122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111353083|NCT00096122|Antiviral Agents|antiviral agents|mesh-ancestor
111353084|NCT00096122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111353085|NCT00096122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111353086|NCT00096122|Immunologic Factors|immunologic factors|mesh-ancestor
111353087|NCT00096122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111353088|NCT00096122|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111353089|NCT00096122|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111353090|NCT00096122|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111353091|NCT00096122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111353092|NCT00003778|Dolastatin 10|dolastatin 10|mesh-list
111353093|NCT00003778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111353094|NCT00003778|Tubulin Modulators|tubulin modulators|mesh-ancestor
111353095|NCT00003778|Antimitotic Agents|antimitotic agents|mesh-ancestor
111353096|NCT00003778|Mitosis Modulators|mitosis modulators|mesh-ancestor
111353097|NCT00003778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111353098|NCT00004042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111353099|NCT00004042|Antibodies|antibodies|mesh-list
111353100|NCT00004042|Immunoglobulins|immunoglobulins|mesh-list
111353101|NCT00004042|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111353102|NCT00004042|Immunologic Factors|immunologic factors|mesh-ancestor
111353103|NCT00004042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111353104|NCT00004042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111353105|NCT00003784|Prednisone|prednisone|mesh-list
111353106|NCT00003784|Cyclophosphamide|cyclophosphamide|mesh-list
111353107|NCT00003784|Doxorubicin|doxorubicin|mesh-list
111353108|NCT00003784|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111353109|NCT00003784|Vincristine|vincristine|mesh-list
111353110|NCT00003784|Tositumomab I-131|tositumomab i-131|mesh-list
111353111|NCT00003784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111353112|NCT00003784|Immunologic Factors|immunologic factors|mesh-ancestor
111353113|NCT00003784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111353114|NCT00003784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111353115|NCT00003784|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111353116|NCT00003784|Alkylating Agents|alkylating agents|mesh-ancestor
111353117|NCT00003784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111353118|NCT00003784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111353119|NCT00003784|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111353120|NCT00003784|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111353121|NCT00003784|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111353122|NCT00003784|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111353123|NCT00003784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111353124|NCT00003784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111353125|NCT00003784|Glucocorticoids|glucocorticoids|mesh-ancestor
111353126|NCT00003784|Hormones|hormones|mesh-ancestor
111353127|NCT00003784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111353128|NCT00003784|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111353129|NCT00003784|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111353130|NCT00003784|Tubulin Modulators|tubulin modulators|mesh-ancestor
111353131|NCT00003784|Antimitotic Agents|antimitotic agents|mesh-ancestor
111353132|NCT00003784|Mitosis Modulators|mitosis modulators|mesh-ancestor
111353133|NCT00003352|Cyclophosphamide|cyclophosphamide|mesh-list
111353134|NCT00003352|Docetaxel|docetaxel|mesh-list
111353135|NCT00003352|Doxorubicin|doxorubicin|mesh-list
111353136|NCT00003352|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111353137|NCT00003352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111353138|NCT00003352|Immunologic Factors|immunologic factors|mesh-ancestor
111353139|NCT00003352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111353140|NCT00003352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111353141|NCT00003352|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111353142|NCT00003352|Alkylating Agents|alkylating agents|mesh-ancestor
111353143|NCT00003352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111353144|NCT00003352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111353145|NCT00003352|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111353146|NCT00003352|Tubulin Modulators|tubulin modulators|mesh-ancestor
111353147|NCT00003352|Antimitotic Agents|antimitotic agents|mesh-ancestor
111353148|NCT00003352|Mitosis Modulators|mitosis modulators|mesh-ancestor
111353149|NCT00003352|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111353150|NCT00003352|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111353151|NCT00003352|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111353152|NCT00003352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111077520|NCT02520505|Citric Acid|citric acid|mesh-list
111353153|NCT00004048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111353154|NCT00004048|Doxorubicin|doxorubicin|mesh-list
111353155|NCT00004048|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111353156|NCT00004048|Antibodies|antibodies|mesh-list
111353157|NCT00004048|Immunoglobulins|immunoglobulins|mesh-list
111353158|NCT00004048|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111353159|NCT00004048|Immunologic Factors|immunologic factors|mesh-ancestor
111353160|NCT00004048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111353161|NCT00004048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111353162|NCT00004048|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111353163|NCT00004048|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111353164|NCT00004048|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111353165|NCT00004048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111353166|NCT00004048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111353167|NCT00003358|Gemcitabine|gemcitabine|mesh-list
111353168|NCT00003358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111353169|NCT00003358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111353170|NCT00003358|Antimetabolites|antimetabolites|mesh-ancestor
111353171|NCT00003358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111353172|NCT00004060|Exatecan|exatecan|mesh-list
111353173|NCT00004060|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111353174|NCT00004060|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111353175|NCT00004060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111353176|NCT00004060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111353177|NCT00004060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111353178|NCT00384826|Paclitaxel|paclitaxel|mesh-list
111353179|NCT00384826|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111353180|NCT00384826|Carboplatin|carboplatin|mesh-list
111353181|NCT00384826|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111353182|NCT00384826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111353183|NCT00384826|Tubulin Modulators|tubulin modulators|mesh-ancestor
111353184|NCT00384826|Antimitotic Agents|antimitotic agents|mesh-ancestor
111353185|NCT00384826|Mitosis Modulators|mitosis modulators|mesh-ancestor
111353186|NCT00384826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111353187|NCT00384826|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111353188|NCT00384826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111353189|NCT00003364|Cyclophosphamide|cyclophosphamide|mesh-list
111353190|NCT00003364|Doxorubicin|doxorubicin|mesh-list
111353191|NCT00003364|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111353192|NCT00003364|Etoposide|etoposide|mesh-list
111353193|NCT00003364|Vincristine|vincristine|mesh-list
111353194|NCT00003364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111353195|NCT00003364|Immunologic Factors|immunologic factors|mesh-ancestor
111353196|NCT00003364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111353197|NCT00003364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111353198|NCT00003364|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111353199|NCT00003364|Alkylating Agents|alkylating agents|mesh-ancestor
111353200|NCT00003364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111353201|NCT00003364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111353202|NCT00003364|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111353203|NCT00003364|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111353204|NCT00003364|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111353205|NCT00003364|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111353206|NCT00003364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111353207|NCT00003364|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111353208|NCT00003364|Tubulin Modulators|tubulin modulators|mesh-ancestor
111353209|NCT00003364|Antimitotic Agents|antimitotic agents|mesh-ancestor
111353210|NCT00003364|Mitosis Modulators|mitosis modulators|mesh-ancestor
111353211|NCT00004066|Gemcitabine|gemcitabine|mesh-list
111353212|NCT00004066|Docetaxel|docetaxel|mesh-list
111353213|NCT00004066|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111353214|NCT00004066|Antimetabolites|antimetabolites|mesh-ancestor
111353215|NCT00004066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111353216|NCT00004066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111353217|NCT00004066|Tubulin Modulators|tubulin modulators|mesh-ancestor
111353218|NCT00004066|Antimitotic Agents|antimitotic agents|mesh-ancestor
111353219|NCT00004066|Mitosis Modulators|mitosis modulators|mesh-ancestor
111353220|NCT00003370|Irofulven|irofulven|mesh-list
111353221|NCT00003370|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111353222|NCT00003370|Alkylating Agents|alkylating agents|mesh-ancestor
111353223|NCT00003370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111353224|NCT00003370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111353225|NCT00003382|Gemcitabine|gemcitabine|mesh-list
111353226|NCT00003382|Topotecan|topotecan|mesh-list
111077583|NCT03385135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111353227|NCT00003382|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111353229|NCT00003382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111353230|NCT00003382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111353231|NCT00003382|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111353232|NCT00003382|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111353233|NCT00003382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111353234|NCT00004834|Imipramine|imipramine|mesh-list
111353235|NCT00004834|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
111353236|NCT00004834|Antidepressive Agents|antidepressive agents|mesh-ancestor
111353237|NCT00004834|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111353238|NCT00004834|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111353239|NCT00004834|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111353240|NCT00004834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111353241|NCT00004834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111353242|NCT00004834|Adrenergic Agents|adrenergic agents|mesh-ancestor
111353243|NCT00004834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111353244|NCT00004834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111353245|NCT00004840|Hormones|hormones|mesh-list
111353246|NCT00004840|Thyrotropin-Releasing Hormone|thyrotropin-releasing hormone|mesh-list
111353247|NCT00004840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111353248|NCT00004840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111353249|NCT00004852|Lamivudine|lamivudine|mesh-list
111353250|NCT00004852|Zidovudine|zidovudine|mesh-list
111353251|NCT00004852|Efavirenz|efavirenz|mesh-list
111353252|NCT00004852|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111353253|NCT00004852|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111353254|NCT00004852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111353255|NCT00004852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111353256|NCT00004852|Antiviral Agents|antiviral agents|mesh-ancestor
111353257|NCT00004852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111353258|NCT00004852|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111353259|NCT00004852|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111353260|NCT00004852|Antimetabolites|antimetabolites|mesh-ancestor
111353261|NCT00004852|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111353262|NCT00004852|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111353263|NCT00004852|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111353264|NCT00004852|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111353265|NCT00004852|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111353266|NCT00004852|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111353267|NCT00004858|Genistein|genistein|mesh-list
111353268|NCT00004858|Immunoconjugates|immunoconjugates|mesh-list
111353269|NCT00004858|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
111353270|NCT00004858|Protective Agents|protective agents|mesh-ancestor
111353271|NCT00004858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111353272|NCT00004858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111353273|NCT00004858|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111353274|NCT00004858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111353275|NCT00004858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111353276|NCT00004858|Phytoestrogens|phytoestrogens|mesh-ancestor
111353277|NCT00004858|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
111353278|NCT00004858|Estrogens|estrogens|mesh-ancestor
111353279|NCT00004858|Hormones|hormones|mesh-ancestor
111353280|NCT00004858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111353281|NCT00004858|Immunologic Factors|immunologic factors|mesh-ancestor
111353282|NCT00004864|Docetaxel|docetaxel|mesh-list
111353283|NCT00004864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111353284|NCT00004864|Tubulin Modulators|tubulin modulators|mesh-ancestor
111353285|NCT00004864|Antimitotic Agents|antimitotic agents|mesh-ancestor
111353286|NCT00004864|Mitosis Modulators|mitosis modulators|mesh-ancestor
111353287|NCT00004864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111353288|NCT00003796|Irofulven|irofulven|mesh-list
111353289|NCT00003796|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111353290|NCT00003796|Alkylating Agents|alkylating agents|mesh-ancestor
111353291|NCT00003796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111353292|NCT00003796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111353293|NCT00003802|NSC 366140|nsc 366140|mesh-list
111353294|NCT00003802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111353295|NCT02972866|Budesonide|budesonide|mesh-list
111353296|NCT02972866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111353297|NCT02972866|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111353298|NCT02972866|Autonomic Agents|autonomic agents|mesh-ancestor
111353299|NCT02972866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111353300|NCT02972866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111353301|NCT02972866|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111353302|NCT02972866|Respiratory System Agents|respiratory system agents|mesh-ancestor
111353303|NCT02972866|Glucocorticoids|glucocorticoids|mesh-ancestor
111353305|NCT02972866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111353306|NCT00003814|Eflornithine|eflornithine|mesh-list
111353307|NCT00003814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111353308|NCT00003814|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
111353309|NCT00003814|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111353310|NCT00003814|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111353311|NCT00003814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111353312|NCT00003814|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
111353313|NCT00003814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111353314|NCT00003814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111353315|NCT00003832|Bromodeoxyuridine|bromodeoxyuridine|mesh-list
111353316|NCT00003832|5-bromouridine|5-bromouridine|mesh-list
111353317|NCT00003832|Antimetabolites|antimetabolites|mesh-ancestor
111353318|NCT00003832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111353319|NCT00003832|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111353320|NCT00003832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111353321|NCT00003832|Antiviral Agents|antiviral agents|mesh-ancestor
111353322|NCT00003832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111353323|NCT00003850|Thalidomide|thalidomide|mesh-list
111353324|NCT00003850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111353325|NCT00003850|Immunologic Factors|immunologic factors|mesh-ancestor
111353326|NCT00003850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111353327|NCT00003850|Leprostatic Agents|leprostatic agents|mesh-ancestor
111353328|NCT00003850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111353329|NCT00003850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111353330|NCT00003850|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111353331|NCT00003850|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111353332|NCT00003850|Growth Substances|growth substances|mesh-ancestor
111353333|NCT00003850|Growth Inhibitors|growth inhibitors|mesh-ancestor
111353334|NCT00003850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111353335|NCT00004072|Carmustine|carmustine|mesh-list
111353336|NCT00004072|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
111353337|NCT00004072|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111353338|NCT00004072|Alkylating Agents|alkylating agents|mesh-ancestor
111353339|NCT00004072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111353340|NCT00004072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111353341|NCT00004072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111353342|NCT00004078|Irinotecan|irinotecan|mesh-list
111353343|NCT00004078|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111353344|NCT00004078|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111353345|NCT00004078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111353346|NCT00004078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111353347|NCT00004078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111353348|NCT00003856|Temoporfin|temoporfin|mesh-list
111353349|NCT00003856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111353350|NCT00003856|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111353351|NCT00003856|Dermatologic Agents|dermatologic agents|mesh-ancestor
111353352|NCT00014222|Paclitaxel|paclitaxel|mesh-list
111353353|NCT00014222|Cyclophosphamide|cyclophosphamide|mesh-list
111353354|NCT00014222|Doxorubicin|doxorubicin|mesh-list
111353355|NCT00014222|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111353356|NCT00014222|Fluorouracil|fluorouracil|mesh-list
111353357|NCT00014222|Epirubicin|epirubicin|mesh-list
111353358|NCT00014222|Epoetin Alfa|epoetin alfa|mesh-list
111353359|NCT00014222|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111353360|NCT00014222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111353361|NCT00014222|Tubulin Modulators|tubulin modulators|mesh-ancestor
111353362|NCT00014222|Antimitotic Agents|antimitotic agents|mesh-ancestor
111353363|NCT00014222|Mitosis Modulators|mitosis modulators|mesh-ancestor
111353364|NCT00014222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111353365|NCT00014222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111353366|NCT00014222|Immunologic Factors|immunologic factors|mesh-ancestor
111353367|NCT00014222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111353368|NCT00014222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111353369|NCT00014222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111353370|NCT00014222|Alkylating Agents|alkylating agents|mesh-ancestor
111353371|NCT00014222|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111353372|NCT00014222|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111353373|NCT00014222|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111077734|NCT03375463|Hormones|hormones|mesh-ancestor
111353374|NCT00014222|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111353375|NCT00014222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111353376|NCT00014222|Antimetabolites|antimetabolites|mesh-ancestor
111353377|NCT00014222|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111353378|NCT00014222|Hematinics|hematinics|mesh-ancestor
111353379|NCT00004870|Irinotecan|irinotecan|mesh-list
111353380|NCT00004870|Oblimersen|oblimersen|mesh-list
111353381|NCT00004870|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111353382|NCT00004870|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111353383|NCT00004870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111353384|NCT00004870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111353385|NCT00004870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111353386|NCT00004084|Epratuzumab|epratuzumab|mesh-list
111353387|NCT00004084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111353388|NCT00004084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111353389|NCT00004876|Thalidomide|thalidomide|mesh-list
111353390|NCT00004876|Carboplatin|carboplatin|mesh-list
111353391|NCT00004876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111353392|NCT00004876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111353393|NCT00004876|Immunologic Factors|immunologic factors|mesh-ancestor
111353394|NCT00004876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111353395|NCT00004876|Leprostatic Agents|leprostatic agents|mesh-ancestor
111353396|NCT00004876|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111353397|NCT00004876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111353398|NCT00004876|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111353399|NCT00004876|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111353400|NCT00004876|Growth Substances|growth substances|mesh-ancestor
111353401|NCT00004876|Growth Inhibitors|growth inhibitors|mesh-ancestor
111353402|NCT00003862|Leucovorin|leucovorin|mesh-list
111353403|NCT00003862|Paclitaxel|paclitaxel|mesh-list
111353404|NCT00003862|Fluorouracil|fluorouracil|mesh-list
111353405|NCT00003862|Calcium|calcium|mesh-list
111353406|NCT00003862|Levoleucovorin|levoleucovorin|mesh-list
111353407|NCT00003862|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111353408|NCT00003862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111353409|NCT00003862|Tubulin Modulators|tubulin modulators|mesh-ancestor
111353410|NCT00003862|Antimitotic Agents|antimitotic agents|mesh-ancestor
110771931|NCT03733470|Sildenafil Citrate|sildenafil citrate|mesh-list
111353411|NCT00003862|Mitosis Modulators|mitosis modulators|mesh-ancestor
111353412|NCT00003862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111353413|NCT00003862|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111353414|NCT00003862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111353415|NCT00003862|Antimetabolites|antimetabolites|mesh-ancestor
111353416|NCT00003862|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111353417|NCT00003862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111353418|NCT00003862|Immunologic Factors|immunologic factors|mesh-ancestor
111353419|NCT00003862|Antidotes|antidotes|mesh-ancestor
111353420|NCT00003862|Protective Agents|protective agents|mesh-ancestor
111353421|NCT00003862|Vitamin B Complex|vitamin b complex|mesh-ancestor
111353422|NCT00003862|Vitamins|vitamins|mesh-ancestor
111353423|NCT00003862|Micronutrients|micronutrients|mesh-ancestor
111353424|NCT00003868|Cyclophosphamide|cyclophosphamide|mesh-list
111353425|NCT00003868|Methotrexate|methotrexate|mesh-list
111353426|NCT00003868|Antibodies|antibodies|mesh-list
111353427|NCT00003868|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111353428|NCT00003868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111353429|NCT00003868|Immunologic Factors|immunologic factors|mesh-ancestor
111353430|NCT00003868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111353431|NCT00003868|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111353432|NCT00003868|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111353433|NCT00003868|Alkylating Agents|alkylating agents|mesh-ancestor
111353434|NCT00003868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111353435|NCT00003868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111353436|NCT00003868|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111353437|NCT00003868|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111353438|NCT00003868|Abortifacient Agents|abortifacient agents|mesh-ancestor
111353439|NCT00003868|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111353440|NCT00003868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111353441|NCT00003868|Antimetabolites|antimetabolites|mesh-ancestor
111353442|NCT00003868|Dermatologic Agents|dermatologic agents|mesh-ancestor
111353443|NCT00003868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111353444|NCT00003868|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111353445|NCT00003868|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111353446|NCT00003874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111353447|NCT00003874|Antibodies|antibodies|mesh-list
110771947|NCT04731376|Hormones|hormones|mesh-ancestor
111353448|NCT00003874|Immunoglobulins|immunoglobulins|mesh-list
111353449|NCT00003874|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111353450|NCT00003874|Immunologic Factors|immunologic factors|mesh-ancestor
111353451|NCT00003874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111353452|NCT00003874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111353453|NCT00004090|Gemcitabine|gemcitabine|mesh-list
111353454|NCT00004090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111353455|NCT00004090|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111353456|NCT00004090|Antimetabolites|antimetabolites|mesh-ancestor
111353457|NCT00004090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111353458|NCT00004102|Leucovorin|leucovorin|mesh-list
111353459|NCT00004102|Fluorouracil|fluorouracil|mesh-list
111353460|NCT00004102|Oxaliplatin|oxaliplatin|mesh-list
111353461|NCT00004102|Calcium|calcium|mesh-list
111353462|NCT00004102|Levoleucovorin|levoleucovorin|mesh-list
111353463|NCT00004102|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111353464|NCT00004102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111353465|NCT00004102|Antimetabolites|antimetabolites|mesh-ancestor
111353466|NCT00004102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111353467|NCT00004102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111353468|NCT00004102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110771972|NCT01296204|Antibodies|antibodies|mesh-list
111353469|NCT00004102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111353470|NCT00004102|Immunologic Factors|immunologic factors|mesh-ancestor
111353471|NCT00004102|Antidotes|antidotes|mesh-ancestor
111353472|NCT00004102|Protective Agents|protective agents|mesh-ancestor
111353473|NCT00004102|Vitamin B Complex|vitamin b complex|mesh-ancestor
111353474|NCT00004102|Vitamins|vitamins|mesh-ancestor
111353475|NCT00004102|Micronutrients|micronutrients|mesh-ancestor
111353476|NCT00003880|Paclitaxel|paclitaxel|mesh-list
111353477|NCT00003880|Carboplatin|carboplatin|mesh-list
111353478|NCT00003880|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111353479|NCT00003880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111353480|NCT00003880|Tubulin Modulators|tubulin modulators|mesh-ancestor
111353481|NCT00003880|Antimitotic Agents|antimitotic agents|mesh-ancestor
111353482|NCT00003880|Mitosis Modulators|mitosis modulators|mesh-ancestor
111353483|NCT00003880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111353484|NCT00004108|Exatecan|exatecan|mesh-list
111353485|NCT00004108|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111353486|NCT00004108|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111353487|NCT00004108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111353488|NCT00004108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111353489|NCT00004108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111353490|NCT00004900|Cyclophosphamide|cyclophosphamide|mesh-list
111353491|NCT00004900|Thiotepa|thiotepa|mesh-list
111353492|NCT00004900|Carboplatin|carboplatin|mesh-list
111353493|NCT00004900|Etoposide|etoposide|mesh-list
111353494|NCT00004900|Anastrozole|anastrozole|mesh-list
111353495|NCT00004900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111353496|NCT00004900|Immunologic Factors|immunologic factors|mesh-ancestor
111353497|NCT00004900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111353498|NCT00004900|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111353499|NCT00004900|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111353500|NCT00004900|Alkylating Agents|alkylating agents|mesh-ancestor
111353501|NCT00004900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111353502|NCT00004900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111353503|NCT00004900|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111353504|NCT00004900|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111353505|NCT00004900|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111353506|NCT00004900|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111353507|NCT00004900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111353508|NCT00004900|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111353509|NCT00004900|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111353510|NCT00004900|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111353511|NCT00004900|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111353512|NCT00004900|Hormone Antagonists|hormone antagonists|mesh-ancestor
111353513|NCT00004900|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111353514|NCT00004114|Cytarabine|cytarabine|mesh-list
111353515|NCT00004114|Cyclophosphamide|cyclophosphamide|mesh-list
111353516|NCT00004114|Fludarabine|fludarabine|mesh-list
111353517|NCT00004114|Fludarabine phosphate|fludarabine phosphate|mesh-list
111353518|NCT00004114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111353519|NCT00004114|Immunologic Factors|immunologic factors|mesh-ancestor
111353520|NCT00004114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111353521|NCT00004114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111353522|NCT00004114|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111353523|NCT00004114|Alkylating Agents|alkylating agents|mesh-ancestor
111353524|NCT00004114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111353525|NCT00004114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111353526|NCT00004114|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111353527|NCT00004114|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111353528|NCT00004114|Antimetabolites|antimetabolites|mesh-ancestor
111353529|NCT00004114|Antiviral Agents|antiviral agents|mesh-ancestor
111353530|NCT00004114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111353531|NCT00004906|Pamidronate|pamidronate|mesh-list
111353532|NCT00004906|Cyclophosphamide|cyclophosphamide|mesh-list
111353533|NCT00004906|Thiotepa|thiotepa|mesh-list
111353534|NCT00004906|Carboplatin|carboplatin|mesh-list
111353535|NCT00004906|Docetaxel|docetaxel|mesh-list
111353536|NCT00004906|Doxorubicin|doxorubicin|mesh-list
111353537|NCT00004906|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111353538|NCT00004906|Etoposide|etoposide|mesh-list
111353539|NCT00004906|Anastrozole|anastrozole|mesh-list
111353540|NCT00004906|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111353541|NCT00004906|Immunologic Factors|immunologic factors|mesh-ancestor
111353542|NCT00004906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111353543|NCT00004906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111353544|NCT00004906|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111353545|NCT00004906|Alkylating Agents|alkylating agents|mesh-ancestor
111353546|NCT00004906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111353547|NCT00004906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111353548|NCT00004906|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111353549|NCT00004906|Tubulin Modulators|tubulin modulators|mesh-ancestor
111353550|NCT00004906|Antimitotic Agents|antimitotic agents|mesh-ancestor
111353551|NCT00004906|Mitosis Modulators|mitosis modulators|mesh-ancestor
111353552|NCT00004906|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111353553|NCT00004906|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111353554|NCT00004906|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111353555|NCT00004906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111353556|NCT00004906|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111353557|NCT00004906|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111353558|NCT00004906|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111353559|NCT00004906|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111353560|NCT00004906|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111353561|NCT00004906|Hormone Antagonists|hormone antagonists|mesh-ancestor
111353562|NCT00004906|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111353563|NCT00004906|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111353564|NCT00004918|Sargramostim|sargramostim|mesh-list
111353565|NCT00004918|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
111353566|NCT00004918|Immunologic Factors|immunologic factors|mesh-ancestor
111353567|NCT00004918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111353568|NCT00004918|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111353569|NCT00003892|ISIS 5132|isis 5132|mesh-list
111353570|NCT00003892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111353571|NCT00003892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111353572|NCT00003892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111353573|NCT00004132|Cyclophosphamide|cyclophosphamide|mesh-list
111353574|NCT00004132|Ifosfamide|ifosfamide|mesh-list
111353575|NCT00004132|Etoposide|etoposide|mesh-list
111353576|NCT00004132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111353577|NCT00004132|Immunologic Factors|immunologic factors|mesh-ancestor
111353578|NCT00004132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111353579|NCT00004132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111353580|NCT00004132|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111353581|NCT00004132|Alkylating Agents|alkylating agents|mesh-ancestor
111353582|NCT00004132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111353583|NCT00004132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111353584|NCT00004132|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111353585|NCT00004132|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111353586|NCT00004132|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111353587|NCT00004132|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111353588|NCT00004132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111353589|NCT00004138|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
111353590|NCT00004138|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111353591|NCT00004138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111353592|NCT05776940|Dexamethasone|dexamethasone|mesh-list
111353593|NCT05776940|Dexamethasone acetate|dexamethasone acetate|mesh-list
111353594|NCT05776940|Bortezomib|bortezomib|mesh-list
111353595|NCT05776940|Daratumumab|daratumumab|mesh-list
111353596|NCT05776940|BB 1101|bb 1101|mesh-list
111353597|NCT05776940|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111353598|NCT05776940|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111353599|NCT05776940|Antiemetics|antiemetics|mesh-ancestor
111353600|NCT05776940|Autonomic Agents|autonomic agents|mesh-ancestor
111353601|NCT05776940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111353602|NCT05776940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111353603|NCT05776940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111353604|NCT05776940|Glucocorticoids|glucocorticoids|mesh-ancestor
111353605|NCT05776940|Hormones|hormones|mesh-ancestor
111353606|NCT05776940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111353607|NCT05776940|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111353608|NCT05776940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111353610|NCT05776940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111353611|NCT05776940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111353612|NCT05776940|Immunologic Factors|immunologic factors|mesh-ancestor
111353613|NCT05776758|Cisplatin|cisplatin|mesh-list
111353614|NCT05776758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111353615|NCT05776407|Cyclophosphamide|cyclophosphamide|mesh-list
111353616|NCT05776407|Fludarabine|fludarabine|mesh-list
111353617|NCT05776407|Etoposide|etoposide|mesh-list
111353618|NCT05776407|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111353619|NCT05776407|Immunologic Factors|immunologic factors|mesh-ancestor
111353620|NCT05776407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111353621|NCT05776407|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111353622|NCT05776407|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111353623|NCT05776407|Alkylating Agents|alkylating agents|mesh-ancestor
111353624|NCT05776407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111353625|NCT05776407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111353626|NCT05776407|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111353627|NCT05776407|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111353628|NCT05776407|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111353629|NCT05776407|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111353630|NCT05776407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111353631|NCT05776212|Fluorides|fluorides|mesh-list
111353632|NCT05776212|Cariostatic Agents|cariostatic agents|mesh-ancestor
111353633|NCT05776212|Protective Agents|protective agents|mesh-ancestor
111353634|NCT05776212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111353635|NCT05776186|Bupivacaine|bupivacaine|mesh-list
111353636|NCT05776186|Anesthetics, Local|anesthetics, local|mesh-ancestor
111353637|NCT05776186|Anesthetics|anesthetics|mesh-ancestor
111353638|NCT05776186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111353639|NCT05776186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111353640|NCT05776186|Sensory System Agents|sensory system agents|mesh-ancestor
110772054|NCT03844932|Cyclosporine|cyclosporine|mesh-list
111353641|NCT05776186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111353642|NCT05776043|Dapagliflozin|dapagliflozin|mesh-list
111353643|NCT05776043|Empagliflozin|empagliflozin|mesh-list
111353644|NCT05776043|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
111353645|NCT05776043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111353646|NCT05776043|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111353647|NCT05776043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111353648|NCT05775965|Aspirin|aspirin|mesh-list
111353649|NCT05775965|Rivaroxaban|rivaroxaban|mesh-list
111353650|NCT05775965|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111353651|NCT05775965|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111353652|NCT05775965|Analgesics|analgesics|mesh-ancestor
111353653|NCT05775965|Sensory System Agents|sensory system agents|mesh-ancestor
111353654|NCT05775965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111353655|NCT05775965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111353656|NCT05775965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111353657|NCT05775965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111353658|NCT05775965|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111353659|NCT05775965|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111353660|NCT05775965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111353661|NCT05775965|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111353662|NCT05775965|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111353663|NCT05775965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111353664|NCT05775965|Antipyretics|antipyretics|mesh-ancestor
111353665|NCT05775965|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111353666|NCT05775965|Antithrombins|antithrombins|mesh-ancestor
111353667|NCT05775965|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111353668|NCT05775965|Protease Inhibitors|protease inhibitors|mesh-ancestor
111353669|NCT05775965|Anticoagulants|anticoagulants|mesh-ancestor
111353670|NCT05775939|Deoxyglucose|deoxyglucose|mesh-list
111353671|NCT05775939|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
111353672|NCT05775939|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111353673|NCT05775939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111353674|NCT05775939|Antimetabolites|antimetabolites|mesh-ancestor
111353675|NCT05775939|Antiviral Agents|antiviral agents|mesh-ancestor
111353676|NCT05775939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111353677|NCT05775900|Capecitabine|capecitabine|mesh-list
111353678|NCT05775900|Cetuximab|cetuximab|mesh-list
111353679|NCT05775900|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111353680|NCT05775900|Antimetabolites|antimetabolites|mesh-ancestor
111353681|NCT05775900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111353682|NCT05775900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111353683|NCT05775900|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111353684|NCT05775874|Tislelizumab|tislelizumab|mesh-list
111353685|NCT05775874|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
111353686|NCT05775874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111353687|NCT05775874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111353688|NCT05775874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111353689|NCT05775861|Dexmedetomidine|dexmedetomidine|mesh-list
111353690|NCT05775861|Ropivacaine|ropivacaine|mesh-list
111353691|NCT05775861|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111353692|NCT05775861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111353693|NCT05775861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111353694|NCT05775861|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111353695|NCT05775861|Analgesics|analgesics|mesh-ancestor
111353696|NCT05775861|Sensory System Agents|sensory system agents|mesh-ancestor
111353697|NCT05775861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111353698|NCT05775861|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111353699|NCT05775861|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111353700|NCT05775861|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111353701|NCT05775861|Adrenergic Agents|adrenergic agents|mesh-ancestor
111353702|NCT05775861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111353703|NCT05775861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111353704|NCT05775861|Anesthetics, Local|anesthetics, local|mesh-ancestor
111353705|NCT05775861|Anesthetics|anesthetics|mesh-ancestor
111353706|NCT05775770|Insulin|insulin|mesh-list
111353707|NCT05775770|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111353708|NCT05775770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111353709|NCT05775705|Antibodies|antibodies|mesh-list
111353710|NCT05775705|Immunologic Factors|immunologic factors|mesh-ancestor
111353711|NCT05775705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111353712|NCT05775692|Fluconazole|fluconazole|mesh-list
111353713|NCT05775692|Antifungal Agents|antifungal agents|mesh-ancestor
111353714|NCT05775692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111353715|NCT05775692|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111353716|NCT05775692|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111353717|NCT05775692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111353718|NCT05775692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111353719|NCT05775692|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111353720|NCT05775692|Hormone Antagonists|hormone antagonists|mesh-ancestor
111353721|NCT05775692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111353722|NCT05775692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111353723|NCT05775692|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111353724|NCT05775692|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111353725|NCT05775536|Aspirin|aspirin|mesh-list
111353726|NCT05775536|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111353727|NCT05775536|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111353728|NCT05775536|Analgesics|analgesics|mesh-ancestor
111353729|NCT05775536|Sensory System Agents|sensory system agents|mesh-ancestor
111353730|NCT05775536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111353731|NCT05775536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111353732|NCT05775536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111353733|NCT05775536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111353734|NCT05775536|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111353735|NCT05775536|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111353736|NCT05775536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111353737|NCT05775536|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111353738|NCT05775536|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111353739|NCT05775536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111353740|NCT05775536|Antipyretics|antipyretics|mesh-ancestor
111353741|NCT00004126|Paclitaxel|paclitaxel|mesh-list
111353742|NCT00004126|Oxaliplatin|oxaliplatin|mesh-list
111353743|NCT00004126|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111353744|NCT00004126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111353745|NCT00004126|Tubulin Modulators|tubulin modulators|mesh-ancestor
111353746|NCT00004126|Antimitotic Agents|antimitotic agents|mesh-ancestor
111353747|NCT00004126|Mitosis Modulators|mitosis modulators|mesh-ancestor
111353748|NCT00004126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111353749|NCT05774964|Folic Acid|folic acid|mesh-list
111353750|NCT05774964|Vitamin A|vitamin a|mesh-list
111353751|NCT05774964|Metronidazole|metronidazole|mesh-list
111353752|NCT05774964|Oxaliplatin|oxaliplatin|mesh-list
111353753|NCT05774964|Cetuximab|cetuximab|mesh-list
111353754|NCT05774964|Tegafur|tegafur|mesh-list
111353755|NCT05774964|Vitamins|vitamins|mesh-ancestor
111353756|NCT05774964|Micronutrients|micronutrients|mesh-ancestor
111353757|NCT05774964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111353758|NCT05774964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111353759|NCT05774964|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111353760|NCT05774964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111353761|NCT05774964|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111353762|NCT05774964|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111353763|NCT05774964|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111353764|NCT05774964|Hematinics|hematinics|mesh-ancestor
111353765|NCT05774964|Vitamin B Complex|vitamin b complex|mesh-ancestor
111353766|NCT05774964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111353767|NCT05774964|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111353768|NCT05774964|Antimetabolites|antimetabolites|mesh-ancestor
111353769|NCT05773976|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111353770|NCT05773976|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111353771|NCT05773963|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111353772|NCT05773963|Lubricant Eye Drops|lubricant eye drops|mesh-list
111353773|NCT05773963|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111353774|NCT05773222|Apixaban|apixaban|mesh-list
111353775|NCT05773222|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111353776|NCT05773222|Antithrombins|antithrombins|mesh-ancestor
111353777|NCT05773222|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111353778|NCT05773222|Protease Inhibitors|protease inhibitors|mesh-ancestor
111353779|NCT05773222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111353780|NCT05773222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111353781|NCT05773222|Anticoagulants|anticoagulants|mesh-ancestor
111353782|NCT05638594|Carboplatin|carboplatin|mesh-list
111353783|NCT05638594|Docetaxel|docetaxel|mesh-list
111353784|NCT05638594|Trastuzumab|trastuzumab|mesh-list
111353785|NCT05638594|Letrozole|letrozole|mesh-list
111353786|NCT05638594|Pertuzumab|pertuzumab|mesh-list
111353787|NCT05638594|Hormones|hormones|mesh-list
111353788|NCT05638594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111353789|NCT05638594|Tubulin Modulators|tubulin modulators|mesh-ancestor
111353790|NCT05638594|Antimitotic Agents|antimitotic agents|mesh-ancestor
111353791|NCT05638594|Mitosis Modulators|mitosis modulators|mesh-ancestor
111353792|NCT05638594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111353793|NCT05638594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111353794|NCT05638594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111353795|NCT05638594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111353796|NCT05638594|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111353797|NCT05638594|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111353798|NCT05638594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111353799|NCT05638594|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111353800|NCT05638594|Hormone Antagonists|hormone antagonists|mesh-ancestor
111353801|NCT05635227|Dexamethasone|dexamethasone|mesh-list
111353802|NCT05635227|Olanzapine|olanzapine|mesh-list
111353803|NCT05635227|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
111353804|NCT05635227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111353805|NCT05635227|Antiemetics|antiemetics|mesh-ancestor
111353806|NCT05635227|Autonomic Agents|autonomic agents|mesh-ancestor
111353807|NCT05635227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111353808|NCT05635227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111353809|NCT05635227|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111353810|NCT05635227|Glucocorticoids|glucocorticoids|mesh-ancestor
111353811|NCT05635227|Hormones|hormones|mesh-ancestor
111353812|NCT05635227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111353813|NCT05635227|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111353814|NCT05635227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111353815|NCT05635227|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111353816|NCT05635227|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111353817|NCT05635227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111353818|NCT05635227|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111353819|NCT05635227|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111353820|NCT05635227|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111353821|NCT05635227|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111353822|NCT05635227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111353823|NCT05635227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111353824|NCT05635227|Serotonin Agents|serotonin agents|mesh-ancestor
111353825|NCT05493475|Fentanyl|fentanyl|mesh-list
111353826|NCT05493475|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111353827|NCT05493475|Narcotics|narcotics|mesh-ancestor
111353828|NCT05493475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111353829|NCT05493475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111353830|NCT05493475|Analgesics|analgesics|mesh-ancestor
111353831|NCT05493475|Sensory System Agents|sensory system agents|mesh-ancestor
111353832|NCT05493475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111353833|NCT05493475|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111353834|NCT05493475|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111353835|NCT05493475|Anesthetics, General|anesthetics, general|mesh-ancestor
111353837|NCT05463341|Fentanyl|fentanyl|mesh-list
111353838|NCT05463341|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111353839|NCT05463341|Narcotics|narcotics|mesh-ancestor
111353840|NCT05463341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111353841|NCT05463341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111353842|NCT05463341|Analgesics|analgesics|mesh-ancestor
111353843|NCT05463341|Sensory System Agents|sensory system agents|mesh-ancestor
111353844|NCT05463341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111353845|NCT05463341|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111353846|NCT05463341|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111353847|NCT05463341|Anesthetics, General|anesthetics, general|mesh-ancestor
111353848|NCT05463341|Anesthetics|anesthetics|mesh-ancestor
111353849|NCT05429970|Etodolac|etodolac|mesh-list
111353850|NCT05429970|Propofol|propofol|mesh-list
111353851|NCT05429970|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111353852|NCT05429970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111353853|NCT05429970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111353854|NCT05429970|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111353855|NCT05429970|Anesthetics, General|anesthetics, general|mesh-ancestor
111353856|NCT05429970|Anesthetics|anesthetics|mesh-ancestor
111353857|NCT05429970|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111353858|NCT05429970|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111353859|NCT05429970|Analgesics|analgesics|mesh-ancestor
111353860|NCT05429970|Sensory System Agents|sensory system agents|mesh-ancestor
111353861|NCT05429970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111353862|NCT05429970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111353863|NCT05429970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111353864|NCT05429970|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111353865|NCT05429970|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111353866|NCT05429970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111353867|NCT05429970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111353868|NCT05376904|Ropivacaine|ropivacaine|mesh-list
111353869|NCT05376904|Anesthetics, Local|anesthetics, local|mesh-ancestor
111353870|NCT05376904|Anesthetics|anesthetics|mesh-ancestor
111353871|NCT05376904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111353872|NCT05376904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111353873|NCT05376904|Sensory System Agents|sensory system agents|mesh-ancestor
111353874|NCT05376904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111353875|NCT05329740|Methylprednisolone|methylprednisolone|mesh-list
111353876|NCT05329740|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111353877|NCT05329740|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111353878|NCT05329740|Prednisolone|prednisolone|mesh-list
111353879|NCT05329740|Prednisolone acetate|prednisolone acetate|mesh-list
111353880|NCT05329740|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111353881|NCT05329740|Prednisolone phosphate|prednisolone phosphate|mesh-list
111353882|NCT05329740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111353883|NCT05329740|Antiemetics|antiemetics|mesh-ancestor
111353884|NCT05329740|Autonomic Agents|autonomic agents|mesh-ancestor
111353885|NCT05329740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111353886|NCT05329740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111353887|NCT05329740|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111353888|NCT05329740|Glucocorticoids|glucocorticoids|mesh-ancestor
111353889|NCT05329740|Hormones|hormones|mesh-ancestor
111353890|NCT05329740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111353891|NCT05329740|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111353892|NCT05329740|Protective Agents|protective agents|mesh-ancestor
111353893|NCT05329740|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111353894|NCT05329740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111353895|NCT05298670|Metformin|metformin|mesh-list
111353896|NCT05298670|Interferons|interferons|mesh-list
111353897|NCT05298670|Interferon-beta|interferon-beta|mesh-list
111353898|NCT05298670|Interferon beta-1a|interferon beta-1a|mesh-list
111353899|NCT05298670|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111353900|NCT05298670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111353901|NCT05298670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111353902|NCT05298670|Antiviral Agents|antiviral agents|mesh-ancestor
111353903|NCT05298670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111353904|NCT05298670|Immunologic Factors|immunologic factors|mesh-ancestor
111353905|NCT05298670|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111353906|NCT05297851|Niacinamide|niacinamide|mesh-list
111353907|NCT05297851|Niacin|niacin|mesh-list
111078272|NCT02929485|Tolcapone|tolcapone|mesh-list
111353908|NCT05297851|Nicotinic Acids|nicotinic acids|mesh-list
111353909|NCT05297851|Riboflavin|riboflavin|mesh-list
111353910|NCT05297851|Vitamin B Complex|vitamin b complex|mesh-ancestor
111353911|NCT05297851|Vitamins|vitamins|mesh-ancestor
111353912|NCT05297851|Micronutrients|micronutrients|mesh-ancestor
111353913|NCT05297851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111353914|NCT05297851|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111353915|NCT05297851|Antimetabolites|antimetabolites|mesh-ancestor
111353916|NCT05297851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111353917|NCT05297851|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111353918|NCT05297851|Vasodilator Agents|vasodilator agents|mesh-ancestor
111353919|NCT05297851|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111353920|NCT05297851|Dermatologic Agents|dermatologic agents|mesh-ancestor
111353921|NCT05252598|Psilocybin|psilocybin|mesh-list
111353922|NCT05252598|Hallucinogens|hallucinogens|mesh-ancestor
111353923|NCT05252598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111353924|NCT05252598|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111353925|NCT05223829|Brexanolone|brexanolone|mesh-list
111353926|NCT05223829|Neurosteroids|neurosteroids|mesh-ancestor
111353927|NCT05223829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111353928|NCT05223829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111353929|NCT05223829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111353930|NCT05223829|GABA Modulators|gaba modulators|mesh-ancestor
111353931|NCT05223829|GABA Agents|gaba agents|mesh-ancestor
111353932|NCT05180006|Bevacizumab|bevacizumab|mesh-list
111353933|NCT05180006|Trastuzumab|trastuzumab|mesh-list
111353934|NCT05180006|Atezolizumab|atezolizumab|mesh-list
111353935|NCT05180006|Pertuzumab|pertuzumab|mesh-list
111353936|NCT05180006|Ipatasertib|ipatasertib|mesh-list
111353937|NCT05180006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111353938|NCT05180006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111353939|NCT05180006|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111353940|NCT05180006|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111353941|NCT05180006|Growth Substances|growth substances|mesh-ancestor
111353942|NCT05180006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111353943|NCT05180006|Growth Inhibitors|growth inhibitors|mesh-ancestor
111353944|NCT05180006|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111353945|NCT05180006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111353946|NCT05180006|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111353947|NCT05180006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111353948|NCT05148884|Befiradol|befiradol|mesh-list
111353949|NCT05148884|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111353950|NCT05148884|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111353951|NCT05148884|Serotonin Agents|serotonin agents|mesh-ancestor
111353952|NCT05148884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111353953|NCT05148884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111353954|NCT05148884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111353955|NCT05099666|Doxorubicin|doxorubicin|mesh-list
111353956|NCT05099666|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111353957|NCT05099666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111353958|NCT05099666|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111353959|NCT05099666|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111353960|NCT05099666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111353961|NCT05099666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111353962|NCT05042817|Sufentanil|sufentanil|mesh-list
111353963|NCT05042817|Morphine|morphine|mesh-list
111353964|NCT05042817|Prilocaine|prilocaine|mesh-list
111353965|NCT05042817|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111353966|NCT05042817|Narcotics|narcotics|mesh-ancestor
111353967|NCT05042817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111353968|NCT05042817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111353969|NCT05042817|Analgesics|analgesics|mesh-ancestor
111353970|NCT05042817|Sensory System Agents|sensory system agents|mesh-ancestor
111353971|NCT05042817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111353972|NCT05042817|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111353973|NCT05042817|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111353974|NCT05042817|Anesthetics, General|anesthetics, general|mesh-ancestor
111353975|NCT05042817|Anesthetics|anesthetics|mesh-ancestor
111353976|NCT05042817|Anesthetics, Local|anesthetics, local|mesh-ancestor
111353977|NCT04914234|Metoprolol|metoprolol|mesh-list
111353978|NCT04914234|Atenolol|atenolol|mesh-list
111353979|NCT04914234|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111353980|NCT04914234|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111353981|NCT04914234|Sympatholytics|sympatholytics|mesh-ancestor
111353982|NCT04914234|Autonomic Agents|autonomic agents|mesh-ancestor
111353983|NCT04914234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111353984|NCT04914234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111353985|NCT04914234|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
111353986|NCT04914234|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111353987|NCT04914234|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111353988|NCT04914234|Adrenergic Agents|adrenergic agents|mesh-ancestor
111353989|NCT04914234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111353990|NCT04914234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111353991|NCT04895566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111353992|NCT04895566|Antibodies|antibodies|mesh-list
111353993|NCT04895566|Immunoglobulins|immunoglobulins|mesh-list
111353994|NCT04895566|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111353995|NCT04895566|Immunologic Factors|immunologic factors|mesh-ancestor
111353996|NCT04895566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111353997|NCT04895566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111353998|NCT04779320|Vedolizumab|vedolizumab|mesh-list
111353999|NCT04779320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111354000|NCT04779307|Vedolizumab|vedolizumab|mesh-list
111354001|NCT04779307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111354002|NCT04762199|Osimertinib|osimertinib|mesh-list
111354003|NCT04762199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111354004|NCT04762199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111354005|NCT04762199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110772169|NCT03882970|Hormones|hormones|mesh-ancestor
111354006|NCT04762199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111354007|NCT04737187|Trifluridine|trifluridine|mesh-list
111354008|NCT04737187|Bevacizumab|bevacizumab|mesh-list
111354009|NCT04737187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111354010|NCT04737187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111354011|NCT04737187|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111354012|NCT04737187|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111354013|NCT04737187|Growth Substances|growth substances|mesh-ancestor
111354014|NCT04737187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111354015|NCT04737187|Growth Inhibitors|growth inhibitors|mesh-ancestor
111354016|NCT04737187|Antimetabolites|antimetabolites|mesh-ancestor
111354017|NCT04737187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111354018|NCT04737187|Antiviral Agents|antiviral agents|mesh-ancestor
111354019|NCT04737187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111354020|NCT04733157|Tranexamic Acid|tranexamic acid|mesh-list
111354021|NCT04733157|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111354022|NCT04733157|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111354023|NCT04733157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111354024|NCT04733157|Hemostatics|hemostatics|mesh-ancestor
111354025|NCT04733157|Coagulants|coagulants|mesh-ancestor
111354026|NCT04723147|Levodopa|levodopa|mesh-list
111354027|NCT04723147|Carbidopa|carbidopa|mesh-list
111354028|NCT04723147|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
111354029|NCT04723147|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111354030|NCT04723147|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111354031|NCT04723147|Dopamine Agents|dopamine agents|mesh-ancestor
111354032|NCT04723147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111354033|NCT04723147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111354034|NCT04723147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111354035|NCT04723147|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
111354036|NCT04723147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111354037|NCT04723147|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111354038|NCT04723147|Immunologic Factors|immunologic factors|mesh-ancestor
111354039|NCT04723147|Dopamine Agonists|dopamine agonists|mesh-ancestor
111354040|NCT04659174|Xanomeline|xanomeline|mesh-list
111354041|NCT04659174|Trospium chloride|trospium chloride|mesh-list
111354042|NCT04659174|Parasympatholytics|parasympatholytics|mesh-ancestor
111354043|NCT04659174|Autonomic Agents|autonomic agents|mesh-ancestor
111354044|NCT04659174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111354045|NCT04659174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111354046|NCT04659174|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111354047|NCT04659174|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111354048|NCT04659174|Cholinergic Agents|cholinergic agents|mesh-ancestor
111354049|NCT04659174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111354050|NCT04659174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111354051|NCT04659174|Urological Agents|urological agents|mesh-ancestor
111354052|NCT04659174|Parasympathomimetics|parasympathomimetics|mesh-ancestor
111354053|NCT04659174|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111354054|NCT04659174|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
111354055|NCT04659174|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111354056|NCT04653662|Carbamide Peroxide|carbamide peroxide|mesh-list
111354057|NCT04653662|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111354058|NCT04653662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111354059|NCT04633122|Sunitinib|sunitinib|mesh-list
111354060|NCT04633122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111354061|NCT04633122|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111354062|NCT04633122|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111354063|NCT04633122|Growth Substances|growth substances|mesh-ancestor
111354064|NCT04633122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111354065|NCT04633122|Growth Inhibitors|growth inhibitors|mesh-ancestor
111354066|NCT04633122|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111354067|NCT04633122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111354068|NCT04633122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111354070|NCT04500158|Anesthetics, Local|anesthetics, local|mesh-ancestor
111354071|NCT04500158|Anesthetics|anesthetics|mesh-ancestor
111354072|NCT04500158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111354073|NCT04500158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111354074|NCT04500158|Sensory System Agents|sensory system agents|mesh-ancestor
111354075|NCT04500158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111354076|NCT04500158|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111354077|NCT04500158|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111354078|NCT04500158|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111354079|NCT04500158|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111354080|NCT04500158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111354081|NCT04439279|Trametinib|trametinib|mesh-list
111354082|NCT04439279|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
111354083|NCT04439279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111354084|NCT04439279|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111354085|NCT04439279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111354086|NCT04439279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111354087|NCT04439279|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
111354088|NCT04439279|Protective Agents|protective agents|mesh-ancestor
111354089|NCT04439279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111354090|NCT04439279|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111354091|NCT04439279|Antioxidants|antioxidants|mesh-ancestor
111354092|NCT04304755|Zoledronic Acid|zoledronic acid|mesh-list
111354093|NCT04304755|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111354094|NCT04304755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111354095|NCT04273165|Etravirine|etravirine|mesh-list
111354096|NCT04273165|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111354097|NCT04273165|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111354098|NCT04273165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111354099|NCT04273165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111354100|NCT04273165|Antiviral Agents|antiviral agents|mesh-ancestor
111354101|NCT04273165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111354102|NCT04179968|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
111354103|NCT04179968|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111354104|NCT04179968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111354105|NCT04140526|Pembrolizumab|pembrolizumab|mesh-list
111354106|NCT04140526|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111354107|NCT04140526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111354108|NCT04140526|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111354109|NCT04140526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111354110|NCT04041128|Olaparib|olaparib|mesh-list
111354111|NCT04041128|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111354112|NCT04041128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111354113|NCT04041128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111354114|NCT04041128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111354115|NCT04030962|Lifitegrast|lifitegrast|mesh-list
111354116|NCT04030962|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
111354117|NCT04030962|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111354118|NCT03951753|Tirzepatide|tirzepatide|mesh-list
111354119|NCT03951753|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111354120|NCT03951753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111354121|NCT03951753|Incretins|incretins|mesh-ancestor
111354122|NCT03951753|Hormones|hormones|mesh-ancestor
111354123|NCT03951753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111354124|NCT03947671|Acetaminophen|acetaminophen|mesh-list
111354125|NCT03947671|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111354126|NCT03947671|Analgesics|analgesics|mesh-ancestor
111354127|NCT03947671|Sensory System Agents|sensory system agents|mesh-ancestor
111354128|NCT03947671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111354129|NCT03947671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111354130|NCT03947671|Antipyretics|antipyretics|mesh-ancestor
111354131|NCT03941964|Azacitidine|azacitidine|mesh-list
111354132|NCT03941964|Decitabine|decitabine|mesh-list
111354133|NCT03941964|Venetoclax|venetoclax|mesh-list
111354134|NCT03941964|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111078490|NCT05127369|Fluoxetine|fluoxetine|mesh-list
111354135|NCT03941964|Antimetabolites|antimetabolites|mesh-ancestor
111354136|NCT03941964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111354137|NCT03941964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111354138|NCT03941964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111354139|NCT03837509|Daratumumab|daratumumab|mesh-list
111354140|NCT03837509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111354141|NCT03808077|Rocuronium|rocuronium|mesh-list
111354142|NCT03808077|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
111354143|NCT03808077|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
111354144|NCT03808077|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111354145|NCT03808077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111354146|NCT03808077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111354147|NCT03630705|Vaccines|vaccines|mesh-list
111354148|NCT03630705|Immunologic Factors|immunologic factors|mesh-ancestor
111354149|NCT03630705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111354150|NCT03603184|Paclitaxel|paclitaxel|mesh-list
111354151|NCT03603184|Carboplatin|carboplatin|mesh-list
111354152|NCT03603184|Atezolizumab|atezolizumab|mesh-list
111354153|NCT03603184|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111354154|NCT03603184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111354155|NCT03603184|Tubulin Modulators|tubulin modulators|mesh-ancestor
111354156|NCT03603184|Antimitotic Agents|antimitotic agents|mesh-ancestor
111354157|NCT03603184|Mitosis Modulators|mitosis modulators|mesh-ancestor
111354158|NCT03603184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111354159|NCT03603184|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111354160|NCT03603184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111354161|NCT03507452|BAY 2287411|bay 2287411|mesh-list
111354162|NCT03507452|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111354163|NCT03507452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111354164|NCT03493490|Diclofenac|diclofenac|mesh-list
111354165|NCT03493490|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111354166|NCT03493490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111354167|NCT03493490|Analgesics|analgesics|mesh-ancestor
111354168|NCT03493490|Sensory System Agents|sensory system agents|mesh-ancestor
111354169|NCT03493490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111354170|NCT03493490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111354171|NCT03493490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111354172|NCT03493490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111354173|NCT03493490|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111354174|NCT03493490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111354175|NCT03493490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111354176|NCT03377491|Paclitaxel|paclitaxel|mesh-list
111354177|NCT03377491|Gemcitabine|gemcitabine|mesh-list
111354178|NCT03377491|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111354179|NCT03377491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111354180|NCT03377491|Tubulin Modulators|tubulin modulators|mesh-ancestor
111354181|NCT03377491|Antimitotic Agents|antimitotic agents|mesh-ancestor
111354182|NCT03377491|Mitosis Modulators|mitosis modulators|mesh-ancestor
111354183|NCT03377491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111354184|NCT03377491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111354185|NCT03377491|Antimetabolites|antimetabolites|mesh-ancestor
111354186|NCT03298087|Leuprolide|leuprolide|mesh-list
111354187|NCT03298087|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111354188|NCT03298087|Fertility Agents|fertility agents|mesh-ancestor
111354189|NCT03298087|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111354190|NCT03298087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111354191|NCT03298087|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111354192|NCT03298087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111354193|NCT03297359|Dalteparin|dalteparin|mesh-list
111354194|NCT03297359|Tinzaparin|tinzaparin|mesh-list
111354195|NCT03297359|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
111354196|NCT03297359|Anticoagulants|anticoagulants|mesh-ancestor
111354197|NCT03297359|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111354198|NCT03297359|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111354199|NCT03297359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111354200|NCT03189719|Pembrolizumab|pembrolizumab|mesh-list
111354201|NCT03189719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111354202|NCT03189719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111354203|NCT03189719|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111354204|NCT03189719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111354205|NCT02889081|Vitamin D|vitamin d|mesh-list
111354206|NCT02889081|Vitamins|vitamins|mesh-ancestor
111354207|NCT02889081|Micronutrients|micronutrients|mesh-ancestor
111354208|NCT02889081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111354209|NCT02889081|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111354210|NCT02856594|Dexmedetomidine|dexmedetomidine|mesh-list
111354211|NCT02856594|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111354212|NCT02856594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111354213|NCT02856594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111354214|NCT02856594|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111354215|NCT02856594|Analgesics|analgesics|mesh-ancestor
111354216|NCT02856594|Sensory System Agents|sensory system agents|mesh-ancestor
111354217|NCT02856594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111354218|NCT02856594|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111354219|NCT02856594|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111354220|NCT02856594|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111354221|NCT02856594|Adrenergic Agents|adrenergic agents|mesh-ancestor
111354222|NCT02856594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111354223|NCT02856594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111354224|NCT02840539|Cytarabine|cytarabine|mesh-list
111354225|NCT02840539|Dexamethasone|dexamethasone|mesh-list
111354226|NCT02840539|Dexamethasone acetate|dexamethasone acetate|mesh-list
111354227|NCT02840539|Bortezomib|bortezomib|mesh-list
111354228|NCT02840539|BB 1101|bb 1101|mesh-list
111354229|NCT02840539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111354230|NCT02840539|Antiemetics|antiemetics|mesh-ancestor
111354231|NCT02840539|Autonomic Agents|autonomic agents|mesh-ancestor
111354232|NCT02840539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111354233|NCT02840539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111354234|NCT02840539|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111354235|NCT02840539|Glucocorticoids|glucocorticoids|mesh-ancestor
111354236|NCT02840539|Hormones|hormones|mesh-ancestor
111354237|NCT02840539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111354238|NCT02840539|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111354239|NCT02840539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111354240|NCT02840539|Protease Inhibitors|protease inhibitors|mesh-ancestor
111354241|NCT02840539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111354242|NCT02840539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111354243|NCT02840539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111354244|NCT02840539|Antimetabolites|antimetabolites|mesh-ancestor
111354245|NCT02840539|Antiviral Agents|antiviral agents|mesh-ancestor
111354246|NCT02840539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111354247|NCT02840539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111354248|NCT02840539|Immunologic Factors|immunologic factors|mesh-ancestor
111354249|NCT02453594|Pembrolizumab|pembrolizumab|mesh-list
111354250|NCT02453594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111354251|NCT02453594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111354252|NCT02453594|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111354253|NCT02453594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111354254|NCT02342782|Cytarabine|cytarabine|mesh-list
111354255|NCT02342782|Etoposide|etoposide|mesh-list
111354256|NCT02342782|Melphalan|melphalan|mesh-list
111354257|NCT02342782|Carmustine|carmustine|mesh-list
111354258|NCT02342782|Basiliximab|basiliximab|mesh-list
111354259|NCT02342782|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111354260|NCT02342782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111354261|NCT02342782|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111354262|NCT02342782|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111354263|NCT02342782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111354264|NCT02342782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111354265|NCT02342782|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111354266|NCT02342782|Antimetabolites|antimetabolites|mesh-ancestor
111354267|NCT02342782|Antiviral Agents|antiviral agents|mesh-ancestor
111354268|NCT02342782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111354269|NCT02342782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111354270|NCT02342782|Immunologic Factors|immunologic factors|mesh-ancestor
111354271|NCT02342782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111354272|NCT02342782|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111354273|NCT02342782|Alkylating Agents|alkylating agents|mesh-ancestor
111354274|NCT02342782|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111354275|NCT02291055|Durvalumab|durvalumab|mesh-list
111354276|NCT02291055|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111354277|NCT02291055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111354278|NCT02112864|Dexamethasone|dexamethasone|mesh-list
111354279|NCT02112864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111354280|NCT02112864|Antiemetics|antiemetics|mesh-ancestor
111354281|NCT02112864|Autonomic Agents|autonomic agents|mesh-ancestor
111354282|NCT02112864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111354283|NCT02112864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111354284|NCT02112864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111354285|NCT02112864|Glucocorticoids|glucocorticoids|mesh-ancestor
111354286|NCT02112864|Hormones|hormones|mesh-ancestor
111354287|NCT02112864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111354288|NCT02112864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111354289|NCT02112864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111354290|NCT01237457|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
111354291|NCT01237457|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111354292|NCT01237457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111354293|NCT00723697|Buprenorphine|buprenorphine|mesh-list
111354294|NCT00723697|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111354295|NCT00723697|Narcotics|narcotics|mesh-ancestor
111354296|NCT00723697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111354297|NCT00723697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111354298|NCT00723697|Analgesics|analgesics|mesh-ancestor
111354299|NCT00723697|Sensory System Agents|sensory system agents|mesh-ancestor
111354300|NCT00723697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111354301|NCT00723697|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111354302|NCT00684073|Buprenorphine|buprenorphine|mesh-list
111354303|NCT00684073|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
111354304|NCT00684073|Naloxone|naloxone|mesh-list
111354305|NCT00684073|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111354306|NCT00684073|Narcotics|narcotics|mesh-ancestor
111354307|NCT00684073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111354308|NCT00684073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111354309|NCT00684073|Analgesics|analgesics|mesh-ancestor
111354310|NCT00684073|Sensory System Agents|sensory system agents|mesh-ancestor
111354311|NCT00684073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111354312|NCT00684073|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111354313|NCT00603109|Rimonabant|rimonabant|mesh-list
111354314|NCT00603109|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111354315|NCT00603109|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
111354316|NCT00603109|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
111354317|NCT00603109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111354318|NCT00603109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111354319|NCT00603109|Hormones|hormones|mesh-ancestor
111354320|NCT00603109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111354321|NCT00603109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111354322|NCT00199095|Cytarabine|cytarabine|mesh-list
111354323|NCT00199095|Dexamethasone|dexamethasone|mesh-list
111354324|NCT00199095|Cyclophosphamide|cyclophosphamide|mesh-list
111354325|NCT00199095|Ifosfamide|ifosfamide|mesh-list
111354326|NCT00199095|Methotrexate|methotrexate|mesh-list
111354327|NCT00199095|Vincristine|vincristine|mesh-list
111354328|NCT00199095|Doxorubicin|doxorubicin|mesh-list
111354329|NCT00199095|Mercaptopurine|mercaptopurine|mesh-list
111354330|NCT00199095|Idarubicin|idarubicin|mesh-list
111354331|NCT00199095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111354332|NCT00199095|Immunologic Factors|immunologic factors|mesh-ancestor
111354333|NCT00199095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111354334|NCT00199095|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111354335|NCT00199095|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111354336|NCT00199095|Alkylating Agents|alkylating agents|mesh-ancestor
111354337|NCT00199095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111354338|NCT00199095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111354339|NCT00199095|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111354340|NCT00199095|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111354341|NCT00199095|Antiemetics|antiemetics|mesh-ancestor
111354342|NCT00199095|Autonomic Agents|autonomic agents|mesh-ancestor
111354343|NCT00199095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111354344|NCT00199095|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111354345|NCT00199095|Glucocorticoids|glucocorticoids|mesh-ancestor
111354346|NCT00199095|Hormones|hormones|mesh-ancestor
111354347|NCT00199095|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111354348|NCT00199095|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111354349|NCT00199095|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111354350|NCT00199095|Abortifacient Agents|abortifacient agents|mesh-ancestor
111354351|NCT00199095|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111354352|NCT00199095|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111354353|NCT00199095|Antimetabolites|antimetabolites|mesh-ancestor
111354354|NCT00199095|Dermatologic Agents|dermatologic agents|mesh-ancestor
111354355|NCT00199095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111354356|NCT00199095|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111354357|NCT00199095|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111354358|NCT00199095|Antiviral Agents|antiviral agents|mesh-ancestor
111354359|NCT00199095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111354360|NCT00199095|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111078715|NCT02519335|Antimitotic Agents|antimitotic agents|mesh-ancestor
111354361|NCT00199095|Tubulin Modulators|tubulin modulators|mesh-ancestor
111354362|NCT00199095|Antimitotic Agents|antimitotic agents|mesh-ancestor
111354363|NCT00199095|Mitosis Modulators|mitosis modulators|mesh-ancestor
111354364|NCT00199095|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111354365|NCT00199095|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111354366|NCT00199095|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111354367|NCT00199056|Cytarabine|cytarabine|mesh-list
111354368|NCT00199056|Dexamethasone|dexamethasone|mesh-list
111354369|NCT00199056|Prednisolone|prednisolone|mesh-list
111354370|NCT00199056|Cyclophosphamide|cyclophosphamide|mesh-list
111354371|NCT00199056|Ifosfamide|ifosfamide|mesh-list
111354372|NCT00199056|Methotrexate|methotrexate|mesh-list
111354373|NCT00199056|Fludarabine|fludarabine|mesh-list
111354374|NCT00199056|Vincristine|vincristine|mesh-list
111354375|NCT00199056|Doxorubicin|doxorubicin|mesh-list
111354376|NCT00199056|Daunorubicin|daunorubicin|mesh-list
111354377|NCT00199056|Asparaginase|asparaginase|mesh-list
111354378|NCT00199056|Mercaptopurine|mercaptopurine|mesh-list
111354379|NCT00199056|Idarubicin|idarubicin|mesh-list
111354380|NCT00199056|Thioguanine|thioguanine|mesh-list
111354381|NCT00199056|Vindesine|vindesine|mesh-list
111354382|NCT00199056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111354383|NCT00199056|Immunologic Factors|immunologic factors|mesh-ancestor
111354384|NCT00199056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111354385|NCT00199056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111354386|NCT00199056|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111354387|NCT00199056|Alkylating Agents|alkylating agents|mesh-ancestor
111354388|NCT00199056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111354389|NCT00199056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111354390|NCT00199056|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111354391|NCT00199056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111354392|NCT00199056|Antiemetics|antiemetics|mesh-ancestor
111354393|NCT00199056|Autonomic Agents|autonomic agents|mesh-ancestor
111354394|NCT00199056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111354395|NCT00199056|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111354396|NCT00199056|Glucocorticoids|glucocorticoids|mesh-ancestor
111354397|NCT00199056|Hormones|hormones|mesh-ancestor
111354398|NCT00199056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111354399|NCT00199056|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111354400|NCT00199056|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111354401|NCT00199056|Abortifacient Agents|abortifacient agents|mesh-ancestor
111354402|NCT00199056|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111354403|NCT00199056|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111354404|NCT00199056|Antimetabolites|antimetabolites|mesh-ancestor
111354405|NCT00199056|Dermatologic Agents|dermatologic agents|mesh-ancestor
111354406|NCT00199056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111354407|NCT00199056|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111354408|NCT00199056|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111354409|NCT00199056|Antiviral Agents|antiviral agents|mesh-ancestor
111354410|NCT00199056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111354411|NCT00199056|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111354412|NCT00199056|Tubulin Modulators|tubulin modulators|mesh-ancestor
111354413|NCT00199056|Antimitotic Agents|antimitotic agents|mesh-ancestor
111354414|NCT00199056|Mitosis Modulators|mitosis modulators|mesh-ancestor
111354415|NCT00199056|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111354416|NCT00199056|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111354417|NCT00199056|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111354418|NCT00199030|Alemtuzumab|alemtuzumab|mesh-list
111354419|NCT00199030|Cladribine|cladribine|mesh-list
111354420|NCT00199030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111354421|NCT00199030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111354422|NCT00199030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111354423|NCT00199030|Immunologic Factors|immunologic factors|mesh-ancestor
111354424|NCT00199030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111354425|NCT00198978|Cytarabine|cytarabine|mesh-list
111354426|NCT00198978|Dexamethasone|dexamethasone|mesh-list
111354427|NCT00198978|Prednisolone|prednisolone|mesh-list
111354428|NCT00198978|Cyclophosphamide|cyclophosphamide|mesh-list
111354429|NCT00198978|Rituximab|rituximab|mesh-list
111354430|NCT00198978|Methotrexate|methotrexate|mesh-list
111354431|NCT00198978|Vincristine|vincristine|mesh-list
111354432|NCT00198978|Asparaginase|asparaginase|mesh-list
111354433|NCT00198978|Mercaptopurine|mercaptopurine|mesh-list
111354434|NCT00198978|Idarubicin|idarubicin|mesh-list
111078792|NCT03364075|Analgesics|analgesics|mesh-ancestor
111354435|NCT00198978|Lenograstim|lenograstim|mesh-list
111354436|NCT00198978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111354437|NCT00198978|Immunologic Factors|immunologic factors|mesh-ancestor
111354438|NCT00198978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111354439|NCT00198978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111354440|NCT00198978|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111354441|NCT00198978|Alkylating Agents|alkylating agents|mesh-ancestor
111354442|NCT00198978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111354443|NCT00198978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111354444|NCT00198978|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111354445|NCT00198978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111354446|NCT00198978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111354447|NCT00198978|Antiemetics|antiemetics|mesh-ancestor
111354448|NCT00198978|Autonomic Agents|autonomic agents|mesh-ancestor
111354449|NCT00198978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111354450|NCT00198978|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111354451|NCT00198978|Glucocorticoids|glucocorticoids|mesh-ancestor
111354452|NCT00198978|Hormones|hormones|mesh-ancestor
111354453|NCT00198978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111354454|NCT00198978|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111354455|NCT00198978|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111354456|NCT00198978|Abortifacient Agents|abortifacient agents|mesh-ancestor
111354457|NCT00198978|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111354458|NCT00198978|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111354459|NCT00198978|Antimetabolites|antimetabolites|mesh-ancestor
111354460|NCT00198978|Dermatologic Agents|dermatologic agents|mesh-ancestor
111354461|NCT00198978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111354462|NCT00198978|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111354463|NCT00198978|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111354464|NCT00198978|Antiviral Agents|antiviral agents|mesh-ancestor
111354465|NCT00198978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111354466|NCT00198978|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111354467|NCT00198978|Tubulin Modulators|tubulin modulators|mesh-ancestor
111354468|NCT00198978|Antimitotic Agents|antimitotic agents|mesh-ancestor
111354469|NCT00198978|Mitosis Modulators|mitosis modulators|mesh-ancestor
111354470|NCT00198978|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111354471|NCT00198978|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111354472|NCT00198978|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111354473|NCT00198978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111354474|NCT00109395|Midazolam|midazolam|mesh-list
111354475|NCT00109395|Lorazepam|lorazepam|mesh-list
111354476|NCT00109395|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111354477|NCT00109395|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111354478|NCT00109395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111354479|NCT00109395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111354480|NCT00109395|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111354481|NCT00109395|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111354482|NCT00109395|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111354483|NCT00109395|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111354484|NCT00109395|Anesthetics, General|anesthetics, general|mesh-ancestor
110772632|NCT05077488|Lidocaine|lidocaine|mesh-list
111354485|NCT00109395|Anesthetics|anesthetics|mesh-ancestor
111354486|NCT00109395|GABA Modulators|gaba modulators|mesh-ancestor
111354487|NCT00109395|GABA Agents|gaba agents|mesh-ancestor
111354488|NCT00109395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111354489|NCT00109395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111354490|NCT00109395|Anticonvulsants|anticonvulsants|mesh-ancestor
111354491|NCT00109395|Antiemetics|antiemetics|mesh-ancestor
111354492|NCT00109395|Autonomic Agents|autonomic agents|mesh-ancestor
111354493|NCT00109395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111354494|NCT00109395|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111354495|NCT01215643|Ribavirin|ribavirin|mesh-list
111354496|NCT01215643|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
111354497|NCT01215643|Antimetabolites|antimetabolites|mesh-ancestor
111354498|NCT01215643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111354499|NCT01215643|Antiviral Agents|antiviral agents|mesh-ancestor
111354500|NCT01215643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111354501|NCT00004924|Paclitaxel|paclitaxel|mesh-list
111354502|NCT00004924|Irinotecan|irinotecan|mesh-list
111354503|NCT00004924|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111354504|NCT00004924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111354505|NCT00004924|Tubulin Modulators|tubulin modulators|mesh-ancestor
111354506|NCT00004924|Antimitotic Agents|antimitotic agents|mesh-ancestor
111354507|NCT00004924|Mitosis Modulators|mitosis modulators|mesh-ancestor
111354508|NCT00004924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111354509|NCT00004924|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111354510|NCT00004924|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111354511|NCT00004924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111354512|NCT00004144|Gemcitabine|gemcitabine|mesh-list
111354513|NCT00004144|Bryostatin 1|bryostatin 1|mesh-list
111354514|NCT00004144|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111354515|NCT00004144|Antimetabolites|antimetabolites|mesh-ancestor
111078862|NCT04773405|Sympathomimetics|sympathomimetics|mesh-ancestor
111354516|NCT00004144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111354517|NCT00004144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111354518|NCT00004144|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111354519|NCT00004144|Immunologic Factors|immunologic factors|mesh-ancestor
111354520|NCT00004144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111354521|NCT00004150|Leucovorin|leucovorin|mesh-list
111354522|NCT00004150|Fluorouracil|fluorouracil|mesh-list
111354523|NCT00004150|Calcium|calcium|mesh-list
111354524|NCT00004150|Levoleucovorin|levoleucovorin|mesh-list
111354525|NCT00004150|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111354526|NCT00004150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111354527|NCT00004150|Antimetabolites|antimetabolites|mesh-ancestor
111354528|NCT00004150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111354529|NCT00004150|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111354530|NCT00004150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111354531|NCT00004150|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111354532|NCT00004150|Immunologic Factors|immunologic factors|mesh-ancestor
111354533|NCT00004150|Antidotes|antidotes|mesh-ancestor
111354534|NCT00004150|Protective Agents|protective agents|mesh-ancestor
111354535|NCT00004150|Vitamin B Complex|vitamin b complex|mesh-ancestor
111354536|NCT00004150|Vitamins|vitamins|mesh-ancestor
111354537|NCT00004150|Micronutrients|micronutrients|mesh-ancestor
111354538|NCT00004930|Doxorubicin|doxorubicin|mesh-list
111354539|NCT00004930|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111354540|NCT00004930|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111354541|NCT00004930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111354542|NCT00004930|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111354543|NCT00004930|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111354544|NCT00004930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111354545|NCT00004930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111354546|NCT00003928|Gemcitabine|gemcitabine|mesh-list
111354547|NCT00003928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111354548|NCT00003928|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111354549|NCT00003928|Antimetabolites|antimetabolites|mesh-ancestor
110772721|NCT01206972|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111354550|NCT00003928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111354551|NCT00004162|Doxorubicin|doxorubicin|mesh-list
111354552|NCT00004162|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111354553|NCT00004162|Methotrexate|methotrexate|mesh-list
111354554|NCT00004162|Vincristine|vincristine|mesh-list
111354555|NCT00004162|Sargramostim|sargramostim|mesh-list
111354556|NCT00004162|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111354557|NCT00004162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111354558|NCT00004162|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111354559|NCT00004162|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111354560|NCT00004162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111354561|NCT00004162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111354562|NCT00004162|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111354563|NCT00004162|Abortifacient Agents|abortifacient agents|mesh-ancestor
111354564|NCT00004162|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111354565|NCT00004162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111354566|NCT00004162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111354567|NCT00004162|Antimetabolites|antimetabolites|mesh-ancestor
111354568|NCT00004162|Dermatologic Agents|dermatologic agents|mesh-ancestor
111354569|NCT00004162|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111354570|NCT00004162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111354571|NCT00004162|Immunologic Factors|immunologic factors|mesh-ancestor
111354572|NCT00004162|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111354573|NCT00004162|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111354574|NCT00004162|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111354575|NCT00004162|Tubulin Modulators|tubulin modulators|mesh-ancestor
111354576|NCT00004162|Antimitotic Agents|antimitotic agents|mesh-ancestor
111354577|NCT00004162|Mitosis Modulators|mitosis modulators|mesh-ancestor
111354578|NCT00004984|Insulin|insulin|mesh-list
111354579|NCT00004984|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111354580|NCT00004984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111354581|NCT00004984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111354582|NCT00004174|Paclitaxel|paclitaxel|mesh-list
111354583|NCT00004174|Cyclophosphamide|cyclophosphamide|mesh-list
111354584|NCT00004174|Thiotepa|thiotepa|mesh-list
111354585|NCT00004174|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111354586|NCT00004174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111354587|NCT00004174|Tubulin Modulators|tubulin modulators|mesh-ancestor
111354588|NCT00004174|Antimitotic Agents|antimitotic agents|mesh-ancestor
111354589|NCT00004174|Mitosis Modulators|mitosis modulators|mesh-ancestor
111354590|NCT00004174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111078941|NCT03353857|Rifampin|rifampin|mesh-list
111354591|NCT00004174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111354592|NCT00004174|Immunologic Factors|immunologic factors|mesh-ancestor
111354593|NCT00004174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111354594|NCT00004174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111354595|NCT00004174|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111354596|NCT00004174|Alkylating Agents|alkylating agents|mesh-ancestor
111354597|NCT00004174|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111354598|NCT01284517|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
111354599|NCT01284517|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111354600|NCT01284517|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111354601|NCT01284517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111354602|NCT01284517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111354603|NCT01284517|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111354604|NCT01284517|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
111354605|NCT01284517|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111354606|NCT01284517|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111354607|NCT01284517|Adrenergic Agents|adrenergic agents|mesh-ancestor
111354608|NCT01284517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111354609|NCT01284517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111354610|NCT01284517|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111354611|NCT01284517|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111354612|NCT01284517|Serotonin Agents|serotonin agents|mesh-ancestor
111354613|NCT01284517|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111354614|NCT01284517|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111354615|NCT01284517|Dopamine Agents|dopamine agents|mesh-ancestor
111354616|NCT00004990|Dexamethasone|dexamethasone|mesh-list
111354617|NCT00004990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111354618|NCT00004990|Antiemetics|antiemetics|mesh-ancestor
111354619|NCT00004990|Autonomic Agents|autonomic agents|mesh-ancestor
111354620|NCT00004990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111354621|NCT00004990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111354622|NCT00004990|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111354623|NCT00004990|Glucocorticoids|glucocorticoids|mesh-ancestor
111354624|NCT00004990|Hormones|hormones|mesh-ancestor
111354625|NCT00004990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111354626|NCT00004990|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111354627|NCT00004990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111354628|NCT01216735|Fluticasone|fluticasone|mesh-list
111354629|NCT01216735|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111354630|NCT01216735|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111354631|NCT01216735|Autonomic Agents|autonomic agents|mesh-ancestor
111354632|NCT01216735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111354633|NCT01216735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111354634|NCT01216735|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111354635|NCT01216735|Respiratory System Agents|respiratory system agents|mesh-ancestor
111354636|NCT01216735|Dermatologic Agents|dermatologic agents|mesh-ancestor
111354637|NCT01216735|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111354638|NCT00004186|Carboplatin|carboplatin|mesh-list
111354639|NCT00004186|Etoposide|etoposide|mesh-list
111354640|NCT00004186|Topotecan|topotecan|mesh-list
111354641|NCT00004186|Ifosfamide|ifosfamide|mesh-list
111354642|NCT00004186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111354643|NCT00004186|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111354644|NCT00004186|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111354645|NCT00004186|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111354646|NCT00004186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111354647|NCT00004186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111354648|NCT00004186|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111354649|NCT00004186|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111354650|NCT00004186|Alkylating Agents|alkylating agents|mesh-ancestor
111354651|NCT00004192|Cytarabine|cytarabine|mesh-list
111354652|NCT00004192|Methylprednisolone|methylprednisolone|mesh-list
111354653|NCT00004192|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111354654|NCT00004192|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111354655|NCT00004192|Prednisolone|prednisolone|mesh-list
111354656|NCT00004192|Prednisolone acetate|prednisolone acetate|mesh-list
111354657|NCT00004192|Etoposide|etoposide|mesh-list
111354658|NCT00004192|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111354659|NCT00004192|Prednisolone phosphate|prednisolone phosphate|mesh-list
111354660|NCT00004192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111354661|NCT00004192|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111354662|NCT00004192|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111354663|NCT00004192|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111354664|NCT00004192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111354665|NCT00004192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111354666|NCT00004192|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111354667|NCT00004192|Antimetabolites|antimetabolites|mesh-ancestor
111354668|NCT00004192|Antiviral Agents|antiviral agents|mesh-ancestor
111354669|NCT00004192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111354670|NCT00004192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111354671|NCT00004192|Immunologic Factors|immunologic factors|mesh-ancestor
111354672|NCT00004192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111354673|NCT00004192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111354674|NCT00004192|Antiemetics|antiemetics|mesh-ancestor
111354675|NCT00004192|Autonomic Agents|autonomic agents|mesh-ancestor
111354676|NCT00004192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111354677|NCT00004192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111354678|NCT00004192|Glucocorticoids|glucocorticoids|mesh-ancestor
111354679|NCT00004192|Hormones|hormones|mesh-ancestor
111354680|NCT00004192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111354681|NCT00004192|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111354682|NCT00004192|Protective Agents|protective agents|mesh-ancestor
111354683|NCT00004192|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111354684|NCT00005002|Lamivudine|lamivudine|mesh-list
111354685|NCT00005002|Zidovudine|zidovudine|mesh-list
111354686|NCT00005002|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
111354687|NCT00005002|Nelfinavir|nelfinavir|mesh-list
111354688|NCT00005002|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111354689|NCT00005002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111354690|NCT00005002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111354691|NCT00005002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111354692|NCT00005002|Antiviral Agents|antiviral agents|mesh-ancestor
111354693|NCT00005002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111354694|NCT00005002|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111354695|NCT00005002|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111354696|NCT00005002|Antimetabolites|antimetabolites|mesh-ancestor
111354697|NCT00005002|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111354698|NCT00005002|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111354699|NCT00005002|Protease Inhibitors|protease inhibitors|mesh-ancestor
111354700|NCT00004198|Sargramostim|sargramostim|mesh-list
111354701|NCT00004198|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
111354702|NCT00004198|Vaccines|vaccines|mesh-list
111354703|NCT00004198|Immunologic Factors|immunologic factors|mesh-ancestor
111354704|NCT00004198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111354705|NCT00004198|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111354706|NCT01264705|Sorafenib|sorafenib|mesh-list
111354707|NCT01264705|Bavituximab|bavituximab|mesh-list
111354708|NCT01264705|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111354709|NCT01264705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111354710|NCT01264705|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111354711|NCT01264705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111354712|NCT01264705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111354713|NCT01264705|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111354714|NCT01264705|Immunologic Factors|immunologic factors|mesh-ancestor
111354715|NCT01264705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111354716|NCT00004204|Temozolomide|temozolomide|mesh-list
111354717|NCT00004204|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111354718|NCT00004204|Alkylating Agents|alkylating agents|mesh-ancestor
111354719|NCT00004204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111354720|NCT00004204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111354721|NCT01217515|Diltiazem|diltiazem|mesh-list
111354722|NCT01217515|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111354723|NCT01217515|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111354724|NCT01217515|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111354725|NCT01217515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111354726|NCT01217515|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111354727|NCT01217515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111354728|NCT01217515|Vasodilator Agents|vasodilator agents|mesh-ancestor
111354729|NCT00005014|Risperidone|risperidone|mesh-list
111354730|NCT00005014|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111354731|NCT00005014|Serotonin Agents|serotonin agents|mesh-ancestor
111354732|NCT00005014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111354733|NCT00005014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111354734|NCT00005014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111354735|NCT00005014|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111354736|NCT00005014|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111354737|NCT00005014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111354738|NCT00005014|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111354739|NCT00005014|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111354740|NCT00005014|Dopamine Agents|dopamine agents|mesh-ancestor
111354742|NCT03009799|Laxatives|laxatives|mesh-ancestor
111354743|NCT03009799|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111354744|NCT00005026|Paclitaxel|paclitaxel|mesh-list
111354745|NCT00005026|Carboplatin|carboplatin|mesh-list
111354746|NCT00005026|Topotecan|topotecan|mesh-list
111354747|NCT00005026|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111354748|NCT00005026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111354749|NCT00005026|Tubulin Modulators|tubulin modulators|mesh-ancestor
111354750|NCT00005026|Antimitotic Agents|antimitotic agents|mesh-ancestor
111354751|NCT00005026|Mitosis Modulators|mitosis modulators|mesh-ancestor
111354752|NCT00005026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111354753|NCT00005026|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111354754|NCT00005026|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111354755|NCT00005026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111354756|NCT00016718|Emtricitabine|emtricitabine|mesh-list
111354757|NCT00016718|Efavirenz|efavirenz|mesh-list
111354758|NCT00016718|Didanosine|didanosine|mesh-list
111354759|NCT00016718|Antiviral Agents|antiviral agents|mesh-ancestor
111354760|NCT00016718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111354761|NCT00016718|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111354762|NCT00016718|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111354763|NCT00016718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111354764|NCT00016718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111354765|NCT00016718|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111354766|NCT00016718|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111354767|NCT00016718|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111354768|NCT00016718|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111354769|NCT00016718|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111354770|NCT00016718|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111354771|NCT00016718|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111354772|NCT00016718|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111354773|NCT00016718|Antimetabolites|antimetabolites|mesh-ancestor
111354774|NCT00004216|Ciprofloxacin|ciprofloxacin|mesh-list
111354775|NCT00004216|Ceftriaxone|ceftriaxone|mesh-list
111354776|NCT00004216|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
111354777|NCT00004216|Cefixime|cefixime|mesh-list
111354778|NCT00004216|Trimethoprim|trimethoprim|mesh-list
111354779|NCT00004216|Sulfamethoxazole|sulfamethoxazole|mesh-list
110772945|NCT01205880|Calcitriol|calcitriol|mesh-list
111354780|NCT00004216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111354781|NCT00004216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111354782|NCT00004216|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111354783|NCT00004216|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111354784|NCT00004216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111354785|NCT00004216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111354786|NCT00004216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111354787|NCT00004216|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111354788|NCT00004216|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111354789|NCT00004216|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111354790|NCT00004216|Antimalarials|antimalarials|mesh-ancestor
111354791|NCT00004216|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111354792|NCT00004216|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111354793|NCT00004216|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111354794|NCT00004216|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111354795|NCT00004216|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
111354796|NCT00005032|Paclitaxel|paclitaxel|mesh-list
111354797|NCT00005032|Oblimersen|oblimersen|mesh-list
111354798|NCT00005032|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111354799|NCT00005032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111354800|NCT00005032|Tubulin Modulators|tubulin modulators|mesh-ancestor
111354801|NCT00005032|Antimitotic Agents|antimitotic agents|mesh-ancestor
111354802|NCT00005032|Mitosis Modulators|mitosis modulators|mesh-ancestor
111354803|NCT00005032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111354804|NCT00005038|Aldesleukin|aldesleukin|mesh-list
111354805|NCT00005038|Histamine|histamine|mesh-list
111354806|NCT00005038|Histamine phosphate|histamine phosphate|mesh-list
111354807|NCT00005038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111354808|NCT00005038|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111354809|NCT00005038|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111354810|NCT00005038|Antiviral Agents|antiviral agents|mesh-ancestor
111354811|NCT00005038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111354812|NCT00005038|Histamine Agonists|histamine agonists|mesh-ancestor
111354813|NCT00005038|Histamine Agents|histamine agents|mesh-ancestor
111354814|NCT00005038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111354815|NCT00005038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111354816|NCT00005038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111354817|NCT00019682|Aldesleukin|aldesleukin|mesh-list
111354818|NCT00019682|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
111354819|NCT00019682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111354820|NCT00019682|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111354821|NCT00019682|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111354822|NCT00019682|Antiviral Agents|antiviral agents|mesh-ancestor
111354823|NCT00019682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111354824|NCT00019682|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111354825|NCT00019682|Immunologic Factors|immunologic factors|mesh-ancestor
111354826|NCT00019682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111354827|NCT00005050|Fluorouracil|fluorouracil|mesh-list
111354828|NCT00005050|Oxaliplatin|oxaliplatin|mesh-list
111354830|NCT00005050|Antimetabolites|antimetabolites|mesh-ancestor
111354831|NCT00005050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111354832|NCT00005050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111354833|NCT00005050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111354834|NCT00005050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111354835|NCT00005050|Immunologic Factors|immunologic factors|mesh-ancestor
111354836|NCT00005050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111354837|NCT00005050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111354838|NCT00005578|Prednisone|prednisone|mesh-list
111354839|NCT00005578|Cyclophosphamide|cyclophosphamide|mesh-list
111354840|NCT00005578|Doxorubicin|doxorubicin|mesh-list
111354841|NCT00005578|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111354842|NCT00005578|Etoposide|etoposide|mesh-list
111354843|NCT00005578|Vincristine|vincristine|mesh-list
111354844|NCT00005578|Bleomycin|bleomycin|mesh-list
111354845|NCT00005578|Dexrazoxane|dexrazoxane|mesh-list
111354846|NCT00005578|Razoxane|razoxane|mesh-list
111354847|NCT00005578|Lenograstim|lenograstim|mesh-list
111354848|NCT00005578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111354849|NCT00005578|Immunologic Factors|immunologic factors|mesh-ancestor
111354850|NCT00005578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111354851|NCT00005578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111354852|NCT00005578|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111354853|NCT00005578|Alkylating Agents|alkylating agents|mesh-ancestor
111354854|NCT00005578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111354855|NCT00005578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111354856|NCT00005578|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111354857|NCT00005578|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111354858|NCT00005578|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111354859|NCT00005578|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111354860|NCT00005578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111354861|NCT00005578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111354862|NCT00005578|Glucocorticoids|glucocorticoids|mesh-ancestor
111354863|NCT00005578|Hormones|hormones|mesh-ancestor
111354864|NCT00005578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111354865|NCT00005578|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111354866|NCT00005578|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111354867|NCT00005578|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111354868|NCT00005578|Tubulin Modulators|tubulin modulators|mesh-ancestor
111354869|NCT00005578|Antimitotic Agents|antimitotic agents|mesh-ancestor
111354870|NCT00005578|Mitosis Modulators|mitosis modulators|mesh-ancestor
111354871|NCT00005578|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111354872|NCT00005578|Protective Agents|protective agents|mesh-ancestor
111354873|NCT00022490|Cytarabine|cytarabine|mesh-list
111354874|NCT00022490|Imatinib Mesylate|imatinib mesylate|mesh-list
111354875|NCT00022490|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111354876|NCT00022490|Antimetabolites|antimetabolites|mesh-ancestor
111354877|NCT00022490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111354878|NCT00022490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111354879|NCT00022490|Antiviral Agents|antiviral agents|mesh-ancestor
111354880|NCT00022490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111354881|NCT00022490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111354882|NCT00022490|Immunologic Factors|immunologic factors|mesh-ancestor
111354883|NCT00022490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111354884|NCT00022490|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111354885|NCT00022490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111354886|NCT00386230|Zidovudine|zidovudine|mesh-list
111354887|NCT00386230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111354888|NCT00386230|Antimetabolites|antimetabolites|mesh-ancestor
111354889|NCT00386230|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111354890|NCT00386230|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111354891|NCT00386230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111354892|NCT00386230|Antiviral Agents|antiviral agents|mesh-ancestor
111354893|NCT00386230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111354894|NCT00386230|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111354895|NCT00386230|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111354896|NCT00097448|Prednisone|prednisone|mesh-list
111354897|NCT00097448|Methylprednisolone|methylprednisolone|mesh-list
111354898|NCT00097448|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111354899|NCT00097448|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111354900|NCT00097448|Prednisolone|prednisolone|mesh-list
111354901|NCT00097448|Prednisolone acetate|prednisolone acetate|mesh-list
111354902|NCT00097448|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111354903|NCT00097448|Prednisolone phosphate|prednisolone phosphate|mesh-list
111354904|NCT00097448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111354905|NCT00097448|Glucocorticoids|glucocorticoids|mesh-ancestor
111354906|NCT00097448|Hormones|hormones|mesh-ancestor
111354907|NCT00097448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111354908|NCT00097448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111354909|NCT00097448|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111354910|NCT00097448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111354911|NCT00097448|Antiemetics|antiemetics|mesh-ancestor
111354912|NCT00097448|Autonomic Agents|autonomic agents|mesh-ancestor
111354913|NCT00097448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111354914|NCT00097448|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111354915|NCT00097448|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111354916|NCT00097448|Protective Agents|protective agents|mesh-ancestor
111354917|NCT00004246|Fludarabine|fludarabine|mesh-list
111354918|NCT00004246|Fludarabine phosphate|fludarabine phosphate|mesh-list
111354919|NCT00004246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111354920|NCT00004246|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111354921|NCT00004246|Antimetabolites|antimetabolites|mesh-ancestor
111354922|NCT00004246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111354923|NCT00004246|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111354924|NCT00004246|Immunologic Factors|immunologic factors|mesh-ancestor
111354925|NCT00004246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111354926|NCT00028262|Cysteamine|cysteamine|mesh-list
111354927|NCT00028262|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
111354928|NCT00028262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111354929|NCT00005056|Bryostatin 1|bryostatin 1|mesh-list
111354930|NCT00005056|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111354931|NCT00005056|Immunologic Factors|immunologic factors|mesh-ancestor
111354932|NCT00005056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111354933|NCT00005056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111354934|NCT00004252|Leucovorin|leucovorin|mesh-list
111354935|NCT00004252|Fluorouracil|fluorouracil|mesh-list
111354936|NCT00004252|Calcium|calcium|mesh-list
111354937|NCT00004252|Levoleucovorin|levoleucovorin|mesh-list
111354938|NCT00004252|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111354939|NCT00004252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111354940|NCT00004252|Antimetabolites|antimetabolites|mesh-ancestor
111354941|NCT00004252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111354942|NCT00004252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111354943|NCT00004252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111354944|NCT00004252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111354945|NCT00004252|Immunologic Factors|immunologic factors|mesh-ancestor
111354946|NCT00004252|Antidotes|antidotes|mesh-ancestor
111354947|NCT00004252|Protective Agents|protective agents|mesh-ancestor
111354948|NCT00004252|Vitamin B Complex|vitamin b complex|mesh-ancestor
111354949|NCT00004252|Vitamins|vitamins|mesh-ancestor
111354950|NCT00004252|Micronutrients|micronutrients|mesh-ancestor
111354951|NCT00005590|Levofloxacin|levofloxacin|mesh-list
111354952|NCT00005590|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111354953|NCT00005590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111354954|NCT00005590|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111354955|NCT00005590|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111354956|NCT00005590|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111354957|NCT00005590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111354958|NCT00005590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111354959|NCT00005590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111354960|NCT00005590|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111354961|NCT00005590|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111354962|NCT00005596|Leucovorin|leucovorin|mesh-list
111354963|NCT00005596|Cytarabine|cytarabine|mesh-list
111354964|NCT00005596|Dexamethasone|dexamethasone|mesh-list
111354965|NCT00005596|Cyclophosphamide|cyclophosphamide|mesh-list
111354966|NCT00005596|Methotrexate|methotrexate|mesh-list
111354967|NCT00005596|Vincristine|vincristine|mesh-list
111354968|NCT00005596|Daunorubicin|daunorubicin|mesh-list
111354969|NCT00005596|Mercaptopurine|mercaptopurine|mesh-list
111354970|NCT00005596|Pegaspargase|pegaspargase|mesh-list
111354971|NCT00005596|Thioguanine|thioguanine|mesh-list
111354972|NCT00005596|Levoleucovorin|levoleucovorin|mesh-list
111354973|NCT00005596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111354974|NCT00005596|Immunologic Factors|immunologic factors|mesh-ancestor
111354975|NCT00005596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111354976|NCT00005596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111354977|NCT00005596|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111354978|NCT00005596|Alkylating Agents|alkylating agents|mesh-ancestor
111354979|NCT00005596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111354980|NCT00005596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111354981|NCT00005596|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111354982|NCT00005596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111354983|NCT00005596|Antiemetics|antiemetics|mesh-ancestor
111354984|NCT00005596|Autonomic Agents|autonomic agents|mesh-ancestor
111354985|NCT00005596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111354986|NCT00005596|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111354987|NCT00005596|Glucocorticoids|glucocorticoids|mesh-ancestor
111354988|NCT00005596|Hormones|hormones|mesh-ancestor
111354989|NCT00005596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111354990|NCT00005596|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111354991|NCT00005596|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111354992|NCT00005596|Abortifacient Agents|abortifacient agents|mesh-ancestor
111354993|NCT00005596|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111354994|NCT00005596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111354995|NCT00005596|Antimetabolites|antimetabolites|mesh-ancestor
111354996|NCT00005596|Dermatologic Agents|dermatologic agents|mesh-ancestor
111354997|NCT00005596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111354998|NCT00005596|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111354999|NCT00005596|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111355000|NCT00005596|Antiviral Agents|antiviral agents|mesh-ancestor
111355001|NCT00005596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111355002|NCT00005596|Antidotes|antidotes|mesh-ancestor
111355003|NCT00005596|Protective Agents|protective agents|mesh-ancestor
111355004|NCT00005596|Vitamin B Complex|vitamin b complex|mesh-ancestor
111355005|NCT00005596|Vitamins|vitamins|mesh-ancestor
111355006|NCT00005596|Micronutrients|micronutrients|mesh-ancestor
111355007|NCT00005596|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111355008|NCT00005596|Tubulin Modulators|tubulin modulators|mesh-ancestor
111355009|NCT00005596|Antimitotic Agents|antimitotic agents|mesh-ancestor
111355010|NCT00005596|Mitosis Modulators|mitosis modulators|mesh-ancestor
111355011|NCT00005596|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111355012|NCT00005596|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111355013|NCT00005596|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111355014|NCT00005068|Leucovorin|leucovorin|mesh-list
111355015|NCT00005068|Fluorouracil|fluorouracil|mesh-list
111355016|NCT00005068|Oxaliplatin|oxaliplatin|mesh-list
111355017|NCT00005068|Irinotecan|irinotecan|mesh-list
111355018|NCT00005068|Calcium|calcium|mesh-list
111355019|NCT00005068|Levoleucovorin|levoleucovorin|mesh-list
111355020|NCT00005068|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111355021|NCT00005068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111355022|NCT00005068|Antimetabolites|antimetabolites|mesh-ancestor
111355023|NCT00005068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111355024|NCT00005068|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111355025|NCT00005068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111355026|NCT00005068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111355027|NCT00005068|Immunologic Factors|immunologic factors|mesh-ancestor
111355028|NCT00005068|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111355029|NCT00005068|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111355030|NCT00005068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111355031|NCT00005068|Antidotes|antidotes|mesh-ancestor
111355032|NCT00005068|Protective Agents|protective agents|mesh-ancestor
111355033|NCT00005068|Vitamin B Complex|vitamin b complex|mesh-ancestor
111355034|NCT00005068|Vitamins|vitamins|mesh-ancestor
111355035|NCT00005068|Micronutrients|micronutrients|mesh-ancestor
111355036|NCT00004264|Docetaxel|docetaxel|mesh-list
111355037|NCT00004264|Amifostine|amifostine|mesh-list
111355038|NCT00004264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111355039|NCT00004264|Tubulin Modulators|tubulin modulators|mesh-ancestor
111355040|NCT00004264|Antimitotic Agents|antimitotic agents|mesh-ancestor
111355041|NCT00004264|Mitosis Modulators|mitosis modulators|mesh-ancestor
111355042|NCT00004264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111355043|NCT00004264|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111355044|NCT00004264|Protective Agents|protective agents|mesh-ancestor
111355045|NCT00004264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111355046|NCT00005074|Alvocidib|alvocidib|mesh-list
111355047|NCT00005074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111355048|NCT00005074|Growth Inhibitors|growth inhibitors|mesh-ancestor
111355049|NCT00005074|Growth Substances|growth substances|mesh-ancestor
111355050|NCT00005074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111355051|NCT00005074|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111355052|NCT00005074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111355053|NCT00005074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111355054|NCT00005602|Carboplatin|carboplatin|mesh-list
111355055|NCT00005602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111355056|NCT00004276|Thalidomide|thalidomide|mesh-list
111355057|NCT00004276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111355058|NCT00004276|Immunologic Factors|immunologic factors|mesh-ancestor
111355059|NCT00004276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111355060|NCT00004276|Leprostatic Agents|leprostatic agents|mesh-ancestor
111355061|NCT00004276|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111355062|NCT00004276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111355063|NCT00004276|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111355064|NCT00004276|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111355065|NCT00004276|Growth Substances|growth substances|mesh-ancestor
111355066|NCT00004276|Growth Inhibitors|growth inhibitors|mesh-ancestor
111355067|NCT00004276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111355068|NCT00004288|Olsalazine|olsalazine|mesh-list
111355069|NCT00004288|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111355070|NCT00004288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111355071|NCT00004288|Analgesics|analgesics|mesh-ancestor
111355072|NCT00004288|Sensory System Agents|sensory system agents|mesh-ancestor
111355073|NCT00004288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111355074|NCT00004288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111355075|NCT00004288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111355076|NCT00004288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111355077|NCT00004288|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111355078|NCT00005086|Gemcitabine|gemcitabine|mesh-list
111355079|NCT00005086|Docetaxel|docetaxel|mesh-list
111355080|NCT00005086|Methotrexate|methotrexate|mesh-list
111355081|NCT00005086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111355082|NCT00005086|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111355083|NCT00005086|Antimetabolites|antimetabolites|mesh-ancestor
111355084|NCT00005086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111355085|NCT00005086|Tubulin Modulators|tubulin modulators|mesh-ancestor
111355086|NCT00005086|Antimitotic Agents|antimitotic agents|mesh-ancestor
111355087|NCT00005086|Mitosis Modulators|mitosis modulators|mesh-ancestor
111355088|NCT00005086|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111355089|NCT00005086|Abortifacient Agents|abortifacient agents|mesh-ancestor
110773446|NCT01302756|Vitamins|vitamins|mesh-ancestor
111355090|NCT00005086|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111355091|NCT00005086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111355092|NCT00005086|Dermatologic Agents|dermatologic agents|mesh-ancestor
111355093|NCT00005086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111355094|NCT00005086|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111355095|NCT00005086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111355096|NCT00005086|Immunologic Factors|immunologic factors|mesh-ancestor
111355097|NCT00005086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111355098|NCT00005086|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111355099|NCT00005614|Gemcitabine|gemcitabine|mesh-list
111355100|NCT00005614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111355101|NCT00005614|Antimetabolites|antimetabolites|mesh-ancestor
111355102|NCT00005614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111355103|NCT00005614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111355104|NCT00101036|Lapatinib|lapatinib|mesh-list
111355105|NCT00101036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111355106|NCT00101036|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111355107|NCT00101036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111355108|NCT00101036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111355109|NCT00004300|Bromocriptine|bromocriptine|mesh-list
111355110|NCT00004300|Sertraline|sertraline|mesh-list
111355111|NCT00004300|Antidepressive Agents|antidepressive agents|mesh-ancestor
111355112|NCT00004300|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111355113|NCT00004300|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111355114|NCT00004300|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111355115|NCT00004300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111355116|NCT00004300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111355117|NCT00004300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111355118|NCT00004300|Serotonin Agents|serotonin agents|mesh-ancestor
111355119|NCT00004300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111355120|NCT00004300|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111355121|NCT00004300|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111355122|NCT00004300|Hormone Antagonists|hormone antagonists|mesh-ancestor
111079464|NCT04475991|Favipiravir|favipiravir|mesh-list
111355123|NCT00004300|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111355124|NCT00004300|Dopamine Agonists|dopamine agonists|mesh-ancestor
111355125|NCT00004300|Dopamine Agents|dopamine agents|mesh-ancestor
111355127|NCT00005626|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111355128|NCT00005626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111355129|NCT00005626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111355130|NCT00005626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111355131|NCT00005626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111355132|NCT00005092|Cyclophosphamide|cyclophosphamide|mesh-list
111355133|NCT00005092|Thiotepa|thiotepa|mesh-list
111355134|NCT00005092|Methoxsalen|methoxsalen|mesh-list
111355135|NCT00005092|Furocoumarins|furocoumarins|mesh-list
111355136|NCT00005092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111355137|NCT00005092|Immunologic Factors|immunologic factors|mesh-ancestor
111355138|NCT00005092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111355139|NCT00005092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111355140|NCT00005092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111355141|NCT00005092|Alkylating Agents|alkylating agents|mesh-ancestor
111355142|NCT00005092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111355143|NCT00005092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111355144|NCT00005092|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111355145|NCT00005092|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111355146|NCT00005092|Dermatologic Agents|dermatologic agents|mesh-ancestor
111355147|NCT00005638|Irinotecan|irinotecan|mesh-list
111355148|NCT00005638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111355149|NCT00005638|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111355150|NCT00005638|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111355151|NCT00005638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111355152|NCT00005638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111355153|NCT00005104|Metformin|metformin|mesh-list
111355154|NCT00005104|Clomiphene|clomiphene|mesh-list
111355155|NCT00005104|Enclomiphene|enclomiphene|mesh-list
111355156|NCT00005104|Zuclomiphene|zuclomiphene|mesh-list
111355157|NCT00005104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111355158|NCT00005104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111355159|NCT00005104|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111355160|NCT00005104|Hormone Antagonists|hormone antagonists|mesh-ancestor
111355161|NCT00005104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111355162|NCT00005104|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111355163|NCT00005104|Fertility Agents|fertility agents|mesh-ancestor
111355164|NCT00005104|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111355165|NCT00005104|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111355166|NCT00005104|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111355167|NCT00005110|Albuterol|albuterol|mesh-list
111355168|NCT00005110|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
111355169|NCT00005110|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111355170|NCT00005110|Autonomic Agents|autonomic agents|mesh-ancestor
111355171|NCT00005110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111355172|NCT00005110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111355173|NCT00005110|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111355174|NCT00005110|Respiratory System Agents|respiratory system agents|mesh-ancestor
111355175|NCT00005110|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111355176|NCT00005110|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111355177|NCT00005110|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111355178|NCT00005110|Adrenergic Agents|adrenergic agents|mesh-ancestor
111355179|NCT00005110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111355180|NCT00005110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111355181|NCT00005110|Tocolytic Agents|tocolytic agents|mesh-ancestor
111355182|NCT00005110|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111355183|NCT00004330|Hormones|hormones|mesh-list
111355184|NCT00004330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111355185|NCT00004330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111355186|NCT00005668|Itraconazole|itraconazole|mesh-list
111355187|NCT00005668|Antifungal Agents|antifungal agents|mesh-ancestor
111355188|NCT00005668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111355189|NCT00005668|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111355190|NCT00005668|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111355191|NCT00005668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111355192|NCT00005668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111355193|NCT00005668|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111355194|NCT00005668|Hormone Antagonists|hormone antagonists|mesh-ancestor
110839552|NCT03413410|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111355195|NCT00005668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111355196|NCT00005668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111355197|NCT00005668|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111355198|NCT00030992|Diphenhydramine|diphenhydramine|mesh-list
111355199|NCT00030992|Promethazine|promethazine|mesh-list
111355200|NCT00030992|Ranitidine|ranitidine|mesh-list
111355201|NCT00030992|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
111355202|NCT00030992|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111355203|NCT00030992|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111355204|NCT00030992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111355205|NCT00030992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111355206|NCT00030992|Anesthetics, Local|anesthetics, local|mesh-ancestor
111355207|NCT00030992|Anesthetics|anesthetics|mesh-ancestor
111355208|NCT00030992|Sensory System Agents|sensory system agents|mesh-ancestor
111355209|NCT00030992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111355210|NCT00030992|Antiemetics|antiemetics|mesh-ancestor
111355211|NCT00030992|Autonomic Agents|autonomic agents|mesh-ancestor
111355212|NCT00030992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111355213|NCT00030992|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111355214|NCT00030992|Histamine Antagonists|histamine antagonists|mesh-ancestor
111355215|NCT00030992|Histamine Agents|histamine agents|mesh-ancestor
111355216|NCT00030992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111355217|NCT00030992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111355218|NCT00030992|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111355219|NCT00030992|Antipruritics|antipruritics|mesh-ancestor
111355220|NCT00030992|Dermatologic Agents|dermatologic agents|mesh-ancestor
111355221|NCT00030992|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111355222|NCT00030992|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
111355223|NCT00004360|Chlorothiazide|chlorothiazide|mesh-list
111355224|NCT00004360|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111355225|NCT00004360|Diuretics|diuretics|mesh-ancestor
111355226|NCT00004360|Natriuretic Agents|natriuretic agents|mesh-ancestor
111355227|NCT00004360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111355228|NCT00004360|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
111355229|NCT00004360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111355230|NCT00004360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111355231|NCT00385450|Nelfinavir|nelfinavir|mesh-list
111355232|NCT00385450|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110573416|NCT00589290|Belinostat|belinostat|mesh-list
111355233|NCT00385450|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111355234|NCT00385450|Protease Inhibitors|protease inhibitors|mesh-ancestor
111355235|NCT00385450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111355236|NCT00385450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111355237|NCT00385450|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111355238|NCT00385450|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111355239|NCT00385450|Antiviral Agents|antiviral agents|mesh-ancestor
111355240|NCT00385450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111355241|NCT00004390|Morphine|morphine|mesh-list
111355242|NCT00004390|Methadone|methadone|mesh-list
111355243|NCT00004390|Nortriptyline|nortriptyline|mesh-list
111355244|NCT00004390|Desipramine|desipramine|mesh-list
111355245|NCT00004390|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111355246|NCT00004390|Narcotics|narcotics|mesh-ancestor
111355247|NCT00004390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111355248|NCT00004390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111355249|NCT00004390|Analgesics|analgesics|mesh-ancestor
111355250|NCT00004390|Sensory System Agents|sensory system agents|mesh-ancestor
111355251|NCT00004390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111355252|NCT00004390|Antitussive Agents|antitussive agents|mesh-ancestor
111355253|NCT00004390|Respiratory System Agents|respiratory system agents|mesh-ancestor
111355254|NCT00004390|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
111355255|NCT00004390|Antidepressive Agents|antidepressive agents|mesh-ancestor
111355256|NCT00004390|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111355257|NCT00004390|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111355258|NCT00004390|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111355259|NCT00004390|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111355260|NCT00004390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111355261|NCT00004390|Adrenergic Agents|adrenergic agents|mesh-ancestor
111355262|NCT00004390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111355263|NCT00004390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111355264|NCT00004396|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
111355265|NCT00004396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111355266|NCT00004396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111355267|NCT00004402|Calcitriol|calcitriol|mesh-list
111355268|NCT00004402|Interferons|interferons|mesh-list
111355269|NCT00004402|Interferon-gamma|interferon-gamma|mesh-list
111355270|NCT00004402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111355271|NCT00004402|Antiviral Agents|antiviral agents|mesh-ancestor
111355272|NCT00004402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111355273|NCT00004402|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111355274|NCT00004402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111355275|NCT00004402|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
111355276|NCT00004402|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111355277|NCT00004402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111355278|NCT00004402|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111355279|NCT00004402|Vitamins|vitamins|mesh-ancestor
111355280|NCT00004402|Micronutrients|micronutrients|mesh-ancestor
111355281|NCT00004402|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111355282|NCT00004420|Evening primrose oil|evening primrose oil|mesh-list
111355283|NCT00004420|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111355284|NCT00004420|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111355285|NCT00004420|Analgesics|analgesics|mesh-ancestor
111355286|NCT00004420|Sensory System Agents|sensory system agents|mesh-ancestor
111355287|NCT00004420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111355288|NCT00004420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111355289|NCT00004420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111355290|NCT00004420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111355291|NCT00004420|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111355292|NCT00004420|Antimetabolites|antimetabolites|mesh-ancestor
111355293|NCT00004420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111355294|NCT00004420|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111355295|NCT00004420|Dermatologic Agents|dermatologic agents|mesh-ancestor
111355296|NCT00004426|Leuprolide|leuprolide|mesh-list
111355297|NCT00004426|Hormones|hormones|mesh-list
111355298|NCT00004426|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111355299|NCT00004426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111355300|NCT00004426|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111355301|NCT00004426|Fertility Agents|fertility agents|mesh-ancestor
111355302|NCT00004426|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111355303|NCT00004426|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111355304|NCT00004426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111355305|NCT00004438|Leuprolide|leuprolide|mesh-list
111355306|NCT00004438|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111355307|NCT00004438|Fertility Agents|fertility agents|mesh-ancestor
111355308|NCT00004438|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111355309|NCT00004438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111355310|NCT00004438|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111355311|NCT00004438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111355312|NCT01217749|Ofatumumab|ofatumumab|mesh-list
111355313|NCT01217749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111355314|NCT02197273|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111355315|NCT02197273|Epinephrine|epinephrine|mesh-list
111355316|NCT02197273|Fentanyl|fentanyl|mesh-list
111355317|NCT02197273|Morphine|morphine|mesh-list
111355318|NCT02197273|Bupivacaine|bupivacaine|mesh-list
111355319|NCT02197273|Ropivacaine|ropivacaine|mesh-list
111355320|NCT02197273|Anesthetics, Local|anesthetics, local|mesh-ancestor
111355321|NCT02197273|Anesthetics|anesthetics|mesh-ancestor
111355322|NCT02197273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111355323|NCT02197273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111355324|NCT02197273|Sensory System Agents|sensory system agents|mesh-ancestor
111355325|NCT02197273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111355326|NCT02197273|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111355327|NCT02197273|Narcotics|narcotics|mesh-ancestor
111355328|NCT02197273|Analgesics|analgesics|mesh-ancestor
111355329|NCT02197273|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111355330|NCT02197273|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111355331|NCT02197273|Anesthetics, General|anesthetics, general|mesh-ancestor
111355332|NCT02197273|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111355333|NCT02197273|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111355334|NCT02197273|Adrenergic Agents|adrenergic agents|mesh-ancestor
111355335|NCT02197273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111355336|NCT02197273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111355337|NCT02197273|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111355338|NCT02197273|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111355339|NCT02197273|Autonomic Agents|autonomic agents|mesh-ancestor
111355340|NCT02197273|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111355341|NCT02197273|Respiratory System Agents|respiratory system agents|mesh-ancestor
111355342|NCT02197273|Mydriatics|mydriatics|mesh-ancestor
111355343|NCT02197273|Sympathomimetics|sympathomimetics|mesh-ancestor
111355344|NCT02197273|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111355345|NCT02197273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111355346|NCT02197273|Glucocorticoids|glucocorticoids|mesh-ancestor
111355347|NCT02197273|Hormones|hormones|mesh-ancestor
111355348|NCT02197273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111355349|NCT02197273|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111355350|NCT02197273|Protective Agents|protective agents|mesh-ancestor
111355351|NCT02197273|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111355352|NCT02197273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111355353|NCT00004444|Paromomycin|paromomycin|mesh-list
111355354|NCT00004444|Streptomycin|streptomycin|mesh-list
111355355|NCT00004444|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111355356|NCT00004444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111355357|NCT00004444|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111355358|NCT00004444|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111355359|NCT00004444|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111355360|NCT00004444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111355361|NCT00004444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111355362|NCT00004450|Interferons|interferons|mesh-list
111355363|NCT00004450|Interferon-beta|interferon-beta|mesh-list
111355364|NCT00004450|Thalidomide|thalidomide|mesh-list
111355365|NCT00004450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111355366|NCT00004450|Antiviral Agents|antiviral agents|mesh-ancestor
111355367|NCT00004450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111355368|NCT00004450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111355369|NCT00004450|Immunologic Factors|immunologic factors|mesh-ancestor
111355370|NCT00004450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111355371|NCT00004450|Leprostatic Agents|leprostatic agents|mesh-ancestor
111355372|NCT00004450|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111355373|NCT00004450|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111355374|NCT00004450|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111355375|NCT00004450|Growth Substances|growth substances|mesh-ancestor
111355376|NCT00004450|Growth Inhibitors|growth inhibitors|mesh-ancestor
111355377|NCT00004468|Calcitriol|calcitriol|mesh-list
111355378|NCT00004468|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111355379|NCT00004468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111355380|NCT00004468|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
111355381|NCT00004468|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111355382|NCT00004468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111355383|NCT00004468|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111355384|NCT00004468|Vitamins|vitamins|mesh-ancestor
111355385|NCT00004468|Micronutrients|micronutrients|mesh-ancestor
111355386|NCT00004468|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111355387|NCT01288807|Milnacipran|milnacipran|mesh-list
111355388|NCT01288807|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111355389|NCT01288807|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111355390|NCT01288807|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111355391|NCT01288807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111355392|NCT01288807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111355393|NCT01288807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111355394|NCT01288807|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111355395|NCT01288807|Analgesics|analgesics|mesh-ancestor
111355396|NCT01288807|Sensory System Agents|sensory system agents|mesh-ancestor
111355397|NCT01288807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111355398|NCT00005764|Lamivudine|lamivudine|mesh-list
111355399|NCT00005764|Zidovudine|zidovudine|mesh-list
111355400|NCT00005764|Abacavir|abacavir|mesh-list
111355401|NCT00005764|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
111355402|NCT00005764|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111355403|NCT00005764|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111355404|NCT00005764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111355405|NCT00005764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111355406|NCT00005764|Antiviral Agents|antiviral agents|mesh-ancestor
111355407|NCT00005764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111355408|NCT00005764|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111355409|NCT00005764|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111355410|NCT00005764|Antimetabolites|antimetabolites|mesh-ancestor
111355411|NCT01289275|Nicotine|nicotine|mesh-list
111355412|NCT01289275|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111355413|NCT01289275|Autonomic Agents|autonomic agents|mesh-ancestor
110839794|NCT05170594|Bevacizumab|bevacizumab|mesh-list
111355414|NCT01289275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111355415|NCT01289275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111355416|NCT01289275|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111355417|NCT01289275|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111355418|NCT01289275|Cholinergic Agents|cholinergic agents|mesh-ancestor
111355419|NCT01289275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111355420|NCT01289275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111355421|NCT00004474|Cyclophosphamide|cyclophosphamide|mesh-list
111355423|NCT00004474|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111355424|NCT00004474|Immunologic Factors|immunologic factors|mesh-ancestor
111355425|NCT00004474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111355426|NCT00004474|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111355427|NCT00004474|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111355428|NCT00004474|Alkylating Agents|alkylating agents|mesh-ancestor
111355429|NCT00004474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111355430|NCT00004474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111355431|NCT00004474|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111355432|NCT00004480|Botulinum Toxins|botulinum toxins|mesh-list
111355433|NCT00004480|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111355434|NCT00004480|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111355435|NCT00004480|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111355436|NCT00004480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111355437|NCT00004480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111355438|NCT00004480|Cholinergic Agents|cholinergic agents|mesh-ancestor
111355439|NCT00004480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111355440|NCT00004480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111355441|NCT00004480|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111355442|NCT00004480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111355443|NCT00004486|Fluoxetine|fluoxetine|mesh-list
111355444|NCT00004486|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111355445|NCT00004486|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111355446|NCT00004486|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111355447|NCT00004486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111355448|NCT00004486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111355449|NCT00004486|Serotonin Agents|serotonin agents|mesh-ancestor
111355450|NCT00004486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111355451|NCT00004486|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111355452|NCT00004486|Antidepressive Agents|antidepressive agents|mesh-ancestor
111355453|NCT00004486|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111355454|NCT00004486|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111355455|NCT00004486|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111355456|NCT00004486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111355457|NCT00004492|Clotrimazole|clotrimazole|mesh-list
111355458|NCT00004492|Miconazole|miconazole|mesh-list
111355459|NCT00004492|Hydroxyurea|hydroxyurea|mesh-list
111355460|NCT00004492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111355461|NCT00004492|Antisickling Agents|antisickling agents|mesh-ancestor
111355462|NCT00004492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111355463|NCT00004492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111355464|NCT00004492|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111355465|NCT00004492|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111355466|NCT00004492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111355467|NCT00004492|Antifungal Agents|antifungal agents|mesh-ancestor
111355468|NCT00004492|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111355469|NCT00004492|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111355470|NCT00004492|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111355471|NCT00004492|Hormone Antagonists|hormone antagonists|mesh-ancestor
111355472|NCT00004492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111355473|NCT00004492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111355474|NCT00004492|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111355475|NCT00004492|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111355476|NCT00005776|Nitric Oxide|nitric oxide|mesh-list
111355477|NCT00005776|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111355478|NCT00005776|Autonomic Agents|autonomic agents|mesh-ancestor
110839889|NCT03268941|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111355479|NCT00005776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111355480|NCT00005776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111355481|NCT00005776|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111355482|NCT00005776|Respiratory System Agents|respiratory system agents|mesh-ancestor
111355483|NCT00005776|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111355484|NCT00005776|Antioxidants|antioxidants|mesh-ancestor
111355485|NCT00005776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111355486|NCT00005776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111355487|NCT00005776|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
111355488|NCT00005776|Vasodilator Agents|vasodilator agents|mesh-ancestor
111355489|NCT00005776|Gasotransmitters|gasotransmitters|mesh-ancestor
111355490|NCT00005776|Protective Agents|protective agents|mesh-ancestor
111355491|NCT00005782|Lenograstim|lenograstim|mesh-list
111079855|NCT03161223|Durvalumab|durvalumab|mesh-list
111355492|NCT00005782|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111355493|NCT00005782|Immunologic Factors|immunologic factors|mesh-ancestor
111355494|NCT00005782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111355496|NCT01290913|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111355497|NCT01290913|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111355498|NCT01290913|Respiratory System Agents|respiratory system agents|mesh-ancestor
111355499|NCT00004552|Acamprosate|acamprosate|mesh-list
111355500|NCT00004552|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111355501|NCT00101660|Dasatinib|dasatinib|mesh-list
111355502|NCT00101660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111355503|NCT00101660|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111355504|NCT00101660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111355505|NCT00101660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111355506|NCT01267279|Zoledronic Acid|zoledronic acid|mesh-list
111355507|NCT01267279|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111355508|NCT01267279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111355509|NCT00005800|Docetaxel|docetaxel|mesh-list
111355510|NCT00005800|Doxorubicin|doxorubicin|mesh-list
111355511|NCT00005800|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111355512|NCT00005800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111355513|NCT00005800|Tubulin Modulators|tubulin modulators|mesh-ancestor
111355514|NCT00005800|Antimitotic Agents|antimitotic agents|mesh-ancestor
111355515|NCT00005800|Mitosis Modulators|mitosis modulators|mesh-ancestor
110839911|NCT05011149|Analgesics|analgesics|mesh-ancestor
111355516|NCT00005800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111355517|NCT00005800|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111355518|NCT00005800|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111355519|NCT00005800|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111355520|NCT00005800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111355521|NCT00004564|Clopidogrel|clopidogrel|mesh-list
111355522|NCT00004564|Atorvastatin|atorvastatin|mesh-list
111355523|NCT00004564|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111355524|NCT00004564|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111355525|NCT00004564|Antimetabolites|antimetabolites|mesh-ancestor
111355526|NCT00004564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111355527|NCT00004564|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111355528|NCT00004564|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111355529|NCT00004564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111355530|NCT00004564|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111355531|NCT00004564|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111355532|NCT00004564|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111355533|NCT00004564|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111355534|NCT00004564|Purinergic Agents|purinergic agents|mesh-ancestor
111355535|NCT00004564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111355536|NCT00004564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111355537|NCT01268527|Calcipotriene|calcipotriene|mesh-list
111355538|NCT01268527|Dermatologic Agents|dermatologic agents|mesh-ancestor
111355539|NCT00005806|Paclitaxel|paclitaxel|mesh-list
111355540|NCT00005806|Carboplatin|carboplatin|mesh-list
111355541|NCT00005806|Gefitinib|gefitinib|mesh-list
111355542|NCT00005806|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111355543|NCT00005806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111355544|NCT00005806|Tubulin Modulators|tubulin modulators|mesh-ancestor
111355545|NCT00005806|Antimitotic Agents|antimitotic agents|mesh-ancestor
111355546|NCT00005806|Mitosis Modulators|mitosis modulators|mesh-ancestor
111355547|NCT00005806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111355548|NCT00005806|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111355549|NCT00005806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111355550|NCT00005812|Temozolomide|temozolomide|mesh-list
111355551|NCT00005812|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111355552|NCT00005812|Alkylating Agents|alkylating agents|mesh-ancestor
111355553|NCT00005812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111355554|NCT00005812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111355555|NCT01270555|Bupropion|bupropion|mesh-list
111355556|NCT01270555|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111355557|NCT01270555|Antidepressive Agents|antidepressive agents|mesh-ancestor
111355558|NCT01270555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111355559|NCT01270555|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111355560|NCT01270555|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111355561|NCT01270555|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111355562|NCT01270555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111355563|NCT01270555|Dopamine Agents|dopamine agents|mesh-ancestor
111355564|NCT01270555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111355565|NCT01270555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111355566|NCT01270555|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111355567|NCT01270555|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111355568|NCT01270555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111355569|NCT00004582|Ritonavir|ritonavir|mesh-list
111355570|NCT00004582|Lopinavir|lopinavir|mesh-list
111355571|NCT00004582|Efavirenz|efavirenz|mesh-list
111355572|NCT00004582|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111355573|NCT00004582|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111355574|NCT00004582|Protease Inhibitors|protease inhibitors|mesh-ancestor
111355575|NCT00004582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111355576|NCT00004582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111355577|NCT00004582|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111355578|NCT00004582|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111355579|NCT00004582|Antiviral Agents|antiviral agents|mesh-ancestor
111355580|NCT00004582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111355581|NCT00004582|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111355582|NCT00004582|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111355583|NCT00004582|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111355584|NCT00004582|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111355585|NCT00004582|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111355586|NCT00004582|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111355587|NCT00004582|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111355588|NCT00004582|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111355589|NCT00004582|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111355590|NCT00004690|Monolaurin|monolaurin|mesh-list
111355591|NCT00004690|Cariostatic Agents|cariostatic agents|mesh-ancestor
111355592|NCT00004690|Protective Agents|protective agents|mesh-ancestor
111355593|NCT00004690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111355594|NCT00004696|Morphine|morphine|mesh-list
111355595|NCT00004696|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111355596|NCT00004696|Narcotics|narcotics|mesh-ancestor
111355597|NCT00004696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110839987|NCT03405454|Durvalumab|durvalumab|mesh-list
111355598|NCT00004696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111355599|NCT00004696|Analgesics|analgesics|mesh-ancestor
111355600|NCT00004696|Sensory System Agents|sensory system agents|mesh-ancestor
111355601|NCT00004696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111355602|NCT00004744|Immunoglobulins|immunoglobulins|mesh-list
111355603|NCT00004744|Antibodies|antibodies|mesh-list
111355604|NCT00004744|gamma-Globulins|gamma-globulins|mesh-list
111355605|NCT00004744|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111355606|NCT00004744|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
111355607|NCT00004744|Immunologic Factors|immunologic factors|mesh-ancestor
111355608|NCT00004744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111355609|NCT01292005|Pentoxifylline|pentoxifylline|mesh-list
111355610|NCT01292005|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111355611|NCT01292005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111355612|NCT01292005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111355613|NCT01292005|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111355614|NCT01292005|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111355615|NCT01292005|Protective Agents|protective agents|mesh-ancestor
111355616|NCT01292005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111355617|NCT01292005|Vasodilator Agents|vasodilator agents|mesh-ancestor
111355618|NCT01292005|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111355619|NCT01292005|Antioxidants|antioxidants|mesh-ancestor
111355620|NCT00004762|Cladribine|cladribine|mesh-list
111355621|NCT00004762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111355622|NCT00004762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111355623|NCT00004762|Immunologic Factors|immunologic factors|mesh-ancestor
111355624|NCT00004762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111355625|NCT00004786|Iloprost|iloprost|mesh-list
111355626|NCT00004786|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111355627|NCT00004786|Vasodilator Agents|vasodilator agents|mesh-ancestor
111355628|NCT01272583|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111355629|NCT01272583|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111355630|NCT01272583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111355631|NCT01272583|Incretins|incretins|mesh-ancestor
111355632|NCT01272583|Hormones|hormones|mesh-ancestor
111355633|NCT01272583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111355634|NCT01272583|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111355635|NCT01272583|Protease Inhibitors|protease inhibitors|mesh-ancestor
111355636|NCT01272583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111355637|NCT01272583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111355638|NCT00004804|Interferons|interferons|mesh-list
111355639|NCT00004804|Interferon-alpha|interferon-alpha|mesh-list
111079998|NCT01376167|Chloroquine|chloroquine|mesh-list
111355640|NCT00004804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111355641|NCT00004804|Antiviral Agents|antiviral agents|mesh-ancestor
111355642|NCT00004804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111355643|NCT00004804|Immunologic Factors|immunologic factors|mesh-ancestor
111355644|NCT00004804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111355646|NCT00386074|Iron Chelating Agents|iron chelating agents|mesh-ancestor
111355647|NCT00386074|Chelating Agents|chelating agents|mesh-ancestor
111355648|NCT00386074|Sequestering Agents|sequestering agents|mesh-ancestor
111355649|NCT00386074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111355650|NCT00004810|Aminosalicylic Acid|aminosalicylic acid|mesh-list
111355651|NCT00004810|Antitubercular Agents|antitubercular agents|mesh-ancestor
111355652|NCT00004810|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111355653|NCT00004810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111355654|NCT00004816|Antibodies|antibodies|mesh-list
111355655|NCT00004816|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111355656|NCT00004816|Immunologic Factors|immunologic factors|mesh-ancestor
111355657|NCT00004816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110840062|NCT02593123|Molgramostim|molgramostim|mesh-list
111355658|NCT01341301|Mycophenolic Acid|mycophenolic acid|mesh-list
111355659|NCT01341301|Cyclophosphamide|cyclophosphamide|mesh-list
111355660|NCT01341301|Tacrolimus|tacrolimus|mesh-list
111355661|NCT01341301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111355662|NCT01341301|Immunologic Factors|immunologic factors|mesh-ancestor
111355663|NCT01341301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111355664|NCT01341301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111355665|NCT01341301|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111355666|NCT01341301|Alkylating Agents|alkylating agents|mesh-ancestor
111355667|NCT01341301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111355668|NCT01341301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111355669|NCT01341301|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111355670|NCT01341301|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111355671|NCT01341301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111355672|NCT01341301|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111355673|NCT01341301|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111355674|NCT01341301|Antitubercular Agents|antitubercular agents|mesh-ancestor
111355675|NCT01341301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111355676|NCT01341301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111355677|NCT01273207|Cyclosporine|cyclosporine|mesh-list
111355678|NCT01273207|Cyclosporins|cyclosporins|mesh-list
111355679|NCT01273207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111355680|NCT01273207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111355681|NCT01273207|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111355682|NCT01273207|Immunologic Factors|immunologic factors|mesh-ancestor
111355683|NCT01273207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111355684|NCT01273207|Antifungal Agents|antifungal agents|mesh-ancestor
111355685|NCT01273207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111355686|NCT01273207|Dermatologic Agents|dermatologic agents|mesh-ancestor
111355687|NCT01273207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111355688|NCT01273207|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111355689|NCT01342549|Naltrexone|naltrexone|mesh-list
111355690|NCT01342549|Valproic Acid|valproic acid|mesh-list
111355691|NCT01342549|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111355692|NCT01342549|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111355693|NCT01342549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111355694|NCT01342549|Sensory System Agents|sensory system agents|mesh-ancestor
111355695|NCT01342549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111355696|NCT01342549|Anticonvulsants|anticonvulsants|mesh-ancestor
111355697|NCT01342549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111355698|NCT01342549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111355699|NCT01342549|GABA Agents|gaba agents|mesh-ancestor
111355700|NCT01342549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111355701|NCT01342549|Antimanic Agents|antimanic agents|mesh-ancestor
111355702|NCT01342549|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111355703|NCT01342549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111355704|NCT01342549|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111355705|NCT01295515|Interferons|interferons|mesh-list
111355706|NCT01295515|Interferon-alpha|interferon-alpha|mesh-list
111355707|NCT01295515|Interferon alpha-2|interferon alpha-2|mesh-list
111355708|NCT01295515|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
111355709|NCT01295515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111355710|NCT01295515|Antiviral Agents|antiviral agents|mesh-ancestor
111355711|NCT01295515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111355712|NCT01295515|Immunologic Factors|immunologic factors|mesh-ancestor
111355713|NCT01295515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111355714|NCT01277341|Bepotastine besilate|bepotastine besilate|mesh-list
111355715|NCT01277341|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111355716|NCT00101816|Dasatinib|dasatinib|mesh-list
111355717|NCT00101816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111355718|NCT00101816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111355719|NCT00101816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111355720|NCT00101816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111355721|NCT00102518|Aripiprazole|aripiprazole|mesh-list
111355722|NCT00102518|Antidepressive Agents|antidepressive agents|mesh-ancestor
111355723|NCT00102518|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111355724|NCT00102518|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111355725|NCT00102518|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111355726|NCT00102518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111355727|NCT00102518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111355728|NCT00102518|Dopamine Agonists|dopamine agonists|mesh-ancestor
111355729|NCT00102518|Dopamine Agents|dopamine agents|mesh-ancestor
111355730|NCT00102518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111355731|NCT00102518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111355732|NCT00102518|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111355733|NCT00102518|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111355734|NCT00102518|Serotonin Agents|serotonin agents|mesh-ancestor
111355735|NCT00102518|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111355736|NCT00102518|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111355737|NCT00102518|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111355738|NCT00102518|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111355739|NCT00103376|Bortezomib|bortezomib|mesh-list
111355740|NCT00103376|Androgens|androgens|mesh-list
111355741|NCT00103376|Androgen Receptor Antagonists|androgen receptor antagonists|mesh-list
111355742|NCT00103376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111355743|NCT00103376|Hormones|hormones|mesh-ancestor
111355744|NCT00103376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111355745|NCT00103376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111355746|NCT00103376|Androgen Antagonists|androgen antagonists|mesh-ancestor
111355747|NCT00103376|Hormone Antagonists|hormone antagonists|mesh-ancestor
111355748|NCT00042224|Clozapine|clozapine|mesh-list
111355749|NCT00042224|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111355750|NCT00042224|Serotonin Agents|serotonin agents|mesh-ancestor
111355751|NCT00042224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111355752|NCT00042224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111355753|NCT00042224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111355754|NCT00042224|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111355755|NCT00042224|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111355756|NCT00042224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111355757|NCT00042224|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111355758|NCT00042224|GABA Antagonists|gaba antagonists|mesh-ancestor
111355759|NCT00042224|GABA Agents|gaba agents|mesh-ancestor
111355760|NCT01296763|Irinotecan|irinotecan|mesh-list
111355761|NCT01296763|Olaparib|olaparib|mesh-list
111355762|NCT01296763|Mitomycins|mitomycins|mesh-list
111355763|NCT01296763|Mitomycin|mitomycin|mesh-list
111355764|NCT01296763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111355765|NCT01296763|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111355766|NCT01296763|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111355767|NCT01296763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111355768|NCT01296763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111355769|NCT01296763|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111355770|NCT01296763|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111355771|NCT01296763|Alkylating Agents|alkylating agents|mesh-ancestor
111355772|NCT01296763|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111355773|NCT01349491|Ranolazine|ranolazine|mesh-list
111355774|NCT01349491|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111355775|NCT01349491|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111355776|NCT01349491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111355777|NCT01280695|Pioglitazone|pioglitazone|mesh-list
111355778|NCT01280695|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111355779|NCT01280695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111355780|NCT00103844|Imatinib Mesylate|imatinib mesylate|mesh-list
111355781|NCT00103844|Dasatinib|dasatinib|mesh-list
111355782|NCT00103844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111355783|NCT00103844|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111355784|NCT00103844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111355785|NCT00103844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111355786|NCT01402375|Acetaminophen|acetaminophen|mesh-list
111355787|NCT01402375|Oxycodone|oxycodone|mesh-list
111355788|NCT01402375|Hydrocodone|hydrocodone|mesh-list
111355789|NCT01402375|Codeine|codeine|mesh-list
111355790|NCT01402375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111355791|NCT01402375|Analgesics|analgesics|mesh-ancestor
111355792|NCT01402375|Sensory System Agents|sensory system agents|mesh-ancestor
111355793|NCT01402375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111355794|NCT01402375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111355795|NCT01402375|Antipyretics|antipyretics|mesh-ancestor
111355796|NCT01402375|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111355797|NCT01402375|Narcotics|narcotics|mesh-ancestor
111355798|NCT01402375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111355799|NCT01402375|Antitussive Agents|antitussive agents|mesh-ancestor
111355800|NCT01402375|Respiratory System Agents|respiratory system agents|mesh-ancestor
111355801|NCT01302379|Metformin|metformin|mesh-list
111355802|NCT01302379|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111355803|NCT01302379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111355804|NCT01351753|Metformin|metformin|mesh-list
111355805|NCT01351753|Topiramate|topiramate|mesh-list
111355806|NCT01351753|Orlistat|orlistat|mesh-list
111355807|NCT01351753|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111355808|NCT01351753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111355809|NCT01351753|Anticonvulsants|anticonvulsants|mesh-ancestor
111355810|NCT01351753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111355811|NCT01351753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111355812|NCT01351753|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111355813|NCT01351753|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111355814|NCT00104858|Cyclosporine|cyclosporine|mesh-list
111355815|NCT00104858|Mycophenolic Acid|mycophenolic acid|mesh-list
111355816|NCT00104858|Rituximab|rituximab|mesh-list
111355817|NCT00104858|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111355818|NCT00104858|Fludarabine|fludarabine|mesh-list
111355819|NCT00104858|Fludarabine phosphate|fludarabine phosphate|mesh-list
111355820|NCT00104858|Antibodies|antibodies|mesh-list
111355821|NCT00104858|Immunoglobulins|immunoglobulins|mesh-list
111355822|NCT00104858|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111355823|NCT00104858|Cyclosporins|cyclosporins|mesh-list
111355824|NCT00104858|Immunologic Factors|immunologic factors|mesh-ancestor
111355825|NCT00104858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111355826|NCT00104858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111355827|NCT00104858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111355828|NCT00104858|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111355829|NCT00104858|Antimetabolites|antimetabolites|mesh-ancestor
111355830|NCT00104858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111355831|NCT00104858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111355832|NCT00104858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111355833|NCT00104858|Antifungal Agents|antifungal agents|mesh-ancestor
111355834|NCT00104858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111355835|NCT00104858|Dermatologic Agents|dermatologic agents|mesh-ancestor
111355836|NCT00104858|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111355837|NCT00104858|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111355838|NCT00104858|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111355839|NCT00104858|Antitubercular Agents|antitubercular agents|mesh-ancestor
111355840|NCT00104858|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111355841|NCT01407523|Levetiracetam|levetiracetam|mesh-list
111355842|NCT01407523|Anticonvulsants|anticonvulsants|mesh-ancestor
111355843|NCT01407523|Nootropic Agents|nootropic agents|mesh-ancestor
111355844|NCT01304407|Calcium|calcium|mesh-list
111355845|NCT01304407|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111355846|NCT01304407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111355847|NCT00106106|Acamprosate|acamprosate|mesh-list
111355848|NCT00106106|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111355849|NCT01304641|Atorvastatin|atorvastatin|mesh-list
111355850|NCT01304641|Simvastatin|simvastatin|mesh-list
111355851|NCT01304641|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111355852|NCT01304641|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111355853|NCT01304641|Antimetabolites|antimetabolites|mesh-ancestor
111355854|NCT01304641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111355855|NCT01304641|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111355856|NCT01304641|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111355857|NCT01304641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111355858|NCT04753112|Valsartan|valsartan|mesh-list
111355859|NCT04753112|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
111355860|NCT04753112|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111355861|NCT04753112|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111355862|NCT04753112|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111355863|NCT04753112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111355864|NCT01409239|Insulin|insulin|mesh-list
111355865|NCT01409239|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111355866|NCT01409239|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111355867|NCT01409239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111355868|NCT00108524|Orlistat|orlistat|mesh-list
111080218|NCT03343873|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111355869|NCT00108524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111355870|NCT00108524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111355871|NCT00108524|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111355872|NCT00108524|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111355873|NCT00052442|10-deazaaminopterin|10-deazaaminopterin|mesh-list
111355874|NCT00052442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111355875|NCT00052442|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111355876|NCT00052442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111355877|NCT00052442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111355878|NCT01410409|Acetaminophen|acetaminophen|mesh-list
111355879|NCT01410409|Pantoprazole|pantoprazole|mesh-list
111355880|NCT01410409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111355881|NCT01410409|Analgesics|analgesics|mesh-ancestor
111355882|NCT01410409|Sensory System Agents|sensory system agents|mesh-ancestor
111355883|NCT01410409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111355884|NCT01410409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111355885|NCT01410409|Antipyretics|antipyretics|mesh-ancestor
111355886|NCT01410409|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111355887|NCT01410409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111355888|NCT01410409|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111355889|NCT01410409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111355890|NCT01410409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111355891|NCT01410565|Apaziquone|apaziquone|mesh-list
111355892|NCT01410565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111355893|NCT01357135|Metformin|metformin|mesh-list
111355894|NCT01357135|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111355895|NCT01357135|Hypoglycemic Agents|hypoglycemic agents|mesh-list
111355896|NCT01357135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111355897|NCT01357135|Incretins|incretins|mesh-ancestor
111355898|NCT01357135|Hormones|hormones|mesh-ancestor
111355899|NCT01357135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111355900|NCT01357135|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111355901|NCT01357135|Protease Inhibitors|protease inhibitors|mesh-ancestor
111355902|NCT01357135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111355903|NCT01357135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111355904|NCT02324335|Brilacidin|brilacidin|mesh-list
111355905|NCT02324335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111355906|NCT01411501|Mosapride|mosapride|mesh-list
111355907|NCT01411501|Citric Acid|citric acid|mesh-list
111355908|NCT01411501|Sodium Citrate|sodium citrate|mesh-list
111355909|NCT01411501|Anticoagulants|anticoagulants|mesh-ancestor
111355910|NCT01411501|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
111355911|NCT01411501|Chelating Agents|chelating agents|mesh-ancestor
111355912|NCT01411501|Sequestering Agents|sequestering agents|mesh-ancestor
111355913|NCT01411501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111355914|NCT01411501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111355915|NCT01411501|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111355916|NCT01411501|Serotonin Agents|serotonin agents|mesh-ancestor
111355917|NCT01411501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111355918|NCT01411501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111355919|NCT01310179|Fludarabine|fludarabine|mesh-list
111355920|NCT01310179|Fludarabine phosphate|fludarabine phosphate|mesh-list
111355921|NCT01310179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111355922|NCT01310179|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111355923|NCT01310179|Antimetabolites|antimetabolites|mesh-ancestor
111355924|NCT01310179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111355925|NCT01310179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111355926|NCT01310179|Immunologic Factors|immunologic factors|mesh-ancestor
111355927|NCT01310179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111355928|NCT01412281|Vaccines|vaccines|mesh-list
111355929|NCT01412281|Immunologic Factors|immunologic factors|mesh-ancestor
111355930|NCT01412281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111355931|NCT01359007|Leucovorin|leucovorin|mesh-list
111355932|NCT01359007|Oxaliplatin|oxaliplatin|mesh-list
111355933|NCT01359007|Irinotecan|irinotecan|mesh-list
111355934|NCT01359007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111355935|NCT01359007|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111355936|NCT01359007|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111355937|NCT01359007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111355938|NCT01359007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111355939|NCT01359007|Antidotes|antidotes|mesh-ancestor
111355940|NCT01359007|Protective Agents|protective agents|mesh-ancestor
111355941|NCT01359007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111355942|NCT01359007|Vitamin B Complex|vitamin b complex|mesh-ancestor
111355943|NCT01359007|Vitamins|vitamins|mesh-ancestor
111355944|NCT01359007|Micronutrients|micronutrients|mesh-ancestor
111080336|NCT02729545|Hormones|hormones|mesh-ancestor
111355945|NCT01414153|Bevacizumab|bevacizumab|mesh-list
111355946|NCT01414153|Ranibizumab|ranibizumab|mesh-list
111355947|NCT01414153|Aflibercept|aflibercept|mesh-list
111355948|NCT01414153|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111355949|NCT01414153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111355950|NCT01414153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111355951|NCT01414153|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111355952|NCT01414153|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111355953|NCT01414153|Growth Substances|growth substances|mesh-ancestor
111355954|NCT01414153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111355955|NCT01414153|Growth Inhibitors|growth inhibitors|mesh-ancestor
111355956|NCT01414153|Immunologic Factors|immunologic factors|mesh-ancestor
111355957|NCT01311895|Hydromorphone|hydromorphone|mesh-list
111355958|NCT01311895|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111355959|NCT01311895|Narcotics|narcotics|mesh-ancestor
111355960|NCT01311895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111355961|NCT01311895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111355962|NCT01311895|Analgesics|analgesics|mesh-ancestor
111355963|NCT01311895|Sensory System Agents|sensory system agents|mesh-ancestor
111355964|NCT01311895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111355965|NCT01362127|Cisplatin|cisplatin|mesh-list
111355966|NCT01362127|Carboplatin|carboplatin|mesh-list
111355967|NCT01362127|Oxaliplatin|oxaliplatin|mesh-list
111355968|NCT01362127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111355969|NCT01362205|Dexmedetomidine|dexmedetomidine|mesh-list
111355970|NCT01362205|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111355971|NCT01362205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111355972|NCT01362205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111355973|NCT01362205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111355974|NCT01362205|Analgesics|analgesics|mesh-ancestor
111355975|NCT01362205|Sensory System Agents|sensory system agents|mesh-ancestor
111355976|NCT01362205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111355977|NCT01362205|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111355978|NCT01362205|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111355979|NCT01362205|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111355980|NCT01362205|Adrenergic Agents|adrenergic agents|mesh-ancestor
111355981|NCT01362205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111355982|NCT01362205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111355983|NCT00052910|Leucovorin|leucovorin|mesh-list
111355984|NCT00052910|Fluorouracil|fluorouracil|mesh-list
111355985|NCT00052910|Epirubicin|epirubicin|mesh-list
111355986|NCT00052910|Calcium|calcium|mesh-list
111355987|NCT00052910|Levoleucovorin|levoleucovorin|mesh-list
111355988|NCT00052910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111355989|NCT00052910|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111355990|NCT00052910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111355991|NCT00052910|Antimetabolites|antimetabolites|mesh-ancestor
111355992|NCT00052910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111355993|NCT00052910|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111355994|NCT00052910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111355995|NCT00052910|Immunologic Factors|immunologic factors|mesh-ancestor
111355996|NCT00052910|Antidotes|antidotes|mesh-ancestor
111355997|NCT00052910|Protective Agents|protective agents|mesh-ancestor
111355998|NCT00052910|Vitamin B Complex|vitamin b complex|mesh-ancestor
111355999|NCT00052910|Vitamins|vitamins|mesh-ancestor
111356000|NCT00052910|Micronutrients|micronutrients|mesh-ancestor
111356001|NCT00052910|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111356002|NCT00052910|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111356003|NCT00052910|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111356004|NCT00052910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111356005|NCT01363843|Leucovorin|leucovorin|mesh-list
111356006|NCT01363843|Oxaliplatin|oxaliplatin|mesh-list
111356007|NCT01363843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111356008|NCT01363843|Antidotes|antidotes|mesh-ancestor
111356009|NCT01363843|Protective Agents|protective agents|mesh-ancestor
111356010|NCT01363843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111356011|NCT01363843|Vitamin B Complex|vitamin b complex|mesh-ancestor
111356012|NCT01363843|Vitamins|vitamins|mesh-ancestor
111356013|NCT01363843|Micronutrients|micronutrients|mesh-ancestor
111356014|NCT02092298|Sodium thiosulfate|sodium thiosulfate|mesh-list
111356015|NCT02092298|Cisplatin|cisplatin|mesh-list
111356016|NCT02092298|Mitomycins|mitomycins|mesh-list
111356017|NCT02092298|Mitomycin|mitomycin|mesh-list
111356018|NCT02092298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111356019|NCT02092298|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111356020|NCT02092298|Alkylating Agents|alkylating agents|mesh-ancestor
111356021|NCT02092298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111356022|NCT02092298|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111356023|NCT02092298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111356024|NCT02092298|Antidotes|antidotes|mesh-ancestor
111356025|NCT02092298|Protective Agents|protective agents|mesh-ancestor
111356026|NCT02092298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111356027|NCT02092298|Antioxidants|antioxidants|mesh-ancestor
111356028|NCT02092298|Antitubercular Agents|antitubercular agents|mesh-ancestor
111356029|NCT02092298|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111356030|NCT02092298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111356031|NCT02092298|Chelating Agents|chelating agents|mesh-ancestor
111356032|NCT02092298|Sequestering Agents|sequestering agents|mesh-ancestor
111356033|NCT00151814|Olmesartan|olmesartan|mesh-list
111356034|NCT00151814|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
111356035|NCT00151814|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111356036|NCT00151814|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111356037|NCT00151814|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111356038|NCT00151814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111356039|NCT00153842|Bexarotene|bexarotene|mesh-list
111356040|NCT00153842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111356041|NCT01314001|Nicotine|nicotine|mesh-list
111356042|NCT01314001|Varenicline|varenicline|mesh-list
111356043|NCT01314001|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111356044|NCT01314001|Autonomic Agents|autonomic agents|mesh-ancestor
111356045|NCT01314001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111356046|NCT01314001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111356047|NCT01314001|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111356048|NCT01314001|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111356049|NCT01314001|Cholinergic Agents|cholinergic agents|mesh-ancestor
111356050|NCT01314001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111356051|NCT01314001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111356052|NCT01363999|Atorvastatin|atorvastatin|mesh-list
111356053|NCT01363999|Dalcetrapib|dalcetrapib|mesh-list
111356054|NCT01363999|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111356055|NCT01363999|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111356056|NCT01363999|Antimetabolites|antimetabolites|mesh-ancestor
111356057|NCT01363999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111356058|NCT01363999|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111356059|NCT01363999|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111356060|NCT01363999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111356061|NCT00257894|Baclofen|baclofen|mesh-list
111356062|NCT00257894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111356063|NCT00257894|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
111356064|NCT00257894|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111356065|NCT00257894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111356066|NCT00257894|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
111356067|NCT00257894|GABA Agonists|gaba agonists|mesh-ancestor
111356068|NCT00257894|GABA Agents|gaba agents|mesh-ancestor
111356069|NCT00257894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111356070|NCT00257894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111356071|NCT00258128|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
111356072|NCT00258128|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111356073|NCT00258128|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111356074|NCT00258128|Analgesics|analgesics|mesh-ancestor
111356075|NCT00258128|Sensory System Agents|sensory system agents|mesh-ancestor
111356076|NCT00258128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111356077|NCT00258128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111356078|NCT00258128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111356079|NCT00258128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111356080|NCT01364623|Methyltestosterone|methyltestosterone|mesh-list
111356081|NCT01364623|Testosterone|testosterone|mesh-list
111356082|NCT01364623|Testosterone undecanoate|testosterone undecanoate|mesh-list
111356083|NCT01364623|Testosterone enanthate|testosterone enanthate|mesh-list
111356084|NCT01364623|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
111356085|NCT01364623|Androgens|androgens|mesh-ancestor
111356086|NCT01364623|Hormones|hormones|mesh-ancestor
111356087|NCT01364623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111356088|NCT01364623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111356089|NCT01364623|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111356090|NCT01364623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111356091|NCT01364623|Anabolic Agents|anabolic agents|mesh-ancestor
111356092|NCT00258206|Cyclophosphamide|cyclophosphamide|mesh-list
111356093|NCT00258206|Rituximab|rituximab|mesh-list
111356094|NCT00258206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111356095|NCT00258206|Immunologic Factors|immunologic factors|mesh-ancestor
111356096|NCT00258206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111356097|NCT00258206|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111356098|NCT00258206|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111356099|NCT00258206|Alkylating Agents|alkylating agents|mesh-ancestor
111356100|NCT00258206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111356101|NCT00258206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111356102|NCT00258206|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111356103|NCT00258206|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111356105|NCT01063907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111356106|NCT01316263|Olaratumab|olaratumab|mesh-list
111356107|NCT01316263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111356108|NCT03015857|Phenylephrine|phenylephrine|mesh-list
111356109|NCT03015857|Oxymetazoline|oxymetazoline|mesh-list
111356110|NCT03015857|Norepinephrine|norepinephrine|mesh-list
111356111|NCT03015857|Fentanyl|fentanyl|mesh-list
111356112|NCT03015857|Bupivacaine|bupivacaine|mesh-list
111356113|NCT03015857|Anesthetics, Local|anesthetics, local|mesh-ancestor
111356114|NCT03015857|Anesthetics|anesthetics|mesh-ancestor
111356115|NCT03015857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111356116|NCT03015857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111356117|NCT03015857|Sensory System Agents|sensory system agents|mesh-ancestor
111356118|NCT03015857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111356119|NCT03015857|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111356120|NCT03015857|Narcotics|narcotics|mesh-ancestor
111356121|NCT03015857|Analgesics|analgesics|mesh-ancestor
111356122|NCT03015857|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111356123|NCT03015857|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111356124|NCT03015857|Anesthetics, General|anesthetics, general|mesh-ancestor
111356125|NCT03015857|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111356126|NCT03015857|Mydriatics|mydriatics|mesh-ancestor
111356127|NCT03015857|Autonomic Agents|autonomic agents|mesh-ancestor
111356128|NCT03015857|Sympathomimetics|sympathomimetics|mesh-ancestor
111356129|NCT03015857|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111356130|NCT03015857|Nasal Decongestants|nasal decongestants|mesh-ancestor
111356131|NCT03015857|Respiratory System Agents|respiratory system agents|mesh-ancestor
111356132|NCT03015857|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111356133|NCT03015857|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111356134|NCT03015857|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111356135|NCT03015857|Adrenergic Agents|adrenergic agents|mesh-ancestor
111356136|NCT03015857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111356137|NCT03015857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111356138|NCT03015857|Protective Agents|protective agents|mesh-ancestor
111356139|NCT03295487|Estrogens|estrogens|mesh-list
111356140|NCT03295487|Hormones|hormones|mesh-ancestor
111356141|NCT03295487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111356142|NCT03295487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111356143|NCT03016091|Pembrolizumab|pembrolizumab|mesh-list
111356144|NCT03016091|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111356145|NCT03016091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111356146|NCT03016091|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111356147|NCT03016091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111356148|NCT03015701|Mifepristone|mifepristone|mesh-list
111356149|NCT03015701|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
111356150|NCT03015701|Abortifacient Agents|abortifacient agents|mesh-ancestor
111356151|NCT03015701|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111356152|NCT03015701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111356153|NCT03015701|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111356154|NCT03015701|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111356155|NCT03015701|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111356156|NCT03015701|Contraceptive Agents|contraceptive agents|mesh-ancestor
111356157|NCT03015701|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
111356158|NCT03015701|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
111356159|NCT03015701|Hormone Antagonists|hormone antagonists|mesh-ancestor
111356160|NCT03015701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111356161|NCT03015701|Luteolytic Agents|luteolytic agents|mesh-ancestor
111356162|NCT03015701|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111356163|NCT03015701|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
111356164|NCT04780061|Vitamin D|vitamin d|mesh-list
111356165|NCT04780061|Cholecalciferol|cholecalciferol|mesh-list
111356166|NCT04780061|Vitamins|vitamins|mesh-list
111356167|NCT04780061|Vitamin K|vitamin k|mesh-list
111356168|NCT04780061|Vitamin K 2|vitamin k 2|mesh-list
111356169|NCT04780061|Micronutrients|micronutrients|mesh-ancestor
111356170|NCT04780061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111356171|NCT04780061|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111356172|NCT04780061|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111356173|NCT04780061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111356174|NCT04780061|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111356175|NCT04780061|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111356176|NCT04780061|Hemostatics|hemostatics|mesh-ancestor
111356177|NCT04780061|Coagulants|coagulants|mesh-ancestor
111356178|NCT02172755|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
111356179|NCT02172755|Anticonvulsants|anticonvulsants|mesh-ancestor
111356180|NCT02172755|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111356181|NCT02172755|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111356182|NCT02172755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111356183|NCT02172755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111356184|NCT02973737|Capecitabine|capecitabine|mesh-list
111356185|NCT02973737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111356186|NCT02973737|Antimetabolites|antimetabolites|mesh-ancestor
111356187|NCT02973737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111356188|NCT02973737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111356189|NCT02762669|Oxytocin|oxytocin|mesh-list
111356190|NCT02762669|Oxytocics|oxytocics|mesh-ancestor
111356191|NCT02762669|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111356192|NCT02762669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111356193|NCT01072643|Dexmedetomidine|dexmedetomidine|mesh-list
111356194|NCT01072643|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111356195|NCT01072643|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111356196|NCT01072643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111356197|NCT01072643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111356198|NCT01072643|Analgesics|analgesics|mesh-ancestor
111356199|NCT01072643|Sensory System Agents|sensory system agents|mesh-ancestor
111356200|NCT01072643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111356201|NCT01072643|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111356202|NCT01072643|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111356203|NCT01072643|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111356204|NCT01072643|Adrenergic Agents|adrenergic agents|mesh-ancestor
111356205|NCT01072643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111356206|NCT01072643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111356207|NCT01076231|Etoposide|etoposide|mesh-list
111356208|NCT01076231|Etoposide phosphate|etoposide phosphate|mesh-list
111356209|NCT01076231|Podophyllotoxin|podophyllotoxin|mesh-list
111356210|NCT01076231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111356211|NCT01076231|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111356212|NCT01076231|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111356213|NCT01076231|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111356214|NCT01076231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111356215|NCT01076231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111356216|NCT01076231|Keratolytic Agents|keratolytic agents|mesh-ancestor
111356217|NCT01076231|Dermatologic Agents|dermatologic agents|mesh-ancestor
111356218|NCT01076231|Tubulin Modulators|tubulin modulators|mesh-ancestor
111356219|NCT01076231|Antimitotic Agents|antimitotic agents|mesh-ancestor
111356220|NCT01076231|Mitosis Modulators|mitosis modulators|mesh-ancestor
111356221|NCT00117962|Carboplatin|carboplatin|mesh-list
111356222|NCT00117962|Pemetrexed|pemetrexed|mesh-list
111356223|NCT00117962|Cetuximab|cetuximab|mesh-list
111356224|NCT00117962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111356225|NCT00117962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111356226|NCT00117962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111356227|NCT00117962|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111356228|NCT00117962|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111356229|NCT00117962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111356230|NCT00118274|Cyclophosphamide|cyclophosphamide|mesh-list
111356231|NCT00118274|Vaccines|vaccines|mesh-list
111356232|NCT00118274|Freund's Adjuvant|freund's adjuvant|mesh-list
111356233|NCT00118274|Immunologic Factors|immunologic factors|mesh-ancestor
111356234|NCT00118274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111356235|NCT00118274|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111356236|NCT00118274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111356237|NCT00118274|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111356238|NCT00118274|Alkylating Agents|alkylating agents|mesh-ancestor
111356239|NCT00118274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111356240|NCT00118274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111356241|NCT00118274|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111356242|NCT00118274|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111356243|NCT01898000|Chlorhexidine|chlorhexidine|mesh-list
110583991|NCT04307511|Analgesics|analgesics|mesh-ancestor
111356244|NCT01898000|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111356245|NCT01898000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111356246|NCT01898000|Disinfectants|disinfectants|mesh-ancestor
111356247|NCT00166166|Fluconazole|fluconazole|mesh-list
111356248|NCT00166166|Nitroprusside|nitroprusside|mesh-list
111356249|NCT00166166|Tetraethylammonium|tetraethylammonium|mesh-list
111356250|NCT00166166|Acetylcholine|acetylcholine|mesh-list
111356252|NCT00166166|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
111356253|NCT00166166|Kininogens|kininogens|mesh-list
111356254|NCT00166166|Antifungal Agents|antifungal agents|mesh-ancestor
111356255|NCT00166166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111356256|NCT00166166|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111356257|NCT00166166|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111356258|NCT00166166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111356259|NCT00166166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111356260|NCT00166166|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111356261|NCT00166166|Hormone Antagonists|hormone antagonists|mesh-ancestor
111356262|NCT00166166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111356263|NCT00166166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111356264|NCT00166166|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111356265|NCT00166166|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111356266|NCT00166166|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111356267|NCT00166166|Vasodilator Agents|vasodilator agents|mesh-ancestor
111356268|NCT00166166|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
111356269|NCT00166166|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111356270|NCT00166166|Cholinergic Agents|cholinergic agents|mesh-ancestor
111356271|NCT00166166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111356272|NCT00166166|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
111356273|NCT00166166|Protease Inhibitors|protease inhibitors|mesh-ancestor
111356274|NCT00166166|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
110584553|NCT00756470|Lapatinib|lapatinib|mesh-list
111356275|NCT00166166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111356276|NCT00118352|Cyclosporine|cyclosporine|mesh-list
111356277|NCT00118352|Mycophenolic Acid|mycophenolic acid|mesh-list
111356278|NCT00118352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111356279|NCT00118352|Alemtuzumab|alemtuzumab|mesh-list
111356280|NCT00118352|Fludarabine|fludarabine|mesh-list
111356281|NCT00118352|Fludarabine phosphate|fludarabine phosphate|mesh-list
111356282|NCT00118352|Antibodies|antibodies|mesh-list
111356283|NCT00118352|Immunoglobulins|immunoglobulins|mesh-list
111356284|NCT00118352|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111356285|NCT00118352|Cyclosporins|cyclosporins|mesh-list
111356286|NCT00118352|Immunologic Factors|immunologic factors|mesh-ancestor
111356287|NCT00118352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111356288|NCT00118352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111356289|NCT00118352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111356290|NCT00118352|Antimetabolites|antimetabolites|mesh-ancestor
111356291|NCT00118352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111356292|NCT00118352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111356293|NCT00118352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111356294|NCT00118352|Antifungal Agents|antifungal agents|mesh-ancestor
111356295|NCT00118352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111356296|NCT00118352|Dermatologic Agents|dermatologic agents|mesh-ancestor
111356297|NCT00118352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111356298|NCT00118352|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111356299|NCT00118352|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111356300|NCT00118352|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111356301|NCT00118352|Antitubercular Agents|antitubercular agents|mesh-ancestor
111356302|NCT00118352|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111356303|NCT01111331|Empagliflozin|empagliflozin|mesh-list
111356304|NCT01111331|Warfarin|warfarin|mesh-list
111356305|NCT01111331|Anticoagulants|anticoagulants|mesh-ancestor
111356306|NCT01111331|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111356307|NCT01111331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111356308|NCT01111331|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111356309|NCT01111331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111356310|NCT00167102|Alefacept|alefacept|mesh-list
111356311|NCT00167102|Dermatologic Agents|dermatologic agents|mesh-ancestor
111356312|NCT00167102|Immunologic Factors|immunologic factors|mesh-ancestor
111356313|NCT00167102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111356314|NCT01859819|Cytarabine|cytarabine|mesh-list
111356315|NCT01859819|Rituximab|rituximab|mesh-list
111356316|NCT01859819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111356317|NCT01859819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111356318|NCT01859819|Immunologic Factors|immunologic factors|mesh-ancestor
111356319|NCT01859819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111356320|NCT01859819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111356321|NCT01859819|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111356322|NCT01859819|Antimetabolites|antimetabolites|mesh-ancestor
111356323|NCT01859819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111356324|NCT01859819|Antiviral Agents|antiviral agents|mesh-ancestor
111356325|NCT01859819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111356326|NCT01859819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111356327|NCT01795313|Imiquimod|imiquimod|mesh-list
111356328|NCT01795313|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111356329|NCT01795313|Immunologic Factors|immunologic factors|mesh-ancestor
111356330|NCT01795313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111356331|NCT01795313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111356332|NCT01795313|Interferon Inducers|interferon inducers|mesh-ancestor
111356333|NCT02176031|Methylprednisolone|methylprednisolone|mesh-list
111356334|NCT02176031|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111356335|NCT02176031|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111356336|NCT02176031|Prednisolone|prednisolone|mesh-list
111356337|NCT02176031|Prednisolone acetate|prednisolone acetate|mesh-list
111356338|NCT02176031|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111356339|NCT02176031|Prednisolone phosphate|prednisolone phosphate|mesh-list
111356340|NCT02176031|Natalizumab|natalizumab|mesh-list
111356341|NCT02176031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111356342|NCT02176031|Antiemetics|antiemetics|mesh-ancestor
111356343|NCT02176031|Autonomic Agents|autonomic agents|mesh-ancestor
111356344|NCT02176031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111356345|NCT02176031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111356346|NCT02176031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111356347|NCT02176031|Glucocorticoids|glucocorticoids|mesh-ancestor
111356348|NCT02176031|Hormones|hormones|mesh-ancestor
111356349|NCT02176031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111356350|NCT02176031|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111356351|NCT02176031|Protective Agents|protective agents|mesh-ancestor
111356352|NCT02176031|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111356353|NCT02176031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111356354|NCT02176031|Immunologic Factors|immunologic factors|mesh-ancestor
111356355|NCT03013361|Bupivacaine|bupivacaine|mesh-list
111356356|NCT03013361|Ropivacaine|ropivacaine|mesh-list
111356357|NCT03013361|Anesthetics, Local|anesthetics, local|mesh-ancestor
111356358|NCT03013361|Anesthetics|anesthetics|mesh-ancestor
111356359|NCT03013361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111356360|NCT03013361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111356361|NCT03013361|Sensory System Agents|sensory system agents|mesh-ancestor
111356362|NCT03013361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111356363|NCT01077401|Ranibizumab|ranibizumab|mesh-list
111356364|NCT01077401|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111356365|NCT01077401|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111356366|NCT01077401|Growth Substances|growth substances|mesh-ancestor
111356367|NCT01077401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111356368|NCT01077401|Growth Inhibitors|growth inhibitors|mesh-ancestor
111356369|NCT01077401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111356370|NCT01316341|Empagliflozin|empagliflozin|mesh-list
111356371|NCT01316341|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111356372|NCT01316341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111356373|NCT01316341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111356374|NCT01316341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111356375|NCT01112735|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
111356376|NCT01112735|Hemostatics|hemostatics|mesh-ancestor
111356377|NCT01112735|Coagulants|coagulants|mesh-ancestor
111356378|NCT03014297|Everolimus|everolimus|mesh-list
111356379|NCT03014297|Fosbretabulin|fosbretabulin|mesh-list
111356380|NCT03014297|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111356381|NCT03014297|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111356382|NCT03014297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111356383|NCT03014297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111356384|NCT03014297|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111356385|NCT03014297|Immunologic Factors|immunologic factors|mesh-ancestor
111356386|NCT03014297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111356387|NCT03014297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111356388|NCT03014297|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111356389|NCT01034111|Metformin|metformin|mesh-list
111356390|NCT01034111|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111356391|NCT01034111|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111356392|NCT01034111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111356393|NCT01034111|Incretins|incretins|mesh-ancestor
111356394|NCT01034111|Hormones|hormones|mesh-ancestor
111356395|NCT01034111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111356396|NCT01034111|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111356397|NCT01034111|Protease Inhibitors|protease inhibitors|mesh-ancestor
111356398|NCT01034111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111356399|NCT01034111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111356400|NCT01114997|Lidocaine|lidocaine|mesh-list
111080749|NCT03342859|Ulipristal acetate|ulipristal acetate|mesh-list
111356401|NCT01114997|Esmolol|esmolol|mesh-list
111356402|NCT01114997|Anesthetics, Local|anesthetics, local|mesh-ancestor
111356403|NCT01114997|Anesthetics|anesthetics|mesh-ancestor
111356404|NCT01114997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111356405|NCT01114997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111356406|NCT01114997|Sensory System Agents|sensory system agents|mesh-ancestor
111356407|NCT01114997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111356408|NCT01114997|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111356409|NCT01114997|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111356410|NCT01114997|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111356411|NCT01114997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111356412|NCT01114997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111356413|NCT01114997|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
111356414|NCT01114997|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111356415|NCT01114997|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111356416|NCT01114997|Adrenergic Agents|adrenergic agents|mesh-ancestor
111356417|NCT01114997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111356418|NCT00118742|Cyclosporine|cyclosporine|mesh-list
111356420|NCT00118742|Mycophenolic Acid|mycophenolic acid|mesh-list
111356421|NCT00118742|Tacrolimus|tacrolimus|mesh-list
111356422|NCT00118742|Cyclosporins|cyclosporins|mesh-list
111356423|NCT00118742|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111356424|NCT00118742|Immunologic Factors|immunologic factors|mesh-ancestor
111356425|NCT00118742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111356426|NCT00118742|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111356427|NCT00118742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111356428|NCT00118742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111356429|NCT00118742|Antifungal Agents|antifungal agents|mesh-ancestor
111356430|NCT00118742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111356431|NCT00118742|Dermatologic Agents|dermatologic agents|mesh-ancestor
111356432|NCT00118742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111356433|NCT00118742|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111356434|NCT00118742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111356435|NCT00118742|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111356436|NCT00118742|Antitubercular Agents|antitubercular agents|mesh-ancestor
111356437|NCT00118742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111356438|NCT01317667|Vaccines|vaccines|mesh-list
111356439|NCT01317667|Immunologic Factors|immunologic factors|mesh-ancestor
111356440|NCT01317667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111356441|NCT00167180|Cyclophosphamide|cyclophosphamide|mesh-list
111356442|NCT00167180|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111356443|NCT00167180|Immunologic Factors|immunologic factors|mesh-ancestor
111356444|NCT00167180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111356445|NCT00167180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111356446|NCT00167180|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111356447|NCT00167180|Alkylating Agents|alkylating agents|mesh-ancestor
111356448|NCT00167180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111356449|NCT00167180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111356450|NCT00167180|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111356451|NCT01317901|Rituximab|rituximab|mesh-list
111356452|NCT01317901|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
111356453|NCT01317901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110234212|NCT05921968|Iron|iron|mesh-list
111356454|NCT01317901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111356455|NCT01317901|Immunologic Factors|immunologic factors|mesh-ancestor
111356456|NCT01317901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111356457|NCT01317901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111356458|NCT01317901|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111356459|NCT01317901|Alkylating Agents|alkylating agents|mesh-ancestor
111356460|NCT01317901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111356461|NCT03008551|Metformin|metformin|mesh-list
111356462|NCT03008551|Empagliflozin|empagliflozin|mesh-list
111356463|NCT03008551|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111356464|NCT03008551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111356465|NCT03008551|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111356466|NCT03008551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111356467|NCT01366885|Vitamin D|vitamin d|mesh-list
111356468|NCT01366885|Cholecalciferol|cholecalciferol|mesh-list
111356469|NCT01366885|Vitamins|vitamins|mesh-ancestor
111356470|NCT01366885|Micronutrients|micronutrients|mesh-ancestor
111356471|NCT01366885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111356472|NCT01366885|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111356473|NCT01366885|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111356474|NCT01899170|Carfentanil|carfentanil|mesh-list
111080833|NCT03340753|Hormones|hormones|mesh-ancestor
111356475|NCT01899170|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111356477|NCT01899170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111356478|NCT01899170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111356479|NCT01899170|Analgesics|analgesics|mesh-ancestor
111356480|NCT01899170|Sensory System Agents|sensory system agents|mesh-ancestor
111356481|NCT01899170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111356482|NCT01425229|Bosentan|bosentan|mesh-list
111356483|NCT01425229|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111356484|NCT01425229|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
111356485|NCT01425229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111356486|NCT00258362|Carboplatin|carboplatin|mesh-list
111356487|NCT00258362|Docetaxel|docetaxel|mesh-list
111356488|NCT00258362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111356489|NCT00258362|Tubulin Modulators|tubulin modulators|mesh-ancestor
111356490|NCT00258362|Antimitotic Agents|antimitotic agents|mesh-ancestor
111356491|NCT00258362|Mitosis Modulators|mitosis modulators|mesh-ancestor
111356492|NCT00258362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111356493|NCT00258830|Vaccines|vaccines|mesh-list
111356494|NCT00258830|Immunologic Factors|immunologic factors|mesh-ancestor
111356495|NCT00258830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111356496|NCT02539368|Infliximab|infliximab|mesh-list
111356497|NCT02539368|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111356498|NCT02539368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111356499|NCT02539368|Dermatologic Agents|dermatologic agents|mesh-ancestor
111356500|NCT02539368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111356501|NCT02539368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111356502|NCT01425307|Hydroxyurea|hydroxyurea|mesh-list
111356503|NCT01425307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111356504|NCT01425307|Antisickling Agents|antisickling agents|mesh-ancestor
111356505|NCT01425307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111356506|NCT01425307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111356507|NCT01425307|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111356508|NCT01035749|Vaccines|vaccines|mesh-list
111356509|NCT01035749|Immunologic Factors|immunologic factors|mesh-ancestor
111356510|NCT01035749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111356511|NCT00123110|Metformin|metformin|mesh-list
111356512|NCT00123110|Leuprolide|leuprolide|mesh-list
111356513|NCT00123110|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111356514|NCT00123110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111356515|NCT00123110|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111356516|NCT00123110|Fertility Agents|fertility agents|mesh-ancestor
111356517|NCT00123110|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111356518|NCT00123110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111356519|NCT00123110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111356520|NCT01425853|Celecoxib|celecoxib|mesh-list
111356521|NCT01425853|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111356522|NCT01425853|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111356523|NCT01425853|Analgesics|analgesics|mesh-ancestor
111356524|NCT01425853|Sensory System Agents|sensory system agents|mesh-ancestor
111356525|NCT01425853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111356526|NCT01425853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111356527|NCT01425853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111356528|NCT01425853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111356529|NCT01425853|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111356530|NCT01425853|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111356531|NCT01425853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111356532|NCT01425853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111356533|NCT01426867|Brimonidine Tartrate|brimonidine tartrate|mesh-list
111356534|NCT01426867|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111356535|NCT01426867|Brinzolamide|brinzolamide|mesh-list
111356536|NCT01426867|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111356537|NCT01426867|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111356538|NCT01426867|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111356539|NCT01426867|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111356540|NCT01426867|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111356541|NCT01426867|Adrenergic Agents|adrenergic agents|mesh-ancestor
111356542|NCT01426867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111356543|NCT01426867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111356544|NCT01426867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111356545|NCT01426867|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
111356546|NCT01426867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111356547|NCT00168428|Botulinum Toxins|botulinum toxins|mesh-list
111356548|NCT00168428|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111356549|NCT00168428|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111356550|NCT00168428|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111356551|NCT00168428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111356552|NCT00168428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111356553|NCT00168428|Cholinergic Agents|cholinergic agents|mesh-ancestor
111356554|NCT00168428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111356555|NCT00168428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111356556|NCT00168428|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111356557|NCT00168428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111356559|NCT01427881|Cyclophosphamide|cyclophosphamide|mesh-list
111356560|NCT01427881|Busulfan|busulfan|mesh-list
111356561|NCT01427881|Fludarabine|fludarabine|mesh-list
111356562|NCT01427881|Fludarabine phosphate|fludarabine phosphate|mesh-list
111356563|NCT01427881|Cyclosporins|cyclosporins|mesh-list
111356564|NCT01427881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111356565|NCT01427881|Immunologic Factors|immunologic factors|mesh-ancestor
111356566|NCT01427881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111356567|NCT01427881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111356568|NCT01427881|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111356569|NCT01427881|Alkylating Agents|alkylating agents|mesh-ancestor
111356570|NCT01427881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111356571|NCT01427881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111356572|NCT01427881|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110841341|NCT00000116|Vitamin A|vitamin a|mesh-list
111356573|NCT01427881|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111356574|NCT01427881|Antimetabolites|antimetabolites|mesh-ancestor
111356575|NCT01427881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111356576|NCT01427881|Antifungal Agents|antifungal agents|mesh-ancestor
111356577|NCT01427881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111356578|NCT01427881|Dermatologic Agents|dermatologic agents|mesh-ancestor
111356579|NCT01427881|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111356580|NCT02112734|Vitamin D|vitamin d|mesh-list
111356581|NCT02112734|Ergocalciferols|ergocalciferols|mesh-list
111356582|NCT02112734|Cholecalciferol|cholecalciferol|mesh-list
111356583|NCT02112734|Vitamins|vitamins|mesh-list
111356584|NCT02112734|Micronutrients|micronutrients|mesh-ancestor
111356585|NCT02112734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111356586|NCT02112734|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111356587|NCT02112734|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111356588|NCT01319773|Cyclosporine|cyclosporine|mesh-list
111356589|NCT01319773|Cyclosporins|cyclosporins|mesh-list
111356590|NCT01319773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111356591|NCT01319773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111356592|NCT01319773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111356593|NCT01319773|Immunologic Factors|immunologic factors|mesh-ancestor
111356594|NCT01319773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111356595|NCT01319773|Antifungal Agents|antifungal agents|mesh-ancestor
111356596|NCT01319773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111356597|NCT01319773|Dermatologic Agents|dermatologic agents|mesh-ancestor
111356598|NCT01319773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111356599|NCT01319773|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111356600|NCT01319851|Alefacept|alefacept|mesh-list
111356601|NCT01319851|Dermatologic Agents|dermatologic agents|mesh-ancestor
111356602|NCT01319851|Immunologic Factors|immunologic factors|mesh-ancestor
111356603|NCT01319851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111356604|NCT04351867|Docetaxel|docetaxel|mesh-list
111356605|NCT04351867|Capecitabine|capecitabine|mesh-list
111356606|NCT04351867|Oxaliplatin|oxaliplatin|mesh-list
111356607|NCT04351867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111356608|NCT04351867|Tubulin Modulators|tubulin modulators|mesh-ancestor
111356609|NCT04351867|Antimitotic Agents|antimitotic agents|mesh-ancestor
111356610|NCT04351867|Mitosis Modulators|mitosis modulators|mesh-ancestor
111356611|NCT04351867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111356612|NCT04351867|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111356613|NCT04351867|Antimetabolites|antimetabolites|mesh-ancestor
111356614|NCT00262730|Temozolomide|temozolomide|mesh-list
111356615|NCT00262730|Poly ICLC|poly iclc|mesh-list
111356616|NCT00262730|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111356617|NCT00262730|Alkylating Agents|alkylating agents|mesh-ancestor
111356618|NCT00262730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111356619|NCT00262730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111356620|NCT00262730|Interferon Inducers|interferon inducers|mesh-ancestor
111356621|NCT00262730|Immunologic Factors|immunologic factors|mesh-ancestor
110841679|NCT02714322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111356622|NCT00262730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111356623|NCT04262934|Vitamin D|vitamin d|mesh-list
111356624|NCT04262934|Cholecalciferol|cholecalciferol|mesh-list
111080973|NCT02162758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111356625|NCT04262934|Vitamins|vitamins|mesh-ancestor
111356626|NCT04262934|Micronutrients|micronutrients|mesh-ancestor
110841735|NCT01345019|Denosumab|denosumab|mesh-list
111356627|NCT04262934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111356628|NCT04262934|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111356629|NCT04262934|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111356631|NCT00262964|Fenofibrate|fenofibrate|mesh-list
111356632|NCT00262964|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111356633|NCT00262964|Antimetabolites|antimetabolites|mesh-ancestor
111356634|NCT00262964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111356635|NCT00262964|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111356636|NCT00262964|Vasodilator Agents|vasodilator agents|mesh-ancestor
111356637|NCT00262964|Vitamin B Complex|vitamin b complex|mesh-ancestor
111356638|NCT00262964|Vitamins|vitamins|mesh-ancestor
111356639|NCT00262964|Micronutrients|micronutrients|mesh-ancestor
111356640|NCT00262964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111356641|NCT00124514|Triptorelin Pamoate|triptorelin pamoate|mesh-list
111356642|NCT00124514|Luteolytic Agents|luteolytic agents|mesh-ancestor
111356643|NCT00124514|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111356644|NCT00124514|Contraceptive Agents|contraceptive agents|mesh-ancestor
111356645|NCT00124514|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111356646|NCT00124514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111356647|NCT00124514|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111356648|NCT00124514|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111356649|NCT00124514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111356650|NCT01899248|Sevoflurane|sevoflurane|mesh-list
111356651|NCT01899248|Desflurane|desflurane|mesh-list
110841955|NCT01251107|Etoposide|etoposide|mesh-list
111356652|NCT01899248|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111356653|NCT01899248|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111356654|NCT01899248|Anesthetics, General|anesthetics, general|mesh-ancestor
111356655|NCT01899248|Anesthetics|anesthetics|mesh-ancestor
111356656|NCT01899248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111356657|NCT01899248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111356658|NCT01322815|Leucovorin|leucovorin|mesh-list
111356659|NCT01322815|Fluorouracil|fluorouracil|mesh-list
111356660|NCT01322815|Oxaliplatin|oxaliplatin|mesh-list
111356661|NCT01322815|Irinotecan|irinotecan|mesh-list
111356662|NCT01322815|Bevacizumab|bevacizumab|mesh-list
111356663|NCT01322815|Levoleucovorin|levoleucovorin|mesh-list
111356664|NCT01322815|Antimetabolites|antimetabolites|mesh-ancestor
111356665|NCT01322815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111356666|NCT01322815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111356667|NCT01322815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111356668|NCT01322815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111356669|NCT01322815|Immunologic Factors|immunologic factors|mesh-ancestor
111356670|NCT01322815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111356671|NCT01322815|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111356672|NCT01322815|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111356673|NCT01322815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111356674|NCT01322815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111356675|NCT01322815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111356676|NCT01322815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110842168|NCT03300570|Dolcanatide|dolcanatide|mesh-list
111356677|NCT01322815|Growth Substances|growth substances|mesh-ancestor
111356678|NCT01322815|Growth Inhibitors|growth inhibitors|mesh-ancestor
111356679|NCT01322815|Antidotes|antidotes|mesh-ancestor
111356680|NCT01322815|Protective Agents|protective agents|mesh-ancestor
111356681|NCT01322815|Vitamin B Complex|vitamin b complex|mesh-ancestor
111356682|NCT01322815|Vitamins|vitamins|mesh-ancestor
111356683|NCT01322815|Micronutrients|micronutrients|mesh-ancestor
111356684|NCT00176228|Lamotrigine|lamotrigine|mesh-list
111356685|NCT00176228|Anticonvulsants|anticonvulsants|mesh-ancestor
111356686|NCT00176228|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111356687|NCT00176228|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111356688|NCT00176228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111356689|NCT00176228|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111356690|NCT00176228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111356691|NCT00176228|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111356692|NCT00176228|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111356693|NCT00176228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111356694|NCT00176228|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111356695|NCT00176228|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111356696|NCT00176306|Levofloxacin|levofloxacin|mesh-list
111356697|NCT00176306|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111356698|NCT00176306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111356699|NCT00176306|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111356700|NCT00176306|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111356701|NCT00176306|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111356702|NCT00176306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111356703|NCT00176306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111356704|NCT00176306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111356705|NCT00176306|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111356706|NCT00176306|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111356708|NCT01429987|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
111356709|NCT01429987|Enzyme Activators|enzyme activators|mesh-ancestor
111356710|NCT01429987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111356711|NCT01429987|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111356712|NCT00265616|Pentobarbital|pentobarbital|mesh-list
111356713|NCT00265616|Thiopental|thiopental|mesh-list
111356714|NCT00265616|Propofol|propofol|mesh-list
111356715|NCT00265616|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111356716|NCT00265616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111356717|NCT00265616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111356718|NCT00265616|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111356719|NCT00265616|Anesthetics, General|anesthetics, general|mesh-ancestor
111356720|NCT00265616|Anesthetics|anesthetics|mesh-ancestor
111356721|NCT00265616|Anticonvulsants|anticonvulsants|mesh-ancestor
111356722|NCT00265616|GABA Modulators|gaba modulators|mesh-ancestor
111356723|NCT00265616|GABA Agents|gaba agents|mesh-ancestor
111356724|NCT00265616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110842339|NCT01253681|Paclitaxel|paclitaxel|mesh-list
111356725|NCT00265616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111356726|NCT00265616|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111356727|NCT00176852|Vidarabine|vidarabine|mesh-list
111356728|NCT00176852|Cyclophosphamide|cyclophosphamide|mesh-list
111356729|NCT00176852|Busulfan|busulfan|mesh-list
111356730|NCT00176852|Fludarabine|fludarabine|mesh-list
111356731|NCT00176852|Fludarabine phosphate|fludarabine phosphate|mesh-list
111356732|NCT00176852|Alemtuzumab|alemtuzumab|mesh-list
111356733|NCT00176852|Antilymphocyte Serum|antilymphocyte serum|mesh-list
111356734|NCT00176852|Lenograstim|lenograstim|mesh-list
110842474|NCT05208398|Apixaban|apixaban|mesh-list
111356735|NCT00176852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111356736|NCT00176852|Immunologic Factors|immunologic factors|mesh-ancestor
111356737|NCT00176852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111356738|NCT00176852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111356739|NCT00176852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111356740|NCT00176852|Alkylating Agents|alkylating agents|mesh-ancestor
111356741|NCT00176852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111356742|NCT00176852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111356743|NCT00176852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111356744|NCT00176852|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111356745|NCT00176852|Antimetabolites|antimetabolites|mesh-ancestor
111356746|NCT00176852|Antiviral Agents|antiviral agents|mesh-ancestor
111356747|NCT00176852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111356748|NCT00176852|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111356749|NCT00176852|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111356750|NCT01323517|Dactinomycin|dactinomycin|mesh-list
111356751|NCT01323517|Ipilimumab|ipilimumab|mesh-list
111356752|NCT01323517|Melphalan|melphalan|mesh-list
111356753|NCT01323517|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111356754|NCT01323517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111356755|NCT01323517|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111356756|NCT01323517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111356757|NCT01323517|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111356758|NCT01323517|Alkylating Agents|alkylating agents|mesh-ancestor
111356759|NCT01323517|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111356760|NCT01323517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111356761|NCT01323517|Immunologic Factors|immunologic factors|mesh-ancestor
111356762|NCT01323517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111356763|NCT01323517|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111356764|NCT01323517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111356765|NCT01323517|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111356766|NCT01323517|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111356767|NCT01323517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111356768|NCT01323517|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111356769|NCT01323595|Celecoxib|celecoxib|mesh-list
111356770|NCT01323595|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111356771|NCT01323595|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111356772|NCT01323595|Analgesics|analgesics|mesh-ancestor
111356773|NCT01323595|Sensory System Agents|sensory system agents|mesh-ancestor
111356774|NCT01323595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111356775|NCT01323595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111356776|NCT01323595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111356777|NCT01323595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111356778|NCT01323595|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111356779|NCT01323595|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111356780|NCT01323595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111356781|NCT01323595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111356782|NCT01376557|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
111356783|NCT01376557|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111356784|NCT01376557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111356785|NCT01376557|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111356786|NCT01376557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111356787|NCT01431391|Leuprolide|leuprolide|mesh-list
111356788|NCT01431391|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111356789|NCT01431391|Fertility Agents|fertility agents|mesh-ancestor
111356790|NCT01431391|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111356791|NCT01431391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110842584|NCT03700970|Bupivacaine|bupivacaine|mesh-list
111356792|NCT01431391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111356793|NCT01431391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111356794|NCT03009097|Atorvastatin|atorvastatin|mesh-list
111356795|NCT03009097|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111356796|NCT03009097|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111356797|NCT03009097|Antimetabolites|antimetabolites|mesh-ancestor
111356798|NCT03009097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111356799|NCT03009097|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111356800|NCT03009097|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111356801|NCT03009097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111356802|NCT01325311|Vitamin D|vitamin d|mesh-list
111356803|NCT01325311|Cholecalciferol|cholecalciferol|mesh-list
111356804|NCT01325311|Genistein|genistein|mesh-list
111356805|NCT01325311|Vitamins|vitamins|mesh-ancestor
111356806|NCT01325311|Micronutrients|micronutrients|mesh-ancestor
111356807|NCT01325311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111356808|NCT01325311|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111356809|NCT01325311|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111356810|NCT01325311|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
111356811|NCT01325311|Protective Agents|protective agents|mesh-ancestor
111356812|NCT01325311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111356813|NCT01325311|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111356814|NCT01325311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111356815|NCT01325311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111356816|NCT01325311|Phytoestrogens|phytoestrogens|mesh-ancestor
111356817|NCT01325311|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
111356818|NCT01325311|Estrogens|estrogens|mesh-ancestor
111356819|NCT01325311|Hormones|hormones|mesh-ancestor
111356820|NCT01325311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111356821|NCT01432015|Aprepitant|aprepitant|mesh-list
111356822|NCT01432015|Fosaprepitant|fosaprepitant|mesh-list
111356823|NCT01432015|Antiemetics|antiemetics|mesh-ancestor
111356824|NCT01432015|Autonomic Agents|autonomic agents|mesh-ancestor
111356825|NCT01432015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111356826|NCT01432015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111356827|NCT01432015|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111356828|NCT01432015|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
111356829|NCT01432015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111356830|NCT01432015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111356831|NCT01080677|Propranolol|propranolol|mesh-list
111356832|NCT01080677|Caffeine|caffeine|mesh-list
111356833|NCT01080677|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111356834|NCT01080677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111356835|NCT01080677|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111356836|NCT01080677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111356837|NCT01080677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111356838|NCT01080677|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
111356839|NCT01080677|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111356840|NCT01080677|Purinergic Agents|purinergic agents|mesh-ancestor
111356841|NCT01080677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111356842|NCT01080677|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111356843|NCT01080677|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111356844|NCT01080677|Adrenergic Agents|adrenergic agents|mesh-ancestor
111356845|NCT01080677|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111356846|NCT01080677|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111356847|NCT01080677|Vasodilator Agents|vasodilator agents|mesh-ancestor
111081197|NCT04492813|Remifentanil|remifentanil|mesh-list
111356848|NCT01378273|Epoetin Alfa|epoetin alfa|mesh-list
111356849|NCT01378273|Hematinics|hematinics|mesh-ancestor
111356850|NCT01432405|Pioglitazone|pioglitazone|mesh-list
111356851|NCT01432405|Exenatide|exenatide|mesh-list
110842808|NCT02519738|Hormones|hormones|mesh-ancestor
111356852|NCT01432405|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111356853|NCT01432405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111356854|NCT01432405|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111356855|NCT01432405|Incretins|incretins|mesh-ancestor
111356856|NCT01432405|Hormones|hormones|mesh-ancestor
111356857|NCT01432405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111356858|NCT01432561|Cysteamine|cysteamine|mesh-list
111356859|NCT01432561|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
111356860|NCT01432561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111356861|NCT01116401|Leuprolide|leuprolide|mesh-list
111356862|NCT01116401|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111356863|NCT01116401|Fertility Agents|fertility agents|mesh-ancestor
111356864|NCT01116401|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111356865|NCT01116401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111356866|NCT01116401|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111356867|NCT01116401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111356868|NCT03008317|Chromium|chromium|mesh-list
111356869|NCT03008317|Trace Elements|trace elements|mesh-ancestor
111356870|NCT03008317|Micronutrients|micronutrients|mesh-ancestor
111356871|NCT03008317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111356872|NCT01433107|Terbinafine|terbinafine|mesh-list
111356873|NCT01433107|Antifungal Agents|antifungal agents|mesh-ancestor
111356874|NCT01433107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111356875|NCT01433107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111356876|NCT01433107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111356877|NCT01082939|Cyclophosphamide|cyclophosphamide|mesh-list
111356878|NCT01082939|Rituximab|rituximab|mesh-list
111356879|NCT01082939|Fludarabine|fludarabine|mesh-list
111356880|NCT01082939|Fludarabine phosphate|fludarabine phosphate|mesh-list
111356881|NCT01082939|Alemtuzumab|alemtuzumab|mesh-list
110843068|NCT05667077|Amantadine|amantadine|mesh-list
111356882|NCT01082939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111356883|NCT01082939|Immunologic Factors|immunologic factors|mesh-ancestor
111356884|NCT01082939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111356885|NCT01082939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111356886|NCT01082939|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111356887|NCT01082939|Alkylating Agents|alkylating agents|mesh-ancestor
111356888|NCT01082939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111356889|NCT01082939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111356890|NCT01082939|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111356891|NCT01082939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111356892|NCT01082939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111356893|NCT01082939|Antimetabolites|antimetabolites|mesh-ancestor
111356894|NCT01381471|Fluticasone|fluticasone|mesh-list
111356895|NCT01381471|Xhance|xhance|mesh-list
111356896|NCT01381471|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
111356897|NCT01381471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111356898|NCT01381471|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111356899|NCT01381471|Autonomic Agents|autonomic agents|mesh-ancestor
111356900|NCT01381471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111356901|NCT01381471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111356902|NCT01381471|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111356903|NCT01381471|Respiratory System Agents|respiratory system agents|mesh-ancestor
111356904|NCT01381471|Dermatologic Agents|dermatologic agents|mesh-ancestor
111356905|NCT01381471|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111356906|NCT01381471|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111356907|NCT01381471|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111356908|NCT01381471|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111356909|NCT01381471|Adrenergic Agents|adrenergic agents|mesh-ancestor
111356910|NCT01381471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111356911|NCT01381471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111356912|NCT05422092|Pioglitazone|pioglitazone|mesh-list
111356913|NCT05422092|Canagliflozin|canagliflozin|mesh-list
111356914|NCT05422092|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111356915|NCT05422092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111356916|NCT05422092|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111356917|NCT05422092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110604697|NCT04016740|Ketamine|ketamine|mesh-list
111356918|NCT05448456|Tranexamic Acid|tranexamic acid|mesh-list
111356919|NCT05448456|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111356920|NCT05448456|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111356921|NCT05448456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111356922|NCT05448456|Hemostatics|hemostatics|mesh-ancestor
111356923|NCT05448456|Coagulants|coagulants|mesh-ancestor
111356924|NCT05448378|Inositol|inositol|mesh-list
111356925|NCT05448378|Vitamin B Complex|vitamin b complex|mesh-ancestor
111356926|NCT05448378|Vitamins|vitamins|mesh-ancestor
111356927|NCT05448378|Micronutrients|micronutrients|mesh-ancestor
111356928|NCT05448378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111356929|NCT01434121|Ascorbic Acid|ascorbic acid|mesh-list
111356930|NCT01434121|Vitamins|vitamins|mesh-ancestor
111356931|NCT01434121|Micronutrients|micronutrients|mesh-ancestor
111356932|NCT01434121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111356933|NCT01434121|Antioxidants|antioxidants|mesh-ancestor
111356934|NCT01434121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111356935|NCT01434121|Protective Agents|protective agents|mesh-ancestor
111356936|NCT01381861|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111356937|NCT01381861|Immunologic Factors|immunologic factors|mesh-ancestor
111356938|NCT01381861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111356939|NCT01040819|Pioglitazone|pioglitazone|mesh-list
111356940|NCT01040819|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111356941|NCT01040819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111356942|NCT01041209|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111356943|NCT01041209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111356944|NCT01084265|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
111356945|NCT01084265|Hormones|hormones|mesh-list
111356946|NCT01084265|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
111356947|NCT01084265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111356948|NCT01084265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111356949|NCT01084265|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111356950|NCT01084499|Letrozole|letrozole|mesh-list
111356951|NCT01084499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111356952|NCT01084499|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111356953|NCT01084499|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111356954|NCT01084499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111356955|NCT01084499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111356956|NCT01084499|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111356957|NCT01084499|Hormone Antagonists|hormone antagonists|mesh-ancestor
111356958|NCT01084499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111356959|NCT01084499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111356960|NCT01118273|Diphenhydramine|diphenhydramine|mesh-list
111356961|NCT01118273|Promethazine|promethazine|mesh-list
111356962|NCT01118273|Ibuprofen|ibuprofen|mesh-list
111356963|NCT01118273|Naproxen|naproxen|mesh-list
111356964|NCT01118273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111356965|NCT01118273|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111356966|NCT01118273|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111356967|NCT01118273|Analgesics|analgesics|mesh-ancestor
111356968|NCT01118273|Sensory System Agents|sensory system agents|mesh-ancestor
111356969|NCT01118273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111356970|NCT01118273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111356971|NCT01118273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111356972|NCT01118273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111356973|NCT01118273|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111356974|NCT01118273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111356975|NCT01118273|Gout Suppressants|gout suppressants|mesh-ancestor
111356976|NCT01118273|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111356977|NCT01118273|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111356978|NCT01118273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111356979|NCT01118273|Anesthetics, Local|anesthetics, local|mesh-ancestor
111356980|NCT01118273|Anesthetics|anesthetics|mesh-ancestor
111356981|NCT01118273|Antiemetics|antiemetics|mesh-ancestor
111356982|NCT01118273|Autonomic Agents|autonomic agents|mesh-ancestor
111356983|NCT01118273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111356984|NCT01118273|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111356985|NCT01118273|Histamine Antagonists|histamine antagonists|mesh-ancestor
111356986|NCT01118273|Histamine Agents|histamine agents|mesh-ancestor
111356987|NCT01118273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111356988|NCT01118273|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111356989|NCT01118273|Antipruritics|antipruritics|mesh-ancestor
111356990|NCT01118273|Dermatologic Agents|dermatologic agents|mesh-ancestor
111356991|NCT01085903|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
111356992|NCT01085903|Modafinil|modafinil|mesh-list
111356993|NCT01085903|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111356994|NCT01085903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111356995|NCT01085903|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
111356996|NCT01085903|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111356997|NCT01085903|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111356998|NCT01085903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111356999|NCT01118741|Disulfiram|disulfiram|mesh-list
111357000|NCT01118741|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111357001|NCT01118741|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
111357002|NCT01118741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111357003|NCT01118741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111357004|NCT01439815|Fluticasone|fluticasone|mesh-list
111357005|NCT01439815|Xhance|xhance|mesh-list
111357006|NCT01439815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111357007|NCT01439815|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111357008|NCT01439815|Autonomic Agents|autonomic agents|mesh-ancestor
111357009|NCT01439815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111357010|NCT01439815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111357011|NCT01439815|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111357012|NCT01439815|Respiratory System Agents|respiratory system agents|mesh-ancestor
111357013|NCT01439815|Dermatologic Agents|dermatologic agents|mesh-ancestor
111357014|NCT01439815|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111357015|NCT01332253|Ibuprofen|ibuprofen|mesh-list
111357016|NCT01332253|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111357017|NCT01332253|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111357018|NCT01332253|Analgesics|analgesics|mesh-ancestor
111357019|NCT01332253|Sensory System Agents|sensory system agents|mesh-ancestor
111357020|NCT01332253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111357021|NCT01332253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110607939|NCT00742404|Dexamethasone|dexamethasone|mesh-list
111357022|NCT01332253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111357023|NCT01332253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111357024|NCT01332253|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111357025|NCT01332253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111357026|NCT01332253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111357027|NCT01332721|Bevacizumab|bevacizumab|mesh-list
111357028|NCT01332721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111357029|NCT01332721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111357030|NCT01332721|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111357031|NCT01332721|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111357032|NCT01332721|Growth Substances|growth substances|mesh-ancestor
111357033|NCT01332721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111357034|NCT01332721|Growth Inhibitors|growth inhibitors|mesh-ancestor
111357035|NCT01384591|Acetylcysteine|acetylcysteine|mesh-list
111357036|NCT01384591|Losartan|losartan|mesh-list
111357037|NCT01384591|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111357038|NCT01384591|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111357039|NCT01384591|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111357040|NCT01384591|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111357041|NCT01384591|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110843713|NCT01159847|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111357042|NCT01384591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111357043|NCT01384591|Antiviral Agents|antiviral agents|mesh-ancestor
111357044|NCT01384591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111357045|NCT01384591|Expectorants|expectorants|mesh-ancestor
111357046|NCT01384591|Respiratory System Agents|respiratory system agents|mesh-ancestor
111357047|NCT01384591|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111357048|NCT01384591|Antioxidants|antioxidants|mesh-ancestor
111357049|NCT01384591|Protective Agents|protective agents|mesh-ancestor
111357050|NCT01384591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111357051|NCT01384591|Antidotes|antidotes|mesh-ancestor
111357052|NCT01086605|Pixantrone|pixantrone|mesh-list
111357053|NCT01086605|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111357054|NCT01086605|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111357055|NCT01086605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111357056|NCT01086605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111357057|NCT01086605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111357058|NCT00265850|Leucovorin|leucovorin|mesh-list
111357059|NCT00265850|Folic Acid|folic acid|mesh-list
110610814|NCT00369967|NuvaRing|nuvaring|mesh-list
111357060|NCT00265850|Bevacizumab|bevacizumab|mesh-list
111357061|NCT00265850|Cetuximab|cetuximab|mesh-list
111357062|NCT00265850|Fluorouracil|fluorouracil|mesh-list
111357063|NCT00265850|Oxaliplatin|oxaliplatin|mesh-list
111357064|NCT00265850|Irinotecan|irinotecan|mesh-list
111357065|NCT00265850|Levoleucovorin|levoleucovorin|mesh-list
111357066|NCT00265850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110611192|NCT00875745|Sorafenib|sorafenib|mesh-list
111357067|NCT00265850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111357068|NCT00265850|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111357069|NCT00265850|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111357070|NCT00265850|Growth Substances|growth substances|mesh-ancestor
111357071|NCT00265850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111357072|NCT00265850|Growth Inhibitors|growth inhibitors|mesh-ancestor
111357073|NCT00265850|Antimetabolites|antimetabolites|mesh-ancestor
110843978|NCT01163903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111357074|NCT00265850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111357075|NCT00265850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111357076|NCT00265850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111357077|NCT00265850|Immunologic Factors|immunologic factors|mesh-ancestor
110561711|NCT02666417|Iron|iron|mesh-list
111357078|NCT00265850|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111357079|NCT00265850|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111357080|NCT00265850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111357081|NCT00265850|Antidotes|antidotes|mesh-ancestor
111357082|NCT00265850|Protective Agents|protective agents|mesh-ancestor
111357083|NCT00265850|Vitamin B Complex|vitamin b complex|mesh-ancestor
111357085|NCT00265850|Micronutrients|micronutrients|mesh-ancestor
111357086|NCT00265850|Hematinics|hematinics|mesh-ancestor
111357087|NCT00125372|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111357088|NCT00125372|Bexarotene|bexarotene|mesh-list
111357089|NCT00125372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111357090|NCT00125372|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111357091|NCT00125372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111357092|NCT00125372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111357093|NCT00125528|Cycloserine|cycloserine|mesh-list
111357094|NCT00125528|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111357095|NCT00125528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111357096|NCT00125528|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111357097|NCT00125528|Antitubercular Agents|antitubercular agents|mesh-ancestor
111357098|NCT00125528|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111357099|NCT00125528|Antimetabolites|antimetabolites|mesh-ancestor
111357100|NCT00125528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111357101|NCT01390909|Oxcarbazepine|oxcarbazepine|mesh-list
111357102|NCT01390909|Anticonvulsants|anticonvulsants|mesh-list
111357103|NCT01390909|Lactitol|lactitol|mesh-list
111357104|NCT01390909|Cathartics|cathartics|mesh-ancestor
111357105|NCT01390909|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111357106|NCT01390909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111357107|NCT01390909|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111357108|NCT01390909|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111357109|NCT01390909|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111357110|NCT01390909|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110844241|NCT04222699|Disinfectants|disinfectants|mesh-ancestor
111357111|NCT01390909|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111357112|NCT01042145|Dexamethasone|dexamethasone|mesh-list
111357113|NCT01042145|Prednisone|prednisone|mesh-list
111357114|NCT01042145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111357115|NCT01042145|Antiemetics|antiemetics|mesh-ancestor
111357116|NCT01042145|Autonomic Agents|autonomic agents|mesh-ancestor
110844312|NCT02778204|Maraviroc|maraviroc|mesh-list
111357117|NCT01042145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111357118|NCT01042145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111357119|NCT01042145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111357120|NCT01042145|Glucocorticoids|glucocorticoids|mesh-ancestor
111357121|NCT01042145|Hormones|hormones|mesh-ancestor
111357122|NCT01042145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111357123|NCT01042145|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111357124|NCT01042145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110844387|NCT00462748|Ezetimibe|ezetimibe|mesh-list
111357125|NCT01043393|Desoximetasone|desoximetasone|mesh-list
111357126|NCT01043393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111357127|NCT01043393|Glucocorticoids|glucocorticoids|mesh-ancestor
111357128|NCT01043393|Hormones|hormones|mesh-ancestor
111357129|NCT01043393|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111357130|NCT01043393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111357131|NCT01087931|Bupivacaine|bupivacaine|mesh-list
110844452|NCT00418834|Ezetimibe|ezetimibe|mesh-list
111357132|NCT01087931|Anesthetics, Local|anesthetics, local|mesh-ancestor
111357133|NCT01087931|Anesthetics|anesthetics|mesh-ancestor
111357134|NCT01087931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111357135|NCT01087931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111357136|NCT01087931|Sensory System Agents|sensory system agents|mesh-ancestor
111357137|NCT01087931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111357138|NCT03009409|Ketamine|ketamine|mesh-list
111357139|NCT03009409|Analgesics|analgesics|mesh-ancestor
111357140|NCT03009409|Sensory System Agents|sensory system agents|mesh-ancestor
111357141|NCT03009409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111357142|NCT03009409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111357143|NCT03009409|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111357144|NCT03009409|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111357145|NCT03009409|Anesthetics, General|anesthetics, general|mesh-ancestor
111357146|NCT03009409|Anesthetics|anesthetics|mesh-ancestor
111357147|NCT03009409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111357148|NCT03009409|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111357149|NCT03009409|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111357150|NCT03009409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111357151|NCT03009409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111357152|NCT00176930|Cyclophosphamide|cyclophosphamide|mesh-list
111357153|NCT00176930|Busulfan|busulfan|mesh-list
111357154|NCT00176930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111357155|NCT00176930|Immunologic Factors|immunologic factors|mesh-ancestor
110844647|NCT03697876|Immunologic Factors|immunologic factors|mesh-ancestor
111357156|NCT00176930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111357157|NCT00176930|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111357158|NCT00176930|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111357159|NCT00176930|Alkylating Agents|alkylating agents|mesh-ancestor
111357160|NCT00176930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111357161|NCT00176930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111357162|NCT00176930|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111357163|NCT01473745|Daminozide|daminozide|mesh-list
111357164|NCT01473745|Plant Growth Regulators|plant growth regulators|mesh-ancestor
111357165|NCT01473745|Growth Substances|growth substances|mesh-ancestor
111357166|NCT01473745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111357167|NCT00178178|Bupivacaine|bupivacaine|mesh-list
111357168|NCT00178178|Anesthetics, Local|anesthetics, local|mesh-ancestor
111357169|NCT00178178|Anesthetics|anesthetics|mesh-ancestor
111357170|NCT00178178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111357171|NCT00178178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110844783|NCT03379012|Sunitinib|sunitinib|mesh-list
111357172|NCT00178178|Sensory System Agents|sensory system agents|mesh-ancestor
111357173|NCT00178178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111357174|NCT01441843|Lorazepam|lorazepam|mesh-list
111357175|NCT01441843|Anticonvulsants|anticonvulsants|mesh-ancestor
111357176|NCT01441843|Antiemetics|antiemetics|mesh-ancestor
111357177|NCT01441843|Autonomic Agents|autonomic agents|mesh-ancestor
111357178|NCT01441843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110844847|NCT05171530|Lenvatinib|lenvatinib|mesh-list
111357179|NCT01441843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111357180|NCT01441843|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111357181|NCT01441843|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111357182|NCT01441843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111357183|NCT01441843|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111357184|NCT01441843|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111357185|NCT01441843|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111357186|NCT01441843|GABA Modulators|gaba modulators|mesh-ancestor
111357187|NCT01441843|GABA Agents|gaba agents|mesh-ancestor
111357188|NCT01441843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111357189|NCT01441843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110844914|NCT04194151|Anesthetics|anesthetics|mesh-ancestor
111357190|NCT00178646|Botulinum Toxins|botulinum toxins|mesh-list
111357191|NCT00178646|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111357192|NCT00178646|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111357193|NCT00178646|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111357194|NCT00178646|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111357195|NCT00178646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111357196|NCT00178646|Cholinergic Agents|cholinergic agents|mesh-ancestor
111357197|NCT00178646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111357198|NCT00178646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111357199|NCT00178646|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111357200|NCT00178646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111357201|NCT01089569|Insulin Glargine|insulin glargine|mesh-list
111357202|NCT01089569|Exenatide|exenatide|mesh-list
111357203|NCT01089569|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111357204|NCT01089569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111357205|NCT01089569|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111357206|NCT01089569|Incretins|incretins|mesh-ancestor
111357207|NCT01089569|Hormones|hormones|mesh-ancestor
111357208|NCT01089569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111357209|NCT00128180|Methylprednisolone|methylprednisolone|mesh-list
111357210|NCT00128180|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111357211|NCT00128180|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111357212|NCT00128180|Prednisolone|prednisolone|mesh-list
111357213|NCT00128180|Prednisolone acetate|prednisolone acetate|mesh-list
111357214|NCT00128180|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111357215|NCT00128180|Prednisolone phosphate|prednisolone phosphate|mesh-list
111357216|NCT00128180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111357217|NCT00128180|Antiemetics|antiemetics|mesh-ancestor
111357218|NCT00128180|Autonomic Agents|autonomic agents|mesh-ancestor
111357219|NCT00128180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111357220|NCT00128180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111357221|NCT00128180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111357222|NCT00128180|Glucocorticoids|glucocorticoids|mesh-ancestor
111357223|NCT00128180|Hormones|hormones|mesh-ancestor
111357224|NCT00128180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111357225|NCT00128180|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111357226|NCT00128180|Protective Agents|protective agents|mesh-ancestor
110844978|NCT01274273|Growth Substances|growth substances|mesh-ancestor
111357227|NCT00128180|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111357228|NCT00128180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111357229|NCT01121939|Bevacizumab|bevacizumab|mesh-list
111357231|NCT01121939|Octreotide|octreotide|mesh-list
111357232|NCT01121939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111357233|NCT01121939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111357234|NCT01121939|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111357235|NCT01121939|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111357236|NCT01121939|Growth Substances|growth substances|mesh-ancestor
111357237|NCT01121939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111357238|NCT01121939|Growth Inhibitors|growth inhibitors|mesh-ancestor
111357239|NCT01121939|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111357240|NCT01121939|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111357241|NCT03013751|Udenafil|udenafil|mesh-list
111357242|NCT03013751|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111357243|NCT03013751|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111357244|NCT03013751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111357245|NCT03013751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111357246|NCT01897844|Somatostatin|somatostatin|mesh-list
111357247|NCT01897844|Hormones|hormones|mesh-ancestor
111357248|NCT01897844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111357249|NCT01897844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111357250|NCT00131378|Hormones|hormones|mesh-list
111357251|NCT00131378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111357252|NCT00131378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111357253|NCT01445821|Methylprednisolone|methylprednisolone|mesh-list
110845018|NCT01167725|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111357254|NCT01445821|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111357255|NCT01445821|Cyclophosphamide|cyclophosphamide|mesh-list
111357256|NCT01445821|Fludarabine|fludarabine|mesh-list
111357257|NCT01445821|Thymoglobulin|thymoglobulin|mesh-list
111357258|NCT01445821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111357259|NCT01445821|Immunologic Factors|immunologic factors|mesh-ancestor
111357260|NCT01445821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111357261|NCT01445821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110845064|NCT01166087|Fluoxetine|fluoxetine|mesh-list
111357262|NCT01445821|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111357263|NCT01445821|Alkylating Agents|alkylating agents|mesh-ancestor
111357264|NCT01445821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111357265|NCT01445821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111357266|NCT01445821|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111357267|NCT01445821|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111357268|NCT01445821|Antiemetics|antiemetics|mesh-ancestor
111357269|NCT01445821|Autonomic Agents|autonomic agents|mesh-ancestor
111357270|NCT01445821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111357271|NCT01445821|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111357272|NCT01445821|Glucocorticoids|glucocorticoids|mesh-ancestor
111357273|NCT01445821|Hormones|hormones|mesh-ancestor
111357274|NCT01445821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111357275|NCT01445821|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111357276|NCT01445821|Protective Agents|protective agents|mesh-ancestor
111357277|NCT01445821|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111357278|NCT00182000|Cycloserine|cycloserine|mesh-list
111357279|NCT00182000|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111357280|NCT00182000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111357281|NCT00182000|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111357282|NCT00182000|Antitubercular Agents|antitubercular agents|mesh-ancestor
111357283|NCT00182000|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111357284|NCT00182000|Antimetabolites|antimetabolites|mesh-ancestor
110845203|NCT03870503|Oxytocics|oxytocics|mesh-ancestor
111357285|NCT00182000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111357286|NCT01092923|Sevoflurane|sevoflurane|mesh-list
111357287|NCT01092923|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111357288|NCT01092923|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111357289|NCT01092923|Anesthetics, General|anesthetics, general|mesh-ancestor
111357290|NCT01092923|Anesthetics|anesthetics|mesh-ancestor
111357291|NCT01092923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111357292|NCT01092923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111357293|NCT03013439|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
111357294|NCT03013439|Hematinics|hematinics|mesh-ancestor
111357295|NCT00131456|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
111357296|NCT00131456|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111357297|NCT00131456|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111357298|NCT00131456|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111357299|NCT00131456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111357300|NCT00131456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111357301|NCT00131456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110845398|NCT02695992|Metoprolol|metoprolol|mesh-list
111357302|NCT00131456|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111357303|NCT00131456|Antidepressive Agents|antidepressive agents|mesh-ancestor
111357304|NCT00131456|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111357305|NCT01093469|Decanoic acid|decanoic acid|mesh-list
111357306|NCT01093469|Petrolatum|petrolatum|mesh-list
111357307|NCT01093469|Emollients|emollients|mesh-ancestor
111357308|NCT01093469|Dermatologic Agents|dermatologic agents|mesh-ancestor
111357309|NCT01093469|Antifungal Agents|antifungal agents|mesh-ancestor
111357310|NCT01093469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111357311|NCT02543658|Neostigmine|neostigmine|mesh-list
111357312|NCT02543658|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111357313|NCT02543658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111357314|NCT02543658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111357315|NCT02543658|Cholinergic Agents|cholinergic agents|mesh-ancestor
111357316|NCT02543658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111357317|NCT02543658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111357318|NCT02543658|Parasympathomimetics|parasympathomimetics|mesh-ancestor
111357319|NCT02543658|Autonomic Agents|autonomic agents|mesh-ancestor
111357320|NCT02543658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111357321|NCT00183092|Quinacrine|quinacrine|mesh-list
111357322|NCT00183092|Anticestodal Agents|anticestodal agents|mesh-ancestor
111357323|NCT00183092|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
111357324|NCT00183092|Anthelmintics|anthelmintics|mesh-ancestor
111357325|NCT00183092|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111357326|NCT00183092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111357327|NCT00183092|Antimalarials|antimalarials|mesh-ancestor
111357328|NCT00183092|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111357329|NCT00183092|Antinematodal Agents|antinematodal agents|mesh-ancestor
111357330|NCT00183092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111357331|NCT00183092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111357332|NCT00183092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111357333|NCT00132002|Vorinostat|vorinostat|mesh-list
111357334|NCT00132002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110845810|NCT04000009|Pimavanserin|pimavanserin|mesh-list
111357335|NCT00132002|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111357336|NCT00132002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111357337|NCT00132002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111357338|NCT00183794|Gemcitabine|gemcitabine|mesh-list
111357339|NCT00183794|Docetaxel|docetaxel|mesh-list
111357340|NCT00183794|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111357341|NCT00183794|Antimetabolites|antimetabolites|mesh-ancestor
110845958|NCT03250182|Glucocorticoids|glucocorticoids|mesh-ancestor
111357342|NCT00183794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111357343|NCT00183794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111357344|NCT00183794|Tubulin Modulators|tubulin modulators|mesh-ancestor
111357345|NCT00183794|Antimitotic Agents|antimitotic agents|mesh-ancestor
111357346|NCT00183794|Mitosis Modulators|mitosis modulators|mesh-ancestor
111357347|NCT00270296|Ritonavir|ritonavir|mesh-list
111357348|NCT00270296|Lopinavir|lopinavir|mesh-list
111357349|NCT00270296|Lamivudine|lamivudine|mesh-list
111357350|NCT00270296|Zidovudine|zidovudine|mesh-list
110846153|NCT03207243|Xhance|xhance|mesh-list
111357351|NCT00270296|Nevirapine|nevirapine|mesh-list
111357352|NCT00270296|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
111357353|NCT00270296|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111357354|NCT00270296|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111357355|NCT00270296|Protease Inhibitors|protease inhibitors|mesh-ancestor
111357356|NCT00270296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111357357|NCT00270296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111357358|NCT00270296|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111357359|NCT00270296|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111357360|NCT00270296|Antiviral Agents|antiviral agents|mesh-ancestor
111357361|NCT00270296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111357362|NCT00270296|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111357363|NCT00270296|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111357364|NCT00270296|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111357365|NCT00270296|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111357366|NCT00270296|Antimetabolites|antimetabolites|mesh-ancestor
111357367|NCT00270296|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111357368|NCT00270296|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111357369|NCT01047527|Nicotine|nicotine|mesh-list
111357370|NCT01047527|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111357371|NCT01047527|Autonomic Agents|autonomic agents|mesh-ancestor
111357372|NCT01047527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111357373|NCT01047527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111357374|NCT01047527|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111357375|NCT01047527|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111357376|NCT01047527|Cholinergic Agents|cholinergic agents|mesh-ancestor
111081725|NCT02476981|Remifentanil|remifentanil|mesh-list
111357377|NCT01047527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110846303|NCT03276078|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111357378|NCT01047527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111357380|NCT03013127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111357381|NCT03013127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111357382|NCT03013127|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111357383|NCT03013127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111357384|NCT01048697|Ethambutol|ethambutol|mesh-list
111357385|NCT01048697|Antitubercular Agents|antitubercular agents|mesh-ancestor
111357386|NCT01048697|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111357387|NCT01048697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110846450|NCT03231228|Cefazolin|cefazolin|mesh-list
111357388|NCT01049243|Fluocinonide|fluocinonide|mesh-list
111357389|NCT01049243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111357390|NCT01049243|Glucocorticoids|glucocorticoids|mesh-ancestor
111357391|NCT01049243|Hormones|hormones|mesh-ancestor
111357392|NCT01049243|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111357393|NCT01049243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111357394|NCT01049243|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111357395|NCT03013205|Triamcinolone|triamcinolone|mesh-list
111357396|NCT03013205|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
111357397|NCT03013205|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
111357398|NCT03013205|Lidocaine|lidocaine|mesh-list
111357399|NCT03013205|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
111357400|NCT03013205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111357401|NCT03013205|Glucocorticoids|glucocorticoids|mesh-ancestor
111357402|NCT03013205|Hormones|hormones|mesh-ancestor
111357403|NCT03013205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111357404|NCT03013205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111357405|NCT03013205|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111357406|NCT03013205|Immunologic Factors|immunologic factors|mesh-ancestor
111357407|NCT03013205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111357408|NCT03013205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111357409|NCT03013205|Anesthetics, Local|anesthetics, local|mesh-ancestor
111357410|NCT03013205|Anesthetics|anesthetics|mesh-ancestor
111357411|NCT03013205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111357412|NCT03013205|Sensory System Agents|sensory system agents|mesh-ancestor
111357413|NCT03013205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111357414|NCT03013205|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111357415|NCT03013205|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111357416|NCT03013205|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111357417|NCT03013205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111357418|NCT01094717|Tazarotene|tazarotene|mesh-list
111357419|NCT01094717|Acitretin|acitretin|mesh-list
111357420|NCT01094717|Dermatologic Agents|dermatologic agents|mesh-ancestor
111357421|NCT01094717|Keratolytic Agents|keratolytic agents|mesh-ancestor
111357422|NCT01095497|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
111357423|NCT01095497|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
111357424|NCT01095497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111357425|NCT01095497|Immunologic Factors|immunologic factors|mesh-ancestor
111357426|NCT01095497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111357427|NCT01095887|Eculizumab|eculizumab|mesh-list
111357428|NCT01095887|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
111357429|NCT01095887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111357430|NCT01095887|Immunologic Factors|immunologic factors|mesh-ancestor
111357431|NCT01095887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111357432|NCT03110315|Suvorexant|suvorexant|mesh-list
111357433|NCT03110315|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111357434|NCT03110315|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110846922|NCT03667326|Analgesics|analgesics|mesh-ancestor
111357435|NCT03110315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111357436|NCT03110315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111357437|NCT03110315|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
111357438|NCT03110315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111357439|NCT03110315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111357440|NCT05307341|Sufentanil|sufentanil|mesh-list
111357441|NCT05307341|Dsuvia|dsuvia|mesh-list
111357442|NCT05307341|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111357443|NCT05307341|Narcotics|narcotics|mesh-ancestor
111357444|NCT05307341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111357445|NCT05307341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111357446|NCT05307341|Analgesics|analgesics|mesh-ancestor
111357447|NCT05307341|Sensory System Agents|sensory system agents|mesh-ancestor
111357448|NCT05307341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111357449|NCT05307341|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111357450|NCT05307341|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111357451|NCT05307341|Anesthetics, General|anesthetics, general|mesh-ancestor
111357452|NCT05307341|Anesthetics|anesthetics|mesh-ancestor
111357453|NCT01100255|Ketamine|ketamine|mesh-list
111357454|NCT01100255|Analgesics|analgesics|mesh-ancestor
111357455|NCT01100255|Sensory System Agents|sensory system agents|mesh-ancestor
111357456|NCT01100255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111357457|NCT01100255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111357458|NCT01100255|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111357459|NCT01100255|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111357460|NCT01100255|Anesthetics, General|anesthetics, general|mesh-ancestor
111357461|NCT01100255|Anesthetics|anesthetics|mesh-ancestor
111357462|NCT01100255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111357463|NCT01100255|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111357464|NCT01100255|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111357465|NCT01100255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111357466|NCT01100255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111357467|NCT03012347|Sunscreening Agents|sunscreening agents|mesh-list
111357468|NCT03012347|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111357469|NCT03012347|Protective Agents|protective agents|mesh-ancestor
111357470|NCT03012347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111357471|NCT03012347|Dermatologic Agents|dermatologic agents|mesh-ancestor
111357472|NCT01100723|Vitamin D|vitamin d|mesh-list
111357473|NCT01100723|Calcitriol|calcitriol|mesh-list
111357474|NCT01100723|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
111357475|NCT01100723|Cinacalcet|cinacalcet|mesh-list
111357476|NCT01100723|Vitamins|vitamins|mesh-ancestor
111357477|NCT01100723|Micronutrients|micronutrients|mesh-ancestor
111357478|NCT01100723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111357479|NCT01100723|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111357480|NCT01100723|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111357481|NCT01100723|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
111357482|NCT01100723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111357483|NCT01100723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111357484|NCT01100723|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111357485|NCT01100723|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
111357486|NCT01100723|Hormone Antagonists|hormone antagonists|mesh-ancestor
110847396|NCT03733171|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111357487|NCT01100723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111357488|NCT05306405|Misoprostol|misoprostol|mesh-list
111357489|NCT05306405|Estradiol|estradiol|mesh-list
111357490|NCT05306405|Estrogens|estrogens|mesh-ancestor
111357491|NCT05306405|Hormones|hormones|mesh-ancestor
111357492|NCT05306405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110847530|NCT03619837|Antiviral Agents|antiviral agents|mesh-ancestor
111357493|NCT05306405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111357494|NCT05306405|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111357495|NCT05306405|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111357496|NCT05306405|Abortifacient Agents|abortifacient agents|mesh-ancestor
111357497|NCT05306405|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111357498|NCT05306405|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111357499|NCT05306405|Oxytocics|oxytocics|mesh-ancestor
111357500|NCT04352621|Ketamine|ketamine|mesh-list
111357501|NCT04352621|Analgesics|analgesics|mesh-ancestor
111357502|NCT04352621|Sensory System Agents|sensory system agents|mesh-ancestor
111357503|NCT04352621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111357504|NCT04352621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111357505|NCT04352621|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111357506|NCT04352621|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111357507|NCT04352621|Anesthetics, General|anesthetics, general|mesh-ancestor
111357508|NCT04352621|Anesthetics|anesthetics|mesh-ancestor
111357509|NCT04352621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111357510|NCT04352621|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111357511|NCT04352621|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111357512|NCT04352621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111357513|NCT04352621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111357514|NCT02246855|Immunoglobulins|immunoglobulins|mesh-list
111357515|NCT02246855|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111357516|NCT02246855|Antibodies|antibodies|mesh-list
111357517|NCT02246855|Immunologic Factors|immunologic factors|mesh-ancestor
111357518|NCT02246855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111357519|NCT05272397|Methylphenidate|methylphenidate|mesh-list
111357520|NCT05272397|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111357521|NCT05272397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111357522|NCT05272397|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111357523|NCT05272397|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111357524|NCT05272397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111357525|NCT05272397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111357526|NCT05272397|Dopamine Agents|dopamine agents|mesh-ancestor
111357527|NCT05272397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111357528|NCT00185900|Magnesium Sulfate|magnesium sulfate|mesh-list
111357529|NCT00185900|Nifedipine|nifedipine|mesh-list
111357530|NCT00185900|Analgesics|analgesics|mesh-ancestor
111357531|NCT00185900|Sensory System Agents|sensory system agents|mesh-ancestor
111357532|NCT00185900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111357533|NCT00185900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111357534|NCT00185900|Anesthetics|anesthetics|mesh-ancestor
111357535|NCT00185900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111357536|NCT00185900|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111357537|NCT00185900|Anticonvulsants|anticonvulsants|mesh-ancestor
111357538|NCT00185900|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111357539|NCT00185900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111357540|NCT00185900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111357541|NCT00185900|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111357542|NCT00185900|Tocolytic Agents|tocolytic agents|mesh-ancestor
111357543|NCT00185900|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111357544|NCT00185900|Vasodilator Agents|vasodilator agents|mesh-ancestor
111357545|NCT00186056|Mifepristone|mifepristone|mesh-list
111357546|NCT00186056|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
111357547|NCT00186056|Abortifacient Agents|abortifacient agents|mesh-ancestor
111357548|NCT00186056|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111357549|NCT00186056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111357550|NCT00186056|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111357551|NCT00186056|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110847857|NCT04508452|Bevacizumab|bevacizumab|mesh-list
111357552|NCT00186056|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111357553|NCT00186056|Contraceptive Agents|contraceptive agents|mesh-ancestor
111357554|NCT00186056|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
111357555|NCT00186056|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
111357556|NCT00186056|Hormone Antagonists|hormone antagonists|mesh-ancestor
111357557|NCT00186056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111357558|NCT00186056|Luteolytic Agents|luteolytic agents|mesh-ancestor
111357559|NCT00186056|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111357560|NCT00186056|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
111357561|NCT00186446|Bupropion|bupropion|mesh-list
111357562|NCT00186446|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111357563|NCT00186446|Antidepressive Agents|antidepressive agents|mesh-ancestor
111357564|NCT00186446|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111357565|NCT00186446|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111357566|NCT00186446|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111357567|NCT00186446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111357568|NCT00186446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111357569|NCT00186446|Dopamine Agents|dopamine agents|mesh-ancestor
111357570|NCT00186446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111357571|NCT00186446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111357572|NCT00186446|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111357573|NCT00186446|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111357574|NCT00186446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111357575|NCT00136760|Bupropion|bupropion|mesh-list
111357576|NCT00136760|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111357577|NCT00136760|Antidepressive Agents|antidepressive agents|mesh-ancestor
111357578|NCT00136760|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111357579|NCT00136760|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111357580|NCT00136760|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111357581|NCT00136760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111357582|NCT00136760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111357583|NCT00136760|Dopamine Agents|dopamine agents|mesh-ancestor
111357584|NCT00136760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111357585|NCT00136760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111357586|NCT00136760|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111357587|NCT00136760|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111357588|NCT00136760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111357589|NCT00189098|Trimethoprim|trimethoprim|mesh-list
111357590|NCT00189098|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
111357591|NCT00189098|Sulfamethoxazole|sulfamethoxazole|mesh-list
111357592|NCT00189098|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111357593|NCT00189098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111357594|NCT00189098|Antimalarials|antimalarials|mesh-ancestor
111357595|NCT00189098|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111357596|NCT00189098|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111357597|NCT00189098|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111357598|NCT00189098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111357599|NCT00189098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111357600|NCT00189098|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111357601|NCT00189098|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
111357602|NCT00189098|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111357603|NCT00189098|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111357604|NCT00145418|Docetaxel|docetaxel|mesh-list
111357605|NCT00145418|Oxaliplatin|oxaliplatin|mesh-list
111357606|NCT00145418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111357607|NCT00145418|Tubulin Modulators|tubulin modulators|mesh-ancestor
111357608|NCT00145418|Antimitotic Agents|antimitotic agents|mesh-ancestor
111357609|NCT00145418|Mitosis Modulators|mitosis modulators|mesh-ancestor
110848237|NCT04443946|Narcotics|narcotics|mesh-ancestor
111357610|NCT00145418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111357611|NCT04751318|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110848313|NCT01187615|Pemetrexed|pemetrexed|mesh-list
111357612|NCT04751318|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111357613|NCT04751318|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111357614|NCT04751318|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111357615|NCT04751318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111357616|NCT04751318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111357617|NCT04751318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111357618|NCT04751318|Analgesics|analgesics|mesh-ancestor
111357619|NCT04751318|Sensory System Agents|sensory system agents|mesh-ancestor
111357620|NCT04751318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111357621|NCT04751318|Antidepressive Agents|antidepressive agents|mesh-ancestor
111357622|NCT04751318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111357623|NCT04751318|Dopamine Agents|dopamine agents|mesh-ancestor
111357624|NCT01107665|Paclitaxel|paclitaxel|mesh-list
111357625|NCT01107665|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111357626|NCT01107665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111357627|NCT01107665|Tubulin Modulators|tubulin modulators|mesh-ancestor
111357628|NCT01107665|Antimitotic Agents|antimitotic agents|mesh-ancestor
111357629|NCT01107665|Mitosis Modulators|mitosis modulators|mesh-ancestor
111357630|NCT01107665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111357631|NCT03012659|Contraceptive Agents|contraceptive agents|mesh-list
111357632|NCT03012659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111357633|NCT03012659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111357634|NCT01447225|Carboplatin|carboplatin|mesh-list
111357635|NCT01447225|Gemcitabine|gemcitabine|mesh-list
111357636|NCT01447225|Pemetrexed|pemetrexed|mesh-list
111357637|NCT01447225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111357638|NCT01447225|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111357639|NCT01447225|Antimetabolites|antimetabolites|mesh-ancestor
111357640|NCT01447225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111357641|NCT01447225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111357642|NCT01447225|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111357643|NCT01447225|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111357644|NCT01447849|Lubiprostone|lubiprostone|mesh-list
111357645|NCT01447849|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
111357646|NCT01447849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111357647|NCT01447849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111357648|NCT00277394|Heparin|heparin|mesh-list
111357649|NCT00277394|Tinzaparin|tinzaparin|mesh-list
111357650|NCT00277394|Anticoagulants|anticoagulants|mesh-ancestor
111357651|NCT00277394|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111357652|NCT00277394|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111357653|NCT00277394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111357654|NCT01450189|Tenofovir|tenofovir|mesh-list
111357655|NCT01450189|Emtricitabine|emtricitabine|mesh-list
110848528|NCT01191203|Copper|copper|mesh-list
111357656|NCT01450189|Raltegravir Potassium|raltegravir potassium|mesh-list
111357657|NCT01450189|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
111357658|NCT01450189|Antiviral Agents|antiviral agents|mesh-ancestor
111357659|NCT01450189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111357660|NCT01450189|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111357661|NCT01450189|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111357662|NCT01450189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111357663|NCT01450189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111357664|NCT01450189|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111357665|NCT01450189|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111357666|NCT01450189|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111357667|NCT01450189|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111082029|NCT05714839|Glucocorticoids|glucocorticoids|mesh-ancestor
111357668|NCT00278876|Imatinib Mesylate|imatinib mesylate|mesh-list
111357669|NCT00278876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111357670|NCT00278876|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111357671|NCT00278876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111357672|NCT00278876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110848562|NCT03729505|Analgesics|analgesics|mesh-ancestor
111357673|NCT01474213|Dexmedetomidine|dexmedetomidine|mesh-list
111357674|NCT01474213|Remifentanil|remifentanil|mesh-list
111357675|NCT01474213|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111357676|NCT01474213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111357677|NCT01474213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111357678|NCT01474213|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111357679|NCT01474213|Analgesics|analgesics|mesh-ancestor
111357680|NCT01474213|Sensory System Agents|sensory system agents|mesh-ancestor
111357681|NCT01474213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111357682|NCT01474213|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111357683|NCT01474213|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111357684|NCT01474213|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111357685|NCT01474213|Adrenergic Agents|adrenergic agents|mesh-ancestor
111357686|NCT01474213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111357687|NCT01474213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111357688|NCT01474213|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111357689|NCT01474213|Narcotics|narcotics|mesh-ancestor
111357690|NCT00147212|Trabectedin|trabectedin|mesh-list
111357691|NCT00147212|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111357692|NCT00147212|Alkylating Agents|alkylating agents|mesh-ancestor
111357693|NCT00147212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111357694|NCT00147212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111357695|NCT01474915|Promethazine|promethazine|mesh-list
111357696|NCT01474915|Diphenhydramine|diphenhydramine|mesh-list
111357697|NCT01474915|Dexamethasone|dexamethasone|mesh-list
111357698|NCT01474915|Ondansetron|ondansetron|mesh-list
111357699|NCT01474915|Aprepitant|aprepitant|mesh-list
111357700|NCT01474915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111357701|NCT01474915|Antiemetics|antiemetics|mesh-ancestor
111357702|NCT01474915|Autonomic Agents|autonomic agents|mesh-ancestor
111357703|NCT01474915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111357704|NCT01474915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111357705|NCT01474915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111357706|NCT01474915|Glucocorticoids|glucocorticoids|mesh-ancestor
111357707|NCT01474915|Hormones|hormones|mesh-ancestor
111357708|NCT01474915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111357709|NCT01474915|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111357710|NCT01474915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111357711|NCT01474915|Antipruritics|antipruritics|mesh-ancestor
111357712|NCT01474915|Dermatologic Agents|dermatologic agents|mesh-ancestor
111357713|NCT01474915|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111357714|NCT01474915|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111357715|NCT01474915|Serotonin Agents|serotonin agents|mesh-ancestor
110848810|NCT01426529|Giapreza|giapreza|mesh-list
111357716|NCT01474915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111357717|NCT01474915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111357718|NCT01474915|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
111357719|NCT01474915|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111357720|NCT01474915|Histamine Antagonists|histamine antagonists|mesh-ancestor
111357721|NCT01474915|Histamine Agents|histamine agents|mesh-ancestor
111357722|NCT01474915|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111357723|NCT01474915|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111357724|NCT01474915|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111357725|NCT01474915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111357726|NCT01474915|Anesthetics, Local|anesthetics, local|mesh-ancestor
111357727|NCT01474915|Anesthetics|anesthetics|mesh-ancestor
111357728|NCT01474915|Sensory System Agents|sensory system agents|mesh-ancestor
111357729|NCT01899794|Mandelic Acids|mandelic acids|mesh-list
111357730|NCT01899794|Oxybutynin|oxybutynin|mesh-list
111357731|NCT01899794|Parasympatholytics|parasympatholytics|mesh-ancestor
111357732|NCT01899794|Autonomic Agents|autonomic agents|mesh-ancestor
111357733|NCT01899794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111357734|NCT01899794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111357735|NCT01899794|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111357736|NCT01899794|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111357737|NCT01899794|Cholinergic Agents|cholinergic agents|mesh-ancestor
111357738|NCT01899794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111357739|NCT01899794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111357740|NCT01899794|Urological Agents|urological agents|mesh-ancestor
111357741|NCT01899794|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111357742|NCT01899794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111357743|NCT01391299|Botulinum Toxins|botulinum toxins|mesh-list
111357744|NCT01391299|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111357745|NCT01391299|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111357746|NCT01391299|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111357747|NCT01391299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111357748|NCT01391299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111357749|NCT01391299|Cholinergic Agents|cholinergic agents|mesh-ancestor
111357750|NCT01391299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111357751|NCT01391299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111357752|NCT01391299|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111357753|NCT01391299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111357754|NCT02099084|Teduglutide|teduglutide|mesh-list
111357755|NCT02099084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111357756|NCT02099084|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111357757|NCT02099084|Protective Agents|protective agents|mesh-ancestor
111357758|NCT02099084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111357759|NCT00281918|Cyclophosphamide|cyclophosphamide|mesh-list
111357760|NCT00281918|Rituximab|rituximab|mesh-list
111357761|NCT00281918|Fludarabine|fludarabine|mesh-list
111357762|NCT00281918|Fludarabine phosphate|fludarabine phosphate|mesh-list
111357763|NCT00281918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111357764|NCT00281918|Immunologic Factors|immunologic factors|mesh-ancestor
111357765|NCT00281918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111357766|NCT00281918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111357767|NCT00281918|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111357768|NCT00281918|Alkylating Agents|alkylating agents|mesh-ancestor
111357769|NCT00281918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111357770|NCT00281918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111357771|NCT00281918|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111357772|NCT00281918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111357773|NCT00281918|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111357774|NCT00281918|Antimetabolites|antimetabolites|mesh-ancestor
111357775|NCT00201734|Paclitaxel|paclitaxel|mesh-list
111357776|NCT00201734|Carboplatin|carboplatin|mesh-list
111357777|NCT00201734|Capecitabine|capecitabine|mesh-list
111357778|NCT00201734|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111357779|NCT00201734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111357780|NCT00201734|Tubulin Modulators|tubulin modulators|mesh-ancestor
111357781|NCT00201734|Antimitotic Agents|antimitotic agents|mesh-ancestor
111357782|NCT00201734|Mitosis Modulators|mitosis modulators|mesh-ancestor
111357783|NCT00201734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111357784|NCT00201734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111357785|NCT00201734|Antimetabolites|antimetabolites|mesh-ancestor
111357786|NCT00203216|Levetiracetam|levetiracetam|mesh-list
111357787|NCT00203216|Anticonvulsants|anticonvulsants|mesh-ancestor
111357788|NCT00203216|Nootropic Agents|nootropic agents|mesh-ancestor
111357789|NCT05156060|Ketamine|ketamine|mesh-list
111357790|NCT05156060|Gabapentin|gabapentin|mesh-list
111357791|NCT05156060|Analgesics|analgesics|mesh-ancestor
111357792|NCT05156060|Sensory System Agents|sensory system agents|mesh-ancestor
111357793|NCT05156060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111357794|NCT05156060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111357795|NCT05156060|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111357796|NCT05156060|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111357797|NCT05156060|Anesthetics, General|anesthetics, general|mesh-ancestor
111357798|NCT05156060|Anesthetics|anesthetics|mesh-ancestor
111357799|NCT05156060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111357800|NCT05156060|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111357801|NCT05156060|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110849323|NCT04539548|Hormones|hormones|mesh-ancestor
111357802|NCT05156060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111357803|NCT05156060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111357804|NCT05156060|Anticonvulsants|anticonvulsants|mesh-ancestor
111357805|NCT05156060|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111357806|NCT05156060|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111357807|NCT05156060|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111357808|NCT05156060|Antimanic Agents|antimanic agents|mesh-ancestor
111357809|NCT00206336|Topiramate|topiramate|mesh-list
111357810|NCT00206336|Anticonvulsants|anticonvulsants|mesh-ancestor
111357811|NCT00206336|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111357812|NCT00206336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111357813|NCT00210470|Zinc|zinc|mesh-list
111357814|NCT00210470|Indomethacin|indomethacin|mesh-list
111357815|NCT00210470|Cyclophosphamide|cyclophosphamide|mesh-list
111357816|NCT00210470|Omeprazole|omeprazole|mesh-list
111357817|NCT00210470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110849455|NCT02517424|Dronabinol|dronabinol|mesh-list
111357818|NCT00210470|Immunologic Factors|immunologic factors|mesh-ancestor
111357819|NCT00210470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111357821|NCT00210470|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111357822|NCT00210470|Alkylating Agents|alkylating agents|mesh-ancestor
111357823|NCT00210470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111357824|NCT00210470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111357825|NCT00210470|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111357826|NCT00210470|Trace Elements|trace elements|mesh-ancestor
111357827|NCT00210470|Micronutrients|micronutrients|mesh-ancestor
111357828|NCT00210470|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111357829|NCT00210470|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111357830|NCT00210470|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111357831|NCT00210470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111357832|NCT00210470|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111357833|NCT00210470|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111357834|NCT00210470|Analgesics|analgesics|mesh-ancestor
111357835|NCT00210470|Sensory System Agents|sensory system agents|mesh-ancestor
111357836|NCT00210470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110849647|NCT04500496|Antimetabolites|antimetabolites|mesh-ancestor
111357837|NCT00210470|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111357838|NCT00210470|Gout Suppressants|gout suppressants|mesh-ancestor
111357839|NCT00210470|Tocolytic Agents|tocolytic agents|mesh-ancestor
111357840|NCT00210470|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111357841|NCT00210470|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111357842|NCT01108445|Everolimus|everolimus|mesh-list
111357843|NCT01108445|Sunitinib|sunitinib|mesh-list
111357844|NCT01108445|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111357845|NCT01108445|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110849730|NCT03730961|Furosemide|furosemide|mesh-list
111357846|NCT01108445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111357847|NCT01108445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111357848|NCT01108445|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111357849|NCT01108445|Immunologic Factors|immunologic factors|mesh-ancestor
111357850|NCT01108445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111357851|NCT01108445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111357852|NCT01108445|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110849789|NCT03728101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111357853|NCT01108445|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111357854|NCT01108445|Growth Substances|growth substances|mesh-ancestor
111357855|NCT01108445|Growth Inhibitors|growth inhibitors|mesh-ancestor
111357856|NCT01108757|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
111357857|NCT01108757|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111357858|NCT01108757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111357859|NCT01108757|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111357860|NCT01108757|Antimalarials|antimalarials|mesh-ancestor
111357861|NCT01108757|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111357862|NCT01108757|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111357863|NCT04352153|Febuxostat|febuxostat|mesh-list
111357864|NCT04352153|Citric Acid|citric acid|mesh-list
111357865|NCT04352153|Anticoagulants|anticoagulants|mesh-ancestor
111357866|NCT04352153|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
111357867|NCT04352153|Chelating Agents|chelating agents|mesh-ancestor
111357868|NCT04352153|Sequestering Agents|sequestering agents|mesh-ancestor
111357869|NCT04352153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111357870|NCT04352153|Gout Suppressants|gout suppressants|mesh-ancestor
111357871|NCT04352153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111357872|NCT05215067|Docetaxel|docetaxel|mesh-list
110849924|NCT01199783|Vancomycin|vancomycin|mesh-list
111357873|NCT05215067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111357874|NCT05215067|Tubulin Modulators|tubulin modulators|mesh-ancestor
111357875|NCT05215067|Antimitotic Agents|antimitotic agents|mesh-ancestor
111357876|NCT05215067|Mitosis Modulators|mitosis modulators|mesh-ancestor
111357877|NCT05215067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111357878|NCT01162733|Vancomycin|vancomycin|mesh-list
111357879|NCT01162733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111357880|NCT01162733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111357881|NCT02530242|Carbon Monoxide|carbon monoxide|mesh-list
111357882|NCT02530242|Antimetabolites|antimetabolites|mesh-ancestor
111357883|NCT02530242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111357884|NCT02530242|Gasotransmitters|gasotransmitters|mesh-ancestor
111357885|NCT02530242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111357886|NCT02530242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111357887|NCT01131065|Immunoglobulins|immunoglobulins|mesh-list
111357888|NCT01131065|Antibodies|antibodies|mesh-list
111357889|NCT01131065|gamma-Globulins|gamma-globulins|mesh-list
111357890|NCT01131065|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111357891|NCT01131065|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
111357892|NCT01131065|Immunologic Factors|immunologic factors|mesh-ancestor
111357893|NCT01131065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111357894|NCT01165541|Quetiapine Fumarate|quetiapine fumarate|mesh-list
111357895|NCT01165541|Mirtazapine|mirtazapine|mesh-list
111357896|NCT01165541|Antidepressive Agents|antidepressive agents|mesh-ancestor
111357897|NCT01165541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111357898|NCT01165541|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111357899|NCT01165541|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111357900|NCT01165541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111357901|NCT01165541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111357902|NCT01165541|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111357903|NCT01165541|Histamine Antagonists|histamine antagonists|mesh-ancestor
111357904|NCT01165541|Histamine Agents|histamine agents|mesh-ancestor
111357905|NCT01165541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111357906|NCT01165541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111357907|NCT01165541|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110850127|NCT01200641|Anticonvulsants|anticonvulsants|mesh-ancestor
111357908|NCT01165541|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
111357909|NCT01165541|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111357910|NCT01165541|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111357911|NCT01165541|Adrenergic Agents|adrenergic agents|mesh-ancestor
111357912|NCT01165541|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111357913|NCT01165541|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111357914|NCT01165541|Serotonin Agents|serotonin agents|mesh-ancestor
111357915|NCT01165541|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111357916|NCT00284180|Trastuzumab|trastuzumab|mesh-list
111357917|NCT00284180|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111357918|NCT00284180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111357919|NCT04087460|Vaccines|vaccines|mesh-list
111357920|NCT04087460|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
111357921|NCT04087460|Immunologic Factors|immunologic factors|mesh-ancestor
111357922|NCT04087460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111357923|NCT05031806|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111357924|NCT05031806|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111357925|NCT01899404|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
111357926|NCT01899404|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111357927|NCT01899404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111357928|NCT00287222|Bevacizumab|bevacizumab|mesh-list
111357929|NCT00287222|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111357930|NCT00287222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111357931|NCT00287222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111357932|NCT00287222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111357933|NCT00287222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111357934|NCT00287222|Growth Substances|growth substances|mesh-ancestor
111357935|NCT00287222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111357936|NCT00287222|Growth Inhibitors|growth inhibitors|mesh-ancestor
111357937|NCT00287222|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111357938|NCT00287222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111357939|NCT00287222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111357940|NCT00218426|Naltrexone|naltrexone|mesh-list
111357941|NCT00218426|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111357942|NCT00218426|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111357943|NCT00218426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111357944|NCT00218426|Sensory System Agents|sensory system agents|mesh-ancestor
111357945|NCT00218426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111357946|NCT01134575|Rituximab|rituximab|mesh-list
111357947|NCT01134575|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
111357948|NCT01134575|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111357949|NCT01134575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111357950|NCT01134575|Immunologic Factors|immunologic factors|mesh-ancestor
111357951|NCT01134575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111357952|NCT01134575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111357953|NCT01134575|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111357954|NCT01134575|Immunotoxins|immunotoxins|mesh-ancestor
111357955|NCT01134575|Immunoconjugates|immunoconjugates|mesh-ancestor
111357956|NCT01790672|Ethanol|ethanol|mesh-list
111357957|NCT01790672|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111357958|NCT01790672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111357959|NCT01790672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111357960|NCT01790672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111357961|NCT00223262|Lamotrigine|lamotrigine|mesh-list
111357962|NCT00223262|Anticonvulsants|anticonvulsants|mesh-ancestor
111357963|NCT00223262|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111357964|NCT00223262|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111357965|NCT00223262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111357966|NCT00223262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111357967|NCT00223262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111357968|NCT00223262|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111357969|NCT00223262|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111357970|NCT00223262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111357971|NCT00223262|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111357972|NCT00223262|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111357973|NCT00290654|Tamoxifen|tamoxifen|mesh-list
111357974|NCT00290654|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111357975|NCT00290654|Hormone Antagonists|hormone antagonists|mesh-ancestor
111357976|NCT00290654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111357977|NCT00290654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111357978|NCT00290654|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111357979|NCT00290654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111357980|NCT00290654|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111357981|NCT00290654|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111357982|NCT00290654|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111357983|NCT00290810|Bevacizumab|bevacizumab|mesh-list
111357984|NCT00290810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111357985|NCT00290810|Antibodies|antibodies|mesh-list
111357986|NCT00290810|Immunoglobulins|immunoglobulins|mesh-list
111357987|NCT00290810|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111357988|NCT00290810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111357989|NCT00290810|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111357990|NCT00290810|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111357991|NCT00290810|Growth Substances|growth substances|mesh-ancestor
111357992|NCT00290810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111357993|NCT00290810|Growth Inhibitors|growth inhibitors|mesh-ancestor
111357994|NCT00290810|Immunologic Factors|immunologic factors|mesh-ancestor
111357995|NCT04042142|Glucagon|glucagon|mesh-list
111357996|NCT04042142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111357997|NCT04042142|Hormones|hormones|mesh-ancestor
111357998|NCT04042142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111357999|NCT04042142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111358000|NCT01138475|Cholecalciferol|cholecalciferol|mesh-list
111358001|NCT01138475|Vitamin D|vitamin d|mesh-list
111358002|NCT01138475|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111358003|NCT01138475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111358004|NCT01138475|Vitamins|vitamins|mesh-ancestor
111358005|NCT01138475|Micronutrients|micronutrients|mesh-ancestor
111358006|NCT01138475|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111358007|NCT00293540|Tamoxifen|tamoxifen|mesh-list
111358008|NCT00293540|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111358009|NCT00293540|Hormone Antagonists|hormone antagonists|mesh-ancestor
111358010|NCT00293540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111358011|NCT00293540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111358012|NCT00293540|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111358013|NCT00293540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111358014|NCT00293540|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111358015|NCT00293540|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111358016|NCT00293540|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111358017|NCT03012113|Mirabegron|mirabegron|mesh-list
111358018|NCT03012113|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
111358019|NCT03012113|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111358020|NCT03012113|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111358021|NCT03012113|Adrenergic Agents|adrenergic agents|mesh-ancestor
111358022|NCT03012113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111358023|NCT03012113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111358024|NCT03012113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111358025|NCT03012113|Urological Agents|urological agents|mesh-ancestor
111358026|NCT01139801|Misoprostol|misoprostol|mesh-list
111358027|NCT01139801|Oxytocin|oxytocin|mesh-list
111358028|NCT01139801|Oxytocics|oxytocics|mesh-ancestor
110850299|NCT02510950|Poly ICLC|poly iclc|mesh-list
111358029|NCT01139801|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111358030|NCT01139801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111358031|NCT01139801|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111358032|NCT01139801|Abortifacient Agents|abortifacient agents|mesh-ancestor
111358033|NCT01139801|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111358034|NCT01139801|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111358035|NCT00294632|Rituximab|rituximab|mesh-list
111358036|NCT00294632|Lenalidomide|lenalidomide|mesh-list
111358037|NCT00294632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111358038|NCT00294632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111358039|NCT00294632|Immunologic Factors|immunologic factors|mesh-ancestor
111358040|NCT00294632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111358041|NCT00294632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111358042|NCT00294632|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111358043|NCT00294632|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111358044|NCT00294632|Growth Substances|growth substances|mesh-ancestor
111358045|NCT00294632|Growth Inhibitors|growth inhibitors|mesh-ancestor
111358046|NCT01898624|Mirabegron|mirabegron|mesh-list
111358047|NCT01898624|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
111358048|NCT01898624|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111358049|NCT01898624|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111358050|NCT01898624|Adrenergic Agents|adrenergic agents|mesh-ancestor
111358051|NCT01898624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111358052|NCT01898624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111358053|NCT01898624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111358054|NCT01898624|Urological Agents|urological agents|mesh-ancestor
111358055|NCT01140191|Gentamicins|gentamicins|mesh-list
111358056|NCT01140191|Paromomycin|paromomycin|mesh-list
111358057|NCT01140191|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111358058|NCT01140191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111358059|NCT01140191|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111358060|NCT01140191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111358061|NCT01140191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111358062|NCT01140191|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111358063|NCT01140191|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111358064|NCT01141049|Gabapentin|gabapentin|mesh-list
111358065|NCT01141049|Analgesics|analgesics|mesh-ancestor
111358066|NCT01141049|Sensory System Agents|sensory system agents|mesh-ancestor
111358067|NCT01141049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111358068|NCT01141049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111358069|NCT01141049|Anticonvulsants|anticonvulsants|mesh-ancestor
111358070|NCT01141049|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111358071|NCT01141049|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111358072|NCT01141049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111358073|NCT01141049|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111358074|NCT01141049|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111358075|NCT01141049|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111358076|NCT01141049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111358077|NCT01141049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111358078|NCT01141049|Antimanic Agents|antimanic agents|mesh-ancestor
111358079|NCT01141595|Verapamil|verapamil|mesh-list
111358080|NCT01141595|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111358081|NCT01141595|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111358082|NCT01141595|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111358083|NCT01141595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111358084|NCT01141595|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111358085|NCT01141595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111358086|NCT01141595|Vasodilator Agents|vasodilator agents|mesh-ancestor
111358087|NCT01167569|Ascorbic Acid|ascorbic acid|mesh-list
111358088|NCT01167569|Vitamins|vitamins|mesh-ancestor
111358089|NCT01167569|Micronutrients|micronutrients|mesh-ancestor
111358090|NCT01167569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111358091|NCT01167569|Antioxidants|antioxidants|mesh-ancestor
111358092|NCT01167569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111358093|NCT01167569|Protective Agents|protective agents|mesh-ancestor
111358094|NCT00296192|Rotigotine|rotigotine|mesh-list
111358095|NCT00296192|Dopamine Agonists|dopamine agonists|mesh-ancestor
111358096|NCT00296192|Dopamine Agents|dopamine agents|mesh-ancestor
111358097|NCT00296192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111358098|NCT00296192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111358099|NCT00296192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111358100|NCT04312139|Lincomycin|lincomycin|mesh-list
111358101|NCT04312139|Calcium|calcium|mesh-list
111358102|NCT04312139|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111358103|NCT04312139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111358104|NCT04312139|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111358105|NCT04312139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111358106|NCT04312139|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111358107|NCT04312139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111358108|NCT04312139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111358109|NCT00297596|Oxaliplatin|oxaliplatin|mesh-list
111358110|NCT00297596|Trastuzumab|trastuzumab|mesh-list
111358111|NCT00297596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111358112|NCT00297596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111358113|NCT01144637|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
111358114|NCT01144637|Antiviral Agents|antiviral agents|mesh-ancestor
111358115|NCT01144637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111358116|NCT00298610|Artesunate|artesunate|mesh-list
111358117|NCT00298610|Atovaquone|atovaquone|mesh-list
111358118|NCT00298610|Proguanil|proguanil|mesh-list
111358119|NCT00298610|Quinidine|quinidine|mesh-list
111358120|NCT00298610|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
111358121|NCT00298610|Antimalarials|antimalarials|mesh-ancestor
111358122|NCT00298610|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111358123|NCT00298610|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111358124|NCT00298610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111358125|NCT00298610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111358126|NCT00298610|Antiviral Agents|antiviral agents|mesh-ancestor
111358127|NCT00298610|Schistosomicides|schistosomicides|mesh-ancestor
111358128|NCT00298610|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
111358129|NCT00298610|Anthelmintics|anthelmintics|mesh-ancestor
111358130|NCT00298610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111358131|NCT00298610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111358132|NCT00298610|Antimetabolites|antimetabolites|mesh-ancestor
111358133|NCT00298610|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111358134|NCT00298610|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111358135|NCT00298610|Adrenergic Agents|adrenergic agents|mesh-ancestor
111358136|NCT00298610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111358137|NCT00298610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111358138|NCT00298610|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111358139|NCT00298610|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111358140|NCT00298610|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111358141|NCT00298610|Cholinergic Agents|cholinergic agents|mesh-ancestor
111358142|NCT00298610|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111358143|NCT00298610|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111358144|NCT00298610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111358145|NCT00298610|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111358146|NCT00298610|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111358147|NCT01144949|Silodosin|silodosin|mesh-list
111358148|NCT01144949|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111358149|NCT01144949|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111358150|NCT01144949|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111358151|NCT01144949|Adrenergic Agents|adrenergic agents|mesh-ancestor
111358152|NCT01144949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111358153|NCT01144949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111358154|NCT01144949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111358155|NCT01144949|Urological Agents|urological agents|mesh-ancestor
111358156|NCT00215930|Carboplatin|carboplatin|mesh-list
111358157|NCT00215930|Gemcitabine|gemcitabine|mesh-list
111358158|NCT00215930|Docetaxel|docetaxel|mesh-list
111358159|NCT00215930|Vinorelbine|vinorelbine|mesh-list
111358160|NCT00215930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111358161|NCT00215930|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111358162|NCT00215930|Antimetabolites|antimetabolites|mesh-ancestor
111358163|NCT00215930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111358164|NCT00215930|Tubulin Modulators|tubulin modulators|mesh-ancestor
111358165|NCT00215930|Antimitotic Agents|antimitotic agents|mesh-ancestor
111358166|NCT00215930|Mitosis Modulators|mitosis modulators|mesh-ancestor
111358167|NCT00215930|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111358168|NCT01145183|Doxazosin|doxazosin|mesh-list
111358169|NCT01145183|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111358170|NCT01145183|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111358171|NCT01145183|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111358172|NCT01145183|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111358173|NCT01145183|Adrenergic Agents|adrenergic agents|mesh-ancestor
111358174|NCT01145183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111358175|NCT01145183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111358176|NCT01145183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111358177|NCT00230126|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111358178|NCT00230126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111358179|NCT00230126|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111358180|NCT00230126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111358181|NCT00230126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111358182|NCT04128722|Sirolimus|sirolimus|mesh-list
111358183|NCT04128722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111358184|NCT04128722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111358185|NCT04128722|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111358186|NCT04128722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111358187|NCT04128722|Antifungal Agents|antifungal agents|mesh-ancestor
111358188|NCT04128722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111358189|NCT04128722|Immunologic Factors|immunologic factors|mesh-ancestor
111082563|NCT03108625|Vortioxetine|vortioxetine|mesh-list
111358190|NCT04128722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111358191|NCT01169519|Sildenafil Citrate|sildenafil citrate|mesh-list
111358192|NCT01169519|Vasodilator Agents|vasodilator agents|mesh-ancestor
111358193|NCT01169519|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111358194|NCT01169519|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111358195|NCT01169519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111358196|NCT01169519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111358197|NCT01169519|Urological Agents|urological agents|mesh-ancestor
111358199|NCT04071977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111358200|NCT04071977|Protective Agents|protective agents|mesh-ancestor
111358201|NCT04071977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111358202|NCT02101190|Opicapone|opicapone|mesh-list
111358203|NCT02101190|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
111358204|NCT02101190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111358205|NCT02101190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111358206|NCT02101190|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111358207|NCT02101190|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111358208|NCT01170533|Omeprazole|omeprazole|mesh-list
111358209|NCT01170533|Pantoprazole|pantoprazole|mesh-list
111358210|NCT01170533|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111358211|NCT01170533|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111358212|NCT01170533|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111358213|NCT01170533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111358214|NCT01170533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111358215|NCT01147601|Timolol|timolol|mesh-list
111358216|NCT01147601|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111358217|NCT01147601|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110850561|NCT01957332|Trastuzumab|trastuzumab|mesh-list
111358218|NCT01147601|Adrenergic Agents|adrenergic agents|mesh-ancestor
111358219|NCT01147601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111358220|NCT01147601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111358221|NCT01147601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111358222|NCT01147601|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111358223|NCT01147601|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111358224|NCT03011645|Ziprasidone|ziprasidone|mesh-list
111358225|NCT03011645|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111358226|NCT03011645|Serotonin Agents|serotonin agents|mesh-ancestor
111358227|NCT03011645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110850594|NCT01860456|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111358228|NCT03011645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111358229|NCT03011645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111358230|NCT03011645|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111358231|NCT03011645|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111358232|NCT03011645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111358233|NCT03011645|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111358234|NCT03011645|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111358235|NCT03011645|Dopamine Agents|dopamine agents|mesh-ancestor
111358236|NCT01149785|Ketoconazole|ketoconazole|mesh-list
111358237|NCT01149785|Crizotinib|crizotinib|mesh-list
111358238|NCT01149785|Antifungal Agents|antifungal agents|mesh-ancestor
111358239|NCT01149785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111358240|NCT01149785|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111358241|NCT01149785|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111358242|NCT01149785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111358243|NCT01149785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111358244|NCT01149785|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111358245|NCT01149785|Hormone Antagonists|hormone antagonists|mesh-ancestor
111358246|NCT01149785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111358247|NCT01149785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111358248|NCT01149785|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111358249|NCT01149785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111358250|NCT01149785|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111358251|NCT02182115|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
111358252|NCT02182115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111358253|NCT03011567|Acetaminophen|acetaminophen|mesh-list
111358254|NCT03011567|Ibuprofen|ibuprofen|mesh-list
111358255|NCT03011567|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111358256|NCT03011567|Analgesics|analgesics|mesh-ancestor
111358257|NCT03011567|Sensory System Agents|sensory system agents|mesh-ancestor
111358258|NCT03011567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111358259|NCT03011567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111358260|NCT03011567|Antipyretics|antipyretics|mesh-ancestor
111358261|NCT03011567|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111358262|NCT03011567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111082636|NCT02299999|Vincristine|vincristine|mesh-list
111358263|NCT03011567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111358264|NCT03011567|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111358265|NCT03011567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111358266|NCT03011567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111358267|NCT01173029|Antihypertensive Agents|antihypertensive agents|mesh-list
111358268|NCT01173029|Calcium Channel Blockers|calcium channel blockers|mesh-list
111358269|NCT01173029|Diuretics|diuretics|mesh-list
111358270|NCT01173029|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
111358271|NCT01173029|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
111358272|NCT01173029|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
111358273|NCT01173029|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
111358274|NCT01173029|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111358275|NCT01173029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111358276|NCT01173029|Natriuretic Agents|natriuretic agents|mesh-ancestor
111358277|NCT01173029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111358278|NCT01173029|Protease Inhibitors|protease inhibitors|mesh-ancestor
111358279|NCT01173029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111358280|NCT01173029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111358281|NCT01173029|Hormone Antagonists|hormone antagonists|mesh-ancestor
111358282|NCT01173029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111358283|NCT01173029|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
111358284|NCT01174823|Bepotastine besilate|bepotastine besilate|mesh-list
111358285|NCT01174823|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110850695|NCT02502682|Chlorhexidine|chlorhexidine|mesh-list
111358286|NCT01174823|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111358287|NCT01174823|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111358288|NCT03886649|Venetoclax|venetoclax|mesh-list
111358289|NCT03886649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111358290|NCT01151813|Varenicline|varenicline|mesh-list
111358291|NCT01151813|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111358292|NCT01151813|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111358293|NCT01151813|Cholinergic Agents|cholinergic agents|mesh-ancestor
111358294|NCT01151813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111358295|NCT01151813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111358296|NCT01151813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111358297|NCT03877991|Cannabidiol|cannabidiol|mesh-list
111358298|NCT03877991|Anticonvulsants|anticonvulsants|mesh-ancestor
111358299|NCT03835949|Atezolizumab|atezolizumab|mesh-list
111358300|NCT03835949|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111358301|NCT03835949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111358302|NCT03835949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111358303|NCT03835949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111358304|NCT01177709|Metformin|metformin|mesh-list
111358305|NCT01177709|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111358306|NCT01177709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111358307|NCT01179113|Esmolol|esmolol|mesh-list
111358308|NCT01179113|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
111358309|NCT01179113|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111358310|NCT01179113|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111358311|NCT01179113|Adrenergic Agents|adrenergic agents|mesh-ancestor
111358312|NCT01179113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111358313|NCT01179113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111358314|NCT01179113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111358315|NCT01152515|Remifentanil|remifentanil|mesh-list
111358316|NCT01152515|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111358317|NCT01152515|Narcotics|narcotics|mesh-ancestor
111358318|NCT01152515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111358319|NCT01152515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111358320|NCT01152515|Analgesics|analgesics|mesh-ancestor
111358321|NCT01152515|Sensory System Agents|sensory system agents|mesh-ancestor
111358322|NCT01152515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111358323|NCT03011177|Linagliptin|linagliptin|mesh-list
111358324|NCT03011177|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111358325|NCT03011177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111358326|NCT03011177|Incretins|incretins|mesh-ancestor
111358327|NCT03011177|Hormones|hormones|mesh-ancestor
111358328|NCT03011177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111358329|NCT03011177|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111358330|NCT03011177|Protease Inhibitors|protease inhibitors|mesh-ancestor
111358331|NCT03011177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111358332|NCT03011177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111358333|NCT03465527|Prednisolone|prednisolone|mesh-list
111358334|NCT03465527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111358335|NCT03465527|Glucocorticoids|glucocorticoids|mesh-ancestor
111358337|NCT03465527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111358338|NCT03465527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111358339|NCT03465527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111358340|NCT03465527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111358341|NCT03418805|Ibuprofen|ibuprofen|mesh-list
111358342|NCT03418805|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111358343|NCT03418805|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111358344|NCT03418805|Analgesics|analgesics|mesh-ancestor
111358345|NCT03418805|Sensory System Agents|sensory system agents|mesh-ancestor
111358346|NCT03418805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111358347|NCT03418805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111358348|NCT03418805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111358349|NCT03418805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111358350|NCT03418805|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111358351|NCT03418805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111358352|NCT03418805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111358353|NCT01156571|Clopidogrel|clopidogrel|mesh-list
111358354|NCT01156571|Cangrelor|cangrelor|mesh-list
111358355|NCT01156571|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111358356|NCT01156571|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111358357|NCT01156571|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111358358|NCT01156571|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111358359|NCT01156571|Purinergic Agents|purinergic agents|mesh-ancestor
111358360|NCT01156571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111358361|NCT01156571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111358362|NCT01156571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111358363|NCT01220687|Nitric Oxide|nitric oxide|mesh-list
111358364|NCT01220687|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111358365|NCT01220687|Autonomic Agents|autonomic agents|mesh-ancestor
111358366|NCT01220687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111358367|NCT01220687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111358368|NCT01220687|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110850784|NCT02508142|Mydriatics|mydriatics|mesh-ancestor
111358369|NCT01220687|Respiratory System Agents|respiratory system agents|mesh-ancestor
111358370|NCT01220687|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111358371|NCT01220687|Antioxidants|antioxidants|mesh-ancestor
111358372|NCT01220687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111358373|NCT01220687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111358374|NCT01220687|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
111358375|NCT01220687|Vasodilator Agents|vasodilator agents|mesh-ancestor
111358376|NCT01220687|Gasotransmitters|gasotransmitters|mesh-ancestor
111358377|NCT01220687|Protective Agents|protective agents|mesh-ancestor
111358378|NCT03010865|Butyric Acid|butyric acid|mesh-list
111358379|NCT03010865|Histamine Antagonists|histamine antagonists|mesh-ancestor
111358380|NCT03010865|Histamine Agents|histamine agents|mesh-ancestor
111358381|NCT03010865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111358382|NCT03010865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111358383|NCT03010865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111358384|NCT01157429|Cycloserine|cycloserine|mesh-list
111358385|NCT01157429|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111358386|NCT01157429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111358387|NCT01157429|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111358388|NCT01157429|Antitubercular Agents|antitubercular agents|mesh-ancestor
111358389|NCT01157429|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111358390|NCT01157429|Antimetabolites|antimetabolites|mesh-ancestor
111358391|NCT01157429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111358392|NCT00234884|Adalimumab|adalimumab|mesh-list
111358393|NCT00234884|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111358394|NCT00234884|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111358395|NCT00234884|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111358396|NCT01602666|Carboplatin|carboplatin|mesh-list
111358397|NCT01602666|Etoposide|etoposide|mesh-list
111358398|NCT01602666|Etoposide phosphate|etoposide phosphate|mesh-list
111358399|NCT01602666|Ifosfamide|ifosfamide|mesh-list
111358400|NCT01602666|Isophosphamide mustard|isophosphamide mustard|mesh-list
111358401|NCT01602666|Podophyllotoxin|podophyllotoxin|mesh-list
111358402|NCT01602666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111358403|NCT01602666|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111358404|NCT01602666|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111358405|NCT01602666|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111358406|NCT01602666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111358407|NCT01602666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110851015|NCT02495662|Prednisolone|prednisolone|mesh-list
111358408|NCT01602666|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111358409|NCT01602666|Alkylating Agents|alkylating agents|mesh-ancestor
111358410|NCT01602666|Keratolytic Agents|keratolytic agents|mesh-ancestor
111358411|NCT01602666|Dermatologic Agents|dermatologic agents|mesh-ancestor
111358412|NCT01602666|Tubulin Modulators|tubulin modulators|mesh-ancestor
111358413|NCT01602666|Antimitotic Agents|antimitotic agents|mesh-ancestor
111358414|NCT01602666|Mitosis Modulators|mitosis modulators|mesh-ancestor
111358415|NCT00300482|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111358416|NCT00300482|Calcium|calcium|mesh-list
111358417|NCT00300482|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111358418|NCT00300482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111358419|NCT00300482|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111358420|NCT00300482|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111358421|NCT00300482|Antimetabolites|antimetabolites|mesh-ancestor
111358422|NCT00300482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111358423|NCT00300482|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111358424|NCT00300482|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111358425|NCT00300482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111358426|NCT00301028|Paclitaxel|paclitaxel|mesh-list
111358427|NCT00301028|Carboplatin|carboplatin|mesh-list
111358428|NCT00301028|Cetuximab|cetuximab|mesh-list
111358429|NCT00301028|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111358430|NCT00301028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111358431|NCT00301028|Tubulin Modulators|tubulin modulators|mesh-ancestor
111358432|NCT00301028|Antimitotic Agents|antimitotic agents|mesh-ancestor
111358433|NCT00301028|Mitosis Modulators|mitosis modulators|mesh-ancestor
111358434|NCT00301028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111358435|NCT00301028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111358436|NCT00301418|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111358437|NCT00301418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111358438|NCT00301418|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110851217|NCT03586609|Venetoclax|venetoclax|mesh-list
111358439|NCT00301418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111358440|NCT00301418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111358441|NCT05414214|Anesthetics|anesthetics|mesh-list
110851265|NCT03341260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111358442|NCT05414214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111358443|NCT05414214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111358444|NCT05014230|Analgesics, Opioid|analgesics, opioid|mesh-list
111358445|NCT05014230|Narcotics|narcotics|mesh-ancestor
110851338|NCT03521635|Pramipexole|pramipexole|mesh-list
111358446|NCT05014230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111358447|NCT05014230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111358448|NCT05014230|Analgesics|analgesics|mesh-ancestor
111358449|NCT05014230|Sensory System Agents|sensory system agents|mesh-ancestor
111358450|NCT05014230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111358451|NCT01896284|Aflibercept|aflibercept|mesh-list
111358452|NCT01896284|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111358453|NCT01896284|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111358454|NCT01896284|Growth Substances|growth substances|mesh-ancestor
111358455|NCT01896284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111358456|NCT01896284|Growth Inhibitors|growth inhibitors|mesh-ancestor
111358457|NCT01896284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111358458|NCT05438160|Coal Tar|coal tar|mesh-list
111358459|NCT05438160|Keratolytic Agents|keratolytic agents|mesh-ancestor
111358460|NCT05438160|Dermatologic Agents|dermatologic agents|mesh-ancestor
111358461|NCT03954990|Metronidazole|metronidazole|mesh-list
111358462|NCT03954990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111358463|NCT03954990|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111358464|NCT03954990|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111358465|NCT03954990|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111358466|NCT01478581|Dexamethasone|dexamethasone|mesh-list
111358467|NCT01478581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111358468|NCT01478581|Antiemetics|antiemetics|mesh-ancestor
111358469|NCT01478581|Autonomic Agents|autonomic agents|mesh-ancestor
111358470|NCT01478581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111358471|NCT01478581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111358472|NCT01478581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111358473|NCT01478581|Glucocorticoids|glucocorticoids|mesh-ancestor
111358474|NCT01478581|Hormones|hormones|mesh-ancestor
111358475|NCT01478581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111358476|NCT01478581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111358477|NCT01478581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111358478|NCT00239642|Iron|iron|mesh-list
111358479|NCT00239642|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
111358480|NCT00239642|Trace Elements|trace elements|mesh-ancestor
111358481|NCT00239642|Micronutrients|micronutrients|mesh-ancestor
111358482|NCT00239642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111358483|NCT00239642|Hematinics|hematinics|mesh-ancestor
111358484|NCT01351896|Lenalidomide|lenalidomide|mesh-list
111358485|NCT01351896|Vaccines|vaccines|mesh-list
111358486|NCT01351896|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
111358487|NCT01351896|Immunologic Factors|immunologic factors|mesh-ancestor
111358488|NCT01351896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111358489|NCT01351896|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111358490|NCT01351896|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111358491|NCT01351896|Growth Substances|growth substances|mesh-ancestor
111358492|NCT01351896|Growth Inhibitors|growth inhibitors|mesh-ancestor
111358493|NCT01351896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111358494|NCT00241904|Propranolol|propranolol|mesh-list
111358495|NCT00241904|Metoprolol|metoprolol|mesh-list
111358496|NCT00241904|Atenolol|atenolol|mesh-list
111358497|NCT00241904|Lisinopril|lisinopril|mesh-list
111358498|NCT00241904|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
111358499|NCT00241904|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
111358500|NCT00241904|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
111358501|NCT00241904|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111358502|NCT00241904|Adrenergic Agents|adrenergic agents|mesh-ancestor
111358503|NCT00241904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111358504|NCT00241904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111358505|NCT00241904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111358506|NCT00241904|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111358507|NCT00241904|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111358508|NCT00241904|Vasodilator Agents|vasodilator agents|mesh-ancestor
111358509|NCT00241904|Sympatholytics|sympatholytics|mesh-ancestor
111358510|NCT00241904|Autonomic Agents|autonomic agents|mesh-ancestor
111358511|NCT00241904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111358512|NCT00241904|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
111358513|NCT00241904|Protease Inhibitors|protease inhibitors|mesh-ancestor
111358514|NCT00241904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111358515|NCT00241904|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111358516|NCT00241904|Protective Agents|protective agents|mesh-ancestor
111358517|NCT01791296|Dexmedetomidine|dexmedetomidine|mesh-list
111358518|NCT01791296|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111358519|NCT01791296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111358520|NCT01791296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111358521|NCT01791296|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111358522|NCT01791296|Analgesics|analgesics|mesh-ancestor
111358523|NCT01791296|Sensory System Agents|sensory system agents|mesh-ancestor
111358524|NCT01791296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111358525|NCT01791296|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111358526|NCT01791296|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111358527|NCT01791296|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111358528|NCT01791296|Adrenergic Agents|adrenergic agents|mesh-ancestor
111358529|NCT01791296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111358530|NCT01791296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111358531|NCT01479127|Silicon|silicon|mesh-list
111358532|NCT01479127|Levodopa|levodopa|mesh-list
111358533|NCT01479127|Carbidopa|carbidopa|mesh-list
111358534|NCT01479127|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111358535|NCT01479127|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111358536|NCT01479127|Dopamine Agents|dopamine agents|mesh-ancestor
111358537|NCT01479127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111358538|NCT01479127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111358539|NCT01479127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111358540|NCT01479127|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
111358541|NCT01479127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111358542|NCT01479127|Trace Elements|trace elements|mesh-ancestor
111358543|NCT01479127|Micronutrients|micronutrients|mesh-ancestor
111358544|NCT03917966|Docetaxel|docetaxel|mesh-list
111358545|NCT03917966|Apatinib|apatinib|mesh-list
111358546|NCT03917966|Nedaplatin|nedaplatin|mesh-list
111358547|NCT03917966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111358548|NCT03917966|Tubulin Modulators|tubulin modulators|mesh-ancestor
111358549|NCT03917966|Antimitotic Agents|antimitotic agents|mesh-ancestor
111358550|NCT03917966|Mitosis Modulators|mitosis modulators|mesh-ancestor
111358551|NCT03917966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111358552|NCT03917966|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111358553|NCT03917966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111358554|NCT00243152|Lamotrigine|lamotrigine|mesh-list
111358555|NCT00243152|Anticonvulsants|anticonvulsants|mesh-list
111358556|NCT00243152|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111358557|NCT00243152|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111358558|NCT00243152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111358559|NCT00243152|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111358560|NCT00243152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111358561|NCT00243152|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111358562|NCT00243152|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111358563|NCT00243152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111358564|NCT00243152|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111358565|NCT00243152|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111358566|NCT01453075|Valacyclovir|valacyclovir|mesh-list
111358567|NCT01453075|Antiviral Agents|antiviral agents|mesh-ancestor
111358568|NCT01453075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111358569|NCT01791374|Rilotumumab|rilotumumab|mesh-list
111358570|NCT01791374|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111358571|NCT01791374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111358572|NCT01791374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111358573|NCT01791374|Immunologic Factors|immunologic factors|mesh-ancestor
111358574|NCT01791374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111358576|NCT03783416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111358577|NCT03783416|Protease Inhibitors|protease inhibitors|mesh-ancestor
111358578|NCT03783416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111358579|NCT03783416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111358580|NCT00248534|Methylprednisolone|methylprednisolone|mesh-list
110658720|NCT00751751|Diuretics|diuretics|mesh-ancestor
111358581|NCT00248534|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111358582|NCT00248534|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111358583|NCT00248534|Prednisolone|prednisolone|mesh-list
111358584|NCT00248534|Prednisolone acetate|prednisolone acetate|mesh-list
111358585|NCT00248534|Rituximab|rituximab|mesh-list
111358586|NCT00248534|Temozolomide|temozolomide|mesh-list
111358587|NCT00248534|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111358588|NCT00248534|Prednisolone phosphate|prednisolone phosphate|mesh-list
111358589|NCT00248534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111358590|NCT00248534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111358591|NCT00248534|Immunologic Factors|immunologic factors|mesh-ancestor
111358592|NCT00248534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111358593|NCT00248534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111358594|NCT00248534|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111358595|NCT00248534|Alkylating Agents|alkylating agents|mesh-ancestor
111358596|NCT00248534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111358597|NCT00248534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111358598|NCT00248534|Antiemetics|antiemetics|mesh-ancestor
111358599|NCT00248534|Autonomic Agents|autonomic agents|mesh-ancestor
111358600|NCT00248534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111358601|NCT00248534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111358602|NCT00248534|Glucocorticoids|glucocorticoids|mesh-ancestor
111358603|NCT00248534|Hormones|hormones|mesh-ancestor
111358604|NCT00248534|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111358605|NCT00248534|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111358606|NCT00248534|Protective Agents|protective agents|mesh-ancestor
111358607|NCT00248534|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111358608|NCT00248612|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
111358609|NCT00248612|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111358610|NCT00248612|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110852077|NCT04828135|Anesthetics|anesthetics|mesh-ancestor
111358611|NCT00248612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111358612|NCT00248612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111358613|NCT00248612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111358614|NCT00248612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111358615|NCT00248612|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111358616|NCT00248612|Antidepressive Agents|antidepressive agents|mesh-ancestor
111358617|NCT00248612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111358618|NCT05266820|Thalidomide|thalidomide|mesh-list
111358619|NCT05266820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111358620|NCT05266820|Immunologic Factors|immunologic factors|mesh-ancestor
111358621|NCT05266820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111358622|NCT05266820|Leprostatic Agents|leprostatic agents|mesh-ancestor
111358623|NCT05266820|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111358624|NCT05266820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111358625|NCT05266820|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111358626|NCT05266820|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111358627|NCT05266820|Growth Substances|growth substances|mesh-ancestor
111358628|NCT05266820|Growth Inhibitors|growth inhibitors|mesh-ancestor
111358629|NCT05266820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111358630|NCT03549650|Pentosan Sulfuric Polyester|pentosan sulfuric polyester|mesh-list
111358631|NCT03549650|Anticoagulants|anticoagulants|mesh-ancestor
111358632|NCT01454791|Diclofenac|diclofenac|mesh-list
111358633|NCT01454791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111358634|NCT01454791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111358635|NCT01454791|Analgesics|analgesics|mesh-ancestor
111358636|NCT01454791|Sensory System Agents|sensory system agents|mesh-ancestor
111358637|NCT01454791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111358638|NCT01454791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111358639|NCT01454791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111358640|NCT01454791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111358641|NCT01454791|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111358642|NCT01454791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111358643|NCT01454791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111358645|NCT02099006|Ketamine|ketamine|mesh-list
111358646|NCT02099006|Gabapentin|gabapentin|mesh-list
111358647|NCT02099006|Amitriptyline|amitriptyline|mesh-list
111358648|NCT02099006|Baclofen|baclofen|mesh-list
111358649|NCT02099006|Loperamide|loperamide|mesh-list
111358650|NCT02099006|Antidiarrheals|antidiarrheals|mesh-list
111358651|NCT02099006|Analgesics|analgesics|mesh-ancestor
111358652|NCT02099006|Sensory System Agents|sensory system agents|mesh-ancestor
111358653|NCT02099006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111358654|NCT02099006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111358655|NCT02099006|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111358656|NCT02099006|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111358657|NCT02099006|Anesthetics, General|anesthetics, general|mesh-ancestor
111358658|NCT02099006|Anesthetics|anesthetics|mesh-ancestor
111358659|NCT02099006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111358660|NCT02099006|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110852469|NCT02329080|Immunologic Factors|immunologic factors|mesh-ancestor
111358661|NCT02099006|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111358662|NCT02099006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111358663|NCT02099006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111358664|NCT02099006|Anticonvulsants|anticonvulsants|mesh-ancestor
110852541|NCT03339544|Celecoxib|celecoxib|mesh-list
111358665|NCT02099006|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111358666|NCT02099006|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111358667|NCT02099006|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111358668|NCT02099006|Antimanic Agents|antimanic agents|mesh-ancestor
111358669|NCT02099006|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110852612|NCT03812003|Analgesics|analgesics|mesh-ancestor
111358670|NCT02099006|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111358671|NCT02099006|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
111358672|NCT02099006|GABA Agonists|gaba agonists|mesh-ancestor
111358673|NCT02099006|GABA Agents|gaba agents|mesh-ancestor
111358674|NCT02099006|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111358675|NCT02099006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110852681|NCT01560065|Folic Acid|folic acid|mesh-list
111358676|NCT02099006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111358677|NCT02099006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111358678|NCT02099006|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111358679|NCT02099006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111358680|NCT02099006|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
111358681|NCT02099006|Antidepressive Agents|antidepressive agents|mesh-ancestor
111358682|NCT02099006|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110852751|NCT02498860|Pemetrexed|pemetrexed|mesh-list
111358683|NCT02099006|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111358684|NCT02099006|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111358685|NCT02099006|Adrenergic Agents|adrenergic agents|mesh-ancestor
111358686|NCT02099006|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111358687|NCT05266274|Azacitidine|azacitidine|mesh-list
111358688|NCT05266274|Antibodies|antibodies|mesh-list
111358689|NCT05266274|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111358690|NCT05266274|Immunologic Factors|immunologic factors|mesh-ancestor
111358691|NCT05266274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111358692|NCT05266274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111358693|NCT05266274|Antimetabolites|antimetabolites|mesh-ancestor
111358694|NCT05266274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111358695|NCT05266274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111358696|NCT05266274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111358697|NCT05265962|Decitabine|decitabine|mesh-list
111358698|NCT05265962|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111358699|NCT05265962|Antimetabolites|antimetabolites|mesh-ancestor
111358700|NCT05265962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111358701|NCT05265962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111358702|NCT05265962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111358703|NCT00324896|Eszopiclone|eszopiclone|mesh-list
111358704|NCT00324896|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111358705|NCT00324896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111358706|NCT00324896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111358707|NCT01479517|Tetracaine|tetracaine|mesh-list
111358708|NCT01479517|Anesthetics, Local|anesthetics, local|mesh-ancestor
111358709|NCT01479517|Anesthetics|anesthetics|mesh-ancestor
111358710|NCT01479517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110852879|NCT03814733|Alprazolam|alprazolam|mesh-list
111358711|NCT01479517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111358712|NCT01479517|Sensory System Agents|sensory system agents|mesh-ancestor
111358713|NCT01479517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111358715|NCT01480219|Antifungal Agents|antifungal agents|mesh-ancestor
111358716|NCT01480219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111358717|NCT01480219|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111358718|NCT01480219|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111358719|NCT01480219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111358720|NCT01480219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111358721|NCT01480219|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111358722|NCT01480219|Hormone Antagonists|hormone antagonists|mesh-ancestor
111358723|NCT01480219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111358724|NCT01480219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111358725|NCT01480219|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111358726|NCT01480297|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
111358727|NCT01480297|Sodium Salicylate|sodium salicylate|mesh-list
111358728|NCT01480297|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111358729|NCT01480297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111358730|NCT01480297|Analgesics|analgesics|mesh-ancestor
111358731|NCT01480297|Sensory System Agents|sensory system agents|mesh-ancestor
111358732|NCT01480297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111358733|NCT01480297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111358734|NCT01480297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111358735|NCT01480297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111358736|NCT01480297|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111358737|NCT01480297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111358738|NCT01480297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111358739|NCT01480843|Insulin Glargine|insulin glargine|mesh-list
111358740|NCT01480843|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111358741|NCT01480843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111358742|NCT01392703|Dasatinib|dasatinib|mesh-list
111358743|NCT01392703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111358744|NCT01392703|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111358745|NCT01392703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111358746|NCT01392703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110853072|NCT03636048|Propofol|propofol|mesh-list
111358747|NCT01392859|Levocetirizine|levocetirizine|mesh-list
111358748|NCT01392859|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
111358749|NCT01392859|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111358750|NCT01392859|Histamine Antagonists|histamine antagonists|mesh-ancestor
111358751|NCT01392859|Histamine Agents|histamine agents|mesh-ancestor
111358752|NCT01392859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111358753|NCT01392859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111358754|NCT01392859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111358755|NCT01457521|Ibuprofen|ibuprofen|mesh-list
111358756|NCT01457521|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111358757|NCT01457521|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111358758|NCT01457521|Analgesics|analgesics|mesh-ancestor
111358759|NCT01457521|Sensory System Agents|sensory system agents|mesh-ancestor
111358760|NCT01457521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111358761|NCT01457521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110107088|NCT01809743|Regadenoson|regadenoson|mesh-list
111358762|NCT01457521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111358763|NCT01457521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111358764|NCT01457521|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111358765|NCT01457521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111358766|NCT01457521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111358767|NCT00325442|Treprostinil|treprostinil|mesh-list
111358768|NCT00325442|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111358769|NCT01393717|Brentuximab Vedotin|brentuximab vedotin|mesh-list
111358770|NCT01393717|Antibodies|antibodies|mesh-list
111358771|NCT01393717|Immunoglobulins|immunoglobulins|mesh-list
111358772|NCT01393717|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111358773|NCT01393717|Immunoconjugates|immunoconjugates|mesh-list
111358774|NCT01393717|Immunologic Factors|immunologic factors|mesh-ancestor
111358775|NCT01393717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111358776|NCT01393717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111358777|NCT01393717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111358778|NCT01393717|Immunotoxins|immunotoxins|mesh-ancestor
111358779|NCT01460875|Interferons|interferons|mesh-list
111358780|NCT01460875|Interferon-alpha|interferon-alpha|mesh-list
111358781|NCT01460875|Interferon alpha-2|interferon alpha-2|mesh-list
111358782|NCT01460875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111358783|NCT01460875|Antiviral Agents|antiviral agents|mesh-ancestor
110853338|NCT03792971|Antioxidants|antioxidants|mesh-ancestor
111358784|NCT01460875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111358785|NCT01460875|Immunologic Factors|immunologic factors|mesh-ancestor
111358786|NCT01460875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111358787|NCT01481545|Leucovorin|leucovorin|mesh-list
111358788|NCT01481545|Bevacizumab|bevacizumab|mesh-list
111358789|NCT01481545|Fluorouracil|fluorouracil|mesh-list
111358790|NCT01481545|Oxaliplatin|oxaliplatin|mesh-list
111358791|NCT01481545|Raltitrexed|raltitrexed|mesh-list
111358792|NCT01481545|Levoleucovorin|levoleucovorin|mesh-list
111358793|NCT01481545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111358794|NCT01481545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111358795|NCT01481545|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111358796|NCT01481545|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111358797|NCT01481545|Growth Substances|growth substances|mesh-ancestor
111358798|NCT01481545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111358799|NCT01481545|Growth Inhibitors|growth inhibitors|mesh-ancestor
111358800|NCT01481545|Antimetabolites|antimetabolites|mesh-ancestor
111358801|NCT01481545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111358802|NCT01481545|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111358803|NCT01481545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111358804|NCT01481545|Immunologic Factors|immunologic factors|mesh-ancestor
111358805|NCT01481545|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111358806|NCT01481545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111358807|NCT01481545|Antidotes|antidotes|mesh-ancestor
111358808|NCT01481545|Protective Agents|protective agents|mesh-ancestor
111358809|NCT01481545|Vitamin B Complex|vitamin b complex|mesh-ancestor
111358810|NCT01481545|Vitamins|vitamins|mesh-ancestor
111358811|NCT01481545|Micronutrients|micronutrients|mesh-ancestor
111358812|NCT01482091|Fentanyl|fentanyl|mesh-list
111358813|NCT01482091|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111358814|NCT01482091|Narcotics|narcotics|mesh-ancestor
111358815|NCT01482091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111358816|NCT01482091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111358817|NCT01482091|Analgesics|analgesics|mesh-ancestor
111358818|NCT01482091|Sensory System Agents|sensory system agents|mesh-ancestor
111358819|NCT01482091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111358820|NCT01482091|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111358821|NCT01482091|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111358822|NCT01482091|Anesthetics, General|anesthetics, general|mesh-ancestor
111358823|NCT01482091|Anesthetics|anesthetics|mesh-ancestor
111358824|NCT00327392|Fospropofol|fospropofol|mesh-list
111358825|NCT00327392|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111358826|NCT00327392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111358827|NCT00327392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111358828|NCT01791608|Zinc|zinc|mesh-list
111358829|NCT01791608|Zinc Sulfate|zinc sulfate|mesh-list
111358830|NCT01791608|Trace Elements|trace elements|mesh-ancestor
111358831|NCT01791608|Micronutrients|micronutrients|mesh-ancestor
111358832|NCT01791608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111358833|NCT01791608|Astringents|astringents|mesh-ancestor
111358834|NCT01791608|Dermatologic Agents|dermatologic agents|mesh-ancestor
111358835|NCT04346030|Triamcinolone|triamcinolone|mesh-list
111358836|NCT04346030|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
111358837|NCT04346030|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
111358838|NCT04346030|Lidocaine|lidocaine|mesh-list
111358839|NCT04346030|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110571137|NCT01022983|Simendan|simendan|mesh-list
111358840|NCT04346030|Anesthetics, Local|anesthetics, local|mesh-ancestor
111358841|NCT04346030|Anesthetics|anesthetics|mesh-ancestor
111358842|NCT04346030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111358843|NCT04346030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111358844|NCT04346030|Sensory System Agents|sensory system agents|mesh-ancestor
111358845|NCT04346030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111358846|NCT04346030|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111358847|NCT04346030|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111358848|NCT04346030|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111358849|NCT04346030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111358850|NCT04346030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111358851|NCT04346030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111358852|NCT04346030|Glucocorticoids|glucocorticoids|mesh-ancestor
111358853|NCT04346030|Hormones|hormones|mesh-ancestor
111358854|NCT04346030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111358855|NCT04346030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111358856|NCT04346030|Immunologic Factors|immunologic factors|mesh-ancestor
111358857|NCT04346030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111358858|NCT05075330|Analgesics, Opioid|analgesics, opioid|mesh-list
111358859|NCT05075330|Narcotics|narcotics|mesh-ancestor
111358860|NCT05075330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111358861|NCT05075330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111358862|NCT05075330|Analgesics|analgesics|mesh-ancestor
111358863|NCT05075330|Sensory System Agents|sensory system agents|mesh-ancestor
111358864|NCT05075330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111358865|NCT02108288|Carteolol|carteolol|mesh-list
111358866|NCT02108288|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111358867|NCT02108288|Latanoprost|latanoprost|mesh-list
111358868|NCT02108288|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111358869|NCT02108288|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111358870|NCT02108288|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111358871|NCT02108288|Adrenergic Agents|adrenergic agents|mesh-ancestor
111358872|NCT02108288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111358873|NCT02108288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111358874|NCT02108288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111358875|NCT02108288|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110853847|NCT03791957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111358876|NCT02108288|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111358877|NCT02108288|Sympatholytics|sympatholytics|mesh-ancestor
111358878|NCT02108288|Autonomic Agents|autonomic agents|mesh-ancestor
111358879|NCT02108288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111358880|NCT02106494|Dexamethasone|dexamethasone|mesh-list
111358881|NCT02106494|Ondansetron|ondansetron|mesh-list
111358882|NCT02106494|Fosaprepitant|fosaprepitant|mesh-list
111358883|NCT02106494|Aprepitant|aprepitant|mesh-list
111358884|NCT02106494|Granisetron|granisetron|mesh-list
111358885|NCT02106494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111358886|NCT02106494|Antiemetics|antiemetics|mesh-ancestor
111358887|NCT02106494|Autonomic Agents|autonomic agents|mesh-ancestor
110853979|NCT05452070|Lidocaine|lidocaine|mesh-list
111358888|NCT02106494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111358889|NCT02106494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111358890|NCT02106494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111358891|NCT02106494|Glucocorticoids|glucocorticoids|mesh-ancestor
111358892|NCT02106494|Hormones|hormones|mesh-ancestor
111358893|NCT02106494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111358894|NCT02106494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111358895|NCT02106494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111358896|NCT02106494|Antipruritics|antipruritics|mesh-ancestor
111358897|NCT02106494|Dermatologic Agents|dermatologic agents|mesh-ancestor
111358898|NCT02106494|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111358899|NCT02106494|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111358900|NCT02106494|Serotonin Agents|serotonin agents|mesh-ancestor
111358901|NCT02106494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111358902|NCT02106494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111358903|NCT02106494|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
111358904|NCT00335504|Sulindac|sulindac|mesh-list
111358905|NCT00335504|Atorvastatin|atorvastatin|mesh-list
111358906|NCT00335504|Calcium|calcium|mesh-list
111358907|NCT00335504|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111358908|NCT00335504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111358909|NCT00335504|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111358910|NCT00335504|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111358911|NCT00335504|Antimetabolites|antimetabolites|mesh-ancestor
111358912|NCT00335504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111358913|NCT00335504|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111358914|NCT00335504|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111358915|NCT00335504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111358916|NCT00335504|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111358917|NCT00335504|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111358918|NCT00335504|Analgesics|analgesics|mesh-ancestor
111358919|NCT00335504|Sensory System Agents|sensory system agents|mesh-ancestor
111358920|NCT00335504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111358921|NCT00335504|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111358922|NCT00335504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111358923|NCT00335504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111358924|NCT00335504|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111358925|NCT01183169|Ribavirin|ribavirin|mesh-list
111358926|NCT01183169|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
111358927|NCT01183169|Antimetabolites|antimetabolites|mesh-ancestor
111358928|NCT01183169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111358929|NCT01183169|Antiviral Agents|antiviral agents|mesh-ancestor
111358930|NCT01183169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111358931|NCT01183481|Aprepitant|aprepitant|mesh-list
111358932|NCT01183481|Granisetron|granisetron|mesh-list
111358933|NCT01183481|Antiemetics|antiemetics|mesh-ancestor
111358934|NCT01183481|Autonomic Agents|autonomic agents|mesh-ancestor
111358935|NCT01183481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111358936|NCT01183481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111358937|NCT01183481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111358938|NCT01183481|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
111358939|NCT01183481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111358940|NCT01183481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111358941|NCT01183481|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111358942|NCT01183481|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111358943|NCT01183481|Serotonin Agents|serotonin agents|mesh-ancestor
111358944|NCT01183559|Paclitaxel|paclitaxel|mesh-list
111358945|NCT01183559|Carboplatin|carboplatin|mesh-list
110854594|NCT01334580|Methadone|methadone|mesh-list
111358946|NCT01183559|Fluorouracil|fluorouracil|mesh-list
111358947|NCT01183559|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111358948|NCT01183559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110854654|NCT01334892|Cyclosporine|cyclosporine|mesh-list
111358949|NCT01183559|Tubulin Modulators|tubulin modulators|mesh-ancestor
111358950|NCT01183559|Antimitotic Agents|antimitotic agents|mesh-ancestor
111358951|NCT01183559|Mitosis Modulators|mitosis modulators|mesh-ancestor
111358952|NCT01183559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111358953|NCT01183559|Antimetabolites|antimetabolites|mesh-ancestor
111358954|NCT01183559|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111358955|NCT01183559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111358956|NCT01183559|Immunologic Factors|immunologic factors|mesh-ancestor
111358957|NCT01183559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111358958|NCT01184417|Phenobarbital|phenobarbital|mesh-list
111358959|NCT01184417|Anticonvulsants|anticonvulsants|mesh-ancestor
111358960|NCT01184417|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111358961|NCT01184417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111358962|NCT01184417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111358963|NCT01184417|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111358964|NCT01184417|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111358965|NCT01184417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111358966|NCT01184417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111358967|NCT01184417|GABA Modulators|gaba modulators|mesh-ancestor
111358968|NCT01184417|GABA Agents|gaba agents|mesh-ancestor
111358969|NCT01184417|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111358970|NCT01184417|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111358971|NCT01184417|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111358972|NCT01159067|Deferasirox|deferasirox|mesh-list
111358973|NCT01159067|Iron Chelating Agents|iron chelating agents|mesh-ancestor
111358974|NCT01159067|Chelating Agents|chelating agents|mesh-ancestor
111358975|NCT01159067|Sequestering Agents|sequestering agents|mesh-ancestor
110854854|NCT03434119|Insulin|insulin|mesh-list
111358976|NCT01159067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111358977|NCT01222091|Propranolol|propranolol|mesh-list
111358978|NCT01222091|Remifentanil|remifentanil|mesh-list
111358979|NCT01222091|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111358980|NCT01222091|Narcotics|narcotics|mesh-ancestor
111358981|NCT01222091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111358982|NCT01222091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111358983|NCT01222091|Analgesics|analgesics|mesh-ancestor
111358984|NCT01222091|Sensory System Agents|sensory system agents|mesh-ancestor
111358985|NCT01222091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111358986|NCT01222091|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111358987|NCT01222091|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111358988|NCT01222091|Adrenergic Agents|adrenergic agents|mesh-ancestor
111358989|NCT01222091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110854924|NCT03719053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111358990|NCT01222091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111358991|NCT01222091|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111358992|NCT01222091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111358993|NCT01222091|Vasodilator Agents|vasodilator agents|mesh-ancestor
111358994|NCT01225055|Teriparatide|teriparatide|mesh-list
110854983|NCT00092664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111358995|NCT01225055|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111358996|NCT01225055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111358997|NCT01225055|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111358998|NCT01336140|Aminophylline|aminophylline|mesh-list
111358999|NCT01336140|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111359000|NCT01336140|Autonomic Agents|autonomic agents|mesh-ancestor
110855068|NCT01307969|Mydriatics|mydriatics|mesh-ancestor
111359001|NCT01336140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111359002|NCT01336140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111359003|NCT01336140|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111359004|NCT01336140|Respiratory System Agents|respiratory system agents|mesh-ancestor
111359005|NCT01336140|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111359006|NCT01336140|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111359007|NCT01336140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111359008|NCT01336140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111359009|NCT01336140|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
111359010|NCT01336140|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111359011|NCT01336140|Purinergic Agents|purinergic agents|mesh-ancestor
111359012|NCT01336140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111359013|NCT01336140|Protective Agents|protective agents|mesh-ancestor
111359014|NCT01184885|Sirolimus|sirolimus|mesh-list
111359015|NCT01184885|Cyclophosphamide|cyclophosphamide|mesh-list
111359016|NCT01184885|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111359017|NCT01184885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110855185|NCT00706030|Antimitotic Agents|antimitotic agents|mesh-ancestor
111359018|NCT01184885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111359019|NCT01184885|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111359020|NCT01184885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111359021|NCT01184885|Antifungal Agents|antifungal agents|mesh-ancestor
111359022|NCT01184885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111359023|NCT01184885|Immunologic Factors|immunologic factors|mesh-ancestor
111359024|NCT01184885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111359025|NCT01184885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111359026|NCT01184885|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111359027|NCT01184885|Alkylating Agents|alkylating agents|mesh-ancestor
111359028|NCT01184885|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111359029|NCT01187381|Trastuzumab|trastuzumab|mesh-list
111359030|NCT01187381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111359031|NCT01187381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111359032|NCT01225289|Vitamin A|vitamin a|mesh-list
111359033|NCT01225289|Retinol palmitate|retinol palmitate|mesh-list
111359034|NCT01225289|Vitamins|vitamins|mesh-ancestor
111359035|NCT01225289|Micronutrients|micronutrients|mesh-ancestor
111359036|NCT01225289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111359037|NCT01225289|Antioxidants|antioxidants|mesh-ancestor
111359038|NCT01225289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111359039|NCT01225289|Protective Agents|protective agents|mesh-ancestor
111359040|NCT01225289|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
111359041|NCT01225289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111359042|NCT01161563|Leuprolide|leuprolide|mesh-list
111359043|NCT01161563|Triptorelin Pamoate|triptorelin pamoate|mesh-list
111359044|NCT01161563|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111359045|NCT01161563|Fertility Agents|fertility agents|mesh-ancestor
111359046|NCT01161563|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110855378|NCT03720067|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111359047|NCT01161563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111359048|NCT01161563|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111359049|NCT01161563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111359050|NCT01161563|Luteolytic Agents|luteolytic agents|mesh-ancestor
111359051|NCT01161563|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111359052|NCT01161563|Contraceptive Agents|contraceptive agents|mesh-ancestor
111359053|NCT01161563|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111359054|NCT01189409|Sennosides|sennosides|mesh-list
111359055|NCT01189409|Laxatives|laxatives|mesh-ancestor
111359056|NCT01189409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111359057|NCT03010475|Furosemide|furosemide|mesh-list
111359058|NCT03010475|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111359059|NCT03010475|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111359060|NCT03010475|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111359061|NCT03010475|Antimetabolites|antimetabolites|mesh-ancestor
111359062|NCT03010475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111359063|NCT03010475|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111359064|NCT03010475|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111359065|NCT03010475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111359066|NCT03010475|Diuretics|diuretics|mesh-ancestor
111359067|NCT03010475|Natriuretic Agents|natriuretic agents|mesh-ancestor
111359068|NCT03010475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111359069|NCT03010475|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
111359070|NCT03010475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111359071|NCT02191865|Nintedanib|nintedanib|mesh-list
111359072|NCT02191865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110855641|NCT01336842|Pemetrexed|pemetrexed|mesh-list
111359073|NCT02191865|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111359074|NCT02191865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111359075|NCT02191865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111359076|NCT04352465|Methotrexate|methotrexate|mesh-list
111359077|NCT04352465|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111359078|NCT04352465|Abortifacient Agents|abortifacient agents|mesh-ancestor
111359079|NCT04352465|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111359080|NCT04352465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111359081|NCT04352465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111359082|NCT04352465|Antimetabolites|antimetabolites|mesh-ancestor
111359083|NCT04352465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111359084|NCT04352465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111359085|NCT04352465|Dermatologic Agents|dermatologic agents|mesh-ancestor
111359086|NCT04352465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111359087|NCT04352465|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111359088|NCT04352465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111359089|NCT04352465|Immunologic Factors|immunologic factors|mesh-ancestor
111359090|NCT04352465|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111359091|NCT04352465|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111359092|NCT01191749|Alemtuzumab|alemtuzumab|mesh-list
111359093|NCT01191749|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111359094|NCT01191749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111359095|NCT00343460|Dexamethasone|dexamethasone|mesh-list
111359096|NCT00343460|Palonosetron|palonosetron|mesh-list
111359097|NCT00343460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111359098|NCT00343460|Antiemetics|antiemetics|mesh-ancestor
111359099|NCT00343460|Autonomic Agents|autonomic agents|mesh-ancestor
111359100|NCT00343460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111359101|NCT00343460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110855913|NCT05371288|Thioctic Acid|thioctic acid|mesh-list
111359102|NCT00343460|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111359103|NCT00343460|Glucocorticoids|glucocorticoids|mesh-ancestor
111359104|NCT00343460|Hormones|hormones|mesh-ancestor
111359105|NCT00343460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111359106|NCT00343460|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111359107|NCT00343460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111359108|NCT00343460|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111359109|NCT00343460|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111359110|NCT00343460|Serotonin Agents|serotonin agents|mesh-ancestor
111359111|NCT00343460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111359112|NCT00343460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110856054|NCT02477956|Vitamin D|vitamin d|mesh-list
111359113|NCT04934696|Contraceptive Agents|contraceptive agents|mesh-list
111359114|NCT04934696|Contraceptives, Oral|contraceptives, oral|mesh-list
111359115|NCT04934696|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111359116|NCT04934696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111359117|NCT04934696|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111359118|NCT01192139|Metformin|metformin|mesh-list
111359119|NCT01192139|Saxagliptin|saxagliptin|mesh-list
110573679|NCT00841568|Tolvaptan|tolvaptan|mesh-list
111359120|NCT01192139|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111359121|NCT01192139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111359122|NCT01192139|Incretins|incretins|mesh-ancestor
111359123|NCT01192139|Hormones|hormones|mesh-ancestor
111359124|NCT01192139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111359125|NCT01192139|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111359126|NCT01192139|Protease Inhibitors|protease inhibitors|mesh-ancestor
111359127|NCT01192139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111359128|NCT01192139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111359129|NCT04892186|Inositol|inositol|mesh-list
111359130|NCT04892186|Metformin|metformin|mesh-list
111359131|NCT04892186|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111359132|NCT04892186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111359133|NCT04892186|Vitamin B Complex|vitamin b complex|mesh-ancestor
111359134|NCT04892186|Vitamins|vitamins|mesh-ancestor
111359135|NCT04892186|Micronutrients|micronutrients|mesh-ancestor
111359136|NCT01229423|Bimatoprost|bimatoprost|mesh-list
111359137|NCT01229423|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111359138|NCT01229891|Vitamin D|vitamin d|mesh-list
111359139|NCT01229891|Ergocalciferols|ergocalciferols|mesh-list
111359140|NCT01229891|Cholecalciferol|cholecalciferol|mesh-list
111359141|NCT01229891|Vitamins|vitamins|mesh-list
111359142|NCT01229891|Micronutrients|micronutrients|mesh-ancestor
111359143|NCT01229891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111359144|NCT01229891|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110856331|NCT03763409|Losartan|losartan|mesh-list
111359145|NCT01229891|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111359146|NCT01283555|Tenofovir|tenofovir|mesh-list
111359147|NCT01283555|Antiviral Agents|antiviral agents|mesh-ancestor
111359148|NCT01283555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111359149|NCT01283555|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111359150|NCT01283555|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111359151|NCT01283555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111359152|NCT01283555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111359153|NCT01283555|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111359154|NCT01283555|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111359155|NCT01194089|Nicotine|nicotine|mesh-list
111359156|NCT01194089|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111359157|NCT01194089|Autonomic Agents|autonomic agents|mesh-ancestor
111359158|NCT01194089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111083576|NCT03372473|Loratadine|loratadine|mesh-list
111359159|NCT01194089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111359160|NCT01194089|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111359161|NCT01194089|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111359162|NCT01194089|Cholinergic Agents|cholinergic agents|mesh-ancestor
111359163|NCT01194089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111359164|NCT01194089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111359166|NCT01650350|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111359167|NCT01650350|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111359168|NCT01650350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111359169|NCT01650350|Sensory System Agents|sensory system agents|mesh-ancestor
111359170|NCT01650350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111359171|NCT00349388|Mesalamine|mesalamine|mesh-list
111359172|NCT00349388|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111359173|NCT00349388|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111359174|NCT00349388|Analgesics|analgesics|mesh-ancestor
111359175|NCT00349388|Sensory System Agents|sensory system agents|mesh-ancestor
111359176|NCT00349388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111359177|NCT00349388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111359178|NCT00349388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111359179|NCT00349388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111359180|NCT00349778|Cyclophosphamide|cyclophosphamide|mesh-list
111359181|NCT00349778|Melphalan|melphalan|mesh-list
111359182|NCT00349778|Carmustine|carmustine|mesh-list
111359183|NCT00349778|Etoposide|etoposide|mesh-list
111359184|NCT00349778|Etoposide phosphate|etoposide phosphate|mesh-list
111359185|NCT00349778|Lenograstim|lenograstim|mesh-list
111359186|NCT00349778|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111359187|NCT00349778|Immunologic Factors|immunologic factors|mesh-ancestor
111359188|NCT00349778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111359189|NCT00349778|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111359190|NCT00349778|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111359191|NCT00349778|Alkylating Agents|alkylating agents|mesh-ancestor
111359192|NCT00349778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111359193|NCT00349778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111359194|NCT00349778|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111359195|NCT00349778|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111359196|NCT00349778|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111359197|NCT00349778|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111359198|NCT00349778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111359199|NCT00349778|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111359200|NCT00305084|Doxorubicin|doxorubicin|mesh-list
111359201|NCT00305084|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111359202|NCT00305084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111359203|NCT00305084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111359204|NCT00305084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111359205|NCT00305084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111359206|NCT00305084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111359207|NCT00305162|Clopidogrel|clopidogrel|mesh-list
111359208|NCT00305162|Cangrelor|cangrelor|mesh-list
111359209|NCT00305162|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111359210|NCT00305162|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111359211|NCT00305162|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111359212|NCT00305162|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111359213|NCT00305162|Purinergic Agents|purinergic agents|mesh-ancestor
111359214|NCT00305162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110856715|NCT04518046|Nivolumab|nivolumab|mesh-list
111359215|NCT00305162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111359216|NCT00305162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111359217|NCT00351416|Letrozole|letrozole|mesh-list
111359218|NCT00351416|Aromatase Inhibitors|aromatase inhibitors|mesh-list
111359219|NCT00351416|LHRH, N-Ac-2-Nal(1)-4-Cl-Phe(2)-3-Pal(3)-Arg(5)-Glu(6)-AlaNH2(10)-|lhrh, n-ac-2-nal(1)-4-cl-phe(2)-3-pal(3)-arg(5)-glu(6)-alanh2(10)-|mesh-list
111359220|NCT00351416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111359221|NCT00351416|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111359222|NCT00351416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111359223|NCT00351416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111359224|NCT00351416|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111359225|NCT00351416|Hormone Antagonists|hormone antagonists|mesh-ancestor
111359226|NCT00351416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111359227|NCT00351416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111359228|NCT00305942|Carboplatin|carboplatin|mesh-list
111359229|NCT00305942|Topotecan|topotecan|mesh-list
111359230|NCT00305942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111359231|NCT00305942|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111359232|NCT00305942|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111359233|NCT00305942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111359234|NCT00305942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111359236|NCT00352976|Sirolimus|sirolimus|mesh-list
111359237|NCT00352976|Cyclophosphamide|cyclophosphamide|mesh-list
111359238|NCT00352976|Fludarabine|fludarabine|mesh-list
111359239|NCT00352976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111359240|NCT00352976|Immunologic Factors|immunologic factors|mesh-ancestor
111359241|NCT00352976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111359242|NCT00352976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111359243|NCT00352976|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111359244|NCT00352976|Alkylating Agents|alkylating agents|mesh-ancestor
111359245|NCT00352976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111359246|NCT00352976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111359247|NCT00352976|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111359248|NCT00352976|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111359249|NCT00352976|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111359250|NCT00352976|Antitubercular Agents|antitubercular agents|mesh-ancestor
111359251|NCT00352976|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111359252|NCT00352976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111359253|NCT00352976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111359254|NCT00352976|Antifungal Agents|antifungal agents|mesh-ancestor
111359255|NCT00306488|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111359256|NCT00306488|Antioxidants|antioxidants|mesh-list
110856984|NCT01342614|Metformin|metformin|mesh-list
111359257|NCT00306488|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111359258|NCT00306488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111359259|NCT00306488|Protective Agents|protective agents|mesh-ancestor
111359260|NCT00306488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111359261|NCT01793636|Everolimus|everolimus|mesh-list
111359262|NCT01793636|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111359263|NCT01793636|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111359264|NCT01793636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111359265|NCT01793636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111359266|NCT01793636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111359267|NCT01793636|Immunologic Factors|immunologic factors|mesh-ancestor
111359268|NCT01793636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111359269|NCT01793636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111359270|NCT00353522|Dalcetrapib|dalcetrapib|mesh-list
111359271|NCT00353522|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111359272|NCT00353522|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111359273|NCT00353522|Antimetabolites|antimetabolites|mesh-ancestor
111359274|NCT00353522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110857109|NCT03309436|Clomiphene|clomiphene|mesh-list
111359275|NCT00353522|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111359276|NCT00310076|Thalidomide|thalidomide|mesh-list
111359277|NCT00310076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111359278|NCT00310076|Immunologic Factors|immunologic factors|mesh-ancestor
111359279|NCT00310076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111359280|NCT00310076|Leprostatic Agents|leprostatic agents|mesh-ancestor
111359281|NCT00310076|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111359282|NCT00310076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111359283|NCT00310076|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111359284|NCT00310076|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111359285|NCT00310076|Growth Substances|growth substances|mesh-ancestor
111359286|NCT00310076|Growth Inhibitors|growth inhibitors|mesh-ancestor
111359287|NCT00310076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111359288|NCT00353834|Insulin|insulin|mesh-list
111359289|NCT00353834|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111359290|NCT00353834|Insulin Glargine|insulin glargine|mesh-list
111359291|NCT00353834|Exenatide|exenatide|mesh-list
111359292|NCT00353834|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111359293|NCT00353834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111359294|NCT00353834|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111359295|NCT00353834|Incretins|incretins|mesh-ancestor
111359296|NCT00353834|Hormones|hormones|mesh-ancestor
111359297|NCT00353834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111359298|NCT05344404|Niacinamide|niacinamide|mesh-list
111359299|NCT05344404|Niacin|niacin|mesh-list
111359300|NCT05344404|Nicotinic Acids|nicotinic acids|mesh-list
111359301|NCT05344404|Vitamin B Complex|vitamin b complex|mesh-ancestor
111359302|NCT05344404|Vitamins|vitamins|mesh-ancestor
111359303|NCT05344404|Micronutrients|micronutrients|mesh-ancestor
111359304|NCT05344404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111359305|NCT05344404|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111359306|NCT05344404|Antimetabolites|antimetabolites|mesh-ancestor
111359307|NCT05344404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111359308|NCT05344404|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111359309|NCT05344404|Vasodilator Agents|vasodilator agents|mesh-ancestor
111359310|NCT00354224|Capecitabine|capecitabine|mesh-list
111359311|NCT00354224|Oxaliplatin|oxaliplatin|mesh-list
111359312|NCT00354224|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111359313|NCT00354224|Antimetabolites|antimetabolites|mesh-ancestor
111359314|NCT00354224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111359315|NCT00354224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111359316|NCT01792388|Vitamin D|vitamin d|mesh-list
111359317|NCT01792388|Vitamins|vitamins|mesh-ancestor
111359318|NCT01792388|Micronutrients|micronutrients|mesh-ancestor
111359319|NCT01792388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111359320|NCT01792388|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111359321|NCT05395104|Midazolam|midazolam|mesh-list
111359322|NCT05395104|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111359323|NCT05395104|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111359324|NCT05395104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111359325|NCT05395104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111359326|NCT05395104|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111359327|NCT05395104|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111359328|NCT05395104|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111359329|NCT05395104|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111359330|NCT05395104|Anesthetics, General|anesthetics, general|mesh-ancestor
111359331|NCT05395104|Anesthetics|anesthetics|mesh-ancestor
111359332|NCT05395104|GABA Modulators|gaba modulators|mesh-ancestor
111359333|NCT05395104|GABA Agents|gaba agents|mesh-ancestor
111359334|NCT05395104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111359335|NCT05395104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111359336|NCT01793870|Carvedilol|carvedilol|mesh-list
111359337|NCT01793870|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111359338|NCT01793870|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111359339|NCT01793870|Adrenergic Agents|adrenergic agents|mesh-ancestor
111359340|NCT01793870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110857490|NCT03220854|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111359341|NCT01793870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111359342|NCT01793870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111359343|NCT01793870|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111359344|NCT01793870|Antioxidants|antioxidants|mesh-ancestor
111359345|NCT01793870|Protective Agents|protective agents|mesh-ancestor
111359346|NCT01793870|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111359347|NCT01793870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110857556|NCT03137784|Bromides|bromides|mesh-list
111359348|NCT01793870|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111359349|NCT01793870|Vasodilator Agents|vasodilator agents|mesh-ancestor
111359350|NCT01793870|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111359351|NCT01793870|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111359352|NCT01793948|Metformin|metformin|mesh-list
111359353|NCT01793948|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111359354|NCT01793948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111359355|NCT00310466|Immunomodulating Agents|immunomodulating agents|mesh-list
111359356|NCT00310466|Immunologic Factors|immunologic factors|mesh-ancestor
111359357|NCT00310466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111359358|NCT00355394|Metoclopramide|metoclopramide|mesh-list
111359359|NCT00355394|Antiemetics|antiemetics|mesh-ancestor
111359360|NCT00355394|Autonomic Agents|autonomic agents|mesh-ancestor
111359361|NCT00355394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111359362|NCT00355394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111359363|NCT00355394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111359364|NCT00355394|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111359365|NCT00355394|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111359366|NCT00355394|Dopamine Agents|dopamine agents|mesh-ancestor
111359367|NCT00355394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111359368|NCT00355394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111359369|NCT00311246|Adalimumab|adalimumab|mesh-list
111359370|NCT00311246|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111359371|NCT00311246|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111359372|NCT00311246|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111359373|NCT02105324|Pancrelipase|pancrelipase|mesh-list
111359374|NCT02105324|Pancreatin|pancreatin|mesh-list
111359375|NCT02105324|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111359376|NCT02105558|Anesthetics|anesthetics|mesh-list
111359377|NCT02105558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110857842|NCT03143166|Dabigatran|dabigatran|mesh-list
111359378|NCT02105558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111359379|NCT02106962|Bacitracin|bacitracin|mesh-list
111359380|NCT02106962|Tranexamic Acid|tranexamic acid|mesh-list
111359381|NCT02106962|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111359382|NCT02106962|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111359383|NCT02106962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111359384|NCT02106962|Hemostatics|hemostatics|mesh-ancestor
111359385|NCT02106962|Coagulants|coagulants|mesh-ancestor
111359386|NCT02106962|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111359387|NCT02106962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111359388|NCT02106962|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111359389|NCT00315146|Pioglitazone|pioglitazone|mesh-list
111359390|NCT00315146|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111359391|NCT00315146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111359392|NCT01792700|Amoxicillin|amoxicillin|mesh-list
111359393|NCT01792700|Moxifloxacin|moxifloxacin|mesh-list
111359394|NCT01792700|Metronidazole|metronidazole|mesh-list
111359395|NCT01792700|Tetracycline|tetracycline|mesh-list
111359396|NCT01792700|Esomeprazole|esomeprazole|mesh-list
111359397|NCT01792700|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111359398|NCT01792700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110858040|NCT01350024|Mydriatics|mydriatics|mesh-ancestor
111359399|NCT01792700|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111359400|NCT01792700|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111359401|NCT01792700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111359402|NCT01792700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111359403|NCT01792700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111359404|NCT01792700|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111359405|NCT01792700|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111359406|NCT01792700|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111359407|NCT01792700|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111359408|NCT01792700|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111359409|NCT01792700|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111359410|NCT00315302|Atropine|atropine|mesh-list
111359411|NCT00315302|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111359412|NCT00315302|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111359413|NCT00315302|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111359414|NCT00315302|Autonomic Agents|autonomic agents|mesh-ancestor
111359415|NCT00315302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111359416|NCT00315302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111359417|NCT00315302|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111359418|NCT00315302|Respiratory System Agents|respiratory system agents|mesh-ancestor
111359419|NCT00315302|Mydriatics|mydriatics|mesh-ancestor
111359420|NCT00315302|Parasympatholytics|parasympatholytics|mesh-ancestor
111359421|NCT00315302|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110858267|NCT04235686|Sympathomimetics|sympathomimetics|mesh-ancestor
111359422|NCT00315302|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111359423|NCT00315302|Cholinergic Agents|cholinergic agents|mesh-ancestor
111359424|NCT00315302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111359425|NCT00315302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111359426|NCT00316862|Irinotecan|irinotecan|mesh-list
111359427|NCT00316862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111359428|NCT00316862|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111359429|NCT00316862|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111359430|NCT00316862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110858400|NCT02465008|Anesthetics|anesthetics|mesh-ancestor
111359431|NCT00316862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111359432|NCT00317720|Trastuzumab|trastuzumab|mesh-list
111359433|NCT00317720|Everolimus|everolimus|mesh-list
111359434|NCT00317720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111359435|NCT00317720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111359436|NCT00317720|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111359437|NCT00317720|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111359438|NCT00317720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111359439|NCT00317720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111359440|NCT00317720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111359441|NCT00317720|Immunologic Factors|immunologic factors|mesh-ancestor
111359442|NCT00317720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111359443|NCT00357032|Belinostat|belinostat|mesh-list
111359444|NCT00357032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111359445|NCT00357032|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111359446|NCT00357032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111359447|NCT00357032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111359448|NCT00357734|Gefitinib|gefitinib|mesh-list
111359449|NCT00357734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111359450|NCT00357734|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111359451|NCT00357734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111359452|NCT00357734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111359453|NCT00318812|Iron|iron|mesh-list
111359454|NCT00318812|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
111359455|NCT00318812|Trace Elements|trace elements|mesh-ancestor
111359456|NCT00318812|Micronutrients|micronutrients|mesh-ancestor
110858680|NCT01822275|Temozolomide|temozolomide|mesh-list
111359457|NCT00318812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111359458|NCT00318812|Hematinics|hematinics|mesh-ancestor
111359459|NCT00362882|Docetaxel|docetaxel|mesh-list
111359460|NCT00362882|Bortezomib|bortezomib|mesh-list
111359461|NCT00362882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111359462|NCT00362882|Tubulin Modulators|tubulin modulators|mesh-ancestor
111359463|NCT00362882|Antimitotic Agents|antimitotic agents|mesh-ancestor
110959204|NCT02582632|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111359464|NCT00362882|Mitosis Modulators|mitosis modulators|mesh-ancestor
110858746|NCT01599494|Hormone Antagonists|hormone antagonists|mesh-ancestor
111359465|NCT00362882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111359466|NCT00365144|Bevacizumab|bevacizumab|mesh-list
111359467|NCT00365144|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111359468|NCT00365144|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111359469|NCT00365144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111359470|NCT00365144|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111359471|NCT00365144|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111359472|NCT00365144|Growth Substances|growth substances|mesh-ancestor
111359473|NCT00365144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111359474|NCT00365144|Growth Inhibitors|growth inhibitors|mesh-ancestor
111359475|NCT00365144|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111359476|NCT00365144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111359477|NCT00365144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111359478|NCT05339022|Coal Tar|coal tar|mesh-list
111359479|NCT05339022|Keratolytic Agents|keratolytic agents|mesh-ancestor
111359480|NCT05339022|Dermatologic Agents|dermatologic agents|mesh-ancestor
111359481|NCT00366626|Naltrexone|naltrexone|mesh-list
111359482|NCT00366626|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111359483|NCT00366626|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111359484|NCT00366626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110858957|NCT00398606|Calcium|calcium|mesh-list
111359485|NCT00366626|Sensory System Agents|sensory system agents|mesh-ancestor
111359486|NCT00366626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111359487|NCT00367016|Omalizumab|omalizumab|mesh-list
111359488|NCT00367016|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111359489|NCT00367016|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111359490|NCT00367016|Respiratory System Agents|respiratory system agents|mesh-ancestor
111359491|NCT04422678|Imatinib Mesylate|imatinib mesylate|mesh-list
111359492|NCT04422678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111359493|NCT04422678|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111359494|NCT04422678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111359495|NCT04422678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111359496|NCT00573378|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110859090|NCT03287128|Gemtuzumab|gemtuzumab|mesh-list
111359497|NCT00573378|Antiviral Agents|antiviral agents|mesh-ancestor
111359498|NCT00573378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111359499|NCT05334654|Enoxaparin|enoxaparin|mesh-list
111359500|NCT05334654|Enoxaparin sodium|enoxaparin sodium|mesh-list
111359501|NCT05334654|Bivalirudin|bivalirudin|mesh-list
111359502|NCT05334654|Anticoagulants|anticoagulants|mesh-ancestor
111359503|NCT05334654|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111359504|NCT05334654|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110859155|NCT06030037|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111359505|NCT05334654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111359506|NCT05334654|Antithrombins|antithrombins|mesh-ancestor
111359507|NCT05334654|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111359508|NCT05334654|Protease Inhibitors|protease inhibitors|mesh-ancestor
110859235|NCT06029296|Diclofenac|diclofenac|mesh-list
111359509|NCT05334654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111359510|NCT03561584|Sulfasalazine|sulfasalazine|mesh-list
111359511|NCT03561584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111359512|NCT03561584|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111359513|NCT03561584|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111359514|NCT03561584|Analgesics|analgesics|mesh-ancestor
111359515|NCT03561584|Sensory System Agents|sensory system agents|mesh-ancestor
110859294|NCT06028932|Immunoconjugates|immunoconjugates|mesh-ancestor
111359516|NCT03561584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111359517|NCT03561584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111359518|NCT03561584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111359519|NCT03561584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110145413|NCT02047162|Bismuth|bismuth|mesh-list
111359520|NCT03561584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111359521|NCT00369512|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111359522|NCT00369512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111359523|NCT00369512|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111359524|NCT00369512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111359525|NCT00369512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111359526|NCT00324272|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
111359527|NCT00324272|Hemostatics|hemostatics|mesh-ancestor
111359528|NCT00324272|Coagulants|coagulants|mesh-ancestor
111359529|NCT00369590|Aflibercept|aflibercept|mesh-list
111359530|NCT00369590|Endothelial Growth Factors|endothelial growth factors|mesh-list
111359531|NCT00369590|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111359532|NCT00369590|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111359533|NCT00369590|Growth Substances|growth substances|mesh-ancestor
111359534|NCT00369590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111359535|NCT00369590|Growth Inhibitors|growth inhibitors|mesh-ancestor
111359536|NCT00369590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111359537|NCT03932136|Sulforaphane|sulforaphane|mesh-list
111359538|NCT03932136|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
111359539|NCT03932136|Protective Agents|protective agents|mesh-ancestor
111359540|NCT03932136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111359541|NCT03932136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111359542|NCT00324350|Hypoglycemic Agents|hypoglycemic agents|mesh-list
111359543|NCT00324350|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
111359544|NCT00324350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111359545|NCT00324350|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111359546|NCT00324350|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111359547|NCT00324350|Antimetabolites|antimetabolites|mesh-ancestor
111359548|NCT00324350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110859641|NCT05782127|Venetoclax|venetoclax|mesh-list
111359549|NCT00324350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111359550|NCT00324350|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111359551|NCT00390182|Gemcitabine|gemcitabine|mesh-list
110859704|NCT05638932|Tofacitinib|tofacitinib|mesh-list
111359552|NCT00390182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111359553|NCT00390182|Antimetabolites|antimetabolites|mesh-ancestor
111359554|NCT00390182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111359555|NCT00390182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111359556|NCT05366868|Metformin|metformin|mesh-list
111359557|NCT05366868|Vildagliptin|vildagliptin|mesh-list
111359558|NCT05366868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111359559|NCT05366868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111359560|NCT05366868|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111359561|NCT05366868|Protease Inhibitors|protease inhibitors|mesh-ancestor
111359562|NCT05366868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110859780|NCT05555862|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
111359563|NCT05366868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111359564|NCT05610774|Dexmedetomidine|dexmedetomidine|mesh-list
111359565|NCT05610774|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111359566|NCT05610774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111359567|NCT05610774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111359568|NCT05610774|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111359569|NCT05610774|Analgesics|analgesics|mesh-ancestor
111359570|NCT05610774|Sensory System Agents|sensory system agents|mesh-ancestor
111359571|NCT05610774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111359572|NCT05610774|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111359573|NCT05610774|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111359574|NCT05610774|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111359575|NCT05610774|Adrenergic Agents|adrenergic agents|mesh-ancestor
111359576|NCT05610774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111359577|NCT05610774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111359578|NCT00369746|Citalopram|citalopram|mesh-list
111359579|NCT00369746|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111359580|NCT00369746|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111359581|NCT00369746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111359582|NCT00369746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111359583|NCT00369746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111359584|NCT00369746|Serotonin Agents|serotonin agents|mesh-ancestor
111359585|NCT00369746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111359586|NCT00369746|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111359587|NCT00369746|Antidepressive Agents|antidepressive agents|mesh-ancestor
111359588|NCT00369746|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111359589|NCT00392054|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
111359590|NCT02525874|Dimethyl Fumarate|dimethyl fumarate|mesh-list
111359591|NCT02525874|Dermatologic Agents|dermatologic agents|mesh-ancestor
111359592|NCT02525874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111359593|NCT02525874|Immunologic Factors|immunologic factors|mesh-ancestor
111359594|NCT02525874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111359595|NCT05329428|Vitamin D|vitamin d|mesh-list
111359596|NCT05329428|Ergocalciferols|ergocalciferols|mesh-list
111359597|NCT05329428|Cholecalciferol|cholecalciferol|mesh-list
111359598|NCT05329428|Vitamins|vitamins|mesh-list
111359599|NCT05329428|Micronutrients|micronutrients|mesh-ancestor
111359600|NCT05329428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110147744|NCT00005998|Cytarabine|cytarabine|mesh-list
111359601|NCT05329428|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111359602|NCT05329428|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111359603|NCT01794572|Melphalan|melphalan|mesh-list
111359604|NCT01794572|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110860232|NCT04864743|Factor VIII|factor viii|mesh-list
111359605|NCT01794572|Alkylating Agents|alkylating agents|mesh-ancestor
111359606|NCT01794572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111359607|NCT01794572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111359608|NCT01794572|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110860306|NCT04767061|Antioxidants|antioxidants|mesh-ancestor
111359609|NCT01794572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111359610|NCT01794572|Immunologic Factors|immunologic factors|mesh-ancestor
111359611|NCT01794572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111359612|NCT00392444|Sunitinib|sunitinib|mesh-list
111359613|NCT00392444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111359614|NCT00392444|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111359615|NCT00392444|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111359616|NCT00392444|Growth Substances|growth substances|mesh-ancestor
111359617|NCT00392444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111359618|NCT00392444|Growth Inhibitors|growth inhibitors|mesh-ancestor
111359619|NCT00392444|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111359620|NCT00392444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110860443|NCT04666701|Sensory System Agents|sensory system agents|mesh-ancestor
111359621|NCT00392444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111359622|NCT02528214|Prednisone|prednisone|mesh-list
111359623|NCT02528214|Prednisolone|prednisolone|mesh-list
111359624|NCT02528214|Albuterol|albuterol|mesh-list
111359625|NCT02528214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111359626|NCT02528214|Glucocorticoids|glucocorticoids|mesh-ancestor
111359627|NCT02528214|Hormones|hormones|mesh-ancestor
111359628|NCT02528214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111359629|NCT02528214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111359630|NCT02528214|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111359631|NCT02528214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111359632|NCT02528214|Autonomic Agents|autonomic agents|mesh-ancestor
111359633|NCT02528214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111359634|NCT02528214|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111359635|NCT02528214|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111359636|NCT02528214|Respiratory System Agents|respiratory system agents|mesh-ancestor
111359637|NCT02528214|Tocolytic Agents|tocolytic agents|mesh-ancestor
111359638|NCT02528214|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111359639|NCT02528214|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111359640|NCT02528214|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111359641|NCT02528214|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111359642|NCT02528214|Adrenergic Agents|adrenergic agents|mesh-ancestor
111359643|NCT02528214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111359644|NCT02528214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111359645|NCT00392678|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
111359646|NCT00392678|Sodium Salicylate|sodium salicylate|mesh-list
111359647|NCT00392678|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111359648|NCT00392678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111359649|NCT00392678|Analgesics|analgesics|mesh-ancestor
111359650|NCT00392678|Sensory System Agents|sensory system agents|mesh-ancestor
111359651|NCT00392678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111359652|NCT00392678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111359653|NCT00392678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111359654|NCT00392678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111359655|NCT00392678|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111359656|NCT00392678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111359657|NCT00392678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111359658|NCT05902299|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111359659|NCT05902299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111359660|NCT05902260|Immunomodulating Agents|immunomodulating agents|mesh-list
111359661|NCT05902260|Immunologic Factors|immunologic factors|mesh-ancestor
111359662|NCT05902260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111359663|NCT05902221|Amoxicillin|amoxicillin|mesh-list
111359664|NCT05902221|Moxifloxacin|moxifloxacin|mesh-list
111359665|NCT05902221|Rifampin|rifampin|mesh-list
111359666|NCT05902221|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
111359667|NCT05902221|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111359668|NCT05902221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110860931|NCT03164616|Durvalumab|durvalumab|mesh-list
111359669|NCT05902221|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111359670|NCT05902221|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111359671|NCT05902221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111359672|NCT05902221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110861002|NCT02853305|Carboplatin|carboplatin|mesh-list
111359673|NCT05902221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111359674|NCT05902221|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111359675|NCT05902221|Contraceptive Agents|contraceptive agents|mesh-ancestor
111359676|NCT05902221|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111359677|NCT05902221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110861080|NCT02593175|Paclitaxel|paclitaxel|mesh-list
111359678|NCT05902221|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
111359679|NCT05902221|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110861146|NCT01931033|Oxytocin|oxytocin|mesh-list
111359680|NCT05902221|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111359681|NCT05902221|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111359682|NCT05902221|Antitubercular Agents|antitubercular agents|mesh-ancestor
111359683|NCT05902221|Leprostatic Agents|leprostatic agents|mesh-ancestor
111359684|NCT05902221|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111359685|NCT05902221|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111359686|NCT05902221|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111359687|NCT05902221|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
111359688|NCT05902221|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
111359689|NCT05902221|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
111359690|NCT05902221|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111359691|NCT05902208|Antiviral Agents|antiviral agents|mesh-list
111359692|NCT05902208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111359693|NCT05902169|Carboplatin|carboplatin|mesh-list
111359694|NCT05902169|Temozolomide|temozolomide|mesh-list
111359695|NCT05902169|Lomustine|lomustine|mesh-list
111359696|NCT05902169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111359697|NCT05902169|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111359698|NCT05902169|Alkylating Agents|alkylating agents|mesh-ancestor
110314502|NCT00451412|Anticoagulants|anticoagulants|mesh-ancestor
111359699|NCT05902169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111359700|NCT05902078|Calcitriol|calcitriol|mesh-list
111359701|NCT05902078|Eldecalcitol|eldecalcitol|mesh-list
110861416|NCT00383721|Formoterol Fumarate|formoterol fumarate|mesh-list
111359702|NCT05902078|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111359703|NCT05902078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111359704|NCT05902078|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
111359705|NCT05902078|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111359706|NCT05902078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111359707|NCT05902078|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111359708|NCT05902078|Vitamins|vitamins|mesh-ancestor
111359709|NCT05902078|Micronutrients|micronutrients|mesh-ancestor
111359710|NCT05902078|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111359711|NCT05901935|Capecitabine|capecitabine|mesh-list
111359712|NCT05901935|Trastuzumab|trastuzumab|mesh-list
111359713|NCT05901935|Vinorelbine|vinorelbine|mesh-list
111359714|NCT05901935|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111359715|NCT05901935|Antimetabolites|antimetabolites|mesh-ancestor
111359716|NCT05901935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111359717|NCT05901935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111359718|NCT05901935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111359719|NCT05901935|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111359720|NCT05901935|Tubulin Modulators|tubulin modulators|mesh-ancestor
111359721|NCT05901935|Antimitotic Agents|antimitotic agents|mesh-ancestor
111359722|NCT05901935|Mitosis Modulators|mitosis modulators|mesh-ancestor
111359723|NCT05901766|Micronutrients|micronutrients|mesh-list
111359724|NCT05901766|Trace Elements|trace elements|mesh-list
111359725|NCT05901766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111359726|NCT05901701|Salicylic Acid|salicylic acid|mesh-list
111359727|NCT05901701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111359728|NCT05901701|Antifungal Agents|antifungal agents|mesh-ancestor
111359729|NCT05901701|Keratolytic Agents|keratolytic agents|mesh-ancestor
111359730|NCT05901701|Dermatologic Agents|dermatologic agents|mesh-ancestor
111359731|NCT05901571|Dexetimide|dexetimide|mesh-list
111359732|NCT05901571|Citalopram|citalopram|mesh-list
111359733|NCT05901571|Escitalopram|escitalopram|mesh-list
111359734|NCT05901571|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111359735|NCT05901571|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111359736|NCT05901571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111359737|NCT05901571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110861835|NCT02460016|Ziresovir|ziresovir|mesh-list
111359738|NCT05901571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111359739|NCT05901571|Serotonin Agents|serotonin agents|mesh-ancestor
111359740|NCT05901571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111359741|NCT05901571|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111359742|NCT05901571|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111359743|NCT05901571|Parasympatholytics|parasympatholytics|mesh-ancestor
111359744|NCT05901571|Autonomic Agents|autonomic agents|mesh-ancestor
110861905|NCT02457130|Ticagrelor|ticagrelor|mesh-list
111359745|NCT05901571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111359746|NCT05901571|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111359747|NCT05901571|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111359748|NCT05901571|Cholinergic Agents|cholinergic agents|mesh-ancestor
110320077|NCT00431613|Docetaxel|docetaxel|mesh-list
111359749|NCT05901571|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111359750|NCT05901571|Antidepressive Agents|antidepressive agents|mesh-ancestor
111359751|NCT05901571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111359752|NCT05901454|Vaccines|vaccines|mesh-list
111359753|NCT05901454|Immunologic Factors|immunologic factors|mesh-ancestor
111359754|NCT05901454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111359755|NCT05901441|Sufentanil|sufentanil|mesh-list
111359756|NCT05901441|Hydromorphone|hydromorphone|mesh-list
111359757|NCT05901441|Ropivacaine|ropivacaine|mesh-list
111359758|NCT05901441|Anesthetics, Local|anesthetics, local|mesh-ancestor
111359759|NCT05901441|Anesthetics|anesthetics|mesh-ancestor
111359760|NCT05901441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111359761|NCT05901441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111359762|NCT05901441|Sensory System Agents|sensory system agents|mesh-ancestor
111359763|NCT05901441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111359764|NCT05901441|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111359766|NCT05901441|Analgesics|analgesics|mesh-ancestor
111359767|NCT05901441|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111359768|NCT05901441|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111359769|NCT05901441|Anesthetics, General|anesthetics, general|mesh-ancestor
111359770|NCT05901389|Lidocaine|lidocaine|mesh-list
111359771|NCT05901389|Anesthetics, Local|anesthetics, local|mesh-ancestor
111359772|NCT05901389|Anesthetics|anesthetics|mesh-ancestor
111359773|NCT05901389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111359774|NCT05901389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111359775|NCT05901389|Sensory System Agents|sensory system agents|mesh-ancestor
111359776|NCT05901389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111359777|NCT05901389|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110862095|NCT02875392|Fucoidan|fucoidan|mesh-list
111359778|NCT05901389|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111359779|NCT05901389|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111359780|NCT05901389|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110862147|NCT01362426|Dopamine Agents|dopamine agents|mesh-ancestor
111359781|NCT05901389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111359782|NCT05901194|Lenvatinib|lenvatinib|mesh-list
111359783|NCT05901194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111359784|NCT05901194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111359785|NCT05901194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111359786|NCT05901194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111359787|NCT05901051|Amoxicillin|amoxicillin|mesh-list
110862219|NCT01359930|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111359788|NCT05901051|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111359789|NCT05901051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111359790|NCT05901012|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
111359791|NCT05901012|Hallucinogens|hallucinogens|mesh-ancestor
111359792|NCT05901012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111359793|NCT05901012|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111359794|NCT05901012|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111359795|NCT05901012|Serotonin Agents|serotonin agents|mesh-ancestor
111359796|NCT05901012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111359797|NCT05901012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111359798|NCT05901012|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111359799|NCT05900921|Paclitaxel|paclitaxel|mesh-list
111359800|NCT05900921|Carboplatin|carboplatin|mesh-list
111359801|NCT05900921|Tislelizumab|tislelizumab|mesh-list
111359802|NCT05900921|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111359803|NCT05900921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111359804|NCT05900921|Tubulin Modulators|tubulin modulators|mesh-ancestor
111359805|NCT05900921|Antimitotic Agents|antimitotic agents|mesh-ancestor
111359806|NCT05900921|Mitosis Modulators|mitosis modulators|mesh-ancestor
111359807|NCT05900921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111359808|NCT05900921|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111359809|NCT05900895|Olaparib|olaparib|mesh-list
111359810|NCT05900895|Estradiol|estradiol|mesh-list
110862420|NCT01317225|Hormones|hormones|mesh-ancestor
111359811|NCT05900895|Estrogens|estrogens|mesh-ancestor
111359812|NCT05900895|Hormones|hormones|mesh-ancestor
111359813|NCT05900895|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111359814|NCT05900895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111359815|NCT05900895|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111359816|NCT05900895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110324896|NCT00463359|Interferon Inducers|interferon inducers|mesh-ancestor
111359817|NCT05900895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111359818|NCT05900895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111359819|NCT05899699|Adapalene|adapalene|mesh-list
110862546|NCT02456428|Pioglitazone|pioglitazone|mesh-list
111359820|NCT05899699|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111359821|NCT05899699|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111359822|NCT05899699|Analgesics|analgesics|mesh-ancestor
110862627|NCT01344681|Hormone Antagonists|hormone antagonists|mesh-ancestor
111359823|NCT05899699|Sensory System Agents|sensory system agents|mesh-ancestor
111359824|NCT05899699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111359825|NCT05899699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111359826|NCT05899699|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111359827|NCT05899699|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111359828|NCT05899699|Dermatologic Agents|dermatologic agents|mesh-ancestor
111359829|NCT05899608|Pembrolizumab|pembrolizumab|mesh-list
111359830|NCT05899608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111359831|NCT05899608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111359832|NCT05899608|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111359833|NCT05899608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111359834|NCT05898854|FAPI-46|fapi-46|mesh-list
111359835|NCT05898854|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111359836|NCT05898854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111359838|NCT05897151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111359839|NCT05897151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111359840|NCT05897138|Lenvatinib|lenvatinib|mesh-list
111359841|NCT05897138|Tislelizumab|tislelizumab|mesh-list
111359842|NCT05897138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111359843|NCT05897138|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111359844|NCT05897138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111359845|NCT05897138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111359846|NCT05897138|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111359847|NCT05895162|Fluconazole|fluconazole|mesh-list
111359848|NCT05895162|Antifungal Agents|antifungal agents|mesh-ancestor
111359849|NCT05895162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111359850|NCT05895162|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111359851|NCT05895162|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111359852|NCT05895162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111359853|NCT05895162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111359854|NCT05895162|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111359855|NCT05895162|Hormone Antagonists|hormone antagonists|mesh-ancestor
111359856|NCT05895162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111359857|NCT05895162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111359858|NCT05895162|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111359859|NCT05895162|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111359860|NCT05894603|Ritonavir|ritonavir|mesh-list
111359861|NCT05894603|Nirmatrelvir|nirmatrelvir|mesh-list
111359862|NCT05894603|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
111359863|NCT05894603|Molnupiravir|molnupiravir|mesh-list
111359864|NCT05894603|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111359865|NCT05894603|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111359866|NCT05894603|Protease Inhibitors|protease inhibitors|mesh-ancestor
111359867|NCT05894603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111359868|NCT05894603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111359869|NCT05894603|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111359870|NCT05894603|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111359871|NCT05894603|Antiviral Agents|antiviral agents|mesh-ancestor
111359872|NCT05894603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111359873|NCT05894603|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111359874|NCT05894603|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111359875|NCT05877326|Anesthetics|anesthetics|mesh-list
111359876|NCT05877326|Propofol|propofol|mesh-list
111359877|NCT05877326|Sevoflurane|sevoflurane|mesh-list
110863237|NCT02454712|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111359878|NCT05877326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111359879|NCT05877326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111359880|NCT05877326|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111359881|NCT05877326|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111359882|NCT05877326|Anesthetics, General|anesthetics, general|mesh-ancestor
110863302|NCT01352559|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111359883|NCT05877326|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111359884|NCT05877326|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111359885|NCT05837000|Magnesium Sulfate|magnesium sulfate|mesh-list
111359886|NCT05837000|Dexmedetomidine|dexmedetomidine|mesh-list
111359887|NCT05837000|Ketamine|ketamine|mesh-list
111359888|NCT05837000|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111359889|NCT05837000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111359890|NCT05837000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111359891|NCT05837000|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111359892|NCT05837000|Analgesics|analgesics|mesh-ancestor
111359893|NCT05837000|Sensory System Agents|sensory system agents|mesh-ancestor
111359894|NCT05837000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111359895|NCT05837000|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111359896|NCT05837000|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111359897|NCT05837000|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111359898|NCT05837000|Adrenergic Agents|adrenergic agents|mesh-ancestor
111359899|NCT05837000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111359900|NCT05837000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111359901|NCT05837000|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111359902|NCT05837000|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111359903|NCT05837000|Anesthetics, General|anesthetics, general|mesh-ancestor
111359904|NCT05837000|Anesthetics|anesthetics|mesh-ancestor
111359905|NCT05837000|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111359906|NCT05837000|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111084299|NCT03282643|Protease Inhibitors|protease inhibitors|mesh-ancestor
111359907|NCT05837000|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111359909|NCT05837000|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111359910|NCT05837000|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111359911|NCT05837000|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111359912|NCT05837000|Tocolytic Agents|tocolytic agents|mesh-ancestor
111359913|NCT05837000|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111359914|NCT05834036|Amoxicillin|amoxicillin|mesh-list
111359915|NCT05834036|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111359916|NCT05834036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111359917|NCT05833139|Itraconazole|itraconazole|mesh-list
111359918|NCT05833139|Antifungal Agents|antifungal agents|mesh-ancestor
111359919|NCT05833139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111359920|NCT05833139|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111359921|NCT05833139|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111359922|NCT05833139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111359923|NCT05833139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111359924|NCT05833139|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111359925|NCT05833139|Hormone Antagonists|hormone antagonists|mesh-ancestor
111359926|NCT05833139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111359927|NCT05833139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111359928|NCT05833139|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111359929|NCT05821296|Methamphetamine|methamphetamine|mesh-list
111359930|NCT05821296|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111359931|NCT05821296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111359932|NCT05821296|Sympathomimetics|sympathomimetics|mesh-ancestor
111359933|NCT05821296|Autonomic Agents|autonomic agents|mesh-ancestor
111359934|NCT05821296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111359935|NCT05821296|Dopamine Agents|dopamine agents|mesh-ancestor
111359936|NCT05821296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111359937|NCT05821296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111359938|NCT05821296|Adrenergic Agents|adrenergic agents|mesh-ancestor
111359939|NCT05821296|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111359940|NCT05821296|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111359941|NCT05821296|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111359942|NCT05821296|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111359943|NCT05736861|Ivermectin|ivermectin|mesh-list
111359944|NCT05736861|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111359945|NCT05736861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111359946|NCT05728372|Copper|copper|mesh-list
111359947|NCT05728372|Pembrolizumab|pembrolizumab|mesh-list
111359948|NCT05728372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111359949|NCT05728372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111359950|NCT05728372|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111359951|NCT05728372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110864007|NCT01562483|Dronabinol|dronabinol|mesh-list
111359952|NCT05728372|Trace Elements|trace elements|mesh-ancestor
111359953|NCT05728372|Micronutrients|micronutrients|mesh-ancestor
111359954|NCT05728372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111359955|NCT05707273|Cyclophosphamide|cyclophosphamide|mesh-list
111359956|NCT05707273|Fludarabine|fludarabine|mesh-list
111359957|NCT05707273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111359958|NCT05707273|Immunologic Factors|immunologic factors|mesh-ancestor
111359959|NCT05707273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111359960|NCT05707273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111359961|NCT05707273|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111359962|NCT05707273|Alkylating Agents|alkylating agents|mesh-ancestor
111359963|NCT05707273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111359964|NCT05707273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111359965|NCT05707273|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111359966|NCT05705856|Ustekinumab|ustekinumab|mesh-list
111359967|NCT05705856|Dermatologic Agents|dermatologic agents|mesh-ancestor
111359968|NCT05672173|Cyclophosphamide|cyclophosphamide|mesh-list
111359969|NCT05672173|Nivolumab|nivolumab|mesh-list
111359970|NCT05672173|Fludarabine|fludarabine|mesh-list
111359971|NCT05672173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111359972|NCT05672173|Immunologic Factors|immunologic factors|mesh-ancestor
111359973|NCT05672173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111359974|NCT05672173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111359975|NCT05672173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111359976|NCT05672173|Alkylating Agents|alkylating agents|mesh-ancestor
111359977|NCT05672173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111359978|NCT05672173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110864247|NCT03225352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111359979|NCT05672173|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111359980|NCT05672173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111359981|NCT05672173|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111359982|NCT05661643|Temozolomide|temozolomide|mesh-list
111359983|NCT05661643|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111359984|NCT05661643|Alkylating Agents|alkylating agents|mesh-ancestor
111359985|NCT05661643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111359986|NCT05661643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111359987|NCT05659056|Paclitaxel|paclitaxel|mesh-list
111359988|NCT05659056|Trastuzumab|trastuzumab|mesh-list
111359989|NCT05659056|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111359990|NCT05659056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111359991|NCT05659056|Tubulin Modulators|tubulin modulators|mesh-ancestor
111359992|NCT05659056|Antimitotic Agents|antimitotic agents|mesh-ancestor
111359993|NCT05659056|Mitosis Modulators|mitosis modulators|mesh-ancestor
110864391|NCT03747341|Anesthetics, General|anesthetics, general|mesh-ancestor
111359994|NCT05659056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111359995|NCT05659056|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111359996|NCT05654649|Dexamethasone|dexamethasone|mesh-list
111359997|NCT05654649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111359998|NCT05654649|Antiemetics|antiemetics|mesh-ancestor
111359999|NCT05654649|Autonomic Agents|autonomic agents|mesh-ancestor
111360000|NCT05654649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111360001|NCT05654649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111360002|NCT05654649|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111360003|NCT05654649|Glucocorticoids|glucocorticoids|mesh-ancestor
111360004|NCT05654649|Hormones|hormones|mesh-ancestor
111360005|NCT05654649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111360006|NCT05654649|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111360007|NCT05654649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111360008|NCT05649748|Treprostinil|treprostinil|mesh-list
111360009|NCT05649748|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111360010|NCT05629234|Osimertinib|osimertinib|mesh-list
111360011|NCT05629234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111360012|NCT05629234|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111360013|NCT05629234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111360014|NCT05629234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111360015|NCT05567315|Anesthetics|anesthetics|mesh-list
111360016|NCT05567315|Anesthetics, Local|anesthetics, local|mesh-list
111360017|NCT05567315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111360018|NCT05567315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111360019|NCT05567315|Sensory System Agents|sensory system agents|mesh-ancestor
111360020|NCT05567315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110339122|NCT02946060|TEMPO|tempo|mesh-list
111360021|NCT05547386|Edetic Acid|edetic acid|mesh-list
111360022|NCT05547386|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
111360023|NCT05547386|Chelating Agents|chelating agents|mesh-ancestor
111360024|NCT05547386|Sequestering Agents|sequestering agents|mesh-ancestor
111360025|NCT05547386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111360026|NCT05547386|Anticoagulants|anticoagulants|mesh-ancestor
111360027|NCT05547386|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
111360028|NCT05547386|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111360029|NCT05519111|Dronabinol|dronabinol|mesh-list
111360030|NCT05519111|Hallucinogens|hallucinogens|mesh-ancestor
111360031|NCT05519111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111360032|NCT05519111|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111360033|NCT05519111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111360034|NCT05519111|Analgesics|analgesics|mesh-ancestor
111360035|NCT05519111|Sensory System Agents|sensory system agents|mesh-ancestor
111360036|NCT05519111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111360037|NCT05519111|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
111360038|NCT05519111|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
111360039|NCT05519111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111360040|NCT05519111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111360041|NCT05519111|Hormones|hormones|mesh-ancestor
111360042|NCT05519111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111360043|NCT05463133|Sirolimus|sirolimus|mesh-list
111360044|NCT05463133|Cyclophosphamide|cyclophosphamide|mesh-list
111360045|NCT05463133|Busulfan|busulfan|mesh-list
111360046|NCT05463133|Alemtuzumab|alemtuzumab|mesh-list
111360047|NCT05463133|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111360048|NCT05463133|Immunologic Factors|immunologic factors|mesh-ancestor
111360049|NCT05463133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111360050|NCT05463133|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111360051|NCT05463133|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111360052|NCT05463133|Alkylating Agents|alkylating agents|mesh-ancestor
111479265|NCT05091346|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111084448|NCT03364829|Glycopyrrolate|glycopyrrolate|mesh-list
111360053|NCT05463133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111360055|NCT05463133|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111360056|NCT05463133|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111360057|NCT05463133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111360058|NCT05463133|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111360059|NCT05463133|Antifungal Agents|antifungal agents|mesh-ancestor
111360060|NCT05463133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111360061|NCT05427474|Propranolol|propranolol|mesh-list
111360062|NCT05427474|Gabapentin|gabapentin|mesh-list
111360063|NCT05427474|Analgesics|analgesics|mesh-ancestor
111360064|NCT05427474|Sensory System Agents|sensory system agents|mesh-ancestor
111360065|NCT05427474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111360066|NCT05427474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111360067|NCT05427474|Anticonvulsants|anticonvulsants|mesh-ancestor
111360068|NCT05427474|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111360069|NCT05427474|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111360070|NCT05427474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111360071|NCT05427474|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111360072|NCT05427474|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111360073|NCT05427474|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111360074|NCT05427474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111360075|NCT05427474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111360076|NCT05427474|Antimanic Agents|antimanic agents|mesh-ancestor
111360077|NCT05427474|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111360078|NCT05427474|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111360079|NCT05427474|Adrenergic Agents|adrenergic agents|mesh-ancestor
111360080|NCT05427474|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111360081|NCT05427474|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111360082|NCT05427474|Vasodilator Agents|vasodilator agents|mesh-ancestor
111360083|NCT05418647|Dialysis Solutions|dialysis solutions|mesh-list
111360084|NCT05418647|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111360085|NCT05340673|Petrolatum|petrolatum|mesh-list
111360086|NCT05340673|Mineral Oil|mineral oil|mesh-list
111360087|NCT05340673|Emollients|emollients|mesh-ancestor
111360088|NCT05340673|Dermatologic Agents|dermatologic agents|mesh-ancestor
111360089|NCT05320406|Leuprolide|leuprolide|mesh-list
111360090|NCT05320406|Relugolix|relugolix|mesh-list
111360091|NCT05320406|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111360092|NCT05320406|Fertility Agents|fertility agents|mesh-ancestor
111360093|NCT05320406|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111360094|NCT05320406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111360095|NCT05320406|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111360096|NCT05320406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111360097|NCT05320406|Androgen Antagonists|androgen antagonists|mesh-ancestor
111360098|NCT05320406|Hormone Antagonists|hormone antagonists|mesh-ancestor
111360099|NCT05320406|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111360100|NCT05312151|Psilocybin|psilocybin|mesh-list
111360101|NCT05312151|Hallucinogens|hallucinogens|mesh-ancestor
110865394|NCT04844528|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111360102|NCT05312151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111360103|NCT05312151|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111360104|NCT05307198|Capecitabine|capecitabine|mesh-list
111360105|NCT05307198|Oxaliplatin|oxaliplatin|mesh-list
111360106|NCT05307198|Antibodies|antibodies|mesh-list
110344927|NCT05485805|Naproxen|naproxen|mesh-list
111360107|NCT05307198|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111360108|NCT05307198|Immunologic Factors|immunologic factors|mesh-ancestor
111360109|NCT05307198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111360110|NCT05307198|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111360111|NCT05307198|Antimetabolites|antimetabolites|mesh-ancestor
111360112|NCT05307198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111360113|NCT05307198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111360114|NCT05299073|Denosumab|denosumab|mesh-list
111360115|NCT05299073|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111360116|NCT05299073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111360117|NCT05221398|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
111360118|NCT05221398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110865579|NCT02448784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111360119|NCT05221398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111360120|NCT05221398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111360121|NCT05213221|Lenvatinib|lenvatinib|mesh-list
111360122|NCT05213221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111360123|NCT05213221|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111360124|NCT05213221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111360125|NCT05213221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111360126|NCT05213208|Propofol|propofol|mesh-list
111360127|NCT05213208|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111360128|NCT05213208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111360129|NCT05213208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111360130|NCT05213208|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111360131|NCT05213208|Anesthetics, General|anesthetics, general|mesh-ancestor
111360132|NCT05213208|Anesthetics|anesthetics|mesh-ancestor
111360133|NCT05212337|Denosumab|denosumab|mesh-list
111360134|NCT05212337|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111360135|NCT05212337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111360136|NCT05123040|Prednisone|prednisone|mesh-list
111360137|NCT05123040|Methylprednisolone|methylprednisolone|mesh-list
110865654|NCT03195634|Antioxidants|antioxidants|mesh-ancestor
111360138|NCT05123040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111360139|NCT05123040|Glucocorticoids|glucocorticoids|mesh-ancestor
111360140|NCT05123040|Hormones|hormones|mesh-ancestor
111360141|NCT05123040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111360142|NCT05123040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111360143|NCT05123040|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111360144|NCT05123040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111360145|NCT05123040|Antiemetics|antiemetics|mesh-ancestor
111360146|NCT05123040|Autonomic Agents|autonomic agents|mesh-ancestor
111360147|NCT05123040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111360148|NCT05123040|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111360149|NCT05123040|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111360150|NCT05123040|Protective Agents|protective agents|mesh-ancestor
111360151|NCT05096702|Primaquine|primaquine|mesh-list
111360152|NCT05096702|Tafenoquine|tafenoquine|mesh-list
111360153|NCT05096702|Antimalarials|antimalarials|mesh-ancestor
111360154|NCT05096702|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111360155|NCT05096702|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111360156|NCT05096702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111360157|NCT05017454|Mometasone Furoate|mometasone furoate|mesh-list
111360158|NCT05017454|Valproic Acid|valproic acid|mesh-list
111360159|NCT05017454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111360160|NCT05017454|Dermatologic Agents|dermatologic agents|mesh-ancestor
111360161|NCT05017454|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111360162|NCT05017454|Anticonvulsants|anticonvulsants|mesh-ancestor
111360163|NCT05017454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110865901|NCT03700814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111360164|NCT05017454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111360165|NCT05017454|GABA Agents|gaba agents|mesh-ancestor
111360166|NCT05017454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111360167|NCT05017454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111360168|NCT05017454|Antimanic Agents|antimanic agents|mesh-ancestor
111360169|NCT05017454|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111360170|NCT05017454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111360171|NCT05017454|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111360172|NCT05013424|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111360173|NCT05013424|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111360174|NCT05013424|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111360175|NCT05013424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111360176|NCT05013424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111360177|NCT05013424|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111360178|NCT05013424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111360179|NCT05013424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111360180|NCT05013424|Cholinergic Agents|cholinergic agents|mesh-ancestor
111360181|NCT05013424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111360182|NCT04999215|Choline|choline|mesh-list
111360183|NCT04999215|Lipotropic Agents|lipotropic agents|mesh-ancestor
111360184|NCT04999215|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111360185|NCT04999215|Antimetabolites|antimetabolites|mesh-ancestor
111360186|NCT04999215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111360187|NCT04999215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111360188|NCT04999215|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111360189|NCT04999215|Nootropic Agents|nootropic agents|mesh-ancestor
111360190|NCT04991025|Certolizumab Pegol|certolizumab pegol|mesh-list
111360191|NCT04991025|Carboplatin|carboplatin|mesh-list
111360192|NCT04991025|Gemcitabine|gemcitabine|mesh-list
111360193|NCT04991025|Nivolumab|nivolumab|mesh-list
111360194|NCT04991025|Pemetrexed|pemetrexed|mesh-list
111360195|NCT04991025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111360196|NCT04991025|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111360197|NCT04991025|Antimetabolites|antimetabolites|mesh-ancestor
111360198|NCT04991025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111360199|NCT04991025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111084598|NCT03264079|Itraconazole|itraconazole|mesh-list
111360200|NCT04991025|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111360201|NCT04991025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111360202|NCT04991025|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111360203|NCT04991025|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111360204|NCT04991025|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111360205|NCT04991025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110866294|NCT05160090|Bupropion|bupropion|mesh-list
111360206|NCT04991025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111360207|NCT04991025|Immunologic Factors|immunologic factors|mesh-ancestor
111360208|NCT04991025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111360209|NCT04991025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111360210|NCT04935658|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
111360211|NCT04935658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111360212|NCT04935658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111360213|NCT04930315|Apatinib|apatinib|mesh-list
111360214|NCT04930315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111360215|NCT04930315|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110866398|NCT02430298|Melatonin|melatonin|mesh-list
111360216|NCT04930315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111360217|NCT04930315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111360218|NCT04887857|Azacitidine|azacitidine|mesh-list
111360219|NCT04887857|Venetoclax|venetoclax|mesh-list
111360220|NCT04887857|Cc-486|cc-486|mesh-list
111360221|NCT04887857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111360222|NCT04887857|Antimetabolites|antimetabolites|mesh-ancestor
111360223|NCT04887857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111360224|NCT04887857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111360225|NCT04887857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111360226|NCT04855266|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
111360227|NCT04855266|Hematinics|hematinics|mesh-ancestor
111360228|NCT04832399|Natalizumab|natalizumab|mesh-list
111360229|NCT04832399|Immunologic Factors|immunologic factors|mesh-ancestor
111360230|NCT04832399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111360231|NCT04772209|Heparin|heparin|mesh-list
111360232|NCT04772209|Anticoagulants|anticoagulants|mesh-ancestor
111360233|NCT04772209|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111360234|NCT04772209|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110866603|NCT03715699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111360235|NCT04772209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111360236|NCT04757662|Tadalafil|tadalafil|mesh-list
111360237|NCT04757662|Vasodilator Agents|vasodilator agents|mesh-ancestor
111360238|NCT04757662|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111360239|NCT04757662|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111360240|NCT04757662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111360241|NCT04757662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111360242|NCT04757662|Urological Agents|urological agents|mesh-ancestor
111360243|NCT04756050|Epinephrine|epinephrine|mesh-list
111360244|NCT04756050|Racepinephrine|racepinephrine|mesh-list
111360245|NCT04756050|Bupivacaine|bupivacaine|mesh-list
111360246|NCT04756050|Prilocaine|prilocaine|mesh-list
111360247|NCT04756050|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111360248|NCT04756050|Epinephryl borate|epinephryl borate|mesh-list
111360249|NCT04756050|Anesthetics, Local|anesthetics, local|mesh-ancestor
111360250|NCT04756050|Anesthetics|anesthetics|mesh-ancestor
110866735|NCT02429518|Miltefosine|miltefosine|mesh-list
111360251|NCT04756050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111360252|NCT04756050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111360253|NCT04756050|Sensory System Agents|sensory system agents|mesh-ancestor
111360254|NCT04756050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111360255|NCT04756050|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111360256|NCT04756050|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111360257|NCT04756050|Adrenergic Agents|adrenergic agents|mesh-ancestor
111360258|NCT04756050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111360259|NCT04756050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111360260|NCT04756050|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111360261|NCT04756050|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111360262|NCT04756050|Autonomic Agents|autonomic agents|mesh-ancestor
111360263|NCT04756050|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111360264|NCT04756050|Respiratory System Agents|respiratory system agents|mesh-ancestor
111360265|NCT04756050|Mydriatics|mydriatics|mesh-ancestor
111360266|NCT04756050|Sympathomimetics|sympathomimetics|mesh-ancestor
111360267|NCT04756050|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111360268|NCT04731103|Lamivudine|lamivudine|mesh-list
111360269|NCT04731103|Zidovudine|zidovudine|mesh-list
111360270|NCT04731103|Abacavir|abacavir|mesh-list
111360271|NCT04731103|Dideoxynucleosides|dideoxynucleosides|mesh-list
111360272|NCT04731103|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111360273|NCT04731103|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111360274|NCT04731103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111360275|NCT04731103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111360276|NCT04731103|Antiviral Agents|antiviral agents|mesh-ancestor
111360277|NCT04731103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111360278|NCT04731103|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111360279|NCT04731103|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111360280|NCT04731103|Antimetabolites|antimetabolites|mesh-ancestor
110347430|NCT03909334|Osimertinib|osimertinib|mesh-list
111360282|NCT04716712|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111360283|NCT04716712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111360284|NCT04683640|gamma-Aminobutyric Acid|gamma-aminobutyric acid|mesh-list
111360285|NCT04683640|GABA Agents|gaba agents|mesh-ancestor
111360286|NCT04683640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111360287|NCT04683640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111360288|NCT04683640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111360289|NCT04680221|Bupivacaine|bupivacaine|mesh-list
111360290|NCT04680221|Anesthetics, Local|anesthetics, local|mesh-ancestor
111360291|NCT04680221|Anesthetics|anesthetics|mesh-ancestor
111360292|NCT04680221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111360293|NCT04680221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111360294|NCT04680221|Sensory System Agents|sensory system agents|mesh-ancestor
110866844|NCT03694886|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111360295|NCT04680221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111360296|NCT04668144|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
111360297|NCT04668144|Cangrelor|cangrelor|mesh-list
110348398|NCT02864394|Docetaxel|docetaxel|mesh-list
111360298|NCT04668144|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111360299|NCT04668144|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111360300|NCT04668144|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111360301|NCT04668144|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111360302|NCT04668144|Purinergic Agents|purinergic agents|mesh-ancestor
111360303|NCT04668144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111360304|NCT04668144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111360305|NCT04668144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111360306|NCT04667078|Cangrelor|cangrelor|mesh-list
111360307|NCT04667078|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110866968|NCT02428972|Anesthetics, General|anesthetics, general|mesh-ancestor
111360308|NCT04667078|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111360309|NCT04667078|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111360310|NCT04667078|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111360311|NCT04667078|Purinergic Agents|purinergic agents|mesh-ancestor
111360312|NCT04667078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111360313|NCT04667078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111360314|NCT04667078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111360315|NCT04644796|Bupivacaine|bupivacaine|mesh-list
111360316|NCT04644796|Anesthetics, Local|anesthetics, local|mesh-ancestor
111360317|NCT04644796|Anesthetics|anesthetics|mesh-ancestor
111360318|NCT04644796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111360319|NCT04644796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111360320|NCT04644796|Sensory System Agents|sensory system agents|mesh-ancestor
111360321|NCT04644796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111360322|NCT04639414|Empagliflozin|empagliflozin|mesh-list
110867098|NCT03689114|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111360323|NCT04639414|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111360324|NCT04639414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111360325|NCT04639414|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111360326|NCT04639414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111360327|NCT04621929|Topiramate|topiramate|mesh-list
111360328|NCT04621929|Phentermine|phentermine|mesh-list
111360329|NCT04621929|Allopurinol|allopurinol|mesh-list
111360330|NCT04621929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111360331|NCT04621929|Anticonvulsants|anticonvulsants|mesh-ancestor
111360332|NCT04621929|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111360333|NCT04621929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111360334|NCT04621929|Antimetabolites|antimetabolites|mesh-ancestor
111360335|NCT04621929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111360336|NCT04621929|Gout Suppressants|gout suppressants|mesh-ancestor
111360337|NCT04621929|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111360338|NCT04621929|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111360339|NCT04621929|Antioxidants|antioxidants|mesh-ancestor
111360340|NCT04621929|Protective Agents|protective agents|mesh-ancestor
111360341|NCT04621929|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111360342|NCT04621929|Appetite Depressants|appetite depressants|mesh-ancestor
111360343|NCT04621929|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111360344|NCT04621929|Sympathomimetics|sympathomimetics|mesh-ancestor
111360345|NCT04621929|Autonomic Agents|autonomic agents|mesh-ancestor
111360346|NCT04621929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111360347|NCT04621929|Adrenergic Agents|adrenergic agents|mesh-ancestor
111360348|NCT04621929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111360349|NCT04572763|Venetoclax|venetoclax|mesh-list
111360350|NCT04572763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111360351|NCT04568161|Cyclophosphamide|cyclophosphamide|mesh-list
111360352|NCT04568161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111360353|NCT04568161|Immunologic Factors|immunologic factors|mesh-ancestor
111360354|NCT04568161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111360355|NCT04568161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111360356|NCT04568161|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110867507|NCT02877927|Linezolid|linezolid|mesh-list
111360357|NCT04568161|Alkylating Agents|alkylating agents|mesh-ancestor
111360358|NCT04568161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111360359|NCT04568161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111360360|NCT04568161|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111360361|NCT04556370|Norepinephrine|norepinephrine|mesh-list
111360362|NCT04556370|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111360363|NCT04556370|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110867580|NCT01442649|Antidotes|antidotes|mesh-ancestor
111360364|NCT04556370|Adrenergic Agents|adrenergic agents|mesh-ancestor
111360365|NCT04556370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111360366|NCT04556370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111360367|NCT04556370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111360368|NCT04556370|Sympathomimetics|sympathomimetics|mesh-ancestor
111360369|NCT04556370|Autonomic Agents|autonomic agents|mesh-ancestor
111360370|NCT04556370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111360371|NCT04556370|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111360372|NCT04535882|polysaccharide-K|polysaccharide-k|mesh-list
111360373|NCT04535882|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111360374|NCT04535882|Immunologic Factors|immunologic factors|mesh-ancestor
111360375|NCT04535882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111360376|NCT04535882|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111360377|NCT04535882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111360378|NCT04535882|Antiviral Agents|antiviral agents|mesh-ancestor
111360379|NCT04535882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111360380|NCT04535882|Interferon Inducers|interferon inducers|mesh-ancestor
111360381|NCT04535882|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111360382|NCT04535882|Protective Agents|protective agents|mesh-ancestor
111360383|NCT04535687|Fluzoparib|fluzoparib|mesh-list
111360384|NCT04535687|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111360385|NCT04535687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111360386|NCT04535687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111360387|NCT04535687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111360388|NCT04527887|Dexamethasone|dexamethasone|mesh-list
111360389|NCT04527887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111360390|NCT04527887|Antiemetics|antiemetics|mesh-ancestor
111360391|NCT04527887|Autonomic Agents|autonomic agents|mesh-ancestor
111360392|NCT04527887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111360393|NCT04527887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111360394|NCT04527887|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110867926|NCT01361997|Ethanol|ethanol|mesh-list
111360395|NCT04527887|Glucocorticoids|glucocorticoids|mesh-ancestor
111360396|NCT04527887|Hormones|hormones|mesh-ancestor
111360397|NCT04527887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111360398|NCT04527887|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111360399|NCT04527887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111360400|NCT04474847|Abatacept|abatacept|mesh-list
111360401|NCT04474847|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110585495|NCT00753506|Artemisinins|artemisinins|mesh-list
111360402|NCT04474847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111360403|NCT04474847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111360404|NCT04474847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111360405|NCT04474847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111360406|NCT04474847|Immunologic Factors|immunologic factors|mesh-ancestor
111360407|NCT04474847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111360408|NCT04474847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111360409|NCT04436926|Analgesics, Opioid|analgesics, opioid|mesh-list
111360410|NCT04436926|Narcotics|narcotics|mesh-ancestor
111360411|NCT04436926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111360412|NCT04436926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111360413|NCT04436926|Analgesics|analgesics|mesh-ancestor
111360414|NCT04436926|Sensory System Agents|sensory system agents|mesh-ancestor
111360415|NCT04436926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111360416|NCT04423055|Contraceptive Agents|contraceptive agents|mesh-list
111360417|NCT04423055|Etonogestrel|etonogestrel|mesh-list
111360418|NCT04423055|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111360419|NCT04423055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111360420|NCT04423055|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111360421|NCT04423055|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111360422|NCT04418401|Antibodies|antibodies|mesh-list
111360423|NCT04418401|Immunologic Factors|immunologic factors|mesh-ancestor
111360424|NCT04418401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111360425|NCT04407754|Inositol|inositol|mesh-list
111360426|NCT04407754|Vitamin B Complex|vitamin b complex|mesh-ancestor
111360427|NCT04407754|Vitamins|vitamins|mesh-ancestor
111360428|NCT04407754|Micronutrients|micronutrients|mesh-ancestor
111360429|NCT04407754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111360430|NCT04385602|Dexmedetomidine|dexmedetomidine|mesh-list
111360431|NCT04385602|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111360432|NCT04385602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111360433|NCT04385602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111360434|NCT04385602|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111360435|NCT04385602|Analgesics|analgesics|mesh-ancestor
111360436|NCT04385602|Sensory System Agents|sensory system agents|mesh-ancestor
111360437|NCT04385602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111360438|NCT04385602|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111360439|NCT04385602|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111360440|NCT04385602|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111360441|NCT04385602|Adrenergic Agents|adrenergic agents|mesh-ancestor
111360442|NCT04385602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111360443|NCT04385602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111360444|NCT04379713|Vaccines|vaccines|mesh-list
110868251|NCT02930343|Hydroxychloroquine|hydroxychloroquine|mesh-list
111360445|NCT04379713|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
111360446|NCT04379713|Immunologic Factors|immunologic factors|mesh-ancestor
111360447|NCT04379713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111360448|NCT04323280|Dexamethasone|dexamethasone|mesh-list
111360449|NCT04323280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111360450|NCT04323280|Antiemetics|antiemetics|mesh-ancestor
111360451|NCT04323280|Autonomic Agents|autonomic agents|mesh-ancestor
111360452|NCT04323280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111360453|NCT04323280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111360454|NCT04323280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111360455|NCT04323280|Glucocorticoids|glucocorticoids|mesh-ancestor
111360456|NCT04323280|Hormones|hormones|mesh-ancestor
111360457|NCT04323280|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110358418|NCT05941897|Durvalumab|durvalumab|mesh-list
111360458|NCT04323280|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111360459|NCT04323280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111360460|NCT04218773|Phenylephrine|phenylephrine|mesh-list
111360461|NCT04218773|Oxymetazoline|oxymetazoline|mesh-list
111360462|NCT04218773|Norepinephrine|norepinephrine|mesh-list
111360463|NCT04218773|Synephrine|synephrine|mesh-list
111360464|NCT04218773|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111360465|NCT04218773|Mydriatics|mydriatics|mesh-ancestor
111360466|NCT04218773|Autonomic Agents|autonomic agents|mesh-ancestor
111360467|NCT04218773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111360468|NCT04218773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111360469|NCT04218773|Sympathomimetics|sympathomimetics|mesh-ancestor
111360470|NCT04218773|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111360471|NCT04218773|Nasal Decongestants|nasal decongestants|mesh-ancestor
111360472|NCT04218773|Respiratory System Agents|respiratory system agents|mesh-ancestor
111360473|NCT04218773|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111360474|NCT04218773|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111360475|NCT04218773|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110868365|NCT03633552|Temozolomide|temozolomide|mesh-list
111360476|NCT04218773|Adrenergic Agents|adrenergic agents|mesh-ancestor
111360477|NCT04218773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111360478|NCT04218773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111360479|NCT04218773|Protective Agents|protective agents|mesh-ancestor
111360480|NCT04217447|Aspirin|aspirin|mesh-list
111360481|NCT04217447|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111360482|NCT04217447|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111360483|NCT04217447|Analgesics|analgesics|mesh-ancestor
111360484|NCT04217447|Sensory System Agents|sensory system agents|mesh-ancestor
111360485|NCT04217447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111360486|NCT04217447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111360487|NCT04217447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111360488|NCT04217447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111360489|NCT04217447|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111360490|NCT04217447|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111360491|NCT04217447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111360492|NCT04217447|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111360493|NCT04217447|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111360494|NCT04217447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111360495|NCT04217447|Antipyretics|antipyretics|mesh-ancestor
111360496|NCT04126031|Ceftazidime|ceftazidime|mesh-list
111360497|NCT04126031|Avibactam|avibactam|mesh-list
111360498|NCT04126031|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
111360499|NCT04126031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111360500|NCT04126031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111360501|NCT04126031|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
111360502|NCT04126031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111360503|NCT04126031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111360504|NCT04100824|Nimodipine|nimodipine|mesh-list
111360505|NCT04100824|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111360506|NCT04100824|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111360507|NCT04100824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111360508|NCT04100824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111360509|NCT04100824|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111360510|NCT04100824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111360511|NCT04100824|Vasodilator Agents|vasodilator agents|mesh-ancestor
111360512|NCT04088851|Metformin|metformin|mesh-list
111360513|NCT04088851|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111360514|NCT04088851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111360515|NCT04074265|Ketorolac|ketorolac|mesh-list
111360516|NCT04074265|Epinephrine|epinephrine|mesh-list
111360517|NCT04074265|Ropivacaine|ropivacaine|mesh-list
111360518|NCT04074265|Anesthetics, Local|anesthetics, local|mesh-ancestor
111360519|NCT04074265|Anesthetics|anesthetics|mesh-ancestor
111360520|NCT04074265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111360521|NCT04074265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111360522|NCT04074265|Sensory System Agents|sensory system agents|mesh-ancestor
111360523|NCT04074265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111360524|NCT04074265|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111360525|NCT04074265|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111360526|NCT04074265|Adrenergic Agents|adrenergic agents|mesh-ancestor
110868809|NCT02416258|Betamethasone|betamethasone|mesh-list
111360527|NCT04074265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111360528|NCT04074265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111360529|NCT04074265|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111360530|NCT04074265|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111360531|NCT04074265|Autonomic Agents|autonomic agents|mesh-ancestor
111360532|NCT04074265|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111360533|NCT04074265|Respiratory System Agents|respiratory system agents|mesh-ancestor
111360534|NCT04074265|Mydriatics|mydriatics|mesh-ancestor
111360535|NCT04074265|Sympathomimetics|sympathomimetics|mesh-ancestor
111360536|NCT04074265|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111360537|NCT04074265|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111360538|NCT04074265|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111360539|NCT04074265|Analgesics|analgesics|mesh-ancestor
111360540|NCT04074265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111360541|NCT04074265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111360542|NCT04074265|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111360543|NCT04074265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111360544|NCT04058067|Aflibercept|aflibercept|mesh-list
111360545|NCT04058067|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110869012|NCT04039503|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111360546|NCT04058067|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111360547|NCT04058067|Growth Substances|growth substances|mesh-ancestor
111360548|NCT04058067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111360549|NCT04058067|Growth Inhibitors|growth inhibitors|mesh-ancestor
111360550|NCT04058067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111360551|NCT03998735|Lobeline|lobeline|mesh-list
111360552|NCT03998735|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111360553|NCT03998735|Autonomic Agents|autonomic agents|mesh-ancestor
111360554|NCT03998735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111360555|NCT03998735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111360556|NCT03998735|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111360557|NCT03998735|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111360558|NCT03998735|Cholinergic Agents|cholinergic agents|mesh-ancestor
111360559|NCT03998735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111360560|NCT03998735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111360561|NCT03998735|Respiratory System Agents|respiratory system agents|mesh-ancestor
111360562|NCT03993327|Iodine|iodine|mesh-list
111360563|NCT03993327|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111360564|NCT03993327|Antibodies|antibodies|mesh-list
111360565|NCT03993327|Immunoglobulins|immunoglobulins|mesh-list
111360566|NCT03993327|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111360567|NCT03993327|Immunologic Factors|immunologic factors|mesh-ancestor
111360568|NCT03993327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111360569|NCT03993327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111360570|NCT03993327|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111360571|NCT03993327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111360572|NCT03993327|Trace Elements|trace elements|mesh-ancestor
111360573|NCT03993327|Micronutrients|micronutrients|mesh-ancestor
111360574|NCT03983057|Antibodies|antibodies|mesh-list
111360575|NCT03983057|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111360576|NCT03983057|Immunologic Factors|immunologic factors|mesh-ancestor
111360577|NCT03983057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111360578|NCT03802799|Cannabidiol|cannabidiol|mesh-list
111084972|NCT03258931|Cytarabine|cytarabine|mesh-list
111360579|NCT03802799|Anticonvulsants|anticonvulsants|mesh-ancestor
111360580|NCT03789110|Nivolumab|nivolumab|mesh-list
111360582|NCT03789110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111360583|NCT03789110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111360584|NCT03789110|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111360585|NCT03789110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111360586|NCT03759028|Acetaminophen|acetaminophen|mesh-list
111360587|NCT03759028|Ibuprofen|ibuprofen|mesh-list
111360588|NCT03759028|Oxycodone|oxycodone|mesh-list
111360589|NCT03759028|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111360590|NCT03759028|Analgesics|analgesics|mesh-ancestor
111360591|NCT03759028|Sensory System Agents|sensory system agents|mesh-ancestor
110869493|NCT02407600|Fosaprepitant|fosaprepitant|mesh-list
111360592|NCT03759028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111360593|NCT03759028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111360594|NCT03759028|Antipyretics|antipyretics|mesh-ancestor
111360595|NCT03759028|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111360596|NCT03759028|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111360597|NCT03759028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111360598|NCT03759028|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111360599|NCT03759028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111360600|NCT03759028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111360601|NCT03759028|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111360602|NCT03759028|Narcotics|narcotics|mesh-ancestor
110869630|NCT03665441|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111360603|NCT03759028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111360604|NCT03716921|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111360605|NCT03716921|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
111360606|NCT03716921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111360607|NCT03716921|Antitubercular Agents|antitubercular agents|mesh-ancestor
111360608|NCT03693560|Metformin|metformin|mesh-list
111360609|NCT03693560|Glimepiride|glimepiride|mesh-list
111360610|NCT03693560|Vildagliptin|vildagliptin|mesh-list
111360611|NCT03693560|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111360612|NCT03693560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111360613|NCT03693560|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111360614|NCT03693560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111360615|NCT03693560|Immunologic Factors|immunologic factors|mesh-ancestor
111360616|NCT03693560|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110587304|NCT00713739|Prazosin|prazosin|mesh-list
111360617|NCT03693560|Protease Inhibitors|protease inhibitors|mesh-ancestor
111360618|NCT03693560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111360619|NCT03693560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111360620|NCT03675893|Metformin|metformin|mesh-list
111360621|NCT03675893|Letrozole|letrozole|mesh-list
111360622|NCT03675893|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111360623|NCT03675893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111360624|NCT03675893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111360625|NCT03675893|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111360626|NCT03675893|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111360627|NCT03675893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111360628|NCT03675893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111360629|NCT03675893|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111360630|NCT03675893|Hormone Antagonists|hormone antagonists|mesh-ancestor
111360631|NCT03675893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111360632|NCT03624062|Insulin|insulin|mesh-list
111360633|NCT03624062|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111360634|NCT03624062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111360635|NCT03574090|Amoxicillin|amoxicillin|mesh-list
111360636|NCT03574090|Clavulanic Acid|clavulanic acid|mesh-list
111360637|NCT03574090|Clavulanic Acids|clavulanic acids|mesh-list
111360638|NCT03574090|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
111360639|NCT03574090|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111360640|NCT03574090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111360641|NCT03574090|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
111360642|NCT03574090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111360643|NCT03574090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111360644|NCT03429543|Empagliflozin|empagliflozin|mesh-list
111360645|NCT03429543|Linagliptin|linagliptin|mesh-list
111360646|NCT03429543|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111360647|NCT03429543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111360648|NCT03429543|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111360649|NCT03429543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111360650|NCT03429543|Incretins|incretins|mesh-ancestor
111360651|NCT03429543|Hormones|hormones|mesh-ancestor
111360652|NCT03429543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111360653|NCT03429543|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111360654|NCT03429543|Protease Inhibitors|protease inhibitors|mesh-ancestor
111360655|NCT03429543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111360656|NCT03417544|Trastuzumab|trastuzumab|mesh-list
111360657|NCT03417544|Atezolizumab|atezolizumab|mesh-list
111360658|NCT03417544|Pertuzumab|pertuzumab|mesh-list
111360659|NCT03417544|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111360660|NCT03417544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111360661|NCT03417544|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111360662|NCT03417544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111360663|NCT03363464|Empagliflozin|empagliflozin|mesh-list
111360664|NCT03363464|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
111360665|NCT03363464|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111360666|NCT03363464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111360667|NCT03363464|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110066585|NCT01539265|Silodosin|silodosin|mesh-list
111360668|NCT03363464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111360669|NCT03363464|Protease Inhibitors|protease inhibitors|mesh-ancestor
111360670|NCT03363464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111360671|NCT03179930|Pembrolizumab|pembrolizumab|mesh-list
111360672|NCT03179930|Entinostat|entinostat|mesh-list
111360673|NCT03179930|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111360674|NCT03179930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111360675|NCT03179930|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111360676|NCT03179930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111360677|NCT03179930|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111360678|NCT03179930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111360679|NCT03113851|Molgramostim|molgramostim|mesh-list
111360680|NCT03113851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111360681|NCT03043313|Trastuzumab|trastuzumab|mesh-list
111360682|NCT03043313|Tucatinib|tucatinib|mesh-list
111360683|NCT03043313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111360684|NCT03043313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111360685|NCT03043313|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111360686|NCT03043313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111360687|NCT03043313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111360688|NCT02903381|Dexamethasone|dexamethasone|mesh-list
111360689|NCT02903381|Nivolumab|nivolumab|mesh-list
111360690|NCT02903381|Lenalidomide|lenalidomide|mesh-list
111360691|NCT02903381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111360692|NCT02903381|Antiemetics|antiemetics|mesh-ancestor
111360693|NCT02903381|Autonomic Agents|autonomic agents|mesh-ancestor
111360694|NCT02903381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111360695|NCT02903381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111360696|NCT02903381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111360697|NCT02903381|Glucocorticoids|glucocorticoids|mesh-ancestor
111360698|NCT02903381|Hormones|hormones|mesh-ancestor
111360699|NCT02903381|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111360700|NCT02903381|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111360701|NCT02903381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111360702|NCT02903381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110870146|NCT05166096|Aspirin|aspirin|mesh-list
111360703|NCT02903381|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111360704|NCT02903381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111360705|NCT02903381|Immunologic Factors|immunologic factors|mesh-ancestor
111360706|NCT02903381|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111360707|NCT02903381|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111360708|NCT02903381|Growth Substances|growth substances|mesh-ancestor
111360709|NCT02903381|Growth Inhibitors|growth inhibitors|mesh-ancestor
111360710|NCT02744391|Levodopa|levodopa|mesh-list
111360711|NCT02744391|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111360712|NCT02744391|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111360713|NCT02744391|Dopamine Agents|dopamine agents|mesh-ancestor
111360714|NCT02744391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111360715|NCT02744391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111360716|NCT02744391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111360717|NCT02462837|Mirabegron|mirabegron|mesh-list
111360718|NCT02462837|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
111360719|NCT02462837|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111360720|NCT02462837|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111360721|NCT02462837|Adrenergic Agents|adrenergic agents|mesh-ancestor
111360722|NCT02462837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111360723|NCT02462837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111360724|NCT02462837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111360725|NCT02462837|Urological Agents|urological agents|mesh-ancestor
111360726|NCT02346201|Methylphenidate|methylphenidate|mesh-list
111360727|NCT02346201|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111360728|NCT02346201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111360729|NCT02346201|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111360730|NCT02346201|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111360731|NCT02346201|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111360732|NCT02346201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111360733|NCT02346201|Dopamine Agents|dopamine agents|mesh-ancestor
111360734|NCT02346201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111360735|NCT02331134|Lenograstim|lenograstim|mesh-list
111360736|NCT02331134|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111360737|NCT02331134|Immunologic Factors|immunologic factors|mesh-ancestor
111360738|NCT02331134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111360739|NCT02078427|BAX 855|bax 855|mesh-list
111360740|NCT02078427|Coagulants|coagulants|mesh-ancestor
111360741|NCT02042378|Rucaparib|rucaparib|mesh-list
111360742|NCT02042378|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111360743|NCT02042378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111360744|NCT02042378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111360745|NCT02042378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111360746|NCT01866930|Interferons|interferons|mesh-list
111360747|NCT01866930|Ribavirin|ribavirin|mesh-list
110587828|NCT04524702|Hydroxychloroquine|hydroxychloroquine|mesh-list
111360748|NCT01866930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111360749|NCT01866930|Antiviral Agents|antiviral agents|mesh-ancestor
111360750|NCT01866930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111360751|NCT01866930|Antimetabolites|antimetabolites|mesh-ancestor
111360752|NCT01866930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111360753|NCT01682187|Lomustine|lomustine|mesh-list
111360754|NCT01682187|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111360755|NCT01682187|Alkylating Agents|alkylating agents|mesh-ancestor
111360756|NCT01682187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111360757|NCT01682187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111360758|NCT01621568|Sunitinib|sunitinib|mesh-list
111360759|NCT01621568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111360760|NCT01621568|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111360761|NCT01621568|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111360762|NCT01621568|Growth Substances|growth substances|mesh-ancestor
111360763|NCT01621568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111360764|NCT01621568|Growth Inhibitors|growth inhibitors|mesh-ancestor
111360765|NCT01621568|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111360766|NCT01621568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111360767|NCT01621568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111360768|NCT01366612|Vidarabine|vidarabine|mesh-list
111360769|NCT01366612|Fludarabine|fludarabine|mesh-list
111360770|NCT01366612|Fludarabine phosphate|fludarabine phosphate|mesh-list
111360771|NCT01366612|Busulfan|busulfan|mesh-list
111360772|NCT01366612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111360773|NCT01366612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111360774|NCT01366612|Antimetabolites|antimetabolites|mesh-ancestor
111360775|NCT01366612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111360776|NCT01366612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111360777|NCT01366612|Immunologic Factors|immunologic factors|mesh-ancestor
111360778|NCT01366612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111360779|NCT01366612|Antiviral Agents|antiviral agents|mesh-ancestor
111360780|NCT01366612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111360781|NCT01366612|Alkylating Agents|alkylating agents|mesh-ancestor
111360782|NCT01366612|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111360783|NCT01366612|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111360784|NCT00813293|Sorafenib|sorafenib|mesh-list
111119226|NCT05224141|Carboplatin|carboplatin|mesh-list
111360785|NCT00813293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111360786|NCT00813293|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111360787|NCT00813293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111360788|NCT00813293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111360789|NCT00481091|Navitoclax|navitoclax|mesh-list
111360790|NCT00481091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111360791|NCT00003641|Interferons|interferons|mesh-list
111360792|NCT00003641|Interferon-alpha|interferon-alpha|mesh-list
111360793|NCT00003641|Interferon alpha-2|interferon alpha-2|mesh-list
111360794|NCT00003641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111360795|NCT00003641|Antiviral Agents|antiviral agents|mesh-ancestor
111360796|NCT00003641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111360797|NCT00003641|Immunologic Factors|immunologic factors|mesh-ancestor
111360798|NCT00003641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111360799|NCT00392834|Leucovorin|leucovorin|mesh-list
111360800|NCT00392834|Cytarabine|cytarabine|mesh-list
111360801|NCT00392834|Hydrocortisone|hydrocortisone|mesh-list
111360802|NCT00392834|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
111360803|NCT00392834|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
111360804|NCT00392834|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
111360805|NCT00392834|Cyclophosphamide|cyclophosphamide|mesh-list
111360807|NCT00392834|Rituximab|rituximab|mesh-list
111360808|NCT00392834|Doxorubicin|doxorubicin|mesh-list
111360809|NCT00392834|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111360810|NCT00392834|Methotrexate|methotrexate|mesh-list
111360811|NCT00392834|Etoposide|etoposide|mesh-list
111360812|NCT00392834|Vincristine|vincristine|mesh-list
111360813|NCT00392834|Levoleucovorin|levoleucovorin|mesh-list
111360814|NCT00392834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111360815|NCT00392834|Immunologic Factors|immunologic factors|mesh-ancestor
111360816|NCT00392834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111360817|NCT00392834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111360818|NCT00392834|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111360819|NCT00392834|Alkylating Agents|alkylating agents|mesh-ancestor
111360820|NCT00392834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111360821|NCT00392834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111360822|NCT00392834|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111360823|NCT00392834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111360824|NCT00392834|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111360825|NCT00392834|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111360826|NCT00392834|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111360827|NCT00392834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111360828|NCT00392834|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111360829|NCT00392834|Abortifacient Agents|abortifacient agents|mesh-ancestor
111360830|NCT00392834|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111360831|NCT00392834|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111360832|NCT00392834|Antimetabolites|antimetabolites|mesh-ancestor
111360833|NCT00392834|Dermatologic Agents|dermatologic agents|mesh-ancestor
111360834|NCT00392834|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111360835|NCT00392834|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111360836|NCT00392834|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111360837|NCT00392834|Antiviral Agents|antiviral agents|mesh-ancestor
111360838|NCT00392834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111360839|NCT00392834|Antidotes|antidotes|mesh-ancestor
111360840|NCT00392834|Protective Agents|protective agents|mesh-ancestor
111360841|NCT00392834|Vitamin B Complex|vitamin b complex|mesh-ancestor
111360842|NCT00392834|Vitamins|vitamins|mesh-ancestor
111360843|NCT00392834|Micronutrients|micronutrients|mesh-ancestor
111360844|NCT00392834|Tubulin Modulators|tubulin modulators|mesh-ancestor
111360845|NCT00392834|Antimitotic Agents|antimitotic agents|mesh-ancestor
111360846|NCT00392834|Mitosis Modulators|mitosis modulators|mesh-ancestor
111360847|NCT00392834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111360848|NCT00393380|Teriparatide|teriparatide|mesh-list
111360849|NCT00393380|Hormones|hormones|mesh-list
111360850|NCT00393380|Parathyroid Hormone|parathyroid hormone|mesh-list
111360851|NCT00393380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111360852|NCT00393380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111360853|NCT00393380|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111360854|NCT00393380|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111360855|NCT05361642|Lidocaine|lidocaine|mesh-list
111360856|NCT05361642|Dexmedetomidine|dexmedetomidine|mesh-list
111360857|NCT05361642|Bupivacaine|bupivacaine|mesh-list
111360858|NCT05361642|Anesthetics, Local|anesthetics, local|mesh-ancestor
111360859|NCT05361642|Anesthetics|anesthetics|mesh-ancestor
111360860|NCT05361642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111360861|NCT05361642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111360862|NCT05361642|Sensory System Agents|sensory system agents|mesh-ancestor
111360863|NCT05361642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111360864|NCT05361642|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111360865|NCT05361642|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111360866|NCT05361642|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111360867|NCT05361642|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111360868|NCT05361642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111360869|NCT05361642|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111360870|NCT05361642|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111360871|NCT05361642|Analgesics|analgesics|mesh-ancestor
111360872|NCT05361642|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111360873|NCT05361642|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111360874|NCT05361642|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111360875|NCT05361642|Adrenergic Agents|adrenergic agents|mesh-ancestor
111360876|NCT05361642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111360877|NCT00395876|Tenecteplase|tenecteplase|mesh-list
111360878|NCT00395876|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111360879|NCT00395876|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111085272|NCT05013437|Promethazine|promethazine|mesh-list
111119967|NCT04443088|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111360880|NCT00395876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111360881|NCT02662634|Paclitaxel|paclitaxel|mesh-list
111360882|NCT02662634|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111360883|NCT02662634|Cisplatin|cisplatin|mesh-list
111360884|NCT02662634|Carboplatin|carboplatin|mesh-list
111360885|NCT02662634|Pemetrexed|pemetrexed|mesh-list
111360886|NCT02662634|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111360887|NCT02662634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111360888|NCT02662634|Tubulin Modulators|tubulin modulators|mesh-ancestor
111360889|NCT02662634|Antimitotic Agents|antimitotic agents|mesh-ancestor
111360890|NCT02662634|Mitosis Modulators|mitosis modulators|mesh-ancestor
111360891|NCT02662634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111360892|NCT02662634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111360893|NCT02662634|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111360894|NCT02662634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111360895|NCT00396032|Tenecteplase|tenecteplase|mesh-list
111360896|NCT00396032|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111360897|NCT00396032|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111360898|NCT00396032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111360899|NCT02277782|Fentanyl|fentanyl|mesh-list
111360900|NCT02277782|Hydromorphone|hydromorphone|mesh-list
111360901|NCT02277782|Bupivacaine|bupivacaine|mesh-list
111360902|NCT02277782|Anesthetics, Local|anesthetics, local|mesh-ancestor
111360903|NCT02277782|Anesthetics|anesthetics|mesh-ancestor
111360904|NCT02277782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111360905|NCT02277782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111360906|NCT02277782|Sensory System Agents|sensory system agents|mesh-ancestor
111360907|NCT02277782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111360908|NCT02277782|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111360909|NCT02277782|Narcotics|narcotics|mesh-ancestor
111360910|NCT02277782|Analgesics|analgesics|mesh-ancestor
111120241|NCT04233866|Antidotes|antidotes|mesh-ancestor
111360911|NCT02277782|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111360912|NCT02277782|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111360913|NCT02277782|Anesthetics, General|anesthetics, general|mesh-ancestor
111360914|NCT05287100|Midodrine|midodrine|mesh-list
111360915|NCT05287100|Sympathomimetics|sympathomimetics|mesh-ancestor
111360916|NCT05287100|Autonomic Agents|autonomic agents|mesh-ancestor
111360917|NCT05287100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111360918|NCT05287100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111360919|NCT05287100|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111360920|NCT05287100|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111360921|NCT05287100|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111360922|NCT05287100|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111360923|NCT05287100|Adrenergic Agents|adrenergic agents|mesh-ancestor
111360924|NCT05287100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111360925|NCT05287100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111360926|NCT02271230|Vitamin D|vitamin d|mesh-list
111360927|NCT02271230|Ergocalciferols|ergocalciferols|mesh-list
111360928|NCT02271230|Cholecalciferol|cholecalciferol|mesh-list
111360929|NCT02271230|Vitamins|vitamins|mesh-list
111360930|NCT02271230|Micronutrients|micronutrients|mesh-ancestor
111360931|NCT02271230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111360932|NCT02271230|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111120376|NCT04121455|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111360933|NCT02271230|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111360934|NCT05321706|Dapagliflozin|dapagliflozin|mesh-list
111360935|NCT05321706|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111360936|NCT05321706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111360937|NCT05321706|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111360938|NCT05321706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111360939|NCT05514990|Dexamethasone|dexamethasone|mesh-list
111360940|NCT05514990|Dexamethasone acetate|dexamethasone acetate|mesh-list
111360941|NCT05514990|Pembrolizumab|pembrolizumab|mesh-list
111360942|NCT05514990|Bortezomib|bortezomib|mesh-list
111360943|NCT05514990|Ichthammol|ichthammol|mesh-list
111360944|NCT05514990|BB 1101|bb 1101|mesh-list
111360945|NCT05514990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111360946|NCT05514990|Antiemetics|antiemetics|mesh-ancestor
111360947|NCT05514990|Autonomic Agents|autonomic agents|mesh-ancestor
111360948|NCT05514990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111360949|NCT05514990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111360950|NCT05514990|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111120506|NCT03937635|Dexamethasone|dexamethasone|mesh-list
111360951|NCT05514990|Glucocorticoids|glucocorticoids|mesh-ancestor
111360952|NCT05514990|Hormones|hormones|mesh-ancestor
111360953|NCT05514990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111360954|NCT05514990|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111360955|NCT05514990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111360956|NCT05514990|Protease Inhibitors|protease inhibitors|mesh-ancestor
111360957|NCT05514990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111360958|NCT05514990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111360959|NCT05514990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111360960|NCT05514990|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111360961|NCT05514990|Dermatologic Agents|dermatologic agents|mesh-ancestor
111360962|NCT00396266|Plerixafor|plerixafor|mesh-list
111360963|NCT00396266|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111360964|NCT00396266|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111360965|NCT00396266|Antiviral Agents|antiviral agents|mesh-ancestor
111360966|NCT00396266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111360967|NCT04271384|Nivolumab|nivolumab|mesh-list
111360968|NCT04271384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111360969|NCT04271384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111360970|NCT04271384|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111360971|NCT04271384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111360972|NCT05610384|Ibuprofen|ibuprofen|mesh-list
111360973|NCT05610384|Ketorolac|ketorolac|mesh-list
111360974|NCT05610384|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111360975|NCT05610384|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111360976|NCT05610384|Analgesics|analgesics|mesh-ancestor
111360977|NCT05610384|Sensory System Agents|sensory system agents|mesh-ancestor
111360978|NCT05610384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111360979|NCT05610384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111360980|NCT05610384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111360981|NCT05610384|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111360982|NCT05610384|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111360983|NCT05610384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111360984|NCT05610384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111360985|NCT03570632|Metformin|metformin|mesh-list
111360986|NCT03570632|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111360987|NCT03570632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111360988|NCT00397904|Irinotecan|irinotecan|mesh-list
111360989|NCT00397904|Cetuximab|cetuximab|mesh-list
111360990|NCT00397904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111360991|NCT00397904|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111360992|NCT00397904|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111360993|NCT00397904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111360994|NCT00397904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111360995|NCT00397904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111360996|NCT00398918|Zonisamide|zonisamide|mesh-list
111360997|NCT00398918|Anticonvulsants|anticonvulsants|mesh-ancestor
111360998|NCT00398918|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111360999|NCT00398918|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111361000|NCT00398918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111361001|NCT00398918|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111361002|NCT00398918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111361003|NCT05380752|Tecovirimat|tecovirimat|mesh-list
111361004|NCT05380752|Antiviral Agents|antiviral agents|mesh-ancestor
111361005|NCT05380752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111361006|NCT00401414|Warfarin|warfarin|mesh-list
111361007|NCT00401414|Anticoagulants|anticoagulants|mesh-ancestor
111361008|NCT00370838|Clonidine|clonidine|mesh-list
111361009|NCT00370838|Levetiracetam|levetiracetam|mesh-list
111361010|NCT00370838|Analgesics|analgesics|mesh-ancestor
111361011|NCT00370838|Sensory System Agents|sensory system agents|mesh-ancestor
111361012|NCT00370838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111361013|NCT00370838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111361014|NCT00370838|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111361015|NCT00370838|Sympatholytics|sympatholytics|mesh-ancestor
111361016|NCT00370838|Autonomic Agents|autonomic agents|mesh-ancestor
111361017|NCT00370838|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111361018|NCT00370838|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111361019|NCT00370838|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111361020|NCT00370838|Adrenergic Agents|adrenergic agents|mesh-ancestor
111361021|NCT00370838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111361022|NCT00370838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111361023|NCT00370838|Anticonvulsants|anticonvulsants|mesh-ancestor
111361024|NCT00370838|Nootropic Agents|nootropic agents|mesh-ancestor
111361025|NCT01795430|Etoposide|etoposide|mesh-list
111120886|NCT03419234|Vitamins|vitamins|mesh-ancestor
111361026|NCT01795430|Etoposide phosphate|etoposide phosphate|mesh-list
111361027|NCT01795430|Melphalan|melphalan|mesh-list
111361028|NCT01795430|Busulfan|busulfan|mesh-list
111361029|NCT01795430|Topotecan|topotecan|mesh-list
111361030|NCT01795430|Ifosfamide|ifosfamide|mesh-list
111361031|NCT01795430|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111361032|NCT01795430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111120961|NCT03133221|Idelalisib|idelalisib|mesh-list
111361033|NCT01795430|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111361034|NCT01795430|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111361035|NCT01795430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111361036|NCT01795430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111361037|NCT01795430|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111361038|NCT01795430|Alkylating Agents|alkylating agents|mesh-ancestor
111361039|NCT01795430|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111361040|NCT01795430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111361041|NCT01795430|Immunologic Factors|immunologic factors|mesh-ancestor
111361042|NCT01795430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111361043|NCT01795430|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111121026|NCT03087071|Trametinib|trametinib|mesh-list
111361044|NCT04750382|Gemcitabine|gemcitabine|mesh-list
111361045|NCT04750382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111361046|NCT04750382|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111361047|NCT04750382|Antimetabolites|antimetabolites|mesh-ancestor
111361048|NCT04750382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111361049|NCT00401882|Metoprolol|metoprolol|mesh-list
111361050|NCT00401882|Epinephrine|epinephrine|mesh-list
111361051|NCT00401882|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111361052|NCT00401882|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111361053|NCT00401882|Adrenergic Agents|adrenergic agents|mesh-ancestor
111361054|NCT00401882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111361055|NCT00401882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111361056|NCT00401882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111361057|NCT00401882|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111361058|NCT00401882|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111361059|NCT00401882|Autonomic Agents|autonomic agents|mesh-ancestor
111361060|NCT00401882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111361061|NCT00401882|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111361062|NCT00401882|Respiratory System Agents|respiratory system agents|mesh-ancestor
111361063|NCT00401882|Mydriatics|mydriatics|mesh-ancestor
111361064|NCT00401882|Sympathomimetics|sympathomimetics|mesh-ancestor
111361065|NCT00401882|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111361066|NCT00401882|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111361067|NCT00401882|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111361068|NCT00401882|Sympatholytics|sympatholytics|mesh-ancestor
111361069|NCT00401882|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
111121151|NCT02797977|Gemcitabine|gemcitabine|mesh-list
111361070|NCT00401882|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111361071|NCT00401882|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111361072|NCT00373334|Nizatidine|nizatidine|mesh-list
111361073|NCT00373334|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111361074|NCT00373334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111361075|NCT00373334|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
111361076|NCT00373334|Histamine Antagonists|histamine antagonists|mesh-ancestor
111361077|NCT00373334|Histamine Agents|histamine agents|mesh-ancestor
111361078|NCT00373334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111361079|NCT00373334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111361080|NCT00373334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111361081|NCT04749914|Dabigatran|dabigatran|mesh-list
111361082|NCT04749914|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111361083|NCT04749914|Lasmiditan|lasmiditan|mesh-list
111361084|NCT04749914|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111361085|NCT04749914|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111361086|NCT04749914|Antimetabolites|antimetabolites|mesh-ancestor
111361087|NCT04749914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111361088|NCT04749914|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111361089|NCT04749914|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111361090|NCT04749914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111361091|NCT04749914|Antithrombins|antithrombins|mesh-ancestor
111361092|NCT04749914|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111361093|NCT04749914|Protease Inhibitors|protease inhibitors|mesh-ancestor
111361094|NCT04749914|Anticoagulants|anticoagulants|mesh-ancestor
111361095|NCT04749914|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111361096|NCT04749914|Serotonin Agents|serotonin agents|mesh-ancestor
111361097|NCT04749914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111361098|NCT04749914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111361099|NCT00402194|Losartan|losartan|mesh-list
111361100|NCT00402194|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111361101|NCT00402194|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111361102|NCT00402194|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111361103|NCT00402194|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111361104|NCT00402194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111361105|NCT05305404|Dexamethasone|dexamethasone|mesh-list
111361106|NCT05305404|Dexamethasone acetate|dexamethasone acetate|mesh-list
111361107|NCT05305404|BB 1101|bb 1101|mesh-list
111361108|NCT05305404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111361109|NCT05305404|Antiemetics|antiemetics|mesh-ancestor
111361110|NCT05305404|Autonomic Agents|autonomic agents|mesh-ancestor
111361111|NCT05305404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111361112|NCT05305404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111361113|NCT05305404|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111361114|NCT05305404|Glucocorticoids|glucocorticoids|mesh-ancestor
111361115|NCT05305404|Hormones|hormones|mesh-ancestor
111361116|NCT05305404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111361117|NCT05305404|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111361118|NCT05305404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111361119|NCT05305404|Protease Inhibitors|protease inhibitors|mesh-ancestor
111361120|NCT05305404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111361121|NCT05305404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111361122|NCT00402896|Mitogens|mitogens|mesh-list
111361123|NCT00402896|Endothelial Growth Factors|endothelial growth factors|mesh-list
111361124|NCT00402896|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
111361125|NCT00402896|Mitosis Modulators|mitosis modulators|mesh-ancestor
111361126|NCT00402896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111361127|NCT00402896|Growth Substances|growth substances|mesh-ancestor
111361128|NCT00402896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111361129|NCT00402896|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111361130|NCT00402896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111361131|NCT05268120|Doxycycline|doxycycline|mesh-list
111361132|NCT05268120|Rifampin|rifampin|mesh-list
111361133|NCT05268120|Trimethoprim|trimethoprim|mesh-list
111361134|NCT05268120|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111361135|NCT05268120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111361136|NCT05268120|Antimalarials|antimalarials|mesh-ancestor
111361137|NCT05268120|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111361138|NCT05268120|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111361139|NCT05268120|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111361140|NCT05268120|Antitubercular Agents|antitubercular agents|mesh-ancestor
111361141|NCT05268120|Leprostatic Agents|leprostatic agents|mesh-ancestor
111361142|NCT05268120|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111361143|NCT05268120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111361144|NCT05268120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111361145|NCT05268120|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111361146|NCT05268120|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111361147|NCT05268120|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
111361148|NCT05268120|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
111361149|NCT05268120|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
111361150|NCT05268120|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111361151|NCT05268120|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111361152|NCT05268120|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111361153|NCT05268120|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111361154|NCT05268120|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
111361155|NCT05268120|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111361156|NCT00405704|Trimethoprim|trimethoprim|mesh-list
111361157|NCT00405704|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
111361158|NCT00405704|Sulfamethoxazole|sulfamethoxazole|mesh-list
111361159|NCT00405704|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111361160|NCT00405704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111361161|NCT00405704|Antimalarials|antimalarials|mesh-ancestor
111361162|NCT00405704|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111361163|NCT00405704|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111361164|NCT00405704|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111361165|NCT00405704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111361166|NCT00405704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111361167|NCT00405704|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111361168|NCT00405704|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
111361169|NCT00405704|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111361170|NCT00405704|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111361171|NCT01657266|Nepafenac|nepafenac|mesh-list
111361172|NCT01657266|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111361173|NCT01657266|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111361174|NCT01657266|Analgesics|analgesics|mesh-ancestor
111361175|NCT01657266|Sensory System Agents|sensory system agents|mesh-ancestor
111361176|NCT01657266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111361177|NCT01657266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111361178|NCT01657266|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111361179|NCT01657266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111361180|NCT00375830|Diphosphonates|diphosphonates|mesh-list
110802754|NCT02127190|CXA-10|cxa-10|mesh-list
111361181|NCT00375830|Methylene diphosphonate|methylene diphosphonate|mesh-list
111361182|NCT00375830|Listerine|listerine|mesh-list
111361183|NCT00375830|Deoxyglucose|deoxyglucose|mesh-list
111361184|NCT00375830|Fluorides|fluorides|mesh-list
111361185|NCT00375830|Sodium Fluoride|sodium fluoride|mesh-list
111361186|NCT00375830|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
111361187|NCT00375830|Technetium Tc 99m Medronate|technetium tc 99m medronate|mesh-list
111361188|NCT00375830|Cariostatic Agents|cariostatic agents|mesh-ancestor
111361189|NCT00375830|Protective Agents|protective agents|mesh-ancestor
111361190|NCT00375830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111361191|NCT00375830|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111361192|NCT00375830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111361193|NCT00375830|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111361194|NCT00375830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111361195|NCT00375830|Antimetabolites|antimetabolites|mesh-ancestor
111361196|NCT00375830|Antiviral Agents|antiviral agents|mesh-ancestor
111361197|NCT00375830|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111361198|NCT05286008|Dexamethasone|dexamethasone|mesh-list
111361199|NCT05286008|Ropivacaine|ropivacaine|mesh-list
111361200|NCT05286008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111361201|NCT05286008|Antiemetics|antiemetics|mesh-ancestor
111361202|NCT05286008|Autonomic Agents|autonomic agents|mesh-ancestor
111361203|NCT05286008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111361204|NCT05286008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111361205|NCT05286008|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111361206|NCT05286008|Glucocorticoids|glucocorticoids|mesh-ancestor
111361207|NCT05286008|Hormones|hormones|mesh-ancestor
111361208|NCT05286008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111361209|NCT05286008|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111361210|NCT05286008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111361211|NCT05286008|Anesthetics, Local|anesthetics, local|mesh-ancestor
111361212|NCT05286008|Anesthetics|anesthetics|mesh-ancestor
111361213|NCT05286008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111361214|NCT05286008|Sensory System Agents|sensory system agents|mesh-ancestor
111361215|NCT05302284|Carboplatin|carboplatin|mesh-list
111361216|NCT05302284|Gemcitabine|gemcitabine|mesh-list
111361217|NCT05302284|Disitamab vedotin|disitamab vedotin|mesh-list
111361218|NCT05302284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111361219|NCT05302284|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111361220|NCT05302284|Antimetabolites|antimetabolites|mesh-ancestor
111361221|NCT05302284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111361222|NCT05302284|Immunoconjugates|immunoconjugates|mesh-ancestor
111361223|NCT05302284|Immunologic Factors|immunologic factors|mesh-ancestor
111361224|NCT05302284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111361225|NCT05300802|Dexmedetomidine|dexmedetomidine|mesh-list
111361226|NCT05300802|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111361227|NCT05300802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111361228|NCT05300802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111361229|NCT05300802|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111361230|NCT05300802|Analgesics|analgesics|mesh-ancestor
111361231|NCT05300802|Sensory System Agents|sensory system agents|mesh-ancestor
111361232|NCT05300802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111121965|NCT05014685|Bismuth|bismuth|mesh-list
111361233|NCT05300802|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111361234|NCT05300802|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111361235|NCT05300802|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111361236|NCT05300802|Adrenergic Agents|adrenergic agents|mesh-ancestor
111361237|NCT05300802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111361238|NCT05300802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111361239|NCT05299476|Bevacizumab|bevacizumab|mesh-list
111361240|NCT05299476|Tislelizumab|tislelizumab|mesh-list
111361241|NCT05299476|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111122026|NCT03078257|Aspirin|aspirin|mesh-list
111361242|NCT05299476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111361243|NCT05299476|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111361244|NCT05299476|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111361245|NCT05299476|Growth Substances|growth substances|mesh-ancestor
111361246|NCT05299476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111361247|NCT05299476|Growth Inhibitors|growth inhibitors|mesh-ancestor
111122094|NCT02336659|Hormones|hormones|mesh-ancestor
111361248|NCT00405938|Bevacizumab|bevacizumab|mesh-list
111361249|NCT00405938|Fulvestrant|fulvestrant|mesh-list
111361250|NCT00405938|Anastrozole|anastrozole|mesh-list
111361251|NCT00405938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111361252|NCT00405938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111361253|NCT00405938|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111361254|NCT00405938|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111361255|NCT00405938|Growth Substances|growth substances|mesh-ancestor
111361256|NCT00405938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111361257|NCT00405938|Growth Inhibitors|growth inhibitors|mesh-ancestor
111361258|NCT00405938|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111361259|NCT00405938|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
111361260|NCT00405938|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111361261|NCT00405938|Hormone Antagonists|hormone antagonists|mesh-ancestor
111122156|NCT04509973|Dexamethasone|dexamethasone|mesh-list
111361262|NCT00405938|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111361263|NCT00405938|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111361264|NCT00405938|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111361265|NCT00405938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111361266|NCT00405938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111361267|NCT05299398|Trazodone|trazodone|mesh-list
111361268|NCT05299398|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111361269|NCT05299398|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111361270|NCT05299398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111361271|NCT05299398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111361272|NCT05299398|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111361273|NCT05299398|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111361274|NCT05299398|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111361275|NCT05299398|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111361276|NCT05299398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111361277|NCT05299398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111361278|NCT05299398|Serotonin Agents|serotonin agents|mesh-ancestor
111361279|NCT05299398|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111361280|NCT05299398|Antidepressive Agents|antidepressive agents|mesh-ancestor
111361281|NCT01793480|Methadone|methadone|mesh-list
111361282|NCT01793480|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111361283|NCT01793480|Narcotics|narcotics|mesh-ancestor
111361284|NCT01793480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111361285|NCT01793480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111361286|NCT01793480|Analgesics|analgesics|mesh-ancestor
111361287|NCT01793480|Sensory System Agents|sensory system agents|mesh-ancestor
111361288|NCT01793480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111361289|NCT01793480|Antitussive Agents|antitussive agents|mesh-ancestor
111361290|NCT01793480|Respiratory System Agents|respiratory system agents|mesh-ancestor
111361291|NCT05299086|Fluticasone|fluticasone|mesh-list
111361292|NCT05299086|Xhance|xhance|mesh-list
111122348|NCT02334475|Hormones|hormones|mesh-ancestor
111361293|NCT05299086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111361294|NCT05299086|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111361295|NCT05299086|Autonomic Agents|autonomic agents|mesh-ancestor
111361296|NCT05299086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111361297|NCT05299086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111361298|NCT05299086|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111361299|NCT05299086|Respiratory System Agents|respiratory system agents|mesh-ancestor
111361300|NCT05299086|Dermatologic Agents|dermatologic agents|mesh-ancestor
111361301|NCT05299086|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111361302|NCT05299008|Bethanechol|bethanechol|mesh-list
111122487|NCT05004545|Propofol|propofol|mesh-list
111361303|NCT05299008|Parasympathomimetics|parasympathomimetics|mesh-ancestor
111361304|NCT05299008|Autonomic Agents|autonomic agents|mesh-ancestor
111361305|NCT05299008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111361306|NCT05299008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111361307|NCT05299008|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
111361308|NCT05299008|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111122552|NCT02331511|Aspirin|aspirin|mesh-list
111361309|NCT05299008|Cholinergic Agents|cholinergic agents|mesh-ancestor
111361310|NCT05299008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111361311|NCT05299008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111361312|NCT05258292|Insulin|insulin|mesh-list
111361313|NCT05258292|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111361314|NCT05258292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111361315|NCT05256264|Ketamine|ketamine|mesh-list
111361316|NCT05256264|Analgesics|analgesics|mesh-ancestor
111361317|NCT05256264|Sensory System Agents|sensory system agents|mesh-ancestor
111361318|NCT05256264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111361319|NCT05256264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111361320|NCT05256264|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111361321|NCT05256264|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111361322|NCT05256264|Anesthetics, General|anesthetics, general|mesh-ancestor
111361323|NCT05256264|Anesthetics|anesthetics|mesh-ancestor
111361324|NCT05256264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111361325|NCT05256264|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111361326|NCT05256264|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111361327|NCT05256264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111361328|NCT05256264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111361329|NCT00379574|Prednisolone|prednisolone|mesh-list
111361330|NCT00379574|Cyclophosphamide|cyclophosphamide|mesh-list
111361332|NCT00379574|Vincristine|vincristine|mesh-list
111361333|NCT00379574|Bortezomib|bortezomib|mesh-list
111361334|NCT00379574|Lenograstim|lenograstim|mesh-list
111361335|NCT00379574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111361336|NCT00379574|Immunologic Factors|immunologic factors|mesh-ancestor
111361337|NCT00379574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111361338|NCT00379574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111361339|NCT00379574|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111361340|NCT00379574|Alkylating Agents|alkylating agents|mesh-ancestor
111361341|NCT00379574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111361342|NCT00379574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111361343|NCT00379574|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111361344|NCT00379574|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111361345|NCT00379574|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111361346|NCT00379574|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111361347|NCT00379574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111361348|NCT00379574|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111361349|NCT00379574|Tubulin Modulators|tubulin modulators|mesh-ancestor
111122887|NCT04498741|GABA Modulators|gaba modulators|mesh-ancestor
111361350|NCT00379574|Antimitotic Agents|antimitotic agents|mesh-ancestor
111361351|NCT00379574|Mitosis Modulators|mitosis modulators|mesh-ancestor
111361352|NCT00379574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111361353|NCT00379574|Glucocorticoids|glucocorticoids|mesh-ancestor
111361354|NCT00379574|Hormones|hormones|mesh-ancestor
111361355|NCT00379574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111361356|NCT00379574|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111361357|NCT00379574|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111361358|NCT05256108|Oxycodone|oxycodone|mesh-list
111361359|NCT05256108|Tramadol|tramadol|mesh-list
111361360|NCT05256108|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111361361|NCT05256108|Narcotics|narcotics|mesh-ancestor
111361362|NCT05256108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111361363|NCT05256108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111361364|NCT05256108|Analgesics|analgesics|mesh-ancestor
111361365|NCT05256108|Sensory System Agents|sensory system agents|mesh-ancestor
111361366|NCT05256108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111361367|NCT00407654|Aflibercept|aflibercept|mesh-list
111361368|NCT00407654|Endothelial Growth Factors|endothelial growth factors|mesh-list
111361369|NCT00407654|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111361370|NCT00407654|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111123099|NCT03142789|Cerivastatin|cerivastatin|mesh-list
111361371|NCT00407654|Growth Substances|growth substances|mesh-ancestor
111361372|NCT00407654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111361373|NCT00407654|Growth Inhibitors|growth inhibitors|mesh-ancestor
111361374|NCT00407654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111361375|NCT05484492|Calcium|calcium|mesh-list
111361376|NCT05484492|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111361377|NCT05484492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111361378|NCT00407888|Paclitaxel|paclitaxel|mesh-list
111361379|NCT00407888|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111361380|NCT00407888|Cyclophosphamide|cyclophosphamide|mesh-list
111361381|NCT00407888|Doxorubicin|doxorubicin|mesh-list
111361382|NCT00407888|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111361383|NCT00407888|Trastuzumab|trastuzumab|mesh-list
111361384|NCT00407888|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111361385|NCT00407888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111361386|NCT00407888|Tubulin Modulators|tubulin modulators|mesh-ancestor
111361387|NCT00407888|Antimitotic Agents|antimitotic agents|mesh-ancestor
111361388|NCT00407888|Mitosis Modulators|mitosis modulators|mesh-ancestor
111361389|NCT00407888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111361390|NCT00407888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111361391|NCT00407888|Immunologic Factors|immunologic factors|mesh-ancestor
111361392|NCT00407888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111361393|NCT00407888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111361394|NCT00407888|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111361395|NCT00407888|Alkylating Agents|alkylating agents|mesh-ancestor
111361396|NCT00407888|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111361397|NCT00407888|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111361398|NCT00407888|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111361399|NCT00407888|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111361400|NCT00407888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111361401|NCT00407888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111361402|NCT00407966|Cytarabine|cytarabine|mesh-list
111361403|NCT00407966|Mitoxantrone|mitoxantrone|mesh-list
111361404|NCT00407966|Alvocidib|alvocidib|mesh-list
111361405|NCT00407966|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111361406|NCT00407966|Antimetabolites|antimetabolites|mesh-ancestor
111361407|NCT00407966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111361408|NCT00407966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111361409|NCT00407966|Antiviral Agents|antiviral agents|mesh-ancestor
111361410|NCT00407966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111361411|NCT00407966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111361412|NCT00407966|Immunologic Factors|immunologic factors|mesh-ancestor
111361413|NCT00407966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111361415|NCT00407966|Sensory System Agents|sensory system agents|mesh-ancestor
111361416|NCT00407966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111361417|NCT00407966|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111361418|NCT00407966|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111361419|NCT00407966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111361420|NCT00407966|Growth Inhibitors|growth inhibitors|mesh-ancestor
111361421|NCT00407966|Growth Substances|growth substances|mesh-ancestor
111361422|NCT00407966|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111361423|NCT00408200|Sotalol|sotalol|mesh-list
111361424|NCT00408200|Flecainide|flecainide|mesh-list
111361425|NCT00408200|Propafenone|propafenone|mesh-list
111361426|NCT00408200|Dofetilide|dofetilide|mesh-list
111361427|NCT00408200|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111361428|NCT00408200|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111361429|NCT00408200|Adrenergic Agents|adrenergic agents|mesh-ancestor
111361430|NCT00408200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111361431|NCT00408200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111361432|NCT00408200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111361433|NCT00408200|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111361434|NCT00408200|Sympatholytics|sympatholytics|mesh-ancestor
111361435|NCT00408200|Autonomic Agents|autonomic agents|mesh-ancestor
111361436|NCT00408200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111361437|NCT00408200|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111361438|NCT00408200|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111361439|NCT00408200|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111361440|NCT00408200|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
111361441|NCT05255406|Aflutinib|aflutinib|mesh-list
111361442|NCT05255406|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111361443|NCT05255406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111361444|NCT05255406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111361445|NCT05250050|Amoxicillin|amoxicillin|mesh-list
111361446|NCT05250050|Metronidazole|metronidazole|mesh-list
111361447|NCT05250050|Clarithromycin|clarithromycin|mesh-list
111361448|NCT05250050|Levofloxacin|levofloxacin|mesh-list
111361449|NCT05250050|Tetracycline|tetracycline|mesh-list
111361450|NCT05250050|Potassium Citrate|potassium citrate|mesh-list
111361451|NCT05250050|Esomeprazole|esomeprazole|mesh-list
111361452|NCT05250050|Bismuth|bismuth|mesh-list
111361453|NCT05250050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111361454|NCT05250050|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111361455|NCT05250050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111361456|NCT05250050|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111361457|NCT05250050|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111361458|NCT05250050|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111361459|NCT05250050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111361460|NCT05250050|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111361461|NCT05250050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111361462|NCT05250050|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111361463|NCT05250050|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111361464|NCT05250050|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111361465|NCT05250050|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111361466|NCT05250050|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111123983|NCT02902757|Deoxyglucose|deoxyglucose|mesh-list
111361467|NCT05250050|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111361468|NCT05250050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111361469|NCT05250050|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111361470|NCT05250050|Antacids|antacids|mesh-ancestor
111361471|NCT05250050|Diuretics|diuretics|mesh-ancestor
111361472|NCT05250050|Natriuretic Agents|natriuretic agents|mesh-ancestor
111361473|NCT05250050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111361474|NCT05250050|Expectorants|expectorants|mesh-ancestor
111361475|NCT05250050|Respiratory System Agents|respiratory system agents|mesh-ancestor
111361476|NCT05294328|Brimonidine Tartrate|brimonidine tartrate|mesh-list
111361477|NCT05294328|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111361478|NCT05294328|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111361479|NCT05294328|Aceclidine|aceclidine|mesh-list
111361480|NCT05294328|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111361481|NCT05294328|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111361482|NCT05294328|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111361483|NCT05294328|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111361484|NCT05294328|Adrenergic Agents|adrenergic agents|mesh-ancestor
111361485|NCT05294328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111361486|NCT05294328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111124049|NCT05089981|Antidotes|antidotes|mesh-ancestor
111361487|NCT05294328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111361488|NCT05294328|Miotics|miotics|mesh-ancestor
111361489|NCT05294328|Autonomic Agents|autonomic agents|mesh-ancestor
111361490|NCT05294328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111361491|NCT05294328|Parasympathomimetics|parasympathomimetics|mesh-ancestor
111361492|NCT05292690|Caffeine|caffeine|mesh-list
111361493|NCT05292690|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111361494|NCT05292690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111361495|NCT05292690|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111361496|NCT05292690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111361497|NCT05292690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111361498|NCT05292690|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
111361499|NCT05292690|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111361500|NCT05292690|Purinergic Agents|purinergic agents|mesh-ancestor
111361501|NCT05292690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111361502|NCT00382148|Omalizumab|omalizumab|mesh-list
111361503|NCT00382148|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111361504|NCT00382148|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111361505|NCT00382148|Respiratory System Agents|respiratory system agents|mesh-ancestor
111361506|NCT05292066|Pregabalin|pregabalin|mesh-list
111361507|NCT05292066|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
111361508|NCT05292066|Analgesics|analgesics|mesh-ancestor
111361509|NCT05292066|Sensory System Agents|sensory system agents|mesh-ancestor
111361510|NCT05292066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111361511|NCT05292066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111361512|NCT05292066|Anticonvulsants|anticonvulsants|mesh-ancestor
111361513|NCT05292066|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111361514|NCT05292066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111361515|NCT05292066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111361516|NCT05292066|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111361517|NCT05292066|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111361518|NCT05292066|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111361519|NCT05292066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111361520|NCT05292066|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111361521|NCT05292066|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111361522|NCT05292066|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111361523|NCT05292066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111361524|NCT05292066|Antidepressive Agents|antidepressive agents|mesh-ancestor
111361525|NCT05292066|Dopamine Agents|dopamine agents|mesh-ancestor
111361526|NCT04270994|Misoprostol|misoprostol|mesh-list
111361527|NCT04270994|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111361528|NCT04270994|Abortifacient Agents|abortifacient agents|mesh-ancestor
111361529|NCT04270994|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111361530|NCT04270994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111361531|NCT04270994|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111361532|NCT04270994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111361533|NCT04270994|Oxytocics|oxytocics|mesh-ancestor
111361534|NCT02111798|Bupropion|bupropion|mesh-list
111361535|NCT02111798|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111361536|NCT02111798|Antidepressive Agents|antidepressive agents|mesh-ancestor
111361537|NCT02111798|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111361538|NCT02111798|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111361539|NCT02111798|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111361540|NCT02111798|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111361541|NCT02111798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111361542|NCT02111798|Dopamine Agents|dopamine agents|mesh-ancestor
111361543|NCT02111798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111361544|NCT02111798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111361545|NCT02111798|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111361546|NCT02111798|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111361547|NCT02111798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111361548|NCT05290662|Cyclophosphamide|cyclophosphamide|mesh-list
111361549|NCT05290662|Fludarabine|fludarabine|mesh-list
111361550|NCT05290662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111361551|NCT05290662|Immunologic Factors|immunologic factors|mesh-ancestor
111361552|NCT05290662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111361553|NCT05290662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111361554|NCT05290662|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111085952|NCT02512601|Anticoagulants|anticoagulants|mesh-ancestor
111361555|NCT05290662|Alkylating Agents|alkylating agents|mesh-ancestor
111361556|NCT05290662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111361557|NCT05290662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111361558|NCT05290662|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111361559|NCT05143502|Fluticasone|fluticasone|mesh-list
111361560|NCT05143502|Xhance|xhance|mesh-list
111361561|NCT05143502|Prednisolone|prednisolone|mesh-list
111361562|NCT05143502|Montelukast|montelukast|mesh-list
111361563|NCT05143502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111361564|NCT05143502|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111361565|NCT05143502|Autonomic Agents|autonomic agents|mesh-ancestor
111361566|NCT05143502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111361567|NCT05143502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111361568|NCT05143502|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111361569|NCT05143502|Respiratory System Agents|respiratory system agents|mesh-ancestor
111361570|NCT05143502|Dermatologic Agents|dermatologic agents|mesh-ancestor
111361571|NCT05143502|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111361572|NCT05143502|Glucocorticoids|glucocorticoids|mesh-ancestor
111361573|NCT05143502|Hormones|hormones|mesh-ancestor
111361574|NCT05143502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111361575|NCT05143502|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111361576|NCT05143502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111361577|NCT05143502|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
111361578|NCT05143502|Hormone Antagonists|hormone antagonists|mesh-ancestor
111361579|NCT05143502|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
111124544|NCT04262869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111361580|NCT05143502|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111361581|NCT05143502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111361582|NCT05290116|Apatinib|apatinib|mesh-list
111361583|NCT05290116|Tislelizumab|tislelizumab|mesh-list
111361584|NCT05290116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111361585|NCT05290116|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111361586|NCT05290116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111361587|NCT05290116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111124613|NCT01117441|Pegaspargase|pegaspargase|mesh-list
111361588|NCT05290116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111361589|NCT00409292|Everolimus|everolimus|mesh-list
111361590|NCT00409292|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111361591|NCT00409292|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111361592|NCT00409292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111361593|NCT00409292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111361594|NCT00409292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111361595|NCT00409292|Immunologic Factors|immunologic factors|mesh-ancestor
111361596|NCT00409292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111361597|NCT00409292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111361598|NCT05246046|Bromides|bromides|mesh-list
111361599|NCT05246046|Tiotropium Bromide|tiotropium bromide|mesh-list
111361600|NCT05246046|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111361601|NCT05246046|Autonomic Agents|autonomic agents|mesh-ancestor
111361602|NCT05246046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111361603|NCT05246046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111361604|NCT05246046|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111361605|NCT05246046|Respiratory System Agents|respiratory system agents|mesh-ancestor
111361606|NCT05246046|Parasympatholytics|parasympatholytics|mesh-ancestor
111361607|NCT05246046|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111361608|NCT05246046|Cholinergic Agents|cholinergic agents|mesh-ancestor
111361609|NCT05246046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111361610|NCT05246046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111361611|NCT05246046|Anticonvulsants|anticonvulsants|mesh-ancestor
111361612|NCT00383942|Misoprostol|misoprostol|mesh-list
111361613|NCT00383942|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111361614|NCT00383942|Abortifacient Agents|abortifacient agents|mesh-ancestor
111361615|NCT00383942|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111124816|NCT01916824|Dopamine Agents|dopamine agents|mesh-ancestor
111361616|NCT00383942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111361617|NCT00383942|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111361618|NCT00383942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111361619|NCT00383942|Oxytocics|oxytocics|mesh-ancestor
111361620|NCT05288400|Amlodipine|amlodipine|mesh-list
111361621|NCT05288400|Bisoprolol|bisoprolol|mesh-list
111361622|NCT05288400|Perindopril|perindopril|mesh-list
111361623|NCT05288400|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111361624|NCT05288400|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111361625|NCT05288400|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111361626|NCT05288400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111361627|NCT05288400|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111361628|NCT05288400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111361629|NCT05288400|Vasodilator Agents|vasodilator agents|mesh-ancestor
111361630|NCT05288400|Sympatholytics|sympatholytics|mesh-ancestor
111361631|NCT05288400|Autonomic Agents|autonomic agents|mesh-ancestor
111361632|NCT05288400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111361633|NCT05288400|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
111361634|NCT05288400|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111361635|NCT05288400|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111361636|NCT05288400|Adrenergic Agents|adrenergic agents|mesh-ancestor
111361637|NCT05288400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111361638|NCT05288400|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
111361639|NCT05288400|Protease Inhibitors|protease inhibitors|mesh-ancestor
111361640|NCT05288400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111361641|NCT05474040|Morphine|morphine|mesh-list
111361642|NCT05474040|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111361643|NCT05474040|Narcotics|narcotics|mesh-ancestor
111361644|NCT05474040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111361645|NCT05474040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111361646|NCT05474040|Analgesics|analgesics|mesh-ancestor
111361647|NCT05474040|Sensory System Agents|sensory system agents|mesh-ancestor
111361648|NCT05474040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111361649|NCT00410150|Albuterol|albuterol|mesh-list
111361650|NCT00410150|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111361651|NCT00410150|Autonomic Agents|autonomic agents|mesh-ancestor
111361652|NCT00410150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111361653|NCT00410150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111361654|NCT00410150|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111361655|NCT00410150|Respiratory System Agents|respiratory system agents|mesh-ancestor
111361656|NCT00410150|Tocolytic Agents|tocolytic agents|mesh-ancestor
111125048|NCT03945721|Niraparib|niraparib|mesh-list
111361657|NCT00410150|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111361658|NCT00410150|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111361659|NCT00410150|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111361660|NCT00410150|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111361661|NCT00410150|Adrenergic Agents|adrenergic agents|mesh-ancestor
111361662|NCT00410150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111361663|NCT00410150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111361664|NCT00385268|Acamprosate|acamprosate|mesh-list
111361665|NCT00385268|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111361666|NCT05287464|Pembrolizumab|pembrolizumab|mesh-list
111361667|NCT05287464|Nivolumab|nivolumab|mesh-list
111361668|NCT05287464|Ipilimumab|ipilimumab|mesh-list
111361669|NCT05287464|Atezolizumab|atezolizumab|mesh-list
111361670|NCT05287464|Avelumab|avelumab|mesh-list
111361671|NCT05287464|Lenvatinib|lenvatinib|mesh-list
111361672|NCT05287464|Axitinib|axitinib|mesh-list
111361673|NCT05287464|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111361674|NCT05287464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111361675|NCT05287464|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111361676|NCT05287464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111361677|NCT05287464|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111361678|NCT05287464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111361679|NCT01657500|Gentamicins|gentamicins|mesh-list
111361680|NCT01657500|Dextrans|dextrans|mesh-list
111361681|NCT01657500|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111361682|NCT01657500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111361683|NCT01657500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111125067|NCT02747407|Vaccines|vaccines|mesh-list
111361684|NCT01657500|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111361685|NCT01657500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111361686|NCT01657500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111361687|NCT01657500|Anticoagulants|anticoagulants|mesh-ancestor
111361688|NCT01657500|Plasma Substitutes|plasma substitutes|mesh-ancestor
111361689|NCT01657500|Blood Substitutes|blood substitutes|mesh-ancestor
111361690|NCT00411086|Rituximab|rituximab|mesh-list
111361691|NCT00411086|Molgramostim|molgramostim|mesh-list
111361692|NCT00411086|Sargramostim|sargramostim|mesh-list
111361693|NCT00411086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111361694|NCT00411086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111361695|NCT00411086|Immunologic Factors|immunologic factors|mesh-ancestor
111361696|NCT00411086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111361697|NCT00411086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111361698|NCT01658904|Melphalan|melphalan|mesh-list
111361699|NCT01658904|Immunologic Factors|immunologic factors|mesh-ancestor
111125125|NCT03063671|Anesthetics|anesthetics|mesh-ancestor
111361700|NCT01658904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111361701|NCT01658904|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111361702|NCT01658904|Alkylating Agents|alkylating agents|mesh-ancestor
111361703|NCT01658904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111361704|NCT01658904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111361705|NCT01658904|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111361706|NCT01658904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111361707|NCT05238948|Midazolam|midazolam|mesh-list
111361708|NCT05238948|CKD-506|ckd-506|mesh-list
111361709|NCT05238948|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111361710|NCT05238948|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111361711|NCT05238948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111361712|NCT05238948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111125173|NCT04979663|Antimetabolites|antimetabolites|mesh-ancestor
111361713|NCT05238948|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111361714|NCT05238948|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111361715|NCT05238948|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111361716|NCT05238948|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111361717|NCT05238948|Anesthetics, General|anesthetics, general|mesh-ancestor
111361718|NCT05238948|Anesthetics|anesthetics|mesh-ancestor
111361719|NCT05238948|GABA Modulators|gaba modulators|mesh-ancestor
111361720|NCT05238948|GABA Agents|gaba agents|mesh-ancestor
111361721|NCT05238948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111361722|NCT05238948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111361723|NCT05238948|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111361724|NCT05238948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111361725|NCT00385580|Dasatinib|dasatinib|mesh-list
111361726|NCT00385580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111361727|NCT00385580|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111361728|NCT00385580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111361729|NCT00385580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111361730|NCT05236530|Metformin|metformin|mesh-list
111361731|NCT05236530|Repaglinide|repaglinide|mesh-list
111361732|NCT05236530|Dolutegravir|dolutegravir|mesh-list
111361733|NCT05236530|Lumefantrine|lumefantrine|mesh-list
111361734|NCT05236530|Midazolam|midazolam|mesh-list
111361735|NCT05236530|Dextromethorphan|dextromethorphan|mesh-list
111361736|NCT05236530|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111361737|NCT05236530|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111361738|NCT05236530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111361739|NCT05236530|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111361740|NCT05236530|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111361741|NCT05236530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111361742|NCT05236530|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111361743|NCT05236530|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111361744|NCT05236530|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111361745|NCT05236530|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111125291|NCT04973579|Anesthetics|anesthetics|mesh-list
111361746|NCT05236530|Anesthetics, General|anesthetics, general|mesh-ancestor
111361747|NCT05236530|Anesthetics|anesthetics|mesh-ancestor
111361748|NCT05236530|GABA Modulators|gaba modulators|mesh-ancestor
111361749|NCT05236530|GABA Agents|gaba agents|mesh-ancestor
111361750|NCT05236530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111361751|NCT05236530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111361752|NCT05236530|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111361753|NCT05236530|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111361754|NCT05236530|Antimetabolites|antimetabolites|mesh-ancestor
111361755|NCT05236530|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111361756|NCT05236530|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111361757|NCT05236530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111361758|NCT05236530|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111361759|NCT05236530|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111361760|NCT05236530|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111361761|NCT05236530|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111361762|NCT05236530|Antiviral Agents|antiviral agents|mesh-ancestor
111361763|NCT05236530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111361764|NCT05236530|Antimalarials|antimalarials|mesh-ancestor
111361765|NCT05236530|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111361766|NCT05236530|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111361767|NCT05236530|Antitussive Agents|antitussive agents|mesh-ancestor
111125355|NCT04437017|Dexamethasone|dexamethasone|mesh-list
111361768|NCT05236530|Respiratory System Agents|respiratory system agents|mesh-ancestor
111361769|NCT05236530|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111361770|NCT05236530|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111361771|NCT00455702|Cycloserine|cycloserine|mesh-list
111361772|NCT00455702|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111361773|NCT00455702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111361774|NCT00455702|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111361775|NCT00455702|Antitubercular Agents|antitubercular agents|mesh-ancestor
111361776|NCT00455702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111361777|NCT00455702|Antimetabolites|antimetabolites|mesh-ancestor
111361778|NCT00455702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111361779|NCT00456014|Desipramine|desipramine|mesh-list
111361780|NCT00456014|Escitalopram|escitalopram|mesh-list
110959205|NCT02582632|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111361781|NCT00456014|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111361782|NCT00456014|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111361783|NCT00456014|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111361784|NCT00456014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111361785|NCT00456014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111361786|NCT00456014|Serotonin Agents|serotonin agents|mesh-ancestor
111125405|NCT05106751|Immunologic Factors|immunologic factors|mesh-ancestor
111361787|NCT00456014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111361788|NCT00456014|Antidepressive Agents|antidepressive agents|mesh-ancestor
111361789|NCT00456014|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111361790|NCT00456014|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
111361791|NCT00456014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111361792|NCT00456014|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111361793|NCT00456014|Adrenergic Agents|adrenergic agents|mesh-ancestor
111361794|NCT05235516|Cisplatin|cisplatin|mesh-list
111361795|NCT05235516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111361796|NCT00411398|Memantine|memantine|mesh-list
111361797|NCT00411398|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111361798|NCT00411398|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111361799|NCT00411398|Dopamine Agents|dopamine agents|mesh-ancestor
111125459|NCT04271293|Edoxaban|edoxaban|mesh-list
111361800|NCT00411398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111361801|NCT00411398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111361802|NCT00411398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111361803|NCT00411398|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111361804|NCT00411398|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111361805|NCT05231694|Mitogens|mitogens|mesh-list
111361806|NCT05231694|Mitosis Modulators|mitosis modulators|mesh-ancestor
111361807|NCT05231694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111361808|NCT00457730|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
111361809|NCT00457730|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111361810|NCT00457730|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111361811|NCT00457730|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111361812|NCT00457730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111361813|NCT00457730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111361814|NCT00457730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111361815|NCT00457730|Analgesics|analgesics|mesh-ancestor
111361816|NCT00457730|Sensory System Agents|sensory system agents|mesh-ancestor
111361817|NCT00457730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111361818|NCT00457730|Antidepressive Agents|antidepressive agents|mesh-ancestor
111361819|NCT00457730|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111361820|NCT00457730|Dopamine Agents|dopamine agents|mesh-ancestor
111361821|NCT00458822|Dexamethasone|dexamethasone|mesh-list
111361822|NCT00458822|Bortezomib|bortezomib|mesh-list
111361823|NCT00458822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111361824|NCT00458822|Antiemetics|antiemetics|mesh-ancestor
111361825|NCT00458822|Autonomic Agents|autonomic agents|mesh-ancestor
111361826|NCT00458822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111361827|NCT00458822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111361828|NCT00458822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111361829|NCT00458822|Glucocorticoids|glucocorticoids|mesh-ancestor
111361830|NCT00458822|Hormones|hormones|mesh-ancestor
111361831|NCT00458822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111361832|NCT00458822|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111361833|NCT00458822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111361834|NCT00389168|Atenolol|atenolol|mesh-list
111361835|NCT00389168|Irbesartan|irbesartan|mesh-list
111361836|NCT00389168|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111361837|NCT00389168|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111361838|NCT00389168|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111361839|NCT00389168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111361840|NCT00389168|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111361841|NCT00389168|Sympatholytics|sympatholytics|mesh-ancestor
111361842|NCT00389168|Autonomic Agents|autonomic agents|mesh-ancestor
111361843|NCT00389168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111361844|NCT00389168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111361845|NCT00389168|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
111361846|NCT00389168|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111361847|NCT00389168|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111361848|NCT00389168|Adrenergic Agents|adrenergic agents|mesh-ancestor
111361849|NCT00389168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111361850|NCT00462020|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111361851|NCT00462020|Metronidazole|metronidazole|mesh-list
111361852|NCT00462020|Ceftriaxone|ceftriaxone|mesh-list
111361853|NCT00462020|Ampicillin|ampicillin|mesh-list
111361854|NCT00462020|Clavulanic Acids|clavulanic acids|mesh-list
111361855|NCT00462020|Clavulanic Acid|clavulanic acid|mesh-list
111361856|NCT00462020|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
111361858|NCT00462020|Antitubercular Agents|antitubercular agents|mesh-ancestor
111361859|NCT00462020|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111125627|NCT03198559|Vorinostat|vorinostat|mesh-list
111361860|NCT00462020|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111361861|NCT00462020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111361862|NCT00462020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111361863|NCT00462020|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
111361864|NCT05177718|Natalizumab|natalizumab|mesh-list
111361865|NCT05177718|Immunologic Factors|immunologic factors|mesh-ancestor
111361866|NCT05177718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111361867|NCT00414206|Mecamylamine|mecamylamine|mesh-list
111361868|NCT00414206|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111361869|NCT00414206|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
111361870|NCT00414206|Autonomic Agents|autonomic agents|mesh-ancestor
111361871|NCT00414206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111361872|NCT00414206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111361873|NCT00414206|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
111361874|NCT00414206|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111361875|NCT00414206|Cholinergic Agents|cholinergic agents|mesh-ancestor
111361876|NCT00414206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111361877|NCT00414206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111361878|NCT05480046|Risperidone|risperidone|mesh-list
111361879|NCT05480046|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111361880|NCT05480046|Serotonin Agents|serotonin agents|mesh-ancestor
111361881|NCT05480046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111361882|NCT05480046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111361883|NCT05480046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111361884|NCT05480046|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111361885|NCT05480046|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111361886|NCT05480046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111361887|NCT05480046|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111361888|NCT05480046|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111361889|NCT05480046|Dopamine Agents|dopamine agents|mesh-ancestor
111361890|NCT04241640|Nefopam|nefopam|mesh-list
111361891|NCT04241640|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111361892|NCT04241640|Analgesics|analgesics|mesh-ancestor
111361893|NCT04241640|Sensory System Agents|sensory system agents|mesh-ancestor
111361894|NCT04241640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111361895|NCT04241640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111361896|NCT00462332|Vidarabine|vidarabine|mesh-list
111361897|NCT00462332|Fludarabine|fludarabine|mesh-list
111361898|NCT00462332|Fludarabine phosphate|fludarabine phosphate|mesh-list
111361899|NCT00462332|Alemtuzumab|alemtuzumab|mesh-list
111361900|NCT00462332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111361901|NCT00462332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111361902|NCT00462332|Antimetabolites|antimetabolites|mesh-ancestor
111125812|NCT03059303|Simeprevir|simeprevir|mesh-list
111361903|NCT00462332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111361904|NCT00462332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111361905|NCT00462332|Immunologic Factors|immunologic factors|mesh-ancestor
111361906|NCT00462332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111361907|NCT00462332|Antiviral Agents|antiviral agents|mesh-ancestor
111361908|NCT00462332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111361909|NCT00462332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111361910|NCT00462644|Fentanyl|fentanyl|mesh-list
111361911|NCT00462644|Midazolam|midazolam|mesh-list
111361912|NCT00462644|Etomidate|etomidate|mesh-list
111361913|NCT00462644|Succinylcholine|succinylcholine|mesh-list
111361914|NCT00462644|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111361915|NCT00462644|Narcotics|narcotics|mesh-ancestor
111361916|NCT00462644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111361917|NCT00462644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111361918|NCT00462644|Analgesics|analgesics|mesh-ancestor
111361919|NCT00462644|Sensory System Agents|sensory system agents|mesh-ancestor
111361920|NCT00462644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111361921|NCT00462644|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111361922|NCT00462644|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111361923|NCT00462644|Anesthetics, General|anesthetics, general|mesh-ancestor
111361924|NCT00462644|Anesthetics|anesthetics|mesh-ancestor
111361925|NCT00462644|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111361926|NCT00462644|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111361927|NCT00462644|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111361928|NCT00462644|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111361929|NCT00462644|GABA Modulators|gaba modulators|mesh-ancestor
111361930|NCT00462644|GABA Agents|gaba agents|mesh-ancestor
111361931|NCT00462644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111361932|NCT00462644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111361933|NCT00462644|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
111361934|NCT00462644|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
111361935|NCT00462644|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111361936|NCT00462722|Ibuprofen|ibuprofen|mesh-list
111361937|NCT00462722|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111125934|NCT04942769|Selenium|selenium|mesh-list
111361938|NCT00462722|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111361939|NCT00462722|Analgesics|analgesics|mesh-ancestor
111361940|NCT00462722|Sensory System Agents|sensory system agents|mesh-ancestor
111361941|NCT00462722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111361942|NCT00462722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111361943|NCT00462722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111361944|NCT00462722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111361945|NCT00462722|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111361946|NCT00462722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111361947|NCT00462722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111361948|NCT00528398|Cytarabine|cytarabine|mesh-list
111361949|NCT00528398|Idarubicin|idarubicin|mesh-list
111361950|NCT00528398|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111361951|NCT00528398|Antimetabolites|antimetabolites|mesh-ancestor
111361952|NCT00528398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111361953|NCT00528398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111361954|NCT00528398|Antiviral Agents|antiviral agents|mesh-ancestor
111361955|NCT00528398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111361956|NCT00528398|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111361957|NCT00528398|Immunologic Factors|immunologic factors|mesh-ancestor
111361958|NCT00528398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111361959|NCT00528398|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111361960|NCT00528398|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111361961|NCT00528398|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111361962|NCT00528398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111361963|NCT00528788|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
111361964|NCT00528788|Vitamins|vitamins|mesh-ancestor
111361965|NCT00528788|Micronutrients|micronutrients|mesh-ancestor
111361966|NCT00528788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111361967|NCT00528788|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111361968|NCT00414518|Ritonavir|ritonavir|mesh-list
111361969|NCT00414518|Lopinavir|lopinavir|mesh-list
111361970|NCT00414518|Tenofovir|tenofovir|mesh-list
111361971|NCT00414518|Emtricitabine|emtricitabine|mesh-list
111361972|NCT00414518|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111361973|NCT00414518|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111361974|NCT00414518|Protease Inhibitors|protease inhibitors|mesh-ancestor
111361975|NCT00414518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111361976|NCT00414518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111361977|NCT00414518|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111361978|NCT00414518|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111361979|NCT00414518|Antiviral Agents|antiviral agents|mesh-ancestor
111361980|NCT00414518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111361981|NCT00414518|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111361982|NCT00414518|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111361983|NCT00414518|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111361984|NCT00414518|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111361985|NCT01795664|Fluticasone|fluticasone|mesh-list
111361986|NCT01795664|Xhance|xhance|mesh-list
111361987|NCT01795664|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
111361988|NCT01795664|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
111361989|NCT01795664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111361990|NCT01795664|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111361991|NCT01795664|Autonomic Agents|autonomic agents|mesh-ancestor
111361992|NCT01795664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111361993|NCT01795664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111361994|NCT01795664|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111125991|NCT04426591|Biotin|biotin|mesh-list
111361995|NCT01795664|Respiratory System Agents|respiratory system agents|mesh-ancestor
111361996|NCT01795664|Dermatologic Agents|dermatologic agents|mesh-ancestor
111361997|NCT01795664|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111361998|NCT01795664|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111361999|NCT01795664|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111362000|NCT01795664|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111362001|NCT01795664|Adrenergic Agents|adrenergic agents|mesh-ancestor
111362002|NCT01795664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111362003|NCT01795664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111362004|NCT01795664|Glucocorticoids|glucocorticoids|mesh-ancestor
111362005|NCT01795664|Hormones|hormones|mesh-ancestor
111362006|NCT01795664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111362007|NCT01795664|Sympathomimetics|sympathomimetics|mesh-ancestor
111362008|NCT05271084|Pentoxifylline|pentoxifylline|mesh-list
111362009|NCT05271084|Dexetimide|dexetimide|mesh-list
111362010|NCT05271084|Citalopram|citalopram|mesh-list
111362011|NCT05271084|Escitalopram|escitalopram|mesh-list
111362012|NCT05271084|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111362013|NCT05271084|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111362014|NCT05271084|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111362015|NCT05271084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111362016|NCT05271084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111362017|NCT05271084|Serotonin Agents|serotonin agents|mesh-ancestor
111362018|NCT05271084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111362019|NCT05271084|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111362020|NCT05271084|Antidepressive Agents|antidepressive agents|mesh-ancestor
111362021|NCT05271084|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111362022|NCT05271084|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111362023|NCT05271084|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111362024|NCT05271084|Parasympatholytics|parasympatholytics|mesh-ancestor
111362025|NCT05271084|Autonomic Agents|autonomic agents|mesh-ancestor
111362026|NCT05271084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111362027|NCT05271084|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111362028|NCT05271084|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111362029|NCT05271084|Cholinergic Agents|cholinergic agents|mesh-ancestor
111362030|NCT05271084|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111362031|NCT05271084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111362032|NCT05271084|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111362033|NCT05271084|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111362034|NCT05271084|Protective Agents|protective agents|mesh-ancestor
111362035|NCT05271084|Vasodilator Agents|vasodilator agents|mesh-ancestor
111362036|NCT05271084|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111362037|NCT05271084|Antioxidants|antioxidants|mesh-ancestor
111362038|NCT00531518|Lamotrigine|lamotrigine|mesh-list
111362039|NCT00531518|Aripiprazole|aripiprazole|mesh-list
111362040|NCT00531518|Bupropion|bupropion|mesh-list
111362041|NCT00531518|Fluoxetine|fluoxetine|mesh-list
111362042|NCT00531518|Sertraline|sertraline|mesh-list
111362043|NCT00531518|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111362044|NCT00531518|Antidepressive Agents|antidepressive agents|mesh-ancestor
111362045|NCT00531518|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111362046|NCT00531518|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111362047|NCT00531518|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111362048|NCT00531518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111362049|NCT00531518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111362050|NCT00531518|Dopamine Agents|dopamine agents|mesh-ancestor
111362051|NCT00531518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111362052|NCT00531518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111362053|NCT00531518|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111362054|NCT00531518|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111362055|NCT00531518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111362056|NCT00531518|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111362057|NCT00531518|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111362058|NCT00531518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111362059|NCT00531518|Dopamine Agonists|dopamine agonists|mesh-ancestor
111362060|NCT00531518|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111362061|NCT00531518|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111362062|NCT00531518|Serotonin Agents|serotonin agents|mesh-ancestor
111362063|NCT00531518|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111362064|NCT00531518|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111362065|NCT00531518|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111362066|NCT00531518|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111362067|NCT00531518|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111362068|NCT00531518|Anticonvulsants|anticonvulsants|mesh-ancestor
111362069|NCT00531518|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111362070|NCT00531518|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111362071|NCT00531518|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111362072|NCT00533546|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
111362073|NCT00533546|Protein C|protein c|mesh-list
111362074|NCT00533546|Anticoagulants|anticoagulants|mesh-ancestor
111362075|NCT00533546|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111362076|NCT00533546|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111362077|NCT00533546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111362078|NCT00533546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111362079|NCT00534794|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
111362080|NCT00534794|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111362081|NCT00534794|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111362083|NCT00534794|Sensory System Agents|sensory system agents|mesh-ancestor
111362084|NCT00534794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111362085|NCT00534794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111362086|NCT00534794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111362087|NCT00534794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111362088|NCT00534794|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111362089|NCT00534794|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
111362090|NCT00534794|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111362091|NCT00534794|Histamine Antagonists|histamine antagonists|mesh-ancestor
111362092|NCT00534794|Histamine Agents|histamine agents|mesh-ancestor
111362093|NCT00534794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111362094|NCT00534794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111362095|NCT01658436|Dactolisib|dactolisib|mesh-list
111362096|NCT01658436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111362097|NCT05168280|Dexmedetomidine|dexmedetomidine|mesh-list
111362098|NCT05168280|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111362099|NCT05168280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111362100|NCT05168280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111362101|NCT05168280|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111362102|NCT05168280|Analgesics|analgesics|mesh-ancestor
111362103|NCT05168280|Sensory System Agents|sensory system agents|mesh-ancestor
111362104|NCT05168280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111362105|NCT05168280|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111362106|NCT05168280|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111362107|NCT05168280|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111362108|NCT05168280|Adrenergic Agents|adrenergic agents|mesh-ancestor
111362109|NCT05168280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111362110|NCT05168280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111362111|NCT05053854|Talazoparib|talazoparib|mesh-list
111362112|NCT05053854|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111362113|NCT05053854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111362114|NCT05053854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111362115|NCT05053854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111362116|NCT00464204|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
111362117|NCT00464204|Plasma Substitutes|plasma substitutes|mesh-ancestor
111362118|NCT00464204|Blood Substitutes|blood substitutes|mesh-ancestor
111362119|NCT00464438|Moxifloxacin|moxifloxacin|mesh-list
111362120|NCT00464438|Gatifloxacin|gatifloxacin|mesh-list
111362121|NCT00464438|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111362122|NCT00464438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111362123|NCT00464438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111362124|NCT00464438|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111362125|NCT00464438|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111362126|NCT00464438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111362127|NCT00464438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111362128|NCT00464438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111362129|NCT00464438|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111362130|NCT00465530|Gentamicins|gentamicins|mesh-list
111362131|NCT00465530|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111362132|NCT00465530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111362133|NCT00465530|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111362134|NCT00465530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111362135|NCT00465530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111362136|NCT00466310|Risperidone|risperidone|mesh-list
111362137|NCT00466310|Aripiprazole|aripiprazole|mesh-list
111362138|NCT00466310|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111362139|NCT00466310|Serotonin Agents|serotonin agents|mesh-ancestor
111362140|NCT00466310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111362141|NCT00466310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111362142|NCT00466310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111362143|NCT00466310|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111362144|NCT00466310|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111362145|NCT00466310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111362146|NCT00466310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111362147|NCT00466310|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111362148|NCT00466310|Dopamine Agents|dopamine agents|mesh-ancestor
111362149|NCT00466310|Antidepressive Agents|antidepressive agents|mesh-ancestor
111362150|NCT00466310|Dopamine Agonists|dopamine agonists|mesh-ancestor
111362151|NCT00466310|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111362152|NCT00466310|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111362153|NCT00466310|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110959206|NCT02582632|Protease Inhibitors|protease inhibitors|mesh-ancestor
111362154|NCT00466310|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111362155|NCT03463460|Pembrolizumab|pembrolizumab|mesh-list
111362157|NCT03463460|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111362158|NCT03463460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111362159|NCT03463460|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111362160|NCT03463460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111362161|NCT03463460|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111362162|NCT03463460|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111362163|NCT03463460|Growth Substances|growth substances|mesh-ancestor
111362164|NCT03463460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111362165|NCT03463460|Growth Inhibitors|growth inhibitors|mesh-ancestor
111362166|NCT03463460|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111362167|NCT03463460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111362168|NCT00535652|Ertapenem|ertapenem|mesh-list
111362169|NCT00535652|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111362170|NCT00535652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111362171|NCT00418028|Capecitabine|capecitabine|mesh-list
111362172|NCT00418028|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111362173|NCT00418028|Antimetabolites|antimetabolites|mesh-ancestor
111362174|NCT00418028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111362175|NCT00418028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111362176|NCT00537290|Rituximab|rituximab|mesh-list
111362177|NCT00537290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111362178|NCT00537290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111362179|NCT00537290|Immunologic Factors|immunologic factors|mesh-ancestor
111362180|NCT00537290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111362181|NCT00537290|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111362182|NCT00538304|Bimatoprost|bimatoprost|mesh-list
111362183|NCT00538304|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111362184|NCT00538304|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111362185|NCT00538304|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111362186|NCT00538616|Dexmedetomidine|dexmedetomidine|mesh-list
111362187|NCT00538616|Propofol|propofol|mesh-list
111362188|NCT00538616|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111362189|NCT00538616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111362190|NCT00538616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111362191|NCT00538616|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111362192|NCT00538616|Analgesics|analgesics|mesh-ancestor
111362193|NCT00538616|Sensory System Agents|sensory system agents|mesh-ancestor
111362194|NCT00538616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111362195|NCT00538616|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111362196|NCT00538616|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111362197|NCT00538616|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111362198|NCT00538616|Adrenergic Agents|adrenergic agents|mesh-ancestor
111362199|NCT00538616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111362200|NCT00538616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111362201|NCT00538616|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111362202|NCT00538616|Anesthetics, General|anesthetics, general|mesh-ancestor
111362203|NCT00538616|Anesthetics|anesthetics|mesh-ancestor
111362204|NCT00469274|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111362205|NCT00469274|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
111362206|NCT00469274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111362207|NCT00469274|Antitubercular Agents|antitubercular agents|mesh-ancestor
111362208|NCT05157126|Gentamicins|gentamicins|mesh-list
111362209|NCT05157126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111362210|NCT05157126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111362211|NCT05157126|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111362212|NCT05157126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111362213|NCT05157126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111362214|NCT00469508|Modafinil|modafinil|mesh-list
111126409|NCT02807779|Glucocorticoids|glucocorticoids|mesh-ancestor
111362215|NCT00469508|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111362216|NCT00469508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111362217|NCT00469508|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
111362218|NCT00469508|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111362219|NCT00469508|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111362220|NCT00469508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111362221|NCT05096832|Vaccines|vaccines|mesh-list
111362222|NCT05096832|Immunologic Factors|immunologic factors|mesh-ancestor
111362223|NCT05096832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111362224|NCT00470600|Ibuprofen|ibuprofen|mesh-list
111362225|NCT00470600|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111362226|NCT00470600|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111362227|NCT00470600|Analgesics|analgesics|mesh-ancestor
111362228|NCT00470600|Sensory System Agents|sensory system agents|mesh-ancestor
111362229|NCT00470600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111362230|NCT00470600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111362231|NCT00470600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111126464|NCT02333149|Melatonin|melatonin|mesh-list
111362232|NCT00470600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111362233|NCT00470600|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111362234|NCT00470600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111362235|NCT00470600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111362236|NCT00471068|Timolol|timolol|mesh-list
111362237|NCT00471068|Travoprost|travoprost|mesh-list
111362238|NCT00471068|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111362239|NCT00471068|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111362240|NCT00471068|Adrenergic Agents|adrenergic agents|mesh-ancestor
111362241|NCT00471068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111362242|NCT00471068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111362243|NCT00471068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111362244|NCT00471068|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111362245|NCT00471068|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111362246|NCT00471380|Timolol|timolol|mesh-list
111362247|NCT00471380|Travoprost|travoprost|mesh-list
111362248|NCT00471380|Dorzolamide|dorzolamide|mesh-list
111362249|NCT00471380|Brinzolamide|brinzolamide|mesh-list
111362250|NCT00471380|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111362251|NCT00471380|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111362252|NCT00471380|Adrenergic Agents|adrenergic agents|mesh-ancestor
111362253|NCT00471380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111362254|NCT00471380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111362255|NCT00471380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111362256|NCT00471380|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111362257|NCT00471380|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111362258|NCT00471380|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
111362259|NCT00471380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111362260|NCT00538850|Fentanyl|fentanyl|mesh-list
111362261|NCT00538850|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111362262|NCT00538850|Narcotics|narcotics|mesh-ancestor
111362263|NCT00538850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111362264|NCT00538850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111362265|NCT00538850|Analgesics|analgesics|mesh-ancestor
111362266|NCT00538850|Sensory System Agents|sensory system agents|mesh-ancestor
111362267|NCT00538850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111362268|NCT00538850|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111362269|NCT00538850|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111362270|NCT00538850|Anesthetics, General|anesthetics, general|mesh-ancestor
111362271|NCT00538850|Anesthetics|anesthetics|mesh-ancestor
111362272|NCT00418262|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
111362273|NCT00418262|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111362274|NCT00418262|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111362275|NCT00418262|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111362276|NCT00418262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111362277|NCT00418262|Adrenergic Agents|adrenergic agents|mesh-ancestor
111362278|NCT00418262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111362279|NCT00418262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111362280|NCT00418574|Abagovomab|abagovomab|mesh-list
111362281|NCT00418574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111362282|NCT00418574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111362283|NCT00473642|Ranibizumab|ranibizumab|mesh-list
111362284|NCT00473642|Verteporfin|verteporfin|mesh-list
111362285|NCT00473642|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111362286|NCT00473642|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111362287|NCT00473642|Growth Substances|growth substances|mesh-ancestor
111362288|NCT00473642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111362289|NCT00473642|Growth Inhibitors|growth inhibitors|mesh-ancestor
111362290|NCT00473642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111362291|NCT00473642|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111362292|NCT00473642|Dermatologic Agents|dermatologic agents|mesh-ancestor
111362293|NCT00539942|PENTA|penta|mesh-list
111362294|NCT00539942|Fondaparinux|fondaparinux|mesh-list
111362295|NCT00539942|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111126777|NCT01597193|Exemestane|exemestane|mesh-list
111362296|NCT00539942|Antithrombins|antithrombins|mesh-ancestor
111362297|NCT00539942|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111362298|NCT00539942|Protease Inhibitors|protease inhibitors|mesh-ancestor
111362299|NCT00539942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111362300|NCT00539942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111362301|NCT00539942|Anticoagulants|anticoagulants|mesh-ancestor
111362302|NCT00539942|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111362303|NCT00539942|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111362304|NCT00419666|Calcitriol|calcitriol|mesh-list
111362305|NCT00419666|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111362306|NCT00419666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111362307|NCT00419666|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
111362308|NCT00419666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111362309|NCT00419666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111362310|NCT00419666|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111362311|NCT00419666|Vitamins|vitamins|mesh-ancestor
111362312|NCT00419666|Micronutrients|micronutrients|mesh-ancestor
111362313|NCT00419666|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111362314|NCT00540722|Acetic Acid|acetic acid|mesh-list
111362315|NCT00540722|Retinol acetate|retinol acetate|mesh-list
111362316|NCT00540722|Gossypol acetic acid|gossypol acetic acid|mesh-list
111362317|NCT00540722|Gossypol|gossypol|mesh-list
111362318|NCT00540722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111362319|NCT00540722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111362320|NCT00540722|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111362321|NCT00540722|Immunologic Factors|immunologic factors|mesh-ancestor
111362322|NCT00540722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111362323|NCT00540722|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
111362324|NCT00540722|Protective Agents|protective agents|mesh-ancestor
111126977|NCT03056495|Vorinostat|vorinostat|mesh-list
111362325|NCT00540722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111362326|NCT00540722|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
111362327|NCT00540722|Contraceptive Agents|contraceptive agents|mesh-ancestor
111362328|NCT00540722|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111362329|NCT00540722|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111362330|NCT00540722|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111362331|NCT00540722|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
111362332|NCT00540722|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
111362333|NCT00542750|Acetylcysteine|acetylcysteine|mesh-list
111362334|NCT00542750|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111362335|NCT00542750|Antiviral Agents|antiviral agents|mesh-ancestor
111362336|NCT00542750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111362337|NCT00542750|Expectorants|expectorants|mesh-ancestor
111362338|NCT00542750|Respiratory System Agents|respiratory system agents|mesh-ancestor
111362339|NCT00542750|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111362340|NCT00542750|Antioxidants|antioxidants|mesh-ancestor
111362341|NCT00542750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111362342|NCT00542750|Protective Agents|protective agents|mesh-ancestor
111362343|NCT00542750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111362344|NCT00542750|Antidotes|antidotes|mesh-ancestor
111362345|NCT00475904|Gabapentin|gabapentin|mesh-list
111362346|NCT00475904|Analgesics|analgesics|mesh-ancestor
111362347|NCT00475904|Sensory System Agents|sensory system agents|mesh-ancestor
111362348|NCT00475904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111362349|NCT00475904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111362350|NCT00475904|Anticonvulsants|anticonvulsants|mesh-ancestor
111362351|NCT00475904|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111362352|NCT00475904|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111362353|NCT00475904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111362354|NCT00475904|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111362355|NCT00475904|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111362356|NCT00475904|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111362357|NCT00475904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111362358|NCT00475904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111362359|NCT00475904|Antimanic Agents|antimanic agents|mesh-ancestor
111362360|NCT00420992|Naltrexone|naltrexone|mesh-list
111362361|NCT00420992|Morphine|morphine|mesh-list
111362362|NCT00420992|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111362363|NCT00420992|Narcotics|narcotics|mesh-ancestor
111362364|NCT00420992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111362365|NCT00420992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111362366|NCT00420992|Analgesics|analgesics|mesh-ancestor
111362367|NCT00420992|Sensory System Agents|sensory system agents|mesh-ancestor
111362368|NCT00420992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111362369|NCT00420992|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111362370|NCT00420992|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111362371|NCT00423878|Olanzapine|olanzapine|mesh-list
111362372|NCT00423878|Risperidone|risperidone|mesh-list
111362373|NCT00423878|Aripiprazole|aripiprazole|mesh-list
111362374|NCT00423878|Quetiapine Fumarate|quetiapine fumarate|mesh-list
111362375|NCT00423878|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111362376|NCT00423878|Serotonin Agents|serotonin agents|mesh-ancestor
111362377|NCT00423878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111362378|NCT00423878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111362379|NCT00423878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111362380|NCT00423878|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111362381|NCT00423878|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111362382|NCT00423878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111362383|NCT00423878|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111362384|NCT00423878|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111362385|NCT00423878|Dopamine Agents|dopamine agents|mesh-ancestor
111362386|NCT00423878|Antiemetics|antiemetics|mesh-ancestor
111362387|NCT00423878|Autonomic Agents|autonomic agents|mesh-ancestor
111362388|NCT00423878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111362389|NCT00423878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111362390|NCT00423878|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111362391|NCT00423878|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111362392|NCT00423878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111362393|NCT00423878|Antidepressive Agents|antidepressive agents|mesh-ancestor
111362394|NCT00423878|Dopamine Agonists|dopamine agonists|mesh-ancestor
111362395|NCT00423878|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111362396|NCT00423878|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111362397|NCT00423878|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111362398|NCT00423878|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111362399|NCT00480740|Dexmedetomidine|dexmedetomidine|mesh-list
111362400|NCT00480740|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111362401|NCT00480740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111362402|NCT00480740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111362403|NCT00480740|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111362404|NCT00480740|Analgesics|analgesics|mesh-ancestor
111362405|NCT00480740|Sensory System Agents|sensory system agents|mesh-ancestor
111362406|NCT00480740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111362407|NCT00480740|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111362408|NCT00480740|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111362409|NCT00480740|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111362410|NCT00480740|Adrenergic Agents|adrenergic agents|mesh-ancestor
111362411|NCT00480740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111362412|NCT00480740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111362413|NCT00424502|Rituximab|rituximab|mesh-list
111362414|NCT00424502|Methotrexate|methotrexate|mesh-list
111362415|NCT00424502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111362416|NCT00424502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111362417|NCT00424502|Immunologic Factors|immunologic factors|mesh-ancestor
111362418|NCT00424502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111362419|NCT00424502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111362420|NCT00424502|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111362421|NCT00424502|Abortifacient Agents|abortifacient agents|mesh-ancestor
111362422|NCT00424502|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111362423|NCT00424502|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111362424|NCT00424502|Antimetabolites|antimetabolites|mesh-ancestor
111362425|NCT00424502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111362426|NCT00424502|Dermatologic Agents|dermatologic agents|mesh-ancestor
111362427|NCT00424502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111362428|NCT00424502|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111362429|NCT00424502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111362430|NCT00424502|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111362431|NCT00425672|Interleukin-2|interleukin-2|mesh-list
111362432|NCT00425672|Denileukin diftitox|denileukin diftitox|mesh-list
111362433|NCT00425672|Immunotoxins|immunotoxins|mesh-list
111362434|NCT00425672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111362435|NCT00425672|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111362436|NCT00425672|Analgesics|analgesics|mesh-ancestor
111362437|NCT00425672|Sensory System Agents|sensory system agents|mesh-ancestor
111362438|NCT00425672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111362439|NCT00425672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111362440|NCT00425672|Immunoconjugates|immunoconjugates|mesh-ancestor
111362441|NCT00425672|Immunologic Factors|immunologic factors|mesh-ancestor
111362442|NCT00544076|Sildenafil Citrate|sildenafil citrate|mesh-list
111362443|NCT00544076|Alprostadil|alprostadil|mesh-list
111362444|NCT00544076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111362445|NCT00544076|Vasodilator Agents|vasodilator agents|mesh-ancestor
111362446|NCT00544076|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111362447|NCT00544076|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111362448|NCT00544076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111362449|NCT00544076|Urological Agents|urological agents|mesh-ancestor
111362450|NCT00544076|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111362451|NCT00544778|Doxorubicin|doxorubicin|mesh-list
111362452|NCT00544778|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111362453|NCT00544778|Dexrazoxane|dexrazoxane|mesh-list
111362454|NCT00544778|Irinotecan|irinotecan|mesh-list
111362455|NCT00544778|Ifosfamide|ifosfamide|mesh-list
111362456|NCT00544778|Razoxane|razoxane|mesh-list
111362457|NCT00544778|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111362458|NCT00544778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111362459|NCT00544778|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111127504|NCT04900415|Vitamin A|vitamin a|mesh-list
111362460|NCT00544778|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111362461|NCT00544778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111362462|NCT00544778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111362463|NCT00544778|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111362464|NCT00544778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111362465|NCT00544778|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111362466|NCT00544778|Alkylating Agents|alkylating agents|mesh-ancestor
111362467|NCT00544778|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111362468|NCT00544778|Protective Agents|protective agents|mesh-ancestor
111362469|NCT00544778|Antimitotic Agents|antimitotic agents|mesh-ancestor
111362470|NCT00544778|Mitosis Modulators|mitosis modulators|mesh-ancestor
111362471|NCT00484874|Tositumomab I-131|tositumomab i-131|mesh-list
111362472|NCT00484874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111362473|NCT00486824|Indomethacin|indomethacin|mesh-list
111362474|NCT00486824|Nifedipine|nifedipine|mesh-list
111362475|NCT00486824|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111362476|NCT00486824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111362477|NCT00486824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111362478|NCT00486824|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111362479|NCT00486824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111362480|NCT00486824|Vasodilator Agents|vasodilator agents|mesh-ancestor
111362481|NCT00486824|Tocolytic Agents|tocolytic agents|mesh-ancestor
111127707|NCT04881851|Folic Acid|folic acid|mesh-list
111362482|NCT00486824|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111362483|NCT00486824|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111362484|NCT00486824|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111362485|NCT00486824|Analgesics|analgesics|mesh-ancestor
111362486|NCT00486824|Sensory System Agents|sensory system agents|mesh-ancestor
111362487|NCT00486824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111362488|NCT00486824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111362489|NCT00486824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111362490|NCT00486824|Gout Suppressants|gout suppressants|mesh-ancestor
111362491|NCT00486824|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111362492|NCT00486824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111362493|NCT00489086|Tazarotene|tazarotene|mesh-list
111362494|NCT00489086|Dermatologic Agents|dermatologic agents|mesh-ancestor
111362495|NCT00489086|Keratolytic Agents|keratolytic agents|mesh-ancestor
111362496|NCT00489866|Aripiprazole|aripiprazole|mesh-list
111362497|NCT00489866|Antidepressive Agents|antidepressive agents|mesh-ancestor
111362498|NCT00489866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111362499|NCT00489866|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111362500|NCT00489866|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111362501|NCT00489866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111362502|NCT00489866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111362503|NCT00489866|Dopamine Agonists|dopamine agonists|mesh-ancestor
111362504|NCT00489866|Dopamine Agents|dopamine agents|mesh-ancestor
111362505|NCT00489866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111362506|NCT00489866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111362507|NCT00489866|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111362508|NCT00489866|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111362509|NCT00489866|Serotonin Agents|serotonin agents|mesh-ancestor
111362510|NCT00489866|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111362511|NCT00489866|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111362512|NCT00489866|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111362513|NCT00489866|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111362514|NCT00546104|Dasatinib|dasatinib|mesh-list
111362515|NCT00546104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111362516|NCT00546104|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111362517|NCT00546104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111362518|NCT00546104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111362519|NCT00546728|Metformin|metformin|mesh-list
111362520|NCT00546728|Exenatide|exenatide|mesh-list
111362521|NCT00546728|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111362522|NCT00546728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111362523|NCT00546728|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111362524|NCT00546728|Incretins|incretins|mesh-ancestor
111362525|NCT00546728|Hormones|hormones|mesh-ancestor
111362526|NCT00546728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111362527|NCT00547586|Bromides|bromides|mesh-list
111362528|NCT00547586|Methylnaltrexone|methylnaltrexone|mesh-list
111362529|NCT00547586|Anticonvulsants|anticonvulsants|mesh-ancestor
111362530|NCT00547586|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111086930|NCT02496377|Glycine|glycine|mesh-list
111362531|NCT00547586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111362532|NCT00547586|Sensory System Agents|sensory system agents|mesh-ancestor
111362533|NCT00547586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111362534|NCT00548132|Chlorhexidine|chlorhexidine|mesh-list
111362535|NCT00548132|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111128112|NCT03044873|Antimetabolites|antimetabolites|mesh-ancestor
111362536|NCT00548132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111362537|NCT00548132|Disinfectants|disinfectants|mesh-ancestor
111362538|NCT00490100|Mecasermin|mecasermin|mesh-list
111362539|NCT00490100|Growth Substances|growth substances|mesh-ancestor
111362540|NCT00490100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111362541|NCT00490802|Oxytocin|oxytocin|mesh-list
111362542|NCT00490802|Oxytocics|oxytocics|mesh-ancestor
111362543|NCT00490802|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111362544|NCT00490802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111362545|NCT00550394|Topiramate|topiramate|mesh-list
111362546|NCT00550394|Quetiapine Fumarate|quetiapine fumarate|mesh-list
111362547|NCT00550394|Antidepressive Agents|antidepressive agents|mesh-ancestor
111362548|NCT00550394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111362549|NCT00550394|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111362550|NCT00550394|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111362551|NCT00550394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111362552|NCT00550394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111362553|NCT00550394|Anticonvulsants|anticonvulsants|mesh-ancestor
111362554|NCT00550394|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111362555|NCT00550862|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
111362556|NCT00550862|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
111362557|NCT00550862|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111362558|NCT00551174|Ibandronic Acid|ibandronic acid|mesh-list
111362559|NCT00551174|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111362560|NCT00551174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111362561|NCT00492206|Cetuximab|cetuximab|mesh-list
111362562|NCT00492206|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111362563|NCT00492206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111128362|NCT02455141|Taxane|taxane|mesh-list
111362564|NCT00431132|Estradiol|estradiol|mesh-list
111362565|NCT00431132|Estrogens|estrogens|mesh-ancestor
111362566|NCT00431132|Hormones|hormones|mesh-ancestor
111362567|NCT00431132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111362568|NCT00431132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111362569|NCT00493064|Niacin|niacin|mesh-list
111362570|NCT00493064|Nicotinic Acids|nicotinic acids|mesh-list
111362571|NCT00493064|Niacinamide|niacinamide|mesh-list
111362572|NCT00493064|Prednisolone|prednisolone|mesh-list
111362573|NCT00493064|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111362574|NCT00493064|Methylprednisolone|methylprednisolone|mesh-list
111362575|NCT00493064|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111362576|NCT00493064|Prednisolone acetate|prednisolone acetate|mesh-list
111362577|NCT00493064|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111362578|NCT00493064|Prednisolone phosphate|prednisolone phosphate|mesh-list
111362579|NCT00493064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111362580|NCT00493064|Glucocorticoids|glucocorticoids|mesh-ancestor
111362581|NCT00493064|Hormones|hormones|mesh-ancestor
111362582|NCT00493064|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111362583|NCT00493064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111362584|NCT00493064|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111362585|NCT00493064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111362586|NCT00493064|Antiemetics|antiemetics|mesh-ancestor
111362587|NCT00493064|Autonomic Agents|autonomic agents|mesh-ancestor
111362588|NCT00493064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111362589|NCT00493064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111362590|NCT00493064|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111362591|NCT00493064|Protective Agents|protective agents|mesh-ancestor
111362592|NCT00493064|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111362593|NCT00493064|Antimetabolites|antimetabolites|mesh-ancestor
111362594|NCT00493064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111362595|NCT00493064|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111362596|NCT00493064|Vasodilator Agents|vasodilator agents|mesh-ancestor
111362597|NCT00493064|Vitamin B Complex|vitamin b complex|mesh-ancestor
111362598|NCT00493064|Vitamins|vitamins|mesh-ancestor
111362599|NCT00493064|Micronutrients|micronutrients|mesh-ancestor
111362600|NCT00552422|Domperidone|domperidone|mesh-list
111362601|NCT00552422|Antiemetics|antiemetics|mesh-ancestor
111362602|NCT00552422|Autonomic Agents|autonomic agents|mesh-ancestor
111362603|NCT00552422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111362604|NCT00552422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111362605|NCT00552422|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111362606|NCT00552422|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111362607|NCT00552422|Dopamine Agents|dopamine agents|mesh-ancestor
111362608|NCT00552422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111362609|NCT00552422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111362610|NCT00432458|Zoledronic Acid|zoledronic acid|mesh-list
111362611|NCT00432458|Thalidomide|thalidomide|mesh-list
111362612|NCT00432458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111362613|NCT00432458|Immunologic Factors|immunologic factors|mesh-ancestor
111362614|NCT00432458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111362615|NCT00432458|Leprostatic Agents|leprostatic agents|mesh-ancestor
111362616|NCT00432458|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111362617|NCT00432458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111362618|NCT00432458|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111362619|NCT00432458|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111362620|NCT00432458|Growth Substances|growth substances|mesh-ancestor
111362621|NCT00432458|Growth Inhibitors|growth inhibitors|mesh-ancestor
111362622|NCT00432458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111362623|NCT00432458|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111362624|NCT00433550|Capecitabine|capecitabine|mesh-list
111362625|NCT00433550|Oxaliplatin|oxaliplatin|mesh-list
111362626|NCT00433550|Irinotecan|irinotecan|mesh-list
111362627|NCT00433550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111362628|NCT00433550|Antimetabolites|antimetabolites|mesh-ancestor
111362629|NCT00433550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111362630|NCT00433550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111362631|NCT00433550|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111362632|NCT00433550|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111128775|NCT05244811|Hormones|hormones|mesh-ancestor
111362633|NCT00433550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111362634|NCT02208037|Mycophenolic Acid|mycophenolic acid|mesh-list
111362635|NCT02208037|Maraviroc|maraviroc|mesh-list
111362636|NCT02208037|Cyclophosphamide|cyclophosphamide|mesh-list
111362637|NCT02208037|Methotrexate|methotrexate|mesh-list
111362638|NCT02208037|Bortezomib|bortezomib|mesh-list
111362639|NCT02208037|Tacrolimus|tacrolimus|mesh-list
111362640|NCT02208037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111362641|NCT02208037|Immunologic Factors|immunologic factors|mesh-ancestor
111362642|NCT02208037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111362643|NCT02208037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111362644|NCT02208037|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111362645|NCT02208037|Alkylating Agents|alkylating agents|mesh-ancestor
111362646|NCT02208037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111362647|NCT02208037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111362648|NCT02208037|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111362649|NCT02208037|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111362650|NCT02208037|Abortifacient Agents|abortifacient agents|mesh-ancestor
111362651|NCT02208037|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111362652|NCT02208037|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111362653|NCT02208037|Antimetabolites|antimetabolites|mesh-ancestor
111362654|NCT02208037|Dermatologic Agents|dermatologic agents|mesh-ancestor
111362655|NCT02208037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111362656|NCT02208037|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111362657|NCT02208037|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111362658|NCT02208037|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111362659|NCT02208037|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111362660|NCT02208037|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111362661|NCT02208037|Antitubercular Agents|antitubercular agents|mesh-ancestor
111362662|NCT02208037|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111362663|NCT02208037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111362664|NCT02208037|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
111362665|NCT02208037|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
111362666|NCT02208037|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111362667|NCT02208037|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111362668|NCT02208037|Antiviral Agents|antiviral agents|mesh-ancestor
111362669|NCT02208037|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
111362670|NCT03007927|Dexamethasone|dexamethasone|mesh-list
111362671|NCT03007927|Bupivacaine|bupivacaine|mesh-list
111362672|NCT03007927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111362673|NCT03007927|Antiemetics|antiemetics|mesh-ancestor
111362674|NCT03007927|Autonomic Agents|autonomic agents|mesh-ancestor
111362675|NCT03007927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111362676|NCT03007927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111362677|NCT03007927|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111362678|NCT03007927|Glucocorticoids|glucocorticoids|mesh-ancestor
111362679|NCT03007927|Hormones|hormones|mesh-ancestor
111362680|NCT03007927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111362681|NCT03007927|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111362682|NCT03007927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111362683|NCT03007927|Anesthetics, Local|anesthetics, local|mesh-ancestor
111362684|NCT03007927|Anesthetics|anesthetics|mesh-ancestor
111362685|NCT03007927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111362686|NCT03007927|Sensory System Agents|sensory system agents|mesh-ancestor
111362687|NCT05150496|Vaccines|vaccines|mesh-list
111362688|NCT05150496|Immunologic Factors|immunologic factors|mesh-ancestor
111362689|NCT05150496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111362690|NCT00496340|Rituximab|rituximab|mesh-list
111362691|NCT00496340|Busulfan|busulfan|mesh-list
111362692|NCT00496340|Pentostatin|pentostatin|mesh-list
111362693|NCT00496340|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111362694|NCT00496340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111362695|NCT00496340|Immunologic Factors|immunologic factors|mesh-ancestor
111129008|NCT04839653|Vancomycin|vancomycin|mesh-list
111362696|NCT00496340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111362697|NCT00496340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111362698|NCT00496340|Alkylating Agents|alkylating agents|mesh-ancestor
111362699|NCT00496340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111362700|NCT00496340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111362701|NCT00496340|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111362702|NCT00496340|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111362703|NCT00496340|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
111362704|NCT00496340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111362705|NCT00496808|Trastuzumab|trastuzumab|mesh-list
111362706|NCT00496808|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111362707|NCT00496808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111362708|NCT01795820|Ticagrelor|ticagrelor|mesh-list
111362709|NCT01795820|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111362710|NCT01795820|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111362711|NCT01795820|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111362712|NCT01795820|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111362713|NCT01795820|Purinergic Agents|purinergic agents|mesh-ancestor
111362714|NCT01795820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111362715|NCT01795820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111362716|NCT01795820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111362717|NCT01484041|Aromatase Inhibitors|aromatase inhibitors|mesh-list
111362718|NCT01484041|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111362719|NCT01484041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111362720|NCT01484041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111362721|NCT01484041|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111362722|NCT01484041|Hormone Antagonists|hormone antagonists|mesh-ancestor
111362723|NCT01484041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111362724|NCT01484041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111362725|NCT00555152|Lapatinib|lapatinib|mesh-list
111362726|NCT00555152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111362727|NCT00555152|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111362728|NCT00555152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111362729|NCT00555152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111362730|NCT01461499|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
111362731|NCT01461499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111362732|NCT00555464|Prednisone|prednisone|mesh-list
111362733|NCT00555464|Prednisolone|prednisolone|mesh-list
111129136|NCT03042377|Calcium, Dietary|calcium, dietary|mesh-list
111362734|NCT00555464|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111362735|NCT00555464|Methylprednisolone|methylprednisolone|mesh-list
111362736|NCT00555464|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111362737|NCT00555464|Prednisolone acetate|prednisolone acetate|mesh-list
111362738|NCT00555464|Vincristine|vincristine|mesh-list
111362739|NCT00555464|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111362740|NCT00555464|Prednisolone phosphate|prednisolone phosphate|mesh-list
111362741|NCT00555464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111362742|NCT00555464|Glucocorticoids|glucocorticoids|mesh-ancestor
111362743|NCT00555464|Hormones|hormones|mesh-ancestor
111362744|NCT00555464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111362745|NCT00555464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111362746|NCT00555464|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111362747|NCT00555464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111362748|NCT00555464|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111362749|NCT00555464|Tubulin Modulators|tubulin modulators|mesh-ancestor
111362750|NCT00555464|Antimitotic Agents|antimitotic agents|mesh-ancestor
111129252|NCT02643355|Analgesics|analgesics|mesh-ancestor
111362751|NCT00555464|Mitosis Modulators|mitosis modulators|mesh-ancestor
111362752|NCT00555464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111362753|NCT00555464|Antiemetics|antiemetics|mesh-ancestor
111362754|NCT00555464|Autonomic Agents|autonomic agents|mesh-ancestor
111362755|NCT00555464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111362756|NCT00555464|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111362757|NCT00555464|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111362758|NCT00555464|Protective Agents|protective agents|mesh-ancestor
111362759|NCT01795976|Cyclophosphamide|cyclophosphamide|mesh-list
111362760|NCT01795976|Fludarabine|fludarabine|mesh-list
111362761|NCT01795976|Interleukin-2|interleukin-2|mesh-list
111362762|NCT01795976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111362763|NCT01795976|Immunologic Factors|immunologic factors|mesh-ancestor
111362764|NCT01795976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111362765|NCT01795976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111362766|NCT01795976|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111362767|NCT01795976|Alkylating Agents|alkylating agents|mesh-ancestor
111129385|NCT00731185|Dermatologic Agents|dermatologic agents|mesh-ancestor
111362768|NCT01795976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111362769|NCT01795976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111362770|NCT01795976|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111362771|NCT01795976|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111362772|NCT01795976|Analgesics|analgesics|mesh-ancestor
111362773|NCT01795976|Sensory System Agents|sensory system agents|mesh-ancestor
111362774|NCT01795976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111362775|NCT01461733|Amiodarone|amiodarone|mesh-list
111362776|NCT01461733|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111362777|NCT01461733|Vasodilator Agents|vasodilator agents|mesh-ancestor
111362778|NCT01461733|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
111362779|NCT01461733|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111362780|NCT01461733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111362781|NCT01461733|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111362782|NCT01461733|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111362783|NCT01461733|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111362784|NCT01461733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111362785|NCT01461733|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111362786|NCT01461733|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111129667|NCT05035849|Acarbose|acarbose|mesh-list
111362787|NCT01461733|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111362788|NCT01462279|Thiamine|thiamine|mesh-list
111362789|NCT01462279|Vitamin B Complex|vitamin b complex|mesh-ancestor
111362790|NCT01462279|Vitamins|vitamins|mesh-ancestor
111362791|NCT01462279|Micronutrients|micronutrients|mesh-ancestor
111362792|NCT01462279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111362793|NCT00435812|Vaccines|vaccines|mesh-list
111362794|NCT00435812|Immunologic Factors|immunologic factors|mesh-ancestor
111362795|NCT00435812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111362796|NCT05081466|Vitamin D|vitamin d|mesh-list
111362797|NCT05081466|Calcium|calcium|mesh-list
111362798|NCT05081466|Vitamins|vitamins|mesh-ancestor
111362799|NCT05081466|Micronutrients|micronutrients|mesh-ancestor
111362800|NCT05081466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111362801|NCT05081466|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111362802|NCT05081466|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111362803|NCT01464229|Iloperidone|iloperidone|mesh-list
111362804|NCT01464229|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111362805|NCT01464229|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111362806|NCT01464229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111362807|NCT01464229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111362808|NCT01464229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111362809|NCT00556478|Lidocaine|lidocaine|mesh-list
111362810|NCT00556478|Prilocaine|prilocaine|mesh-list
111362811|NCT00556478|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
111362812|NCT00556478|Anesthetics, Local|anesthetics, local|mesh-ancestor
111362813|NCT00556478|Anesthetics|anesthetics|mesh-ancestor
111362814|NCT00556478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111362815|NCT00556478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111362816|NCT00556478|Sensory System Agents|sensory system agents|mesh-ancestor
111362817|NCT00556478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111129886|NCT03094663|Cefazolin|cefazolin|mesh-list
111362818|NCT00556478|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111362819|NCT00556478|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111362820|NCT00556478|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111362821|NCT00556478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111362822|NCT00556478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111362823|NCT00556478|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
111362824|NCT00500240|Insulin|insulin|mesh-list
111362825|NCT00500240|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111362826|NCT00500240|Insulin Glargine|insulin glargine|mesh-list
111362827|NCT00500240|Insulin Aspart|insulin aspart|mesh-list
111362828|NCT00500240|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111130004|NCT05038969|Esomeprazole|esomeprazole|mesh-list
111362829|NCT00500240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111362830|NCT01469767|Fluocinonide|fluocinonide|mesh-list
111362831|NCT01469767|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111362832|NCT01469767|Glucocorticoids|glucocorticoids|mesh-ancestor
111362833|NCT01469767|Hormones|hormones|mesh-ancestor
111362834|NCT01469767|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111362835|NCT01469767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111130080|NCT05028907|Viscosupplements|viscosupplements|mesh-ancestor
111362836|NCT01469767|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111362837|NCT03246620|Diazepam|diazepam|mesh-list
111362838|NCT03246620|Haloperidol|haloperidol|mesh-list
111362839|NCT03246620|Olanzapine|olanzapine|mesh-list
111362840|NCT03246620|Haloperidol decanoate|haloperidol decanoate|mesh-list
111362841|NCT03246620|Antiemetics|antiemetics|mesh-ancestor
111362842|NCT03246620|Autonomic Agents|autonomic agents|mesh-ancestor
111362843|NCT03246620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111362844|NCT03246620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111362845|NCT03246620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111362846|NCT03246620|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111362847|NCT03246620|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111362848|NCT03246620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111362849|NCT03246620|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111362850|NCT03246620|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111362851|NCT03246620|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111362852|NCT03246620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111130213|NCT05021731|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111362853|NCT03246620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111362854|NCT03246620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111362855|NCT03246620|Serotonin Agents|serotonin agents|mesh-ancestor
111362856|NCT03246620|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111362857|NCT03246620|Dopamine Agents|dopamine agents|mesh-ancestor
111130297|NCT03091699|Nicotine|nicotine|mesh-list
111362858|NCT03246620|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111362859|NCT03246620|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111362860|NCT03246620|Anticonvulsants|anticonvulsants|mesh-ancestor
111362861|NCT03246620|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111362862|NCT03246620|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
111362863|NCT03246620|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111362864|NCT03246620|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111362865|NCT03246620|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111362866|NCT03246620|Anesthetics, General|anesthetics, general|mesh-ancestor
111362867|NCT03246620|Anesthetics|anesthetics|mesh-ancestor
111362868|NCT03246620|GABA Modulators|gaba modulators|mesh-ancestor
111362869|NCT03246620|GABA Agents|gaba agents|mesh-ancestor
111362870|NCT05080218|Adalimumab|adalimumab|mesh-list
111362871|NCT05080218|Golimumab|golimumab|mesh-list
111362872|NCT05080218|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
111362873|NCT05080218|Etanercept|etanercept|mesh-list
111362874|NCT05080218|Abatacept|abatacept|mesh-list
111362875|NCT05080218|Upadacitinib|upadacitinib|mesh-list
111362876|NCT05080218|Ixekizumab|ixekizumab|mesh-list
111362877|NCT05080218|Tofacitinib|tofacitinib|mesh-list
111362878|NCT05080218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111362879|NCT05080218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111362880|NCT05080218|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111362881|NCT05080218|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111362882|NCT05080218|Analgesics|analgesics|mesh-ancestor
111362883|NCT05080218|Sensory System Agents|sensory system agents|mesh-ancestor
111362884|NCT05080218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111362885|NCT05080218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111362886|NCT05080218|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111362887|NCT05080218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111362888|NCT05080218|Immunologic Factors|immunologic factors|mesh-ancestor
111362889|NCT05080218|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111362890|NCT05080218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111362891|NCT05080218|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111362892|NCT05080218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111362893|NCT05080218|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
111362894|NCT05080218|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111362895|NCT05080218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111362896|NCT05080218|Dermatologic Agents|dermatologic agents|mesh-ancestor
111362897|NCT01470859|Levodopa|levodopa|mesh-list
111362898|NCT01470859|Carbidopa|carbidopa|mesh-list
111362899|NCT01470859|Pramipexole|pramipexole|mesh-list
111362900|NCT01470859|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
111362901|NCT01470859|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111362902|NCT01470859|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111362903|NCT01470859|Dopamine Agents|dopamine agents|mesh-ancestor
111362904|NCT01470859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111362905|NCT01470859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111362906|NCT01470859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111362907|NCT01470859|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
111362908|NCT01470859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111087309|NCT05024799|Anesthetics|anesthetics|mesh-ancestor
111362909|NCT01470859|Antioxidants|antioxidants|mesh-ancestor
111362910|NCT01470859|Protective Agents|protective agents|mesh-ancestor
111362911|NCT01470859|Dopamine Agonists|dopamine agonists|mesh-ancestor
111362912|NCT01470859|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111362913|NCT01470859|Immunologic Factors|immunologic factors|mesh-ancestor
111362914|NCT00436046|Interferons|interferons|mesh-list
111362915|NCT00436046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111362916|NCT00436046|Antiviral Agents|antiviral agents|mesh-ancestor
111362917|NCT00436046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111362918|NCT01471639|Ketorolac|ketorolac|mesh-list
111362919|NCT01471639|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111362920|NCT01471639|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111362921|NCT01471639|Analgesics|analgesics|mesh-ancestor
111362922|NCT01471639|Sensory System Agents|sensory system agents|mesh-ancestor
111362923|NCT01471639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111362924|NCT01471639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111362925|NCT01471639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111362926|NCT01471639|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111362927|NCT01471639|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111362928|NCT01471639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111362929|NCT01471639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111362930|NCT05622656|Dexmedetomidine|dexmedetomidine|mesh-list
111362931|NCT05622656|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111362932|NCT05622656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111130512|NCT05001061|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111362933|NCT05622656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111362934|NCT05622656|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111362935|NCT05622656|Analgesics|analgesics|mesh-ancestor
111362936|NCT05622656|Sensory System Agents|sensory system agents|mesh-ancestor
111362937|NCT05622656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111362938|NCT05622656|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111362939|NCT05622656|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111362940|NCT05622656|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111362941|NCT05622656|Adrenergic Agents|adrenergic agents|mesh-ancestor
111362942|NCT05622656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111362943|NCT05622656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111362944|NCT05079126|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
111362945|NCT05079126|Antioxidants|antioxidants|mesh-ancestor
111362946|NCT05079126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111362947|NCT05079126|Protective Agents|protective agents|mesh-ancestor
111362948|NCT05079126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111362949|NCT05079126|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
111362950|NCT05079126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111362951|NCT05140278|Artesunate|artesunate|mesh-list
111362952|NCT05140278|Antimalarials|antimalarials|mesh-ancestor
111362953|NCT05140278|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111362954|NCT05140278|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111362955|NCT05140278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111362956|NCT05140278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111362957|NCT05140278|Antiviral Agents|antiviral agents|mesh-ancestor
111362958|NCT05140278|Schistosomicides|schistosomicides|mesh-ancestor
111362959|NCT05140278|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
111362960|NCT05140278|Anthelmintics|anthelmintics|mesh-ancestor
111362961|NCT00436904|Rituximab|rituximab|mesh-list
111362962|NCT00436904|Alemtuzumab|alemtuzumab|mesh-list
111362963|NCT00436904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111362964|NCT00436904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111362965|NCT00436904|Immunologic Factors|immunologic factors|mesh-ancestor
111362966|NCT00436904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111362967|NCT00436904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111362968|NCT00438854|Dasatinib|dasatinib|mesh-list
111362969|NCT00438854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111362970|NCT00438854|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111362971|NCT00438854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111362972|NCT00438854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111362973|NCT01485055|Infliximab|infliximab|mesh-list
111362974|NCT01485055|Basiliximab|basiliximab|mesh-list
111362975|NCT01485055|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111362976|NCT01485055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111362977|NCT01485055|Dermatologic Agents|dermatologic agents|mesh-ancestor
111362978|NCT01485055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111362979|NCT01485055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111362980|NCT01485055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111362981|NCT01485055|Immunologic Factors|immunologic factors|mesh-ancestor
111362982|NCT01485055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111362983|NCT05028348|Dexamethasone|dexamethasone|mesh-list
111362984|NCT05028348|Pomalidomide|pomalidomide|mesh-list
111362985|NCT05028348|Elotuzumab|elotuzumab|mesh-list
111362986|NCT05028348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111362987|NCT05028348|Antiemetics|antiemetics|mesh-ancestor
111362988|NCT05028348|Autonomic Agents|autonomic agents|mesh-ancestor
111130834|NCT05011669|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111362989|NCT05028348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111362990|NCT05028348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111362991|NCT05028348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111362992|NCT05028348|Glucocorticoids|glucocorticoids|mesh-ancestor
111362993|NCT05028348|Hormones|hormones|mesh-ancestor
111362994|NCT05028348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111362995|NCT05028348|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111362996|NCT05028348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111362997|NCT05028348|Immunologic Factors|immunologic factors|mesh-ancestor
111362998|NCT05028348|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111362999|NCT05028348|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111363000|NCT05028348|Growth Substances|growth substances|mesh-ancestor
111363001|NCT05028348|Growth Inhibitors|growth inhibitors|mesh-ancestor
111363002|NCT01486615|Melatonin|melatonin|mesh-list
111363003|NCT01486615|Alprazolam|alprazolam|mesh-list
111363004|NCT01486615|Azaperone|azaperone|mesh-list
111363005|NCT01486615|Antioxidants|antioxidants|mesh-ancestor
111363006|NCT01486615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111363007|NCT01486615|Protective Agents|protective agents|mesh-ancestor
111363008|NCT01486615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111363009|NCT01486615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111363010|NCT01486615|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111363011|NCT01486615|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111363012|NCT01486615|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111363013|NCT01486615|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111363014|NCT01486615|GABA Modulators|gaba modulators|mesh-ancestor
111363015|NCT01486615|GABA Agents|gaba agents|mesh-ancestor
111363016|NCT01486615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111363017|NCT01486615|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111363018|NCT01486615|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111363019|NCT01486615|Dopamine Agents|dopamine agents|mesh-ancestor
111363020|NCT00503750|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111363021|NCT00503750|Vinorelbine|vinorelbine|mesh-list
111363022|NCT00503750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111363023|NCT00503750|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111131026|NCT04433611|Lidocaine|lidocaine|mesh-list
111363024|NCT00503750|Tubulin Modulators|tubulin modulators|mesh-ancestor
111363025|NCT00503750|Antimitotic Agents|antimitotic agents|mesh-ancestor
111363026|NCT00503750|Mitosis Modulators|mitosis modulators|mesh-ancestor
111363027|NCT00503750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111363028|NCT05077332|Celecoxib|celecoxib|mesh-list
111363029|NCT05077332|Famotidine|famotidine|mesh-list
111363030|NCT05077332|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111363031|NCT05077332|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111363032|NCT05077332|Analgesics|analgesics|mesh-ancestor
111363033|NCT05077332|Sensory System Agents|sensory system agents|mesh-ancestor
111363034|NCT05077332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111363035|NCT05077332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111363036|NCT05077332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111363037|NCT05077332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111363038|NCT05077332|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111363039|NCT05077332|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111363040|NCT05077332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111363041|NCT05077332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111363042|NCT05077332|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111363043|NCT05077332|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111363044|NCT05077332|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
111363045|NCT05077332|Histamine Antagonists|histamine antagonists|mesh-ancestor
111363046|NCT05077332|Histamine Agents|histamine agents|mesh-ancestor
111363047|NCT05077332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111363048|NCT00439946|Treprostinil|treprostinil|mesh-list
111363049|NCT00439946|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111363050|NCT04227678|Heparin|heparin|mesh-list
111363051|NCT04227678|Anticoagulants|anticoagulants|mesh-ancestor
111363052|NCT04227678|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111363053|NCT04227678|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111363054|NCT04227678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111363055|NCT00508118|Nicardipine|nicardipine|mesh-list
111363056|NCT00508118|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111363057|NCT00508118|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111363058|NCT00508118|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111363059|NCT00508118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111363060|NCT00508118|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110959207|NCT02582632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111363061|NCT00508118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111363062|NCT00508118|Vasodilator Agents|vasodilator agents|mesh-ancestor
111363063|NCT05139030|Bupivacaine|bupivacaine|mesh-list
111363064|NCT05139030|Anesthetics, Local|anesthetics, local|mesh-ancestor
111363065|NCT05139030|Anesthetics|anesthetics|mesh-ancestor
111363066|NCT05139030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111363067|NCT05139030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111363068|NCT05139030|Sensory System Agents|sensory system agents|mesh-ancestor
111363069|NCT05139030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111363070|NCT00440180|Anastrozole|anastrozole|mesh-list
111363071|NCT00440180|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111363072|NCT00440180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111363073|NCT00440180|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111363074|NCT00440180|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111363075|NCT00440180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111363076|NCT00440180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111363077|NCT00440180|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111131267|NCT05001919|Mitogens|mitogens|mesh-list
111363078|NCT00440180|Hormone Antagonists|hormone antagonists|mesh-ancestor
111363079|NCT00440180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111363080|NCT00440180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111363081|NCT05021094|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
111363082|NCT05021094|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
111363083|NCT05021094|Estradiol|estradiol|mesh-list
111363084|NCT05021094|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
111363085|NCT05021094|Dydrogesterone|dydrogesterone|mesh-list
111363086|NCT05021094|Estrogens|estrogens|mesh-ancestor
111363087|NCT05021094|Hormones|hormones|mesh-ancestor
111363088|NCT05021094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111131401|NCT04785755|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111363089|NCT05021094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111363090|NCT05021094|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111363091|NCT05021094|Contraceptive Agents|contraceptive agents|mesh-ancestor
111363092|NCT05021094|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111363093|NCT05021094|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111363094|NCT05021094|Progestins|progestins|mesh-ancestor
111363095|NCT01364298|Pregabalin|pregabalin|mesh-list
111363096|NCT01364298|Gabapentin|gabapentin|mesh-list
111363097|NCT01364298|Analgesics|analgesics|mesh-ancestor
111363098|NCT01364298|Sensory System Agents|sensory system agents|mesh-ancestor
111363099|NCT01364298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111363100|NCT01364298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111363101|NCT01364298|Anticonvulsants|anticonvulsants|mesh-ancestor
111363102|NCT01364298|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111363103|NCT01364298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111363104|NCT01364298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111363105|NCT01364298|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111363106|NCT01364298|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111363107|NCT01364298|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111363108|NCT01364298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111363109|NCT01364298|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111363110|NCT01364298|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111363111|NCT01364298|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111363112|NCT01364298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111363113|NCT01364298|Antimanic Agents|antimanic agents|mesh-ancestor
111363114|NCT04421742|Beclomethasone|beclomethasone|mesh-list
111363115|NCT04421742|Formoterol Fumarate|formoterol fumarate|mesh-list
111363116|NCT04421742|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111363117|NCT04421742|Autonomic Agents|autonomic agents|mesh-ancestor
111363118|NCT04421742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111363119|NCT04421742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111363120|NCT04421742|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111363121|NCT04421742|Respiratory System Agents|respiratory system agents|mesh-ancestor
111363122|NCT04421742|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111363123|NCT04421742|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111363124|NCT04421742|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111363125|NCT04421742|Adrenergic Agents|adrenergic agents|mesh-ancestor
111363126|NCT04421742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111363127|NCT04421742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111363128|NCT04421742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111363129|NCT04421742|Glucocorticoids|glucocorticoids|mesh-ancestor
111363130|NCT04421742|Hormones|hormones|mesh-ancestor
111363131|NCT04421742|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111363132|NCT01488019|Formoterol Fumarate|formoterol fumarate|mesh-list
111363133|NCT01488019|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111363134|NCT01488019|Autonomic Agents|autonomic agents|mesh-ancestor
111363135|NCT01488019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111363136|NCT01488019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111363137|NCT01488019|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111363138|NCT01488019|Respiratory System Agents|respiratory system agents|mesh-ancestor
111363139|NCT01488019|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111363140|NCT01488019|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111363141|NCT01488019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111363142|NCT01488019|Adrenergic Agents|adrenergic agents|mesh-ancestor
111363143|NCT01488019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111363144|NCT01488019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111363145|NCT01488409|Acipimox|acipimox|mesh-list
111363146|NCT01488409|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111363147|NCT01488409|Antimetabolites|antimetabolites|mesh-ancestor
111363148|NCT01488409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111363149|NCT01488409|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111363150|NCT01488877|Spironolactone|spironolactone|mesh-list
111363151|NCT01488877|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
111363152|NCT01488877|Hormone Antagonists|hormone antagonists|mesh-ancestor
111363153|NCT01488877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111363154|NCT01488877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111363155|NCT01488877|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
111363156|NCT01488877|Diuretics|diuretics|mesh-ancestor
111363157|NCT01488877|Natriuretic Agents|natriuretic agents|mesh-ancestor
111363158|NCT01364922|Acetaminophen|acetaminophen|mesh-list
111363159|NCT01364922|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
111363160|NCT01364922|Hydrocodone|hydrocodone|mesh-list
111363161|NCT01364922|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111363162|NCT01364922|Analgesics|analgesics|mesh-ancestor
111363163|NCT01364922|Sensory System Agents|sensory system agents|mesh-ancestor
111363164|NCT01364922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111363165|NCT01364922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111363166|NCT01364922|Antipyretics|antipyretics|mesh-ancestor
111363167|NCT01364922|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111363168|NCT01364922|Narcotics|narcotics|mesh-ancestor
111363169|NCT01364922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111363170|NCT01364922|Antitussive Agents|antitussive agents|mesh-ancestor
111363171|NCT01364922|Respiratory System Agents|respiratory system agents|mesh-ancestor
111363172|NCT01364922|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111363173|NCT01364922|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111363174|NCT01364922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111363175|NCT01489969|Melatonin|melatonin|mesh-list
111363176|NCT01489969|Antioxidants|antioxidants|mesh-ancestor
111131916|NCT05078463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111363177|NCT01489969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111363178|NCT01489969|Protective Agents|protective agents|mesh-ancestor
111363179|NCT01489969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111363180|NCT01489969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111363181|NCT00509288|Aldesleukin|aldesleukin|mesh-list
111363182|NCT00509288|Cyclophosphamide|cyclophosphamide|mesh-list
111363183|NCT00509288|Fludarabine|fludarabine|mesh-list
111363184|NCT00509288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111363185|NCT00509288|Immunologic Factors|immunologic factors|mesh-ancestor
111363186|NCT00509288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111131993|NCT04331639|Vitamin D|vitamin d|mesh-list
111363187|NCT00509288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111363188|NCT00509288|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111363189|NCT00509288|Alkylating Agents|alkylating agents|mesh-ancestor
111363190|NCT00509288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111363191|NCT00509288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111363192|NCT00509288|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111363193|NCT00509288|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111363194|NCT00509288|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111363195|NCT00509288|Antiviral Agents|antiviral agents|mesh-ancestor
111363196|NCT00509288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111363197|NCT00442364|Polidocanol|polidocanol|mesh-list
111363198|NCT00442364|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
111363199|NCT00442364|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111363200|NCT00510224|Octreotide|octreotide|mesh-list
111363201|NCT00510224|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111132129|NCT04426487|Hormones|hormones|mesh-ancestor
111363202|NCT00510224|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111363203|NCT00510224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111363204|NCT05070156|Vaccines|vaccines|mesh-list
111363205|NCT05070156|Immunologic Factors|immunologic factors|mesh-ancestor
111363206|NCT05070156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111363207|NCT00511706|Dexamethasone|dexamethasone|mesh-list
111363208|NCT00511706|Ranibizumab|ranibizumab|mesh-list
111363209|NCT00511706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111087604|NCT03092193|Naproxen|naproxen|mesh-list
111363210|NCT00511706|Antiemetics|antiemetics|mesh-ancestor
111363212|NCT00511706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111363213|NCT00511706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111363214|NCT00511706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111363215|NCT00511706|Glucocorticoids|glucocorticoids|mesh-ancestor
111363216|NCT00511706|Hormones|hormones|mesh-ancestor
111132250|NCT05025813|Pembrolizumab|pembrolizumab|mesh-list
111363217|NCT00511706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111363218|NCT00511706|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111363219|NCT00511706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111363220|NCT00511706|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111363221|NCT00511706|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111363222|NCT00511706|Growth Substances|growth substances|mesh-ancestor
111363223|NCT00511706|Growth Inhibitors|growth inhibitors|mesh-ancestor
111363224|NCT05067894|Vaccines|vaccines|mesh-list
111363225|NCT05067894|Immunologic Factors|immunologic factors|mesh-ancestor
111363226|NCT05067894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111363227|NCT01493947|Metronidazole|metronidazole|mesh-list
111363228|NCT01493947|Ivermectin|ivermectin|mesh-list
111363229|NCT01493947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111363230|NCT01493947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111363231|NCT01493947|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111363232|NCT01493947|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111363233|NCT00445484|Lenalidomide|lenalidomide|mesh-list
111363234|NCT00445484|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
111363235|NCT00445484|Immunologic Factors|immunologic factors|mesh-ancestor
111363236|NCT00445484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111363237|NCT00445484|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111363238|NCT00445484|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111363239|NCT00445484|Growth Substances|growth substances|mesh-ancestor
111363240|NCT00445484|Growth Inhibitors|growth inhibitors|mesh-ancestor
111363241|NCT00445484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111363242|NCT01495585|Lonafarnib|lonafarnib|mesh-list
111132380|NCT05054361|Mannitol|mannitol|mesh-list
111363243|NCT01495585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111363244|NCT01495585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111363245|NCT00446264|Sirolimus|sirolimus|mesh-list
111363246|NCT00446264|Tacrolimus|tacrolimus|mesh-list
111363247|NCT00446264|Daclizumab|daclizumab|mesh-list
111363248|NCT00446264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111363249|NCT00446264|Immunologic Factors|immunologic factors|mesh-ancestor
111363250|NCT00446264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111363251|NCT00446264|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111363252|NCT00446264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111363253|NCT00446264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111363254|NCT00446264|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111363255|NCT00446264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111363256|NCT00446264|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111363257|NCT00446264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111363258|NCT00446264|Antifungal Agents|antifungal agents|mesh-ancestor
111363259|NCT01495819|Nicotine|nicotine|mesh-list
111363260|NCT01495819|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111363261|NCT01495819|Autonomic Agents|autonomic agents|mesh-ancestor
111363262|NCT01495819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111363263|NCT01495819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111363264|NCT01495819|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111363265|NCT01495819|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111363266|NCT01495819|Cholinergic Agents|cholinergic agents|mesh-ancestor
111363267|NCT01495819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111363268|NCT01495819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111363269|NCT04214886|Cyclophosphamide|cyclophosphamide|mesh-list
111363270|NCT04214886|Fludarabine|fludarabine|mesh-list
111363271|NCT04214886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111363272|NCT04214886|Immunologic Factors|immunologic factors|mesh-ancestor
111363273|NCT04214886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111363274|NCT04214886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111363275|NCT04214886|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111363276|NCT04214886|Alkylating Agents|alkylating agents|mesh-ancestor
111363277|NCT04214886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111363278|NCT04214886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111363279|NCT04214886|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111363280|NCT00512876|Bevacizumab|bevacizumab|mesh-list
111363281|NCT00512876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111363282|NCT00512876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111363283|NCT00512876|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111363284|NCT00512876|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111363285|NCT00512876|Growth Substances|growth substances|mesh-ancestor
111363286|NCT00512876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111363287|NCT00512876|Growth Inhibitors|growth inhibitors|mesh-ancestor
111363288|NCT05127876|Ephedrine|ephedrine|mesh-list
111363289|NCT05127876|Pseudoephedrine|pseudoephedrine|mesh-list
111363290|NCT05127876|Ondansetron|ondansetron|mesh-list
111363291|NCT05127876|Antiemetics|antiemetics|mesh-ancestor
111363292|NCT05127876|Autonomic Agents|autonomic agents|mesh-ancestor
111363293|NCT05127876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111363294|NCT05127876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111363295|NCT05127876|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111363296|NCT05127876|Antipruritics|antipruritics|mesh-ancestor
111363297|NCT05127876|Dermatologic Agents|dermatologic agents|mesh-ancestor
111363298|NCT05127876|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111363299|NCT05127876|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111363300|NCT05127876|Serotonin Agents|serotonin agents|mesh-ancestor
111363301|NCT05127876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111363302|NCT05127876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111363303|NCT05127876|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111363304|NCT05127876|Sympathomimetics|sympathomimetics|mesh-ancestor
111363305|NCT05127876|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111363306|NCT05127876|Adrenergic Agents|adrenergic agents|mesh-ancestor
111363307|NCT05127876|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111363308|NCT05127876|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111363309|NCT05127876|Respiratory System Agents|respiratory system agents|mesh-ancestor
111363310|NCT05127876|Nasal Decongestants|nasal decongestants|mesh-ancestor
111363311|NCT01496131|Cyclophosphamide|cyclophosphamide|mesh-list
111363312|NCT01496131|Goserelin|goserelin|mesh-list
111363313|NCT01496131|Immunologic Factors|immunologic factors|mesh-ancestor
111363314|NCT01496131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111363315|NCT01496131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111363316|NCT01496131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111363317|NCT01496131|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111363318|NCT01496131|Alkylating Agents|alkylating agents|mesh-ancestor
111363319|NCT01496131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111363320|NCT01496131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111363321|NCT01496131|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111363322|NCT01496131|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111363323|NCT02520726|Sertraline|sertraline|mesh-list
111363324|NCT02520726|Antidepressive Agents|antidepressive agents|mesh-ancestor
111363325|NCT02520726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111132709|NCT01752491|Ascorbic Acid|ascorbic acid|mesh-list
111363326|NCT02520726|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111363327|NCT02520726|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111363328|NCT02520726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111363329|NCT02520726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111363330|NCT02520726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111363331|NCT02520726|Serotonin Agents|serotonin agents|mesh-ancestor
111363332|NCT02520726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111363333|NCT00450242|Lidocaine|lidocaine|mesh-list
111363334|NCT00450242|Anesthetics, Local|anesthetics, local|mesh-ancestor
111363335|NCT00450242|Anesthetics|anesthetics|mesh-ancestor
111363336|NCT00450242|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111363337|NCT00450242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111363338|NCT00450242|Sensory System Agents|sensory system agents|mesh-ancestor
111363339|NCT00450242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111363340|NCT00450242|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111363341|NCT00450242|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111363342|NCT00450242|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111363343|NCT00450242|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111363344|NCT00450242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111363345|NCT00517010|Ranibizumab|ranibizumab|mesh-list
111363346|NCT00517010|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111363347|NCT00517010|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111363348|NCT00517010|Growth Substances|growth substances|mesh-ancestor
111363349|NCT00517010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111363350|NCT00517010|Growth Inhibitors|growth inhibitors|mesh-ancestor
111363351|NCT00517010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111363352|NCT00517556|Contraceptive Agents|contraceptive agents|mesh-list
111363353|NCT00517556|Contraceptives, Oral|contraceptives, oral|mesh-list
111363354|NCT00517556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111363355|NCT00517556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111363356|NCT00517556|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111363357|NCT00519584|Bupivacaine|bupivacaine|mesh-list
111363358|NCT00519584|Ropivacaine|ropivacaine|mesh-list
111087762|NCT03084783|Dexamethasone|dexamethasone|mesh-list
111363359|NCT00519584|Anesthetics, Local|anesthetics, local|mesh-ancestor
111363360|NCT00519584|Anesthetics|anesthetics|mesh-ancestor
111363361|NCT00519584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111363362|NCT00519584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111363363|NCT00519584|Sensory System Agents|sensory system agents|mesh-ancestor
111363364|NCT00519584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111363365|NCT05122884|Milrinone|milrinone|mesh-list
111363366|NCT05122884|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111363367|NCT05122884|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111363368|NCT05122884|Vasodilator Agents|vasodilator agents|mesh-ancestor
111363369|NCT05122884|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
111363370|NCT05122884|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111363371|NCT05122884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111363372|NCT05122884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111363373|NCT05122884|Protective Agents|protective agents|mesh-ancestor
111363374|NCT05122884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111363375|NCT00520286|Modafinil|modafinil|mesh-list
111363376|NCT00520286|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111363377|NCT00520286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111363378|NCT00520286|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
111363379|NCT00520286|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111363380|NCT00520286|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111363381|NCT00520286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111363382|NCT01796288|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111363383|NCT01796288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111363384|NCT01796288|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111363385|NCT01796288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111363386|NCT01796288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111363387|NCT01395043|Epinephrine|epinephrine|mesh-list
111363388|NCT01395043|Bupivacaine|bupivacaine|mesh-list
111363389|NCT01395043|Anesthetics, Local|anesthetics, local|mesh-ancestor
111363390|NCT01395043|Anesthetics|anesthetics|mesh-ancestor
111363391|NCT01395043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111363392|NCT01395043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111363393|NCT01395043|Sensory System Agents|sensory system agents|mesh-ancestor
111363394|NCT01395043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111132915|NCT02518113|Hormones|hormones|mesh-ancestor
111363395|NCT01395043|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111363396|NCT01395043|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111363397|NCT01395043|Adrenergic Agents|adrenergic agents|mesh-ancestor
111363398|NCT01395043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111363399|NCT01395043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111363400|NCT01395043|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111363401|NCT01395043|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111363402|NCT01395043|Autonomic Agents|autonomic agents|mesh-ancestor
111363403|NCT01395043|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111363404|NCT01395043|Respiratory System Agents|respiratory system agents|mesh-ancestor
111363405|NCT01395043|Mydriatics|mydriatics|mesh-ancestor
111363406|NCT01395043|Sympathomimetics|sympathomimetics|mesh-ancestor
111363407|NCT01395043|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111363408|NCT00521456|Ketorolac|ketorolac|mesh-list
111363409|NCT00521456|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111363410|NCT00521456|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111363411|NCT00521456|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111363412|NCT00521456|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111363413|NCT00521456|Analgesics|analgesics|mesh-ancestor
111363414|NCT00521456|Sensory System Agents|sensory system agents|mesh-ancestor
111363415|NCT00521456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111363416|NCT00521456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111363417|NCT00521456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111363418|NCT00521456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111363419|NCT00521456|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111363420|NCT00521456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111363421|NCT00521456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111363422|NCT01796366|Insulin|insulin|mesh-list
111363423|NCT01796366|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111363424|NCT01796366|Insulin Glargine|insulin glargine|mesh-list
111363425|NCT01796366|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111363426|NCT01796366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111363427|NCT03326180|Bupivacaine|bupivacaine|mesh-list
111363428|NCT03326180|Anesthetics, Local|anesthetics, local|mesh-ancestor
111363429|NCT03326180|Anesthetics|anesthetics|mesh-ancestor
111363430|NCT03326180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111087829|NCT03119857|Androgen Antagonists|androgen antagonists|mesh-list
111363431|NCT03326180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111363432|NCT03326180|Sensory System Agents|sensory system agents|mesh-ancestor
111363433|NCT03326180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111363434|NCT01498549|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
111363435|NCT01498549|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111363436|NCT01498549|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111363437|NCT01498549|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111363438|NCT01498549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111363439|NCT01498549|Adrenergic Agents|adrenergic agents|mesh-ancestor
111363440|NCT01498549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111363441|NCT01498549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111363442|NCT01796444|Hormones|hormones|mesh-list
111363443|NCT01796444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111363444|NCT01796444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111363445|NCT01542541|Rifaximin|rifaximin|mesh-list
111363446|NCT01542541|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111363447|NCT01542541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111363448|NCT01542541|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111363449|NCT00524264|Ketorolac|ketorolac|mesh-list
111363450|NCT00524264|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111363451|NCT00524264|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111363452|NCT00524264|Analgesics|analgesics|mesh-ancestor
111363453|NCT00524264|Sensory System Agents|sensory system agents|mesh-ancestor
111363454|NCT00524264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111363455|NCT00524264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111363456|NCT00524264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111363457|NCT00524264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111363458|NCT00524264|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111363459|NCT00524264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111363460|NCT00524264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111363461|NCT00452426|Analgesics, Opioid|analgesics, opioid|mesh-list
111363462|NCT00452426|Narcotics|narcotics|mesh-ancestor
111363463|NCT00452426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111363464|NCT00452426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111363465|NCT00452426|Analgesics|analgesics|mesh-ancestor
111363466|NCT00452426|Sensory System Agents|sensory system agents|mesh-ancestor
111363467|NCT00452426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111363468|NCT05117814|Zanubrutinib|zanubrutinib|mesh-list
111363469|NCT05117814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111363470|NCT05117814|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111363471|NCT05117814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111363472|NCT05117814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111363473|NCT00524342|Oprelvekin|oprelvekin|mesh-list
111363474|NCT00524342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111363475|NCT00524576|Vaccines|vaccines|mesh-list
111363476|NCT00524576|Immunologic Factors|immunologic factors|mesh-ancestor
111363477|NCT00524576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111363478|NCT02516202|Estradiol|estradiol|mesh-list
111363479|NCT02516202|Estrogens|estrogens|mesh-ancestor
111363480|NCT02516202|Hormones|hormones|mesh-ancestor
111363481|NCT02516202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111363482|NCT02516202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111363483|NCT00526058|Clotrimazole|clotrimazole|mesh-list
111363484|NCT00526058|Miconazole|miconazole|mesh-list
111363485|NCT00526058|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111363486|NCT00526058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111363487|NCT00526058|Antifungal Agents|antifungal agents|mesh-ancestor
111363488|NCT00526058|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111363489|NCT00526058|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111363490|NCT00526058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111363491|NCT00526058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111363492|NCT00526058|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111363493|NCT00526058|Hormone Antagonists|hormone antagonists|mesh-ancestor
111363494|NCT00526058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111363495|NCT00526058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111363496|NCT00526058|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111363497|NCT00526058|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111363498|NCT00526292|Cyclophosphamide|cyclophosphamide|mesh-list
111363499|NCT00526292|Fludarabine|fludarabine|mesh-list
111363500|NCT00526292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111363501|NCT00526292|Immunologic Factors|immunologic factors|mesh-ancestor
111363502|NCT00526292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111363503|NCT00526292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111087904|NCT03078309|Cannabidiol|cannabidiol|mesh-list
111133387|NCT02450487|Piroxicam|piroxicam|mesh-list
111363504|NCT00526292|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111363506|NCT00526292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111363507|NCT00526292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111363508|NCT00526292|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111363509|NCT02124044|Asunaprevir|asunaprevir|mesh-list
111363510|NCT02124044|Protease Inhibitors|protease inhibitors|mesh-ancestor
111363511|NCT02124044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111363512|NCT02124044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111363513|NCT01502761|Magnesium Sulfate|magnesium sulfate|mesh-list
111363514|NCT01502761|Analgesics|analgesics|mesh-ancestor
111363515|NCT01502761|Sensory System Agents|sensory system agents|mesh-ancestor
111363516|NCT01502761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111363517|NCT01502761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111363518|NCT01502761|Anesthetics|anesthetics|mesh-ancestor
111363519|NCT01502761|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111363520|NCT01502761|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111363521|NCT01502761|Anticonvulsants|anticonvulsants|mesh-ancestor
111363522|NCT01502761|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111363523|NCT01502761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111363524|NCT01502761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111363525|NCT01502761|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111363526|NCT01502761|Tocolytic Agents|tocolytic agents|mesh-ancestor
111363527|NCT01502761|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111363528|NCT01504477|Bortezomib|bortezomib|mesh-list
111363529|NCT01504477|Panitumumab|panitumumab|mesh-list
111363530|NCT01504477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111363531|NCT01504477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111363532|NCT02124512|Rifaximin|rifaximin|mesh-list
111363533|NCT02124512|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111363534|NCT02124512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111363535|NCT02124512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111363536|NCT01504711|Fosaprepitant|fosaprepitant|mesh-list
111363537|NCT01504711|Aprepitant|aprepitant|mesh-list
111363538|NCT01504711|Antiemetics|antiemetics|mesh-ancestor
111363539|NCT01504711|Autonomic Agents|autonomic agents|mesh-ancestor
111363540|NCT01504711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111363541|NCT01504711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111363542|NCT01504711|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111363543|NCT01504711|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
111363544|NCT01504711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111363545|NCT01504711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111363546|NCT02209519|Metronidazole|metronidazole|mesh-list
111363547|NCT02209519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111363548|NCT02209519|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111363549|NCT02209519|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111363550|NCT02209519|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111363551|NCT02129660|Glycopyrrolate|glycopyrrolate|mesh-list
111363552|NCT02129660|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111363553|NCT02129660|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111363554|NCT02129660|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111363555|NCT02129660|Cholinergic Agents|cholinergic agents|mesh-ancestor
111363556|NCT02129660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111363557|NCT02129660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111363558|NCT02129660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111363559|NCT01505179|Ranolazine|ranolazine|mesh-list
111363560|NCT01505179|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111363561|NCT01505179|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111363562|NCT01505179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111363563|NCT01797848|Ribavirin|ribavirin|mesh-list
111363564|NCT01797848|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
111363565|NCT01797848|Antimetabolites|antimetabolites|mesh-ancestor
111363566|NCT01797848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111363567|NCT01797848|Antiviral Agents|antiviral agents|mesh-ancestor
111363568|NCT01797848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111363569|NCT01398943|Antioxidants|antioxidants|mesh-list
111363570|NCT01398943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111363571|NCT01398943|Protective Agents|protective agents|mesh-ancestor
111363572|NCT01398943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111363573|NCT01550341|Buprenorphine|buprenorphine|mesh-list
111363574|NCT01550341|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
111363575|NCT01550341|Naloxone|naloxone|mesh-list
111363576|NCT01550341|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111363577|NCT01550341|Narcotics|narcotics|mesh-ancestor
111363578|NCT01550341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111363579|NCT01550341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111363580|NCT01550341|Analgesics|analgesics|mesh-ancestor
111363581|NCT01550341|Sensory System Agents|sensory system agents|mesh-ancestor
111363582|NCT01550341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111363583|NCT01550341|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111363584|NCT02125292|Mesalamine|mesalamine|mesh-list
111363585|NCT02125292|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111363586|NCT02125292|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111363587|NCT02125292|Analgesics|analgesics|mesh-ancestor
111363588|NCT02125292|Sensory System Agents|sensory system agents|mesh-ancestor
111363589|NCT02125292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111363590|NCT02125292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111363591|NCT02125292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111363592|NCT02125292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111363593|NCT01653912|Paclitaxel|paclitaxel|mesh-list
111363594|NCT01653912|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111363595|NCT01653912|Carboplatin|carboplatin|mesh-list
111363596|NCT01653912|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111363597|NCT01653912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111363598|NCT01653912|Tubulin Modulators|tubulin modulators|mesh-ancestor
111363599|NCT01653912|Antimitotic Agents|antimitotic agents|mesh-ancestor
111363600|NCT01653912|Mitosis Modulators|mitosis modulators|mesh-ancestor
111363601|NCT01653912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111363602|NCT04132388|Adalimumab|adalimumab|mesh-list
111363603|NCT04132388|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111363604|NCT04132388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111363605|NCT04132388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111363606|NCT02514174|Afatinib|afatinib|mesh-list
111363607|NCT02514174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111363608|NCT02514174|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111363609|NCT02514174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111363610|NCT02514174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111363611|NCT02132468|Fosbretabulin|fosbretabulin|mesh-list
111363612|NCT02132468|Combretastatin|combretastatin|mesh-list
111363613|NCT02132468|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111363614|NCT02132468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111363615|NCT02132468|Tubulin Modulators|tubulin modulators|mesh-ancestor
111363616|NCT02132468|Antimitotic Agents|antimitotic agents|mesh-ancestor
111363617|NCT02132468|Mitosis Modulators|mitosis modulators|mesh-ancestor
111133953|NCT02463357|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111363618|NCT02132468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111363619|NCT01508455|Fentanyl|fentanyl|mesh-list
111363620|NCT01508455|Midazolam|midazolam|mesh-list
111363621|NCT01508455|Dexmedetomidine|dexmedetomidine|mesh-list
111363622|NCT01508455|Morphine|morphine|mesh-list
111363623|NCT01508455|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111363624|NCT01508455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111363625|NCT01508455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111363626|NCT01508455|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111363627|NCT01508455|Analgesics|analgesics|mesh-ancestor
111134015|NCT04959253|Psilocybin|psilocybin|mesh-list
111363628|NCT01508455|Sensory System Agents|sensory system agents|mesh-ancestor
111363629|NCT01508455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111363630|NCT01508455|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111363631|NCT01508455|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111363632|NCT01508455|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111363633|NCT01508455|Adrenergic Agents|adrenergic agents|mesh-ancestor
111363634|NCT01508455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111363635|NCT01508455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111363636|NCT01508455|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111363637|NCT01508455|Narcotics|narcotics|mesh-ancestor
111363638|NCT01508455|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111363639|NCT01508455|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111363640|NCT01508455|Anesthetics, General|anesthetics, general|mesh-ancestor
111363641|NCT01508455|Anesthetics|anesthetics|mesh-ancestor
111363642|NCT01508455|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111363643|NCT01508455|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111363644|NCT01508455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111363645|NCT01508455|GABA Modulators|gaba modulators|mesh-ancestor
111363646|NCT01508455|GABA Agents|gaba agents|mesh-ancestor
111363647|NCT01509625|Fulvestrant|fulvestrant|mesh-list
111363648|NCT01509625|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111363649|NCT01509625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111363650|NCT01509625|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
111363651|NCT01509625|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111363652|NCT01509625|Hormone Antagonists|hormone antagonists|mesh-ancestor
111363653|NCT01509625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111363654|NCT01509625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111363655|NCT02482428|Imiquimod|imiquimod|mesh-list
111363656|NCT02482428|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111363657|NCT02482428|Immunologic Factors|immunologic factors|mesh-ancestor
111363658|NCT02482428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111363659|NCT02482428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111363660|NCT02482428|Interferon Inducers|interferon inducers|mesh-ancestor
111363661|NCT01510327|Aspirin|aspirin|mesh-list
111363662|NCT01510327|Everolimus|everolimus|mesh-list
111363663|NCT01510327|Ticlopidine|ticlopidine|mesh-list
111363664|NCT01510327|Clopidogrel|clopidogrel|mesh-list
111363665|NCT01510327|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111363666|NCT01510327|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111363667|NCT01510327|Analgesics|analgesics|mesh-ancestor
111363668|NCT01510327|Sensory System Agents|sensory system agents|mesh-ancestor
111363669|NCT01510327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111363670|NCT01510327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111363671|NCT01510327|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111363672|NCT01510327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111363673|NCT01510327|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111363674|NCT01510327|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111363675|NCT01510327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111363676|NCT01510327|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111363677|NCT01510327|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111363678|NCT01510327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111363679|NCT01510327|Antipyretics|antipyretics|mesh-ancestor
111363680|NCT01510327|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111363681|NCT01510327|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111363682|NCT01510327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111363683|NCT01510327|Immunologic Factors|immunologic factors|mesh-ancestor
111363684|NCT01510327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111363685|NCT01510327|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111134281|NCT04946929|Heparin|heparin|mesh-list
111363686|NCT01510327|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111363687|NCT01510327|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111363688|NCT01510327|Purinergic Agents|purinergic agents|mesh-ancestor
111363689|NCT01510327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111363690|NCT01510327|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111363691|NCT01510327|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111363692|NCT01401595|Dexetimide|dexetimide|mesh-list
111363693|NCT01401595|Citalopram|citalopram|mesh-list
111363694|NCT01401595|Escitalopram|escitalopram|mesh-list
111363695|NCT01401595|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111363696|NCT01401595|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111363697|NCT01401595|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111363698|NCT01401595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111363699|NCT01401595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111363700|NCT01401595|Serotonin Agents|serotonin agents|mesh-ancestor
111363701|NCT01401595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111363702|NCT01401595|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111363703|NCT01401595|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111363704|NCT01401595|Parasympatholytics|parasympatholytics|mesh-ancestor
111363705|NCT01401595|Autonomic Agents|autonomic agents|mesh-ancestor
111363706|NCT01401595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111363707|NCT01401595|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111363708|NCT01401595|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111363709|NCT01401595|Cholinergic Agents|cholinergic agents|mesh-ancestor
111363710|NCT01401595|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111134383|NCT04946227|Pembrolizumab|pembrolizumab|mesh-list
111363711|NCT01401595|Antidepressive Agents|antidepressive agents|mesh-ancestor
111363712|NCT01401595|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111363713|NCT01511809|Ritonavir|ritonavir|mesh-list
111363714|NCT01511809|Atazanavir Sulfate|atazanavir sulfate|mesh-list
111363715|NCT01511809|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111363716|NCT01511809|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111363717|NCT01511809|Protease Inhibitors|protease inhibitors|mesh-ancestor
111363718|NCT01511809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111363719|NCT01511809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111363720|NCT01511809|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111363721|NCT01511809|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111363722|NCT01511809|Antiviral Agents|antiviral agents|mesh-ancestor
111363723|NCT01511809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111363724|NCT01511809|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111363725|NCT01511809|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111363726|NCT02480712|Sofosbuvir|sofosbuvir|mesh-list
111088128|NCT03221569|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111363727|NCT02480712|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
111363728|NCT02480712|Velpatasvir|velpatasvir|mesh-list
111363729|NCT02480712|Antiviral Agents|antiviral agents|mesh-ancestor
111363730|NCT02480712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111363731|NCT03916094|Trastuzumab|trastuzumab|mesh-list
111363732|NCT03916094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111363733|NCT03916094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111363734|NCT04986852|Pembrolizumab|pembrolizumab|mesh-list
111363735|NCT04986852|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111363736|NCT04986852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111363737|NCT04986852|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111363738|NCT04986852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111363739|NCT00115700|Prednisolone|prednisolone|mesh-list
111363740|NCT00115700|Cyclophosphamide|cyclophosphamide|mesh-list
111363741|NCT00115700|Rituximab|rituximab|mesh-list
111363742|NCT00115700|Vincristine|vincristine|mesh-list
111363743|NCT00115700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111363744|NCT00115700|Immunologic Factors|immunologic factors|mesh-ancestor
111363745|NCT00115700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111363746|NCT00115700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111363747|NCT00115700|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111363748|NCT00115700|Alkylating Agents|alkylating agents|mesh-ancestor
111363749|NCT00115700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111363750|NCT00115700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111363751|NCT00115700|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111363752|NCT00115700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111363753|NCT00115700|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111363754|NCT00115700|Tubulin Modulators|tubulin modulators|mesh-ancestor
111363755|NCT00115700|Antimitotic Agents|antimitotic agents|mesh-ancestor
111363756|NCT00115700|Mitosis Modulators|mitosis modulators|mesh-ancestor
111363757|NCT00115700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111363758|NCT00115700|Glucocorticoids|glucocorticoids|mesh-ancestor
111363759|NCT00115700|Hormones|hormones|mesh-ancestor
111363760|NCT00115700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111363761|NCT00115700|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111363762|NCT01553539|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
111363763|NCT01553539|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111363764|NCT01553539|Vasodilator Agents|vasodilator agents|mesh-ancestor
111363765|NCT03243890|Vitamin D|vitamin d|mesh-list
111363766|NCT03243890|Vitamin K 2|vitamin k 2|mesh-list
111363767|NCT03243890|Vitamin K|vitamin k|mesh-list
111363768|NCT03243890|Menaquinone 7|menaquinone 7|mesh-list
111363769|NCT03243890|Vitamins|vitamins|mesh-ancestor
111363770|NCT03243890|Micronutrients|micronutrients|mesh-ancestor
111363771|NCT03243890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111363772|NCT03243890|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111363773|NCT03243890|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111363774|NCT03243890|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111363775|NCT03243890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111363776|NCT03243890|Hemostatics|hemostatics|mesh-ancestor
111363777|NCT03243890|Coagulants|coagulants|mesh-ancestor
111363778|NCT00560612|Paroxetine|paroxetine|mesh-list
111363779|NCT00560612|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111363780|NCT00560612|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111363781|NCT00560612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111363782|NCT00560612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111363783|NCT00560612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111363784|NCT00560612|Serotonin Agents|serotonin agents|mesh-ancestor
111363785|NCT00560612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111363786|NCT00560612|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111363787|NCT00560612|Antidepressive Agents|antidepressive agents|mesh-ancestor
111363788|NCT00560612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111363789|NCT00560612|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111363790|NCT00560612|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111363791|NCT00560612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111363792|NCT01556347|Rituximab|rituximab|mesh-list
111363793|NCT01556347|Bortezomib|bortezomib|mesh-list
111363794|NCT01556347|Thymoglobulin|thymoglobulin|mesh-list
111363795|NCT01556347|Antilymphocyte Serum|antilymphocyte serum|mesh-list
111363796|NCT01556347|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111363797|NCT01556347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111363798|NCT01556347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111363799|NCT01556347|Immunologic Factors|immunologic factors|mesh-ancestor
111363800|NCT01556347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111363801|NCT01556347|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111363802|NCT01556347|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111363803|NCT00561002|Vaccines|vaccines|mesh-list
111363804|NCT00561002|Immunologic Factors|immunologic factors|mesh-ancestor
111363805|NCT00561002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111363806|NCT03236792|Dexamethasone|dexamethasone|mesh-list
111363807|NCT03236792|Cyclophosphamide|cyclophosphamide|mesh-list
111363808|NCT03236792|Ixazomib|ixazomib|mesh-list
111363809|NCT03236792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111363810|NCT03236792|Immunologic Factors|immunologic factors|mesh-ancestor
111363811|NCT03236792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111363812|NCT03236792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111363813|NCT03236792|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111363814|NCT03236792|Alkylating Agents|alkylating agents|mesh-ancestor
111363815|NCT03236792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111363816|NCT03236792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111363817|NCT03236792|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111363818|NCT03236792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111363819|NCT03236792|Antiemetics|antiemetics|mesh-ancestor
111363820|NCT03236792|Autonomic Agents|autonomic agents|mesh-ancestor
111363821|NCT03236792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111363822|NCT03236792|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111363823|NCT03236792|Glucocorticoids|glucocorticoids|mesh-ancestor
111363824|NCT03236792|Hormones|hormones|mesh-ancestor
111363825|NCT03236792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111363826|NCT03236792|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111363827|NCT03236792|Protease Inhibitors|protease inhibitors|mesh-ancestor
111363828|NCT03236792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111363829|NCT03725384|Ascorbic Acid|ascorbic acid|mesh-list
111363830|NCT03725384|Iron|iron|mesh-list
111363831|NCT03725384|Vitamins|vitamins|mesh-ancestor
111363832|NCT03725384|Micronutrients|micronutrients|mesh-ancestor
111363833|NCT03725384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111363834|NCT03725384|Trace Elements|trace elements|mesh-ancestor
111363835|NCT03725384|Antioxidants|antioxidants|mesh-ancestor
111363836|NCT03725384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111363837|NCT03725384|Protective Agents|protective agents|mesh-ancestor
111363838|NCT01556425|Naltrexone|naltrexone|mesh-list
111363839|NCT01556425|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111363840|NCT01556425|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111363841|NCT01556425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111363842|NCT01556425|Sensory System Agents|sensory system agents|mesh-ancestor
111363843|NCT01556425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111363844|NCT01798628|Abiraterone Acetate|abiraterone acetate|mesh-list
111363845|NCT01798628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111363846|NCT01798628|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111363847|NCT01798628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111363848|NCT01798628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111363849|NCT01798628|Hormone Antagonists|hormone antagonists|mesh-ancestor
111363850|NCT01798628|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111363851|NCT01798628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111363852|NCT01798628|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111363853|NCT00562328|Rituximab|rituximab|mesh-list
111363854|NCT00562328|Alemtuzumab|alemtuzumab|mesh-list
111363855|NCT00562328|Sargramostim|sargramostim|mesh-list
111363856|NCT00562328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111363857|NCT00562328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111363858|NCT00562328|Immunologic Factors|immunologic factors|mesh-ancestor
111363859|NCT00562328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111363860|NCT00562328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111363861|NCT01514149|Metformin|metformin|mesh-list
111363862|NCT01514149|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111363863|NCT01514149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111363864|NCT05566093|Ethanol|ethanol|mesh-list
111363865|NCT05566093|Polidocanol|polidocanol|mesh-list
111363866|NCT05566093|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111363867|NCT05566093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111363868|NCT05566093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111363869|NCT05566093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111363870|NCT05566093|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
111363871|NCT05566093|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111363872|NCT01558063|Ketamine|ketamine|mesh-list
111363873|NCT01558063|Analgesics|analgesics|mesh-ancestor
111363874|NCT01558063|Sensory System Agents|sensory system agents|mesh-ancestor
111363875|NCT01558063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111134972|NCT03054259|Hormones|hormones|mesh-ancestor
111363876|NCT01558063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111363877|NCT01558063|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111363878|NCT01558063|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111363879|NCT01558063|Anesthetics, General|anesthetics, general|mesh-ancestor
111363881|NCT01558063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111363882|NCT01558063|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111363883|NCT01558063|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111363884|NCT01558063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111363885|NCT01558063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111363886|NCT03641846|Tadalafil|tadalafil|mesh-list
111363887|NCT03641846|Vasodilator Agents|vasodilator agents|mesh-ancestor
111363888|NCT03641846|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111363889|NCT03641846|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111363890|NCT03641846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111363891|NCT03641846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111363892|NCT03641846|Urological Agents|urological agents|mesh-ancestor
111363893|NCT03474458|Doxycycline|doxycycline|mesh-list
111363894|NCT03474458|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111363895|NCT03474458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111363896|NCT03474458|Antimalarials|antimalarials|mesh-ancestor
111363897|NCT03474458|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111363898|NCT03474458|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111363899|NCT01516957|Brodalumab|brodalumab|mesh-list
111363900|NCT01516957|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111363901|NCT01516957|Dermatologic Agents|dermatologic agents|mesh-ancestor
111363902|NCT01516957|Immunologic Factors|immunologic factors|mesh-ancestor
111363903|NCT01516957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111363904|NCT01519063|Naltrexone|naltrexone|mesh-list
111363905|NCT01519063|Memantine|memantine|mesh-list
111363906|NCT01519063|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111363907|NCT01519063|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111363908|NCT01519063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111363909|NCT01519063|Sensory System Agents|sensory system agents|mesh-ancestor
111363910|NCT01519063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111363911|NCT01519063|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111363912|NCT01519063|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111363913|NCT01519063|Dopamine Agents|dopamine agents|mesh-ancestor
111363914|NCT01519063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111363915|NCT01519063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111363916|NCT01519063|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111363917|NCT01519063|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111363918|NCT01559857|Pioglitazone|pioglitazone|mesh-list
111363919|NCT01559857|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111363920|NCT01559857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111363921|NCT05565625|Sunscreening Agents|sunscreening agents|mesh-list
111363922|NCT05565625|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111363923|NCT05565625|Protective Agents|protective agents|mesh-ancestor
111363924|NCT05565625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111363925|NCT05565625|Dermatologic Agents|dermatologic agents|mesh-ancestor
111363926|NCT00754208|Methylphenidate|methylphenidate|mesh-list
111363927|NCT00754208|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111363928|NCT00754208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111363929|NCT00754208|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111363930|NCT00754208|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111363931|NCT00754208|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111363932|NCT00754208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111363933|NCT00754208|Dopamine Agents|dopamine agents|mesh-ancestor
111363934|NCT00754208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111363935|NCT01562041|Ranolazine|ranolazine|mesh-list
111363936|NCT01562041|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111363937|NCT01562041|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111363938|NCT01562041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111363939|NCT00634166|Anti-Infective Agents|anti-infective agents|mesh-list
111363940|NCT00634166|Amphotericin B|amphotericin b|mesh-list
111363941|NCT00634166|Clotrimazole|clotrimazole|mesh-list
111363942|NCT00634166|Miconazole|miconazole|mesh-list
111363943|NCT00634166|Bacitracin|bacitracin|mesh-list
111363944|NCT00634166|Mafenide|mafenide|mesh-list
111363945|NCT00634166|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111363946|NCT00634166|Antifungal Agents|antifungal agents|mesh-list
111363947|NCT00634166|Amebicides|amebicides|mesh-ancestor
111363948|NCT00634166|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111363949|NCT00634166|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111363950|NCT00634166|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111363951|NCT00634166|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111363952|NCT00634166|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111363953|NCT00634166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111088356|NCT02490527|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111363954|NCT00634166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111363955|NCT00634166|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111363956|NCT00634166|Hormone Antagonists|hormone antagonists|mesh-ancestor
111363957|NCT00634166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111363958|NCT00634166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111363959|NCT00634166|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111363960|NCT00634166|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111363961|NCT00634166|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
111363962|NCT00565370|Capecitabine|capecitabine|mesh-list
111363963|NCT00565370|Sorafenib|sorafenib|mesh-list
111135258|NCT04814875|Doxorubicin|doxorubicin|mesh-list
111363964|NCT00565370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111363965|NCT00565370|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111363966|NCT00565370|Antimetabolites|antimetabolites|mesh-ancestor
111363967|NCT00565370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111363968|NCT00565370|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111363969|NCT00565370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111363970|NCT03303950|Cyclophosphamide|cyclophosphamide|mesh-list
111363971|NCT03303950|Busulfan|busulfan|mesh-list
111363972|NCT03303950|Fludarabine|fludarabine|mesh-list
111363973|NCT03303950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111363974|NCT03303950|Immunologic Factors|immunologic factors|mesh-ancestor
111135324|NCT02453841|Mydriatics|mydriatics|mesh-ancestor
111363975|NCT03303950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111363976|NCT03303950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111363977|NCT03303950|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111363978|NCT03303950|Alkylating Agents|alkylating agents|mesh-ancestor
111363979|NCT03303950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111363980|NCT03303950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111363981|NCT03303950|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111363982|NCT01563055|Ofatumumab|ofatumumab|mesh-list
111135401|NCT04888819|Fexuprazan|fexuprazan|mesh-list
111363983|NCT01563055|Chlorambucil|chlorambucil|mesh-list
111363984|NCT01563055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111363985|NCT01563055|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111363986|NCT01563055|Alkylating Agents|alkylating agents|mesh-ancestor
111363987|NCT01563055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111363988|NCT00565916|Estradiol|estradiol|mesh-list
111363989|NCT00565916|Estrogens|estrogens|mesh-list
111363990|NCT00565916|Progesterone|progesterone|mesh-list
111363991|NCT00565916|Hormones|hormones|mesh-ancestor
111363992|NCT00565916|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111363993|NCT00565916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111363994|NCT00565916|Progestins|progestins|mesh-ancestor
111363995|NCT03258320|Docetaxel|docetaxel|mesh-list
111363996|NCT03258320|Mitoxantrone|mitoxantrone|mesh-list
111363997|NCT03258320|Satraplatin|satraplatin|mesh-list
111363998|NCT03258320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111363999|NCT03258320|Tubulin Modulators|tubulin modulators|mesh-ancestor
111364000|NCT03258320|Antimitotic Agents|antimitotic agents|mesh-ancestor
111364001|NCT03258320|Mitosis Modulators|mitosis modulators|mesh-ancestor
111135517|NCT02419755|Analgesics|analgesics|mesh-ancestor
111364002|NCT03258320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111364003|NCT03258320|Analgesics|analgesics|mesh-ancestor
111364004|NCT03258320|Sensory System Agents|sensory system agents|mesh-ancestor
111364005|NCT03258320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111364006|NCT03258320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111364007|NCT03258320|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111364008|NCT03258320|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111364009|NCT03258320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111364010|NCT01797926|Losartan|losartan|mesh-list
111364011|NCT01797926|Amlodipine|amlodipine|mesh-list
111364012|NCT01797926|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111364013|NCT01797926|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111364014|NCT01797926|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111364015|NCT01797926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111364016|NCT01797926|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111364017|NCT01797926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111364018|NCT01797926|Vasodilator Agents|vasodilator agents|mesh-ancestor
111364019|NCT01797926|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111364020|NCT01797926|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111364021|NCT01797926|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111364022|NCT03008083|Clopidogrel|clopidogrel|mesh-list
111364023|NCT03008083|Ticagrelor|ticagrelor|mesh-list
111364024|NCT03008083|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111364025|NCT03008083|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111364026|NCT03008083|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111364027|NCT03008083|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111364029|NCT03008083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111364030|NCT03008083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111364031|NCT03008083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111364032|NCT05559398|Glenzocimab|glenzocimab|mesh-list
111364033|NCT05559398|Anticoagulants|anticoagulants|mesh-ancestor
111364034|NCT00566150|Levetiracetam|levetiracetam|mesh-list
111364035|NCT00566150|Anticonvulsants|anticonvulsants|mesh-ancestor
111364036|NCT00566150|Nootropic Agents|nootropic agents|mesh-ancestor
111364037|NCT00566540|Paclitaxel|paclitaxel|mesh-list
111364038|NCT00566540|Cisplatin|cisplatin|mesh-list
111364039|NCT00566540|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111364040|NCT00566540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111364041|NCT00566540|Tubulin Modulators|tubulin modulators|mesh-ancestor
111364042|NCT00566540|Antimitotic Agents|antimitotic agents|mesh-ancestor
111364043|NCT00566540|Mitosis Modulators|mitosis modulators|mesh-ancestor
111364044|NCT00566540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111364045|NCT00567008|Varenicline|varenicline|mesh-list
111364046|NCT00567008|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111364047|NCT00567008|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111364048|NCT00567008|Cholinergic Agents|cholinergic agents|mesh-ancestor
111364049|NCT00567008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111364050|NCT00567008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111364051|NCT00567008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111364052|NCT00567320|Varenicline|varenicline|mesh-list
111364053|NCT00567320|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111364054|NCT00567320|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111364055|NCT00567320|Cholinergic Agents|cholinergic agents|mesh-ancestor
111364056|NCT00567320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111364057|NCT00567320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111364058|NCT00567320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111364059|NCT01522417|Tirofiban|tirofiban|mesh-list
111364060|NCT01522417|Eptifibatide|eptifibatide|mesh-list
111364061|NCT01522417|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111364062|NCT01522417|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111364063|NCT01522417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111135782|NCT04884919|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111364064|NCT01522417|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111364065|NCT00568022|Capecitabine|capecitabine|mesh-list
111364066|NCT00568022|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111364067|NCT00568022|Antimetabolites|antimetabolites|mesh-ancestor
111364068|NCT00568022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111364069|NCT00568022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111364070|NCT01522963|Nicotine|nicotine|mesh-list
111364071|NCT01522963|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111364072|NCT01522963|Autonomic Agents|autonomic agents|mesh-ancestor
111364073|NCT01522963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111364074|NCT01522963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111364075|NCT01522963|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111364076|NCT01522963|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111364077|NCT01522963|Cholinergic Agents|cholinergic agents|mesh-ancestor
111364078|NCT01522963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111135892|NCT04112095|Norgestrel|norgestrel|mesh-list
111364079|NCT01522963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111364080|NCT03094286|Durvalumab|durvalumab|mesh-list
111364081|NCT03094286|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111364082|NCT03094286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111364083|NCT03071666|Vitamin B 12|vitamin b 12|mesh-list
111364084|NCT03071666|Vitamins|vitamins|mesh-ancestor
111364085|NCT03071666|Micronutrients|micronutrients|mesh-ancestor
111364086|NCT03071666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111364087|NCT03071666|Vitamin B Complex|vitamin b complex|mesh-ancestor
111364088|NCT05533580|Sufentanil|sufentanil|mesh-list
111364089|NCT05533580|Dsuvia|dsuvia|mesh-list
111364090|NCT05533580|Propofol|propofol|mesh-list
111364091|NCT05533580|Cisatracurium|cisatracurium|mesh-list
111364092|NCT05533580|Atracurium|atracurium|mesh-list
111364093|NCT05533580|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111364094|NCT05533580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111364095|NCT05533580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111364096|NCT05533580|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111364097|NCT05533580|Anesthetics, General|anesthetics, general|mesh-ancestor
111364098|NCT05533580|Anesthetics|anesthetics|mesh-ancestor
111364099|NCT05533580|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111364100|NCT05533580|Narcotics|narcotics|mesh-ancestor
111364101|NCT05533580|Analgesics|analgesics|mesh-ancestor
111364102|NCT05533580|Sensory System Agents|sensory system agents|mesh-ancestor
111364103|NCT05533580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111364104|NCT05533580|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111364105|NCT05533580|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
111364106|NCT05533580|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111136035|NCT05216575|Almitrine|almitrine|mesh-list
111364107|NCT05533580|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
111364108|NCT05533580|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
111364109|NCT05533580|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111364110|NCT05533580|Cholinergic Agents|cholinergic agents|mesh-ancestor
111364111|NCT05533580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111364112|NCT05533580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111364113|NCT02129426|Midazolam|midazolam|mesh-list
111364114|NCT02129426|Dexmedetomidine|dexmedetomidine|mesh-list
111364115|NCT02129426|Ketamine|ketamine|mesh-list
111364116|NCT02129426|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111364117|NCT02129426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111364118|NCT02129426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111364119|NCT02129426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111364120|NCT02129426|Analgesics|analgesics|mesh-ancestor
111364121|NCT02129426|Sensory System Agents|sensory system agents|mesh-ancestor
111364122|NCT02129426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111364123|NCT02129426|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111364124|NCT02129426|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111364125|NCT02129426|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111364126|NCT02129426|Adrenergic Agents|adrenergic agents|mesh-ancestor
111136158|NCT04864717|Doxycycline|doxycycline|mesh-list
111364127|NCT02129426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111364128|NCT02129426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111364129|NCT02129426|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111136217|NCT05531591|Dopamine Agents|dopamine agents|mesh-ancestor
111364130|NCT02129426|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111364131|NCT02129426|Anesthetics, General|anesthetics, general|mesh-ancestor
111364132|NCT02129426|Anesthetics|anesthetics|mesh-ancestor
111364133|NCT02129426|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111364134|NCT02129426|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111364135|NCT02129426|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111364136|NCT02129426|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111364137|NCT02129426|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111364138|NCT02129426|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111364139|NCT02129426|GABA Modulators|gaba modulators|mesh-ancestor
111364140|NCT02129426|GABA Agents|gaba agents|mesh-ancestor
111364141|NCT01523821|Protease Inhibitors|protease inhibitors|mesh-list
111364142|NCT01523821|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
111364143|NCT01523821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111364144|NCT01523821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111364145|NCT01523821|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
111364146|NCT01523821|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111364147|NCT05409716|Hemostatics|hemostatics|mesh-list
111364148|NCT05409716|Coagulants|coagulants|mesh-ancestor
111364149|NCT05395910|Paclitaxel|paclitaxel|mesh-list
111364150|NCT05395910|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111364151|NCT05395910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111364152|NCT05395910|Tubulin Modulators|tubulin modulators|mesh-ancestor
111364153|NCT05395910|Antimitotic Agents|antimitotic agents|mesh-ancestor
111364154|NCT05395910|Mitosis Modulators|mitosis modulators|mesh-ancestor
111364155|NCT05395910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111364156|NCT05389046|Dexetimide|dexetimide|mesh-list
111364157|NCT05389046|Aripiprazole|aripiprazole|mesh-list
111364158|NCT05389046|Citalopram|citalopram|mesh-list
111364159|NCT05389046|Escitalopram|escitalopram|mesh-list
111364160|NCT05389046|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111364161|NCT05389046|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111364162|NCT05389046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111364163|NCT05389046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111364164|NCT05389046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111364165|NCT05389046|Serotonin Agents|serotonin agents|mesh-ancestor
111364166|NCT05389046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111364167|NCT05389046|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111136476|NCT05506319|Arginine Vasopressin|arginine vasopressin|mesh-list
111364168|NCT05389046|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111364169|NCT05389046|Parasympatholytics|parasympatholytics|mesh-ancestor
111364170|NCT05389046|Autonomic Agents|autonomic agents|mesh-ancestor
111136547|NCT02570711|Paclitaxel|paclitaxel|mesh-list
111364171|NCT05389046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111364172|NCT05389046|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111364173|NCT05389046|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111364174|NCT05389046|Cholinergic Agents|cholinergic agents|mesh-ancestor
111364175|NCT05389046|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111364176|NCT05389046|Antidepressive Agents|antidepressive agents|mesh-ancestor
111364177|NCT05389046|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111364178|NCT05389046|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111364179|NCT05389046|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111364180|NCT05389046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111364181|NCT05389046|Dopamine Agonists|dopamine agonists|mesh-ancestor
111364182|NCT05389046|Dopamine Agents|dopamine agents|mesh-ancestor
111364183|NCT05389046|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111364184|NCT05389046|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111364185|NCT05389046|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111364186|NCT05389046|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111364187|NCT05389046|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111364188|NCT05389046|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111364189|NCT01566409|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
111364190|NCT01566409|Laxatives|laxatives|mesh-ancestor
111364191|NCT01566409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111364192|NCT02184416|Everolimus|everolimus|mesh-list
111364193|NCT02184416|Temsirolimus|temsirolimus|mesh-list
111364194|NCT02184416|Sorafenib|sorafenib|mesh-list
111364195|NCT02184416|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111364196|NCT02184416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111364197|NCT02184416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111364198|NCT02184416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111364199|NCT02184416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111364200|NCT02184416|Immunologic Factors|immunologic factors|mesh-ancestor
111364201|NCT02184416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111364202|NCT02184416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111364203|NCT01568905|Nicotine|nicotine|mesh-list
111364204|NCT01568905|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111364205|NCT01568905|Autonomic Agents|autonomic agents|mesh-ancestor
111364206|NCT01568905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111364207|NCT01568905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111364208|NCT01568905|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111364209|NCT01568905|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111364210|NCT01568905|Cholinergic Agents|cholinergic agents|mesh-ancestor
111136821|NCT04429711|Ivermectin|ivermectin|mesh-list
111364211|NCT01568905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111364212|NCT01568905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111364213|NCT01569451|Rituximab|rituximab|mesh-list
111364214|NCT01569451|Glatiramer Acetate|glatiramer acetate|mesh-list
111364215|NCT01569451|(T,G)-A-L|(t,g)-a-l|mesh-list
111364216|NCT01569451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111364217|NCT01569451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111364218|NCT01569451|Immunologic Factors|immunologic factors|mesh-ancestor
111364219|NCT01569451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111364220|NCT01569451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111364221|NCT01569451|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111136952|NCT04848259|Dexamethasone|dexamethasone|mesh-list
111364222|NCT01569451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111364223|NCT02132936|Calcipotriene|calcipotriene|mesh-list
111364224|NCT02132936|Dermatologic Agents|dermatologic agents|mesh-ancestor
111364225|NCT01528891|Dexmedetomidine|dexmedetomidine|mesh-list
111364226|NCT01528891|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111364227|NCT01528891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111364228|NCT01528891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111364229|NCT01528891|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111364230|NCT01528891|Analgesics|analgesics|mesh-ancestor
111364231|NCT01528891|Sensory System Agents|sensory system agents|mesh-ancestor
111364232|NCT01528891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111364233|NCT01528891|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111364234|NCT01528891|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111364235|NCT01528891|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111364236|NCT01528891|Adrenergic Agents|adrenergic agents|mesh-ancestor
111364237|NCT01528891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111364238|NCT01528891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111364239|NCT01529203|Botulinum Toxins|botulinum toxins|mesh-list
111364240|NCT01529203|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111364241|NCT01529203|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111364242|NCT01529203|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111364243|NCT01529203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111364244|NCT01529203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111364245|NCT01529203|Cholinergic Agents|cholinergic agents|mesh-ancestor
111364246|NCT01529203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111364247|NCT01529203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111364248|NCT01529203|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111364249|NCT01529203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111364250|NCT01529827|Mycophenolic Acid|mycophenolic acid|mesh-list
111364251|NCT01529827|Methotrexate|methotrexate|mesh-list
111364252|NCT01529827|Fludarabine phosphate|fludarabine phosphate|mesh-list
111364253|NCT01529827|Fludarabine|fludarabine|mesh-list
111364254|NCT01529827|Melphalan|melphalan|mesh-list
111364255|NCT01529827|Tacrolimus|tacrolimus|mesh-list
111364256|NCT01529827|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111364257|NCT01529827|Abortifacient Agents|abortifacient agents|mesh-ancestor
111364258|NCT01529827|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111364259|NCT01529827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111364260|NCT01529827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111364261|NCT01529827|Antimetabolites|antimetabolites|mesh-ancestor
111364262|NCT01529827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111364263|NCT01529827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111364264|NCT01529827|Dermatologic Agents|dermatologic agents|mesh-ancestor
111364265|NCT01529827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111364266|NCT01529827|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111364267|NCT01529827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111364268|NCT01529827|Immunologic Factors|immunologic factors|mesh-ancestor
111364269|NCT01529827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111364270|NCT01529827|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111364271|NCT01529827|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111364272|NCT01529827|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111364273|NCT01529827|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111364274|NCT01529827|Antitubercular Agents|antitubercular agents|mesh-ancestor
111364275|NCT01529827|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111364276|NCT01529827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111364277|NCT01529827|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111364278|NCT01529827|Alkylating Agents|alkylating agents|mesh-ancestor
111364279|NCT01529827|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111364280|NCT01571557|Dexamethasone|dexamethasone|mesh-list
111364281|NCT01571557|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111364282|NCT01571557|Antiemetics|antiemetics|mesh-ancestor
111364283|NCT01571557|Autonomic Agents|autonomic agents|mesh-ancestor
111364284|NCT01571557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111364285|NCT01571557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111364286|NCT01571557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111364287|NCT01571557|Glucocorticoids|glucocorticoids|mesh-ancestor
111364288|NCT01571557|Hormones|hormones|mesh-ancestor
111364289|NCT01571557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111364290|NCT01571557|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111364291|NCT01571557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111364292|NCT00569660|Azacitidine|azacitidine|mesh-list
111364293|NCT00569660|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111364294|NCT00569660|Antimetabolites|antimetabolites|mesh-ancestor
111364295|NCT00569660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111364296|NCT00569660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111364297|NCT00569660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111364298|NCT01573273|Oxytocin|oxytocin|mesh-list
111364299|NCT01573273|Oxytocics|oxytocics|mesh-ancestor
111364300|NCT01573273|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111364301|NCT01573273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111364302|NCT00572234|Bupropion|bupropion|mesh-list
111364303|NCT00572234|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111364304|NCT00572234|Antidepressive Agents|antidepressive agents|mesh-ancestor
111364305|NCT00572234|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111137467|NCT04822909|Thalidomide|thalidomide|mesh-list
111364306|NCT00572234|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111364307|NCT00572234|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111364308|NCT00572234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111364309|NCT00572234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111364310|NCT00572234|Dopamine Agents|dopamine agents|mesh-ancestor
111364311|NCT00572234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111364312|NCT00572234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111364313|NCT00572234|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111364314|NCT00572234|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111364315|NCT00572234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111364316|NCT00572468|Simvastatin|simvastatin|mesh-list
111364317|NCT00572468|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111364318|NCT00572468|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111364319|NCT00572468|Antimetabolites|antimetabolites|mesh-ancestor
111364320|NCT00572468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111364321|NCT00572468|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111364322|NCT00572468|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111364323|NCT00572468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111364324|NCT02339246|Tacrolimus|tacrolimus|mesh-list
111364325|NCT02339246|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111364326|NCT02339246|Immunologic Factors|immunologic factors|mesh-ancestor
111364327|NCT02339246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111364328|NCT02339246|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111364329|NCT02339246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111364330|NCT02339246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111364331|NCT00572936|Timolol|timolol|mesh-list
111364332|NCT00572936|Dorzolamide|dorzolamide|mesh-list
111364333|NCT00572936|Latanoprost|latanoprost|mesh-list
111364334|NCT00572936|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111364335|NCT00572936|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111364336|NCT00572936|Adrenergic Agents|adrenergic agents|mesh-ancestor
111364337|NCT00572936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111364338|NCT00572936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111364339|NCT00572936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111364340|NCT00572936|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111364341|NCT00572936|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111364342|NCT00572936|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
111364343|NCT00572936|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111364344|NCT00572936|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
111364345|NCT00572936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111364346|NCT05085626|Fluzoparib|fluzoparib|mesh-list
111364347|NCT05085626|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111137799|NCT04796857|Antibodies|antibodies|mesh-list
111364348|NCT05085626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111364349|NCT05085626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111364350|NCT05085626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111364351|NCT05041946|Methylphenidate|methylphenidate|mesh-list
111364352|NCT05041946|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111364353|NCT05041946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111364354|NCT05041946|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111364355|NCT05041946|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111364356|NCT05041946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111364357|NCT05041946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111364358|NCT05041946|Dopamine Agents|dopamine agents|mesh-ancestor
111364359|NCT05041946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111364360|NCT05092412|Carboplatin|carboplatin|mesh-list
111364361|NCT05092412|Etoposide|etoposide|mesh-list
111364362|NCT05092412|Durvalumab|durvalumab|mesh-list
111364363|NCT05092412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111364364|NCT05092412|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111364365|NCT05092412|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111364366|NCT05092412|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111364367|NCT05092412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111364368|NCT05092412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111364369|NCT05092412|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111364370|NCT00574340|Hypoglycemic Agents|hypoglycemic agents|mesh-list
111364371|NCT00574340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111364372|NCT05004896|Midazolam|midazolam|mesh-list
111364373|NCT05004896|Ketamine|ketamine|mesh-list
111364374|NCT05004896|Analgesics|analgesics|mesh-ancestor
111364375|NCT05004896|Sensory System Agents|sensory system agents|mesh-ancestor
111364376|NCT05004896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111364377|NCT05004896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111364378|NCT05004896|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111364379|NCT05004896|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111364380|NCT05004896|Anesthetics, General|anesthetics, general|mesh-ancestor
111364381|NCT05004896|Anesthetics|anesthetics|mesh-ancestor
111364382|NCT05004896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111364383|NCT05004896|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111364384|NCT05004896|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111364385|NCT05004896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111364386|NCT05004896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111364387|NCT05004896|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111364388|NCT05004896|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111364389|NCT05004896|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111364390|NCT05004896|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111364391|NCT05004896|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111364392|NCT05004896|GABA Modulators|gaba modulators|mesh-ancestor
111364393|NCT05004896|GABA Agents|gaba agents|mesh-ancestor
111364394|NCT00576680|Temozolomide|temozolomide|mesh-list
111364395|NCT00576680|Everolimus|everolimus|mesh-list
111364396|NCT00576680|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111364397|NCT00576680|Alkylating Agents|alkylating agents|mesh-ancestor
111364398|NCT00576680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111364399|NCT00576680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111364400|NCT00576680|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111364401|NCT00576680|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111088825|NCT03203317|Insulin|insulin|mesh-list
111364402|NCT00576680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111364403|NCT00576680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111364404|NCT00576680|Immunologic Factors|immunologic factors|mesh-ancestor
111364405|NCT00576680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111364406|NCT04866602|Atovaquone|atovaquone|mesh-list
111364407|NCT04866602|Proguanil|proguanil|mesh-list
111364408|NCT04866602|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
111364409|NCT04866602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111364410|NCT04866602|Antimalarials|antimalarials|mesh-ancestor
111364411|NCT04866602|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111364412|NCT04866602|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111364413|NCT04866602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111364414|NCT04866602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111364415|NCT04866602|Antimetabolites|antimetabolites|mesh-ancestor
111364416|NCT04730648|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-list
111364417|NCT04730648|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111364418|NCT04730648|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111364419|NCT04730648|Antimetabolites|antimetabolites|mesh-ancestor
111138326|NCT04134325|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111364420|NCT04730648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111364421|NCT04730648|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111364422|NCT04730648|Protease Inhibitors|protease inhibitors|mesh-ancestor
111364423|NCT04730648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111364424|NCT04730648|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111364425|NCT00578552|Gabapentin|gabapentin|mesh-list
111364426|NCT00578552|Analgesics|analgesics|mesh-ancestor
111364427|NCT00578552|Sensory System Agents|sensory system agents|mesh-ancestor
111364428|NCT00578552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111364429|NCT00578552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111364430|NCT00578552|Anticonvulsants|anticonvulsants|mesh-ancestor
111364431|NCT00578552|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111364432|NCT00578552|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111364433|NCT00578552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111364434|NCT00578552|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111364435|NCT00578552|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111364436|NCT00578552|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111364437|NCT00578552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111364438|NCT00578552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111364439|NCT00578552|Antimanic Agents|antimanic agents|mesh-ancestor
111364440|NCT01532089|Bevacizumab|bevacizumab|mesh-list
111364441|NCT01532089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111138455|NCT05347459|Dapagliflozin|dapagliflozin|mesh-list
111364442|NCT01532089|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111364443|NCT01532089|Endothelial Growth Factors|endothelial growth factors|mesh-list
111364444|NCT01532089|Antibodies|antibodies|mesh-list
111364445|NCT01532089|Immunoglobulins|immunoglobulins|mesh-list
111364446|NCT01532089|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111364447|NCT01532089|Immunoglobulin G|immunoglobulin g|mesh-list
111364448|NCT01532089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111364449|NCT01532089|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111364450|NCT01532089|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111364451|NCT01532089|Growth Substances|growth substances|mesh-ancestor
111364452|NCT01532089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111364453|NCT01532089|Growth Inhibitors|growth inhibitors|mesh-ancestor
111364454|NCT01532089|Immunologic Factors|immunologic factors|mesh-ancestor
111364455|NCT01532089|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111364456|NCT01532089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111364457|NCT01532089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111364458|NCT00579878|Hydroxychloroquine|hydroxychloroquine|mesh-list
111364459|NCT00579878|Sulfasalazine|sulfasalazine|mesh-list
111364460|NCT00579878|Methotrexate|methotrexate|mesh-list
111364461|NCT00579878|Leflunomide|leflunomide|mesh-list
111364462|NCT00579878|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111364463|NCT00579878|Abortifacient Agents|abortifacient agents|mesh-ancestor
111364464|NCT00579878|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111364465|NCT00579878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111364466|NCT00579878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111364467|NCT00579878|Antimetabolites|antimetabolites|mesh-ancestor
111138646|NCT01666951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111364468|NCT00579878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111364469|NCT00579878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111364470|NCT00579878|Dermatologic Agents|dermatologic agents|mesh-ancestor
111364471|NCT00579878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111364472|NCT00579878|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111364473|NCT00579878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111364474|NCT00579878|Immunologic Factors|immunologic factors|mesh-ancestor
111364475|NCT00579878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111138713|NCT01905631|Promethazine|promethazine|mesh-list
111364476|NCT00579878|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111364477|NCT00579878|Antimalarials|antimalarials|mesh-ancestor
111364478|NCT00579878|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111364479|NCT00579878|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111364480|NCT00579878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111364481|NCT00579878|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111364482|NCT00579878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111364483|NCT00579878|Analgesics|analgesics|mesh-ancestor
111364484|NCT00579878|Sensory System Agents|sensory system agents|mesh-ancestor
111364485|NCT00579878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111364486|NCT00579878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111364487|NCT00579878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111364488|NCT01533259|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
111364489|NCT01533259|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111364490|NCT01533259|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111364491|NCT01533259|Antiviral Agents|antiviral agents|mesh-ancestor
111364492|NCT01533259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111364493|NCT05246072|Ivermectin|ivermectin|mesh-list
111364494|NCT05246072|Colchicine|colchicine|mesh-list
111364495|NCT05246072|Gout Suppressants|gout suppressants|mesh-ancestor
111364496|NCT05246072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111364497|NCT05246072|Tubulin Modulators|tubulin modulators|mesh-ancestor
111364498|NCT05246072|Antimitotic Agents|antimitotic agents|mesh-ancestor
111364499|NCT05246072|Mitosis Modulators|mitosis modulators|mesh-ancestor
111364500|NCT05246072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111364501|NCT05246072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111364502|NCT05246072|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111364503|NCT05246072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111364504|NCT02135432|Ivacaftor|ivacaftor|mesh-list
111364505|NCT02135432|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
111364506|NCT02135432|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111364507|NCT02135432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111364508|NCT05245994|Carboplatin|carboplatin|mesh-list
111364509|NCT05245994|Etoposide|etoposide|mesh-list
111364510|NCT05245994|Durvalumab|durvalumab|mesh-list
111364511|NCT05245994|Olaparib|olaparib|mesh-list
111364512|NCT05245994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111364513|NCT05245994|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111364514|NCT05245994|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111364515|NCT05245994|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111364516|NCT05245994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111364517|NCT05245994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111364518|NCT05245994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111364519|NCT05245994|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111364520|NCT05245604|Cyclosporine|cyclosporine|mesh-list
111364521|NCT05245604|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111364522|NCT05245604|Cyclosporins|cyclosporins|mesh-list
111364523|NCT05245604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111364524|NCT05245604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111364525|NCT05245604|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111364526|NCT05245604|Immunologic Factors|immunologic factors|mesh-ancestor
111364527|NCT05245604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111364528|NCT05245604|Antifungal Agents|antifungal agents|mesh-ancestor
111364529|NCT05245604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111364530|NCT05245604|Dermatologic Agents|dermatologic agents|mesh-ancestor
111364531|NCT05245604|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111364532|NCT05245604|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111364533|NCT05245604|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111364534|NCT05245448|Tetrandrine|tetrandrine|mesh-list
111364535|NCT05245448|Antimalarials|antimalarials|mesh-ancestor
111364536|NCT05245448|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111364537|NCT05245448|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111364538|NCT05245448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111364539|NCT05245448|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111364540|NCT05245448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111364541|NCT05245448|Antiviral Agents|antiviral agents|mesh-ancestor
111364542|NCT05245448|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111364543|NCT05245448|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111364544|NCT05245448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111364545|NCT05245448|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111364546|NCT05245448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111364547|NCT05245448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111364548|NCT05245448|Immunologic Factors|immunologic factors|mesh-ancestor
111364549|NCT00581048|Vitamin E|vitamin e|mesh-list
111364550|NCT00581048|Tocopherols|tocopherols|mesh-list
111364551|NCT00581048|alpha-Tocopherol|alpha-tocopherol|mesh-list
111088958|NCT04456959|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
111364552|NCT00581048|Vitamins|vitamins|mesh-ancestor
111364553|NCT00581048|Micronutrients|micronutrients|mesh-ancestor
111364554|NCT00581048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111364555|NCT00581048|Antioxidants|antioxidants|mesh-ancestor
111364556|NCT00581048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111364557|NCT00581048|Protective Agents|protective agents|mesh-ancestor
111364558|NCT01798472|Cimetidine|cimetidine|mesh-list
111364559|NCT01798472|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111364560|NCT01798472|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111364561|NCT01798472|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
111364562|NCT01798472|Histamine Antagonists|histamine antagonists|mesh-ancestor
111364563|NCT01798472|Histamine Agents|histamine agents|mesh-ancestor
111364564|NCT01798472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111364565|NCT01798472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111364566|NCT01798472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111364567|NCT01798472|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111364568|NCT01798472|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111364569|NCT01798472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111364570|NCT01579513|Methylprednisolone|methylprednisolone|mesh-list
111364571|NCT01579513|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111364572|NCT01579513|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111364573|NCT01579513|Prednisolone|prednisolone|mesh-list
111364574|NCT01579513|Prednisolone acetate|prednisolone acetate|mesh-list
111364575|NCT01579513|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111364576|NCT01579513|Prednisolone phosphate|prednisolone phosphate|mesh-list
111364577|NCT01579513|Glucocorticoids|glucocorticoids|mesh-list
111364578|NCT01579513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111364579|NCT01579513|Antiemetics|antiemetics|mesh-ancestor
111364580|NCT01579513|Autonomic Agents|autonomic agents|mesh-ancestor
111364581|NCT01579513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111364582|NCT01579513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111364583|NCT01579513|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111364584|NCT01579513|Hormones|hormones|mesh-ancestor
111364585|NCT01579513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111364586|NCT01579513|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111364587|NCT01579513|Protective Agents|protective agents|mesh-ancestor
111364588|NCT01579513|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111364589|NCT01579513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111364590|NCT01534897|Dabrafenib|dabrafenib|mesh-list
111364591|NCT01534897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111364592|NCT01534897|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111364593|NCT01534897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111364594|NCT01534897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111364595|NCT05121350|Epirubicin|epirubicin|mesh-list
111364596|NCT05121350|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111364597|NCT05121350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111364598|NCT05121350|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111364599|NCT05121350|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111364600|NCT05121350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111364601|NCT05121350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111364602|NCT00583622|Bevacizumab|bevacizumab|mesh-list
111364603|NCT00583622|Carboplatin|carboplatin|mesh-list
111364604|NCT00583622|Gemcitabine|gemcitabine|mesh-list
111364605|NCT00583622|Docetaxel|docetaxel|mesh-list
111364606|NCT00583622|Melphalan|melphalan|mesh-list
111364607|NCT00583622|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111364608|NCT00583622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111364609|NCT00583622|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111364610|NCT00583622|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111364611|NCT00583622|Growth Substances|growth substances|mesh-ancestor
111364612|NCT00583622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111364613|NCT00583622|Growth Inhibitors|growth inhibitors|mesh-ancestor
111364614|NCT00583622|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111364615|NCT00583622|Antimetabolites|antimetabolites|mesh-ancestor
111364616|NCT00583622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111364617|NCT00583622|Tubulin Modulators|tubulin modulators|mesh-ancestor
111364618|NCT00583622|Antimitotic Agents|antimitotic agents|mesh-ancestor
111364619|NCT00583622|Mitosis Modulators|mitosis modulators|mesh-ancestor
111364620|NCT00583622|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111139563|NCT04582669|Hormones|hormones|mesh-ancestor
111364621|NCT00583622|Alkylating Agents|alkylating agents|mesh-ancestor
111364622|NCT00583622|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111364623|NCT00583622|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111364624|NCT00583622|Immunologic Factors|immunologic factors|mesh-ancestor
111364625|NCT00583700|Vitamin E|vitamin e|mesh-list
111364626|NCT00583700|Pentoxifylline|pentoxifylline|mesh-list
111089036|NCT02483195|Diuretics|diuretics|mesh-ancestor
111364627|NCT00583700|Vitamins|vitamins|mesh-ancestor
111364628|NCT00583700|Micronutrients|micronutrients|mesh-ancestor
111364629|NCT00583700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111364630|NCT00583700|Antioxidants|antioxidants|mesh-ancestor
111364631|NCT00583700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111364632|NCT00583700|Protective Agents|protective agents|mesh-ancestor
111364633|NCT00583700|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111364634|NCT00583700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111364635|NCT00583700|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111364636|NCT00583700|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111364637|NCT00583700|Vasodilator Agents|vasodilator agents|mesh-ancestor
111364638|NCT00583700|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111364639|NCT05540743|Adalimumab|adalimumab|mesh-list
111364640|NCT05540743|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111364641|NCT05540743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111364642|NCT05540743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111364643|NCT01537315|Hydroxychloroquine|hydroxychloroquine|mesh-list
111364644|NCT01537315|Antimalarials|antimalarials|mesh-ancestor
111364645|NCT01537315|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111364646|NCT01537315|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111364647|NCT01537315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111364648|NCT01537315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111364649|NCT01537315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111364650|NCT01537315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111364651|NCT04257188|Anesthetics|anesthetics|mesh-list
111364652|NCT04257188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111364653|NCT04257188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111364654|NCT04224428|Fexofenadine|fexofenadine|mesh-list
111364655|NCT04224428|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111364656|NCT04224428|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
111364657|NCT04224428|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111364658|NCT04224428|Histamine Antagonists|histamine antagonists|mesh-ancestor
111364659|NCT04224428|Histamine Agents|histamine agents|mesh-ancestor
111364660|NCT04224428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111364661|NCT04224428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111364662|NCT04224428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111364663|NCT04224194|Adalimumab|adalimumab|mesh-list
111364664|NCT04224194|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111364665|NCT04224194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111364666|NCT04224194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111364667|NCT00584948|Memantine|memantine|mesh-list
111364668|NCT00584948|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111364669|NCT00584948|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111364670|NCT00584948|Dopamine Agents|dopamine agents|mesh-ancestor
111364671|NCT00584948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111364672|NCT00584948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111364673|NCT00584948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111364674|NCT00584948|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111364675|NCT00584948|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111364676|NCT00605072|Metoprolol|metoprolol|mesh-list
111364677|NCT00605072|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
111364678|NCT00605072|Candesartan|candesartan|mesh-list
111364679|NCT00605072|Candesartan cilexetil|candesartan cilexetil|mesh-list
111364680|NCT00605072|Lisinopril|lisinopril|mesh-list
111364681|NCT00605072|Nifedipine|nifedipine|mesh-list
111364682|NCT00605072|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111364683|NCT00605072|Diuretics|diuretics|mesh-ancestor
111364684|NCT00605072|Natriuretic Agents|natriuretic agents|mesh-ancestor
111364685|NCT00605072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111364686|NCT00605072|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
111364687|NCT00605072|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111364688|NCT00605072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111364689|NCT00605072|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111364690|NCT00605072|Sympatholytics|sympatholytics|mesh-ancestor
111364691|NCT00605072|Autonomic Agents|autonomic agents|mesh-ancestor
111364692|NCT00605072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111364693|NCT00605072|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
111364694|NCT00605072|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111364695|NCT00605072|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111364696|NCT00605072|Adrenergic Agents|adrenergic agents|mesh-ancestor
111364697|NCT00605072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111139783|NCT03313206|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111364698|NCT00605072|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111364699|NCT00605072|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111364700|NCT00605072|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111479266|NCT05091346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111364701|NCT00605072|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111364702|NCT00605072|Vasodilator Agents|vasodilator agents|mesh-ancestor
111364703|NCT00605072|Tocolytic Agents|tocolytic agents|mesh-ancestor
111364704|NCT00605072|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111364705|NCT00605072|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
111364706|NCT00605072|Protease Inhibitors|protease inhibitors|mesh-ancestor
111364707|NCT00605072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111364708|NCT00605072|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111364709|NCT00605072|Protective Agents|protective agents|mesh-ancestor
111364710|NCT00585104|Simendan|simendan|mesh-list
111364711|NCT00585104|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111364712|NCT00585104|Vasodilator Agents|vasodilator agents|mesh-ancestor
111364713|NCT00585104|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
111364714|NCT00585104|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111364715|NCT00585104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111364716|NCT00585104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111364717|NCT00585104|Protective Agents|protective agents|mesh-ancestor
111364718|NCT00585104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111364719|NCT00585182|Enoxaparin|enoxaparin|mesh-list
111364720|NCT00585182|Anticoagulants|anticoagulants|mesh-ancestor
111364721|NCT00585182|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111364722|NCT00585182|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111364723|NCT00585182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111364724|NCT04856228|Lidocaine|lidocaine|mesh-list
111364725|NCT04856228|Anesthetics, Local|anesthetics, local|mesh-ancestor
111364726|NCT04856228|Anesthetics|anesthetics|mesh-ancestor
111364727|NCT04856228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111364728|NCT04856228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111364729|NCT04856228|Sensory System Agents|sensory system agents|mesh-ancestor
111364730|NCT04856228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111364731|NCT04856228|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111364732|NCT04856228|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111364733|NCT04856228|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111364734|NCT04856228|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111364735|NCT04856228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111364736|NCT00605384|Tenofovir|tenofovir|mesh-list
111364737|NCT00605384|Lamivudine|lamivudine|mesh-list
111364738|NCT00605384|Entecavir|entecavir|mesh-list
111364739|NCT00605384|Adefovir|adefovir|mesh-list
111364740|NCT00605384|Antiviral Agents|antiviral agents|mesh-ancestor
111364741|NCT00605384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111364742|NCT00605384|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111364743|NCT00605384|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111139890|NCT00995475|Fluticasone|fluticasone|mesh-list
111364744|NCT00605384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111364745|NCT00605384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111364746|NCT00605384|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111364747|NCT00605384|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111364748|NCT00586196|Donepezil|donepezil|mesh-list
111364749|NCT00586196|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111364750|NCT00586196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111364751|NCT00586196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111364752|NCT00586196|Cholinergic Agents|cholinergic agents|mesh-ancestor
111364753|NCT00586196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111364754|NCT00586196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111364755|NCT00586196|Nootropic Agents|nootropic agents|mesh-ancestor
111364756|NCT00605696|Insulin|insulin|mesh-list
111364757|NCT00605696|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111364758|NCT00605696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111364759|NCT00587132|Secretin|secretin|mesh-list
111364760|NCT00587132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111364761|NCT00587132|Hormones|hormones|mesh-ancestor
111364762|NCT00587132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111364763|NCT00587132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111364764|NCT00587678|Simvastatin|simvastatin|mesh-list
111364765|NCT00587678|Ezetimibe|ezetimibe|mesh-list
111364766|NCT00587678|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111364767|NCT00587678|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111364768|NCT00587678|Antimetabolites|antimetabolites|mesh-ancestor
111364769|NCT00587678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111364770|NCT00587678|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111139945|NCT04425187|Gefitinib|gefitinib|mesh-list
111364771|NCT00587678|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111364772|NCT00587678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111364773|NCT02138006|Insulin|insulin|mesh-list
111364774|NCT02138006|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111089184|NCT02478515|Growth Substances|growth substances|mesh-ancestor
111364776|NCT02138006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111364777|NCT04545008|Acetylcysteine|acetylcysteine|mesh-list
111364778|NCT04545008|Famotidine|famotidine|mesh-list
111364779|NCT04545008|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111364780|NCT04545008|Antiviral Agents|antiviral agents|mesh-ancestor
111364781|NCT04545008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111364782|NCT04545008|Expectorants|expectorants|mesh-ancestor
111364783|NCT04545008|Respiratory System Agents|respiratory system agents|mesh-ancestor
111364784|NCT04545008|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111364785|NCT04545008|Antioxidants|antioxidants|mesh-ancestor
111364786|NCT04545008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111364787|NCT04545008|Protective Agents|protective agents|mesh-ancestor
111364788|NCT04545008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111364789|NCT04545008|Antidotes|antidotes|mesh-ancestor
111364790|NCT04545008|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111364791|NCT04545008|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111364792|NCT04545008|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
111364793|NCT04545008|Histamine Antagonists|histamine antagonists|mesh-ancestor
111364794|NCT04545008|Histamine Agents|histamine agents|mesh-ancestor
111364795|NCT04545008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111364796|NCT04527770|Dexamethasone|dexamethasone|mesh-list
111364797|NCT04527770|Midazolam|midazolam|mesh-list
111364798|NCT04527770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111364799|NCT04527770|Antiemetics|antiemetics|mesh-ancestor
111364800|NCT04527770|Autonomic Agents|autonomic agents|mesh-ancestor
111364801|NCT04527770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111364802|NCT04527770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111364803|NCT04527770|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111364804|NCT04527770|Glucocorticoids|glucocorticoids|mesh-ancestor
111364805|NCT04527770|Hormones|hormones|mesh-ancestor
111365082|NCT03007303|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111364806|NCT04527770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111364807|NCT04527770|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111364808|NCT04527770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111364809|NCT04527770|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111364810|NCT04527770|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111364811|NCT04527770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111364812|NCT04527770|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111364813|NCT04527770|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111364814|NCT04527770|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111364815|NCT04527770|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111364816|NCT04527770|Anesthetics, General|anesthetics, general|mesh-ancestor
111364817|NCT04527770|Anesthetics|anesthetics|mesh-ancestor
111364818|NCT04527770|GABA Modulators|gaba modulators|mesh-ancestor
111364819|NCT04527770|GABA Agents|gaba agents|mesh-ancestor
111364820|NCT04527770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111364821|NCT04527770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111364822|NCT01798940|Pioglitazone|pioglitazone|mesh-list
111364823|NCT01798940|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111364824|NCT01798940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111364825|NCT00609128|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
111364826|NCT00609128|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111364827|NCT00609128|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111140096|NCT02575339|Sorafenib|sorafenib|mesh-list
111364828|NCT00609128|Analgesics|analgesics|mesh-ancestor
111364829|NCT00609128|Sensory System Agents|sensory system agents|mesh-ancestor
111364830|NCT00609128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111364831|NCT00609128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111364832|NCT00609128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111364833|NCT00609128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111364834|NCT00609128|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111364835|NCT00609128|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
111364836|NCT00609128|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111364837|NCT00609128|Histamine Antagonists|histamine antagonists|mesh-ancestor
111364838|NCT00609128|Histamine Agents|histamine agents|mesh-ancestor
111364839|NCT00609128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111364840|NCT00609128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111364841|NCT00668564|Cyclophosphamide|cyclophosphamide|mesh-list
111364842|NCT00668564|Busulfan|busulfan|mesh-list
111364843|NCT00668564|Alemtuzumab|alemtuzumab|mesh-list
111364844|NCT00668564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111364845|NCT00668564|Immunologic Factors|immunologic factors|mesh-ancestor
111140214|NCT05518279|Coagulants|coagulants|mesh-ancestor
111364846|NCT00668564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111364847|NCT00668564|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111364848|NCT00668564|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111364849|NCT00668564|Alkylating Agents|alkylating agents|mesh-ancestor
111089259|NCT04996485|Ustekinumab|ustekinumab|mesh-list
111364850|NCT00668564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111364851|NCT00668564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111364852|NCT00668564|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111364853|NCT00668564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111364854|NCT00610688|Vitamin D|vitamin d|mesh-list
111364855|NCT00610688|Ergocalciferols|ergocalciferols|mesh-list
111364856|NCT00610688|Cholecalciferol|cholecalciferol|mesh-list
111364857|NCT00610688|Vitamins|vitamins|mesh-list
111364858|NCT00610688|Micronutrients|micronutrients|mesh-ancestor
111364859|NCT00610688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111364860|NCT00610688|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111364861|NCT00610688|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111364862|NCT00669578|Pomalidomide|pomalidomide|mesh-list
111364863|NCT00669578|Immunologic Factors|immunologic factors|mesh-ancestor
111364864|NCT00669578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111364865|NCT00669578|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111364866|NCT00669578|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111364867|NCT00669578|Growth Substances|growth substances|mesh-ancestor
111364868|NCT00669578|Growth Inhibitors|growth inhibitors|mesh-ancestor
111364869|NCT00669578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111364870|NCT02137382|Pancrelipase|pancrelipase|mesh-list
111364871|NCT02137382|Pancreatin|pancreatin|mesh-list
111140412|NCT02573311|Tamsulosin|tamsulosin|mesh-list
111364872|NCT02137382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111364873|NCT00611468|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111364874|NCT00611468|Topotecan|topotecan|mesh-list
111364875|NCT00611468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111364876|NCT00611468|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111364877|NCT00611468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111364878|NCT00611468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111364879|NCT00611468|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111364880|NCT00611468|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111364881|NCT00670202|Fasudil|fasudil|mesh-list
111364882|NCT00670202|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111364883|NCT00670202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111364884|NCT00670202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111140478|NCT05515315|Paclitaxel|paclitaxel|mesh-list
111364885|NCT00670202|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111364886|NCT00670202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111364887|NCT00670202|Vasodilator Agents|vasodilator agents|mesh-ancestor
111364888|NCT00670202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111364889|NCT00670202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111364890|NCT00670982|Bevacizumab|bevacizumab|mesh-list
111364891|NCT00670982|Trastuzumab|trastuzumab|mesh-list
111364892|NCT00670982|Vinorelbine|vinorelbine|mesh-list
111364893|NCT00670982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111364894|NCT00670982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111364895|NCT00670982|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111364896|NCT00670982|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111364897|NCT00670982|Growth Substances|growth substances|mesh-ancestor
111364898|NCT00670982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111364899|NCT00670982|Growth Inhibitors|growth inhibitors|mesh-ancestor
111140604|NCT04812379|Serotonin Agents|serotonin agents|mesh-ancestor
111364900|NCT00670982|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111364901|NCT00670982|Tubulin Modulators|tubulin modulators|mesh-ancestor
111364902|NCT00670982|Antimitotic Agents|antimitotic agents|mesh-ancestor
111364903|NCT00670982|Mitosis Modulators|mitosis modulators|mesh-ancestor
111364904|NCT00670982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111364905|NCT00612560|Anastrozole|anastrozole|mesh-list
111364906|NCT00612560|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111364907|NCT00612560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111364908|NCT00612560|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111364909|NCT00612560|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111364910|NCT00612560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111364911|NCT00612560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111364912|NCT00612560|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111364913|NCT00612560|Hormone Antagonists|hormone antagonists|mesh-ancestor
111365083|NCT03007303|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111364914|NCT00612560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111364915|NCT00612560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111364916|NCT00612716|Cyclophosphamide|cyclophosphamide|mesh-list
111364917|NCT00612716|Busulfan|busulfan|mesh-list
111364918|NCT00612716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111364919|NCT00612716|Immunologic Factors|immunologic factors|mesh-ancestor
111364920|NCT00612716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111364921|NCT00612716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111364922|NCT00612716|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111364923|NCT00612716|Alkylating Agents|alkylating agents|mesh-ancestor
111364924|NCT00612716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111364925|NCT00612716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111364926|NCT00612716|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111364927|NCT00613028|Bevacizumab|bevacizumab|mesh-list
111364928|NCT00613028|Etoposide|etoposide|mesh-list
111364929|NCT00613028|Temozolomide|temozolomide|mesh-list
111364930|NCT00613028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111364931|NCT00613028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111364932|NCT00613028|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111364933|NCT00613028|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111364934|NCT00613028|Growth Substances|growth substances|mesh-ancestor
111364935|NCT00613028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111364936|NCT00613028|Growth Inhibitors|growth inhibitors|mesh-ancestor
111364937|NCT00613028|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111364938|NCT00613028|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111364939|NCT00613028|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111364940|NCT00613028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111364941|NCT00613028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111364942|NCT00613028|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111364943|NCT00613028|Alkylating Agents|alkylating agents|mesh-ancestor
111364944|NCT01799798|Denosumab|denosumab|mesh-list
111364945|NCT01799798|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111364946|NCT01799798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111364947|NCT00614198|Caseins|caseins|mesh-list
111364948|NCT00614198|Chelating Agents|chelating agents|mesh-ancestor
111364949|NCT00614198|Sequestering Agents|sequestering agents|mesh-ancestor
111364950|NCT00614198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111364951|NCT00616772|Choline|choline|mesh-list
111364952|NCT00616772|Atorvastatin|atorvastatin|mesh-list
111364953|NCT00616772|Fenofibric acid|fenofibric acid|mesh-list
111364954|NCT00616772|Fenofibrate|fenofibrate|mesh-list
111364955|NCT00616772|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111364956|NCT00616772|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111364957|NCT00616772|Antimetabolites|antimetabolites|mesh-ancestor
111364958|NCT00616772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111364959|NCT00616772|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111364960|NCT00616772|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111364961|NCT00616772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111364962|NCT00616772|Lipotropic Agents|lipotropic agents|mesh-ancestor
111364963|NCT00616772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111364964|NCT00616772|Nootropic Agents|nootropic agents|mesh-ancestor
111364965|NCT00672854|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
111364966|NCT00672854|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
111364967|NCT00672854|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
111364968|NCT00672854|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111364969|NCT00672932|Raltegravir Potassium|raltegravir potassium|mesh-list
111364970|NCT00672932|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111364971|NCT00672932|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111364972|NCT00672932|Antiviral Agents|antiviral agents|mesh-ancestor
111364973|NCT00672932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111364974|NCT00672932|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111364975|NCT00672932|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111364976|NCT00672932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111364977|NCT00672932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111364978|NCT02513550|Ixekizumab|ixekizumab|mesh-list
111364979|NCT02513550|Dermatologic Agents|dermatologic agents|mesh-ancestor
111364980|NCT00673712|Analgesics, Opioid|analgesics, opioid|mesh-list
111364981|NCT00673712|Narcotics|narcotics|mesh-ancestor
111364982|NCT00673712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111364983|NCT00673712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111364984|NCT00673712|Analgesics|analgesics|mesh-ancestor
111364985|NCT00673712|Sensory System Agents|sensory system agents|mesh-ancestor
111364986|NCT00673712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111364987|NCT04062032|Aspirin|aspirin|mesh-list
111364988|NCT04062032|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111364989|NCT04062032|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111364990|NCT04062032|Analgesics|analgesics|mesh-ancestor
111364991|NCT04062032|Sensory System Agents|sensory system agents|mesh-ancestor
111364992|NCT04062032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111364993|NCT04062032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111364994|NCT04062032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111364995|NCT04062032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111364996|NCT04062032|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111364997|NCT04062032|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111364998|NCT04062032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111364999|NCT04062032|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111365000|NCT04062032|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111365001|NCT04062032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111365002|NCT04062032|Antipyretics|antipyretics|mesh-ancestor
111365003|NCT00617396|Quetiapine Fumarate|quetiapine fumarate|mesh-list
111365004|NCT00617396|Antidepressive Agents|antidepressive agents|mesh-ancestor
111365005|NCT00617396|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111365006|NCT00617396|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111365007|NCT00617396|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111365008|NCT00617396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111365009|NCT00617396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111365010|NCT03722966|Nicotine|nicotine|mesh-list
111365011|NCT03722966|Varenicline|varenicline|mesh-list
111365012|NCT03722966|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111365013|NCT03722966|Autonomic Agents|autonomic agents|mesh-ancestor
111365014|NCT03722966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111365015|NCT03722966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111365016|NCT03722966|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111365017|NCT03722966|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111141024|NCT04352101|Dopamine Agents|dopamine agents|mesh-ancestor
111365018|NCT03722966|Cholinergic Agents|cholinergic agents|mesh-ancestor
111365019|NCT03722966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111365020|NCT03722966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111365021|NCT01581541|9H-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-N-(1-methylethyl)-|9h-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-n-(1-methylethyl)-|mesh-list
111365022|NCT01581541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111365023|NCT01582477|Bupivacaine|bupivacaine|mesh-list
111365024|NCT01582477|Anesthetics, Local|anesthetics, local|mesh-ancestor
111365025|NCT01582477|Anesthetics|anesthetics|mesh-ancestor
111365026|NCT01582477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111365027|NCT01582477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111365028|NCT01582477|Sensory System Agents|sensory system agents|mesh-ancestor
111365029|NCT01582477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111365030|NCT03001687|Vitamin D|vitamin d|mesh-list
111365031|NCT03001687|Vitamins|vitamins|mesh-ancestor
111365032|NCT03001687|Micronutrients|micronutrients|mesh-ancestor
111365033|NCT03001687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111365034|NCT03001687|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111365035|NCT03001609|Abivertinib|abivertinib|mesh-list
111365036|NCT03001609|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111365037|NCT03001609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111365038|NCT03001609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111365039|NCT03007381|Ketorolac|ketorolac|mesh-list
111365040|NCT03007381|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
111365041|NCT03007381|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111365042|NCT03007381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111365043|NCT03007381|Analgesics|analgesics|mesh-ancestor
111365044|NCT03007381|Sensory System Agents|sensory system agents|mesh-ancestor
111365045|NCT03007381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111365046|NCT03007381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111365047|NCT03007381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111365048|NCT03007381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111365049|NCT03007381|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111365050|NCT03007381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111365051|NCT03007381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111365052|NCT01585129|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111365053|NCT01585129|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
111365054|NCT01585129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111141212|NCT05479747|Analgesics|analgesics|mesh-list
111365055|NCT01585129|Antitubercular Agents|antitubercular agents|mesh-ancestor
111365056|NCT01585207|Vigabatrin|vigabatrin|mesh-list
111365057|NCT01585207|Anticonvulsants|anticonvulsants|mesh-ancestor
111365058|NCT01585207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111365059|NCT01585207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111365090|NCT01585441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111365091|NCT01585441|Hormone Antagonists|hormone antagonists|mesh-ancestor
111365092|NCT01585441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111365093|NCT01585441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111365094|NCT01585441|Urological Agents|urological agents|mesh-ancestor
111365095|NCT00617942|Paclitaxel|paclitaxel|mesh-list
111365096|NCT00617942|Carboplatin|carboplatin|mesh-list
111365097|NCT00617942|Trastuzumab|trastuzumab|mesh-list
111365098|NCT00617942|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111365099|NCT00617942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111365100|NCT00617942|Tubulin Modulators|tubulin modulators|mesh-ancestor
111365101|NCT00617942|Antimitotic Agents|antimitotic agents|mesh-ancestor
111365102|NCT00617942|Mitosis Modulators|mitosis modulators|mesh-ancestor
111365103|NCT00617942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111365104|NCT00617942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111365105|NCT00618332|Mometasone Furoate|mometasone furoate|mesh-list
111365106|NCT00618332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111365107|NCT00618332|Dermatologic Agents|dermatologic agents|mesh-ancestor
111365108|NCT00618332|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111365109|NCT01588561|Nicotine|nicotine|mesh-list
111365110|NCT01588561|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111365111|NCT01588561|Autonomic Agents|autonomic agents|mesh-ancestor
111365112|NCT01588561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111365113|NCT01588561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111365114|NCT01588561|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111365115|NCT01588561|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111365116|NCT01588561|Cholinergic Agents|cholinergic agents|mesh-ancestor
111365117|NCT01588561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111365118|NCT01588561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111365119|NCT00619190|Aripiprazole|aripiprazole|mesh-list
111365120|NCT00619190|Antidepressive Agents|antidepressive agents|mesh-ancestor
111365121|NCT00619190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111365122|NCT00619190|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111365123|NCT00619190|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111365124|NCT00619190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111365125|NCT00619190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111365126|NCT00619190|Dopamine Agonists|dopamine agonists|mesh-ancestor
111365127|NCT00619190|Dopamine Agents|dopamine agents|mesh-ancestor
111365128|NCT00619190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111365129|NCT00619190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111365130|NCT00619190|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111365131|NCT00619190|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111365132|NCT00619190|Serotonin Agents|serotonin agents|mesh-ancestor
111365133|NCT00619190|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111365134|NCT00619190|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111365135|NCT00619190|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111365136|NCT00619190|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111365137|NCT01589263|Tamsulosin|tamsulosin|mesh-list
111365138|NCT01589263|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111365139|NCT01589263|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111365140|NCT01589263|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111365141|NCT01589263|Adrenergic Agents|adrenergic agents|mesh-ancestor
111365142|NCT01589263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111365143|NCT01589263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111365144|NCT01589263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111365145|NCT01589263|Urological Agents|urological agents|mesh-ancestor
111365146|NCT01590979|Ranolazine|ranolazine|mesh-list
111365147|NCT01590979|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111365148|NCT01590979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111365149|NCT01590979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111365151|NCT00619970|Lactulose|lactulose|mesh-list
111365152|NCT00619970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111365153|NCT00619970|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111365154|NCT00619970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111365155|NCT01591837|Vaccines|vaccines|mesh-list
111365156|NCT01591837|Immunologic Factors|immunologic factors|mesh-ancestor
111365157|NCT01591837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111365158|NCT01592851|Fluorides|fluorides|mesh-list
111365159|NCT01592851|Tin Fluorides|tin fluorides|mesh-list
111365160|NCT01592851|Fluorophosphate|fluorophosphate|mesh-list
111365161|NCT01592851|Cariostatic Agents|cariostatic agents|mesh-ancestor
111365162|NCT01592851|Protective Agents|protective agents|mesh-ancestor
111365163|NCT01592851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111365164|NCT00675584|Budesonide|budesonide|mesh-list
111365165|NCT00675584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111365166|NCT00675584|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111365167|NCT00675584|Autonomic Agents|autonomic agents|mesh-ancestor
111365168|NCT00675584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111365169|NCT00675584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111365170|NCT00675584|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111365171|NCT00675584|Respiratory System Agents|respiratory system agents|mesh-ancestor
111365172|NCT00675584|Glucocorticoids|glucocorticoids|mesh-ancestor
111365173|NCT00675584|Hormones|hormones|mesh-ancestor
111365174|NCT00675584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111365175|NCT03376646|Paclitaxel|paclitaxel|mesh-list
111365176|NCT03376646|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111365177|NCT03376646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111365178|NCT03376646|Tubulin Modulators|tubulin modulators|mesh-ancestor
111365179|NCT03376646|Antimitotic Agents|antimitotic agents|mesh-ancestor
111365180|NCT03376646|Mitosis Modulators|mitosis modulators|mesh-ancestor
111365181|NCT03376646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111365182|NCT00676364|Lidocaine|lidocaine|mesh-list
111365183|NCT00676364|Anesthetics, Local|anesthetics, local|mesh-list
111365184|NCT00676364|Anesthetics|anesthetics|mesh-list
111365185|NCT00676364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111365186|NCT00676364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110504708|NCT03813108|Artemether|artemether|mesh-list
111365187|NCT00676364|Sensory System Agents|sensory system agents|mesh-ancestor
111365188|NCT00676364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111365189|NCT00676364|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111365190|NCT00676364|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111365191|NCT00676364|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111365192|NCT00676364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111365193|NCT00676364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111365194|NCT00676676|Testosterone|testosterone|mesh-list
111365195|NCT00676676|Androgens|androgens|mesh-ancestor
111365196|NCT00676676|Hormones|hormones|mesh-ancestor
111365197|NCT00676676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111365198|NCT00676676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111365199|NCT00621530|Ketorolac|ketorolac|mesh-list
111365200|NCT00621530|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
111365201|NCT00621530|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111365202|NCT00621530|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111365203|NCT00621530|Analgesics|analgesics|mesh-ancestor
111365204|NCT00621530|Sensory System Agents|sensory system agents|mesh-ancestor
111365205|NCT00621530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111365206|NCT00621530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111365207|NCT00621530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111365208|NCT00621530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111365209|NCT00621530|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111365210|NCT00621530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111000938|NCT02855359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111365211|NCT00621530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111365212|NCT02513472|Pembrolizumab|pembrolizumab|mesh-list
111365213|NCT02513472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111365214|NCT02513472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111365215|NCT02513472|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111365216|NCT02513472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111365217|NCT00621686|Bevacizumab|bevacizumab|mesh-list
111365218|NCT00621686|Sorafenib|sorafenib|mesh-list
111365219|NCT00621686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110504747|NCT03417154|Cyclophosphamide|cyclophosphamide|mesh-list
111365220|NCT00621686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111365221|NCT00621686|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111365222|NCT00621686|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111365223|NCT00621686|Growth Substances|growth substances|mesh-ancestor
111365224|NCT00621686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111365225|NCT00621686|Growth Inhibitors|growth inhibitors|mesh-ancestor
111365226|NCT00621686|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111365227|NCT00621686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111365228|NCT00621686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111365229|NCT02924714|Imatinib Mesylate|imatinib mesylate|mesh-list
111365230|NCT02924714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111365231|NCT02924714|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110453625|NCT01093612|Copper|copper|mesh-list
111365232|NCT02924714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111365233|NCT02924714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111365234|NCT00678470|Alefacept|alefacept|mesh-list
111365235|NCT00678470|Dermatologic Agents|dermatologic agents|mesh-ancestor
111365236|NCT00678470|Immunologic Factors|immunologic factors|mesh-ancestor
111365237|NCT00678470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111365238|NCT00623012|Sirolimus|sirolimus|mesh-list
111365239|NCT00623012|Tacrolimus|tacrolimus|mesh-list
111365240|NCT00623012|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111365241|NCT00623012|Immunologic Factors|immunologic factors|mesh-ancestor
111365242|NCT00623012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111365243|NCT00623012|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111365244|NCT00623012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111365245|NCT00623012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111365246|NCT00623012|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111365247|NCT00623012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111365248|NCT00623012|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111365249|NCT00623012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111365250|NCT00623012|Antifungal Agents|antifungal agents|mesh-ancestor
111365251|NCT01799954|Vaccines|vaccines|mesh-list
111365252|NCT01799954|Immunologic Factors|immunologic factors|mesh-ancestor
111365253|NCT01799954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111365254|NCT00623714|Fluticasone|fluticasone|mesh-list
111365255|NCT00623714|Xhance|xhance|mesh-list
111365256|NCT00623714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111365257|NCT00623714|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111365258|NCT00623714|Autonomic Agents|autonomic agents|mesh-ancestor
111365259|NCT00623714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111365260|NCT00623714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111365261|NCT00623714|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111365262|NCT00623714|Respiratory System Agents|respiratory system agents|mesh-ancestor
111365263|NCT00623714|Dermatologic Agents|dermatologic agents|mesh-ancestor
111365264|NCT00623714|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111365265|NCT02174822|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
111365266|NCT02174822|Paroxetine|paroxetine|mesh-list
111365267|NCT02174822|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111365268|NCT02174822|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111365269|NCT02174822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111365270|NCT02174822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111365271|NCT02174822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111365272|NCT02174822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111365273|NCT02174822|Analgesics|analgesics|mesh-ancestor
111365274|NCT02174822|Sensory System Agents|sensory system agents|mesh-ancestor
111365275|NCT02174822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111365276|NCT02174822|Antidepressive Agents|antidepressive agents|mesh-ancestor
111365277|NCT02174822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111365278|NCT02174822|Dopamine Agents|dopamine agents|mesh-ancestor
111365279|NCT02174822|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111365280|NCT02174822|Serotonin Agents|serotonin agents|mesh-ancestor
111365281|NCT02174822|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111365282|NCT02174822|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111365283|NCT02174822|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111365284|NCT02174822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111365285|NCT00624416|Prednisolone|prednisolone|mesh-list
111365286|NCT00624416|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111365287|NCT00624416|Methylprednisolone|methylprednisolone|mesh-list
111365288|NCT00624416|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111365289|NCT00624416|Prednisolone acetate|prednisolone acetate|mesh-list
111365290|NCT00624416|Cortisone|cortisone|mesh-list
111365291|NCT00624416|Isoproterenol|isoproterenol|mesh-list
111365292|NCT00624416|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111365293|NCT00624416|Prednisolone phosphate|prednisolone phosphate|mesh-list
111365294|NCT00624416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111365295|NCT00624416|Glucocorticoids|glucocorticoids|mesh-ancestor
111365297|NCT00624416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111365298|NCT00624416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111365299|NCT00624416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111365300|NCT00624416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111365301|NCT00624416|Antiemetics|antiemetics|mesh-ancestor
110453833|NCT01007448|Bexarotene|bexarotene|mesh-list
111365302|NCT00624416|Autonomic Agents|autonomic agents|mesh-ancestor
111365303|NCT00624416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111365304|NCT00624416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111365305|NCT00624416|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111365306|NCT00624416|Protective Agents|protective agents|mesh-ancestor
111365307|NCT00624416|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111365308|NCT00624416|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111365309|NCT00624416|Adrenergic Agents|adrenergic agents|mesh-ancestor
111365310|NCT00624416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111365311|NCT00624416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111365312|NCT00624416|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111365313|NCT00624416|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111365314|NCT00624416|Respiratory System Agents|respiratory system agents|mesh-ancestor
111365315|NCT00624416|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111365316|NCT00624416|Sympathomimetics|sympathomimetics|mesh-ancestor
111365317|NCT01872260|Letrozole|letrozole|mesh-list
110504852|NCT02593526|Bumetanide|bumetanide|mesh-list
111365318|NCT01872260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111365319|NCT01872260|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111365320|NCT01872260|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111365321|NCT01872260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111365322|NCT01872260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111365323|NCT01872260|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111365324|NCT01872260|Hormone Antagonists|hormone antagonists|mesh-ancestor
111365325|NCT01872260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110504855|NCT02593526|Diuretics|diuretics|mesh-ancestor
111365326|NCT01872260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111365327|NCT00626210|Modafinil|modafinil|mesh-list
111365328|NCT00626210|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111365329|NCT00626210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111365330|NCT00626210|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
111365331|NCT00626210|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111365332|NCT00626210|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110504867|NCT02476097|Esomeprazole|esomeprazole|mesh-list
111365333|NCT00626210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111365334|NCT00653276|Cyclosporine|cyclosporine|mesh-list
111365335|NCT00653276|Ezetimibe|ezetimibe|mesh-list
111365336|NCT00653276|Cyclosporins|cyclosporins|mesh-list
111365337|NCT00653276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111365338|NCT00653276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111365339|NCT00653276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111365340|NCT00653276|Immunologic Factors|immunologic factors|mesh-ancestor
111365341|NCT00653276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111365342|NCT00653276|Antifungal Agents|antifungal agents|mesh-ancestor
110504874|NCT03946358|Atezolizumab|atezolizumab|mesh-list
111365343|NCT00653276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111365344|NCT00653276|Dermatologic Agents|dermatologic agents|mesh-ancestor
111365345|NCT00653276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111365346|NCT00653276|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111365347|NCT00653276|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111365348|NCT00653276|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111365349|NCT00653276|Antimetabolites|antimetabolites|mesh-ancestor
111365350|NCT00653276|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111365351|NCT00683852|Aripiprazole|aripiprazole|mesh-list
111365352|NCT00683852|Antidepressive Agents|antidepressive agents|mesh-ancestor
111365353|NCT00683852|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111365354|NCT00683852|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111365355|NCT00683852|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110504881|NCT02115282|Entinostat|entinostat|mesh-list
111365356|NCT00683852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111365357|NCT00683852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111365358|NCT00683852|Dopamine Agonists|dopamine agonists|mesh-ancestor
111365359|NCT00683852|Dopamine Agents|dopamine agents|mesh-ancestor
111365360|NCT00683852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111365361|NCT00683852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111365362|NCT00683852|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111365363|NCT00683852|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111365364|NCT00683852|Serotonin Agents|serotonin agents|mesh-ancestor
111365365|NCT00683852|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111365366|NCT00683852|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111365367|NCT00683852|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111089779|NCT04433481|Anticoagulants|anticoagulants|mesh-ancestor
111365368|NCT00683852|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111365369|NCT03006835|Clopidogrel|clopidogrel|mesh-list
111365370|NCT03006835|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110504902|NCT02051218|Denosumab|denosumab|mesh-list
111365371|NCT03006835|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111365372|NCT03006835|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111365373|NCT03006835|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111365374|NCT03006835|Purinergic Agents|purinergic agents|mesh-ancestor
111365375|NCT03006835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111365376|NCT03006835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111365377|NCT03006835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111365378|NCT03006757|Titanium dioxide|titanium dioxide|mesh-list
111365379|NCT03006757|Sunscreening Agents|sunscreening agents|mesh-ancestor
111365380|NCT03006757|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110504913|NCT01905046|Metformin|metformin|mesh-list
111365381|NCT03006757|Protective Agents|protective agents|mesh-ancestor
111365382|NCT03006757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111365383|NCT03006757|Dermatologic Agents|dermatologic agents|mesh-ancestor
111365384|NCT03006757|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111365385|NCT05566405|Anesthetics|anesthetics|mesh-list
111365386|NCT05566405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111365387|NCT05566405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111365388|NCT03000127|Testosterone|testosterone|mesh-list
111365389|NCT03000127|Androgens|androgens|mesh-ancestor
111365390|NCT03000127|Hormones|hormones|mesh-ancestor
111365391|NCT03000127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111365392|NCT03000127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111365393|NCT02999815|Immunoglobulins|immunoglobulins|mesh-list
111365394|NCT02999815|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111365395|NCT02999815|Antibodies|antibodies|mesh-list
111365396|NCT02999815|Antitoxins|antitoxins|mesh-list
111365397|NCT02999815|Immunologic Factors|immunologic factors|mesh-ancestor
111365398|NCT02999815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111365399|NCT03006679|Meropenem|meropenem|mesh-list
111365400|NCT03006679|Tazobactam|tazobactam|mesh-list
111365401|NCT03006679|Piperacillin|piperacillin|mesh-list
111365402|NCT03006679|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
111365403|NCT03006679|Vaborbactam|vaborbactam|mesh-list
111365404|NCT03006679|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111365405|NCT03006679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111365406|NCT03006679|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
111365407|NCT03006679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111365408|NCT03006679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111365409|NCT03006445|Dotinurad|dotinurad|mesh-list
111365410|NCT03006445|Uricosuric Agents|uricosuric agents|mesh-ancestor
111365411|NCT03006445|Gout Suppressants|gout suppressants|mesh-ancestor
111365412|NCT03006445|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111365413|NCT03006211|Nitric Oxide|nitric oxide|mesh-list
111365414|NCT03006211|Nitrous Oxide|nitrous oxide|mesh-list
111365415|NCT03006211|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111365416|NCT03006211|Anesthetics, General|anesthetics, general|mesh-ancestor
111365417|NCT03006211|Anesthetics|anesthetics|mesh-ancestor
111365418|NCT03006211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111365419|NCT03006211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111365420|NCT03006211|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111365421|NCT03006211|Analgesics|analgesics|mesh-ancestor
111365422|NCT03006211|Sensory System Agents|sensory system agents|mesh-ancestor
111365423|NCT03006211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111365424|NCT03006211|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111365425|NCT03006211|Autonomic Agents|autonomic agents|mesh-ancestor
111365426|NCT03006211|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111365427|NCT03006211|Respiratory System Agents|respiratory system agents|mesh-ancestor
111365428|NCT03006211|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111365429|NCT03006211|Antioxidants|antioxidants|mesh-ancestor
111365430|NCT03006211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111365431|NCT03006211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111365432|NCT03006211|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
111365433|NCT03006211|Vasodilator Agents|vasodilator agents|mesh-ancestor
111365434|NCT03006211|Gasotransmitters|gasotransmitters|mesh-ancestor
111365435|NCT03006211|Protective Agents|protective agents|mesh-ancestor
111365436|NCT02248051|CXA-10|cxa-10|mesh-list
111365437|NCT02248051|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111365438|NCT02247505|Tadalafil|tadalafil|mesh-list
111365439|NCT02247505|Tamsulosin|tamsulosin|mesh-list
111365440|NCT02247505|Vasodilator Agents|vasodilator agents|mesh-ancestor
111365441|NCT02247505|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111365442|NCT02247505|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111365443|NCT02247505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111479267|NCT05091346|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111365444|NCT02247505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111365445|NCT02247505|Urological Agents|urological agents|mesh-ancestor
111365446|NCT02247505|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110504977|NCT00890149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111365447|NCT02247505|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111365448|NCT02247505|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111365449|NCT02247505|Adrenergic Agents|adrenergic agents|mesh-ancestor
111365450|NCT02247505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111365451|NCT02247505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111365453|NCT04707625|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111365454|NCT04707625|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111365455|NCT04707625|Growth Substances|growth substances|mesh-ancestor
111365456|NCT04707625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111365457|NCT04707625|Growth Inhibitors|growth inhibitors|mesh-ancestor
111365458|NCT04707625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111365459|NCT02248129|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
111365460|NCT02248129|Telmisartan|telmisartan|mesh-list
111365461|NCT02248129|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111365462|NCT02248129|Diuretics|diuretics|mesh-ancestor
111365463|NCT02248129|Natriuretic Agents|natriuretic agents|mesh-ancestor
111365464|NCT02248129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111365465|NCT02248129|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
111365466|NCT02248129|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111365467|NCT02248129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111365468|NCT02248129|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111365469|NCT02248129|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111365470|NCT02248207|Pramipexole|pramipexole|mesh-list
111365471|NCT02248207|Antioxidants|antioxidants|mesh-ancestor
111365472|NCT02248207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111365473|NCT02248207|Protective Agents|protective agents|mesh-ancestor
111365474|NCT02248207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111365475|NCT02248207|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111365476|NCT02248207|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111365477|NCT02248207|Dopamine Agonists|dopamine agonists|mesh-ancestor
111365478|NCT02248207|Dopamine Agents|dopamine agents|mesh-ancestor
111365479|NCT02248207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111365480|NCT00683930|Mycophenolic Acid|mycophenolic acid|mesh-list
111365481|NCT00683930|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111365482|NCT00683930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111365483|NCT00683930|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111365484|NCT00683930|Antitubercular Agents|antitubercular agents|mesh-ancestor
111365485|NCT00683930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111365486|NCT00683930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111365487|NCT00683930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111365488|NCT00683930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111365489|NCT00684242|Lenalidomide|lenalidomide|mesh-list
111365490|NCT00684242|Immunologic Factors|immunologic factors|mesh-ancestor
111365491|NCT00684242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111365492|NCT00684242|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111365493|NCT00684242|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111365494|NCT00684242|Growth Substances|growth substances|mesh-ancestor
111365495|NCT00684242|Growth Inhibitors|growth inhibitors|mesh-ancestor
111365496|NCT00684242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111365497|NCT00651560|Simvastatin|simvastatin|mesh-list
111365498|NCT00651560|Ezetimibe|ezetimibe|mesh-list
111365499|NCT00651560|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111365500|NCT00651560|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111365501|NCT00651560|Antimetabolites|antimetabolites|mesh-ancestor
111365502|NCT00651560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111365503|NCT00651560|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111365504|NCT00651560|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111365505|NCT00651560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111365506|NCT00684554|Buprenorphine|buprenorphine|mesh-list
111365507|NCT00684554|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111365508|NCT00684554|Narcotics|narcotics|mesh-ancestor
111365509|NCT00684554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111365510|NCT00684554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111365511|NCT00684554|Analgesics|analgesics|mesh-ancestor
111365512|NCT00684554|Sensory System Agents|sensory system agents|mesh-ancestor
111365513|NCT00684554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111365514|NCT00684554|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111365515|NCT00551876|Simvastatin|simvastatin|mesh-list
111365516|NCT00551876|Ezetimibe|ezetimibe|mesh-list
111365517|NCT00551876|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111365518|NCT00551876|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111365519|NCT00551876|Antimetabolites|antimetabolites|mesh-ancestor
111365520|NCT00551876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111365521|NCT00551876|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111365522|NCT00551876|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111365523|NCT00551876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111365524|NCT04451863|Caryophyllene|caryophyllene|mesh-list
111365525|NCT04451863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111365526|NCT04451863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111365527|NCT04451863|Analgesics|analgesics|mesh-ancestor
111365528|NCT04451863|Sensory System Agents|sensory system agents|mesh-ancestor
111365529|NCT04451863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111365530|NCT04451863|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111365531|NCT04451863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111365532|NCT04451863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111365533|NCT00628394|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
111365534|NCT00628394|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111365535|NCT00628394|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111365536|NCT00628394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111365537|NCT00628394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111365538|NCT00628394|Adrenergic Agents|adrenergic agents|mesh-ancestor
111365539|NCT00628394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111365540|NCT00628394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111365541|NCT00251576|Heparin|heparin|mesh-list
111365542|NCT00251576|Calcium heparin|calcium heparin|mesh-list
111365543|NCT00251576|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
111365544|NCT00251576|Tinzaparin|tinzaparin|mesh-list
111365545|NCT00251576|Dalteparin|dalteparin|mesh-list
111365546|NCT00251576|Tirofiban|tirofiban|mesh-list
111365547|NCT00251576|Simvastatin|simvastatin|mesh-list
111365548|NCT00251576|Anticoagulants|anticoagulants|mesh-ancestor
111365549|NCT00251576|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111365550|NCT00251576|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111365551|NCT00251576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111365552|NCT00251576|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111365553|NCT00251576|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111365554|NCT00251576|Antimetabolites|antimetabolites|mesh-ancestor
111365555|NCT00251576|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111365556|NCT00251576|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111365557|NCT00251576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111365558|NCT00251576|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111365559|NCT04387604|Ranibizumab|ranibizumab|mesh-list
111365560|NCT04387604|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111365561|NCT04387604|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111365562|NCT04387604|Growth Substances|growth substances|mesh-ancestor
111365563|NCT04387604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111365564|NCT04387604|Growth Inhibitors|growth inhibitors|mesh-ancestor
111365565|NCT04387604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111365566|NCT03005665|Acetazolamide|acetazolamide|mesh-list
111365567|NCT03005665|Anticonvulsants|anticonvulsants|mesh-ancestor
111365568|NCT03005665|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
111365569|NCT03005665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111365570|NCT03005665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111365571|NCT03005665|Diuretics|diuretics|mesh-ancestor
111365572|NCT03005665|Natriuretic Agents|natriuretic agents|mesh-ancestor
111365573|NCT03005665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111365574|NCT00628628|Rasburicase|rasburicase|mesh-list
111365575|NCT00628628|Gout Suppressants|gout suppressants|mesh-ancestor
111365576|NCT00628628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111365577|NCT04386811|Calcitriol|calcitriol|mesh-list
111365578|NCT04386811|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111365579|NCT04386811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111365580|NCT04386811|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
111365581|NCT04386811|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111365582|NCT04386811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111365583|NCT04386811|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111365584|NCT04386811|Vitamins|vitamins|mesh-ancestor
111365585|NCT04386811|Micronutrients|micronutrients|mesh-ancestor
111365586|NCT04386811|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111365587|NCT04357873|Pembrolizumab|pembrolizumab|mesh-list
111365588|NCT04357873|Vorinostat|vorinostat|mesh-list
111365589|NCT04357873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111365590|NCT04357873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111365591|NCT04357873|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111090001|NCT02470637|Insulin Lispro|insulin lispro|mesh-list
111365592|NCT04357873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111365593|NCT04357873|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111365594|NCT04357873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111365596|NCT00630734|Darunavir|darunavir|mesh-list
111365597|NCT00630734|Pravastatin|pravastatin|mesh-list
111365598|NCT00630734|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111365599|NCT00630734|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111365600|NCT00630734|Protease Inhibitors|protease inhibitors|mesh-ancestor
111365601|NCT00630734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111365602|NCT00630734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111365603|NCT00630734|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111365604|NCT00630734|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111365605|NCT00630734|Antiviral Agents|antiviral agents|mesh-ancestor
111365606|NCT00630734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111365607|NCT00630734|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111365608|NCT00630734|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111365609|NCT00630734|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111365610|NCT00630734|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111365611|NCT00630734|Antimetabolites|antimetabolites|mesh-ancestor
111365612|NCT00630734|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111365613|NCT00630734|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111365614|NCT05644249|Doxorubicin|doxorubicin|mesh-list
111365615|NCT05644249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111365616|NCT05644249|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111365617|NCT05644249|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111365618|NCT05644249|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111365619|NCT05644249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111365620|NCT05644249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111365621|NCT00686582|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
111365622|NCT00686582|Antiviral Agents|antiviral agents|mesh-ancestor
111365623|NCT00686582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111365624|NCT00631358|Dexamethasone|dexamethasone|mesh-list
111365625|NCT00631358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111365626|NCT00631358|Antiemetics|antiemetics|mesh-ancestor
111365627|NCT00631358|Autonomic Agents|autonomic agents|mesh-ancestor
111365628|NCT00631358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111365629|NCT00631358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111365630|NCT00631358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111365631|NCT00631358|Glucocorticoids|glucocorticoids|mesh-ancestor
111365632|NCT00631358|Hormones|hormones|mesh-ancestor
111000939|NCT02855359|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111365633|NCT00631358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111365634|NCT00631358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111365635|NCT00631358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111365636|NCT02248753|Metoprolol|metoprolol|mesh-list
111365637|NCT02248753|Digoxin|digoxin|mesh-list
111365638|NCT02248753|Amiodarone|amiodarone|mesh-list
111365639|NCT02248753|Verapamil|verapamil|mesh-list
111365640|NCT02248753|Flecainide|flecainide|mesh-list
111365641|NCT02248753|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111365642|NCT02248753|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111365643|NCT02248753|Sympatholytics|sympatholytics|mesh-ancestor
111365644|NCT02248753|Autonomic Agents|autonomic agents|mesh-ancestor
111365645|NCT02248753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111365646|NCT02248753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111365647|NCT02248753|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
111365648|NCT02248753|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111365649|NCT02248753|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111365650|NCT02248753|Adrenergic Agents|adrenergic agents|mesh-ancestor
111365651|NCT02248753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111365652|NCT02248753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111365653|NCT02248753|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111365654|NCT02248753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111365655|NCT02248753|Protective Agents|protective agents|mesh-ancestor
111365656|NCT02248753|Vasodilator Agents|vasodilator agents|mesh-ancestor
111365657|NCT02248753|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
111365658|NCT02248753|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111365659|NCT02248753|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111365660|NCT02248753|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111365661|NCT02248753|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111365662|NCT02248753|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111365663|NCT02248753|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111365664|NCT02248753|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111365665|NCT02248753|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111365666|NCT02248753|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111365667|NCT02248753|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111365668|NCT00687674|Dexamethasone|dexamethasone|mesh-list
111365669|NCT00687674|Lenalidomide|lenalidomide|mesh-list
111365670|NCT00687674|Sorafenib|sorafenib|mesh-list
111365671|NCT00687674|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111365672|NCT00687674|Antiemetics|antiemetics|mesh-ancestor
111365673|NCT00687674|Autonomic Agents|autonomic agents|mesh-ancestor
111365674|NCT00687674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111365675|NCT00687674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111365676|NCT00687674|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111365677|NCT00687674|Glucocorticoids|glucocorticoids|mesh-ancestor
111365678|NCT00687674|Hormones|hormones|mesh-ancestor
111365679|NCT00687674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111365680|NCT00687674|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111365681|NCT00687674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111365682|NCT00687674|Immunologic Factors|immunologic factors|mesh-ancestor
111365683|NCT00687674|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111365684|NCT00687674|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111365685|NCT00687674|Growth Substances|growth substances|mesh-ancestor
111365686|NCT00687674|Growth Inhibitors|growth inhibitors|mesh-ancestor
111365687|NCT00687674|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111365688|NCT00687674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111365689|NCT00687674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111365690|NCT00687908|Adapalene|adapalene|mesh-list
111365691|NCT00687908|Benzoyl Peroxide|benzoyl peroxide|mesh-list
111365692|NCT00687908|Dermatologic Agents|dermatologic agents|mesh-ancestor
111365693|NCT00687908|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111365694|NCT00687908|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111365695|NCT00687908|Analgesics|analgesics|mesh-ancestor
111365696|NCT00687908|Sensory System Agents|sensory system agents|mesh-ancestor
111365697|NCT00687908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111365698|NCT00687908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111365699|NCT00687908|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111365700|NCT00687908|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111365701|NCT00689078|Loteprednol Etabonate|loteprednol etabonate|mesh-list
111365702|NCT00689078|Prednisolone|prednisolone|mesh-list
111365703|NCT00689078|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111365704|NCT00689078|Methylprednisolone|methylprednisolone|mesh-list
111365705|NCT00689078|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111365706|NCT00689078|Prednisolone acetate|prednisolone acetate|mesh-list
111365707|NCT00689078|Lubricant Eye Drops|lubricant eye drops|mesh-list
111365708|NCT00689078|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111365709|NCT00689078|Prednisolone phosphate|prednisolone phosphate|mesh-list
111365710|NCT00689078|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111365711|NCT00689078|Glucocorticoids|glucocorticoids|mesh-ancestor
111365712|NCT00689078|Hormones|hormones|mesh-ancestor
111365713|NCT00689078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111365714|NCT00689078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111365715|NCT00689078|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111365716|NCT00689078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111365717|NCT00689078|Antiemetics|antiemetics|mesh-ancestor
111365718|NCT00689078|Autonomic Agents|autonomic agents|mesh-ancestor
111365719|NCT00689078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111365720|NCT00689078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111365721|NCT00689078|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111365722|NCT00689078|Protective Agents|protective agents|mesh-ancestor
110505226|NCT00751166|Cetirizine|cetirizine|mesh-list
111365723|NCT00689078|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
111365724|NCT00689078|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111365725|NCT00689078|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111365726|NCT05568979|Vaccines|vaccines|mesh-list
111365727|NCT05568979|Immunologic Factors|immunologic factors|mesh-ancestor
111365728|NCT05568979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111365729|NCT03005353|Clotrimazole|clotrimazole|mesh-list
111365730|NCT03005353|Miconazole|miconazole|mesh-list
111365731|NCT03005353|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111365732|NCT03005353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111365733|NCT03005353|Antifungal Agents|antifungal agents|mesh-ancestor
111365734|NCT03005353|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111365735|NCT03005353|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111365736|NCT03005353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111090151|NCT02469545|Escitalopram|escitalopram|mesh-list
111365737|NCT03005353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111365738|NCT03005353|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111365739|NCT03005353|Hormone Antagonists|hormone antagonists|mesh-ancestor
111365740|NCT03005353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111365741|NCT03005353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111365742|NCT03005353|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111365743|NCT03005353|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111365745|NCT00588536|Methotrexate|methotrexate|mesh-list
111365746|NCT00588536|Thioguanine|thioguanine|mesh-list
111365747|NCT00588536|Calcium|calcium|mesh-list
111365748|NCT00588536|Levoleucovorin|levoleucovorin|mesh-list
111365749|NCT00588536|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111365750|NCT00588536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111365751|NCT00588536|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111365752|NCT00588536|Abortifacient Agents|abortifacient agents|mesh-ancestor
111365753|NCT00588536|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111365754|NCT00588536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111365755|NCT00588536|Antimetabolites|antimetabolites|mesh-ancestor
111365756|NCT00588536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111365757|NCT00588536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111365758|NCT00588536|Dermatologic Agents|dermatologic agents|mesh-ancestor
111365759|NCT00588536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111365760|NCT00588536|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111365761|NCT00588536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111365762|NCT00588536|Immunologic Factors|immunologic factors|mesh-ancestor
111365763|NCT00588536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111365764|NCT00588536|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111365765|NCT00588536|Antidotes|antidotes|mesh-ancestor
111365766|NCT00588536|Protective Agents|protective agents|mesh-ancestor
111365767|NCT00588536|Vitamin B Complex|vitamin b complex|mesh-ancestor
111365768|NCT00588536|Vitamins|vitamins|mesh-ancestor
111365769|NCT00588536|Micronutrients|micronutrients|mesh-ancestor
111365770|NCT03977233|Leucovorin|leucovorin|mesh-list
111365771|NCT03977233|Oxaliplatin|oxaliplatin|mesh-list
111365772|NCT03977233|Irinotecan|irinotecan|mesh-list
111365773|NCT03977233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111365774|NCT03977233|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111365775|NCT03977233|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111365776|NCT03977233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111365777|NCT03977233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111365778|NCT03977233|Antidotes|antidotes|mesh-ancestor
111365779|NCT03977233|Protective Agents|protective agents|mesh-ancestor
111365780|NCT03977233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111365781|NCT03977233|Vitamin B Complex|vitamin b complex|mesh-ancestor
111365782|NCT03977233|Vitamins|vitamins|mesh-ancestor
111365783|NCT03977233|Micronutrients|micronutrients|mesh-ancestor
111365784|NCT03951649|Acetaminophen|acetaminophen|mesh-list
111365785|NCT03951649|Caffeine|caffeine|mesh-list
111365786|NCT03951649|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111365787|NCT03951649|Analgesics|analgesics|mesh-ancestor
111365788|NCT03951649|Sensory System Agents|sensory system agents|mesh-ancestor
111365789|NCT03951649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111365790|NCT03951649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111365791|NCT03951649|Antipyretics|antipyretics|mesh-ancestor
111365792|NCT03951649|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111365793|NCT03951649|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111365794|NCT03951649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111365795|NCT03951649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111365796|NCT03951649|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
111365797|NCT03951649|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111365798|NCT03951649|Purinergic Agents|purinergic agents|mesh-ancestor
111365799|NCT03951649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111365800|NCT00590018|Hydrocortisone|hydrocortisone|mesh-list
111365801|NCT00590018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111365802|NCT02219503|Ritonavir|ritonavir|mesh-list
111365803|NCT02219503|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111365804|NCT02219503|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111365805|NCT02219503|Protease Inhibitors|protease inhibitors|mesh-ancestor
111365806|NCT02219503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111365807|NCT02219503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111365808|NCT02219503|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111365809|NCT02219503|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111365810|NCT02219503|Antiviral Agents|antiviral agents|mesh-ancestor
111365811|NCT02219503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111365812|NCT02219503|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111365813|NCT02219503|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111365814|NCT00592124|Tenofovir|tenofovir|mesh-list
111365815|NCT00592124|Antiviral Agents|antiviral agents|mesh-ancestor
111365816|NCT00592124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111365817|NCT00592124|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111365818|NCT00592124|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111365819|NCT00592124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111365820|NCT00592124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111365821|NCT00592124|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111365822|NCT00592124|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111365823|NCT02221219|Indomethacin|indomethacin|mesh-list
111365824|NCT02221219|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111365825|NCT02221219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111365826|NCT02221219|Analgesics|analgesics|mesh-ancestor
111365827|NCT02221219|Sensory System Agents|sensory system agents|mesh-ancestor
111365828|NCT02221219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111365829|NCT02221219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111365830|NCT02221219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111365831|NCT02221219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111365832|NCT02221219|Gout Suppressants|gout suppressants|mesh-ancestor
111365833|NCT02221219|Tocolytic Agents|tocolytic agents|mesh-ancestor
111365834|NCT02221219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111365835|NCT02221219|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111365836|NCT02221219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111365837|NCT02221219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111365838|NCT00593450|Bevacizumab|bevacizumab|mesh-list
111365839|NCT00593450|Ranibizumab|ranibizumab|mesh-list
111365840|NCT00593450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111365841|NCT00593450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111365842|NCT00593450|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111365843|NCT00593450|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111365844|NCT00593450|Growth Substances|growth substances|mesh-ancestor
111365845|NCT00593450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111365846|NCT00593450|Growth Inhibitors|growth inhibitors|mesh-ancestor
111365847|NCT00631748|Quetiapine Fumarate|quetiapine fumarate|mesh-list
111365848|NCT00631748|Antidepressive Agents|antidepressive agents|mesh-ancestor
111365849|NCT00631748|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111365850|NCT00631748|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111365851|NCT00631748|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111365852|NCT00631748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111365853|NCT00631748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111365854|NCT00594230|Panobinostat|panobinostat|mesh-list
111365855|NCT00594230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111365856|NCT00594230|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111365857|NCT00594230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111365858|NCT00594230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111365859|NCT00594308|Cyclosporine|cyclosporine|mesh-list
111365860|NCT00594308|Mycophenolic Acid|mycophenolic acid|mesh-list
111365861|NCT00594308|Cyclophosphamide|cyclophosphamide|mesh-list
111365862|NCT00594308|Fludarabine|fludarabine|mesh-list
111365863|NCT00594308|Cyclosporins|cyclosporins|mesh-list
111365864|NCT00594308|Basiliximab|basiliximab|mesh-list
111365865|NCT00594308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111365866|NCT00594308|Immunologic Factors|immunologic factors|mesh-ancestor
111365867|NCT00594308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111365868|NCT00594308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111365869|NCT00594308|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111365870|NCT00594308|Alkylating Agents|alkylating agents|mesh-ancestor
111365871|NCT00594308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111365872|NCT00594308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111365873|NCT00594308|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111365874|NCT00594308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111365875|NCT00594308|Antifungal Agents|antifungal agents|mesh-ancestor
111365876|NCT00594308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111365877|NCT00594308|Dermatologic Agents|dermatologic agents|mesh-ancestor
111365878|NCT00594308|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111365879|NCT00594308|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111365880|NCT00594308|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111365881|NCT00594308|Antitubercular Agents|antitubercular agents|mesh-ancestor
111365882|NCT00594308|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111365883|NCT02137538|Letrozole|letrozole|mesh-list
111365884|NCT02137538|Anastrozole|anastrozole|mesh-list
111365885|NCT02137538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111365886|NCT02137538|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111365887|NCT02137538|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111365888|NCT02137538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111365889|NCT02137538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111365890|NCT02137538|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111365891|NCT02137538|Hormone Antagonists|hormone antagonists|mesh-ancestor
111000940|NCT02855359|Alkylating Agents|alkylating agents|mesh-ancestor
111365892|NCT02137538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111365893|NCT02137538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111365894|NCT02137538|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111365895|NCT00595556|Zonisamide|zonisamide|mesh-list
111365896|NCT00595556|Anticonvulsants|anticonvulsants|mesh-ancestor
111365897|NCT00595556|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111365898|NCT00595556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111365899|NCT00595556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111365900|NCT00595556|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111365901|NCT00595556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111365902|NCT00595790|Vaccines|vaccines|mesh-list
111365903|NCT00595790|Immunologic Factors|immunologic factors|mesh-ancestor
111365904|NCT00595790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111365905|NCT00595946|Lubiprostone|lubiprostone|mesh-list
111365906|NCT00595946|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
111365907|NCT00595946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111365908|NCT00595946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111365909|NCT00597038|Dasatinib|dasatinib|mesh-list
111365910|NCT00597038|Dacarbazine|dacarbazine|mesh-list
111365911|NCT00597038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111365912|NCT00597038|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111365913|NCT00597038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111365914|NCT00597038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111365915|NCT00597038|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111365916|NCT00597038|Alkylating Agents|alkylating agents|mesh-ancestor
111365917|NCT00597428|Lubiprostone|lubiprostone|mesh-list
111365918|NCT00597428|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
111365919|NCT00597428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111365920|NCT00597428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111365921|NCT00597818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
111365922|NCT00597818|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
111365923|NCT00597818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111365924|NCT00597818|Analgesics|analgesics|mesh-ancestor
111365925|NCT00597818|Sensory System Agents|sensory system agents|mesh-ancestor
111365926|NCT00597818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111365927|NCT00597818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111365928|NCT00597818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111365929|NCT00597896|Pramipexole|pramipexole|mesh-list
111365930|NCT00597896|Antioxidants|antioxidants|mesh-ancestor
111365931|NCT00597896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111365932|NCT00597896|Protective Agents|protective agents|mesh-ancestor
111365933|NCT00597896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111365934|NCT00597896|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111365935|NCT00597896|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111365936|NCT00597896|Dopamine Agonists|dopamine agonists|mesh-ancestor
111365937|NCT00597896|Dopamine Agents|dopamine agents|mesh-ancestor
111365938|NCT00597896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111365939|NCT01790282|Estradiol|estradiol|mesh-list
111365940|NCT01790282|Progesterone|progesterone|mesh-list
111365941|NCT01790282|Estrogens|estrogens|mesh-ancestor
111365942|NCT01790282|Hormones|hormones|mesh-ancestor
111365943|NCT01790282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111365944|NCT01790282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111365945|NCT01790282|Progestins|progestins|mesh-ancestor
111365946|NCT03843541|Acetylcysteine|acetylcysteine|mesh-list
111365947|NCT03843541|Ambroxol|ambroxol|mesh-list
111365948|NCT03843541|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111365949|NCT03843541|Antiviral Agents|antiviral agents|mesh-ancestor
111365950|NCT03843541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111365951|NCT03843541|Expectorants|expectorants|mesh-ancestor
111365952|NCT03843541|Respiratory System Agents|respiratory system agents|mesh-ancestor
111365953|NCT03843541|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111365954|NCT03843541|Antioxidants|antioxidants|mesh-ancestor
111365955|NCT03843541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111365956|NCT03843541|Protective Agents|protective agents|mesh-ancestor
111365957|NCT03843541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111365958|NCT03843541|Antidotes|antidotes|mesh-ancestor
111365959|NCT00639158|Choline|choline|mesh-list
111365960|NCT00639158|Atorvastatin|atorvastatin|mesh-list
111365961|NCT00639158|Ezetimibe|ezetimibe|mesh-list
111365962|NCT00639158|Fenofibric acid|fenofibric acid|mesh-list
111365963|NCT00639158|Fenofibrate|fenofibrate|mesh-list
111365964|NCT00639158|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111365965|NCT00639158|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111365966|NCT00639158|Antimetabolites|antimetabolites|mesh-ancestor
111365967|NCT00639158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111365968|NCT00639158|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111365969|NCT00639158|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111365970|NCT00639158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111365971|NCT00639158|Lipotropic Agents|lipotropic agents|mesh-ancestor
111365972|NCT00639158|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111365973|NCT00639158|Nootropic Agents|nootropic agents|mesh-ancestor
111365974|NCT02248987|Antipsychotic Agents|antipsychotic agents|mesh-list
111365975|NCT02248987|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111365976|NCT02248987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111365977|NCT02248987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111365978|NCT02248987|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111365979|NCT00692978|Fluticasone|fluticasone|mesh-list
111365980|NCT00692978|Xhance|xhance|mesh-list
111365981|NCT00692978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111365982|NCT00692978|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111365983|NCT00692978|Autonomic Agents|autonomic agents|mesh-ancestor
111365984|NCT00692978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111365985|NCT00692978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111365986|NCT00692978|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111365987|NCT00692978|Respiratory System Agents|respiratory system agents|mesh-ancestor
111365988|NCT00692978|Dermatologic Agents|dermatologic agents|mesh-ancestor
111365989|NCT00692978|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111365990|NCT00601718|Rituximab|rituximab|mesh-list
111365991|NCT00601718|Carboplatin|carboplatin|mesh-list
111365992|NCT00601718|Etoposide|etoposide|mesh-list
111365993|NCT00601718|Etoposide phosphate|etoposide phosphate|mesh-list
111365994|NCT00601718|Ifosfamide|ifosfamide|mesh-list
111365995|NCT00601718|Vorinostat|vorinostat|mesh-list
111365996|NCT00601718|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111365997|NCT00601718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111365998|NCT00601718|Immunologic Factors|immunologic factors|mesh-ancestor
111365999|NCT00601718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111366000|NCT00601718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111366001|NCT00601718|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111366002|NCT00601718|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111366003|NCT00601718|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111366004|NCT00601718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111366005|NCT00601718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111366006|NCT00601718|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111366007|NCT00601718|Alkylating Agents|alkylating agents|mesh-ancestor
111366008|NCT00601718|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111366009|NCT00601796|Cyclophosphamide|cyclophosphamide|mesh-list
111366010|NCT00601796|Tretinoin|tretinoin|mesh-list
111366011|NCT00601796|Vaccines|vaccines|mesh-list
111366012|NCT00601796|Immunologic Factors|immunologic factors|mesh-ancestor
111366013|NCT00601796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111366014|NCT00601796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111366015|NCT00601796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111366016|NCT00601796|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111366017|NCT00601796|Alkylating Agents|alkylating agents|mesh-ancestor
111366018|NCT00601796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111366019|NCT00601796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111366020|NCT00601796|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111366021|NCT00601796|Keratolytic Agents|keratolytic agents|mesh-ancestor
111366022|NCT00601796|Dermatologic Agents|dermatologic agents|mesh-ancestor
111366023|NCT00693992|Sunitinib|sunitinib|mesh-list
111366024|NCT00693992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111366025|NCT00693992|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111366026|NCT00693992|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111366027|NCT00693992|Growth Substances|growth substances|mesh-ancestor
111366028|NCT00693992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111366029|NCT00693992|Growth Inhibitors|growth inhibitors|mesh-ancestor
111366030|NCT00693992|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111366031|NCT00693992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111366032|NCT00693992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111366033|NCT00645710|Gemcitabine|gemcitabine|mesh-list
111366034|NCT00645710|Floxuridine|floxuridine|mesh-list
111366035|NCT00645710|Antibodies|antibodies|mesh-list
111366036|NCT00645710|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111366037|NCT00645710|Immunologic Factors|immunologic factors|mesh-ancestor
111366038|NCT00645710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111366039|NCT00645710|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111366040|NCT00645710|Antimetabolites|antimetabolites|mesh-ancestor
111366041|NCT00645710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111366042|NCT00645710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111366043|NCT00603044|Fluticasone|fluticasone|mesh-list
111366045|NCT00603044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111366046|NCT00603044|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111366047|NCT00603044|Autonomic Agents|autonomic agents|mesh-ancestor
111366048|NCT00603044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111366049|NCT00603044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111366050|NCT00603044|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111366051|NCT00603044|Respiratory System Agents|respiratory system agents|mesh-ancestor
111366052|NCT00603044|Dermatologic Agents|dermatologic agents|mesh-ancestor
111366053|NCT00603044|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111366054|NCT00646646|Midazolam|midazolam|mesh-list
111366055|NCT00646646|Dexmedetomidine|dexmedetomidine|mesh-list
111366056|NCT00646646|Propofol|propofol|mesh-list
111366057|NCT00646646|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111366058|NCT00646646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111366059|NCT00646646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111366060|NCT00646646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111366061|NCT00646646|Analgesics|analgesics|mesh-ancestor
111366062|NCT00646646|Sensory System Agents|sensory system agents|mesh-ancestor
111366063|NCT00646646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111366064|NCT00646646|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111366065|NCT00646646|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111366066|NCT00646646|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111366067|NCT00646646|Adrenergic Agents|adrenergic agents|mesh-ancestor
111366068|NCT00646646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111366069|NCT00646646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111366070|NCT00646646|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111366071|NCT00646646|Anesthetics, General|anesthetics, general|mesh-ancestor
111366072|NCT00646646|Anesthetics|anesthetics|mesh-ancestor
111366073|NCT00646646|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111366074|NCT00646646|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111366075|NCT00646646|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111366076|NCT00646646|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111366077|NCT00646646|GABA Modulators|gaba modulators|mesh-ancestor
111366078|NCT00646646|GABA Agents|gaba agents|mesh-ancestor
111366079|NCT02998424|Propofol|propofol|mesh-list
111366080|NCT02998424|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111366081|NCT02998424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111366082|NCT02998424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111366083|NCT02998424|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111366084|NCT02998424|Anesthetics, General|anesthetics, general|mesh-ancestor
111366085|NCT02998424|Anesthetics|anesthetics|mesh-ancestor
111366086|NCT00696488|Fluorouracil|fluorouracil|mesh-list
111366087|NCT00696488|Antimetabolites|antimetabolites|mesh-ancestor
111366088|NCT00696488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111366089|NCT00696488|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111366090|NCT00696488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111366091|NCT00696488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111366092|NCT00696488|Immunologic Factors|immunologic factors|mesh-ancestor
111366093|NCT00696488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111366094|NCT00648908|4-Aminopyridine|4-aminopyridine|mesh-list
111366095|NCT00648908|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
111366096|NCT00648908|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111366097|NCT00648908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111366098|NCT00650078|Prednisone|prednisone|mesh-list
111366099|NCT00650078|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111366100|NCT00650078|Glucocorticoids|glucocorticoids|mesh-ancestor
111366101|NCT00650078|Hormones|hormones|mesh-ancestor
111366102|NCT00650078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111366103|NCT00650078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111366104|NCT00650078|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111366105|NCT00650078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111366106|NCT01799486|Adefovir|adefovir|mesh-list
111366107|NCT01799486|Telbivudine|telbivudine|mesh-list
111366108|NCT01799486|Antiviral Agents|antiviral agents|mesh-ancestor
111366109|NCT01799486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111366110|NCT01799486|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111366111|NCT01799486|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111366112|NCT01799486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111366113|NCT01799486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111366114|NCT00650546|Exenatide|exenatide|mesh-list
111090524|NCT03301181|Rifampin|rifampin|mesh-list
111366115|NCT00650546|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111366116|NCT00650546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111366117|NCT00650546|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111366118|NCT00650546|Incretins|incretins|mesh-ancestor
111366119|NCT00650546|Hormones|hormones|mesh-ancestor
111366120|NCT00650546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111366121|NCT00650858|Plasminogen|plasminogen|mesh-list
111366122|NCT00650858|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
110152987|NCT04142983|Vaccines|vaccines|mesh-list
111366123|NCT00650858|Fibrinolytic Agents|fibrinolytic agents|mesh-list
111366124|NCT00650858|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111366125|NCT00650858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111366126|NCT00651482|Bevacizumab|bevacizumab|mesh-list
111366127|NCT00651482|Everolimus|everolimus|mesh-list
111366128|NCT00651482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111366129|NCT00651482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111366130|NCT00651482|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111366131|NCT00651482|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111366132|NCT00651482|Growth Substances|growth substances|mesh-ancestor
111366133|NCT00651482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111366134|NCT00651482|Growth Inhibitors|growth inhibitors|mesh-ancestor
111366135|NCT00651482|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111366136|NCT00651482|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111366137|NCT00651482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111366138|NCT00651482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111366139|NCT00651482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111366140|NCT00651482|Immunologic Factors|immunologic factors|mesh-ancestor
111366141|NCT00654836|Bevacizumab|bevacizumab|mesh-list
111366142|NCT00654836|Carboplatin|carboplatin|mesh-list
111366143|NCT00654836|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111366144|NCT00654836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111366145|NCT00654836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111366146|NCT00654836|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111366147|NCT00654836|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111366148|NCT00654836|Growth Substances|growth substances|mesh-ancestor
111366149|NCT00654836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111366150|NCT00654836|Growth Inhibitors|growth inhibitors|mesh-ancestor
111366151|NCT02997800|Labetalol|labetalol|mesh-list
111366152|NCT02997800|Fentanyl|fentanyl|mesh-list
111366153|NCT02997800|Esmolol|esmolol|mesh-list
111366154|NCT02997800|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111366155|NCT02997800|Narcotics|narcotics|mesh-ancestor
111366156|NCT02997800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111366157|NCT02997800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111366158|NCT02997800|Analgesics|analgesics|mesh-ancestor
111366159|NCT02997800|Sensory System Agents|sensory system agents|mesh-ancestor
111366160|NCT02997800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111366161|NCT02997800|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111366162|NCT02997800|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111366163|NCT02997800|Anesthetics, General|anesthetics, general|mesh-ancestor
111366164|NCT02997800|Anesthetics|anesthetics|mesh-ancestor
111366165|NCT02997800|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
111366166|NCT02997800|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111366167|NCT02997800|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111366168|NCT02997800|Adrenergic Agents|adrenergic agents|mesh-ancestor
111366169|NCT02997800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111366170|NCT02997800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111366171|NCT02997800|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111366172|NCT02997800|Sympathomimetics|sympathomimetics|mesh-ancestor
111366173|NCT02997800|Autonomic Agents|autonomic agents|mesh-ancestor
111366174|NCT02997800|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111366175|NCT02997800|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111366176|NCT00701636|Daptomycin|daptomycin|mesh-list
111366177|NCT00701636|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111366178|NCT00701636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111366179|NCT00701714|Epoetin Alfa|epoetin alfa|mesh-list
111366180|NCT00701714|Hematinics|hematinics|mesh-ancestor
111366181|NCT00655538|Dalcetrapib|dalcetrapib|mesh-list
111366182|NCT00655538|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111366183|NCT00655538|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111366184|NCT00655538|Antimetabolites|antimetabolites|mesh-ancestor
111366185|NCT00655538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111366186|NCT00655538|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111366187|NCT00656630|Naltrexone|naltrexone|mesh-list
110455935|NCT00843193|Xhance|xhance|mesh-list
111366188|NCT00656630|Acamprosate|acamprosate|mesh-list
111366189|NCT00656630|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111366190|NCT00656630|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111366191|NCT00656630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111366192|NCT00656630|Sensory System Agents|sensory system agents|mesh-ancestor
111366193|NCT00656630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111366194|NCT01362998|Fentanyl|fentanyl|mesh-list
111366195|NCT01362998|Morphine|morphine|mesh-list
111366196|NCT01362998|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111366197|NCT01362998|Narcotics|narcotics|mesh-ancestor
111366198|NCT01362998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111366199|NCT01362998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111366200|NCT01362998|Analgesics|analgesics|mesh-ancestor
111366201|NCT01362998|Sensory System Agents|sensory system agents|mesh-ancestor
111366202|NCT01362998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111366203|NCT01362998|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111366204|NCT01362998|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111366205|NCT01362998|Anesthetics, General|anesthetics, general|mesh-ancestor
111366206|NCT01362998|Anesthetics|anesthetics|mesh-ancestor
111366207|NCT04387526|Sofosbuvir|sofosbuvir|mesh-list
111366208|NCT04387526|Antiviral Agents|antiviral agents|mesh-ancestor
111366209|NCT04387526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111366210|NCT00658112|Benzoyl Peroxide|benzoyl peroxide|mesh-list
111366211|NCT00658112|Dermatologic Agents|dermatologic agents|mesh-ancestor
111366212|NCT02997332|Docetaxel|docetaxel|mesh-list
111366213|NCT02997332|Fluorouracil|fluorouracil|mesh-list
111366214|NCT02997332|Durvalumab|durvalumab|mesh-list
111366215|NCT02997332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111366216|NCT02997332|Tubulin Modulators|tubulin modulators|mesh-ancestor
111366217|NCT02997332|Antimitotic Agents|antimitotic agents|mesh-ancestor
111366218|NCT02997332|Mitosis Modulators|mitosis modulators|mesh-ancestor
111366219|NCT02997332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111366220|NCT02997332|Antimetabolites|antimetabolites|mesh-ancestor
111366221|NCT02997332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111366222|NCT02997332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111366223|NCT02997332|Immunologic Factors|immunologic factors|mesh-ancestor
111366224|NCT02997332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111366225|NCT02997332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111366226|NCT04345094|Hydroquinone|hydroquinone|mesh-list
111366227|NCT04345094|Antioxidants|antioxidants|mesh-ancestor
110505737|NCT00092768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111366228|NCT04345094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111366229|NCT04345094|Protective Agents|protective agents|mesh-ancestor
111366230|NCT04345094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111366231|NCT04345094|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111366232|NCT00702884|Sunitinib|sunitinib|mesh-list
111366233|NCT00702884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111366234|NCT00702884|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111366235|NCT00702884|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111366236|NCT00702884|Growth Substances|growth substances|mesh-ancestor
111366237|NCT00702884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111366238|NCT00702884|Growth Inhibitors|growth inhibitors|mesh-ancestor
111366239|NCT00702884|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111366240|NCT00702884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111366241|NCT00702884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111366242|NCT00703508|Metformin|metformin|mesh-list
111366243|NCT00703508|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111366244|NCT00703508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111366245|NCT01284335|Gemcitabine|gemcitabine|mesh-list
111366246|NCT01284335|Docetaxel|docetaxel|mesh-list
111366247|NCT01284335|Temozolomide|temozolomide|mesh-list
111366248|NCT01284335|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111366249|NCT01284335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111366250|NCT01284335|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111366251|NCT01284335|Antimetabolites|antimetabolites|mesh-ancestor
111366252|NCT01284335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111366253|NCT01284335|Tubulin Modulators|tubulin modulators|mesh-ancestor
110153130|NCT03937609|Infliximab|infliximab|mesh-list
111366254|NCT01284335|Antimitotic Agents|antimitotic agents|mesh-ancestor
111366255|NCT01284335|Mitosis Modulators|mitosis modulators|mesh-ancestor
111366256|NCT01284335|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111366257|NCT01284335|Alkylating Agents|alkylating agents|mesh-ancestor
111366258|NCT01284335|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111366259|NCT01284335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111366260|NCT01194479|Formoterol Fumarate|formoterol fumarate|mesh-list
111366261|NCT01194479|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111366262|NCT01194479|Autonomic Agents|autonomic agents|mesh-ancestor
111366263|NCT01194479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111366264|NCT01194479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111366265|NCT01194479|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111366266|NCT01194479|Respiratory System Agents|respiratory system agents|mesh-ancestor
111366267|NCT01194479|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111366268|NCT01194479|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111090679|NCT05294055|Cyclophosphamide|cyclophosphamide|mesh-list
111366269|NCT01194479|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111366270|NCT01194479|Adrenergic Agents|adrenergic agents|mesh-ancestor
111366271|NCT01194479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111366272|NCT01194479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111366273|NCT01230593|Tobramycin|tobramycin|mesh-list
111366274|NCT01230593|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
111366275|NCT01230593|Dexamethasone|dexamethasone|mesh-list
111366276|NCT01230593|Dexamethasone acetate|dexamethasone acetate|mesh-list
111366277|NCT01230593|BB 1101|bb 1101|mesh-list
111366278|NCT01230593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111366279|NCT01230593|Antiemetics|antiemetics|mesh-ancestor
111366280|NCT01230593|Autonomic Agents|autonomic agents|mesh-ancestor
111366281|NCT01230593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111366282|NCT01230593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111366283|NCT01230593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111366284|NCT01230593|Glucocorticoids|glucocorticoids|mesh-ancestor
111366285|NCT01230593|Hormones|hormones|mesh-ancestor
111366286|NCT01230593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111366287|NCT01230593|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111366288|NCT01230593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111366289|NCT01230593|Protease Inhibitors|protease inhibitors|mesh-ancestor
111366290|NCT01230593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111366291|NCT01230593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111366292|NCT01230593|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111366293|NCT01230593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111366294|NCT01230593|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
111366295|NCT01230593|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111366296|NCT01195025|Chrysarobin|chrysarobin|mesh-list
111366297|NCT01195025|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
111366298|NCT01195025|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111366299|NCT01195025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111366300|NCT01195025|Analgesics|analgesics|mesh-ancestor
111366301|NCT01195025|Sensory System Agents|sensory system agents|mesh-ancestor
111366302|NCT01195025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111366303|NCT01195025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111366304|NCT01195025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110505837|NCT03223220|GABA Modulators|gaba modulators|mesh-ancestor
111366305|NCT01195025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111366306|NCT01195025|Plasma Substitutes|plasma substitutes|mesh-ancestor
111366307|NCT01195025|Blood Substitutes|blood substitutes|mesh-ancestor
111366308|NCT00703664|Bortezomib|bortezomib|mesh-list
111366309|NCT00703664|Vorinostat|vorinostat|mesh-list
111366310|NCT00703664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111366311|NCT00703664|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111366312|NCT00703664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111366313|NCT00703664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111366314|NCT00658736|Triamcinolone|triamcinolone|mesh-list
111366315|NCT00658736|Bupivacaine|bupivacaine|mesh-list
111366316|NCT00658736|Anesthetics, Local|anesthetics, local|mesh-ancestor
111366317|NCT00658736|Anesthetics|anesthetics|mesh-ancestor
111366318|NCT00658736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111366319|NCT00658736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111366320|NCT00658736|Sensory System Agents|sensory system agents|mesh-ancestor
111366321|NCT00658736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111366322|NCT00658736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111366323|NCT00658736|Glucocorticoids|glucocorticoids|mesh-ancestor
111366324|NCT00658736|Hormones|hormones|mesh-ancestor
111366325|NCT00658736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111366326|NCT00659360|Saracatinib|saracatinib|mesh-list
111366327|NCT00659360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111366328|NCT00659360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111366329|NCT00659360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111366330|NCT01197833|Polidocanol|polidocanol|mesh-list
111366331|NCT01197833|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
111366332|NCT01197833|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111366333|NCT04270370|Atorvastatin|atorvastatin|mesh-list
111366334|NCT04270370|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111366335|NCT04270370|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111366336|NCT04270370|Antimetabolites|antimetabolites|mesh-ancestor
111366337|NCT04270370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111366338|NCT04270370|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111366339|NCT04270370|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111366340|NCT04270370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111366341|NCT01288781|Acetazolamide|acetazolamide|mesh-list
111366342|NCT01288781|Anticonvulsants|anticonvulsants|mesh-ancestor
111366343|NCT01288781|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
111366344|NCT01288781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111366345|NCT01288781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111366346|NCT01288781|Diuretics|diuretics|mesh-ancestor
111366347|NCT01288781|Natriuretic Agents|natriuretic agents|mesh-ancestor
111366348|NCT01288781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111366349|NCT02990078|Sildenafil Citrate|sildenafil citrate|mesh-list
111366350|NCT02990078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111366351|NCT02990078|Vasodilator Agents|vasodilator agents|mesh-ancestor
111366352|NCT02990078|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111366353|NCT02990078|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111366354|NCT02990078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111366355|NCT02990078|Urological Agents|urological agents|mesh-ancestor
111366356|NCT01288859|Curcumin|curcumin|mesh-list
111366357|NCT01288859|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111366358|NCT01288859|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111366359|NCT01288859|Analgesics|analgesics|mesh-ancestor
111366360|NCT01288859|Sensory System Agents|sensory system agents|mesh-ancestor
111366361|NCT01288859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111366362|NCT01288859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111366363|NCT01288859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111366364|NCT01288859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111366365|NCT01288859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111366366|NCT01288859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111366367|NCT01288859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111366368|NCT01235195|Sertraline|sertraline|mesh-list
111366369|NCT01235195|Antidepressive Agents|antidepressive agents|mesh-ancestor
111366370|NCT01235195|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111366371|NCT01235195|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111366372|NCT01235195|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111366373|NCT01235195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111366374|NCT01235195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111366375|NCT01235195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111366376|NCT01235195|Serotonin Agents|serotonin agents|mesh-ancestor
111366377|NCT01235195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111366378|NCT02996942|Factor VIII|factor viii|mesh-list
111366379|NCT02996942|Coagulants|coagulants|mesh-ancestor
111366380|NCT01199237|Glycopyrrolate|glycopyrrolate|mesh-list
111366381|NCT01199237|Sevoflurane|sevoflurane|mesh-list
111366382|NCT01199237|Desflurane|desflurane|mesh-list
111366383|NCT01199237|Rocuronium|rocuronium|mesh-list
111366384|NCT01199237|Neostigmine|neostigmine|mesh-list
111366385|NCT01199237|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111366386|NCT01199237|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111366387|NCT01199237|Anesthetics, General|anesthetics, general|mesh-ancestor
111366388|NCT01199237|Anesthetics|anesthetics|mesh-ancestor
111366389|NCT01199237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111366390|NCT01199237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111366391|NCT01199237|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
111366392|NCT01199237|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
111366393|NCT01199237|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111366394|NCT01199237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111366395|NCT01199237|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111366396|NCT01199237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111366397|NCT01199237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111366398|NCT01199237|Cholinergic Agents|cholinergic agents|mesh-ancestor
111366399|NCT01199237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111366400|NCT01199237|Parasympathomimetics|parasympathomimetics|mesh-ancestor
111366401|NCT01199237|Autonomic Agents|autonomic agents|mesh-ancestor
111366402|NCT01199237|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111366403|NCT01199237|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111366404|NCT01199237|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111366405|NCT01235897|Paclitaxel|paclitaxel|mesh-list
111366406|NCT01235897|Trastuzumab|trastuzumab|mesh-list
111366407|NCT01235897|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111366408|NCT01235897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111366409|NCT01235897|Tubulin Modulators|tubulin modulators|mesh-ancestor
111366410|NCT01235897|Antimitotic Agents|antimitotic agents|mesh-ancestor
111366411|NCT01235897|Mitosis Modulators|mitosis modulators|mesh-ancestor
111366412|NCT01235897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111366413|NCT01235897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111366414|NCT01236053|Gabapentin|gabapentin|mesh-list
111366415|NCT01236053|Analgesics|analgesics|mesh-ancestor
111366416|NCT01236053|Sensory System Agents|sensory system agents|mesh-ancestor
111366417|NCT01236053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111366418|NCT01236053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111366419|NCT01236053|Anticonvulsants|anticonvulsants|mesh-ancestor
111366420|NCT01236053|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111366421|NCT01236053|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111366422|NCT01236053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111366423|NCT01236053|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111366424|NCT01236053|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111366425|NCT01236053|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111366426|NCT01236053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111366427|NCT01236053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111366428|NCT01236053|Antimanic Agents|antimanic agents|mesh-ancestor
111366429|NCT00703976|Bevacizumab|bevacizumab|mesh-list
111366431|NCT00703976|Pemetrexed|pemetrexed|mesh-list
111366432|NCT00703976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111366433|NCT00703976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111366434|NCT00703976|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111366435|NCT00703976|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111366436|NCT00703976|Growth Substances|growth substances|mesh-ancestor
111366437|NCT00703976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111366438|NCT00703976|Growth Inhibitors|growth inhibitors|mesh-ancestor
111366439|NCT00703976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111366440|NCT00703976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111366441|NCT00703976|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111366442|NCT00703976|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111366443|NCT00661544|Ascorbic Acid|ascorbic acid|mesh-list
111366444|NCT00661544|Melphalan|melphalan|mesh-list
111366445|NCT00661544|Arsenic Trioxide|arsenic trioxide|mesh-list
111366446|NCT00661544|Vitamins|vitamins|mesh-ancestor
111366447|NCT00661544|Micronutrients|micronutrients|mesh-ancestor
111366448|NCT00661544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111366449|NCT00661544|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111366450|NCT00661544|Alkylating Agents|alkylating agents|mesh-ancestor
111366451|NCT00661544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111366452|NCT00661544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111366453|NCT00661544|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111366454|NCT00661544|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111366455|NCT00661544|Immunologic Factors|immunologic factors|mesh-ancestor
111366456|NCT00661544|Antioxidants|antioxidants|mesh-ancestor
111366457|NCT00661544|Protective Agents|protective agents|mesh-ancestor
111366458|NCT00706550|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
111366459|NCT00706550|Immunologic Factors|immunologic factors|mesh-ancestor
111366460|NCT00706550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111366461|NCT02979392|Paclitaxel|paclitaxel|mesh-list
111366462|NCT02979392|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111366463|NCT02979392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111366464|NCT02979392|Tubulin Modulators|tubulin modulators|mesh-ancestor
111366465|NCT02979392|Antimitotic Agents|antimitotic agents|mesh-ancestor
111366466|NCT02979392|Mitosis Modulators|mitosis modulators|mesh-ancestor
111366467|NCT02979392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111366468|NCT02999906|Treprostinil|treprostinil|mesh-list
111366469|NCT02999906|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111366470|NCT01238471|Propranolol|propranolol|mesh-list
111366471|NCT01238471|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111366472|NCT01238471|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111366473|NCT01238471|Adrenergic Agents|adrenergic agents|mesh-ancestor
111366474|NCT01238471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111366475|NCT01238471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111366476|NCT01238471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111366477|NCT01238471|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111366478|NCT01238471|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111366479|NCT01238471|Vasodilator Agents|vasodilator agents|mesh-ancestor
111366480|NCT00664430|Calcitriol|calcitriol|mesh-list
111366481|NCT00664430|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111366482|NCT00664430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111366483|NCT00664430|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
111366484|NCT00664430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111366485|NCT00664430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111366486|NCT00664430|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111366487|NCT00664430|Vitamins|vitamins|mesh-ancestor
111366488|NCT00664430|Micronutrients|micronutrients|mesh-ancestor
111366489|NCT00664430|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111366490|NCT01292447|Lidocaine|lidocaine|mesh-list
111366491|NCT01292447|Anesthetics, Local|anesthetics, local|mesh-ancestor
111366492|NCT01292447|Anesthetics|anesthetics|mesh-ancestor
111366493|NCT01292447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111366494|NCT01292447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111366495|NCT01292447|Sensory System Agents|sensory system agents|mesh-ancestor
111366496|NCT01292447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111366497|NCT01292447|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111366498|NCT01292447|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111366499|NCT01292447|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111366500|NCT01292447|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111366501|NCT01292447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111366502|NCT00704912|Orlistat|orlistat|mesh-list
111366503|NCT00704912|Contraceptive Agents|contraceptive agents|mesh-list
111000941|NCT02855359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111366504|NCT00704912|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
111366505|NCT00704912|Contraceptives, Oral|contraceptives, oral|mesh-list
111366506|NCT00704912|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111366507|NCT00704912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111366508|NCT00704912|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111366509|NCT00704912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111366510|NCT00704912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111366511|NCT00704912|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111366512|NCT00704912|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111366513|NCT00704912|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
111366514|NCT00704912|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111366515|NCT00704912|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111366516|NCT00704912|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
111366517|NCT00704912|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111366518|NCT02195921|Antiemetics|antiemetics|mesh-list
111366519|NCT02195921|Autonomic Agents|autonomic agents|mesh-ancestor
111366520|NCT02195921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111366521|NCT02195921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111366522|NCT02195921|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111366523|NCT02189213|Sertraline|sertraline|mesh-list
111366524|NCT02189213|Antidepressive Agents|antidepressive agents|mesh-ancestor
111366525|NCT02189213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111366526|NCT02189213|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111366527|NCT02189213|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111366528|NCT02189213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111366529|NCT02189213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111366530|NCT02189213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111366531|NCT02189213|Serotonin Agents|serotonin agents|mesh-ancestor
111366532|NCT02189213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111366533|NCT01241903|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111366534|NCT01241903|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111366535|NCT01241903|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111366536|NCT01241903|Antimetabolites|antimetabolites|mesh-ancestor
111366537|NCT01241903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111366538|NCT01241903|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111366539|NCT01241903|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111366540|NCT01241903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111366541|NCT00666848|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111366542|NCT00666848|Enalapril|enalapril|mesh-list
111366543|NCT00666848|Enalaprilat|enalaprilat|mesh-list
111366544|NCT00666848|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111366545|NCT00666848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111366546|NCT00666848|Incretins|incretins|mesh-ancestor
111366547|NCT00666848|Hormones|hormones|mesh-ancestor
111366548|NCT00666848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111366549|NCT00666848|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111366550|NCT00666848|Protease Inhibitors|protease inhibitors|mesh-ancestor
111366551|NCT00666848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111366552|NCT00666848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111366553|NCT00666848|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
111366554|NCT00666848|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111366555|NCT01287377|Nicotine|nicotine|mesh-list
111366556|NCT01287377|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111366557|NCT01287377|Autonomic Agents|autonomic agents|mesh-ancestor
111366558|NCT01287377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111366559|NCT01287377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111366560|NCT01287377|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111366561|NCT01287377|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111366562|NCT01287377|Cholinergic Agents|cholinergic agents|mesh-ancestor
111366563|NCT01287377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111366564|NCT01287377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111366565|NCT01511042|Norepinephrine|norepinephrine|mesh-list
111366566|NCT01511042|Angiotensin II|angiotensin ii|mesh-list
111366567|NCT01511042|Giapreza|giapreza|mesh-list
111366568|NCT01511042|Angiotensinogen|angiotensinogen|mesh-list
111366569|NCT01511042|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111366570|NCT01511042|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111366571|NCT01511042|Adrenergic Agents|adrenergic agents|mesh-ancestor
111366572|NCT01511042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111366573|NCT01511042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111366574|NCT01511042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111366575|NCT01511042|Sympathomimetics|sympathomimetics|mesh-ancestor
111366576|NCT01511042|Autonomic Agents|autonomic agents|mesh-ancestor
111366577|NCT01511042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111366578|NCT01511042|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111366579|NCT01511042|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111366580|NCT01511042|Protease Inhibitors|protease inhibitors|mesh-ancestor
111366581|NCT01511042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111366582|NCT00667004|Ecabet|ecabet|mesh-list
111366583|NCT00667004|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111366584|NCT00667004|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111366585|NCT00667004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111366586|NCT00667004|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111366587|NCT00667004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111366588|NCT00667004|Protease Inhibitors|protease inhibitors|mesh-ancestor
111366589|NCT00667004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111366590|NCT00667004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111366591|NCT00667004|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
111366592|NCT00667004|Protective Agents|protective agents|mesh-ancestor
111366593|NCT00667004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111366594|NCT00667004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111366595|NCT01204853|Sitaxsentan|sitaxsentan|mesh-list
111366596|NCT01204853|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
111366597|NCT01204853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111366598|NCT01028846|Diazoxide|diazoxide|mesh-list
111366599|NCT01028846|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111366600|NCT01028846|Vasodilator Agents|vasodilator agents|mesh-ancestor
111366601|NCT04386122|Loxoprofen|loxoprofen|mesh-list
111366602|NCT04386122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111366603|NCT04386122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111366604|NCT04386122|Analgesics|analgesics|mesh-ancestor
111366605|NCT04386122|Sensory System Agents|sensory system agents|mesh-ancestor
111366606|NCT04386122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111366607|NCT04386122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111366608|NCT04386122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111366609|NCT04386122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111366610|NCT03009461|Sorafenib|sorafenib|mesh-list
111366611|NCT03009461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111366612|NCT03009461|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111366613|NCT03009461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111366614|NCT03009461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111366615|NCT02990702|Bupivacaine|bupivacaine|mesh-list
111366616|NCT02990702|Anesthetics, Local|anesthetics, local|mesh-ancestor
111366617|NCT02990702|Anesthetics|anesthetics|mesh-ancestor
111366618|NCT02990702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111366619|NCT02990702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111366620|NCT02990702|Sensory System Agents|sensory system agents|mesh-ancestor
111366621|NCT02990702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111366622|NCT02995304|Midazolam|midazolam|mesh-list
111366623|NCT02995304|Morphine|morphine|mesh-list
111366624|NCT02995304|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111366625|NCT02995304|Narcotics|narcotics|mesh-ancestor
111366626|NCT02995304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111366627|NCT02995304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111366628|NCT02995304|Analgesics|analgesics|mesh-ancestor
111366629|NCT02995304|Sensory System Agents|sensory system agents|mesh-ancestor
111366630|NCT02995304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111366631|NCT02995304|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111366632|NCT02995304|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111366633|NCT02995304|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111366634|NCT02995304|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111366635|NCT02995304|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111366636|NCT02995304|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111366637|NCT02995304|Anesthetics, General|anesthetics, general|mesh-ancestor
111366638|NCT02995304|Anesthetics|anesthetics|mesh-ancestor
111366639|NCT02995304|GABA Modulators|gaba modulators|mesh-ancestor
111366640|NCT02995304|GABA Agents|gaba agents|mesh-ancestor
111366641|NCT02995304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111366642|NCT02995304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111366644|NCT02990858|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
111366645|NCT02990858|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
111366646|NCT02990858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111366647|NCT02990858|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111366648|NCT02990858|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111366649|NCT02990858|Antiviral Agents|antiviral agents|mesh-ancestor
111366650|NCT02990858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111366651|NCT00725504|Lidocaine|lidocaine|mesh-list
111366652|NCT00725504|Anesthetics, Local|anesthetics, local|mesh-ancestor
111366653|NCT00725504|Anesthetics|anesthetics|mesh-ancestor
111366654|NCT00725504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111366655|NCT00725504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111366656|NCT00725504|Sensory System Agents|sensory system agents|mesh-ancestor
111366657|NCT00725504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111366658|NCT00725504|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111366659|NCT00725504|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111366660|NCT00725504|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111366661|NCT00725504|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111366662|NCT00725504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111366663|NCT03830684|Baicalein|baicalein|mesh-list
111366664|NCT03830684|Antioxidants|antioxidants|mesh-ancestor
111366665|NCT03830684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111366666|NCT03830684|Protective Agents|protective agents|mesh-ancestor
111366667|NCT03830684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111366668|NCT03830684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111366669|NCT03830684|Prostaglandin Antagonists|prostaglandin antagonists|mesh-ancestor
111366670|NCT03830684|Hormone Antagonists|hormone antagonists|mesh-ancestor
111366671|NCT03830684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111366672|NCT02990546|Midodrine|midodrine|mesh-list
111366673|NCT02990546|Sympathomimetics|sympathomimetics|mesh-ancestor
111366674|NCT02990546|Autonomic Agents|autonomic agents|mesh-ancestor
111366675|NCT02990546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111366676|NCT02990546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111366677|NCT02990546|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111366678|NCT02990546|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111366679|NCT02990546|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111366680|NCT02990546|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111366681|NCT02990546|Adrenergic Agents|adrenergic agents|mesh-ancestor
111366682|NCT02990546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111366683|NCT02990546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111366684|NCT00727064|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
111366685|NCT00727064|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
111366686|NCT00727064|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111366687|NCT00727064|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111366688|NCT00727064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111366689|NCT00727064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111366690|NCT00727064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111366691|NCT00727064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111366692|NCT00727064|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111366693|NCT00727064|Antidepressive Agents|antidepressive agents|mesh-ancestor
111366694|NCT00727064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111366695|NCT01294163|Propofol|propofol|mesh-list
111366696|NCT01294163|Sevoflurane|sevoflurane|mesh-list
111366697|NCT01294163|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111366698|NCT01294163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111366699|NCT01294163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111366700|NCT01294163|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111366701|NCT01294163|Anesthetics, General|anesthetics, general|mesh-ancestor
111366702|NCT01294163|Anesthetics|anesthetics|mesh-ancestor
111366703|NCT01294163|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111366704|NCT01294163|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111366705|NCT01294319|Dexamethasone|dexamethasone|mesh-list
111366706|NCT01294319|Dexamethasone acetate|dexamethasone acetate|mesh-list
111366707|NCT01294319|Spironolactone|spironolactone|mesh-list
111366708|NCT01294319|Mifepristone|mifepristone|mesh-list
111366709|NCT01294319|BB 1101|bb 1101|mesh-list
111366710|NCT01294319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111366711|NCT01294319|Antiemetics|antiemetics|mesh-ancestor
111366712|NCT01294319|Autonomic Agents|autonomic agents|mesh-ancestor
111366713|NCT01294319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111366714|NCT01294319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111366715|NCT01294319|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111366716|NCT01294319|Glucocorticoids|glucocorticoids|mesh-ancestor
111366717|NCT01294319|Hormones|hormones|mesh-ancestor
111366718|NCT01294319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111366719|NCT01294319|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111366720|NCT01294319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111366721|NCT01294319|Protease Inhibitors|protease inhibitors|mesh-ancestor
111366722|NCT01294319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111366723|NCT01294319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111366724|NCT01294319|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
111366725|NCT01294319|Hormone Antagonists|hormone antagonists|mesh-ancestor
111366726|NCT01294319|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
111366727|NCT01294319|Diuretics|diuretics|mesh-ancestor
111366728|NCT01294319|Natriuretic Agents|natriuretic agents|mesh-ancestor
111366729|NCT01294319|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
111366730|NCT01294319|Abortifacient Agents|abortifacient agents|mesh-ancestor
111366731|NCT01294319|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111366732|NCT01294319|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111366733|NCT01294319|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111366734|NCT01294319|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111366735|NCT01294319|Contraceptive Agents|contraceptive agents|mesh-ancestor
111366736|NCT01294319|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
111366737|NCT01294319|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
111366738|NCT01294319|Luteolytic Agents|luteolytic agents|mesh-ancestor
111366739|NCT01294319|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111366740|NCT01294319|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
111366741|NCT00727298|Infliximab|infliximab|mesh-list
111366742|NCT00727298|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111366743|NCT00727298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111366744|NCT00727298|Dermatologic Agents|dermatologic agents|mesh-ancestor
111366745|NCT00727298|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111366746|NCT00727298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111366747|NCT02990312|Sirolimus|sirolimus|mesh-list
111366748|NCT02990312|Maraviroc|maraviroc|mesh-list
111366749|NCT02990312|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111366750|NCT02990312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111366751|NCT02990312|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111366752|NCT02990312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111366753|NCT02990312|Antifungal Agents|antifungal agents|mesh-ancestor
111366754|NCT02990312|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111366755|NCT02990312|Immunologic Factors|immunologic factors|mesh-ancestor
111366756|NCT02990312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111366757|NCT02990312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110153664|NCT00001011|Zidovudine|zidovudine|mesh-list
111366758|NCT02990312|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
111366759|NCT02990312|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
111366760|NCT02990312|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111366761|NCT02990312|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111366762|NCT02990312|Antiviral Agents|antiviral agents|mesh-ancestor
111366763|NCT02990312|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
111366764|NCT01295879|Vitamin D|vitamin d|mesh-list
111366765|NCT01295879|Ergocalciferols|ergocalciferols|mesh-list
111366766|NCT01295879|Vitamins|vitamins|mesh-ancestor
111366767|NCT01295879|Micronutrients|micronutrients|mesh-ancestor
111366768|NCT01295879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111366769|NCT01295879|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111366770|NCT01295879|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111366771|NCT01244633|Ecopipam|ecopipam|mesh-list
111366772|NCT01244633|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111366773|NCT01244633|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111366774|NCT01244633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111366775|NCT01244633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111366776|NCT01244633|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111366777|NCT01244633|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111366778|NCT01244633|Dopamine Agents|dopamine agents|mesh-ancestor
111366779|NCT01244633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111366780|NCT01244633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111366781|NCT01296191|Moxifloxacin|moxifloxacin|mesh-list
111366782|NCT01296191|Besifloxacin|besifloxacin|mesh-list
111366783|NCT01296191|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111366784|NCT01296191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111366785|NCT01296191|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111366786|NCT01296191|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111366787|NCT01296191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110506338|NCT00839605|Analgesics|analgesics|mesh-ancestor
111366788|NCT01296191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111366789|NCT01296191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111366790|NCT01244711|Quetiapine Fumarate|quetiapine fumarate|mesh-list
111366791|NCT01244711|Antidepressive Agents|antidepressive agents|mesh-ancestor
111366792|NCT01244711|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111366793|NCT01244711|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111366794|NCT01244711|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111366795|NCT01244711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111366796|NCT01244711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111366797|NCT01210079|Gabapentin|gabapentin|mesh-list
111366798|NCT01210079|Analgesics|analgesics|mesh-ancestor
111366799|NCT01210079|Sensory System Agents|sensory system agents|mesh-ancestor
111366800|NCT01210079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111366801|NCT01210079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111366802|NCT01210079|Anticonvulsants|anticonvulsants|mesh-ancestor
111366803|NCT01210079|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111366804|NCT01210079|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111366805|NCT01210079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111366806|NCT01210079|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111366807|NCT01210079|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111366808|NCT01210079|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111366809|NCT01210079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111366810|NCT01210079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111366811|NCT01210079|Antimanic Agents|antimanic agents|mesh-ancestor
111366812|NCT01245647|Naltrexone|naltrexone|mesh-list
111366813|NCT01245647|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111366814|NCT01245647|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111366815|NCT01245647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111366816|NCT01245647|Sensory System Agents|sensory system agents|mesh-ancestor
111366817|NCT01245647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111366818|NCT00708110|Dolutegravir|dolutegravir|mesh-list
111366819|NCT00708110|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111366820|NCT00708110|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111366821|NCT00708110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111366822|NCT00708110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111366823|NCT00708110|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111366824|NCT00708110|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111366825|NCT00708110|Antiviral Agents|antiviral agents|mesh-ancestor
111366826|NCT00708110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111366827|NCT01296815|Bevacizumab|bevacizumab|mesh-list
111366828|NCT01296815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111366829|NCT01296815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111366830|NCT01296815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111366831|NCT01296815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111366832|NCT01296815|Growth Substances|growth substances|mesh-ancestor
111366833|NCT01296815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111366834|NCT01296815|Growth Inhibitors|growth inhibitors|mesh-ancestor
111366835|NCT01276262|Contraceptive Agents|contraceptive agents|mesh-list
111366836|NCT01276262|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
111366837|NCT01276262|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
111366838|NCT01276262|Contraceptives, Oral|contraceptives, oral|mesh-list
111366839|NCT01276262|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111366840|NCT01276262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111366841|NCT01276262|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111366842|NCT01276262|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111366843|NCT01276262|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
111366844|NCT01276262|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111366845|NCT01276262|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111366846|NCT01276262|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
111366847|NCT01276262|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
111366848|NCT01276262|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
111366849|NCT01276496|Paclitaxel|paclitaxel|mesh-list
111366850|NCT01276496|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111366851|NCT01276496|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110506400|NCT05660694|Protective Agents|protective agents|mesh-ancestor
111366852|NCT01276496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111366853|NCT01276496|Tubulin Modulators|tubulin modulators|mesh-ancestor
111366854|NCT01276496|Antimitotic Agents|antimitotic agents|mesh-ancestor
111366855|NCT01276496|Mitosis Modulators|mitosis modulators|mesh-ancestor
111366856|NCT01276496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111366857|NCT01297595|Crizotinib|crizotinib|mesh-list
111366858|NCT01297595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111366859|NCT01297595|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111366860|NCT01297595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111366861|NCT01297595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111366862|NCT02992418|Vaccines|vaccines|mesh-list
111091279|NCT02462369|Hormones|hormones|mesh-ancestor
111366863|NCT02992418|Immunologic Factors|immunologic factors|mesh-ancestor
111366864|NCT02992418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111366865|NCT01276730|Interferons|interferons|mesh-list
111366866|NCT01276730|Tretinoin|tretinoin|mesh-list
111366867|NCT01276730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111366868|NCT01276730|Antiviral Agents|antiviral agents|mesh-ancestor
111366869|NCT01276730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111366870|NCT01276730|Keratolytic Agents|keratolytic agents|mesh-ancestor
111366871|NCT01276730|Dermatologic Agents|dermatologic agents|mesh-ancestor
111366872|NCT01298063|Afatinib|afatinib|mesh-list
111366873|NCT01298063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110506422|NCT00840229|Hormones|hormones|mesh-ancestor
111366874|NCT01298063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111366875|NCT01298063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111366876|NCT01298063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111366877|NCT02999594|Tramadol|tramadol|mesh-list
111366878|NCT02999594|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111366879|NCT02999594|Narcotics|narcotics|mesh-ancestor
111366880|NCT02999594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111366881|NCT02999594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111366882|NCT02999594|Analgesics|analgesics|mesh-ancestor
111366883|NCT02999594|Sensory System Agents|sensory system agents|mesh-ancestor
111366884|NCT02999594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111366885|NCT01298219|Lubiprostone|lubiprostone|mesh-list
111366886|NCT01298219|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
111366887|NCT01298219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111366888|NCT01298219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111366889|NCT01276886|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111366890|NCT01276886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111366891|NCT02322242|Dexamethasone|dexamethasone|mesh-list
111366892|NCT02322242|Dexamethasone acetate|dexamethasone acetate|mesh-list
111366893|NCT02322242|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
111366894|NCT02322242|BB 1101|bb 1101|mesh-list
111366895|NCT02322242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111366896|NCT02322242|Antiemetics|antiemetics|mesh-ancestor
111366897|NCT02322242|Autonomic Agents|autonomic agents|mesh-ancestor
111366898|NCT02322242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111366899|NCT02322242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111366900|NCT02322242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111366901|NCT02322242|Glucocorticoids|glucocorticoids|mesh-ancestor
111366902|NCT02322242|Hormones|hormones|mesh-ancestor
111366903|NCT02322242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111366904|NCT02322242|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111366905|NCT02322242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111366906|NCT02322242|Protease Inhibitors|protease inhibitors|mesh-ancestor
111366907|NCT02322242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111366908|NCT02322242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111366909|NCT01211873|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
111366910|NCT01211873|Chelating Agents|chelating agents|mesh-ancestor
111366911|NCT01211873|Sequestering Agents|sequestering agents|mesh-ancestor
111366912|NCT01211873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111366913|NCT02993588|Melatonin|melatonin|mesh-list
111366914|NCT02993588|Antioxidants|antioxidants|mesh-ancestor
111366915|NCT02993588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111366916|NCT02993588|Protective Agents|protective agents|mesh-ancestor
111366917|NCT02993588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111366918|NCT02993588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111366919|NCT01270178|Entecavir|entecavir|mesh-list
111366920|NCT01270178|Antiviral Agents|antiviral agents|mesh-ancestor
111366921|NCT01270178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111366922|NCT01270412|Mitogens|mitogens|mesh-list
111366923|NCT01270412|Hyaluronic Acid|hyaluronic acid|mesh-list
111366924|NCT01270412|Mitosis Modulators|mitosis modulators|mesh-ancestor
111366925|NCT01270412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111366926|NCT01270412|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111366927|NCT01270412|Immunologic Factors|immunologic factors|mesh-ancestor
111366928|NCT01270412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111366929|NCT01270412|Viscosupplements|viscosupplements|mesh-ancestor
111366930|NCT01270412|Protective Agents|protective agents|mesh-ancestor
111366931|NCT02992496|Midazolam|midazolam|mesh-list
111366932|NCT02992496|Ketamine|ketamine|mesh-list
111366933|NCT02992496|Analgesics|analgesics|mesh-ancestor
111366934|NCT02992496|Sensory System Agents|sensory system agents|mesh-ancestor
111366935|NCT02992496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111366936|NCT02992496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111366937|NCT02992496|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111366938|NCT02992496|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111366939|NCT02992496|Anesthetics, General|anesthetics, general|mesh-ancestor
111366940|NCT02992496|Anesthetics|anesthetics|mesh-ancestor
111366941|NCT02992496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111366942|NCT02992496|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110506501|NCT00834457|Antimetabolites|antimetabolites|mesh-ancestor
111366943|NCT02992496|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111366944|NCT02992496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111366945|NCT02992496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111366946|NCT02992496|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111366947|NCT02992496|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111366948|NCT02992496|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111366949|NCT02992496|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111366950|NCT02992496|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111366951|NCT02992496|GABA Modulators|gaba modulators|mesh-ancestor
111366952|NCT02992496|GABA Agents|gaba agents|mesh-ancestor
111366953|NCT00729482|Everolimus|everolimus|mesh-list
111366954|NCT00729482|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111366955|NCT00729482|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111366956|NCT00729482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111366957|NCT00729482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111366958|NCT00729482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111366959|NCT00729482|Immunologic Factors|immunologic factors|mesh-ancestor
111366960|NCT00729482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111366961|NCT00729482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111366962|NCT01270490|Interferons|interferons|mesh-list
111366963|NCT01270490|Interferon-gamma|interferon-gamma|mesh-list
111366964|NCT01270490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111366965|NCT01270490|Antiviral Agents|antiviral agents|mesh-ancestor
110506520|NCT02824926|Ketoconazole|ketoconazole|mesh-list
111366966|NCT01270490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111366967|NCT01278056|Deferasirox|deferasirox|mesh-list
111366968|NCT01278056|Iron Chelating Agents|iron chelating agents|mesh-ancestor
111366969|NCT01278056|Chelating Agents|chelating agents|mesh-ancestor
111366970|NCT01278056|Sequestering Agents|sequestering agents|mesh-ancestor
111366971|NCT01278056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111366972|NCT02992652|Allopurinol|allopurinol|mesh-list
111366973|NCT02992652|Antimetabolites|antimetabolites|mesh-ancestor
111366974|NCT02992652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111366975|NCT02992652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111366976|NCT02992652|Gout Suppressants|gout suppressants|mesh-ancestor
111366977|NCT02992652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111366978|NCT02992652|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111366979|NCT02992652|Antioxidants|antioxidants|mesh-ancestor
111366980|NCT02992652|Protective Agents|protective agents|mesh-ancestor
111366981|NCT02992652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111366982|NCT01270724|Paclitaxel|paclitaxel|mesh-list
111366983|NCT01270724|Gemcitabine|gemcitabine|mesh-list
111366984|NCT01270724|Oxaliplatin|oxaliplatin|mesh-list
111366985|NCT01270724|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111366986|NCT01270724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111366987|NCT01270724|Tubulin Modulators|tubulin modulators|mesh-ancestor
111366988|NCT01270724|Antimitotic Agents|antimitotic agents|mesh-ancestor
111366989|NCT01270724|Mitosis Modulators|mitosis modulators|mesh-ancestor
111366990|NCT01270724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111366991|NCT01270724|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111366992|NCT01270724|Antimetabolites|antimetabolites|mesh-ancestor
111366993|NCT00709826|Gemcitabine|gemcitabine|mesh-list
111366994|NCT00709826|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111366995|NCT00709826|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111366996|NCT00709826|Antimetabolites|antimetabolites|mesh-ancestor
111366997|NCT00709826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111366998|NCT00709826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111366999|NCT00709826|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111367000|NCT00709826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111367001|NCT01271114|Terlipressin|terlipressin|mesh-list
111367002|NCT01271114|Norepinephrine|norepinephrine|mesh-list
111367003|NCT01271114|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111367004|NCT01271114|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111367005|NCT01271114|Adrenergic Agents|adrenergic agents|mesh-ancestor
111367006|NCT01271114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111367007|NCT01271114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111367008|NCT01271114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111367009|NCT01271114|Sympathomimetics|sympathomimetics|mesh-ancestor
111367010|NCT01271114|Autonomic Agents|autonomic agents|mesh-ancestor
111367011|NCT01271114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111367012|NCT01271114|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111367013|NCT01271114|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111367014|NCT02992340|Gemcitabine|gemcitabine|mesh-list
111367016|NCT02992340|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111367017|NCT02992340|Antimetabolites|antimetabolites|mesh-ancestor
111367018|NCT02992340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111367019|NCT00711464|Modafinil|modafinil|mesh-list
111367020|NCT00711464|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111367021|NCT00711464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111367022|NCT00711464|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
111367023|NCT00711464|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111367024|NCT00711464|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111367025|NCT00711464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111367026|NCT01278290|Triptorelin Pamoate|triptorelin pamoate|mesh-list
111367027|NCT01278290|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
111367028|NCT01278290|Luteolytic Agents|luteolytic agents|mesh-ancestor
111367029|NCT01278290|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111367030|NCT01278290|Contraceptive Agents|contraceptive agents|mesh-ancestor
111367031|NCT01278290|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111367032|NCT01278290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111367033|NCT01278290|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111367034|NCT01278290|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111367035|NCT01278290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111367036|NCT01278290|Hormones|hormones|mesh-ancestor
111367037|NCT01278290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111367038|NCT01278446|Caseins|caseins|mesh-list
111367039|NCT01278446|Chelating Agents|chelating agents|mesh-ancestor
111367040|NCT01278446|Sequestering Agents|sequestering agents|mesh-ancestor
111367041|NCT01278446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111367042|NCT02339558|Nivolumab|nivolumab|mesh-list
111367043|NCT02339558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111367044|NCT02339558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111367045|NCT02339558|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111367046|NCT02339558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111367047|NCT00731198|Drotaverin|drotaverin|mesh-list
111367048|NCT00731198|Scopolamine|scopolamine|mesh-list
111367049|NCT00731198|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
111367050|NCT00731198|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111367051|NCT00731198|Antiemetics|antiemetics|mesh-ancestor
111367052|NCT00731198|Autonomic Agents|autonomic agents|mesh-ancestor
111367053|NCT00731198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111367054|NCT00731198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111367055|NCT00731198|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111367056|NCT00731198|Mydriatics|mydriatics|mesh-ancestor
111367057|NCT00731198|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111367058|NCT00731198|Cholinergic Agents|cholinergic agents|mesh-ancestor
111367059|NCT00731198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111367060|NCT00731198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111367061|NCT00731198|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111367062|NCT00731198|Parasympatholytics|parasympatholytics|mesh-ancestor
111367063|NCT00731198|Analgesics|analgesics|mesh-ancestor
111367064|NCT00731198|Sensory System Agents|sensory system agents|mesh-ancestor
111367065|NCT00731198|Vasodilator Agents|vasodilator agents|mesh-ancestor
111367066|NCT01278602|Rituximab|rituximab|mesh-list
111367067|NCT01278602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111367068|NCT01278602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111367069|NCT01278602|Immunologic Factors|immunologic factors|mesh-ancestor
111367070|NCT01278602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111367071|NCT01278602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111367072|NCT00712244|Hyaluronic Acid|hyaluronic acid|mesh-list
111367073|NCT00712244|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111367074|NCT00712244|Immunologic Factors|immunologic factors|mesh-ancestor
110506629|NCT00633672|Histamine Agents|histamine agents|mesh-ancestor
111367075|NCT00712244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111367076|NCT00712244|Viscosupplements|viscosupplements|mesh-ancestor
111367077|NCT00712244|Protective Agents|protective agents|mesh-ancestor
111367078|NCT02991950|Parnaparin|parnaparin|mesh-list
111367079|NCT02991950|Anticoagulants|anticoagulants|mesh-ancestor
111367080|NCT02991950|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111367081|NCT02991950|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111367082|NCT02991950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111367083|NCT01271582|Leucovorin|leucovorin|mesh-list
111367084|NCT01271582|Irinotecan|irinotecan|mesh-list
111367085|NCT01271582|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111367086|NCT01271582|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111367087|NCT01271582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111091503|NCT03742193|Apatinib|apatinib|mesh-list
111367088|NCT01271582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111367089|NCT01271582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111367090|NCT01271582|Antidotes|antidotes|mesh-ancestor
111367091|NCT01271582|Protective Agents|protective agents|mesh-ancestor
111367092|NCT01271582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111367093|NCT01271582|Vitamin B Complex|vitamin b complex|mesh-ancestor
111367094|NCT01271582|Vitamins|vitamins|mesh-ancestor
111367095|NCT01271582|Micronutrients|micronutrients|mesh-ancestor
111367096|NCT01271660|Pregabalin|pregabalin|mesh-list
111367097|NCT01271660|Analgesics|analgesics|mesh-ancestor
111367098|NCT01271660|Sensory System Agents|sensory system agents|mesh-ancestor
111367099|NCT01271660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111367100|NCT01271660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111367101|NCT01271660|Anticonvulsants|anticonvulsants|mesh-ancestor
111367102|NCT01271660|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111367103|NCT01271660|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111367104|NCT01271660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111367105|NCT01271660|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111367106|NCT01271660|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111367107|NCT01271660|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111367108|NCT01271660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111367109|NCT01271660|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111367110|NCT00731588|Biotin|biotin|mesh-list
111367111|NCT00731588|Vitamin B Complex|vitamin b complex|mesh-ancestor
111367112|NCT00731588|Vitamins|vitamins|mesh-ancestor
111367113|NCT00731588|Micronutrients|micronutrients|mesh-ancestor
111367114|NCT00731588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111367115|NCT01271894|Efavirenz|efavirenz|mesh-list
111367116|NCT01271894|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111367117|NCT01271894|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111367118|NCT01271894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111367119|NCT01271894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111367120|NCT01271894|Antiviral Agents|antiviral agents|mesh-ancestor
111367121|NCT01271894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111367122|NCT01271894|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111367123|NCT01271894|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111367124|NCT01271894|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111367125|NCT01271894|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111367126|NCT01271894|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111367127|NCT01271894|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111367128|NCT01278758|Vadimezan|vadimezan|mesh-list
111367129|NCT01278758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111367130|NCT00717626|Factor VIII|factor viii|mesh-list
111367131|NCT00717626|Coagulants|coagulants|mesh-ancestor
111367132|NCT01272128|Interferons|interferons|mesh-list
111367133|NCT01272128|Interferon-beta|interferon-beta|mesh-list
111367134|NCT01272128|Interferon beta-1a|interferon beta-1a|mesh-list
111367135|NCT01272128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111367136|NCT01272128|Antiviral Agents|antiviral agents|mesh-ancestor
111367137|NCT01272128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111367138|NCT01272128|Immunologic Factors|immunologic factors|mesh-ancestor
111367139|NCT01272128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111367140|NCT01272128|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111367141|NCT00719186|Letrozole|letrozole|mesh-list
111367142|NCT00719186|Clomiphene|clomiphene|mesh-list
111367143|NCT00719186|Enclomiphene|enclomiphene|mesh-list
111367144|NCT00719186|Zuclomiphene|zuclomiphene|mesh-list
111367145|NCT00719186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111367146|NCT00719186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111367147|NCT00719186|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111367148|NCT00719186|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111367149|NCT00719186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111367150|NCT00719186|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111367151|NCT00719186|Hormone Antagonists|hormone antagonists|mesh-ancestor
111367152|NCT00719186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111367153|NCT00719186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111367154|NCT00719186|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111367155|NCT00719186|Fertility Agents|fertility agents|mesh-ancestor
111367156|NCT00719186|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111367157|NCT00719186|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111367158|NCT00719186|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111367159|NCT00721136|Heparin|heparin|mesh-list
111367160|NCT00721136|Warfarin|warfarin|mesh-list
111367161|NCT00721136|Anticoagulants|anticoagulants|mesh-ancestor
111367162|NCT00721136|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111367163|NCT00721136|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111367164|NCT00721136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111367165|NCT00737204|Modafinil|modafinil|mesh-list
111367166|NCT00737204|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111367167|NCT00737204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111367168|NCT00737204|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
111367169|NCT00737204|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111367170|NCT00737204|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111367171|NCT00737204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111367172|NCT00722072|Sorafenib|sorafenib|mesh-list
111367173|NCT00722072|Fulvestrant|fulvestrant|mesh-list
111367174|NCT00722072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111367175|NCT00722072|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111367176|NCT00722072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111000942|NCT02855359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111367177|NCT00722072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111367178|NCT00722072|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111367179|NCT00722072|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
111367180|NCT00722072|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111367181|NCT00722072|Hormone Antagonists|hormone antagonists|mesh-ancestor
111367182|NCT00722072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111367183|NCT00722072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111367184|NCT01275170|Imipenem|imipenem|mesh-list
111367185|NCT01275170|Relebactam|relebactam|mesh-list
111367186|NCT01275170|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
111367187|NCT01275170|Midazolam|midazolam|mesh-list
111367188|NCT01275170|Caffeine|caffeine|mesh-list
111367189|NCT01275170|Omeprazole|omeprazole|mesh-list
111367190|NCT01275170|Cilastatin|cilastatin|mesh-list
111367191|NCT01275170|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111367192|NCT01275170|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111367193|NCT01275170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111367194|NCT01275170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111367195|NCT01275170|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111367196|NCT01275170|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111367197|NCT01275170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111367198|NCT01275170|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111367199|NCT01275170|Anesthetics, General|anesthetics, general|mesh-ancestor
111367200|NCT01275170|Anesthetics|anesthetics|mesh-ancestor
111367201|NCT01275170|GABA Modulators|gaba modulators|mesh-ancestor
111367202|NCT01275170|GABA Agents|gaba agents|mesh-ancestor
111367203|NCT01275170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111367204|NCT01275170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111367205|NCT01275170|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111367206|NCT01275170|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111367207|NCT01275170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111367208|NCT01275170|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
111367209|NCT01275170|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111367210|NCT01275170|Purinergic Agents|purinergic agents|mesh-ancestor
111367211|NCT01275170|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111367212|NCT01275170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111367213|NCT01275170|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111367214|NCT01275170|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111367215|NCT01275170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111367216|NCT01275170|Protease Inhibitors|protease inhibitors|mesh-ancestor
111367217|NCT01275170|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
111367218|NCT04385654|Axitinib|axitinib|mesh-list
111367219|NCT04385654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111367220|NCT04385654|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111367221|NCT04385654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111367222|NCT04385654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111367223|NCT01273064|Interferons|interferons|mesh-list
111367224|NCT01273064|Ribavirin|ribavirin|mesh-list
111367225|NCT01273064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111367226|NCT01273064|Antiviral Agents|antiviral agents|mesh-ancestor
111367227|NCT01273064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111367228|NCT01273064|Antimetabolites|antimetabolites|mesh-ancestor
111367229|NCT01273064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111367230|NCT01272986|Immunoglobulin G|immunoglobulin g|mesh-list
111367231|NCT01272986|Immunologic Factors|immunologic factors|mesh-ancestor
111367232|NCT01272986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111367233|NCT01272908|Rituximab|rituximab|mesh-list
111367234|NCT01272908|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110506803|NCT05659212|Lidocaine|lidocaine|mesh-list
111367235|NCT01272908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111367236|NCT01272908|Immunologic Factors|immunologic factors|mesh-ancestor
111367237|NCT01272908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111367238|NCT01272908|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111367239|NCT01271504|Sorafenib|sorafenib|mesh-list
111367240|NCT01271504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111367241|NCT01271504|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111367242|NCT01271504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111367243|NCT01271504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111367244|NCT02144714|Adalimumab|adalimumab|mesh-list
111367245|NCT02144714|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111367246|NCT02144714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111367247|NCT02144714|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111367248|NCT00741026|Olanzapine|olanzapine|mesh-list
111367249|NCT00741026|Antiemetics|antiemetics|mesh-ancestor
111367250|NCT00741026|Autonomic Agents|autonomic agents|mesh-ancestor
111367251|NCT00741026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111367252|NCT00741026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111367253|NCT00741026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111367254|NCT00741026|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111367255|NCT00741026|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111367256|NCT00741026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111367257|NCT00741026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111367258|NCT00741026|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111367259|NCT00741026|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111367260|NCT00741026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111367261|NCT00741026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111367262|NCT00741026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111367263|NCT00741026|Serotonin Agents|serotonin agents|mesh-ancestor
111367264|NCT00741104|Infliximab|infliximab|mesh-list
111367265|NCT00741104|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111367266|NCT00741104|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111367267|NCT00741104|Dermatologic Agents|dermatologic agents|mesh-ancestor
111367268|NCT00741104|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111367269|NCT00741104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111367270|NCT01273298|Bisoprolol|bisoprolol|mesh-list
111367271|NCT01273298|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111367272|NCT01273298|Sympatholytics|sympatholytics|mesh-ancestor
111367273|NCT01273298|Autonomic Agents|autonomic agents|mesh-ancestor
110506839|NCT00835939|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111367274|NCT01273298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111367275|NCT01273298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111367276|NCT01273298|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
111367277|NCT01273298|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111367278|NCT01273298|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111367279|NCT01273298|Adrenergic Agents|adrenergic agents|mesh-ancestor
111367280|NCT01273298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111367281|NCT01273298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111367282|NCT01270802|Tenofovir|tenofovir|mesh-list
111367283|NCT01270802|Emtricitabine|emtricitabine|mesh-list
111367284|NCT01270802|Efavirenz|efavirenz|mesh-list
111367285|NCT01270802|Raltegravir Potassium|raltegravir potassium|mesh-list
111367286|NCT01270802|Antiviral Agents|antiviral agents|mesh-ancestor
111367287|NCT01270802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111367288|NCT01270802|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111367289|NCT01270802|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110506866|NCT00961571|Sunitinib|sunitinib|mesh-list
111367290|NCT01270802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111367291|NCT01270802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111367292|NCT01270802|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111367293|NCT01270802|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111367294|NCT01270802|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111367295|NCT01270802|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111367296|NCT01270802|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111367297|NCT01270802|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111367298|NCT01270802|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111367299|NCT01270802|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111367300|NCT01270802|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111367301|NCT01270802|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111367302|NCT01273454|Hydromorphone|hydromorphone|mesh-list
111367303|NCT01273454|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111367304|NCT01273454|Narcotics|narcotics|mesh-ancestor
111367305|NCT01273454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111367306|NCT01273454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111367307|NCT01273454|Analgesics|analgesics|mesh-ancestor
111367308|NCT01273454|Sensory System Agents|sensory system agents|mesh-ancestor
111367309|NCT01273454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111367310|NCT01270256|Budesonide|budesonide|mesh-list
111367311|NCT01270256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111367312|NCT01270256|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111367313|NCT01270256|Autonomic Agents|autonomic agents|mesh-ancestor
111367314|NCT01270256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111367315|NCT01270256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111367316|NCT01270256|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111367317|NCT01270256|Respiratory System Agents|respiratory system agents|mesh-ancestor
111367318|NCT01270256|Glucocorticoids|glucocorticoids|mesh-ancestor
111367319|NCT01270256|Hormones|hormones|mesh-ancestor
111367320|NCT01270256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111367321|NCT01279694|Prednisone|prednisone|mesh-list
111367322|NCT01279694|Melphalan|melphalan|mesh-list
111367323|NCT01279694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111367324|NCT01279694|Glucocorticoids|glucocorticoids|mesh-ancestor
111367325|NCT01279694|Hormones|hormones|mesh-ancestor
111367326|NCT01279694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111367327|NCT01279694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111367328|NCT01279694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111367329|NCT01279694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111367330|NCT01279694|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111367331|NCT01279694|Alkylating Agents|alkylating agents|mesh-ancestor
111367332|NCT01279694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111367333|NCT01279694|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111367334|NCT01279694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111367335|NCT01279694|Immunologic Factors|immunologic factors|mesh-ancestor
111367336|NCT01273532|Tapentadol|tapentadol|mesh-list
111367337|NCT01273532|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111367338|NCT01273532|Narcotics|narcotics|mesh-ancestor
111367339|NCT01273532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111367340|NCT01273532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111367341|NCT01273532|Analgesics|analgesics|mesh-ancestor
111367342|NCT01273532|Sensory System Agents|sensory system agents|mesh-ancestor
111367343|NCT01273532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111367344|NCT01273532|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111367345|NCT01273532|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111367346|NCT01273532|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111367347|NCT01273532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111367348|NCT01273532|Adrenergic Agents|adrenergic agents|mesh-ancestor
111367349|NCT01273532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111367350|NCT00744380|Midazolam|midazolam|mesh-list
111367351|NCT00744380|Dexmedetomidine|dexmedetomidine|mesh-list
111367352|NCT00744380|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111367353|NCT00744380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111367354|NCT00744380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111367355|NCT00744380|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111367356|NCT00744380|Analgesics|analgesics|mesh-ancestor
111367357|NCT00744380|Sensory System Agents|sensory system agents|mesh-ancestor
111367358|NCT00744380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111367359|NCT00744380|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111367360|NCT00744380|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111367361|NCT00744380|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111367362|NCT00744380|Adrenergic Agents|adrenergic agents|mesh-ancestor
111367363|NCT00744380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111367364|NCT00744380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111367365|NCT00744380|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111367366|NCT00744380|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111367367|NCT00744380|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111367368|NCT00744380|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111367369|NCT00744380|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111367370|NCT00744380|Anesthetics, General|anesthetics, general|mesh-ancestor
111367371|NCT00744380|Anesthetics|anesthetics|mesh-ancestor
111367372|NCT00744380|GABA Modulators|gaba modulators|mesh-ancestor
111367373|NCT00744380|GABA Agents|gaba agents|mesh-ancestor
111367374|NCT00744692|Fludarabine|fludarabine|mesh-list
111367375|NCT00744692|Melphalan|melphalan|mesh-list
111367376|NCT00744692|Thiotepa|thiotepa|mesh-list
111367377|NCT00744692|Hydroxyurea|hydroxyurea|mesh-list
111367378|NCT00744692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111367379|NCT00744692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111367380|NCT00744692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111367381|NCT00744692|Immunologic Factors|immunologic factors|mesh-ancestor
111367382|NCT00744692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111367383|NCT00744692|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111367384|NCT00744692|Alkylating Agents|alkylating agents|mesh-ancestor
111367385|NCT00744692|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111367386|NCT00744692|Antisickling Agents|antisickling agents|mesh-ancestor
111367387|NCT00744692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111091807|NCT04429347|Anticonvulsants|anticonvulsants|mesh-ancestor
111367388|NCT00744692|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111367390|NCT00744848|Bupivacaine|bupivacaine|mesh-list
111367391|NCT00744848|Anesthetics, Local|anesthetics, local|mesh-ancestor
111367392|NCT00744848|Anesthetics|anesthetics|mesh-ancestor
111367393|NCT00744848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111367394|NCT00744848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111367395|NCT00744848|Sensory System Agents|sensory system agents|mesh-ancestor
111367396|NCT00744848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111367397|NCT00744848|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111367398|NCT00744848|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111367399|NCT00744848|Adrenergic Agents|adrenergic agents|mesh-ancestor
111367400|NCT00744848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111367401|NCT00744848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111367402|NCT00744848|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111367403|NCT00744848|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111367404|NCT00744848|Autonomic Agents|autonomic agents|mesh-ancestor
111367405|NCT00744848|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111367406|NCT00744848|Respiratory System Agents|respiratory system agents|mesh-ancestor
111367407|NCT00744848|Mydriatics|mydriatics|mesh-ancestor
111367408|NCT00744848|Sympathomimetics|sympathomimetics|mesh-ancestor
110506960|NCT04284215|Paclitaxel|paclitaxel|mesh-list
111367409|NCT00744848|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111367410|NCT03830606|Paclitaxel|paclitaxel|mesh-list
111367411|NCT03830606|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111367412|NCT03830606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111367413|NCT03830606|Tubulin Modulators|tubulin modulators|mesh-ancestor
111367414|NCT03830606|Antimitotic Agents|antimitotic agents|mesh-ancestor
111367415|NCT03830606|Mitosis Modulators|mitosis modulators|mesh-ancestor
111367416|NCT03830606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111367417|NCT01278134|Ritonavir|ritonavir|mesh-list
111367418|NCT01278134|Ribavirin|ribavirin|mesh-list
111367419|NCT01278134|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
111367420|NCT01278134|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111367421|NCT01278134|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111367422|NCT01278134|Protease Inhibitors|protease inhibitors|mesh-ancestor
111367423|NCT01278134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111367424|NCT01278134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111367425|NCT01278134|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111367426|NCT01278134|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111367427|NCT01278134|Antiviral Agents|antiviral agents|mesh-ancestor
111367428|NCT01278134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111367429|NCT01278134|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111367430|NCT01278134|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111367431|NCT01278134|Antimetabolites|antimetabolites|mesh-ancestor
111367432|NCT01273844|Bortezomib|bortezomib|mesh-list
111367433|NCT01273844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111367434|NCT01271348|Etoricoxib|etoricoxib|mesh-list
111367435|NCT01271348|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111367436|NCT01271348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111367437|NCT01271348|Analgesics|analgesics|mesh-ancestor
111367438|NCT01271348|Sensory System Agents|sensory system agents|mesh-ancestor
111367439|NCT01271348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111367440|NCT01271348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111367441|NCT01271348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111367442|NCT01271348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111367443|NCT01271348|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111367444|NCT01271348|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111367445|NCT01271348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111367446|NCT01271348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111367447|NCT04385264|Hydroxychloroquine|hydroxychloroquine|mesh-list
111367448|NCT04385264|Mannitol|mannitol|mesh-list
111367449|NCT04385264|Antimalarials|antimalarials|mesh-ancestor
111367450|NCT04385264|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111367451|NCT04385264|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111367452|NCT04385264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111367453|NCT04385264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111367454|NCT04385264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111367455|NCT04385264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111367456|NCT04385264|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
111367457|NCT04385264|Diuretics|diuretics|mesh-ancestor
111367458|NCT04385264|Natriuretic Agents|natriuretic agents|mesh-ancestor
111367459|NCT04385264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111367460|NCT00746954|Acetazolamide|acetazolamide|mesh-list
111367461|NCT00746954|Buspirone|buspirone|mesh-list
111367462|NCT00746954|Anticonvulsants|anticonvulsants|mesh-ancestor
111091880|NCT04980105|Protective Agents|protective agents|mesh-ancestor
111367463|NCT00746954|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
111367464|NCT00746954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111367465|NCT00746954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111367466|NCT00746954|Diuretics|diuretics|mesh-ancestor
111367467|NCT00746954|Natriuretic Agents|natriuretic agents|mesh-ancestor
111367468|NCT00746954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111367469|NCT00746954|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111367470|NCT00746954|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111367471|NCT00746954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111367472|NCT00746954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111367473|NCT00746954|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111367474|NCT00746954|Serotonin Agents|serotonin agents|mesh-ancestor
111367475|NCT00746954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111367476|NCT00752102|Calcitriol|calcitriol|mesh-list
111367477|NCT00752102|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110507036|NCT02818140|Ropivacaine|ropivacaine|mesh-list
111367478|NCT00752102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111367479|NCT00752102|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
111367480|NCT00752102|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111367481|NCT00752102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111367482|NCT00752102|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111367483|NCT00752102|Vitamins|vitamins|mesh-ancestor
111367484|NCT00752102|Micronutrients|micronutrients|mesh-ancestor
111367485|NCT00752102|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111367486|NCT00723632|Ribavirin|ribavirin|mesh-list
111367487|NCT00723632|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
111367488|NCT00723632|Antimetabolites|antimetabolites|mesh-ancestor
111367489|NCT00723632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111367490|NCT00723632|Antiviral Agents|antiviral agents|mesh-ancestor
111367491|NCT00723632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111367492|NCT01279616|Mycophenolic Acid|mycophenolic acid|mesh-list
111367493|NCT01279616|Cyclophosphamide|cyclophosphamide|mesh-list
111367494|NCT01279616|Busulfan|busulfan|mesh-list
111367495|NCT01279616|Rituximab|rituximab|mesh-list
111367496|NCT01279616|Fludarabine|fludarabine|mesh-list
111367497|NCT01279616|Fludarabine phosphate|fludarabine phosphate|mesh-list
111367498|NCT01279616|Tacrolimus|tacrolimus|mesh-list
111367499|NCT01279616|Thymoglobulin|thymoglobulin|mesh-list
111367500|NCT01279616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111367501|NCT01279616|Immunologic Factors|immunologic factors|mesh-ancestor
111367502|NCT01279616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111367503|NCT01279616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111367504|NCT01279616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111367505|NCT01279616|Alkylating Agents|alkylating agents|mesh-ancestor
111367506|NCT01279616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111367507|NCT01279616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111367508|NCT01279616|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111367509|NCT01279616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111367510|NCT01279616|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111367511|NCT01279616|Antimetabolites|antimetabolites|mesh-ancestor
111367512|NCT01279616|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111367513|NCT01279616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111367514|NCT01279616|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111367515|NCT01279616|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111367516|NCT01279616|Antitubercular Agents|antitubercular agents|mesh-ancestor
111367517|NCT01279616|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111367518|NCT01279616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111367519|NCT01275638|Prednisolone|prednisolone|mesh-list
111367520|NCT01275638|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111367521|NCT01275638|Methylprednisolone|methylprednisolone|mesh-list
111367522|NCT01275638|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111367523|NCT01275638|Prednisolone acetate|prednisolone acetate|mesh-list
111367524|NCT01275638|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111367525|NCT01275638|Prednisolone phosphate|prednisolone phosphate|mesh-list
111367526|NCT01275638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111367527|NCT01275638|Glucocorticoids|glucocorticoids|mesh-ancestor
111367528|NCT01275638|Hormones|hormones|mesh-ancestor
111367529|NCT01275638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111367530|NCT01275638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111367531|NCT01275638|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111367532|NCT01275638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111367533|NCT01275638|Antiemetics|antiemetics|mesh-ancestor
111367534|NCT01275638|Autonomic Agents|autonomic agents|mesh-ancestor
111367535|NCT01275638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111367536|NCT01275638|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111367537|NCT01275638|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111367538|NCT01275638|Protective Agents|protective agents|mesh-ancestor
111367539|NCT00724568|Dexamethasone|dexamethasone|mesh-list
111367540|NCT00724568|Lenalidomide|lenalidomide|mesh-list
111367541|NCT00724568|Bortezomib|bortezomib|mesh-list
111367542|NCT00724568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111367543|NCT00724568|Antiemetics|antiemetics|mesh-ancestor
111367544|NCT00724568|Autonomic Agents|autonomic agents|mesh-ancestor
111367545|NCT00724568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111367546|NCT00724568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111367547|NCT00724568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111367548|NCT00724568|Glucocorticoids|glucocorticoids|mesh-ancestor
111367549|NCT00724568|Hormones|hormones|mesh-ancestor
111367550|NCT00724568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111367551|NCT00724568|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111367552|NCT00724568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111367553|NCT00724568|Immunologic Factors|immunologic factors|mesh-ancestor
111367554|NCT00724568|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111367555|NCT00724568|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111367556|NCT00724568|Growth Substances|growth substances|mesh-ancestor
111367557|NCT00724568|Growth Inhibitors|growth inhibitors|mesh-ancestor
111367558|NCT01274000|Ramosetron|ramosetron|mesh-list
111367559|NCT01274000|Antiemetics|antiemetics|mesh-ancestor
111367560|NCT01274000|Autonomic Agents|autonomic agents|mesh-ancestor
111367561|NCT01274000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111367562|NCT01274000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111367563|NCT01274000|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111367564|NCT01274000|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111367565|NCT01274000|Serotonin Agents|serotonin agents|mesh-ancestor
111367566|NCT01274000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111367567|NCT01274000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111367568|NCT04272320|Bupivacaine|bupivacaine|mesh-list
111367569|NCT04272320|Anesthetics, Local|anesthetics, local|mesh-ancestor
111367570|NCT04272320|Anesthetics|anesthetics|mesh-ancestor
111367571|NCT04272320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111367572|NCT04272320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111367573|NCT04272320|Sensory System Agents|sensory system agents|mesh-ancestor
111367574|NCT04272320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111367575|NCT01277744|Cisplatin|cisplatin|mesh-list
111367576|NCT01277744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111367577|NCT01277822|Losartan|losartan|mesh-list
111367578|NCT01277822|Amlodipine|amlodipine|mesh-list
111367579|NCT01277822|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111367580|NCT01277822|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111367581|NCT01277822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111367582|NCT01277822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111367583|NCT01277822|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111367584|NCT01277822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111367585|NCT01277822|Vasodilator Agents|vasodilator agents|mesh-ancestor
111367586|NCT01277822|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111367587|NCT01277822|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111367588|NCT01277822|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111367589|NCT00249002|Paclitaxel|paclitaxel|mesh-list
111367590|NCT00249002|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111367591|NCT00249002|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111367592|NCT00249002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111367593|NCT00249002|Tubulin Modulators|tubulin modulators|mesh-ancestor
111367594|NCT00249002|Antimitotic Agents|antimitotic agents|mesh-ancestor
111367595|NCT00249002|Mitosis Modulators|mitosis modulators|mesh-ancestor
111367596|NCT00249002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111367597|NCT00748826|Infliximab|infliximab|mesh-list
111367598|NCT00748826|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111367599|NCT00748826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111367600|NCT00748826|Dermatologic Agents|dermatologic agents|mesh-ancestor
111367601|NCT00748826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111367602|NCT00748826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111367603|NCT00246740|Doxycycline|doxycycline|mesh-list
111367604|NCT00246740|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111367605|NCT00246740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111367606|NCT00246740|Antimalarials|antimalarials|mesh-ancestor
111367607|NCT00246740|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111367608|NCT00246740|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111367609|NCT01274624|Leucovorin|leucovorin|mesh-list
111367610|NCT01274624|Bevacizumab|bevacizumab|mesh-list
111367611|NCT01274624|Fluorouracil|fluorouracil|mesh-list
111367612|NCT01274624|Irinotecan|irinotecan|mesh-list
111367613|NCT01274624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111367614|NCT01274624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111367615|NCT01274624|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111367616|NCT01274624|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111367617|NCT01274624|Growth Substances|growth substances|mesh-ancestor
111367618|NCT01274624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111367619|NCT01274624|Growth Inhibitors|growth inhibitors|mesh-ancestor
111367620|NCT01274624|Antimetabolites|antimetabolites|mesh-ancestor
111367621|NCT01274624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111367622|NCT01274624|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111367623|NCT01274624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111367624|NCT01274624|Immunologic Factors|immunologic factors|mesh-ancestor
111367625|NCT01274624|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111367626|NCT01274624|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111367627|NCT01274624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111367628|NCT01274624|Antidotes|antidotes|mesh-ancestor
111367629|NCT01274624|Protective Agents|protective agents|mesh-ancestor
110507191|NCT04205136|Diuretics|diuretics|mesh-ancestor
111367630|NCT01274624|Vitamin B Complex|vitamin b complex|mesh-ancestor
111367631|NCT01274624|Vitamins|vitamins|mesh-ancestor
111367632|NCT01274624|Micronutrients|micronutrients|mesh-ancestor
111367633|NCT00761930|Listerine|listerine|mesh-list
111367634|NCT00761930|Triclosan|triclosan|mesh-list
111367635|NCT00761930|Fluorides|fluorides|mesh-list
111367636|NCT00761930|Sodium Fluoride|sodium fluoride|mesh-list
111367637|NCT00761930|Cariostatic Agents|cariostatic agents|mesh-ancestor
111367638|NCT00761930|Protective Agents|protective agents|mesh-ancestor
111367639|NCT00761930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111367640|NCT00761930|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111367641|NCT00761930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111367642|NCT00761930|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
111367643|NCT00761930|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111367644|NCT00761930|Antimetabolites|antimetabolites|mesh-ancestor
111367645|NCT00761930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111367646|NCT00761930|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111367647|NCT00245102|Sorafenib|sorafenib|mesh-list
111367648|NCT00245102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111367649|NCT00245102|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111367650|NCT00245102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111367651|NCT00245102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111367652|NCT01275014|Dexamethasone|dexamethasone|mesh-list
111367653|NCT01275014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111367654|NCT01275014|Antiemetics|antiemetics|mesh-ancestor
111367655|NCT01275014|Autonomic Agents|autonomic agents|mesh-ancestor
111367656|NCT01275014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111367657|NCT01275014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111367658|NCT01275014|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111367659|NCT01275014|Glucocorticoids|glucocorticoids|mesh-ancestor
111367660|NCT01275014|Hormones|hormones|mesh-ancestor
111367661|NCT01275014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111367662|NCT01275014|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111367663|NCT01275014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111367664|NCT01275248|Ondansetron|ondansetron|mesh-list
111367665|NCT01275248|Antiemetics|antiemetics|mesh-ancestor
111367666|NCT01275248|Autonomic Agents|autonomic agents|mesh-ancestor
111367667|NCT01275248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111367668|NCT01275248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111367669|NCT01275248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111367670|NCT01275248|Antipruritics|antipruritics|mesh-ancestor
111367671|NCT01275248|Dermatologic Agents|dermatologic agents|mesh-ancestor
111367672|NCT01275248|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111367673|NCT01275248|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111367674|NCT01275248|Serotonin Agents|serotonin agents|mesh-ancestor
111367675|NCT01275248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111367676|NCT01275248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111367677|NCT00756236|Metoprolol|metoprolol|mesh-list
111367678|NCT00756236|Esmolol|esmolol|mesh-list
111367679|NCT00756236|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111367680|NCT00756236|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111367681|NCT00756236|Sympatholytics|sympatholytics|mesh-ancestor
111367682|NCT00756236|Autonomic Agents|autonomic agents|mesh-ancestor
111367683|NCT00756236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111367684|NCT00756236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111367685|NCT00756236|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
111367686|NCT00756236|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111367687|NCT00756236|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111367688|NCT00756236|Adrenergic Agents|adrenergic agents|mesh-ancestor
111092105|NCT03194815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111367689|NCT00756236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111367690|NCT00756236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111367692|NCT00762320|Lopinavir|lopinavir|mesh-list
111367693|NCT00762320|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111367694|NCT00762320|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111367695|NCT00762320|Protease Inhibitors|protease inhibitors|mesh-ancestor
111367696|NCT00762320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111367697|NCT00762320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111367698|NCT00762320|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111367699|NCT00762320|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111367700|NCT00762320|Antiviral Agents|antiviral agents|mesh-ancestor
111367701|NCT00762320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111367702|NCT00762320|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111367703|NCT00762320|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111367704|NCT00244712|Tenofovir|tenofovir|mesh-list
111367705|NCT00244712|Lamivudine|lamivudine|mesh-list
111367706|NCT00244712|Emtricitabine|emtricitabine|mesh-list
111367707|NCT00244712|Abacavir|abacavir|mesh-list
111367708|NCT00244712|Antiviral Agents|antiviral agents|mesh-ancestor
111367709|NCT00244712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111367710|NCT00244712|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111367711|NCT00244712|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111367712|NCT00244712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111367713|NCT00244712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111367714|NCT00244712|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111367715|NCT00244712|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111367716|NCT00725270|Mifepristone|mifepristone|mesh-list
111367717|NCT00725270|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
111367718|NCT00725270|Abortifacient Agents|abortifacient agents|mesh-ancestor
111367719|NCT00725270|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111367720|NCT00725270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111367721|NCT00725270|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111367722|NCT00725270|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111367723|NCT00725270|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111367724|NCT00725270|Contraceptive Agents|contraceptive agents|mesh-ancestor
111367725|NCT00725270|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
111367726|NCT00725270|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
111367727|NCT00725270|Hormone Antagonists|hormone antagonists|mesh-ancestor
111367728|NCT00725270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111367729|NCT00725270|Luteolytic Agents|luteolytic agents|mesh-ancestor
111367730|NCT00725270|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111367731|NCT00725270|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
111367732|NCT00243932|Ubiquinone|ubiquinone|mesh-list
111367733|NCT00243932|Coenzyme Q10|coenzyme q10|mesh-list
111367734|NCT00243932|Micronutrients|micronutrients|mesh-ancestor
111367735|NCT00243932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111367736|NCT00243932|Vitamins|vitamins|mesh-ancestor
111367737|NCT00243386|Factor VIII|factor viii|mesh-list
111367738|NCT00243386|Coagulants|coagulants|mesh-ancestor
111367739|NCT03807362|CC-11050|cc-11050|mesh-list
111367740|NCT03807362|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
111367741|NCT03807362|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111367742|NCT03807362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111367743|NCT03807362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111367744|NCT01275560|Metronidazole|metronidazole|mesh-list
111367745|NCT01275560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111367746|NCT01275560|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111367747|NCT01275560|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111367748|NCT01275560|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111367749|NCT00762710|Prazosin|prazosin|mesh-list
111367750|NCT00762710|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111367751|NCT00762710|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111367752|NCT00762710|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111367753|NCT00762710|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111367754|NCT00762710|Adrenergic Agents|adrenergic agents|mesh-ancestor
111367755|NCT00762710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111367756|NCT00762710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111367757|NCT00762710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111367758|NCT00756548|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
111367759|NCT00756548|Laxatives|laxatives|mesh-ancestor
111367760|NCT00756548|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111367761|NCT00243074|Cediranib|cediranib|mesh-list
111367762|NCT00243074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111367763|NCT00243074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111092180|NCT03286673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111367764|NCT00243074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111367765|NCT00243074|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111367766|NCT00241358|Plerixafor|plerixafor|mesh-list
111367767|NCT00241358|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111367768|NCT00241358|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111367769|NCT00241358|Antiviral Agents|antiviral agents|mesh-ancestor
111367770|NCT00241358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111367771|NCT00778310|Methylphenidate|methylphenidate|mesh-list
111367772|NCT00778310|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111367773|NCT00778310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111367774|NCT00778310|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111367775|NCT00778310|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111367776|NCT00778310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111367777|NCT00778310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111367778|NCT00778310|Dopamine Agents|dopamine agents|mesh-ancestor
111367779|NCT00778310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111367780|NCT03801278|Bemarituzumab|bemarituzumab|mesh-list
111367781|NCT03801278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111367782|NCT03801278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111367783|NCT01247285|Fluoxetine|fluoxetine|mesh-list
111367784|NCT01247285|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111367785|NCT01247285|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111367786|NCT01247285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111367787|NCT01247285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111367788|NCT01247285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111367789|NCT01247285|Serotonin Agents|serotonin agents|mesh-ancestor
111367790|NCT01247285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111367791|NCT01247285|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111367792|NCT01247285|Antidepressive Agents|antidepressive agents|mesh-ancestor
111367793|NCT01247285|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111367794|NCT01247285|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111367795|NCT01247285|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111367796|NCT01247285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111367797|NCT03806582|Norepinephrine|norepinephrine|mesh-list
111367798|NCT03806582|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111367799|NCT03806582|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111367800|NCT03806582|Adrenergic Agents|adrenergic agents|mesh-ancestor
111367801|NCT03806582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111367802|NCT03806582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111367803|NCT03806582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111367804|NCT03806582|Sympathomimetics|sympathomimetics|mesh-ancestor
111367805|NCT03806582|Autonomic Agents|autonomic agents|mesh-ancestor
110507348|NCT02812992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111367806|NCT03806582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111367807|NCT03806582|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111367808|NCT00779558|Heparin|heparin|mesh-list
111367809|NCT00779558|Calcium heparin|calcium heparin|mesh-list
111367810|NCT00779558|Anticoagulants|anticoagulants|mesh-ancestor
111367811|NCT00779558|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111367812|NCT00779558|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111367813|NCT00779558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111367814|NCT00758342|Travoprost|travoprost|mesh-list
111367815|NCT00758342|Brinzolamide|brinzolamide|mesh-list
111367816|NCT00758342|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111367817|NCT00758342|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
111367818|NCT00758342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111367819|NCT00758342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111367820|NCT01301183|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
111367821|NCT01301183|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
111367822|NCT01301183|Estradiol|estradiol|mesh-list
111367823|NCT01301183|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
111367824|NCT01301183|Mecasermin|mecasermin|mesh-list
111367825|NCT01301183|Estrogens|estrogens|mesh-ancestor
111367826|NCT01301183|Hormones|hormones|mesh-ancestor
111367827|NCT01301183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111367828|NCT01301183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111367829|NCT01301183|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111367830|NCT01301183|Contraceptive Agents|contraceptive agents|mesh-ancestor
111367831|NCT01301183|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111367832|NCT01301183|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111367833|NCT01301183|Growth Substances|growth substances|mesh-ancestor
111367834|NCT00758420|Polidocanol|polidocanol|mesh-list
111367835|NCT00758420|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
111367836|NCT00758420|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111367837|NCT01213043|Protease Inhibitors|protease inhibitors|mesh-list
111367838|NCT01213043|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
111367839|NCT01213043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111367840|NCT01213043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111367841|NCT01213043|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
111367842|NCT01213043|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111367843|NCT01213199|Adapalene|adapalene|mesh-list
111367844|NCT01213199|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111367845|NCT01213199|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111367846|NCT01213199|Analgesics|analgesics|mesh-ancestor
111367847|NCT01213199|Sensory System Agents|sensory system agents|mesh-ancestor
111367848|NCT01213199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111367849|NCT01213199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111367850|NCT01213199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111367851|NCT01213199|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111367852|NCT01213199|Dermatologic Agents|dermatologic agents|mesh-ancestor
111367853|NCT03809702|Pregabalin|pregabalin|mesh-list
111367854|NCT03809702|Analgesics|analgesics|mesh-ancestor
111367855|NCT03809702|Sensory System Agents|sensory system agents|mesh-ancestor
111367856|NCT03809702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111367857|NCT03809702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111367858|NCT03809702|Anticonvulsants|anticonvulsants|mesh-ancestor
111367859|NCT03809702|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111367860|NCT03809702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111367861|NCT03809702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111367862|NCT03809702|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111367863|NCT03809702|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111367864|NCT03809702|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111367865|NCT03809702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111367866|NCT03809702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111367867|NCT03806036|Vitamin D|vitamin d|mesh-list
111367868|NCT03806036|Clomiphene|clomiphene|mesh-list
111367869|NCT03806036|Enclomiphene|enclomiphene|mesh-list
111367870|NCT03806036|Zuclomiphene|zuclomiphene|mesh-list
111367871|NCT03806036|Vitamins|vitamins|mesh-ancestor
111367872|NCT03806036|Micronutrients|micronutrients|mesh-ancestor
110507405|NCT00621985|Hormones|hormones|mesh-ancestor
111367873|NCT03806036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111367874|NCT03806036|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111367875|NCT03806036|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111367876|NCT03806036|Hormone Antagonists|hormone antagonists|mesh-ancestor
111367877|NCT03806036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111367878|NCT03806036|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111367879|NCT03806036|Fertility Agents|fertility agents|mesh-ancestor
111367880|NCT03806036|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111367881|NCT03806036|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111367882|NCT03806036|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111367883|NCT00780026|Insulin|insulin|mesh-list
111367884|NCT00780026|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111367885|NCT00780026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111367886|NCT01214057|Remifentanil|remifentanil|mesh-list
111367887|NCT01214057|Propofol|propofol|mesh-list
111367888|NCT01214057|Sevoflurane|sevoflurane|mesh-list
111367889|NCT01214057|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111367890|NCT01214057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111367891|NCT01214057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111367892|NCT01214057|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111367893|NCT01214057|Anesthetics, General|anesthetics, general|mesh-ancestor
111367894|NCT01214057|Anesthetics|anesthetics|mesh-ancestor
111367895|NCT01214057|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111367896|NCT01214057|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111367897|NCT01214057|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111367898|NCT01214057|Narcotics|narcotics|mesh-ancestor
111367899|NCT01214057|Analgesics|analgesics|mesh-ancestor
111367900|NCT01214057|Sensory System Agents|sensory system agents|mesh-ancestor
111367901|NCT01214057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111367902|NCT03809546|Dronabinol|dronabinol|mesh-list
111367903|NCT03809546|Hallucinogens|hallucinogens|mesh-ancestor
111367904|NCT03809546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111367905|NCT03809546|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111367906|NCT03809546|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111367907|NCT03809546|Analgesics|analgesics|mesh-ancestor
111367908|NCT03809546|Sensory System Agents|sensory system agents|mesh-ancestor
111367909|NCT03809546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111367910|NCT03809546|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
111367911|NCT03809546|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
111367912|NCT03809546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111367913|NCT03809546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111367914|NCT03809546|Hormones|hormones|mesh-ancestor
111367915|NCT03809546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111367916|NCT03809312|Amoxicillin|amoxicillin|mesh-list
111367917|NCT03809312|Clavulanic Acids|clavulanic acids|mesh-list
111367918|NCT03809312|Clavulanic Acid|clavulanic acid|mesh-list
111367919|NCT03809312|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111367920|NCT03809312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111367921|NCT03809312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111367922|NCT03809312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111367923|NCT03809312|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
111367924|NCT01247363|Globalagliatin|globalagliatin|mesh-list
111367925|NCT01247363|Enzyme Activators|enzyme activators|mesh-ancestor
111367926|NCT01247363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111367927|NCT00780494|Bevacizumab|bevacizumab|mesh-list
111367928|NCT00780494|Carboplatin|carboplatin|mesh-list
111367929|NCT00780494|Capecitabine|capecitabine|mesh-list
111367930|NCT00780494|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111367931|NCT00780494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111367932|NCT00780494|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111367933|NCT00780494|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111367934|NCT00780494|Growth Substances|growth substances|mesh-ancestor
111367935|NCT00780494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111367936|NCT00780494|Growth Inhibitors|growth inhibitors|mesh-ancestor
111367937|NCT00780494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111367938|NCT00780494|Antimetabolites|antimetabolites|mesh-ancestor
111367939|NCT00780494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111367940|NCT00763412|Repaglinide|repaglinide|mesh-list
111367941|NCT00763412|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111367942|NCT00763412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111367943|NCT01302743|Metformin|metformin|mesh-list
111367944|NCT01302743|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111367945|NCT01302743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111367946|NCT00763490|Mycophenolic Acid|mycophenolic acid|mesh-list
111367947|NCT00763490|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111367948|NCT00763490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111367949|NCT00763490|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111367950|NCT00763490|Antitubercular Agents|antitubercular agents|mesh-ancestor
111367951|NCT00763490|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111367952|NCT00763490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111367953|NCT00763490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111367954|NCT00763490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111367955|NCT01214759|Tenofovir|tenofovir|mesh-list
111367956|NCT01214759|Emtricitabine|emtricitabine|mesh-list
111367957|NCT01214759|Raltegravir Potassium|raltegravir potassium|mesh-list
111367958|NCT01214759|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
111367959|NCT01214759|Antiviral Agents|antiviral agents|mesh-ancestor
111367960|NCT01214759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111367961|NCT01214759|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111367962|NCT01214759|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111367963|NCT01214759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111367964|NCT01214759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111367965|NCT01214759|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111367966|NCT01214759|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111367967|NCT01214759|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111367968|NCT01214759|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111367969|NCT00780962|Acetylcysteine|acetylcysteine|mesh-list
111367970|NCT00780962|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111367971|NCT00780962|Antiviral Agents|antiviral agents|mesh-ancestor
111367972|NCT00780962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111367973|NCT00780962|Expectorants|expectorants|mesh-ancestor
111367974|NCT00780962|Respiratory System Agents|respiratory system agents|mesh-ancestor
111367975|NCT00780962|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111367976|NCT00780962|Antioxidants|antioxidants|mesh-ancestor
111367977|NCT00780962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111367978|NCT00780962|Protective Agents|protective agents|mesh-ancestor
111367979|NCT00780962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111367980|NCT00780962|Antidotes|antidotes|mesh-ancestor
111367981|NCT00764738|Ranibizumab|ranibizumab|mesh-list
111367982|NCT00764738|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111367983|NCT00764738|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111367984|NCT00764738|Growth Substances|growth substances|mesh-ancestor
111367985|NCT00764738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111367986|NCT00764738|Growth Inhibitors|growth inhibitors|mesh-ancestor
111367987|NCT00764738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110959208|NCT02582632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111367988|NCT00781508|Sildenafil Citrate|sildenafil citrate|mesh-list
111367989|NCT00781508|Vasodilator Agents|vasodilator agents|mesh-ancestor
111367990|NCT00781508|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111367991|NCT00781508|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111367992|NCT00781508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111367993|NCT00781508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111367994|NCT00781508|Urological Agents|urological agents|mesh-ancestor
111367995|NCT03805568|Dexmedetomidine|dexmedetomidine|mesh-list
111367996|NCT03805568|Remifentanil|remifentanil|mesh-list
111367997|NCT03805568|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111367998|NCT03805568|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111367999|NCT03805568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111368000|NCT03805568|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111368001|NCT03805568|Analgesics|analgesics|mesh-ancestor
111368002|NCT03805568|Sensory System Agents|sensory system agents|mesh-ancestor
111368003|NCT03805568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111368004|NCT03805568|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111368005|NCT03805568|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111368006|NCT03805568|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111368007|NCT03805568|Adrenergic Agents|adrenergic agents|mesh-ancestor
111368008|NCT03805568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111368009|NCT03805568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111368010|NCT03805568|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111368011|NCT03805568|Narcotics|narcotics|mesh-ancestor
111368013|NCT00781898|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111368014|NCT00781898|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111368015|NCT00781898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111368016|NCT00781898|Sensory System Agents|sensory system agents|mesh-ancestor
111368017|NCT00781898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111368018|NCT00765128|Ketorolac|ketorolac|mesh-list
111368019|NCT00765128|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111368020|NCT00765128|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111368021|NCT00765128|Analgesics|analgesics|mesh-ancestor
111368022|NCT00765128|Sensory System Agents|sensory system agents|mesh-ancestor
111368023|NCT00765128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111368024|NCT00765128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111368025|NCT00765128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111368026|NCT00765128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111368027|NCT00765128|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111368028|NCT00765128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111368029|NCT00765128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111368030|NCT00765206|Omeprazole|omeprazole|mesh-list
111368031|NCT00765206|Omeprazole, sodium bicarbonate drug combination|omeprazole, sodium bicarbonate drug combination|mesh-list
111368032|NCT00765206|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111368033|NCT00765206|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111368034|NCT00765206|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111368035|NCT00765206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111368036|NCT00765206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111368037|NCT03809156|Ambrisentan|ambrisentan|mesh-list
111368038|NCT03809156|Riociguat|riociguat|mesh-list
111368039|NCT03809156|Enzyme Activators|enzyme activators|mesh-ancestor
111368040|NCT03809156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111368041|NCT03809156|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111368042|NCT03808844|Propofol|propofol|mesh-list
111368043|NCT03808844|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111368044|NCT03808844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111368045|NCT03808844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111368046|NCT03808844|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111368047|NCT03808844|Anesthetics, General|anesthetics, general|mesh-ancestor
111368048|NCT03808844|Anesthetics|anesthetics|mesh-ancestor
111368049|NCT03809078|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
111368050|NCT03809078|Bombesin|bombesin|mesh-list
111368051|NCT03809078|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111368052|NCT03809078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111368053|NCT03809078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111368054|NCT03809078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111368055|NCT05316428|Ethanol|ethanol|mesh-list
111368056|NCT05316428|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111368057|NCT05316428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111368058|NCT05316428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111368059|NCT05316428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111368060|NCT03805178|Abatacept|abatacept|mesh-list
111368061|NCT03805178|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111368062|NCT03805178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111368063|NCT03805178|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111368064|NCT03805178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111368065|NCT03805178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111368066|NCT03805178|Immunologic Factors|immunologic factors|mesh-ancestor
111368067|NCT03805178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111368068|NCT03805178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111368070|NCT01303835|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111368071|NCT01303835|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111368072|NCT01303835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111368073|NCT01303835|Sensory System Agents|sensory system agents|mesh-ancestor
111368074|NCT01303835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111368075|NCT01250717|Dexamethasone|dexamethasone|mesh-list
111368076|NCT01250717|Goserelin|goserelin|mesh-list
111368077|NCT01250717|Estramustine|estramustine|mesh-list
111368078|NCT01250717|Docetaxel|docetaxel|mesh-list
111368079|NCT01250717|Bicalutamide|bicalutamide|mesh-list
111368080|NCT01250717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111368081|NCT01250717|Antiemetics|antiemetics|mesh-ancestor
111368082|NCT01250717|Autonomic Agents|autonomic agents|mesh-ancestor
111368083|NCT01250717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111368084|NCT01250717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111368085|NCT01250717|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111368086|NCT01250717|Glucocorticoids|glucocorticoids|mesh-ancestor
111368087|NCT01250717|Hormones|hormones|mesh-ancestor
111368088|NCT01250717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111368089|NCT01250717|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111368090|NCT01250717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111368091|NCT01250717|Tubulin Modulators|tubulin modulators|mesh-ancestor
111368092|NCT01250717|Antimitotic Agents|antimitotic agents|mesh-ancestor
111368093|NCT01250717|Mitosis Modulators|mitosis modulators|mesh-ancestor
111368094|NCT01250717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111368095|NCT01250717|Androgen Antagonists|androgen antagonists|mesh-ancestor
111368096|NCT01250717|Hormone Antagonists|hormone antagonists|mesh-ancestor
111368097|NCT01250717|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111368098|NCT01250717|Alkylating Agents|alkylating agents|mesh-ancestor
111368099|NCT03804866|Doxorubicin|doxorubicin|mesh-list
111368100|NCT03804866|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111368101|NCT03804866|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111368102|NCT03804866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111368103|NCT03804866|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111368104|NCT03804866|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111368105|NCT03804866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111368106|NCT03804866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111368107|NCT01251575|Cyclosporine|cyclosporine|mesh-list
111368108|NCT01251575|Sirolimus|sirolimus|mesh-list
111368109|NCT01251575|Mycophenolic Acid|mycophenolic acid|mesh-list
111368110|NCT01251575|Fludarabine|fludarabine|mesh-list
111368111|NCT01251575|Fludarabine phosphate|fludarabine phosphate|mesh-list
111368112|NCT01251575|Cyclosporins|cyclosporins|mesh-list
111368113|NCT01251575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111368114|NCT01251575|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111368115|NCT01251575|Antimetabolites|antimetabolites|mesh-ancestor
111368116|NCT01251575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111368117|NCT01251575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111368118|NCT01251575|Immunologic Factors|immunologic factors|mesh-ancestor
111368119|NCT01251575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111368120|NCT01251575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111368121|NCT01251575|Antifungal Agents|antifungal agents|mesh-ancestor
111368122|NCT01251575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111368123|NCT01251575|Dermatologic Agents|dermatologic agents|mesh-ancestor
111368124|NCT01251575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111368125|NCT01251575|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111368126|NCT01251575|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111368127|NCT01251575|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111368128|NCT01251575|Antitubercular Agents|antitubercular agents|mesh-ancestor
111368129|NCT01251575|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111368130|NCT00782756|Bevacizumab|bevacizumab|mesh-list
111368131|NCT00782756|Temozolomide|temozolomide|mesh-list
111368132|NCT00782756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111092551|NCT03272711|Serotonin Agents|serotonin agents|mesh-ancestor
111368133|NCT00782756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111368134|NCT00782756|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111368135|NCT00782756|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111368136|NCT00782756|Growth Substances|growth substances|mesh-ancestor
111368137|NCT00782756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111368138|NCT00782756|Growth Inhibitors|growth inhibitors|mesh-ancestor
111368139|NCT00782756|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111368140|NCT00782756|Alkylating Agents|alkylating agents|mesh-ancestor
111368141|NCT00782756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111368143|NCT03808142|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111368144|NCT03808142|Immunologic Factors|immunologic factors|mesh-ancestor
111368145|NCT03808142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111368146|NCT01306175|Empagliflozin|empagliflozin|mesh-list
111368147|NCT01306175|Digoxin|digoxin|mesh-list
111368148|NCT01306175|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111368149|NCT01306175|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111368150|NCT01306175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111368151|NCT01306175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111368152|NCT01306175|Protective Agents|protective agents|mesh-ancestor
111368153|NCT01306175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111368154|NCT01306175|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111368155|NCT01306175|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111368156|NCT01215929|Dextroamphetamine|dextroamphetamine|mesh-list
111368157|NCT01215929|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111368158|NCT01215929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111368159|NCT01215929|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111368160|NCT01215929|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110507718|NCT00961961|Fluoxetine|fluoxetine|mesh-list
111368161|NCT01215929|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111368162|NCT01215929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111368163|NCT01215929|Dopamine Agents|dopamine agents|mesh-ancestor
111368164|NCT01215929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111368165|NCT00767624|Antidepressive Agents|antidepressive agents|mesh-list
111368166|NCT00767624|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111368167|NCT01216241|Daptomycin|daptomycin|mesh-list
111368168|NCT01216241|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111368169|NCT01216241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111368170|NCT01216397|Metformin|metformin|mesh-list
111368171|NCT01216397|Linagliptin|linagliptin|mesh-list
111368172|NCT01216397|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111368173|NCT01216397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111368174|NCT01216397|Incretins|incretins|mesh-ancestor
111368175|NCT01216397|Hormones|hormones|mesh-ancestor
111368176|NCT01216397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111368177|NCT01216397|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111368178|NCT01216397|Protease Inhibitors|protease inhibitors|mesh-ancestor
111368179|NCT01216397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111368180|NCT01216397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111368181|NCT04345406|Chloroquine|chloroquine|mesh-list
111368182|NCT04345406|Enalapril|enalapril|mesh-list
111368183|NCT04345406|Captopril|captopril|mesh-list
111368184|NCT04345406|Amebicides|amebicides|mesh-ancestor
111368185|NCT04345406|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111368186|NCT04345406|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111368187|NCT04345406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111368188|NCT04345406|Antimalarials|antimalarials|mesh-ancestor
111368189|NCT04345406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111368190|NCT04345406|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
111368191|NCT04345406|Protease Inhibitors|protease inhibitors|mesh-ancestor
111368192|NCT04345406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111368193|NCT04345406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111368194|NCT04345406|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111368195|NCT05621174|Dextroamphetamine|dextroamphetamine|mesh-list
111368196|NCT05621174|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111368197|NCT05621174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111368198|NCT05621174|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111368199|NCT05621174|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111368200|NCT05621174|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111368201|NCT05621174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111368202|NCT05621174|Dopamine Agents|dopamine agents|mesh-ancestor
111368203|NCT05621174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111368204|NCT01216943|Timolol|timolol|mesh-list
111368205|NCT01216943|Brimonidine Tartrate|brimonidine tartrate|mesh-list
111368206|NCT01216943|Bimatoprost|bimatoprost|mesh-list
111368207|NCT01216943|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111368208|NCT01216943|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111368209|NCT01216943|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110959209|NCT02582632|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111368210|NCT01216943|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111368211|NCT01216943|Adrenergic Agents|adrenergic agents|mesh-ancestor
111368212|NCT01216943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111368213|NCT01216943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111368214|NCT01216943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111368215|NCT01216943|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111368216|NCT01216943|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111368217|NCT01216943|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110507762|NCT03296033|Enoxaparin|enoxaparin|mesh-list
111368218|NCT01216943|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111368219|NCT01216943|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111368220|NCT00783614|Aspirin|aspirin|mesh-list
111368221|NCT00783614|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
111368222|NCT00783614|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111368223|NCT00783614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111368224|NCT00783614|Analgesics|analgesics|mesh-ancestor
111368225|NCT00783614|Sensory System Agents|sensory system agents|mesh-ancestor
111368226|NCT00783614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111368227|NCT00783614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111368228|NCT00783614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111368229|NCT00783614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111368230|NCT00783614|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111368231|NCT00783614|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111368232|NCT00783614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111368233|NCT00783614|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111368234|NCT00783614|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111368235|NCT00783614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111368236|NCT00783614|Antipyretics|antipyretics|mesh-ancestor
111368237|NCT00783614|Antiviral Agents|antiviral agents|mesh-ancestor
111368238|NCT00783614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111368239|NCT01252745|Methyltestosterone|methyltestosterone|mesh-list
111368240|NCT01252745|Testosterone|testosterone|mesh-list
111368241|NCT01252745|Testosterone undecanoate|testosterone undecanoate|mesh-list
111368242|NCT01252745|Testosterone enanthate|testosterone enanthate|mesh-list
111368243|NCT01252745|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
111368244|NCT01252745|Androgens|androgens|mesh-ancestor
111368245|NCT01252745|Hormones|hormones|mesh-ancestor
111368246|NCT01252745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111368247|NCT01252745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111368248|NCT01252745|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111368249|NCT01252745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111368250|NCT01252745|Anabolic Agents|anabolic agents|mesh-ancestor
111368251|NCT04278872|SJX-653|sjx-653|mesh-list
111368252|NCT04278872|Hormone Antagonists|hormone antagonists|mesh-ancestor
111368253|NCT04278872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111368254|NCT04278872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111368255|NCT03807596|Hyaluronic Acid|hyaluronic acid|mesh-list
111368256|NCT03807596|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111368257|NCT03807596|Immunologic Factors|immunologic factors|mesh-ancestor
111368258|NCT03807596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111368259|NCT03807596|Viscosupplements|viscosupplements|mesh-ancestor
111368260|NCT03807596|Protective Agents|protective agents|mesh-ancestor
111368261|NCT01217411|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
111368262|NCT01217411|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
111368263|NCT01217411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111368264|NCT01217411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111368265|NCT01253525|Paclitaxel|paclitaxel|mesh-list
111368266|NCT01253525|Ramucirumab|ramucirumab|mesh-list
111368267|NCT01253525|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111368268|NCT01253525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111368269|NCT01253525|Tubulin Modulators|tubulin modulators|mesh-ancestor
111368270|NCT01253525|Antimitotic Agents|antimitotic agents|mesh-ancestor
111368271|NCT01253525|Mitosis Modulators|mitosis modulators|mesh-ancestor
111368272|NCT01253525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111368273|NCT05310968|Aspirin|aspirin|mesh-list
111368274|NCT05310968|Tirofiban|tirofiban|mesh-list
111368275|NCT05310968|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111368276|NCT05310968|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111368277|NCT05310968|Analgesics|analgesics|mesh-ancestor
111368278|NCT05310968|Sensory System Agents|sensory system agents|mesh-ancestor
111368279|NCT05310968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111368280|NCT05310968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111368281|NCT05310968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111092703|NCT03263741|Paclitaxel|paclitaxel|mesh-list
111368282|NCT05310968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111368283|NCT05310968|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111368284|NCT05310968|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111368285|NCT05310968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111368286|NCT05310968|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111368287|NCT05310968|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111368288|NCT05310968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111368289|NCT05310968|Antipyretics|antipyretics|mesh-ancestor
111368290|NCT00768716|Acetaminophen|acetaminophen|mesh-list
111368291|NCT00768716|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111368292|NCT00768716|Analgesics|analgesics|mesh-ancestor
111368293|NCT00768716|Sensory System Agents|sensory system agents|mesh-ancestor
111368294|NCT00768716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111368295|NCT00768716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111368296|NCT00768716|Antipyretics|antipyretics|mesh-ancestor
111368297|NCT05743634|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111368298|NCT05743634|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111368299|NCT05743634|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111368300|NCT05743634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111368301|NCT05743634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111368302|NCT05743634|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111368303|NCT05743634|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111368304|NCT05743634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111368305|NCT05743634|Cholinergic Agents|cholinergic agents|mesh-ancestor
111368306|NCT05743634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111368307|NCT05583188|Paclitaxel|paclitaxel|mesh-list
111368308|NCT05583188|Vinorelbine|vinorelbine|mesh-list
111368309|NCT05583188|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111368310|NCT05583188|Gemcitabine|gemcitabine|mesh-list
111368311|NCT05583188|Nivolumab|nivolumab|mesh-list
111368312|NCT05583188|Pemetrexed|pemetrexed|mesh-list
111368313|NCT05583188|Carboplatin|carboplatin|mesh-list
111368314|NCT05583188|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111368315|NCT05583188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111368316|NCT05583188|Tubulin Modulators|tubulin modulators|mesh-ancestor
111368317|NCT05583188|Antimitotic Agents|antimitotic agents|mesh-ancestor
111368318|NCT05583188|Mitosis Modulators|mitosis modulators|mesh-ancestor
111368319|NCT05583188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110507882|NCT02804490|Beta Carotene|beta carotene|mesh-list
111368320|NCT05583188|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111368321|NCT05583188|Antimetabolites|antimetabolites|mesh-ancestor
111368322|NCT05583188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111368323|NCT05583188|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111368324|NCT05583188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111368325|NCT05583188|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111368326|NCT05583188|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111368327|NCT01218971|Naltrexone|naltrexone|mesh-list
111368328|NCT01218971|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111368329|NCT01218971|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111368330|NCT01218971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111368331|NCT01218971|Sensory System Agents|sensory system agents|mesh-ancestor
111368332|NCT01218971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111368333|NCT01337687|Oxytocin|oxytocin|mesh-list
111368334|NCT01337687|Oxytocics|oxytocics|mesh-ancestor
111368335|NCT01337687|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111368336|NCT01337687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111368337|NCT04351919|Azithromycin|azithromycin|mesh-list
111368338|NCT04351919|Hydroxychloroquine|hydroxychloroquine|mesh-list
111368339|NCT04351919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111368340|NCT04351919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111368341|NCT04351919|Antimalarials|antimalarials|mesh-ancestor
111368342|NCT04351919|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111368343|NCT04351919|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111368344|NCT04351919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111368345|NCT04351919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111368346|NCT04351919|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111368347|NCT00769886|Ketotifen|ketotifen|mesh-list
111368348|NCT00769886|Naphazoline|naphazoline|mesh-list
111368349|NCT00769886|Antipruritics|antipruritics|mesh-ancestor
111368350|NCT00769886|Dermatologic Agents|dermatologic agents|mesh-ancestor
111368351|NCT00769886|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111368352|NCT00769886|Histamine Antagonists|histamine antagonists|mesh-ancestor
111368353|NCT00769886|Histamine Agents|histamine agents|mesh-ancestor
111368354|NCT00769886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111092770|NCT03262961|Sildenafil Citrate|sildenafil citrate|mesh-list
111368355|NCT00769886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111368356|NCT00769886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111368357|NCT00769886|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111368358|NCT00769886|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111368359|NCT00769886|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111368360|NCT00769886|Adrenergic Agents|adrenergic agents|mesh-ancestor
111368361|NCT00769886|Nasal Decongestants|nasal decongestants|mesh-ancestor
111368362|NCT00769886|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111368363|NCT00769886|Respiratory System Agents|respiratory system agents|mesh-ancestor
111368364|NCT00794144|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
111368365|NCT00794144|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111368366|NCT00794144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111368367|NCT00794144|Analgesics|analgesics|mesh-ancestor
111368368|NCT00794144|Sensory System Agents|sensory system agents|mesh-ancestor
111368369|NCT00794144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111368370|NCT00794144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111368371|NCT00794144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111368372|NCT00794144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111368373|NCT00794144|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111368374|NCT00794144|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110507933|NCT00815295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111368375|NCT00794144|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111368376|NCT00794144|Histamine Antagonists|histamine antagonists|mesh-ancestor
111368377|NCT00794144|Histamine Agents|histamine agents|mesh-ancestor
111368378|NCT00794144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111368379|NCT00794144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111368380|NCT01309451|Dexamethasone|dexamethasone|mesh-list
111368381|NCT01309451|Bevacizumab|bevacizumab|mesh-list
111368382|NCT01309451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111368383|NCT01309451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111368384|NCT01309451|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111368385|NCT01309451|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111368386|NCT01309451|Growth Substances|growth substances|mesh-ancestor
111368387|NCT01309451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111368388|NCT01309451|Growth Inhibitors|growth inhibitors|mesh-ancestor
111368389|NCT01309451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111368390|NCT01309451|Antiemetics|antiemetics|mesh-ancestor
111368391|NCT01309451|Autonomic Agents|autonomic agents|mesh-ancestor
111368392|NCT01309451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111368393|NCT01309451|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111368394|NCT01309451|Glucocorticoids|glucocorticoids|mesh-ancestor
111368395|NCT01309451|Hormones|hormones|mesh-ancestor
111368396|NCT01309451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111368397|NCT01309451|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111368398|NCT00771056|Hydroxychloroquine|hydroxychloroquine|mesh-list
111368399|NCT00771056|Antimalarials|antimalarials|mesh-ancestor
111368400|NCT00771056|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111368401|NCT00771056|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111368402|NCT00771056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111368403|NCT00771056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111368404|NCT00771056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111368405|NCT00771056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111368406|NCT00795002|Cytarabine|cytarabine|mesh-list
111368407|NCT00795002|Mitoxantrone|mitoxantrone|mesh-list
111368408|NCT00795002|Alvocidib|alvocidib|mesh-list
111368409|NCT00795002|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111368410|NCT00795002|Antimetabolites|antimetabolites|mesh-ancestor
111368411|NCT00795002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111368412|NCT00795002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111368413|NCT00795002|Antiviral Agents|antiviral agents|mesh-ancestor
111368414|NCT00795002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111368415|NCT00795002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111368416|NCT00795002|Immunologic Factors|immunologic factors|mesh-ancestor
111368417|NCT00795002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111368418|NCT00795002|Analgesics|analgesics|mesh-ancestor
111368419|NCT00795002|Sensory System Agents|sensory system agents|mesh-ancestor
111368420|NCT00795002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111368421|NCT00795002|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111368422|NCT00795002|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111368423|NCT00795002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111368424|NCT00795002|Growth Inhibitors|growth inhibitors|mesh-ancestor
111368425|NCT00795002|Growth Substances|growth substances|mesh-ancestor
111368426|NCT00795002|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111368427|NCT05742698|Nabilone|nabilone|mesh-list
111368428|NCT05742698|Antiemetics|antiemetics|mesh-ancestor
111368429|NCT05742698|Autonomic Agents|autonomic agents|mesh-ancestor
111368430|NCT05742698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111368431|NCT05742698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111368432|NCT05742698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111368433|NCT05742698|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111368434|NCT05742698|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111368435|NCT05742698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111368436|NCT05742698|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111368437|NCT03802838|Amisulpride|amisulpride|mesh-list
111368438|NCT03802838|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111368439|NCT03802838|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111368440|NCT03802838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111368441|NCT03802838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111368442|NCT03802838|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111368443|NCT03802838|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111368444|NCT03802838|Dopamine Agents|dopamine agents|mesh-ancestor
111368445|NCT03802838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111368446|NCT03802838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111368447|NCT03802838|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111368448|NCT03802838|Antidepressive Agents|antidepressive agents|mesh-ancestor
111368449|NCT00772304|Azelastine|azelastine|mesh-list
111368450|NCT00772304|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
111368451|NCT00772304|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111368452|NCT00772304|Autonomic Agents|autonomic agents|mesh-ancestor
111368453|NCT00772304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111368454|NCT00772304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111368455|NCT00772304|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111368456|NCT00772304|Respiratory System Agents|respiratory system agents|mesh-ancestor
111368457|NCT00772304|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
111368458|NCT00772304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111368459|NCT00772304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111368460|NCT00772304|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111368461|NCT00772304|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
111368462|NCT00772304|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111368463|NCT00772304|Histamine Antagonists|histamine antagonists|mesh-ancestor
111368464|NCT00772304|Histamine Agents|histamine agents|mesh-ancestor
111368465|NCT00772304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111368466|NCT00772304|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111368467|NCT00772304|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111368468|NCT00772304|Analgesics|analgesics|mesh-ancestor
111368469|NCT00772304|Sensory System Agents|sensory system agents|mesh-ancestor
111368470|NCT00772304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111368471|NCT00772304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111368472|NCT01310231|Metformin|metformin|mesh-list
111368473|NCT01310231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111368474|NCT01310231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111368475|NCT00789074|Varenicline|varenicline|mesh-list
111368476|NCT00789074|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111368477|NCT00789074|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111368478|NCT00789074|Cholinergic Agents|cholinergic agents|mesh-ancestor
111368479|NCT00789074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111368480|NCT00789074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111368481|NCT00789074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111368482|NCT01338857|Sorafenib|sorafenib|mesh-list
111368483|NCT01338857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111368484|NCT01338857|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111368485|NCT01338857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111368486|NCT01338857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111368487|NCT01339013|Anesthetics|anesthetics|mesh-list
111368488|NCT01339013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111368489|NCT01339013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111368490|NCT01339091|Vancomycin|vancomycin|mesh-list
111368491|NCT01339091|Linezolid|linezolid|mesh-list
111368492|NCT01339091|Dalbavancin|dalbavancin|mesh-list
111368493|NCT01339091|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111368494|NCT01339091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111368495|NCT01339091|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111368496|NCT01339091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111368497|NCT01339091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111368498|NCT01339247|Halofantrine|halofantrine|mesh-list
111368499|NCT01339247|Paroxetine|paroxetine|mesh-list
111368500|NCT01339247|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111368501|NCT01339247|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111368502|NCT01339247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111368503|NCT01339247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111368504|NCT01339247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111368505|NCT01339247|Serotonin Agents|serotonin agents|mesh-ancestor
111368506|NCT01339247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111368507|NCT01339247|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111368508|NCT01339247|Antidepressive Agents|antidepressive agents|mesh-ancestor
111368509|NCT01339247|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111368510|NCT01339247|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111368511|NCT01339247|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111368512|NCT01339247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111368513|NCT01339247|Antimalarials|antimalarials|mesh-ancestor
111368514|NCT01339247|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111368515|NCT01339247|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111368516|NCT01339247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111368517|NCT00772772|Vitamin D|vitamin d|mesh-list
111368518|NCT00772772|Ergocalciferols|ergocalciferols|mesh-list
111368519|NCT00772772|Cholecalciferol|cholecalciferol|mesh-list
111368520|NCT00772772|Vitamins|vitamins|mesh-list
111368521|NCT00772772|Micronutrients|micronutrients|mesh-ancestor
111368522|NCT00772772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111368523|NCT00772772|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111368524|NCT00772772|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111368525|NCT00773474|Lonafarnib|lonafarnib|mesh-list
111368526|NCT00773474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111368527|NCT00773474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111368528|NCT01310855|Gefitinib|gefitinib|mesh-list
111368529|NCT01310855|Cediranib|cediranib|mesh-list
111368530|NCT01310855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111368531|NCT01310855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111368532|NCT01310855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111368533|NCT01310855|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111368534|NCT00773786|Formoterol Fumarate|formoterol fumarate|mesh-list
111368535|NCT00773786|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111368536|NCT00773786|Autonomic Agents|autonomic agents|mesh-ancestor
111368537|NCT00773786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111368538|NCT00773786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111368539|NCT00773786|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111368540|NCT00773786|Respiratory System Agents|respiratory system agents|mesh-ancestor
110508127|NCT05980000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111368541|NCT00773786|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111368542|NCT00773786|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111368543|NCT00773786|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111368544|NCT00773786|Adrenergic Agents|adrenergic agents|mesh-ancestor
111368545|NCT00773786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111368546|NCT00773786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111368547|NCT01258049|Artemether|artemether|mesh-list
111368548|NCT01258049|Quinine|quinine|mesh-list
111368549|NCT01258049|Antimalarials|antimalarials|mesh-ancestor
111368550|NCT01258049|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111368551|NCT01258049|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111368552|NCT01258049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111368553|NCT01258049|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
111368554|NCT01258049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111368555|NCT01258049|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111368556|NCT01258049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111368557|NCT01258049|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111368558|NCT01258049|Analgesics|analgesics|mesh-ancestor
111368559|NCT01258049|Sensory System Agents|sensory system agents|mesh-ancestor
111368560|NCT03802214|Vedolizumab|vedolizumab|mesh-list
111368561|NCT03802214|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111368562|NCT03801746|Cyclosporine|cyclosporine|mesh-list
111368563|NCT03801746|Rifampin|rifampin|mesh-list
111368564|NCT03801746|Probenecid|probenecid|mesh-list
111368565|NCT03801746|Cyclosporins|cyclosporins|mesh-list
111368566|NCT03801746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111368567|NCT03801746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111368568|NCT03801746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111368569|NCT03801746|Immunologic Factors|immunologic factors|mesh-ancestor
111368570|NCT03801746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111368571|NCT03801746|Antifungal Agents|antifungal agents|mesh-ancestor
111368572|NCT03801746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111368573|NCT03801746|Dermatologic Agents|dermatologic agents|mesh-ancestor
111368574|NCT03801746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111368575|NCT03801746|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111368576|NCT03801746|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111368577|NCT03801746|Antitubercular Agents|antitubercular agents|mesh-ancestor
111368578|NCT03801746|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111368579|NCT03801746|Leprostatic Agents|leprostatic agents|mesh-ancestor
111368580|NCT03801746|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111368581|NCT03801746|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111368582|NCT03801746|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111368583|NCT03801746|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
111368584|NCT03801746|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
111368585|NCT03801746|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
111368586|NCT03801746|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111368587|NCT03801746|Uricosuric Agents|uricosuric agents|mesh-ancestor
111368588|NCT03801746|Gout Suppressants|gout suppressants|mesh-ancestor
111368589|NCT03801668|Paclitaxel|paclitaxel|mesh-list
111368590|NCT03801668|Oxaliplatin|oxaliplatin|mesh-list
111368591|NCT03801668|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111368592|NCT03801668|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111368593|NCT03801668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111368594|NCT03801668|Tubulin Modulators|tubulin modulators|mesh-ancestor
111368595|NCT03801668|Antimitotic Agents|antimitotic agents|mesh-ancestor
111368596|NCT03801668|Mitosis Modulators|mitosis modulators|mesh-ancestor
111368597|NCT03801668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111368598|NCT05414006|Ketamine|ketamine|mesh-list
111368599|NCT05414006|Esketamine|esketamine|mesh-list
111368600|NCT05414006|Analgesics|analgesics|mesh-ancestor
111368601|NCT05414006|Sensory System Agents|sensory system agents|mesh-ancestor
111368602|NCT05414006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111368603|NCT05414006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111368604|NCT05414006|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111368605|NCT05414006|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111368606|NCT05414006|Anesthetics, General|anesthetics, general|mesh-ancestor
111368607|NCT05414006|Anesthetics|anesthetics|mesh-ancestor
111368608|NCT05414006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111368609|NCT05414006|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111368610|NCT05414006|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111368611|NCT05414006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111368612|NCT05414006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111368613|NCT05414006|Antidepressive Agents|antidepressive agents|mesh-ancestor
111368614|NCT05414006|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111368615|NCT02199041|Mycophenolic Acid|mycophenolic acid|mesh-list
111368616|NCT02199041|Methylprednisolone|methylprednisolone|mesh-list
111368617|NCT02199041|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111368618|NCT02199041|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111368619|NCT02199041|Prednisolone|prednisolone|mesh-list
111368620|NCT02199041|Prednisolone acetate|prednisolone acetate|mesh-list
111368621|NCT02199041|Cyclophosphamide|cyclophosphamide|mesh-list
111368622|NCT02199041|Melphalan|melphalan|mesh-list
111368623|NCT02199041|Mechlorethamine|mechlorethamine|mesh-list
111368624|NCT02199041|Thiotepa|thiotepa|mesh-list
111368625|NCT02199041|Fludarabine|fludarabine|mesh-list
111368626|NCT02199041|Tacrolimus|tacrolimus|mesh-list
111368627|NCT02199041|Lenograstim|lenograstim|mesh-list
111368628|NCT02199041|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111368629|NCT02199041|Prednisolone phosphate|prednisolone phosphate|mesh-list
111368630|NCT02199041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111368631|NCT02199041|Immunologic Factors|immunologic factors|mesh-ancestor
111368632|NCT02199041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111368633|NCT02199041|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111368634|NCT02199041|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111368635|NCT02199041|Alkylating Agents|alkylating agents|mesh-ancestor
111368636|NCT02199041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111368637|NCT02199041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111368638|NCT02199041|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111368639|NCT02199041|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111368640|NCT02199041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111368641|NCT02199041|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111368642|NCT02199041|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111368643|NCT02199041|Antitubercular Agents|antitubercular agents|mesh-ancestor
111368644|NCT02199041|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111368645|NCT02199041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111368646|NCT02199041|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111368647|NCT02199041|Antiemetics|antiemetics|mesh-ancestor
111368648|NCT02199041|Autonomic Agents|autonomic agents|mesh-ancestor
111368649|NCT02199041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111368650|NCT02199041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111368651|NCT02199041|Glucocorticoids|glucocorticoids|mesh-ancestor
111368652|NCT02199041|Hormones|hormones|mesh-ancestor
111368653|NCT02199041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111368654|NCT02199041|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111368655|NCT02199041|Protective Agents|protective agents|mesh-ancestor
111368656|NCT02199041|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111368657|NCT02199041|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111368658|NCT00789776|Mycophenolic Acid|mycophenolic acid|mesh-list
111368659|NCT00789776|Cyclophosphamide|cyclophosphamide|mesh-list
111368660|NCT00789776|Fludarabine|fludarabine|mesh-list
111368661|NCT00789776|Fludarabine phosphate|fludarabine phosphate|mesh-list
111368663|NCT00789776|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111368664|NCT00789776|Immunologic Factors|immunologic factors|mesh-ancestor
111368665|NCT00789776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111368666|NCT00789776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111368667|NCT00789776|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111368668|NCT00789776|Alkylating Agents|alkylating agents|mesh-ancestor
111368669|NCT00789776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111368670|NCT00789776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111368671|NCT00789776|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111368672|NCT00789776|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111368673|NCT00789776|Antimetabolites|antimetabolites|mesh-ancestor
111368674|NCT00789776|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111368675|NCT00789776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111368676|NCT00789776|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111368677|NCT00789776|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111368678|NCT00789776|Antitubercular Agents|antitubercular agents|mesh-ancestor
111368679|NCT00789776|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111368680|NCT00789776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111368681|NCT03801590|Riboflavin|riboflavin|mesh-list
111368682|NCT03801590|Vitamin B Complex|vitamin b complex|mesh-ancestor
111368683|NCT03801590|Vitamins|vitamins|mesh-ancestor
111368684|NCT03801590|Micronutrients|micronutrients|mesh-ancestor
111368685|NCT03801590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111368686|NCT03801590|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111368687|NCT03801590|Dermatologic Agents|dermatologic agents|mesh-ancestor
111368688|NCT00775658|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
111368689|NCT00775658|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111368690|NCT00775658|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111368691|NCT00775658|Analgesics|analgesics|mesh-ancestor
111368692|NCT00775658|Sensory System Agents|sensory system agents|mesh-ancestor
111368693|NCT00775658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111368694|NCT00775658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111368695|NCT00775658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111368696|NCT00775658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111368697|NCT00775658|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111368698|NCT00775658|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
111368699|NCT00775658|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111368700|NCT00775658|Histamine Antagonists|histamine antagonists|mesh-ancestor
111368701|NCT00775658|Histamine Agents|histamine agents|mesh-ancestor
111368702|NCT00775658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111368703|NCT00775658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111368704|NCT02199197|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
111368705|NCT02199197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111368706|NCT00799604|Clevidipine|clevidipine|mesh-list
111368707|NCT00799604|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111368708|NCT00799604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111368709|NCT00799604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111368710|NCT00799604|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111368711|NCT00799604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111368712|NCT01259063|Gemcitabine|gemcitabine|mesh-list
111368713|NCT01259063|Everolimus|everolimus|mesh-list
111368714|NCT01259063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111368715|NCT01259063|Antimetabolites|antimetabolites|mesh-ancestor
111368716|NCT01259063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111368717|NCT01259063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111368718|NCT01259063|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111368719|NCT01259063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111368720|NCT01259063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111368721|NCT01259063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111368722|NCT01259063|Immunologic Factors|immunologic factors|mesh-ancestor
111368723|NCT01259063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111368724|NCT04383548|Immunoglobulins|immunoglobulins|mesh-list
111368725|NCT04383548|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111368726|NCT04383548|Antibodies|antibodies|mesh-list
111368727|NCT04383548|Immunologic Factors|immunologic factors|mesh-ancestor
111368728|NCT04383548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111368729|NCT01313897|Bortezomib|bortezomib|mesh-list
111368730|NCT01313897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111368731|NCT01341977|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111368732|NCT04351763|Amiodarone|amiodarone|mesh-list
111368733|NCT04351763|Verapamil|verapamil|mesh-list
111368734|NCT04351763|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111368735|NCT04351763|Vasodilator Agents|vasodilator agents|mesh-ancestor
111368736|NCT04351763|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
111368737|NCT04351763|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111368738|NCT04351763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111368739|NCT04351763|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111368740|NCT04351763|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111368741|NCT04351763|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111368742|NCT04351763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111368743|NCT04351763|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111368744|NCT04351763|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111368745|NCT04351763|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111368746|NCT04351763|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111368747|NCT04351763|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111368748|NCT04351763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111368749|NCT00801398|Oxymorphone|oxymorphone|mesh-list
111368750|NCT00801398|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111368751|NCT00801398|Narcotics|narcotics|mesh-ancestor
111368752|NCT00801398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111368753|NCT00801398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111368754|NCT00801398|Analgesics|analgesics|mesh-ancestor
111368755|NCT00801398|Sensory System Agents|sensory system agents|mesh-ancestor
111368756|NCT00801398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111368757|NCT00801398|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111368759|NCT01342523|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111368760|NCT01342523|Autonomic Agents|autonomic agents|mesh-ancestor
111368761|NCT01342523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111368762|NCT01342523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111368763|NCT01342523|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111368764|NCT01342523|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111368765|NCT01342523|Cholinergic Agents|cholinergic agents|mesh-ancestor
111368766|NCT01342523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111368767|NCT01342523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111368768|NCT01342757|Temozolomide|temozolomide|mesh-list
111368769|NCT01342757|Vorinostat|vorinostat|mesh-list
111368770|NCT01342757|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111368771|NCT01342757|Alkylating Agents|alkylating agents|mesh-ancestor
111368772|NCT01342757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111368773|NCT01342757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111368774|NCT01342757|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111368775|NCT01342757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111368776|NCT02199743|Haloperidol|haloperidol|mesh-list
111368777|NCT02199743|Haloperidol decanoate|haloperidol decanoate|mesh-list
111368778|NCT02199743|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
111368779|NCT02199743|Perphenazine|perphenazine|mesh-list
111368780|NCT02199743|Antiemetics|antiemetics|mesh-ancestor
111368781|NCT02199743|Autonomic Agents|autonomic agents|mesh-ancestor
111368782|NCT02199743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111368783|NCT02199743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111368784|NCT02199743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111368785|NCT02199743|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111368786|NCT02199743|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111368787|NCT02199743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111368788|NCT02199743|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111368789|NCT02199743|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111368790|NCT02199743|Dopamine Agents|dopamine agents|mesh-ancestor
111368791|NCT02199743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111368792|NCT02199743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111368793|NCT02199743|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111368794|NCT02199743|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
111368795|NCT02199743|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111368796|NCT02199743|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111368797|NCT02199743|Adrenergic Agents|adrenergic agents|mesh-ancestor
111368798|NCT02199743|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111368799|NCT02199743|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111368800|NCT02199743|Serotonin Agents|serotonin agents|mesh-ancestor
111368801|NCT02199743|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111368802|NCT00776594|Bevacizumab|bevacizumab|mesh-list
111368803|NCT00776594|Bicalutamide|bicalutamide|mesh-list
111368804|NCT00776594|Androgens|androgens|mesh-list
111368805|NCT00776594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111368806|NCT00776594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111368807|NCT00776594|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111368808|NCT00776594|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111368810|NCT00776594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111368811|NCT00776594|Growth Inhibitors|growth inhibitors|mesh-ancestor
111368812|NCT00776594|Hormones|hormones|mesh-ancestor
111368813|NCT00776594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111368814|NCT00776594|Androgen Antagonists|androgen antagonists|mesh-ancestor
111368815|NCT00776594|Hormone Antagonists|hormone antagonists|mesh-ancestor
111368816|NCT00777062|Naltrexone|naltrexone|mesh-list
111368817|NCT00777062|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111368818|NCT00777062|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111368819|NCT00777062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111368820|NCT00777062|Sensory System Agents|sensory system agents|mesh-ancestor
111368821|NCT00777062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111368822|NCT02193347|Temozolomide|temozolomide|mesh-list
111368823|NCT02193347|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111368824|NCT02193347|Alkylating Agents|alkylating agents|mesh-ancestor
111368825|NCT02193347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111368826|NCT02193347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111368827|NCT01318577|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111368828|NCT01318967|Furosemide|furosemide|mesh-list
111368829|NCT01318967|Diuretics|diuretics|mesh-ancestor
111368830|NCT01318967|Natriuretic Agents|natriuretic agents|mesh-ancestor
111368831|NCT01318967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111368832|NCT01318967|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
111368833|NCT01318967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111368834|NCT01318967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111368835|NCT01319045|Iloprost|iloprost|mesh-list
111368836|NCT01319045|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111368837|NCT01319045|Vasodilator Agents|vasodilator agents|mesh-ancestor
111368838|NCT01348607|Methylphenidate|methylphenidate|mesh-list
111368839|NCT01348607|Modafinil|modafinil|mesh-list
111368840|NCT01348607|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111368841|NCT01348607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111368842|NCT01348607|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111368843|NCT01348607|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111368844|NCT01348607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111368845|NCT01348607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111368846|NCT01348607|Dopamine Agents|dopamine agents|mesh-ancestor
111368847|NCT01348607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111368848|NCT01348607|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
111368849|NCT01348607|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111368850|NCT01348607|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111368851|NCT01268111|Ergocalciferols|ergocalciferols|mesh-list
111368852|NCT01268111|Vitamin D|vitamin d|mesh-list
111368853|NCT01268111|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111368854|NCT01268111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111368855|NCT01268111|Vitamins|vitamins|mesh-ancestor
111368856|NCT01268111|Micronutrients|micronutrients|mesh-ancestor
111368857|NCT01268111|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111368858|NCT01349231|Ketamine|ketamine|mesh-list
111368859|NCT01349231|Analgesics|analgesics|mesh-ancestor
111368860|NCT01349231|Sensory System Agents|sensory system agents|mesh-ancestor
111368861|NCT01349231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111368862|NCT01349231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111368863|NCT01349231|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111368864|NCT01349231|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111368865|NCT01349231|Anesthetics, General|anesthetics, general|mesh-ancestor
111368866|NCT01349231|Anesthetics|anesthetics|mesh-ancestor
111368867|NCT01349231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111368868|NCT01349231|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111368869|NCT01349231|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111368870|NCT01349231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111368871|NCT01349231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111368872|NCT01350245|Mycophenolic Acid|mycophenolic acid|mesh-list
111368873|NCT01350245|Cyclophosphamide|cyclophosphamide|mesh-list
111368874|NCT01350245|Tacrolimus|tacrolimus|mesh-list
111368875|NCT01350245|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111368876|NCT01350245|Immunologic Factors|immunologic factors|mesh-ancestor
111368877|NCT01350245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111368878|NCT01350245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111368879|NCT01350245|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111368880|NCT01350245|Alkylating Agents|alkylating agents|mesh-ancestor
110959210|NCT02582632|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111368881|NCT01350245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111368882|NCT01350245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111368883|NCT01350245|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111368884|NCT01350245|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111368885|NCT01350245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111368886|NCT01350245|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111368887|NCT01350245|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111368888|NCT01350245|Antitubercular Agents|antitubercular agents|mesh-ancestor
111368889|NCT01350245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111368890|NCT01350245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111368891|NCT01321151|Resveratrol|resveratrol|mesh-list
111368892|NCT01321151|Antioxidants|antioxidants|mesh-ancestor
111368893|NCT01321151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111368894|NCT01321151|Protective Agents|protective agents|mesh-ancestor
111368895|NCT01321151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111368896|NCT01321151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111368897|NCT01321151|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111368898|NCT01350947|Azacitidine|azacitidine|mesh-list
111368899|NCT01350947|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111368900|NCT01350947|Antimetabolites|antimetabolites|mesh-ancestor
111368901|NCT01350947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111368902|NCT01350947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111368903|NCT01350947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111368904|NCT01269047|Exenatide|exenatide|mesh-list
111368905|NCT01269047|Pramlintide|pramlintide|mesh-list
111368906|NCT01269047|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111368907|NCT01269047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111368908|NCT01269047|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111368909|NCT01269047|Incretins|incretins|mesh-ancestor
111368910|NCT01269047|Hormones|hormones|mesh-ancestor
111368911|NCT01269047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111368912|NCT03800264|Hydrocortisone|hydrocortisone|mesh-list
111368913|NCT03800264|Bisoprolol|bisoprolol|mesh-list
111368914|NCT03800264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111368915|NCT03800264|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111368916|NCT03800264|Sympatholytics|sympatholytics|mesh-ancestor
111368917|NCT03800264|Autonomic Agents|autonomic agents|mesh-ancestor
111368918|NCT03800264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111368919|NCT03800264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111368920|NCT03800264|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
111368921|NCT03800264|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111368922|NCT03800264|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111368923|NCT03800264|Adrenergic Agents|adrenergic agents|mesh-ancestor
111368924|NCT03800264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111368925|NCT03800264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111368926|NCT05287724|Acetylcysteine|acetylcysteine|mesh-list
111368927|NCT05287724|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111368928|NCT05287724|Antiviral Agents|antiviral agents|mesh-ancestor
111368929|NCT05287724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111368930|NCT05287724|Expectorants|expectorants|mesh-ancestor
111368931|NCT05287724|Respiratory System Agents|respiratory system agents|mesh-ancestor
111368932|NCT05287724|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111368933|NCT05287724|Antioxidants|antioxidants|mesh-ancestor
111368934|NCT05287724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111368935|NCT05287724|Protective Agents|protective agents|mesh-ancestor
111368936|NCT05287724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111368937|NCT05287724|Antidotes|antidotes|mesh-ancestor
111368938|NCT01321541|Rituximab|rituximab|mesh-list
111368939|NCT01321541|Gemcitabine|gemcitabine|mesh-list
111368940|NCT01321541|Pixantrone|pixantrone|mesh-list
111368941|NCT01321541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111368942|NCT01321541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111368943|NCT01321541|Immunologic Factors|immunologic factors|mesh-ancestor
111368944|NCT01321541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111368945|NCT01321541|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111368946|NCT01321541|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111368947|NCT01321541|Antimetabolites|antimetabolites|mesh-ancestor
111368948|NCT01321541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111368949|NCT01321541|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111368950|NCT01321541|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111368951|NCT01321541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111368952|NCT03801434|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
111368953|NCT03801434|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111368954|NCT03801434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111368955|NCT03801434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111368956|NCT05201612|Pembrolizumab|pembrolizumab|mesh-list
111368957|NCT05201612|Olaparib|olaparib|mesh-list
111368958|NCT05201612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111368959|NCT05201612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111368960|NCT05201612|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111368961|NCT05201612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111368962|NCT05201612|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111368963|NCT05201612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111368964|NCT01271855|Glycerol|glycerol|mesh-list
111368965|NCT01271855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111368966|NCT01271855|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
111368967|NCT01271855|Protective Agents|protective agents|mesh-ancestor
111368968|NCT04865978|Warfarin|warfarin|mesh-list
111368969|NCT04865978|Apixaban|apixaban|mesh-list
111368970|NCT04865978|Anticoagulants|anticoagulants|mesh-ancestor
111368971|NCT04865978|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111368972|NCT04865978|Antithrombins|antithrombins|mesh-ancestor
111368973|NCT04865978|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111368974|NCT04865978|Protease Inhibitors|protease inhibitors|mesh-ancestor
111368975|NCT04865978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111368976|NCT04865978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111368977|NCT01354145|Celecoxib|celecoxib|mesh-list
111368978|NCT01354145|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111368979|NCT01354145|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111368980|NCT01354145|Analgesics|analgesics|mesh-ancestor
111368981|NCT01354145|Sensory System Agents|sensory system agents|mesh-ancestor
111368982|NCT01354145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111368983|NCT01354145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111368984|NCT01354145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111368985|NCT01354145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111368986|NCT01354145|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111368987|NCT01354145|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111368988|NCT01354145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111368989|NCT01354145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111368990|NCT05168462|Norepinephrine|norepinephrine|mesh-list
111368991|NCT05168462|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111368992|NCT05168462|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111368993|NCT05168462|Adrenergic Agents|adrenergic agents|mesh-ancestor
111368994|NCT05168462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111368995|NCT05168462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111368996|NCT05168462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111368997|NCT05168462|Sympathomimetics|sympathomimetics|mesh-ancestor
111368998|NCT05168462|Autonomic Agents|autonomic agents|mesh-ancestor
111368999|NCT05168462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111369000|NCT05168462|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111369001|NCT02196857|Azacitidine|azacitidine|mesh-list
111369002|NCT02196857|Sorafenib|sorafenib|mesh-list
111369003|NCT02196857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111369004|NCT02196857|Antimetabolites|antimetabolites|mesh-ancestor
111369005|NCT02196857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111369006|NCT02196857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111369007|NCT02196857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111369008|NCT02196857|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111369009|NCT01272245|Cytarabine|cytarabine|mesh-list
111369010|NCT01272245|Homoharringtonine|homoharringtonine|mesh-list
111369011|NCT01272245|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111369012|NCT01272245|Antimetabolites|antimetabolites|mesh-ancestor
111369013|NCT01272245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111369014|NCT01272245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111369015|NCT01272245|Antiviral Agents|antiviral agents|mesh-ancestor
111369016|NCT01272245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111369017|NCT01272245|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111369018|NCT01272245|Immunologic Factors|immunologic factors|mesh-ancestor
111369019|NCT01272245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111369020|NCT01272245|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111369021|NCT01272245|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111369022|NCT01272245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111369023|NCT00802100|Metformin|metformin|mesh-list
111369024|NCT00802100|Benztropine|benztropine|mesh-list
111369025|NCT00802100|Olanzapine|olanzapine|mesh-list
111369026|NCT00802100|Aripiprazole|aripiprazole|mesh-list
111369027|NCT00802100|Perphenazine|perphenazine|mesh-list
111369028|NCT00802100|Simvastatin|simvastatin|mesh-list
111369029|NCT00802100|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111369030|NCT00802100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111369031|NCT00802100|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111369032|NCT00802100|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111369033|NCT00802100|Antimetabolites|antimetabolites|mesh-ancestor
111369034|NCT00802100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111369035|NCT00802100|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111369036|NCT00802100|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111369037|NCT00802100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111369039|NCT00802100|Autonomic Agents|autonomic agents|mesh-ancestor
111369040|NCT00802100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111369041|NCT00802100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111369042|NCT00802100|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111369043|NCT00802100|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111369044|NCT00802100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111369045|NCT00802100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111369046|NCT00802100|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111369047|NCT00802100|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111369048|NCT00802100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111369049|NCT00802100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111369050|NCT00802100|Serotonin Agents|serotonin agents|mesh-ancestor
111369051|NCT00802100|Antidepressive Agents|antidepressive agents|mesh-ancestor
111369052|NCT00802100|Dopamine Agonists|dopamine agonists|mesh-ancestor
111369053|NCT00802100|Dopamine Agents|dopamine agents|mesh-ancestor
111369054|NCT00802100|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111369055|NCT00802100|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111369056|NCT00802100|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111369057|NCT00802100|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111369058|NCT00802100|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111369059|NCT00802100|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111369060|NCT00802100|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111369061|NCT00802100|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111369062|NCT00802100|Parasympatholytics|parasympatholytics|mesh-ancestor
111369063|NCT00802100|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111369064|NCT00802100|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111369065|NCT00802100|Cholinergic Agents|cholinergic agents|mesh-ancestor
111369066|NCT00802100|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111369067|NCT00809276|Cyclophosphamide|cyclophosphamide|mesh-list
111369068|NCT00809276|Busulfan|busulfan|mesh-list
111369069|NCT00809276|Fludarabine|fludarabine|mesh-list
111369070|NCT00809276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111369071|NCT00809276|Immunologic Factors|immunologic factors|mesh-ancestor
111369072|NCT00809276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111369073|NCT00809276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111369074|NCT00809276|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111369075|NCT00809276|Alkylating Agents|alkylating agents|mesh-ancestor
111369076|NCT00809276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111369077|NCT00809276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111369078|NCT00809276|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111369079|NCT00802412|Topiramate|topiramate|mesh-list
111369080|NCT00802412|Anticonvulsants|anticonvulsants|mesh-ancestor
111369081|NCT00802412|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111369082|NCT00802412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111369083|NCT01355705|Aspirin|aspirin|mesh-list
111369084|NCT01355705|Dexamethasone|dexamethasone|mesh-list
111369085|NCT01355705|Dexamethasone acetate|dexamethasone acetate|mesh-list
111369086|NCT01355705|Lenalidomide|lenalidomide|mesh-list
111369087|NCT01355705|Amrubicin|amrubicin|mesh-list
111369088|NCT01355705|BB 1101|bb 1101|mesh-list
111369089|NCT01355705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111369090|NCT01355705|Antiemetics|antiemetics|mesh-ancestor
111369091|NCT01355705|Autonomic Agents|autonomic agents|mesh-ancestor
111369092|NCT01355705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111369093|NCT01355705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111369094|NCT01355705|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111369095|NCT01355705|Glucocorticoids|glucocorticoids|mesh-ancestor
111369096|NCT01355705|Hormones|hormones|mesh-ancestor
111369097|NCT01355705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111369098|NCT01355705|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111369099|NCT01355705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111369100|NCT01355705|Protease Inhibitors|protease inhibitors|mesh-ancestor
111369101|NCT01355705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111369102|NCT01355705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111369103|NCT01355705|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111369104|NCT01355705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111369105|NCT01355705|Analgesics|analgesics|mesh-ancestor
111369106|NCT01355705|Sensory System Agents|sensory system agents|mesh-ancestor
111369108|NCT01355705|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111369109|NCT01355705|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111369110|NCT01355705|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111369111|NCT01355705|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111369112|NCT01355705|Antipyretics|antipyretics|mesh-ancestor
111369113|NCT01355705|Immunologic Factors|immunologic factors|mesh-ancestor
111369114|NCT01355705|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111369115|NCT01355705|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111369116|NCT01355705|Growth Substances|growth substances|mesh-ancestor
111369117|NCT01355705|Growth Inhibitors|growth inhibitors|mesh-ancestor
111369118|NCT01327157|Salicylic Acid|salicylic acid|mesh-list
111369119|NCT01327157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111369120|NCT01327157|Antifungal Agents|antifungal agents|mesh-ancestor
111369121|NCT01327157|Keratolytic Agents|keratolytic agents|mesh-ancestor
111369122|NCT01327157|Dermatologic Agents|dermatologic agents|mesh-ancestor
111369123|NCT00802880|Dacarbazine|dacarbazine|mesh-list
111369124|NCT00802880|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111369125|NCT00802880|Alkylating Agents|alkylating agents|mesh-ancestor
111369126|NCT00802880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111369127|NCT00802880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111369128|NCT03839888|Atropine|atropine|mesh-list
111369129|NCT03839888|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111369130|NCT03839888|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111369131|NCT03839888|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111369132|NCT03839888|Autonomic Agents|autonomic agents|mesh-ancestor
111369133|NCT03839888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111369134|NCT03839888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111369135|NCT03839888|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111369136|NCT03839888|Respiratory System Agents|respiratory system agents|mesh-ancestor
111369137|NCT03839888|Mydriatics|mydriatics|mesh-ancestor
111369138|NCT03839888|Parasympatholytics|parasympatholytics|mesh-ancestor
111369139|NCT03839888|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111369140|NCT03839888|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111369141|NCT03839888|Cholinergic Agents|cholinergic agents|mesh-ancestor
111369142|NCT03839888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111369143|NCT03839888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111369144|NCT05089526|Lidocaine|lidocaine|mesh-list
111369145|NCT05089526|Fentanyl|fentanyl|mesh-list
111369146|NCT05089526|Dexmedetomidine|dexmedetomidine|mesh-list
111369147|NCT05089526|Ketamine|ketamine|mesh-list
111369148|NCT05089526|Anesthetics, Local|anesthetics, local|mesh-ancestor
111369149|NCT05089526|Anesthetics|anesthetics|mesh-ancestor
111369150|NCT05089526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111369151|NCT05089526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111369152|NCT05089526|Sensory System Agents|sensory system agents|mesh-ancestor
111369153|NCT05089526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111369154|NCT05089526|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111369155|NCT05089526|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111369156|NCT05089526|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111369157|NCT05089526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111369158|NCT05089526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111369159|NCT05089526|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111369160|NCT05089526|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111369161|NCT05089526|Analgesics|analgesics|mesh-ancestor
111369162|NCT05089526|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111369163|NCT05089526|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111369164|NCT05089526|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111369165|NCT05089526|Adrenergic Agents|adrenergic agents|mesh-ancestor
111369166|NCT05089526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111369167|NCT05089526|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111369168|NCT05089526|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111369169|NCT05089526|Anesthetics, General|anesthetics, general|mesh-ancestor
111369170|NCT05089526|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111369171|NCT05089526|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111369172|NCT05089526|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111369173|NCT05089526|Narcotics|narcotics|mesh-ancestor
111369174|NCT05089526|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111369175|NCT04382846|Nitazoxanide|nitazoxanide|mesh-list
111369176|NCT04382846|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111369177|NCT04382846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111369178|NCT01274897|Lactitol|lactitol|mesh-list
111369179|NCT01274897|Cathartics|cathartics|mesh-ancestor
111369180|NCT01274897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111369181|NCT02323217|Isocarboxazid|isocarboxazid|mesh-list
111369182|NCT02323217|Idazoxan|idazoxan|mesh-list
111369183|NCT02323217|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
111369184|NCT02323217|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111369185|NCT02323217|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111369186|NCT02323217|Adrenergic Agents|adrenergic agents|mesh-ancestor
111369187|NCT02323217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111369188|NCT02323217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111369189|NCT02323217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111369190|NCT02323217|Antidepressive Agents|antidepressive agents|mesh-ancestor
111369191|NCT02323217|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111369192|NCT02323217|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
111369193|NCT02323217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111369194|NCT04382768|Ibuprofen|ibuprofen|mesh-list
111369195|NCT04382768|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111369196|NCT04382768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111369197|NCT04382768|Analgesics|analgesics|mesh-ancestor
111369198|NCT04382768|Sensory System Agents|sensory system agents|mesh-ancestor
111369199|NCT04382768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111369200|NCT04382768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111369201|NCT04382768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111369202|NCT04382768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111369203|NCT04382768|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111369204|NCT04382768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111369205|NCT04382768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111369206|NCT03932162|Insulin|insulin|mesh-list
111369207|NCT03932162|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111369208|NCT03932162|Mitogens|mitogens|mesh-list
111369209|NCT03932162|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111369210|NCT03932162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111369211|NCT03932162|Mitosis Modulators|mitosis modulators|mesh-ancestor
111369212|NCT03932162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111369213|NCT04155164|Metformin|metformin|mesh-list
111369214|NCT04155164|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111369215|NCT04155164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111369216|NCT00806078|Quinine|quinine|mesh-list
111369217|NCT00806078|Antimalarials|antimalarials|mesh-ancestor
111369218|NCT00806078|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111369219|NCT00806078|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111369220|NCT00806078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111369221|NCT00806078|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
111369222|NCT00806078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111369223|NCT00806078|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111369224|NCT00806078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111369225|NCT00806078|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111369226|NCT00806078|Analgesics|analgesics|mesh-ancestor
111369227|NCT00806078|Sensory System Agents|sensory system agents|mesh-ancestor
111369228|NCT00806234|Metformin|metformin|mesh-list
111369229|NCT00806234|Olanzapine|olanzapine|mesh-list
111369230|NCT00806234|Risperidone|risperidone|mesh-list
111369231|NCT00806234|Aripiprazole|aripiprazole|mesh-list
111369232|NCT00806234|Quetiapine Fumarate|quetiapine fumarate|mesh-list
111369233|NCT00806234|Paliperidone Palmitate|paliperidone palmitate|mesh-list
111369234|NCT00806234|Ziprasidone|ziprasidone|mesh-list
111369235|NCT00806234|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
111369236|NCT00806234|Asenapine|asenapine|mesh-list
111369237|NCT00806234|Iloperidone|iloperidone|mesh-list
111369238|NCT00806234|Perphenazine|perphenazine|mesh-list
111369239|NCT00806234|Fluoxetine|fluoxetine|mesh-list
111369240|NCT00806234|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111369241|NCT00806234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111369242|NCT00806234|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111369243|NCT00806234|Serotonin Agents|serotonin agents|mesh-ancestor
111369244|NCT00806234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111369245|NCT00806234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111369246|NCT00806234|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111369247|NCT00806234|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111369248|NCT00806234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111369249|NCT00806234|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111369250|NCT00806234|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111369251|NCT00806234|Dopamine Agents|dopamine agents|mesh-ancestor
111369252|NCT00806234|Antiemetics|antiemetics|mesh-ancestor
111369253|NCT00806234|Autonomic Agents|autonomic agents|mesh-ancestor
111369254|NCT00806234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111369255|NCT00806234|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111369256|NCT00806234|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111369257|NCT00806234|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111369258|NCT00806234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111369259|NCT00806234|Antidepressive Agents|antidepressive agents|mesh-ancestor
111369260|NCT00806234|Dopamine Agonists|dopamine agonists|mesh-ancestor
111369261|NCT00806234|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111369262|NCT00806234|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111369263|NCT00806234|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111369264|NCT00806234|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111369265|NCT00806234|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111369266|NCT00806234|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111369267|NCT00806234|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111369268|NCT00806234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111369269|NCT00806234|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
111369270|NCT00806234|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111369271|NCT00806234|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111369272|NCT00806234|Adrenergic Agents|adrenergic agents|mesh-ancestor
111369273|NCT01275365|Methyltestosterone|methyltestosterone|mesh-list
111369274|NCT01275365|Testosterone|testosterone|mesh-list
111369275|NCT01275365|Testosterone undecanoate|testosterone undecanoate|mesh-list
111369276|NCT01275365|Testosterone enanthate|testosterone enanthate|mesh-list
111369277|NCT01275365|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
111369278|NCT01275365|Androgens|androgens|mesh-ancestor
111369279|NCT01275365|Hormones|hormones|mesh-ancestor
111369280|NCT01275365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111369281|NCT01275365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111369282|NCT01275365|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111369283|NCT01275365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111369284|NCT01275365|Anabolic Agents|anabolic agents|mesh-ancestor
111369285|NCT00811850|Timolol|timolol|mesh-list
111369286|NCT00811850|Brimonidine Tartrate|brimonidine tartrate|mesh-list
111369287|NCT00811850|Dorzolamide|dorzolamide|mesh-list
111369288|NCT00811850|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111369289|NCT00811850|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111369290|NCT00811850|Maleic acid|maleic acid|mesh-list
111369291|NCT00811850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111369292|NCT00811850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111369293|NCT00811850|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111369294|NCT00811850|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111369295|NCT00811850|Adrenergic Agents|adrenergic agents|mesh-ancestor
111369296|NCT00811850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111369297|NCT00811850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111369298|NCT00811850|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111369299|NCT00811850|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111369300|NCT00811850|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111369301|NCT00811850|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111369302|NCT00811850|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111369303|NCT00811850|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
111369304|NCT03678506|Apixaban|apixaban|mesh-list
111369305|NCT03678506|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111369306|NCT03678506|Antithrombins|antithrombins|mesh-ancestor
111369307|NCT03678506|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111369308|NCT03678506|Protease Inhibitors|protease inhibitors|mesh-ancestor
111369309|NCT03678506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111369310|NCT03678506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111369311|NCT03678506|Anticoagulants|anticoagulants|mesh-ancestor
111369312|NCT00844298|Cytarabine|cytarabine|mesh-list
111369313|NCT00844298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111369314|NCT00844298|Antimetabolites|antimetabolites|mesh-ancestor
111369315|NCT00844298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111369316|NCT00844298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111369317|NCT00844298|Antiviral Agents|antiviral agents|mesh-ancestor
111369318|NCT00844298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111369319|NCT00844298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111369320|NCT00844298|Immunologic Factors|immunologic factors|mesh-ancestor
111369321|NCT00844298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111369322|NCT01329185|Valganciclovir|valganciclovir|mesh-list
111369323|NCT01329185|Antiviral Agents|antiviral agents|mesh-ancestor
111369324|NCT01329185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111369325|NCT01276301|Empagliflozin|empagliflozin|mesh-list
111369326|NCT01276301|Verapamil|verapamil|mesh-list
111369327|NCT01276301|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111369328|NCT01276301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111369329|NCT01276301|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111369330|NCT01276301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111369331|NCT01276301|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111369332|NCT01276301|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110959211|NCT02582632|Antiviral Agents|antiviral agents|mesh-ancestor
111369333|NCT01276301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111369334|NCT01276301|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111369335|NCT01276301|Vasodilator Agents|vasodilator agents|mesh-ancestor
111369336|NCT00845000|Levodopa|levodopa|mesh-list
111369337|NCT00845000|Carbidopa|carbidopa|mesh-list
111369338|NCT00845000|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111369339|NCT00845000|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111369340|NCT00845000|Dopamine Agents|dopamine agents|mesh-ancestor
111369341|NCT00845000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111369342|NCT00845000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110508995|NCT04512235|Antiemetics|antiemetics|mesh-ancestor
111369343|NCT00845000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111369344|NCT00845000|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
111369345|NCT00845000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111369346|NCT01330043|Bupropion|bupropion|mesh-list
111369347|NCT01330043|Nicotine|nicotine|mesh-list
111369348|NCT01330043|Varenicline|varenicline|mesh-list
111369349|NCT01330043|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111369350|NCT01330043|Autonomic Agents|autonomic agents|mesh-ancestor
111369351|NCT01330043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111369352|NCT01330043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111369353|NCT01330043|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111369354|NCT01330043|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111369355|NCT01330043|Cholinergic Agents|cholinergic agents|mesh-ancestor
111369356|NCT01330043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111369357|NCT01330043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111369358|NCT01330043|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111369359|NCT01330043|Antidepressive Agents|antidepressive agents|mesh-ancestor
111369360|NCT01330043|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111369361|NCT01330043|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111369362|NCT01330043|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111369363|NCT01330043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111369364|NCT01330043|Dopamine Agents|dopamine agents|mesh-ancestor
111369365|NCT01330043|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111369366|NCT01330043|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111369367|NCT01330043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111369368|NCT01330355|Gatifloxacin|gatifloxacin|mesh-list
111369369|NCT01330355|Besifloxacin|besifloxacin|mesh-list
111369370|NCT01330355|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111369371|NCT01330355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111369372|NCT01330355|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
111369373|NCT01330355|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111369374|NCT01330355|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111369375|NCT01330355|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111369376|NCT01330355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111369377|NCT01330355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111369378|NCT01330355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111369379|NCT02193815|Calcitriol|calcitriol|mesh-list
111369380|NCT02193815|Calcipotriene|calcipotriene|mesh-list
111369381|NCT02193815|Tofacitinib|tofacitinib|mesh-list
111369382|NCT02193815|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
111369383|NCT02193815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111369384|NCT02193815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111369385|NCT02193815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111369386|NCT02193815|Dermatologic Agents|dermatologic agents|mesh-ancestor
111369387|NCT02193815|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111369388|NCT02193815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111369389|NCT02193815|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
111369390|NCT02193815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111369391|NCT02193815|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111369392|NCT02193815|Vitamins|vitamins|mesh-ancestor
111369393|NCT02193815|Micronutrients|micronutrients|mesh-ancestor
111369394|NCT02193815|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111369395|NCT01277081|Acetaminophen|acetaminophen|mesh-list
111369396|NCT01277081|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111369397|NCT01277081|Analgesics|analgesics|mesh-ancestor
111369398|NCT01277081|Sensory System Agents|sensory system agents|mesh-ancestor
111369399|NCT01277081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111369400|NCT01277081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111369401|NCT01277081|Antipyretics|antipyretics|mesh-ancestor
111369402|NCT01361633|Cycloserine|cycloserine|mesh-list
111369403|NCT01361633|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111369404|NCT01361633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111369405|NCT01361633|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111369406|NCT01361633|Antitubercular Agents|antitubercular agents|mesh-ancestor
111369407|NCT01361633|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111369408|NCT01361633|Antimetabolites|antimetabolites|mesh-ancestor
111369409|NCT01361633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111369410|NCT01331213|Pregabalin|pregabalin|mesh-list
111369411|NCT01331213|Analgesics|analgesics|mesh-ancestor
111369412|NCT01331213|Sensory System Agents|sensory system agents|mesh-ancestor
111369413|NCT01331213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111369414|NCT01331213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111369415|NCT01331213|Anticonvulsants|anticonvulsants|mesh-ancestor
111369416|NCT01331213|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111369417|NCT01331213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111369418|NCT01331213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111369419|NCT01331213|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111369420|NCT01331213|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111369421|NCT01331213|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111369422|NCT01331213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111369423|NCT01331213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111369424|NCT01332071|Metformin|metformin|mesh-list
111369425|NCT01332071|Rosiglitazone|rosiglitazone|mesh-list
111369426|NCT01332071|Maleic acid|maleic acid|mesh-list
111369427|NCT01332071|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111369428|NCT01332071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111369429|NCT01332071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111369430|NCT01332071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111369431|NCT01277159|Dexamethasone|dexamethasone|mesh-list
111369432|NCT01277159|Dexamethasone acetate|dexamethasone acetate|mesh-list
111369433|NCT01277159|Buprenorphine|buprenorphine|mesh-list
111369434|NCT01277159|BB 1101|bb 1101|mesh-list
111369435|NCT01277159|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111369436|NCT01277159|Antiemetics|antiemetics|mesh-ancestor
111369437|NCT01277159|Autonomic Agents|autonomic agents|mesh-ancestor
111369438|NCT01277159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111369439|NCT01277159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111369440|NCT01277159|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111369441|NCT01277159|Glucocorticoids|glucocorticoids|mesh-ancestor
111369442|NCT01277159|Hormones|hormones|mesh-ancestor
111369443|NCT01277159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111369444|NCT01277159|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111369445|NCT01277159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111369446|NCT01277159|Protease Inhibitors|protease inhibitors|mesh-ancestor
111369447|NCT01277159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111369448|NCT01277159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111369449|NCT01277159|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111369450|NCT01277159|Narcotics|narcotics|mesh-ancestor
111369451|NCT01277159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111369452|NCT01277159|Analgesics|analgesics|mesh-ancestor
111369453|NCT01277159|Sensory System Agents|sensory system agents|mesh-ancestor
111369454|NCT01277159|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111369455|NCT01362959|Nicotine|nicotine|mesh-list
111369456|NCT01362959|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111369457|NCT01362959|Autonomic Agents|autonomic agents|mesh-ancestor
111369458|NCT01362959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111369459|NCT01362959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111369460|NCT01362959|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111369461|NCT01362959|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111369462|NCT01362959|Cholinergic Agents|cholinergic agents|mesh-ancestor
111369463|NCT01362959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111369464|NCT01362959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111369465|NCT01332461|Fluticasone|fluticasone|mesh-list
111369466|NCT01332461|Xhance|xhance|mesh-list
111369467|NCT01332461|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
111369468|NCT01332461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111369469|NCT01332461|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111369470|NCT01332461|Autonomic Agents|autonomic agents|mesh-ancestor
111369471|NCT01332461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111369472|NCT01332461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111369473|NCT01332461|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111369474|NCT01332461|Respiratory System Agents|respiratory system agents|mesh-ancestor
111369475|NCT01332461|Dermatologic Agents|dermatologic agents|mesh-ancestor
111369476|NCT01332461|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111369477|NCT01332461|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111369478|NCT01332461|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111369479|NCT01332461|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111369480|NCT01332461|Adrenergic Agents|adrenergic agents|mesh-ancestor
111369481|NCT01332461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111369482|NCT01332461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111369483|NCT01279187|Teriparatide|teriparatide|mesh-list
111369484|NCT01279187|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111369485|NCT01279187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111369486|NCT01279187|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111369487|NCT01280123|Pioglitazone|pioglitazone|mesh-list
111369488|NCT01280123|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111369489|NCT01280123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111369490|NCT03608696|Buprenorphine|buprenorphine|mesh-list
111369491|NCT03608696|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111369492|NCT03608696|Narcotics|narcotics|mesh-ancestor
111369493|NCT03608696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111369494|NCT03608696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111369495|NCT03608696|Analgesics|analgesics|mesh-ancestor
111369496|NCT03608696|Sensory System Agents|sensory system agents|mesh-ancestor
111369497|NCT03608696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111369498|NCT03608696|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111369499|NCT01334723|Finasteride|finasteride|mesh-list
111369500|NCT01334723|Dutasteride|dutasteride|mesh-list
111369501|NCT01334723|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-list
111369502|NCT01334723|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111369503|NCT01334723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111369504|NCT01334723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111369505|NCT01334723|Hormone Antagonists|hormone antagonists|mesh-ancestor
111369506|NCT01334723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111369507|NCT01334723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111369508|NCT01334723|Urological Agents|urological agents|mesh-ancestor
111369509|NCT04311710|Nivolumab|nivolumab|mesh-list
111369510|NCT04311710|Ipilimumab|ipilimumab|mesh-list
111369511|NCT04311710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111369512|NCT04311710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111369513|NCT04311710|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111369514|NCT04311710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111369515|NCT01334957|Ibuprofen|ibuprofen|mesh-list
111369516|NCT01334957|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111369517|NCT01334957|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111369518|NCT01334957|Analgesics|analgesics|mesh-ancestor
111369519|NCT01334957|Sensory System Agents|sensory system agents|mesh-ancestor
111369520|NCT01334957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111369521|NCT01334957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111369522|NCT01334957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111369523|NCT01334957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111369524|NCT01334957|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111369525|NCT01334957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111369526|NCT01334957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111369527|NCT01402427|Verapamil|verapamil|mesh-list
111369528|NCT01402427|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111369529|NCT01402427|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111369530|NCT01402427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111369531|NCT01402427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111369532|NCT01402427|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111369533|NCT01402427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111369534|NCT01402427|Vasodilator Agents|vasodilator agents|mesh-ancestor
111369535|NCT01365611|Fluticasone|fluticasone|mesh-list
111369536|NCT01365611|Xhance|xhance|mesh-list
111369537|NCT01365611|Ketorolac|ketorolac|mesh-list
111369538|NCT01365611|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
111369539|NCT01365611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111369540|NCT01365611|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111369541|NCT01365611|Autonomic Agents|autonomic agents|mesh-ancestor
111369542|NCT01365611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111369543|NCT01365611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111369544|NCT01365611|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111369545|NCT01365611|Respiratory System Agents|respiratory system agents|mesh-ancestor
111369546|NCT01365611|Dermatologic Agents|dermatologic agents|mesh-ancestor
111369547|NCT01365611|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111369548|NCT01365611|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111369549|NCT01365611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111369550|NCT01365611|Analgesics|analgesics|mesh-ancestor
111369551|NCT01365611|Sensory System Agents|sensory system agents|mesh-ancestor
111369552|NCT01365611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111369553|NCT01365611|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111369554|NCT01365611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111369555|NCT01365611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111369556|NCT01472549|Ethanol|ethanol|mesh-list
111369557|NCT01472549|Chlorhexidine|chlorhexidine|mesh-list
111369558|NCT01472549|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111369559|NCT01472549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111369560|NCT01472549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111369561|NCT01472549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111369562|NCT01472549|Disinfectants|disinfectants|mesh-ancestor
111369563|NCT00852644|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
111369564|NCT00852644|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111369565|NCT00852644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111369566|NCT01404923|Mebeverine|mebeverine|mesh-list
111369567|NCT01404923|Alverine|alverine|mesh-list
111369568|NCT01404923|Parasympatholytics|parasympatholytics|mesh-list
111369569|NCT01404923|Autonomic Agents|autonomic agents|mesh-ancestor
111369570|NCT01404923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111369571|NCT01404923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111369572|NCT01404923|Anticonvulsants|anticonvulsants|mesh-ancestor
111369573|NCT01368263|Letrozole|letrozole|mesh-list
111369574|NCT01368263|Anastrozole|anastrozole|mesh-list
111369575|NCT01368263|Goserelin|goserelin|mesh-list
111369576|NCT01368263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111369577|NCT01368263|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111369578|NCT01368263|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111369579|NCT01368263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111369580|NCT01368263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111369581|NCT01368263|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111369582|NCT01368263|Hormone Antagonists|hormone antagonists|mesh-ancestor
111369583|NCT01368263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111369584|NCT01368263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111369585|NCT01368263|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111369586|NCT00815360|Triamcinolone|triamcinolone|mesh-list
111369587|NCT00815360|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
111369588|NCT00815360|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
111369589|NCT00815360|Ranibizumab|ranibizumab|mesh-list
111369590|NCT00815360|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
111369591|NCT00815360|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111369592|NCT00815360|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111369593|NCT00815360|Growth Substances|growth substances|mesh-ancestor
111369594|NCT00815360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111369595|NCT00815360|Growth Inhibitors|growth inhibitors|mesh-ancestor
111369596|NCT00815360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111369597|NCT00815360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111369598|NCT00815360|Glucocorticoids|glucocorticoids|mesh-ancestor
111369599|NCT00815360|Hormones|hormones|mesh-ancestor
111369600|NCT00815360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111369601|NCT00815360|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111369602|NCT00815360|Immunologic Factors|immunologic factors|mesh-ancestor
111369603|NCT00815360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111369604|NCT00815360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111369605|NCT01474109|Macitentan|macitentan|mesh-list
111369606|NCT01474109|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
111369607|NCT01474109|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
111369608|NCT01474109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111369609|NCT01474109|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
111369610|NCT01405937|Ribavirin|ribavirin|mesh-list
111369611|NCT01405937|Antimetabolites|antimetabolites|mesh-ancestor
111369612|NCT01405937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111369613|NCT01405937|Antiviral Agents|antiviral agents|mesh-ancestor
111369614|NCT01405937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111369615|NCT01368653|Nicotine|nicotine|mesh-list
111369616|NCT01368653|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111369617|NCT01368653|Autonomic Agents|autonomic agents|mesh-ancestor
111369618|NCT01368653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111369619|NCT01368653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111369620|NCT01368653|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111369621|NCT01368653|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111369622|NCT01368653|Cholinergic Agents|cholinergic agents|mesh-ancestor
111369623|NCT01368653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111369624|NCT01368653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111369625|NCT01407107|Nitroglycerin|nitroglycerin|mesh-list
111369626|NCT01407107|Vasodilator Agents|vasodilator agents|mesh-ancestor
111369627|NCT01368809|Fentanyl|fentanyl|mesh-list
111369628|NCT01368809|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111369629|NCT01368809|Narcotics|narcotics|mesh-ancestor
111369630|NCT01368809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111369631|NCT01368809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111369632|NCT01368809|Analgesics|analgesics|mesh-ancestor
111369633|NCT01368809|Sensory System Agents|sensory system agents|mesh-ancestor
111369634|NCT01368809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110509289|NCT03005366|Flecainide|flecainide|mesh-list
111369635|NCT01368809|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111369636|NCT01368809|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111369637|NCT01368809|Anesthetics, General|anesthetics, general|mesh-ancestor
111369638|NCT01368809|Anesthetics|anesthetics|mesh-ancestor
111369639|NCT01369745|Prednisone|prednisone|mesh-list
111369640|NCT01369745|Prednisolone|prednisolone|mesh-list
111369641|NCT01369745|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111369642|NCT01369745|Methylprednisolone|methylprednisolone|mesh-list
111369643|NCT01369745|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111369644|NCT01369745|Prednisolone acetate|prednisolone acetate|mesh-list
111369645|NCT01369745|Dipyridamole|dipyridamole|mesh-list
111369646|NCT01369745|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111369647|NCT01369745|Prednisolone phosphate|prednisolone phosphate|mesh-list
111369648|NCT01369745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111369649|NCT01369745|Glucocorticoids|glucocorticoids|mesh-ancestor
111369650|NCT01369745|Hormones|hormones|mesh-ancestor
111369651|NCT01369745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111369652|NCT01369745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111369653|NCT01369745|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111369654|NCT01369745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111369655|NCT01369745|Antiemetics|antiemetics|mesh-ancestor
111369656|NCT01369745|Autonomic Agents|autonomic agents|mesh-ancestor
111369657|NCT01369745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111369658|NCT01369745|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111369659|NCT01369745|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111369660|NCT01369745|Protective Agents|protective agents|mesh-ancestor
111369661|NCT01369745|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111369662|NCT01369745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111369663|NCT01369745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111369664|NCT01369745|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111369665|NCT01369745|Vasodilator Agents|vasodilator agents|mesh-ancestor
111369666|NCT01475513|Moxifloxacin|moxifloxacin|mesh-list
111369667|NCT01475513|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
111369668|NCT01475513|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111369669|NCT01475513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111369670|NCT01475513|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111369671|NCT01475513|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111369672|NCT01475513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111369673|NCT01475513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111369674|NCT01475513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111369675|NCT01475513|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111369676|NCT01475513|Contraceptive Agents|contraceptive agents|mesh-ancestor
111369677|NCT01475513|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111369678|NCT01475513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111369679|NCT01475513|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
111369680|NCT01475513|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111369681|NCT01475513|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111369682|NCT01407575|Buprenorphine|buprenorphine|mesh-list
111369683|NCT01407575|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111369684|NCT01407575|Narcotics|narcotics|mesh-ancestor
111369685|NCT01407575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111369686|NCT01407575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111369687|NCT01407575|Analgesics|analgesics|mesh-ancestor
111369688|NCT01407575|Sensory System Agents|sensory system agents|mesh-ancestor
111369689|NCT01407575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111369690|NCT01407575|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111369691|NCT01476449|Ranibizumab|ranibizumab|mesh-list
111369692|NCT01476449|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111369693|NCT01476449|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110509337|NCT02232152|Fluorouracil|fluorouracil|mesh-list
111369694|NCT01476449|Growth Substances|growth substances|mesh-ancestor
111369695|NCT01476449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111369696|NCT01476449|Growth Inhibitors|growth inhibitors|mesh-ancestor
111369697|NCT01476449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111369698|NCT01370369|Testosterone|testosterone|mesh-list
111369699|NCT01370369|Androgens|androgens|mesh-ancestor
111369700|NCT01370369|Hormones|hormones|mesh-ancestor
111369701|NCT01370369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111369702|NCT01370369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111369703|NCT01477463|Vitamin D|vitamin d|mesh-list
111369704|NCT01477463|Ergocalciferols|ergocalciferols|mesh-list
111369705|NCT01477463|Cholecalciferol|cholecalciferol|mesh-list
111369706|NCT01477463|Vitamins|vitamins|mesh-list
111369707|NCT01477463|Micronutrients|micronutrients|mesh-ancestor
111369708|NCT01477463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111369709|NCT01477463|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111369710|NCT01477463|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111369711|NCT02203565|Sodium Hypochlorite|sodium hypochlorite|mesh-list
111369712|NCT02203565|Eusol|eusol|mesh-list
111369713|NCT02203565|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111369714|NCT02203565|Disinfectants|disinfectants|mesh-ancestor
111369715|NCT02203565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111369716|NCT01375127|Tofacitinib|tofacitinib|mesh-list
111369717|NCT01375127|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
111369718|NCT01375127|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111369719|NCT01375127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111369720|NCT01375127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111369721|NCT00857714|Lapatinib|lapatinib|mesh-list
111369722|NCT00857714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111369723|NCT00857714|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111369724|NCT00857714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111369725|NCT00857714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111369726|NCT00858962|Raltegravir Potassium|raltegravir potassium|mesh-list
111369727|NCT00858962|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111369728|NCT00858962|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111369729|NCT00858962|Antiviral Agents|antiviral agents|mesh-ancestor
111369730|NCT00858962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111369731|NCT00858962|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111369732|NCT00858962|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111369733|NCT00858962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111369734|NCT00858962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111369735|NCT01376297|Dexamethasone|dexamethasone|mesh-list
111369736|NCT01376297|Aprepitant|aprepitant|mesh-list
111369737|NCT01376297|Palonosetron|palonosetron|mesh-list
111369738|NCT01376297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111369739|NCT01376297|Antiemetics|antiemetics|mesh-ancestor
111369740|NCT01376297|Autonomic Agents|autonomic agents|mesh-ancestor
111369741|NCT01376297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111369742|NCT01376297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111369743|NCT01376297|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111369744|NCT01376297|Glucocorticoids|glucocorticoids|mesh-ancestor
111369745|NCT01376297|Hormones|hormones|mesh-ancestor
111369746|NCT01376297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111369747|NCT01376297|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111369748|NCT01376297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111369749|NCT01376297|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
111369750|NCT01376297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111369751|NCT01376297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111369752|NCT01376297|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111369753|NCT01376297|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111369754|NCT01376297|Serotonin Agents|serotonin agents|mesh-ancestor
111369755|NCT00859040|Pasireotide|pasireotide|mesh-list
111369756|NCT00859040|Hormones|hormones|mesh-ancestor
111369757|NCT00859040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111369758|NCT00859040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111369759|NCT00859508|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
111369760|NCT00859508|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
111369761|NCT00859508|Estradiol|estradiol|mesh-list
111369762|NCT00859508|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
111369763|NCT00859508|Estrogens|estrogens|mesh-ancestor
111369764|NCT00859508|Hormones|hormones|mesh-ancestor
111369765|NCT00859508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111369766|NCT00859508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111369767|NCT00859508|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111369768|NCT00859508|Contraceptive Agents|contraceptive agents|mesh-ancestor
111369769|NCT00859508|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111369770|NCT00859508|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111369771|NCT01377467|Denosumab|denosumab|mesh-list
111369772|NCT01377467|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111369773|NCT01377467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111369774|NCT02348762|Acetylcysteine|acetylcysteine|mesh-list
111369775|NCT02348762|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111369776|NCT02348762|Glycine|glycine|mesh-list
111369777|NCT02348762|Antiviral Agents|antiviral agents|mesh-ancestor
111369778|NCT02348762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111369779|NCT02348762|Expectorants|expectorants|mesh-ancestor
111369780|NCT02348762|Respiratory System Agents|respiratory system agents|mesh-ancestor
111369781|NCT02348762|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111369782|NCT02348762|Antioxidants|antioxidants|mesh-ancestor
111369783|NCT02348762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111369784|NCT02348762|Protective Agents|protective agents|mesh-ancestor
111369785|NCT02348762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111369786|NCT02348762|Antidotes|antidotes|mesh-ancestor
111369787|NCT02348762|Glycine Agents|glycine agents|mesh-ancestor
111369788|NCT02348762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111369789|NCT01377623|Dexmedetomidine|dexmedetomidine|mesh-list
111369790|NCT01377623|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111369791|NCT01377623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111369792|NCT01377623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111369793|NCT01377623|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111369794|NCT01377623|Analgesics|analgesics|mesh-ancestor
111369795|NCT01377623|Sensory System Agents|sensory system agents|mesh-ancestor
111369796|NCT01377623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111369797|NCT01377623|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111369798|NCT01377623|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111369799|NCT01377623|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111369800|NCT01377623|Adrenergic Agents|adrenergic agents|mesh-ancestor
111369801|NCT01377623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111369802|NCT01377623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111369803|NCT01486043|Metformin|metformin|mesh-list
111369804|NCT01486043|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111369805|NCT01486043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111369806|NCT01490723|Mycophenolic Acid|mycophenolic acid|mesh-list
111369807|NCT01490723|Rituximab|rituximab|mesh-list
111369808|NCT01490723|Methotrexate|methotrexate|mesh-list
111369809|NCT01490723|Fludarabine|fludarabine|mesh-list
111369810|NCT01490723|Fludarabine phosphate|fludarabine phosphate|mesh-list
111369811|NCT01490723|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
111369812|NCT01490723|Tacrolimus|tacrolimus|mesh-list
111369813|NCT01490723|Thymoglobulin|thymoglobulin|mesh-list
111369814|NCT01490723|Antilymphocyte Serum|antilymphocyte serum|mesh-list
111369815|NCT01490723|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111369816|NCT01490723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111369817|NCT01490723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111369818|NCT01490723|Immunologic Factors|immunologic factors|mesh-ancestor
111369819|NCT01490723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111369820|NCT01490723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111369821|NCT01490723|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111369822|NCT01490723|Abortifacient Agents|abortifacient agents|mesh-ancestor
111369823|NCT01490723|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111369824|NCT01490723|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111369825|NCT01490723|Antimetabolites|antimetabolites|mesh-ancestor
111369826|NCT01490723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111369827|NCT01490723|Dermatologic Agents|dermatologic agents|mesh-ancestor
111369828|NCT01490723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111369829|NCT01490723|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111369830|NCT01490723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111369831|NCT01490723|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111369832|NCT01490723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111369833|NCT01490723|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111369834|NCT01490723|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111369835|NCT01490723|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111369836|NCT01490723|Antitubercular Agents|antitubercular agents|mesh-ancestor
111369837|NCT01490723|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111369838|NCT01490723|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111369839|NCT01490723|Alkylating Agents|alkylating agents|mesh-ancestor
111369840|NCT01491113|Levetiracetam|levetiracetam|mesh-list
111369841|NCT01491113|Anticonvulsants|anticonvulsants|mesh-ancestor
111369842|NCT01491113|Nootropic Agents|nootropic agents|mesh-ancestor
111369843|NCT03839498|Axitinib|axitinib|mesh-list
111369844|NCT03839498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111369845|NCT03839498|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111369846|NCT03839498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111369847|NCT03839498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111369848|NCT02252432|Ketamine|ketamine|mesh-list
111369849|NCT02252432|Methadone|methadone|mesh-list
111369850|NCT02252432|Analgesics|analgesics|mesh-ancestor
111369851|NCT02252432|Sensory System Agents|sensory system agents|mesh-ancestor
111369852|NCT02252432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111369853|NCT02252432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111369854|NCT02252432|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111369855|NCT02252432|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111369856|NCT02252432|Anesthetics, General|anesthetics, general|mesh-ancestor
111369857|NCT02252432|Anesthetics|anesthetics|mesh-ancestor
111369858|NCT02252432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111369859|NCT02252432|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111369860|NCT02252432|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111369861|NCT02252432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111369862|NCT02252432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111369863|NCT02252432|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111369864|NCT02252432|Narcotics|narcotics|mesh-ancestor
111369865|NCT02252432|Antitussive Agents|antitussive agents|mesh-ancestor
111369866|NCT02252432|Respiratory System Agents|respiratory system agents|mesh-ancestor
111369867|NCT01492673|Cyclophosphamide|cyclophosphamide|mesh-list
111369868|NCT01492673|Bevacizumab|bevacizumab|mesh-list
111369869|NCT01492673|Topotecan|topotecan|mesh-list
111369870|NCT01492673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111369871|NCT01492673|Immunologic Factors|immunologic factors|mesh-ancestor
111369872|NCT01492673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111369873|NCT01492673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111369874|NCT01492673|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111369875|NCT01492673|Alkylating Agents|alkylating agents|mesh-ancestor
111369876|NCT01492673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110509530|NCT00375609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111369877|NCT01492673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111369878|NCT01492673|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111369879|NCT01492673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111369880|NCT01492673|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111369881|NCT01492673|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111369882|NCT01492673|Growth Substances|growth substances|mesh-ancestor
111369883|NCT01492673|Growth Inhibitors|growth inhibitors|mesh-ancestor
111369884|NCT01492673|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111369885|NCT01492673|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111369886|NCT01492673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111369887|NCT00818324|Rebamipide|rebamipide|mesh-list
111369888|NCT00818324|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111369889|NCT00818324|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111369890|NCT00818324|Antioxidants|antioxidants|mesh-ancestor
111369891|NCT00818324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111369892|NCT00818324|Protective Agents|protective agents|mesh-ancestor
111369893|NCT00818324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111369894|NCT00818324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111369895|NCT01419275|Xenon|xenon|mesh-list
111369896|NCT01419275|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111369897|NCT01419275|Anesthetics, General|anesthetics, general|mesh-ancestor
111369898|NCT01419275|Anesthetics|anesthetics|mesh-ancestor
111369899|NCT01419275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111369900|NCT01419275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111369901|NCT02155010|Dexmedetomidine|dexmedetomidine|mesh-list
111369902|NCT02155010|Bupivacaine|bupivacaine|mesh-list
111369903|NCT02155010|Anesthetics, Local|anesthetics, local|mesh-ancestor
111369904|NCT02155010|Anesthetics|anesthetics|mesh-ancestor
111369905|NCT02155010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111369906|NCT02155010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111369907|NCT02155010|Sensory System Agents|sensory system agents|mesh-ancestor
111369908|NCT02155010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111369909|NCT02155010|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111369910|NCT02155010|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111369911|NCT02155010|Analgesics|analgesics|mesh-ancestor
111369912|NCT02155010|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111369913|NCT02155010|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111369914|NCT02155010|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111369915|NCT02155010|Adrenergic Agents|adrenergic agents|mesh-ancestor
111369916|NCT02155010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111369917|NCT02155010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111369918|NCT01495481|Adenosine|adenosine|mesh-list
111369919|NCT01495481|Dexmedetomidine|dexmedetomidine|mesh-list
111369920|NCT01495481|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111369921|NCT01495481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111369922|NCT01495481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111369923|NCT01495481|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111369924|NCT01495481|Analgesics|analgesics|mesh-ancestor
111369925|NCT01495481|Sensory System Agents|sensory system agents|mesh-ancestor
111369926|NCT01495481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111369927|NCT01495481|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111369928|NCT01495481|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111369929|NCT01495481|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111369930|NCT01495481|Adrenergic Agents|adrenergic agents|mesh-ancestor
111369931|NCT01495481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111369932|NCT01495481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111369933|NCT01495481|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111369934|NCT01495481|Vasodilator Agents|vasodilator agents|mesh-ancestor
111369935|NCT01495481|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
111369936|NCT01495481|Purinergic Agonists|purinergic agonists|mesh-ancestor
111369937|NCT01495481|Purinergic Agents|purinergic agents|mesh-ancestor
111369938|NCT01379183|Erythromycin|erythromycin|mesh-list
111369939|NCT01379183|Erythromycin Estolate|erythromycin estolate|mesh-list
111369940|NCT01379183|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
111369941|NCT01379183|Erythromycin stearate|erythromycin stearate|mesh-list
111369942|NCT01379183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111369943|NCT01379183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111369944|NCT01379183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111369945|NCT01379183|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111369946|NCT01379183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111369947|NCT01379183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111369948|NCT01380197|Morphine|morphine|mesh-list
111369949|NCT01380197|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111369950|NCT01380197|Narcotics|narcotics|mesh-ancestor
111369951|NCT01380197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111369952|NCT01380197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111369953|NCT01380197|Analgesics|analgesics|mesh-ancestor
111369954|NCT01380197|Sensory System Agents|sensory system agents|mesh-ancestor
111369955|NCT01380197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111369956|NCT00862784|Leucovorin|leucovorin|mesh-list
111369957|NCT00862784|Folic Acid|folic acid|mesh-list
111369958|NCT00862784|Oxaliplatin|oxaliplatin|mesh-list
111369959|NCT00862784|Fluorouracil|fluorouracil|mesh-list
111369960|NCT00862784|Ramucirumab|ramucirumab|mesh-list
111369961|NCT00862784|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111369962|NCT00862784|Levoleucovorin|levoleucovorin|mesh-list
111369963|NCT00862784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111369964|NCT00862784|Antimetabolites|antimetabolites|mesh-ancestor
111369965|NCT00862784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111369966|NCT00862784|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111369967|NCT00862784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111369968|NCT00862784|Immunologic Factors|immunologic factors|mesh-ancestor
111369969|NCT00862784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111369970|NCT00862784|Antidotes|antidotes|mesh-ancestor
111369971|NCT00862784|Protective Agents|protective agents|mesh-ancestor
111369972|NCT00862784|Vitamin B Complex|vitamin b complex|mesh-ancestor
111369973|NCT00862784|Vitamins|vitamins|mesh-ancestor
111369974|NCT00862784|Micronutrients|micronutrients|mesh-ancestor
111369975|NCT00862784|Hematinics|hematinics|mesh-ancestor
111369976|NCT00864032|Sorafenib|sorafenib|mesh-list
111369977|NCT00864032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111369978|NCT00864032|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111369979|NCT00864032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111369980|NCT00864032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111369981|NCT00820664|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
111369982|NCT00820664|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
111369983|NCT00820664|Estradiol|estradiol|mesh-list
111369984|NCT00820664|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
111369985|NCT00820664|Estrogens|estrogens|mesh-ancestor
111369986|NCT00820664|Hormones|hormones|mesh-ancestor
111369987|NCT00820664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111369988|NCT00820664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111369989|NCT00820664|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111369990|NCT00820664|Contraceptive Agents|contraceptive agents|mesh-ancestor
111369991|NCT00820664|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111369992|NCT00820664|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111369993|NCT01380743|1-Deoxynojirimycin|1-deoxynojirimycin|mesh-list
111369994|NCT01380743|Antiviral Agents|antiviral agents|mesh-ancestor
111369995|NCT01380743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111369996|NCT01380743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111369997|NCT01380743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111369998|NCT01419977|Dalteparin|dalteparin|mesh-list
111369999|NCT01419977|Tinzaparin|tinzaparin|mesh-list
111370000|NCT01419977|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
111370001|NCT01419977|Anticoagulants|anticoagulants|mesh-ancestor
111370002|NCT01419977|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111370003|NCT01419977|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111370004|NCT01419977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111370005|NCT01499147|Vidarabine|vidarabine|mesh-list
111370006|NCT01499147|Fludarabine|fludarabine|mesh-list
111370007|NCT01499147|Fludarabine phosphate|fludarabine phosphate|mesh-list
111370008|NCT01499147|Melphalan|melphalan|mesh-list
111370009|NCT01499147|Busulfan|busulfan|mesh-list
111370010|NCT01499147|Thymoglobulin|thymoglobulin|mesh-list
111094424|NCT03051711|Pyrazole|pyrazole|mesh-list
111370011|NCT01499147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111370012|NCT01499147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111370013|NCT01499147|Antimetabolites|antimetabolites|mesh-ancestor
111370014|NCT01499147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111370015|NCT01499147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111370016|NCT01499147|Immunologic Factors|immunologic factors|mesh-ancestor
111370017|NCT01499147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111370018|NCT01499147|Antiviral Agents|antiviral agents|mesh-ancestor
111370019|NCT01499147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111370020|NCT01499147|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111370021|NCT01499147|Alkylating Agents|alkylating agents|mesh-ancestor
111370022|NCT01499147|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111370023|NCT00823082|Antithrombins|antithrombins|mesh-list
111370024|NCT00823082|Antithrombin III|antithrombin iii|mesh-list
111370025|NCT00823082|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111370026|NCT00823082|Protease Inhibitors|protease inhibitors|mesh-ancestor
111370027|NCT00823082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111370028|NCT00823082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111370029|NCT00823082|Anticoagulants|anticoagulants|mesh-ancestor
111370030|NCT01382303|Pentoxifylline|pentoxifylline|mesh-list
111370031|NCT01382303|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111370032|NCT01382303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111370033|NCT01382303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111370034|NCT01382303|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111370035|NCT01382303|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111370036|NCT01382303|Protective Agents|protective agents|mesh-ancestor
111370037|NCT01382303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111370038|NCT01382303|Vasodilator Agents|vasodilator agents|mesh-ancestor
111370039|NCT01382303|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111370040|NCT01382303|Antioxidants|antioxidants|mesh-ancestor
111370041|NCT05236634|Tadalafil|tadalafil|mesh-list
111370042|NCT05236634|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
111370043|NCT05236634|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
111370044|NCT05236634|Vasodilator Agents|vasodilator agents|mesh-ancestor
111370045|NCT05236634|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111370046|NCT05236634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111370047|NCT05236634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111370048|NCT05236634|Urological Agents|urological agents|mesh-ancestor
111370049|NCT05236634|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111370050|NCT05236634|Adrenergic Agents|adrenergic agents|mesh-ancestor
111370051|NCT05236634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111370052|NCT05236634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111370053|NCT01422161|Botulinum Toxins|botulinum toxins|mesh-list
111370054|NCT01422161|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111370055|NCT01422161|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111370056|NCT01422161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111370057|NCT01422161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111370058|NCT01422161|Cholinergic Agents|cholinergic agents|mesh-ancestor
111370059|NCT01422161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111370060|NCT01422161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111370061|NCT01422161|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111370062|NCT01422161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111370063|NCT05236166|Anticonvulsants|anticonvulsants|mesh-list
111370064|NCT01502813|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
111370065|NCT01502813|Nootropic Agents|nootropic agents|mesh-ancestor
111370066|NCT00865202|Tryptophan|tryptophan|mesh-list
111370067|NCT00865202|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111370068|NCT00865202|Antidepressive Agents|antidepressive agents|mesh-ancestor
111370069|NCT00865202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111370070|NCT01424033|Acetylcysteine|acetylcysteine|mesh-list
111370071|NCT01424033|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111370072|NCT01424033|Antiviral Agents|antiviral agents|mesh-ancestor
111370073|NCT01424033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111370074|NCT01424033|Expectorants|expectorants|mesh-ancestor
111370075|NCT01424033|Respiratory System Agents|respiratory system agents|mesh-ancestor
111370076|NCT01424033|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111370077|NCT01424033|Antioxidants|antioxidants|mesh-ancestor
111370078|NCT01424033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111370079|NCT01424033|Protective Agents|protective agents|mesh-ancestor
111370080|NCT01424033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111370081|NCT01424033|Antidotes|antidotes|mesh-ancestor
111370082|NCT01503749|Lenograstim|lenograstim|mesh-list
111370083|NCT01503749|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111370084|NCT01503749|Immunologic Factors|immunologic factors|mesh-ancestor
111370085|NCT01503749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111370086|NCT00867932|Eculizumab|eculizumab|mesh-list
111370087|NCT00867932|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
111370088|NCT00867932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111370089|NCT00867932|Immunologic Factors|immunologic factors|mesh-ancestor
111370090|NCT00867932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111370091|NCT00825266|Pioglitazone|pioglitazone|mesh-list
111370092|NCT00825266|Bosentan|bosentan|mesh-list
111370093|NCT00825266|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111370094|NCT00825266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111370095|NCT00825266|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111370096|NCT00825266|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
111370097|NCT00825266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111370098|NCT01385189|Aluminum Hydroxide|aluminum hydroxide|mesh-list
111370099|NCT01385189|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111370100|NCT01385189|Immunologic Factors|immunologic factors|mesh-ancestor
111370101|NCT01385189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111370102|NCT01385189|Antacids|antacids|mesh-ancestor
111370103|NCT01385189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111370104|NCT01385189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111370105|NCT01386983|Finasteride|finasteride|mesh-list
111370106|NCT01386983|Dutasteride|dutasteride|mesh-list
111370107|NCT01386983|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
111370108|NCT01386983|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111370109|NCT01386983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111370110|NCT01386983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111370111|NCT01386983|Hormone Antagonists|hormone antagonists|mesh-ancestor
111370112|NCT01386983|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111370113|NCT01386983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111370114|NCT01386983|Urological Agents|urological agents|mesh-ancestor
111370115|NCT01387139|Ketamine|ketamine|mesh-list
111370116|NCT01387139|Propofol|propofol|mesh-list
111370117|NCT01387139|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111370118|NCT01387139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111370119|NCT01387139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111370120|NCT01387139|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111370121|NCT01387139|Anesthetics, General|anesthetics, general|mesh-ancestor
111370122|NCT01387139|Anesthetics|anesthetics|mesh-ancestor
111370123|NCT01387139|Analgesics|analgesics|mesh-ancestor
111370124|NCT01387139|Sensory System Agents|sensory system agents|mesh-ancestor
111370125|NCT01387139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111370126|NCT01387139|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111370127|NCT01387139|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111370128|NCT01387139|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111370129|NCT01387139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111370130|NCT01387139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111370131|NCT00870896|Tiotropium Bromide|tiotropium bromide|mesh-list
111370132|NCT00870896|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111370133|NCT00870896|Autonomic Agents|autonomic agents|mesh-ancestor
111370134|NCT00870896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111370135|NCT00870896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111370136|NCT00870896|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111370137|NCT00870896|Respiratory System Agents|respiratory system agents|mesh-ancestor
111370138|NCT00870896|Parasympatholytics|parasympatholytics|mesh-ancestor
111370139|NCT00870896|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111370140|NCT00870896|Cholinergic Agents|cholinergic agents|mesh-ancestor
111370141|NCT00870896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111370142|NCT00870896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111370143|NCT00825344|Etanercept|etanercept|mesh-list
111370144|NCT00825344|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111370145|NCT00825344|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111370146|NCT00825344|Analgesics|analgesics|mesh-ancestor
111370147|NCT00825344|Sensory System Agents|sensory system agents|mesh-ancestor
111370148|NCT00825344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111370149|NCT00825344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111370150|NCT00825344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111370151|NCT00825344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111370152|NCT00825344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111370153|NCT00825344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111370154|NCT00825344|Immunologic Factors|immunologic factors|mesh-ancestor
111370155|NCT01426763|Complement C1s|complement c1s|mesh-list
111370156|NCT01426763|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
111370157|NCT01426763|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
111370158|NCT01426763|Immunologic Factors|immunologic factors|mesh-ancestor
111370159|NCT01426763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111370160|NCT01426763|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
111094583|NCT04894617|Analgesics|analgesics|mesh-ancestor
111370161|NCT01426763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111370162|NCT00825500|Loxapine|loxapine|mesh-list
111370163|NCT00825500|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111370164|NCT00825500|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111370165|NCT00825500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111370166|NCT00825500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111370167|NCT00825500|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111370168|NCT00825500|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111370169|NCT00825500|Dopamine Agents|dopamine agents|mesh-ancestor
111370170|NCT00825500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111370171|NCT00825500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111370172|NCT01505933|Dexmedetomidine|dexmedetomidine|mesh-list
111370173|NCT01505933|Propofol|propofol|mesh-list
111370174|NCT01505933|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111370175|NCT01505933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111370176|NCT01505933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111370177|NCT01505933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111370178|NCT01505933|Analgesics|analgesics|mesh-ancestor
111370179|NCT01505933|Sensory System Agents|sensory system agents|mesh-ancestor
111370180|NCT01505933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110509834|NCT00865111|Dopamine Agents|dopamine agents|mesh-ancestor
111370181|NCT01505933|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111370182|NCT01505933|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111370183|NCT01505933|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111370184|NCT01505933|Adrenergic Agents|adrenergic agents|mesh-ancestor
111370185|NCT01505933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111370186|NCT01505933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111370187|NCT01505933|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111370188|NCT01505933|Anesthetics, General|anesthetics, general|mesh-ancestor
111370189|NCT01505933|Anesthetics|anesthetics|mesh-ancestor
111370190|NCT00825734|Sorafenib|sorafenib|mesh-list
111370191|NCT00825734|Epothilones|epothilones|mesh-list
111370192|NCT00825734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111370193|NCT00825734|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111370194|NCT00825734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111370195|NCT00825734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111370196|NCT00825734|Tubulin Modulators|tubulin modulators|mesh-ancestor
111370197|NCT00825734|Antimitotic Agents|antimitotic agents|mesh-ancestor
111370198|NCT00825734|Mitosis Modulators|mitosis modulators|mesh-ancestor
111370199|NCT00872534|Aspirin|aspirin|mesh-list
111370200|NCT00872534|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111370201|NCT00872534|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111370202|NCT00872534|Analgesics|analgesics|mesh-ancestor
111370203|NCT00872534|Sensory System Agents|sensory system agents|mesh-ancestor
111370204|NCT00872534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111370205|NCT00872534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111370206|NCT00872534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111370207|NCT00872534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111370208|NCT00872534|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111370209|NCT00872534|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111370210|NCT00872534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111370211|NCT00872534|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111370212|NCT00872534|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111370213|NCT00872534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111370214|NCT00872534|Antipyretics|antipyretics|mesh-ancestor
111370215|NCT02513160|Beclomethasone|beclomethasone|mesh-list
111370216|NCT02513160|Albuterol|albuterol|mesh-list
111370217|NCT02513160|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111370218|NCT02513160|Autonomic Agents|autonomic agents|mesh-ancestor
111370219|NCT02513160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111370220|NCT02513160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111370221|NCT02513160|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111370222|NCT02513160|Respiratory System Agents|respiratory system agents|mesh-ancestor
111370223|NCT02513160|Tocolytic Agents|tocolytic agents|mesh-ancestor
111370224|NCT02513160|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111370225|NCT02513160|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111370226|NCT02513160|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111370227|NCT02513160|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111370228|NCT02513160|Adrenergic Agents|adrenergic agents|mesh-ancestor
111370229|NCT02513160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111370230|NCT02513160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111370231|NCT02513160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111370232|NCT02513160|Glucocorticoids|glucocorticoids|mesh-ancestor
111370233|NCT02513160|Hormones|hormones|mesh-ancestor
111370234|NCT02513160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111370235|NCT01507103|Cyclophosphamide|cyclophosphamide|mesh-list
111370236|NCT01507103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111370237|NCT01507103|Immunologic Factors|immunologic factors|mesh-ancestor
111370238|NCT01507103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111370239|NCT01507103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111370240|NCT01507103|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111370241|NCT01507103|Alkylating Agents|alkylating agents|mesh-ancestor
111370242|NCT01507103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111370243|NCT01507103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111370244|NCT01507103|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111370245|NCT02480010|Pertuzumab|pertuzumab|mesh-list
111370246|NCT02480010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111370247|NCT02480010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111370248|NCT00876200|Minoxidil|minoxidil|mesh-list
111370249|NCT00876200|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111370250|NCT00876200|Vasodilator Agents|vasodilator agents|mesh-ancestor
111370251|NCT02512302|Glycopyrrolate|glycopyrrolate|mesh-list
111370252|NCT02512302|Bromides|bromides|mesh-list
111370253|NCT02512302|Charcoal|charcoal|mesh-list
111370254|NCT02512302|Anticonvulsants|anticonvulsants|mesh-ancestor
111370255|NCT02512302|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111370256|NCT02512302|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111370257|NCT02512302|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111370258|NCT02512302|Cholinergic Agents|cholinergic agents|mesh-ancestor
111370259|NCT02512302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111370260|NCT02512302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111370261|NCT02512302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111370262|NCT02512302|Antidotes|antidotes|mesh-ancestor
111370263|NCT02512302|Protective Agents|protective agents|mesh-ancestor
111370264|NCT01507181|Midazolam|midazolam|mesh-list
111370265|NCT01507181|Ketamine|ketamine|mesh-list
111370266|NCT01507181|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-list
111370267|NCT01507181|N-Methylaspartate|n-methylaspartate|mesh-list
111370268|NCT01507181|Analgesics|analgesics|mesh-ancestor
111370269|NCT01507181|Sensory System Agents|sensory system agents|mesh-ancestor
111370270|NCT01507181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111370271|NCT01507181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111370272|NCT01507181|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111370273|NCT01507181|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111370274|NCT01507181|Anesthetics, General|anesthetics, general|mesh-ancestor
111370275|NCT01507181|Anesthetics|anesthetics|mesh-ancestor
111370276|NCT01507181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111370277|NCT01507181|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111370278|NCT01507181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111370279|NCT01507181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111370280|NCT01507181|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111370281|NCT01507181|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111370282|NCT01507181|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111370283|NCT01507181|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111370284|NCT01507181|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111370285|NCT01507181|GABA Modulators|gaba modulators|mesh-ancestor
111370286|NCT01507181|GABA Agents|gaba agents|mesh-ancestor
111370287|NCT01507181|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
111370288|NCT01428245|Estradiol|estradiol|mesh-list
111370289|NCT01428245|Estrogens|estrogens|mesh-list
111370290|NCT01428245|Progesterone|progesterone|mesh-list
111370291|NCT01428245|Hormones|hormones|mesh-ancestor
111370292|NCT01428245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111370293|NCT01428245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111370294|NCT01428245|Progestins|progestins|mesh-ancestor
111370295|NCT00877370|Ertapenem|ertapenem|mesh-list
111370296|NCT00877370|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111370297|NCT00877370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111370298|NCT00877604|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
111370299|NCT00877604|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
111370300|NCT00877604|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111370301|NCT00877604|Antiviral Agents|antiviral agents|mesh-ancestor
111370302|NCT00877604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111370303|NCT01508117|Axitinib|axitinib|mesh-list
111370304|NCT01508117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111370305|NCT01508117|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111370306|NCT01508117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111370307|NCT01508117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111370308|NCT00878228|Ondansetron|ondansetron|mesh-list
111370309|NCT00878228|Antiemetics|antiemetics|mesh-ancestor
111370310|NCT00878228|Autonomic Agents|autonomic agents|mesh-ancestor
111094723|NCT04885803|Vitamin D|vitamin d|mesh-list
111370311|NCT00878228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111370312|NCT00878228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111370313|NCT00878228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111370314|NCT00878228|Antipruritics|antipruritics|mesh-ancestor
111370315|NCT00878228|Dermatologic Agents|dermatologic agents|mesh-ancestor
111370316|NCT00878228|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111370317|NCT00878228|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111370318|NCT00878228|Serotonin Agents|serotonin agents|mesh-ancestor
111370319|NCT00878228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111370320|NCT00878228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111370321|NCT01391273|Bimatoprost|bimatoprost|mesh-list
111370322|NCT01391273|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111370323|NCT01391273|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111370324|NCT01429259|Meropenem|meropenem|mesh-list
111370325|NCT01429259|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111370326|NCT01429259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111370327|NCT05177198|Clindamycin|clindamycin|mesh-list
111370328|NCT05177198|Clindamycin palmitate|clindamycin palmitate|mesh-list
111370329|NCT05177198|Clindamycin phosphate|clindamycin phosphate|mesh-list
111370330|NCT05177198|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111370331|NCT05177198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111370332|NCT05177198|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111370333|NCT05177198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111370334|NCT05177198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111370335|NCT01392989|Cyclosporine|cyclosporine|mesh-list
111370336|NCT01392989|Mycophenolic Acid|mycophenolic acid|mesh-list
111370337|NCT01392989|Cyclosporins|cyclosporins|mesh-list
111370338|NCT01392989|Thymoglobulin|thymoglobulin|mesh-list
111370339|NCT01392989|Antilymphocyte Serum|antilymphocyte serum|mesh-list
111370340|NCT01392989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111370341|NCT01392989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111370342|NCT01392989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111370343|NCT01392989|Immunologic Factors|immunologic factors|mesh-ancestor
111370344|NCT01392989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111370345|NCT01392989|Antifungal Agents|antifungal agents|mesh-ancestor
111370346|NCT01392989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111370347|NCT01392989|Dermatologic Agents|dermatologic agents|mesh-ancestor
111370348|NCT01392989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111370349|NCT01392989|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111370350|NCT01392989|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111370351|NCT01392989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111370352|NCT01392989|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111370353|NCT01392989|Antitubercular Agents|antitubercular agents|mesh-ancestor
111370354|NCT01392989|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111370355|NCT01393457|Levodopa|levodopa|mesh-list
111370356|NCT01393457|Carbidopa|carbidopa|mesh-list
111370357|NCT01393457|Ropinirole|ropinirole|mesh-list
111370358|NCT01393457|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111370359|NCT01393457|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111370360|NCT01393457|Dopamine Agents|dopamine agents|mesh-ancestor
111370361|NCT01393457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111370362|NCT01393457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111370363|NCT01393457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111370364|NCT01393457|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
111370365|NCT01393457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111370366|NCT01393457|Dopamine Agonists|dopamine agonists|mesh-ancestor
111370367|NCT02518464|Ticagrelor|ticagrelor|mesh-list
111370368|NCT02518464|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111370369|NCT02518464|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111370370|NCT02518464|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111370371|NCT02518464|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111370372|NCT02518464|Purinergic Agents|purinergic agents|mesh-ancestor
111370373|NCT02518464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111370374|NCT02518464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111370375|NCT02518464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111370376|NCT02479230|Gemcitabine|gemcitabine|mesh-list
111370377|NCT02479230|Vaccines|vaccines|mesh-list
111370378|NCT02479230|Immunologic Factors|immunologic factors|mesh-ancestor
111370379|NCT02479230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111370380|NCT02479230|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111370381|NCT02479230|Antimetabolites|antimetabolites|mesh-ancestor
111370382|NCT02479230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111370383|NCT02479230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111370384|NCT04985136|Sorafenib|sorafenib|mesh-list
111370385|NCT04985136|Apatinib|apatinib|mesh-list
111370386|NCT04985136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111370387|NCT04985136|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111370388|NCT04985136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111370389|NCT04985136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111370390|NCT04411446|Vitamin D|vitamin d|mesh-list
111370391|NCT04411446|Cholecalciferol|cholecalciferol|mesh-list
111370392|NCT04411446|Vitamins|vitamins|mesh-ancestor
111370393|NCT04411446|Micronutrients|micronutrients|mesh-ancestor
111370394|NCT04411446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111370395|NCT04411446|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111370396|NCT04411446|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111370397|NCT01510379|Promethazine|promethazine|mesh-list
111370398|NCT01510379|Diphenhydramine|diphenhydramine|mesh-list
111370399|NCT01510379|Ondansetron|ondansetron|mesh-list
111370400|NCT01510379|Antiemetics|antiemetics|mesh-ancestor
111370401|NCT01510379|Autonomic Agents|autonomic agents|mesh-ancestor
111370402|NCT01510379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111370403|NCT01510379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111370404|NCT01510379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111370405|NCT01510379|Antipruritics|antipruritics|mesh-ancestor
111370406|NCT01510379|Dermatologic Agents|dermatologic agents|mesh-ancestor
111370407|NCT01510379|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111370408|NCT01510379|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111370409|NCT01510379|Serotonin Agents|serotonin agents|mesh-ancestor
111370410|NCT01510379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111370411|NCT01510379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111370412|NCT01510379|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111370413|NCT01510379|Histamine Antagonists|histamine antagonists|mesh-ancestor
111370414|NCT01510379|Histamine Agents|histamine agents|mesh-ancestor
111370415|NCT01510379|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111370416|NCT01510379|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111370417|NCT01510379|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111370418|NCT01510379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111370419|NCT01510379|Anesthetics, Local|anesthetics, local|mesh-ancestor
111370420|NCT01510379|Anesthetics|anesthetics|mesh-ancestor
111370421|NCT01510379|Sensory System Agents|sensory system agents|mesh-ancestor
111370422|NCT01363986|Trastuzumab|trastuzumab|mesh-list
111370423|NCT01363986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111370424|NCT01363986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111370425|NCT01510457|Milnacipran|milnacipran|mesh-list
111370426|NCT01510457|Levomilnacipran|levomilnacipran|mesh-list
111370427|NCT01510457|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111370428|NCT01510457|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111370429|NCT01510457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111370430|NCT01510457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111370431|NCT01510457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111370432|NCT01510457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111370433|NCT01510457|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111370434|NCT01510457|Analgesics|analgesics|mesh-ancestor
111370435|NCT01510457|Sensory System Agents|sensory system agents|mesh-ancestor
110510088|NCT02805426|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111370436|NCT01510457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111370437|NCT01510457|Antidepressive Agents|antidepressive agents|mesh-ancestor
111370438|NCT01510457|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111370439|NCT02478372|Bupivacaine|bupivacaine|mesh-list
111370440|NCT02478372|Ropivacaine|ropivacaine|mesh-list
111370441|NCT02478372|Levobupivacaine|levobupivacaine|mesh-list
111370442|NCT02478372|Anesthetics, Local|anesthetics, local|mesh-ancestor
111370443|NCT02478372|Anesthetics|anesthetics|mesh-ancestor
111370444|NCT02478372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111370445|NCT02478372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111370446|NCT02478372|Sensory System Agents|sensory system agents|mesh-ancestor
111370447|NCT02478372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111370448|NCT01511315|Ustekinumab|ustekinumab|mesh-list
111370449|NCT01511315|Dermatologic Agents|dermatologic agents|mesh-ancestor
111370450|NCT01654536|Ciclesonide|ciclesonide|mesh-list
111370451|NCT01654536|Glucocorticoids|glucocorticoids|mesh-ancestor
111370452|NCT01654536|Hormones|hormones|mesh-ancestor
111370453|NCT01654536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111370454|NCT01654536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111370455|NCT01654536|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111370456|NCT01654380|Insulin Glargine|insulin glargine|mesh-list
111370457|NCT01654380|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111370458|NCT01654380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111370459|NCT02509026|Etanercept|etanercept|mesh-list
111370460|NCT02509026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111370461|NCT02509026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111370462|NCT02509026|Analgesics|analgesics|mesh-ancestor
111370463|NCT02509026|Sensory System Agents|sensory system agents|mesh-ancestor
111094878|NCT04876521|Olanzapine|olanzapine|mesh-list
111370464|NCT02509026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111370465|NCT02509026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111370466|NCT02509026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111370467|NCT02509026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111370468|NCT02509026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111370469|NCT02509026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111370470|NCT02509026|Immunologic Factors|immunologic factors|mesh-ancestor
111370471|NCT03439280|Dexamethasone|dexamethasone|mesh-list
111370472|NCT03439280|Pomalidomide|pomalidomide|mesh-list
111370473|NCT03439280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111370474|NCT03439280|Antiemetics|antiemetics|mesh-ancestor
111370475|NCT03439280|Autonomic Agents|autonomic agents|mesh-ancestor
111370476|NCT03439280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111370477|NCT03439280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111370478|NCT03439280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111370479|NCT03439280|Glucocorticoids|glucocorticoids|mesh-ancestor
111370480|NCT03439280|Hormones|hormones|mesh-ancestor
111370481|NCT03439280|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111370482|NCT03439280|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111370483|NCT03439280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111370484|NCT03439280|Immunologic Factors|immunologic factors|mesh-ancestor
111370485|NCT03439280|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111370486|NCT03439280|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111370487|NCT03439280|Growth Substances|growth substances|mesh-ancestor
111370488|NCT03439280|Growth Inhibitors|growth inhibitors|mesh-ancestor
111370489|NCT00828074|Sorafenib|sorafenib|mesh-list
111370490|NCT00828074|Vinorelbine|vinorelbine|mesh-list
111370491|NCT00828074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111370492|NCT00828074|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111370493|NCT00828074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111370494|NCT00828074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111370495|NCT00828074|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111370496|NCT00828074|Tubulin Modulators|tubulin modulators|mesh-ancestor
111370497|NCT00828074|Antimitotic Agents|antimitotic agents|mesh-ancestor
111370498|NCT00828074|Mitosis Modulators|mitosis modulators|mesh-ancestor
111370499|NCT03434444|Propranolol|propranolol|mesh-list
111370500|NCT03434444|Oxytocin|oxytocin|mesh-list
111370501|NCT03434444|Oxytocics|oxytocics|mesh-ancestor
111370502|NCT03434444|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111370503|NCT03434444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111370504|NCT03434444|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111370505|NCT03434444|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111370506|NCT03434444|Adrenergic Agents|adrenergic agents|mesh-ancestor
111370507|NCT03434444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111370508|NCT03434444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111370509|NCT03434444|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111370510|NCT03434444|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111370511|NCT03434444|Vasodilator Agents|vasodilator agents|mesh-ancestor
111370512|NCT04382300|Thalidomide|thalidomide|mesh-list
111370513|NCT04382300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111370514|NCT04382300|Immunologic Factors|immunologic factors|mesh-ancestor
111370515|NCT04382300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111370516|NCT04382300|Leprostatic Agents|leprostatic agents|mesh-ancestor
111370517|NCT04382300|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111370518|NCT04382300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111370519|NCT04382300|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111370520|NCT04382300|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111370521|NCT04382300|Growth Substances|growth substances|mesh-ancestor
111370522|NCT04382300|Growth Inhibitors|growth inhibitors|mesh-ancestor
111370523|NCT04382300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111370524|NCT01430819|Vaccines|vaccines|mesh-list
111370525|NCT01430819|Immunologic Factors|immunologic factors|mesh-ancestor
111370526|NCT01430819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111370527|NCT00828542|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
111370528|NCT00828542|Medroxyprogesterone|medroxyprogesterone|mesh-list
111370529|NCT00828542|Desogestrel|desogestrel|mesh-list
111370530|NCT00828542|Etonogestrel|etonogestrel|mesh-list
111370531|NCT00828542|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111370532|NCT00828542|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111370533|NCT00828542|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111370534|NCT00828542|Contraceptive Agents|contraceptive agents|mesh-ancestor
111370535|NCT00828542|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111370536|NCT00828542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111370537|NCT00828542|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111094948|NCT04875819|Immunologic Factors|immunologic factors|mesh-ancestor
111370538|NCT00828542|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111370539|NCT00828542|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
111370540|NCT00828542|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111370541|NCT00828542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111370542|NCT00828542|Progestins|progestins|mesh-ancestor
111370543|NCT00828542|Hormones|hormones|mesh-ancestor
111370544|NCT00828542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111370545|NCT01395329|Metoprolol|metoprolol|mesh-list
111370546|NCT01395329|Nebivolol|nebivolol|mesh-list
111370547|NCT01395329|Nitroprusside|nitroprusside|mesh-list
111370548|NCT01395329|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
111370549|NCT01395329|BQ 788|bq 788|mesh-list
111370550|NCT01395329|Acetylcholine|acetylcholine|mesh-list
111370551|NCT01395329|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111370552|NCT01395329|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111370553|NCT01395329|Sympatholytics|sympatholytics|mesh-ancestor
111370554|NCT01395329|Autonomic Agents|autonomic agents|mesh-ancestor
111370555|NCT01395329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111370556|NCT01395329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111370557|NCT01395329|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
111370558|NCT01395329|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111370559|NCT01395329|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111370560|NCT01395329|Adrenergic Agents|adrenergic agents|mesh-ancestor
111370561|NCT01395329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111370562|NCT01395329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111370563|NCT01395329|Vasodilator Agents|vasodilator agents|mesh-ancestor
110510214|NCT00864019|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111370564|NCT01395329|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
111370565|NCT01395329|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111370566|NCT01395329|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111370567|NCT01395329|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
111370568|NCT01395329|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111370569|NCT01395329|Cholinergic Agents|cholinergic agents|mesh-ancestor
111370570|NCT01395329|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
111370571|NCT01395329|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
111370572|NCT00882206|Cytarabine|cytarabine|mesh-list
111370573|NCT00882206|Prednisone|prednisone|mesh-list
111370574|NCT00882206|Doxorubicin|doxorubicin|mesh-list
111370575|NCT00882206|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111370576|NCT00882206|Methotrexate|methotrexate|mesh-list
111370577|NCT00882206|Vincristine|vincristine|mesh-list
111370578|NCT00882206|Imatinib Mesylate|imatinib mesylate|mesh-list
111370579|NCT00882206|Decitabine|decitabine|mesh-list
111370580|NCT00882206|Asparaginase|asparaginase|mesh-list
111370581|NCT00882206|Vorinostat|vorinostat|mesh-list
111370582|NCT00882206|Pegaspargase|pegaspargase|mesh-list
111370583|NCT00882206|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111370584|NCT00882206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111370585|NCT00882206|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111370586|NCT00882206|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111370587|NCT00882206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111370588|NCT00882206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111370589|NCT00882206|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111370590|NCT00882206|Glucocorticoids|glucocorticoids|mesh-ancestor
111370591|NCT00882206|Hormones|hormones|mesh-ancestor
111370592|NCT00882206|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111370593|NCT00882206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111370594|NCT00882206|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111370595|NCT00882206|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111370596|NCT00882206|Abortifacient Agents|abortifacient agents|mesh-ancestor
111370597|NCT00882206|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111370598|NCT00882206|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111370599|NCT00882206|Antimetabolites|antimetabolites|mesh-ancestor
111370600|NCT00882206|Dermatologic Agents|dermatologic agents|mesh-ancestor
111370601|NCT00882206|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111370602|NCT00882206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111370603|NCT00882206|Immunologic Factors|immunologic factors|mesh-ancestor
111370604|NCT00882206|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111370605|NCT00882206|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111370606|NCT00882206|Antiviral Agents|antiviral agents|mesh-ancestor
111370607|NCT00882206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111370608|NCT00882206|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111370609|NCT00882206|Tubulin Modulators|tubulin modulators|mesh-ancestor
111370610|NCT00882206|Antimitotic Agents|antimitotic agents|mesh-ancestor
111370611|NCT00882206|Mitosis Modulators|mitosis modulators|mesh-ancestor
111370612|NCT00882206|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111370613|NCT00882206|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111370614|NCT00831272|Naltrexone|naltrexone|mesh-list
111370615|NCT00831272|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111370616|NCT00831272|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111370617|NCT00831272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111370618|NCT00831272|Sensory System Agents|sensory system agents|mesh-ancestor
111370619|NCT00831272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111370620|NCT00885092|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111370621|NCT01512251|Vemurafenib|vemurafenib|mesh-list
111370622|NCT01512251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111370623|NCT01512251|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111370624|NCT01512251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111370625|NCT01512251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111370626|NCT00885638|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111370627|NCT00885638|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111370628|NCT00885638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111370629|NCT00885638|Incretins|incretins|mesh-ancestor
111370630|NCT00885638|Hormones|hormones|mesh-ancestor
111370631|NCT00885638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111370632|NCT00885638|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110157632|NCT00276601|Cytarabine|cytarabine|mesh-list
111370633|NCT00885638|Protease Inhibitors|protease inhibitors|mesh-ancestor
111370634|NCT00885638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111370635|NCT00885638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111370636|NCT01512797|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111370637|NCT01512797|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111370638|NCT01512797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111370639|NCT01512797|Incretins|incretins|mesh-ancestor
111370640|NCT01512797|Hormones|hormones|mesh-ancestor
111370641|NCT01512797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111370642|NCT01512797|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111370643|NCT01512797|Protease Inhibitors|protease inhibitors|mesh-ancestor
111370644|NCT01512797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111370645|NCT01512797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111370646|NCT05620940|Naltrexone|naltrexone|mesh-list
111370647|NCT05620940|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111370648|NCT05620940|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111370649|NCT05620940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111370650|NCT05620940|Sensory System Agents|sensory system agents|mesh-ancestor
111370651|NCT05620940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111370652|NCT01395797|Pioglitazone|pioglitazone|mesh-list
111370653|NCT01395797|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111370654|NCT01395797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111370655|NCT05124704|Ropivacaine|ropivacaine|mesh-list
111370656|NCT05124704|Anesthetics, Local|anesthetics, local|mesh-ancestor
111370657|NCT05124704|Anesthetics|anesthetics|mesh-ancestor
111370658|NCT05124704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111370659|NCT05124704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111370660|NCT05124704|Sensory System Agents|sensory system agents|mesh-ancestor
111370661|NCT05124704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111370662|NCT02203019|Fentanyl|fentanyl|mesh-list
111370663|NCT02203019|Dexmedetomidine|dexmedetomidine|mesh-list
111370664|NCT02203019|Propofol|propofol|mesh-list
111370665|NCT02203019|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111370666|NCT02203019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111370667|NCT02203019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111370668|NCT02203019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111370669|NCT02203019|Analgesics|analgesics|mesh-ancestor
111370670|NCT02203019|Sensory System Agents|sensory system agents|mesh-ancestor
111370671|NCT02203019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111370672|NCT02203019|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111370673|NCT02203019|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111370674|NCT02203019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111370675|NCT02203019|Adrenergic Agents|adrenergic agents|mesh-ancestor
111370676|NCT02203019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111370677|NCT02203019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111370678|NCT02203019|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111370679|NCT02203019|Anesthetics, General|anesthetics, general|mesh-ancestor
111370680|NCT02203019|Anesthetics|anesthetics|mesh-ancestor
111370681|NCT02203019|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111370682|NCT02203019|Narcotics|narcotics|mesh-ancestor
111370683|NCT02203019|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111370684|NCT00886262|Vasopressins|vasopressins|mesh-list
111370685|NCT00886262|Arginine Vasopressin|arginine vasopressin|mesh-list
111370686|NCT00886262|Hemostatics|hemostatics|mesh-ancestor
111370687|NCT00886262|Coagulants|coagulants|mesh-ancestor
111370688|NCT00886262|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111370689|NCT00886262|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
111370690|NCT00886262|Natriuretic Agents|natriuretic agents|mesh-ancestor
111370691|NCT00886262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111370693|NCT00887510|Trandolapril|trandolapril|mesh-list
111370694|NCT00887510|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111370695|NCT00887510|Diuretics|diuretics|mesh-ancestor
111370696|NCT00887510|Natriuretic Agents|natriuretic agents|mesh-ancestor
111370697|NCT00887510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111370698|NCT00887510|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
111370699|NCT00887510|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111370700|NCT00887510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111370701|NCT00887510|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
111370702|NCT00887510|Protease Inhibitors|protease inhibitors|mesh-ancestor
111370703|NCT00887510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111370704|NCT01431989|Amoxicillin|amoxicillin|mesh-list
111370705|NCT01431989|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111370706|NCT01431989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111370707|NCT01397591|Bortezomib|bortezomib|mesh-list
111370708|NCT01397591|Ofatumumab|ofatumumab|mesh-list
111370709|NCT01397591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111370710|NCT03855332|Cilostazol|cilostazol|mesh-list
111370711|NCT03855332|Sildenafil Citrate|sildenafil citrate|mesh-list
111370712|NCT03855332|Vasodilator Agents|vasodilator agents|mesh-ancestor
111370713|NCT03855332|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111370714|NCT03855332|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111370715|NCT03855332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111370716|NCT03855332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111370717|NCT03855332|Urological Agents|urological agents|mesh-ancestor
111370718|NCT03855332|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111370719|NCT03855332|Autonomic Agents|autonomic agents|mesh-ancestor
111370720|NCT03855332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111370721|NCT03855332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111370722|NCT03855332|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111370723|NCT03855332|Respiratory System Agents|respiratory system agents|mesh-ancestor
111370724|NCT03855332|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111370725|NCT03855332|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111370726|NCT03855332|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111370727|NCT03855332|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111370728|NCT03855332|Protective Agents|protective agents|mesh-ancestor
111370729|NCT03855332|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
111370730|NCT02335580|Somatostatin|somatostatin|mesh-list
111370731|NCT02335580|Hormones|hormones|mesh-ancestor
111370732|NCT02335580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111370733|NCT02335580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111370734|NCT02476968|Olaparib|olaparib|mesh-list
111370735|NCT02476968|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111370736|NCT02476968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111370737|NCT02476968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111370738|NCT02476968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111370739|NCT01514513|Permethrin|permethrin|mesh-list
111370740|NCT01514513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111370741|NCT01514513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111370742|NCT04981860|Povidone-Iodine|povidone-iodine|mesh-list
111370743|NCT04981860|Povidone|povidone|mesh-list
111370744|NCT04981860|Plasma Substitutes|plasma substitutes|mesh-ancestor
111370745|NCT04981860|Blood Substitutes|blood substitutes|mesh-ancestor
111370746|NCT04981860|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111370747|NCT04981860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111370748|NCT01432145|Methotrexate|methotrexate|mesh-list
111370749|NCT01432145|Mercaptopurine|mercaptopurine|mesh-list
111370750|NCT01432145|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111370751|NCT01432145|Abortifacient Agents|abortifacient agents|mesh-ancestor
111370752|NCT01432145|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111370753|NCT01432145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111370754|NCT01432145|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111370755|NCT01432145|Antimetabolites|antimetabolites|mesh-ancestor
111370756|NCT01432145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111370757|NCT01432145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111370758|NCT01432145|Dermatologic Agents|dermatologic agents|mesh-ancestor
111370759|NCT01432145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111370760|NCT01432145|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111370761|NCT01432145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111370762|NCT01432145|Immunologic Factors|immunologic factors|mesh-ancestor
111370763|NCT01432145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110959212|NCT02582632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111370764|NCT01432145|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111370765|NCT04979520|Brodalumab|brodalumab|mesh-list
111370766|NCT04979520|Dermatologic Agents|dermatologic agents|mesh-ancestor
111370767|NCT01432379|Botulinum Toxins|botulinum toxins|mesh-list
111370768|NCT01432379|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111370769|NCT01432379|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111370770|NCT01432379|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111370771|NCT01432379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111370772|NCT01432379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111370773|NCT01432379|Cholinergic Agents|cholinergic agents|mesh-ancestor
111370774|NCT01432379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111370775|NCT01432379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111370776|NCT01432379|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111370777|NCT01432379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111370778|NCT02504892|Everolimus|everolimus|mesh-list
111370779|NCT02504892|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111370780|NCT02504892|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111370781|NCT02504892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111370782|NCT02504892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111370783|NCT02504892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111370784|NCT02504892|Immunologic Factors|immunologic factors|mesh-ancestor
111370785|NCT02504892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111370786|NCT02504892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111370787|NCT01432535|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
111370788|NCT01432535|Antiviral Agents|antiviral agents|mesh-ancestor
111370789|NCT01432535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111370790|NCT05946811|Macitentan|macitentan|mesh-list
111370791|NCT05946811|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
111370792|NCT05946811|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
111370793|NCT05946811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111370794|NCT05946811|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
111370795|NCT05946772|Cyclosporine|cyclosporine|mesh-list
111370796|NCT05946772|Cyclosporins|cyclosporins|mesh-list
111370797|NCT05946772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111370798|NCT05946772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111370799|NCT05946772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111370800|NCT05946772|Immunologic Factors|immunologic factors|mesh-ancestor
111370801|NCT05946772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111370802|NCT05946772|Antifungal Agents|antifungal agents|mesh-ancestor
111370803|NCT05946772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111370804|NCT05946772|Dermatologic Agents|dermatologic agents|mesh-ancestor
111370805|NCT05946772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111370806|NCT05946772|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111370807|NCT05946655|Metronidazole|metronidazole|mesh-list
111370808|NCT05946655|Ofloxacin|ofloxacin|mesh-list
111370809|NCT05946655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111370810|NCT05946655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111370811|NCT05946655|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111370812|NCT05946655|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111370813|NCT05946655|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111370814|NCT05946655|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111370815|NCT05946655|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111370816|NCT05946655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111370817|NCT05946655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111370818|NCT05946655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111370819|NCT05946655|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111370820|NCT05946655|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111370821|NCT05946642|Ivermectin|ivermectin|mesh-list
111370822|NCT05946642|Pyrimethamine|pyrimethamine|mesh-list
111370823|NCT05946642|Piperaquine|piperaquine|mesh-list
111370824|NCT05946642|Sulfadoxine|sulfadoxine|mesh-list
111370825|NCT05946642|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
111370826|NCT05946642|Amodiaquine|amodiaquine|mesh-list
111370827|NCT05946642|Artenimol|artenimol|mesh-list
111370828|NCT05946642|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111370829|NCT05946642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111370830|NCT05946642|Antimalarials|antimalarials|mesh-ancestor
111370831|NCT05946642|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111370832|NCT05946642|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111370833|NCT05946642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111370834|NCT05946642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111370835|NCT05946642|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111370836|NCT05946564|Pioglitazone|pioglitazone|mesh-list
111370837|NCT05946564|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111370838|NCT05946564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111370839|NCT05946486|Rituximab|rituximab|mesh-list
111370840|NCT05946486|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111370841|NCT05946486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111370842|NCT05946486|Immunologic Factors|immunologic factors|mesh-ancestor
111370843|NCT05946486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111370844|NCT05946486|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111370845|NCT05946148|Empagliflozin|empagliflozin|mesh-list
111370846|NCT05946148|Dulaglutide|dulaglutide|mesh-list
111370847|NCT05946148|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111370848|NCT05946148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111370849|NCT05946148|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111370850|NCT05946148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111370851|NCT05946135|Lansoprazole|lansoprazole|mesh-list
111370852|NCT05946135|Dexlansoprazole|dexlansoprazole|mesh-list
111370853|NCT05946135|Fexuprazan|fexuprazan|mesh-list
111370854|NCT05946135|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111370855|NCT05946135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111370856|NCT05946135|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111370857|NCT05946135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111370858|NCT05946135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111370859|NCT05946122|Atorvastatin|atorvastatin|mesh-list
111370860|NCT05946122|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111370861|NCT05946122|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111370862|NCT05946122|Antimetabolites|antimetabolites|mesh-ancestor
111370863|NCT05946122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111370864|NCT05946122|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111370865|NCT05946122|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111370866|NCT05946122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111370867|NCT05946005|Povidone-Iodine|povidone-iodine|mesh-list
111370868|NCT05946005|Lidocaine|lidocaine|mesh-list
111370869|NCT05946005|Povidone|povidone|mesh-list
111370870|NCT05946005|Anesthetics, Local|anesthetics, local|mesh-ancestor
111370871|NCT05946005|Anesthetics|anesthetics|mesh-ancestor
111370872|NCT05946005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111370873|NCT05946005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111370874|NCT05946005|Sensory System Agents|sensory system agents|mesh-ancestor
111370875|NCT05946005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111370876|NCT05946005|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111370877|NCT05946005|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111370878|NCT05946005|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111370879|NCT05946005|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110510543|NCT00872365|Micronutrients|micronutrients|mesh-list
111370880|NCT05946005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111370881|NCT05946005|Plasma Substitutes|plasma substitutes|mesh-ancestor
111370882|NCT05946005|Blood Substitutes|blood substitutes|mesh-ancestor
111370883|NCT05946005|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111370884|NCT05946005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111370886|NCT05945979|Vitamin B Complex|vitamin b complex|mesh-ancestor
111370887|NCT05945979|Vitamins|vitamins|mesh-ancestor
111370888|NCT05945979|Micronutrients|micronutrients|mesh-ancestor
111370889|NCT05945979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111370890|NCT05945797|Dexamethasone|dexamethasone|mesh-list
111370891|NCT05945797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111370892|NCT05945797|Antiemetics|antiemetics|mesh-ancestor
111370893|NCT05945797|Autonomic Agents|autonomic agents|mesh-ancestor
111370894|NCT05945797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111370895|NCT05945797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111370896|NCT05945797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111370897|NCT05945797|Glucocorticoids|glucocorticoids|mesh-ancestor
111370898|NCT05945797|Hormones|hormones|mesh-ancestor
111370899|NCT05945797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111370900|NCT05945797|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111370901|NCT05945797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111370902|NCT05945771|Grape Seed Extract|grape seed extract|mesh-list
111370903|NCT05945771|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111370904|NCT05945771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111370905|NCT05945771|Antioxidants|antioxidants|mesh-ancestor
111370906|NCT05945771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111370907|NCT05945771|Protective Agents|protective agents|mesh-ancestor
111370908|NCT05945771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111370909|NCT05945745|Immunomodulating Agents|immunomodulating agents|mesh-list
111370910|NCT05945745|Immunologic Factors|immunologic factors|mesh-ancestor
111370911|NCT05945745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111370912|NCT05945732|Trastuzumab|trastuzumab|mesh-list
111370913|NCT05945732|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
111370914|NCT05945732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111370915|NCT05945732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111370916|NCT05945732|Immunoconjugates|immunoconjugates|mesh-ancestor
111370917|NCT05945732|Immunologic Factors|immunologic factors|mesh-ancestor
111370918|NCT05945732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111370919|NCT05945680|Tranexamic Acid|tranexamic acid|mesh-list
111370920|NCT05945680|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111370921|NCT05945680|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111370922|NCT05945680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111370923|NCT05945680|Hemostatics|hemostatics|mesh-ancestor
111370924|NCT05945680|Coagulants|coagulants|mesh-ancestor
111370925|NCT05945420|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
111370926|NCT05945420|Hemostatics|hemostatics|mesh-ancestor
111370927|NCT05945420|Coagulants|coagulants|mesh-ancestor
111370928|NCT05945420|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
111370929|NCT05945420|Natriuretic Agents|natriuretic agents|mesh-ancestor
111370930|NCT05945420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111370931|NCT05945368|Trastuzumab|trastuzumab|mesh-list
111370932|NCT05945368|Pertuzumab|pertuzumab|mesh-list
111370933|NCT05945368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111370934|NCT05945368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111370935|NCT05945342|Fluoxetine|fluoxetine|mesh-list
111370936|NCT05945342|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111370937|NCT05945342|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111370938|NCT05945342|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111370939|NCT05945342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111370940|NCT05945342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111370941|NCT05945342|Serotonin Agents|serotonin agents|mesh-ancestor
111370942|NCT05945342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111370943|NCT05945342|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111370944|NCT05945342|Antidepressive Agents|antidepressive agents|mesh-ancestor
111370945|NCT05945342|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111370946|NCT05945342|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111370947|NCT05945342|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111370948|NCT05945342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111370949|NCT05945173|Ethanol|ethanol|mesh-list
111370950|NCT05945173|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111370951|NCT05945173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111370952|NCT05945173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111370953|NCT05945173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111370954|NCT05944952|Buprenorphine|buprenorphine|mesh-list
111370955|NCT05944952|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
111370956|NCT05944952|Naloxone|naloxone|mesh-list
111370957|NCT05944952|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111370958|NCT05944952|Narcotics|narcotics|mesh-ancestor
111370959|NCT05944952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111370960|NCT05944952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111370961|NCT05944952|Analgesics|analgesics|mesh-ancestor
111370962|NCT05944952|Sensory System Agents|sensory system agents|mesh-ancestor
111370963|NCT05944952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111370964|NCT05944952|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111370965|NCT05944107|Heparin|heparin|mesh-list
111370966|NCT05944107|Anticoagulants|anticoagulants|mesh-ancestor
111370967|NCT05944107|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111370968|NCT05944107|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111370969|NCT05944107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111370970|NCT05943080|Epinephrine|epinephrine|mesh-list
111370971|NCT05943080|Racepinephrine|racepinephrine|mesh-list
111370972|NCT05943080|Bupivacaine|bupivacaine|mesh-list
111370973|NCT05943080|Epinephryl borate|epinephryl borate|mesh-list
111370974|NCT05943080|Anesthetics, Local|anesthetics, local|mesh-ancestor
111370975|NCT05943080|Anesthetics|anesthetics|mesh-ancestor
111370976|NCT05943080|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111370977|NCT05943080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111370978|NCT05943080|Sensory System Agents|sensory system agents|mesh-ancestor
111370979|NCT05943080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111370980|NCT05943080|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111370981|NCT05943080|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111370982|NCT05943080|Adrenergic Agents|adrenergic agents|mesh-ancestor
111370983|NCT05943080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111370984|NCT05943080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111370985|NCT05943080|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111370986|NCT05943080|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111370987|NCT05943080|Autonomic Agents|autonomic agents|mesh-ancestor
111095403|NCT03222089|Oxaliplatin|oxaliplatin|mesh-list
111370988|NCT05943080|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111370989|NCT05943080|Respiratory System Agents|respiratory system agents|mesh-ancestor
111370990|NCT05943080|Mydriatics|mydriatics|mesh-ancestor
111370991|NCT05943080|Sympathomimetics|sympathomimetics|mesh-ancestor
111370992|NCT05943080|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111370993|NCT05938946|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111370994|NCT05929495|Metformin|metformin|mesh-list
111370995|NCT05929495|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111370996|NCT05929495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111370997|NCT05889468|Aspirin|aspirin|mesh-list
111370998|NCT05889468|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111370999|NCT05889468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111371000|NCT05889468|Analgesics|analgesics|mesh-ancestor
111371001|NCT05889468|Sensory System Agents|sensory system agents|mesh-ancestor
111371002|NCT05889468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111371003|NCT05889468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111371004|NCT05889468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111371005|NCT05889468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111371006|NCT05889468|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111371007|NCT05889468|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111371008|NCT05889468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111371009|NCT05889468|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111371010|NCT05889468|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111371011|NCT05889468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111371012|NCT05889468|Antipyretics|antipyretics|mesh-ancestor
111371013|NCT05879120|Pembrolizumab|pembrolizumab|mesh-list
111371014|NCT05879120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111371015|NCT05879120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111371016|NCT05879120|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111371017|NCT05879120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111371018|NCT05867147|Moxifloxacin|moxifloxacin|mesh-list
111371019|NCT05867147|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
111371020|NCT05867147|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111371021|NCT05867147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111371022|NCT05867147|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111371023|NCT05867147|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111371024|NCT05867147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111371025|NCT05867147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111371026|NCT05867147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111371027|NCT05867147|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111371028|NCT05867147|Contraceptive Agents|contraceptive agents|mesh-ancestor
111371029|NCT05867147|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111371030|NCT05867147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111371031|NCT05867147|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
111371032|NCT05867147|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111371033|NCT05867147|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111371034|NCT05827484|Losartan|losartan|mesh-list
111371035|NCT05827484|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111371036|NCT05827484|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111371037|NCT05827484|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111371038|NCT05827484|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111371039|NCT05827484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111371040|NCT05820841|Acalabrutinib|acalabrutinib|mesh-list
111371041|NCT05820841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111371042|NCT05818085|Allopurinol|allopurinol|mesh-list
111371043|NCT05818085|Antimetabolites|antimetabolites|mesh-ancestor
111371044|NCT05818085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111371045|NCT05818085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111371046|NCT05818085|Gout Suppressants|gout suppressants|mesh-ancestor
111371047|NCT05818085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111371048|NCT05818085|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111371049|NCT05818085|Antioxidants|antioxidants|mesh-ancestor
111371050|NCT05818085|Protective Agents|protective agents|mesh-ancestor
111371051|NCT05818085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111371052|NCT05806567|Belumosudil|belumosudil|mesh-list
111371053|NCT05806567|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111371054|NCT05806567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111371055|NCT05806567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111371056|NCT05786443|Empagliflozin|empagliflozin|mesh-list
111371057|NCT05786443|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111371058|NCT05786443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111371059|NCT05786443|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111371060|NCT05786443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111371061|NCT05731518|Irinotecan|irinotecan|mesh-list
111371062|NCT05731518|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111371063|NCT05731518|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111371064|NCT05731518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111371065|NCT05731518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111371066|NCT05731518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111371067|NCT05728944|Brimonidine Tartrate|brimonidine tartrate|mesh-list
111371068|NCT05728944|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111371069|NCT05728944|Aceclidine|aceclidine|mesh-list
111371070|NCT05728944|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111371071|NCT05728944|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111371072|NCT05728944|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111371073|NCT05728944|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111371074|NCT05728944|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111371075|NCT05728944|Adrenergic Agents|adrenergic agents|mesh-ancestor
111371076|NCT05728944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111371077|NCT05728944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111371078|NCT05728944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111371079|NCT05728944|Miotics|miotics|mesh-ancestor
111371080|NCT05728944|Autonomic Agents|autonomic agents|mesh-ancestor
111371081|NCT05728944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111371082|NCT05728944|Parasympathomimetics|parasympathomimetics|mesh-ancestor
111371083|NCT05722561|Nicotine|nicotine|mesh-list
111371084|NCT05722561|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111371085|NCT05722561|Autonomic Agents|autonomic agents|mesh-ancestor
111371086|NCT05722561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111371087|NCT05722561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111371088|NCT05722561|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111371089|NCT05722561|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111371090|NCT05722561|Cholinergic Agents|cholinergic agents|mesh-ancestor
111371091|NCT05722561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111371092|NCT05722561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111371093|NCT05712278|Cytarabine|cytarabine|mesh-list
111371094|NCT05712278|Fludarabine|fludarabine|mesh-list
111371095|NCT05712278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111371096|NCT05712278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111371097|NCT05712278|Antimetabolites|antimetabolites|mesh-ancestor
111371098|NCT05712278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111371099|NCT05712278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111371100|NCT05712278|Immunologic Factors|immunologic factors|mesh-ancestor
111371101|NCT05712278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111371102|NCT05712278|Antiviral Agents|antiviral agents|mesh-ancestor
111371103|NCT05712278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111371104|NCT05696795|Abrocitinib|abrocitinib|mesh-list
111371105|NCT05696795|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111371106|NCT05696795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111371107|NCT05696795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111371108|NCT05687123|Sunitinib|sunitinib|mesh-list
111371109|NCT05687123|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
111371110|NCT05687123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111371111|NCT05687123|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111371112|NCT05687123|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111371113|NCT05687123|Growth Substances|growth substances|mesh-ancestor
111371114|NCT05687123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111371115|NCT05687123|Growth Inhibitors|growth inhibitors|mesh-ancestor
111371116|NCT05687123|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111371117|NCT05687123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111371118|NCT05687123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111371119|NCT05687123|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111371120|NCT05687110|Novobiocin|novobiocin|mesh-list
111371121|NCT05687110|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111371122|NCT05687110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111371123|NCT05687110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111371124|NCT05687110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111371125|NCT05687110|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111371126|NCT05683392|Insulin|insulin|mesh-list
111371127|NCT05683392|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111371128|NCT05683392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111371129|NCT05674565|Magnesium Sulfate|magnesium sulfate|mesh-list
111371130|NCT05674565|Analgesics|analgesics|mesh-ancestor
111371131|NCT05674565|Sensory System Agents|sensory system agents|mesh-ancestor
111371132|NCT05674565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111371133|NCT05674565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111371134|NCT05674565|Anesthetics|anesthetics|mesh-ancestor
111371135|NCT05674565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111371136|NCT05674565|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111371137|NCT05674565|Anticonvulsants|anticonvulsants|mesh-ancestor
111371138|NCT05674565|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111371139|NCT05674565|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111371140|NCT05674565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111371141|NCT05674565|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111371142|NCT05674565|Tocolytic Agents|tocolytic agents|mesh-ancestor
111371143|NCT05674565|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111371144|NCT05656027|Brimonidine Tartrate|brimonidine tartrate|mesh-list
111371145|NCT05656027|Aceclidine|aceclidine|mesh-list
111371146|NCT05656027|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111371147|NCT05656027|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111371148|NCT05656027|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111371149|NCT05656027|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111371150|NCT05656027|Adrenergic Agents|adrenergic agents|mesh-ancestor
111371151|NCT05656027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111371152|NCT05656027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111371153|NCT05656027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111371154|NCT05656027|Miotics|miotics|mesh-ancestor
111371155|NCT05656027|Autonomic Agents|autonomic agents|mesh-ancestor
111371156|NCT05656027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111371157|NCT05656027|Parasympathomimetics|parasympathomimetics|mesh-ancestor
111371158|NCT05554276|Antibodies|antibodies|mesh-list
111371159|NCT05554276|Immunologic Factors|immunologic factors|mesh-ancestor
111371160|NCT05554276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111371161|NCT05531942|Aspirin|aspirin|mesh-list
111371162|NCT05531942|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111371163|NCT05531942|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111371164|NCT05531942|Analgesics|analgesics|mesh-ancestor
111371165|NCT05531942|Sensory System Agents|sensory system agents|mesh-ancestor
111371166|NCT05531942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111371167|NCT05531942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111371168|NCT05531942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111371169|NCT05531942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111371170|NCT05531942|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111371171|NCT05531942|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111371172|NCT05531942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111371173|NCT05531942|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111371174|NCT05531942|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111371175|NCT05531942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111371176|NCT05531942|Antipyretics|antipyretics|mesh-ancestor
111371177|NCT05479916|Caseins|caseins|mesh-list
111371178|NCT05479916|Chelating Agents|chelating agents|mesh-ancestor
111371179|NCT05479916|Sequestering Agents|sequestering agents|mesh-ancestor
111371180|NCT05479916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111371181|NCT05466279|Midazolam|midazolam|mesh-list
111371182|NCT05466279|Propofol|propofol|mesh-list
111371183|NCT05466279|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111371184|NCT05466279|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111371185|NCT05466279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111371186|NCT05466279|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111371187|NCT05466279|Anesthetics, General|anesthetics, general|mesh-ancestor
111371188|NCT05466279|Anesthetics|anesthetics|mesh-ancestor
111371189|NCT05466279|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111371190|NCT05466279|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111371191|NCT05466279|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111371192|NCT05466279|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111371193|NCT05466279|GABA Modulators|gaba modulators|mesh-ancestor
111371194|NCT05466279|GABA Agents|gaba agents|mesh-ancestor
111371195|NCT05466279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111371196|NCT05466279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111371197|NCT05451940|Hydroxyurea|hydroxyurea|mesh-list
111371198|NCT05451940|Epoetin Alfa|epoetin alfa|mesh-list
111371199|NCT05451940|Hematinics|hematinics|mesh-list
111371200|NCT05451940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111371201|NCT05451940|Antisickling Agents|antisickling agents|mesh-ancestor
111371202|NCT05451940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111371203|NCT05451940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111371204|NCT05451940|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111371205|NCT05447559|Cefazolin|cefazolin|mesh-list
111371206|NCT05447559|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111371207|NCT05447559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111371208|NCT05422664|Lacosamide|lacosamide|mesh-list
111371209|NCT05422664|Anticonvulsants|anticonvulsants|mesh-ancestor
111371210|NCT05422664|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111371211|NCT05422664|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111371212|NCT05422664|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111371213|NCT05422664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111371214|NCT05411497|Cyclophosphamide|cyclophosphamide|mesh-list
111371215|NCT05411497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111371216|NCT05411497|Immunologic Factors|immunologic factors|mesh-ancestor
111371217|NCT05411497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111371218|NCT05411497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111371219|NCT05411497|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111371220|NCT05411497|Alkylating Agents|alkylating agents|mesh-ancestor
111371221|NCT05411497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111371222|NCT05411497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111371223|NCT05411497|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111371224|NCT05403086|Ketamine|ketamine|mesh-list
111371225|NCT05403086|Psilocybin|psilocybin|mesh-list
111371226|NCT05403086|Hallucinogens|hallucinogens|mesh-list
111371227|NCT05403086|Analgesics|analgesics|mesh-ancestor
111371228|NCT05403086|Sensory System Agents|sensory system agents|mesh-ancestor
111371229|NCT05403086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111371230|NCT05403086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111371231|NCT05403086|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111371232|NCT05403086|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111371233|NCT05403086|Anesthetics, General|anesthetics, general|mesh-ancestor
111371234|NCT05403086|Anesthetics|anesthetics|mesh-ancestor
111371235|NCT05403086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111371236|NCT05403086|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111371237|NCT05403086|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111371238|NCT05403086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111371239|NCT05403086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111371240|NCT05403086|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111371241|NCT05388929|Analgesics, Opioid|analgesics, opioid|mesh-list
111371242|NCT05388929|Methocarbamol|methocarbamol|mesh-list
111371243|NCT05388929|Narcotics|narcotics|mesh-ancestor
111371244|NCT05388929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111371245|NCT05388929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111371246|NCT05388929|Analgesics|analgesics|mesh-ancestor
111371247|NCT05388929|Sensory System Agents|sensory system agents|mesh-ancestor
111371248|NCT05388929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111371249|NCT05388929|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
111371250|NCT05388929|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111371251|NCT05341583|Ensartinib|ensartinib|mesh-list
111371252|NCT05341583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111371253|NCT05341583|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111371254|NCT05341583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111000943|NCT02855359|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111371255|NCT05341583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111371256|NCT05256069|Propranolol|propranolol|mesh-list
111371257|NCT05256069|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111371258|NCT05256069|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111371259|NCT05256069|Adrenergic Agents|adrenergic agents|mesh-ancestor
111371260|NCT05256069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111371261|NCT05256069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111371262|NCT05256069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111371263|NCT05256069|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111371264|NCT05256069|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111371265|NCT05256069|Vasodilator Agents|vasodilator agents|mesh-ancestor
111371266|NCT05199571|Ofatumumab|ofatumumab|mesh-list
111371267|NCT05199571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111371268|NCT05160805|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111371269|NCT05160805|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111371270|NCT05155436|Amlodipine|amlodipine|mesh-list
111371271|NCT05155436|Telmisartan|telmisartan|mesh-list
111371272|NCT05155436|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111371273|NCT05155436|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111371274|NCT05155436|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111371275|NCT05155436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111371276|NCT05155436|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111371277|NCT05155436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111371278|NCT05155436|Vasodilator Agents|vasodilator agents|mesh-ancestor
111371279|NCT05155436|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111371280|NCT05155436|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111371281|NCT05103696|Propofol|propofol|mesh-list
111371282|NCT05103696|Etomidate|etomidate|mesh-list
111371283|NCT05103696|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111371284|NCT05103696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111371285|NCT05103696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111371286|NCT05103696|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111371287|NCT05103696|Anesthetics, General|anesthetics, general|mesh-ancestor
111371288|NCT05103696|Anesthetics|anesthetics|mesh-ancestor
111371289|NCT04984811|Atezolizumab|atezolizumab|mesh-list
111371290|NCT04984811|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111371291|NCT04984811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111371292|NCT04984811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111371293|NCT04984811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111371294|NCT04981041|Clopidogrel|clopidogrel|mesh-list
111371295|NCT04981041|Ticagrelor|ticagrelor|mesh-list
111371296|NCT04981041|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
111371297|NCT04981041|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111371298|NCT04981041|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111371299|NCT04981041|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111371300|NCT04981041|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111371301|NCT04981041|Purinergic Agents|purinergic agents|mesh-ancestor
111371302|NCT04981041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111371303|NCT04981041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111371304|NCT04981041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111371305|NCT04898725|Vitamin D|vitamin d|mesh-list
111371306|NCT04898725|Cholecalciferol|cholecalciferol|mesh-list
111371307|NCT04898725|Vitamins|vitamins|mesh-ancestor
111371308|NCT04898725|Micronutrients|micronutrients|mesh-ancestor
111371309|NCT04898725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111371310|NCT04898725|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111371311|NCT04898725|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111371312|NCT04894435|Vaccines|vaccines|mesh-list
111371313|NCT04894435|Immunologic Factors|immunologic factors|mesh-ancestor
111371314|NCT04894435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111371315|NCT04862975|Tenofovir|tenofovir|mesh-list
111371316|NCT04862975|Emtricitabine|emtricitabine|mesh-list
111371317|NCT04862975|Efavirenz|efavirenz|mesh-list
111371318|NCT04862975|Dolutegravir|dolutegravir|mesh-list
111371319|NCT04862975|Antiviral Agents|antiviral agents|mesh-ancestor
111371320|NCT04862975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111371321|NCT04862975|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111371322|NCT04862975|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111371323|NCT04862975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111371324|NCT04862975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111371325|NCT04862975|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111371326|NCT04862975|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111371327|NCT04862975|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111371328|NCT04862975|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111371329|NCT04862975|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111371330|NCT04862975|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111371331|NCT04862975|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111371332|NCT04862975|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111371333|NCT04862975|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111371334|NCT04862975|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111371335|NCT04840550|Lansoprazole|lansoprazole|mesh-list
111371336|NCT04840550|Dexlansoprazole|dexlansoprazole|mesh-list
111371337|NCT04840550|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111371338|NCT04840550|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111371339|NCT04840550|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111371340|NCT04840550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111371341|NCT04840550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111371342|NCT04756063|Ascorbic Acid|ascorbic acid|mesh-list
111371343|NCT04756063|Vitamins|vitamins|mesh-ancestor
111371344|NCT04756063|Micronutrients|micronutrients|mesh-ancestor
111371345|NCT04756063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111371346|NCT04756063|Antioxidants|antioxidants|mesh-ancestor
111371347|NCT04756063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111371348|NCT04756063|Protective Agents|protective agents|mesh-ancestor
111371349|NCT04744662|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111371350|NCT04744662|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111371351|NCT04736745|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111371352|NCT04736745|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111371353|NCT04736745|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111371354|NCT04736745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111371355|NCT04736745|Cholinergic Agents|cholinergic agents|mesh-ancestor
111371356|NCT04736745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111371357|NCT04736745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111371358|NCT04731844|Curcumin|curcumin|mesh-list
111371359|NCT04731844|Piperine|piperine|mesh-list
111371360|NCT04731844|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111371361|NCT04731844|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111371362|NCT04731844|Analgesics|analgesics|mesh-ancestor
111371363|NCT04731844|Sensory System Agents|sensory system agents|mesh-ancestor
111371364|NCT04731844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111371365|NCT04731844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111371366|NCT04731844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111371367|NCT04731844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111371368|NCT04731844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111371369|NCT04731844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111371370|NCT04731844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111371371|NCT04731844|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111371372|NCT04660539|Mycophenolic Acid|mycophenolic acid|mesh-list
111371373|NCT04660539|Azathioprine|azathioprine|mesh-list
111371374|NCT04660539|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111371375|NCT04660539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111371376|NCT04660539|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111371377|NCT04660539|Antitubercular Agents|antitubercular agents|mesh-ancestor
111371378|NCT04660539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111371379|NCT04660539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111371380|NCT04660539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111371381|NCT04660539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111371382|NCT04660539|Antimetabolites|antimetabolites|mesh-ancestor
111371383|NCT04660539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111371384|NCT04660539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111371385|NCT04660539|Immunologic Factors|immunologic factors|mesh-ancestor
111371386|NCT04660539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111371387|NCT04660539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111371388|NCT04520607|Lorecivivint|lorecivivint|mesh-list
111371389|NCT04520607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111371390|NCT04512365|Dronabinol|dronabinol|mesh-list
111371391|NCT04512365|Hallucinogens|hallucinogens|mesh-ancestor
111371392|NCT04512365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111371393|NCT04512365|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111371394|NCT04512365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111371395|NCT04512365|Analgesics|analgesics|mesh-ancestor
111371396|NCT04512365|Sensory System Agents|sensory system agents|mesh-ancestor
111371397|NCT04512365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111371398|NCT04512365|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
111371399|NCT04512365|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
111371400|NCT04512365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111371401|NCT04512365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111371402|NCT04512365|Hormones|hormones|mesh-ancestor
111371403|NCT04512365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111371404|NCT04480853|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
111371405|NCT04480853|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
111371406|NCT04480853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111371407|NCT04480853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111371408|NCT04480853|Immunologic Factors|immunologic factors|mesh-ancestor
111371409|NCT04480853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111371410|NCT04452214|Carboplatin|carboplatin|mesh-list
111371411|NCT04452214|Pembrolizumab|pembrolizumab|mesh-list
111371412|NCT04452214|Pemetrexed|pemetrexed|mesh-list
111371413|NCT04452214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111371414|NCT04452214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111371415|NCT04452214|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111371416|NCT04452214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111371417|NCT04452214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111371418|NCT04452214|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111371419|NCT04452214|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111371420|NCT04431258|Folfirinox|folfirinox|mesh-list
111371421|NCT04431258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111371422|NCT04417621|Trametinib|trametinib|mesh-list
111371423|NCT04417621|Naporafenib|naporafenib|mesh-list
111371424|NCT04417621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111371425|NCT04417621|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111371426|NCT04417621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111371427|NCT04417621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111371428|NCT04398719|Capsaicin|capsaicin|mesh-list
111371429|NCT04398719|Antipruritics|antipruritics|mesh-ancestor
111371430|NCT04398719|Dermatologic Agents|dermatologic agents|mesh-ancestor
111371431|NCT04398719|Sensory System Agents|sensory system agents|mesh-ancestor
111371432|NCT04398719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111371433|NCT04398719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111371434|NCT04373317|Pimavanserin|pimavanserin|mesh-list
111371435|NCT04373317|Quetiapine Fumarate|quetiapine fumarate|mesh-list
111371436|NCT04373317|Antidepressive Agents|antidepressive agents|mesh-ancestor
111371437|NCT04373317|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111371438|NCT04373317|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111371439|NCT04373317|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111371440|NCT04373317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111371441|NCT04373317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111371442|NCT04373317|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111371443|NCT04373317|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111371444|NCT04373317|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111371445|NCT04373317|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111371446|NCT04373317|Serotonin Agents|serotonin agents|mesh-ancestor
111371447|NCT04373317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111371448|NCT04373317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111371449|NCT04339270|Azithromycin|azithromycin|mesh-list
111371450|NCT04339270|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111371451|NCT04339270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111371452|NCT04262193|Suvorexant|suvorexant|mesh-list
111371453|NCT04262193|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111371454|NCT04262193|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111371455|NCT04262193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111371456|NCT04262193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111371457|NCT04262193|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
111371458|NCT04262193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111371459|NCT04262193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111371460|NCT04261439|Tislelizumab|tislelizumab|mesh-list
111371461|NCT04261439|Spartalizumab|spartalizumab|mesh-list
111371462|NCT04261439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111371463|NCT04261439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111371464|NCT04261439|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111371465|NCT04261439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111371466|NCT04207944|Sulindac|sulindac|mesh-list
111371467|NCT04207944|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111371468|NCT04207944|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111371469|NCT04207944|Analgesics|analgesics|mesh-ancestor
111371470|NCT04207944|Sensory System Agents|sensory system agents|mesh-ancestor
111371471|NCT04207944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111371472|NCT04207944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111371473|NCT04207944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111371474|NCT04207944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111371475|NCT04207944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111371476|NCT04207944|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111371477|NCT04207944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111371478|NCT04207944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111371479|NCT04184622|Tirzepatide|tirzepatide|mesh-list
111371480|NCT04184622|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111371481|NCT04184622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111371482|NCT04184622|Incretins|incretins|mesh-ancestor
111371483|NCT04184622|Hormones|hormones|mesh-ancestor
111371484|NCT04184622|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111371485|NCT04080427|Dronabinol|dronabinol|mesh-list
111371486|NCT04080427|Hallucinogens|hallucinogens|mesh-ancestor
111371487|NCT04080427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111371488|NCT04080427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111371489|NCT04080427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111371490|NCT04080427|Analgesics|analgesics|mesh-ancestor
111371491|NCT04080427|Sensory System Agents|sensory system agents|mesh-ancestor
111371492|NCT04080427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111371493|NCT04080427|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
111371494|NCT04080427|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
111371495|NCT04080427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111371496|NCT04080427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111371497|NCT04080427|Hormones|hormones|mesh-ancestor
111371498|NCT04080427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111371499|NCT04032704|Pembrolizumab|pembrolizumab|mesh-list
111371500|NCT04032704|SGN-LIV1A|sgn-liv1a|mesh-list
111371501|NCT04032704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111371502|NCT04032704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111371503|NCT04032704|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111371504|NCT04032704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111371505|NCT04032704|Immunoconjugates|immunoconjugates|mesh-ancestor
111371506|NCT04032704|Immunologic Factors|immunologic factors|mesh-ancestor
111371507|NCT04032704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111371508|NCT03941262|Pembrolizumab|pembrolizumab|mesh-list
111371509|NCT03941262|Avelumab|avelumab|mesh-list
111371510|NCT03941262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111371511|NCT03941262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111371512|NCT03941262|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111371513|NCT03941262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111371514|NCT03933631|Ofloxacin|ofloxacin|mesh-list
111371515|NCT03933631|Prednisolone|prednisolone|mesh-list
111371516|NCT03933631|Prednisolone acetate|prednisolone acetate|mesh-list
111371517|NCT03933631|Pilocarpine|pilocarpine|mesh-list
111371518|NCT03933631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111371519|NCT03933631|Glucocorticoids|glucocorticoids|mesh-ancestor
111371520|NCT03933631|Hormones|hormones|mesh-ancestor
111371521|NCT03933631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111371522|NCT03933631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111371523|NCT03933631|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111371524|NCT03933631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111371525|NCT03933631|Autonomic Agents|autonomic agents|mesh-ancestor
111371526|NCT03933631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111371527|NCT03933631|Miotics|miotics|mesh-ancestor
111371528|NCT03933631|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
111371529|NCT03933631|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111371530|NCT03933631|Cholinergic Agents|cholinergic agents|mesh-ancestor
111371531|NCT03933631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111371532|NCT03933631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111371533|NCT03933631|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111371534|NCT03933631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111371535|NCT03933631|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111371536|NCT03933631|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111371537|NCT03933631|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111371538|NCT03933631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111371539|NCT03933631|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111371540|NCT03933631|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111371541|NCT03919435|Trimethoprim|trimethoprim|mesh-list
111371542|NCT03919435|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
111371543|NCT03919435|Sulfamethoxazole|sulfamethoxazole|mesh-list
111371544|NCT03919435|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111371545|NCT03919435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111371546|NCT03919435|Antimalarials|antimalarials|mesh-ancestor
111371547|NCT03919435|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111371548|NCT03919435|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111371549|NCT03919435|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111371550|NCT03919435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111371551|NCT03919435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111371552|NCT03919435|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111371553|NCT03919435|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
111371554|NCT03919435|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111371555|NCT03919435|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111371556|NCT03911414|Inositol|inositol|mesh-list
111371557|NCT03911414|Acetylcysteine|acetylcysteine|mesh-list
111371558|NCT03911414|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111371559|NCT03911414|Antiviral Agents|antiviral agents|mesh-ancestor
111371560|NCT03911414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111371561|NCT03911414|Expectorants|expectorants|mesh-ancestor
111371562|NCT03911414|Respiratory System Agents|respiratory system agents|mesh-ancestor
111371563|NCT03911414|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111371564|NCT03911414|Antioxidants|antioxidants|mesh-ancestor
111371565|NCT03911414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111371566|NCT03911414|Protective Agents|protective agents|mesh-ancestor
111371567|NCT03911414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111371568|NCT03911414|Antidotes|antidotes|mesh-ancestor
111371569|NCT03911414|Vitamin B Complex|vitamin b complex|mesh-ancestor
111371570|NCT03911414|Vitamins|vitamins|mesh-ancestor
111371571|NCT03911414|Micronutrients|micronutrients|mesh-ancestor
111371572|NCT03901001|Sirolimus|sirolimus|mesh-list
111371573|NCT03901001|Oseltamivir|oseltamivir|mesh-list
111371574|NCT03901001|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111371575|NCT03901001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111371576|NCT03901001|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111371577|NCT03901001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111371578|NCT03901001|Antifungal Agents|antifungal agents|mesh-ancestor
111371579|NCT03901001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111371580|NCT03901001|Immunologic Factors|immunologic factors|mesh-ancestor
111371581|NCT03901001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111371582|NCT03901001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111096009|NCT04839471|Afatinib|afatinib|mesh-list
111371583|NCT03901001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111371584|NCT03901001|Antiviral Agents|antiviral agents|mesh-ancestor
111371585|NCT03900988|Acetylcysteine|acetylcysteine|mesh-list
111371586|NCT03900988|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111371587|NCT03900988|Antiviral Agents|antiviral agents|mesh-ancestor
111371588|NCT03900988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111371589|NCT03900988|Expectorants|expectorants|mesh-ancestor
111371590|NCT03900988|Respiratory System Agents|respiratory system agents|mesh-ancestor
111371591|NCT03900988|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111371592|NCT03900988|Antioxidants|antioxidants|mesh-ancestor
111371593|NCT03900988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111371594|NCT03900988|Protective Agents|protective agents|mesh-ancestor
111371595|NCT03900988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111371596|NCT03900988|Antidotes|antidotes|mesh-ancestor
111371597|NCT03900754|Oxytocin|oxytocin|mesh-list
111371598|NCT03900754|Oxytocics|oxytocics|mesh-ancestor
111371599|NCT03900754|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111371600|NCT03900754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111371601|NCT03861091|Risedronic Acid|risedronic acid|mesh-list
111371602|NCT03861091|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111371603|NCT03861091|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111371604|NCT03861091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111371605|NCT03861091|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111371606|NCT03861091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111371607|NCT03861091|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111371608|NCT03781414|Tacrolimus|tacrolimus|mesh-list
111371609|NCT03781414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111371610|NCT03781414|Immunologic Factors|immunologic factors|mesh-ancestor
111371611|NCT03781414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111371612|NCT03781414|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111371613|NCT03781414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111371614|NCT03781414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111371615|NCT03772717|Immunoglobulins|immunoglobulins|mesh-list
111371616|NCT03772717|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111371617|NCT03772717|gamma-Globulins|gamma-globulins|mesh-list
111371618|NCT03772717|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
111371619|NCT03772717|Immunologic Factors|immunologic factors|mesh-ancestor
111371620|NCT03772717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111371621|NCT03740100|MTOR Inhibitors|mtor inhibitors|mesh-list
111371622|NCT03740100|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111371623|NCT03740100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111371624|NCT03740100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111371625|NCT03740100|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111371626|NCT03740100|Immunologic Factors|immunologic factors|mesh-ancestor
111371627|NCT03740100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111371628|NCT03740100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111371629|NCT03718065|Lofexidine|lofexidine|mesh-list
111371630|NCT03718065|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111371631|NCT03718065|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111371632|NCT03718065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111371633|NCT03718065|Sensory System Agents|sensory system agents|mesh-ancestor
111371634|NCT03718065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111371635|NCT03718065|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111371636|NCT03718065|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111371637|NCT03718065|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111371638|NCT03718065|Adrenergic Agents|adrenergic agents|mesh-ancestor
111371639|NCT03718065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111371640|NCT03718065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111371641|NCT03706690|Durvalumab|durvalumab|mesh-list
111371642|NCT03706690|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111371643|NCT03706690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111371644|NCT03456700|Sirolimus|sirolimus|mesh-list
111371645|NCT03456700|Auranofin|auranofin|mesh-list
111371646|NCT03456700|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111371647|NCT03456700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111371648|NCT03456700|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111371649|NCT03456700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111371650|NCT03456700|Antifungal Agents|antifungal agents|mesh-ancestor
111371651|NCT03456700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111371652|NCT03456700|Immunologic Factors|immunologic factors|mesh-ancestor
111371653|NCT03456700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111096083|NCT03040167|Epinephrine|epinephrine|mesh-list
111371654|NCT03456700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111371655|NCT03401450|Bupivacaine|bupivacaine|mesh-list
111371656|NCT03401450|Anesthetics, Local|anesthetics, local|mesh-ancestor
111371657|NCT03401450|Anesthetics|anesthetics|mesh-ancestor
111371658|NCT03401450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111371659|NCT03401450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111371660|NCT03401450|Sensory System Agents|sensory system agents|mesh-ancestor
111371661|NCT03401450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111371662|NCT03356483|Niacin|niacin|mesh-list
111371663|NCT03356483|Nicotinic Acids|nicotinic acids|mesh-list
111371664|NCT03356483|Psilocybin|psilocybin|mesh-list
111371665|NCT03356483|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111371666|NCT03356483|Antimetabolites|antimetabolites|mesh-ancestor
111371667|NCT03356483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111371668|NCT03356483|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111371669|NCT03356483|Vasodilator Agents|vasodilator agents|mesh-ancestor
111371670|NCT03356483|Vitamin B Complex|vitamin b complex|mesh-ancestor
111371671|NCT03356483|Vitamins|vitamins|mesh-ancestor
111371672|NCT03356483|Micronutrients|micronutrients|mesh-ancestor
111371673|NCT03356483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111371674|NCT03356483|Hallucinogens|hallucinogens|mesh-ancestor
111371675|NCT03356483|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111371676|NCT03326063|Ifetroban|ifetroban|mesh-list
111371677|NCT03326063|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111371678|NCT03324984|Bupivacaine|bupivacaine|mesh-list
111371679|NCT03324984|Chloroprocaine|chloroprocaine|mesh-list
111371680|NCT03324984|Anesthetics, Local|anesthetics, local|mesh-ancestor
111371681|NCT03324984|Anesthetics|anesthetics|mesh-ancestor
111371682|NCT03324984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111371683|NCT03324984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111371684|NCT03324984|Sensory System Agents|sensory system agents|mesh-ancestor
111371685|NCT03324984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111371686|NCT03310957|Pembrolizumab|pembrolizumab|mesh-list
111371687|NCT03310957|SGN-LIV1A|sgn-liv1a|mesh-list
111371688|NCT03310957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111371689|NCT03310957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111371690|NCT03310957|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111371691|NCT03310957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111371692|NCT03310957|Immunoconjugates|immunoconjugates|mesh-ancestor
111371693|NCT03310957|Immunologic Factors|immunologic factors|mesh-ancestor
111371694|NCT03310957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111371695|NCT03275857|Cisplatin|cisplatin|mesh-list
111371696|NCT03275857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111371697|NCT03260712|Gemcitabine|gemcitabine|mesh-list
111371698|NCT03260712|Pembrolizumab|pembrolizumab|mesh-list
111371699|NCT03260712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111371700|NCT03260712|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111371701|NCT03260712|Antimetabolites|antimetabolites|mesh-ancestor
111371702|NCT03260712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111371703|NCT03260712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111371704|NCT03260712|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111371705|NCT03128359|Mycophenolic Acid|mycophenolic acid|mesh-list
111371706|NCT03128359|Cyclophosphamide|cyclophosphamide|mesh-list
111371707|NCT03128359|Melphalan|melphalan|mesh-list
111371708|NCT03128359|Busulfan|busulfan|mesh-list
111371709|NCT03128359|Fludarabine|fludarabine|mesh-list
111371710|NCT03128359|Fludarabine phosphate|fludarabine phosphate|mesh-list
111371711|NCT03128359|Tacrolimus|tacrolimus|mesh-list
111371712|NCT03128359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111371713|NCT03128359|Immunologic Factors|immunologic factors|mesh-ancestor
111371714|NCT03128359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111371715|NCT03128359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111371716|NCT03128359|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111371717|NCT03128359|Alkylating Agents|alkylating agents|mesh-ancestor
111371718|NCT03128359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111371719|NCT03128359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111371720|NCT03128359|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111371721|NCT03128359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111371722|NCT03128359|Antimetabolites|antimetabolites|mesh-ancestor
111371723|NCT03128359|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111371724|NCT03128359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111371725|NCT03128359|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111371726|NCT03128359|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111371727|NCT03128359|Antitubercular Agents|antitubercular agents|mesh-ancestor
111371728|NCT03128359|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111371729|NCT03128359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111371730|NCT02764762|Adalimumab|adalimumab|mesh-list
111371731|NCT02764762|Methotrexate|methotrexate|mesh-list
111371732|NCT02764762|Vedolizumab|vedolizumab|mesh-list
111371733|NCT02764762|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111371734|NCT02764762|Abortifacient Agents|abortifacient agents|mesh-ancestor
111371735|NCT02764762|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111371736|NCT02764762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111371737|NCT02764762|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111371739|NCT02764762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111371740|NCT02764762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111371741|NCT02764762|Dermatologic Agents|dermatologic agents|mesh-ancestor
111371742|NCT02764762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111371743|NCT02764762|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111371744|NCT02764762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111371745|NCT02764762|Immunologic Factors|immunologic factors|mesh-ancestor
111371746|NCT02764762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111371747|NCT02764762|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111371748|NCT02764762|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111371749|NCT02764762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111371750|NCT02764762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111371751|NCT02666547|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
111371752|NCT02666547|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111371753|NCT02666547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111371754|NCT02654990|Dexamethasone|dexamethasone|mesh-list
111371755|NCT02654990|Bortezomib|bortezomib|mesh-list
111371756|NCT02654990|Panobinostat|panobinostat|mesh-list
111371757|NCT02654990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111371758|NCT02654990|Antiemetics|antiemetics|mesh-ancestor
111371759|NCT02654990|Autonomic Agents|autonomic agents|mesh-ancestor
111371760|NCT02654990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111371761|NCT02654990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110511438|NCT02785068|Antidotes|antidotes|mesh-ancestor
111371762|NCT02654990|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111371763|NCT02654990|Glucocorticoids|glucocorticoids|mesh-ancestor
111371764|NCT02654990|Hormones|hormones|mesh-ancestor
111371765|NCT02654990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111371766|NCT02654990|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111371767|NCT02654990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111371768|NCT02654990|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111371769|NCT02654990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111371770|NCT02654990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111371771|NCT02650401|Entrectinib|entrectinib|mesh-list
111371772|NCT02650401|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111371773|NCT02650401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111371774|NCT02650401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111371775|NCT02568267|Entrectinib|entrectinib|mesh-list
111371776|NCT02568267|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111371777|NCT02568267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111371778|NCT02568267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111371779|NCT02521363|Taxane|taxane|mesh-list
111371780|NCT02521363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111371781|NCT02407509|Everolimus|everolimus|mesh-list
111371782|NCT02407509|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111371783|NCT02407509|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111371784|NCT02407509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111371785|NCT02407509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111371786|NCT02407509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111371787|NCT02407509|Immunologic Factors|immunologic factors|mesh-ancestor
111371788|NCT02407509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111371789|NCT02407509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111371790|NCT02340962|Interferons|interferons|mesh-list
111371791|NCT02340962|Ribavirin|ribavirin|mesh-list
111371792|NCT02340962|Interferon-alpha|interferon-alpha|mesh-list
111371793|NCT02340962|Interferon alpha-2|interferon alpha-2|mesh-list
111371794|NCT02340962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111371795|NCT02340962|Antiviral Agents|antiviral agents|mesh-ancestor
111371796|NCT02340962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110959213|NCT02582632|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110959214|NCT02582632|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110959215|NCT05381974|Psilocybin|psilocybin|mesh-list
110959216|NCT05381974|Hallucinogens|hallucinogens|mesh-ancestor
110959217|NCT05381974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110959218|NCT05381974|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110959219|NCT02178722|Pembrolizumab|pembrolizumab|mesh-list
110959220|NCT02178722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110959221|NCT02178722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110959222|NCT02178722|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110959223|NCT02178722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111371797|NCT02340962|Antimetabolites|antimetabolites|mesh-ancestor
111371798|NCT02340962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111371799|NCT02340962|Immunologic Factors|immunologic factors|mesh-ancestor
111371800|NCT02340962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111371801|NCT02309645|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
111371802|NCT02309645|Hemostatics|hemostatics|mesh-ancestor
111371803|NCT02309645|Coagulants|coagulants|mesh-ancestor
111371804|NCT01750073|Paclitaxel|paclitaxel|mesh-list
111371805|NCT01750073|Cyclophosphamide|cyclophosphamide|mesh-list
111371806|NCT01750073|Doxorubicin|doxorubicin|mesh-list
111371807|NCT01750073|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111371808|NCT01750073|Trastuzumab|trastuzumab|mesh-list
111371809|NCT01750073|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110511504|NCT05275686|Fluticasone|fluticasone|mesh-list
111371810|NCT01750073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111371811|NCT01750073|Antibodies|antibodies|mesh-list
111371812|NCT01750073|Immunoglobulins|immunoglobulins|mesh-list
111371813|NCT01750073|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111371814|NCT01750073|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111371815|NCT01750073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111371816|NCT01750073|Tubulin Modulators|tubulin modulators|mesh-ancestor
111371817|NCT01750073|Antimitotic Agents|antimitotic agents|mesh-ancestor
111371818|NCT01750073|Mitosis Modulators|mitosis modulators|mesh-ancestor
111371819|NCT01750073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111371820|NCT01750073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111371821|NCT01750073|Immunologic Factors|immunologic factors|mesh-ancestor
111371822|NCT01750073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111371823|NCT01750073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111371824|NCT01750073|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111371825|NCT01750073|Alkylating Agents|alkylating agents|mesh-ancestor
111371826|NCT01750073|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111371827|NCT01750073|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111371828|NCT01750073|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111371829|NCT01750073|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111371830|NCT01750073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111371831|NCT01582191|Everolimus|everolimus|mesh-list
111371832|NCT01582191|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111371833|NCT01582191|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111371834|NCT01582191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111371835|NCT01582191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111371836|NCT01582191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111371837|NCT01582191|Immunologic Factors|immunologic factors|mesh-ancestor
111371838|NCT01582191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111371839|NCT01582191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111371840|NCT01120249|Everolimus|everolimus|mesh-list
111371841|NCT01120249|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111371842|NCT01120249|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111371843|NCT01120249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111371844|NCT01120249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111371845|NCT01120249|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111371846|NCT01120249|Immunologic Factors|immunologic factors|mesh-ancestor
111371847|NCT01120249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111371848|NCT01120249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111371849|NCT00788125|Carboplatin|carboplatin|mesh-list
111371850|NCT00788125|Etoposide|etoposide|mesh-list
111371851|NCT00788125|Dasatinib|dasatinib|mesh-list
111371852|NCT00788125|Ifosfamide|ifosfamide|mesh-list
111371853|NCT00788125|Etoposide phosphate|etoposide phosphate|mesh-list
111371854|NCT00788125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111371855|NCT00788125|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111371856|NCT00788125|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111371857|NCT00788125|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111371858|NCT00788125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111371859|NCT00788125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111371860|NCT00788125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111371861|NCT00788125|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111371862|NCT00788125|Alkylating Agents|alkylating agents|mesh-ancestor
111371863|NCT00676715|Interferons|interferons|mesh-list
111371864|NCT00676715|Interferon-beta|interferon-beta|mesh-list
111371865|NCT00676715|Ocrelizumab|ocrelizumab|mesh-list
111371866|NCT00676715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111371867|NCT00676715|Antiviral Agents|antiviral agents|mesh-ancestor
111371868|NCT00676715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111371869|NCT00676715|Immunologic Factors|immunologic factors|mesh-ancestor
111371870|NCT00676715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111371871|NCT00579969|Timolol|timolol|mesh-list
111371872|NCT00579969|Latanoprost|latanoprost|mesh-list
111371873|NCT00579969|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111371874|NCT00579969|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111371875|NCT00579969|Adrenergic Agents|adrenergic agents|mesh-ancestor
111371876|NCT00579969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111371877|NCT00579969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111371878|NCT00579969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111371879|NCT00579969|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111371880|NCT00579969|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111371881|NCT00579969|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
111371882|NCT00579969|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111371883|NCT00516373|Olaparib|olaparib|mesh-list
111371884|NCT00516373|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
111371885|NCT00516373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111371886|NCT00516373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111371887|NCT00516373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111371888|NCT00890162|Omalizumab|omalizumab|mesh-list
111371889|NCT00890162|Epinephrine|epinephrine|mesh-list
111371890|NCT00890162|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111371891|NCT00890162|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111371892|NCT00890162|Adrenergic Agents|adrenergic agents|mesh-ancestor
111371893|NCT00890162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111371894|NCT00890162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111371895|NCT00890162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111371896|NCT00890162|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111371897|NCT00890162|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111371898|NCT00890162|Autonomic Agents|autonomic agents|mesh-ancestor
111371899|NCT00890162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111371900|NCT00890162|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111371901|NCT00890162|Respiratory System Agents|respiratory system agents|mesh-ancestor
111371902|NCT00890162|Mydriatics|mydriatics|mesh-ancestor
111371903|NCT00890162|Sympathomimetics|sympathomimetics|mesh-ancestor
111371904|NCT00890162|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111371905|NCT00890162|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111371906|NCT01433081|Magnesium Sulfate|magnesium sulfate|mesh-list
111371907|NCT01433081|Analgesics|analgesics|mesh-ancestor
111371908|NCT01433081|Sensory System Agents|sensory system agents|mesh-ancestor
111371909|NCT01433081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111371910|NCT01433081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111371911|NCT01433081|Anesthetics|anesthetics|mesh-ancestor
111371912|NCT01433081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111371913|NCT01433081|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111371914|NCT01433081|Anticonvulsants|anticonvulsants|mesh-ancestor
111371915|NCT01433081|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111371916|NCT01433081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111371917|NCT01433081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111371918|NCT01433081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111371919|NCT01433081|Tocolytic Agents|tocolytic agents|mesh-ancestor
111371920|NCT01433081|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111371921|NCT00890396|Hydroxyurea|hydroxyurea|mesh-list
111371922|NCT00890396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111371923|NCT00890396|Antisickling Agents|antisickling agents|mesh-ancestor
111371924|NCT00890396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111371925|NCT00890396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111371926|NCT00890396|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111371927|NCT01401023|Tigecycline|tigecycline|mesh-list
111371928|NCT01401023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111371929|NCT01401023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111371930|NCT01401023|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111371931|NCT01401023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111371932|NCT01401023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111371933|NCT01515995|Magnesium Sulfate|magnesium sulfate|mesh-list
111371934|NCT01515995|Analgesics|analgesics|mesh-ancestor
111371935|NCT01515995|Sensory System Agents|sensory system agents|mesh-ancestor
111371936|NCT01515995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111371937|NCT01515995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111371938|NCT01515995|Anesthetics|anesthetics|mesh-ancestor
111371939|NCT01515995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111371940|NCT01515995|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111371941|NCT01515995|Anticonvulsants|anticonvulsants|mesh-ancestor
111371942|NCT01515995|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111371943|NCT01515995|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111371944|NCT01515995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111371945|NCT01515995|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111371946|NCT01515995|Tocolytic Agents|tocolytic agents|mesh-ancestor
111371947|NCT01515995|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111371948|NCT01436045|Insulin glulisine|insulin glulisine|mesh-list
111371949|NCT01436045|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111371950|NCT01436045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111371951|NCT01519271|Rivastigmine|rivastigmine|mesh-list
111371952|NCT01519271|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111371953|NCT01519271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111371954|NCT01519271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111371955|NCT01519271|Cholinergic Agents|cholinergic agents|mesh-ancestor
111371956|NCT01519271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111371957|NCT01519271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111371958|NCT01519271|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111371959|NCT01519271|Protective Agents|protective agents|mesh-ancestor
111371960|NCT01436279|Mifepristone|mifepristone|mesh-list
111371961|NCT01436279|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
111371962|NCT01436279|Abortifacient Agents|abortifacient agents|mesh-ancestor
111371963|NCT01436279|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111371964|NCT01436279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111371965|NCT01436279|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111371966|NCT01436279|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111371967|NCT01436279|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111371968|NCT01436279|Contraceptive Agents|contraceptive agents|mesh-ancestor
111371969|NCT01436279|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
111371970|NCT01436279|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
111371971|NCT01436279|Hormone Antagonists|hormone antagonists|mesh-ancestor
111371972|NCT01436279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111371973|NCT01436279|Luteolytic Agents|luteolytic agents|mesh-ancestor
111371974|NCT01436279|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111371975|NCT01436279|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
111371976|NCT02210195|Aprepitant|aprepitant|mesh-list
111371977|NCT02210195|Antiemetics|antiemetics|mesh-ancestor
111371978|NCT02210195|Autonomic Agents|autonomic agents|mesh-ancestor
111371979|NCT02210195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111371980|NCT02210195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111371981|NCT02210195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111371982|NCT02210195|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
111371983|NCT02210195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111371984|NCT02210195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111371985|NCT01437449|Carboplatin|carboplatin|mesh-list
111371986|NCT01437449|Docetaxel|docetaxel|mesh-list
111371987|NCT01437449|Cetuximab|cetuximab|mesh-list
111371988|NCT01437449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111371989|NCT01437449|Tubulin Modulators|tubulin modulators|mesh-ancestor
111371990|NCT01437449|Antimitotic Agents|antimitotic agents|mesh-ancestor
111371991|NCT01437449|Mitosis Modulators|mitosis modulators|mesh-ancestor
111371992|NCT01437449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111371993|NCT01437449|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111371994|NCT00836888|Nivolumab|nivolumab|mesh-list
111371995|NCT00836888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111371996|NCT00836888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111371997|NCT00836888|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111371998|NCT00836888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111371999|NCT02262026|Saracatinib|saracatinib|mesh-list
111372000|NCT02262026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111372001|NCT02262026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111372002|NCT02262026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111372003|NCT00889226|Atorvastatin|atorvastatin|mesh-list
111372004|NCT00889226|Pitavastatin|pitavastatin|mesh-list
111372005|NCT00889226|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111372006|NCT00889226|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111372007|NCT00889226|Antimetabolites|antimetabolites|mesh-ancestor
111372008|NCT00889226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111372009|NCT00889226|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111372010|NCT00889226|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111372011|NCT00889226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111372012|NCT00837200|Doxorubicin|doxorubicin|mesh-list
111372013|NCT00837200|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111372014|NCT00837200|Asparaginase|asparaginase|mesh-list
111372015|NCT00837200|Pegaspargase|pegaspargase|mesh-list
111372016|NCT00837200|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111372017|NCT00837200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111372018|NCT00837200|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111372019|NCT00837200|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111372020|NCT00837200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110959224|NCT03523572|Nivolumab|nivolumab|mesh-list
111372021|NCT00837200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111372022|NCT00837512|Insulin|insulin|mesh-list
111372023|NCT00837512|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111372024|NCT00837512|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111372025|NCT00837512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111372026|NCT00837590|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
111372027|NCT00837590|Sodium Salicylate|sodium salicylate|mesh-list
111372028|NCT00837590|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111372029|NCT00837590|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111372030|NCT00837590|Analgesics|analgesics|mesh-ancestor
111372031|NCT00837590|Sensory System Agents|sensory system agents|mesh-ancestor
111372032|NCT00837590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110511755|NCT00613951|Insulin|insulin|mesh-list
111372033|NCT00837590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111372034|NCT00837590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111372035|NCT00837590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111372036|NCT00837590|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111372037|NCT00837590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111372038|NCT00837590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111372039|NCT00891176|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
111372040|NCT00891176|Immunologic Factors|immunologic factors|mesh-ancestor
111372041|NCT00891176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111372042|NCT00839540|Caspofungin|caspofungin|mesh-list
111372043|NCT00839540|Micafungin|micafungin|mesh-list
111372044|NCT00839540|Antifungal Agents|antifungal agents|mesh-ancestor
111372045|NCT00839540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111372046|NCT00839540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111372047|NCT00839540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111372048|NCT02966912|Magnesium Oxide|magnesium oxide|mesh-list
111372049|NCT02966912|Antacids|antacids|mesh-ancestor
111372050|NCT02966912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111372051|NCT02966912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111372052|NCT01437605|Poly I-C|poly i-c|mesh-list
111372053|NCT01437605|Interferon Inducers|interferon inducers|mesh-ancestor
111372054|NCT01437605|Immunologic Factors|immunologic factors|mesh-ancestor
111372055|NCT01437605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111372056|NCT01437605|Antiviral Agents|antiviral agents|mesh-ancestor
111372057|NCT01437605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111372058|NCT01541735|Pantoprazole|pantoprazole|mesh-list
111372059|NCT01541735|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111372060|NCT01541735|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111372061|NCT01541735|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111372062|NCT01541735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111372063|NCT01541735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111372064|NCT01541891|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111372065|NCT01541891|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111372066|NCT01520207|Mannitol|mannitol|mesh-list
111372067|NCT01520207|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
111372068|NCT01520207|Diuretics|diuretics|mesh-ancestor
111372069|NCT01520207|Natriuretic Agents|natriuretic agents|mesh-ancestor
111372070|NCT01520207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111372071|NCT01203722|Mycophenolic Acid|mycophenolic acid|mesh-list
111372072|NCT01203722|Sirolimus|sirolimus|mesh-list
111372073|NCT01203722|Fludarabine|fludarabine|mesh-list
111372074|NCT01203722|Cyclophosphamide|cyclophosphamide|mesh-list
111372075|NCT01203722|Tacrolimus|tacrolimus|mesh-list
111372076|NCT01203722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111372077|NCT01203722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111372078|NCT01203722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111372079|NCT01203722|Immunologic Factors|immunologic factors|mesh-ancestor
111372080|NCT01203722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111372081|NCT01203722|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111372082|NCT01203722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111372083|NCT01203722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111372084|NCT01203722|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111372085|NCT01203722|Alkylating Agents|alkylating agents|mesh-ancestor
111372086|NCT01203722|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111372087|NCT01203722|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111372088|NCT01203722|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111372089|NCT01203722|Antitubercular Agents|antitubercular agents|mesh-ancestor
111372090|NCT01203722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111372091|NCT01203722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111372092|NCT01203722|Antifungal Agents|antifungal agents|mesh-ancestor
111372093|NCT01520519|Rituximab|rituximab|mesh-list
111372094|NCT01520519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111372095|NCT01520519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111372096|NCT01520519|Immunologic Factors|immunologic factors|mesh-ancestor
110511797|NCT03927105|Nivolumab|nivolumab|mesh-list
111372097|NCT01520519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111372098|NCT01520519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111372099|NCT03008057|Vitamin D|vitamin d|mesh-list
111372100|NCT03008057|Ergocalciferols|ergocalciferols|mesh-list
111372101|NCT03008057|Cholecalciferol|cholecalciferol|mesh-list
111372102|NCT03008057|Vitamins|vitamins|mesh-list
111372103|NCT03008057|Micronutrients|micronutrients|mesh-ancestor
111372104|NCT03008057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111372105|NCT03008057|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111372106|NCT03008057|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111372107|NCT01542125|Lidocaine|lidocaine|mesh-list
111372108|NCT01542125|Anesthetics, Local|anesthetics, local|mesh-ancestor
111372109|NCT01542125|Anesthetics|anesthetics|mesh-ancestor
111372110|NCT01542125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111372111|NCT01542125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111372112|NCT01542125|Sensory System Agents|sensory system agents|mesh-ancestor
111372113|NCT01542125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111372114|NCT01542125|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111372115|NCT01542125|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111372116|NCT01542125|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111372117|NCT01542125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111372118|NCT01542125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111372119|NCT03216668|Silymarin|silymarin|mesh-list
111372120|NCT03216668|Antioxidants|antioxidants|mesh-ancestor
111372121|NCT03216668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111372122|NCT03216668|Protective Agents|protective agents|mesh-ancestor
111372123|NCT03216668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111372124|NCT02548832|Bezafibrate|bezafibrate|mesh-list
111372125|NCT02548832|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111372126|NCT02548832|Antimetabolites|antimetabolites|mesh-ancestor
111372127|NCT02548832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111372128|NCT02548832|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111372129|NCT03216278|Metformin|metformin|mesh-list
111372130|NCT03216278|Dapagliflozin|dapagliflozin|mesh-list
111372131|NCT03216278|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111372132|NCT03216278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111372133|NCT03216278|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111372134|NCT03216278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111372135|NCT05310344|Paclitaxel|paclitaxel|mesh-list
111372136|NCT05310344|Bevacizumab|bevacizumab|mesh-list
111372137|NCT05310344|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111372138|NCT05310344|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111372139|NCT05310344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111372140|NCT05310344|Tubulin Modulators|tubulin modulators|mesh-ancestor
111372141|NCT05310344|Antimitotic Agents|antimitotic agents|mesh-ancestor
111372142|NCT05310344|Mitosis Modulators|mitosis modulators|mesh-ancestor
111372143|NCT05310344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111372144|NCT05310344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111372145|NCT05310344|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111372146|NCT05310344|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111372147|NCT05310344|Growth Substances|growth substances|mesh-ancestor
111372148|NCT05310344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111372149|NCT05310344|Growth Inhibitors|growth inhibitors|mesh-ancestor
111372150|NCT04381520|Antihypertensive Agents|antihypertensive agents|mesh-list
111372151|NCT00837902|Atenolol|atenolol|mesh-list
111372152|NCT00837902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111372153|NCT00837902|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111372154|NCT00837902|Sympatholytics|sympatholytics|mesh-ancestor
111372155|NCT00837902|Autonomic Agents|autonomic agents|mesh-ancestor
111372156|NCT00837902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110511869|NCT00630695|Lanreotide|lanreotide|mesh-list
111372157|NCT00837902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111372158|NCT00837902|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
111372159|NCT00837902|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111372160|NCT00837902|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111372161|NCT00837902|Adrenergic Agents|adrenergic agents|mesh-ancestor
111372162|NCT00837902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111372163|NCT00837902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111372164|NCT04382144|Bupivacaine|bupivacaine|mesh-list
111372165|NCT04382144|Anesthetics, Local|anesthetics, local|mesh-ancestor
111372166|NCT04382144|Anesthetics|anesthetics|mesh-ancestor
111372167|NCT04382144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111372168|NCT04382144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111372169|NCT04382144|Sensory System Agents|sensory system agents|mesh-ancestor
111096587|NCT04828395|Paclitaxel|paclitaxel|mesh-list
111372170|NCT04382144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111372172|NCT03215966|Macitentan|macitentan|mesh-list
111372173|NCT03215966|Vasodilator Agents|vasodilator agents|mesh-ancestor
111372174|NCT03215966|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111372175|NCT03215966|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111372176|NCT03215966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111372177|NCT03215966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111372178|NCT03215966|Urological Agents|urological agents|mesh-ancestor
111372179|NCT03215966|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
111372180|NCT03215966|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
111372181|NCT03215966|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
111372182|NCT03215498|Insulin|insulin|mesh-list
111372183|NCT03215498|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111372184|NCT03215498|Insulin Aspart|insulin aspart|mesh-list
111372185|NCT03215498|Insulin, Long-Acting|insulin, long-acting|mesh-list
111372186|NCT03215498|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
111372187|NCT03215498|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111372188|NCT03215498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111372189|NCT01441037|Danazol|danazol|mesh-list
111372190|NCT01441037|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111372191|NCT01441037|Hormone Antagonists|hormone antagonists|mesh-ancestor
111372192|NCT01441037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111372193|NCT01441037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111372194|NCT00891878|Capecitabine|capecitabine|mesh-list
111372195|NCT00891878|Sunitinib|sunitinib|mesh-list
111372196|NCT00891878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111372197|NCT00891878|Antimetabolites|antimetabolites|mesh-ancestor
111372198|NCT00891878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111372199|NCT00891878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111372200|NCT00891878|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111372201|NCT00891878|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111372202|NCT00891878|Growth Substances|growth substances|mesh-ancestor
111372203|NCT00891878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111372204|NCT00891878|Growth Inhibitors|growth inhibitors|mesh-ancestor
111372205|NCT00891878|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111372206|NCT00891878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111372207|NCT01445873|Sitaxsentan|sitaxsentan|mesh-list
111372208|NCT01445873|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
111372209|NCT01445873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111372210|NCT03838328|Tranexamic Acid|tranexamic acid|mesh-list
111372211|NCT03838328|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111372212|NCT03838328|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111372213|NCT03838328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111372214|NCT03838328|Hemostatics|hemostatics|mesh-ancestor
111372215|NCT03838328|Coagulants|coagulants|mesh-ancestor
111372216|NCT01526213|Fexofenadine|fexofenadine|mesh-list
111372217|NCT01526213|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111372218|NCT01526213|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
111372219|NCT01526213|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111372220|NCT01526213|Histamine Antagonists|histamine antagonists|mesh-ancestor
111372221|NCT01526213|Histamine Agents|histamine agents|mesh-ancestor
111372222|NCT01526213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111372223|NCT01526213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111372224|NCT01526213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111372225|NCT01549223|Misoprostol|misoprostol|mesh-list
111372226|NCT01549223|Oxytocin|oxytocin|mesh-list
111372227|NCT01549223|Carboprost|carboprost|mesh-list
111372228|NCT01549223|Carboprost tromethamine|carboprost tromethamine|mesh-list
111372229|NCT01549223|Methylergonovine|methylergonovine|mesh-list
111372230|NCT01549223|Maleic acid|maleic acid|mesh-list
111372231|NCT01549223|Oxytocics|oxytocics|mesh-ancestor
111372232|NCT01549223|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111372233|NCT01549223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111372234|NCT01549223|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111372235|NCT01549223|Abortifacient Agents|abortifacient agents|mesh-ancestor
111372236|NCT01549223|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111372237|NCT01549223|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111372238|NCT01549223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111372239|NCT01549223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111372240|NCT00895934|Azacitidine|azacitidine|mesh-list
111372241|NCT00895934|Vorinostat|vorinostat|mesh-list
111372242|NCT00895934|Gemtuzumab|gemtuzumab|mesh-list
111372243|NCT00895934|Calicheamicins|calicheamicins|mesh-list
111372244|NCT00895934|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111372245|NCT00895934|Antimetabolites|antimetabolites|mesh-ancestor
111372246|NCT00895934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111372247|NCT00895934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111372248|NCT00895934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111372249|NCT00895934|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111372250|NCT00895934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111372251|NCT00895934|Immunotoxins|immunotoxins|mesh-ancestor
111372252|NCT00895934|Immunoconjugates|immunoconjugates|mesh-ancestor
111372253|NCT00895934|Immunologic Factors|immunologic factors|mesh-ancestor
111372254|NCT00895934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111372255|NCT00895934|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111372256|NCT01550471|Ciclesonide|ciclesonide|mesh-list
111372257|NCT01550471|Beclomethasone|beclomethasone|mesh-list
111372258|NCT01550471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111372259|NCT01550471|Glucocorticoids|glucocorticoids|mesh-ancestor
111372260|NCT01550471|Hormones|hormones|mesh-ancestor
111372261|NCT01550471|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111372262|NCT01550471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111372263|NCT01550471|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111372264|NCT01550471|Respiratory System Agents|respiratory system agents|mesh-ancestor
111372265|NCT01550471|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111372266|NCT03215264|Hydroxychloroquine|hydroxychloroquine|mesh-list
111372267|NCT03215264|Entinostat|entinostat|mesh-list
111372268|NCT03215264|Antimalarials|antimalarials|mesh-ancestor
111372269|NCT03215264|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111372270|NCT03215264|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111372271|NCT03215264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111372272|NCT03215264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111372273|NCT03215264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111372274|NCT03215264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111372275|NCT03215264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111372276|NCT03215264|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111372277|NCT01447511|Rifampin|rifampin|mesh-list
111372278|NCT01447511|Fluconazole|fluconazole|mesh-list
111372279|NCT01447511|Warfarin|warfarin|mesh-list
111372280|NCT01447511|Anticoagulants|anticoagulants|mesh-ancestor
111372281|NCT01447511|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111372282|NCT01447511|Antitubercular Agents|antitubercular agents|mesh-ancestor
111372283|NCT01447511|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111372284|NCT01447511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111372285|NCT01447511|Leprostatic Agents|leprostatic agents|mesh-ancestor
111372286|NCT01447511|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111372287|NCT01447511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111372288|NCT01447511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111372289|NCT01447511|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111372290|NCT01447511|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111372291|NCT01447511|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
111372292|NCT01447511|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
111372293|NCT01447511|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
111372294|NCT01447511|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111372295|NCT01447511|Antifungal Agents|antifungal agents|mesh-ancestor
111372296|NCT01447511|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111372297|NCT01447511|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111372298|NCT01447511|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111372299|NCT01447511|Hormone Antagonists|hormone antagonists|mesh-ancestor
111372300|NCT01447511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111372301|NCT01447511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111372302|NCT01447511|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111372303|NCT01447511|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111372304|NCT01831622|Methylphenidate|methylphenidate|mesh-list
111372305|NCT01831622|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111372306|NCT01831622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111372307|NCT01831622|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111372308|NCT01831622|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111372309|NCT01831622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111372310|NCT01831622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111372311|NCT01831622|Dopamine Agents|dopamine agents|mesh-ancestor
111372312|NCT01831622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111372313|NCT04380818|Ritonavir|ritonavir|mesh-list
111372314|NCT04380818|Lopinavir|lopinavir|mesh-list
111372315|NCT04380818|Azithromycin|azithromycin|mesh-list
111372316|NCT04380818|Hydroxychloroquine|hydroxychloroquine|mesh-list
111372317|NCT04380818|Heparin|heparin|mesh-list
110959225|NCT03523572|Trastuzumab|trastuzumab|mesh-list
111372318|NCT04380818|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
111372319|NCT04380818|Tinzaparin|tinzaparin|mesh-list
111372320|NCT04380818|Dalteparin|dalteparin|mesh-list
111372321|NCT04380818|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111372322|NCT04380818|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111372323|NCT04380818|Protease Inhibitors|protease inhibitors|mesh-ancestor
111372324|NCT04380818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111372325|NCT04380818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111372326|NCT04380818|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111372327|NCT04380818|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111372328|NCT04380818|Antiviral Agents|antiviral agents|mesh-ancestor
111372329|NCT04380818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111372330|NCT04380818|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111372331|NCT04380818|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111372332|NCT04380818|Anticoagulants|anticoagulants|mesh-ancestor
111372333|NCT04380818|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111372334|NCT04380818|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111372335|NCT04380818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111372336|NCT04380818|Antimalarials|antimalarials|mesh-ancestor
111372337|NCT04380818|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111372338|NCT04380818|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111372339|NCT04380818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111372340|NCT05312294|Vaccines|vaccines|mesh-list
111372341|NCT05312294|Immunologic Factors|immunologic factors|mesh-ancestor
111372342|NCT05312294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111372343|NCT01550705|Isoniazid|isoniazid|mesh-list
111372344|NCT01550705|Antitubercular Agents|antitubercular agents|mesh-ancestor
111372345|NCT01550705|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111372346|NCT01550705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111372347|NCT01550705|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
111372348|NCT01550705|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111372349|NCT01550705|Antimetabolites|antimetabolites|mesh-ancestor
111372350|NCT01550705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111372351|NCT01550705|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111372352|NCT01831700|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
111372353|NCT01831700|Lisinopril|lisinopril|mesh-list
111372354|NCT01831700|Hydrochlorothiazide, lisinopril drug combination|hydrochlorothiazide, lisinopril drug combination|mesh-list
111372355|NCT01831700|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111372356|NCT01831700|Diuretics|diuretics|mesh-ancestor
111372357|NCT01831700|Natriuretic Agents|natriuretic agents|mesh-ancestor
111372358|NCT01831700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111372359|NCT01831700|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
111372360|NCT01831700|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111372361|NCT01831700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111372362|NCT01831700|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
111372363|NCT01831700|Protease Inhibitors|protease inhibitors|mesh-ancestor
111372364|NCT01831700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111372365|NCT01831700|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111372366|NCT01831700|Protective Agents|protective agents|mesh-ancestor
111372367|NCT01531439|Naloxone|naloxone|mesh-list
111372368|NCT01531439|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111372369|NCT01531439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111372370|NCT01531439|Sensory System Agents|sensory system agents|mesh-ancestor
111372371|NCT01531439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111372372|NCT03214874|Torsemide|torsemide|mesh-list
111372373|NCT03214874|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111372374|NCT03214874|Diuretics|diuretics|mesh-ancestor
111372375|NCT03214874|Natriuretic Agents|natriuretic agents|mesh-ancestor
111372376|NCT03214874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111372377|NCT03214874|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
111372378|NCT03214874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111372379|NCT03214874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111372380|NCT02504268|Methotrexate|methotrexate|mesh-list
111372381|NCT02504268|Abatacept|abatacept|mesh-list
111372382|NCT02504268|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111372383|NCT02504268|Abortifacient Agents|abortifacient agents|mesh-ancestor
111372384|NCT02504268|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111372385|NCT02504268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111372386|NCT02504268|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111372387|NCT02504268|Antimetabolites|antimetabolites|mesh-ancestor
111372388|NCT02504268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111372389|NCT02504268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111372390|NCT02504268|Dermatologic Agents|dermatologic agents|mesh-ancestor
110959226|NCT03523572|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
111372391|NCT02504268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111372392|NCT02504268|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111372393|NCT02504268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111372394|NCT02504268|Immunologic Factors|immunologic factors|mesh-ancestor
111372395|NCT02504268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111372396|NCT02504268|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111372397|NCT02504268|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111372398|NCT02504268|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111372399|NCT00904826|Eculizumab|eculizumab|mesh-list
111372400|NCT00904826|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
111372401|NCT00904826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111372402|NCT00904826|Immunologic Factors|immunologic factors|mesh-ancestor
111372403|NCT00904826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111372404|NCT05311514|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111372405|NCT05311514|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111372406|NCT01448525|Bimatoprost|bimatoprost|mesh-list
111372407|NCT01448525|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111372408|NCT01448525|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111372409|NCT01448525|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111372410|NCT01654302|Lidocaine|lidocaine|mesh-list
111372411|NCT01654302|Tetracaine|tetracaine|mesh-list
111372412|NCT01654302|Anesthetics, Local|anesthetics, local|mesh-ancestor
111372413|NCT01654302|Anesthetics|anesthetics|mesh-ancestor
111372414|NCT01654302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111372415|NCT01654302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111372416|NCT01654302|Sensory System Agents|sensory system agents|mesh-ancestor
111372417|NCT01654302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111372418|NCT01654302|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111372419|NCT01654302|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111372420|NCT01654302|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111372421|NCT01654302|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111372422|NCT01654302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111372423|NCT01832558|Eplerenone|eplerenone|mesh-list
111372424|NCT01832558|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
111372425|NCT01832558|Hormone Antagonists|hormone antagonists|mesh-ancestor
111372426|NCT01832558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111372427|NCT01832558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111372428|NCT01832558|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
111372429|NCT01832558|Diuretics|diuretics|mesh-ancestor
111372430|NCT01832558|Natriuretic Agents|natriuretic agents|mesh-ancestor
111372431|NCT01832558|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111372432|NCT02476422|Ibuprofen|ibuprofen|mesh-list
111372433|NCT02476422|Diclofenac|diclofenac|mesh-list
111372434|NCT02476422|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111372435|NCT02476422|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111372436|NCT02476422|Analgesics|analgesics|mesh-ancestor
111372437|NCT02476422|Sensory System Agents|sensory system agents|mesh-ancestor
111372438|NCT02476422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111372439|NCT02476422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111372440|NCT02476422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111372441|NCT02476422|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111372442|NCT02476422|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111372443|NCT02476422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111372444|NCT02476422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111372445|NCT01450319|Cetuximab|cetuximab|mesh-list
111372446|NCT01450319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111372447|NCT01450319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111372448|NCT01552343|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
111372449|NCT01552343|Hemostatics|hemostatics|mesh-ancestor
111372450|NCT01552343|Coagulants|coagulants|mesh-ancestor
111372451|NCT01552343|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
111372452|NCT01552343|Natriuretic Agents|natriuretic agents|mesh-ancestor
111372453|NCT01552343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111372454|NCT02475564|Resveratrol|resveratrol|mesh-list
111372455|NCT02475564|Antioxidants|antioxidants|mesh-ancestor
111372456|NCT02475564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111372457|NCT02475564|Protective Agents|protective agents|mesh-ancestor
111372458|NCT02475564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111372459|NCT02475564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111372460|NCT02475564|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111372461|NCT00893984|Nebivolol|nebivolol|mesh-list
111372462|NCT00893984|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111372463|NCT00893984|Vasodilator Agents|vasodilator agents|mesh-ancestor
111372464|NCT00893984|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
111372465|NCT00893984|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111372466|NCT00893984|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111372467|NCT00893984|Adrenergic Agents|adrenergic agents|mesh-ancestor
111372468|NCT00893984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111372469|NCT00893984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111372470|NCT00893984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111372471|NCT01832870|Ipilimumab|ipilimumab|mesh-list
111372472|NCT01832870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111372473|NCT01832870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111372474|NCT01832870|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111372475|NCT01832870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111372476|NCT01553201|Botulinum Toxins|botulinum toxins|mesh-list
111372477|NCT01553201|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111372478|NCT01553201|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111372479|NCT01553201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111372480|NCT01553201|Cholinergic Agents|cholinergic agents|mesh-ancestor
111372481|NCT01553201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111372482|NCT01553201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111372483|NCT03214172|Rivaroxaban|rivaroxaban|mesh-list
111372484|NCT03214172|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111372485|NCT03214172|Antithrombins|antithrombins|mesh-ancestor
111372486|NCT03214172|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111372487|NCT03214172|Protease Inhibitors|protease inhibitors|mesh-ancestor
111372488|NCT03214172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111372489|NCT03214172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111372490|NCT03214172|Anticoagulants|anticoagulants|mesh-ancestor
111372491|NCT01832948|Leucovorin|leucovorin|mesh-list
111372492|NCT01832948|Folic Acid|folic acid|mesh-list
111372493|NCT01832948|Oxaliplatin|oxaliplatin|mesh-list
111372494|NCT01832948|Endostar protein|endostar protein|mesh-list
111372495|NCT01832948|Levoleucovorin|levoleucovorin|mesh-list
111372496|NCT01832948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111372497|NCT01832948|Antidotes|antidotes|mesh-ancestor
111372498|NCT01832948|Protective Agents|protective agents|mesh-ancestor
111372499|NCT01832948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111372500|NCT01832948|Vitamin B Complex|vitamin b complex|mesh-ancestor
111372501|NCT01832948|Vitamins|vitamins|mesh-ancestor
111372502|NCT01832948|Micronutrients|micronutrients|mesh-ancestor
111372503|NCT01832948|Hematinics|hematinics|mesh-ancestor
111372504|NCT01832948|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111372505|NCT01832948|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111372506|NCT01832948|Growth Substances|growth substances|mesh-ancestor
111372507|NCT01832948|Growth Inhibitors|growth inhibitors|mesh-ancestor
111372508|NCT01533077|Levodopa|levodopa|mesh-list
111372509|NCT01533077|Carbidopa|carbidopa|mesh-list
111372510|NCT01533077|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
111372511|NCT01533077|Opicapone|opicapone|mesh-list
111372512|NCT01533077|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111372513|NCT01533077|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111372514|NCT01533077|Dopamine Agents|dopamine agents|mesh-ancestor
111372515|NCT01533077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111372516|NCT01533077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111372517|NCT01533077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111372518|NCT01533077|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
111372519|NCT01533077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111372520|NCT01533077|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111372521|NCT01533077|Immunologic Factors|immunologic factors|mesh-ancestor
111372522|NCT01533077|Dopamine Agonists|dopamine agonists|mesh-ancestor
111372523|NCT01533077|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
111372524|NCT01534013|Insulin|insulin|mesh-list
111372525|NCT01534013|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111372526|NCT01534013|Pancrelipase|pancrelipase|mesh-list
111372527|NCT01534013|Pancreatin|pancreatin|mesh-list
111372528|NCT01534013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111372529|NCT01534013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111372530|NCT01534013|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111372531|NCT03211988|Entinostat|entinostat|mesh-list
111372532|NCT03211988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111372533|NCT03211988|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111372534|NCT03211988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111372535|NCT03211988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111372536|NCT01833728|Acetaminophen|acetaminophen|mesh-list
111372537|NCT01833728|Propacetamol|propacetamol|mesh-list
111372538|NCT01833728|Nefopam|nefopam|mesh-list
111372539|NCT01833728|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111372540|NCT01833728|Analgesics|analgesics|mesh-ancestor
111372541|NCT01833728|Sensory System Agents|sensory system agents|mesh-ancestor
111372542|NCT01833728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111372543|NCT01833728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111372544|NCT01833728|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111372545|NCT01833728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111372546|NCT01833728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111372548|NCT03213392|Anesthetics|anesthetics|mesh-list
111372549|NCT03213392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111372550|NCT03213392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111372551|NCT03219788|Remifentanil|remifentanil|mesh-list
111372552|NCT03219788|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111372553|NCT03219788|Narcotics|narcotics|mesh-ancestor
111372554|NCT03219788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111372555|NCT03219788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111372556|NCT03219788|Analgesics|analgesics|mesh-ancestor
111372557|NCT03219788|Sensory System Agents|sensory system agents|mesh-ancestor
111372558|NCT03219788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111372559|NCT03219710|Dexamethasone|dexamethasone|mesh-list
111372560|NCT03219710|Ondansetron|ondansetron|mesh-list
111372561|NCT03219710|Olanzapine|olanzapine|mesh-list
111372562|NCT03219710|Aprepitant|aprepitant|mesh-list
111372563|NCT03219710|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111372564|NCT03219710|Antiemetics|antiemetics|mesh-ancestor
111372565|NCT03219710|Autonomic Agents|autonomic agents|mesh-ancestor
111372566|NCT03219710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111372567|NCT03219710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111372568|NCT03219710|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111372569|NCT03219710|Glucocorticoids|glucocorticoids|mesh-ancestor
111372570|NCT03219710|Hormones|hormones|mesh-ancestor
111372571|NCT03219710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111372572|NCT03219710|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111372573|NCT03219710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111372574|NCT03219710|Antipruritics|antipruritics|mesh-ancestor
111372575|NCT03219710|Dermatologic Agents|dermatologic agents|mesh-ancestor
111372576|NCT03219710|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111372577|NCT03219710|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111372578|NCT03219710|Serotonin Agents|serotonin agents|mesh-ancestor
111372579|NCT03219710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111000944|NCT02855359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111372580|NCT03219710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111372581|NCT03219710|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111372582|NCT03219710|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111372583|NCT03219710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111372584|NCT03219710|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111372585|NCT03219710|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111372586|NCT03219710|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111372587|NCT03219710|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111372588|NCT03219710|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
111372589|NCT01532141|Opicapone|opicapone|mesh-list
111372590|NCT01532141|Rasagiline|rasagiline|mesh-list
111372591|NCT01532141|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
111372592|NCT01532141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111372593|NCT01532141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111372594|NCT01532141|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111372595|NCT01532141|Protective Agents|protective agents|mesh-ancestor
111372596|NCT01532141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111372597|NCT01532141|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
111372598|NCT01532141|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111372599|NCT01532141|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111372600|NCT00899600|Ketamine|ketamine|mesh-list
111372601|NCT00899600|Analgesics|analgesics|mesh-ancestor
111372602|NCT00899600|Sensory System Agents|sensory system agents|mesh-ancestor
111372603|NCT00899600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111372604|NCT00899600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111372605|NCT00899600|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111372606|NCT00899600|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111372607|NCT00899600|Anesthetics, General|anesthetics, general|mesh-ancestor
111372608|NCT00899600|Anesthetics|anesthetics|mesh-ancestor
111372609|NCT00899600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111372610|NCT00899600|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111372611|NCT00899600|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111372612|NCT00899600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111372613|NCT00899600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111372614|NCT03219554|Palbociclib|palbociclib|mesh-list
111372615|NCT03219554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111372616|NCT03219554|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111372617|NCT03219554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111372618|NCT03219554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111372619|NCT01554371|Cyclophosphamide|cyclophosphamide|mesh-list
111372620|NCT01554371|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111372621|NCT01554371|Immunologic Factors|immunologic factors|mesh-ancestor
111372622|NCT01554371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111372623|NCT01554371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111372624|NCT01554371|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111372625|NCT01554371|Alkylating Agents|alkylating agents|mesh-ancestor
111372626|NCT01554371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111372627|NCT01554371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111372628|NCT01554371|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111372629|NCT01451411|Conivaptan|conivaptan|mesh-list
111372630|NCT01451411|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
111372631|NCT01451411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111372632|NCT01451411|Natriuretic Agents|natriuretic agents|mesh-ancestor
111372633|NCT01451411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111372634|NCT03837938|Dipropizine|dipropizine|mesh-list
111372635|NCT03837938|Antitussive Agents|antitussive agents|mesh-ancestor
111372636|NCT03837938|Respiratory System Agents|respiratory system agents|mesh-ancestor
111372637|NCT01554683|Levetiracetam|levetiracetam|mesh-list
111372638|NCT01554683|Anticonvulsants|anticonvulsants|mesh-ancestor
110512348|NCT02834546|Sorafenib|sorafenib|mesh-list
111372639|NCT01554683|Nootropic Agents|nootropic agents|mesh-ancestor
111372640|NCT00905060|Temozolomide|temozolomide|mesh-list
111372641|NCT00905060|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111372642|NCT00905060|Alkylating Agents|alkylating agents|mesh-ancestor
111372643|NCT00905060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111372644|NCT00905060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111372645|NCT01535573|Dexetimide|dexetimide|mesh-list
111372646|NCT01535573|Citalopram|citalopram|mesh-list
111372647|NCT01535573|Escitalopram|escitalopram|mesh-list
111372648|NCT01535573|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111372649|NCT01535573|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111372650|NCT01535573|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111372651|NCT01535573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111372652|NCT01535573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111372653|NCT01535573|Serotonin Agents|serotonin agents|mesh-ancestor
111372654|NCT01535573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111372655|NCT01535573|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111372656|NCT01535573|Antidepressive Agents|antidepressive agents|mesh-ancestor
111372657|NCT01535573|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111372658|NCT01535573|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111372659|NCT01535573|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111372660|NCT01535573|Parasympatholytics|parasympatholytics|mesh-ancestor
111372661|NCT01535573|Autonomic Agents|autonomic agents|mesh-ancestor
111372662|NCT01535573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111372663|NCT01535573|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111372664|NCT01535573|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111372665|NCT01535573|Cholinergic Agents|cholinergic agents|mesh-ancestor
111372666|NCT01834508|Entecavir|entecavir|mesh-list
111372667|NCT01834508|Adefovir|adefovir|mesh-list
111372668|NCT01834508|Antiviral Agents|antiviral agents|mesh-ancestor
111372669|NCT01834508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111372670|NCT01834508|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111372671|NCT01834508|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111372672|NCT01834508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111372673|NCT01834508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111372674|NCT01537835|Anti-Infective Agents|anti-infective agents|mesh-list
111372675|NCT01537835|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111372676|NCT03213002|Capecitabine|capecitabine|mesh-list
111372677|NCT03213002|Temozolomide|temozolomide|mesh-list
111372678|NCT03213002|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111372679|NCT03213002|Antimetabolites|antimetabolites|mesh-ancestor
111372680|NCT03213002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111372681|NCT03213002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111372682|NCT03213002|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111372683|NCT03213002|Alkylating Agents|alkylating agents|mesh-ancestor
111372684|NCT01556633|Oseltamivir|oseltamivir|mesh-list
111372685|NCT01556633|Antiviral Agents|antiviral agents|mesh-ancestor
111372686|NCT01556633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111372687|NCT01556633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111372688|NCT01556633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111372689|NCT03218852|Prednisone|prednisone|mesh-list
111372690|NCT03218852|Cyclophosphamide|cyclophosphamide|mesh-list
111372691|NCT03218852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111372693|NCT03218852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111372694|NCT03218852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111372695|NCT03218852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111372696|NCT03218852|Alkylating Agents|alkylating agents|mesh-ancestor
111372697|NCT03218852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111372698|NCT03218852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111372699|NCT03218852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111372700|NCT03218852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111372701|NCT03218852|Glucocorticoids|glucocorticoids|mesh-ancestor
111372702|NCT03218852|Hormones|hormones|mesh-ancestor
111372703|NCT03218852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111372704|NCT03218852|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111372705|NCT01834898|Oxycodone|oxycodone|mesh-list
111372706|NCT01834898|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111372707|NCT01834898|Narcotics|narcotics|mesh-ancestor
111372708|NCT01834898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111372709|NCT01834898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111372710|NCT01834898|Analgesics|analgesics|mesh-ancestor
111372711|NCT01834898|Sensory System Agents|sensory system agents|mesh-ancestor
111372712|NCT01834898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111372713|NCT01557959|Docetaxel|docetaxel|mesh-list
111372714|NCT01557959|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111372715|NCT01557959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111372716|NCT01557959|Tubulin Modulators|tubulin modulators|mesh-ancestor
111372717|NCT01557959|Antimitotic Agents|antimitotic agents|mesh-ancestor
111372718|NCT01557959|Mitosis Modulators|mitosis modulators|mesh-ancestor
111372719|NCT01557959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111372720|NCT01557959|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111372721|NCT01557959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111372722|NCT03212456|Analgesics, Opioid|analgesics, opioid|mesh-list
111372723|NCT03212456|Ropivacaine|ropivacaine|mesh-list
111372724|NCT03212456|Anesthetics, Local|anesthetics, local|mesh-ancestor
111372725|NCT03212456|Anesthetics|anesthetics|mesh-ancestor
111372726|NCT03212456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111372727|NCT03212456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111372728|NCT03212456|Sensory System Agents|sensory system agents|mesh-ancestor
111372729|NCT03212456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111372730|NCT03212456|Narcotics|narcotics|mesh-ancestor
111372731|NCT03212456|Analgesics|analgesics|mesh-ancestor
111372732|NCT03217838|Azacitidine|azacitidine|mesh-list
111372733|NCT03217838|Venetoclax|venetoclax|mesh-list
111372734|NCT03217838|Pyrazole|pyrazole|mesh-list
111372735|NCT03217838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111372736|NCT03217838|Antimetabolites|antimetabolites|mesh-ancestor
111372737|NCT03217838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111372738|NCT03217838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111372739|NCT03217838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111372740|NCT01558661|Axitinib|axitinib|mesh-list
111372741|NCT01558661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111372742|NCT01558661|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111372743|NCT01558661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111372744|NCT01558661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111372745|NCT01835288|Arsenic Trioxide|arsenic trioxide|mesh-list
111372746|NCT01835288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111372747|NCT02502864|Cyclophosphamide|cyclophosphamide|mesh-list
111372748|NCT02502864|Docetaxel|docetaxel|mesh-list
111372749|NCT02502864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111372750|NCT02502864|Immunologic Factors|immunologic factors|mesh-ancestor
111372751|NCT02502864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111372752|NCT02502864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111372753|NCT02502864|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111372754|NCT02502864|Alkylating Agents|alkylating agents|mesh-ancestor
111372755|NCT02502864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111372756|NCT02502864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111372757|NCT02502864|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111372758|NCT02502864|Tubulin Modulators|tubulin modulators|mesh-ancestor
111372759|NCT02502864|Antimitotic Agents|antimitotic agents|mesh-ancestor
111372760|NCT02502864|Mitosis Modulators|mitosis modulators|mesh-ancestor
111372761|NCT03217760|Hydrocortisone|hydrocortisone|mesh-list
111372762|NCT03217760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111372763|NCT03217292|Tramadol|tramadol|mesh-list
111097188|NCT02593539|Nemiralisib|nemiralisib|mesh-list
111372764|NCT03217292|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111372765|NCT03217292|Narcotics|narcotics|mesh-ancestor
111372766|NCT03217292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111372767|NCT03217292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111372768|NCT03217292|Analgesics|analgesics|mesh-ancestor
111372769|NCT03217292|Sensory System Agents|sensory system agents|mesh-ancestor
111372770|NCT03217292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111372771|NCT03217448|Warfarin|warfarin|mesh-list
111372772|NCT03217448|Dabigatran|dabigatran|mesh-list
111372773|NCT03217448|Anticoagulants|anticoagulants|mesh-ancestor
111372774|NCT03217448|Antithrombins|antithrombins|mesh-ancestor
111372775|NCT03217448|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111372776|NCT03217448|Protease Inhibitors|protease inhibitors|mesh-ancestor
111372777|NCT03217448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111372778|NCT03217448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111372779|NCT01457573|Tamsulosin|tamsulosin|mesh-list
111372780|NCT01457573|Solifenacin Succinate|solifenacin succinate|mesh-list
111372781|NCT01457573|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111372782|NCT01457573|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111372783|NCT01457573|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111372784|NCT01457573|Adrenergic Agents|adrenergic agents|mesh-ancestor
111372785|NCT01457573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111372786|NCT01457573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111372787|NCT01457573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111372788|NCT01457573|Urological Agents|urological agents|mesh-ancestor
111372789|NCT01457573|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111372790|NCT01457573|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111372791|NCT01457573|Cholinergic Agents|cholinergic agents|mesh-ancestor
111372792|NCT01560143|Tigecycline|tigecycline|mesh-list
111372793|NCT01560143|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111372794|NCT01560143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111372795|NCT01560143|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111372796|NCT01560143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111372797|NCT01560143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111372798|NCT01836224|Terlipressin|terlipressin|mesh-list
111372799|NCT01836224|Norepinephrine|norepinephrine|mesh-list
111372800|NCT01836224|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111372801|NCT01836224|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111372802|NCT01836224|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111372803|NCT01836224|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111372804|NCT01836224|Adrenergic Agents|adrenergic agents|mesh-ancestor
111372805|NCT01836224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111372806|NCT01836224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111372807|NCT01836224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111372808|NCT01836224|Sympathomimetics|sympathomimetics|mesh-ancestor
111372809|NCT01836224|Autonomic Agents|autonomic agents|mesh-ancestor
111372810|NCT01836224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111372811|NCT01836536|Bevacizumab|bevacizumab|mesh-list
111372812|NCT01836536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111372813|NCT01836536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111372814|NCT01836536|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111372815|NCT01836536|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111372816|NCT01836536|Growth Substances|growth substances|mesh-ancestor
111372817|NCT01836536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111372818|NCT01836536|Growth Inhibitors|growth inhibitors|mesh-ancestor
111372819|NCT03216980|Antioxidants|antioxidants|mesh-list
111372820|NCT03216980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111372821|NCT03216980|Protective Agents|protective agents|mesh-ancestor
111372822|NCT03216980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111372823|NCT00895232|Iron|iron|mesh-list
111372824|NCT00895232|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
111372825|NCT00895232|Trace Elements|trace elements|mesh-ancestor
111372826|NCT00895232|Micronutrients|micronutrients|mesh-ancestor
111372827|NCT00895232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111372828|NCT00895232|Hematinics|hematinics|mesh-ancestor
111372829|NCT03211052|Leuprolide|leuprolide|mesh-list
111372830|NCT03211052|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111372831|NCT03211052|Fertility Agents|fertility agents|mesh-ancestor
111372832|NCT03211052|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111372833|NCT03211052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111372834|NCT03211052|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111372835|NCT03211052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111372836|NCT01560923|Tryptophan|tryptophan|mesh-list
111372837|NCT01560923|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111372838|NCT01560923|Antidepressive Agents|antidepressive agents|mesh-ancestor
111372839|NCT01560923|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111372840|NCT01839032|Vinorelbine|vinorelbine|mesh-list
111372841|NCT01839032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111372842|NCT01839032|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111372843|NCT01839032|Tubulin Modulators|tubulin modulators|mesh-ancestor
111372844|NCT01839032|Antimitotic Agents|antimitotic agents|mesh-ancestor
111372845|NCT01839032|Mitosis Modulators|mitosis modulators|mesh-ancestor
111372846|NCT01839032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111372848|NCT01457885|Clofarabine|clofarabine|mesh-list
111372849|NCT01457885|Alkylating Agents|alkylating agents|mesh-ancestor
111372850|NCT01457885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111372851|NCT01457885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111372852|NCT01457885|Immunologic Factors|immunologic factors|mesh-ancestor
111372853|NCT01457885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111372854|NCT01457885|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111372855|NCT01457885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111372856|NCT01457885|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111372857|NCT01457885|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111372858|NCT01457885|Antimetabolites|antimetabolites|mesh-ancestor
111372859|NCT01460225|Lubiprostone|lubiprostone|mesh-list
111372860|NCT01460225|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
111372861|NCT01460225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111372862|NCT01460225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111372863|NCT01561469|Vancomycin|vancomycin|mesh-list
111372864|NCT01561469|Linezolid|linezolid|mesh-list
111372865|NCT01561469|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111372866|NCT01561469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111372867|NCT01561469|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111372868|NCT01561469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111372869|NCT01561469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111372870|NCT01561703|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111372871|NCT01561703|Amoxicillin|amoxicillin|mesh-list
111372872|NCT01561703|Azithromycin|azithromycin|mesh-list
111372873|NCT01561703|Clindamycin|clindamycin|mesh-list
111372874|NCT01561703|Clavulanic Acid|clavulanic acid|mesh-list
111372875|NCT01561703|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
111372876|NCT01561703|Cephalexin|cephalexin|mesh-list
111372877|NCT01561703|Cefdinir|cefdinir|mesh-list
111372878|NCT01561703|Cefaclor|cefaclor|mesh-list
111372879|NCT01561703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111372880|NCT01561703|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111372881|NCT01561703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111372882|NCT01561703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111372883|NCT01561703|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
111372884|NCT01839500|Trastuzumab|trastuzumab|mesh-list
111372885|NCT01839500|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111372886|NCT01839500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111372887|NCT02501928|Fesoterodine|fesoterodine|mesh-list
111372888|NCT02501928|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111372889|NCT02501928|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111372890|NCT02501928|Cholinergic Agents|cholinergic agents|mesh-ancestor
111372891|NCT02501928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111372892|NCT02501928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111372893|NCT02501928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111372894|NCT02501928|Urological Agents|urological agents|mesh-ancestor
111372895|NCT01462253|Cyclophosphamide|cyclophosphamide|mesh-list
111372896|NCT01462253|Clofarabine|clofarabine|mesh-list
111372897|NCT01462253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111372898|NCT01462253|Immunologic Factors|immunologic factors|mesh-ancestor
111372899|NCT01462253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111372900|NCT01462253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111372901|NCT01462253|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111372902|NCT01462253|Alkylating Agents|alkylating agents|mesh-ancestor
111372903|NCT01462253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111372904|NCT01462253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111372905|NCT01462253|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111372906|NCT01462253|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111372907|NCT01462253|Antimetabolites|antimetabolites|mesh-ancestor
111372908|NCT01837394|Acetaminophen|acetaminophen|mesh-list
111372909|NCT01837394|Morphine|morphine|mesh-list
111372910|NCT01837394|Ondansetron|ondansetron|mesh-list
111372911|NCT01837394|Metoclopramide|metoclopramide|mesh-list
111372912|NCT01837394|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111372913|NCT01837394|Narcotics|narcotics|mesh-ancestor
111372914|NCT01837394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111372915|NCT01837394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111372916|NCT01837394|Analgesics|analgesics|mesh-ancestor
111372917|NCT01837394|Sensory System Agents|sensory system agents|mesh-ancestor
111097342|NCT03195023|Diuretics|diuretics|mesh-ancestor
111372918|NCT01837394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111372919|NCT01837394|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111372920|NCT01837394|Antipyretics|antipyretics|mesh-ancestor
111372921|NCT01837394|Antiemetics|antiemetics|mesh-ancestor
111372922|NCT01837394|Autonomic Agents|autonomic agents|mesh-ancestor
111372923|NCT01837394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111372924|NCT01837394|Antipruritics|antipruritics|mesh-ancestor
111372925|NCT01837394|Dermatologic Agents|dermatologic agents|mesh-ancestor
111372926|NCT01837394|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111372927|NCT01837394|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111372928|NCT01837394|Serotonin Agents|serotonin agents|mesh-ancestor
111372929|NCT01837394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111372930|NCT01837394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111372931|NCT01837394|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111372932|NCT01837394|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111372933|NCT01837394|Dopamine Agents|dopamine agents|mesh-ancestor
111372934|NCT01462565|Epoprostenol|epoprostenol|mesh-list
111372936|NCT01462565|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111372937|NCT01462565|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111372938|NCT01462565|Vasodilator Agents|vasodilator agents|mesh-ancestor
111372939|NCT01837628|Lidocaine|lidocaine|mesh-list
111372940|NCT01837628|Mineral Oil|mineral oil|mesh-list
111372941|NCT01837628|Anesthetics, Local|anesthetics, local|mesh-ancestor
111372942|NCT01837628|Anesthetics|anesthetics|mesh-ancestor
111372943|NCT01837628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111372944|NCT01837628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111372945|NCT01837628|Sensory System Agents|sensory system agents|mesh-ancestor
111372946|NCT01837628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111372947|NCT01837628|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111372948|NCT01837628|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111372949|NCT01837628|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111372950|NCT01837628|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111372951|NCT01837628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111372952|NCT01837628|Emollients|emollients|mesh-ancestor
111372953|NCT01837628|Dermatologic Agents|dermatologic agents|mesh-ancestor
111372954|NCT01462877|Fenofibrate|fenofibrate|mesh-list
111372955|NCT01462877|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111372956|NCT01462877|Antimetabolites|antimetabolites|mesh-ancestor
111372957|NCT01462877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111372958|NCT01462877|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111372959|NCT04972656|Ambrisentan|ambrisentan|mesh-list
111372960|NCT04972656|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111372961|NCT03210506|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
111372962|NCT03210506|Antiviral Agents|antiviral agents|mesh-ancestor
111372963|NCT03210506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111372964|NCT02500758|Chloroxylenol|chloroxylenol|mesh-list
111372965|NCT02500758|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111372966|NCT02500758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111372967|NCT02500758|Disinfectants|disinfectants|mesh-ancestor
111372968|NCT02500758|Schistosomicides|schistosomicides|mesh-ancestor
111372969|NCT02500758|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
111372970|NCT02500758|Anthelmintics|anthelmintics|mesh-ancestor
111372971|NCT02500758|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111372972|NCT01839812|Cosyntropin|cosyntropin|mesh-list
111372973|NCT01839812|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
111372974|NCT01839812|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
111372975|NCT01839812|beta-Endorphin|beta-endorphin|mesh-list
111372976|NCT01839812|Hormones|hormones|mesh-ancestor
111372977|NCT01839812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111372978|NCT01839812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111372979|NCT01839812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111372980|NCT01839812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111372981|NCT01839890|Paclitaxel|paclitaxel|mesh-list
111372982|NCT01839890|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111372983|NCT01839890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111372984|NCT01839890|Tubulin Modulators|tubulin modulators|mesh-ancestor
111372985|NCT01839890|Antimitotic Agents|antimitotic agents|mesh-ancestor
111372986|NCT01839890|Mitosis Modulators|mitosis modulators|mesh-ancestor
111372987|NCT01839890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111372988|NCT02205983|Acetaminophen|acetaminophen|mesh-list
111372989|NCT02205983|Hydromorphone|hydromorphone|mesh-list
111372990|NCT02205983|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111372991|NCT02205983|Analgesics|analgesics|mesh-ancestor
111372992|NCT02205983|Sensory System Agents|sensory system agents|mesh-ancestor
111372993|NCT02205983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111372994|NCT02205983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111372995|NCT02205983|Antipyretics|antipyretics|mesh-ancestor
111372996|NCT02205983|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111372997|NCT02205983|Narcotics|narcotics|mesh-ancestor
111372998|NCT02205983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111372999|NCT01839968|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
111373000|NCT01839968|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111373001|NCT03210038|Lidocaine|lidocaine|mesh-list
111373002|NCT03210038|Anesthetics, Local|anesthetics, local|mesh-ancestor
111373003|NCT03210038|Anesthetics|anesthetics|mesh-ancestor
111373004|NCT03210038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111373005|NCT03210038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111373006|NCT03210038|Sensory System Agents|sensory system agents|mesh-ancestor
111373007|NCT03210038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111373008|NCT03210038|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111373009|NCT03210038|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111373010|NCT03210038|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111373011|NCT03210038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111373012|NCT03210038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111373013|NCT02472756|Rituximab|rituximab|mesh-list
111373014|NCT02472756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111373015|NCT02472756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111373016|NCT02472756|Immunologic Factors|immunologic factors|mesh-ancestor
111373017|NCT02472756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111373018|NCT02472756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111373019|NCT01464359|Cyclophosphamide|cyclophosphamide|mesh-list
111373020|NCT01464359|Busulfan|busulfan|mesh-list
111373021|NCT01464359|Fludarabine|fludarabine|mesh-list
111373022|NCT01464359|Interleukin-2|interleukin-2|mesh-list
111373023|NCT01464359|Allopurinol|allopurinol|mesh-list
111373024|NCT01464359|Levetiracetam|levetiracetam|mesh-list
111373025|NCT01464359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111373026|NCT01464359|Immunologic Factors|immunologic factors|mesh-ancestor
111373027|NCT01464359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111373028|NCT01464359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111373029|NCT01464359|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111373030|NCT01464359|Alkylating Agents|alkylating agents|mesh-ancestor
111373031|NCT01464359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111373032|NCT01464359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111373033|NCT01464359|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111373034|NCT01464359|Antimetabolites|antimetabolites|mesh-ancestor
111373035|NCT01464359|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111373036|NCT01464359|Analgesics|analgesics|mesh-ancestor
111373037|NCT01464359|Sensory System Agents|sensory system agents|mesh-ancestor
111373038|NCT01464359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111373039|NCT01464359|Anticonvulsants|anticonvulsants|mesh-ancestor
111373040|NCT01464359|Nootropic Agents|nootropic agents|mesh-ancestor
111373041|NCT01464359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111373042|NCT01464359|Gout Suppressants|gout suppressants|mesh-ancestor
111373043|NCT01464359|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111373044|NCT01464359|Antioxidants|antioxidants|mesh-ancestor
111373045|NCT01464359|Protective Agents|protective agents|mesh-ancestor
111373046|NCT04969224|Ivacaftor|ivacaftor|mesh-list
111373047|NCT04969224|Elexacaftor|elexacaftor|mesh-list
111373048|NCT04969224|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
111373049|NCT04969224|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111373050|NCT04969224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111373051|NCT01838252|Hyaluronic Acid|hyaluronic acid|mesh-list
111373052|NCT01838252|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111373053|NCT01838252|Immunologic Factors|immunologic factors|mesh-ancestor
111373054|NCT01838252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111373055|NCT01838252|Viscosupplements|viscosupplements|mesh-ancestor
111373056|NCT01838252|Protective Agents|protective agents|mesh-ancestor
111373057|NCT01838330|Psyllium|psyllium|mesh-list
111373058|NCT01838330|Cathartics|cathartics|mesh-ancestor
111373059|NCT01838330|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111373060|NCT02498652|Allopurinol|allopurinol|mesh-list
111373061|NCT02498652|Verinurad|verinurad|mesh-list
111373062|NCT02498652|Antimetabolites|antimetabolites|mesh-ancestor
111373063|NCT02498652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111373064|NCT02498652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111373065|NCT02498652|Gout Suppressants|gout suppressants|mesh-ancestor
111373066|NCT02498652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111373067|NCT02498652|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111373068|NCT02498652|Antioxidants|antioxidants|mesh-ancestor
111373069|NCT02498652|Protective Agents|protective agents|mesh-ancestor
111373070|NCT02498652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111373071|NCT03213158|Ixazomib|ixazomib|mesh-list
111373072|NCT03213158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111373073|NCT03213158|Protease Inhibitors|protease inhibitors|mesh-ancestor
111373074|NCT03213158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111373075|NCT03213158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111373076|NCT02498418|Rifaximin|rifaximin|mesh-list
111373077|NCT02498418|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111373078|NCT02498418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111373079|NCT02498418|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111373080|NCT03219476|Tamoxifen|tamoxifen|mesh-list
111373081|NCT03219476|Letrozole|letrozole|mesh-list
111373082|NCT03219476|Anastrozole|anastrozole|mesh-list
111373083|NCT03219476|Exemestane|exemestane|mesh-list
111373084|NCT03219476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111373085|NCT03219476|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111373086|NCT03219476|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111373087|NCT03219476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111373088|NCT03219476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111373089|NCT03219476|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111373090|NCT03219476|Hormone Antagonists|hormone antagonists|mesh-ancestor
111373091|NCT03219476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111373092|NCT03219476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111373093|NCT03219476|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111373094|NCT03219476|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111373095|NCT03219476|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110512796|NCT02833376|Chlorhexidine|chlorhexidine|mesh-list
111373096|NCT03219476|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111373097|NCT02472366|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
111373098|NCT02472366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111373099|NCT02472366|Glucocorticoids|glucocorticoids|mesh-ancestor
111373100|NCT02472366|Hormones|hormones|mesh-ancestor
111373101|NCT02472366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111373102|NCT02472366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111373103|NCT01724606|Sorafenib|sorafenib|mesh-list
111373104|NCT01724606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111373105|NCT01724606|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111373106|NCT01724606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111373107|NCT01724606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111373108|NCT03219164|Aztreonam|aztreonam|mesh-list
111373109|NCT03219164|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111373110|NCT03219164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111373111|NCT01720238|Lamivudine|lamivudine|mesh-list
111373112|NCT01720238|Adefovir|adefovir|mesh-list
111373113|NCT01720238|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
111373114|NCT01720238|Entecavir|entecavir|mesh-list
111373115|NCT01720238|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111373116|NCT01720238|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111373117|NCT01720238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111373118|NCT01720238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111373119|NCT01720238|Antiviral Agents|antiviral agents|mesh-ancestor
111373120|NCT01720238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111373121|NCT01720238|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111373122|NCT01720238|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111373123|NCT03836222|Pentoxifylline|pentoxifylline|mesh-list
111373124|NCT03836222|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111373125|NCT03836222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111373126|NCT03836222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111373127|NCT03836222|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111373128|NCT03836222|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111373129|NCT03836222|Protective Agents|protective agents|mesh-ancestor
111373130|NCT03836222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111373131|NCT03836222|Vasodilator Agents|vasodilator agents|mesh-ancestor
111373132|NCT03836222|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111373133|NCT03836222|Antioxidants|antioxidants|mesh-ancestor
111373134|NCT01830218|Anesthetics|anesthetics|mesh-list
111373135|NCT01830218|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111373136|NCT01830218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111373137|NCT00910208|Morphine|morphine|mesh-list
111373138|NCT00910208|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111373139|NCT00910208|Narcotics|narcotics|mesh-ancestor
111373140|NCT00910208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111373141|NCT00910208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111373142|NCT00910208|Analgesics|analgesics|mesh-ancestor
111373143|NCT00910208|Sensory System Agents|sensory system agents|mesh-ancestor
111373144|NCT00910208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111373145|NCT01566539|Vasopressins|vasopressins|mesh-list
111373146|NCT01566539|Arginine Vasopressin|arginine vasopressin|mesh-list
111097577|NCT03120221|Iodine|iodine|mesh-list
111373148|NCT01566539|Oxytocin|oxytocin|mesh-list
111373149|NCT01566539|Oxytocics|oxytocics|mesh-ancestor
111373150|NCT01566539|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111373151|NCT01566539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111373152|NCT01566539|Anticonvulsants|anticonvulsants|mesh-ancestor
111373153|NCT01566539|Antiemetics|antiemetics|mesh-ancestor
111373154|NCT01566539|Autonomic Agents|autonomic agents|mesh-ancestor
111373155|NCT01566539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111373156|NCT01566539|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111373157|NCT01566539|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111373158|NCT01566539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110512865|NCT04246502|Pertuzumab|pertuzumab|mesh-list
111373159|NCT01566539|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111373160|NCT01566539|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111373161|NCT01566539|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111373162|NCT01566539|GABA Modulators|gaba modulators|mesh-ancestor
111373163|NCT01566539|GABA Agents|gaba agents|mesh-ancestor
111373164|NCT01566539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111373165|NCT01566539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111373166|NCT01566539|Hemostatics|hemostatics|mesh-ancestor
111373167|NCT01566539|Coagulants|coagulants|mesh-ancestor
111373168|NCT01566539|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111373169|NCT01566539|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
111373170|NCT01566539|Natriuretic Agents|natriuretic agents|mesh-ancestor
111373171|NCT04967664|Capsaicin|capsaicin|mesh-list
111373172|NCT04967664|Antipruritics|antipruritics|mesh-ancestor
111373173|NCT04967664|Dermatologic Agents|dermatologic agents|mesh-ancestor
111373174|NCT04967664|Sensory System Agents|sensory system agents|mesh-ancestor
111373175|NCT04967664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111373176|NCT04967664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111373177|NCT01725776|Milrinone|milrinone|mesh-list
111373178|NCT01725776|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111373179|NCT01725776|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111373180|NCT01725776|Vasodilator Agents|vasodilator agents|mesh-ancestor
111373181|NCT01725776|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
111373182|NCT01725776|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111373183|NCT01725776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111373184|NCT01725776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111373185|NCT01725776|Protective Agents|protective agents|mesh-ancestor
111373186|NCT01725776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111373187|NCT01830296|Morphine|morphine|mesh-list
111373188|NCT01830296|Remifentanil|remifentanil|mesh-list
111373189|NCT01830296|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111373190|NCT01830296|Narcotics|narcotics|mesh-ancestor
111373191|NCT01830296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111373192|NCT01830296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111373193|NCT01830296|Analgesics|analgesics|mesh-ancestor
111373194|NCT01830296|Sensory System Agents|sensory system agents|mesh-ancestor
111373195|NCT01830296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111373196|NCT05564819|Acetaminophen|acetaminophen|mesh-list
111373197|NCT05564819|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111373198|NCT05564819|Analgesics|analgesics|mesh-ancestor
111373199|NCT05564819|Sensory System Agents|sensory system agents|mesh-ancestor
111373200|NCT05564819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111373201|NCT05564819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111373202|NCT05564819|Antipyretics|antipyretics|mesh-ancestor
111373203|NCT01720394|Dinoprostone|dinoprostone|mesh-list
111373204|NCT01720394|Oxytocics|oxytocics|mesh-ancestor
111373205|NCT01720394|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111373206|NCT01720394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111373207|NCT01467947|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
111373208|NCT01467947|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
111373209|NCT01467947|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
111373210|NCT01467947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111373211|NCT01467947|Immunologic Factors|immunologic factors|mesh-ancestor
111373212|NCT01467947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111373213|NCT00910520|Botulinum Toxins|botulinum toxins|mesh-list
111373214|NCT00910520|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111373215|NCT00910520|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111373216|NCT00910520|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111373217|NCT00910520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111373218|NCT00910520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111373219|NCT00910520|Cholinergic Agents|cholinergic agents|mesh-ancestor
111373220|NCT00910520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111373221|NCT00910520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111373222|NCT00910520|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111373223|NCT00910520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111373224|NCT01568255|Ergocalciferols|ergocalciferols|mesh-list
111373225|NCT01568255|Vitamin D|vitamin d|mesh-list
111373226|NCT01568255|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111373227|NCT01568255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111373228|NCT01568255|Vitamins|vitamins|mesh-ancestor
111373229|NCT01568255|Micronutrients|micronutrients|mesh-ancestor
111373230|NCT01568255|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111373231|NCT01720628|Angiogenin|angiogenin|mesh-list
111373232|NCT01720628|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
111373233|NCT01720628|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111373234|NCT01720628|Growth Substances|growth substances|mesh-ancestor
111373235|NCT01720628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111373236|NCT01569191|Anti-Allergic Agents|anti-allergic agents|mesh-list
111373237|NCT01569191|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111373238|NCT01569191|Lubricant Eye Drops|lubricant eye drops|mesh-list
111373239|NCT01569191|Epinastine|epinastine|mesh-list
111373240|NCT01569191|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111373241|NCT01569191|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111373242|NCT01569191|Histamine Antagonists|histamine antagonists|mesh-ancestor
111373243|NCT01569191|Histamine Agents|histamine agents|mesh-ancestor
111373244|NCT01569191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111373245|NCT01569191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111373246|NCT01569191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111373247|NCT03409874|Diclofenac|diclofenac|mesh-list
111373248|NCT03409874|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111373249|NCT03409874|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111373250|NCT03409874|Analgesics|analgesics|mesh-ancestor
111373251|NCT03409874|Sensory System Agents|sensory system agents|mesh-ancestor
111373252|NCT03409874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111373253|NCT03409874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111373254|NCT03409874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111373255|NCT03409874|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111373256|NCT03409874|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111373257|NCT03409874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111373258|NCT03409874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111373259|NCT01726088|Modafinil|modafinil|mesh-list
111373260|NCT01726088|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111373261|NCT01726088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111373262|NCT01726088|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
111373263|NCT01726088|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111373264|NCT01726088|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111373265|NCT01726088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111373266|NCT01468337|Interferons|interferons|mesh-list
111373267|NCT01468337|Interferon-gamma|interferon-gamma|mesh-list
111373268|NCT01468337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111373269|NCT01468337|Antiviral Agents|antiviral agents|mesh-ancestor
111373270|NCT01468337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111373271|NCT00911612|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
111373272|NCT00911612|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111373273|NCT00911612|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111373274|NCT00911612|Antimetabolites|antimetabolites|mesh-ancestor
111373275|NCT00911612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111373276|NCT00911612|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111373277|NCT05562089|Paclitaxel|paclitaxel|mesh-list
111373278|NCT05562089|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111373279|NCT05562089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111373280|NCT05562089|Tubulin Modulators|tubulin modulators|mesh-ancestor
111373281|NCT05562089|Antimitotic Agents|antimitotic agents|mesh-ancestor
111373282|NCT05562089|Mitosis Modulators|mitosis modulators|mesh-ancestor
111373283|NCT05562089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111373284|NCT01726478|Oxytocin|oxytocin|mesh-list
111373285|NCT01726478|Oxytocics|oxytocics|mesh-ancestor
111373286|NCT01726478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111373287|NCT01726478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111373288|NCT04379492|Hydroxychloroquine|hydroxychloroquine|mesh-list
111373289|NCT04379492|Antimalarials|antimalarials|mesh-ancestor
111373290|NCT04379492|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111373291|NCT04379492|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111373292|NCT04379492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111373293|NCT04379492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111373294|NCT04379492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111373295|NCT04379492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111373296|NCT03409250|Ranibizumab|ranibizumab|mesh-list
111373297|NCT03409250|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111373298|NCT03409250|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111373299|NCT03409250|Growth Substances|growth substances|mesh-ancestor
111373300|NCT03409250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111373301|NCT03409250|Growth Inhibitors|growth inhibitors|mesh-ancestor
111373302|NCT03409250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111373303|NCT01569815|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
111373304|NCT01569815|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111373305|NCT01569815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111373306|NCT01469585|Doxycycline|doxycycline|mesh-list
111373307|NCT01469585|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111373308|NCT01469585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111373309|NCT01469585|Antimalarials|antimalarials|mesh-ancestor
111373310|NCT01469585|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111373311|NCT01469585|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111373312|NCT01720940|Vancomycin|vancomycin|mesh-list
111373313|NCT01720940|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111373314|NCT01720940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111373315|NCT00915590|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
111373316|NCT00915590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111373317|NCT01721798|Copper|copper|mesh-list
111373318|NCT01721798|Levonorgestrel|levonorgestrel|mesh-list
111373319|NCT01721798|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111373320|NCT01721798|Contraceptive Agents|contraceptive agents|mesh-ancestor
111373321|NCT01721798|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111373322|NCT01721798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111373323|NCT01721798|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111373324|NCT01721798|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111373325|NCT01721798|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111373326|NCT01721798|Trace Elements|trace elements|mesh-ancestor
111373327|NCT01721798|Micronutrients|micronutrients|mesh-ancestor
111373328|NCT02497404|Fludarabine|fludarabine|mesh-list
111373329|NCT02497404|Azacitidine|azacitidine|mesh-list
111373330|NCT02497404|Melphalan|melphalan|mesh-list
111373331|NCT02497404|Alemtuzumab|alemtuzumab|mesh-list
111373332|NCT02497404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111373333|NCT02497404|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111373334|NCT02497404|Antimetabolites|antimetabolites|mesh-ancestor
111373335|NCT02497404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111373336|NCT02497404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111373337|NCT02497404|Immunologic Factors|immunologic factors|mesh-ancestor
111373338|NCT02497404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111373339|NCT02497404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111373340|NCT02497404|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111373341|NCT02497404|Alkylating Agents|alkylating agents|mesh-ancestor
111373342|NCT02497404|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111373343|NCT02497404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111373344|NCT01573169|Enoxaparin|enoxaparin|mesh-list
111373345|NCT01573169|Anticoagulants|anticoagulants|mesh-ancestor
111373346|NCT01573169|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111373347|NCT01573169|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111373348|NCT01573169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111373349|NCT04205994|Tolcapone|tolcapone|mesh-list
111373350|NCT04205994|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111373351|NCT04205994|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111373352|NCT04205994|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
111373353|NCT04205994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111373354|NCT04205994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111373355|NCT02218307|Mupirocin|mupirocin|mesh-list
111373356|NCT02218307|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111373357|NCT02218307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111373358|NCT02218307|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111373359|NCT02218307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111373360|NCT02218307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111373361|NCT01722110|Indomethacin|indomethacin|mesh-list
111373362|NCT01722110|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111373363|NCT01722110|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111373364|NCT01722110|Analgesics|analgesics|mesh-ancestor
111373365|NCT01722110|Sensory System Agents|sensory system agents|mesh-ancestor
111373366|NCT01722110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111373367|NCT01722110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111373368|NCT01722110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111373369|NCT01722110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111373370|NCT01722110|Gout Suppressants|gout suppressants|mesh-ancestor
111373371|NCT01722110|Tocolytic Agents|tocolytic agents|mesh-ancestor
111373372|NCT01722110|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111373373|NCT01722110|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111373374|NCT01722110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111373375|NCT01722110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111373376|NCT01573949|Metformin|metformin|mesh-list
111373377|NCT01573949|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111373378|NCT01573949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111373379|NCT01574183|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
111373380|NCT01574183|Antidepressive Agents|antidepressive agents|mesh-ancestor
111373381|NCT01574183|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111373382|NCT01574183|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111373383|NCT01574183|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111373384|NCT01574183|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111373385|NCT01574183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111373386|NCT01574183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111373387|NCT01574183|Serotonin Agents|serotonin agents|mesh-ancestor
111373388|NCT01574183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111373389|NCT01574183|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111373390|NCT01574183|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111373391|NCT01574807|Lidocaine|lidocaine|mesh-list
111373392|NCT01574807|Mepivacaine|mepivacaine|mesh-list
111373393|NCT01574807|Anesthetics, Local|anesthetics, local|mesh-ancestor
111373394|NCT01574807|Anesthetics|anesthetics|mesh-ancestor
111373395|NCT01574807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111373396|NCT01574807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111373397|NCT01574807|Sensory System Agents|sensory system agents|mesh-ancestor
111373398|NCT01574807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111373399|NCT01574807|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111373400|NCT01574807|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111373401|NCT01574807|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111373402|NCT01574807|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111373403|NCT01574807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111373404|NCT01575275|Aminolevulinic Acid|aminolevulinic acid|mesh-list
111373405|NCT01575275|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111373406|NCT01575275|Dermatologic Agents|dermatologic agents|mesh-ancestor
111373407|NCT01728272|Metoprolol|metoprolol|mesh-list
111373408|NCT01728272|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111373409|NCT01728272|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111373410|NCT01728272|Sympatholytics|sympatholytics|mesh-ancestor
111373411|NCT01728272|Autonomic Agents|autonomic agents|mesh-ancestor
111373412|NCT01728272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111373413|NCT01728272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111373414|NCT01728272|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
111373415|NCT01728272|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111373416|NCT01728272|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111373417|NCT01728272|Adrenergic Agents|adrenergic agents|mesh-ancestor
111373418|NCT01728272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111373419|NCT01728272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111373420|NCT03835286|Ascorbic Acid|ascorbic acid|mesh-list
111373421|NCT03835286|Vitamins|vitamins|mesh-ancestor
111373422|NCT03835286|Micronutrients|micronutrients|mesh-ancestor
111373423|NCT03835286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111373424|NCT03835286|Antioxidants|antioxidants|mesh-ancestor
111373425|NCT03835286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111373426|NCT03835286|Protective Agents|protective agents|mesh-ancestor
111373427|NCT04377386|Vitamin D|vitamin d|mesh-list
111373428|NCT04377386|Ergocalciferols|ergocalciferols|mesh-list
111373429|NCT04377386|Cholecalciferol|cholecalciferol|mesh-list
111373430|NCT04377386|Vitamins|vitamins|mesh-list
111373431|NCT04377386|Micronutrients|micronutrients|mesh-ancestor
111373432|NCT04377386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111373433|NCT04377386|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111373434|NCT04377386|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111373435|NCT01728740|Metformin|metformin|mesh-list
111373436|NCT01728740|Acarbose|acarbose|mesh-list
111373437|NCT01728740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111373438|NCT01728740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111373439|NCT01728740|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
111373440|NCT01728740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111373441|NCT01728740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111373442|NCT01728818|Gemcitabine|gemcitabine|mesh-list
111373443|NCT01728818|Afatinib|afatinib|mesh-list
111373444|NCT01728818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111373445|NCT01728818|Antimetabolites|antimetabolites|mesh-ancestor
111373446|NCT01728818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110513164|NCT04699422|Pirinitramide|pirinitramide|mesh-list
111373447|NCT01728818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111373448|NCT01728818|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111373449|NCT01728818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111373450|NCT03835520|Immunomodulating Agents|immunomodulating agents|mesh-list
111373451|NCT03835520|Immunologic Factors|immunologic factors|mesh-ancestor
111373452|NCT03835520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111373453|NCT01728974|Anesthetics|anesthetics|mesh-list
111373454|NCT01728974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111373455|NCT01728974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111373456|NCT03407300|Docetaxel|docetaxel|mesh-list
111373457|NCT03407300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111373458|NCT03407300|Tubulin Modulators|tubulin modulators|mesh-ancestor
111373459|NCT03407300|Antimitotic Agents|antimitotic agents|mesh-ancestor
111373460|NCT03407300|Mitosis Modulators|mitosis modulators|mesh-ancestor
111373461|NCT03407300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111373462|NCT01722968|Paclitaxel|paclitaxel|mesh-list
111373463|NCT01722968|Bevacizumab|bevacizumab|mesh-list
111373464|NCT01722968|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111373465|NCT01722968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111373466|NCT01722968|Tubulin Modulators|tubulin modulators|mesh-ancestor
111373467|NCT01722968|Antimitotic Agents|antimitotic agents|mesh-ancestor
111373468|NCT01722968|Mitosis Modulators|mitosis modulators|mesh-ancestor
111373469|NCT01722968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111373470|NCT01722968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111373471|NCT01722968|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111373472|NCT01722968|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111373473|NCT01722968|Growth Substances|growth substances|mesh-ancestor
111373474|NCT01722968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111373475|NCT01722968|Growth Inhibitors|growth inhibitors|mesh-ancestor
111373476|NCT04379180|Bosentan|bosentan|mesh-list
111373477|NCT04379180|Sildenafil Citrate|sildenafil citrate|mesh-list
111373478|NCT04379180|Tadalafil|tadalafil|mesh-list
111373479|NCT04379180|Vasodilator Agents|vasodilator agents|mesh-ancestor
111373480|NCT04379180|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111373481|NCT04379180|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111373482|NCT04379180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111373483|NCT04379180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111373484|NCT04379180|Urological Agents|urological agents|mesh-ancestor
111373485|NCT04379180|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111373486|NCT04379180|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
111373487|NCT01576523|Complement C1s|complement c1s|mesh-list
111373488|NCT01576523|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
111373489|NCT01576523|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
111373490|NCT01576523|Immunologic Factors|immunologic factors|mesh-ancestor
111373491|NCT01576523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111373492|NCT01576523|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
111373493|NCT01576523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111373494|NCT03406676|Methylene Blue|methylene blue|mesh-list
111373495|NCT03406676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111373496|NCT03406676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111373497|NCT03001739|Urapidil|urapidil|mesh-list
111373498|NCT03001739|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111373499|NCT03001739|Vasodilator Agents|vasodilator agents|mesh-ancestor
111373500|NCT03001739|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111373501|NCT03001739|Serotonin Agents|serotonin agents|mesh-ancestor
111373502|NCT03001739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111373503|NCT03001739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111373504|NCT03001739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111373505|NCT03001739|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111373506|NCT03001739|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111373507|NCT03001739|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111373508|NCT03001739|Adrenergic Agents|adrenergic agents|mesh-ancestor
111373509|NCT03001661|Dinoprostone|dinoprostone|mesh-list
111373510|NCT03001661|Oxytocics|oxytocics|mesh-ancestor
111373511|NCT03001661|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111373512|NCT03001661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111373513|NCT03006965|Factor VIII|factor viii|mesh-list
111373514|NCT03006965|BAX 855|bax 855|mesh-list
111373515|NCT03006965|Coagulants|coagulants|mesh-ancestor
111373516|NCT04379102|Anesthetics|anesthetics|mesh-list
111373517|NCT04379102|Anesthetics, Local|anesthetics, local|mesh-list
111373518|NCT04379102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111373519|NCT04379102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111373520|NCT04379102|Sensory System Agents|sensory system agents|mesh-ancestor
111373521|NCT04379102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111373522|NCT02469246|Lamivudine|lamivudine|mesh-list
111373523|NCT02469246|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111373524|NCT02469246|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111373525|NCT02469246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111373526|NCT02469246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111373527|NCT02469246|Antiviral Agents|antiviral agents|mesh-ancestor
111373528|NCT02469246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111373529|NCT02469246|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111373530|NCT02469246|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111373531|NCT01723202|Trametinib|trametinib|mesh-list
111373532|NCT01723202|Dabrafenib|dabrafenib|mesh-list
111373533|NCT01723202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111373534|NCT01723202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111373535|NCT01723202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111373536|NCT01723202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111373537|NCT01578317|Vaccines|vaccines|mesh-list
111373538|NCT01578317|Immunologic Factors|immunologic factors|mesh-ancestor
111373539|NCT01578317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111373540|NCT03830216|Insulin|insulin|mesh-list
111373541|NCT03830216|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111373542|NCT03830216|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111373543|NCT03830216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111373544|NCT01726946|Ribavirin|ribavirin|mesh-list
111373545|NCT01726946|Antimetabolites|antimetabolites|mesh-ancestor
111373546|NCT01726946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111373547|NCT01726946|Antiviral Agents|antiviral agents|mesh-ancestor
111373548|NCT01726946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111373549|NCT01723670|1-(3',4'-dichloro-2-fluoro(1,1'-biphenyl)-4-yl)cyclopropanecarboxylic acid|1-(3',4'-dichloro-2-fluoro(1,1'-biphenyl)-4-yl)cyclopropanecarboxylic acid|mesh-list
111373550|NCT01723670|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
111373551|NCT01723670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111373552|NCT01723670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111373553|NCT01723748|Hormones|hormones|mesh-list
111000945|NCT02855359|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111373554|NCT01723748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111373555|NCT01723748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111373556|NCT02469090|Apomorphine|apomorphine|mesh-list
111373557|NCT02469090|Emetics|emetics|mesh-ancestor
111373558|NCT02469090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111373559|NCT02469090|Autonomic Agents|autonomic agents|mesh-ancestor
111373560|NCT02469090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111373561|NCT02469090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111373562|NCT02469090|Dopamine Agonists|dopamine agonists|mesh-ancestor
111373563|NCT02469090|Dopamine Agents|dopamine agents|mesh-ancestor
111373564|NCT02469090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111373565|NCT02469090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111373566|NCT02496000|Insulin|insulin|mesh-list
111373567|NCT02496000|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111373568|NCT02496000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111373569|NCT02517528|Ritonavir|ritonavir|mesh-list
111373570|NCT02517528|Ribavirin|ribavirin|mesh-list
111373571|NCT02517528|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111373572|NCT02517528|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111373573|NCT02517528|Protease Inhibitors|protease inhibitors|mesh-ancestor
111373574|NCT02517528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111373575|NCT02517528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111373576|NCT02517528|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111373577|NCT02517528|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111373578|NCT02517528|Antiviral Agents|antiviral agents|mesh-ancestor
111373579|NCT02517528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111373580|NCT02517528|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111373581|NCT02517528|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111373582|NCT02517528|Antimetabolites|antimetabolites|mesh-ancestor
111373583|NCT01727336|Axitinib|axitinib|mesh-list
111373584|NCT01727336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111373585|NCT01727336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111373586|NCT01727336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111373587|NCT01727336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111373588|NCT01578707|Ofatumumab|ofatumumab|mesh-list
111373589|NCT01578707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111373590|NCT03835442|Baclofen|baclofen|mesh-list
111373591|NCT03835442|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
111373592|NCT03835442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111373593|NCT03835442|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111373594|NCT03835442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111373595|NCT03835442|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
111373596|NCT03835442|GABA Agonists|gaba agonists|mesh-ancestor
111373598|NCT03835442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111373599|NCT03835442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111373600|NCT01722656|Aflibercept|aflibercept|mesh-list
110513330|NCT00802737|Ofatumumab|ofatumumab|mesh-list
111373601|NCT01722656|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111373602|NCT01722656|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111373603|NCT01722656|Growth Substances|growth substances|mesh-ancestor
111373604|NCT01722656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111373605|NCT01722656|Growth Inhibitors|growth inhibitors|mesh-ancestor
111373606|NCT01722656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111373607|NCT04963764|Amoxicillin|amoxicillin|mesh-list
111373608|NCT04963764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111373609|NCT04963764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111373610|NCT03405584|Amoxicillin|amoxicillin|mesh-list
111373611|NCT03405584|Potassium Citrate|potassium citrate|mesh-list
111373612|NCT03405584|Esomeprazole|esomeprazole|mesh-list
111373613|NCT03405584|Bismuth|bismuth|mesh-list
111373614|NCT03405584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111373615|NCT03405584|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111373616|NCT03405584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111373617|NCT03405584|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111373618|NCT03405584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111373619|NCT03405584|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111373620|NCT03405584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111373621|NCT03405584|Antacids|antacids|mesh-ancestor
111373622|NCT03405584|Diuretics|diuretics|mesh-ancestor
111373623|NCT03405584|Natriuretic Agents|natriuretic agents|mesh-ancestor
111373624|NCT03405584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111373625|NCT03405584|Expectorants|expectorants|mesh-ancestor
111373626|NCT03405584|Respiratory System Agents|respiratory system agents|mesh-ancestor
111373627|NCT03007121|Sufentanil|sufentanil|mesh-list
111373628|NCT03007121|Morphine|morphine|mesh-list
111373629|NCT03007121|Dsuvia|dsuvia|mesh-list
111373630|NCT03007121|Bupivacaine|bupivacaine|mesh-list
111373631|NCT03007121|Anesthetics, Local|anesthetics, local|mesh-ancestor
111373632|NCT03007121|Anesthetics|anesthetics|mesh-ancestor
111373633|NCT03007121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111373634|NCT03007121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111373635|NCT03007121|Sensory System Agents|sensory system agents|mesh-ancestor
111373636|NCT03007121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111373637|NCT03007121|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111373638|NCT03007121|Narcotics|narcotics|mesh-ancestor
111373639|NCT03007121|Analgesics|analgesics|mesh-ancestor
111373640|NCT03007121|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111373641|NCT03007121|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111373642|NCT03007121|Anesthetics, General|anesthetics, general|mesh-ancestor
111373643|NCT01725152|Ganaxolone|ganaxolone|mesh-list
111373644|NCT01725152|Neurosteroids|neurosteroids|mesh-ancestor
111373645|NCT01725152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111373646|NCT01725152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111373647|NCT01725152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111373648|NCT01725152|GABA Modulators|gaba modulators|mesh-ancestor
111373649|NCT01725152|GABA Agents|gaba agents|mesh-ancestor
111373650|NCT02980913|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111373651|NCT02980913|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111373652|NCT02981303|Pembrolizumab|pembrolizumab|mesh-list
111373653|NCT02981303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111373654|NCT02981303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111373655|NCT02981303|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111373656|NCT02981303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111373657|NCT02981459|Mirabegron|mirabegron|mesh-list
111373658|NCT02981459|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
111373659|NCT02981459|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111373660|NCT02981459|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111373661|NCT02981459|Adrenergic Agents|adrenergic agents|mesh-ancestor
111373662|NCT02981459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111373663|NCT02981459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111373664|NCT02981459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111373665|NCT02981459|Urological Agents|urological agents|mesh-ancestor
111373666|NCT01724138|Deferasirox|deferasirox|mesh-list
111373667|NCT01724138|Iron Chelating Agents|iron chelating agents|mesh-ancestor
111373668|NCT01724138|Chelating Agents|chelating agents|mesh-ancestor
111373669|NCT01724138|Sequestering Agents|sequestering agents|mesh-ancestor
111373670|NCT01724138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111373671|NCT03006809|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111373672|NCT03006809|Metronidazole|metronidazole|mesh-list
111373673|NCT03006809|Vancomycin|vancomycin|mesh-list
111373674|NCT03006809|Neomycin|neomycin|mesh-list
111373675|NCT03006809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111373676|NCT03006809|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111373677|NCT03006809|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111373678|NCT03006809|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111373679|NCT03006809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111373680|NCT03006809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111373681|NCT01580423|Aprepitant|aprepitant|mesh-list
111373682|NCT01580423|Antiemetics|antiemetics|mesh-ancestor
111373683|NCT01580423|Autonomic Agents|autonomic agents|mesh-ancestor
111373684|NCT01580423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111373685|NCT01580423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111373686|NCT01580423|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111373687|NCT01580423|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
111373688|NCT01580423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111373689|NCT01580423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111373690|NCT01049984|Rasagiline|rasagiline|mesh-list
111373691|NCT01049984|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
111373692|NCT01049984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111373693|NCT01049984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111373694|NCT01049984|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111373695|NCT01049984|Protective Agents|protective agents|mesh-ancestor
111373696|NCT01049984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111373697|NCT03001271|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
111373698|NCT03001271|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111373699|NCT03001271|Vasodilator Agents|vasodilator agents|mesh-ancestor
111373700|NCT03001349|Octreotide|octreotide|mesh-list
111373701|NCT03001349|Edotreotide|edotreotide|mesh-list
111373702|NCT03001349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111373703|NCT03001349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111373704|NCT03001349|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111373705|NCT03001349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111373706|NCT03001349|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111373707|NCT03001193|Oxytocin|oxytocin|mesh-list
111373708|NCT03001193|Oxytocics|oxytocics|mesh-ancestor
111373709|NCT03001193|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111373710|NCT03001193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111373711|NCT01049360|Formoterol Fumarate|formoterol fumarate|mesh-list
111373712|NCT01049360|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111373713|NCT01049360|Autonomic Agents|autonomic agents|mesh-ancestor
111373714|NCT01049360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111373715|NCT01049360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111373716|NCT01049360|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111373717|NCT01049360|Respiratory System Agents|respiratory system agents|mesh-ancestor
111373718|NCT01049360|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111373719|NCT01049360|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111373720|NCT01049360|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111373721|NCT01049360|Adrenergic Agents|adrenergic agents|mesh-ancestor
111373722|NCT01049360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111373723|NCT01049360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111373724|NCT02494596|Capecitabine|capecitabine|mesh-list
111373725|NCT02494596|Pertuzumab|pertuzumab|mesh-list
111373726|NCT02494596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111373727|NCT02494596|Antimetabolites|antimetabolites|mesh-ancestor
111373728|NCT02494596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111373729|NCT02494596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111373730|NCT02494596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111373731|NCT01048502|Fenofibrate|fenofibrate|mesh-list
111373732|NCT01048502|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111373733|NCT01048502|Antimetabolites|antimetabolites|mesh-ancestor
111373734|NCT01048502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111373735|NCT01048502|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111373736|NCT01583543|Olaparib|olaparib|mesh-list
111373737|NCT01583543|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111373738|NCT01583543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111373739|NCT01583543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111373740|NCT01583543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111373741|NCT01724372|Aripiprazole|aripiprazole|mesh-list
111373742|NCT01724372|Antipsychotic Agents|antipsychotic agents|mesh-list
111373743|NCT01724372|Fluoxetine|fluoxetine|mesh-list
111373744|NCT01724372|Antidepressive Agents|antidepressive agents|mesh-list
111373745|NCT01724372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111373746|NCT01724372|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111373747|NCT01724372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111373748|NCT01724372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111373750|NCT01724372|Dopamine Agents|dopamine agents|mesh-ancestor
111373751|NCT01724372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111373752|NCT01724372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111373753|NCT01724372|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111373754|NCT01724372|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111373755|NCT01724372|Serotonin Agents|serotonin agents|mesh-ancestor
111373756|NCT01724372|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111373757|NCT01724372|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111373758|NCT01724372|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111373759|NCT01724372|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111373760|NCT01724372|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111373761|NCT01724372|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111373762|NCT01724372|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111373763|NCT01724372|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111373764|NCT01724372|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111373765|NCT01724372|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111373766|NCT01724372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111373767|NCT02464410|Analgesics, Opioid|analgesics, opioid|mesh-list
111373768|NCT02464410|Narcotics|narcotics|mesh-ancestor
111373769|NCT02464410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111373770|NCT02464410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111373771|NCT02464410|Analgesics|analgesics|mesh-ancestor
111373772|NCT02464410|Sensory System Agents|sensory system agents|mesh-ancestor
111373773|NCT02464410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111373774|NCT03006419|Thymoglobulin|thymoglobulin|mesh-list
111373775|NCT03006419|Basiliximab|basiliximab|mesh-list
111373776|NCT03006419|Immunologic Factors|immunologic factors|mesh-ancestor
111373777|NCT03006419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111373778|NCT03006419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111373779|NCT03405272|Antibodies|antibodies|mesh-list
111373780|NCT03405272|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111373781|NCT03405272|Immunologic Factors|immunologic factors|mesh-ancestor
111373782|NCT03405272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111373783|NCT03405194|Efavirenz|efavirenz|mesh-list
111373784|NCT03405194|Cobicistat|cobicistat|mesh-list
111373785|NCT03405194|Elvitegravir|elvitegravir|mesh-list
111373786|NCT03405194|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111373787|NCT03405194|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111373788|NCT03405194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111373789|NCT03405194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111373790|NCT03405194|Antiviral Agents|antiviral agents|mesh-ancestor
111373791|NCT03405194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111373792|NCT03405194|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111373793|NCT03405194|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111373794|NCT03405194|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111373795|NCT03405194|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111373796|NCT03405194|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111373797|NCT03405194|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111373798|NCT03405194|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111373799|NCT03405194|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111373800|NCT03405194|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111373801|NCT03405194|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111373802|NCT03006107|Piroxicam|piroxicam|mesh-list
111373803|NCT03006107|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111373804|NCT03006107|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111373805|NCT03006107|Analgesics|analgesics|mesh-ancestor
111373806|NCT03006107|Sensory System Agents|sensory system agents|mesh-ancestor
111373807|NCT03006107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111373808|NCT03006107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111373809|NCT03006107|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111373810|NCT03006107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111373811|NCT03006107|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111373812|NCT03006107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111373813|NCT03006107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111373814|NCT01046396|Adapalene|adapalene|mesh-list
111373815|NCT01046396|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111373816|NCT01046396|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111373817|NCT01046396|Analgesics|analgesics|mesh-ancestor
111373818|NCT01046396|Sensory System Agents|sensory system agents|mesh-ancestor
111373819|NCT01046396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111373820|NCT01046396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111373821|NCT01046396|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111373822|NCT01046396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111373823|NCT01046396|Dermatologic Agents|dermatologic agents|mesh-ancestor
111373824|NCT01046084|Lansoprazole|lansoprazole|mesh-list
111373825|NCT01046084|Dexlansoprazole|dexlansoprazole|mesh-list
111373826|NCT01046084|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111373827|NCT01046084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111373828|NCT01046084|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111373829|NCT01046084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111373830|NCT01046084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111373831|NCT01045694|Triamcinolone|triamcinolone|mesh-list
111373832|NCT01045694|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
111373833|NCT01045694|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
111373834|NCT01045694|Lidocaine|lidocaine|mesh-list
111373835|NCT01045694|Botulinum Toxins|botulinum toxins|mesh-list
111373836|NCT01045694|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111373837|NCT01045694|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111373838|NCT01045694|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
111373839|NCT01045694|Anesthetics, Local|anesthetics, local|mesh-ancestor
111373840|NCT01045694|Anesthetics|anesthetics|mesh-ancestor
111373841|NCT01045694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111373842|NCT01045694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111373843|NCT01045694|Sensory System Agents|sensory system agents|mesh-ancestor
111373844|NCT01045694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111373845|NCT01045694|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111373846|NCT01045694|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111373847|NCT01045694|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111373848|NCT01045694|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111373849|NCT01045694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111373850|NCT01045694|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111373851|NCT01045694|Cholinergic Agents|cholinergic agents|mesh-ancestor
111373852|NCT01045694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111373853|NCT01045694|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111373854|NCT01045694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111373855|NCT01045694|Glucocorticoids|glucocorticoids|mesh-ancestor
111373856|NCT01045694|Hormones|hormones|mesh-ancestor
111373857|NCT01045694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111373858|NCT01045694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111373859|NCT01045694|Immunologic Factors|immunologic factors|mesh-ancestor
111373860|NCT01045694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111373861|NCT01586975|Aspirin|aspirin|mesh-list
111373862|NCT01586975|Clopidogrel|clopidogrel|mesh-list
111373863|NCT01586975|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111373864|NCT01586975|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111373865|NCT01586975|Analgesics|analgesics|mesh-ancestor
111373866|NCT01586975|Sensory System Agents|sensory system agents|mesh-ancestor
111373867|NCT01586975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111373868|NCT01586975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111373869|NCT01586975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111373870|NCT01586975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111373871|NCT01586975|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111373872|NCT01586975|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111373873|NCT01586975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111373874|NCT01586975|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111373875|NCT01586975|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111373876|NCT01586975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111373877|NCT01586975|Antipyretics|antipyretics|mesh-ancestor
111373878|NCT01586975|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111373879|NCT01586975|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111373880|NCT01586975|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111373881|NCT01586975|Purinergic Agents|purinergic agents|mesh-ancestor
111373882|NCT01586975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111373883|NCT03000413|Fentanyl|fentanyl|mesh-list
111373884|NCT03000413|Ketamine|ketamine|mesh-list
111373885|NCT03000413|Analgesics|analgesics|mesh-ancestor
111373886|NCT03000413|Sensory System Agents|sensory system agents|mesh-ancestor
111373887|NCT03000413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111373888|NCT03000413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111373889|NCT03000413|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111373890|NCT03000413|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111373891|NCT03000413|Anesthetics, General|anesthetics, general|mesh-ancestor
111373892|NCT03000413|Anesthetics|anesthetics|mesh-ancestor
111373893|NCT03000413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111373894|NCT03000413|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111373895|NCT03000413|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111373896|NCT03000413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111373897|NCT03000413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111373898|NCT03000413|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111373899|NCT03000413|Narcotics|narcotics|mesh-ancestor
111373900|NCT03000413|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111373901|NCT01724918|Lacosamide|lacosamide|mesh-list
111373902|NCT01724918|Anticonvulsants|anticonvulsants|mesh-ancestor
111373903|NCT01724918|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111373904|NCT01724918|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111373905|NCT01724918|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111373906|NCT01724918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111373907|NCT01588457|Lamotrigine|lamotrigine|mesh-list
111373908|NCT01588457|Valproic Acid|valproic acid|mesh-list
111373909|NCT01588457|Quetiapine Fumarate|quetiapine fumarate|mesh-list
111373910|NCT01588457|Lithium Carbonate|lithium carbonate|mesh-list
111373911|NCT01588457|Antidepressive Agents|antidepressive agents|mesh-ancestor
111373912|NCT01588457|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111373913|NCT01588457|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111373914|NCT01588457|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111373915|NCT01588457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111373916|NCT01588457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111373917|NCT01588457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111373918|NCT01588457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111373919|NCT01588457|Antimanic Agents|antimanic agents|mesh-ancestor
111373920|NCT01588457|Anticonvulsants|anticonvulsants|mesh-ancestor
111373921|NCT01588457|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111373922|NCT01588457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111373923|NCT01588457|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111373924|NCT01588457|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111373925|NCT01588457|GABA Agents|gaba agents|mesh-ancestor
111373926|NCT01588457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111373927|NCT03005639|Vemurafenib|vemurafenib|mesh-list
111373928|NCT03005639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111373929|NCT03005639|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111373930|NCT03005639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111373931|NCT03005639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111373932|NCT01590875|Adenosine|adenosine|mesh-list
111373933|NCT01590875|Analgesics|analgesics|mesh-ancestor
111373934|NCT01590875|Sensory System Agents|sensory system agents|mesh-ancestor
111373935|NCT01590875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111373936|NCT01590875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111373937|NCT01590875|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111373938|NCT01590875|Vasodilator Agents|vasodilator agents|mesh-ancestor
111373939|NCT01590875|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
111373940|NCT01590875|Purinergic Agonists|purinergic agonists|mesh-ancestor
111373941|NCT01590875|Purinergic Agents|purinergic agents|mesh-ancestor
111373942|NCT01590875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111373943|NCT01590875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111373944|NCT03404414|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
111373945|NCT03404414|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111373946|NCT03404414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111373947|NCT01725230|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111373948|NCT01725230|Simvastatin|simvastatin|mesh-list
111373949|NCT01725230|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111373950|NCT01725230|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111373951|NCT01725230|Antimetabolites|antimetabolites|mesh-ancestor
111373952|NCT01725230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111373953|NCT01725230|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111373954|NCT01725230|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111373955|NCT01725230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111373956|NCT01591733|Capecitabine|capecitabine|mesh-list
111373957|NCT01591733|Oxaliplatin|oxaliplatin|mesh-list
111373958|NCT01591733|Irinotecan|irinotecan|mesh-list
111373959|NCT01591733|Folfirinox|folfirinox|mesh-list
111373960|NCT01591733|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111373961|NCT01591733|Antimetabolites|antimetabolites|mesh-ancestor
111373962|NCT01591733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111373963|NCT01591733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111373964|NCT01591733|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111373965|NCT01591733|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111373966|NCT01591733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111373967|NCT03005405|Methamphetamine|methamphetamine|mesh-list
111373968|NCT03005405|Fluorides|fluorides|mesh-list
111373969|NCT03005405|Cariostatic Agents|cariostatic agents|mesh-ancestor
111373970|NCT03005405|Protective Agents|protective agents|mesh-ancestor
111373971|NCT03005405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111373972|NCT03005405|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111373973|NCT03005405|Sympathomimetics|sympathomimetics|mesh-ancestor
111373974|NCT03005405|Autonomic Agents|autonomic agents|mesh-ancestor
111373975|NCT03005405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111373976|NCT03005405|Dopamine Agents|dopamine agents|mesh-ancestor
111373977|NCT03005405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111373978|NCT03005405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111373979|NCT03005405|Adrenergic Agents|adrenergic agents|mesh-ancestor
111373980|NCT03005405|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111373981|NCT03005405|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111373982|NCT03005405|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110513713|NCT00799617|Androgens|androgens|mesh-ancestor
111373983|NCT03005405|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111373984|NCT03005717|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
111373985|NCT03005717|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111373986|NCT03005717|Autonomic Agents|autonomic agents|mesh-ancestor
111373987|NCT03005717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111373988|NCT03005717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111373989|NCT03005717|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111373990|NCT03005717|Respiratory System Agents|respiratory system agents|mesh-ancestor
111373991|NCT03005717|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111373992|NCT03005717|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111373993|NCT03005717|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111373994|NCT03005717|Adrenergic Agents|adrenergic agents|mesh-ancestor
111373995|NCT03005717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111373996|NCT03005717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111373997|NCT03005483|Gabapentin|gabapentin|mesh-list
111373998|NCT03005483|Analgesics|analgesics|mesh-ancestor
111373999|NCT03005483|Sensory System Agents|sensory system agents|mesh-ancestor
111374000|NCT03005483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111374001|NCT03005483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111374002|NCT03005483|Anticonvulsants|anticonvulsants|mesh-ancestor
111374003|NCT03005483|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111374004|NCT03005483|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111374005|NCT03005483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111374006|NCT03005483|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111374007|NCT03005483|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111374008|NCT03005483|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111374009|NCT03005483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111374010|NCT03005483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111374011|NCT03005483|Antimanic Agents|antimanic agents|mesh-ancestor
111374012|NCT01593215|Yohimbine|yohimbine|mesh-list
111374013|NCT01593215|Mydriatics|mydriatics|mesh-ancestor
111374014|NCT01593215|Autonomic Agents|autonomic agents|mesh-ancestor
111374015|NCT01593215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111374016|NCT01593215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111374017|NCT01593215|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
111374018|NCT01593215|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111374019|NCT01593215|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111374020|NCT01593215|Adrenergic Agents|adrenergic agents|mesh-ancestor
111374021|NCT01593215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111374022|NCT01593215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111374023|NCT01593215|Urological Agents|urological agents|mesh-ancestor
111374024|NCT05404919|Tenofovir|tenofovir|mesh-list
111374025|NCT05404919|Entecavir|entecavir|mesh-list
111374026|NCT05404919|Immunoglobulins|immunoglobulins|mesh-list
111374027|NCT05404919|Antibodies|antibodies|mesh-list
111374028|NCT05404919|gamma-Globulins|gamma-globulins|mesh-list
111374029|NCT05404919|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111374030|NCT05404919|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
111374031|NCT05404919|Antiviral Agents|antiviral agents|mesh-ancestor
111374032|NCT05404919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111374033|NCT05404919|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111374034|NCT05404919|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111374035|NCT05404919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111374036|NCT05404919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111374037|NCT05404919|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111374038|NCT05404919|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111374039|NCT05404919|Immunologic Factors|immunologic factors|mesh-ancestor
111374040|NCT05404919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111374041|NCT03005015|Doxorubicin|doxorubicin|mesh-list
111374042|NCT03005015|Lenvatinib|lenvatinib|mesh-list
111374043|NCT03005015|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111098465|NCT05592171|Chlorotrianisene|chlorotrianisene|mesh-list
111374044|NCT03005015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111374045|NCT03005015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111374046|NCT03005015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111374047|NCT03005015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111374048|NCT03005015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111374049|NCT03005015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111374050|NCT03005171|Lidocaine|lidocaine|mesh-list
111374051|NCT03005171|Bupivacaine|bupivacaine|mesh-list
111374052|NCT03005171|Anesthetics, Local|anesthetics, local|mesh-ancestor
111374053|NCT03005171|Anesthetics|anesthetics|mesh-ancestor
111374054|NCT03005171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111374055|NCT03005171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111374056|NCT03005171|Sensory System Agents|sensory system agents|mesh-ancestor
111374057|NCT03005171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111374058|NCT03005171|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111374059|NCT03005171|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111374060|NCT03005171|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111374061|NCT03005171|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111374062|NCT03005171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111374063|NCT01041638|Vitamin A|vitamin a|mesh-list
111374064|NCT01041638|Aldesleukin|aldesleukin|mesh-list
111374065|NCT01041638|Interleukin-2|interleukin-2|mesh-list
111374066|NCT01041638|Tretinoin|tretinoin|mesh-list
111374067|NCT01041638|Dinutuximab|dinutuximab|mesh-list
111374068|NCT01041638|Isotretinoin|isotretinoin|mesh-list
111374069|NCT01041638|Sargramostim|sargramostim|mesh-list
111374070|NCT01041638|Vitamins|vitamins|mesh-ancestor
111374071|NCT01041638|Micronutrients|micronutrients|mesh-ancestor
111374072|NCT01041638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111374073|NCT01041638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111374074|NCT01041638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111374075|NCT01041638|Analgesics|analgesics|mesh-ancestor
111374076|NCT01041638|Sensory System Agents|sensory system agents|mesh-ancestor
111374077|NCT01041638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111374078|NCT01041638|Immunologic Factors|immunologic factors|mesh-ancestor
111374079|NCT01041638|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111374080|NCT01041638|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111374081|NCT01041638|Antiviral Agents|antiviral agents|mesh-ancestor
111374082|NCT01041638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111374083|NCT01041638|Keratolytic Agents|keratolytic agents|mesh-ancestor
111374084|NCT01041638|Dermatologic Agents|dermatologic agents|mesh-ancestor
111374085|NCT03004625|Ribavirin|ribavirin|mesh-list
111374086|NCT03004625|Asunaprevir|asunaprevir|mesh-list
111374087|NCT03004625|Antimetabolites|antimetabolites|mesh-ancestor
111374088|NCT03004625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111374089|NCT03004625|Antiviral Agents|antiviral agents|mesh-ancestor
111374090|NCT03004625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111374091|NCT03004625|Protease Inhibitors|protease inhibitors|mesh-ancestor
111374092|NCT03004625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111374093|NCT05566301|Clopidogrel|clopidogrel|mesh-list
111374094|NCT05566301|Ticagrelor|ticagrelor|mesh-list
111374095|NCT05566301|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111374096|NCT05566301|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111374097|NCT05566301|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111374098|NCT05566301|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111374099|NCT05566301|Purinergic Agents|purinergic agents|mesh-ancestor
111374100|NCT05566301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111374101|NCT05566301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111374102|NCT05566301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111374103|NCT03404024|Mitogens|mitogens|mesh-list
111374104|NCT03404024|Mitosis Modulators|mitosis modulators|mesh-ancestor
111374105|NCT03404024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111374106|NCT05131919|Pembrolizumab|pembrolizumab|mesh-list
111374107|NCT05131919|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111374108|NCT05131919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111374109|NCT05131919|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111374110|NCT05131919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111374111|NCT01725542|Ribavirin|ribavirin|mesh-list
111374112|NCT01725542|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
111374113|NCT01725542|Asunaprevir|asunaprevir|mesh-list
111374114|NCT01725542|Antimetabolites|antimetabolites|mesh-ancestor
111000946|NCT02855359|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111374115|NCT01725542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111374116|NCT01725542|Antiviral Agents|antiviral agents|mesh-ancestor
111374117|NCT01725542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111374118|NCT01725542|Protease Inhibitors|protease inhibitors|mesh-ancestor
111374119|NCT01725542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111374120|NCT01725620|Etanercept|etanercept|mesh-list
111374121|NCT01725620|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111374122|NCT01725620|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111374123|NCT01725620|Analgesics|analgesics|mesh-ancestor
111374124|NCT01725620|Sensory System Agents|sensory system agents|mesh-ancestor
111374125|NCT01725620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111374126|NCT01725620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111374127|NCT01725620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111374128|NCT01725620|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111374129|NCT01725620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111374130|NCT01725620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111374131|NCT01725620|Immunologic Factors|immunologic factors|mesh-ancestor
111374132|NCT01045460|Cyclophosphamide|cyclophosphamide|mesh-list
111374133|NCT01045460|Melphalan|melphalan|mesh-list
111374134|NCT01045460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111374135|NCT01045460|Immunologic Factors|immunologic factors|mesh-ancestor
111374136|NCT01045460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111374137|NCT01045460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111374138|NCT01045460|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111374139|NCT01045460|Alkylating Agents|alkylating agents|mesh-ancestor
111374140|NCT01045460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111374141|NCT01045460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111374142|NCT01045460|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111374143|NCT03403790|Quetiapine Fumarate|quetiapine fumarate|mesh-list
111374144|NCT03403790|Antidepressive Agents|antidepressive agents|mesh-ancestor
111374145|NCT03403790|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111374146|NCT03403790|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111374147|NCT03403790|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111374148|NCT03403790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111374149|NCT03403790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111374150|NCT05014919|Vortioxetine|vortioxetine|mesh-list
111374151|NCT05014919|Antidepressive Agents|antidepressive agents|mesh-ancestor
111374152|NCT05014919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111374153|NCT05014919|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111374154|NCT05014919|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111374155|NCT05014919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111374156|NCT05014919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111374157|NCT05014919|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111374158|NCT05014919|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111374159|NCT05014919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111374160|NCT05014919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111374161|NCT05014919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111374162|NCT05014919|Serotonin Agents|serotonin agents|mesh-ancestor
111374163|NCT05014919|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111374164|NCT05014919|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111374165|NCT05014919|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111374166|NCT05014919|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111374167|NCT05672537|Gemcitabine|gemcitabine|mesh-list
111374168|NCT05672537|Durvalumab|durvalumab|mesh-list
111374169|NCT05672537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111374170|NCT05672537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111374171|NCT05672537|Antimetabolites|antimetabolites|mesh-ancestor
111374172|NCT05672537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111374173|NCT05672537|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111374174|NCT03400592|Irinotecan|irinotecan|mesh-list
111374175|NCT03400592|Nimotuzumab|nimotuzumab|mesh-list
111374176|NCT03400592|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111374177|NCT03400592|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111374178|NCT03400592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111374179|NCT03400592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111374180|NCT03400592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111374181|NCT03400592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111374182|NCT02218463|Estradiol|estradiol|mesh-list
111374183|NCT02218463|Estrogens|estrogens|mesh-ancestor
111374184|NCT02218463|Hormones|hormones|mesh-ancestor
111374185|NCT02218463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111374186|NCT02218463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111374187|NCT00919802|Oxytocin|oxytocin|mesh-list
111374188|NCT00919802|Oxytocics|oxytocics|mesh-ancestor
111374189|NCT00919802|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111374190|NCT00919802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111374191|NCT02222129|Bupivacaine|bupivacaine|mesh-list
111374192|NCT02222129|Anesthetics, Local|anesthetics, local|mesh-ancestor
111374193|NCT02222129|Anesthetics|anesthetics|mesh-ancestor
111374194|NCT02222129|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111374195|NCT02222129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111374196|NCT02222129|Sensory System Agents|sensory system agents|mesh-ancestor
111374197|NCT02222129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111374198|NCT03003611|Anesthetics|anesthetics|mesh-list
111374199|NCT03003611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111374200|NCT03003611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111374201|NCT03401294|Leucovorin|leucovorin|mesh-list
111374202|NCT03401294|Bevacizumab|bevacizumab|mesh-list
111374203|NCT03401294|Oxaliplatin|oxaliplatin|mesh-list
111374204|NCT03401294|Irinotecan|irinotecan|mesh-list
111374205|NCT03401294|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111374206|NCT03401294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111374207|NCT03401294|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111374208|NCT03401294|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111374209|NCT03401294|Growth Substances|growth substances|mesh-ancestor
111374210|NCT03401294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111374211|NCT03401294|Growth Inhibitors|growth inhibitors|mesh-ancestor
111374212|NCT03401294|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111374213|NCT03401294|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111374214|NCT03401294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111374215|NCT03401294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111374216|NCT03401294|Antidotes|antidotes|mesh-ancestor
111374217|NCT03401294|Protective Agents|protective agents|mesh-ancestor
111374218|NCT03401294|Vitamin B Complex|vitamin b complex|mesh-ancestor
111374219|NCT03401294|Vitamins|vitamins|mesh-ancestor
111374220|NCT03401294|Micronutrients|micronutrients|mesh-ancestor
111374221|NCT03402698|Cholecalciferol|cholecalciferol|mesh-list
111374222|NCT03402698|Vitamin D|vitamin d|mesh-list
111374223|NCT03402698|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111374224|NCT03402698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111374225|NCT03402698|Vitamins|vitamins|mesh-ancestor
111374226|NCT03402698|Micronutrients|micronutrients|mesh-ancestor
111374227|NCT03402698|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111374228|NCT03406520|Chlorhexidine|chlorhexidine|mesh-list
111374229|NCT03406520|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111374230|NCT03406520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111374231|NCT03406520|Disinfectants|disinfectants|mesh-ancestor
111374232|NCT02248181|Pramipexole|pramipexole|mesh-list
111374233|NCT02248181|Antioxidants|antioxidants|mesh-ancestor
111374234|NCT02248181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111374235|NCT02248181|Protective Agents|protective agents|mesh-ancestor
111374236|NCT02248181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111374237|NCT02248181|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111374238|NCT02248181|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111374239|NCT02248181|Dopamine Agonists|dopamine agonists|mesh-ancestor
111374240|NCT02248181|Dopamine Agents|dopamine agents|mesh-ancestor
111374241|NCT02248181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111374242|NCT03003143|Vigabatrin|vigabatrin|mesh-list
111374243|NCT03003143|Anticonvulsants|anticonvulsants|mesh-ancestor
111374244|NCT03003143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111374245|NCT03003143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111374246|NCT03003143|GABA Agents|gaba agents|mesh-ancestor
111374247|NCT03003143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111374248|NCT03003143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111374249|NCT02462928|Ranibizumab|ranibizumab|mesh-list
111374250|NCT02462928|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111374251|NCT02462928|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111374252|NCT02462928|Growth Substances|growth substances|mesh-ancestor
111374253|NCT02462928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111374254|NCT02462928|Growth Inhibitors|growth inhibitors|mesh-ancestor
111374255|NCT02462928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111374256|NCT03002831|Tegafur|tegafur|mesh-list
111374257|NCT03002831|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111374258|NCT03002831|Antimetabolites|antimetabolites|mesh-ancestor
111374259|NCT03002831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111374260|NCT03002831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111374261|NCT02248259|Itraconazole|itraconazole|mesh-list
111374262|NCT02248259|BI 409306|bi 409306|mesh-list
111374263|NCT02248259|Antifungal Agents|antifungal agents|mesh-ancestor
111374264|NCT02248259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111374265|NCT02248259|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111374266|NCT02248259|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111098685|NCT04062201|Antimetabolites|antimetabolites|mesh-ancestor
111374267|NCT02248259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111374268|NCT02248259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111374269|NCT02248259|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111374270|NCT02248259|Hormone Antagonists|hormone antagonists|mesh-ancestor
111374271|NCT02248259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111374272|NCT02248259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111374273|NCT02248259|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111374274|NCT02248259|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111374275|NCT04526951|Aspirin|aspirin|mesh-list
111374276|NCT04526951|Tenecteplase|tenecteplase|mesh-list
111374277|NCT04526951|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111374278|NCT04526951|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111374279|NCT04526951|Analgesics|analgesics|mesh-ancestor
111374280|NCT04526951|Sensory System Agents|sensory system agents|mesh-ancestor
111374281|NCT04526951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111374282|NCT04526951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111374283|NCT04526951|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111374284|NCT04526951|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111374285|NCT04526951|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111374286|NCT04526951|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111374287|NCT04526951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111374288|NCT04526951|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111374289|NCT04526951|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111374290|NCT04526951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111374291|NCT04526951|Antipyretics|antipyretics|mesh-ancestor
111374292|NCT02248415|Anesthetics|anesthetics|mesh-list
111374293|NCT02248415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111374294|NCT02248415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111374295|NCT02248571|Bevacizumab|bevacizumab|mesh-list
111374296|NCT02248571|Capecitabine|capecitabine|mesh-list
111374297|NCT02248571|Everolimus|everolimus|mesh-list
111374298|NCT02248571|Exemestane|exemestane|mesh-list
111374299|NCT02248571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111374300|NCT02248571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111374301|NCT02248571|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111374302|NCT02248571|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111374303|NCT02248571|Growth Substances|growth substances|mesh-ancestor
111374304|NCT02248571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111374305|NCT02248571|Growth Inhibitors|growth inhibitors|mesh-ancestor
111374306|NCT02248571|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111374307|NCT02248571|Antimetabolites|antimetabolites|mesh-ancestor
111374308|NCT02248571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111374309|NCT02248571|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111374310|NCT02248571|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111374311|NCT02248571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111374312|NCT02248571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111374313|NCT02248571|Immunologic Factors|immunologic factors|mesh-ancestor
111374314|NCT02248571|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111374315|NCT02248571|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111374316|NCT02248571|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111374317|NCT02248571|Hormone Antagonists|hormone antagonists|mesh-ancestor
111374318|NCT02248571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111374319|NCT00019604|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
111374320|NCT00019604|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111374321|NCT00019604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111374322|NCT03002675|Exenatide|exenatide|mesh-list
111374323|NCT03002675|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111374324|NCT03002675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111374325|NCT03002675|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111374326|NCT03002675|Incretins|incretins|mesh-ancestor
111374327|NCT03002675|Hormones|hormones|mesh-ancestor
111374328|NCT03002675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111374329|NCT02246270|Heparin|heparin|mesh-list
111374330|NCT02246270|Calcium heparin|calcium heparin|mesh-list
111374331|NCT02246270|Anticoagulants|anticoagulants|mesh-ancestor
111374332|NCT02246270|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111374333|NCT02246270|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111374334|NCT02246270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111374335|NCT02247557|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111374336|NCT02247557|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111374337|NCT02247557|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111374338|NCT02247557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111374339|NCT02247557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111374340|NCT02247557|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111374341|NCT02247557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111374342|NCT02247557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111374343|NCT02247557|Cholinergic Agents|cholinergic agents|mesh-ancestor
111098765|NCT05695287|Propofol|propofol|mesh-list
111374344|NCT02247557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111374345|NCT04374188|Ciprofloxacin|ciprofloxacin|mesh-list
111374346|NCT04374188|Levofloxacin|levofloxacin|mesh-list
111374347|NCT04374188|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111374348|NCT04374188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111374349|NCT04374188|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111374350|NCT04374188|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111374351|NCT04374188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111374352|NCT04374188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111374353|NCT04374188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111374354|NCT04374188|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111374355|NCT04374188|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111374356|NCT04374188|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111374357|NCT04374032|Enkephalin, Methionine|enkephalin, methionine|mesh-list
111374358|NCT04374032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111374359|NCT04374032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111374360|NCT04374032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111374361|NCT03401606|Dexmedetomidine|dexmedetomidine|mesh-list
111374362|NCT03401606|Remifentanil|remifentanil|mesh-list
111374363|NCT03401606|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111374364|NCT03401606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111374365|NCT03401606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111374366|NCT03401606|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111374367|NCT03401606|Analgesics|analgesics|mesh-ancestor
111374368|NCT03401606|Sensory System Agents|sensory system agents|mesh-ancestor
111374369|NCT03401606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111374370|NCT03401606|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111374371|NCT03401606|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111374372|NCT03401606|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111374373|NCT03401606|Adrenergic Agents|adrenergic agents|mesh-ancestor
111374374|NCT03401606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111374375|NCT03401606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111374376|NCT03401606|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111374377|NCT03401606|Narcotics|narcotics|mesh-ancestor
111374378|NCT02516592|Fluticasone|fluticasone|mesh-list
111374379|NCT02516592|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
111374380|NCT02516592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111374381|NCT02516592|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111374382|NCT02516592|Autonomic Agents|autonomic agents|mesh-ancestor
111374383|NCT02516592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111374384|NCT02516592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111374385|NCT02516592|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111374386|NCT02516592|Respiratory System Agents|respiratory system agents|mesh-ancestor
111374387|NCT02516592|Dermatologic Agents|dermatologic agents|mesh-ancestor
111374388|NCT02516592|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111374389|NCT02516592|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111374390|NCT02516592|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111374391|NCT02516592|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111374392|NCT02516592|Adrenergic Agents|adrenergic agents|mesh-ancestor
111374393|NCT02516592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111374394|NCT02516592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111374395|NCT03401372|Doxycycline|doxycycline|mesh-list
111374396|NCT03401372|Dexamethasone|dexamethasone|mesh-list
111374397|NCT03401372|Cyclophosphamide|cyclophosphamide|mesh-list
111374398|NCT03401372|Bortezomib|bortezomib|mesh-list
111374399|NCT03401372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111374400|NCT03401372|Immunologic Factors|immunologic factors|mesh-ancestor
111374401|NCT03401372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111374402|NCT03401372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111374403|NCT03401372|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111374404|NCT03401372|Alkylating Agents|alkylating agents|mesh-ancestor
111374405|NCT03401372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111374406|NCT03401372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111374407|NCT03401372|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111374408|NCT03401372|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111374409|NCT03401372|Antiemetics|antiemetics|mesh-ancestor
111374410|NCT03401372|Autonomic Agents|autonomic agents|mesh-ancestor
111374411|NCT03401372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111374412|NCT03401372|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111374413|NCT03401372|Glucocorticoids|glucocorticoids|mesh-ancestor
111374414|NCT03401372|Hormones|hormones|mesh-ancestor
111374415|NCT03401372|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111374416|NCT03401372|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111374417|NCT03401372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111374418|NCT03401372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111374419|NCT03401372|Antimalarials|antimalarials|mesh-ancestor
111374420|NCT03401372|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111374421|NCT03401372|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111374422|NCT04934904|Ropivacaine|ropivacaine|mesh-list
111374423|NCT04934904|Anesthetics, Local|anesthetics, local|mesh-ancestor
111374424|NCT04934904|Anesthetics|anesthetics|mesh-ancestor
111374425|NCT04934904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111374426|NCT04934904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111374427|NCT04934904|Sensory System Agents|sensory system agents|mesh-ancestor
111374428|NCT04934904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111374429|NCT02219321|Lidocaine|lidocaine|mesh-list
111374430|NCT02219321|Anesthetics, Local|anesthetics, local|mesh-ancestor
111374431|NCT02219321|Anesthetics|anesthetics|mesh-ancestor
111374432|NCT02219321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111374433|NCT02219321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111374434|NCT02219321|Sensory System Agents|sensory system agents|mesh-ancestor
111374435|NCT02219321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111374436|NCT02219321|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111374437|NCT02219321|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111374438|NCT02219321|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111374439|NCT02219321|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111374440|NCT02219321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111374441|NCT04955574|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111374442|NCT04955574|Metronidazole|metronidazole|mesh-list
111374443|NCT04955574|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
111374444|NCT04955574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111374445|NCT04955574|Antitubercular Agents|antitubercular agents|mesh-ancestor
111374446|NCT04955574|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111374447|NCT04955574|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111374448|NCT04716335|Harmine|harmine|mesh-list
111374449|NCT04716335|Hallucinogens|hallucinogens|mesh-ancestor
111374450|NCT04716335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111374451|NCT04716335|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111374452|NCT04716335|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
111374453|NCT04716335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111374454|NCT04716335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111374455|NCT02221349|Listerine|listerine|mesh-list
111374456|NCT02221349|Fluorides|fluorides|mesh-list
111374457|NCT02221349|Sodium Fluoride|sodium fluoride|mesh-list
111374458|NCT02221349|Tin Fluorides|tin fluorides|mesh-list
111374459|NCT02221349|Cariostatic Agents|cariostatic agents|mesh-ancestor
111374460|NCT02221349|Protective Agents|protective agents|mesh-ancestor
111374461|NCT02221349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111374462|NCT02221349|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111374463|NCT02221349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111374464|NCT02461758|Vaccines|vaccines|mesh-list
111374465|NCT02461758|Immunologic Factors|immunologic factors|mesh-ancestor
111374466|NCT02461758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111374467|NCT02461290|Rituximab|rituximab|mesh-list
111374468|NCT02461290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111374469|NCT02461290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111374470|NCT02461290|Immunologic Factors|immunologic factors|mesh-ancestor
111374471|NCT02461290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111374472|NCT02461290|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111374473|NCT04376528|Cyclosporine|cyclosporine|mesh-list
111374474|NCT04376528|Mycophenolic Acid|mycophenolic acid|mesh-list
111374475|NCT04376528|Cyclosporins|cyclosporins|mesh-list
111374476|NCT04376528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111374477|NCT04376528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111374478|NCT04376528|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111374479|NCT04376528|Immunologic Factors|immunologic factors|mesh-ancestor
111374480|NCT04376528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111374481|NCT04376528|Antifungal Agents|antifungal agents|mesh-ancestor
111374482|NCT04376528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111374483|NCT04376528|Dermatologic Agents|dermatologic agents|mesh-ancestor
111374484|NCT04376528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111374485|NCT04376528|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111374486|NCT04376528|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111374487|NCT04376528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111374488|NCT04376528|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111374489|NCT04376528|Antitubercular Agents|antitubercular agents|mesh-ancestor
111374490|NCT04376528|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111374491|NCT02461134|Ponesimod|ponesimod|mesh-list
111374492|NCT02461134|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
111374493|NCT02461134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111374494|NCT02461134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111374495|NCT02461134|Immunologic Factors|immunologic factors|mesh-ancestor
111374496|NCT02461134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111374498|NCT04373018|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
111374499|NCT04373018|Hydrogen Peroxide|hydrogen peroxide|mesh-list
111374500|NCT04373018|Sodium Hypochlorite|sodium hypochlorite|mesh-list
111374501|NCT04373018|Eusol|eusol|mesh-list
111374502|NCT04373018|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111374503|NCT04373018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111374504|NCT04373018|Disinfectants|disinfectants|mesh-ancestor
111374505|NCT04373018|Dermatologic Agents|dermatologic agents|mesh-ancestor
111374506|NCT04594733|Minocycline|minocycline|mesh-list
111374507|NCT04594733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111374508|NCT04594733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111374509|NCT02223065|Dapagliflozin|dapagliflozin|mesh-list
111374510|NCT02223065|Saxagliptin|saxagliptin|mesh-list
111374511|NCT02223065|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111374512|NCT02223065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111374513|NCT02223065|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111374514|NCT02223065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111374515|NCT02223065|Incretins|incretins|mesh-ancestor
111374516|NCT02223065|Hormones|hormones|mesh-ancestor
111374517|NCT02223065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111374518|NCT02223065|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111374519|NCT02223065|Protease Inhibitors|protease inhibitors|mesh-ancestor
111374520|NCT02223065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111374521|NCT04366232|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
111374522|NCT04366232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111374523|NCT02241200|Darbepoetin alfa|darbepoetin alfa|mesh-list
111374524|NCT02241200|Hematinics|hematinics|mesh-ancestor
111374525|NCT02241278|Ketamine|ketamine|mesh-list
111374526|NCT02241278|Analgesics|analgesics|mesh-ancestor
111374527|NCT02241278|Sensory System Agents|sensory system agents|mesh-ancestor
111374528|NCT02241278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111374529|NCT02241278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111374530|NCT02241278|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111374531|NCT02241278|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111374532|NCT02241278|Anesthetics, General|anesthetics, general|mesh-ancestor
111374533|NCT02241278|Anesthetics|anesthetics|mesh-ancestor
111374534|NCT02241278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111374535|NCT02241278|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111374536|NCT02241278|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111374537|NCT02241278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111374538|NCT02241278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111374539|NCT04347512|Azithromycin|azithromycin|mesh-list
111374540|NCT04347512|Hydroxychloroquine|hydroxychloroquine|mesh-list
111374541|NCT04347512|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111374542|NCT04347512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111374543|NCT04347512|Antimalarials|antimalarials|mesh-ancestor
111374544|NCT04347512|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111374545|NCT04347512|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111374546|NCT04347512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111374547|NCT04347512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111374548|NCT04347512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111374549|NCT02460978|Dapagliflozin|dapagliflozin|mesh-list
111374550|NCT02460978|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111374551|NCT02460978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111374552|NCT02460978|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111374553|NCT02460978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111374554|NCT04372316|Vitamin B 12|vitamin b 12|mesh-list
111374555|NCT04372316|Vitamin B Complex|vitamin b complex|mesh-ancestor
111374556|NCT04372316|Vitamins|vitamins|mesh-ancestor
111374557|NCT04372316|Micronutrients|micronutrients|mesh-ancestor
111374558|NCT04372316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111374559|NCT02221739|Ipilimumab|ipilimumab|mesh-list
111374560|NCT02221739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111374561|NCT02221739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111374562|NCT02221739|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111374563|NCT02221739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111374564|NCT02241356|Methamphetamine|methamphetamine|mesh-list
111374565|NCT02241356|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111374566|NCT02241356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111374567|NCT02241356|Sympathomimetics|sympathomimetics|mesh-ancestor
111374568|NCT02241356|Autonomic Agents|autonomic agents|mesh-ancestor
111374569|NCT02241356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111374570|NCT02241356|Dopamine Agents|dopamine agents|mesh-ancestor
111374571|NCT02241356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111374572|NCT02241356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111374573|NCT02241356|Adrenergic Agents|adrenergic agents|mesh-ancestor
111374574|NCT02241356|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111374575|NCT02241356|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111374576|NCT02241356|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111374577|NCT02241356|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111374578|NCT04365686|Propofol|propofol|mesh-list
111374579|NCT04365686|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111374580|NCT04365686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111374581|NCT04365686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111374582|NCT04365686|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111374583|NCT04365686|Anesthetics, General|anesthetics, general|mesh-ancestor
111374584|NCT04365686|Anesthetics|anesthetics|mesh-ancestor
111374585|NCT02241590|Entecavir|entecavir|mesh-list
111374586|NCT02241590|Antiviral Agents|antiviral agents|mesh-ancestor
111374587|NCT02241590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111374588|NCT04083755|Ferric Compounds|ferric compounds|mesh-list
111374589|NCT04083755|Hematinics|hematinics|mesh-ancestor
111374590|NCT04372082|Hydroxychloroquine|hydroxychloroquine|mesh-list
111374591|NCT04372082|Niclosamide|niclosamide|mesh-list
111374592|NCT04372082|Diltiazem|diltiazem|mesh-list
111374593|NCT04372082|Antimalarials|antimalarials|mesh-ancestor
111374594|NCT04372082|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111374595|NCT04372082|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111374596|NCT04372082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111374597|NCT04372082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111374598|NCT04372082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111374599|NCT04372082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111374600|NCT04372082|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111374601|NCT04372082|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111374602|NCT04372082|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111374603|NCT04372082|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111374604|NCT04372082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111374605|NCT04372082|Vasodilator Agents|vasodilator agents|mesh-ancestor
111374606|NCT04372082|Anticestodal Agents|anticestodal agents|mesh-ancestor
111374607|NCT04372082|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
111374608|NCT04372082|Anthelmintics|anthelmintics|mesh-ancestor
111374609|NCT04372082|Antinematodal Agents|antinematodal agents|mesh-ancestor
111374610|NCT05363111|Daratumumab|daratumumab|mesh-list
111374611|NCT05363111|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111374612|NCT05363111|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
111374613|NCT05363111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111374614|NCT05363111|Immunologic Factors|immunologic factors|mesh-ancestor
111374615|NCT05363111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111374616|NCT05363111|Chelating Agents|chelating agents|mesh-ancestor
111374617|NCT05363111|Sequestering Agents|sequestering agents|mesh-ancestor
111374618|NCT05363111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111374619|NCT02489448|Durvalumab|durvalumab|mesh-list
111374620|NCT02489448|Tremelimumab|tremelimumab|mesh-list
111374621|NCT02489448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111374622|NCT02489448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111374623|NCT00926588|Analgesics|analgesics|mesh-list
111374624|NCT00926588|Sensory System Agents|sensory system agents|mesh-ancestor
111374625|NCT00926588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111374626|NCT00926588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111374627|NCT04371926|Hydroxychloroquine|hydroxychloroquine|mesh-list
111374628|NCT04371926|Antimalarials|antimalarials|mesh-ancestor
111374629|NCT04371926|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111374630|NCT04371926|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111374631|NCT04371926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111374632|NCT04371926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110514363|NCT00901069|Immunologic Factors|immunologic factors|mesh-ancestor
111374633|NCT04371926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111374634|NCT04371926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111374635|NCT02248883|Moxifloxacin|moxifloxacin|mesh-list
111374636|NCT02248883|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111374637|NCT02248883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111374638|NCT02248883|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111374639|NCT02248883|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111374640|NCT02248883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111374641|NCT02248883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111374642|NCT02248883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111099057|NCT02441465|Vemurafenib|vemurafenib|mesh-list
111374643|NCT04364906|Anesthetics|anesthetics|mesh-list
111374644|NCT04364906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111374645|NCT04364906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111374646|NCT04134845|Dantrolene|dantrolene|mesh-list
111374647|NCT04134845|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
111374648|NCT04134845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111374649|NCT04134845|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111374650|NCT04134845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111374651|NCT02488980|Mefloquine|mefloquine|mesh-list
111374652|NCT02488980|Tafenoquine|tafenoquine|mesh-list
111374653|NCT02488980|Antimalarials|antimalarials|mesh-ancestor
111374654|NCT02488980|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111374655|NCT02488980|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111374656|NCT02488980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111374657|NCT02227667|Durvalumab|durvalumab|mesh-list
111374658|NCT02227667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111374659|NCT02227667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111374660|NCT02242214|Misoprostol|misoprostol|mesh-list
111374661|NCT02242214|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111374662|NCT02242214|Abortifacient Agents|abortifacient agents|mesh-ancestor
111374663|NCT02242214|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111374664|NCT02242214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111374665|NCT02242214|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111374666|NCT02242214|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111374667|NCT02242214|Oxytocics|oxytocics|mesh-ancestor
111374668|NCT02245256|Dexmedetomidine|dexmedetomidine|mesh-list
111374669|NCT02245256|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111374670|NCT02245256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111374671|NCT02245256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111374672|NCT02245256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111374673|NCT02245256|Analgesics|analgesics|mesh-ancestor
111374674|NCT02245256|Sensory System Agents|sensory system agents|mesh-ancestor
111374675|NCT02245256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111374676|NCT02245256|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111374677|NCT02245256|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111374678|NCT02245256|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111374679|NCT02245256|Adrenergic Agents|adrenergic agents|mesh-ancestor
111374680|NCT02245256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111374681|NCT02245256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111374682|NCT05208983|Vaccines|vaccines|mesh-list
111374683|NCT05208983|Immunologic Factors|immunologic factors|mesh-ancestor
111374684|NCT05208983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111374685|NCT02242292|Scopolamine|scopolamine|mesh-list
111374686|NCT02242292|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
111374687|NCT02242292|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111374688|NCT02242292|Antiemetics|antiemetics|mesh-ancestor
111374689|NCT02242292|Autonomic Agents|autonomic agents|mesh-ancestor
111374690|NCT02242292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111374691|NCT02242292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111374692|NCT02242292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111374693|NCT02242292|Mydriatics|mydriatics|mesh-ancestor
111374694|NCT02242292|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111374695|NCT02242292|Cholinergic Agents|cholinergic agents|mesh-ancestor
111374696|NCT02242292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110514425|NCT02756598|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111374697|NCT02242292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111374698|NCT02242292|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111374699|NCT02242292|Parasympatholytics|parasympatholytics|mesh-ancestor
111374700|NCT02242370|Telmisartan|telmisartan|mesh-list
111374701|NCT02242370|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111374702|NCT02242370|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111374703|NCT02242370|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111374704|NCT02242370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111374705|NCT04371146|Methylphenidate|methylphenidate|mesh-list
111374706|NCT04371146|Reboxetine|reboxetine|mesh-list
111374707|NCT04371146|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111374708|NCT04371146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111374709|NCT04371146|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111374710|NCT04371146|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111374711|NCT04371146|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111374712|NCT04371146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111374713|NCT04371146|Dopamine Agents|dopamine agents|mesh-ancestor
111374714|NCT04371146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111374715|NCT04371146|Antidepressive Agents|antidepressive agents|mesh-ancestor
111374716|NCT04371146|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111374717|NCT04371146|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111374718|NCT04371146|Adrenergic Agents|adrenergic agents|mesh-ancestor
111374719|NCT01623479|Bimatoprost|bimatoprost|mesh-list
111374720|NCT01623479|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111374721|NCT04347200|Anticoagulants|anticoagulants|mesh-list
111374722|NCT04347200|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
111374723|NCT04364516|Vitamin K|vitamin k|mesh-list
111374724|NCT04364516|Anticoagulants|anticoagulants|mesh-list
111374725|NCT04364516|Vitamins|vitamins|mesh-ancestor
111374726|NCT04364516|Micronutrients|micronutrients|mesh-ancestor
111374727|NCT04364516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111374728|NCT04364516|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111374729|NCT04364516|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111374730|NCT04364516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111374731|NCT04364516|Hemostatics|hemostatics|mesh-ancestor
111374732|NCT04364516|Coagulants|coagulants|mesh-ancestor
111374733|NCT01623869|Trebananib|trebananib|mesh-list
111374734|NCT01623869|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111374735|NCT01623869|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111374736|NCT01623869|Growth Substances|growth substances|mesh-ancestor
111374737|NCT01623869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111374738|NCT01623869|Growth Inhibitors|growth inhibitors|mesh-ancestor
111374739|NCT01623869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111374740|NCT02242838|Telmisartan|telmisartan|mesh-list
111374741|NCT02242838|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111374742|NCT02242838|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111374743|NCT02242838|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111374744|NCT02242838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111374745|NCT03207347|Niraparib|niraparib|mesh-list
111374746|NCT03207347|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111374747|NCT03207347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111374748|NCT03207347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111374749|NCT03207347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111374750|NCT02249039|Clonidine|clonidine|mesh-list
111374751|NCT02249039|Analgesics|analgesics|mesh-ancestor
111374752|NCT02249039|Sensory System Agents|sensory system agents|mesh-ancestor
111374753|NCT02249039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111374754|NCT02249039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111374755|NCT02249039|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111374756|NCT02249039|Sympatholytics|sympatholytics|mesh-ancestor
111374757|NCT02249039|Autonomic Agents|autonomic agents|mesh-ancestor
111374758|NCT02249039|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111374759|NCT02249039|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111374760|NCT02249039|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111374761|NCT02249039|Adrenergic Agents|adrenergic agents|mesh-ancestor
111374762|NCT02249039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111374763|NCT02249039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111374764|NCT04370288|Acetylcysteine|acetylcysteine|mesh-list
111374765|NCT04370288|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111374766|NCT04370288|Methylene Blue|methylene blue|mesh-list
111374767|NCT04370288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111374768|NCT04370288|Antioxidants|antioxidants|mesh-ancestor
111374769|NCT04370288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111374770|NCT04370288|Protective Agents|protective agents|mesh-ancestor
111374771|NCT04370288|Antiviral Agents|antiviral agents|mesh-ancestor
111374772|NCT04370288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111374773|NCT04370288|Expectorants|expectorants|mesh-ancestor
111374774|NCT04370288|Respiratory System Agents|respiratory system agents|mesh-ancestor
111374775|NCT04370288|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111374776|NCT04370288|Antidotes|antidotes|mesh-ancestor
111374777|NCT04370288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111374778|NCT02993705|Trabectedin|trabectedin|mesh-list
111374779|NCT02993705|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111374780|NCT02993705|Alkylating Agents|alkylating agents|mesh-ancestor
111374781|NCT02993705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111374782|NCT02993705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111374783|NCT02243618|Rebamipide|rebamipide|mesh-list
111374784|NCT02243618|Polaprezinc|polaprezinc|mesh-list
111374785|NCT02243618|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111374786|NCT02243618|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111374787|NCT02243618|Antioxidants|antioxidants|mesh-ancestor
111374788|NCT02243618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111374789|NCT02243618|Protective Agents|protective agents|mesh-ancestor
111374790|NCT02243618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111374791|NCT02243618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111374792|NCT02243852|Hormones|hormones|mesh-list
111374793|NCT02243852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111374794|NCT02243852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111374795|NCT03102125|Regadenoson|regadenoson|mesh-list
111374796|NCT03102125|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
111374797|NCT03102125|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
111374798|NCT03102125|Purinergic Agonists|purinergic agonists|mesh-ancestor
111374799|NCT03102125|Purinergic Agents|purinergic agents|mesh-ancestor
111374800|NCT03102125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111374801|NCT03102125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111374802|NCT03102125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111374803|NCT04369586|Meplazumab|meplazumab|mesh-list
111374804|NCT04369586|Antiviral Agents|antiviral agents|mesh-ancestor
111374805|NCT04369586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111374806|NCT02231177|Tiotropium Bromide|tiotropium bromide|mesh-list
111374807|NCT02231177|Olodaterol|olodaterol|mesh-list
111374808|NCT02231177|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111374809|NCT02231177|Autonomic Agents|autonomic agents|mesh-ancestor
111374810|NCT02231177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111374811|NCT02231177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111374812|NCT02231177|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111374813|NCT02231177|Respiratory System Agents|respiratory system agents|mesh-ancestor
111374814|NCT02231177|Parasympatholytics|parasympatholytics|mesh-ancestor
111374815|NCT02231177|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111374816|NCT02231177|Cholinergic Agents|cholinergic agents|mesh-ancestor
111374817|NCT02231177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111374818|NCT02231177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111374819|NCT03283007|Nintedanib|nintedanib|mesh-list
111374820|NCT03283007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111374821|NCT03283007|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111374822|NCT03283007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110514553|NCT00895063|Cholinergic Agents|cholinergic agents|mesh-ancestor
111374823|NCT03283007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111374824|NCT02244086|Bupivacaine|bupivacaine|mesh-list
111374825|NCT02244086|Anesthetics, Local|anesthetics, local|mesh-ancestor
111374826|NCT02244086|Anesthetics|anesthetics|mesh-ancestor
111374827|NCT02244086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111374828|NCT02244086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111374829|NCT02244086|Sensory System Agents|sensory system agents|mesh-ancestor
111374830|NCT02244086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111374831|NCT01630109|Metoclopramide|metoclopramide|mesh-list
111374832|NCT01630109|Antiemetics|antiemetics|mesh-ancestor
111374833|NCT01630109|Autonomic Agents|autonomic agents|mesh-ancestor
111374834|NCT01630109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111374835|NCT01630109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111374836|NCT01630109|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111374837|NCT01630109|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111374838|NCT01630109|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111374839|NCT01630109|Dopamine Agents|dopamine agents|mesh-ancestor
111374840|NCT01630109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111374841|NCT01630109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111374842|NCT04367948|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
111374843|NCT04367948|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111374844|NCT04367948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111374845|NCT01632215|Gabapentin|gabapentin|mesh-list
111374846|NCT01632215|Anticonvulsants|anticonvulsants|mesh-list
111374847|NCT01632215|Analgesics|analgesics|mesh-ancestor
111374848|NCT01632215|Sensory System Agents|sensory system agents|mesh-ancestor
111374849|NCT01632215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111374850|NCT01632215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111374851|NCT01632215|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111374852|NCT01632215|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111374853|NCT01632215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111374854|NCT01632215|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111374855|NCT01632215|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111374856|NCT01632215|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111374857|NCT01632215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111374858|NCT01632215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111374859|NCT01632215|Antimanic Agents|antimanic agents|mesh-ancestor
111374860|NCT02244242|Tamsulosin|tamsulosin|mesh-list
111374861|NCT02244242|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111374862|NCT02244242|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111374863|NCT02244242|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111374864|NCT02244242|Adrenergic Agents|adrenergic agents|mesh-ancestor
111374865|NCT02244242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111374866|NCT02244242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111374867|NCT02244242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111374868|NCT02244242|Urological Agents|urological agents|mesh-ancestor
111374869|NCT02244320|Tamsulosin|tamsulosin|mesh-list
111374870|NCT02244320|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111374871|NCT02244320|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111374872|NCT02244320|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111374873|NCT02244320|Adrenergic Agents|adrenergic agents|mesh-ancestor
111374874|NCT02244320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111374875|NCT02244320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111374876|NCT02244320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111374877|NCT02244320|Urological Agents|urological agents|mesh-ancestor
111374878|NCT02244632|Bevacizumab|bevacizumab|mesh-list
111374879|NCT02244632|Fluorouracil|fluorouracil|mesh-list
111374880|NCT02244632|Oxaliplatin|oxaliplatin|mesh-list
111374881|NCT02244632|Irinotecan|irinotecan|mesh-list
111374882|NCT02244632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111374883|NCT02244632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111374884|NCT02244632|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111374885|NCT02244632|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111374886|NCT02244632|Growth Substances|growth substances|mesh-ancestor
111374887|NCT02244632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111374888|NCT02244632|Growth Inhibitors|growth inhibitors|mesh-ancestor
111374889|NCT02244632|Antimetabolites|antimetabolites|mesh-ancestor
111374890|NCT02244632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111374891|NCT02244632|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111374892|NCT02244632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111374893|NCT02244632|Immunologic Factors|immunologic factors|mesh-ancestor
111374894|NCT02244632|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111374895|NCT02244632|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111374896|NCT02244632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111374897|NCT03060083|Nicotine|nicotine|mesh-list
111374898|NCT03060083|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111374899|NCT03060083|Autonomic Agents|autonomic agents|mesh-ancestor
111374900|NCT03060083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111374901|NCT03060083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111374902|NCT03060083|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111374903|NCT03060083|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111374904|NCT03060083|Cholinergic Agents|cholinergic agents|mesh-ancestor
111374905|NCT03060083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111374906|NCT03060083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111374907|NCT02244710|Clopidogrel|clopidogrel|mesh-list
111374908|NCT02244710|Ticagrelor|ticagrelor|mesh-list
111374909|NCT02244710|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111374910|NCT02244710|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111374911|NCT02244710|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111374912|NCT02244710|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111374913|NCT02244710|Purinergic Agents|purinergic agents|mesh-ancestor
111374914|NCT02244710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111374915|NCT02244710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111374916|NCT02244710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111374917|NCT04362332|Hydroxychloroquine|hydroxychloroquine|mesh-list
111374918|NCT04362332|Chloroquine|chloroquine|mesh-list
111374919|NCT04362332|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
111374920|NCT04362332|Antimalarials|antimalarials|mesh-ancestor
111374921|NCT04362332|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111374922|NCT04362332|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111374923|NCT04362332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111374924|NCT04362332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111374925|NCT04362332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111374926|NCT04362332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111374927|NCT04362332|Amebicides|amebicides|mesh-ancestor
111374928|NCT04362332|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111374929|NCT04362332|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111374930|NCT04362332|Analgesics|analgesics|mesh-ancestor
111374931|NCT04362332|Sensory System Agents|sensory system agents|mesh-ancestor
111374932|NCT04362332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111374933|NCT04362332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111374934|NCT04362332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111374935|NCT04362332|Filaricides|filaricides|mesh-ancestor
111374936|NCT04362332|Antinematodal Agents|antinematodal agents|mesh-ancestor
111374937|NCT04362332|Anthelmintics|anthelmintics|mesh-ancestor
111374938|NCT02308241|Ribavirin|ribavirin|mesh-list
111374939|NCT02308241|Antimetabolites|antimetabolites|mesh-ancestor
111374940|NCT02308241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111374941|NCT02308241|Antiviral Agents|antiviral agents|mesh-ancestor
111374942|NCT02308241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111374943|NCT00932282|Omalizumab|omalizumab|mesh-list
111374944|NCT00932282|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111374945|NCT00932282|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111374946|NCT00932282|Respiratory System Agents|respiratory system agents|mesh-ancestor
111374947|NCT01632995|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
111374948|NCT01632995|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111374949|NCT01632995|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111374950|NCT01632995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111374951|NCT01632995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111374952|NCT01632995|Antiviral Agents|antiviral agents|mesh-ancestor
111374953|NCT01632995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111374954|NCT01632995|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111374955|NCT01632995|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111374956|NCT02245022|Tenofovir|tenofovir|mesh-list
111374957|NCT02245022|Lamivudine|lamivudine|mesh-list
111374958|NCT02245022|Efavirenz|efavirenz|mesh-list
111374959|NCT02245022|Dolutegravir|dolutegravir|mesh-list
111374960|NCT02245022|Antiviral Agents|antiviral agents|mesh-ancestor
111374961|NCT02245022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111374962|NCT02245022|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111374963|NCT02245022|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111374964|NCT02245022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111374965|NCT02245022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111374966|NCT02245022|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111374967|NCT02245022|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111374968|NCT02245022|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111374969|NCT02245022|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111374970|NCT02245022|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111374971|NCT02245022|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111374972|NCT02245022|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111374973|NCT02245022|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111374974|NCT02245022|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111374975|NCT02245022|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111374976|NCT02224313|Estradiol|estradiol|mesh-list
111374977|NCT02224313|Progesterone|progesterone|mesh-list
111374978|NCT02224313|Estrogens|estrogens|mesh-ancestor
111374979|NCT02224313|Hormones|hormones|mesh-ancestor
111374980|NCT02224313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111374981|NCT02224313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111374982|NCT02224313|Progestins|progestins|mesh-ancestor
111374983|NCT04362410|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111374984|NCT04362410|Immunologic Factors|immunologic factors|mesh-ancestor
111374985|NCT04362410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111374986|NCT02460198|Pembrolizumab|pembrolizumab|mesh-list
111374987|NCT02460198|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111374988|NCT02460198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111374989|NCT02460198|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111374990|NCT02460198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111374991|NCT01633853|Vitamin D|vitamin d|mesh-list
111374992|NCT01633853|Ergocalciferols|ergocalciferols|mesh-list
111374993|NCT01633853|Cholecalciferol|cholecalciferol|mesh-list
111374994|NCT01633853|Vitamins|vitamins|mesh-list
111374995|NCT01633853|Micronutrients|micronutrients|mesh-ancestor
111374996|NCT01633853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111374997|NCT01633853|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111374998|NCT01633853|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111374999|NCT04361552|Immunoglobulins|immunoglobulins|mesh-list
111375000|NCT04361552|Immunoglobulin G|immunoglobulin g|mesh-list
111375001|NCT04361552|Immunologic Factors|immunologic factors|mesh-ancestor
111375002|NCT04361552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111375003|NCT04376216|Prednisone|prednisone|mesh-list
111375004|NCT04376216|Prednisolone|prednisolone|mesh-list
111375005|NCT04376216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111375006|NCT04376216|Glucocorticoids|glucocorticoids|mesh-ancestor
111375007|NCT04376216|Hormones|hormones|mesh-ancestor
111375008|NCT04376216|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111375009|NCT04376216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111375010|NCT04376216|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111375011|NCT04376216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111375012|NCT02452320|Acetaminophen|acetaminophen|mesh-list
111375013|NCT02452320|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111375014|NCT02452320|Analgesics|analgesics|mesh-ancestor
111375015|NCT02452320|Sensory System Agents|sensory system agents|mesh-ancestor
111375016|NCT02452320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111099431|NCT05532501|Oxytocics|oxytocics|mesh-ancestor
111375017|NCT02452320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111375018|NCT02452320|Antipyretics|antipyretics|mesh-ancestor
111375020|NCT02459964|Hydromorphone|hydromorphone|mesh-list
111375021|NCT02459964|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111375022|NCT02459964|Narcotics|narcotics|mesh-ancestor
111375023|NCT02459964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111375024|NCT02459964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111375025|NCT02459964|Analgesics|analgesics|mesh-ancestor
111375026|NCT02459964|Sensory System Agents|sensory system agents|mesh-ancestor
111375027|NCT02459964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111375028|NCT02459964|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111375029|NCT02459964|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111375030|NCT02459964|Anesthetics, General|anesthetics, general|mesh-ancestor
111375031|NCT02459964|Anesthetics|anesthetics|mesh-ancestor
111375032|NCT01635101|Acetaminophen|acetaminophen|mesh-list
111375033|NCT01635101|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111375034|NCT01635101|Analgesics|analgesics|mesh-ancestor
111375035|NCT01635101|Sensory System Agents|sensory system agents|mesh-ancestor
111375036|NCT01635101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111375037|NCT01635101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111375038|NCT01635101|Antipyretics|antipyretics|mesh-ancestor
111375039|NCT02087111|Interferons|interferons|mesh-list
111375040|NCT02087111|Ribavirin|ribavirin|mesh-list
111375041|NCT02087111|Interferon-alpha|interferon-alpha|mesh-list
111375042|NCT02087111|Interferon alpha-2|interferon alpha-2|mesh-list
111375043|NCT02087111|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
111375044|NCT02087111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111375045|NCT02087111|Antiviral Agents|antiviral agents|mesh-ancestor
111375046|NCT02087111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111375047|NCT02087111|Antimetabolites|antimetabolites|mesh-ancestor
111375048|NCT02087111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111375049|NCT02087111|Immunologic Factors|immunologic factors|mesh-ancestor
111375050|NCT02087111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111375051|NCT00932438|Leucovorin|leucovorin|mesh-list
111375052|NCT00932438|Bevacizumab|bevacizumab|mesh-list
111375053|NCT00932438|Fluorouracil|fluorouracil|mesh-list
111375054|NCT00932438|Oxaliplatin|oxaliplatin|mesh-list
111375055|NCT00932438|Irinotecan|irinotecan|mesh-list
111375056|NCT00932438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111375057|NCT00932438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111375058|NCT00932438|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111375059|NCT00932438|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111375060|NCT00932438|Growth Substances|growth substances|mesh-ancestor
111375061|NCT00932438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111375062|NCT00932438|Growth Inhibitors|growth inhibitors|mesh-ancestor
111375063|NCT00932438|Antimetabolites|antimetabolites|mesh-ancestor
111375064|NCT00932438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110514799|NCT00604253|Isophane insulin, beef|isophane insulin, beef|mesh-list
111375065|NCT00932438|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111375066|NCT00932438|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111375067|NCT00932438|Immunologic Factors|immunologic factors|mesh-ancestor
111375068|NCT00932438|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111375069|NCT00932438|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111375070|NCT00932438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111375071|NCT00932438|Antidotes|antidotes|mesh-ancestor
111375072|NCT00932438|Protective Agents|protective agents|mesh-ancestor
111375073|NCT00932438|Vitamin B Complex|vitamin b complex|mesh-ancestor
111375074|NCT00932438|Vitamins|vitamins|mesh-ancestor
111375075|NCT00932438|Micronutrients|micronutrients|mesh-ancestor
111375076|NCT01869413|Tranexamic Acid|tranexamic acid|mesh-list
111375077|NCT01869413|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111375078|NCT01869413|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111375079|NCT01869413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111375080|NCT01869413|Hemostatics|hemostatics|mesh-ancestor
111375081|NCT01869413|Coagulants|coagulants|mesh-ancestor
111375082|NCT02982512|Dexmedetomidine|dexmedetomidine|mesh-list
111375083|NCT02982512|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111375084|NCT02982512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111375085|NCT02982512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111375086|NCT02982512|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111375087|NCT02982512|Analgesics|analgesics|mesh-ancestor
111375088|NCT02982512|Sensory System Agents|sensory system agents|mesh-ancestor
111375089|NCT02982512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111375090|NCT02982512|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111375091|NCT02982512|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111375092|NCT02982512|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111375093|NCT02982512|Adrenergic Agents|adrenergic agents|mesh-ancestor
111375094|NCT02982512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111375095|NCT02982512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111375097|NCT01555697|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111375098|NCT01555697|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111375099|NCT01555697|Dopamine Agents|dopamine agents|mesh-ancestor
111375100|NCT01555697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111375101|NCT01555697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111375102|NCT01555697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111375103|NCT01555697|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111375104|NCT01555697|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111375105|NCT02982434|Botulinum Toxins|botulinum toxins|mesh-list
111375106|NCT02982434|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111375107|NCT02982434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111375108|NCT02982434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111375109|NCT02982434|Cholinergic Agents|cholinergic agents|mesh-ancestor
111375110|NCT02982434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111375111|NCT02982434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111375112|NCT02451930|Pembrolizumab|pembrolizumab|mesh-list
111375113|NCT02451930|Necitumumab|necitumumab|mesh-list
111375114|NCT02451930|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111375115|NCT02451930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111375116|NCT02451930|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111375117|NCT02451930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111375118|NCT04358120|Hyaluronic Acid|hyaluronic acid|mesh-list
111375119|NCT04358120|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111375120|NCT04358120|Immunologic Factors|immunologic factors|mesh-ancestor
111375121|NCT04358120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111375122|NCT04358120|Viscosupplements|viscosupplements|mesh-ancestor
111375123|NCT04358120|Protective Agents|protective agents|mesh-ancestor
111375124|NCT00932828|Immunomodulating Agents|immunomodulating agents|mesh-list
110514862|NCT04547166|Bevacizumab|bevacizumab|mesh-list
111375125|NCT00932828|Immunologic Factors|immunologic factors|mesh-list
111375126|NCT00932828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111375127|NCT00928694|Fenofibrate|fenofibrate|mesh-list
111375128|NCT00928694|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111375129|NCT00928694|Antimetabolites|antimetabolites|mesh-ancestor
111375130|NCT00928694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111375131|NCT00928694|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111375132|NCT01639157|Buspirone|buspirone|mesh-list
111375133|NCT01639157|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111375134|NCT01639157|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111375135|NCT01639157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111375136|NCT01639157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111375137|NCT01639157|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111375138|NCT01639157|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111375139|NCT01639157|Serotonin Agents|serotonin agents|mesh-ancestor
111375140|NCT01639157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111375141|NCT01639157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111375142|NCT02451696|Everolimus|everolimus|mesh-list
111375143|NCT02451696|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111375144|NCT02451696|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111375145|NCT02451696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111375146|NCT02451696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111375147|NCT02451696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111375148|NCT02451696|Immunologic Factors|immunologic factors|mesh-ancestor
111375149|NCT02451696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111375150|NCT02451696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111375151|NCT00928772|Midazolam|midazolam|mesh-list
111375152|NCT00928772|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111375153|NCT00928772|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111375154|NCT00928772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111375155|NCT00928772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111375156|NCT00928772|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111375157|NCT00928772|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111375158|NCT00928772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111375159|NCT00928772|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111375160|NCT00928772|Anesthetics, General|anesthetics, general|mesh-ancestor
111375161|NCT00928772|Anesthetics|anesthetics|mesh-ancestor
111375162|NCT00928772|GABA Modulators|gaba modulators|mesh-ancestor
111375163|NCT00928772|GABA Agents|gaba agents|mesh-ancestor
111375164|NCT00928772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111375165|NCT00928772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111375166|NCT02459418|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
111375167|NCT02459418|Hormones|hormones|mesh-ancestor
111375168|NCT02459418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111375169|NCT02459418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111375170|NCT04361318|Hydroxychloroquine|hydroxychloroquine|mesh-list
111375171|NCT04361318|Nitazoxanide|nitazoxanide|mesh-list
111375172|NCT04361318|Antimalarials|antimalarials|mesh-ancestor
111375173|NCT04361318|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111375174|NCT04361318|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111375175|NCT04361318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111375176|NCT04361318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111375177|NCT04361318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111375178|NCT04361318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111375179|NCT04925076|Ethanol|ethanol|mesh-list
111375180|NCT04925076|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111375181|NCT04925076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111375182|NCT04925076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111375183|NCT04925076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111375184|NCT01598207|Dronabinol|dronabinol|mesh-list
111375185|NCT01598207|Hallucinogens|hallucinogens|mesh-ancestor
111375186|NCT01598207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111375187|NCT01598207|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111375188|NCT01598207|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111375189|NCT01598207|Analgesics|analgesics|mesh-ancestor
111375190|NCT01598207|Sensory System Agents|sensory system agents|mesh-ancestor
111375191|NCT01598207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111375192|NCT01598207|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
111375193|NCT01598207|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
111375194|NCT01598207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111375195|NCT01598207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111375196|NCT01598207|Hormones|hormones|mesh-ancestor
111375197|NCT01598207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111375198|NCT01640171|Ketorolac|ketorolac|mesh-list
111375199|NCT01640171|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
111375200|NCT01640171|Lidocaine|lidocaine|mesh-list
111375201|NCT01640171|Proxymetacaine|proxymetacaine|mesh-list
111375202|NCT01640171|Anesthetics|anesthetics|mesh-list
111375203|NCT01640171|Anesthetics, Local|anesthetics, local|mesh-ancestor
111375204|NCT01640171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111375205|NCT01640171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111375206|NCT01640171|Sensory System Agents|sensory system agents|mesh-ancestor
111375207|NCT01640171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111375208|NCT01640171|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111375209|NCT01640171|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111375210|NCT01640171|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111375211|NCT01640171|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111375212|NCT01640171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111375213|NCT01640171|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111375214|NCT01640171|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111375215|NCT01640171|Analgesics|analgesics|mesh-ancestor
111375216|NCT01640171|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111375217|NCT01640171|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111375218|NCT01640171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111375219|NCT04361474|Budesonide|budesonide|mesh-list
111375220|NCT04361474|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111375221|NCT04361474|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111375222|NCT04361474|Autonomic Agents|autonomic agents|mesh-ancestor
111375223|NCT04361474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111375224|NCT04361474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111375225|NCT04361474|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111375226|NCT04361474|Respiratory System Agents|respiratory system agents|mesh-ancestor
111375227|NCT04361474|Glucocorticoids|glucocorticoids|mesh-ancestor
111375228|NCT04361474|Hormones|hormones|mesh-ancestor
111375229|NCT04361474|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111375230|NCT04366622|Riociguat|riociguat|mesh-list
111375231|NCT04366622|Enzyme Activators|enzyme activators|mesh-ancestor
111375232|NCT04366622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111375233|NCT02245334|Povidone-Iodine|povidone-iodine|mesh-list
111375234|NCT02245334|Povidone|povidone|mesh-list
111375235|NCT02245334|Plasma Substitutes|plasma substitutes|mesh-ancestor
111375236|NCT02245334|Blood Substitutes|blood substitutes|mesh-ancestor
111375237|NCT02245334|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111375238|NCT02245334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111375239|NCT04762160|Rituximab|rituximab|mesh-list
111375240|NCT04762160|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111099655|NCT02429765|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111375241|NCT04762160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111375242|NCT04762160|Immunologic Factors|immunologic factors|mesh-ancestor
111375243|NCT04762160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111375244|NCT04762160|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111375245|NCT02487498|Glycopyrrolate|glycopyrrolate|mesh-list
111375246|NCT02487498|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111375247|NCT02487498|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111375248|NCT02487498|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111375249|NCT02487498|Cholinergic Agents|cholinergic agents|mesh-ancestor
111375250|NCT02487498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111375251|NCT02487498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111375252|NCT02487498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111375253|NCT04356872|Doxorubicin|doxorubicin|mesh-list
111375254|NCT04356872|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111375255|NCT04356872|Ifosfamide|ifosfamide|mesh-list
111375256|NCT04356872|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111375257|NCT04356872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111375258|NCT04356872|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111375259|NCT04356872|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111375260|NCT04356872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111375261|NCT04356872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111375262|NCT04356872|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111375263|NCT04356872|Alkylating Agents|alkylating agents|mesh-ancestor
111375264|NCT02487108|Acetaminophen|acetaminophen|mesh-list
111375265|NCT02487108|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
111375266|NCT02487108|Hydrocodone|hydrocodone|mesh-list
111375267|NCT02487108|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111375268|NCT02487108|Analgesics|analgesics|mesh-ancestor
111375269|NCT02487108|Sensory System Agents|sensory system agents|mesh-ancestor
111375270|NCT02487108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111375271|NCT02487108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111375272|NCT02487108|Antipyretics|antipyretics|mesh-ancestor
111375273|NCT02487108|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111375274|NCT02487108|Narcotics|narcotics|mesh-ancestor
111375275|NCT02487108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111375276|NCT02487108|Antitussive Agents|antitussive agents|mesh-ancestor
111375277|NCT02487108|Respiratory System Agents|respiratory system agents|mesh-ancestor
111375278|NCT02487108|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111375279|NCT02487108|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111375280|NCT02487108|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111375281|NCT02487030|Sofosbuvir|sofosbuvir|mesh-list
111375282|NCT02487030|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
111375283|NCT02487030|Ledipasvir|ledipasvir|mesh-list
111375284|NCT02487030|Antiviral Agents|antiviral agents|mesh-ancestor
111375285|NCT02487030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111375286|NCT02486952|Prednisone|prednisone|mesh-list
111375287|NCT02486952|Cyclophosphamide|cyclophosphamide|mesh-list
111375288|NCT02486952|Rituximab|rituximab|mesh-list
111375289|NCT02486952|Vincristine|vincristine|mesh-list
111375290|NCT02486952|Doxorubicin|doxorubicin|mesh-list
111375291|NCT02486952|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111375292|NCT02486952|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111375293|NCT02486952|Immunologic Factors|immunologic factors|mesh-ancestor
111375294|NCT02486952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111375295|NCT02486952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111375296|NCT02486952|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111375297|NCT02486952|Alkylating Agents|alkylating agents|mesh-ancestor
111375298|NCT02486952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111375299|NCT02486952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111375300|NCT02486952|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111375301|NCT02486952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111375302|NCT02486952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111375303|NCT02486952|Glucocorticoids|glucocorticoids|mesh-ancestor
111375304|NCT02486952|Hormones|hormones|mesh-ancestor
111375305|NCT02486952|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111375306|NCT02486952|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111375307|NCT02486952|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111375308|NCT02486952|Tubulin Modulators|tubulin modulators|mesh-ancestor
111375309|NCT02486952|Antimitotic Agents|antimitotic agents|mesh-ancestor
111375310|NCT02486952|Mitosis Modulators|mitosis modulators|mesh-ancestor
111375311|NCT02486952|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110515051|NCT00906139|Propofol|propofol|mesh-list
111375312|NCT02486952|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111375313|NCT02486952|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111375314|NCT02486952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110959227|NCT03523572|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111375315|NCT02486796|Ubiquinone|ubiquinone|mesh-list
111375316|NCT02486796|Coenzyme Q10|coenzyme q10|mesh-list
111375317|NCT02486796|Melatonin|melatonin|mesh-list
111375318|NCT02486796|Antioxidants|antioxidants|mesh-ancestor
111375319|NCT02486796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111375320|NCT02486796|Protective Agents|protective agents|mesh-ancestor
111375321|NCT02486796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111375322|NCT02486796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111375323|NCT02486796|Micronutrients|micronutrients|mesh-ancestor
111375324|NCT02486796|Vitamins|vitamins|mesh-ancestor
111375325|NCT00620477|Levobupivacaine|levobupivacaine|mesh-list
111375326|NCT00620477|Anesthetics, Local|anesthetics, local|mesh-ancestor
111375327|NCT00620477|Anesthetics|anesthetics|mesh-ancestor
111375328|NCT00620477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111375329|NCT00620477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111375330|NCT00620477|Sensory System Agents|sensory system agents|mesh-ancestor
111375331|NCT00620477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111375332|NCT01641653|Midazolam|midazolam|mesh-list
111375333|NCT01641653|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111375334|NCT01641653|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111375335|NCT01641653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111375336|NCT01641653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111375337|NCT01641653|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111375338|NCT01641653|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111375339|NCT01641653|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111375340|NCT01641653|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111375341|NCT01641653|Anesthetics, General|anesthetics, general|mesh-ancestor
111375342|NCT01641653|Anesthetics|anesthetics|mesh-ancestor
111375343|NCT01641653|GABA Modulators|gaba modulators|mesh-ancestor
111375344|NCT01641653|GABA Agents|gaba agents|mesh-ancestor
111375345|NCT01641653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111375346|NCT01641653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111375347|NCT01600703|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111375348|NCT01600703|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111375349|NCT01600703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111375350|NCT01600703|Incretins|incretins|mesh-ancestor
111375351|NCT01600703|Hormones|hormones|mesh-ancestor
111375352|NCT01600703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111375353|NCT01600703|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111375354|NCT01600703|Protease Inhibitors|protease inhibitors|mesh-ancestor
111375355|NCT01600703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111375356|NCT01600703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111375357|NCT02450526|Botulinum Toxins|botulinum toxins|mesh-list
111375358|NCT02450526|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111375359|NCT02450526|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111375360|NCT02450526|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111375361|NCT02450526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111375362|NCT02450526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111375363|NCT02450526|Cholinergic Agents|cholinergic agents|mesh-ancestor
111375364|NCT02450526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111375365|NCT02450526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111375366|NCT02450526|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111375367|NCT02450526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111375368|NCT01605539|Cannabidiol|cannabidiol|mesh-list
111375369|NCT01605539|Anticonvulsants|anticonvulsants|mesh-ancestor
111375370|NCT02458638|Atezolizumab|atezolizumab|mesh-list
111375371|NCT02458638|Antibodies|antibodies|mesh-list
111375372|NCT02458638|Immunologic Factors|immunologic factors|mesh-ancestor
111375373|NCT02458638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110515117|NCT02852681|Diuretics|diuretics|mesh-ancestor
111375374|NCT02458638|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111375375|NCT02458638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111375376|NCT02458638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111375377|NCT02458638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111375378|NCT01607411|Fluorides|fluorides|mesh-list
111375379|NCT01607411|Cariostatic Agents|cariostatic agents|mesh-ancestor
111375380|NCT01607411|Protective Agents|protective agents|mesh-ancestor
111375381|NCT01607411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111375382|NCT01691339|Vaccines|vaccines|mesh-list
111375383|NCT01691339|Immunologic Factors|immunologic factors|mesh-ancestor
111375384|NCT01691339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111375385|NCT02233751|Methyltestosterone|methyltestosterone|mesh-list
111375386|NCT02233751|Testosterone|testosterone|mesh-list
111375387|NCT02233751|Testosterone undecanoate|testosterone undecanoate|mesh-list
111375388|NCT02233751|Testosterone enanthate|testosterone enanthate|mesh-list
111375389|NCT02233751|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
111375390|NCT02233751|Androgens|androgens|mesh-ancestor
111375391|NCT02233751|Hormones|hormones|mesh-ancestor
111375392|NCT02233751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111375393|NCT02233751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111375394|NCT02233751|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111375395|NCT02233751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111375396|NCT02233751|Anabolic Agents|anabolic agents|mesh-ancestor
111375397|NCT01607645|Cytarabine|cytarabine|mesh-list
111375398|NCT01607645|Decitabine|decitabine|mesh-list
111375399|NCT01607645|Azacitidine|azacitidine|mesh-list
111375400|NCT01607645|Idarubicin|idarubicin|mesh-list
111375401|NCT01607645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111375402|NCT01607645|Antimetabolites|antimetabolites|mesh-ancestor
111375403|NCT01607645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111375404|NCT01607645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111375405|NCT01607645|Antiviral Agents|antiviral agents|mesh-ancestor
111375406|NCT01607645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111375407|NCT01607645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111375408|NCT01607645|Immunologic Factors|immunologic factors|mesh-ancestor
111375409|NCT01607645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111375410|NCT01607645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111375411|NCT01607645|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111375412|NCT01607645|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111375413|NCT01607645|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111375414|NCT01647581|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
111375415|NCT01647581|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
111375416|NCT01647581|beta-Endorphin|beta-endorphin|mesh-list
111375417|NCT01647581|Hormones|hormones|mesh-ancestor
111375418|NCT01647581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111375419|NCT01647581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111375420|NCT01647581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111375421|NCT01647581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111375422|NCT01608659|Botulinum Toxins|botulinum toxins|mesh-list
111375423|NCT01608659|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111375424|NCT01608659|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111375425|NCT01608659|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110515178|NCT02755350|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111375426|NCT01608659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111375427|NCT01608659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111375428|NCT01608659|Cholinergic Agents|cholinergic agents|mesh-ancestor
111375429|NCT01608659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111375430|NCT01608659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111375431|NCT01608659|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111375432|NCT01608659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111375433|NCT01649609|Mycophenolic Acid|mycophenolic acid|mesh-list
111375434|NCT01649609|Sirolimus|sirolimus|mesh-list
111375435|NCT01649609|Tacrolimus|tacrolimus|mesh-list
111375436|NCT01649609|Antimetabolites|antimetabolites|mesh-list
111375437|NCT01649609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111375438|NCT01649609|Immunologic Factors|immunologic factors|mesh-ancestor
111375439|NCT01649609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111375440|NCT01649609|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111375441|NCT01649609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111375442|NCT01649609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111375443|NCT01649609|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111375444|NCT01649609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111375445|NCT01649609|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111375446|NCT01649609|Antitubercular Agents|antitubercular agents|mesh-ancestor
111375447|NCT01649609|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111375448|NCT01649609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111375449|NCT01649609|Antifungal Agents|antifungal agents|mesh-ancestor
111375450|NCT02449902|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
111375451|NCT02449902|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
111375452|NCT02449902|Estradiol|estradiol|mesh-list
111375453|NCT02449902|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
111375454|NCT02449902|Estrogens|estrogens|mesh-ancestor
111375455|NCT02449902|Hormones|hormones|mesh-ancestor
111375456|NCT02449902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111375457|NCT02449902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111375458|NCT02449902|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111375459|NCT02449902|Contraceptive Agents|contraceptive agents|mesh-ancestor
111375460|NCT02449902|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111375461|NCT02449902|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111375462|NCT02449044|Tolvaptan|tolvaptan|mesh-list
111375463|NCT02449044|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
111375464|NCT02449044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111375465|NCT02449044|Natriuretic Agents|natriuretic agents|mesh-ancestor
111375466|NCT02449044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111375468|NCT04942626|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
111375469|NCT04942626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111375470|NCT04942626|Antimetabolites|antimetabolites|mesh-ancestor
111375471|NCT04942626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111375472|NCT04942626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111375473|NCT04942626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111375474|NCT04942470|Propolis|propolis|mesh-list
111375475|NCT04942470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111375476|NCT02228681|Tamoxifen|tamoxifen|mesh-list
111375477|NCT02228681|Everolimus|everolimus|mesh-list
111375478|NCT02228681|Letrozole|letrozole|mesh-list
111375479|NCT02228681|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
111375480|NCT02228681|Medroxyprogesterone|medroxyprogesterone|mesh-list
111375481|NCT02228681|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111375482|NCT02228681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111375483|NCT02228681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111375484|NCT02228681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111375485|NCT02228681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111375486|NCT02228681|Immunologic Factors|immunologic factors|mesh-ancestor
111375487|NCT02228681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111375488|NCT02228681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111375489|NCT02228681|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111375490|NCT02228681|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111375491|NCT02228681|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111375492|NCT02228681|Hormone Antagonists|hormone antagonists|mesh-ancestor
111375493|NCT02228681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111375494|NCT02228681|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111375495|NCT02228681|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111375496|NCT02228681|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111375497|NCT02228681|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111375498|NCT02228681|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111375499|NCT02228681|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111375500|NCT02228681|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111375501|NCT02228681|Contraceptive Agents|contraceptive agents|mesh-ancestor
111375502|NCT02228681|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111375503|NCT02228681|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111375504|NCT02228681|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111375505|NCT02228681|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
111375506|NCT00942578|Prednisone|prednisone|mesh-list
111375507|NCT00942578|Bevacizumab|bevacizumab|mesh-list
111375508|NCT00942578|Lenalidomide|lenalidomide|mesh-list
111375509|NCT00942578|Docetaxel|docetaxel|mesh-list
111375510|NCT00942578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111375511|NCT00942578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111375512|NCT00942578|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111375513|NCT00942578|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111375514|NCT00942578|Growth Substances|growth substances|mesh-ancestor
111375515|NCT00942578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111375516|NCT00942578|Growth Inhibitors|growth inhibitors|mesh-ancestor
111375517|NCT00942578|Tubulin Modulators|tubulin modulators|mesh-ancestor
111375518|NCT00942578|Antimitotic Agents|antimitotic agents|mesh-ancestor
111375519|NCT00942578|Mitosis Modulators|mitosis modulators|mesh-ancestor
111375520|NCT00942578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111375521|NCT00942578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111375522|NCT00942578|Glucocorticoids|glucocorticoids|mesh-ancestor
111375523|NCT00942578|Hormones|hormones|mesh-ancestor
111375524|NCT00942578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111375525|NCT00942578|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111375526|NCT00942578|Immunologic Factors|immunologic factors|mesh-ancestor
111375527|NCT02229461|Aspirin|aspirin|mesh-list
111375528|NCT02229461|Naproxen|naproxen|mesh-list
111375529|NCT02229461|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110515275|NCT05520723|Loperamide|loperamide|mesh-list
111375530|NCT02229461|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111375531|NCT02229461|Analgesics|analgesics|mesh-ancestor
111375532|NCT02229461|Sensory System Agents|sensory system agents|mesh-ancestor
111375533|NCT02229461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111375534|NCT02229461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111375535|NCT02229461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111375536|NCT02229461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111375537|NCT02229461|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111375538|NCT02229461|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111375539|NCT02229461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111375540|NCT02229461|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111375541|NCT02229461|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111375542|NCT02229461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111375543|NCT02229461|Antipyretics|antipyretics|mesh-ancestor
111375544|NCT02229461|Gout Suppressants|gout suppressants|mesh-ancestor
111375545|NCT04641104|Thiamine|thiamine|mesh-list
111375546|NCT04641104|Vitamin B Complex|vitamin b complex|mesh-ancestor
111375547|NCT04641104|Vitamins|vitamins|mesh-ancestor
111375548|NCT04641104|Micronutrients|micronutrients|mesh-ancestor
111375549|NCT04641104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111375550|NCT04359680|Nitazoxanide|nitazoxanide|mesh-list
111375551|NCT04359680|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111375552|NCT04359680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111375553|NCT02237417|Aripiprazole|aripiprazole|mesh-list
111375554|NCT02237417|Antipsychotic Agents|antipsychotic agents|mesh-list
111375555|NCT02237417|Antidepressive Agents|antidepressive agents|mesh-ancestor
111375556|NCT02237417|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111375557|NCT02237417|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111375558|NCT02237417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111375559|NCT02237417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111375560|NCT02237417|Dopamine Agonists|dopamine agonists|mesh-ancestor
111375561|NCT02237417|Dopamine Agents|dopamine agents|mesh-ancestor
111375562|NCT02237417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111375563|NCT02237417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111375564|NCT02237417|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111375565|NCT02237417|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111375566|NCT02237417|Serotonin Agents|serotonin agents|mesh-ancestor
111375567|NCT02237417|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111375568|NCT02237417|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111375569|NCT02237417|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111375570|NCT02237417|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111375571|NCT04603898|Ascorbic Acid|ascorbic acid|mesh-list
111375572|NCT04603898|Antioxidants|antioxidants|mesh-ancestor
111375573|NCT04603898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111375574|NCT04603898|Protective Agents|protective agents|mesh-ancestor
111375575|NCT04603898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111375576|NCT04603898|Vitamins|vitamins|mesh-ancestor
111375577|NCT04603898|Micronutrients|micronutrients|mesh-ancestor
111375578|NCT02245490|Tamsulosin|tamsulosin|mesh-list
111375579|NCT02245490|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111375580|NCT02245490|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111375581|NCT02245490|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111375582|NCT02245490|Adrenergic Agents|adrenergic agents|mesh-ancestor
111375583|NCT02245490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111375584|NCT02245490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111375585|NCT02245490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111375586|NCT02245490|Urological Agents|urological agents|mesh-ancestor
111375587|NCT04355936|Telmisartan|telmisartan|mesh-list
111375588|NCT04355936|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111375589|NCT04355936|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111375590|NCT04355936|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111375591|NCT04355936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111375592|NCT00934934|Anidulafungin|anidulafungin|mesh-list
111375593|NCT00934934|Antifungal Agents|antifungal agents|mesh-ancestor
111375594|NCT00934934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111375595|NCT01651793|Caffeine|caffeine|mesh-list
111375596|NCT01651793|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110515334|NCT00605215|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111375597|NCT01651793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111375598|NCT01651793|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111375599|NCT01651793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111375600|NCT01651793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111375601|NCT01651793|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
111375602|NCT01651793|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111375603|NCT01651793|Purinergic Agents|purinergic agents|mesh-ancestor
111375604|NCT01651793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111375605|NCT01652495|Methylprednisolone|methylprednisolone|mesh-list
111375606|NCT01652495|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111375607|NCT01652495|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111375608|NCT01652495|Prednisolone|prednisolone|mesh-list
111375609|NCT01652495|Prednisolone acetate|prednisolone acetate|mesh-list
111375610|NCT01652495|Triamcinolone|triamcinolone|mesh-list
111375611|NCT01652495|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
111375612|NCT01652495|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
111375613|NCT01652495|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111375614|NCT01652495|Prednisolone phosphate|prednisolone phosphate|mesh-list
111375615|NCT01652495|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
111375616|NCT01652495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111375618|NCT01652495|Autonomic Agents|autonomic agents|mesh-ancestor
111375619|NCT01652495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111375620|NCT01652495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111375621|NCT01652495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111375622|NCT01652495|Glucocorticoids|glucocorticoids|mesh-ancestor
111375623|NCT01652495|Hormones|hormones|mesh-ancestor
111375624|NCT01652495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111375625|NCT01652495|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111375626|NCT01652495|Protective Agents|protective agents|mesh-ancestor
111375627|NCT01652495|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111375628|NCT01652495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111375629|NCT01652495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111375630|NCT01652495|Immunologic Factors|immunologic factors|mesh-ancestor
111375631|NCT01652495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111375632|NCT01652495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111375633|NCT00935792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111375634|NCT00935792|Alemtuzumab|alemtuzumab|mesh-list
111375635|NCT00935792|Everolimus|everolimus|mesh-list
111375636|NCT00935792|Antibodies|antibodies|mesh-list
111375637|NCT00935792|Immunoglobulins|immunoglobulins|mesh-list
111375638|NCT00935792|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111375639|NCT00935792|Immunologic Factors|immunologic factors|mesh-ancestor
111375640|NCT00935792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111375641|NCT00935792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111375642|NCT00935792|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111375643|NCT00935792|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111375644|NCT00935792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111375645|NCT00935792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111375646|NCT00935792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111375647|NCT01699607|Amphetamine|amphetamine|mesh-list
111375648|NCT01699607|Dextroamphetamine|dextroamphetamine|mesh-list
111375649|NCT01699607|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111375650|NCT01699607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111375651|NCT01699607|Sympathomimetics|sympathomimetics|mesh-ancestor
111375652|NCT01699607|Autonomic Agents|autonomic agents|mesh-ancestor
111375653|NCT01699607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111375654|NCT01699607|Dopamine Agents|dopamine agents|mesh-ancestor
111375655|NCT01699607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111375656|NCT01699607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111375657|NCT01699607|Adrenergic Agents|adrenergic agents|mesh-ancestor
111375658|NCT01699607|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111375659|NCT01699607|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111375660|NCT01699607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111375661|NCT01699607|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111375662|NCT04355468|Analgesics, Opioid|analgesics, opioid|mesh-list
111375663|NCT04355468|Anesthetics|anesthetics|mesh-list
111375664|NCT04355468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111375665|NCT04355468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111375666|NCT04355468|Narcotics|narcotics|mesh-ancestor
111375667|NCT04355468|Analgesics|analgesics|mesh-ancestor
111375668|NCT04355468|Sensory System Agents|sensory system agents|mesh-ancestor
111375669|NCT04355468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111375670|NCT01653509|Acyclovir|acyclovir|mesh-list
111375671|NCT01653509|Antiviral Agents|antiviral agents|mesh-ancestor
111375672|NCT01653509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111375673|NCT01614509|Triamcinolone|triamcinolone|mesh-list
111375674|NCT01614509|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
111375675|NCT01614509|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
111375676|NCT01614509|Bevacizumab|bevacizumab|mesh-list
111375677|NCT01614509|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
111375678|NCT01614509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111375679|NCT01614509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111375680|NCT01614509|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111375681|NCT01614509|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111375682|NCT01614509|Growth Substances|growth substances|mesh-ancestor
111375683|NCT01614509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111375684|NCT01614509|Growth Inhibitors|growth inhibitors|mesh-ancestor
111375685|NCT01614509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111375686|NCT01614509|Glucocorticoids|glucocorticoids|mesh-ancestor
111375687|NCT01614509|Hormones|hormones|mesh-ancestor
111375688|NCT01614509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111375689|NCT01614509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111375690|NCT01614509|Immunologic Factors|immunologic factors|mesh-ancestor
111375691|NCT01614509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111375692|NCT01614509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111375693|NCT01614743|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
111375694|NCT01614743|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111375695|NCT01614743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111375696|NCT01614743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111375697|NCT01614743|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111375698|NCT01614743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111375699|NCT01614743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111375700|NCT01614743|Cholinergic Agents|cholinergic agents|mesh-ancestor
111375701|NCT01614743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111375703|NCT00943202|Immunologic Factors|immunologic factors|mesh-ancestor
111375704|NCT00943202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111375705|NCT01654445|Tenecteplase|tenecteplase|mesh-list
111375706|NCT01654445|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111375707|NCT01654445|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111375708|NCT01654445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111375709|NCT01703039|Riluzole|riluzole|mesh-list
111375710|NCT01703039|Sertraline|sertraline|mesh-list
111375711|NCT01703039|Antidepressive Agents|antidepressive agents|mesh-ancestor
111375712|NCT01703039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111375713|NCT01703039|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111375714|NCT01703039|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111375715|NCT01703039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111375716|NCT01703039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111375717|NCT01703039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111375718|NCT01703039|Serotonin Agents|serotonin agents|mesh-ancestor
111375719|NCT01703039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111375720|NCT01703039|Anticonvulsants|anticonvulsants|mesh-ancestor
111375721|NCT01703039|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111375722|NCT01703039|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111375723|NCT01703039|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111375724|NCT01703039|Protective Agents|protective agents|mesh-ancestor
111375725|NCT01656629|Vitamin D|vitamin d|mesh-list
111375726|NCT01656629|Alendronate|alendronate|mesh-list
111375727|NCT01656629|Teriparatide|teriparatide|mesh-list
111375728|NCT01656629|Calcium|calcium|mesh-list
111375729|NCT01656629|Vitamins|vitamins|mesh-ancestor
111375730|NCT01656629|Micronutrients|micronutrients|mesh-ancestor
111375731|NCT01656629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111375732|NCT01656629|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111375733|NCT01656629|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111375734|NCT01703507|Ipilimumab|ipilimumab|mesh-list
111375735|NCT01703507|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111375736|NCT01703507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111375737|NCT01703507|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111375738|NCT01703507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111375739|NCT02158520|Paclitaxel|paclitaxel|mesh-list
111375740|NCT02158520|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111375741|NCT02158520|Bevacizumab|bevacizumab|mesh-list
111375742|NCT02158520|Ipilimumab|ipilimumab|mesh-list
111375743|NCT02158520|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111375744|NCT02158520|Endothelial Growth Factors|endothelial growth factors|mesh-list
111375745|NCT02158520|Antibodies|antibodies|mesh-list
111375746|NCT02158520|Immunoglobulins|immunoglobulins|mesh-list
111375747|NCT02158520|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111375748|NCT02158520|Immunoglobulin G|immunoglobulin g|mesh-list
111375749|NCT02158520|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111375750|NCT02158520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111375751|NCT02158520|Tubulin Modulators|tubulin modulators|mesh-ancestor
111375752|NCT02158520|Antimitotic Agents|antimitotic agents|mesh-ancestor
111375753|NCT02158520|Mitosis Modulators|mitosis modulators|mesh-ancestor
111375754|NCT02158520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111375755|NCT02158520|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111375756|NCT02158520|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111375757|NCT02158520|Growth Substances|growth substances|mesh-ancestor
111375758|NCT02158520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111375759|NCT02158520|Growth Inhibitors|growth inhibitors|mesh-ancestor
111375760|NCT02158520|Immunologic Factors|immunologic factors|mesh-ancestor
111375761|NCT02158520|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111375762|NCT01704521|Ribavirin|ribavirin|mesh-list
111100174|NCT02422121|RNS60|rns60|mesh-list
111375764|NCT01704521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111375765|NCT01704521|Antiviral Agents|antiviral agents|mesh-ancestor
111375766|NCT01704521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111375767|NCT01617083|Azithromycin|azithromycin|mesh-list
111375768|NCT01617083|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111375769|NCT01617083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111375770|NCT04359524|Vitamin D|vitamin d|mesh-list
111375771|NCT04359524|Cholecalciferol|cholecalciferol|mesh-list
111375772|NCT04359524|Vitamins|vitamins|mesh-ancestor
111375773|NCT04359524|Micronutrients|micronutrients|mesh-ancestor
111375774|NCT04359524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111375775|NCT04359524|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111375776|NCT04359524|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111375777|NCT01658657|Metoprolol|metoprolol|mesh-list
111375778|NCT01658657|Amlodipine|amlodipine|mesh-list
111375779|NCT01658657|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
111375780|NCT01658657|Lisinopril|lisinopril|mesh-list
111375781|NCT01658657|Hydrochlorothiazide, lisinopril drug combination|hydrochlorothiazide, lisinopril drug combination|mesh-list
111375782|NCT01658657|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111375783|NCT01658657|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111375784|NCT01658657|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111375785|NCT01658657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111375786|NCT01658657|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111375787|NCT01658657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111375788|NCT01658657|Vasodilator Agents|vasodilator agents|mesh-ancestor
111375789|NCT01658657|Diuretics|diuretics|mesh-ancestor
111375790|NCT01658657|Natriuretic Agents|natriuretic agents|mesh-ancestor
111375791|NCT01658657|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
111375792|NCT01658657|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111375793|NCT01658657|Sympatholytics|sympatholytics|mesh-ancestor
111375794|NCT01658657|Autonomic Agents|autonomic agents|mesh-ancestor
111375795|NCT01658657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111375796|NCT01658657|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
111375797|NCT01658657|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111375798|NCT01658657|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111375799|NCT01658657|Adrenergic Agents|adrenergic agents|mesh-ancestor
111375800|NCT01658657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111375801|NCT01658657|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
111375802|NCT01658657|Protease Inhibitors|protease inhibitors|mesh-ancestor
111375803|NCT01658657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111375804|NCT01658657|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111375805|NCT01658657|Protective Agents|protective agents|mesh-ancestor
111375806|NCT04359212|Heparin|heparin|mesh-list
111375807|NCT04359212|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
111375808|NCT04359212|Tinzaparin|tinzaparin|mesh-list
111375809|NCT04359212|Dalteparin|dalteparin|mesh-list
111375810|NCT04359212|PENTA|penta|mesh-list
111375811|NCT04359212|Fondaparinux|fondaparinux|mesh-list
111375812|NCT04359212|Anticoagulants|anticoagulants|mesh-ancestor
111375813|NCT04359212|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111375814|NCT04359212|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111375815|NCT04359212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111375816|NCT04359212|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111375817|NCT04359212|Antithrombins|antithrombins|mesh-ancestor
111375818|NCT04359212|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111375819|NCT04359212|Protease Inhibitors|protease inhibitors|mesh-ancestor
111375820|NCT04359212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111375821|NCT01620047|Fentanyl|fentanyl|mesh-list
111375822|NCT01620047|Ropivacaine|ropivacaine|mesh-list
111375823|NCT01620047|Anesthetics, Local|anesthetics, local|mesh-ancestor
111375824|NCT01620047|Anesthetics|anesthetics|mesh-ancestor
111375825|NCT01620047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111375826|NCT01620047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111375827|NCT01620047|Sensory System Agents|sensory system agents|mesh-ancestor
111375828|NCT01620047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111375829|NCT01620047|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111375830|NCT01620047|Narcotics|narcotics|mesh-ancestor
111375831|NCT01620047|Analgesics|analgesics|mesh-ancestor
111375832|NCT01620047|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111375833|NCT01620047|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111375834|NCT01620047|Anesthetics, General|anesthetics, general|mesh-ancestor
111375835|NCT00944450|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111375836|NCT00944450|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111375837|NCT00944450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111375838|NCT00944450|Incretins|incretins|mesh-ancestor
111375839|NCT00944450|Hormones|hormones|mesh-ancestor
111375840|NCT00944450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111375841|NCT00944450|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111375842|NCT00944450|Protease Inhibitors|protease inhibitors|mesh-ancestor
111375843|NCT00944450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111375844|NCT00944450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111375845|NCT03875144|Cisplatin|cisplatin|mesh-list
111375846|NCT03875144|Doxorubicin|doxorubicin|mesh-list
111375847|NCT03875144|Pemetrexed|pemetrexed|mesh-list
111375848|NCT03875144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111375849|NCT03875144|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111375850|NCT03875144|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111375851|NCT03875144|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111375852|NCT03875144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111375853|NCT03875144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111375854|NCT03875144|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111375855|NCT03875144|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111375856|NCT01661621|Doxazosin|doxazosin|mesh-list
111375857|NCT01661621|Tolterodine Tartrate|tolterodine tartrate|mesh-list
111375858|NCT01661621|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111375859|NCT01661621|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111375860|NCT01661621|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111375861|NCT01661621|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111375862|NCT01661621|Adrenergic Agents|adrenergic agents|mesh-ancestor
111375863|NCT01661621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111375864|NCT01661621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111375865|NCT01661621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111375866|NCT01661621|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111375867|NCT01661621|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111375868|NCT01661621|Cholinergic Agents|cholinergic agents|mesh-ancestor
111375869|NCT01661621|Urological Agents|urological agents|mesh-ancestor
111375870|NCT01620593|Metformin|metformin|mesh-list
111375871|NCT01620593|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111375872|NCT01620593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111375873|NCT00939536|Zolpidem|zolpidem|mesh-list
111375874|NCT00939536|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111375875|NCT00939536|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111375876|NCT00939536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111375877|NCT00939536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111375878|NCT00939536|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
111375879|NCT00939536|GABA Agonists|gaba agonists|mesh-ancestor
111375880|NCT00939536|GABA Agents|gaba agents|mesh-ancestor
111375881|NCT00939536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111375882|NCT00939536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111375883|NCT02982122|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
111375884|NCT04358354|Fluorouracil|fluorouracil|mesh-list
111375885|NCT04358354|Oxaliplatin|oxaliplatin|mesh-list
111375886|NCT04358354|Irinotecan|irinotecan|mesh-list
111375887|NCT04358354|Antimetabolites|antimetabolites|mesh-ancestor
111375888|NCT04358354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111375889|NCT04358354|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111375890|NCT04358354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111375891|NCT04358354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111375892|NCT04358354|Immunologic Factors|immunologic factors|mesh-ancestor
111375893|NCT04358354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111375894|NCT04358354|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111375895|NCT04358354|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111375896|NCT04358354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111375897|NCT03516968|Cholecalciferol|cholecalciferol|mesh-list
111375898|NCT03516968|Vitamin D|vitamin d|mesh-list
111375899|NCT03516968|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111375900|NCT03516968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111375901|NCT03516968|Vitamins|vitamins|mesh-ancestor
111375902|NCT03516968|Micronutrients|micronutrients|mesh-ancestor
111375903|NCT03516968|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111375904|NCT04355156|Axitinib|axitinib|mesh-list
111375905|NCT04355156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110515649|NCT00005112|Hormones|hormones|mesh-list
111375906|NCT04355156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111375907|NCT04355156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111375908|NCT04355156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111375909|NCT03320018|Minocycline|minocycline|mesh-list
111375910|NCT03320018|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111375911|NCT03320018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111375912|NCT03032666|Sofosbuvir|sofosbuvir|mesh-list
111375913|NCT03032666|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
111375914|NCT03032666|Velpatasvir|velpatasvir|mesh-list
111375915|NCT03032666|Antiviral Agents|antiviral agents|mesh-ancestor
111375916|NCT03032666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111375917|NCT04354376|Telmisartan|telmisartan|mesh-list
111375918|NCT04354376|1,4-dihydropyridine|1,4-dihydropyridine|mesh-list
111375919|NCT04354376|Diuretics|diuretics|mesh-list
111375920|NCT04354376|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
111375921|NCT04354376|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
111375922|NCT04354376|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111375923|NCT04354376|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111375924|NCT04354376|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111375925|NCT04354376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111375926|NCT04354376|Natriuretic Agents|natriuretic agents|mesh-ancestor
111375927|NCT04354376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111375928|NCT04354376|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111375929|NCT04354376|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111375930|NCT04354376|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111375931|NCT02777372|Sertraline|sertraline|mesh-list
111375932|NCT02777372|Antidepressive Agents|antidepressive agents|mesh-ancestor
111375933|NCT02777372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111375934|NCT02777372|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111375935|NCT02777372|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111375936|NCT02777372|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111375937|NCT02777372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111375938|NCT02777372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111375939|NCT02777372|Serotonin Agents|serotonin agents|mesh-ancestor
111375940|NCT02777372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111375941|NCT03032042|Azithromycin|azithromycin|mesh-list
111375942|NCT03032042|Albendazole|albendazole|mesh-list
111375943|NCT03032042|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111375944|NCT03032042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111375945|NCT03032042|Anthelmintics|anthelmintics|mesh-ancestor
111375946|NCT03032042|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111375947|NCT03032042|Anticestodal Agents|anticestodal agents|mesh-ancestor
111375948|NCT03032042|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
111375949|NCT03032042|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111375950|NCT03032042|Tubulin Modulators|tubulin modulators|mesh-ancestor
111375951|NCT03032042|Antimitotic Agents|antimitotic agents|mesh-ancestor
111375952|NCT03032042|Mitosis Modulators|mitosis modulators|mesh-ancestor
111375953|NCT03032042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111375954|NCT03032042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111375955|NCT01623323|Fluticasone|fluticasone|mesh-list
111375956|NCT01623323|Xhance|xhance|mesh-list
111375957|NCT01623323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111375958|NCT01623323|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111375959|NCT01623323|Autonomic Agents|autonomic agents|mesh-ancestor
111375960|NCT01623323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111375961|NCT01623323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111375962|NCT01623323|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111375963|NCT01623323|Respiratory System Agents|respiratory system agents|mesh-ancestor
111375964|NCT01623323|Dermatologic Agents|dermatologic agents|mesh-ancestor
111375965|NCT01623323|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111375966|NCT01709747|Hydromorphone|hydromorphone|mesh-list
111375967|NCT01709747|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111375968|NCT01709747|Narcotics|narcotics|mesh-ancestor
111375969|NCT01709747|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111375970|NCT01709747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111375971|NCT01709747|Analgesics|analgesics|mesh-ancestor
111375972|NCT01709747|Sensory System Agents|sensory system agents|mesh-ancestor
111375973|NCT01709747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111375974|NCT03031808|Lidocaine|lidocaine|mesh-list
111375975|NCT03031808|Rocuronium|rocuronium|mesh-list
111375976|NCT03031808|Anesthetics, Local|anesthetics, local|mesh-ancestor
111375977|NCT03031808|Anesthetics|anesthetics|mesh-ancestor
111375978|NCT03031808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111375979|NCT03031808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111375980|NCT03031808|Sensory System Agents|sensory system agents|mesh-ancestor
111375981|NCT03031808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111375982|NCT03031808|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111375983|NCT03031808|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111375984|NCT03031808|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111375985|NCT03031808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111375986|NCT03031808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111375987|NCT03031808|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
111375988|NCT03031808|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
111375989|NCT03031808|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111375990|NCT01662791|Rifaximin|rifaximin|mesh-list
111375991|NCT01662791|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111375992|NCT01662791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111375993|NCT01662791|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111375994|NCT03035084|Vitamin D|vitamin d|mesh-list
111375995|NCT03035084|Ergocalciferols|ergocalciferols|mesh-list
111375996|NCT03035084|Cholecalciferol|cholecalciferol|mesh-list
111375997|NCT03035084|Vitamins|vitamins|mesh-list
111375998|NCT03035084|Micronutrients|micronutrients|mesh-ancestor
111375999|NCT03035084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111376000|NCT03035084|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111376001|NCT03035084|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111376002|NCT03034850|Doxorubicin|doxorubicin|mesh-list
111376003|NCT03034850|Fluorouracil|fluorouracil|mesh-list
111376004|NCT03034850|Ifosfamide|ifosfamide|mesh-list
111376005|NCT03034850|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111376006|NCT03034850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111376007|NCT03034850|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111376008|NCT03034850|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111376009|NCT03034850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111376010|NCT03034850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111376011|NCT03034850|Antimetabolites|antimetabolites|mesh-ancestor
111376012|NCT03034850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111376013|NCT03034850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111376014|NCT03034850|Immunologic Factors|immunologic factors|mesh-ancestor
111376015|NCT03034850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111376016|NCT03034850|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111376017|NCT03034850|Alkylating Agents|alkylating agents|mesh-ancestor
111376018|NCT01663259|Cetuximab|cetuximab|mesh-list
111376019|NCT01663259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111376020|NCT01663259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111376021|NCT03031184|Mirtazapine|mirtazapine|mesh-list
111376022|NCT03031184|Antidepressive Agents|antidepressive agents|mesh-ancestor
111376023|NCT03031184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111376024|NCT03031184|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111376025|NCT03031184|Histamine Antagonists|histamine antagonists|mesh-ancestor
111376026|NCT03031184|Histamine Agents|histamine agents|mesh-ancestor
111376027|NCT03031184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111376028|NCT03031184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111376029|NCT03031184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111376030|NCT03031184|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111376031|NCT03031184|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111376032|NCT03031184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111376033|NCT03031184|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
111376034|NCT03031184|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111376035|NCT03031184|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111376036|NCT03031184|Adrenergic Agents|adrenergic agents|mesh-ancestor
111376037|NCT03031184|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111376038|NCT03031184|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111376039|NCT03031184|Serotonin Agents|serotonin agents|mesh-ancestor
111376040|NCT03031184|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111376041|NCT02238977|Bupropion|bupropion|mesh-list
111376042|NCT02238977|Fluoxetine|fluoxetine|mesh-list
111376043|NCT02238977|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111376044|NCT02238977|Antidepressive Agents|antidepressive agents|mesh-ancestor
111376045|NCT02238977|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111376046|NCT02238977|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111376047|NCT02238977|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111376048|NCT02238977|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111376049|NCT02238977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111376050|NCT02238977|Dopamine Agents|dopamine agents|mesh-ancestor
111376051|NCT02238977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111376052|NCT02238977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111376053|NCT02238977|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111376054|NCT02238977|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111376055|NCT02238977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111376056|NCT02238977|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111376057|NCT02238977|Serotonin Agents|serotonin agents|mesh-ancestor
111376058|NCT03034382|Lidocaine|lidocaine|mesh-list
111376059|NCT03034382|Epinephrine|epinephrine|mesh-list
111376060|NCT03034382|Morphine|morphine|mesh-list
111376061|NCT03034382|Nalbuphine|nalbuphine|mesh-list
111376062|NCT03034382|Bupivacaine|bupivacaine|mesh-list
111376063|NCT03034382|Anesthetics, Local|anesthetics, local|mesh-ancestor
111376064|NCT03034382|Anesthetics|anesthetics|mesh-ancestor
111376065|NCT03034382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111376066|NCT03034382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111376067|NCT03034382|Sensory System Agents|sensory system agents|mesh-ancestor
111376068|NCT03034382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111376069|NCT03034382|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111376070|NCT03034382|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111376071|NCT03034382|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111376072|NCT03034382|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111376073|NCT03034382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111376074|NCT03034382|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111376075|NCT03034382|Narcotics|narcotics|mesh-ancestor
111376076|NCT03034382|Analgesics|analgesics|mesh-ancestor
111376077|NCT03034382|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111376078|NCT03034382|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111376079|NCT03034382|Adrenergic Agents|adrenergic agents|mesh-ancestor
111376080|NCT03034382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111376081|NCT03034382|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111376082|NCT03034382|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111376083|NCT03034382|Autonomic Agents|autonomic agents|mesh-ancestor
111376084|NCT03034382|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111376085|NCT03034382|Respiratory System Agents|respiratory system agents|mesh-ancestor
111376086|NCT03034382|Mydriatics|mydriatics|mesh-ancestor
111376087|NCT03034382|Sympathomimetics|sympathomimetics|mesh-ancestor
111376088|NCT03034382|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111376089|NCT01664741|Nicotine|nicotine|mesh-list
111376090|NCT01664741|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111376091|NCT01664741|Autonomic Agents|autonomic agents|mesh-ancestor
111376092|NCT01664741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111376093|NCT01664741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111376094|NCT01664741|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111376095|NCT01664741|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111376096|NCT01664741|Cholinergic Agents|cholinergic agents|mesh-ancestor
111376097|NCT01664741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111376098|NCT01664741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111376099|NCT02062346|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
111376100|NCT02062346|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111376101|NCT02062346|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
111376102|NCT02062346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111376103|NCT03030950|Dexmedetomidine|dexmedetomidine|mesh-list
111376104|NCT03030950|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111376105|NCT03030950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111376106|NCT03030950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111376107|NCT03030950|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111376108|NCT03030950|Analgesics|analgesics|mesh-ancestor
111376109|NCT03030950|Sensory System Agents|sensory system agents|mesh-ancestor
111376110|NCT03030950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111376111|NCT03030950|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111376112|NCT03030950|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111376113|NCT03030950|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111376114|NCT03030950|Adrenergic Agents|adrenergic agents|mesh-ancestor
110515865|NCT02823236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111376115|NCT03030950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111376116|NCT03030950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111376117|NCT02022644|Irinotecan|irinotecan|mesh-list
111376118|NCT02022644|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111376119|NCT02022644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111376120|NCT02022644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111376121|NCT02022644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111376122|NCT02022644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111376123|NCT01664897|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111376124|NCT01664897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111376125|NCT01664897|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111376126|NCT01664897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111376127|NCT01664897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111376128|NCT03030716|Proanthocyanidin|proanthocyanidin|mesh-list
111376129|NCT03030716|Grape Seed Extract|grape seed extract|mesh-list
111376130|NCT03030716|Procyanidin|procyanidin|mesh-list
111376131|NCT03030716|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111376132|NCT03030716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111376133|NCT03030716|Antioxidants|antioxidants|mesh-ancestor
111376134|NCT03030716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111376135|NCT03030716|Protective Agents|protective agents|mesh-ancestor
111376136|NCT03030716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111100549|NCT02571777|Fluticasone|fluticasone|mesh-list
111376137|NCT03030716|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111376138|NCT03030716|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111376139|NCT03030716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111376140|NCT04353362|Amoxicillin|amoxicillin|mesh-list
111376141|NCT04353362|Metronidazole|metronidazole|mesh-list
111376142|NCT04353362|Ofloxacin|ofloxacin|mesh-list
111376143|NCT04353362|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111376144|NCT04353362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111376145|NCT04353362|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111376146|NCT04353362|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111376147|NCT04353362|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111376148|NCT04353362|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111376149|NCT04353362|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111376150|NCT04353362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111376151|NCT04353362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111376152|NCT04353362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111376153|NCT04353362|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111376154|NCT04353362|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111376155|NCT00946478|Pimecrolimus|pimecrolimus|mesh-list
111376156|NCT00946478|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111376157|NCT00946478|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111376158|NCT00946478|Analgesics|analgesics|mesh-ancestor
111376159|NCT00946478|Sensory System Agents|sensory system agents|mesh-ancestor
111376160|NCT00946478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111376161|NCT00946478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111376162|NCT00946478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111376163|NCT00946478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111376164|NCT00946478|Dermatologic Agents|dermatologic agents|mesh-ancestor
111376165|NCT00946478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110515936|NCT02825186|Hormones|hormones|mesh-ancestor
111376166|NCT00946478|Immunologic Factors|immunologic factors|mesh-ancestor
111376167|NCT00946478|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111376168|NCT00946478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111376169|NCT00946478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111376170|NCT02249741|Ibandronic Acid|ibandronic acid|mesh-list
111376171|NCT02249741|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111376172|NCT02249741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111376173|NCT03033836|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
111376174|NCT03033836|Dolutegravir|dolutegravir|mesh-list
111376175|NCT03033836|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111376176|NCT03033836|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111376177|NCT03033836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111376178|NCT03033836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111376179|NCT03033836|Antiviral Agents|antiviral agents|mesh-ancestor
111376180|NCT03033836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111376181|NCT03033836|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111376182|NCT03033836|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111376183|NCT03033836|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111376184|NCT03033836|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111376185|NCT03030560|Lidocaine|lidocaine|mesh-list
111376186|NCT03030560|Anesthetics, Local|anesthetics, local|mesh-ancestor
111376187|NCT03030560|Anesthetics|anesthetics|mesh-ancestor
111376188|NCT03030560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111376189|NCT03030560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111376190|NCT03030560|Sensory System Agents|sensory system agents|mesh-ancestor
111376191|NCT03030560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111376192|NCT03030560|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111376193|NCT03030560|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111376194|NCT03030560|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111376195|NCT03030560|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111376196|NCT03030560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111376197|NCT03033368|Rilpivirine|rilpivirine|mesh-list
111376198|NCT03033368|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111376199|NCT03033368|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111376200|NCT03033368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111376201|NCT03033368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111376202|NCT03033368|Antiviral Agents|antiviral agents|mesh-ancestor
111376203|NCT03033368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111376204|NCT03033368|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111376205|NCT03033368|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111376206|NCT03031262|Cytarabine|cytarabine|mesh-list
111376207|NCT03031262|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111376208|NCT03031262|Antimetabolites|antimetabolites|mesh-ancestor
111376209|NCT03031262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111376210|NCT03031262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111376211|NCT03031262|Antiviral Agents|antiviral agents|mesh-ancestor
111376212|NCT03031262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111376213|NCT03031262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111376214|NCT03031262|Immunologic Factors|immunologic factors|mesh-ancestor
111376215|NCT03031262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111376216|NCT03032978|Calcium, Dietary|calcium, dietary|mesh-list
111376217|NCT03032978|Calcium|calcium|mesh-list
111376218|NCT03032978|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111376219|NCT03032978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111376220|NCT03032978|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111376221|NCT03030248|Vancomycin|vancomycin|mesh-list
111376222|NCT03030248|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111376223|NCT03030248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111376224|NCT03028532|Clomiphene|clomiphene|mesh-list
111376225|NCT03028532|Enclomiphene|enclomiphene|mesh-list
111376226|NCT03028532|Zuclomiphene|zuclomiphene|mesh-list
111376227|NCT03028532|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111376228|NCT03028532|Hormone Antagonists|hormone antagonists|mesh-ancestor
111376229|NCT03028532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111376230|NCT03028532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111376231|NCT03028532|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111376232|NCT03028532|Fertility Agents|fertility agents|mesh-ancestor
111376233|NCT03028532|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111376234|NCT03028532|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111376235|NCT03028532|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111376236|NCT03017768|Tryptophan|tryptophan|mesh-list
111376237|NCT03017768|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111376238|NCT03017768|Antidepressive Agents|antidepressive agents|mesh-ancestor
111376239|NCT03017768|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111376240|NCT01006538|Ranibizumab|ranibizumab|mesh-list
111376241|NCT01006538|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111376242|NCT01006538|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111376243|NCT01006538|Growth Substances|growth substances|mesh-ancestor
111376244|NCT01006538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111376245|NCT01006538|Growth Inhibitors|growth inhibitors|mesh-ancestor
111376246|NCT01006538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111376247|NCT03017222|Ondansetron|ondansetron|mesh-list
111376248|NCT03017222|Ramosetron|ramosetron|mesh-list
111376249|NCT03017222|Antiemetics|antiemetics|mesh-ancestor
111376250|NCT03017222|Autonomic Agents|autonomic agents|mesh-ancestor
111376251|NCT03017222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111376252|NCT03017222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111376253|NCT03017222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111376254|NCT03017222|Antipruritics|antipruritics|mesh-ancestor
111376255|NCT03017222|Dermatologic Agents|dermatologic agents|mesh-ancestor
111376256|NCT03017222|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111376257|NCT03017222|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111376258|NCT03017222|Serotonin Agents|serotonin agents|mesh-ancestor
111376259|NCT03017222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111376260|NCT03017222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111376261|NCT03025724|Aminolevulinic Acid|aminolevulinic acid|mesh-list
111376262|NCT03025724|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111376263|NCT03025724|Dermatologic Agents|dermatologic agents|mesh-ancestor
111376264|NCT01010282|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
111376265|NCT01010282|Lubricant Eye Drops|lubricant eye drops|mesh-list
111376266|NCT01010282|Glycerol|glycerol|mesh-list
111376267|NCT01010282|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
111376268|NCT01010282|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111376269|NCT01010282|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
111376270|NCT01010282|Protective Agents|protective agents|mesh-ancestor
111376271|NCT01010282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111376272|NCT01010282|Laxatives|laxatives|mesh-ancestor
111376273|NCT01010282|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111376274|NCT03016988|Cytarabine|cytarabine|mesh-list
111376275|NCT03016988|Fludarabine|fludarabine|mesh-list
111376276|NCT03016988|Bortezomib|bortezomib|mesh-list
111376277|NCT03016988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111376278|NCT03016988|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111376279|NCT03016988|Antimetabolites|antimetabolites|mesh-ancestor
111376280|NCT03016988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111376281|NCT03016988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111376282|NCT03016988|Immunologic Factors|immunologic factors|mesh-ancestor
111376283|NCT03016988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111376284|NCT03016988|Antiviral Agents|antiviral agents|mesh-ancestor
111376285|NCT03016988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111376286|NCT03017066|Anesthetics|anesthetics|mesh-list
111376287|NCT03017066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111376288|NCT03017066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111376289|NCT03016832|Irbesartan|irbesartan|mesh-list
111376290|NCT03016832|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111376291|NCT03016832|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111376292|NCT03016832|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111376293|NCT03016832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111376294|NCT00955916|Cytarabine|cytarabine|mesh-list
111376295|NCT00955916|Imatinib Mesylate|imatinib mesylate|mesh-list
111376296|NCT00955916|Cladribine|cladribine|mesh-list
111376297|NCT00955916|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111376298|NCT00955916|Antimetabolites|antimetabolites|mesh-ancestor
111376299|NCT00955916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111376300|NCT00955916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111376301|NCT00955916|Antiviral Agents|antiviral agents|mesh-ancestor
111376302|NCT00955916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111376303|NCT00955916|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111376304|NCT00955916|Immunologic Factors|immunologic factors|mesh-ancestor
111376305|NCT00955916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111376306|NCT00955916|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111376307|NCT00955916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111376308|NCT01668017|Niacinamide|niacinamide|mesh-list
111376309|NCT01668017|Vitamin B Complex|vitamin b complex|mesh-ancestor
111376310|NCT01668017|Vitamins|vitamins|mesh-ancestor
111376311|NCT01668017|Micronutrients|micronutrients|mesh-ancestor
111376312|NCT01668017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111376313|NCT01010984|Doxorubicin|doxorubicin|mesh-list
111376314|NCT01010984|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111376315|NCT01010984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111376316|NCT01010984|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111376317|NCT01010984|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111376318|NCT01010984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111376319|NCT01010984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111376320|NCT01011218|Modafinil|modafinil|mesh-list
111376321|NCT01011218|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111376322|NCT01011218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111376323|NCT01011218|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
111376324|NCT01011218|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111376325|NCT01011218|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111376326|NCT01011218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111376327|NCT03023306|Antiemetics|antiemetics|mesh-list
111376328|NCT03023306|Autonomic Agents|autonomic agents|mesh-ancestor
111376329|NCT03023306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111376330|NCT03023306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111376331|NCT03023306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111376332|NCT05710367|Dapagliflozin|dapagliflozin|mesh-list
111376333|NCT05710367|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111376334|NCT05710367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111376335|NCT05710367|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111376336|NCT05710367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111376337|NCT00957242|Warfarin|warfarin|mesh-list
111376338|NCT00957242|Anticoagulants|anticoagulants|mesh-ancestor
111376339|NCT01014728|Propofol|propofol|mesh-list
111376340|NCT01014728|Sevoflurane|sevoflurane|mesh-list
111376341|NCT01014728|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111376342|NCT01014728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111376343|NCT01014728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111376344|NCT01014728|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111376345|NCT01014728|Anesthetics, General|anesthetics, general|mesh-ancestor
111376346|NCT01014728|Anesthetics|anesthetics|mesh-ancestor
111376347|NCT01014728|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111376348|NCT01014728|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111376349|NCT01015586|Lamotrigine|lamotrigine|mesh-list
111376350|NCT01015586|Anticonvulsants|anticonvulsants|mesh-ancestor
111376351|NCT01015586|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111376352|NCT01015586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111376353|NCT01015586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111376354|NCT01015586|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111376355|NCT01015586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111376356|NCT01015586|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111376357|NCT01015586|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111376358|NCT01015586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111376359|NCT01015586|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111376360|NCT01015586|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111376362|NCT01680653|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
111376363|NCT01680653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111376364|NCT01680653|Hormones|hormones|mesh-ancestor
111376365|NCT01680653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111376366|NCT01680653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111376367|NCT01680653|Incretins|incretins|mesh-ancestor
111376368|NCT02448810|Fluorouracil|fluorouracil|mesh-list
111376369|NCT02448810|Panitumumab|panitumumab|mesh-list
111376370|NCT02448810|Antimetabolites|antimetabolites|mesh-ancestor
111376371|NCT02448810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111376372|NCT02448810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111376373|NCT02448810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111376374|NCT02448810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111376375|NCT02448810|Immunologic Factors|immunologic factors|mesh-ancestor
111376376|NCT02448810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111376377|NCT02448810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111376378|NCT01680887|Varenicline|varenicline|mesh-list
111376379|NCT01680887|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111376380|NCT01680887|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111376381|NCT01680887|Cholinergic Agents|cholinergic agents|mesh-ancestor
111376382|NCT01680887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111376383|NCT01680887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111376384|NCT01680887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111376385|NCT01016678|Naproxen|naproxen|mesh-list
111376386|NCT01016678|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111376387|NCT01016678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111376388|NCT01016678|Analgesics|analgesics|mesh-ancestor
111376389|NCT01016678|Sensory System Agents|sensory system agents|mesh-ancestor
111376390|NCT01016678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111376391|NCT01016678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111376392|NCT01016678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111376393|NCT01016678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111376394|NCT01016678|Gout Suppressants|gout suppressants|mesh-ancestor
111376395|NCT01016678|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111376396|NCT01016678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111376397|NCT01016678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111376398|NCT02457546|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
111376399|NCT02457546|Hemostatics|hemostatics|mesh-ancestor
111376400|NCT02457546|Coagulants|coagulants|mesh-ancestor
111376401|NCT01016834|Sumatriptan|sumatriptan|mesh-list
111376402|NCT01016834|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111376403|NCT01016834|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111376404|NCT01016834|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111376405|NCT01016834|Serotonin Agents|serotonin agents|mesh-ancestor
111376406|NCT01016834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111376407|NCT01016834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111376408|NCT01016834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111376409|NCT04923594|Mazindol|mazindol|mesh-list
111376410|NCT04923594|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111376411|NCT04923594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111376412|NCT04923594|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111376413|NCT04923594|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111376414|NCT04923594|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111376415|NCT04923594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111376416|NCT04923594|Adrenergic Agents|adrenergic agents|mesh-ancestor
111376417|NCT04923594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111376418|NCT04923594|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111376419|NCT04923594|Dopamine Agents|dopamine agents|mesh-ancestor
111376420|NCT00961532|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
111376421|NCT00961532|Hemostatics|hemostatics|mesh-ancestor
111376422|NCT00961532|Coagulants|coagulants|mesh-ancestor
111376423|NCT00961532|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
111376424|NCT00961532|Natriuretic Agents|natriuretic agents|mesh-ancestor
111376425|NCT00961532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111376426|NCT02447718|Vaccines|vaccines|mesh-list
111376427|NCT02447718|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
111376428|NCT02447718|Immunologic Factors|immunologic factors|mesh-ancestor
111376429|NCT02447718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111376430|NCT03016442|Dinoprostone|dinoprostone|mesh-list
111376431|NCT03016442|Oxytocics|oxytocics|mesh-ancestor
111376432|NCT03016442|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111376433|NCT03016442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111376434|NCT01682135|Ramucirumab|ramucirumab|mesh-list
111376435|NCT01682135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111376436|NCT02249897|Cholestyramine Resin|cholestyramine resin|mesh-list
111376437|NCT02249897|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111376438|NCT02249897|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111376439|NCT02249897|Antimetabolites|antimetabolites|mesh-ancestor
111376440|NCT02249897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110516212|NCT04216758|Paclitaxel|paclitaxel|mesh-list
111376441|NCT02249897|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111376442|NCT00963872|Cyclophosphamide|cyclophosphamide|mesh-list
111376443|NCT00963872|Fludarabine|fludarabine|mesh-list
111376444|NCT00963872|Fludarabine phosphate|fludarabine phosphate|mesh-list
111376445|NCT00963872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111376446|NCT00963872|Immunologic Factors|immunologic factors|mesh-ancestor
111376447|NCT00963872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111376448|NCT00963872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111376449|NCT00963872|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111376450|NCT00963872|Alkylating Agents|alkylating agents|mesh-ancestor
111376451|NCT00963872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111376452|NCT00963872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111376453|NCT00963872|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111376454|NCT00963872|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111376455|NCT00963872|Antimetabolites|antimetabolites|mesh-ancestor
111376456|NCT00964496|Thalidomide|thalidomide|mesh-list
111376457|NCT00964496|Ferrous succinate|ferrous succinate|mesh-list
111376458|NCT00964496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111376459|NCT00964496|Immunologic Factors|immunologic factors|mesh-ancestor
111376460|NCT00964496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111376461|NCT00964496|Leprostatic Agents|leprostatic agents|mesh-ancestor
111376462|NCT00964496|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111376463|NCT00964496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111376464|NCT00964496|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111376465|NCT00964496|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111376466|NCT00964496|Growth Substances|growth substances|mesh-ancestor
111376467|NCT00964496|Growth Inhibitors|growth inhibitors|mesh-ancestor
111376468|NCT00964496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111376469|NCT00964496|Hematinics|hematinics|mesh-ancestor
111376470|NCT01685411|Mycophenolic Acid|mycophenolic acid|mesh-list
111376471|NCT01685411|Cyclophosphamide|cyclophosphamide|mesh-list
111376472|NCT01685411|Busulfan|busulfan|mesh-list
111376473|NCT01685411|Allopurinol|allopurinol|mesh-list
111376474|NCT01685411|Levetiracetam|levetiracetam|mesh-list
111376475|NCT01685411|Tacrolimus|tacrolimus|mesh-list
111376476|NCT01685411|Antilymphocyte Serum|antilymphocyte serum|mesh-list
111376477|NCT01685411|Lenograstim|lenograstim|mesh-list
111376478|NCT01685411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111376479|NCT01685411|Immunologic Factors|immunologic factors|mesh-ancestor
111376480|NCT01685411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111376481|NCT01685411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111376482|NCT01685411|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111376483|NCT01685411|Alkylating Agents|alkylating agents|mesh-ancestor
111376484|NCT01685411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111376485|NCT01685411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111376486|NCT01685411|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111376487|NCT01685411|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111376488|NCT01685411|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111376489|NCT01685411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111376490|NCT01685411|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111376491|NCT01685411|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111376492|NCT01685411|Antitubercular Agents|antitubercular agents|mesh-ancestor
111376493|NCT01685411|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111376494|NCT01685411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111376495|NCT01685411|Anticonvulsants|anticonvulsants|mesh-ancestor
111376496|NCT01685411|Nootropic Agents|nootropic agents|mesh-ancestor
110516263|NCT00908089|Analgesics|analgesics|mesh-ancestor
111376497|NCT01685411|Antimetabolites|antimetabolites|mesh-ancestor
111376498|NCT01685411|Gout Suppressants|gout suppressants|mesh-ancestor
111376499|NCT01685411|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111376500|NCT01685411|Antioxidants|antioxidants|mesh-ancestor
111376501|NCT01685411|Protective Agents|protective agents|mesh-ancestor
111376502|NCT02243813|Psilocybin|psilocybin|mesh-list
111376503|NCT02243813|Hallucinogens|hallucinogens|mesh-ancestor
111376504|NCT02243813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111376505|NCT02243813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111376506|NCT02991209|Testosterone|testosterone|mesh-list
111376507|NCT02991209|Androgens|androgens|mesh-ancestor
111376508|NCT02991209|Hormones|hormones|mesh-ancestor
111376509|NCT02991209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111376510|NCT02991209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111100926|NCT02414945|Fludarabine|fludarabine|mesh-list
111376511|NCT03019562|Fentanyl|fentanyl|mesh-list
111376512|NCT03019562|Oxycodone|oxycodone|mesh-list
111376513|NCT03019562|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111376514|NCT03019562|Narcotics|narcotics|mesh-ancestor
111376515|NCT03019562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111376516|NCT03019562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111376517|NCT03019562|Analgesics|analgesics|mesh-ancestor
111376518|NCT03019562|Sensory System Agents|sensory system agents|mesh-ancestor
111376519|NCT03019562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111376520|NCT03019562|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111376521|NCT03019562|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111376522|NCT03019562|Anesthetics, General|anesthetics, general|mesh-ancestor
111376523|NCT03019562|Anesthetics|anesthetics|mesh-ancestor
111376524|NCT00969878|Aluminum Hydroxide|aluminum hydroxide|mesh-list
111376525|NCT00969878|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111376526|NCT00969878|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111376527|NCT00969878|Immunologic Factors|immunologic factors|mesh-ancestor
111376528|NCT00969878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111376529|NCT00969878|Antacids|antacids|mesh-ancestor
111376530|NCT00969878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111376531|NCT00969878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111376532|NCT05677919|Venetoclax|venetoclax|mesh-list
111376533|NCT05677919|Pirtobrutinib|pirtobrutinib|mesh-list
111376534|NCT05677919|Pyrazole|pyrazole|mesh-list
111376535|NCT05677919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111376536|NCT05677919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111376537|NCT05677919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111376538|NCT05677919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111376539|NCT00970814|Levetiracetam|levetiracetam|mesh-list
111376540|NCT00970814|Anticonvulsants|anticonvulsants|mesh-ancestor
111376541|NCT00970814|Nootropic Agents|nootropic agents|mesh-ancestor
111376542|NCT02486406|Ritonavir|ritonavir|mesh-list
111376543|NCT02486406|Ribavirin|ribavirin|mesh-list
111376544|NCT02486406|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111376545|NCT02486406|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111376546|NCT02486406|Protease Inhibitors|protease inhibitors|mesh-ancestor
111376547|NCT02486406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111376548|NCT02486406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111376549|NCT02486406|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111376550|NCT02486406|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111376551|NCT02486406|Antiviral Agents|antiviral agents|mesh-ancestor
111376552|NCT02486406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111376553|NCT02486406|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111376554|NCT02486406|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111376555|NCT02486406|Antimetabolites|antimetabolites|mesh-ancestor
111376556|NCT01688609|Paclitaxel|paclitaxel|mesh-list
111376557|NCT01688609|Trastuzumab|trastuzumab|mesh-list
111376558|NCT01688609|Lapatinib|lapatinib|mesh-list
111376559|NCT01688609|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111376560|NCT01688609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111376561|NCT01688609|Tubulin Modulators|tubulin modulators|mesh-ancestor
111376562|NCT01688609|Antimitotic Agents|antimitotic agents|mesh-ancestor
111376563|NCT01688609|Mitosis Modulators|mitosis modulators|mesh-ancestor
111376564|NCT01688609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111376565|NCT01688609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111376566|NCT01688609|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111376567|NCT01688609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111376568|NCT02485158|Dronabinol|dronabinol|mesh-list
111376569|NCT02485158|Amphetamine|amphetamine|mesh-list
111376570|NCT02485158|Dextroamphetamine|dextroamphetamine|mesh-list
111376571|NCT02485158|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111376572|NCT02485158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111376573|NCT02485158|Sympathomimetics|sympathomimetics|mesh-ancestor
111376574|NCT02485158|Autonomic Agents|autonomic agents|mesh-ancestor
111376575|NCT02485158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111376576|NCT02485158|Dopamine Agents|dopamine agents|mesh-ancestor
111376577|NCT02485158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111376578|NCT02485158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111376579|NCT02485158|Adrenergic Agents|adrenergic agents|mesh-ancestor
111376580|NCT02485158|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111376581|NCT02485158|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111376582|NCT02485158|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111376583|NCT02485158|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111376584|NCT02485158|Hallucinogens|hallucinogens|mesh-ancestor
111376585|NCT02485158|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111376586|NCT02485158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111376587|NCT02485158|Analgesics|analgesics|mesh-ancestor
111376588|NCT02485158|Sensory System Agents|sensory system agents|mesh-ancestor
111376589|NCT02485158|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
111376590|NCT02485158|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
111376591|NCT02485158|Hormones|hormones|mesh-ancestor
111376592|NCT02485158|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111376593|NCT02455518|Acetaminophen|acetaminophen|mesh-list
111376594|NCT02455518|Ibuprofen|ibuprofen|mesh-list
111376595|NCT02455518|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
111376596|NCT02455518|Oxycodone|oxycodone|mesh-list
111376597|NCT02455518|Hydrocodone|hydrocodone|mesh-list
111376598|NCT02455518|Codeine|codeine|mesh-list
111376599|NCT02455518|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111376600|NCT02455518|Analgesics|analgesics|mesh-ancestor
111376601|NCT02455518|Sensory System Agents|sensory system agents|mesh-ancestor
111376602|NCT02455518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111376603|NCT02455518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111376604|NCT02455518|Antipyretics|antipyretics|mesh-ancestor
111376605|NCT02455518|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111376606|NCT02455518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111376607|NCT02455518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111376608|NCT02455518|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111376609|NCT02455518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111376610|NCT02455518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111376611|NCT02455518|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111376612|NCT02455518|Narcotics|narcotics|mesh-ancestor
111376613|NCT02455518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111376614|NCT02455518|Antitussive Agents|antitussive agents|mesh-ancestor
111376615|NCT02455518|Respiratory System Agents|respiratory system agents|mesh-ancestor
111376616|NCT00972374|Brimonidine Tartrate|brimonidine tartrate|mesh-list
111376617|NCT00972374|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111376618|NCT00972374|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111376619|NCT00972374|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111376620|NCT00972374|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111376621|NCT00972374|Adrenergic Agents|adrenergic agents|mesh-ancestor
111376622|NCT00972374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111376623|NCT00972374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111376624|NCT00972374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111376625|NCT03018626|Prednisone|prednisone|mesh-list
111376626|NCT03018626|Cyclophosphamide|cyclophosphamide|mesh-list
111376627|NCT03018626|Rituximab|rituximab|mesh-list
111376628|NCT03018626|Doxorubicin|doxorubicin|mesh-list
111376629|NCT03018626|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111376630|NCT03018626|Etoposide|etoposide|mesh-list
111376631|NCT03018626|Vincristine|vincristine|mesh-list
111376632|NCT03018626|Bleomycin|bleomycin|mesh-list
111376633|NCT03018626|Vindesine|vindesine|mesh-list
111376634|NCT03018626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111376635|NCT03018626|Immunologic Factors|immunologic factors|mesh-ancestor
111376636|NCT03018626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111376637|NCT03018626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111376638|NCT03018626|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111376639|NCT03018626|Alkylating Agents|alkylating agents|mesh-ancestor
111376640|NCT03018626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111376641|NCT03018626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111376642|NCT03018626|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111376643|NCT03018626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111376644|NCT03018626|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111376645|NCT03018626|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111376646|NCT03018626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111376647|NCT03018626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111376648|NCT03018626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111376649|NCT03018626|Glucocorticoids|glucocorticoids|mesh-ancestor
111376650|NCT03018626|Hormones|hormones|mesh-ancestor
111376651|NCT03018626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111376652|NCT03018626|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111376653|NCT03018626|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111376654|NCT03018626|Tubulin Modulators|tubulin modulators|mesh-ancestor
111376655|NCT03018626|Antimitotic Agents|antimitotic agents|mesh-ancestor
111376656|NCT03018626|Mitosis Modulators|mitosis modulators|mesh-ancestor
111376657|NCT01689779|Vitamin D|vitamin d|mesh-list
111376658|NCT01689779|Cholecalciferol|cholecalciferol|mesh-list
111376659|NCT01689779|Vitamins|vitamins|mesh-ancestor
111376660|NCT01689779|Micronutrients|micronutrients|mesh-ancestor
111376661|NCT01689779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111376662|NCT01689779|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111376663|NCT01689779|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111376664|NCT05388500|Paclitaxel|paclitaxel|mesh-list
111376665|NCT05388500|Trastuzumab|trastuzumab|mesh-list
111376666|NCT05388500|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111376667|NCT05388500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111376668|NCT05388500|Tubulin Modulators|tubulin modulators|mesh-ancestor
111376669|NCT05388500|Antimitotic Agents|antimitotic agents|mesh-ancestor
111376670|NCT05388500|Mitosis Modulators|mitosis modulators|mesh-ancestor
111376671|NCT05388500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111376672|NCT05388500|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110516428|NCT00931645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111376673|NCT00974246|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
111376674|NCT00974246|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111376675|NCT00974246|Autonomic Agents|autonomic agents|mesh-ancestor
111376676|NCT00974246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111376677|NCT00974246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111376678|NCT00974246|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111376679|NCT00974246|Respiratory System Agents|respiratory system agents|mesh-ancestor
111376680|NCT00974246|Glucocorticoids|glucocorticoids|mesh-ancestor
111376681|NCT00974246|Hormones|hormones|mesh-ancestor
111376682|NCT00974246|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111376683|NCT00974246|Sympathomimetics|sympathomimetics|mesh-ancestor
111376684|NCT00974480|Tretinoin|tretinoin|mesh-list
111376685|NCT00974480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111376686|NCT00974480|Keratolytic Agents|keratolytic agents|mesh-ancestor
111376687|NCT00974480|Dermatologic Agents|dermatologic agents|mesh-ancestor
111376688|NCT00975650|Testosterone|testosterone|mesh-list
111376689|NCT00975650|Androgens|androgens|mesh-ancestor
111376690|NCT00975650|Hormones|hormones|mesh-ancestor
111376691|NCT00975650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111376692|NCT00975650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111376693|NCT00979940|Atorvastatin|atorvastatin|mesh-list
111376694|NCT00979940|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111376695|NCT00979940|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111376696|NCT00979940|Antimetabolites|antimetabolites|mesh-ancestor
111376697|NCT00979940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111376698|NCT00979940|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111376699|NCT00979940|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111376700|NCT00979940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111376701|NCT03018236|Ethanol|ethanol|mesh-list
111376702|NCT03018236|Acetylcysteine|acetylcysteine|mesh-list
111376703|NCT03018236|Cocaine|cocaine|mesh-list
111376704|NCT03018236|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111376705|NCT03018236|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111376706|NCT03018236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111376707|NCT03018236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111376708|NCT03018236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111376709|NCT03018236|Antiviral Agents|antiviral agents|mesh-ancestor
111376710|NCT03018236|Expectorants|expectorants|mesh-ancestor
111376711|NCT03018236|Respiratory System Agents|respiratory system agents|mesh-ancestor
111376712|NCT03018236|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111376713|NCT03018236|Antioxidants|antioxidants|mesh-ancestor
111376714|NCT03018236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111376715|NCT03018236|Protective Agents|protective agents|mesh-ancestor
111376716|NCT03018236|Antidotes|antidotes|mesh-ancestor
111376717|NCT03018236|Anesthetics, Local|anesthetics, local|mesh-ancestor
111376718|NCT03018236|Anesthetics|anesthetics|mesh-ancestor
111376719|NCT03018236|Sensory System Agents|sensory system agents|mesh-ancestor
111376720|NCT03018236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111376721|NCT03018236|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111376722|NCT03018236|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111376723|NCT03018236|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111376724|NCT03018236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111376725|NCT03018236|Dopamine Agents|dopamine agents|mesh-ancestor
111376726|NCT03018236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111376727|NCT00982592|Leucovorin|leucovorin|mesh-list
111376728|NCT00982592|Fluorouracil|fluorouracil|mesh-list
111376729|NCT00982592|Oxaliplatin|oxaliplatin|mesh-list
111376730|NCT00982592|Calcium|calcium|mesh-list
111376731|NCT00982592|Levoleucovorin|levoleucovorin|mesh-list
111376732|NCT00982592|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111376733|NCT00982592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111376734|NCT00982592|Antimetabolites|antimetabolites|mesh-ancestor
111376735|NCT00982592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111376736|NCT00982592|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111376737|NCT00982592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111376738|NCT00982592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111376739|NCT00982592|Immunologic Factors|immunologic factors|mesh-ancestor
111376740|NCT00982592|Antidotes|antidotes|mesh-ancestor
111376741|NCT00982592|Protective Agents|protective agents|mesh-ancestor
111376742|NCT00982592|Vitamin B Complex|vitamin b complex|mesh-ancestor
111376743|NCT00982592|Vitamins|vitamins|mesh-ancestor
111376744|NCT00982592|Micronutrients|micronutrients|mesh-ancestor
111376745|NCT00983216|Ketoconazole|ketoconazole|mesh-list
111376746|NCT00983216|Colchicine|colchicine|mesh-list
111376747|NCT00983216|Gout Suppressants|gout suppressants|mesh-ancestor
111376748|NCT00983216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111376749|NCT00983216|Tubulin Modulators|tubulin modulators|mesh-ancestor
111376750|NCT00983216|Antimitotic Agents|antimitotic agents|mesh-ancestor
111376751|NCT00983216|Mitosis Modulators|mitosis modulators|mesh-ancestor
111376752|NCT00983216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111376753|NCT00983216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111376754|NCT00983216|Antifungal Agents|antifungal agents|mesh-ancestor
111376755|NCT00983216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111376756|NCT00983216|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111376757|NCT00983216|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111376758|NCT00983216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111376759|NCT00983216|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111376760|NCT00983216|Hormone Antagonists|hormone antagonists|mesh-ancestor
111376761|NCT00983216|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111376762|NCT00983216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111376763|NCT00983216|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111376764|NCT01788020|Dexamethasone|dexamethasone|mesh-list
111376765|NCT01788020|Dexamethasone acetate|dexamethasone acetate|mesh-list
111376766|NCT01788020|Cyclophosphamide|cyclophosphamide|mesh-list
111376767|NCT01788020|Rituximab|rituximab|mesh-list
111376768|NCT01788020|Bortezomib|bortezomib|mesh-list
111376769|NCT01788020|BB 1101|bb 1101|mesh-list
111376770|NCT01788020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111376771|NCT01788020|Immunologic Factors|immunologic factors|mesh-ancestor
111376772|NCT01788020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111376773|NCT01788020|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111376774|NCT01788020|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111376775|NCT01788020|Alkylating Agents|alkylating agents|mesh-ancestor
111376776|NCT01788020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111376777|NCT01788020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111376778|NCT01788020|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111376779|NCT01788020|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111376780|NCT01788020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111376781|NCT01788020|Antiemetics|antiemetics|mesh-ancestor
111376782|NCT01788020|Autonomic Agents|autonomic agents|mesh-ancestor
110516546|NCT03211338|Progesterone|progesterone|mesh-list
111376783|NCT01788020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111376784|NCT01788020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111376785|NCT01788020|Glucocorticoids|glucocorticoids|mesh-ancestor
111376786|NCT01788020|Hormones|hormones|mesh-ancestor
111376787|NCT01788020|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111376788|NCT01788020|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111376789|NCT01788020|Protease Inhibitors|protease inhibitors|mesh-ancestor
111376790|NCT01788020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111376791|NCT02249585|Iodine|iodine|mesh-list
111376792|NCT02249585|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111376793|NCT02249585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111376794|NCT02249585|Trace Elements|trace elements|mesh-ancestor
111376795|NCT02249585|Micronutrients|micronutrients|mesh-ancestor
111376796|NCT02249585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111376797|NCT05478863|Caffeine|caffeine|mesh-list
111376798|NCT05478863|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111376799|NCT05478863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111376800|NCT05478863|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111376801|NCT05478863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111376802|NCT05478863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111376803|NCT05478863|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
111376804|NCT05478863|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111376805|NCT05478863|Purinergic Agents|purinergic agents|mesh-ancestor
111376806|NCT05478863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111376807|NCT01774487|Pentoxifylline|pentoxifylline|mesh-list
111376808|NCT01774487|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111376809|NCT01774487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111376810|NCT01774487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111376811|NCT01774487|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111376812|NCT01774487|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111376813|NCT01774487|Protective Agents|protective agents|mesh-ancestor
111376814|NCT01774487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111376815|NCT01774487|Vasodilator Agents|vasodilator agents|mesh-ancestor
111376816|NCT01774487|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111376818|NCT02161484|Bupivacaine|bupivacaine|mesh-list
111376819|NCT02161484|Anesthetics, Local|anesthetics, local|mesh-ancestor
111376820|NCT02161484|Anesthetics|anesthetics|mesh-ancestor
111376821|NCT02161484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111376822|NCT02161484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111376823|NCT02161484|Sensory System Agents|sensory system agents|mesh-ancestor
111376824|NCT02161484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111376825|NCT00988832|Infliximab|infliximab|mesh-list
111376826|NCT00988832|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111376827|NCT00988832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111376828|NCT00988832|Dermatologic Agents|dermatologic agents|mesh-ancestor
111376829|NCT00988832|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111376830|NCT00988832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111376831|NCT01023776|Vaccines|vaccines|mesh-list
111376832|NCT01023776|Immunologic Factors|immunologic factors|mesh-ancestor
111376833|NCT01023776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111376834|NCT00989768|Botulinum Toxins|botulinum toxins|mesh-list
110516599|NCT02748330|Analgesics|analgesics|mesh-ancestor
111376835|NCT00989768|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111376836|NCT00989768|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111376837|NCT00989768|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111376838|NCT00989768|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111376839|NCT00989768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111376840|NCT00989768|Cholinergic Agents|cholinergic agents|mesh-ancestor
111376841|NCT00989768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111376842|NCT00989768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111376843|NCT00989768|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111376844|NCT00989768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111376845|NCT00990236|Enoxaparin|enoxaparin|mesh-list
111376846|NCT00990236|Enoxaparin sodium|enoxaparin sodium|mesh-list
111376847|NCT00990236|Anticoagulants|anticoagulants|mesh-ancestor
111376848|NCT00990236|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111376849|NCT00990236|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111376850|NCT00990236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111376851|NCT01024010|Vidarabine|vidarabine|mesh-list
111376852|NCT01024010|Cyclophosphamide|cyclophosphamide|mesh-list
111376853|NCT01024010|Ofatumumab|ofatumumab|mesh-list
111376854|NCT01024010|Pentostatin|pentostatin|mesh-list
111376855|NCT01024010|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111376856|NCT01024010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111376857|NCT01024010|Immunologic Factors|immunologic factors|mesh-ancestor
111376858|NCT01024010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111376859|NCT01024010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111376860|NCT01024010|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111376861|NCT01024010|Alkylating Agents|alkylating agents|mesh-ancestor
111376862|NCT01024010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111376863|NCT01024010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111376864|NCT01024010|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111376865|NCT01024010|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
111376866|NCT01024010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111376867|NCT01024010|Antimetabolites|antimetabolites|mesh-ancestor
111376868|NCT01024010|Antiviral Agents|antiviral agents|mesh-ancestor
111376869|NCT01024010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111376870|NCT02484690|Ranibizumab|ranibizumab|mesh-list
111376871|NCT02484690|Faricimab|faricimab|mesh-list
111376872|NCT02484690|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111376873|NCT02484690|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111376874|NCT02484690|Growth Substances|growth substances|mesh-ancestor
111376875|NCT02484690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111376876|NCT02484690|Growth Inhibitors|growth inhibitors|mesh-ancestor
111376877|NCT02484690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111376878|NCT01027598|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111376879|NCT01027598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111376880|NCT01027598|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111376881|NCT01027598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111376882|NCT01027598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111376883|NCT01654224|Vaccines|vaccines|mesh-list
111376884|NCT01654224|Immunologic Factors|immunologic factors|mesh-ancestor
111376885|NCT01654224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111376886|NCT02447328|Fulvestrant|fulvestrant|mesh-list
111376887|NCT02447328|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111376888|NCT02447328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111376889|NCT02447328|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
111376890|NCT02447328|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111376891|NCT02447328|Hormone Antagonists|hormone antagonists|mesh-ancestor
111376892|NCT02447328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111376893|NCT02447328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111376894|NCT02447250|Albuterol|albuterol|mesh-list
111376895|NCT02447250|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111376896|NCT02447250|Autonomic Agents|autonomic agents|mesh-ancestor
111376897|NCT02447250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111376898|NCT02447250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111376899|NCT02447250|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111376900|NCT02447250|Respiratory System Agents|respiratory system agents|mesh-ancestor
111376901|NCT02447250|Tocolytic Agents|tocolytic agents|mesh-ancestor
111376902|NCT02447250|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111376903|NCT02447250|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111376904|NCT02447250|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111376905|NCT02447250|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111376906|NCT02447250|Adrenergic Agents|adrenergic agents|mesh-ancestor
111376907|NCT02447250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111376908|NCT02447250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111376909|NCT00993200|Warfarin|warfarin|mesh-list
111376910|NCT00993200|Anticoagulants|anticoagulants|mesh-ancestor
111376911|NCT00993824|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
111376912|NCT00993824|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111376913|NCT00993824|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111376914|NCT00993824|Antimetabolites|antimetabolites|mesh-ancestor
111376915|NCT00993824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111376916|NCT00993824|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111376917|NCT02447172|Gentamicins|gentamicins|mesh-list
111376918|NCT02447172|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111376919|NCT02447172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111376920|NCT02447172|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111376921|NCT02447172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111376922|NCT02447172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111376923|NCT02163824|Loteprednol Etabonate|loteprednol etabonate|mesh-list
111376924|NCT02163824|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111376925|NCT04200066|Tamoxifen|tamoxifen|mesh-list
111376926|NCT04200066|Temozolomide|temozolomide|mesh-list
111376927|NCT04200066|Maprotiline|maprotiline|mesh-list
111376928|NCT04200066|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111376929|NCT04200066|Alkylating Agents|alkylating agents|mesh-ancestor
111376930|NCT04200066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111376931|NCT04200066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111376932|NCT04200066|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111376933|NCT04200066|Hormone Antagonists|hormone antagonists|mesh-ancestor
111376934|NCT04200066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111376935|NCT04200066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111376936|NCT04200066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111376937|NCT04200066|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111376938|NCT04200066|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111376939|NCT04200066|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111376940|NCT04200066|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111376941|NCT04200066|Antidepressive Agents|antidepressive agents|mesh-ancestor
111376942|NCT04200066|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111376943|NCT04200066|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111376944|NCT04200066|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111376945|NCT04200066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111376946|NCT04200066|Adrenergic Agents|adrenergic agents|mesh-ancestor
111376947|NCT04200066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111376948|NCT02455050|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
111376949|NCT02455050|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111376950|NCT02455050|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111376951|NCT02455050|Laxatives|laxatives|mesh-ancestor
111376952|NCT02455050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111376953|NCT00994760|Fentanyl|fentanyl|mesh-list
111376954|NCT00994760|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111376955|NCT00994760|Narcotics|narcotics|mesh-ancestor
111376956|NCT00994760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111376957|NCT00994760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111376958|NCT00994760|Analgesics|analgesics|mesh-ancestor
111376959|NCT00994760|Sensory System Agents|sensory system agents|mesh-ancestor
111376960|NCT00994760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111376961|NCT00994760|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111376962|NCT00994760|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111376963|NCT00994760|Anesthetics, General|anesthetics, general|mesh-ancestor
111376964|NCT00994760|Anesthetics|anesthetics|mesh-ancestor
111101381|NCT02408705|Hormones|hormones|mesh-ancestor
111376965|NCT00995072|Metoprolol|metoprolol|mesh-list
111376966|NCT00995072|Nebivolol|nebivolol|mesh-list
111376967|NCT00995072|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111376968|NCT00995072|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111376969|NCT00995072|Sympatholytics|sympatholytics|mesh-ancestor
111376970|NCT00995072|Autonomic Agents|autonomic agents|mesh-ancestor
111376971|NCT00995072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111376972|NCT00995072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111376973|NCT00995072|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
111376974|NCT00995072|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111376975|NCT00995072|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111376976|NCT00995072|Adrenergic Agents|adrenergic agents|mesh-ancestor
111376977|NCT00995072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111376978|NCT00995072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111376979|NCT00995072|Vasodilator Agents|vasodilator agents|mesh-ancestor
111376980|NCT00995072|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
111376981|NCT00995072|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111376982|NCT00995072|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111376983|NCT01027910|Doxorubicin|doxorubicin|mesh-list
111376984|NCT01027910|Abexinostat|abexinostat|mesh-list
111376985|NCT01027910|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111376986|NCT01027910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111376987|NCT01027910|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111376988|NCT01027910|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111376989|NCT01027910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111376990|NCT01027910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111376991|NCT01027910|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111376992|NCT01031420|Doxorubicin|doxorubicin|mesh-list
111376993|NCT01031420|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111376994|NCT01031420|Methotrexate|methotrexate|mesh-list
111376995|NCT01031420|Vinblastine|vinblastine|mesh-list
111376996|NCT01031420|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111376997|NCT01031420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111376998|NCT01031420|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111376999|NCT01031420|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111377000|NCT01031420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111377001|NCT01031420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111377002|NCT01031420|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111377003|NCT01031420|Abortifacient Agents|abortifacient agents|mesh-ancestor
111377004|NCT01031420|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111377005|NCT01031420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111377006|NCT01031420|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111377007|NCT01031420|Antimetabolites|antimetabolites|mesh-ancestor
111377008|NCT01031420|Dermatologic Agents|dermatologic agents|mesh-ancestor
111377009|NCT01031420|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111377010|NCT01031420|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111377011|NCT01031420|Immunologic Factors|immunologic factors|mesh-ancestor
111377012|NCT01031420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111377013|NCT01031420|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111377014|NCT01031420|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111377015|NCT01031420|Tubulin Modulators|tubulin modulators|mesh-ancestor
111377016|NCT01031420|Antimitotic Agents|antimitotic agents|mesh-ancestor
111377017|NCT01031420|Mitosis Modulators|mitosis modulators|mesh-ancestor
111377018|NCT01031498|Ondansetron|ondansetron|mesh-list
111377019|NCT01031498|Palonosetron|palonosetron|mesh-list
111377020|NCT01031498|Antiemetics|antiemetics|mesh-ancestor
111377021|NCT01031498|Autonomic Agents|autonomic agents|mesh-ancestor
111377022|NCT01031498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110516780|NCT02743260|Antimetabolites|antimetabolites|mesh-ancestor
111377023|NCT01031498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111377024|NCT01031498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111377025|NCT01031498|Antipruritics|antipruritics|mesh-ancestor
111377026|NCT01031498|Dermatologic Agents|dermatologic agents|mesh-ancestor
111377027|NCT01031498|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111377028|NCT01031498|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111377029|NCT01031498|Serotonin Agents|serotonin agents|mesh-ancestor
111377030|NCT01031498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111377031|NCT01031498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111377032|NCT01031810|Tranylcypromine|tranylcypromine|mesh-list
111377033|NCT01031810|Antidepressive Agents|antidepressive agents|mesh-ancestor
111377034|NCT01031810|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111377035|NCT01031810|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
111377036|NCT01031810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111377037|NCT01031810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111377038|NCT01031810|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111377039|NCT01031810|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111377040|NCT01031810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111377041|NCT01031810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111377042|NCT00998426|Immunoglobulins|immunoglobulins|mesh-list
111377043|NCT00998426|Antibodies|antibodies|mesh-list
111377044|NCT00998426|gamma-Globulins|gamma-globulins|mesh-list
111377045|NCT00998426|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111377046|NCT00998426|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
111377047|NCT00998426|Immunoglobulin G|immunoglobulin g|mesh-list
111377048|NCT00998426|Immunologic Factors|immunologic factors|mesh-ancestor
111377049|NCT00998426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111377050|NCT00998582|Tenofovir|tenofovir|mesh-list
111377051|NCT00998582|Antiviral Agents|antiviral agents|mesh-ancestor
111377052|NCT00998582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111377053|NCT00998582|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111377054|NCT00998582|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111377055|NCT00998582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111377056|NCT00998582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111377057|NCT00998582|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111377058|NCT00998582|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111377059|NCT02168660|Vitamin D|vitamin d|mesh-list
111377060|NCT02168660|Cholecalciferol|cholecalciferol|mesh-list
111377061|NCT02168660|Vitamins|vitamins|mesh-ancestor
111377062|NCT02168660|Micronutrients|micronutrients|mesh-ancestor
111377063|NCT02168660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110516843|NCT02743104|Analgesics|analgesics|mesh-ancestor
111377064|NCT02168660|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111377065|NCT02168660|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111377066|NCT01003106|Ranibizumab|ranibizumab|mesh-list
111377067|NCT01003106|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111377068|NCT01003106|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111377069|NCT01003106|Growth Substances|growth substances|mesh-ancestor
111377070|NCT01003106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111377071|NCT01003106|Growth Inhibitors|growth inhibitors|mesh-ancestor
111377072|NCT01003106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111377073|NCT01003418|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
111377074|NCT01003418|Immunologic Factors|immunologic factors|mesh-ancestor
111377075|NCT01003418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111377076|NCT01004042|Botulinum Toxins|botulinum toxins|mesh-list
111377077|NCT01004042|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111377078|NCT01004042|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111377079|NCT01004042|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111377080|NCT01004042|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111377081|NCT01004042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111377082|NCT01004042|Cholinergic Agents|cholinergic agents|mesh-ancestor
111377083|NCT01004042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111377084|NCT01004042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111377085|NCT01004042|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111377086|NCT01004042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111377087|NCT01004354|Ergocalciferols|ergocalciferols|mesh-list
111377088|NCT01004354|Vitamin D|vitamin d|mesh-list
111377089|NCT01004354|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111377090|NCT01004354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111377091|NCT01004354|Vitamins|vitamins|mesh-ancestor
111377092|NCT01004354|Micronutrients|micronutrients|mesh-ancestor
111377093|NCT01004354|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111377094|NCT02417064|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
111377095|NCT02417064|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
111377096|NCT02417064|Sertraline|sertraline|mesh-list
111377097|NCT02417064|Antidepressive Agents|antidepressive agents|mesh-list
111377098|NCT02417064|Esketamine|esketamine|mesh-list
111377099|NCT02417064|Escitalopram|escitalopram|mesh-list
111377100|NCT02417064|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111377101|NCT02417064|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111377102|NCT02417064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111377103|NCT02417064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111377104|NCT02417064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111377105|NCT02417064|Serotonin Agents|serotonin agents|mesh-ancestor
111377106|NCT02417064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111377107|NCT02417064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111377108|NCT02417064|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111377109|NCT02417064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111377110|NCT02417064|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111377111|NCT02417064|Analgesics|analgesics|mesh-ancestor
111377112|NCT02417064|Sensory System Agents|sensory system agents|mesh-ancestor
111377113|NCT02417064|Dopamine Agents|dopamine agents|mesh-ancestor
111101535|NCT02406911|Ticagrelor|ticagrelor|mesh-list
111377114|NCT01004744|Anastrozole|anastrozole|mesh-list
111377115|NCT01004744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111377116|NCT01004744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111377117|NCT01004744|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111377118|NCT01004744|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111377119|NCT01004744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111377120|NCT01004744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111377121|NCT01004744|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111377122|NCT01004744|Hormone Antagonists|hormone antagonists|mesh-ancestor
111000947|NCT02855359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111377123|NCT01004744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111377124|NCT01004744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111377125|NCT01005290|Ramipril|ramipril|mesh-list
111377126|NCT01005290|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
111377127|NCT01005290|Protease Inhibitors|protease inhibitors|mesh-ancestor
111377128|NCT01005290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111377129|NCT01005290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111377130|NCT01005290|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111377131|NCT04478474|Ganciclovir|ganciclovir|mesh-list
111377132|NCT04478474|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
111377133|NCT04478474|Antiviral Agents|antiviral agents|mesh-ancestor
111377134|NCT04478474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111377135|NCT04478474|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111377136|NCT04478474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111377137|NCT04478474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111377138|NCT05592860|Insulin|insulin|mesh-list
111377139|NCT05592860|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111377140|NCT05592860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111377141|NCT01051778|Aspirin|aspirin|mesh-list
111377142|NCT01051778|Heparin|heparin|mesh-list
111377143|NCT01051778|Enoxaparin|enoxaparin|mesh-list
111377144|NCT01051778|Calcium heparin|calcium heparin|mesh-list
111377145|NCT01051778|Calcium|calcium|mesh-list
111377146|NCT01051778|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111377147|NCT01051778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111377148|NCT01051778|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111377149|NCT01051778|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111377150|NCT01051778|Analgesics|analgesics|mesh-ancestor
111377151|NCT01051778|Sensory System Agents|sensory system agents|mesh-ancestor
111377152|NCT01051778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111377153|NCT01051778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111377154|NCT01051778|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111377155|NCT01051778|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111377156|NCT01051778|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111377157|NCT01051778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111377158|NCT01051778|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111377159|NCT01051778|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111377160|NCT01051778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111377161|NCT01051778|Antipyretics|antipyretics|mesh-ancestor
111377162|NCT01051778|Anticoagulants|anticoagulants|mesh-ancestor
111377163|NCT02169440|Opicapone|opicapone|mesh-list
111377164|NCT02169440|Warfarin|warfarin|mesh-list
111377165|NCT02169440|Anticoagulants|anticoagulants|mesh-ancestor
111377166|NCT02169440|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
111377167|NCT02169440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111377168|NCT02169440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111377169|NCT02169440|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111377170|NCT02169440|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111377171|NCT03015350|Sevoflurane|sevoflurane|mesh-list
111377172|NCT03015350|Desflurane|desflurane|mesh-list
111377173|NCT03015350|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111377174|NCT03015350|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111377175|NCT03015350|Anesthetics, General|anesthetics, general|mesh-ancestor
111377176|NCT03015350|Anesthetics|anesthetics|mesh-ancestor
110516947|NCT02741232|Epinephryl borate|epinephryl borate|mesh-list
111377177|NCT03015350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111377178|NCT03015350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111377179|NCT01054742|Ribavirin|ribavirin|mesh-list
111377180|NCT01054742|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
111377181|NCT01054742|Antimetabolites|antimetabolites|mesh-ancestor
111377182|NCT01054742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111377183|NCT01054742|Antiviral Agents|antiviral agents|mesh-ancestor
111377184|NCT01054742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111377185|NCT04171466|Metronidazole|metronidazole|mesh-list
111377186|NCT04171466|Ciprofloxacin|ciprofloxacin|mesh-list
111377187|NCT04171466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111377188|NCT04171466|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111377189|NCT04171466|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111377190|NCT04171466|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111377191|NCT04171466|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111377192|NCT04171466|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111377193|NCT04171466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111377194|NCT04171466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111377195|NCT04171466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111377196|NCT04171466|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111377197|NCT04171466|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111377199|NCT02170376|Carbidopa|carbidopa|mesh-list
111377200|NCT02170376|Opicapone|opicapone|mesh-list
111377201|NCT02170376|Entacapone|entacapone|mesh-list
111377202|NCT02170376|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111377203|NCT02170376|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111377204|NCT02170376|Dopamine Agents|dopamine agents|mesh-ancestor
111377205|NCT02170376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111377206|NCT02170376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111377207|NCT02170376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111377208|NCT02170376|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
111377209|NCT02170376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111377210|NCT02170376|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
111377211|NCT02170532|Albuterol|albuterol|mesh-list
111377212|NCT02170532|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111377213|NCT02170532|Autonomic Agents|autonomic agents|mesh-ancestor
111377214|NCT02170532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111377215|NCT02170532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111377216|NCT02170532|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111377217|NCT02170532|Respiratory System Agents|respiratory system agents|mesh-ancestor
111377218|NCT02170532|Tocolytic Agents|tocolytic agents|mesh-ancestor
111377219|NCT02170532|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111377220|NCT02170532|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111377221|NCT02170532|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111377222|NCT02170532|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111377223|NCT02170532|Adrenergic Agents|adrenergic agents|mesh-ancestor
111377224|NCT02170532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111377225|NCT02170532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111377226|NCT04079582|Dialysis Solutions|dialysis solutions|mesh-list
111377227|NCT04079582|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111377228|NCT02175212|Ascorbic Acid|ascorbic acid|mesh-list
111377229|NCT02175212|Methyltestosterone|methyltestosterone|mesh-list
111377230|NCT02175212|Androgens|androgens|mesh-list
111377231|NCT02175212|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
111377232|NCT02175212|Hormones|hormones|mesh-ancestor
111377233|NCT02175212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111377234|NCT02175212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111377235|NCT02175212|Antioxidants|antioxidants|mesh-ancestor
111377236|NCT02175212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111377237|NCT02175212|Protective Agents|protective agents|mesh-ancestor
111377238|NCT02175212|Vitamins|vitamins|mesh-ancestor
111377239|NCT02175212|Micronutrients|micronutrients|mesh-ancestor
111377240|NCT02175212|Estrogens|estrogens|mesh-ancestor
111377241|NCT02175212|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111377242|NCT02175212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111377243|NCT02175212|Anabolic Agents|anabolic agents|mesh-ancestor
111377244|NCT03014882|Acetylcysteine|acetylcysteine|mesh-list
111377245|NCT03014882|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111377246|NCT03014882|Antiviral Agents|antiviral agents|mesh-ancestor
111377247|NCT03014882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111377248|NCT03014882|Expectorants|expectorants|mesh-ancestor
111377249|NCT03014882|Respiratory System Agents|respiratory system agents|mesh-ancestor
111377250|NCT03014882|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111377251|NCT03014882|Antioxidants|antioxidants|mesh-ancestor
111377252|NCT03014882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111377253|NCT03014882|Protective Agents|protective agents|mesh-ancestor
111377254|NCT03014882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111377255|NCT03014882|Antidotes|antidotes|mesh-ancestor
111377256|NCT02171234|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
111377257|NCT02171234|Anticonvulsants|anticonvulsants|mesh-ancestor
111377258|NCT02171234|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111377259|NCT02171234|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111377260|NCT02171234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111377261|NCT02171234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111377262|NCT01061528|Nicotine|nicotine|mesh-list
111377263|NCT01061528|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111377264|NCT01061528|Autonomic Agents|autonomic agents|mesh-ancestor
111377265|NCT01061528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111377266|NCT01061528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111377267|NCT01061528|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111377268|NCT01061528|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111377269|NCT01061528|Cholinergic Agents|cholinergic agents|mesh-ancestor
111377270|NCT01061528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111377271|NCT01061528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111377272|NCT01062230|Bortezomib|bortezomib|mesh-list
111377273|NCT01062230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111377274|NCT01064882|Bimatoprost|bimatoprost|mesh-list
111377275|NCT01064882|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111377276|NCT01064882|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111377277|NCT01064882|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111377278|NCT01065506|Nicotine|nicotine|mesh-list
111377279|NCT01065506|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111377280|NCT01065506|Autonomic Agents|autonomic agents|mesh-ancestor
111377281|NCT01065506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111377282|NCT01065506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111377283|NCT01065506|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111377284|NCT01065506|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111377285|NCT01065506|Cholinergic Agents|cholinergic agents|mesh-ancestor
111377286|NCT01065506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111377287|NCT01065506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111377288|NCT03817736|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
111377289|NCT03817736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111377290|NCT03817736|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111377291|NCT03817736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111377292|NCT03811886|Natalizumab|natalizumab|mesh-list
111377293|NCT03811886|Immunologic Factors|immunologic factors|mesh-ancestor
111377294|NCT03811886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111377295|NCT01066364|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
111377296|NCT01066364|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111377297|NCT01066364|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111377298|NCT01066364|Antimetabolites|antimetabolites|mesh-ancestor
111377299|NCT01066364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111377300|NCT01066364|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111377301|NCT01066520|Diclofenac|diclofenac|mesh-list
111377302|NCT01066520|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111377303|NCT01066520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111377304|NCT01066520|Analgesics|analgesics|mesh-ancestor
111377305|NCT01066520|Sensory System Agents|sensory system agents|mesh-ancestor
111377306|NCT01066520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111377307|NCT01066520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111377308|NCT01066520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111377309|NCT01066520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111377310|NCT01066520|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111377311|NCT01066520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111377312|NCT01066520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111377313|NCT03014804|Nivolumab|nivolumab|mesh-list
111377314|NCT03014804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111377315|NCT03014804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111377316|NCT03014804|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111377317|NCT03014804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111377318|NCT05224388|Heparin|heparin|mesh-list
111377319|NCT05224388|Enoxaparin|enoxaparin|mesh-list
111377320|NCT05224388|Anticoagulants|anticoagulants|mesh-ancestor
111377321|NCT05224388|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111377322|NCT05224388|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111377323|NCT05224388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111377324|NCT03520790|Paclitaxel|paclitaxel|mesh-list
111377325|NCT03520790|Gemcitabine|gemcitabine|mesh-list
111377326|NCT03520790|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111377327|NCT03520790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111377328|NCT03520790|Tubulin Modulators|tubulin modulators|mesh-ancestor
111377329|NCT03520790|Antimitotic Agents|antimitotic agents|mesh-ancestor
111377330|NCT03520790|Mitosis Modulators|mitosis modulators|mesh-ancestor
111377331|NCT03520790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111377332|NCT03520790|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111377333|NCT03520790|Antimetabolites|antimetabolites|mesh-ancestor
111377334|NCT02416908|Cytarabine|cytarabine|mesh-list
111377335|NCT02416908|Plerixafor|plerixafor|mesh-list
111377336|NCT02416908|2'-deoxyadenosine|2'-deoxyadenosine|mesh-list
111377337|NCT02416908|Cladribine|cladribine|mesh-list
111377338|NCT02416908|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111377339|NCT02416908|Antimetabolites|antimetabolites|mesh-ancestor
111377340|NCT02416908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111377341|NCT02416908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111377342|NCT02416908|Antiviral Agents|antiviral agents|mesh-ancestor
111377343|NCT02416908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111377344|NCT02416908|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111377345|NCT02416908|Immunologic Factors|immunologic factors|mesh-ancestor
111377346|NCT02416908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111377347|NCT02416908|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111377348|NCT02416908|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111377349|NCT01070810|Thiamine|thiamine|mesh-list
111377350|NCT01070810|Vitamin B Complex|vitamin b complex|mesh-ancestor
111377351|NCT01070810|Vitamins|vitamins|mesh-ancestor
111377352|NCT01070810|Micronutrients|micronutrients|mesh-ancestor
111000948|NCT02855359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111377353|NCT01070810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111377354|NCT01071044|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
111377355|NCT01071044|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111377356|NCT01071044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111377357|NCT01071044|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111377358|NCT01071044|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111377359|NCT01071044|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111377360|NCT01071044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111377361|NCT01071044|Dopamine Agents|dopamine agents|mesh-ancestor
111377362|NCT01071044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111377363|NCT05150756|Lidocaine|lidocaine|mesh-list
111377364|NCT05150756|Morphine|morphine|mesh-list
111377365|NCT05150756|Anesthetics, Local|anesthetics, local|mesh-ancestor
111377366|NCT05150756|Anesthetics|anesthetics|mesh-ancestor
111377367|NCT05150756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111377368|NCT05150756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111377369|NCT05150756|Sensory System Agents|sensory system agents|mesh-ancestor
111377370|NCT05150756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111377371|NCT05150756|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111377372|NCT05150756|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111377373|NCT05150756|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111377374|NCT05150756|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111377375|NCT05150756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111377376|NCT05150756|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111377377|NCT05150756|Narcotics|narcotics|mesh-ancestor
111377378|NCT05150756|Analgesics|analgesics|mesh-ancestor
111377379|NCT01072136|Azithromycin|azithromycin|mesh-list
111377380|NCT01072136|Cefixime|cefixime|mesh-list
111377381|NCT01072136|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111377382|NCT01072136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111377383|NCT05135858|Methotrexate|methotrexate|mesh-list
111377384|NCT05135858|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111377385|NCT05135858|Abortifacient Agents|abortifacient agents|mesh-ancestor
111377386|NCT05135858|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111377387|NCT05135858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111377388|NCT05135858|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111377389|NCT05135858|Antimetabolites|antimetabolites|mesh-ancestor
111377390|NCT05135858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111377391|NCT05135858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111377392|NCT05135858|Dermatologic Agents|dermatologic agents|mesh-ancestor
111377393|NCT05135858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111377394|NCT05135858|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111377395|NCT05135858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111377396|NCT05135858|Immunologic Factors|immunologic factors|mesh-ancestor
111377397|NCT05135858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111377398|NCT05135858|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111377399|NCT03012230|Pembrolizumab|pembrolizumab|mesh-list
111377400|NCT03012230|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111377401|NCT03012230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111377402|NCT03012230|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111377403|NCT03012230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111377404|NCT03005444|Enoxaparin|enoxaparin|mesh-list
111377405|NCT03005444|Nadroparin|nadroparin|mesh-list
111377406|NCT03005444|Rivaroxaban|rivaroxaban|mesh-list
111377407|NCT03005444|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111377408|NCT03005444|Antithrombins|antithrombins|mesh-ancestor
111377409|NCT03005444|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110517179|NCT04306692|Inositol|inositol|mesh-list
111377410|NCT03005444|Protease Inhibitors|protease inhibitors|mesh-ancestor
111377411|NCT03005444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111377412|NCT03005444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111377413|NCT03005444|Anticoagulants|anticoagulants|mesh-ancestor
111377414|NCT03005444|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111377415|NCT03005444|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111377416|NCT01076270|Plerixafor|plerixafor|mesh-list
111377417|NCT01076270|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111377418|NCT01076270|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111377419|NCT01076270|Antiviral Agents|antiviral agents|mesh-ancestor
111377420|NCT01076270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111377421|NCT01076504|Carboplatin|carboplatin|mesh-list
111377422|NCT01076504|Amrubicin|amrubicin|mesh-list
111377423|NCT01076504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111377424|NCT01076972|Ritonavir|ritonavir|mesh-list
111377425|NCT01076972|Lopinavir|lopinavir|mesh-list
111377426|NCT01076972|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111377427|NCT01076972|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111377428|NCT01076972|Protease Inhibitors|protease inhibitors|mesh-ancestor
111377429|NCT01076972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111377430|NCT01076972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111377431|NCT01076972|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111377432|NCT01076972|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111377433|NCT01076972|Antiviral Agents|antiviral agents|mesh-ancestor
111377434|NCT01076972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111377435|NCT01076972|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111377436|NCT01076972|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111377437|NCT02174432|Nalbuphine|nalbuphine|mesh-list
111377438|NCT02174432|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111377439|NCT02174432|Narcotics|narcotics|mesh-ancestor
111377440|NCT02174432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111377441|NCT02174432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111377442|NCT02174432|Analgesics|analgesics|mesh-ancestor
111377443|NCT02174432|Sensory System Agents|sensory system agents|mesh-ancestor
111377444|NCT02174432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111377445|NCT02176382|Zoledronic Acid|zoledronic acid|mesh-list
111377446|NCT02176382|Denosumab|denosumab|mesh-list
111377447|NCT02176382|Teriparatide|teriparatide|mesh-list
111377448|NCT02176382|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111377449|NCT02176382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111377450|NCT02176382|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111377451|NCT01077596|Bupropion|bupropion|mesh-list
111377452|NCT01077596|Antidepressive Agents|antidepressive agents|mesh-list
111377453|NCT01077596|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-list
111377454|NCT01077596|Serotonin|serotonin|mesh-list
111377455|NCT01077596|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
111377456|NCT01077596|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111377457|NCT01077596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111377458|NCT01077596|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111377459|NCT01077596|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111377460|NCT01077596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111377461|NCT01077596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111377462|NCT01077596|Dopamine Agents|dopamine agents|mesh-ancestor
111377463|NCT01077596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111377464|NCT01077596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111377465|NCT01077596|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111377466|NCT01077596|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111377467|NCT01077596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111377468|NCT01077596|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111377469|NCT01077596|Serotonin Agents|serotonin agents|mesh-ancestor
111377470|NCT03013712|Immunomodulating Agents|immunomodulating agents|mesh-list
111377471|NCT03013712|Immunologic Factors|immunologic factors|mesh-ancestor
110517242|NCT00925093|Linezolid|linezolid|mesh-list
111377472|NCT03013712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111377473|NCT02740868|Xenon|xenon|mesh-list
111377474|NCT02740868|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111377475|NCT02740868|Anesthetics, General|anesthetics, general|mesh-ancestor
111377476|NCT02740868|Anesthetics|anesthetics|mesh-ancestor
111377477|NCT02740868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111377478|NCT02740868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111377479|NCT02414958|Empagliflozin|empagliflozin|mesh-list
111377480|NCT02414958|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111377481|NCT02414958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111377482|NCT02414958|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111377483|NCT02414958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111377484|NCT03016208|Misoprostol|misoprostol|mesh-list
111377485|NCT03016208|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111377486|NCT03016208|Abortifacient Agents|abortifacient agents|mesh-ancestor
111377487|NCT03016208|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111377488|NCT03016208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111377489|NCT03016208|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111377490|NCT03016208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111377491|NCT03016208|Oxytocics|oxytocics|mesh-ancestor
111377492|NCT03013790|Melatonin|melatonin|mesh-list
111377493|NCT03013790|Antioxidants|antioxidants|mesh-ancestor
111377494|NCT03013790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111377495|NCT03013790|Protective Agents|protective agents|mesh-ancestor
111377496|NCT03013790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111377497|NCT03013790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111377498|NCT01078376|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
111377499|NCT01078376|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111377500|NCT01078376|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111377501|NCT01078376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111377502|NCT02485184|Propranolol|propranolol|mesh-list
111377503|NCT02485184|Warfarin|warfarin|mesh-list
111377504|NCT02485184|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
111377505|NCT02485184|Anticoagulants|anticoagulants|mesh-ancestor
111377506|NCT02485184|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111377507|NCT02485184|Adrenergic Agents|adrenergic agents|mesh-ancestor
111377508|NCT02485184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111377509|NCT02485184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111377510|NCT02485184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111377511|NCT02485184|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111377512|NCT02485184|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111377513|NCT02485184|Vasodilator Agents|vasodilator agents|mesh-ancestor
111377514|NCT03015818|Calcium|calcium|mesh-list
111377515|NCT03015818|Fluorides|fluorides|mesh-list
111377516|NCT03015818|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111377517|NCT03015818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111377518|NCT03015818|Cariostatic Agents|cariostatic agents|mesh-ancestor
111377519|NCT03015818|Protective Agents|protective agents|mesh-ancestor
111377520|NCT01080248|Gemcitabine|gemcitabine|mesh-list
111377521|NCT01080248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111377522|NCT01080248|Antimetabolites|antimetabolites|mesh-ancestor
111377523|NCT01080248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111377524|NCT01080248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111377525|NCT02452476|Poractant alfa|poractant alfa|mesh-list
111377526|NCT02452476|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
111377527|NCT02452476|Respiratory System Agents|respiratory system agents|mesh-ancestor
111377528|NCT01082588|Pravastatin|pravastatin|mesh-list
111377529|NCT01082588|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111377530|NCT01082588|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111377531|NCT01082588|Antimetabolites|antimetabolites|mesh-ancestor
111377532|NCT01082588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111377533|NCT01082588|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111377534|NCT01082588|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111377535|NCT01082588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111377536|NCT02413398|Dapagliflozin|dapagliflozin|mesh-list
110517298|NCT02814500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111377537|NCT02413398|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111377538|NCT02413398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111377539|NCT02413398|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111377540|NCT02413398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111377541|NCT02441946|Anastrozole|anastrozole|mesh-list
111377542|NCT02441946|Loperamide|loperamide|mesh-list
111377543|NCT02441946|Antidiarrheals|antidiarrheals|mesh-list
111377544|NCT02441946|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111377545|NCT02441946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111377546|NCT02441946|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111377547|NCT02441946|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111377548|NCT02441946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111377549|NCT02441946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111377550|NCT02441946|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111377551|NCT02441946|Hormone Antagonists|hormone antagonists|mesh-ancestor
111377552|NCT02441946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111377553|NCT02441946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111377554|NCT02441946|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111377555|NCT01083368|Sirolimus|sirolimus|mesh-list
111377556|NCT01083368|Bevacizumab|bevacizumab|mesh-list
111377557|NCT01083368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111377558|NCT01083368|Temsirolimus|temsirolimus|mesh-list
111377559|NCT01083368|MTOR Inhibitors|mtor inhibitors|mesh-list
111377560|NCT01083368|Antibodies|antibodies|mesh-list
111377561|NCT01083368|Immunoglobulins|immunoglobulins|mesh-list
111377562|NCT01083368|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111377563|NCT01083368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111377564|NCT01083368|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111377565|NCT01083368|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111377566|NCT01083368|Growth Substances|growth substances|mesh-ancestor
111377567|NCT01083368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111377568|NCT01083368|Growth Inhibitors|growth inhibitors|mesh-ancestor
111377569|NCT01083368|Immunologic Factors|immunologic factors|mesh-ancestor
111377570|NCT01083368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111377571|NCT01083368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111377572|NCT01083368|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111377573|NCT01083368|Antifungal Agents|antifungal agents|mesh-ancestor
111377574|NCT01083368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111377575|NCT01083368|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111377576|NCT01083368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111377577|NCT01083368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111377578|NCT02387580|Artefenomel|artefenomel|mesh-list
111377579|NCT02387580|Antimalarials|antimalarials|mesh-ancestor
111377580|NCT02387580|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111377581|NCT02387580|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111377582|NCT02387580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111377583|NCT02440854|Afatinib|afatinib|mesh-list
111377584|NCT02440854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111377585|NCT02440854|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111377586|NCT02440854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111377587|NCT02440854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111377588|NCT01084148|V0034CR|v0034cr|mesh-list
111377589|NCT01084148|Emollients|emollients|mesh-ancestor
111377590|NCT01084148|Dermatologic Agents|dermatologic agents|mesh-ancestor
111377591|NCT01085006|Tranexamic Acid|tranexamic acid|mesh-list
111377592|NCT01085006|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111377593|NCT01085006|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111377594|NCT01085006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111377595|NCT01085006|Hemostatics|hemostatics|mesh-ancestor
111377596|NCT01085006|Coagulants|coagulants|mesh-ancestor
111377597|NCT01085786|Amoxicillin|amoxicillin|mesh-list
111377598|NCT01085786|Metronidazole|metronidazole|mesh-list
111377599|NCT01085786|Clarithromycin|clarithromycin|mesh-list
111377600|NCT01085786|Esomeprazole|esomeprazole|mesh-list
111377601|NCT01085786|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111377602|NCT01085786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111377603|NCT01085786|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111377604|NCT01085786|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111377605|NCT01085786|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111377606|NCT01085786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111377607|NCT01085786|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111377608|NCT01085786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111377609|NCT01085786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111377610|NCT01085786|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111377611|NCT01085786|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111377612|NCT01085786|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111377613|NCT02170220|Vortioxetine|vortioxetine|mesh-list
111377614|NCT02170220|Antidepressive Agents|antidepressive agents|mesh-ancestor
111377615|NCT02170220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111377616|NCT02170220|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111377617|NCT02170220|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111377618|NCT02170220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111377619|NCT02170220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111377620|NCT02170220|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111377621|NCT02170220|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111377622|NCT02170220|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111377623|NCT02170220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111377624|NCT02170220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111377625|NCT02170220|Serotonin Agents|serotonin agents|mesh-ancestor
111377626|NCT02170220|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111377627|NCT02170220|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111377628|NCT02170220|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111377629|NCT02170220|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111377630|NCT01036802|Warfarin|warfarin|mesh-list
111377631|NCT01036802|Anticoagulants|anticoagulants|mesh-ancestor
111377632|NCT01037192|Vancomycin|vancomycin|mesh-list
111377633|NCT01037192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111377634|NCT01037192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111377635|NCT02386098|Ritonavir|ritonavir|mesh-list
111377636|NCT02386098|Atazanavir Sulfate|atazanavir sulfate|mesh-list
111377637|NCT02386098|Tenofovir|tenofovir|mesh-list
111377638|NCT02386098|Dolutegravir|dolutegravir|mesh-list
111377639|NCT02386098|BMS-955176|bms-955176|mesh-list
111102056|NCT02057458|Sildenafil Citrate|sildenafil citrate|mesh-list
111377640|NCT02386098|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111377641|NCT02386098|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111377642|NCT02386098|Protease Inhibitors|protease inhibitors|mesh-ancestor
111377643|NCT02386098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111377644|NCT02386098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111377645|NCT02386098|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111377646|NCT02386098|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111377647|NCT02386098|Antiviral Agents|antiviral agents|mesh-ancestor
111377648|NCT02386098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111377649|NCT02386098|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111377650|NCT02386098|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111377651|NCT02386098|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111377652|NCT02386098|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111377653|NCT02386098|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111377654|NCT02386098|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111377655|NCT01089062|Dihydroergotamine|dihydroergotamine|mesh-list
111377656|NCT01089062|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111377657|NCT01089062|Dopamine Agonists|dopamine agonists|mesh-ancestor
111377658|NCT01089062|Dopamine Agents|dopamine agents|mesh-ancestor
111377659|NCT01089062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111377660|NCT01089062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111377661|NCT01089062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111377662|NCT01089062|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111377663|NCT01089062|Analgesics|analgesics|mesh-ancestor
111377664|NCT01089062|Sensory System Agents|sensory system agents|mesh-ancestor
111377665|NCT01089062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111377666|NCT02412618|Misoprostol|misoprostol|mesh-list
111377667|NCT02412618|Mifepristone|mifepristone|mesh-list
111377668|NCT02412618|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111377669|NCT02412618|Abortifacient Agents|abortifacient agents|mesh-ancestor
111377670|NCT02412618|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111377671|NCT02412618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111377672|NCT02412618|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111377673|NCT02412618|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111377674|NCT02412618|Oxytocics|oxytocics|mesh-ancestor
111377675|NCT02412618|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
111377676|NCT02412618|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111377677|NCT02412618|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111377678|NCT02412618|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111377679|NCT02412618|Contraceptive Agents|contraceptive agents|mesh-ancestor
111377680|NCT02412618|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
111377681|NCT02412618|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
111377682|NCT02412618|Hormone Antagonists|hormone antagonists|mesh-ancestor
111377683|NCT02412618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111377684|NCT02412618|Luteolytic Agents|luteolytic agents|mesh-ancestor
111377685|NCT02412618|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111377686|NCT02412618|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
111377687|NCT02179892|Acetaminophen|acetaminophen|mesh-list
111377688|NCT02179892|Dexamethasone|dexamethasone|mesh-list
111377689|NCT02179892|Dexamethasone acetate|dexamethasone acetate|mesh-list
111377690|NCT02179892|Bupivacaine|bupivacaine|mesh-list
111377691|NCT02179892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111377692|NCT02179892|Antiemetics|antiemetics|mesh-ancestor
111377693|NCT02179892|Autonomic Agents|autonomic agents|mesh-ancestor
111377694|NCT02179892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111377695|NCT02179892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111377696|NCT02179892|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111377697|NCT02179892|Glucocorticoids|glucocorticoids|mesh-ancestor
111377698|NCT02179892|Hormones|hormones|mesh-ancestor
111377699|NCT02179892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111377700|NCT02179892|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111377701|NCT02179892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111377702|NCT02179892|Anesthetics, Local|anesthetics, local|mesh-ancestor
111377703|NCT02179892|Anesthetics|anesthetics|mesh-ancestor
111377704|NCT02179892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111377705|NCT02179892|Sensory System Agents|sensory system agents|mesh-ancestor
111377706|NCT02179892|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111377707|NCT02179892|Analgesics|analgesics|mesh-ancestor
111377708|NCT02179892|Antipyretics|antipyretics|mesh-ancestor
111377709|NCT01092338|Vitamin D|vitamin d|mesh-list
110517485|NCT05787509|Progesterone|progesterone|mesh-list
111377710|NCT01092338|Cholecalciferol|cholecalciferol|mesh-list
111377711|NCT01092338|Vitamins|vitamins|mesh-ancestor
111377712|NCT01092338|Micronutrients|micronutrients|mesh-ancestor
111377713|NCT01092338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111377714|NCT01092338|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110959228|NCT03523572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111377715|NCT01092338|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111377716|NCT01110434|Topiramate|topiramate|mesh-list
111377717|NCT01110434|Anticonvulsants|anticonvulsants|mesh-ancestor
111377718|NCT01110434|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111377719|NCT01110434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111377720|NCT01042496|Lamotrigine|lamotrigine|mesh-list
111377721|NCT01042496|Anticonvulsants|anticonvulsants|mesh-ancestor
111377722|NCT01042496|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111377723|NCT01042496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111377724|NCT01042496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111377725|NCT01042496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111377726|NCT01042496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111377727|NCT01042496|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111377728|NCT01042496|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111377729|NCT01042496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111377730|NCT01042496|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111377731|NCT01042496|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111377732|NCT01111058|Everolimus|everolimus|mesh-list
111377733|NCT01111058|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111377734|NCT01111058|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111377735|NCT01111058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111377736|NCT01111058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111377737|NCT01111058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111377738|NCT01111058|Immunologic Factors|immunologic factors|mesh-ancestor
111377739|NCT01111058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111377740|NCT01111058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111377741|NCT01094522|Morphine|morphine|mesh-list
111377742|NCT01094522|Methadone|methadone|mesh-list
111377743|NCT01094522|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111377744|NCT01094522|Narcotics|narcotics|mesh-ancestor
111377745|NCT01094522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111377746|NCT01094522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111377747|NCT01094522|Analgesics|analgesics|mesh-ancestor
111377748|NCT01094522|Sensory System Agents|sensory system agents|mesh-ancestor
111377749|NCT01094522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111377750|NCT01094522|Antitussive Agents|antitussive agents|mesh-ancestor
111377751|NCT01094522|Respiratory System Agents|respiratory system agents|mesh-ancestor
111377752|NCT02178800|Cabotegravir|cabotegravir|mesh-list
111377753|NCT02178800|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111377754|NCT02178800|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111377755|NCT02178800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111377756|NCT02178800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111377757|NCT02178800|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110164950|NCT00022126|Antiemetics|antiemetics|mesh-ancestor
111377758|NCT02178800|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111377759|NCT02178800|Antiviral Agents|antiviral agents|mesh-ancestor
111377760|NCT02178800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111377761|NCT01044212|Psyllium|psyllium|mesh-list
111377762|NCT01044212|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
111377763|NCT01044212|Cathartics|cathartics|mesh-ancestor
111377764|NCT01044212|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111377765|NCT01044212|Antidiarrheals|antidiarrheals|mesh-ancestor
111377766|NCT02174510|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
111377767|NCT02174510|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111377768|NCT02174510|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111377769|NCT02174510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111377770|NCT02174510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111377771|NCT02174510|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111377772|NCT02174510|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
111377773|NCT02174510|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111377774|NCT02174510|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111377775|NCT02174510|Adrenergic Agents|adrenergic agents|mesh-ancestor
111377776|NCT02174510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111377777|NCT02174510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111377778|NCT02174510|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111377779|NCT02174510|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111377780|NCT02174510|Serotonin Agents|serotonin agents|mesh-ancestor
111377781|NCT02174510|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111377782|NCT02174510|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111377783|NCT02174510|Dopamine Agents|dopamine agents|mesh-ancestor
111377784|NCT00585195|Itraconazole|itraconazole|mesh-list
111377785|NCT00585195|Rifampin|rifampin|mesh-list
111377786|NCT00585195|Crizotinib|crizotinib|mesh-list
111377787|NCT00585195|Antifungal Agents|antifungal agents|mesh-ancestor
111377788|NCT00585195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111377789|NCT00585195|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111377790|NCT00585195|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111377791|NCT00585195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111377792|NCT00585195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111377793|NCT00585195|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111377794|NCT00585195|Hormone Antagonists|hormone antagonists|mesh-ancestor
111377795|NCT00585195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111377796|NCT00585195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111377797|NCT00585195|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111377798|NCT00585195|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111377799|NCT00585195|Antitubercular Agents|antitubercular agents|mesh-ancestor
111377800|NCT00585195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111377801|NCT00585195|Leprostatic Agents|leprostatic agents|mesh-ancestor
111377802|NCT00585195|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111377803|NCT00585195|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111377804|NCT00585195|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111377805|NCT00585195|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
111377806|NCT00585195|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
111377807|NCT00585195|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
111377808|NCT00585195|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111377809|NCT00585195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111377810|NCT00585195|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111377811|NCT01113398|Bevacizumab|bevacizumab|mesh-list
111377812|NCT01113398|Rilotumumab|rilotumumab|mesh-list
111377813|NCT01113398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111377814|NCT01113398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111377815|NCT01113398|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111377816|NCT01113398|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111377817|NCT01113398|Growth Substances|growth substances|mesh-ancestor
111377818|NCT01113398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111377819|NCT01113398|Growth Inhibitors|growth inhibitors|mesh-ancestor
111377820|NCT03013556|Tenofovir|tenofovir|mesh-list
111377821|NCT03013556|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
111377822|NCT03013556|Interferon-alpha|interferon-alpha|mesh-list
111377823|NCT03013556|Antiviral Agents|antiviral agents|mesh-ancestor
111377824|NCT03013556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111377825|NCT03013556|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111377826|NCT03013556|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111377827|NCT03013556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111377828|NCT03013556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111377829|NCT03013556|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111377830|NCT03013556|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111377831|NCT03013556|Immunologic Factors|immunologic factors|mesh-ancestor
111377832|NCT03013556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111377833|NCT01113632|Ofatumumab|ofatumumab|mesh-list
111377834|NCT01113632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111377835|NCT00458835|Ciclesonide|ciclesonide|mesh-list
111377836|NCT00458835|Glucocorticoids|glucocorticoids|mesh-ancestor
111377837|NCT00458835|Hormones|hormones|mesh-ancestor
111377838|NCT00458835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111377839|NCT00458835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111377840|NCT00458835|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111377841|NCT01044758|Levetiracetam|levetiracetam|mesh-list
111377842|NCT01044758|Anticonvulsants|anticonvulsants|mesh-ancestor
111377843|NCT01044758|Nootropic Agents|nootropic agents|mesh-ancestor
111377844|NCT01115582|Cholic Acids|cholic acids|mesh-list
111377845|NCT01115582|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111377846|NCT03013400|Ebselen|ebselen|mesh-list
111377847|NCT03013400|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111377848|NCT03013400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111377849|NCT03013400|Analgesics|analgesics|mesh-ancestor
111377850|NCT03013400|Sensory System Agents|sensory system agents|mesh-ancestor
111377851|NCT03013400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111377852|NCT03013400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111377853|NCT03013400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111377854|NCT03013400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111377855|NCT03013400|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111377856|NCT03013400|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111377857|NCT03013400|Antioxidants|antioxidants|mesh-ancestor
111377858|NCT03013400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111377859|NCT03013400|Protective Agents|protective agents|mesh-ancestor
111377860|NCT03013400|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111377861|NCT03013400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111377862|NCT03013400|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111377863|NCT02439138|Idelalisib|idelalisib|mesh-list
111377864|NCT02439138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111377865|NCT02439138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111377866|NCT02439138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111377867|NCT01097642|Cetuximab|cetuximab|mesh-list
111377868|NCT01097642|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111377869|NCT01097642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111377870|NCT01048658|Sevoflurane|sevoflurane|mesh-list
111377871|NCT01048658|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111377872|NCT01048658|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111377873|NCT01048658|Anesthetics, General|anesthetics, general|mesh-ancestor
111377874|NCT01048658|Anesthetics|anesthetics|mesh-ancestor
111377875|NCT01048658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111377876|NCT01048658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111377877|NCT04341675|Sirolimus|sirolimus|mesh-list
111377878|NCT04341675|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111377879|NCT04341675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111377880|NCT04341675|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111377881|NCT04341675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111377882|NCT04341675|Antifungal Agents|antifungal agents|mesh-ancestor
111377883|NCT04341675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111377884|NCT04341675|Immunologic Factors|immunologic factors|mesh-ancestor
111377885|NCT04341675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111377886|NCT02445807|Clobetasol|clobetasol|mesh-list
111377887|NCT02445807|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111377888|NCT02445807|Glucocorticoids|glucocorticoids|mesh-ancestor
111377889|NCT02445807|Hormones|hormones|mesh-ancestor
111377890|NCT02445807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111377891|NCT02445807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111377892|NCT00362973|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
111377893|NCT00362973|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111377894|NCT00362973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111377895|NCT01116986|Nicotine|nicotine|mesh-list
111377896|NCT01116986|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111377897|NCT01116986|Autonomic Agents|autonomic agents|mesh-ancestor
111377898|NCT01116986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111377899|NCT01116986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111377900|NCT01116986|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111377901|NCT01116986|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111377902|NCT01116986|Cholinergic Agents|cholinergic agents|mesh-ancestor
111377903|NCT01116986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111377904|NCT01116986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111377905|NCT01098500|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
111377906|NCT01098500|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111377907|NCT01098500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111377908|NCT01098500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111377909|NCT01099202|Epoetin Alfa|epoetin alfa|mesh-list
111377910|NCT01099202|Hematinics|hematinics|mesh-ancestor
111377911|NCT02448303|Pembrolizumab|pembrolizumab|mesh-list
111377912|NCT02448303|Acalabrutinib|acalabrutinib|mesh-list
111377913|NCT02448303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111377914|NCT02448303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111377915|NCT02448303|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111377916|NCT02448303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111377917|NCT02415855|Dabigatran|dabigatran|mesh-list
111377918|NCT02415855|Antithrombins|antithrombins|mesh-ancestor
111377919|NCT02415855|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111377920|NCT02415855|Protease Inhibitors|protease inhibitors|mesh-ancestor
111377921|NCT02415855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111377922|NCT02415855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111377923|NCT02415855|Anticoagulants|anticoagulants|mesh-ancestor
111377924|NCT00363285|Cyproterone Acetate|cyproterone acetate|mesh-list
111377925|NCT00363285|Hormones|hormones|mesh-list
111377926|NCT00363285|Cyproterone|cyproterone|mesh-list
111377927|NCT00363285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111377928|NCT00363285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111377929|NCT00363285|Androgen Antagonists|androgen antagonists|mesh-ancestor
111377930|NCT00363285|Hormone Antagonists|hormone antagonists|mesh-ancestor
111377931|NCT00363285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111377932|NCT00363285|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
111377933|NCT00363285|Contraceptive Agents|contraceptive agents|mesh-ancestor
111377934|NCT00363285|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111377935|NCT02424357|Povidone-Iodine|povidone-iodine|mesh-list
111377936|NCT02424357|Povidone|povidone|mesh-list
111377937|NCT02424357|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111377938|NCT02424357|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111377940|NCT02424357|Blood Substitutes|blood substitutes|mesh-ancestor
111377941|NCT02424357|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111377942|NCT02424357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111377943|NCT02425449|Succinylcholine|succinylcholine|mesh-list
111377944|NCT02425449|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
111377945|NCT02425449|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
111377946|NCT02425449|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111377947|NCT02425449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111377948|NCT02425449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111377949|NCT02455167|Ribavirin|ribavirin|mesh-list
111377950|NCT02455167|Sofosbuvir|sofosbuvir|mesh-list
111377951|NCT02455167|Antimetabolites|antimetabolites|mesh-ancestor
111377952|NCT02455167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111377953|NCT02455167|Antiviral Agents|antiviral agents|mesh-ancestor
111377954|NCT02455167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111377955|NCT02434497|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111377956|NCT02434497|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111377957|NCT02434497|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111377958|NCT02434497|Antimetabolites|antimetabolites|mesh-ancestor
111377959|NCT02434497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111377960|NCT02434497|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111377961|NCT02434497|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111377962|NCT02434497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111377963|NCT02435901|Cyclosporine|cyclosporine|mesh-list
111377964|NCT02435901|Mycophenolic Acid|mycophenolic acid|mesh-list
111377965|NCT02435901|Fludarabine|fludarabine|mesh-list
111377966|NCT02435901|Melphalan|melphalan|mesh-list
111377967|NCT02435901|Alemtuzumab|alemtuzumab|mesh-list
111377968|NCT02435901|Tacrolimus|tacrolimus|mesh-list
111377969|NCT02435901|Cyclosporins|cyclosporins|mesh-list
111377970|NCT02435901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111377971|NCT02435901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111377972|NCT02435901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111377973|NCT02435901|Immunologic Factors|immunologic factors|mesh-ancestor
111377974|NCT02435901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111377975|NCT02435901|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111377976|NCT02435901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111377977|NCT02435901|Antifungal Agents|antifungal agents|mesh-ancestor
111377978|NCT02435901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111377979|NCT02435901|Dermatologic Agents|dermatologic agents|mesh-ancestor
111377980|NCT02435901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111377981|NCT02435901|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111377982|NCT02435901|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111377983|NCT02435901|Antitubercular Agents|antitubercular agents|mesh-ancestor
111377984|NCT02435901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111377985|NCT02435901|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111377986|NCT02435901|Alkylating Agents|alkylating agents|mesh-ancestor
111377987|NCT02435901|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111377988|NCT02435901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111377989|NCT02437383|Propranolol|propranolol|mesh-list
111377990|NCT02437383|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111377991|NCT02437383|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111377992|NCT02437383|Adrenergic Agents|adrenergic agents|mesh-ancestor
111377993|NCT02437383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111377994|NCT02437383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111377995|NCT02437383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111377996|NCT02437383|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111377997|NCT02437383|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111377998|NCT02437383|Vasodilator Agents|vasodilator agents|mesh-ancestor
111377999|NCT02385708|Chlorhexidine|chlorhexidine|mesh-list
111378000|NCT02385708|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
111378001|NCT02385708|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111378002|NCT02385708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111378003|NCT02385708|Disinfectants|disinfectants|mesh-ancestor
111378004|NCT02385708|Dermatologic Agents|dermatologic agents|mesh-ancestor
111378005|NCT01099358|Fluorouracil|fluorouracil|mesh-list
111378006|NCT01099358|Cetuximab|cetuximab|mesh-list
111378007|NCT01099358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111378008|NCT01099358|Antimetabolites|antimetabolites|mesh-ancestor
111378009|NCT01099358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111378010|NCT01099358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111378011|NCT01099358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111378012|NCT01099358|Immunologic Factors|immunologic factors|mesh-ancestor
111378013|NCT01099358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111378014|NCT01099358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111378015|NCT01118624|Vitamins|vitamins|mesh-list
111378016|NCT01118624|Folic Acid|folic acid|mesh-list
111378017|NCT01118624|Vitamin B 12|vitamin b 12|mesh-list
111378018|NCT01118624|Vitamin B Complex|vitamin b complex|mesh-list
111378019|NCT01118624|10-deazaaminopterin|10-deazaaminopterin|mesh-list
111378020|NCT01118624|Aminopterin|aminopterin|mesh-list
111378021|NCT01118624|Micronutrients|micronutrients|mesh-ancestor
111378022|NCT01118624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111378023|NCT01118624|Hematinics|hematinics|mesh-ancestor
111378024|NCT01118624|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111378025|NCT01118624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111378026|NCT01118624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111378027|NCT01118624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111378028|NCT02439879|Thioctic Acid|thioctic acid|mesh-list
111378029|NCT02439879|Antioxidants|antioxidants|mesh-ancestor
111378030|NCT02439879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111378031|NCT02439879|Protective Agents|protective agents|mesh-ancestor
111378032|NCT02439879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111378033|NCT02439879|Vitamin B Complex|vitamin b complex|mesh-ancestor
111378034|NCT02439879|Vitamins|vitamins|mesh-ancestor
111378035|NCT02439879|Micronutrients|micronutrients|mesh-ancestor
111378036|NCT03371108|Insulin Glargine|insulin glargine|mesh-list
111378037|NCT03371108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111378038|NCT03371108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111378039|NCT01100606|Pancrelipase|pancrelipase|mesh-list
111378040|NCT01100606|Pancreatin|pancreatin|mesh-list
111378041|NCT01100606|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111378042|NCT03013010|Oxaliplatin|oxaliplatin|mesh-list
111378043|NCT03013010|Tegafur|tegafur|mesh-list
111378044|NCT03013010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111378045|NCT03013010|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111378046|NCT03013010|Antimetabolites|antimetabolites|mesh-ancestor
111378047|NCT03013010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111378048|NCT02518191|Goserelin|goserelin|mesh-list
111378049|NCT02518191|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111378050|NCT02518191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111378051|NCT01119794|Bortezomib|bortezomib|mesh-list
111378052|NCT01119794|Ofatumumab|ofatumumab|mesh-list
111378053|NCT01119794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111378054|NCT02926196|Avelumab|avelumab|mesh-list
111378055|NCT02926196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111378056|NCT02926196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111378057|NCT01103414|Pioglitazone|pioglitazone|mesh-list
111378058|NCT01103414|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111378059|NCT01103414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111378060|NCT02180828|Fluconazole|fluconazole|mesh-list
111378061|NCT02180828|Clotrimazole|clotrimazole|mesh-list
111378062|NCT02180828|Miconazole|miconazole|mesh-list
111378063|NCT02180828|Antifungal Agents|antifungal agents|mesh-ancestor
111378064|NCT02180828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111378065|NCT02180828|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111378066|NCT02180828|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111378067|NCT02180828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111378068|NCT02180828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111378069|NCT02180828|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111378070|NCT02180828|Hormone Antagonists|hormone antagonists|mesh-ancestor
111378071|NCT02180828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111378072|NCT02180828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111378073|NCT02180828|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111378074|NCT02180828|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111378075|NCT02180828|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111378076|NCT02180828|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111378077|NCT02525523|Alicaforsen|alicaforsen|mesh-list
111378078|NCT02525523|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111378079|NCT02525523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111378080|NCT02525523|Immunologic Factors|immunologic factors|mesh-ancestor
111378081|NCT02525523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111378082|NCT02528409|Vortioxetine|vortioxetine|mesh-list
111378083|NCT02528409|Antidepressive Agents|antidepressive agents|mesh-ancestor
111378084|NCT02528409|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111378085|NCT02528409|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111378086|NCT02528409|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111378087|NCT02528409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111378088|NCT02528409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111102521|NCT03176849|Vitamin D|vitamin d|mesh-list
111378089|NCT02528409|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111378090|NCT02528409|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111378091|NCT02528409|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111378092|NCT02528409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111378093|NCT02528409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111378094|NCT02528409|Serotonin Agents|serotonin agents|mesh-ancestor
111378095|NCT02528409|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111378096|NCT02528409|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111378097|NCT02528409|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111378098|NCT02528409|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111378099|NCT02530281|Glycopyrrolate|glycopyrrolate|mesh-list
111378100|NCT02530281|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111378101|NCT02530281|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111378102|NCT02530281|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111378103|NCT02530281|Cholinergic Agents|cholinergic agents|mesh-ancestor
111378104|NCT02530281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111378105|NCT02530281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111378106|NCT02530281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111378107|NCT03013634|Dexmedetomidine|dexmedetomidine|mesh-list
111378108|NCT03013634|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111378109|NCT03013634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111378110|NCT03013634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111378111|NCT03013634|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111378112|NCT03013634|Analgesics|analgesics|mesh-ancestor
111378113|NCT03013634|Sensory System Agents|sensory system agents|mesh-ancestor
111378114|NCT03013634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111378115|NCT03013634|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111378116|NCT03013634|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111378117|NCT03013634|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111378118|NCT03013634|Adrenergic Agents|adrenergic agents|mesh-ancestor
111378119|NCT03013634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111378120|NCT03013634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111378121|NCT02980094|Vitamins|vitamins|mesh-list
111378122|NCT02980094|Vitamin E|vitamin e|mesh-list
111378123|NCT02980094|Tocopherols|tocopherols|mesh-list
111378124|NCT02980094|Tocotrienols|tocotrienols|mesh-list
111378125|NCT02980094|alpha-Tocopherol|alpha-tocopherol|mesh-list
111378126|NCT02980094|Selenium|selenium|mesh-list
111378127|NCT02980094|Antioxidants|antioxidants|mesh-list
111378128|NCT02980094|Micronutrients|micronutrients|mesh-ancestor
111378129|NCT02980094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111378130|NCT02980094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111378131|NCT02980094|Protective Agents|protective agents|mesh-ancestor
111378132|NCT02980094|Trace Elements|trace elements|mesh-ancestor
111378133|NCT03013322|Physostigmine|physostigmine|mesh-list
111378134|NCT03013322|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111378135|NCT03013322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111378136|NCT03013322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111378137|NCT03013322|Cholinergic Agents|cholinergic agents|mesh-ancestor
111378138|NCT03013322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111378139|NCT03013322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111378140|NCT03013322|Miotics|miotics|mesh-ancestor
111378141|NCT03013322|Autonomic Agents|autonomic agents|mesh-ancestor
111378142|NCT03013322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111378143|NCT02469597|Furosemide|furosemide|mesh-list
111378144|NCT02469597|Diuretics|diuretics|mesh-ancestor
111378145|NCT02469597|Natriuretic Agents|natriuretic agents|mesh-ancestor
111378146|NCT02469597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111378147|NCT02469597|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
111378148|NCT02469597|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111378149|NCT02469597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111378150|NCT02183792|Furosemide|furosemide|mesh-list
111378151|NCT02183792|Tolvaptan|tolvaptan|mesh-list
111378152|NCT02183792|Diuretics|diuretics|mesh-ancestor
111378153|NCT02183792|Natriuretic Agents|natriuretic agents|mesh-ancestor
111378154|NCT02183792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111378155|NCT02183792|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
111378156|NCT02183792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111378157|NCT02183792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111378158|NCT02183792|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
111378159|NCT00363519|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111378160|NCT00363519|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111378161|NCT00363519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111378162|NCT00363519|Incretins|incretins|mesh-ancestor
111102589|NCT04272801|Tamoxifen|tamoxifen|mesh-list
111378163|NCT00363519|Hormones|hormones|mesh-ancestor
111378164|NCT00363519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111378165|NCT00363519|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111378166|NCT00363519|Protease Inhibitors|protease inhibitors|mesh-ancestor
111378167|NCT00363519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111378168|NCT00363519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111378169|NCT04743687|Zanubrutinib|zanubrutinib|mesh-list
111378170|NCT04743687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111378171|NCT04743687|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111378172|NCT04743687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111378173|NCT04743687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111378174|NCT02542761|Carbon Fiber|carbon fiber|mesh-list
111378175|NCT02542761|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111378176|NCT02542761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111378177|NCT02475837|Vorapaxar|vorapaxar|mesh-list
111378178|NCT02475837|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111378179|NCT01124786|Gemcitabine|gemcitabine|mesh-list
111378180|NCT01124786|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111378181|NCT01124786|Antimetabolites|antimetabolites|mesh-ancestor
111378182|NCT01124786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111378183|NCT01124786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111378184|NCT01125098|Amoxicillin|amoxicillin|mesh-list
111378185|NCT01125098|Clavulanic Acid|clavulanic acid|mesh-list
111378186|NCT01125098|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
111378187|NCT01125098|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111378188|NCT01125098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111378189|NCT01125098|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
111378190|NCT01125098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111378191|NCT01125098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111378192|NCT02478489|Naltrexone|naltrexone|mesh-list
111378193|NCT02478489|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111378194|NCT02478489|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111378195|NCT02478489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111378196|NCT02478489|Sensory System Agents|sensory system agents|mesh-ancestor
111378197|NCT02478489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111378198|NCT02322320|Lenalidomide|lenalidomide|mesh-list
111378199|NCT02322320|Immunologic Factors|immunologic factors|mesh-ancestor
111378200|NCT02322320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111378201|NCT02322320|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111378202|NCT02322320|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111378203|NCT02322320|Growth Substances|growth substances|mesh-ancestor
111378204|NCT02322320|Growth Inhibitors|growth inhibitors|mesh-ancestor
111378205|NCT02322320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111378206|NCT05308160|Dapagliflozin|dapagliflozin|mesh-list
111378207|NCT05308160|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111378208|NCT05308160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111378209|NCT05308160|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111378210|NCT05308160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111378211|NCT01127438|Fospropofol|fospropofol|mesh-list
111378212|NCT01127438|Propofol|propofol|mesh-list
111378213|NCT01127438|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111378214|NCT01127438|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111378215|NCT01127438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111378216|NCT01127438|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111378217|NCT01127438|Anesthetics, General|anesthetics, general|mesh-ancestor
111378218|NCT01127438|Anesthetics|anesthetics|mesh-ancestor
111378219|NCT05307614|Moxifloxacin|moxifloxacin|mesh-list
111378220|NCT05307614|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
111378221|NCT05307614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111378222|NCT05307614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111378223|NCT05307614|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111378224|NCT05307614|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111378225|NCT05307614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111378226|NCT05307614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111378227|NCT05307614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111378228|NCT05307614|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111378229|NCT05307614|Contraceptive Agents|contraceptive agents|mesh-ancestor
111378230|NCT05307614|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111378231|NCT05307614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111378232|NCT05307614|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
111378233|NCT05307614|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111378234|NCT05307614|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111378235|NCT02481219|Erythromycin|erythromycin|mesh-list
111378237|NCT02481219|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
111378238|NCT02481219|Erythromycin stearate|erythromycin stearate|mesh-list
111378239|NCT02481219|Metoclopramide|metoclopramide|mesh-list
111378240|NCT02481219|Bisacodyl|bisacodyl|mesh-list
111378241|NCT02481219|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111378242|NCT02481219|Antiemetics|antiemetics|mesh-ancestor
111378243|NCT02481219|Autonomic Agents|autonomic agents|mesh-ancestor
111378244|NCT02481219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111378245|NCT02481219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111378246|NCT02481219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111378247|NCT02481219|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111378248|NCT02481219|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111378249|NCT02481219|Dopamine Agents|dopamine agents|mesh-ancestor
111378250|NCT02481219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111378251|NCT02481219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111378252|NCT02481219|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111378253|NCT02481219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111378254|NCT02481219|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111378255|NCT02481219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111378256|NCT02481219|Cathartics|cathartics|mesh-ancestor
111378257|NCT02481219|Laxatives|laxatives|mesh-ancestor
111378258|NCT02481297|Rituximab|rituximab|mesh-list
111378259|NCT02481297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111378260|NCT02481297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111378261|NCT02481297|Immunologic Factors|immunologic factors|mesh-ancestor
111378262|NCT02481297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111378263|NCT02481297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111378264|NCT02481375|Iron|iron|mesh-list
111378265|NCT02481375|Trace Elements|trace elements|mesh-list
111378266|NCT02481375|Micronutrients|micronutrients|mesh-list
111378267|NCT02481375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111378268|NCT01164098|Rituximab|rituximab|mesh-list
111378269|NCT01164098|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111378270|NCT01164098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111378271|NCT01164098|Immunologic Factors|immunologic factors|mesh-ancestor
111378272|NCT01164098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111378273|NCT01164098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111378274|NCT01165112|Rituximab|rituximab|mesh-list
111378275|NCT01165112|Carboplatin|carboplatin|mesh-list
111378276|NCT01165112|Etoposide|etoposide|mesh-list
111378277|NCT01165112|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
111378278|NCT01165112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111378279|NCT01165112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111378280|NCT01165112|Immunologic Factors|immunologic factors|mesh-ancestor
111378281|NCT01165112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111378282|NCT01165112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111378283|NCT01165112|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111378284|NCT01165112|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111378285|NCT01165112|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111378286|NCT01165112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111378287|NCT01165112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111378288|NCT01165112|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111378289|NCT01165112|Alkylating Agents|alkylating agents|mesh-ancestor
111378290|NCT01129778|Omeprazole|omeprazole|mesh-list
111378291|NCT01129778|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
111378292|NCT01129778|Omeprazole, sodium bicarbonate drug combination|omeprazole, sodium bicarbonate drug combination|mesh-list
111378293|NCT01129778|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111378294|NCT01129778|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111378295|NCT01129778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111378296|NCT01129778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111378297|NCT02556333|Tenofovir|tenofovir|mesh-list
111378298|NCT02556333|Emtricitabine|emtricitabine|mesh-list
111378299|NCT02556333|Antiviral Agents|antiviral agents|mesh-ancestor
111378300|NCT02556333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111378301|NCT02556333|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111378302|NCT02556333|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111378303|NCT02556333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111378304|NCT02556333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111378305|NCT02556333|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111378306|NCT02556333|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111378307|NCT01166126|Sirolimus|sirolimus|mesh-list
111378308|NCT01166126|Temsirolimus|temsirolimus|mesh-list
111378309|NCT01166126|MTOR Inhibitors|mtor inhibitors|mesh-list
111378310|NCT01166126|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111378311|NCT01166126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111378312|NCT01166126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111378313|NCT01166126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111378314|NCT01166126|Immunologic Factors|immunologic factors|mesh-ancestor
111378315|NCT01166126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111378316|NCT01166126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111378317|NCT01166126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111378318|NCT01166126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111378319|NCT01166126|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111378320|NCT01166126|Antifungal Agents|antifungal agents|mesh-ancestor
111378321|NCT05306990|Atorvastatin|atorvastatin|mesh-list
111378322|NCT05306990|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111378323|NCT05306990|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111378324|NCT05306990|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111378325|NCT05306990|Antimetabolites|antimetabolites|mesh-ancestor
111378326|NCT05306990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111378327|NCT05306990|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111378328|NCT05306990|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111378329|NCT05306990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111378330|NCT02557035|Dexamethasone|dexamethasone|mesh-list
111378331|NCT02557035|Palonosetron|palonosetron|mesh-list
111378332|NCT02557035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111378333|NCT02557035|Antiemetics|antiemetics|mesh-ancestor
111378334|NCT02557035|Autonomic Agents|autonomic agents|mesh-ancestor
111378335|NCT02557035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111378336|NCT02557035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111378337|NCT02557035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111378338|NCT02557035|Glucocorticoids|glucocorticoids|mesh-ancestor
111378339|NCT02557035|Hormones|hormones|mesh-ancestor
111378340|NCT02557035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111378341|NCT02557035|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111378342|NCT02557035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111378343|NCT02557035|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111378344|NCT02557035|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111378345|NCT02557035|Serotonin Agents|serotonin agents|mesh-ancestor
111378346|NCT02557035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111378347|NCT02557035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111378348|NCT04341207|Azithromycin|azithromycin|mesh-list
111378349|NCT04341207|Hydroxychloroquine|hydroxychloroquine|mesh-list
111378350|NCT04341207|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111378351|NCT04341207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111378352|NCT04341207|Antimalarials|antimalarials|mesh-ancestor
111378353|NCT04341207|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111378354|NCT04341207|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111378355|NCT04341207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111378356|NCT04341207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111378357|NCT04341207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111378358|NCT02411292|Enoxaparin|enoxaparin|mesh-list
111378359|NCT02411292|Anticoagulants|anticoagulants|mesh-ancestor
111378360|NCT02411292|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111378361|NCT02411292|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111378362|NCT02411292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111378363|NCT02486211|Amantadine|amantadine|mesh-list
111378364|NCT02486211|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111378365|NCT02486211|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111378366|NCT02486211|Antiviral Agents|antiviral agents|mesh-ancestor
111378367|NCT02486211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111378368|NCT02486211|Dopamine Agents|dopamine agents|mesh-ancestor
111378369|NCT02486211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111378370|NCT02486211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111378371|NCT02486211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111378372|NCT02486211|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111378373|NCT02486211|Analgesics|analgesics|mesh-ancestor
111378374|NCT02486211|Sensory System Agents|sensory system agents|mesh-ancestor
111378375|NCT02486211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111378376|NCT01167452|Trimethoprim|trimethoprim|mesh-list
111378377|NCT01167452|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
111378378|NCT01167452|Sulfamethoxazole|sulfamethoxazole|mesh-list
111378379|NCT01167452|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111378380|NCT01167452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111378381|NCT01167452|Antimalarials|antimalarials|mesh-ancestor
111378382|NCT01167452|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111378383|NCT01167452|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111378384|NCT01167452|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111378385|NCT01167452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111102814|NCT03748095|Tazobactam|tazobactam|mesh-list
111378386|NCT01167452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111378387|NCT01167452|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111378388|NCT01167452|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
111378389|NCT01167452|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111378390|NCT01167452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111378391|NCT02487225|Pentoxifylline|pentoxifylline|mesh-list
111378392|NCT02487225|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111378393|NCT02487225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111378394|NCT02487225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111378395|NCT02487225|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111378396|NCT02487225|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111378397|NCT02487225|Protective Agents|protective agents|mesh-ancestor
111378398|NCT02487225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111378399|NCT02487225|Vasodilator Agents|vasodilator agents|mesh-ancestor
111378400|NCT02487225|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111378401|NCT02487225|Antioxidants|antioxidants|mesh-ancestor
111378402|NCT02384850|Leucovorin|leucovorin|mesh-list
111378403|NCT02384850|Folic Acid|folic acid|mesh-list
111378404|NCT02384850|Fluorouracil|fluorouracil|mesh-list
111378405|NCT02384850|Oxaliplatin|oxaliplatin|mesh-list
111378406|NCT02384850|Levoleucovorin|levoleucovorin|mesh-list
111378407|NCT02384850|Antimetabolites|antimetabolites|mesh-ancestor
111378408|NCT02384850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111378409|NCT02384850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111378410|NCT02384850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111378411|NCT02384850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111378412|NCT02384850|Immunologic Factors|immunologic factors|mesh-ancestor
111378413|NCT02384850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111378414|NCT02384850|Antidotes|antidotes|mesh-ancestor
111378415|NCT02384850|Protective Agents|protective agents|mesh-ancestor
111378416|NCT02384850|Vitamin B Complex|vitamin b complex|mesh-ancestor
111378417|NCT02384850|Vitamins|vitamins|mesh-ancestor
111378418|NCT02384850|Micronutrients|micronutrients|mesh-ancestor
111378419|NCT02384850|Hematinics|hematinics|mesh-ancestor
111378420|NCT02558829|Insulin|insulin|mesh-list
111378421|NCT02558829|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111378422|NCT02558829|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111378423|NCT02558829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111378424|NCT02487303|Acetaminophen|acetaminophen|mesh-list
111378425|NCT02487303|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111378426|NCT02487303|Analgesics|analgesics|mesh-ancestor
111378427|NCT02487303|Sensory System Agents|sensory system agents|mesh-ancestor
111378428|NCT02487303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111378429|NCT02487303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111378430|NCT02487303|Antipyretics|antipyretics|mesh-ancestor
111378431|NCT01168934|Crizotinib|crizotinib|mesh-list
111378432|NCT01168934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111378433|NCT01168934|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111378434|NCT01168934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111378435|NCT01168934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111378436|NCT05305508|Mannitol|mannitol|mesh-list
111378437|NCT05305508|Calcium Dobesilate|calcium dobesilate|mesh-list
111378438|NCT05305508|Calcium|calcium|mesh-list
111378439|NCT05305508|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111378440|NCT05305508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111378441|NCT05305508|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
111378442|NCT05305508|Diuretics|diuretics|mesh-ancestor
111378443|NCT05305508|Natriuretic Agents|natriuretic agents|mesh-ancestor
111378444|NCT05305508|Hemostatics|hemostatics|mesh-ancestor
111378445|NCT05305508|Coagulants|coagulants|mesh-ancestor
111378446|NCT01170884|Timolol|timolol|mesh-list
111378447|NCT01170884|Brimonidine Tartrate|brimonidine tartrate|mesh-list
111378448|NCT01170884|Bimatoprost|bimatoprost|mesh-list
111378449|NCT01170884|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111378450|NCT01170884|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111378451|NCT01170884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111378452|NCT01170884|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111378453|NCT01170884|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111378454|NCT01170884|Adrenergic Agents|adrenergic agents|mesh-ancestor
111378455|NCT01170884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111378456|NCT01170884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111378457|NCT01170884|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111378458|NCT01170884|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111102880|NCT05481957|Vortioxetine|vortioxetine|mesh-list
111378459|NCT01170884|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111378460|NCT01170884|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111378461|NCT01170884|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111378462|NCT01171118|Physostigmine|physostigmine|mesh-list
111378463|NCT01171118|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111378465|NCT01171118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111378466|NCT01171118|Cholinergic Agents|cholinergic agents|mesh-ancestor
111378467|NCT01171118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111378468|NCT01171118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111378469|NCT01171118|Miotics|miotics|mesh-ancestor
111378470|NCT01171118|Autonomic Agents|autonomic agents|mesh-ancestor
111378471|NCT01171118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111378472|NCT03011918|Vitamin D|vitamin d|mesh-list
111378473|NCT03011918|Vitamins|vitamins|mesh-ancestor
111378474|NCT03011918|Micronutrients|micronutrients|mesh-ancestor
111378475|NCT03011918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111378476|NCT03011918|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111378477|NCT05296460|Dapsone|dapsone|mesh-list
111378478|NCT05296460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111378479|NCT05296460|Antimalarials|antimalarials|mesh-ancestor
111378480|NCT05296460|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111378481|NCT05296460|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111378482|NCT05296460|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111378483|NCT05296460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111378484|NCT05296460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111378485|NCT05296460|Leprostatic Agents|leprostatic agents|mesh-ancestor
111378486|NCT05296460|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111378487|NCT01136798|Exenatide|exenatide|mesh-list
111378488|NCT01136798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111378489|NCT01136798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111378490|NCT01136798|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111378491|NCT01136798|Incretins|incretins|mesh-ancestor
111378492|NCT01136798|Hormones|hormones|mesh-ancestor
111378493|NCT01136798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111378494|NCT01172522|Fexofenadine|fexofenadine|mesh-list
111378495|NCT01172522|Terfenadine|terfenadine|mesh-list
111378496|NCT01172522|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111378497|NCT01172522|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
111378498|NCT01172522|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111378499|NCT01172522|Histamine Antagonists|histamine antagonists|mesh-ancestor
111378500|NCT01172522|Histamine Agents|histamine agents|mesh-ancestor
111378501|NCT01172522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111378502|NCT01172522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111378503|NCT01172522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111378504|NCT01172600|Nitrous Oxide|nitrous oxide|mesh-list
111378505|NCT01172600|Entonox|entonox|mesh-list
111378506|NCT01172600|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111378507|NCT01172600|Anesthetics, General|anesthetics, general|mesh-ancestor
111378508|NCT01172600|Anesthetics|anesthetics|mesh-ancestor
111378509|NCT01172600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111378510|NCT01172600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111378511|NCT01172600|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111378512|NCT01172600|Analgesics|analgesics|mesh-ancestor
111378513|NCT01172600|Sensory System Agents|sensory system agents|mesh-ancestor
111378514|NCT01172600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111378515|NCT01172600|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
111378516|NCT02246816|Opium|opium|mesh-list
111378517|NCT02246816|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111378518|NCT02246816|Narcotics|narcotics|mesh-ancestor
111378519|NCT02246816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111378520|NCT02246816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111378521|NCT02246816|Analgesics|analgesics|mesh-ancestor
111378522|NCT02246816|Sensory System Agents|sensory system agents|mesh-ancestor
111378523|NCT02246816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111378524|NCT02246816|Antidiarrheals|antidiarrheals|mesh-ancestor
111378525|NCT02246816|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111378526|NCT02246816|Antitussive Agents|antitussive agents|mesh-ancestor
111378527|NCT02246816|Respiratory System Agents|respiratory system agents|mesh-ancestor
111378528|NCT01137890|Zonisamide|zonisamide|mesh-list
111378529|NCT01137890|Cocaine|cocaine|mesh-list
111378530|NCT01137890|Anticonvulsants|anticonvulsants|mesh-ancestor
111378531|NCT01137890|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111378532|NCT01137890|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111378533|NCT01137890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111378534|NCT01137890|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111378535|NCT01137890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111378536|NCT01137890|Anesthetics, Local|anesthetics, local|mesh-ancestor
111378537|NCT01137890|Anesthetics|anesthetics|mesh-ancestor
111378538|NCT01137890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111378539|NCT01137890|Sensory System Agents|sensory system agents|mesh-ancestor
111378540|NCT01137890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111378541|NCT01137890|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111378542|NCT01137890|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111378543|NCT01137890|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111378544|NCT01137890|Dopamine Agents|dopamine agents|mesh-ancestor
111378545|NCT01137890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111378546|NCT01138124|Gabapentin|gabapentin|mesh-list
111378547|NCT01138124|Analgesics|analgesics|mesh-ancestor
111378548|NCT01138124|Sensory System Agents|sensory system agents|mesh-ancestor
111378549|NCT01138124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111378550|NCT01138124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111378551|NCT01138124|Anticonvulsants|anticonvulsants|mesh-ancestor
111378552|NCT01138124|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111378553|NCT01138124|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111378554|NCT01138124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111378555|NCT01138124|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111378556|NCT01138124|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111378557|NCT01138124|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111378558|NCT01138124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111378559|NCT01138124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111378560|NCT01138124|Antimanic Agents|antimanic agents|mesh-ancestor
111378561|NCT02560779|Sorafenib|sorafenib|mesh-list
111378562|NCT02560779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111378563|NCT02560779|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111378564|NCT02560779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111378565|NCT02560779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111378566|NCT01138514|Clindamycin|clindamycin|mesh-list
111378567|NCT01138514|Clindamycin palmitate|clindamycin palmitate|mesh-list
111378568|NCT01138514|Clindamycin phosphate|clindamycin phosphate|mesh-list
111378569|NCT01138514|Benzoyl Peroxide|benzoyl peroxide|mesh-list
111378570|NCT01138514|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111378571|NCT01138514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111378572|NCT01138514|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111378573|NCT01138514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111378574|NCT01138514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111378575|NCT01138514|Dermatologic Agents|dermatologic agents|mesh-ancestor
111378576|NCT02561481|Sulforaphane|sulforaphane|mesh-list
111378577|NCT02561481|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
111378578|NCT02561481|Protective Agents|protective agents|mesh-ancestor
111378579|NCT02561481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111378580|NCT02561481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111378581|NCT01173848|Cholecalciferol|cholecalciferol|mesh-list
111378582|NCT01173848|Vitamin D|vitamin d|mesh-list
111378583|NCT01173848|Ergocalciferols|ergocalciferols|mesh-list
111378584|NCT01173848|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111378585|NCT01173848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111378586|NCT01173848|Vitamins|vitamins|mesh-ancestor
111378587|NCT01173848|Micronutrients|micronutrients|mesh-ancestor
111378588|NCT01173848|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111378589|NCT01174082|Vaccines|vaccines|mesh-list
111378590|NCT01174082|Sargramostim|sargramostim|mesh-list
111378591|NCT01174082|Immunologic Factors|immunologic factors|mesh-ancestor
111378592|NCT01174082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111378593|NCT01175798|Vitamin D|vitamin d|mesh-list
111378594|NCT01175798|Cholecalciferol|cholecalciferol|mesh-list
111378595|NCT01175798|Vitamins|vitamins|mesh-ancestor
111378596|NCT01175798|Micronutrients|micronutrients|mesh-ancestor
111378597|NCT01175798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111378598|NCT01175798|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111378599|NCT01175798|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111378600|NCT02246894|Factor VIII|factor viii|mesh-list
111378601|NCT02246894|Coagulants|coagulants|mesh-ancestor
111378602|NCT03011996|Amoxicillin|amoxicillin|mesh-list
111378603|NCT03011996|Clarithromycin|clarithromycin|mesh-list
111378604|NCT03011996|Pantoprazole|pantoprazole|mesh-list
111378605|NCT03011996|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111378606|NCT03011996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111378607|NCT03011996|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111378608|NCT03011996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111378609|NCT03011996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111378610|NCT03011996|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111378611|NCT03011996|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111378612|NCT03011996|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111378613|NCT03011996|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111378614|NCT03011996|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111378615|NCT01178216|Rituximab|rituximab|mesh-list
111378616|NCT01178216|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111378617|NCT01178216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111378618|NCT01178216|Immunologic Factors|immunologic factors|mesh-ancestor
111378619|NCT01178216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111378620|NCT01178216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111378622|NCT01178528|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111378623|NCT01178528|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111378624|NCT01178528|Adrenergic Agents|adrenergic agents|mesh-ancestor
111378625|NCT01178528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111378626|NCT01178528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111378627|NCT01178528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111378628|NCT01178528|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111378629|NCT01178528|Antioxidants|antioxidants|mesh-ancestor
111378630|NCT01178528|Protective Agents|protective agents|mesh-ancestor
111378631|NCT01178528|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111378632|NCT01178528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111378633|NCT01178528|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111378634|NCT01178528|Vasodilator Agents|vasodilator agents|mesh-ancestor
111378635|NCT01178528|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111378636|NCT01178528|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111378637|NCT02980250|Domperidone|domperidone|mesh-list
111378638|NCT02980250|Antiemetics|antiemetics|mesh-ancestor
111378639|NCT02980250|Autonomic Agents|autonomic agents|mesh-ancestor
111378640|NCT02980250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111378641|NCT02980250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111378642|NCT02980250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111378643|NCT02980250|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111378644|NCT02980250|Dopamine Agents|dopamine agents|mesh-ancestor
111378645|NCT02980250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111378646|NCT02980250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111378647|NCT02491437|Progesterone|progesterone|mesh-list
111378648|NCT02491437|Dydrogesterone|dydrogesterone|mesh-list
111378649|NCT02491437|Progestins|progestins|mesh-ancestor
111378650|NCT02491437|Hormones|hormones|mesh-ancestor
111378651|NCT02491437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111378652|NCT02491437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111378653|NCT02383758|Bisacodyl|bisacodyl|mesh-list
111378654|NCT02383758|Glycerol|glycerol|mesh-list
111378655|NCT02383758|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
111378656|NCT02383758|Protective Agents|protective agents|mesh-ancestor
111378657|NCT02383758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111378658|NCT02383758|Cathartics|cathartics|mesh-ancestor
111378659|NCT02383758|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111378660|NCT02383758|Laxatives|laxatives|mesh-ancestor
111378661|NCT02492451|Progesterone|progesterone|mesh-list
111378662|NCT02492451|Progestins|progestins|mesh-ancestor
111378663|NCT02492451|Hormones|hormones|mesh-ancestor
111378664|NCT02492451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111378665|NCT02492451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111378666|NCT02410278|Dimethyl Fumarate|dimethyl fumarate|mesh-list
111378667|NCT02410278|Montelukast|montelukast|mesh-list
111378668|NCT02410278|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111378669|NCT02410278|Respiratory System Agents|respiratory system agents|mesh-ancestor
111378670|NCT02410278|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
111378671|NCT02410278|Hormone Antagonists|hormone antagonists|mesh-ancestor
111378672|NCT02410278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111378673|NCT02410278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111378674|NCT02410278|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
111378675|NCT02410278|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111378676|NCT02410278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111378677|NCT02410278|Dermatologic Agents|dermatologic agents|mesh-ancestor
111378678|NCT02410278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111378679|NCT02410278|Immunologic Factors|immunologic factors|mesh-ancestor
111378680|NCT01181258|Methylprednisolone|methylprednisolone|mesh-list
111378681|NCT01181258|Cyclophosphamide|cyclophosphamide|mesh-list
111378682|NCT01181258|Rituximab|rituximab|mesh-list
111378683|NCT01181258|Fludarabine|fludarabine|mesh-list
111378684|NCT01181258|Interleukin-2|interleukin-2|mesh-list
111378685|NCT01181258|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111378686|NCT01181258|Immunologic Factors|immunologic factors|mesh-ancestor
111378687|NCT01181258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111378688|NCT01181258|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111378689|NCT01181258|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111378690|NCT01181258|Alkylating Agents|alkylating agents|mesh-ancestor
111378691|NCT01181258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111378692|NCT01181258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111378693|NCT01181258|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111378694|NCT01181258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111378695|NCT01181258|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111378696|NCT01181258|Antiemetics|antiemetics|mesh-ancestor
111378697|NCT01181258|Autonomic Agents|autonomic agents|mesh-ancestor
111378698|NCT01181258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111378699|NCT01181258|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111378700|NCT01181258|Glucocorticoids|glucocorticoids|mesh-ancestor
111378701|NCT01181258|Hormones|hormones|mesh-ancestor
111378702|NCT01181258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111378703|NCT01181258|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111378704|NCT01181258|Protective Agents|protective agents|mesh-ancestor
111378705|NCT01181258|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111378706|NCT01181258|Analgesics|analgesics|mesh-ancestor
111378707|NCT01181258|Sensory System Agents|sensory system agents|mesh-ancestor
111378708|NCT02570139|Protective Agents|protective agents|mesh-list
111378709|NCT02570139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111378710|NCT02410200|Dimethyl Fumarate|dimethyl fumarate|mesh-list
111378711|NCT02410200|Dermatologic Agents|dermatologic agents|mesh-ancestor
111378712|NCT02410200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111378713|NCT02410200|Immunologic Factors|immunologic factors|mesh-ancestor
111378714|NCT02410200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111378715|NCT02409732|Aminolevulinic Acid|aminolevulinic acid|mesh-list
111378716|NCT02409732|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111378717|NCT02409732|Dermatologic Agents|dermatologic agents|mesh-ancestor
111378718|NCT02494713|Ketoconazole|ketoconazole|mesh-list
111378719|NCT02494713|Docetaxel|docetaxel|mesh-list
111378720|NCT02494713|Doxorubicin|doxorubicin|mesh-list
111378721|NCT02494713|Estramustine|estramustine|mesh-list
111378722|NCT02494713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111378723|NCT02494713|Tubulin Modulators|tubulin modulators|mesh-ancestor
111378724|NCT02494713|Antimitotic Agents|antimitotic agents|mesh-ancestor
111378725|NCT02494713|Mitosis Modulators|mitosis modulators|mesh-ancestor
111378726|NCT02494713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111378727|NCT02494713|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111378728|NCT02494713|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111378729|NCT02494713|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111378730|NCT02494713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111378731|NCT02494713|Antifungal Agents|antifungal agents|mesh-ancestor
111378732|NCT02494713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111378733|NCT02494713|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111378734|NCT02494713|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111378735|NCT02494713|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111378736|NCT02494713|Hormone Antagonists|hormone antagonists|mesh-ancestor
111378737|NCT02494713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111378738|NCT02494713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111378739|NCT02494713|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111378740|NCT02494713|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111378741|NCT02494713|Alkylating Agents|alkylating agents|mesh-ancestor
111378742|NCT02494713|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111378743|NCT02495103|Metformin|metformin|mesh-list
111378744|NCT02495103|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111378745|NCT02495103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111378746|NCT02382276|Nalmefene|nalmefene|mesh-list
111378747|NCT02382276|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111378748|NCT02382276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111378749|NCT02382276|Sensory System Agents|sensory system agents|mesh-ancestor
111378750|NCT02382276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111378751|NCT02571153|Ketamine|ketamine|mesh-list
111378752|NCT02571153|Analgesics|analgesics|mesh-ancestor
111378753|NCT02571153|Sensory System Agents|sensory system agents|mesh-ancestor
111378754|NCT02571153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111378755|NCT02571153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111378756|NCT02571153|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111378757|NCT02571153|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111378758|NCT02571153|Anesthetics, General|anesthetics, general|mesh-ancestor
111378759|NCT02571153|Anesthetics|anesthetics|mesh-ancestor
111378760|NCT02571153|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111378761|NCT02571153|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111378762|NCT02571153|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111378763|NCT02571153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111378764|NCT02571153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111378765|NCT04573322|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
111378767|NCT04573322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111378768|NCT04573322|Protective Agents|protective agents|mesh-ancestor
111378769|NCT04573322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111378770|NCT04573322|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
111378771|NCT04573322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111378772|NCT01143818|Methyltestosterone|methyltestosterone|mesh-list
111378773|NCT01143818|Testosterone|testosterone|mesh-list
111378774|NCT01143818|Testosterone undecanoate|testosterone undecanoate|mesh-list
111378775|NCT01143818|Testosterone enanthate|testosterone enanthate|mesh-list
111378776|NCT01143818|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
111378777|NCT01143818|Androgens|androgens|mesh-ancestor
111378778|NCT01143818|Hormones|hormones|mesh-ancestor
111378779|NCT01143818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111378780|NCT01143818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111378781|NCT01143818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111378782|NCT01143818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111378783|NCT01143818|Anabolic Agents|anabolic agents|mesh-ancestor
111378784|NCT02573181|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
111378785|NCT02573181|Immunologic Factors|immunologic factors|mesh-ancestor
111378786|NCT02573181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111378787|NCT02498769|Botulinum Toxins|botulinum toxins|mesh-list
111378788|NCT02498769|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111378789|NCT02498769|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111378790|NCT02498769|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111378791|NCT02498769|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111378792|NCT02498769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111378793|NCT02498769|Cholinergic Agents|cholinergic agents|mesh-ancestor
111378794|NCT02498769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111378795|NCT02498769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111378796|NCT02498769|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111378797|NCT02498769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111378798|NCT01650558|Chloroquine|chloroquine|mesh-list
111378799|NCT01650558|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
111378800|NCT01650558|Amebicides|amebicides|mesh-ancestor
111378801|NCT01650558|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111378802|NCT01650558|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111378803|NCT01650558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111378804|NCT01650558|Antimalarials|antimalarials|mesh-ancestor
111378805|NCT01650558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111378806|NCT01650558|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111378807|NCT01650558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111378808|NCT02579343|Dexetimide|dexetimide|mesh-list
111378809|NCT02579343|Citalopram|citalopram|mesh-list
111378810|NCT02579343|Escitalopram|escitalopram|mesh-list
111378811|NCT02579343|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111378812|NCT02579343|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111378813|NCT02579343|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111378814|NCT02579343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111378815|NCT02579343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111378816|NCT02579343|Serotonin Agents|serotonin agents|mesh-ancestor
111378817|NCT02579343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111378818|NCT02579343|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111378819|NCT02579343|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111378820|NCT02579343|Parasympatholytics|parasympatholytics|mesh-ancestor
111378821|NCT02579343|Autonomic Agents|autonomic agents|mesh-ancestor
111378822|NCT02579343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111378823|NCT02579343|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111378824|NCT02579343|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111378825|NCT02579343|Cholinergic Agents|cholinergic agents|mesh-ancestor
111378826|NCT02579343|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111378827|NCT02579343|Antidepressive Agents|antidepressive agents|mesh-ancestor
111378828|NCT02579343|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111378829|NCT01144442|Paclitaxel|paclitaxel|mesh-list
111378830|NCT01144442|Carboplatin|carboplatin|mesh-list
111378831|NCT01144442|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111378832|NCT01144442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111378833|NCT01144442|Tubulin Modulators|tubulin modulators|mesh-ancestor
111378834|NCT01144442|Antimitotic Agents|antimitotic agents|mesh-ancestor
111378835|NCT01144442|Mitosis Modulators|mitosis modulators|mesh-ancestor
111378836|NCT01144442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111378837|NCT02499081|Ixazomib|ixazomib|mesh-list
111378838|NCT02499081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111378839|NCT02499081|Protease Inhibitors|protease inhibitors|mesh-ancestor
111378840|NCT02499081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111378841|NCT02499081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111378842|NCT02380248|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111378843|NCT02380248|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111378844|NCT02501265|Nicotine|nicotine|mesh-list
111378845|NCT02501265|Varenicline|varenicline|mesh-list
111378846|NCT02501265|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111378847|NCT02501265|Autonomic Agents|autonomic agents|mesh-ancestor
111378848|NCT02501265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111378849|NCT02501265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111378850|NCT02501265|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111378851|NCT02501265|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111378852|NCT02501265|Cholinergic Agents|cholinergic agents|mesh-ancestor
111378853|NCT02501265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111378854|NCT02501265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111378855|NCT02408016|Aldesleukin|aldesleukin|mesh-list
111378856|NCT02408016|Cyclophosphamide|cyclophosphamide|mesh-list
111378857|NCT02408016|Interleukin-2|interleukin-2|mesh-list
111378858|NCT02408016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111378859|NCT02408016|Immunologic Factors|immunologic factors|mesh-ancestor
111378860|NCT02408016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111378861|NCT02408016|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111378862|NCT02408016|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111378863|NCT02408016|Alkylating Agents|alkylating agents|mesh-ancestor
111378864|NCT02408016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111378865|NCT02408016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111378866|NCT02408016|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111378867|NCT02408016|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111378868|NCT02408016|Analgesics|analgesics|mesh-ancestor
111378869|NCT02408016|Sensory System Agents|sensory system agents|mesh-ancestor
111378870|NCT02408016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111378871|NCT02408016|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111378872|NCT02408016|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111378873|NCT02408016|Antiviral Agents|antiviral agents|mesh-ancestor
111378874|NCT02408016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111378875|NCT02579421|Progesterone|progesterone|mesh-list
111378876|NCT02579421|Progestins|progestins|mesh-ancestor
111378877|NCT02579421|Hormones|hormones|mesh-ancestor
111378878|NCT02579421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111378879|NCT02579421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111378880|NCT00422175|Siponimod|siponimod|mesh-list
111378881|NCT00422175|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
111378882|NCT00422175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111378883|NCT00422175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111378884|NCT00422175|Immunologic Factors|immunologic factors|mesh-ancestor
111378885|NCT00422175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111378886|NCT01186250|Pioglitazone|pioglitazone|mesh-list
111378887|NCT01186250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111378888|NCT01186250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111378889|NCT01186406|Bevacizumab|bevacizumab|mesh-list
111378890|NCT01186406|Temozolomide|temozolomide|mesh-list
111378891|NCT01186406|Carmustine|carmustine|mesh-list
111378892|NCT01186406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111378893|NCT01186406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111378894|NCT01186406|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111378895|NCT01186406|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111378896|NCT01186406|Growth Substances|growth substances|mesh-ancestor
111378897|NCT01186406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111378898|NCT01186406|Growth Inhibitors|growth inhibitors|mesh-ancestor
111378899|NCT01186406|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111378900|NCT01186406|Alkylating Agents|alkylating agents|mesh-ancestor
111378901|NCT01186406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111378902|NCT02407704|Lorazepam|lorazepam|mesh-list
111378903|NCT02407704|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
111378904|NCT02407704|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111378905|NCT02407704|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111378906|NCT02407704|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111378907|NCT02407704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111378908|NCT02407704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111378909|NCT02407704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111378910|NCT02407704|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111378911|NCT02407704|Antidepressive Agents|antidepressive agents|mesh-ancestor
111103330|NCT03206073|Durvalumab|durvalumab|mesh-list
111378912|NCT02407704|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111378913|NCT02407704|Anticonvulsants|anticonvulsants|mesh-ancestor
111378914|NCT02407704|Antiemetics|antiemetics|mesh-ancestor
111378915|NCT02407704|Autonomic Agents|autonomic agents|mesh-ancestor
111378916|NCT02407704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111378917|NCT02407704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111378918|NCT02407704|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111378919|NCT02407704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111378920|NCT02407704|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111378921|NCT02407704|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111378922|NCT02407704|GABA Modulators|gaba modulators|mesh-ancestor
111378923|NCT02407704|GABA Agents|gaba agents|mesh-ancestor
111378924|NCT02581839|Dexamethasone|dexamethasone|mesh-list
111378925|NCT02581839|Dexamethasone acetate|dexamethasone acetate|mesh-list
111378926|NCT02581839|BB 1101|bb 1101|mesh-list
111378927|NCT02581839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111378928|NCT02581839|Antiemetics|antiemetics|mesh-ancestor
111378929|NCT02581839|Autonomic Agents|autonomic agents|mesh-ancestor
111378930|NCT02581839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111378931|NCT02581839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111378932|NCT02581839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111378933|NCT02581839|Glucocorticoids|glucocorticoids|mesh-ancestor
111378934|NCT02581839|Hormones|hormones|mesh-ancestor
111378935|NCT02581839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111378936|NCT02581839|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111378937|NCT02581839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111378938|NCT02581839|Protease Inhibitors|protease inhibitors|mesh-ancestor
111378939|NCT02581839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111378940|NCT02581839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111378941|NCT02504775|Acetaminophen|acetaminophen|mesh-list
111378942|NCT02504775|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111378943|NCT02504775|Analgesics|analgesics|mesh-ancestor
111378944|NCT02504775|Sensory System Agents|sensory system agents|mesh-ancestor
111378945|NCT02504775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111378946|NCT02504775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111378947|NCT02504775|Antipyretics|antipyretics|mesh-ancestor
111378948|NCT02504931|Sertraline|sertraline|mesh-list
111378949|NCT02504931|Antidepressive Agents|antidepressive agents|mesh-ancestor
111378950|NCT02504931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111378951|NCT02504931|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111378952|NCT02504931|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111378953|NCT02504931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111378954|NCT02504931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111378955|NCT02504931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111378956|NCT02504931|Serotonin Agents|serotonin agents|mesh-ancestor
111378957|NCT02504931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111378958|NCT02584725|Tranexamic Acid|tranexamic acid|mesh-list
111378959|NCT02584725|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111378960|NCT02584725|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111378961|NCT02584725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111378962|NCT02584725|Hemostatics|hemostatics|mesh-ancestor
111378963|NCT02584725|Coagulants|coagulants|mesh-ancestor
111378964|NCT04423029|Nivolumab|nivolumab|mesh-list
111378965|NCT04423029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111378966|NCT04423029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111378967|NCT04423029|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111378968|NCT04423029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111378969|NCT01186562|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111378970|NCT01186562|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111378971|NCT01186562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111378972|NCT01186562|Incretins|incretins|mesh-ancestor
111378973|NCT01186562|Hormones|hormones|mesh-ancestor
111378974|NCT01186562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111378975|NCT01186562|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111378976|NCT01186562|Protease Inhibitors|protease inhibitors|mesh-ancestor
111378977|NCT01186562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111378978|NCT01186562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111378979|NCT01187498|Oxybutynin|oxybutynin|mesh-list
111378980|NCT01187498|Parasympatholytics|parasympatholytics|mesh-ancestor
111378981|NCT01187498|Autonomic Agents|autonomic agents|mesh-ancestor
111378982|NCT01187498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111378983|NCT01187498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111378984|NCT01187498|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111378985|NCT01187498|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111378986|NCT01187498|Cholinergic Agents|cholinergic agents|mesh-ancestor
111378987|NCT01187498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111378988|NCT01187498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111378989|NCT01187498|Urological Agents|urological agents|mesh-ancestor
111378990|NCT01148420|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
111378991|NCT01148420|Medroxyprogesterone|medroxyprogesterone|mesh-list
111378992|NCT01148420|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111378993|NCT01148420|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111378994|NCT01148420|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111378995|NCT01148420|Contraceptive Agents|contraceptive agents|mesh-ancestor
111378996|NCT01148420|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111378997|NCT01148420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111378998|NCT01148420|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111378999|NCT01148420|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111379000|NCT01148420|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
111379001|NCT01148420|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111379002|NCT01148420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111379003|NCT01149434|Everolimus|everolimus|mesh-list
111379004|NCT01149434|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111379005|NCT01149434|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111379006|NCT01149434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111379007|NCT01149434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111379008|NCT01149434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111379009|NCT01149434|Immunologic Factors|immunologic factors|mesh-ancestor
111379010|NCT01149434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111379011|NCT01149434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111379012|NCT01150760|Alvimopan|alvimopan|mesh-list
111379013|NCT01150760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111379014|NCT01150838|Propofol|propofol|mesh-list
111379015|NCT01150838|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111379016|NCT01150838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111379017|NCT01150838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111379018|NCT01150838|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111379019|NCT01150838|Anesthetics, General|anesthetics, general|mesh-ancestor
111379020|NCT01150838|Anesthetics|anesthetics|mesh-ancestor
111379021|NCT01189292|Dexamethasone|dexamethasone|mesh-list
111379022|NCT01189292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111379023|NCT01189292|Antiemetics|antiemetics|mesh-ancestor
111379024|NCT01189292|Autonomic Agents|autonomic agents|mesh-ancestor
111379025|NCT01189292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111379026|NCT01189292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111379027|NCT01189292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111379028|NCT01189292|Glucocorticoids|glucocorticoids|mesh-ancestor
111379029|NCT01189292|Hormones|hormones|mesh-ancestor
111379030|NCT01189292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111379031|NCT01189292|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111379032|NCT01189292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111379033|NCT01189370|Sorafenib|sorafenib|mesh-list
111379034|NCT01189370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111379035|NCT01189370|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111379036|NCT01189370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111379037|NCT01189370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111379038|NCT01189760|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111379039|NCT01189760|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111379040|NCT01189760|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111379041|NCT01189760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111379042|NCT01189760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111379043|NCT01189760|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111379044|NCT01189760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111379045|NCT01189760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111379046|NCT01189760|Cholinergic Agents|cholinergic agents|mesh-ancestor
111379047|NCT01189760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111379048|NCT03010202|Dexamethasone|dexamethasone|mesh-list
111379049|NCT03010202|Rituximab|rituximab|mesh-list
111379050|NCT03010202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111379051|NCT03010202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111379052|NCT03010202|Immunologic Factors|immunologic factors|mesh-ancestor
111379053|NCT03010202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111379054|NCT03010202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111379055|NCT03010202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111379056|NCT03010202|Antiemetics|antiemetics|mesh-ancestor
111379057|NCT03010202|Autonomic Agents|autonomic agents|mesh-ancestor
111379058|NCT03010202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111379059|NCT03010202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111103482|NCT02544321|Bromocriptine|bromocriptine|mesh-list
111379060|NCT03010202|Glucocorticoids|glucocorticoids|mesh-ancestor
111379062|NCT03010202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111379063|NCT03010202|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111379064|NCT01191320|Enclomiphene|enclomiphene|mesh-list
111379065|NCT01191320|Clomiphene|clomiphene|mesh-list
111379066|NCT01191320|Zuclomiphene|zuclomiphene|mesh-list
111379067|NCT01191320|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111379068|NCT01191320|Hormone Antagonists|hormone antagonists|mesh-ancestor
111379069|NCT01191320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111379070|NCT01191320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111379071|NCT01191320|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111379072|NCT01191320|Fertility Agents|fertility agents|mesh-ancestor
111379073|NCT01191320|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111379074|NCT01191320|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111379075|NCT01191320|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111379076|NCT01151852|Imatinib Mesylate|imatinib mesylate|mesh-list
111379077|NCT01151852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111379078|NCT01151852|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111379079|NCT01151852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111379080|NCT01151852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111379081|NCT01191398|Atropine|atropine|mesh-list
111379082|NCT01191398|Glycopyrrolate|glycopyrrolate|mesh-list
111379083|NCT01191398|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111379084|NCT01191398|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111379085|NCT01191398|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111379086|NCT01191398|Autonomic Agents|autonomic agents|mesh-ancestor
111379087|NCT01191398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111379088|NCT01191398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111379089|NCT01191398|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111379090|NCT01191398|Respiratory System Agents|respiratory system agents|mesh-ancestor
111379091|NCT01191398|Mydriatics|mydriatics|mesh-ancestor
111379092|NCT01191398|Parasympatholytics|parasympatholytics|mesh-ancestor
111379093|NCT01191398|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111379094|NCT01191398|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111379095|NCT01191398|Cholinergic Agents|cholinergic agents|mesh-ancestor
111379096|NCT01191398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111379097|NCT01191398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111379098|NCT01191476|Propofol|propofol|mesh-list
111379099|NCT01191476|Sevoflurane|sevoflurane|mesh-list
111379100|NCT01191476|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111379101|NCT01191476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111379102|NCT01191476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111379103|NCT01191476|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111379104|NCT01191476|Anesthetics, General|anesthetics, general|mesh-ancestor
111379105|NCT01191476|Anesthetics|anesthetics|mesh-ancestor
111379106|NCT01191476|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111379107|NCT01191476|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111379108|NCT02508207|Ivacaftor|ivacaftor|mesh-list
111379109|NCT02508207|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
111379110|NCT02508207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111379111|NCT02508207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111379112|NCT02509065|Pancrelipase|pancrelipase|mesh-list
111379113|NCT02509065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111379114|NCT01194674|Plasminogen|plasminogen|mesh-list
111379115|NCT01194674|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111379116|NCT01194674|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111379117|NCT01194674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111379118|NCT02509767|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
111379119|NCT02509767|Medroxyprogesterone|medroxyprogesterone|mesh-list
111379120|NCT02509767|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111379121|NCT02509767|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111379122|NCT02509767|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111379123|NCT02509767|Contraceptive Agents|contraceptive agents|mesh-ancestor
111379124|NCT02509767|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111379125|NCT02509767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111379126|NCT02509767|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111379127|NCT02509767|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111379128|NCT02509767|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
111379129|NCT02509767|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111379130|NCT02509767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111379131|NCT01154192|Dexamethasone|dexamethasone|mesh-list
111379132|NCT01154192|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
111103554|NCT02532855|Incretins|incretins|mesh-ancestor
111379133|NCT01154192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111379135|NCT01154192|Autonomic Agents|autonomic agents|mesh-ancestor
111379136|NCT01154192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111379137|NCT01154192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111379138|NCT01154192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111379139|NCT01154192|Glucocorticoids|glucocorticoids|mesh-ancestor
111379140|NCT01154192|Hormones|hormones|mesh-ancestor
110518915|NCT03112434|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111379141|NCT01154192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111379142|NCT01154192|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111379143|NCT01154192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111379144|NCT01154192|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111379145|NCT02511561|Ciprofloxacin|ciprofloxacin|mesh-list
111379146|NCT02511561|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111379147|NCT02511561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111379148|NCT02511561|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111379149|NCT02511561|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111379150|NCT02511561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111379151|NCT02511561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111379152|NCT02511561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111379153|NCT02511561|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111379154|NCT02511561|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111379155|NCT01195922|Sirolimus|sirolimus|mesh-list
111379156|NCT01195922|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111379157|NCT01195922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111379158|NCT01195922|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111379159|NCT01195922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111379160|NCT01195922|Antifungal Agents|antifungal agents|mesh-ancestor
111379161|NCT01195922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111379162|NCT01195922|Immunologic Factors|immunologic factors|mesh-ancestor
111379163|NCT01195922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111379164|NCT02512575|Prednisolone|prednisolone|mesh-list
111379165|NCT02512575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111379166|NCT02512575|Glucocorticoids|glucocorticoids|mesh-ancestor
111379167|NCT02512575|Hormones|hormones|mesh-ancestor
111379168|NCT02512575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111379169|NCT02512575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111379170|NCT02512575|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111379171|NCT02512575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111379172|NCT01199744|Zanamivir|zanamivir|mesh-list
111379173|NCT01199744|Antiviral Agents|antiviral agents|mesh-ancestor
111379174|NCT01199744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111379175|NCT01199744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111379176|NCT01199744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111379177|NCT03702374|Antioxidants|antioxidants|mesh-list
111379178|NCT03702374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111379179|NCT03702374|Protective Agents|protective agents|mesh-ancestor
111379180|NCT03702374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111379181|NCT02512809|Dexmedetomidine|dexmedetomidine|mesh-list
111379182|NCT02512809|Isoflurane|isoflurane|mesh-list
111379183|NCT02512809|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111379184|NCT02512809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111379185|NCT02512809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111379186|NCT02512809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111379187|NCT02512809|Analgesics|analgesics|mesh-ancestor
111379188|NCT02512809|Sensory System Agents|sensory system agents|mesh-ancestor
111379189|NCT02512809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111379190|NCT02512809|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111379191|NCT02512809|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111379192|NCT02512809|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111379193|NCT02512809|Adrenergic Agents|adrenergic agents|mesh-ancestor
111379194|NCT02512809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111379195|NCT02512809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111379196|NCT02512809|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111379197|NCT02512809|Anesthetics, General|anesthetics, general|mesh-ancestor
111379198|NCT02512809|Anesthetics|anesthetics|mesh-ancestor
111379199|NCT01201772|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
111379200|NCT01201772|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111379201|NCT01202162|Sevoflurane|sevoflurane|mesh-list
111379202|NCT01202162|Desflurane|desflurane|mesh-list
111379203|NCT01202162|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111379204|NCT01202162|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111379205|NCT01202162|Anesthetics, General|anesthetics, general|mesh-ancestor
111379206|NCT01202162|Anesthetics|anesthetics|mesh-ancestor
111379207|NCT01202162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111379208|NCT01202162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111379209|NCT01159262|Fentanyl|fentanyl|mesh-list
111379210|NCT01159262|Midazolam|midazolam|mesh-list
111379211|NCT01159262|Dexmedetomidine|dexmedetomidine|mesh-list
111379212|NCT01159262|Morphine|morphine|mesh-list
111379213|NCT01159262|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111379214|NCT01159262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111379215|NCT01159262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111379216|NCT01159262|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111379217|NCT01159262|Analgesics|analgesics|mesh-ancestor
111379218|NCT01159262|Sensory System Agents|sensory system agents|mesh-ancestor
111379219|NCT01159262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111379220|NCT01159262|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111379221|NCT01159262|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111379222|NCT01159262|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111379223|NCT01159262|Adrenergic Agents|adrenergic agents|mesh-ancestor
111379224|NCT01159262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111379225|NCT01159262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111379226|NCT01159262|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111379227|NCT01159262|Narcotics|narcotics|mesh-ancestor
111379228|NCT01159262|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111379229|NCT01159262|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111379230|NCT01159262|Anesthetics, General|anesthetics, general|mesh-ancestor
111379231|NCT01159262|Anesthetics|anesthetics|mesh-ancestor
111379232|NCT01159262|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111379233|NCT01159262|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111379234|NCT01159262|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111379235|NCT01159262|GABA Modulators|gaba modulators|mesh-ancestor
111379236|NCT01159262|GABA Agents|gaba agents|mesh-ancestor
111379237|NCT03011060|Capecitabine|capecitabine|mesh-list
111379238|NCT03011060|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111379239|NCT03011060|Antimetabolites|antimetabolites|mesh-ancestor
111379240|NCT03011060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111379241|NCT03011060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111379242|NCT03010670|Oxytocin|oxytocin|mesh-list
111379243|NCT03010670|Oxytocics|oxytocics|mesh-ancestor
111379244|NCT03010670|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111379245|NCT03010670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111379246|NCT04377711|Ciclesonide|ciclesonide|mesh-list
111379247|NCT04377711|Glucocorticoids|glucocorticoids|mesh-ancestor
111379248|NCT04377711|Hormones|hormones|mesh-ancestor
111379249|NCT04377711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111379250|NCT04377711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111379251|NCT04377711|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111379252|NCT04366713|Capecitabine|capecitabine|mesh-list
111379253|NCT04366713|Loperamide|loperamide|mesh-list
111379254|NCT04366713|Antidiarrheals|antidiarrheals|mesh-list
111379255|NCT04366713|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111379256|NCT04366713|Antimetabolites|antimetabolites|mesh-ancestor
111379257|NCT04366713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111379258|NCT04366713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111379259|NCT04366713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111379260|NCT03413384|Ceftriaxone|ceftriaxone|mesh-list
110519039|NCT02812394|Immunologic Factors|immunologic factors|mesh-ancestor
111379261|NCT03413384|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111379262|NCT03413384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111379263|NCT02976441|Temozolomide|temozolomide|mesh-list
111379264|NCT02976441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111379265|NCT02976441|Alkylating Agents|alkylating agents|mesh-ancestor
111379266|NCT02976441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111379267|NCT02976441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111379268|NCT00363753|Aspirin|aspirin|mesh-list
111379269|NCT00363753|Clopidogrel|clopidogrel|mesh-list
111379270|NCT00363753|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111379271|NCT00363753|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111379272|NCT00363753|Analgesics|analgesics|mesh-ancestor
111379273|NCT00363753|Sensory System Agents|sensory system agents|mesh-ancestor
111379274|NCT00363753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111379275|NCT00363753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111379276|NCT00363753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111379277|NCT00363753|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111379278|NCT00363753|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111379279|NCT00363753|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111379280|NCT00363753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111379281|NCT00363753|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111379282|NCT00363753|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111379283|NCT00363753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111379285|NCT00363753|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111379286|NCT00363753|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111379287|NCT00363753|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111379288|NCT00363753|Purinergic Agents|purinergic agents|mesh-ancestor
111379289|NCT00363753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111379290|NCT02434770|Vaccines|vaccines|mesh-list
111379291|NCT02434770|Immunologic Factors|immunologic factors|mesh-ancestor
111379292|NCT02434770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111379293|NCT01203644|Bupivacaine|bupivacaine|mesh-list
111379294|NCT01203644|Anesthetics, Local|anesthetics, local|mesh-ancestor
111379295|NCT01203644|Anesthetics|anesthetics|mesh-ancestor
111379296|NCT01203644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111379297|NCT01203644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111379298|NCT01203644|Sensory System Agents|sensory system agents|mesh-ancestor
111379299|NCT01203644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111379300|NCT00363831|Oxaliplatin|oxaliplatin|mesh-list
111379301|NCT00363831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111379302|NCT02433834|Glycopyrrolate|glycopyrrolate|mesh-list
111379303|NCT02433834|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
111379304|NCT02433834|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111379305|NCT02433834|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111379306|NCT02433834|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111379307|NCT02433834|Cholinergic Agents|cholinergic agents|mesh-ancestor
111379308|NCT02433834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111379309|NCT02433834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111379310|NCT02433834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111379311|NCT02433834|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111379312|NCT02433834|Autonomic Agents|autonomic agents|mesh-ancestor
111379313|NCT02433834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111379314|NCT02433834|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111379315|NCT02433834|Respiratory System Agents|respiratory system agents|mesh-ancestor
111379316|NCT02433834|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111379317|NCT02433834|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111379318|NCT02433834|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111379319|NCT02433834|Adrenergic Agents|adrenergic agents|mesh-ancestor
111379320|NCT02433678|Dapagliflozin|dapagliflozin|mesh-list
111379321|NCT02433678|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111379322|NCT02433678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111379323|NCT02433678|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111379324|NCT02433678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111379325|NCT00363909|Dexetimide|dexetimide|mesh-list
111379326|NCT00363909|Citalopram|citalopram|mesh-list
111379327|NCT00363909|Escitalopram|escitalopram|mesh-list
111379328|NCT00363909|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111379329|NCT00363909|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111379330|NCT00363909|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111379331|NCT00363909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111379332|NCT00363909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111379333|NCT00363909|Serotonin Agents|serotonin agents|mesh-ancestor
111379334|NCT00363909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111379335|NCT00363909|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111379336|NCT00363909|Antidepressive Agents|antidepressive agents|mesh-ancestor
111379337|NCT00363909|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111379338|NCT00363909|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111379339|NCT00363909|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111379340|NCT00363909|Parasympatholytics|parasympatholytics|mesh-ancestor
111379341|NCT00363909|Autonomic Agents|autonomic agents|mesh-ancestor
111379342|NCT00363909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111379343|NCT00363909|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111379344|NCT00363909|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111379345|NCT00363909|Cholinergic Agents|cholinergic agents|mesh-ancestor
111379346|NCT01205828|Temozolomide|temozolomide|mesh-list
111379347|NCT01205828|Veliparib|veliparib|mesh-list
111379348|NCT01205828|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111379349|NCT01205828|Alkylating Agents|alkylating agents|mesh-ancestor
111379350|NCT01205828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111379351|NCT01205828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111379352|NCT01205828|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111379353|NCT01205828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111379354|NCT02515305|Clindamycin|clindamycin|mesh-list
111379355|NCT02515305|Clindamycin palmitate|clindamycin palmitate|mesh-list
111379356|NCT02515305|Clindamycin phosphate|clindamycin phosphate|mesh-list
111379357|NCT02515305|Benzoyl Peroxide|benzoyl peroxide|mesh-list
111379358|NCT02515305|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111379359|NCT02515305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111379360|NCT02515305|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111379361|NCT02515305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111379362|NCT02515305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111379363|NCT02515305|Dermatologic Agents|dermatologic agents|mesh-ancestor
111379364|NCT01206452|Prednisone|prednisone|mesh-list
111379365|NCT01206452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111379366|NCT01206452|Glucocorticoids|glucocorticoids|mesh-ancestor
111379367|NCT01206452|Hormones|hormones|mesh-ancestor
111379368|NCT01206452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111379369|NCT01206452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111379370|NCT01206452|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111379371|NCT01206452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111379372|NCT01206608|Bupivacaine|bupivacaine|mesh-list
111379373|NCT01206608|Anesthetics, Local|anesthetics, local|mesh-ancestor
111379374|NCT01206608|Anesthetics|anesthetics|mesh-ancestor
111379375|NCT01206608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111379376|NCT01206608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110519159|NCT00932165|Exemestane|exemestane|mesh-list
111379377|NCT01206608|Sensory System Agents|sensory system agents|mesh-ancestor
111379378|NCT01206608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111379379|NCT03010436|Benralizumab|benralizumab|mesh-list
111379380|NCT03010436|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111379381|NCT03010436|Respiratory System Agents|respiratory system agents|mesh-ancestor
111379382|NCT02432040|Atorvastatin|atorvastatin|mesh-list
111379383|NCT02432040|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111379384|NCT02432040|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111379385|NCT02432040|Antimetabolites|antimetabolites|mesh-ancestor
111379386|NCT02432040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111379387|NCT02432040|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111379388|NCT02432040|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111379389|NCT02432040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111379390|NCT02517021|Dexamethasone|dexamethasone|mesh-list
111379391|NCT02517021|Palonosetron|palonosetron|mesh-list
111379392|NCT02517021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111379393|NCT02517021|Antiemetics|antiemetics|mesh-ancestor
111379394|NCT02517021|Autonomic Agents|autonomic agents|mesh-ancestor
111379395|NCT02517021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111379396|NCT02517021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111379397|NCT02517021|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111379398|NCT02517021|Glucocorticoids|glucocorticoids|mesh-ancestor
111379399|NCT02517021|Hormones|hormones|mesh-ancestor
111379400|NCT02517021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111379401|NCT02517021|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111379402|NCT02517021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111379403|NCT02517021|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111379404|NCT02517021|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111379405|NCT02517021|Serotonin Agents|serotonin agents|mesh-ancestor
111379406|NCT02517021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111379407|NCT02517021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111379408|NCT05859217|Atezolizumab|atezolizumab|mesh-list
111379409|NCT05859217|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111379410|NCT05859217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111379411|NCT05859217|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111379412|NCT05859217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111379413|NCT05859126|Choline|choline|mesh-list
111379414|NCT05859126|Lipotropic Agents|lipotropic agents|mesh-ancestor
111379415|NCT05859126|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111379416|NCT05859126|Antimetabolites|antimetabolites|mesh-ancestor
111379417|NCT05859126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111379418|NCT05859126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111379419|NCT05859126|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111379420|NCT05859126|Nootropic Agents|nootropic agents|mesh-ancestor
111379421|NCT05858671|Fenugreek seed meal|fenugreek seed meal|mesh-list
111379422|NCT05858671|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111379423|NCT05858671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111379424|NCT05858645|Deucravacitinib|deucravacitinib|mesh-list
111379425|NCT05858645|Dermatologic Agents|dermatologic agents|mesh-ancestor
111379426|NCT05858645|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111379427|NCT05858645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111379428|NCT05858645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111379429|NCT05858216|Chlorpheniramine|chlorpheniramine|mesh-list
111379430|NCT05858216|Antipruritics|antipruritics|mesh-ancestor
111379431|NCT05858216|Dermatologic Agents|dermatologic agents|mesh-ancestor
111379432|NCT05858216|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111379433|NCT05858216|Histamine Antagonists|histamine antagonists|mesh-ancestor
111379434|NCT05858216|Histamine Agents|histamine agents|mesh-ancestor
111379435|NCT05858216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111379436|NCT05858216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110519224|NCT05906199|Antipyretics|antipyretics|mesh-ancestor
111379437|NCT05858216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111379438|NCT05858216|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111379439|NCT05858177|Temozolomide|temozolomide|mesh-list
111379440|NCT05858177|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111379441|NCT05858177|Alkylating Agents|alkylating agents|mesh-ancestor
111379442|NCT05858177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111379443|NCT05858177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111379444|NCT05857982|Dexamethasone|dexamethasone|mesh-list
111379445|NCT05857982|Mitoxantrone|mitoxantrone|mesh-list
111379446|NCT05857982|Daratumumab|daratumumab|mesh-list
111379447|NCT05857982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111379448|NCT05857982|Antiemetics|antiemetics|mesh-ancestor
111379449|NCT05857982|Autonomic Agents|autonomic agents|mesh-ancestor
111379450|NCT05857982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111379451|NCT05857982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111379452|NCT05857982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111379453|NCT05857982|Glucocorticoids|glucocorticoids|mesh-ancestor
111379454|NCT05857982|Hormones|hormones|mesh-ancestor
111379455|NCT05857982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111379456|NCT05857982|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111379457|NCT05857982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111379458|NCT05857982|Analgesics|analgesics|mesh-ancestor
111379459|NCT05857982|Sensory System Agents|sensory system agents|mesh-ancestor
111379460|NCT05857982|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111379461|NCT05857982|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111379462|NCT05857982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111379463|NCT05857982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111379464|NCT05857891|Epoetin Alfa|epoetin alfa|mesh-list
111379465|NCT05857891|Hematinics|hematinics|mesh-ancestor
111379466|NCT05844618|Triamcinolone|triamcinolone|mesh-list
111379467|NCT05844618|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
111379468|NCT05844618|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
111379469|NCT05844618|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
111379470|NCT05844618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111379471|NCT05844618|Glucocorticoids|glucocorticoids|mesh-ancestor
111379472|NCT05844618|Hormones|hormones|mesh-ancestor
111379473|NCT05844618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111379474|NCT05844618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111379475|NCT05844618|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111379476|NCT05844618|Immunologic Factors|immunologic factors|mesh-ancestor
111379477|NCT05844618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111379478|NCT05844618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111379479|NCT05836025|Sirolimus|sirolimus|mesh-list
111379480|NCT05836025|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111379481|NCT05836025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111379482|NCT05836025|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111379483|NCT05836025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111379484|NCT05836025|Antifungal Agents|antifungal agents|mesh-ancestor
111379485|NCT05836025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111379486|NCT05836025|Immunologic Factors|immunologic factors|mesh-ancestor
111379487|NCT05836025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111379488|NCT05796752|Memantine|memantine|mesh-list
111379489|NCT05796752|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111379490|NCT05796752|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111379491|NCT05796752|Dopamine Agents|dopamine agents|mesh-ancestor
111379492|NCT05796752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111379493|NCT05796752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111379494|NCT05796752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111379495|NCT05796752|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111379496|NCT05796752|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111379497|NCT05794971|Irinotecan|irinotecan|mesh-list
111379498|NCT05794971|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111379499|NCT05794971|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111379500|NCT05794971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111379501|NCT05794971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111379502|NCT05794971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111379503|NCT05785195|Nitric Oxide|nitric oxide|mesh-list
111379504|NCT05785195|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111379505|NCT05785195|Autonomic Agents|autonomic agents|mesh-ancestor
111379506|NCT05785195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111379507|NCT05785195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111379509|NCT05785195|Respiratory System Agents|respiratory system agents|mesh-ancestor
111379510|NCT05785195|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111379511|NCT05785195|Antioxidants|antioxidants|mesh-ancestor
111379512|NCT05785195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111379513|NCT05785195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111379514|NCT05785195|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
111379515|NCT05785195|Vasodilator Agents|vasodilator agents|mesh-ancestor
111379516|NCT05785195|Gasotransmitters|gasotransmitters|mesh-ancestor
111379517|NCT05785195|Protective Agents|protective agents|mesh-ancestor
111379518|NCT05735717|Rituximab|rituximab|mesh-list
111379519|NCT05735717|Fludarabine|fludarabine|mesh-list
111379520|NCT05735717|Melphalan|melphalan|mesh-list
111379521|NCT05735717|Busulfan|busulfan|mesh-list
111379522|NCT05735717|Levetiracetam|levetiracetam|mesh-list
111379523|NCT05735717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111379524|NCT05735717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111379525|NCT05735717|Immunologic Factors|immunologic factors|mesh-ancestor
111379526|NCT05735717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111379527|NCT05735717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111379528|NCT05735717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111379529|NCT05735717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111379530|NCT05735717|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111379531|NCT05735717|Alkylating Agents|alkylating agents|mesh-ancestor
111379532|NCT05735717|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111379533|NCT05735717|Anticonvulsants|anticonvulsants|mesh-ancestor
111379534|NCT05735717|Nootropic Agents|nootropic agents|mesh-ancestor
111379535|NCT05693675|Methadone|methadone|mesh-list
111379536|NCT05693675|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111379537|NCT05693675|Narcotics|narcotics|mesh-ancestor
111379538|NCT05693675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111379539|NCT05693675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111379540|NCT05693675|Analgesics|analgesics|mesh-ancestor
111379541|NCT05693675|Sensory System Agents|sensory system agents|mesh-ancestor
111379542|NCT05693675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111379543|NCT05693675|Antitussive Agents|antitussive agents|mesh-ancestor
111379544|NCT05693675|Respiratory System Agents|respiratory system agents|mesh-ancestor
111379545|NCT05655273|Tacrolimus|tacrolimus|mesh-list
111379546|NCT05655273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111379547|NCT05655273|Immunologic Factors|immunologic factors|mesh-ancestor
111379548|NCT05655273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111379549|NCT05655273|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111379550|NCT05655273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111379551|NCT05655273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111379552|NCT05642078|Vaccines|vaccines|mesh-list
111379553|NCT05642078|Immunologic Factors|immunologic factors|mesh-ancestor
111379554|NCT05642078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111379555|NCT05624151|Magnesium Sulfate|magnesium sulfate|mesh-list
111379556|NCT05624151|Dexmedetomidine|dexmedetomidine|mesh-list
111379557|NCT05624151|Bupivacaine|bupivacaine|mesh-list
111379558|NCT05624151|Anesthetics, Local|anesthetics, local|mesh-ancestor
111379559|NCT05624151|Anesthetics|anesthetics|mesh-ancestor
111379560|NCT05624151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111379561|NCT05624151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111379562|NCT05624151|Sensory System Agents|sensory system agents|mesh-ancestor
111379563|NCT05624151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111379564|NCT05624151|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111379565|NCT05624151|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111379566|NCT05624151|Analgesics|analgesics|mesh-ancestor
111379567|NCT05624151|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111379568|NCT05624151|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111379569|NCT05624151|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111379570|NCT05624151|Adrenergic Agents|adrenergic agents|mesh-ancestor
111379571|NCT05624151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111379572|NCT05624151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111379573|NCT05624151|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111379574|NCT05624151|Anticonvulsants|anticonvulsants|mesh-ancestor
111379575|NCT05624151|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111379576|NCT05624151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111379577|NCT05624151|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111379578|NCT05624151|Tocolytic Agents|tocolytic agents|mesh-ancestor
111379579|NCT05624151|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111379580|NCT05620914|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
111379581|NCT05620914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111379582|NCT05620914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111379584|NCT05584007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111379585|NCT05584007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111379586|NCT05570292|Folic Acid|folic acid|mesh-list
111379587|NCT05570292|Domperidone|domperidone|mesh-list
111379588|NCT05570292|Hematinics|hematinics|mesh-ancestor
111379589|NCT05570292|Vitamin B Complex|vitamin b complex|mesh-ancestor
111379590|NCT05570292|Vitamins|vitamins|mesh-ancestor
111379591|NCT05570292|Micronutrients|micronutrients|mesh-ancestor
111379592|NCT05570292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111379593|NCT05570292|Antiemetics|antiemetics|mesh-ancestor
111379594|NCT05570292|Autonomic Agents|autonomic agents|mesh-ancestor
111379595|NCT05570292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111379596|NCT05570292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111379597|NCT05570292|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111379598|NCT05570292|Dopamine Agents|dopamine agents|mesh-ancestor
111379599|NCT05570292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111379600|NCT05570292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111379601|NCT05554939|Cyclophosphamide|cyclophosphamide|mesh-list
111379602|NCT05554939|Mechlorethamine|mechlorethamine|mesh-list
111379603|NCT05554939|Doxorubicin|doxorubicin|mesh-list
111379604|NCT05554939|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111379605|NCT05554939|Fludarabine|fludarabine|mesh-list
111379606|NCT05554939|Fludarabine phosphate|fludarabine phosphate|mesh-list
111379607|NCT05554939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111379608|NCT05554939|Immunologic Factors|immunologic factors|mesh-ancestor
111379609|NCT05554939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111379610|NCT05554939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111379611|NCT05554939|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111379612|NCT05554939|Alkylating Agents|alkylating agents|mesh-ancestor
111379613|NCT05554939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111379614|NCT05554939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111379615|NCT05554939|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111379616|NCT05554939|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111379617|NCT05554939|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111379618|NCT05554939|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111379619|NCT05554939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111379620|NCT05554939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111379621|NCT05554939|Antimetabolites|antimetabolites|mesh-ancestor
111379622|NCT05545891|Aripiprazole|aripiprazole|mesh-list
111379623|NCT05545891|Antidepressive Agents|antidepressive agents|mesh-ancestor
111379624|NCT05545891|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111379625|NCT05545891|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111379626|NCT05545891|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111379627|NCT05545891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111379628|NCT05545891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111379629|NCT05545891|Dopamine Agonists|dopamine agonists|mesh-ancestor
111379630|NCT05545891|Dopamine Agents|dopamine agents|mesh-ancestor
111379631|NCT05545891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111379632|NCT05545891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111379633|NCT05545891|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111379634|NCT05545891|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111379635|NCT05545891|Serotonin Agents|serotonin agents|mesh-ancestor
111379636|NCT05545891|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111379637|NCT05545891|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111379638|NCT05545891|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111379639|NCT05545891|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111379640|NCT05533697|Pembrolizumab|pembrolizumab|mesh-list
111379641|NCT05533697|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111379642|NCT05533697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111379643|NCT05533697|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111379644|NCT05533697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111379645|NCT05528458|Osimertinib|osimertinib|mesh-list
111379646|NCT05528458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111379647|NCT05528458|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111379648|NCT05528458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111379649|NCT05528458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111379650|NCT05467761|Psilocybin|psilocybin|mesh-list
111379651|NCT05467761|Hallucinogens|hallucinogens|mesh-ancestor
111379652|NCT05467761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111379653|NCT05467761|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111379654|NCT05440864|Durvalumab|durvalumab|mesh-list
111104086|NCT02084056|Metformin|metformin|mesh-list
111379655|NCT05440864|Tremelimumab|tremelimumab|mesh-list
111379656|NCT05440864|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111379657|NCT05440864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111379658|NCT05418361|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
111379659|NCT05418361|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
111379660|NCT05418361|Protease Inhibitors|protease inhibitors|mesh-ancestor
111379661|NCT05418361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111379662|NCT05418361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111379663|NCT05379530|Anesthetics|anesthetics|mesh-list
111379664|NCT05379530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111379665|NCT05379530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111379666|NCT05282901|Pembrolizumab|pembrolizumab|mesh-list
111379667|NCT05282901|Lenvatinib|lenvatinib|mesh-list
111379668|NCT05282901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111379669|NCT05282901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111379670|NCT05282901|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111379671|NCT05282901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111379672|NCT05282901|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111379673|NCT05282901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111379674|NCT05272605|Vaccines|vaccines|mesh-list
111379675|NCT05272605|Immunologic Factors|immunologic factors|mesh-ancestor
111379676|NCT05272605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111379677|NCT05265286|Factor VIII|factor viii|mesh-list
111379678|NCT05265286|Coagulants|coagulants|mesh-ancestor
111379679|NCT05233202|Simendan|simendan|mesh-list
111379680|NCT05233202|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111379681|NCT05233202|Vasodilator Agents|vasodilator agents|mesh-ancestor
111379682|NCT05233202|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
111379683|NCT05233202|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111379684|NCT05233202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111379685|NCT05233202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111379686|NCT05233202|Protective Agents|protective agents|mesh-ancestor
111379687|NCT05233202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111379688|NCT05232123|Cannabidiol|cannabidiol|mesh-list
111379689|NCT05232123|Anticonvulsants|anticonvulsants|mesh-ancestor
111379690|NCT05229055|Ketamine|ketamine|mesh-list
111379691|NCT05229055|Analgesics|analgesics|mesh-ancestor
111379692|NCT05229055|Sensory System Agents|sensory system agents|mesh-ancestor
111379693|NCT05229055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111379694|NCT05229055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111379695|NCT05229055|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111379696|NCT05229055|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111379697|NCT05229055|Anesthetics, General|anesthetics, general|mesh-ancestor
111379698|NCT05229055|Anesthetics|anesthetics|mesh-ancestor
111379699|NCT05229055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111379700|NCT05229055|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111379701|NCT05229055|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111379702|NCT05229055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111379703|NCT05229055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111379704|NCT05151471|Edaravone|edaravone|mesh-list
111379705|NCT05151471|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111379706|NCT05151471|Antioxidants|antioxidants|mesh-ancestor
111379707|NCT05151471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111379708|NCT05151471|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111379709|NCT05151471|Protective Agents|protective agents|mesh-ancestor
111379710|NCT05151471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111379711|NCT05009992|TIC10 compound|tic10 compound|mesh-list
111379712|NCT05009992|Dopamine|dopamine|mesh-list
111379713|NCT05009992|GDC-0084|gdc-0084|mesh-list
111379714|NCT05009992|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111379715|NCT05009992|Sympathomimetics|sympathomimetics|mesh-ancestor
111379716|NCT05009992|Autonomic Agents|autonomic agents|mesh-ancestor
111379717|NCT05009992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111379718|NCT05009992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111379719|NCT05009992|Dopamine Agents|dopamine agents|mesh-ancestor
111379720|NCT05009992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111379721|NCT05009992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111379722|NCT05009992|Protective Agents|protective agents|mesh-ancestor
111379723|NCT05009992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111379724|NCT05009992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111379725|NCT04986072|Nitroprusside|nitroprusside|mesh-list
111379726|NCT04986072|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111379727|NCT04986072|Vasodilator Agents|vasodilator agents|mesh-ancestor
111379728|NCT04986072|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
111379729|NCT04986072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111379730|NCT04965935|Dapagliflozin|dapagliflozin|mesh-list
111379731|NCT04965935|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111379732|NCT04965935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111379733|NCT04965935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111379734|NCT04965935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111379735|NCT04964869|Epinephrine|epinephrine|mesh-list
111379736|NCT04964869|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111379737|NCT04964869|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111379738|NCT04964869|Adrenergic Agents|adrenergic agents|mesh-ancestor
111379739|NCT04964869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111379740|NCT04964869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111379741|NCT04964869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111379742|NCT04964869|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111379743|NCT04964869|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111379744|NCT04964869|Autonomic Agents|autonomic agents|mesh-ancestor
111379745|NCT04964869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111379746|NCT04964869|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111379747|NCT04964869|Respiratory System Agents|respiratory system agents|mesh-ancestor
111379748|NCT04964869|Mydriatics|mydriatics|mesh-ancestor
111379749|NCT04964869|Sympathomimetics|sympathomimetics|mesh-ancestor
111379750|NCT04964869|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111379751|NCT04936841|Pembrolizumab|pembrolizumab|mesh-list
111379752|NCT04936841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111379753|NCT04936841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111379754|NCT04936841|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111379755|NCT04936841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111379756|NCT04930536|Acalabrutinib|acalabrutinib|mesh-list
111379757|NCT04930536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111379758|NCT04893291|Sirolimus|sirolimus|mesh-list
111379759|NCT04893291|Everolimus|everolimus|mesh-list
111379760|NCT04893291|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111379761|NCT04893291|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111379762|NCT04893291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111379763|NCT04893291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111379764|NCT04893291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111379765|NCT04893291|Immunologic Factors|immunologic factors|mesh-ancestor
111379766|NCT04893291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111379767|NCT04893291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111379768|NCT04893291|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111379769|NCT04893291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111379770|NCT04893291|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111379771|NCT04893291|Antifungal Agents|antifungal agents|mesh-ancestor
111379772|NCT04803422|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111379773|NCT04803422|Amoxicillin|amoxicillin|mesh-list
111379774|NCT04803422|Metronidazole|metronidazole|mesh-list
111379775|NCT04803422|Tazobactam|tazobactam|mesh-list
111379776|NCT04803422|Piperacillin|piperacillin|mesh-list
111379777|NCT04803422|Clavulanic Acids|clavulanic acids|mesh-list
111379778|NCT04803422|Clavulanic Acid|clavulanic acid|mesh-list
111379779|NCT04803422|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
111379780|NCT04803422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111379781|NCT04803422|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111379782|NCT04803422|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111379783|NCT04803422|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
111379784|NCT04803422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111379785|NCT04803422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111379786|NCT04791943|Melatonin|melatonin|mesh-list
111379787|NCT04791943|Antioxidants|antioxidants|mesh-ancestor
111379788|NCT04791943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111379789|NCT04791943|Protective Agents|protective agents|mesh-ancestor
111379790|NCT04791943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111379791|NCT04791943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111379792|NCT04770532|Insulin|insulin|mesh-list
111379793|NCT04770532|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111379794|NCT04770532|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111379795|NCT04770532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111379796|NCT04731779|Cannabidiol|cannabidiol|mesh-list
111379797|NCT04731779|Anticonvulsants|anticonvulsants|mesh-ancestor
111379798|NCT04717765|Vitamin E|vitamin e|mesh-list
111379799|NCT04717765|alpha-Tocopherol|alpha-tocopherol|mesh-list
111379800|NCT04717765|Tocopherols|tocopherols|mesh-list
111379801|NCT04717765|Antioxidants|antioxidants|mesh-ancestor
111379802|NCT04717765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111379803|NCT04717765|Protective Agents|protective agents|mesh-ancestor
111379804|NCT04717765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111379805|NCT04717765|Vitamins|vitamins|mesh-ancestor
111379806|NCT04717765|Micronutrients|micronutrients|mesh-ancestor
111379807|NCT04715568|Losartan|losartan|mesh-list
111379808|NCT04715568|Antihypertensive Agents|antihypertensive agents|mesh-list
111379809|NCT04715568|Angiotensin II|angiotensin ii|mesh-list
111379810|NCT04715568|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
111379811|NCT04715568|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111379812|NCT04715568|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111379813|NCT04715568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111379814|NCT04715568|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111379815|NCT04665947|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
111379816|NCT04665947|Chelating Agents|chelating agents|mesh-ancestor
111379817|NCT04665947|Sequestering Agents|sequestering agents|mesh-ancestor
111379818|NCT04665947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111379819|NCT04658849|Pioglitazone|pioglitazone|mesh-list
111379820|NCT04658849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111379821|NCT04658849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111379823|NCT04616313|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111379824|NCT04616313|Anesthetics, General|anesthetics, general|mesh-ancestor
111379825|NCT04616313|Anesthetics|anesthetics|mesh-ancestor
111379826|NCT04616313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111379827|NCT04616313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111379828|NCT04577404|Edaravone|edaravone|mesh-list
111379829|NCT04577404|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111379830|NCT04577404|Antioxidants|antioxidants|mesh-ancestor
111379831|NCT04577404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111379832|NCT04577404|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111379833|NCT04577404|Protective Agents|protective agents|mesh-ancestor
111379834|NCT04577404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111379835|NCT04566887|Acalabrutinib|acalabrutinib|mesh-list
111379836|NCT04566887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111379837|NCT04452747|Dinoprostone|dinoprostone|mesh-list
111379838|NCT04452747|Oxytocics|oxytocics|mesh-ancestor
111379839|NCT04452747|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111379840|NCT04452747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111379841|NCT04421339|Melatonin|melatonin|mesh-list
111379842|NCT04421339|Antioxidants|antioxidants|mesh-ancestor
111379843|NCT04421339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111379844|NCT04421339|Protective Agents|protective agents|mesh-ancestor
111379845|NCT04421339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111379846|NCT04421339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111379847|NCT04418661|Pembrolizumab|pembrolizumab|mesh-list
111379848|NCT04418661|Adagrasib|adagrasib|mesh-list
111379849|NCT04418661|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111379850|NCT04418661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111379851|NCT04418661|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111379852|NCT04418661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111379853|NCT04342572|Melphalan|melphalan|mesh-list
111379854|NCT04342572|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111379855|NCT04342572|Alkylating Agents|alkylating agents|mesh-ancestor
111379856|NCT04342572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111379857|NCT04342572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111379858|NCT04342572|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111379859|NCT04342572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111379860|NCT04342572|Immunologic Factors|immunologic factors|mesh-ancestor
111379861|NCT04342572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111379862|NCT04250051|Vidarabine|vidarabine|mesh-list
111379863|NCT04250051|Cytarabine|cytarabine|mesh-list
111379864|NCT04250051|Fludarabine|fludarabine|mesh-list
111379865|NCT04250051|Fludarabine phosphate|fludarabine phosphate|mesh-list
111379866|NCT04250051|Ivosidenib|ivosidenib|mesh-list
111379867|NCT04250051|Lenograstim|lenograstim|mesh-list
111379868|NCT04250051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111379869|NCT04250051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111379870|NCT04250051|Antimetabolites|antimetabolites|mesh-ancestor
111379871|NCT04250051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110519653|NCT05222984|Decitabine|decitabine|mesh-list
111379872|NCT04250051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111379873|NCT04250051|Immunologic Factors|immunologic factors|mesh-ancestor
111379874|NCT04250051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111379875|NCT04250051|Antiviral Agents|antiviral agents|mesh-ancestor
111379876|NCT04250051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111379877|NCT04250051|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111379878|NCT04250051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111379879|NCT04204980|Daratumumab|daratumumab|mesh-list
111379880|NCT04204980|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111379881|NCT04204980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111379882|NCT04204980|Immunologic Factors|immunologic factors|mesh-ancestor
111379883|NCT04204980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111379884|NCT04165824|Edaravone|edaravone|mesh-list
111379885|NCT04165824|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111379886|NCT04165824|Antioxidants|antioxidants|mesh-ancestor
111379887|NCT04165824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111379888|NCT04165824|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111379889|NCT04165824|Protective Agents|protective agents|mesh-ancestor
111379890|NCT04165824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111379891|NCT04108039|Cetrorelix|cetrorelix|mesh-list
111379892|NCT04108039|Progesterone|progesterone|mesh-list
111379893|NCT04108039|Ganirelix|ganirelix|mesh-list
111379894|NCT04108039|Progestins|progestins|mesh-ancestor
111379895|NCT04108039|Hormones|hormones|mesh-ancestor
111379896|NCT04108039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111379897|NCT04108039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111379898|NCT04108039|Hormone Antagonists|hormone antagonists|mesh-ancestor
111379899|NCT04108039|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111379900|NCT04108039|Fertility Agents|fertility agents|mesh-ancestor
111379901|NCT04108039|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111379902|NCT04069169|Lidocaine|lidocaine|mesh-list
111379903|NCT04069169|Anesthetics, Local|anesthetics, local|mesh-ancestor
111379904|NCT04069169|Anesthetics|anesthetics|mesh-ancestor
111379905|NCT04069169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111379906|NCT04069169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111379907|NCT04069169|Sensory System Agents|sensory system agents|mesh-ancestor
111379908|NCT04069169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111379909|NCT04069169|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111379910|NCT04069169|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111379911|NCT04069169|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111379912|NCT04069169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111379913|NCT04069169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111379914|NCT03997097|Sildenafil Citrate|sildenafil citrate|mesh-list
111379915|NCT03997097|Vasodilator Agents|vasodilator agents|mesh-ancestor
111379916|NCT03997097|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111379917|NCT03997097|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111379918|NCT03997097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111379919|NCT03997097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111379920|NCT03997097|Urological Agents|urological agents|mesh-ancestor
111379921|NCT03988036|Pembrolizumab|pembrolizumab|mesh-list
111379922|NCT03988036|Trastuzumab|trastuzumab|mesh-list
111379923|NCT03988036|Pertuzumab|pertuzumab|mesh-list
111379924|NCT03988036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111379925|NCT03988036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111379926|NCT03988036|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111379927|NCT03988036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111379928|NCT03899987|Aspirin|aspirin|mesh-list
111379929|NCT03899987|Interferons|interferons|mesh-list
111379930|NCT03899987|Interferon-alpha|interferon-alpha|mesh-list
111379931|NCT03899987|Interferon alpha-2|interferon alpha-2|mesh-list
111379932|NCT03899987|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
111379933|NCT03899987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111379934|NCT03899987|Antiviral Agents|antiviral agents|mesh-ancestor
111379935|NCT03899987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110519724|NCT04548999|Histamine Agents|histamine agents|mesh-ancestor
111379936|NCT03899987|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111379937|NCT03899987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111379938|NCT03899987|Analgesics|analgesics|mesh-ancestor
111379939|NCT03899987|Sensory System Agents|sensory system agents|mesh-ancestor
111379940|NCT03899987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111379941|NCT03899987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111379942|NCT03899987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111379943|NCT03899987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111379944|NCT03899987|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111379945|NCT03899987|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111379946|NCT03899987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111379947|NCT03899987|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111379948|NCT03899987|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111379949|NCT03899987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111379950|NCT03899987|Antipyretics|antipyretics|mesh-ancestor
111379951|NCT03899987|Immunologic Factors|immunologic factors|mesh-ancestor
111379952|NCT03850028|Atezolizumab|atezolizumab|mesh-list
111379953|NCT03850028|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111379954|NCT03850028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111379955|NCT03850028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111379956|NCT03850028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111379957|NCT03725436|Paclitaxel|paclitaxel|mesh-list
111379958|NCT03725436|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111379959|NCT03725436|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111379960|NCT03725436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111379961|NCT03725436|Tubulin Modulators|tubulin modulators|mesh-ancestor
111379962|NCT03725436|Antimitotic Agents|antimitotic agents|mesh-ancestor
111379963|NCT03725436|Mitosis Modulators|mitosis modulators|mesh-ancestor
111379964|NCT03725436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111379965|NCT03678688|Bedaquiline|bedaquiline|mesh-list
111379966|NCT03678688|Diarylquinolines|diarylquinolines|mesh-list
111379967|NCT03678688|Antitubercular Agents|antitubercular agents|mesh-ancestor
111379968|NCT03678688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111379969|NCT03678688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111379970|NCT03602612|Cyclophosphamide|cyclophosphamide|mesh-list
111379971|NCT03602612|Fludarabine|fludarabine|mesh-list
111379972|NCT03602612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111379973|NCT03602612|Immunologic Factors|immunologic factors|mesh-ancestor
111379974|NCT03602612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111379975|NCT03602612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111379976|NCT03602612|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111379977|NCT03602612|Alkylating Agents|alkylating agents|mesh-ancestor
111379978|NCT03602612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111379979|NCT03602612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111379980|NCT03602612|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111379981|NCT03554044|Tamoxifen|tamoxifen|mesh-list
111379982|NCT03554044|Paclitaxel|paclitaxel|mesh-list
111379983|NCT03554044|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111379984|NCT03554044|Carboplatin|carboplatin|mesh-list
111379985|NCT03554044|Gemcitabine|gemcitabine|mesh-list
111379986|NCT03554044|Letrozole|letrozole|mesh-list
111379987|NCT03554044|Fulvestrant|fulvestrant|mesh-list
111379988|NCT03554044|Anastrozole|anastrozole|mesh-list
111379989|NCT03554044|Exemestane|exemestane|mesh-list
111379990|NCT03554044|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
111379991|NCT03554044|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111379992|NCT03554044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111379993|NCT03554044|Tubulin Modulators|tubulin modulators|mesh-ancestor
111379994|NCT03554044|Antimitotic Agents|antimitotic agents|mesh-ancestor
111379995|NCT03554044|Mitosis Modulators|mitosis modulators|mesh-ancestor
111379996|NCT03554044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111379997|NCT03554044|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111379998|NCT03554044|Antimetabolites|antimetabolites|mesh-ancestor
111379999|NCT03554044|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111380000|NCT03554044|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111380001|NCT03554044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111380002|NCT03554044|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111380003|NCT03554044|Hormone Antagonists|hormone antagonists|mesh-ancestor
111380004|NCT03554044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111380005|NCT03554044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111380006|NCT03554044|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111380007|NCT03554044|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111380008|NCT03554044|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111380009|NCT03554044|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111380010|NCT03554044|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
111380011|NCT03554044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111380012|NCT03524937|Melatonin|melatonin|mesh-list
111380013|NCT03524937|Antioxidants|antioxidants|mesh-ancestor
111380014|NCT03524937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111380015|NCT03524937|Protective Agents|protective agents|mesh-ancestor
111380016|NCT03524937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111380017|NCT03524937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111380018|NCT03505710|Trastuzumab|trastuzumab|mesh-list
111380019|NCT03505710|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
111380020|NCT03505710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111380021|NCT03505710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111380022|NCT03505710|Immunoconjugates|immunoconjugates|mesh-ancestor
111380023|NCT03505710|Immunologic Factors|immunologic factors|mesh-ancestor
111380024|NCT03505710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111380025|NCT03435458|Misoprostol|misoprostol|mesh-list
111380026|NCT03435458|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111380027|NCT03435458|Abortifacient Agents|abortifacient agents|mesh-ancestor
111380028|NCT03435458|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111380029|NCT03435458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111380030|NCT03435458|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111380031|NCT03435458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110959229|NCT03523572|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111380033|NCT03323476|Mycophenolic Acid|mycophenolic acid|mesh-list
111380034|NCT03323476|Prednisone|prednisone|mesh-list
111380035|NCT03323476|Rituximab|rituximab|mesh-list
111380036|NCT03323476|Immunosuppressive Agents|immunosuppressive agents|mesh-list
111380037|NCT03323476|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111380038|NCT03323476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111380039|NCT03323476|Immunologic Factors|immunologic factors|mesh-ancestor
111380040|NCT03323476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111380041|NCT03323476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111380042|NCT03323476|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111380043|NCT03323476|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111380044|NCT03323476|Antitubercular Agents|antitubercular agents|mesh-ancestor
111380045|NCT03323476|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111380046|NCT03323476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111380047|NCT03323476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111380048|NCT03323476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111380049|NCT03323476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111380050|NCT03323476|Glucocorticoids|glucocorticoids|mesh-ancestor
111380051|NCT03323476|Hormones|hormones|mesh-ancestor
111380052|NCT03323476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111380053|NCT03323476|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111380054|NCT03260569|Nitric Oxide|nitric oxide|mesh-list
111380055|NCT03260569|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111380056|NCT03260569|Autonomic Agents|autonomic agents|mesh-ancestor
111380057|NCT03260569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111380058|NCT03260569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111380059|NCT03260569|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111380060|NCT03260569|Respiratory System Agents|respiratory system agents|mesh-ancestor
110519854|NCT04337827|Immunologic Factors|immunologic factors|mesh-ancestor
111380061|NCT03260569|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111380062|NCT03260569|Antioxidants|antioxidants|mesh-ancestor
111380063|NCT03260569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111380064|NCT03260569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111380065|NCT03260569|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
111380066|NCT03260569|Vasodilator Agents|vasodilator agents|mesh-ancestor
111380067|NCT03260569|Gasotransmitters|gasotransmitters|mesh-ancestor
111380068|NCT03260569|Protective Agents|protective agents|mesh-ancestor
111380069|NCT03188796|Vitamin D|vitamin d|mesh-list
111380070|NCT03188796|Cholecalciferol|cholecalciferol|mesh-list
111380071|NCT03188796|Vitamins|vitamins|mesh-ancestor
111380072|NCT03188796|Micronutrients|micronutrients|mesh-ancestor
111380073|NCT03188796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111380074|NCT03188796|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111380075|NCT03188796|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111380076|NCT03184194|Cyclophosphamide|cyclophosphamide|mesh-list
111380077|NCT03184194|Nivolumab|nivolumab|mesh-list
111380078|NCT03184194|Daratumumab|daratumumab|mesh-list
111380079|NCT03184194|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111380080|NCT03184194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111380081|NCT03184194|Immunologic Factors|immunologic factors|mesh-ancestor
111380082|NCT03184194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111380083|NCT03184194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111380084|NCT03184194|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111380085|NCT03184194|Alkylating Agents|alkylating agents|mesh-ancestor
111380086|NCT03184194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111380087|NCT03184194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111380088|NCT03184194|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111380089|NCT03184194|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111380090|NCT03184194|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111380091|NCT03096041|Analgesics|analgesics|mesh-list
111380092|NCT03096041|Sensory System Agents|sensory system agents|mesh-ancestor
111380093|NCT03096041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111380094|NCT03096041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111380095|NCT03018366|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
111380096|NCT03018366|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
111380097|NCT03018366|Estradiol|estradiol|mesh-list
111380098|NCT03018366|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
111380099|NCT03018366|Progesterone|progesterone|mesh-list
111380100|NCT03018366|Estrogens|estrogens|mesh-ancestor
111380101|NCT03018366|Hormones|hormones|mesh-ancestor
111104534|NCT04540133|Protease Inhibitors|protease inhibitors|mesh-ancestor
111380102|NCT03018366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111380103|NCT03018366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111380104|NCT03018366|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111380105|NCT03018366|Contraceptive Agents|contraceptive agents|mesh-ancestor
111380106|NCT03018366|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111380107|NCT03018366|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111380109|NCT02889159|Imiquimod|imiquimod|mesh-list
111380110|NCT02889159|Histamine|histamine|mesh-list
111380111|NCT02889159|Histamine phosphate|histamine phosphate|mesh-list
111380112|NCT02889159|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111380113|NCT02889159|Immunologic Factors|immunologic factors|mesh-ancestor
111380114|NCT02889159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111380115|NCT02889159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111380116|NCT02889159|Interferon Inducers|interferon inducers|mesh-ancestor
111380117|NCT02889159|Histamine Agonists|histamine agonists|mesh-ancestor
111380118|NCT02889159|Histamine Agents|histamine agents|mesh-ancestor
111380119|NCT02889159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111380120|NCT02889159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111380121|NCT02841280|Chlorthalidone|chlorthalidone|mesh-list
111380122|NCT02841280|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111380123|NCT02841280|Diuretics|diuretics|mesh-ancestor
111380124|NCT02841280|Natriuretic Agents|natriuretic agents|mesh-ancestor
111380125|NCT02841280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111380126|NCT02841280|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
111380127|NCT02841280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111380128|NCT02841280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111380129|NCT02813356|Naloxegol|naloxegol|mesh-list
111380130|NCT02813356|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111380131|NCT02813356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111380132|NCT02813356|Sensory System Agents|sensory system agents|mesh-ancestor
111380133|NCT02813356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111380134|NCT02760329|Nitric Oxide|nitric oxide|mesh-list
111380135|NCT02760329|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111380136|NCT02760329|Autonomic Agents|autonomic agents|mesh-ancestor
111380137|NCT02760329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111380138|NCT02760329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111380139|NCT02760329|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111380140|NCT02760329|Respiratory System Agents|respiratory system agents|mesh-ancestor
111380141|NCT02760329|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111380142|NCT02760329|Antioxidants|antioxidants|mesh-ancestor
111380143|NCT02760329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111380144|NCT02760329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111380145|NCT02760329|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
111380146|NCT02760329|Vasodilator Agents|vasodilator agents|mesh-ancestor
111380147|NCT02760329|Gasotransmitters|gasotransmitters|mesh-ancestor
111380148|NCT02760329|Protective Agents|protective agents|mesh-ancestor
111380149|NCT02723500|Xenon|xenon|mesh-list
111380150|NCT02723500|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111380151|NCT02723500|Anesthetics, General|anesthetics, general|mesh-ancestor
111380152|NCT02723500|Anesthetics|anesthetics|mesh-ancestor
111380153|NCT02723500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111380154|NCT02723500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111380155|NCT02678182|Capecitabine|capecitabine|mesh-list
111380156|NCT02678182|Trastuzumab|trastuzumab|mesh-list
111380157|NCT02678182|Durvalumab|durvalumab|mesh-list
111380158|NCT02678182|Ramucirumab|ramucirumab|mesh-list
111380159|NCT02678182|Rucaparib|rucaparib|mesh-list
111380160|NCT02678182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111380161|NCT02678182|Antimetabolites|antimetabolites|mesh-ancestor
111380162|NCT02678182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111380163|NCT02678182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111380164|NCT02678182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111380165|NCT02678182|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111380166|NCT02678182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111380167|NCT02620865|Calcium, Dietary|calcium, dietary|mesh-list
111380168|NCT02620865|Leucovorin|leucovorin|mesh-list
111380169|NCT02620865|Folic Acid|folic acid|mesh-list
111380170|NCT02620865|Aldesleukin|aldesleukin|mesh-list
111380171|NCT02620865|Paclitaxel|paclitaxel|mesh-list
111380172|NCT02620865|Camptothecin|camptothecin|mesh-list
111380173|NCT02620865|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111380174|NCT02620865|Gemcitabine|gemcitabine|mesh-list
111380175|NCT02620865|Fluorouracil|fluorouracil|mesh-list
111380176|NCT02620865|Oxaliplatin|oxaliplatin|mesh-list
111380177|NCT02620865|Irinotecan|irinotecan|mesh-list
111380178|NCT02620865|Interleukin-2|interleukin-2|mesh-list
111380179|NCT02620865|Antibodies|antibodies|mesh-list
111380180|NCT02620865|Immunoglobulins|immunoglobulins|mesh-list
111380181|NCT02620865|Sargramostim|sargramostim|mesh-list
111380182|NCT02620865|Calcium|calcium|mesh-list
111380183|NCT02620865|Levoleucovorin|levoleucovorin|mesh-list
111380184|NCT02620865|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111380185|NCT02620865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111380186|NCT02620865|Tubulin Modulators|tubulin modulators|mesh-ancestor
111380187|NCT02620865|Antimitotic Agents|antimitotic agents|mesh-ancestor
111380188|NCT02620865|Mitosis Modulators|mitosis modulators|mesh-ancestor
111380189|NCT02620865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111380190|NCT02620865|Immunologic Factors|immunologic factors|mesh-ancestor
111380191|NCT02620865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111380192|NCT02620865|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111380193|NCT02620865|Antimetabolites|antimetabolites|mesh-ancestor
111380194|NCT02620865|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111380195|NCT02620865|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111380196|NCT02620865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111380197|NCT02620865|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111380198|NCT02620865|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111380199|NCT02620865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111380200|NCT02620865|Antidotes|antidotes|mesh-ancestor
111380201|NCT02620865|Protective Agents|protective agents|mesh-ancestor
111380202|NCT02620865|Vitamin B Complex|vitamin b complex|mesh-ancestor
111380203|NCT02620865|Vitamins|vitamins|mesh-ancestor
111380204|NCT02620865|Micronutrients|micronutrients|mesh-ancestor
111380205|NCT02620865|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111380206|NCT02620865|Analgesics|analgesics|mesh-ancestor
111380207|NCT02620865|Sensory System Agents|sensory system agents|mesh-ancestor
111380208|NCT02620865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111380209|NCT02620865|Hematinics|hematinics|mesh-ancestor
111380210|NCT02620865|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111380211|NCT02620865|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111380212|NCT02620865|Antiviral Agents|antiviral agents|mesh-ancestor
111380213|NCT02620865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111380214|NCT02505477|Acetylcysteine|acetylcysteine|mesh-list
111380215|NCT02505477|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111380216|NCT02505477|Antiviral Agents|antiviral agents|mesh-ancestor
111380217|NCT02505477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111380218|NCT02505477|Expectorants|expectorants|mesh-ancestor
111380219|NCT02505477|Respiratory System Agents|respiratory system agents|mesh-ancestor
111380220|NCT02505477|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111380221|NCT02505477|Antioxidants|antioxidants|mesh-ancestor
111380222|NCT02505477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111380223|NCT02505477|Protective Agents|protective agents|mesh-ancestor
111380224|NCT02505477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111380225|NCT02505477|Antidotes|antidotes|mesh-ancestor
111380226|NCT02484885|Xenon|xenon|mesh-list
111380227|NCT02484885|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111380228|NCT02484885|Anesthetics, General|anesthetics, general|mesh-ancestor
111380229|NCT02484885|Anesthetics|anesthetics|mesh-ancestor
111380230|NCT02484885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111380231|NCT02484885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111380232|NCT02418572|Testosterone|testosterone|mesh-list
111380233|NCT02418572|Androgens|androgens|mesh-ancestor
111380234|NCT02418572|Hormones|hormones|mesh-ancestor
111380235|NCT02418572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111380236|NCT02418572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111380237|NCT02345330|Interleukin-12|interleukin-12|mesh-list
110520031|NCT03853954|Anesthetics|anesthetics|mesh-ancestor
111380238|NCT02345330|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111380239|NCT02345330|Immunologic Factors|immunologic factors|mesh-ancestor
111380240|NCT02345330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111380241|NCT02345330|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111380242|NCT02345330|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111380243|NCT02345330|Growth Substances|growth substances|mesh-ancestor
111380244|NCT02345330|Growth Inhibitors|growth inhibitors|mesh-ancestor
111380245|NCT02345330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111380246|NCT01665677|Atorvastatin|atorvastatin|mesh-list
111380247|NCT01665677|Calcium|calcium|mesh-list
111380248|NCT01665677|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111380249|NCT01665677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111380250|NCT01665677|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111380251|NCT01665677|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111380252|NCT01665677|Antimetabolites|antimetabolites|mesh-ancestor
111380253|NCT01665677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111380254|NCT01665677|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111380255|NCT01665677|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111380256|NCT01665677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111380257|NCT01530373|Clonidine|clonidine|mesh-list
111380258|NCT01530373|Solifenacin Succinate|solifenacin succinate|mesh-list
111380259|NCT01530373|Analgesics|analgesics|mesh-ancestor
111380260|NCT01530373|Sensory System Agents|sensory system agents|mesh-ancestor
111380261|NCT01530373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111380262|NCT01530373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111380263|NCT01530373|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111380265|NCT01530373|Autonomic Agents|autonomic agents|mesh-ancestor
111380266|NCT01530373|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111380267|NCT01530373|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111380268|NCT01530373|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111380269|NCT01530373|Adrenergic Agents|adrenergic agents|mesh-ancestor
111380270|NCT01530373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111380271|NCT01530373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111380272|NCT01530373|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111380273|NCT01530373|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111380274|NCT01530373|Cholinergic Agents|cholinergic agents|mesh-ancestor
111380275|NCT01530373|Urological Agents|urological agents|mesh-ancestor
111380276|NCT01499953|PENTA|penta|mesh-list
111380277|NCT01499953|Rivaroxaban|rivaroxaban|mesh-list
111380278|NCT01499953|Fondaparinux|fondaparinux|mesh-list
111380279|NCT01499953|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111380280|NCT01499953|Antithrombins|antithrombins|mesh-ancestor
111380281|NCT01499953|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111380282|NCT01499953|Protease Inhibitors|protease inhibitors|mesh-ancestor
111380283|NCT01499953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111380284|NCT01499953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111380285|NCT01499953|Anticoagulants|anticoagulants|mesh-ancestor
111380286|NCT01499953|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111380287|NCT01499953|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111380288|NCT01440816|Interleukin-12|interleukin-12|mesh-list
111380289|NCT01440816|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111380290|NCT01440816|Immunologic Factors|immunologic factors|mesh-ancestor
111380291|NCT01440816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111380292|NCT01440816|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111380293|NCT01440816|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111380294|NCT01440816|Growth Substances|growth substances|mesh-ancestor
111380295|NCT01440816|Growth Inhibitors|growth inhibitors|mesh-ancestor
111380296|NCT01440816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111380297|NCT01348919|Dexamethasone|dexamethasone|mesh-list
111380298|NCT01348919|Lenalidomide|lenalidomide|mesh-list
111380299|NCT01348919|Delanzomib|delanzomib|mesh-list
111380300|NCT01348919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111380301|NCT01348919|Antiemetics|antiemetics|mesh-ancestor
111380302|NCT01348919|Autonomic Agents|autonomic agents|mesh-ancestor
111380303|NCT01348919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111380304|NCT01348919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111380305|NCT01348919|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111380306|NCT01348919|Glucocorticoids|glucocorticoids|mesh-ancestor
111380307|NCT01348919|Hormones|hormones|mesh-ancestor
110520100|NCT03532139|Enoxaparin sodium|enoxaparin sodium|mesh-list
111380308|NCT01348919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111380309|NCT01348919|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111380310|NCT01348919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111380311|NCT01348919|Immunologic Factors|immunologic factors|mesh-ancestor
111380312|NCT01348919|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111380313|NCT01348919|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111380314|NCT01348919|Growth Substances|growth substances|mesh-ancestor
111380315|NCT01348919|Growth Inhibitors|growth inhibitors|mesh-ancestor
111380316|NCT01348919|Proteasome Inhibitors|proteasome inhibitors|mesh-ancestor
111380317|NCT01348919|Protease Inhibitors|protease inhibitors|mesh-ancestor
111380318|NCT01348919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111380319|NCT01348919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111380320|NCT01333046|Azacitidine|azacitidine|mesh-list
111380321|NCT01333046|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111380322|NCT01333046|Antimetabolites|antimetabolites|mesh-ancestor
111380323|NCT01333046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111380324|NCT01333046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111380325|NCT01333046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111380326|NCT01280994|Xenon|xenon|mesh-list
111380327|NCT01280994|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111380328|NCT01280994|Anesthetics, General|anesthetics, general|mesh-ancestor
111380329|NCT01280994|Anesthetics|anesthetics|mesh-ancestor
111380330|NCT01280994|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111380331|NCT01280994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111380332|NCT01217970|Ibudilast|ibudilast|mesh-list
111380333|NCT01217970|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111380334|NCT01217970|Autonomic Agents|autonomic agents|mesh-ancestor
111380335|NCT01217970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111380336|NCT01217970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111380337|NCT01217970|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111380338|NCT01217970|Respiratory System Agents|respiratory system agents|mesh-ancestor
111380339|NCT01217970|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111380341|NCT01217970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111380342|NCT01217970|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111380343|NCT01217970|Vasodilator Agents|vasodilator agents|mesh-ancestor
111380344|NCT02431806|Milnacipran|milnacipran|mesh-list
111380345|NCT02431806|Fluoxetine|fluoxetine|mesh-list
111380346|NCT02431806|Levomilnacipran|levomilnacipran|mesh-list
111380347|NCT02431806|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111380348|NCT02431806|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111380349|NCT02431806|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111380350|NCT02431806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111380351|NCT02431806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111380352|NCT02431806|Serotonin Agents|serotonin agents|mesh-ancestor
111380353|NCT02431806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111380354|NCT02431806|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111380355|NCT02431806|Antidepressive Agents|antidepressive agents|mesh-ancestor
111380356|NCT02431806|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111380357|NCT02431806|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111380358|NCT02431806|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111380359|NCT02431806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111380360|NCT02431806|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111380361|NCT02431806|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111380362|NCT02431806|Analgesics|analgesics|mesh-ancestor
111380363|NCT02431806|Sensory System Agents|sensory system agents|mesh-ancestor
111380364|NCT02431806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111380365|NCT05159193|Cyclophosphamide|cyclophosphamide|mesh-list
111380366|NCT05159193|Carboplatin|carboplatin|mesh-list
111380367|NCT05159193|Docetaxel|docetaxel|mesh-list
111380368|NCT05159193|Doxorubicin|doxorubicin|mesh-list
111380369|NCT05159193|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111380370|NCT05159193|Trastuzumab|trastuzumab|mesh-list
111380371|NCT05159193|Pertuzumab|pertuzumab|mesh-list
110520173|NCT03317457|Doxorubicin|doxorubicin|mesh-list
111380372|NCT05159193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111380373|NCT05159193|Immunologic Factors|immunologic factors|mesh-ancestor
111380374|NCT05159193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111380375|NCT05159193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111380376|NCT05159193|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111380377|NCT05159193|Alkylating Agents|alkylating agents|mesh-ancestor
111380378|NCT05159193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111380379|NCT05159193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111380380|NCT05159193|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111380381|NCT05159193|Tubulin Modulators|tubulin modulators|mesh-ancestor
111380382|NCT05159193|Antimitotic Agents|antimitotic agents|mesh-ancestor
111380383|NCT05159193|Mitosis Modulators|mitosis modulators|mesh-ancestor
111380384|NCT05159193|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111380385|NCT05159193|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111380386|NCT05159193|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111380387|NCT05159193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111380388|NCT05159193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111380389|NCT05220813|Lidocaine|lidocaine|mesh-list
111380390|NCT05220813|Bupivacaine|bupivacaine|mesh-list
111380391|NCT05220813|Anesthetics, Local|anesthetics, local|mesh-ancestor
111380392|NCT05220813|Anesthetics|anesthetics|mesh-ancestor
111380393|NCT05220813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111380394|NCT05220813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111380395|NCT05220813|Sensory System Agents|sensory system agents|mesh-ancestor
111380396|NCT05220813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111380397|NCT05220813|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111380398|NCT05220813|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111380399|NCT05220813|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111380400|NCT05220813|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111380401|NCT05220813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111380402|NCT01650246|Lesinurad|lesinurad|mesh-list
111380403|NCT01650246|Gout Suppressants|gout suppressants|mesh-ancestor
111380404|NCT01650246|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111380405|NCT01650246|Uricosuric Agents|uricosuric agents|mesh-ancestor
111380406|NCT01212302|Clopidogrel|clopidogrel|mesh-list
111380407|NCT01212302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111380408|NCT01212302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111380409|NCT01212302|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111104829|NCT02367755|Antiemetics|antiemetics|mesh-ancestor
111380410|NCT01212302|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111380411|NCT01212302|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111380413|NCT01212302|Purinergic Agents|purinergic agents|mesh-ancestor
111380414|NCT01212302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111380415|NCT01284296|Chrysarobin|chrysarobin|mesh-list
111380416|NCT01284296|Lidocaine|lidocaine|mesh-list
111380417|NCT01284296|Anesthetics, Local|anesthetics, local|mesh-ancestor
111380418|NCT01284296|Anesthetics|anesthetics|mesh-ancestor
111380419|NCT01284296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111380420|NCT01284296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111380421|NCT01284296|Sensory System Agents|sensory system agents|mesh-ancestor
111380422|NCT01284296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111380423|NCT01284296|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111380424|NCT01284296|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111380425|NCT01284296|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111380426|NCT01284296|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111380427|NCT01284296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111380428|NCT01284296|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111380429|NCT01284296|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111380430|NCT01284296|Analgesics|analgesics|mesh-ancestor
111380431|NCT01284296|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111380432|NCT01284296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111380433|NCT00364143|Irinotecan|irinotecan|mesh-list
111380434|NCT00364143|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111380435|NCT00364143|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111380436|NCT00364143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111380437|NCT00364143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111380438|NCT00364143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111380439|NCT01652664|Timolol|timolol|mesh-list
111380440|NCT01652664|Travoprost|travoprost|mesh-list
111380441|NCT01652664|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111380442|NCT01652664|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111380443|NCT01652664|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111380444|NCT01652664|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111380445|NCT01652664|Adrenergic Agents|adrenergic agents|mesh-ancestor
111380446|NCT01652664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111380447|NCT01652664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111380448|NCT01652664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111380449|NCT01652664|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111380450|NCT01652664|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111380451|NCT04055649|Paclitaxel|paclitaxel|mesh-list
111380452|NCT04055649|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111380453|NCT04055649|TIC10 compound|tic10 compound|mesh-list
111380454|NCT04055649|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111380455|NCT04055649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111380456|NCT04055649|Tubulin Modulators|tubulin modulators|mesh-ancestor
111380457|NCT04055649|Antimitotic Agents|antimitotic agents|mesh-ancestor
111380458|NCT04055649|Mitosis Modulators|mitosis modulators|mesh-ancestor
111380459|NCT04055649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111380460|NCT04899492|Nicotine|nicotine|mesh-list
111380461|NCT04899492|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111380462|NCT04899492|Autonomic Agents|autonomic agents|mesh-ancestor
111380463|NCT04899492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111380464|NCT04899492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111380465|NCT04899492|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111380466|NCT04899492|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111380467|NCT04899492|Cholinergic Agents|cholinergic agents|mesh-ancestor
111380468|NCT04899492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111380469|NCT04899492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111380470|NCT00364221|Rosiglitazone|rosiglitazone|mesh-list
111380471|NCT00364221|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111380472|NCT00364221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111380473|NCT01286402|Bupropion|bupropion|mesh-list
111380474|NCT01286402|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111380475|NCT01286402|Antidepressive Agents|antidepressive agents|mesh-ancestor
111380476|NCT01286402|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111380477|NCT01286402|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111380478|NCT01286402|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111380479|NCT01286402|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111380480|NCT01286402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111380481|NCT01286402|Dopamine Agents|dopamine agents|mesh-ancestor
111380482|NCT01286402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111380483|NCT01286402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111380484|NCT01286402|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111380485|NCT01286402|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111380486|NCT01286402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111380487|NCT01222832|Bacitracin|bacitracin|mesh-list
111380488|NCT01222832|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111380489|NCT01222832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111380490|NCT01222832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111380491|NCT04297605|Paclitaxel|paclitaxel|mesh-list
111380492|NCT04297605|Pembrolizumab|pembrolizumab|mesh-list
111380493|NCT04297605|Pemetrexed|pemetrexed|mesh-list
111380494|NCT04297605|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111380495|NCT04297605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111380496|NCT04297605|Tubulin Modulators|tubulin modulators|mesh-ancestor
111380497|NCT04297605|Antimitotic Agents|antimitotic agents|mesh-ancestor
111380498|NCT04297605|Mitosis Modulators|mitosis modulators|mesh-ancestor
111380499|NCT04297605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111380500|NCT04297605|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111380501|NCT04297605|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111380502|NCT04297605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111380503|NCT04297605|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111380504|NCT04297605|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111380505|NCT02379390|Prednisone|prednisone|mesh-list
111380506|NCT02379390|Abiraterone Acetate|abiraterone acetate|mesh-list
111380507|NCT02379390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111380508|NCT02379390|Glucocorticoids|glucocorticoids|mesh-ancestor
111380509|NCT02379390|Hormones|hormones|mesh-ancestor
111380510|NCT02379390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111380511|NCT02379390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111380512|NCT02379390|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111380513|NCT02379390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111380514|NCT02379390|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111380515|NCT02379390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111380516|NCT02379390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111380517|NCT02379390|Hormone Antagonists|hormone antagonists|mesh-ancestor
111380518|NCT02379390|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111380519|NCT04932915|Niclosamide|niclosamide|mesh-list
111380520|NCT04932915|Anticestodal Agents|anticestodal agents|mesh-ancestor
111380521|NCT04932915|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
111380522|NCT04932915|Anthelmintics|anthelmintics|mesh-ancestor
111380523|NCT04932915|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111380524|NCT04932915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111380525|NCT04932915|Antinematodal Agents|antinematodal agents|mesh-ancestor
111380526|NCT01223378|Latanoprost|latanoprost|mesh-list
111380527|NCT01223378|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
111380528|NCT01223378|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111380529|NCT03780075|177Lu-EB-PSMA-617|177lu-eb-psma-617|mesh-list
111380530|NCT03780075|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111380531|NCT03780075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111380532|NCT01224626|Linezolid|linezolid|mesh-list
111380533|NCT01224626|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111380534|NCT01224626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111380535|NCT01224626|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111380536|NCT01224626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111380537|NCT01224626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111380538|NCT01289522|Cetuximab|cetuximab|mesh-list
111380539|NCT01289522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111380540|NCT01289522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111380541|NCT01226420|Alefacept|alefacept|mesh-list
111380542|NCT01226420|Dermatologic Agents|dermatologic agents|mesh-ancestor
111380543|NCT01226420|Immunologic Factors|immunologic factors|mesh-ancestor
111380544|NCT01226420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111380545|NCT04743453|Dapagliflozin|dapagliflozin|mesh-list
111380546|NCT04743453|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111380547|NCT04743453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111380548|NCT04743453|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111380549|NCT04743453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111380550|NCT04274517|Chlorhexidine|chlorhexidine|mesh-list
111380551|NCT04274517|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
111380552|NCT04274517|Povidone-Iodine|povidone-iodine|mesh-list
111380553|NCT04274517|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111380554|NCT04274517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111380555|NCT04274517|Disinfectants|disinfectants|mesh-ancestor
111380556|NCT04274517|Dermatologic Agents|dermatologic agents|mesh-ancestor
111380557|NCT00365001|Methotrexate|methotrexate|mesh-list
111380558|NCT00365001|Simvastatin|simvastatin|mesh-list
111380559|NCT00365001|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111380560|NCT00365001|Abortifacient Agents|abortifacient agents|mesh-ancestor
111380561|NCT00365001|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111380562|NCT00365001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111380563|NCT00365001|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111380564|NCT00365001|Antimetabolites|antimetabolites|mesh-ancestor
111380565|NCT00365001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111380566|NCT00365001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111380567|NCT00365001|Dermatologic Agents|dermatologic agents|mesh-ancestor
111380568|NCT00365001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111380569|NCT00365001|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111380570|NCT00365001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111380571|NCT00365001|Immunologic Factors|immunologic factors|mesh-ancestor
111380572|NCT00365001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111380573|NCT00365001|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111380574|NCT00365001|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111380575|NCT00365001|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111380576|NCT00365001|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111380577|NCT00365001|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111380578|NCT01289912|Everolimus|everolimus|mesh-list
111380579|NCT01289912|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111380580|NCT01289912|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111380581|NCT01289912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111380582|NCT01289912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111380583|NCT01289912|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111380584|NCT01289912|Immunologic Factors|immunologic factors|mesh-ancestor
111380585|NCT01289912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111380586|NCT01289912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111380587|NCT03192345|Cemiplimab|cemiplimab|mesh-list
111380588|NCT03192345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111380589|NCT03192345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111380590|NCT03069963|Alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|mesh-list
111380591|NCT03069963|Antacids|antacids|mesh-ancestor
111380592|NCT03069963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111380593|NCT03069963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111380594|NCT01227434|Palbociclib|palbociclib|mesh-list
111380595|NCT01227434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111380596|NCT01227434|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111380597|NCT01227434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111380598|NCT01227434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111380599|NCT01714739|Nivolumab|nivolumab|mesh-list
111380600|NCT01714739|Ipilimumab|ipilimumab|mesh-list
111380601|NCT01714739|Immunoglobulins|immunoglobulins|mesh-list
110520425|NCT01552434|Sirolimus|sirolimus|mesh-list
111380602|NCT01714739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111380603|NCT01714739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111380604|NCT01714739|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111380605|NCT01714739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111380606|NCT01714739|Immunologic Factors|immunologic factors|mesh-ancestor
111380607|NCT01714739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111380608|NCT02377479|Letrozole|letrozole|mesh-list
111380609|NCT02377479|Clomiphene|clomiphene|mesh-list
111380610|NCT02377479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111380611|NCT02377479|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111380612|NCT02377479|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111380613|NCT02377479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111380614|NCT02377479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111380615|NCT02377479|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111380616|NCT02377479|Hormone Antagonists|hormone antagonists|mesh-ancestor
111380617|NCT02377479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111380618|NCT02377479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111380619|NCT02377479|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111380620|NCT02377479|Fertility Agents|fertility agents|mesh-ancestor
111380621|NCT02377479|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111380622|NCT02377479|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111380623|NCT02377479|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111380624|NCT01291784|Antibodies|antibodies|mesh-list
111380625|NCT01291784|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111380626|NCT01291784|Immunologic Factors|immunologic factors|mesh-ancestor
111380627|NCT01291784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111380628|NCT05457647|Riboflavin|riboflavin|mesh-list
111380629|NCT05457647|Vitamin B Complex|vitamin b complex|mesh-ancestor
111380630|NCT05457647|Vitamins|vitamins|mesh-ancestor
111380631|NCT05457647|Micronutrients|micronutrients|mesh-ancestor
111380632|NCT05457647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111380633|NCT05457647|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111380634|NCT05457647|Dermatologic Agents|dermatologic agents|mesh-ancestor
111380635|NCT01213316|Raltegravir Potassium|raltegravir potassium|mesh-list
111380636|NCT01213316|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111380637|NCT01213316|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111380638|NCT01213316|Antiviral Agents|antiviral agents|mesh-ancestor
111380639|NCT01213316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111380640|NCT01213316|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111380641|NCT01213316|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111380642|NCT01213316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111380643|NCT01213316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111380644|NCT05439629|Ranibizumab|ranibizumab|mesh-list
111380645|NCT05439629|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111380646|NCT05439629|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111380647|NCT05439629|Growth Substances|growth substances|mesh-ancestor
111380648|NCT05439629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111380649|NCT05439629|Growth Inhibitors|growth inhibitors|mesh-ancestor
111380650|NCT05439629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111380651|NCT01229228|Naproxen|naproxen|mesh-list
111380652|NCT01229228|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111380653|NCT01229228|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111380654|NCT01229228|Analgesics|analgesics|mesh-ancestor
111380655|NCT01229228|Sensory System Agents|sensory system agents|mesh-ancestor
111380656|NCT01229228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111380657|NCT01229228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111380658|NCT01229228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111380659|NCT01229228|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111380660|NCT01229228|Gout Suppressants|gout suppressants|mesh-ancestor
111380661|NCT01229228|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111380662|NCT01229228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111380663|NCT01229228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111380664|NCT01292252|Teriparatide|teriparatide|mesh-list
111380665|NCT01292252|Parathyroid Hormone|parathyroid hormone|mesh-list
111380666|NCT01292252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111380667|NCT01292252|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111380668|NCT01292252|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111380669|NCT02192684|Pioglitazone|pioglitazone|mesh-list
111380670|NCT02192684|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111380671|NCT02192684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111380672|NCT02243579|Pembrolizumab|pembrolizumab|mesh-list
111380673|NCT02243579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111380674|NCT02243579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111380675|NCT02243579|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111380676|NCT02243579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111380677|NCT00003407|Cytarabine|cytarabine|mesh-list
111380678|NCT00003407|Mitoxantrone|mitoxantrone|mesh-list
111380679|NCT00003407|Amifostine|amifostine|mesh-list
111380680|NCT00003407|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111380681|NCT00003407|Antimetabolites|antimetabolites|mesh-ancestor
111380682|NCT00003407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111380683|NCT00003407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111380684|NCT00003407|Antiviral Agents|antiviral agents|mesh-ancestor
111380685|NCT00003407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111380686|NCT00003407|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111380687|NCT00003407|Immunologic Factors|immunologic factors|mesh-ancestor
111380688|NCT00003407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111380689|NCT00003407|Analgesics|analgesics|mesh-ancestor
111380690|NCT00003407|Sensory System Agents|sensory system agents|mesh-ancestor
111380691|NCT00003407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111380692|NCT00003407|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111380693|NCT00003407|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111380694|NCT00003407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111380695|NCT00003407|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111380696|NCT00003407|Protective Agents|protective agents|mesh-ancestor
111380697|NCT04838717|Doxycycline|doxycycline|mesh-list
111380698|NCT04838717|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111380699|NCT04838717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111380700|NCT04838717|Antimalarials|antimalarials|mesh-ancestor
111380701|NCT04838717|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111380702|NCT04838717|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111380703|NCT01710137|Varenicline|varenicline|mesh-list
111105132|NCT02358707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111380704|NCT01710137|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111380705|NCT01710137|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111380706|NCT01710137|Cholinergic Agents|cholinergic agents|mesh-ancestor
111380707|NCT01710137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111380708|NCT01710137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111380709|NCT01710137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111380710|NCT01710839|Ranibizumab|ranibizumab|mesh-list
111380711|NCT01710839|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110520542|NCT00082797|Leucovorin|leucovorin|mesh-list
111380712|NCT01710839|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111380713|NCT01710839|Growth Substances|growth substances|mesh-ancestor
111380714|NCT01710839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111380715|NCT01710839|Growth Inhibitors|growth inhibitors|mesh-ancestor
111380716|NCT01710839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111380717|NCT01215110|Bedaquiline|bedaquiline|mesh-list
111380718|NCT01215110|Antitubercular Agents|antitubercular agents|mesh-ancestor
111380719|NCT01215110|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111380720|NCT01215110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111380721|NCT02980757|Gliclazide|gliclazide|mesh-list
111380722|NCT02980757|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111380723|NCT02980757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111380724|NCT01229462|Timolol|timolol|mesh-list
111380725|NCT01229462|Brimonidine Tartrate|brimonidine tartrate|mesh-list
111380726|NCT01229462|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111380727|NCT01229462|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111380728|NCT01229462|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111380729|NCT01229462|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111380730|NCT01229462|Adrenergic Agents|adrenergic agents|mesh-ancestor
111380731|NCT01229462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111380732|NCT01229462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111380733|NCT01229462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111380734|NCT01229462|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111380735|NCT01229462|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111380736|NCT01229462|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111380737|NCT01229462|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111380738|NCT01229462|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111380739|NCT01292642|Nicotine|nicotine|mesh-list
111380740|NCT01292642|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111380741|NCT01292642|Autonomic Agents|autonomic agents|mesh-ancestor
111380742|NCT01292642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111380743|NCT01292642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111380744|NCT01292642|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111380745|NCT01292642|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111380746|NCT01292642|Cholinergic Agents|cholinergic agents|mesh-ancestor
111380747|NCT01292642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111380748|NCT01292642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111380749|NCT01231334|Clindamycin|clindamycin|mesh-list
111380750|NCT01231334|Clindamycin palmitate|clindamycin palmitate|mesh-list
111380751|NCT01231334|Clindamycin phosphate|clindamycin phosphate|mesh-list
111380752|NCT01231334|Dapsone|dapsone|mesh-list
111380753|NCT01231334|Adapalene|adapalene|mesh-list
111380754|NCT01231334|Benzoyl Peroxide|benzoyl peroxide|mesh-list
111380755|NCT01231334|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111380756|NCT01231334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111380757|NCT01231334|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111380758|NCT01231334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111380759|NCT01231334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111380760|NCT01231334|Dermatologic Agents|dermatologic agents|mesh-ancestor
111380761|NCT01231334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111380762|NCT01231334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111380763|NCT01231334|Analgesics|analgesics|mesh-ancestor
111380764|NCT01231334|Sensory System Agents|sensory system agents|mesh-ancestor
111380765|NCT01231334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111380766|NCT01231334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111380767|NCT01231334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111380768|NCT01231334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111380769|NCT01231334|Antimalarials|antimalarials|mesh-ancestor
111380770|NCT01231334|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111380771|NCT01231334|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111380772|NCT01231334|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111380773|NCT01231334|Leprostatic Agents|leprostatic agents|mesh-ancestor
111380774|NCT04771481|Metoclopramide|metoclopramide|mesh-list
111380775|NCT04771481|Antiemetics|antiemetics|mesh-ancestor
111380776|NCT04771481|Autonomic Agents|autonomic agents|mesh-ancestor
111380777|NCT04771481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111380778|NCT04771481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111380779|NCT04771481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111380780|NCT04771481|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111380781|NCT04771481|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111380782|NCT04771481|Dopamine Agents|dopamine agents|mesh-ancestor
111380783|NCT04771481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111380784|NCT04771481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111380785|NCT01292798|Ranibizumab|ranibizumab|mesh-list
111380786|NCT01292798|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111380787|NCT01292798|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111380788|NCT01292798|Growth Substances|growth substances|mesh-ancestor
111380789|NCT01292798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111380790|NCT01292798|Growth Inhibitors|growth inhibitors|mesh-ancestor
111380791|NCT01292798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111380792|NCT03009500|Methylprednisolone|methylprednisolone|mesh-list
111380793|NCT03009500|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111380794|NCT03009500|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111380795|NCT03009500|Prednisolone|prednisolone|mesh-list
111380796|NCT03009500|Prednisolone acetate|prednisolone acetate|mesh-list
111380797|NCT03009500|Lidocaine|lidocaine|mesh-list
111380798|NCT03009500|Bupivacaine|bupivacaine|mesh-list
111380799|NCT03009500|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111380800|NCT03009500|Prednisolone phosphate|prednisolone phosphate|mesh-list
111380801|NCT03009500|Anesthetics, Local|anesthetics, local|mesh-ancestor
111380802|NCT03009500|Anesthetics|anesthetics|mesh-ancestor
111380803|NCT03009500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111380804|NCT03009500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111380805|NCT03009500|Sensory System Agents|sensory system agents|mesh-ancestor
111380806|NCT03009500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111380807|NCT03009500|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111380808|NCT03009500|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111380809|NCT03009500|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111380810|NCT03009500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111380811|NCT03009500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111380812|NCT03009500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111380813|NCT03009500|Antiemetics|antiemetics|mesh-ancestor
111380814|NCT03009500|Autonomic Agents|autonomic agents|mesh-ancestor
111380815|NCT03009500|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111380816|NCT03009500|Glucocorticoids|glucocorticoids|mesh-ancestor
111380817|NCT03009500|Hormones|hormones|mesh-ancestor
111380818|NCT03009500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111380819|NCT03009500|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111380820|NCT03009500|Protective Agents|protective agents|mesh-ancestor
111380821|NCT03009500|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111380822|NCT03009500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111380823|NCT01715207|Atenolol|atenolol|mesh-list
111380824|NCT01715207|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111380825|NCT01715207|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111380826|NCT01715207|Sympatholytics|sympatholytics|mesh-ancestor
111380827|NCT01715207|Autonomic Agents|autonomic agents|mesh-ancestor
111380828|NCT01715207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111380829|NCT01715207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111380830|NCT01715207|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
111380831|NCT01715207|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111380832|NCT01715207|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111380833|NCT01715207|Adrenergic Agents|adrenergic agents|mesh-ancestor
111380834|NCT01715207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111380835|NCT01715207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111380836|NCT01716221|Dexetimide|dexetimide|mesh-list
111380837|NCT01716221|Bupropion|bupropion|mesh-list
111380838|NCT01716221|Citalopram|citalopram|mesh-list
111380839|NCT01716221|Escitalopram|escitalopram|mesh-list
111380840|NCT01716221|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111380841|NCT01716221|Antidepressive Agents|antidepressive agents|mesh-ancestor
111380842|NCT01716221|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111380843|NCT01716221|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111380844|NCT01716221|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111380845|NCT01716221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111380846|NCT01716221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111380847|NCT01716221|Dopamine Agents|dopamine agents|mesh-ancestor
111380848|NCT01716221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111380849|NCT01716221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111380850|NCT01716221|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111380851|NCT01716221|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111380852|NCT01716221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111380853|NCT01716221|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111380854|NCT01716221|Serotonin Agents|serotonin agents|mesh-ancestor
111380855|NCT01716221|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111380856|NCT01716221|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111380857|NCT01716221|Parasympatholytics|parasympatholytics|mesh-ancestor
111380858|NCT01716221|Autonomic Agents|autonomic agents|mesh-ancestor
111380859|NCT01716221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111380860|NCT01716221|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111380861|NCT01716221|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111380862|NCT01716221|Cholinergic Agents|cholinergic agents|mesh-ancestor
111380863|NCT01215344|Diphosphonates|diphosphonates|mesh-list
111380864|NCT01215344|Dexamethasone|dexamethasone|mesh-list
111380865|NCT01215344|Dexamethasone acetate|dexamethasone acetate|mesh-list
111380866|NCT01215344|Doxorubicin|doxorubicin|mesh-list
111380867|NCT01215344|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111380868|NCT01215344|Lenalidomide|lenalidomide|mesh-list
111380869|NCT01215344|Bortezomib|bortezomib|mesh-list
111380870|NCT01215344|BB 1101|bb 1101|mesh-list
111380871|NCT01215344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111380872|NCT01215344|Antiemetics|antiemetics|mesh-ancestor
111380873|NCT01215344|Autonomic Agents|autonomic agents|mesh-ancestor
111380874|NCT01215344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111380875|NCT01215344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111380876|NCT01215344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111380877|NCT01215344|Glucocorticoids|glucocorticoids|mesh-ancestor
111380878|NCT01215344|Hormones|hormones|mesh-ancestor
111380879|NCT01215344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111380880|NCT01215344|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111380881|NCT01215344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111380882|NCT01215344|Protease Inhibitors|protease inhibitors|mesh-ancestor
111380883|NCT01215344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111380884|NCT01215344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111380885|NCT01215344|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111380886|NCT01215344|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111380887|NCT01215344|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111380888|NCT01215344|Immunologic Factors|immunologic factors|mesh-ancestor
111380889|NCT01215344|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111380890|NCT01215344|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111380891|NCT01215344|Growth Substances|growth substances|mesh-ancestor
111380892|NCT01215344|Growth Inhibitors|growth inhibitors|mesh-ancestor
111380893|NCT01215344|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111380894|NCT01231412|Cyclosporine|cyclosporine|mesh-list
111380895|NCT01231412|Sirolimus|sirolimus|mesh-list
111380896|NCT01231412|Mycophenolic Acid|mycophenolic acid|mesh-list
111380897|NCT01231412|Fludarabine|fludarabine|mesh-list
111380898|NCT01231412|Fludarabine phosphate|fludarabine phosphate|mesh-list
111380899|NCT01231412|Cyclosporins|cyclosporins|mesh-list
111380900|NCT01231412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111380901|NCT01231412|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111380902|NCT01231412|Antimetabolites|antimetabolites|mesh-ancestor
111380903|NCT01231412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111380904|NCT01231412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111380905|NCT01231412|Immunologic Factors|immunologic factors|mesh-ancestor
111380906|NCT01231412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111380907|NCT01231412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111380908|NCT01231412|Antifungal Agents|antifungal agents|mesh-ancestor
111380909|NCT01231412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111380910|NCT01231412|Dermatologic Agents|dermatologic agents|mesh-ancestor
111380911|NCT01231412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111380912|NCT01231412|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111380913|NCT01231412|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111380914|NCT01231412|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111380915|NCT01231412|Antitubercular Agents|antitubercular agents|mesh-ancestor
111380916|NCT01231412|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111380917|NCT01719653|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
111380918|NCT01719653|Laxatives|laxatives|mesh-ancestor
111380919|NCT01719653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111380920|NCT04580771|Cisplatin|cisplatin|mesh-list
111380921|NCT04580771|Vaccines|vaccines|mesh-list
111380922|NCT04580771|Immunologic Factors|immunologic factors|mesh-ancestor
111380923|NCT04580771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111380924|NCT04580771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111380925|NCT01720277|Vaccines|vaccines|mesh-list
111380926|NCT01720277|Immunologic Factors|immunologic factors|mesh-ancestor
111380927|NCT01720277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111380928|NCT04514393|Methotrexate|methotrexate|mesh-list
111380929|NCT04514393|Temozolomide|temozolomide|mesh-list
111380930|NCT04514393|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111380931|NCT04514393|Abortifacient Agents|abortifacient agents|mesh-ancestor
111380932|NCT04514393|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111380933|NCT04514393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111380934|NCT04514393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111380935|NCT04514393|Antimetabolites|antimetabolites|mesh-ancestor
111380936|NCT04514393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111380937|NCT04514393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111380938|NCT04514393|Dermatologic Agents|dermatologic agents|mesh-ancestor
111380939|NCT04514393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111380940|NCT04514393|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111380941|NCT04514393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111380942|NCT04514393|Immunologic Factors|immunologic factors|mesh-ancestor
111380943|NCT04514393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111380944|NCT04514393|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111380945|NCT04514393|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111380946|NCT04514393|Alkylating Agents|alkylating agents|mesh-ancestor
111380947|NCT01232504|Molgramostim|molgramostim|mesh-list
111380948|NCT01232504|Lenograstim|lenograstim|mesh-list
111380949|NCT01232504|Sargramostim|sargramostim|mesh-list
111380950|NCT01232504|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111380951|NCT01232504|Immunologic Factors|immunologic factors|mesh-ancestor
111380952|NCT01232504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111380953|NCT01232504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111380954|NCT01737593|Acetaminophen|acetaminophen|mesh-list
111380955|NCT01737593|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111380956|NCT01737593|Analgesics|analgesics|mesh-ancestor
111380957|NCT01737593|Sensory System Agents|sensory system agents|mesh-ancestor
111380958|NCT01737593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111380959|NCT01737593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111380960|NCT01737593|Antipyretics|antipyretics|mesh-ancestor
111380962|NCT01217840|Ergocalciferols|ergocalciferols|mesh-list
111380963|NCT01217840|Vitamins|vitamins|mesh-ancestor
111380964|NCT01217840|Micronutrients|micronutrients|mesh-ancestor
111380965|NCT01217840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111380966|NCT01217840|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111380967|NCT01217840|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111380968|NCT01721603|Trametinib|trametinib|mesh-list
111380969|NCT01721603|Dabrafenib|dabrafenib|mesh-list
111380970|NCT01721603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111380971|NCT01721603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111380972|NCT01721603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111380973|NCT01721603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111380974|NCT01296542|Moxifloxacin|moxifloxacin|mesh-list
111380975|NCT01296542|Besifloxacin|besifloxacin|mesh-list
111380976|NCT01296542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111380977|NCT01296542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111380978|NCT01296542|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111380979|NCT01296542|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111380980|NCT01296542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111380981|NCT01296542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111380982|NCT01296542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111380983|NCT01234766|Rituximab|rituximab|mesh-list
111380984|NCT01234766|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
111380985|NCT01234766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111380986|NCT01234766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111380987|NCT01234766|Immunologic Factors|immunologic factors|mesh-ancestor
111380988|NCT01234766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111380989|NCT01234766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111380990|NCT01234766|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111380991|NCT01234766|Alkylating Agents|alkylating agents|mesh-ancestor
111380992|NCT01234766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111380993|NCT01234922|Losartan|losartan|mesh-list
111380994|NCT01234922|Ramipril|ramipril|mesh-list
111380995|NCT01234922|Lisinopril|lisinopril|mesh-list
111380996|NCT01234922|Benazepril|benazepril|mesh-list
111380997|NCT01234922|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111380998|NCT01234922|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111380999|NCT01234922|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111381000|NCT01234922|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111381001|NCT01234922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111381002|NCT01234922|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
111381003|NCT01234922|Protease Inhibitors|protease inhibitors|mesh-ancestor
111381004|NCT01234922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111381005|NCT01234922|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111381006|NCT01234922|Protective Agents|protective agents|mesh-ancestor
111381007|NCT01234922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111381008|NCT01337336|Fluticasone|fluticasone|mesh-list
111381009|NCT01337336|Xhance|xhance|mesh-list
111381010|NCT01337336|Tiotropium Bromide|tiotropium bromide|mesh-list
111381011|NCT01337336|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
111381012|NCT01337336|Ipratropium|ipratropium|mesh-list
111381013|NCT01337336|Cholinergic Antagonists|cholinergic antagonists|mesh-list
111381014|NCT01337336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111381015|NCT01337336|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111381016|NCT01337336|Autonomic Agents|autonomic agents|mesh-ancestor
111381017|NCT01337336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111381018|NCT01337336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111381019|NCT01337336|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111381020|NCT01337336|Respiratory System Agents|respiratory system agents|mesh-ancestor
111381021|NCT01337336|Dermatologic Agents|dermatologic agents|mesh-ancestor
111381022|NCT01337336|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111381023|NCT01337336|Parasympatholytics|parasympatholytics|mesh-ancestor
111381024|NCT01337336|Cholinergic Agents|cholinergic agents|mesh-ancestor
111381025|NCT01337336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111381026|NCT01337336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111381027|NCT01337336|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111381028|NCT01337336|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111381029|NCT01337336|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111381030|NCT01337336|Adrenergic Agents|adrenergic agents|mesh-ancestor
111381031|NCT01239212|Levetiracetam|levetiracetam|mesh-list
111381032|NCT01239212|Anticonvulsants|anticonvulsants|mesh-ancestor
111381033|NCT01239212|Nootropic Agents|nootropic agents|mesh-ancestor
111381034|NCT01242644|Ketorolac|ketorolac|mesh-list
111381035|NCT01242644|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
111381036|NCT01242644|Morphine|morphine|mesh-list
111381037|NCT01242644|Ropivacaine|ropivacaine|mesh-list
111381038|NCT01242644|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111381039|NCT01242644|Narcotics|narcotics|mesh-ancestor
111381040|NCT01242644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111381041|NCT01242644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111381042|NCT01242644|Analgesics|analgesics|mesh-ancestor
111381043|NCT01242644|Sensory System Agents|sensory system agents|mesh-ancestor
111381044|NCT01242644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111381045|NCT01242644|Anesthetics, Local|anesthetics, local|mesh-ancestor
111381046|NCT01242644|Anesthetics|anesthetics|mesh-ancestor
111381047|NCT01242644|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111381048|NCT01242644|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111381049|NCT01242644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111381050|NCT01242644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111381051|NCT01242644|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111381052|NCT01242644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111381053|NCT01242644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111381054|NCT01303406|Idebenone|idebenone|mesh-list
111381055|NCT01303406|Antioxidants|antioxidants|mesh-ancestor
111381056|NCT01303406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111381057|NCT01303406|Protective Agents|protective agents|mesh-ancestor
111381058|NCT01303406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111381059|NCT02597907|Aprepitant|aprepitant|mesh-list
111381060|NCT02597907|Palonosetron|palonosetron|mesh-list
111381061|NCT02597907|Ramosetron|ramosetron|mesh-list
111381062|NCT02597907|Antiemetics|antiemetics|mesh-ancestor
111381063|NCT02597907|Autonomic Agents|autonomic agents|mesh-ancestor
111381064|NCT02597907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111381065|NCT02597907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111381066|NCT02597907|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111381067|NCT02597907|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
111381068|NCT02597907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111381069|NCT02597907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111381070|NCT02597907|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111381071|NCT02597907|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111381072|NCT02597907|Serotonin Agents|serotonin agents|mesh-ancestor
111381073|NCT02600325|Grazoprevir|grazoprevir|mesh-list
111381074|NCT02600325|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
111381075|NCT02600325|Antiviral Agents|antiviral agents|mesh-ancestor
111381076|NCT02600325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111381077|NCT02600715|Morphine|morphine|mesh-list
111381078|NCT02600715|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111381079|NCT02600715|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111381080|NCT02600715|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111381081|NCT02600715|Narcotics|narcotics|mesh-ancestor
111381082|NCT02600715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111381083|NCT02600715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111381084|NCT02600715|Analgesics|analgesics|mesh-ancestor
111381085|NCT02600715|Sensory System Agents|sensory system agents|mesh-ancestor
111381086|NCT02600715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111381087|NCT02600715|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111381088|NCT02600715|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111381089|NCT02600715|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111381090|NCT02600715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111381091|NCT02600715|Cholinergic Agents|cholinergic agents|mesh-ancestor
111381092|NCT02600715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111381093|NCT04743297|Dinoprostone|dinoprostone|mesh-list
111381094|NCT04743297|Oxytocics|oxytocics|mesh-ancestor
111381095|NCT04743297|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111381096|NCT04743297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111381097|NCT04176783|Analgesics, Opioid|analgesics, opioid|mesh-list
111381098|NCT04176783|Narcotics|narcotics|mesh-ancestor
111381099|NCT04176783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111381100|NCT04176783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111381101|NCT04176783|Analgesics|analgesics|mesh-ancestor
111381102|NCT04176783|Sensory System Agents|sensory system agents|mesh-ancestor
111381103|NCT04176783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111381104|NCT00365313|Celecoxib|celecoxib|mesh-list
111381105|NCT00365313|Esomeprazole|esomeprazole|mesh-list
111381106|NCT00365313|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111381107|NCT00365313|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111381108|NCT00365313|Analgesics|analgesics|mesh-ancestor
111381109|NCT00365313|Sensory System Agents|sensory system agents|mesh-ancestor
111381110|NCT00365313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111381111|NCT00365313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111381112|NCT00365313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111381113|NCT00365313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111381114|NCT00365313|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111381115|NCT00365313|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111381116|NCT00365313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111381117|NCT00365313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111381118|NCT00365313|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111381119|NCT00365313|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111381120|NCT00365313|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111381121|NCT02605395|Rabeprazole|rabeprazole|mesh-list
111381122|NCT02605395|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111381123|NCT02605395|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111381124|NCT02605395|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111381125|NCT02605395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111381126|NCT02605395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111381127|NCT04166721|Atezolizumab|atezolizumab|mesh-list
111381128|NCT04166721|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110520946|NCT04261517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111381129|NCT04166721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111381130|NCT04166721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111381131|NCT04166721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111381132|NCT04343001|Aspirin|aspirin|mesh-list
111381133|NCT04343001|Losartan|losartan|mesh-list
111381134|NCT04343001|Simvastatin|simvastatin|mesh-list
111381135|NCT04343001|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111381136|NCT04343001|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111381137|NCT04343001|Analgesics|analgesics|mesh-ancestor
111381138|NCT04343001|Sensory System Agents|sensory system agents|mesh-ancestor
111381139|NCT04343001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111381140|NCT04343001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111381141|NCT04343001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111381142|NCT04343001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111381143|NCT04343001|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111381144|NCT04343001|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111381145|NCT04343001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111381146|NCT04343001|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111381147|NCT04343001|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111381148|NCT04343001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111381149|NCT04343001|Antipyretics|antipyretics|mesh-ancestor
111381150|NCT04343001|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111381151|NCT04343001|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111381152|NCT04343001|Antimetabolites|antimetabolites|mesh-ancestor
111381153|NCT04343001|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111381154|NCT04343001|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111381155|NCT04343001|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111381156|NCT04343001|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111381157|NCT04343001|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111381158|NCT04343001|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111381159|NCT02865135|Vaccines|vaccines|mesh-list
111105571|NCT02353325|Vitamins|vitamins|mesh-ancestor
111381160|NCT02865135|Immunologic Factors|immunologic factors|mesh-ancestor
111381161|NCT02865135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111381162|NCT04742205|Tranexamic Acid|tranexamic acid|mesh-list
111381163|NCT04742205|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111381164|NCT04742205|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111381165|NCT04742205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111381166|NCT04742205|Hemostatics|hemostatics|mesh-ancestor
111381167|NCT04742205|Coagulants|coagulants|mesh-ancestor
111381168|NCT04743063|Losartan|losartan|mesh-list
111381169|NCT04743063|Valsartan|valsartan|mesh-list
111381170|NCT04743063|Telmisartan|telmisartan|mesh-list
111381171|NCT04743063|Candesartan|candesartan|mesh-list
111381172|NCT04743063|Olmesartan|olmesartan|mesh-list
111381173|NCT04743063|Irbesartan|irbesartan|mesh-list
111381174|NCT04743063|Eprosartan|eprosartan|mesh-list
111381175|NCT04743063|Angiotensin II|angiotensin ii|mesh-list
111381176|NCT04743063|Giapreza|giapreza|mesh-list
111381177|NCT04743063|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
111381178|NCT04743063|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
111381179|NCT04743063|Angiotensinogen|angiotensinogen|mesh-list
111381180|NCT04743063|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111381181|NCT04743063|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111381182|NCT04743063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111381183|NCT04743063|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111381184|NCT04743063|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111381185|NCT04743063|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111381186|NCT04743063|Protease Inhibitors|protease inhibitors|mesh-ancestor
111381187|NCT04743063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111381188|NCT04743063|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
111381189|NCT01739699|Acetaminophen|acetaminophen|mesh-list
111381190|NCT01739699|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111381191|NCT01739699|Analgesics|analgesics|mesh-ancestor
111381192|NCT01739699|Sensory System Agents|sensory system agents|mesh-ancestor
111381193|NCT01739699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111381194|NCT01739699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111381195|NCT01739699|Antipyretics|antipyretics|mesh-ancestor
111381196|NCT04154787|Rituximab|rituximab|mesh-list
111381197|NCT04154787|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111381198|NCT04154787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111381199|NCT04154787|Immunologic Factors|immunologic factors|mesh-ancestor
111381200|NCT04154787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111381201|NCT04154787|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111381202|NCT01740713|Deferiprone|deferiprone|mesh-list
111381203|NCT01740713|Iron Chelating Agents|iron chelating agents|mesh-ancestor
111381204|NCT01740713|Chelating Agents|chelating agents|mesh-ancestor
111381205|NCT01740713|Sequestering Agents|sequestering agents|mesh-ancestor
111381206|NCT01740713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111381207|NCT02613117|Fluorides|fluorides|mesh-list
111381208|NCT02613117|Tin Fluorides|tin fluorides|mesh-list
111381209|NCT02613117|Cariostatic Agents|cariostatic agents|mesh-ancestor
111381210|NCT02613117|Protective Agents|protective agents|mesh-ancestor
111381211|NCT02613117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111381212|NCT01742117|Clopidogrel|clopidogrel|mesh-list
111381213|NCT01742117|Ticagrelor|ticagrelor|mesh-list
111381214|NCT01742117|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111381215|NCT01742117|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111381216|NCT01742117|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111381217|NCT01742117|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111381218|NCT01742117|Purinergic Agents|purinergic agents|mesh-ancestor
111381219|NCT01742117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111381220|NCT01742117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111381221|NCT01742117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111381222|NCT02613897|Dapagliflozin|dapagliflozin|mesh-list
111381223|NCT02613897|Saxagliptin|saxagliptin|mesh-list
111381224|NCT02613897|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111381225|NCT02613897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111381226|NCT02613897|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111381227|NCT02613897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111381228|NCT02613897|Incretins|incretins|mesh-ancestor
111381229|NCT02613897|Hormones|hormones|mesh-ancestor
111381230|NCT02613897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111381231|NCT02613897|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111381232|NCT02613897|Protease Inhibitors|protease inhibitors|mesh-ancestor
111381233|NCT02613897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111381234|NCT02615535|Alprostadil|alprostadil|mesh-list
111381235|NCT02615535|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111381237|NCT02615535|Urological Agents|urological agents|mesh-ancestor
111381238|NCT05732181|Lidocaine|lidocaine|mesh-list
111381239|NCT05732181|Anesthetics, Local|anesthetics, local|mesh-ancestor
111381240|NCT05732181|Anesthetics|anesthetics|mesh-ancestor
111381241|NCT05732181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111381242|NCT05732181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111381243|NCT05732181|Sensory System Agents|sensory system agents|mesh-ancestor
111381244|NCT05732181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111381245|NCT05732181|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111381246|NCT05732181|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111381247|NCT05732181|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111381248|NCT05732181|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111381249|NCT05732181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111381250|NCT01342172|Lenalidomide|lenalidomide|mesh-list
111381251|NCT01342172|Immunologic Factors|immunologic factors|mesh-ancestor
111381252|NCT01342172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111381253|NCT01342172|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111381254|NCT01342172|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111381255|NCT01342172|Growth Substances|growth substances|mesh-ancestor
111381256|NCT01342172|Growth Inhibitors|growth inhibitors|mesh-ancestor
111381257|NCT01342172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111381258|NCT01243112|Lidocaine|lidocaine|mesh-list
111381259|NCT01243112|Epinephrine|epinephrine|mesh-list
111381260|NCT01243112|Racepinephrine|racepinephrine|mesh-list
111381261|NCT01243112|Bupivacaine|bupivacaine|mesh-list
111381262|NCT01243112|Epinephryl borate|epinephryl borate|mesh-list
111381263|NCT01243112|Anesthetics, Local|anesthetics, local|mesh-ancestor
111381264|NCT01243112|Anesthetics|anesthetics|mesh-ancestor
111381265|NCT01243112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111381266|NCT01243112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111381267|NCT01243112|Sensory System Agents|sensory system agents|mesh-ancestor
111381268|NCT01243112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111381269|NCT01243112|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111381270|NCT01243112|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111381271|NCT01243112|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111381272|NCT01243112|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111381273|NCT01243112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111381274|NCT01243112|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111381275|NCT01243112|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111381276|NCT01243112|Adrenergic Agents|adrenergic agents|mesh-ancestor
111381277|NCT01243112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111381278|NCT01243112|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111381279|NCT01243112|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111381280|NCT01243112|Autonomic Agents|autonomic agents|mesh-ancestor
111381281|NCT01243112|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111381282|NCT01243112|Respiratory System Agents|respiratory system agents|mesh-ancestor
111381283|NCT01243112|Mydriatics|mydriatics|mesh-ancestor
111381284|NCT01243112|Sympathomimetics|sympathomimetics|mesh-ancestor
111381285|NCT01243112|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111381286|NCT01243580|Moxifloxacin|moxifloxacin|mesh-list
111381287|NCT01243580|Contraceptive Agents|contraceptive agents|mesh-list
111381288|NCT01243580|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
111381289|NCT01243580|Contraceptives, Oral|contraceptives, oral|mesh-list
111381290|NCT01243580|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111381291|NCT01243580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111381292|NCT01243580|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111381293|NCT01243580|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111381294|NCT01243580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111381295|NCT01243580|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111381296|NCT01243580|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111381297|NCT01243580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111381298|NCT01243580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111381299|NCT01243580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111381300|NCT01243580|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111381301|NCT01243580|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
111381302|NCT01743521|Ribavirin|ribavirin|mesh-list
111381303|NCT01743521|Antimetabolites|antimetabolites|mesh-ancestor
111381304|NCT01743521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111381305|NCT01743521|Antiviral Agents|antiviral agents|mesh-ancestor
111381306|NCT01743521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111105719|NCT02342717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111381307|NCT00361803|Topotecan|topotecan|mesh-list
111381308|NCT00361803|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111381309|NCT00361803|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111381310|NCT00361803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111381311|NCT00361803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111381312|NCT00361803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111381313|NCT00361881|Acyclovir|acyclovir|mesh-list
111381314|NCT00361881|Hydrocortisone|hydrocortisone|mesh-list
111381315|NCT00361881|Antiviral Agents|antiviral agents|mesh-ancestor
111381316|NCT00361881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111381317|NCT00361881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111381318|NCT01743677|Moxifloxacin|moxifloxacin|mesh-list
111381319|NCT01743677|Tofacitinib|tofacitinib|mesh-list
111381320|NCT01743677|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111381321|NCT01743677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111381322|NCT01743677|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111381323|NCT01743677|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111381324|NCT01743677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111381325|NCT01743677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111381326|NCT01743677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111381327|NCT01743677|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
111381328|NCT01743677|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111381329|NCT00365937|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
111381330|NCT00365937|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
111381331|NCT00365937|Immunologic Factors|immunologic factors|mesh-ancestor
111381332|NCT00365937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111381333|NCT01246076|Lenalidomide|lenalidomide|mesh-list
111381334|NCT01246076|Immunologic Factors|immunologic factors|mesh-ancestor
111381335|NCT01246076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111381336|NCT01246076|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111381337|NCT01246076|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111381338|NCT01246076|Growth Substances|growth substances|mesh-ancestor
111381339|NCT01246076|Growth Inhibitors|growth inhibitors|mesh-ancestor
111381340|NCT01246076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111381341|NCT00364455|Epoetin Alfa|epoetin alfa|mesh-list
111381342|NCT00364455|Hematinics|hematinics|mesh-ancestor
111381343|NCT01307462|Fluticasone|fluticasone|mesh-list
111381344|NCT01307462|Xhance|xhance|mesh-list
111381345|NCT01307462|Azithromycin|azithromycin|mesh-list
111381346|NCT01307462|Montelukast|montelukast|mesh-list
111381347|NCT01307462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111381348|NCT01307462|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111381349|NCT01307462|Autonomic Agents|autonomic agents|mesh-ancestor
111381350|NCT01307462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111381351|NCT01307462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111381352|NCT01307462|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111381353|NCT01307462|Respiratory System Agents|respiratory system agents|mesh-ancestor
111381354|NCT01307462|Dermatologic Agents|dermatologic agents|mesh-ancestor
111381355|NCT01307462|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111381356|NCT01307462|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111381357|NCT01307462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111381358|NCT01307462|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
111381359|NCT01307462|Hormone Antagonists|hormone antagonists|mesh-ancestor
111381360|NCT01307462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111381361|NCT01307462|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
111381362|NCT01307462|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111381363|NCT01307462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111381364|NCT05731089|Aflibercept|aflibercept|mesh-list
111381365|NCT05731089|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111381366|NCT05731089|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111381367|NCT05731089|Growth Substances|growth substances|mesh-ancestor
111381368|NCT05731089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111381369|NCT05731089|Growth Inhibitors|growth inhibitors|mesh-ancestor
111381370|NCT05731089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111381371|NCT01307618|Interleukin-12|interleukin-12|mesh-list
111381372|NCT01307618|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111381373|NCT01307618|Immunologic Factors|immunologic factors|mesh-ancestor
111381374|NCT01307618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111381375|NCT01307618|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111381376|NCT01307618|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111381377|NCT01307618|Growth Substances|growth substances|mesh-ancestor
111381378|NCT01307618|Growth Inhibitors|growth inhibitors|mesh-ancestor
111381379|NCT01307618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111381380|NCT01307930|Anidulafungin|anidulafungin|mesh-list
111381381|NCT01307930|Antifungal Agents|antifungal agents|mesh-ancestor
111381382|NCT01307930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111381383|NCT05371197|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
111381384|NCT05371197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111381385|NCT05371197|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111381386|NCT05371197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111381387|NCT01746095|Vancomycin|vancomycin|mesh-list
111381388|NCT01746095|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111381389|NCT01746095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111381390|NCT05730777|Paclitaxel|paclitaxel|mesh-list
111381391|NCT05730777|Carboplatin|carboplatin|mesh-list
111381392|NCT05730777|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111381393|NCT05730777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111381394|NCT05730777|Tubulin Modulators|tubulin modulators|mesh-ancestor
111381395|NCT05730777|Antimitotic Agents|antimitotic agents|mesh-ancestor
111381396|NCT05730777|Mitosis Modulators|mitosis modulators|mesh-ancestor
111381397|NCT05730777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111381398|NCT04425239|Leucovorin|leucovorin|mesh-list
111381399|NCT04425239|Folic Acid|folic acid|mesh-list
111381400|NCT04425239|Fluorouracil|fluorouracil|mesh-list
111381401|NCT04425239|Irinotecan|irinotecan|mesh-list
111381402|NCT04425239|Panitumumab|panitumumab|mesh-list
111381403|NCT04425239|Levoleucovorin|levoleucovorin|mesh-list
111381404|NCT04425239|Antimetabolites|antimetabolites|mesh-ancestor
111381405|NCT04425239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111381406|NCT04425239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111381407|NCT04425239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111381408|NCT04425239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111381409|NCT04425239|Immunologic Factors|immunologic factors|mesh-ancestor
111381410|NCT04425239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111381411|NCT04425239|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111381412|NCT04425239|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111381413|NCT04425239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111381414|NCT04425239|Antidotes|antidotes|mesh-ancestor
111381415|NCT04425239|Protective Agents|protective agents|mesh-ancestor
111381416|NCT04425239|Vitamin B Complex|vitamin b complex|mesh-ancestor
111381417|NCT04425239|Vitamins|vitamins|mesh-ancestor
111381418|NCT04425239|Micronutrients|micronutrients|mesh-ancestor
111381419|NCT04425239|Hematinics|hematinics|mesh-ancestor
111381420|NCT04425239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111381421|NCT01309802|Botulinum Toxins|botulinum toxins|mesh-list
111381422|NCT01309802|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111381423|NCT01309802|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111381424|NCT01309802|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111381425|NCT01309802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111381426|NCT01309802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111381427|NCT01309802|Cholinergic Agents|cholinergic agents|mesh-ancestor
111381428|NCT01309802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111381429|NCT01309802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111381430|NCT01309802|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111381431|NCT01309802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111381432|NCT00366093|Eszopiclone|eszopiclone|mesh-list
111381433|NCT00366093|Zopiclone|zopiclone|mesh-list
111381434|NCT00366093|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111381435|NCT00366093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111381436|NCT00366093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111381437|NCT04379999|Aspirin|aspirin|mesh-list
111381438|NCT04379999|Atorvastatin|atorvastatin|mesh-list
111381439|NCT04379999|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111381440|NCT04379999|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111381441|NCT04379999|Analgesics|analgesics|mesh-ancestor
111381442|NCT04379999|Sensory System Agents|sensory system agents|mesh-ancestor
111381443|NCT04379999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111381444|NCT04379999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111381445|NCT04379999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111381446|NCT04379999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111381447|NCT04379999|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111381448|NCT04379999|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111381449|NCT04379999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111381450|NCT04379999|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111381451|NCT04379999|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111381452|NCT04379999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111381453|NCT04379999|Antipyretics|antipyretics|mesh-ancestor
111381454|NCT04379999|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111381455|NCT04379999|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111381456|NCT04379999|Antimetabolites|antimetabolites|mesh-ancestor
111381457|NCT04379999|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111381458|NCT04379999|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111381459|NCT03009422|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
111381460|NCT03009422|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111381461|NCT03009422|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111381462|NCT03009422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111381463|NCT03009422|Schistosomicides|schistosomicides|mesh-ancestor
111381464|NCT03009422|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
111381465|NCT03009422|Anthelmintics|anthelmintics|mesh-ancestor
111381466|NCT05730621|Aspirin|aspirin|mesh-list
111381467|NCT05730621|Sarpogrelate|sarpogrelate|mesh-list
111381468|NCT05730621|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111381469|NCT05730621|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111381470|NCT05730621|Analgesics|analgesics|mesh-ancestor
111381471|NCT05730621|Sensory System Agents|sensory system agents|mesh-ancestor
111381472|NCT05730621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111381473|NCT05730621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111381474|NCT05730621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111381475|NCT05730621|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111381476|NCT05730621|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111381477|NCT05730621|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111381478|NCT05730621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111381479|NCT05730621|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111381480|NCT05730621|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111381481|NCT05730621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111381482|NCT05730621|Antipyretics|antipyretics|mesh-ancestor
111381483|NCT05730621|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111381484|NCT05730621|Serotonin Agents|serotonin agents|mesh-ancestor
111381485|NCT05730621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111381486|NCT01346072|Tolvaptan|tolvaptan|mesh-list
111381487|NCT01346072|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
111381488|NCT01346072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111381489|NCT01346072|Natriuretic Agents|natriuretic agents|mesh-ancestor
111381490|NCT01346072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111381491|NCT04292483|Nitric Oxide|nitric oxide|mesh-list
111381492|NCT04292483|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111381493|NCT04292483|Autonomic Agents|autonomic agents|mesh-ancestor
111381494|NCT04292483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111381495|NCT04292483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111381496|NCT04292483|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111381497|NCT04292483|Respiratory System Agents|respiratory system agents|mesh-ancestor
111381498|NCT04292483|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111381499|NCT04292483|Antioxidants|antioxidants|mesh-ancestor
111381500|NCT04292483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111381501|NCT04292483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111381502|NCT04292483|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
111381503|NCT04292483|Vasodilator Agents|vasodilator agents|mesh-ancestor
111381504|NCT04292483|Gasotransmitters|gasotransmitters|mesh-ancestor
111381505|NCT04292483|Protective Agents|protective agents|mesh-ancestor
111381506|NCT01347008|Sildenafil Citrate|sildenafil citrate|mesh-list
111381507|NCT01347008|Citric Acid|citric acid|mesh-list
111381508|NCT01347008|Sodium Citrate|sodium citrate|mesh-list
111381509|NCT01347008|Anticoagulants|anticoagulants|mesh-ancestor
111381510|NCT01347008|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
111381511|NCT01347008|Chelating Agents|chelating agents|mesh-ancestor
111381512|NCT01347008|Sequestering Agents|sequestering agents|mesh-ancestor
111381513|NCT01347008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111381514|NCT01347008|Vasodilator Agents|vasodilator agents|mesh-ancestor
111381515|NCT01347008|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111381516|NCT01347008|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111381517|NCT01347008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111381518|NCT01347008|Urological Agents|urological agents|mesh-ancestor
111381519|NCT05343429|Aspirin|aspirin|mesh-list
111381520|NCT05343429|Benzydamine|benzydamine|mesh-list
111381521|NCT05343429|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111381522|NCT05343429|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111381523|NCT05343429|Analgesics|analgesics|mesh-ancestor
111381524|NCT05343429|Sensory System Agents|sensory system agents|mesh-ancestor
111381525|NCT05343429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111381526|NCT05343429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111381527|NCT05343429|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111381528|NCT05343429|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111381529|NCT05343429|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111381530|NCT05343429|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111381531|NCT05343429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111381532|NCT05343429|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111381533|NCT05343429|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111381534|NCT05343429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111381535|NCT05343429|Antipyretics|antipyretics|mesh-ancestor
111381536|NCT01310582|Sevoflurane|sevoflurane|mesh-list
111381537|NCT01310582|Desflurane|desflurane|mesh-list
111381538|NCT01310582|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111381539|NCT01310582|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111381540|NCT01310582|Anesthetics, General|anesthetics, general|mesh-ancestor
111381541|NCT01310582|Anesthetics|anesthetics|mesh-ancestor
111381542|NCT01310582|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111381543|NCT01310582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111381544|NCT01311674|Vaccines|vaccines|mesh-list
111381545|NCT01311674|Immunologic Factors|immunologic factors|mesh-ancestor
111381546|NCT01311674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111381547|NCT05081193|Methyltestosterone|methyltestosterone|mesh-list
111381548|NCT05081193|Testosterone|testosterone|mesh-list
111381549|NCT05081193|Testosterone undecanoate|testosterone undecanoate|mesh-list
111381550|NCT05081193|Testosterone enanthate|testosterone enanthate|mesh-list
111381551|NCT05081193|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
111381552|NCT05081193|Androgens|androgens|mesh-ancestor
111381553|NCT05081193|Hormones|hormones|mesh-ancestor
111381554|NCT05081193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111381555|NCT05081193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111381556|NCT05081193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111381557|NCT05081193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111381558|NCT05081193|Anabolic Agents|anabolic agents|mesh-ancestor
111381559|NCT01349972|Cytarabine|cytarabine|mesh-list
111381560|NCT01349972|Daunorubicin|daunorubicin|mesh-list
111381561|NCT01349972|Mitoxantrone|mitoxantrone|mesh-list
111381562|NCT01349972|Alvocidib|alvocidib|mesh-list
111381563|NCT01349972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111381564|NCT01349972|Antimetabolites|antimetabolites|mesh-ancestor
111381565|NCT01349972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111381566|NCT01349972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111381567|NCT01349972|Antiviral Agents|antiviral agents|mesh-ancestor
111381568|NCT01349972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111381569|NCT01349972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111381570|NCT01349972|Immunologic Factors|immunologic factors|mesh-ancestor
111381571|NCT01349972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111381572|NCT01349972|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111381573|NCT01349972|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111381574|NCT01349972|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111381575|NCT01349972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111381576|NCT01349972|Analgesics|analgesics|mesh-ancestor
111381577|NCT01349972|Sensory System Agents|sensory system agents|mesh-ancestor
111381578|NCT01349972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111381579|NCT01349972|Growth Inhibitors|growth inhibitors|mesh-ancestor
111381580|NCT01349972|Growth Substances|growth substances|mesh-ancestor
111381581|NCT01349972|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111381582|NCT01248104|Tranexamic Acid|tranexamic acid|mesh-list
111381583|NCT01248104|Aminocaproic Acid|aminocaproic acid|mesh-list
111381584|NCT01248104|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111381585|NCT01248104|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111381586|NCT01248104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111381587|NCT01248104|Hemostatics|hemostatics|mesh-ancestor
111381588|NCT01248104|Coagulants|coagulants|mesh-ancestor
111381589|NCT01748045|Nitric Oxide|nitric oxide|mesh-list
111381590|NCT01748045|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111381591|NCT01748045|Autonomic Agents|autonomic agents|mesh-ancestor
111381592|NCT01748045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110521404|NCT02802644|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111381593|NCT01748045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111381594|NCT01748045|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111381595|NCT01748045|Respiratory System Agents|respiratory system agents|mesh-ancestor
111381596|NCT01748045|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111381597|NCT01748045|Antioxidants|antioxidants|mesh-ancestor
111381598|NCT01748045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111381599|NCT01748045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111381600|NCT01748045|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
111381601|NCT01748045|Vasodilator Agents|vasodilator agents|mesh-ancestor
111381602|NCT01748045|Gasotransmitters|gasotransmitters|mesh-ancestor
111381603|NCT01748045|Protective Agents|protective agents|mesh-ancestor
111381604|NCT01312766|Menotropins|menotropins|mesh-list
111381605|NCT01312766|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111381606|NCT01312766|Fertility Agents|fertility agents|mesh-ancestor
111381607|NCT01312766|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111381608|NCT01312766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111381609|NCT01749215|Topiramate|topiramate|mesh-list
111381610|NCT01749215|Anticonvulsants|anticonvulsants|mesh-ancestor
111106011|NCT02938013|Velpatasvir|velpatasvir|mesh-list
111381611|NCT01749215|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111381612|NCT01749215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111381613|NCT04522167|Aflibercept|aflibercept|mesh-list
111381614|NCT04522167|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111381615|NCT04522167|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111381616|NCT04522167|Growth Substances|growth substances|mesh-ancestor
111381617|NCT04522167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111381618|NCT04522167|Growth Inhibitors|growth inhibitors|mesh-ancestor
111381619|NCT04522167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111381620|NCT01248416|Letrozole|letrozole|mesh-list
111381621|NCT01248416|Anastrozole|anastrozole|mesh-list
111381622|NCT01248416|Hormones|hormones|mesh-list
111381623|NCT01248416|Aromatase Inhibitors|aromatase inhibitors|mesh-list
111381624|NCT01248416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111381625|NCT01248416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111381626|NCT01248416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111381627|NCT01248416|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111381628|NCT01248416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111381629|NCT01248416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111381630|NCT01248416|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111381631|NCT01248416|Hormone Antagonists|hormone antagonists|mesh-ancestor
111381632|NCT01248416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111381633|NCT01749293|Cyclophosphamide|cyclophosphamide|mesh-list
111381634|NCT01749293|Busulfan|busulfan|mesh-list
111381635|NCT01749293|Fludarabine|fludarabine|mesh-list
111381636|NCT01749293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111381637|NCT01749293|Immunologic Factors|immunologic factors|mesh-ancestor
111381638|NCT01749293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111381639|NCT01749293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111381640|NCT01749293|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111381641|NCT01749293|Alkylating Agents|alkylating agents|mesh-ancestor
111381642|NCT01749293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111381643|NCT01749293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111381644|NCT01749293|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111381645|NCT01250210|Levonorgestrel|levonorgestrel|mesh-list
111381646|NCT01250210|Ethinyl Estradiol|ethinyl estradiol|mesh-list
111381647|NCT01250210|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
111381648|NCT01250210|Estradiol|estradiol|mesh-list
111381649|NCT01250210|Estrogens|estrogens|mesh-ancestor
111381650|NCT01250210|Hormones|hormones|mesh-ancestor
111381651|NCT01250210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111381652|NCT01250210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111381653|NCT01250210|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111381654|NCT01250210|Contraceptive Agents|contraceptive agents|mesh-ancestor
111381655|NCT01250210|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111381656|NCT01250210|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110521474|NCT02725242|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111381657|NCT01250210|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111381658|NCT01250210|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111381659|NCT01250210|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111381660|NCT01250210|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
111381661|NCT01749605|Ciprofloxacin|ciprofloxacin|mesh-list
111381662|NCT01749605|Nitrofurantoin|nitrofurantoin|mesh-list
111381663|NCT01749605|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111381664|NCT01749605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111381665|NCT01749605|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111381666|NCT01749605|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111381667|NCT01749605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111381668|NCT01749605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111381669|NCT01749605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111381670|NCT01749605|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111381671|NCT01749605|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111381672|NCT01749605|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111381673|NCT01312844|Scopolamine|scopolamine|mesh-list
111381674|NCT01312844|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
111381675|NCT01312844|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111381676|NCT01312844|Antiemetics|antiemetics|mesh-ancestor
111381677|NCT01312844|Autonomic Agents|autonomic agents|mesh-ancestor
111381678|NCT01312844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111381679|NCT01312844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111381680|NCT01312844|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111381681|NCT01312844|Mydriatics|mydriatics|mesh-ancestor
111381682|NCT01312844|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111381683|NCT01312844|Cholinergic Agents|cholinergic agents|mesh-ancestor
111381684|NCT01312844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111381685|NCT01312844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111381686|NCT01312844|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111106086|NCT03189901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111381688|NCT01750931|Meloxicam|meloxicam|mesh-list
111381689|NCT01750931|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111381690|NCT01750931|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111381691|NCT01750931|Analgesics|analgesics|mesh-ancestor
111381692|NCT01750931|Sensory System Agents|sensory system agents|mesh-ancestor
111381693|NCT01750931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111381694|NCT01750931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111381695|NCT01750931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111381696|NCT01750931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111381697|NCT01750931|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111381698|NCT01750931|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111381699|NCT01750931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111381700|NCT01750931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111381701|NCT01731041|Ticagrelor|ticagrelor|mesh-list
111381702|NCT01731041|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111381703|NCT01731041|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111381704|NCT01731041|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111381705|NCT01731041|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111381706|NCT01731041|Purinergic Agents|purinergic agents|mesh-ancestor
111381707|NCT01731041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111381708|NCT01731041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111381709|NCT01731041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111381710|NCT01313936|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
111381711|NCT01313936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111381712|NCT01313936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111381713|NCT01313936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111381714|NCT01313936|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111381715|NCT01752413|Ferrous gluconate|ferrous gluconate|mesh-list
111381716|NCT01752413|Hematinics|hematinics|mesh-ancestor
111381717|NCT01731119|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
111381718|NCT01731119|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111381719|NCT01731119|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111381720|NCT01731119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111381721|NCT01731119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111381722|NCT01731119|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111381723|NCT01731119|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
111381724|NCT01731119|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111381725|NCT01731119|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111381726|NCT01731119|Adrenergic Agents|adrenergic agents|mesh-ancestor
111381727|NCT01731119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111381728|NCT01731119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111381729|NCT01731119|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111381730|NCT01731119|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111381731|NCT01731119|Serotonin Agents|serotonin agents|mesh-ancestor
111381732|NCT01731119|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111381733|NCT01731119|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111381734|NCT01731119|Dopamine Agents|dopamine agents|mesh-ancestor
111381735|NCT01732445|Danazol|danazol|mesh-list
111381736|NCT01732445|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
111381737|NCT01732445|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111381738|NCT01732445|Hormone Antagonists|hormone antagonists|mesh-ancestor
111381739|NCT01732445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111381740|NCT01732445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111381741|NCT01732445|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111381742|NCT01732445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111381743|NCT01732445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111381744|NCT01250834|Dulaglutide|dulaglutide|mesh-list
111381745|NCT01250834|Atorvastatin|atorvastatin|mesh-list
111381746|NCT01250834|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111381747|NCT01250834|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111381748|NCT01250834|Antimetabolites|antimetabolites|mesh-ancestor
111381749|NCT01250834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111381750|NCT01250834|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111381751|NCT01250834|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111381752|NCT01250834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111381753|NCT01250834|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111381754|NCT01250834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111381755|NCT04387695|Sorafenib|sorafenib|mesh-list
111381756|NCT04387695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111381757|NCT04387695|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111381758|NCT04387695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111381759|NCT04387695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111381760|NCT01354652|Lamivudine|lamivudine|mesh-list
111381761|NCT01354652|Entecavir|entecavir|mesh-list
111381762|NCT01354652|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111381763|NCT01354652|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111381764|NCT01354652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111381765|NCT01354652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111381766|NCT01354652|Antiviral Agents|antiviral agents|mesh-ancestor
111381767|NCT01354652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111381768|NCT01354652|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111381769|NCT01354652|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111381770|NCT01753739|Bepotastine besilate|bepotastine besilate|mesh-list
111381771|NCT01753739|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111381772|NCT01250990|Niacin|niacin|mesh-list
111381773|NCT01250990|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111381774|NCT01250990|Antimetabolites|antimetabolites|mesh-ancestor
111381775|NCT01250990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111381776|NCT01250990|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111381777|NCT01250990|Vasodilator Agents|vasodilator agents|mesh-ancestor
111381778|NCT01250990|Vitamin B Complex|vitamin b complex|mesh-ancestor
111381779|NCT01250990|Vitamins|vitamins|mesh-ancestor
111381780|NCT01250990|Micronutrients|micronutrients|mesh-ancestor
111381781|NCT01250990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111381782|NCT02990975|Ketamine|ketamine|mesh-list
111381783|NCT02990975|Analgesics|analgesics|mesh-ancestor
111381784|NCT02990975|Sensory System Agents|sensory system agents|mesh-ancestor
111381785|NCT02990975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111381786|NCT02990975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111381787|NCT02990975|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111381788|NCT02990975|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111381789|NCT02990975|Anesthetics, General|anesthetics, general|mesh-ancestor
111381790|NCT02990975|Anesthetics|anesthetics|mesh-ancestor
111381791|NCT02990975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111381792|NCT02990975|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111381793|NCT02990975|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111381794|NCT02990975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111381795|NCT02990975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111381796|NCT01315574|Travoprost|travoprost|mesh-list
111381797|NCT01315574|Latanoprost|latanoprost|mesh-list
111381798|NCT01315574|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
111381799|NCT01315574|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111381800|NCT01315574|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111381801|NCT00422331|Lithium Carbonate|lithium carbonate|mesh-list
111381802|NCT00422331|Antidepressive Agents|antidepressive agents|mesh-ancestor
111381803|NCT00422331|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111381804|NCT00422331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111381805|NCT00422331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111381806|NCT00422331|Antimanic Agents|antimanic agents|mesh-ancestor
111381807|NCT00422331|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111381808|NCT00422331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111381809|NCT00422331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111381810|NCT01316042|Metformin|metformin|mesh-list
111381811|NCT01316042|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111381812|NCT01316042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111381813|NCT01754909|Enalapril|enalapril|mesh-list
111381814|NCT01754909|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
111381815|NCT01754909|Protease Inhibitors|protease inhibitors|mesh-ancestor
111381816|NCT01754909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111381817|NCT01754909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111381818|NCT01754909|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111381819|NCT04340349|Hydroxychloroquine|hydroxychloroquine|mesh-list
111381820|NCT04340349|Bromhexine|bromhexine|mesh-list
111381821|NCT04340349|Antimalarials|antimalarials|mesh-ancestor
111381822|NCT04340349|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111381823|NCT04340349|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111381824|NCT04340349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111381825|NCT04340349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111381826|NCT04340349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111381827|NCT04340349|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111381828|NCT04340349|Expectorants|expectorants|mesh-ancestor
111381829|NCT04340349|Respiratory System Agents|respiratory system agents|mesh-ancestor
111381830|NCT04268771|Rituximab|rituximab|mesh-list
111381831|NCT04268771|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111381832|NCT04268771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111381833|NCT04268771|Immunologic Factors|immunologic factors|mesh-ancestor
111381834|NCT04268771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111381835|NCT04268771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111381836|NCT04267809|Vitamin D|vitamin d|mesh-list
111381837|NCT04267809|Metformin|metformin|mesh-list
111381838|NCT04267809|Calcium|calcium|mesh-list
111381839|NCT04267809|Vitamins|vitamins|mesh-ancestor
111381840|NCT04267809|Micronutrients|micronutrients|mesh-ancestor
111381841|NCT04267809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111381842|NCT04267809|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111381843|NCT04267809|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111381844|NCT04267809|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111381845|NCT02242409|Paclitaxel|paclitaxel|mesh-list
111381846|NCT02242409|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111381847|NCT02242409|Gemcitabine|gemcitabine|mesh-list
111381848|NCT02242409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111381849|NCT02242409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111381850|NCT02242409|Tubulin Modulators|tubulin modulators|mesh-ancestor
111381851|NCT02242409|Antimitotic Agents|antimitotic agents|mesh-ancestor
111381852|NCT02242409|Mitosis Modulators|mitosis modulators|mesh-ancestor
111381853|NCT02242409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111381854|NCT02242409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111381855|NCT02242409|Antimetabolites|antimetabolites|mesh-ancestor
111381856|NCT00366873|Calcium|calcium|mesh-list
111381857|NCT00366873|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111381858|NCT00366873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111381859|NCT05317325|Vaccines|vaccines|mesh-list
111381860|NCT05317325|Immunologic Factors|immunologic factors|mesh-ancestor
111381861|NCT05317325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111381862|NCT04182399|Zonisamide|zonisamide|mesh-list
111381863|NCT04182399|Anticonvulsants|anticonvulsants|mesh-ancestor
111381864|NCT04182399|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111381865|NCT04182399|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111381866|NCT04182399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111381867|NCT04182399|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111381868|NCT04182399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111381869|NCT04246619|Pregabalin|pregabalin|mesh-list
111381870|NCT04246619|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
111381871|NCT04246619|Analgesics|analgesics|mesh-ancestor
111381872|NCT04246619|Sensory System Agents|sensory system agents|mesh-ancestor
111381873|NCT04246619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111381874|NCT04246619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111381875|NCT04246619|Anticonvulsants|anticonvulsants|mesh-ancestor
111381876|NCT04246619|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111381877|NCT04246619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111381878|NCT04246619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111381879|NCT04246619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111381880|NCT04246619|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111381881|NCT04246619|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111381882|NCT04246619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111381883|NCT04246619|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111381884|NCT04246619|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111381885|NCT04246619|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111381886|NCT04246619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111381887|NCT04246619|Antidepressive Agents|antidepressive agents|mesh-ancestor
111381888|NCT04246619|Dopamine Agents|dopamine agents|mesh-ancestor
111381889|NCT01757561|Propofol|propofol|mesh-list
111381890|NCT01757561|Sevoflurane|sevoflurane|mesh-list
111381891|NCT01757561|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111381892|NCT01757561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111381893|NCT01757561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111381894|NCT01757561|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111381895|NCT01757561|Anesthetics, General|anesthetics, general|mesh-ancestor
111381896|NCT01757561|Anesthetics|anesthetics|mesh-ancestor
111381897|NCT01757561|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111381898|NCT01757561|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111381899|NCT02618187|Vancomycin|vancomycin|mesh-list
111381900|NCT02618187|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111381901|NCT02618187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111381902|NCT05316857|Itraconazole|itraconazole|mesh-list
111381903|NCT05316857|Rifampin|rifampin|mesh-list
111381904|NCT05316857|Antifungal Agents|antifungal agents|mesh-ancestor
111381905|NCT05316857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111381906|NCT05316857|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111381907|NCT05316857|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111381908|NCT05316857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111381909|NCT05316857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111381910|NCT05316857|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111381911|NCT05316857|Hormone Antagonists|hormone antagonists|mesh-ancestor
111381912|NCT05316857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111381913|NCT05316857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111381914|NCT05316857|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111381915|NCT05316857|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111381916|NCT05316857|Antitubercular Agents|antitubercular agents|mesh-ancestor
111381917|NCT05316857|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111381918|NCT05316857|Leprostatic Agents|leprostatic agents|mesh-ancestor
111381919|NCT05316857|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111381920|NCT05316857|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111381921|NCT05316857|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111381922|NCT05316857|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
111381923|NCT05316857|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
111381924|NCT05316857|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
111381925|NCT05316857|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111381926|NCT01759277|Anesthetics|anesthetics|mesh-list
111381927|NCT01759277|Anesthetics, Local|anesthetics, local|mesh-list
111381928|NCT01759277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111381929|NCT01759277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111381930|NCT01759277|Sensory System Agents|sensory system agents|mesh-ancestor
111381931|NCT01759277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111381932|NCT02618343|Ondansetron|ondansetron|mesh-list
111381933|NCT02618343|Antiemetics|antiemetics|mesh-ancestor
111381934|NCT02618343|Autonomic Agents|autonomic agents|mesh-ancestor
111381935|NCT02618343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111381936|NCT02618343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111381937|NCT02618343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111381938|NCT02618343|Antipruritics|antipruritics|mesh-ancestor
111381939|NCT02618343|Dermatologic Agents|dermatologic agents|mesh-ancestor
111381940|NCT02618343|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111381941|NCT02618343|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111381942|NCT02618343|Serotonin Agents|serotonin agents|mesh-ancestor
111381943|NCT02618343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111381944|NCT02618343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111381945|NCT02991053|Ketamine|ketamine|mesh-list
111381946|NCT02991053|Analgesics|analgesics|mesh-ancestor
111381947|NCT02991053|Sensory System Agents|sensory system agents|mesh-ancestor
111381948|NCT02991053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111381949|NCT02991053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111381950|NCT02991053|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111381951|NCT02991053|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111381952|NCT02991053|Anesthetics, General|anesthetics, general|mesh-ancestor
111381953|NCT02991053|Anesthetics|anesthetics|mesh-ancestor
111381954|NCT02991053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111381955|NCT02991053|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111381956|NCT02991053|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111381957|NCT02991053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111381958|NCT02991053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111381959|NCT01251536|Cetuximab|cetuximab|mesh-list
111381960|NCT01251536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111381961|NCT01251536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111381962|NCT02620683|Lidocaine|lidocaine|mesh-list
111381963|NCT02620683|Anesthetics, Local|anesthetics, local|mesh-ancestor
111381964|NCT02620683|Anesthetics|anesthetics|mesh-ancestor
111381965|NCT02620683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111381966|NCT02620683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111381967|NCT02620683|Sensory System Agents|sensory system agents|mesh-ancestor
111381968|NCT02620683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111381969|NCT02620683|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111381970|NCT02620683|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111381971|NCT02620683|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111381972|NCT02620683|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111381973|NCT02620683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111381974|NCT01355588|Ketorolac|ketorolac|mesh-list
111381975|NCT01355588|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
111381976|NCT01355588|Lidocaine|lidocaine|mesh-list
111381977|NCT01355588|Anesthetics, Local|anesthetics, local|mesh-ancestor
111381978|NCT01355588|Anesthetics|anesthetics|mesh-ancestor
111381979|NCT01355588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111381980|NCT01355588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111381981|NCT01355588|Sensory System Agents|sensory system agents|mesh-ancestor
111381982|NCT01355588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111381983|NCT01355588|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111381984|NCT01355588|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111381985|NCT01355588|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111381986|NCT01355588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111381987|NCT01355588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111381988|NCT01355588|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111381989|NCT01355588|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111381990|NCT01355588|Analgesics|analgesics|mesh-ancestor
111381991|NCT01355588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111381992|NCT01355588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111381993|NCT01355588|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111381994|NCT01355588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111381995|NCT02621619|Acetaminophen|acetaminophen|mesh-list
111381996|NCT02621619|Hydromorphone|hydromorphone|mesh-list
111381997|NCT02621619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111381998|NCT02621619|Analgesics|analgesics|mesh-ancestor
111381999|NCT02621619|Sensory System Agents|sensory system agents|mesh-ancestor
111382000|NCT02621619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111382001|NCT02621619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111382002|NCT02621619|Antipyretics|antipyretics|mesh-ancestor
111382003|NCT02621619|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111382004|NCT02621619|Narcotics|narcotics|mesh-ancestor
111382005|NCT02621619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111382006|NCT01253642|Docetaxel|docetaxel|mesh-list
111382007|NCT01253642|Phenelzine|phenelzine|mesh-list
111382008|NCT01253642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111382009|NCT01253642|Tubulin Modulators|tubulin modulators|mesh-ancestor
111382010|NCT01253642|Antimitotic Agents|antimitotic agents|mesh-ancestor
111382011|NCT01253642|Mitosis Modulators|mitosis modulators|mesh-ancestor
111382012|NCT01253642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111382013|NCT01253642|Antidepressive Agents|antidepressive agents|mesh-ancestor
111382014|NCT01253642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111382015|NCT01253642|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
111382016|NCT01253642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111382017|NCT01357148|Metformin|metformin|mesh-list
111382018|NCT01357148|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111382019|NCT01357148|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111382020|NCT01357148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111382021|NCT01357148|Incretins|incretins|mesh-ancestor
111382022|NCT01357148|Hormones|hormones|mesh-ancestor
111382023|NCT01357148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111382024|NCT01357148|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111382025|NCT01357148|Protease Inhibitors|protease inhibitors|mesh-ancestor
111382026|NCT01357148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111382027|NCT01357148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111382028|NCT02623803|Lidocaine|lidocaine|mesh-list
111382029|NCT02623803|Anesthetics, Local|anesthetics, local|mesh-ancestor
111382030|NCT02623803|Anesthetics|anesthetics|mesh-ancestor
111382031|NCT02623803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111382032|NCT02623803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111382033|NCT02623803|Sensory System Agents|sensory system agents|mesh-ancestor
111382034|NCT02623803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111382035|NCT02623803|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111382036|NCT02623803|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111382037|NCT02623803|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111382038|NCT02623803|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111382039|NCT02623803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111382040|NCT02322788|Terbutaline|terbutaline|mesh-list
111382041|NCT02322788|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111382042|NCT02322788|Autonomic Agents|autonomic agents|mesh-ancestor
111382043|NCT02322788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111382044|NCT02322788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111382045|NCT02322788|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111382046|NCT02322788|Respiratory System Agents|respiratory system agents|mesh-ancestor
111382047|NCT02322788|Sympathomimetics|sympathomimetics|mesh-ancestor
111382048|NCT02322788|Tocolytic Agents|tocolytic agents|mesh-ancestor
111382049|NCT02322788|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111382050|NCT02322788|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111382051|NCT02322788|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111382052|NCT02322788|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111382053|NCT02322788|Adrenergic Agents|adrenergic agents|mesh-ancestor
111382054|NCT02322788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111382055|NCT02322788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111382056|NCT02625207|Maraviroc|maraviroc|mesh-list
111382057|NCT02625207|Darunavir|darunavir|mesh-list
111382058|NCT02625207|Cobicistat|cobicistat|mesh-list
111382059|NCT02625207|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
111382060|NCT02625207|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
111382061|NCT02625207|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
111382062|NCT02625207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111382063|NCT02625207|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111382064|NCT02625207|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111382065|NCT02625207|Antiviral Agents|antiviral agents|mesh-ancestor
111382066|NCT02625207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111382067|NCT02625207|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
111382068|NCT02625207|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111382069|NCT02625207|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111382070|NCT02625207|Protease Inhibitors|protease inhibitors|mesh-ancestor
111382071|NCT02625207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111382072|NCT02625207|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111382073|NCT02625207|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111382074|NCT05315999|Palonosetron|palonosetron|mesh-list
111382075|NCT05315999|Antiemetics|antiemetics|mesh-ancestor
111382076|NCT05315999|Autonomic Agents|autonomic agents|mesh-ancestor
111382077|NCT05315999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111382078|NCT05315999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111382079|NCT05315999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111382080|NCT05315999|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111382081|NCT05315999|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111382082|NCT05315999|Serotonin Agents|serotonin agents|mesh-ancestor
111382083|NCT05315999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111382084|NCT05315999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111382085|NCT01763645|Paclitaxel|paclitaxel|mesh-list
111382086|NCT01763645|Bevacizumab|bevacizumab|mesh-list
111382087|NCT01763645|Carboplatin|carboplatin|mesh-list
111382088|NCT01763645|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111382089|NCT01763645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111382090|NCT01763645|Tubulin Modulators|tubulin modulators|mesh-ancestor
111382091|NCT01763645|Antimitotic Agents|antimitotic agents|mesh-ancestor
111382092|NCT01763645|Mitosis Modulators|mitosis modulators|mesh-ancestor
111382093|NCT01763645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111382094|NCT01763645|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111382095|NCT01763645|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111382096|NCT01763645|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111382097|NCT01763645|Growth Substances|growth substances|mesh-ancestor
111382098|NCT01763645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111382099|NCT01763645|Growth Inhibitors|growth inhibitors|mesh-ancestor
111382100|NCT02253173|Estradiol|estradiol|mesh-list
111382101|NCT02253173|Estrogens|estrogens|mesh-ancestor
111382102|NCT02253173|Hormones|hormones|mesh-ancestor
111382103|NCT02253173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111382104|NCT02253173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111382105|NCT03924791|Dexamethasone|dexamethasone|mesh-list
111382106|NCT03924791|Methylprednisolone|methylprednisolone|mesh-list
111382107|NCT03924791|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111382108|NCT03924791|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111382109|NCT03924791|Prednisolone|prednisolone|mesh-list
111382110|NCT03924791|Prednisolone acetate|prednisolone acetate|mesh-list
111382111|NCT03924791|Lidocaine|lidocaine|mesh-list
111382112|NCT03924791|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111382113|NCT03924791|Prednisolone phosphate|prednisolone phosphate|mesh-list
111382114|NCT03924791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111382115|NCT03924791|Antiemetics|antiemetics|mesh-ancestor
111382116|NCT03924791|Autonomic Agents|autonomic agents|mesh-ancestor
111382117|NCT03924791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111382118|NCT03924791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111382119|NCT03924791|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111382120|NCT03924791|Glucocorticoids|glucocorticoids|mesh-ancestor
111382121|NCT03924791|Hormones|hormones|mesh-ancestor
111382122|NCT03924791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110521959|NCT00941239|Metformin|metformin|mesh-list
111382123|NCT03924791|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111382124|NCT03924791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111382125|NCT03924791|Anesthetics, Local|anesthetics, local|mesh-ancestor
111382126|NCT03924791|Anesthetics|anesthetics|mesh-ancestor
111382127|NCT03924791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111106552|NCT03191539|Apremilast|apremilast|mesh-list
111382128|NCT03924791|Sensory System Agents|sensory system agents|mesh-ancestor
111382129|NCT03924791|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111382130|NCT03924791|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111382131|NCT03924791|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111382132|NCT03924791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111382133|NCT03924791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111382134|NCT03924791|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111382135|NCT03924791|Protective Agents|protective agents|mesh-ancestor
111382136|NCT01318694|Ribavirin|ribavirin|mesh-list
111382137|NCT01318694|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
111382138|NCT01318694|Antimetabolites|antimetabolites|mesh-ancestor
111382139|NCT01318694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111382140|NCT01318694|Antiviral Agents|antiviral agents|mesh-ancestor
111382141|NCT01318694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111382142|NCT03009578|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
111382143|NCT03009578|Hematinics|hematinics|mesh-ancestor
111382144|NCT01361048|Metronidazole|metronidazole|mesh-list
111382145|NCT01361048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111382146|NCT01361048|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111382147|NCT01361048|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111382148|NCT01361048|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111382149|NCT01766219|Thioctic Acid|thioctic acid|mesh-list
111382150|NCT01766219|Antioxidants|antioxidants|mesh-ancestor
111382151|NCT01766219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111382152|NCT01766219|Protective Agents|protective agents|mesh-ancestor
111382153|NCT01766219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111382154|NCT01766219|Vitamin B Complex|vitamin b complex|mesh-ancestor
111382155|NCT01766219|Vitamins|vitamins|mesh-ancestor
111382156|NCT01766219|Micronutrients|micronutrients|mesh-ancestor
111382157|NCT01767155|Doxorubicin|doxorubicin|mesh-list
111382158|NCT01767155|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111382159|NCT01767155|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111382160|NCT01767155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111382161|NCT01767155|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111382162|NCT01767155|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111382163|NCT01767155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111382164|NCT01767155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111382165|NCT01362686|Rivastigmine|rivastigmine|mesh-list
111382166|NCT01362686|Donepezil|donepezil|mesh-list
111382167|NCT01362686|Galantamine|galantamine|mesh-list
111382168|NCT01362686|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111382169|NCT01362686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111382170|NCT01362686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111382171|NCT01362686|Cholinergic Agents|cholinergic agents|mesh-ancestor
111382172|NCT01362686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111382173|NCT01362686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111382174|NCT01362686|Nootropic Agents|nootropic agents|mesh-ancestor
111382175|NCT01362686|Parasympathomimetics|parasympathomimetics|mesh-ancestor
111382176|NCT01362686|Autonomic Agents|autonomic agents|mesh-ancestor
111382177|NCT01362686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111382178|NCT01362686|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111382179|NCT01362686|Protective Agents|protective agents|mesh-ancestor
111382180|NCT01322048|Propranolol|propranolol|mesh-list
111382181|NCT01322048|Clonidine|clonidine|mesh-list
111382182|NCT01322048|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111382183|NCT01322048|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111382184|NCT01322048|Adrenergic Agents|adrenergic agents|mesh-ancestor
110522023|NCT00925769|Growth Substances|growth substances|mesh-ancestor
111382185|NCT01322048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111382186|NCT01322048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111382187|NCT01322048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111382188|NCT01322048|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111382189|NCT01322048|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111382190|NCT01322048|Vasodilator Agents|vasodilator agents|mesh-ancestor
111382191|NCT01322048|Analgesics|analgesics|mesh-ancestor
111382192|NCT01322048|Sensory System Agents|sensory system agents|mesh-ancestor
111382193|NCT01322048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111382194|NCT01322048|Sympatholytics|sympatholytics|mesh-ancestor
111382195|NCT01322048|Autonomic Agents|autonomic agents|mesh-ancestor
111382196|NCT01322048|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111382197|NCT01322048|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111382198|NCT01322048|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111382199|NCT01322360|Morphine|morphine|mesh-list
111382200|NCT01322360|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111382201|NCT01322360|Narcotics|narcotics|mesh-ancestor
111382202|NCT01322360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111382203|NCT01322360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111382204|NCT01322360|Analgesics|analgesics|mesh-ancestor
111382205|NCT01322360|Sensory System Agents|sensory system agents|mesh-ancestor
111382206|NCT01322360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111382207|NCT04351724|Ritonavir|ritonavir|mesh-list
111382209|NCT04351724|Hydroxychloroquine|hydroxychloroquine|mesh-list
111382210|NCT04351724|Chloroquine|chloroquine|mesh-list
111382211|NCT04351724|Remdesivir|remdesivir|mesh-list
111382212|NCT04351724|Candesartan|candesartan|mesh-list
111382213|NCT04351724|Candesartan cilexetil|candesartan cilexetil|mesh-list
111382214|NCT04351724|Antihypertensive Agents|antihypertensive agents|mesh-list
111382215|NCT04351724|Rivaroxaban|rivaroxaban|mesh-list
111382216|NCT04351724|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111382217|NCT04351724|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111382218|NCT04351724|Protease Inhibitors|protease inhibitors|mesh-ancestor
111382219|NCT04351724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111382220|NCT04351724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111382221|NCT04351724|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111382222|NCT04351724|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111382223|NCT04351724|Antiviral Agents|antiviral agents|mesh-ancestor
111382224|NCT04351724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111382225|NCT04351724|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111382226|NCT04351724|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111382227|NCT04351724|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111382228|NCT04351724|Antithrombins|antithrombins|mesh-ancestor
111382229|NCT04351724|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111382230|NCT04351724|Anticoagulants|anticoagulants|mesh-ancestor
111382231|NCT04351724|Antimalarials|antimalarials|mesh-ancestor
111382232|NCT04351724|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111382233|NCT04351724|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111382234|NCT04351724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111382235|NCT04351724|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111382236|NCT04351724|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111382237|NCT04351724|Amebicides|amebicides|mesh-ancestor
111382238|NCT04351724|Antimetabolites|antimetabolites|mesh-ancestor
111382239|NCT01767701|Raltegravir Potassium|raltegravir potassium|mesh-list
111382240|NCT01767701|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111382241|NCT01767701|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111382242|NCT01767701|Antiviral Agents|antiviral agents|mesh-ancestor
111382243|NCT01767701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111382244|NCT01767701|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111382245|NCT01767701|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111382246|NCT01767701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111382247|NCT01767701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111382248|NCT04351412|Fluorides|fluorides|mesh-list
111382249|NCT04351412|Fluorides, Topical|fluorides, topical|mesh-list
110522087|NCT00941473|Hormones|hormones|mesh-ancestor
111382250|NCT04351412|Cariostatic Agents|cariostatic agents|mesh-ancestor
111382251|NCT04351412|Protective Agents|protective agents|mesh-ancestor
111382252|NCT04351412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111382253|NCT01364090|Interferons|interferons|mesh-list
111382254|NCT01364090|Ribavirin|ribavirin|mesh-list
111382255|NCT01364090|Interferon-alpha|interferon-alpha|mesh-list
111382256|NCT01364090|Interferon alpha-2|interferon alpha-2|mesh-list
111382257|NCT01364090|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
111382258|NCT01364090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111382259|NCT01364090|Antiviral Agents|antiviral agents|mesh-ancestor
111382260|NCT01364090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111382261|NCT01364090|Antimetabolites|antimetabolites|mesh-ancestor
111382262|NCT01364090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111382263|NCT01364090|Immunologic Factors|immunologic factors|mesh-ancestor
111382264|NCT01364090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111382265|NCT03684785|Pembrolizumab|pembrolizumab|mesh-list
111382266|NCT03684785|Cemiplimab|cemiplimab|mesh-list
111382267|NCT03684785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111382268|NCT03684785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111382269|NCT03684785|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111382270|NCT03684785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111382271|NCT01364558|Diazepam|diazepam|mesh-list
111382272|NCT01364558|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111382273|NCT01364558|Anticonvulsants|anticonvulsants|mesh-ancestor
111382274|NCT01364558|Antiemetics|antiemetics|mesh-ancestor
111382275|NCT01364558|Autonomic Agents|autonomic agents|mesh-ancestor
111382276|NCT01364558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111382277|NCT01364558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111382278|NCT01364558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111382279|NCT01364558|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111382280|NCT01364558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111382281|NCT01364558|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
111382282|NCT01364558|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111382283|NCT01364558|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111382284|NCT01364558|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111106680|NCT03142607|Metronidazole|metronidazole|mesh-list
111382285|NCT01364558|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111382286|NCT01364558|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111382287|NCT01364558|Anesthetics, General|anesthetics, general|mesh-ancestor
111382288|NCT01364558|Anesthetics|anesthetics|mesh-ancestor
111382289|NCT01364558|GABA Modulators|gaba modulators|mesh-ancestor
111382290|NCT01364558|GABA Agents|gaba agents|mesh-ancestor
111382291|NCT01364558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111382292|NCT01364558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111382293|NCT01323140|Testosterone|testosterone|mesh-list
111382294|NCT01323140|Androgens|androgens|mesh-ancestor
111382295|NCT01323140|Hormones|hormones|mesh-ancestor
111382296|NCT01323140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111382297|NCT01323140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111382298|NCT03516305|Alprazolam|alprazolam|mesh-list
111382299|NCT03516305|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111382300|NCT03516305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111382301|NCT03516305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111382302|NCT03516305|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111382303|NCT03516305|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111382304|NCT03516305|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111382305|NCT03516305|GABA Modulators|gaba modulators|mesh-ancestor
111382306|NCT03516305|GABA Agents|gaba agents|mesh-ancestor
111382307|NCT03516305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111382308|NCT03516305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111382309|NCT03823287|Aflibercept|aflibercept|mesh-list
111382310|NCT03823287|Faricimab|faricimab|mesh-list
111382311|NCT03823287|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111382312|NCT03823287|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111382313|NCT03823287|Growth Substances|growth substances|mesh-ancestor
111382314|NCT03823287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111382315|NCT03823287|Growth Inhibitors|growth inhibitors|mesh-ancestor
111382316|NCT03823287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111382317|NCT02244671|Botulinum Toxins|botulinum toxins|mesh-list
111382318|NCT02244671|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111382319|NCT02244671|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111382320|NCT02244671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111382321|NCT02244671|Cholinergic Agents|cholinergic agents|mesh-ancestor
110522143|NCT02793050|Trabectedin|trabectedin|mesh-list
111382322|NCT02244671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111382323|NCT02244671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111382324|NCT02626611|Omalizumab|omalizumab|mesh-list
111382325|NCT02626611|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111382326|NCT02626611|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111382327|NCT02626611|Respiratory System Agents|respiratory system agents|mesh-ancestor
111382328|NCT01260662|Ketamine|ketamine|mesh-list
111382329|NCT01260662|Propofol|propofol|mesh-list
111382330|NCT01260662|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111382331|NCT01260662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111382332|NCT01260662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111382333|NCT01260662|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111382334|NCT01260662|Anesthetics, General|anesthetics, general|mesh-ancestor
111382335|NCT01260662|Anesthetics|anesthetics|mesh-ancestor
111382336|NCT01260662|Analgesics|analgesics|mesh-ancestor
111382337|NCT01260662|Sensory System Agents|sensory system agents|mesh-ancestor
111382338|NCT01260662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111382339|NCT01260662|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111382340|NCT01260662|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111382341|NCT01260662|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111382342|NCT01260662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111382343|NCT01260662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111382344|NCT02327117|Tranexamic Acid|tranexamic acid|mesh-list
111382345|NCT02327117|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111382346|NCT02327117|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111382347|NCT02327117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111382348|NCT02327117|Hemostatics|hemostatics|mesh-ancestor
111382349|NCT02327117|Coagulants|coagulants|mesh-ancestor
111382350|NCT01365650|Fluticasone|fluticasone|mesh-list
111382351|NCT01365650|Xhance|xhance|mesh-list
111382352|NCT01365650|Ketorolac|ketorolac|mesh-list
111382353|NCT01365650|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
111382354|NCT01365650|Phenylephrine|phenylephrine|mesh-list
111382355|NCT01365650|Oxymetazoline|oxymetazoline|mesh-list
111382356|NCT01365650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111382357|NCT01365650|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111382358|NCT01365650|Autonomic Agents|autonomic agents|mesh-ancestor
111382359|NCT01365650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111382360|NCT01365650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111382361|NCT01365650|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111382362|NCT01365650|Respiratory System Agents|respiratory system agents|mesh-ancestor
111382363|NCT01365650|Dermatologic Agents|dermatologic agents|mesh-ancestor
111382364|NCT01365650|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111382365|NCT01365650|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111382366|NCT01365650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111382367|NCT01365650|Analgesics|analgesics|mesh-ancestor
111382368|NCT01365650|Sensory System Agents|sensory system agents|mesh-ancestor
111382369|NCT01365650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111382370|NCT01365650|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111382371|NCT01365650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111382372|NCT01365650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111382373|NCT01365650|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111382374|NCT01365650|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111382375|NCT01365650|Adrenergic Agents|adrenergic agents|mesh-ancestor
111382376|NCT01365650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111382377|NCT01365650|Sympathomimetics|sympathomimetics|mesh-ancestor
111382378|NCT01365650|Nasal Decongestants|nasal decongestants|mesh-ancestor
111382379|NCT01365650|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111382380|NCT01365650|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111382381|NCT01365650|Mydriatics|mydriatics|mesh-ancestor
111382382|NCT01365650|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111382383|NCT01365650|Protective Agents|protective agents|mesh-ancestor
111382384|NCT01324700|Dexetimide|dexetimide|mesh-list
111382385|NCT01324700|Citalopram|citalopram|mesh-list
111382386|NCT01324700|Escitalopram|escitalopram|mesh-list
111382387|NCT01324700|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
111382388|NCT01324700|Serotonin|serotonin|mesh-list
111382389|NCT01324700|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111382390|NCT01324700|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111382391|NCT01324700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111382392|NCT01324700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111382393|NCT01324700|Serotonin Agents|serotonin agents|mesh-ancestor
111382394|NCT01324700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111382395|NCT01324700|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111382396|NCT01324700|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111382397|NCT01324700|Parasympatholytics|parasympatholytics|mesh-ancestor
111382398|NCT01324700|Autonomic Agents|autonomic agents|mesh-ancestor
111382399|NCT01324700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111382400|NCT01324700|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111382401|NCT01324700|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111382402|NCT01324700|Cholinergic Agents|cholinergic agents|mesh-ancestor
111382403|NCT01324700|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111382404|NCT01324700|Antidepressive Agents|antidepressive agents|mesh-ancestor
111382405|NCT01324700|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111382406|NCT01324700|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111382407|NCT04769297|Ketamine|ketamine|mesh-list
111382408|NCT04769297|Analgesics|analgesics|mesh-ancestor
111382409|NCT04769297|Sensory System Agents|sensory system agents|mesh-ancestor
111382410|NCT04769297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111382411|NCT04769297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111382412|NCT04769297|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111382413|NCT04769297|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111382414|NCT04769297|Anesthetics, General|anesthetics, general|mesh-ancestor
111382415|NCT04769297|Anesthetics|anesthetics|mesh-ancestor
111382416|NCT04769297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111382417|NCT04769297|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111382418|NCT04769297|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111382419|NCT04769297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111382420|NCT04769297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111382421|NCT02631057|Warfarin|warfarin|mesh-list
111382422|NCT02631057|Dabigatran|dabigatran|mesh-list
111382423|NCT02631057|Anticoagulants|anticoagulants|mesh-ancestor
111382424|NCT02631057|Antithrombins|antithrombins|mesh-ancestor
111382425|NCT02631057|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111382426|NCT02631057|Protease Inhibitors|protease inhibitors|mesh-ancestor
111382427|NCT02631057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111382428|NCT02631057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111382429|NCT02631525|Propofol|propofol|mesh-list
111382430|NCT02631525|Desflurane|desflurane|mesh-list
111382431|NCT02631525|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111382432|NCT02631525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111382433|NCT02631525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111382434|NCT02631525|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111382435|NCT02631525|Anesthetics, General|anesthetics, general|mesh-ancestor
111382436|NCT02631525|Anesthetics|anesthetics|mesh-ancestor
111106835|NCT02432833|Tacrolimus|tacrolimus|mesh-list
111382437|NCT02631525|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111382438|NCT03162497|Azithromycin|azithromycin|mesh-list
111382439|NCT03162497|Doxycycline|doxycycline|mesh-list
111382440|NCT03162497|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111382441|NCT03162497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111382442|NCT03162497|Antimalarials|antimalarials|mesh-ancestor
111382443|NCT03162497|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111382444|NCT03162497|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111382445|NCT05167643|Anastrozole|anastrozole|mesh-list
111382446|NCT05167643|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111382447|NCT05167643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111382448|NCT05167643|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111382449|NCT05167643|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111382450|NCT05167643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111382451|NCT05167643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111382452|NCT05167643|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111382453|NCT05167643|Hormone Antagonists|hormone antagonists|mesh-ancestor
111382454|NCT05167643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111382455|NCT05167643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111382456|NCT01366196|Pregabalin|pregabalin|mesh-list
111382457|NCT01366196|Analgesics|analgesics|mesh-ancestor
111382458|NCT01366196|Sensory System Agents|sensory system agents|mesh-ancestor
111382459|NCT01366196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111382460|NCT01366196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111382461|NCT01366196|Anticonvulsants|anticonvulsants|mesh-ancestor
111382462|NCT01366196|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111382463|NCT01366196|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111382464|NCT01366196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111382465|NCT01366196|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111382466|NCT01366196|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111382467|NCT01366196|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111382468|NCT01366196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111382469|NCT01366196|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111382470|NCT01366976|Acetaminophen|acetaminophen|mesh-list
111382471|NCT01366976|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111382472|NCT01366976|Analgesics|analgesics|mesh-ancestor
111382473|NCT01366976|Sensory System Agents|sensory system agents|mesh-ancestor
111382474|NCT01366976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111382475|NCT01366976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111382476|NCT01366976|Antipyretics|antipyretics|mesh-ancestor
111382477|NCT01777217|Solifenacin Succinate|solifenacin succinate|mesh-list
111382478|NCT01777217|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111382479|NCT01777217|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111382480|NCT01777217|Cholinergic Agents|cholinergic agents|mesh-ancestor
111382481|NCT01777217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111382482|NCT01777217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111382483|NCT01777217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111382484|NCT01777217|Urological Agents|urological agents|mesh-ancestor
111382485|NCT02251379|Fluticasone|fluticasone|mesh-list
111382487|NCT02251379|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
111382488|NCT02251379|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111382489|NCT02251379|Autonomic Agents|autonomic agents|mesh-ancestor
111382490|NCT02251379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111382491|NCT02251379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111382492|NCT02251379|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111382493|NCT02251379|Respiratory System Agents|respiratory system agents|mesh-ancestor
111382494|NCT02251379|Glucocorticoids|glucocorticoids|mesh-ancestor
111382495|NCT02251379|Hormones|hormones|mesh-ancestor
111382496|NCT02251379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111382497|NCT02251379|Sympathomimetics|sympathomimetics|mesh-ancestor
111382498|NCT02251379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111382499|NCT02251379|Dermatologic Agents|dermatologic agents|mesh-ancestor
111382500|NCT02251379|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111382501|NCT02255513|Methylphenidate|methylphenidate|mesh-list
111382502|NCT02255513|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111382503|NCT02255513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111382504|NCT02255513|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111382505|NCT02255513|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111382506|NCT02255513|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111382507|NCT02255513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111382508|NCT02255513|Dopamine Agents|dopamine agents|mesh-ancestor
110959230|NCT03523572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111382509|NCT02255513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111382510|NCT01778465|Salicylic Acid|salicylic acid|mesh-list
111382511|NCT01778465|Salicylates|salicylates|mesh-list
111382512|NCT01778465|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111382513|NCT01778465|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111382514|NCT01778465|Analgesics|analgesics|mesh-ancestor
111382515|NCT01778465|Sensory System Agents|sensory system agents|mesh-ancestor
111382516|NCT01778465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111382517|NCT01778465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111382518|NCT01778465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111382519|NCT01778465|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111382520|NCT01778465|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111382521|NCT01778465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111382522|NCT01778465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111382523|NCT01778465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111382524|NCT01778465|Antifungal Agents|antifungal agents|mesh-ancestor
111382525|NCT01778465|Keratolytic Agents|keratolytic agents|mesh-ancestor
111382526|NCT01778465|Dermatologic Agents|dermatologic agents|mesh-ancestor
111382527|NCT01779167|Thalidomide|thalidomide|mesh-list
111382528|NCT01779167|Rituximab|rituximab|mesh-list
111382529|NCT01779167|Lenalidomide|lenalidomide|mesh-list
111382530|NCT01779167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111382531|NCT01779167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111382532|NCT01779167|Immunologic Factors|immunologic factors|mesh-ancestor
111382533|NCT01779167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111382534|NCT01779167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111382535|NCT01779167|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111382536|NCT01779167|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111382537|NCT01779167|Growth Substances|growth substances|mesh-ancestor
111382538|NCT01779167|Growth Inhibitors|growth inhibitors|mesh-ancestor
111382539|NCT01779167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111382540|NCT01779167|Leprostatic Agents|leprostatic agents|mesh-ancestor
111382541|NCT01779167|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111382542|NCT01779167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111382543|NCT01780337|Oxytocin|oxytocin|mesh-list
111382544|NCT01780337|Oxytocics|oxytocics|mesh-ancestor
111382545|NCT01780337|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111382546|NCT01780337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111382547|NCT02251613|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
111382548|NCT02251613|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111382549|NCT02251613|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111382550|NCT02251613|Epinastine|epinastine|mesh-list
111382551|NCT02251613|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111382552|NCT02251613|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111382553|NCT02251613|Analgesics|analgesics|mesh-ancestor
111382554|NCT02251613|Sensory System Agents|sensory system agents|mesh-ancestor
111382555|NCT02251613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111382556|NCT02251613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111382557|NCT02251613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111382558|NCT02251613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111382559|NCT02251613|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111382560|NCT02251613|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
111382561|NCT02251613|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111382562|NCT02251613|Histamine Antagonists|histamine antagonists|mesh-ancestor
111382563|NCT02251613|Histamine Agents|histamine agents|mesh-ancestor
111382564|NCT02251613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111382565|NCT02251613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111382566|NCT02865473|Pilocarpine|pilocarpine|mesh-list
111382567|NCT02865473|Miotics|miotics|mesh-ancestor
111382568|NCT02865473|Autonomic Agents|autonomic agents|mesh-ancestor
111382569|NCT02865473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111382570|NCT02865473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111382571|NCT02865473|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
111382572|NCT02865473|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111382573|NCT02865473|Cholinergic Agents|cholinergic agents|mesh-ancestor
111382574|NCT02865473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111382575|NCT02865473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111382576|NCT02850419|Doxorubicin|doxorubicin|mesh-list
111382577|NCT02850419|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111382578|NCT02850419|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111382579|NCT02850419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110522416|NCT00943345|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111382580|NCT02850419|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111382581|NCT02850419|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111382582|NCT02850419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110959231|NCT03523572|Immunoconjugates|immunoconjugates|mesh-ancestor
111382583|NCT02850419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111382584|NCT02841371|Edetic Acid|edetic acid|mesh-list
111382585|NCT02841371|Pentetic Acid|pentetic acid|mesh-list
111382586|NCT02841371|Antidotes|antidotes|mesh-ancestor
111382587|NCT02841371|Protective Agents|protective agents|mesh-ancestor
111382588|NCT02841371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111382589|NCT02841371|Chelating Agents|chelating agents|mesh-ancestor
111382590|NCT02841371|Sequestering Agents|sequestering agents|mesh-ancestor
111382591|NCT02841371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111382592|NCT02841371|Iron Chelating Agents|iron chelating agents|mesh-ancestor
111382593|NCT02841371|Anticoagulants|anticoagulants|mesh-ancestor
111382594|NCT02841371|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
111382595|NCT01783847|Prednisolone|prednisolone|mesh-list
111382596|NCT01783847|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111382597|NCT01783847|Methylprednisolone|methylprednisolone|mesh-list
111382598|NCT01783847|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111382599|NCT01783847|Prednisolone acetate|prednisolone acetate|mesh-list
111382600|NCT01783847|Epoetin Alfa|epoetin alfa|mesh-list
111382601|NCT01783847|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111382602|NCT01783847|Prednisolone phosphate|prednisolone phosphate|mesh-list
111382603|NCT01783847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111382604|NCT01783847|Glucocorticoids|glucocorticoids|mesh-ancestor
111382605|NCT01783847|Hormones|hormones|mesh-ancestor
111382606|NCT01783847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111382607|NCT01783847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111382608|NCT01783847|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111382609|NCT01783847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111382610|NCT01783847|Antiemetics|antiemetics|mesh-ancestor
111382611|NCT01783847|Autonomic Agents|autonomic agents|mesh-ancestor
111382612|NCT01783847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111382613|NCT01783847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111382614|NCT01783847|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111382615|NCT01783847|Protective Agents|protective agents|mesh-ancestor
111382616|NCT01783847|Hematinics|hematinics|mesh-ancestor
111382617|NCT02585375|Latanoprost|latanoprost|mesh-list
111382618|NCT02585375|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
111382619|NCT02585375|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111382620|NCT02516813|Peposertib|peposertib|mesh-list
111382621|NCT02516813|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111382622|NCT02516813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111382623|NCT02516813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111382624|NCT01785095|Hormones|hormones|mesh-list
111382625|NCT01785095|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
111382626|NCT01785095|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111382627|NCT01785095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111382628|NCT01786343|Decitabine|decitabine|mesh-list
111382629|NCT01786343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111382630|NCT01786343|Antimetabolites|antimetabolites|mesh-ancestor
111382631|NCT01786343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111382632|NCT01786343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111382633|NCT01786343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111382634|NCT03362775|Propofol|propofol|mesh-list
111382635|NCT03362775|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111382636|NCT03362775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111382637|NCT03362775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111382638|NCT03362775|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111382639|NCT03362775|Anesthetics, General|anesthetics, general|mesh-ancestor
111382640|NCT03362775|Anesthetics|anesthetics|mesh-ancestor
111382641|NCT01786967|Fesoterodine|fesoterodine|mesh-list
111382642|NCT01786967|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111382643|NCT01786967|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111382644|NCT01786967|Cholinergic Agents|cholinergic agents|mesh-ancestor
111382645|NCT01786967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111382646|NCT01786967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111382647|NCT01786967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111382648|NCT01786967|Urological Agents|urological agents|mesh-ancestor
111382649|NCT02392871|Trametinib|trametinib|mesh-list
111382650|NCT02392871|Dabrafenib|dabrafenib|mesh-list
111382651|NCT02392871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111382652|NCT02392871|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111382653|NCT02392871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111382654|NCT02392871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111382655|NCT02382575|Rituximab|rituximab|mesh-list
110959232|NCT03523572|Immunologic Factors|immunologic factors|mesh-ancestor
111382656|NCT02382575|Tacrolimus|tacrolimus|mesh-list
111382657|NCT02382575|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
111382658|NCT02382575|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111382659|NCT02382575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111382660|NCT02382575|Immunologic Factors|immunologic factors|mesh-ancestor
111382661|NCT02382575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111382662|NCT02382575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111382663|NCT02382575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111382664|NCT02382575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111382665|NCT02382575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111382666|NCT01807871|Nicotine|nicotine|mesh-list
111382667|NCT01807871|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111382668|NCT01807871|Autonomic Agents|autonomic agents|mesh-ancestor
111382669|NCT01807871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111382670|NCT01807871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111382671|NCT01807871|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111382672|NCT01807871|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111382673|NCT01807871|Cholinergic Agents|cholinergic agents|mesh-ancestor
111382674|NCT01807871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111382675|NCT01807871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111382676|NCT01263938|Atorvastatin|atorvastatin|mesh-list
111382677|NCT01263938|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111382678|NCT01263938|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111382679|NCT01263938|Antimetabolites|antimetabolites|mesh-ancestor
111382680|NCT01263938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111382681|NCT01263938|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111382682|NCT01263938|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111382683|NCT01263938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111382684|NCT02327741|Clopidogrel|clopidogrel|mesh-list
111382685|NCT02327741|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111382686|NCT02327741|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111382687|NCT02327741|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111382688|NCT02327741|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111382689|NCT02327741|Purinergic Agents|purinergic agents|mesh-ancestor
111382690|NCT02327741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111000949|NCT02855359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111382691|NCT02327741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111382692|NCT02327741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111382693|NCT00367185|Thalidomide|thalidomide|mesh-list
111382694|NCT00367185|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111382695|NCT00367185|Immunologic Factors|immunologic factors|mesh-ancestor
111382696|NCT00367185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111382697|NCT00367185|Leprostatic Agents|leprostatic agents|mesh-ancestor
111382698|NCT00367185|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111382699|NCT00367185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111382700|NCT00367185|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111382701|NCT00367185|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111382702|NCT00367185|Growth Substances|growth substances|mesh-ancestor
111382703|NCT00367185|Growth Inhibitors|growth inhibitors|mesh-ancestor
111382704|NCT00367185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111382705|NCT02635035|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
111382706|NCT02635035|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111382707|NCT02635035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111382708|NCT02635035|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111382709|NCT02635035|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111382710|NCT02635035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111382711|NCT02635035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111382712|NCT02635035|Dopamine Agents|dopamine agents|mesh-ancestor
111382713|NCT02635035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111382714|NCT03283137|Pembrolizumab|pembrolizumab|mesh-list
111382715|NCT03283137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111382716|NCT03283137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111382717|NCT03283137|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111382718|NCT03283137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111382719|NCT01267136|Acetaminophen|acetaminophen|mesh-list
111382720|NCT01267136|Tramadol|tramadol|mesh-list
111382721|NCT01267136|Codeine|codeine|mesh-list
111382722|NCT01267136|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111382723|NCT01267136|Analgesics|analgesics|mesh-ancestor
111382724|NCT01267136|Sensory System Agents|sensory system agents|mesh-ancestor
111382725|NCT01267136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111382726|NCT01267136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111382727|NCT01267136|Antipyretics|antipyretics|mesh-ancestor
111382728|NCT01267136|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111382729|NCT01267136|Narcotics|narcotics|mesh-ancestor
111382730|NCT01267136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111382731|NCT01267136|Antitussive Agents|antitussive agents|mesh-ancestor
111382732|NCT01267136|Respiratory System Agents|respiratory system agents|mesh-ancestor
111382733|NCT01370564|Diuretics|diuretics|mesh-list
111382734|NCT01370564|Natriuretic Agents|natriuretic agents|mesh-ancestor
111382735|NCT01370564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111382736|NCT00367263|Ciclesonide|ciclesonide|mesh-list
111382737|NCT00367263|Glucocorticoids|glucocorticoids|mesh-ancestor
111382738|NCT00367263|Hormones|hormones|mesh-ancestor
111382739|NCT00367263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111382740|NCT00367263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111382741|NCT00367263|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111382742|NCT02637999|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
111382743|NCT02637999|Interferon alpha-2|interferon alpha-2|mesh-list
111382744|NCT02637999|Antiviral Agents|antiviral agents|mesh-ancestor
111382745|NCT02637999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111382746|NCT02637999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111382747|NCT01371110|Midazolam|midazolam|mesh-list
111382748|NCT01371110|Ketamine|ketamine|mesh-list
111382749|NCT01371110|Analgesics|analgesics|mesh-ancestor
111382750|NCT01371110|Sensory System Agents|sensory system agents|mesh-ancestor
111382751|NCT01371110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111382752|NCT01371110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111382753|NCT01371110|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111382754|NCT01371110|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111382755|NCT01371110|Anesthetics, General|anesthetics, general|mesh-ancestor
111382756|NCT01371110|Anesthetics|anesthetics|mesh-ancestor
111382757|NCT01371110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111382758|NCT01371110|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111382759|NCT01371110|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111382760|NCT01371110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111382761|NCT01371110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111382762|NCT01371110|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111382763|NCT01371110|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111382764|NCT01371110|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111382765|NCT01371110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111382766|NCT01371110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111382767|NCT01371110|GABA Modulators|gaba modulators|mesh-ancestor
111382768|NCT01371110|GABA Agents|gaba agents|mesh-ancestor
111382769|NCT01791491|Abatacept|abatacept|mesh-list
111382770|NCT01791491|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111382771|NCT01791491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111382772|NCT01791491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111382773|NCT01791491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111382774|NCT01791491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111382775|NCT01791491|Immunologic Factors|immunologic factors|mesh-ancestor
111382776|NCT01791491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111382777|NCT01791491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111382778|NCT00367419|Erythromycin|erythromycin|mesh-list
111382779|NCT00367419|Erythromycin Estolate|erythromycin estolate|mesh-list
111382780|NCT00367419|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
111382781|NCT00367419|Erythromycin stearate|erythromycin stearate|mesh-list
111382782|NCT00367419|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111382783|NCT00367419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111382784|NCT00367419|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111382785|NCT00367419|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111382786|NCT00367419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111382787|NCT00367419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111382788|NCT01372202|Paclitaxel|paclitaxel|mesh-list
111382789|NCT01372202|Fluorouracil|fluorouracil|mesh-list
111382790|NCT01372202|Oxaliplatin|oxaliplatin|mesh-list
111382791|NCT01372202|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111382792|NCT01372202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111382793|NCT01372202|Tubulin Modulators|tubulin modulators|mesh-ancestor
111382794|NCT01372202|Antimitotic Agents|antimitotic agents|mesh-ancestor
111382795|NCT01372202|Mitosis Modulators|mitosis modulators|mesh-ancestor
111382796|NCT01372202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111382797|NCT01372202|Antimetabolites|antimetabolites|mesh-ancestor
111382798|NCT01372202|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111382799|NCT01372202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111382800|NCT01372202|Immunologic Factors|immunologic factors|mesh-ancestor
111382801|NCT01372202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111382802|NCT01811147|Norepinephrine|norepinephrine|mesh-list
111382803|NCT01811147|Serotonin|serotonin|mesh-list
111382804|NCT01811147|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
111382805|NCT01811147|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111382806|NCT01811147|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111382807|NCT01811147|Adrenergic Agents|adrenergic agents|mesh-ancestor
111382808|NCT01811147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111382809|NCT01811147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111382810|NCT01811147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111382812|NCT01811147|Autonomic Agents|autonomic agents|mesh-ancestor
111382813|NCT01811147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111382814|NCT01811147|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111382815|NCT01811147|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111382816|NCT01811147|Serotonin Agents|serotonin agents|mesh-ancestor
111382817|NCT01811147|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111382818|NCT01811147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111382819|NCT01373450|Liraglutide|liraglutide|mesh-list
111382820|NCT01373450|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111382821|NCT01373450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111382822|NCT01373450|Incretins|incretins|mesh-ancestor
111382823|NCT01373450|Hormones|hormones|mesh-ancestor
111382824|NCT01373450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111382825|NCT01793285|Etanercept|etanercept|mesh-list
111382826|NCT01793285|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111382827|NCT01793285|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111382828|NCT01793285|Analgesics|analgesics|mesh-ancestor
111382829|NCT01793285|Sensory System Agents|sensory system agents|mesh-ancestor
111382830|NCT01793285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111382831|NCT01793285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111382832|NCT01793285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111382833|NCT01793285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111382834|NCT01793285|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111382835|NCT01793285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111382836|NCT01793285|Immunologic Factors|immunologic factors|mesh-ancestor
111382837|NCT05049525|Itraconazole|itraconazole|mesh-list
111382838|NCT05049525|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
111382839|NCT05049525|Terbinafine|terbinafine|mesh-list
111382840|NCT05049525|Antifungal Agents|antifungal agents|mesh-ancestor
111382841|NCT05049525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111382842|NCT05049525|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111382843|NCT05049525|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111382844|NCT05049525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111382845|NCT05049525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111382846|NCT05049525|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111382847|NCT05049525|Hormone Antagonists|hormone antagonists|mesh-ancestor
111382848|NCT05049525|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111382849|NCT05049525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111382850|NCT05049525|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111382851|NCT01811693|Nitroglycerin|nitroglycerin|mesh-list
111382852|NCT01811693|Vasodilator Agents|vasodilator agents|mesh-ancestor
111382853|NCT02639637|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111382854|NCT02639637|Valsartan|valsartan|mesh-list
111382855|NCT02639637|Enalaprilat|enalaprilat|mesh-list
111382856|NCT02639637|Enalapril|enalapril|mesh-list
111382857|NCT02639637|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111382858|NCT02639637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111382859|NCT02639637|Incretins|incretins|mesh-ancestor
111382860|NCT02639637|Hormones|hormones|mesh-ancestor
111382861|NCT02639637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111382862|NCT02639637|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111382863|NCT02639637|Protease Inhibitors|protease inhibitors|mesh-ancestor
111382864|NCT02639637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111382865|NCT02639637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111382866|NCT02639637|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111382867|NCT02639637|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111382868|NCT02639637|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111382869|NCT02639637|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
111382870|NCT01332188|Cetirizine|cetirizine|mesh-list
111382871|NCT01332188|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111382872|NCT01332188|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
111382873|NCT01332188|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111382874|NCT01332188|Histamine Antagonists|histamine antagonists|mesh-ancestor
111382875|NCT01332188|Histamine Agents|histamine agents|mesh-ancestor
111382876|NCT01332188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111382877|NCT01332188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111382878|NCT01332188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111382879|NCT01794455|Candesartan|candesartan|mesh-list
111382880|NCT01794455|Candesartan cilexetil|candesartan cilexetil|mesh-list
111382881|NCT01794455|Sertraline|sertraline|mesh-list
111382882|NCT01794455|Antidepressive Agents|antidepressive agents|mesh-ancestor
111382883|NCT01794455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111382884|NCT01794455|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111382885|NCT01794455|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111382886|NCT01794455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111382887|NCT01794455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111382888|NCT01794455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111382889|NCT01794455|Serotonin Agents|serotonin agents|mesh-ancestor
111382890|NCT01794455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111382891|NCT01794455|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111382892|NCT01794455|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111382893|NCT01794455|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111382895|NCT01332500|Sumatriptan|sumatriptan|mesh-list
111382896|NCT01332500|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111382897|NCT01332500|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111382898|NCT01332500|Analgesics|analgesics|mesh-ancestor
111382899|NCT01332500|Sensory System Agents|sensory system agents|mesh-ancestor
111382900|NCT01332500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111382901|NCT01332500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111382902|NCT01332500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111382903|NCT01332500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111382904|NCT01332500|Gout Suppressants|gout suppressants|mesh-ancestor
111382905|NCT01332500|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111382906|NCT01332500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111382907|NCT01332500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111382908|NCT01332500|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111382909|NCT01332500|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111382910|NCT01332500|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111382911|NCT01332500|Serotonin Agents|serotonin agents|mesh-ancestor
111382912|NCT01332500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111382913|NCT01812005|Rituximab|rituximab|mesh-list
111382914|NCT01812005|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111382915|NCT01812005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111382916|NCT01812005|Immunologic Factors|immunologic factors|mesh-ancestor
111382917|NCT01812005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111382918|NCT01812005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111382919|NCT01332578|Acetaminophen|acetaminophen|mesh-list
111382920|NCT01332578|Ascorbic Acid|ascorbic acid|mesh-list
111382921|NCT01332578|Phenylephrine|phenylephrine|mesh-list
111382922|NCT01332578|Oxymetazoline|oxymetazoline|mesh-list
111382923|NCT01332578|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111382924|NCT01332578|Analgesics|analgesics|mesh-ancestor
111382925|NCT01332578|Sensory System Agents|sensory system agents|mesh-ancestor
111382926|NCT01332578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111382927|NCT01332578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111382928|NCT01332578|Antipyretics|antipyretics|mesh-ancestor
111382929|NCT01332578|Antioxidants|antioxidants|mesh-ancestor
111382930|NCT01332578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111382931|NCT01332578|Protective Agents|protective agents|mesh-ancestor
111382932|NCT01332578|Vitamins|vitamins|mesh-ancestor
111382933|NCT01332578|Micronutrients|micronutrients|mesh-ancestor
111382934|NCT01332578|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111382935|NCT01332578|Mydriatics|mydriatics|mesh-ancestor
111382936|NCT01332578|Autonomic Agents|autonomic agents|mesh-ancestor
111382937|NCT01332578|Sympathomimetics|sympathomimetics|mesh-ancestor
111382938|NCT01332578|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111382939|NCT01332578|Nasal Decongestants|nasal decongestants|mesh-ancestor
111382940|NCT01332578|Respiratory System Agents|respiratory system agents|mesh-ancestor
111382941|NCT01332578|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111382942|NCT01332578|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111382943|NCT01332578|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111382944|NCT01332578|Adrenergic Agents|adrenergic agents|mesh-ancestor
111382945|NCT01332578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111382946|NCT01333592|Mitiglinide|mitiglinide|mesh-list
111382947|NCT01333592|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111382948|NCT01333592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111382949|NCT01375946|Contraceptive Agents|contraceptive agents|mesh-list
111382950|NCT01375946|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111382951|NCT01375946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111382952|NCT01267292|Buspirone|buspirone|mesh-list
111382953|NCT01267292|Methylphenidate|methylphenidate|mesh-list
111382954|NCT01267292|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111382955|NCT01267292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111382956|NCT01267292|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111382957|NCT01267292|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111382958|NCT01267292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111382959|NCT01267292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111382960|NCT01267292|Dopamine Agents|dopamine agents|mesh-ancestor
111382961|NCT01267292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111382962|NCT01267292|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111382963|NCT01267292|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111382964|NCT01267292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111382965|NCT01267292|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111382966|NCT01267292|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111382967|NCT01267292|Serotonin Agents|serotonin agents|mesh-ancestor
111382968|NCT01734161|Dexamethasone|dexamethasone|mesh-list
111382969|NCT01734161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111382970|NCT01734161|Antiemetics|antiemetics|mesh-ancestor
111382971|NCT01734161|Autonomic Agents|autonomic agents|mesh-ancestor
111382972|NCT01734161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111382973|NCT01734161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111382974|NCT01734161|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111382975|NCT01734161|Glucocorticoids|glucocorticoids|mesh-ancestor
111382976|NCT01734161|Hormones|hormones|mesh-ancestor
111382977|NCT01734161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111382978|NCT01734161|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111382979|NCT01734161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111382980|NCT01734239|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
111382981|NCT01734239|Immunologic Factors|immunologic factors|mesh-ancestor
111382982|NCT01734239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111382983|NCT01797575|Aspirin|aspirin|mesh-list
111382984|NCT01797575|Acetylcysteine|acetylcysteine|mesh-list
111382985|NCT01797575|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111382986|NCT01797575|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111382987|NCT01797575|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111382988|NCT01797575|Analgesics|analgesics|mesh-ancestor
111382989|NCT01797575|Sensory System Agents|sensory system agents|mesh-ancestor
111382990|NCT01797575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111382991|NCT01797575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111382992|NCT01797575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111382993|NCT01797575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111382994|NCT01797575|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111382995|NCT01797575|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111382996|NCT01797575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111382997|NCT01797575|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111382998|NCT01797575|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111382999|NCT01797575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111383000|NCT01797575|Antipyretics|antipyretics|mesh-ancestor
111383001|NCT01797575|Antiviral Agents|antiviral agents|mesh-ancestor
111383002|NCT01797575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111383003|NCT01797575|Expectorants|expectorants|mesh-ancestor
111383004|NCT01797575|Respiratory System Agents|respiratory system agents|mesh-ancestor
111383005|NCT01797575|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111383006|NCT01797575|Antioxidants|antioxidants|mesh-ancestor
111383007|NCT01797575|Protective Agents|protective agents|mesh-ancestor
111383008|NCT01797575|Antidotes|antidotes|mesh-ancestor
111383009|NCT02641353|Thalidomide|thalidomide|mesh-list
111383010|NCT02641353|Apremilast|apremilast|mesh-list
111383011|NCT02641353|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111383012|NCT02641353|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111383013|NCT02641353|Analgesics|analgesics|mesh-ancestor
111383014|NCT02641353|Sensory System Agents|sensory system agents|mesh-ancestor
111383015|NCT02641353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111383016|NCT02641353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111383017|NCT02641353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111383018|NCT02641353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111383019|NCT02641353|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
111383020|NCT02641353|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111383021|NCT02641353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111383022|NCT02641353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111383023|NCT02641353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111383024|NCT02641353|Immunologic Factors|immunologic factors|mesh-ancestor
111383025|NCT02641353|Leprostatic Agents|leprostatic agents|mesh-ancestor
110522880|NCT05949099|Nirogacestat|nirogacestat|mesh-list
111383026|NCT02641353|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111383027|NCT02641353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111383028|NCT02641353|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111383029|NCT02641353|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111383030|NCT02641353|Growth Substances|growth substances|mesh-ancestor
111383031|NCT02641353|Growth Inhibitors|growth inhibitors|mesh-ancestor
111383032|NCT02641353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111383034|NCT01378520|Antifungal Agents|antifungal agents|mesh-ancestor
111383035|NCT01378520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111383036|NCT01378520|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111383037|NCT01378520|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111383038|NCT01378520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111383039|NCT01378520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111383040|NCT01378520|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111383041|NCT01378520|Hormone Antagonists|hormone antagonists|mesh-ancestor
111383042|NCT01378520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111383043|NCT01378520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111383044|NCT01378520|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111383045|NCT01378988|Dexmedetomidine|dexmedetomidine|mesh-list
111383046|NCT01378988|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111383047|NCT01378988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111383048|NCT01378988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111383049|NCT01378988|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111383050|NCT01378988|Analgesics|analgesics|mesh-ancestor
111383051|NCT01378988|Sensory System Agents|sensory system agents|mesh-ancestor
111383052|NCT01378988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111383053|NCT01378988|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111383054|NCT01378988|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111383055|NCT01378988|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111383056|NCT01378988|Adrenergic Agents|adrenergic agents|mesh-ancestor
111383057|NCT01378988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111383058|NCT01378988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111383059|NCT01335620|Tenofovir|tenofovir|mesh-list
111383060|NCT01335620|Emtricitabine|emtricitabine|mesh-list
111383061|NCT01335620|Raltegravir Potassium|raltegravir potassium|mesh-list
111383062|NCT01335620|Antiviral Agents|antiviral agents|mesh-ancestor
111383063|NCT01335620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111383064|NCT01335620|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111383065|NCT01335620|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111383066|NCT01335620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111383067|NCT01335620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111383068|NCT01335620|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111383069|NCT01335620|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111383070|NCT01335620|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111383071|NCT01335620|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111383072|NCT01335932|Ganciclovir|ganciclovir|mesh-list
111383073|NCT01335932|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
111383074|NCT01335932|Antiviral Agents|antiviral agents|mesh-ancestor
111383075|NCT01335932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111383076|NCT01335932|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111383077|NCT01335932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111383078|NCT01335932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111383079|NCT01273766|Deferasirox|deferasirox|mesh-list
111383080|NCT01273766|Iron Chelating Agents|iron chelating agents|mesh-ancestor
111383081|NCT01273766|Chelating Agents|chelating agents|mesh-ancestor
111383082|NCT01273766|Sequestering Agents|sequestering agents|mesh-ancestor
111383083|NCT01273766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111383084|NCT01403246|Lenalidomide|lenalidomide|mesh-list
111383085|NCT01403246|Chlorambucil|chlorambucil|mesh-list
111383086|NCT01403246|Immunologic Factors|immunologic factors|mesh-ancestor
111383087|NCT01403246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111383088|NCT01403246|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111383089|NCT01403246|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111383090|NCT01403246|Growth Substances|growth substances|mesh-ancestor
111383091|NCT01403246|Growth Inhibitors|growth inhibitors|mesh-ancestor
111383092|NCT01403246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111383093|NCT01403246|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111383094|NCT01403246|Alkylating Agents|alkylating agents|mesh-ancestor
111383095|NCT01403246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111383096|NCT01734551|Clonidine|clonidine|mesh-list
111383097|NCT01734551|Morphine|morphine|mesh-list
111383098|NCT01734551|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111383099|NCT01734551|Narcotics|narcotics|mesh-ancestor
111383100|NCT01734551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111383101|NCT01734551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111383102|NCT01734551|Analgesics|analgesics|mesh-ancestor
111383103|NCT01734551|Sensory System Agents|sensory system agents|mesh-ancestor
111383104|NCT01734551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111383105|NCT01734551|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111383106|NCT01734551|Sympatholytics|sympatholytics|mesh-ancestor
111383107|NCT01734551|Autonomic Agents|autonomic agents|mesh-ancestor
111383108|NCT01734551|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111383109|NCT01734551|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111383110|NCT01734551|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111383111|NCT01734551|Adrenergic Agents|adrenergic agents|mesh-ancestor
111383112|NCT01734551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111383113|NCT01734551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111383114|NCT01404260|Carboplatin|carboplatin|mesh-list
111383115|NCT01404260|Gemcitabine|gemcitabine|mesh-list
111383116|NCT01404260|Gefitinib|gefitinib|mesh-list
111383117|NCT01404260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111383118|NCT01404260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111383119|NCT01404260|Antimetabolites|antimetabolites|mesh-ancestor
111383120|NCT01404260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111383121|NCT01404260|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111383122|NCT01404260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111383123|NCT02235909|Losartan|losartan|mesh-list
111383124|NCT02235909|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
111383125|NCT02235909|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111383126|NCT02235909|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111383127|NCT02235909|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111383128|NCT02235909|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111383129|NCT02235909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111383130|NCT01404572|Atazanavir Sulfate|atazanavir sulfate|mesh-list
111383131|NCT01404572|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111383132|NCT01404572|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111383133|NCT01404572|Protease Inhibitors|protease inhibitors|mesh-ancestor
111383134|NCT01404572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111383135|NCT01404572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111383136|NCT01404572|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111383137|NCT01404572|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111383138|NCT01404572|Antiviral Agents|antiviral agents|mesh-ancestor
111383139|NCT01404572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111383140|NCT01381406|Tiotropium Bromide|tiotropium bromide|mesh-list
111383141|NCT01381406|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111383142|NCT01381406|Autonomic Agents|autonomic agents|mesh-ancestor
111383143|NCT01381406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111383144|NCT01381406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111383145|NCT01381406|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111383146|NCT01381406|Respiratory System Agents|respiratory system agents|mesh-ancestor
111383147|NCT01381406|Parasympatholytics|parasympatholytics|mesh-ancestor
111383148|NCT01381406|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111383149|NCT01381406|Cholinergic Agents|cholinergic agents|mesh-ancestor
111383150|NCT01381406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111383151|NCT01381406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111383152|NCT01799213|Meloxicam|meloxicam|mesh-list
111383153|NCT01799213|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111383154|NCT01799213|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111383155|NCT01799213|Analgesics|analgesics|mesh-ancestor
111383156|NCT01799213|Sensory System Agents|sensory system agents|mesh-ancestor
111383157|NCT01799213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111383158|NCT01799213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111383159|NCT01799213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111383160|NCT01799213|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111383161|NCT01799213|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111383162|NCT01799213|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111383163|NCT01799213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111383164|NCT01799213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111383165|NCT01383200|Lidocaine|lidocaine|mesh-list
111383166|NCT01383200|Tetracaine|tetracaine|mesh-list
111383167|NCT01383200|Anesthetics, Local|anesthetics, local|mesh-ancestor
111383168|NCT01383200|Anesthetics|anesthetics|mesh-ancestor
111383169|NCT01383200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111383170|NCT01383200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111383171|NCT01383200|Sensory System Agents|sensory system agents|mesh-ancestor
111383172|NCT01383200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111383173|NCT01383200|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111383174|NCT01383200|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111383175|NCT01383200|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111383176|NCT01383200|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111383177|NCT01383200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111107593|NCT03106597|Amlodipine|amlodipine|mesh-list
111383178|NCT05588037|Dexamethasone|dexamethasone|mesh-list
111383179|NCT05588037|Dexamethasone acetate|dexamethasone acetate|mesh-list
111383180|NCT05588037|BB 1101|bb 1101|mesh-list
111383181|NCT05588037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111383182|NCT05588037|Antiemetics|antiemetics|mesh-ancestor
111383183|NCT05588037|Autonomic Agents|autonomic agents|mesh-ancestor
111383184|NCT05588037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111383185|NCT05588037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111383186|NCT05588037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111383187|NCT05588037|Glucocorticoids|glucocorticoids|mesh-ancestor
111383188|NCT05588037|Hormones|hormones|mesh-ancestor
111383189|NCT05588037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111383190|NCT05588037|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111383191|NCT05588037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111383192|NCT05588037|Protease Inhibitors|protease inhibitors|mesh-ancestor
110523056|NCT05690087|Lidocaine|lidocaine|mesh-list
111383193|NCT05588037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111383194|NCT05588037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111383195|NCT02194088|Diclofenac|diclofenac|mesh-list
111383196|NCT02194088|Atropine|atropine|mesh-list
111383197|NCT02194088|Analgesics|analgesics|mesh-list
111383198|NCT02194088|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111383199|NCT02194088|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111383200|NCT02194088|Sensory System Agents|sensory system agents|mesh-ancestor
111383201|NCT02194088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111383202|NCT02194088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111383203|NCT02194088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111383204|NCT02194088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111383205|NCT02194088|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111383206|NCT02194088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111383207|NCT02194088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111383208|NCT02194088|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111383209|NCT02194088|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111383210|NCT02194088|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111383211|NCT02194088|Autonomic Agents|autonomic agents|mesh-ancestor
111383212|NCT02194088|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111383213|NCT02194088|Respiratory System Agents|respiratory system agents|mesh-ancestor
111383214|NCT02194088|Mydriatics|mydriatics|mesh-ancestor
111383215|NCT02194088|Parasympatholytics|parasympatholytics|mesh-ancestor
111383216|NCT02194088|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111383217|NCT02194088|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111383218|NCT02194088|Cholinergic Agents|cholinergic agents|mesh-ancestor
111383219|NCT02194088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111383220|NCT02023593|Leucovorin|leucovorin|mesh-list
111383221|NCT02023593|Fluorouracil|fluorouracil|mesh-list
111383222|NCT02023593|Irinotecan|irinotecan|mesh-list
111383223|NCT02023593|Antimetabolites|antimetabolites|mesh-ancestor
111383224|NCT02023593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111383225|NCT02023593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111383226|NCT02023593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111383227|NCT02023593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111383228|NCT02023593|Immunologic Factors|immunologic factors|mesh-ancestor
111383229|NCT02023593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111383230|NCT02023593|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111383231|NCT02023593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111383232|NCT02023593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111383233|NCT02023593|Antidotes|antidotes|mesh-ancestor
111383234|NCT02023593|Protective Agents|protective agents|mesh-ancestor
111383235|NCT02023593|Vitamin B Complex|vitamin b complex|mesh-ancestor
111383236|NCT02023593|Vitamins|vitamins|mesh-ancestor
111383237|NCT02023593|Micronutrients|micronutrients|mesh-ancestor
111383238|NCT01978431|Cocaine|cocaine|mesh-list
111383239|NCT01978431|Methylphenidate|methylphenidate|mesh-list
111383240|NCT01978431|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111383241|NCT01978431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111383242|NCT01978431|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111383243|NCT01978431|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111383244|NCT01978431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111383245|NCT01978431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111383246|NCT01978431|Dopamine Agents|dopamine agents|mesh-ancestor
111383247|NCT01978431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111383248|NCT01978431|Anesthetics, Local|anesthetics, local|mesh-ancestor
111383249|NCT01978431|Anesthetics|anesthetics|mesh-ancestor
111383250|NCT01978431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111383251|NCT01978431|Sensory System Agents|sensory system agents|mesh-ancestor
111383252|NCT01978431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111383253|NCT01978431|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111383254|NCT01406444|Risedronic Acid|risedronic acid|mesh-list
111383255|NCT01406444|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111383256|NCT01406444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111383257|NCT01406444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111383258|NCT01406444|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111383259|NCT01406444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111383260|NCT01406444|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111383261|NCT02685267|Prednisone|prednisone|mesh-list
111383262|NCT02685267|Docetaxel|docetaxel|mesh-list
111383263|NCT02685267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111383264|NCT02685267|Tubulin Modulators|tubulin modulators|mesh-ancestor
111383265|NCT02685267|Antimitotic Agents|antimitotic agents|mesh-ancestor
111383266|NCT02685267|Mitosis Modulators|mitosis modulators|mesh-ancestor
111383267|NCT02685267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111383268|NCT02685267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111383269|NCT02685267|Glucocorticoids|glucocorticoids|mesh-ancestor
111383270|NCT02685267|Hormones|hormones|mesh-ancestor
111383271|NCT02685267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111383272|NCT02685267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111383273|NCT02685267|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111383274|NCT02257541|Imatinib Mesylate|imatinib mesylate|mesh-list
111383275|NCT02257541|Infigratinib|infigratinib|mesh-list
111383276|NCT02257541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111383277|NCT02257541|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111383278|NCT02257541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111383279|NCT02257541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111383280|NCT01817855|AZD7624|azd7624|mesh-list
111383281|NCT01817855|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111383282|NCT01817855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111383283|NCT01817855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111383284|NCT00368121|Dexamethasone|dexamethasone|mesh-list
111383285|NCT00368121|Cetuximab|cetuximab|mesh-list
111383286|NCT00368121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111383287|NCT00368121|Antiemetics|antiemetics|mesh-ancestor
111383288|NCT00368121|Autonomic Agents|autonomic agents|mesh-ancestor
111383289|NCT00368121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111383290|NCT00368121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111383291|NCT00368121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111383292|NCT00368121|Glucocorticoids|glucocorticoids|mesh-ancestor
111383293|NCT00368121|Hormones|hormones|mesh-ancestor
111383294|NCT00368121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111383295|NCT00368121|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111383296|NCT00368121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111383297|NCT00368121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111383298|NCT00367497|Cytarabine|cytarabine|mesh-list
111383299|NCT00367497|Methylprednisolone|methylprednisolone|mesh-list
111383300|NCT00367497|Rituximab|rituximab|mesh-list
111383301|NCT00367497|Etoposide|etoposide|mesh-list
111383302|NCT00367497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111383303|NCT00367497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111383304|NCT00367497|Immunologic Factors|immunologic factors|mesh-ancestor
111383305|NCT00367497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111383306|NCT00367497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111383307|NCT00367497|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111383308|NCT00367497|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111383309|NCT00367497|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111383310|NCT00367497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111383311|NCT00367497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111383312|NCT00367497|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111383313|NCT00367497|Antimetabolites|antimetabolites|mesh-ancestor
111383314|NCT00367497|Antiviral Agents|antiviral agents|mesh-ancestor
111383315|NCT00367497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111383316|NCT00367497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111383317|NCT00367497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111383318|NCT00367497|Antiemetics|antiemetics|mesh-ancestor
111383319|NCT00367497|Autonomic Agents|autonomic agents|mesh-ancestor
111383320|NCT00367497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111383321|NCT00367497|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111383322|NCT00367497|Glucocorticoids|glucocorticoids|mesh-ancestor
111383323|NCT00367497|Hormones|hormones|mesh-ancestor
111383324|NCT00367497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111383325|NCT00367497|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111383326|NCT00367497|Protective Agents|protective agents|mesh-ancestor
111383327|NCT01387178|Fluticasone|fluticasone|mesh-list
111383328|NCT01387178|Xhance|xhance|mesh-list
111383329|NCT01387178|Bromides|bromides|mesh-list
111383330|NCT01387178|Tiotropium Bromide|tiotropium bromide|mesh-list
111383331|NCT01387178|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
111383332|NCT01387178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111383333|NCT01387178|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111383334|NCT01387178|Autonomic Agents|autonomic agents|mesh-ancestor
111383335|NCT01387178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111383336|NCT01387178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111383337|NCT01387178|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111383338|NCT01387178|Respiratory System Agents|respiratory system agents|mesh-ancestor
111383339|NCT01387178|Dermatologic Agents|dermatologic agents|mesh-ancestor
111383340|NCT01387178|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111383341|NCT01387178|Parasympatholytics|parasympatholytics|mesh-ancestor
111383342|NCT01387178|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111383343|NCT01387178|Cholinergic Agents|cholinergic agents|mesh-ancestor
111383344|NCT01387178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111383345|NCT01387178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111383346|NCT01387178|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111383347|NCT01387178|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111383348|NCT01387178|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111383349|NCT01387178|Adrenergic Agents|adrenergic agents|mesh-ancestor
111383350|NCT01387178|Anticonvulsants|anticonvulsants|mesh-ancestor
111383351|NCT01805297|Aflibercept|aflibercept|mesh-list
111383352|NCT01805297|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111383353|NCT01805297|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111383354|NCT01805297|Growth Substances|growth substances|mesh-ancestor
111383355|NCT01805297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111383356|NCT01805297|Growth Inhibitors|growth inhibitors|mesh-ancestor
111383357|NCT01805297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111383358|NCT01389284|Naproxen|naproxen|mesh-list
111383359|NCT01389284|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111383360|NCT01389284|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111383361|NCT01389284|Analgesics|analgesics|mesh-ancestor
111383362|NCT01389284|Sensory System Agents|sensory system agents|mesh-ancestor
111383363|NCT01389284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111383364|NCT01389284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111383365|NCT01389284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111383366|NCT01389284|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111383367|NCT01389284|Gout Suppressants|gout suppressants|mesh-ancestor
111383368|NCT01389284|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111383369|NCT01389284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111383370|NCT01389284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111383371|NCT01794143|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111383372|NCT01794143|Liraglutide|liraglutide|mesh-list
111383373|NCT01794143|Glimepiride|glimepiride|mesh-list
111383374|NCT01794143|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
111383375|NCT01794143|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111383376|NCT01794143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111383377|NCT01794143|Incretins|incretins|mesh-ancestor
111383378|NCT01794143|Hormones|hormones|mesh-ancestor
111383379|NCT01794143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111383380|NCT01794143|Protease Inhibitors|protease inhibitors|mesh-ancestor
111383381|NCT01794143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111383382|NCT01794143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111383383|NCT01794143|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111383384|NCT01794143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111383385|NCT01794143|Immunologic Factors|immunologic factors|mesh-ancestor
111383386|NCT01547741|Paclitaxel|paclitaxel|mesh-list
111383387|NCT01547741|Docetaxel|docetaxel|mesh-list
110523242|NCT05287035|Hormones|hormones|mesh-ancestor
111383388|NCT01547741|Cyclophosphamide|cyclophosphamide|mesh-list
111383389|NCT01547741|Doxorubicin|doxorubicin|mesh-list
111383390|NCT01547741|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111383391|NCT01547741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111383392|NCT01547741|Tubulin Modulators|tubulin modulators|mesh-ancestor
111383393|NCT01547741|Antimitotic Agents|antimitotic agents|mesh-ancestor
111383394|NCT01547741|Mitosis Modulators|mitosis modulators|mesh-ancestor
111383395|NCT01547741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111383396|NCT01547741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111383397|NCT01547741|Immunologic Factors|immunologic factors|mesh-ancestor
111383398|NCT01547741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111383399|NCT01547741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111383400|NCT01547741|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111383401|NCT01547741|Alkylating Agents|alkylating agents|mesh-ancestor
111383402|NCT01547741|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111383403|NCT01547741|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110671266|NCT00833729|Etanercept|etanercept|mesh-list
111383404|NCT01547741|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111383405|NCT01547741|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111383406|NCT01547741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111383407|NCT01390064|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
111383408|NCT01390064|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111383409|NCT01390064|Immunologic Factors|immunologic factors|mesh-ancestor
111383410|NCT01390064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111383411|NCT01473368|Amoxicillin|amoxicillin|mesh-list
111383412|NCT01473368|Clavulanic Acid|clavulanic acid|mesh-list
111383413|NCT01473368|Clavulanic Acids|clavulanic acids|mesh-list
111383414|NCT01473368|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
111383415|NCT01473368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111383416|NCT01473368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111383417|NCT01473368|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
111383418|NCT01473368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111383419|NCT01473368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111383420|NCT04351490|Cholecalciferol|cholecalciferol|mesh-list
111383421|NCT04351490|Vitamin D|vitamin d|mesh-list
111383422|NCT04351490|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111383423|NCT04351490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111383424|NCT04351490|Vitamins|vitamins|mesh-ancestor
111383425|NCT04351490|Micronutrients|micronutrients|mesh-ancestor
111383426|NCT04351490|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111383427|NCT01391312|Botulinum Toxins|botulinum toxins|mesh-list
111383428|NCT01391312|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111383429|NCT01391312|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111383430|NCT01391312|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111383431|NCT01391312|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111383432|NCT01391312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111383433|NCT01391312|Cholinergic Agents|cholinergic agents|mesh-ancestor
111383434|NCT01391312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111383435|NCT01391312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111383436|NCT01391312|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111383437|NCT01391312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111383438|NCT03008252|Caseins|caseins|mesh-list
111383439|NCT03008252|Chelating Agents|chelating agents|mesh-ancestor
111383440|NCT03008252|Sequestering Agents|sequestering agents|mesh-ancestor
111383441|NCT03008252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111383442|NCT05328635|Candesartan|candesartan|mesh-list
111383443|NCT05328635|Candesartan cilexetil|candesartan cilexetil|mesh-list
111383444|NCT05328635|Gabapentin|gabapentin|mesh-list
111383445|NCT05328635|Analgesics|analgesics|mesh-ancestor
111383446|NCT05328635|Sensory System Agents|sensory system agents|mesh-ancestor
111383447|NCT05328635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111383448|NCT05328635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111383449|NCT05328635|Anticonvulsants|anticonvulsants|mesh-ancestor
111383450|NCT05328635|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111383451|NCT05328635|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111383452|NCT05328635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111383453|NCT05328635|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111383454|NCT05328635|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111383455|NCT05328635|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111383456|NCT05328635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111383457|NCT05328635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111383458|NCT05328635|Antimanic Agents|antimanic agents|mesh-ancestor
111383459|NCT05328635|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111383460|NCT05328635|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111383461|NCT05328635|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111383462|NCT01391858|Pregabalin|pregabalin|mesh-list
111383463|NCT01391858|Analgesics|analgesics|mesh-ancestor
111383464|NCT01391858|Sensory System Agents|sensory system agents|mesh-ancestor
111383465|NCT01391858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111383466|NCT01391858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111383467|NCT01391858|Anticonvulsants|anticonvulsants|mesh-ancestor
111383468|NCT01391858|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111383469|NCT01391858|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111383470|NCT01391858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111383471|NCT01391858|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111383472|NCT01391858|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111383473|NCT01391858|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111383474|NCT01391858|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111383475|NCT01391858|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111383476|NCT05587257|Minoxidil|minoxidil|mesh-list
111383477|NCT05587257|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111383478|NCT05587257|Vasodilator Agents|vasodilator agents|mesh-ancestor
111383479|NCT01825655|Cetirizine|cetirizine|mesh-list
111383480|NCT01825655|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111383481|NCT01825655|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
111383482|NCT01825655|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111383483|NCT01825655|Histamine Antagonists|histamine antagonists|mesh-ancestor
111383484|NCT01825655|Histamine Agents|histamine agents|mesh-ancestor
111383485|NCT01825655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111383486|NCT01825655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111383487|NCT01825655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111383488|NCT02249663|Fluticasone|fluticasone|mesh-list
111383489|NCT02249663|Xhance|xhance|mesh-list
111383490|NCT02249663|Azelastine|azelastine|mesh-list
111383491|NCT02249663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111383492|NCT02249663|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111383493|NCT02249663|Autonomic Agents|autonomic agents|mesh-ancestor
111383494|NCT02249663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111383495|NCT02249663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111383496|NCT02249663|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111383497|NCT02249663|Respiratory System Agents|respiratory system agents|mesh-ancestor
111383498|NCT02249663|Dermatologic Agents|dermatologic agents|mesh-ancestor
111383499|NCT02249663|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111383500|NCT02249663|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
111383501|NCT02249663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111383502|NCT02249663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111383503|NCT02249663|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
111383504|NCT02249663|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111383505|NCT02249663|Histamine Antagonists|histamine antagonists|mesh-ancestor
111383506|NCT02249663|Histamine Agents|histamine agents|mesh-ancestor
111383507|NCT02249663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111383508|NCT04237623|Sargramostim|sargramostim|mesh-list
111383509|NCT04237623|Immunologic Factors|immunologic factors|mesh-ancestor
111383510|NCT04237623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111383511|NCT01825889|Evacetrapib|evacetrapib|mesh-list
111383512|NCT01825889|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111383513|NCT01825889|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111383514|NCT01825889|Antimetabolites|antimetabolites|mesh-ancestor
111383515|NCT01825889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111383516|NCT01825889|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111383517|NCT02692755|Letrozole|letrozole|mesh-list
111383518|NCT02692755|Fulvestrant|fulvestrant|mesh-list
111383519|NCT02692755|Palbociclib|palbociclib|mesh-list
111383520|NCT02692755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111383521|NCT02692755|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111383522|NCT02692755|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111383523|NCT02692755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111383524|NCT02692755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111383525|NCT02692755|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111383526|NCT02692755|Hormone Antagonists|hormone antagonists|mesh-ancestor
111383527|NCT02692755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111383528|NCT02692755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111383529|NCT02692755|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111383530|NCT02692755|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
111383531|NCT02692755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111383532|NCT01829399|Epinephrine|epinephrine|mesh-list
111383533|NCT01829399|Bupivacaine|bupivacaine|mesh-list
111383534|NCT01829399|Anesthetics, Local|anesthetics, local|mesh-ancestor
111383535|NCT01829399|Anesthetics|anesthetics|mesh-ancestor
111383536|NCT01829399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111383537|NCT01829399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111383538|NCT01829399|Sensory System Agents|sensory system agents|mesh-ancestor
111383539|NCT01829399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111383540|NCT01829399|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111383541|NCT01829399|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111383542|NCT01829399|Adrenergic Agents|adrenergic agents|mesh-ancestor
111383543|NCT01829399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111383544|NCT01829399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111383545|NCT01829399|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111383546|NCT01829399|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111383547|NCT01829399|Autonomic Agents|autonomic agents|mesh-ancestor
111383548|NCT01829399|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111383549|NCT01829399|Respiratory System Agents|respiratory system agents|mesh-ancestor
111383550|NCT01829399|Mydriatics|mydriatics|mesh-ancestor
111383551|NCT01829399|Sympathomimetics|sympathomimetics|mesh-ancestor
111383552|NCT01829399|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111383553|NCT01394510|Acetylcysteine|acetylcysteine|mesh-list
111383554|NCT01394510|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111383555|NCT01394510|Antiviral Agents|antiviral agents|mesh-ancestor
111383556|NCT01394510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111383557|NCT01394510|Expectorants|expectorants|mesh-ancestor
111383558|NCT01394510|Respiratory System Agents|respiratory system agents|mesh-ancestor
111383559|NCT01394510|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111383560|NCT01394510|Antioxidants|antioxidants|mesh-ancestor
111000950|NCT02855359|Glucocorticoids|glucocorticoids|mesh-ancestor
111383561|NCT01394510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111383562|NCT01394510|Protective Agents|protective agents|mesh-ancestor
111383563|NCT01394510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111383564|NCT01394510|Antidotes|antidotes|mesh-ancestor
111383565|NCT05580549|Ethanol|ethanol|mesh-list
111383566|NCT05580549|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111383567|NCT05580549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111383568|NCT05580549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111383569|NCT05580549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111383570|NCT05327621|Pamiparib|pamiparib|mesh-list
111383571|NCT05327621|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111383572|NCT05327621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111383573|NCT05327621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111383574|NCT05327621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111383575|NCT00367731|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
111383576|NCT00367731|Antiviral Agents|antiviral agents|mesh-ancestor
111383577|NCT00367731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111383578|NCT05326841|Vitamin D|vitamin d|mesh-list
111383579|NCT05326841|Cholecalciferol|cholecalciferol|mesh-list
111383580|NCT05326841|Vitamins|vitamins|mesh-ancestor
111383581|NCT05326841|Micronutrients|micronutrients|mesh-ancestor
111383582|NCT05326841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111383583|NCT05326841|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111383584|NCT05326841|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111383585|NCT01412372|Mesalamine|mesalamine|mesh-list
111383586|NCT01412372|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111383587|NCT01412372|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111383588|NCT01412372|Analgesics|analgesics|mesh-ancestor
111383589|NCT01412372|Sensory System Agents|sensory system agents|mesh-ancestor
111383590|NCT01412372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111383591|NCT01412372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111383592|NCT01412372|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111383593|NCT01412372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111383594|NCT01414010|Amoxicillin|amoxicillin|mesh-list
111383595|NCT01414010|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111383596|NCT01414010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111383597|NCT01415960|Leuprolide|leuprolide|mesh-list
111383598|NCT01415960|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111383599|NCT01415960|Fertility Agents|fertility agents|mesh-ancestor
111383600|NCT01415960|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111383601|NCT01415960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111383602|NCT01415960|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111383603|NCT01415960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111383604|NCT01833845|Ribavirin|ribavirin|mesh-list
111383605|NCT01833845|Hydroxychloroquine|hydroxychloroquine|mesh-list
111383606|NCT01833845|Antimetabolites|antimetabolites|mesh-ancestor
111383607|NCT01833845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111383608|NCT01833845|Antiviral Agents|antiviral agents|mesh-ancestor
111383609|NCT01833845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111383610|NCT01833845|Antimalarials|antimalarials|mesh-ancestor
111383611|NCT01833845|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111383612|NCT01833845|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111383613|NCT01833845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111383614|NCT01833845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111383615|NCT01416194|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
111383616|NCT01416194|Bazedoxifene|bazedoxifene|mesh-list
111383617|NCT01416194|Diphosphonates|diphosphonates|mesh-list
111383618|NCT01416194|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111383619|NCT01416194|Hormone Antagonists|hormone antagonists|mesh-ancestor
111383620|NCT01416194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111383621|NCT01416194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111383622|NCT01416194|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111383623|NCT01416194|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111383624|NCT01416194|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111383625|NCT01416584|Methadone|methadone|mesh-list
111383626|NCT01416584|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111108044|NCT04837235|Hemay005|hemay005|mesh-list
111383627|NCT01416584|Narcotics|narcotics|mesh-ancestor
111383628|NCT01416584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111383629|NCT01416584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111383630|NCT01416584|Analgesics|analgesics|mesh-ancestor
111383631|NCT01416584|Sensory System Agents|sensory system agents|mesh-ancestor
111383632|NCT01416584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111383633|NCT01416584|Antitussive Agents|antitussive agents|mesh-ancestor
111383634|NCT01416584|Respiratory System Agents|respiratory system agents|mesh-ancestor
111383635|NCT02698215|Naltrexone|naltrexone|mesh-list
111383636|NCT02698215|Varenicline|varenicline|mesh-list
111383637|NCT02698215|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111383638|NCT02698215|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111383639|NCT02698215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111383640|NCT02698215|Sensory System Agents|sensory system agents|mesh-ancestor
111383641|NCT02698215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111383642|NCT02698215|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111383643|NCT02698215|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111383644|NCT02698215|Cholinergic Agents|cholinergic agents|mesh-ancestor
111383645|NCT02698215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111383646|NCT02698215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111383647|NCT04172961|Cyclosporine|cyclosporine|mesh-list
111383648|NCT04172961|Lifitegrast|lifitegrast|mesh-list
111383649|NCT04172961|Cyclosporins|cyclosporins|mesh-list
111383650|NCT04172961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111383651|NCT04172961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111383652|NCT04172961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111383653|NCT04172961|Immunologic Factors|immunologic factors|mesh-ancestor
111383654|NCT04172961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111383655|NCT04172961|Antifungal Agents|antifungal agents|mesh-ancestor
111383656|NCT04172961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111383657|NCT04172961|Dermatologic Agents|dermatologic agents|mesh-ancestor
111383658|NCT04172961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111383659|NCT04172961|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111383660|NCT04172961|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
111383661|NCT04172961|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111383662|NCT01480232|Nicotine|nicotine|mesh-list
111383663|NCT01480232|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111383664|NCT01480232|Autonomic Agents|autonomic agents|mesh-ancestor
111383665|NCT01480232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111383666|NCT01480232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111383667|NCT01480232|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111383668|NCT01480232|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111383669|NCT01480232|Cholinergic Agents|cholinergic agents|mesh-ancestor
111383670|NCT01480232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111383671|NCT01480232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111383672|NCT04049799|Analgesics, Opioid|analgesics, opioid|mesh-list
111383673|NCT04049799|Narcotics|narcotics|mesh-ancestor
111383674|NCT04049799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111383675|NCT04049799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111383676|NCT04049799|Analgesics|analgesics|mesh-ancestor
111383677|NCT04049799|Sensory System Agents|sensory system agents|mesh-ancestor
111383678|NCT04049799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111383679|NCT01399268|Hydrocortisone|hydrocortisone|mesh-list
111383680|NCT01399268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111383681|NCT03008876|Acetaminophen|acetaminophen|mesh-list
111383682|NCT03008876|Ibuprofen|ibuprofen|mesh-list
111383683|NCT03008876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111383684|NCT03008876|Analgesics|analgesics|mesh-ancestor
111383685|NCT03008876|Sensory System Agents|sensory system agents|mesh-ancestor
111383686|NCT03008876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111383687|NCT03008876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111383688|NCT03008876|Antipyretics|antipyretics|mesh-ancestor
111383689|NCT03008876|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111383690|NCT03008876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111383691|NCT03008876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111383692|NCT03008876|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111383693|NCT03008876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111383694|NCT03008876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111383695|NCT05414487|Ofatumumab|ofatumumab|mesh-list
111383696|NCT05414487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111383697|NCT02701257|Glucagon|glucagon|mesh-list
111383698|NCT02701257|Pancrelipase|pancrelipase|mesh-list
111383699|NCT02701257|Pancreatin|pancreatin|mesh-list
111383700|NCT02701257|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
111383701|NCT02701257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111383702|NCT02701257|Hormones|hormones|mesh-ancestor
111383703|NCT02701257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111383704|NCT02701257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111383705|NCT02701257|Incretins|incretins|mesh-ancestor
111383707|NCT01836029|Fluorouracil|fluorouracil|mesh-list
111383708|NCT01836029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111383709|NCT01836029|Antimetabolites|antimetabolites|mesh-ancestor
111383710|NCT01836029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111383711|NCT01836029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111383712|NCT01836029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111383713|NCT01836029|Immunologic Factors|immunologic factors|mesh-ancestor
111383714|NCT01836029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111383715|NCT02703909|Rocuronium|rocuronium|mesh-list
111383716|NCT02703909|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
111383717|NCT02703909|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
111383718|NCT02703909|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111383719|NCT02703909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111383720|NCT02703909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111383721|NCT01836185|Evacetrapib|evacetrapib|mesh-list
111383722|NCT01836185|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111383723|NCT01836185|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111383724|NCT01836185|Antimetabolites|antimetabolites|mesh-ancestor
111383725|NCT01836185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111383726|NCT01836185|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111383727|NCT02706249|Enoxaparin|enoxaparin|mesh-list
111383728|NCT02706249|Anticoagulants|anticoagulants|mesh-ancestor
111383729|NCT02706249|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111383730|NCT02706249|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111383731|NCT02706249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111383732|NCT04740021|Carboplatin|carboplatin|mesh-list
111383733|NCT04740021|Etoposide|etoposide|mesh-list
111383734|NCT04740021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111383735|NCT04740021|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111383736|NCT04740021|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111383737|NCT04740021|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111383738|NCT04740021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111383739|NCT04740021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111383740|NCT02708433|Lidocaine|lidocaine|mesh-list
111383741|NCT02708433|Anesthetics, Local|anesthetics, local|mesh-ancestor
111383742|NCT02708433|Anesthetics|anesthetics|mesh-ancestor
111383743|NCT02708433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111383744|NCT02708433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111383745|NCT02708433|Sensory System Agents|sensory system agents|mesh-ancestor
111383746|NCT02708433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111383747|NCT02708433|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111383748|NCT02708433|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111383749|NCT02708433|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111383750|NCT02708433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111383751|NCT02708433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111383752|NCT03575013|Docetaxel|docetaxel|mesh-list
111383753|NCT03575013|Avelumab|avelumab|mesh-list
111383754|NCT03575013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111383755|NCT03575013|Tubulin Modulators|tubulin modulators|mesh-ancestor
111383756|NCT03575013|Antimitotic Agents|antimitotic agents|mesh-ancestor
111383757|NCT03575013|Mitosis Modulators|mitosis modulators|mesh-ancestor
111383758|NCT03575013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111383759|NCT03575013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111383760|NCT00559637|Epoetin Alfa|epoetin alfa|mesh-list
111383761|NCT00559637|Hematinics|hematinics|mesh-ancestor
111383762|NCT03349281|Cytarabine|cytarabine|mesh-list
111383763|NCT03349281|Dexamethasone|dexamethasone|mesh-list
111383764|NCT03349281|Hydrocortisone|hydrocortisone|mesh-list
111383765|NCT03349281|Doxorubicin|doxorubicin|mesh-list
111383766|NCT03349281|Methotrexate|methotrexate|mesh-list
111383767|NCT03349281|Vincristine|vincristine|mesh-list
111383768|NCT03349281|Asparaginase|asparaginase|mesh-list
111383769|NCT03349281|Pegaspargase|pegaspargase|mesh-list
111383770|NCT03349281|Pevonedistat|pevonedistat|mesh-list
111383771|NCT03349281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111383772|NCT03349281|Antiemetics|antiemetics|mesh-ancestor
111383773|NCT03349281|Autonomic Agents|autonomic agents|mesh-ancestor
111383774|NCT03349281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111383775|NCT03349281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111383776|NCT03349281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111383777|NCT03349281|Glucocorticoids|glucocorticoids|mesh-ancestor
111383778|NCT03349281|Hormones|hormones|mesh-ancestor
111383779|NCT03349281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111383780|NCT03349281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111108170|NCT05737511|Diazepam|diazepam|mesh-list
111383781|NCT03349281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111383782|NCT03349281|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111383783|NCT03349281|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111383784|NCT03349281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111383785|NCT03349281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111383786|NCT03349281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111383787|NCT03349281|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111383788|NCT03349281|Abortifacient Agents|abortifacient agents|mesh-ancestor
111383789|NCT03349281|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111383790|NCT03349281|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111383791|NCT03349281|Antimetabolites|antimetabolites|mesh-ancestor
111383792|NCT03349281|Dermatologic Agents|dermatologic agents|mesh-ancestor
111383793|NCT03349281|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111383794|NCT03349281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111383795|NCT03349281|Immunologic Factors|immunologic factors|mesh-ancestor
111383796|NCT03349281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111383797|NCT03349281|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111383798|NCT03349281|Antiviral Agents|antiviral agents|mesh-ancestor
111383799|NCT03349281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111383800|NCT03349281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111383801|NCT03349281|Tubulin Modulators|tubulin modulators|mesh-ancestor
111383802|NCT03349281|Antimitotic Agents|antimitotic agents|mesh-ancestor
111383803|NCT03349281|Mitosis Modulators|mitosis modulators|mesh-ancestor
111383805|NCT03206151|Folic Acid|folic acid|mesh-list
111383806|NCT03206151|Fluorouracil|fluorouracil|mesh-list
111383807|NCT03206151|Irinotecan|irinotecan|mesh-list
111383808|NCT03206151|Levoleucovorin|levoleucovorin|mesh-list
111383809|NCT03206151|Antimetabolites|antimetabolites|mesh-ancestor
111383810|NCT03206151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111383811|NCT03206151|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111383812|NCT03206151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111383813|NCT03206151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111383814|NCT03206151|Immunologic Factors|immunologic factors|mesh-ancestor
111383815|NCT03206151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111383816|NCT03206151|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111383817|NCT03206151|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111383818|NCT03206151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111383819|NCT03206151|Antidotes|antidotes|mesh-ancestor
111383820|NCT03206151|Protective Agents|protective agents|mesh-ancestor
111383821|NCT03206151|Vitamin B Complex|vitamin b complex|mesh-ancestor
111383822|NCT03206151|Vitamins|vitamins|mesh-ancestor
111383823|NCT03206151|Micronutrients|micronutrients|mesh-ancestor
111383824|NCT03206151|Hematinics|hematinics|mesh-ancestor
111383825|NCT01841021|Brentuximab Vedotin|brentuximab vedotin|mesh-list
111383826|NCT01841021|Immunoconjugates|immunoconjugates|mesh-list
111383827|NCT01841021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111383828|NCT01841021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111383829|NCT01841021|Immunotoxins|immunotoxins|mesh-ancestor
111383830|NCT01841021|Immunologic Factors|immunologic factors|mesh-ancestor
111383831|NCT01841021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111383832|NCT02714283|Azithromycin|azithromycin|mesh-list
111383833|NCT02714283|Erythromycin|erythromycin|mesh-list
111383834|NCT02714283|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111383835|NCT02714283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111383836|NCT02714283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111383837|NCT02714283|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111383838|NCT02714283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111383839|NCT02714283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111383840|NCT04810949|Vitamin D|vitamin d|mesh-list
111383841|NCT04810949|Cholecalciferol|cholecalciferol|mesh-list
111383842|NCT04810949|Vitamins|vitamins|mesh-ancestor
111383843|NCT04810949|Micronutrients|micronutrients|mesh-ancestor
111383844|NCT04810949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111383845|NCT04810949|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111383846|NCT04810949|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111383847|NCT04795583|Prednisone|prednisone|mesh-list
111383848|NCT04795583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111383849|NCT04795583|Glucocorticoids|glucocorticoids|mesh-ancestor
111383850|NCT04795583|Hormones|hormones|mesh-ancestor
111383851|NCT04795583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111383852|NCT04795583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111383853|NCT04795583|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111383854|NCT04795583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111383855|NCT02722239|Metformin|metformin|mesh-list
111383856|NCT02722239|Dapagliflozin|dapagliflozin|mesh-list
111383857|NCT02722239|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111383858|NCT02722239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111383859|NCT02722239|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111383860|NCT02722239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111383862|NCT02578641|Gemcitabine|gemcitabine|mesh-list
111383863|NCT02578641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111383864|NCT02578641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111383865|NCT02578641|Antimetabolites|antimetabolites|mesh-ancestor
111383866|NCT02578641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111383867|NCT05084859|Prednisone|prednisone|mesh-list
111383868|NCT05084859|Docetaxel|docetaxel|mesh-list
111383869|NCT05084859|Panitumumab|panitumumab|mesh-list
111383870|NCT05084859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111383871|NCT05084859|Tubulin Modulators|tubulin modulators|mesh-ancestor
111383872|NCT05084859|Antimitotic Agents|antimitotic agents|mesh-ancestor
111383873|NCT05084859|Mitosis Modulators|mitosis modulators|mesh-ancestor
111383874|NCT05084859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111383875|NCT05084859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111383876|NCT05084859|Glucocorticoids|glucocorticoids|mesh-ancestor
111383877|NCT05084859|Hormones|hormones|mesh-ancestor
111383878|NCT05084859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111383879|NCT05084859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111383880|NCT05084859|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111383881|NCT05084859|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111383882|NCT01846871|Tivozanib|tivozanib|mesh-list
111383883|NCT01846871|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111383884|NCT01846871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111383885|NCT01846871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111383886|NCT02431260|INCB054329|incb054329|mesh-list
111383887|NCT02431260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111383888|NCT02055963|Minocycline|minocycline|mesh-list
111383889|NCT02055963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111383890|NCT02055963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111383891|NCT01848041|Phenylephrine|phenylephrine|mesh-list
111383892|NCT01848041|Oxymetazoline|oxymetazoline|mesh-list
111383893|NCT01848041|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111383894|NCT01848041|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111383895|NCT01848041|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111383896|NCT01848041|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111383897|NCT01848041|Adrenergic Agents|adrenergic agents|mesh-ancestor
111383898|NCT01848041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111383899|NCT01848041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111383900|NCT01848041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111383901|NCT01848041|Sympathomimetics|sympathomimetics|mesh-ancestor
111383902|NCT01848041|Autonomic Agents|autonomic agents|mesh-ancestor
111383903|NCT01848041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111383904|NCT01848041|Nasal Decongestants|nasal decongestants|mesh-ancestor
111383905|NCT01848041|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111383906|NCT01848041|Respiratory System Agents|respiratory system agents|mesh-ancestor
111383907|NCT01848041|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111383908|NCT01848041|Mydriatics|mydriatics|mesh-ancestor
111383909|NCT01848041|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111383910|NCT01848041|Protective Agents|protective agents|mesh-ancestor
111383911|NCT02724033|Dexamethasone|dexamethasone|mesh-list
111383912|NCT02724033|Ondansetron|ondansetron|mesh-list
111383913|NCT02724033|Antiemetics|antiemetics|mesh-list
111383914|NCT02724033|Bupivacaine|bupivacaine|mesh-list
111383915|NCT02724033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111383916|NCT02724033|Autonomic Agents|autonomic agents|mesh-ancestor
111383917|NCT02724033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111383918|NCT02724033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111383919|NCT02724033|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111383920|NCT02724033|Glucocorticoids|glucocorticoids|mesh-ancestor
111383921|NCT02724033|Hormones|hormones|mesh-ancestor
111383922|NCT02724033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111383923|NCT02724033|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111383924|NCT02724033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111383925|NCT02724033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111383926|NCT02724033|Anesthetics, Local|anesthetics, local|mesh-ancestor
111383927|NCT02724033|Anesthetics|anesthetics|mesh-ancestor
111383928|NCT02724033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111383929|NCT02724033|Sensory System Agents|sensory system agents|mesh-ancestor
111383930|NCT02724033|Antipruritics|antipruritics|mesh-ancestor
111383931|NCT02724033|Dermatologic Agents|dermatologic agents|mesh-ancestor
111108329|NCT05694689|Vitamin D|vitamin d|mesh-list
111383933|NCT02724033|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111383934|NCT02724033|Serotonin Agents|serotonin agents|mesh-ancestor
111383935|NCT02724033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111383936|NCT02724423|Diazepam|diazepam|mesh-list
111383937|NCT02724423|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111383938|NCT02724423|Anticonvulsants|anticonvulsants|mesh-ancestor
111383939|NCT02724423|Antiemetics|antiemetics|mesh-ancestor
111383940|NCT02724423|Autonomic Agents|autonomic agents|mesh-ancestor
111383941|NCT02724423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111383942|NCT02724423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111383943|NCT02724423|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111383944|NCT02724423|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111383945|NCT02724423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111383946|NCT02724423|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
111383947|NCT02724423|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111383948|NCT02724423|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111383949|NCT02724423|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111383950|NCT02724423|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111383951|NCT02724423|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111383952|NCT02724423|Anesthetics, General|anesthetics, general|mesh-ancestor
111383953|NCT02724423|Anesthetics|anesthetics|mesh-ancestor
111383954|NCT02724423|GABA Modulators|gaba modulators|mesh-ancestor
111383955|NCT02724423|GABA Agents|gaba agents|mesh-ancestor
111383956|NCT02724423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111383957|NCT02724423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111383958|NCT02989259|Apatinib|apatinib|mesh-list
111383959|NCT02989259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111383960|NCT02989259|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111383961|NCT02989259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111383962|NCT02989259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111383963|NCT04950621|Propofol|propofol|mesh-list
111383964|NCT04950621|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111383965|NCT04950621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111383966|NCT04950621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111383967|NCT04950621|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111383968|NCT04950621|Anesthetics, General|anesthetics, general|mesh-ancestor
111383969|NCT04950621|Anesthetics|anesthetics|mesh-ancestor
111383970|NCT01848899|Bivalirudin|bivalirudin|mesh-list
111383971|NCT01848899|Antithrombins|antithrombins|mesh-ancestor
111383972|NCT01848899|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111383973|NCT01848899|Protease Inhibitors|protease inhibitors|mesh-ancestor
111383974|NCT01848899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111383975|NCT01848899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111383976|NCT01848899|Anticoagulants|anticoagulants|mesh-ancestor
111383977|NCT02731833|Fluorides|fluorides|mesh-list
111383978|NCT02731833|Tin Fluorides|tin fluorides|mesh-list
111383979|NCT02731833|Fluorophosphate|fluorophosphate|mesh-list
111383980|NCT02731833|Cariostatic Agents|cariostatic agents|mesh-ancestor
111383981|NCT02731833|Protective Agents|protective agents|mesh-ancestor
111383982|NCT02731833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111383983|NCT01852019|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
111383984|NCT01852019|Cangrelor|cangrelor|mesh-list
111383985|NCT01852019|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111383986|NCT01852019|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111383987|NCT01852019|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111383988|NCT01852019|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111383989|NCT01852019|Purinergic Agents|purinergic agents|mesh-ancestor
111383990|NCT01852019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111383991|NCT01852019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111383992|NCT01852019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111383993|NCT04457219|Hemostatics|hemostatics|mesh-list
111383994|NCT04457219|Coagulants|coagulants|mesh-ancestor
111383995|NCT01852175|Ticagrelor|ticagrelor|mesh-list
111383996|NCT01852175|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
111383997|NCT01852175|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111383998|NCT01852175|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111383999|NCT01852175|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111384000|NCT01852175|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111384001|NCT01852175|Purinergic Agents|purinergic agents|mesh-ancestor
111384002|NCT01852175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111384003|NCT01852175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111384004|NCT01852175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111384005|NCT02429934|Abatacept|abatacept|mesh-list
111384006|NCT02429934|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111384007|NCT02429934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110523963|NCT02823665|Atropine|atropine|mesh-list
111384008|NCT02429934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111384009|NCT02429934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111384010|NCT02429934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111384011|NCT02429934|Immunologic Factors|immunologic factors|mesh-ancestor
111384012|NCT02429934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111384013|NCT02429934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111384014|NCT01852955|Acetaminophen|acetaminophen|mesh-list
111384015|NCT01852955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111384016|NCT01852955|Analgesics|analgesics|mesh-ancestor
111384017|NCT01852955|Sensory System Agents|sensory system agents|mesh-ancestor
111384018|NCT01852955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111384019|NCT01852955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111384020|NCT01852955|Antipyretics|antipyretics|mesh-ancestor
111384021|NCT00558467|Pramipexole|pramipexole|mesh-list
111384022|NCT00558467|Antioxidants|antioxidants|mesh-ancestor
111384023|NCT00558467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111384024|NCT00558467|Protective Agents|protective agents|mesh-ancestor
111384025|NCT00558467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111384026|NCT00558467|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111384027|NCT00558467|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111384028|NCT00558467|Dopamine Agonists|dopamine agonists|mesh-ancestor
111384029|NCT00558467|Dopamine Agents|dopamine agents|mesh-ancestor
111384030|NCT00558467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111384031|NCT04226495|Sufentanil|sufentanil|mesh-list
111384033|NCT04226495|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111384034|NCT04226495|Narcotics|narcotics|mesh-ancestor
111384035|NCT04226495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111384036|NCT04226495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111384037|NCT04226495|Analgesics|analgesics|mesh-ancestor
111384038|NCT04226495|Sensory System Agents|sensory system agents|mesh-ancestor
111384039|NCT04226495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111384040|NCT04226495|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111384041|NCT04226495|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111384042|NCT04226495|Anesthetics, General|anesthetics, general|mesh-ancestor
111384043|NCT04226495|Anesthetics|anesthetics|mesh-ancestor
111384044|NCT02401230|Tenofovir|tenofovir|mesh-list
111384045|NCT02401230|Emtricitabine|emtricitabine|mesh-list
111384046|NCT02401230|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
111384047|NCT02401230|Antiviral Agents|antiviral agents|mesh-ancestor
111384048|NCT02401230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111384049|NCT02401230|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111384050|NCT02401230|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111384051|NCT02401230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111384052|NCT02401230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111384053|NCT02401230|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111384054|NCT02401230|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111384055|NCT01854359|Idebenone|idebenone|mesh-list
111384056|NCT01854359|Antioxidants|antioxidants|mesh-ancestor
111384057|NCT01854359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111384058|NCT01854359|Protective Agents|protective agents|mesh-ancestor
111384059|NCT01854359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111384060|NCT01854593|Bevacizumab|bevacizumab|mesh-list
111384061|NCT01854593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111384062|NCT01854593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111384063|NCT01854593|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111384064|NCT01854593|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111384065|NCT01854593|Growth Substances|growth substances|mesh-ancestor
111384066|NCT01854593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111384067|NCT01854593|Growth Inhibitors|growth inhibitors|mesh-ancestor
111384068|NCT01855997|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
111384069|NCT01855997|Interferon alpha-2|interferon alpha-2|mesh-list
111384070|NCT01855997|Antiviral Agents|antiviral agents|mesh-ancestor
111384071|NCT01855997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111384072|NCT01855997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111384073|NCT02734953|Nitric Oxide|nitric oxide|mesh-list
111384074|NCT02734953|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111384075|NCT02734953|Autonomic Agents|autonomic agents|mesh-ancestor
111384076|NCT02734953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111384077|NCT02734953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111384078|NCT02734953|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111384079|NCT02734953|Respiratory System Agents|respiratory system agents|mesh-ancestor
111384080|NCT02734953|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111384081|NCT02734953|Antioxidants|antioxidants|mesh-ancestor
111108475|NCT05377619|Buspirone|buspirone|mesh-list
111384082|NCT02734953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111384083|NCT02734953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111384084|NCT02734953|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
111384085|NCT02734953|Vasodilator Agents|vasodilator agents|mesh-ancestor
111384086|NCT02734953|Gasotransmitters|gasotransmitters|mesh-ancestor
111384087|NCT02734953|Protective Agents|protective agents|mesh-ancestor
111384088|NCT02428608|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111384089|NCT02428608|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111384090|NCT02428608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111384091|NCT02428608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111384092|NCT02428608|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111384093|NCT02428608|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111384094|NCT02428608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111384095|NCT02428608|Cholinergic Agents|cholinergic agents|mesh-ancestor
111384096|NCT02428608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111384097|NCT02735187|Vitamin D|vitamin d|mesh-list
111384098|NCT02735187|Vitamins|vitamins|mesh-ancestor
111384099|NCT02735187|Micronutrients|micronutrients|mesh-ancestor
111384100|NCT02735187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111384101|NCT02735187|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111384102|NCT02428296|Sirolimus|sirolimus|mesh-list
111384103|NCT02428296|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111384104|NCT02428296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111384105|NCT02428296|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111384106|NCT02428296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111384107|NCT02428296|Antifungal Agents|antifungal agents|mesh-ancestor
111384108|NCT02428296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111384109|NCT02428296|Immunologic Factors|immunologic factors|mesh-ancestor
111384110|NCT02428296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111384111|NCT02643615|Propofol|propofol|mesh-list
111384112|NCT02643615|Desflurane|desflurane|mesh-list
111384113|NCT02643615|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111384114|NCT02643615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111384115|NCT02643615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111384116|NCT02643615|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111384117|NCT02643615|Anesthetics, General|anesthetics, general|mesh-ancestor
111384118|NCT02643615|Anesthetics|anesthetics|mesh-ancestor
111384119|NCT02643615|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111384120|NCT02265341|Ponatinib|ponatinib|mesh-list
111384121|NCT02265341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111384122|NCT02265341|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111384123|NCT02265341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111384124|NCT02265341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111384125|NCT05679479|Meplazumab|meplazumab|mesh-list
111384126|NCT05679479|Antiviral Agents|antiviral agents|mesh-ancestor
111384127|NCT05679479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111384128|NCT01421186|Dexamethasone|dexamethasone|mesh-list
111384129|NCT01421186|Lenalidomide|lenalidomide|mesh-list
111384130|NCT01421186|Pomalidomide|pomalidomide|mesh-list
111384131|NCT01421186|Felzartamab|felzartamab|mesh-list
111384132|NCT01421186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111384133|NCT01421186|Antiemetics|antiemetics|mesh-ancestor
111384134|NCT01421186|Autonomic Agents|autonomic agents|mesh-ancestor
111384135|NCT01421186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111384136|NCT01421186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111384137|NCT01421186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111384138|NCT01421186|Glucocorticoids|glucocorticoids|mesh-ancestor
111384139|NCT01421186|Hormones|hormones|mesh-ancestor
111384140|NCT01421186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111384141|NCT01421186|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111384142|NCT01421186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111384143|NCT01421186|Immunologic Factors|immunologic factors|mesh-ancestor
111384144|NCT01421186|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111384145|NCT01421186|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111384146|NCT01421186|Growth Substances|growth substances|mesh-ancestor
111384147|NCT01421186|Growth Inhibitors|growth inhibitors|mesh-ancestor
111384148|NCT01860287|Buprenorphine|buprenorphine|mesh-list
111384149|NCT01860287|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111384150|NCT01860287|Narcotics|narcotics|mesh-ancestor
111384151|NCT01860287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111384152|NCT01860287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111384153|NCT01860287|Analgesics|analgesics|mesh-ancestor
111384154|NCT01860287|Sensory System Agents|sensory system agents|mesh-ancestor
111108566|NCT03177109|Fluorides|fluorides|mesh-list
111384155|NCT01860287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111384156|NCT01860287|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111384157|NCT01421498|Lifitegrast|lifitegrast|mesh-list
111384158|NCT01421498|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
111384159|NCT01421498|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111384160|NCT01422200|Vaccines|vaccines|mesh-list
111384161|NCT01422200|Immunologic Factors|immunologic factors|mesh-ancestor
111384162|NCT01422200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111384163|NCT01860521|Sufentanil|sufentanil|mesh-list
111384164|NCT01860521|Levobupivacaine|levobupivacaine|mesh-list
111384165|NCT01860521|Gemeprost|gemeprost|mesh-list
111384166|NCT01860521|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111384167|NCT01860521|Narcotics|narcotics|mesh-ancestor
111384168|NCT01860521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111384169|NCT01860521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111384170|NCT01860521|Analgesics|analgesics|mesh-ancestor
111384171|NCT01860521|Sensory System Agents|sensory system agents|mesh-ancestor
111384172|NCT01860521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111384173|NCT01860521|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111384174|NCT01860521|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111384175|NCT01860521|Anesthetics, General|anesthetics, general|mesh-ancestor
111384176|NCT01860521|Anesthetics|anesthetics|mesh-ancestor
111384177|NCT01860521|Anesthetics, Local|anesthetics, local|mesh-ancestor
111384178|NCT01860521|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111384179|NCT01860521|Abortifacient Agents|abortifacient agents|mesh-ancestor
111384180|NCT01860521|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111384181|NCT01400906|Fluticasone|fluticasone|mesh-list
111384182|NCT01400906|Xhance|xhance|mesh-list
111384183|NCT01400906|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111384184|NCT01400906|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111384185|NCT01400906|Autonomic Agents|autonomic agents|mesh-ancestor
111384186|NCT01400906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111384187|NCT01400906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111384188|NCT01400906|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111384189|NCT01400906|Respiratory System Agents|respiratory system agents|mesh-ancestor
111384190|NCT01400906|Dermatologic Agents|dermatologic agents|mesh-ancestor
111384191|NCT01400906|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111384192|NCT00367653|Azithromycin|azithromycin|mesh-list
111384193|NCT00367653|Chloroquine|chloroquine|mesh-list
111384194|NCT00367653|Mefloquine|mefloquine|mesh-list
111384195|NCT00367653|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111384196|NCT00367653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111384197|NCT00367653|Amebicides|amebicides|mesh-ancestor
111384198|NCT00367653|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111384199|NCT00367653|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111384200|NCT00367653|Antimalarials|antimalarials|mesh-ancestor
111384201|NCT00367653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111384202|NCT01485380|Dexmedetomidine|dexmedetomidine|mesh-list
111384203|NCT01485380|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111384204|NCT01485380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111384205|NCT01485380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111384206|NCT01485380|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111384207|NCT01485380|Analgesics|analgesics|mesh-ancestor
111384208|NCT01485380|Sensory System Agents|sensory system agents|mesh-ancestor
111384209|NCT01485380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111384210|NCT01485380|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111384211|NCT01485380|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111384212|NCT01485380|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111384213|NCT01485380|Adrenergic Agents|adrenergic agents|mesh-ancestor
111384214|NCT01485380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111384215|NCT01485380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111384216|NCT05445297|Amiodarone|amiodarone|mesh-list
111384217|NCT05445297|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111384218|NCT05445297|Vasodilator Agents|vasodilator agents|mesh-ancestor
111384219|NCT05445297|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
111384220|NCT05445297|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111384221|NCT05445297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111384222|NCT05445297|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111384223|NCT05445297|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111384224|NCT05445297|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111384225|NCT05445297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111384226|NCT05445297|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111384227|NCT05445297|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111384228|NCT05445297|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111384229|NCT00556673|Fluticasone|fluticasone|mesh-list
111384230|NCT00556673|Mometasone Furoate|mometasone furoate|mesh-list
111384231|NCT00556673|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
111384232|NCT00556673|Maleic acid|maleic acid|mesh-list
111384233|NCT00556673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111384234|NCT00556673|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111384235|NCT00556673|Autonomic Agents|autonomic agents|mesh-ancestor
111384236|NCT00556673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111384237|NCT00556673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111384238|NCT00556673|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111384239|NCT00556673|Respiratory System Agents|respiratory system agents|mesh-ancestor
111384240|NCT00556673|Dermatologic Agents|dermatologic agents|mesh-ancestor
111384241|NCT00556673|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111384242|NCT00556673|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111384243|NCT00556673|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111384244|NCT00556673|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111384245|NCT00556673|Adrenergic Agents|adrenergic agents|mesh-ancestor
111384246|NCT00556673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111384247|NCT00556673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111384248|NCT00556673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111384249|NCT05437029|Plant Lectins|plant lectins|mesh-list
111384250|NCT05437029|Agglutinins|agglutinins|mesh-ancestor
111384251|NCT05437029|Immunologic Factors|immunologic factors|mesh-ancestor
111384252|NCT05437029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111384253|NCT05437029|Coagulants|coagulants|mesh-ancestor
111384254|NCT05437029|Hemagglutinins|hemagglutinins|mesh-ancestor
111384255|NCT01422434|Calcitriol|calcitriol|mesh-list
111384256|NCT01422434|Betamethasone|betamethasone|mesh-list
111384257|NCT01422434|Betamethasone Valerate|betamethasone valerate|mesh-list
111384258|NCT01422434|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
111384259|NCT01422434|Betamethasone benzoate|betamethasone benzoate|mesh-list
111384260|NCT01422434|Calcipotriene|calcipotriene|mesh-list
111384261|NCT01422434|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
111384262|NCT01422434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111384263|NCT01422434|Glucocorticoids|glucocorticoids|mesh-ancestor
111384264|NCT01422434|Hormones|hormones|mesh-ancestor
111384265|NCT01422434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111384266|NCT01422434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111384267|NCT01422434|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111384268|NCT01422434|Respiratory System Agents|respiratory system agents|mesh-ancestor
111384269|NCT01422434|Dermatologic Agents|dermatologic agents|mesh-ancestor
111384270|NCT01422434|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111384271|NCT01422434|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
111384272|NCT01422434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111384273|NCT01422434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111384274|NCT01422434|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111384275|NCT01422434|Vitamins|vitamins|mesh-ancestor
111384276|NCT01422434|Micronutrients|micronutrients|mesh-ancestor
111384277|NCT01422434|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111384278|NCT01861457|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
111384279|NCT01861457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111384280|NCT02270255|Lidocaine|lidocaine|mesh-list
111384281|NCT02270255|Ropivacaine|ropivacaine|mesh-list
111384282|NCT02270255|Anesthetics, Local|anesthetics, local|mesh-ancestor
111384283|NCT02270255|Anesthetics|anesthetics|mesh-ancestor
111384284|NCT02270255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111384285|NCT02270255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111384286|NCT02270255|Sensory System Agents|sensory system agents|mesh-ancestor
111384287|NCT02270255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111384288|NCT02270255|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111384289|NCT02270255|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111384290|NCT02270255|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111384291|NCT02270255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111384292|NCT02270255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111384293|NCT02651259|Vitamins|vitamins|mesh-list
111384294|NCT02651259|Pyridoxine|pyridoxine|mesh-list
111384295|NCT02651259|Pyridoxal|pyridoxal|mesh-list
111384296|NCT02651259|Vitamin B 6|vitamin b 6|mesh-list
111384297|NCT02651259|Vitamin B Complex|vitamin b complex|mesh-list
111384298|NCT02651259|Isoniazid|isoniazid|mesh-list
111384299|NCT02651259|Rifapentine|rifapentine|mesh-list
111384300|NCT02651259|Rifamycins|rifamycins|mesh-list
111384301|NCT02651259|Hydrazine|hydrazine|mesh-list
111384302|NCT02651259|Micronutrients|micronutrients|mesh-ancestor
111384303|NCT02651259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111384304|NCT02651259|Antitubercular Agents|antitubercular agents|mesh-ancestor
111384305|NCT02651259|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111384306|NCT02651259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111384307|NCT02651259|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
111384308|NCT02651259|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111384309|NCT02651259|Antimetabolites|antimetabolites|mesh-ancestor
110959238|NCT03526224|Dimethyl Fumarate|dimethyl fumarate|mesh-list
111384310|NCT02651259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111384311|NCT02651259|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111384312|NCT02651259|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111384313|NCT02651259|Leprostatic Agents|leprostatic agents|mesh-ancestor
111384314|NCT02651259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111384315|NCT02271425|Evacetrapib|evacetrapib|mesh-list
111384316|NCT02271425|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111384317|NCT02271425|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111384318|NCT02271425|Antimetabolites|antimetabolites|mesh-ancestor
111384319|NCT02271425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111384320|NCT02271425|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111384321|NCT05442411|Parecoxib|parecoxib|mesh-list
111384322|NCT05442411|Ropivacaine|ropivacaine|mesh-list
111384323|NCT05442411|Anesthetics, Local|anesthetics, local|mesh-ancestor
111384324|NCT05442411|Anesthetics|anesthetics|mesh-ancestor
111384325|NCT05442411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111384326|NCT05442411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111384327|NCT05442411|Sensory System Agents|sensory system agents|mesh-ancestor
111384328|NCT05442411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111384329|NCT05442411|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111384330|NCT05442411|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111384331|NCT05442411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111384332|NCT05442411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111384333|NCT05442411|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111384334|NCT05442411|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111384335|NCT05442411|Analgesics|analgesics|mesh-ancestor
111384336|NCT05442411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111384337|NCT05442411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111384338|NCT02651415|Perindopril|perindopril|mesh-list
111384339|NCT02651415|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
111384340|NCT02651415|Protease Inhibitors|protease inhibitors|mesh-ancestor
111384341|NCT02651415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111384342|NCT02651415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111384343|NCT02651415|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111384344|NCT00555425|Buprenorphine|buprenorphine|mesh-list
111384345|NCT00555425|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
111384346|NCT00555425|Naloxone|naloxone|mesh-list
111384347|NCT00555425|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111384348|NCT00555425|Narcotics|narcotics|mesh-ancestor
111384349|NCT00555425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111384350|NCT00555425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111384351|NCT00555425|Analgesics|analgesics|mesh-ancestor
111384352|NCT00555425|Sensory System Agents|sensory system agents|mesh-ancestor
111384353|NCT00555425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111384354|NCT00555425|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111384355|NCT05444673|Cisplatin|cisplatin|mesh-list
111384356|NCT05444673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111384357|NCT04338633|Calcium, Dietary|calcium, dietary|mesh-list
111384358|NCT04338633|Calcium|calcium|mesh-list
111384359|NCT04338633|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111384360|NCT04338633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111384361|NCT04338633|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111384362|NCT01488188|Vaccines|vaccines|mesh-list
111384363|NCT01488188|Immunologic Factors|immunologic factors|mesh-ancestor
111384364|NCT01488188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111384365|NCT01489670|Bimatoprost|bimatoprost|mesh-list
111384366|NCT01489670|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111384367|NCT01489670|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111384368|NCT01489670|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111384369|NCT01427504|Etravirine|etravirine|mesh-list
111384370|NCT01427504|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111384371|NCT01427504|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111384372|NCT01427504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111384373|NCT01427504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111384374|NCT01427504|Antiviral Agents|antiviral agents|mesh-ancestor
111384375|NCT01427504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111384376|NCT03169361|Ixazomib|ixazomib|mesh-list
111384377|NCT03169361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111384378|NCT03169361|Protease Inhibitors|protease inhibitors|mesh-ancestor
111384379|NCT03169361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111384380|NCT03169361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111384381|NCT02265965|Nitroglycerin|nitroglycerin|mesh-list
111384382|NCT02265965|Vasodilator Agents|vasodilator agents|mesh-ancestor
111384383|NCT03021083|Fentanyl|fentanyl|mesh-list
111384384|NCT03021083|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111384385|NCT03021083|Narcotics|narcotics|mesh-ancestor
111384386|NCT03021083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111384387|NCT03021083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111384388|NCT03021083|Analgesics|analgesics|mesh-ancestor
111384389|NCT03021083|Sensory System Agents|sensory system agents|mesh-ancestor
111384390|NCT03021083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111384391|NCT03021083|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111384392|NCT03021083|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111384393|NCT03021083|Anesthetics, General|anesthetics, general|mesh-ancestor
111384394|NCT03021083|Anesthetics|anesthetics|mesh-ancestor
111384395|NCT03000257|Venetoclax|venetoclax|mesh-list
111384396|NCT03000257|Rovalpituzumab tesirine|rovalpituzumab tesirine|mesh-list
111384397|NCT03000257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111384398|NCT03000257|Immunoconjugates|immunoconjugates|mesh-ancestor
111384399|NCT03000257|Immunologic Factors|immunologic factors|mesh-ancestor
111384400|NCT03000257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111384401|NCT02945813|Metformin|metformin|mesh-list
111384402|NCT02945813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111384403|NCT02945813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111384404|NCT05442801|Tropicamide|tropicamide|mesh-list
111384405|NCT05442801|Cyclopentolate|cyclopentolate|mesh-list
111384406|NCT05442801|Mydriatics|mydriatics|mesh-ancestor
111384407|NCT05442801|Autonomic Agents|autonomic agents|mesh-ancestor
111384408|NCT05442801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111384409|NCT05442801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111384410|NCT05442801|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111384411|NCT05442801|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111384412|NCT05442801|Cholinergic Agents|cholinergic agents|mesh-ancestor
111384413|NCT05442801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111384414|NCT05442801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111384415|NCT05442801|Parasympatholytics|parasympatholytics|mesh-ancestor
111384416|NCT05339373|Aceclofenac|aceclofenac|mesh-list
111384417|NCT05339373|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111384418|NCT05339373|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111384419|NCT05339373|Analgesics|analgesics|mesh-ancestor
111384420|NCT05339373|Sensory System Agents|sensory system agents|mesh-ancestor
111384421|NCT05339373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111384422|NCT05339373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111384423|NCT05339373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111384424|NCT05339373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111384425|NCT05439993|Paclitaxel|paclitaxel|mesh-list
111384426|NCT05439993|Tepotinib|tepotinib|mesh-list
111384427|NCT05439993|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111384428|NCT05439993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111384429|NCT05439993|Tubulin Modulators|tubulin modulators|mesh-ancestor
111384430|NCT05439993|Antimitotic Agents|antimitotic agents|mesh-ancestor
111384431|NCT05439993|Mitosis Modulators|mitosis modulators|mesh-ancestor
111384432|NCT05439993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111384433|NCT00554099|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111384434|NCT00554099|Mesalamine|mesalamine|mesh-list
111384435|NCT00554099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111384436|NCT00554099|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111384437|NCT00554099|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111384438|NCT00554099|Analgesics|analgesics|mesh-ancestor
111384439|NCT00554099|Sensory System Agents|sensory system agents|mesh-ancestor
111384440|NCT00554099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111384441|NCT00554099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111384442|NCT00554099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111384443|NCT00554099|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111384444|NCT02664909|Tranexamic Acid|tranexamic acid|mesh-list
111384445|NCT02664909|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111384446|NCT02664909|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111384447|NCT02664909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111384448|NCT02664909|Hemostatics|hemostatics|mesh-ancestor
111384449|NCT02664909|Coagulants|coagulants|mesh-ancestor
111384450|NCT00368589|Atorvastatin|atorvastatin|mesh-list
111384451|NCT00368589|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111384452|NCT00368589|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111384453|NCT00368589|Antimetabolites|antimetabolites|mesh-ancestor
111384454|NCT00368589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111384455|NCT00368589|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111384456|NCT00368589|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111384457|NCT00368589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111384458|NCT00553319|Amphetamine|amphetamine|mesh-list
111384459|NCT00553319|Adderall|adderall|mesh-list
111384460|NCT00553319|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111384461|NCT00553319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111384462|NCT00553319|Sympathomimetics|sympathomimetics|mesh-ancestor
111384463|NCT00553319|Autonomic Agents|autonomic agents|mesh-ancestor
111384464|NCT00553319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111384466|NCT00553319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111384467|NCT00553319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111384468|NCT00553319|Adrenergic Agents|adrenergic agents|mesh-ancestor
111384469|NCT00553319|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111384470|NCT00553319|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111384471|NCT00553319|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111384472|NCT00553319|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111384473|NCT00369291|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
111384474|NCT00369291|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111384475|NCT00369291|Immunologic Factors|immunologic factors|mesh-ancestor
111384476|NCT00369291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111384477|NCT01868633|Dexamethasone|dexamethasone|mesh-list
111384478|NCT01868633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111384479|NCT01868633|Antiemetics|antiemetics|mesh-ancestor
111384480|NCT01868633|Autonomic Agents|autonomic agents|mesh-ancestor
111384481|NCT01868633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111384482|NCT01868633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111384483|NCT01868633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111384484|NCT01868633|Glucocorticoids|glucocorticoids|mesh-ancestor
111384485|NCT01868633|Hormones|hormones|mesh-ancestor
111384486|NCT01868633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111384487|NCT01868633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111384488|NCT01868633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111384489|NCT04738773|Naltrexone|naltrexone|mesh-list
111384490|NCT04738773|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111384491|NCT04738773|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111384492|NCT04738773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111384493|NCT04738773|Sensory System Agents|sensory system agents|mesh-ancestor
111384494|NCT04738773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111384495|NCT03833063|Botulinum Toxins|botulinum toxins|mesh-list
111384496|NCT03833063|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111384497|NCT03833063|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111384498|NCT03833063|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111384499|NCT03833063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111384500|NCT03833063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111384501|NCT03833063|Cholinergic Agents|cholinergic agents|mesh-ancestor
111384502|NCT03833063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111384503|NCT03833063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111384504|NCT03833063|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111384505|NCT03833063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111384506|NCT02676375|Bupropion|bupropion|mesh-list
111384507|NCT02676375|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111384508|NCT02676375|Antidepressive Agents|antidepressive agents|mesh-ancestor
111384509|NCT02676375|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111384510|NCT02676375|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111384511|NCT02676375|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111384512|NCT02676375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111384513|NCT02676375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111384514|NCT02676375|Dopamine Agents|dopamine agents|mesh-ancestor
111384515|NCT02676375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111384516|NCT02676375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111384517|NCT02676375|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111384518|NCT02676375|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111384519|NCT02676375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111384520|NCT01871441|Mycophenolic Acid|mycophenolic acid|mesh-list
111384521|NCT01871441|Cyclophosphamide|cyclophosphamide|mesh-list
111384522|NCT01871441|Tacrolimus|tacrolimus|mesh-list
111384523|NCT01871441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111384524|NCT01871441|Immunologic Factors|immunologic factors|mesh-ancestor
111384525|NCT01871441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111384526|NCT01871441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111384527|NCT01871441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111384528|NCT01871441|Alkylating Agents|alkylating agents|mesh-ancestor
111384529|NCT01871441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111384530|NCT01871441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111384531|NCT01871441|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111384532|NCT01871441|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111384533|NCT01871441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111384534|NCT01871441|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111384535|NCT01871441|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111384536|NCT01871441|Antitubercular Agents|antitubercular agents|mesh-ancestor
111384537|NCT01871441|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111384538|NCT01871441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111384539|NCT04338711|Tofacitinib|tofacitinib|mesh-list
111384540|NCT04338711|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
111384541|NCT04338711|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111384542|NCT04338711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111384543|NCT04338711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111384544|NCT01874951|Naltrexone|naltrexone|mesh-list
111384545|NCT01874951|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111384546|NCT01874951|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111384547|NCT01874951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111384548|NCT01874951|Sensory System Agents|sensory system agents|mesh-ancestor
111384549|NCT01874951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111384550|NCT04739241|Insulin|insulin|mesh-list
111384551|NCT04739241|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111384552|NCT04739241|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111384553|NCT04739241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111384554|NCT03024437|Bevacizumab|bevacizumab|mesh-list
111384555|NCT03024437|Atezolizumab|atezolizumab|mesh-list
111384556|NCT03024437|Entinostat|entinostat|mesh-list
110524528|NCT02787278|Otaplimastat|otaplimastat|mesh-list
111384557|NCT03024437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111384558|NCT03024437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111384559|NCT03024437|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111384560|NCT03024437|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111384561|NCT03024437|Growth Substances|growth substances|mesh-ancestor
111384562|NCT03024437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111384563|NCT03024437|Growth Inhibitors|growth inhibitors|mesh-ancestor
111384564|NCT03024437|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111384565|NCT03024437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111384566|NCT03024437|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111384567|NCT03024437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111384568|NCT01489826|HU 211|hu 211|mesh-list
111384569|NCT01489826|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111384570|NCT01489826|Antiemetics|antiemetics|mesh-ancestor
111384571|NCT01489826|Autonomic Agents|autonomic agents|mesh-ancestor
111384572|NCT01489826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111384573|NCT01489826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111384574|NCT01489826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111384575|NCT01489826|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111384576|NCT01489826|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111384577|NCT01489826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111384578|NCT01489826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111384579|NCT01489826|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111384580|NCT01489826|Protective Agents|protective agents|mesh-ancestor
111384581|NCT02677623|Mannitol|mannitol|mesh-list
111384582|NCT02677623|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
111384583|NCT02677623|Diuretics|diuretics|mesh-ancestor
111384584|NCT02677623|Natriuretic Agents|natriuretic agents|mesh-ancestor
111384585|NCT02677623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111384586|NCT02677701|Azithromycin|azithromycin|mesh-list
111384587|NCT02677701|Tobramycin|tobramycin|mesh-list
111384588|NCT02677701|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111384589|NCT02677701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111384590|NCT01543178|Rifaximin|rifaximin|mesh-list
111384591|NCT01543178|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111384592|NCT01543178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111384593|NCT01543178|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111384594|NCT01649856|Rituximab|rituximab|mesh-list
111384595|NCT01649856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111384596|NCT01649856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111384597|NCT01649856|Immunologic Factors|immunologic factors|mesh-ancestor
111384598|NCT01649856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111384599|NCT01649856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111384600|NCT01543568|Aflibercept|aflibercept|mesh-list
111384601|NCT01543568|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111384602|NCT01543568|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111384603|NCT01543568|Growth Substances|growth substances|mesh-ancestor
111384604|NCT01543568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111384605|NCT01543568|Growth Inhibitors|growth inhibitors|mesh-ancestor
111384606|NCT01543568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111384607|NCT02681757|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111384608|NCT02681757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111384609|NCT02375724|Bromides|bromides|mesh-list
111384610|NCT02375724|Anticonvulsants|anticonvulsants|mesh-ancestor
111384611|NCT02398188|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
111384612|NCT02398188|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111384613|NCT02398188|Autonomic Agents|autonomic agents|mesh-ancestor
111384614|NCT02398188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111384615|NCT02398188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111384616|NCT02398188|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111384617|NCT02398188|Respiratory System Agents|respiratory system agents|mesh-ancestor
111384618|NCT02398188|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111384619|NCT02398188|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111384620|NCT02398188|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111384621|NCT02398188|Adrenergic Agents|adrenergic agents|mesh-ancestor
111384622|NCT02398188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111384623|NCT02398188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111384624|NCT02425098|Vaccines|vaccines|mesh-list
111384625|NCT02425098|Immunologic Factors|immunologic factors|mesh-ancestor
111384626|NCT02425098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111384627|NCT02424630|Ropivacaine|ropivacaine|mesh-list
111384628|NCT02424630|Anesthetics, Local|anesthetics, local|mesh-ancestor
111384629|NCT02424630|Anesthetics|anesthetics|mesh-ancestor
111384630|NCT02424630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111384631|NCT02424630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111384632|NCT02424630|Sensory System Agents|sensory system agents|mesh-ancestor
111384633|NCT02424630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111384634|NCT02397408|Choline|choline|mesh-list
111384635|NCT02397408|Lipotropic Agents|lipotropic agents|mesh-ancestor
111384636|NCT02397408|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111384637|NCT02397408|Antimetabolites|antimetabolites|mesh-ancestor
111384638|NCT02397408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111384639|NCT02397408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111384640|NCT02397408|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111384641|NCT02397408|Nootropic Agents|nootropic agents|mesh-ancestor
111384642|NCT02397096|Ritonavir|ritonavir|mesh-list
111384643|NCT02397096|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
111384644|NCT02397096|Tenofovir|tenofovir|mesh-list
111384645|NCT02397096|Lamivudine|lamivudine|mesh-list
111384646|NCT02397096|Cobicistat|cobicistat|mesh-list
111384647|NCT02397096|Elvitegravir|elvitegravir|mesh-list
111384648|NCT02397096|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
111384649|NCT02397096|Protease Inhibitors|protease inhibitors|mesh-list
111384650|NCT02397096|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111384651|NCT02397096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111384652|NCT02397096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111384653|NCT02397096|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111384654|NCT02397096|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111384655|NCT02397096|Antiviral Agents|antiviral agents|mesh-ancestor
111384656|NCT02397096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111384657|NCT02397096|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111384658|NCT02397096|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111384659|NCT02397096|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111384660|NCT02397096|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111384661|NCT02396316|Aflibercept|aflibercept|mesh-list
111384662|NCT02396316|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111384663|NCT02396316|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111384664|NCT02396316|Growth Substances|growth substances|mesh-ancestor
111384665|NCT02396316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111384666|NCT02396316|Growth Inhibitors|growth inhibitors|mesh-ancestor
111384667|NCT02396316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111384668|NCT02682381|Teduglutide|teduglutide|mesh-list
111384669|NCT02682381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111384670|NCT02682381|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111384671|NCT02682381|Protective Agents|protective agents|mesh-ancestor
111384672|NCT02682381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111384673|NCT04915950|APD791|apd791|mesh-list
111384674|NCT04915950|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111384675|NCT04915950|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111384676|NCT04915950|Serotonin Agents|serotonin agents|mesh-ancestor
111384677|NCT04915950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111384678|NCT04915950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111384679|NCT04915950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111384680|NCT04976595|Testosterone|testosterone|mesh-list
111384681|NCT04976595|Androgens|androgens|mesh-ancestor
111384682|NCT04976595|Hormones|hormones|mesh-ancestor
111384683|NCT04976595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111384684|NCT04976595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111384685|NCT00367965|Eszopiclone|eszopiclone|mesh-list
111384686|NCT00367965|Zopiclone|zopiclone|mesh-list
111384687|NCT00367965|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111384688|NCT00367965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111384689|NCT00367965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111384691|NCT02683161|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111384692|NCT02683161|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111384693|NCT02683161|Cholinergic Agents|cholinergic agents|mesh-ancestor
111384694|NCT02683161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111384695|NCT02683161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110524658|NCT02783144|Glucocorticoids|glucocorticoids|mesh-ancestor
111384696|NCT02683161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111384697|NCT02683707|Lidocaine|lidocaine|mesh-list
111384698|NCT02683707|Fentanyl|fentanyl|mesh-list
111384699|NCT02683707|Midazolam|midazolam|mesh-list
111384700|NCT02683707|Anesthetics, Local|anesthetics, local|mesh-ancestor
111384701|NCT02683707|Anesthetics|anesthetics|mesh-ancestor
111384702|NCT02683707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111384703|NCT02683707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111384704|NCT02683707|Sensory System Agents|sensory system agents|mesh-ancestor
111384705|NCT02683707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111384706|NCT02683707|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111384707|NCT02683707|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111384708|NCT02683707|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111384709|NCT02683707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111384710|NCT02683707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111384711|NCT02683707|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111384712|NCT02683707|Narcotics|narcotics|mesh-ancestor
111384713|NCT02683707|Analgesics|analgesics|mesh-ancestor
111384714|NCT02683707|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111384715|NCT02683707|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111384716|NCT02683707|Anesthetics, General|anesthetics, general|mesh-ancestor
111384717|NCT02683707|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111384718|NCT02683707|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111384719|NCT02683707|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111384720|NCT02683707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111384721|NCT02683707|GABA Modulators|gaba modulators|mesh-ancestor
111384722|NCT02683707|GABA Agents|gaba agents|mesh-ancestor
111384723|NCT02683707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111384724|NCT02371980|Vortioxetine|vortioxetine|mesh-list
111384725|NCT02371980|Antidepressive Agents|antidepressive agents|mesh-ancestor
111384726|NCT02371980|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111384727|NCT02371980|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111384728|NCT02371980|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111384729|NCT02371980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111384730|NCT02371980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111384731|NCT02371980|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111384732|NCT02371980|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111384733|NCT02371980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111384734|NCT02371980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111384735|NCT02371980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111384736|NCT02371980|Serotonin Agents|serotonin agents|mesh-ancestor
111384737|NCT02371980|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111384738|NCT02371980|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111384739|NCT02371980|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111384740|NCT02371980|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111384741|NCT02867865|Gemcitabine|gemcitabine|mesh-list
111384742|NCT02867865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111384743|NCT02867865|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111384744|NCT02867865|Antimetabolites|antimetabolites|mesh-ancestor
111384745|NCT02867865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111384746|NCT05447949|Levobupivacaine|levobupivacaine|mesh-list
111384747|NCT05447949|Anesthetics, Local|anesthetics, local|mesh-ancestor
111384748|NCT05447949|Anesthetics|anesthetics|mesh-ancestor
111384749|NCT05447949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111384750|NCT05447949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111384751|NCT05447949|Sensory System Agents|sensory system agents|mesh-ancestor
111384752|NCT05447949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111384753|NCT05447871|Bupivacaine|bupivacaine|mesh-list
111384754|NCT05447871|Anesthetics, Local|anesthetics, local|mesh-ancestor
111384755|NCT05447871|Anesthetics|anesthetics|mesh-ancestor
111384756|NCT05447871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111384757|NCT05447871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111384758|NCT05447871|Sensory System Agents|sensory system agents|mesh-ancestor
111384759|NCT05447871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111384760|NCT00369447|Nimotuzumab|nimotuzumab|mesh-list
111384761|NCT00369447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111109154|NCT04177498|ON 01910|on 01910|mesh-list
111384762|NCT00369447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111384763|NCT04772235|Osimertinib|osimertinib|mesh-list
111384764|NCT04772235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111384765|NCT04772235|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111384766|NCT04772235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111384767|NCT04772235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111384768|NCT04766463|Morphine|morphine|mesh-list
111384769|NCT04766463|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111384770|NCT04766463|Narcotics|narcotics|mesh-ancestor
111384771|NCT04766463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111384772|NCT04766463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111384773|NCT04766463|Analgesics|analgesics|mesh-ancestor
111384774|NCT04766463|Sensory System Agents|sensory system agents|mesh-ancestor
111384775|NCT04766463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111384776|NCT00823563|Adenosine|adenosine|mesh-list
111384777|NCT00823563|Nitroglycerin|nitroglycerin|mesh-list
111384778|NCT00823563|Vasodilator Agents|vasodilator agents|mesh-ancestor
111384779|NCT00823563|Analgesics|analgesics|mesh-ancestor
111384780|NCT00823563|Sensory System Agents|sensory system agents|mesh-ancestor
111384781|NCT00823563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111384782|NCT00823563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111384783|NCT00823563|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111384784|NCT00823563|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
111384785|NCT00823563|Purinergic Agonists|purinergic agonists|mesh-ancestor
111384786|NCT00823563|Purinergic Agents|purinergic agents|mesh-ancestor
111384787|NCT00823563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111384788|NCT00823563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111384789|NCT05447169|Antibodies|antibodies|mesh-list
111384790|NCT05447169|Immunologic Factors|immunologic factors|mesh-ancestor
111384791|NCT05447169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111384792|NCT04652193|Anesthetics|anesthetics|mesh-list
111384793|NCT04652193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111384794|NCT04652193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111384795|NCT05451147|Metformin|metformin|mesh-list
111384796|NCT05451147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111384797|NCT05451147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111384798|NCT04553367|Meropenem|meropenem|mesh-list
111384799|NCT04553367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111384800|NCT04553367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111384801|NCT00369837|Clevidipine|clevidipine|mesh-list
111384802|NCT00369837|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111384803|NCT00369837|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111384804|NCT00369837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111384805|NCT00369837|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111384806|NCT00369837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111384807|NCT05449899|Cyclophosphamide|cyclophosphamide|mesh-list
111384808|NCT05449899|Busulfan|busulfan|mesh-list
111384809|NCT05449899|Fludarabine|fludarabine|mesh-list
111384810|NCT05449899|Decitabine|decitabine|mesh-list
111384811|NCT05449899|Lenograstim|lenograstim|mesh-list
111384812|NCT05449899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111384813|NCT05449899|Immunologic Factors|immunologic factors|mesh-ancestor
111384814|NCT05449899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111384815|NCT05449899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111384816|NCT05449899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111384817|NCT05449899|Alkylating Agents|alkylating agents|mesh-ancestor
111384818|NCT05449899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111384819|NCT05449899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111384820|NCT05449899|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111384821|NCT05449899|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111384822|NCT05449899|Antimetabolites|antimetabolites|mesh-ancestor
111384823|NCT05449899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111384824|NCT05449899|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111384825|NCT05441631|Insulin|insulin|mesh-list
111384826|NCT05441631|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111384827|NCT05441631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111384828|NCT05441631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111384829|NCT01546454|Leuprolide|leuprolide|mesh-list
111384830|NCT01546454|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
111384831|NCT01546454|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
111384832|NCT01546454|Levonorgestrel|levonorgestrel|mesh-list
111384833|NCT01546454|Ethinyl Estradiol|ethinyl estradiol|mesh-list
111384834|NCT01546454|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
111384835|NCT01546454|Estradiol|estradiol|mesh-list
110524806|NCT04231682|Denosumab|denosumab|mesh-list
111384836|NCT01546454|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
111384837|NCT01546454|Progesterone|progesterone|mesh-list
111384838|NCT01546454|Estrogens|estrogens|mesh-ancestor
111384839|NCT01546454|Hormones|hormones|mesh-ancestor
111384840|NCT01546454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111384841|NCT01546454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111384842|NCT01546454|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111384843|NCT01546454|Contraceptive Agents|contraceptive agents|mesh-ancestor
111384844|NCT01546454|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111384845|NCT01546454|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111384846|NCT01546454|Progestins|progestins|mesh-ancestor
111384847|NCT01546454|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111384848|NCT01546454|Fertility Agents|fertility agents|mesh-ancestor
111384849|NCT01546454|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111384850|NCT01546454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111384851|NCT01546454|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111384852|NCT01546454|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111384853|NCT01546454|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111384854|NCT01546454|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
111384855|NCT00368901|Darbepoetin alfa|darbepoetin alfa|mesh-list
111384856|NCT00368901|Hematinics|hematinics|mesh-ancestor
111384857|NCT05430867|Memantine|memantine|mesh-list
111384858|NCT05430867|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111384859|NCT05430867|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111384860|NCT05430867|Dopamine Agents|dopamine agents|mesh-ancestor
111384861|NCT05430867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111384862|NCT05430867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111384863|NCT05430867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111384864|NCT05430867|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111384865|NCT05430867|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111384866|NCT05448885|Cisplatin|cisplatin|mesh-list
111384867|NCT05448885|Gemcitabine|gemcitabine|mesh-list
111384868|NCT05448885|Tislelizumab|tislelizumab|mesh-list
111384869|NCT05448885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111384870|NCT05448885|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111384871|NCT05448885|Antimetabolites|antimetabolites|mesh-ancestor
111384872|NCT05448885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111384873|NCT05448885|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111384874|NCT01547000|Guanfacine|guanfacine|mesh-list
111384875|NCT01547000|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111384876|NCT01547000|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111384877|NCT01547000|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111384878|NCT01547000|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111384879|NCT01547000|Adrenergic Agents|adrenergic agents|mesh-ancestor
111384880|NCT01547000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111384881|NCT01547000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111384882|NCT01547000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111384883|NCT02980016|Isoniazid|isoniazid|mesh-list
111384884|NCT02980016|Rifapentine|rifapentine|mesh-list
111384885|NCT02980016|Rifampin|rifampin|mesh-list
111384886|NCT02980016|Antitubercular Agents|antitubercular agents|mesh-ancestor
111384887|NCT02980016|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111384888|NCT02980016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111384889|NCT02980016|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
111384890|NCT02980016|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111384891|NCT02980016|Antimetabolites|antimetabolites|mesh-ancestor
111384892|NCT02980016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111384893|NCT02980016|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111384894|NCT02980016|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111384895|NCT02980016|Leprostatic Agents|leprostatic agents|mesh-ancestor
111384896|NCT02980016|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111384897|NCT02980016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111384898|NCT02980016|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111384899|NCT02980016|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111384900|NCT02980016|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
111384901|NCT02980016|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
111384902|NCT02980016|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
111384903|NCT02980016|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111384904|NCT01493180|Rebamipide|rebamipide|mesh-list
111384905|NCT01493180|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111384906|NCT01493180|Hyaluronic Acid|hyaluronic acid|mesh-list
111384907|NCT01493180|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111384908|NCT01493180|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111384909|NCT01493180|Immunologic Factors|immunologic factors|mesh-ancestor
111384910|NCT01493180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111384911|NCT01493180|Viscosupplements|viscosupplements|mesh-ancestor
111384912|NCT01493180|Protective Agents|protective agents|mesh-ancestor
111384913|NCT01493180|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111384914|NCT01493180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111384915|NCT01493180|Antioxidants|antioxidants|mesh-ancestor
111384916|NCT01493180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111384917|NCT01493180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111384918|NCT01431014|Dexamethasone|dexamethasone|mesh-list
111384919|NCT01431014|Dexamethasone acetate|dexamethasone acetate|mesh-list
111384920|NCT01431014|BB 1101|bb 1101|mesh-list
111384921|NCT01431014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111384922|NCT01431014|Antiemetics|antiemetics|mesh-ancestor
111384923|NCT01431014|Autonomic Agents|autonomic agents|mesh-ancestor
111384924|NCT01431014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111384925|NCT01431014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111384926|NCT01431014|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111384927|NCT01431014|Glucocorticoids|glucocorticoids|mesh-ancestor
111384928|NCT01431014|Hormones|hormones|mesh-ancestor
111384929|NCT01431014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111384930|NCT01431014|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111384931|NCT01431014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111384932|NCT01431014|Protease Inhibitors|protease inhibitors|mesh-ancestor
111384933|NCT01431014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111384934|NCT01431014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111384935|NCT01431170|Trimethoprim|trimethoprim|mesh-list
111384936|NCT01431170|Polymyxins|polymyxins|mesh-list
111384937|NCT01431170|Polymyxin B|polymyxin b|mesh-list
111384938|NCT01431170|Besifloxacin|besifloxacin|mesh-list
111384939|NCT01431170|Fluoroquinolones|fluoroquinolones|mesh-list
111384940|NCT01431170|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111384941|NCT01431170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111384942|NCT01431170|Antimalarials|antimalarials|mesh-ancestor
111384943|NCT01431170|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111384944|NCT01431170|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111384945|NCT01431170|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111384946|NCT01431170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111384947|NCT01431170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111384948|NCT01431170|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111384949|NCT01431170|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
111384950|NCT01431170|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111384951|NCT01431170|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111384952|NCT01431170|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111384953|NCT01431170|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111384954|NCT01431170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111384955|NCT01431170|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111384956|NCT05448183|Gemcitabine|gemcitabine|mesh-list
111384957|NCT05448183|Oxaliplatin|oxaliplatin|mesh-list
111384958|NCT05448183|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111384959|NCT05448183|Antimetabolites|antimetabolites|mesh-ancestor
111384960|NCT05448183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111384961|NCT05448183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111384962|NCT04732455|Lidocaine|lidocaine|mesh-list
111384963|NCT04732455|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
111384964|NCT04732455|Anesthetics, Local|anesthetics, local|mesh-ancestor
111384965|NCT04732455|Anesthetics|anesthetics|mesh-ancestor
111384966|NCT04732455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111384967|NCT04732455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111384968|NCT04732455|Sensory System Agents|sensory system agents|mesh-ancestor
111384969|NCT04732455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111384970|NCT04732455|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111384971|NCT04732455|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111384972|NCT04732455|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111384973|NCT04732455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111384974|NCT04732455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111384975|NCT04732455|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111384976|NCT04732455|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111384977|NCT04732455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111384978|NCT04732455|Analgesics|analgesics|mesh-ancestor
111384979|NCT04732455|Antidepressive Agents|antidepressive agents|mesh-ancestor
111384980|NCT04732455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111384981|NCT04732455|Dopamine Agents|dopamine agents|mesh-ancestor
111384982|NCT04306965|Apremilast|apremilast|mesh-list
111384983|NCT04306965|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111384984|NCT04306965|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111384985|NCT04306965|Analgesics|analgesics|mesh-ancestor
111384986|NCT04306965|Sensory System Agents|sensory system agents|mesh-ancestor
111109389|NCT03168997|Memantine|memantine|mesh-list
111384987|NCT04306965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111384988|NCT04306965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111384990|NCT04306965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111384991|NCT04306965|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
111384992|NCT04306965|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111384993|NCT04306965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111384994|NCT04306965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111384995|NCT02371746|Travoprost|travoprost|mesh-list
111384996|NCT02371746|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111384997|NCT01431794|Paclitaxel|paclitaxel|mesh-list
111384998|NCT01431794|Gemcitabine|gemcitabine|mesh-list
111384999|NCT01431794|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111385000|NCT01431794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111385001|NCT01431794|Tubulin Modulators|tubulin modulators|mesh-ancestor
111385002|NCT01431794|Antimitotic Agents|antimitotic agents|mesh-ancestor
111385003|NCT01431794|Mitosis Modulators|mitosis modulators|mesh-ancestor
111385004|NCT01431794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111385005|NCT01431794|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111385006|NCT01431794|Antimetabolites|antimetabolites|mesh-ancestor
111385007|NCT01497860|Vinorelbine|vinorelbine|mesh-list
111385008|NCT01497860|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111385009|NCT01497860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111385010|NCT01497860|Tubulin Modulators|tubulin modulators|mesh-ancestor
111385011|NCT01497860|Antimitotic Agents|antimitotic agents|mesh-ancestor
111385012|NCT01497860|Mitosis Modulators|mitosis modulators|mesh-ancestor
111385013|NCT01497860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111385014|NCT02213900|Haloperidol|haloperidol|mesh-list
111385015|NCT02213900|Haloperidol decanoate|haloperidol decanoate|mesh-list
111385016|NCT02213900|Antiemetics|antiemetics|mesh-ancestor
111385017|NCT02213900|Autonomic Agents|autonomic agents|mesh-ancestor
111385018|NCT02213900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111385019|NCT02213900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111385020|NCT02213900|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111385021|NCT02213900|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111385022|NCT02213900|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111385023|NCT02213900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111385024|NCT02213900|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111385025|NCT02213900|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111385026|NCT02213900|Dopamine Agents|dopamine agents|mesh-ancestor
111385027|NCT02213900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111385028|NCT02213900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111385029|NCT02213900|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111385030|NCT02370888|Lenalidomide|lenalidomide|mesh-list
111385031|NCT02370888|Immunologic Factors|immunologic factors|mesh-ancestor
111385032|NCT02370888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111385033|NCT02370888|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111385034|NCT02370888|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111385035|NCT02370888|Growth Substances|growth substances|mesh-ancestor
111385036|NCT02370888|Growth Inhibitors|growth inhibitors|mesh-ancestor
111385037|NCT02370888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111385038|NCT05358873|Antibodies|antibodies|mesh-list
111385039|NCT05358873|Immunologic Factors|immunologic factors|mesh-ancestor
111385040|NCT05358873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111385041|NCT02214290|Caffeine|caffeine|mesh-list
111385042|NCT02214290|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111385043|NCT02214290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111385044|NCT02214290|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111385045|NCT02214290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111385046|NCT02214290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111385047|NCT02214290|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
111385048|NCT02214290|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111385049|NCT02214290|Purinergic Agents|purinergic agents|mesh-ancestor
111385050|NCT02214290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111385051|NCT03160911|Hemostatics|hemostatics|mesh-list
111385052|NCT03160911|Coagulants|coagulants|mesh-ancestor
111385053|NCT04685499|Pembrolizumab|pembrolizumab|mesh-list
111385054|NCT04685499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111385055|NCT04685499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111385056|NCT04685499|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111385057|NCT04685499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111385058|NCT04678869|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111385059|NCT04678869|Ciprofloxacin|ciprofloxacin|mesh-list
111385060|NCT04678869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111385061|NCT04678869|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111385062|NCT04678869|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111385063|NCT04678869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111385064|NCT04678869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111385065|NCT04678869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111385066|NCT04678869|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111385067|NCT04678869|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111385068|NCT00369603|Donepezil|donepezil|mesh-list
111385069|NCT00369603|Galantamine|galantamine|mesh-list
111385070|NCT00369603|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111385071|NCT00369603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111385072|NCT00369603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111385073|NCT00369603|Cholinergic Agents|cholinergic agents|mesh-ancestor
111385074|NCT00369603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111385075|NCT00369603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111385076|NCT00369603|Nootropic Agents|nootropic agents|mesh-ancestor
111385077|NCT00369603|Parasympathomimetics|parasympathomimetics|mesh-ancestor
111385078|NCT00369603|Autonomic Agents|autonomic agents|mesh-ancestor
111385079|NCT00369603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111385080|NCT01551056|Cetirizine|cetirizine|mesh-list
111385081|NCT01551056|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111385082|NCT01551056|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
111385083|NCT01551056|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111385084|NCT01551056|Histamine Antagonists|histamine antagonists|mesh-ancestor
111385085|NCT01551056|Histamine Agents|histamine agents|mesh-ancestor
111385086|NCT01551056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111385087|NCT01551056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111385088|NCT01551056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111385089|NCT05227131|Capecitabine|capecitabine|mesh-list
111385090|NCT05227131|Tucatinib|tucatinib|mesh-list
111385091|NCT05227131|Margetuximab|margetuximab|mesh-list
111385092|NCT05227131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111385093|NCT05227131|Antimetabolites|antimetabolites|mesh-ancestor
111385094|NCT05227131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111385095|NCT05227131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111385096|NCT05227131|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111385097|NCT05227131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111385098|NCT01499498|Sildenafil Citrate|sildenafil citrate|mesh-list
111385099|NCT01499498|Vasodilator Agents|vasodilator agents|mesh-ancestor
111385100|NCT01499498|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111385101|NCT01499498|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111385102|NCT01499498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111385103|NCT01499498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111385104|NCT01499498|Urological Agents|urological agents|mesh-ancestor
111385105|NCT01499654|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
111385106|NCT01499654|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111385107|NCT01499654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111385108|NCT02421588|Doxorubicin|doxorubicin|mesh-list
111385109|NCT02421588|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111385110|NCT02421588|Topotecan|topotecan|mesh-list
111385111|NCT02421588|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111385112|NCT02421588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111385113|NCT02421588|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111385114|NCT02421588|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111385115|NCT02421588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111385116|NCT02421588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111385117|NCT02421588|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111385118|NCT02768727|Xenon|xenon|mesh-list
111385119|NCT02768727|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111385120|NCT02768727|Anesthetics, General|anesthetics, general|mesh-ancestor
111385121|NCT02768727|Anesthetics|anesthetics|mesh-ancestor
111385122|NCT02768727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111385123|NCT02768727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111385124|NCT02688309|Dexamethasone|dexamethasone|mesh-list
111385125|NCT02688309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111385126|NCT02688309|Antiemetics|antiemetics|mesh-ancestor
111385127|NCT02688309|Autonomic Agents|autonomic agents|mesh-ancestor
111385128|NCT02688309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111385129|NCT02688309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111385130|NCT02688309|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111385131|NCT02688309|Glucocorticoids|glucocorticoids|mesh-ancestor
111385132|NCT02688309|Hormones|hormones|mesh-ancestor
111385133|NCT02688309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111385134|NCT02688309|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111385135|NCT02688309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111385136|NCT00370851|Bevacizumab|bevacizumab|mesh-list
111385137|NCT00370851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111385138|NCT00370851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111385139|NCT00370851|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111385140|NCT00370851|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111385141|NCT00370851|Growth Substances|growth substances|mesh-ancestor
111385142|NCT00370851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111385143|NCT00370851|Growth Inhibitors|growth inhibitors|mesh-ancestor
111385144|NCT05124171|Vaccines|vaccines|mesh-list
111385145|NCT05124171|Immunologic Factors|immunologic factors|mesh-ancestor
111385146|NCT05124171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111385147|NCT00370305|Rosiglitazone|rosiglitazone|mesh-list
111385148|NCT00370305|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111385149|NCT00370305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111385150|NCT00371007|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111385151|NCT00371007|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111385152|NCT00371007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111385153|NCT00371007|Incretins|incretins|mesh-ancestor
111385154|NCT00371007|Hormones|hormones|mesh-ancestor
111385155|NCT00371007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111385156|NCT00371007|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111385157|NCT00371007|Protease Inhibitors|protease inhibitors|mesh-ancestor
111385158|NCT00371007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111385159|NCT00371007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111385160|NCT02421510|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
111385161|NCT02421510|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111385162|NCT02421510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111385163|NCT02421510|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111385164|NCT02421510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111385165|NCT00552617|Rocuronium|rocuronium|mesh-list
111385166|NCT00552617|Vecuronium Bromide|vecuronium bromide|mesh-list
111385167|NCT00552617|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
111385168|NCT00552617|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
111385169|NCT00552617|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111385170|NCT00552617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111385171|NCT00552617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111385172|NCT00552617|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
111385173|NCT00552617|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111385174|NCT00552617|Cholinergic Agents|cholinergic agents|mesh-ancestor
111385175|NCT00552617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111385176|NCT00552617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111385177|NCT04387305|Tranexamic Acid|tranexamic acid|mesh-list
111385178|NCT04387305|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111385179|NCT04387305|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111385180|NCT04387305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111385181|NCT04387305|Hemostatics|hemostatics|mesh-ancestor
111385182|NCT04387305|Coagulants|coagulants|mesh-ancestor
111385183|NCT02421120|Tazobactam|tazobactam|mesh-list
111385184|NCT02421120|Ceftolozane|ceftolozane|mesh-list
111385185|NCT02421120|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
111385186|NCT02421120|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111385187|NCT02421120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111385188|NCT02421120|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
111385189|NCT02421120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111385190|NCT02421120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111385191|NCT02421120|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111385192|NCT03022877|Simendan|simendan|mesh-list
111385193|NCT03022877|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111385194|NCT03022877|Vasodilator Agents|vasodilator agents|mesh-ancestor
111385195|NCT03022877|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
111385196|NCT03022877|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111385197|NCT03022877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111385198|NCT03022877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111385199|NCT03022877|Protective Agents|protective agents|mesh-ancestor
111385200|NCT03022877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111385201|NCT02420262|Insulin|insulin|mesh-list
111385202|NCT02420262|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111385203|NCT02420262|Insulin Glargine|insulin glargine|mesh-list
111385204|NCT02420262|Insulin Aspart|insulin aspart|mesh-list
111385205|NCT02420262|Liraglutide|liraglutide|mesh-list
111385206|NCT02420262|Xultophy|xultophy|mesh-list
111109606|NCT04719065|Mitoxantrone|mitoxantrone|mesh-list
111385207|NCT02420262|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111385208|NCT02420262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111385209|NCT02420262|Incretins|incretins|mesh-ancestor
111385210|NCT02420262|Hormones|hormones|mesh-ancestor
111385211|NCT02420262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111385212|NCT00369993|Fluticasone|fluticasone|mesh-list
111385213|NCT00369993|Xhance|xhance|mesh-list
111385214|NCT00369993|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
111385215|NCT00369993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111385216|NCT00369993|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111385217|NCT00369993|Autonomic Agents|autonomic agents|mesh-ancestor
111385218|NCT00369993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111385219|NCT00369993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111385220|NCT00369993|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111385221|NCT00369993|Respiratory System Agents|respiratory system agents|mesh-ancestor
111385222|NCT00369993|Dermatologic Agents|dermatologic agents|mesh-ancestor
111385223|NCT00369993|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111385224|NCT00369993|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111385225|NCT00369993|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111385226|NCT00369993|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111385227|NCT00369993|Adrenergic Agents|adrenergic agents|mesh-ancestor
111385228|NCT00369993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111385229|NCT00369993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111385230|NCT00552305|Lacosamide|lacosamide|mesh-list
111385231|NCT00552305|Anticonvulsants|anticonvulsants|mesh-ancestor
111385232|NCT00552305|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111385233|NCT00552305|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111385234|NCT00552305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111385235|NCT00552305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111385236|NCT02278887|Cyclophosphamide|cyclophosphamide|mesh-list
111385237|NCT02278887|Fludarabine|fludarabine|mesh-list
111385238|NCT02278887|Ipilimumab|ipilimumab|mesh-list
111385239|NCT02278887|Interleukin-2|interleukin-2|mesh-list
111385240|NCT02278887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111385241|NCT02278887|Immunologic Factors|immunologic factors|mesh-ancestor
111385242|NCT02278887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111385243|NCT02278887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111385244|NCT02278887|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111385245|NCT02278887|Alkylating Agents|alkylating agents|mesh-ancestor
111385246|NCT02278887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111385247|NCT02278887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111385248|NCT02278887|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111385249|NCT02278887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111385250|NCT02278887|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111385251|NCT02278887|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111385252|NCT02278887|Analgesics|analgesics|mesh-ancestor
111385253|NCT02278887|Sensory System Agents|sensory system agents|mesh-ancestor
111385254|NCT02278887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111385255|NCT04168203|Apixaban|apixaban|mesh-list
110525220|NCT00636870|Histamine Agents|histamine agents|mesh-ancestor
111385256|NCT04168203|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111385257|NCT04168203|Antithrombins|antithrombins|mesh-ancestor
111385258|NCT04168203|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111385259|NCT04168203|Protease Inhibitors|protease inhibitors|mesh-ancestor
111385260|NCT04168203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111385261|NCT04168203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111385262|NCT04168203|Anticoagulants|anticoagulants|mesh-ancestor
111385263|NCT04135989|Everolimus|everolimus|mesh-list
111385264|NCT04135989|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111385265|NCT04135989|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111385266|NCT04135989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111385267|NCT04135989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111385268|NCT04135989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111385269|NCT04135989|Immunologic Factors|immunologic factors|mesh-ancestor
111385270|NCT04135989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111385271|NCT04135989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111385272|NCT01854255|Cisplatin|cisplatin|mesh-list
111385273|NCT01854255|Doxorubicin|doxorubicin|mesh-list
111385274|NCT01854255|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111385275|NCT01854255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111385276|NCT01854255|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111385277|NCT01854255|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111385278|NCT01854255|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111385279|NCT01854255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111385280|NCT01854255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111385281|NCT01555281|Nelfinavir|nelfinavir|mesh-list
111385282|NCT01555281|Dexamethasone|dexamethasone|mesh-list
111385284|NCT01555281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111385285|NCT01555281|Antiemetics|antiemetics|mesh-ancestor
111385286|NCT01555281|Autonomic Agents|autonomic agents|mesh-ancestor
111385287|NCT01555281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111385288|NCT01555281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111385289|NCT01555281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111385290|NCT01555281|Glucocorticoids|glucocorticoids|mesh-ancestor
111385291|NCT01555281|Hormones|hormones|mesh-ancestor
111385292|NCT01555281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111385293|NCT01555281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111385294|NCT01555281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111385295|NCT01555281|Immunologic Factors|immunologic factors|mesh-ancestor
111385296|NCT01555281|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111385297|NCT01555281|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111385298|NCT01555281|Growth Substances|growth substances|mesh-ancestor
111385299|NCT01555281|Growth Inhibitors|growth inhibitors|mesh-ancestor
111385300|NCT01555281|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111385301|NCT01555281|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111385302|NCT01555281|Protease Inhibitors|protease inhibitors|mesh-ancestor
111385303|NCT01555281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111385304|NCT01555281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111385305|NCT01555281|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111385306|NCT01555281|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111385307|NCT01555281|Antiviral Agents|antiviral agents|mesh-ancestor
111385308|NCT01555281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111385309|NCT00370539|Triamcinolone|triamcinolone|mesh-list
111385310|NCT00370539|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
111385311|NCT00370539|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
111385312|NCT00370539|Bevacizumab|bevacizumab|mesh-list
111385313|NCT00370539|Verteporfin|verteporfin|mesh-list
111385314|NCT00370539|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
111385315|NCT00370539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111385316|NCT00370539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111385317|NCT00370539|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111385318|NCT00370539|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111385319|NCT00370539|Growth Substances|growth substances|mesh-ancestor
111385320|NCT00370539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111385321|NCT00370539|Growth Inhibitors|growth inhibitors|mesh-ancestor
111385322|NCT00370539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111385323|NCT00370539|Glucocorticoids|glucocorticoids|mesh-ancestor
111385324|NCT00370539|Hormones|hormones|mesh-ancestor
111385325|NCT00370539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111385326|NCT00370539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111385327|NCT00370539|Immunologic Factors|immunologic factors|mesh-ancestor
111385328|NCT00370539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111385329|NCT00370539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111385330|NCT00370539|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111385331|NCT00370539|Dermatologic Agents|dermatologic agents|mesh-ancestor
111385332|NCT03996057|Methenamine|methenamine|mesh-list
111385333|NCT03996057|Methenamine hippurate|methenamine hippurate|mesh-list
111385334|NCT03996057|Methenamine mandelate|methenamine mandelate|mesh-list
111385335|NCT03996057|Estrogens|estrogens|mesh-list
111385336|NCT03996057|Hormones|hormones|mesh-ancestor
111385337|NCT03996057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111385338|NCT03996057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111385339|NCT03996057|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111385340|NCT03996057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111385341|NCT03996057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111385342|NCT03150875|Docetaxel|docetaxel|mesh-list
111385343|NCT03150875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111385344|NCT03150875|Tubulin Modulators|tubulin modulators|mesh-ancestor
111385345|NCT03150875|Antimitotic Agents|antimitotic agents|mesh-ancestor
111385346|NCT03150875|Mitosis Modulators|mitosis modulators|mesh-ancestor
111385347|NCT03150875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111385348|NCT00552071|Octreotide|octreotide|mesh-list
111385349|NCT00552071|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111385350|NCT00552071|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111385351|NCT00552071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111385352|NCT00673335|Letrozole|letrozole|mesh-list
111385353|NCT00673335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111385354|NCT00673335|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111385355|NCT00673335|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111385356|NCT00673335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111385357|NCT00673335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111385358|NCT00673335|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111385359|NCT00673335|Hormone Antagonists|hormone antagonists|mesh-ancestor
111385360|NCT00673335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111385361|NCT00673335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111385362|NCT04880889|Pantothenic Acid|pantothenic acid|mesh-list
111385363|NCT04880889|Thiamine|thiamine|mesh-list
111385364|NCT04880889|Vitamin B Complex|vitamin b complex|mesh-ancestor
111385365|NCT04880889|Vitamins|vitamins|mesh-ancestor
111385366|NCT04880889|Micronutrients|micronutrients|mesh-ancestor
111385367|NCT04880889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111385368|NCT03833427|Pembrolizumab|pembrolizumab|mesh-list
111385369|NCT03833427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111385370|NCT03833427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111385371|NCT03833427|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111385372|NCT03833427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111385373|NCT04849377|Cisplatin|cisplatin|mesh-list
111385374|NCT04849377|Carboplatin|carboplatin|mesh-list
111385375|NCT04849377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111385376|NCT05511779|Brincidofovir|brincidofovir|mesh-list
111385377|NCT05511779|Antiviral Agents|antiviral agents|mesh-ancestor
111385378|NCT05511779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111385379|NCT00551525|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
111385380|NCT00551525|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111385381|NCT00551525|Analgesics|analgesics|mesh-ancestor
111385382|NCT00551525|Sensory System Agents|sensory system agents|mesh-ancestor
111000951|NCT02855359|Hormones|hormones|mesh-ancestor
111385383|NCT00551525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111385384|NCT00551525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111385385|NCT04802031|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111385386|NCT04802031|Immunologic Factors|immunologic factors|mesh-ancestor
111385387|NCT04802031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111385388|NCT05454345|Moxifloxacin|moxifloxacin|mesh-list
111385389|NCT05454345|Rifampin|rifampin|mesh-list
111385390|NCT05454345|Isoniazid|isoniazid|mesh-list
111385391|NCT05454345|Pyrazinamide|pyrazinamide|mesh-list
111385392|NCT05454345|Ethambutol|ethambutol|mesh-list
111385393|NCT05454345|Rifapentine|rifapentine|mesh-list
111385394|NCT05454345|Sitafloxacin|sitafloxacin|mesh-list
111385395|NCT05454345|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111385396|NCT05454345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111385397|NCT05454345|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111385398|NCT05454345|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111385399|NCT05454345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111385400|NCT05454345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111385401|NCT05454345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111385402|NCT05454345|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111385403|NCT05454345|Antitubercular Agents|antitubercular agents|mesh-ancestor
111385404|NCT05454345|Leprostatic Agents|leprostatic agents|mesh-ancestor
111385405|NCT05454345|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111385406|NCT05454345|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111385407|NCT05454345|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111385408|NCT05454345|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
111385409|NCT05454345|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
111385410|NCT05454345|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
111385411|NCT05454345|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111385412|NCT05454345|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
111385413|NCT05454345|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111385414|NCT05454345|Antimetabolites|antimetabolites|mesh-ancestor
111385415|NCT05454345|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111385416|NCT04459611|Paclitaxel|paclitaxel|mesh-list
111385417|NCT04459611|Carboplatin|carboplatin|mesh-list
111385418|NCT04459611|Pemetrexed|pemetrexed|mesh-list
111385419|NCT04459611|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111385420|NCT04459611|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111385421|NCT04459611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111385422|NCT04459611|Tubulin Modulators|tubulin modulators|mesh-ancestor
111385423|NCT04459611|Antimitotic Agents|antimitotic agents|mesh-ancestor
111385424|NCT04459611|Mitosis Modulators|mitosis modulators|mesh-ancestor
111385425|NCT04459611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111385426|NCT04459611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111385427|NCT04459611|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111385428|NCT04459611|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111385429|NCT00370617|Metformin|metformin|mesh-list
111385430|NCT00370617|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111109837|NCT04481971|Prednisolone|prednisolone|mesh-list
111385431|NCT00370617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111385432|NCT01553708|Sulfadiazine|sulfadiazine|mesh-list
111385433|NCT01553708|Silver Sulfadiazine|silver sulfadiazine|mesh-list
111385434|NCT01553708|Mitogens|mitogens|mesh-list
111385435|NCT01553708|Mitosis Modulators|mitosis modulators|mesh-ancestor
111385436|NCT01553708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111385437|NCT01553708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111385438|NCT01553708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111385439|NCT01553708|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111385440|NCT01553708|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111385441|NCT01553708|Coccidiostats|coccidiostats|mesh-ancestor
111385442|NCT01553708|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111385443|NCT02370498|Paclitaxel|paclitaxel|mesh-list
111385444|NCT02370498|Pembrolizumab|pembrolizumab|mesh-list
111385445|NCT02370498|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111385446|NCT02370498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111385447|NCT02370498|Tubulin Modulators|tubulin modulators|mesh-ancestor
111385448|NCT02370498|Antimitotic Agents|antimitotic agents|mesh-ancestor
111385449|NCT02370498|Mitosis Modulators|mitosis modulators|mesh-ancestor
111385450|NCT02370498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111385451|NCT02370498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111385452|NCT02370498|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111385453|NCT01554488|Fluticasone|fluticasone|mesh-list
111385454|NCT01554488|Xhance|xhance|mesh-list
111385455|NCT01554488|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111385456|NCT01554488|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111385457|NCT01554488|Autonomic Agents|autonomic agents|mesh-ancestor
111385458|NCT01554488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111385459|NCT01554488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111385460|NCT01554488|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111385461|NCT01554488|Respiratory System Agents|respiratory system agents|mesh-ancestor
111385462|NCT01554488|Dermatologic Agents|dermatologic agents|mesh-ancestor
111385463|NCT01554488|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111385464|NCT02347332|Methotrexate|methotrexate|mesh-list
111385465|NCT02347332|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111385466|NCT02347332|Abortifacient Agents|abortifacient agents|mesh-ancestor
111385467|NCT02347332|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111385468|NCT02347332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111385469|NCT02347332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111385470|NCT02347332|Antimetabolites|antimetabolites|mesh-ancestor
111385471|NCT02347332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111385472|NCT02347332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111385473|NCT02347332|Dermatologic Agents|dermatologic agents|mesh-ancestor
111385474|NCT02347332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111385475|NCT02347332|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111385476|NCT02347332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111385477|NCT02347332|Immunologic Factors|immunologic factors|mesh-ancestor
111385478|NCT02347332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111385479|NCT02347332|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111385480|NCT01502306|Nicotine|nicotine|mesh-list
111385481|NCT01502306|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111385482|NCT01502306|Autonomic Agents|autonomic agents|mesh-ancestor
111385483|NCT01502306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111385484|NCT01502306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111385485|NCT01502306|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111385486|NCT01502306|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111385487|NCT01502306|Cholinergic Agents|cholinergic agents|mesh-ancestor
111385488|NCT01502306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111385489|NCT01502306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111385490|NCT03325959|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
111385491|NCT03325959|Analgesics|analgesics|mesh-ancestor
111385492|NCT03325959|Sensory System Agents|sensory system agents|mesh-ancestor
111385493|NCT03325959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111385494|NCT03325959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111385495|NCT03325959|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111385496|NCT03325959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111385497|NCT03325959|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111385498|NCT03325959|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111385499|NCT03325959|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111385500|NCT03325959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111385501|NCT03325959|Antidepressive Agents|antidepressive agents|mesh-ancestor
111385502|NCT03325959|Dopamine Agents|dopamine agents|mesh-ancestor
111385503|NCT02347176|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111385504|NCT02347176|Immunologic Factors|immunologic factors|mesh-ancestor
111385505|NCT02347176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111385506|NCT05451381|Dexmedetomidine|dexmedetomidine|mesh-list
111109912|NCT05105009|Furosemide|furosemide|mesh-list
111385507|NCT05451381|Propofol|propofol|mesh-list
111385508|NCT05451381|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111385509|NCT05451381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111385510|NCT05451381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111385511|NCT05451381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111385512|NCT05451381|Analgesics|analgesics|mesh-ancestor
111385513|NCT05451381|Sensory System Agents|sensory system agents|mesh-ancestor
111385514|NCT05451381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111385515|NCT05451381|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111385516|NCT05451381|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111385517|NCT05451381|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111385518|NCT05451381|Adrenergic Agents|adrenergic agents|mesh-ancestor
111385519|NCT05451381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111385520|NCT05451381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111385521|NCT05451381|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111385522|NCT05451381|Anesthetics, General|anesthetics, general|mesh-ancestor
111385523|NCT05451381|Anesthetics|anesthetics|mesh-ancestor
111385524|NCT05450913|Lidocaine|lidocaine|mesh-list
111385525|NCT05450913|Anesthetics, Local|anesthetics, local|mesh-list
111385526|NCT05450913|Anesthetics|anesthetics|mesh-list
111385527|NCT05450913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111385528|NCT05450913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111385529|NCT05450913|Sensory System Agents|sensory system agents|mesh-ancestor
111385530|NCT05450913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111385531|NCT05450913|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111385532|NCT05450913|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111385533|NCT05450913|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111385534|NCT05450913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111385535|NCT05450913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111385536|NCT02215070|Pasireotide|pasireotide|mesh-list
111385537|NCT02215070|Hormones|hormones|mesh-ancestor
111385538|NCT02215070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111385539|NCT02215070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111385540|NCT04000737|Sorafenib|sorafenib|mesh-list
111385541|NCT04000737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111385542|NCT04000737|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111385543|NCT04000737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111385544|NCT04000737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111385545|NCT02347098|Atorvastatin|atorvastatin|mesh-list
111385546|NCT02347098|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
111385547|NCT02347098|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111385548|NCT02347098|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111385549|NCT02347098|Antimetabolites|antimetabolites|mesh-ancestor
111385550|NCT02347098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111385551|NCT02347098|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111385552|NCT02347098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111385553|NCT03708237|Gabapentin|gabapentin|mesh-list
111385554|NCT03708237|Ropinirole|ropinirole|mesh-list
111385555|NCT03708237|Analgesics|analgesics|mesh-ancestor
111385556|NCT03708237|Sensory System Agents|sensory system agents|mesh-ancestor
111385557|NCT03708237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111385558|NCT03708237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111385559|NCT03708237|Anticonvulsants|anticonvulsants|mesh-ancestor
111385560|NCT03708237|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111385561|NCT03708237|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111385562|NCT03708237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111385563|NCT03708237|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111385564|NCT03708237|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111385565|NCT03708237|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111385566|NCT03708237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111385567|NCT03708237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111385568|NCT03708237|Antimanic Agents|antimanic agents|mesh-ancestor
111385569|NCT03708237|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111385570|NCT03708237|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111385571|NCT03708237|Dopamine Agonists|dopamine agonists|mesh-ancestor
111385572|NCT03708237|Dopamine Agents|dopamine agents|mesh-ancestor
111385573|NCT01556594|Glucagon|glucagon|mesh-list
111385574|NCT01556594|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
111385575|NCT01556594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111385576|NCT01556594|Hormones|hormones|mesh-ancestor
111385577|NCT01556594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111385578|NCT01556594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111385579|NCT01556594|Incretins|incretins|mesh-ancestor
111385580|NCT00371319|Mycophenolic Acid|mycophenolic acid|mesh-list
111385581|NCT00371319|Tacrolimus|tacrolimus|mesh-list
111385582|NCT00371319|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111385583|NCT00371319|Immunologic Factors|immunologic factors|mesh-ancestor
111385584|NCT00371319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111385585|NCT00371319|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111385586|NCT00371319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111385587|NCT00371319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111385588|NCT00371319|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111385589|NCT00371319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111385590|NCT00371319|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111385591|NCT00371319|Antitubercular Agents|antitubercular agents|mesh-ancestor
111385592|NCT00371319|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111385593|NCT00371319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111385594|NCT01439672|Insulin|insulin|mesh-list
111385595|NCT01439672|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111385596|NCT01439672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111385597|NCT03465111|Hormones|hormones|mesh-list
111385598|NCT03465111|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
111385599|NCT03465111|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
111385600|NCT03465111|beta-Endorphin|beta-endorphin|mesh-list
111385601|NCT03465111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111385602|NCT03465111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111385603|NCT03465111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111385604|NCT03465111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111385605|NCT01440764|Furosemide|furosemide|mesh-list
111385606|NCT01440764|Diuretics|diuretics|mesh-ancestor
111385607|NCT01440764|Natriuretic Agents|natriuretic agents|mesh-ancestor
111385608|NCT01440764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111385609|NCT01440764|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
111385610|NCT01440764|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111385611|NCT01440764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111385612|NCT01557452|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
111385613|NCT01557452|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111385614|NCT01557452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111385615|NCT01557452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111385616|NCT05283837|Pertuzumab|pertuzumab|mesh-list
111385617|NCT05283837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111385618|NCT05283837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111385619|NCT02209610|Fentanyl|fentanyl|mesh-list
111385620|NCT02209610|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111385621|NCT02209610|Narcotics|narcotics|mesh-ancestor
111385622|NCT02209610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111385623|NCT02209610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111385624|NCT02209610|Analgesics|analgesics|mesh-ancestor
111385625|NCT02209610|Sensory System Agents|sensory system agents|mesh-ancestor
111385626|NCT02209610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111385627|NCT02209610|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111385628|NCT02209610|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111385629|NCT02209610|Anesthetics, General|anesthetics, general|mesh-ancestor
111385630|NCT02209610|Anesthetics|anesthetics|mesh-ancestor
111385631|NCT01441076|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
111385632|NCT01441076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111385633|NCT05244993|Paclitaxel|paclitaxel|mesh-list
111385634|NCT05244993|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111385635|NCT05244993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111385636|NCT05244993|Tubulin Modulators|tubulin modulators|mesh-ancestor
111385637|NCT05244993|Antimitotic Agents|antimitotic agents|mesh-ancestor
111385638|NCT05244993|Mitosis Modulators|mitosis modulators|mesh-ancestor
111385639|NCT05244993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111385640|NCT03289299|Dexamethasone|dexamethasone|mesh-list
111385641|NCT03289299|Lenalidomide|lenalidomide|mesh-list
111385642|NCT03289299|Daratumumab|daratumumab|mesh-list
111385643|NCT03289299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111385644|NCT03289299|Antiemetics|antiemetics|mesh-ancestor
111385645|NCT03289299|Autonomic Agents|autonomic agents|mesh-ancestor
111385646|NCT03289299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111385647|NCT03289299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111385648|NCT03289299|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111385649|NCT03289299|Glucocorticoids|glucocorticoids|mesh-ancestor
111385650|NCT03289299|Hormones|hormones|mesh-ancestor
111385651|NCT03289299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111385652|NCT03289299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111385653|NCT03289299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111385654|NCT03289299|Immunologic Factors|immunologic factors|mesh-ancestor
111385655|NCT03289299|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111385656|NCT03289299|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111385657|NCT03289299|Growth Substances|growth substances|mesh-ancestor
111385658|NCT03289299|Growth Inhibitors|growth inhibitors|mesh-ancestor
111385659|NCT01558700|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110525625|NCT00952003|Antimitotic Agents|antimitotic agents|mesh-ancestor
111385660|NCT01558700|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111385661|NCT01558700|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111385662|NCT01558700|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111385663|NCT01558700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111385664|NCT01558700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111385665|NCT01558700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111385666|NCT01558700|Analgesics|analgesics|mesh-ancestor
111385667|NCT01558700|Sensory System Agents|sensory system agents|mesh-ancestor
111385668|NCT01558700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111385669|NCT01558700|Antidepressive Agents|antidepressive agents|mesh-ancestor
111385670|NCT01558700|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111385671|NCT01558700|Dopamine Agents|dopamine agents|mesh-ancestor
111385672|NCT02757105|Ondansetron|ondansetron|mesh-list
111385673|NCT02757105|Antiemetics|antiemetics|mesh-ancestor
111385674|NCT02757105|Autonomic Agents|autonomic agents|mesh-ancestor
111385675|NCT02757105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111385676|NCT02757105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111385677|NCT02757105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111385678|NCT02757105|Antipruritics|antipruritics|mesh-ancestor
111385679|NCT02757105|Dermatologic Agents|dermatologic agents|mesh-ancestor
111385680|NCT02757105|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111385681|NCT02757105|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111385682|NCT02757105|Serotonin Agents|serotonin agents|mesh-ancestor
111385683|NCT02757105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111385684|NCT02757105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111385685|NCT05083845|Anesthetics|anesthetics|mesh-list
111385686|NCT05083845|Anesthetics, Local|anesthetics, local|mesh-list
111385687|NCT05083845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111385688|NCT05083845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111385689|NCT05083845|Sensory System Agents|sensory system agents|mesh-ancestor
111385690|NCT05083845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111385691|NCT00371553|Sunitinib|sunitinib|mesh-list
111385692|NCT00371553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111385693|NCT00371553|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111385694|NCT00371553|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111385695|NCT00371553|Growth Substances|growth substances|mesh-ancestor
111385696|NCT00371553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111385697|NCT00371553|Growth Inhibitors|growth inhibitors|mesh-ancestor
111385698|NCT00371553|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111385699|NCT00371553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111385700|NCT00371553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111385701|NCT02892201|Pembrolizumab|pembrolizumab|mesh-list
111385702|NCT02892201|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111385703|NCT02892201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111385704|NCT02892201|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111385705|NCT02892201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111385706|NCT01507220|Morphine|morphine|mesh-list
111385707|NCT01507220|Bupivacaine|bupivacaine|mesh-list
111385708|NCT01507220|Anesthetics, Local|anesthetics, local|mesh-ancestor
111385709|NCT01507220|Anesthetics|anesthetics|mesh-ancestor
111385710|NCT01507220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111385711|NCT01507220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111385712|NCT01507220|Sensory System Agents|sensory system agents|mesh-ancestor
111385713|NCT01507220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111385714|NCT01507220|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111385715|NCT01507220|Narcotics|narcotics|mesh-ancestor
111385716|NCT01507220|Analgesics|analgesics|mesh-ancestor
111385717|NCT01509404|Valganciclovir|valganciclovir|mesh-list
111385718|NCT01509404|Antiviral Agents|antiviral agents|mesh-ancestor
111385719|NCT01509404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111385720|NCT01562132|Fluconazole|fluconazole|mesh-list
111385721|NCT01562132|Flucytosine|flucytosine|mesh-list
111385722|NCT01562132|Antifungal Agents|antifungal agents|mesh-ancestor
111385723|NCT01562132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111385724|NCT01562132|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111385725|NCT01562132|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111385726|NCT01562132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111385727|NCT01562132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111385728|NCT01562132|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111110131|NCT03830411|Docetaxel|docetaxel|mesh-list
111385729|NCT01562132|Hormone Antagonists|hormone antagonists|mesh-ancestor
111385730|NCT01562132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111385731|NCT01562132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111385732|NCT01562132|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111385733|NCT01562132|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111385734|NCT01562132|Antimetabolites|antimetabolites|mesh-ancestor
111385735|NCT02762331|Ascorbic Acid|ascorbic acid|mesh-list
111385736|NCT02762331|Vitamins|vitamins|mesh-ancestor
111385737|NCT02762331|Micronutrients|micronutrients|mesh-ancestor
111385738|NCT02762331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111385739|NCT02762331|Antioxidants|antioxidants|mesh-ancestor
111385740|NCT02762331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111385741|NCT02762331|Protective Agents|protective agents|mesh-ancestor
111385742|NCT02762799|Lenograstim|lenograstim|mesh-list
111385743|NCT02762799|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111385744|NCT02762799|Immunologic Factors|immunologic factors|mesh-ancestor
111385745|NCT02762799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111385746|NCT01447706|Paclitaxel|paclitaxel|mesh-list
111385747|NCT01447706|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111385748|NCT01447706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111385749|NCT01447706|Tubulin Modulators|tubulin modulators|mesh-ancestor
111385750|NCT01447706|Antimitotic Agents|antimitotic agents|mesh-ancestor
111385751|NCT01447706|Mitosis Modulators|mitosis modulators|mesh-ancestor
111385752|NCT01447706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111385753|NCT01509638|Bupivacaine|bupivacaine|mesh-list
111385754|NCT01509638|Anesthetics, Local|anesthetics, local|mesh-ancestor
111385755|NCT01509638|Anesthetics|anesthetics|mesh-ancestor
111385756|NCT01509638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111385757|NCT01509638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111385758|NCT01509638|Sensory System Agents|sensory system agents|mesh-ancestor
111385759|NCT01509638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111385760|NCT04336917|Lidocaine|lidocaine|mesh-list
111385761|NCT04336917|Bupivacaine|bupivacaine|mesh-list
111385762|NCT04336917|Anesthetics, Local|anesthetics, local|mesh-list
111385763|NCT04336917|Anesthetics|anesthetics|mesh-list
111385764|NCT04336917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111385765|NCT04336917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111385766|NCT04336917|Sensory System Agents|sensory system agents|mesh-ancestor
111385767|NCT04336917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111385768|NCT04336917|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111385769|NCT04336917|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111385770|NCT04336917|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111385771|NCT04336917|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111385772|NCT04336917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111385773|NCT01448486|Raltegravir Potassium|raltegravir potassium|mesh-list
111385774|NCT01448486|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111385775|NCT01448486|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111385776|NCT01448486|Antiviral Agents|antiviral agents|mesh-ancestor
111385777|NCT01448486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111385778|NCT01448486|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111385779|NCT01448486|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111385780|NCT01448486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111385781|NCT01448486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111385782|NCT01562678|Liraglutide|liraglutide|mesh-list
111385783|NCT01562678|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111385784|NCT01562678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111385785|NCT01562678|Incretins|incretins|mesh-ancestor
111385786|NCT01562678|Hormones|hormones|mesh-ancestor
111385787|NCT01562678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111385788|NCT02767869|Magnesium Oxide|magnesium oxide|mesh-list
111385789|NCT02767869|Antacids|antacids|mesh-ancestor
111385790|NCT02767869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111385791|NCT02767869|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111385792|NCT01449266|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
111385793|NCT01449266|Chelating Agents|chelating agents|mesh-ancestor
111385794|NCT01449266|Sequestering Agents|sequestering agents|mesh-ancestor
111385795|NCT01449266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111385796|NCT02767947|Luliconazole|luliconazole|mesh-list
111385797|NCT02767947|Antifungal Agents|antifungal agents|mesh-ancestor
111385798|NCT02767947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111385799|NCT02770365|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
111385800|NCT02770365|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
111385801|NCT02770365|Estradiol|estradiol|mesh-list
111385802|NCT02770365|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
111385804|NCT02770365|Hormones|hormones|mesh-ancestor
111385805|NCT02770365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111385806|NCT02770365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111385807|NCT02770365|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111385808|NCT02770365|Contraceptive Agents|contraceptive agents|mesh-ancestor
111385809|NCT02770365|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111385810|NCT02770365|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111385811|NCT02770521|Insulin Lispro|insulin lispro|mesh-list
111385812|NCT02770521|Treprostinil|treprostinil|mesh-list
111385813|NCT02770521|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111385814|NCT02770521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111385815|NCT02770521|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111385816|NCT02346240|Etanercept|etanercept|mesh-list
111385817|NCT02346240|Certolizumab Pegol|certolizumab pegol|mesh-list
111385818|NCT02346240|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111385819|NCT02346240|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111385820|NCT02346240|Analgesics|analgesics|mesh-ancestor
111385821|NCT02346240|Sensory System Agents|sensory system agents|mesh-ancestor
111385822|NCT02346240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111385823|NCT02346240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111385824|NCT02346240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111385825|NCT02346240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111385826|NCT02346240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111385827|NCT02346240|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111385828|NCT02346240|Immunologic Factors|immunologic factors|mesh-ancestor
111385829|NCT02346240|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111385830|NCT01511978|Amifampridine|amifampridine|mesh-list
111385831|NCT01511978|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111385832|NCT01511978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111385833|NCT01511978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111385834|NCT01511978|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
111385835|NCT01511978|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111385836|NCT01511978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111385837|NCT02772783|Insulin|insulin|mesh-list
111385838|NCT02772783|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111385839|NCT02772783|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111385840|NCT02772783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111385841|NCT02774343|Pioglitazone|pioglitazone|mesh-list
111385842|NCT02774343|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111385843|NCT02774343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111385844|NCT05349045|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
111385845|NCT05349045|Antibodies|antibodies|mesh-list
111385846|NCT05349045|Immunologic Factors|immunologic factors|mesh-ancestor
111385847|NCT05349045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111385848|NCT05349045|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111385849|NCT05349045|Growth Substances|growth substances|mesh-ancestor
111385850|NCT05349045|Growth Inhibitors|growth inhibitors|mesh-ancestor
111385851|NCT05349045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111385852|NCT02392104|Warfarin|warfarin|mesh-list
111385853|NCT02392104|Anticoagulants|anticoagulants|mesh-ancestor
111385854|NCT04336605|Analgesics|analgesics|mesh-list
111385855|NCT04336605|Sensory System Agents|sensory system agents|mesh-ancestor
111385856|NCT04336605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111385857|NCT04336605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111385858|NCT01450826|Ondansetron|ondansetron|mesh-list
111385859|NCT01450826|Aprepitant|aprepitant|mesh-list
111385860|NCT01450826|Antiemetics|antiemetics|mesh-ancestor
111385861|NCT01450826|Autonomic Agents|autonomic agents|mesh-ancestor
111385862|NCT01450826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111385863|NCT01450826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111385864|NCT01450826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111385865|NCT01450826|Antipruritics|antipruritics|mesh-ancestor
111385866|NCT01450826|Dermatologic Agents|dermatologic agents|mesh-ancestor
111385867|NCT01450826|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111385868|NCT01450826|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111385869|NCT01450826|Serotonin Agents|serotonin agents|mesh-ancestor
111385870|NCT01450826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111385871|NCT01450826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111385872|NCT01450826|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
111385873|NCT05349903|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
111385874|NCT05349903|Antioxidants|antioxidants|mesh-ancestor
111385875|NCT05349903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111385876|NCT05349903|Protective Agents|protective agents|mesh-ancestor
111385877|NCT05349903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111385878|NCT05349903|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
111385879|NCT05349903|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
111385880|NCT05349903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111385881|NCT05349903|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111385882|NCT05349825|Losartan|losartan|mesh-list
111385883|NCT05349825|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111385884|NCT05349825|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111385885|NCT05349825|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111385886|NCT05349825|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111385887|NCT05349825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111385888|NCT01451996|Loratadine|loratadine|mesh-list
111385889|NCT01451996|Antipruritics|antipruritics|mesh-ancestor
111385890|NCT01451996|Dermatologic Agents|dermatologic agents|mesh-ancestor
111385891|NCT01451996|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111385892|NCT01451996|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
111385893|NCT01451996|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111385894|NCT01451996|Histamine Antagonists|histamine antagonists|mesh-ancestor
111385895|NCT01451996|Histamine Agents|histamine agents|mesh-ancestor
111385896|NCT01451996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111385897|NCT01451996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111385898|NCT01451996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111385899|NCT01512446|Alendronate|alendronate|mesh-list
111385900|NCT01512446|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111385901|NCT01512446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111385902|NCT04334967|Ascorbic Acid|ascorbic acid|mesh-list
111385903|NCT04334967|Hydroxychloroquine|hydroxychloroquine|mesh-list
111385904|NCT04334967|Vitamins|vitamins|mesh-ancestor
111385905|NCT04334967|Micronutrients|micronutrients|mesh-ancestor
111385906|NCT04334967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111385907|NCT04334967|Antimalarials|antimalarials|mesh-ancestor
111385908|NCT04334967|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111385909|NCT04334967|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111385910|NCT04334967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111385911|NCT04334967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111385912|NCT04334967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111385913|NCT04334967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111385914|NCT04334967|Antioxidants|antioxidants|mesh-ancestor
111385915|NCT04334967|Protective Agents|protective agents|mesh-ancestor
111385916|NCT04335123|Losartan|losartan|mesh-list
111385917|NCT04335123|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111385918|NCT04335123|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111385919|NCT04335123|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111385920|NCT04335123|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111385921|NCT04335123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111385922|NCT05453565|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
111385923|NCT02742987|Clopidogrel|clopidogrel|mesh-list
111385924|NCT02742987|Ticagrelor|ticagrelor|mesh-list
111385925|NCT02742987|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111385926|NCT02742987|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111385927|NCT02742987|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111385928|NCT02742987|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111385929|NCT02742987|Purinergic Agents|purinergic agents|mesh-ancestor
111385930|NCT02742987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111385931|NCT02742987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111385932|NCT02742987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111385933|NCT05450055|Lidocaine|lidocaine|mesh-list
111385934|NCT05450055|Analgesics|analgesics|mesh-list
111385935|NCT05450055|Anesthetics, Local|anesthetics, local|mesh-ancestor
111385936|NCT05450055|Anesthetics|anesthetics|mesh-ancestor
111385937|NCT05450055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111385938|NCT05450055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111385939|NCT05450055|Sensory System Agents|sensory system agents|mesh-ancestor
111385940|NCT05450055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111385941|NCT05450055|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111385942|NCT05450055|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111385943|NCT05450055|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111385944|NCT05450055|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111385945|NCT05450055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111385946|NCT02743377|Rolipram|rolipram|mesh-list
111385947|NCT02743377|Antidepressive Agents|antidepressive agents|mesh-ancestor
111385948|NCT02743377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111385949|NCT02743377|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
111385950|NCT02743377|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111385951|NCT02743377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111385952|NCT02743377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111385954|NCT05437965|Immunosuppressive Agents|immunosuppressive agents|mesh-list
111385955|NCT05437965|Hormones|hormones|mesh-ancestor
111385956|NCT05437965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111385957|NCT05437965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111385958|NCT05437965|Immunologic Factors|immunologic factors|mesh-ancestor
111385959|NCT00372099|Calcitonin|calcitonin|mesh-list
111385960|NCT00372099|Salmon calcitonin|salmon calcitonin|mesh-list
111385961|NCT00372099|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
111385962|NCT00372099|Katacalcin|katacalcin|mesh-list
111385963|NCT00372099|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111385964|NCT00372099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111385965|NCT00372099|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111385966|NCT00372099|Vasodilator Agents|vasodilator agents|mesh-ancestor
111385967|NCT02748525|Cholecystokinin|cholecystokinin|mesh-list
111385968|NCT02748525|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
111385969|NCT02748525|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111385970|NCT01454414|Permethrin|permethrin|mesh-list
111385971|NCT01454414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111385972|NCT01454414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111385973|NCT04335513|Insulin|insulin|mesh-list
111385974|NCT04335513|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111385975|NCT04335513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111385976|NCT01568528|Oxytocin|oxytocin|mesh-list
111385977|NCT01568528|Oxytocics|oxytocics|mesh-ancestor
111385978|NCT01568528|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111385979|NCT01568528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111385980|NCT05013255|Pioglitazone|pioglitazone|mesh-list
111385981|NCT05013255|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111385982|NCT05013255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111385983|NCT01461668|Retapamulin|retapamulin|mesh-list
111385984|NCT01461668|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111385985|NCT01461668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111385986|NCT00372177|Immunoglobulin Fab Fragments|immunoglobulin fab fragments|mesh-list
111385987|NCT00372177|Immunologic Factors|immunologic factors|mesh-ancestor
111385988|NCT00372177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111385989|NCT05177991|Bupivacaine|bupivacaine|mesh-list
111385990|NCT05177991|Anesthetics, Local|anesthetics, local|mesh-ancestor
111385991|NCT05177991|Anesthetics|anesthetics|mesh-ancestor
111385992|NCT05177991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111385993|NCT05177991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111385994|NCT05177991|Sensory System Agents|sensory system agents|mesh-ancestor
111385995|NCT05177991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111385996|NCT01461824|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
111385997|NCT01461824|Medroxyprogesterone|medroxyprogesterone|mesh-list
111385998|NCT01461824|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111385999|NCT01461824|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111386000|NCT01461824|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111386001|NCT01461824|Contraceptive Agents|contraceptive agents|mesh-ancestor
111386002|NCT01461824|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111386003|NCT01461824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111386004|NCT01461824|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111386005|NCT01461824|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111386006|NCT01461824|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
111386007|NCT01461824|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111386008|NCT01461824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111386009|NCT04080843|Capecitabine|capecitabine|mesh-list
111386010|NCT04080843|Oxaliplatin|oxaliplatin|mesh-list
111386011|NCT04080843|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111386012|NCT04080843|Antimetabolites|antimetabolites|mesh-ancestor
111386013|NCT04080843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111386014|NCT04080843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111386015|NCT04737837|Lacosamide|lacosamide|mesh-list
111386016|NCT04737837|Anticonvulsants|anticonvulsants|mesh-ancestor
111386017|NCT04737837|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111386018|NCT04737837|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111386019|NCT04737837|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111386020|NCT04737837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111386021|NCT05456763|Butyric Acid|butyric acid|mesh-list
111386022|NCT05456763|Histamine Antagonists|histamine antagonists|mesh-ancestor
111386023|NCT05456763|Histamine Agents|histamine agents|mesh-ancestor
111386024|NCT05456763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111110431|NCT01984138|Estradiol|estradiol|mesh-list
111386025|NCT05456763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111386026|NCT05456763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111386027|NCT05456061|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111386028|NCT05456061|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111386029|NCT02369874|Durvalumab|durvalumab|mesh-list
111386030|NCT02369874|Tremelimumab|tremelimumab|mesh-list
111386031|NCT02369874|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111386032|NCT02369874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111386033|NCT02369874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111386034|NCT02369874|Immunologic Factors|immunologic factors|mesh-ancestor
111386035|NCT02369874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111386036|NCT00372645|Folic Acid|folic acid|mesh-list
111386037|NCT00372645|Hematinics|hematinics|mesh-ancestor
111386038|NCT00372645|Vitamin B Complex|vitamin b complex|mesh-ancestor
111386039|NCT00372645|Vitamins|vitamins|mesh-ancestor
111386040|NCT00372645|Micronutrients|micronutrients|mesh-ancestor
111386041|NCT00372645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111386042|NCT00372723|Infliximab|infliximab|mesh-list
111386043|NCT00372723|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111386044|NCT00372723|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111386045|NCT00372723|Dermatologic Agents|dermatologic agents|mesh-ancestor
111386046|NCT00372723|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111386047|NCT00372723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111386048|NCT00372801|Ibuprofen|ibuprofen|mesh-list
111386049|NCT00372801|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111386050|NCT00372801|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111386051|NCT00372801|Analgesics|analgesics|mesh-ancestor
111386052|NCT00372801|Sensory System Agents|sensory system agents|mesh-ancestor
111386053|NCT00372801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111386054|NCT00372801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111386055|NCT00372801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111386056|NCT00372801|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111386057|NCT00372801|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111386058|NCT00372801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111386059|NCT00372801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111386060|NCT04797429|Hypoglycemic Agents|hypoglycemic agents|mesh-list
111386061|NCT04797429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111386062|NCT05455359|Famotidine|famotidine|mesh-list
111386063|NCT05455359|Prucalopride|prucalopride|mesh-list
111386064|NCT05455359|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111386065|NCT05455359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111386066|NCT05455359|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
111386067|NCT05455359|Histamine Antagonists|histamine antagonists|mesh-ancestor
111386068|NCT05455359|Histamine Agents|histamine agents|mesh-ancestor
111386069|NCT05455359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111386070|NCT05455359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111386071|NCT05455359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111386072|NCT05455359|Laxatives|laxatives|mesh-ancestor
111386073|NCT05455359|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
111386074|NCT05455359|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111386075|NCT05455359|Serotonin Agents|serotonin agents|mesh-ancestor
111386076|NCT00373503|Lofexidine|lofexidine|mesh-list
111386077|NCT00373503|Dronabinol|dronabinol|mesh-list
111386078|NCT00373503|Hallucinogens|hallucinogens|mesh-ancestor
111386079|NCT00373503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111386080|NCT00373503|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111386081|NCT00373503|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111386082|NCT00373503|Analgesics|analgesics|mesh-ancestor
111386083|NCT00373503|Sensory System Agents|sensory system agents|mesh-ancestor
111386084|NCT00373503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111386085|NCT00373503|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
111386086|NCT00373503|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
111386087|NCT00373503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111386088|NCT00373503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111386089|NCT00373503|Hormones|hormones|mesh-ancestor
111386090|NCT00373503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111386091|NCT00373503|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111386092|NCT00373503|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111386093|NCT00373503|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111386094|NCT00373503|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111386095|NCT00373503|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111386096|NCT00373503|Adrenergic Agents|adrenergic agents|mesh-ancestor
111386097|NCT01515176|Ofatumumab|ofatumumab|mesh-list
111386098|NCT01515176|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111386099|NCT01515176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110959239|NCT03526224|Dermatologic Agents|dermatologic agents|mesh-ancestor
111386100|NCT01515176|Immunologic Factors|immunologic factors|mesh-ancestor
111386101|NCT01515176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111386102|NCT01515410|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
111386103|NCT01515410|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111386104|NCT01515410|Immunologic Factors|immunologic factors|mesh-ancestor
111386105|NCT01515410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111386106|NCT01515410|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111386107|NCT01515410|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111386108|NCT01515410|Dopamine Agonists|dopamine agonists|mesh-ancestor
111386109|NCT01515410|Dopamine Agents|dopamine agents|mesh-ancestor
111386110|NCT01515410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111386111|NCT01515410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111386112|NCT01515566|Fentanyl|fentanyl|mesh-list
111386113|NCT01515566|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111386114|NCT01515566|Narcotics|narcotics|mesh-ancestor
111386115|NCT01515566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111386116|NCT01515566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111386117|NCT01515566|Analgesics|analgesics|mesh-ancestor
111386118|NCT01515566|Sensory System Agents|sensory system agents|mesh-ancestor
111386119|NCT01515566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111386120|NCT01515566|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111386121|NCT01515566|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111386122|NCT01515566|Anesthetics, General|anesthetics, general|mesh-ancestor
111386123|NCT01515566|Anesthetics|anesthetics|mesh-ancestor
111386124|NCT00708045|Deoxyglucose|deoxyglucose|mesh-list
111386125|NCT00708045|Antimetabolites|antimetabolites|mesh-ancestor
111386126|NCT00708045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111386127|NCT00708045|Antiviral Agents|antiviral agents|mesh-ancestor
111386128|NCT00708045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111386129|NCT01516268|Sufentanil|sufentanil|mesh-list
111386130|NCT01516268|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111386131|NCT01516268|Narcotics|narcotics|mesh-ancestor
111386132|NCT01516268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111386133|NCT01516268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111386134|NCT01516268|Analgesics|analgesics|mesh-ancestor
111386135|NCT01516268|Sensory System Agents|sensory system agents|mesh-ancestor
111386136|NCT01516268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111386137|NCT01516268|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111386138|NCT01516268|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111386139|NCT01516268|Anesthetics, General|anesthetics, general|mesh-ancestor
111386140|NCT01516268|Anesthetics|anesthetics|mesh-ancestor
111386141|NCT05440968|Chrysarobin|chrysarobin|mesh-list
111386142|NCT05440968|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111386143|NCT05440968|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111386144|NCT05440968|Analgesics|analgesics|mesh-ancestor
111386145|NCT05440968|Sensory System Agents|sensory system agents|mesh-ancestor
111386146|NCT05440968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111386147|NCT05440968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111386148|NCT05440968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111386149|NCT05440968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111386150|NCT01516424|Risperidone|risperidone|mesh-list
111386151|NCT01516424|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111386152|NCT01516424|Serotonin Agents|serotonin agents|mesh-ancestor
111386153|NCT01516424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111386154|NCT01516424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111386155|NCT01516424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111386156|NCT01516424|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111386157|NCT01516424|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111386158|NCT01516424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111386159|NCT01516424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111386160|NCT01516424|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111386161|NCT01516424|Dopamine Agents|dopamine agents|mesh-ancestor
111386162|NCT02368314|Enoxaparin|enoxaparin|mesh-list
111386163|NCT02368314|Enoxaparin sodium|enoxaparin sodium|mesh-list
111386164|NCT02368314|Anticoagulants|anticoagulants|mesh-ancestor
111386165|NCT02368314|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111386166|NCT02368314|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111386167|NCT02368314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111386168|NCT01463384|Minocycline|minocycline|mesh-list
111386169|NCT01463384|Tetracycline|tetracycline|mesh-list
111386170|NCT01463384|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111386171|NCT01463384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111386172|NCT01463384|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111386173|NCT01463384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111386174|NCT01463384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111386175|NCT02785185|Clobetasol|clobetasol|mesh-list
111386176|NCT02785185|Halobetasol|halobetasol|mesh-list
111386177|NCT02785185|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111386178|NCT02785185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111386179|NCT02785185|Glucocorticoids|glucocorticoids|mesh-ancestor
111386180|NCT02785185|Hormones|hormones|mesh-ancestor
111386181|NCT02785185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111386182|NCT02785185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111386183|NCT02787057|Moxifloxacin|moxifloxacin|mesh-list
111386184|NCT02787057|Vancomycin|vancomycin|mesh-list
111386185|NCT02787057|Ceftazidime|ceftazidime|mesh-list
111386186|NCT02787057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111386187|NCT02787057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111386188|NCT02787057|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111386189|NCT02787057|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111386190|NCT02787057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111386191|NCT02787057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111386192|NCT02787057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111386193|NCT01468532|Prednisone|prednisone|mesh-list
111386194|NCT01468532|Docetaxel|docetaxel|mesh-list
111386195|NCT01468532|Pasireotide|pasireotide|mesh-list
111386196|NCT01468532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111386197|NCT01468532|Tubulin Modulators|tubulin modulators|mesh-ancestor
111386198|NCT01468532|Antimitotic Agents|antimitotic agents|mesh-ancestor
111386199|NCT01468532|Mitosis Modulators|mitosis modulators|mesh-ancestor
111386200|NCT01468532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111386201|NCT01468532|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111386202|NCT01468532|Glucocorticoids|glucocorticoids|mesh-ancestor
111386203|NCT01468532|Hormones|hormones|mesh-ancestor
111386204|NCT01468532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111386205|NCT01468532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111386206|NCT01468532|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111386207|NCT05062317|Leucovorin|leucovorin|mesh-list
111386208|NCT05062317|Bevacizumab|bevacizumab|mesh-list
111386209|NCT05062317|Fluorouracil|fluorouracil|mesh-list
111386210|NCT05062317|Capecitabine|capecitabine|mesh-list
111386211|NCT05062317|Oxaliplatin|oxaliplatin|mesh-list
111386212|NCT05062317|Irinotecan|irinotecan|mesh-list
111386213|NCT05062317|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111386214|NCT05062317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111386215|NCT05062317|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111386216|NCT05062317|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111386217|NCT05062317|Growth Substances|growth substances|mesh-ancestor
111386218|NCT05062317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111386219|NCT05062317|Growth Inhibitors|growth inhibitors|mesh-ancestor
111386220|NCT05062317|Antimetabolites|antimetabolites|mesh-ancestor
111386221|NCT05062317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111386222|NCT05062317|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111386223|NCT05062317|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111386224|NCT05062317|Immunologic Factors|immunologic factors|mesh-ancestor
111386225|NCT05062317|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111386226|NCT05062317|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111386227|NCT05062317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111386228|NCT05062317|Antidotes|antidotes|mesh-ancestor
111386229|NCT05062317|Protective Agents|protective agents|mesh-ancestor
111386230|NCT05062317|Vitamin B Complex|vitamin b complex|mesh-ancestor
111386231|NCT05062317|Vitamins|vitamins|mesh-ancestor
111386232|NCT05062317|Micronutrients|micronutrients|mesh-ancestor
111386233|NCT01469234|Loratadine|loratadine|mesh-list
111386234|NCT01469234|Fexofenadine|fexofenadine|mesh-list
111386235|NCT01469234|Terfenadine|terfenadine|mesh-list
111386236|NCT01469234|Antipruritics|antipruritics|mesh-ancestor
111386237|NCT01469234|Dermatologic Agents|dermatologic agents|mesh-ancestor
111386238|NCT01469234|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111386239|NCT01469234|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
111386240|NCT01469234|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111386241|NCT01469234|Histamine Antagonists|histamine antagonists|mesh-ancestor
111386242|NCT01469234|Histamine Agents|histamine agents|mesh-ancestor
111386243|NCT01469234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111386244|NCT01469234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111386245|NCT01469234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111386246|NCT05045937|Vitamin D|vitamin d|mesh-list
111386247|NCT05045937|Vitamins|vitamins|mesh-list
111386248|NCT05045937|Ivermectin|ivermectin|mesh-list
111386249|NCT05045937|Remdesivir|remdesivir|mesh-list
111386250|NCT05045937|Ibuprofen|ibuprofen|mesh-list
111386251|NCT05045937|Budesonide|budesonide|mesh-list
111386252|NCT05045937|Melatonin|melatonin|mesh-list
111386253|NCT05045937|Albuterol|albuterol|mesh-list
111110654|NCT03166891|Chiauranib|chiauranib|mesh-list
111386254|NCT05045937|Quercetin|quercetin|mesh-list
111386255|NCT05045937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111386256|NCT05045937|Micronutrients|micronutrients|mesh-ancestor
111386257|NCT05045937|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111386258|NCT05045937|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111386259|NCT05045937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111386260|NCT05045937|Analgesics|analgesics|mesh-ancestor
111386261|NCT05045937|Sensory System Agents|sensory system agents|mesh-ancestor
111386262|NCT05045937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111386263|NCT05045937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111386264|NCT05045937|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111386265|NCT05045937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111386266|NCT05045937|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111386267|NCT05045937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111386268|NCT05045937|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111386269|NCT05045937|Autonomic Agents|autonomic agents|mesh-ancestor
111386270|NCT05045937|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111386271|NCT05045937|Respiratory System Agents|respiratory system agents|mesh-ancestor
111386272|NCT05045937|Glucocorticoids|glucocorticoids|mesh-ancestor
111386273|NCT05045937|Hormones|hormones|mesh-ancestor
111386274|NCT05045937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111386275|NCT05045937|Antioxidants|antioxidants|mesh-ancestor
111386276|NCT05045937|Protective Agents|protective agents|mesh-ancestor
111386277|NCT05045937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111386278|NCT05045937|Tocolytic Agents|tocolytic agents|mesh-ancestor
111386279|NCT05045937|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111386280|NCT05045937|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111386281|NCT05045937|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111386282|NCT05045937|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111386283|NCT05045937|Adrenergic Agents|adrenergic agents|mesh-ancestor
111386284|NCT05045937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111386285|NCT05045937|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111386286|NCT05045937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111386287|NCT05045937|Antimetabolites|antimetabolites|mesh-ancestor
111386288|NCT05045937|Antiviral Agents|antiviral agents|mesh-ancestor
111386289|NCT00373581|Cocaine|cocaine|mesh-list
111386290|NCT00373581|Vigabatrin|vigabatrin|mesh-list
111386291|NCT00373581|Anesthetics, Local|anesthetics, local|mesh-ancestor
111386292|NCT00373581|Anesthetics|anesthetics|mesh-ancestor
111386293|NCT00373581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111386294|NCT00373581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111386295|NCT00373581|Sensory System Agents|sensory system agents|mesh-ancestor
111386296|NCT00373581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111386297|NCT00373581|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111386298|NCT00373581|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111386299|NCT00373581|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111386300|NCT00373581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111386301|NCT00373581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111386302|NCT00373581|Dopamine Agents|dopamine agents|mesh-ancestor
111386303|NCT00373581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111386304|NCT00373581|Anticonvulsants|anticonvulsants|mesh-ancestor
111386305|NCT00373581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111386306|NCT00373581|GABA Agents|gaba agents|mesh-ancestor
111386307|NCT01470170|Alfentanil|alfentanil|mesh-list
111386308|NCT01470170|Propofol|propofol|mesh-list
111386309|NCT01470170|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111386310|NCT01470170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111386311|NCT01470170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111386312|NCT01470170|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111386313|NCT01470170|Anesthetics, General|anesthetics, general|mesh-ancestor
111386314|NCT01470170|Anesthetics|anesthetics|mesh-ancestor
111386315|NCT01470170|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111386316|NCT01470170|Narcotics|narcotics|mesh-ancestor
111386317|NCT01470170|Analgesics|analgesics|mesh-ancestor
111386318|NCT01470170|Sensory System Agents|sensory system agents|mesh-ancestor
111386319|NCT01470170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111386320|NCT04311567|Methotrexate|methotrexate|mesh-list
111386321|NCT04311567|Tofacitinib|tofacitinib|mesh-list
111386322|NCT04311567|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111386323|NCT04311567|Abortifacient Agents|abortifacient agents|mesh-ancestor
111386324|NCT04311567|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111386325|NCT04311567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111386326|NCT04311567|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111386327|NCT04311567|Antimetabolites|antimetabolites|mesh-ancestor
111386328|NCT04311567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111386329|NCT04311567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111386330|NCT04311567|Dermatologic Agents|dermatologic agents|mesh-ancestor
111110732|NCT03169777|Vitamins|vitamins|mesh-ancestor
111386331|NCT04311567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111386332|NCT04311567|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111386333|NCT04311567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111386334|NCT04311567|Immunologic Factors|immunologic factors|mesh-ancestor
111386335|NCT04311567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111386336|NCT04311567|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111386337|NCT04311567|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
111386338|NCT04311567|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111386339|NCT04259775|Insulin|insulin|mesh-list
111386340|NCT04259775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111386341|NCT04259775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111386342|NCT05037825|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
111386343|NCT05037825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111386344|NCT05037825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111386345|NCT05037825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111386346|NCT01573052|Chlordiazepoxide|chlordiazepoxide|mesh-list
111386347|NCT01573052|Gabapentin|gabapentin|mesh-list
111386348|NCT01573052|Analgesics|analgesics|mesh-ancestor
111386349|NCT01573052|Sensory System Agents|sensory system agents|mesh-ancestor
111386350|NCT01573052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111386351|NCT01573052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111386352|NCT01573052|Anticonvulsants|anticonvulsants|mesh-ancestor
111386353|NCT01573052|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111386354|NCT01573052|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111386355|NCT01573052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111386356|NCT01573052|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111386357|NCT01573052|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111386358|NCT01573052|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111386359|NCT01573052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111386360|NCT01573052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111386361|NCT01573052|Antimanic Agents|antimanic agents|mesh-ancestor
111386362|NCT01573052|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111386363|NCT01573052|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111386364|NCT01573052|GABA Modulators|gaba modulators|mesh-ancestor
111386365|NCT01573052|GABA Agents|gaba agents|mesh-ancestor
111386366|NCT01521260|Chlorhexidine|chlorhexidine|mesh-list
111386367|NCT01521260|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111386368|NCT01521260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111386369|NCT01521260|Disinfectants|disinfectants|mesh-ancestor
111386370|NCT01523834|Panobinostat|panobinostat|mesh-list
111386371|NCT01523834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111386372|NCT01523834|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111386373|NCT01523834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111386374|NCT01523834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111386375|NCT01472432|Vildagliptin|vildagliptin|mesh-list
111386376|NCT01472432|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111386377|NCT01472432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111386378|NCT01472432|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111386379|NCT01472432|Protease Inhibitors|protease inhibitors|mesh-ancestor
111386380|NCT01472432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111386381|NCT01472432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111386382|NCT01524302|Levofloxacin|levofloxacin|mesh-list
111386383|NCT01524302|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
111386384|NCT01524302|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111386385|NCT01524302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111386386|NCT01524302|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111386387|NCT01524302|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111386388|NCT01524302|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111386389|NCT01524302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111386390|NCT01524302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111386391|NCT01524302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111386392|NCT01524302|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110526371|NCT02773316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111386393|NCT01524302|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111386394|NCT02802111|Albuterol|albuterol|mesh-list
111386395|NCT02802111|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111386396|NCT02802111|Autonomic Agents|autonomic agents|mesh-ancestor
111386397|NCT02802111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111386398|NCT02802111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111386399|NCT02802111|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111386400|NCT02802111|Respiratory System Agents|respiratory system agents|mesh-ancestor
111386401|NCT02802111|Tocolytic Agents|tocolytic agents|mesh-ancestor
111386402|NCT02802111|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111386403|NCT02802111|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111386404|NCT02802111|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111386405|NCT02802111|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111386406|NCT02802111|Adrenergic Agents|adrenergic agents|mesh-ancestor
111386407|NCT02802111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111386408|NCT02802111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111386409|NCT01576874|Oxytocin|oxytocin|mesh-list
111386410|NCT01576874|Oxytocics|oxytocics|mesh-ancestor
111386411|NCT01576874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111386412|NCT01576874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111386413|NCT01576952|Bromfenac|bromfenac|mesh-list
111386414|NCT01576952|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111386415|NCT01576952|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111386416|NCT01576952|Analgesics|analgesics|mesh-ancestor
111386417|NCT01576952|Sensory System Agents|sensory system agents|mesh-ancestor
111386418|NCT01576952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111386419|NCT01576952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111386420|NCT01576952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111386421|NCT01576952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111386422|NCT01577966|Sulfasalazine|sulfasalazine|mesh-list
111386423|NCT01577966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111386424|NCT01577966|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111386425|NCT01577966|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111386426|NCT01577966|Analgesics|analgesics|mesh-ancestor
111386427|NCT01577966|Sensory System Agents|sensory system agents|mesh-ancestor
111386428|NCT01577966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111386429|NCT01577966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111386430|NCT01577966|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111386431|NCT01577966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111386432|NCT01577966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111386433|NCT02345226|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
111386434|NCT02345226|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111386435|NCT02345226|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111386436|NCT02345226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111386437|NCT02345226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111386438|NCT02345226|Antiviral Agents|antiviral agents|mesh-ancestor
111386439|NCT02345226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111386440|NCT02345226|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111386441|NCT02345226|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111386442|NCT02802501|Primaquine|primaquine|mesh-list
111386443|NCT02802501|Piperaquine|piperaquine|mesh-list
111386444|NCT02802501|Artenimol|artenimol|mesh-list
111386445|NCT02802501|Tafenoquine|tafenoquine|mesh-list
111386446|NCT02802501|Antimalarials|antimalarials|mesh-ancestor
111386447|NCT02802501|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111386448|NCT02802501|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111386449|NCT02802501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111386450|NCT01528592|Levodopa|levodopa|mesh-list
111386451|NCT01528592|Carbidopa|carbidopa|mesh-list
111386452|NCT01528592|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
111386453|NCT01528592|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111386454|NCT01528592|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111386455|NCT01528592|Dopamine Agents|dopamine agents|mesh-ancestor
111386456|NCT01528592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111386457|NCT01528592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111386458|NCT01528592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111386459|NCT01528592|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
111386460|NCT01528592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111386461|NCT01528592|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111386462|NCT01528592|Immunologic Factors|immunologic factors|mesh-ancestor
111386463|NCT01528592|Dopamine Agonists|dopamine agonists|mesh-ancestor
111386464|NCT01578278|Fluticasone|fluticasone|mesh-list
111386465|NCT01578278|Xhance|xhance|mesh-list
111386466|NCT01578278|Bepotastine besilate|bepotastine besilate|mesh-list
111386467|NCT01578278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111386468|NCT01578278|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111386469|NCT01578278|Autonomic Agents|autonomic agents|mesh-ancestor
111386470|NCT01578278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111386471|NCT01578278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111386472|NCT01578278|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111386473|NCT01578278|Respiratory System Agents|respiratory system agents|mesh-ancestor
111386474|NCT01578278|Dermatologic Agents|dermatologic agents|mesh-ancestor
111386475|NCT01578278|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111386476|NCT02803749|Buspirone|buspirone|mesh-list
111386477|NCT02803749|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111386478|NCT02803749|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111110885|NCT02393599|Dopamine Agents|dopamine agents|mesh-ancestor
111386479|NCT02803749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111386480|NCT02803749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111386481|NCT02803749|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111386482|NCT02803749|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111386483|NCT02803749|Serotonin Agents|serotonin agents|mesh-ancestor
111386484|NCT02803749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111386485|NCT02803749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111386486|NCT01578980|Pancrelipase|pancrelipase|mesh-list
111386487|NCT01578980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111386488|NCT01529060|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
111386489|NCT01529060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111386490|NCT00372879|Vitamin E|vitamin e|mesh-list
111386491|NCT00372879|Vitamins|vitamins|mesh-ancestor
111386492|NCT00372879|Micronutrients|micronutrients|mesh-ancestor
111386493|NCT00372879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111386494|NCT00372879|Antioxidants|antioxidants|mesh-ancestor
111386495|NCT00372879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111386496|NCT00372879|Protective Agents|protective agents|mesh-ancestor
111386497|NCT02806869|Ibuprofen|ibuprofen|mesh-list
111386498|NCT02806869|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111386499|NCT02806869|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111386500|NCT02806869|Analgesics|analgesics|mesh-ancestor
111386501|NCT02806869|Sensory System Agents|sensory system agents|mesh-ancestor
111386502|NCT02806869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111386503|NCT02806869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111386504|NCT02806869|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111386505|NCT02806869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111386506|NCT02806869|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111386507|NCT02806869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111386508|NCT02806869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111386509|NCT03910101|Botulinum Toxins|botulinum toxins|mesh-list
111386510|NCT03910101|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111386511|NCT03910101|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111386512|NCT03910101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111386513|NCT03910101|Cholinergic Agents|cholinergic agents|mesh-ancestor
111386514|NCT03910101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111386515|NCT03910101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111386516|NCT02813265|Loteprednol Etabonate|loteprednol etabonate|mesh-list
111386517|NCT02813265|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111386518|NCT05564858|Antibodies|antibodies|mesh-list
110526513|NCT00643227|Azithromycin|azithromycin|mesh-list
111386519|NCT05564858|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111386520|NCT05564858|Immunoconjugates|immunoconjugates|mesh-list
111386521|NCT05564858|Immunologic Factors|immunologic factors|mesh-ancestor
111386522|NCT05564858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111386523|NCT02814279|Dipyrone|dipyrone|mesh-list
111386524|NCT02814279|Chlorhexidine|chlorhexidine|mesh-list
111386525|NCT02814279|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111386526|NCT02814279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111386527|NCT02814279|Disinfectants|disinfectants|mesh-ancestor
111386528|NCT02814279|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111386529|NCT02814279|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111386530|NCT02814279|Analgesics|analgesics|mesh-ancestor
111386531|NCT02814279|Sensory System Agents|sensory system agents|mesh-ancestor
111386532|NCT02814279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111386533|NCT02814279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111386534|NCT02814279|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111386535|NCT02814279|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111386536|NCT02814279|Antipyretics|antipyretics|mesh-ancestor
111386537|NCT00373659|Ranibizumab|ranibizumab|mesh-list
111386538|NCT00373659|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111386539|NCT00373659|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111386540|NCT00373659|Growth Substances|growth substances|mesh-ancestor
111386541|NCT00373659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111386542|NCT00373659|Growth Inhibitors|growth inhibitors|mesh-ancestor
111386543|NCT00373659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111386544|NCT02885025|Fluticasone|fluticasone|mesh-list
111386545|NCT02885025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111386546|NCT02885025|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111386547|NCT02885025|Autonomic Agents|autonomic agents|mesh-ancestor
111386548|NCT02885025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111386549|NCT02885025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111386550|NCT02885025|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111386551|NCT02885025|Respiratory System Agents|respiratory system agents|mesh-ancestor
111386552|NCT02885025|Dermatologic Agents|dermatologic agents|mesh-ancestor
111386553|NCT02885025|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111386554|NCT01580618|Tenecteplase|tenecteplase|mesh-list
111386555|NCT01580618|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111386556|NCT01580618|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111386557|NCT01580618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111386558|NCT01581710|Montelukast|montelukast|mesh-list
111386559|NCT01581710|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111386560|NCT01581710|Respiratory System Agents|respiratory system agents|mesh-ancestor
111386561|NCT01581710|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
111386562|NCT01581710|Hormone Antagonists|hormone antagonists|mesh-ancestor
111386563|NCT01581710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111386564|NCT01581710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111386565|NCT01581710|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
111386566|NCT01581710|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111386567|NCT01581710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111386568|NCT01582490|Bupivacaine|bupivacaine|mesh-list
111386569|NCT01582490|Anesthetics, Local|anesthetics, local|mesh-ancestor
111386570|NCT01582490|Anesthetics|anesthetics|mesh-ancestor
111386571|NCT01582490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111386572|NCT01582490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111386573|NCT01582490|Sensory System Agents|sensory system agents|mesh-ancestor
111386574|NCT01582490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111386575|NCT01582880|Riboflavin|riboflavin|mesh-list
111386576|NCT01582880|Vitamins|vitamins|mesh-ancestor
111386577|NCT01582880|Micronutrients|micronutrients|mesh-ancestor
111386578|NCT01582880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111386579|NCT01582880|Vitamin B Complex|vitamin b complex|mesh-ancestor
111386580|NCT01582880|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111386581|NCT01582880|Dermatologic Agents|dermatologic agents|mesh-ancestor
111386582|NCT02889393|Teduglutide|teduglutide|mesh-list
111386583|NCT02889393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111386584|NCT02889393|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111386585|NCT02889393|Protective Agents|protective agents|mesh-ancestor
111386586|NCT02889393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111386587|NCT02818569|Dexmedetomidine|dexmedetomidine|mesh-list
111386588|NCT02818569|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111386589|NCT02818569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111386590|NCT02818569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111386591|NCT02818569|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111386592|NCT02818569|Analgesics|analgesics|mesh-ancestor
111386593|NCT02818569|Sensory System Agents|sensory system agents|mesh-ancestor
111386594|NCT02818569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111386595|NCT02818569|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111386596|NCT02818569|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111386597|NCT02818569|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111386598|NCT02818569|Adrenergic Agents|adrenergic agents|mesh-ancestor
111386599|NCT02818569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111386600|NCT02818569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111386601|NCT03581409|Aspirin|aspirin|mesh-list
111386602|NCT03581409|Cilostazol|cilostazol|mesh-list
111386603|NCT03581409|Clopidogrel|clopidogrel|mesh-list
111386604|NCT03581409|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
111386605|NCT03581409|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111386606|NCT03581409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111386607|NCT03581409|Analgesics|analgesics|mesh-ancestor
111386608|NCT03581409|Sensory System Agents|sensory system agents|mesh-ancestor
111386609|NCT03581409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111386610|NCT03581409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111386611|NCT03581409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111386612|NCT03581409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111386613|NCT03581409|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111386614|NCT03581409|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111386615|NCT03581409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111386616|NCT03581409|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111386617|NCT03581409|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111386618|NCT03581409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111386619|NCT03581409|Antipyretics|antipyretics|mesh-ancestor
111386620|NCT03581409|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111386621|NCT03581409|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111386622|NCT03581409|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111386623|NCT03581409|Purinergic Agents|purinergic agents|mesh-ancestor
111386624|NCT03581409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111386625|NCT03581409|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111386626|NCT03581409|Autonomic Agents|autonomic agents|mesh-ancestor
111386627|NCT03581409|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111386628|NCT03581409|Respiratory System Agents|respiratory system agents|mesh-ancestor
111386629|NCT03581409|Vasodilator Agents|vasodilator agents|mesh-ancestor
111386630|NCT03581409|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111386631|NCT03581409|Protective Agents|protective agents|mesh-ancestor
111386632|NCT03581409|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
111386633|NCT03581409|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111386634|NCT01533116|Levodopa|levodopa|mesh-list
111386635|NCT01533116|Carbidopa|carbidopa|mesh-list
111386636|NCT01533116|Opicapone|opicapone|mesh-list
111386637|NCT01533116|Benserazide|benserazide|mesh-list
111386638|NCT01533116|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111386639|NCT01533116|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111386640|NCT01533116|Dopamine Agents|dopamine agents|mesh-ancestor
111386641|NCT01533116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111386642|NCT01533116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111386643|NCT01533116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111386644|NCT01533116|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
111386645|NCT01533116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111386646|NCT01533116|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
111386647|NCT03510741|Acetylcysteine|acetylcysteine|mesh-list
111386648|NCT03510741|Sodium Benzoate|sodium benzoate|mesh-list
111386649|NCT03510741|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111386650|NCT03510741|Antiviral Agents|antiviral agents|mesh-ancestor
111386651|NCT03510741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111386652|NCT03510741|Expectorants|expectorants|mesh-ancestor
111386653|NCT03510741|Respiratory System Agents|respiratory system agents|mesh-ancestor
111386654|NCT03510741|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111386655|NCT03510741|Antioxidants|antioxidants|mesh-ancestor
111386656|NCT03510741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111386657|NCT03510741|Protective Agents|protective agents|mesh-ancestor
111386658|NCT03510741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111386659|NCT03510741|Antidotes|antidotes|mesh-ancestor
111386660|NCT03510741|Antifungal Agents|antifungal agents|mesh-ancestor
111386661|NCT05556044|Empagliflozin|empagliflozin|mesh-list
111386662|NCT05556044|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111386663|NCT05556044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111386664|NCT05556044|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111386665|NCT05556044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111386666|NCT01584518|Furosemide|furosemide|mesh-list
111386667|NCT01584518|Diuretics|diuretics|mesh-ancestor
111386668|NCT01584518|Natriuretic Agents|natriuretic agents|mesh-ancestor
111386669|NCT01584518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111386670|NCT01584518|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
111386671|NCT01584518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111386672|NCT01584518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111386673|NCT02901249|Lithium Carbonate|lithium carbonate|mesh-list
111386674|NCT02901249|Sertraline|sertraline|mesh-list
111386675|NCT02901249|Nortriptyline|nortriptyline|mesh-list
111386676|NCT02901249|Antidepressive Agents|antidepressive agents|mesh-ancestor
111386677|NCT02901249|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111386678|NCT02901249|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111386679|NCT02901249|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111386680|NCT02901249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111386681|NCT02901249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111386682|NCT02901249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111386683|NCT02901249|Serotonin Agents|serotonin agents|mesh-ancestor
111386684|NCT02901249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111386685|NCT02901249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111386686|NCT02901249|Antimanic Agents|antimanic agents|mesh-ancestor
111386687|NCT02901249|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111386688|NCT02901249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111386689|NCT02901249|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
111386690|NCT02901249|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111386691|NCT02901249|Adrenergic Agents|adrenergic agents|mesh-ancestor
111386692|NCT02212028|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
111386693|NCT02212028|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111386694|NCT00373815|Everolimus|everolimus|mesh-list
111386695|NCT00373815|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111386696|NCT00373815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111386697|NCT00373815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111386698|NCT00373815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111386699|NCT00373815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111386700|NCT00373815|Immunologic Factors|immunologic factors|mesh-ancestor
110526709|NCT04177875|Paclitaxel|paclitaxel|mesh-list
111386701|NCT00373815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111386702|NCT00373815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111386703|NCT01586312|Hyaluronic Acid|hyaluronic acid|mesh-list
111386704|NCT01586312|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111386705|NCT01586312|Immunologic Factors|immunologic factors|mesh-ancestor
111386706|NCT01586312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111386707|NCT01586312|Viscosupplements|viscosupplements|mesh-ancestor
111386708|NCT01586312|Protective Agents|protective agents|mesh-ancestor
111386709|NCT00373893|Lidocaine|lidocaine|mesh-list
111386710|NCT00373893|Anesthetics, Local|anesthetics, local|mesh-ancestor
111386711|NCT00373893|Anesthetics|anesthetics|mesh-ancestor
111386712|NCT00373893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111386713|NCT00373893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111386714|NCT00373893|Sensory System Agents|sensory system agents|mesh-ancestor
111386715|NCT00373893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111386716|NCT00373893|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111386717|NCT00373893|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111386718|NCT00373893|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111386719|NCT00373893|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111386720|NCT00373893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111386721|NCT02977299|Aripiprazole|aripiprazole|mesh-list
111386722|NCT02977299|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
111386723|NCT02977299|Antidepressive Agents|antidepressive agents|mesh-ancestor
111386724|NCT02977299|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111386725|NCT02977299|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111386726|NCT02977299|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111386727|NCT02977299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111386728|NCT02977299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111386729|NCT02977299|Dopamine Agonists|dopamine agonists|mesh-ancestor
111386730|NCT02977299|Dopamine Agents|dopamine agents|mesh-ancestor
111386731|NCT02977299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111386732|NCT02977299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111386733|NCT02977299|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111386734|NCT02977299|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111386735|NCT02977299|Serotonin Agents|serotonin agents|mesh-ancestor
111386736|NCT02977299|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111386737|NCT02977299|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111386738|NCT02977299|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111386739|NCT02977299|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111386740|NCT02977299|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111386741|NCT02977299|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111386742|NCT02977299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111386743|NCT02977299|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111386744|NCT02212106|Vaccines|vaccines|mesh-list
111386745|NCT02212106|Immunologic Factors|immunologic factors|mesh-ancestor
111386746|NCT02212106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111386747|NCT02903121|Tamoxifen|tamoxifen|mesh-list
111386748|NCT02903121|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111386749|NCT02903121|Hormone Antagonists|hormone antagonists|mesh-ancestor
111386750|NCT02903121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111386751|NCT02903121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111386752|NCT02903121|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111386753|NCT02903121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111386754|NCT02903121|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111386755|NCT02903121|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111386756|NCT02903121|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111386757|NCT02904915|Lidocaine|lidocaine|mesh-list
111386758|NCT02904915|Anesthetics, Local|anesthetics, local|mesh-ancestor
111386759|NCT02904915|Anesthetics|anesthetics|mesh-ancestor
111386760|NCT02904915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111386761|NCT02904915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111386762|NCT02904915|Sensory System Agents|sensory system agents|mesh-ancestor
111386763|NCT02904915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111386764|NCT02904915|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111386765|NCT02904915|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111386766|NCT02904915|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111386767|NCT02904915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111386768|NCT02904915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111386769|NCT02907489|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111386770|NCT02907489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
111386771|NCT02907489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111386772|NCT01535924|Gemcitabine|gemcitabine|mesh-list
111386773|NCT01535924|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
111386774|NCT01535924|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111386775|NCT01535924|Antimetabolites|antimetabolites|mesh-ancestor
111386776|NCT01535924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111386777|NCT01535924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111386778|NCT01535924|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111386779|NCT01535924|Alkylating Agents|alkylating agents|mesh-ancestor
111386780|NCT02909439|Neostigmine|neostigmine|mesh-list
111386781|NCT02909439|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111386782|NCT02909439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111386783|NCT02909439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111386784|NCT02909439|Cholinergic Agents|cholinergic agents|mesh-ancestor
111386785|NCT02909439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111386786|NCT02909439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111386787|NCT02909439|Parasympathomimetics|parasympathomimetics|mesh-ancestor
111386788|NCT02909439|Autonomic Agents|autonomic agents|mesh-ancestor
111386789|NCT02909439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111386790|NCT01536938|Calcitriol|calcitriol|mesh-list
111386791|NCT01536938|Betamethasone|betamethasone|mesh-list
111386792|NCT01536938|Betamethasone Valerate|betamethasone valerate|mesh-list
111386793|NCT01536938|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
111386794|NCT01536938|Betamethasone benzoate|betamethasone benzoate|mesh-list
111386795|NCT01536938|Calcipotriene|calcipotriene|mesh-list
111386796|NCT01536938|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
111386797|NCT01536938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111386798|NCT01536938|Glucocorticoids|glucocorticoids|mesh-ancestor
111386799|NCT01536938|Hormones|hormones|mesh-ancestor
111386800|NCT01536938|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111386801|NCT01536938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111386802|NCT01536938|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111386803|NCT01536938|Respiratory System Agents|respiratory system agents|mesh-ancestor
111386804|NCT01536938|Dermatologic Agents|dermatologic agents|mesh-ancestor
111386805|NCT01536938|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111386806|NCT01536938|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
111386807|NCT01536938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111386808|NCT01536938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111386809|NCT01536938|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111386810|NCT01536938|Vitamins|vitamins|mesh-ancestor
111386811|NCT01536938|Micronutrients|micronutrients|mesh-ancestor
111386812|NCT01536938|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111386813|NCT01588418|Exenatide|exenatide|mesh-list
110526818|NCT00915473|Antiemetics|antiemetics|mesh-ancestor
111386814|NCT01588418|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111386815|NCT01588418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111386816|NCT01588418|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111386817|NCT01588418|Incretins|incretins|mesh-ancestor
111386818|NCT01588418|Hormones|hormones|mesh-ancestor
111386819|NCT01588418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111386820|NCT03007160|Potassium Citrate|potassium citrate|mesh-list
111386821|NCT03007160|Diuretics|diuretics|mesh-ancestor
111386822|NCT03007160|Natriuretic Agents|natriuretic agents|mesh-ancestor
111386823|NCT03007160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111386824|NCT03007160|Expectorants|expectorants|mesh-ancestor
111386825|NCT03007160|Respiratory System Agents|respiratory system agents|mesh-ancestor
111386826|NCT03007004|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
111386827|NCT03007004|Botulinum Toxins|botulinum toxins|mesh-list
111386828|NCT03007004|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111386829|NCT03007004|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111386830|NCT03007004|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111386831|NCT03007004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111386832|NCT03007004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111386833|NCT03007004|Cholinergic Agents|cholinergic agents|mesh-ancestor
111386834|NCT03007004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111386835|NCT03007004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111386836|NCT03007004|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111386837|NCT03007004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111386838|NCT03007004|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111386839|NCT02914119|Rocuronium|rocuronium|mesh-list
111386840|NCT02914119|Mivacurium|mivacurium|mesh-list
111386841|NCT02914119|Cisatracurium|cisatracurium|mesh-list
111386842|NCT02914119|Succinylcholine|succinylcholine|mesh-list
111386843|NCT02914119|Neostigmine|neostigmine|mesh-list
111386844|NCT02914119|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
111386845|NCT02914119|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
111386846|NCT02914119|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111386847|NCT02914119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111386848|NCT02914119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111386849|NCT02914119|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111386850|NCT02914119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111386851|NCT02914119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111386852|NCT02914119|Cholinergic Agents|cholinergic agents|mesh-ancestor
111386853|NCT02914119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111386854|NCT02914119|Parasympathomimetics|parasympathomimetics|mesh-ancestor
111386855|NCT02914119|Autonomic Agents|autonomic agents|mesh-ancestor
111386856|NCT02914119|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
111386857|NCT01589510|Bimatoprost|bimatoprost|mesh-list
111386858|NCT01589510|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111386859|NCT01589510|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111386860|NCT01589510|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111386861|NCT02914509|Travoprost|travoprost|mesh-list
111386862|NCT02914509|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111386863|NCT02840097|Tranexamic Acid|tranexamic acid|mesh-list
111386864|NCT02840097|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111386865|NCT02840097|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111386866|NCT02840097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111386867|NCT02840097|Hemostatics|hemostatics|mesh-ancestor
111386868|NCT02840097|Coagulants|coagulants|mesh-ancestor
111386869|NCT02841033|Daratumumab|daratumumab|mesh-list
111386870|NCT02841033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111386871|NCT02988089|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111386872|NCT02988089|Amoxicillin|amoxicillin|mesh-list
111386873|NCT02988089|Metronidazole|metronidazole|mesh-list
111386874|NCT02988089|Clarithromycin|clarithromycin|mesh-list
111386875|NCT02988089|Levofloxacin|levofloxacin|mesh-list
111386876|NCT02988089|Ofloxacin|ofloxacin|mesh-list
111386877|NCT02988089|Tetracycline|tetracycline|mesh-list
111386878|NCT02988089|Tinidazole|tinidazole|mesh-list
111386879|NCT02988089|Furazolidone|furazolidone|mesh-list
111386880|NCT02988089|Bismuth|bismuth|mesh-list
111386881|NCT02988089|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
111386882|NCT02988089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111386883|NCT02988089|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111386884|NCT02988089|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111386885|NCT02988089|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111386886|NCT02988089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111386887|NCT02988089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111386888|NCT02988089|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111386889|NCT02988089|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111386890|NCT02988089|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111386891|NCT02988089|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111386892|NCT02988089|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111386893|NCT02988089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111386894|NCT02988089|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111386895|NCT02988089|Antacids|antacids|mesh-ancestor
111386896|NCT02988089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111386897|NCT02988089|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111386898|NCT02988089|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
111386899|NCT02988089|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
111386900|NCT02988089|Alkylating Agents|alkylating agents|mesh-ancestor
111386901|NCT02430233|Progesterone|progesterone|mesh-list
111386902|NCT02430233|Progestins|progestins|mesh-ancestor
111386903|NCT02430233|Hormones|hormones|mesh-ancestor
111386904|NCT02430233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111386905|NCT02430233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111386906|NCT01589978|Aspirin|aspirin|mesh-list
111386907|NCT01589978|Salicylic Acid|salicylic acid|mesh-list
111386908|NCT01589978|Salicylates|salicylates|mesh-list
111386909|NCT01589978|Ticlopidine|ticlopidine|mesh-list
111386910|NCT01589978|Clopidogrel|clopidogrel|mesh-list
111386911|NCT01589978|Ticagrelor|ticagrelor|mesh-list
111386912|NCT01589978|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
111386913|NCT01589978|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111386914|NCT01589978|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111386915|NCT01589978|Analgesics|analgesics|mesh-ancestor
111386916|NCT01589978|Sensory System Agents|sensory system agents|mesh-ancestor
111386917|NCT01589978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111386918|NCT01589978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111386919|NCT01589978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111386920|NCT01589978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111386921|NCT01589978|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111386922|NCT01589978|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111386923|NCT01589978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111386924|NCT01589978|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111386925|NCT01589978|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111386926|NCT01589978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111386927|NCT01589978|Antipyretics|antipyretics|mesh-ancestor
111386928|NCT01589978|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111386929|NCT01589978|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111386930|NCT01589978|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111386931|NCT01589978|Purinergic Agents|purinergic agents|mesh-ancestor
111386932|NCT01589978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111386933|NCT01589978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111386934|NCT01589978|Antifungal Agents|antifungal agents|mesh-ancestor
111386935|NCT01589978|Keratolytic Agents|keratolytic agents|mesh-ancestor
111386936|NCT01589978|Dermatologic Agents|dermatologic agents|mesh-ancestor
111386937|NCT01589978|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111386938|NCT01589978|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111386939|NCT01592006|Ribavirin|ribavirin|mesh-list
111386940|NCT01592006|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
111386941|NCT01592006|Antimetabolites|antimetabolites|mesh-ancestor
111386942|NCT01592006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111386943|NCT01592006|Antiviral Agents|antiviral agents|mesh-ancestor
111386944|NCT01592006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111386945|NCT00551291|Mycophenolic Acid|mycophenolic acid|mesh-list
111386946|NCT00551291|Prednisone|prednisone|mesh-list
111386947|NCT00551291|Epoetin Alfa|epoetin alfa|mesh-list
111386948|NCT00551291|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111386949|NCT00551291|Glucocorticoids|glucocorticoids|mesh-ancestor
111386950|NCT00551291|Hormones|hormones|mesh-ancestor
111386951|NCT00551291|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111386952|NCT00551291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111386953|NCT00551291|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111386954|NCT00551291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111386955|NCT00551291|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111386956|NCT00551291|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111386957|NCT00551291|Antitubercular Agents|antitubercular agents|mesh-ancestor
111386958|NCT00551291|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111386959|NCT00551291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111386960|NCT00551291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111386961|NCT00551291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111386962|NCT00551291|Hematinics|hematinics|mesh-ancestor
111386963|NCT02981264|Lidocaine|lidocaine|mesh-list
111386964|NCT02981264|Anesthetics, Local|anesthetics, local|mesh-ancestor
111386965|NCT02981264|Anesthetics|anesthetics|mesh-ancestor
111386966|NCT02981264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111386967|NCT02981264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111386968|NCT02981264|Sensory System Agents|sensory system agents|mesh-ancestor
111386969|NCT02981264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111386970|NCT02981264|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111386971|NCT02981264|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111386972|NCT02981264|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111386973|NCT02981264|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111386974|NCT02981264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111386975|NCT01593722|Ivermectin|ivermectin|mesh-list
111386976|NCT01593722|Diethylcarbamazine|diethylcarbamazine|mesh-list
111386977|NCT01593722|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111386978|NCT01593722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111386979|NCT01593722|Filaricides|filaricides|mesh-ancestor
111386980|NCT01593722|Antinematodal Agents|antinematodal agents|mesh-ancestor
111386981|NCT01593722|Anthelmintics|anthelmintics|mesh-ancestor
111386982|NCT01593722|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
111386983|NCT01593722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111386984|NCT01593722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111386985|NCT01594424|Immunoglobulins|immunoglobulins|mesh-list
111386986|NCT01594424|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111386987|NCT01594424|Antibodies|antibodies|mesh-list
111386988|NCT01594424|gamma-Globulins|gamma-globulins|mesh-list
111386989|NCT01594424|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
111386990|NCT01594424|Immunologic Factors|immunologic factors|mesh-ancestor
111386991|NCT01594424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111386992|NCT01595282|Ibuprofen|ibuprofen|mesh-list
111386993|NCT01595282|Ketorolac|ketorolac|mesh-list
111386994|NCT01595282|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111386995|NCT01595282|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111386996|NCT01595282|Analgesics|analgesics|mesh-ancestor
111386997|NCT01595282|Sensory System Agents|sensory system agents|mesh-ancestor
111386998|NCT01595282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111386999|NCT01595282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111387000|NCT01595282|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111387001|NCT01595282|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111387002|NCT01595282|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111387003|NCT01595282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111111410|NCT04718389|Benralizumab|benralizumab|mesh-list
111387004|NCT01595282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111387006|NCT01595516|Nebivolol|nebivolol|mesh-list
111387007|NCT01595516|Bradykinin|bradykinin|mesh-list
111387008|NCT01595516|Kininogens|kininogens|mesh-list
111387009|NCT01595516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111387010|NCT01595516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111387011|NCT01595516|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111387012|NCT01595516|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111387013|NCT01595516|Sympatholytics|sympatholytics|mesh-ancestor
111387014|NCT01595516|Autonomic Agents|autonomic agents|mesh-ancestor
111387015|NCT01595516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111387016|NCT01595516|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
111387017|NCT01595516|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111387018|NCT01595516|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111387019|NCT01595516|Adrenergic Agents|adrenergic agents|mesh-ancestor
111387020|NCT01595516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111387021|NCT01595516|Vasodilator Agents|vasodilator agents|mesh-ancestor
111387022|NCT01595516|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
111387023|NCT01595516|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111387024|NCT01595516|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111387025|NCT01595516|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
111387026|NCT01595516|Protease Inhibitors|protease inhibitors|mesh-ancestor
111387027|NCT01595516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111387028|NCT01596842|Cholecalciferol|cholecalciferol|mesh-list
111387029|NCT01596842|Vitamin D|vitamin d|mesh-list
111387030|NCT01596842|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111387031|NCT01596842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111387032|NCT01596842|Vitamins|vitamins|mesh-ancestor
111387033|NCT01596842|Micronutrients|micronutrients|mesh-ancestor
111387034|NCT01596842|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111387035|NCT02217800|Octreotide|octreotide|mesh-list
111387036|NCT02217800|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111387037|NCT02217800|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111387038|NCT02217800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111387039|NCT02218190|Alvimopan|alvimopan|mesh-list
111387040|NCT02218190|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111387041|NCT03006614|Cisplatin|cisplatin|mesh-list
111387042|NCT03006614|Gemcitabine|gemcitabine|mesh-list
111387043|NCT03006614|Docetaxel|docetaxel|mesh-list
111387044|NCT03006614|Capecitabine|capecitabine|mesh-list
111387045|NCT03006614|Trastuzumab|trastuzumab|mesh-list
111387046|NCT03006614|Vinorelbine|vinorelbine|mesh-list
111387047|NCT03006614|Epirubicin|epirubicin|mesh-list
111387048|NCT03006614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111387049|NCT03006614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111387050|NCT03006614|Antimetabolites|antimetabolites|mesh-ancestor
111387051|NCT03006614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111387052|NCT03006614|Tubulin Modulators|tubulin modulators|mesh-ancestor
111387053|NCT03006614|Antimitotic Agents|antimitotic agents|mesh-ancestor
111387054|NCT03006614|Mitosis Modulators|mitosis modulators|mesh-ancestor
111387055|NCT03006614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111387056|NCT03006614|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111387057|NCT03006614|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111387058|NCT03006614|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111387059|NCT03006614|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111387060|NCT03006614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111387061|NCT03001466|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111387062|NCT03001466|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111387063|NCT03006380|Oxytocin|oxytocin|mesh-list
111387064|NCT03006380|Oxytocics|oxytocics|mesh-ancestor
111387065|NCT03006380|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111387066|NCT03006380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111387067|NCT02981030|Misoprostol|misoprostol|mesh-list
111387068|NCT02981030|Mifepristone|mifepristone|mesh-list
111387069|NCT02981030|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111387070|NCT02981030|Abortifacient Agents|abortifacient agents|mesh-ancestor
111387071|NCT02981030|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111387072|NCT02981030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111387073|NCT02981030|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111387074|NCT02981030|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111387075|NCT02981030|Oxytocics|oxytocics|mesh-ancestor
111387076|NCT02981030|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
111387077|NCT02981030|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111387078|NCT02981030|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111387079|NCT02981030|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111387080|NCT02981030|Contraceptive Agents|contraceptive agents|mesh-ancestor
111387081|NCT02981030|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
111387082|NCT02981030|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
111387083|NCT02981030|Hormone Antagonists|hormone antagonists|mesh-ancestor
111387084|NCT02981030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111387085|NCT02981030|Luteolytic Agents|luteolytic agents|mesh-ancestor
111387086|NCT02981030|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111387087|NCT02981030|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
111387088|NCT03006146|Molgramostim|molgramostim|mesh-list
111387089|NCT03006146|Sargramostim|sargramostim|mesh-list
111387090|NCT03006146|Immunologic Factors|immunologic factors|mesh-ancestor
111387091|NCT03006146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111387092|NCT03006146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111387093|NCT00551213|Capecitabine|capecitabine|mesh-list
111387094|NCT00551213|Irinotecan|irinotecan|mesh-list
111387095|NCT00551213|Cetuximab|cetuximab|mesh-list
111387096|NCT00551213|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111387097|NCT00551213|Antimetabolites|antimetabolites|mesh-ancestor
111387098|NCT00551213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111387099|NCT00551213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111387100|NCT00551213|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111387101|NCT00551213|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111387102|NCT00551213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111387103|NCT00551213|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111387104|NCT01999361|Mycophenolic Acid|mycophenolic acid|mesh-list
111387105|NCT01999361|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111387106|NCT01999361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111387107|NCT01999361|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111387108|NCT01999361|Antitubercular Agents|antitubercular agents|mesh-ancestor
111387109|NCT01999361|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111387110|NCT01999361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111387111|NCT01999361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111387112|NCT01999361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111387113|NCT03006471|Dapagliflozin|dapagliflozin|mesh-list
111387114|NCT03006471|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111387115|NCT03006471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111387116|NCT03006471|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111387117|NCT03006471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111387118|NCT01684397|Bevacizumab|bevacizumab|mesh-list
111387119|NCT01684397|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111387120|NCT01684397|Endothelial Growth Factors|endothelial growth factors|mesh-list
111387121|NCT01684397|Antibodies|antibodies|mesh-list
111387122|NCT01684397|Immunoglobulins|immunoglobulins|mesh-list
111387123|NCT01684397|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111387124|NCT01684397|Immunoglobulin G|immunoglobulin g|mesh-list
111387125|NCT01684397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111387126|NCT01684397|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111387127|NCT01684397|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111387128|NCT01684397|Growth Substances|growth substances|mesh-ancestor
111387129|NCT01684397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111387130|NCT01684397|Growth Inhibitors|growth inhibitors|mesh-ancestor
111387131|NCT01684397|Immunologic Factors|immunologic factors|mesh-ancestor
111387132|NCT03005678|Denosumab|denosumab|mesh-list
111387133|NCT03005678|Alendronate|alendronate|mesh-list
111387134|NCT03005678|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111387135|NCT03005678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111387136|NCT03008889|Acetylcysteine|acetylcysteine|mesh-list
111387137|NCT03008889|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111387138|NCT03008889|Antiviral Agents|antiviral agents|mesh-ancestor
111387139|NCT03008889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111387140|NCT03008889|Expectorants|expectorants|mesh-ancestor
111387141|NCT03008889|Respiratory System Agents|respiratory system agents|mesh-ancestor
111387142|NCT03008889|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111387143|NCT03008889|Antioxidants|antioxidants|mesh-ancestor
111387144|NCT03008889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111387145|NCT03008889|Protective Agents|protective agents|mesh-ancestor
111387146|NCT03008889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111387147|NCT03008889|Antidotes|antidotes|mesh-ancestor
111387148|NCT04980482|Interferons|interferons|mesh-list
111387149|NCT04980482|Interferon-alpha|interferon-alpha|mesh-list
111387150|NCT04980482|Interferon alpha-2|interferon alpha-2|mesh-list
111387151|NCT04980482|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
111387152|NCT04980482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111387153|NCT04980482|Antiviral Agents|antiviral agents|mesh-ancestor
111111566|NCT05129033|Omalizumab|omalizumab|mesh-list
111387154|NCT04980482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111387155|NCT04980482|Immunologic Factors|immunologic factors|mesh-ancestor
110527141|NCT02764736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111387156|NCT04980482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111387157|NCT03005210|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
111387158|NCT03005210|Antiviral Agents|antiviral agents|mesh-ancestor
111387159|NCT03005210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111387160|NCT03000218|Metformin|metformin|mesh-list
111387161|NCT03000218|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
111387162|NCT03000218|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111387163|NCT03000218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111387164|NCT03000218|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
111387165|NCT03000218|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111387166|NCT03010683|Metformin|metformin|mesh-list
111387167|NCT03010683|Liraglutide|liraglutide|mesh-list
111387168|NCT03010683|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111387169|NCT03010683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111387170|NCT03010683|Incretins|incretins|mesh-ancestor
111387171|NCT03010683|Hormones|hormones|mesh-ancestor
111387172|NCT03010683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111387173|NCT04877678|Bepotastine besilate|bepotastine besilate|mesh-list
111387174|NCT04877678|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111387175|NCT02918097|Risperidone|risperidone|mesh-list
111387176|NCT02918097|Lithium Carbonate|lithium carbonate|mesh-list
111387177|NCT02918097|Sertraline|sertraline|mesh-list
111387178|NCT02918097|Nortriptyline|nortriptyline|mesh-list
111387179|NCT02918097|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111387180|NCT02918097|Serotonin Agents|serotonin agents|mesh-ancestor
111387181|NCT02918097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111387182|NCT02918097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111387183|NCT02918097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111387184|NCT02918097|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111387185|NCT02918097|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111387186|NCT02918097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111387187|NCT02918097|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111387188|NCT02918097|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111387189|NCT02918097|Dopamine Agents|dopamine agents|mesh-ancestor
111387190|NCT02918097|Antidepressive Agents|antidepressive agents|mesh-ancestor
111387191|NCT02918097|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111387192|NCT02918097|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111387193|NCT02918097|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111387194|NCT02918097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111387195|NCT02918097|Antimanic Agents|antimanic agents|mesh-ancestor
111387196|NCT02918097|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
111387197|NCT02918097|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111387198|NCT02918097|Adrenergic Agents|adrenergic agents|mesh-ancestor
111387199|NCT05408585|Anesthetics|anesthetics|mesh-list
111387200|NCT05408585|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111387201|NCT05408585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111387202|NCT02999204|Vitamin D|vitamin d|mesh-list
111387203|NCT02999204|Cholecalciferol|cholecalciferol|mesh-list
111387204|NCT02999204|Vitamins|vitamins|mesh-ancestor
111387205|NCT02999204|Micronutrients|micronutrients|mesh-ancestor
111387206|NCT02999204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111387207|NCT02999204|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111387208|NCT02999204|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111387209|NCT03012477|Adavosertib|adavosertib|mesh-list
111387210|NCT03012477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111387211|NCT03012477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111387212|NCT02919111|Edetic Acid|edetic acid|mesh-list
111387213|NCT02919111|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
111387214|NCT02919111|Chelating Agents|chelating agents|mesh-ancestor
111387215|NCT02919111|Sequestering Agents|sequestering agents|mesh-ancestor
111387216|NCT02919111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111387217|NCT02919111|Anticoagulants|anticoagulants|mesh-ancestor
111387218|NCT02919111|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
111387219|NCT02919111|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111387220|NCT02999126|Remifentanil|remifentanil|mesh-list
111387221|NCT02999126|Propofol|propofol|mesh-list
111387222|NCT02999126|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111387223|NCT02999126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111387224|NCT02999126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111387225|NCT02999126|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111387226|NCT02999126|Anesthetics, General|anesthetics, general|mesh-ancestor
111387227|NCT02999126|Anesthetics|anesthetics|mesh-ancestor
111387228|NCT02999126|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111387229|NCT02999126|Narcotics|narcotics|mesh-ancestor
111387230|NCT02999126|Analgesics|analgesics|mesh-ancestor
111387231|NCT02999126|Sensory System Agents|sensory system agents|mesh-ancestor
111387232|NCT02999126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111387233|NCT03019887|Methotrimeprazine|methotrimeprazine|mesh-list
111387234|NCT03019887|Haloperidol|haloperidol|mesh-list
111387235|NCT03019887|Olanzapine|olanzapine|mesh-list
111387236|NCT03019887|Risperidone|risperidone|mesh-list
111387237|NCT03019887|Aripiprazole|aripiprazole|mesh-list
111387238|NCT03019887|Quetiapine Fumarate|quetiapine fumarate|mesh-list
111387239|NCT03019887|Paliperidone Palmitate|paliperidone palmitate|mesh-list
111387240|NCT03019887|Haloperidol decanoate|haloperidol decanoate|mesh-list
111387241|NCT03019887|Perphenazine|perphenazine|mesh-list
111387242|NCT03019887|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111387243|NCT03019887|Serotonin Agents|serotonin agents|mesh-ancestor
111387244|NCT03019887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111387245|NCT03019887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111387246|NCT03019887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111387247|NCT03019887|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111387248|NCT03019887|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111387249|NCT03019887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111387250|NCT03019887|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111387251|NCT03019887|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111387252|NCT03019887|Dopamine Agents|dopamine agents|mesh-ancestor
111387253|NCT03019887|Antiemetics|antiemetics|mesh-ancestor
111387254|NCT03019887|Autonomic Agents|autonomic agents|mesh-ancestor
111387255|NCT03019887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111387256|NCT03019887|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111387257|NCT03019887|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111387258|NCT03019887|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111387259|NCT03019887|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111387260|NCT03019887|Antidepressive Agents|antidepressive agents|mesh-ancestor
111387261|NCT03019887|Dopamine Agonists|dopamine agonists|mesh-ancestor
111387262|NCT03019887|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111387263|NCT03019887|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111387264|NCT03019887|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111387265|NCT03019887|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111387266|NCT03019887|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111387267|NCT03019887|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111387268|NCT03019887|Analgesics|analgesics|mesh-ancestor
111387269|NCT03019887|Sensory System Agents|sensory system agents|mesh-ancestor
111387270|NCT02998970|Empagliflozin|empagliflozin|mesh-list
111387271|NCT02998970|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111387272|NCT02998970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111387273|NCT02998970|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111387274|NCT02998970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111387275|NCT05406752|Acetaminophen|acetaminophen|mesh-list
111387276|NCT05406752|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111387277|NCT05406752|Analgesics|analgesics|mesh-ancestor
111387278|NCT05406752|Sensory System Agents|sensory system agents|mesh-ancestor
111387279|NCT05406752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111387280|NCT05406752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111387281|NCT05406752|Antipyretics|antipyretics|mesh-ancestor
111387282|NCT02247362|Hemagglutinins|hemagglutinins|mesh-list
111387283|NCT02247362|Vaccines|vaccines|mesh-list
111387284|NCT02247362|Immunologic Factors|immunologic factors|mesh-ancestor
111387285|NCT02247362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111387286|NCT02247362|Agglutinins|agglutinins|mesh-ancestor
111387287|NCT02247362|Coagulants|coagulants|mesh-ancestor
111387288|NCT02920749|Anesthetics|anesthetics|mesh-list
111387289|NCT02920749|Propofol|propofol|mesh-list
111387290|NCT02920749|Sevoflurane|sevoflurane|mesh-list
111387291|NCT02920749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111387292|NCT02920749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111387293|NCT02920749|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111387294|NCT02920749|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111387295|NCT02920749|Anesthetics, General|anesthetics, general|mesh-ancestor
111387296|NCT02920749|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111387297|NCT02920749|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111387298|NCT02248142|Pramipexole|pramipexole|mesh-list
111387299|NCT02248142|Antioxidants|antioxidants|mesh-ancestor
111387300|NCT02248142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111387301|NCT02248142|Protective Agents|protective agents|mesh-ancestor
111387302|NCT02248142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111387303|NCT02248142|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111387304|NCT02248142|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111387305|NCT02248142|Dopamine Agonists|dopamine agonists|mesh-ancestor
111387306|NCT02248142|Dopamine Agents|dopamine agents|mesh-ancestor
111111714|NCT05133635|Hormones|hormones|mesh-ancestor
111387307|NCT02248142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111387308|NCT04667780|Colchicine|colchicine|mesh-list
111387309|NCT04667780|Gout Suppressants|gout suppressants|mesh-ancestor
111387310|NCT04667780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111387311|NCT04667780|Tubulin Modulators|tubulin modulators|mesh-ancestor
111387312|NCT04667780|Antimitotic Agents|antimitotic agents|mesh-ancestor
111387313|NCT04667780|Mitosis Modulators|mitosis modulators|mesh-ancestor
111387314|NCT04667780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111387315|NCT04667780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111387316|NCT02248220|Pramipexole|pramipexole|mesh-list
111387317|NCT02248220|Antioxidants|antioxidants|mesh-ancestor
111387318|NCT02248220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111387319|NCT02248220|Protective Agents|protective agents|mesh-ancestor
111387320|NCT02248220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111387321|NCT02248220|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111387322|NCT02248220|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111387323|NCT02248220|Dopamine Agonists|dopamine agonists|mesh-ancestor
111387324|NCT02248220|Dopamine Agents|dopamine agents|mesh-ancestor
111387325|NCT02248220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111387327|NCT02921061|Decitabine|decitabine|mesh-list
111387328|NCT02921061|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
111387329|NCT02921061|Mitoxantrone|mitoxantrone|mesh-list
111387330|NCT02921061|Cladribine|cladribine|mesh-list
111387331|NCT02921061|Lenograstim|lenograstim|mesh-list
111387332|NCT02921061|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111387333|NCT02921061|Antimetabolites|antimetabolites|mesh-ancestor
111387334|NCT02921061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111387335|NCT02921061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111387336|NCT02921061|Antiviral Agents|antiviral agents|mesh-ancestor
111387337|NCT02921061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111387338|NCT02921061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111387339|NCT02921061|Immunologic Factors|immunologic factors|mesh-ancestor
111387340|NCT02921061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111387341|NCT02921061|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111387342|NCT02921061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111387343|NCT02921061|Analgesics|analgesics|mesh-ancestor
111387344|NCT02921061|Sensory System Agents|sensory system agents|mesh-ancestor
111387345|NCT02921061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111387346|NCT02921061|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111387347|NCT02921061|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111387348|NCT05310422|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111387349|NCT05310422|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111387350|NCT03004118|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
111387351|NCT03004118|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
111387352|NCT03004118|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111387353|NCT03004196|Chlorhexidine|chlorhexidine|mesh-list
111387354|NCT03004196|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111387355|NCT03004196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111387356|NCT03004196|Disinfectants|disinfectants|mesh-ancestor
111387357|NCT02281409|Mogamulizumab|mogamulizumab|mesh-list
111387358|NCT02281409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111387359|NCT05200442|Cetuximab|cetuximab|mesh-list
111387360|NCT05200442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111387361|NCT05200442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111387362|NCT02859441|Ranibizumab|ranibizumab|mesh-list
111387363|NCT02859441|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111387364|NCT02859441|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111387365|NCT02859441|Growth Substances|growth substances|mesh-ancestor
111387366|NCT02859441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111387367|NCT02859441|Growth Inhibitors|growth inhibitors|mesh-ancestor
111387368|NCT02859441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111387369|NCT01880099|Galantamine|galantamine|mesh-list
111387370|NCT01880099|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
111387371|NCT01880099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111387372|NCT01880099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111387373|NCT01880099|Cholinergic Agents|cholinergic agents|mesh-ancestor
111387374|NCT01880099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111387375|NCT01880099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111387376|NCT01880099|Parasympathomimetics|parasympathomimetics|mesh-ancestor
111387377|NCT01880099|Autonomic Agents|autonomic agents|mesh-ancestor
111387378|NCT01880099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111387379|NCT01880099|Nootropic Agents|nootropic agents|mesh-ancestor
111387380|NCT04287803|Methoxyflurane|methoxyflurane|mesh-list
111387381|NCT04287803|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111387382|NCT04287803|Anesthetics, General|anesthetics, general|mesh-ancestor
111387383|NCT04287803|Anesthetics|anesthetics|mesh-ancestor
111387384|NCT04287803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111387385|NCT04287803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111387386|NCT02860845|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111387387|NCT02860845|Clindamycin|clindamycin|mesh-list
111387388|NCT02860845|Clindamycin palmitate|clindamycin palmitate|mesh-list
111387389|NCT02860845|Clindamycin phosphate|clindamycin phosphate|mesh-list
111387390|NCT02860845|Clotrimazole|clotrimazole|mesh-list
111387391|NCT02860845|Miconazole|miconazole|mesh-list
111387392|NCT02860845|Antifungal Agents|antifungal agents|mesh-list
111387393|NCT02860845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111387394|NCT02860845|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111387395|NCT02860845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111387396|NCT02860845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111387397|NCT02860845|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111387398|NCT02860845|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111387399|NCT02860845|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111387400|NCT02860845|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111387401|NCT02860845|Hormone Antagonists|hormone antagonists|mesh-ancestor
111387402|NCT02860845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111387403|NCT02860845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111387404|NCT02860845|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111387405|NCT02860845|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111387406|NCT03003884|Propofol|propofol|mesh-list
111387407|NCT03003884|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111387408|NCT03003884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111387409|NCT03003884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111387410|NCT03003884|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111387411|NCT03003884|Anesthetics, General|anesthetics, general|mesh-ancestor
111387412|NCT03003884|Anesthetics|anesthetics|mesh-ancestor
111387413|NCT01880723|Albuterol|albuterol|mesh-list
111387414|NCT01880723|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111387415|NCT01880723|Autonomic Agents|autonomic agents|mesh-ancestor
111387416|NCT01880723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111387417|NCT01880723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111387418|NCT01880723|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111387419|NCT01880723|Respiratory System Agents|respiratory system agents|mesh-ancestor
111387420|NCT01880723|Tocolytic Agents|tocolytic agents|mesh-ancestor
111387421|NCT01880723|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111387422|NCT01880723|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111387423|NCT01880723|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111387424|NCT01880723|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111387425|NCT01880723|Adrenergic Agents|adrenergic agents|mesh-ancestor
111387426|NCT01880723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111387427|NCT01880723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111387428|NCT02248454|Insulin Lispro|insulin lispro|mesh-list
111387429|NCT02248454|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111387430|NCT02248454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111387431|NCT04466618|Heparin|heparin|mesh-list
111387432|NCT04466618|Calcium heparin|calcium heparin|mesh-list
111387433|NCT04466618|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
111387434|NCT04466618|Anticoagulants|anticoagulants|mesh-ancestor
111387435|NCT04466618|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111387436|NCT04466618|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111387437|NCT04466618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111387438|NCT04466618|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
111387439|NCT04466618|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
111387440|NCT04466618|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111387441|NCT01881113|Cetirizine|cetirizine|mesh-list
111387442|NCT01881113|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111387443|NCT01881113|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
111387444|NCT01881113|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111387445|NCT01881113|Histamine Antagonists|histamine antagonists|mesh-ancestor
111387446|NCT01881113|Histamine Agents|histamine agents|mesh-ancestor
111387447|NCT01881113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111387448|NCT01881113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111387449|NCT01881113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111387450|NCT05140694|Empagliflozin|empagliflozin|mesh-list
111387451|NCT05140694|Dulaglutide|dulaglutide|mesh-list
111387452|NCT05140694|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
111387453|NCT05140694|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111387454|NCT05140694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111387455|NCT05140694|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111387456|NCT05140694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111387457|NCT05140694|Immunologic Factors|immunologic factors|mesh-ancestor
111387458|NCT02987699|Leucovorin|leucovorin|mesh-list
111387459|NCT02987699|Oxaliplatin|oxaliplatin|mesh-list
111387460|NCT02987699|Fluorouracil|fluorouracil|mesh-list
111387461|NCT02987699|Levoleucovorin|levoleucovorin|mesh-list
111387462|NCT02987699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111387463|NCT02987699|Antidotes|antidotes|mesh-ancestor
111387464|NCT02987699|Protective Agents|protective agents|mesh-ancestor
111387465|NCT02987699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111387466|NCT02987699|Vitamin B Complex|vitamin b complex|mesh-ancestor
111387467|NCT02987699|Vitamins|vitamins|mesh-ancestor
111387468|NCT02987699|Micronutrients|micronutrients|mesh-ancestor
111387469|NCT02987699|Antimetabolites|antimetabolites|mesh-ancestor
111387470|NCT02987699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111387471|NCT02987699|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111387472|NCT02987699|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111387473|NCT02987699|Immunologic Factors|immunologic factors|mesh-ancestor
111387474|NCT03003728|Melphalan|melphalan|mesh-list
111387475|NCT03003728|Elotuzumab|elotuzumab|mesh-list
111387476|NCT03003728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111387477|NCT03003728|Alkylating Agents|alkylating agents|mesh-ancestor
111387478|NCT03003728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111387479|NCT03003728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111387480|NCT03003728|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111387481|NCT03003728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111387482|NCT03003728|Immunologic Factors|immunologic factors|mesh-ancestor
111387483|NCT03003728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111387484|NCT05672810|Fibrin fragment D|fibrin fragment d|mesh-list
111387485|NCT05672810|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111387486|NCT05672810|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111387487|NCT05672810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111387488|NCT05672810|Hemostatics|hemostatics|mesh-ancestor
111387489|NCT05672810|Coagulants|coagulants|mesh-ancestor
111387490|NCT00559247|Asunaprevir|asunaprevir|mesh-list
111387491|NCT00559247|Protease Inhibitors|protease inhibitors|mesh-ancestor
111387492|NCT00559247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111387493|NCT00559247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111387494|NCT03003416|Dexamethasone|dexamethasone|mesh-list
111387495|NCT03003416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111387496|NCT03003416|Antiemetics|antiemetics|mesh-ancestor
111387497|NCT03003416|Autonomic Agents|autonomic agents|mesh-ancestor
111387498|NCT03003416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111387499|NCT03003416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111387500|NCT03003416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111387501|NCT03003416|Glucocorticoids|glucocorticoids|mesh-ancestor
111387502|NCT03003416|Hormones|hormones|mesh-ancestor
111387503|NCT03003416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111387504|NCT03003416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111387505|NCT03003416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111387506|NCT02988869|Formoterol Fumarate|formoterol fumarate|mesh-list
111387507|NCT02988869|Tiotropium Bromide|tiotropium bromide|mesh-list
111387508|NCT02988869|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111387509|NCT02988869|Autonomic Agents|autonomic agents|mesh-ancestor
111387510|NCT02988869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111387511|NCT02988869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111387512|NCT02988869|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111387513|NCT02988869|Respiratory System Agents|respiratory system agents|mesh-ancestor
111387514|NCT02988869|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111387515|NCT02988869|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111387516|NCT02988869|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111387517|NCT02988869|Adrenergic Agents|adrenergic agents|mesh-ancestor
111387518|NCT02988869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111387519|NCT02988869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111387520|NCT02988869|Parasympatholytics|parasympatholytics|mesh-ancestor
111387521|NCT02988869|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111387522|NCT02988869|Cholinergic Agents|cholinergic agents|mesh-ancestor
111387523|NCT03028467|Folic Acid|folic acid|mesh-list
111387524|NCT03028467|Methotrexate|methotrexate|mesh-list
111387525|NCT03028467|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111387526|NCT03028467|Abortifacient Agents|abortifacient agents|mesh-ancestor
111387527|NCT03028467|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111387528|NCT03028467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111387529|NCT03028467|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110527513|NCT02768168|Dezocine|dezocine|mesh-list
111387530|NCT03028467|Antimetabolites|antimetabolites|mesh-ancestor
111387531|NCT03028467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111387532|NCT03028467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111387533|NCT03028467|Dermatologic Agents|dermatologic agents|mesh-ancestor
111387534|NCT03028467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111387535|NCT03028467|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111387536|NCT03028467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111387537|NCT03028467|Immunologic Factors|immunologic factors|mesh-ancestor
111387538|NCT03028467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111387539|NCT03028467|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111387540|NCT03028467|Hematinics|hematinics|mesh-ancestor
111387541|NCT03028467|Vitamin B Complex|vitamin b complex|mesh-ancestor
111387543|NCT03028467|Micronutrients|micronutrients|mesh-ancestor
111387544|NCT02222870|Vaccines|vaccines|mesh-list
111387545|NCT02222870|Immunologic Factors|immunologic factors|mesh-ancestor
111387546|NCT02222870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111387547|NCT02223260|Dabigatran|dabigatran|mesh-list
111387548|NCT02223260|Antithrombins|antithrombins|mesh-ancestor
111387549|NCT02223260|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111387550|NCT02223260|Protease Inhibitors|protease inhibitors|mesh-ancestor
111387551|NCT02223260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111387552|NCT02223260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111387553|NCT02223260|Anticoagulants|anticoagulants|mesh-ancestor
111387554|NCT02863263|Povidone-Iodine|povidone-iodine|mesh-list
111387555|NCT02863263|Povidone|povidone|mesh-list
111387556|NCT02863263|Plasma Substitutes|plasma substitutes|mesh-ancestor
111387557|NCT02863263|Blood Substitutes|blood substitutes|mesh-ancestor
111387558|NCT02863263|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111387559|NCT02863263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111387560|NCT02223338|Ciprofloxacin|ciprofloxacin|mesh-list
111387561|NCT02223338|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111387562|NCT02223338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111387563|NCT02223338|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111387564|NCT02223338|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111387565|NCT02223338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111387566|NCT02223338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111387567|NCT02223338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111387568|NCT02223338|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111387569|NCT02223338|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111387570|NCT01887587|Dexamethasone|dexamethasone|mesh-list
111387571|NCT01887587|Doxorubicin|doxorubicin|mesh-list
111387572|NCT01887587|Vincristine|vincristine|mesh-list
111387573|NCT01887587|Ixazomib|ixazomib|mesh-list
111387574|NCT01887587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111387575|NCT01887587|Antiemetics|antiemetics|mesh-ancestor
111387576|NCT01887587|Autonomic Agents|autonomic agents|mesh-ancestor
111387577|NCT01887587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111387578|NCT01887587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111387579|NCT01887587|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111387580|NCT01887587|Glucocorticoids|glucocorticoids|mesh-ancestor
111387581|NCT01887587|Hormones|hormones|mesh-ancestor
111387582|NCT01887587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111387583|NCT01887587|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111387584|NCT01887587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111387585|NCT01887587|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111387586|NCT01887587|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111387587|NCT01887587|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111387588|NCT01887587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111387589|NCT01887587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111387590|NCT01887587|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111387591|NCT01887587|Tubulin Modulators|tubulin modulators|mesh-ancestor
111387592|NCT01887587|Antimitotic Agents|antimitotic agents|mesh-ancestor
111387593|NCT01887587|Mitosis Modulators|mitosis modulators|mesh-ancestor
111387594|NCT01887587|Protease Inhibitors|protease inhibitors|mesh-ancestor
111387595|NCT03029091|Losartan|losartan|mesh-list
111387596|NCT03029091|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111387597|NCT03029091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111387598|NCT03029091|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111387599|NCT03029091|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111387600|NCT03029091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111387601|NCT02997410|Salicylic Acid|salicylic acid|mesh-list
111387602|NCT02997410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111387603|NCT02997410|Antifungal Agents|antifungal agents|mesh-ancestor
111387604|NCT02997410|Keratolytic Agents|keratolytic agents|mesh-ancestor
111387605|NCT02997410|Dermatologic Agents|dermatologic agents|mesh-ancestor
111387606|NCT00374205|Artesunate|artesunate|mesh-list
111387607|NCT00374205|Lumefantrine|lumefantrine|mesh-list
111387608|NCT00374205|Artemether|artemether|mesh-list
111387609|NCT00374205|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
111387610|NCT00374205|Amodiaquine|amodiaquine|mesh-list
111387611|NCT00374205|Antimalarials|antimalarials|mesh-ancestor
111387612|NCT00374205|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111387613|NCT00374205|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111387614|NCT00374205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111387615|NCT00374205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111387616|NCT00374205|Antiviral Agents|antiviral agents|mesh-ancestor
111387617|NCT00374205|Schistosomicides|schistosomicides|mesh-ancestor
111387618|NCT00374205|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
111387619|NCT00374205|Anthelmintics|anthelmintics|mesh-ancestor
111387620|NCT02248844|Botulinum Toxins|botulinum toxins|mesh-list
111387621|NCT02248844|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111387622|NCT02248844|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111387623|NCT02248844|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111387624|NCT02248844|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111387625|NCT02248844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111387626|NCT02248844|Cholinergic Agents|cholinergic agents|mesh-ancestor
111387627|NCT02248844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111387628|NCT02248844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111387629|NCT02248844|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111387630|NCT02248844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111387631|NCT03029715|Dexmedetomidine|dexmedetomidine|mesh-list
111387632|NCT03029715|Remifentanil|remifentanil|mesh-list
111387633|NCT03029715|Propofol|propofol|mesh-list
111387634|NCT03029715|Desflurane|desflurane|mesh-list
111387635|NCT03029715|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111387636|NCT03029715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111387637|NCT03029715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111387638|NCT03029715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111387639|NCT03029715|Analgesics|analgesics|mesh-ancestor
111387640|NCT03029715|Sensory System Agents|sensory system agents|mesh-ancestor
111387641|NCT03029715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111387642|NCT03029715|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111387643|NCT03029715|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111387644|NCT03029715|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111387645|NCT03029715|Adrenergic Agents|adrenergic agents|mesh-ancestor
111387646|NCT03029715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111387647|NCT03029715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111387648|NCT03029715|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111387649|NCT03029715|Anesthetics, General|anesthetics, general|mesh-ancestor
111387650|NCT03029715|Anesthetics|anesthetics|mesh-ancestor
111387651|NCT03029715|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111387652|NCT03029715|Narcotics|narcotics|mesh-ancestor
111387653|NCT03029715|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111387654|NCT00555035|Dolutegravir|dolutegravir|mesh-list
111387655|NCT00555035|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111387656|NCT00555035|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111387657|NCT00555035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111387658|NCT00555035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111387659|NCT00555035|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111387660|NCT00555035|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111387661|NCT00555035|Antiviral Agents|antiviral agents|mesh-ancestor
111387662|NCT00555035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111387663|NCT03035955|Azelaic acid|azelaic acid|mesh-list
111387664|NCT03035955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111387665|NCT03035955|Dermatologic Agents|dermatologic agents|mesh-ancestor
111387666|NCT03830060|Hydrocortisone|hydrocortisone|mesh-list
111387667|NCT03830060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111387668|NCT02927223|Atropine|atropine|mesh-list
111387669|NCT02927223|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111387670|NCT02927223|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111387671|NCT02927223|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111387672|NCT02927223|Autonomic Agents|autonomic agents|mesh-ancestor
111387673|NCT02927223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111387674|NCT02927223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111387675|NCT02927223|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111387676|NCT02927223|Respiratory System Agents|respiratory system agents|mesh-ancestor
111387677|NCT02927223|Mydriatics|mydriatics|mesh-ancestor
111387678|NCT02927223|Parasympatholytics|parasympatholytics|mesh-ancestor
111387679|NCT02927223|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111387680|NCT02927223|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111387681|NCT02927223|Cholinergic Agents|cholinergic agents|mesh-ancestor
111387682|NCT02927223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111387683|NCT02927223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111387684|NCT03002792|Anesthetics|anesthetics|mesh-list
111387685|NCT03002792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111387686|NCT03002792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111387687|NCT02927457|GSK2646264|gsk2646264|mesh-list
111387688|NCT02927457|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111387689|NCT02927457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111387690|NCT02927457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111387692|NCT01891331|Antifungal Agents|antifungal agents|mesh-ancestor
111387693|NCT01891331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111387694|NCT01891331|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111387695|NCT01891331|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111387696|NCT01891331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111387697|NCT01891331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111387698|NCT01891331|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111387699|NCT01891331|Hormone Antagonists|hormone antagonists|mesh-ancestor
111387700|NCT01891331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111387701|NCT01891331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111387702|NCT01891331|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111387703|NCT01891331|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111387704|NCT02247518|Tadalafil|tadalafil|mesh-list
111387705|NCT02247518|Tamsulosin|tamsulosin|mesh-list
111387706|NCT02247518|Vasodilator Agents|vasodilator agents|mesh-ancestor
111387707|NCT02247518|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111387708|NCT02247518|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111387709|NCT02247518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111387710|NCT02247518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111387711|NCT02247518|Urological Agents|urological agents|mesh-ancestor
111387712|NCT02247518|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111387713|NCT02247518|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111387714|NCT02247518|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111387715|NCT02247518|Adrenergic Agents|adrenergic agents|mesh-ancestor
111387716|NCT02247518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111387717|NCT02247518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111387718|NCT02867163|Tranexamic Acid|tranexamic acid|mesh-list
111387719|NCT02867163|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111387720|NCT02867163|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111387721|NCT02867163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111387722|NCT02867163|Hemostatics|hemostatics|mesh-ancestor
111387723|NCT02867163|Coagulants|coagulants|mesh-ancestor
111387724|NCT04067609|Dexamethasone|dexamethasone|mesh-list
111387725|NCT04067609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111387726|NCT04067609|Antiemetics|antiemetics|mesh-ancestor
111387727|NCT04067609|Autonomic Agents|autonomic agents|mesh-ancestor
111387728|NCT04067609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111387729|NCT04067609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111387730|NCT04067609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111387731|NCT04067609|Glucocorticoids|glucocorticoids|mesh-ancestor
111387732|NCT04067609|Hormones|hormones|mesh-ancestor
111387733|NCT04067609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111387734|NCT04067609|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111387735|NCT04067609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111387736|NCT03022097|Bromides|bromides|mesh-list
111387737|NCT03022097|Formoterol Fumarate|formoterol fumarate|mesh-list
111387738|NCT03022097|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111387739|NCT03022097|Autonomic Agents|autonomic agents|mesh-ancestor
111387740|NCT03022097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111387741|NCT03022097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111387742|NCT03022097|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111387743|NCT03022097|Respiratory System Agents|respiratory system agents|mesh-ancestor
111387744|NCT03022097|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111387745|NCT03022097|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111387746|NCT03022097|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111387747|NCT03022097|Adrenergic Agents|adrenergic agents|mesh-ancestor
111387748|NCT03022097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111387749|NCT03022097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111387750|NCT03022097|Anticonvulsants|anticonvulsants|mesh-ancestor
111387751|NCT03002636|Anesthetics|anesthetics|mesh-list
111387752|NCT03002636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111387753|NCT03002636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111387754|NCT03039543|Rocuronium|rocuronium|mesh-list
111387755|NCT03039543|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
111387756|NCT03039543|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
111387757|NCT03039543|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111387758|NCT03039543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111387759|NCT03039543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111387760|NCT04047875|Norethindrone|norethindrone|mesh-list
111387761|NCT04047875|Norethindrone Acetate|norethindrone acetate|mesh-list
111387762|NCT04047875|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111387763|NCT04047875|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111387764|NCT04047875|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111387765|NCT04047875|Contraceptive Agents|contraceptive agents|mesh-ancestor
111387766|NCT04047875|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111387767|NCT04047875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111387768|NCT04047875|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111387769|NCT04047875|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111387770|NCT03002090|Iron|iron|mesh-list
111387771|NCT03002090|Trace Elements|trace elements|mesh-ancestor
111387772|NCT03002090|Micronutrients|micronutrients|mesh-ancestor
111387773|NCT03002090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111387774|NCT02328755|Methotrexate|methotrexate|mesh-list
111387775|NCT02328755|Tacrolimus|tacrolimus|mesh-list
111387776|NCT02328755|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111387777|NCT02328755|Abortifacient Agents|abortifacient agents|mesh-ancestor
111387778|NCT02328755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111387779|NCT02328755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111387780|NCT02328755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111387781|NCT02328755|Antimetabolites|antimetabolites|mesh-ancestor
111387782|NCT02328755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111387783|NCT02328755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111387784|NCT02328755|Dermatologic Agents|dermatologic agents|mesh-ancestor
111387785|NCT02328755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111387786|NCT02328755|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111387787|NCT02328755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111387788|NCT02328755|Immunologic Factors|immunologic factors|mesh-ancestor
111387789|NCT02328755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111387790|NCT02328755|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111387791|NCT02328755|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111387792|NCT02870283|Carbamazepine|carbamazepine|mesh-list
111387793|NCT02870283|Valproic Acid|valproic acid|mesh-list
111387794|NCT02870283|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111387795|NCT02870283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111387796|NCT02870283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111387797|NCT02870283|Antimanic Agents|antimanic agents|mesh-ancestor
111387798|NCT02870283|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111387799|NCT02870283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111387800|NCT02870283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111387801|NCT02870283|Anticonvulsants|anticonvulsants|mesh-ancestor
111387802|NCT02870283|GABA Agents|gaba agents|mesh-ancestor
111387803|NCT02870283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111387804|NCT02870283|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111387805|NCT02870283|Analgesics|analgesics|mesh-ancestor
111387806|NCT02870283|Sensory System Agents|sensory system agents|mesh-ancestor
111387807|NCT02870283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111387808|NCT02870283|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111387809|NCT02870283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111387810|NCT02870283|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111387811|NCT02870283|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111387812|NCT02931045|Clopidogrel|clopidogrel|mesh-list
111387813|NCT02931045|Ticagrelor|ticagrelor|mesh-list
111387814|NCT02931045|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111387815|NCT02931045|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111387816|NCT02931045|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111387817|NCT02931045|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111387818|NCT02931045|Purinergic Agents|purinergic agents|mesh-ancestor
111387819|NCT02931045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111387820|NCT02931045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111387821|NCT02931045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111387822|NCT03040011|Dexamethasone|dexamethasone|mesh-list
111387823|NCT03040011|Bupivacaine|bupivacaine|mesh-list
111387824|NCT03040011|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111387825|NCT03040011|Antiemetics|antiemetics|mesh-ancestor
111387826|NCT03040011|Autonomic Agents|autonomic agents|mesh-ancestor
111387827|NCT03040011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111387828|NCT03040011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111387829|NCT03040011|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111387830|NCT03040011|Glucocorticoids|glucocorticoids|mesh-ancestor
111387831|NCT03040011|Hormones|hormones|mesh-ancestor
111387832|NCT03040011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111387833|NCT03040011|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111387834|NCT03040011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111387835|NCT03040011|Anesthetics, Local|anesthetics, local|mesh-ancestor
111112233|NCT05900401|Rituximab|rituximab|mesh-list
111387836|NCT03040011|Anesthetics|anesthetics|mesh-ancestor
111387837|NCT03040011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111387838|NCT03040011|Sensory System Agents|sensory system agents|mesh-ancestor
111387839|NCT02225132|Hydroxyurea|hydroxyurea|mesh-list
111387840|NCT02225132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111387841|NCT02225132|Antisickling Agents|antisickling agents|mesh-ancestor
111387842|NCT02225132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111387843|NCT02225132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111387844|NCT02225132|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111387845|NCT03040479|Lasmiditan|lasmiditan|mesh-list
111387846|NCT03040479|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111387847|NCT03040479|Serotonin Agents|serotonin agents|mesh-ancestor
111387848|NCT03040479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111387849|NCT03040479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111387850|NCT03040479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111387851|NCT02872857|Galantamine|galantamine|mesh-list
111387852|NCT02872857|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111387853|NCT02872857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111387854|NCT02872857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111387855|NCT02872857|Cholinergic Agents|cholinergic agents|mesh-ancestor
111387856|NCT02872857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111387857|NCT02872857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111387858|NCT02872857|Parasympathomimetics|parasympathomimetics|mesh-ancestor
111387859|NCT02872857|Autonomic Agents|autonomic agents|mesh-ancestor
111387860|NCT02872857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111387861|NCT02872857|Nootropic Agents|nootropic agents|mesh-ancestor
111387862|NCT02996318|Sirolimus|sirolimus|mesh-list
111387863|NCT02996318|Paclitaxel|paclitaxel|mesh-list
111387864|NCT02996318|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111387865|NCT02996318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111387866|NCT02996318|Tubulin Modulators|tubulin modulators|mesh-ancestor
111387867|NCT02996318|Antimitotic Agents|antimitotic agents|mesh-ancestor
111387868|NCT02996318|Mitosis Modulators|mitosis modulators|mesh-ancestor
111387869|NCT02996318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111387870|NCT02996318|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111387871|NCT02996318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111387872|NCT02996318|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111387873|NCT02996318|Antifungal Agents|antifungal agents|mesh-ancestor
111387874|NCT02996318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111387875|NCT02996318|Immunologic Factors|immunologic factors|mesh-ancestor
111387876|NCT02996318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111387877|NCT05197751|Aluminum Hydroxide|aluminum hydroxide|mesh-list
111387878|NCT05197751|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111387879|NCT05197751|Immunologic Factors|immunologic factors|mesh-ancestor
111387880|NCT05197751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111387881|NCT05197751|Antacids|antacids|mesh-ancestor
111387882|NCT05197751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111387883|NCT05197751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111387884|NCT02994602|ST 1435|st 1435|mesh-list
111387885|NCT02994602|Testosterone|testosterone|mesh-list
111387886|NCT02994602|Androgens|androgens|mesh-ancestor
111387887|NCT02994602|Hormones|hormones|mesh-ancestor
111387888|NCT02994602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111387889|NCT02994602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111387890|NCT02994602|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111387891|NCT02994602|Contraceptive Agents|contraceptive agents|mesh-ancestor
111387892|NCT02994602|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111387893|NCT02994602|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111387894|NCT03297710|Trifluridine|trifluridine|mesh-list
111387895|NCT03297710|Antimetabolites|antimetabolites|mesh-ancestor
111387896|NCT03297710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111387897|NCT03297710|Antiviral Agents|antiviral agents|mesh-ancestor
111387898|NCT03297710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111387899|NCT04350671|Interferons|interferons|mesh-list
111387900|NCT04350671|Ritonavir|ritonavir|mesh-list
111387901|NCT04350671|Lopinavir|lopinavir|mesh-list
111387902|NCT04350671|Interferon-beta|interferon-beta|mesh-list
111387903|NCT04350671|Interferon beta-1a|interferon beta-1a|mesh-list
111387904|NCT04350671|Hydroxychloroquine|hydroxychloroquine|mesh-list
111387905|NCT04350671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111387906|NCT04350671|Antiviral Agents|antiviral agents|mesh-ancestor
111387907|NCT04350671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111387908|NCT04350671|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111387909|NCT04350671|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111387910|NCT04350671|Protease Inhibitors|protease inhibitors|mesh-ancestor
111387911|NCT04350671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111387912|NCT04350671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111387913|NCT04350671|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111387914|NCT04350671|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111387915|NCT04350671|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111387916|NCT04350671|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111387917|NCT04350671|Antimalarials|antimalarials|mesh-ancestor
111387918|NCT04350671|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111387919|NCT04350671|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111387920|NCT04350671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111387921|NCT04350671|Immunologic Factors|immunologic factors|mesh-ancestor
111387922|NCT04350671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111387923|NCT04350671|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111387924|NCT04850846|Metformin|metformin|mesh-list
111387925|NCT04850846|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111387926|NCT04850846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111387927|NCT05166083|Testosterone|testosterone|mesh-list
111387928|NCT05166083|Androgens|androgens|mesh-ancestor
111387929|NCT05166083|Hormones|hormones|mesh-ancestor
111387930|NCT05166083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111387931|NCT05166083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111387932|NCT04707794|Sevoflurane|sevoflurane|mesh-list
111387933|NCT04707794|Desflurane|desflurane|mesh-list
111387934|NCT04707794|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111387935|NCT04707794|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111387936|NCT04707794|Anesthetics, General|anesthetics, general|mesh-ancestor
111387937|NCT04707794|Anesthetics|anesthetics|mesh-ancestor
111387938|NCT04707794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111387939|NCT04707794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111387940|NCT04667312|Durvalumab|durvalumab|mesh-list
111387941|NCT04667312|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111387942|NCT04667312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111387943|NCT02759588|Bevacizumab|bevacizumab|mesh-list
111387944|NCT02759588|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111387945|NCT02759588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111387946|NCT02759588|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111387947|NCT02759588|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111387948|NCT02759588|Growth Substances|growth substances|mesh-ancestor
111387949|NCT02759588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111387950|NCT02759588|Growth Inhibitors|growth inhibitors|mesh-ancestor
111387951|NCT03045861|Cobicistat|cobicistat|mesh-list
111387952|NCT03045861|GSK-2838232|gsk-2838232|mesh-list
111387953|NCT03045861|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111387954|NCT03045861|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111387955|NCT03045861|Antiviral Agents|antiviral agents|mesh-ancestor
111387956|NCT03045861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111387957|NCT03045861|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111387958|NCT03045861|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111387959|NCT03045861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111387960|NCT03045861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111387961|NCT02249078|Quetmolimab|quetmolimab|mesh-list
111387962|NCT02249078|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111387963|NCT01903265|Cyclobenzaprine|cyclobenzaprine|mesh-list
111387964|NCT01903265|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
111387965|NCT01903265|Antidepressive Agents|antidepressive agents|mesh-ancestor
111387966|NCT01903265|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111387967|NCT01903265|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
111387968|NCT01903265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111387969|NCT01903265|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111387970|NCT01903265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111387971|NCT01903265|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111387972|NCT01903265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111387973|NCT01907321|Capsaicin|capsaicin|mesh-list
111387974|NCT01907321|Antipruritics|antipruritics|mesh-ancestor
111387975|NCT01907321|Dermatologic Agents|dermatologic agents|mesh-ancestor
111387976|NCT01907321|Sensory System Agents|sensory system agents|mesh-ancestor
111387977|NCT01907321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111387978|NCT01907321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111387979|NCT02219516|Verinurad|verinurad|mesh-list
111387980|NCT02219516|Gout Suppressants|gout suppressants|mesh-ancestor
111387981|NCT02219516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111387982|NCT04976777|Dexamethasone|dexamethasone|mesh-list
111387983|NCT04976777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111387984|NCT04976777|Antiemetics|antiemetics|mesh-ancestor
111387985|NCT04976777|Autonomic Agents|autonomic agents|mesh-ancestor
111387986|NCT04976777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111387987|NCT04976777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111387988|NCT04976777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111387989|NCT04976777|Glucocorticoids|glucocorticoids|mesh-ancestor
111387990|NCT04976777|Hormones|hormones|mesh-ancestor
111387991|NCT04976777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111387992|NCT04976777|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111387993|NCT04976777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111387994|NCT02247596|Resveratrol|resveratrol|mesh-list
111387995|NCT02247596|Antioxidants|antioxidants|mesh-ancestor
111387996|NCT02247596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111387997|NCT02247596|Protective Agents|protective agents|mesh-ancestor
111387998|NCT02247596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111387999|NCT02247596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111388000|NCT02247596|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111388001|NCT03686657|Metformin|metformin|mesh-list
111388002|NCT03686657|Celecoxib|celecoxib|mesh-list
111388003|NCT03686657|Valsartan|valsartan|mesh-list
111388004|NCT03686657|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111388005|NCT03686657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111388006|NCT03686657|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111388007|NCT03686657|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111388008|NCT03686657|Analgesics|analgesics|mesh-ancestor
111388009|NCT03686657|Sensory System Agents|sensory system agents|mesh-ancestor
111388010|NCT03686657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111388011|NCT03686657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111388012|NCT03686657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111388013|NCT03686657|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111388014|NCT03686657|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111388015|NCT03686657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111388016|NCT03686657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111388017|NCT03686657|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111388018|NCT03686657|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111388019|NCT03686657|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111388020|NCT02476058|Diphenhydramine|diphenhydramine|mesh-list
111388021|NCT02476058|Promethazine|promethazine|mesh-list
111388022|NCT02476058|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111388023|NCT02476058|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111388024|NCT02476058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111388025|NCT02476058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111388026|NCT02476058|Anesthetics, Local|anesthetics, local|mesh-ancestor
111388027|NCT02476058|Anesthetics|anesthetics|mesh-ancestor
111388028|NCT02476058|Sensory System Agents|sensory system agents|mesh-ancestor
111388029|NCT02476058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111388030|NCT02476058|Antiemetics|antiemetics|mesh-ancestor
111388031|NCT02476058|Autonomic Agents|autonomic agents|mesh-ancestor
111388032|NCT02476058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111388033|NCT02476058|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111388034|NCT02476058|Histamine Antagonists|histamine antagonists|mesh-ancestor
111388035|NCT02476058|Histamine Agents|histamine agents|mesh-ancestor
111388036|NCT02476058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111388037|NCT02476058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111388038|NCT02476058|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111388039|NCT02476058|Antipruritics|antipruritics|mesh-ancestor
111388040|NCT02476058|Dermatologic Agents|dermatologic agents|mesh-ancestor
111388041|NCT03050619|Empagliflozin|empagliflozin|mesh-list
111388042|NCT03050619|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
111388043|NCT03050619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111388044|NCT03050619|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111388045|NCT03050619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111388046|NCT02071394|Xenon|xenon|mesh-list
111388047|NCT02071394|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111388048|NCT02071394|Anesthetics, General|anesthetics, general|mesh-ancestor
111388049|NCT02071394|Anesthetics|anesthetics|mesh-ancestor
111388050|NCT02071394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111388051|NCT02071394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111388052|NCT01911065|Vaccines|vaccines|mesh-list
111388053|NCT01911065|Immunologic Factors|immunologic factors|mesh-ancestor
111388054|NCT01911065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111388055|NCT02995772|Tamoxifen|tamoxifen|mesh-list
111388056|NCT02995772|Fluorouracil|fluorouracil|mesh-list
111388057|NCT02995772|Letrozole|letrozole|mesh-list
111388058|NCT02995772|Anastrozole|anastrozole|mesh-list
111388059|NCT02995772|Exemestane|exemestane|mesh-list
111388060|NCT02995772|Aromatase Inhibitors|aromatase inhibitors|mesh-list
111388061|NCT02995772|Antimetabolites|antimetabolites|mesh-ancestor
111388062|NCT02995772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111388063|NCT02995772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111388064|NCT02995772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111388065|NCT02995772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111388066|NCT02995772|Immunologic Factors|immunologic factors|mesh-ancestor
111388067|NCT02995772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111388068|NCT02995772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111388069|NCT02995772|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111388070|NCT02995772|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111388071|NCT02995772|Hormone Antagonists|hormone antagonists|mesh-ancestor
111388072|NCT02995772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111388073|NCT02995772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111388074|NCT02995772|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111388075|NCT02995772|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111388076|NCT02995772|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111388077|NCT02987465|Norepinephrine|norepinephrine|mesh-list
111388078|NCT02987465|Acetylcholine|acetylcholine|mesh-list
111388079|NCT02987465|Darbepoetin alfa|darbepoetin alfa|mesh-list
111388080|NCT02987465|Hematinics|hematinics|mesh-ancestor
111388081|NCT02987465|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111388082|NCT02987465|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111388083|NCT02987465|Adrenergic Agents|adrenergic agents|mesh-ancestor
111388084|NCT02987465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111388085|NCT02987465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111388086|NCT02987465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111388087|NCT02987465|Sympathomimetics|sympathomimetics|mesh-ancestor
111388088|NCT02987465|Autonomic Agents|autonomic agents|mesh-ancestor
111388089|NCT02987465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111388090|NCT02987465|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111388091|NCT02987465|Vasodilator Agents|vasodilator agents|mesh-ancestor
111388092|NCT02987465|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111388093|NCT02987465|Cholinergic Agents|cholinergic agents|mesh-ancestor
111388094|NCT04895579|Durvalumab|durvalumab|mesh-list
111388095|NCT04895579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111388096|NCT04895579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111388097|NCT02227316|Acetaminophen|acetaminophen|mesh-list
111388098|NCT02227316|Ibuprofen|ibuprofen|mesh-list
111388099|NCT02227316|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111388100|NCT02227316|Analgesics|analgesics|mesh-ancestor
111388101|NCT02227316|Sensory System Agents|sensory system agents|mesh-ancestor
111388102|NCT02227316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111388103|NCT02227316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111388104|NCT02227316|Antipyretics|antipyretics|mesh-ancestor
111388105|NCT02227316|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111388106|NCT02227316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111388107|NCT02227316|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111388108|NCT02227316|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111388109|NCT02227316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111388110|NCT02227316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111388111|NCT00555971|Omalizumab|omalizumab|mesh-list
111388112|NCT00555971|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111388113|NCT00555971|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111388114|NCT00555971|Respiratory System Agents|respiratory system agents|mesh-ancestor
111388115|NCT02943213|Chlorpromazine|chlorpromazine|mesh-list
111388116|NCT02943213|Antiemetics|antiemetics|mesh-ancestor
111388117|NCT02943213|Autonomic Agents|autonomic agents|mesh-ancestor
111388118|NCT02943213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111388119|NCT02943213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111388120|NCT02943213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111388121|NCT02943213|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111388122|NCT02943213|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111388123|NCT02943213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111388124|NCT02943213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111388125|NCT02943213|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111388126|NCT02943213|Dopamine Agents|dopamine agents|mesh-ancestor
111388127|NCT02943213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111388128|NCT02943213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111388129|NCT01850108|Mycophenolic Acid|mycophenolic acid|mesh-list
111388130|NCT01850108|Sirolimus|sirolimus|mesh-list
111388131|NCT01850108|Cyclophosphamide|cyclophosphamide|mesh-list
111388132|NCT01850108|Fludarabine|fludarabine|mesh-list
111388133|NCT01850108|Thymoglobulin|thymoglobulin|mesh-list
111388134|NCT01850108|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111388135|NCT01850108|Immunologic Factors|immunologic factors|mesh-ancestor
111388136|NCT01850108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111388137|NCT01850108|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111388138|NCT01850108|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111388139|NCT01850108|Alkylating Agents|alkylating agents|mesh-ancestor
111388140|NCT01850108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111388141|NCT01850108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111388142|NCT01850108|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111388143|NCT01850108|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111388144|NCT01850108|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111388145|NCT01850108|Antitubercular Agents|antitubercular agents|mesh-ancestor
111388146|NCT01850108|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111388147|NCT01850108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111388148|NCT01850108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111388149|NCT01850108|Antifungal Agents|antifungal agents|mesh-ancestor
111388150|NCT01822652|Cyclophosphamide|cyclophosphamide|mesh-list
111388151|NCT01822652|Pembrolizumab|pembrolizumab|mesh-list
111388152|NCT01822652|Fludarabine|fludarabine|mesh-list
111388153|NCT01822652|Fludarabine phosphate|fludarabine phosphate|mesh-list
111388154|NCT01822652|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111388155|NCT01822652|Immunologic Factors|immunologic factors|mesh-ancestor
111388156|NCT01822652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111388157|NCT01822652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111388158|NCT01822652|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111388159|NCT01822652|Alkylating Agents|alkylating agents|mesh-ancestor
111388160|NCT01822652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111388161|NCT01822652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111388162|NCT01822652|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111388163|NCT01822652|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111388164|NCT01822652|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111388165|NCT01822652|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111388166|NCT01822652|Antimetabolites|antimetabolites|mesh-ancestor
111388167|NCT02249234|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111388168|NCT02249234|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111388169|NCT02249234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111388170|NCT02249234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111388171|NCT02249234|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111388172|NCT02249234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111388173|NCT02249234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111388174|NCT02249234|Cholinergic Agents|cholinergic agents|mesh-ancestor
111388175|NCT02249234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111388177|NCT01338740|Infliximab|infliximab|mesh-list
111388178|NCT01338740|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111388179|NCT01338740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111388180|NCT01338740|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111388181|NCT01338740|Dermatologic Agents|dermatologic agents|mesh-ancestor
111388182|NCT01338740|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111388183|NCT02944461|Dapsone|dapsone|mesh-list
111388184|NCT02944461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111388185|NCT02944461|Antimalarials|antimalarials|mesh-ancestor
111388186|NCT02944461|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111388187|NCT02944461|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111388188|NCT02944461|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111388189|NCT02944461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111388190|NCT02944461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111388191|NCT02944461|Leprostatic Agents|leprostatic agents|mesh-ancestor
111388192|NCT02944461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111388193|NCT05376722|Prednisone|prednisone|mesh-list
111388194|NCT05376722|Pamiparib|pamiparib|mesh-list
111388195|NCT05376722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111388196|NCT05376722|Glucocorticoids|glucocorticoids|mesh-ancestor
111388197|NCT05376722|Hormones|hormones|mesh-ancestor
111388198|NCT05376722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111388199|NCT05376722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111388200|NCT05376722|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111388201|NCT05376722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111388202|NCT05376722|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111388203|NCT05376722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111388204|NCT05376722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111388205|NCT04737057|Fluorides|fluorides|mesh-list
111388206|NCT04737057|Cariostatic Agents|cariostatic agents|mesh-ancestor
111388207|NCT04737057|Protective Agents|protective agents|mesh-ancestor
111388208|NCT04737057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111388209|NCT03111381|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
111388210|NCT03111381|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111388211|NCT03111381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111388212|NCT03111381|Analgesics|analgesics|mesh-ancestor
111388213|NCT03111381|Sensory System Agents|sensory system agents|mesh-ancestor
111388214|NCT03111381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111388215|NCT03111381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111388216|NCT03111381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111388217|NCT03111381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111388218|NCT03111381|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111388219|NCT03111381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111388220|NCT03111381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111388221|NCT02946489|Ketamine|ketamine|mesh-list
111388222|NCT02946489|Analgesics|analgesics|mesh-ancestor
111388223|NCT02946489|Sensory System Agents|sensory system agents|mesh-ancestor
111388224|NCT02946489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111388225|NCT02946489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111388226|NCT02946489|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111388227|NCT02946489|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111388228|NCT02946489|Anesthetics, General|anesthetics, general|mesh-ancestor
111388229|NCT02946489|Anesthetics|anesthetics|mesh-ancestor
111388230|NCT02946489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111388231|NCT02946489|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111388232|NCT02946489|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111388233|NCT02946489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111388234|NCT02946489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111388235|NCT02949921|Lidocaine|lidocaine|mesh-list
111388236|NCT02949921|Anesthetics, Local|anesthetics, local|mesh-ancestor
111388237|NCT02949921|Anesthetics|anesthetics|mesh-ancestor
111388238|NCT02949921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111388239|NCT02949921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111388240|NCT02949921|Sensory System Agents|sensory system agents|mesh-ancestor
111388241|NCT02949921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111388242|NCT02949921|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111388243|NCT02949921|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111388244|NCT02949921|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111388245|NCT02949921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111388246|NCT02949921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111388247|NCT02227706|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
111388248|NCT02227706|Hemostatics|hemostatics|mesh-ancestor
111388249|NCT02227706|Coagulants|coagulants|mesh-ancestor
111388250|NCT03112863|Vitamin A|vitamin a|mesh-list
111388251|NCT03112863|Retinol palmitate|retinol palmitate|mesh-list
111388252|NCT03112863|Vitamins|vitamins|mesh-ancestor
111388253|NCT03112863|Micronutrients|micronutrients|mesh-ancestor
111388254|NCT03112863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111388255|NCT03112863|Antioxidants|antioxidants|mesh-ancestor
111388256|NCT03112863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111388257|NCT03112863|Protective Agents|protective agents|mesh-ancestor
111388258|NCT03112863|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
111388259|NCT03112863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111388260|NCT02950467|Psilocybin|psilocybin|mesh-list
111388261|NCT02950467|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
111388262|NCT02950467|Hallucinogens|hallucinogens|mesh-ancestor
111388263|NCT02950467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111388264|NCT02950467|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111388265|NCT02950467|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111388266|NCT02950467|Serotonin Agents|serotonin agents|mesh-ancestor
111388267|NCT02950467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111388268|NCT02950467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111388269|NCT02950467|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111388270|NCT01930487|Antioxidants|antioxidants|mesh-list
111388271|NCT01930487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111388272|NCT01930487|Protective Agents|protective agents|mesh-ancestor
111388273|NCT01930487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111388274|NCT03864068|Inositol|inositol|mesh-list
111388275|NCT03864068|Vitamin B Complex|vitamin b complex|mesh-ancestor
111388276|NCT03864068|Vitamins|vitamins|mesh-ancestor
111388277|NCT03864068|Micronutrients|micronutrients|mesh-ancestor
111388278|NCT03864068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111388279|NCT03063255|Anesthetics|anesthetics|mesh-list
111388280|NCT03063255|Mepivacaine|mepivacaine|mesh-list
111388281|NCT03063255|Rocuronium|rocuronium|mesh-list
111388282|NCT03063255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111388283|NCT03063255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111388284|NCT03063255|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
111388285|NCT03063255|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
111388286|NCT03063255|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111388287|NCT03063255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111388288|NCT03063255|Anesthetics, Local|anesthetics, local|mesh-ancestor
111388289|NCT03063255|Sensory System Agents|sensory system agents|mesh-ancestor
111388290|NCT05249114|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
111388291|NCT05249114|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111388292|NCT05249114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111388293|NCT05245292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111388294|NCT05245292|Antibodies|antibodies|mesh-list
111388295|NCT05245292|Immunoglobulins|immunoglobulins|mesh-list
111388296|NCT05245292|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111388297|NCT05245292|Antibodies, Blocking|antibodies, blocking|mesh-list
111388298|NCT05245292|Immunologic Factors|immunologic factors|mesh-ancestor
111388299|NCT05245292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111388300|NCT05245292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111388301|NCT03115827|Carbidopa|carbidopa|mesh-list
111388302|NCT03115827|Droxidopa|droxidopa|mesh-list
111388303|NCT03115827|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111388304|NCT03115827|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111388305|NCT03115827|Dopamine Agents|dopamine agents|mesh-ancestor
111388306|NCT03115827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111388307|NCT03115827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111388308|NCT03115827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111388309|NCT03115827|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
111388310|NCT03115827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111388311|NCT01915823|Fluticasone|fluticasone|mesh-list
111388312|NCT01915823|Xhance|xhance|mesh-list
111388313|NCT01915823|Azelastine|azelastine|mesh-list
111388314|NCT01915823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111388315|NCT01915823|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111388316|NCT01915823|Autonomic Agents|autonomic agents|mesh-ancestor
111388317|NCT01915823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111388318|NCT01915823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111388319|NCT01915823|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111388320|NCT01915823|Respiratory System Agents|respiratory system agents|mesh-ancestor
111388321|NCT01915823|Dermatologic Agents|dermatologic agents|mesh-ancestor
111388322|NCT01915823|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111388323|NCT01915823|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
111388324|NCT01915823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111388325|NCT01915823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111388326|NCT01915823|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
111388327|NCT01915823|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111388328|NCT01915823|Histamine Antagonists|histamine antagonists|mesh-ancestor
111388329|NCT01915823|Histamine Agents|histamine agents|mesh-ancestor
111388330|NCT01915823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111388331|NCT05199194|Tenecteplase|tenecteplase|mesh-list
111388332|NCT05199194|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111388333|NCT05199194|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111388334|NCT05199194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111388335|NCT01916681|Misoprostol|misoprostol|mesh-list
111388336|NCT01916681|Oxytocin|oxytocin|mesh-list
111388337|NCT01916681|Oxytocics|oxytocics|mesh-ancestor
111388338|NCT01916681|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111388339|NCT01916681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111388340|NCT01916681|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111388341|NCT01916681|Abortifacient Agents|abortifacient agents|mesh-ancestor
111388342|NCT01916681|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111388343|NCT01916681|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111388344|NCT05735951|Stiripentol|stiripentol|mesh-list
111388345|NCT05735951|Anticonvulsants|anticonvulsants|mesh-ancestor
111388346|NCT01917773|Octreotide|octreotide|mesh-list
111388347|NCT01917773|Bisacodyl|bisacodyl|mesh-list
111388348|NCT01917773|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111388349|NCT01917773|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111388350|NCT01917773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111388351|NCT01917773|Cathartics|cathartics|mesh-ancestor
111388352|NCT01917773|Laxatives|laxatives|mesh-ancestor
111388353|NCT02283749|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
111388354|NCT02283749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111388355|NCT01934231|Amoxicillin|amoxicillin|mesh-list
111388356|NCT01934231|Clavulanic Acid|clavulanic acid|mesh-list
111388357|NCT01934231|Clavulanic Acids|clavulanic acids|mesh-list
111388358|NCT01934231|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
111388359|NCT01934231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111388360|NCT01934231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111388361|NCT01934231|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
111388362|NCT01934231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111388363|NCT01934231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111388364|NCT01935791|Glucagon|glucagon|mesh-list
111388365|NCT01935791|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
111388366|NCT01935791|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111388367|NCT01935791|Hormones|hormones|mesh-ancestor
111388368|NCT01935791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111388369|NCT01935791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111388370|NCT01935791|Incretins|incretins|mesh-ancestor
111388371|NCT03074409|Oxytocin|oxytocin|mesh-list
111388372|NCT03074409|Oxytocics|oxytocics|mesh-ancestor
111388373|NCT03074409|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111388374|NCT03074409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111388375|NCT02955147|Prednisone|prednisone|mesh-list
111388376|NCT02955147|Ustekinumab|ustekinumab|mesh-list
111388377|NCT02955147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111388378|NCT02955147|Glucocorticoids|glucocorticoids|mesh-ancestor
111388379|NCT02955147|Hormones|hormones|mesh-ancestor
111388380|NCT02955147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111388381|NCT02955147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111388382|NCT02955147|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111388383|NCT02955147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111388384|NCT02955147|Dermatologic Agents|dermatologic agents|mesh-ancestor
111388385|NCT03119181|Lidocaine|lidocaine|mesh-list
111388386|NCT03119181|Epinephrine|epinephrine|mesh-list
111388387|NCT03119181|Racepinephrine|racepinephrine|mesh-list
111388388|NCT03119181|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111388389|NCT03119181|Epinephryl borate|epinephryl borate|mesh-list
110528367|NCT02862210|Antimanic Agents|antimanic agents|mesh-ancestor
111388390|NCT03119181|Anesthetics, Local|anesthetics, local|mesh-ancestor
111388391|NCT03119181|Anesthetics|anesthetics|mesh-ancestor
111388392|NCT03119181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111388393|NCT03119181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111388394|NCT03119181|Sensory System Agents|sensory system agents|mesh-ancestor
111388395|NCT03119181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111388396|NCT03119181|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111388397|NCT03119181|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111388398|NCT03119181|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111388399|NCT03119181|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111388400|NCT03119181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111388401|NCT03119181|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111388402|NCT03119181|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111388403|NCT03119181|Adrenergic Agents|adrenergic agents|mesh-ancestor
111388404|NCT03119181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111388405|NCT03119181|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111388406|NCT03119181|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111388407|NCT03119181|Autonomic Agents|autonomic agents|mesh-ancestor
111388408|NCT03119181|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111388409|NCT03119181|Respiratory System Agents|respiratory system agents|mesh-ancestor
111388410|NCT03119181|Mydriatics|mydriatics|mesh-ancestor
111388411|NCT03119181|Sympathomimetics|sympathomimetics|mesh-ancestor
111388412|NCT03119181|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111388413|NCT01691534|Pyrazinamide|pyrazinamide|mesh-list
111388414|NCT01691534|Clofazimine|clofazimine|mesh-list
111388415|NCT01691534|Antitubercular Agents|antitubercular agents|mesh-ancestor
111388416|NCT01691534|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111388417|NCT01691534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111388418|NCT01691534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111388419|NCT01691534|Leprostatic Agents|leprostatic agents|mesh-ancestor
111388420|NCT01691690|Acetaminophen|acetaminophen|mesh-list
111388421|NCT01691690|Dexamethasone|dexamethasone|mesh-list
111388422|NCT01691690|Midazolam|midazolam|mesh-list
111388423|NCT01691690|Morphine|morphine|mesh-list
111388424|NCT01691690|Nitrous Oxide|nitrous oxide|mesh-list
111388425|NCT01691690|Ondansetron|ondansetron|mesh-list
111388426|NCT01691690|Propofol|propofol|mesh-list
111388427|NCT01691690|Sevoflurane|sevoflurane|mesh-list
111388428|NCT01691690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111388429|NCT01691690|Antiemetics|antiemetics|mesh-ancestor
111388430|NCT01691690|Autonomic Agents|autonomic agents|mesh-ancestor
111388431|NCT01691690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111388432|NCT01691690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111388433|NCT01691690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111388434|NCT01691690|Glucocorticoids|glucocorticoids|mesh-ancestor
111388435|NCT01691690|Hormones|hormones|mesh-ancestor
111388436|NCT01691690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111388437|NCT01691690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111388438|NCT01691690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111388439|NCT01691690|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111388440|NCT01691690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111388441|NCT01691690|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111388442|NCT01691690|Anesthetics, General|anesthetics, general|mesh-ancestor
111388443|NCT01691690|Anesthetics|anesthetics|mesh-ancestor
111388444|NCT01691690|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111388445|NCT01691690|Narcotics|narcotics|mesh-ancestor
111388446|NCT01691690|Analgesics|analgesics|mesh-ancestor
111388447|NCT01691690|Sensory System Agents|sensory system agents|mesh-ancestor
111388448|NCT01691690|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111388449|NCT01691690|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111388450|NCT01691690|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111388451|NCT01691690|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111388452|NCT01691690|GABA Modulators|gaba modulators|mesh-ancestor
111388453|NCT01691690|GABA Agents|gaba agents|mesh-ancestor
111388454|NCT01691690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111388455|NCT01691690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111388456|NCT01691690|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111388457|NCT01691690|Antipyretics|antipyretics|mesh-ancestor
111388458|NCT01691690|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111388459|NCT01691690|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111388460|NCT01691690|Antipruritics|antipruritics|mesh-ancestor
111388461|NCT01691690|Dermatologic Agents|dermatologic agents|mesh-ancestor
111388462|NCT01691690|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111388463|NCT01691690|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111388464|NCT01691690|Serotonin Agents|serotonin agents|mesh-ancestor
111388465|NCT01694108|BCG Vaccine|bcg vaccine|mesh-list
111388466|NCT01694108|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111388467|NCT01694108|Immunologic Factors|immunologic factors|mesh-ancestor
111388468|NCT01694108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111388469|NCT02283827|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
111388470|NCT02283827|Phenytoin|phenytoin|mesh-list
111388471|NCT02283827|Anticonvulsants|anticonvulsants|mesh-ancestor
111388472|NCT02283827|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111388473|NCT02283827|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111388474|NCT02283827|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111388475|NCT02283827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111388476|NCT02283827|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
111388477|NCT02283827|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111388478|NCT01626092|Cyclosporine|cyclosporine|mesh-list
111388479|NCT01626092|Mycophenolic Acid|mycophenolic acid|mesh-list
111388480|NCT01626092|Melphalan|melphalan|mesh-list
111388481|NCT01626092|Alemtuzumab|alemtuzumab|mesh-list
111388482|NCT01626092|Clofarabine|clofarabine|mesh-list
111388483|NCT01626092|Cyclosporins|cyclosporins|mesh-list
111388484|NCT01626092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111388485|NCT01626092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111388486|NCT01626092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111388487|NCT01626092|Immunologic Factors|immunologic factors|mesh-ancestor
111388488|NCT01626092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111388489|NCT01626092|Antifungal Agents|antifungal agents|mesh-ancestor
111388490|NCT01626092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111388491|NCT01626092|Dermatologic Agents|dermatologic agents|mesh-ancestor
111388492|NCT01626092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111388493|NCT01626092|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111388494|NCT01626092|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111388495|NCT01626092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111388496|NCT01626092|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111388497|NCT01626092|Antitubercular Agents|antitubercular agents|mesh-ancestor
111388498|NCT01626092|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111388499|NCT01626092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111388500|NCT01626092|Alkylating Agents|alkylating agents|mesh-ancestor
111388501|NCT01626092|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111388502|NCT01626092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111388503|NCT01626092|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111388504|NCT01626092|Antimetabolites|antimetabolites|mesh-ancestor
111388505|NCT01694966|Methylene Blue|methylene blue|mesh-list
111388506|NCT01694966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111388507|NCT01694966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111388508|NCT01937975|Grazoprevir|grazoprevir|mesh-list
111388509|NCT01937975|Antiviral Agents|antiviral agents|mesh-ancestor
111388510|NCT01937975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111388511|NCT01628588|Bimatoprost|bimatoprost|mesh-list
111388512|NCT01628588|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111388513|NCT00374985|Docetaxel|docetaxel|mesh-list
111388514|NCT00374985|Oxaliplatin|oxaliplatin|mesh-list
111388515|NCT00374985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111388516|NCT00374985|Tubulin Modulators|tubulin modulators|mesh-ancestor
111388517|NCT00374985|Antimitotic Agents|antimitotic agents|mesh-ancestor
111388518|NCT00374985|Mitosis Modulators|mitosis modulators|mesh-ancestor
111388519|NCT00374985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111112902|NCT04401267|Antihypertensive Agents|antihypertensive agents|mesh-list
111388521|NCT01695668|Cyclosporine|cyclosporine|mesh-list
111388522|NCT01695668|Cyclosporins|cyclosporins|mesh-list
111388523|NCT01695668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111388524|NCT01695668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111388525|NCT01695668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111388526|NCT01695668|Immunologic Factors|immunologic factors|mesh-ancestor
111388527|NCT01695668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111388528|NCT01695668|Antifungal Agents|antifungal agents|mesh-ancestor
111388529|NCT01695668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111388530|NCT01695668|Dermatologic Agents|dermatologic agents|mesh-ancestor
111388531|NCT01695668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111388532|NCT01695668|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111388533|NCT01695668|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111388534|NCT03270020|Denosumab|denosumab|mesh-list
111388535|NCT03270020|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111388536|NCT03270020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111388537|NCT01921751|Paclitaxel|paclitaxel|mesh-list
111388538|NCT01921751|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111388539|NCT01921751|Gemcitabine|gemcitabine|mesh-list
111388540|NCT01921751|Capecitabine|capecitabine|mesh-list
111388541|NCT01921751|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111388542|NCT01921751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111388543|NCT01921751|Tubulin Modulators|tubulin modulators|mesh-ancestor
111388544|NCT01921751|Antimitotic Agents|antimitotic agents|mesh-ancestor
111388545|NCT01921751|Mitosis Modulators|mitosis modulators|mesh-ancestor
111388546|NCT01921751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111388547|NCT01921751|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111388548|NCT01921751|Antimetabolites|antimetabolites|mesh-ancestor
111388549|NCT02958345|Vaccines|vaccines|mesh-list
111388550|NCT02958345|Immunologic Factors|immunologic factors|mesh-ancestor
111388551|NCT02958345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111388552|NCT01629134|Hyaluronic Acid|hyaluronic acid|mesh-list
111388553|NCT01629134|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111388554|NCT01629134|Immunologic Factors|immunologic factors|mesh-ancestor
111388555|NCT01629134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111388556|NCT01629134|Viscosupplements|viscosupplements|mesh-ancestor
111388557|NCT01629134|Protective Agents|protective agents|mesh-ancestor
111388558|NCT01629290|Sodium fluoride topical preparation|sodium fluoride topical preparation|mesh-list
111388559|NCT01629290|Cariostatic Agents|cariostatic agents|mesh-ancestor
111388560|NCT01629290|Protective Agents|protective agents|mesh-ancestor
111388561|NCT01629290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111388562|NCT01696760|Aspirin|aspirin|mesh-list
111388563|NCT01696760|Enoxaparin|enoxaparin|mesh-list
111388564|NCT01696760|Enoxaparin sodium|enoxaparin sodium|mesh-list
111388565|NCT01696760|Anticoagulants|anticoagulants|mesh-ancestor
111388566|NCT01696760|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111388567|NCT01696760|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111388568|NCT01696760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111388569|NCT01696760|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111388570|NCT01696760|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111388571|NCT01696760|Analgesics|analgesics|mesh-ancestor
111388572|NCT01696760|Sensory System Agents|sensory system agents|mesh-ancestor
111388573|NCT01696760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111388574|NCT01696760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111388575|NCT01696760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111388576|NCT01696760|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111388577|NCT01696760|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111388578|NCT01696760|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111388579|NCT01696760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111388580|NCT01696760|Antipyretics|antipyretics|mesh-ancestor
111388581|NCT01924169|Lenalidomide|lenalidomide|mesh-list
111388582|NCT01924169|Vaccines|vaccines|mesh-list
111388583|NCT01924169|Immunologic Factors|immunologic factors|mesh-ancestor
111388584|NCT01924169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111388585|NCT01924169|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111388586|NCT01924169|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111388587|NCT01924169|Growth Substances|growth substances|mesh-ancestor
111388588|NCT01924169|Growth Inhibitors|growth inhibitors|mesh-ancestor
111388589|NCT01924169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111388590|NCT02958969|Apixaban|apixaban|mesh-list
111388591|NCT02958969|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111112989|NCT04122625|Nivolumab|nivolumab|mesh-list
111388592|NCT02958969|Antithrombins|antithrombins|mesh-ancestor
111388593|NCT02958969|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111388594|NCT02958969|Protease Inhibitors|protease inhibitors|mesh-ancestor
111388595|NCT02958969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111388596|NCT02958969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111388597|NCT02958969|Anticoagulants|anticoagulants|mesh-ancestor
111388598|NCT01924871|Remifentanil|remifentanil|mesh-list
111388599|NCT01924871|Desflurane|desflurane|mesh-list
111388600|NCT01924871|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111388601|NCT01924871|Narcotics|narcotics|mesh-ancestor
111388602|NCT01924871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111388603|NCT01924871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111388604|NCT01924871|Analgesics|analgesics|mesh-ancestor
111388605|NCT01924871|Sensory System Agents|sensory system agents|mesh-ancestor
111388606|NCT01924871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111388607|NCT01924871|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111388608|NCT01924871|Anesthetics, General|anesthetics, general|mesh-ancestor
111388609|NCT01924871|Anesthetics|anesthetics|mesh-ancestor
111388610|NCT01698710|Paclitaxel|paclitaxel|mesh-list
111388611|NCT01698710|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111388612|NCT01698710|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111388613|NCT01698710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111388614|NCT01698710|Tubulin Modulators|tubulin modulators|mesh-ancestor
111388615|NCT01698710|Antimitotic Agents|antimitotic agents|mesh-ancestor
111388616|NCT01698710|Mitosis Modulators|mitosis modulators|mesh-ancestor
111388617|NCT01698710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111388618|NCT01924949|Sofosbuvir|sofosbuvir|mesh-list
111388619|NCT01924949|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
111388620|NCT01924949|Ledipasvir|ledipasvir|mesh-list
111388621|NCT01924949|Antiviral Agents|antiviral agents|mesh-ancestor
111388622|NCT01924949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111388623|NCT01938989|Methamphetamine|methamphetamine|mesh-list
111388624|NCT01938989|beta-Endorphin|beta-endorphin|mesh-list
111388625|NCT01938989|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
111388626|NCT01938989|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
111388627|NCT01938989|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111388628|NCT01938989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111388629|NCT01938989|Sympathomimetics|sympathomimetics|mesh-ancestor
111388630|NCT01938989|Autonomic Agents|autonomic agents|mesh-ancestor
111388631|NCT01938989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111388632|NCT01938989|Dopamine Agents|dopamine agents|mesh-ancestor
111388633|NCT01938989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111388634|NCT01938989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111388635|NCT01938989|Adrenergic Agents|adrenergic agents|mesh-ancestor
111388636|NCT01938989|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111388637|NCT01938989|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111388638|NCT01938989|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111388639|NCT01938989|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111388640|NCT01938989|Hormones|hormones|mesh-ancestor
111388641|NCT01938989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111388642|NCT01939301|Nitric Oxide|nitric oxide|mesh-list
111388643|NCT01939301|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111388644|NCT01939301|Autonomic Agents|autonomic agents|mesh-ancestor
111388645|NCT01939301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111388646|NCT01939301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111388647|NCT01939301|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111388648|NCT01939301|Respiratory System Agents|respiratory system agents|mesh-ancestor
111388649|NCT01939301|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111388650|NCT01939301|Antioxidants|antioxidants|mesh-ancestor
111388651|NCT01939301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111388652|NCT01939301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111388653|NCT01939301|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
111388654|NCT01939301|Vasodilator Agents|vasodilator agents|mesh-ancestor
111388655|NCT01939301|Gasotransmitters|gasotransmitters|mesh-ancestor
111388656|NCT01939301|Protective Agents|protective agents|mesh-ancestor
111388657|NCT03078075|Naltrexone|naltrexone|mesh-list
111388658|NCT03078075|Bupropion|bupropion|mesh-list
111388659|NCT03078075|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111388660|NCT03078075|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111388661|NCT03078075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111388662|NCT03078075|Sensory System Agents|sensory system agents|mesh-ancestor
111388663|NCT03078075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111388664|NCT03078075|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111388665|NCT03078075|Antidepressive Agents|antidepressive agents|mesh-ancestor
111388666|NCT03078075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111388667|NCT03078075|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111388668|NCT03078075|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111388669|NCT03078075|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111113052|NCT03767075|Atezolizumab|atezolizumab|mesh-list
111388670|NCT03078075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111388672|NCT03078075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111388673|NCT03078075|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111388674|NCT03078075|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111388675|NCT03078075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111388676|NCT01926977|Ranibizumab|ranibizumab|mesh-list
111388677|NCT01926977|Aflibercept|aflibercept|mesh-list
111388678|NCT01926977|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111388679|NCT01926977|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111388680|NCT01926977|Growth Substances|growth substances|mesh-ancestor
111388681|NCT01926977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111388682|NCT01926977|Growth Inhibitors|growth inhibitors|mesh-ancestor
111388683|NCT01926977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111388684|NCT01928693|Moxifloxacin|moxifloxacin|mesh-list
111388685|NCT01928693|Gatifloxacin|gatifloxacin|mesh-list
111388686|NCT01928693|Besifloxacin|besifloxacin|mesh-list
111388687|NCT01928693|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111388688|NCT01928693|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111388689|NCT01928693|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
111388690|NCT01928693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111388691|NCT01928693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111388692|NCT01928693|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111388693|NCT01928693|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111388694|NCT01928693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111388695|NCT01928693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111388696|NCT01928693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111388697|NCT01928693|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111388698|NCT01928693|Contraceptive Agents|contraceptive agents|mesh-ancestor
111388699|NCT01928693|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111388700|NCT01928693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111388701|NCT01928693|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
111388702|NCT01928693|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111388703|NCT01928693|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111388704|NCT01928849|Valproic Acid|valproic acid|mesh-list
111388705|NCT01928849|Anticonvulsants|anticonvulsants|mesh-ancestor
111388706|NCT01928849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111388707|NCT01928849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111388708|NCT01928849|GABA Agents|gaba agents|mesh-ancestor
111388709|NCT01928849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111388710|NCT01928849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111388711|NCT01928849|Antimanic Agents|antimanic agents|mesh-ancestor
111388712|NCT01928849|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111388713|NCT01928849|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111388714|NCT01928849|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111388715|NCT01631552|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
111388716|NCT01631552|Immunoconjugates|immunoconjugates|mesh-ancestor
111388717|NCT01631552|Immunologic Factors|immunologic factors|mesh-ancestor
111388718|NCT01631552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111388719|NCT03081117|Insulin|insulin|mesh-list
111388720|NCT03081117|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111388721|NCT03081117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111388722|NCT01944293|Midazolam|midazolam|mesh-list
111388723|NCT01944293|Ketamine|ketamine|mesh-list
111388724|NCT01944293|Analgesics|analgesics|mesh-ancestor
111388725|NCT01944293|Sensory System Agents|sensory system agents|mesh-ancestor
111388726|NCT01944293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111388727|NCT01944293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111388728|NCT01944293|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111388729|NCT01944293|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111388730|NCT01944293|Anesthetics, General|anesthetics, general|mesh-ancestor
111388731|NCT01944293|Anesthetics|anesthetics|mesh-ancestor
111388732|NCT01944293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111388733|NCT01944293|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111388734|NCT01944293|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111388735|NCT01944293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111388736|NCT01944293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111388737|NCT01944293|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111388738|NCT01944293|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111388739|NCT01944293|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111388740|NCT01944293|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111388741|NCT01944293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111388742|NCT01944293|GABA Modulators|gaba modulators|mesh-ancestor
111388743|NCT01944293|GABA Agents|gaba agents|mesh-ancestor
111388744|NCT01944371|Disulfiram|disulfiram|mesh-list
111388745|NCT01944371|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111388746|NCT01944371|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
111388747|NCT01944371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111388748|NCT01944371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111388749|NCT02343120|Zanubrutinib|zanubrutinib|mesh-list
111388750|NCT02343120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111388751|NCT02343120|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111388752|NCT02343120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111388753|NCT02343120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111388754|NCT01631630|Pioglitazone|pioglitazone|mesh-list
111388755|NCT01631630|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111388756|NCT01631630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111388757|NCT03837860|Oxycodone|oxycodone|mesh-list
111388758|NCT03837860|Risperidone|risperidone|mesh-list
111388759|NCT03837860|Ziprasidone|ziprasidone|mesh-list
111388760|NCT03837860|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111388761|NCT03837860|Narcotics|narcotics|mesh-ancestor
111388762|NCT03837860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111388763|NCT03837860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111388764|NCT03837860|Analgesics|analgesics|mesh-ancestor
111388765|NCT03837860|Sensory System Agents|sensory system agents|mesh-ancestor
111388766|NCT03837860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111388767|NCT03837860|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111388768|NCT03837860|Serotonin Agents|serotonin agents|mesh-ancestor
111388769|NCT03837860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111388770|NCT03837860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111388771|NCT03837860|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111388772|NCT03837860|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111388773|NCT03837860|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111388774|NCT03837860|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111388775|NCT03837860|Dopamine Agents|dopamine agents|mesh-ancestor
111388776|NCT02289989|Hydrocortisone|hydrocortisone|mesh-list
111388777|NCT02289989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111388778|NCT03076112|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111388779|NCT03076112|Ipragliflozin|ipragliflozin|mesh-list
111388780|NCT03076112|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111388781|NCT03076112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111388782|NCT03076112|Incretins|incretins|mesh-ancestor
111388783|NCT03076112|Hormones|hormones|mesh-ancestor
111388784|NCT03076112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111388785|NCT03076112|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111388786|NCT03076112|Protease Inhibitors|protease inhibitors|mesh-ancestor
111388787|NCT03076112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111388788|NCT03076112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111388789|NCT03076112|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111388790|NCT03129945|Indomethacin|indomethacin|mesh-list
111388791|NCT03129945|Nifedipine|nifedipine|mesh-list
111388792|NCT03129945|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111388793|NCT03129945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111388794|NCT03129945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111388795|NCT03129945|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111388796|NCT03129945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111388797|NCT03129945|Vasodilator Agents|vasodilator agents|mesh-ancestor
111388798|NCT03129945|Tocolytic Agents|tocolytic agents|mesh-ancestor
111388799|NCT03129945|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111388800|NCT03129945|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111388801|NCT03129945|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111388802|NCT03129945|Analgesics|analgesics|mesh-ancestor
111388803|NCT03129945|Sensory System Agents|sensory system agents|mesh-ancestor
111388804|NCT03129945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111388805|NCT03129945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111388806|NCT03129945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111388807|NCT03129945|Gout Suppressants|gout suppressants|mesh-ancestor
111388808|NCT03129945|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111388809|NCT03129945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111388810|NCT01700036|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
111388811|NCT01700036|Protein C Inhibitor|protein c inhibitor|mesh-list
111388812|NCT01700036|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
111388813|NCT01700036|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111388814|NCT01700036|Protease Inhibitors|protease inhibitors|mesh-ancestor
111388815|NCT01700036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111388816|NCT01700036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111388817|NCT01950299|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
111388818|NCT01950299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111388820|NCT03093207|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111388821|NCT03093207|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111388822|NCT03093207|Analgesics|analgesics|mesh-ancestor
110528792|NCT03116126|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111388823|NCT03093207|Sensory System Agents|sensory system agents|mesh-ancestor
111388824|NCT03093207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111388825|NCT03093207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111388826|NCT03093207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111388827|NCT03093207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111388828|NCT03093207|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111388829|NCT03093207|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111388830|NCT03093207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111388831|NCT03093207|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111388832|NCT03093207|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111388833|NCT03093207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111388834|NCT03093207|Antipyretics|antipyretics|mesh-ancestor
111388835|NCT05482451|Nivolumab|nivolumab|mesh-list
111388836|NCT05482451|Tretinoin|tretinoin|mesh-list
111388837|NCT05482451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111388838|NCT05482451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111388839|NCT05482451|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111388840|NCT05482451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111388841|NCT05482451|Keratolytic Agents|keratolytic agents|mesh-ancestor
111388842|NCT05482451|Dermatologic Agents|dermatologic agents|mesh-ancestor
111388843|NCT02228408|Hydralazine|hydralazine|mesh-list
111388844|NCT02228408|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111388845|NCT02228408|Vasodilator Agents|vasodilator agents|mesh-ancestor
111388846|NCT01951391|Benzalkonium Compounds|benzalkonium compounds|mesh-list
111388847|NCT01951391|Triclocarban|triclocarban|mesh-list
111388848|NCT01951391|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111388849|NCT01951391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111388850|NCT02342886|Moxifloxacin|moxifloxacin|mesh-list
111388851|NCT02342886|Rifampin|rifampin|mesh-list
111388852|NCT02342886|Isoniazid|isoniazid|mesh-list
111388853|NCT02342886|Pyrazinamide|pyrazinamide|mesh-list
111388854|NCT02342886|Ethambutol|ethambutol|mesh-list
111388855|NCT02342886|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111388856|NCT02342886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111388857|NCT02342886|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111388858|NCT02342886|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111388859|NCT02342886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111388860|NCT02342886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111388861|NCT02342886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111388862|NCT02342886|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111388863|NCT02342886|Antitubercular Agents|antitubercular agents|mesh-ancestor
111388864|NCT02342886|Leprostatic Agents|leprostatic agents|mesh-ancestor
111388865|NCT02342886|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111388866|NCT02342886|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111388867|NCT02342886|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111388868|NCT02342886|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
111388869|NCT02342886|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
111388870|NCT02342886|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
111388871|NCT02342886|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111388872|NCT02342886|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
111388873|NCT02342886|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111388874|NCT02342886|Antimetabolites|antimetabolites|mesh-ancestor
111388875|NCT02342886|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111388876|NCT04350281|Interferons|interferons|mesh-list
111388877|NCT04350281|Interferon-beta|interferon-beta|mesh-list
111388878|NCT04350281|Hydroxychloroquine|hydroxychloroquine|mesh-list
111388879|NCT04350281|Interferon beta-1b|interferon beta-1b|mesh-list
111388880|NCT04350281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111388881|NCT04350281|Antiviral Agents|antiviral agents|mesh-ancestor
111388882|NCT04350281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111388883|NCT04350281|Antimalarials|antimalarials|mesh-ancestor
111388884|NCT04350281|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111388885|NCT04350281|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111388886|NCT04350281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111388887|NCT04350281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111388888|NCT04350281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111388889|NCT04350281|Immunologic Factors|immunologic factors|mesh-ancestor
111388890|NCT04350281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111388891|NCT04350281|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111113276|NCT00579826|Letrozole|letrozole|mesh-list
111388892|NCT02389998|Hyoscyamine|hyoscyamine|mesh-list
111388893|NCT02389998|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111388894|NCT02389998|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111388895|NCT02389998|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111388897|NCT02389998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111388898|NCT02389998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111388899|NCT02389998|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111388900|NCT02389998|Respiratory System Agents|respiratory system agents|mesh-ancestor
111388901|NCT02389998|Mydriatics|mydriatics|mesh-ancestor
111388902|NCT02389998|Parasympatholytics|parasympatholytics|mesh-ancestor
111388903|NCT02389998|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111388904|NCT02389998|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111388905|NCT02389998|Cholinergic Agents|cholinergic agents|mesh-ancestor
111388906|NCT02389998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111388907|NCT02389998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111388908|NCT02389764|Nintedanib|nintedanib|mesh-list
111388909|NCT02389764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111388910|NCT02389764|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111388911|NCT02389764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111388912|NCT02389764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111388913|NCT04903470|Bisacodyl|bisacodyl|mesh-list
111388914|NCT04903470|Cathartics|cathartics|mesh-ancestor
111388915|NCT04903470|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111388916|NCT04903470|Laxatives|laxatives|mesh-ancestor
111388917|NCT01647932|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
111388918|NCT01647932|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111388919|NCT01647932|Diuretics|diuretics|mesh-ancestor
111388920|NCT01647932|Natriuretic Agents|natriuretic agents|mesh-ancestor
111388921|NCT01647932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111388922|NCT01647932|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
111388923|NCT01647932|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111388924|NCT01647932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111388925|NCT04903002|Oxytocin|oxytocin|mesh-list
111388926|NCT04903002|Oxytocics|oxytocics|mesh-ancestor
111388927|NCT04903002|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111388928|NCT04903002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111388929|NCT02366130|Denosumab|denosumab|mesh-list
111388930|NCT02366130|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
111388931|NCT02366130|Hormones|hormones|mesh-list
111388932|NCT02366130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111388933|NCT02366130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111388934|NCT02366130|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111388935|NCT02366130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111388936|NCT01635062|Calcitriol|calcitriol|mesh-list
111388937|NCT01635062|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
111388938|NCT01635062|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111388939|NCT01635062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111388940|NCT01635062|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
111388941|NCT01635062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111388942|NCT01635062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111388943|NCT01635062|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111388944|NCT01635062|Vitamins|vitamins|mesh-ancestor
111388945|NCT01635062|Micronutrients|micronutrients|mesh-ancestor
111388946|NCT01635062|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111388947|NCT01637090|Everolimus|everolimus|mesh-list
111388948|NCT01637090|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111388949|NCT01637090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111388950|NCT01637090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110528933|NCT03812588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111388951|NCT01637090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111388952|NCT01637090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111388953|NCT01637090|Immunologic Factors|immunologic factors|mesh-ancestor
111388954|NCT01637090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111388955|NCT01637090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111388956|NCT02389452|Hylan|hylan|mesh-list
111388957|NCT02389452|Viscosupplements|viscosupplements|mesh-ancestor
111388958|NCT02389452|Protective Agents|protective agents|mesh-ancestor
111388959|NCT02389452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111388960|NCT02365584|Lanreotide|lanreotide|mesh-list
111388961|NCT02365584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111388962|NCT02342418|Tedizolid|tedizolid|mesh-list
111388963|NCT02342418|Tedizolid phosphate|tedizolid phosphate|mesh-list
111388964|NCT02342418|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111388965|NCT02342418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111388966|NCT05727449|Anesthetics|anesthetics|mesh-list
111388967|NCT05727449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110959240|NCT03526224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111388968|NCT05727449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111388969|NCT03102645|Imipramine|imipramine|mesh-list
111388970|NCT03102645|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
111388971|NCT03102645|Antidepressive Agents|antidepressive agents|mesh-ancestor
111388972|NCT03102645|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111388973|NCT03102645|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111388974|NCT03102645|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111388975|NCT03102645|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111388976|NCT03102645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111388977|NCT03102645|Adrenergic Agents|adrenergic agents|mesh-ancestor
111388978|NCT03102645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111388979|NCT03102645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111388980|NCT01639352|Pasireotide|pasireotide|mesh-list
111388981|NCT01639352|Hormones|hormones|mesh-ancestor
111388982|NCT01639352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111388983|NCT01639352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111388984|NCT01705496|Fialuridine|fialuridine|mesh-list
111388985|NCT01705496|Antiviral Agents|antiviral agents|mesh-ancestor
111388986|NCT01705496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111388987|NCT01705496|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111388988|NCT01705496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111388989|NCT01705496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111388990|NCT02287415|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
111388991|NCT02287415|Warfarin|warfarin|mesh-list
111388992|NCT02287415|Anticoagulants|anticoagulants|mesh-ancestor
111388993|NCT02287415|Anticonvulsants|anticonvulsants|mesh-ancestor
111388994|NCT02287415|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111388995|NCT02287415|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111388996|NCT02287415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111388997|NCT02287415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111388998|NCT02312934|Nicotine|nicotine|mesh-list
111388999|NCT02312934|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111389000|NCT02312934|Autonomic Agents|autonomic agents|mesh-ancestor
111389001|NCT02312934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111389002|NCT02312934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111389003|NCT02312934|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111389004|NCT02312934|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111389005|NCT02312934|Cholinergic Agents|cholinergic agents|mesh-ancestor
111389006|NCT02312934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111389007|NCT02312934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111389008|NCT04707027|Aflibercept|aflibercept|mesh-list
111389009|NCT04707027|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111389010|NCT04707027|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111389011|NCT04707027|Growth Substances|growth substances|mesh-ancestor
111389012|NCT04707027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111389013|NCT04707027|Growth Inhibitors|growth inhibitors|mesh-ancestor
111389014|NCT04707027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111389015|NCT01602068|Dexamethasone|dexamethasone|mesh-list
111389016|NCT01602068|Citric Acid|citric acid|mesh-list
111389017|NCT01602068|Sodium Citrate|sodium citrate|mesh-list
111389018|NCT01602068|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
111389019|NCT01602068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111389020|NCT01602068|Antiemetics|antiemetics|mesh-ancestor
111389021|NCT01602068|Autonomic Agents|autonomic agents|mesh-ancestor
111389022|NCT01602068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111389023|NCT01602068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111389024|NCT01602068|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111389025|NCT01602068|Glucocorticoids|glucocorticoids|mesh-ancestor
111389026|NCT01602068|Hormones|hormones|mesh-ancestor
111389027|NCT01602068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111389028|NCT01602068|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111389029|NCT01602068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111389030|NCT01602068|Anticoagulants|anticoagulants|mesh-ancestor
111389031|NCT01602068|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
111389032|NCT01602068|Chelating Agents|chelating agents|mesh-ancestor
111389033|NCT01602068|Sequestering Agents|sequestering agents|mesh-ancestor
111389034|NCT01602068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111389035|NCT02978157|Amoxicillin|amoxicillin|mesh-list
111389036|NCT02978157|Levofloxacin|levofloxacin|mesh-list
111389037|NCT02978157|Ofloxacin|ofloxacin|mesh-list
111389038|NCT02978157|Tetracycline|tetracycline|mesh-list
111389039|NCT02978157|Esomeprazole|esomeprazole|mesh-list
111389040|NCT02978157|Bismuth|bismuth|mesh-list
111389041|NCT02978157|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111389042|NCT02978157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111113423|NCT04719221|Evolocumab|evolocumab|mesh-list
111389043|NCT02978157|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111389044|NCT02978157|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111389045|NCT02978157|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111389046|NCT02978157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111389047|NCT02978157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111389048|NCT02978157|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111389049|NCT02978157|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111389050|NCT02978157|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111389051|NCT02978157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111389052|NCT02978157|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111389053|NCT02978157|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111389055|NCT02978157|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111389056|NCT01705964|Epinephrine|epinephrine|mesh-list
111389057|NCT01705964|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111389058|NCT01705964|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111389059|NCT01705964|Adrenergic Agents|adrenergic agents|mesh-ancestor
111389060|NCT01705964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111389061|NCT01705964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111389062|NCT01705964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111389063|NCT01705964|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111389064|NCT01705964|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111389065|NCT01705964|Autonomic Agents|autonomic agents|mesh-ancestor
111389066|NCT01705964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111389067|NCT01705964|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111389068|NCT01705964|Respiratory System Agents|respiratory system agents|mesh-ancestor
111389069|NCT01705964|Mydriatics|mydriatics|mesh-ancestor
111389070|NCT01705964|Sympathomimetics|sympathomimetics|mesh-ancestor
111389071|NCT01705964|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111389072|NCT02341482|Itraconazole|itraconazole|mesh-list
111389073|NCT02341482|Antifungal Agents|antifungal agents|mesh-ancestor
111389074|NCT02341482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111389075|NCT02341482|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111389076|NCT02341482|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111389077|NCT02341482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111389078|NCT02341482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111389079|NCT02341482|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111389080|NCT02341482|Hormone Antagonists|hormone antagonists|mesh-ancestor
111389081|NCT02341482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111389082|NCT02341482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111389083|NCT02341482|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111389084|NCT03140631|Protamines|protamines|mesh-list
111389085|NCT03140631|Heparin Antagonists|heparin antagonists|mesh-ancestor
111389086|NCT03140631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111389087|NCT03140631|Coagulants|coagulants|mesh-ancestor
111389088|NCT04420260|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
111389089|NCT04420260|Immunologic Factors|immunologic factors|mesh-ancestor
111389090|NCT04420260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111389091|NCT00422643|Hyaluronic Acid|hyaluronic acid|mesh-list
111389092|NCT00422643|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111389093|NCT00422643|Immunologic Factors|immunologic factors|mesh-ancestor
111389094|NCT00422643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111389095|NCT00422643|Viscosupplements|viscosupplements|mesh-ancestor
111389096|NCT00422643|Protective Agents|protective agents|mesh-ancestor
111389097|NCT05405907|Hemostatics|hemostatics|mesh-list
111389098|NCT05405907|Coagulants|coagulants|mesh-ancestor
111389099|NCT01706588|Diclofenac|diclofenac|mesh-list
111389100|NCT01706588|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111389101|NCT01706588|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111389102|NCT01706588|Analgesics|analgesics|mesh-ancestor
111389103|NCT01706588|Sensory System Agents|sensory system agents|mesh-ancestor
111389104|NCT01706588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111389105|NCT01706588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111389106|NCT01706588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111389107|NCT01706588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111389108|NCT01706588|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111389109|NCT01706588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111389110|NCT01706588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111389111|NCT01602692|Lidocaine|lidocaine|mesh-list
111389112|NCT01602692|Epinephrine|epinephrine|mesh-list
111389113|NCT01602692|Racepinephrine|racepinephrine|mesh-list
111389114|NCT01602692|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111389115|NCT01602692|Epinephryl borate|epinephryl borate|mesh-list
110959241|NCT03526224|Immunologic Factors|immunologic factors|mesh-ancestor
111389117|NCT01602692|Anesthetics|anesthetics|mesh-ancestor
111389118|NCT01602692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111389119|NCT01602692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111389120|NCT01602692|Sensory System Agents|sensory system agents|mesh-ancestor
111389121|NCT01602692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111389122|NCT01602692|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111389123|NCT01602692|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111389124|NCT01602692|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111389125|NCT01602692|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111389126|NCT01602692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111389127|NCT01602692|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111389128|NCT01602692|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111389129|NCT01602692|Adrenergic Agents|adrenergic agents|mesh-ancestor
111389130|NCT01602692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111389131|NCT01602692|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111389132|NCT01602692|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111389133|NCT01602692|Autonomic Agents|autonomic agents|mesh-ancestor
111389134|NCT01602692|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111389135|NCT01602692|Respiratory System Agents|respiratory system agents|mesh-ancestor
111389136|NCT01602692|Mydriatics|mydriatics|mesh-ancestor
111389137|NCT01602692|Sympathomimetics|sympathomimetics|mesh-ancestor
111389138|NCT01602692|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111389139|NCT01603940|Losartan|losartan|mesh-list
111389140|NCT01603940|Benazepril|benazepril|mesh-list
111389141|NCT01603940|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111389142|NCT01603940|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111389143|NCT01603940|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111389144|NCT01603940|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111389145|NCT01603940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111389146|NCT01603940|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
111389147|NCT01603940|Protease Inhibitors|protease inhibitors|mesh-ancestor
111389148|NCT01603940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111389149|NCT01605032|Bortezomib|bortezomib|mesh-list
111389150|NCT01605032|Melphalan|melphalan|mesh-list
111389151|NCT01605032|Busulfan|busulfan|mesh-list
111389152|NCT01605032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111389153|NCT01605032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111389154|NCT01605032|Alkylating Agents|alkylating agents|mesh-ancestor
111389155|NCT01605032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111389156|NCT01605032|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111389157|NCT01605032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111389158|NCT01605032|Immunologic Factors|immunologic factors|mesh-ancestor
111389159|NCT01605032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111389160|NCT01706666|Dexamethasone|dexamethasone|mesh-list
111389161|NCT01706666|Cyclophosphamide|cyclophosphamide|mesh-list
111389162|NCT01706666|Lenalidomide|lenalidomide|mesh-list
111389163|NCT01706666|Bortezomib|bortezomib|mesh-list
111389164|NCT01706666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111389165|NCT01706666|Immunologic Factors|immunologic factors|mesh-ancestor
111389166|NCT01706666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111389167|NCT01706666|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111389168|NCT01706666|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111389169|NCT01706666|Alkylating Agents|alkylating agents|mesh-ancestor
111389170|NCT01706666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111389171|NCT01706666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111389172|NCT01706666|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111389173|NCT01706666|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111389174|NCT01706666|Antiemetics|antiemetics|mesh-ancestor
111389175|NCT01706666|Autonomic Agents|autonomic agents|mesh-ancestor
111389176|NCT01706666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111389177|NCT01706666|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111389178|NCT01706666|Glucocorticoids|glucocorticoids|mesh-ancestor
111389179|NCT01706666|Hormones|hormones|mesh-ancestor
111389180|NCT01706666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111389181|NCT01706666|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111389182|NCT01706666|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111389183|NCT01706666|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111389184|NCT01706666|Growth Substances|growth substances|mesh-ancestor
111389185|NCT01706666|Growth Inhibitors|growth inhibitors|mesh-ancestor
111389186|NCT03149991|Ketamine|ketamine|mesh-list
111389187|NCT03149991|Brexpiprazole|brexpiprazole|mesh-list
111389188|NCT03149991|Analgesics|analgesics|mesh-ancestor
111389189|NCT03149991|Sensory System Agents|sensory system agents|mesh-ancestor
111113599|NCT03832049|Vaccines|vaccines|mesh-list
111389190|NCT03149991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111389191|NCT03149991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111389192|NCT03149991|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111389193|NCT03149991|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111389194|NCT03149991|Anesthetics, General|anesthetics, general|mesh-ancestor
111389195|NCT03149991|Anesthetics|anesthetics|mesh-ancestor
111389196|NCT03149991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111389197|NCT03149991|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111389198|NCT03149991|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111389199|NCT03149991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111389200|NCT03149991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111389201|NCT03149991|Serotonin Agents|serotonin agents|mesh-ancestor
111389202|NCT03149991|Dopamine Agonists|dopamine agonists|mesh-ancestor
111389203|NCT03149991|Dopamine Agents|dopamine agents|mesh-ancestor
111389204|NCT05704439|Antihypertensive Agents|antihypertensive agents|mesh-list
111389205|NCT05400993|Cyclophosphamide|cyclophosphamide|mesh-list
111389206|NCT05400993|Docetaxel|docetaxel|mesh-list
111389207|NCT05400993|Epirubicin|epirubicin|mesh-list
111389208|NCT05400993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111389209|NCT05400993|Immunologic Factors|immunologic factors|mesh-ancestor
111389210|NCT05400993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111389211|NCT05400993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111389212|NCT05400993|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111389213|NCT05400993|Alkylating Agents|alkylating agents|mesh-ancestor
111389214|NCT05400993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111389215|NCT05400993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111389216|NCT05400993|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111389217|NCT05400993|Tubulin Modulators|tubulin modulators|mesh-ancestor
111389218|NCT05400993|Antimitotic Agents|antimitotic agents|mesh-ancestor
111389219|NCT05400993|Mitosis Modulators|mitosis modulators|mesh-ancestor
111389220|NCT05400993|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111389221|NCT05400993|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111389222|NCT05400993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111389223|NCT05400993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111389224|NCT01605890|Tenofovir|tenofovir|mesh-list
111389225|NCT01605890|Emtricitabine|emtricitabine|mesh-list
111389226|NCT01605890|Raltegravir Potassium|raltegravir potassium|mesh-list
111389227|NCT01605890|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
111389228|NCT01605890|Antiviral Agents|antiviral agents|mesh-ancestor
111389229|NCT01605890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111389230|NCT01605890|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111389231|NCT01605890|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111389232|NCT01605890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111389233|NCT01605890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111389234|NCT01605890|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111389235|NCT01605890|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111389236|NCT01605890|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111389237|NCT01605890|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111389238|NCT02288273|Exenatide|exenatide|mesh-list
111389239|NCT02288273|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111389240|NCT02288273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111389241|NCT02288273|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111389242|NCT02288273|Incretins|incretins|mesh-ancestor
111389243|NCT02288273|Hormones|hormones|mesh-ancestor
111389244|NCT02288273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111389245|NCT01606124|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
111389246|NCT01606124|Antioxidants|antioxidants|mesh-ancestor
111389247|NCT01606124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111389248|NCT01606124|Protective Agents|protective agents|mesh-ancestor
111389249|NCT01606124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111389250|NCT01606124|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
111389251|NCT01606124|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
111389252|NCT01606124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111389253|NCT01606124|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111389254|NCT01607450|Glucagon|glucagon|mesh-list
111389255|NCT01607450|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
111389256|NCT01607450|Incretins|incretins|mesh-ancestor
111389257|NCT01607450|Hormones|hormones|mesh-ancestor
111389258|NCT01607450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111389259|NCT01607450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111389260|NCT01607450|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111389261|NCT05738993|Pertuzumab|pertuzumab|mesh-list
111389262|NCT05738993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111389263|NCT05738993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111389264|NCT01709474|Vitamin D|vitamin d|mesh-list
111389265|NCT01709474|Ergocalciferols|ergocalciferols|mesh-list
111389266|NCT01709474|Cholecalciferol|cholecalciferol|mesh-list
111389267|NCT01709474|Vitamins|vitamins|mesh-list
111389268|NCT01709474|Micronutrients|micronutrients|mesh-ancestor
111389269|NCT01709474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111389270|NCT01709474|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111389271|NCT01709474|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111389272|NCT02992808|Menotropins|menotropins|mesh-list
111389273|NCT02992808|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111389274|NCT02992808|Fertility Agents|fertility agents|mesh-ancestor
111389275|NCT02992808|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111389276|NCT02992808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111389277|NCT02992886|Raltitrexed|raltitrexed|mesh-list
111389278|NCT02992886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111389279|NCT02992886|Antimetabolites|antimetabolites|mesh-ancestor
111389280|NCT02992886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111389281|NCT02992886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111389282|NCT02992886|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111389283|NCT02992886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111389284|NCT02331095|Warfarin|warfarin|mesh-list
111389285|NCT02331095|Rivaroxaban|rivaroxaban|mesh-list
111389286|NCT02331095|Atorvastatin|atorvastatin|mesh-list
111389287|NCT02331095|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111389288|NCT02331095|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111389289|NCT02331095|Antimetabolites|antimetabolites|mesh-ancestor
111389290|NCT02331095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111389291|NCT02331095|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111389292|NCT02331095|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111389293|NCT02331095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111389294|NCT02331095|Anticoagulants|anticoagulants|mesh-ancestor
111389295|NCT02331095|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111389296|NCT02331095|Antithrombins|antithrombins|mesh-ancestor
111389297|NCT02331095|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111389298|NCT02331095|Protease Inhibitors|protease inhibitors|mesh-ancestor
111389299|NCT01640834|Glucagon|glucagon|mesh-list
111389300|NCT01640834|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111389301|NCT01640834|Hormones|hormones|mesh-ancestor
111389302|NCT01640834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111389303|NCT01640834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111389304|NCT03029273|Cyclophosphamide|cyclophosphamide|mesh-list
111389305|NCT03029273|Fludarabine|fludarabine|mesh-list
111389306|NCT03029273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111389307|NCT03029273|Immunologic Factors|immunologic factors|mesh-ancestor
111389308|NCT03029273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111389309|NCT03029273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111389310|NCT03029273|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111389311|NCT03029273|Alkylating Agents|alkylating agents|mesh-ancestor
111389312|NCT03029273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111389313|NCT03029273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111389314|NCT03029273|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111389315|NCT05316935|Letrozole|letrozole|mesh-list
111389316|NCT05316935|Ethinyl Estradiol|ethinyl estradiol|mesh-list
111389317|NCT05316935|Cyproterone|cyproterone|mesh-list
111389318|NCT05316935|Cyproterone acetate, ethinyl estradiol drug combination|cyproterone acetate, ethinyl estradiol drug combination|mesh-list
111389319|NCT05316935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111389320|NCT05316935|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111389321|NCT05316935|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111389322|NCT05316935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111389323|NCT05316935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111389324|NCT05316935|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111389325|NCT05316935|Hormone Antagonists|hormone antagonists|mesh-ancestor
111389326|NCT05316935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111389327|NCT05316935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111389328|NCT05316935|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111389329|NCT05316935|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111389330|NCT05316935|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111389331|NCT05316935|Contraceptive Agents|contraceptive agents|mesh-ancestor
111389332|NCT05316935|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111389333|NCT05316935|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111389334|NCT05316935|Estrogens|estrogens|mesh-ancestor
111389335|NCT05316935|Hormones|hormones|mesh-ancestor
111389336|NCT05316935|Androgen Antagonists|androgen antagonists|mesh-ancestor
111389337|NCT05738759|Anesthetics|anesthetics|mesh-list
111389338|NCT05738759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111389339|NCT05738759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111389340|NCT05738681|Acetylcysteine|acetylcysteine|mesh-list
111389341|NCT05738681|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111389342|NCT05738681|Antiviral Agents|antiviral agents|mesh-ancestor
111389343|NCT05738681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111389344|NCT05738681|Expectorants|expectorants|mesh-ancestor
111389345|NCT05738681|Respiratory System Agents|respiratory system agents|mesh-ancestor
111389346|NCT05738681|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111389347|NCT05738681|Antioxidants|antioxidants|mesh-ancestor
110529329|NCT02731040|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111389348|NCT05738681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111389349|NCT05738681|Protective Agents|protective agents|mesh-ancestor
111389350|NCT05738681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111389351|NCT05738681|Antidotes|antidotes|mesh-ancestor
111389352|NCT01642082|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
111389353|NCT01642082|Immunologic Factors|immunologic factors|mesh-ancestor
111389354|NCT01642082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111389355|NCT02288819|Diuretics|diuretics|mesh-list
111389356|NCT02288819|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
111389357|NCT02288819|Natriuretic Agents|natriuretic agents|mesh-ancestor
111389358|NCT02288819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111389359|NCT02288819|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111389360|NCT02288819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111389361|NCT01642238|Aspirin|aspirin|mesh-list
111389362|NCT01642238|Hirudins|hirudins|mesh-list
111389363|NCT01642238|Bivalirudin|bivalirudin|mesh-list
111389364|NCT01642238|Clopidogrel|clopidogrel|mesh-list
111389365|NCT01642238|Ticagrelor|ticagrelor|mesh-list
111389366|NCT01642238|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111389367|NCT01642238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111389368|NCT01642238|Analgesics|analgesics|mesh-ancestor
111389369|NCT01642238|Sensory System Agents|sensory system agents|mesh-ancestor
111389370|NCT01642238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111389371|NCT01642238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111389372|NCT01642238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111389373|NCT01642238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111389374|NCT01642238|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111389375|NCT01642238|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111389376|NCT01642238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111389377|NCT01642238|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111389378|NCT01642238|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111389379|NCT01642238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111389380|NCT01642238|Antipyretics|antipyretics|mesh-ancestor
111389381|NCT01642238|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111389382|NCT01642238|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111389383|NCT01642238|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111389384|NCT01642238|Purinergic Agents|purinergic agents|mesh-ancestor
111389385|NCT01642238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111389386|NCT01642238|Antithrombins|antithrombins|mesh-ancestor
111389387|NCT01642238|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111389388|NCT01642238|Protease Inhibitors|protease inhibitors|mesh-ancestor
111389389|NCT01642238|Anticoagulants|anticoagulants|mesh-ancestor
111389390|NCT05259995|Oxymetazoline|oxymetazoline|mesh-list
111389391|NCT05259995|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111389392|NCT05259995|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111389393|NCT05259995|Adrenergic Agents|adrenergic agents|mesh-ancestor
111389394|NCT05259995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111389395|NCT05259995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111389396|NCT05259995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111389397|NCT05259995|Sympathomimetics|sympathomimetics|mesh-ancestor
111389398|NCT05259995|Autonomic Agents|autonomic agents|mesh-ancestor
111389399|NCT05259995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111389400|NCT05259995|Nasal Decongestants|nasal decongestants|mesh-ancestor
111389401|NCT05259995|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111389402|NCT05259995|Respiratory System Agents|respiratory system agents|mesh-ancestor
111389403|NCT03028883|Buprenorphine|buprenorphine|mesh-list
111389404|NCT03028883|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111389405|NCT03028883|Narcotics|narcotics|mesh-ancestor
111389406|NCT03028883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111389407|NCT03028883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111389408|NCT03028883|Analgesics|analgesics|mesh-ancestor
111389409|NCT03028883|Sensory System Agents|sensory system agents|mesh-ancestor
111389410|NCT03028883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111389411|NCT03028883|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111389412|NCT05238467|Antibodies|antibodies|mesh-list
111389413|NCT05238467|Immunologic Factors|immunologic factors|mesh-ancestor
111389414|NCT05238467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111389415|NCT02290613|Ambrisentan|ambrisentan|mesh-list
111389416|NCT02290613|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111389417|NCT02986685|Rabeprazole|rabeprazole|mesh-list
111389418|NCT02986685|Trimebutine|trimebutine|mesh-list
111389419|NCT02986685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110529396|NCT02729870|Laxatives|laxatives|mesh-ancestor
111389420|NCT02986685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111389421|NCT02986685|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111389422|NCT02986685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111389423|NCT02986685|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111389424|NCT02986685|Parasympatholytics|parasympatholytics|mesh-ancestor
111389425|NCT02986685|Autonomic Agents|autonomic agents|mesh-ancestor
111389426|NCT02986685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111389427|NCT02986685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111389428|NCT01610570|Plicamycin|plicamycin|mesh-list
111389429|NCT01610570|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111389430|NCT01610570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111389431|NCT01610570|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111389432|NCT01610570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111389433|NCT01610570|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111389434|NCT01610570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111389435|NCT01610570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111389436|NCT01610570|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111389437|NCT01611662|Gemcitabine|gemcitabine|mesh-list
111389438|NCT01611662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111389439|NCT01611662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111389440|NCT01611662|Antimetabolites|antimetabolites|mesh-ancestor
111389441|NCT01611662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111389442|NCT05200481|Carboplatin|carboplatin|mesh-list
111389443|NCT05200481|Pemetrexed|pemetrexed|mesh-list
111389444|NCT05200481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111389445|NCT05200481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111389446|NCT05200481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111389447|NCT05200481|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111389448|NCT05200481|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111389449|NCT01615484|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111389450|NCT05139563|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
111389451|NCT05139563|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
111389452|NCT05139563|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
111389453|NCT05139563|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111389454|NCT01646762|Paclitaxel|paclitaxel|mesh-list
111389455|NCT01646762|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111389456|NCT01646762|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111389457|NCT01646762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111389458|NCT01646762|Tubulin Modulators|tubulin modulators|mesh-ancestor
111389459|NCT01646762|Antimitotic Agents|antimitotic agents|mesh-ancestor
111389460|NCT01646762|Mitosis Modulators|mitosis modulators|mesh-ancestor
111389461|NCT01646762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111389462|NCT04997525|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
111389463|NCT04997525|Estradiol|estradiol|mesh-list
111389464|NCT04997525|Progesterone|progesterone|mesh-list
111389465|NCT04997525|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
111389466|NCT04997525|Estrogens|estrogens|mesh-ancestor
111389467|NCT04997525|Hormones|hormones|mesh-ancestor
111389468|NCT04997525|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111389469|NCT04997525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111389470|NCT04997525|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111389471|NCT04997525|Progestins|progestins|mesh-ancestor
111389472|NCT01649180|Axitinib|axitinib|mesh-list
111389473|NCT01649180|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
111389474|NCT01649180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111389475|NCT01649180|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111389476|NCT01649180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111389477|NCT01649180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111389478|NCT04408313|Naltrexone|naltrexone|mesh-list
111389479|NCT04408313|Buprenorphine|buprenorphine|mesh-list
111389480|NCT04408313|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111389481|NCT04408313|Narcotics|narcotics|mesh-ancestor
111389482|NCT04408313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111389483|NCT04408313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111389484|NCT04408313|Analgesics|analgesics|mesh-ancestor
111389485|NCT04408313|Sensory System Agents|sensory system agents|mesh-ancestor
111389486|NCT04408313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111389487|NCT04408313|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111389488|NCT04408313|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111389489|NCT01619774|Trametinib|trametinib|mesh-list
111389490|NCT01619774|Dabrafenib|dabrafenib|mesh-list
111389491|NCT01619774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111389492|NCT01619774|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111389493|NCT01619774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111389494|NCT01619774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111389495|NCT01651442|Zolpidem|zolpidem|mesh-list
111389496|NCT01651442|Trazodone|trazodone|mesh-list
111389497|NCT01651442|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111389498|NCT01651442|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111389499|NCT01651442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111389500|NCT01651442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111389501|NCT01651442|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
111389502|NCT01651442|GABA Agonists|gaba agonists|mesh-ancestor
111389503|NCT01651442|GABA Agents|gaba agents|mesh-ancestor
111389504|NCT01651442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111389505|NCT01651442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111389506|NCT01651442|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111389507|NCT01651442|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111389508|NCT01651442|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111389509|NCT01651442|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111389510|NCT01651442|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111389511|NCT01651442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111389512|NCT01651442|Serotonin Agents|serotonin agents|mesh-ancestor
111389513|NCT01651442|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111389514|NCT01651442|Antidepressive Agents|antidepressive agents|mesh-ancestor
111389515|NCT04901975|Spironolactone|spironolactone|mesh-list
111389516|NCT04901975|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
111389517|NCT04901975|Hormone Antagonists|hormone antagonists|mesh-ancestor
111389518|NCT04901975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111389519|NCT04901975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111389520|NCT04901975|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
111389521|NCT04901975|Diuretics|diuretics|mesh-ancestor
111389522|NCT04901975|Natriuretic Agents|natriuretic agents|mesh-ancestor
111389523|NCT05421416|Loratadine|loratadine|mesh-list
111389524|NCT05421416|Antipruritics|antipruritics|mesh-ancestor
111389525|NCT05421416|Dermatologic Agents|dermatologic agents|mesh-ancestor
111389526|NCT05421416|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111389527|NCT05421416|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
111389528|NCT05421416|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111389529|NCT05421416|Histamine Antagonists|histamine antagonists|mesh-ancestor
111389530|NCT05421416|Histamine Agents|histamine agents|mesh-ancestor
111389531|NCT05421416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111389532|NCT05421416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111389533|NCT05421416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111389534|NCT04868045|Hormones|hormones|mesh-list
111389535|NCT04868045|Thyrotropin-Releasing Hormone|thyrotropin-releasing hormone|mesh-list
111389536|NCT04868045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111389537|NCT04868045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111389538|NCT04803539|Capecitabine|capecitabine|mesh-list
111389539|NCT04803539|Apatinib|apatinib|mesh-list
111389540|NCT04803539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111389541|NCT04803539|Antimetabolites|antimetabolites|mesh-ancestor
111389542|NCT04803539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111389543|NCT04803539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111389544|NCT04803539|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111389545|NCT04803539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111389546|NCT04799015|Dexamethasone|dexamethasone|mesh-list
111389547|NCT04799015|Metoclopramide|metoclopramide|mesh-list
111389548|NCT04799015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111389549|NCT04799015|Antiemetics|antiemetics|mesh-ancestor
111389550|NCT04799015|Autonomic Agents|autonomic agents|mesh-ancestor
111389551|NCT04799015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111389552|NCT04799015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111389553|NCT04799015|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111389554|NCT04799015|Glucocorticoids|glucocorticoids|mesh-ancestor
111389555|NCT04799015|Hormones|hormones|mesh-ancestor
111389556|NCT04799015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111389557|NCT04799015|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111389558|NCT04799015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111389559|NCT04799015|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111389560|NCT04799015|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111389561|NCT04799015|Dopamine Agents|dopamine agents|mesh-ancestor
111389562|NCT04799015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111389563|NCT04799015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111389564|NCT01658228|Donepezil|donepezil|mesh-list
111389565|NCT01658228|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
111389566|NCT01658228|Citalopram|citalopram|mesh-list
111389567|NCT01658228|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111389568|NCT01658228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111389569|NCT01658228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111389570|NCT01658228|Cholinergic Agents|cholinergic agents|mesh-ancestor
111389571|NCT01658228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111389572|NCT01658228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111389573|NCT01658228|Nootropic Agents|nootropic agents|mesh-ancestor
111389574|NCT01658228|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111389575|NCT01658228|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111389576|NCT01658228|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111389577|NCT01658228|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111389578|NCT01658228|Antidepressive Agents|antidepressive agents|mesh-ancestor
111389579|NCT01658228|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111389580|NCT01658228|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111389581|NCT01658228|Serotonin Agents|serotonin agents|mesh-ancestor
111389582|NCT05709938|Insulin|insulin|mesh-list
111389583|NCT05709938|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111389584|NCT05709938|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111389585|NCT05709938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111389586|NCT01659866|Ciprofloxacin|ciprofloxacin|mesh-list
111389587|NCT01659866|Gentamicins|gentamicins|mesh-list
111389588|NCT01659866|Ceftriaxone|ceftriaxone|mesh-list
111389589|NCT01659866|Imipenem|imipenem|mesh-list
111389590|NCT01659866|Amikacin|amikacin|mesh-list
111389591|NCT01659866|Cefuroxime|cefuroxime|mesh-list
111389592|NCT01659866|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
111389593|NCT01659866|Aztreonam|aztreonam|mesh-list
111389594|NCT01659866|Trimethoprim|trimethoprim|mesh-list
111389595|NCT01659866|Sulfamethoxazole|sulfamethoxazole|mesh-list
111389596|NCT01659866|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111389597|NCT01659866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111389598|NCT01659866|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111389599|NCT01659866|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111389600|NCT01659866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111389601|NCT01659866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111389602|NCT01659866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111389603|NCT01659866|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111389604|NCT01659866|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111389605|NCT01659866|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111389606|NCT01659866|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111389607|NCT01659866|Antimalarials|antimalarials|mesh-ancestor
111389608|NCT01659866|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111389609|NCT01659866|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111389610|NCT01659866|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111389611|NCT01659866|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111389612|NCT01659866|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
111389613|NCT02249702|Gemcitabine|gemcitabine|mesh-list
111389614|NCT02249702|Docetaxel|docetaxel|mesh-list
111389615|NCT02249702|Trabectedin|trabectedin|mesh-list
111389616|NCT02249702|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111389617|NCT02249702|Antimetabolites|antimetabolites|mesh-ancestor
111389618|NCT02249702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111389619|NCT02249702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111389620|NCT02249702|Tubulin Modulators|tubulin modulators|mesh-ancestor
111389621|NCT02249702|Antimitotic Agents|antimitotic agents|mesh-ancestor
111389622|NCT02249702|Mitosis Modulators|mitosis modulators|mesh-ancestor
111389623|NCT02249702|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111389624|NCT02249702|Alkylating Agents|alkylating agents|mesh-ancestor
111389625|NCT02947529|Tranexamic Acid|tranexamic acid|mesh-list
111389626|NCT02947529|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111389627|NCT02947529|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111389628|NCT02947529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111389629|NCT02947529|Hemostatics|hemostatics|mesh-ancestor
111389630|NCT02947529|Coagulants|coagulants|mesh-ancestor
111389631|NCT01660802|Dexamethasone|dexamethasone|mesh-list
111389632|NCT01660802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111389633|NCT01660802|Antiemetics|antiemetics|mesh-ancestor
111389634|NCT01660802|Autonomic Agents|autonomic agents|mesh-ancestor
111389635|NCT01660802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111389636|NCT01660802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111114036|NCT02379715|Desflurane|desflurane|mesh-list
111389637|NCT01660802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111389638|NCT01660802|Glucocorticoids|glucocorticoids|mesh-ancestor
111389639|NCT01660802|Hormones|hormones|mesh-ancestor
111389640|NCT01660802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111389641|NCT01660802|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111389642|NCT01660802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111389643|NCT02899325|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
111389644|NCT02899325|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111389645|NCT02899325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111389646|NCT01661114|Gemcitabine|gemcitabine|mesh-list
111389647|NCT01661114|Fluorouracil|fluorouracil|mesh-list
111389648|NCT01661114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111389649|NCT01661114|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111389650|NCT01661114|Antimetabolites|antimetabolites|mesh-ancestor
111389651|NCT01661114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111389652|NCT01661114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111389653|NCT01661114|Immunologic Factors|immunologic factors|mesh-ancestor
111389654|NCT01661114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111389655|NCT02683265|Methylphenidate|methylphenidate|mesh-list
111389656|NCT02683265|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111389657|NCT02683265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111389658|NCT02683265|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111389659|NCT02683265|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111389660|NCT02683265|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111389661|NCT02683265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111389662|NCT02683265|Dopamine Agents|dopamine agents|mesh-ancestor
111389663|NCT02683265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111389664|NCT02987829|Androgen Receptor Antagonists|androgen receptor antagonists|mesh-list
111389665|NCT02987829|Androgen Antagonists|androgen antagonists|mesh-ancestor
111389666|NCT02987829|Hormone Antagonists|hormone antagonists|mesh-ancestor
111389667|NCT02987829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111389668|NCT02987829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111389669|NCT02988843|Bevacizumab|bevacizumab|mesh-list
111389670|NCT02988843|Brentuximab Vedotin|brentuximab vedotin|mesh-list
111389671|NCT02988843|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111389672|NCT02988843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111389673|NCT02988843|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111389674|NCT02988843|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111389675|NCT02988843|Growth Substances|growth substances|mesh-ancestor
111389676|NCT02988843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111389677|NCT02988843|Growth Inhibitors|growth inhibitors|mesh-ancestor
111389678|NCT02988843|Immunotoxins|immunotoxins|mesh-ancestor
111389679|NCT02988843|Immunoconjugates|immunoconjugates|mesh-ancestor
111389680|NCT02988843|Immunologic Factors|immunologic factors|mesh-ancestor
111389681|NCT01661270|Aflibercept|aflibercept|mesh-list
111389682|NCT01661270|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111389683|NCT01661270|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111389684|NCT01661270|Growth Substances|growth substances|mesh-ancestor
111389685|NCT01661270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111389686|NCT01661270|Growth Inhibitors|growth inhibitors|mesh-ancestor
111389687|NCT01661270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111389688|NCT03000309|Apremilast|apremilast|mesh-list
111389689|NCT03000309|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111389690|NCT03000309|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111389691|NCT03000309|Analgesics|analgesics|mesh-ancestor
111389692|NCT03000309|Sensory System Agents|sensory system agents|mesh-ancestor
111389693|NCT03000309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111389694|NCT03000309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111389695|NCT03000309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111389696|NCT03000309|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111389697|NCT03000309|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
111389698|NCT03000309|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111389699|NCT03000309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111389700|NCT03000309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111389701|NCT02992028|Vitamins|vitamins|mesh-list
111389702|NCT02992028|Micronutrients|micronutrients|mesh-ancestor
111389703|NCT02992028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111389704|NCT03165981|Vaccines|vaccines|mesh-list
111389705|NCT03165981|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
111389706|NCT03165981|Immunologic Factors|immunologic factors|mesh-ancestor
111389707|NCT03165981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111389708|NCT02249780|Parathyroid Hormone|parathyroid hormone|mesh-list
111389709|NCT02249780|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111389710|NCT02249780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111114093|NCT02378623|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111389711|NCT03170661|Rocuronium|rocuronium|mesh-list
111389712|NCT03170661|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
111389713|NCT03170661|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
111389714|NCT03170661|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111389715|NCT03170661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111389716|NCT03170661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111389717|NCT03175731|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
111389718|NCT03175731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111389719|NCT03175731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111389720|NCT01662908|Heparin|heparin|mesh-list
111389721|NCT01662908|Enoxaparin|enoxaparin|mesh-list
111389722|NCT01662908|Calcium heparin|calcium heparin|mesh-list
111389723|NCT01662908|Warfarin|warfarin|mesh-list
111389724|NCT01662908|Edoxaban|edoxaban|mesh-list
111389725|NCT01662908|Anticoagulants|anticoagulants|mesh-ancestor
111389726|NCT01662908|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111389727|NCT01662908|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111389728|NCT01662908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111389729|NCT01662908|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111389730|NCT01662908|Antithrombins|antithrombins|mesh-ancestor
111389731|NCT01662908|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111389732|NCT01662908|Protease Inhibitors|protease inhibitors|mesh-ancestor
111389733|NCT01662908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111389734|NCT00375297|Sildenafil Citrate|sildenafil citrate|mesh-list
111389735|NCT00375297|Vasodilator Agents|vasodilator agents|mesh-ancestor
111389736|NCT00375297|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111389737|NCT00375297|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111389738|NCT00375297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111389739|NCT00375297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111389740|NCT00375297|Urological Agents|urological agents|mesh-ancestor
111389741|NCT02234570|Oxfendazole|oxfendazole|mesh-list
111389742|NCT02234570|Anthelmintics|anthelmintics|mesh-ancestor
111389743|NCT02234570|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111389744|NCT02234570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111389745|NCT02234570|Antinematodal Agents|antinematodal agents|mesh-ancestor
111389746|NCT04525599|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
111389747|NCT04525599|Immunologic Factors|immunologic factors|mesh-ancestor
111389748|NCT04525599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111389749|NCT02240030|Levodopa|levodopa|mesh-list
111389750|NCT02240030|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111389751|NCT02240030|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111389752|NCT02240030|Dopamine Agents|dopamine agents|mesh-ancestor
111389753|NCT02240030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111389754|NCT02240030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111389755|NCT02240030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111389756|NCT03180489|Dapagliflozin|dapagliflozin|mesh-list
111389757|NCT03180489|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111389758|NCT03180489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111389759|NCT03180489|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111389760|NCT03180489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111389761|NCT03471663|Palbociclib|palbociclib|mesh-list
111389762|NCT03471663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111389763|NCT03471663|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111389764|NCT03471663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111389765|NCT03471663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111389766|NCT01664858|Calcium|calcium|mesh-list
111389767|NCT01664858|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111389768|NCT01664858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111389769|NCT04348695|Simvastatin|simvastatin|mesh-list
111389770|NCT04348695|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111389771|NCT04348695|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111389772|NCT04348695|Antimetabolites|antimetabolites|mesh-ancestor
111389773|NCT04348695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111389774|NCT04348695|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111389775|NCT04348695|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111389776|NCT04348695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111389777|NCT04316871|Morphine|morphine|mesh-list
111389778|NCT04316871|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111389779|NCT04316871|Narcotics|narcotics|mesh-ancestor
111389780|NCT04316871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111389781|NCT04316871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111389782|NCT04316871|Analgesics|analgesics|mesh-ancestor
111389783|NCT04316871|Sensory System Agents|sensory system agents|mesh-ancestor
111389784|NCT04316871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111389785|NCT05364567|Vitamin D|vitamin d|mesh-list
111389786|NCT05364567|Cholecalciferol|cholecalciferol|mesh-list
111389787|NCT05364567|Vitamins|vitamins|mesh-ancestor
111389788|NCT05364567|Micronutrients|micronutrients|mesh-ancestor
111389789|NCT05364567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111389790|NCT05364567|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111389791|NCT05364567|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111389792|NCT00375765|Dutasteride|dutasteride|mesh-list
111389793|NCT00375765|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
111389794|NCT00375765|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111389795|NCT00375765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111389796|NCT00375765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111389797|NCT00375765|Hormone Antagonists|hormone antagonists|mesh-ancestor
111389798|NCT00375765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111389799|NCT00375765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111389800|NCT03325647|Methyltestosterone|methyltestosterone|mesh-list
111389801|NCT03325647|Testosterone|testosterone|mesh-list
111389802|NCT03325647|Testosterone undecanoate|testosterone undecanoate|mesh-list
111389803|NCT03325647|Testosterone enanthate|testosterone enanthate|mesh-list
111389804|NCT03325647|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
111389805|NCT03325647|Androgens|androgens|mesh-ancestor
111389806|NCT03325647|Hormones|hormones|mesh-ancestor
111389807|NCT03325647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111389808|NCT03325647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111389809|NCT03325647|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111389810|NCT03325647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111389811|NCT03325647|Anabolic Agents|anabolic agents|mesh-ancestor
111389812|NCT01665950|Simvastatin|simvastatin|mesh-list
111389813|NCT01665950|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111389814|NCT01665950|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111389815|NCT01665950|Antimetabolites|antimetabolites|mesh-ancestor
111389816|NCT01665950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111389817|NCT01665950|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111389818|NCT01665950|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111389819|NCT01665950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111389820|NCT01667978|Ritonavir|ritonavir|mesh-list
111389821|NCT01667978|Atazanavir Sulfate|atazanavir sulfate|mesh-list
111389822|NCT01667978|Norethindrone|norethindrone|mesh-list
111389823|NCT01667978|Norethindrone Acetate|norethindrone acetate|mesh-list
111389824|NCT01667978|Protease Inhibitors|protease inhibitors|mesh-list
111389825|NCT01667978|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111389826|NCT01667978|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111389827|NCT01667978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111389828|NCT01667978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111389829|NCT01667978|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111389830|NCT01667978|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111389831|NCT01667978|Antiviral Agents|antiviral agents|mesh-ancestor
111389832|NCT01667978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111389833|NCT01667978|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111389834|NCT01667978|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111389835|NCT01667978|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111389836|NCT01667978|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111389837|NCT01667978|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111389838|NCT01667978|Contraceptive Agents|contraceptive agents|mesh-ancestor
111389839|NCT01667978|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111389840|NCT01667978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111389841|NCT01667978|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111389842|NCT01667978|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111389843|NCT03282669|Morphine|morphine|mesh-list
111389844|NCT03282669|Hydromorphone|hydromorphone|mesh-list
111389845|NCT03282669|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111389846|NCT03282669|Narcotics|narcotics|mesh-ancestor
111389847|NCT03282669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111389848|NCT03282669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111389849|NCT03282669|Analgesics|analgesics|mesh-ancestor
111389850|NCT03282669|Sensory System Agents|sensory system agents|mesh-ancestor
111389851|NCT03282669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111389852|NCT00375843|Sertraline|sertraline|mesh-list
111389853|NCT00375843|Escitalopram|escitalopram|mesh-list
111389854|NCT00375843|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111389855|NCT00375843|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111389856|NCT00375843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111389857|NCT00375843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111389858|NCT00375843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111389859|NCT00375843|Serotonin Agents|serotonin agents|mesh-ancestor
111389860|NCT00375843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111389861|NCT00375843|Antidepressive Agents|antidepressive agents|mesh-ancestor
111389862|NCT00375843|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111389863|NCT03247569|Edoxaban|edoxaban|mesh-list
111389864|NCT03247569|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111389865|NCT03247569|Antithrombins|antithrombins|mesh-ancestor
111389866|NCT03247569|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111389867|NCT03247569|Protease Inhibitors|protease inhibitors|mesh-ancestor
111389868|NCT03247569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111389869|NCT03247569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111389870|NCT03247569|Anticoagulants|anticoagulants|mesh-ancestor
111389871|NCT01668836|Resveratrol|resveratrol|mesh-list
111389872|NCT01668836|Antioxidants|antioxidants|mesh-ancestor
111389873|NCT01668836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111389874|NCT01668836|Protective Agents|protective agents|mesh-ancestor
111389875|NCT01668836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111389876|NCT01668836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111389877|NCT01668836|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111389878|NCT03744663|Buprenorphine|buprenorphine|mesh-list
111389879|NCT03744663|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
111389880|NCT03744663|Naloxone|naloxone|mesh-list
111389881|NCT03744663|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111389882|NCT03744663|Narcotics|narcotics|mesh-ancestor
111389883|NCT03744663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111389884|NCT03744663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111389885|NCT03744663|Analgesics|analgesics|mesh-ancestor
111389886|NCT03744663|Sensory System Agents|sensory system agents|mesh-ancestor
111389887|NCT03744663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111389888|NCT03744663|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111389889|NCT01669538|Galantamine|galantamine|mesh-list
111389890|NCT01669538|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111389891|NCT01669538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111389892|NCT01669538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111389893|NCT01669538|Cholinergic Agents|cholinergic agents|mesh-ancestor
111389894|NCT01669538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111389895|NCT01669538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111389896|NCT01669538|Parasympathomimetics|parasympathomimetics|mesh-ancestor
111389897|NCT01669538|Autonomic Agents|autonomic agents|mesh-ancestor
111389898|NCT01669538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111389899|NCT01669538|Nootropic Agents|nootropic agents|mesh-ancestor
111389900|NCT00375375|Lactulose|lactulose|mesh-list
111389901|NCT00375375|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111389902|NCT04333095|Bupivacaine|bupivacaine|mesh-list
111389903|NCT04333095|Anesthetics, Local|anesthetics, local|mesh-ancestor
111389904|NCT04333095|Anesthetics|anesthetics|mesh-ancestor
111389905|NCT04333095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110529929|NCT02717780|Sevoflurane|sevoflurane|mesh-list
111389906|NCT04333095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111389907|NCT04333095|Sensory System Agents|sensory system agents|mesh-ancestor
111389908|NCT04333095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111389909|NCT05045144|Vaccines|vaccines|mesh-list
111389910|NCT05045144|Immunologic Factors|immunologic factors|mesh-ancestor
111389911|NCT05045144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111389912|NCT00375687|Triptorelin Pamoate|triptorelin pamoate|mesh-list
111389913|NCT00375687|Luteolytic Agents|luteolytic agents|mesh-ancestor
111389914|NCT00375687|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111389915|NCT00375687|Contraceptive Agents|contraceptive agents|mesh-ancestor
111389916|NCT00375687|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111389917|NCT00375687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111389918|NCT00375687|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111389919|NCT00375687|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111389920|NCT00375687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111389921|NCT01658241|Panobinostat|panobinostat|mesh-list
111389922|NCT01658241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111389923|NCT01658241|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111389924|NCT01658241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111389925|NCT01658241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111389926|NCT01455051|Ofatumumab|ofatumumab|mesh-list
111389927|NCT01455051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111389928|NCT01673828|Pregnanolone|pregnanolone|mesh-list
111389929|NCT01673828|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111389930|NCT01673828|Anesthetics|anesthetics|mesh-ancestor
111389931|NCT01673828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111389932|NCT01673828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111389933|NCT05325099|Azacitidine|azacitidine|mesh-list
111389934|NCT05325099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111389935|NCT05325099|Antimetabolites|antimetabolites|mesh-ancestor
111389936|NCT05325099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111389938|NCT05325099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111389939|NCT02296775|Rituximab|rituximab|mesh-list
111389940|NCT02296775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111389941|NCT02296775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111389942|NCT02296775|Immunologic Factors|immunologic factors|mesh-ancestor
111389943|NCT02296775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111389944|NCT02296775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111389945|NCT01675778|Hydromorphone|hydromorphone|mesh-list
111389946|NCT01675778|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111389947|NCT01675778|Narcotics|narcotics|mesh-ancestor
111389948|NCT01675778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111389949|NCT01675778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111389950|NCT01675778|Analgesics|analgesics|mesh-ancestor
111389951|NCT01675778|Sensory System Agents|sensory system agents|mesh-ancestor
111389952|NCT01675778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111389953|NCT04736589|Sirolimus|sirolimus|mesh-list
111389954|NCT04736589|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111389955|NCT04736589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111389956|NCT04736589|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111389957|NCT04736589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111389958|NCT04736589|Antifungal Agents|antifungal agents|mesh-ancestor
111389959|NCT04736589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111389960|NCT04736589|Immunologic Factors|immunologic factors|mesh-ancestor
111389961|NCT04736589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111389962|NCT05201859|Capecitabine|capecitabine|mesh-list
111389963|NCT05201859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111389964|NCT05201859|Antimetabolites|antimetabolites|mesh-ancestor
110529971|NCT05291390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111389965|NCT05201859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111389966|NCT05201859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111389967|NCT02594111|Colchicine|colchicine|mesh-list
111389968|NCT02594111|Gout Suppressants|gout suppressants|mesh-ancestor
111389969|NCT02594111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111389970|NCT02594111|Tubulin Modulators|tubulin modulators|mesh-ancestor
111389971|NCT02594111|Antimitotic Agents|antimitotic agents|mesh-ancestor
111389972|NCT02594111|Mitosis Modulators|mitosis modulators|mesh-ancestor
111389973|NCT02594111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111389974|NCT02594111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111389975|NCT03186261|Chlorhexidine|chlorhexidine|mesh-list
111389976|NCT03186261|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
111389977|NCT03186261|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111389978|NCT03186261|Fluorides|fluorides|mesh-list
111389979|NCT03186261|Cariostatic Agents|cariostatic agents|mesh-ancestor
111389980|NCT03186261|Protective Agents|protective agents|mesh-ancestor
111389981|NCT03186261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111389982|NCT03186261|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111389983|NCT03186261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111389984|NCT03186261|Disinfectants|disinfectants|mesh-ancestor
111389985|NCT03186261|Dermatologic Agents|dermatologic agents|mesh-ancestor
111389986|NCT02589353|Acarbose|acarbose|mesh-list
111389987|NCT02589353|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
111389988|NCT02589353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111389989|NCT02589353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111389990|NCT02589353|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111389991|NCT02589353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111389992|NCT02986607|Parathyroid Hormone|parathyroid hormone|mesh-list
111389993|NCT02986607|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111389994|NCT02986607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111389995|NCT01678976|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
111389996|NCT01678976|Oxcarbazepine|oxcarbazepine|mesh-list
111389997|NCT01678976|Anticonvulsants|anticonvulsants|mesh-ancestor
111389998|NCT01678976|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111389999|NCT01678976|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111390000|NCT01678976|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111390001|NCT01678976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111390002|NCT01678976|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111390003|NCT01678976|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111390004|NCT04645667|Tacrolimus|tacrolimus|mesh-list
111390005|NCT04645667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111390006|NCT04645667|Immunologic Factors|immunologic factors|mesh-ancestor
111390007|NCT04645667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111390008|NCT04645667|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111390009|NCT04645667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111390010|NCT04645667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111390011|NCT02249936|Omeprazole|omeprazole|mesh-list
111390012|NCT02249936|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111390013|NCT02249936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111390014|NCT02249936|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111390015|NCT02249936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111390016|NCT02249936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111390017|NCT03190005|Clopidogrel|clopidogrel|mesh-list
111390018|NCT03190005|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111390019|NCT03190005|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111390020|NCT03190005|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111390021|NCT03190005|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111390022|NCT03190005|Purinergic Agents|purinergic agents|mesh-ancestor
111390023|NCT03190005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111390024|NCT03190005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111390025|NCT03190005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111390026|NCT04816214|Carboplatin|carboplatin|mesh-list
111390027|NCT04816214|Pemetrexed|pemetrexed|mesh-list
111390028|NCT04816214|Osimertinib|osimertinib|mesh-list
111390029|NCT04816214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111390030|NCT04816214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110530035|NCT02712944|Testosterone|testosterone|mesh-list
111390031|NCT04816214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111390032|NCT04816214|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111390033|NCT04816214|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111390034|NCT04816214|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111390035|NCT01461915|Paclitaxel|paclitaxel|mesh-list
111390036|NCT01461915|Gemcitabine|gemcitabine|mesh-list
111390037|NCT01461915|Heparin|heparin|mesh-list
111390038|NCT01461915|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111390039|NCT01461915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111390040|NCT01461915|Tubulin Modulators|tubulin modulators|mesh-ancestor
111390041|NCT01461915|Antimitotic Agents|antimitotic agents|mesh-ancestor
111390042|NCT01461915|Mitosis Modulators|mitosis modulators|mesh-ancestor
111390043|NCT01461915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111390044|NCT01461915|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111390045|NCT01461915|Antimetabolites|antimetabolites|mesh-ancestor
111390046|NCT01461915|Anticoagulants|anticoagulants|mesh-ancestor
111390047|NCT01461915|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111390048|NCT01461915|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111390049|NCT01682642|Goserelin|goserelin|mesh-list
111390050|NCT01682642|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111390051|NCT01682642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111390052|NCT01683422|Gemcitabine|gemcitabine|mesh-list
111390053|NCT01683422|Capecitabine|capecitabine|mesh-list
111390054|NCT01683422|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111390055|NCT01683422|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111390056|NCT01683422|Antimetabolites|antimetabolites|mesh-ancestor
111390057|NCT01683422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111390058|NCT01683422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111390059|NCT01683422|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111390060|NCT01683422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111390061|NCT03194373|Carboplatin|carboplatin|mesh-list
111390062|NCT03194373|Palbociclib|palbociclib|mesh-list
111390063|NCT03194373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111390064|NCT03194373|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111390065|NCT03194373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111390066|NCT03194373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111390067|NCT05066061|Analgesics|analgesics|mesh-list
111390068|NCT05066061|Anti-Anxiety Agents|anti-anxiety agents|mesh-list
111390069|NCT05066061|Sensory System Agents|sensory system agents|mesh-ancestor
111390070|NCT05066061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111390071|NCT05066061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111390072|NCT05066061|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111390073|NCT05066061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111390074|NCT05066061|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111390075|NCT03197025|Aldesleukin|aldesleukin|mesh-list
111390076|NCT03197025|Interleukin-2|interleukin-2|mesh-list
111390077|NCT03197025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111390078|NCT03197025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111390079|NCT03197025|Analgesics|analgesics|mesh-ancestor
111390080|NCT03197025|Sensory System Agents|sensory system agents|mesh-ancestor
111390081|NCT03197025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111390082|NCT03197025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111390083|NCT03197025|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111390084|NCT03197025|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111390085|NCT03197025|Antiviral Agents|antiviral agents|mesh-ancestor
111390086|NCT03197025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111390087|NCT02249546|Amoxicillin|amoxicillin|mesh-list
111390088|NCT02249546|Clarithromycin|clarithromycin|mesh-list
111390089|NCT02249546|Acetylcysteine|acetylcysteine|mesh-list
111390090|NCT02249546|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111390091|NCT02249546|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111390092|NCT02249546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111390093|NCT02249546|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111390094|NCT02249546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111390095|NCT02249546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111390096|NCT02249546|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111390097|NCT02249546|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111390098|NCT02249546|Antiviral Agents|antiviral agents|mesh-ancestor
111390099|NCT02249546|Expectorants|expectorants|mesh-ancestor
111390100|NCT02249546|Respiratory System Agents|respiratory system agents|mesh-ancestor
111390101|NCT02249546|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111390102|NCT02249546|Antioxidants|antioxidants|mesh-ancestor
111390103|NCT02249546|Protective Agents|protective agents|mesh-ancestor
111390104|NCT02249546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111390105|NCT02249546|Antidotes|antidotes|mesh-ancestor
111390106|NCT02303093|gamma-Globulins|gamma-globulins|mesh-list
111390107|NCT02303093|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111390108|NCT02303093|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
111390109|NCT02303093|Immunologic Factors|immunologic factors|mesh-ancestor
111390110|NCT02303093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111390111|NCT04960215|Ubiquinone|ubiquinone|mesh-list
111390112|NCT04960215|Coenzyme Q10|coenzyme q10|mesh-list
111390113|NCT04960215|Micronutrients|micronutrients|mesh-ancestor
111390114|NCT04960215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111390115|NCT04960215|Vitamins|vitamins|mesh-ancestor
111390116|NCT02333045|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
111390117|NCT02333045|Maraviroc|maraviroc|mesh-list
111390118|NCT02333045|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111390119|NCT02333045|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111390120|NCT02333045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111390121|NCT02333045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111390122|NCT02333045|Antiviral Agents|antiviral agents|mesh-ancestor
111390123|NCT02333045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111390124|NCT02333045|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111390125|NCT02333045|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111390126|NCT02333045|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
111390127|NCT02333045|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
111390128|NCT02333045|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
111390129|NCT01684748|Olmesartan|olmesartan|mesh-list
111390130|NCT01684748|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
111390131|NCT01684748|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111390132|NCT01684748|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111390133|NCT01684748|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111390134|NCT01684748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111390135|NCT04028063|Doxorubicin|doxorubicin|mesh-list
111390136|NCT04028063|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111390137|NCT04028063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111390138|NCT04028063|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111390139|NCT04028063|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111390140|NCT04028063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111390141|NCT04028063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111390142|NCT01685684|Oxycodone|oxycodone|mesh-list
111390143|NCT01685684|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111390144|NCT01685684|Narcotics|narcotics|mesh-ancestor
111390145|NCT01685684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111390146|NCT01685684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111390147|NCT01685684|Analgesics|analgesics|mesh-ancestor
111390148|NCT01685684|Sensory System Agents|sensory system agents|mesh-ancestor
111390149|NCT01685684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111390150|NCT03978767|Acetaminophen|acetaminophen|mesh-list
111390151|NCT03978767|Ibuprofen|ibuprofen|mesh-list
111390152|NCT03978767|Ketorolac|ketorolac|mesh-list
111390153|NCT03978767|Oxycodone|oxycodone|mesh-list
111390154|NCT03978767|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111390155|NCT03978767|Analgesics|analgesics|mesh-ancestor
111390156|NCT03978767|Sensory System Agents|sensory system agents|mesh-ancestor
111390157|NCT03978767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111390158|NCT03978767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111390159|NCT03978767|Antipyretics|antipyretics|mesh-ancestor
111390160|NCT03978767|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111390162|NCT03978767|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111390163|NCT03978767|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111390164|NCT03978767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111390165|NCT03978767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111390166|NCT03978767|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111390167|NCT03978767|Narcotics|narcotics|mesh-ancestor
111390168|NCT03978767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111390169|NCT04436133|Vaccines|vaccines|mesh-list
111390170|NCT04436133|Immunologic Factors|immunologic factors|mesh-ancestor
111390171|NCT04436133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111390172|NCT01685996|Zonisamide|zonisamide|mesh-list
111390173|NCT01685996|Anticonvulsants|anticonvulsants|mesh-ancestor
111390174|NCT01685996|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111390175|NCT01685996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111390176|NCT01685996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111390177|NCT01685996|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111390178|NCT01685996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111390179|NCT03207399|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
111390180|NCT03207399|Antiviral Agents|antiviral agents|mesh-ancestor
111390181|NCT03207399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111390182|NCT04543409|Benralizumab|benralizumab|mesh-list
111390183|NCT04543409|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111390184|NCT04543409|Respiratory System Agents|respiratory system agents|mesh-ancestor
111390185|NCT02196155|Cortisone|cortisone|mesh-list
111390186|NCT02196155|Botulinum Toxins|botulinum toxins|mesh-list
111390187|NCT02196155|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111390188|NCT02196155|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111390189|NCT02196155|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111390190|NCT02196155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111390191|NCT02196155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111390192|NCT02196155|Cholinergic Agents|cholinergic agents|mesh-ancestor
111390193|NCT02196155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111390194|NCT02196155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111390195|NCT02196155|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111390196|NCT02196155|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111390197|NCT02196155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111390198|NCT02175173|Rufinamide|rufinamide|mesh-list
111390199|NCT02175173|Anticonvulsants|anticonvulsants|mesh-ancestor
111390200|NCT02175173|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111390201|NCT02175173|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111390202|NCT02175173|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111390203|NCT02175173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111390204|NCT04121403|Rituximab|rituximab|mesh-list
111390205|NCT04121403|Cladribine|cladribine|mesh-list
111390206|NCT04121403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111390207|NCT04121403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111390208|NCT04121403|Immunologic Factors|immunologic factors|mesh-ancestor
111390209|NCT04121403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111390210|NCT04121403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111390211|NCT04121403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111390212|NCT03224403|Acetaminophen|acetaminophen|mesh-list
111390213|NCT03224403|Ibuprofen|ibuprofen|mesh-list
111390214|NCT03224403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111390215|NCT03224403|Analgesics|analgesics|mesh-ancestor
111390216|NCT03224403|Sensory System Agents|sensory system agents|mesh-ancestor
111390217|NCT03224403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111390218|NCT03224403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111390219|NCT03224403|Antipyretics|antipyretics|mesh-ancestor
111390220|NCT03224403|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111390221|NCT03224403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111390222|NCT03224403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111390223|NCT03224403|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111390224|NCT03224403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111390225|NCT03224403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111390226|NCT02334059|Ketamine|ketamine|mesh-list
111390227|NCT02334059|Analgesics|analgesics|mesh-ancestor
111390228|NCT02334059|Sensory System Agents|sensory system agents|mesh-ancestor
111390229|NCT02334059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111390230|NCT02334059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111390231|NCT02334059|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111390232|NCT02334059|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111390233|NCT02334059|Anesthetics, General|anesthetics, general|mesh-ancestor
111390234|NCT02334059|Anesthetics|anesthetics|mesh-ancestor
111390235|NCT02334059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111390236|NCT02334059|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111390237|NCT02334059|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111390238|NCT02334059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111390239|NCT02334059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111390240|NCT04501523|Capecitabine|capecitabine|mesh-list
111390241|NCT04501523|Tislelizumab|tislelizumab|mesh-list
111390242|NCT04501523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111390243|NCT04501523|Antimetabolites|antimetabolites|mesh-ancestor
111390244|NCT04501523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111390245|NCT04501523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111390246|NCT04501523|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111390247|NCT04499573|Cytarabine|cytarabine|mesh-list
111390248|NCT04499573|Dexamethasone|dexamethasone|mesh-list
111390249|NCT04499573|Cyclophosphamide|cyclophosphamide|mesh-list
111390250|NCT04499573|Fludarabine|fludarabine|mesh-list
111390251|NCT04499573|Etoposide|etoposide|mesh-list
111390252|NCT04499573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111390253|NCT04499573|Immunologic Factors|immunologic factors|mesh-ancestor
111390254|NCT04499573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111390255|NCT04499573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111390256|NCT04499573|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111390257|NCT04499573|Alkylating Agents|alkylating agents|mesh-ancestor
111390258|NCT04499573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111390259|NCT04499573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111390260|NCT04499573|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111390261|NCT04499573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111390262|NCT04499573|Antiemetics|antiemetics|mesh-ancestor
111390263|NCT04499573|Autonomic Agents|autonomic agents|mesh-ancestor
111390264|NCT04499573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111390265|NCT04499573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111390266|NCT04499573|Glucocorticoids|glucocorticoids|mesh-ancestor
111390267|NCT04499573|Hormones|hormones|mesh-ancestor
111390268|NCT04499573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111390269|NCT04499573|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111390270|NCT04499573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111390271|NCT04499573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111390272|NCT04499573|Antimetabolites|antimetabolites|mesh-ancestor
111390273|NCT04499573|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111390274|NCT04499573|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111390275|NCT04499573|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111390276|NCT04499573|Antiviral Agents|antiviral agents|mesh-ancestor
111390277|NCT04499573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111390278|NCT03425097|Fexofenadine|fexofenadine|mesh-list
111390279|NCT03425097|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111390280|NCT03425097|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
111390281|NCT03425097|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111390282|NCT03425097|Histamine Antagonists|histamine antagonists|mesh-ancestor
111390283|NCT03425097|Histamine Agents|histamine agents|mesh-ancestor
111390284|NCT03425097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111390285|NCT03425097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111390286|NCT03425097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111390287|NCT01926041|Varenicline|varenicline|mesh-list
111390288|NCT01926041|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111390289|NCT01926041|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111390290|NCT01926041|Cholinergic Agents|cholinergic agents|mesh-ancestor
111390291|NCT01926041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111390292|NCT01926041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111390293|NCT01926041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111390294|NCT01769027|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111390295|NCT01769027|Azithromycin|azithromycin|mesh-list
111390296|NCT01769027|Penicillins|penicillins|mesh-list
111390297|NCT01769027|Sertraline|sertraline|mesh-list
111390298|NCT01769027|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111390299|NCT01769027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111390300|NCT01769027|Antidepressive Agents|antidepressive agents|mesh-ancestor
111390301|NCT01769027|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111390302|NCT01769027|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111390303|NCT01769027|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111390304|NCT01769027|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111390305|NCT01769027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111390306|NCT01769027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111390307|NCT01769027|Serotonin Agents|serotonin agents|mesh-ancestor
111390308|NCT01769027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111390310|NCT04706637|Dapagliflozin|dapagliflozin|mesh-list
111390311|NCT04706637|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111390312|NCT04706637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111390313|NCT04706637|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111390314|NCT04706637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111390315|NCT04706949|Carboplatin|carboplatin|mesh-list
111390316|NCT04706949|Pemetrexed|pemetrexed|mesh-list
111390317|NCT04706949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111390318|NCT04706949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111390319|NCT04706949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111390320|NCT04706949|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111390321|NCT04706949|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111390322|NCT02299349|Epinephrine|epinephrine|mesh-list
111390323|NCT02299349|Racepinephrine|racepinephrine|mesh-list
111390324|NCT02299349|Morphine|morphine|mesh-list
111390325|NCT02299349|Bupivacaine|bupivacaine|mesh-list
111390326|NCT02299349|Epinephryl borate|epinephryl borate|mesh-list
111390327|NCT02299349|Anesthetics, Local|anesthetics, local|mesh-ancestor
111390328|NCT02299349|Anesthetics|anesthetics|mesh-ancestor
111390329|NCT02299349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111390330|NCT02299349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111390331|NCT02299349|Sensory System Agents|sensory system agents|mesh-ancestor
111390332|NCT02299349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111390333|NCT02299349|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111390334|NCT02299349|Narcotics|narcotics|mesh-ancestor
111390335|NCT02299349|Analgesics|analgesics|mesh-ancestor
111390336|NCT02299349|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111390337|NCT02299349|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111390338|NCT02299349|Adrenergic Agents|adrenergic agents|mesh-ancestor
111390339|NCT02299349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111390340|NCT02299349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111390341|NCT02299349|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111390342|NCT02299349|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111390343|NCT02299349|Autonomic Agents|autonomic agents|mesh-ancestor
111390344|NCT02299349|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111390345|NCT02299349|Respiratory System Agents|respiratory system agents|mesh-ancestor
111390346|NCT02299349|Mydriatics|mydriatics|mesh-ancestor
111390347|NCT02299349|Sympathomimetics|sympathomimetics|mesh-ancestor
111390348|NCT02299349|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111390349|NCT03296163|Paclitaxel|paclitaxel|mesh-list
111390350|NCT03296163|Bevacizumab|bevacizumab|mesh-list
111390351|NCT03296163|Carboplatin|carboplatin|mesh-list
111390352|NCT03296163|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111390353|NCT03296163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111390354|NCT03296163|Tubulin Modulators|tubulin modulators|mesh-ancestor
111390355|NCT03296163|Antimitotic Agents|antimitotic agents|mesh-ancestor
111390356|NCT03296163|Mitosis Modulators|mitosis modulators|mesh-ancestor
111390357|NCT03296163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111390358|NCT03296163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111390359|NCT03296163|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111390360|NCT03296163|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111390361|NCT03296163|Growth Substances|growth substances|mesh-ancestor
111390362|NCT03296163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111390363|NCT03296163|Growth Inhibitors|growth inhibitors|mesh-ancestor
111390364|NCT00376155|Pyrimethamine|pyrimethamine|mesh-list
111390365|NCT00376155|Sulfadoxine|sulfadoxine|mesh-list
111390366|NCT00376155|Amodiaquine|amodiaquine|mesh-list
111390367|NCT00376155|Antimalarials|antimalarials|mesh-ancestor
111390368|NCT00376155|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111390369|NCT00376155|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111390370|NCT00376155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111390371|NCT00376155|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111390372|NCT00376155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111390373|NCT00376155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111390374|NCT00376155|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111390375|NCT01989221|Granisetron|granisetron|mesh-list
111390376|NCT01989221|Antiemetics|antiemetics|mesh-ancestor
111390377|NCT01989221|Autonomic Agents|autonomic agents|mesh-ancestor
111390378|NCT01989221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111390379|NCT01989221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111390380|NCT01989221|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111390381|NCT01989221|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111390382|NCT01989221|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111390383|NCT01989221|Serotonin Agents|serotonin agents|mesh-ancestor
111390384|NCT01989221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111390385|NCT01989221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111390386|NCT03226899|Colchicine|colchicine|mesh-list
111390387|NCT03226899|Allopurinol|allopurinol|mesh-list
111390388|NCT03226899|Febuxostat|febuxostat|mesh-list
111390389|NCT03226899|Lesinurad|lesinurad|mesh-list
111390390|NCT03226899|Gout Suppressants|gout suppressants|mesh-ancestor
111390391|NCT03226899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111390392|NCT03226899|Tubulin Modulators|tubulin modulators|mesh-ancestor
111390393|NCT03226899|Antimitotic Agents|antimitotic agents|mesh-ancestor
111390394|NCT03226899|Mitosis Modulators|mitosis modulators|mesh-ancestor
111390395|NCT03226899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111390396|NCT03226899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111390397|NCT03226899|Antimetabolites|antimetabolites|mesh-ancestor
111390398|NCT03226899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111390399|NCT03226899|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111390400|NCT03226899|Antioxidants|antioxidants|mesh-ancestor
111390401|NCT03226899|Protective Agents|protective agents|mesh-ancestor
111390402|NCT03226899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111390403|NCT03226899|Uricosuric Agents|uricosuric agents|mesh-ancestor
111390404|NCT01990703|Levonorgestrel|levonorgestrel|mesh-list
111390405|NCT01990703|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111390406|NCT01990703|Contraceptive Agents|contraceptive agents|mesh-ancestor
111390407|NCT01990703|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111390408|NCT01990703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111390409|NCT01990703|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111390410|NCT01990703|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111390411|NCT01990703|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111390412|NCT03230175|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111390413|NCT03230175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111390414|NCT01992185|Sunscreening Agents|sunscreening agents|mesh-list
111390415|NCT01992185|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111390416|NCT01992185|Protective Agents|protective agents|mesh-ancestor
111390417|NCT01992185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111390418|NCT01992185|Dermatologic Agents|dermatologic agents|mesh-ancestor
111390419|NCT04332627|Neostigmine|neostigmine|mesh-list
111390420|NCT04332627|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111390421|NCT04332627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111390422|NCT04332627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111390423|NCT04332627|Cholinergic Agents|cholinergic agents|mesh-ancestor
111390424|NCT04332627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111390425|NCT04332627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111390426|NCT04332627|Parasympathomimetics|parasympathomimetics|mesh-ancestor
111390427|NCT04332627|Autonomic Agents|autonomic agents|mesh-ancestor
111390428|NCT04332627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111390429|NCT03440229|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
111390430|NCT03440229|Laxatives|laxatives|mesh-ancestor
111390431|NCT03440229|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111390432|NCT01963091|Oxytocin|oxytocin|mesh-list
111390433|NCT01963091|Oxytocics|oxytocics|mesh-ancestor
111390434|NCT01963091|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111390435|NCT01963091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111390436|NCT02306759|Ketamine|ketamine|mesh-list
111390437|NCT02306759|Analgesics|analgesics|mesh-ancestor
111390438|NCT02306759|Sensory System Agents|sensory system agents|mesh-ancestor
111390439|NCT02306759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111390440|NCT02306759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111390441|NCT02306759|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111390442|NCT02306759|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111390443|NCT02306759|Anesthetics, General|anesthetics, general|mesh-ancestor
111390444|NCT02306759|Anesthetics|anesthetics|mesh-ancestor
111390445|NCT02306759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111390446|NCT02306759|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111390447|NCT02306759|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111390448|NCT02306759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111390449|NCT02306759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111390450|NCT03298113|Protective Agents|protective agents|mesh-list
111390451|NCT03298113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111390452|NCT03232749|Methylprednisolone|methylprednisolone|mesh-list
111390453|NCT03232749|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111390454|NCT03232749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111390455|NCT03232749|Antiemetics|antiemetics|mesh-ancestor
111390456|NCT03232749|Autonomic Agents|autonomic agents|mesh-ancestor
111390457|NCT03232749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111390458|NCT03232749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111390459|NCT03232749|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111390460|NCT03232749|Glucocorticoids|glucocorticoids|mesh-ancestor
111390461|NCT03232749|Hormones|hormones|mesh-ancestor
111390462|NCT03232749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111390463|NCT03232749|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111390464|NCT03232749|Protective Agents|protective agents|mesh-ancestor
111390465|NCT01687400|Decitabine|decitabine|mesh-list
111390466|NCT01687400|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111390467|NCT01687400|Antimetabolites|antimetabolites|mesh-ancestor
111390468|NCT01687400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111390469|NCT01687400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111390470|NCT01687400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111390471|NCT01688102|Vitamin D|vitamin d|mesh-list
111390472|NCT01688102|Cholecalciferol|cholecalciferol|mesh-list
111390473|NCT01688102|Vitamins|vitamins|mesh-ancestor
111390474|NCT01688102|Micronutrients|micronutrients|mesh-ancestor
111390475|NCT01688102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111390476|NCT01688102|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111390477|NCT01688102|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111390478|NCT01994993|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111390479|NCT01994993|Metronidazole|metronidazole|mesh-list
111390480|NCT01994993|Clindamycin|clindamycin|mesh-list
111390481|NCT01994993|Clindamycin palmitate|clindamycin palmitate|mesh-list
111390482|NCT01994993|Clindamycin phosphate|clindamycin phosphate|mesh-list
111390483|NCT01994993|Gentamicins|gentamicins|mesh-list
111390484|NCT01994993|Tazobactam|tazobactam|mesh-list
111390485|NCT01994993|Piperacillin|piperacillin|mesh-list
111390486|NCT01994993|Ampicillin|ampicillin|mesh-list
111390487|NCT01994993|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
111390488|NCT01994993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111390489|NCT01994993|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111390490|NCT01994993|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111390491|NCT01994993|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111390492|NCT01994993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111390493|NCT01994993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111390494|NCT01994993|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
111390495|NCT01688336|Leucovorin|leucovorin|mesh-list
111390496|NCT01688336|Oxaliplatin|oxaliplatin|mesh-list
111390497|NCT01688336|Irinotecan|irinotecan|mesh-list
111390498|NCT01688336|Folfirinox|folfirinox|mesh-list
111390499|NCT01688336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111390500|NCT01688336|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111390501|NCT01688336|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111390502|NCT01688336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111390503|NCT01688336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111390504|NCT01688336|Antidotes|antidotes|mesh-ancestor
111390505|NCT01688336|Protective Agents|protective agents|mesh-ancestor
111390506|NCT01688336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111390507|NCT01688336|Vitamin B Complex|vitamin b complex|mesh-ancestor
111390508|NCT01688336|Vitamins|vitamins|mesh-ancestor
111390509|NCT01688336|Micronutrients|micronutrients|mesh-ancestor
111390510|NCT01963481|Cyclophosphamide|cyclophosphamide|mesh-list
111390511|NCT01963481|Exemestane|exemestane|mesh-list
111390512|NCT01963481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111390513|NCT01963481|Immunologic Factors|immunologic factors|mesh-ancestor
111390514|NCT01963481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111390515|NCT01963481|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111390516|NCT01963481|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111390517|NCT01963481|Alkylating Agents|alkylating agents|mesh-ancestor
111390518|NCT01963481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111390519|NCT01963481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111390520|NCT01963481|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111390521|NCT01963481|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111390522|NCT01963481|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111390523|NCT01963481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111390524|NCT01963481|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111390525|NCT01963481|Hormone Antagonists|hormone antagonists|mesh-ancestor
111390526|NCT01963481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111390527|NCT04436744|Palbociclib|palbociclib|mesh-list
111390528|NCT04436744|Anastrozole|anastrozole|mesh-list
111390529|NCT04436744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111390530|NCT04436744|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111390531|NCT04436744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111390532|NCT04436744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111390533|NCT04436744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111390534|NCT04436744|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111390535|NCT04436744|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111390536|NCT04436744|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111390537|NCT04436744|Hormone Antagonists|hormone antagonists|mesh-ancestor
111390538|NCT04436744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111390539|NCT04436744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111390540|NCT01963793|Aprepitant|aprepitant|mesh-list
111390541|NCT01963793|Fosaprepitant|fosaprepitant|mesh-list
111390542|NCT01963793|Antiemetics|antiemetics|mesh-ancestor
111390543|NCT01963793|Autonomic Agents|autonomic agents|mesh-ancestor
111390544|NCT01963793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111390545|NCT01963793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111390546|NCT01963793|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111390547|NCT01963793|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
111390548|NCT01963793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111390549|NCT01963793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111390550|NCT03449433|Insulin|insulin|mesh-list
111390551|NCT03449433|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111390552|NCT03449433|Insulin Aspart|insulin aspart|mesh-list
111390553|NCT03449433|Insulin, Long-Acting|insulin, long-acting|mesh-list
111390554|NCT03449433|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
111390555|NCT03449433|Insulin Lispro|insulin lispro|mesh-list
111390556|NCT03449433|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111390557|NCT03449433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111390558|NCT03241485|Morphine|morphine|mesh-list
111390559|NCT03241485|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111390560|NCT03241485|Narcotics|narcotics|mesh-ancestor
111390561|NCT03241485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111390562|NCT03241485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111390563|NCT03241485|Analgesics|analgesics|mesh-ancestor
111390564|NCT03241485|Sensory System Agents|sensory system agents|mesh-ancestor
111390565|NCT03241485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111390566|NCT04313504|Niraparib|niraparib|mesh-list
111390567|NCT04313504|Dostarlimab|dostarlimab|mesh-list
111390568|NCT04313504|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111390569|NCT04313504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111390570|NCT04313504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111390571|NCT04313504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111390572|NCT01996943|Ethanol|ethanol|mesh-list
111390573|NCT01996943|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111390574|NCT01996943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111390575|NCT01996943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111390576|NCT01996943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111390577|NCT04812626|Triamcinolone|triamcinolone|mesh-list
111390578|NCT04812626|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
111390579|NCT04812626|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
111390580|NCT04812626|Fluorouracil|fluorouracil|mesh-list
111390581|NCT04812626|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
111390582|NCT04812626|Antimetabolites|antimetabolites|mesh-ancestor
110530641|NCT00885105|Vaccines|vaccines|mesh-list
111390583|NCT04812626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111390584|NCT04812626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111390585|NCT04812626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111390586|NCT04812626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111390587|NCT04812626|Immunologic Factors|immunologic factors|mesh-ancestor
111390588|NCT04812626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111390589|NCT04812626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111390590|NCT04812626|Glucocorticoids|glucocorticoids|mesh-ancestor
111390591|NCT04812626|Hormones|hormones|mesh-ancestor
111390592|NCT04812626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111390593|NCT04812626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111390594|NCT04197986|Infigratinib|infigratinib|mesh-list
111390595|NCT04197986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111390596|NCT01997411|Glucagon|glucagon|mesh-list
111390597|NCT01997411|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
111390598|NCT01997411|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111390599|NCT01997411|Hormones|hormones|mesh-ancestor
111390600|NCT01997411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111390601|NCT01997411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111390602|NCT01997411|Incretins|incretins|mesh-ancestor
111390603|NCT03534635|Pembrolizumab|pembrolizumab|mesh-list
111390604|NCT03534635|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111390605|NCT03534635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111390606|NCT03534635|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111390607|NCT03534635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111390608|NCT01999517|Nitroglycerin|nitroglycerin|mesh-list
111115021|NCT05046041|Misoprostol|misoprostol|mesh-list
111390609|NCT01999517|Vasodilator Agents|vasodilator agents|mesh-ancestor
111390610|NCT02657486|Infigratinib|infigratinib|mesh-list
111390611|NCT02657486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111390613|NCT01999985|Afatinib|afatinib|mesh-list
111390614|NCT01999985|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
111390615|NCT01999985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111390616|NCT01999985|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111390617|NCT01999985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111390618|NCT01999985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111390619|NCT01968317|Metformin|metformin|mesh-list
111390620|NCT01968317|Megestrol|megestrol|mesh-list
111390621|NCT01968317|Megestrol Acetate|megestrol acetate|mesh-list
111390622|NCT01968317|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111390623|NCT01968317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111390624|NCT01968317|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111390625|NCT01968317|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111390626|NCT01968317|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111390627|NCT01968317|Contraceptive Agents|contraceptive agents|mesh-ancestor
111390628|NCT01968317|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111390629|NCT01968317|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111390630|NCT01968317|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111390631|NCT01968317|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111390632|NCT01968317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111390633|NCT01968317|Appetite Stimulants|appetite stimulants|mesh-ancestor
111390634|NCT01968317|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111390635|NCT01971593|Eplerenone|eplerenone|mesh-list
111390636|NCT01971593|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
111390637|NCT01971593|Hormone Antagonists|hormone antagonists|mesh-ancestor
111390638|NCT01971593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111390639|NCT01971593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111390640|NCT01971593|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
111390641|NCT01971593|Diuretics|diuretics|mesh-ancestor
111390642|NCT01971593|Natriuretic Agents|natriuretic agents|mesh-ancestor
111390643|NCT01971593|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111390644|NCT02986451|Clarithromycin|clarithromycin|mesh-list
111390645|NCT02986451|Dexamethasone|dexamethasone|mesh-list
111390646|NCT02986451|Lenalidomide|lenalidomide|mesh-list
111390647|NCT02986451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111390648|NCT02986451|Antiemetics|antiemetics|mesh-ancestor
111390649|NCT02986451|Autonomic Agents|autonomic agents|mesh-ancestor
111390650|NCT02986451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111390651|NCT02986451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111390652|NCT02986451|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111390653|NCT02986451|Glucocorticoids|glucocorticoids|mesh-ancestor
111390654|NCT02986451|Hormones|hormones|mesh-ancestor
111390655|NCT02986451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111390656|NCT02986451|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110530710|NCT02707328|Mitosis Modulators|mitosis modulators|mesh-ancestor
111390657|NCT02986451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111390658|NCT02986451|Immunologic Factors|immunologic factors|mesh-ancestor
111390659|NCT02986451|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111390660|NCT02986451|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111390661|NCT02986451|Growth Substances|growth substances|mesh-ancestor
111390662|NCT02986451|Growth Inhibitors|growth inhibitors|mesh-ancestor
111390663|NCT02986451|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111390664|NCT02986451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111390665|NCT02986451|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111390666|NCT02986451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111390667|NCT02986451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111390668|NCT02986451|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111390669|NCT02986451|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111390670|NCT03245463|Hyaluronic Acid|hyaluronic acid|mesh-list
111390671|NCT03245463|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111390672|NCT03245463|Immunologic Factors|immunologic factors|mesh-ancestor
111390673|NCT03245463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111390674|NCT03245463|Viscosupplements|viscosupplements|mesh-ancestor
111390675|NCT03245463|Protective Agents|protective agents|mesh-ancestor
111390676|NCT01974245|Cholecalciferol|cholecalciferol|mesh-list
111390677|NCT01974245|Vitamin D|vitamin d|mesh-list
111390678|NCT01974245|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111390679|NCT01974245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111390680|NCT01974245|Vitamins|vitamins|mesh-ancestor
111390681|NCT01974245|Micronutrients|micronutrients|mesh-ancestor
111390682|NCT01974245|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111390683|NCT03307005|Zolpidem|zolpidem|mesh-list
111390684|NCT03307005|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111115098|NCT01970488|Adalimumab|adalimumab|mesh-list
111390685|NCT03307005|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111390686|NCT03307005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111390687|NCT03307005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111390688|NCT03307005|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
111390689|NCT03307005|GABA Agonists|gaba agonists|mesh-ancestor
111390690|NCT03307005|GABA Agents|gaba agents|mesh-ancestor
111390691|NCT03307005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111390692|NCT03307005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111390693|NCT02005601|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
111390694|NCT02005601|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111390695|NCT02005601|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111390696|NCT02005601|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111390697|NCT02005601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111390698|NCT02005601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111390699|NCT02005601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111390700|NCT02005601|Analgesics|analgesics|mesh-ancestor
111390701|NCT02005601|Sensory System Agents|sensory system agents|mesh-ancestor
111390702|NCT02005601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111390703|NCT02005601|Antidepressive Agents|antidepressive agents|mesh-ancestor
111390704|NCT02005601|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111390705|NCT02005601|Dopamine Agents|dopamine agents|mesh-ancestor
111390706|NCT02007863|Fludarabine|fludarabine|mesh-list
111390707|NCT02007863|Melphalan|melphalan|mesh-list
111390708|NCT02007863|Busulfan|busulfan|mesh-list
111390709|NCT02007863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111390710|NCT02007863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111390711|NCT02007863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111390712|NCT02007863|Immunologic Factors|immunologic factors|mesh-ancestor
111390713|NCT02007863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111390714|NCT02007863|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111390715|NCT02007863|Alkylating Agents|alkylating agents|mesh-ancestor
111390716|NCT02007863|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111390717|NCT03460899|Hypoglycemic Agents|hypoglycemic agents|mesh-list
111390718|NCT03460899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111390719|NCT02305277|Opicapone|opicapone|mesh-list
111390720|NCT02305277|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
111390721|NCT02305277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111390722|NCT02305277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111390723|NCT02305277|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111390724|NCT02305277|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111390725|NCT03309657|Tazobactam|tazobactam|mesh-list
111390726|NCT03309657|Ceftolozane|ceftolozane|mesh-list
111390727|NCT03309657|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
111390728|NCT03309657|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111390729|NCT03309657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111390730|NCT03309657|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
111390731|NCT03309657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111390732|NCT03309657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111390733|NCT03309657|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111390734|NCT03463161|Pembrolizumab|pembrolizumab|mesh-list
111390735|NCT03463161|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111390736|NCT03463161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111390737|NCT03463161|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111390738|NCT03463161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111390739|NCT03467685|Anesthetics|anesthetics|mesh-list
110530787|NCT05024006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111390740|NCT03467685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111390741|NCT03467685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111390742|NCT03468075|Ascorbic Acid|ascorbic acid|mesh-list
111390743|NCT03468075|Gemcitabine|gemcitabine|mesh-list
111390744|NCT03468075|Vitamins|vitamins|mesh-ancestor
111390745|NCT03468075|Micronutrients|micronutrients|mesh-ancestor
111390746|NCT03468075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111390747|NCT03468075|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111390748|NCT03468075|Antimetabolites|antimetabolites|mesh-ancestor
111390749|NCT03468075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111390750|NCT03468075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111390751|NCT03468075|Antioxidants|antioxidants|mesh-ancestor
111390752|NCT03468075|Protective Agents|protective agents|mesh-ancestor
111390753|NCT03468933|Plasminogen|plasminogen|mesh-list
111390754|NCT03468933|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
111390755|NCT03468933|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111390756|NCT03468933|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110530814|NCT03781544|Diclofenac|diclofenac|mesh-list
111390757|NCT03468933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111390758|NCT03472287|Diacerein|diacerein|mesh-list
111390759|NCT03472287|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111390760|NCT02219984|Anticoagulants|anticoagulants|mesh-list
111390761|NCT02067416|Paclitaxel|paclitaxel|mesh-list
111390762|NCT02067416|Docetaxel|docetaxel|mesh-list
111390763|NCT02067416|Epirubicin|epirubicin|mesh-list
111390765|NCT02067416|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111390766|NCT02067416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111390767|NCT02067416|Tubulin Modulators|tubulin modulators|mesh-ancestor
111390768|NCT02067416|Antimitotic Agents|antimitotic agents|mesh-ancestor
111390769|NCT02067416|Mitosis Modulators|mitosis modulators|mesh-ancestor
111390770|NCT02067416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110530829|NCT03781544|Narcotics|narcotics|mesh-ancestor
111390771|NCT02067416|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111390772|NCT02067416|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111390773|NCT02067416|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111390774|NCT02067416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111390775|NCT03258645|Dabigatran|dabigatran|mesh-list
111390776|NCT03258645|Antithrombins|antithrombins|mesh-ancestor
111390777|NCT03258645|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111390778|NCT03258645|Protease Inhibitors|protease inhibitors|mesh-ancestor
111390779|NCT03258645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111390780|NCT03258645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111390781|NCT03258645|Anticoagulants|anticoagulants|mesh-ancestor
111390782|NCT03482583|Nicotine|nicotine|mesh-list
111390783|NCT03482583|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111390784|NCT03482583|Autonomic Agents|autonomic agents|mesh-ancestor
111390785|NCT03482583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111390786|NCT03482583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111390787|NCT03482583|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111390788|NCT03482583|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111390789|NCT03482583|Cholinergic Agents|cholinergic agents|mesh-ancestor
111390790|NCT03482583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111390791|NCT03482583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111390792|NCT02010203|BCG Vaccine|bcg vaccine|mesh-list
111390793|NCT02010203|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111390794|NCT02010203|Immunologic Factors|immunologic factors|mesh-ancestor
111390795|NCT02010203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111390796|NCT03261999|Leuprolide|leuprolide|mesh-list
111390797|NCT03261999|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111390798|NCT03261999|Fertility Agents|fertility agents|mesh-ancestor
111390799|NCT03261999|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111390800|NCT03261999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111390801|NCT03261999|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111390802|NCT03261999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111390803|NCT03482973|Bupivacaine|bupivacaine|mesh-list
111390804|NCT03482973|Anesthetics, Local|anesthetics, local|mesh-ancestor
111390805|NCT03482973|Anesthetics|anesthetics|mesh-ancestor
111390806|NCT03482973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111390807|NCT03482973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111390808|NCT03482973|Sensory System Agents|sensory system agents|mesh-ancestor
111390809|NCT03482973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111390810|NCT01602380|Fulvestrant|fulvestrant|mesh-list
111390811|NCT01602380|Anastrozole|anastrozole|mesh-list
111390812|NCT01602380|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111390813|NCT01602380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111390814|NCT01602380|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
111390815|NCT01602380|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111390816|NCT01602380|Hormone Antagonists|hormone antagonists|mesh-ancestor
111390817|NCT01602380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111390818|NCT01602380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111390819|NCT01602380|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111390820|NCT01602380|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111390821|NCT01602380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111390822|NCT01602380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111390823|NCT03483675|Immunosuppressive Agents|immunosuppressive agents|mesh-list
111390824|NCT03483675|Immunologic Factors|immunologic factors|mesh-ancestor
111390825|NCT03483675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111390826|NCT03327051|Omeprazole|omeprazole|mesh-list
111390827|NCT03327051|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111390828|NCT03327051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111390829|NCT03327051|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111390830|NCT03327051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111390831|NCT03327051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111390832|NCT02057939|Leuprolide|leuprolide|mesh-list
111390833|NCT02057939|Androgens|androgens|mesh-list
111390834|NCT02057939|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111390835|NCT02057939|Fertility Agents|fertility agents|mesh-ancestor
111390836|NCT02057939|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110530873|NCT02706860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111390837|NCT02057939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111390838|NCT02057939|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111390839|NCT02057939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111390840|NCT02057939|Hormones|hormones|mesh-ancestor
111390841|NCT02057939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111390842|NCT03496467|Nepafenac|nepafenac|mesh-list
111390843|NCT03496467|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110458746|NCT04287894|Durvalumab|durvalumab|mesh-list
111390844|NCT03496467|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111390845|NCT03496467|Analgesics|analgesics|mesh-ancestor
111390846|NCT03496467|Sensory System Agents|sensory system agents|mesh-ancestor
111390847|NCT03496467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111390848|NCT03496467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111390849|NCT03496467|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111390850|NCT03496467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111390851|NCT02058251|Oxytocin|oxytocin|mesh-list
111390852|NCT02058251|Oxytocics|oxytocics|mesh-ancestor
111390853|NCT02058251|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111390854|NCT02058251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111390855|NCT03329937|Niraparib|niraparib|mesh-list
111390856|NCT03329937|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111390857|NCT03329937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111390858|NCT03329937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111390859|NCT03329937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110458877|NCT01120184|Paclitaxel|paclitaxel|mesh-list
111390860|NCT01710254|Regadenoson|regadenoson|mesh-list
111390861|NCT01710254|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
111390862|NCT01710254|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
111390863|NCT01710254|Purinergic Agonists|purinergic agonists|mesh-ancestor
111390864|NCT01710254|Purinergic Agents|purinergic agents|mesh-ancestor
111390865|NCT01710254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111390866|NCT01710254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111390867|NCT01710254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111390868|NCT03496545|Acetaminophen|acetaminophen|mesh-list
111390869|NCT03496545|Bromocriptine|bromocriptine|mesh-list
110530902|NCT03764540|Prednisone|prednisone|mesh-list
111390870|NCT03496545|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111390871|NCT03496545|Analgesics|analgesics|mesh-ancestor
111390872|NCT03496545|Sensory System Agents|sensory system agents|mesh-ancestor
111390873|NCT03496545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111390874|NCT03496545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111390875|NCT03496545|Antipyretics|antipyretics|mesh-ancestor
111390876|NCT03496545|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111390877|NCT03496545|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111390878|NCT03496545|Hormone Antagonists|hormone antagonists|mesh-ancestor
111390879|NCT03496545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111390880|NCT03496545|Dopamine Agonists|dopamine agonists|mesh-ancestor
111390881|NCT03496545|Dopamine Agents|dopamine agents|mesh-ancestor
111390882|NCT03496545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111390883|NCT03496545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111390884|NCT01710332|Aflibercept|aflibercept|mesh-list
111390885|NCT01710332|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111390886|NCT01710332|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111390887|NCT01710332|Growth Substances|growth substances|mesh-ancestor
111390888|NCT01710332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111390889|NCT01710332|Growth Inhibitors|growth inhibitors|mesh-ancestor
111390890|NCT01710332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111390891|NCT02311907|Paclitaxel|paclitaxel|mesh-list
111390892|NCT02311907|Carboplatin|carboplatin|mesh-list
111390893|NCT02311907|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111390894|NCT02311907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111390895|NCT02311907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111390896|NCT02311907|Tubulin Modulators|tubulin modulators|mesh-ancestor
111390897|NCT02311907|Antimitotic Agents|antimitotic agents|mesh-ancestor
111390898|NCT02311907|Mitosis Modulators|mitosis modulators|mesh-ancestor
111390899|NCT02311907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111390900|NCT02013245|Vaccines|vaccines|mesh-list
111390901|NCT02013245|Immunologic Factors|immunologic factors|mesh-ancestor
111390902|NCT02013245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111390903|NCT01980485|Carbon Monoxide|carbon monoxide|mesh-list
111390904|NCT01980485|Antimetabolites|antimetabolites|mesh-ancestor
111390905|NCT01980485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111390906|NCT01980485|Gasotransmitters|gasotransmitters|mesh-ancestor
111390907|NCT01980485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111390908|NCT01980485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111390909|NCT01981967|Vaccines|vaccines|mesh-list
111390910|NCT01981967|Immunologic Factors|immunologic factors|mesh-ancestor
111390911|NCT01981967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111390912|NCT01982123|Edetic Acid|edetic acid|mesh-list
111390913|NCT01982123|Pentetic Acid|pentetic acid|mesh-list
111390914|NCT01982123|Technetium Tc 99m Pentetate|technetium tc 99m pentetate|mesh-list
111390915|NCT01982123|Technetium Tc 99m Aggregated Albumin|technetium tc 99m aggregated albumin|mesh-list
111390916|NCT01982123|Antidotes|antidotes|mesh-ancestor
111390917|NCT01982123|Protective Agents|protective agents|mesh-ancestor
111390918|NCT01982123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111390919|NCT01982123|Chelating Agents|chelating agents|mesh-ancestor
111390920|NCT01982123|Sequestering Agents|sequestering agents|mesh-ancestor
111390921|NCT01982123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111390922|NCT01982123|Iron Chelating Agents|iron chelating agents|mesh-ancestor
111390923|NCT01982123|Anticoagulants|anticoagulants|mesh-ancestor
111390924|NCT01982123|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
111390925|NCT01982123|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111390926|NCT02061683|Bimatoprost|bimatoprost|mesh-list
111390927|NCT02061683|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111390928|NCT01711658|Lapatinib|lapatinib|mesh-list
111390929|NCT01711658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111390930|NCT01711658|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111390931|NCT01711658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111390932|NCT01711658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111390933|NCT01712360|Naftifine|naftifine|mesh-list
111390934|NCT01712360|Antifungal Agents|antifungal agents|mesh-ancestor
111390935|NCT01712360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111390936|NCT02396147|Relugolix|relugolix|mesh-list
111390937|NCT02396147|Androgen Antagonists|androgen antagonists|mesh-ancestor
111390938|NCT02396147|Hormone Antagonists|hormone antagonists|mesh-ancestor
111390939|NCT02396147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111390940|NCT02396147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111390941|NCT01713608|Artefenomel|artefenomel|mesh-list
111390942|NCT01713608|Antimalarials|antimalarials|mesh-ancestor
111390943|NCT01713608|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111390944|NCT01713608|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111390945|NCT01713608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111390946|NCT02018627|Glucagon|glucagon|mesh-list
111390947|NCT02018627|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
111390948|NCT02018627|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111390949|NCT02018627|Hormones|hormones|mesh-ancestor
111390950|NCT02018627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111390951|NCT02018627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111390952|NCT02018627|Incretins|incretins|mesh-ancestor
111390953|NCT03476330|Quercetin|quercetin|mesh-list
111390954|NCT03476330|Antioxidants|antioxidants|mesh-ancestor
110530976|NCT05264558|Antiviral Agents|antiviral agents|mesh-ancestor
111390955|NCT03476330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111390956|NCT03476330|Protective Agents|protective agents|mesh-ancestor
111390957|NCT03476330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111390958|NCT04413344|Bromocriptine|bromocriptine|mesh-list
111390959|NCT04413344|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111390960|NCT04413344|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111390961|NCT04413344|Hormone Antagonists|hormone antagonists|mesh-ancestor
111390962|NCT04413344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111390963|NCT04413344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111390964|NCT04413344|Dopamine Agonists|dopamine agonists|mesh-ancestor
111390965|NCT04413344|Dopamine Agents|dopamine agents|mesh-ancestor
111390966|NCT04413344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111390967|NCT04413344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111390968|NCT01717742|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
111390969|NCT01717742|Plasminogen|plasminogen|mesh-list
111390970|NCT01717742|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111390971|NCT01717742|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111390972|NCT01717742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111390973|NCT01717898|Prednisone|prednisone|mesh-list
111390974|NCT01717898|Abiraterone Acetate|abiraterone acetate|mesh-list
111390975|NCT01717898|Dactolisib|dactolisib|mesh-list
111390976|NCT01717898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111390977|NCT01717898|Glucocorticoids|glucocorticoids|mesh-ancestor
111390978|NCT01717898|Hormones|hormones|mesh-ancestor
110531001|NCT00636896|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111390979|NCT01717898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111390980|NCT01717898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111390981|NCT01717898|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111390982|NCT01717898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111390983|NCT01717898|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111390984|NCT01717898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111390985|NCT01717898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111390986|NCT01717898|Hormone Antagonists|hormone antagonists|mesh-ancestor
111390987|NCT01717898|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111390988|NCT01737944|Methotrexate|methotrexate|mesh-list
111390989|NCT01737944|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111390990|NCT01737944|Abortifacient Agents|abortifacient agents|mesh-ancestor
111390991|NCT01737944|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111390992|NCT01737944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111390993|NCT01737944|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111390994|NCT01737944|Antimetabolites|antimetabolites|mesh-ancestor
111390995|NCT01737944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111390996|NCT01737944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111390997|NCT01737944|Dermatologic Agents|dermatologic agents|mesh-ancestor
111390998|NCT01737944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111390999|NCT01737944|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111391000|NCT01737944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111391001|NCT01737944|Immunologic Factors|immunologic factors|mesh-ancestor
111391002|NCT01737944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111391003|NCT01737944|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111391004|NCT01740206|Methylphenidate|methylphenidate|mesh-list
111391005|NCT01740206|Amphetamine|amphetamine|mesh-list
111391006|NCT01740206|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111391007|NCT01740206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111391008|NCT01740206|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111391009|NCT01740206|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111391010|NCT01740206|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111391011|NCT01740206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111391012|NCT01740206|Dopamine Agents|dopamine agents|mesh-ancestor
111391013|NCT01740206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111391014|NCT01740206|Sympathomimetics|sympathomimetics|mesh-ancestor
111391015|NCT01740206|Autonomic Agents|autonomic agents|mesh-ancestor
111391016|NCT01740206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111391017|NCT01740206|Adrenergic Agents|adrenergic agents|mesh-ancestor
111391018|NCT01740206|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111391019|NCT01740362|Tofacitinib|tofacitinib|mesh-list
111391020|NCT01740362|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
111391021|NCT01740362|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111391022|NCT01740362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111391023|NCT01740362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111391024|NCT02068157|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
111391025|NCT02068157|Trioxsalen|trioxsalen|mesh-list
111391026|NCT02068157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111391027|NCT02068157|Dermatologic Agents|dermatologic agents|mesh-ancestor
111391028|NCT02068157|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111391029|NCT01741454|Tamsulosin|tamsulosin|mesh-list
111391030|NCT01741454|Tolterodine Tartrate|tolterodine tartrate|mesh-list
111391031|NCT01741454|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111391032|NCT01741454|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111391033|NCT01741454|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111391034|NCT01741454|Adrenergic Agents|adrenergic agents|mesh-ancestor
111391035|NCT01741454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111391036|NCT01741454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111391037|NCT01741454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111391038|NCT01741454|Urological Agents|urological agents|mesh-ancestor
111391039|NCT01741454|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110531031|NCT02693444|Lidocaine|lidocaine|mesh-list
111391040|NCT01741454|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111391041|NCT01741454|Cholinergic Agents|cholinergic agents|mesh-ancestor
111391042|NCT01720316|Glycine|glycine|mesh-list
111391043|NCT01720316|Glycine Agents|glycine agents|mesh-ancestor
111391044|NCT01720316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111391045|NCT01720316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111391046|NCT01720316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111391047|NCT02399345|Ritonavir|ritonavir|mesh-list
111391048|NCT02399345|Ribavirin|ribavirin|mesh-list
111391049|NCT02399345|Sofosbuvir|sofosbuvir|mesh-list
111391050|NCT02399345|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111391051|NCT02399345|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111391052|NCT02399345|Protease Inhibitors|protease inhibitors|mesh-ancestor
111391053|NCT02399345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111391054|NCT02399345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111391055|NCT02399345|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111391056|NCT02399345|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111391057|NCT02399345|Antiviral Agents|antiviral agents|mesh-ancestor
111391058|NCT02399345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111391059|NCT02399345|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111391060|NCT02399345|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111391062|NCT02400437|Dexamethasone|dexamethasone|mesh-list
111391063|NCT02400437|Rituximab|rituximab|mesh-list
111391064|NCT02400437|Ixazomib|ixazomib|mesh-list
111391065|NCT02400437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111391066|NCT02400437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111391067|NCT02400437|Immunologic Factors|immunologic factors|mesh-ancestor
111391068|NCT02400437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111391069|NCT02400437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111391070|NCT02400437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111391071|NCT02400437|Antiemetics|antiemetics|mesh-ancestor
111391072|NCT02400437|Autonomic Agents|autonomic agents|mesh-ancestor
111391073|NCT02400437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111391074|NCT02400437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111391075|NCT02400437|Glucocorticoids|glucocorticoids|mesh-ancestor
111391076|NCT02400437|Hormones|hormones|mesh-ancestor
111391077|NCT02400437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111391078|NCT02400437|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111391079|NCT02400437|Protease Inhibitors|protease inhibitors|mesh-ancestor
111391080|NCT02400437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111391081|NCT02400437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111391082|NCT02024477|Saxagliptin|saxagliptin|mesh-list
111391083|NCT02024477|Incretins|incretins|mesh-ancestor
111391084|NCT02024477|Hormones|hormones|mesh-ancestor
111391085|NCT02024477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111391086|NCT02024477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111391087|NCT02024477|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111391088|NCT02024477|Protease Inhibitors|protease inhibitors|mesh-ancestor
111391089|NCT02024477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111391090|NCT02024477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111391091|NCT02024477|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111391092|NCT02024711|Hyaluronic Acid|hyaluronic acid|mesh-list
111391093|NCT02024711|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111391094|NCT02024711|Immunologic Factors|immunologic factors|mesh-ancestor
111391095|NCT02024711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111391096|NCT02024711|Viscosupplements|viscosupplements|mesh-ancestor
111391097|NCT02024711|Protective Agents|protective agents|mesh-ancestor
111391098|NCT02071823|Opicapone|opicapone|mesh-list
111391099|NCT02071823|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
111391100|NCT02071823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111391101|NCT02071823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111391102|NCT02071823|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111391103|NCT02071823|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111391104|NCT02029703|Hylan|hylan|mesh-list
111391105|NCT02029703|Viscosupplements|viscosupplements|mesh-ancestor
111391106|NCT02029703|Protective Agents|protective agents|mesh-ancestor
111391107|NCT02029703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111391108|NCT02406443|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111391109|NCT02406443|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111391110|NCT02406443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111391111|NCT02406443|Incretins|incretins|mesh-ancestor
111391112|NCT02406443|Hormones|hormones|mesh-ancestor
111391113|NCT02406443|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111391114|NCT02406443|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111391115|NCT02406443|Protease Inhibitors|protease inhibitors|mesh-ancestor
110531139|NCT00613964|Diuretics|diuretics|mesh-list
111391116|NCT02406443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111391117|NCT02406443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111391118|NCT02032433|Naltrexone|naltrexone|mesh-list
111391119|NCT02032433|Buprenorphine|buprenorphine|mesh-list
111391120|NCT02032433|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
111391121|NCT02032433|Naloxone|naloxone|mesh-list
111391122|NCT02032433|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111391123|NCT02032433|Narcotics|narcotics|mesh-ancestor
111391124|NCT02032433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111391125|NCT02032433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111391126|NCT02032433|Analgesics|analgesics|mesh-ancestor
111391127|NCT02032433|Sensory System Agents|sensory system agents|mesh-ancestor
111391128|NCT02032433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111391129|NCT02032433|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111391130|NCT02032433|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111391131|NCT02342015|Atorvastatin|atorvastatin|mesh-list
111115542|NCT05049473|Immunologic Factors|immunologic factors|mesh-ancestor
111391132|NCT02342015|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111391133|NCT02342015|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111391134|NCT02342015|Antimetabolites|antimetabolites|mesh-ancestor
111391135|NCT02342015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111391136|NCT02342015|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111391137|NCT02342015|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111391138|NCT02342015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111391139|NCT02342327|Menthol|menthol|mesh-list
111391140|NCT02342327|Antipruritics|antipruritics|mesh-ancestor
111391141|NCT02342327|Dermatologic Agents|dermatologic agents|mesh-ancestor
111391142|NCT01721564|Bosentan|bosentan|mesh-list
111391143|NCT01721564|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111391144|NCT01721564|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
111391145|NCT01721564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111391146|NCT02342561|Anti-Infective Agents|anti-infective agents|mesh-list
111391147|NCT02342561|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111391148|NCT02343575|Valproic Acid|valproic acid|mesh-list
111391149|NCT02343575|Haloperidol|haloperidol|mesh-list
111391150|NCT02343575|Haloperidol decanoate|haloperidol decanoate|mesh-list
111391151|NCT02343575|Antiemetics|antiemetics|mesh-ancestor
111391152|NCT02343575|Autonomic Agents|autonomic agents|mesh-ancestor
111391153|NCT02343575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111391154|NCT02343575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111391155|NCT02343575|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111391156|NCT02343575|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111391157|NCT02343575|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111391158|NCT02343575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111391159|NCT02343575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111391160|NCT02343575|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111391161|NCT02343575|Dopamine Agents|dopamine agents|mesh-ancestor
111391162|NCT02343575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111391163|NCT02343575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111391164|NCT02343575|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111391165|NCT02343575|Anticonvulsants|anticonvulsants|mesh-ancestor
111391166|NCT02343575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111391167|NCT02343575|GABA Agents|gaba agents|mesh-ancestor
111391168|NCT02343575|Antimanic Agents|antimanic agents|mesh-ancestor
111391169|NCT01744574|Progesterone|progesterone|mesh-list
111391170|NCT01744574|Progestins|progestins|mesh-ancestor
111391171|NCT01744574|Hormones|hormones|mesh-ancestor
111391172|NCT01744574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111391173|NCT01744574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111391174|NCT01744730|Clindamycin|clindamycin|mesh-list
111391175|NCT01744730|Clindamycin palmitate|clindamycin palmitate|mesh-list
111391176|NCT01744730|Clindamycin phosphate|clindamycin phosphate|mesh-list
111391177|NCT01744730|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111391178|NCT01744730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111391179|NCT01744730|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110531171|NCT00657891|Omalizumab|omalizumab|mesh-list
111391180|NCT01744730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111391181|NCT01744730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111391182|NCT00354965|Amoxicillin|amoxicillin|mesh-list
111391183|NCT00354965|Clavulanic Acid|clavulanic acid|mesh-list
111391184|NCT00354965|Clavulanic Acids|clavulanic acids|mesh-list
111391185|NCT00354965|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
111391186|NCT00354965|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111391187|NCT00354965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111391188|NCT00354965|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
111391189|NCT00354965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111391190|NCT00354965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111391191|NCT02037425|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111391192|NCT02037425|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111391193|NCT02037425|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111391194|NCT02037425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111391195|NCT02037425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111391196|NCT02037425|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111391197|NCT02037425|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111391198|NCT02037425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110531203|NCT00880269|Panobinostat|panobinostat|mesh-list
111391199|NCT02037425|Cholinergic Agents|cholinergic agents|mesh-ancestor
111391200|NCT02037425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111391201|NCT00355043|Zinc Sulfate|zinc sulfate|mesh-list
111391202|NCT00355043|Astringents|astringents|mesh-ancestor
111391203|NCT00355043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111391204|NCT00355043|Dermatologic Agents|dermatologic agents|mesh-ancestor
111391205|NCT02037893|Antipyrine|antipyrine|mesh-list
111391206|NCT02037893|Benzocaine|benzocaine|mesh-list
111391207|NCT02037893|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111115619|NCT02361619|Diclofenac|diclofenac|mesh-list
111391208|NCT02037893|Anesthetics, Local|anesthetics, local|mesh-ancestor
111391210|NCT02037893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111391211|NCT02037893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111391212|NCT02037893|Sensory System Agents|sensory system agents|mesh-ancestor
111391213|NCT02037893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110531221|NCT00880191|Analgesics|analgesics|mesh-ancestor
111391214|NCT02037893|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111391215|NCT02037893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111391216|NCT02037893|Analgesics|analgesics|mesh-ancestor
111391217|NCT02037893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111391218|NCT02037893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111391219|NCT02040623|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111391220|NCT02040623|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111391221|NCT02041325|Lenalidomide|lenalidomide|mesh-list
111391222|NCT02041325|Immunologic Factors|immunologic factors|mesh-ancestor
111391223|NCT02041325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111391224|NCT02041325|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111391225|NCT02041325|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111391226|NCT02041325|Growth Substances|growth substances|mesh-ancestor
111391227|NCT02041325|Growth Inhibitors|growth inhibitors|mesh-ancestor
111391228|NCT02041325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111391229|NCT01723514|Erenumab|erenumab|mesh-list
110531233|NCT00659451|Losartan|losartan|mesh-list
111391230|NCT01723514|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
111391231|NCT01723514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111391232|NCT01723514|Analgesics|analgesics|mesh-ancestor
111391233|NCT01723514|Sensory System Agents|sensory system agents|mesh-ancestor
111391234|NCT01723514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110531247|NCT00911313|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111391235|NCT01723514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111391236|NCT02044367|Dabigatran|dabigatran|mesh-list
111391237|NCT02044367|Antithrombins|antithrombins|mesh-ancestor
111391238|NCT02044367|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111391239|NCT02044367|Protease Inhibitors|protease inhibitors|mesh-ancestor
111391240|NCT02044367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111391241|NCT02044367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111391242|NCT02044367|Anticoagulants|anticoagulants|mesh-ancestor
111391243|NCT01745822|Tenofovir|tenofovir|mesh-list
111391244|NCT01745822|Antiviral Agents|antiviral agents|mesh-ancestor
111391245|NCT01745822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111391246|NCT01745822|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111391247|NCT01745822|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111391248|NCT01745822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111391249|NCT01745822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111391250|NCT01745822|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111391251|NCT01745822|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111391252|NCT05718869|Zanubrutinib|zanubrutinib|mesh-list
111391253|NCT05718869|Immunoglobulins|immunoglobulins|mesh-list
111391254|NCT05718869|Immunologic Factors|immunologic factors|mesh-ancestor
111391255|NCT05718869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111391256|NCT05718869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111391257|NCT05718869|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111391258|NCT05718869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111391259|NCT05718869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111391260|NCT02354339|Magnesium Oxide|magnesium oxide|mesh-list
111391261|NCT02354339|Antacids|antacids|mesh-ancestor
111391262|NCT02354339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111391263|NCT02354339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111391264|NCT01747850|Ethanol|ethanol|mesh-list
111391265|NCT01747850|Nabiximols|nabiximols|mesh-list
111391266|NCT01747850|Dronabinol|dronabinol|mesh-list
111391267|NCT01747850|Cannabidiol|cannabidiol|mesh-list
111391268|NCT01747850|Peppermint oil|peppermint oil|mesh-list
111391269|NCT01747850|Anticonvulsants|anticonvulsants|mesh-ancestor
111391270|NCT01747850|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111391271|NCT01747850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111391272|NCT01747850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111391273|NCT01747850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111391274|NCT01747850|Analgesics|analgesics|mesh-ancestor
111391275|NCT01747850|Sensory System Agents|sensory system agents|mesh-ancestor
111391276|NCT01747850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111391277|NCT01747850|Hallucinogens|hallucinogens|mesh-ancestor
111391278|NCT01747850|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111391279|NCT01747850|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111391280|NCT01747850|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
111391281|NCT01747850|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
111391282|NCT01747850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110531276|NCT00659919|Trazodone|trazodone|mesh-list
111391283|NCT01747850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111391284|NCT01747850|Hormones|hormones|mesh-ancestor
111391285|NCT01747850|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111391286|NCT01747850|Antiemetics|antiemetics|mesh-ancestor
111391287|NCT01747850|Autonomic Agents|autonomic agents|mesh-ancestor
111391288|NCT01747850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111391289|NCT01747850|Parasympatholytics|parasympatholytics|mesh-ancestor
111391290|NCT01727414|Methylphenidate|methylphenidate|mesh-list
111391291|NCT01727414|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111391292|NCT01727414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111391293|NCT01727414|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111391294|NCT01727414|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111391295|NCT01727414|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111391296|NCT01727414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111391297|NCT01727414|Dopamine Agents|dopamine agents|mesh-ancestor
111391298|NCT01727414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111391299|NCT02048891|Triptorelin Pamoate|triptorelin pamoate|mesh-list
111391300|NCT02048891|Progesterone|progesterone|mesh-list
111391301|NCT02048891|Progestins|progestins|mesh-ancestor
111391302|NCT02048891|Hormones|hormones|mesh-ancestor
111391303|NCT02048891|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110531302|NCT00659997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111391304|NCT02048891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111391305|NCT02048891|Luteolytic Agents|luteolytic agents|mesh-ancestor
111391306|NCT02048891|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111391307|NCT02048891|Contraceptive Agents|contraceptive agents|mesh-ancestor
111391308|NCT02048891|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111391309|NCT02048891|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111391310|NCT02048891|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111391311|NCT02048891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111391312|NCT01727726|Quetiapine Fumarate|quetiapine fumarate|mesh-list
111391313|NCT01727726|Brexpiprazole|brexpiprazole|mesh-list
111391314|NCT01727726|Antidepressive Agents|antidepressive agents|mesh-ancestor
110531329|NCT00660621|Bevacizumab|bevacizumab|mesh-list
111391315|NCT01727726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111391316|NCT01727726|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111391317|NCT01727726|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111391318|NCT01727726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111391319|NCT01727726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111391320|NCT01727726|Serotonin Agents|serotonin agents|mesh-ancestor
111391321|NCT01727726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111391322|NCT01727726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111391323|NCT01727726|Dopamine Agonists|dopamine agonists|mesh-ancestor
111391324|NCT01727726|Dopamine Agents|dopamine agents|mesh-ancestor
111391325|NCT02355821|Bisoprolol|bisoprolol|mesh-list
111391326|NCT02355821|Moxonidine|moxonidine|mesh-list
111391327|NCT02355821|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111391328|NCT02355821|Sympatholytics|sympatholytics|mesh-ancestor
111391329|NCT02355821|Autonomic Agents|autonomic agents|mesh-ancestor
111391330|NCT02355821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111391331|NCT02355821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111391332|NCT02355821|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
111391333|NCT02355821|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111391334|NCT02355821|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111391335|NCT02355821|Adrenergic Agents|adrenergic agents|mesh-ancestor
111391336|NCT02355821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111391337|NCT02355821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111391338|NCT01748240|Azacitidine|azacitidine|mesh-list
111391339|NCT01748240|Vorinostat|vorinostat|mesh-list
111391340|NCT01748240|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111391341|NCT01748240|Antimetabolites|antimetabolites|mesh-ancestor
111391342|NCT01748240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111391343|NCT01748240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111391344|NCT01748240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111391345|NCT01748240|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111391346|NCT01748942|Dexamethasone|dexamethasone|mesh-list
111391347|NCT01748942|Dexamethasone acetate|dexamethasone acetate|mesh-list
111391348|NCT01748942|Ichthammol|ichthammol|mesh-list
111391349|NCT01748942|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
111391350|NCT01748942|BB 1101|bb 1101|mesh-list
111391351|NCT01748942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111391352|NCT01748942|Antiemetics|antiemetics|mesh-ancestor
111391353|NCT01748942|Autonomic Agents|autonomic agents|mesh-ancestor
111391354|NCT01748942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111391355|NCT01748942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111391356|NCT01748942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111391357|NCT01748942|Glucocorticoids|glucocorticoids|mesh-ancestor
111391358|NCT01748942|Hormones|hormones|mesh-ancestor
111391359|NCT01748942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111391360|NCT01748942|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111391361|NCT01748942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111391362|NCT01748942|Protease Inhibitors|protease inhibitors|mesh-ancestor
111391363|NCT01748942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111391364|NCT01748942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111391365|NCT01748942|Dermatologic Agents|dermatologic agents|mesh-ancestor
111391366|NCT02355977|Minocycline|minocycline|mesh-list
111391367|NCT02355977|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111391368|NCT02355977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111391369|NCT01749410|Botulinum Toxins|botulinum toxins|mesh-list
111391370|NCT01749410|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111391371|NCT01749410|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111391372|NCT01749410|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110531350|NCT02632305|Antimetabolites|antimetabolites|mesh-ancestor
111391373|NCT01749410|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111391374|NCT01749410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111391375|NCT01749410|Cholinergic Agents|cholinergic agents|mesh-ancestor
111391376|NCT01749410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111391377|NCT01749410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111391378|NCT01749410|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111391379|NCT01749410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111391380|NCT01729598|Valproic Acid|valproic acid|mesh-list
111391381|NCT01729598|Anticonvulsants|anticonvulsants|mesh-ancestor
111391382|NCT01729598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111391383|NCT01729598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111391384|NCT01729598|GABA Agents|gaba agents|mesh-ancestor
111391385|NCT01729598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111391386|NCT01729598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111391387|NCT01729598|Antimanic Agents|antimanic agents|mesh-ancestor
111391388|NCT01729598|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111391389|NCT01729598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111391390|NCT01729598|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111391391|NCT05718011|Dexmedetomidine|dexmedetomidine|mesh-list
111391392|NCT05718011|Ketamine|ketamine|mesh-list
111391393|NCT05718011|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111391394|NCT05718011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111391395|NCT05718011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110531395|NCT02630823|Antimitotic Agents|antimitotic agents|mesh-ancestor
111391396|NCT05718011|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111391397|NCT05718011|Analgesics|analgesics|mesh-ancestor
111391398|NCT05718011|Sensory System Agents|sensory system agents|mesh-ancestor
111391399|NCT05718011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111391400|NCT05718011|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111391401|NCT05718011|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111391402|NCT05718011|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111391403|NCT05718011|Adrenergic Agents|adrenergic agents|mesh-ancestor
111391404|NCT05718011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111391405|NCT05718011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111391406|NCT05718011|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111391407|NCT05718011|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111391408|NCT05718011|Anesthetics, General|anesthetics, general|mesh-ancestor
111391409|NCT05718011|Anesthetics|anesthetics|mesh-ancestor
111391410|NCT05718011|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111391411|NCT05718011|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111391412|NCT05717933|Hormones|hormones|mesh-list
111391413|NCT05717933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111391414|NCT05717933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111391415|NCT01730846|Doxazosin|doxazosin|mesh-list
111391416|NCT01730846|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111391417|NCT01730846|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111391418|NCT01730846|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111391419|NCT01730846|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111391420|NCT01730846|Adrenergic Agents|adrenergic agents|mesh-ancestor
111391421|NCT01730846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111391422|NCT01730846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111391423|NCT01730846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111391424|NCT02314403|Rituximab|rituximab|mesh-list
111391425|NCT02314403|Abatacept|abatacept|mesh-list
111391426|NCT02314403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111391427|NCT02314403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111391428|NCT02314403|Immunologic Factors|immunologic factors|mesh-ancestor
111391429|NCT02314403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111115843|NCT05024825|Narcotics|narcotics|mesh-ancestor
111391430|NCT02314403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111391431|NCT02314403|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111391432|NCT02314403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111391433|NCT02314403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111391434|NCT02052557|Bupivacaine|bupivacaine|mesh-list
111391435|NCT02052557|Anesthetics, Local|anesthetics, local|mesh-ancestor
111391436|NCT02052557|Anesthetics|anesthetics|mesh-ancestor
111391437|NCT02052557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111391438|NCT02052557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111391439|NCT02052557|Sensory System Agents|sensory system agents|mesh-ancestor
111391440|NCT02052557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111391441|NCT02052635|Clopidogrel|clopidogrel|mesh-list
111391442|NCT02052635|Ticagrelor|ticagrelor|mesh-list
111391443|NCT02052635|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111391444|NCT02052635|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111391445|NCT02052635|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111391446|NCT02052635|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111391447|NCT02052635|Purinergic Agents|purinergic agents|mesh-ancestor
111391448|NCT02052635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111391449|NCT02052635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111391450|NCT02052635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111391451|NCT01732718|Atorvastatin|atorvastatin|mesh-list
111391452|NCT01732718|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111391453|NCT01732718|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111391454|NCT01732718|Antimetabolites|antimetabolites|mesh-ancestor
111391455|NCT01732718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111391456|NCT01732718|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111391457|NCT01732718|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111391458|NCT01732718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111391459|NCT02362373|Levonorgestrel|levonorgestrel|mesh-list
111391460|NCT02362373|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111391461|NCT02362373|Contraceptive Agents|contraceptive agents|mesh-ancestor
111391462|NCT02362373|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111391463|NCT02362373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111391464|NCT02362373|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111391465|NCT02362373|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111391466|NCT02362373|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111391467|NCT02363621|Ranibizumab|ranibizumab|mesh-list
111391468|NCT02363621|Aflibercept|aflibercept|mesh-list
111391469|NCT02363621|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111391470|NCT02363621|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111391471|NCT02363621|Growth Substances|growth substances|mesh-ancestor
111391472|NCT02363621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111391473|NCT02363621|Growth Inhibitors|growth inhibitors|mesh-ancestor
111391474|NCT02363621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111391475|NCT01749956|Leucovorin|leucovorin|mesh-list
111391476|NCT01749956|Fluorouracil|fluorouracil|mesh-list
111391477|NCT01749956|Oxaliplatin|oxaliplatin|mesh-list
111391478|NCT01749956|Aflibercept|aflibercept|mesh-list
111391479|NCT01749956|Antimetabolites|antimetabolites|mesh-ancestor
111391480|NCT01749956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111391481|NCT01749956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111391482|NCT01749956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111391483|NCT01749956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111391484|NCT01749956|Immunologic Factors|immunologic factors|mesh-ancestor
111391485|NCT01749956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111391486|NCT01749956|Antidotes|antidotes|mesh-ancestor
111391487|NCT01749956|Protective Agents|protective agents|mesh-ancestor
111391488|NCT01749956|Vitamin B Complex|vitamin b complex|mesh-ancestor
111391489|NCT01749956|Vitamins|vitamins|mesh-ancestor
111391490|NCT01749956|Micronutrients|micronutrients|mesh-ancestor
111391491|NCT01749956|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111391492|NCT01749956|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111391493|NCT01749956|Growth Substances|growth substances|mesh-ancestor
111391494|NCT01749956|Growth Inhibitors|growth inhibitors|mesh-ancestor
111391495|NCT02365961|Clonidine|clonidine|mesh-list
111391496|NCT02365961|Epinephrine|epinephrine|mesh-list
111391497|NCT02365961|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111391498|NCT02365961|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111391499|NCT02365961|Adrenergic Agents|adrenergic agents|mesh-ancestor
111391500|NCT02365961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111391501|NCT02365961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111391502|NCT02365961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111391503|NCT02365961|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111391504|NCT02365961|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111391506|NCT02365961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111391507|NCT02365961|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111391508|NCT02365961|Respiratory System Agents|respiratory system agents|mesh-ancestor
111391509|NCT02365961|Mydriatics|mydriatics|mesh-ancestor
111391510|NCT02365961|Sympathomimetics|sympathomimetics|mesh-ancestor
111391511|NCT02365961|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111391512|NCT02365961|Analgesics|analgesics|mesh-ancestor
111391513|NCT02365961|Sensory System Agents|sensory system agents|mesh-ancestor
111391514|NCT02365961|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111391515|NCT02365961|Sympatholytics|sympatholytics|mesh-ancestor
110531517|NCT00667641|Paclitaxel|paclitaxel|mesh-list
111391516|NCT02365961|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111391517|NCT05532059|Cisplatin|cisplatin|mesh-list
111391518|NCT05532059|Gemcitabine|gemcitabine|mesh-list
111391519|NCT05532059|Lenvatinib|lenvatinib|mesh-list
111391520|NCT05532059|Tislelizumab|tislelizumab|mesh-list
111391521|NCT05532059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111391522|NCT05532059|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111391523|NCT05532059|Antimetabolites|antimetabolites|mesh-ancestor
111391524|NCT05532059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111391525|NCT05532059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111391526|NCT05532059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111391527|NCT05532059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111391528|NCT03809234|Ondansetron|ondansetron|mesh-list
111391529|NCT03809234|Antiemetics|antiemetics|mesh-ancestor
111391530|NCT03809234|Autonomic Agents|autonomic agents|mesh-ancestor
111391531|NCT03809234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111391532|NCT03809234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111391533|NCT03809234|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111391534|NCT03809234|Antipruritics|antipruritics|mesh-ancestor
111391535|NCT03809234|Dermatologic Agents|dermatologic agents|mesh-ancestor
111391536|NCT03809234|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111391537|NCT03809234|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111391538|NCT03809234|Serotonin Agents|serotonin agents|mesh-ancestor
111391539|NCT03809234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111391540|NCT03809234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111391541|NCT03711188|Nivolumab|nivolumab|mesh-list
111391542|NCT03711188|Ipilimumab|ipilimumab|mesh-list
111391543|NCT03711188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111391544|NCT03711188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111391545|NCT03711188|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111391546|NCT03711188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111391547|NCT02366663|Cytarabine|cytarabine|mesh-list
111391548|NCT02366663|Rituximab|rituximab|mesh-list
111391549|NCT02366663|Etoposide|etoposide|mesh-list
111391550|NCT02366663|Melphalan|melphalan|mesh-list
111391551|NCT02366663|Carmustine|carmustine|mesh-list
111391552|NCT02366663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111391553|NCT02366663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111391554|NCT02366663|Immunologic Factors|immunologic factors|mesh-ancestor
111391555|NCT02366663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111391556|NCT02366663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111391557|NCT02366663|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111391558|NCT02366663|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111391559|NCT02366663|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111391560|NCT02366663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111391561|NCT02366663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111391562|NCT02366663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111391563|NCT02366663|Antimetabolites|antimetabolites|mesh-ancestor
111391564|NCT02366663|Antiviral Agents|antiviral agents|mesh-ancestor
111391565|NCT02366663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111391566|NCT02366663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111391567|NCT02366663|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111391568|NCT02366663|Alkylating Agents|alkylating agents|mesh-ancestor
111391569|NCT02366663|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111391570|NCT01754480|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
111391571|NCT01754480|Hemostatics|hemostatics|mesh-ancestor
111391572|NCT01754480|Coagulants|coagulants|mesh-ancestor
111391573|NCT02367599|Vitamin D|vitamin d|mesh-list
111391574|NCT02367599|Vitamins|vitamins|mesh-ancestor
111391575|NCT02367599|Micronutrients|micronutrients|mesh-ancestor
111391576|NCT02367599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111391577|NCT02367599|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111391578|NCT02368457|Tocopherols|tocopherols|mesh-list
111391579|NCT02368457|Vitamin E|vitamin e|mesh-list
111391580|NCT02368457|Tocotrienols|tocotrienols|mesh-list
111391581|NCT02368457|alpha-Tocopherol|alpha-tocopherol|mesh-list
111391582|NCT02368457|Pentoxifylline|pentoxifylline|mesh-list
111391583|NCT02368457|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111391584|NCT02368457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111391585|NCT02368457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111391586|NCT02368457|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111391587|NCT02368457|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111391588|NCT02368457|Protective Agents|protective agents|mesh-ancestor
111391589|NCT02368457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111391590|NCT02368457|Vasodilator Agents|vasodilator agents|mesh-ancestor
111391591|NCT02368457|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111391592|NCT02368457|Antioxidants|antioxidants|mesh-ancestor
111391594|NCT02368457|Micronutrients|micronutrients|mesh-ancestor
111391595|NCT02371187|Dapagliflozin|dapagliflozin|mesh-list
111391596|NCT02371187|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111391597|NCT02371187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111391598|NCT02371187|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111391599|NCT02371187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111391600|NCT02373137|Ofloxacin|ofloxacin|mesh-list
111391601|NCT02373137|Prednisolone|prednisolone|mesh-list
111391602|NCT02373137|Phenylephrine|phenylephrine|mesh-list
111391603|NCT02373137|Oxymetazoline|oxymetazoline|mesh-list
111391604|NCT02373137|Tropicamide|tropicamide|mesh-list
111391605|NCT02373137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111391606|NCT02373137|Glucocorticoids|glucocorticoids|mesh-ancestor
111391607|NCT02373137|Hormones|hormones|mesh-ancestor
111391608|NCT02373137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111391609|NCT02373137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111391610|NCT02373137|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111391611|NCT02373137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111391612|NCT02373137|Autonomic Agents|autonomic agents|mesh-ancestor
111391613|NCT02373137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111391614|NCT02373137|Protective Agents|protective agents|mesh-ancestor
111391615|NCT02373137|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111391616|NCT02373137|Mydriatics|mydriatics|mesh-ancestor
111391617|NCT02373137|Sympathomimetics|sympathomimetics|mesh-ancestor
111391618|NCT02373137|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111391619|NCT02373137|Nasal Decongestants|nasal decongestants|mesh-ancestor
111391620|NCT02373137|Respiratory System Agents|respiratory system agents|mesh-ancestor
111391621|NCT02373137|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111391622|NCT02373137|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110531646|NCT03555968|Hormones|hormones|mesh-ancestor
111391623|NCT02373137|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111391624|NCT02373137|Adrenergic Agents|adrenergic agents|mesh-ancestor
111391625|NCT02373137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111391626|NCT02373137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111391627|NCT02373137|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111391628|NCT02373137|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111391629|NCT02373137|Cholinergic Agents|cholinergic agents|mesh-ancestor
111391630|NCT02373137|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111391631|NCT02373137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111391632|NCT02373137|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111391633|NCT02373137|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111391634|NCT02373137|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111391635|NCT02373137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111391636|NCT02373137|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111391637|NCT02373137|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111391638|NCT05488067|Atorvastatin|atorvastatin|mesh-list
111391639|NCT05488067|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111391640|NCT05488067|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111391641|NCT05488067|Antimetabolites|antimetabolites|mesh-ancestor
111391642|NCT05488067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111391643|NCT05488067|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111391644|NCT05488067|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111391645|NCT05488067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111391646|NCT02373371|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
111391647|NCT02373371|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111391648|NCT02373371|Dermatologic Agents|dermatologic agents|mesh-ancestor
111391649|NCT00354653|Lamivudine|lamivudine|mesh-list
111391650|NCT00354653|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111391651|NCT00354653|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111391652|NCT00354653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111391653|NCT00354653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111391654|NCT00354653|Antiviral Agents|antiviral agents|mesh-ancestor
111391655|NCT00354653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111391656|NCT00354653|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111391657|NCT00354653|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111391658|NCT00354731|Pentoxifylline|pentoxifylline|mesh-list
111391659|NCT00354731|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111391660|NCT00354731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111391661|NCT00354731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111391662|NCT00354731|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111391663|NCT00354731|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111391664|NCT00354731|Protective Agents|protective agents|mesh-ancestor
111391665|NCT00354731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111391666|NCT00354731|Vasodilator Agents|vasodilator agents|mesh-ancestor
111391667|NCT00354731|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111391668|NCT00354731|Antioxidants|antioxidants|mesh-ancestor
111391669|NCT00354809|Casopitant|casopitant|mesh-list
111391670|NCT00354809|Antiemetics|antiemetics|mesh-ancestor
111391671|NCT00354809|Autonomic Agents|autonomic agents|mesh-ancestor
111391672|NCT00354809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111391673|NCT00354809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111391674|NCT00354809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111391675|NCT00354809|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
111391676|NCT00354809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111391677|NCT00354809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111391678|NCT04769258|Vaccines|vaccines|mesh-list
111391679|NCT04769258|Immunologic Factors|immunologic factors|mesh-ancestor
111391680|NCT04769258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111391681|NCT01762904|Ethanol|ethanol|mesh-list
111391682|NCT01762904|Chlorhexidine|chlorhexidine|mesh-list
111391683|NCT01762904|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
111391684|NCT01762904|Triclosan|triclosan|mesh-list
111391685|NCT01762904|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
111391686|NCT01762904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111391687|NCT01762904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111391688|NCT01762904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111391689|NCT01762904|Disinfectants|disinfectants|mesh-ancestor
111391690|NCT01762904|Dermatologic Agents|dermatologic agents|mesh-ancestor
111391691|NCT01762904|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
111391692|NCT01762904|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111391693|NCT01762904|Antimetabolites|antimetabolites|mesh-ancestor
111391694|NCT01762904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111391695|NCT01762904|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111391696|NCT02376257|Cycloserine|cycloserine|mesh-list
111391697|NCT02376257|Modafinil|modafinil|mesh-list
111391698|NCT02376257|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111391699|NCT02376257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111391700|NCT02376257|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
111391701|NCT02376257|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111391702|NCT02376257|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111391703|NCT02376257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111391704|NCT02376257|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111391705|NCT02376257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111391706|NCT02376257|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111391707|NCT02376257|Antitubercular Agents|antitubercular agents|mesh-ancestor
111391708|NCT02376257|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111391709|NCT02376257|Antimetabolites|antimetabolites|mesh-ancestor
111391710|NCT01762982|Benzalkonium Compounds|benzalkonium compounds|mesh-list
111391711|NCT01762982|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111391712|NCT01762982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111391713|NCT03211286|Tranexamic Acid|tranexamic acid|mesh-list
111391714|NCT03211286|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111391715|NCT03211286|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111391716|NCT03211286|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111391717|NCT03211286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111391718|NCT03211286|Hemostatics|hemostatics|mesh-ancestor
111391719|NCT03211286|Coagulants|coagulants|mesh-ancestor
111391720|NCT01763606|Aspirin|aspirin|mesh-list
111391721|NCT01763606|Enoxaparin|enoxaparin|mesh-list
111391722|NCT01763606|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111391723|NCT01763606|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111391724|NCT01763606|Analgesics|analgesics|mesh-ancestor
111391725|NCT01763606|Sensory System Agents|sensory system agents|mesh-ancestor
111391726|NCT01763606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111391727|NCT01763606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111391728|NCT01763606|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111391729|NCT01763606|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111391730|NCT01763606|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111391731|NCT01763606|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111391732|NCT01763606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111391733|NCT01763606|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111391734|NCT01763606|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111391735|NCT01763606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111391736|NCT01763606|Antipyretics|antipyretics|mesh-ancestor
111391737|NCT01763606|Anticoagulants|anticoagulants|mesh-ancestor
111391738|NCT03161756|Denosumab|denosumab|mesh-list
111391739|NCT03161756|Nivolumab|nivolumab|mesh-list
111391740|NCT03161756|Ipilimumab|ipilimumab|mesh-list
111391741|NCT03161756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111391742|NCT03161756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111391743|NCT03161756|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111391744|NCT03161756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111391745|NCT03161756|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111391746|NCT03161756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111391747|NCT01766024|Interferons|interferons|mesh-list
111391748|NCT01766024|Interferon-beta|interferon-beta|mesh-list
111391749|NCT01766024|Interferon beta-1a|interferon beta-1a|mesh-list
111391750|NCT01766024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111391751|NCT01766024|Antiviral Agents|antiviral agents|mesh-ancestor
111391752|NCT01766024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111391753|NCT01766024|Immunologic Factors|immunologic factors|mesh-ancestor
111391754|NCT01766024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111391755|NCT01766024|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111391756|NCT01767506|Azithromycin|azithromycin|mesh-list
111391757|NCT01767506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111391758|NCT01767506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111391759|NCT02383043|Cocaine|cocaine|mesh-list
111391760|NCT02383043|Amphetamine|amphetamine|mesh-list
111391761|NCT02383043|Dextroamphetamine|dextroamphetamine|mesh-list
111391762|NCT02383043|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111391763|NCT02383043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111391764|NCT02383043|Sympathomimetics|sympathomimetics|mesh-ancestor
111391765|NCT02383043|Autonomic Agents|autonomic agents|mesh-ancestor
111391766|NCT02383043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111391767|NCT02383043|Dopamine Agents|dopamine agents|mesh-ancestor
111391768|NCT02383043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111391769|NCT02383043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111391770|NCT02383043|Adrenergic Agents|adrenergic agents|mesh-ancestor
111391771|NCT02383043|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111391772|NCT02383043|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111391773|NCT02383043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111391774|NCT02383043|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111391775|NCT02383043|Anesthetics, Local|anesthetics, local|mesh-ancestor
111391776|NCT02383043|Anesthetics|anesthetics|mesh-ancestor
111391777|NCT02383043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111391778|NCT02383043|Sensory System Agents|sensory system agents|mesh-ancestor
111391779|NCT02383043|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111391780|NCT01768520|Celecoxib|celecoxib|mesh-list
111391781|NCT01768520|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111391782|NCT01768520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111391783|NCT01768520|Analgesics|analgesics|mesh-ancestor
111391784|NCT01768520|Sensory System Agents|sensory system agents|mesh-ancestor
111391785|NCT01768520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111391786|NCT01768520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111391787|NCT01768520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111391788|NCT01768520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111391789|NCT01768520|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111391790|NCT01768520|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111391791|NCT01768520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111391792|NCT01768520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111391793|NCT00355589|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
111391794|NCT00355589|Ramipril|ramipril|mesh-list
111391795|NCT00355589|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111391796|NCT00355589|Diuretics|diuretics|mesh-ancestor
111391797|NCT00355589|Natriuretic Agents|natriuretic agents|mesh-ancestor
111391798|NCT00355589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111391799|NCT00355589|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
111391800|NCT00355589|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111391801|NCT00355589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111391802|NCT00355589|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
111391803|NCT00355589|Protease Inhibitors|protease inhibitors|mesh-ancestor
111391804|NCT00355589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111391805|NCT01769222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111391807|NCT01769222|Antibodies|antibodies|mesh-list
111391808|NCT01769222|Immunoglobulins|immunoglobulins|mesh-list
111391809|NCT01769222|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111391810|NCT01769222|Immunologic Factors|immunologic factors|mesh-ancestor
111391811|NCT01769222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111391812|NCT01769222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111391813|NCT01769222|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111391814|NCT01769222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111391815|NCT02386319|Melatonin|melatonin|mesh-list
111391816|NCT02386319|Antioxidants|antioxidants|mesh-ancestor
111391817|NCT02386319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111391818|NCT02386319|Protective Agents|protective agents|mesh-ancestor
111391819|NCT02386319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110531837|NCT03794336|Analgesics|analgesics|mesh-ancestor
111391820|NCT02386319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111391821|NCT02240888|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
111391822|NCT02240888|Immunologic Factors|immunologic factors|mesh-ancestor
111391823|NCT02240888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111391824|NCT02387801|Ixekizumab|ixekizumab|mesh-list
111391825|NCT02387801|Dermatologic Agents|dermatologic agents|mesh-ancestor
111391826|NCT02259608|BCG Vaccine|bcg vaccine|mesh-list
111391827|NCT02259608|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111391828|NCT02259608|Immunologic Factors|immunologic factors|mesh-ancestor
111391829|NCT02259608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111391830|NCT05284097|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
111391831|NCT05284097|Antiviral Agents|antiviral agents|mesh-ancestor
111391832|NCT05284097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111391833|NCT02326844|Talazoparib|talazoparib|mesh-list
111391834|NCT02326844|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111391835|NCT02326844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110531857|NCT03774914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111391836|NCT02326844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111391837|NCT02326844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111391838|NCT02239874|Vitamin D|vitamin d|mesh-list
111391839|NCT02239874|Ergocalciferols|ergocalciferols|mesh-list
111391840|NCT02239874|Cholecalciferol|cholecalciferol|mesh-list
111391841|NCT02239874|Vitamins|vitamins|mesh-list
111391842|NCT02239874|Micronutrients|micronutrients|mesh-ancestor
111391843|NCT02239874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111391844|NCT02239874|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111391845|NCT02239874|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111391846|NCT01771952|Hyaluronic Acid|hyaluronic acid|mesh-list
111391847|NCT01771952|Hylan|hylan|mesh-list
111391848|NCT01771952|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111391849|NCT01771952|Immunologic Factors|immunologic factors|mesh-ancestor
111391850|NCT01771952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111391851|NCT01771952|Viscosupplements|viscosupplements|mesh-ancestor
111391852|NCT01771952|Protective Agents|protective agents|mesh-ancestor
111391853|NCT02389361|Acetaminophen|acetaminophen|mesh-list
111391854|NCT02389361|Tramadol|tramadol|mesh-list
111391855|NCT02389361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111391856|NCT02389361|Analgesics|analgesics|mesh-ancestor
111391857|NCT02389361|Sensory System Agents|sensory system agents|mesh-ancestor
111391858|NCT02389361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111391859|NCT02389361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111391860|NCT02389361|Antipyretics|antipyretics|mesh-ancestor
111391861|NCT02389361|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111391862|NCT02389361|Narcotics|narcotics|mesh-ancestor
111391863|NCT02389361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111391864|NCT02252354|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111391865|NCT02252354|Relugolix|relugolix|mesh-list
111391866|NCT02252354|Androgen Antagonists|androgen antagonists|mesh-ancestor
111391867|NCT02252354|Hormone Antagonists|hormone antagonists|mesh-ancestor
110531886|NCT05343806|Tocolytic Agents|tocolytic agents|mesh-ancestor
111391868|NCT02252354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111391869|NCT02252354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111391870|NCT02393339|Acetaminophen|acetaminophen|mesh-list
111391871|NCT02393339|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111391872|NCT02393339|Analgesics|analgesics|mesh-ancestor
110531896|NCT02704598|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111391873|NCT02393339|Sensory System Agents|sensory system agents|mesh-ancestor
111391874|NCT02393339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111391875|NCT02393339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111391876|NCT02393339|Antipyretics|antipyretics|mesh-ancestor
111391877|NCT05235191|Methadone|methadone|mesh-list
111116289|NCT03148561|Oxytocics|oxytocics|mesh-ancestor
111391878|NCT05235191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111391879|NCT05235191|Narcotics|narcotics|mesh-ancestor
111391880|NCT05235191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111391881|NCT05235191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111391883|NCT05235191|Sensory System Agents|sensory system agents|mesh-ancestor
111391884|NCT05235191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111391885|NCT05235191|Antitussive Agents|antitussive agents|mesh-ancestor
111391886|NCT05235191|Respiratory System Agents|respiratory system agents|mesh-ancestor
111391887|NCT01774604|Indomethacin|indomethacin|mesh-list
111391888|NCT01774604|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111391889|NCT01774604|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111391890|NCT01774604|Analgesics|analgesics|mesh-ancestor
111391891|NCT01774604|Sensory System Agents|sensory system agents|mesh-ancestor
111391892|NCT01774604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111391893|NCT01774604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111391894|NCT01774604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111391895|NCT01774604|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111391896|NCT01774604|Gout Suppressants|gout suppressants|mesh-ancestor
111391897|NCT01774604|Tocolytic Agents|tocolytic agents|mesh-ancestor
111391898|NCT01774604|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111391899|NCT01774604|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111391900|NCT01774604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111391901|NCT01774604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111391902|NCT01777412|Bevacizumab|bevacizumab|mesh-list
111391903|NCT01777412|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111391904|NCT01777412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111391905|NCT01777412|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111391906|NCT01777412|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111391907|NCT01777412|Growth Substances|growth substances|mesh-ancestor
111391908|NCT01777412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111391909|NCT01777412|Growth Inhibitors|growth inhibitors|mesh-ancestor
111391910|NCT02236910|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
111391911|NCT02236910|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
111391912|NCT02236910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111391913|NCT04873349|Oleuropein|oleuropein|mesh-list
111391914|NCT04873349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111391915|NCT04873349|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111391916|NCT04873349|Vasodilator Agents|vasodilator agents|mesh-ancestor
111391917|NCT01780454|Rituximab|rituximab|mesh-list
111391918|NCT01780454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111391919|NCT01780454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111391920|NCT01780454|Immunologic Factors|immunologic factors|mesh-ancestor
111391921|NCT01780454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111391922|NCT01780454|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111391923|NCT04869449|Ketoconazole|ketoconazole|mesh-list
111391924|NCT04869449|Antifungal Agents|antifungal agents|mesh-ancestor
111391925|NCT04869449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111391926|NCT04869449|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111391927|NCT04869449|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111391928|NCT04869449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111391929|NCT04869449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111391930|NCT04869449|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111391931|NCT04869449|Hormone Antagonists|hormone antagonists|mesh-ancestor
111391932|NCT04869449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111391933|NCT04869449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111391934|NCT04869449|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111391935|NCT00355901|Visilizumab|visilizumab|mesh-list
111391936|NCT00355901|Immunologic Factors|immunologic factors|mesh-ancestor
111391937|NCT00355901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111391938|NCT00355667|Furosemide|furosemide|mesh-list
111391939|NCT00355667|Azosemide|azosemide|mesh-list
111391940|NCT00355667|Diuretics|diuretics|mesh-ancestor
111391941|NCT00355667|Natriuretic Agents|natriuretic agents|mesh-ancestor
111391942|NCT00355667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111391943|NCT00355667|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
111391944|NCT00355667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111391945|NCT00355667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111391946|NCT02364336|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
111391947|NCT02364336|Antiviral Agents|antiviral agents|mesh-ancestor
111391948|NCT02364336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111391949|NCT04419948|Ibuprofen|ibuprofen|mesh-list
111391950|NCT04419948|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111391951|NCT04419948|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111391952|NCT04419948|Analgesics|analgesics|mesh-ancestor
111116364|NCT03146689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111391953|NCT04419948|Sensory System Agents|sensory system agents|mesh-ancestor
111391954|NCT04419948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111391955|NCT04419948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111391956|NCT04419948|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111391957|NCT04419948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111391958|NCT04419948|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111391959|NCT04419948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111391960|NCT04419948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111391961|NCT01312922|Dexetimide|dexetimide|mesh-list
111391962|NCT01312922|Pipamperone|pipamperone|mesh-list
111391963|NCT01312922|Citalopram|citalopram|mesh-list
111391964|NCT01312922|Escitalopram|escitalopram|mesh-list
111391965|NCT01312922|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111391966|NCT01312922|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110531997|NCT00615368|Epoetin Alfa|epoetin alfa|mesh-list
111391967|NCT01312922|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111391968|NCT01312922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111391969|NCT01312922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111391970|NCT01312922|Serotonin Agents|serotonin agents|mesh-ancestor
111391971|NCT01312922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111391972|NCT01312922|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111391973|NCT01312922|Antidepressive Agents|antidepressive agents|mesh-ancestor
111391974|NCT01312922|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111391975|NCT01312922|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111391976|NCT01312922|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111391977|NCT01312922|Parasympatholytics|parasympatholytics|mesh-ancestor
111391978|NCT01312922|Autonomic Agents|autonomic agents|mesh-ancestor
111391979|NCT01312922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111391980|NCT01312922|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111391981|NCT01312922|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111391982|NCT01312922|Cholinergic Agents|cholinergic agents|mesh-ancestor
111391983|NCT01312922|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111391984|NCT01312922|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111391985|NCT01312922|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111391986|NCT01312922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111391987|NCT01783574|Methyltestosterone|methyltestosterone|mesh-list
111391988|NCT01783574|Testosterone|testosterone|mesh-list
111391989|NCT01783574|Testosterone undecanoate|testosterone undecanoate|mesh-list
111391990|NCT01783574|Testosterone enanthate|testosterone enanthate|mesh-list
111391991|NCT01783574|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
111391992|NCT01783574|Androgens|androgens|mesh-ancestor
111391993|NCT01783574|Hormones|hormones|mesh-ancestor
111391994|NCT01783574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111391995|NCT01783574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110532021|NCT02703272|Immunologic Factors|immunologic factors|mesh-ancestor
111391996|NCT01783574|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111391997|NCT01783574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111391998|NCT01783574|Anabolic Agents|anabolic agents|mesh-ancestor
111391999|NCT03656783|Tenofovir|tenofovir|mesh-list
111392000|NCT03656783|Emtricitabine|emtricitabine|mesh-list
111392001|NCT03656783|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
111392002|NCT03656783|Antiviral Agents|antiviral agents|mesh-ancestor
111392003|NCT03656783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111392004|NCT03656783|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111392005|NCT03656783|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111392006|NCT03656783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111392007|NCT03656783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111392008|NCT03656783|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111392009|NCT03656783|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111392010|NCT01784666|Isradipine|isradipine|mesh-list
111392011|NCT01784666|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111392012|NCT01784666|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110532039|NCT02703272|Antimitotic Agents|antimitotic agents|mesh-ancestor
111392013|NCT01784666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111392014|NCT01784666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111392015|NCT01784666|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111392016|NCT01784666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111392017|NCT01784666|Vasodilator Agents|vasodilator agents|mesh-ancestor
111392018|NCT04296695|Tenofovir|tenofovir|mesh-list
111392019|NCT04296695|Efavirenz|efavirenz|mesh-list
111392020|NCT04296695|Antiviral Agents|antiviral agents|mesh-ancestor
111392021|NCT04296695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111392022|NCT04296695|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111392023|NCT04296695|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111392024|NCT04296695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111392025|NCT04296695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111392026|NCT04296695|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111392027|NCT04296695|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111392028|NCT04296695|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111392029|NCT04296695|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111392030|NCT04296695|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111392031|NCT04296695|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111392032|NCT04296695|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111392033|NCT04296695|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111392034|NCT04259645|Bupivacaine|bupivacaine|mesh-list
111392035|NCT04259645|Anesthetics, Local|anesthetics, local|mesh-ancestor
111392036|NCT04259645|Anesthetics|anesthetics|mesh-ancestor
111392037|NCT04259645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111392038|NCT04259645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111392039|NCT04259645|Sensory System Agents|sensory system agents|mesh-ancestor
111392040|NCT04259645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111392041|NCT01787006|Fluorouracil|fluorouracil|mesh-list
111392042|NCT01787006|Cetuximab|cetuximab|mesh-list
111392043|NCT01787006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111392044|NCT01787006|Antimetabolites|antimetabolites|mesh-ancestor
111392045|NCT01787006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111392046|NCT01787006|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111392047|NCT01787006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111392048|NCT01787006|Immunologic Factors|immunologic factors|mesh-ancestor
111392049|NCT01787006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111392050|NCT01787006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111392051|NCT02260622|Aspirin|aspirin|mesh-list
111392052|NCT02260622|Rivaroxaban|rivaroxaban|mesh-list
111392053|NCT02260622|Clopidogrel|clopidogrel|mesh-list
111392054|NCT02260622|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111392055|NCT02260622|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111392056|NCT02260622|Analgesics|analgesics|mesh-ancestor
111392057|NCT02260622|Sensory System Agents|sensory system agents|mesh-ancestor
111392058|NCT02260622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111392059|NCT02260622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111392060|NCT02260622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111392061|NCT02260622|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111392062|NCT02260622|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111392063|NCT02260622|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111392064|NCT02260622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111392065|NCT02260622|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111392066|NCT02260622|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111392067|NCT02260622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111392068|NCT02260622|Antipyretics|antipyretics|mesh-ancestor
111392069|NCT02260622|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111392070|NCT02260622|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111392071|NCT02260622|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111392072|NCT02260622|Purinergic Agents|purinergic agents|mesh-ancestor
111392073|NCT02260622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111392074|NCT02260622|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111392075|NCT02260622|Antithrombins|antithrombins|mesh-ancestor
111392076|NCT02260622|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111392077|NCT02260622|Protease Inhibitors|protease inhibitors|mesh-ancestor
111392078|NCT02260622|Anticoagulants|anticoagulants|mesh-ancestor
111392079|NCT03186209|Benralizumab|benralizumab|mesh-list
111392080|NCT03186209|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111392081|NCT03186209|Respiratory System Agents|respiratory system agents|mesh-ancestor
111392082|NCT02261948|Simendan|simendan|mesh-list
111392083|NCT02261948|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111392084|NCT02261948|Vasodilator Agents|vasodilator agents|mesh-ancestor
111392085|NCT02261948|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
111392086|NCT02261948|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111392087|NCT02261948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111392088|NCT02261948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111392089|NCT02261948|Protective Agents|protective agents|mesh-ancestor
111392090|NCT02261948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111392091|NCT01787240|Escitalopram|escitalopram|mesh-list
111392092|NCT01787240|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111392093|NCT01787240|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111392094|NCT01787240|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111392095|NCT01787240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111392096|NCT01787240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111392097|NCT01787240|Serotonin Agents|serotonin agents|mesh-ancestor
111392098|NCT01787240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111392099|NCT00357149|Cisplatin|cisplatin|mesh-list
111392100|NCT00357149|Docetaxel|docetaxel|mesh-list
111392101|NCT00357149|Fluorouracil|fluorouracil|mesh-list
111392102|NCT00357149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111392103|NCT00357149|Tubulin Modulators|tubulin modulators|mesh-ancestor
111392104|NCT00357149|Antimitotic Agents|antimitotic agents|mesh-ancestor
111392105|NCT00357149|Mitosis Modulators|mitosis modulators|mesh-ancestor
111392106|NCT00357149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111392107|NCT00357149|Antimetabolites|antimetabolites|mesh-ancestor
111392108|NCT00357149|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111392109|NCT00357149|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111392110|NCT00357149|Immunologic Factors|immunologic factors|mesh-ancestor
110187755|NCT05549206|Vaccines|vaccines|mesh-list
111392111|NCT00357149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111392112|NCT04903652|Vinorelbine|vinorelbine|mesh-list
111392113|NCT04903652|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111392114|NCT04903652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111392115|NCT04903652|Tubulin Modulators|tubulin modulators|mesh-ancestor
111392116|NCT04903652|Antimitotic Agents|antimitotic agents|mesh-ancestor
111392117|NCT04903652|Mitosis Modulators|mitosis modulators|mesh-ancestor
110532130|NCT02699138|Serotonin Agents|serotonin agents|mesh-ancestor
111392118|NCT04903652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111392119|NCT04071821|Cetirizine|cetirizine|mesh-list
111392120|NCT04071821|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111392121|NCT04071821|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
111392122|NCT04071821|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111392123|NCT04071821|Histamine Antagonists|histamine antagonists|mesh-ancestor
111392124|NCT04071821|Histamine Agents|histamine agents|mesh-ancestor
111392125|NCT04071821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111392126|NCT04071821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111392127|NCT04071821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111392128|NCT03064295|Adenosine|adenosine|mesh-list
111392129|NCT03064295|Regadenoson|regadenoson|mesh-list
111392130|NCT03064295|Analgesics|analgesics|mesh-ancestor
111392131|NCT03064295|Sensory System Agents|sensory system agents|mesh-ancestor
111392132|NCT03064295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111392133|NCT03064295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111392134|NCT03064295|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111392135|NCT03064295|Vasodilator Agents|vasodilator agents|mesh-ancestor
111392136|NCT03064295|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
111392137|NCT03064295|Purinergic Agonists|purinergic agonists|mesh-ancestor
111392138|NCT03064295|Purinergic Agents|purinergic agents|mesh-ancestor
111392139|NCT03064295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110462863|NCT00594646|Tenofovir|tenofovir|mesh-list
111392140|NCT03064295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111392141|NCT03064295|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
111392142|NCT01789814|Clopidogrel|clopidogrel|mesh-list
111392143|NCT01789814|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
111392144|NCT01789814|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111392145|NCT01789814|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111392146|NCT01789814|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111392147|NCT01789814|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111392148|NCT01789814|Purinergic Agents|purinergic agents|mesh-ancestor
111392149|NCT01789814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111392150|NCT01789814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111392151|NCT01789814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111392152|NCT00356447|Estradiol|estradiol|mesh-list
111392153|NCT00356447|Estrogens|estrogens|mesh-ancestor
111392154|NCT00356447|Hormones|hormones|mesh-ancestor
111392155|NCT00356447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111392156|NCT00356447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111392157|NCT01736852|Oxytocin|oxytocin|mesh-list
111392158|NCT01736852|Oxytocics|oxytocics|mesh-ancestor
111392159|NCT01736852|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111392160|NCT01736852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111392161|NCT01810952|Insulin|insulin|mesh-list
111392162|NCT01810952|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111392163|NCT01810952|Insulin Glargine|insulin glargine|mesh-list
111392164|NCT01810952|Insulin, Isophane|insulin, isophane|mesh-list
111392165|NCT01810952|Isophane Insulin, Human|isophane insulin, human|mesh-list
111392166|NCT01810952|Isophane insulin, beef|isophane insulin, beef|mesh-list
111392167|NCT01810952|Insulin Lispro|insulin lispro|mesh-list
111392168|NCT01810952|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111392169|NCT01810952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111392170|NCT04059887|Atezolizumab|atezolizumab|mesh-list
111392171|NCT04059887|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111392172|NCT04059887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110532182|NCT00700076|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111392173|NCT04059887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111392174|NCT04059887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111392175|NCT01877642|Lorazepam|lorazepam|mesh-list
111392177|NCT01877642|Anticonvulsants|anticonvulsants|mesh-ancestor
111392178|NCT01877642|Antiemetics|antiemetics|mesh-ancestor
111392179|NCT01877642|Autonomic Agents|autonomic agents|mesh-ancestor
111392180|NCT01877642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110532191|NCT02698514|Sevoflurane|sevoflurane|mesh-list
111392181|NCT01877642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111392182|NCT01877642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111392183|NCT01877642|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111392184|NCT01877642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111392185|NCT01877642|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111392186|NCT01877642|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111392187|NCT01877642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111392188|NCT01877642|GABA Modulators|gaba modulators|mesh-ancestor
111392189|NCT01877642|GABA Agents|gaba agents|mesh-ancestor
111392190|NCT01877642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111392191|NCT01877642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111392192|NCT01877642|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111392193|NCT01877642|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111392194|NCT01877642|Dopamine Agents|dopamine agents|mesh-ancestor
111392195|NCT02819843|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
111392196|NCT02819843|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111392197|NCT02819843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111392198|NCT01878656|Sevoflurane|sevoflurane|mesh-list
111392199|NCT01878656|Desflurane|desflurane|mesh-list
111392200|NCT01878656|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111392201|NCT01878656|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111392202|NCT01878656|Anesthetics, General|anesthetics, general|mesh-ancestor
111392203|NCT01878656|Anesthetics|anesthetics|mesh-ancestor
111392204|NCT01878656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110532206|NCT03739853|Sulfasalazine|sulfasalazine|mesh-list
111392205|NCT01878656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111392206|NCT01811654|Hyaluronic Acid|hyaluronic acid|mesh-list
111392207|NCT01811654|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111392208|NCT01811654|Immunologic Factors|immunologic factors|mesh-ancestor
111392209|NCT01811654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111392210|NCT01811654|Viscosupplements|viscosupplements|mesh-ancestor
111392211|NCT01811654|Protective Agents|protective agents|mesh-ancestor
111392212|NCT02266472|Metformin|metformin|mesh-list
111392213|NCT02266472|Empagliflozin|empagliflozin|mesh-list
111392214|NCT02266472|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111392215|NCT02266472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111392216|NCT02266472|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111392217|NCT02266472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111392218|NCT03500289|Midazolam|midazolam|mesh-list
111392219|NCT03500289|Ketamine|ketamine|mesh-list
111392220|NCT03500289|Analgesics|analgesics|mesh-ancestor
111392221|NCT03500289|Sensory System Agents|sensory system agents|mesh-ancestor
111392222|NCT03500289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111392223|NCT03500289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111392224|NCT03500289|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111392225|NCT03500289|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111392226|NCT03500289|Anesthetics, General|anesthetics, general|mesh-ancestor
111392227|NCT03500289|Anesthetics|anesthetics|mesh-ancestor
111392228|NCT03500289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111392229|NCT03500289|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111392230|NCT03500289|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111392231|NCT03500289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110532244|NCT00615602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111392232|NCT03500289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111392233|NCT03500289|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111392234|NCT03500289|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111392235|NCT03500289|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111392236|NCT03500289|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111392237|NCT03500289|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111392238|NCT03500289|GABA Modulators|gaba modulators|mesh-ancestor
111392239|NCT03500289|GABA Agents|gaba agents|mesh-ancestor
111392240|NCT01812044|Lidocaine|lidocaine|mesh-list
111392241|NCT01812044|Bupivacaine|bupivacaine|mesh-list
111392242|NCT01812044|Anesthetics, Local|anesthetics, local|mesh-list
111392243|NCT01812044|Anesthetics|anesthetics|mesh-list
111392244|NCT01812044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111392245|NCT01812044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111392246|NCT01812044|Sensory System Agents|sensory system agents|mesh-ancestor
111392247|NCT01812044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111392248|NCT01812044|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111392249|NCT01812044|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111392250|NCT01812044|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111392251|NCT01812044|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111392252|NCT01812044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111392254|NCT03974789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111392255|NCT03974789|Antiemetics|antiemetics|mesh-ancestor
111392256|NCT03974789|Autonomic Agents|autonomic agents|mesh-ancestor
111392257|NCT03974789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111392258|NCT03974789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111392259|NCT03974789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111392260|NCT03974789|Glucocorticoids|glucocorticoids|mesh-ancestor
111392261|NCT03974789|Hormones|hormones|mesh-ancestor
111392262|NCT03974789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111392263|NCT03974789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110532261|NCT02698748|Chloroquine|chloroquine|mesh-list
111392264|NCT03974789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111392265|NCT01812668|Fluorides|fluorides|mesh-list
111392266|NCT01812668|Cariostatic Agents|cariostatic agents|mesh-ancestor
111392267|NCT01812668|Protective Agents|protective agents|mesh-ancestor
111392268|NCT01812668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111392269|NCT02570477|Vancomycin|vancomycin|mesh-list
111392270|NCT02570477|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111392271|NCT02570477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111392272|NCT04344821|Calcium|calcium|mesh-list
111392273|NCT04344821|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111392274|NCT04344821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111392275|NCT04351100|Diacerein|diacerein|mesh-list
111392276|NCT04351100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111392277|NCT05328674|Mitogens|mitogens|mesh-list
111392278|NCT05328674|Mitosis Modulators|mitosis modulators|mesh-ancestor
111392279|NCT05328674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111392280|NCT01798316|Acetaminophen|acetaminophen|mesh-list
111392281|NCT01798316|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111392282|NCT01798316|Analgesics|analgesics|mesh-ancestor
111392283|NCT01798316|Sensory System Agents|sensory system agents|mesh-ancestor
111392284|NCT01798316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111392285|NCT01798316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111392286|NCT01798316|Antipyretics|antipyretics|mesh-ancestor
111392287|NCT03883763|Bupivacaine|bupivacaine|mesh-list
111392288|NCT03883763|Anesthetics, Local|anesthetics, local|mesh-ancestor
111392289|NCT03883763|Anesthetics|anesthetics|mesh-ancestor
111392290|NCT03883763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111392291|NCT03883763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111392292|NCT03883763|Sensory System Agents|sensory system agents|mesh-ancestor
111392293|NCT03883763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111392294|NCT01798394|Progesterone|progesterone|mesh-list
111392295|NCT01798394|Progestins|progestins|mesh-ancestor
111392296|NCT01798394|Hormones|hormones|mesh-ancestor
111392297|NCT01798394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111392298|NCT01798394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111392299|NCT01798550|Enoxaparin|enoxaparin|mesh-list
111392300|NCT01798550|Anticoagulants|anticoagulants|mesh-ancestor
111392301|NCT01798550|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111392302|NCT01798550|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111392303|NCT01798550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111392304|NCT00357305|Cytarabine|cytarabine|mesh-list
111392305|NCT00357305|Etoposide|etoposide|mesh-list
111392306|NCT00357305|Etoposide phosphate|etoposide phosphate|mesh-list
111392307|NCT00357305|Vorinostat|vorinostat|mesh-list
111392308|NCT00357305|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111392309|NCT00357305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111392310|NCT00357305|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111392311|NCT00357305|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111392312|NCT00357305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111392313|NCT00357305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111392314|NCT00357305|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111392315|NCT00357305|Antimetabolites|antimetabolites|mesh-ancestor
111392316|NCT00357305|Antiviral Agents|antiviral agents|mesh-ancestor
111392317|NCT00357305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111392318|NCT00357305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111392319|NCT00357305|Immunologic Factors|immunologic factors|mesh-ancestor
111392320|NCT00357305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111392321|NCT00357305|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111392322|NCT02340000|Amoxicillin|amoxicillin|mesh-list
111392323|NCT02340000|Clavulanic Acid|clavulanic acid|mesh-list
111392324|NCT02340000|Clavulanic Acids|clavulanic acids|mesh-list
111392325|NCT02340000|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
111392326|NCT02340000|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111116782|NCT05990686|Fentanyl|fentanyl|mesh-list
111392328|NCT02340000|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
111392329|NCT02340000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111392330|NCT02340000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111392331|NCT01813214|Vemurafenib|vemurafenib|mesh-list
111392332|NCT01813214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111392333|NCT01813214|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111392334|NCT01813214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110532343|NCT00906347|Misoprostol|misoprostol|mesh-list
111392335|NCT01813214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111392336|NCT01815008|Aspirin|aspirin|mesh-list
111392337|NCT01815008|Clopidogrel|clopidogrel|mesh-list
111392338|NCT01815008|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111392339|NCT01815008|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111392340|NCT01815008|Analgesics|analgesics|mesh-ancestor
111392341|NCT01815008|Sensory System Agents|sensory system agents|mesh-ancestor
111392342|NCT01815008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111392343|NCT01815008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111392344|NCT01815008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111392345|NCT01815008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111392346|NCT01815008|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111392347|NCT01815008|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111392348|NCT01815008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111392349|NCT01815008|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111392350|NCT01815008|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110532370|NCT00616070|Difluprednate|difluprednate|mesh-list
111392351|NCT01815008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111392352|NCT01815008|Antipyretics|antipyretics|mesh-ancestor
111392353|NCT01815008|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111392354|NCT01815008|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111392355|NCT01815008|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111392356|NCT01815008|Purinergic Agents|purinergic agents|mesh-ancestor
111392357|NCT01815008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111392358|NCT01801124|Bupivacaine|bupivacaine|mesh-list
111392359|NCT01801124|Anesthetics, Local|anesthetics, local|mesh-ancestor
111392360|NCT01801124|Anesthetics|anesthetics|mesh-ancestor
111392361|NCT01801124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111392362|NCT01801124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111392363|NCT01801124|Sensory System Agents|sensory system agents|mesh-ancestor
111392364|NCT01801124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111392365|NCT00357461|Ipilimumab|ipilimumab|mesh-list
111392366|NCT00357461|Vaccines|vaccines|mesh-list
111392367|NCT00357461|Freund's Adjuvant|freund's adjuvant|mesh-list
111392368|NCT00357461|Immunologic Factors|immunologic factors|mesh-ancestor
111392369|NCT00357461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111392370|NCT00357461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111392371|NCT00357461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111392372|NCT00357461|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111392373|NCT00357461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111392374|NCT00357461|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111392375|NCT00357539|Azithromycin|azithromycin|mesh-list
111392376|NCT00357539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111392377|NCT00357539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111392378|NCT03331965|Metoclopramide|metoclopramide|mesh-list
111392379|NCT03331965|Antiemetics|antiemetics|mesh-ancestor
111392380|NCT03331965|Autonomic Agents|autonomic agents|mesh-ancestor
111392381|NCT03331965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111392382|NCT03331965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111392383|NCT03331965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111392384|NCT03331965|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111392385|NCT03331965|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111392386|NCT03331965|Dopamine Agents|dopamine agents|mesh-ancestor
111392387|NCT03331965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111392388|NCT03331965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111392389|NCT03278223|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111392390|NCT03279237|Leucovorin|leucovorin|mesh-list
111392391|NCT03279237|Paclitaxel|paclitaxel|mesh-list
111392392|NCT03279237|Carboplatin|carboplatin|mesh-list
111392393|NCT03279237|Fluorouracil|fluorouracil|mesh-list
111392394|NCT03279237|Oxaliplatin|oxaliplatin|mesh-list
111392395|NCT03279237|Irinotecan|irinotecan|mesh-list
111392396|NCT03279237|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111392397|NCT03279237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111392398|NCT03279237|Tubulin Modulators|tubulin modulators|mesh-ancestor
111392399|NCT03279237|Antimitotic Agents|antimitotic agents|mesh-ancestor
111392400|NCT03279237|Mitosis Modulators|mitosis modulators|mesh-ancestor
111116813|NCT05990374|Tirzepatide|tirzepatide|mesh-list
111392401|NCT03279237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111392402|NCT03279237|Antimetabolites|antimetabolites|mesh-ancestor
111392403|NCT03279237|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111392404|NCT03279237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111392405|NCT03279237|Immunologic Factors|immunologic factors|mesh-ancestor
111392406|NCT03279237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111392407|NCT03279237|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111392408|NCT03279237|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111392409|NCT03279237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111392410|NCT03279237|Antidotes|antidotes|mesh-ancestor
111392411|NCT03279237|Protective Agents|protective agents|mesh-ancestor
111392412|NCT03279237|Vitamin B Complex|vitamin b complex|mesh-ancestor
111392413|NCT03279237|Vitamins|vitamins|mesh-ancestor
111392414|NCT03279237|Micronutrients|micronutrients|mesh-ancestor
111392415|NCT03282591|Serlopitant|serlopitant|mesh-list
111392416|NCT03282591|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
111392417|NCT03282591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111392418|NCT03282591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111392419|NCT03282591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111392420|NCT03509883|Apixaban|apixaban|mesh-list
111392421|NCT03509883|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111392422|NCT03509883|Antithrombins|antithrombins|mesh-ancestor
111392423|NCT03509883|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111392424|NCT03509883|Protease Inhibitors|protease inhibitors|mesh-ancestor
110464292|NCT00684190|GABA Agents|gaba agents|mesh-ancestor
111392425|NCT03509883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111392426|NCT03509883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111392427|NCT03509883|Anticoagulants|anticoagulants|mesh-ancestor
111392428|NCT03336645|Midazolam|midazolam|mesh-list
111392429|NCT03336645|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111392430|NCT03336645|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111392431|NCT03336645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111392432|NCT03336645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111392433|NCT03336645|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111392434|NCT03336645|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111392435|NCT03336645|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111392436|NCT03336645|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111392437|NCT03336645|Anesthetics, General|anesthetics, general|mesh-ancestor
111392438|NCT03336645|Anesthetics|anesthetics|mesh-ancestor
111392439|NCT03336645|GABA Modulators|gaba modulators|mesh-ancestor
111392440|NCT03336645|GABA Agents|gaba agents|mesh-ancestor
110532456|NCT03087773|Empagliflozin|empagliflozin|mesh-list
111392441|NCT03336645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111392442|NCT03336645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111392443|NCT00376311|Calcitonin|calcitonin|mesh-list
111392444|NCT00376311|Salmon calcitonin|salmon calcitonin|mesh-list
111392445|NCT00376311|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
111392446|NCT00376311|Katacalcin|katacalcin|mesh-list
111392447|NCT00376311|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111392448|NCT00376311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111392449|NCT00376311|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111392450|NCT00376311|Vasodilator Agents|vasodilator agents|mesh-ancestor
111392451|NCT03511521|Insulin|insulin|mesh-list
111392452|NCT03511521|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111392453|NCT03511521|Insulin Aspart|insulin aspart|mesh-list
111392454|NCT03511521|Insulin, Isophane|insulin, isophane|mesh-list
111392455|NCT03511521|Isophane Insulin, Human|isophane insulin, human|mesh-list
111392456|NCT03511521|Isophane insulin, beef|isophane insulin, beef|mesh-list
111392457|NCT03511521|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111392458|NCT03511521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111392459|NCT00376077|Methylprednisolone|methylprednisolone|mesh-list
111392460|NCT00376077|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111392461|NCT00376077|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111392462|NCT00376077|gamma-Globulins|gamma-globulins|mesh-list
111392463|NCT00376077|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
111392464|NCT00376077|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111392465|NCT00376077|Antiemetics|antiemetics|mesh-ancestor
111392466|NCT00376077|Autonomic Agents|autonomic agents|mesh-ancestor
111392467|NCT00376077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111392468|NCT00376077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111392469|NCT00376077|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111392470|NCT00376077|Glucocorticoids|glucocorticoids|mesh-ancestor
111392471|NCT00376077|Hormones|hormones|mesh-ancestor
111392472|NCT00376077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111392473|NCT00376077|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111392474|NCT00376077|Protective Agents|protective agents|mesh-ancestor
111392475|NCT00376077|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111392476|NCT00376077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111116886|NCT05964647|Ketanserin|ketanserin|mesh-list
111392478|NCT03519243|Darbepoetin alfa|darbepoetin alfa|mesh-list
111392479|NCT03519243|Hematinics|hematinics|mesh-ancestor
111392480|NCT03577275|Moxifloxacin|moxifloxacin|mesh-list
111392481|NCT03577275|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111392482|NCT03577275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111392483|NCT03577275|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111392484|NCT03577275|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111392485|NCT03577275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111392486|NCT03577275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111392487|NCT03577275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111392488|NCT03521505|Dexmedetomidine|dexmedetomidine|mesh-list
111392489|NCT03521505|Propofol|propofol|mesh-list
111392490|NCT03521505|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111392491|NCT03521505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111392492|NCT03521505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110532498|NCT03356834|Tenofovir|tenofovir|mesh-list
111392493|NCT03521505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111392494|NCT03521505|Analgesics|analgesics|mesh-ancestor
111392495|NCT03521505|Sensory System Agents|sensory system agents|mesh-ancestor
111392496|NCT03521505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111392497|NCT03521505|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111392498|NCT03521505|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111392499|NCT03521505|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110464599|NCT00873730|Etanercept|etanercept|mesh-list
111392500|NCT03521505|Adrenergic Agents|adrenergic agents|mesh-ancestor
111392501|NCT03521505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111392502|NCT03521505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111392503|NCT03521505|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111392504|NCT03521505|Anesthetics, General|anesthetics, general|mesh-ancestor
111392505|NCT03521505|Anesthetics|anesthetics|mesh-ancestor
111392506|NCT03522441|Clindamycin|clindamycin|mesh-list
111392507|NCT03522441|Clindamycin palmitate|clindamycin palmitate|mesh-list
111392508|NCT03522441|Clindamycin phosphate|clindamycin phosphate|mesh-list
111392509|NCT03522441|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111392510|NCT03522441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111392511|NCT03522441|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111392512|NCT03522441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111392513|NCT03522441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111392514|NCT03530631|Adderall|adderall|mesh-list
111392515|NCT03530631|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111392516|NCT03530631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111392517|NCT03350217|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
111392518|NCT03350217|Plasma Substitutes|plasma substitutes|mesh-ancestor
111392519|NCT03350217|Blood Substitutes|blood substitutes|mesh-ancestor
111392520|NCT03351933|Immunoglobulins|immunoglobulins|mesh-list
111392521|NCT03351933|Antibodies|antibodies|mesh-list
111392522|NCT03351933|gamma-Globulins|gamma-globulins|mesh-list
111392523|NCT03351933|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111392524|NCT03351933|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
111392525|NCT03351933|Immunologic Factors|immunologic factors|mesh-ancestor
111392526|NCT03351933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111392527|NCT03594045|Apixaban|apixaban|mesh-list
111392528|NCT03594045|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111392529|NCT03594045|Antithrombins|antithrombins|mesh-ancestor
111392530|NCT03594045|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111392531|NCT03594045|Protease Inhibitors|protease inhibitors|mesh-ancestor
111392532|NCT03594045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111392533|NCT03594045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111392534|NCT03594045|Anticoagulants|anticoagulants|mesh-ancestor
111392535|NCT03595449|Lidocaine|lidocaine|mesh-list
111392536|NCT03595449|Anesthetics, Local|anesthetics, local|mesh-ancestor
111392537|NCT03595449|Anesthetics|anesthetics|mesh-ancestor
111392538|NCT03595449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111392539|NCT03595449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111392540|NCT03595449|Sensory System Agents|sensory system agents|mesh-ancestor
111392541|NCT03595449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111392542|NCT03595449|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111392543|NCT03595449|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111392544|NCT03595449|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110532544|NCT04213898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111392545|NCT03595449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111392546|NCT03595449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111392547|NCT03597009|Nivolumab|nivolumab|mesh-list
111392548|NCT03597009|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
111116966|NCT05881265|Venetoclax|venetoclax|mesh-list
111392549|NCT03597009|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111392550|NCT03597009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111392551|NCT03597009|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111392552|NCT03597009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111392553|NCT03352323|Phenylephrine|phenylephrine|mesh-list
111392554|NCT03352323|Oxymetazoline|oxymetazoline|mesh-list
111392555|NCT03352323|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111392556|NCT03352323|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111392557|NCT03352323|Adrenergic Agents|adrenergic agents|mesh-ancestor
111392558|NCT03352323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111392559|NCT03352323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111392560|NCT03352323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111392561|NCT03352323|Sympathomimetics|sympathomimetics|mesh-ancestor
111392562|NCT03352323|Autonomic Agents|autonomic agents|mesh-ancestor
111392563|NCT03352323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111392564|NCT03352323|Nasal Decongestants|nasal decongestants|mesh-ancestor
111392565|NCT03352323|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111392566|NCT03352323|Respiratory System Agents|respiratory system agents|mesh-ancestor
111392567|NCT03352323|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111392568|NCT03352323|Mydriatics|mydriatics|mesh-ancestor
111392569|NCT03352323|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111392570|NCT03352323|Protective Agents|protective agents|mesh-ancestor
111392571|NCT04734639|Butyl phosphorotrithioate|butyl phosphorotrithioate|mesh-list
111392572|NCT04734639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111392573|NCT04734639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111392574|NCT03357393|Midazolam|midazolam|mesh-list
111392575|NCT03357393|Glycopyrrolate|glycopyrrolate|mesh-list
111392576|NCT03357393|Scopolamine|scopolamine|mesh-list
111392577|NCT03357393|Morphine|morphine|mesh-list
111392578|NCT03357393|Propofol|propofol|mesh-list
111392579|NCT03357393|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
111392580|NCT03357393|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111392581|NCT03357393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111392582|NCT03357393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111392583|NCT03357393|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111392584|NCT03357393|Anesthetics, General|anesthetics, general|mesh-ancestor
111392585|NCT03357393|Anesthetics|anesthetics|mesh-ancestor
111392586|NCT03357393|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111392587|NCT03357393|Narcotics|narcotics|mesh-ancestor
111392588|NCT03357393|Analgesics|analgesics|mesh-ancestor
111392589|NCT03357393|Sensory System Agents|sensory system agents|mesh-ancestor
111392590|NCT03357393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111392591|NCT03357393|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111392592|NCT03357393|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111392593|NCT03357393|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111392594|NCT03357393|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111392595|NCT03357393|GABA Modulators|gaba modulators|mesh-ancestor
111392596|NCT03357393|GABA Agents|gaba agents|mesh-ancestor
111392597|NCT03357393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111392598|NCT03357393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111392599|NCT03357393|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111392600|NCT03357393|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111392601|NCT03357393|Cholinergic Agents|cholinergic agents|mesh-ancestor
111392602|NCT03357393|Antiemetics|antiemetics|mesh-ancestor
111392603|NCT03357393|Autonomic Agents|autonomic agents|mesh-ancestor
111392604|NCT03357393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111392605|NCT03357393|Mydriatics|mydriatics|mesh-ancestor
111392606|NCT03357393|Parasympatholytics|parasympatholytics|mesh-ancestor
111392607|NCT03541941|Bupivacaine|bupivacaine|mesh-list
111392608|NCT03541941|Anesthetics, Local|anesthetics, local|mesh-ancestor
111392609|NCT03541941|Anesthetics|anesthetics|mesh-ancestor
111392610|NCT03541941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111392611|NCT03541941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111392612|NCT03541941|Sensory System Agents|sensory system agents|mesh-ancestor
111392613|NCT03541941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111392614|NCT00376467|Imatinib Mesylate|imatinib mesylate|mesh-list
111392615|NCT00376467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111392616|NCT00376467|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111392617|NCT00376467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111392618|NCT00376467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111392619|NCT03556761|Furosemide|furosemide|mesh-list
111392620|NCT03556761|Diuretics|diuretics|mesh-ancestor
111392621|NCT03556761|Natriuretic Agents|natriuretic agents|mesh-ancestor
111392622|NCT03556761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111392623|NCT03556761|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110532618|NCT00907517|Cytarabine|cytarabine|mesh-list
111392624|NCT03556761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111392625|NCT03556761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111392626|NCT03559179|Analgesics, Opioid|analgesics, opioid|mesh-list
111392627|NCT03559179|Narcotics|narcotics|mesh-ancestor
111392628|NCT03559179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111392629|NCT03559179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111392630|NCT03559179|Analgesics|analgesics|mesh-ancestor
111392631|NCT03559179|Sensory System Agents|sensory system agents|mesh-ancestor
110465090|NCT04265274|Copper|copper|mesh-list
111392632|NCT03559179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111392633|NCT03366207|Ciprofloxacin|ciprofloxacin|mesh-list
111392634|NCT03366207|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111392635|NCT03366207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111392636|NCT03366207|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111392637|NCT03366207|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111392638|NCT03366207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111392639|NCT03366207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111392640|NCT03366207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111392641|NCT03366207|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111392642|NCT03366207|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111392643|NCT03368235|Prednisolone|prednisolone|mesh-list
111392644|NCT03368235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111392645|NCT03368235|Glucocorticoids|glucocorticoids|mesh-ancestor
111392646|NCT03368235|Hormones|hormones|mesh-ancestor
110532644|NCT00905021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111392647|NCT03368235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111392648|NCT03368235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111392649|NCT03368235|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111392650|NCT03368235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111392651|NCT02310750|PF-06700841|pf-06700841|mesh-list
111392652|NCT02310750|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111392653|NCT02310750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111392654|NCT02310750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111392655|NCT03615807|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111392656|NCT03615807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111392657|NCT02310672|Macitentan|macitentan|mesh-list
111392658|NCT02310672|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
111392659|NCT02310672|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
111392660|NCT02310672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111392661|NCT02310672|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
111392662|NCT03626415|Abrocitinib|abrocitinib|mesh-list
111392663|NCT03626415|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111392664|NCT03626415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110532666|NCT02677805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111392665|NCT03626415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111392666|NCT04373421|Chlorhexidine|chlorhexidine|mesh-list
111392667|NCT04373421|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
111392668|NCT04373421|Benzydamine|benzydamine|mesh-list
111392669|NCT04373421|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111392670|NCT04373421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111392671|NCT04373421|Disinfectants|disinfectants|mesh-ancestor
111392672|NCT04373421|Dermatologic Agents|dermatologic agents|mesh-ancestor
111392673|NCT04373421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111392674|NCT03632109|Gentamicins|gentamicins|mesh-list
111392675|NCT03632109|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111392676|NCT03632109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111392677|NCT03632109|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111392678|NCT03632109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111392679|NCT03632109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111392680|NCT02363946|Diphenhydramine|diphenhydramine|mesh-list
111392681|NCT02363946|Promethazine|promethazine|mesh-list
111392682|NCT02363946|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111392683|NCT02363946|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111392684|NCT02363946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111392685|NCT02363946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111392686|NCT02363946|Anesthetics, Local|anesthetics, local|mesh-ancestor
111392687|NCT02363946|Anesthetics|anesthetics|mesh-ancestor
111392688|NCT02363946|Sensory System Agents|sensory system agents|mesh-ancestor
111392689|NCT02363946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111392690|NCT02363946|Antiemetics|antiemetics|mesh-ancestor
111392691|NCT02363946|Autonomic Agents|autonomic agents|mesh-ancestor
111392692|NCT02363946|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111392693|NCT02363946|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111392694|NCT02363946|Histamine Antagonists|histamine antagonists|mesh-ancestor
111392695|NCT02363946|Histamine Agents|histamine agents|mesh-ancestor
111392696|NCT02363946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111392697|NCT02363946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111392698|NCT02363946|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111392699|NCT02363946|Antipruritics|antipruritics|mesh-ancestor
111392700|NCT02363946|Dermatologic Agents|dermatologic agents|mesh-ancestor
111392701|NCT02363478|Buspirone|buspirone|mesh-list
111392702|NCT02363478|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111392703|NCT02363478|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111392704|NCT02363478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111392705|NCT02363478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111392706|NCT02363478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111392707|NCT02363478|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111392708|NCT02363478|Serotonin Agents|serotonin agents|mesh-ancestor
111392709|NCT02363478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111392710|NCT02363478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111392711|NCT02338362|Fluticasone|fluticasone|mesh-list
111392712|NCT02338362|Xhance|xhance|mesh-list
111392713|NCT02338362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111392714|NCT02338362|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111392715|NCT02338362|Autonomic Agents|autonomic agents|mesh-ancestor
111392716|NCT02338362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111392717|NCT02338362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111392718|NCT02338362|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111392719|NCT02338362|Respiratory System Agents|respiratory system agents|mesh-ancestor
111392720|NCT02338362|Dermatologic Agents|dermatologic agents|mesh-ancestor
111392721|NCT02338362|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111392722|NCT01803074|Ritonavir|ritonavir|mesh-list
111392723|NCT01803074|Atazanavir Sulfate|atazanavir sulfate|mesh-list
111392724|NCT01803074|Tenofovir|tenofovir|mesh-list
111392725|NCT01803074|Emtricitabine|emtricitabine|mesh-list
111392726|NCT01803074|BMS-955176|bms-955176|mesh-list
111392727|NCT01803074|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111392728|NCT01803074|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111392729|NCT01803074|Protease Inhibitors|protease inhibitors|mesh-ancestor
111392730|NCT01803074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111392731|NCT01803074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111392732|NCT01803074|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111392733|NCT01803074|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111392734|NCT01803074|Antiviral Agents|antiviral agents|mesh-ancestor
111392735|NCT01803074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111392736|NCT01803074|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111392737|NCT01803074|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111392738|NCT01803074|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111392739|NCT01803074|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111392740|NCT05327894|Blinatumomab|blinatumomab|mesh-list
111392741|NCT05327894|Antibodies, Bispecific|antibodies, bispecific|mesh-list
111392742|NCT05327894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111392743|NCT05327894|Immunologic Factors|immunologic factors|mesh-ancestor
111392744|NCT05327894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111392745|NCT05327660|Carbon Monoxide|carbon monoxide|mesh-list
111392746|NCT05327660|Antimetabolites|antimetabolites|mesh-ancestor
111392747|NCT05327660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111392748|NCT05327660|Gasotransmitters|gasotransmitters|mesh-ancestor
111392749|NCT05327660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111392750|NCT05327660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111392751|NCT01822886|Gemcitabine|gemcitabine|mesh-list
111392752|NCT01822886|Romidepsin|romidepsin|mesh-list
110532751|NCT00620490|Anesthetics|anesthetics|mesh-ancestor
111392753|NCT01822886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111392754|NCT01822886|Antimetabolites|antimetabolites|mesh-ancestor
111392755|NCT01822886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111392756|NCT01822886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111392757|NCT01822886|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111392758|NCT01822886|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111392759|NCT01822886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111392760|NCT01823510|Aspirin|aspirin|mesh-list
111392761|NCT01823510|Clopidogrel|clopidogrel|mesh-list
111392762|NCT01823510|Ticagrelor|ticagrelor|mesh-list
111392763|NCT01823510|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111392764|NCT01823510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111392765|NCT01823510|Analgesics|analgesics|mesh-ancestor
111392766|NCT01823510|Sensory System Agents|sensory system agents|mesh-ancestor
111392767|NCT01823510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111392768|NCT01823510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111392769|NCT01823510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111392770|NCT01823510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111392771|NCT01823510|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111392772|NCT01823510|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111392773|NCT01823510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111392774|NCT01823510|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111392775|NCT01823510|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111392776|NCT01823510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111392777|NCT01823510|Antipyretics|antipyretics|mesh-ancestor
111392778|NCT01823510|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111392779|NCT01823510|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111392780|NCT01823510|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111392781|NCT01823510|Purinergic Agents|purinergic agents|mesh-ancestor
110532769|NCT01898520|Nabiximols|nabiximols|mesh-list
111392782|NCT01823510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111392783|NCT05327582|Paclitaxel|paclitaxel|mesh-list
111392784|NCT05327582|Durvalumab|durvalumab|mesh-list
111392785|NCT05327582|Lenvatinib|lenvatinib|mesh-list
111392786|NCT05327582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111392787|NCT05327582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111392788|NCT05327582|Tubulin Modulators|tubulin modulators|mesh-ancestor
111392789|NCT05327582|Antimitotic Agents|antimitotic agents|mesh-ancestor
111392790|NCT05327582|Mitosis Modulators|mitosis modulators|mesh-ancestor
111392791|NCT05327582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111392792|NCT05327582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111392793|NCT05327582|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111392794|NCT05327582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111392795|NCT02271698|Dexamethasone|dexamethasone|mesh-list
111392796|NCT02271698|Dexamethasone acetate|dexamethasone acetate|mesh-list
111392797|NCT02271698|BB 1101|bb 1101|mesh-list
111392798|NCT02271698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111392799|NCT02271698|Antiemetics|antiemetics|mesh-ancestor
111392800|NCT02271698|Autonomic Agents|autonomic agents|mesh-ancestor
111392801|NCT02271698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111392802|NCT02271698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110465863|NCT04258956|Axitinib|axitinib|mesh-list
111392803|NCT02271698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111392804|NCT02271698|Glucocorticoids|glucocorticoids|mesh-ancestor
111392805|NCT02271698|Hormones|hormones|mesh-ancestor
111392806|NCT02271698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111392807|NCT02271698|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111392808|NCT02271698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111392809|NCT02271698|Protease Inhibitors|protease inhibitors|mesh-ancestor
111392810|NCT02271698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110532815|NCT00619398|Tacrolimus|tacrolimus|mesh-list
111392811|NCT02271698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111392812|NCT02328404|Vitamin D|vitamin d|mesh-list
111392813|NCT02328404|Cholecalciferol|cholecalciferol|mesh-list
111392814|NCT02328404|Vitamins|vitamins|mesh-ancestor
111392815|NCT02328404|Micronutrients|micronutrients|mesh-ancestor
111392816|NCT02328404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111392817|NCT02328404|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111392818|NCT02328404|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111392819|NCT05748236|Lamotrigine|lamotrigine|mesh-list
111392820|NCT05748236|Carbamazepine|carbamazepine|mesh-list
111392821|NCT05748236|Anticonvulsants|anticonvulsants|mesh-ancestor
111392822|NCT05748236|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110532820|NCT00619398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111392823|NCT05748236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111392824|NCT05748236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111392825|NCT05748236|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111392826|NCT05748236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111392827|NCT05748236|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111392828|NCT05748236|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111392829|NCT05748236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111392830|NCT05748236|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111392831|NCT05748236|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111392832|NCT05748236|Antimanic Agents|antimanic agents|mesh-ancestor
111392833|NCT05748236|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111392834|NCT05748236|Analgesics|analgesics|mesh-ancestor
111392835|NCT05748236|Sensory System Agents|sensory system agents|mesh-ancestor
111392836|NCT05748236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111392837|NCT05748236|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111392838|NCT05748236|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111392839|NCT01829516|Oxytocin|oxytocin|mesh-list
111392840|NCT01829516|Oxytocics|oxytocics|mesh-ancestor
111392841|NCT01829516|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111392842|NCT01829516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111392843|NCT01830140|Bimatoprost|bimatoprost|mesh-list
111392844|NCT01830140|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111392845|NCT01830842|Nicotine|nicotine|mesh-list
111392846|NCT01830842|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111392847|NCT01830842|Autonomic Agents|autonomic agents|mesh-ancestor
111392848|NCT01830842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111392849|NCT01830842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111392850|NCT01830842|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111392851|NCT01830842|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111392852|NCT01830842|Cholinergic Agents|cholinergic agents|mesh-ancestor
111392853|NCT01830842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111392854|NCT01830842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111392855|NCT01831232|Cytarabine|cytarabine|mesh-list
111392856|NCT01831232|Idarubicin|idarubicin|mesh-list
111392857|NCT01831232|Pravastatin|pravastatin|mesh-list
111392858|NCT01831232|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111392859|NCT01831232|Antimetabolites|antimetabolites|mesh-ancestor
111392860|NCT01831232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110466182|NCT00859456|Sunitinib|sunitinib|mesh-list
111392861|NCT01831232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111392862|NCT01831232|Antiviral Agents|antiviral agents|mesh-ancestor
111392863|NCT01831232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111392864|NCT01831232|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111392865|NCT01831232|Immunologic Factors|immunologic factors|mesh-ancestor
111392866|NCT01831232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111392867|NCT01831232|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111392868|NCT01831232|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111392869|NCT01831232|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111392870|NCT01831232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111392871|NCT01831232|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110532872|NCT04209426|Tacrine|tacrine|mesh-list
111392872|NCT01831232|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111392873|NCT01831232|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111392874|NCT01831232|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111392875|NCT01831934|Vaccines|vaccines|mesh-list
111392876|NCT01831934|Immunologic Factors|immunologic factors|mesh-ancestor
111392877|NCT01831934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111392878|NCT01833026|Albuterol|albuterol|mesh-list
111392879|NCT01833026|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111392880|NCT01833026|Autonomic Agents|autonomic agents|mesh-ancestor
111392881|NCT01833026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111392882|NCT01833026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111392883|NCT01833026|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111392884|NCT01833026|Respiratory System Agents|respiratory system agents|mesh-ancestor
111392885|NCT01833026|Tocolytic Agents|tocolytic agents|mesh-ancestor
111392886|NCT01833026|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111392887|NCT01833026|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111392888|NCT01833026|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111392889|NCT01833026|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111392890|NCT01833026|Adrenergic Agents|adrenergic agents|mesh-ancestor
111392891|NCT01833026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111392892|NCT01833026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111392893|NCT03383523|Praziquantel|praziquantel|mesh-list
111392894|NCT03383523|Emodepside|emodepside|mesh-list
111392895|NCT03383523|Toltrazuril|toltrazuril|mesh-list
111392896|NCT03383523|Anthelmintics|anthelmintics|mesh-ancestor
111392897|NCT03383523|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110532882|NCT04209426|Nootropic Agents|nootropic agents|mesh-ancestor
111392898|NCT03383523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111392899|NCT03383523|Coccidiostats|coccidiostats|mesh-ancestor
111392900|NCT03383523|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111392901|NCT00377091|PENTA|penta|mesh-list
111392902|NCT00377091|Fondaparinux|fondaparinux|mesh-list
111392903|NCT00377091|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111392904|NCT00377091|Antithrombins|antithrombins|mesh-ancestor
111392905|NCT00377091|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111392906|NCT00377091|Protease Inhibitors|protease inhibitors|mesh-ancestor
111392907|NCT00377091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111392908|NCT00377091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111392909|NCT00377091|Anticoagulants|anticoagulants|mesh-ancestor
111392910|NCT00377091|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111392911|NCT00377091|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111392912|NCT01835912|Citric Acid|citric acid|mesh-list
110532909|NCT04211844|Sofosbuvir|sofosbuvir|mesh-list
111392913|NCT01835912|Sodium Citrate|sodium citrate|mesh-list
111392914|NCT01835912|Anticoagulants|anticoagulants|mesh-ancestor
111392915|NCT01835912|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
111392916|NCT01835912|Chelating Agents|chelating agents|mesh-ancestor
111392917|NCT01835912|Sequestering Agents|sequestering agents|mesh-ancestor
111392918|NCT01835912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111392919|NCT05747768|Midazolam|midazolam|mesh-list
111392920|NCT05747768|Dabigatran|dabigatran|mesh-list
111392921|NCT05747768|Atorvastatin|atorvastatin|mesh-list
111392922|NCT05747768|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111392923|NCT05747768|Pitavastatin|pitavastatin|mesh-list
111392924|NCT05747768|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111392925|NCT05747768|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111392926|NCT05747768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111392927|NCT05747768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111392928|NCT05747768|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111392929|NCT05747768|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111392930|NCT05747768|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110532937|NCT02847143|Oxytocin|oxytocin|mesh-list
111392931|NCT05747768|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111392932|NCT05747768|Anesthetics, General|anesthetics, general|mesh-ancestor
111392933|NCT05747768|Anesthetics|anesthetics|mesh-ancestor
111392934|NCT05747768|GABA Modulators|gaba modulators|mesh-ancestor
111392935|NCT05747768|GABA Agents|gaba agents|mesh-ancestor
111392936|NCT05747768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111392937|NCT05747768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111392938|NCT05747768|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111392939|NCT05747768|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111392940|NCT05747768|Antimetabolites|antimetabolites|mesh-ancestor
111392941|NCT05747768|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111392942|NCT05747768|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111392943|NCT05747768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111392944|NCT05747768|Antithrombins|antithrombins|mesh-ancestor
111392945|NCT05747768|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111392946|NCT05747768|Protease Inhibitors|protease inhibitors|mesh-ancestor
111392947|NCT05747768|Anticoagulants|anticoagulants|mesh-ancestor
111392948|NCT04410159|Povidone-Iodine|povidone-iodine|mesh-list
111392949|NCT04410159|Listerine|listerine|mesh-list
111392950|NCT04410159|Povidone|povidone|mesh-list
111392951|NCT04410159|Plasma Substitutes|plasma substitutes|mesh-ancestor
111392952|NCT04410159|Blood Substitutes|blood substitutes|mesh-ancestor
111392953|NCT04410159|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111392954|NCT04410159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111392955|NCT03398421|Itraconazole|itraconazole|mesh-list
111392956|NCT03398421|Nemiralisib|nemiralisib|mesh-list
111392957|NCT03398421|Antifungal Agents|antifungal agents|mesh-ancestor
111392958|NCT03398421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111392959|NCT03398421|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111392960|NCT03398421|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111392961|NCT03398421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111392962|NCT03398421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111392963|NCT03398421|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111392964|NCT03398421|Hormone Antagonists|hormone antagonists|mesh-ancestor
111392965|NCT03398421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110532977|NCT00619944|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111392966|NCT03398421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111392967|NCT03398421|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111392968|NCT03398421|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111392969|NCT01839110|Ranolazine|ranolazine|mesh-list
111392970|NCT01839110|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111392971|NCT01839110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110532979|NCT00619944|Antiviral Agents|antiviral agents|mesh-ancestor
111392972|NCT01839110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111392973|NCT00559754|Bevacizumab|bevacizumab|mesh-list
111392974|NCT00559754|Docetaxel|docetaxel|mesh-list
111392975|NCT00559754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111392976|NCT00559754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111392977|NCT00559754|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111392978|NCT00559754|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111392979|NCT00559754|Growth Substances|growth substances|mesh-ancestor
111392980|NCT00559754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111392981|NCT00559754|Growth Inhibitors|growth inhibitors|mesh-ancestor
111392982|NCT00559754|Tubulin Modulators|tubulin modulators|mesh-ancestor
111392983|NCT00559754|Antimitotic Agents|antimitotic agents|mesh-ancestor
111392984|NCT00559754|Mitosis Modulators|mitosis modulators|mesh-ancestor
111392985|NCT00559754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111392986|NCT03402243|Menthol|menthol|mesh-list
111392987|NCT03402243|Antipruritics|antipruritics|mesh-ancestor
111392988|NCT03402243|Dermatologic Agents|dermatologic agents|mesh-ancestor
111392989|NCT01841606|Ondansetron|ondansetron|mesh-list
111392990|NCT01841606|Antiemetics|antiemetics|mesh-ancestor
111392991|NCT01841606|Autonomic Agents|autonomic agents|mesh-ancestor
111392992|NCT01841606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111392993|NCT01841606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111392994|NCT01841606|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111392995|NCT01841606|Antipruritics|antipruritics|mesh-ancestor
111392996|NCT01841606|Dermatologic Agents|dermatologic agents|mesh-ancestor
111392997|NCT01841606|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111392998|NCT01841606|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111392999|NCT01841606|Serotonin Agents|serotonin agents|mesh-ancestor
111393000|NCT01841606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111393001|NCT01841606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111393002|NCT04392141|Colchicine|colchicine|mesh-list
111393003|NCT04392141|Gout Suppressants|gout suppressants|mesh-ancestor
111393004|NCT04392141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111393005|NCT04392141|Tubulin Modulators|tubulin modulators|mesh-ancestor
111393006|NCT04392141|Antimitotic Agents|antimitotic agents|mesh-ancestor
111393007|NCT04392141|Mitosis Modulators|mitosis modulators|mesh-ancestor
111393008|NCT04392141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111393009|NCT04392141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111393010|NCT04838054|Chlorine dioxide|chlorine dioxide|mesh-list
111393011|NCT04838054|Dental Disinfectants|dental disinfectants|mesh-ancestor
111393012|NCT04838054|Disinfectants|disinfectants|mesh-ancestor
111393013|NCT04838054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111393014|NCT00559364|Omeprazole|omeprazole|mesh-list
111393015|NCT00559364|Pancrelipase|pancrelipase|mesh-list
111393016|NCT00559364|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
111393017|NCT00559364|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111393018|NCT00559364|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111393019|NCT00559364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111393020|NCT00559364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111393021|NCT05746676|Hyaluronic Acid|hyaluronic acid|mesh-list
111393022|NCT05746676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111393023|NCT05746676|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111393024|NCT05746676|Immunologic Factors|immunologic factors|mesh-ancestor
111393025|NCT05746676|Viscosupplements|viscosupplements|mesh-ancestor
111393026|NCT05746676|Protective Agents|protective agents|mesh-ancestor
111393027|NCT05746598|Cisplatin|cisplatin|mesh-list
111393028|NCT05746598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111393029|NCT05745974|Fibrin fragment D|fibrin fragment d|mesh-list
111393030|NCT05745974|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111393031|NCT05745974|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111393032|NCT05745974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111393033|NCT05745974|Hemostatics|hemostatics|mesh-ancestor
111393034|NCT05745974|Coagulants|coagulants|mesh-ancestor
111393035|NCT02306850|Pembrolizumab|pembrolizumab|mesh-list
110533044|NCT01497509|Mydriatics|mydriatics|mesh-ancestor
111393036|NCT02306850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111393037|NCT02306850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111393038|NCT02306850|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111393039|NCT02306850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111393040|NCT02306694|Factor VIII|factor viii|mesh-list
111393041|NCT02306694|Coagulants|coagulants|mesh-ancestor
111393042|NCT01648140|Interferons|interferons|mesh-list
111393043|NCT01648140|Ribavirin|ribavirin|mesh-list
111393044|NCT01648140|Interferon-alpha|interferon-alpha|mesh-list
111393045|NCT01648140|Interferon alpha-2|interferon alpha-2|mesh-list
111393046|NCT01648140|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
111393047|NCT01648140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111393048|NCT01648140|Antiviral Agents|antiviral agents|mesh-ancestor
111393049|NCT01648140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111393050|NCT01648140|Antimetabolites|antimetabolites|mesh-ancestor
111393051|NCT01648140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111393052|NCT01648140|Immunologic Factors|immunologic factors|mesh-ancestor
111393053|NCT01648140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111393054|NCT02335242|Sildenafil Citrate|sildenafil citrate|mesh-list
111393055|NCT02335242|Vasodilator Agents|vasodilator agents|mesh-ancestor
111393056|NCT02335242|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111393057|NCT02335242|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111393058|NCT02335242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111393059|NCT02335242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111393060|NCT02335242|Urological Agents|urological agents|mesh-ancestor
111393061|NCT02334384|Anti-Infective Agents|anti-infective agents|mesh-list
111393062|NCT02334384|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111393063|NCT02305758|Bevacizumab|bevacizumab|mesh-list
111393064|NCT02305758|Fluorouracil|fluorouracil|mesh-list
111393065|NCT02305758|Veliparib|veliparib|mesh-list
111393066|NCT02305758|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110533070|NCT00618228|Balsalazide|balsalazide|mesh-list
111393067|NCT02305758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111393068|NCT02305758|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111393069|NCT02305758|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111393070|NCT02305758|Growth Substances|growth substances|mesh-ancestor
111393071|NCT02305758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111393072|NCT02305758|Growth Inhibitors|growth inhibitors|mesh-ancestor
111393073|NCT02305758|Antimetabolites|antimetabolites|mesh-ancestor
111393074|NCT02305758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111393075|NCT02305758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111393076|NCT02305758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111393077|NCT02305758|Immunologic Factors|immunologic factors|mesh-ancestor
111393078|NCT02305758|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111393079|NCT02305758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111393080|NCT04392219|Molnupiravir|molnupiravir|mesh-list
111393081|NCT04392219|Antiviral Agents|antiviral agents|mesh-ancestor
111393082|NCT04392219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111393083|NCT04365153|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111393084|NCT04365153|Immunologic Factors|immunologic factors|mesh-ancestor
111393085|NCT04365153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111393086|NCT03654417|Lidocaine|lidocaine|mesh-list
111393087|NCT03654417|Anesthetics, Local|anesthetics, local|mesh-ancestor
111393088|NCT03654417|Anesthetics|anesthetics|mesh-ancestor
111393089|NCT03654417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111393090|NCT03654417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111393091|NCT03654417|Sensory System Agents|sensory system agents|mesh-ancestor
110533081|NCT03711305|Etoposide|etoposide|mesh-list
111393092|NCT03654417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111393093|NCT03654417|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111393094|NCT03654417|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111393095|NCT03654417|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111393096|NCT03654417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111393097|NCT03654417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111393098|NCT00376701|Bevacizumab|bevacizumab|mesh-list
111393099|NCT00376701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111393100|NCT00376701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111393101|NCT00376701|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111393102|NCT00376701|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111393103|NCT00376701|Growth Substances|growth substances|mesh-ancestor
111393104|NCT00376701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111393105|NCT00376701|Growth Inhibitors|growth inhibitors|mesh-ancestor
111393106|NCT04358991|Ceftazidime|ceftazidime|mesh-list
111393107|NCT04358991|Avibactam|avibactam|mesh-list
111393108|NCT04358991|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
111393109|NCT04358991|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111393110|NCT04358991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111393111|NCT04358991|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
111393112|NCT04358991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111393113|NCT04358991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111393114|NCT04338009|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
111393115|NCT04338009|Protease Inhibitors|protease inhibitors|mesh-ancestor
111393116|NCT04338009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111393117|NCT04338009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111393118|NCT02303574|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111393119|NCT02354976|Fenofibrate|fenofibrate|mesh-list
111393120|NCT02354976|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111393121|NCT02354976|Antimetabolites|antimetabolites|mesh-ancestor
111393122|NCT02354976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111393123|NCT02354976|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111393124|NCT02303262|Gemcitabine|gemcitabine|mesh-list
111393125|NCT02303262|Mocetinostat|mocetinostat|mesh-list
111393126|NCT02303262|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111393127|NCT02303262|Antimetabolites|antimetabolites|mesh-ancestor
111393128|NCT02303262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111393129|NCT02303262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111393130|NCT02303262|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111393131|NCT02303262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111393132|NCT00558896|Dexamethasone|dexamethasone|mesh-list
111393133|NCT00558896|Pomalidomide|pomalidomide|mesh-list
111393134|NCT00558896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111393135|NCT00558896|Antiemetics|antiemetics|mesh-ancestor
111393136|NCT00558896|Autonomic Agents|autonomic agents|mesh-ancestor
111393137|NCT00558896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111393138|NCT00558896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111393139|NCT00558896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111393140|NCT00558896|Glucocorticoids|glucocorticoids|mesh-ancestor
111393141|NCT00558896|Hormones|hormones|mesh-ancestor
111393142|NCT00558896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111393143|NCT00558896|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111393144|NCT00558896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111393145|NCT00558896|Immunologic Factors|immunologic factors|mesh-ancestor
111393146|NCT00558896|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111393147|NCT00558896|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111393148|NCT00558896|Growth Substances|growth substances|mesh-ancestor
111393149|NCT00558896|Growth Inhibitors|growth inhibitors|mesh-ancestor
111393150|NCT01857362|Nitisinone|nitisinone|mesh-list
111393151|NCT01857362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111393152|NCT01857362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111393153|NCT02265224|Acetylcysteine|acetylcysteine|mesh-list
111393154|NCT02265224|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111393155|NCT02265224|Antiviral Agents|antiviral agents|mesh-ancestor
110533159|NCT02845661|Analgesics|analgesics|mesh-ancestor
111393156|NCT02265224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111393157|NCT02265224|Expectorants|expectorants|mesh-ancestor
111393158|NCT02265224|Respiratory System Agents|respiratory system agents|mesh-ancestor
111393159|NCT02265224|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111393160|NCT02265224|Antioxidants|antioxidants|mesh-ancestor
111393161|NCT02265224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111393162|NCT02265224|Protective Agents|protective agents|mesh-ancestor
111393163|NCT02265224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111393164|NCT02265224|Antidotes|antidotes|mesh-ancestor
111393166|NCT01859078|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111393167|NCT01859078|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111393168|NCT01859078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111393169|NCT01859078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111393170|NCT01859078|Protective Agents|protective agents|mesh-ancestor
111393171|NCT01859078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111393172|NCT00558428|Amlodipine|amlodipine|mesh-list
111393173|NCT00558428|Telmisartan|telmisartan|mesh-list
111393174|NCT00558428|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
111393175|NCT00558428|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111393176|NCT00558428|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111393177|NCT00558428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111393178|NCT00558428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111393179|NCT00558428|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111393180|NCT00558428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111393181|NCT00558428|Vasodilator Agents|vasodilator agents|mesh-ancestor
111393182|NCT00558428|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111393183|NCT00558428|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111393184|NCT05314725|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
111393185|NCT05314725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111393186|NCT05314725|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111393187|NCT05314725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111393188|NCT04310085|Lumefantrine|lumefantrine|mesh-list
111393189|NCT04310085|Artemether|artemether|mesh-list
111393190|NCT04310085|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
111393191|NCT04310085|Antimalarials|antimalarials|mesh-ancestor
111393192|NCT04310085|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111393193|NCT04310085|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111393194|NCT04310085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111393195|NCT00558272|Zoledronic Acid|zoledronic acid|mesh-list
111393196|NCT00558272|Saracatinib|saracatinib|mesh-list
111393197|NCT00558272|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111393198|NCT00558272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111393199|NCT00558272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111393200|NCT00558272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111393201|NCT00558272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111393202|NCT01859312|Hydrocortisone|hydrocortisone|mesh-list
111393203|NCT01859312|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
111393204|NCT01859312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111393205|NCT03407625|Misoprostol|misoprostol|mesh-list
111393206|NCT03407625|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111393207|NCT03407625|Abortifacient Agents|abortifacient agents|mesh-ancestor
110533208|NCT02845349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111393208|NCT03407625|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111393209|NCT03407625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111393210|NCT03407625|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111393211|NCT03407625|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111393212|NCT03407625|Oxytocics|oxytocics|mesh-ancestor
111393213|NCT03666663|Lidocaine|lidocaine|mesh-list
111393214|NCT03666663|Bupivacaine|bupivacaine|mesh-list
111393215|NCT03666663|Ropivacaine|ropivacaine|mesh-list
111393216|NCT03666663|Anesthetics, Local|anesthetics, local|mesh-ancestor
111393217|NCT03666663|Anesthetics|anesthetics|mesh-ancestor
111393218|NCT03666663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111393219|NCT03666663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111393220|NCT03666663|Sensory System Agents|sensory system agents|mesh-ancestor
111393221|NCT03666663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111393222|NCT03666663|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111393223|NCT03666663|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111393224|NCT03666663|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111393225|NCT03666663|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111393226|NCT03666663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111393227|NCT05692154|Fexofenadine|fexofenadine|mesh-list
111393228|NCT05692154|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111393229|NCT05692154|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
111393230|NCT05692154|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111393231|NCT05692154|Histamine Antagonists|histamine antagonists|mesh-ancestor
111393232|NCT05692154|Histamine Agents|histamine agents|mesh-ancestor
111393233|NCT05692154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111393234|NCT05692154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111393235|NCT05692154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111393237|NCT01863134|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111393238|NCT03415581|Oxycodone|oxycodone|mesh-list
111393239|NCT03415581|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111393240|NCT03415581|Narcotics|narcotics|mesh-ancestor
111393241|NCT03415581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110533251|NCT04288206|Cefazolin|cefazolin|mesh-list
111393242|NCT03415581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111393243|NCT03415581|Analgesics|analgesics|mesh-ancestor
111393244|NCT03415581|Sensory System Agents|sensory system agents|mesh-ancestor
111393245|NCT03415581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111393246|NCT00557492|Bevacizumab|bevacizumab|mesh-list
111393247|NCT00557492|Gemcitabine|gemcitabine|mesh-list
111393248|NCT00557492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111393249|NCT00557492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111393250|NCT00557492|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111393251|NCT00557492|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111393252|NCT00557492|Growth Substances|growth substances|mesh-ancestor
111393253|NCT00557492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111393254|NCT00557492|Growth Inhibitors|growth inhibitors|mesh-ancestor
111393255|NCT00557492|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111393256|NCT00557492|Antimetabolites|antimetabolites|mesh-ancestor
111393257|NCT00557492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111393258|NCT01865708|Ethanol|ethanol|mesh-list
111393259|NCT01865708|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111393260|NCT01865708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111393261|NCT01865708|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111393262|NCT01865708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111393263|NCT04203225|Lidocaine|lidocaine|mesh-list
111393264|NCT04203225|Epinephrine|epinephrine|mesh-list
111393265|NCT04203225|Tetracaine|tetracaine|mesh-list
111393266|NCT04203225|Anesthetics, Local|anesthetics, local|mesh-ancestor
111393267|NCT04203225|Anesthetics|anesthetics|mesh-ancestor
111393268|NCT04203225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110533268|NCT02771249|Antimetabolites|antimetabolites|mesh-ancestor
111393269|NCT04203225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111393270|NCT04203225|Sensory System Agents|sensory system agents|mesh-ancestor
111393271|NCT04203225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111393272|NCT04203225|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111393273|NCT04203225|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111393274|NCT04203225|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111393275|NCT04203225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111393276|NCT04203225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111393277|NCT04203225|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111393278|NCT04203225|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111393279|NCT04203225|Adrenergic Agents|adrenergic agents|mesh-ancestor
111393280|NCT04203225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111393281|NCT04203225|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111393282|NCT04203225|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111393283|NCT04203225|Autonomic Agents|autonomic agents|mesh-ancestor
111393284|NCT04203225|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111393285|NCT04203225|Respiratory System Agents|respiratory system agents|mesh-ancestor
111393286|NCT04203225|Mydriatics|mydriatics|mesh-ancestor
111393287|NCT04203225|Sympathomimetics|sympathomimetics|mesh-ancestor
111393288|NCT04203225|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111393289|NCT05314257|Granisetron|granisetron|mesh-list
111393290|NCT05314257|Antiemetics|antiemetics|mesh-ancestor
111393291|NCT05314257|Autonomic Agents|autonomic agents|mesh-ancestor
111393292|NCT05314257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111393293|NCT05314257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111393294|NCT05314257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111393295|NCT05314257|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111393296|NCT05314257|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111393297|NCT05314257|Serotonin Agents|serotonin agents|mesh-ancestor
111393298|NCT05314257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111393299|NCT05314257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111393300|NCT02354586|Niraparib|niraparib|mesh-list
111393301|NCT02354586|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111393302|NCT02354586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111393303|NCT02354586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111117712|NCT03717194|Ertugliflozin|ertugliflozin|mesh-list
111393304|NCT02354586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111393305|NCT01866410|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111393306|NCT01866410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111393307|NCT01866410|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111393308|NCT01866410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111393309|NCT01866410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111393310|NCT00377325|Cyclosporine|cyclosporine|mesh-list
111393311|NCT00377325|Cyclosporins|cyclosporins|mesh-list
111393312|NCT00377325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111393313|NCT00377325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111393314|NCT00377325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111393315|NCT00377325|Immunologic Factors|immunologic factors|mesh-ancestor
111393316|NCT00377325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111393317|NCT00377325|Antifungal Agents|antifungal agents|mesh-ancestor
111393318|NCT00377325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111393319|NCT00377325|Dermatologic Agents|dermatologic agents|mesh-ancestor
111393320|NCT00377325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111393321|NCT00377325|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111393322|NCT02332824|Candesartan|candesartan|mesh-list
111393323|NCT02332824|Candesartan cilexetil|candesartan cilexetil|mesh-list
111393324|NCT02332824|Imarikiren hydrochloride|imarikiren hydrochloride|mesh-list
111393325|NCT02332824|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111393326|NCT02332824|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111393327|NCT02332824|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111393328|NCT02332824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111393329|NCT02332824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111393331|NCT03701061|Immunologic Factors|immunologic factors|mesh-ancestor
111393332|NCT03701061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111393333|NCT03420014|Doxorubicin|doxorubicin|mesh-list
111393334|NCT03420014|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111393335|NCT03420014|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111393336|NCT03420014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111393337|NCT03420014|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111393338|NCT03420014|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111393339|NCT03420014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111393340|NCT03420014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111393341|NCT03705273|Dexamethasone|dexamethasone|mesh-list
111393342|NCT03705273|Dexamethasone acetate|dexamethasone acetate|mesh-list
111393343|NCT03705273|BB 1101|bb 1101|mesh-list
111393344|NCT03705273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111393345|NCT03705273|Antiemetics|antiemetics|mesh-ancestor
111393346|NCT03705273|Autonomic Agents|autonomic agents|mesh-ancestor
111393347|NCT03705273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111393348|NCT03705273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111393349|NCT03705273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111393350|NCT03705273|Glucocorticoids|glucocorticoids|mesh-ancestor
111393351|NCT03705273|Hormones|hormones|mesh-ancestor
111393352|NCT03705273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111393353|NCT03705273|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111393354|NCT03705273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111393355|NCT03705273|Protease Inhibitors|protease inhibitors|mesh-ancestor
111393356|NCT03705273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111393357|NCT03705273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111393358|NCT04184271|Fluorides|fluorides|mesh-list
111393359|NCT04184271|Cariostatic Agents|cariostatic agents|mesh-ancestor
111393360|NCT04184271|Protective Agents|protective agents|mesh-ancestor
111393361|NCT04184271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111393362|NCT03936387|Ropivacaine|ropivacaine|mesh-list
111393363|NCT03936387|Anesthetics, Local|anesthetics, local|mesh-ancestor
111393364|NCT03936387|Anesthetics|anesthetics|mesh-ancestor
111393365|NCT03936387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111393366|NCT03936387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111393367|NCT03936387|Sensory System Agents|sensory system agents|mesh-ancestor
111393368|NCT03936387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111393369|NCT04173429|Nadroparin|nadroparin|mesh-list
111393370|NCT04173429|Warfarin|warfarin|mesh-list
111393371|NCT04173429|Calcium|calcium|mesh-list
111393372|NCT04173429|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111393373|NCT04173429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111393374|NCT04173429|Anticoagulants|anticoagulants|mesh-ancestor
111393375|NCT04173429|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111393376|NCT04173429|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110533371|NCT02689362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111393377|NCT04173429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111393378|NCT03710187|Hydrocortisone|hydrocortisone|mesh-list
111393379|NCT03710187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111393380|NCT04167189|Lidocaine|lidocaine|mesh-list
111393381|NCT04167189|Anesthetics, Local|anesthetics, local|mesh-ancestor
111393382|NCT04167189|Anesthetics|anesthetics|mesh-ancestor
111393383|NCT04167189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111393384|NCT04167189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111393385|NCT04167189|Sensory System Agents|sensory system agents|mesh-ancestor
111393386|NCT04167189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111393387|NCT04167189|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111393388|NCT04167189|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111393389|NCT04167189|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111393390|NCT04167189|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111393391|NCT04167189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111393392|NCT03929367|Oxytocin|oxytocin|mesh-list
111393393|NCT03929367|Oxytocics|oxytocics|mesh-ancestor
111393394|NCT03929367|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111393395|NCT03929367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111393396|NCT04149405|Diphosphonates|diphosphonates|mesh-list
111393397|NCT04149405|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111393398|NCT04149405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111393399|NCT00556712|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111393400|NCT00556712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111393401|NCT00556712|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111393402|NCT00556712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111393403|NCT00556712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111393404|NCT03717051|Nicotine|nicotine|mesh-list
111393405|NCT03717051|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111393406|NCT03717051|Autonomic Agents|autonomic agents|mesh-ancestor
111393407|NCT03717051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111393408|NCT03717051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111393409|NCT03717051|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111393410|NCT03717051|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111393411|NCT03717051|Cholinergic Agents|cholinergic agents|mesh-ancestor
111393412|NCT03717051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111393413|NCT03717051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111393414|NCT04350320|Colchicine|colchicine|mesh-list
111393415|NCT04350320|Gout Suppressants|gout suppressants|mesh-ancestor
111393416|NCT04350320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111393417|NCT04350320|Tubulin Modulators|tubulin modulators|mesh-ancestor
111393418|NCT04350320|Antimitotic Agents|antimitotic agents|mesh-ancestor
111393419|NCT04350320|Mitosis Modulators|mitosis modulators|mesh-ancestor
111393420|NCT04350320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111393421|NCT04350320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111393422|NCT03920865|Risdiplam|risdiplam|mesh-list
111393423|NCT03920865|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111393424|NCT03920865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111393425|NCT03920865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111393426|NCT00556322|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111393427|NCT00556322|Docetaxel|docetaxel|mesh-list
111393428|NCT00556322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111393429|NCT00556322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111393430|NCT00556322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111393431|NCT00556322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111393432|NCT00556322|Tubulin Modulators|tubulin modulators|mesh-ancestor
111393433|NCT00556322|Antimitotic Agents|antimitotic agents|mesh-ancestor
111393434|NCT00556322|Mitosis Modulators|mitosis modulators|mesh-ancestor
111393435|NCT04137627|Melatonin|melatonin|mesh-list
111393436|NCT04137627|Antioxidants|antioxidants|mesh-ancestor
111393437|NCT04137627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111393438|NCT04137627|Protective Agents|protective agents|mesh-ancestor
111393439|NCT04137627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111393440|NCT04137627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111393441|NCT04136145|Belimumab|belimumab|mesh-list
111393442|NCT04136145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111393443|NCT04136145|Immunologic Factors|immunologic factors|mesh-ancestor
111393444|NCT04136145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111393445|NCT01869686|Denosumab|denosumab|mesh-list
111393446|NCT01869686|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111393447|NCT01869686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111393448|NCT03360890|Docetaxel|docetaxel|mesh-list
111393449|NCT03360890|Pembrolizumab|pembrolizumab|mesh-list
111393450|NCT03360890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111393451|NCT03360890|Tubulin Modulators|tubulin modulators|mesh-ancestor
111393452|NCT03360890|Antimitotic Agents|antimitotic agents|mesh-ancestor
111393453|NCT03360890|Mitosis Modulators|mitosis modulators|mesh-ancestor
111393454|NCT03360890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111393455|NCT03360890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111393456|NCT03360890|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111393457|NCT03862755|Heparin|heparin|mesh-list
110468127|NCT00918138|Metformin|metformin|mesh-list
111393458|NCT03862755|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
111393459|NCT03862755|Tinzaparin|tinzaparin|mesh-list
111393460|NCT03862755|Dalteparin|dalteparin|mesh-list
111393461|NCT03862755|Anticoagulants|anticoagulants|mesh-ancestor
111393462|NCT03862755|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111393463|NCT03862755|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111393464|NCT03862755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111393465|NCT02332590|Adalimumab|adalimumab|mesh-list
111393466|NCT02332590|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111393467|NCT02332590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111393468|NCT02332590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111393469|NCT04076787|Sunitinib|sunitinib|mesh-list
111393470|NCT04076787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110468195|NCT02603965|Copper|copper|mesh-list
111393471|NCT04076787|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111393472|NCT04076787|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111393473|NCT04076787|Growth Substances|growth substances|mesh-ancestor
111393474|NCT04076787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111393475|NCT04076787|Growth Inhibitors|growth inhibitors|mesh-ancestor
111393476|NCT04076787|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111393477|NCT04076787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111393478|NCT04076787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111393479|NCT00554840|Varenicline|varenicline|mesh-list
111393480|NCT00554840|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111393481|NCT00554840|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111393482|NCT00554840|Cholinergic Agents|cholinergic agents|mesh-ancestor
111393483|NCT00554840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111393484|NCT00554840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111393485|NCT00554840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111393486|NCT04069221|Cobicistat|cobicistat|mesh-list
111393487|NCT04069221|Artefenomel|artefenomel|mesh-list
111393488|NCT04069221|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111393489|NCT04069221|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111393490|NCT04069221|Antiviral Agents|antiviral agents|mesh-ancestor
111393491|NCT04069221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111393492|NCT04069221|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111393493|NCT04069221|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111393494|NCT04069221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111393495|NCT04069221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111393496|NCT04069221|Antimalarials|antimalarials|mesh-ancestor
111393497|NCT04069221|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111393498|NCT04069221|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111393499|NCT03054038|Afatinib|afatinib|mesh-list
111393500|NCT03054038|Necitumumab|necitumumab|mesh-list
111393501|NCT03054038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111393502|NCT03054038|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111393503|NCT03054038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111393504|NCT03054038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111393505|NCT03054038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111393506|NCT02302716|Hypoglycemic Agents|hypoglycemic agents|mesh-list
110533503|NCT03711318|Analgesics|analgesics|mesh-ancestor
111393507|NCT02302716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111393508|NCT03958071|Pirfenidone|pirfenidone|mesh-list
111393509|NCT03958071|Nintedanib|nintedanib|mesh-list
111393510|NCT03958071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111393511|NCT03958071|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111393512|NCT03958071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111393513|NCT03958071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111393514|NCT03958071|Analgesics|analgesics|mesh-ancestor
111393515|NCT03958071|Sensory System Agents|sensory system agents|mesh-ancestor
111393516|NCT03958071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111393517|NCT03958071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111393518|NCT03958071|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111393519|NCT03958071|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111393520|NCT03958071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111393521|NCT03958071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111393522|NCT04066647|Dexamethasone|dexamethasone|mesh-list
111393523|NCT04066647|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111393524|NCT04066647|Antiemetics|antiemetics|mesh-ancestor
111393525|NCT04066647|Autonomic Agents|autonomic agents|mesh-ancestor
111393526|NCT04066647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111393527|NCT04066647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111393528|NCT04066647|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111393529|NCT04066647|Glucocorticoids|glucocorticoids|mesh-ancestor
111393530|NCT04066647|Hormones|hormones|mesh-ancestor
111393531|NCT04066647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111393532|NCT04066647|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110533547|NCT02153645|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111393533|NCT04066647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111393534|NCT04041453|Ivermectin|ivermectin|mesh-list
111393535|NCT04041453|Albendazole|albendazole|mesh-list
111393536|NCT04041453|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111393537|NCT04041453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111393538|NCT04041453|Anthelmintics|anthelmintics|mesh-ancestor
111393539|NCT04041453|Anticestodal Agents|anticestodal agents|mesh-ancestor
111393540|NCT04041453|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
111393541|NCT04041453|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111393542|NCT04041453|Tubulin Modulators|tubulin modulators|mesh-ancestor
111393543|NCT04041453|Antimitotic Agents|antimitotic agents|mesh-ancestor
111393544|NCT04041453|Mitosis Modulators|mitosis modulators|mesh-ancestor
111393545|NCT04041453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111393546|NCT04041453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111393547|NCT02354508|Pasireotide|pasireotide|mesh-list
111393548|NCT02354508|Hormones|hormones|mesh-ancestor
110533564|NCT02688738|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111393549|NCT02354508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111393550|NCT02354508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111393551|NCT00554216|Topiramate|topiramate|mesh-list
111393552|NCT00554216|Phentermine|phentermine|mesh-list
111393553|NCT00554216|Anticonvulsants|anticonvulsants|mesh-ancestor
111393554|NCT00554216|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111393555|NCT00554216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111393556|NCT00554216|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111393557|NCT00554216|Appetite Depressants|appetite depressants|mesh-ancestor
111393558|NCT00554216|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111393559|NCT00554216|Sympathomimetics|sympathomimetics|mesh-ancestor
111393560|NCT00554216|Autonomic Agents|autonomic agents|mesh-ancestor
111393561|NCT00554216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111393562|NCT00554216|Adrenergic Agents|adrenergic agents|mesh-ancestor
111393563|NCT00554216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111393564|NCT00554216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111393565|NCT02353572|Dexamethasone|dexamethasone|mesh-list
111393566|NCT02353572|Bortezomib|bortezomib|mesh-list
111393567|NCT02353572|Melphalan|melphalan|mesh-list
111393568|NCT02353572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111393569|NCT02353572|Antiemetics|antiemetics|mesh-ancestor
111393570|NCT02353572|Autonomic Agents|autonomic agents|mesh-ancestor
111393571|NCT02353572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111393572|NCT02353572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111393573|NCT02353572|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111393574|NCT02353572|Glucocorticoids|glucocorticoids|mesh-ancestor
111393575|NCT02353572|Hormones|hormones|mesh-ancestor
111393576|NCT02353572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111393577|NCT02353572|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111393578|NCT02353572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111393579|NCT02353572|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111393580|NCT02353572|Alkylating Agents|alkylating agents|mesh-ancestor
111393581|NCT02353572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111393582|NCT02353572|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111393583|NCT02353572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111393584|NCT02353572|Immunologic Factors|immunologic factors|mesh-ancestor
111393585|NCT03886701|Isoniazid|isoniazid|mesh-list
111393586|NCT03886701|Rifapentine|rifapentine|mesh-list
111393587|NCT03886701|Antitubercular Agents|antitubercular agents|mesh-ancestor
111393588|NCT03886701|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111393589|NCT03886701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111393590|NCT03886701|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
111393591|NCT03886701|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111393592|NCT03886701|Antimetabolites|antimetabolites|mesh-ancestor
111393593|NCT03886701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111393594|NCT03886701|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111393595|NCT03886701|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111393596|NCT03886701|Leprostatic Agents|leprostatic agents|mesh-ancestor
111393597|NCT00552578|Buprenorphine|buprenorphine|mesh-list
111393598|NCT00552578|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
111393599|NCT00552578|Naloxone|naloxone|mesh-list
111393600|NCT00552578|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111393601|NCT00552578|Narcotics|narcotics|mesh-ancestor
111393602|NCT00552578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111393603|NCT00552578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111393604|NCT00552578|Analgesics|analgesics|mesh-ancestor
111393605|NCT00552578|Sensory System Agents|sensory system agents|mesh-ancestor
110533617|NCT00092807|Antimetabolites|antimetabolites|mesh-ancestor
111393606|NCT00552578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111393607|NCT00552578|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111393608|NCT02301936|Sofosbuvir|sofosbuvir|mesh-list
111393609|NCT02301936|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
111393610|NCT02301936|Ledipasvir|ledipasvir|mesh-list
111393611|NCT02301936|Antiviral Agents|antiviral agents|mesh-ancestor
111393612|NCT02301936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111393613|NCT03881163|Acetylcysteine|acetylcysteine|mesh-list
111393614|NCT03881163|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111393615|NCT03881163|Antiviral Agents|antiviral agents|mesh-ancestor
110469142|NCT00888381|Vaccines|vaccines|mesh-list
111393616|NCT03881163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111393617|NCT03881163|Expectorants|expectorants|mesh-ancestor
111393618|NCT03881163|Respiratory System Agents|respiratory system agents|mesh-ancestor
111393619|NCT03881163|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111393620|NCT03881163|Antioxidants|antioxidants|mesh-ancestor
111393621|NCT03881163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111393622|NCT03881163|Protective Agents|protective agents|mesh-ancestor
111393623|NCT03881163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111393624|NCT03881163|Antidotes|antidotes|mesh-ancestor
111393625|NCT03848871|Betamethasone|betamethasone|mesh-list
111393626|NCT03848871|Betamethasone Valerate|betamethasone valerate|mesh-list
111393627|NCT03848871|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
111393628|NCT03848871|Betamethasone benzoate|betamethasone benzoate|mesh-list
111393629|NCT03848871|Calcipotriene|calcipotriene|mesh-list
111393630|NCT03848871|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
111393631|NCT03848871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111393632|NCT03848871|Glucocorticoids|glucocorticoids|mesh-ancestor
111393633|NCT03848871|Hormones|hormones|mesh-ancestor
111393634|NCT03848871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111393635|NCT03848871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111393636|NCT03848871|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111393637|NCT03848871|Respiratory System Agents|respiratory system agents|mesh-ancestor
111393638|NCT03848871|Dermatologic Agents|dermatologic agents|mesh-ancestor
111393639|NCT04032327|Bupivacaine|bupivacaine|mesh-list
111393640|NCT04032327|Anesthetics, Local|anesthetics, local|mesh-ancestor
111393641|NCT04032327|Anesthetics|anesthetics|mesh-ancestor
111393642|NCT04032327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111393643|NCT04032327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111393644|NCT04032327|Sensory System Agents|sensory system agents|mesh-ancestor
111393645|NCT04032327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111393646|NCT04041219|Tacrolimus|tacrolimus|mesh-list
111393647|NCT04041219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111393648|NCT04041219|Immunologic Factors|immunologic factors|mesh-ancestor
111393649|NCT04041219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111393650|NCT04041219|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111393651|NCT04041219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111393652|NCT04041219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111393653|NCT00552344|Certolizumab Pegol|certolizumab pegol|mesh-list
111393654|NCT00552344|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111393655|NCT00552344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111393656|NCT00552344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111393657|NCT00552344|Immunologic Factors|immunologic factors|mesh-ancestor
111393658|NCT00552344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111393659|NCT00552344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111393660|NCT02814968|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
111393661|NCT02814968|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111393662|NCT02814968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110469355|NCT02825121|Iodine|iodine|mesh-list
111393663|NCT03879603|Aluminum Hydroxide|aluminum hydroxide|mesh-list
111393664|NCT03879603|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111393665|NCT03879603|Immunologic Factors|immunologic factors|mesh-ancestor
111393666|NCT03879603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111393667|NCT03879603|Antacids|antacids|mesh-ancestor
111393668|NCT03879603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111393669|NCT03879603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111393670|NCT00553514|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
111393671|NCT00553514|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
111393672|NCT00553514|Hormones|hormones|mesh-ancestor
111393673|NCT00553514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111393674|NCT00553514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111393675|NCT00553514|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111393676|NCT02813642|Mitogens|mitogens|mesh-list
111393677|NCT02813642|Mitosis Modulators|mitosis modulators|mesh-ancestor
111393678|NCT02813642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111393679|NCT03852537|Methylprednisolone|methylprednisolone|mesh-list
111393680|NCT03852537|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111393681|NCT03852537|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111393682|NCT03852537|Prednisolone|prednisolone|mesh-list
110533685|NCT02574728|Sirolimus|sirolimus|mesh-list
111393683|NCT03852537|Prednisolone acetate|prednisolone acetate|mesh-list
111393684|NCT03852537|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111393685|NCT03852537|Prednisolone phosphate|prednisolone phosphate|mesh-list
111393686|NCT03852537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111393687|NCT03852537|Antiemetics|antiemetics|mesh-ancestor
111393688|NCT03852537|Autonomic Agents|autonomic agents|mesh-ancestor
111393689|NCT03852537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111393690|NCT03852537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111393691|NCT03852537|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111393692|NCT03852537|Glucocorticoids|glucocorticoids|mesh-ancestor
111393693|NCT03852537|Hormones|hormones|mesh-ancestor
111393694|NCT03852537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111393695|NCT03852537|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111393696|NCT03852537|Protective Agents|protective agents|mesh-ancestor
111393697|NCT03852537|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111393698|NCT03852537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111393699|NCT03875859|Benzoic Acid|benzoic acid|mesh-list
111393700|NCT03875859|Antifungal Agents|antifungal agents|mesh-ancestor
111393701|NCT03875859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111393702|NCT00553202|Cyclosporine|cyclosporine|mesh-list
111393703|NCT00553202|Methylprednisolone|methylprednisolone|mesh-list
111393704|NCT00553202|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111393705|NCT00553202|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111393706|NCT00553202|Prednisolone|prednisolone|mesh-list
111393707|NCT00553202|Prednisolone acetate|prednisolone acetate|mesh-list
111393708|NCT00553202|Cyclophosphamide|cyclophosphamide|mesh-list
111393709|NCT00553202|Busulfan|busulfan|mesh-list
111393710|NCT00553202|Methotrexate|methotrexate|mesh-list
111393711|NCT00553202|Tacrolimus|tacrolimus|mesh-list
111393712|NCT00553202|Cyclosporins|cyclosporins|mesh-list
111393713|NCT00553202|Thymoglobulin|thymoglobulin|mesh-list
111393714|NCT00553202|Antilymphocyte Serum|antilymphocyte serum|mesh-list
111393715|NCT00553202|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111393716|NCT00553202|Prednisolone phosphate|prednisolone phosphate|mesh-list
111393717|NCT00553202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111393718|NCT00553202|Immunologic Factors|immunologic factors|mesh-ancestor
111393719|NCT00553202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111393720|NCT00553202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111393721|NCT00553202|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110469520|NCT05659251|Paclitaxel|paclitaxel|mesh-list
111393722|NCT00553202|Alkylating Agents|alkylating agents|mesh-ancestor
111393723|NCT00553202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111393724|NCT00553202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111393725|NCT00553202|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111393726|NCT00553202|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111393727|NCT00553202|Abortifacient Agents|abortifacient agents|mesh-ancestor
111393728|NCT00553202|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111393729|NCT00553202|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111393730|NCT00553202|Antimetabolites|antimetabolites|mesh-ancestor
111393731|NCT00553202|Dermatologic Agents|dermatologic agents|mesh-ancestor
111393732|NCT00553202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111393733|NCT00553202|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111393734|NCT00553202|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111393735|NCT00553202|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111393736|NCT00553202|Antifungal Agents|antifungal agents|mesh-ancestor
111393737|NCT00553202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111393738|NCT00553202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111393739|NCT00553202|Antiemetics|antiemetics|mesh-ancestor
111393740|NCT00553202|Autonomic Agents|autonomic agents|mesh-ancestor
111393741|NCT00553202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111393742|NCT00553202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111393743|NCT00553202|Glucocorticoids|glucocorticoids|mesh-ancestor
111393744|NCT00553202|Hormones|hormones|mesh-ancestor
111393745|NCT00553202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111393746|NCT00553202|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111393747|NCT00553202|Protective Agents|protective agents|mesh-ancestor
111393748|NCT00553202|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111393749|NCT00552188|Atreleuton|atreleuton|mesh-list
111393750|NCT00552188|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
111393751|NCT00552188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110533754|NCT00638742|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111393752|NCT00552188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111393753|NCT00377793|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
111393754|NCT00377793|Vasodilator Agents|vasodilator agents|mesh-ancestor
111393755|NCT00377793|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111393756|NCT00377793|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111393757|NCT00377793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111393758|NCT00377793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111393759|NCT00377793|Urological Agents|urological agents|mesh-ancestor
111393760|NCT04027803|Eculizumab|eculizumab|mesh-list
111393761|NCT04027803|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
111393762|NCT04027803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111393763|NCT04027803|Immunologic Factors|immunologic factors|mesh-ancestor
111393764|NCT04027803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111393765|NCT00552110|Mometasone Furoate|mometasone furoate|mesh-list
111393766|NCT00552110|Phenylephrine|phenylephrine|mesh-list
111393767|NCT00552110|Oxymetazoline|oxymetazoline|mesh-list
111393768|NCT00552110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111393769|NCT00552110|Dermatologic Agents|dermatologic agents|mesh-ancestor
111393770|NCT00552110|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111393771|NCT00552110|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111393772|NCT00552110|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111393773|NCT00552110|Adrenergic Agents|adrenergic agents|mesh-ancestor
111393774|NCT00552110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111393775|NCT00552110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111393776|NCT00552110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111393777|NCT00552110|Sympathomimetics|sympathomimetics|mesh-ancestor
111393778|NCT00552110|Autonomic Agents|autonomic agents|mesh-ancestor
111393779|NCT00552110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111393780|NCT00552110|Nasal Decongestants|nasal decongestants|mesh-ancestor
111393781|NCT00552110|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111393782|NCT00552110|Respiratory System Agents|respiratory system agents|mesh-ancestor
111393783|NCT00552110|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111393784|NCT00552110|Mydriatics|mydriatics|mesh-ancestor
111393785|NCT00552110|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111393786|NCT00552110|Protective Agents|protective agents|mesh-ancestor
111393787|NCT02301624|Eculizumab|eculizumab|mesh-list
111393788|NCT02301624|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
111393789|NCT02301624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111393790|NCT02301624|Immunologic Factors|immunologic factors|mesh-ancestor
111393791|NCT02301624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111393792|NCT02007122|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
111393793|NCT02007122|Cephalosporins|cephalosporins|mesh-list
111393794|NCT02007122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111393795|NCT02007122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111393796|NCT03250520|Titanium dioxide|titanium dioxide|mesh-list
111393797|NCT03250520|Sunscreening Agents|sunscreening agents|mesh-ancestor
111393798|NCT03250520|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111393799|NCT03250520|Protective Agents|protective agents|mesh-ancestor
111393800|NCT03250520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111393801|NCT03250520|Dermatologic Agents|dermatologic agents|mesh-ancestor
111393802|NCT03250520|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111393803|NCT03847389|Clobetasol|clobetasol|mesh-list
111393804|NCT03847389|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111393805|NCT03847389|Glucocorticoids|glucocorticoids|mesh-ancestor
111393806|NCT03847389|Hormones|hormones|mesh-ancestor
110533799|NCT02686086|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111393807|NCT03847389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111393808|NCT03847389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111393809|NCT02351934|Celecoxib|celecoxib|mesh-list
111393810|NCT02351934|Furosemide|furosemide|mesh-list
111393811|NCT02351934|Gabapentin|gabapentin|mesh-list
111393812|NCT02351934|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111393813|NCT02351934|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111393814|NCT02351934|Analgesics|analgesics|mesh-ancestor
111393815|NCT02351934|Sensory System Agents|sensory system agents|mesh-ancestor
111393816|NCT02351934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111393817|NCT02351934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111393818|NCT02351934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111393819|NCT02351934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111393820|NCT02351934|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111393821|NCT02351934|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111393822|NCT02351934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111393823|NCT02351934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111393824|NCT02351934|Anticonvulsants|anticonvulsants|mesh-ancestor
111393825|NCT02351934|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111393826|NCT02351934|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111393827|NCT02351934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111393828|NCT02351934|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111393829|NCT02351934|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111393830|NCT02351934|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111393831|NCT02351934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111393832|NCT02351934|Antimanic Agents|antimanic agents|mesh-ancestor
111393833|NCT02351934|Diuretics|diuretics|mesh-ancestor
111393834|NCT02351934|Natriuretic Agents|natriuretic agents|mesh-ancestor
111393835|NCT02351934|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
111393836|NCT02351934|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111393837|NCT00377481|Darbepoetin alfa|darbepoetin alfa|mesh-list
111393838|NCT00377481|Hematinics|hematinics|mesh-ancestor
111393839|NCT00377559|Docetaxel|docetaxel|mesh-list
111393840|NCT00377559|Doxorubicin|doxorubicin|mesh-list
111393841|NCT00377559|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111393842|NCT00377559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111393843|NCT00377559|Tubulin Modulators|tubulin modulators|mesh-ancestor
111393844|NCT00377559|Antimitotic Agents|antimitotic agents|mesh-ancestor
111393845|NCT00377559|Mitosis Modulators|mitosis modulators|mesh-ancestor
111393846|NCT00377559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111393847|NCT00377559|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111393848|NCT00377559|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111393849|NCT00377559|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111393850|NCT00377559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111393851|NCT03026348|Aluminum phosphate|aluminum phosphate|mesh-list
111393852|NCT03026348|Vaccines|vaccines|mesh-list
111393853|NCT03026348|Immunologic Factors|immunologic factors|mesh-ancestor
111393854|NCT03026348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111393855|NCT03026348|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111393856|NCT03026348|Antacids|antacids|mesh-ancestor
111393857|NCT03026348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110533862|NCT00622752|Nicotine|nicotine|mesh-list
111393858|NCT03026348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111393859|NCT04763408|Sorafenib|sorafenib|mesh-list
111393860|NCT04763408|Lenvatinib|lenvatinib|mesh-list
111393861|NCT04763408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111393862|NCT04763408|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111393863|NCT04763408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111393864|NCT04763408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111393865|NCT03825939|Tranexamic Acid|tranexamic acid|mesh-list
111393866|NCT03825939|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111393867|NCT03825939|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111393868|NCT03825939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111393869|NCT03825939|Hemostatics|hemostatics|mesh-ancestor
111393870|NCT03825939|Coagulants|coagulants|mesh-ancestor
111393871|NCT03988647|Pembrolizumab|pembrolizumab|mesh-list
111393872|NCT03988647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111393873|NCT03988647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111393874|NCT03988647|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111393875|NCT03988647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111393876|NCT00551642|Nitric Oxide|nitric oxide|mesh-list
111393877|NCT00551642|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111393878|NCT00551642|Autonomic Agents|autonomic agents|mesh-ancestor
110533876|NCT02686008|Olaparib|olaparib|mesh-list
111393879|NCT00551642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111393880|NCT00551642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111393881|NCT00551642|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111393882|NCT00551642|Respiratory System Agents|respiratory system agents|mesh-ancestor
111393883|NCT00551642|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111393884|NCT00551642|Antioxidants|antioxidants|mesh-ancestor
111393885|NCT00551642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111393886|NCT00551642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110533899|NCT03384654|Vincristine|vincristine|mesh-list
111393887|NCT00551642|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
111393888|NCT00551642|Vasodilator Agents|vasodilator agents|mesh-ancestor
111393889|NCT00551642|Gasotransmitters|gasotransmitters|mesh-ancestor
111393890|NCT00551642|Protective Agents|protective agents|mesh-ancestor
111393891|NCT02799212|Somatostatin|somatostatin|mesh-list
111393892|NCT02799212|Hormones|hormones|mesh-ancestor
111393893|NCT02799212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111393894|NCT02799212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111393895|NCT04690322|Factor VIII|factor viii|mesh-list
111393896|NCT04690322|BAX 855|bax 855|mesh-list
111393897|NCT04690322|Antibodies, Bispecific|antibodies, bispecific|mesh-list
111393898|NCT04690322|Coagulants|coagulants|mesh-ancestor
111393899|NCT04690322|Immunologic Factors|immunologic factors|mesh-ancestor
111393900|NCT04690322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111393901|NCT02648282|Cyclophosphamide|cyclophosphamide|mesh-list
111393902|NCT02648282|Pembrolizumab|pembrolizumab|mesh-list
111393903|NCT02648282|Vaccines|vaccines|mesh-list
111393904|NCT02648282|Immunologic Factors|immunologic factors|mesh-ancestor
111393905|NCT02648282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111393906|NCT02648282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111118260|NCT05915104|Budesonide|budesonide|mesh-list
111393907|NCT02648282|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111393908|NCT02648282|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111393909|NCT02648282|Alkylating Agents|alkylating agents|mesh-ancestor
111393910|NCT02648282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111393911|NCT02648282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111393912|NCT02648282|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111393913|NCT02648282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111393914|NCT02648282|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111393915|NCT04004481|Morphine|morphine|mesh-list
111393916|NCT04004481|Tramadol|tramadol|mesh-list
111393917|NCT04004481|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111393918|NCT04004481|Narcotics|narcotics|mesh-ancestor
111393919|NCT04004481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111393920|NCT04004481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111393921|NCT04004481|Analgesics|analgesics|mesh-ancestor
111393922|NCT04004481|Sensory System Agents|sensory system agents|mesh-ancestor
111393923|NCT04004481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111393924|NCT03997851|Acetaminophen|acetaminophen|mesh-list
111393925|NCT03997851|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111393926|NCT03997851|Analgesics|analgesics|mesh-ancestor
111393927|NCT03997851|Sensory System Agents|sensory system agents|mesh-ancestor
111393928|NCT03997851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111393929|NCT03997851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111393930|NCT03997851|Antipyretics|antipyretics|mesh-ancestor
111393931|NCT03989427|Listerine|listerine|mesh-list
111393932|NCT03989427|Sodium Fluoride|sodium fluoride|mesh-list
111393933|NCT03989427|Cariostatic Agents|cariostatic agents|mesh-ancestor
111393934|NCT03989427|Protective Agents|protective agents|mesh-ancestor
111393935|NCT03989427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110533936|NCT02685462|Digoxin|digoxin|mesh-list
111393936|NCT03989427|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111393937|NCT03989427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111393938|NCT03007719|Fluorides|fluorides|mesh-list
111393939|NCT03007719|Cariostatic Agents|cariostatic agents|mesh-ancestor
111393940|NCT03007719|Protective Agents|protective agents|mesh-ancestor
111393941|NCT03007719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111393942|NCT02985801|Pancrelipase|pancrelipase|mesh-list
111393943|NCT02985801|Pancreatin|pancreatin|mesh-list
111393944|NCT02985801|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111393945|NCT02988362|Amlodipine|amlodipine|mesh-list
111393946|NCT02988362|Candesartan|candesartan|mesh-list
111393947|NCT02988362|Candesartan cilexetil|candesartan cilexetil|mesh-list
111393948|NCT02988362|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111393949|NCT02988362|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111393950|NCT02988362|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111393951|NCT02988362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111393952|NCT02988362|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111393953|NCT02988362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111393954|NCT02988362|Vasodilator Agents|vasodilator agents|mesh-ancestor
111393955|NCT02988362|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111393956|NCT02988362|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111393957|NCT02988440|Sorafenib|sorafenib|mesh-list
111393958|NCT02988440|Spartalizumab|spartalizumab|mesh-list
111393959|NCT02988440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111393960|NCT02988440|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111393961|NCT02988440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111393962|NCT02988440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111393963|NCT02988440|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111393964|NCT02988440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111393965|NCT05405192|Dostarlimab|dostarlimab|mesh-list
111393966|NCT05405192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111393967|NCT00550550|Fluticasone|fluticasone|mesh-list
111393968|NCT00550550|Mometasone Furoate|mometasone furoate|mesh-list
111393969|NCT00550550|Loratadine|loratadine|mesh-list
111393970|NCT00550550|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
111393971|NCT00550550|Prednisone|prednisone|mesh-list
111393972|NCT00550550|Albuterol|albuterol|mesh-list
111393973|NCT00550550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111393974|NCT00550550|Glucocorticoids|glucocorticoids|mesh-ancestor
111393975|NCT00550550|Hormones|hormones|mesh-ancestor
111393976|NCT00550550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111393977|NCT00550550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111393978|NCT00550550|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111393979|NCT00550550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111393980|NCT00550550|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111393981|NCT00550550|Autonomic Agents|autonomic agents|mesh-ancestor
111393982|NCT00550550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111393983|NCT00550550|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111393984|NCT00550550|Respiratory System Agents|respiratory system agents|mesh-ancestor
111393985|NCT00550550|Dermatologic Agents|dermatologic agents|mesh-ancestor
111393986|NCT00550550|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110470167|NCT02807415|Ivacaftor|ivacaftor|mesh-list
111393987|NCT00550550|Tocolytic Agents|tocolytic agents|mesh-ancestor
111393988|NCT00550550|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111393989|NCT00550550|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111393990|NCT00550550|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111393991|NCT00550550|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111393992|NCT00550550|Adrenergic Agents|adrenergic agents|mesh-ancestor
111393993|NCT00550550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111393994|NCT00550550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111393995|NCT00550550|Antipruritics|antipruritics|mesh-ancestor
111393996|NCT00550550|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
111393997|NCT00550550|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111393998|NCT00550550|Histamine Antagonists|histamine antagonists|mesh-ancestor
111393999|NCT00550550|Histamine Agents|histamine agents|mesh-ancestor
111394000|NCT00550550|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111394001|NCT00550550|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111394002|NCT00550550|Analgesics|analgesics|mesh-ancestor
111394003|NCT00550550|Sensory System Agents|sensory system agents|mesh-ancestor
111394004|NCT00550550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111394005|NCT01590680|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
111394006|NCT01590680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111394007|NCT01590680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111394008|NCT01590680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111394009|NCT01590680|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111394010|NCT02971839|Ivacaftor|ivacaftor|mesh-list
111394011|NCT02971839|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
111394012|NCT02971839|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111394013|NCT02971839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111394014|NCT02974803|Trametinib|trametinib|mesh-list
111394015|NCT02974803|Dabrafenib|dabrafenib|mesh-list
111394016|NCT02974803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111394017|NCT02974803|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111394018|NCT02974803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111394019|NCT02974803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111394020|NCT02281136|Aminolevulinic Acid|aminolevulinic acid|mesh-list
111394021|NCT02281136|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111394022|NCT02281136|Dermatologic Agents|dermatologic agents|mesh-ancestor
111394023|NCT00558038|Lactulose|lactulose|mesh-list
111394024|NCT00558038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111394025|NCT01507233|Morphine|morphine|mesh-list
111394026|NCT01507233|Bupivacaine|bupivacaine|mesh-list
111394027|NCT01507233|Anesthetics, Local|anesthetics, local|mesh-ancestor
111394028|NCT01507233|Anesthetics|anesthetics|mesh-ancestor
111394029|NCT01507233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111394030|NCT01507233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111394031|NCT01507233|Sensory System Agents|sensory system agents|mesh-ancestor
111394032|NCT01507233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110534034|NCT05663736|Glimepiride|glimepiride|mesh-list
111394033|NCT01507233|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111394034|NCT01507233|Narcotics|narcotics|mesh-ancestor
111394035|NCT01507233|Analgesics|analgesics|mesh-ancestor
111394036|NCT02301390|Amiodarone|amiodarone|mesh-list
111394037|NCT02301390|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111394038|NCT02301390|Vasodilator Agents|vasodilator agents|mesh-ancestor
111394039|NCT02301390|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
111394040|NCT02301390|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111394041|NCT02301390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111394042|NCT02301390|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111394043|NCT02301390|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111394044|NCT02301390|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111394045|NCT02301390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111394046|NCT02301390|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111394047|NCT02301390|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111394048|NCT02301390|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111394049|NCT02278562|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
111394050|NCT02278562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111394051|NCT00378417|Vaccines|vaccines|mesh-list
111394052|NCT00378417|Immunologic Factors|immunologic factors|mesh-ancestor
111394053|NCT00378417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111394054|NCT01487499|Cisplatin|cisplatin|mesh-list
111394055|NCT01487499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111394056|NCT01483209|Botulinum Toxins|botulinum toxins|mesh-list
111394057|NCT01483209|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111394058|NCT01483209|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111118392|NCT05914194|Mazindol|mazindol|mesh-list
111394059|NCT01483209|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111394060|NCT01483209|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111394061|NCT01483209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111394062|NCT01483209|Cholinergic Agents|cholinergic agents|mesh-ancestor
111394063|NCT01483209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111394064|NCT01483209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111394065|NCT01483209|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111394066|NCT01483209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111394067|NCT02281448|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
111394068|NCT02281448|Contraceptive Agents|contraceptive agents|mesh-list
111394069|NCT02281448|Contraceptives, Oral|contraceptives, oral|mesh-list
111394070|NCT02281448|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
111394071|NCT02281448|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111394072|NCT02281448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111394073|NCT02281448|Anticonvulsants|anticonvulsants|mesh-ancestor
111394074|NCT02281448|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111394075|NCT02281448|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111394076|NCT02281448|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111394077|NCT02281448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111394078|NCT02281448|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111394080|NCT00378729|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110534092|NCT04182828|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111394081|NCT00378729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111394082|NCT00378495|Miltefosine|miltefosine|mesh-list
111394083|NCT00378495|Antifungal Agents|antifungal agents|mesh-ancestor
111394084|NCT00378495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111394085|NCT00378495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111394086|NCT00378495|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111394087|NCT00378495|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111394088|NCT02281526|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
111394089|NCT02281526|Anticonvulsants|anticonvulsants|mesh-ancestor
111394090|NCT02281526|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111394091|NCT02281526|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111394092|NCT02281526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111394093|NCT02281526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111394094|NCT03802227|Oxycodone|oxycodone|mesh-list
111394095|NCT03802227|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111394096|NCT03802227|Narcotics|narcotics|mesh-ancestor
111394097|NCT03802227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111394098|NCT03802227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111394099|NCT03802227|Analgesics|analgesics|mesh-ancestor
111394100|NCT03802227|Sensory System Agents|sensory system agents|mesh-ancestor
111394101|NCT03802227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111394102|NCT02749617|Apixaban|apixaban|mesh-list
111394103|NCT02749617|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111394104|NCT02749617|Antithrombins|antithrombins|mesh-ancestor
111394105|NCT02749617|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111394106|NCT02749617|Protease Inhibitors|protease inhibitors|mesh-ancestor
111394107|NCT02749617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110534126|NCT01009788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111394108|NCT02749617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111394109|NCT02749617|Anticoagulants|anticoagulants|mesh-ancestor
111394110|NCT02749227|Pasireotide|pasireotide|mesh-list
111394111|NCT02749227|Hormones|hormones|mesh-ancestor
111394112|NCT02749227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111394113|NCT02749227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111394114|NCT02746263|Acetaminophen|acetaminophen|mesh-list
111394115|NCT02746263|Morphine|morphine|mesh-list
111394116|NCT02746263|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111394117|NCT02746263|Narcotics|narcotics|mesh-ancestor
111394118|NCT02746263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111394119|NCT02746263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111394120|NCT02746263|Analgesics|analgesics|mesh-ancestor
111394121|NCT02746263|Sensory System Agents|sensory system agents|mesh-ancestor
111394122|NCT02746263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111394123|NCT02746263|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111394124|NCT02746263|Antipyretics|antipyretics|mesh-ancestor
111394125|NCT01394211|Anastrozole|anastrozole|mesh-list
111394126|NCT01394211|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111394127|NCT01394211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111394128|NCT01394211|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111394129|NCT01394211|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111394130|NCT01394211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111394131|NCT01394211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111394132|NCT01394211|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111394133|NCT01394211|Hormone Antagonists|hormone antagonists|mesh-ancestor
111394134|NCT01394211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111394135|NCT01394211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111394136|NCT02717949|Ribavirin|ribavirin|mesh-list
111394137|NCT02717949|Sofosbuvir|sofosbuvir|mesh-list
111394138|NCT02717949|Ledipasvir|ledipasvir|mesh-list
111394139|NCT02717949|Antimetabolites|antimetabolites|mesh-ancestor
111394140|NCT02717949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111394141|NCT02717949|Antiviral Agents|antiviral agents|mesh-ancestor
111394142|NCT02717949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111394143|NCT02300610|Cisplatin|cisplatin|mesh-list
111394144|NCT02300610|Gemcitabine|gemcitabine|mesh-list
111394145|NCT02300610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111394146|NCT02300610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111394147|NCT02300610|Antimetabolites|antimetabolites|mesh-ancestor
111394148|NCT02300610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111394149|NCT01880840|Azelastine|azelastine|mesh-list
111394150|NCT01880840|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111394151|NCT01880840|Autonomic Agents|autonomic agents|mesh-ancestor
111394152|NCT01880840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111394153|NCT01880840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111394154|NCT01880840|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111394155|NCT01880840|Respiratory System Agents|respiratory system agents|mesh-ancestor
111394156|NCT01880840|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
111394157|NCT01880840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111394158|NCT01880840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111394159|NCT01880840|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111394160|NCT01880840|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
111394161|NCT01880840|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111394162|NCT01880840|Histamine Antagonists|histamine antagonists|mesh-ancestor
111394163|NCT01880840|Histamine Agents|histamine agents|mesh-ancestor
111394164|NCT01880840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111394165|NCT01377441|Ibuprofen|ibuprofen|mesh-list
111394166|NCT01377441|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
111394167|NCT01377441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
111394168|NCT01377441|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111394169|NCT01377441|Analgesics|analgesics|mesh-ancestor
111394170|NCT01377441|Sensory System Agents|sensory system agents|mesh-ancestor
111394171|NCT01377441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111394172|NCT01377441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111394173|NCT01377441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111394174|NCT01377441|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111394175|NCT01377441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111394176|NCT01377441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111394177|NCT01882868|Leucovorin|leucovorin|mesh-list
111394178|NCT01882868|Irinotecan|irinotecan|mesh-list
111394179|NCT01882868|Aflibercept|aflibercept|mesh-list
111394180|NCT01882868|Levoleucovorin|levoleucovorin|mesh-list
111394181|NCT01882868|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111394182|NCT01882868|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111394183|NCT01882868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111394184|NCT01882868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111394185|NCT01882868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111394186|NCT01882868|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111394187|NCT01882868|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111394188|NCT01882868|Growth Substances|growth substances|mesh-ancestor
111394189|NCT01882868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111394190|NCT01882868|Growth Inhibitors|growth inhibitors|mesh-ancestor
111394191|NCT01882868|Antidotes|antidotes|mesh-ancestor
111394192|NCT01882868|Protective Agents|protective agents|mesh-ancestor
111394193|NCT01882868|Vitamin B Complex|vitamin b complex|mesh-ancestor
111394194|NCT01882868|Vitamins|vitamins|mesh-ancestor
111394195|NCT01882868|Micronutrients|micronutrients|mesh-ancestor
111394196|NCT01383447|Imatinib Mesylate|imatinib mesylate|mesh-list
111394197|NCT01383447|Entinostat|entinostat|mesh-list
111394198|NCT01383447|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
111394199|NCT01383447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111394200|NCT01383447|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111394201|NCT01383447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111394202|NCT01383447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111394203|NCT02300298|Docetaxel|docetaxel|mesh-list
111394204|NCT02300298|Nintedanib|nintedanib|mesh-list
111394205|NCT02300298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111394206|NCT02300298|Tubulin Modulators|tubulin modulators|mesh-ancestor
111394207|NCT02300298|Antimitotic Agents|antimitotic agents|mesh-ancestor
111394208|NCT02300298|Mitosis Modulators|mitosis modulators|mesh-ancestor
111394209|NCT02300298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111394210|NCT02300298|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111394211|NCT02300298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111394212|NCT02300220|Ciprofloxacin|ciprofloxacin|mesh-list
111394213|NCT02300220|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111394214|NCT02300220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111394215|NCT02300220|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111394216|NCT02300220|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111394217|NCT02300220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111394218|NCT02300220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111394219|NCT02300220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111394220|NCT02300220|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111394221|NCT02300220|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111394222|NCT01379469|Carbamazepine|carbamazepine|mesh-list
111394223|NCT01379469|Anticonvulsants|anticonvulsants|mesh-ancestor
111394224|NCT01379469|Antimanic Agents|antimanic agents|mesh-ancestor
111394225|NCT01379469|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111394226|NCT01379469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111394227|NCT01379469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111394228|NCT01379469|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111394229|NCT01379469|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111394230|NCT01379469|Analgesics|analgesics|mesh-ancestor
111394231|NCT01379469|Sensory System Agents|sensory system agents|mesh-ancestor
111394232|NCT01379469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111394233|NCT01379469|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111394234|NCT01379469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111394235|NCT01379469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110534255|NCT02777580|Purinergic Agents|purinergic agents|mesh-ancestor
111394236|NCT01379469|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111394237|NCT01379469|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111394238|NCT01309581|Ketamine|ketamine|mesh-list
111394239|NCT01309581|Methohexital|methohexital|mesh-list
111394240|NCT01309581|Analgesics|analgesics|mesh-ancestor
111394241|NCT01309581|Sensory System Agents|sensory system agents|mesh-ancestor
111394242|NCT01309581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111394243|NCT01309581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111394244|NCT01309581|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111394245|NCT01309581|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111394246|NCT01309581|Anesthetics, General|anesthetics, general|mesh-ancestor
111394247|NCT01309581|Anesthetics|anesthetics|mesh-ancestor
111394248|NCT01309581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111394249|NCT01309581|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111394250|NCT01309581|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111394251|NCT01309581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111394252|NCT01309581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111394253|NCT05289050|Ketamine|ketamine|mesh-list
111394254|NCT05289050|Esketamine|esketamine|mesh-list
111394255|NCT05289050|Analgesics|analgesics|mesh-ancestor
111394256|NCT05289050|Sensory System Agents|sensory system agents|mesh-ancestor
111394257|NCT05289050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111394258|NCT05289050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111394259|NCT05289050|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111394260|NCT05289050|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111394261|NCT05289050|Anesthetics, General|anesthetics, general|mesh-ancestor
111394262|NCT05289050|Anesthetics|anesthetics|mesh-ancestor
111394263|NCT05289050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110534273|NCT04628663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111394264|NCT05289050|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111394265|NCT05289050|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111394266|NCT05289050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111394267|NCT05289050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111394268|NCT05289050|Antidepressive Agents|antidepressive agents|mesh-ancestor
111394269|NCT05289050|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111394270|NCT02987738|Dapagliflozin|dapagliflozin|mesh-list
111394271|NCT02987738|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111394272|NCT02987738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111394273|NCT02987738|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111394274|NCT02987738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111394275|NCT01292265|Certolizumab Pegol|certolizumab pegol|mesh-list
111394276|NCT01292265|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111394277|NCT01292265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111394278|NCT01292265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111394279|NCT01292265|Immunologic Factors|immunologic factors|mesh-ancestor
111394280|NCT01292265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111394281|NCT01292265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111394282|NCT01885910|Doxycycline|doxycycline|mesh-list
111394284|NCT01885910|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111394285|NCT01885910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111394286|NCT01885910|Antimalarials|antimalarials|mesh-ancestor
111394287|NCT01885910|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111394288|NCT01885910|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111394289|NCT01885910|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111394290|NCT01885910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111394291|NCT01885910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111394292|NCT01885910|Leprostatic Agents|leprostatic agents|mesh-ancestor
111394293|NCT02658357|Risperidone|risperidone|mesh-list
111394294|NCT02658357|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111394295|NCT02658357|Serotonin Agents|serotonin agents|mesh-ancestor
111394296|NCT02658357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111394297|NCT02658357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111394298|NCT02658357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111394299|NCT02658357|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111394300|NCT02658357|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111394301|NCT02658357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111394302|NCT02658357|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111394303|NCT02658357|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111394304|NCT02658357|Dopamine Agents|dopamine agents|mesh-ancestor
111394305|NCT02988908|Donepezil|donepezil|mesh-list
111394306|NCT02988908|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111394307|NCT02988908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111394308|NCT02988908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111394309|NCT02988908|Cholinergic Agents|cholinergic agents|mesh-ancestor
111394310|NCT02988908|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110534327|NCT00909948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111394311|NCT02988908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111394312|NCT02988908|Nootropic Agents|nootropic agents|mesh-ancestor
111394313|NCT02326272|Certolizumab Pegol|certolizumab pegol|mesh-list
111394314|NCT02326272|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111394315|NCT02326272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111394316|NCT02326272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111394317|NCT02326272|Immunologic Factors|immunologic factors|mesh-ancestor
111394318|NCT02326272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111394319|NCT02326272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111394320|NCT02325414|Zoledronic Acid|zoledronic acid|mesh-list
111394321|NCT02325414|Diphosphonates|diphosphonates|mesh-list
111394322|NCT02325414|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111394323|NCT02325414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111394324|NCT02349048|Sofosbuvir|sofosbuvir|mesh-list
111394325|NCT02349048|Simeprevir|simeprevir|mesh-list
111394326|NCT02349048|Antiviral Agents|antiviral agents|mesh-ancestor
111394327|NCT02349048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111394328|NCT02349048|Protease Inhibitors|protease inhibitors|mesh-ancestor
111394329|NCT02349048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111394330|NCT02349048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111394331|NCT01280643|Leucovorin|leucovorin|mesh-list
111394332|NCT01280643|Bevacizumab|bevacizumab|mesh-list
111394333|NCT01280643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111394334|NCT01280643|Cetuximab|cetuximab|mesh-list
111394335|NCT01280643|Fluorouracil|fluorouracil|mesh-list
111394336|NCT01280643|Capecitabine|capecitabine|mesh-list
111394337|NCT01280643|Oxaliplatin|oxaliplatin|mesh-list
111394338|NCT01280643|Irinotecan|irinotecan|mesh-list
111394339|NCT01280643|Antibodies|antibodies|mesh-list
111394340|NCT01280643|Immunoglobulins|immunoglobulins|mesh-list
111394341|NCT01280643|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111394342|NCT01280643|Levoleucovorin|levoleucovorin|mesh-list
111394343|NCT01280643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111394344|NCT01280643|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111394345|NCT01280643|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111394346|NCT01280643|Growth Substances|growth substances|mesh-ancestor
111394347|NCT01280643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111394348|NCT01280643|Growth Inhibitors|growth inhibitors|mesh-ancestor
111394349|NCT01280643|Immunologic Factors|immunologic factors|mesh-ancestor
111394350|NCT01280643|Antimetabolites|antimetabolites|mesh-ancestor
111394351|NCT01280643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111394352|NCT01280643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111394353|NCT01280643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111394354|NCT01280643|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111394355|NCT01280643|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111394356|NCT01280643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111394357|NCT01280643|Antidotes|antidotes|mesh-ancestor
111394358|NCT01280643|Protective Agents|protective agents|mesh-ancestor
111394359|NCT01280643|Vitamin B Complex|vitamin b complex|mesh-ancestor
111394360|NCT01280643|Vitamins|vitamins|mesh-ancestor
111394361|NCT01280643|Micronutrients|micronutrients|mesh-ancestor
111394362|NCT01888952|Prednisone|prednisone|mesh-list
111394363|NCT01888952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111394364|NCT01888952|Glucocorticoids|glucocorticoids|mesh-ancestor
111394365|NCT01888952|Hormones|hormones|mesh-ancestor
111394366|NCT01888952|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111394367|NCT01888952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110534381|NCT00642330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111394368|NCT01888952|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111394369|NCT01888952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111394370|NCT02299206|Zinc Oxide|zinc oxide|mesh-list
111394371|NCT02299206|Dermatologic Agents|dermatologic agents|mesh-ancestor
111394372|NCT02299206|Sunscreening Agents|sunscreening agents|mesh-ancestor
111394373|NCT02299206|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111394374|NCT02299206|Protective Agents|protective agents|mesh-ancestor
111394375|NCT02299206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111394376|NCT02640573|Hydroxyurea|hydroxyurea|mesh-list
111394377|NCT02640573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111394378|NCT02640573|Antisickling Agents|antisickling agents|mesh-ancestor
111394379|NCT02640573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111394380|NCT02640573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111394381|NCT02640573|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111394382|NCT02298192|Liraglutide|liraglutide|mesh-list
111394383|NCT02298192|Xultophy|xultophy|mesh-list
111394384|NCT02298192|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111394385|NCT02298192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111394386|NCT02298192|Incretins|incretins|mesh-ancestor
111394387|NCT02298192|Hormones|hormones|mesh-ancestor
111394388|NCT02298192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111394389|NCT01893632|Gabapentin|gabapentin|mesh-list
111394390|NCT01893632|Analgesics|analgesics|mesh-ancestor
111394391|NCT01893632|Sensory System Agents|sensory system agents|mesh-ancestor
111394392|NCT01893632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110534413|NCT02842931|Hormones|hormones|mesh-ancestor
111394393|NCT01893632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111394394|NCT01893632|Anticonvulsants|anticonvulsants|mesh-ancestor
111394395|NCT01893632|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111394396|NCT01893632|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111394397|NCT01893632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111394398|NCT01893632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111394399|NCT01893632|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111394400|NCT01893632|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111394401|NCT01893632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110534419|NCT04183296|Propofol|propofol|mesh-list
111394402|NCT01893632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111394403|NCT01893632|Antimanic Agents|antimanic agents|mesh-ancestor
111394404|NCT01272141|Everolimus|everolimus|mesh-list
111394405|NCT01272141|Lapatinib|lapatinib|mesh-list
111394406|NCT01272141|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111394407|NCT01272141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111394408|NCT01272141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111394409|NCT01272141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111394410|NCT01272141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111394411|NCT01272141|Immunologic Factors|immunologic factors|mesh-ancestor
111394412|NCT01272141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111394413|NCT01272141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111394414|NCT01895036|Naltrexone|naltrexone|mesh-list
111394415|NCT01895036|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111394416|NCT01895036|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111394417|NCT01895036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111394418|NCT01895036|Sensory System Agents|sensory system agents|mesh-ancestor
111394419|NCT01895036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111394420|NCT03781479|Amifampridine|amifampridine|mesh-list
111394421|NCT03781479|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111394422|NCT03781479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111394423|NCT03781479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111394424|NCT03781479|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
111394425|NCT03781479|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111394426|NCT03781479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111394427|NCT01223001|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
111394428|NCT01223001|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111394429|NCT01223001|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111394430|NCT01223001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111394431|NCT01223001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111394432|NCT01223001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111394433|NCT01223001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111394434|NCT01223001|Analgesics|analgesics|mesh-ancestor
111394435|NCT01223001|Sensory System Agents|sensory system agents|mesh-ancestor
111394436|NCT01223001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111394437|NCT01223001|Antidepressive Agents|antidepressive agents|mesh-ancestor
111394438|NCT01223001|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111394439|NCT01223001|Dopamine Agents|dopamine agents|mesh-ancestor
111394440|NCT02608905|Dapagliflozin|dapagliflozin|mesh-list
111394441|NCT02608905|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111394442|NCT02608905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111394443|NCT02608905|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110534464|NCT02677584|Caffeine|caffeine|mesh-list
111394444|NCT02608905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111394445|NCT01213329|Alemtuzumab|alemtuzumab|mesh-list
111394446|NCT01213329|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111394447|NCT01213329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111394448|NCT03964532|Avelumab|avelumab|mesh-list
111394449|NCT03964532|Talazoparib|talazoparib|mesh-list
111394450|NCT03964532|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111394451|NCT03964532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111394452|NCT03964532|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111394453|NCT03964532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111394454|NCT03964532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111394455|NCT01189071|Darifenacin|darifenacin|mesh-list
111394456|NCT01189071|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111394457|NCT01189071|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111394458|NCT01189071|Cholinergic Agents|cholinergic agents|mesh-ancestor
111394459|NCT01189071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111394460|NCT01189071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111394461|NCT01189071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111394462|NCT01189071|Urological Agents|urological agents|mesh-ancestor
111394463|NCT02515851|Bupivacaine|bupivacaine|mesh-list
111394464|NCT02515851|Anesthetics, Local|anesthetics, local|mesh-ancestor
111394465|NCT02515851|Anesthetics|anesthetics|mesh-ancestor
111394466|NCT02515851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111394467|NCT02515851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111394468|NCT02515851|Sensory System Agents|sensory system agents|mesh-ancestor
111394469|NCT02515851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111394470|NCT02492295|Propofol|propofol|mesh-list
111394471|NCT02492295|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111394472|NCT02492295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111394473|NCT02492295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111394474|NCT02492295|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111394475|NCT02492295|Anesthetics, General|anesthetics, general|mesh-ancestor
111394476|NCT02492295|Anesthetics|anesthetics|mesh-ancestor
111394477|NCT02468583|Triamcinolone|triamcinolone|mesh-list
111394478|NCT02468583|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
111394479|NCT02468583|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
111394480|NCT02468583|FX006|fx006|mesh-list
111394481|NCT02468583|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
111394482|NCT02468583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111394483|NCT02468583|Glucocorticoids|glucocorticoids|mesh-ancestor
111394484|NCT02468583|Hormones|hormones|mesh-ancestor
111394485|NCT02468583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111394486|NCT02468583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111394487|NCT02468583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110534515|NCT00896051|Etravirine|etravirine|mesh-list
111394488|NCT02468583|Immunologic Factors|immunologic factors|mesh-ancestor
111394489|NCT02468583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111394490|NCT02468583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111394491|NCT03763929|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
111394492|NCT03763929|Antioxidants|antioxidants|mesh-ancestor
111394493|NCT03763929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111394494|NCT03763929|Protective Agents|protective agents|mesh-ancestor
111394495|NCT03763929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111394496|NCT03763929|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
111394497|NCT03763929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111394498|NCT01118013|Mycophenolic Acid|mycophenolic acid|mesh-list
111394499|NCT01118013|Methotrexate|methotrexate|mesh-list
111394500|NCT01118013|Fludarabine phosphate|fludarabine phosphate|mesh-list
111394501|NCT01118013|Fludarabine|fludarabine|mesh-list
111394502|NCT01118013|Busulfan|busulfan|mesh-list
111394503|NCT01118013|Tacrolimus|tacrolimus|mesh-list
111394504|NCT01118013|Antilymphocyte Serum|antilymphocyte serum|mesh-list
111394505|NCT01118013|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111394506|NCT01118013|Abortifacient Agents|abortifacient agents|mesh-ancestor
111394507|NCT01118013|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111394508|NCT01118013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111118848|NCT05672459|Cyclophosphamide|cyclophosphamide|mesh-list
111394509|NCT01118013|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111394511|NCT01118013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111394512|NCT01118013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111394513|NCT01118013|Dermatologic Agents|dermatologic agents|mesh-ancestor
111394514|NCT01118013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111394515|NCT01118013|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111394516|NCT01118013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111394517|NCT01118013|Immunologic Factors|immunologic factors|mesh-ancestor
111394518|NCT01118013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111394519|NCT01118013|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111394520|NCT01118013|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111394521|NCT01118013|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110534551|NCT00894647|Imiquimod|imiquimod|mesh-list
111394522|NCT01118013|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111394523|NCT01118013|Antitubercular Agents|antitubercular agents|mesh-ancestor
111394524|NCT01118013|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111394525|NCT01118013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111394526|NCT01118013|Alkylating Agents|alkylating agents|mesh-ancestor
111394527|NCT01118013|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111394528|NCT01118013|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111394529|NCT00378027|PENTA|penta|mesh-list
111394530|NCT00378027|Fondaparinux|fondaparinux|mesh-list
111394531|NCT00378027|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111394532|NCT00378027|Antithrombins|antithrombins|mesh-ancestor
111394533|NCT00378027|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111394534|NCT00378027|Protease Inhibitors|protease inhibitors|mesh-ancestor
111394535|NCT00378027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111394536|NCT00378027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111394537|NCT00378027|Anticoagulants|anticoagulants|mesh-ancestor
111394538|NCT00378027|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111394539|NCT00378027|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111394540|NCT00552032|Mometasone Furoate|mometasone furoate|mesh-list
111394541|NCT00552032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111394542|NCT00552032|Dermatologic Agents|dermatologic agents|mesh-ancestor
111394543|NCT00552032|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111394544|NCT02429583|Vaccines|vaccines|mesh-list
111394545|NCT02429583|Immunologic Factors|immunologic factors|mesh-ancestor
111394546|NCT02429583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111394547|NCT02413047|Methotrexate|methotrexate|mesh-list
111394548|NCT02413047|Mercaptopurine|mercaptopurine|mesh-list
111394549|NCT02413047|Azathioprine|azathioprine|mesh-list
111394550|NCT02413047|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111394551|NCT02413047|Abortifacient Agents|abortifacient agents|mesh-ancestor
111394552|NCT02413047|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111394553|NCT02413047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111394554|NCT02413047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111394555|NCT02413047|Antimetabolites|antimetabolites|mesh-ancestor
111394556|NCT02413047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111394557|NCT02413047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111394558|NCT02413047|Dermatologic Agents|dermatologic agents|mesh-ancestor
111394559|NCT02413047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111394560|NCT02413047|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111394561|NCT02413047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111394562|NCT02413047|Immunologic Factors|immunologic factors|mesh-ancestor
111394563|NCT02413047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111394564|NCT02413047|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111394565|NCT02277548|Pregabalin|pregabalin|mesh-list
111394566|NCT02277548|Analgesics|analgesics|mesh-ancestor
111394567|NCT02277548|Sensory System Agents|sensory system agents|mesh-ancestor
111394568|NCT02277548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111394569|NCT02277548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111394570|NCT02277548|Anticonvulsants|anticonvulsants|mesh-ancestor
111394571|NCT02277548|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111394572|NCT02277548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110534600|NCT00633269|Olaparib|olaparib|mesh-list
111394573|NCT02277548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111394574|NCT02277548|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111394575|NCT02277548|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111394576|NCT02277548|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111394577|NCT02277548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111394578|NCT02277548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111394579|NCT02411643|Calcipotriene|calcipotriene|mesh-list
111394580|NCT02411643|Dermatologic Agents|dermatologic agents|mesh-ancestor
111394581|NCT01085643|Lubiprostone|lubiprostone|mesh-list
111394582|NCT01085643|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
111394583|NCT01085643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110534602|NCT00633269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111394584|NCT01085643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111394585|NCT03028766|Adavosertib|adavosertib|mesh-list
111394586|NCT03028766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111394587|NCT03028766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111394588|NCT01071993|Atorvastatin|atorvastatin|mesh-list
111394589|NCT01071993|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111394590|NCT01071993|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111394591|NCT01071993|Antimetabolites|antimetabolites|mesh-ancestor
111394592|NCT01071993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111394593|NCT01071993|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111394594|NCT01071993|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111394595|NCT01071993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111394596|NCT03756818|Paclitaxel|paclitaxel|mesh-list
111394597|NCT03756818|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111394598|NCT03756818|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
111394599|NCT03756818|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111394600|NCT03756818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111394601|NCT03756818|Tubulin Modulators|tubulin modulators|mesh-ancestor
111394602|NCT03756818|Antimitotic Agents|antimitotic agents|mesh-ancestor
111394603|NCT03756818|Mitosis Modulators|mitosis modulators|mesh-ancestor
111394604|NCT03756818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111394605|NCT03756818|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111394606|NCT03756818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111394607|NCT01065051|Riociguat|riociguat|mesh-list
111394608|NCT01065051|Enzyme Activators|enzyme activators|mesh-ancestor
111394609|NCT01065051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111394610|NCT02379585|Paclitaxel|paclitaxel|mesh-list
111394611|NCT02379585|Docetaxel|docetaxel|mesh-list
111394612|NCT02379585|Cyclophosphamide|cyclophosphamide|mesh-list
111394613|NCT02379585|Doxorubicin|doxorubicin|mesh-list
111394614|NCT02379585|Trastuzumab|trastuzumab|mesh-list
111394615|NCT02379585|Pertuzumab|pertuzumab|mesh-list
110472666|NCT04301024|Analgesics|analgesics|mesh-ancestor
111394616|NCT02379585|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111394617|NCT02379585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111394618|NCT02379585|Tubulin Modulators|tubulin modulators|mesh-ancestor
111394619|NCT02379585|Antimitotic Agents|antimitotic agents|mesh-ancestor
111394620|NCT02379585|Mitosis Modulators|mitosis modulators|mesh-ancestor
110871811|NCT04546620|Mitosis Modulators|mitosis modulators|mesh-ancestor
111394621|NCT02379585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111394622|NCT02379585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111394623|NCT02379585|Immunologic Factors|immunologic factors|mesh-ancestor
111394624|NCT02379585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111394625|NCT02379585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111394626|NCT02379585|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111394627|NCT02379585|Alkylating Agents|alkylating agents|mesh-ancestor
111394628|NCT02379585|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111394629|NCT02379585|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111394630|NCT02379585|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111394631|NCT02379585|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111394632|NCT02379585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111394633|NCT02379585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111394634|NCT01048125|Nitroprusside|nitroprusside|mesh-list
111394635|NCT01048125|Phenylephrine|phenylephrine|mesh-list
111394636|NCT01048125|Oxymetazoline|oxymetazoline|mesh-list
111394637|NCT01048125|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111394638|NCT01048125|Mydriatics|mydriatics|mesh-ancestor
111394639|NCT01048125|Autonomic Agents|autonomic agents|mesh-ancestor
111394640|NCT01048125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111394641|NCT01048125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111394642|NCT01048125|Sympathomimetics|sympathomimetics|mesh-ancestor
111394643|NCT01048125|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111394644|NCT01048125|Nasal Decongestants|nasal decongestants|mesh-ancestor
111394645|NCT01048125|Respiratory System Agents|respiratory system agents|mesh-ancestor
111394646|NCT01048125|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111394647|NCT01048125|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111394648|NCT01048125|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111394649|NCT01048125|Adrenergic Agents|adrenergic agents|mesh-ancestor
111394650|NCT01048125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111394651|NCT01048125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111394652|NCT01048125|Protective Agents|protective agents|mesh-ancestor
111394653|NCT01048125|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111394654|NCT01048125|Vasodilator Agents|vasodilator agents|mesh-ancestor
111394655|NCT01048125|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
111394656|NCT01901588|Dexmedetomidine|dexmedetomidine|mesh-list
111394657|NCT01901588|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111394658|NCT01901588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111394659|NCT01901588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111394660|NCT01901588|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111394661|NCT01901588|Analgesics|analgesics|mesh-ancestor
111394662|NCT01901588|Sensory System Agents|sensory system agents|mesh-ancestor
111394663|NCT01901588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110871859|NCT01381614|Sunitinib|sunitinib|mesh-list
111394664|NCT01901588|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111394665|NCT01901588|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111394666|NCT01901588|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111394667|NCT01901588|Adrenergic Agents|adrenergic agents|mesh-ancestor
111394668|NCT01901588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111394669|NCT01901588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111394670|NCT03673124|Letrozole|letrozole|mesh-list
111394671|NCT03673124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111394672|NCT03673124|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111394673|NCT03673124|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111394674|NCT03673124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111394675|NCT03673124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110871871|NCT01381536|Belimumab|belimumab|mesh-list
111394676|NCT03673124|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111394677|NCT03673124|Hormone Antagonists|hormone antagonists|mesh-ancestor
111394678|NCT03673124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111394679|NCT03673124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111394680|NCT01025271|Daptomycin|daptomycin|mesh-list
111394681|NCT01025271|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111394682|NCT01025271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111394683|NCT01902758|Ambrisentan|ambrisentan|mesh-list
111394684|NCT01902758|Theophylline|theophylline|mesh-list
111394685|NCT01902758|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111394686|NCT01902758|Autonomic Agents|autonomic agents|mesh-ancestor
111394687|NCT01902758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111394688|NCT01902758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111394689|NCT01902758|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111394690|NCT01902758|Respiratory System Agents|respiratory system agents|mesh-ancestor
111394691|NCT01902758|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111394692|NCT01902758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111394693|NCT01902758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111394694|NCT01902758|Vasodilator Agents|vasodilator agents|mesh-ancestor
111394695|NCT01902758|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
111394696|NCT01902758|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111394697|NCT01902758|Purinergic Agents|purinergic agents|mesh-ancestor
111394698|NCT01902758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111394699|NCT01902758|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111394700|NCT01020903|Aprepitant|aprepitant|mesh-list
111394701|NCT01020903|Antiemetics|antiemetics|mesh-ancestor
111394702|NCT01020903|Autonomic Agents|autonomic agents|mesh-ancestor
111394703|NCT01020903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111394704|NCT01020903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111394705|NCT01020903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111394706|NCT01020903|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
111394707|NCT01020903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111394708|NCT01020903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111394709|NCT02318901|Pembrolizumab|pembrolizumab|mesh-list
111394710|NCT02318901|Trastuzumab|trastuzumab|mesh-list
111394711|NCT02318901|Cetuximab|cetuximab|mesh-list
111394712|NCT02318901|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
111394713|NCT02318901|Maytansine|maytansine|mesh-list
111394714|NCT02318901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111394715|NCT02318901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111394716|NCT02318901|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111394717|NCT02318901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111394718|NCT02318901|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111394719|NCT02318901|Tubulin Modulators|tubulin modulators|mesh-ancestor
111394720|NCT02318901|Antimitotic Agents|antimitotic agents|mesh-ancestor
111394721|NCT02318901|Mitosis Modulators|mitosis modulators|mesh-ancestor
111394722|NCT02318901|Immunotoxins|immunotoxins|mesh-ancestor
111394723|NCT02318901|Immunoconjugates|immunoconjugates|mesh-ancestor
111394724|NCT02318901|Immunologic Factors|immunologic factors|mesh-ancestor
111394725|NCT02318901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111394726|NCT01904864|Iron|iron|mesh-list
111394727|NCT01904864|Micronutrients|micronutrients|mesh-ancestor
111394728|NCT01904864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111394729|NCT01904864|Trace Elements|trace elements|mesh-ancestor
111394730|NCT01016847|Montelukast|montelukast|mesh-list
111394731|NCT01016847|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111394732|NCT01016847|Respiratory System Agents|respiratory system agents|mesh-ancestor
111394733|NCT01016847|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
111394734|NCT01016847|Hormone Antagonists|hormone antagonists|mesh-ancestor
111394735|NCT01016847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111394736|NCT01016847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111394737|NCT01016847|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
111394738|NCT01016847|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111394739|NCT01016847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111394740|NCT00989937|Oxytocin|oxytocin|mesh-list
111394741|NCT00989937|Oxytocics|oxytocics|mesh-ancestor
111394742|NCT00989937|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111394743|NCT00989937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111394744|NCT00982995|Palonosetron|palonosetron|mesh-list
111394745|NCT00982995|Antiemetics|antiemetics|mesh-ancestor
111394746|NCT00982995|Autonomic Agents|autonomic agents|mesh-ancestor
111394747|NCT00982995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111394748|NCT00982995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111394749|NCT00982995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111394750|NCT00982995|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111394751|NCT00982995|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111394752|NCT00982995|Serotonin Agents|serotonin agents|mesh-ancestor
111394753|NCT00982995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110871947|NCT03631134|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111394754|NCT00982995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111394755|NCT00965055|Atorvastatin|atorvastatin|mesh-list
111394756|NCT00965055|Ezetimibe|ezetimibe|mesh-list
111394757|NCT00965055|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111394758|NCT00965055|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111394759|NCT00965055|Antimetabolites|antimetabolites|mesh-ancestor
111394760|NCT00965055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111394761|NCT00965055|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111394762|NCT00965055|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111394763|NCT00965055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111394764|NCT02266797|Dexamethasone|dexamethasone|mesh-list
111394765|NCT02266797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111394766|NCT02266797|Antiemetics|antiemetics|mesh-ancestor
111394767|NCT02266797|Autonomic Agents|autonomic agents|mesh-ancestor
111394768|NCT02266797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111394769|NCT02266797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111394770|NCT02266797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111394771|NCT02266797|Glucocorticoids|glucocorticoids|mesh-ancestor
111394772|NCT02266797|Hormones|hormones|mesh-ancestor
111394773|NCT02266797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111394774|NCT02266797|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111394775|NCT02266797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111394776|NCT00378183|Risperidone|risperidone|mesh-list
111394777|NCT00378183|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111394778|NCT00378183|Serotonin Agents|serotonin agents|mesh-ancestor
111394779|NCT00378183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111394780|NCT00378183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111394781|NCT00378183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111394782|NCT00378183|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111394783|NCT00378183|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111394784|NCT00378183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111394785|NCT00378183|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110473322|NCT02845986|Oxaliplatin|oxaliplatin|mesh-list
111394786|NCT00378183|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111394787|NCT00378183|Dopamine Agents|dopamine agents|mesh-ancestor
111394788|NCT01906658|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
111394789|NCT01906658|Hormones|hormones|mesh-ancestor
111394790|NCT01906658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111394791|NCT01906658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111394792|NCT01908062|Naltrexone|naltrexone|mesh-list
111394793|NCT01908062|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111394794|NCT01908062|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111394795|NCT01908062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111394796|NCT01908062|Sensory System Agents|sensory system agents|mesh-ancestor
111394797|NCT01908062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111394798|NCT00924807|Sorafenib|sorafenib|mesh-list
111394799|NCT00924807|Leuprolide|leuprolide|mesh-list
111394800|NCT00924807|Bicalutamide|bicalutamide|mesh-list
111394801|NCT00924807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111394802|NCT00924807|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111394803|NCT00924807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110871989|NCT03668054|Growth Substances|growth substances|mesh-ancestor
111394804|NCT00924807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111394805|NCT00924807|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111394806|NCT00924807|Fertility Agents|fertility agents|mesh-ancestor
111119139|NCT05339087|Riociguat|riociguat|mesh-list
111394807|NCT00924807|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111394808|NCT00924807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111394809|NCT00924807|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111394810|NCT00924807|Androgen Antagonists|androgen antagonists|mesh-ancestor
111394811|NCT00924807|Hormone Antagonists|hormone antagonists|mesh-ancestor
111394812|NCT00924807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111394813|NCT00896025|Acetylcysteine|acetylcysteine|mesh-list
111394814|NCT00896025|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111394815|NCT00896025|Antiviral Agents|antiviral agents|mesh-ancestor
111394816|NCT00896025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111394817|NCT00896025|Expectorants|expectorants|mesh-ancestor
111394818|NCT00896025|Respiratory System Agents|respiratory system agents|mesh-ancestor
111394819|NCT00896025|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111394820|NCT00896025|Antioxidants|antioxidants|mesh-ancestor
111394821|NCT00896025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111394822|NCT00896025|Protective Agents|protective agents|mesh-ancestor
111394823|NCT00896025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111394824|NCT00896025|Antidotes|antidotes|mesh-ancestor
111394825|NCT02162979|Sildenafil Citrate|sildenafil citrate|mesh-list
110872011|NCT03638401|Narcotics|narcotics|mesh-ancestor
111394826|NCT02162979|Vasodilator Agents|vasodilator agents|mesh-ancestor
111394827|NCT02162979|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111394828|NCT02162979|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111394829|NCT02162979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111394830|NCT02162979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111394831|NCT02162979|Urological Agents|urological agents|mesh-ancestor
111394832|NCT03734601|Mycophenolic Acid|mycophenolic acid|mesh-list
111394833|NCT03734601|Tacrolimus|tacrolimus|mesh-list
111394834|NCT03734601|Antilymphocyte Serum|antilymphocyte serum|mesh-list
111394835|NCT03734601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111394836|NCT03734601|Immunologic Factors|immunologic factors|mesh-ancestor
111394837|NCT03734601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111394838|NCT03734601|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111394839|NCT03734601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111394840|NCT03734601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111394841|NCT03734601|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111394842|NCT03734601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111394843|NCT03734601|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111394844|NCT03734601|Antitubercular Agents|antitubercular agents|mesh-ancestor
111394845|NCT03734601|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111394846|NCT03734601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111394847|NCT01908842|Buprenorphine|buprenorphine|mesh-list
111394848|NCT01908842|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111394849|NCT01908842|Narcotics|narcotics|mesh-ancestor
111394850|NCT01908842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111394851|NCT01908842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111394852|NCT01908842|Analgesics|analgesics|mesh-ancestor
111394853|NCT01908842|Sensory System Agents|sensory system agents|mesh-ancestor
111394854|NCT01908842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111394855|NCT01908842|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111394856|NCT00833859|Gemcitabine|gemcitabine|mesh-list
111394857|NCT00833859|Capecitabine|capecitabine|mesh-list
111394858|NCT00833859|Docetaxel|docetaxel|mesh-list
111394859|NCT00833859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111394860|NCT00833859|Antimetabolites|antimetabolites|mesh-ancestor
111394861|NCT00833859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111394862|NCT00833859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111394863|NCT00833859|Tubulin Modulators|tubulin modulators|mesh-ancestor
111394864|NCT00833859|Antimitotic Agents|antimitotic agents|mesh-ancestor
111394865|NCT00833859|Mitosis Modulators|mitosis modulators|mesh-ancestor
111394866|NCT00832299|Leucovorin|leucovorin|mesh-list
111394867|NCT00832299|Fluorouracil|fluorouracil|mesh-list
111394868|NCT00832299|Oxaliplatin|oxaliplatin|mesh-list
111394869|NCT00832299|Antimetabolites|antimetabolites|mesh-ancestor
111394870|NCT00832299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111394871|NCT00832299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111394872|NCT00832299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111394873|NCT00832299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111394874|NCT00832299|Immunologic Factors|immunologic factors|mesh-ancestor
111394875|NCT00832299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111394876|NCT00832299|Antidotes|antidotes|mesh-ancestor
111394877|NCT00832299|Protective Agents|protective agents|mesh-ancestor
111394878|NCT00832299|Vitamin B Complex|vitamin b complex|mesh-ancestor
111394879|NCT00832299|Vitamins|vitamins|mesh-ancestor
111394880|NCT00832299|Micronutrients|micronutrients|mesh-ancestor
110872068|NCT02942407|Warfarin|warfarin|mesh-list
111394881|NCT03723447|Dexamethasone|dexamethasone|mesh-list
111394882|NCT03723447|Epinephrine|epinephrine|mesh-list
111394883|NCT03723447|Bupivacaine|bupivacaine|mesh-list
111394884|NCT03723447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111394885|NCT03723447|Antiemetics|antiemetics|mesh-ancestor
111394886|NCT03723447|Autonomic Agents|autonomic agents|mesh-ancestor
111394887|NCT03723447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111394888|NCT03723447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111394889|NCT03723447|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111394890|NCT03723447|Glucocorticoids|glucocorticoids|mesh-ancestor
111394891|NCT03723447|Hormones|hormones|mesh-ancestor
111394892|NCT03723447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110872087|NCT03667352|Fentanyl|fentanyl|mesh-list
111394893|NCT03723447|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111394894|NCT03723447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111394895|NCT03723447|Anesthetics, Local|anesthetics, local|mesh-ancestor
111394896|NCT03723447|Anesthetics|anesthetics|mesh-ancestor
111394897|NCT03723447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111394898|NCT03723447|Sensory System Agents|sensory system agents|mesh-ancestor
110473911|NCT02776059|Hormones|hormones|mesh-ancestor
111394899|NCT03723447|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111394900|NCT03723447|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111394901|NCT03723447|Adrenergic Agents|adrenergic agents|mesh-ancestor
111394902|NCT03723447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111394903|NCT03723447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111394904|NCT03723447|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111394905|NCT03723447|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111394906|NCT03723447|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111394907|NCT03723447|Respiratory System Agents|respiratory system agents|mesh-ancestor
111394908|NCT03723447|Mydriatics|mydriatics|mesh-ancestor
111394909|NCT03723447|Sympathomimetics|sympathomimetics|mesh-ancestor
110872102|NCT03320941|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111394910|NCT03723447|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111394911|NCT00836355|Minocycline|minocycline|mesh-list
111394912|NCT00836355|Enoxaparin|enoxaparin|mesh-list
111394913|NCT00836355|Anticoagulants|anticoagulants|mesh-ancestor
111394914|NCT00836355|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111394915|NCT00836355|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111394916|NCT00836355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111394917|NCT00836355|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111394918|NCT00836355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111394919|NCT00816777|Irinotecan|irinotecan|mesh-list
111394920|NCT00816777|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111394921|NCT00816777|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111394922|NCT00816777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111394923|NCT00816777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111394924|NCT00816777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111394925|NCT00823095|Nitric Oxide|nitric oxide|mesh-list
111394926|NCT00823095|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111394927|NCT00823095|Autonomic Agents|autonomic agents|mesh-ancestor
111394928|NCT00823095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111394929|NCT00823095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111394930|NCT00823095|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111394931|NCT00823095|Respiratory System Agents|respiratory system agents|mesh-ancestor
111394932|NCT00823095|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111394933|NCT00823095|Antioxidants|antioxidants|mesh-ancestor
111394934|NCT00823095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111394935|NCT00823095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111394936|NCT00823095|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
111394937|NCT00823095|Vasodilator Agents|vasodilator agents|mesh-ancestor
111394938|NCT00823095|Gasotransmitters|gasotransmitters|mesh-ancestor
111394939|NCT00823095|Protective Agents|protective agents|mesh-ancestor
111394940|NCT00803283|Morphine|morphine|mesh-list
111394941|NCT00803283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111394942|NCT00803283|Narcotics|narcotics|mesh-ancestor
111394943|NCT00803283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111394944|NCT00803283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111394945|NCT00803283|Analgesics|analgesics|mesh-ancestor
111394946|NCT00803283|Sensory System Agents|sensory system agents|mesh-ancestor
111394947|NCT00803283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111394948|NCT03701295|Azacitidine|azacitidine|mesh-list
111394949|NCT03701295|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111394950|NCT03701295|Antimetabolites|antimetabolites|mesh-ancestor
111394951|NCT03701295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111394952|NCT03701295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111394953|NCT03701295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111394954|NCT00799773|Rituximab|rituximab|mesh-list
111394955|NCT00799773|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111394956|NCT00799773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111394957|NCT00799773|Immunologic Factors|immunologic factors|mesh-ancestor
111394958|NCT00799773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111394959|NCT00799773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111394960|NCT00760461|Domperidone|domperidone|mesh-list
111394961|NCT00760461|Antiemetics|antiemetics|mesh-ancestor
111394962|NCT00760461|Autonomic Agents|autonomic agents|mesh-ancestor
111394963|NCT00760461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111394964|NCT00760461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111394965|NCT00760461|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111394966|NCT00760461|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111394967|NCT00760461|Dopamine Agents|dopamine agents|mesh-ancestor
111394968|NCT00760461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111394969|NCT00760461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110474309|NCT02767635|Hormones|hormones|mesh-ancestor
111394970|NCT00750555|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111394971|NCT00750555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111394972|NCT00750555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111394973|NCT00750555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111394974|NCT00750555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111394975|NCT01941615|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
111394976|NCT01941615|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
110872179|NCT01380912|Hormones|hormones|mesh-ancestor
111394977|NCT01941615|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111394978|NCT01941615|Contraceptive Agents|contraceptive agents|mesh-ancestor
111394979|NCT01941615|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111394980|NCT01941615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111394981|NCT01941615|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
111394982|NCT01941615|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111394983|NCT01941615|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111394984|NCT01941615|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111394985|NCT01941615|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111394986|NCT01941615|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
110474398|NCT04091815|Anesthetics|anesthetics|mesh-list
111394987|NCT01941615|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
111394988|NCT01941615|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
111394989|NCT01901679|Celecoxib|celecoxib|mesh-list
111394990|NCT01901679|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111394991|NCT01901679|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111394992|NCT01901679|Analgesics|analgesics|mesh-ancestor
111394993|NCT01901679|Sensory System Agents|sensory system agents|mesh-ancestor
111394994|NCT01901679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111394995|NCT01901679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111394996|NCT01901679|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111394997|NCT01901679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111394998|NCT01901679|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111394999|NCT01901679|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111395000|NCT01901679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111395001|NCT01901679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111395002|NCT00688935|Melatonin|melatonin|mesh-list
111395003|NCT00688935|Antioxidants|antioxidants|mesh-ancestor
110872200|NCT01569204|Cyclophosphamide|cyclophosphamide|mesh-list
111395004|NCT00688935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111395005|NCT00688935|Protective Agents|protective agents|mesh-ancestor
111395006|NCT00688935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111395007|NCT00688935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111395008|NCT00684255|Fludarabine|fludarabine|mesh-list
111395009|NCT00684255|Busulfan|busulfan|mesh-list
111395010|NCT00684255|Alemtuzumab|alemtuzumab|mesh-list
111395011|NCT00684255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111395012|NCT00684255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111395013|NCT00684255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111395014|NCT00684255|Immunologic Factors|immunologic factors|mesh-ancestor
111395015|NCT00684255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111395016|NCT00684255|Alkylating Agents|alkylating agents|mesh-ancestor
111395017|NCT00684255|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111395018|NCT00684255|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111395019|NCT00684255|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111395020|NCT00668265|Quetiapine Fumarate|quetiapine fumarate|mesh-list
111395021|NCT00668265|Antidepressive Agents|antidepressive agents|mesh-ancestor
111395022|NCT00668265|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111395023|NCT00668265|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111395024|NCT00668265|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111395025|NCT00668265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111395026|NCT00668265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111395027|NCT01856361|Ramipril|ramipril|mesh-list
111395028|NCT01856361|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
111395029|NCT01856361|Protease Inhibitors|protease inhibitors|mesh-ancestor
111119366|NCT05088252|Propofol|propofol|mesh-list
111395030|NCT01856361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110872223|NCT01569204|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111395031|NCT01856361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111395032|NCT01856361|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111395033|NCT00642603|Bevacizumab|bevacizumab|mesh-list
111395034|NCT00642603|Capecitabine|capecitabine|mesh-list
111395035|NCT00642603|Oxaliplatin|oxaliplatin|mesh-list
111395036|NCT00642603|Irinotecan|irinotecan|mesh-list
111395037|NCT00642603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111395038|NCT00642603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110872238|NCT04439890|Carboplatin|carboplatin|mesh-list
111395039|NCT00642603|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111395040|NCT00642603|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111395041|NCT00642603|Growth Substances|growth substances|mesh-ancestor
111395042|NCT00642603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111395043|NCT00642603|Growth Inhibitors|growth inhibitors|mesh-ancestor
111395044|NCT00642603|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111395045|NCT00642603|Antimetabolites|antimetabolites|mesh-ancestor
111395046|NCT00642603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111395047|NCT00642603|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110872245|NCT02324725|Naltrexone|naltrexone|mesh-list
111395048|NCT00642603|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111395049|NCT00642603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111395050|NCT01841931|Buprenorphine|buprenorphine|mesh-list
111395051|NCT01841931|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
111395052|NCT01841931|Naloxone|naloxone|mesh-list
111395053|NCT01841931|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111395054|NCT01841931|Narcotics|narcotics|mesh-ancestor
111395055|NCT01841931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111395056|NCT01841931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111395057|NCT01841931|Analgesics|analgesics|mesh-ancestor
111395058|NCT01841931|Sensory System Agents|sensory system agents|mesh-ancestor
111395059|NCT01841931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111395060|NCT01841931|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111395061|NCT00633087|Deoxyglucose|deoxyglucose|mesh-list
111395062|NCT00633087|Antimetabolites|antimetabolites|mesh-ancestor
111395063|NCT00633087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111395064|NCT00633087|Antiviral Agents|antiviral agents|mesh-ancestor
111395065|NCT00633087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111395066|NCT04713891|Atezolizumab|atezolizumab|mesh-list
111395067|NCT04713891|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111395068|NCT04713891|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111395069|NCT04713891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111395070|NCT04713891|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111395071|NCT04713891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111395072|NCT04713891|Immunologic Factors|immunologic factors|mesh-ancestor
111395073|NCT04713891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111395074|NCT00379509|Lapatinib|lapatinib|mesh-list
111395075|NCT00379509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111395076|NCT00379509|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111395077|NCT00379509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111395078|NCT00379509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111395079|NCT04706247|Anesthetics|anesthetics|mesh-list
111395080|NCT04706247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111395081|NCT04706247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111395082|NCT00597909|Sodium Benzoate|sodium benzoate|mesh-list
111395083|NCT00597909|Phenylacetic acid|phenylacetic acid|mesh-list
111395084|NCT00597909|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111395085|NCT00597909|Antimetabolites|antimetabolites|mesh-ancestor
111395086|NCT00597909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111395087|NCT00597909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110872289|NCT05675644|Diuretics|diuretics|mesh-ancestor
111395088|NCT00597909|Antifungal Agents|antifungal agents|mesh-ancestor
111395089|NCT00597909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111395090|NCT00422955|Rosiglitazone|rosiglitazone|mesh-list
111395091|NCT00422955|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111395092|NCT00422955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111395093|NCT00588471|Simvastatin|simvastatin|mesh-list
111395094|NCT00588471|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111395095|NCT00588471|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111395096|NCT00588471|Antimetabolites|antimetabolites|mesh-ancestor
111395097|NCT00588471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111395098|NCT00588471|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111395099|NCT00588471|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110872301|NCT03525379|Resveratrol|resveratrol|mesh-list
111395100|NCT00588471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111395101|NCT05600673|Bimatoprost|bimatoprost|mesh-list
111395102|NCT05600673|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111395103|NCT01784991|Morphine|morphine|mesh-list
111119449|NCT04995978|Pioglitazone|pioglitazone|mesh-list
111395104|NCT01784991|Hydromorphone|hydromorphone|mesh-list
111395105|NCT01784991|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111395106|NCT01784991|Narcotics|narcotics|mesh-ancestor
111395107|NCT01784991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111395108|NCT01784991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111395109|NCT01784991|Analgesics|analgesics|mesh-ancestor
111395110|NCT01784991|Sensory System Agents|sensory system agents|mesh-ancestor
111395111|NCT01784991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111395112|NCT01760889|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
111395113|NCT01760889|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111395114|NCT01760889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111395115|NCT01760889|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111395116|NCT01760889|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111395117|NCT01760889|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111395118|NCT01760889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111395119|NCT01760889|Dopamine Agents|dopamine agents|mesh-ancestor
111395120|NCT01760889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111395121|NCT05600517|Fluorides|fluorides|mesh-list
111395122|NCT05600517|Cariostatic Agents|cariostatic agents|mesh-ancestor
111395123|NCT05600517|Protective Agents|protective agents|mesh-ancestor
111395124|NCT05600517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111395125|NCT01745913|Fludarabine|fludarabine|mesh-list
111395126|NCT01745913|Melphalan|melphalan|mesh-list
111395127|NCT01745913|Thymoglobulin|thymoglobulin|mesh-list
111395128|NCT01745913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111395129|NCT01745913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111395130|NCT01745913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111395131|NCT01745913|Immunologic Factors|immunologic factors|mesh-ancestor
111395132|NCT01745913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111395133|NCT01745913|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111395134|NCT01745913|Alkylating Agents|alkylating agents|mesh-ancestor
111395135|NCT01745913|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111395136|NCT01691079|Bromides|bromides|mesh-list
111395137|NCT01691079|Ipratropium|ipratropium|mesh-list
111395138|NCT01691079|Anticonvulsants|anticonvulsants|mesh-ancestor
111395139|NCT01691079|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111395140|NCT01691079|Autonomic Agents|autonomic agents|mesh-ancestor
111395141|NCT01691079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111395142|NCT01691079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111395143|NCT01691079|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111395144|NCT01691079|Respiratory System Agents|respiratory system agents|mesh-ancestor
111395145|NCT01691079|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111395146|NCT01691079|Cholinergic Agents|cholinergic agents|mesh-ancestor
111395147|NCT01691079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111395148|NCT01691079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111395149|NCT01673061|Lidocaine|lidocaine|mesh-list
111395150|NCT01673061|Epinephrine|epinephrine|mesh-list
111395151|NCT01673061|Norflurane|norflurane|mesh-list
111395152|NCT01673061|Anesthetics, Local|anesthetics, local|mesh-ancestor
111395153|NCT01673061|Anesthetics|anesthetics|mesh-ancestor
111395154|NCT01673061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111395155|NCT01673061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111395156|NCT01673061|Sensory System Agents|sensory system agents|mesh-ancestor
111395157|NCT01673061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111395158|NCT01673061|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111395159|NCT01673061|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111395160|NCT01673061|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111395161|NCT01673061|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111395162|NCT01673061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111395163|NCT01673061|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111395164|NCT01673061|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110203044|NCT00051389|Fosinopril|fosinopril|mesh-list
111395165|NCT01673061|Adrenergic Agents|adrenergic agents|mesh-ancestor
111395166|NCT01673061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111395167|NCT01673061|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111395168|NCT01673061|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111395169|NCT01673061|Autonomic Agents|autonomic agents|mesh-ancestor
111395170|NCT01673061|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111395171|NCT01673061|Respiratory System Agents|respiratory system agents|mesh-ancestor
111395172|NCT01673061|Mydriatics|mydriatics|mesh-ancestor
111395173|NCT01673061|Sympathomimetics|sympathomimetics|mesh-ancestor
111395174|NCT01673061|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111395175|NCT05599347|Azithromycin|azithromycin|mesh-list
111395176|NCT05599347|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111395177|NCT05599347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111395178|NCT01621737|Oxytocin|oxytocin|mesh-list
111119527|NCT04900220|Hormones|hormones|mesh-ancestor
111395179|NCT01621737|Oxytocics|oxytocics|mesh-ancestor
111395180|NCT01621737|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111395181|NCT01621737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111395182|NCT00379665|Cisplatin|cisplatin|mesh-list
111395183|NCT00379665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111395184|NCT00357383|Azithromycin|azithromycin|mesh-list
111395185|NCT00357383|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111395186|NCT00357383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111395187|NCT01598025|Fludarabine|fludarabine|mesh-list
111395188|NCT01598025|Fludarabine phosphate|fludarabine phosphate|mesh-list
111395189|NCT01598025|Melphalan|melphalan|mesh-list
111395190|NCT01598025|Thiotepa|thiotepa|mesh-list
111395191|NCT01598025|Antilymphocyte Serum|antilymphocyte serum|mesh-list
111395192|NCT01598025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111395193|NCT01598025|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111395194|NCT01598025|Antimetabolites|antimetabolites|mesh-ancestor
111395195|NCT01598025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111395196|NCT01598025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111395197|NCT01598025|Immunologic Factors|immunologic factors|mesh-ancestor
111395198|NCT01598025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111395199|NCT01598025|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111395200|NCT01598025|Alkylating Agents|alkylating agents|mesh-ancestor
111395201|NCT01598025|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111395202|NCT01587963|Ascorbic Acid|ascorbic acid|mesh-list
111395203|NCT01587963|Antioxidants|antioxidants|mesh-ancestor
111395204|NCT01587963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111395205|NCT01587963|Protective Agents|protective agents|mesh-ancestor
111395206|NCT01587963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111395207|NCT01587963|Vitamins|vitamins|mesh-ancestor
111395208|NCT01587963|Micronutrients|micronutrients|mesh-ancestor
111395209|NCT01648751|Estrogens|estrogens|mesh-list
111395210|NCT01648751|Hormones|hormones|mesh-ancestor
111395211|NCT01648751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111395212|NCT01648751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111395213|NCT05550519|Tenofovir|tenofovir|mesh-list
111395214|NCT05550519|Entecavir|entecavir|mesh-list
111395215|NCT05550519|Antiviral Agents|antiviral agents|mesh-ancestor
111395216|NCT05550519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111395217|NCT05550519|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111395218|NCT05550519|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111395219|NCT05550519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111395220|NCT05550519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111395221|NCT05550519|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111395222|NCT05550519|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111395223|NCT01203371|Naftopidil|naftopidil|mesh-list
111395224|NCT01203371|Tamsulosin|tamsulosin|mesh-list
111395225|NCT01203371|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111395226|NCT01203371|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111395227|NCT01203371|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111395228|NCT01203371|Adrenergic Agents|adrenergic agents|mesh-ancestor
111395229|NCT01203371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111395230|NCT01203371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111395231|NCT01203371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111395232|NCT01203371|Urological Agents|urological agents|mesh-ancestor
111395233|NCT01203371|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111395234|NCT01203371|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111395235|NCT01203371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111395236|NCT01203371|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111395237|NCT01203371|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111395238|NCT01549977|Febuxostat|febuxostat|mesh-list
111395239|NCT01549977|Gout Suppressants|gout suppressants|mesh-ancestor
111395240|NCT01549977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111395241|NCT00357617|Celecoxib|celecoxib|mesh-list
111395242|NCT00357617|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111395243|NCT00357617|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111395244|NCT00357617|Analgesics|analgesics|mesh-ancestor
111395245|NCT00357617|Sensory System Agents|sensory system agents|mesh-ancestor
110872429|NCT01380288|Rivastigmine|rivastigmine|mesh-list
111395246|NCT00357617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111395247|NCT00357617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111395248|NCT00357617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111395249|NCT00357617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111395250|NCT00357617|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111395251|NCT00357617|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111119596|NCT04865042|Anticonvulsants|anticonvulsants|mesh-ancestor
111395252|NCT00357617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111395253|NCT00357617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111395254|NCT01548651|Saxagliptin|saxagliptin|mesh-list
111395255|NCT01548651|Incretins|incretins|mesh-ancestor
111395257|NCT01548651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111395258|NCT01548651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111395259|NCT01548651|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111395260|NCT01548651|Protease Inhibitors|protease inhibitors|mesh-ancestor
111395261|NCT01548651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111395262|NCT01548651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111395263|NCT01548651|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111395264|NCT01533753|Gabapentin|gabapentin|mesh-list
111395265|NCT01533753|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
111395266|NCT01533753|Analgesics|analgesics|mesh-ancestor
111395267|NCT01533753|Sensory System Agents|sensory system agents|mesh-ancestor
111395268|NCT01533753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111395269|NCT01533753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111395270|NCT01533753|Anticonvulsants|anticonvulsants|mesh-ancestor
111395271|NCT01533753|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111395272|NCT01533753|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111395273|NCT01533753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111395274|NCT01533753|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110872480|NCT05422716|GABA Agonists|gaba agonists|mesh-ancestor
111395275|NCT01533753|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111395276|NCT01533753|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111395277|NCT01533753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111395278|NCT01533753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111395279|NCT01533753|Antimanic Agents|antimanic agents|mesh-ancestor
111395280|NCT01533753|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111395281|NCT01533753|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111395282|NCT01533753|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111395283|NCT01533753|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111395284|NCT01533753|Antidepressive Agents|antidepressive agents|mesh-ancestor
111395285|NCT05722301|Methyltestosterone|methyltestosterone|mesh-list
111395286|NCT05722301|Testosterone|testosterone|mesh-list
111395287|NCT05722301|Testosterone undecanoate|testosterone undecanoate|mesh-list
111395288|NCT05722301|Testosterone enanthate|testosterone enanthate|mesh-list
111395289|NCT05722301|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
111395290|NCT05722301|Androgens|androgens|mesh-ancestor
111395291|NCT05722301|Hormones|hormones|mesh-ancestor
111395292|NCT05722301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111395293|NCT05722301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110872494|NCT05421936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111395294|NCT05722301|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111395295|NCT05722301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111395296|NCT05722301|Anabolic Agents|anabolic agents|mesh-ancestor
111395297|NCT01534143|Sirolimus|sirolimus|mesh-list
111395298|NCT01534143|Fludarabine|fludarabine|mesh-list
111395299|NCT01534143|Fludarabine phosphate|fludarabine phosphate|mesh-list
111395300|NCT01534143|Bortezomib|bortezomib|mesh-list
111395301|NCT01534143|Busulfan|busulfan|mesh-list
111395302|NCT01534143|Tacrolimus|tacrolimus|mesh-list
111395303|NCT01534143|Thymoglobulin|thymoglobulin|mesh-list
111395304|NCT01534143|Antilymphocyte Serum|antilymphocyte serum|mesh-list
111395305|NCT01534143|Immunoglobulins|immunoglobulins|mesh-list
111395306|NCT01534143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111395307|NCT01534143|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111395308|NCT01534143|Antimetabolites|antimetabolites|mesh-ancestor
111395309|NCT01534143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111395310|NCT01534143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111395311|NCT01534143|Immunologic Factors|immunologic factors|mesh-ancestor
111395312|NCT01534143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111395313|NCT01534143|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111395314|NCT01534143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111395315|NCT01534143|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111395316|NCT01534143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111395317|NCT01534143|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111395318|NCT01534143|Antifungal Agents|antifungal agents|mesh-ancestor
111395319|NCT01534143|Alkylating Agents|alkylating agents|mesh-ancestor
111395320|NCT01534143|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111395321|NCT01534143|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111395322|NCT05722067|Calcium|calcium|mesh-list
111395323|NCT05722067|Ionophores|ionophores|mesh-list
111395324|NCT05722067|Calcium Ionophores|calcium ionophores|mesh-list
111395325|NCT05722067|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111395326|NCT05722067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111395327|NCT05722067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111119671|NCT04664023|Vaccines|vaccines|mesh-list
111395328|NCT05722067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111395329|NCT01692171|Heparin|heparin|mesh-list
111395330|NCT01692171|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
111395331|NCT01692171|Tinzaparin|tinzaparin|mesh-list
111395332|NCT01692171|Dalteparin|dalteparin|mesh-list
111395333|NCT01692171|Anticoagulants|anticoagulants|mesh-ancestor
111395334|NCT01692171|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111395335|NCT01692171|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111395336|NCT01692171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111395337|NCT05723315|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
111395338|NCT05723315|Natriuretic Agents|natriuretic agents|mesh-ancestor
111395339|NCT05723315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111395340|NCT00570531|Paclitaxel|paclitaxel|mesh-list
111395341|NCT00570531|Bevacizumab|bevacizumab|mesh-list
110872505|NCT03725423|Apatinib|apatinib|mesh-list
111395342|NCT00570531|Fluorouracil|fluorouracil|mesh-list
111395343|NCT00570531|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111395344|NCT00570531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111395345|NCT00570531|Tubulin Modulators|tubulin modulators|mesh-ancestor
111395346|NCT00570531|Antimitotic Agents|antimitotic agents|mesh-ancestor
111395347|NCT00570531|Mitosis Modulators|mitosis modulators|mesh-ancestor
111395348|NCT00570531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111395349|NCT00570531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111395350|NCT00570531|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111395351|NCT00570531|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111395352|NCT00570531|Growth Substances|growth substances|mesh-ancestor
111395353|NCT00570531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111395354|NCT00570531|Growth Inhibitors|growth inhibitors|mesh-ancestor
111395355|NCT00570531|Antimetabolites|antimetabolites|mesh-ancestor
111395356|NCT00570531|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111395357|NCT00570531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111395358|NCT00570531|Immunologic Factors|immunologic factors|mesh-ancestor
111395359|NCT05258565|Plasminogen|plasminogen|mesh-list
111395360|NCT05258565|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
111395361|NCT05258565|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111395362|NCT05258565|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111395363|NCT05258565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111395364|NCT05715437|Ketamine|ketamine|mesh-list
111395365|NCT05715437|Bupivacaine|bupivacaine|mesh-list
111395366|NCT05715437|Anesthetics, Local|anesthetics, local|mesh-ancestor
111395367|NCT05715437|Anesthetics|anesthetics|mesh-ancestor
111395368|NCT05715437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111395369|NCT05715437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111395370|NCT05715437|Sensory System Agents|sensory system agents|mesh-ancestor
111395371|NCT05715437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111395372|NCT05715437|Analgesics|analgesics|mesh-ancestor
111395373|NCT05715437|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111395374|NCT05715437|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111395375|NCT05715437|Anesthetics, General|anesthetics, general|mesh-ancestor
111395376|NCT05715437|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111395377|NCT05715437|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111395378|NCT05715437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111395379|NCT05715437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111395380|NCT05721443|Cetuximab|cetuximab|mesh-list
111395381|NCT05721443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111395382|NCT05721443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111395383|NCT00523809|Bevacizumab|bevacizumab|mesh-list
111395384|NCT00523809|Fludarabine|fludarabine|mesh-list
111395385|NCT00523809|Fludarabine phosphate|fludarabine phosphate|mesh-list
111395386|NCT00523809|Melphalan|melphalan|mesh-list
111395387|NCT00523809|Thymoglobulin|thymoglobulin|mesh-list
111395388|NCT00523809|Antilymphocyte Serum|antilymphocyte serum|mesh-list
111395389|NCT00523809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111395390|NCT00523809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111395391|NCT00523809|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111395392|NCT00523809|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111395393|NCT00523809|Growth Substances|growth substances|mesh-ancestor
110872551|NCT02999984|Busulfan|busulfan|mesh-list
111395394|NCT00523809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111395395|NCT00523809|Growth Inhibitors|growth inhibitors|mesh-ancestor
111395396|NCT00523809|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111395397|NCT00523809|Antimetabolites|antimetabolites|mesh-ancestor
111395398|NCT00523809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111395399|NCT00523809|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111395400|NCT00523809|Immunologic Factors|immunologic factors|mesh-ancestor
111395401|NCT00523809|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111395402|NCT00523809|Alkylating Agents|alkylating agents|mesh-ancestor
111395403|NCT00523809|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111395404|NCT00501345|Aspirin|aspirin|mesh-list
111395405|NCT00501345|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111395406|NCT00501345|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111395407|NCT00501345|Analgesics|analgesics|mesh-ancestor
111395408|NCT00501345|Sensory System Agents|sensory system agents|mesh-ancestor
111395409|NCT00501345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111395410|NCT00501345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111395411|NCT00501345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111395412|NCT00501345|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111395413|NCT00501345|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111395414|NCT00501345|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111395415|NCT00501345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111395416|NCT00501345|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111395417|NCT00501345|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111395418|NCT00501345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111395419|NCT00501345|Antipyretics|antipyretics|mesh-ancestor
111395420|NCT00357773|Azithromycin|azithromycin|mesh-list
111395421|NCT00357773|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111395422|NCT00357773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111395423|NCT00487461|Simvastatin|simvastatin|mesh-list
111395424|NCT00487461|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111395425|NCT00487461|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111395426|NCT00487461|Antimetabolites|antimetabolites|mesh-ancestor
111395427|NCT00487461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111395428|NCT00487461|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111395429|NCT00487461|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111395430|NCT00487461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111395431|NCT04972383|Hyaluronic Acid|hyaluronic acid|mesh-list
111395432|NCT04972383|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111395433|NCT04972383|Immunologic Factors|immunologic factors|mesh-ancestor
111395434|NCT04972383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111395435|NCT04972383|Viscosupplements|viscosupplements|mesh-ancestor
111395436|NCT04972383|Protective Agents|protective agents|mesh-ancestor
111395437|NCT00356187|Propranolol|propranolol|mesh-list
111395438|NCT00356187|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111395439|NCT00356187|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111395440|NCT00356187|Adrenergic Agents|adrenergic agents|mesh-ancestor
111395441|NCT00356187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111395442|NCT00356187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111395443|NCT00356187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111395444|NCT00356187|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111395445|NCT00356187|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111395446|NCT00356187|Vasodilator Agents|vasodilator agents|mesh-ancestor
111395447|NCT02224729|Dexamethasone|dexamethasone|mesh-list
111395448|NCT02224729|Bortezomib|bortezomib|mesh-list
111395449|NCT02224729|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
111395450|NCT02224729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111395451|NCT02224729|Antiemetics|antiemetics|mesh-ancestor
111395452|NCT02224729|Autonomic Agents|autonomic agents|mesh-ancestor
111395453|NCT02224729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111395454|NCT02224729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111395455|NCT02224729|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111395456|NCT02224729|Glucocorticoids|glucocorticoids|mesh-ancestor
111395457|NCT02224729|Hormones|hormones|mesh-ancestor
111395458|NCT02224729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111395459|NCT02224729|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111395460|NCT02224729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111395461|NCT02224729|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111395462|NCT02224729|Alkylating Agents|alkylating agents|mesh-ancestor
111395463|NCT02224729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111395464|NCT00305643|Celecoxib|celecoxib|mesh-list
111395465|NCT00305643|Capecitabine|capecitabine|mesh-list
111395466|NCT00305643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111395467|NCT00305643|Antimetabolites|antimetabolites|mesh-ancestor
111395468|NCT00305643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111395469|NCT00305643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111395470|NCT00305643|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111395471|NCT00305643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111395472|NCT00305643|Analgesics|analgesics|mesh-ancestor
111395473|NCT00305643|Sensory System Agents|sensory system agents|mesh-ancestor
111395474|NCT00305643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111395475|NCT00305643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111119818|NCT04557449|Anesthetics|anesthetics|mesh-ancestor
111395476|NCT00305643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111395477|NCT00305643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111395478|NCT00305643|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111395479|NCT00305643|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111395480|NCT00305643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111395481|NCT03004105|Durvalumab|durvalumab|mesh-list
111395482|NCT03004105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111395483|NCT03004105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111395484|NCT00271011|Irinotecan|irinotecan|mesh-list
111395485|NCT00271011|Cetuximab|cetuximab|mesh-list
111395486|NCT00271011|Mitomycins|mitomycins|mesh-list
111395487|NCT00271011|Mitomycin|mitomycin|mesh-list
111395488|NCT00271011|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111395489|NCT00271011|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111395490|NCT00271011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111395491|NCT00271011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111395492|NCT00271011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111395493|NCT00271011|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111395494|NCT00271011|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111395495|NCT00271011|Alkylating Agents|alkylating agents|mesh-ancestor
111395496|NCT00271011|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111395497|NCT03312530|Atezolizumab|atezolizumab|mesh-list
111395498|NCT03312530|Venetoclax|venetoclax|mesh-list
111395499|NCT03312530|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111395500|NCT03312530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111395501|NCT03312530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111395502|NCT03312530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111395503|NCT05697965|Vancomycin|vancomycin|mesh-list
111395504|NCT05697965|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111395505|NCT05697965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111395506|NCT00179127|Insulin Glargine|insulin glargine|mesh-list
111395507|NCT00179127|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111395508|NCT00179127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111395509|NCT05720273|Calcitriol|calcitriol|mesh-list
111395510|NCT05720273|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111395511|NCT05720273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111395512|NCT05720273|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
111395513|NCT05720273|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111395514|NCT05720273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111395515|NCT05720273|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111395516|NCT05720273|Vitamins|vitamins|mesh-ancestor
111395517|NCT05720273|Micronutrients|micronutrients|mesh-ancestor
111395518|NCT05720273|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111395519|NCT00183963|Tamoxifen|tamoxifen|mesh-list
111395520|NCT00183963|Fulvestrant|fulvestrant|mesh-list
111395521|NCT00183963|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111395522|NCT00183963|Hormone Antagonists|hormone antagonists|mesh-ancestor
111395523|NCT00183963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111395524|NCT00183963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111395525|NCT00183963|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111395526|NCT00183963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111395527|NCT00183963|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111395528|NCT00183963|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111395529|NCT00183963|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111395530|NCT00183963|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
111395531|NCT00176631|Docetaxel|docetaxel|mesh-list
111395532|NCT00176631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111395533|NCT00176631|Tubulin Modulators|tubulin modulators|mesh-ancestor
111395534|NCT00176631|Antimitotic Agents|antimitotic agents|mesh-ancestor
111395535|NCT00176631|Mitosis Modulators|mitosis modulators|mesh-ancestor
111395536|NCT00176631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111395537|NCT05719961|Insulin|insulin|mesh-list
111395538|NCT05719961|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111395539|NCT05719961|Insulin Aspart|insulin aspart|mesh-list
111395540|NCT05719961|Insulin, Long-Acting|insulin, long-acting|mesh-list
111395541|NCT05719961|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
111395542|NCT05719961|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111395543|NCT05719961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111395544|NCT01910636|Sofosbuvir|sofosbuvir|mesh-list
111395545|NCT01910636|Antiviral Agents|antiviral agents|mesh-ancestor
111395546|NCT01910636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111395547|NCT04317807|Levetiracetam|levetiracetam|mesh-list
111395548|NCT04317807|Anticonvulsants|anticonvulsants|mesh-ancestor
111119895|NCT04527549|Protective Agents|protective agents|mesh-ancestor
111395549|NCT04317807|Nootropic Agents|nootropic agents|mesh-ancestor
111395550|NCT00118053|Carboplatin|carboplatin|mesh-list
111395552|NCT00118053|Trastuzumab|trastuzumab|mesh-list
111395553|NCT00118053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111395554|NCT00118053|Tubulin Modulators|tubulin modulators|mesh-ancestor
111395555|NCT00118053|Antimitotic Agents|antimitotic agents|mesh-ancestor
111395556|NCT00118053|Mitosis Modulators|mitosis modulators|mesh-ancestor
111395557|NCT00118053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111395558|NCT00118053|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111395559|NCT04225611|Dexamethasone|dexamethasone|mesh-list
111395560|NCT04225611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111395561|NCT04225611|Antiemetics|antiemetics|mesh-ancestor
111395562|NCT04225611|Autonomic Agents|autonomic agents|mesh-ancestor
111395563|NCT04225611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111395564|NCT04225611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111395565|NCT04225611|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111395566|NCT04225611|Glucocorticoids|glucocorticoids|mesh-ancestor
111395567|NCT04225611|Hormones|hormones|mesh-ancestor
111395568|NCT04225611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111395569|NCT04225611|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111395570|NCT04225611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111395571|NCT00379977|Vaccines|vaccines|mesh-list
111395572|NCT00379977|Immunologic Factors|immunologic factors|mesh-ancestor
111395573|NCT00379977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111395574|NCT05669885|Sildenafil Citrate|sildenafil citrate|mesh-list
111395575|NCT05669885|Vasodilator Agents|vasodilator agents|mesh-ancestor
111395576|NCT05669885|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111395577|NCT05669885|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111395578|NCT05669885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111395579|NCT05669885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111395580|NCT05669885|Urological Agents|urological agents|mesh-ancestor
111395581|NCT00955929|Sildenafil Citrate|sildenafil citrate|mesh-list
111395582|NCT00955929|Alprostadil|alprostadil|mesh-list
111395583|NCT00955929|Vasodilator Agents|vasodilator agents|mesh-ancestor
111395584|NCT00955929|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111395585|NCT00955929|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111395586|NCT00955929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111395587|NCT00955929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111395588|NCT00955929|Urological Agents|urological agents|mesh-ancestor
111395589|NCT00955929|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111395590|NCT00357851|Aprotinin|aprotinin|mesh-list
111395591|NCT00357851|Hemostatics|hemostatics|mesh-ancestor
111395592|NCT00357851|Coagulants|coagulants|mesh-ancestor
111395593|NCT00357851|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
111395594|NCT00357851|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111395595|NCT00357851|Protease Inhibitors|protease inhibitors|mesh-ancestor
111395596|NCT00357851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111395597|NCT00357851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111395598|NCT00358319|Valproic Acid|valproic acid|mesh-list
111395599|NCT00358319|Anticonvulsants|anticonvulsants|mesh-ancestor
111395600|NCT00358319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111395601|NCT00358319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111395602|NCT00358319|GABA Agents|gaba agents|mesh-ancestor
111395603|NCT00358319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111395604|NCT00358319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111395605|NCT00358319|Antimanic Agents|antimanic agents|mesh-ancestor
111395606|NCT00358319|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111395607|NCT00358319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111395608|NCT00358319|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111395609|NCT05663801|Magnesium Sulfate|magnesium sulfate|mesh-list
111395610|NCT05663801|Ketamine|ketamine|mesh-list
111395611|NCT05663801|Bupivacaine|bupivacaine|mesh-list
111395612|NCT05663801|Anesthetics, Local|anesthetics, local|mesh-ancestor
111395613|NCT05663801|Anesthetics|anesthetics|mesh-ancestor
111395614|NCT05663801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111395615|NCT05663801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111395616|NCT05663801|Sensory System Agents|sensory system agents|mesh-ancestor
111395617|NCT05663801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111395618|NCT05663801|Analgesics|analgesics|mesh-ancestor
111395619|NCT05663801|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111395620|NCT05663801|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111395621|NCT05663801|Anesthetics, General|anesthetics, general|mesh-ancestor
111395622|NCT05663801|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111395623|NCT05663801|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111395624|NCT05663801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111395625|NCT05663801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111395626|NCT05663801|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111395627|NCT05663801|Anticonvulsants|anticonvulsants|mesh-ancestor
111395628|NCT05663801|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111395629|NCT05663801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111395630|NCT05663801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111395631|NCT05663801|Tocolytic Agents|tocolytic agents|mesh-ancestor
111395632|NCT05663801|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111395633|NCT00000105|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
111395634|NCT00000105|Freund's Adjuvant|freund's adjuvant|mesh-list
111395635|NCT00000105|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111395636|NCT00000105|Immunologic Factors|immunologic factors|mesh-ancestor
111395637|NCT00000105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111395638|NCT00000117|Immunoglobulins|immunoglobulins|mesh-list
111395639|NCT00000117|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111395640|NCT00000117|Antibodies|antibodies|mesh-list
111395641|NCT00000117|Immunologic Factors|immunologic factors|mesh-ancestor
111395642|NCT00000117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111395643|NCT00000123|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
111395644|NCT00000123|Vasodilator Agents|vasodilator agents|mesh-ancestor
111395645|NCT00000123|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
111395646|NCT00000123|Protective Agents|protective agents|mesh-ancestor
111395647|NCT00000123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111395648|NCT00380133|Prednisolone|prednisolone|mesh-list
111395649|NCT00380133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111395650|NCT00380133|Glucocorticoids|glucocorticoids|mesh-ancestor
111395651|NCT00380133|Hormones|hormones|mesh-ancestor
111395652|NCT00380133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111395653|NCT00380133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111395654|NCT00380133|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111395655|NCT00380133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111395656|NCT02959229|Lactoferrin|lactoferrin|mesh-list
111395657|NCT02959229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111395658|NCT02953665|Liraglutide|liraglutide|mesh-list
111395659|NCT02953665|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111395660|NCT02953665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111395661|NCT02953665|Incretins|incretins|mesh-ancestor
111395662|NCT02953665|Hormones|hormones|mesh-ancestor
111395663|NCT02953665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111395664|NCT00000189|Gepirone|gepirone|mesh-list
111395665|NCT00000189|Antidepressive Agents|antidepressive agents|mesh-ancestor
111395666|NCT00000189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111395667|NCT00000189|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111395668|NCT00000189|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111395669|NCT00000189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111395670|NCT00000189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111395671|NCT00000189|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111395672|NCT00000189|Serotonin Agents|serotonin agents|mesh-ancestor
111395673|NCT00000189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111395674|NCT00000189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111395675|NCT02681211|Diphenhydramine|diphenhydramine|mesh-list
111395676|NCT02681211|Promethazine|promethazine|mesh-list
111395677|NCT02681211|Ketorolac|ketorolac|mesh-list
111395678|NCT02681211|Metoclopramide|metoclopramide|mesh-list
111395679|NCT02681211|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111395680|NCT02681211|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111395681|NCT02681211|Analgesics|analgesics|mesh-ancestor
111395682|NCT02681211|Sensory System Agents|sensory system agents|mesh-ancestor
111395683|NCT02681211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111395684|NCT02681211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111395685|NCT02681211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111395686|NCT02681211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111395687|NCT02681211|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111395688|NCT02681211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111395689|NCT02681211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111395690|NCT02681211|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111395691|NCT02681211|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111395692|NCT02681211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111395693|NCT02681211|Anesthetics, Local|anesthetics, local|mesh-ancestor
111395694|NCT02681211|Anesthetics|anesthetics|mesh-ancestor
111395695|NCT02681211|Antiemetics|antiemetics|mesh-ancestor
111395696|NCT02681211|Autonomic Agents|autonomic agents|mesh-ancestor
111395697|NCT02681211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111395698|NCT02681211|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111395699|NCT02681211|Histamine Antagonists|histamine antagonists|mesh-ancestor
111395700|NCT02681211|Histamine Agents|histamine agents|mesh-ancestor
111395701|NCT02681211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111395702|NCT02681211|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111395703|NCT02681211|Antipruritics|antipruritics|mesh-ancestor
111395704|NCT02681211|Dermatologic Agents|dermatologic agents|mesh-ancestor
111395705|NCT02681211|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111395706|NCT02681211|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111395707|NCT02681211|Dopamine Agents|dopamine agents|mesh-ancestor
111395708|NCT00000195|Naltrexone|naltrexone|mesh-list
111395709|NCT00000195|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111395710|NCT00000195|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111395711|NCT00000195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111395712|NCT00000195|Sensory System Agents|sensory system agents|mesh-ancestor
111395713|NCT00000195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111395714|NCT00000201|Selegiline|selegiline|mesh-list
111395715|NCT00000201|Antidepressive Agents|antidepressive agents|mesh-ancestor
111395716|NCT00000201|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111395717|NCT00000201|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111395718|NCT00000201|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111395719|NCT00000201|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
111395720|NCT00000201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111395721|NCT00000201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111395722|NCT00000201|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111395723|NCT00000201|Protective Agents|protective agents|mesh-ancestor
111395724|NCT00000201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111395725|NCT00000207|Buprenorphine|buprenorphine|mesh-list
111395726|NCT00000207|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111395727|NCT00000207|Narcotics|narcotics|mesh-ancestor
111395728|NCT00000207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111395729|NCT00000207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111395730|NCT00000207|Analgesics|analgesics|mesh-ancestor
111395731|NCT00000207|Sensory System Agents|sensory system agents|mesh-ancestor
111395732|NCT00000207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111395733|NCT00000207|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111395734|NCT02295774|Methylene Blue|methylene blue|mesh-list
111395735|NCT02295774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111395736|NCT02295774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111395737|NCT01807611|Mycophenolic Acid|mycophenolic acid|mesh-list
111395738|NCT01807611|Cyclophosphamide|cyclophosphamide|mesh-list
111395739|NCT01807611|Melphalan|melphalan|mesh-list
111395740|NCT01807611|Mechlorethamine|mechlorethamine|mesh-list
111395741|NCT01807611|Thiotepa|thiotepa|mesh-list
111395742|NCT01807611|Fludarabine|fludarabine|mesh-list
111395743|NCT01807611|Lenograstim|lenograstim|mesh-list
111395744|NCT01807611|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111395745|NCT01807611|Immunologic Factors|immunologic factors|mesh-ancestor
111395746|NCT01807611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111395747|NCT01807611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111395748|NCT01807611|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111395749|NCT01807611|Alkylating Agents|alkylating agents|mesh-ancestor
111395750|NCT01807611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111395751|NCT01807611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111395752|NCT01807611|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111395753|NCT01807611|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111395754|NCT01807611|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111395755|NCT01807611|Antitubercular Agents|antitubercular agents|mesh-ancestor
111395756|NCT01807611|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111395757|NCT01807611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111395758|NCT01807611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111395759|NCT01807611|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111395760|NCT02977949|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
111395761|NCT02977949|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111395762|NCT02977949|Hormone Antagonists|hormone antagonists|mesh-ancestor
111395763|NCT02977949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111395764|NCT02977949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111395765|NCT02977949|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111395766|NCT02977949|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111395767|NCT02977949|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111395768|NCT02294682|Gepotidacin|gepotidacin|mesh-list
111395769|NCT02294682|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111395770|NCT02294682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111395771|NCT02294682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111395772|NCT02294682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111395773|NCT01692717|Losartan|losartan|mesh-list
111395774|NCT01692717|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
111395775|NCT01692717|Atorvastatin|atorvastatin|mesh-list
111395776|NCT01692717|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111120121|NCT04301492|Serotonin Agents|serotonin agents|mesh-ancestor
111395777|NCT01692717|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111395778|NCT01692717|Antimetabolites|antimetabolites|mesh-ancestor
110872929|NCT03304873|Retapamulin|retapamulin|mesh-list
111395779|NCT01692717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111395780|NCT01692717|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111395781|NCT01692717|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111395782|NCT01692717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111395783|NCT01692717|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111395784|NCT01692717|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111395785|NCT01692717|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111395786|NCT01692717|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111395787|NCT01692717|Diuretics|diuretics|mesh-ancestor
111395788|NCT01692717|Natriuretic Agents|natriuretic agents|mesh-ancestor
111395789|NCT01692717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111395790|NCT01692717|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
111395791|NCT01692717|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111395792|NCT00355277|Amitriptyline|amitriptyline|mesh-list
111395793|NCT00355277|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
111395794|NCT00355277|Antidepressive Agents|antidepressive agents|mesh-ancestor
111395795|NCT00355277|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111395796|NCT00355277|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111395797|NCT00355277|Analgesics|analgesics|mesh-ancestor
111395798|NCT00355277|Sensory System Agents|sensory system agents|mesh-ancestor
111395799|NCT00355277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111395800|NCT00355277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111395801|NCT00355277|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111395802|NCT00355277|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111395803|NCT00355277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111395804|NCT00355277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111395805|NCT00355277|Adrenergic Agents|adrenergic agents|mesh-ancestor
111395806|NCT00355277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111395807|NCT00000735|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
111395808|NCT00000735|Antiviral Agents|antiviral agents|mesh-ancestor
111395809|NCT00000735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111395810|NCT00000213|Fluoxetine|fluoxetine|mesh-list
111395811|NCT00000213|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111395812|NCT00000213|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111395813|NCT00000213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111395814|NCT00000213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111395815|NCT00000213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111395816|NCT00000213|Serotonin Agents|serotonin agents|mesh-ancestor
111395817|NCT00000213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111395818|NCT00000213|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111395819|NCT00000213|Antidepressive Agents|antidepressive agents|mesh-ancestor
111395820|NCT00000213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111395821|NCT00000213|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111395822|NCT00000213|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111395823|NCT00000213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111395824|NCT00000219|Buprenorphine|buprenorphine|mesh-list
111395825|NCT00000219|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111395826|NCT00000219|Narcotics|narcotics|mesh-ancestor
111395827|NCT00000219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111395828|NCT00000219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111395829|NCT00000219|Analgesics|analgesics|mesh-ancestor
111395830|NCT00000219|Sensory System Agents|sensory system agents|mesh-ancestor
111395831|NCT00000219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111395832|NCT00000219|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111395833|NCT00000225|Buprenorphine|buprenorphine|mesh-list
111395834|NCT00000225|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111395835|NCT00000225|Narcotics|narcotics|mesh-ancestor
111395836|NCT00000225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111395837|NCT00000225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111395838|NCT00000225|Analgesics|analgesics|mesh-ancestor
111395839|NCT00000225|Sensory System Agents|sensory system agents|mesh-ancestor
111395840|NCT00000225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111395841|NCT00000225|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111395842|NCT02294604|Chlorhexidine|chlorhexidine|mesh-list
111395843|NCT02294604|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
111395844|NCT02294604|Povidone-Iodine|povidone-iodine|mesh-list
111395845|NCT02294604|Povidone|povidone|mesh-list
111395846|NCT02294604|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111395847|NCT02294604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111395848|NCT02294604|Disinfectants|disinfectants|mesh-ancestor
111120199|NCT04240054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111395849|NCT02294604|Dermatologic Agents|dermatologic agents|mesh-ancestor
111395850|NCT02294604|Plasma Substitutes|plasma substitutes|mesh-ancestor
111395851|NCT02294604|Blood Substitutes|blood substitutes|mesh-ancestor
111395852|NCT01645176|Hydroxychloroquine|hydroxychloroquine|mesh-list
111395853|NCT01645176|Atorvastatin|atorvastatin|mesh-list
111395854|NCT01645176|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111395855|NCT01645176|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111395856|NCT01645176|Antimetabolites|antimetabolites|mesh-ancestor
111395857|NCT01645176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111395858|NCT01645176|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111395859|NCT01645176|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111395860|NCT01645176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111395861|NCT01645176|Antimalarials|antimalarials|mesh-ancestor
111395862|NCT01645176|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111395863|NCT01645176|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111395864|NCT01645176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111395865|NCT01645176|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111395866|NCT03465735|Heparin|heparin|mesh-list
111395867|NCT03465735|Enoxaparin|enoxaparin|mesh-list
111395868|NCT03465735|Dalteparin|dalteparin|mesh-list
111395869|NCT03465735|Warfarin|warfarin|mesh-list
111395870|NCT03465735|Rivaroxaban|rivaroxaban|mesh-list
111395871|NCT03465735|Dabigatran|dabigatran|mesh-list
111395872|NCT03465735|Apixaban|apixaban|mesh-list
111395873|NCT03465735|Edoxaban|edoxaban|mesh-list
111395874|NCT03465735|Anticoagulants|anticoagulants|mesh-ancestor
111395875|NCT03465735|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111395876|NCT03465735|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111395877|NCT03465735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111395878|NCT03465735|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111395879|NCT03465735|Antithrombins|antithrombins|mesh-ancestor
111395880|NCT03465735|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111395881|NCT03465735|Protease Inhibitors|protease inhibitors|mesh-ancestor
111395882|NCT03465735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111395883|NCT05637671|Paroxetine|paroxetine|mesh-list
111395884|NCT05637671|Oxybutynin|oxybutynin|mesh-list
111395885|NCT05637671|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111395886|NCT05637671|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111395887|NCT05637671|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111395888|NCT05637671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111395889|NCT05637671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111395890|NCT05637671|Serotonin Agents|serotonin agents|mesh-ancestor
111395891|NCT05637671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111395892|NCT05637671|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111395893|NCT05637671|Antidepressive Agents|antidepressive agents|mesh-ancestor
111395894|NCT05637671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111395895|NCT05637671|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111395896|NCT05637671|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111395897|NCT05637671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111395898|NCT05637671|Parasympatholytics|parasympatholytics|mesh-ancestor
111395899|NCT05637671|Autonomic Agents|autonomic agents|mesh-ancestor
111395900|NCT05637671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111395901|NCT05637671|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111395902|NCT05637671|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111395903|NCT05637671|Cholinergic Agents|cholinergic agents|mesh-ancestor
111395904|NCT05637671|Urological Agents|urological agents|mesh-ancestor
111395905|NCT02322216|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
111395906|NCT02322216|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111395907|NCT02322216|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111395908|NCT02322216|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111395909|NCT02322216|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111395910|NCT02322216|Analgesics|analgesics|mesh-ancestor
111395911|NCT02322216|Sensory System Agents|sensory system agents|mesh-ancestor
111395912|NCT02322216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111395913|NCT02322216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111395914|NCT02322216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111395915|NCT02322216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111395916|NCT02322216|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111395917|NCT02322216|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
111395918|NCT02322216|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111395919|NCT02322216|Histamine Antagonists|histamine antagonists|mesh-ancestor
111395920|NCT02322216|Histamine Agents|histamine agents|mesh-ancestor
111395921|NCT02322216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111395922|NCT02322216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111395923|NCT03447639|Povidone-Iodine|povidone-iodine|mesh-list
111395924|NCT03447639|Povidone|povidone|mesh-list
111120282|NCT04191135|Carboplatin|carboplatin|mesh-list
111395925|NCT03447639|Plasma Substitutes|plasma substitutes|mesh-ancestor
111395926|NCT03447639|Blood Substitutes|blood substitutes|mesh-ancestor
111395927|NCT03447639|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111395928|NCT03447639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111395929|NCT03425799|Tranexamic Acid|tranexamic acid|mesh-list
111395930|NCT03425799|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111395931|NCT03425799|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111395932|NCT03425799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111395933|NCT03425799|Hemostatics|hemostatics|mesh-ancestor
111395934|NCT03425799|Coagulants|coagulants|mesh-ancestor
111395935|NCT03363633|Sodium Tetradecyl Sulfate|sodium tetradecyl sulfate|mesh-list
111395936|NCT03363633|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
111395937|NCT03363633|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111395938|NCT03360903|Caffeine|caffeine|mesh-list
111395939|NCT03360903|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111395940|NCT03360903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111395941|NCT03360903|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111395942|NCT03360903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111395943|NCT03360903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111395944|NCT03360903|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
111395945|NCT03360903|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111395946|NCT03360903|Purinergic Agents|purinergic agents|mesh-ancestor
111395947|NCT03360903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111395948|NCT00000231|Buprenorphine|buprenorphine|mesh-list
111395949|NCT00000231|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111395950|NCT00000231|Narcotics|narcotics|mesh-ancestor
111395951|NCT00000231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111395952|NCT00000231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111395953|NCT00000231|Analgesics|analgesics|mesh-ancestor
111395954|NCT00000231|Sensory System Agents|sensory system agents|mesh-ancestor
111395955|NCT00000231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111395956|NCT00000231|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111395957|NCT00000237|Buprenorphine|buprenorphine|mesh-list
111395958|NCT00000237|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111395959|NCT00000237|Narcotics|narcotics|mesh-ancestor
111395960|NCT00000237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111395961|NCT00000237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111395962|NCT00000237|Analgesics|analgesics|mesh-ancestor
111395963|NCT00000237|Sensory System Agents|sensory system agents|mesh-ancestor
111395964|NCT00000237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111395965|NCT00000237|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111395966|NCT00000765|Zidovudine|zidovudine|mesh-list
111395967|NCT00000765|Antimetabolites|antimetabolites|mesh-ancestor
111395968|NCT00000765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111395969|NCT00000765|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111395970|NCT00000765|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111395971|NCT00000765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111395972|NCT00000765|Antiviral Agents|antiviral agents|mesh-ancestor
111395973|NCT00000765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111395974|NCT00000765|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111395975|NCT00000765|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111395976|NCT00000243|Buprenorphine|buprenorphine|mesh-list
111395977|NCT00000243|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111395978|NCT00000243|Narcotics|narcotics|mesh-ancestor
111395979|NCT00000243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111395980|NCT00000243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111395981|NCT00000243|Analgesics|analgesics|mesh-ancestor
111395982|NCT00000243|Sensory System Agents|sensory system agents|mesh-ancestor
111395983|NCT00000243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111395984|NCT00000243|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111395985|NCT00000771|Paromomycin|paromomycin|mesh-list
111395986|NCT00000771|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111395987|NCT00000771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111395988|NCT00000771|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111395989|NCT00000771|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111395990|NCT05575505|Pentoxifylline|pentoxifylline|mesh-list
111395991|NCT05575505|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111395992|NCT05575505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111395993|NCT05575505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111395994|NCT05575505|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111395995|NCT05575505|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111395996|NCT05575505|Protective Agents|protective agents|mesh-ancestor
111395997|NCT05575505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111395998|NCT05575505|Vasodilator Agents|vasodilator agents|mesh-ancestor
111395999|NCT05575505|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111396000|NCT05575505|Antioxidants|antioxidants|mesh-ancestor
111396001|NCT00000249|Nitrous Oxide|nitrous oxide|mesh-list
111396002|NCT00000249|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111396003|NCT00000249|Anesthetics, General|anesthetics, general|mesh-ancestor
111396004|NCT00000249|Anesthetics|anesthetics|mesh-ancestor
111396005|NCT00000249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111396006|NCT00000249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111396007|NCT00000249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111396008|NCT00000249|Analgesics|analgesics|mesh-ancestor
111396009|NCT00000249|Sensory System Agents|sensory system agents|mesh-ancestor
111396010|NCT00000249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111396011|NCT00000261|Nitrous Oxide|nitrous oxide|mesh-list
111396012|NCT00000261|Sevoflurane|sevoflurane|mesh-list
111396013|NCT00000261|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111396014|NCT00000261|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111396015|NCT00000261|Anesthetics, General|anesthetics, general|mesh-ancestor
111396016|NCT00000261|Anesthetics|anesthetics|mesh-ancestor
111396017|NCT00000261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111396018|NCT00000261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111396019|NCT00000261|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111396020|NCT00000261|Analgesics|analgesics|mesh-ancestor
111396021|NCT00000261|Sensory System Agents|sensory system agents|mesh-ancestor
111396022|NCT00000261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111396023|NCT00000801|Cytarabine|cytarabine|mesh-list
111396024|NCT00000801|Dexamethasone|dexamethasone|mesh-list
111396025|NCT00000801|Cyclophosphamide|cyclophosphamide|mesh-list
111396026|NCT00000801|Doxorubicin|doxorubicin|mesh-list
111396027|NCT00000801|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111396028|NCT00000801|Vincristine|vincristine|mesh-list
111396029|NCT00000801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111396030|NCT00000801|Immunologic Factors|immunologic factors|mesh-ancestor
111396031|NCT00000801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111396032|NCT00000801|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111396033|NCT00000801|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111396034|NCT00000801|Alkylating Agents|alkylating agents|mesh-ancestor
111396035|NCT00000801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111396036|NCT00000801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111396037|NCT00000801|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111396038|NCT00000801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111396039|NCT00000801|Antiemetics|antiemetics|mesh-ancestor
111396040|NCT00000801|Autonomic Agents|autonomic agents|mesh-ancestor
111396041|NCT00000801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111396042|NCT00000801|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111396043|NCT00000801|Glucocorticoids|glucocorticoids|mesh-ancestor
111396044|NCT00000801|Hormones|hormones|mesh-ancestor
111396045|NCT00000801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111396046|NCT00000801|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111396047|NCT00000801|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111396048|NCT00000801|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111396049|NCT00000801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111396050|NCT00000801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111396051|NCT00000801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111396052|NCT00000801|Antimetabolites|antimetabolites|mesh-ancestor
111396053|NCT00000801|Antiviral Agents|antiviral agents|mesh-ancestor
111396054|NCT00000801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111396055|NCT00000801|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111396056|NCT00000801|Tubulin Modulators|tubulin modulators|mesh-ancestor
111396057|NCT00000801|Antimitotic Agents|antimitotic agents|mesh-ancestor
111396058|NCT00000801|Mitosis Modulators|mitosis modulators|mesh-ancestor
111396059|NCT00000267|Risperidone|risperidone|mesh-list
111396060|NCT00000267|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111396061|NCT00000267|Serotonin Agents|serotonin agents|mesh-ancestor
111396062|NCT00000267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111396063|NCT00000267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111396064|NCT00000267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111396065|NCT00000267|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111396066|NCT00000267|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111396067|NCT00000267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111396068|NCT00000267|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111396069|NCT00000267|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111396070|NCT00000267|Dopamine Agents|dopamine agents|mesh-ancestor
111396071|NCT00000807|Etoposide|etoposide|mesh-list
111396072|NCT00000807|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111396073|NCT00000807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111396074|NCT00000807|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111396075|NCT00000807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111120461|NCT04045431|Hylan|hylan|mesh-list
111396076|NCT00000807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111396077|NCT00000807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111396078|NCT00001677|Methotrexate|methotrexate|mesh-list
111396079|NCT00001677|Fludarabine|fludarabine|mesh-list
111396080|NCT00001677|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111396081|NCT00001677|Abortifacient Agents|abortifacient agents|mesh-ancestor
111396082|NCT00001677|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111396083|NCT00001677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111396084|NCT00001677|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111396085|NCT00001677|Antimetabolites|antimetabolites|mesh-ancestor
111396086|NCT00001677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111396087|NCT00001677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111396088|NCT00001677|Dermatologic Agents|dermatologic agents|mesh-ancestor
111396089|NCT00001677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111396090|NCT00001677|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111396091|NCT00001677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111396092|NCT00001677|Immunologic Factors|immunologic factors|mesh-ancestor
111396093|NCT00001677|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111396094|NCT00001677|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111396095|NCT00001689|Vincristine|vincristine|mesh-list
111396096|NCT00001689|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111396097|NCT00001689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111396098|NCT00001689|Tubulin Modulators|tubulin modulators|mesh-ancestor
111396099|NCT00001689|Antimitotic Agents|antimitotic agents|mesh-ancestor
111396100|NCT00001689|Mitosis Modulators|mitosis modulators|mesh-ancestor
111396101|NCT00001689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111396102|NCT00001713|Heparin|heparin|mesh-list
111396103|NCT00001713|Plasminogen|plasminogen|mesh-list
111396104|NCT00001713|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
111396105|NCT00001713|Warfarin|warfarin|mesh-list
111396106|NCT00001713|Anticoagulants|anticoagulants|mesh-ancestor
111396107|NCT00001713|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111396108|NCT00001713|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111396109|NCT00001713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111396110|NCT00000273|Fentanyl|fentanyl|mesh-list
111396111|NCT00000273|Morphine|morphine|mesh-list
111396112|NCT00000273|Oxycodone|oxycodone|mesh-list
111396113|NCT00000273|Buprenorphine|buprenorphine|mesh-list
111396114|NCT00000273|Methadone|methadone|mesh-list
111396115|NCT00000273|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111396116|NCT00000273|Narcotics|narcotics|mesh-ancestor
111396117|NCT00000273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111396118|NCT00000273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111396119|NCT00000273|Analgesics|analgesics|mesh-ancestor
111396120|NCT00000273|Sensory System Agents|sensory system agents|mesh-ancestor
111396121|NCT00000273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111396122|NCT00000273|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111396123|NCT00000273|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111396124|NCT00000273|Anesthetics, General|anesthetics, general|mesh-ancestor
111396125|NCT00000273|Anesthetics|anesthetics|mesh-ancestor
111396126|NCT00000273|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111396127|NCT00000273|Antitussive Agents|antitussive agents|mesh-ancestor
111396128|NCT00000273|Respiratory System Agents|respiratory system agents|mesh-ancestor
111396129|NCT00000819|Prednisone|prednisone|mesh-list
111396130|NCT00000819|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111396131|NCT00000819|Glucocorticoids|glucocorticoids|mesh-ancestor
111396132|NCT00000819|Hormones|hormones|mesh-ancestor
111396133|NCT00000819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111396134|NCT00000819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111396135|NCT00000819|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111396136|NCT00000819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111396137|NCT00000279|Clonidine|clonidine|mesh-list
111396138|NCT00000279|Analgesics|analgesics|mesh-ancestor
111396139|NCT00000279|Sensory System Agents|sensory system agents|mesh-ancestor
111396140|NCT00000279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111396141|NCT00000279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111396142|NCT00000279|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111396143|NCT00000279|Sympatholytics|sympatholytics|mesh-ancestor
111396144|NCT00000279|Autonomic Agents|autonomic agents|mesh-ancestor
111396145|NCT00000279|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111396146|NCT00000279|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111396147|NCT00000279|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111396148|NCT00000279|Adrenergic Agents|adrenergic agents|mesh-ancestor
111396149|NCT00000279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111396150|NCT00000279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111396151|NCT00000825|Aldesleukin|aldesleukin|mesh-list
111396152|NCT00000825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111396153|NCT00000825|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111396154|NCT00000825|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111396155|NCT00000825|Antiviral Agents|antiviral agents|mesh-ancestor
111396156|NCT00000825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111396158|NCT00000285|Anticonvulsants|anticonvulsants|mesh-ancestor
111396159|NCT00000285|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111396160|NCT00000285|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111396161|NCT00000285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111396162|NCT00000285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111396163|NCT00000285|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
111396164|NCT00000285|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111396165|NCT00001737|Cyclosporine|cyclosporine|mesh-list
111396166|NCT00001737|Cyclosporins|cyclosporins|mesh-list
111396167|NCT00001737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111396168|NCT00001737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111396169|NCT00001737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111396170|NCT00001737|Immunologic Factors|immunologic factors|mesh-ancestor
111396171|NCT00001737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111396172|NCT00001737|Antifungal Agents|antifungal agents|mesh-ancestor
111396173|NCT00001737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111396174|NCT00001737|Dermatologic Agents|dermatologic agents|mesh-ancestor
111396175|NCT00001737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111396176|NCT00001737|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111396177|NCT00000843|Adefovir|adefovir|mesh-list
111396178|NCT00000843|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
111396179|NCT00000843|Antiviral Agents|antiviral agents|mesh-ancestor
111396180|NCT00000843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111396181|NCT00000843|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111396182|NCT00000843|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111396183|NCT00000843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111396184|NCT00000843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111396185|NCT05362487|Bromides|bromides|mesh-list
111396186|NCT05362487|Tiotropium Bromide|tiotropium bromide|mesh-list
111396187|NCT05362487|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111396188|NCT05362487|Autonomic Agents|autonomic agents|mesh-ancestor
111396189|NCT05362487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111396190|NCT05362487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111396191|NCT05362487|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111396192|NCT05362487|Respiratory System Agents|respiratory system agents|mesh-ancestor
111396193|NCT05362487|Parasympatholytics|parasympatholytics|mesh-ancestor
111396194|NCT05362487|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111396195|NCT05362487|Cholinergic Agents|cholinergic agents|mesh-ancestor
111396196|NCT05362487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111396197|NCT05362487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111396198|NCT05362487|Anticonvulsants|anticonvulsants|mesh-ancestor
111396199|NCT00000291|Labetalol|labetalol|mesh-list
111396200|NCT00000291|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111396201|NCT00000291|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111396202|NCT00000291|Adrenergic Agents|adrenergic agents|mesh-ancestor
111396203|NCT00000291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111396204|NCT00000291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111396205|NCT00000291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111396206|NCT00000291|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111396207|NCT00000291|Sympathomimetics|sympathomimetics|mesh-ancestor
111396208|NCT00000291|Autonomic Agents|autonomic agents|mesh-ancestor
111396209|NCT00000291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111396210|NCT00000291|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111396211|NCT00000291|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111396212|NCT00000861|Indinavir|indinavir|mesh-list
111396213|NCT00000861|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111396214|NCT00000861|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111396215|NCT00000861|Protease Inhibitors|protease inhibitors|mesh-ancestor
111396216|NCT00000861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111396217|NCT00000861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111396218|NCT00000861|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111396219|NCT00000861|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111396220|NCT00000861|Antiviral Agents|antiviral agents|mesh-ancestor
111396221|NCT00000861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111396222|NCT00000297|Labetalol|labetalol|mesh-list
111396223|NCT00000297|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111396224|NCT00000297|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111396225|NCT00000297|Adrenergic Agents|adrenergic agents|mesh-ancestor
111396226|NCT00000297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111396227|NCT00000297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111396228|NCT00000297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111396229|NCT00000297|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111396230|NCT00000297|Sympathomimetics|sympathomimetics|mesh-ancestor
111396231|NCT00000297|Autonomic Agents|autonomic agents|mesh-ancestor
111396232|NCT00000297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111396233|NCT00000297|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111396234|NCT00000297|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111396236|NCT00359879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111396237|NCT00359879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111396238|NCT00359879|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111396239|NCT00359879|Incretins|incretins|mesh-ancestor
111396240|NCT00359879|Hormones|hormones|mesh-ancestor
111396241|NCT00359879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111396242|NCT00000303|Baclofen|baclofen|mesh-list
111396243|NCT00000303|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
111396244|NCT00000303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111396245|NCT00000303|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111396246|NCT00000303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111396247|NCT00000303|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
111396248|NCT00000303|GABA Agonists|gaba agonists|mesh-ancestor
111396249|NCT00000303|GABA Agents|gaba agents|mesh-ancestor
111396250|NCT00000303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111396251|NCT00000303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111396252|NCT00001785|Interferons|interferons|mesh-list
111396253|NCT00001785|Interferon-beta|interferon-beta|mesh-list
111396254|NCT00001785|Interferon beta-1a|interferon beta-1a|mesh-list
111396255|NCT00001785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111396256|NCT00001785|Antiviral Agents|antiviral agents|mesh-ancestor
111396257|NCT00001785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111396258|NCT00001785|Immunologic Factors|immunologic factors|mesh-ancestor
111396259|NCT00001785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111396260|NCT00001785|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111396261|NCT00001827|Aldesleukin|aldesleukin|mesh-list
111396262|NCT00001827|Sargramostim|sargramostim|mesh-list
111396263|NCT00001827|Freund's Adjuvant|freund's adjuvant|mesh-list
111396264|NCT00001827|Immunologic Factors|immunologic factors|mesh-ancestor
111396265|NCT00001827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111396266|NCT00001827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111396267|NCT00001827|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111396268|NCT00001827|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111396269|NCT00001827|Antiviral Agents|antiviral agents|mesh-ancestor
111396270|NCT00001827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111396271|NCT00001827|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111396272|NCT01647516|Ozanimod|ozanimod|mesh-list
111396273|NCT01647516|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
111396274|NCT01647516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111396275|NCT01647516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111396276|NCT01647516|Immunologic Factors|immunologic factors|mesh-ancestor
111396277|NCT01647516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111396278|NCT00001839|Cyclosporine|cyclosporine|mesh-list
111396279|NCT00001839|Cyclosporins|cyclosporins|mesh-list
111396280|NCT00001839|Antilymphocyte Serum|antilymphocyte serum|mesh-list
111396281|NCT00001839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111396282|NCT00001839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111396283|NCT00001839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111396284|NCT00001839|Immunologic Factors|immunologic factors|mesh-ancestor
111396285|NCT00001839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111396286|NCT00001839|Antifungal Agents|antifungal agents|mesh-ancestor
111396287|NCT00001839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111396288|NCT00001839|Dermatologic Agents|dermatologic agents|mesh-ancestor
111396289|NCT00001839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111396290|NCT00001839|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111396291|NCT00000885|Lamivudine|lamivudine|mesh-list
111396292|NCT00000885|Zidovudine|zidovudine|mesh-list
111396293|NCT00000885|Efavirenz|efavirenz|mesh-list
111396294|NCT00000885|Abacavir|abacavir|mesh-list
111396295|NCT00000885|Stavudine|stavudine|mesh-list
111396296|NCT00000885|Didanosine|didanosine|mesh-list
111396297|NCT00000885|Adefovir|adefovir|mesh-list
111396298|NCT00000885|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
111396299|NCT00000885|Nelfinavir|nelfinavir|mesh-list
111396300|NCT00000885|Indinavir|indinavir|mesh-list
111396301|NCT00000885|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111396302|NCT00000885|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111396303|NCT00000885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111396304|NCT00000885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111396305|NCT00000885|Antiviral Agents|antiviral agents|mesh-ancestor
111396306|NCT00000885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111396307|NCT00000885|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111396308|NCT00000885|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111396309|NCT00000885|Antimetabolites|antimetabolites|mesh-ancestor
111396310|NCT00000885|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111396311|NCT00000885|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111396312|NCT00000885|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111396313|NCT00000885|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111396314|NCT00000885|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111396315|NCT00000885|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111396316|NCT00000885|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111396317|NCT00000885|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111396318|NCT00000885|Protease Inhibitors|protease inhibitors|mesh-ancestor
111396319|NCT01647282|Minocycline|minocycline|mesh-list
111396320|NCT01647282|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111396321|NCT01647282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111396322|NCT00000897|Zidovudine|zidovudine|mesh-list
111396323|NCT00000897|Antimetabolites|antimetabolites|mesh-ancestor
111396324|NCT00000897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111396325|NCT00000897|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111396326|NCT00000897|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111396327|NCT00000897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111396328|NCT00000897|Antiviral Agents|antiviral agents|mesh-ancestor
111396329|NCT00000897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110873468|NCT04694248|Rivaroxaban|rivaroxaban|mesh-list
111396330|NCT00000897|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111396331|NCT00000897|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111396332|NCT05347979|Dabigatran|dabigatran|mesh-list
111396333|NCT05347979|Antithrombins|antithrombins|mesh-ancestor
111396334|NCT05347979|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111396335|NCT05347979|Protease Inhibitors|protease inhibitors|mesh-ancestor
111396336|NCT05347979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111396337|NCT05347979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111396338|NCT05347979|Anticoagulants|anticoagulants|mesh-ancestor
111396339|NCT00000909|Aldesleukin|aldesleukin|mesh-list
111396340|NCT00000909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111396341|NCT00000909|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111396342|NCT00000909|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111396343|NCT00000909|Antiviral Agents|antiviral agents|mesh-ancestor
111396344|NCT00000909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111396345|NCT05444699|Prednisolone|prednisolone|mesh-list
111396346|NCT05444699|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111396347|NCT05444699|Methylprednisolone|methylprednisolone|mesh-list
111396348|NCT05444699|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111396349|NCT05444699|Prednisolone acetate|prednisolone acetate|mesh-list
111396350|NCT05444699|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111396351|NCT05444699|Prednisolone phosphate|prednisolone phosphate|mesh-list
111396352|NCT05444699|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111396353|NCT05444699|Glucocorticoids|glucocorticoids|mesh-ancestor
111396354|NCT05444699|Hormones|hormones|mesh-ancestor
111396355|NCT05444699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111396356|NCT05444699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111396357|NCT05444699|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111396358|NCT05444699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111396359|NCT05444699|Antiemetics|antiemetics|mesh-ancestor
111396360|NCT05444699|Autonomic Agents|autonomic agents|mesh-ancestor
111396361|NCT05444699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111396362|NCT05444699|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111396363|NCT05444699|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111396364|NCT05444699|Protective Agents|protective agents|mesh-ancestor
111396365|NCT00001863|Leflunomide|leflunomide|mesh-list
111396366|NCT00001863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111396367|NCT00001863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111396368|NCT00001863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111396369|NCT00001863|Immunologic Factors|immunologic factors|mesh-ancestor
111396370|NCT00001863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111396371|NCT00000921|Prednisone|prednisone|mesh-list
111396372|NCT00000921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111396373|NCT00000921|Glucocorticoids|glucocorticoids|mesh-ancestor
111396374|NCT00000921|Hormones|hormones|mesh-ancestor
111396375|NCT00000921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111396376|NCT00000921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111396377|NCT00000921|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111396378|NCT00000921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111396379|NCT02321436|Botulinum Toxins|botulinum toxins|mesh-list
111396380|NCT02321436|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111120800|NCT03542695|Copper|copper|mesh-list
111396381|NCT02321436|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111396382|NCT02321436|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111396383|NCT02321436|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111396384|NCT02321436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111396385|NCT02321436|Cholinergic Agents|cholinergic agents|mesh-ancestor
111396386|NCT02321436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111396387|NCT02321436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111396388|NCT02321436|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111396389|NCT02321436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111396390|NCT05325515|Alendronate|alendronate|mesh-list
111396391|NCT05325515|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111396392|NCT05325515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111396393|NCT00000939|Efavirenz|efavirenz|mesh-list
111396394|NCT00000939|Stavudine|stavudine|mesh-list
111396395|NCT00000939|Didanosine|didanosine|mesh-list
111396396|NCT00000939|Hydroxyurea|hydroxyurea|mesh-list
111396397|NCT00000939|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111396398|NCT00000939|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111396399|NCT00000939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111396400|NCT00000939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111396401|NCT00000939|Antiviral Agents|antiviral agents|mesh-ancestor
111396402|NCT00000939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111396403|NCT00000939|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111396404|NCT00000939|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111396405|NCT00000939|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111396406|NCT00000939|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111396407|NCT00000939|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111396408|NCT00000939|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111396409|NCT00000939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111396410|NCT00000939|Antisickling Agents|antisickling agents|mesh-ancestor
111396411|NCT00000939|Antimetabolites|antimetabolites|mesh-ancestor
111396412|NCT00000939|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111396413|NCT00000939|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111396414|NCT00000945|Cidofovir|cidofovir|mesh-list
111396415|NCT00000945|Probenecid|probenecid|mesh-list
111396416|NCT00000945|Uricosuric Agents|uricosuric agents|mesh-ancestor
111396417|NCT00000945|Gout Suppressants|gout suppressants|mesh-ancestor
111396418|NCT00000945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111396419|NCT00000945|Antiviral Agents|antiviral agents|mesh-ancestor
111396420|NCT00000945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111396421|NCT00000945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111396422|NCT00000945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111396423|NCT04344041|Cholecalciferol|cholecalciferol|mesh-list
111396424|NCT04344041|Vitamin D|vitamin d|mesh-list
111396425|NCT04344041|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111396426|NCT04344041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111396427|NCT04344041|Vitamins|vitamins|mesh-ancestor
111396428|NCT04344041|Micronutrients|micronutrients|mesh-ancestor
111396429|NCT04344041|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111396430|NCT00000963|Didanosine|didanosine|mesh-list
111396431|NCT00000963|Antimetabolites|antimetabolites|mesh-ancestor
111396432|NCT00000963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111396433|NCT00000963|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111396434|NCT00000963|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111396435|NCT00000963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111396436|NCT00000963|Antiviral Agents|antiviral agents|mesh-ancestor
111396437|NCT00000963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111396438|NCT00000963|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111396439|NCT00000963|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111396440|NCT02319642|Certolizumab Pegol|certolizumab pegol|mesh-list
111396441|NCT02319642|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111396442|NCT02319642|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111396443|NCT02319642|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111396444|NCT02319642|Immunologic Factors|immunologic factors|mesh-ancestor
111396445|NCT02319642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111396446|NCT02319642|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111396447|NCT00001893|Etanercept|etanercept|mesh-list
111396448|NCT00001893|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111396449|NCT00001893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111396450|NCT00001893|Analgesics|analgesics|mesh-ancestor
111396451|NCT00001893|Sensory System Agents|sensory system agents|mesh-ancestor
111396452|NCT00001893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111396453|NCT00001893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111396454|NCT00001893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111396455|NCT00001893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111396456|NCT00001893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111396457|NCT00001893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111396458|NCT00001893|Immunologic Factors|immunologic factors|mesh-ancestor
111396459|NCT00000981|Fiacitabine|fiacitabine|mesh-list
111396460|NCT00000981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111396461|NCT00000981|Antiviral Agents|antiviral agents|mesh-ancestor
111396462|NCT00000981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111396463|NCT02280096|4-Aminopyridine|4-aminopyridine|mesh-list
111396464|NCT02280096|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
111396465|NCT02280096|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111396466|NCT02280096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111396467|NCT00001905|Interferons|interferons|mesh-list
111396468|NCT00001905|Interferon-gamma|interferon-gamma|mesh-list
111396469|NCT00001905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111396470|NCT00001905|Antiviral Agents|antiviral agents|mesh-ancestor
111396471|NCT00001905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111396473|NCT00000987|Doxorubicin|doxorubicin|mesh-list
111396474|NCT00000987|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111396475|NCT00000987|Bleomycin|bleomycin|mesh-list
111396476|NCT00000987|Vincristine|vincristine|mesh-list
111396477|NCT00000987|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111396478|NCT00000987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111396479|NCT00000987|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111396480|NCT00000987|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111396481|NCT00000987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111396482|NCT00000987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111396483|NCT00000987|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111396484|NCT00000987|Tubulin Modulators|tubulin modulators|mesh-ancestor
111396485|NCT00000987|Antimitotic Agents|antimitotic agents|mesh-ancestor
111396486|NCT00000987|Mitosis Modulators|mitosis modulators|mesh-ancestor
111396487|NCT00000987|Antimetabolites|antimetabolites|mesh-ancestor
111396488|NCT00000987|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111396489|NCT00000987|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111396490|NCT00000987|Antiviral Agents|antiviral agents|mesh-ancestor
111396491|NCT00000987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111396492|NCT00000987|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111396493|NCT00000987|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111396494|NCT00001911|Interleukin-12|interleukin-12|mesh-list
111396495|NCT00001911|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111396496|NCT00001911|Immunologic Factors|immunologic factors|mesh-ancestor
111396497|NCT00001911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111396498|NCT00001911|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111396499|NCT00001911|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111396500|NCT00001911|Growth Substances|growth substances|mesh-ancestor
111396501|NCT00001911|Growth Inhibitors|growth inhibitors|mesh-ancestor
111396502|NCT00001911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111396503|NCT00001929|Eliprodil|eliprodil|mesh-list
111396504|NCT00001929|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111396505|NCT00001929|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111396506|NCT00001929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111396507|NCT00001929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111396508|NCT00001929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111396509|NCT00001929|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111396510|NCT00001929|Protective Agents|protective agents|mesh-ancestor
111396511|NCT00358553|Insulin|insulin|mesh-list
111396512|NCT00358553|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111396513|NCT00358553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111396514|NCT00000993|Zidovudine|zidovudine|mesh-list
111396515|NCT00000993|Antimetabolites|antimetabolites|mesh-ancestor
111396516|NCT00000993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111396517|NCT00000993|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111396518|NCT00000993|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111396519|NCT00000993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111396520|NCT00000993|Antiviral Agents|antiviral agents|mesh-ancestor
111396521|NCT00000993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111396522|NCT00000993|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111396523|NCT00000993|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111396524|NCT00359177|Casopitant|casopitant|mesh-list
111396525|NCT00359177|Antiemetics|antiemetics|mesh-ancestor
111396526|NCT00359177|Autonomic Agents|autonomic agents|mesh-ancestor
111396527|NCT00359177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111396528|NCT00359177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111396529|NCT00359177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111396530|NCT00359177|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
111120880|NCT03419234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111396531|NCT00359177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111396532|NCT00359177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111396533|NCT00001017|Fluconazole|fluconazole|mesh-list
111396534|NCT00001017|Amphotericin B|amphotericin b|mesh-list
111396535|NCT00001017|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
111396536|NCT00001017|Antifungal Agents|antifungal agents|mesh-ancestor
111396537|NCT00001017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111396538|NCT00001017|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111396539|NCT00001017|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111396540|NCT00001017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111396541|NCT00001017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111396542|NCT00001017|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111396543|NCT00001017|Hormone Antagonists|hormone antagonists|mesh-ancestor
111396544|NCT00001017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111396545|NCT00001017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111396546|NCT00001017|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111396547|NCT00001017|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111396548|NCT00001017|Amebicides|amebicides|mesh-ancestor
111396549|NCT00001017|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111396550|NCT00001017|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111396551|NCT00001017|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111396552|NCT02279862|Ipilimumab|ipilimumab|mesh-list
111396553|NCT02279862|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111396554|NCT02279862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111396555|NCT02279862|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111396556|NCT02279862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111396557|NCT00001965|Cyclosporine|cyclosporine|mesh-list
111396558|NCT00001965|Cyclosporins|cyclosporins|mesh-list
111396559|NCT00001965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111396560|NCT00001965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111396561|NCT00001965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111396562|NCT00001965|Immunologic Factors|immunologic factors|mesh-ancestor
111396563|NCT00001965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111396564|NCT00001965|Antifungal Agents|antifungal agents|mesh-ancestor
111396565|NCT00001965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111396566|NCT00001965|Dermatologic Agents|dermatologic agents|mesh-ancestor
111396567|NCT00001965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111396568|NCT00001965|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111396569|NCT00001023|Azithromycin|azithromycin|mesh-list
111396570|NCT00001023|Clarithromycin|clarithromycin|mesh-list
111396571|NCT00001023|Rifabutin|rifabutin|mesh-list
111396572|NCT00001023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111396573|NCT00001023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111396574|NCT00001023|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111396575|NCT00001023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111396576|NCT00001023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111396577|NCT00001023|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111396578|NCT00001023|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111396579|NCT00001023|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111396580|NCT00001023|Antitubercular Agents|antitubercular agents|mesh-ancestor
111396581|NCT00001035|Interferons|interferons|mesh-list
111396582|NCT00001035|Interferon-alpha|interferon-alpha|mesh-list
111396583|NCT00001035|Interferon alpha-2|interferon alpha-2|mesh-list
111396584|NCT00001035|Zidovudine|zidovudine|mesh-list
111396585|NCT00001035|Didanosine|didanosine|mesh-list
111396586|NCT00001035|Zalcitabine|zalcitabine|mesh-list
111396587|NCT00001035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111396588|NCT00001035|Antiviral Agents|antiviral agents|mesh-ancestor
111396589|NCT00001035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111396590|NCT00001035|Immunologic Factors|immunologic factors|mesh-ancestor
111396591|NCT00001035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111396592|NCT00001035|Antimetabolites|antimetabolites|mesh-ancestor
111396593|NCT00001035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111396594|NCT00001035|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111396595|NCT00001035|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111396596|NCT00001035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111396597|NCT00001035|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111396598|NCT00001035|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111396599|NCT05503901|Timolol|timolol|mesh-list
111396600|NCT05503901|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111396601|NCT05503901|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111396602|NCT05503901|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111396603|NCT05503901|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111396604|NCT05503901|Adrenergic Agents|adrenergic agents|mesh-ancestor
111396605|NCT05503901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111396606|NCT05503901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111396607|NCT05503901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111396608|NCT05503901|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111396609|NCT05503901|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111396611|NCT00001053|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111396612|NCT00001053|Immunologic Factors|immunologic factors|mesh-ancestor
111396613|NCT00001053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111396614|NCT00001053|Antacids|antacids|mesh-ancestor
111396615|NCT00001053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111396616|NCT00001053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111396617|NCT00001989|Zidovudine|zidovudine|mesh-list
111396618|NCT00001989|Trichosanthin|trichosanthin|mesh-list
111396619|NCT00001989|Antimetabolites|antimetabolites|mesh-ancestor
111396620|NCT00001989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111396621|NCT00001989|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111396622|NCT00001989|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111396623|NCT00001989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111396624|NCT00001989|Antiviral Agents|antiviral agents|mesh-ancestor
111396625|NCT00001989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111396626|NCT00001989|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111396627|NCT00001989|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111396628|NCT00001989|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111396629|NCT00001989|Abortifacient Agents|abortifacient agents|mesh-ancestor
111396630|NCT00001989|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111396631|NCT00001989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111396632|NCT00001989|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111396633|NCT00001989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111396634|NCT00001059|Doxorubicin|doxorubicin|mesh-list
111396635|NCT00001059|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111396636|NCT00001059|Bleomycin|bleomycin|mesh-list
111396637|NCT00001059|Vincristine|vincristine|mesh-list
111396638|NCT00001059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111396639|NCT00001059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111396640|NCT00001059|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111396641|NCT00001059|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111396642|NCT00001059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111396643|NCT00001059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111396644|NCT00001059|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111396645|NCT00001059|Tubulin Modulators|tubulin modulators|mesh-ancestor
111396646|NCT00001059|Antimitotic Agents|antimitotic agents|mesh-ancestor
111396647|NCT00001059|Mitosis Modulators|mitosis modulators|mesh-ancestor
111396648|NCT00001065|Amphotericin B|amphotericin b|mesh-list
111396649|NCT00001065|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
111396650|NCT00001065|Amebicides|amebicides|mesh-ancestor
111396651|NCT00001065|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111396652|NCT00001065|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111396653|NCT00001065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111396654|NCT00001065|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111396655|NCT00001065|Antifungal Agents|antifungal agents|mesh-ancestor
111396656|NCT02977637|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
111396657|NCT02977637|Hematinics|hematinics|mesh-ancestor
111396658|NCT02977637|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
111396659|NCT02977637|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111396660|NCT00001995|Rifabutin|rifabutin|mesh-list
111396661|NCT00001995|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111396662|NCT00001995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111396663|NCT00001995|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111396664|NCT00001995|Antitubercular Agents|antitubercular agents|mesh-ancestor
111396665|NCT05501483|Pioglitazone|pioglitazone|mesh-list
111396666|NCT05501483|Empagliflozin|empagliflozin|mesh-list
111396667|NCT05501483|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111396668|NCT05501483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111396669|NCT05501483|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111396670|NCT05501483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111396671|NCT00002001|Zidovudine|zidovudine|mesh-list
111396672|NCT00002001|Didanosine|didanosine|mesh-list
111396673|NCT00002001|Zalcitabine|zalcitabine|mesh-list
111396674|NCT00002001|Antimetabolites|antimetabolites|mesh-ancestor
111396675|NCT00002001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111396676|NCT00002001|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111396677|NCT00002001|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111396678|NCT00002001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111396679|NCT00002001|Antiviral Agents|antiviral agents|mesh-ancestor
111121034|NCT03087071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111396680|NCT00002001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111396681|NCT00002001|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111396682|NCT00002001|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111396683|NCT00002007|Zidovudine|zidovudine|mesh-list
111396684|NCT00002007|Sargramostim|sargramostim|mesh-list
111396685|NCT00002007|Antimetabolites|antimetabolites|mesh-ancestor
111396686|NCT00002007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111396687|NCT00002007|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111396688|NCT00002007|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111396689|NCT00002007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111396690|NCT00002007|Antiviral Agents|antiviral agents|mesh-ancestor
111396691|NCT00002007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111396692|NCT00002007|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111396693|NCT00002007|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111396694|NCT00002007|Immunologic Factors|immunologic factors|mesh-ancestor
111396695|NCT00002007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111396696|NCT00001095|Lamivudine|lamivudine|mesh-list
111396697|NCT00001095|Zidovudine|zidovudine|mesh-list
111396698|NCT00001095|Nevirapine|nevirapine|mesh-list
111396699|NCT00001095|Stavudine|stavudine|mesh-list
111396700|NCT00001095|Indinavir|indinavir|mesh-list
111396701|NCT00001095|Amprenavir|amprenavir|mesh-list
111396702|NCT00001095|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111396703|NCT00001095|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111396704|NCT00001095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111396705|NCT00001095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111396706|NCT00001095|Antiviral Agents|antiviral agents|mesh-ancestor
111396707|NCT00001095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111396708|NCT00001095|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111396709|NCT00001095|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111396710|NCT00001095|Antimetabolites|antimetabolites|mesh-ancestor
111396711|NCT00001095|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111396712|NCT00001095|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111396713|NCT00001095|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111396714|NCT00001095|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110873856|NCT04483960|Nafamostat|nafamostat|mesh-list
111396715|NCT00001095|Protease Inhibitors|protease inhibitors|mesh-ancestor
111396716|NCT00001095|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111396717|NCT00001095|Antitubercular Agents|antitubercular agents|mesh-ancestor
111396718|NCT00001095|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111396719|NCT02294058|Interferons|interferons|mesh-list
111396720|NCT02294058|Interferon-beta|interferon-beta|mesh-list
111396721|NCT02294058|Interferon beta-1a|interferon beta-1a|mesh-list
111396722|NCT02294058|Ozanimod|ozanimod|mesh-list
111396723|NCT02294058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111396724|NCT02294058|Antiviral Agents|antiviral agents|mesh-ancestor
111396725|NCT02294058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111396726|NCT02294058|Immunologic Factors|immunologic factors|mesh-ancestor
111396727|NCT02294058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111396728|NCT02294058|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111396729|NCT02294058|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
111396730|NCT02294058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111396731|NCT02294058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111396732|NCT00002013|Zidovudine|zidovudine|mesh-list
111396733|NCT00002013|Antimetabolites|antimetabolites|mesh-ancestor
111396734|NCT00002013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111396735|NCT00002013|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111396736|NCT00002013|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111396737|NCT00002013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111396738|NCT00002013|Antiviral Agents|antiviral agents|mesh-ancestor
111396739|NCT00002013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111396740|NCT00002013|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111396741|NCT00002013|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111396742|NCT00359333|Gemcitabine|gemcitabine|mesh-list
111396743|NCT00359333|Docetaxel|docetaxel|mesh-list
111396744|NCT00359333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111396745|NCT00359333|Antimetabolites|antimetabolites|mesh-ancestor
111396746|NCT00359333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111396747|NCT00359333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111396748|NCT00359333|Tubulin Modulators|tubulin modulators|mesh-ancestor
111396749|NCT00359333|Antimitotic Agents|antimitotic agents|mesh-ancestor
111396750|NCT00359333|Mitosis Modulators|mitosis modulators|mesh-ancestor
111396751|NCT00001101|Doxycycline|doxycycline|mesh-list
111396752|NCT00001101|Ceftriaxone|ceftriaxone|mesh-list
111396753|NCT00001101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111121110|NCT02905110|Methotrexate|methotrexate|mesh-list
111396754|NCT00001101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111396755|NCT00001101|Antimalarials|antimalarials|mesh-ancestor
111396756|NCT00001101|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111396757|NCT00001101|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111396758|NCT00001107|Fluconazole|fluconazole|mesh-list
111396759|NCT00001107|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
111396760|NCT00001107|Antifungal Agents|antifungal agents|mesh-ancestor
111396761|NCT00001107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111396762|NCT00001107|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111396763|NCT00001107|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111396764|NCT00001107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111396765|NCT00001107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111396766|NCT00001107|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111396767|NCT00001107|Hormone Antagonists|hormone antagonists|mesh-ancestor
111396768|NCT00001107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111396769|NCT00001107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111396770|NCT00001107|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111396771|NCT00001107|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111396772|NCT00001107|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111396773|NCT00001107|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111396774|NCT00002019|Amphotericin B|amphotericin b|mesh-list
111396775|NCT00002019|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
111396776|NCT00002019|Amebicides|amebicides|mesh-ancestor
111396777|NCT00002019|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111396778|NCT00002019|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111396779|NCT00002019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111396780|NCT00002019|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111396781|NCT00002019|Antifungal Agents|antifungal agents|mesh-ancestor
111396782|NCT00002025|Ganciclovir|ganciclovir|mesh-list
111396783|NCT00002025|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
111396784|NCT00002025|Antiviral Agents|antiviral agents|mesh-ancestor
111396785|NCT00002025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111396786|NCT00002025|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111396787|NCT00002025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111396788|NCT00002025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111396789|NCT00001131|Aldesleukin|aldesleukin|mesh-list
111396790|NCT00001131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111396791|NCT00001131|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111396792|NCT00001131|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111396793|NCT00001131|Antiviral Agents|antiviral agents|mesh-ancestor
111396794|NCT00001131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111396795|NCT00001155|Cyclophosphamide|cyclophosphamide|mesh-list
111396796|NCT00001155|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111396797|NCT00001155|Immunologic Factors|immunologic factors|mesh-ancestor
111396798|NCT00001155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111396799|NCT00001155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111396800|NCT00001155|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111396801|NCT00001155|Alkylating Agents|alkylating agents|mesh-ancestor
111396802|NCT00001155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111396803|NCT00001155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111396804|NCT00001155|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111396805|NCT00002037|Trifluridine|trifluridine|mesh-list
111396806|NCT00002037|Antimetabolites|antimetabolites|mesh-ancestor
111396807|NCT00002037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111396808|NCT00002037|Antiviral Agents|antiviral agents|mesh-ancestor
111396809|NCT00002037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111396810|NCT00001197|Hydroxyurea|hydroxyurea|mesh-list
111396811|NCT00001197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111396812|NCT00001197|Antisickling Agents|antisickling agents|mesh-ancestor
111396813|NCT00001197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111396814|NCT00001197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111396815|NCT00001197|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111396816|NCT05270057|Prednisone|prednisone|mesh-list
111396817|NCT05270057|Cyclophosphamide|cyclophosphamide|mesh-list
111396818|NCT05270057|Rituximab|rituximab|mesh-list
111396819|NCT05270057|Doxorubicin|doxorubicin|mesh-list
111396820|NCT05270057|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111396821|NCT05270057|Etoposide|etoposide|mesh-list
111396822|NCT05270057|Vincristine|vincristine|mesh-list
111396823|NCT05270057|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
111396824|NCT05270057|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111396825|NCT05270057|Immunologic Factors|immunologic factors|mesh-ancestor
111396826|NCT05270057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111396827|NCT05270057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111396828|NCT05270057|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111396829|NCT05270057|Alkylating Agents|alkylating agents|mesh-ancestor
111396830|NCT05270057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111396831|NCT05270057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111396832|NCT05270057|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111396833|NCT05270057|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111396834|NCT05270057|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111396835|NCT05270057|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111396836|NCT05270057|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111396837|NCT05270057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111396838|NCT05270057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111396839|NCT05270057|Glucocorticoids|glucocorticoids|mesh-ancestor
111396841|NCT05270057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111396842|NCT05270057|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111396843|NCT05270057|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111396844|NCT05270057|Tubulin Modulators|tubulin modulators|mesh-ancestor
111396845|NCT05270057|Antimitotic Agents|antimitotic agents|mesh-ancestor
110873990|NCT04381936|Colchicine|colchicine|mesh-list
111396846|NCT05270057|Mitosis Modulators|mitosis modulators|mesh-ancestor
111396847|NCT00002043|Dapsone|dapsone|mesh-list
111396848|NCT00002043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111396849|NCT00002043|Antimalarials|antimalarials|mesh-ancestor
111396850|NCT00002043|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111396851|NCT00002043|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111396852|NCT00002043|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111396853|NCT00002043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111396854|NCT00002043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111396855|NCT00002043|Leprostatic Agents|leprostatic agents|mesh-ancestor
111396856|NCT00002043|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111396857|NCT00001209|Cyclophosphamide|cyclophosphamide|mesh-list
111396858|NCT00001209|Ifosfamide|ifosfamide|mesh-list
111396859|NCT00001209|Vincristine|vincristine|mesh-list
111396860|NCT00001209|Doxorubicin|doxorubicin|mesh-list
111396861|NCT00001209|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111396862|NCT00001209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111396863|NCT00001209|Immunologic Factors|immunologic factors|mesh-ancestor
111396864|NCT00001209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111396865|NCT00001209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111396866|NCT00001209|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111396867|NCT00001209|Alkylating Agents|alkylating agents|mesh-ancestor
111396868|NCT00001209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111396869|NCT00001209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111396870|NCT00001209|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111396871|NCT00001209|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111396872|NCT00001209|Tubulin Modulators|tubulin modulators|mesh-ancestor
111396873|NCT00001209|Antimitotic Agents|antimitotic agents|mesh-ancestor
111396874|NCT00001209|Mitosis Modulators|mitosis modulators|mesh-ancestor
111396875|NCT00001209|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111396876|NCT00001209|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111396877|NCT00001209|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111396878|NCT00001209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111396879|NCT00002049|Thymopentin|thymopentin|mesh-list
111396880|NCT00002049|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111396881|NCT00002049|Immunologic Factors|immunologic factors|mesh-ancestor
111396882|NCT00002049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111396883|NCT05044637|Primaquine|primaquine|mesh-list
111396884|NCT05044637|Antimalarials|antimalarials|mesh-ancestor
111396885|NCT05044637|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111396886|NCT05044637|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111396887|NCT05044637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111396888|NCT05043077|Phenylephrine|phenylephrine|mesh-list
111396889|NCT05043077|Oxymetazoline|oxymetazoline|mesh-list
111396890|NCT05043077|Tropicamide|tropicamide|mesh-list
111396891|NCT05043077|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111396892|NCT05043077|Mydriatics|mydriatics|mesh-ancestor
111396893|NCT05043077|Autonomic Agents|autonomic agents|mesh-ancestor
111396894|NCT05043077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111396895|NCT05043077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111396896|NCT05043077|Sympathomimetics|sympathomimetics|mesh-ancestor
111396897|NCT05043077|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111396898|NCT05043077|Nasal Decongestants|nasal decongestants|mesh-ancestor
111396899|NCT05043077|Respiratory System Agents|respiratory system agents|mesh-ancestor
111396900|NCT05043077|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111396901|NCT05043077|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111396902|NCT05043077|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111396903|NCT05043077|Adrenergic Agents|adrenergic agents|mesh-ancestor
111396904|NCT05043077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111396905|NCT05043077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111396906|NCT05043077|Protective Agents|protective agents|mesh-ancestor
111396907|NCT05043077|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111396908|NCT05043077|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111396909|NCT05043077|Cholinergic Agents|cholinergic agents|mesh-ancestor
111396910|NCT00002055|Pentamidine|pentamidine|mesh-list
111396911|NCT00002055|Antifungal Agents|antifungal agents|mesh-ancestor
111396912|NCT00002055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111396913|NCT00002055|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111396914|NCT00002055|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111396915|NCT00002055|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
111396917|NCT05031455|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111396918|NCT05031455|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111396919|NCT05031455|Analgesics|analgesics|mesh-ancestor
111396920|NCT05031455|Sensory System Agents|sensory system agents|mesh-ancestor
111396921|NCT05031455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111396922|NCT05031455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111396923|NCT05031455|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111396924|NCT05031455|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111396925|NCT05031455|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111396926|NCT05031455|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111396927|NCT05031455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111396928|NCT05031455|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111396929|NCT05031455|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111396930|NCT05031455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111396931|NCT05031455|Antipyretics|antipyretics|mesh-ancestor
111396932|NCT05029973|Bevacizumab|bevacizumab|mesh-list
111396933|NCT05029973|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111396934|NCT05029973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111396935|NCT05029973|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111396936|NCT05029973|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111396937|NCT05029973|Growth Substances|growth substances|mesh-ancestor
111396938|NCT05029973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111396939|NCT05029973|Growth Inhibitors|growth inhibitors|mesh-ancestor
111396940|NCT00002061|Inosine Pranobex|inosine pranobex|mesh-list
111396941|NCT00002061|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111396942|NCT00002061|Immunologic Factors|immunologic factors|mesh-ancestor
111396943|NCT00002061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111396944|NCT00002061|Antiviral Agents|antiviral agents|mesh-ancestor
111396945|NCT00002061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111396946|NCT00002067|Megestrol|megestrol|mesh-list
111396947|NCT00002067|Megestrol Acetate|megestrol acetate|mesh-list
111396948|NCT00002067|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111396949|NCT00002067|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111396950|NCT00002067|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111396951|NCT00002067|Contraceptive Agents|contraceptive agents|mesh-ancestor
111396952|NCT00002067|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111396953|NCT00002067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111396954|NCT00002067|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111396955|NCT00002067|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111396956|NCT00002067|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111396957|NCT00002067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111396958|NCT00002067|Appetite Stimulants|appetite stimulants|mesh-ancestor
111396959|NCT00002067|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111396960|NCT00380835|Amrubicin|amrubicin|mesh-list
111396961|NCT00380835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111396962|NCT00001311|Heparin|heparin|mesh-list
111396963|NCT00001311|Anticoagulants|anticoagulants|mesh-ancestor
111396964|NCT00001311|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111396965|NCT00001311|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111396966|NCT00001311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111396967|NCT05016713|Chlorhexidine|chlorhexidine|mesh-list
111396968|NCT05016713|Fluorides|fluorides|mesh-list
111396969|NCT05016713|Cariostatic Agents|cariostatic agents|mesh-ancestor
111396970|NCT05016713|Protective Agents|protective agents|mesh-ancestor
111396971|NCT05016713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111396972|NCT05016713|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111396973|NCT05016713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111396974|NCT05016713|Disinfectants|disinfectants|mesh-ancestor
111396975|NCT00002073|Epoetin Alfa|epoetin alfa|mesh-list
111396976|NCT00002073|Hematinics|hematinics|mesh-ancestor
111396977|NCT00001317|Interferons|interferons|mesh-list
111396978|NCT00001317|Interferon-gamma|interferon-gamma|mesh-list
111396979|NCT00001317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111396980|NCT00001317|Antiviral Agents|antiviral agents|mesh-ancestor
111396981|NCT00001317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111396982|NCT00001335|Topotecan|topotecan|mesh-list
111396983|NCT00001335|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111396984|NCT00001335|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111396985|NCT00001335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111396986|NCT00001335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111396987|NCT00001335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111396989|NCT00002079|Zidovudine|zidovudine|mesh-list
111396990|NCT00002079|Antimetabolites|antimetabolites|mesh-ancestor
111396991|NCT00002079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111396992|NCT00002079|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111396993|NCT00002079|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111396994|NCT00002079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111396995|NCT00002079|Antiviral Agents|antiviral agents|mesh-ancestor
111396996|NCT00002079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111396997|NCT00002079|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111396998|NCT00002079|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111396999|NCT00002079|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
111397000|NCT00002079|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111397001|NCT00002079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111397002|NCT00002085|Azithromycin|azithromycin|mesh-list
111397003|NCT00002085|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111397004|NCT00002085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111397005|NCT00001383|Paclitaxel|paclitaxel|mesh-list
111397006|NCT00001383|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111397007|NCT00001383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111397008|NCT00001383|Tubulin Modulators|tubulin modulators|mesh-ancestor
111397009|NCT00001383|Antimitotic Agents|antimitotic agents|mesh-ancestor
111397010|NCT00001383|Mitosis Modulators|mitosis modulators|mesh-ancestor
111397011|NCT00001383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111397012|NCT00002091|Pentoxifylline|pentoxifylline|mesh-list
111397013|NCT00002091|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111397014|NCT00002091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111397015|NCT00002091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111397016|NCT00002091|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111397017|NCT00002091|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111397018|NCT00002091|Protective Agents|protective agents|mesh-ancestor
111397019|NCT00002091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111397020|NCT00002091|Vasodilator Agents|vasodilator agents|mesh-ancestor
111397021|NCT00002091|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111397022|NCT00002091|Antioxidants|antioxidants|mesh-ancestor
111397023|NCT00001407|Interferons|interferons|mesh-list
111397024|NCT00001407|Interferon-gamma|interferon-gamma|mesh-list
111397025|NCT00001407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111397026|NCT00001407|Antiviral Agents|antiviral agents|mesh-ancestor
111397027|NCT00001407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111397028|NCT00002097|Nystatin|nystatin|mesh-list
111397029|NCT00002097|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111397030|NCT00002097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111397031|NCT00002097|Antifungal Agents|antifungal agents|mesh-ancestor
111397032|NCT00002097|Ionophores|ionophores|mesh-ancestor
111397033|NCT00002097|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111397034|NCT00002097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111397035|NCT00001431|Gemcitabine|gemcitabine|mesh-list
111397036|NCT00001431|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111397037|NCT00001431|Antimetabolites|antimetabolites|mesh-ancestor
111397038|NCT00001431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111397039|NCT00001431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111397040|NCT00002103|Leucovorin|leucovorin|mesh-list
111397041|NCT00002103|Trimetrexate|trimetrexate|mesh-list
111397042|NCT00002103|Calcium|calcium|mesh-list
111397043|NCT00002103|Levoleucovorin|levoleucovorin|mesh-list
111397044|NCT00002103|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111397045|NCT00002103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111397046|NCT00002103|Antidotes|antidotes|mesh-ancestor
111397047|NCT00002103|Protective Agents|protective agents|mesh-ancestor
111397048|NCT00002103|Vitamin B Complex|vitamin b complex|mesh-ancestor
111397049|NCT00002103|Vitamins|vitamins|mesh-ancestor
111397050|NCT00002103|Micronutrients|micronutrients|mesh-ancestor
111397051|NCT00002103|Antifungal Agents|antifungal agents|mesh-ancestor
111397052|NCT00002103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111397053|NCT00002103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111397054|NCT00002103|Antimetabolites|antimetabolites|mesh-ancestor
111397055|NCT00002103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111397056|NCT00002103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111397057|NCT00002103|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111397058|NCT00002103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111397059|NCT00001437|Pentoxifylline|pentoxifylline|mesh-list
111397060|NCT00001437|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111397062|NCT00001437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111397063|NCT00001437|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111397064|NCT00001437|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111397065|NCT00001437|Protective Agents|protective agents|mesh-ancestor
111397066|NCT00001437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111397067|NCT00001437|Vasodilator Agents|vasodilator agents|mesh-ancestor
111397068|NCT00001437|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111397069|NCT00001437|Antioxidants|antioxidants|mesh-ancestor
111397070|NCT00360191|Buspirone|buspirone|mesh-list
111397071|NCT00360191|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111397072|NCT00360191|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111397073|NCT00360191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111397074|NCT00360191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111397075|NCT00360191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111397076|NCT00360191|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111397077|NCT00360191|Serotonin Agents|serotonin agents|mesh-ancestor
111397078|NCT00360191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111397079|NCT00360191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111397080|NCT00001443|Indinavir|indinavir|mesh-list
111397081|NCT00001443|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111397082|NCT00001443|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111397083|NCT00001443|Protease Inhibitors|protease inhibitors|mesh-ancestor
111397084|NCT00001443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111397085|NCT00001443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111397086|NCT00001443|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111397087|NCT00001443|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111397088|NCT00001443|Antiviral Agents|antiviral agents|mesh-ancestor
111397089|NCT00001443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111397090|NCT00001449|Leucovorin|leucovorin|mesh-list
111397091|NCT00001449|Gemcitabine|gemcitabine|mesh-list
111397092|NCT00001449|Floxuridine|floxuridine|mesh-list
111397093|NCT00001449|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111397094|NCT00001449|Antimetabolites|antimetabolites|mesh-ancestor
111397095|NCT00001449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111397096|NCT00001449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111397097|NCT00001449|Antidotes|antidotes|mesh-ancestor
111397098|NCT00001449|Protective Agents|protective agents|mesh-ancestor
111397099|NCT00001449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111397100|NCT00001449|Vitamin B Complex|vitamin b complex|mesh-ancestor
111397101|NCT00001449|Vitamins|vitamins|mesh-ancestor
111397102|NCT00001449|Micronutrients|micronutrients|mesh-ancestor
111397103|NCT00002109|Zidovudine|zidovudine|mesh-list
111397104|NCT00002109|Stavudine|stavudine|mesh-list
111397105|NCT00002109|Didanosine|didanosine|mesh-list
111397106|NCT00002109|Zalcitabine|zalcitabine|mesh-list
111397107|NCT00002109|Thymopentin|thymopentin|mesh-list
111397108|NCT00002109|Antimetabolites|antimetabolites|mesh-ancestor
111397109|NCT00002109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111397110|NCT00002109|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111397111|NCT00002109|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111397112|NCT00002109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111397113|NCT00002109|Antiviral Agents|antiviral agents|mesh-ancestor
111397114|NCT00002109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111397115|NCT00002109|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111397116|NCT00002109|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111397117|NCT00002109|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111397118|NCT00002109|Immunologic Factors|immunologic factors|mesh-ancestor
111397119|NCT00002109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111397120|NCT00359567|Palonosetron|palonosetron|mesh-list
111397121|NCT00359567|Granisetron|granisetron|mesh-list
111397122|NCT00359567|Antiemetics|antiemetics|mesh-ancestor
111397123|NCT00359567|Autonomic Agents|autonomic agents|mesh-ancestor
111397124|NCT00359567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111397125|NCT00359567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111397126|NCT00359567|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111397127|NCT00359567|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111397128|NCT00359567|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111397129|NCT00359567|Serotonin Agents|serotonin agents|mesh-ancestor
111397130|NCT00359567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111397131|NCT00359567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111397132|NCT00381147|Clarithromycin|clarithromycin|mesh-list
111397133|NCT00381147|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111397134|NCT00381147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111397135|NCT00381147|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111397136|NCT00381147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111397137|NCT00381147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111397138|NCT00381147|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111397139|NCT00381147|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111397140|NCT05210465|Dobutamine|dobutamine|mesh-list
111397141|NCT05210465|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111397142|NCT05210465|Sympathomimetics|sympathomimetics|mesh-ancestor
111397143|NCT05210465|Autonomic Agents|autonomic agents|mesh-ancestor
111397144|NCT05210465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111397145|NCT05210465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111397146|NCT05210465|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
111397147|NCT05210465|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111397148|NCT05210465|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111397149|NCT05210465|Adrenergic Agents|adrenergic agents|mesh-ancestor
111397150|NCT05210465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111397151|NCT05210465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111397152|NCT05210465|Protective Agents|protective agents|mesh-ancestor
111397153|NCT00002115|Adefovir|adefovir|mesh-list
111397154|NCT00002115|Antiviral Agents|antiviral agents|mesh-ancestor
111397155|NCT00002115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111397156|NCT00002115|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111397157|NCT00002115|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111397158|NCT00002115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111397159|NCT00002115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111397160|NCT04983407|Paclitaxel|paclitaxel|mesh-list
111397161|NCT04983407|Gemcitabine|gemcitabine|mesh-list
111397162|NCT04983407|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111397163|NCT04983407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111397164|NCT04983407|Tubulin Modulators|tubulin modulators|mesh-ancestor
111397165|NCT04983407|Antimitotic Agents|antimitotic agents|mesh-ancestor
111397166|NCT04983407|Mitosis Modulators|mitosis modulators|mesh-ancestor
111397167|NCT04983407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111397168|NCT04983407|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111397169|NCT04983407|Antimetabolites|antimetabolites|mesh-ancestor
111397170|NCT00001569|Paclitaxel|paclitaxel|mesh-list
111397171|NCT00001569|Cisplatin|cisplatin|mesh-list
111397172|NCT00001569|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111397173|NCT00001569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111397174|NCT00001569|Tubulin Modulators|tubulin modulators|mesh-ancestor
111397175|NCT00001569|Antimitotic Agents|antimitotic agents|mesh-ancestor
111397176|NCT00001569|Mitosis Modulators|mitosis modulators|mesh-ancestor
111397177|NCT00001569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111397178|NCT00001587|Melphalan|melphalan|mesh-list
111397179|NCT00001587|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111397180|NCT00001587|Alkylating Agents|alkylating agents|mesh-ancestor
111397181|NCT00001587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111397182|NCT00001587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111397183|NCT00001587|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111397184|NCT00001587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111397185|NCT00001587|Immunologic Factors|immunologic factors|mesh-ancestor
111397186|NCT00001587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111397187|NCT00002127|Thalidomide|thalidomide|mesh-list
111397188|NCT00002127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111397189|NCT00002127|Immunologic Factors|immunologic factors|mesh-ancestor
111397190|NCT00002127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111397191|NCT00002127|Leprostatic Agents|leprostatic agents|mesh-ancestor
111397192|NCT00002127|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111397193|NCT00002127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111397194|NCT00002127|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111397195|NCT00002127|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111397196|NCT00002127|Growth Substances|growth substances|mesh-ancestor
111397197|NCT00002127|Growth Inhibitors|growth inhibitors|mesh-ancestor
111397198|NCT00002127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111397199|NCT00001599|Thalidomide|thalidomide|mesh-list
111397200|NCT00001599|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111397201|NCT00001599|Immunologic Factors|immunologic factors|mesh-ancestor
111397202|NCT00001599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111397203|NCT00001599|Leprostatic Agents|leprostatic agents|mesh-ancestor
111397204|NCT00001599|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111397205|NCT00001599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111397206|NCT00001599|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111397207|NCT00001599|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111397208|NCT00001599|Growth Substances|growth substances|mesh-ancestor
111397209|NCT00001599|Growth Inhibitors|growth inhibitors|mesh-ancestor
111397210|NCT00001599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111397211|NCT00380913|Nabilone|nabilone|mesh-list
111397212|NCT00380913|Antiemetics|antiemetics|mesh-ancestor
111397213|NCT00380913|Autonomic Agents|autonomic agents|mesh-ancestor
111397214|NCT00380913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111397215|NCT00380913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111397216|NCT00380913|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111397217|NCT00380913|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111397218|NCT00380913|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111397219|NCT00380913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111397220|NCT00380913|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111397221|NCT00002133|Itraconazole|itraconazole|mesh-list
111397222|NCT00002133|Antifungal Agents|antifungal agents|mesh-ancestor
111397223|NCT00002133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111397224|NCT00002133|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111397225|NCT00002133|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111397226|NCT00002133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111397227|NCT00002133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111397228|NCT00002133|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111397229|NCT00002133|Hormone Antagonists|hormone antagonists|mesh-ancestor
111397230|NCT00002133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111397231|NCT00002133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111397232|NCT00002133|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111397233|NCT00001629|Angiotensin II|angiotensin ii|mesh-list
111397234|NCT00001629|Giapreza|giapreza|mesh-list
111397235|NCT00001629|Angiotensinogen|angiotensinogen|mesh-list
111397236|NCT00001629|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-list
111397237|NCT00001629|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111397238|NCT00001629|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111397239|NCT00001629|Protease Inhibitors|protease inhibitors|mesh-ancestor
111397240|NCT00001629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111397241|NCT00001629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111397242|NCT00001629|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111397243|NCT00002139|Azithromycin|azithromycin|mesh-list
111397244|NCT00002139|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111397245|NCT00002139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111397246|NCT00002295|Inosine Pranobex|inosine pranobex|mesh-list
111397247|NCT00002295|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111397248|NCT00002295|Immunologic Factors|immunologic factors|mesh-ancestor
111397249|NCT00002295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111397250|NCT00002295|Antiviral Agents|antiviral agents|mesh-ancestor
111397251|NCT00002295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111397252|NCT00002145|Foscarnet|foscarnet|mesh-list
111397253|NCT00002145|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
111397254|NCT00002145|Antiviral Agents|antiviral agents|mesh-ancestor
111397255|NCT00002145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111397256|NCT00002145|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111397257|NCT00002145|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111397258|NCT00002145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111397259|NCT00002145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111397260|NCT00002301|Foscarnet|foscarnet|mesh-list
111397261|NCT00002301|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
111397262|NCT00002301|Antiviral Agents|antiviral agents|mesh-ancestor
111397263|NCT00002301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111397264|NCT00002301|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111397265|NCT00002301|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111397266|NCT00002301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111397267|NCT00002301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111397268|NCT00002307|Zidovudine|zidovudine|mesh-list
111397269|NCT00002307|Stavudine|stavudine|mesh-list
111397270|NCT00002307|Antimetabolites|antimetabolites|mesh-ancestor
111397271|NCT00002307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111397272|NCT00002307|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111397273|NCT00002307|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111397274|NCT00002307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111397275|NCT00002307|Antiviral Agents|antiviral agents|mesh-ancestor
111397276|NCT00002307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111397277|NCT00002307|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111397278|NCT00002307|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111397279|NCT00002313|Didanosine|didanosine|mesh-list
111397280|NCT00002313|Nystatin|nystatin|mesh-list
111397281|NCT00002313|Antimetabolites|antimetabolites|mesh-ancestor
111397282|NCT00002313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111397283|NCT00002313|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111397284|NCT00002313|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111397285|NCT00002313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111397286|NCT00002313|Antiviral Agents|antiviral agents|mesh-ancestor
111397287|NCT00002313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111397288|NCT00002313|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111397289|NCT00002313|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111397290|NCT00002313|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111397291|NCT00002313|Antifungal Agents|antifungal agents|mesh-ancestor
111397292|NCT00002313|Ionophores|ionophores|mesh-ancestor
111397293|NCT00002313|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111397294|NCT00002157|Thalidomide|thalidomide|mesh-list
111397295|NCT00002157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111397296|NCT00002157|Immunologic Factors|immunologic factors|mesh-ancestor
111397297|NCT00002157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111397298|NCT00002157|Leprostatic Agents|leprostatic agents|mesh-ancestor
111397299|NCT00002157|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111397300|NCT00002157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111397301|NCT00002157|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111397302|NCT00002157|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111397303|NCT00002157|Growth Substances|growth substances|mesh-ancestor
111397304|NCT00002157|Growth Inhibitors|growth inhibitors|mesh-ancestor
111397305|NCT00002157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111397306|NCT00002319|Doxorubicin|doxorubicin|mesh-list
111397307|NCT00002319|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111397308|NCT00002319|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111397309|NCT00002319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111397310|NCT00002319|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111397311|NCT00002319|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111397312|NCT00002319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111397313|NCT00002319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111397314|NCT00002163|Abacavir|abacavir|mesh-list
111397315|NCT00002163|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111397316|NCT00002163|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111397317|NCT00002163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111397318|NCT00002163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111397319|NCT00002163|Antiviral Agents|antiviral agents|mesh-ancestor
110874458|NCT02358304|Katacalcin|katacalcin|mesh-list
111397320|NCT00002163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111397321|NCT00002163|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111397322|NCT00002163|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111397323|NCT00002325|Fluconazole|fluconazole|mesh-list
111397324|NCT00002325|Antifungal Agents|antifungal agents|mesh-ancestor
111397325|NCT00002325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111397326|NCT00002325|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111397327|NCT00002325|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111397328|NCT00002325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111397329|NCT00002325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111397330|NCT00002325|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111397331|NCT00002325|Hormone Antagonists|hormone antagonists|mesh-ancestor
111397332|NCT00002325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111397333|NCT00002325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111397334|NCT00002325|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111397335|NCT00002325|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111397336|NCT00002331|Clarithromycin|clarithromycin|mesh-list
111397337|NCT00002331|Ethambutol|ethambutol|mesh-list
111397338|NCT00002331|Clofazimine|clofazimine|mesh-list
111397339|NCT00002331|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111397340|NCT00002331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111397341|NCT00002331|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111397342|NCT00002331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111397343|NCT00002331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111397344|NCT00002331|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111397345|NCT00002331|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111397346|NCT00002331|Antitubercular Agents|antitubercular agents|mesh-ancestor
111397347|NCT00002331|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111397348|NCT00002331|Leprostatic Agents|leprostatic agents|mesh-ancestor
111397349|NCT00002337|Vesnarinone|vesnarinone|mesh-list
111397350|NCT00002337|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111397351|NCT00002337|Immunologic Factors|immunologic factors|mesh-ancestor
111397352|NCT00002337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111397353|NCT00002337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111397354|NCT00002337|Antiviral Agents|antiviral agents|mesh-ancestor
111397355|NCT00002337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111397356|NCT00002337|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111397357|NCT00002337|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111397358|NCT00002337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111397359|NCT00002337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111397360|NCT00002337|Protective Agents|protective agents|mesh-ancestor
111397361|NCT00002169|Nelfinavir|nelfinavir|mesh-list
111397362|NCT00002169|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111397363|NCT00002169|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111397364|NCT00002169|Protease Inhibitors|protease inhibitors|mesh-ancestor
111397365|NCT00002169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111397366|NCT00002169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111397367|NCT00002169|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111397368|NCT00002169|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111397369|NCT00002169|Antiviral Agents|antiviral agents|mesh-ancestor
111397370|NCT00002169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111397371|NCT02293902|Folic Acid|folic acid|mesh-list
111397372|NCT02293902|Methotrexate|methotrexate|mesh-list
111397373|NCT02293902|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111397374|NCT02293902|Abortifacient Agents|abortifacient agents|mesh-ancestor
111397375|NCT02293902|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111397376|NCT02293902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111397377|NCT02293902|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111397378|NCT02293902|Antimetabolites|antimetabolites|mesh-ancestor
111397379|NCT02293902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111397380|NCT02293902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111397381|NCT02293902|Dermatologic Agents|dermatologic agents|mesh-ancestor
111397382|NCT02293902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111397383|NCT02293902|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111397384|NCT02293902|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111397385|NCT02293902|Immunologic Factors|immunologic factors|mesh-ancestor
111397386|NCT02293902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111397387|NCT02293902|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111397388|NCT02293902|Hematinics|hematinics|mesh-ancestor
111397389|NCT02293902|Vitamin B Complex|vitamin b complex|mesh-ancestor
111397390|NCT02293902|Vitamins|vitamins|mesh-ancestor
111397391|NCT02293902|Micronutrients|micronutrients|mesh-ancestor
111397392|NCT00002343|Ethambutol|ethambutol|mesh-list
111397393|NCT00002343|Rifabutin|rifabutin|mesh-list
111397394|NCT00002343|Antitubercular Agents|antitubercular agents|mesh-ancestor
111397395|NCT00002343|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111397396|NCT00002343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111397397|NCT00002343|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111397398|NCT00002349|Stavudine|stavudine|mesh-list
111397399|NCT00002349|Antimetabolites|antimetabolites|mesh-ancestor
111397400|NCT00002349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111397401|NCT00002349|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111397402|NCT00002349|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111397403|NCT00002349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111397404|NCT00002349|Antiviral Agents|antiviral agents|mesh-ancestor
111397405|NCT00002349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111397406|NCT00002349|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111397407|NCT00002349|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111397408|NCT04706013|Pyridoxal|pyridoxal|mesh-list
111397409|NCT04706013|Pyridoxal Phosphate|pyridoxal phosphate|mesh-list
111397410|NCT04706013|Vitamin B Complex|vitamin b complex|mesh-ancestor
111397411|NCT04706013|Vitamins|vitamins|mesh-ancestor
111397412|NCT04706013|Micronutrients|micronutrients|mesh-ancestor
111397413|NCT04706013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111397414|NCT00002355|Fomivirsen|fomivirsen|mesh-list
111397415|NCT00002355|Antiviral Agents|antiviral agents|mesh-ancestor
111397416|NCT00002355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111397417|NCT02278614|Timolol|timolol|mesh-list
111397418|NCT02278614|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111397419|NCT02278614|Latanoprost|latanoprost|mesh-list
111397420|NCT02278614|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111397421|NCT02278614|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111397422|NCT02278614|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111397423|NCT02278614|Adrenergic Agents|adrenergic agents|mesh-ancestor
111397424|NCT02278614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111397425|NCT02278614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111397426|NCT02278614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111397427|NCT02278614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111397428|NCT02278614|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111397429|NCT00002361|Ritonavir|ritonavir|mesh-list
111397430|NCT00002361|Indinavir|indinavir|mesh-list
111397431|NCT00002361|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111397432|NCT00002361|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111121790|NCT00003388|Glucocorticoids|glucocorticoids|mesh-ancestor
111397433|NCT00002361|Protease Inhibitors|protease inhibitors|mesh-ancestor
111397434|NCT00002361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111397435|NCT00002361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111397437|NCT00002361|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111397438|NCT00002361|Antiviral Agents|antiviral agents|mesh-ancestor
111397439|NCT00002361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111397440|NCT00002361|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111397441|NCT00002361|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111397442|NCT00002181|Cidofovir|cidofovir|mesh-list
111397443|NCT00002181|Antiviral Agents|antiviral agents|mesh-ancestor
111397444|NCT00002181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111397445|NCT00002181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110874594|NCT01382238|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111397446|NCT00002181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111397447|NCT00002367|Lamivudine|lamivudine|mesh-list
111397448|NCT00002367|Zidovudine|zidovudine|mesh-list
111397449|NCT00002367|Saquinavir|saquinavir|mesh-list
111397450|NCT00002367|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111397451|NCT00002367|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111397452|NCT00002367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111397453|NCT00002367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111397454|NCT00002367|Antiviral Agents|antiviral agents|mesh-ancestor
111397455|NCT00002367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111397456|NCT00002367|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111397457|NCT00002367|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111397458|NCT00002367|Antimetabolites|antimetabolites|mesh-ancestor
111397459|NCT00002367|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111397460|NCT00002367|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111397461|NCT00002367|Protease Inhibitors|protease inhibitors|mesh-ancestor
111397462|NCT00002367|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111397463|NCT00002367|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111397464|NCT00002187|Fomivirsen|fomivirsen|mesh-list
111397465|NCT00002187|Antiviral Agents|antiviral agents|mesh-ancestor
111397466|NCT00002187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111397467|NCT00002373|Maribavir|maribavir|mesh-list
111397468|NCT00002373|Antiviral Agents|antiviral agents|mesh-ancestor
111397469|NCT00002373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111397470|NCT00002379|Lamivudine|lamivudine|mesh-list
111397471|NCT00002379|Zidovudine|zidovudine|mesh-list
111397472|NCT00002379|Stavudine|stavudine|mesh-list
111397473|NCT00002379|Adefovir|adefovir|mesh-list
111397474|NCT00002379|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
111397475|NCT00002379|Indinavir|indinavir|mesh-list
111397476|NCT00002379|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111397477|NCT00002379|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111397478|NCT00002379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111397479|NCT00002379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111397480|NCT00002379|Antiviral Agents|antiviral agents|mesh-ancestor
111397481|NCT00002379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111397482|NCT00002379|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111397483|NCT00002379|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111397484|NCT00002379|Antimetabolites|antimetabolites|mesh-ancestor
111397485|NCT00002379|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111397486|NCT00002379|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111397487|NCT00002379|Protease Inhibitors|protease inhibitors|mesh-ancestor
111397488|NCT00359723|Methylphenidate|methylphenidate|mesh-list
111397489|NCT00359723|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111397490|NCT00359723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111397491|NCT00359723|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111397492|NCT00359723|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111397493|NCT00359723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111397494|NCT00359723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111397495|NCT00359723|Dopamine Agents|dopamine agents|mesh-ancestor
111397496|NCT00359723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111397497|NCT00002193|Amprenavir|amprenavir|mesh-list
111397498|NCT00002193|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111397499|NCT00002193|Antitubercular Agents|antitubercular agents|mesh-ancestor
111397500|NCT00002193|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111397501|NCT00002193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111397502|NCT00002193|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111397503|NCT00002193|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111397504|NCT00002193|Protease Inhibitors|protease inhibitors|mesh-ancestor
111397505|NCT00002193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111397506|NCT00002193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111397507|NCT00002193|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111397508|NCT00002193|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111397509|NCT00002193|Antiviral Agents|antiviral agents|mesh-ancestor
111397510|NCT00002391|Lamivudine|lamivudine|mesh-list
111397511|NCT00002391|Zidovudine|zidovudine|mesh-list
111397512|NCT00002391|Abacavir|abacavir|mesh-list
111397513|NCT00002391|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111397514|NCT00002391|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111397516|NCT00002391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111397517|NCT00002391|Antiviral Agents|antiviral agents|mesh-ancestor
111397518|NCT00002391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111397519|NCT00002391|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111397520|NCT00002391|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111397521|NCT00002391|Antimetabolites|antimetabolites|mesh-ancestor
111397522|NCT00002199|Lamivudine|lamivudine|mesh-list
111397523|NCT00002199|Zidovudine|zidovudine|mesh-list
111397524|NCT00002199|Abacavir|abacavir|mesh-list
111397525|NCT00002199|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
111397526|NCT00002199|Indinavir|indinavir|mesh-list
111397527|NCT00002199|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111397528|NCT00002199|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111397529|NCT00002199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111397530|NCT00002199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111397531|NCT00002199|Antiviral Agents|antiviral agents|mesh-ancestor
111397532|NCT00002199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111397533|NCT00002199|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111397534|NCT00002199|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111397535|NCT00002199|Antimetabolites|antimetabolites|mesh-ancestor
111397536|NCT00002199|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111397537|NCT00002199|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111397538|NCT00002199|Protease Inhibitors|protease inhibitors|mesh-ancestor
111397539|NCT00002397|Lamivudine|lamivudine|mesh-list
111397540|NCT00002397|Stavudine|stavudine|mesh-list
111397541|NCT00002397|Nelfinavir|nelfinavir|mesh-list
111397542|NCT00002397|Saquinavir|saquinavir|mesh-list
111397543|NCT00002397|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111397544|NCT00002397|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111397545|NCT00002397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111397546|NCT00002397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111397547|NCT00002397|Antiviral Agents|antiviral agents|mesh-ancestor
111397548|NCT00002397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111397549|NCT00002397|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111397550|NCT00002397|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111397551|NCT00002397|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111397552|NCT00002397|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111397553|NCT00002397|Protease Inhibitors|protease inhibitors|mesh-ancestor
111397554|NCT00002397|Antimetabolites|antimetabolites|mesh-ancestor
111397555|NCT00002397|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111397556|NCT00002397|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111397557|NCT00002205|Abacavir|abacavir|mesh-list
111397558|NCT00002205|Amprenavir|amprenavir|mesh-list
111397559|NCT00002205|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111397560|NCT00002205|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111397561|NCT00002205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111397562|NCT00002205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111397563|NCT00002205|Antiviral Agents|antiviral agents|mesh-ancestor
111397564|NCT00002205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111397565|NCT00002205|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111397566|NCT00002205|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111397567|NCT00002205|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111397568|NCT00002205|Antitubercular Agents|antitubercular agents|mesh-ancestor
111397569|NCT00002205|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111397570|NCT00002205|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111397571|NCT00002205|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111397572|NCT00002205|Protease Inhibitors|protease inhibitors|mesh-ancestor
111397573|NCT02977169|Cisplatin|cisplatin|mesh-list
111397574|NCT02977169|Carboplatin|carboplatin|mesh-list
111397575|NCT02977169|Pemetrexed|pemetrexed|mesh-list
111397576|NCT02977169|Vinorelbine|vinorelbine|mesh-list
111397577|NCT02977169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111397578|NCT02977169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111397579|NCT02977169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111397580|NCT02977169|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111397581|NCT02977169|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111397582|NCT02977169|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111397583|NCT02977169|Tubulin Modulators|tubulin modulators|mesh-ancestor
111397584|NCT02977169|Antimitotic Agents|antimitotic agents|mesh-ancestor
111397585|NCT02977169|Mitosis Modulators|mitosis modulators|mesh-ancestor
111397586|NCT00002409|Lamivudine|lamivudine|mesh-list
111397587|NCT00002409|Zidovudine|zidovudine|mesh-list
111397588|NCT00002409|Abacavir|abacavir|mesh-list
111121937|NCT00002650|Folic Acid|folic acid|mesh-list
110874728|NCT00979212|Paclitaxel|paclitaxel|mesh-list
111397589|NCT00002409|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
111397590|NCT00002409|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111397591|NCT00002409|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111397592|NCT00002409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111397593|NCT00002409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111397594|NCT00002409|Antiviral Agents|antiviral agents|mesh-ancestor
111397595|NCT00002409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111397596|NCT00002409|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111397597|NCT00002409|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111397598|NCT00002409|Antimetabolites|antimetabolites|mesh-ancestor
111397600|NCT00002211|Stavudine|stavudine|mesh-list
111397601|NCT00002211|Didanosine|didanosine|mesh-list
111397602|NCT00002211|Delavirdine|delavirdine|mesh-list
111397603|NCT00002211|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111397604|NCT00002211|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111397605|NCT00002211|Protease Inhibitors|protease inhibitors|mesh-ancestor
111397606|NCT00002211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111397607|NCT00002211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111397608|NCT00002211|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111397609|NCT00002211|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111397610|NCT00002211|Antiviral Agents|antiviral agents|mesh-ancestor
111397611|NCT00002211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111397612|NCT00002211|Antimetabolites|antimetabolites|mesh-ancestor
111397613|NCT00002211|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111397614|NCT00002211|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111397615|NCT00002415|Tenofovir|tenofovir|mesh-list
111397616|NCT00002415|Antiviral Agents|antiviral agents|mesh-ancestor
111397617|NCT00002415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111397618|NCT00002415|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111397619|NCT00002415|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111397620|NCT00002415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111397621|NCT00002415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111397622|NCT00002415|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111397623|NCT00002415|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111397624|NCT00381537|Carbamazepine|carbamazepine|mesh-list
111397625|NCT00381537|Phenobarbital|phenobarbital|mesh-list
111397626|NCT00381537|Anticonvulsants|anticonvulsants|mesh-ancestor
111397627|NCT00381537|Antimanic Agents|antimanic agents|mesh-ancestor
111397628|NCT00381537|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111397629|NCT00381537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111397630|NCT00381537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111397631|NCT00381537|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111397632|NCT00381537|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111397633|NCT00381537|Analgesics|analgesics|mesh-ancestor
111397634|NCT00381537|Sensory System Agents|sensory system agents|mesh-ancestor
111397635|NCT00381537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111397636|NCT00381537|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111397637|NCT00381537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111397638|NCT00381537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111397639|NCT00381537|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111397640|NCT00381537|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111397641|NCT00381537|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111397642|NCT00381537|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111397643|NCT00381537|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111397644|NCT00381537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111397645|NCT00381537|GABA Modulators|gaba modulators|mesh-ancestor
111397646|NCT00381537|GABA Agents|gaba agents|mesh-ancestor
111397647|NCT00381537|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111397648|NCT00002427|Stavudine|stavudine|mesh-list
111397649|NCT00002427|Didanosine|didanosine|mesh-list
111397650|NCT00002427|Hydroxyurea|hydroxyurea|mesh-list
111397651|NCT00002427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111397652|NCT00002427|Antisickling Agents|antisickling agents|mesh-ancestor
111397653|NCT00002427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111397654|NCT00002427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111397655|NCT00002427|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111397656|NCT00002427|Antimetabolites|antimetabolites|mesh-ancestor
111397657|NCT00002427|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111397658|NCT00002427|Antiviral Agents|antiviral agents|mesh-ancestor
111397659|NCT00002427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111397660|NCT00002427|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111397661|NCT00002427|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111122014|NCT03078569|Testosterone|testosterone|mesh-list
111397662|NCT00002223|Ritonavir|ritonavir|mesh-list
111397663|NCT00002223|Indinavir|indinavir|mesh-list
111397664|NCT00002223|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111397665|NCT00002223|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111397666|NCT00002223|Protease Inhibitors|protease inhibitors|mesh-ancestor
111397667|NCT00002223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111397668|NCT00002223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111397669|NCT00002223|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111397670|NCT00002223|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111397671|NCT00002223|Antiviral Agents|antiviral agents|mesh-ancestor
111397672|NCT00002223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111397673|NCT00002223|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111397674|NCT00002223|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111397675|NCT00002433|Interferons|interferons|mesh-list
111397676|NCT00002433|Interferon-gamma|interferon-gamma|mesh-list
111397677|NCT00002433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111397678|NCT00002433|Antiviral Agents|antiviral agents|mesh-ancestor
111397679|NCT00002433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111397680|NCT00002439|Alitretinoin|alitretinoin|mesh-list
111397681|NCT00002439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111397682|NCT00002439|Dermatologic Agents|dermatologic agents|mesh-ancestor
111397683|NCT00002229|Saquinavir|saquinavir|mesh-list
111397684|NCT00002229|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111397685|NCT00002229|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111397686|NCT00002229|Protease Inhibitors|protease inhibitors|mesh-ancestor
111397687|NCT00002229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111397688|NCT00002229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111397689|NCT00002229|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111397690|NCT00002229|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111397691|NCT00002229|Antiviral Agents|antiviral agents|mesh-ancestor
111397692|NCT00002229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111397693|NCT00002229|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111397694|NCT00002229|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111397695|NCT00002451|Ritonavir|ritonavir|mesh-list
111397696|NCT00002451|Indinavir|indinavir|mesh-list
111397697|NCT00002451|Lamivudine|lamivudine|mesh-list
111397698|NCT00002451|Stavudine|stavudine|mesh-list
111397699|NCT00002451|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111397700|NCT00002451|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111397701|NCT00002451|Protease Inhibitors|protease inhibitors|mesh-ancestor
111397702|NCT00002451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111397703|NCT00002451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111397704|NCT00002451|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111397705|NCT00002451|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111397706|NCT00002451|Antiviral Agents|antiviral agents|mesh-ancestor
111397707|NCT00002451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111397708|NCT00002451|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111397709|NCT00002451|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111397710|NCT00002451|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111397711|NCT00002451|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111397712|NCT00002451|Antimetabolites|antimetabolites|mesh-ancestor
111397713|NCT00002235|Efavirenz|efavirenz|mesh-list
111397714|NCT00002235|Nelfinavir|nelfinavir|mesh-list
111397715|NCT00002235|Indinavir|indinavir|mesh-list
111397716|NCT00002235|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111397717|NCT00002235|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111397718|NCT00002235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111397719|NCT00002235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111397720|NCT00002235|Antiviral Agents|antiviral agents|mesh-ancestor
111397721|NCT00002235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111397722|NCT00002235|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111397723|NCT00002235|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111397724|NCT00002235|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111397725|NCT00002235|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111397726|NCT00002235|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111397727|NCT00002235|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111397728|NCT00002235|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111397729|NCT00002235|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111397730|NCT00002235|Protease Inhibitors|protease inhibitors|mesh-ancestor
111397731|NCT00002235|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111397732|NCT00002235|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111397733|NCT00002463|Leucovorin|leucovorin|mesh-list
111397734|NCT00002463|Prednisone|prednisone|mesh-list
111397735|NCT00002463|Methotrexate|methotrexate|mesh-list
111122093|NCT02336659|Incretins|incretins|mesh-ancestor
111397736|NCT00002463|Vincristine|vincristine|mesh-list
111397737|NCT00002463|Procarbazine|procarbazine|mesh-list
111397738|NCT00002463|Mechlorethamine|mechlorethamine|mesh-list
111397739|NCT00002463|Calcium|calcium|mesh-list
111397740|NCT00002463|Levoleucovorin|levoleucovorin|mesh-list
111397741|NCT00002463|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111397742|NCT00002463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111397743|NCT00002463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111397744|NCT00002463|Glucocorticoids|glucocorticoids|mesh-ancestor
111397745|NCT00002463|Hormones|hormones|mesh-ancestor
111397746|NCT00002463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111397747|NCT00002463|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111397748|NCT00002463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111397749|NCT00002463|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111397750|NCT00002463|Abortifacient Agents|abortifacient agents|mesh-ancestor
111397751|NCT00002463|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111397752|NCT00002463|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111397753|NCT00002463|Antimetabolites|antimetabolites|mesh-ancestor
111397754|NCT00002463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111397755|NCT00002463|Dermatologic Agents|dermatologic agents|mesh-ancestor
111397756|NCT00002463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111397757|NCT00002463|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111397758|NCT00002463|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111397759|NCT00002463|Immunologic Factors|immunologic factors|mesh-ancestor
111397760|NCT00002463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111397761|NCT00002463|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111397762|NCT00002463|Antidotes|antidotes|mesh-ancestor
111397763|NCT00002463|Protective Agents|protective agents|mesh-ancestor
111397764|NCT00002463|Vitamin B Complex|vitamin b complex|mesh-ancestor
111397765|NCT00002463|Vitamins|vitamins|mesh-ancestor
111397766|NCT00002463|Micronutrients|micronutrients|mesh-ancestor
111397767|NCT00002463|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111397768|NCT00002463|Tubulin Modulators|tubulin modulators|mesh-ancestor
111397769|NCT00002463|Antimitotic Agents|antimitotic agents|mesh-ancestor
111397770|NCT00002463|Mitosis Modulators|mitosis modulators|mesh-ancestor
111397771|NCT00002463|Alkylating Agents|alkylating agents|mesh-ancestor
111397772|NCT00002463|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111397773|NCT00002247|Ganciclovir|ganciclovir|mesh-list
111397774|NCT00002247|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
111397775|NCT00002247|Antiviral Agents|antiviral agents|mesh-ancestor
111397776|NCT00002247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111397777|NCT00002247|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111397778|NCT00002247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111397779|NCT00002247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111397780|NCT00002475|Interferons|interferons|mesh-list
111397781|NCT00002475|Interferon-alpha|interferon-alpha|mesh-list
111397782|NCT00002475|Interferon-gamma|interferon-gamma|mesh-list
111397783|NCT00002475|Cyclophosphamide|cyclophosphamide|mesh-list
111397784|NCT00002475|Vaccines|vaccines|mesh-list
111397785|NCT00002475|Sargramostim|sargramostim|mesh-list
111397786|NCT00002475|Immunologic Factors|immunologic factors|mesh-ancestor
111397787|NCT00002475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111397788|NCT00002475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111397789|NCT00002475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111397790|NCT00002475|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111397791|NCT00002475|Alkylating Agents|alkylating agents|mesh-ancestor
111397792|NCT00002475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111397793|NCT00002475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111397794|NCT00002475|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111397795|NCT00002475|Antiviral Agents|antiviral agents|mesh-ancestor
111397796|NCT00002475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111397797|NCT00002481|Cytarabine|cytarabine|mesh-list
111397798|NCT00002481|Dexamethasone|dexamethasone|mesh-list
111397799|NCT00002481|Cyclophosphamide|cyclophosphamide|mesh-list
111397800|NCT00002481|Etoposide|etoposide|mesh-list
111397801|NCT00002481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111397802|NCT00002481|Immunologic Factors|immunologic factors|mesh-ancestor
111397803|NCT00002481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111397804|NCT00002481|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111397805|NCT00002481|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111397806|NCT00002481|Alkylating Agents|alkylating agents|mesh-ancestor
111397807|NCT00002481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111397808|NCT00002481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111397809|NCT00002481|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111397810|NCT00002481|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111397811|NCT00002481|Antiemetics|antiemetics|mesh-ancestor
111122157|NCT04509973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111397812|NCT00002481|Autonomic Agents|autonomic agents|mesh-ancestor
111397813|NCT00002481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111397814|NCT00002481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111397815|NCT00002481|Glucocorticoids|glucocorticoids|mesh-ancestor
111397816|NCT00002481|Hormones|hormones|mesh-ancestor
111397817|NCT00002481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111397818|NCT00002481|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111397819|NCT00002481|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111397820|NCT00002481|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111397821|NCT00002481|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111397822|NCT00002481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111397823|NCT00002481|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111397824|NCT00002481|Antimetabolites|antimetabolites|mesh-ancestor
111397825|NCT00002481|Antiviral Agents|antiviral agents|mesh-ancestor
111397826|NCT00002481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111397827|NCT00002253|Octreotide|octreotide|mesh-list
111397828|NCT00002253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111397829|NCT00002253|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111397830|NCT00002253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111397831|NCT04862585|Diphenhydramine|diphenhydramine|mesh-list
111397832|NCT04862585|Promethazine|promethazine|mesh-list
111397833|NCT04862585|Dexamethasone|dexamethasone|mesh-list
111397834|NCT04862585|Dexamethasone acetate|dexamethasone acetate|mesh-list
111397835|NCT04862585|Paclitaxel|paclitaxel|mesh-list
111397836|NCT04862585|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111397837|NCT04862585|Famotidine|famotidine|mesh-list
111397838|NCT04862585|Ranitidine|ranitidine|mesh-list
111397839|NCT04862585|Cimetidine|cimetidine|mesh-list
111397840|NCT04862585|BB 1101|bb 1101|mesh-list
111397841|NCT04862585|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111397842|NCT04862585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111397843|NCT04862585|Tubulin Modulators|tubulin modulators|mesh-ancestor
111397844|NCT04862585|Antimitotic Agents|antimitotic agents|mesh-ancestor
111397845|NCT04862585|Mitosis Modulators|mitosis modulators|mesh-ancestor
111397846|NCT04862585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111397847|NCT04862585|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111397848|NCT04862585|Antiemetics|antiemetics|mesh-ancestor
111397849|NCT04862585|Autonomic Agents|autonomic agents|mesh-ancestor
111397850|NCT04862585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111397851|NCT04862585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111397852|NCT04862585|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111397853|NCT04862585|Glucocorticoids|glucocorticoids|mesh-ancestor
111397854|NCT04862585|Hormones|hormones|mesh-ancestor
111397855|NCT04862585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111397856|NCT04862585|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111397857|NCT04862585|Protease Inhibitors|protease inhibitors|mesh-ancestor
111397858|NCT04862585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111397859|NCT04862585|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111397860|NCT04862585|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111397861|NCT04862585|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111397862|NCT04862585|Anesthetics, Local|anesthetics, local|mesh-ancestor
111397863|NCT04862585|Anesthetics|anesthetics|mesh-ancestor
111397864|NCT04862585|Sensory System Agents|sensory system agents|mesh-ancestor
111397865|NCT04862585|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111397866|NCT04862585|Histamine Antagonists|histamine antagonists|mesh-ancestor
111397867|NCT04862585|Histamine Agents|histamine agents|mesh-ancestor
111397868|NCT04862585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111397869|NCT04862585|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111397870|NCT04862585|Antipruritics|antipruritics|mesh-ancestor
111397871|NCT04862585|Dermatologic Agents|dermatologic agents|mesh-ancestor
111397872|NCT04862585|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111397873|NCT04862585|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
111397874|NCT04862585|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111397875|NCT04862585|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111397876|NCT00002487|Methotrexate|methotrexate|mesh-list
111397877|NCT00002487|Dipyridamole|dipyridamole|mesh-list
111397878|NCT00002487|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111397879|NCT00002487|Abortifacient Agents|abortifacient agents|mesh-ancestor
111397880|NCT00002487|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111397881|NCT00002487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111397882|NCT00002487|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111397883|NCT00002487|Antimetabolites|antimetabolites|mesh-ancestor
111397884|NCT00002487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111397885|NCT00002487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111397886|NCT00002487|Dermatologic Agents|dermatologic agents|mesh-ancestor
111397887|NCT00002487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111397888|NCT00002487|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111397889|NCT00002487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111397890|NCT00002487|Immunologic Factors|immunologic factors|mesh-ancestor
111397891|NCT00002487|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111397892|NCT00002487|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111397893|NCT00002487|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111397894|NCT00002487|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111397895|NCT00002487|Vasodilator Agents|vasodilator agents|mesh-ancestor
111397896|NCT00002493|Doxorubicin|doxorubicin|mesh-list
111397897|NCT00002493|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111397898|NCT00002493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111397899|NCT00002493|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111397900|NCT00002493|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111397901|NCT00002493|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111397902|NCT00002493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111397903|NCT00002493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111397904|NCT00002259|Mitoxantrone|mitoxantrone|mesh-list
111397905|NCT00002259|Analgesics|analgesics|mesh-ancestor
111397906|NCT00002259|Sensory System Agents|sensory system agents|mesh-ancestor
111397907|NCT00002259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111397908|NCT00002259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111397909|NCT00002259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111397910|NCT00002259|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111397911|NCT00002259|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111397912|NCT00002259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111397913|NCT00002259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111397914|NCT00002499|Cytarabine|cytarabine|mesh-list
111397915|NCT00002499|Dexamethasone|dexamethasone|mesh-list
111397916|NCT00002499|Prednisone|prednisone|mesh-list
111397917|NCT00002499|Methotrexate|methotrexate|mesh-list
111397918|NCT00002499|Vincristine|vincristine|mesh-list
111397919|NCT00002499|Daunorubicin|daunorubicin|mesh-list
111397920|NCT00002499|Asparaginase|asparaginase|mesh-list
111397921|NCT00002499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111397922|NCT00002499|Antiemetics|antiemetics|mesh-ancestor
111397923|NCT00002499|Autonomic Agents|autonomic agents|mesh-ancestor
111397924|NCT00002499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111397925|NCT00002499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111397926|NCT00002499|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111397927|NCT00002499|Glucocorticoids|glucocorticoids|mesh-ancestor
111397928|NCT00002499|Hormones|hormones|mesh-ancestor
110875063|NCT03723941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111397929|NCT00002499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111397930|NCT00002499|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111397931|NCT00002499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111397932|NCT00002499|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111397933|NCT00002499|Abortifacient Agents|abortifacient agents|mesh-ancestor
111397934|NCT00002499|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111397935|NCT00002499|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111397936|NCT00002499|Antimetabolites|antimetabolites|mesh-ancestor
111397937|NCT00002499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111397938|NCT00002499|Dermatologic Agents|dermatologic agents|mesh-ancestor
111397939|NCT00002499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111397940|NCT00002499|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111397941|NCT00002499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111397942|NCT00002499|Immunologic Factors|immunologic factors|mesh-ancestor
111397943|NCT00002499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111397944|NCT00002499|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111397945|NCT00002499|Antiviral Agents|antiviral agents|mesh-ancestor
111397946|NCT00002499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111397947|NCT00002499|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111397948|NCT00002499|Tubulin Modulators|tubulin modulators|mesh-ancestor
111397949|NCT00002499|Antimitotic Agents|antimitotic agents|mesh-ancestor
111397950|NCT00002499|Mitosis Modulators|mitosis modulators|mesh-ancestor
111397951|NCT00002499|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111397952|NCT00002499|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111397953|NCT00002499|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111397954|NCT00002505|Interferons|interferons|mesh-list
111397955|NCT00002505|Interferon-gamma|interferon-gamma|mesh-list
111397956|NCT00002505|Vaccines|vaccines|mesh-list
111397957|NCT00002505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111397958|NCT00002505|Antiviral Agents|antiviral agents|mesh-ancestor
111397959|NCT00002505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111397960|NCT00002505|Immunologic Factors|immunologic factors|mesh-ancestor
111397961|NCT00002505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111397962|NCT00002265|Zalcitabine|zalcitabine|mesh-list
111397963|NCT00002265|Antimetabolites|antimetabolites|mesh-ancestor
111397964|NCT00002265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111397965|NCT00002265|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111397966|NCT00002265|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111397967|NCT00002265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111397968|NCT00002265|Antiviral Agents|antiviral agents|mesh-ancestor
111397969|NCT00002265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111397970|NCT00002265|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111397971|NCT00002265|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111397972|NCT04933331|Silver Nitrate|silver nitrate|mesh-list
111397973|NCT04933331|Fluorides|fluorides|mesh-list
111397974|NCT04933331|Fluorides, Topical|fluorides, topical|mesh-list
111397975|NCT04933331|Cariostatic Agents|cariostatic agents|mesh-ancestor
111397976|NCT04933331|Protective Agents|protective agents|mesh-ancestor
111397977|NCT04933331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111397978|NCT04933331|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111397979|NCT04933331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111397980|NCT00002271|Alovudine|alovudine|mesh-list
111397981|NCT00002271|Antiviral Agents|antiviral agents|mesh-ancestor
111397982|NCT00002271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111397983|NCT00002517|Cytarabine|cytarabine|mesh-list
111397984|NCT00002517|Dexamethasone|dexamethasone|mesh-list
111397985|NCT00002517|Etoposide|etoposide|mesh-list
111397986|NCT00002517|Daunorubicin|daunorubicin|mesh-list
111397987|NCT00002517|Mitoxantrone|mitoxantrone|mesh-list
111397988|NCT00002517|Idarubicin|idarubicin|mesh-list
111397989|NCT00002517|Thioguanine|thioguanine|mesh-list
111397990|NCT00002517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111397991|NCT00002517|Antiemetics|antiemetics|mesh-ancestor
111397992|NCT00002517|Autonomic Agents|autonomic agents|mesh-ancestor
111397993|NCT00002517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111397994|NCT00002517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111397995|NCT00002517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111397996|NCT00002517|Glucocorticoids|glucocorticoids|mesh-ancestor
111397997|NCT00002517|Hormones|hormones|mesh-ancestor
111397998|NCT00002517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111397999|NCT00002517|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111398000|NCT00002517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111398001|NCT00002517|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111398002|NCT00002517|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111398003|NCT00002517|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111398004|NCT00002517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111398005|NCT00002517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111398006|NCT00002517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111398007|NCT00002517|Antimetabolites|antimetabolites|mesh-ancestor
111398008|NCT00002517|Antiviral Agents|antiviral agents|mesh-ancestor
111398009|NCT00002517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111398010|NCT00002517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111398011|NCT00002517|Immunologic Factors|immunologic factors|mesh-ancestor
111398012|NCT00002517|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111398013|NCT00002517|Analgesics|analgesics|mesh-ancestor
111398014|NCT00002517|Sensory System Agents|sensory system agents|mesh-ancestor
111398015|NCT00002277|Fluconazole|fluconazole|mesh-list
111398016|NCT00002277|Amphotericin B|amphotericin b|mesh-list
111398017|NCT00002277|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
111398018|NCT00002277|Antifungal Agents|antifungal agents|mesh-ancestor
111398019|NCT00002277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111398020|NCT00002277|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111398021|NCT00002277|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111398022|NCT00002277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111398023|NCT00002277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111398024|NCT00002277|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111398025|NCT00002277|Hormone Antagonists|hormone antagonists|mesh-ancestor
111398026|NCT00002277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111398027|NCT00002277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111398028|NCT00002277|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111398029|NCT00002277|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111398030|NCT00002277|Amebicides|amebicides|mesh-ancestor
111398031|NCT00002277|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111398032|NCT00002277|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111398033|NCT00002277|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111398034|NCT04469075|Clindamycin|clindamycin|mesh-list
111398035|NCT04469075|Clindamycin palmitate|clindamycin palmitate|mesh-list
111398036|NCT04469075|Clindamycin phosphate|clindamycin phosphate|mesh-list
111398037|NCT04469075|Triamcinolone|triamcinolone|mesh-list
111398038|NCT04469075|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
111398039|NCT04469075|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
111398040|NCT04469075|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
111398041|NCT04469075|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111398042|NCT04469075|Glucocorticoids|glucocorticoids|mesh-ancestor
111398043|NCT04469075|Hormones|hormones|mesh-ancestor
111398044|NCT04469075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111398045|NCT04469075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111398046|NCT04469075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111398047|NCT04469075|Immunologic Factors|immunologic factors|mesh-ancestor
111398048|NCT04469075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111398049|NCT04469075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111398050|NCT04469075|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111398051|NCT04469075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111398052|NCT04469075|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111398053|NCT00002523|Leucovorin|leucovorin|mesh-list
111398054|NCT00002523|Fluorouracil|fluorouracil|mesh-list
111398055|NCT00002523|Calcium|calcium|mesh-list
111398056|NCT00002523|Levoleucovorin|levoleucovorin|mesh-list
111398057|NCT00002523|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111398058|NCT00002523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111398059|NCT00002523|Antimetabolites|antimetabolites|mesh-ancestor
111398060|NCT00002523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111398061|NCT00002523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111398062|NCT00002523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111398063|NCT00002523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111398064|NCT00002523|Immunologic Factors|immunologic factors|mesh-ancestor
111398065|NCT00002523|Antidotes|antidotes|mesh-ancestor
111398066|NCT00002523|Protective Agents|protective agents|mesh-ancestor
111398067|NCT00002523|Vitamin B Complex|vitamin b complex|mesh-ancestor
111398068|NCT00002523|Vitamins|vitamins|mesh-ancestor
111398069|NCT00002523|Micronutrients|micronutrients|mesh-ancestor
111398070|NCT00002529|Tamoxifen|tamoxifen|mesh-list
111398071|NCT00002529|Toremifene|toremifene|mesh-list
111398072|NCT00002529|Cyclophosphamide|cyclophosphamide|mesh-list
111398073|NCT00002529|Doxorubicin|doxorubicin|mesh-list
111398074|NCT00002529|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111398075|NCT00002529|Epirubicin|epirubicin|mesh-list
111398076|NCT00002529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111398077|NCT00002529|Immunologic Factors|immunologic factors|mesh-ancestor
111398078|NCT00002529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111398079|NCT00002529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111398080|NCT00002529|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111398081|NCT00002529|Alkylating Agents|alkylating agents|mesh-ancestor
111398082|NCT00002529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111398083|NCT00002529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111398084|NCT00002529|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111398085|NCT00002529|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111398086|NCT00002529|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111398087|NCT00002529|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111398088|NCT00002529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111398089|NCT00002529|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111398090|NCT00002529|Hormone Antagonists|hormone antagonists|mesh-ancestor
111398091|NCT00002529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111398092|NCT00002529|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111398093|NCT00002529|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111398094|NCT00002529|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111398095|NCT00002529|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111398096|NCT04832087|Teduglutide|teduglutide|mesh-list
111398097|NCT04832087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111398098|NCT04832087|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111398099|NCT04832087|Protective Agents|protective agents|mesh-ancestor
111398100|NCT04832087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111398101|NCT00002217|Lamivudine|lamivudine|mesh-list
111398102|NCT00002217|Zidovudine|zidovudine|mesh-list
111398103|NCT00002217|Abacavir|abacavir|mesh-list
111398104|NCT00002217|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
111398105|NCT00002217|Amprenavir|amprenavir|mesh-list
111398106|NCT00002217|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111398107|NCT00002217|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111398108|NCT00002217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111398109|NCT00002217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111398110|NCT00002217|Antiviral Agents|antiviral agents|mesh-ancestor
111398111|NCT00002217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111398112|NCT00002217|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111398113|NCT00002217|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111398114|NCT00002217|Antimetabolites|antimetabolites|mesh-ancestor
111398115|NCT00002217|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111398116|NCT00002217|Antitubercular Agents|antitubercular agents|mesh-ancestor
111398117|NCT00002217|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111398118|NCT00002217|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111398119|NCT00002217|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111398120|NCT00002217|Protease Inhibitors|protease inhibitors|mesh-ancestor
111398121|NCT00002283|Trimethoprim|trimethoprim|mesh-list
111398122|NCT00002283|Dapsone|dapsone|mesh-list
111398123|NCT00002283|Sulfamethoxazole|sulfamethoxazole|mesh-list
111398124|NCT00002283|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111398125|NCT00002283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111398126|NCT00002283|Antimalarials|antimalarials|mesh-ancestor
111398127|NCT00002283|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111398128|NCT00002283|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111398129|NCT00002283|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111398130|NCT00002283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111398131|NCT00002283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111398132|NCT00002283|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111398133|NCT00002283|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
111398134|NCT00002283|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111398135|NCT00002283|Leprostatic Agents|leprostatic agents|mesh-ancestor
111398136|NCT00002283|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111398137|NCT04826237|Dexamethasone|dexamethasone|mesh-list
111398138|NCT04826237|Methylprednisolone|methylprednisolone|mesh-list
111398139|NCT04826237|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111398140|NCT04826237|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111398141|NCT04826237|Prednisolone|prednisolone|mesh-list
111398142|NCT04826237|Prednisolone acetate|prednisolone acetate|mesh-list
111398143|NCT04826237|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
111398144|NCT04826237|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111398145|NCT04826237|Prednisolone phosphate|prednisolone phosphate|mesh-list
111398146|NCT04826237|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111398147|NCT04826237|Antiemetics|antiemetics|mesh-ancestor
111398148|NCT04826237|Autonomic Agents|autonomic agents|mesh-ancestor
111398149|NCT04826237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111398150|NCT04826237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111398151|NCT04826237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111398152|NCT04826237|Glucocorticoids|glucocorticoids|mesh-ancestor
111398153|NCT04826237|Hormones|hormones|mesh-ancestor
111398154|NCT04826237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111398155|NCT04826237|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111398156|NCT04826237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111398157|NCT04826237|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111398158|NCT04826237|Protective Agents|protective agents|mesh-ancestor
111398159|NCT04826237|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111398160|NCT04826237|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111398161|NCT04826237|Antimetabolites|antimetabolites|mesh-ancestor
111398162|NCT04826237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111398163|NCT04826237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111398164|NCT04826237|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111398165|NCT00002535|Aldesleukin|aldesleukin|mesh-list
111398166|NCT00002535|Indomethacin|indomethacin|mesh-list
111398167|NCT00002535|Cyclophosphamide|cyclophosphamide|mesh-list
111398168|NCT00002535|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111398169|NCT00002535|Immunologic Factors|immunologic factors|mesh-ancestor
111398170|NCT00002535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111398171|NCT00002535|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111398172|NCT00002535|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111398173|NCT00002535|Alkylating Agents|alkylating agents|mesh-ancestor
111398174|NCT00002535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111398175|NCT00002535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111398176|NCT00002535|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111398177|NCT00002535|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111398178|NCT00002535|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111398179|NCT00002535|Antiviral Agents|antiviral agents|mesh-ancestor
111398180|NCT00002535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111398181|NCT00002535|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111398182|NCT00002535|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111398183|NCT00002535|Analgesics|analgesics|mesh-ancestor
111398184|NCT00002535|Sensory System Agents|sensory system agents|mesh-ancestor
111398185|NCT00002535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111398186|NCT00002535|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111398187|NCT00002535|Gout Suppressants|gout suppressants|mesh-ancestor
111398188|NCT00002535|Tocolytic Agents|tocolytic agents|mesh-ancestor
111398189|NCT00002535|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111398190|NCT00002535|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111398191|NCT00002535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111398192|NCT00002547|Cytarabine|cytarabine|mesh-list
111398193|NCT00002547|Cyclosporine|cyclosporine|mesh-list
111398194|NCT00002547|Cyclophosphamide|cyclophosphamide|mesh-list
111398195|NCT00002547|Busulfan|busulfan|mesh-list
111398196|NCT00002547|Methotrexate|methotrexate|mesh-list
111398197|NCT00002547|Cyclosporins|cyclosporins|mesh-list
111398198|NCT00002547|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111398200|NCT00002547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111398201|NCT00002547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111398202|NCT00002547|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111398203|NCT00002547|Alkylating Agents|alkylating agents|mesh-ancestor
111398204|NCT00002547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111398205|NCT00002547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111398206|NCT00002547|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111398207|NCT00002547|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111398208|NCT00002547|Abortifacient Agents|abortifacient agents|mesh-ancestor
111398209|NCT00002547|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111398210|NCT00002547|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111398211|NCT00002547|Antimetabolites|antimetabolites|mesh-ancestor
111398212|NCT00002547|Dermatologic Agents|dermatologic agents|mesh-ancestor
111398213|NCT00002547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111398214|NCT00002547|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111398215|NCT00002547|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111398216|NCT00002547|Antiviral Agents|antiviral agents|mesh-ancestor
111398217|NCT00002547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111398218|NCT00002547|Antifungal Agents|antifungal agents|mesh-ancestor
111398219|NCT00002547|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111398220|NCT00002289|Thymopentin|thymopentin|mesh-list
111398221|NCT00002289|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111398222|NCT00002289|Immunologic Factors|immunologic factors|mesh-ancestor
111398223|NCT00002289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111398224|NCT00002553|Cobalt|cobalt|mesh-list
111398225|NCT00002553|Cyclophosphamide|cyclophosphamide|mesh-list
111398226|NCT00002553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111398227|NCT00002553|Immunologic Factors|immunologic factors|mesh-ancestor
111398228|NCT00002553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111398229|NCT00002553|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111398230|NCT00002553|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111398231|NCT00002553|Alkylating Agents|alkylating agents|mesh-ancestor
111398232|NCT00002553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111398233|NCT00002553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111398234|NCT00002553|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111398235|NCT00002553|Trace Elements|trace elements|mesh-ancestor
111398236|NCT00002553|Micronutrients|micronutrients|mesh-ancestor
111398237|NCT00002559|Paclitaxel|paclitaxel|mesh-list
111398238|NCT00002559|Ifosfamide|ifosfamide|mesh-list
111398239|NCT00002559|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111398240|NCT00002559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111398241|NCT00002559|Tubulin Modulators|tubulin modulators|mesh-ancestor
111398242|NCT00002559|Antimitotic Agents|antimitotic agents|mesh-ancestor
111398243|NCT00002559|Mitosis Modulators|mitosis modulators|mesh-ancestor
111398244|NCT00002559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111398245|NCT00002559|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111398246|NCT00002559|Alkylating Agents|alkylating agents|mesh-ancestor
111398247|NCT00002565|Cytarabine|cytarabine|mesh-list
111398248|NCT00002565|Prednisone|prednisone|mesh-list
111398249|NCT00002565|Methylprednisolone|methylprednisolone|mesh-list
111398250|NCT00002565|Cyclophosphamide|cyclophosphamide|mesh-list
111398251|NCT00002565|Ifosfamide|ifosfamide|mesh-list
111398252|NCT00002565|Doxorubicin|doxorubicin|mesh-list
111398253|NCT00002565|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111398254|NCT00002565|Etoposide|etoposide|mesh-list
111398255|NCT00002565|Vincristine|vincristine|mesh-list
111398256|NCT00002565|Mitoxantrone|mitoxantrone|mesh-list
111398257|NCT00002565|Idarubicin|idarubicin|mesh-list
111398258|NCT00002565|Bleomycin|bleomycin|mesh-list
111398259|NCT00002565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111398260|NCT00002565|Immunologic Factors|immunologic factors|mesh-ancestor
111398261|NCT00002565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111398262|NCT00002565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111398263|NCT00002565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111398264|NCT00002565|Alkylating Agents|alkylating agents|mesh-ancestor
111398265|NCT00002565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111398266|NCT00002565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111398267|NCT00002565|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111398268|NCT00002565|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111398269|NCT00002565|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111398270|NCT00002565|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111398271|NCT00002565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111398272|NCT00002565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111398273|NCT00002565|Glucocorticoids|glucocorticoids|mesh-ancestor
111398274|NCT00002565|Hormones|hormones|mesh-ancestor
111398275|NCT00002565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111398276|NCT00002565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111398277|NCT00002565|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111398278|NCT00002565|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111398279|NCT00002565|Antimetabolites|antimetabolites|mesh-ancestor
111398280|NCT00002565|Antiviral Agents|antiviral agents|mesh-ancestor
111398281|NCT00002565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111398282|NCT00002565|Tubulin Modulators|tubulin modulators|mesh-ancestor
111398283|NCT00002565|Antimitotic Agents|antimitotic agents|mesh-ancestor
111398284|NCT00002565|Mitosis Modulators|mitosis modulators|mesh-ancestor
111398285|NCT00002565|Antiemetics|antiemetics|mesh-ancestor
111398286|NCT00002565|Autonomic Agents|autonomic agents|mesh-ancestor
111398287|NCT00002565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111398288|NCT00002565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111398289|NCT00002565|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111398290|NCT00002565|Protective Agents|protective agents|mesh-ancestor
111398291|NCT00002565|Analgesics|analgesics|mesh-ancestor
111398292|NCT00002565|Sensory System Agents|sensory system agents|mesh-ancestor
111398293|NCT00002571|Leucovorin|leucovorin|mesh-list
111398294|NCT00002571|Cytarabine|cytarabine|mesh-list
111398295|NCT00002571|Trimethoprim|trimethoprim|mesh-list
111398296|NCT00002571|Sulfamethoxazole|sulfamethoxazole|mesh-list
111398297|NCT00002571|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
111398298|NCT00002571|Prednisone|prednisone|mesh-list
111398299|NCT00002571|Cyclophosphamide|cyclophosphamide|mesh-list
111398300|NCT00002571|Doxorubicin|doxorubicin|mesh-list
111398301|NCT00002571|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111398302|NCT00002571|Methotrexate|methotrexate|mesh-list
111398303|NCT00002571|Etoposide|etoposide|mesh-list
111398304|NCT00002571|Vincristine|vincristine|mesh-list
111398305|NCT00002571|Bleomycin|bleomycin|mesh-list
111398306|NCT00002571|Levoleucovorin|levoleucovorin|mesh-list
111398307|NCT00002571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111398308|NCT00002571|Immunologic Factors|immunologic factors|mesh-ancestor
111398309|NCT00002571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111398310|NCT00002571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111398311|NCT00002571|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111398312|NCT00002571|Alkylating Agents|alkylating agents|mesh-ancestor
111398313|NCT00002571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111398314|NCT00002571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111398315|NCT00002571|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111398316|NCT00002571|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111398317|NCT00002571|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111398318|NCT00002571|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111398319|NCT00002571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111398320|NCT00002571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111398321|NCT00002571|Glucocorticoids|glucocorticoids|mesh-ancestor
111398322|NCT00002571|Hormones|hormones|mesh-ancestor
111398323|NCT00002571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111398324|NCT00002571|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111398325|NCT00002571|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111398326|NCT00002571|Abortifacient Agents|abortifacient agents|mesh-ancestor
111398327|NCT00002571|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111398328|NCT00002571|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111398329|NCT00002571|Antimetabolites|antimetabolites|mesh-ancestor
111398330|NCT00002571|Dermatologic Agents|dermatologic agents|mesh-ancestor
111398331|NCT00002571|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111398332|NCT00002571|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111398333|NCT00002571|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111398334|NCT00002571|Antiviral Agents|antiviral agents|mesh-ancestor
111398335|NCT00002571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111398336|NCT00002571|Antidotes|antidotes|mesh-ancestor
111398337|NCT00002571|Protective Agents|protective agents|mesh-ancestor
111398338|NCT00002571|Vitamin B Complex|vitamin b complex|mesh-ancestor
111398339|NCT00002571|Vitamins|vitamins|mesh-ancestor
111398340|NCT00002571|Micronutrients|micronutrients|mesh-ancestor
111398341|NCT00002571|Tubulin Modulators|tubulin modulators|mesh-ancestor
111398342|NCT00002571|Antimitotic Agents|antimitotic agents|mesh-ancestor
111398343|NCT00002571|Mitosis Modulators|mitosis modulators|mesh-ancestor
111398344|NCT00002571|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111398345|NCT00002571|Antimalarials|antimalarials|mesh-ancestor
111398346|NCT00002571|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111398347|NCT00002571|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111398348|NCT00002571|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111398349|NCT00002571|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
111398350|NCT00002571|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111398351|NCT00002571|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111398353|NCT00360815|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111398354|NCT00360815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111398355|NCT00002583|Vinorelbine|vinorelbine|mesh-list
111398356|NCT00002583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111398357|NCT00002583|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111398358|NCT00002583|Tubulin Modulators|tubulin modulators|mesh-ancestor
111398359|NCT00002583|Antimitotic Agents|antimitotic agents|mesh-ancestor
111398360|NCT00002583|Mitosis Modulators|mitosis modulators|mesh-ancestor
111398361|NCT00002583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111398362|NCT00002589|Aldesleukin|aldesleukin|mesh-list
111398363|NCT00002589|Muromonab-CD3|muromonab-cd3|mesh-list
111398364|NCT00002589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111398365|NCT00002589|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111398366|NCT00002589|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111398367|NCT00002589|Antiviral Agents|antiviral agents|mesh-ancestor
111398368|NCT00002589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111398369|NCT00002589|Immunologic Factors|immunologic factors|mesh-ancestor
111398370|NCT00002589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111398371|NCT00002589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111398372|NCT02223871|Lumefantrine|lumefantrine|mesh-list
111398373|NCT02223871|Artemether|artemether|mesh-list
111398374|NCT02223871|Primaquine|primaquine|mesh-list
111398375|NCT02223871|Antimalarials|antimalarials|mesh-ancestor
111398376|NCT02223871|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111398377|NCT02223871|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111398378|NCT02223871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111398379|NCT00002595|Toremifene|toremifene|mesh-list
111398380|NCT00002595|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111398381|NCT00002595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111398382|NCT00002595|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111398383|NCT00002595|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111398384|NCT00002595|Hormone Antagonists|hormone antagonists|mesh-ancestor
111398385|NCT00002595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111398386|NCT00002595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111398387|NCT00002595|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111398388|NCT03004339|Betamethasone|betamethasone|mesh-list
111398389|NCT03004339|Betamethasone Valerate|betamethasone valerate|mesh-list
111398390|NCT03004339|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
111398391|NCT03004339|Betamethasone benzoate|betamethasone benzoate|mesh-list
111398392|NCT03004339|Calcipotriene|calcipotriene|mesh-list
111398393|NCT03004339|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
111398394|NCT03004339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111398395|NCT03004339|Glucocorticoids|glucocorticoids|mesh-ancestor
111398396|NCT03004339|Hormones|hormones|mesh-ancestor
111398397|NCT03004339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111398398|NCT03004339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111398399|NCT03004339|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111398400|NCT03004339|Respiratory System Agents|respiratory system agents|mesh-ancestor
111398401|NCT03004339|Dermatologic Agents|dermatologic agents|mesh-ancestor
111398402|NCT00002619|Carboplatin|carboplatin|mesh-list
111398403|NCT00002619|Thiotepa|thiotepa|mesh-list
111398404|NCT00002619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111398405|NCT00002619|Immunologic Factors|immunologic factors|mesh-ancestor
111398406|NCT00002619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111398407|NCT00002619|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111398408|NCT00002619|Alkylating Agents|alkylating agents|mesh-ancestor
111398409|NCT00002619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111398410|NCT00002619|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111398411|NCT00002619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111398412|NCT00002625|Topotecan|topotecan|mesh-list
111398413|NCT00002625|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111398414|NCT00002625|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111398415|NCT00002625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111398416|NCT00002625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111398417|NCT00002625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111398418|NCT00360737|Antitoxins|antitoxins|mesh-list
111398419|NCT00360737|Botulinum Antitoxin|botulinum antitoxin|mesh-list
111398420|NCT00360737|Immunologic Factors|immunologic factors|mesh-ancestor
111398421|NCT00360737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111398422|NCT05752305|Dexamethasone|dexamethasone|mesh-list
111398423|NCT05752305|Methylprednisolone|methylprednisolone|mesh-list
111398424|NCT05752305|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111398425|NCT05752305|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111398426|NCT05752305|Prednisolone|prednisolone|mesh-list
111398427|NCT05752305|Prednisolone acetate|prednisolone acetate|mesh-list
111398428|NCT05752305|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111398429|NCT05752305|Prednisolone phosphate|prednisolone phosphate|mesh-list
111398430|NCT05752305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111398431|NCT05752305|Antiemetics|antiemetics|mesh-ancestor
111398432|NCT05752305|Autonomic Agents|autonomic agents|mesh-ancestor
111398433|NCT05752305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111398434|NCT05752305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111398435|NCT05752305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111398436|NCT05752305|Glucocorticoids|glucocorticoids|mesh-ancestor
111398437|NCT05752305|Hormones|hormones|mesh-ancestor
111398438|NCT05752305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111398439|NCT05752305|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111398440|NCT05752305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111398441|NCT05752305|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111398442|NCT05752305|Protective Agents|protective agents|mesh-ancestor
111398443|NCT04343729|Methylprednisolone|methylprednisolone|mesh-list
111398444|NCT04343729|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111398445|NCT04343729|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111398446|NCT04343729|Prednisolone|prednisolone|mesh-list
111398447|NCT04343729|Prednisolone acetate|prednisolone acetate|mesh-list
111398448|NCT04343729|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111398449|NCT04343729|Prednisolone phosphate|prednisolone phosphate|mesh-list
111398450|NCT04343729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111398451|NCT04343729|Antiemetics|antiemetics|mesh-ancestor
111398452|NCT04343729|Autonomic Agents|autonomic agents|mesh-ancestor
111398453|NCT04343729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111398454|NCT04343729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111398455|NCT04343729|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111398456|NCT04343729|Glucocorticoids|glucocorticoids|mesh-ancestor
111398457|NCT04343729|Hormones|hormones|mesh-ancestor
111398458|NCT04343729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111398459|NCT04343729|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111398460|NCT04343729|Protective Agents|protective agents|mesh-ancestor
111398461|NCT04343729|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111398462|NCT04343729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111398463|NCT00002631|Fluorouracil|fluorouracil|mesh-list
111398464|NCT00002631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111398465|NCT00002631|Antimetabolites|antimetabolites|mesh-ancestor
111398466|NCT00002631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110875595|NCT02344888|Hematinics|hematinics|mesh-ancestor
111398467|NCT00002631|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111398468|NCT00002631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111398469|NCT00002631|Immunologic Factors|immunologic factors|mesh-ancestor
111398470|NCT00002631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111398471|NCT00002637|Interferons|interferons|mesh-list
111398472|NCT00002637|Aldesleukin|aldesleukin|mesh-list
111398473|NCT00002637|Interferon-gamma|interferon-gamma|mesh-list
111398474|NCT00002637|Vaccines|vaccines|mesh-list
111398475|NCT00002637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111398476|NCT00002637|Antiviral Agents|antiviral agents|mesh-ancestor
111398477|NCT00002637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111398478|NCT00002637|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111398479|NCT00002637|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111398480|NCT00002637|Immunologic Factors|immunologic factors|mesh-ancestor
111398481|NCT00002637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111398482|NCT02977013|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
111398483|NCT02977013|Dalteparin|dalteparin|mesh-list
111398484|NCT02977013|Anticoagulants|anticoagulants|mesh-ancestor
111398485|NCT02977013|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111398486|NCT02977013|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111398487|NCT02977013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111398488|NCT05806918|Interferons|interferons|mesh-list
111398489|NCT05806918|Interferon alpha-2|interferon alpha-2|mesh-list
111398490|NCT05806918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111398491|NCT05806918|Antiviral Agents|antiviral agents|mesh-ancestor
111398492|NCT05806918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111398493|NCT00002241|Ritonavir|ritonavir|mesh-list
111398494|NCT00002241|Indinavir|indinavir|mesh-list
111398495|NCT00002241|Lamivudine|lamivudine|mesh-list
111398496|NCT00002241|Stavudine|stavudine|mesh-list
111398497|NCT00002241|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111398498|NCT00002241|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111398499|NCT00002241|Protease Inhibitors|protease inhibitors|mesh-ancestor
111398500|NCT00002241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111398501|NCT00002241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111398502|NCT00002241|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111398503|NCT00002241|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111122835|NCT05002361|Dexamethasone|dexamethasone|mesh-list
111398504|NCT00002241|Antiviral Agents|antiviral agents|mesh-ancestor
111398506|NCT00002241|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111398507|NCT00002241|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111398508|NCT00002241|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111398509|NCT00002241|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111398510|NCT00002241|Antimetabolites|antimetabolites|mesh-ancestor
111398511|NCT05806853|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
111398512|NCT05806853|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111398513|NCT05806853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111398514|NCT05806723|Atorvastatin|atorvastatin|mesh-list
111398515|NCT05806723|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111398516|NCT05806723|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111398517|NCT05806723|Antimetabolites|antimetabolites|mesh-ancestor
111398518|NCT05806723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111398519|NCT05806723|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111398520|NCT05806723|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111398521|NCT05806723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111398522|NCT05806697|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
111398523|NCT05806697|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111398524|NCT05806697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111398525|NCT05806671|Fulvestrant|fulvestrant|mesh-list
111398526|NCT05806671|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111398527|NCT05806671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111398528|NCT05806671|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
111398529|NCT05806671|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111398530|NCT05806671|Hormone Antagonists|hormone antagonists|mesh-ancestor
111398531|NCT05806671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111398532|NCT05806671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111398533|NCT05806515|Carboplatin|carboplatin|mesh-list
111398534|NCT05806515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111398535|NCT05806476|Caffeine|caffeine|mesh-list
111398536|NCT05806476|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111398537|NCT05806476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111398538|NCT05806476|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111398539|NCT05806476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111398540|NCT05806476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111398541|NCT05806476|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
111398542|NCT05806476|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111398543|NCT05806476|Purinergic Agents|purinergic agents|mesh-ancestor
111398544|NCT05806476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111398545|NCT05806385|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
111398546|NCT05806385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111398547|NCT05806385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111398548|NCT05806385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111398549|NCT05806307|Vasopressins|vasopressins|mesh-list
111398550|NCT05806307|Arginine Vasopressin|arginine vasopressin|mesh-list
111398551|NCT05806307|Epinephrine|epinephrine|mesh-list
111398552|NCT05806307|Bupivacaine|bupivacaine|mesh-list
111398553|NCT05806307|Misoprostol|misoprostol|mesh-list
111398554|NCT05806307|Ethamsylate|ethamsylate|mesh-list
111398555|NCT05806307|Oxytocin|oxytocin|mesh-list
111398556|NCT05806307|Carbetocin|carbetocin|mesh-list
111398557|NCT05806307|Anesthetics, Local|anesthetics, local|mesh-ancestor
111398558|NCT05806307|Anesthetics|anesthetics|mesh-ancestor
111398559|NCT05806307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111398560|NCT05806307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111398561|NCT05806307|Sensory System Agents|sensory system agents|mesh-ancestor
111398562|NCT05806307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111398563|NCT05806307|Oxytocics|oxytocics|mesh-ancestor
111398564|NCT05806307|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111398565|NCT05806307|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111398566|NCT05806307|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111398567|NCT05806307|Adrenergic Agents|adrenergic agents|mesh-ancestor
111398568|NCT05806307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111398569|NCT05806307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111398570|NCT05806307|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111398571|NCT05806307|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111398572|NCT05806307|Autonomic Agents|autonomic agents|mesh-ancestor
111398573|NCT05806307|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111398574|NCT05806307|Respiratory System Agents|respiratory system agents|mesh-ancestor
111398575|NCT05806307|Mydriatics|mydriatics|mesh-ancestor
111398576|NCT05806307|Sympathomimetics|sympathomimetics|mesh-ancestor
111398577|NCT05806307|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111398578|NCT05806307|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111398579|NCT05806307|Abortifacient Agents|abortifacient agents|mesh-ancestor
111398580|NCT05806307|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111398581|NCT05806307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111398582|NCT05806307|Hemostatics|hemostatics|mesh-ancestor
111398583|NCT05806307|Coagulants|coagulants|mesh-ancestor
111398584|NCT05806307|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
111398585|NCT05806307|Natriuretic Agents|natriuretic agents|mesh-ancestor
111398586|NCT05806047|Fulvestrant|fulvestrant|mesh-list
111398587|NCT05806047|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111398588|NCT05806047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111398589|NCT05806047|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
111398590|NCT05806047|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111398591|NCT05806047|Hormone Antagonists|hormone antagonists|mesh-ancestor
111398592|NCT05806047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111398593|NCT05806047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111398594|NCT05805930|Prednisone|prednisone|mesh-list
111398595|NCT05805930|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
111398596|NCT05805930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111398597|NCT05805930|Glucocorticoids|glucocorticoids|mesh-ancestor
111398598|NCT05805930|Hormones|hormones|mesh-ancestor
111398599|NCT05805930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111398600|NCT05805930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111398601|NCT05805930|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111398602|NCT05805930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111398603|NCT05805930|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111398604|NCT05805800|Dexamethasone|dexamethasone|mesh-list
111398605|NCT05805800|Olanzapine|olanzapine|mesh-list
111398606|NCT05805800|Serotonin|serotonin|mesh-list
111398607|NCT05805800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111398608|NCT05805800|Antiemetics|antiemetics|mesh-ancestor
111398609|NCT05805800|Autonomic Agents|autonomic agents|mesh-ancestor
111398610|NCT05805800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111398611|NCT05805800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111398612|NCT05805800|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111398613|NCT05805800|Glucocorticoids|glucocorticoids|mesh-ancestor
111398614|NCT05805800|Hormones|hormones|mesh-ancestor
111398615|NCT05805800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111398616|NCT05805800|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111398617|NCT05805800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111398618|NCT05805800|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111398619|NCT05805800|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111398620|NCT05805800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111398621|NCT05805800|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111398622|NCT05805800|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111398623|NCT05805800|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111398624|NCT05805800|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111398625|NCT05805800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111398626|NCT05805800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111398627|NCT05805800|Serotonin Agents|serotonin agents|mesh-ancestor
111398628|NCT05805800|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111398629|NCT05805631|Pemetrexed|pemetrexed|mesh-list
111398630|NCT05805631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111398631|NCT05805631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111398632|NCT05805631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111398633|NCT05805631|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111398634|NCT05805631|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111398635|NCT05805553|Nandrolone Decanoate|nandrolone decanoate|mesh-list
111398636|NCT05805553|Propranolol|propranolol|mesh-list
111398637|NCT05805553|Nandrolone|nandrolone|mesh-list
111398638|NCT05805553|Nandrolone phenpropionate|nandrolone phenpropionate|mesh-list
111398639|NCT05805553|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111398640|NCT05805553|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111398641|NCT05805553|Adrenergic Agents|adrenergic agents|mesh-ancestor
111398642|NCT05805553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111398643|NCT05805553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111398644|NCT05805553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111398645|NCT05805553|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111398646|NCT05805553|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111398647|NCT05805553|Vasodilator Agents|vasodilator agents|mesh-ancestor
111398648|NCT05805553|Androgens|androgens|mesh-ancestor
111398649|NCT05805553|Hormones|hormones|mesh-ancestor
111398650|NCT05805553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111122989|NCT03145285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111398651|NCT05805553|Anabolic Agents|anabolic agents|mesh-ancestor
111398652|NCT05805553|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111398653|NCT05804747|Edoxaban|edoxaban|mesh-list
111398654|NCT05804747|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111398655|NCT05804747|Antithrombins|antithrombins|mesh-ancestor
111398656|NCT05804747|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111398657|NCT05804747|Protease Inhibitors|protease inhibitors|mesh-ancestor
111398658|NCT05804747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111398659|NCT05804747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111398660|NCT05804747|Anticoagulants|anticoagulants|mesh-ancestor
111398661|NCT05800938|Isosorbide|isosorbide|mesh-list
111398662|NCT05800938|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
111398663|NCT05800938|Diuretics|diuretics|mesh-ancestor
111398664|NCT05800938|Natriuretic Agents|natriuretic agents|mesh-ancestor
111398665|NCT05800938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111398666|NCT05797935|Dapagliflozin|dapagliflozin|mesh-list
111398667|NCT05797935|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110875812|NCT03148444|Cephalexin|cephalexin|mesh-list
111398668|NCT05797935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111398669|NCT05797935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111398670|NCT05797935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111398671|NCT05775237|Vitamins|vitamins|mesh-list
111398672|NCT05775237|Ascorbic Acid|ascorbic acid|mesh-list
111398673|NCT05775237|Curcumin|curcumin|mesh-list
111398674|NCT05775237|Micronutrients|micronutrients|mesh-ancestor
111398675|NCT05775237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111398676|NCT05775237|Antioxidants|antioxidants|mesh-ancestor
111398677|NCT05775237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111398678|NCT05775237|Protective Agents|protective agents|mesh-ancestor
111398679|NCT05775237|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111398680|NCT05775237|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111398681|NCT05775237|Analgesics|analgesics|mesh-ancestor
111398682|NCT05775237|Sensory System Agents|sensory system agents|mesh-ancestor
111398683|NCT05775237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111398684|NCT05775237|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111398685|NCT05775237|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111398686|NCT05775237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111398687|NCT05775237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111398688|NCT05751044|Cytarabine|cytarabine|mesh-list
111398689|NCT05751044|Dexamethasone|dexamethasone|mesh-list
111398690|NCT05751044|Cyclophosphamide|cyclophosphamide|mesh-list
111398691|NCT05751044|Venetoclax|venetoclax|mesh-list
111398692|NCT05751044|Dasatinib|dasatinib|mesh-list
111398693|NCT05751044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111398694|NCT05751044|Immunologic Factors|immunologic factors|mesh-ancestor
111398695|NCT05751044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111398696|NCT05751044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111398697|NCT05751044|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111398698|NCT05751044|Alkylating Agents|alkylating agents|mesh-ancestor
111398699|NCT05751044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111398700|NCT05751044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111398701|NCT05751044|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111398702|NCT05751044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111398703|NCT05751044|Antiemetics|antiemetics|mesh-ancestor
111398704|NCT05751044|Autonomic Agents|autonomic agents|mesh-ancestor
111398705|NCT05751044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111398706|NCT05751044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111398707|NCT05751044|Glucocorticoids|glucocorticoids|mesh-ancestor
111398708|NCT05751044|Hormones|hormones|mesh-ancestor
111398709|NCT05751044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111398710|NCT05751044|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111398711|NCT05751044|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111398712|NCT05751044|Antimetabolites|antimetabolites|mesh-ancestor
111398713|NCT05751044|Antiviral Agents|antiviral agents|mesh-ancestor
111398714|NCT05751044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111398715|NCT05751044|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111398716|NCT05751044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111398717|NCT05709093|Azacitidine|azacitidine|mesh-list
111398718|NCT05709093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111398719|NCT05709093|Antimetabolites|antimetabolites|mesh-ancestor
111398720|NCT05709093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111398721|NCT05709093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111398722|NCT05709093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111398723|NCT05690646|Ritonavir|ritonavir|mesh-list
111398724|NCT05690646|Nirmatrelvir|nirmatrelvir|mesh-list
111398725|NCT05690646|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
111398726|NCT05690646|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
111123066|NCT03072485|Antifungal Agents|antifungal agents|mesh-ancestor
111398727|NCT05690646|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111398728|NCT05690646|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111398729|NCT05690646|Protease Inhibitors|protease inhibitors|mesh-ancestor
111398730|NCT05690646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111398731|NCT05690646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111398733|NCT05690646|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111398734|NCT05690646|Antiviral Agents|antiviral agents|mesh-ancestor
110593381|NCT00784485|Omalizumab|omalizumab|mesh-list
111398735|NCT05690646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111398736|NCT05690646|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111398737|NCT05690646|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111398738|NCT05690646|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
111398739|NCT05690646|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111398740|NCT05648201|Raltegravir Potassium|raltegravir potassium|mesh-list
111398741|NCT05648201|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111398742|NCT05648201|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111398743|NCT05648201|Antiviral Agents|antiviral agents|mesh-ancestor
111398744|NCT05648201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111398745|NCT05648201|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111398746|NCT05648201|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111398747|NCT05648201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111398748|NCT05648201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111398749|NCT05607004|Exemestane|exemestane|mesh-list
111398750|NCT05607004|Goserelin|goserelin|mesh-list
111398751|NCT05607004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111398752|NCT05607004|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111398753|NCT05607004|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111398754|NCT05607004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111398755|NCT05607004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111398756|NCT05607004|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111398757|NCT05607004|Hormone Antagonists|hormone antagonists|mesh-ancestor
111398758|NCT05607004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111398759|NCT05607004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111398760|NCT05607004|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111398761|NCT05604300|Vitamin E|vitamin e|mesh-list
111398762|NCT05604300|Vitamins|vitamins|mesh-ancestor
111398763|NCT05604300|Micronutrients|micronutrients|mesh-ancestor
111398764|NCT05604300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111398765|NCT05604300|Antioxidants|antioxidants|mesh-ancestor
111398766|NCT05604300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111398767|NCT05604300|Protective Agents|protective agents|mesh-ancestor
111398768|NCT05511870|Etripamil|etripamil|mesh-list
111398769|NCT05511870|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111398770|NCT05511870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111398771|NCT05511870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111398772|NCT05511870|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111398773|NCT05511870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111398774|NCT05492851|Hylan|hylan|mesh-list
111398775|NCT05492851|Viscosupplements|viscosupplements|mesh-ancestor
111398776|NCT05492851|Protective Agents|protective agents|mesh-ancestor
111398777|NCT05492851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111398778|NCT05423535|Fibrin Foam|fibrin foam|mesh-list
111398779|NCT05423535|Hemostatics|hemostatics|mesh-ancestor
111398780|NCT05423535|Coagulants|coagulants|mesh-ancestor
111398781|NCT05414409|Metformin|metformin|mesh-list
111398782|NCT05414409|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111398783|NCT05414409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111398784|NCT05411575|Plerixafor|plerixafor|mesh-list
111398785|NCT05411575|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111398786|NCT05411575|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111398787|NCT05411575|Antiviral Agents|antiviral agents|mesh-ancestor
111398788|NCT05411575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111398789|NCT05367401|Azacitidine|azacitidine|mesh-list
111398790|NCT05367401|Magrolimab|magrolimab|mesh-list
111398791|NCT05367401|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111398792|NCT05367401|Antimetabolites|antimetabolites|mesh-ancestor
111398793|NCT05367401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111398794|NCT05367401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111398795|NCT05367401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111398796|NCT05367401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111398797|NCT05297448|Rifaximin|rifaximin|mesh-list
111398798|NCT05297448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111398799|NCT05297448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111398800|NCT05297448|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111398801|NCT05161156|Bromides|bromides|mesh-list
111398802|NCT05161156|Tiotropium Bromide|tiotropium bromide|mesh-list
111398803|NCT05161156|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111398804|NCT05161156|Autonomic Agents|autonomic agents|mesh-ancestor
111398805|NCT05161156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111398806|NCT05161156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111398807|NCT05161156|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111398808|NCT05161156|Respiratory System Agents|respiratory system agents|mesh-ancestor
111398809|NCT05161156|Parasympatholytics|parasympatholytics|mesh-ancestor
111398810|NCT05161156|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111398811|NCT05161156|Cholinergic Agents|cholinergic agents|mesh-ancestor
111398812|NCT05161156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111398813|NCT05161156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111398814|NCT05161156|Anticonvulsants|anticonvulsants|mesh-ancestor
111398815|NCT05132101|Palbociclib|palbociclib|mesh-list
111398816|NCT05132101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111398817|NCT05132101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111398818|NCT05132101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111398819|NCT05132101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111398820|NCT05062395|Deoxyglucose|deoxyglucose|mesh-list
111398821|NCT05062395|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
111398822|NCT05062395|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111398823|NCT05062395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111398824|NCT05062395|Antimetabolites|antimetabolites|mesh-ancestor
111398825|NCT05062395|Antiviral Agents|antiviral agents|mesh-ancestor
111398826|NCT05062395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111398827|NCT05045950|Memantine|memantine|mesh-list
111398828|NCT05045950|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111398829|NCT05045950|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111398830|NCT05045950|Dopamine Agents|dopamine agents|mesh-ancestor
111398831|NCT05045950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111398832|NCT05045950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111398833|NCT05045950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111398834|NCT05045950|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111398835|NCT05045950|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111398836|NCT04947514|Tranexamic Acid|tranexamic acid|mesh-list
111398837|NCT04947514|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111398838|NCT04947514|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111398839|NCT04947514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111398840|NCT04947514|Hemostatics|hemostatics|mesh-ancestor
111398841|NCT04947514|Coagulants|coagulants|mesh-ancestor
111398842|NCT04924101|Cisplatin|cisplatin|mesh-list
111398843|NCT04924101|Carboplatin|carboplatin|mesh-list
111398844|NCT04924101|Pembrolizumab|pembrolizumab|mesh-list
111398845|NCT04924101|Etoposide|etoposide|mesh-list
111398846|NCT04924101|Etoposide phosphate|etoposide phosphate|mesh-list
111398847|NCT04924101|Lenvatinib|lenvatinib|mesh-list
111398848|NCT04924101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111398849|NCT04924101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111398850|NCT04924101|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111398851|NCT04924101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111398852|NCT04924101|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111398853|NCT04924101|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111398854|NCT04924101|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111398855|NCT04924101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111398856|NCT04924101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111398857|NCT04860011|Dapagliflozin|dapagliflozin|mesh-list
111398858|NCT04860011|Metolazone|metolazone|mesh-list
111398859|NCT04860011|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111398860|NCT04860011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111398861|NCT04860011|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111398862|NCT04860011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111398863|NCT04860011|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111398864|NCT04860011|Diuretics|diuretics|mesh-ancestor
111398865|NCT04860011|Natriuretic Agents|natriuretic agents|mesh-ancestor
111398866|NCT04860011|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
111398867|NCT04860011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111398868|NCT04735978|Nivolumab|nivolumab|mesh-list
111398869|NCT04735978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111398870|NCT04735978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111398871|NCT04735978|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111398872|NCT04735978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111398873|NCT04704050|Dronedarone|dronedarone|mesh-list
111398874|NCT04704050|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111398875|NCT04669210|Mycophenolic Acid|mycophenolic acid|mesh-list
111398876|NCT04669210|Tacrolimus|tacrolimus|mesh-list
111398877|NCT04669210|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111398878|NCT04669210|Immunologic Factors|immunologic factors|mesh-ancestor
111398879|NCT04669210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111398880|NCT04669210|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111398881|NCT04669210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111398882|NCT04669210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111398883|NCT04669210|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111398884|NCT04669210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111398885|NCT04669210|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111398886|NCT04669210|Antitubercular Agents|antitubercular agents|mesh-ancestor
111398887|NCT04669210|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111398888|NCT04669210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111398889|NCT04655157|Nivolumab|nivolumab|mesh-list
111398890|NCT04655157|Ipilimumab|ipilimumab|mesh-list
111398891|NCT04655157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111398892|NCT04655157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111398893|NCT04655157|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111398894|NCT04655157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111398895|NCT04650269|Emtricitabine|emtricitabine|mesh-list
111398896|NCT04650269|Antiviral Agents|antiviral agents|mesh-ancestor
111398897|NCT04650269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111398898|NCT04650269|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111398899|NCT04650269|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111398900|NCT04650269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111398901|NCT04650269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111398902|NCT04650269|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111398903|NCT04650269|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111398904|NCT04629196|Ustekinumab|ustekinumab|mesh-list
111398905|NCT04629196|Dermatologic Agents|dermatologic agents|mesh-ancestor
111398906|NCT04591808|Perindopril|perindopril|mesh-list
111398907|NCT04591808|Atorvastatin|atorvastatin|mesh-list
111398908|NCT04591808|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111398909|NCT04591808|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111398910|NCT04591808|Antimetabolites|antimetabolites|mesh-ancestor
111398911|NCT04591808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111398912|NCT04591808|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111398913|NCT04591808|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111398914|NCT04591808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111398915|NCT04591808|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
111398916|NCT04591808|Protease Inhibitors|protease inhibitors|mesh-ancestor
111398917|NCT04591808|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111398918|NCT04587687|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111398919|NCT04587687|Brentuximab Vedotin|brentuximab vedotin|mesh-list
111398920|NCT04587687|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
111398921|NCT04587687|Antibodies|antibodies|mesh-list
111398922|NCT04587687|Immunoglobulins|immunoglobulins|mesh-list
111398923|NCT04587687|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111398924|NCT04587687|Immunoconjugates|immunoconjugates|mesh-list
111398925|NCT04587687|Immunologic Factors|immunologic factors|mesh-ancestor
111398926|NCT04587687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111398927|NCT04587687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111398928|NCT04587687|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111398929|NCT04587687|Alkylating Agents|alkylating agents|mesh-ancestor
111398930|NCT04587687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111398931|NCT04587687|Immunotoxins|immunotoxins|mesh-ancestor
111398932|NCT04578600|Lenalidomide|lenalidomide|mesh-list
111398933|NCT04578600|Azacitidine|azacitidine|mesh-list
111398934|NCT04578600|Obinutuzumab|obinutuzumab|mesh-list
111398935|NCT04578600|Immunologic Factors|immunologic factors|mesh-ancestor
111398936|NCT04578600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111398937|NCT04578600|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111398938|NCT04578600|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111398939|NCT04578600|Growth Substances|growth substances|mesh-ancestor
111398940|NCT04578600|Growth Inhibitors|growth inhibitors|mesh-ancestor
111398941|NCT04578600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111398942|NCT04578600|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111398943|NCT04578600|Antimetabolites|antimetabolites|mesh-ancestor
111398944|NCT04578600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111398945|NCT04578600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111398946|NCT04578600|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111398947|NCT04471987|Interleukin-12|interleukin-12|mesh-list
111398948|NCT04471987|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111398949|NCT04471987|Immunologic Factors|immunologic factors|mesh-ancestor
111398950|NCT04471987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111398951|NCT04471987|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111123302|NCT03139747|Everolimus|everolimus|mesh-list
111398952|NCT04471987|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111398953|NCT04471987|Growth Substances|growth substances|mesh-ancestor
111398954|NCT04471987|Growth Inhibitors|growth inhibitors|mesh-ancestor
111398955|NCT04471987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111398956|NCT04405037|Alvimopan|alvimopan|mesh-list
111398957|NCT04405037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111398958|NCT04389177|Paclitaxel|paclitaxel|mesh-list
111398959|NCT04389177|Cisplatin|cisplatin|mesh-list
111398960|NCT04389177|Pembrolizumab|pembrolizumab|mesh-list
111398961|NCT04389177|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111398962|NCT04389177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111398963|NCT04389177|Tubulin Modulators|tubulin modulators|mesh-ancestor
111398964|NCT04389177|Antimitotic Agents|antimitotic agents|mesh-ancestor
111398965|NCT04389177|Mitosis Modulators|mitosis modulators|mesh-ancestor
111398966|NCT04389177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111398967|NCT04389177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111398968|NCT04389177|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111398969|NCT04368988|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111398970|NCT04365257|Prazosin|prazosin|mesh-list
111398971|NCT04365257|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-list
111398972|NCT04365257|Adrenergic Antagonists|adrenergic antagonists|mesh-list
111398973|NCT04365257|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111398974|NCT04365257|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111398975|NCT04365257|Adrenergic Agents|adrenergic agents|mesh-ancestor
111398976|NCT04365257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111398977|NCT04365257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111398978|NCT04365257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111398979|NCT04341545|Letrozole|letrozole|mesh-list
111398980|NCT04341545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111398981|NCT04341545|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111398982|NCT04341545|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111398983|NCT04341545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111398984|NCT04341545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111398985|NCT04341545|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111398986|NCT04341545|Hormone Antagonists|hormone antagonists|mesh-ancestor
111398987|NCT04341545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111398988|NCT04341545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111398989|NCT04220021|Metformin|metformin|mesh-list
111398990|NCT04220021|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111398991|NCT04220021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111398992|NCT04219722|Hyaluronic Acid|hyaluronic acid|mesh-list
111398993|NCT04219722|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111398994|NCT04219722|Immunologic Factors|immunologic factors|mesh-ancestor
111398995|NCT04219722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111398996|NCT04219722|Viscosupplements|viscosupplements|mesh-ancestor
111398997|NCT04219722|Protective Agents|protective agents|mesh-ancestor
111398998|NCT04191304|Benralizumab|benralizumab|mesh-list
111398999|NCT04191304|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111399000|NCT04191304|Respiratory System Agents|respiratory system agents|mesh-ancestor
111399001|NCT04186299|Clonidine|clonidine|mesh-list
111399002|NCT04186299|Epinephrine|epinephrine|mesh-list
111399003|NCT04186299|Carticaine|carticaine|mesh-list
111399004|NCT04186299|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111399005|NCT04186299|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111399006|NCT04186299|Adrenergic Agents|adrenergic agents|mesh-ancestor
111399007|NCT04186299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111399008|NCT04186299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111399009|NCT04186299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111399010|NCT04186299|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111399011|NCT04186299|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111399012|NCT04186299|Autonomic Agents|autonomic agents|mesh-ancestor
110876136|NCT03489551|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111399013|NCT04186299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111399014|NCT04186299|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111399015|NCT04186299|Respiratory System Agents|respiratory system agents|mesh-ancestor
111399016|NCT04186299|Mydriatics|mydriatics|mesh-ancestor
111399017|NCT04186299|Sympathomimetics|sympathomimetics|mesh-ancestor
111399018|NCT04186299|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111399019|NCT04186299|Analgesics|analgesics|mesh-ancestor
111399020|NCT04186299|Sensory System Agents|sensory system agents|mesh-ancestor
111399021|NCT04186299|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111399022|NCT04186299|Sympatholytics|sympatholytics|mesh-ancestor
111399023|NCT04186299|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111399024|NCT04186299|Anesthetics, Local|anesthetics, local|mesh-ancestor
111399025|NCT04186299|Anesthetics|anesthetics|mesh-ancestor
111399026|NCT04186299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111123372|NCT04986371|Niraparib|niraparib|mesh-list
111399027|NCT04165096|Acetaminophen|acetaminophen|mesh-list
111399028|NCT04165096|Diphenhydramine|diphenhydramine|mesh-list
111399029|NCT04165096|Promethazine|promethazine|mesh-list
111399030|NCT04165096|Pembrolizumab|pembrolizumab|mesh-list
111399031|NCT04165096|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111399032|NCT04165096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111399033|NCT04165096|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111399034|NCT04165096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111399035|NCT04165096|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111399036|NCT04165096|Analgesics|analgesics|mesh-ancestor
111399037|NCT04165096|Sensory System Agents|sensory system agents|mesh-ancestor
111399038|NCT04165096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111399039|NCT04165096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111399040|NCT04165096|Antipyretics|antipyretics|mesh-ancestor
111399041|NCT04165096|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111399042|NCT04165096|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111399043|NCT04165096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111399044|NCT04165096|Anesthetics, Local|anesthetics, local|mesh-ancestor
111399045|NCT04165096|Anesthetics|anesthetics|mesh-ancestor
111399046|NCT04165096|Antiemetics|antiemetics|mesh-ancestor
111399047|NCT04165096|Autonomic Agents|autonomic agents|mesh-ancestor
111399048|NCT04165096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111399049|NCT04165096|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111399050|NCT04165096|Histamine Antagonists|histamine antagonists|mesh-ancestor
111399051|NCT04165096|Histamine Agents|histamine agents|mesh-ancestor
111399052|NCT04165096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111399053|NCT04165096|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111399054|NCT04165096|Antipruritics|antipruritics|mesh-ancestor
111399055|NCT04165096|Dermatologic Agents|dermatologic agents|mesh-ancestor
111399056|NCT04068753|Niraparib|niraparib|mesh-list
111399057|NCT04068753|Dostarlimab|dostarlimab|mesh-list
111399058|NCT04068753|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111399059|NCT04068753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111399060|NCT04068753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111399061|NCT04068753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111399062|NCT04005690|Olaparib|olaparib|mesh-list
111399063|NCT04005690|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
111399064|NCT04005690|Onvansertib|onvansertib|mesh-list
111399065|NCT04005690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111399066|NCT04005690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111399067|NCT04005690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111399068|NCT04005690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111399069|NCT03927222|Temozolomide|temozolomide|mesh-list
111399070|NCT03927222|Molgramostim|molgramostim|mesh-list
111399071|NCT03927222|Sargramostim|sargramostim|mesh-list
111399072|NCT03927222|Immunologic Factors|immunologic factors|mesh-ancestor
111399073|NCT03927222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111399074|NCT03927222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110876212|NCT03105466|Hormones|hormones|mesh-ancestor
111399075|NCT03927222|Alkylating Agents|alkylating agents|mesh-ancestor
111399076|NCT03927222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111399077|NCT03927222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111399078|NCT03869892|Trifluridine|trifluridine|mesh-list
111399079|NCT03869892|Bevacizumab|bevacizumab|mesh-list
111399080|NCT03869892|Capecitabine|capecitabine|mesh-list
111399081|NCT03869892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111399082|NCT03869892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111399083|NCT03869892|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111399084|NCT03869892|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111399085|NCT03869892|Growth Substances|growth substances|mesh-ancestor
111399086|NCT03869892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111399087|NCT03869892|Growth Inhibitors|growth inhibitors|mesh-ancestor
111399088|NCT03869892|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111399089|NCT03869892|Antimetabolites|antimetabolites|mesh-ancestor
111399090|NCT03869892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111399091|NCT03869892|Antiviral Agents|antiviral agents|mesh-ancestor
111399092|NCT03869892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111399093|NCT03822663|Caffeine|caffeine|mesh-list
111399094|NCT03822663|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111399095|NCT03822663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111399096|NCT03822663|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111399097|NCT03822663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111399098|NCT03822663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111399099|NCT03822663|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
111399100|NCT03822663|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111399101|NCT03822663|Purinergic Agents|purinergic agents|mesh-ancestor
110840643|NCT03395002|Xhance|xhance|mesh-list
111399102|NCT03822663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111399103|NCT03801525|Venetoclax|venetoclax|mesh-list
111399104|NCT03801525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111399105|NCT03767933|Acetaminophen|acetaminophen|mesh-list
111399106|NCT03767933|Ibuprofen|ibuprofen|mesh-list
111399107|NCT03767933|Hydromorphone|hydromorphone|mesh-list
111399108|NCT03767933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111399109|NCT03767933|Analgesics|analgesics|mesh-ancestor
111399110|NCT03767933|Sensory System Agents|sensory system agents|mesh-ancestor
111399111|NCT03767933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111399112|NCT03767933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111399113|NCT03767933|Antipyretics|antipyretics|mesh-ancestor
111399114|NCT03767933|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111399115|NCT03767933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111399116|NCT03767933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111399117|NCT03767933|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111399118|NCT03767933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111399119|NCT03767933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111399120|NCT03767933|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111399121|NCT03767933|Narcotics|narcotics|mesh-ancestor
111399122|NCT03767933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111399123|NCT03701919|Botulinum Toxins|botulinum toxins|mesh-list
111399124|NCT03701919|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111399125|NCT03701919|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111399126|NCT03701919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111399127|NCT03701919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111399128|NCT03701919|Cholinergic Agents|cholinergic agents|mesh-ancestor
111399129|NCT03701919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111399130|NCT03701919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111399131|NCT03701919|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111399132|NCT03701919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111399133|NCT03636152|Hydroxychloroquine|hydroxychloroquine|mesh-list
111399134|NCT03636152|Chloroquine|chloroquine|mesh-list
111399135|NCT03636152|Antimalarials|antimalarials|mesh-ancestor
111399136|NCT03636152|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111399137|NCT03636152|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111399138|NCT03636152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111399139|NCT03636152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111399140|NCT03636152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111399141|NCT03636152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111399142|NCT03636152|Amebicides|amebicides|mesh-ancestor
111399143|NCT03633604|HBOC 201|hboc 201|mesh-list
111399144|NCT03633604|Blood Substitutes|blood substitutes|mesh-ancestor
111399145|NCT03555916|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111399146|NCT03555916|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111399147|NCT03555916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111399148|NCT03555916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111399149|NCT03555916|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111399150|NCT03555916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111399151|NCT03555916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111399152|NCT03555916|Cholinergic Agents|cholinergic agents|mesh-ancestor
111399153|NCT03555916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111399154|NCT03474497|Pembrolizumab|pembrolizumab|mesh-list
111399155|NCT03474497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111399156|NCT03474497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111399157|NCT03474497|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111399158|NCT03474497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111399159|NCT03395223|Methylene Blue|methylene blue|mesh-list
111399160|NCT03395223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111399161|NCT03395223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111399162|NCT03289650|Tacrolimus|tacrolimus|mesh-list
111399163|NCT03289650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111399164|NCT03289650|Immunologic Factors|immunologic factors|mesh-ancestor
111399165|NCT03289650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111399166|NCT03289650|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111399167|NCT03289650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111399168|NCT03289650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111399169|NCT03255070|Immunoconjugates|immunoconjugates|mesh-list
111399170|NCT03255070|Immunologic Factors|immunologic factors|mesh-ancestor
111399171|NCT03255070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111399172|NCT03192397|Mycophenolic Acid|mycophenolic acid|mesh-list
111399173|NCT03192397|Sirolimus|sirolimus|mesh-list
111399174|NCT03192397|Cyclophosphamide|cyclophosphamide|mesh-list
111399175|NCT03192397|Melphalan|melphalan|mesh-list
111399176|NCT03192397|Fludarabine|fludarabine|mesh-list
111399177|NCT03192397|Fludarabine phosphate|fludarabine phosphate|mesh-list
111399178|NCT03192397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111399179|NCT03192397|Immunologic Factors|immunologic factors|mesh-ancestor
111399180|NCT03192397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111399181|NCT03192397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111399182|NCT03192397|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111399183|NCT03192397|Alkylating Agents|alkylating agents|mesh-ancestor
111399184|NCT03192397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111399185|NCT03192397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111399186|NCT03192397|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111399187|NCT03192397|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111399188|NCT03192397|Antimetabolites|antimetabolites|mesh-ancestor
111399189|NCT03192397|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111399190|NCT03192397|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111399191|NCT03192397|Antitubercular Agents|antitubercular agents|mesh-ancestor
111399192|NCT03192397|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111399193|NCT03192397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111399194|NCT03192397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111399195|NCT03192397|Antifungal Agents|antifungal agents|mesh-ancestor
111399197|NCT02975492|Ergocalciferols|ergocalciferols|mesh-list
111399198|NCT02975492|Cholecalciferol|cholecalciferol|mesh-list
111399199|NCT02975492|Vitamins|vitamins|mesh-list
111399200|NCT02975492|Micronutrients|micronutrients|mesh-ancestor
111399201|NCT02975492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111399202|NCT02975492|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111399203|NCT02975492|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111399204|NCT02867267|Thymalfasin|thymalfasin|mesh-list
111399205|NCT02867267|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111399206|NCT02867267|Immunologic Factors|immunologic factors|mesh-ancestor
111399207|NCT02867267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111399208|NCT02821832|Rifampin|rifampin|mesh-list
111399209|NCT02821832|Isoniazid|isoniazid|mesh-list
111399210|NCT02821832|Pyrazinamide|pyrazinamide|mesh-list
111399211|NCT02821832|Ethambutol|ethambutol|mesh-list
111399212|NCT02821832|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111399213|NCT02821832|Antitubercular Agents|antitubercular agents|mesh-ancestor
111399214|NCT02821832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111399215|NCT02821832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111399216|NCT02821832|Leprostatic Agents|leprostatic agents|mesh-ancestor
111399217|NCT02821832|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111399218|NCT02821832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111399219|NCT02821832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111399220|NCT02821832|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111399221|NCT02821832|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111399222|NCT02821832|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
111399223|NCT02821832|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
111399224|NCT02821832|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
111399225|NCT02821832|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111399226|NCT02821832|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
111399227|NCT02821832|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111399228|NCT02821832|Antimetabolites|antimetabolites|mesh-ancestor
111399229|NCT02821832|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111399230|NCT02813148|Naloxegol|naloxegol|mesh-list
111399231|NCT02813148|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111399232|NCT02813148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111399233|NCT02813148|Sensory System Agents|sensory system agents|mesh-ancestor
111399234|NCT02813148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111399235|NCT02756611|Venetoclax|venetoclax|mesh-list
111399236|NCT02756611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111399237|NCT02673359|Progesterone|progesterone|mesh-list
111399238|NCT02673359|Progestins|progestins|mesh-ancestor
111399239|NCT02673359|Hormones|hormones|mesh-ancestor
111399240|NCT02673359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111399241|NCT02673359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111399242|NCT02629809|Cyclophosphamide|cyclophosphamide|mesh-list
111399243|NCT02629809|Fludarabine|fludarabine|mesh-list
111399244|NCT02629809|Fludarabine phosphate|fludarabine phosphate|mesh-list
111399245|NCT02629809|Obinutuzumab|obinutuzumab|mesh-list
111399246|NCT02629809|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111399247|NCT02629809|Immunologic Factors|immunologic factors|mesh-ancestor
111399248|NCT02629809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111399249|NCT02629809|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111399250|NCT02629809|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111399251|NCT02629809|Alkylating Agents|alkylating agents|mesh-ancestor
111399252|NCT02629809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111399253|NCT02629809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111399254|NCT02629809|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111399255|NCT02629809|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111399256|NCT02629809|Antimetabolites|antimetabolites|mesh-ancestor
111399257|NCT02629809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111399258|NCT02624518|Gastrin-Releasing Peptide|gastrin-releasing peptide|mesh-list
111399259|NCT02624518|Bombesin|bombesin|mesh-list
111399260|NCT02624518|Gastrins|gastrins|mesh-list
111399261|NCT02624518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111399262|NCT02624518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111399263|NCT02624518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111399264|NCT02624518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111399265|NCT02624518|Hormones|hormones|mesh-ancestor
111399266|NCT02624518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111399267|NCT02303171|Enoxaparin|enoxaparin|mesh-list
111399268|NCT02303171|Warfarin|warfarin|mesh-list
111399269|NCT02303171|Anticoagulants|anticoagulants|mesh-ancestor
111399270|NCT02303171|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111399271|NCT02303171|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111399272|NCT02303171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111399273|NCT02287623|Bupivacaine|bupivacaine|mesh-list
111399274|NCT02287623|Anesthetics, Local|anesthetics, local|mesh-ancestor
111399275|NCT02287623|Anesthetics|anesthetics|mesh-ancestor
111399276|NCT02287623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111399277|NCT02287623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111399278|NCT02287623|Sensory System Agents|sensory system agents|mesh-ancestor
111399279|NCT02287623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111399280|NCT02266329|Prazosin|prazosin|mesh-list
111399281|NCT02266329|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111399282|NCT02266329|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111399283|NCT02266329|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111399284|NCT02266329|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111399285|NCT02266329|Adrenergic Agents|adrenergic agents|mesh-ancestor
111399286|NCT02266329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111399287|NCT02266329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111399288|NCT02266329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111399289|NCT01794520|Dexamethasone|dexamethasone|mesh-list
111399290|NCT01794520|Venetoclax|venetoclax|mesh-list
111399291|NCT01794520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111399292|NCT01794520|Antiemetics|antiemetics|mesh-ancestor
111399293|NCT01794520|Autonomic Agents|autonomic agents|mesh-ancestor
111399294|NCT01794520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111399295|NCT01794520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111399296|NCT01794520|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111399297|NCT01794520|Glucocorticoids|glucocorticoids|mesh-ancestor
111399298|NCT01794520|Hormones|hormones|mesh-ancestor
111399299|NCT01794520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111399300|NCT01794520|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111399301|NCT01794520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111399302|NCT01653678|Vitamin D|vitamin d|mesh-list
111399303|NCT01653678|Ergocalciferols|ergocalciferols|mesh-list
111399304|NCT01653678|Cholecalciferol|cholecalciferol|mesh-list
111399305|NCT01653678|Vitamins|vitamins|mesh-list
111399306|NCT01653678|Micronutrients|micronutrients|mesh-ancestor
111399307|NCT01653678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111399308|NCT01653678|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111399309|NCT01653678|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111399310|NCT01370811|Mandelic Acids|mandelic acids|mesh-list
111399311|NCT01370811|Clonidine|clonidine|mesh-list
111399312|NCT01370811|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111399313|NCT01370811|Oxybutynin|oxybutynin|mesh-list
111399314|NCT01370811|Analgesics|analgesics|mesh-ancestor
111399315|NCT01370811|Sensory System Agents|sensory system agents|mesh-ancestor
111399316|NCT01370811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111399317|NCT01370811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111399318|NCT01370811|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111399319|NCT01370811|Sympatholytics|sympatholytics|mesh-ancestor
111399320|NCT01370811|Autonomic Agents|autonomic agents|mesh-ancestor
111399321|NCT01370811|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111399322|NCT01370811|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111399323|NCT01370811|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111399324|NCT01370811|Adrenergic Agents|adrenergic agents|mesh-ancestor
111399325|NCT01370811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111399326|NCT01370811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111399327|NCT01370811|Parasympatholytics|parasympatholytics|mesh-ancestor
111399328|NCT01370811|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111399329|NCT01370811|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111399330|NCT01370811|Cholinergic Agents|cholinergic agents|mesh-ancestor
111399331|NCT01370811|Urological Agents|urological agents|mesh-ancestor
111399332|NCT01370811|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111399333|NCT01370811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111399334|NCT01323569|Nabiximols|nabiximols|mesh-list
111399335|NCT01323569|Dronabinol|dronabinol|mesh-list
111399336|NCT01323569|Analgesics|analgesics|mesh-ancestor
111399337|NCT01323569|Sensory System Agents|sensory system agents|mesh-ancestor
111399338|NCT01323569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111399339|NCT01323569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111399340|NCT01323569|Hallucinogens|hallucinogens|mesh-ancestor
111399341|NCT01323569|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111399342|NCT01323569|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111399343|NCT01323569|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
111399344|NCT01323569|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
111399345|NCT01323569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111399346|NCT01323569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111399347|NCT01323569|Hormones|hormones|mesh-ancestor
111399348|NCT01323569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111399349|NCT01323465|Rifampin|rifampin|mesh-list
111399350|NCT01323465|Ketoconazole|ketoconazole|mesh-list
111399351|NCT01323465|Nabiximols|nabiximols|mesh-list
111399352|NCT01323465|Omeprazole|omeprazole|mesh-list
111399353|NCT01323465|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111399354|NCT01323465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111399355|NCT01323465|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111399356|NCT01323465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111399357|NCT01323465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111399358|NCT01323465|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111399359|NCT01323465|Antitubercular Agents|antitubercular agents|mesh-ancestor
111399360|NCT01323465|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111399361|NCT01323465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111399362|NCT01323465|Leprostatic Agents|leprostatic agents|mesh-ancestor
111399363|NCT01323465|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111399364|NCT01323465|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111399365|NCT01323465|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111399366|NCT01323465|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
111399367|NCT01323465|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
111399368|NCT01323465|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
111399369|NCT01323465|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111399370|NCT01323465|Antifungal Agents|antifungal agents|mesh-ancestor
111399371|NCT01323465|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111399372|NCT01323465|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111399373|NCT01323465|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111399374|NCT01323465|Hormone Antagonists|hormone antagonists|mesh-ancestor
111399375|NCT01323465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111399376|NCT01323465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111399377|NCT01323465|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111399378|NCT01323465|Analgesics|analgesics|mesh-ancestor
111399379|NCT01323465|Sensory System Agents|sensory system agents|mesh-ancestor
111399380|NCT01323465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111399381|NCT01322464|Nabiximols|nabiximols|mesh-list
111399382|NCT01322464|Analgesics|analgesics|mesh-ancestor
111399383|NCT01322464|Sensory System Agents|sensory system agents|mesh-ancestor
111399384|NCT01322464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111399385|NCT01322464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111399386|NCT01322139|Moxifloxacin|moxifloxacin|mesh-list
111399387|NCT01322139|Nabiximols|nabiximols|mesh-list
111399388|NCT01322139|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
111399389|NCT01322139|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111399390|NCT01322139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111399391|NCT01322139|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111399392|NCT01322139|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111399393|NCT01322139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111399394|NCT01322139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111399395|NCT01322139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110876531|NCT02974010|Analgesics|analgesics|mesh-ancestor
111399396|NCT01322139|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111399397|NCT01322139|Contraceptive Agents|contraceptive agents|mesh-ancestor
111399398|NCT01322139|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111399399|NCT01322139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111399400|NCT01322139|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
111399401|NCT01322139|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111399402|NCT01322139|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111399403|NCT01322139|Analgesics|analgesics|mesh-ancestor
111399404|NCT01322139|Sensory System Agents|sensory system agents|mesh-ancestor
111399405|NCT01322139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111399406|NCT01165632|Fluorides|fluorides|mesh-list
111399407|NCT01165632|Cariostatic Agents|cariostatic agents|mesh-ancestor
111399408|NCT01165632|Protective Agents|protective agents|mesh-ancestor
111399409|NCT01165632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111399410|NCT01019850|Vorinostat|vorinostat|mesh-list
111399411|NCT01019850|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
111399412|NCT01019850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111399413|NCT01019850|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111399414|NCT01019850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111399415|NCT01019850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111399416|NCT01019850|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111399417|NCT00885326|Zoledronic Acid|zoledronic acid|mesh-list
111399418|NCT00885326|Cyclophosphamide|cyclophosphamide|mesh-list
111399419|NCT00885326|Bevacizumab|bevacizumab|mesh-list
111399420|NCT00885326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111399421|NCT00885326|Immunologic Factors|immunologic factors|mesh-ancestor
111399422|NCT00885326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111399423|NCT00885326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111399424|NCT00885326|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111399425|NCT00885326|Alkylating Agents|alkylating agents|mesh-ancestor
111399426|NCT00885326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111399427|NCT00885326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111399428|NCT00885326|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111399429|NCT00885326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111399430|NCT00885326|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111399431|NCT00885326|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111399432|NCT00885326|Growth Substances|growth substances|mesh-ancestor
111399433|NCT00885326|Growth Inhibitors|growth inhibitors|mesh-ancestor
111399434|NCT00885326|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111399435|NCT00606138|Ranibizumab|ranibizumab|mesh-list
111399436|NCT00606138|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111399437|NCT00606138|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111399438|NCT00606138|Growth Substances|growth substances|mesh-ancestor
111399439|NCT00606138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111399440|NCT00606138|Growth Inhibitors|growth inhibitors|mesh-ancestor
111399441|NCT00606138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111399442|NCT00005835|Melphalan|melphalan|mesh-list
111399443|NCT00005835|Buthionine Sulfoximine|buthionine sulfoximine|mesh-list
111399444|NCT00005835|Immunologic Factors|immunologic factors|mesh-ancestor
111399445|NCT00005835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111399446|NCT00005835|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111399447|NCT00005835|Alkylating Agents|alkylating agents|mesh-ancestor
111399448|NCT00005835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111399449|NCT00005835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111399450|NCT00005835|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111399451|NCT00005835|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111399452|NCT00005835|Antimetabolites|antimetabolites|mesh-ancestor
111399453|NCT00005835|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111399454|NCT00005835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111399455|NCT00005835|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111399456|NCT00005835|Protective Agents|protective agents|mesh-ancestor
111399457|NCT04401995|Nivolumab|nivolumab|mesh-list
111399458|NCT04401995|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111399459|NCT04401995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111399460|NCT04401995|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110876595|NCT02329756|Tranexamic Acid|tranexamic acid|mesh-list
111399461|NCT04401995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111399462|NCT00002643|Cobalt|cobalt|mesh-list
111399463|NCT00002643|Cyclophosphamide|cyclophosphamide|mesh-list
111399464|NCT00002643|Ifosfamide|ifosfamide|mesh-list
111399465|NCT00002643|Doxorubicin|doxorubicin|mesh-list
111399466|NCT00002643|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111399467|NCT00002643|Etoposide|etoposide|mesh-list
111399468|NCT00002643|Vincristine|vincristine|mesh-list
111399469|NCT00002643|Topotecan|topotecan|mesh-list
111399470|NCT00002643|Amifostine|amifostine|mesh-list
111399471|NCT00002643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111399472|NCT00002643|Immunologic Factors|immunologic factors|mesh-ancestor
111399473|NCT00002643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111399474|NCT00002643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111399475|NCT00002643|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111399476|NCT00002643|Alkylating Agents|alkylating agents|mesh-ancestor
111399477|NCT00002643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111399478|NCT00002643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111399479|NCT00002643|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111399480|NCT00002643|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111399481|NCT00002643|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111399482|NCT00002643|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111399483|NCT00002643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111399484|NCT00002643|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111399485|NCT00002643|Tubulin Modulators|tubulin modulators|mesh-ancestor
111399486|NCT00002643|Antimitotic Agents|antimitotic agents|mesh-ancestor
111399487|NCT00002643|Mitosis Modulators|mitosis modulators|mesh-ancestor
111399488|NCT00002643|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111399489|NCT00002643|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111399490|NCT00002643|Protective Agents|protective agents|mesh-ancestor
111399491|NCT00002643|Trace Elements|trace elements|mesh-ancestor
111399492|NCT00002643|Micronutrients|micronutrients|mesh-ancestor
111399493|NCT00002649|Aldesleukin|aldesleukin|mesh-list
111399494|NCT00002649|Cyclophosphamide|cyclophosphamide|mesh-list
111399495|NCT00002649|Etoposide|etoposide|mesh-list
111399496|NCT00002649|Etoposide phosphate|etoposide phosphate|mesh-list
111399497|NCT00002649|Interleukin-2|interleukin-2|mesh-list
111399498|NCT00002649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111399499|NCT00002649|Immunologic Factors|immunologic factors|mesh-ancestor
111399500|NCT00002649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111399501|NCT00002649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111399502|NCT00002649|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111399503|NCT00002649|Alkylating Agents|alkylating agents|mesh-ancestor
111399504|NCT00002649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111399505|NCT00002649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111399506|NCT00002649|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111399507|NCT00002649|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111399508|NCT00002649|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111399509|NCT00002649|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111399510|NCT00002649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111399511|NCT00002649|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111399512|NCT00002649|Analgesics|analgesics|mesh-ancestor
111399513|NCT00002649|Sensory System Agents|sensory system agents|mesh-ancestor
111399514|NCT00002649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111399515|NCT00002649|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111399516|NCT00002649|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111399517|NCT00002649|Antiviral Agents|antiviral agents|mesh-ancestor
111399518|NCT00002649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111399519|NCT01151605|Insulin|insulin|mesh-list
111399520|NCT01151605|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111399521|NCT01151605|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111399522|NCT01151605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111399523|NCT03003871|Chlorhexidine|chlorhexidine|mesh-list
111399524|NCT03003871|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
111399525|NCT03003871|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111399526|NCT03003871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111399527|NCT03003871|Disinfectants|disinfectants|mesh-ancestor
111399528|NCT03003871|Dermatologic Agents|dermatologic agents|mesh-ancestor
111399529|NCT00995059|Sirolimus|sirolimus|mesh-list
111399530|NCT00995059|Bortezomib|bortezomib|mesh-list
111399531|NCT00995059|Melphalan|melphalan|mesh-list
111399532|NCT00995059|Tacrolimus|tacrolimus|mesh-list
111399533|NCT00995059|Thymoglobulin|thymoglobulin|mesh-list
111399534|NCT00995059|Antilymphocyte Serum|antilymphocyte serum|mesh-list
111399535|NCT00995059|Immunoglobulins|immunoglobulins|mesh-list
111399536|NCT00995059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111399537|NCT00995059|Immunologic Factors|immunologic factors|mesh-ancestor
111399538|NCT00995059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111399539|NCT00995059|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111399540|NCT00995059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111399541|NCT00995059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111399542|NCT00995059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111399543|NCT00995059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111399544|NCT00995059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111399545|NCT00995059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111399546|NCT00995059|Antifungal Agents|antifungal agents|mesh-ancestor
111399547|NCT00995059|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111399548|NCT00995059|Alkylating Agents|alkylating agents|mesh-ancestor
111399549|NCT00995059|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111399550|NCT02249299|Nabiximols|nabiximols|mesh-list
111123888|NCT01794793|Pasireotide|pasireotide|mesh-list
111399551|NCT02249299|Analgesics|analgesics|mesh-ancestor
111399552|NCT02249299|Sensory System Agents|sensory system agents|mesh-ancestor
111399553|NCT02249299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111399554|NCT02249299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111399555|NCT00002679|Tamoxifen|tamoxifen|mesh-list
111399556|NCT00002679|Paclitaxel|paclitaxel|mesh-list
111399557|NCT00002679|Cyclophosphamide|cyclophosphamide|mesh-list
111399558|NCT00002679|Doxorubicin|doxorubicin|mesh-list
111399559|NCT00002679|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111399560|NCT00002679|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111399561|NCT00002679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111399562|NCT00002679|Tubulin Modulators|tubulin modulators|mesh-ancestor
111399563|NCT00002679|Antimitotic Agents|antimitotic agents|mesh-ancestor
111399564|NCT00002679|Mitosis Modulators|mitosis modulators|mesh-ancestor
111399565|NCT00002679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111399566|NCT00002679|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111399567|NCT00002679|Immunologic Factors|immunologic factors|mesh-ancestor
111399568|NCT00002679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111399569|NCT00002679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111399570|NCT00002679|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111399571|NCT00002679|Alkylating Agents|alkylating agents|mesh-ancestor
111399572|NCT00002679|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111399573|NCT00002679|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111399574|NCT00002679|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111399575|NCT00002679|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111399576|NCT00002679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111399577|NCT00002679|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111399578|NCT00002679|Hormone Antagonists|hormone antagonists|mesh-ancestor
111399579|NCT00002679|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111399580|NCT00002679|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111399581|NCT00002679|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111399582|NCT00002679|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111399583|NCT00002679|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111399584|NCT00002691|Leucovorin|leucovorin|mesh-list
111399585|NCT00002691|Cytarabine|cytarabine|mesh-list
111399586|NCT00002691|Dexamethasone|dexamethasone|mesh-list
111399587|NCT00002691|Cyclophosphamide|cyclophosphamide|mesh-list
111399588|NCT00002691|Methotrexate|methotrexate|mesh-list
111399589|NCT00002691|Etoposide|etoposide|mesh-list
111399590|NCT00002691|Vincristine|vincristine|mesh-list
111399591|NCT00002691|Daunorubicin|daunorubicin|mesh-list
111399592|NCT00002691|Asparaginase|asparaginase|mesh-list
111399593|NCT00002691|Levoleucovorin|levoleucovorin|mesh-list
111399594|NCT00002691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111399595|NCT00002691|Immunologic Factors|immunologic factors|mesh-ancestor
111399596|NCT00002691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111399597|NCT00002691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111399598|NCT00002691|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111399599|NCT00002691|Alkylating Agents|alkylating agents|mesh-ancestor
111399600|NCT00002691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111399601|NCT00002691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111399602|NCT00002691|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111399603|NCT00002691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111399604|NCT00002691|Antiemetics|antiemetics|mesh-ancestor
111399605|NCT00002691|Autonomic Agents|autonomic agents|mesh-ancestor
111399606|NCT00002691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111399607|NCT00002691|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111399608|NCT00002691|Glucocorticoids|glucocorticoids|mesh-ancestor
111399609|NCT00002691|Hormones|hormones|mesh-ancestor
111399610|NCT00002691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111399611|NCT00002691|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111399612|NCT00002691|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111399613|NCT00002691|Abortifacient Agents|abortifacient agents|mesh-ancestor
111399614|NCT00002691|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111399615|NCT00002691|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111399616|NCT00002691|Antimetabolites|antimetabolites|mesh-ancestor
111399617|NCT00002691|Dermatologic Agents|dermatologic agents|mesh-ancestor
111399618|NCT00002691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111399619|NCT00002691|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111399620|NCT00002691|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111399621|NCT00002691|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111399622|NCT00002691|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111399623|NCT00002691|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111399624|NCT00002691|Antiviral Agents|antiviral agents|mesh-ancestor
111399625|NCT00002691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111399626|NCT00002691|Antidotes|antidotes|mesh-ancestor
111399627|NCT00002691|Protective Agents|protective agents|mesh-ancestor
111399628|NCT00002691|Vitamin B Complex|vitamin b complex|mesh-ancestor
111123975|NCT03630835|Annexin A5|annexin a5|mesh-list
111399629|NCT00002691|Vitamins|vitamins|mesh-ancestor
111399630|NCT00002691|Micronutrients|micronutrients|mesh-ancestor
111399631|NCT00002691|Tubulin Modulators|tubulin modulators|mesh-ancestor
111399632|NCT00002691|Antimitotic Agents|antimitotic agents|mesh-ancestor
111399633|NCT00002691|Mitosis Modulators|mitosis modulators|mesh-ancestor
111399634|NCT00002691|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111399635|NCT03003637|Nivolumab|nivolumab|mesh-list
111399636|NCT03003637|Ipilimumab|ipilimumab|mesh-list
111399637|NCT03003637|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111399638|NCT03003637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111399639|NCT03003637|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111399640|NCT03003637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111399641|NCT04054115|Alprostadil|alprostadil|mesh-list
111399642|NCT04054115|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111399643|NCT04054115|Vasodilator Agents|vasodilator agents|mesh-ancestor
111399644|NCT04054115|Urological Agents|urological agents|mesh-ancestor
111399645|NCT00002697|Carboplatin|carboplatin|mesh-list
111399646|NCT00002697|Etoposide|etoposide|mesh-list
111399647|NCT00002697|Ifosfamide|ifosfamide|mesh-list
111399648|NCT00002697|Sargramostim|sargramostim|mesh-list
111399649|NCT00002697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111399650|NCT00002697|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111399651|NCT00002697|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111399652|NCT00002697|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111399653|NCT00002697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111399654|NCT00002697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111399655|NCT00002697|Immunologic Factors|immunologic factors|mesh-ancestor
111399656|NCT00002697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111399657|NCT00002697|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111399658|NCT00002697|Alkylating Agents|alkylating agents|mesh-ancestor
111399659|NCT04488601|Sirolimus|sirolimus|mesh-list
111399660|NCT04488601|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111399661|NCT04488601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111399662|NCT04488601|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111399663|NCT04488601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111399664|NCT04488601|Antifungal Agents|antifungal agents|mesh-ancestor
111399665|NCT04488601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111399666|NCT04488601|Immunologic Factors|immunologic factors|mesh-ancestor
111399667|NCT04488601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111399668|NCT05032807|Cannabidiol|cannabidiol|mesh-list
111399669|NCT05032807|Anticonvulsants|anticonvulsants|mesh-ancestor
111399670|NCT00002715|Prednisone|prednisone|mesh-list
111399671|NCT00002715|Doxorubicin|doxorubicin|mesh-list
111399672|NCT00002715|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111399673|NCT00002715|Bleomycin|bleomycin|mesh-list
111399674|NCT00002715|Etoposide|etoposide|mesh-list
111399675|NCT00002715|Vincristine|vincristine|mesh-list
111399676|NCT00002715|Vinblastine|vinblastine|mesh-list
111399677|NCT00002715|Mechlorethamine|mechlorethamine|mesh-list
111399678|NCT00002715|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111399679|NCT00002715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111399680|NCT00002715|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111399681|NCT00002715|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111399682|NCT00002715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111399683|NCT00002715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111399684|NCT00002715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111399685|NCT00002715|Glucocorticoids|glucocorticoids|mesh-ancestor
111399686|NCT00002715|Hormones|hormones|mesh-ancestor
111399687|NCT00002715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111399688|NCT00002715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111399689|NCT00002715|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111399690|NCT00002715|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111399691|NCT00002715|Tubulin Modulators|tubulin modulators|mesh-ancestor
111399692|NCT00002715|Antimitotic Agents|antimitotic agents|mesh-ancestor
111399693|NCT00002715|Mitosis Modulators|mitosis modulators|mesh-ancestor
111399694|NCT00002715|Alkylating Agents|alkylating agents|mesh-ancestor
111399695|NCT00002715|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111399696|NCT04972513|Nitric Oxide|nitric oxide|mesh-list
111399697|NCT04972513|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111399698|NCT04972513|Autonomic Agents|autonomic agents|mesh-ancestor
111399699|NCT04972513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111399700|NCT04972513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111399701|NCT04972513|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111399702|NCT04972513|Respiratory System Agents|respiratory system agents|mesh-ancestor
111399703|NCT04972513|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111399704|NCT04972513|Antioxidants|antioxidants|mesh-ancestor
111399705|NCT04972513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111124067|NCT04132817|Paclitaxel|paclitaxel|mesh-list
111399706|NCT04972513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111399707|NCT04972513|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
111399709|NCT04972513|Gasotransmitters|gasotransmitters|mesh-ancestor
111399710|NCT04972513|Protective Agents|protective agents|mesh-ancestor
111399711|NCT02976467|Fulacimstat|fulacimstat|mesh-list
111399712|NCT02976467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111399713|NCT02976467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111399714|NCT02981095|Bupivacaine|bupivacaine|mesh-list
111399715|NCT02981095|Anesthetics, Local|anesthetics, local|mesh-ancestor
111399716|NCT02981095|Anesthetics|anesthetics|mesh-ancestor
111399717|NCT02981095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111399718|NCT02981095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111399719|NCT02981095|Sensory System Agents|sensory system agents|mesh-ancestor
111399720|NCT02981095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111399721|NCT00002721|Doxorubicin|doxorubicin|mesh-list
111399722|NCT00002721|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111399723|NCT00002721|Estramustine|estramustine|mesh-list
111399724|NCT00002721|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111399725|NCT00002721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111399726|NCT00002721|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111399727|NCT00002721|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111399728|NCT00002721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111399729|NCT00002721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111399730|NCT00002721|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111399731|NCT00002721|Alkylating Agents|alkylating agents|mesh-ancestor
111399732|NCT00002721|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111399733|NCT04739345|Pentoxifylline|pentoxifylline|mesh-list
111399734|NCT04739345|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111399735|NCT04739345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111399736|NCT04739345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111399737|NCT04739345|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111399738|NCT04739345|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111399739|NCT04739345|Protective Agents|protective agents|mesh-ancestor
111399740|NCT04739345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111399741|NCT04739345|Vasodilator Agents|vasodilator agents|mesh-ancestor
111399742|NCT04739345|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111399743|NCT04739345|Antioxidants|antioxidants|mesh-ancestor
111399744|NCT01625455|Aprepitant|aprepitant|mesh-list
111399745|NCT01625455|Antiemetics|antiemetics|mesh-ancestor
111399746|NCT01625455|Autonomic Agents|autonomic agents|mesh-ancestor
111399747|NCT01625455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111399748|NCT01625455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111399749|NCT01625455|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111399750|NCT01625455|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
111399751|NCT01625455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111399752|NCT01625455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111399753|NCT05751681|Cetrorelix|cetrorelix|mesh-list
111399754|NCT05751681|Dydrogesterone|dydrogesterone|mesh-list
111399755|NCT05751681|Progestins|progestins|mesh-list
111399756|NCT05751681|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111399757|NCT05751681|Fertility Agents|fertility agents|mesh-ancestor
111399758|NCT05751681|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111399759|NCT05751681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111399760|NCT05751681|Hormone Antagonists|hormone antagonists|mesh-ancestor
111399761|NCT05751681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111399762|NCT05751681|Hormones|hormones|mesh-ancestor
111399763|NCT02976623|Metronidazole|metronidazole|mesh-list
111399764|NCT02976623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111399765|NCT02976623|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111399766|NCT02976623|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111399767|NCT02976623|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111399768|NCT00002733|Interferons|interferons|mesh-list
111399769|NCT00002733|Interferon-alpha|interferon-alpha|mesh-list
111399770|NCT00002733|Aldesleukin|aldesleukin|mesh-list
111399771|NCT00002733|Cimetidine|cimetidine|mesh-list
111399772|NCT00002733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111399773|NCT00002733|Antiviral Agents|antiviral agents|mesh-ancestor
111399774|NCT00002733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111399775|NCT00002733|Immunologic Factors|immunologic factors|mesh-ancestor
111399776|NCT00002733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111399777|NCT00002733|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111399778|NCT00002733|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111399779|NCT00002733|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111399780|NCT00002733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111399781|NCT00002733|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
111124117|NCT04021381|Cathartics|cathartics|mesh-ancestor
111399782|NCT00002733|Histamine Antagonists|histamine antagonists|mesh-ancestor
111399783|NCT00002733|Histamine Agents|histamine agents|mesh-ancestor
111399784|NCT00002733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110876914|NCT02327728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111399785|NCT00002733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111399786|NCT00002733|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111399787|NCT00002733|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111399788|NCT00002733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111399789|NCT01625923|Olanzapine|olanzapine|mesh-list
111399790|NCT01625923|Antiemetics|antiemetics|mesh-ancestor
111399791|NCT01625923|Autonomic Agents|autonomic agents|mesh-ancestor
111399792|NCT01625923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111399793|NCT01625923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111399794|NCT01625923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111399795|NCT01625923|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111399796|NCT01625923|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111399797|NCT01625923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111399798|NCT01625923|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111399799|NCT01625923|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111399800|NCT01625923|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111399801|NCT01625923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111399802|NCT01625923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111399803|NCT01625923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111399804|NCT01625923|Serotonin Agents|serotonin agents|mesh-ancestor
111399805|NCT00002751|Antibodies|antibodies|mesh-list
111399806|NCT00002751|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111399807|NCT00002751|Immunologic Factors|immunologic factors|mesh-ancestor
111399808|NCT00002751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111399809|NCT00002757|Cytarabine|cytarabine|mesh-list
111399810|NCT00002757|Prednisone|prednisone|mesh-list
111399811|NCT00002757|Prednisolone|prednisolone|mesh-list
111399812|NCT00002757|Hydrocortisone|hydrocortisone|mesh-list
111399813|NCT00002757|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
111399814|NCT00002757|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
111399815|NCT00002757|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
111399816|NCT00002757|Cyclophosphamide|cyclophosphamide|mesh-list
111399817|NCT00002757|Doxorubicin|doxorubicin|mesh-list
111399818|NCT00002757|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111399819|NCT00002757|Methotrexate|methotrexate|mesh-list
111399820|NCT00002757|Etoposide|etoposide|mesh-list
111399821|NCT00002757|Vincristine|vincristine|mesh-list
111399822|NCT00002757|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111399823|NCT00002757|Immunologic Factors|immunologic factors|mesh-ancestor
111399824|NCT00002757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111399825|NCT00002757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111399826|NCT00002757|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111399827|NCT00002757|Alkylating Agents|alkylating agents|mesh-ancestor
111399828|NCT00002757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111399829|NCT00002757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111399830|NCT00002757|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111399831|NCT00002757|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111399832|NCT00002757|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111399833|NCT00002757|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111399834|NCT00002757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111399835|NCT00002757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111399836|NCT00002757|Glucocorticoids|glucocorticoids|mesh-ancestor
111399837|NCT00002757|Hormones|hormones|mesh-ancestor
111399838|NCT00002757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111399839|NCT00002757|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111399840|NCT00002757|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110876984|NCT05078788|Glucocorticoids|glucocorticoids|mesh-ancestor
111399841|NCT00002757|Abortifacient Agents|abortifacient agents|mesh-ancestor
111399842|NCT00002757|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111399843|NCT00002757|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111399844|NCT00002757|Antimetabolites|antimetabolites|mesh-ancestor
111399845|NCT00002757|Dermatologic Agents|dermatologic agents|mesh-ancestor
111399846|NCT00002757|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111399847|NCT00002757|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111399848|NCT00002757|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111399849|NCT00002757|Antiviral Agents|antiviral agents|mesh-ancestor
111399850|NCT00002757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111399851|NCT00002757|Tubulin Modulators|tubulin modulators|mesh-ancestor
111399852|NCT00002757|Antimitotic Agents|antimitotic agents|mesh-ancestor
111399853|NCT00002757|Mitosis Modulators|mitosis modulators|mesh-ancestor
111399854|NCT00002763|Interferons|interferons|mesh-list
111399855|NCT00002763|Interferon-alpha|interferon-alpha|mesh-list
111399856|NCT00002763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111124208|NCT03136705|Niacin|niacin|mesh-list
111399857|NCT00002763|Antiviral Agents|antiviral agents|mesh-ancestor
111399858|NCT00002763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111399859|NCT00002763|Immunologic Factors|immunologic factors|mesh-ancestor
111399860|NCT00002763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111399861|NCT00002775|Docetaxel|docetaxel|mesh-list
111399862|NCT00002775|Estramustine|estramustine|mesh-list
111399863|NCT00002775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111399864|NCT00002775|Tubulin Modulators|tubulin modulators|mesh-ancestor
111399865|NCT00002775|Antimitotic Agents|antimitotic agents|mesh-ancestor
111399866|NCT00002775|Mitosis Modulators|mitosis modulators|mesh-ancestor
111399867|NCT00002775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111399868|NCT00002775|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111399869|NCT00002775|Alkylating Agents|alkylating agents|mesh-ancestor
111399870|NCT00002775|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111399871|NCT01631149|Rocuronium|rocuronium|mesh-list
111399872|NCT01631149|Atracurium|atracurium|mesh-list
111399873|NCT01631149|Mivacurium|mivacurium|mesh-list
111399874|NCT01631149|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
111399875|NCT01631149|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
111399876|NCT01631149|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111399877|NCT01631149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111399878|NCT01631149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111399879|NCT01631149|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
111399880|NCT01631149|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111399881|NCT01631149|Cholinergic Agents|cholinergic agents|mesh-ancestor
111399882|NCT01631149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111399883|NCT01631149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111399884|NCT00002787|Aldesleukin|aldesleukin|mesh-list
111399885|NCT00002787|Interleukin-2|interleukin-2|mesh-list
111399886|NCT00002787|Vaccines|vaccines|mesh-list
111399887|NCT00002787|Immunoglobulins|immunoglobulins|mesh-list
111399888|NCT00002787|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111399889|NCT00002787|Antibodies|antibodies|mesh-list
111399890|NCT00002787|Sargramostim|sargramostim|mesh-list
111399891|NCT00002787|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
111399892|NCT00002787|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
111399893|NCT00002787|Immunologic Factors|immunologic factors|mesh-ancestor
111399894|NCT00002787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111399895|NCT00002787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111399896|NCT00002787|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111399897|NCT00002787|Analgesics|analgesics|mesh-ancestor
111399898|NCT00002787|Sensory System Agents|sensory system agents|mesh-ancestor
111399899|NCT00002787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111399900|NCT00002787|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111399901|NCT00002787|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111399902|NCT00002787|Antiviral Agents|antiviral agents|mesh-ancestor
111399903|NCT00002787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111399904|NCT00002787|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111399905|NCT02975453|Rivaroxaban|rivaroxaban|mesh-list
111399906|NCT02975453|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111399907|NCT02975453|Antithrombins|antithrombins|mesh-ancestor
111399908|NCT02975453|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111399909|NCT02975453|Protease Inhibitors|protease inhibitors|mesh-ancestor
111399910|NCT02975453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111399911|NCT02975453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111399912|NCT02975453|Anticoagulants|anticoagulants|mesh-ancestor
111399913|NCT00002793|Leucovorin|leucovorin|mesh-list
111399914|NCT00002793|Fluorouracil|fluorouracil|mesh-list
111399915|NCT00002793|Calcium|calcium|mesh-list
111399916|NCT00002793|Levoleucovorin|levoleucovorin|mesh-list
111399917|NCT00002793|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111399918|NCT00002793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111399919|NCT00002793|Antimetabolites|antimetabolites|mesh-ancestor
111399920|NCT00002793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111399921|NCT00002793|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111399922|NCT00002793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111399923|NCT00002793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111399924|NCT00002793|Immunologic Factors|immunologic factors|mesh-ancestor
111399925|NCT00002793|Antidotes|antidotes|mesh-ancestor
111399926|NCT00002793|Protective Agents|protective agents|mesh-ancestor
111399927|NCT00002793|Vitamin B Complex|vitamin b complex|mesh-ancestor
111399928|NCT00002793|Vitamins|vitamins|mesh-ancestor
111399929|NCT00002793|Micronutrients|micronutrients|mesh-ancestor
111399930|NCT01632709|Bupivacaine|bupivacaine|mesh-list
111399931|NCT01632709|Anesthetics, Local|anesthetics, local|mesh-ancestor
111399932|NCT01632709|Anesthetics|anesthetics|mesh-ancestor
111399933|NCT01632709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111399934|NCT01632709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111399935|NCT01632709|Sensory System Agents|sensory system agents|mesh-ancestor
111399936|NCT01632709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111399937|NCT05751291|Bupivacaine|bupivacaine|mesh-list
111399938|NCT05751291|Anesthetics, Local|anesthetics, local|mesh-ancestor
111399939|NCT05751291|Anesthetics|anesthetics|mesh-ancestor
111399940|NCT05751291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111399941|NCT05751291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111399942|NCT05751291|Sensory System Agents|sensory system agents|mesh-ancestor
111399943|NCT05751291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111399944|NCT01634191|Apremilast|apremilast|mesh-list
111399945|NCT01634191|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111399946|NCT01634191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111399947|NCT01634191|Analgesics|analgesics|mesh-ancestor
111399948|NCT01634191|Sensory System Agents|sensory system agents|mesh-ancestor
111399949|NCT01634191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111399950|NCT01634191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111399951|NCT01634191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111399952|NCT01634191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111399953|NCT01634191|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
111399954|NCT01634191|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111399955|NCT01634191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111399956|NCT01634191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111399957|NCT04005443|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
111399958|NCT04005443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111399959|NCT04003649|Nivolumab|nivolumab|mesh-list
111399960|NCT04003649|Ipilimumab|ipilimumab|mesh-list
111399961|NCT04003649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111399962|NCT04003649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111399963|NCT04003649|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111399964|NCT04003649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111399965|NCT05713851|Dapagliflozin|dapagliflozin|mesh-list
111399966|NCT05713851|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111399967|NCT05713851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111399968|NCT05713851|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111399969|NCT05713851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111399970|NCT00361907|Insulin|insulin|mesh-list
111399971|NCT00361907|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111399972|NCT00361907|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111399973|NCT00361907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111399974|NCT05710185|Deucravacitinib|deucravacitinib|mesh-list
111399975|NCT05710185|Dermatologic Agents|dermatologic agents|mesh-ancestor
111399976|NCT05710185|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111399977|NCT05710185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111399978|NCT05710185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111399979|NCT04276493|Docetaxel|docetaxel|mesh-list
111399980|NCT04276493|Capecitabine|capecitabine|mesh-list
111399981|NCT04276493|Oxaliplatin|oxaliplatin|mesh-list
111399982|NCT04276493|Tislelizumab|tislelizumab|mesh-list
111399983|NCT04276493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111399984|NCT04276493|Tubulin Modulators|tubulin modulators|mesh-ancestor
111399985|NCT04276493|Antimitotic Agents|antimitotic agents|mesh-ancestor
111399986|NCT04276493|Mitosis Modulators|mitosis modulators|mesh-ancestor
111399987|NCT04276493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111399988|NCT04276493|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111399989|NCT04276493|Antimetabolites|antimetabolites|mesh-ancestor
111399990|NCT04276493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111399991|NCT04266197|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
111399992|NCT04266197|Vasodilator Agents|vasodilator agents|mesh-ancestor
111399993|NCT04266197|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111399994|NCT04266197|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111399995|NCT04266197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111399996|NCT04266197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111399997|NCT04266197|Urological Agents|urological agents|mesh-ancestor
111399998|NCT05669313|Rivaroxaban|rivaroxaban|mesh-list
111399999|NCT05669313|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111400000|NCT05669313|Antithrombins|antithrombins|mesh-ancestor
111400001|NCT05669313|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111400002|NCT05669313|Protease Inhibitors|protease inhibitors|mesh-ancestor
111400003|NCT05669313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111400004|NCT05669313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111400005|NCT05669313|Anticoagulants|anticoagulants|mesh-ancestor
111400006|NCT04343963|Bromides|bromides|mesh-list
111400007|NCT04343963|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
111400008|NCT04343963|Anticonvulsants|anticonvulsants|mesh-ancestor
111400009|NCT04343963|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111400010|NCT04343963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111400011|NCT04343963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111400012|NCT04343963|Cholinergic Agents|cholinergic agents|mesh-ancestor
111400013|NCT04343963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111400014|NCT04343963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111400015|NCT04248179|Sufentanil|sufentanil|mesh-list
111400016|NCT04248179|Ropivacaine|ropivacaine|mesh-list
111400017|NCT04248179|Anesthetics, Local|anesthetics, local|mesh-ancestor
111400018|NCT04248179|Anesthetics|anesthetics|mesh-ancestor
111400019|NCT04248179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111400020|NCT04248179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111400021|NCT04248179|Sensory System Agents|sensory system agents|mesh-ancestor
111400022|NCT04248179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111400023|NCT04248179|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111400024|NCT04248179|Narcotics|narcotics|mesh-ancestor
111400025|NCT04248179|Analgesics|analgesics|mesh-ancestor
111400026|NCT04248179|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111400027|NCT04248179|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111400028|NCT04248179|Anesthetics, General|anesthetics, general|mesh-ancestor
111400029|NCT00361517|Amphotericin B|amphotericin b|mesh-list
111400030|NCT00361517|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
111400031|NCT00361517|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
111400032|NCT00361517|Deoxycholic Acid|deoxycholic acid|mesh-list
111400033|NCT00361517|Amebicides|amebicides|mesh-ancestor
111400034|NCT00361517|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111400035|NCT00361517|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111400036|NCT00361517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111400037|NCT00361517|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111400038|NCT00361517|Antifungal Agents|antifungal agents|mesh-ancestor
111400039|NCT00361517|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
111400040|NCT00361517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111400041|NCT05447507|Dexmedetomidine|dexmedetomidine|mesh-list
111400042|NCT05447507|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111400043|NCT05447507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111400044|NCT05447507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111400045|NCT05447507|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111400046|NCT05447507|Analgesics|analgesics|mesh-ancestor
111400047|NCT05447507|Sensory System Agents|sensory system agents|mesh-ancestor
111400048|NCT05447507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111400049|NCT05447507|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111400050|NCT05447507|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111400051|NCT05447507|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111400052|NCT05447507|Adrenergic Agents|adrenergic agents|mesh-ancestor
111400053|NCT05447507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111400054|NCT05447507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111400055|NCT01635439|Dinoprostone|dinoprostone|mesh-list
111400056|NCT01635439|Oxytocics|oxytocics|mesh-ancestor
111400057|NCT01635439|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111400058|NCT01635439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111400059|NCT01636063|Misoprostol|misoprostol|mesh-list
111400060|NCT01636063|Mifepristone|mifepristone|mesh-list
111400061|NCT01636063|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111400062|NCT01636063|Abortifacient Agents|abortifacient agents|mesh-ancestor
111400063|NCT01636063|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111400064|NCT01636063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111400065|NCT01636063|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111400066|NCT01636063|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111400067|NCT01636063|Oxytocics|oxytocics|mesh-ancestor
111400068|NCT01636063|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
111400069|NCT01636063|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111400070|NCT01636063|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111400071|NCT01636063|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111400072|NCT01636063|Contraceptive Agents|contraceptive agents|mesh-ancestor
111400073|NCT01636063|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
111400074|NCT01636063|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
111400075|NCT01636063|Hormone Antagonists|hormone antagonists|mesh-ancestor
111400076|NCT01636063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111400077|NCT01636063|Luteolytic Agents|luteolytic agents|mesh-ancestor
111400078|NCT01636063|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111400079|NCT01636063|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
111400080|NCT05635305|Zoliflodacin|zoliflodacin|mesh-list
111400081|NCT05635305|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111400082|NCT05635305|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111124407|NCT01700569|Antidotes|antidotes|mesh-ancestor
111400083|NCT05635305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111400084|NCT05635305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111400085|NCT05635305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111400086|NCT05749575|Paclitaxel|paclitaxel|mesh-list
111400087|NCT05749575|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111400088|NCT05749575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111400089|NCT05749575|Tubulin Modulators|tubulin modulators|mesh-ancestor
111400090|NCT05749575|Antimitotic Agents|antimitotic agents|mesh-ancestor
111400091|NCT05749575|Mitosis Modulators|mitosis modulators|mesh-ancestor
111400092|NCT05749575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111400093|NCT04178005|Cladribine|cladribine|mesh-list
111400094|NCT04178005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111400095|NCT04178005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111400096|NCT04178005|Immunologic Factors|immunologic factors|mesh-ancestor
111400097|NCT04178005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111400098|NCT05623761|Fluorides|fluorides|mesh-list
111400099|NCT05623761|Cariostatic Agents|cariostatic agents|mesh-ancestor
111400100|NCT05623761|Protective Agents|protective agents|mesh-ancestor
111400101|NCT05623761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111400102|NCT04231331|Ertugliflozin|ertugliflozin|mesh-list
111400103|NCT04231331|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111400104|NCT04231331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111400105|NCT04231331|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111400106|NCT04231331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111400107|NCT00361985|Esomeprazole|esomeprazole|mesh-list
111400108|NCT00361985|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111400109|NCT00361985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111400110|NCT00361985|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111400111|NCT00361985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111400112|NCT00361985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111400113|NCT00362063|Hormones|hormones|mesh-list
111400114|NCT00362063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111400115|NCT00362063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111400116|NCT00382239|Exenatide|exenatide|mesh-list
111400117|NCT00382239|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111400118|NCT00382239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111400119|NCT00382239|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111400120|NCT00382239|Incretins|incretins|mesh-ancestor
111400121|NCT00382239|Hormones|hormones|mesh-ancestor
111400122|NCT00382239|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111400123|NCT04004845|Misoprostol|misoprostol|mesh-list
111400124|NCT04004845|Oxytocin|oxytocin|mesh-list
111400125|NCT04004845|Oxytocics|oxytocics|mesh-ancestor
111400126|NCT04004845|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111400127|NCT04004845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111400128|NCT04004845|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111400129|NCT04004845|Abortifacient Agents|abortifacient agents|mesh-ancestor
111400130|NCT04004845|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111400131|NCT04004845|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111400132|NCT01637935|Pioglitazone|pioglitazone|mesh-list
111400133|NCT01637935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111400134|NCT01637935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111400135|NCT00382083|Acetaminophen|acetaminophen|mesh-list
111400136|NCT00382083|Ibuprofen|ibuprofen|mesh-list
111400137|NCT00382083|Lidocaine|lidocaine|mesh-list
111400138|NCT00382083|Anesthetics, Local|anesthetics, local|mesh-ancestor
111400139|NCT00382083|Anesthetics|anesthetics|mesh-ancestor
111400140|NCT00382083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111400141|NCT00382083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111400142|NCT00382083|Sensory System Agents|sensory system agents|mesh-ancestor
111400143|NCT00382083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111400144|NCT00382083|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111400145|NCT00382083|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111400146|NCT00382083|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111400147|NCT00382083|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111400148|NCT00382083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111400149|NCT00382083|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111400150|NCT00382083|Analgesics|analgesics|mesh-ancestor
111400151|NCT00382083|Antipyretics|antipyretics|mesh-ancestor
111400152|NCT00382083|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111400153|NCT00382083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111400154|NCT00382083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111400155|NCT00382083|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111400156|NCT00382083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111400157|NCT01640197|Resveratrol|resveratrol|mesh-list
111400158|NCT01640197|Antioxidants|antioxidants|mesh-ancestor
111400159|NCT01640197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111400160|NCT01640197|Protective Agents|protective agents|mesh-ancestor
111400161|NCT01640197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111400162|NCT01640197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111400163|NCT01640197|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111400164|NCT01641445|Topiramate|topiramate|mesh-list
111400165|NCT01641445|Anticonvulsants|anticonvulsants|mesh-ancestor
111400166|NCT01641445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111400167|NCT01641445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111400168|NCT04185311|Nivolumab|nivolumab|mesh-list
111400169|NCT04185311|Ipilimumab|ipilimumab|mesh-list
111400170|NCT04185311|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
111400171|NCT04185311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111400172|NCT04185311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111400173|NCT04185311|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111400174|NCT04185311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111400175|NCT05513937|Amlodipine|amlodipine|mesh-list
111400176|NCT05513937|Nebivolol|nebivolol|mesh-list
111400177|NCT05513937|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111400178|NCT05513937|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111400179|NCT05513937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111400180|NCT05513937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111400181|NCT05513937|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111400182|NCT05513937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111400183|NCT05513937|Vasodilator Agents|vasodilator agents|mesh-ancestor
111400184|NCT05513937|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
111400185|NCT05513937|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111400186|NCT05513937|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111400187|NCT05513937|Adrenergic Agents|adrenergic agents|mesh-ancestor
111400188|NCT05513937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111400189|NCT01642147|Anesthetics|anesthetics|mesh-list
111400190|NCT01642147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111400191|NCT01642147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111400192|NCT04584749|Lidocaine|lidocaine|mesh-list
111400193|NCT04584749|Anesthetics, Local|anesthetics, local|mesh-ancestor
111400194|NCT04584749|Anesthetics|anesthetics|mesh-ancestor
111400195|NCT04584749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111400196|NCT04584749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111400197|NCT04584749|Sensory System Agents|sensory system agents|mesh-ancestor
111400198|NCT04584749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111400199|NCT04584749|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111400200|NCT04584749|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111400201|NCT04584749|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111400202|NCT04584749|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111400203|NCT04584749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111400204|NCT01644331|Tolvaptan|tolvaptan|mesh-list
111400205|NCT01644331|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
111400206|NCT01644331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111400207|NCT01644331|Natriuretic Agents|natriuretic agents|mesh-ancestor
111400208|NCT01644331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111400209|NCT00362141|Levetiracetam|levetiracetam|mesh-list
111400210|NCT00362141|Anticonvulsants|anticonvulsants|mesh-ancestor
111400211|NCT00362141|Nootropic Agents|nootropic agents|mesh-ancestor
111400212|NCT05733897|Hydroxychloroquine|hydroxychloroquine|mesh-list
111400213|NCT05733897|Antimalarials|antimalarials|mesh-ancestor
111400214|NCT05733897|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111400215|NCT05733897|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111400216|NCT05733897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111400217|NCT05733897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111400218|NCT05733897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111400219|NCT05733897|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111400220|NCT01646671|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
111400221|NCT01646671|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111400222|NCT01646671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111400223|NCT03561259|Vorinostat|vorinostat|mesh-list
111400224|NCT03561259|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
111400225|NCT03561259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111400226|NCT03561259|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111400227|NCT03561259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111400228|NCT03561259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111400229|NCT03561259|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111400230|NCT03002935|Coenzyme Q10|coenzyme q10|mesh-list
111400231|NCT03002935|Micronutrients|micronutrients|mesh-ancestor
111400232|NCT03002935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111400233|NCT03002935|Vitamins|vitamins|mesh-ancestor
111400234|NCT03788291|Rituximab|rituximab|mesh-list
111400235|NCT03788291|Acalabrutinib|acalabrutinib|mesh-list
111400236|NCT03788291|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111400237|NCT03788291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111400238|NCT03788291|Immunologic Factors|immunologic factors|mesh-ancestor
111400239|NCT03788291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111400240|NCT03788291|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111400241|NCT04593459|Metformin|metformin|mesh-list
111400242|NCT04593459|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111400243|NCT04593459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111400244|NCT04120883|Hydroxychloroquine|hydroxychloroquine|mesh-list
111400245|NCT04120883|Antimalarials|antimalarials|mesh-ancestor
111400246|NCT04120883|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111400247|NCT04120883|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111400248|NCT04120883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111400249|NCT04120883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111400250|NCT04120883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111400251|NCT04120883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111400252|NCT03775109|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111400253|NCT03775109|Immunologic Factors|immunologic factors|mesh-ancestor
111400254|NCT03775109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111400255|NCT03251924|Nivolumab|nivolumab|mesh-list
111400256|NCT03251924|Ipilimumab|ipilimumab|mesh-list
111400257|NCT03251924|Antibodies|antibodies|mesh-list
111400258|NCT03251924|Immunoglobulins|immunoglobulins|mesh-list
111400259|NCT03251924|Antibodies, Blocking|antibodies, blocking|mesh-list
111400260|NCT03251924|Immunologic Factors|immunologic factors|mesh-ancestor
111400261|NCT03251924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111400262|NCT03251924|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111400263|NCT03251924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111400264|NCT03251924|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111400265|NCT03251924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111400266|NCT01651351|Protease Inhibitors|protease inhibitors|mesh-list
111400267|NCT01651351|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
111400268|NCT01651351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111400269|NCT01651351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111400270|NCT01651351|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
111400271|NCT01651351|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111400272|NCT03762317|Clonidine|clonidine|mesh-list
111400273|NCT03762317|Analgesics|analgesics|mesh-ancestor
111400274|NCT03762317|Sensory System Agents|sensory system agents|mesh-ancestor
111400275|NCT03762317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111400276|NCT03762317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111400277|NCT03762317|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111400278|NCT03762317|Sympatholytics|sympatholytics|mesh-ancestor
111400279|NCT03762317|Autonomic Agents|autonomic agents|mesh-ancestor
111400280|NCT03762317|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111400281|NCT03762317|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111400282|NCT03762317|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111400283|NCT03762317|Adrenergic Agents|adrenergic agents|mesh-ancestor
111400284|NCT03762317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111400285|NCT03762317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111400286|NCT04383639|Locust bean gum|locust bean gum|mesh-list
111400287|NCT04383639|Antidiarrheals|antidiarrheals|mesh-ancestor
111400288|NCT04383639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111400289|NCT03083431|Propranolol|propranolol|mesh-list
111400290|NCT03083431|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111400291|NCT03083431|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111400292|NCT03083431|Adrenergic Agents|adrenergic agents|mesh-ancestor
111400293|NCT03083431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111400294|NCT03083431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111400295|NCT03083431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111400296|NCT03083431|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111400297|NCT03083431|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111400298|NCT03083431|Vasodilator Agents|vasodilator agents|mesh-ancestor
111400299|NCT02975921|Povidone-Iodine|povidone-iodine|mesh-list
111400300|NCT02975921|Povidone|povidone|mesh-list
111400301|NCT02975921|Plasma Substitutes|plasma substitutes|mesh-ancestor
111400302|NCT02975921|Blood Substitutes|blood substitutes|mesh-ancestor
111400303|NCT02975921|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111400304|NCT02975921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111400305|NCT05452785|Minocycline|minocycline|mesh-list
111400306|NCT05452785|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111400307|NCT05452785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111400308|NCT03002545|Magnesium citrate|magnesium citrate|mesh-list
111400309|NCT03002545|Cathartics|cathartics|mesh-ancestor
111400310|NCT03002545|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111400311|NCT04517747|Ramucirumab|ramucirumab|mesh-list
111400312|NCT04517747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111400313|NCT02219581|Dexamethasone|dexamethasone|mesh-list
111400314|NCT02219581|Dexamethasone acetate|dexamethasone acetate|mesh-list
111400315|NCT02219581|BB 1101|bb 1101|mesh-list
111400316|NCT02219581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111400317|NCT02219581|Antiemetics|antiemetics|mesh-ancestor
111400318|NCT02219581|Autonomic Agents|autonomic agents|mesh-ancestor
111400319|NCT02219581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111400320|NCT02219581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111400321|NCT02219581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111400322|NCT02219581|Glucocorticoids|glucocorticoids|mesh-ancestor
111400323|NCT02219581|Hormones|hormones|mesh-ancestor
111400324|NCT02219581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111400325|NCT02219581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111400326|NCT02219581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111400327|NCT02219581|Protease Inhibitors|protease inhibitors|mesh-ancestor
111400328|NCT02219581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111400329|NCT02219581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111400330|NCT01912274|Azacitidine|azacitidine|mesh-list
111400331|NCT01912274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111400332|NCT01912274|Antimetabolites|antimetabolites|mesh-ancestor
111400333|NCT01912274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111400334|NCT01912274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111400335|NCT01912274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111400336|NCT01654861|Ascorbic Acid|ascorbic acid|mesh-list
111400337|NCT01654861|Gemcitabine|gemcitabine|mesh-list
111400338|NCT01654861|Vitamins|vitamins|mesh-ancestor
111400339|NCT01654861|Micronutrients|micronutrients|mesh-ancestor
111400340|NCT01654861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111400341|NCT01654861|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111400342|NCT01654861|Antimetabolites|antimetabolites|mesh-ancestor
111400343|NCT01654861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111400344|NCT01654861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111400345|NCT01654861|Antioxidants|antioxidants|mesh-ancestor
111400346|NCT01654861|Protective Agents|protective agents|mesh-ancestor
111400347|NCT01934582|Treprostinil|treprostinil|mesh-list
111400348|NCT01934582|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111400349|NCT05735834|Rituximab|rituximab|mesh-list
111400350|NCT05735834|Zanubrutinib|zanubrutinib|mesh-list
111400351|NCT05735834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111400352|NCT05735834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111400353|NCT05735834|Immunologic Factors|immunologic factors|mesh-ancestor
111400354|NCT05735834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111400355|NCT05735834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111400356|NCT05735834|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111400357|NCT05735834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111400358|NCT05735834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111400359|NCT05184777|Estradiol|estradiol|mesh-list
111400360|NCT05184777|Progesterone|progesterone|mesh-list
111400361|NCT05184777|Estrogens|estrogens|mesh-ancestor
111400362|NCT05184777|Hormones|hormones|mesh-ancestor
111400363|NCT05184777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111400364|NCT05184777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111400365|NCT05184777|Progestins|progestins|mesh-ancestor
111400366|NCT01912352|Methylphenidate|methylphenidate|mesh-list
111400367|NCT01912352|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111400368|NCT01912352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111400369|NCT01912352|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111400370|NCT01912352|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111400371|NCT01912352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111400372|NCT01912352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111400373|NCT01912352|Dopamine Agents|dopamine agents|mesh-ancestor
111400374|NCT01912352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111400375|NCT02975843|Beclomethasone|beclomethasone|mesh-list
111400376|NCT02975843|Glycopyrrolate|glycopyrrolate|mesh-list
111400377|NCT02975843|Formoterol Fumarate|formoterol fumarate|mesh-list
111400378|NCT02975843|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111400379|NCT02975843|Autonomic Agents|autonomic agents|mesh-ancestor
111400380|NCT02975843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111400381|NCT02975843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111400382|NCT02975843|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111400383|NCT02975843|Respiratory System Agents|respiratory system agents|mesh-ancestor
111400384|NCT02975843|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111400385|NCT02975843|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111400386|NCT02975843|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111400387|NCT02975843|Adrenergic Agents|adrenergic agents|mesh-ancestor
111400388|NCT02975843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111400389|NCT02975843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111400390|NCT02975843|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111400391|NCT02975843|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111400392|NCT02975843|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111400393|NCT02975843|Cholinergic Agents|cholinergic agents|mesh-ancestor
111400394|NCT02975843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111400395|NCT02975843|Glucocorticoids|glucocorticoids|mesh-ancestor
111400396|NCT02975843|Hormones|hormones|mesh-ancestor
111400397|NCT02975843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111400398|NCT01655563|Tacrolimus|tacrolimus|mesh-list
111400399|NCT01655563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111400400|NCT01655563|Immunologic Factors|immunologic factors|mesh-ancestor
111400401|NCT01655563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111400402|NCT01655563|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111400403|NCT01655563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111400404|NCT01655563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111400405|NCT01655719|Pioglitazone|pioglitazone|mesh-list
111400406|NCT01655719|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111400407|NCT01655719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111400408|NCT05735756|Citalopram|citalopram|mesh-list
111400409|NCT05735756|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111400410|NCT05735756|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111400411|NCT05735756|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111400412|NCT05735756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111400413|NCT05735756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111400414|NCT05735756|Serotonin Agents|serotonin agents|mesh-ancestor
111400415|NCT05735756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111400416|NCT05735756|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111400417|NCT05735756|Antidepressive Agents|antidepressive agents|mesh-ancestor
111400418|NCT05735756|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111400419|NCT01936844|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
111400420|NCT01936844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111400421|NCT02987348|Insulin|insulin|mesh-list
111400422|NCT02987348|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111400423|NCT02987348|Exenatide|exenatide|mesh-list
111400424|NCT02987348|Insulin, Long-Acting|insulin, long-acting|mesh-list
111400425|NCT02987348|Glucagon|glucagon|mesh-list
111400426|NCT02987348|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
111400427|NCT02987348|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111400428|NCT02987348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111400429|NCT02987348|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111400430|NCT02987348|Incretins|incretins|mesh-ancestor
111400431|NCT02987348|Hormones|hormones|mesh-ancestor
111400432|NCT02987348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111400433|NCT02987348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111400434|NCT01656031|Cytarabine|cytarabine|mesh-list
111400435|NCT01656031|Clofarabine|clofarabine|mesh-list
111400436|NCT01656031|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111400437|NCT01656031|Antimetabolites|antimetabolites|mesh-ancestor
111400438|NCT01656031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111400439|NCT01656031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111400440|NCT01656031|Antiviral Agents|antiviral agents|mesh-ancestor
111400441|NCT01656031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111400442|NCT01656031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111400443|NCT01656031|Immunologic Factors|immunologic factors|mesh-ancestor
111400444|NCT01656031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111400445|NCT01656187|Memantine|memantine|mesh-list
111400446|NCT01656187|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111400447|NCT01656187|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111400448|NCT01656187|Dopamine Agents|dopamine agents|mesh-ancestor
111400449|NCT01656187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111400450|NCT01656187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111400451|NCT01656187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111400452|NCT01656187|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111400453|NCT01656187|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111400454|NCT01658839|Travoprost|travoprost|mesh-list
111400455|NCT01658839|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111400456|NCT01658839|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110959242|NCT03526224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111400457|NCT01658839|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111400458|NCT01658995|Doxycycline|doxycycline|mesh-list
111400459|NCT01658995|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111400460|NCT01658995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111400461|NCT01658995|Antimalarials|antimalarials|mesh-ancestor
111400462|NCT01658995|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111400463|NCT01658995|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111400464|NCT01350141|Bococizumab|bococizumab|mesh-list
111400465|NCT01350141|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111400466|NCT01350141|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111400467|NCT01350141|Antimetabolites|antimetabolites|mesh-ancestor
111400468|NCT01350141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111400469|NCT01350141|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111400470|NCT01662115|Nicotine|nicotine|mesh-list
111400471|NCT01662115|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111400472|NCT01662115|Autonomic Agents|autonomic agents|mesh-ancestor
111400473|NCT01662115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111400474|NCT01662115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111400475|NCT01662115|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111400476|NCT01662115|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111400477|NCT01662115|Cholinergic Agents|cholinergic agents|mesh-ancestor
111400478|NCT01662115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111400479|NCT01662115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111400480|NCT01598545|Hydromorphone|hydromorphone|mesh-list
111400481|NCT01598545|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111400482|NCT01598545|Narcotics|narcotics|mesh-ancestor
111400483|NCT01598545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111400484|NCT01598545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111400485|NCT01598545|Analgesics|analgesics|mesh-ancestor
111400486|NCT01598545|Sensory System Agents|sensory system agents|mesh-ancestor
111400487|NCT01598545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111400488|NCT01598701|Acetaminophen|acetaminophen|mesh-list
111400489|NCT01598701|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111400490|NCT01598701|Analgesics|analgesics|mesh-ancestor
111400491|NCT01598701|Sensory System Agents|sensory system agents|mesh-ancestor
111400492|NCT01598701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111400493|NCT01598701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111400494|NCT01598701|Antipyretics|antipyretics|mesh-ancestor
111400495|NCT00000309|Risperidone|risperidone|mesh-list
111400496|NCT00000309|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111400497|NCT00000309|Serotonin Agents|serotonin agents|mesh-ancestor
111400498|NCT00000309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111400499|NCT00000309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111400500|NCT00000309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111400501|NCT00000309|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111400502|NCT00000309|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111400503|NCT00000309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111400504|NCT00000309|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111400505|NCT00000309|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111400506|NCT00000309|Dopamine Agents|dopamine agents|mesh-ancestor
111400507|NCT00000315|Cocaine|cocaine|mesh-list
111400508|NCT00000315|Anesthetics, Local|anesthetics, local|mesh-ancestor
111400509|NCT00000315|Anesthetics|anesthetics|mesh-ancestor
111400510|NCT00000315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111400511|NCT00000315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111400512|NCT00000315|Sensory System Agents|sensory system agents|mesh-ancestor
111400513|NCT00000315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111400514|NCT00000315|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111400515|NCT00000315|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111400516|NCT00000315|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111400517|NCT00000315|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111400518|NCT00000315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111400519|NCT00000315|Dopamine Agents|dopamine agents|mesh-ancestor
111400520|NCT00000315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111400521|NCT00000321|Desipramine|desipramine|mesh-list
111400522|NCT00000321|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
111400523|NCT00000321|Antidepressive Agents|antidepressive agents|mesh-ancestor
111400524|NCT00000321|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111400525|NCT00000321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111400526|NCT00000321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111400527|NCT00000321|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111400528|NCT00000321|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111400529|NCT00000321|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111400530|NCT00000321|Adrenergic Agents|adrenergic agents|mesh-ancestor
111400531|NCT00000321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111400532|NCT00000321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111400533|NCT05125029|Botulinum Toxins|botulinum toxins|mesh-list
111400534|NCT05125029|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111400535|NCT05125029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111400536|NCT05125029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111400537|NCT05125029|Cholinergic Agents|cholinergic agents|mesh-ancestor
111400538|NCT05125029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111400539|NCT05125029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111400541|NCT01940276|Abiraterone Acetate|abiraterone acetate|mesh-list
111400542|NCT01940276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111400543|NCT01940276|Glucocorticoids|glucocorticoids|mesh-ancestor
111400544|NCT01940276|Hormones|hormones|mesh-ancestor
111400545|NCT01940276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111400546|NCT01940276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111400547|NCT01940276|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111400548|NCT01940276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111400549|NCT01940276|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111400550|NCT01940276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111400551|NCT01940276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111400552|NCT01940276|Hormone Antagonists|hormone antagonists|mesh-ancestor
111400553|NCT01940276|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111400554|NCT00000327|Heroin|heroin|mesh-list
111400555|NCT00000327|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111400556|NCT00000327|Narcotics|narcotics|mesh-ancestor
111400557|NCT00000327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111400558|NCT00000327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111400559|NCT00000327|Analgesics|analgesics|mesh-ancestor
111400560|NCT00000327|Sensory System Agents|sensory system agents|mesh-ancestor
111400561|NCT00000327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111400562|NCT01919216|Citalopram|citalopram|mesh-list
111400563|NCT01919216|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111400564|NCT01919216|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111400565|NCT01919216|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111400566|NCT01919216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111400567|NCT01919216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111400568|NCT01919216|Serotonin Agents|serotonin agents|mesh-ancestor
111400569|NCT01919216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111400570|NCT01919216|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111400571|NCT01919216|Antidepressive Agents|antidepressive agents|mesh-ancestor
111400572|NCT01919216|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111400573|NCT01940510|Rifampin|rifampin|mesh-list
111400574|NCT01940510|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111400575|NCT01940510|Antitubercular Agents|antitubercular agents|mesh-ancestor
111400576|NCT01940510|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111400577|NCT01940510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111400578|NCT01940510|Leprostatic Agents|leprostatic agents|mesh-ancestor
111400579|NCT01940510|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111400580|NCT01940510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111400581|NCT01940510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111400582|NCT01940510|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111400583|NCT01940510|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111400584|NCT01940510|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
111400585|NCT01940510|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
111400586|NCT01940510|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
111400587|NCT01940510|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111400588|NCT00380289|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
111400589|NCT00380289|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111400590|NCT00380289|Adrenergic Agents|adrenergic agents|mesh-ancestor
111400591|NCT00380289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111400592|NCT00380289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111400593|NCT00380289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111400594|NCT05364645|Carboplatin|carboplatin|mesh-list
111400595|NCT05364645|Pemetrexed|pemetrexed|mesh-list
111400596|NCT05364645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111400597|NCT05364645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111400598|NCT05364645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111400599|NCT05364645|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111400600|NCT05364645|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111400601|NCT01919450|Regadenoson|regadenoson|mesh-list
111124946|NCT04389775|Hormones|hormones|mesh-ancestor
111400602|NCT01919450|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
111400603|NCT01919450|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
111400604|NCT01919450|Purinergic Agonists|purinergic agonists|mesh-ancestor
111400605|NCT01919450|Purinergic Agents|purinergic agents|mesh-ancestor
111400606|NCT01919450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110877743|NCT01373697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111400607|NCT01919450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111400608|NCT01919450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111400609|NCT01602679|Progesterone|progesterone|mesh-list
111400610|NCT01602679|Progestins|progestins|mesh-ancestor
111400611|NCT01602679|Hormones|hormones|mesh-ancestor
111400612|NCT01602679|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111400613|NCT01602679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111400614|NCT01919606|Bupivacaine|bupivacaine|mesh-list
111400615|NCT01919606|Anesthetics, Local|anesthetics, local|mesh-ancestor
111400616|NCT01919606|Anesthetics|anesthetics|mesh-ancestor
111400617|NCT01919606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111400618|NCT01919606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111400619|NCT01919606|Sensory System Agents|sensory system agents|mesh-ancestor
111400620|NCT01919606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111400621|NCT01919996|Azithromycin|azithromycin|mesh-list
111400622|NCT01919996|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111400623|NCT01919996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111400624|NCT05735132|Lidocaine|lidocaine|mesh-list
111400625|NCT05735132|Anesthetics, Local|anesthetics, local|mesh-ancestor
111400626|NCT05735132|Anesthetics|anesthetics|mesh-ancestor
111400627|NCT05735132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111400628|NCT05735132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111400629|NCT05735132|Sensory System Agents|sensory system agents|mesh-ancestor
111400630|NCT05735132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111400631|NCT05735132|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111400632|NCT05735132|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111400633|NCT05735132|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111400634|NCT05735132|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111400635|NCT05735132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111400636|NCT01667029|Sulfasalazine|sulfasalazine|mesh-list
111400637|NCT01667029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111400638|NCT01667029|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111400639|NCT01667029|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111400640|NCT01667029|Analgesics|analgesics|mesh-ancestor
111400641|NCT01667029|Sensory System Agents|sensory system agents|mesh-ancestor
111400642|NCT01667029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111400643|NCT01667029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111400644|NCT01667029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111400645|NCT01667029|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111400646|NCT01667029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111400647|NCT01943864|Trametinib|trametinib|mesh-list
111400648|NCT01943864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111400649|NCT01943864|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111400650|NCT01943864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111400651|NCT01943864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111400652|NCT01607203|Triptorelin Pamoate|triptorelin pamoate|mesh-list
111400653|NCT01607203|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
111400654|NCT01607203|Luteolytic Agents|luteolytic agents|mesh-ancestor
111400655|NCT01607203|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111400656|NCT01607203|Contraceptive Agents|contraceptive agents|mesh-ancestor
111400657|NCT01607203|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111400658|NCT01607203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111400659|NCT01607203|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111400660|NCT01607203|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111400661|NCT01607203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111400662|NCT00000333|Benztropine|benztropine|mesh-list
111400663|NCT00000333|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111400664|NCT00000333|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111400665|NCT00000333|Parasympatholytics|parasympatholytics|mesh-ancestor
111400666|NCT00000333|Autonomic Agents|autonomic agents|mesh-ancestor
111400667|NCT00000333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111400668|NCT00000333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111400669|NCT00000333|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111400670|NCT00000333|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111400671|NCT00000333|Cholinergic Agents|cholinergic agents|mesh-ancestor
111400672|NCT00000333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111400673|NCT00000333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111400674|NCT00000333|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111400675|NCT00000333|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111400676|NCT00000333|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111400677|NCT00000333|Dopamine Agents|dopamine agents|mesh-ancestor
111400678|NCT00000339|Risperidone|risperidone|mesh-list
111400679|NCT00000339|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111400680|NCT00000339|Serotonin Agents|serotonin agents|mesh-ancestor
111400681|NCT00000339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111400682|NCT00000339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111400683|NCT00000339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111400684|NCT00000339|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111400685|NCT00000339|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111400686|NCT00000339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111400687|NCT00000339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111400688|NCT00000339|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111400689|NCT00000339|Dopamine Agents|dopamine agents|mesh-ancestor
111400690|NCT00000345|Lofexidine|lofexidine|mesh-list
111400691|NCT00000345|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111400692|NCT00000345|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111400693|NCT00000345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111400694|NCT00000345|Sensory System Agents|sensory system agents|mesh-ancestor
111400695|NCT00000345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111400696|NCT00000345|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111400697|NCT00000345|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111400698|NCT00000345|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111400699|NCT00000345|Adrenergic Agents|adrenergic agents|mesh-ancestor
111400700|NCT00000345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111400701|NCT00000345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111400702|NCT00000357|Buprenorphine|buprenorphine|mesh-list
111400703|NCT00000357|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111400704|NCT00000357|Narcotics|narcotics|mesh-ancestor
111400705|NCT00000357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111400706|NCT00000357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111400707|NCT00000357|Analgesics|analgesics|mesh-ancestor
111400708|NCT00000357|Sensory System Agents|sensory system agents|mesh-ancestor
111400709|NCT00000357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111400710|NCT00000357|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111400711|NCT05095311|Cetirizine|cetirizine|mesh-list
111400712|NCT05095311|Nedocromil|nedocromil|mesh-list
111400713|NCT05095311|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111400714|NCT05095311|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
111400715|NCT05095311|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111400716|NCT05095311|Histamine Antagonists|histamine antagonists|mesh-ancestor
111400717|NCT05095311|Histamine Agents|histamine agents|mesh-ancestor
111400718|NCT05095311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111400719|NCT05095311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111400720|NCT05095311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111400721|NCT05095311|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
111400722|NCT05095311|Immunologic Factors|immunologic factors|mesh-ancestor
111400723|NCT05095311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111400724|NCT05095311|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111400725|NCT05095311|Respiratory System Agents|respiratory system agents|mesh-ancestor
111400726|NCT01922336|Infliximab|infliximab|mesh-list
111400727|NCT01922336|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111400728|NCT01922336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111400729|NCT01922336|Dermatologic Agents|dermatologic agents|mesh-ancestor
111400730|NCT01922336|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111400731|NCT01922336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111400732|NCT04330755|Magnesium Sulfate|magnesium sulfate|mesh-list
111400733|NCT04330755|Simendan|simendan|mesh-list
111400734|NCT04330755|Analgesics|analgesics|mesh-ancestor
111400735|NCT04330755|Sensory System Agents|sensory system agents|mesh-ancestor
111400736|NCT04330755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111400737|NCT04330755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111400738|NCT04330755|Anesthetics|anesthetics|mesh-ancestor
111400739|NCT04330755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111400740|NCT04330755|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111400741|NCT04330755|Anticonvulsants|anticonvulsants|mesh-ancestor
111400742|NCT04330755|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111400743|NCT04330755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111400744|NCT04330755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111400745|NCT04330755|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111400746|NCT04330755|Tocolytic Agents|tocolytic agents|mesh-ancestor
111125099|NCT01402271|Paclitaxel|paclitaxel|mesh-list
111400747|NCT04330755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111400748|NCT04330755|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111400749|NCT04330755|Vasodilator Agents|vasodilator agents|mesh-ancestor
111400750|NCT04330755|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
111400751|NCT04330755|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111400752|NCT04330755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111400753|NCT04330755|Protective Agents|protective agents|mesh-ancestor
111400755|NCT01608295|Antidepressive Agents|antidepressive agents|mesh-list
111400756|NCT01608295|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
111400757|NCT01608295|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111400758|NCT01608295|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111400759|NCT01608295|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111400760|NCT01608295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111400761|NCT01608295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111400762|NCT01608295|Serotonin Agents|serotonin agents|mesh-ancestor
111400763|NCT01608295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111400764|NCT01608295|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111400765|NCT01608295|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111400766|NCT01608295|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111400767|NCT01608295|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111400768|NCT01608295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111400769|NCT01608295|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111400770|NCT01608295|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111400771|NCT04713189|Fentanyl|fentanyl|mesh-list
111400772|NCT04713189|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111400773|NCT04713189|Narcotics|narcotics|mesh-ancestor
111400774|NCT04713189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111400775|NCT04713189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111400776|NCT04713189|Analgesics|analgesics|mesh-ancestor
111400777|NCT04713189|Sensory System Agents|sensory system agents|mesh-ancestor
111400778|NCT04713189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111400779|NCT04713189|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111400780|NCT04713189|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111400781|NCT04713189|Anesthetics, General|anesthetics, general|mesh-ancestor
111400782|NCT04713189|Anesthetics|anesthetics|mesh-ancestor
111400783|NCT01610011|Glycine|glycine|mesh-list
111400784|NCT01610011|Glycine Agents|glycine agents|mesh-ancestor
111400785|NCT01610011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111400786|NCT01610011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111400787|NCT01610011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111400788|NCT00000399|Hormones|hormones|mesh-list
111400789|NCT00000399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111400790|NCT00000399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111400791|NCT02237989|Acetaminophen|acetaminophen|mesh-list
111400792|NCT02237989|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111400793|NCT02237989|Analgesics|analgesics|mesh-ancestor
111400794|NCT02237989|Sensory System Agents|sensory system agents|mesh-ancestor
111400795|NCT02237989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111400796|NCT02237989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111400797|NCT02237989|Antipyretics|antipyretics|mesh-ancestor
111400798|NCT00000429|Calcium Carbonate|calcium carbonate|mesh-list
111400799|NCT00000429|Calcium|calcium|mesh-list
111400800|NCT00000429|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111400801|NCT00000429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111400802|NCT00000429|Antacids|antacids|mesh-ancestor
111400803|NCT00000429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111400804|NCT00000429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111400805|NCT01673191|Dexamethasone|dexamethasone|mesh-list
111400806|NCT01673191|Prednisolone acetate|prednisolone acetate|mesh-list
111400807|NCT01673191|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111400808|NCT01673191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111400809|NCT01673191|Antiemetics|antiemetics|mesh-ancestor
111400810|NCT01673191|Autonomic Agents|autonomic agents|mesh-ancestor
111400811|NCT01673191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111400812|NCT01673191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111400813|NCT01673191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111400814|NCT01673191|Glucocorticoids|glucocorticoids|mesh-ancestor
111400815|NCT01673191|Hormones|hormones|mesh-ancestor
111400816|NCT01673191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110877956|NCT05733000|Antioxidants|antioxidants|mesh-ancestor
111400817|NCT01673191|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111400818|NCT01673191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111400819|NCT01673191|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111400820|NCT01925144|Omeprazole|omeprazole|mesh-list
111400821|NCT01925144|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111400822|NCT01925144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111400824|NCT01925144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111400825|NCT01925144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111400826|NCT00000441|Carbamazepine|carbamazepine|mesh-list
111400827|NCT00000441|Lorazepam|lorazepam|mesh-list
111400828|NCT00000441|Anticonvulsants|anticonvulsants|mesh-ancestor
111400829|NCT00000441|Antiemetics|antiemetics|mesh-ancestor
111400830|NCT00000441|Autonomic Agents|autonomic agents|mesh-ancestor
111400831|NCT00000441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111400832|NCT00000441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111400833|NCT00000441|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111400834|NCT00000441|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111400835|NCT00000441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111400836|NCT00000441|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111400837|NCT00000441|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111400838|NCT00000441|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111400839|NCT00000441|GABA Modulators|gaba modulators|mesh-ancestor
111400840|NCT00000441|GABA Agents|gaba agents|mesh-ancestor
111400841|NCT00000441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111400842|NCT00000441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111400843|NCT00000441|Antimanic Agents|antimanic agents|mesh-ancestor
111400844|NCT00000441|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111400845|NCT00000441|Analgesics|analgesics|mesh-ancestor
111400846|NCT00000441|Sensory System Agents|sensory system agents|mesh-ancestor
111400847|NCT00000441|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111400848|NCT00000441|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111400849|NCT00000441|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111400850|NCT00000441|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111400851|NCT00000447|Naltrexone|naltrexone|mesh-list
111400852|NCT00000447|Nicotine|nicotine|mesh-list
111400853|NCT00000447|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111400854|NCT00000447|Autonomic Agents|autonomic agents|mesh-ancestor
111400855|NCT00000447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111400856|NCT00000447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111400857|NCT00000447|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111400858|NCT00000447|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111400859|NCT00000447|Cholinergic Agents|cholinergic agents|mesh-ancestor
111400860|NCT00000447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111400861|NCT00000447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111400862|NCT00000447|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111400863|NCT00000447|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111400864|NCT00000447|Sensory System Agents|sensory system agents|mesh-ancestor
111400865|NCT01927718|Thalidomide|thalidomide|mesh-list
111400866|NCT01927718|Lenalidomide|lenalidomide|mesh-list
111400867|NCT01927718|Immunologic Factors|immunologic factors|mesh-ancestor
111400868|NCT01927718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111400869|NCT01927718|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111400870|NCT01927718|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111400871|NCT01927718|Growth Substances|growth substances|mesh-ancestor
111400872|NCT01927718|Growth Inhibitors|growth inhibitors|mesh-ancestor
111400873|NCT01927718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111400874|NCT01927718|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111400875|NCT01927718|Leprostatic Agents|leprostatic agents|mesh-ancestor
111400876|NCT01927718|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111400877|NCT01927718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111400878|NCT05066607|Dexamethasone|dexamethasone|mesh-list
111400879|NCT05066607|Pomalidomide|pomalidomide|mesh-list
111400880|NCT05066607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111400881|NCT05066607|Antiemetics|antiemetics|mesh-ancestor
111400882|NCT05066607|Autonomic Agents|autonomic agents|mesh-ancestor
111400883|NCT05066607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111400884|NCT05066607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111400885|NCT05066607|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111400886|NCT05066607|Glucocorticoids|glucocorticoids|mesh-ancestor
111400887|NCT05066607|Hormones|hormones|mesh-ancestor
111400888|NCT05066607|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111400889|NCT05066607|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111400890|NCT05066607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111400891|NCT05066607|Immunologic Factors|immunologic factors|mesh-ancestor
111400892|NCT05066607|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111400893|NCT05066607|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111400894|NCT05066607|Growth Substances|growth substances|mesh-ancestor
111400895|NCT05066607|Growth Inhibitors|growth inhibitors|mesh-ancestor
111400896|NCT01948310|Ranolazine|ranolazine|mesh-list
111400897|NCT01948310|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111400898|NCT01948310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111400899|NCT01948310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111400900|NCT01948388|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
111400901|NCT01948388|Hormones|hormones|mesh-ancestor
111400902|NCT01948388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111400903|NCT01948388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111400904|NCT01675297|Cholecalciferol|cholecalciferol|mesh-list
111400905|NCT01675297|Vitamin D|vitamin d|mesh-list
111400906|NCT01675297|Risedronic Acid|risedronic acid|mesh-list
111400907|NCT01675297|Etidronic Acid|etidronic acid|mesh-list
111400908|NCT01675297|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111400909|NCT01675297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111400910|NCT01675297|Vitamins|vitamins|mesh-ancestor
111400911|NCT01675297|Micronutrients|micronutrients|mesh-ancestor
111400912|NCT01675297|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111400913|NCT01675297|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111400914|NCT01675297|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111400915|NCT01675297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111400916|NCT05295537|Liver Extracts|liver extracts|mesh-list
111400917|NCT05295537|Hematinics|hematinics|mesh-ancestor
111400918|NCT02287376|Diclofenac|diclofenac|mesh-list
111400919|NCT02287376|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111400920|NCT02287376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111400921|NCT02287376|Analgesics|analgesics|mesh-ancestor
111400922|NCT02287376|Sensory System Agents|sensory system agents|mesh-ancestor
111400923|NCT02287376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111400924|NCT02287376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111400925|NCT02287376|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111400926|NCT02287376|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111400927|NCT02287376|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111400928|NCT02287376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111400929|NCT02287376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111400930|NCT01928186|Alovudine|alovudine|mesh-list
111400931|NCT01928186|Antiviral Agents|antiviral agents|mesh-ancestor
111400932|NCT01928186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111400933|NCT01611571|Teriparatide|teriparatide|mesh-list
111400934|NCT01611571|Risedronic Acid|risedronic acid|mesh-list
111400935|NCT01611571|Etidronic Acid|etidronic acid|mesh-list
111400936|NCT01611571|Parathyroid Hormone|parathyroid hormone|mesh-list
111400937|NCT01611571|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111400938|NCT01611571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111400939|NCT01611571|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111400940|NCT01611571|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111400941|NCT01611571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111400942|NCT01611571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111400943|NCT00000477|Lovastatin|lovastatin|mesh-list
111400944|NCT00000477|L 647318|l 647318|mesh-list
111400945|NCT00000477|Dihydromevinolin|dihydromevinolin|mesh-list
111400946|NCT00000477|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111400947|NCT00000477|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111400948|NCT00000477|Antimetabolites|antimetabolites|mesh-ancestor
111400949|NCT00000477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111400950|NCT00000477|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111400951|NCT00000477|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111400952|NCT00000477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111400953|NCT00000483|Niacin|niacin|mesh-list
111400954|NCT00000483|Clofibrate|clofibrate|mesh-list
111400955|NCT00000483|Estrogens|estrogens|mesh-list
111400956|NCT00000483|Hormones|hormones|mesh-ancestor
111400957|NCT00000483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111400958|NCT00000483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111400959|NCT00000483|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111400960|NCT00000483|Antimetabolites|antimetabolites|mesh-ancestor
111400961|NCT00000483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111400962|NCT00000483|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111400963|NCT00000483|Vasodilator Agents|vasodilator agents|mesh-ancestor
111400964|NCT00000483|Vitamin B Complex|vitamin b complex|mesh-ancestor
111400965|NCT00000483|Vitamins|vitamins|mesh-ancestor
111400966|NCT00000483|Micronutrients|micronutrients|mesh-ancestor
111400967|NCT00000483|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111400968|NCT00000507|Streptokinase|streptokinase|mesh-list
111400969|NCT00000507|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111400970|NCT00000507|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111400971|NCT00000507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111400972|NCT00380445|Vildagliptin|vildagliptin|mesh-list
111400973|NCT00380445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111125318|NCT02660281|Melphalan|melphalan|mesh-list
111400974|NCT00380445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111400975|NCT00380445|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111400976|NCT00380445|Protease Inhibitors|protease inhibitors|mesh-ancestor
111400977|NCT00380445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111400978|NCT00380445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111400979|NCT01950260|Hormones|hormones|mesh-list
111400980|NCT01950260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111400981|NCT01950260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111400982|NCT01676311|Huperzine A|huperzine a|mesh-list
111400983|NCT01676311|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111400984|NCT01676311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111400985|NCT01676311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111400986|NCT01676311|Cholinergic Agents|cholinergic agents|mesh-ancestor
111400987|NCT01676311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111400988|NCT01676311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111400989|NCT01676311|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111400990|NCT01676311|Protective Agents|protective agents|mesh-ancestor
111400991|NCT01951118|Donepezil|donepezil|mesh-list
111400992|NCT01951118|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111400993|NCT01951118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111400994|NCT01951118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111400995|NCT01951118|Cholinergic Agents|cholinergic agents|mesh-ancestor
111400996|NCT01951118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111400997|NCT01951118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111400998|NCT01951118|Nootropic Agents|nootropic agents|mesh-ancestor
111400999|NCT01951820|Lidocaine|lidocaine|mesh-list
111401000|NCT01951820|Tetracaine|tetracaine|mesh-list
111401001|NCT01951820|Carticaine|carticaine|mesh-list
111401002|NCT01951820|Benzocaine|benzocaine|mesh-list
111401003|NCT01951820|Anesthetics, Local|anesthetics, local|mesh-ancestor
111401004|NCT01951820|Anesthetics|anesthetics|mesh-ancestor
111401005|NCT01951820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111401006|NCT01951820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111401007|NCT01951820|Sensory System Agents|sensory system agents|mesh-ancestor
111401008|NCT01951820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111401009|NCT01951820|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111401010|NCT01951820|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111401011|NCT01951820|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111401012|NCT01951820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111401013|NCT01951820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111401014|NCT01952444|Ciprofloxacin|ciprofloxacin|mesh-list
111401015|NCT01952444|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111401016|NCT01952444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111401017|NCT01952444|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111401018|NCT01952444|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111401019|NCT01952444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111401020|NCT01952444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111401021|NCT01952444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111401022|NCT01952444|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111401023|NCT01952444|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111401024|NCT01614847|Lubricant Eye Drops|lubricant eye drops|mesh-list
111401025|NCT01614847|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
111401026|NCT01614847|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111401027|NCT00382629|Butylated Hydroxytoluene|butylated hydroxytoluene|mesh-list
111401028|NCT00382629|Antioxidants|antioxidants|mesh-ancestor
111401029|NCT00382629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111401030|NCT00382629|Protective Agents|protective agents|mesh-ancestor
111401031|NCT00382629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111401032|NCT00000513|Atenolol|atenolol|mesh-list
111401033|NCT00000513|Chlorthalidone|chlorthalidone|mesh-list
111401034|NCT00000513|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111401035|NCT00000513|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111401036|NCT00000513|Sympatholytics|sympatholytics|mesh-ancestor
111401037|NCT00000513|Autonomic Agents|autonomic agents|mesh-ancestor
111401038|NCT00000513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111401039|NCT00000513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111401040|NCT00000513|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
111401041|NCT00000513|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111401042|NCT00000513|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111401043|NCT00000513|Adrenergic Agents|adrenergic agents|mesh-ancestor
111401044|NCT00000513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111401045|NCT00000513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111401046|NCT00000513|Diuretics|diuretics|mesh-ancestor
111401047|NCT00000513|Natriuretic Agents|natriuretic agents|mesh-ancestor
111401048|NCT00000513|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
111401049|NCT00000513|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111401050|NCT00000543|Calcium|calcium|mesh-list
111401051|NCT00000543|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111401052|NCT00000543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111401053|NCT00000549|Hormones|hormones|mesh-list
111401054|NCT00000549|Estrogens|estrogens|mesh-list
111401055|NCT00000549|Progestins|progestins|mesh-list
111401056|NCT00000549|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111401057|NCT00000549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111401058|NCT01617577|Lenograstim|lenograstim|mesh-list
111401059|NCT01617577|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111401060|NCT01617577|Immunologic Factors|immunologic factors|mesh-ancestor
111401061|NCT01617577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111401062|NCT01701037|Trametinib|trametinib|mesh-list
111401063|NCT01701037|Dabrafenib|dabrafenib|mesh-list
111401064|NCT01701037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111401065|NCT01701037|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111401066|NCT01701037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111401067|NCT01701037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111401068|NCT00000585|Penicillins|penicillins|mesh-list
111401069|NCT00000585|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111401070|NCT00000585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111401071|NCT01701115|Bupivacaine|bupivacaine|mesh-list
111401072|NCT01701115|Anesthetics, Local|anesthetics, local|mesh-list
111401073|NCT01701115|Mepivacaine|mepivacaine|mesh-list
111401074|NCT01701115|Anesthetics|anesthetics|mesh-list
110878232|NCT05186454|Dexamethasone|dexamethasone|mesh-list
111401075|NCT01701115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111401076|NCT01701115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111401077|NCT01701115|Sensory System Agents|sensory system agents|mesh-ancestor
111401078|NCT01701115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111401079|NCT00000597|Nandrolone Decanoate|nandrolone decanoate|mesh-list
111401080|NCT00000597|Nandrolone|nandrolone|mesh-list
111401081|NCT00000597|Nandrolone phenpropionate|nandrolone phenpropionate|mesh-list
111401082|NCT00000597|Antilymphocyte Serum|antilymphocyte serum|mesh-list
111401083|NCT00000597|Androgens|androgens|mesh-ancestor
111401084|NCT00000597|Hormones|hormones|mesh-ancestor
111401085|NCT00000597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111401086|NCT00000597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111401087|NCT00000597|Anabolic Agents|anabolic agents|mesh-ancestor
111401088|NCT00000597|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111401089|NCT00000597|Immunologic Factors|immunologic factors|mesh-ancestor
111401090|NCT00000597|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111401091|NCT01621009|Bupropion|bupropion|mesh-list
111401092|NCT01621009|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111401093|NCT01621009|Antidepressive Agents|antidepressive agents|mesh-ancestor
111401094|NCT01621009|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111401095|NCT01621009|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111401096|NCT01621009|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111401097|NCT01621009|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111401098|NCT01621009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111401099|NCT01621009|Dopamine Agents|dopamine agents|mesh-ancestor
111401100|NCT01621009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111401101|NCT01621009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111401102|NCT01621009|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111401103|NCT01621009|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111401104|NCT01621009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111401105|NCT04830969|Chlorhexidine|chlorhexidine|mesh-list
111401106|NCT04830969|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
111401107|NCT04830969|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111401108|NCT04830969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111401109|NCT04830969|Disinfectants|disinfectants|mesh-ancestor
111401110|NCT04830969|Dermatologic Agents|dermatologic agents|mesh-ancestor
111401111|NCT01683331|Insulin|insulin|mesh-list
111401112|NCT01683331|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111401113|NCT01683331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111401114|NCT02986880|Botulinum Toxins|botulinum toxins|mesh-list
111401115|NCT02986880|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111401116|NCT02986880|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111401117|NCT02986880|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111401118|NCT02986880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111401119|NCT02986880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111401120|NCT02986880|Cholinergic Agents|cholinergic agents|mesh-ancestor
111401121|NCT02986880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111401122|NCT02986880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111401123|NCT02986880|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111401124|NCT02986880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111401125|NCT02290106|Pitavastatin|pitavastatin|mesh-list
111401126|NCT02290106|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111401127|NCT02290106|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111401128|NCT02290106|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111401129|NCT02290106|Antimetabolites|antimetabolites|mesh-ancestor
111401130|NCT02290106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111401131|NCT02290106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111401132|NCT02290106|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111401133|NCT00000621|Tretinoin|tretinoin|mesh-list
111401134|NCT00000621|Isotretinoin|isotretinoin|mesh-list
111401135|NCT00000621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111401136|NCT00000621|Keratolytic Agents|keratolytic agents|mesh-ancestor
111401137|NCT00000621|Dermatologic Agents|dermatologic agents|mesh-ancestor
111401138|NCT04818957|Vitamin D|vitamin d|mesh-list
111401139|NCT04818957|Cholecalciferol|cholecalciferol|mesh-list
111401140|NCT04818957|Vitamins|vitamins|mesh-ancestor
111401141|NCT04818957|Micronutrients|micronutrients|mesh-ancestor
111401142|NCT04818957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111401143|NCT04818957|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111401144|NCT04818957|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111401145|NCT01621477|Cytarabine|cytarabine|mesh-list
111401146|NCT01621477|Plerixafor|plerixafor|mesh-list
111401147|NCT01621477|Mycophenolic Acid|mycophenolic acid|mesh-list
111401148|NCT01621477|Cyclophosphamide|cyclophosphamide|mesh-list
111401149|NCT01621477|Busulfan|busulfan|mesh-list
111401150|NCT01621477|Clofarabine|clofarabine|mesh-list
111401151|NCT01621477|Tacrolimus|tacrolimus|mesh-list
111401152|NCT01621477|Thymoglobulin|thymoglobulin|mesh-list
111401153|NCT01621477|Antilymphocyte Serum|antilymphocyte serum|mesh-list
111401154|NCT01621477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111401155|NCT01621477|Immunologic Factors|immunologic factors|mesh-ancestor
111401156|NCT01621477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111401157|NCT01621477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111401158|NCT01621477|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111401159|NCT01621477|Alkylating Agents|alkylating agents|mesh-ancestor
111401160|NCT01621477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111401161|NCT01621477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111401162|NCT01621477|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111401163|NCT01621477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111401164|NCT01621477|Antimetabolites|antimetabolites|mesh-ancestor
111401165|NCT01621477|Antiviral Agents|antiviral agents|mesh-ancestor
111401166|NCT01621477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111401167|NCT01621477|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111401168|NCT01621477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111401169|NCT01621477|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111401170|NCT01621477|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111401171|NCT01621477|Antitubercular Agents|antitubercular agents|mesh-ancestor
111401172|NCT01621477|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111401173|NCT01621477|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111401174|NCT01621477|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111401175|NCT00000627|Fluconazole|fluconazole|mesh-list
111401176|NCT00000627|Antifungal Agents|antifungal agents|mesh-ancestor
111401177|NCT00000627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111401178|NCT00000627|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111401179|NCT00000627|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111401180|NCT00000627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111401181|NCT00000627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111401182|NCT00000627|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111401183|NCT00000627|Hormone Antagonists|hormone antagonists|mesh-ancestor
111401184|NCT00000627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111401185|NCT00000627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111401186|NCT00000627|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111401187|NCT00000627|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111401188|NCT00000633|Vaccines|vaccines|mesh-list
111401189|NCT00000633|Immunologic Factors|immunologic factors|mesh-ancestor
111401190|NCT00000633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111401191|NCT01621633|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
111401192|NCT01621633|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111401193|NCT01621633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111401194|NCT05479214|Metformin|metformin|mesh-list
111401195|NCT05479214|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111125542|NCT04962425|Trastuzumab|trastuzumab|mesh-list
111401196|NCT05479214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111401197|NCT00000657|Zidovudine|zidovudine|mesh-list
111401198|NCT00000657|Didanosine|didanosine|mesh-list
111401199|NCT00000657|Antimetabolites|antimetabolites|mesh-ancestor
111401200|NCT00000657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111401201|NCT00000657|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111401202|NCT00000657|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111401203|NCT00000657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111401204|NCT00000657|Antiviral Agents|antiviral agents|mesh-ancestor
111401205|NCT00000657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111401206|NCT00000657|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111401207|NCT00000657|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111401208|NCT01701505|Phenylephrine|phenylephrine|mesh-list
111401209|NCT01701505|Oxymetazoline|oxymetazoline|mesh-list
111401210|NCT01701505|Tetracaine|tetracaine|mesh-list
111401211|NCT01701505|Anesthetics, Local|anesthetics, local|mesh-ancestor
111401212|NCT01701505|Anesthetics|anesthetics|mesh-ancestor
111401213|NCT01701505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111401214|NCT01701505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111401215|NCT01701505|Sensory System Agents|sensory system agents|mesh-ancestor
111401216|NCT01701505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111401217|NCT01701505|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111401218|NCT01701505|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111401219|NCT01701505|Adrenergic Agents|adrenergic agents|mesh-ancestor
111401220|NCT01701505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111401221|NCT01701505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111401222|NCT01701505|Sympathomimetics|sympathomimetics|mesh-ancestor
111401223|NCT01701505|Autonomic Agents|autonomic agents|mesh-ancestor
111401224|NCT01701505|Nasal Decongestants|nasal decongestants|mesh-ancestor
111401225|NCT01701505|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111401226|NCT01701505|Respiratory System Agents|respiratory system agents|mesh-ancestor
111401227|NCT01701505|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111401228|NCT01701505|Mydriatics|mydriatics|mesh-ancestor
111401229|NCT01701505|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111401230|NCT01701505|Protective Agents|protective agents|mesh-ancestor
111401231|NCT00000663|CD4 Immunoadhesins|cd4 immunoadhesins|mesh-list
111401232|NCT00000663|Immunologic Factors|immunologic factors|mesh-ancestor
111401233|NCT00000663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111401234|NCT00000669|Didanosine|didanosine|mesh-list
111401235|NCT00000669|Antimetabolites|antimetabolites|mesh-ancestor
111401236|NCT00000669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111401237|NCT00000669|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111401238|NCT00000669|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111401239|NCT00000669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111401240|NCT00000669|Antiviral Agents|antiviral agents|mesh-ancestor
111401241|NCT00000669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111401242|NCT00000669|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111401243|NCT00000669|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111401244|NCT01622257|Metformin|metformin|mesh-list
111401245|NCT01622257|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111401246|NCT01622257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111401247|NCT04942899|Capecitabine|capecitabine|mesh-list
111401248|NCT04942899|Letrozole|letrozole|mesh-list
111401249|NCT04942899|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111401250|NCT04942899|Antimetabolites|antimetabolites|mesh-ancestor
111401251|NCT04942899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111401252|NCT04942899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111401253|NCT04942899|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111401254|NCT04942899|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111401255|NCT04942899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111401256|NCT04942899|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111401257|NCT04942899|Hormone Antagonists|hormone antagonists|mesh-ancestor
111401258|NCT04942899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111401259|NCT04942899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111401260|NCT00000693|Zidovudine|zidovudine|mesh-list
111401261|NCT00000693|Acyclovir|acyclovir|mesh-list
111401262|NCT00000693|Antimetabolites|antimetabolites|mesh-ancestor
111401263|NCT00000693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111401264|NCT00000693|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111401265|NCT00000693|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111401266|NCT00000693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111401267|NCT00000693|Antiviral Agents|antiviral agents|mesh-ancestor
111401268|NCT00000693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111401269|NCT00000693|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111125620|NCT03293017|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111401270|NCT00000693|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111401272|NCT04752033|Hydromorphone|hydromorphone|mesh-list
111401273|NCT04752033|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111401274|NCT04752033|Narcotics|narcotics|mesh-ancestor
111401275|NCT04752033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111401276|NCT04752033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111401277|NCT04752033|Analgesics|analgesics|mesh-ancestor
111401278|NCT04752033|Sensory System Agents|sensory system agents|mesh-ancestor
111401279|NCT04752033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111401280|NCT02987270|Piperaquine|piperaquine|mesh-list
111401281|NCT02987270|Artenimol|artenimol|mesh-list
111401282|NCT02987270|Antimalarials|antimalarials|mesh-ancestor
111401283|NCT02987270|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111401284|NCT02987270|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111401285|NCT02987270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111401286|NCT00000699|Ribavirin|ribavirin|mesh-list
111401287|NCT00000699|Inosine Pranobex|inosine pranobex|mesh-list
111401288|NCT00000699|Antimetabolites|antimetabolites|mesh-ancestor
111401289|NCT00000699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111401290|NCT00000699|Antiviral Agents|antiviral agents|mesh-ancestor
111401291|NCT00000699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111401292|NCT00000699|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111401293|NCT00000699|Immunologic Factors|immunologic factors|mesh-ancestor
111401294|NCT00000699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111401295|NCT04931979|Pembrolizumab|pembrolizumab|mesh-list
111401296|NCT04931979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111401297|NCT04931979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111401298|NCT04931979|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111401299|NCT04931979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111401300|NCT00000723|Leucovorin|leucovorin|mesh-list
111401301|NCT00000723|Zidovudine|zidovudine|mesh-list
111401302|NCT00000723|Dexamethasone|dexamethasone|mesh-list
111401303|NCT00000723|Methotrexate|methotrexate|mesh-list
111401304|NCT00000723|Calcium|calcium|mesh-list
111401305|NCT00000723|Levoleucovorin|levoleucovorin|mesh-list
111401306|NCT00000723|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111401307|NCT00000723|Antiemetics|antiemetics|mesh-ancestor
111401308|NCT00000723|Autonomic Agents|autonomic agents|mesh-ancestor
111401309|NCT00000723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111401310|NCT00000723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111401311|NCT00000723|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111401312|NCT00000723|Glucocorticoids|glucocorticoids|mesh-ancestor
111401313|NCT00000723|Hormones|hormones|mesh-ancestor
111401314|NCT00000723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111401315|NCT00000723|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111401316|NCT00000723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111401317|NCT00000723|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111401318|NCT00000723|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111401319|NCT00000723|Abortifacient Agents|abortifacient agents|mesh-ancestor
111401320|NCT00000723|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111401321|NCT00000723|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111401322|NCT00000723|Antimetabolites|antimetabolites|mesh-ancestor
110878465|NCT03646916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111401323|NCT00000723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111401324|NCT00000723|Dermatologic Agents|dermatologic agents|mesh-ancestor
111401325|NCT00000723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111401326|NCT00000723|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111401327|NCT00000723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111401328|NCT00000723|Immunologic Factors|immunologic factors|mesh-ancestor
111401329|NCT00000723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111401330|NCT00000723|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111401331|NCT00000723|Antidotes|antidotes|mesh-ancestor
111401332|NCT00000723|Protective Agents|protective agents|mesh-ancestor
111401333|NCT00000723|Vitamin B Complex|vitamin b complex|mesh-ancestor
111401334|NCT00000723|Vitamins|vitamins|mesh-ancestor
111401335|NCT00000723|Micronutrients|micronutrients|mesh-ancestor
111401336|NCT00000723|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111401337|NCT00000723|Antiviral Agents|antiviral agents|mesh-ancestor
111401338|NCT00000723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111401339|NCT00000723|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111401340|NCT00000723|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111401341|NCT02329964|Neostigmine|neostigmine|mesh-list
111401342|NCT02329964|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
111401343|NCT02329964|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111401344|NCT02329964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111401345|NCT02329964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111401346|NCT02329964|Cholinergic Agents|cholinergic agents|mesh-ancestor
111401347|NCT02329964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111401348|NCT02329964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111401349|NCT02329964|Parasympathomimetics|parasympathomimetics|mesh-ancestor
111401350|NCT02329964|Autonomic Agents|autonomic agents|mesh-ancestor
111401351|NCT02329964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111401352|NCT04750395|Haloperidol|haloperidol|mesh-list
111401353|NCT04750395|Olanzapine|olanzapine|mesh-list
111401354|NCT04750395|Haloperidol decanoate|haloperidol decanoate|mesh-list
111401355|NCT04750395|Antiemetics|antiemetics|mesh-ancestor
111401356|NCT04750395|Autonomic Agents|autonomic agents|mesh-ancestor
111401357|NCT04750395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111401358|NCT04750395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111401359|NCT04750395|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111401360|NCT04750395|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111401361|NCT04750395|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111401362|NCT04750395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111401363|NCT04750395|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111401364|NCT04750395|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111401365|NCT04750395|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111401366|NCT04750395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111401367|NCT04750395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111401368|NCT04750395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111401369|NCT04750395|Serotonin Agents|serotonin agents|mesh-ancestor
111401370|NCT04750395|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111401371|NCT04750395|Dopamine Agents|dopamine agents|mesh-ancestor
111401372|NCT04750395|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111401373|NCT00000729|Foscarnet|foscarnet|mesh-list
111401374|NCT00000729|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
111401375|NCT00000729|Antiviral Agents|antiviral agents|mesh-ancestor
111401376|NCT00000729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111401377|NCT00000729|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111401378|NCT00000729|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111401379|NCT00000729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111401380|NCT00000729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111401381|NCT03438773|Tacrolimus|tacrolimus|mesh-list
111401382|NCT03438773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111401383|NCT03438773|Immunologic Factors|immunologic factors|mesh-ancestor
111401384|NCT03438773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111401385|NCT03438773|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111401386|NCT03438773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111401387|NCT03438773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111401388|NCT02974985|Hyaluronic Acid|hyaluronic acid|mesh-list
111401389|NCT02974985|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111401390|NCT02974985|Immunologic Factors|immunologic factors|mesh-ancestor
111401391|NCT02974985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111401392|NCT02974985|Viscosupplements|viscosupplements|mesh-ancestor
111401393|NCT02974985|Protective Agents|protective agents|mesh-ancestor
111401394|NCT01704781|Lenalidomide|lenalidomide|mesh-list
111401395|NCT01704781|Immunologic Factors|immunologic factors|mesh-ancestor
111401396|NCT01704781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111401397|NCT01704781|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111401398|NCT01704781|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111401399|NCT01704781|Growth Substances|growth substances|mesh-ancestor
111401400|NCT01704781|Growth Inhibitors|growth inhibitors|mesh-ancestor
111401401|NCT01704781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111401402|NCT02288156|Capsaicin|capsaicin|mesh-list
111401403|NCT02288156|Antipruritics|antipruritics|mesh-ancestor
111401404|NCT02288156|Dermatologic Agents|dermatologic agents|mesh-ancestor
111401405|NCT02288156|Sensory System Agents|sensory system agents|mesh-ancestor
111401406|NCT02288156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111401407|NCT02288156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111401408|NCT04699383|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
111401409|NCT04699383|Allopurinol|allopurinol|mesh-list
111401410|NCT04699383|Antimetabolites|antimetabolites|mesh-ancestor
111401411|NCT04699383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111401412|NCT04699383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111401413|NCT04699383|Gout Suppressants|gout suppressants|mesh-ancestor
111401414|NCT04699383|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111401415|NCT04699383|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111401416|NCT04699383|Antioxidants|antioxidants|mesh-ancestor
111401417|NCT04699383|Protective Agents|protective agents|mesh-ancestor
111401418|NCT04699383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111401419|NCT04699383|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111401420|NCT04699383|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111401421|NCT04699383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111401422|NCT04699383|Schistosomicides|schistosomicides|mesh-ancestor
111401423|NCT04699383|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
111401424|NCT04699383|Anthelmintics|anthelmintics|mesh-ancestor
111401425|NCT05700266|Aspirin|aspirin|mesh-list
111401426|NCT05700266|Rivaroxaban|rivaroxaban|mesh-list
111401427|NCT05700266|Clopidogrel|clopidogrel|mesh-list
111401428|NCT05700266|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111401429|NCT05700266|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111401430|NCT05700266|Analgesics|analgesics|mesh-ancestor
111401431|NCT05700266|Sensory System Agents|sensory system agents|mesh-ancestor
111401432|NCT05700266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111401433|NCT05700266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111401434|NCT05700266|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111401435|NCT05700266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111401436|NCT05700266|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111401437|NCT05700266|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111401438|NCT05700266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111401439|NCT05700266|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111401440|NCT05700266|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111401441|NCT05700266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111401442|NCT05700266|Antipyretics|antipyretics|mesh-ancestor
111401443|NCT05700266|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111401444|NCT05700266|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111401445|NCT05700266|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111401446|NCT05700266|Purinergic Agents|purinergic agents|mesh-ancestor
111401447|NCT05700266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111401448|NCT05700266|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111401449|NCT05700266|Antithrombins|antithrombins|mesh-ancestor
111401450|NCT05700266|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111401451|NCT05700266|Protease Inhibitors|protease inhibitors|mesh-ancestor
111401452|NCT05700266|Anticoagulants|anticoagulants|mesh-ancestor
111401453|NCT05423132|Ropivacaine|ropivacaine|mesh-list
111401454|NCT05423132|Anesthetics, Local|anesthetics, local|mesh-ancestor
111401455|NCT05423132|Anesthetics|anesthetics|mesh-ancestor
111401456|NCT05423132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111401457|NCT05423132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111401458|NCT05423132|Sensory System Agents|sensory system agents|mesh-ancestor
111401459|NCT05423132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111401460|NCT02975219|Bevacizumab|bevacizumab|mesh-list
111401461|NCT02975219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111401462|NCT02975219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111401463|NCT02975219|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111401464|NCT02975219|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111401465|NCT02975219|Growth Substances|growth substances|mesh-ancestor
111401466|NCT02975219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111401467|NCT02975219|Growth Inhibitors|growth inhibitors|mesh-ancestor
111401468|NCT01686451|Simvastatin|simvastatin|mesh-list
111401469|NCT01686451|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111401470|NCT01686451|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111401471|NCT01686451|Antimetabolites|antimetabolites|mesh-ancestor
111401472|NCT01686451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111401473|NCT01686451|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111401474|NCT01686451|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111401475|NCT01686451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111401476|NCT00361751|Fenofibrate|fenofibrate|mesh-list
111401477|NCT00361751|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111401478|NCT00361751|Antimetabolites|antimetabolites|mesh-ancestor
111401479|NCT00361751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111401480|NCT00361751|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111401481|NCT05681702|Aspirin|aspirin|mesh-list
111401482|NCT05681702|Clopidogrel|clopidogrel|mesh-list
111401483|NCT05681702|Ticagrelor|ticagrelor|mesh-list
111401484|NCT05681702|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
111401485|NCT05681702|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111401486|NCT05681702|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111401487|NCT05681702|Analgesics|analgesics|mesh-ancestor
111401488|NCT05681702|Sensory System Agents|sensory system agents|mesh-ancestor
111401489|NCT05681702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111401490|NCT05681702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111401491|NCT05681702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111401492|NCT05681702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111401493|NCT05681702|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111401494|NCT05681702|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111401495|NCT05681702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111401496|NCT05681702|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111401497|NCT05681702|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111401498|NCT05681702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111401499|NCT05681702|Antipyretics|antipyretics|mesh-ancestor
111401500|NCT05681702|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111401501|NCT05681702|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111401502|NCT05681702|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111401503|NCT05681702|Purinergic Agents|purinergic agents|mesh-ancestor
111401504|NCT05681702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111401505|NCT04675983|Fluorouracil|fluorouracil|mesh-list
111401506|NCT04675983|Capecitabine|capecitabine|mesh-list
111401507|NCT04675983|Oxaliplatin|oxaliplatin|mesh-list
111401508|NCT04675983|Ramucirumab|ramucirumab|mesh-list
111401509|NCT04675983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111401510|NCT04675983|Antimetabolites|antimetabolites|mesh-ancestor
111401511|NCT04675983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111401512|NCT04675983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111401513|NCT04675983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111401514|NCT04675983|Immunologic Factors|immunologic factors|mesh-ancestor
111401515|NCT04675983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111401516|NCT03668951|Dexmedetomidine|dexmedetomidine|mesh-list
111401517|NCT03668951|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111401518|NCT03668951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111401519|NCT03668951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111401520|NCT03668951|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111401521|NCT03668951|Analgesics|analgesics|mesh-ancestor
111401522|NCT03668951|Sensory System Agents|sensory system agents|mesh-ancestor
111401523|NCT03668951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111401524|NCT03668951|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111401525|NCT03668951|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111401526|NCT03668951|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111401527|NCT03668951|Adrenergic Agents|adrenergic agents|mesh-ancestor
111401528|NCT03668951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111401529|NCT03668951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111401530|NCT04889703|Salicylic Acid|salicylic acid|mesh-list
111401531|NCT04889703|Salicylates|salicylates|mesh-list
111401532|NCT04889703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111401533|NCT04889703|Antifungal Agents|antifungal agents|mesh-ancestor
111401534|NCT04889703|Keratolytic Agents|keratolytic agents|mesh-ancestor
111401535|NCT04889703|Dermatologic Agents|dermatologic agents|mesh-ancestor
111401536|NCT04889703|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111401537|NCT04889703|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111401538|NCT04889703|Analgesics|analgesics|mesh-ancestor
111401539|NCT04889703|Sensory System Agents|sensory system agents|mesh-ancestor
111401540|NCT04889703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111401541|NCT04889703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111401542|NCT04889703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111401543|NCT04889703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111401544|NCT04889703|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111401545|NCT04889703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111401546|NCT04889703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111401547|NCT00421811|Melphalan|melphalan|mesh-list
111401548|NCT00421811|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111401549|NCT00421811|Alkylating Agents|alkylating agents|mesh-ancestor
111401550|NCT00421811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111401551|NCT00421811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111401552|NCT00421811|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111401553|NCT00421811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111401554|NCT00421811|Immunologic Factors|immunologic factors|mesh-ancestor
111401555|NCT00421811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111401556|NCT03363893|Fulvestrant|fulvestrant|mesh-list
111401557|NCT03363893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111401558|NCT03363893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111401559|NCT03363893|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
111401560|NCT03363893|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111401561|NCT03363893|Hormone Antagonists|hormone antagonists|mesh-ancestor
111401562|NCT03363893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111401563|NCT03363893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111401564|NCT01687387|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111401565|NCT01706263|Salicylic Acid|salicylic acid|mesh-list
111401566|NCT01706263|Salicylates|salicylates|mesh-list
111401567|NCT01706263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111401568|NCT01706263|Antifungal Agents|antifungal agents|mesh-ancestor
111401569|NCT01706263|Keratolytic Agents|keratolytic agents|mesh-ancestor
111401570|NCT01706263|Dermatologic Agents|dermatologic agents|mesh-ancestor
111401571|NCT01706263|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111401572|NCT01706263|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111401573|NCT01706263|Analgesics|analgesics|mesh-ancestor
111401574|NCT01706263|Sensory System Agents|sensory system agents|mesh-ancestor
111401575|NCT01706263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111401576|NCT01706263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111401577|NCT01706263|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111401578|NCT01706263|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111401579|NCT01706263|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111401580|NCT01706263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111401581|NCT01706263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111401582|NCT05738798|Immunomodulating Agents|immunomodulating agents|mesh-list
111401583|NCT05738798|Immunologic Factors|immunologic factors|mesh-ancestor
111401584|NCT05738798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111401585|NCT04342247|Methyltestosterone|methyltestosterone|mesh-list
111401586|NCT04342247|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
111401587|NCT04342247|Testosterone|testosterone|mesh-list
111401588|NCT04342247|Testosterone undecanoate|testosterone undecanoate|mesh-list
111401589|NCT04342247|Testosterone enanthate|testosterone enanthate|mesh-list
111401590|NCT04342247|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111401591|NCT04342247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111401592|NCT04342247|Anabolic Agents|anabolic agents|mesh-ancestor
111401593|NCT04342247|Hormones|hormones|mesh-ancestor
111401594|NCT04342247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111401595|NCT04342247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111401596|NCT04342247|Androgens|androgens|mesh-ancestor
111401597|NCT05738642|Thrombin|thrombin|mesh-list
111401598|NCT05738642|Hemostatics|hemostatics|mesh-ancestor
111401599|NCT05738642|Coagulants|coagulants|mesh-ancestor
111401600|NCT01690663|Dexamethasone|dexamethasone|mesh-list
111401601|NCT01690663|Bupivacaine|bupivacaine|mesh-list
111401602|NCT01690663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111401603|NCT01690663|Antiemetics|antiemetics|mesh-ancestor
111401604|NCT01690663|Autonomic Agents|autonomic agents|mesh-ancestor
111401605|NCT01690663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111401606|NCT01690663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111401607|NCT01690663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111401608|NCT01690663|Glucocorticoids|glucocorticoids|mesh-ancestor
111401609|NCT01690663|Hormones|hormones|mesh-ancestor
111401610|NCT01690663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111401611|NCT01690663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111401612|NCT01690663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111401613|NCT01690663|Anesthetics, Local|anesthetics, local|mesh-ancestor
111401614|NCT01690663|Anesthetics|anesthetics|mesh-ancestor
111401615|NCT01690663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111401616|NCT01690663|Sensory System Agents|sensory system agents|mesh-ancestor
111401617|NCT05738564|Lidocaine|lidocaine|mesh-list
111401618|NCT05738564|Epinephrine|epinephrine|mesh-list
111401619|NCT05738564|Oxymetazoline|oxymetazoline|mesh-list
111401620|NCT05738564|Anesthetics, Local|anesthetics, local|mesh-ancestor
111401621|NCT05738564|Anesthetics|anesthetics|mesh-ancestor
111401622|NCT05738564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111401623|NCT05738564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111401624|NCT05738564|Sensory System Agents|sensory system agents|mesh-ancestor
111401625|NCT05738564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111401626|NCT05738564|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111401627|NCT05738564|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111401628|NCT05738564|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111401629|NCT05738564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111401630|NCT05738564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111401631|NCT05738564|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111401632|NCT05738564|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111401633|NCT05738564|Adrenergic Agents|adrenergic agents|mesh-ancestor
111401634|NCT05738564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111401635|NCT05738564|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111401636|NCT05738564|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111401637|NCT05738564|Autonomic Agents|autonomic agents|mesh-ancestor
111401638|NCT05738564|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111401639|NCT05738564|Respiratory System Agents|respiratory system agents|mesh-ancestor
111401640|NCT05738564|Mydriatics|mydriatics|mesh-ancestor
111401641|NCT05738564|Sympathomimetics|sympathomimetics|mesh-ancestor
111401642|NCT05738564|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111401643|NCT05738564|Nasal Decongestants|nasal decongestants|mesh-ancestor
111401644|NCT05343572|Plerixafor|plerixafor|mesh-list
111401645|NCT05343572|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111126004|NCT04948385|Propofol|propofol|mesh-list
111401646|NCT05343572|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111401647|NCT05343572|Antiviral Agents|antiviral agents|mesh-ancestor
111401648|NCT05343572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111401649|NCT04350086|Dexmedetomidine|dexmedetomidine|mesh-list
111401650|NCT04350086|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111401651|NCT04350086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111401652|NCT04350086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111401653|NCT04350086|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111401654|NCT04350086|Analgesics|analgesics|mesh-ancestor
111401655|NCT04350086|Sensory System Agents|sensory system agents|mesh-ancestor
111401656|NCT04350086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111401657|NCT04350086|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111401658|NCT04350086|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111401659|NCT04350086|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111401660|NCT04350086|Adrenergic Agents|adrenergic agents|mesh-ancestor
111401661|NCT04350086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111401662|NCT04350086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111401663|NCT05738408|Nicotine|nicotine|mesh-list
111401664|NCT05738408|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111401665|NCT05738408|Autonomic Agents|autonomic agents|mesh-ancestor
111401666|NCT05738408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111401667|NCT05738408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111401668|NCT05738408|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111401669|NCT05738408|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111401670|NCT05738408|Cholinergic Agents|cholinergic agents|mesh-ancestor
111401671|NCT05738408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111401672|NCT05738408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111401673|NCT01352117|Tenofovir|tenofovir|mesh-list
111401674|NCT01352117|Emtricitabine|emtricitabine|mesh-list
111401675|NCT01352117|Efavirenz|efavirenz|mesh-list
111401676|NCT01352117|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
111401677|NCT01352117|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
111401678|NCT01352117|Etoposide|etoposide|mesh-list
111401679|NCT01352117|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111401680|NCT01352117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111401681|NCT01352117|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111401682|NCT01352117|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111401683|NCT01352117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111401684|NCT01352117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111401685|NCT01352117|Antiviral Agents|antiviral agents|mesh-ancestor
111401686|NCT01352117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111401687|NCT01352117|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111401688|NCT01352117|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111401689|NCT01352117|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111401690|NCT01352117|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111401691|NCT01352117|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111401692|NCT01352117|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111401693|NCT01352117|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111401694|NCT01352117|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111401695|NCT01352117|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111401696|NCT01352117|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111401697|NCT03379207|Dimercaprol|dimercaprol|mesh-list
111401698|NCT03379207|Chelating Agents|chelating agents|mesh-ancestor
111401699|NCT03379207|Sequestering Agents|sequestering agents|mesh-ancestor
111401700|NCT03379207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111401701|NCT02974439|Amlodipine|amlodipine|mesh-list
111401702|NCT02974439|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111401703|NCT02974439|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111401704|NCT02974439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111401705|NCT02974439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111401706|NCT02974439|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111401707|NCT02974439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111401708|NCT02974439|Vasodilator Agents|vasodilator agents|mesh-ancestor
111401709|NCT03340727|Caffeine|caffeine|mesh-list
111401710|NCT03340727|Caffeine citrate|caffeine citrate|mesh-list
111401711|NCT03340727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111401712|NCT03340727|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111401713|NCT03340727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111401714|NCT03340727|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111401715|NCT03340727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111401716|NCT03340727|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
111401717|NCT03340727|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111401718|NCT03340727|Purinergic Agents|purinergic agents|mesh-ancestor
111126119|NCT02655679|Ether|ether|mesh-list
111401720|NCT04612179|Sirolimus|sirolimus|mesh-list
111401721|NCT04612179|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111401722|NCT04612179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111401723|NCT04612179|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111401724|NCT04612179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111401725|NCT04612179|Antifungal Agents|antifungal agents|mesh-ancestor
111401726|NCT04612179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111401727|NCT04612179|Immunologic Factors|immunologic factors|mesh-ancestor
111401728|NCT04612179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111401729|NCT05578820|Ganciclovir|ganciclovir|mesh-list
111401730|NCT05578820|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
111401731|NCT05578820|Antiviral Agents|antiviral agents|mesh-ancestor
111401732|NCT05578820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111401733|NCT05578820|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111401734|NCT05578820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111401735|NCT05578820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111401736|NCT01707043|Calcitriol|calcitriol|mesh-list
111401737|NCT01707043|Betamethasone|betamethasone|mesh-list
111401738|NCT01707043|Betamethasone Valerate|betamethasone valerate|mesh-list
111401739|NCT01707043|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
111401740|NCT01707043|Betamethasone benzoate|betamethasone benzoate|mesh-list
111401741|NCT01707043|Calcipotriene|calcipotriene|mesh-list
111401742|NCT01707043|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
111401743|NCT01707043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111401744|NCT01707043|Glucocorticoids|glucocorticoids|mesh-ancestor
111401745|NCT01707043|Hormones|hormones|mesh-ancestor
111401746|NCT01707043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111401747|NCT01707043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111401748|NCT01707043|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111401749|NCT01707043|Respiratory System Agents|respiratory system agents|mesh-ancestor
111401750|NCT01707043|Dermatologic Agents|dermatologic agents|mesh-ancestor
111401751|NCT01707043|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111401752|NCT01707043|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
111401753|NCT01707043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111401754|NCT01707043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110878907|NCT04661137|Glucocorticoids|glucocorticoids|mesh-ancestor
111401755|NCT01707043|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111401756|NCT01707043|Vitamins|vitamins|mesh-ancestor
111401757|NCT01707043|Micronutrients|micronutrients|mesh-ancestor
111401758|NCT01707043|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111401759|NCT04258839|Brexpiprazole|brexpiprazole|mesh-list
111401760|NCT04258839|Serotonin Agents|serotonin agents|mesh-ancestor
111401761|NCT04258839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111401762|NCT04258839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111401763|NCT04258839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111401764|NCT04258839|Dopamine Agonists|dopamine agonists|mesh-ancestor
111401765|NCT04258839|Dopamine Agents|dopamine agents|mesh-ancestor
111401766|NCT01708525|Deuterium Oxide|deuterium oxide|mesh-list
111401767|NCT01708525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111401768|NCT01708525|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111401769|NCT01708525|Protective Agents|protective agents|mesh-ancestor
111401770|NCT01708525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111401771|NCT03634917|Calcium, Dietary|calcium, dietary|mesh-list
111401772|NCT03634917|Acamprosate|acamprosate|mesh-list
111401773|NCT03634917|Calcium Carbonate|calcium carbonate|mesh-list
111401774|NCT03634917|Calcium|calcium|mesh-list
111401775|NCT03634917|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111401776|NCT03634917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111401777|NCT03634917|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111401778|NCT03634917|Antacids|antacids|mesh-ancestor
111401779|NCT03634917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111401780|NCT03634917|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111401781|NCT03634917|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111401782|NCT05058872|Levonorgestrel|levonorgestrel|mesh-list
111401783|NCT05058872|Ethinyl Estradiol|ethinyl estradiol|mesh-list
111401784|NCT05058872|Estradiol|estradiol|mesh-list
111401785|NCT05058872|Estrogens|estrogens|mesh-ancestor
111401786|NCT05058872|Hormones|hormones|mesh-ancestor
111401787|NCT05058872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111401788|NCT05058872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111401789|NCT05058872|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111401790|NCT05058872|Contraceptive Agents|contraceptive agents|mesh-ancestor
111401791|NCT05058872|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111126153|NCT04418999|Hormones|hormones|mesh-ancestor
111401792|NCT05058872|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111401793|NCT05058872|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111401794|NCT05058872|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111401795|NCT05058872|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111401796|NCT04595565|Carboplatin|carboplatin|mesh-list
111401797|NCT04595565|Capecitabine|capecitabine|mesh-list
111401798|NCT04595565|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
111401799|NCT04595565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111401800|NCT04595565|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111401801|NCT04595565|Antimetabolites|antimetabolites|mesh-ancestor
111401802|NCT04595565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111401803|NCT04595565|Immunoconjugates|immunoconjugates|mesh-ancestor
111401804|NCT04595565|Immunologic Factors|immunologic factors|mesh-ancestor
111401805|NCT04595565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111401806|NCT02284880|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
111401807|NCT02284880|Anticonvulsants|anticonvulsants|mesh-ancestor
111401808|NCT02284880|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111401809|NCT02284880|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111401810|NCT02284880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111401811|NCT02284880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111401812|NCT03538899|Busulfan|busulfan|mesh-list
111401813|NCT03538899|Alkylating Agents|alkylating agents|mesh-ancestor
111401814|NCT03538899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111401815|NCT03538899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111401816|NCT03538899|Immunologic Factors|immunologic factors|mesh-ancestor
111401817|NCT03538899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111401818|NCT03538899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111401819|NCT03538899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111401820|NCT03538899|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111401821|NCT04230681|Fentanyl|fentanyl|mesh-list
111401822|NCT04230681|Hydromorphone|hydromorphone|mesh-list
111401823|NCT04230681|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111401824|NCT04230681|Narcotics|narcotics|mesh-ancestor
111401825|NCT04230681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111401826|NCT04230681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111401827|NCT04230681|Analgesics|analgesics|mesh-ancestor
111401828|NCT04230681|Sensory System Agents|sensory system agents|mesh-ancestor
111401829|NCT04230681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111401830|NCT04230681|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111401831|NCT04230681|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111401832|NCT04230681|Anesthetics, General|anesthetics, general|mesh-ancestor
111401833|NCT04230681|Anesthetics|anesthetics|mesh-ancestor
111401834|NCT01708603|Ustekinumab|ustekinumab|mesh-list
111401835|NCT01708603|Brodalumab|brodalumab|mesh-list
111401836|NCT01708603|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111401837|NCT01708603|Dermatologic Agents|dermatologic agents|mesh-ancestor
111401838|NCT01708603|Immunologic Factors|immunologic factors|mesh-ancestor
111401839|NCT01708603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111401840|NCT03523221|Dexamethasone|dexamethasone|mesh-list
111401841|NCT03523221|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111401842|NCT03523221|Antiemetics|antiemetics|mesh-ancestor
111401843|NCT03523221|Autonomic Agents|autonomic agents|mesh-ancestor
111401844|NCT03523221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111401845|NCT03523221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111401846|NCT03523221|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111401847|NCT03523221|Glucocorticoids|glucocorticoids|mesh-ancestor
111401848|NCT03523221|Hormones|hormones|mesh-ancestor
111401849|NCT03523221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111401850|NCT03523221|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111401851|NCT03523221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111401852|NCT03590171|Bortezomib|bortezomib|mesh-list
111401853|NCT03590171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111401854|NCT00362765|Metformin|metformin|mesh-list
111401855|NCT00362765|Fenofibrate|fenofibrate|mesh-list
111401856|NCT00362765|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111401857|NCT00362765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111401858|NCT00362765|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111401859|NCT00362765|Antimetabolites|antimetabolites|mesh-ancestor
111401860|NCT00362765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111401861|NCT00362765|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111401862|NCT03430011|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
111401863|NCT03430011|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111401864|NCT03543839|Belimumab|belimumab|mesh-list
111401865|NCT03543839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111401866|NCT03543839|Immunologic Factors|immunologic factors|mesh-ancestor
111126224|NCT04516993|Antipyretics|antipyretics|mesh-ancestor
111401867|NCT03543839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111401868|NCT04173507|Avelumab|avelumab|mesh-list
111401869|NCT04173507|Talazoparib|talazoparib|mesh-list
111401870|NCT04173507|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111401871|NCT04173507|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111401872|NCT04173507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111401873|NCT04173507|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111401874|NCT04173507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111401875|NCT04173507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111401876|NCT04173507|Immunologic Factors|immunologic factors|mesh-ancestor
111401877|NCT04173507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111401878|NCT05033756|Pembrolizumab|pembrolizumab|mesh-list
111401879|NCT05033756|Olaparib|olaparib|mesh-list
111401880|NCT05033756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111401881|NCT05033756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111401882|NCT05033756|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111401883|NCT05033756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111401884|NCT05033756|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111401885|NCT05033756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111401886|NCT03522077|Hemostatics|hemostatics|mesh-list
111401887|NCT03522077|Coagulants|coagulants|mesh-ancestor
111401888|NCT02980562|Bisacodyl|bisacodyl|mesh-list
111401889|NCT02980562|Cathartics|cathartics|mesh-ancestor
111401890|NCT02980562|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111401891|NCT02980562|Laxatives|laxatives|mesh-ancestor
111401892|NCT03266393|Tacrolimus|tacrolimus|mesh-list
111401893|NCT03266393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111401894|NCT03266393|Immunologic Factors|immunologic factors|mesh-ancestor
111401895|NCT03266393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111401896|NCT03266393|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111401897|NCT03266393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111401898|NCT03266393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111401899|NCT00421967|Ketorolac|ketorolac|mesh-list
111401900|NCT00421967|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
111401901|NCT00421967|Epinephrine|epinephrine|mesh-list
111401902|NCT00421967|Racepinephrine|racepinephrine|mesh-list
111401903|NCT00421967|Ropivacaine|ropivacaine|mesh-list
111401904|NCT00421967|Epinephryl borate|epinephryl borate|mesh-list
111401905|NCT00421967|Anesthetics, Local|anesthetics, local|mesh-ancestor
111401906|NCT00421967|Anesthetics|anesthetics|mesh-ancestor
111401907|NCT00421967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111401908|NCT00421967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111401909|NCT00421967|Sensory System Agents|sensory system agents|mesh-ancestor
111401910|NCT00421967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111401911|NCT00421967|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111401912|NCT00421967|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111401913|NCT00421967|Analgesics|analgesics|mesh-ancestor
111401914|NCT00421967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111401915|NCT00421967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111401916|NCT00421967|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111401917|NCT00421967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111401918|NCT00421967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111401919|NCT00421967|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111401920|NCT00421967|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111401921|NCT00421967|Adrenergic Agents|adrenergic agents|mesh-ancestor
111401922|NCT00421967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111401923|NCT00421967|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111401924|NCT00421967|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111401925|NCT00421967|Autonomic Agents|autonomic agents|mesh-ancestor
111401926|NCT00421967|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111401927|NCT00421967|Respiratory System Agents|respiratory system agents|mesh-ancestor
111401928|NCT00421967|Mydriatics|mydriatics|mesh-ancestor
111401929|NCT00421967|Sympathomimetics|sympathomimetics|mesh-ancestor
111401930|NCT00421967|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111401931|NCT03209687|Menotropins|menotropins|mesh-list
111401932|NCT03209687|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111401933|NCT03209687|Fertility Agents|fertility agents|mesh-ancestor
111401934|NCT03209687|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111401935|NCT03209687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111401936|NCT04997798|Trastuzumab|trastuzumab|mesh-list
111401937|NCT04997798|Exemestane|exemestane|mesh-list
111401938|NCT04997798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111401939|NCT04997798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111401940|NCT04997798|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111401941|NCT04997798|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111401942|NCT04997798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111401943|NCT04997798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111401944|NCT04997798|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111401945|NCT04997798|Hormone Antagonists|hormone antagonists|mesh-ancestor
111401946|NCT04997798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111401947|NCT04997798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111401948|NCT00362531|Prednisone|prednisone|mesh-list
111401949|NCT00362531|Tacrolimus|tacrolimus|mesh-list
111401950|NCT00362531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111401951|NCT00362531|Glucocorticoids|glucocorticoids|mesh-ancestor
111401952|NCT00362531|Hormones|hormones|mesh-ancestor
111401953|NCT00362531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111401954|NCT00362531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111401955|NCT00362531|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111401956|NCT00362531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111401957|NCT00362531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111401958|NCT00362531|Immunologic Factors|immunologic factors|mesh-ancestor
111401959|NCT00362531|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111401960|NCT00362531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111401961|NCT00362531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111401962|NCT04330443|Pulmonary Surfactants|pulmonary surfactants|mesh-list
111401963|NCT04330443|Respiratory System Agents|respiratory system agents|mesh-ancestor
111401964|NCT04330677|Oxytocin|oxytocin|mesh-list
111401965|NCT04330677|Estrogens|estrogens|mesh-list
111401966|NCT04330677|Oxytocics|oxytocics|mesh-ancestor
111401967|NCT04330677|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111401968|NCT04330677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111401969|NCT04330677|Hormones|hormones|mesh-ancestor
111401970|NCT04330677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111401971|NCT04965116|Contraceptive Agents|contraceptive agents|mesh-list
111401972|NCT04965116|Progestins|progestins|mesh-list
111401973|NCT04965116|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111401974|NCT04965116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111401975|NCT04965116|Hormones|hormones|mesh-ancestor
111401976|NCT04965116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111401977|NCT03200847|Pembrolizumab|pembrolizumab|mesh-list
111401978|NCT03200847|Tretinoin|tretinoin|mesh-list
111401979|NCT03200847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111401980|NCT03200847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111401981|NCT03200847|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111401982|NCT03200847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111401983|NCT03200847|Keratolytic Agents|keratolytic agents|mesh-ancestor
111401984|NCT03200847|Dermatologic Agents|dermatologic agents|mesh-ancestor
111401985|NCT02259517|Guanfacine|guanfacine|mesh-list
111401986|NCT02259517|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
111401987|NCT02259517|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111401988|NCT02259517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111401989|NCT02259517|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111401990|NCT02259517|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111401991|NCT02259517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111401992|NCT02259517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111401993|NCT02259517|Dopamine Agents|dopamine agents|mesh-ancestor
111401994|NCT02259517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111401995|NCT02259517|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111401996|NCT02259517|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111401997|NCT02259517|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111401998|NCT02259517|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111401999|NCT02259517|Adrenergic Agents|adrenergic agents|mesh-ancestor
111402000|NCT04358588|Nitric Oxide|nitric oxide|mesh-list
111402001|NCT04358588|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111402002|NCT04358588|Autonomic Agents|autonomic agents|mesh-ancestor
111402003|NCT04358588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111402004|NCT04358588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111402005|NCT04358588|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111402006|NCT04358588|Respiratory System Agents|respiratory system agents|mesh-ancestor
111402007|NCT04358588|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111402008|NCT04358588|Antioxidants|antioxidants|mesh-ancestor
111402009|NCT04358588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111402010|NCT04358588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111402011|NCT04358588|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
111402012|NCT04358588|Vasodilator Agents|vasodilator agents|mesh-ancestor
111402013|NCT04358588|Gasotransmitters|gasotransmitters|mesh-ancestor
111402014|NCT04358588|Protective Agents|protective agents|mesh-ancestor
111402015|NCT03166761|Dexamethasone|dexamethasone|mesh-list
111402016|NCT03166761|Triamcinolone|triamcinolone|mesh-list
111402017|NCT03166761|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
111126422|NCT02680561|Xhance|xhance|mesh-list
111402018|NCT03166761|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
111402019|NCT03166761|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
111402020|NCT03166761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111402022|NCT03166761|Autonomic Agents|autonomic agents|mesh-ancestor
111402023|NCT03166761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111402024|NCT03166761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111402025|NCT03166761|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111402026|NCT03166761|Glucocorticoids|glucocorticoids|mesh-ancestor
111402027|NCT03166761|Hormones|hormones|mesh-ancestor
111402028|NCT03166761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111402029|NCT03166761|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111402030|NCT03166761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111402031|NCT03166761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111402032|NCT03166761|Immunologic Factors|immunologic factors|mesh-ancestor
111402033|NCT03166761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111402034|NCT03166761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111402035|NCT04195256|Dexmedetomidine|dexmedetomidine|mesh-list
111402036|NCT04195256|Ketamine|ketamine|mesh-list
111402037|NCT04195256|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111402038|NCT04195256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111402039|NCT04195256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111402040|NCT04195256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111402041|NCT04195256|Analgesics|analgesics|mesh-ancestor
111402042|NCT04195256|Sensory System Agents|sensory system agents|mesh-ancestor
111402043|NCT04195256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111402044|NCT04195256|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111402045|NCT04195256|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111402046|NCT04195256|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111402047|NCT04195256|Adrenergic Agents|adrenergic agents|mesh-ancestor
111402048|NCT04195256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111402049|NCT04195256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111402050|NCT04195256|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111402051|NCT04195256|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111402052|NCT04195256|Anesthetics, General|anesthetics, general|mesh-ancestor
111402053|NCT04195256|Anesthetics|anesthetics|mesh-ancestor
111402054|NCT04195256|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111402055|NCT04195256|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111402056|NCT00002901|Docetaxel|docetaxel|mesh-list
111402057|NCT00002901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111402058|NCT00002901|Tubulin Modulators|tubulin modulators|mesh-ancestor
111402059|NCT00002901|Antimitotic Agents|antimitotic agents|mesh-ancestor
111402060|NCT00002901|Mitosis Modulators|mitosis modulators|mesh-ancestor
111402061|NCT00002901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111402062|NCT00002907|Bryostatin 1|bryostatin 1|mesh-list
111402063|NCT00002907|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111402064|NCT00002907|Immunologic Factors|immunologic factors|mesh-ancestor
111402065|NCT00002907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111402066|NCT00002907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111402067|NCT01710787|Phenylephrine|phenylephrine|mesh-list
111402068|NCT01710787|Oxymetazoline|oxymetazoline|mesh-list
111402069|NCT01710787|Tetracaine|tetracaine|mesh-list
111402070|NCT01710787|Anesthetics, Local|anesthetics, local|mesh-ancestor
111402071|NCT01710787|Anesthetics|anesthetics|mesh-ancestor
111402072|NCT01710787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111402073|NCT01710787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111402074|NCT01710787|Sensory System Agents|sensory system agents|mesh-ancestor
111402075|NCT01710787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111402076|NCT01710787|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111402077|NCT01710787|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111402078|NCT01710787|Adrenergic Agents|adrenergic agents|mesh-ancestor
111402079|NCT01710787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111402080|NCT01710787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111402081|NCT01710787|Sympathomimetics|sympathomimetics|mesh-ancestor
111402082|NCT01710787|Autonomic Agents|autonomic agents|mesh-ancestor
111402083|NCT01710787|Nasal Decongestants|nasal decongestants|mesh-ancestor
111402084|NCT01710787|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111402085|NCT01710787|Respiratory System Agents|respiratory system agents|mesh-ancestor
111402086|NCT01710787|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111402087|NCT01710787|Mydriatics|mydriatics|mesh-ancestor
111402088|NCT01710787|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111402089|NCT01710787|Protective Agents|protective agents|mesh-ancestor
111402090|NCT01711177|Travoprost|travoprost|mesh-list
111402091|NCT01711177|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111402092|NCT02277990|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111402093|NCT02277990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111402094|NCT01715233|Leucovorin|leucovorin|mesh-list
111402095|NCT01715233|Carboplatin|carboplatin|mesh-list
111402096|NCT01715233|Docetaxel|docetaxel|mesh-list
111402097|NCT01715233|Fluorouracil|fluorouracil|mesh-list
111402098|NCT01715233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111402099|NCT01715233|Tubulin Modulators|tubulin modulators|mesh-ancestor
111402100|NCT01715233|Antimitotic Agents|antimitotic agents|mesh-ancestor
111402101|NCT01715233|Mitosis Modulators|mitosis modulators|mesh-ancestor
111402102|NCT01715233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111402103|NCT01715233|Antimetabolites|antimetabolites|mesh-ancestor
111402104|NCT01715233|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111402105|NCT01715233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111402106|NCT01715233|Immunologic Factors|immunologic factors|mesh-ancestor
111402107|NCT01715233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111402108|NCT01715233|Antidotes|antidotes|mesh-ancestor
111402109|NCT01715233|Protective Agents|protective agents|mesh-ancestor
111402110|NCT01715233|Vitamin B Complex|vitamin b complex|mesh-ancestor
111402111|NCT01715233|Vitamins|vitamins|mesh-ancestor
111402112|NCT01715233|Micronutrients|micronutrients|mesh-ancestor
111402113|NCT05145283|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
111402114|NCT05145283|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
111402115|NCT05145283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111402116|NCT05145283|Immunologic Factors|immunologic factors|mesh-ancestor
111402117|NCT05145283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111402118|NCT04826588|Methylprednisolone|methylprednisolone|mesh-list
111402119|NCT04826588|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111402120|NCT04826588|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111402121|NCT04826588|Prednisolone|prednisolone|mesh-list
111402122|NCT04826588|Prednisolone acetate|prednisolone acetate|mesh-list
111402123|NCT04826588|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111402124|NCT04826588|Prednisolone phosphate|prednisolone phosphate|mesh-list
111402125|NCT04826588|Immunoglobulins|immunoglobulins|mesh-list
111402126|NCT04826588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111402127|NCT04826588|Antiemetics|antiemetics|mesh-ancestor
111402128|NCT04826588|Autonomic Agents|autonomic agents|mesh-ancestor
111402129|NCT04826588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111402130|NCT04826588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111402131|NCT04826588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111402132|NCT04826588|Glucocorticoids|glucocorticoids|mesh-ancestor
111402133|NCT04826588|Hormones|hormones|mesh-ancestor
111402134|NCT04826588|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111402135|NCT04826588|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111402136|NCT04826588|Protective Agents|protective agents|mesh-ancestor
111402137|NCT04826588|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111402138|NCT04826588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111402139|NCT04826588|Immunologic Factors|immunologic factors|mesh-ancestor
111402140|NCT01719367|Atenolol|atenolol|mesh-list
111402141|NCT01719367|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111402142|NCT01719367|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111402143|NCT01719367|Sympatholytics|sympatholytics|mesh-ancestor
111402144|NCT01719367|Autonomic Agents|autonomic agents|mesh-ancestor
111402145|NCT01719367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111402146|NCT01719367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111402147|NCT01719367|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
111402148|NCT01719367|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111402149|NCT01719367|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111402150|NCT01719367|Adrenergic Agents|adrenergic agents|mesh-ancestor
111402151|NCT01719367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111402152|NCT01719367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111402153|NCT02276040|Bupivacaine|bupivacaine|mesh-list
111402154|NCT02276040|Anesthetics, Local|anesthetics, local|mesh-ancestor
111402155|NCT02276040|Anesthetics|anesthetics|mesh-ancestor
111402156|NCT02276040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111402157|NCT02276040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111402158|NCT02276040|Sensory System Agents|sensory system agents|mesh-ancestor
111402159|NCT02276040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111402160|NCT02250703|Midazolam|midazolam|mesh-list
111402161|NCT02250703|Dexmedetomidine|dexmedetomidine|mesh-list
111402162|NCT02250703|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111402163|NCT02250703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111402164|NCT02250703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111402165|NCT02250703|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111402166|NCT02250703|Analgesics|analgesics|mesh-ancestor
111126528|NCT05229913|Esketamine|esketamine|mesh-list
111402167|NCT02250703|Sensory System Agents|sensory system agents|mesh-ancestor
111402168|NCT02250703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111402169|NCT02250703|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111402170|NCT02250703|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111402171|NCT02250703|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111402172|NCT02250703|Adrenergic Agents|adrenergic agents|mesh-ancestor
111402173|NCT02250703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111402174|NCT02250703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111402175|NCT02250703|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111402176|NCT02250703|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111402177|NCT02250703|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111402178|NCT02250703|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111402179|NCT02250703|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111402180|NCT02250703|Anesthetics, General|anesthetics, general|mesh-ancestor
111402181|NCT02250703|Anesthetics|anesthetics|mesh-ancestor
111402182|NCT02250703|GABA Modulators|gaba modulators|mesh-ancestor
111402183|NCT02250703|GABA Agents|gaba agents|mesh-ancestor
111402184|NCT02314728|Misoprostol|misoprostol|mesh-list
111402185|NCT02314728|Oxytocin|oxytocin|mesh-list
111402186|NCT02314728|Oxytocics|oxytocics|mesh-ancestor
111402187|NCT02314728|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111402188|NCT02314728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111402189|NCT02314728|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111402190|NCT02314728|Abortifacient Agents|abortifacient agents|mesh-ancestor
111402191|NCT02314728|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111402192|NCT02314728|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110879349|NCT04690231|Ifosfamide|ifosfamide|mesh-list
111402193|NCT03135860|Nitric Oxide|nitric oxide|mesh-list
111402194|NCT03135860|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111402195|NCT03135860|Autonomic Agents|autonomic agents|mesh-ancestor
111402196|NCT03135860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111402197|NCT03135860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111402198|NCT03135860|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111402199|NCT03135860|Respiratory System Agents|respiratory system agents|mesh-ancestor
111402200|NCT03135860|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111402201|NCT03135860|Antioxidants|antioxidants|mesh-ancestor
111402202|NCT03135860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111402203|NCT03135860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111402204|NCT03135860|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
111402205|NCT03135860|Vasodilator Agents|vasodilator agents|mesh-ancestor
111402206|NCT03135860|Gasotransmitters|gasotransmitters|mesh-ancestor
111402207|NCT03135860|Protective Agents|protective agents|mesh-ancestor
111402208|NCT02275338|Lanreotide|lanreotide|mesh-list
111402209|NCT02275338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111402210|NCT01646268|Rotigotine|rotigotine|mesh-list
111402211|NCT01646268|Dopamine Agonists|dopamine agonists|mesh-ancestor
111402212|NCT01646268|Dopamine Agents|dopamine agents|mesh-ancestor
111402213|NCT01646268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111402214|NCT01646268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111402215|NCT01646268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111402216|NCT03988634|Valsartan|valsartan|mesh-list
111402217|NCT03988634|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
111402218|NCT03988634|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111402219|NCT03988634|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111402220|NCT03988634|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111402221|NCT03988634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111402222|NCT02294630|Pulmonary Surfactants|pulmonary surfactants|mesh-list
111402223|NCT02294630|Respiratory System Agents|respiratory system agents|mesh-ancestor
111402224|NCT01722487|Chlorambucil|chlorambucil|mesh-list
111402225|NCT01722487|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111402226|NCT01722487|Alkylating Agents|alkylating agents|mesh-ancestor
111402227|NCT01722487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111402228|NCT01722487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111402229|NCT02795858|Octreotide|octreotide|mesh-list
111402230|NCT02795858|Ramucirumab|ramucirumab|mesh-list
111402231|NCT02795858|Lanreotide|lanreotide|mesh-list
111402232|NCT02795858|Somatostatin|somatostatin|mesh-list
111402233|NCT02795858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111402234|NCT02795858|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111402235|NCT02795858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111402236|NCT02795858|Hormones|hormones|mesh-ancestor
111402237|NCT02795858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111402238|NCT02795858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111402239|NCT02730962|Vancomycin|vancomycin|mesh-list
111402240|NCT02730962|Clindamycin|clindamycin|mesh-list
111402241|NCT02730962|Clindamycin palmitate|clindamycin palmitate|mesh-list
111402242|NCT02730962|Clindamycin phosphate|clindamycin phosphate|mesh-list
111402243|NCT02730962|Neomycin|neomycin|mesh-list
111402244|NCT02730962|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111402245|NCT02730962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111402246|NCT02730962|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111402247|NCT02730962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111402248|NCT02730962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111402249|NCT02296346|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111402250|NCT02296346|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111402251|NCT02296346|Methylprednisolone|methylprednisolone|mesh-list
111402252|NCT02296346|Prednisolone|prednisolone|mesh-list
111402253|NCT02296346|Prednisolone acetate|prednisolone acetate|mesh-list
111402254|NCT02296346|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111402255|NCT02296346|Prednisolone phosphate|prednisolone phosphate|mesh-list
111402256|NCT02296346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111402257|NCT02296346|Glucocorticoids|glucocorticoids|mesh-ancestor
111402258|NCT02296346|Hormones|hormones|mesh-ancestor
111402259|NCT02296346|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111402260|NCT02296346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111402261|NCT02296346|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111402262|NCT02296346|Protective Agents|protective agents|mesh-ancestor
111402263|NCT02296346|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111402264|NCT02296346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111402265|NCT02296346|Antiemetics|antiemetics|mesh-ancestor
111402266|NCT02296346|Autonomic Agents|autonomic agents|mesh-ancestor
111402267|NCT02296346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111402268|NCT02296346|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111402269|NCT01726621|Insulin|insulin|mesh-list
111402270|NCT01726621|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111402271|NCT01726621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111402272|NCT02372630|Linagliptin|linagliptin|mesh-list
111402273|NCT02372630|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111402274|NCT02372630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111402275|NCT02372630|Incretins|incretins|mesh-ancestor
111402276|NCT02372630|Hormones|hormones|mesh-ancestor
111402277|NCT02372630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111402278|NCT02372630|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111402279|NCT02372630|Protease Inhibitors|protease inhibitors|mesh-ancestor
111402280|NCT02372630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111402281|NCT02372630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111402282|NCT02318654|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
111402283|NCT02318654|Anesthetics, Local|anesthetics, local|mesh-ancestor
111402284|NCT02318654|Anesthetics|anesthetics|mesh-ancestor
111402285|NCT02318654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111402286|NCT02318654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111402287|NCT02318654|Sensory System Agents|sensory system agents|mesh-ancestor
111402288|NCT02318654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111402289|NCT02318654|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
111402290|NCT04349930|Cannabidiol|cannabidiol|mesh-list
111402291|NCT04349930|Anticonvulsants|anticonvulsants|mesh-ancestor
111402292|NCT02303990|Pembrolizumab|pembrolizumab|mesh-list
111402293|NCT02303990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111402294|NCT02303990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111402295|NCT02303990|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111402296|NCT02303990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111402297|NCT01727089|Bevacizumab|bevacizumab|mesh-list
111402298|NCT01727089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111402299|NCT01727089|Endothelial Growth Factors|endothelial growth factors|mesh-list
111402300|NCT01727089|Antibodies|antibodies|mesh-list
111402301|NCT01727089|Immunoglobulins|immunoglobulins|mesh-list
111402302|NCT01727089|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111402303|NCT01727089|Immunoglobulin G|immunoglobulin g|mesh-list
111402304|NCT01727089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111402305|NCT01727089|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111402306|NCT01727089|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111402307|NCT01727089|Growth Substances|growth substances|mesh-ancestor
111402308|NCT01727089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111402309|NCT01727089|Growth Inhibitors|growth inhibitors|mesh-ancestor
111402310|NCT01727089|Immunologic Factors|immunologic factors|mesh-ancestor
111402311|NCT01727791|Pregabalin|pregabalin|mesh-list
111402312|NCT01727791|Analgesics|analgesics|mesh-ancestor
111402313|NCT01727791|Sensory System Agents|sensory system agents|mesh-ancestor
111402314|NCT01727791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111402315|NCT01727791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111402316|NCT01727791|Anticonvulsants|anticonvulsants|mesh-ancestor
111402317|NCT01727791|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111402318|NCT01727791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111126676|NCT03954613|Nootropic Agents|nootropic agents|mesh-ancestor
111402319|NCT01727791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111402320|NCT01727791|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111402321|NCT01727791|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111402322|NCT01727791|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111402323|NCT01727791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111402324|NCT01727791|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111402325|NCT01728337|Botulinum Toxins|botulinum toxins|mesh-list
110879483|NCT04385173|Temozolomide|temozolomide|mesh-list
111402326|NCT01728337|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111402327|NCT01728337|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111402328|NCT01728337|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111402329|NCT01728337|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111402330|NCT01728337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111402331|NCT01728337|Cholinergic Agents|cholinergic agents|mesh-ancestor
111402332|NCT01728337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111402333|NCT01728337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111402334|NCT01728337|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111402335|NCT01728337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111402336|NCT02247193|Botulinum Toxins|botulinum toxins|mesh-list
111402337|NCT02247193|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111402338|NCT02247193|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111402339|NCT02247193|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111402340|NCT02247193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111402341|NCT02247193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111402342|NCT02247193|Cholinergic Agents|cholinergic agents|mesh-ancestor
111402343|NCT02247193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111402344|NCT02247193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111402345|NCT02247193|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111402346|NCT02247193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111402347|NCT02245087|Atorvastatin|atorvastatin|mesh-list
111402348|NCT02245087|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111402349|NCT02245087|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111402350|NCT02245087|Antimetabolites|antimetabolites|mesh-ancestor
111402351|NCT02245087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111402352|NCT02245087|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111402353|NCT02245087|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111402354|NCT02245087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111402355|NCT04726969|Ivermectin|ivermectin|mesh-list
111402356|NCT04726969|Albendazole|albendazole|mesh-list
111402357|NCT04726969|Moxidectin|moxidectin|mesh-list
111402358|NCT04726969|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111402359|NCT04726969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111402360|NCT04726969|Anthelmintics|anthelmintics|mesh-ancestor
111402361|NCT04726969|Anticestodal Agents|anticestodal agents|mesh-ancestor
111402362|NCT04726969|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
111402363|NCT04726969|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111402364|NCT04726969|Tubulin Modulators|tubulin modulators|mesh-ancestor
111402365|NCT04726969|Antimitotic Agents|antimitotic agents|mesh-ancestor
111402366|NCT04726969|Mitosis Modulators|mitosis modulators|mesh-ancestor
111402367|NCT04726969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111402368|NCT04726969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111402369|NCT04726969|Antinematodal Agents|antinematodal agents|mesh-ancestor
111402370|NCT03174275|Paclitaxel|paclitaxel|mesh-list
111402371|NCT03174275|Carboplatin|carboplatin|mesh-list
111402372|NCT03174275|Durvalumab|durvalumab|mesh-list
111402373|NCT03174275|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111402374|NCT03174275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111402375|NCT03174275|Tubulin Modulators|tubulin modulators|mesh-ancestor
111402376|NCT03174275|Antimitotic Agents|antimitotic agents|mesh-ancestor
111402377|NCT03174275|Mitosis Modulators|mitosis modulators|mesh-ancestor
111402378|NCT03174275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111402379|NCT03174275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111402380|NCT01731691|Protease Inhibitors|protease inhibitors|mesh-list
111402381|NCT01731691|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
111402382|NCT01731691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111402383|NCT01731691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111402384|NCT01731691|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
111402385|NCT01731691|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111402386|NCT02247739|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
111402387|NCT02247739|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
111402388|NCT02247739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111402389|NCT02247739|Immunologic Factors|immunologic factors|mesh-ancestor
111402390|NCT02247739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111402391|NCT02975141|Paclitaxel|paclitaxel|mesh-list
111402392|NCT02975141|Gemcitabine|gemcitabine|mesh-list
111402393|NCT02975141|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111402394|NCT02975141|Afatinib|afatinib|mesh-list
111402395|NCT02975141|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111402396|NCT02975141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111402397|NCT02975141|Tubulin Modulators|tubulin modulators|mesh-ancestor
111402398|NCT02975141|Antimitotic Agents|antimitotic agents|mesh-ancestor
111402399|NCT02975141|Mitosis Modulators|mitosis modulators|mesh-ancestor
111402400|NCT02975141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111402401|NCT02975141|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111402402|NCT02975141|Antimetabolites|antimetabolites|mesh-ancestor
111402403|NCT02975141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111402404|NCT02975141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111402405|NCT03452891|Simvastatin|simvastatin|mesh-list
111402406|NCT03452891|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111402407|NCT03452891|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111402408|NCT03452891|Antimetabolites|antimetabolites|mesh-ancestor
111402409|NCT03452891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111402410|NCT03452891|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111402411|NCT03452891|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111402412|NCT03452891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111402413|NCT04341935|Linagliptin|linagliptin|mesh-list
111402414|NCT04341935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111402415|NCT04341935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111402416|NCT04341935|Incretins|incretins|mesh-ancestor
111402417|NCT04341935|Hormones|hormones|mesh-ancestor
111402418|NCT04341935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111402419|NCT04341935|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111402420|NCT04341935|Protease Inhibitors|protease inhibitors|mesh-ancestor
111402421|NCT04341935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111402422|NCT04341935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111402423|NCT05317039|Calcium|calcium|mesh-list
111402424|NCT05317039|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111402425|NCT05317039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111402426|NCT05316883|Clozapine|clozapine|mesh-list
111402427|NCT05316883|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111402428|NCT05316883|Serotonin Agents|serotonin agents|mesh-ancestor
111402429|NCT05316883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111402430|NCT05316883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111402431|NCT05316883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111402432|NCT05316883|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111402433|NCT05316883|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111402434|NCT05316883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111402435|NCT05316883|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111402436|NCT05316883|GABA Antagonists|gaba antagonists|mesh-ancestor
111402437|NCT05316883|GABA Agents|gaba agents|mesh-ancestor
111402438|NCT05316649|Chrysarobin|chrysarobin|mesh-list
111402439|NCT05316649|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111402440|NCT05316649|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111402441|NCT05316649|Analgesics|analgesics|mesh-ancestor
111402442|NCT05316649|Sensory System Agents|sensory system agents|mesh-ancestor
111402443|NCT05316649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111402444|NCT05316649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111402445|NCT05316649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111402446|NCT05316649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111402447|NCT03990363|Allopurinol|allopurinol|mesh-list
111402448|NCT03990363|Verinurad|verinurad|mesh-list
111402449|NCT03990363|Antimetabolites|antimetabolites|mesh-ancestor
111402450|NCT03990363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111402451|NCT03990363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111402452|NCT03990363|Gout Suppressants|gout suppressants|mesh-ancestor
111402453|NCT03990363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111402454|NCT03990363|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111402455|NCT03990363|Antioxidants|antioxidants|mesh-ancestor
111402456|NCT03990363|Protective Agents|protective agents|mesh-ancestor
111402457|NCT03990363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111402458|NCT04341857|Antibodies|antibodies|mesh-list
111402459|NCT04341857|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111402460|NCT04341857|Immunologic Factors|immunologic factors|mesh-ancestor
111402461|NCT04341857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111402462|NCT00002913|Paclitaxel|paclitaxel|mesh-list
111402463|NCT00002913|Topotecan|topotecan|mesh-list
111402464|NCT00002913|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111402465|NCT00002913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111402466|NCT00002913|Tubulin Modulators|tubulin modulators|mesh-ancestor
111126826|NCT04430777|Coagulants|coagulants|mesh-ancestor
111402467|NCT00002913|Antimitotic Agents|antimitotic agents|mesh-ancestor
111402468|NCT00002913|Mitosis Modulators|mitosis modulators|mesh-ancestor
111402469|NCT00002913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111402470|NCT00002913|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111402471|NCT00002913|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111402472|NCT00002913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111402473|NCT00002919|Doxorubicin|doxorubicin|mesh-list
111402474|NCT00002919|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111402475|NCT00002919|Methotrexate|methotrexate|mesh-list
111402476|NCT00002919|Vinblastine|vinblastine|mesh-list
111402477|NCT00002919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111402478|NCT00002919|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111402479|NCT00002919|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111402480|NCT00002919|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111402481|NCT00002919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111402482|NCT00002919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111402483|NCT00002919|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111402484|NCT00002919|Abortifacient Agents|abortifacient agents|mesh-ancestor
111402485|NCT00002919|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111402486|NCT00002919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111402487|NCT00002919|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111402488|NCT00002919|Antimetabolites|antimetabolites|mesh-ancestor
111402489|NCT00002919|Dermatologic Agents|dermatologic agents|mesh-ancestor
111402490|NCT00002919|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111402491|NCT00002919|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111402492|NCT00002919|Immunologic Factors|immunologic factors|mesh-ancestor
111402493|NCT00002919|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111402494|NCT00002919|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111402495|NCT00002919|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111402496|NCT00002919|Tubulin Modulators|tubulin modulators|mesh-ancestor
111402497|NCT00002919|Antimitotic Agents|antimitotic agents|mesh-ancestor
111402498|NCT00002919|Mitosis Modulators|mitosis modulators|mesh-ancestor
111402500|NCT03083405|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
111402501|NCT03083405|Antidepressive Agents|antidepressive agents|mesh-ancestor
111402502|NCT03083405|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111402503|NCT03083405|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111402504|NCT03083405|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111402505|NCT03083405|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111402506|NCT03083405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111402507|NCT03083405|Adrenergic Agents|adrenergic agents|mesh-ancestor
111402508|NCT03083405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111402509|NCT03083405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111402510|NCT00383799|Amiodarone|amiodarone|mesh-list
111402511|NCT00383799|Procainamide|procainamide|mesh-list
111402512|NCT00383799|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111402513|NCT00383799|Vasodilator Agents|vasodilator agents|mesh-ancestor
111402514|NCT00383799|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
111402515|NCT00383799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111402516|NCT00383799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111402517|NCT00383799|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111402518|NCT00383799|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111402519|NCT00383799|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111402520|NCT00383799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111402521|NCT00383799|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111402522|NCT00383799|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111402523|NCT00383799|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111402524|NCT00383799|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111402525|NCT04635241|Heparin|heparin|mesh-list
111402526|NCT04635241|Calcium heparin|calcium heparin|mesh-list
111402527|NCT04635241|Anticoagulants|anticoagulants|mesh-ancestor
111402528|NCT04635241|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111402529|NCT04635241|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111402530|NCT04635241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111402531|NCT03954483|Triazolam|triazolam|mesh-list
111402532|NCT03954483|Buspirone|buspirone|mesh-list
111402533|NCT03954483|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111402534|NCT03954483|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111402535|NCT03954483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111402536|NCT03954483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111402537|NCT03954483|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111402538|NCT03954483|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111402539|NCT03954483|Serotonin Agents|serotonin agents|mesh-ancestor
111402540|NCT03954483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111402541|NCT03954483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111402542|NCT03954483|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111402543|NCT03954483|GABA Modulators|gaba modulators|mesh-ancestor
111402544|NCT03954483|GABA Agents|gaba agents|mesh-ancestor
111402545|NCT04545541|Heparin|heparin|mesh-list
111402546|NCT04545541|Calcium heparin|calcium heparin|mesh-list
111402547|NCT04545541|Anticoagulants|anticoagulants|mesh-ancestor
111402548|NCT04545541|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111402549|NCT04545541|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111402550|NCT04545541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111402551|NCT00002925|Aldesleukin|aldesleukin|mesh-list
111402552|NCT00002925|Etoposide|etoposide|mesh-list
111402553|NCT00002925|Daunorubicin|daunorubicin|mesh-list
111402554|NCT00002925|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111402555|NCT00002925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111402556|NCT00002925|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111402557|NCT00002925|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111402558|NCT00002925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111402559|NCT00002925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111402560|NCT00002925|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111402561|NCT00002925|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111402562|NCT00002925|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111402563|NCT00002925|Antiviral Agents|antiviral agents|mesh-ancestor
111402564|NCT00002925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111402565|NCT00002937|Paclitaxel|paclitaxel|mesh-list
111402566|NCT00002937|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111402567|NCT00002937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111402568|NCT00002937|Tubulin Modulators|tubulin modulators|mesh-ancestor
111402569|NCT00002937|Antimitotic Agents|antimitotic agents|mesh-ancestor
111402570|NCT00002937|Mitosis Modulators|mitosis modulators|mesh-ancestor
111402571|NCT00002937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111402572|NCT02922777|Docetaxel|docetaxel|mesh-list
111402573|NCT02922777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111402574|NCT02922777|Tubulin Modulators|tubulin modulators|mesh-ancestor
111402575|NCT02922777|Antimitotic Agents|antimitotic agents|mesh-ancestor
111402576|NCT02922777|Mitosis Modulators|mitosis modulators|mesh-ancestor
111402577|NCT02922777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111402578|NCT02918955|Cisplatin|cisplatin|mesh-list
111402579|NCT02918955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111402580|NCT00002943|Cyclophosphamide|cyclophosphamide|mesh-list
111402581|NCT00002943|Carboplatin|carboplatin|mesh-list
111402582|NCT00002943|Etoposide|etoposide|mesh-list
111402583|NCT00002943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111402584|NCT00002943|Immunologic Factors|immunologic factors|mesh-ancestor
111402585|NCT00002943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111402586|NCT00002943|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111402587|NCT00002943|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111402588|NCT00002943|Alkylating Agents|alkylating agents|mesh-ancestor
111402589|NCT00002943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111402590|NCT00002943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111402591|NCT00002943|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111402592|NCT00002943|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111402593|NCT00002943|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111402594|NCT00002943|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111402595|NCT00002943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111402596|NCT00002949|Paclitaxel|paclitaxel|mesh-list
111402597|NCT00002949|Vinorelbine|vinorelbine|mesh-list
111402598|NCT00002949|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111402599|NCT00002949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111402600|NCT00002949|Tubulin Modulators|tubulin modulators|mesh-ancestor
111402601|NCT00002949|Antimitotic Agents|antimitotic agents|mesh-ancestor
111402602|NCT00002949|Mitosis Modulators|mitosis modulators|mesh-ancestor
111402603|NCT00002949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111402604|NCT05315557|Terlipressin|terlipressin|mesh-list
111402605|NCT05315557|Vasopressins|vasopressins|mesh-list
111402606|NCT05315557|Arginine Vasopressin|arginine vasopressin|mesh-list
111402607|NCT05315557|Hemostatics|hemostatics|mesh-ancestor
111402608|NCT05315557|Coagulants|coagulants|mesh-ancestor
111402609|NCT05315557|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111402610|NCT05315557|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
111402611|NCT05315557|Natriuretic Agents|natriuretic agents|mesh-ancestor
111402612|NCT05315557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111402613|NCT05315557|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111402614|NCT00002955|Leucovorin|leucovorin|mesh-list
111402615|NCT00002955|Trimetrexate|trimetrexate|mesh-list
111402616|NCT00002955|Fluorouracil|fluorouracil|mesh-list
111402617|NCT00002955|Calcium|calcium|mesh-list
111402618|NCT00002955|Levoleucovorin|levoleucovorin|mesh-list
111402619|NCT00002955|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111402620|NCT00002955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111402621|NCT00002955|Antimetabolites|antimetabolites|mesh-ancestor
111402622|NCT00002955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111402623|NCT00002955|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111402624|NCT00002955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111402625|NCT00002955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111402626|NCT00002955|Immunologic Factors|immunologic factors|mesh-ancestor
111402627|NCT00002955|Antidotes|antidotes|mesh-ancestor
111402628|NCT00002955|Protective Agents|protective agents|mesh-ancestor
111402629|NCT00002955|Vitamin B Complex|vitamin b complex|mesh-ancestor
111402630|NCT00002955|Vitamins|vitamins|mesh-ancestor
111402631|NCT00002955|Micronutrients|micronutrients|mesh-ancestor
111402632|NCT00002955|Antifungal Agents|antifungal agents|mesh-ancestor
111402633|NCT00002955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111402634|NCT00002955|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111402635|NCT00002955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111402636|NCT00002961|Cyclosporine|cyclosporine|mesh-list
111402637|NCT00002961|Cyclophosphamide|cyclophosphamide|mesh-list
111402638|NCT00002961|Busulfan|busulfan|mesh-list
111402639|NCT00002961|Methotrexate|methotrexate|mesh-list
111402640|NCT00002961|Etoposide|etoposide|mesh-list
111402641|NCT00002961|Etoposide phosphate|etoposide phosphate|mesh-list
111402642|NCT00002961|Cyclosporins|cyclosporins|mesh-list
111402643|NCT00002961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111402644|NCT00002961|Immunologic Factors|immunologic factors|mesh-ancestor
111402645|NCT00002961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111402646|NCT00002961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111402647|NCT00002961|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111402648|NCT00002961|Alkylating Agents|alkylating agents|mesh-ancestor
111402649|NCT00002961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111402650|NCT00002961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111402651|NCT00002961|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111402652|NCT00002961|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111402653|NCT00002961|Abortifacient Agents|abortifacient agents|mesh-ancestor
111402654|NCT00002961|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111402655|NCT00002961|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111402656|NCT00002961|Antimetabolites|antimetabolites|mesh-ancestor
111402657|NCT00002961|Dermatologic Agents|dermatologic agents|mesh-ancestor
111402658|NCT00002961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111402659|NCT00002961|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111402660|NCT00002961|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111402661|NCT00002961|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111402662|NCT00002961|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111402663|NCT00002961|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111402664|NCT00002961|Antifungal Agents|antifungal agents|mesh-ancestor
111402665|NCT00002961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111402666|NCT00002961|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111402667|NCT00002967|Tamoxifen|tamoxifen|mesh-list
111402668|NCT00002967|Cyclophosphamide|cyclophosphamide|mesh-list
111402669|NCT00002967|Doxorubicin|doxorubicin|mesh-list
111402670|NCT00002967|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111402671|NCT00002967|Octreotide|octreotide|mesh-list
111402672|NCT00002967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111402673|NCT00002967|Immunologic Factors|immunologic factors|mesh-ancestor
111402674|NCT00002967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111402675|NCT00002967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111402676|NCT00002967|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111402677|NCT00002967|Alkylating Agents|alkylating agents|mesh-ancestor
111402678|NCT00002967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111402679|NCT00002967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111402680|NCT00002967|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111402681|NCT00002967|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111402682|NCT00002967|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111402683|NCT00002967|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111402684|NCT00002967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111402685|NCT00002967|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111402686|NCT00002967|Hormone Antagonists|hormone antagonists|mesh-ancestor
111402687|NCT00002967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111402688|NCT00002967|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111402689|NCT00002967|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111402690|NCT00002967|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111402691|NCT00002967|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111402692|NCT00002967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111127050|NCT04909151|Adrenergic Agents|adrenergic agents|mesh-ancestor
111402693|NCT00002973|Melphalan|melphalan|mesh-list
111402694|NCT00002973|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111402695|NCT00002973|Alkylating Agents|alkylating agents|mesh-ancestor
111402696|NCT00002973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111402697|NCT00002973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111402698|NCT00002973|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111402699|NCT00002973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111402700|NCT00002973|Immunologic Factors|immunologic factors|mesh-ancestor
111402701|NCT00002973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111402702|NCT00002985|Doxorubicin|doxorubicin|mesh-list
111402703|NCT00002985|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111402704|NCT00002985|Daunorubicin|daunorubicin|mesh-list
111402705|NCT00002985|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111402706|NCT00002985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111402707|NCT00002985|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111402708|NCT00002985|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111402709|NCT00002985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111402710|NCT00002985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111402711|NCT00363389|Misoprostol|misoprostol|mesh-list
111402712|NCT00363389|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111402713|NCT00363389|Abortifacient Agents|abortifacient agents|mesh-ancestor
111402714|NCT00363389|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111402715|NCT00363389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111402716|NCT00363389|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111402717|NCT00363389|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111402718|NCT00363389|Oxytocics|oxytocics|mesh-ancestor
111402719|NCT03057431|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
111402720|NCT03057431|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111402721|NCT03057431|Diuretics|diuretics|mesh-ancestor
111402722|NCT03057431|Natriuretic Agents|natriuretic agents|mesh-ancestor
111402723|NCT03057431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111402724|NCT03057431|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
111402725|NCT03057431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111402726|NCT03057431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111402727|NCT00003003|Mitoxantrone|mitoxantrone|mesh-list
111402728|NCT00003003|Mitomycins|mitomycins|mesh-list
111402729|NCT00003003|Mitomycin|mitomycin|mesh-list
111402730|NCT00003003|Sargramostim|sargramostim|mesh-list
111402731|NCT00003003|Immunologic Factors|immunologic factors|mesh-ancestor
111402732|NCT00003003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111402733|NCT00003003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111402734|NCT00003003|Analgesics|analgesics|mesh-ancestor
111402735|NCT00003003|Sensory System Agents|sensory system agents|mesh-ancestor
111402736|NCT00003003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111402737|NCT00003003|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111402738|NCT00003003|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111402739|NCT00003003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111402740|NCT00003003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111402741|NCT00003003|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111402742|NCT00003003|Alkylating Agents|alkylating agents|mesh-ancestor
111402743|NCT00003003|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111402744|NCT00003009|Aldesleukin|aldesleukin|mesh-list
111402745|NCT00003009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111402746|NCT00003009|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111402747|NCT00003009|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111402748|NCT00003009|Antiviral Agents|antiviral agents|mesh-ancestor
111402749|NCT00003009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111402750|NCT00003015|Carboplatin|carboplatin|mesh-list
111402751|NCT00003015|Vincristine|vincristine|mesh-list
111402752|NCT00003015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111402753|NCT00003015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111402754|NCT00003015|Tubulin Modulators|tubulin modulators|mesh-ancestor
111402755|NCT00003015|Antimitotic Agents|antimitotic agents|mesh-ancestor
111402756|NCT00003015|Mitosis Modulators|mitosis modulators|mesh-ancestor
111402757|NCT00003015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111402758|NCT04204837|Nivolumab|nivolumab|mesh-list
111402759|NCT04204837|Relatlimab|relatlimab|mesh-list
111402760|NCT04204837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111402761|NCT04204837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111402762|NCT04204837|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110879926|NCT04707183|Lidocaine|lidocaine|mesh-list
111402763|NCT04204837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111402764|NCT00003021|Bizelesin|bizelesin|mesh-list
111402765|NCT00003021|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111402766|NCT00003021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111402767|NCT00003021|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111402768|NCT00003021|Alkylating Agents|alkylating agents|mesh-ancestor
111402769|NCT00003021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111402770|NCT00003039|Alvocidib|alvocidib|mesh-list
111402771|NCT00003039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111402772|NCT00003039|Growth Inhibitors|growth inhibitors|mesh-ancestor
111402773|NCT00003039|Growth Substances|growth substances|mesh-ancestor
111402774|NCT00003039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111402775|NCT00003039|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111402776|NCT00003039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111402777|NCT00003039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111402778|NCT00383877|Insulin|insulin|mesh-list
111402779|NCT00383877|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111402780|NCT00383877|Insulin Detemir|insulin detemir|mesh-list
111402781|NCT00383877|Isophane Insulin, Human|isophane insulin, human|mesh-list
111402782|NCT00383877|Insulin, Isophane|insulin, isophane|mesh-list
111402783|NCT00383877|Isophane insulin, beef|isophane insulin, beef|mesh-list
111402784|NCT00383877|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111402785|NCT00383877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111402786|NCT00003063|Leucovorin|leucovorin|mesh-list
111402787|NCT00003063|Interferons|interferons|mesh-list
111402788|NCT00003063|Interferon-alpha|interferon-alpha|mesh-list
111402789|NCT00003063|Levamisole|levamisole|mesh-list
111402790|NCT00003063|Fluorouracil|fluorouracil|mesh-list
111402791|NCT00003063|Calcium|calcium|mesh-list
111402792|NCT00003063|Levoleucovorin|levoleucovorin|mesh-list
111402793|NCT00003063|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111402794|NCT00003063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111402795|NCT00003063|Antimetabolites|antimetabolites|mesh-ancestor
111402796|NCT00003063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111402797|NCT00003063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111402798|NCT00003063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111402799|NCT00003063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111402800|NCT00003063|Immunologic Factors|immunologic factors|mesh-ancestor
111402801|NCT00003063|Antiviral Agents|antiviral agents|mesh-ancestor
111402802|NCT00003063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111402803|NCT00003063|Antidotes|antidotes|mesh-ancestor
111402804|NCT00003063|Protective Agents|protective agents|mesh-ancestor
111402805|NCT00003063|Vitamin B Complex|vitamin b complex|mesh-ancestor
111402806|NCT00003063|Vitamins|vitamins|mesh-ancestor
111402807|NCT00003063|Micronutrients|micronutrients|mesh-ancestor
111402808|NCT00003063|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111402809|NCT00003063|Antinematodal Agents|antinematodal agents|mesh-ancestor
111402810|NCT00003063|Anthelmintics|anthelmintics|mesh-ancestor
111402811|NCT00003063|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111402812|NCT00003063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111402813|NCT00003075|Fenretinide|fenretinide|mesh-list
111402814|NCT00003075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111402815|NCT00003075|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
111402816|NCT00003075|Protective Agents|protective agents|mesh-ancestor
111402817|NCT00003075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111402818|NCT00003081|Melphalan|melphalan|mesh-list
111402819|NCT00003081|Busulfan|busulfan|mesh-list
111402820|NCT00003081|Thiotepa|thiotepa|mesh-list
111402821|NCT00003081|Immunologic Factors|immunologic factors|mesh-ancestor
111402822|NCT00003081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111402823|NCT00003081|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111402824|NCT00003081|Alkylating Agents|alkylating agents|mesh-ancestor
111402825|NCT00003081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111402826|NCT00003081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111402827|NCT00003081|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111402828|NCT00003081|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111402829|NCT02348385|Amphetamine|amphetamine|mesh-list
111402830|NCT02348385|Dextroamphetamine|dextroamphetamine|mesh-list
111402831|NCT02348385|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111402832|NCT02348385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111402833|NCT02348385|Sympathomimetics|sympathomimetics|mesh-ancestor
111402834|NCT02348385|Autonomic Agents|autonomic agents|mesh-ancestor
111402835|NCT02348385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111402836|NCT02348385|Dopamine Agents|dopamine agents|mesh-ancestor
111402837|NCT02348385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111402838|NCT02348385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111402839|NCT02348385|Adrenergic Agents|adrenergic agents|mesh-ancestor
111402840|NCT02348385|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111402841|NCT02348385|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111402842|NCT02348385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111402843|NCT02348385|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111402844|NCT00003087|Paclitaxel|paclitaxel|mesh-list
111402845|NCT00003087|Cisplatin|cisplatin|mesh-list
111402846|NCT00003087|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111402847|NCT00003087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111402848|NCT00003087|Tubulin Modulators|tubulin modulators|mesh-ancestor
111402849|NCT00003087|Antimitotic Agents|antimitotic agents|mesh-ancestor
111402850|NCT00003087|Mitosis Modulators|mitosis modulators|mesh-ancestor
111402851|NCT00003087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111402853|NCT00003093|Carboplatin|carboplatin|mesh-list
111402854|NCT00003093|Doxorubicin|doxorubicin|mesh-list
111402855|NCT00003093|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111402856|NCT00003093|Etoposide|etoposide|mesh-list
111402857|NCT00003093|Molgramostim|molgramostim|mesh-list
111402858|NCT00003093|Lenograstim|lenograstim|mesh-list
111402859|NCT00003093|Sargramostim|sargramostim|mesh-list
111402860|NCT00003093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111402861|NCT00003093|Immunologic Factors|immunologic factors|mesh-ancestor
111402862|NCT00003093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111402863|NCT00003093|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111402864|NCT00003093|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111402865|NCT00003093|Alkylating Agents|alkylating agents|mesh-ancestor
111402866|NCT00003093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111402867|NCT00003093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111402868|NCT00003093|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111402869|NCT00003093|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111402870|NCT00003093|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111402871|NCT00003093|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111402872|NCT00003093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111402873|NCT00003093|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111402874|NCT00003093|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111402875|NCT00003099|Tamoxifen|tamoxifen|mesh-list
111402876|NCT00003099|Fenretinide|fenretinide|mesh-list
111402877|NCT00003099|Retinamide|retinamide|mesh-list
111402878|NCT00003099|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111402879|NCT00003099|Hormone Antagonists|hormone antagonists|mesh-ancestor
111402880|NCT00003099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111402881|NCT00003099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111402882|NCT00003099|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111402883|NCT00003099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111402884|NCT00003099|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111402885|NCT00003099|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111402886|NCT00003099|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111402887|NCT00003099|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
111402888|NCT00003099|Protective Agents|protective agents|mesh-ancestor
111402889|NCT00003105|Paclitaxel|paclitaxel|mesh-list
111402890|NCT00003105|Gemcitabine|gemcitabine|mesh-list
111402891|NCT00003105|Doxorubicin|doxorubicin|mesh-list
111402892|NCT00003105|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111402893|NCT00003105|Ifosfamide|ifosfamide|mesh-list
111402894|NCT00003105|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111402895|NCT00003105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111402896|NCT00003105|Tubulin Modulators|tubulin modulators|mesh-ancestor
111402897|NCT00003105|Antimitotic Agents|antimitotic agents|mesh-ancestor
111402898|NCT00003105|Mitosis Modulators|mitosis modulators|mesh-ancestor
111402899|NCT00003105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111402900|NCT00003105|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111402901|NCT00003105|Antimetabolites|antimetabolites|mesh-ancestor
111402902|NCT00003105|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111402903|NCT00003105|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111402904|NCT00003105|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111402905|NCT00003105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111402906|NCT00003105|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111402907|NCT00003105|Alkylating Agents|alkylating agents|mesh-ancestor
111402908|NCT00003111|Paclitaxel|paclitaxel|mesh-list
111402909|NCT00003111|Carboplatin|carboplatin|mesh-list
111402910|NCT00003111|Irinotecan|irinotecan|mesh-list
111402911|NCT00003111|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111402912|NCT00003111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111402913|NCT00003111|Tubulin Modulators|tubulin modulators|mesh-ancestor
111402914|NCT00003111|Antimitotic Agents|antimitotic agents|mesh-ancestor
111402915|NCT00003111|Mitosis Modulators|mitosis modulators|mesh-ancestor
111402916|NCT00003111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111402917|NCT00003111|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111402918|NCT00003111|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111402919|NCT00003111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111402920|NCT00003117|Paclitaxel|paclitaxel|mesh-list
111402921|NCT00003117|Carboplatin|carboplatin|mesh-list
111402922|NCT00003117|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111402923|NCT00003117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111402924|NCT00003117|Tubulin Modulators|tubulin modulators|mesh-ancestor
111402925|NCT00003117|Antimitotic Agents|antimitotic agents|mesh-ancestor
111402926|NCT00003117|Mitosis Modulators|mitosis modulators|mesh-ancestor
111402927|NCT00003117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111402928|NCT02240329|Capsaicin|capsaicin|mesh-list
111402929|NCT02240329|Antipruritics|antipruritics|mesh-ancestor
111402930|NCT02240329|Dermatologic Agents|dermatologic agents|mesh-ancestor
111402931|NCT02240329|Sensory System Agents|sensory system agents|mesh-ancestor
111402932|NCT02240329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111402933|NCT02240329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111402934|NCT00003123|Amifostine|amifostine|mesh-list
111402935|NCT00003123|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111402936|NCT00003123|Protective Agents|protective agents|mesh-ancestor
111402937|NCT00003123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111402938|NCT03981523|Benzonidazole|benzonidazole|mesh-list
111402939|NCT03981523|Nifurtimox|nifurtimox|mesh-list
111402940|NCT03981523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111402941|NCT03981523|Immunologic Factors|immunologic factors|mesh-ancestor
111402942|NCT03981523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111402943|NCT03981523|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
111402944|NCT03981523|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111402945|NCT03981523|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111402946|NCT03981523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111402947|NCT03965923|Tenofovir|tenofovir|mesh-list
111402948|NCT03965923|Emtricitabine|emtricitabine|mesh-list
111402949|NCT03965923|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
111402950|NCT03965923|Dapivirine|dapivirine|mesh-list
111402951|NCT03965923|Antiviral Agents|antiviral agents|mesh-ancestor
111402952|NCT03965923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111402953|NCT03965923|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111402954|NCT03965923|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111402955|NCT03965923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111402956|NCT03965923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111402957|NCT03965923|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111402958|NCT03965923|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111402959|NCT03962725|Dexmedetomidine|dexmedetomidine|mesh-list
111402960|NCT03962725|Ketamine|ketamine|mesh-list
111402961|NCT03962725|Propofol|propofol|mesh-list
111402962|NCT03962725|Anesthetics|anesthetics|mesh-list
111402963|NCT03962725|Rocuronium|rocuronium|mesh-list
111402964|NCT03962725|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
111402965|NCT03962725|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111402966|NCT03962725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111402967|NCT03962725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111402968|NCT03962725|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111402969|NCT03962725|Analgesics|analgesics|mesh-ancestor
111402970|NCT03962725|Sensory System Agents|sensory system agents|mesh-ancestor
111402971|NCT03962725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111402972|NCT03962725|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111402973|NCT03962725|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111402974|NCT03962725|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111402975|NCT03962725|Adrenergic Agents|adrenergic agents|mesh-ancestor
111402976|NCT03962725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111402977|NCT03962725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111402978|NCT03962725|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111402979|NCT03962725|Anesthetics, General|anesthetics, general|mesh-ancestor
111402980|NCT03962725|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111402981|NCT03962725|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111402982|NCT03962725|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111402983|NCT03962725|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
111402984|NCT03962725|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111402985|NCT05699473|Calcium, Dietary|calcium, dietary|mesh-list
111402986|NCT05699473|Tetrahydrofolates|tetrahydrofolates|mesh-list
111402987|NCT05699473|Calcium|calcium|mesh-list
111402988|NCT05699473|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111402989|NCT05699473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111402990|NCT05699473|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111402991|NCT05699473|Vitamin B Complex|vitamin b complex|mesh-ancestor
111402992|NCT05699473|Vitamins|vitamins|mesh-ancestor
111402993|NCT05699473|Micronutrients|micronutrients|mesh-ancestor
111402994|NCT02210559|Paclitaxel|paclitaxel|mesh-list
111402995|NCT02210559|Gemcitabine|gemcitabine|mesh-list
111402996|NCT02210559|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111402997|NCT02210559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111402998|NCT02210559|Tubulin Modulators|tubulin modulators|mesh-ancestor
111402999|NCT02210559|Antimitotic Agents|antimitotic agents|mesh-ancestor
111403000|NCT02210559|Mitosis Modulators|mitosis modulators|mesh-ancestor
111403001|NCT02210559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111403002|NCT02210559|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111403003|NCT02210559|Antimetabolites|antimetabolites|mesh-ancestor
111403004|NCT00003135|Doxorubicin|doxorubicin|mesh-list
111403005|NCT00003135|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111403006|NCT00003135|Fluorouracil|fluorouracil|mesh-list
111403007|NCT00003135|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111403008|NCT00003135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111403009|NCT00003135|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111403010|NCT00003135|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111403011|NCT00003135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111403012|NCT00003135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111403013|NCT00003135|Antimetabolites|antimetabolites|mesh-ancestor
111403014|NCT00003135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111403015|NCT00003135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111403016|NCT00003135|Immunologic Factors|immunologic factors|mesh-ancestor
111403017|NCT00003135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111403019|NCT03439891|Sorafenib|sorafenib|mesh-list
111403020|NCT03439891|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111403021|NCT03439891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111403022|NCT03439891|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111403023|NCT03439891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111403024|NCT03439891|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111403025|NCT03439891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111403026|NCT00003141|Cyclophosphamide|cyclophosphamide|mesh-list
111403027|NCT00003141|Thiotepa|thiotepa|mesh-list
111403028|NCT00003141|Cisplatin|cisplatin|mesh-list
111403029|NCT00003141|Carboplatin|carboplatin|mesh-list
111403030|NCT00003141|Etoposide|etoposide|mesh-list
111403031|NCT00003141|Vincristine|vincristine|mesh-list
111403032|NCT00003141|Lenograstim|lenograstim|mesh-list
111403033|NCT00003141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111403034|NCT00003141|Immunologic Factors|immunologic factors|mesh-ancestor
111403035|NCT00003141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111403036|NCT00003141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111403037|NCT00003141|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111403038|NCT00003141|Alkylating Agents|alkylating agents|mesh-ancestor
111403039|NCT00003141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111403040|NCT00003141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111403041|NCT00003141|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111403042|NCT00003141|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111403043|NCT00003141|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111403044|NCT00003141|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111403045|NCT00003141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111403046|NCT00003141|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111403047|NCT00003141|Tubulin Modulators|tubulin modulators|mesh-ancestor
111403048|NCT00003141|Antimitotic Agents|antimitotic agents|mesh-ancestor
111403049|NCT00003141|Mitosis Modulators|mitosis modulators|mesh-ancestor
111403050|NCT04867135|Amikacin|amikacin|mesh-list
111403051|NCT04867135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111403052|NCT04867135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111403053|NCT01740817|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
111403054|NCT01740817|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
111403055|NCT01740817|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
111403056|NCT01740817|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111403057|NCT04728217|Factor VIII|factor viii|mesh-list
111403058|NCT04728217|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
111403059|NCT04728217|Coagulants|coagulants|mesh-ancestor
111403060|NCT04728217|Immunologic Factors|immunologic factors|mesh-ancestor
111403061|NCT04728217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111403062|NCT04581343|Paclitaxel|paclitaxel|mesh-list
111403063|NCT04581343|Gemcitabine|gemcitabine|mesh-list
111403064|NCT04581343|Spartalizumab|spartalizumab|mesh-list
111403065|NCT04581343|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111403066|NCT04581343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111403067|NCT04581343|Tubulin Modulators|tubulin modulators|mesh-ancestor
111403068|NCT04581343|Antimitotic Agents|antimitotic agents|mesh-ancestor
111403069|NCT04581343|Mitosis Modulators|mitosis modulators|mesh-ancestor
111403070|NCT04581343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111403071|NCT04581343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111403072|NCT04581343|Antimetabolites|antimetabolites|mesh-ancestor
111403073|NCT04581343|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111403074|NCT04581343|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111403075|NCT01743859|Lenalidomide|lenalidomide|mesh-list
111403076|NCT01743859|Azacitidine|azacitidine|mesh-list
111403077|NCT01743859|Immunologic Factors|immunologic factors|mesh-ancestor
111403078|NCT01743859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111403079|NCT01743859|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111403080|NCT01743859|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111403081|NCT01743859|Growth Substances|growth substances|mesh-ancestor
111403082|NCT01743859|Growth Inhibitors|growth inhibitors|mesh-ancestor
111403083|NCT01743859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111403084|NCT01743859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111403085|NCT01743859|Antimetabolites|antimetabolites|mesh-ancestor
111403086|NCT01743859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111403087|NCT01743859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111403088|NCT01746043|Minocycline|minocycline|mesh-list
111403089|NCT01746043|Modafinil|modafinil|mesh-list
111403090|NCT01746043|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111403091|NCT01746043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111403092|NCT01746043|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111403093|NCT01746043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111403094|NCT01746043|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
111403095|NCT01746043|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111403096|NCT01746043|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111403097|NCT01746043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111403098|NCT05635903|Diazepam|diazepam|mesh-list
111403099|NCT05635903|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111403100|NCT05635903|Anticonvulsants|anticonvulsants|mesh-ancestor
111403101|NCT05635903|Antiemetics|antiemetics|mesh-ancestor
110880251|NCT03532555|Zinc|zinc|mesh-list
111403102|NCT05635903|Autonomic Agents|autonomic agents|mesh-ancestor
111403103|NCT05635903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111403104|NCT05635903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111403105|NCT05635903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111403106|NCT05635903|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111403107|NCT05635903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111403108|NCT05635903|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
111403109|NCT05635903|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111403110|NCT05635903|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111403111|NCT05635903|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111403112|NCT05635903|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111403113|NCT05635903|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111403114|NCT05635903|Anesthetics, General|anesthetics, general|mesh-ancestor
111403115|NCT05635903|Anesthetics|anesthetics|mesh-ancestor
111403116|NCT05635903|GABA Modulators|gaba modulators|mesh-ancestor
111403117|NCT05635903|GABA Agents|gaba agents|mesh-ancestor
111403118|NCT05635903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111403119|NCT05635903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111403120|NCT01746511|Glycerol|glycerol|mesh-list
111403121|NCT01746511|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
111403122|NCT01746511|Protective Agents|protective agents|mesh-ancestor
111403123|NCT01746511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111403124|NCT01746979|Gemcitabine|gemcitabine|mesh-list
111403125|NCT01746979|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111403126|NCT01746979|Antimetabolites|antimetabolites|mesh-ancestor
111403127|NCT01746979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111403128|NCT01746979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111403129|NCT05614453|Tislelizumab|tislelizumab|mesh-list
111403130|NCT05614453|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111403131|NCT05614453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111403132|NCT01754389|Sirolimus|sirolimus|mesh-list
111403133|NCT01754389|Methotrexate|methotrexate|mesh-list
111403134|NCT01754389|Bortezomib|bortezomib|mesh-list
111403135|NCT01754389|Tacrolimus|tacrolimus|mesh-list
111403136|NCT01754389|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111403137|NCT01754389|Abortifacient Agents|abortifacient agents|mesh-ancestor
111403138|NCT01754389|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111403139|NCT01754389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111403140|NCT01754389|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111403141|NCT01754389|Antimetabolites|antimetabolites|mesh-ancestor
111403142|NCT01754389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111403143|NCT01754389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111403144|NCT01754389|Dermatologic Agents|dermatologic agents|mesh-ancestor
111403145|NCT01754389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111403146|NCT01754389|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111403147|NCT01754389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111403148|NCT01754389|Immunologic Factors|immunologic factors|mesh-ancestor
111403149|NCT01754389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111403150|NCT01754389|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111403151|NCT01754389|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111403152|NCT01754389|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111403153|NCT01754389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111403154|NCT01754389|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111403155|NCT01754389|Antifungal Agents|antifungal agents|mesh-ancestor
111403157|NCT01754623|Fluorouracil|fluorouracil|mesh-list
111403158|NCT01754623|Capecitabine|capecitabine|mesh-list
111403159|NCT01754623|Docetaxel|docetaxel|mesh-list
111403160|NCT01754623|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111403161|NCT01754623|Antimetabolites|antimetabolites|mesh-ancestor
111403162|NCT01754623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111403163|NCT01754623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111403164|NCT01754623|Tubulin Modulators|tubulin modulators|mesh-ancestor
111403165|NCT01754623|Antimitotic Agents|antimitotic agents|mesh-ancestor
111403166|NCT01754623|Mitosis Modulators|mitosis modulators|mesh-ancestor
111403167|NCT01754623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111403168|NCT01754623|Immunologic Factors|immunologic factors|mesh-ancestor
111403169|NCT01754623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111403170|NCT01755169|Ketamine|ketamine|mesh-list
111403171|NCT01755169|Analgesics|analgesics|mesh-ancestor
111403172|NCT01755169|Sensory System Agents|sensory system agents|mesh-ancestor
111403173|NCT01755169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111403174|NCT01755169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111403175|NCT01755169|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111403176|NCT01755169|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111403177|NCT01755169|Anesthetics, General|anesthetics, general|mesh-ancestor
111403178|NCT01755169|Anesthetics|anesthetics|mesh-ancestor
111403179|NCT01755169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111403180|NCT01755169|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111403181|NCT01755169|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111403182|NCT01755169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111403183|NCT01755169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111403184|NCT01755949|Colchicine|colchicine|mesh-list
111403185|NCT01755949|Gout Suppressants|gout suppressants|mesh-ancestor
111403186|NCT01755949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111403187|NCT01755949|Tubulin Modulators|tubulin modulators|mesh-ancestor
111403188|NCT01755949|Antimitotic Agents|antimitotic agents|mesh-ancestor
111403189|NCT01755949|Mitosis Modulators|mitosis modulators|mesh-ancestor
111403190|NCT01755949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111403191|NCT01755949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111403192|NCT01756885|Varenicline|varenicline|mesh-list
111403193|NCT01756885|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111403194|NCT01756885|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111403195|NCT01756885|Cholinergic Agents|cholinergic agents|mesh-ancestor
111403196|NCT01756885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111403197|NCT01756885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111403198|NCT01756885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111403199|NCT04172701|Cholinergic Agents|cholinergic agents|mesh-list
111403200|NCT04172701|Muscarinic Antagonists|muscarinic antagonists|mesh-list
111403201|NCT04172701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111403202|NCT04172701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111403203|NCT04172701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111403204|NCT04172701|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111403205|NCT01760785|Valproic Acid|valproic acid|mesh-list
111403206|NCT01760785|Anticonvulsants|anticonvulsants|mesh-ancestor
111403207|NCT01760785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111403208|NCT01760785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111403209|NCT01760785|GABA Agents|gaba agents|mesh-ancestor
111403210|NCT01760785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111403211|NCT01760785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111403212|NCT01760785|Antimanic Agents|antimanic agents|mesh-ancestor
111403213|NCT01760785|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111403214|NCT01760785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111403215|NCT01760785|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111403216|NCT04062097|Vitamin K|vitamin k|mesh-list
111403217|NCT04062097|Dabigatran|dabigatran|mesh-list
111403218|NCT04062097|Vitamins|vitamins|mesh-ancestor
111403219|NCT04062097|Micronutrients|micronutrients|mesh-ancestor
111403220|NCT04062097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111403221|NCT04062097|Antithrombins|antithrombins|mesh-ancestor
111403222|NCT04062097|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111403223|NCT04062097|Protease Inhibitors|protease inhibitors|mesh-ancestor
111403224|NCT04062097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111127577|NCT04888403|Nedaplatin|nedaplatin|mesh-list
111403225|NCT04062097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111403226|NCT04062097|Anticoagulants|anticoagulants|mesh-ancestor
111403227|NCT04062097|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111403228|NCT04062097|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111403230|NCT04062097|Coagulants|coagulants|mesh-ancestor
111403231|NCT02241655|Anesthetics|anesthetics|mesh-list
111403232|NCT02241655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111403233|NCT02241655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111403234|NCT04005079|Ofloxacin|ofloxacin|mesh-list
111403235|NCT04005079|Prednisolone|prednisolone|mesh-list
111403236|NCT04005079|Pilocarpine|pilocarpine|mesh-list
111403237|NCT04005079|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111403238|NCT04005079|Glucocorticoids|glucocorticoids|mesh-ancestor
111403239|NCT04005079|Hormones|hormones|mesh-ancestor
111403240|NCT04005079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111403241|NCT04005079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111403242|NCT04005079|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111403243|NCT04005079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111403244|NCT04005079|Autonomic Agents|autonomic agents|mesh-ancestor
111403245|NCT04005079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111403246|NCT04005079|Miotics|miotics|mesh-ancestor
111403247|NCT04005079|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
111403248|NCT04005079|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111403249|NCT04005079|Cholinergic Agents|cholinergic agents|mesh-ancestor
111403250|NCT04005079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111403251|NCT04005079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111403252|NCT04005079|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111403253|NCT04005079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111403254|NCT04005079|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111403255|NCT04005079|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111403256|NCT04005079|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111403257|NCT04005079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111403258|NCT04005079|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111403259|NCT04005079|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111403260|NCT01762501|Amlodipine|amlodipine|mesh-list
111403261|NCT01762501|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
111403262|NCT01762501|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111403263|NCT01762501|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111403264|NCT01762501|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111403265|NCT01762501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111403266|NCT01762501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111403267|NCT01762501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111403268|NCT01762501|Vasodilator Agents|vasodilator agents|mesh-ancestor
111403269|NCT01762501|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111403270|NCT01762501|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111403271|NCT01764607|Sirolimus|sirolimus|mesh-list
111403272|NCT01764607|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111403273|NCT01764607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111403274|NCT01764607|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111403275|NCT01764607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111403276|NCT01764607|Antifungal Agents|antifungal agents|mesh-ancestor
111403277|NCT01764607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111403278|NCT01764607|Immunologic Factors|immunologic factors|mesh-ancestor
111403279|NCT01764607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111403280|NCT01764685|Topiramate|topiramate|mesh-list
111403281|NCT01764685|Anticonvulsants|anticonvulsants|mesh-ancestor
111403282|NCT01764685|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111403283|NCT01764685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111403284|NCT05115409|Rituximab|rituximab|mesh-list
111403285|NCT05115409|Antibodies|antibodies|mesh-list
111403286|NCT05115409|Immunologic Factors|immunologic factors|mesh-ancestor
111403287|NCT05115409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111403288|NCT05115409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111403289|NCT05115409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111403290|NCT05115409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111403291|NCT01766713|Ezetimibe|ezetimibe|mesh-list
111403292|NCT01766713|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111403293|NCT01766713|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111403294|NCT01766713|Antimetabolites|antimetabolites|mesh-ancestor
111403295|NCT01766713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111403296|NCT01766713|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111403297|NCT01767103|Deferiprone|deferiprone|mesh-list
111403298|NCT01767103|Iron Chelating Agents|iron chelating agents|mesh-ancestor
111403299|NCT01767103|Chelating Agents|chelating agents|mesh-ancestor
111403301|NCT01767103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111403302|NCT01769209|Cytarabine|cytarabine|mesh-list
111403303|NCT01769209|Dexamethasone|dexamethasone|mesh-list
111403304|NCT01769209|Doxorubicin|doxorubicin|mesh-list
111403305|NCT01769209|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111403306|NCT01769209|Methotrexate|methotrexate|mesh-list
111403307|NCT01769209|Vincristine|vincristine|mesh-list
111403308|NCT01769209|Bortezomib|bortezomib|mesh-list
111403309|NCT01769209|Asparaginase|asparaginase|mesh-list
111403310|NCT01769209|Pegaspargase|pegaspargase|mesh-list
111403311|NCT01769209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111403312|NCT01769209|Antiemetics|antiemetics|mesh-ancestor
111403313|NCT01769209|Autonomic Agents|autonomic agents|mesh-ancestor
111403314|NCT01769209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111403315|NCT01769209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111403316|NCT01769209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111403317|NCT01769209|Glucocorticoids|glucocorticoids|mesh-ancestor
111403318|NCT01769209|Hormones|hormones|mesh-ancestor
111403319|NCT01769209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111403320|NCT01769209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111403321|NCT01769209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111403322|NCT01769209|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111403323|NCT01769209|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111403324|NCT01769209|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111403325|NCT01769209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111403326|NCT01769209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111403327|NCT01769209|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111403328|NCT01769209|Abortifacient Agents|abortifacient agents|mesh-ancestor
111403329|NCT01769209|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111403330|NCT01769209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111403331|NCT01769209|Antimetabolites|antimetabolites|mesh-ancestor
111403332|NCT01769209|Dermatologic Agents|dermatologic agents|mesh-ancestor
111403333|NCT01769209|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111403334|NCT01769209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111403335|NCT01769209|Immunologic Factors|immunologic factors|mesh-ancestor
111403336|NCT01769209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111403337|NCT01769209|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111403338|NCT01769209|Antiviral Agents|antiviral agents|mesh-ancestor
111403339|NCT01769209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111403340|NCT01769209|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111403341|NCT01769209|Tubulin Modulators|tubulin modulators|mesh-ancestor
111403342|NCT01769209|Antimitotic Agents|antimitotic agents|mesh-ancestor
111403343|NCT01769209|Mitosis Modulators|mitosis modulators|mesh-ancestor
111403344|NCT01769365|Amoxicillin|amoxicillin|mesh-list
111403345|NCT01769365|Metronidazole|metronidazole|mesh-list
111403346|NCT01769365|Clarithromycin|clarithromycin|mesh-list
111403347|NCT01769365|Pantoprazole|pantoprazole|mesh-list
111403348|NCT01769365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111403349|NCT01769365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111403350|NCT01769365|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111403351|NCT01769365|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111403352|NCT01769365|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111403353|NCT01769365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111403354|NCT01769365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111403355|NCT01769365|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111403356|NCT01769365|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111403357|NCT01769365|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111403358|NCT01769365|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111403359|NCT01769365|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111403360|NCT01771627|Nicotine|nicotine|mesh-list
111403361|NCT01771627|Varenicline|varenicline|mesh-list
111403362|NCT01771627|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111403363|NCT01771627|Autonomic Agents|autonomic agents|mesh-ancestor
111403364|NCT01771627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111403365|NCT01771627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111403366|NCT01771627|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111403367|NCT01771627|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111403368|NCT01771627|Cholinergic Agents|cholinergic agents|mesh-ancestor
111403369|NCT01771627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111403370|NCT01771627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111403371|NCT03749629|Psychotropic Drugs|psychotropic drugs|mesh-list
111127730|NCT04871633|Hormones|hormones|mesh-ancestor
111403372|NCT03682393|Hydrocortisone|hydrocortisone|mesh-list
111403373|NCT03682393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111403374|NCT03499483|Tenofovir|tenofovir|mesh-list
111403375|NCT03499483|Emtricitabine|emtricitabine|mesh-list
111403376|NCT03499483|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
111403377|NCT03499483|Antiviral Agents|antiviral agents|mesh-ancestor
111403378|NCT03499483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111403379|NCT03499483|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111403380|NCT03499483|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111403381|NCT03499483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111403382|NCT03499483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111403383|NCT03499483|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111403384|NCT03499483|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111403385|NCT04350931|BCG Vaccine|bcg vaccine|mesh-list
111403386|NCT04350931|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111403387|NCT04350931|Immunologic Factors|immunologic factors|mesh-ancestor
111403388|NCT04350931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111403389|NCT01673867|Docetaxel|docetaxel|mesh-list
111403390|NCT01673867|Nivolumab|nivolumab|mesh-list
111403391|NCT01673867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111403392|NCT01673867|Tubulin Modulators|tubulin modulators|mesh-ancestor
111403393|NCT01673867|Antimitotic Agents|antimitotic agents|mesh-ancestor
111403394|NCT01673867|Mitosis Modulators|mitosis modulators|mesh-ancestor
111403395|NCT01673867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111403396|NCT01673867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111403397|NCT01673867|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111403398|NCT01777945|Docetaxel|docetaxel|mesh-list
111403399|NCT01777945|Capecitabine|capecitabine|mesh-list
111403400|NCT01777945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111403401|NCT01777945|Tubulin Modulators|tubulin modulators|mesh-ancestor
111403402|NCT01777945|Antimitotic Agents|antimitotic agents|mesh-ancestor
111403403|NCT01777945|Mitosis Modulators|mitosis modulators|mesh-ancestor
111403404|NCT01777945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111403405|NCT01777945|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111403406|NCT01777945|Antimetabolites|antimetabolites|mesh-ancestor
111403407|NCT03012581|Nivolumab|nivolumab|mesh-list
111403408|NCT03012581|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111403409|NCT03012581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111403410|NCT03012581|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111403411|NCT03012581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111403412|NCT05451043|Paclitaxel|paclitaxel|mesh-list
111403413|NCT05451043|Gemcitabine|gemcitabine|mesh-list
111403414|NCT05451043|Durvalumab|durvalumab|mesh-list
111403415|NCT05451043|Tremelimumab|tremelimumab|mesh-list
111403416|NCT05451043|Propranolol|propranolol|mesh-list
111403417|NCT05451043|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111403418|NCT05451043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111403419|NCT05451043|Tubulin Modulators|tubulin modulators|mesh-ancestor
111403420|NCT05451043|Antimitotic Agents|antimitotic agents|mesh-ancestor
111403421|NCT05451043|Mitosis Modulators|mitosis modulators|mesh-ancestor
111403422|NCT05451043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111403423|NCT05451043|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111403424|NCT05451043|Antimetabolites|antimetabolites|mesh-ancestor
111403425|NCT05451043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111403426|NCT05451043|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111403427|NCT05451043|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111403428|NCT05451043|Adrenergic Agents|adrenergic agents|mesh-ancestor
111403429|NCT05451043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111403430|NCT05451043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111403431|NCT05451043|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111403432|NCT05451043|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111403433|NCT05451043|Vasodilator Agents|vasodilator agents|mesh-ancestor
111403434|NCT02652169|Amikacin|amikacin|mesh-list
111403435|NCT02652169|Teicoplanin|teicoplanin|mesh-list
111403436|NCT02652169|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111403437|NCT02652169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111403438|NCT02478775|Cetrorelix|cetrorelix|mesh-list
111403439|NCT02478775|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111403440|NCT02478775|Fertility Agents|fertility agents|mesh-ancestor
111403441|NCT02478775|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111403442|NCT02478775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111403443|NCT02478775|Hormone Antagonists|hormone antagonists|mesh-ancestor
111403444|NCT02478775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111403445|NCT01783561|Caffeine|caffeine|mesh-list
111403446|NCT01783561|Caffeine citrate|caffeine citrate|mesh-list
111403447|NCT01783561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111403448|NCT01783561|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111403449|NCT01783561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111127809|NCT04870541|Nefopam|nefopam|mesh-list
111403450|NCT01783561|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111403451|NCT01783561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111403452|NCT01783561|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
111403453|NCT01783561|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111403454|NCT01783561|Purinergic Agents|purinergic agents|mesh-ancestor
111403455|NCT01783561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111403457|NCT02452931|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111403458|NCT02452931|Fertility Agents|fertility agents|mesh-ancestor
111403459|NCT02452931|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111403460|NCT02452931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111403461|NCT02452931|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111403462|NCT02452931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111403463|NCT04744727|Acetaminophen|acetaminophen|mesh-list
111403464|NCT04744727|Meperidine|meperidine|mesh-list
111403465|NCT04744727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111403466|NCT04744727|Analgesics|analgesics|mesh-ancestor
111403467|NCT04744727|Sensory System Agents|sensory system agents|mesh-ancestor
111403468|NCT04744727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111403469|NCT04744727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111403470|NCT04744727|Antipyretics|antipyretics|mesh-ancestor
111403471|NCT04744727|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111403472|NCT04744727|Narcotics|narcotics|mesh-ancestor
111403473|NCT04744727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111403474|NCT04744727|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111403475|NCT02454179|Pembrolizumab|pembrolizumab|mesh-list
111403476|NCT02454179|Acalabrutinib|acalabrutinib|mesh-list
111403477|NCT02454179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111403478|NCT02454179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111403479|NCT02454179|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111403480|NCT02454179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111403481|NCT02041533|Paclitaxel|paclitaxel|mesh-list
111403482|NCT02041533|Carboplatin|carboplatin|mesh-list
111403483|NCT02041533|Gemcitabine|gemcitabine|mesh-list
111403484|NCT02041533|Nivolumab|nivolumab|mesh-list
111403485|NCT02041533|Pemetrexed|pemetrexed|mesh-list
111403486|NCT02041533|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111403487|NCT02041533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111403488|NCT02041533|Tubulin Modulators|tubulin modulators|mesh-ancestor
111403489|NCT02041533|Antimitotic Agents|antimitotic agents|mesh-ancestor
111403490|NCT02041533|Mitosis Modulators|mitosis modulators|mesh-ancestor
111403491|NCT02041533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111403492|NCT02041533|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111403493|NCT02041533|Antimetabolites|antimetabolites|mesh-ancestor
111403494|NCT02041533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111403495|NCT02041533|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111403496|NCT02041533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111403497|NCT02041533|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111403498|NCT02041533|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111403499|NCT02260531|Trastuzumab|trastuzumab|mesh-list
111403500|NCT02260531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111403501|NCT02260531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111403502|NCT02458235|Azacitidine|azacitidine|mesh-list
111403503|NCT02458235|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111403504|NCT02458235|Antimetabolites|antimetabolites|mesh-ancestor
111403505|NCT02458235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111403506|NCT02458235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111403507|NCT02458235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111403508|NCT02115997|Prednisone|prednisone|mesh-list
111403509|NCT02115997|Methylprednisolone|methylprednisolone|mesh-list
111403510|NCT02115997|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111403511|NCT02115997|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111403512|NCT02115997|Prednisolone|prednisolone|mesh-list
111403513|NCT02115997|Prednisolone acetate|prednisolone acetate|mesh-list
111403514|NCT02115997|Rituximab|rituximab|mesh-list
111403515|NCT02115997|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111403516|NCT02115997|Prednisolone phosphate|prednisolone phosphate|mesh-list
111403517|NCT02115997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111403518|NCT02115997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111403519|NCT02115997|Immunologic Factors|immunologic factors|mesh-ancestor
111403520|NCT02115997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111403521|NCT02115997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111403522|NCT02115997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111403523|NCT02115997|Glucocorticoids|glucocorticoids|mesh-ancestor
111403524|NCT02115997|Hormones|hormones|mesh-ancestor
111403525|NCT02115997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111403526|NCT02115997|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111403527|NCT02115997|Antiemetics|antiemetics|mesh-ancestor
111403528|NCT02115997|Autonomic Agents|autonomic agents|mesh-ancestor
111403529|NCT02115997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111403530|NCT02115997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111403531|NCT02115997|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111403532|NCT02115997|Protective Agents|protective agents|mesh-ancestor
111403533|NCT01805323|Dexamethasone|dexamethasone|mesh-list
111403534|NCT01805323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111403535|NCT01805323|Antiemetics|antiemetics|mesh-ancestor
111403536|NCT01805323|Autonomic Agents|autonomic agents|mesh-ancestor
111403537|NCT01805323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111403538|NCT01805323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111403539|NCT01805323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111403540|NCT01805323|Glucocorticoids|glucocorticoids|mesh-ancestor
111403541|NCT01805323|Hormones|hormones|mesh-ancestor
111403542|NCT01805323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111403543|NCT01805323|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111403544|NCT01805323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111403545|NCT01641055|Caseins|caseins|mesh-list
111403546|NCT01641055|Chelating Agents|chelating agents|mesh-ancestor
111403547|NCT01641055|Sequestering Agents|sequestering agents|mesh-ancestor
111403548|NCT01641055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111403549|NCT01788631|Regadenoson|regadenoson|mesh-list
111403550|NCT01788631|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
111403551|NCT01788631|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
111403552|NCT01788631|Purinergic Agonists|purinergic agonists|mesh-ancestor
111403553|NCT01788631|Purinergic Agents|purinergic agents|mesh-ancestor
111403554|NCT01788631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111403555|NCT01788631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111403556|NCT01788631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111403557|NCT00907283|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111403558|NCT00907283|Deferiprone|deferiprone|mesh-list
111403559|NCT00907283|Iron Chelating Agents|iron chelating agents|mesh-ancestor
111403560|NCT00907283|Chelating Agents|chelating agents|mesh-ancestor
111403561|NCT00907283|Sequestering Agents|sequestering agents|mesh-ancestor
111403562|NCT00907283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111403563|NCT01789255|Cyclosporine|cyclosporine|mesh-list
111403564|NCT01789255|Methotrexate|methotrexate|mesh-list
111403565|NCT01789255|Vorinostat|vorinostat|mesh-list
111403566|NCT01789255|Tacrolimus|tacrolimus|mesh-list
111403567|NCT01789255|Cyclosporins|cyclosporins|mesh-list
111403568|NCT01789255|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111403569|NCT01789255|Abortifacient Agents|abortifacient agents|mesh-ancestor
111403570|NCT01789255|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111403571|NCT01789255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111403572|NCT01789255|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111403573|NCT01789255|Antimetabolites|antimetabolites|mesh-ancestor
111403574|NCT01789255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111403575|NCT01789255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111403576|NCT01789255|Dermatologic Agents|dermatologic agents|mesh-ancestor
111403577|NCT01789255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111403578|NCT01789255|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111403579|NCT01789255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111403580|NCT01789255|Immunologic Factors|immunologic factors|mesh-ancestor
111403581|NCT01789255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111403582|NCT01789255|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111403583|NCT01789255|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111403584|NCT01789255|Antifungal Agents|antifungal agents|mesh-ancestor
111403585|NCT01789255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111403586|NCT01789255|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111403587|NCT02464163|Hemagglutinins|hemagglutinins|mesh-list
111403588|NCT02464163|Agglutinins|agglutinins|mesh-ancestor
111403589|NCT02464163|Immunologic Factors|immunologic factors|mesh-ancestor
111403590|NCT02464163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111403591|NCT02464163|Coagulants|coagulants|mesh-ancestor
111403592|NCT01808755|Trimethoprim|trimethoprim|mesh-list
111403593|NCT01808755|Sulfamethoxazole|sulfamethoxazole|mesh-list
111403594|NCT01808755|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111403595|NCT01808755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111403596|NCT01808755|Antimalarials|antimalarials|mesh-ancestor
111403597|NCT01808755|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111403598|NCT01808755|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111403599|NCT01808755|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111403600|NCT01808755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111403601|NCT01808755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111403602|NCT01808755|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111403603|NCT01808755|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
111403604|NCT01808755|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111403606|NCT02694809|Estrogens|estrogens|mesh-list
111403607|NCT02694809|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
111403608|NCT02694809|Hormones|hormones|mesh-ancestor
111403609|NCT02694809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111403610|NCT02694809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111403611|NCT02694809|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111403612|NCT02694809|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111403613|NCT02694809|Hormone Antagonists|hormone antagonists|mesh-ancestor
111403614|NCT02694809|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111403615|NCT00568997|Pimecrolimus|pimecrolimus|mesh-list
111403616|NCT00568997|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111403617|NCT00568997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111403618|NCT00568997|Analgesics|analgesics|mesh-ancestor
111403619|NCT00568997|Sensory System Agents|sensory system agents|mesh-ancestor
111403620|NCT00568997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111403621|NCT00568997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111403622|NCT00568997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111403623|NCT00568997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111403624|NCT00568997|Dermatologic Agents|dermatologic agents|mesh-ancestor
111403625|NCT00568997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111403626|NCT00568997|Immunologic Factors|immunologic factors|mesh-ancestor
111403627|NCT00568997|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111403628|NCT00568997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111403629|NCT00568997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111403630|NCT00362687|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
111403631|NCT00362687|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111403632|NCT00362687|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111403633|NCT00362687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111403634|NCT00362687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111403635|NCT00362687|Antiviral Agents|antiviral agents|mesh-ancestor
111403636|NCT00362687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111403637|NCT00362687|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111403638|NCT00362687|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111403639|NCT01790659|Gentamicins|gentamicins|mesh-list
111403640|NCT01790659|Paromomycin|paromomycin|mesh-list
111403641|NCT01790659|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111403642|NCT01790659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111403643|NCT01790659|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111403644|NCT01790659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111403645|NCT01790659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111403646|NCT01790659|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111403647|NCT01790659|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111403648|NCT02469701|Nivolumab|nivolumab|mesh-list
111403649|NCT02469701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111403650|NCT02469701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111403651|NCT02469701|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111403652|NCT02469701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111403653|NCT01733953|Atorvastatin|atorvastatin|mesh-list
111403654|NCT01733953|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111403655|NCT01733953|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111403656|NCT01733953|Antimetabolites|antimetabolites|mesh-ancestor
111403657|NCT01733953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111403658|NCT01733953|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111403659|NCT01733953|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111403660|NCT01733953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111403661|NCT00362921|Carmustine|carmustine|mesh-list
111403662|NCT00362921|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
111403663|NCT00362921|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111403664|NCT00362921|Alkylating Agents|alkylating agents|mesh-ancestor
111403665|NCT00362921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111403666|NCT00362921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111403667|NCT00362921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111403668|NCT01734889|Nitisinone|nitisinone|mesh-list
111403669|NCT01734889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111403670|NCT01734889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111403671|NCT01736527|Loteprednol Etabonate|loteprednol etabonate|mesh-list
111403672|NCT01736527|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111403673|NCT01796665|Clindamycin|clindamycin|mesh-list
111403674|NCT01796665|Clindamycin palmitate|clindamycin palmitate|mesh-list
111403675|NCT01796665|Clindamycin phosphate|clindamycin phosphate|mesh-list
111403676|NCT01796665|Benzoyl Peroxide|benzoyl peroxide|mesh-list
111403677|NCT01796665|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111403678|NCT01796665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111403679|NCT01796665|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111403680|NCT01796665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111403681|NCT01796665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111403682|NCT01796665|Dermatologic Agents|dermatologic agents|mesh-ancestor
111403683|NCT01798225|Doxycycline|doxycycline|mesh-list
111403684|NCT01798225|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111403685|NCT01798225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111403686|NCT01798225|Antimalarials|antimalarials|mesh-ancestor
111403687|NCT01798225|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111403688|NCT01798225|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111403689|NCT01800877|Phenylephrine|phenylephrine|mesh-list
111403690|NCT01800877|Dopamine|dopamine|mesh-list
111403691|NCT01800877|Vasopressins|vasopressins|mesh-list
111403692|NCT01800877|Epinephrine|epinephrine|mesh-list
111403693|NCT01800877|Norepinephrine|norepinephrine|mesh-list
111403694|NCT01800877|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
111403695|NCT01800877|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111403696|NCT01800877|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111403697|NCT01800877|Adrenergic Agents|adrenergic agents|mesh-ancestor
111403698|NCT01800877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111403699|NCT01800877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111403700|NCT01800877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111403701|NCT01800877|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111403702|NCT01800877|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111403703|NCT01800877|Autonomic Agents|autonomic agents|mesh-ancestor
111403704|NCT01800877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111403705|NCT01800877|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111403706|NCT01800877|Respiratory System Agents|respiratory system agents|mesh-ancestor
111403707|NCT01800877|Mydriatics|mydriatics|mesh-ancestor
111403708|NCT01800877|Sympathomimetics|sympathomimetics|mesh-ancestor
111403709|NCT01800877|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111403710|NCT01800877|Nasal Decongestants|nasal decongestants|mesh-ancestor
111403711|NCT01800877|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111403712|NCT01800877|Protective Agents|protective agents|mesh-ancestor
111403713|NCT01800877|Hemostatics|hemostatics|mesh-ancestor
111403714|NCT01800877|Coagulants|coagulants|mesh-ancestor
111403715|NCT01800877|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
111403716|NCT01800877|Natriuretic Agents|natriuretic agents|mesh-ancestor
111403717|NCT01800877|Dopamine Agents|dopamine agents|mesh-ancestor
111403718|NCT02471651|Dexamethasone|dexamethasone|mesh-list
111403719|NCT02471651|Ranibizumab|ranibizumab|mesh-list
111403720|NCT02471651|Aflibercept|aflibercept|mesh-list
111403721|NCT02471651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111403722|NCT02471651|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111403723|NCT02471651|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111403724|NCT02471651|Growth Substances|growth substances|mesh-ancestor
111403725|NCT02471651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111403726|NCT02471651|Growth Inhibitors|growth inhibitors|mesh-ancestor
111403727|NCT02471651|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111403728|NCT02471651|Antiemetics|antiemetics|mesh-ancestor
111403729|NCT02471651|Autonomic Agents|autonomic agents|mesh-ancestor
111403730|NCT02471651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111403731|NCT02471651|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111403732|NCT02471651|Glucocorticoids|glucocorticoids|mesh-ancestor
111403733|NCT02471651|Hormones|hormones|mesh-ancestor
111403734|NCT02471651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111403735|NCT02471651|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111403736|NCT02477423|Gentamicins|gentamicins|mesh-list
111403737|NCT02477423|Ampicillin|ampicillin|mesh-list
111403738|NCT02477423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111403739|NCT02477423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111403740|NCT02477423|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111403741|NCT02477423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111403742|NCT02477423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111403743|NCT00363701|Esomeprazole|esomeprazole|mesh-list
111403744|NCT00363701|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111403745|NCT00363701|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111403746|NCT00363701|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111403747|NCT00363701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111403748|NCT00363701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111403749|NCT04744571|Aspirin|aspirin|mesh-list
111403750|NCT04744571|Metoprolol|metoprolol|mesh-list
111403751|NCT04744571|Clopidogrel|clopidogrel|mesh-list
111403752|NCT04744571|Ticagrelor|ticagrelor|mesh-list
111403753|NCT04744571|Atorvastatin|atorvastatin|mesh-list
111403754|NCT04744571|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111403755|NCT04744571|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111403756|NCT04744571|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111403757|NCT04744571|Analgesics|analgesics|mesh-ancestor
111403758|NCT04744571|Sensory System Agents|sensory system agents|mesh-ancestor
111403759|NCT04744571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111403760|NCT04744571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111403761|NCT04744571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111403762|NCT04744571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111403763|NCT04744571|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111403764|NCT04744571|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111403765|NCT04744571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110880933|NCT04689347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111403766|NCT04744571|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111403767|NCT04744571|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111403768|NCT04744571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111403769|NCT04744571|Antipyretics|antipyretics|mesh-ancestor
111403770|NCT04744571|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111403771|NCT04744571|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111403772|NCT04744571|Antimetabolites|antimetabolites|mesh-ancestor
111403773|NCT04744571|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111403774|NCT04744571|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111403775|NCT04744571|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111403776|NCT04744571|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111403777|NCT04744571|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111403778|NCT04744571|Purinergic Agents|purinergic agents|mesh-ancestor
111403779|NCT04744571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111403780|NCT04744571|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111403781|NCT04744571|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111403782|NCT04744571|Sympatholytics|sympatholytics|mesh-ancestor
111403783|NCT04744571|Autonomic Agents|autonomic agents|mesh-ancestor
111403784|NCT04744571|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
111403785|NCT04744571|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111403786|NCT04744571|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111403787|NCT04744571|Adrenergic Agents|adrenergic agents|mesh-ancestor
111403788|NCT00363155|KRN 7000|krn 7000|mesh-list
111403789|NCT00363155|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111403790|NCT00363155|Immunologic Factors|immunologic factors|mesh-ancestor
111403791|NCT00363155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111403792|NCT00363155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111403793|NCT02519387|Buprenorphine|buprenorphine|mesh-list
111403794|NCT02519387|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111403795|NCT02519387|Narcotics|narcotics|mesh-ancestor
111403796|NCT02519387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111403797|NCT02519387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111403798|NCT02519387|Analgesics|analgesics|mesh-ancestor
111403799|NCT02519387|Sensory System Agents|sensory system agents|mesh-ancestor
111403800|NCT02519387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111403801|NCT02519387|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111403802|NCT02257957|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111403803|NCT02257957|Hyaluronic Acid|hyaluronic acid|mesh-list
111403804|NCT02257957|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111403805|NCT02257957|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111403806|NCT02257957|Immunologic Factors|immunologic factors|mesh-ancestor
111403807|NCT02257957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111403808|NCT02257957|Viscosupplements|viscosupplements|mesh-ancestor
111403809|NCT02257957|Protective Agents|protective agents|mesh-ancestor
111403810|NCT02524769|Estrogens|estrogens|mesh-list
111403811|NCT02524769|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
111403812|NCT02524769|Hormones|hormones|mesh-ancestor
111403813|NCT02524769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111403814|NCT02524769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111403815|NCT02525549|Adapalene|adapalene|mesh-list
111403816|NCT02525549|Benzoyl Peroxide|benzoyl peroxide|mesh-list
111403817|NCT02525549|Dermatologic Agents|dermatologic agents|mesh-ancestor
111403818|NCT02525549|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111403819|NCT02525549|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111403820|NCT02525549|Analgesics|analgesics|mesh-ancestor
111403821|NCT02525549|Sensory System Agents|sensory system agents|mesh-ancestor
111403822|NCT02525549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111403823|NCT02525549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111403824|NCT02525549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111403825|NCT02525549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111403826|NCT01878799|Sofosbuvir|sofosbuvir|mesh-list
111403827|NCT01878799|Ledipasvir|ledipasvir|mesh-list
111403828|NCT01878799|Antiviral Agents|antiviral agents|mesh-ancestor
111403829|NCT01878799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111403830|NCT02527265|Insulin|insulin|mesh-list
111403831|NCT02527265|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111403832|NCT02527265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111403833|NCT01879345|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
111403834|NCT01879345|Anticonvulsants|anticonvulsants|mesh-ancestor
111403835|NCT01879345|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111403836|NCT01879345|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111403837|NCT01879345|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111403838|NCT01879345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111403839|NCT01804075|Morphine|morphine|mesh-list
111403840|NCT01804075|Methadone|methadone|mesh-list
111403841|NCT01804075|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111403842|NCT01804075|Narcotics|narcotics|mesh-ancestor
111403843|NCT01804075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111403844|NCT01804075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111403845|NCT01804075|Analgesics|analgesics|mesh-ancestor
111403846|NCT01804075|Sensory System Agents|sensory system agents|mesh-ancestor
111403847|NCT01804075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111403848|NCT01804075|Antitussive Agents|antitussive agents|mesh-ancestor
111403849|NCT01804075|Respiratory System Agents|respiratory system agents|mesh-ancestor
111403850|NCT02416193|Vitamin D|vitamin d|mesh-list
111403851|NCT02416193|Ergocalciferols|ergocalciferols|mesh-list
111403852|NCT02416193|Cholecalciferol|cholecalciferol|mesh-list
111403853|NCT02416193|Vitamins|vitamins|mesh-list
111403854|NCT02416193|Micronutrients|micronutrients|mesh-ancestor
111403855|NCT02416193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111403856|NCT02416193|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111403857|NCT02416193|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111403858|NCT02530151|Clonidine|clonidine|mesh-list
111403859|NCT02530151|Morphine|morphine|mesh-list
111403860|NCT02530151|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111403861|NCT02530151|Narcotics|narcotics|mesh-ancestor
111403862|NCT02530151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111403863|NCT02530151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111403864|NCT02530151|Analgesics|analgesics|mesh-ancestor
111403865|NCT02530151|Sensory System Agents|sensory system agents|mesh-ancestor
111403866|NCT02530151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111403867|NCT02530151|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111403868|NCT02530151|Sympatholytics|sympatholytics|mesh-ancestor
111403869|NCT02530151|Autonomic Agents|autonomic agents|mesh-ancestor
111403870|NCT02530151|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111403871|NCT02530151|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111403872|NCT02530151|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111403873|NCT02530151|Adrenergic Agents|adrenergic agents|mesh-ancestor
111403874|NCT02530151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111403875|NCT02530151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111403876|NCT02530541|Chlorhexidine|chlorhexidine|mesh-list
111403877|NCT02530541|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
111403878|NCT02530541|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111403879|NCT02530541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111403880|NCT02530541|Disinfectants|disinfectants|mesh-ancestor
111403881|NCT02530541|Dermatologic Agents|dermatologic agents|mesh-ancestor
111403882|NCT01804465|Ipilimumab|ipilimumab|mesh-list
111403883|NCT01804465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111403884|NCT01804465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111403885|NCT01804465|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111403886|NCT01804465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111403887|NCT02531321|Levonorgestrel|levonorgestrel|mesh-list
111403888|NCT02531321|Ethinyl Estradiol|ethinyl estradiol|mesh-list
111403889|NCT02531321|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
111403890|NCT02531321|Estradiol|estradiol|mesh-list
111403891|NCT02531321|Estrogens|estrogens|mesh-ancestor
111403892|NCT02531321|Hormones|hormones|mesh-ancestor
111403893|NCT02531321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111403894|NCT02531321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111403895|NCT02531321|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111403896|NCT02531321|Contraceptive Agents|contraceptive agents|mesh-ancestor
111403897|NCT02531321|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111403898|NCT02531321|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111403899|NCT02531321|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111403900|NCT02531321|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111403901|NCT02531321|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111403902|NCT02531321|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
111403903|NCT01805089|Melatonin|melatonin|mesh-list
111128255|NCT04636333|Vaccines|vaccines|mesh-list
111403904|NCT01805089|Antioxidants|antioxidants|mesh-ancestor
111403905|NCT01805089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111403906|NCT01805089|Protective Agents|protective agents|mesh-ancestor
111403907|NCT01805089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111403908|NCT01805089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111403909|NCT02417129|Rituximab|rituximab|mesh-list
111403910|NCT02417129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111403911|NCT02417129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111403912|NCT02417129|Immunologic Factors|immunologic factors|mesh-ancestor
111403913|NCT02417129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111403914|NCT02417129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111403915|NCT01879735|Cholylsarcosine|cholylsarcosine|mesh-list
111403916|NCT01879735|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111403917|NCT02417831|Tamsulosin|tamsulosin|mesh-list
111403918|NCT02417831|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111403919|NCT02417831|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111403920|NCT02417831|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111403921|NCT02417831|Adrenergic Agents|adrenergic agents|mesh-ancestor
111403922|NCT02417831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111403923|NCT02417831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111403924|NCT02417831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111403925|NCT02417831|Urological Agents|urological agents|mesh-ancestor
111403926|NCT02419547|Fentanyl|fentanyl|mesh-list
111403927|NCT02419547|Midazolam|midazolam|mesh-list
111403928|NCT02419547|Propofol|propofol|mesh-list
111403929|NCT02419547|Sevoflurane|sevoflurane|mesh-list
111403930|NCT02419547|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111403931|NCT02419547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111403932|NCT02419547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111403933|NCT02419547|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111403934|NCT02419547|Anesthetics, General|anesthetics, general|mesh-ancestor
111403935|NCT02419547|Anesthetics|anesthetics|mesh-ancestor
111403936|NCT02419547|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111403937|NCT02419547|Narcotics|narcotics|mesh-ancestor
111403938|NCT02419547|Analgesics|analgesics|mesh-ancestor
111403939|NCT02419547|Sensory System Agents|sensory system agents|mesh-ancestor
111403940|NCT02419547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111403941|NCT02419547|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111403942|NCT02419547|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111403943|NCT02419547|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111403944|NCT02419547|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111403945|NCT02419547|GABA Modulators|gaba modulators|mesh-ancestor
111403946|NCT02419547|GABA Agents|gaba agents|mesh-ancestor
111403947|NCT02419547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111403948|NCT02419547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111403949|NCT02419547|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111403950|NCT02419547|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111403951|NCT02533427|Ethinyl Estradiol|ethinyl estradiol|mesh-list
111403952|NCT02533427|Norgestimate|norgestimate|mesh-list
111403953|NCT02533427|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
111403954|NCT02533427|Estradiol|estradiol|mesh-list
111403955|NCT02533427|Estrogens|estrogens|mesh-ancestor
111403956|NCT02533427|Hormones|hormones|mesh-ancestor
111403957|NCT02533427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111403958|NCT02533427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111403959|NCT02533427|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111403960|NCT02533427|Contraceptive Agents|contraceptive agents|mesh-ancestor
111403961|NCT02533427|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111403962|NCT02533427|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111403963|NCT02533427|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111403964|NCT02533427|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111403965|NCT02533427|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111403966|NCT02533427|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
111403967|NCT05328817|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111403968|NCT05328817|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
111403969|NCT05328817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111403970|NCT05328817|Antitubercular Agents|antitubercular agents|mesh-ancestor
111403971|NCT05328427|Tin Fluorides|tin fluorides|mesh-list
111403972|NCT05328427|Cariostatic Agents|cariostatic agents|mesh-ancestor
111403973|NCT05328427|Protective Agents|protective agents|mesh-ancestor
111403974|NCT05328427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111403975|NCT02533505|Budesonide|budesonide|mesh-list
111403976|NCT02533505|Formoterol Fumarate|formoterol fumarate|mesh-list
111403977|NCT02533505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111403978|NCT02533505|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111403979|NCT02533505|Autonomic Agents|autonomic agents|mesh-ancestor
111403980|NCT02533505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111403981|NCT02533505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111403982|NCT02533505|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111403983|NCT02533505|Respiratory System Agents|respiratory system agents|mesh-ancestor
111403984|NCT02533505|Glucocorticoids|glucocorticoids|mesh-ancestor
111403985|NCT02533505|Hormones|hormones|mesh-ancestor
111403986|NCT02533505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111403987|NCT02533505|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111403988|NCT02533505|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111403989|NCT02533505|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111403990|NCT02533505|Adrenergic Agents|adrenergic agents|mesh-ancestor
111403991|NCT02533505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111403992|NCT02533505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111403993|NCT02420015|Bupropion|bupropion|mesh-list
111403994|NCT02420015|Nicotine|nicotine|mesh-list
111403995|NCT02420015|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111403996|NCT02420015|Autonomic Agents|autonomic agents|mesh-ancestor
111403997|NCT02420015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111403998|NCT02420015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111403999|NCT02420015|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111404000|NCT02420015|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111404001|NCT02420015|Cholinergic Agents|cholinergic agents|mesh-ancestor
111404002|NCT02420015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111404003|NCT02420015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111404004|NCT02420015|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111404005|NCT02420015|Antidepressive Agents|antidepressive agents|mesh-ancestor
111404006|NCT02420015|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111404007|NCT02420015|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111404008|NCT02420015|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111404009|NCT02420015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111404010|NCT02420015|Dopamine Agents|dopamine agents|mesh-ancestor
111404011|NCT02420015|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111404012|NCT02420015|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111404013|NCT02420015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111404014|NCT05326867|Lidocaine|lidocaine|mesh-list
111404015|NCT05326867|Anesthetics, Local|anesthetics, local|mesh-ancestor
111404016|NCT05326867|Anesthetics|anesthetics|mesh-ancestor
111404017|NCT05326867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111404018|NCT05326867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111404019|NCT05326867|Sensory System Agents|sensory system agents|mesh-ancestor
111404020|NCT05326867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111404021|NCT05326867|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111404022|NCT05326867|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111404023|NCT05326867|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111404024|NCT05326867|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111404025|NCT05326867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111404026|NCT05324995|Celecoxib|celecoxib|mesh-list
111404027|NCT05324995|Epinephrine|epinephrine|mesh-list
111404028|NCT05324995|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111404029|NCT05324995|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111404030|NCT05324995|Adrenergic Agents|adrenergic agents|mesh-ancestor
111404031|NCT05324995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111404032|NCT05324995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111404033|NCT05324995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111404034|NCT05324995|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111404035|NCT05324995|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111404036|NCT05324995|Autonomic Agents|autonomic agents|mesh-ancestor
111404037|NCT05324995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111404038|NCT05324995|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111404039|NCT05324995|Respiratory System Agents|respiratory system agents|mesh-ancestor
111404040|NCT05324995|Mydriatics|mydriatics|mesh-ancestor
111404041|NCT05324995|Sympathomimetics|sympathomimetics|mesh-ancestor
111404042|NCT05324995|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111404043|NCT05324995|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111404044|NCT05324995|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111404045|NCT05324995|Analgesics|analgesics|mesh-ancestor
111404046|NCT05324995|Sensory System Agents|sensory system agents|mesh-ancestor
111404047|NCT05324995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111404048|NCT05324995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111404049|NCT05324995|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111404050|NCT05324995|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111404051|NCT05324995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111404052|NCT05318521|Ibuprofen|ibuprofen|mesh-list
111404053|NCT05318521|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111404054|NCT05318521|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111404055|NCT05318521|Analgesics|analgesics|mesh-ancestor
111404056|NCT05318521|Sensory System Agents|sensory system agents|mesh-ancestor
111404057|NCT05318521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111404058|NCT05318521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111404059|NCT05318521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111404060|NCT05318521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111404061|NCT05318521|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111404062|NCT05318521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111404063|NCT05318521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111404064|NCT02420873|Maytansine|maytansine|mesh-list
111404065|NCT02420873|Lorvotuzumab mertansine|lorvotuzumab mertansine|mesh-list
111404066|NCT02420873|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111404067|NCT02420873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111404068|NCT02420873|Tubulin Modulators|tubulin modulators|mesh-ancestor
111404069|NCT02420873|Antimitotic Agents|antimitotic agents|mesh-ancestor
111404070|NCT02420873|Mitosis Modulators|mitosis modulators|mesh-ancestor
111404071|NCT02420873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111404072|NCT02420873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111404073|NCT02420873|Immunotoxins|immunotoxins|mesh-ancestor
111404074|NCT02420873|Immunoconjugates|immunoconjugates|mesh-ancestor
111404075|NCT02420873|Immunologic Factors|immunologic factors|mesh-ancestor
111404076|NCT02420873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111404077|NCT02534129|Petrolatum|petrolatum|mesh-list
111404078|NCT02534129|Emollients|emollients|mesh-ancestor
111404079|NCT02534129|Dermatologic Agents|dermatologic agents|mesh-ancestor
111404080|NCT02420951|Bupivacaine|bupivacaine|mesh-list
111404081|NCT02420951|Anesthetics, Local|anesthetics, local|mesh-ancestor
111404082|NCT02420951|Anesthetics|anesthetics|mesh-ancestor
111404083|NCT02420951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110881225|NCT03665545|Poly I-C|poly i-c|mesh-list
111404084|NCT02420951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111404085|NCT02420951|Sensory System Agents|sensory system agents|mesh-ancestor
111404086|NCT02420951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111404087|NCT02267083|Doxorubicin|doxorubicin|mesh-list
111404088|NCT02267083|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111404089|NCT02267083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111404090|NCT02267083|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111404091|NCT02267083|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111404092|NCT02267083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111404093|NCT02267083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111404094|NCT05748145|Metronidazole|metronidazole|mesh-list
111404095|NCT05748145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111404096|NCT05748145|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111404097|NCT05748145|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111404098|NCT05748145|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111404099|NCT02535611|Memantine|memantine|mesh-list
111404100|NCT02535611|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111404101|NCT02535611|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111404102|NCT02535611|Dopamine Agents|dopamine agents|mesh-ancestor
111404103|NCT02535611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111404104|NCT02535611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111404105|NCT02535611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111404106|NCT02535611|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111404107|NCT02535611|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111404108|NCT01823497|Morphine|morphine|mesh-list
111404109|NCT01823497|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111404110|NCT01823497|Narcotics|narcotics|mesh-ancestor
111404111|NCT01823497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111404112|NCT01823497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111404113|NCT01823497|Analgesics|analgesics|mesh-ancestor
111404114|NCT01823497|Sensory System Agents|sensory system agents|mesh-ancestor
111404115|NCT01823497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111404116|NCT00363935|Dexmedetomidine|dexmedetomidine|mesh-list
111404117|NCT00363935|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111404118|NCT00363935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111404119|NCT00363935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111404120|NCT00363935|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111404121|NCT00363935|Analgesics|analgesics|mesh-ancestor
111404122|NCT00363935|Sensory System Agents|sensory system agents|mesh-ancestor
111404123|NCT00363935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111404124|NCT00363935|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111404125|NCT00363935|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111404126|NCT00363935|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111404127|NCT00363935|Adrenergic Agents|adrenergic agents|mesh-ancestor
111404128|NCT00363935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111404129|NCT00363935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111404130|NCT05747521|Doxorubicin|doxorubicin|mesh-list
111404131|NCT05747521|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111404132|NCT05747521|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111404133|NCT05747521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111404134|NCT05747521|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111404135|NCT05747521|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111404136|NCT05747521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111404137|NCT05747521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111404138|NCT02537873|Cocaine|cocaine|mesh-list
111404139|NCT02537873|Anesthetics, Local|anesthetics, local|mesh-ancestor
111404140|NCT02537873|Anesthetics|anesthetics|mesh-ancestor
111404141|NCT02537873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111404142|NCT02537873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111404143|NCT02537873|Sensory System Agents|sensory system agents|mesh-ancestor
111404144|NCT02537873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111404145|NCT02537873|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111404146|NCT02537873|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111404147|NCT02537873|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111404148|NCT02537873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111404149|NCT02537873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111404150|NCT02537873|Dopamine Agents|dopamine agents|mesh-ancestor
111404151|NCT02537873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111404152|NCT02537951|Lidocaine|lidocaine|mesh-list
111404153|NCT02537951|Prilocaine|prilocaine|mesh-list
110881297|NCT02553473|Doxycycline|doxycycline|mesh-list
111404154|NCT02537951|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
111404155|NCT02537951|Capsaicin|capsaicin|mesh-list
111404156|NCT02537951|Anesthetics, Local|anesthetics, local|mesh-ancestor
111404157|NCT02537951|Anesthetics|anesthetics|mesh-ancestor
111404158|NCT02537951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111404159|NCT02537951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111404160|NCT02537951|Sensory System Agents|sensory system agents|mesh-ancestor
111404161|NCT02537951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111404162|NCT02537951|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111404163|NCT02537951|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111404164|NCT02537951|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111404165|NCT02537951|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111404166|NCT02537951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111404167|NCT02537951|Antipruritics|antipruritics|mesh-ancestor
111404168|NCT02537951|Dermatologic Agents|dermatologic agents|mesh-ancestor
111404169|NCT02537951|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
111404170|NCT02487485|Sirolimus|sirolimus|mesh-list
111404171|NCT02487485|Ketamine|ketamine|mesh-list
111404172|NCT02487485|Analgesics|analgesics|mesh-ancestor
111404173|NCT02487485|Sensory System Agents|sensory system agents|mesh-ancestor
111404174|NCT02487485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111404175|NCT02487485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111404176|NCT02487485|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111404177|NCT02487485|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111404178|NCT02487485|Anesthetics, General|anesthetics, general|mesh-ancestor
111404179|NCT02487485|Anesthetics|anesthetics|mesh-ancestor
111404180|NCT02487485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111404181|NCT02487485|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111404182|NCT02487485|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111404183|NCT02487485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111404184|NCT02487485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111404185|NCT02487485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111404186|NCT02487485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111404187|NCT02487485|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111404188|NCT02487485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111404189|NCT02487485|Antifungal Agents|antifungal agents|mesh-ancestor
111404190|NCT02487485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111404191|NCT02487485|Immunologic Factors|immunologic factors|mesh-ancestor
111404192|NCT02487563|Decitabine|decitabine|mesh-list
111404193|NCT02487563|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111404194|NCT02487563|Antimetabolites|antimetabolites|mesh-ancestor
111404195|NCT02487563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111404196|NCT02487563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111404197|NCT02487563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111404198|NCT02427737|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
111404199|NCT02427737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111404200|NCT02427737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111404201|NCT02489357|Pembrolizumab|pembrolizumab|mesh-list
111404202|NCT02489357|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111404203|NCT02489357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111404204|NCT02489357|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111404205|NCT02489357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111404206|NCT02490293|Cephalosporins|cephalosporins|mesh-list
111404207|NCT02490293|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111404208|NCT02490293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111404209|NCT02539511|Ketamine|ketamine|mesh-list
111404210|NCT02539511|Analgesics|analgesics|mesh-ancestor
111404211|NCT02539511|Sensory System Agents|sensory system agents|mesh-ancestor
111404212|NCT02539511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111404213|NCT02539511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111404214|NCT02539511|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111404215|NCT02539511|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111404216|NCT02539511|Anesthetics, General|anesthetics, general|mesh-ancestor
111404217|NCT02539511|Anesthetics|anesthetics|mesh-ancestor
110881368|NCT00972738|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111404218|NCT02539511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111404219|NCT02539511|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111404220|NCT02539511|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111404221|NCT02539511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111404222|NCT02539511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111404223|NCT02493257|Ethanol|ethanol|mesh-list
111404224|NCT02493257|Capsaicin|capsaicin|mesh-list
111404225|NCT02493257|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111404226|NCT02493257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111404227|NCT02493257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111404228|NCT02493257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111404229|NCT02493257|Antipruritics|antipruritics|mesh-ancestor
111404230|NCT02493257|Dermatologic Agents|dermatologic agents|mesh-ancestor
111404231|NCT02493257|Sensory System Agents|sensory system agents|mesh-ancestor
111404232|NCT02493257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111404233|NCT02430389|Remifentanil|remifentanil|mesh-list
111404234|NCT02430389|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111404235|NCT02430389|Narcotics|narcotics|mesh-ancestor
111404236|NCT02430389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111404237|NCT02430389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111404238|NCT02430389|Analgesics|analgesics|mesh-ancestor
111404239|NCT02430389|Sensory System Agents|sensory system agents|mesh-ancestor
111404240|NCT02430389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111404241|NCT02431637|Piperaquine|piperaquine|mesh-list
111404242|NCT02431637|Antimalarials|antimalarials|mesh-ancestor
111404243|NCT02431637|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111404244|NCT02431637|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111404245|NCT02431637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111404246|NCT02545907|Thalidomide|thalidomide|mesh-list
111404247|NCT02545907|Dexamethasone|dexamethasone|mesh-list
111404248|NCT02545907|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111404249|NCT02545907|Antiemetics|antiemetics|mesh-ancestor
111404250|NCT02545907|Autonomic Agents|autonomic agents|mesh-ancestor
111404251|NCT02545907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111404252|NCT02545907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111404253|NCT02545907|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111404254|NCT02545907|Glucocorticoids|glucocorticoids|mesh-ancestor
111404255|NCT02545907|Hormones|hormones|mesh-ancestor
110881434|NCT00442338|Aminophylline|aminophylline|mesh-list
111404256|NCT02545907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111404257|NCT02545907|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111404258|NCT02545907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111404259|NCT02545907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111404260|NCT02545907|Immunologic Factors|immunologic factors|mesh-ancestor
111404261|NCT02545907|Leprostatic Agents|leprostatic agents|mesh-ancestor
111404262|NCT02545907|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111404263|NCT02545907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111404264|NCT02545907|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111404265|NCT02545907|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111404266|NCT02545907|Growth Substances|growth substances|mesh-ancestor
111404267|NCT02545907|Growth Inhibitors|growth inhibitors|mesh-ancestor
111404268|NCT02495831|Diclofenac|diclofenac|mesh-list
111404269|NCT02495831|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111404270|NCT02495831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111404271|NCT02495831|Analgesics|analgesics|mesh-ancestor
111404272|NCT02495831|Sensory System Agents|sensory system agents|mesh-ancestor
111404273|NCT02495831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111404274|NCT02495831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111404275|NCT02495831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111404276|NCT02495831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111404277|NCT02495831|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111404278|NCT02495831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111404279|NCT02495831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111404280|NCT02498483|Acetaminophen|acetaminophen|mesh-list
111404281|NCT02498483|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111404282|NCT02498483|Analgesics|analgesics|mesh-ancestor
111404283|NCT02498483|Sensory System Agents|sensory system agents|mesh-ancestor
111404284|NCT02498483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111404285|NCT02498483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111404286|NCT02498483|Antipyretics|antipyretics|mesh-ancestor
111404287|NCT02547623|Dexamethasone|dexamethasone|mesh-list
111404288|NCT02547623|Prednisolone|prednisolone|mesh-list
111404289|NCT02547623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111404290|NCT02547623|Antiemetics|antiemetics|mesh-ancestor
111404291|NCT02547623|Autonomic Agents|autonomic agents|mesh-ancestor
111404292|NCT02547623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111404293|NCT02547623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111404294|NCT02547623|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111404295|NCT02547623|Glucocorticoids|glucocorticoids|mesh-ancestor
111404296|NCT02547623|Hormones|hormones|mesh-ancestor
111404297|NCT02547623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111404298|NCT02547623|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111404299|NCT02547623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111404300|NCT02547779|Plasma-lyte 148|plasma-lyte 148|mesh-list
111404301|NCT02547779|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
111404302|NCT02547779|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111404303|NCT00559585|Abatacept|abatacept|mesh-list
111404304|NCT00559585|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111404305|NCT00559585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111404306|NCT00559585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111404307|NCT00559585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111404308|NCT00559585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111404309|NCT00559585|Immunologic Factors|immunologic factors|mesh-ancestor
111404310|NCT00559585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111404311|NCT00559585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111404312|NCT01824901|Docetaxel|docetaxel|mesh-list
111404313|NCT01824901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111404314|NCT01824901|Tubulin Modulators|tubulin modulators|mesh-ancestor
111404315|NCT01824901|Antimitotic Agents|antimitotic agents|mesh-ancestor
111404316|NCT01824901|Mitosis Modulators|mitosis modulators|mesh-ancestor
111404317|NCT01824901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111404318|NCT00559507|Saracatinib|saracatinib|mesh-list
111404319|NCT00559507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111404320|NCT00559507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111404321|NCT00559507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111404322|NCT04969627|Metformin|metformin|mesh-list
111404323|NCT04969627|Exenatide|exenatide|mesh-list
111404324|NCT04969627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111404325|NCT04969627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111404326|NCT04969627|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111404327|NCT04969627|Incretins|incretins|mesh-ancestor
111404328|NCT04969627|Hormones|hormones|mesh-ancestor
111404329|NCT04969627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111404330|NCT04953325|Vaccines|vaccines|mesh-list
111404331|NCT04953325|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
111404332|NCT04953325|Immunologic Factors|immunologic factors|mesh-ancestor
111404333|NCT04953325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111404334|NCT01826851|Bupivacaine|bupivacaine|mesh-list
111404335|NCT01826851|Anesthetics, Local|anesthetics, local|mesh-ancestor
111404336|NCT01826851|Anesthetics|anesthetics|mesh-ancestor
111404337|NCT01826851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111404338|NCT01826851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111404339|NCT01826851|Sensory System Agents|sensory system agents|mesh-ancestor
111404340|NCT01826851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111404341|NCT02499497|Androgens|androgens|mesh-list
111404342|NCT02499497|Hormones|hormones|mesh-ancestor
111404343|NCT02499497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111404344|NCT02499497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111404345|NCT01827475|Acetaminophen|acetaminophen|mesh-list
111404346|NCT01827475|Ibuprofen|ibuprofen|mesh-list
111404347|NCT01827475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111404348|NCT01827475|Analgesics|analgesics|mesh-ancestor
111404349|NCT01827475|Sensory System Agents|sensory system agents|mesh-ancestor
111404350|NCT01827475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111404351|NCT01827475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111404352|NCT01827475|Antipyretics|antipyretics|mesh-ancestor
111404353|NCT01827475|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111404354|NCT01827475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111404355|NCT01827475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111404356|NCT01827475|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111404357|NCT01827475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111404358|NCT01827475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111404359|NCT02434523|Amitriptyline|amitriptyline|mesh-list
111404360|NCT02434523|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
111404361|NCT02434523|Antidepressive Agents|antidepressive agents|mesh-ancestor
111404362|NCT02434523|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111404363|NCT02434523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111404364|NCT02434523|Analgesics|analgesics|mesh-ancestor
111404365|NCT02434523|Sensory System Agents|sensory system agents|mesh-ancestor
111404366|NCT02434523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111404367|NCT02434523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111404368|NCT02434523|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111404369|NCT02434523|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111404370|NCT02434523|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111404371|NCT02434523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111404372|NCT02434523|Adrenergic Agents|adrenergic agents|mesh-ancestor
111404373|NCT02434523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111404374|NCT02501135|Bupivacaine|bupivacaine|mesh-list
111404375|NCT02501135|Ropivacaine|ropivacaine|mesh-list
111404376|NCT02501135|Anesthetics, Local|anesthetics, local|mesh-ancestor
111404377|NCT02501135|Anesthetics|anesthetics|mesh-ancestor
111404378|NCT02501135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111404379|NCT02501135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111404380|NCT02501135|Sensory System Agents|sensory system agents|mesh-ancestor
111404381|NCT02501135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111404382|NCT02550743|Capecitabine|capecitabine|mesh-list
111404383|NCT02550743|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111404384|NCT02550743|Antimetabolites|antimetabolites|mesh-ancestor
111404385|NCT02550743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111404386|NCT02550743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111404388|NCT02437253|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111404389|NCT02437253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111404390|NCT02437253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111404391|NCT01829503|Cytarabine|cytarabine|mesh-list
111404392|NCT01829503|Decitabine|decitabine|mesh-list
111404393|NCT01829503|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111404394|NCT01829503|Antimetabolites|antimetabolites|mesh-ancestor
111404395|NCT01829503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111404396|NCT01829503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111404397|NCT01829503|Antiviral Agents|antiviral agents|mesh-ancestor
111404398|NCT01829503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111404399|NCT01829503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111404400|NCT01829503|Immunologic Factors|immunologic factors|mesh-ancestor
111404401|NCT01829503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111404402|NCT01829503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111404403|NCT05742763|Acetaminophen|acetaminophen|mesh-list
111404404|NCT05742763|Ibuprofen|ibuprofen|mesh-list
111404405|NCT05742763|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111404406|NCT05742763|Analgesics|analgesics|mesh-ancestor
111404407|NCT05742763|Sensory System Agents|sensory system agents|mesh-ancestor
111404408|NCT05742763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111404409|NCT05742763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111404410|NCT05742763|Antipyretics|antipyretics|mesh-ancestor
111404411|NCT05742763|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111404412|NCT05742763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111404413|NCT05742763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111404414|NCT05742763|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111404415|NCT05742763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111404416|NCT05742763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111404417|NCT02504723|Carvedilol|carvedilol|mesh-list
111404418|NCT02504723|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111404419|NCT02504723|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111404420|NCT02504723|Adrenergic Agents|adrenergic agents|mesh-ancestor
111404421|NCT02504723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111404422|NCT02504723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111404423|NCT02504723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111404424|NCT02504723|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111404425|NCT02504723|Antioxidants|antioxidants|mesh-ancestor
111404426|NCT02504723|Protective Agents|protective agents|mesh-ancestor
111404427|NCT02504723|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111404428|NCT02504723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111404429|NCT02504723|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111404430|NCT02504723|Vasodilator Agents|vasodilator agents|mesh-ancestor
111404431|NCT02504723|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111404432|NCT02504723|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111404434|NCT02439281|Ropivacaine|ropivacaine|mesh-list
111404435|NCT02439281|Anesthetics, Local|anesthetics, local|mesh-ancestor
111404436|NCT02439281|Anesthetics|anesthetics|mesh-ancestor
111404437|NCT02439281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111404438|NCT02439281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111404439|NCT02439281|Sensory System Agents|sensory system agents|mesh-ancestor
111404440|NCT02439281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111404441|NCT02439281|Analgesics|analgesics|mesh-ancestor
111404442|NCT02439281|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111404443|NCT02439281|Sympatholytics|sympatholytics|mesh-ancestor
111404444|NCT02439281|Autonomic Agents|autonomic agents|mesh-ancestor
111404445|NCT02439281|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111404446|NCT02439281|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111404447|NCT02439281|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111404448|NCT02439281|Adrenergic Agents|adrenergic agents|mesh-ancestor
111404449|NCT02439281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111404450|NCT02439281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111404451|NCT02505269|Doxorubicin|doxorubicin|mesh-list
111404452|NCT02505269|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111404453|NCT02505269|Dacarbazine|dacarbazine|mesh-list
111404454|NCT02505269|Brentuximab Vedotin|brentuximab vedotin|mesh-list
111404455|NCT02505269|Imidazole|imidazole|mesh-list
111404456|NCT02505269|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111404457|NCT02505269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111404458|NCT02505269|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111404459|NCT02505269|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111404460|NCT02505269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111404461|NCT02505269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111404462|NCT02505269|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111404463|NCT02505269|Alkylating Agents|alkylating agents|mesh-ancestor
111404464|NCT02505269|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111404465|NCT02505269|Immunotoxins|immunotoxins|mesh-ancestor
111404466|NCT02505269|Immunoconjugates|immunoconjugates|mesh-ancestor
111404467|NCT02505269|Immunologic Factors|immunologic factors|mesh-ancestor
111404468|NCT02505269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111404469|NCT00422123|Quetiapine Fumarate|quetiapine fumarate|mesh-list
111404470|NCT00422123|Antidepressive Agents|antidepressive agents|mesh-ancestor
111404471|NCT00422123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111404472|NCT00422123|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111404473|NCT00422123|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111404474|NCT00422123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111404475|NCT00422123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111404476|NCT00559273|Darbepoetin alfa|darbepoetin alfa|mesh-list
111404477|NCT00559273|Hematinics|hematinics|mesh-ancestor
111404478|NCT02506673|Midazolam|midazolam|mesh-list
111404479|NCT02506673|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111404480|NCT02506673|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111404481|NCT02506673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111404482|NCT02506673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111404483|NCT02506673|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111404484|NCT02506673|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111404485|NCT02506673|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111404486|NCT02506673|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111404487|NCT02506673|Anesthetics, General|anesthetics, general|mesh-ancestor
111404488|NCT02506673|Anesthetics|anesthetics|mesh-ancestor
111404489|NCT02506673|GABA Modulators|gaba modulators|mesh-ancestor
111404490|NCT02506673|GABA Agents|gaba agents|mesh-ancestor
111404491|NCT02506673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111404492|NCT02506673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111404493|NCT02508077|Calcium, Dietary|calcium, dietary|mesh-list
111404494|NCT02508077|Leucovorin|leucovorin|mesh-list
111404495|NCT02508077|Folic Acid|folic acid|mesh-list
111404496|NCT02508077|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111404497|NCT02508077|Panitumumab|panitumumab|mesh-list
111404498|NCT02508077|Fluorouracil|fluorouracil|mesh-list
111128861|NCT04850417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111404499|NCT02508077|Irinotecan|irinotecan|mesh-list
111404500|NCT02508077|Camptothecin|camptothecin|mesh-list
111404501|NCT02508077|Antibodies|antibodies|mesh-list
111404502|NCT02508077|Immunoglobulins|immunoglobulins|mesh-list
111404504|NCT02508077|Calcium|calcium|mesh-list
111404505|NCT02508077|Levoleucovorin|levoleucovorin|mesh-list
111404506|NCT02508077|Immunologic Factors|immunologic factors|mesh-ancestor
111404507|NCT02508077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111404508|NCT02508077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111404509|NCT02508077|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111404510|NCT02508077|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111404511|NCT02508077|Antimetabolites|antimetabolites|mesh-ancestor
111404512|NCT02508077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111404513|NCT02508077|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111404514|NCT02508077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111404515|NCT02508077|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111404516|NCT02508077|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111404517|NCT02508077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111404518|NCT02508077|Antidotes|antidotes|mesh-ancestor
111404519|NCT02508077|Protective Agents|protective agents|mesh-ancestor
111404520|NCT02508077|Vitamin B Complex|vitamin b complex|mesh-ancestor
111404521|NCT02508077|Vitamins|vitamins|mesh-ancestor
111404522|NCT02508077|Micronutrients|micronutrients|mesh-ancestor
111404523|NCT02508077|Hematinics|hematinics|mesh-ancestor
111404524|NCT02508077|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111404525|NCT00558259|Dabigatran|dabigatran|mesh-list
111404526|NCT00558259|Antithrombins|antithrombins|mesh-ancestor
111404527|NCT00558259|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111404528|NCT00558259|Protease Inhibitors|protease inhibitors|mesh-ancestor
111404529|NCT00558259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111404530|NCT00558259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111404531|NCT00558259|Anticoagulants|anticoagulants|mesh-ancestor
111404532|NCT02508389|Avasopasem manganese|avasopasem manganese|mesh-list
111404533|NCT02508389|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111404534|NCT02508389|Antioxidants|antioxidants|mesh-ancestor
111404535|NCT02508389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111404536|NCT02508389|Protective Agents|protective agents|mesh-ancestor
111404537|NCT02508389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111404538|NCT02509481|Ivermectin|ivermectin|mesh-list
111404539|NCT02509481|Albendazole|albendazole|mesh-list
111404540|NCT02509481|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111404541|NCT02509481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111404542|NCT02509481|Anthelmintics|anthelmintics|mesh-ancestor
111404543|NCT02509481|Anticestodal Agents|anticestodal agents|mesh-ancestor
111404544|NCT02509481|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
111404545|NCT02509481|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111404546|NCT02509481|Tubulin Modulators|tubulin modulators|mesh-ancestor
111404547|NCT02509481|Antimitotic Agents|antimitotic agents|mesh-ancestor
111404548|NCT02509481|Mitosis Modulators|mitosis modulators|mesh-ancestor
111404549|NCT02509481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111404550|NCT02509481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111404551|NCT04341077|Fluzoparib|fluzoparib|mesh-list
111404552|NCT04341077|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111404553|NCT04341077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111404554|NCT04341077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111404555|NCT04341077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111404556|NCT02561897|Warfarin|warfarin|mesh-list
111404557|NCT02561897|Edoxaban|edoxaban|mesh-list
111404558|NCT02561897|Anticoagulants|anticoagulants|mesh-ancestor
111404559|NCT02561897|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111404560|NCT02561897|Antithrombins|antithrombins|mesh-ancestor
111404561|NCT02561897|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111404562|NCT02561897|Protease Inhibitors|protease inhibitors|mesh-ancestor
111404563|NCT02561897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111404564|NCT02561897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111404565|NCT02512679|Cyclophosphamide|cyclophosphamide|mesh-list
111404566|NCT02512679|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111404567|NCT02512679|Immunologic Factors|immunologic factors|mesh-ancestor
111404568|NCT02512679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111404569|NCT02512679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111404570|NCT02512679|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111404571|NCT02512679|Alkylating Agents|alkylating agents|mesh-ancestor
111404572|NCT02512679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111404573|NCT02512679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111404574|NCT02512679|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111404575|NCT02562521|Nicotine|nicotine|mesh-list
111404576|NCT02562521|Varenicline|varenicline|mesh-list
111404577|NCT02562521|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111404578|NCT02562521|Autonomic Agents|autonomic agents|mesh-ancestor
111404579|NCT02562521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111404580|NCT02562521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111404581|NCT02562521|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111404582|NCT02562521|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111404583|NCT02562521|Cholinergic Agents|cholinergic agents|mesh-ancestor
111404584|NCT02562521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111404585|NCT02562521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111404586|NCT02562755|Sorafenib|sorafenib|mesh-list
111404587|NCT02562755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111404588|NCT02562755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111404589|NCT02562755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111404590|NCT02562755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111404591|NCT05446883|Paclitaxel|paclitaxel|mesh-list
111404592|NCT05446883|Carboplatin|carboplatin|mesh-list
111404593|NCT05446883|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111404594|NCT05446883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111404595|NCT05446883|Tubulin Modulators|tubulin modulators|mesh-ancestor
111404596|NCT05446883|Antimitotic Agents|antimitotic agents|mesh-ancestor
111404597|NCT05446883|Mitosis Modulators|mitosis modulators|mesh-ancestor
111404598|NCT05446883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111404599|NCT00363857|Ropinirole|ropinirole|mesh-list
111404600|NCT00363857|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111404601|NCT00363857|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111404602|NCT00363857|Dopamine Agonists|dopamine agonists|mesh-ancestor
111404603|NCT00363857|Dopamine Agents|dopamine agents|mesh-ancestor
111404604|NCT00363857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111404605|NCT00363857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111404606|NCT00363857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111404607|NCT00558103|Lapatinib|lapatinib|mesh-list
111404608|NCT00558103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111404609|NCT00558103|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111404610|NCT00558103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111404611|NCT00558103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111404612|NCT02974361|Ibuprofen|ibuprofen|mesh-list
111404613|NCT02974361|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111404614|NCT02974361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111404615|NCT02974361|Analgesics|analgesics|mesh-ancestor
111404616|NCT02974361|Sensory System Agents|sensory system agents|mesh-ancestor
111404617|NCT02974361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111404618|NCT02974361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111404619|NCT02974361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111404620|NCT02974361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111404621|NCT02974361|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111404622|NCT02974361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111404623|NCT02974361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111404624|NCT05690815|Tenofovir|tenofovir|mesh-list
111404625|NCT05690815|Emtricitabine|emtricitabine|mesh-list
111404626|NCT05690815|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
111404627|NCT05690815|Antiviral Agents|antiviral agents|mesh-ancestor
111404628|NCT05690815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111404629|NCT05690815|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111404630|NCT05690815|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111404631|NCT05690815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111404632|NCT05690815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111404633|NCT05690815|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111404634|NCT05690815|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111404635|NCT02569541|Fusidic Acid|fusidic acid|mesh-list
111404636|NCT02569541|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111404637|NCT02569541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111404638|NCT02569541|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111404639|NCT02569541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111404640|NCT02569541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111404641|NCT04477733|Butorphanol|butorphanol|mesh-list
111404642|NCT04477733|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111404643|NCT04477733|Narcotics|narcotics|mesh-ancestor
111404644|NCT04477733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111404645|NCT04477733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111404646|NCT04477733|Analgesics|analgesics|mesh-ancestor
111404647|NCT04477733|Sensory System Agents|sensory system agents|mesh-ancestor
111404648|NCT04477733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111404649|NCT04477733|Antitussive Agents|antitussive agents|mesh-ancestor
111404650|NCT04477733|Respiratory System Agents|respiratory system agents|mesh-ancestor
111404651|NCT04477733|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111404652|NCT00558025|Pramipexole|pramipexole|mesh-list
111404653|NCT00558025|Antioxidants|antioxidants|mesh-ancestor
111404654|NCT00558025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111404655|NCT00558025|Protective Agents|protective agents|mesh-ancestor
111404656|NCT00558025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111404657|NCT00558025|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111404658|NCT00558025|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111404659|NCT00558025|Dopamine Agonists|dopamine agonists|mesh-ancestor
111404660|NCT00558025|Dopamine Agents|dopamine agents|mesh-ancestor
111404661|NCT00558025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111404662|NCT02576249|Methylprednisolone|methylprednisolone|mesh-list
111404663|NCT02576249|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111404664|NCT02576249|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111404665|NCT02576249|Prednisolone|prednisolone|mesh-list
111404666|NCT02576249|Prednisolone acetate|prednisolone acetate|mesh-list
111404667|NCT02576249|Ropivacaine|ropivacaine|mesh-list
111404668|NCT02576249|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111404669|NCT02576249|Prednisolone phosphate|prednisolone phosphate|mesh-list
111404670|NCT02576249|Anesthetics, Local|anesthetics, local|mesh-ancestor
111404671|NCT02576249|Anesthetics|anesthetics|mesh-ancestor
111404672|NCT02576249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111404673|NCT02576249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111404674|NCT02576249|Sensory System Agents|sensory system agents|mesh-ancestor
111404675|NCT02576249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111404676|NCT02576249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111404677|NCT02576249|Antiemetics|antiemetics|mesh-ancestor
111404678|NCT02576249|Autonomic Agents|autonomic agents|mesh-ancestor
111404679|NCT02576249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111404680|NCT02576249|Glucocorticoids|glucocorticoids|mesh-ancestor
111404682|NCT02576249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111404683|NCT02576249|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111404684|NCT02576249|Protective Agents|protective agents|mesh-ancestor
111404685|NCT02576249|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111404686|NCT02576249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111404687|NCT03868657|Moxifloxacin|moxifloxacin|mesh-list
111404688|NCT03868657|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111404689|NCT03868657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111404690|NCT03868657|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111404691|NCT03868657|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111404692|NCT03868657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111404693|NCT03868657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111404694|NCT03868657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111404695|NCT01834261|Oxytocin|oxytocin|mesh-list
111404696|NCT01834261|Oxytocics|oxytocics|mesh-ancestor
111404697|NCT01834261|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111404698|NCT01834261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111404699|NCT02578901|Tranexamic Acid|tranexamic acid|mesh-list
111404700|NCT02578901|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111404701|NCT02578901|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111404702|NCT02578901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111404703|NCT02578901|Hemostatics|hemostatics|mesh-ancestor
111404704|NCT02578901|Coagulants|coagulants|mesh-ancestor
111404705|NCT02579057|Furosemide|furosemide|mesh-list
111404706|NCT02579057|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111404707|NCT02579057|Diuretics|diuretics|mesh-ancestor
111404708|NCT02579057|Natriuretic Agents|natriuretic agents|mesh-ancestor
111404709|NCT02579057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111404710|NCT02579057|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
111404711|NCT02579057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111404712|NCT02579057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111404713|NCT00557245|Tenofovir|tenofovir|mesh-list
111404714|NCT00557245|Emtricitabine|emtricitabine|mesh-list
111404715|NCT00557245|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
111404716|NCT00557245|Antiviral Agents|antiviral agents|mesh-ancestor
111404717|NCT00557245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111404718|NCT00557245|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111404719|NCT00557245|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111404720|NCT00557245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111404721|NCT00557245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111404722|NCT00557245|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111404723|NCT00557245|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111404724|NCT00364091|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111404725|NCT00364091|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111404726|NCT04743011|Heparin|heparin|mesh-list
111404727|NCT04743011|Calcium heparin|calcium heparin|mesh-list
111404728|NCT04743011|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111404729|NCT04743011|Anticoagulants|anticoagulants|mesh-ancestor
111404730|NCT04743011|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111404731|NCT04743011|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111404732|NCT04743011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111404733|NCT03528941|Lamivudine|lamivudine|mesh-list
111404734|NCT03528941|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111404735|NCT03528941|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111404736|NCT03528941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111404737|NCT03528941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111404738|NCT03528941|Antiviral Agents|antiviral agents|mesh-ancestor
111404739|NCT03528941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111404740|NCT03528941|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111404741|NCT03528941|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111404742|NCT01836133|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111404743|NCT01836133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111404744|NCT01836133|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111404745|NCT01836133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111404746|NCT01836133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111404747|NCT00365183|Pemetrexed|pemetrexed|mesh-list
111404748|NCT00365183|Motexafin gadolinium|motexafin gadolinium|mesh-list
111404749|NCT00365183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111404750|NCT00365183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111404751|NCT00365183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111404752|NCT00365183|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111404753|NCT00365183|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111404754|NCT00365183|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111404755|NCT00365183|Dermatologic Agents|dermatologic agents|mesh-ancestor
111404756|NCT01837069|Metoprolol|metoprolol|mesh-list
111404757|NCT01837069|Lisinopril|lisinopril|mesh-list
111404758|NCT01837069|Atorvastatin|atorvastatin|mesh-list
111404759|NCT01837069|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
111404760|NCT01837069|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111404761|NCT01837069|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111404762|NCT01837069|Antimetabolites|antimetabolites|mesh-ancestor
111404763|NCT01837069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111404764|NCT01837069|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111404765|NCT01837069|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111404766|NCT01837069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111404767|NCT01837069|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111404768|NCT01837069|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111404769|NCT01837069|Sympatholytics|sympatholytics|mesh-ancestor
111404770|NCT01837069|Autonomic Agents|autonomic agents|mesh-ancestor
111404771|NCT01837069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111404772|NCT01837069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111404773|NCT01837069|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
111404774|NCT01837069|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111404775|NCT01837069|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111404776|NCT01837069|Adrenergic Agents|adrenergic agents|mesh-ancestor
111404777|NCT01837069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111404778|NCT01837069|Protease Inhibitors|protease inhibitors|mesh-ancestor
111404779|NCT01837069|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111404780|NCT01837069|Protective Agents|protective agents|mesh-ancestor
111404781|NCT02289690|Carboplatin|carboplatin|mesh-list
111404782|NCT02289690|Etoposide|etoposide|mesh-list
111404783|NCT02289690|Veliparib|veliparib|mesh-list
111404784|NCT02289690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111404785|NCT02289690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111404786|NCT02289690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111404787|NCT02289690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111404788|NCT02289690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111404789|NCT02289690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111404790|NCT02289690|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111404791|NCT02268955|Ibuprofen|ibuprofen|mesh-list
110881941|NCT05089123|Immunologic Factors|immunologic factors|mesh-ancestor
111404792|NCT02268955|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111404793|NCT02268955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111404794|NCT02268955|Analgesics|analgesics|mesh-ancestor
111404795|NCT02268955|Sensory System Agents|sensory system agents|mesh-ancestor
111404796|NCT02268955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111404797|NCT02268955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111404798|NCT02268955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111404799|NCT02268955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111404800|NCT02268955|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111129165|NCT04859621|Vitamin D|vitamin d|mesh-list
111404801|NCT02268955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111404802|NCT02268955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111404803|NCT02585843|Spironolactone|spironolactone|mesh-list
111404804|NCT02585843|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
111404805|NCT02585843|Hormone Antagonists|hormone antagonists|mesh-ancestor
111404806|NCT02585843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111404807|NCT02585843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111404808|NCT02585843|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
111404809|NCT02585843|Diuretics|diuretics|mesh-ancestor
111404810|NCT02585843|Natriuretic Agents|natriuretic agents|mesh-ancestor
111404811|NCT01838317|Pioglitazone|pioglitazone|mesh-list
111404812|NCT01838317|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111404813|NCT01838317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111404815|NCT05249231|Cariostatic Agents|cariostatic agents|mesh-ancestor
111404816|NCT05249231|Protective Agents|protective agents|mesh-ancestor
111404817|NCT05249231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111404818|NCT05249153|Sufentanil|sufentanil|mesh-list
111404819|NCT05249153|Dexmedetomidine|dexmedetomidine|mesh-list
111404820|NCT05249153|Dsuvia|dsuvia|mesh-list
111404821|NCT05249153|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111404822|NCT05249153|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111404823|NCT05249153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111404824|NCT05249153|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111404825|NCT05249153|Analgesics|analgesics|mesh-ancestor
111404826|NCT05249153|Sensory System Agents|sensory system agents|mesh-ancestor
111404827|NCT05249153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111404828|NCT05249153|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111404829|NCT05249153|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111404830|NCT05249153|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111404831|NCT05249153|Adrenergic Agents|adrenergic agents|mesh-ancestor
111404832|NCT05249153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111404833|NCT05249153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111404834|NCT05249153|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111404835|NCT05249153|Narcotics|narcotics|mesh-ancestor
111404836|NCT05249153|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111404837|NCT05249153|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111404838|NCT05249153|Anesthetics, General|anesthetics, general|mesh-ancestor
111404839|NCT05249153|Anesthetics|anesthetics|mesh-ancestor
111404840|NCT02961257|Prednisone|prednisone|mesh-list
111404841|NCT02961257|Lenograstim|lenograstim|mesh-list
111404842|NCT02961257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111404843|NCT02961257|Glucocorticoids|glucocorticoids|mesh-ancestor
111404844|NCT02961257|Hormones|hormones|mesh-ancestor
111404845|NCT02961257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111404846|NCT02961257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111404847|NCT02961257|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111404848|NCT02961257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111404849|NCT02961257|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111404850|NCT02961257|Immunologic Factors|immunologic factors|mesh-ancestor
111404851|NCT02271217|4-Aminopyridine|4-aminopyridine|mesh-list
110882007|NCT03255629|Hormones|hormones|mesh-ancestor
111404852|NCT02271217|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
111404853|NCT02271217|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111404854|NCT02271217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111404855|NCT02989519|Progesterone|progesterone|mesh-list
111404856|NCT02989519|Dydrogesterone|dydrogesterone|mesh-list
111404857|NCT02989519|Progestins|progestins|mesh-ancestor
111404858|NCT02989519|Hormones|hormones|mesh-ancestor
111404859|NCT02989519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111404860|NCT02989519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111404861|NCT02429375|Brentuximab Vedotin|brentuximab vedotin|mesh-list
111404862|NCT02429375|Mocetinostat|mocetinostat|mesh-list
111404863|NCT02429375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111404864|NCT02429375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111404865|NCT02429375|Immunotoxins|immunotoxins|mesh-ancestor
111404866|NCT02429375|Immunoconjugates|immunoconjugates|mesh-ancestor
111404867|NCT02429375|Immunologic Factors|immunologic factors|mesh-ancestor
111404868|NCT02429375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111404869|NCT02429375|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111404870|NCT02429375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111404871|NCT02429375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111404872|NCT02289456|Paclitaxel|paclitaxel|mesh-list
111404873|NCT02289456|Carboplatin|carboplatin|mesh-list
111404874|NCT02289456|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111404875|NCT02289456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111404877|NCT02289456|Antimitotic Agents|antimitotic agents|mesh-ancestor
111404878|NCT02289456|Mitosis Modulators|mitosis modulators|mesh-ancestor
111404879|NCT02289456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111404880|NCT02589977|Regadenoson|regadenoson|mesh-list
111404881|NCT02589977|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
111404882|NCT02589977|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
111404883|NCT02589977|Purinergic Agonists|purinergic agonists|mesh-ancestor
111404884|NCT02589977|Purinergic Agents|purinergic agents|mesh-ancestor
111404885|NCT02589977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111404886|NCT02589977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111404887|NCT02589977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111404888|NCT02274948|Metformin|metformin|mesh-list
111404889|NCT02274948|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111404890|NCT02274948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111404891|NCT02274792|Etanercept|etanercept|mesh-list
111404892|NCT02274792|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111404893|NCT02274792|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111404894|NCT02274792|Analgesics|analgesics|mesh-ancestor
111404895|NCT02274792|Sensory System Agents|sensory system agents|mesh-ancestor
111404896|NCT02274792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111404897|NCT02274792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111404898|NCT02274792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111404899|NCT02274792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111404900|NCT02274792|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111404901|NCT02274792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111404902|NCT02274792|Immunologic Factors|immunologic factors|mesh-ancestor
111404903|NCT05432466|Celiprolol|celiprolol|mesh-list
111404904|NCT05432466|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111404905|NCT05432466|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110882072|NCT03106987|Olaparib|olaparib|mesh-list
111404906|NCT05432466|Sympathomimetics|sympathomimetics|mesh-ancestor
111404907|NCT05432466|Autonomic Agents|autonomic agents|mesh-ancestor
111404908|NCT05432466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111404909|NCT05432466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111404910|NCT05432466|Vasodilator Agents|vasodilator agents|mesh-ancestor
111404911|NCT05432466|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
111404912|NCT05432466|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111404913|NCT05432466|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111404914|NCT05432466|Adrenergic Agents|adrenergic agents|mesh-ancestor
111404915|NCT05432466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111404916|NCT05432466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111404917|NCT02592629|Triamcinolone|triamcinolone|mesh-list
111404918|NCT02592629|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
111404919|NCT02592629|Lidocaine|lidocaine|mesh-list
111404920|NCT02592629|Ethyl Chloride|ethyl chloride|mesh-list
111404921|NCT02592629|Anesthetics, Local|anesthetics, local|mesh-ancestor
111404922|NCT02592629|Anesthetics|anesthetics|mesh-ancestor
111404923|NCT02592629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111404924|NCT02592629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111404925|NCT02592629|Sensory System Agents|sensory system agents|mesh-ancestor
111404926|NCT02592629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111404927|NCT02592629|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111404928|NCT02592629|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111404929|NCT02592629|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111404930|NCT02592629|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111404931|NCT02592629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111404932|NCT02592629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111404933|NCT02592629|Glucocorticoids|glucocorticoids|mesh-ancestor
111404934|NCT02592629|Hormones|hormones|mesh-ancestor
111404935|NCT02592629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111404936|NCT02592629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111404937|NCT02592629|Immunologic Factors|immunologic factors|mesh-ancestor
111404938|NCT02596451|Diclofenac|diclofenac|mesh-list
111404939|NCT02596451|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111404940|NCT02596451|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111404941|NCT02596451|Analgesics|analgesics|mesh-ancestor
111404942|NCT02596451|Sensory System Agents|sensory system agents|mesh-ancestor
111404943|NCT02596451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111404944|NCT02596451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111404945|NCT02596451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111404946|NCT02596451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111404947|NCT02596451|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111404948|NCT02596451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111404949|NCT02596451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111404951|NCT01839799|Gemcitabine|gemcitabine|mesh-list
111404952|NCT01839799|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111404953|NCT01839799|Folfirinox|folfirinox|mesh-list
111404954|NCT01839799|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111404955|NCT01839799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111404956|NCT01839799|Tubulin Modulators|tubulin modulators|mesh-ancestor
111404957|NCT01839799|Antimitotic Agents|antimitotic agents|mesh-ancestor
111404958|NCT01839799|Mitosis Modulators|mitosis modulators|mesh-ancestor
111404959|NCT01839799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111404960|NCT01839799|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111404961|NCT01839799|Antimetabolites|antimetabolites|mesh-ancestor
111404962|NCT03062059|Gemcitabine|gemcitabine|mesh-list
111404963|NCT03062059|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111404964|NCT03062059|Antimetabolites|antimetabolites|mesh-ancestor
111404965|NCT03062059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111404966|NCT03062059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111404967|NCT02597543|Regadenoson|regadenoson|mesh-list
111404968|NCT02597543|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
111404969|NCT02597543|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
111404970|NCT02597543|Purinergic Agonists|purinergic agonists|mesh-ancestor
111404971|NCT02597543|Purinergic Agents|purinergic agents|mesh-ancestor
111404972|NCT02597543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111404973|NCT02597543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111404974|NCT02597543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111404975|NCT00553501|Rituximab|rituximab|mesh-list
111404976|NCT00553501|Epratuzumab|epratuzumab|mesh-list
111404977|NCT00553501|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111404978|NCT00553501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111404979|NCT00553501|Immunologic Factors|immunologic factors|mesh-ancestor
111404980|NCT00553501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111404981|NCT00553501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111404982|NCT02599649|Nivolumab|nivolumab|mesh-list
111404983|NCT02599649|Azacitidine|azacitidine|mesh-list
111404984|NCT02599649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111404985|NCT02599649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111404986|NCT02599649|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111404987|NCT02599649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111404988|NCT02599649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111404989|NCT02599649|Antimetabolites|antimetabolites|mesh-ancestor
111404990|NCT02599649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111404991|NCT01840345|Acetylcysteine|acetylcysteine|mesh-list
111404992|NCT01840345|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111404993|NCT01840345|Antiviral Agents|antiviral agents|mesh-ancestor
111404994|NCT01840345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111404995|NCT01840345|Expectorants|expectorants|mesh-ancestor
111404996|NCT01840345|Respiratory System Agents|respiratory system agents|mesh-ancestor
111404997|NCT01840345|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111404998|NCT01840345|Antioxidants|antioxidants|mesh-ancestor
111404999|NCT01840345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111405000|NCT01840345|Protective Agents|protective agents|mesh-ancestor
111405001|NCT01840345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111405002|NCT01840345|Antidotes|antidotes|mesh-ancestor
111405003|NCT00364481|Omeprazole|omeprazole|mesh-list
111405004|NCT00364481|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111405005|NCT00364481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111405006|NCT00364481|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111405007|NCT00364481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111405008|NCT00364481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111405009|NCT02601833|Fluorides|fluorides|mesh-list
111405010|NCT02601833|Cariostatic Agents|cariostatic agents|mesh-ancestor
111405011|NCT02601833|Protective Agents|protective agents|mesh-ancestor
111405012|NCT02601833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111405013|NCT00553267|Amlodipine|amlodipine|mesh-list
111405014|NCT00553267|Telmisartan|telmisartan|mesh-list
111405015|NCT00553267|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
111405016|NCT00553267|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111405017|NCT00553267|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111405018|NCT00553267|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111405019|NCT00553267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111405020|NCT00553267|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111405021|NCT00553267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111405022|NCT00553267|Vasodilator Agents|vasodilator agents|mesh-ancestor
111405023|NCT00553267|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111405024|NCT00553267|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111405025|NCT00364559|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111405026|NCT00364559|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111405027|NCT00364559|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111405028|NCT00364559|Antimetabolites|antimetabolites|mesh-ancestor
111405029|NCT00364559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111405030|NCT00364559|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111405031|NCT00364559|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111405032|NCT00364559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111405033|NCT02271984|Praziquantel|praziquantel|mesh-list
111405034|NCT02271984|Anthelmintics|anthelmintics|mesh-ancestor
111405035|NCT02271984|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111405036|NCT02271984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111405037|NCT02604173|Budesonide|budesonide|mesh-list
111405038|NCT02604173|Acetazolamide|acetazolamide|mesh-list
111405039|NCT02604173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111405040|NCT02604173|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111405041|NCT02604173|Autonomic Agents|autonomic agents|mesh-ancestor
111405042|NCT02604173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111405043|NCT02604173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111405044|NCT02604173|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111405045|NCT02604173|Respiratory System Agents|respiratory system agents|mesh-ancestor
111405046|NCT02604173|Glucocorticoids|glucocorticoids|mesh-ancestor
111405047|NCT02604173|Hormones|hormones|mesh-ancestor
111405048|NCT02604173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111405049|NCT02604173|Anticonvulsants|anticonvulsants|mesh-ancestor
111405050|NCT02604173|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
111405051|NCT02604173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111405052|NCT02604173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111405053|NCT02604173|Diuretics|diuretics|mesh-ancestor
111405054|NCT02604173|Natriuretic Agents|natriuretic agents|mesh-ancestor
111405055|NCT02287038|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
111405056|NCT02287038|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111405057|NCT02287038|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111405058|NCT02287038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111405059|NCT02287038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111405060|NCT02287038|Adrenergic Agents|adrenergic agents|mesh-ancestor
111405061|NCT02287038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111405062|NCT02287038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111405063|NCT00365339|Ritonavir|ritonavir|mesh-list
111405064|NCT00365339|Atazanavir Sulfate|atazanavir sulfate|mesh-list
111405065|NCT00365339|Tenofovir|tenofovir|mesh-list
111405066|NCT00365339|Aripiprazole|aripiprazole|mesh-list
111405067|NCT00365339|Famotidine|famotidine|mesh-list
111405068|NCT00365339|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111405069|NCT00365339|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111405070|NCT00365339|Protease Inhibitors|protease inhibitors|mesh-ancestor
111405071|NCT00365339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111405072|NCT00365339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111405073|NCT00365339|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111405074|NCT00365339|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111405075|NCT00365339|Antiviral Agents|antiviral agents|mesh-ancestor
111405076|NCT00365339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111405077|NCT00365339|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111405078|NCT00365339|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111405079|NCT00365339|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111405080|NCT00365339|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111405081|NCT00365339|Antidepressive Agents|antidepressive agents|mesh-ancestor
111405082|NCT00365339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111405083|NCT00365339|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111405084|NCT00365339|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111405085|NCT00365339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111405086|NCT00365339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111405087|NCT00365339|Dopamine Agonists|dopamine agonists|mesh-ancestor
111405088|NCT00365339|Dopamine Agents|dopamine agents|mesh-ancestor
111405089|NCT00365339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111405090|NCT00365339|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111405091|NCT00365339|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111405092|NCT00365339|Serotonin Agents|serotonin agents|mesh-ancestor
111405093|NCT00365339|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111405094|NCT00365339|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111405095|NCT00365339|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111405096|NCT00365339|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111405097|NCT00365339|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111405098|NCT00365339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111405099|NCT00365339|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
111405100|NCT00365339|Histamine Antagonists|histamine antagonists|mesh-ancestor
111405101|NCT00365339|Histamine Agents|histamine agents|mesh-ancestor
111405102|NCT02815033|Choline|choline|mesh-list
111405103|NCT02815033|Lipotropic Agents|lipotropic agents|mesh-ancestor
111405104|NCT02815033|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111405105|NCT02815033|Antimetabolites|antimetabolites|mesh-ancestor
111405106|NCT02815033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111405107|NCT02815033|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111405108|NCT02815033|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111405109|NCT02815033|Nootropic Agents|nootropic agents|mesh-ancestor
111405110|NCT00366119|Ramipril|ramipril|mesh-list
111405111|NCT00366119|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
111405112|NCT00366119|Protease Inhibitors|protease inhibitors|mesh-ancestor
111405113|NCT00366119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111405114|NCT00366119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111405115|NCT00366119|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111405116|NCT05371301|Paclitaxel|paclitaxel|mesh-list
111405117|NCT05371301|Carboplatin|carboplatin|mesh-list
111405118|NCT05371301|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111405119|NCT05371301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111405120|NCT05371301|Tubulin Modulators|tubulin modulators|mesh-ancestor
111405121|NCT05371301|Antimitotic Agents|antimitotic agents|mesh-ancestor
111405122|NCT05371301|Mitosis Modulators|mitosis modulators|mesh-ancestor
111405123|NCT05371301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111405124|NCT02285166|Hypolipidemic Agents|hypolipidemic agents|mesh-list
111405125|NCT02285166|Antimetabolites|antimetabolites|mesh-ancestor
111405126|NCT02285166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111405127|NCT02285166|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111405128|NCT02605187|Acetaminophen|acetaminophen|mesh-list
111405129|NCT02605187|Ibuprofen|ibuprofen|mesh-list
111405130|NCT02605187|Morphine|morphine|mesh-list
111405131|NCT02605187|Gabapentin|gabapentin|mesh-list
111405132|NCT02605187|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111405133|NCT02605187|Narcotics|narcotics|mesh-ancestor
111405134|NCT02605187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111405135|NCT02605187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111405136|NCT02605187|Analgesics|analgesics|mesh-ancestor
111405137|NCT02605187|Sensory System Agents|sensory system agents|mesh-ancestor
111405138|NCT02605187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111405139|NCT02605187|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111405140|NCT02605187|Antipyretics|antipyretics|mesh-ancestor
111405141|NCT02605187|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111405142|NCT02605187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111405143|NCT02605187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111405144|NCT02605187|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111405145|NCT02605187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111405146|NCT02605187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111405147|NCT02605187|Anticonvulsants|anticonvulsants|mesh-ancestor
111405148|NCT02605187|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111405149|NCT02605187|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111405150|NCT02605187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111405151|NCT02605187|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111405152|NCT02605187|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111405153|NCT02605187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111405154|NCT02605187|Antimanic Agents|antimanic agents|mesh-ancestor
111405155|NCT05592197|Lenvatinib|lenvatinib|mesh-list
111405156|NCT05592197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111405157|NCT05592197|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111405158|NCT05592197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111405159|NCT05592197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111405160|NCT02989207|Mitomycins|mitomycins|mesh-list
111405161|NCT02989207|Mitomycin|mitomycin|mesh-list
111405162|NCT02989207|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111405163|NCT02989207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111405164|NCT02989207|Alkylating Agents|alkylating agents|mesh-ancestor
111405165|NCT02989207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111405166|NCT02989207|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111405167|NCT02989207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111405168|NCT02647099|Aspirin|aspirin|mesh-list
111405169|NCT02647099|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111405170|NCT02647099|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111405171|NCT02647099|Analgesics|analgesics|mesh-ancestor
111405172|NCT02647099|Sensory System Agents|sensory system agents|mesh-ancestor
111405173|NCT02647099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111405174|NCT02647099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111405175|NCT02647099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111405176|NCT02647099|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111405177|NCT02647099|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111405178|NCT02647099|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111405179|NCT02647099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111405180|NCT02647099|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111405181|NCT02647099|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111405182|NCT02647099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111405184|NCT01843621|Vaccines|vaccines|mesh-list
111405185|NCT01843621|Immunologic Factors|immunologic factors|mesh-ancestor
111405186|NCT01843621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111405187|NCT02608229|Paclitaxel|paclitaxel|mesh-list
111405188|NCT02608229|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111405189|NCT02608229|Gemcitabine|gemcitabine|mesh-list
111405190|NCT02608229|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111405191|NCT02608229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111405192|NCT02608229|Tubulin Modulators|tubulin modulators|mesh-ancestor
111405193|NCT02608229|Antimitotic Agents|antimitotic agents|mesh-ancestor
111405194|NCT02608229|Mitosis Modulators|mitosis modulators|mesh-ancestor
111405195|NCT02608229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111405196|NCT02608229|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111405197|NCT02608229|Antimetabolites|antimetabolites|mesh-ancestor
111405198|NCT00555061|Retapamulin|retapamulin|mesh-list
111405199|NCT00555061|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111405200|NCT00555061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111405201|NCT01642212|Budesonide|budesonide|mesh-list
111405202|NCT01642212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111405203|NCT01642212|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111405204|NCT01642212|Autonomic Agents|autonomic agents|mesh-ancestor
111405205|NCT01642212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111405206|NCT01642212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111405207|NCT01642212|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111405208|NCT01642212|Respiratory System Agents|respiratory system agents|mesh-ancestor
111405209|NCT01642212|Glucocorticoids|glucocorticoids|mesh-ancestor
111405210|NCT01642212|Hormones|hormones|mesh-ancestor
111405211|NCT01642212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111405212|NCT05649618|Cyclophosphamide|cyclophosphamide|mesh-list
111405213|NCT05649618|Fludarabine|fludarabine|mesh-list
111405214|NCT05649618|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111405215|NCT05649618|Immunologic Factors|immunologic factors|mesh-ancestor
111405216|NCT05649618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111405217|NCT05649618|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111405218|NCT05649618|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111405219|NCT05649618|Alkylating Agents|alkylating agents|mesh-ancestor
111405220|NCT05649618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111405221|NCT05649618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111405222|NCT05649618|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111405223|NCT00552175|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
111405224|NCT00552175|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111405225|NCT00552175|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111405226|NCT00552175|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111405227|NCT00552175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111405228|NCT00552175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111405229|NCT00552175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111405230|NCT00552175|Analgesics|analgesics|mesh-ancestor
111405231|NCT00552175|Sensory System Agents|sensory system agents|mesh-ancestor
111405232|NCT00552175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111405233|NCT00552175|Antidepressive Agents|antidepressive agents|mesh-ancestor
111405234|NCT00552175|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111405235|NCT00552175|Dopamine Agents|dopamine agents|mesh-ancestor
111405236|NCT01644474|Ezetimibe|ezetimibe|mesh-list
111405237|NCT01644474|Alirocumab|alirocumab|mesh-list
111405238|NCT01644474|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111405239|NCT01644474|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111405240|NCT01644474|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111405241|NCT01644474|Antimetabolites|antimetabolites|mesh-ancestor
111405242|NCT01644474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111405243|NCT01644474|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111405244|NCT01644474|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
111405245|NCT01644474|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111405246|NCT01644474|Protease Inhibitors|protease inhibitors|mesh-ancestor
111405247|NCT01644474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111405248|NCT01644474|Immunologic Factors|immunologic factors|mesh-ancestor
111405249|NCT01644474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111405250|NCT02989129|Quercetin|quercetin|mesh-list
111405251|NCT02989129|Antioxidants|antioxidants|mesh-ancestor
111405252|NCT02989129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111405253|NCT02989129|Protective Agents|protective agents|mesh-ancestor
111405254|NCT02989129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111405255|NCT01847131|Phenylephrine|phenylephrine|mesh-list
111405256|NCT01847131|Oxymetazoline|oxymetazoline|mesh-list
111405257|NCT01847131|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111405258|NCT01847131|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111405259|NCT01847131|Adrenergic Agents|adrenergic agents|mesh-ancestor
111405260|NCT01847131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111405261|NCT01847131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111405262|NCT01847131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111405263|NCT01847131|Sympathomimetics|sympathomimetics|mesh-ancestor
111405264|NCT01847131|Autonomic Agents|autonomic agents|mesh-ancestor
111405265|NCT01847131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111405266|NCT01847131|Nasal Decongestants|nasal decongestants|mesh-ancestor
111405267|NCT01847131|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111405268|NCT01847131|Respiratory System Agents|respiratory system agents|mesh-ancestor
111405269|NCT01847131|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111405270|NCT01847131|Mydriatics|mydriatics|mesh-ancestor
111405271|NCT01847131|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111405272|NCT01847131|Protective Agents|protective agents|mesh-ancestor
111405273|NCT02285010|Pregabalin|pregabalin|mesh-list
111405274|NCT02285010|Analgesics|analgesics|mesh-ancestor
111405275|NCT02285010|Sensory System Agents|sensory system agents|mesh-ancestor
111405276|NCT02285010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111405277|NCT02285010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111405278|NCT02285010|Anticonvulsants|anticonvulsants|mesh-ancestor
111405279|NCT02285010|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111405280|NCT02285010|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111405281|NCT02285010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111405282|NCT02285010|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111405283|NCT02285010|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111405284|NCT02285010|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111405285|NCT02285010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111405286|NCT02285010|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111405287|NCT02617667|Cyclosporine|cyclosporine|mesh-list
111405288|NCT02617667|Cyclosporins|cyclosporins|mesh-list
111405289|NCT02617667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111405290|NCT02617667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111405291|NCT02617667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111405292|NCT02617667|Immunologic Factors|immunologic factors|mesh-ancestor
111405293|NCT02617667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111405294|NCT02617667|Antifungal Agents|antifungal agents|mesh-ancestor
111405295|NCT02617667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111405296|NCT02617667|Dermatologic Agents|dermatologic agents|mesh-ancestor
111405297|NCT02617667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111405298|NCT02617667|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111405299|NCT03023449|Nitric Oxide|nitric oxide|mesh-list
111405300|NCT03023449|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111405301|NCT03023449|Autonomic Agents|autonomic agents|mesh-ancestor
111405302|NCT03023449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111405303|NCT03023449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111405304|NCT03023449|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111405305|NCT03023449|Respiratory System Agents|respiratory system agents|mesh-ancestor
111405306|NCT03023449|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111405307|NCT03023449|Antioxidants|antioxidants|mesh-ancestor
111405308|NCT03023449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111405309|NCT03023449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111405310|NCT03023449|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
111405311|NCT03023449|Vasodilator Agents|vasodilator agents|mesh-ancestor
111405312|NCT03023449|Gasotransmitters|gasotransmitters|mesh-ancestor
111405313|NCT03023449|Protective Agents|protective agents|mesh-ancestor
111405314|NCT01848067|Prednisone|prednisone|mesh-list
111405315|NCT01848067|Abiraterone Acetate|abiraterone acetate|mesh-list
111405316|NCT01848067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111405317|NCT01848067|Glucocorticoids|glucocorticoids|mesh-ancestor
111405318|NCT01848067|Hormones|hormones|mesh-ancestor
111405319|NCT01848067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111405320|NCT01848067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111405321|NCT01848067|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111405322|NCT01848067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111405323|NCT01848067|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111405324|NCT01848067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111405325|NCT01848067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111405326|NCT01848067|Hormone Antagonists|hormone antagonists|mesh-ancestor
111405327|NCT01848067|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111405328|NCT05731973|Sufentanil|sufentanil|mesh-list
111405329|NCT05731973|Oxycodone|oxycodone|mesh-list
111405330|NCT05731973|Analgesics, Opioid|analgesics, opioid|mesh-list
111405331|NCT05731973|Bupivacaine|bupivacaine|mesh-list
111405332|NCT05731973|Anesthetics, Local|anesthetics, local|mesh-ancestor
111405333|NCT05731973|Anesthetics|anesthetics|mesh-ancestor
111405334|NCT05731973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111405335|NCT05731973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111405336|NCT05731973|Sensory System Agents|sensory system agents|mesh-ancestor
111405337|NCT05731973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111405338|NCT05731973|Narcotics|narcotics|mesh-ancestor
111405339|NCT05731973|Analgesics|analgesics|mesh-ancestor
111405340|NCT05731973|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111405341|NCT05731973|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111405342|NCT05731973|Anesthetics, General|anesthetics, general|mesh-ancestor
111405343|NCT05068349|3-n-butylphthalide|3-n-butylphthalide|mesh-list
111405344|NCT05068349|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111405345|NCT05068349|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111405346|NCT05068349|Protective Agents|protective agents|mesh-ancestor
111405347|NCT05068349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111405348|NCT05452577|Estazolam|estazolam|mesh-list
111405349|NCT05452577|Anticonvulsants|anticonvulsants|mesh-ancestor
111405350|NCT05452577|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111405351|NCT05452577|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111405352|NCT05452577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111405353|NCT05452577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111405354|NCT05452577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111405355|NCT05452577|GABA Modulators|gaba modulators|mesh-ancestor
111405356|NCT05452577|GABA Agents|gaba agents|mesh-ancestor
111405357|NCT05452577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111405358|NCT05452577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111405359|NCT00364871|Naltrexone|naltrexone|mesh-list
111405360|NCT00364871|Bupropion|bupropion|mesh-list
111405361|NCT00364871|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111405362|NCT00364871|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111405363|NCT00364871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111405364|NCT00364871|Sensory System Agents|sensory system agents|mesh-ancestor
111405365|NCT00364871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111405366|NCT00364871|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111405367|NCT00364871|Antidepressive Agents|antidepressive agents|mesh-ancestor
111405368|NCT00364871|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111405369|NCT00364871|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111405370|NCT00364871|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110882528|NCT03883581|Antimalarials|antimalarials|mesh-ancestor
111405371|NCT00364871|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111405372|NCT00364871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111405373|NCT00364871|Dopamine Agents|dopamine agents|mesh-ancestor
111405374|NCT00364871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111405375|NCT00364871|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111405376|NCT00364871|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111405377|NCT00364871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111405378|NCT00551161|Memantine|memantine|mesh-list
111405379|NCT00551161|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111405380|NCT00551161|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111405381|NCT00551161|Dopamine Agents|dopamine agents|mesh-ancestor
111405382|NCT00551161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111405383|NCT00551161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111405384|NCT00551161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111405385|NCT00551161|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111405386|NCT00551161|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111405387|NCT00550771|Paclitaxel|paclitaxel|mesh-list
111405388|NCT00550771|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111405389|NCT00550771|Cyclophosphamide|cyclophosphamide|mesh-list
111405390|NCT00550771|Doxorubicin|doxorubicin|mesh-list
111405391|NCT00550771|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111405392|NCT00550771|Trastuzumab|trastuzumab|mesh-list
111405393|NCT00550771|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111405394|NCT00550771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111405395|NCT00550771|Tubulin Modulators|tubulin modulators|mesh-ancestor
111405396|NCT00550771|Antimitotic Agents|antimitotic agents|mesh-ancestor
111129774|NCT04816253|Glucocorticoids|glucocorticoids|mesh-ancestor
111405397|NCT00550771|Mitosis Modulators|mitosis modulators|mesh-ancestor
111405398|NCT00550771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111405399|NCT00550771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111405400|NCT00550771|Immunologic Factors|immunologic factors|mesh-ancestor
111405401|NCT00550771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111405402|NCT00550771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111405403|NCT00550771|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111405404|NCT00550771|Alkylating Agents|alkylating agents|mesh-ancestor
111405405|NCT00550771|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111405406|NCT00550771|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111405407|NCT00550771|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111405408|NCT00550771|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111405409|NCT00550771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111405410|NCT00550771|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111405411|NCT01852669|Furosemide|furosemide|mesh-list
111405412|NCT01852669|Diuretics|diuretics|mesh-ancestor
111405413|NCT01852669|Natriuretic Agents|natriuretic agents|mesh-ancestor
111405414|NCT01852669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111405415|NCT01852669|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
111405416|NCT01852669|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111405417|NCT01852669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111405418|NCT04741295|Heparin|heparin|mesh-list
111405419|NCT04741295|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
111405420|NCT04741295|Tinzaparin|tinzaparin|mesh-list
111405421|NCT04741295|Dalteparin|dalteparin|mesh-list
111405422|NCT04741295|Anticoagulants|anticoagulants|mesh-ancestor
111405423|NCT04741295|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111405424|NCT04741295|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111405425|NCT04741295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111405426|NCT00550537|Paclitaxel|paclitaxel|mesh-list
111405427|NCT00550537|Bevacizumab|bevacizumab|mesh-list
111405428|NCT00550537|Carboplatin|carboplatin|mesh-list
111405429|NCT00550537|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111405430|NCT00550537|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111405431|NCT00550537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111405432|NCT00550537|Tubulin Modulators|tubulin modulators|mesh-ancestor
111405433|NCT00550537|Antimitotic Agents|antimitotic agents|mesh-ancestor
111405434|NCT00550537|Mitosis Modulators|mitosis modulators|mesh-ancestor
111405435|NCT00550537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111405436|NCT00550537|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111405437|NCT00550537|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111405438|NCT00550537|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111405439|NCT00550537|Growth Substances|growth substances|mesh-ancestor
111405440|NCT00550537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111405441|NCT00550537|Growth Inhibitors|growth inhibitors|mesh-ancestor
111405442|NCT00550537|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111405443|NCT00550537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111405444|NCT04801043|Imipenem|imipenem|mesh-list
111405445|NCT04801043|Cilastatin|cilastatin|mesh-list
111405446|NCT04801043|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111405447|NCT04801043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111405448|NCT04801043|Protease Inhibitors|protease inhibitors|mesh-ancestor
111405449|NCT04801043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111405450|NCT04801043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111405451|NCT05706701|Nicotine|nicotine|mesh-list
111405452|NCT05706701|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111405453|NCT05706701|Autonomic Agents|autonomic agents|mesh-ancestor
111405454|NCT05706701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111405455|NCT05706701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111405456|NCT05706701|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111405457|NCT05706701|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111405458|NCT05706701|Cholinergic Agents|cholinergic agents|mesh-ancestor
111405459|NCT05706701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111405460|NCT05706701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111405461|NCT04734197|Cyclosporine|cyclosporine|mesh-list
111405462|NCT04734197|Mycophenolic Acid|mycophenolic acid|mesh-list
111405463|NCT04734197|Betamethasone|betamethasone|mesh-list
111405464|NCT04734197|Betamethasone Valerate|betamethasone valerate|mesh-list
111405465|NCT04734197|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
111405466|NCT04734197|Betamethasone benzoate|betamethasone benzoate|mesh-list
111405467|NCT04734197|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111405468|NCT04734197|Lifitegrast|lifitegrast|mesh-list
111405469|NCT04734197|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111405470|NCT04734197|Cyclosporins|cyclosporins|mesh-list
111405471|NCT04734197|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
111129856|NCT03096223|KHK4083|khk4083|mesh-list
111405472|NCT04734197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111405473|NCT04734197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111405474|NCT04734197|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111405475|NCT04734197|Immunologic Factors|immunologic factors|mesh-ancestor
111405476|NCT04734197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111405477|NCT04734197|Antifungal Agents|antifungal agents|mesh-ancestor
111405478|NCT04734197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111405479|NCT04734197|Dermatologic Agents|dermatologic agents|mesh-ancestor
111405480|NCT04734197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111405481|NCT04734197|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111405482|NCT04734197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111405483|NCT04734197|Glucocorticoids|glucocorticoids|mesh-ancestor
111405484|NCT04734197|Hormones|hormones|mesh-ancestor
111405485|NCT04734197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111405486|NCT04734197|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111405487|NCT04734197|Respiratory System Agents|respiratory system agents|mesh-ancestor
111405488|NCT04734197|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111405489|NCT04734197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111405490|NCT04734197|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111405491|NCT04734197|Antitubercular Agents|antitubercular agents|mesh-ancestor
111405492|NCT04734197|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111405493|NCT00550147|Quetiapine Fumarate|quetiapine fumarate|mesh-list
111405494|NCT00550147|Methylphenidate|methylphenidate|mesh-list
111405495|NCT00550147|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111405496|NCT00550147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111405497|NCT00550147|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111405498|NCT00550147|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111405499|NCT00550147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111405500|NCT00550147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111405501|NCT00550147|Dopamine Agents|dopamine agents|mesh-ancestor
111405502|NCT00550147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111405503|NCT00550147|Antidepressive Agents|antidepressive agents|mesh-ancestor
111405504|NCT00550147|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111405505|NCT00550147|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111405506|NCT00550147|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111405507|NCT00550147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111405508|NCT05688215|Calcium, Dietary|calcium, dietary|mesh-list
111405509|NCT05688215|Leucovorin|leucovorin|mesh-list
111405510|NCT05688215|Folic Acid|folic acid|mesh-list
111405511|NCT05688215|Fluorouracil|fluorouracil|mesh-list
111405512|NCT05688215|Oxaliplatin|oxaliplatin|mesh-list
111405513|NCT05688215|Irinotecan|irinotecan|mesh-list
111405514|NCT05688215|Quemliclustat|quemliclustat|mesh-list
111405515|NCT05688215|Calcium|calcium|mesh-list
111405516|NCT05688215|Levoleucovorin|levoleucovorin|mesh-list
111405517|NCT05688215|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111405518|NCT05688215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111405519|NCT05688215|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111405520|NCT05688215|Antimetabolites|antimetabolites|mesh-ancestor
111405521|NCT05688215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111405522|NCT05688215|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111405523|NCT05688215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111405524|NCT05688215|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111405525|NCT05688215|Immunologic Factors|immunologic factors|mesh-ancestor
111405526|NCT05688215|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111405527|NCT05688215|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111405528|NCT05688215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111405529|NCT05688215|Antidotes|antidotes|mesh-ancestor
111405530|NCT05688215|Protective Agents|protective agents|mesh-ancestor
111405531|NCT05688215|Vitamin B Complex|vitamin b complex|mesh-ancestor
111405532|NCT05688215|Vitamins|vitamins|mesh-ancestor
111405533|NCT05688215|Micronutrients|micronutrients|mesh-ancestor
111405534|NCT05688215|Hematinics|hematinics|mesh-ancestor
111405535|NCT05688215|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111405536|NCT05688215|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111405537|NCT00557401|Arbaclofen placarbil|arbaclofen placarbil|mesh-list
111405538|NCT00557401|Baclofen|baclofen|mesh-list
111405539|NCT00557401|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
111405540|NCT00557401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111405541|NCT00557401|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111405542|NCT00557401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111405543|NCT00557401|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
111405544|NCT00557401|GABA Agonists|gaba agonists|mesh-ancestor
111405545|NCT00557401|GABA Agents|gaba agents|mesh-ancestor
111405546|NCT00557401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111405547|NCT00557401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111405548|NCT02264353|Donepezil|donepezil|mesh-list
111405549|NCT02264353|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111405550|NCT02264353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111405551|NCT02264353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111405552|NCT02264353|Cholinergic Agents|cholinergic agents|mesh-ancestor
111405553|NCT02264353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111405554|NCT02264353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111405555|NCT02264353|Nootropic Agents|nootropic agents|mesh-ancestor
111405556|NCT02265913|Acyclovir|acyclovir|mesh-list
111405557|NCT02265913|Antiviral Agents|antiviral agents|mesh-ancestor
111405558|NCT02265913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111405559|NCT02624843|Ethanol|ethanol|mesh-list
111405560|NCT02624843|Benzyl Alcohol|benzyl alcohol|mesh-list
111405561|NCT02624843|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111405562|NCT02624843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111405563|NCT02624843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111405564|NCT02624843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111405565|NCT02624843|Anesthetics, Local|anesthetics, local|mesh-ancestor
111405566|NCT02624843|Anesthetics|anesthetics|mesh-ancestor
111405567|NCT02624843|Sensory System Agents|sensory system agents|mesh-ancestor
111405568|NCT02624843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111405569|NCT02279641|Allopurinol|allopurinol|mesh-list
111405570|NCT02279641|Verinurad|verinurad|mesh-list
111405571|NCT02279641|Antimetabolites|antimetabolites|mesh-ancestor
111405572|NCT02279641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111405573|NCT02279641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111405574|NCT02279641|Gout Suppressants|gout suppressants|mesh-ancestor
111405575|NCT02279641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111405576|NCT02279641|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111405577|NCT02279641|Antioxidants|antioxidants|mesh-ancestor
111405578|NCT02279641|Protective Agents|protective agents|mesh-ancestor
111405579|NCT02279641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111405580|NCT02629991|Oxytocin|oxytocin|mesh-list
111405581|NCT02629991|Oxytocics|oxytocics|mesh-ancestor
111405582|NCT02629991|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111405583|NCT02629991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111405584|NCT00553657|Tolterodine Tartrate|tolterodine tartrate|mesh-list
111405585|NCT00553657|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111405586|NCT00553657|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111405587|NCT00553657|Cholinergic Agents|cholinergic agents|mesh-ancestor
111405588|NCT00553657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111405589|NCT00553657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111405590|NCT00553657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111405591|NCT00553657|Urological Agents|urological agents|mesh-ancestor
111405592|NCT05142709|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
111405593|NCT05142709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111405594|NCT05142709|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111405595|NCT05142709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111405596|NCT04992143|Sorafenib|sorafenib|mesh-list
111405597|NCT04992143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111405598|NCT04992143|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111405599|NCT04992143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111405600|NCT04992143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111405601|NCT04485065|Azacitidine|azacitidine|mesh-list
111405602|NCT04485065|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111405603|NCT04485065|Antimetabolites|antimetabolites|mesh-ancestor
111405604|NCT04485065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111405605|NCT04485065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111405606|NCT04485065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111405607|NCT03769129|Pembrolizumab|pembrolizumab|mesh-list
111405608|NCT03769129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111405609|NCT03769129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111405610|NCT03769129|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111405611|NCT03769129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111405612|NCT00367445|Insulin|insulin|mesh-list
111405613|NCT00367445|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111405614|NCT00367445|Insulin Glargine|insulin glargine|mesh-list
111405615|NCT00367445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111405616|NCT00367445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111405617|NCT01866943|Tranexamic Acid|tranexamic acid|mesh-list
111405618|NCT01866943|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111405619|NCT01866943|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111405620|NCT01866943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111405621|NCT01866943|Hemostatics|hemostatics|mesh-ancestor
111405622|NCT01866943|Coagulants|coagulants|mesh-ancestor
111130038|NCT05029453|Apatinib|apatinib|mesh-list
111405623|NCT01868425|Acetaminophen|acetaminophen|mesh-list
111405624|NCT01868425|Ketamine|ketamine|mesh-list
111405625|NCT01868425|Gabapentin|gabapentin|mesh-list
111405626|NCT01868425|Bupivacaine|bupivacaine|mesh-list
111405627|NCT01868425|Anesthetics, Local|anesthetics, local|mesh-ancestor
111405628|NCT01868425|Anesthetics|anesthetics|mesh-ancestor
111405629|NCT01868425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111405630|NCT01868425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111405631|NCT01868425|Sensory System Agents|sensory system agents|mesh-ancestor
111405632|NCT01868425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111405633|NCT01868425|Analgesics|analgesics|mesh-ancestor
111405634|NCT01868425|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111405635|NCT01868425|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111405636|NCT01868425|Anesthetics, General|anesthetics, general|mesh-ancestor
111405637|NCT01868425|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111405638|NCT01868425|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111405639|NCT01868425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110882794|NCT02740335|Protein C|protein c|mesh-list
111405640|NCT01868425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111405641|NCT01868425|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111405642|NCT01868425|Antipyretics|antipyretics|mesh-ancestor
111405643|NCT01868425|Anticonvulsants|anticonvulsants|mesh-ancestor
111405644|NCT01868425|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111405645|NCT01868425|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111405646|NCT01868425|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111405647|NCT01868425|Antimanic Agents|antimanic agents|mesh-ancestor
111405648|NCT00550459|Tolvaptan|tolvaptan|mesh-list
111405649|NCT00550459|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
111405650|NCT00550459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111405651|NCT00550459|Natriuretic Agents|natriuretic agents|mesh-ancestor
111405652|NCT00550459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111405653|NCT01871077|Ketorolac|ketorolac|mesh-list
111405654|NCT01871077|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111405655|NCT01871077|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111405656|NCT01871077|Analgesics|analgesics|mesh-ancestor
111405657|NCT01871077|Sensory System Agents|sensory system agents|mesh-ancestor
111405658|NCT01871077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111405659|NCT01871077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111405660|NCT01871077|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111405661|NCT01871077|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111405662|NCT01871077|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111405663|NCT01871077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111405664|NCT01871077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111405665|NCT01874119|Fosaprepitant|fosaprepitant|mesh-list
111405666|NCT01874119|Aprepitant|aprepitant|mesh-list
111405667|NCT01874119|Antiemetics|antiemetics|mesh-ancestor
111405668|NCT01874119|Autonomic Agents|autonomic agents|mesh-ancestor
111405669|NCT01874119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111405670|NCT01874119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111405671|NCT01874119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111405672|NCT01874119|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
111405673|NCT01874119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111405674|NCT01874119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111405675|NCT02823145|Fenfluramine|fenfluramine|mesh-list
111405676|NCT02823145|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111405677|NCT02823145|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111405678|NCT02823145|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111405679|NCT02823145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111405680|NCT02823145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111405681|NCT02823145|Serotonin Agents|serotonin agents|mesh-ancestor
111405682|NCT02823145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111405683|NCT02280811|Aldesleukin|aldesleukin|mesh-list
111405684|NCT02280811|Cyclophosphamide|cyclophosphamide|mesh-list
111405685|NCT02280811|Fludarabine|fludarabine|mesh-list
111405686|NCT02280811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111405687|NCT02280811|Immunologic Factors|immunologic factors|mesh-ancestor
111405688|NCT02280811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111405689|NCT02280811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111405690|NCT02280811|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111405691|NCT02280811|Alkylating Agents|alkylating agents|mesh-ancestor
111405692|NCT02280811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111405693|NCT02280811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111405694|NCT02280811|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111405695|NCT02280811|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111405696|NCT02280811|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111130099|NCT05028049|Dsuvia|dsuvia|mesh-list
111405697|NCT02280811|Antiviral Agents|antiviral agents|mesh-ancestor
111405698|NCT02280811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111405699|NCT01930747|Remifentanil|remifentanil|mesh-list
111405700|NCT01930747|Sevoflurane|sevoflurane|mesh-list
111405702|NCT01930747|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111405703|NCT01930747|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111405704|NCT01930747|Anesthetics, General|anesthetics, general|mesh-ancestor
111405705|NCT01930747|Anesthetics|anesthetics|mesh-ancestor
111405706|NCT01930747|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111405707|NCT01930747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111405708|NCT01930747|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
111405709|NCT01930747|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
111405710|NCT01930747|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111405711|NCT01930747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111405712|NCT01930747|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111405713|NCT01930747|Narcotics|narcotics|mesh-ancestor
111405714|NCT01930747|Analgesics|analgesics|mesh-ancestor
111405715|NCT01930747|Sensory System Agents|sensory system agents|mesh-ancestor
111405716|NCT01931527|Rasburicase|rasburicase|mesh-list
111405717|NCT01931527|Gout Suppressants|gout suppressants|mesh-ancestor
111405718|NCT01931527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111405719|NCT02639429|Misoprostol|misoprostol|mesh-list
111405720|NCT02639429|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111405721|NCT02639429|Abortifacient Agents|abortifacient agents|mesh-ancestor
111405722|NCT02639429|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111405723|NCT02639429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111405724|NCT02639429|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111405725|NCT02639429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111405726|NCT02639429|Oxytocics|oxytocics|mesh-ancestor
111405727|NCT01936363|Niacinamide|niacinamide|mesh-list
111405728|NCT01936363|Vitamin B Complex|vitamin b complex|mesh-ancestor
111405729|NCT01936363|Vitamins|vitamins|mesh-ancestor
111405730|NCT01936363|Micronutrients|micronutrients|mesh-ancestor
111405731|NCT01936363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111405732|NCT04893629|Digoxin|digoxin|mesh-list
111405733|NCT04893629|Captopril|captopril|mesh-list
111405734|NCT04893629|Furosemide|furosemide|mesh-list
111405735|NCT04893629|Diuretics|diuretics|mesh-ancestor
111405736|NCT04893629|Natriuretic Agents|natriuretic agents|mesh-ancestor
111405737|NCT04893629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111405738|NCT04893629|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
111405739|NCT04893629|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111405740|NCT04893629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111405741|NCT04893629|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111405742|NCT04893629|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111405743|NCT04893629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111405744|NCT04893629|Protective Agents|protective agents|mesh-ancestor
111405745|NCT04893629|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
111405746|NCT04893629|Protease Inhibitors|protease inhibitors|mesh-ancestor
111405747|NCT04893629|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111405748|NCT04891991|Infliximab|infliximab|mesh-list
111405749|NCT04891991|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111405750|NCT04891991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111405751|NCT04891991|Dermatologic Agents|dermatologic agents|mesh-ancestor
111405752|NCT04891991|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111405753|NCT04891991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111405754|NCT01936519|Cyclosporine|cyclosporine|mesh-list
111405755|NCT01936519|Mycophenolic Acid|mycophenolic acid|mesh-list
111405756|NCT01936519|Everolimus|everolimus|mesh-list
111405757|NCT01936519|Tacrolimus|tacrolimus|mesh-list
111405758|NCT01936519|Cyclosporins|cyclosporins|mesh-list
111405759|NCT01936519|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
111405760|NCT01936519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111405761|NCT01936519|Immunologic Factors|immunologic factors|mesh-ancestor
111405762|NCT01936519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111405763|NCT01936519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111405764|NCT01936519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111405765|NCT01936519|Antifungal Agents|antifungal agents|mesh-ancestor
111405766|NCT01936519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111405767|NCT01936519|Dermatologic Agents|dermatologic agents|mesh-ancestor
111405768|NCT01936519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111405769|NCT01936519|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111405770|NCT01936519|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111405771|NCT01936519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111405772|NCT01936519|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111405773|NCT01936519|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111405774|NCT01936519|Antitubercular Agents|antitubercular agents|mesh-ancestor
111405775|NCT01936519|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111405776|NCT04507841|Niraparib|niraparib|mesh-list
111405777|NCT04507841|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111405778|NCT04507841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111405779|NCT04507841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111405780|NCT04507841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111405781|NCT01936909|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
111405782|NCT01936909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111405783|NCT01938079|Ketamine|ketamine|mesh-list
111405784|NCT01938079|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
111405785|NCT01938079|Analgesics|analgesics|mesh-ancestor
111405786|NCT01938079|Sensory System Agents|sensory system agents|mesh-ancestor
111405787|NCT01938079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111405788|NCT01938079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111405789|NCT01938079|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111405790|NCT01938079|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111405791|NCT01938079|Anesthetics, General|anesthetics, general|mesh-ancestor
111405792|NCT01938079|Anesthetics|anesthetics|mesh-ancestor
111405793|NCT01938079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111405794|NCT01938079|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111405795|NCT01938079|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111405796|NCT01938079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111405797|NCT01938079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111405798|NCT02641691|Leucovorin|leucovorin|mesh-list
111405799|NCT02641691|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
111405800|NCT02641691|Tetrahydrofolates|tetrahydrofolates|mesh-list
111405801|NCT02641691|Fluorouracil|fluorouracil|mesh-list
111405802|NCT02641691|Oxaliplatin|oxaliplatin|mesh-list
111405803|NCT02641691|Levoleucovorin|levoleucovorin|mesh-list
111405804|NCT02641691|Antimetabolites|antimetabolites|mesh-ancestor
111405805|NCT02641691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111405806|NCT02641691|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111405807|NCT02641691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111405808|NCT02641691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111405809|NCT02641691|Immunologic Factors|immunologic factors|mesh-ancestor
111405810|NCT02641691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111405811|NCT02641691|Antidotes|antidotes|mesh-ancestor
111405812|NCT02641691|Protective Agents|protective agents|mesh-ancestor
111405813|NCT02641691|Vitamin B Complex|vitamin b complex|mesh-ancestor
111405814|NCT02641691|Vitamins|vitamins|mesh-ancestor
111405815|NCT02641691|Micronutrients|micronutrients|mesh-ancestor
111405816|NCT04047251|Topotecan|topotecan|mesh-list
111405817|NCT04047251|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111405818|NCT04047251|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111405819|NCT04047251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111405820|NCT04047251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111405821|NCT04047251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111405822|NCT04045613|Atezolizumab|atezolizumab|mesh-list
111405823|NCT04045613|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111405824|NCT04045613|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111405825|NCT04045613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111405826|NCT04045613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111405827|NCT04045613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111405828|NCT04045613|Immunologic Factors|immunologic factors|mesh-ancestor
111405829|NCT04045613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111405830|NCT05588999|Salicylic Acid|salicylic acid|mesh-list
111405831|NCT05588999|Salicylates|salicylates|mesh-list
111405832|NCT05588999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111405833|NCT05588999|Antifungal Agents|antifungal agents|mesh-ancestor
111405834|NCT05588999|Keratolytic Agents|keratolytic agents|mesh-ancestor
111405835|NCT05588999|Dermatologic Agents|dermatologic agents|mesh-ancestor
111405836|NCT05588999|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111405837|NCT05588999|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111405838|NCT05588999|Analgesics|analgesics|mesh-ancestor
111405839|NCT05588999|Sensory System Agents|sensory system agents|mesh-ancestor
111405840|NCT05588999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111405841|NCT05588999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111405842|NCT05588999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111405843|NCT05588999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111405844|NCT05588999|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111405845|NCT05588999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111405846|NCT05588999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111405847|NCT01643928|Rituximab|rituximab|mesh-list
111405848|NCT01643928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111405849|NCT01643928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111405850|NCT01643928|Immunologic Factors|immunologic factors|mesh-ancestor
111405851|NCT01643928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111405852|NCT01643928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111405853|NCT04234997|Suvorexant|suvorexant|mesh-list
111405854|NCT04234997|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111405855|NCT04234997|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111405856|NCT04234997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111405857|NCT04234997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111405858|NCT04234997|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
111405859|NCT04234997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111405860|NCT04234997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111405861|NCT03750071|Avelumab|avelumab|mesh-list
111405862|NCT03750071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111405863|NCT03750071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111405864|NCT03635567|Paclitaxel|paclitaxel|mesh-list
111405865|NCT03635567|Bevacizumab|bevacizumab|mesh-list
111405866|NCT03635567|Carboplatin|carboplatin|mesh-list
111405867|NCT03635567|Pembrolizumab|pembrolizumab|mesh-list
111405868|NCT03635567|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111405869|NCT03635567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111405870|NCT03635567|Tubulin Modulators|tubulin modulators|mesh-ancestor
111405871|NCT03635567|Antimitotic Agents|antimitotic agents|mesh-ancestor
111405872|NCT03635567|Mitosis Modulators|mitosis modulators|mesh-ancestor
111405873|NCT03635567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111405874|NCT03635567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111405875|NCT03635567|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111405876|NCT03635567|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111405877|NCT03635567|Growth Substances|growth substances|mesh-ancestor
111405878|NCT03635567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111405879|NCT03635567|Growth Inhibitors|growth inhibitors|mesh-ancestor
111405880|NCT03635567|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111405881|NCT05588531|Cefepime|cefepime|mesh-list
111405882|NCT05588531|Avibactam|avibactam|mesh-list
111405883|NCT05588531|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111405884|NCT05588531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111405885|NCT05588531|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
111405886|NCT05588531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111405887|NCT05588531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111405888|NCT05588297|Bevacizumab|bevacizumab|mesh-list
111405889|NCT05588297|Nivolumab|nivolumab|mesh-list
111405890|NCT05588297|Capecitabine|capecitabine|mesh-list
111405891|NCT05588297|Oxaliplatin|oxaliplatin|mesh-list
111405892|NCT05588297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111405893|NCT05588297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111405894|NCT05588297|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111405895|NCT05588297|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111405896|NCT05588297|Growth Substances|growth substances|mesh-ancestor
111405897|NCT05588297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111405898|NCT05588297|Growth Inhibitors|growth inhibitors|mesh-ancestor
111405899|NCT05588297|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111405900|NCT05588297|Antimetabolites|antimetabolites|mesh-ancestor
111405901|NCT05588297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111405902|NCT05588297|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111405903|NCT05588219|Cisplatin|cisplatin|mesh-list
111405904|NCT05588219|Tislelizumab|tislelizumab|mesh-list
111405905|NCT05588219|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
111405906|NCT05588219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111405907|NCT05588219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111405908|NCT05588219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111405909|NCT02303405|Pioglitazone|pioglitazone|mesh-list
111405910|NCT02303405|Hydroxychloroquine|hydroxychloroquine|mesh-list
111405911|NCT02303405|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111405912|NCT02303405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111405913|NCT02303405|Antimalarials|antimalarials|mesh-ancestor
111405914|NCT02303405|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111405915|NCT02303405|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111405916|NCT02303405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111405917|NCT02303405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111405918|NCT02303405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111405919|NCT02303405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111405920|NCT02164955|Pomalidomide|pomalidomide|mesh-list
111405921|NCT02164955|Immunologic Factors|immunologic factors|mesh-ancestor
111405922|NCT02164955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111405923|NCT02164955|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111405924|NCT02164955|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111405925|NCT02164955|Growth Substances|growth substances|mesh-ancestor
111405926|NCT02164955|Growth Inhibitors|growth inhibitors|mesh-ancestor
111405927|NCT02164955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111405928|NCT05587361|Propranolol|propranolol|mesh-list
111405929|NCT05587361|Nicotine|nicotine|mesh-list
111405930|NCT05587361|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111405931|NCT05587361|Autonomic Agents|autonomic agents|mesh-ancestor
111405932|NCT05587361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111405933|NCT05587361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111405934|NCT05587361|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111405935|NCT05587361|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111405936|NCT05587361|Cholinergic Agents|cholinergic agents|mesh-ancestor
111405937|NCT05587361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111405938|NCT05587361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111405939|NCT05587361|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111405940|NCT05587361|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111405941|NCT05587361|Adrenergic Agents|adrenergic agents|mesh-ancestor
111405942|NCT05587361|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111405943|NCT05587361|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111405944|NCT05587361|Vasodilator Agents|vasodilator agents|mesh-ancestor
111405945|NCT01943461|Avelumab|avelumab|mesh-list
111405946|NCT01943461|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111405947|NCT01943461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111405948|NCT01943461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111405949|NCT01943461|Immunologic Factors|immunologic factors|mesh-ancestor
111405950|NCT01943461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111405951|NCT00422435|Paclitaxel|paclitaxel|mesh-list
111405952|NCT00422435|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111405953|NCT00422435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111405954|NCT00422435|Tubulin Modulators|tubulin modulators|mesh-ancestor
111405955|NCT00422435|Antimitotic Agents|antimitotic agents|mesh-ancestor
111405956|NCT00422435|Mitosis Modulators|mitosis modulators|mesh-ancestor
111405957|NCT00422435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111405958|NCT00702481|Nimotuzumab|nimotuzumab|mesh-list
111405959|NCT00702481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111405960|NCT00702481|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111405961|NCT03559049|Carboplatin|carboplatin|mesh-list
111405962|NCT03559049|Pembrolizumab|pembrolizumab|mesh-list
111405963|NCT03559049|Pemetrexed|pemetrexed|mesh-list
111405964|NCT03559049|Rucaparib|rucaparib|mesh-list
111405965|NCT03559049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111405966|NCT03559049|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111405967|NCT03559049|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111405968|NCT03559049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111405969|NCT03559049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111405970|NCT03559049|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111405971|NCT03559049|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111405972|NCT03559049|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111405973|NCT05559437|Bupivacaine|bupivacaine|mesh-list
111405974|NCT05559437|Levobupivacaine|levobupivacaine|mesh-list
111405975|NCT05559437|Anesthetics, Local|anesthetics, local|mesh-ancestor
111405976|NCT05559437|Anesthetics|anesthetics|mesh-ancestor
111405977|NCT05559437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111405978|NCT05559437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111405979|NCT05559437|Sensory System Agents|sensory system agents|mesh-ancestor
111405980|NCT05559437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111405981|NCT00367211|Naproxen|naproxen|mesh-list
111405982|NCT00367211|Omeprazole|omeprazole|mesh-list
111405983|NCT00367211|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111405984|NCT00367211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111405985|NCT00367211|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111405986|NCT00367211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111405987|NCT00367211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111405988|NCT00367211|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111405989|NCT00367211|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111405990|NCT00367211|Analgesics|analgesics|mesh-ancestor
111405991|NCT00367211|Sensory System Agents|sensory system agents|mesh-ancestor
111405992|NCT00367211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111405993|NCT00367211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111405994|NCT00367211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111405995|NCT00367211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111405996|NCT00367211|Gout Suppressants|gout suppressants|mesh-ancestor
111405997|NCT00367211|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111405998|NCT02646449|Mirtazapine|mirtazapine|mesh-list
111405999|NCT02646449|Antidepressive Agents|antidepressive agents|mesh-ancestor
111406000|NCT02646449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111406001|NCT02646449|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111406002|NCT02646449|Histamine Antagonists|histamine antagonists|mesh-ancestor
111406003|NCT02646449|Histamine Agents|histamine agents|mesh-ancestor
111406004|NCT02646449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111406005|NCT02646449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111406006|NCT02646449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111406007|NCT02646449|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111406008|NCT02646449|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111406009|NCT02646449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111406010|NCT02646449|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
111406011|NCT02646449|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111406012|NCT02646449|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111406013|NCT02646449|Adrenergic Agents|adrenergic agents|mesh-ancestor
111406014|NCT02646449|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111406015|NCT02646449|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111406016|NCT02646449|Serotonin Agents|serotonin agents|mesh-ancestor
111406017|NCT02646449|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111406018|NCT04339361|Lidocaine|lidocaine|mesh-list
111406019|NCT04339361|Dinoprostone|dinoprostone|mesh-list
111406020|NCT04339361|Anesthetics, Local|anesthetics, local|mesh-ancestor
111406021|NCT04339361|Anesthetics|anesthetics|mesh-ancestor
111406022|NCT04339361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111406023|NCT04339361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111406024|NCT04339361|Sensory System Agents|sensory system agents|mesh-ancestor
111406025|NCT04339361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111406026|NCT04339361|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111406027|NCT04339361|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111406028|NCT04339361|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111406029|NCT04339361|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111406030|NCT04339361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111406031|NCT04339361|Oxytocics|oxytocics|mesh-ancestor
111406032|NCT04339361|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111406033|NCT05369351|Mirabegron|mirabegron|mesh-list
111406034|NCT05369351|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
111406035|NCT05369351|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111406036|NCT05369351|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111406037|NCT05369351|Adrenergic Agents|adrenergic agents|mesh-ancestor
111406038|NCT05369351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111406039|NCT05369351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111406040|NCT05369351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111406041|NCT05369351|Urological Agents|urological agents|mesh-ancestor
111406042|NCT02653391|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111406043|NCT02653391|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110883212|NCT03671070|Mydriatics|mydriatics|mesh-ancestor
111406044|NCT05303987|Dexmedetomidine|dexmedetomidine|mesh-list
111406045|NCT05303987|Propofol|propofol|mesh-list
111406046|NCT05303987|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111406047|NCT05303987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111406048|NCT05303987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111406049|NCT05303987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111406050|NCT05303987|Analgesics|analgesics|mesh-ancestor
111406051|NCT05303987|Sensory System Agents|sensory system agents|mesh-ancestor
111406052|NCT05303987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111406053|NCT05303987|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111406054|NCT05303987|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111406055|NCT05303987|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111406056|NCT05303987|Adrenergic Agents|adrenergic agents|mesh-ancestor
111406057|NCT05303987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111406058|NCT05303987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111406059|NCT05303987|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111406060|NCT05303987|Anesthetics, General|anesthetics, general|mesh-ancestor
111406061|NCT05303987|Anesthetics|anesthetics|mesh-ancestor
111406062|NCT02654483|Serlopitant|serlopitant|mesh-list
111406063|NCT02654483|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
111406064|NCT02654483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111406065|NCT02654483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111406066|NCT02654483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111406067|NCT02655653|Tranexamic Acid|tranexamic acid|mesh-list
111406068|NCT02655653|Aminocaproic Acid|aminocaproic acid|mesh-list
111406069|NCT02655653|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111406070|NCT02655653|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111406071|NCT02655653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111406072|NCT02655653|Hemostatics|hemostatics|mesh-ancestor
111406073|NCT02655653|Coagulants|coagulants|mesh-ancestor
111406074|NCT03081143|Paclitaxel|paclitaxel|mesh-list
111406075|NCT03081143|Ramucirumab|ramucirumab|mesh-list
111406076|NCT03081143|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111406077|NCT03081143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111406078|NCT03081143|Tubulin Modulators|tubulin modulators|mesh-ancestor
111406079|NCT03081143|Antimitotic Agents|antimitotic agents|mesh-ancestor
111406080|NCT03081143|Mitosis Modulators|mitosis modulators|mesh-ancestor
111406081|NCT03081143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111406082|NCT02658461|Trastuzumab|trastuzumab|mesh-list
111406083|NCT02658461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111406084|NCT02658461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111406085|NCT00367913|Clarithromycin|clarithromycin|mesh-list
111406086|NCT00367913|Ciprofloxacin|ciprofloxacin|mesh-list
111406087|NCT00367913|Rifampin|rifampin|mesh-list
111406088|NCT00367913|Ethambutol|ethambutol|mesh-list
111406089|NCT00367913|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111406090|NCT00367913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111406091|NCT00367913|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111406092|NCT00367913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111406093|NCT00367913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111406094|NCT00367913|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111406095|NCT00367913|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111406096|NCT00367913|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111406097|NCT00367913|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111406098|NCT00367913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111406099|NCT00367913|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111406100|NCT00367913|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111406101|NCT00367913|Antitubercular Agents|antitubercular agents|mesh-ancestor
111406102|NCT00367913|Leprostatic Agents|leprostatic agents|mesh-ancestor
111406103|NCT00367913|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111406104|NCT00367913|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111406105|NCT00367913|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111406106|NCT00367913|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
111406107|NCT00367913|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
111406108|NCT00367913|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
111406109|NCT00367913|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111406110|NCT02659787|Buprenorphine|buprenorphine|mesh-list
111406111|NCT02659787|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111406112|NCT02659787|Narcotics|narcotics|mesh-ancestor
111406113|NCT02659787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111406114|NCT02659787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111406115|NCT02659787|Analgesics|analgesics|mesh-ancestor
111406116|NCT02659787|Sensory System Agents|sensory system agents|mesh-ancestor
111406117|NCT02659787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111406118|NCT02659787|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111406119|NCT05044871|Paclitaxel|paclitaxel|mesh-list
111406120|NCT05044871|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111406121|NCT05044871|Bevacizumab|bevacizumab|mesh-list
111406122|NCT05044871|Tislelizumab|tislelizumab|mesh-list
111406123|NCT05044871|Pamiparib|pamiparib|mesh-list
111406124|NCT05044871|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111406125|NCT05044871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111406126|NCT05044871|Tubulin Modulators|tubulin modulators|mesh-ancestor
111406127|NCT05044871|Antimitotic Agents|antimitotic agents|mesh-ancestor
111406128|NCT05044871|Mitosis Modulators|mitosis modulators|mesh-ancestor
111406129|NCT05044871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111406130|NCT05044871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111406131|NCT05044871|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111406132|NCT05044871|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111406133|NCT05044871|Growth Substances|growth substances|mesh-ancestor
111406134|NCT05044871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111406135|NCT05044871|Growth Inhibitors|growth inhibitors|mesh-ancestor
111406136|NCT05044871|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111406137|NCT05044871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111406138|NCT04931693|Acetaminophen|acetaminophen|mesh-list
111406139|NCT04931693|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111406140|NCT04931693|Analgesics|analgesics|mesh-ancestor
111406141|NCT04931693|Sensory System Agents|sensory system agents|mesh-ancestor
111406142|NCT04931693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111406143|NCT04931693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111406144|NCT04931693|Antipyretics|antipyretics|mesh-ancestor
111406145|NCT02271594|Insulin|insulin|mesh-list
111406146|NCT02271594|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111406147|NCT02271594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111406148|NCT04817969|Cimetidine|cimetidine|mesh-list
111406150|NCT04817969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111406151|NCT04817969|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
111406152|NCT04817969|Histamine Antagonists|histamine antagonists|mesh-ancestor
111406153|NCT04817969|Histamine Agents|histamine agents|mesh-ancestor
111406154|NCT04817969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111406155|NCT04817969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111406156|NCT04817969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111406157|NCT04817969|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111406158|NCT04817969|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111406159|NCT04817969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111406160|NCT05649228|Capsaicin|capsaicin|mesh-list
111406161|NCT05649228|Antipruritics|antipruritics|mesh-ancestor
111406162|NCT05649228|Dermatologic Agents|dermatologic agents|mesh-ancestor
111406163|NCT05649228|Sensory System Agents|sensory system agents|mesh-ancestor
111406164|NCT05649228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111406165|NCT05649228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111406166|NCT02350517|Paclitaxel|paclitaxel|mesh-list
111406167|NCT02350517|Endostar protein|endostar protein|mesh-list
111406168|NCT02350517|Endostatins|endostatins|mesh-list
111406169|NCT02350517|Nedaplatin|nedaplatin|mesh-list
111406170|NCT02350517|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111406171|NCT02350517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111406172|NCT02350517|Tubulin Modulators|tubulin modulators|mesh-ancestor
111406173|NCT02350517|Antimitotic Agents|antimitotic agents|mesh-ancestor
111406174|NCT02350517|Mitosis Modulators|mitosis modulators|mesh-ancestor
111406175|NCT02350517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111406176|NCT02350517|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111406177|NCT02350517|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111406178|NCT02350517|Growth Substances|growth substances|mesh-ancestor
111406179|NCT02350517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111406180|NCT02350517|Growth Inhibitors|growth inhibitors|mesh-ancestor
111406181|NCT02270736|Botulinum Toxins|botulinum toxins|mesh-list
111406182|NCT02270736|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111406183|NCT02270736|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111406184|NCT02270736|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
111406185|NCT02270736|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111406186|NCT02270736|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111406187|NCT02270736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111406188|NCT02270736|Cholinergic Agents|cholinergic agents|mesh-ancestor
111406189|NCT02270736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111406190|NCT02270736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111406191|NCT02270736|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111406192|NCT02270736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111406193|NCT02205047|Fluorouracil|fluorouracil|mesh-list
111406194|NCT02205047|Capecitabine|capecitabine|mesh-list
111406195|NCT02205047|Trastuzumab|trastuzumab|mesh-list
111406196|NCT02205047|Pertuzumab|pertuzumab|mesh-list
111406197|NCT02205047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111406198|NCT02205047|Antimetabolites|antimetabolites|mesh-ancestor
111406199|NCT02205047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111406200|NCT02205047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111406201|NCT02205047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111406202|NCT02205047|Immunologic Factors|immunologic factors|mesh-ancestor
111406203|NCT02205047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111406204|NCT02205047|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111406205|NCT04878198|Melatonin|melatonin|mesh-list
111406206|NCT04878198|Antioxidants|antioxidants|mesh-ancestor
111406207|NCT04878198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111406208|NCT04878198|Protective Agents|protective agents|mesh-ancestor
111406209|NCT04878198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111406210|NCT04878198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111406211|NCT04651595|Morphine|morphine|mesh-list
111406212|NCT04651595|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111406213|NCT04651595|Narcotics|narcotics|mesh-ancestor
111406214|NCT04651595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111406215|NCT04651595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111406216|NCT04651595|Analgesics|analgesics|mesh-ancestor
111406217|NCT04651595|Sensory System Agents|sensory system agents|mesh-ancestor
111406218|NCT04651595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111406219|NCT02669615|Melphalan|melphalan|mesh-list
111406220|NCT02669615|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111406221|NCT02669615|Alkylating Agents|alkylating agents|mesh-ancestor
111406222|NCT02669615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111406223|NCT02669615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111406224|NCT02669615|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111406225|NCT02669615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111406226|NCT02669615|Immunologic Factors|immunologic factors|mesh-ancestor
111406227|NCT02669615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111406228|NCT02672111|Buprenorphine|buprenorphine|mesh-list
111406229|NCT02672111|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111406230|NCT02672111|Narcotics|narcotics|mesh-ancestor
111406231|NCT02672111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111406232|NCT02672111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111406233|NCT02672111|Analgesics|analgesics|mesh-ancestor
111406234|NCT02672111|Sensory System Agents|sensory system agents|mesh-ancestor
111406235|NCT02672111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111406236|NCT02672111|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111406237|NCT00586391|Ipilimumab|ipilimumab|mesh-list
111406238|NCT00586391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111406239|NCT00586391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111406240|NCT00586391|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111406241|NCT00586391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111406242|NCT05432843|Pregabalin|pregabalin|mesh-list
111406243|NCT05432843|Analgesics|analgesics|mesh-ancestor
111406244|NCT05432843|Sensory System Agents|sensory system agents|mesh-ancestor
111406245|NCT05432843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111406246|NCT05432843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111406247|NCT05432843|Anticonvulsants|anticonvulsants|mesh-ancestor
111406248|NCT05432843|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111406249|NCT05432843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111406250|NCT05432843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111406251|NCT05432843|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111406252|NCT05432843|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111406253|NCT05432843|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111406254|NCT05432843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111406255|NCT05432843|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111406256|NCT02679911|Ciclopirox|ciclopirox|mesh-list
111406257|NCT02679911|Amorolfine|amorolfine|mesh-list
111406258|NCT02679911|Antifungal Agents|antifungal agents|mesh-ancestor
111406259|NCT02679911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111406260|NCT02680301|Triamcinolone|triamcinolone|mesh-list
111406261|NCT02680301|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
111406262|NCT02680301|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
111406263|NCT02680301|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
111406264|NCT02680301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111406265|NCT02680301|Glucocorticoids|glucocorticoids|mesh-ancestor
111406266|NCT02680301|Hormones|hormones|mesh-ancestor
111406267|NCT02680301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111406268|NCT02680301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111406269|NCT02680301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111406270|NCT02680301|Immunologic Factors|immunologic factors|mesh-ancestor
111406271|NCT02680301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111406272|NCT02680301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111406273|NCT02680457|Insulin|insulin|mesh-list
111406274|NCT02680457|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111406275|NCT02680457|Insulin Glargine|insulin glargine|mesh-list
111406276|NCT02680457|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111406277|NCT02680457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111406278|NCT02283762|Riociguat|riociguat|mesh-list
111406279|NCT02283762|Enzyme Activators|enzyme activators|mesh-ancestor
111406280|NCT02283762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111406281|NCT02692391|Indomethacin|indomethacin|mesh-list
111406282|NCT02692391|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111406283|NCT02692391|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111406284|NCT02692391|Analgesics|analgesics|mesh-ancestor
111406285|NCT02692391|Sensory System Agents|sensory system agents|mesh-ancestor
111406286|NCT02692391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111406287|NCT02692391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111406288|NCT02692391|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110883459|NCT03668964|Vitamin D|vitamin d|mesh-list
111406289|NCT02692391|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111406290|NCT02692391|Gout Suppressants|gout suppressants|mesh-ancestor
111406291|NCT02692391|Tocolytic Agents|tocolytic agents|mesh-ancestor
111406292|NCT02692391|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111406293|NCT02692391|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111406294|NCT02692391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111406295|NCT02692391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111406296|NCT02696291|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111406297|NCT02682563|Dapagliflozin|dapagliflozin|mesh-list
111406298|NCT02682563|Gliclazide|gliclazide|mesh-list
111406299|NCT02682563|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111406300|NCT02682563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111406301|NCT02682563|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111406302|NCT02682563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111406303|NCT02697071|Ketamine|ketamine|mesh-list
111406304|NCT02697071|Analgesics|analgesics|mesh-ancestor
111406305|NCT02697071|Sensory System Agents|sensory system agents|mesh-ancestor
111406306|NCT02697071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111406307|NCT02697071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111406308|NCT02697071|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111406309|NCT02697071|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111406310|NCT02697071|Anesthetics, General|anesthetics, general|mesh-ancestor
111406311|NCT02697071|Anesthetics|anesthetics|mesh-ancestor
111406312|NCT02697071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111406313|NCT02697071|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111406314|NCT02697071|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111406315|NCT02697071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111406316|NCT02697071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111406317|NCT02283294|Warfarin|warfarin|mesh-list
111406318|NCT02283294|Apixaban|apixaban|mesh-list
111406319|NCT02283294|Anticoagulants|anticoagulants|mesh-ancestor
111406320|NCT02283294|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111406321|NCT02283294|Antithrombins|antithrombins|mesh-ancestor
111406322|NCT02283294|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111406323|NCT02283294|Protease Inhibitors|protease inhibitors|mesh-ancestor
111406324|NCT02283294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111406325|NCT02283294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111406326|NCT05648994|Paclitaxel|paclitaxel|mesh-list
111406327|NCT05648994|Cyclophosphamide|cyclophosphamide|mesh-list
111406328|NCT05648994|Fludarabine|fludarabine|mesh-list
111406329|NCT05648994|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111406330|NCT05648994|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111406331|NCT05648994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111406332|NCT05648994|Tubulin Modulators|tubulin modulators|mesh-ancestor
111406333|NCT05648994|Antimitotic Agents|antimitotic agents|mesh-ancestor
111406334|NCT05648994|Mitosis Modulators|mitosis modulators|mesh-ancestor
111406335|NCT05648994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111406336|NCT05648994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111406337|NCT05648994|Immunologic Factors|immunologic factors|mesh-ancestor
111406338|NCT05648994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111406339|NCT05648994|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111406340|NCT05648994|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111406341|NCT05648994|Alkylating Agents|alkylating agents|mesh-ancestor
111406342|NCT05648994|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111406343|NCT04869306|Hyaluronic Acid|hyaluronic acid|mesh-list
111406344|NCT04869306|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111406345|NCT04869306|Immunologic Factors|immunologic factors|mesh-ancestor
111406346|NCT04869306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111406347|NCT04869306|Viscosupplements|viscosupplements|mesh-ancestor
111406348|NCT04869306|Protective Agents|protective agents|mesh-ancestor
111406349|NCT02268864|Simeprevir|simeprevir|mesh-list
111406350|NCT02268864|Antiviral Agents|antiviral agents|mesh-ancestor
111406351|NCT02268864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111406352|NCT02268864|Protease Inhibitors|protease inhibitors|mesh-ancestor
111406353|NCT02268864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111406354|NCT02268864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111406355|NCT02703779|Plerixafor|plerixafor|mesh-list
111406356|NCT02703779|Bortezomib|bortezomib|mesh-list
111406357|NCT02703779|Lenograstim|lenograstim|mesh-list
111406358|NCT02703779|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111406359|NCT02703779|Immunologic Factors|immunologic factors|mesh-ancestor
111406360|NCT02703779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111406361|NCT02703779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111406362|NCT02703779|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111406363|NCT02703779|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111406364|NCT02703779|Antiviral Agents|antiviral agents|mesh-ancestor
111406365|NCT02703779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111406366|NCT04738955|Micafungin|micafungin|mesh-list
111406367|NCT04738955|Antifungal Agents|antifungal agents|mesh-ancestor
111406368|NCT04738955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111406369|NCT02268396|Glycopyrrolate|glycopyrrolate|mesh-list
111406370|NCT02268396|Formoterol Fumarate|formoterol fumarate|mesh-list
111406371|NCT02268396|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111406372|NCT02268396|Autonomic Agents|autonomic agents|mesh-ancestor
111406373|NCT02268396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111406374|NCT02268396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111406375|NCT02268396|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111406376|NCT02268396|Respiratory System Agents|respiratory system agents|mesh-ancestor
111406377|NCT02268396|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111406378|NCT02268396|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111406379|NCT02268396|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111406380|NCT02268396|Adrenergic Agents|adrenergic agents|mesh-ancestor
111406381|NCT02268396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111406382|NCT02268396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111406383|NCT02268396|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111406384|NCT02268396|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111406385|NCT02268396|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111406386|NCT02268396|Cholinergic Agents|cholinergic agents|mesh-ancestor
111406387|NCT05648526|Ketamine|ketamine|mesh-list
111406388|NCT05648526|Analgesics|analgesics|mesh-ancestor
111406389|NCT05648526|Sensory System Agents|sensory system agents|mesh-ancestor
111406390|NCT05648526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111406391|NCT05648526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111406392|NCT05648526|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111406393|NCT05648526|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111406394|NCT05648526|Anesthetics, General|anesthetics, general|mesh-ancestor
111406395|NCT05648526|Anesthetics|anesthetics|mesh-ancestor
111406396|NCT05648526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111406397|NCT05648526|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111406398|NCT05648526|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111406399|NCT05648526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111406400|NCT05648526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111406401|NCT02705807|Epoprostenol|epoprostenol|mesh-list
111406402|NCT02705807|Tezosentan|tezosentan|mesh-list
111406403|NCT02705807|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111406404|NCT02705807|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111406405|NCT02705807|Vasodilator Agents|vasodilator agents|mesh-ancestor
111406406|NCT01643772|Oxycodone|oxycodone|mesh-list
111406407|NCT01643772|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111406408|NCT01643772|Narcotics|narcotics|mesh-ancestor
111406409|NCT01643772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111406410|NCT01643772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111406411|NCT01643772|Analgesics|analgesics|mesh-ancestor
111406412|NCT01643772|Sensory System Agents|sensory system agents|mesh-ancestor
111406413|NCT01643772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111406414|NCT02707523|Azithromycin|azithromycin|mesh-list
111406415|NCT02707523|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111406416|NCT02707523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111406417|NCT02712047|Fluticasone|fluticasone|mesh-list
111406418|NCT02712047|Xhance|xhance|mesh-list
111406419|NCT02712047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111406420|NCT02712047|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111406421|NCT02712047|Autonomic Agents|autonomic agents|mesh-ancestor
111406422|NCT02712047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111406423|NCT02712047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111406424|NCT02712047|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111406425|NCT02712047|Respiratory System Agents|respiratory system agents|mesh-ancestor
111406426|NCT02712047|Dermatologic Agents|dermatologic agents|mesh-ancestor
111406427|NCT02712047|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111406428|NCT02717273|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111406429|NCT02717273|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
111406430|NCT02717273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111406431|NCT02717273|Antitubercular Agents|antitubercular agents|mesh-ancestor
111406432|NCT00369239|Risperidone|risperidone|mesh-list
111406433|NCT00369239|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111406434|NCT00369239|Serotonin Agents|serotonin agents|mesh-ancestor
111406435|NCT00369239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111406436|NCT00369239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111406437|NCT00369239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111406438|NCT00369239|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111406439|NCT00369239|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111406440|NCT00369239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111406441|NCT00369239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111406442|NCT00369239|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111406443|NCT00369239|Dopamine Agents|dopamine agents|mesh-ancestor
111406444|NCT03833921|Prednisone|prednisone|mesh-list
111406445|NCT03833921|Abiraterone Acetate|abiraterone acetate|mesh-list
111406446|NCT03833921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111406447|NCT03833921|Glucocorticoids|glucocorticoids|mesh-ancestor
111406448|NCT03833921|Hormones|hormones|mesh-ancestor
111406449|NCT03833921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111406450|NCT03833921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111406451|NCT03833921|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111406453|NCT03833921|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111406454|NCT03833921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111406455|NCT03833921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111406456|NCT03833921|Hormone Antagonists|hormone antagonists|mesh-ancestor
111406457|NCT03833921|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111406458|NCT05215925|Carboplatin|carboplatin|mesh-list
111406459|NCT05215925|Docetaxel|docetaxel|mesh-list
111406460|NCT05215925|Pemetrexed|pemetrexed|mesh-list
111406461|NCT05215925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111406462|NCT05215925|Tubulin Modulators|tubulin modulators|mesh-ancestor
111406463|NCT05215925|Antimitotic Agents|antimitotic agents|mesh-ancestor
111406464|NCT05215925|Mitosis Modulators|mitosis modulators|mesh-ancestor
111406465|NCT05215925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111406466|NCT05215925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111406467|NCT05215925|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111406468|NCT05215925|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111406469|NCT05159687|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
111406470|NCT05159687|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111406471|NCT05159687|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111406472|NCT05159687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111406473|NCT05159687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111406474|NCT05159687|Adrenergic Agents|adrenergic agents|mesh-ancestor
111406475|NCT05159687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111406476|NCT05159687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111406477|NCT02721017|Fentanyl|fentanyl|mesh-list
111406478|NCT02721017|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111406479|NCT02721017|Narcotics|narcotics|mesh-ancestor
111406480|NCT02721017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111406481|NCT02721017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111406482|NCT02721017|Analgesics|analgesics|mesh-ancestor
111406483|NCT02721017|Sensory System Agents|sensory system agents|mesh-ancestor
111406484|NCT02721017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111406485|NCT02721017|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111406486|NCT02721017|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111406487|NCT02721017|Anesthetics, General|anesthetics, general|mesh-ancestor
111406488|NCT02721017|Anesthetics|anesthetics|mesh-ancestor
111406489|NCT02721641|Trastuzumab|trastuzumab|mesh-list
111406490|NCT02721641|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111406491|NCT02721641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111406492|NCT03649061|Etanercept|etanercept|mesh-list
111406493|NCT03649061|Leflunomide|leflunomide|mesh-list
111406494|NCT03649061|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111406495|NCT03649061|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111406496|NCT03649061|Analgesics|analgesics|mesh-ancestor
111406497|NCT03649061|Sensory System Agents|sensory system agents|mesh-ancestor
111406498|NCT03649061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111406499|NCT03649061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111406500|NCT03649061|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111406501|NCT03649061|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111406502|NCT03649061|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111406503|NCT03649061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111406504|NCT03649061|Immunologic Factors|immunologic factors|mesh-ancestor
111406505|NCT03649061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111406506|NCT03649061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111406507|NCT02265744|Antibodies|antibodies|mesh-list
111406508|NCT02265744|Immunologic Factors|immunologic factors|mesh-ancestor
111406509|NCT02265744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111406510|NCT05109143|Indomethacin|indomethacin|mesh-list
111406511|NCT05109143|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111406512|NCT05109143|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111406513|NCT05109143|Analgesics|analgesics|mesh-ancestor
111406514|NCT05109143|Sensory System Agents|sensory system agents|mesh-ancestor
111406515|NCT05109143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111406516|NCT05109143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111406517|NCT05109143|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111406518|NCT05109143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111406519|NCT05109143|Gout Suppressants|gout suppressants|mesh-ancestor
111406520|NCT05109143|Tocolytic Agents|tocolytic agents|mesh-ancestor
111406521|NCT05109143|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111406522|NCT05109143|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111130911|NCT03075241|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111406523|NCT05109143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111406524|NCT05109143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111406525|NCT03614663|Cannabidiol|cannabidiol|mesh-list
111406526|NCT03614663|Anticonvulsants|anticonvulsants|mesh-ancestor
111406527|NCT00085735|Cyclophosphamide|cyclophosphamide|mesh-list
111406528|NCT00085735|Lomustine|lomustine|mesh-list
111406529|NCT00085735|Cisplatin|cisplatin|mesh-list
111406530|NCT00085735|Vincristine|vincristine|mesh-list
111406531|NCT00085735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111406532|NCT00085735|Immunologic Factors|immunologic factors|mesh-ancestor
111406533|NCT00085735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111406534|NCT00085735|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111406535|NCT00085735|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111406536|NCT00085735|Alkylating Agents|alkylating agents|mesh-ancestor
111406537|NCT00085735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111406538|NCT00085735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111406539|NCT00085735|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111406540|NCT00085735|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111406541|NCT00085735|Tubulin Modulators|tubulin modulators|mesh-ancestor
111406542|NCT00085735|Antimitotic Agents|antimitotic agents|mesh-ancestor
111406543|NCT00085735|Mitosis Modulators|mitosis modulators|mesh-ancestor
111406544|NCT03578783|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
111406545|NCT03578783|Anesthetics, Local|anesthetics, local|mesh-ancestor
111406546|NCT03578783|Anesthetics|anesthetics|mesh-ancestor
110883703|NCT03665766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111406547|NCT03578783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111406548|NCT03578783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111406549|NCT03578783|Sensory System Agents|sensory system agents|mesh-ancestor
111406550|NCT03578783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111406551|NCT03578783|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
111406552|NCT05544786|Ritonavir|ritonavir|mesh-list
111406553|NCT05544786|Nirmatrelvir|nirmatrelvir|mesh-list
111406554|NCT05544786|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
111406555|NCT05544786|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111406556|NCT05544786|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111406557|NCT05544786|Protease Inhibitors|protease inhibitors|mesh-ancestor
111406558|NCT05544786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111406559|NCT05544786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111406560|NCT05544786|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111406561|NCT05544786|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111406562|NCT05544786|Antiviral Agents|antiviral agents|mesh-ancestor
111406563|NCT05544786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111406564|NCT05544786|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111406565|NCT05544786|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111406566|NCT02726789|Interferons|interferons|mesh-list
111406567|NCT02726789|Interferon-alpha|interferon-alpha|mesh-list
111406568|NCT02726789|Interferon alpha-2|interferon alpha-2|mesh-list
111406569|NCT02726789|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
111406570|NCT02726789|Entecavir|entecavir|mesh-list
111406571|NCT02726789|REP 2139|rep 2139|mesh-list
111406572|NCT02726789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111406573|NCT02726789|Antiviral Agents|antiviral agents|mesh-ancestor
111406574|NCT02726789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111406575|NCT02726789|Immunologic Factors|immunologic factors|mesh-ancestor
111406576|NCT02726789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111406577|NCT02731313|Trastuzumab|trastuzumab|mesh-list
111406578|NCT02731313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111406579|NCT02731313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111406580|NCT02281591|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
111406581|NCT02281591|Anticonvulsants|anticonvulsants|mesh-ancestor
111406582|NCT02281591|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111406583|NCT02281591|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111406584|NCT02281591|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111406585|NCT02281591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111406586|NCT02731469|Darbepoetin alfa|darbepoetin alfa|mesh-list
111406587|NCT02731469|Hematinics|hematinics|mesh-ancestor
111406588|NCT01944319|Meropenem|meropenem|mesh-list
111406589|NCT01944319|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111406590|NCT01944319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111406591|NCT00368303|Paroxetine|paroxetine|mesh-list
111406592|NCT00368303|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111406593|NCT00368303|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111406594|NCT00368303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111406595|NCT00368303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111406596|NCT00368303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111406597|NCT00368303|Serotonin Agents|serotonin agents|mesh-ancestor
111406598|NCT00368303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111406599|NCT00368303|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111406600|NCT00368303|Antidepressive Agents|antidepressive agents|mesh-ancestor
111406601|NCT00368303|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111406602|NCT00368303|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111406603|NCT00368303|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111406604|NCT00368303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111406605|NCT00368381|Hydrocortisone|hydrocortisone|mesh-list
111406606|NCT00368381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111406607|NCT05020145|Vaccines|vaccines|mesh-list
111406608|NCT05020145|Immunologic Factors|immunologic factors|mesh-ancestor
111406609|NCT05020145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111406610|NCT02734355|Amlodipine|amlodipine|mesh-list
111406611|NCT02734355|Telmisartan|telmisartan|mesh-list
111406612|NCT02734355|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
111406613|NCT02734355|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111406614|NCT02734355|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111406615|NCT02734355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111406616|NCT02734355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111406617|NCT02734355|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111406618|NCT02734355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111406619|NCT02734355|Vasodilator Agents|vasodilator agents|mesh-ancestor
111406620|NCT02734355|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111406621|NCT02734355|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111406622|NCT00369395|Volociximab|volociximab|mesh-list
111406623|NCT00369395|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111406624|NCT00369395|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111406625|NCT00369395|Growth Substances|growth substances|mesh-ancestor
111406626|NCT00369395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111406627|NCT00369395|Growth Inhibitors|growth inhibitors|mesh-ancestor
111406628|NCT00369395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111406629|NCT01947907|Hormones|hormones|mesh-list
111406630|NCT01947907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111406631|NCT01947907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111406632|NCT01948141|Nintedanib|nintedanib|mesh-list
111406633|NCT01948141|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
111406634|NCT01948141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111406635|NCT01948141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111406636|NCT01948141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111406637|NCT01948141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111406638|NCT04938323|BCG Vaccine|bcg vaccine|mesh-list
111406639|NCT04938323|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111406640|NCT04938323|Immunologic Factors|immunologic factors|mesh-ancestor
111406641|NCT04938323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111406642|NCT05446493|Tadalafil|tadalafil|mesh-list
111406643|NCT05446493|Vasodilator Agents|vasodilator agents|mesh-ancestor
111406644|NCT05446493|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111406645|NCT05446493|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111406646|NCT05446493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111406647|NCT05446493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111406648|NCT05446493|Urological Agents|urological agents|mesh-ancestor
111406649|NCT05445479|Doxycycline|doxycycline|mesh-list
111406650|NCT05445479|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111406651|NCT05445479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111406652|NCT05445479|Antimalarials|antimalarials|mesh-ancestor
111406653|NCT05445479|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111406654|NCT05445479|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111406655|NCT02711735|Vaccines|vaccines|mesh-list
111406656|NCT02711735|Immunologic Factors|immunologic factors|mesh-ancestor
111406657|NCT02711735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111406658|NCT05445011|Cyclophosphamide|cyclophosphamide|mesh-list
111406659|NCT05445011|Fludarabine|fludarabine|mesh-list
111406660|NCT05445011|Fludarabine phosphate|fludarabine phosphate|mesh-list
111406661|NCT05445011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111406662|NCT05445011|Immunologic Factors|immunologic factors|mesh-ancestor
111406663|NCT05445011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111406664|NCT05445011|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111406665|NCT05445011|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111406666|NCT05445011|Alkylating Agents|alkylating agents|mesh-ancestor
111406667|NCT05445011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111406668|NCT05445011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111406669|NCT05445011|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111406670|NCT05445011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111406671|NCT05445011|Antimetabolites|antimetabolites|mesh-ancestor
111406672|NCT04744181|Folic Acid|folic acid|mesh-list
111406673|NCT04744181|Vitamin B Complex|vitamin b complex|mesh-list
111406674|NCT04744181|Vitamins|vitamins|mesh-ancestor
111406675|NCT04744181|Micronutrients|micronutrients|mesh-ancestor
111406676|NCT04744181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111406677|NCT04744181|Hematinics|hematinics|mesh-ancestor
111406678|NCT01970345|Mecasermin|mecasermin|mesh-list
111406679|NCT01970345|Growth Substances|growth substances|mesh-ancestor
111406680|NCT01970345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111406681|NCT00619931|APD791|apd791|mesh-list
111406682|NCT00619931|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111406683|NCT00619931|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111406684|NCT00619931|Serotonin Agents|serotonin agents|mesh-ancestor
111406685|NCT00619931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111406686|NCT00619931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111406687|NCT00619931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111406688|NCT04739111|Antibodies|antibodies|mesh-list
111406689|NCT04739111|Immunoglobulins|immunoglobulins|mesh-list
111406690|NCT04739111|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111406691|NCT04739111|Immunologic Factors|immunologic factors|mesh-ancestor
111406692|NCT04739111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111406693|NCT04768231|Rifampin|rifampin|mesh-list
111406694|NCT04768231|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111406695|NCT04768231|Antitubercular Agents|antitubercular agents|mesh-ancestor
111406696|NCT04768231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111406697|NCT04768231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111406698|NCT04768231|Leprostatic Agents|leprostatic agents|mesh-ancestor
111406699|NCT04768231|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111406700|NCT04768231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111406701|NCT04768231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111406702|NCT04768231|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111406703|NCT04768231|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111406704|NCT04768231|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
111406705|NCT04768231|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
111406706|NCT04768231|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
111406707|NCT04768231|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111406708|NCT05452187|Immunosuppressive Agents|immunosuppressive agents|mesh-list
111406709|NCT05452187|Immunologic Factors|immunologic factors|mesh-ancestor
111406710|NCT05452187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111406711|NCT01889797|Rituximab|rituximab|mesh-list
111406712|NCT01889797|Obinutuzumab|obinutuzumab|mesh-list
111406713|NCT01889797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111406714|NCT01889797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111406715|NCT01889797|Immunologic Factors|immunologic factors|mesh-ancestor
111406716|NCT01889797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111406717|NCT01889797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111406718|NCT00369551|Paclitaxel|paclitaxel|mesh-list
111406719|NCT00369551|Bevacizumab|bevacizumab|mesh-list
111406720|NCT00369551|Carboplatin|carboplatin|mesh-list
111406721|NCT00369551|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111406722|NCT00369551|Antibodies|antibodies|mesh-list
111406723|NCT00369551|Immunoglobulins|immunoglobulins|mesh-list
111406724|NCT00369551|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111406725|NCT00369551|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111406726|NCT00369551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111406727|NCT00369551|Tubulin Modulators|tubulin modulators|mesh-ancestor
111406728|NCT00369551|Antimitotic Agents|antimitotic agents|mesh-ancestor
111406729|NCT00369551|Mitosis Modulators|mitosis modulators|mesh-ancestor
111406730|NCT00369551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110883894|NCT02999178|Nintedanib|nintedanib|mesh-list
111406731|NCT00369551|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111406732|NCT00369551|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111406733|NCT00369551|Growth Substances|growth substances|mesh-ancestor
111406734|NCT00369551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111406735|NCT00369551|Growth Inhibitors|growth inhibitors|mesh-ancestor
111406736|NCT00369551|Immunologic Factors|immunologic factors|mesh-ancestor
111406737|NCT04537793|Ivacaftor|ivacaftor|mesh-list
111406738|NCT04537793|Elexacaftor|elexacaftor|mesh-list
111406739|NCT04537793|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
111406740|NCT04537793|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111406741|NCT04537793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111406742|NCT05437601|Carotenoids|carotenoids|mesh-list
111406743|NCT05437601|Antioxidants|antioxidants|mesh-ancestor
111406744|NCT05437601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111406745|NCT05437601|Protective Agents|protective agents|mesh-ancestor
111406746|NCT05437601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111406747|NCT05449145|Vitamin D|vitamin d|mesh-list
111131136|NCT03072121|Adrenergic Agents|adrenergic agents|mesh-ancestor
111406749|NCT05449145|Micronutrients|micronutrients|mesh-ancestor
111406750|NCT05449145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111406751|NCT05449145|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111406752|NCT05447039|Montelukast|montelukast|mesh-list
111406753|NCT05447039|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111406754|NCT05447039|Respiratory System Agents|respiratory system agents|mesh-ancestor
111406755|NCT05447039|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
111406756|NCT05447039|Hormone Antagonists|hormone antagonists|mesh-ancestor
111406757|NCT05447039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111406758|NCT05447039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111406759|NCT05447039|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
111406760|NCT05447039|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111406761|NCT05447039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111406762|NCT05446805|Corticosterone|corticosterone|mesh-list
111406763|NCT05446805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111406764|NCT05446415|Glucagon|glucagon|mesh-list
111406765|NCT05446415|Incretins|incretins|mesh-list
111406766|NCT05446415|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111406767|NCT05446415|Hormones|hormones|mesh-ancestor
111406768|NCT05446415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111406769|NCT05446415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111406770|NCT05448365|Vitamin D|vitamin d|mesh-list
111406771|NCT05448365|Vitamins|vitamins|mesh-list
111406772|NCT05448365|Inositol|inositol|mesh-list
111406773|NCT05448365|Vitamin B 6|vitamin b 6|mesh-list
111406774|NCT05448365|Pyridoxal|pyridoxal|mesh-list
111406775|NCT05448365|Pyridoxine|pyridoxine|mesh-list
111406776|NCT05448365|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
111406777|NCT05448365|Micronutrients|micronutrients|mesh-ancestor
111406778|NCT05448365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111406779|NCT05448365|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111406780|NCT05448365|Vitamin B Complex|vitamin b complex|mesh-ancestor
111406781|NCT05448365|Antioxidants|antioxidants|mesh-ancestor
111406782|NCT05448365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111406783|NCT05448365|Protective Agents|protective agents|mesh-ancestor
111406784|NCT05448365|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
111406785|NCT05448365|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
111406786|NCT05448365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111406787|NCT05448365|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111406788|NCT00370799|Betamethasone|betamethasone|mesh-list
111406789|NCT00370799|Betamethasone Valerate|betamethasone valerate|mesh-list
111406790|NCT00370799|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
111406791|NCT00370799|Betamethasone benzoate|betamethasone benzoate|mesh-list
111406792|NCT00370799|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111406793|NCT00370799|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
111406794|NCT00370799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111406795|NCT00370799|Glucocorticoids|glucocorticoids|mesh-ancestor
111406796|NCT00370799|Hormones|hormones|mesh-ancestor
111406797|NCT00370799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111406798|NCT00370799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111406799|NCT00370799|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111406800|NCT00370799|Respiratory System Agents|respiratory system agents|mesh-ancestor
111406801|NCT02661971|Leucovorin|leucovorin|mesh-list
111406802|NCT02661971|Docetaxel|docetaxel|mesh-list
111406803|NCT02661971|Fluorouracil|fluorouracil|mesh-list
111406804|NCT02661971|Oxaliplatin|oxaliplatin|mesh-list
111406805|NCT02661971|Ramucirumab|ramucirumab|mesh-list
111406806|NCT02661971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111406807|NCT02661971|Tubulin Modulators|tubulin modulators|mesh-ancestor
111406808|NCT02661971|Antimitotic Agents|antimitotic agents|mesh-ancestor
111406809|NCT02661971|Mitosis Modulators|mitosis modulators|mesh-ancestor
111406810|NCT02661971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111406811|NCT02661971|Antimetabolites|antimetabolites|mesh-ancestor
111406812|NCT02661971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111406813|NCT02661971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111406814|NCT02661971|Immunologic Factors|immunologic factors|mesh-ancestor
111406815|NCT02661971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111406816|NCT02661971|Antidotes|antidotes|mesh-ancestor
111406817|NCT02661971|Protective Agents|protective agents|mesh-ancestor
111406818|NCT02661971|Vitamin B Complex|vitamin b complex|mesh-ancestor
111406819|NCT02661971|Vitamins|vitamins|mesh-ancestor
111406820|NCT02661971|Micronutrients|micronutrients|mesh-ancestor
111406821|NCT05442905|Anesthetics|anesthetics|mesh-list
111406822|NCT05442905|Propofol|propofol|mesh-list
111406823|NCT05442905|Sevoflurane|sevoflurane|mesh-list
111406824|NCT05442905|Atracurium|atracurium|mesh-list
111406825|NCT05442905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111406826|NCT05442905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111406827|NCT05442905|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111406828|NCT05442905|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111406829|NCT05442905|Anesthetics, General|anesthetics, general|mesh-ancestor
111406830|NCT05442905|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111406831|NCT05442905|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111406832|NCT05442905|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
111406833|NCT05442905|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
111406834|NCT05442905|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111406835|NCT05442905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111406836|NCT05442905|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
111406837|NCT05442905|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111406838|NCT05442905|Cholinergic Agents|cholinergic agents|mesh-ancestor
111406839|NCT05442905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111406840|NCT05442905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111406841|NCT00369863|Triamcinolone|triamcinolone|mesh-list
111406842|NCT00369863|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
111406843|NCT00369863|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
111406844|NCT00369863|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
111406845|NCT00369863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111406846|NCT00369863|Glucocorticoids|glucocorticoids|mesh-ancestor
111406847|NCT00369863|Hormones|hormones|mesh-ancestor
111406848|NCT00369863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111406849|NCT00369863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110884017|NCT04055844|Decitabine|decitabine|mesh-list
111406850|NCT00369863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111406851|NCT00369863|Immunologic Factors|immunologic factors|mesh-ancestor
111406852|NCT00369863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111406853|NCT00369863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111406854|NCT01890343|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
111406855|NCT01890343|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111406856|NCT01890343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111406857|NCT02588027|Ibuprofen|ibuprofen|mesh-list
111406858|NCT02588027|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111406859|NCT02588027|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111406860|NCT02588027|Analgesics|analgesics|mesh-ancestor
111406861|NCT02588027|Sensory System Agents|sensory system agents|mesh-ancestor
111406862|NCT02588027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111406863|NCT02588027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111406864|NCT02588027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111406865|NCT02588027|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111406866|NCT02588027|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111406867|NCT02588027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111406868|NCT02588027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111406869|NCT04449965|Povidone-Iodine|povidone-iodine|mesh-list
111406870|NCT04449965|Povidone|povidone|mesh-list
111406871|NCT04449965|Plasma Substitutes|plasma substitutes|mesh-ancestor
111406872|NCT04449965|Blood Substitutes|blood substitutes|mesh-ancestor
111406873|NCT04449965|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111406874|NCT04449965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111406875|NCT05431673|Doxycycline|doxycycline|mesh-list
111406876|NCT05431673|Ciprofloxacin|ciprofloxacin|mesh-list
111406877|NCT05431673|Rifampin|rifampin|mesh-list
111406878|NCT05431673|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111406879|NCT05431673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111406880|NCT05431673|Antimalarials|antimalarials|mesh-ancestor
111406881|NCT05431673|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111406882|NCT05431673|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111406883|NCT05431673|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111406884|NCT05431673|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111406885|NCT05431673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111406886|NCT05431673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111406887|NCT05431673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111406888|NCT05431673|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111406889|NCT05431673|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111406890|NCT05431673|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111406891|NCT05431673|Antitubercular Agents|antitubercular agents|mesh-ancestor
111406892|NCT05431673|Leprostatic Agents|leprostatic agents|mesh-ancestor
111406893|NCT05431673|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111406894|NCT05431673|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111406895|NCT05431673|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111406896|NCT05431673|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
111406897|NCT05431673|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
111406898|NCT05431673|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
111406899|NCT05431673|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111406900|NCT01951651|Exenatide|exenatide|mesh-list
111406901|NCT01951651|Glipizide|glipizide|mesh-list
111406902|NCT01951651|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111406903|NCT01951651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111406904|NCT01951651|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111406905|NCT01951651|Incretins|incretins|mesh-ancestor
111406906|NCT01951651|Hormones|hormones|mesh-ancestor
111406907|NCT01951651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111406908|NCT02466581|Hydroxychloroquine|hydroxychloroquine|mesh-list
111406909|NCT02466581|Sulfasalazine|sulfasalazine|mesh-list
111406910|NCT02466581|Prednisolone|prednisolone|mesh-list
111406911|NCT02466581|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111406912|NCT02466581|Methylprednisolone|methylprednisolone|mesh-list
111406913|NCT02466581|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111406914|NCT02466581|Prednisolone acetate|prednisolone acetate|mesh-list
111406915|NCT02466581|Certolizumab Pegol|certolizumab pegol|mesh-list
111406916|NCT02466581|Abatacept|abatacept|mesh-list
111406917|NCT02466581|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111406918|NCT02466581|Prednisolone phosphate|prednisolone phosphate|mesh-list
111406919|NCT02466581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111406920|NCT02466581|Glucocorticoids|glucocorticoids|mesh-ancestor
111406921|NCT02466581|Hormones|hormones|mesh-ancestor
111406922|NCT02466581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111406923|NCT02466581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111406924|NCT02466581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111406925|NCT02466581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111406926|NCT02466581|Antiemetics|antiemetics|mesh-ancestor
111406927|NCT02466581|Autonomic Agents|autonomic agents|mesh-ancestor
111406928|NCT02466581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111406929|NCT02466581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111406930|NCT02466581|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111406931|NCT02466581|Protective Agents|protective agents|mesh-ancestor
111406932|NCT02466581|Antimalarials|antimalarials|mesh-ancestor
111406933|NCT02466581|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111406934|NCT02466581|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111406935|NCT02466581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111406936|NCT02466581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111406937|NCT02466581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111406938|NCT02466581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111406939|NCT02466581|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111406940|NCT02466581|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111406941|NCT02466581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111406942|NCT02466581|Immunologic Factors|immunologic factors|mesh-ancestor
111406943|NCT02466581|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111406944|NCT02466581|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111406945|NCT02466581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111406946|NCT02466581|Analgesics|analgesics|mesh-ancestor
111406947|NCT02466581|Sensory System Agents|sensory system agents|mesh-ancestor
111406948|NCT01951963|Ketamine|ketamine|mesh-list
111406949|NCT01951963|Morphine|morphine|mesh-list
111406950|NCT01951963|Analgesics|analgesics|mesh-ancestor
111406951|NCT01951963|Sensory System Agents|sensory system agents|mesh-ancestor
111406952|NCT01951963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111406953|NCT01951963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111406954|NCT01951963|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111406955|NCT01951963|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111406956|NCT01951963|Anesthetics, General|anesthetics, general|mesh-ancestor
111406957|NCT01951963|Anesthetics|anesthetics|mesh-ancestor
111406958|NCT01951963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111406959|NCT01951963|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111406960|NCT01951963|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111406961|NCT01951963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111406962|NCT01951963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111406963|NCT01951963|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111406964|NCT01951963|Narcotics|narcotics|mesh-ancestor
111406965|NCT02377271|Bosentan|bosentan|mesh-list
111406966|NCT02377271|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111406967|NCT02377271|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
111406968|NCT02377271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111406969|NCT01894555|Aspirin|aspirin|mesh-list
111406970|NCT01894555|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111406971|NCT01894555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111406972|NCT01894555|Analgesics|analgesics|mesh-ancestor
111406973|NCT01894555|Sensory System Agents|sensory system agents|mesh-ancestor
111406974|NCT01894555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111406975|NCT01894555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111406976|NCT01894555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111406977|NCT01894555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111406978|NCT01894555|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111406979|NCT01894555|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111406980|NCT01894555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111406981|NCT01894555|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111406982|NCT01894555|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111406983|NCT01894555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111406985|NCT01953211|Contraceptive Agents|contraceptive agents|mesh-list
111406986|NCT01953211|Norinyl|norinyl|mesh-list
111406987|NCT01953211|Contraceptives, Oral|contraceptives, oral|mesh-list
111406988|NCT01953211|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
111406989|NCT01953211|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111406990|NCT01953211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111406991|NCT01953211|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111406992|NCT01953211|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111406993|NCT01953211|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111406994|NCT02028221|Metformin|metformin|mesh-list
111406995|NCT02028221|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111406996|NCT02028221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111406997|NCT05735197|Dapagliflozin|dapagliflozin|mesh-list
111406998|NCT05735197|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111406999|NCT05735197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111407000|NCT05735197|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111407001|NCT05735197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111407002|NCT00370097|Fluticasone|fluticasone|mesh-list
111407003|NCT00370097|Xhance|xhance|mesh-list
111407004|NCT00370097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111407005|NCT00370097|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111407006|NCT00370097|Autonomic Agents|autonomic agents|mesh-ancestor
111407007|NCT00370097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111407008|NCT00370097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111407009|NCT00370097|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111407010|NCT00370097|Respiratory System Agents|respiratory system agents|mesh-ancestor
111407011|NCT00370097|Dermatologic Agents|dermatologic agents|mesh-ancestor
111407012|NCT00370097|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111407013|NCT01897285|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
111407014|NCT01897285|Laxatives|laxatives|mesh-ancestor
111407015|NCT01897285|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111407016|NCT00370253|Terlipressin|terlipressin|mesh-list
111407017|NCT00370253|Norepinephrine|norepinephrine|mesh-list
111407018|NCT00370253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111407019|NCT00370253|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111407020|NCT00370253|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111407021|NCT00370253|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111407022|NCT00370253|Adrenergic Agents|adrenergic agents|mesh-ancestor
111407023|NCT00370253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111407024|NCT00370253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111407025|NCT00370253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111407026|NCT00370253|Sympathomimetics|sympathomimetics|mesh-ancestor
111407027|NCT00370253|Autonomic Agents|autonomic agents|mesh-ancestor
111407028|NCT00370253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111407029|NCT01491815|Abatacept|abatacept|mesh-list
111407030|NCT01491815|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111407031|NCT01491815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111407032|NCT01491815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111407033|NCT01491815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111407034|NCT01491815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111407035|NCT01491815|Immunologic Factors|immunologic factors|mesh-ancestor
111407036|NCT01491815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111407037|NCT01491815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111407038|NCT04359953|Azithromycin|azithromycin|mesh-list
111407039|NCT04359953|Hydroxychloroquine|hydroxychloroquine|mesh-list
111407040|NCT04359953|Telmisartan|telmisartan|mesh-list
111407041|NCT04359953|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111407042|NCT04359953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111407043|NCT04359953|Antimalarials|antimalarials|mesh-ancestor
111407044|NCT04359953|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111407045|NCT04359953|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111407046|NCT04359953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111407047|NCT04359953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111407048|NCT04359953|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111131453|NCT05214573|Glucagon|glucagon|mesh-list
111407049|NCT04359953|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111407050|NCT04359953|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111407051|NCT04359953|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111407053|NCT05364515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111407054|NCT05364515|Glucocorticoids|glucocorticoids|mesh-ancestor
111407055|NCT05364515|Hormones|hormones|mesh-ancestor
111407056|NCT05364515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111407057|NCT05364515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111407058|NCT01438073|Hormones|hormones|mesh-list
111407059|NCT01438073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111407060|NCT01438073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111407061|NCT04338191|Leucovorin|leucovorin|mesh-list
111407062|NCT04338191|Fluorouracil|fluorouracil|mesh-list
111407063|NCT04338191|Oxaliplatin|oxaliplatin|mesh-list
111407064|NCT04338191|Irinotecan|irinotecan|mesh-list
111407065|NCT04338191|Levoleucovorin|levoleucovorin|mesh-list
111407066|NCT04338191|Antimetabolites|antimetabolites|mesh-ancestor
111407067|NCT04338191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111407068|NCT04338191|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111407069|NCT04338191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111407070|NCT04338191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111407071|NCT04338191|Immunologic Factors|immunologic factors|mesh-ancestor
111407072|NCT04338191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111407073|NCT04338191|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111407074|NCT04338191|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111407075|NCT04338191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111407076|NCT04338191|Antidotes|antidotes|mesh-ancestor
111407077|NCT04338191|Protective Agents|protective agents|mesh-ancestor
111407078|NCT04338191|Vitamin B Complex|vitamin b complex|mesh-ancestor
111407079|NCT04338191|Vitamins|vitamins|mesh-ancestor
111407080|NCT04338191|Micronutrients|micronutrients|mesh-ancestor
111407081|NCT00371033|Pregabalin|pregabalin|mesh-list
111407082|NCT00371033|Analgesics|analgesics|mesh-ancestor
111407083|NCT00371033|Sensory System Agents|sensory system agents|mesh-ancestor
111407084|NCT00371033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111407085|NCT00371033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111407086|NCT00371033|Anticonvulsants|anticonvulsants|mesh-ancestor
111407087|NCT00371033|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111407088|NCT00371033|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111407089|NCT00371033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111407090|NCT00371033|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111407091|NCT00371033|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111407092|NCT00371033|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111407093|NCT00371033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111407094|NCT00371033|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111407095|NCT00371111|Triamcinolone|triamcinolone|mesh-list
111407096|NCT00371111|Bevacizumab|bevacizumab|mesh-list
111407097|NCT00371111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111407098|NCT00371111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111407099|NCT00371111|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111407100|NCT00371111|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111407101|NCT00371111|Growth Substances|growth substances|mesh-ancestor
111407102|NCT00371111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111407103|NCT00371111|Growth Inhibitors|growth inhibitors|mesh-ancestor
111407104|NCT00371111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111407105|NCT00371111|Glucocorticoids|glucocorticoids|mesh-ancestor
111407106|NCT00371111|Hormones|hormones|mesh-ancestor
111407107|NCT00371111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111407108|NCT05454683|Melatonin|melatonin|mesh-list
111407109|NCT05454683|Antioxidants|antioxidants|mesh-ancestor
111407110|NCT05454683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111407111|NCT05454683|Protective Agents|protective agents|mesh-ancestor
111407112|NCT05454683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111407113|NCT05454683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111407114|NCT05139095|Apatinib|apatinib|mesh-list
111407115|NCT05139095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111407116|NCT05139095|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111407117|NCT05139095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111407118|NCT05139095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111407119|NCT04108247|Fluzoparib|fluzoparib|mesh-list
111407120|NCT04108247|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111407121|NCT04108247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111407122|NCT04108247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111407123|NCT04108247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111407124|NCT05453435|Entecavir|entecavir|mesh-list
111407125|NCT05453435|Antiviral Agents|antiviral agents|mesh-ancestor
111407126|NCT05453435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111407127|NCT03029845|Propranolol|propranolol|mesh-list
111407128|NCT03029845|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111407129|NCT03029845|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111407130|NCT03029845|Adrenergic Agents|adrenergic agents|mesh-ancestor
111407131|NCT03029845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111407132|NCT03029845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111407133|NCT03029845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111407134|NCT03029845|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111407135|NCT03029845|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111407136|NCT03029845|Vasodilator Agents|vasodilator agents|mesh-ancestor
111407137|NCT05451719|Capecitabine|capecitabine|mesh-list
111407138|NCT05451719|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111407139|NCT05451719|Antimetabolites|antimetabolites|mesh-ancestor
111407140|NCT05451719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111407141|NCT05451719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111407142|NCT01955629|Capecitabine|capecitabine|mesh-list
111407143|NCT01955629|Oxaliplatin|oxaliplatin|mesh-list
111407144|NCT01955629|Aflibercept|aflibercept|mesh-list
111407145|NCT01955629|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111407146|NCT01955629|Antimetabolites|antimetabolites|mesh-ancestor
111407147|NCT01955629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111407148|NCT01955629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111407149|NCT01955629|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111407150|NCT01955629|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111407151|NCT01955629|Growth Substances|growth substances|mesh-ancestor
111407152|NCT01955629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111407153|NCT01955629|Growth Inhibitors|growth inhibitors|mesh-ancestor
111407154|NCT01898689|Ropivacaine|ropivacaine|mesh-list
111407155|NCT01898689|Anesthetics, Local|anesthetics, local|mesh-ancestor
111407156|NCT01898689|Anesthetics|anesthetics|mesh-ancestor
111407157|NCT01898689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111407158|NCT01898689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111407159|NCT01898689|Sensory System Agents|sensory system agents|mesh-ancestor
111407160|NCT01898689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111407161|NCT05062577|Buprenorphine|buprenorphine|mesh-list
111407162|NCT05062577|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
111407163|NCT05062577|ASP8062|asp8062|mesh-list
111407164|NCT05062577|Naloxone|naloxone|mesh-list
111407165|NCT05062577|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111407166|NCT05062577|Narcotics|narcotics|mesh-ancestor
111407167|NCT05062577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111407168|NCT05062577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111407169|NCT05062577|Analgesics|analgesics|mesh-ancestor
111407170|NCT05062577|Sensory System Agents|sensory system agents|mesh-ancestor
111407171|NCT05062577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111407172|NCT05062577|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111407173|NCT05062577|GABA Modulators|gaba modulators|mesh-ancestor
111407174|NCT05062577|GABA Agents|gaba agents|mesh-ancestor
111407175|NCT05062577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111407176|NCT05062577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111407177|NCT05448989|Atropine|atropine|mesh-list
111407178|NCT05448989|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111407179|NCT05448989|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111407180|NCT05448989|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111407181|NCT05448989|Autonomic Agents|autonomic agents|mesh-ancestor
111407182|NCT05448989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111407183|NCT05448989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111407184|NCT05448989|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111407185|NCT05448989|Respiratory System Agents|respiratory system agents|mesh-ancestor
111407186|NCT05448989|Mydriatics|mydriatics|mesh-ancestor
111407187|NCT05448989|Parasympatholytics|parasympatholytics|mesh-ancestor
111407188|NCT05448989|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111407189|NCT05448989|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111407190|NCT05448989|Cholinergic Agents|cholinergic agents|mesh-ancestor
111407191|NCT05448989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111407192|NCT05448989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111407193|NCT00370565|Insulin|insulin|mesh-list
111407194|NCT00370565|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111407195|NCT00370565|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111407196|NCT00370565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111407197|NCT05039723|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
111407198|NCT05039723|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111407199|NCT05039723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111407200|NCT05039723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111407201|NCT05039723|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111407202|NCT05039723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111407203|NCT05039723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111407204|NCT05039723|Cholinergic Agents|cholinergic agents|mesh-ancestor
111407205|NCT05039723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111407206|NCT00370019|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
111407207|NCT00370019|Medroxyprogesterone|medroxyprogesterone|mesh-list
111407208|NCT00370019|Estradiol|estradiol|mesh-list
111407209|NCT00370019|Estrogens|estrogens|mesh-ancestor
111407210|NCT00370019|Hormones|hormones|mesh-ancestor
111407211|NCT00370019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111407212|NCT00370019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111407213|NCT00370019|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111407214|NCT00370019|Contraceptive Agents|contraceptive agents|mesh-ancestor
111407215|NCT00370019|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111407216|NCT00370019|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111407217|NCT00370019|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111407218|NCT00370019|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111407219|NCT00370019|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111407220|NCT00370019|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
111407221|NCT00370019|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111407222|NCT00370019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111407223|NCT03888131|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
111407224|NCT03888131|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111407225|NCT03888131|Respiratory System Agents|respiratory system agents|mesh-ancestor
111407226|NCT01900249|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111407227|NCT01900249|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111407228|NCT04969211|Iloperidone|iloperidone|mesh-list
111407229|NCT04969211|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111407230|NCT04969211|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111407231|NCT04969211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111407232|NCT04969211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111407233|NCT04969211|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111407234|NCT01901575|Remifentanil|remifentanil|mesh-list
111407235|NCT01901575|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111407236|NCT01901575|Narcotics|narcotics|mesh-ancestor
111407237|NCT01901575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111407238|NCT01901575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111407239|NCT01901575|Analgesics|analgesics|mesh-ancestor
111407240|NCT01901575|Sensory System Agents|sensory system agents|mesh-ancestor
111407241|NCT01901575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111407242|NCT03754049|Dexamethasone|dexamethasone|mesh-list
111407243|NCT03754049|Dexamethasone acetate|dexamethasone acetate|mesh-list
111407244|NCT03754049|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
111407245|NCT03754049|BB 1101|bb 1101|mesh-list
111407246|NCT03754049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111407247|NCT03754049|Antiemetics|antiemetics|mesh-ancestor
111407248|NCT03754049|Autonomic Agents|autonomic agents|mesh-ancestor
110884436|NCT03040141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111407249|NCT03754049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111407250|NCT03754049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111407251|NCT03754049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111407252|NCT03754049|Glucocorticoids|glucocorticoids|mesh-ancestor
111407253|NCT03754049|Hormones|hormones|mesh-ancestor
111407254|NCT03754049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111407255|NCT03754049|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111407256|NCT03754049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111407257|NCT03754049|Protease Inhibitors|protease inhibitors|mesh-ancestor
111407258|NCT03754049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111407259|NCT03754049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111407260|NCT01901809|Dopamine|dopamine|mesh-list
111407261|NCT01901809|Furosemide|furosemide|mesh-list
111407262|NCT01901809|Diuretics|diuretics|mesh-ancestor
111407263|NCT01901809|Natriuretic Agents|natriuretic agents|mesh-ancestor
111407264|NCT01901809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111407265|NCT01901809|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
111407266|NCT01901809|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111407267|NCT01901809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111407268|NCT01901809|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111407269|NCT01901809|Sympathomimetics|sympathomimetics|mesh-ancestor
111407270|NCT01901809|Autonomic Agents|autonomic agents|mesh-ancestor
111407271|NCT01901809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111407272|NCT01901809|Dopamine Agents|dopamine agents|mesh-ancestor
111407273|NCT01901809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111407274|NCT01901809|Protective Agents|protective agents|mesh-ancestor
111407276|NCT03029533|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111407277|NCT03029533|Fertility Agents|fertility agents|mesh-ancestor
111407278|NCT03029533|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111407279|NCT03029533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111407280|NCT03029533|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111407281|NCT03029533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111407282|NCT04921007|Bupivacaine|bupivacaine|mesh-list
111407283|NCT04921007|Anesthetics, Local|anesthetics, local|mesh-ancestor
111407284|NCT04921007|Anesthetics|anesthetics|mesh-ancestor
111407285|NCT04921007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111407286|NCT04921007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111407287|NCT04921007|Sensory System Agents|sensory system agents|mesh-ancestor
111407288|NCT04921007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111407289|NCT01904071|Morphine|morphine|mesh-list
111407290|NCT01904071|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111407291|NCT01904071|Narcotics|narcotics|mesh-ancestor
111407292|NCT01904071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111407293|NCT01904071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111407294|NCT01904071|Analgesics|analgesics|mesh-ancestor
111407295|NCT01904071|Sensory System Agents|sensory system agents|mesh-ancestor
111407296|NCT01904071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111407297|NCT01907113|Empagliflozin|empagliflozin|mesh-list
111407298|NCT01907113|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111407299|NCT01907113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111407300|NCT01907113|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111407301|NCT01907113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111407302|NCT00370643|Insulin|insulin|mesh-list
111407303|NCT00370643|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111407304|NCT00370643|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111407305|NCT00370643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111407306|NCT01908127|Salicylic Acid|salicylic acid|mesh-list
111407307|NCT01908127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111407308|NCT01908127|Antifungal Agents|antifungal agents|mesh-ancestor
111407309|NCT01908127|Keratolytic Agents|keratolytic agents|mesh-ancestor
111407310|NCT01908127|Dermatologic Agents|dermatologic agents|mesh-ancestor
111407311|NCT04679831|Praziquantel|praziquantel|mesh-list
111407312|NCT04679831|Anthelmintics|anthelmintics|mesh-ancestor
111407313|NCT04679831|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111407314|NCT04679831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111407315|NCT01908751|Vitamin D|vitamin d|mesh-list
111407316|NCT01908751|Ergocalciferols|ergocalciferols|mesh-list
111407317|NCT01908751|Cholecalciferol|cholecalciferol|mesh-list
111407318|NCT01908751|Vitamins|vitamins|mesh-list
111407319|NCT01908751|Micronutrients|micronutrients|mesh-ancestor
111407320|NCT01908751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111407321|NCT01908751|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111407322|NCT01908751|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111407323|NCT00370721|Bevacizumab|bevacizumab|mesh-list
111407324|NCT00370721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111407325|NCT00370721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111407326|NCT00370721|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111407327|NCT00370721|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111407328|NCT00370721|Growth Substances|growth substances|mesh-ancestor
111407329|NCT00370721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111407330|NCT00370721|Growth Inhibitors|growth inhibitors|mesh-ancestor
111407331|NCT01909141|Metformin|metformin|mesh-list
111407332|NCT01909141|Pioglitazone|pioglitazone|mesh-list
111407333|NCT01909141|Carbamide Peroxide|carbamide peroxide|mesh-list
111407334|NCT01909141|Letrozole|letrozole|mesh-list
111407335|NCT01909141|Clomiphene|clomiphene|mesh-list
111407336|NCT01909141|Enclomiphene|enclomiphene|mesh-list
111407337|NCT01909141|Zuclomiphene|zuclomiphene|mesh-list
111407338|NCT01909141|Hormones|hormones|mesh-list
111407339|NCT01909141|Estradiol|estradiol|mesh-list
111407340|NCT01909141|Testosterone|testosterone|mesh-list
111407341|NCT01909141|Progesterone|progesterone|mesh-list
111407342|NCT01909141|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
111407343|NCT01909141|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111407344|NCT01909141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111407345|NCT01909141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111131736|NCT04338659|Immunologic Factors|immunologic factors|mesh-ancestor
111407346|NCT01909141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111407347|NCT01909141|Estrogens|estrogens|mesh-ancestor
111407348|NCT01909141|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111407349|NCT01909141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111407350|NCT01909141|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111407351|NCT01909141|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111407352|NCT01909141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111407353|NCT01909141|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111407354|NCT01909141|Hormone Antagonists|hormone antagonists|mesh-ancestor
111407355|NCT01909141|Androgens|androgens|mesh-ancestor
111407356|NCT01909141|Progestins|progestins|mesh-ancestor
111407357|NCT01909141|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111407358|NCT01909141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111407359|NCT01909141|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111407360|NCT01909141|Fertility Agents|fertility agents|mesh-ancestor
111407361|NCT01909141|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111407362|NCT01909141|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111407363|NCT04486859|Rivaroxaban|rivaroxaban|mesh-list
111407364|NCT04486859|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111407365|NCT04486859|Antithrombins|antithrombins|mesh-ancestor
111407366|NCT04486859|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111407367|NCT04486859|Protease Inhibitors|protease inhibitors|mesh-ancestor
111407368|NCT04486859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111407369|NCT04486859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111407370|NCT04486859|Anticoagulants|anticoagulants|mesh-ancestor
111407371|NCT01910311|Rifampin|rifampin|mesh-list
111407372|NCT01910311|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111407373|NCT01910311|Antitubercular Agents|antitubercular agents|mesh-ancestor
111407374|NCT01910311|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111407375|NCT01910311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111407376|NCT01910311|Leprostatic Agents|leprostatic agents|mesh-ancestor
110884548|NCT04485325|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
111407377|NCT01910311|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111407378|NCT01910311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111407379|NCT01910311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111407380|NCT01910311|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111407381|NCT01910311|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111407382|NCT01910311|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
111407383|NCT01910311|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
111407384|NCT01910311|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
111407385|NCT01910311|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111407386|NCT04404959|Ropivacaine|ropivacaine|mesh-list
111407387|NCT04404959|Anesthetics|anesthetics|mesh-list
111407388|NCT04404959|Anesthetics, Local|anesthetics, local|mesh-ancestor
111407389|NCT04404959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111407390|NCT04404959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111407391|NCT04404959|Sensory System Agents|sensory system agents|mesh-ancestor
111407392|NCT04404959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111407393|NCT04403711|Dexmedetomidine|dexmedetomidine|mesh-list
111407394|NCT04403711|Anesthetics|anesthetics|mesh-list
111407395|NCT04403711|Anesthetics, Local|anesthetics, local|mesh-list
111407396|NCT04403711|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111407397|NCT04403711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111407398|NCT04403711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111407399|NCT04403711|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111407400|NCT04403711|Analgesics|analgesics|mesh-ancestor
111407401|NCT04403711|Sensory System Agents|sensory system agents|mesh-ancestor
111407402|NCT04403711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111407403|NCT04403711|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111407404|NCT04403711|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111407405|NCT04403711|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111407406|NCT04403711|Adrenergic Agents|adrenergic agents|mesh-ancestor
111407407|NCT04403711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111407408|NCT04403711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111407409|NCT01911169|Vitamin D|vitamin d|mesh-list
111407410|NCT01911169|Cholecalciferol|cholecalciferol|mesh-list
111407411|NCT01911169|Vitamins|vitamins|mesh-list
111407412|NCT01911169|Micronutrients|micronutrients|mesh-ancestor
111407413|NCT01911169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111407414|NCT01911169|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111407415|NCT01911169|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111407416|NCT04403087|Trimebutine|trimebutine|mesh-list
111407417|NCT04403087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111407418|NCT04403087|Parasympatholytics|parasympatholytics|mesh-ancestor
111407419|NCT04403087|Autonomic Agents|autonomic agents|mesh-ancestor
111407420|NCT04403087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111407421|NCT04403087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111407422|NCT04358393|Azacitidine|azacitidine|mesh-list
111407423|NCT04358393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111131812|NCT05170919|Adrenergic Agents|adrenergic agents|mesh-ancestor
111407424|NCT04358393|Antimetabolites|antimetabolites|mesh-ancestor
111407425|NCT04358393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111407426|NCT04358393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111407427|NCT04358393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111407428|NCT04748887|Superoxide Dismutase|superoxide dismutase|mesh-list
111407429|NCT04748887|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111407430|NCT04748887|Antioxidants|antioxidants|mesh-ancestor
111407431|NCT04748887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111407432|NCT04748887|Protective Agents|protective agents|mesh-ancestor
111407433|NCT04748887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111407434|NCT01916629|Sunscreening Agents|sunscreening agents|mesh-list
111407435|NCT01916629|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111407436|NCT01916629|Protective Agents|protective agents|mesh-ancestor
111407437|NCT01916629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111407438|NCT01916629|Dermatologic Agents|dermatologic agents|mesh-ancestor
111407439|NCT01916941|Prazosin|prazosin|mesh-list
111407440|NCT01916941|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111407441|NCT01916941|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111407442|NCT01916941|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111407443|NCT01916941|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111407444|NCT01916941|Adrenergic Agents|adrenergic agents|mesh-ancestor
111407445|NCT01916941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111407446|NCT01916941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111407447|NCT01916941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111407448|NCT04768985|Acalabrutinib|acalabrutinib|mesh-list
111407449|NCT04768985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111407450|NCT04210037|Paclitaxel|paclitaxel|mesh-list
111407451|NCT04210037|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111407452|NCT04210037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111407453|NCT04210037|Tubulin Modulators|tubulin modulators|mesh-ancestor
111407454|NCT04210037|Antimitotic Agents|antimitotic agents|mesh-ancestor
111407455|NCT04210037|Mitosis Modulators|mitosis modulators|mesh-ancestor
111407456|NCT04210037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111407457|NCT00371501|Aspirin|aspirin|mesh-list
111407458|NCT00371501|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111407459|NCT00371501|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111407460|NCT00371501|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111407461|NCT00371501|Analgesics|analgesics|mesh-ancestor
111407462|NCT00371501|Sensory System Agents|sensory system agents|mesh-ancestor
111407463|NCT00371501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111407464|NCT00371501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111407465|NCT00371501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111407466|NCT00371501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111407467|NCT00371501|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111407468|NCT00371501|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111407469|NCT00371501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111407470|NCT00371501|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111407471|NCT00371501|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111407472|NCT00371501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111407473|NCT00371501|Antipyretics|antipyretics|mesh-ancestor
111407474|NCT00371501|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111407475|NCT00371501|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111407476|NCT00371501|Antimetabolites|antimetabolites|mesh-ancestor
111407477|NCT00371501|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111407478|NCT00371501|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111407479|NCT03251651|Dexmedetomidine|dexmedetomidine|mesh-list
111407480|NCT03251651|Propofol|propofol|mesh-list
111407481|NCT03251651|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111407482|NCT03251651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111407483|NCT03251651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111407484|NCT03251651|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111407485|NCT03251651|Analgesics|analgesics|mesh-ancestor
111407486|NCT03251651|Sensory System Agents|sensory system agents|mesh-ancestor
111407487|NCT03251651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111407488|NCT03251651|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111407489|NCT03251651|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111407490|NCT03251651|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111407491|NCT03251651|Adrenergic Agents|adrenergic agents|mesh-ancestor
111407492|NCT03251651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111407493|NCT03251651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111407494|NCT03251651|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111407495|NCT03251651|Anesthetics, General|anesthetics, general|mesh-ancestor
111407496|NCT03251651|Anesthetics|anesthetics|mesh-ancestor
111407497|NCT05738707|Vaccines|vaccines|mesh-list
111407498|NCT05738707|Immunologic Factors|immunologic factors|mesh-ancestor
111407499|NCT05738707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111407500|NCT05738629|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111407501|NCT05738629|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111407503|NCT05349071|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111407504|NCT05349071|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111407505|NCT05349071|Prednisolone|prednisolone|mesh-list
111407506|NCT05349071|Prednisolone acetate|prednisolone acetate|mesh-list
111407507|NCT05349071|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111407508|NCT05349071|Prednisolone phosphate|prednisolone phosphate|mesh-list
111407509|NCT05349071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111407510|NCT05349071|Antiemetics|antiemetics|mesh-ancestor
111407511|NCT05349071|Autonomic Agents|autonomic agents|mesh-ancestor
111407512|NCT05349071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111407513|NCT05349071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111407514|NCT05349071|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111407515|NCT05349071|Glucocorticoids|glucocorticoids|mesh-ancestor
111407516|NCT05349071|Hormones|hormones|mesh-ancestor
111407517|NCT05349071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111407518|NCT05349071|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111407519|NCT05349071|Protective Agents|protective agents|mesh-ancestor
111407520|NCT05349071|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111407521|NCT05349071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111407522|NCT01929889|Iloperidone|iloperidone|mesh-list
111407523|NCT01929889|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111407524|NCT01929889|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111407525|NCT01929889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111407526|NCT01929889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111407527|NCT01929889|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111407528|NCT05738473|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111407529|NCT05738473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111407530|NCT05725135|Propofol|propofol|mesh-list
111407531|NCT05725135|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111407532|NCT05725135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111407533|NCT05725135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111407534|NCT05725135|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111407535|NCT05725135|Anesthetics, General|anesthetics, general|mesh-ancestor
111407536|NCT05725135|Anesthetics|anesthetics|mesh-ancestor
111407537|NCT05738317|Paclitaxel|paclitaxel|mesh-list
111407538|NCT05738317|Bevacizumab|bevacizumab|mesh-list
111407539|NCT05738317|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111407540|NCT05738317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111407541|NCT05738317|Tubulin Modulators|tubulin modulators|mesh-ancestor
111407542|NCT05738317|Antimitotic Agents|antimitotic agents|mesh-ancestor
111407543|NCT05738317|Mitosis Modulators|mitosis modulators|mesh-ancestor
111407544|NCT05738317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111407545|NCT05738317|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111407546|NCT05738317|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111407547|NCT05738317|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111407548|NCT05738317|Growth Substances|growth substances|mesh-ancestor
111407549|NCT05738317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111407550|NCT05738317|Growth Inhibitors|growth inhibitors|mesh-ancestor
111407551|NCT02284555|Mupirocin|mupirocin|mesh-list
111407552|NCT02284555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111407553|NCT02284555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111407554|NCT02284555|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111407555|NCT02284555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111407556|NCT02284555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111407557|NCT03029689|Raltegravir Potassium|raltegravir potassium|mesh-list
111407558|NCT03029689|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111407559|NCT03029689|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111407560|NCT03029689|Antiviral Agents|antiviral agents|mesh-ancestor
111407561|NCT03029689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111407562|NCT03029689|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111407563|NCT03029689|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111407564|NCT03029689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111407565|NCT03029689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111407566|NCT02287909|Clopidogrel|clopidogrel|mesh-list
111407567|NCT02287909|Ticagrelor|ticagrelor|mesh-list
111407568|NCT02287909|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111407569|NCT02287909|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111407570|NCT02287909|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111407571|NCT02287909|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111407572|NCT02287909|Purinergic Agents|purinergic agents|mesh-ancestor
111407574|NCT02287909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111407575|NCT02287909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111407576|NCT00371579|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111407577|NCT00371579|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111407578|NCT00371579|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111407579|NCT00371579|Antimetabolites|antimetabolites|mesh-ancestor
111407580|NCT00371579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111407581|NCT00371579|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111407582|NCT00371579|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111407583|NCT00371579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111407584|NCT02833805|Mycophenolic Acid|mycophenolic acid|mesh-list
111407585|NCT02833805|Cyclophosphamide|cyclophosphamide|mesh-list
111407586|NCT02833805|Fludarabine|fludarabine|mesh-list
111407587|NCT02833805|Tacrolimus|tacrolimus|mesh-list
111407588|NCT02833805|Thymoglobulin|thymoglobulin|mesh-list
111407589|NCT02833805|Antilymphocyte Serum|antilymphocyte serum|mesh-list
111407590|NCT02833805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111407591|NCT02833805|Immunologic Factors|immunologic factors|mesh-ancestor
111407592|NCT02833805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111407593|NCT02833805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111407594|NCT02833805|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111407595|NCT02833805|Alkylating Agents|alkylating agents|mesh-ancestor
111407596|NCT02833805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111407597|NCT02833805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111407598|NCT02833805|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111407599|NCT02833805|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111407600|NCT02833805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111407601|NCT02833805|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111407602|NCT02833805|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111407603|NCT02833805|Antitubercular Agents|antitubercular agents|mesh-ancestor
111407604|NCT02833805|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111407605|NCT02833805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111407606|NCT02327195|Methylphenidate|methylphenidate|mesh-list
111407607|NCT02327195|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111407608|NCT02327195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111407609|NCT02327195|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111407610|NCT02327195|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111407611|NCT02327195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111407612|NCT02327195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111407613|NCT02327195|Dopamine Agents|dopamine agents|mesh-ancestor
111407614|NCT02327195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111407615|NCT04768465|Prednisone|prednisone|mesh-list
111407616|NCT04768465|Bromides|bromides|mesh-list
111407617|NCT04768465|Tacrolimus|tacrolimus|mesh-list
111407618|NCT04768465|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
111407619|NCT04768465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111407620|NCT04768465|Glucocorticoids|glucocorticoids|mesh-ancestor
111407621|NCT04768465|Hormones|hormones|mesh-ancestor
111407622|NCT04768465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111407623|NCT04768465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111407624|NCT04768465|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111407625|NCT04768465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111407626|NCT04768465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111407627|NCT04768465|Immunologic Factors|immunologic factors|mesh-ancestor
111407628|NCT04768465|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111407629|NCT04768465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111407630|NCT04768465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111407631|NCT04768465|Anticonvulsants|anticonvulsants|mesh-ancestor
111407632|NCT04768465|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111407633|NCT04768465|Cholinergic Agents|cholinergic agents|mesh-ancestor
111407634|NCT04768465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111407635|NCT01614665|Tacrolimus|tacrolimus|mesh-list
111407636|NCT01614665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111407637|NCT01614665|Immunologic Factors|immunologic factors|mesh-ancestor
111407638|NCT01614665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111407639|NCT01614665|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111407640|NCT01614665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111407641|NCT01614665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111407642|NCT05691829|Pembrolizumab|pembrolizumab|mesh-list
111407643|NCT05691829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111407644|NCT05691829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111407645|NCT05691829|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111407646|NCT05691829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111407647|NCT00371735|Artesunate|artesunate|mesh-list
111407648|NCT00371735|Dapsone|dapsone|mesh-list
111407649|NCT00371735|Chlorproguanil|chlorproguanil|mesh-list
111407650|NCT00371735|Proguanil|proguanil|mesh-list
111407651|NCT00371735|Antimalarials|antimalarials|mesh-ancestor
111407652|NCT00371735|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111407653|NCT00371735|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111407654|NCT00371735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111407655|NCT00371735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111407656|NCT00371735|Antiviral Agents|antiviral agents|mesh-ancestor
111407657|NCT00371735|Schistosomicides|schistosomicides|mesh-ancestor
111407658|NCT00371735|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
111407659|NCT00371735|Anthelmintics|anthelmintics|mesh-ancestor
111407660|NCT00371735|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111407661|NCT00371735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111407662|NCT00371735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111407663|NCT00371735|Leprostatic Agents|leprostatic agents|mesh-ancestor
111407664|NCT00371735|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111407665|NCT00371735|Antimetabolites|antimetabolites|mesh-ancestor
111407666|NCT05052307|Vaccines|vaccines|mesh-list
111407667|NCT05052307|Immunologic Factors|immunologic factors|mesh-ancestor
111407668|NCT05052307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111407669|NCT05332457|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
111407670|NCT05332457|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111407671|NCT05332457|Adrenergic Agents|adrenergic agents|mesh-ancestor
111407672|NCT05332457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111407673|NCT05332457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111407674|NCT05332457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111407675|NCT05417659|Niacin|niacin|mesh-list
111407676|NCT05417659|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111407677|NCT05417659|Antimetabolites|antimetabolites|mesh-ancestor
111407678|NCT05417659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111407679|NCT05417659|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111407680|NCT05417659|Vasodilator Agents|vasodilator agents|mesh-ancestor
111407681|NCT05417659|Vitamin B Complex|vitamin b complex|mesh-ancestor
111407682|NCT05417659|Vitamins|vitamins|mesh-ancestor
111407683|NCT05417659|Micronutrients|micronutrients|mesh-ancestor
111407684|NCT05417659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111407685|NCT02762513|Axitinib|axitinib|mesh-list
111407686|NCT02762513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111407687|NCT02762513|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111407688|NCT02762513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111407689|NCT02762513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111407690|NCT02958761|Hyaluronic Acid|hyaluronic acid|mesh-list
111407691|NCT02958761|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111407692|NCT02958761|Immunologic Factors|immunologic factors|mesh-ancestor
111407693|NCT02958761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111407694|NCT02958761|Viscosupplements|viscosupplements|mesh-ancestor
111407695|NCT02958761|Protective Agents|protective agents|mesh-ancestor
111407696|NCT05215535|Liver Extracts|liver extracts|mesh-list
111407697|NCT05215535|Hematinics|hematinics|mesh-ancestor
111407698|NCT02767271|Luliconazole|luliconazole|mesh-list
111407699|NCT02767271|Antifungal Agents|antifungal agents|mesh-ancestor
111407700|NCT02767271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111407701|NCT05647993|Azithromycin|azithromycin|mesh-list
111407702|NCT05647993|Cefazolin|cefazolin|mesh-list
111407703|NCT05647993|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111407704|NCT05647993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111407705|NCT02741687|Insulin|insulin|mesh-list
111407706|NCT02741687|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111407707|NCT02741687|Insulin Glargine|insulin glargine|mesh-list
111407708|NCT02741687|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111407709|NCT02741687|Insulin Aspart|insulin aspart|mesh-list
111407710|NCT02741687|Insulin Lispro|insulin lispro|mesh-list
111407711|NCT02741687|Insulin Detemir|insulin detemir|mesh-list
111407712|NCT02741687|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111407713|NCT02741687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111407714|NCT02741687|Incretins|incretins|mesh-ancestor
111407715|NCT02741687|Hormones|hormones|mesh-ancestor
111407716|NCT02741687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111407717|NCT02741687|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111407718|NCT02741687|Protease Inhibitors|protease inhibitors|mesh-ancestor
111407719|NCT02741687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111407720|NCT02741687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111132111|NCT02588261|Gefitinib|gefitinib|mesh-list
111407721|NCT05361499|Amoxicillin|amoxicillin|mesh-list
111407722|NCT05361499|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111407723|NCT05361499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111407725|NCT04337099|TEMPO|tempo|mesh-list
111407726|NCT04337099|TEMPOL-H|tempol-h|mesh-list
111407727|NCT04337099|Antioxidants|antioxidants|mesh-ancestor
111407728|NCT04337099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111407729|NCT04337099|Protective Agents|protective agents|mesh-ancestor
111407730|NCT04337099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111407731|NCT04337099|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111407732|NCT04337099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111407733|NCT04337099|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111407734|NCT04337099|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111407735|NCT05630677|Rabeprazole|rabeprazole|mesh-list
111407736|NCT05630677|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111407737|NCT05630677|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111407738|NCT05630677|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111407739|NCT05630677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111407740|NCT05630677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111407741|NCT05627791|Oxytocin|oxytocin|mesh-list
111407742|NCT05627791|Oxytocics|oxytocics|mesh-ancestor
111407743|NCT05627791|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111407744|NCT05627791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111407745|NCT02771093|Alogliptin|alogliptin|mesh-list
111407746|NCT02771093|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111407747|NCT02771093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111407748|NCT02771093|Incretins|incretins|mesh-ancestor
111407749|NCT02771093|Hormones|hormones|mesh-ancestor
111407750|NCT02771093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111407751|NCT02771093|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111407752|NCT02771093|Protease Inhibitors|protease inhibitors|mesh-ancestor
111407753|NCT02771093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111407754|NCT02771093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111407755|NCT05306587|Daratumumab|daratumumab|mesh-list
111407756|NCT05306587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111407757|NCT04337879|Oxaliplatin|oxaliplatin|mesh-list
111407758|NCT04337879|Irinotecan|irinotecan|mesh-list
111407759|NCT04337879|Calcium|calcium|mesh-list
111407760|NCT04337879|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111407761|NCT04337879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111407762|NCT04337879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111407763|NCT04337879|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111407764|NCT04337879|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111407765|NCT04337879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111407766|NCT04337879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111407767|NCT02745353|Naloxegol|naloxegol|mesh-list
111407768|NCT02745353|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111407769|NCT02745353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111407770|NCT02745353|Sensory System Agents|sensory system agents|mesh-ancestor
111407771|NCT02745353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111407772|NCT04778839|Paclitaxel|paclitaxel|mesh-list
111407773|NCT04778839|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111407774|NCT04778839|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111407775|NCT04778839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111407776|NCT04778839|Tubulin Modulators|tubulin modulators|mesh-ancestor
111407777|NCT04778839|Antimitotic Agents|antimitotic agents|mesh-ancestor
111407778|NCT04778839|Mitosis Modulators|mitosis modulators|mesh-ancestor
111407779|NCT04778839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111407780|NCT05602207|Abrocitinib|abrocitinib|mesh-list
111407781|NCT05602207|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111407782|NCT05602207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111407783|NCT05602207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111407784|NCT02746991|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
111407785|NCT02746991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111407786|NCT02746991|Glucocorticoids|glucocorticoids|mesh-ancestor
111407787|NCT02746991|Hormones|hormones|mesh-ancestor
111407788|NCT02746991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111407789|NCT02746991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111407790|NCT02747615|Tranexamic Acid|tranexamic acid|mesh-list
111407791|NCT02747615|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111407792|NCT02747615|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111407793|NCT02747615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111407794|NCT02747615|Hemostatics|hemostatics|mesh-ancestor
111407795|NCT02747615|Coagulants|coagulants|mesh-ancestor
111407796|NCT02775617|Azithromycin|azithromycin|mesh-list
111407797|NCT02775617|Ivermectin|ivermectin|mesh-list
111407798|NCT02775617|Permethrin|permethrin|mesh-list
111407799|NCT02775617|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111407800|NCT02775617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111407801|NCT02775617|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111407802|NCT02775617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111407803|NCT02775617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111407804|NCT00371813|Varenicline|varenicline|mesh-list
111407805|NCT00371813|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111407806|NCT00371813|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111407807|NCT00371813|Cholinergic Agents|cholinergic agents|mesh-ancestor
111407808|NCT00371813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111407809|NCT00371813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111407810|NCT00371813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111407811|NCT02748785|Methotrexate|methotrexate|mesh-list
111407812|NCT02748785|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111407813|NCT02748785|Abortifacient Agents|abortifacient agents|mesh-ancestor
111407814|NCT02748785|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111407815|NCT02748785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111407816|NCT02748785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111407817|NCT02748785|Antimetabolites|antimetabolites|mesh-ancestor
111407818|NCT02748785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111407819|NCT02748785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111407820|NCT02748785|Dermatologic Agents|dermatologic agents|mesh-ancestor
111407821|NCT02748785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111407822|NCT02748785|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111407823|NCT02748785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111407824|NCT02748785|Immunologic Factors|immunologic factors|mesh-ancestor
111407825|NCT02748785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111407826|NCT02748785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111407827|NCT02295553|Ketamine|ketamine|mesh-list
111407828|NCT02295553|Propofol|propofol|mesh-list
111407829|NCT02295553|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111407830|NCT02295553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111407831|NCT02295553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111407832|NCT02295553|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111407833|NCT02295553|Anesthetics, General|anesthetics, general|mesh-ancestor
111407834|NCT02295553|Anesthetics|anesthetics|mesh-ancestor
111407835|NCT02295553|Analgesics|analgesics|mesh-ancestor
111407836|NCT02295553|Sensory System Agents|sensory system agents|mesh-ancestor
111407837|NCT02295553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111407838|NCT02295553|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111407839|NCT02295553|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111407840|NCT02295553|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111407841|NCT02295553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111407842|NCT02295553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111407843|NCT02296099|Bupivacaine|bupivacaine|mesh-list
111407844|NCT02296099|Anesthetics, Local|anesthetics, local|mesh-ancestor
111407845|NCT02296099|Anesthetics|anesthetics|mesh-ancestor
111407846|NCT02296099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111407847|NCT02296099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111407848|NCT02296099|Sensory System Agents|sensory system agents|mesh-ancestor
111407849|NCT02296099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111407850|NCT05455073|Folic Acid|folic acid|mesh-list
111407851|NCT05455073|Hematinics|hematinics|mesh-ancestor
111407852|NCT05455073|Vitamin B Complex|vitamin b complex|mesh-ancestor
111407853|NCT05455073|Vitamins|vitamins|mesh-ancestor
111407854|NCT05455073|Micronutrients|micronutrients|mesh-ancestor
111407855|NCT05455073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111407856|NCT04334993|Blinatumomab|blinatumomab|mesh-list
111407857|NCT04334993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111407858|NCT05349929|Ibuprofen|ibuprofen|mesh-list
111407859|NCT05349929|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111407860|NCT05349929|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111407861|NCT05349929|Analgesics|analgesics|mesh-ancestor
111407862|NCT05349929|Sensory System Agents|sensory system agents|mesh-ancestor
111407863|NCT05349929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111407864|NCT05349929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111407865|NCT05349929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111407866|NCT05349929|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111407867|NCT05349929|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111407868|NCT05349929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111407869|NCT05349929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111407870|NCT04669171|Rituximab|rituximab|mesh-list
111407871|NCT04669171|Lenalidomide|lenalidomide|mesh-list
110885049|NCT01331785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111407872|NCT04669171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111407873|NCT04669171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111407874|NCT04669171|Immunologic Factors|immunologic factors|mesh-ancestor
111407875|NCT04669171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111407876|NCT04669171|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111407877|NCT04669171|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111407878|NCT04669171|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111407879|NCT04669171|Growth Substances|growth substances|mesh-ancestor
111407880|NCT04669171|Growth Inhibitors|growth inhibitors|mesh-ancestor
111407881|NCT04757675|Dexmedetomidine|dexmedetomidine|mesh-list
111407882|NCT04757675|Ketamine|ketamine|mesh-list
111407883|NCT04757675|Esketamine|esketamine|mesh-list
111407884|NCT04757675|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111407885|NCT04757675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111407886|NCT04757675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111407887|NCT04757675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111407888|NCT04757675|Analgesics|analgesics|mesh-ancestor
111407889|NCT04757675|Sensory System Agents|sensory system agents|mesh-ancestor
111407890|NCT04757675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111407891|NCT04757675|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111407892|NCT04757675|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111407893|NCT04757675|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111407894|NCT04757675|Adrenergic Agents|adrenergic agents|mesh-ancestor
111407895|NCT04757675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111407896|NCT04757675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111407897|NCT04757675|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111407898|NCT04757675|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111407899|NCT04757675|Anesthetics, General|anesthetics, general|mesh-ancestor
111407900|NCT04757675|Anesthetics|anesthetics|mesh-ancestor
111407901|NCT04757675|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111407902|NCT04757675|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111407903|NCT04757675|Antidepressive Agents|antidepressive agents|mesh-ancestor
111407904|NCT04757675|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111407905|NCT04611529|Ibuprofen|ibuprofen|mesh-list
111407906|NCT04611529|Diclofenac|diclofenac|mesh-list
111407907|NCT04611529|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111407908|NCT04611529|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111407909|NCT04611529|Analgesics|analgesics|mesh-ancestor
111407910|NCT04611529|Sensory System Agents|sensory system agents|mesh-ancestor
111407911|NCT04611529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111407912|NCT04611529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111407913|NCT04611529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111407914|NCT04611529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111407915|NCT04611529|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111407916|NCT04611529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111407917|NCT04611529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111407918|NCT05323721|Pyrimethamine|pyrimethamine|mesh-list
111407919|NCT05323721|Piperaquine|piperaquine|mesh-list
111407920|NCT05323721|Sulfadoxine|sulfadoxine|mesh-list
111407921|NCT05323721|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
111407922|NCT05323721|Amodiaquine|amodiaquine|mesh-list
111407923|NCT05323721|Artenimol|artenimol|mesh-list
111407924|NCT05323721|Antimalarials|antimalarials|mesh-ancestor
111407925|NCT05323721|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111407926|NCT05323721|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110885125|NCT04853875|Amoxicillin|amoxicillin|mesh-list
111407927|NCT05323721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111407928|NCT05323721|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111407929|NCT05323721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111407930|NCT05323721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111407931|NCT05323721|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111407932|NCT05288075|Glycopyrrolate|glycopyrrolate|mesh-list
111407933|NCT05288075|Charcoal|charcoal|mesh-list
111407934|NCT05288075|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111407935|NCT05288075|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111407936|NCT05288075|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111407937|NCT05288075|Cholinergic Agents|cholinergic agents|mesh-ancestor
111407938|NCT05288075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111407939|NCT05288075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111407940|NCT05288075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111407941|NCT05288075|Antidotes|antidotes|mesh-ancestor
111407942|NCT05288075|Protective Agents|protective agents|mesh-ancestor
111407943|NCT05272787|Sunscreening Agents|sunscreening agents|mesh-list
111407944|NCT05272787|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111407945|NCT05272787|Protective Agents|protective agents|mesh-ancestor
111407946|NCT05272787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111407947|NCT05272787|Dermatologic Agents|dermatologic agents|mesh-ancestor
111407948|NCT05145569|Paclitaxel|paclitaxel|mesh-list
111407949|NCT05145569|Carboplatin|carboplatin|mesh-list
111407950|NCT05145569|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111407951|NCT05145569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111407952|NCT05145569|Tubulin Modulators|tubulin modulators|mesh-ancestor
111407953|NCT05145569|Antimitotic Agents|antimitotic agents|mesh-ancestor
111407954|NCT05145569|Mitosis Modulators|mitosis modulators|mesh-ancestor
111407955|NCT05145569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111407956|NCT04566991|Deferoxamine|deferoxamine|mesh-list
111407957|NCT04566991|Siderophores|siderophores|mesh-ancestor
111407958|NCT04566991|Iron Chelating Agents|iron chelating agents|mesh-ancestor
111407959|NCT04566991|Chelating Agents|chelating agents|mesh-ancestor
111407960|NCT04566991|Sequestering Agents|sequestering agents|mesh-ancestor
111407961|NCT04566991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111407962|NCT03763175|Lovastatin|lovastatin|mesh-list
111407963|NCT03763175|L 647318|l 647318|mesh-list
111407964|NCT03763175|Dihydromevinolin|dihydromevinolin|mesh-list
111407965|NCT03763175|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111407966|NCT03763175|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111407967|NCT03763175|Antimetabolites|antimetabolites|mesh-ancestor
111407968|NCT03763175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111407969|NCT03763175|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111407970|NCT03763175|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111407971|NCT03763175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111407972|NCT04365049|Paclitaxel|paclitaxel|mesh-list
111407973|NCT04365049|Gemcitabine|gemcitabine|mesh-list
111407974|NCT04365049|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111407975|NCT04365049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111407976|NCT04365049|Tubulin Modulators|tubulin modulators|mesh-ancestor
111407977|NCT04365049|Antimitotic Agents|antimitotic agents|mesh-ancestor
111407978|NCT04365049|Mitosis Modulators|mitosis modulators|mesh-ancestor
111407979|NCT04365049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111407980|NCT04365049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111407981|NCT04365049|Antimetabolites|antimetabolites|mesh-ancestor
111407982|NCT03092011|Clonidine|clonidine|mesh-list
111407983|NCT03092011|Morphine|morphine|mesh-list
111407984|NCT03092011|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111407985|NCT03092011|Narcotics|narcotics|mesh-ancestor
111407986|NCT03092011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111407987|NCT03092011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111407988|NCT03092011|Analgesics|analgesics|mesh-ancestor
111407989|NCT03092011|Sensory System Agents|sensory system agents|mesh-ancestor
111407990|NCT03092011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111407991|NCT03092011|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111407992|NCT03092011|Sympatholytics|sympatholytics|mesh-ancestor
111407993|NCT03092011|Autonomic Agents|autonomic agents|mesh-ancestor
111407994|NCT03092011|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111407995|NCT03092011|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111407996|NCT03092011|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111407997|NCT03092011|Adrenergic Agents|adrenergic agents|mesh-ancestor
111407998|NCT03092011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111407999|NCT03092011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111408000|NCT00372515|Gefitinib|gefitinib|mesh-list
111408001|NCT00372515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111408002|NCT00372515|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111408003|NCT00372515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111408004|NCT00372515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111408005|NCT04448119|Favipiravir|favipiravir|mesh-list
111408006|NCT04448119|Antiviral Agents|antiviral agents|mesh-ancestor
111408007|NCT04448119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111408008|NCT03047473|Avelumab|avelumab|mesh-list
111408009|NCT03047473|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111408010|NCT03047473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111408011|NCT02990845|Pembrolizumab|pembrolizumab|mesh-list
111408012|NCT02990845|Leuprolide|leuprolide|mesh-list
111408013|NCT02990845|Exemestane|exemestane|mesh-list
111408014|NCT02990845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111408015|NCT02990845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111408016|NCT02990845|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111408017|NCT02990845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111408018|NCT02990845|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111408019|NCT02990845|Fertility Agents|fertility agents|mesh-ancestor
111408020|NCT02990845|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111408021|NCT02990845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111408022|NCT02990845|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111408023|NCT02990845|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111408024|NCT02990845|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111408025|NCT02990845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111408026|NCT02990845|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111408027|NCT02990845|Hormone Antagonists|hormone antagonists|mesh-ancestor
111408028|NCT02990845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111408029|NCT04438213|Ertugliflozin|ertugliflozin|mesh-list
111408030|NCT04438213|Metolazone|metolazone|mesh-list
111408031|NCT04438213|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111408032|NCT04438213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111408033|NCT04438213|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111408034|NCT04438213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111408035|NCT04438213|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111408036|NCT04438213|Diuretics|diuretics|mesh-ancestor
111408037|NCT04438213|Natriuretic Agents|natriuretic agents|mesh-ancestor
111408038|NCT04438213|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
111408039|NCT04438213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111408040|NCT01987219|Bromides|bromides|mesh-list
111408041|NCT01987219|Albuterol|albuterol|mesh-list
111408042|NCT01987219|Ipratropium|ipratropium|mesh-list
111408043|NCT01987219|Anticonvulsants|anticonvulsants|mesh-ancestor
111408044|NCT01987219|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111408045|NCT01987219|Autonomic Agents|autonomic agents|mesh-ancestor
111408046|NCT01987219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111408047|NCT01987219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111408048|NCT01987219|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111408049|NCT01987219|Respiratory System Agents|respiratory system agents|mesh-ancestor
111408050|NCT01987219|Tocolytic Agents|tocolytic agents|mesh-ancestor
111408051|NCT01987219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111408052|NCT01987219|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111408053|NCT01987219|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111408054|NCT01987219|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111408055|NCT01987219|Adrenergic Agents|adrenergic agents|mesh-ancestor
111408056|NCT01987219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111408057|NCT01987219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111408058|NCT01987219|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111408059|NCT01987219|Cholinergic Agents|cholinergic agents|mesh-ancestor
111408060|NCT04265053|Ketorolac|ketorolac|mesh-list
111408061|NCT04265053|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
111408062|NCT04265053|Estradiol|estradiol|mesh-list
111408063|NCT04265053|Testosterone|testosterone|mesh-list
111408064|NCT04265053|Ganirelix|ganirelix|mesh-list
111408065|NCT04265053|Estrogens|estrogens|mesh-ancestor
111408066|NCT04265053|Hormones|hormones|mesh-ancestor
111408067|NCT04265053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110885249|NCT01338103|Rituximab|rituximab|mesh-list
111408068|NCT04265053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111408069|NCT04265053|Androgens|androgens|mesh-ancestor
111408070|NCT04265053|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111408071|NCT04265053|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111408072|NCT04265053|Analgesics|analgesics|mesh-ancestor
111408073|NCT04265053|Sensory System Agents|sensory system agents|mesh-ancestor
111408074|NCT04265053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111408075|NCT04265053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111408076|NCT04265053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111408077|NCT04265053|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111408078|NCT04265053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111408079|NCT04265053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111408080|NCT04265053|Hormone Antagonists|hormone antagonists|mesh-ancestor
111408081|NCT04332497|Ibuprofen|ibuprofen|mesh-list
111408082|NCT04332497|Fentanyl|fentanyl|mesh-list
111408083|NCT04332497|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111408084|NCT04332497|Narcotics|narcotics|mesh-ancestor
111408085|NCT04332497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111408086|NCT04332497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111408087|NCT04332497|Analgesics|analgesics|mesh-ancestor
111408088|NCT04332497|Sensory System Agents|sensory system agents|mesh-ancestor
111408089|NCT04332497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111408090|NCT04332497|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111408091|NCT04332497|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111408092|NCT04332497|Anesthetics, General|anesthetics, general|mesh-ancestor
111408093|NCT04332497|Anesthetics|anesthetics|mesh-ancestor
111408094|NCT04332497|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111408095|NCT04332497|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111408096|NCT04332497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111408097|NCT04332497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111408098|NCT04332497|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111408099|NCT04332497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111408100|NCT04332497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111408101|NCT02633137|Cytarabine|cytarabine|mesh-list
111408102|NCT02633137|Lenalidomide|lenalidomide|mesh-list
111408103|NCT02633137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111408104|NCT02633137|Antimetabolites|antimetabolites|mesh-ancestor
111408105|NCT02633137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111408106|NCT02633137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111408107|NCT02633137|Antiviral Agents|antiviral agents|mesh-ancestor
111408108|NCT02633137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111408109|NCT02633137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111408110|NCT02633137|Immunologic Factors|immunologic factors|mesh-ancestor
111408111|NCT02633137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111408112|NCT02633137|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111408113|NCT02633137|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111408114|NCT02633137|Growth Substances|growth substances|mesh-ancestor
111408115|NCT02633137|Growth Inhibitors|growth inhibitors|mesh-ancestor
111408116|NCT04258397|Pirfenidone|pirfenidone|mesh-list
111408117|NCT04258397|Analgesics|analgesics|mesh-ancestor
111408118|NCT04258397|Sensory System Agents|sensory system agents|mesh-ancestor
111408119|NCT04258397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111408120|NCT04258397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111408121|NCT04258397|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111408122|NCT04258397|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111408123|NCT04258397|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111408124|NCT04258397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111408125|NCT04258397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111408126|NCT04707209|Sirolimus|sirolimus|mesh-list
111408127|NCT04707209|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111408128|NCT04707209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111408129|NCT04707209|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111408130|NCT04707209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111408131|NCT04707209|Antifungal Agents|antifungal agents|mesh-ancestor
111408132|NCT04707209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111408133|NCT04707209|Immunologic Factors|immunologic factors|mesh-ancestor
111408134|NCT04707209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111408135|NCT01989793|Losartan|losartan|mesh-list
111408136|NCT01989793|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111408137|NCT01989793|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111408138|NCT01989793|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111408139|NCT01989793|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111408140|NCT01989793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111408141|NCT01992523|Ticagrelor|ticagrelor|mesh-list
111408142|NCT01992523|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111408143|NCT01992523|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111408144|NCT01992523|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111408145|NCT01992523|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111408146|NCT01992523|Purinergic Agents|purinergic agents|mesh-ancestor
111408147|NCT01992523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111408148|NCT01992523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111408149|NCT01992523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111408150|NCT04186247|Azithromycin|azithromycin|mesh-list
111408151|NCT04186247|Metronidazole|metronidazole|mesh-list
111408152|NCT04186247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111408153|NCT04186247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111408154|NCT04186247|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111408155|NCT04186247|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111408156|NCT00373373|Sorafenib|sorafenib|mesh-list
111408157|NCT00373373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111408158|NCT00373373|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111408159|NCT00373373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111408160|NCT00373373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111408161|NCT00373451|Heparin|heparin|mesh-list
111408162|NCT00373451|Calcium heparin|calcium heparin|mesh-list
111408163|NCT00373451|Bivalirudin|bivalirudin|mesh-list
111408164|NCT00373451|Abciximab|abciximab|mesh-list
111408165|NCT00373451|Anticoagulants|anticoagulants|mesh-ancestor
111408166|NCT00373451|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111408167|NCT00373451|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111408168|NCT00373451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111408169|NCT00373451|Antithrombins|antithrombins|mesh-ancestor
111408170|NCT00373451|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111408171|NCT00373451|Protease Inhibitors|protease inhibitors|mesh-ancestor
111408172|NCT00373451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111408173|NCT00373451|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111408174|NCT01387763|Interferons|interferons|mesh-list
111408175|NCT01387763|Interferon-alpha|interferon-alpha|mesh-list
111132572|NCT00660673|Levodopa|levodopa|mesh-list
111408176|NCT01387763|Interferon alpha-2|interferon alpha-2|mesh-list
111408177|NCT01387763|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
111408178|NCT01387763|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
111408179|NCT01387763|Hydroxyurea|hydroxyurea|mesh-list
111408180|NCT01387763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111408181|NCT01387763|Antiviral Agents|antiviral agents|mesh-ancestor
111408182|NCT01387763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111408183|NCT01387763|Immunologic Factors|immunologic factors|mesh-ancestor
110885366|NCT01377597|Growth Inhibitors|growth inhibitors|mesh-ancestor
111408184|NCT01387763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111408185|NCT01387763|Antisickling Agents|antisickling agents|mesh-ancestor
111408186|NCT01387763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111408187|NCT01387763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111408188|NCT01387763|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111408189|NCT00373061|Omalizumab|omalizumab|mesh-list
111408190|NCT00373061|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111408191|NCT00373061|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111408192|NCT00373061|Respiratory System Agents|respiratory system agents|mesh-ancestor
111408193|NCT00707213|Deoxyglucose|deoxyglucose|mesh-list
111408194|NCT00707213|Antimetabolites|antimetabolites|mesh-ancestor
111408195|NCT00707213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111408196|NCT00707213|Antiviral Agents|antiviral agents|mesh-ancestor
111408197|NCT00707213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111408198|NCT01993849|Acetylcysteine|acetylcysteine|mesh-list
111408199|NCT01993849|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111408200|NCT01993849|Antiviral Agents|antiviral agents|mesh-ancestor
111408201|NCT01993849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111408202|NCT01993849|Expectorants|expectorants|mesh-ancestor
111408203|NCT01993849|Respiratory System Agents|respiratory system agents|mesh-ancestor
111408204|NCT01993849|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111408205|NCT01993849|Antioxidants|antioxidants|mesh-ancestor
111408206|NCT01993849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111408207|NCT01993849|Protective Agents|protective agents|mesh-ancestor
111408208|NCT01993849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111408209|NCT01993849|Antidotes|antidotes|mesh-ancestor
111408210|NCT02778113|Glucagon|glucagon|mesh-list
111408211|NCT02778113|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
111408212|NCT02778113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111408213|NCT02778113|Hormones|hormones|mesh-ancestor
111408214|NCT02778113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111408215|NCT02778113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111408216|NCT02778113|Incretins|incretins|mesh-ancestor
111408217|NCT04982237|Paclitaxel|paclitaxel|mesh-list
111408218|NCT04982237|Bevacizumab|bevacizumab|mesh-list
111408219|NCT04982237|Carboplatin|carboplatin|mesh-list
111408220|NCT04982237|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111408221|NCT04982237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111408222|NCT04982237|Tubulin Modulators|tubulin modulators|mesh-ancestor
111408223|NCT04982237|Antimitotic Agents|antimitotic agents|mesh-ancestor
111408224|NCT04982237|Mitosis Modulators|mitosis modulators|mesh-ancestor
111408225|NCT04982237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111408226|NCT04982237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111408227|NCT04982237|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111408228|NCT04982237|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111408229|NCT04982237|Growth Substances|growth substances|mesh-ancestor
111408230|NCT04982237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111408231|NCT04982237|Growth Inhibitors|growth inhibitors|mesh-ancestor
111408232|NCT01996657|Warfarin|warfarin|mesh-list
111408233|NCT01996657|Anticoagulants|anticoagulants|mesh-ancestor
111408234|NCT02316379|Xenon|xenon|mesh-list
111408235|NCT02316379|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111408236|NCT02316379|Anesthetics, General|anesthetics, general|mesh-ancestor
111408237|NCT02316379|Anesthetics|anesthetics|mesh-ancestor
111408238|NCT02316379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111408239|NCT02316379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111408240|NCT02303977|Gemcitabine|gemcitabine|mesh-list
111408241|NCT02303977|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111408242|NCT02303977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111408243|NCT02303977|Antimetabolites|antimetabolites|mesh-ancestor
111408244|NCT02303977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111408245|NCT02303977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111408246|NCT01997515|Ketamine|ketamine|mesh-list
111408247|NCT01997515|Analgesics|analgesics|mesh-ancestor
111408248|NCT01997515|Sensory System Agents|sensory system agents|mesh-ancestor
111408249|NCT01997515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111408250|NCT01997515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111408251|NCT01997515|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111408252|NCT01997515|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111408253|NCT01997515|Anesthetics, General|anesthetics, general|mesh-ancestor
111408254|NCT01997515|Anesthetics|anesthetics|mesh-ancestor
111408255|NCT01997515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111408256|NCT01997515|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111408257|NCT01997515|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111408258|NCT01997515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111408259|NCT01997515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111408260|NCT04333823|Dapagliflozin|dapagliflozin|mesh-list
111408261|NCT04333823|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111408262|NCT04333823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111408263|NCT04333823|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111408264|NCT04333823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111408265|NCT01997905|Protein S|protein s|mesh-list
111408266|NCT01997905|Anticoagulants|anticoagulants|mesh-ancestor
111408267|NCT02788019|Ropivacaine|ropivacaine|mesh-list
111408268|NCT02788019|Anesthetics, Local|anesthetics, local|mesh-ancestor
111408269|NCT02788019|Anesthetics|anesthetics|mesh-ancestor
111408270|NCT02788019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111408271|NCT02788019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111408272|NCT02788019|Sensory System Agents|sensory system agents|mesh-ancestor
111408273|NCT02788019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111408274|NCT02788097|Progesterone|progesterone|mesh-list
111408275|NCT02788097|Progestins|progestins|mesh-ancestor
111408276|NCT02788097|Hormones|hormones|mesh-ancestor
111408277|NCT02788097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111408278|NCT02788097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111408279|NCT02789033|Isosorbide|isosorbide|mesh-list
111408280|NCT02789033|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
111408281|NCT02789033|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
111408282|NCT02789033|Chitosan|chitosan|mesh-list
111408283|NCT02789033|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
111408284|NCT02789033|Diuretics|diuretics|mesh-ancestor
111408285|NCT02789033|Natriuretic Agents|natriuretic agents|mesh-ancestor
111408286|NCT02789033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111408287|NCT02789033|Vasodilator Agents|vasodilator agents|mesh-ancestor
111408288|NCT02789033|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
111408289|NCT02789033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111408290|NCT02789033|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111408291|NCT02789033|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111408292|NCT02789033|Antimetabolites|antimetabolites|mesh-ancestor
111408293|NCT02789033|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111408294|NCT02789033|Chelating Agents|chelating agents|mesh-ancestor
111408295|NCT02789033|Sequestering Agents|sequestering agents|mesh-ancestor
111408296|NCT02789033|Hemostatics|hemostatics|mesh-ancestor
111408297|NCT02789033|Coagulants|coagulants|mesh-ancestor
111408298|NCT00372827|Travoprost|travoprost|mesh-list
111408299|NCT00372827|Brinzolamide|brinzolamide|mesh-list
111408300|NCT00372827|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111408301|NCT00372827|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
111408302|NCT00372827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111408303|NCT00372827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111408304|NCT02278315|Dexamethasone|dexamethasone|mesh-list
111408305|NCT02278315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111408306|NCT02278315|Antiemetics|antiemetics|mesh-ancestor
111408307|NCT02278315|Autonomic Agents|autonomic agents|mesh-ancestor
111408308|NCT02278315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111408309|NCT02278315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111408310|NCT02278315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111408311|NCT02278315|Glucocorticoids|glucocorticoids|mesh-ancestor
111408312|NCT02278315|Hormones|hormones|mesh-ancestor
111408313|NCT02278315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111408314|NCT02278315|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111408315|NCT02278315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111408316|NCT02795117|Ivermectin|ivermectin|mesh-list
111408317|NCT02795117|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111408318|NCT02795117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111408319|NCT02882633|Bupivacaine|bupivacaine|mesh-list
111408320|NCT02882633|Anesthetics, Local|anesthetics, local|mesh-ancestor
111408321|NCT02882633|Anesthetics|anesthetics|mesh-ancestor
111408322|NCT02882633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111408323|NCT02882633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111408324|NCT02882633|Sensory System Agents|sensory system agents|mesh-ancestor
111408325|NCT02882633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111408326|NCT00373607|Artesunate|artesunate|mesh-list
111408327|NCT00373607|Piperaquine|piperaquine|mesh-list
111408328|NCT00373607|Mefloquine|mefloquine|mesh-list
111408329|NCT00373607|Antimalarials|antimalarials|mesh-ancestor
111408330|NCT00373607|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111408331|NCT00373607|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111408332|NCT00373607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111408333|NCT00373607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111408334|NCT00373607|Antiviral Agents|antiviral agents|mesh-ancestor
111408335|NCT00373607|Schistosomicides|schistosomicides|mesh-ancestor
111408336|NCT00373607|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110885581|NCT05030129|Vitamin B 6|vitamin b 6|mesh-list
111408337|NCT00373607|Anthelmintics|anthelmintics|mesh-ancestor
111408338|NCT02882711|Ketamine|ketamine|mesh-list
111408339|NCT02882711|Analgesics|analgesics|mesh-ancestor
111408340|NCT02882711|Sensory System Agents|sensory system agents|mesh-ancestor
111408341|NCT02882711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111408342|NCT02882711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111408343|NCT02882711|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110885584|NCT05030129|Ergoloid Mesylates|ergoloid mesylates|mesh-list
111408344|NCT02882711|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111408345|NCT02882711|Anesthetics, General|anesthetics, general|mesh-ancestor
111408346|NCT02882711|Anesthetics|anesthetics|mesh-ancestor
111408347|NCT02882711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111408348|NCT02882711|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111408349|NCT02882711|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111408350|NCT02882711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111408351|NCT02882711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111408352|NCT02794337|Sorafenib|sorafenib|mesh-list
111408353|NCT02794337|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
111408354|NCT02794337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111408355|NCT02794337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111408356|NCT02794337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111408357|NCT02794337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111408358|NCT02590523|Moxifloxacin|moxifloxacin|mesh-list
111408359|NCT02590523|Vancomycin|vancomycin|mesh-list
111408360|NCT02590523|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111408361|NCT02590523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111408362|NCT02590523|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111408363|NCT02590523|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111408364|NCT02590523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110885592|NCT05030129|Antidepressive Agents|antidepressive agents|mesh-ancestor
111408365|NCT02590523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111408366|NCT02590523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111408367|NCT02895035|Ketorolac|ketorolac|mesh-list
111408368|NCT02895035|Phenylephrine|phenylephrine|mesh-list
111408369|NCT02895035|Epinephrine|epinephrine|mesh-list
111408370|NCT02895035|Oxymetazoline|oxymetazoline|mesh-list
111408371|NCT02895035|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111408372|NCT02895035|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111408373|NCT02895035|Adrenergic Agents|adrenergic agents|mesh-ancestor
111408374|NCT02895035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111408375|NCT02895035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111408376|NCT02895035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111408377|NCT02895035|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111408378|NCT02895035|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111408379|NCT02895035|Autonomic Agents|autonomic agents|mesh-ancestor
111408380|NCT02895035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111408381|NCT02895035|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111408382|NCT02895035|Respiratory System Agents|respiratory system agents|mesh-ancestor
111408383|NCT02895035|Mydriatics|mydriatics|mesh-ancestor
111408384|NCT02895035|Sympathomimetics|sympathomimetics|mesh-ancestor
111408385|NCT02895035|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111408386|NCT02895035|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111408387|NCT02895035|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111408388|NCT02895035|Analgesics|analgesics|mesh-ancestor
111408389|NCT02895035|Sensory System Agents|sensory system agents|mesh-ancestor
111408390|NCT02895035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111408391|NCT02895035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111408392|NCT02895035|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111408393|NCT02895035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111408394|NCT02895035|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111408395|NCT02895035|Nasal Decongestants|nasal decongestants|mesh-ancestor
111408396|NCT02895035|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111408397|NCT02895035|Protective Agents|protective agents|mesh-ancestor
111408398|NCT02802449|Vitamin D|vitamin d|mesh-list
111408399|NCT02802449|Ergocalciferols|ergocalciferols|mesh-list
111408400|NCT02802449|Cholecalciferol|cholecalciferol|mesh-list
111408401|NCT02802449|Calcifediol|calcifediol|mesh-list
111408402|NCT02802449|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
111408403|NCT02802449|Vitamins|vitamins|mesh-list
111408404|NCT02802449|Micronutrients|micronutrients|mesh-ancestor
111408405|NCT02802449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111408406|NCT02802449|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111408407|NCT02802449|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111408409|NCT02803229|Adderall|adderall|mesh-list
111408410|NCT02803229|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111408411|NCT02803229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111408412|NCT02803229|Sympathomimetics|sympathomimetics|mesh-ancestor
111408413|NCT02803229|Autonomic Agents|autonomic agents|mesh-ancestor
111408414|NCT02803229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111408415|NCT02803229|Dopamine Agents|dopamine agents|mesh-ancestor
111408416|NCT02803229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111408417|NCT02803229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111408418|NCT02803229|Adrenergic Agents|adrenergic agents|mesh-ancestor
111408419|NCT02803229|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111408420|NCT02803229|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111408421|NCT02803229|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111408422|NCT02803229|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111408423|NCT01938001|Rituximab|rituximab|mesh-list
111408424|NCT01938001|Lenalidomide|lenalidomide|mesh-list
111408425|NCT01938001|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111408426|NCT01938001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111408427|NCT01938001|Immunologic Factors|immunologic factors|mesh-ancestor
111408428|NCT01938001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111408429|NCT01938001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111408430|NCT01938001|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111408431|NCT01938001|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111408432|NCT01938001|Growth Substances|growth substances|mesh-ancestor
111408433|NCT01938001|Growth Inhibitors|growth inhibitors|mesh-ancestor
111408434|NCT02805179|Temozolomide|temozolomide|mesh-list
111408435|NCT02805179|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111408436|NCT02805179|Alkylating Agents|alkylating agents|mesh-ancestor
111408437|NCT02805179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111408438|NCT02805179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111408439|NCT02896595|Anesthetics|anesthetics|mesh-list
111408440|NCT02896595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111408441|NCT02896595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111408442|NCT02003911|Azithromycin|azithromycin|mesh-list
111408443|NCT02003911|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111408444|NCT02003911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111408445|NCT04147351|Bevacizumab|bevacizumab|mesh-list
111408446|NCT04147351|Atezolizumab|atezolizumab|mesh-list
111408447|NCT04147351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111408448|NCT04147351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111408449|NCT04147351|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111408450|NCT04147351|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111408451|NCT04147351|Growth Substances|growth substances|mesh-ancestor
111408452|NCT04147351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111408453|NCT04147351|Growth Inhibitors|growth inhibitors|mesh-ancestor
111408454|NCT04147351|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111408455|NCT04147351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111408456|NCT02004613|Dexmedetomidine|dexmedetomidine|mesh-list
111408457|NCT02004613|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111408458|NCT02004613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111408459|NCT02004613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111408460|NCT02004613|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111408461|NCT02004613|Analgesics|analgesics|mesh-ancestor
111408462|NCT02004613|Sensory System Agents|sensory system agents|mesh-ancestor
111408463|NCT02004613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111408464|NCT02004613|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111408465|NCT02004613|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111408466|NCT02004613|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111408467|NCT02004613|Adrenergic Agents|adrenergic agents|mesh-ancestor
111408468|NCT02004613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111408469|NCT02004613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111408470|NCT01754779|Potassium Citrate|potassium citrate|mesh-list
111408471|NCT01754779|Citric Acid|citric acid|mesh-list
111408472|NCT01754779|Sodium Citrate|sodium citrate|mesh-list
111408473|NCT01754779|Anticoagulants|anticoagulants|mesh-ancestor
111408474|NCT01754779|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
111408475|NCT01754779|Chelating Agents|chelating agents|mesh-ancestor
111408476|NCT01754779|Sequestering Agents|sequestering agents|mesh-ancestor
111408477|NCT01754779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111408478|NCT01754779|Diuretics|diuretics|mesh-ancestor
111408479|NCT01754779|Natriuretic Agents|natriuretic agents|mesh-ancestor
111408480|NCT01754779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111408481|NCT01754779|Expectorants|expectorants|mesh-ancestor
111408482|NCT01754779|Respiratory System Agents|respiratory system agents|mesh-ancestor
111408483|NCT02149277|Lenograstim|lenograstim|mesh-list
111408484|NCT02149277|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111408485|NCT02149277|Immunologic Factors|immunologic factors|mesh-ancestor
111408486|NCT02149277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111408487|NCT02896907|Calcium, Dietary|calcium, dietary|mesh-list
111408488|NCT02896907|Vitamins|vitamins|mesh-list
111408489|NCT02896907|Leucovorin|leucovorin|mesh-list
111408490|NCT02896907|Ascorbic Acid|ascorbic acid|mesh-list
111408491|NCT02896907|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
111408492|NCT02896907|Tetrahydrofolates|tetrahydrofolates|mesh-list
111408493|NCT02896907|Fluorouracil|fluorouracil|mesh-list
111408494|NCT02896907|Oxaliplatin|oxaliplatin|mesh-list
111408495|NCT02896907|Irinotecan|irinotecan|mesh-list
111408496|NCT02896907|Camptothecin|camptothecin|mesh-list
111408497|NCT02896907|Calcium|calcium|mesh-list
111408498|NCT02896907|Levoleucovorin|levoleucovorin|mesh-list
111408499|NCT02896907|Micronutrients|micronutrients|mesh-ancestor
111408500|NCT02896907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111408501|NCT02896907|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111408502|NCT02896907|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111408503|NCT02896907|Antimetabolites|antimetabolites|mesh-ancestor
111408504|NCT02896907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111408505|NCT02896907|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111408506|NCT02896907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111408507|NCT02896907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111408508|NCT02896907|Immunologic Factors|immunologic factors|mesh-ancestor
111408509|NCT02896907|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111408510|NCT02896907|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111408511|NCT02896907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111408512|NCT02896907|Antidotes|antidotes|mesh-ancestor
111408513|NCT02896907|Protective Agents|protective agents|mesh-ancestor
111408514|NCT02896907|Vitamin B Complex|vitamin b complex|mesh-ancestor
111408515|NCT02896907|Antioxidants|antioxidants|mesh-ancestor
111408516|NCT02896907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111408517|NCT02005549|Bevacizumab|bevacizumab|mesh-list
111408518|NCT02005549|Docetaxel|docetaxel|mesh-list
111408519|NCT02005549|Capecitabine|capecitabine|mesh-list
111408520|NCT02005549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111408521|NCT02005549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111408522|NCT02005549|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111408523|NCT02005549|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111408524|NCT02005549|Growth Substances|growth substances|mesh-ancestor
111408525|NCT02005549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111408526|NCT02005549|Growth Inhibitors|growth inhibitors|mesh-ancestor
111408527|NCT02005549|Tubulin Modulators|tubulin modulators|mesh-ancestor
111408528|NCT02005549|Antimitotic Agents|antimitotic agents|mesh-ancestor
111408529|NCT02005549|Mitosis Modulators|mitosis modulators|mesh-ancestor
111408530|NCT02005549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111408531|NCT02005549|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110885765|NCT03080493|Narcotics|narcotics|mesh-ancestor
111408532|NCT02005549|Antimetabolites|antimetabolites|mesh-ancestor
111408533|NCT04349696|Mitiglinide|mitiglinide|mesh-list
111408534|NCT04349696|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111408535|NCT04349696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111408536|NCT02810873|Copper|copper|mesh-list
111408537|NCT02810873|Deoxyglucose|deoxyglucose|mesh-list
111408538|NCT02810873|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
111408539|NCT02810873|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111408540|NCT02810873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111408541|NCT02810873|Trace Elements|trace elements|mesh-ancestor
111408542|NCT02810873|Micronutrients|micronutrients|mesh-ancestor
111408543|NCT02810873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111408544|NCT02810873|Antimetabolites|antimetabolites|mesh-ancestor
111408545|NCT02810873|Antiviral Agents|antiviral agents|mesh-ancestor
111408546|NCT02810873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111408547|NCT04492358|Prednisone|prednisone|mesh-list
111408548|NCT04492358|Colchicine|colchicine|mesh-list
111408549|NCT04492358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111408550|NCT04492358|Glucocorticoids|glucocorticoids|mesh-ancestor
111408551|NCT04492358|Hormones|hormones|mesh-ancestor
111408552|NCT04492358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111408553|NCT04492358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111408554|NCT04492358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111408555|NCT04492358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111408556|NCT04492358|Gout Suppressants|gout suppressants|mesh-ancestor
111408557|NCT04492358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111408558|NCT04492358|Tubulin Modulators|tubulin modulators|mesh-ancestor
111408559|NCT04492358|Antimitotic Agents|antimitotic agents|mesh-ancestor
111132941|NCT04981093|Dexamethasone|dexamethasone|mesh-list
111408560|NCT04492358|Mitosis Modulators|mitosis modulators|mesh-ancestor
111408561|NCT04492358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111408562|NCT03488420|Edoxaban|edoxaban|mesh-list
111408563|NCT03488420|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111408564|NCT03488420|Antithrombins|antithrombins|mesh-ancestor
110885798|NCT03655392|Autonomic Agents|autonomic agents|mesh-ancestor
111408565|NCT03488420|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111408566|NCT03488420|Protease Inhibitors|protease inhibitors|mesh-ancestor
111408567|NCT03488420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111408568|NCT03488420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111408569|NCT03488420|Anticoagulants|anticoagulants|mesh-ancestor
111408570|NCT01066663|Pyrimethamine|pyrimethamine|mesh-list
111408571|NCT01066663|Antimalarials|antimalarials|mesh-ancestor
111408572|NCT01066663|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110476517|NCT02719431|Warfarin|warfarin|mesh-list
111408573|NCT01066663|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111408574|NCT01066663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111408575|NCT01066663|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111408576|NCT01066663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111408577|NCT01066663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111408578|NCT01959685|Enclomiphene|enclomiphene|mesh-list
111408579|NCT01959685|Clomiphene|clomiphene|mesh-list
111408580|NCT01959685|Zuclomiphene|zuclomiphene|mesh-list
111408581|NCT01959685|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111408582|NCT01959685|Hormone Antagonists|hormone antagonists|mesh-ancestor
111408583|NCT01959685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111408584|NCT01959685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111408585|NCT01959685|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111408586|NCT01959685|Fertility Agents|fertility agents|mesh-ancestor
111408587|NCT01959685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111408588|NCT01959685|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111408589|NCT01959685|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111408590|NCT02901899|Pembrolizumab|pembrolizumab|mesh-list
111408591|NCT02901899|Guadecitabine|guadecitabine|mesh-list
111408592|NCT02901899|Azacitidine|azacitidine|mesh-list
111408593|NCT02901899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111408594|NCT02901899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111408595|NCT02901899|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111408596|NCT02901899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111408597|NCT02901899|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111408598|NCT02901899|Antimetabolites|antimetabolites|mesh-ancestor
111408599|NCT02901899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111408600|NCT04333589|Favipiravir|favipiravir|mesh-list
111408601|NCT04333589|Antiviral Agents|antiviral agents|mesh-ancestor
111408602|NCT04333589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111408603|NCT02902913|Ibuprofen|ibuprofen|mesh-list
111408604|NCT02902913|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111408605|NCT02902913|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111408606|NCT02902913|Analgesics|analgesics|mesh-ancestor
111408607|NCT02902913|Sensory System Agents|sensory system agents|mesh-ancestor
111408608|NCT02902913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111408609|NCT02902913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111408610|NCT02902913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111408611|NCT02902913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111408612|NCT02902913|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111408613|NCT02902913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110885844|NCT01066104|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111408614|NCT02902913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111408615|NCT03417986|Thiethylperazine|thiethylperazine|mesh-list
111408616|NCT03417986|Antiemetics|antiemetics|mesh-ancestor
111408617|NCT03417986|Autonomic Agents|autonomic agents|mesh-ancestor
111408618|NCT03417986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111408619|NCT03417986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111408620|NCT03417986|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111408621|NCT03417986|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111408622|NCT03417986|Dopamine Agents|dopamine agents|mesh-ancestor
111408623|NCT03417986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111408624|NCT03417986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110885865|NCT03654144|Dienogest|dienogest|mesh-list
111408625|NCT04349228|Hydroxychloroquine|hydroxychloroquine|mesh-list
111408626|NCT04349228|Antimalarials|antimalarials|mesh-ancestor
111408627|NCT04349228|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111408628|NCT04349228|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111408629|NCT04349228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111408630|NCT04349228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111408631|NCT04349228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111408632|NCT04349228|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111408633|NCT02301416|Topiramate|topiramate|mesh-list
111408634|NCT02301416|Phentermine|phentermine|mesh-list
111408635|NCT02301416|Anticonvulsants|anticonvulsants|mesh-ancestor
111408636|NCT02301416|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111408637|NCT02301416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111408638|NCT02301416|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111408639|NCT02301416|Appetite Depressants|appetite depressants|mesh-ancestor
111408640|NCT02301416|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111408641|NCT02301416|Sympathomimetics|sympathomimetics|mesh-ancestor
111408642|NCT02301416|Autonomic Agents|autonomic agents|mesh-ancestor
111408643|NCT02301416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111408644|NCT02301416|Adrenergic Agents|adrenergic agents|mesh-ancestor
111408645|NCT02301416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110885879|NCT02591615|Paclitaxel|paclitaxel|mesh-list
111408646|NCT02301416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111408647|NCT02815709|Morphine|morphine|mesh-list
111408648|NCT02815709|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111408649|NCT02815709|Narcotics|narcotics|mesh-ancestor
111408650|NCT02815709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111408651|NCT02815709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111408652|NCT02815709|Analgesics|analgesics|mesh-ancestor
111408653|NCT02815709|Sensory System Agents|sensory system agents|mesh-ancestor
111408654|NCT02815709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111408655|NCT02912195|Lidocaine|lidocaine|mesh-list
111408656|NCT02912195|Morphine|morphine|mesh-list
111408657|NCT02912195|Anesthetics, Local|anesthetics, local|mesh-ancestor
111408658|NCT02912195|Anesthetics|anesthetics|mesh-ancestor
111408659|NCT02912195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111408660|NCT02912195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111408661|NCT02912195|Sensory System Agents|sensory system agents|mesh-ancestor
111408662|NCT02912195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111408663|NCT02912195|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111408664|NCT02912195|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111408665|NCT02912195|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111408666|NCT02912195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111408667|NCT02912195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111408668|NCT02912195|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111408669|NCT02912195|Narcotics|narcotics|mesh-ancestor
111408670|NCT02912195|Analgesics|analgesics|mesh-ancestor
111408671|NCT01960075|Fosphenytoin|fosphenytoin|mesh-list
111408672|NCT01960075|Levetiracetam|levetiracetam|mesh-list
111408673|NCT01960075|Valproic Acid|valproic acid|mesh-list
111408674|NCT01960075|Anticonvulsants|anticonvulsants|mesh-ancestor
111408675|NCT01960075|Nootropic Agents|nootropic agents|mesh-ancestor
111408676|NCT01960075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111408677|NCT01960075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111408678|NCT01960075|GABA Agents|gaba agents|mesh-ancestor
110207570|NCT00188227|Midazolam|midazolam|mesh-list
111408679|NCT01960075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111408680|NCT01960075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111408681|NCT01960075|Antimanic Agents|antimanic agents|mesh-ancestor
111408682|NCT01960075|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111408683|NCT01960075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111408684|NCT01960075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111408685|NCT01960075|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111408686|NCT01960075|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111408687|NCT01988246|Aflibercept|aflibercept|mesh-list
111408688|NCT01988246|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111408689|NCT01988246|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111408690|NCT01988246|Growth Substances|growth substances|mesh-ancestor
111408691|NCT01988246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111408692|NCT01988246|Growth Inhibitors|growth inhibitors|mesh-ancestor
111408693|NCT01988246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111408694|NCT01990898|Cyclosporine|cyclosporine|mesh-list
111408695|NCT01990898|Cyclosporins|cyclosporins|mesh-list
111408696|NCT01990898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111408697|NCT01990898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111408698|NCT01990898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111408699|NCT01990898|Immunologic Factors|immunologic factors|mesh-ancestor
111408700|NCT01990898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111408701|NCT01990898|Antifungal Agents|antifungal agents|mesh-ancestor
111408702|NCT01990898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111408703|NCT01990898|Dermatologic Agents|dermatologic agents|mesh-ancestor
111408704|NCT01990898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111408705|NCT01990898|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111408706|NCT01960387|Cytarabine|cytarabine|mesh-list
111408707|NCT01960387|Clofarabine|clofarabine|mesh-list
111408708|NCT01960387|Antimetabolites|antimetabolites|mesh-list
111408709|NCT01960387|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111408710|NCT01960387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111408711|NCT01960387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111408712|NCT01960387|Antiviral Agents|antiviral agents|mesh-ancestor
111408713|NCT01960387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111408714|NCT01960387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111408715|NCT01960387|Immunologic Factors|immunologic factors|mesh-ancestor
111408716|NCT01960387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111408718|NCT02823431|Anesthetics, Local|anesthetics, local|mesh-ancestor
111408719|NCT02823431|Anesthetics|anesthetics|mesh-ancestor
110885951|NCT01379079|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111408720|NCT02823431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111408721|NCT02823431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111408722|NCT02823431|Sensory System Agents|sensory system agents|mesh-ancestor
111408723|NCT02823431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111408724|NCT02823431|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111408725|NCT02823431|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111408726|NCT02823431|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111408727|NCT02823431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111408728|NCT02823431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110885967|NCT01379001|Nootropic Agents|nootropic agents|mesh-ancestor
111408729|NCT02824913|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111408730|NCT02824913|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111408731|NCT03008213|Palonosetron|palonosetron|mesh-list
111408732|NCT03008213|Antiemetics|antiemetics|mesh-ancestor
111408733|NCT03008213|Autonomic Agents|autonomic agents|mesh-ancestor
111408734|NCT03008213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110885973|NCT01379001|Mydriatics|mydriatics|mesh-ancestor
111408735|NCT03008213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111408736|NCT03008213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111408737|NCT03008213|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111408738|NCT03008213|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111408739|NCT03008213|Serotonin Agents|serotonin agents|mesh-ancestor
111408740|NCT03008213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111408741|NCT03008213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111408742|NCT02059070|Bupivacaine|bupivacaine|mesh-list
111408743|NCT02059070|Ropivacaine|ropivacaine|mesh-list
111408744|NCT02059070|Anesthetics, Local|anesthetics, local|mesh-ancestor
111408745|NCT02059070|Anesthetics|anesthetics|mesh-ancestor
111408746|NCT02059070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111408747|NCT02059070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111408748|NCT02059070|Sensory System Agents|sensory system agents|mesh-ancestor
111408749|NCT02059070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111408750|NCT01962961|Acetylcysteine|acetylcysteine|mesh-list
111408751|NCT01962961|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111408752|NCT01962961|Antiviral Agents|antiviral agents|mesh-ancestor
111408753|NCT01962961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111408754|NCT01962961|Expectorants|expectorants|mesh-ancestor
111408755|NCT01962961|Respiratory System Agents|respiratory system agents|mesh-ancestor
111408756|NCT01962961|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111408757|NCT01962961|Antioxidants|antioxidants|mesh-ancestor
111408758|NCT01962961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111408759|NCT01962961|Protective Agents|protective agents|mesh-ancestor
111408760|NCT01962961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111408761|NCT01962961|Antidotes|antidotes|mesh-ancestor
111408762|NCT03010631|Lubiprostone|lubiprostone|mesh-list
111408763|NCT03010631|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
111408764|NCT03010631|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111408765|NCT03010631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111408766|NCT00374621|Isosorbide|isosorbide|mesh-list
111408767|NCT00374621|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
111408768|NCT00374621|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
111408769|NCT00374621|Misoprostol|misoprostol|mesh-list
111408770|NCT00374621|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111408771|NCT00374621|Abortifacient Agents|abortifacient agents|mesh-ancestor
111408772|NCT00374621|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111408773|NCT00374621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111408774|NCT00374621|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111408775|NCT00374621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111408776|NCT00374621|Oxytocics|oxytocics|mesh-ancestor
111408777|NCT00374621|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
111408778|NCT00374621|Diuretics|diuretics|mesh-ancestor
111408779|NCT00374621|Natriuretic Agents|natriuretic agents|mesh-ancestor
111408780|NCT00374621|Vasodilator Agents|vasodilator agents|mesh-ancestor
111408781|NCT00374621|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
110208122|NCT00191347|Pemetrexed|pemetrexed|mesh-list
111408782|NCT00374621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111408783|NCT03012191|Gentamicins|gentamicins|mesh-list
111408784|NCT03012191|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111408785|NCT03012191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111408786|NCT03012191|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111408787|NCT03012191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111408788|NCT03012191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111408789|NCT01994486|Sofosbuvir|sofosbuvir|mesh-list
111408790|NCT01994486|Antiviral Agents|antiviral agents|mesh-ancestor
111408791|NCT01994486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111408792|NCT01967641|Buprenorphine|buprenorphine|mesh-list
111408793|NCT01967641|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
111408794|NCT01967641|Naloxone|naloxone|mesh-list
111408795|NCT01967641|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111408796|NCT01967641|Narcotics|narcotics|mesh-ancestor
111408797|NCT01967641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111408798|NCT01967641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111408799|NCT01967641|Analgesics|analgesics|mesh-ancestor
111408800|NCT01967641|Sensory System Agents|sensory system agents|mesh-ancestor
111408801|NCT01967641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111408802|NCT01967641|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111408803|NCT01968421|Broncho-Vaxom|broncho-vaxom|mesh-list
111408804|NCT01968421|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111408805|NCT01968421|Immunologic Factors|immunologic factors|mesh-ancestor
111408806|NCT01968421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111408807|NCT02913521|Diclofenac|diclofenac|mesh-list
111408808|NCT02913521|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111408809|NCT02913521|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111408810|NCT02913521|Analgesics|analgesics|mesh-ancestor
111408811|NCT02913521|Sensory System Agents|sensory system agents|mesh-ancestor
111408812|NCT02913521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111408813|NCT02913521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111408814|NCT02913521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111408815|NCT02913521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110886046|NCT01380483|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111408816|NCT02913521|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111408817|NCT02913521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111408818|NCT02913521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111408819|NCT01969201|Hormones|hormones|mesh-list
111408820|NCT01969201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111408821|NCT01969201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111408822|NCT01962428|Ticagrelor|ticagrelor|mesh-list
111408823|NCT01962428|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111408824|NCT01962428|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110886058|NCT01378845|Bosentan|bosentan|mesh-list
111408825|NCT01962428|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111408826|NCT01962428|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111408827|NCT01962428|Purinergic Agents|purinergic agents|mesh-ancestor
111408828|NCT01962428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111408829|NCT01962428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111408830|NCT01962428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111408831|NCT01999400|Mesalamine|mesalamine|mesh-list
111408832|NCT01999400|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111408833|NCT01999400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111408834|NCT01999400|Analgesics|analgesics|mesh-ancestor
111408835|NCT01999400|Sensory System Agents|sensory system agents|mesh-ancestor
111408836|NCT01999400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111408837|NCT01999400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111408838|NCT01999400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111408839|NCT01999400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111408840|NCT01969435|Cytarabine|cytarabine|mesh-list
111408841|NCT01969435|Etoposide|etoposide|mesh-list
111408842|NCT01969435|Melphalan|melphalan|mesh-list
111408843|NCT01969435|Carmustine|carmustine|mesh-list
111408844|NCT01969435|Etoposide phosphate|etoposide phosphate|mesh-list
111408845|NCT01969435|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111408846|NCT01969435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111408847|NCT01969435|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111408848|NCT01969435|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111408849|NCT01969435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111408850|NCT01969435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111408851|NCT01969435|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111408852|NCT01969435|Antimetabolites|antimetabolites|mesh-ancestor
111408853|NCT01969435|Antiviral Agents|antiviral agents|mesh-ancestor
111408854|NCT01969435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111408855|NCT01969435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111408856|NCT01969435|Immunologic Factors|immunologic factors|mesh-ancestor
111408857|NCT01969435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111408858|NCT01969435|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111408859|NCT01969435|Alkylating Agents|alkylating agents|mesh-ancestor
111408860|NCT01969435|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111408861|NCT01965002|Aspirin|aspirin|mesh-list
111408862|NCT01965002|Enoxaparin|enoxaparin|mesh-list
111408863|NCT01965002|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111408864|NCT01965002|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111408865|NCT01965002|Analgesics|analgesics|mesh-ancestor
111408866|NCT01965002|Sensory System Agents|sensory system agents|mesh-ancestor
111408867|NCT01965002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111408868|NCT01965002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110477967|NCT00589420|Docetaxel|docetaxel|mesh-list
111408869|NCT01965002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111408870|NCT01965002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111408871|NCT01965002|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111408872|NCT01965002|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111408873|NCT01965002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111408874|NCT01965002|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111408875|NCT01965002|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111408876|NCT01965002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111408877|NCT01965002|Antipyretics|antipyretics|mesh-ancestor
111408878|NCT01965002|Anticoagulants|anticoagulants|mesh-ancestor
111408879|NCT02304757|Alendronate|alendronate|mesh-list
111408880|NCT02304757|Methylene diphosphonate|methylene diphosphonate|mesh-list
111408881|NCT02304757|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111408882|NCT02304757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111408883|NCT01969747|Empagliflozin|empagliflozin|mesh-list
111408884|NCT01969747|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111408885|NCT01969747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111408886|NCT01969747|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111408887|NCT01969747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111408888|NCT02002832|Risperidone|risperidone|mesh-list
111408889|NCT02002832|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
111408890|NCT02002832|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111408891|NCT02002832|Serotonin Agents|serotonin agents|mesh-ancestor
111408892|NCT02002832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110886131|NCT02237534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111408893|NCT02002832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111408894|NCT02002832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111408895|NCT02002832|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111408896|NCT02002832|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111408897|NCT02002832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111408898|NCT02002832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111408899|NCT02002832|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111408900|NCT02002832|Dopamine Agents|dopamine agents|mesh-ancestor
111408901|NCT02002832|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
111408902|NCT02002832|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111408903|NCT02002832|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111408904|NCT02002832|Adrenergic Agents|adrenergic agents|mesh-ancestor
111408905|NCT02002832|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111408906|NCT02002832|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111408907|NCT01966718|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
111408908|NCT01966718|Hormones|hormones|mesh-ancestor
111408909|NCT01966718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111408910|NCT01966718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111408911|NCT02308501|Alcaftadine|alcaftadine|mesh-list
110234899|NCT04318405|Iron|iron|mesh-list
111408912|NCT02308501|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111408913|NCT02308501|Histamine Antagonists|histamine antagonists|mesh-ancestor
111408914|NCT02308501|Histamine Agents|histamine agents|mesh-ancestor
111408915|NCT02308501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111408916|NCT02308501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111408917|NCT02308501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111408918|NCT02006108|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
111408919|NCT02006108|Hematinics|hematinics|mesh-ancestor
111408920|NCT02006108|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
111408921|NCT02006108|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111408922|NCT02006342|Insulin|insulin|mesh-list
111408923|NCT02006342|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111408924|NCT02006342|Insulin Glargine|insulin glargine|mesh-list
111408925|NCT02006342|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111408926|NCT02006342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111408927|NCT01968356|Ethanol|ethanol|mesh-list
111408928|NCT01968356|Chlorhexidine|chlorhexidine|mesh-list
111408929|NCT01968356|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
111408930|NCT01968356|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111408931|NCT01968356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111408932|NCT01968356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111408933|NCT01968356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111408934|NCT01968356|Disinfectants|disinfectants|mesh-ancestor
111408935|NCT01968356|Dermatologic Agents|dermatologic agents|mesh-ancestor
111408936|NCT02008682|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111408937|NCT02008682|Liraglutide|liraglutide|mesh-list
111408938|NCT02008682|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111408939|NCT02008682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111408940|NCT02008682|Incretins|incretins|mesh-ancestor
111408941|NCT02008682|Hormones|hormones|mesh-ancestor
111408942|NCT02008682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111408943|NCT02008682|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111408944|NCT02008682|Protease Inhibitors|protease inhibitors|mesh-ancestor
110886189|NCT03652896|Hematinics|hematinics|mesh-ancestor
111408945|NCT02008682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111408946|NCT02008682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111408947|NCT01969916|Regadenoson|regadenoson|mesh-list
111408948|NCT01969916|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
111408949|NCT01969916|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
111408950|NCT01969916|Purinergic Agonists|purinergic agonists|mesh-ancestor
111408951|NCT01969916|Purinergic Agents|purinergic agents|mesh-ancestor
111408952|NCT01969916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111408953|NCT01969916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111408954|NCT01969916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111408955|NCT00373919|Erythromycin|erythromycin|mesh-list
111408956|NCT00373919|Erythromycin Estolate|erythromycin estolate|mesh-list
111408957|NCT00373919|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
111408958|NCT00373919|Erythromycin stearate|erythromycin stearate|mesh-list
111408959|NCT00373919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111408960|NCT00373919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111408961|NCT00373919|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111408962|NCT00373919|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111408963|NCT00373919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111408964|NCT00373919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111408965|NCT02916407|Sevoflurane|sevoflurane|mesh-list
111408966|NCT02916407|Desflurane|desflurane|mesh-list
111408967|NCT02916407|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111408968|NCT02916407|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111408969|NCT02916407|Anesthetics, General|anesthetics, general|mesh-ancestor
111408970|NCT02916407|Anesthetics|anesthetics|mesh-ancestor
111408971|NCT02916407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111408972|NCT02916407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111408973|NCT02918357|Edetic Acid|edetic acid|mesh-list
111408974|NCT02918357|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
111408975|NCT02918357|Chelating Agents|chelating agents|mesh-ancestor
111408976|NCT02918357|Sequestering Agents|sequestering agents|mesh-ancestor
111408977|NCT02918357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111408978|NCT02918357|Anticoagulants|anticoagulants|mesh-ancestor
110886227|NCT01378533|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111408979|NCT02918357|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
111408980|NCT02918357|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111408981|NCT02829983|Clarithromycin|clarithromycin|mesh-list
111408982|NCT02829983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111408983|NCT02829983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111408984|NCT02829983|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111408985|NCT02829983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111408986|NCT02829983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111408987|NCT02829983|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111408988|NCT02829983|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111408989|NCT02012192|Paclitaxel|paclitaxel|mesh-list
111408990|NCT02012192|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111408991|NCT02012192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111408992|NCT02012192|Tubulin Modulators|tubulin modulators|mesh-ancestor
111408993|NCT02012192|Antimitotic Agents|antimitotic agents|mesh-ancestor
111408994|NCT02012192|Mitosis Modulators|mitosis modulators|mesh-ancestor
111408995|NCT02012192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111408996|NCT02066792|Cycloserine|cycloserine|mesh-list
111408997|NCT02066792|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111408998|NCT02066792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111408999|NCT02066792|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111409000|NCT02066792|Antitubercular Agents|antitubercular agents|mesh-ancestor
111409001|NCT02066792|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111409002|NCT02066792|Antimetabolites|antimetabolites|mesh-ancestor
111409003|NCT02066792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111409004|NCT02922959|Naloxone|naloxone|mesh-list
111409005|NCT02922959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111409006|NCT02922959|Sensory System Agents|sensory system agents|mesh-ancestor
111409007|NCT02922959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111409008|NCT02922959|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111409009|NCT02014363|Amitriptyline|amitriptyline|mesh-list
111409010|NCT02014363|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
111409012|NCT02014363|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111409013|NCT02014363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111409014|NCT02014363|Analgesics|analgesics|mesh-ancestor
111409015|NCT02014363|Sensory System Agents|sensory system agents|mesh-ancestor
111409016|NCT02014363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111409017|NCT02014363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111409018|NCT02014363|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111409019|NCT02014363|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111409020|NCT02014363|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111409021|NCT02014363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111409022|NCT02014363|Adrenergic Agents|adrenergic agents|mesh-ancestor
111409023|NCT02014363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111409024|NCT02067806|Chloroprocaine|chloroprocaine|mesh-list
111409025|NCT02067806|Anesthetics, Local|anesthetics, local|mesh-ancestor
111409026|NCT02067806|Anesthetics|anesthetics|mesh-ancestor
111409027|NCT02067806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111409028|NCT02067806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111409029|NCT02067806|Sensory System Agents|sensory system agents|mesh-ancestor
111409030|NCT02067806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111409031|NCT02833415|Empagliflozin|empagliflozin|mesh-list
111409032|NCT02833415|Glycerol|glycerol|mesh-list
111409033|NCT02833415|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111409034|NCT02833415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111409035|NCT02833415|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111409036|NCT02833415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111409037|NCT02833415|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
111409038|NCT02833415|Protective Agents|protective agents|mesh-ancestor
111409039|NCT02012348|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111409040|NCT02012348|Benzalkonium Compounds|benzalkonium compounds|mesh-list
111409041|NCT02012348|Triclocarban|triclocarban|mesh-list
111409042|NCT02012348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111409043|NCT02012348|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111409044|NCT02834663|Ranibizumab|ranibizumab|mesh-list
111409045|NCT02834663|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111409046|NCT02834663|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111409047|NCT02834663|Growth Substances|growth substances|mesh-ancestor
111409048|NCT02834663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111409049|NCT02834663|Growth Inhibitors|growth inhibitors|mesh-ancestor
111409050|NCT02834663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111409051|NCT01973036|Oxytocin|oxytocin|mesh-list
111409052|NCT01973036|Oxytocics|oxytocics|mesh-ancestor
111409053|NCT01973036|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111409054|NCT01973036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111409055|NCT02017327|Bimatoprost|bimatoprost|mesh-list
111409056|NCT02017327|Latanoprost|latanoprost|mesh-list
111409057|NCT02017327|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
111409058|NCT02017327|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111409059|NCT02017327|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111409060|NCT02837237|Mineralocorticoids|mineralocorticoids|mesh-list
111409061|NCT02837237|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
111409062|NCT02837237|Hormones|hormones|mesh-ancestor
111409063|NCT02837237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111409064|NCT02837237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111409065|NCT02837237|Hormone Antagonists|hormone antagonists|mesh-ancestor
111409066|NCT02837237|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
111409067|NCT02837237|Diuretics|diuretics|mesh-ancestor
111409068|NCT02837237|Natriuretic Agents|natriuretic agents|mesh-ancestor
111409069|NCT02018107|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
111409070|NCT02018107|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111409071|NCT02018107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111409072|NCT02018653|Calcium, Dietary|calcium, dietary|mesh-list
111409073|NCT02018653|Antidiarrheals|antidiarrheals|mesh-list
111409074|NCT02018653|Calcium Aluminosilicate|calcium aluminosilicate|mesh-list
111409075|NCT02018653|Calcium|calcium|mesh-list
111409076|NCT02018653|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111409077|NCT02018653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111409078|NCT02018653|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110870590|NCT02392780|Hormones|hormones|mesh-ancestor
111409079|NCT02018653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111409080|NCT02923895|Fluorides|fluorides|mesh-list
111409081|NCT02923895|Tin Fluorides|tin fluorides|mesh-list
111409082|NCT02923895|Fluorophosphate|fluorophosphate|mesh-list
111409083|NCT02923895|Cariostatic Agents|cariostatic agents|mesh-ancestor
111409084|NCT02923895|Protective Agents|protective agents|mesh-ancestor
111409085|NCT02923895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111409086|NCT01973348|Methamphetamine|methamphetamine|mesh-list
111409087|NCT01973348|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111409088|NCT01973348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111409089|NCT01973348|Sympathomimetics|sympathomimetics|mesh-ancestor
111409090|NCT01973348|Autonomic Agents|autonomic agents|mesh-ancestor
111409091|NCT01973348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111409092|NCT01973348|Dopamine Agents|dopamine agents|mesh-ancestor
111409093|NCT01973348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111409094|NCT01973348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111409095|NCT01973348|Adrenergic Agents|adrenergic agents|mesh-ancestor
111409096|NCT01973348|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111409097|NCT01973348|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111409098|NCT01973348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111409099|NCT01973348|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111409101|NCT02839889|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111409102|NCT02839889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111409103|NCT02839889|Sensory System Agents|sensory system agents|mesh-ancestor
111409104|NCT02839889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111409105|NCT01971385|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111409106|NCT01971385|Squaric acid dibutyl ester|squaric acid dibutyl ester|mesh-list
111409107|NCT01971385|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111409108|NCT01971385|Immunologic Factors|immunologic factors|mesh-ancestor
111409109|NCT01971385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111409110|NCT02925611|Desflurane|desflurane|mesh-list
111409111|NCT02925611|Isoflurane|isoflurane|mesh-list
111409112|NCT02925611|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111409113|NCT02925611|Anesthetics, General|anesthetics, general|mesh-ancestor
111409114|NCT02925611|Anesthetics|anesthetics|mesh-ancestor
111409115|NCT02925611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111409116|NCT02925611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111409117|NCT01973335|Spironolactone|spironolactone|mesh-list
111409118|NCT01973335|Acetazolamide|acetazolamide|mesh-list
111409119|NCT01973335|Bumetanide|bumetanide|mesh-list
111409120|NCT01973335|Diuretics|diuretics|mesh-list
110870773|NCT02392156|Factor VIII|factor viii|mesh-list
111409121|NCT01973335|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
111409122|NCT01973335|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
111409123|NCT01973335|Hormone Antagonists|hormone antagonists|mesh-ancestor
111409124|NCT01973335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111409125|NCT01973335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111409126|NCT01973335|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
111409127|NCT01973335|Natriuretic Agents|natriuretic agents|mesh-ancestor
111409128|NCT01973335|Anticonvulsants|anticonvulsants|mesh-ancestor
111409129|NCT01973335|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
111409130|NCT01973335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111409131|NCT01973335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111409132|NCT01973335|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111409133|NCT01973413|Insulin|insulin|mesh-list
111409134|NCT01973413|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111409135|NCT01973413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111409136|NCT02021461|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
111409137|NCT02021461|Anticonvulsants|anticonvulsants|mesh-ancestor
111409138|NCT02021461|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111409139|NCT02021461|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111409140|NCT02021461|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111409141|NCT02021461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111409142|NCT02929667|Fluoxetine|fluoxetine|mesh-list
111409143|NCT02929667|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111409144|NCT02929667|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111409145|NCT02929667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111409146|NCT02929667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111409147|NCT02929667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111409148|NCT02929667|Serotonin Agents|serotonin agents|mesh-ancestor
111409149|NCT02929667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111409150|NCT02929667|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111409151|NCT02929667|Antidepressive Agents|antidepressive agents|mesh-ancestor
111409152|NCT02929667|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111409153|NCT02929667|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111409154|NCT02929667|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111409155|NCT02929667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111409156|NCT02021929|Sorafenib|sorafenib|mesh-list
111409157|NCT02021929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111409158|NCT02021929|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111409159|NCT02021929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110870998|NCT03582215|Sensory System Agents|sensory system agents|mesh-ancestor
111409160|NCT02021929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111409161|NCT02929823|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111409162|NCT02929823|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111409164|NCT02023411|Hormones|hormones|mesh-list
111409165|NCT02023411|Parathyroid Hormone|parathyroid hormone|mesh-list
111409166|NCT02023411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111409167|NCT02023411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111409168|NCT02023411|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111409169|NCT02023411|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111409170|NCT02068820|Fluorophosphate|fluorophosphate|mesh-list
111409171|NCT02068820|Cariostatic Agents|cariostatic agents|mesh-ancestor
111409172|NCT02068820|Protective Agents|protective agents|mesh-ancestor
111409173|NCT02068820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111409174|NCT01975519|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111409175|NCT01975519|Immunologic Factors|immunologic factors|mesh-ancestor
111409176|NCT01975519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111409177|NCT02934191|Acetaminophen|acetaminophen|mesh-list
111409178|NCT02934191|Celecoxib|celecoxib|mesh-list
111409179|NCT02934191|Oxycodone|oxycodone|mesh-list
111409180|NCT02934191|Calcium Carbonate|calcium carbonate|mesh-list
111409181|NCT02934191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111409182|NCT02934191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111409183|NCT02934191|Analgesics|analgesics|mesh-ancestor
111409184|NCT02934191|Sensory System Agents|sensory system agents|mesh-ancestor
111409185|NCT02934191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111409186|NCT02934191|Antipyretics|antipyretics|mesh-ancestor
111409187|NCT02934191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111409188|NCT02934191|Narcotics|narcotics|mesh-ancestor
111409189|NCT02934191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111409190|NCT02934191|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111409191|NCT02934191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111409192|NCT02934191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111409193|NCT02934191|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111409194|NCT02934191|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111409195|NCT02934191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110871186|NCT05095831|Pancrelipase|pancrelipase|mesh-list
111409196|NCT02934191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111409197|NCT02934191|Antacids|antacids|mesh-ancestor
111409198|NCT02934191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111409199|NCT02937623|Calcium|calcium|mesh-list
111409200|NCT02937623|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111409201|NCT02937623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111409202|NCT01977781|Methylprednisolone|methylprednisolone|mesh-list
111409203|NCT01977781|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110871249|NCT03706339|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111409204|NCT01977781|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111409205|NCT01977781|Prednisolone|prednisolone|mesh-list
111409206|NCT01977781|Prednisolone acetate|prednisolone acetate|mesh-list
111409207|NCT01977781|Tacrolimus|tacrolimus|mesh-list
111409208|NCT01977781|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111409209|NCT01977781|Prednisolone phosphate|prednisolone phosphate|mesh-list
111409210|NCT01977781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111409211|NCT01977781|Immunologic Factors|immunologic factors|mesh-ancestor
111409212|NCT01977781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111409213|NCT01977781|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111409214|NCT01977781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111409215|NCT01977781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111409216|NCT01977781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111409217|NCT01977781|Antiemetics|antiemetics|mesh-ancestor
111409218|NCT01977781|Autonomic Agents|autonomic agents|mesh-ancestor
111409219|NCT01977781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111409220|NCT01977781|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111409221|NCT01977781|Glucocorticoids|glucocorticoids|mesh-ancestor
111409222|NCT01977781|Hormones|hormones|mesh-ancestor
111409223|NCT01977781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111409224|NCT01977781|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111409225|NCT01977781|Protective Agents|protective agents|mesh-ancestor
111409226|NCT01977781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111409227|NCT01977781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111409228|NCT02070302|Botulinum Toxins|botulinum toxins|mesh-list
111409229|NCT02070302|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111409230|NCT02070302|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111409231|NCT02070302|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111409232|NCT02070302|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111409233|NCT02070302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111409234|NCT02070302|Cholinergic Agents|cholinergic agents|mesh-ancestor
111409235|NCT02070302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111409236|NCT02070302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111409237|NCT02070302|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111409238|NCT02070302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111409239|NCT02938949|Alirocumab|alirocumab|mesh-list
111409240|NCT02938949|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
111409241|NCT02938949|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111409242|NCT02938949|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111409243|NCT02938949|Antimetabolites|antimetabolites|mesh-ancestor
111409244|NCT02938949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111409245|NCT02938949|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111409246|NCT02938949|Protease Inhibitors|protease inhibitors|mesh-ancestor
111409247|NCT02938949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111409248|NCT02938949|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111409249|NCT02025439|Amantadine|amantadine|mesh-list
111409250|NCT02025439|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111409251|NCT02025439|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111409252|NCT02025439|Antiviral Agents|antiviral agents|mesh-ancestor
111409253|NCT02025439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111409254|NCT02025439|Dopamine Agents|dopamine agents|mesh-ancestor
111409255|NCT02025439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111409256|NCT02025439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111409257|NCT02025439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111409258|NCT02025439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111409259|NCT02025439|Analgesics|analgesics|mesh-ancestor
111409260|NCT02025439|Sensory System Agents|sensory system agents|mesh-ancestor
111409261|NCT02025439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111409262|NCT02939651|Pembrolizumab|pembrolizumab|mesh-list
111409263|NCT02939651|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111409264|NCT02939651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111409265|NCT02939651|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111409266|NCT02939651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111409267|NCT02026297|Tranexamic Acid|tranexamic acid|mesh-list
111409268|NCT02026297|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111409269|NCT02026297|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111409270|NCT02026297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111409271|NCT02026297|Hemostatics|hemostatics|mesh-ancestor
111409272|NCT02026297|Coagulants|coagulants|mesh-ancestor
111409273|NCT02070692|Tamoxifen|tamoxifen|mesh-list
111409274|NCT02070692|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111409275|NCT02070692|Hormone Antagonists|hormone antagonists|mesh-ancestor
111409276|NCT02070692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111409277|NCT02070692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111409278|NCT02070692|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111409279|NCT02070692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111409280|NCT02070692|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111409281|NCT02070692|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110871643|NCT03678116|Caffeine|caffeine|mesh-list
111409282|NCT02070692|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111409283|NCT02015234|Cyclobenzaprine|cyclobenzaprine|mesh-list
111409284|NCT02015234|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
111409285|NCT02015234|Antidepressive Agents|antidepressive agents|mesh-ancestor
111409286|NCT02015234|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111409287|NCT02015234|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
111409288|NCT02015234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111409289|NCT02015234|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110871689|NCT05405686|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
111409290|NCT02015234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111409291|NCT02015234|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111409292|NCT02015234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111409293|NCT02869451|Bupropion|bupropion|mesh-list
111409294|NCT02869451|Nicotine|nicotine|mesh-list
111409295|NCT02869451|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111409296|NCT02869451|Autonomic Agents|autonomic agents|mesh-ancestor
111409297|NCT02869451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111409298|NCT02869451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111409299|NCT02869451|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111409300|NCT02869451|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111409301|NCT02869451|Cholinergic Agents|cholinergic agents|mesh-ancestor
111409302|NCT02869451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111409303|NCT02869451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111409304|NCT02869451|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111409305|NCT02869451|Antidepressive Agents|antidepressive agents|mesh-ancestor
111409306|NCT02869451|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111409307|NCT02869451|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111409308|NCT02869451|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111409309|NCT02869451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111409310|NCT02869451|Dopamine Agents|dopamine agents|mesh-ancestor
111409311|NCT02869451|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111409312|NCT02869451|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111409313|NCT02869451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111409314|NCT02305316|Opicapone|opicapone|mesh-list
110828236|NCT01178203|Naproxen|naproxen|mesh-list
111409315|NCT02305316|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
111409316|NCT02305316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111409317|NCT02305316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111409318|NCT02305316|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111409319|NCT02305316|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111409320|NCT02944565|Daratumumab|daratumumab|mesh-list
111409321|NCT02944565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111409322|NCT02870309|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
111409323|NCT02870309|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
111409324|NCT02870309|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111409325|NCT02870309|Protease Inhibitors|protease inhibitors|mesh-ancestor
111409326|NCT02870309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111409327|NCT02870309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111409328|NCT01979276|Dexamethasone|dexamethasone|mesh-list
111409329|NCT01979276|Pomalidomide|pomalidomide|mesh-list
111409330|NCT01979276|Romidepsin|romidepsin|mesh-list
111409331|NCT01979276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111409332|NCT01979276|Antiemetics|antiemetics|mesh-ancestor
111409333|NCT01979276|Autonomic Agents|autonomic agents|mesh-ancestor
111409334|NCT01979276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111409335|NCT01979276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111409336|NCT01979276|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111409337|NCT01979276|Glucocorticoids|glucocorticoids|mesh-ancestor
111409338|NCT01979276|Hormones|hormones|mesh-ancestor
111409339|NCT01979276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111409340|NCT01979276|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111409341|NCT01979276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111409342|NCT01979276|Immunologic Factors|immunologic factors|mesh-ancestor
111409343|NCT01979276|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110828402|NCT04934579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111409344|NCT01979276|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111409345|NCT01979276|Growth Substances|growth substances|mesh-ancestor
111409346|NCT01979276|Growth Inhibitors|growth inhibitors|mesh-ancestor
111409347|NCT01979276|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111409348|NCT01979276|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111409349|NCT01979276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111409350|NCT01979276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111409351|NCT02871011|Nitric Oxide|nitric oxide|mesh-list
111409352|NCT02871011|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111409353|NCT02871011|Autonomic Agents|autonomic agents|mesh-ancestor
111409354|NCT02871011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110828486|NCT01176175|Hormones|hormones|mesh-ancestor
111409355|NCT02871011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111409356|NCT02871011|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111409357|NCT02871011|Respiratory System Agents|respiratory system agents|mesh-ancestor
111409358|NCT02871011|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111409359|NCT02871011|Antioxidants|antioxidants|mesh-ancestor
111409360|NCT02871011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111409361|NCT02871011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111409362|NCT02871011|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
111409363|NCT02871011|Vasodilator Agents|vasodilator agents|mesh-ancestor
111409364|NCT02871011|Gasotransmitters|gasotransmitters|mesh-ancestor
111409365|NCT02871011|Protective Agents|protective agents|mesh-ancestor
111409366|NCT02344238|Riboflavin|riboflavin|mesh-list
111409367|NCT02344238|Vitamin B Complex|vitamin b complex|mesh-ancestor
111409368|NCT02344238|Vitamins|vitamins|mesh-ancestor
111409369|NCT02344238|Micronutrients|micronutrients|mesh-ancestor
111409370|NCT02344238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111409371|NCT02344238|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111409372|NCT02344238|Dermatologic Agents|dermatologic agents|mesh-ancestor
111409373|NCT02344316|Melatonin|melatonin|mesh-list
111409374|NCT02344316|Antioxidants|antioxidants|mesh-ancestor
111409375|NCT02344316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111409376|NCT02344316|Protective Agents|protective agents|mesh-ancestor
111409377|NCT02344316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111409378|NCT02344316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111133781|NCT05674253|Hydrocortisone|hydrocortisone|mesh-list
111409379|NCT02344628|Azithromycin|azithromycin|mesh-list
111409380|NCT02344628|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110828534|NCT01174927|Analgesics|analgesics|mesh-ancestor
111409381|NCT02344628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111409382|NCT02345486|Plasma-lyte 148|plasma-lyte 148|mesh-list
111409383|NCT02345486|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
111409384|NCT02345486|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111409385|NCT02019758|Fluticasone|fluticasone|mesh-list
111409386|NCT02019758|Budesonide|budesonide|mesh-list
111409387|NCT02019758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111409388|NCT02019758|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111409389|NCT02019758|Autonomic Agents|autonomic agents|mesh-ancestor
111409390|NCT02019758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111409391|NCT02019758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111409392|NCT02019758|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111409393|NCT02019758|Respiratory System Agents|respiratory system agents|mesh-ancestor
111409394|NCT02019758|Dermatologic Agents|dermatologic agents|mesh-ancestor
111409395|NCT02019758|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111409396|NCT02019758|Glucocorticoids|glucocorticoids|mesh-ancestor
111409397|NCT02019758|Hormones|hormones|mesh-ancestor
111409398|NCT02019758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111409399|NCT01980589|Dexamethasone|dexamethasone|mesh-list
111409400|NCT01980589|Cyclophosphamide|cyclophosphamide|mesh-list
111409401|NCT01980589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111409402|NCT01980589|Immunologic Factors|immunologic factors|mesh-ancestor
111409403|NCT01980589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111409404|NCT01980589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111409405|NCT01980589|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111409406|NCT01980589|Alkylating Agents|alkylating agents|mesh-ancestor
111409407|NCT01980589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111409408|NCT01980589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111409409|NCT01980589|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111409410|NCT01980589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111409411|NCT01980589|Antiemetics|antiemetics|mesh-ancestor
111409412|NCT01980589|Autonomic Agents|autonomic agents|mesh-ancestor
111409413|NCT01980589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111409414|NCT01980589|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111409415|NCT01980589|Glucocorticoids|glucocorticoids|mesh-ancestor
111409416|NCT01980589|Hormones|hormones|mesh-ancestor
111409417|NCT01980589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111409418|NCT01980589|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111409419|NCT02021942|Pasireotide|pasireotide|mesh-list
111409420|NCT02021942|Hormones|hormones|mesh-ancestor
111409421|NCT02021942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111409422|NCT02021942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111409423|NCT01981759|Cycloserine|cycloserine|mesh-list
111409424|NCT01981759|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111409425|NCT01981759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111409426|NCT01981759|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111409427|NCT01981759|Antitubercular Agents|antitubercular agents|mesh-ancestor
111409428|NCT01981759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111409429|NCT01981759|Antimetabolites|antimetabolites|mesh-ancestor
111409430|NCT01981759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111409431|NCT01980524|Acipimox|acipimox|mesh-list
111409432|NCT01980524|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111409433|NCT01980524|Antimetabolites|antimetabolites|mesh-ancestor
111409434|NCT01980524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111409435|NCT01980524|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111409436|NCT01982539|Diclofenac|diclofenac|mesh-list
111409437|NCT01982539|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111409438|NCT01982539|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111409439|NCT01982539|Analgesics|analgesics|mesh-ancestor
111409440|NCT01982539|Sensory System Agents|sensory system agents|mesh-ancestor
111409441|NCT01982539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111409442|NCT01982539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111409443|NCT01982539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111409444|NCT01982539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111409445|NCT01982539|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111409446|NCT01982539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111409447|NCT01982539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111409448|NCT01982695|Losartan|losartan|mesh-list
111409449|NCT01982695|Lisinopril|lisinopril|mesh-list
111409450|NCT01982695|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111409451|NCT01982695|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111409452|NCT01982695|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111409453|NCT01982695|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111409454|NCT01982695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111409455|NCT01982695|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
111409456|NCT01982695|Protease Inhibitors|protease inhibitors|mesh-ancestor
111409457|NCT01982695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111409458|NCT01982695|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111409459|NCT01982695|Protective Agents|protective agents|mesh-ancestor
111409460|NCT01982695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111409461|NCT01981772|Lidocaine|lidocaine|mesh-list
111409462|NCT01981772|Epinephrine|epinephrine|mesh-list
111409463|NCT01981772|Racepinephrine|racepinephrine|mesh-list
111409464|NCT01981772|Epinephryl borate|epinephryl borate|mesh-list
111409465|NCT01981772|Anesthetics, Local|anesthetics, local|mesh-ancestor
111409466|NCT01981772|Anesthetics|anesthetics|mesh-ancestor
111409467|NCT01981772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111409468|NCT01981772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111409469|NCT01981772|Sensory System Agents|sensory system agents|mesh-ancestor
111409470|NCT01981772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111409471|NCT01981772|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111409472|NCT01981772|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111409473|NCT01981772|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111409474|NCT01981772|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111409475|NCT01981772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111409476|NCT01981772|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111409477|NCT01981772|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111409478|NCT01981772|Adrenergic Agents|adrenergic agents|mesh-ancestor
111409479|NCT01981772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111409480|NCT01981772|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111409481|NCT01981772|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111409482|NCT01981772|Autonomic Agents|autonomic agents|mesh-ancestor
111409483|NCT01981772|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111409484|NCT01981772|Respiratory System Agents|respiratory system agents|mesh-ancestor
111409485|NCT01981772|Mydriatics|mydriatics|mesh-ancestor
111409486|NCT01981772|Sympathomimetics|sympathomimetics|mesh-ancestor
111409487|NCT01981772|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111409488|NCT01982240|Bisacodyl|bisacodyl|mesh-list
111409489|NCT01982240|Plecanatide|plecanatide|mesh-list
111409490|NCT01982240|Cathartics|cathartics|mesh-ancestor
111409491|NCT01982240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111409492|NCT01982240|Laxatives|laxatives|mesh-ancestor
111409493|NCT01982240|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
111409494|NCT01982240|Enzyme Activators|enzyme activators|mesh-ancestor
111409495|NCT01982240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111409496|NCT02029495|Brodalumab|brodalumab|mesh-list
111409497|NCT02029495|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111409498|NCT02029495|Dermatologic Agents|dermatologic agents|mesh-ancestor
111409499|NCT02029495|Immunologic Factors|immunologic factors|mesh-ancestor
111409500|NCT02029495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111409501|NCT01985425|Colchicine|colchicine|mesh-list
111409502|NCT01985425|Gout Suppressants|gout suppressants|mesh-ancestor
111409503|NCT01985425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111409504|NCT01985425|Tubulin Modulators|tubulin modulators|mesh-ancestor
111409505|NCT01985425|Antimitotic Agents|antimitotic agents|mesh-ancestor
111409506|NCT01985425|Mitosis Modulators|mitosis modulators|mesh-ancestor
111409507|NCT01985425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111409508|NCT01985425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111409509|NCT02348918|Bevacizumab|bevacizumab|mesh-list
111409510|NCT02348918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111409511|NCT02348918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111409512|NCT02348918|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111409513|NCT02348918|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111409514|NCT02348918|Growth Substances|growth substances|mesh-ancestor
111409515|NCT02348918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111409516|NCT02348918|Growth Inhibitors|growth inhibitors|mesh-ancestor
111409517|NCT01985581|Guanfacine|guanfacine|mesh-list
111409518|NCT01985581|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111409519|NCT01985581|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111409520|NCT01985581|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111409521|NCT01985581|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111409522|NCT01985581|Adrenergic Agents|adrenergic agents|mesh-ancestor
111409523|NCT01985581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111409524|NCT01985581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111409525|NCT01985581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111409526|NCT02024204|Fluticasone|fluticasone|mesh-list
111409527|NCT02024204|Xhance|xhance|mesh-list
111409528|NCT02024204|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
111409529|NCT02024204|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
111409530|NCT02024204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111409531|NCT02024204|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111409532|NCT02024204|Autonomic Agents|autonomic agents|mesh-ancestor
111409533|NCT02024204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111409534|NCT02024204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111409535|NCT02024204|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111409536|NCT02024204|Respiratory System Agents|respiratory system agents|mesh-ancestor
111409537|NCT02024204|Dermatologic Agents|dermatologic agents|mesh-ancestor
111409538|NCT02024204|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111409539|NCT02024204|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111409540|NCT02024204|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111409541|NCT02024204|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111409542|NCT02024204|Adrenergic Agents|adrenergic agents|mesh-ancestor
111409543|NCT02024204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111409544|NCT02024204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111409545|NCT02024204|Glucocorticoids|glucocorticoids|mesh-ancestor
111409546|NCT02024204|Hormones|hormones|mesh-ancestor
111409547|NCT02024204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111409548|NCT02024204|Sympathomimetics|sympathomimetics|mesh-ancestor
111409549|NCT03930745|TOL-463|tol-463|mesh-list
111409550|NCT03930745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111409551|NCT02034019|Dexamethasone|dexamethasone|mesh-list
111409552|NCT02034019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111409553|NCT02034019|Antiemetics|antiemetics|mesh-ancestor
111409554|NCT02034019|Autonomic Agents|autonomic agents|mesh-ancestor
111409555|NCT02034019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111409556|NCT02034019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111409557|NCT02034019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111409558|NCT02034019|Glucocorticoids|glucocorticoids|mesh-ancestor
111409559|NCT02034019|Hormones|hormones|mesh-ancestor
111409560|NCT02034019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111409561|NCT02034019|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111409562|NCT02034019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111409563|NCT02349152|Fentanyl|fentanyl|mesh-list
111409564|NCT02349152|Remifentanil|remifentanil|mesh-list
111409565|NCT02349152|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111409566|NCT02349152|Narcotics|narcotics|mesh-ancestor
111409567|NCT02349152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111409568|NCT02349152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111409569|NCT02349152|Analgesics|analgesics|mesh-ancestor
111409570|NCT02349152|Sensory System Agents|sensory system agents|mesh-ancestor
111409571|NCT02349152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111409572|NCT02349152|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111409573|NCT02349152|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111409574|NCT02349152|Anesthetics, General|anesthetics, general|mesh-ancestor
111409575|NCT02349152|Anesthetics|anesthetics|mesh-ancestor
111409576|NCT02035345|Carboplatin|carboplatin|mesh-list
111409577|NCT02035345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111409578|NCT01986361|Flurbiprofen|flurbiprofen|mesh-list
111409579|NCT01986361|Analgesics|analgesics|mesh-ancestor
111409580|NCT01986361|Sensory System Agents|sensory system agents|mesh-ancestor
111409581|NCT01986361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111409582|NCT01986361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110829149|NCT00003875|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111409583|NCT01986361|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111409584|NCT01986361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111409585|NCT01986361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111409586|NCT01986361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111409587|NCT01986361|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111409588|NCT01986361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111409589|NCT01986361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111409590|NCT01983020|Lidocaine|lidocaine|mesh-list
111409591|NCT01983020|Ketamine|ketamine|mesh-list
111409592|NCT01983020|Anesthetics, Local|anesthetics, local|mesh-ancestor
111409593|NCT01983020|Anesthetics|anesthetics|mesh-ancestor
111409594|NCT01983020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111409595|NCT01983020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111409596|NCT01983020|Sensory System Agents|sensory system agents|mesh-ancestor
110829209|NCT03709056|Anesthetics|anesthetics|mesh-ancestor
111409597|NCT01983020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111409598|NCT01983020|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111409599|NCT01983020|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111409600|NCT01983020|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111409601|NCT01983020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111409602|NCT01983020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111409603|NCT01983020|Analgesics|analgesics|mesh-ancestor
111409604|NCT01983020|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111409605|NCT01983020|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111409606|NCT01983020|Anesthetics, General|anesthetics, general|mesh-ancestor
111409607|NCT01983020|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111409608|NCT01983020|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111409609|NCT01983020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111409610|NCT02058511|Anesthetics|anesthetics|mesh-list
111409611|NCT02058511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111409612|NCT02058511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111409613|NCT01983566|Omeprazole|omeprazole|mesh-list
111409614|NCT01983566|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111409615|NCT01983566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111409616|NCT01983566|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111409617|NCT01983566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111409618|NCT01983566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111409619|NCT01983878|Ramucirumab|ramucirumab|mesh-list
111409620|NCT01983878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111409621|NCT02396732|Aspirin|aspirin|mesh-list
111409622|NCT02396732|Enoxaparin|enoxaparin|mesh-list
111409623|NCT02396732|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111409624|NCT02396732|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111409625|NCT02396732|Analgesics|analgesics|mesh-ancestor
111409626|NCT02396732|Sensory System Agents|sensory system agents|mesh-ancestor
111409627|NCT02396732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111409628|NCT02396732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111409629|NCT02396732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111409630|NCT02396732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111409631|NCT02396732|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111409632|NCT02396732|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110829379|NCT02524639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111409633|NCT02396732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111409634|NCT02396732|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111409635|NCT02396732|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111409636|NCT02396732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111409637|NCT02396732|Antipyretics|antipyretics|mesh-ancestor
111409638|NCT02396732|Anticoagulants|anticoagulants|mesh-ancestor
111409639|NCT02352974|Vitamin D|vitamin d|mesh-list
111409640|NCT02352974|Vitamins|vitamins|mesh-ancestor
111409641|NCT02352974|Micronutrients|micronutrients|mesh-ancestor
111409642|NCT02352974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111409643|NCT02352974|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111409644|NCT02353754|Morphine|morphine|mesh-list
111409645|NCT02353754|Bupivacaine|bupivacaine|mesh-list
111409646|NCT02353754|Anesthetics, Local|anesthetics, local|mesh-ancestor
111409647|NCT02353754|Anesthetics|anesthetics|mesh-ancestor
111409648|NCT02353754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111409649|NCT02353754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111409650|NCT02353754|Sensory System Agents|sensory system agents|mesh-ancestor
111409651|NCT02353754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111409652|NCT02353754|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111409653|NCT02353754|Narcotics|narcotics|mesh-ancestor
111409654|NCT02353754|Analgesics|analgesics|mesh-ancestor
111409655|NCT02354378|Dexmedetomidine|dexmedetomidine|mesh-list
110829511|NCT01101659|Ketamine|ketamine|mesh-list
111409656|NCT02354378|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111409657|NCT02354378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111409658|NCT02354378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111409659|NCT02354378|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111409660|NCT02354378|Analgesics|analgesics|mesh-ancestor
111409661|NCT02354378|Sensory System Agents|sensory system agents|mesh-ancestor
111409662|NCT02354378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111409663|NCT02354378|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111409664|NCT02354378|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111409665|NCT02354378|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111409666|NCT02354378|Adrenergic Agents|adrenergic agents|mesh-ancestor
110829574|NCT03948191|Hormones|hormones|mesh-ancestor
111409667|NCT02354378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111409668|NCT02354378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111409669|NCT02059213|Palbociclib|palbociclib|mesh-list
111409670|NCT02059213|Leuprolide|leuprolide|mesh-list
111409671|NCT02059213|Goserelin|goserelin|mesh-list
111409672|NCT02059213|Bicalutamide|bicalutamide|mesh-list
111409673|NCT02059213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111409674|NCT02059213|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111409675|NCT02059213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111409676|NCT02059213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111409677|NCT02059213|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111409678|NCT02059213|Fertility Agents|fertility agents|mesh-ancestor
111409679|NCT02059213|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111409680|NCT02059213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111409681|NCT02059213|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111409682|NCT02059213|Androgen Antagonists|androgen antagonists|mesh-ancestor
111409683|NCT02059213|Hormone Antagonists|hormone antagonists|mesh-ancestor
111409684|NCT02059213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111409685|NCT02037061|Bupivacaine|bupivacaine|mesh-list
111409686|NCT02037061|Anesthetics, Local|anesthetics, local|mesh-ancestor
111409687|NCT02037061|Anesthetics|anesthetics|mesh-ancestor
111409688|NCT02037061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111409689|NCT02037061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111409690|NCT02037061|Sensory System Agents|sensory system agents|mesh-ancestor
111409691|NCT02037061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111409692|NCT02354534|Artesunate|artesunate|mesh-list
111409693|NCT02354534|Antimalarials|antimalarials|mesh-ancestor
111409694|NCT02354534|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111409695|NCT02354534|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111409696|NCT02354534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111409697|NCT02354534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111409698|NCT02354534|Antiviral Agents|antiviral agents|mesh-ancestor
111409699|NCT02354534|Schistosomicides|schistosomicides|mesh-ancestor
111409700|NCT02354534|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
111409701|NCT02354534|Anthelmintics|anthelmintics|mesh-ancestor
111409702|NCT02355158|Clonidine|clonidine|mesh-list
111409703|NCT02355158|Analgesics|analgesics|mesh-ancestor
111409704|NCT02355158|Sensory System Agents|sensory system agents|mesh-ancestor
111409705|NCT02355158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111409706|NCT02355158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111409707|NCT02355158|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111409708|NCT02355158|Sympatholytics|sympatholytics|mesh-ancestor
111409709|NCT02355158|Autonomic Agents|autonomic agents|mesh-ancestor
111409710|NCT02355158|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111409711|NCT02355158|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111409712|NCT02355158|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111409713|NCT02355158|Adrenergic Agents|adrenergic agents|mesh-ancestor
111409714|NCT02355158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111409715|NCT02355158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111409716|NCT02033876|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
111409717|NCT02033876|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
111409718|NCT02033876|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111409719|NCT02061397|Sirolimus|sirolimus|mesh-list
111409720|NCT02061397|Everolimus|everolimus|mesh-list
111409721|NCT02061397|Simvastatin|simvastatin|mesh-list
111409722|NCT02061397|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111409723|NCT02061397|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111409724|NCT02061397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111409725|NCT02061397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111409726|NCT02061397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111409727|NCT02061397|Immunologic Factors|immunologic factors|mesh-ancestor
111409728|NCT02061397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111409729|NCT02061397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111409730|NCT02061397|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111409731|NCT02061397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111409732|NCT02061397|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111409733|NCT02061397|Antifungal Agents|antifungal agents|mesh-ancestor
111409734|NCT02061397|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111409735|NCT02061397|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111409736|NCT02061397|Antimetabolites|antimetabolites|mesh-ancestor
110829872|NCT03473626|Alicaforsen|alicaforsen|mesh-list
111409737|NCT02061397|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111409738|NCT02061397|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111409739|NCT02062177|Midazolam|midazolam|mesh-list
111409740|NCT02062177|Propofol|propofol|mesh-list
111409741|NCT02062177|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111409742|NCT02062177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111409743|NCT02062177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111409744|NCT02062177|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111409745|NCT02062177|Anesthetics, General|anesthetics, general|mesh-ancestor
111409746|NCT02062177|Anesthetics|anesthetics|mesh-ancestor
111409747|NCT02062177|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111409748|NCT02062177|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111409749|NCT02062177|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111409750|NCT02062177|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111409751|NCT02062177|GABA Modulators|gaba modulators|mesh-ancestor
111409752|NCT02062177|GABA Agents|gaba agents|mesh-ancestor
111409753|NCT02062177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111409754|NCT02062177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111409755|NCT02034578|Apixaban|apixaban|mesh-list
111409756|NCT02034578|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111409757|NCT02034578|Antithrombins|antithrombins|mesh-ancestor
111409758|NCT02034578|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111409759|NCT02034578|Protease Inhibitors|protease inhibitors|mesh-ancestor
111409760|NCT02034578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111409761|NCT02034578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111409762|NCT02034578|Anticoagulants|anticoagulants|mesh-ancestor
111409764|NCT02403830|Methylnaltrexone|methylnaltrexone|mesh-list
111409765|NCT02403830|Ticagrelor|ticagrelor|mesh-list
111409766|NCT02403830|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111409767|NCT02403830|Narcotics|narcotics|mesh-ancestor
111409768|NCT02403830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111409769|NCT02403830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111409770|NCT02403830|Analgesics|analgesics|mesh-ancestor
111409771|NCT02403830|Sensory System Agents|sensory system agents|mesh-ancestor
111409772|NCT02403830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111409773|NCT02403830|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111409774|NCT02403830|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111409775|NCT02403830|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111409776|NCT02403830|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111409777|NCT02403830|Purinergic Agents|purinergic agents|mesh-ancestor
111409778|NCT02403830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111409779|NCT02403830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110830066|NCT01190293|Efavirenz|efavirenz|mesh-list
111409780|NCT02403830|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111409781|NCT02036840|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111409782|NCT02036840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111409783|NCT02951195|Ivacaftor|ivacaftor|mesh-list
111409784|NCT02951195|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
111409785|NCT02951195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111409786|NCT02951195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111409787|NCT02037230|Gemcitabine|gemcitabine|mesh-list
111409788|NCT02037230|Adavosertib|adavosertib|mesh-list
111409789|NCT02037230|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111409790|NCT02037230|Antimetabolites|antimetabolites|mesh-ancestor
110830118|NCT03947411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111409791|NCT02037230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111409792|NCT02037230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111409793|NCT02037230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111409794|NCT02312882|Tofacitinib|tofacitinib|mesh-list
111409795|NCT02312882|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
111409796|NCT02312882|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111409797|NCT02312882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111409798|NCT02312882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111409799|NCT02877095|Furosemide|furosemide|mesh-list
111409800|NCT02877095|Diuretics|diuretics|mesh-ancestor
111409801|NCT02877095|Natriuretic Agents|natriuretic agents|mesh-ancestor
111409802|NCT02877095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111409803|NCT02877095|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
111409804|NCT02877095|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111409805|NCT02877095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111409806|NCT02877485|Triamcinolone|triamcinolone|mesh-list
111409807|NCT02877485|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
111409808|NCT02877485|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
111409809|NCT02877485|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
111409810|NCT02877485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111409811|NCT02877485|Glucocorticoids|glucocorticoids|mesh-ancestor
111409812|NCT02877485|Hormones|hormones|mesh-ancestor
111409813|NCT02877485|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111409814|NCT02877485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111409815|NCT02877485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111409816|NCT02877485|Immunologic Factors|immunologic factors|mesh-ancestor
111409817|NCT02877485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111409818|NCT02877485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111409819|NCT00374387|NuvaRing|nuvaring|mesh-list
111409820|NCT00374387|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111409821|NCT00374387|Contraceptive Agents|contraceptive agents|mesh-ancestor
111409822|NCT00374387|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111409823|NCT00374387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111409824|NCT03023891|Prednisone|prednisone|mesh-list
111409825|NCT03023891|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111409826|NCT03023891|Glucocorticoids|glucocorticoids|mesh-ancestor
111409827|NCT03023891|Hormones|hormones|mesh-ancestor
111409828|NCT03023891|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111409829|NCT03023891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111409830|NCT03023891|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111409831|NCT03023891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111409832|NCT03028025|Hemostatics|hemostatics|mesh-list
111409833|NCT03028025|Coagulants|coagulants|mesh-ancestor
111409834|NCT02955329|Nicotine|nicotine|mesh-list
111409835|NCT02955329|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111409836|NCT02955329|Autonomic Agents|autonomic agents|mesh-ancestor
111409837|NCT02955329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111409838|NCT02955329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111409839|NCT02955329|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111409840|NCT02955329|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111409841|NCT02955329|Cholinergic Agents|cholinergic agents|mesh-ancestor
111409842|NCT02955329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111409843|NCT02955329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111409844|NCT02359058|Capecitabine|capecitabine|mesh-list
111409845|NCT02359058|Oxaliplatin|oxaliplatin|mesh-list
111409846|NCT02359058|Ramucirumab|ramucirumab|mesh-list
111409847|NCT02359058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111409848|NCT02359058|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111409849|NCT02359058|Antimetabolites|antimetabolites|mesh-ancestor
111409850|NCT02359058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111409851|NCT02404610|Propofol|propofol|mesh-list
111409852|NCT02404610|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
111409853|NCT02404610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111409854|NCT02404610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111409855|NCT02404610|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111409856|NCT02404610|Anesthetics, General|anesthetics, general|mesh-ancestor
111409857|NCT02404610|Anesthetics|anesthetics|mesh-ancestor
111409858|NCT03110003|Bupivacaine|bupivacaine|mesh-list
111409859|NCT03110003|Anesthetics, Local|anesthetics, local|mesh-ancestor
111409860|NCT03110003|Anesthetics|anesthetics|mesh-ancestor
111409861|NCT03110003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111409862|NCT03110003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111409863|NCT03110003|Sensory System Agents|sensory system agents|mesh-ancestor
111409864|NCT03110003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111409865|NCT03114995|Tirofiban|tirofiban|mesh-list
111409866|NCT03114995|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111409867|NCT03114995|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111409868|NCT03114995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111409869|NCT03114995|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111409870|NCT02959853|Anastrozole|anastrozole|mesh-list
111409871|NCT02959853|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111409872|NCT02959853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111409873|NCT02959853|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111409874|NCT02959853|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111409875|NCT02959853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111409876|NCT02959853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111409877|NCT02959853|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111409878|NCT02959853|Hormone Antagonists|hormone antagonists|mesh-ancestor
111409879|NCT02959853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111409880|NCT02959853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111409881|NCT00374465|Verapamil|verapamil|mesh-list
111409882|NCT00374465|Carvedilol|carvedilol|mesh-list
111409883|NCT00374465|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111409884|NCT00374465|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111409885|NCT00374465|Adrenergic Agents|adrenergic agents|mesh-ancestor
111409886|NCT00374465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111409887|NCT00374465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111409888|NCT00374465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111409889|NCT00374465|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111409890|NCT00374465|Antioxidants|antioxidants|mesh-ancestor
111409891|NCT00374465|Protective Agents|protective agents|mesh-ancestor
111409892|NCT00374465|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111409893|NCT00374465|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111409894|NCT00374465|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111409895|NCT00374465|Vasodilator Agents|vasodilator agents|mesh-ancestor
111409896|NCT00374465|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111409897|NCT00374465|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111409898|NCT00374465|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111409899|NCT02040116|Rituximab|rituximab|mesh-list
111409900|NCT02040116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111409901|NCT02040116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111409902|NCT02040116|Immunologic Factors|immunologic factors|mesh-ancestor
111409903|NCT02040116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111409904|NCT02040116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111134315|NCT04933279|Iodine|iodine|mesh-list
111409905|NCT02360774|Canagliflozin|canagliflozin|mesh-list
111409906|NCT02360774|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111409907|NCT02360774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111409908|NCT02360774|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111409909|NCT02360774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111409910|NCT02361476|Clonidine|clonidine|mesh-list
111409911|NCT02361476|Analgesics|analgesics|mesh-ancestor
111409912|NCT02361476|Sensory System Agents|sensory system agents|mesh-ancestor
111409913|NCT02361476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111409914|NCT02361476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111409915|NCT02361476|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111409916|NCT02361476|Sympatholytics|sympatholytics|mesh-ancestor
111409917|NCT02361476|Autonomic Agents|autonomic agents|mesh-ancestor
111409918|NCT02361476|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111409919|NCT02361476|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111409920|NCT02361476|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111409921|NCT02361476|Adrenergic Agents|adrenergic agents|mesh-ancestor
111409922|NCT02361476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111409923|NCT02361476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111409924|NCT02363270|Ketamine|ketamine|mesh-list
111409925|NCT02363270|Analgesics|analgesics|mesh-ancestor
111409926|NCT02363270|Sensory System Agents|sensory system agents|mesh-ancestor
111409927|NCT02363270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111409928|NCT02363270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111409929|NCT02363270|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111409930|NCT02363270|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111409931|NCT02363270|Anesthetics, General|anesthetics, general|mesh-ancestor
111409932|NCT02363270|Anesthetics|anesthetics|mesh-ancestor
111409933|NCT02363270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111409934|NCT02363270|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111409935|NCT02363270|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111409936|NCT02363270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111409937|NCT02363270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111409938|NCT02042534|Warfarin|warfarin|mesh-list
111409939|NCT02042534|Rivaroxaban|rivaroxaban|mesh-list
111409940|NCT02042534|Anticoagulants|anticoagulants|mesh-ancestor
111409941|NCT02042534|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111409942|NCT02042534|Antithrombins|antithrombins|mesh-ancestor
111409943|NCT02042534|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111409944|NCT02042534|Protease Inhibitors|protease inhibitors|mesh-ancestor
111409945|NCT02042534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111409946|NCT02042534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111409947|NCT02043704|Acetaminophen|acetaminophen|mesh-list
111409948|NCT02043704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111409949|NCT02043704|Analgesics|analgesics|mesh-ancestor
111409950|NCT02043704|Sensory System Agents|sensory system agents|mesh-ancestor
111409951|NCT02043704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111409952|NCT02043704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111409953|NCT02043704|Antipyretics|antipyretics|mesh-ancestor
111409954|NCT02410382|Dexamethasone|dexamethasone|mesh-list
111409955|NCT02410382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111409956|NCT02410382|Antiemetics|antiemetics|mesh-ancestor
111409957|NCT02410382|Autonomic Agents|autonomic agents|mesh-ancestor
111409958|NCT02410382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111409959|NCT02410382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111409960|NCT02410382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111409961|NCT02410382|Glucocorticoids|glucocorticoids|mesh-ancestor
111409962|NCT02410382|Hormones|hormones|mesh-ancestor
111409963|NCT02410382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111409964|NCT02410382|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111409965|NCT02410382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111409966|NCT03038867|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
111409967|NCT03038867|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111409968|NCT03038867|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111409969|NCT03038867|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110830641|NCT01192165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111409970|NCT03038867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111409971|NCT03038867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111409972|NCT03038867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111409973|NCT03038867|Analgesics|analgesics|mesh-ancestor
111409974|NCT03038867|Sensory System Agents|sensory system agents|mesh-ancestor
111409975|NCT03038867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111409976|NCT03038867|Antidepressive Agents|antidepressive agents|mesh-ancestor
111409977|NCT03038867|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111409978|NCT03038867|Dopamine Agents|dopamine agents|mesh-ancestor
111409979|NCT03119831|Ethanol|ethanol|mesh-list
111409980|NCT03119831|Chlorhexidine|chlorhexidine|mesh-list
111409981|NCT03119831|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
111409982|NCT03119831|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111409983|NCT03119831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111409984|NCT03119831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111409985|NCT03119831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111409986|NCT03119831|Disinfectants|disinfectants|mesh-ancestor
111409987|NCT03119831|Dermatologic Agents|dermatologic agents|mesh-ancestor
111409988|NCT02965781|Squaric acid dibutyl ester|squaric acid dibutyl ester|mesh-list
111409989|NCT02965781|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111409990|NCT02965781|Immunologic Factors|immunologic factors|mesh-ancestor
111409991|NCT02965781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111409992|NCT03124121|Golimumab|golimumab|mesh-list
111409993|NCT03124121|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111409994|NCT03124121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111409995|NCT03124121|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111409996|NCT03124121|Immunologic Factors|immunologic factors|mesh-ancestor
111409997|NCT03124121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111409998|NCT03042299|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
111409999|NCT03042299|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111410000|NCT03042299|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111410001|NCT03042299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111410002|NCT00374699|Bortezomib|bortezomib|mesh-list
111410003|NCT00374699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111410004|NCT00374777|Nitrazepam|nitrazepam|mesh-list
111410005|NCT00374777|Zolpidem|zolpidem|mesh-list
111410006|NCT00374777|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111410007|NCT00374777|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111410008|NCT00374777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111410009|NCT00374777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111410010|NCT00374777|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
111410011|NCT00374777|GABA Agonists|gaba agonists|mesh-ancestor
111410012|NCT00374777|GABA Agents|gaba agents|mesh-ancestor
111410013|NCT00374777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111410014|NCT00374777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111410015|NCT00374777|Anticonvulsants|anticonvulsants|mesh-ancestor
111410016|NCT00374777|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111410017|NCT00374777|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111410018|NCT00374777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111410019|NCT00374777|GABA Modulators|gaba modulators|mesh-ancestor
111410020|NCT02044796|Cytarabine|cytarabine|mesh-list
111410021|NCT02044796|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
111410022|NCT02044796|Mitoxantrone|mitoxantrone|mesh-list
111410023|NCT02044796|Cladribine|cladribine|mesh-list
111410024|NCT02044796|Lenograstim|lenograstim|mesh-list
111410025|NCT02044796|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111410026|NCT02044796|Antimetabolites|antimetabolites|mesh-ancestor
111410027|NCT02044796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111410028|NCT02044796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111410029|NCT02044796|Antiviral Agents|antiviral agents|mesh-ancestor
111410030|NCT02044796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111410031|NCT02044796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111410032|NCT02044796|Immunologic Factors|immunologic factors|mesh-ancestor
111410033|NCT02044796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111410034|NCT02044796|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111410035|NCT02044796|Analgesics|analgesics|mesh-ancestor
111410036|NCT02044796|Sensory System Agents|sensory system agents|mesh-ancestor
111410037|NCT02044796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111410038|NCT02044796|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111410039|NCT02044796|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111410040|NCT02044796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111410041|NCT02973503|Grazoprevir|grazoprevir|mesh-list
111410042|NCT02973503|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
111410043|NCT02973503|Antiviral Agents|antiviral agents|mesh-ancestor
111410044|NCT02973503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111410045|NCT03127943|Lidocaine|lidocaine|mesh-list
111410046|NCT03127943|Anesthetics, Local|anesthetics, local|mesh-ancestor
111410047|NCT03127943|Anesthetics|anesthetics|mesh-ancestor
111410048|NCT03127943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111410049|NCT03127943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111410050|NCT03127943|Sensory System Agents|sensory system agents|mesh-ancestor
111410051|NCT03127943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111410052|NCT03127943|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111410053|NCT03127943|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111410054|NCT03127943|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111410055|NCT03127943|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111410056|NCT03127943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111410058|NCT03048383|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111410059|NCT03048383|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111410060|NCT03048383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111410061|NCT03048383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111410062|NCT03048383|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111410063|NCT03048383|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111410064|NCT03048383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111410065|NCT03048383|Cholinergic Agents|cholinergic agents|mesh-ancestor
111410066|NCT03048383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111410067|NCT02045264|Icatibant|icatibant|mesh-list
111410068|NCT02045264|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111410069|NCT02045264|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111410070|NCT02045264|Analgesics|analgesics|mesh-ancestor
111410071|NCT02045264|Sensory System Agents|sensory system agents|mesh-ancestor
111410072|NCT02045264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111410073|NCT02045264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111410074|NCT02045264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111410075|NCT02045264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111410076|NCT02045264|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
111410077|NCT02045264|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
111410078|NCT02045264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111410079|NCT02045264|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
111410080|NCT02045264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111410081|NCT02045264|Immunologic Factors|immunologic factors|mesh-ancestor
111410082|NCT02975297|Exenatide|exenatide|mesh-list
111410083|NCT02975297|Nicotine|nicotine|mesh-list
111410084|NCT02975297|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111410085|NCT02975297|Autonomic Agents|autonomic agents|mesh-ancestor
111410086|NCT02975297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111410087|NCT02975297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111410088|NCT02975297|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111410089|NCT02975297|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111410090|NCT02975297|Cholinergic Agents|cholinergic agents|mesh-ancestor
111410091|NCT02975297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111410092|NCT02975297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111410093|NCT02975297|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111410094|NCT02975297|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111410095|NCT02975297|Incretins|incretins|mesh-ancestor
111410096|NCT02975297|Hormones|hormones|mesh-ancestor
111410097|NCT02975297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111410098|NCT02046200|Ethanol|ethanol|mesh-list
111410099|NCT02046200|Ivermectin|ivermectin|mesh-list
111410100|NCT02046200|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111410101|NCT02046200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111410102|NCT02046200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111410103|NCT02046200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111410104|NCT02046200|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111410105|NCT02978339|Curcumin|curcumin|mesh-list
111410106|NCT02978339|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111410107|NCT02978339|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111410108|NCT02978339|Analgesics|analgesics|mesh-ancestor
111410109|NCT02978339|Sensory System Agents|sensory system agents|mesh-ancestor
111410110|NCT02978339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111410111|NCT02978339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111410112|NCT02978339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111410113|NCT02978339|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111410114|NCT02978339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111410115|NCT02978339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111410116|NCT02978339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111410117|NCT02367872|Imarikiren hydrochloride|imarikiren hydrochloride|mesh-list
111410118|NCT02367872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110830919|NCT01113671|Protective Agents|protective agents|mesh-ancestor
111410119|NCT02367872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111410120|NCT00374855|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
111410121|NCT00374855|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111410122|NCT00374855|Diuretics|diuretics|mesh-ancestor
111410123|NCT00374855|Natriuretic Agents|natriuretic agents|mesh-ancestor
111410124|NCT00374855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111410125|NCT00374855|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
111134522|NCT03387917|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111410126|NCT00374855|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111410127|NCT00374855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111410129|NCT02412644|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111410130|NCT02412644|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111410131|NCT02412644|Analgesics|analgesics|mesh-ancestor
111410132|NCT02412644|Sensory System Agents|sensory system agents|mesh-ancestor
111410133|NCT02412644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111410134|NCT02412644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111410135|NCT02412644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111410136|NCT02412644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111410137|NCT02412644|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
111410138|NCT02412644|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111410139|NCT02412644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111410140|NCT02412644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111410141|NCT02413034|Vancomycin|vancomycin|mesh-list
111410142|NCT02413034|Cefazolin|cefazolin|mesh-list
111410143|NCT02413034|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111410144|NCT02413034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111410145|NCT04737473|Anesthetics|anesthetics|mesh-list
111410146|NCT04737473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111410147|NCT04737473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111410148|NCT02369900|Esmolol|esmolol|mesh-list
111410149|NCT02369900|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111410150|NCT02369900|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111410151|NCT02369900|Adrenergic Agents|adrenergic agents|mesh-ancestor
111410152|NCT02369900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111410153|NCT02369900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111410154|NCT02369900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111410155|NCT02369900|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
111410156|NCT03054857|Dexmedetomidine|dexmedetomidine|mesh-list
111410157|NCT03054857|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111410158|NCT03054857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111410159|NCT03054857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111410160|NCT03054857|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111410161|NCT03054857|Analgesics|analgesics|mesh-ancestor
111410162|NCT03054857|Sensory System Agents|sensory system agents|mesh-ancestor
111410163|NCT03054857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111410164|NCT03054857|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111410165|NCT03054857|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111410166|NCT03054857|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111410167|NCT03054857|Adrenergic Agents|adrenergic agents|mesh-ancestor
111410168|NCT03054857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111410169|NCT03054857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111410170|NCT02414204|Sildenafil Citrate|sildenafil citrate|mesh-list
111410171|NCT02414204|Vasodilator Agents|vasodilator agents|mesh-ancestor
111410172|NCT02414204|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111410173|NCT02414204|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111410174|NCT02414204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111410175|NCT02414204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111410176|NCT02414204|Urological Agents|urological agents|mesh-ancestor
111410177|NCT02989493|Doxazosin|doxazosin|mesh-list
111410178|NCT02989493|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111410179|NCT02989493|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111410180|NCT02989493|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111410181|NCT02989493|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110831077|NCT03715881|Prednisolone|prednisolone|mesh-list
111410182|NCT02989493|Adrenergic Agents|adrenergic agents|mesh-ancestor
111410183|NCT02989493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111410184|NCT02989493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111410185|NCT02989493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111410186|NCT02050334|Caffeic acid|caffeic acid|mesh-list
111410187|NCT02050334|Antioxidants|antioxidants|mesh-ancestor
111410188|NCT02050334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111410189|NCT02050334|Protective Agents|protective agents|mesh-ancestor
111410190|NCT02050334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111410191|NCT02371850|Nicotine|nicotine|mesh-list
111410192|NCT02371850|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111410193|NCT02371850|Autonomic Agents|autonomic agents|mesh-ancestor
111410194|NCT02371850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111410195|NCT02371850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111410196|NCT02371850|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111410197|NCT02371850|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110075355|NCT01597206|Cobalt|cobalt|mesh-list
111410198|NCT02371850|Cholinergic Agents|cholinergic agents|mesh-ancestor
111410199|NCT02371850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111410200|NCT02371850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111410201|NCT03144635|Grazoprevir|grazoprevir|mesh-list
111410202|NCT03144635|Antiviral Agents|antiviral agents|mesh-ancestor
111410203|NCT03144635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111410204|NCT03145259|Diclofenac|diclofenac|mesh-list
111410205|NCT03145259|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
111410206|NCT03145259|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111410207|NCT03145259|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111410208|NCT03145259|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111410209|NCT03145259|Analgesics|analgesics|mesh-ancestor
111410210|NCT03145259|Sensory System Agents|sensory system agents|mesh-ancestor
111410211|NCT03145259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111410212|NCT03145259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111410213|NCT03145259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111410214|NCT03145259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111410215|NCT03145259|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111410216|NCT03145259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111410217|NCT03145259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111410218|NCT00354692|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
111410219|NCT00354692|Ferric gluconate|ferric gluconate|mesh-list
111410220|NCT00354692|Hematinics|hematinics|mesh-ancestor
111410221|NCT02989727|Lamotrigine|lamotrigine|mesh-list
111410222|NCT02989727|Anticonvulsants|anticonvulsants|mesh-ancestor
111410223|NCT02989727|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111410224|NCT02989727|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110831192|NCT01111253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111410225|NCT02989727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111410226|NCT02989727|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111410227|NCT02989727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111410228|NCT02989727|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111410229|NCT02989727|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111410230|NCT02989727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111410231|NCT02989727|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111410232|NCT02989727|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111410233|NCT02039947|Trametinib|trametinib|mesh-list
111410234|NCT02039947|Dabrafenib|dabrafenib|mesh-list
111410235|NCT02039947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111410236|NCT02039947|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111410237|NCT02039947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111410238|NCT02039947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111410239|NCT02052752|Benzoyl Peroxide|benzoyl peroxide|mesh-list
111410240|NCT02052752|Dermatologic Agents|dermatologic agents|mesh-ancestor
111410241|NCT02996591|Dexamethasone|dexamethasone|mesh-list
111410242|NCT02996591|Dexamethasone acetate|dexamethasone acetate|mesh-list
111410243|NCT02996591|Midazolam|midazolam|mesh-list
111410244|NCT02996591|Glycopyrrolate|glycopyrrolate|mesh-list
111410245|NCT02996591|Ketamine|ketamine|mesh-list
111410246|NCT02996591|Bupivacaine|bupivacaine|mesh-list
111410247|NCT02996591|Mepivacaine|mepivacaine|mesh-list
111410248|NCT02996591|Anesthetics|anesthetics|mesh-list
111410249|NCT02996591|Propofol|propofol|mesh-list
111410250|NCT02996591|Sevoflurane|sevoflurane|mesh-list
111410251|NCT02996591|BB 1101|bb 1101|mesh-list
111410252|NCT02996591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111410253|NCT02996591|Antiemetics|antiemetics|mesh-ancestor
111410254|NCT02996591|Autonomic Agents|autonomic agents|mesh-ancestor
111410255|NCT02996591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111410256|NCT02996591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111410257|NCT02996591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111410258|NCT02996591|Glucocorticoids|glucocorticoids|mesh-ancestor
111410259|NCT02996591|Hormones|hormones|mesh-ancestor
111410260|NCT02996591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111410261|NCT02996591|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111410262|NCT02996591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111410263|NCT02996591|Protease Inhibitors|protease inhibitors|mesh-ancestor
111410264|NCT02996591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111410265|NCT02996591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111410266|NCT02996591|Anesthetics, Local|anesthetics, local|mesh-ancestor
111410267|NCT02996591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111410268|NCT02996591|Sensory System Agents|sensory system agents|mesh-ancestor
111410269|NCT02996591|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111410270|NCT02996591|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111410271|NCT02996591|Anesthetics, General|anesthetics, general|mesh-ancestor
111410272|NCT02996591|Analgesics|analgesics|mesh-ancestor
111134673|NCT04917679|Diacerein|diacerein|mesh-list
111410273|NCT02996591|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111410274|NCT02996591|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111410275|NCT02996591|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111410276|NCT02996591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111410277|NCT02996591|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111410278|NCT02996591|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111410279|NCT02996591|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111410280|NCT02996591|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111410281|NCT02996591|GABA Modulators|gaba modulators|mesh-ancestor
111410282|NCT02996591|GABA Agents|gaba agents|mesh-ancestor
111410283|NCT02996591|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111410284|NCT02996591|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111410285|NCT02996591|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111410286|NCT02996591|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111410287|NCT02996591|Cholinergic Agents|cholinergic agents|mesh-ancestor
111410288|NCT03066947|Interferons|interferons|mesh-list
111410289|NCT03066947|Interferon-alpha|interferon-alpha|mesh-list
111410290|NCT03066947|Interferon alpha-2|interferon alpha-2|mesh-list
111410291|NCT03066947|Cyclophosphamide|cyclophosphamide|mesh-list
111410292|NCT03066947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111410293|NCT03066947|Immunologic Factors|immunologic factors|mesh-ancestor
111410294|NCT03066947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111410295|NCT03066947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111410296|NCT03066947|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111410297|NCT03066947|Alkylating Agents|alkylating agents|mesh-ancestor
111410298|NCT03066947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111410299|NCT03066947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111410300|NCT03066947|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111410301|NCT03066947|Antiviral Agents|antiviral agents|mesh-ancestor
111410302|NCT03066947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111410303|NCT02043145|Botulinum Toxins|botulinum toxins|mesh-list
111410304|NCT02043145|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111410305|NCT02043145|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111410306|NCT02043145|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111410307|NCT02043145|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111410308|NCT02043145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111410309|NCT02043145|Cholinergic Agents|cholinergic agents|mesh-ancestor
111410310|NCT02043145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111410311|NCT02043145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111410312|NCT02043145|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111410313|NCT02043145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111410314|NCT02062801|Ephedrine|ephedrine|mesh-list
111410315|NCT02062801|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111410316|NCT02062801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111410317|NCT02062801|Sympathomimetics|sympathomimetics|mesh-ancestor
111410318|NCT02062801|Autonomic Agents|autonomic agents|mesh-ancestor
111410319|NCT02062801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111410320|NCT02062801|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111410321|NCT02062801|Adrenergic Agents|adrenergic agents|mesh-ancestor
111410322|NCT02062801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110831394|NCT05156437|Cefepime|cefepime|mesh-list
111410323|NCT02062801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111410324|NCT03152591|Licogliflozin|licogliflozin|mesh-list
111410325|NCT03152591|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111410326|NCT03152591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111410327|NCT03152591|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111410328|NCT03152591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111410329|NCT02063035|Tranexamic Acid|tranexamic acid|mesh-list
111410330|NCT02063035|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111410331|NCT02063035|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111410332|NCT02063035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111410333|NCT02063035|Hemostatics|hemostatics|mesh-ancestor
111410334|NCT02063035|Coagulants|coagulants|mesh-ancestor
111410335|NCT00375245|Sirolimus|sirolimus|mesh-list
111410336|NCT00375245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111410337|NCT00375245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111410338|NCT00375245|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111410339|NCT00375245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111410340|NCT00375245|Antifungal Agents|antifungal agents|mesh-ancestor
111410341|NCT00375245|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111410342|NCT00375245|Immunologic Factors|immunologic factors|mesh-ancestor
111410343|NCT00375245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111410344|NCT02043379|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111410345|NCT02043379|Immunologic Factors|immunologic factors|mesh-ancestor
111410346|NCT02043379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111410347|NCT02054156|Azithromycin|azithromycin|mesh-list
111134754|NCT04916353|Hormones|hormones|mesh-ancestor
111410349|NCT02054156|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111410350|NCT02054156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111410352|NCT03159143|Oxaliplatin|oxaliplatin|mesh-list
111410353|NCT03159143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111410354|NCT03159143|Tubulin Modulators|tubulin modulators|mesh-ancestor
111410355|NCT03159143|Antimitotic Agents|antimitotic agents|mesh-ancestor
111410356|NCT03159143|Mitosis Modulators|mitosis modulators|mesh-ancestor
111410357|NCT03159143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111410358|NCT03068897|Ibuprofen|ibuprofen|mesh-list
111410359|NCT03068897|Tizanidine|tizanidine|mesh-list
111410360|NCT03068897|Baclofen|baclofen|mesh-list
111410361|NCT03068897|Metaxalone|metaxalone|mesh-list
111410362|NCT03068897|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111410363|NCT03068897|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111410364|NCT03068897|Analgesics|analgesics|mesh-ancestor
111410365|NCT03068897|Sensory System Agents|sensory system agents|mesh-ancestor
111410366|NCT03068897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111410367|NCT03068897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111410368|NCT03068897|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111410369|NCT03068897|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111410370|NCT03068897|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111410371|NCT03068897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111410372|NCT03068897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111410373|NCT03068897|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
111410374|NCT03068897|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110077759|NCT01612741|Acarbose|acarbose|mesh-list
111410375|NCT03068897|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
111410376|NCT03068897|GABA Agonists|gaba agonists|mesh-ancestor
111410377|NCT03068897|GABA Agents|gaba agents|mesh-ancestor
111410378|NCT03068897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111410379|NCT03068897|Anticonvulsants|anticonvulsants|mesh-ancestor
111410380|NCT03068897|Parasympatholytics|parasympatholytics|mesh-ancestor
111410381|NCT03068897|Autonomic Agents|autonomic agents|mesh-ancestor
111410382|NCT03068897|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111410383|NCT03068897|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111410384|NCT03068897|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111410385|NCT03068897|Adrenergic Agents|adrenergic agents|mesh-ancestor
111410386|NCT02049476|Dexamethasone|dexamethasone|mesh-list
111410387|NCT02049476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111410388|NCT02049476|Antiemetics|antiemetics|mesh-ancestor
111410389|NCT02049476|Autonomic Agents|autonomic agents|mesh-ancestor
111410390|NCT02049476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111410391|NCT02049476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111410392|NCT02049476|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111410393|NCT02049476|Glucocorticoids|glucocorticoids|mesh-ancestor
111410394|NCT02049476|Hormones|hormones|mesh-ancestor
111410395|NCT02049476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111410396|NCT02049476|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111410397|NCT02049476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111410398|NCT02299297|Tofacitinib|tofacitinib|mesh-list
111410399|NCT02299297|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
111410400|NCT02299297|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111410401|NCT02299297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111410402|NCT02299297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111410403|NCT03069677|Midazolam|midazolam|mesh-list
111410404|NCT03069677|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111410405|NCT03069677|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111410406|NCT03069677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111410407|NCT03069677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111410408|NCT03069677|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111410409|NCT03069677|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111410410|NCT03069677|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111410411|NCT03069677|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111410412|NCT03069677|Anesthetics, General|anesthetics, general|mesh-ancestor
111410413|NCT03069677|Anesthetics|anesthetics|mesh-ancestor
111410414|NCT03069677|GABA Modulators|gaba modulators|mesh-ancestor
111410415|NCT03069677|GABA Agents|gaba agents|mesh-ancestor
111410416|NCT03069677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110831791|NCT01122407|Trimethaphan|trimethaphan|mesh-list
111410417|NCT03069677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111410418|NCT02044393|Itraconazole|itraconazole|mesh-list
111410419|NCT02044393|Antifungal Agents|antifungal agents|mesh-ancestor
111410420|NCT02044393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111410421|NCT02044393|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111410422|NCT02044393|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111410423|NCT02044393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111410424|NCT02044393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111410425|NCT02044393|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111410426|NCT02044393|Hormone Antagonists|hormone antagonists|mesh-ancestor
111410427|NCT02044393|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111410428|NCT02044393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111410429|NCT02044393|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111410430|NCT05405465|Golimumab|golimumab|mesh-list
111410431|NCT05405465|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111410432|NCT05405465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111410433|NCT05405465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111410434|NCT05405465|Immunologic Factors|immunologic factors|mesh-ancestor
111410435|NCT05405465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111410436|NCT02064907|Dexlansoprazole|dexlansoprazole|mesh-list
111410437|NCT02064907|Lansoprazole|lansoprazole|mesh-list
111410438|NCT02064907|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111410439|NCT02064907|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111410440|NCT02064907|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111410441|NCT02064907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111410442|NCT02064907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111410443|NCT02064985|Ticagrelor|ticagrelor|mesh-list
111410444|NCT02064985|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111410445|NCT02064985|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111410446|NCT02064985|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111410447|NCT02064985|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111410448|NCT02064985|Purinergic Agents|purinergic agents|mesh-ancestor
111410449|NCT02064985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110831981|NCT01217099|Prednisolone|prednisolone|mesh-list
111410450|NCT02064985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111410451|NCT02064985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111410452|NCT03170219|Furosemide|furosemide|mesh-list
111410453|NCT03170219|Diuretics|diuretics|mesh-ancestor
111410454|NCT03170219|Natriuretic Agents|natriuretic agents|mesh-ancestor
111410455|NCT03170219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111410456|NCT03170219|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
111410457|NCT03170219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111410458|NCT03170219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110832053|NCT03933761|Pamiparib|pamiparib|mesh-list
111410459|NCT00375557|Valproic Acid|valproic acid|mesh-list
111410460|NCT00375557|Quetiapine Fumarate|quetiapine fumarate|mesh-list
111410461|NCT00375557|Antidepressive Agents|antidepressive agents|mesh-ancestor
111410462|NCT00375557|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111410463|NCT00375557|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111410464|NCT00375557|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111410465|NCT00375557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111410466|NCT00375557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111410467|NCT00375557|Anticonvulsants|anticonvulsants|mesh-ancestor
111410468|NCT00375557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111410469|NCT00375557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111410470|NCT00375557|GABA Agents|gaba agents|mesh-ancestor
110832107|NCT02735473|Nootropic Agents|nootropic agents|mesh-ancestor
111410471|NCT00375557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111410472|NCT00375557|Antimanic Agents|antimanic agents|mesh-ancestor
111410473|NCT03177395|Acetylcysteine|acetylcysteine|mesh-list
111410474|NCT03177395|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111410475|NCT03177395|Antiviral Agents|antiviral agents|mesh-ancestor
111410476|NCT03177395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111410477|NCT03177395|Expectorants|expectorants|mesh-ancestor
111410478|NCT03177395|Respiratory System Agents|respiratory system agents|mesh-ancestor
111410479|NCT03177395|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111410480|NCT03177395|Antioxidants|antioxidants|mesh-ancestor
111410481|NCT03177395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111410482|NCT03177395|Protective Agents|protective agents|mesh-ancestor
110832171|NCT01125215|Antipruritics|antipruritics|mesh-ancestor
111410483|NCT03177395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111410484|NCT03177395|Antidotes|antidotes|mesh-ancestor
111410485|NCT05159999|Antihypertensive Agents|antihypertensive agents|mesh-list
111410486|NCT03179345|Pregabalin|pregabalin|mesh-list
111410487|NCT03179345|Gabapentin|gabapentin|mesh-list
111410488|NCT03179345|Analgesics|analgesics|mesh-ancestor
111410489|NCT03179345|Sensory System Agents|sensory system agents|mesh-ancestor
111410490|NCT03179345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111410491|NCT03179345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111410492|NCT03179345|Anticonvulsants|anticonvulsants|mesh-ancestor
111410493|NCT03179345|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110832233|NCT05281861|Antidepressive Agents|antidepressive agents|mesh-ancestor
111410494|NCT03179345|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111410495|NCT03179345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111410496|NCT03179345|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111410497|NCT03179345|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111410498|NCT03179345|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111410499|NCT03179345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111410500|NCT03179345|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111410501|NCT03179345|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111410502|NCT03179345|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111410503|NCT03179345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111410504|NCT03179345|Antimanic Agents|antimanic agents|mesh-ancestor
111410506|NCT03086213|Sufentanil|sufentanil|mesh-list
111410507|NCT03086213|Dexmedetomidine|dexmedetomidine|mesh-list
111410508|NCT03086213|Dsuvia|dsuvia|mesh-list
111410509|NCT03086213|Ropivacaine|ropivacaine|mesh-list
111410510|NCT03086213|Propofol|propofol|mesh-list
111410511|NCT03086213|Anesthetics, Local|anesthetics, local|mesh-ancestor
111410512|NCT03086213|Anesthetics|anesthetics|mesh-ancestor
111410513|NCT03086213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111410514|NCT03086213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111410515|NCT03086213|Sensory System Agents|sensory system agents|mesh-ancestor
111410516|NCT03086213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111410517|NCT03086213|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111410518|NCT03086213|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111410519|NCT03086213|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111410520|NCT03086213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111410521|NCT03086213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111410522|NCT03086213|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111410523|NCT03086213|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111410524|NCT03086213|Analgesics|analgesics|mesh-ancestor
111410525|NCT03086213|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111410526|NCT03086213|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111410527|NCT03086213|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111410528|NCT03086213|Adrenergic Agents|adrenergic agents|mesh-ancestor
111410529|NCT03086213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111410530|NCT03086213|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111410531|NCT03086213|Anesthetics, General|anesthetics, general|mesh-ancestor
111410532|NCT03086213|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111410533|NCT03086213|Narcotics|narcotics|mesh-ancestor
111410534|NCT03086213|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111410535|NCT02378714|Varenicline|varenicline|mesh-list
111410536|NCT02378714|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111410537|NCT02378714|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111410538|NCT02378714|Cholinergic Agents|cholinergic agents|mesh-ancestor
111410539|NCT02378714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111410540|NCT02378714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111410541|NCT02378714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111410542|NCT03091673|Glucagon|glucagon|mesh-list
111410543|NCT03091673|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
111410544|NCT03091673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111410545|NCT03091673|Hormones|hormones|mesh-ancestor
111410546|NCT03091673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111410547|NCT03091673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111410548|NCT03091673|Incretins|incretins|mesh-ancestor
111410549|NCT02382848|Prazosin|prazosin|mesh-list
111410550|NCT02382848|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111410551|NCT02382848|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111410552|NCT02382848|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111410553|NCT02382848|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111410554|NCT02382848|Adrenergic Agents|adrenergic agents|mesh-ancestor
111410555|NCT02382848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111410556|NCT02382848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111410557|NCT02382848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111410558|NCT02065687|Metformin|metformin|mesh-list
111410559|NCT02065687|Paclitaxel|paclitaxel|mesh-list
111410560|NCT02065687|Carboplatin|carboplatin|mesh-list
111410561|NCT02065687|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110832565|NCT03441789|Hormones|hormones|mesh-ancestor
111410562|NCT02065687|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111410563|NCT02065687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111410564|NCT02065687|Tubulin Modulators|tubulin modulators|mesh-ancestor
111410565|NCT02065687|Antimitotic Agents|antimitotic agents|mesh-ancestor
111410566|NCT02065687|Mitosis Modulators|mitosis modulators|mesh-ancestor
111410567|NCT02065687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111410568|NCT02065687|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111410569|NCT02065687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111410570|NCT03096353|Naloxone|naloxone|mesh-list
111410571|NCT03096353|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110852074|NCT04828135|Xenon|xenon|mesh-list
111410572|NCT03096353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111410573|NCT03096353|Sensory System Agents|sensory system agents|mesh-ancestor
111410574|NCT03096353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111410575|NCT03098615|Efinaconazole|efinaconazole|mesh-list
111410576|NCT03098615|Antifungal Agents|antifungal agents|mesh-ancestor
111410577|NCT03098615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111410578|NCT05363501|Naloxone|naloxone|mesh-list
111410579|NCT05363501|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111410580|NCT05363501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111410581|NCT05363501|Sensory System Agents|sensory system agents|mesh-ancestor
111410582|NCT05363501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111410583|NCT04736927|Midazolam|midazolam|mesh-list
111410584|NCT04736927|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111410585|NCT04736927|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111410586|NCT04736927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111410587|NCT04736927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111410588|NCT04736927|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110832667|NCT01223729|Vitamins|vitamins|mesh-ancestor
111410589|NCT04736927|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111410590|NCT04736927|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111410591|NCT04736927|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111410592|NCT04736927|Anesthetics, General|anesthetics, general|mesh-ancestor
111410593|NCT04736927|Anesthetics|anesthetics|mesh-ancestor
111410594|NCT04736927|GABA Modulators|gaba modulators|mesh-ancestor
111410595|NCT04736927|GABA Agents|gaba agents|mesh-ancestor
111410596|NCT04736927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111410597|NCT04736927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111410598|NCT03810703|Amphetamine|amphetamine|mesh-list
111410599|NCT03810703|Dextroamphetamine|dextroamphetamine|mesh-list
111410600|NCT03810703|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111410601|NCT03810703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111410602|NCT03810703|Sympathomimetics|sympathomimetics|mesh-ancestor
111410603|NCT03810703|Autonomic Agents|autonomic agents|mesh-ancestor
111410604|NCT03810703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111410605|NCT03810703|Dopamine Agents|dopamine agents|mesh-ancestor
111410606|NCT03810703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111410607|NCT03810703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111410608|NCT03810703|Adrenergic Agents|adrenergic agents|mesh-ancestor
111410609|NCT03810703|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110832789|NCT01126307|Vasodilator Agents|vasodilator agents|mesh-ancestor
111410610|NCT03810703|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111410611|NCT03810703|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111410612|NCT03810703|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111410613|NCT02389088|Letrozole|letrozole|mesh-list
111410614|NCT02389088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111410615|NCT02389088|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111410616|NCT02389088|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111410617|NCT02389088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110832847|NCT01218425|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
111410618|NCT02389088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111410619|NCT02389088|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111410620|NCT02389088|Hormone Antagonists|hormone antagonists|mesh-ancestor
111410621|NCT02389088|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111410622|NCT02389088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111410623|NCT02068027|Clonidine|clonidine|mesh-list
111410624|NCT02068027|Analgesics|analgesics|mesh-ancestor
111410625|NCT02068027|Sensory System Agents|sensory system agents|mesh-ancestor
111410626|NCT02068027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111410627|NCT02068027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111410628|NCT02068027|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111410629|NCT02068027|Sympatholytics|sympatholytics|mesh-ancestor
111410630|NCT02068027|Autonomic Agents|autonomic agents|mesh-ancestor
111410631|NCT02068027|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111410632|NCT02068027|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111410633|NCT02068027|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111410634|NCT02068027|Adrenergic Agents|adrenergic agents|mesh-ancestor
111410635|NCT02068027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111410636|NCT02068027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111410637|NCT02392208|Telavancin|telavancin|mesh-list
111410638|NCT02392208|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111410639|NCT02392208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110832926|NCT03468790|Budesonide|budesonide|mesh-list
111410640|NCT05185583|Methylphenidate|methylphenidate|mesh-list
111410641|NCT05185583|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111410642|NCT05185583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111410643|NCT05185583|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111410644|NCT05185583|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111410645|NCT05185583|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111410646|NCT05185583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111410647|NCT05185583|Dopamine Agents|dopamine agents|mesh-ancestor
111410648|NCT05185583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111410649|NCT04645121|Carbon Monoxide|carbon monoxide|mesh-list
110832965|NCT01224353|Vitamins|vitamins|mesh-ancestor
111410650|NCT04645121|Antimetabolites|antimetabolites|mesh-ancestor
111410651|NCT04645121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111410652|NCT04645121|Gasotransmitters|gasotransmitters|mesh-ancestor
111410653|NCT04645121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111410654|NCT04645121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111410655|NCT04603937|Aflibercept|aflibercept|mesh-list
111410656|NCT04603937|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111410657|NCT04603937|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111410658|NCT04603937|Growth Substances|growth substances|mesh-ancestor
111410659|NCT04603937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111410660|NCT04603937|Growth Inhibitors|growth inhibitors|mesh-ancestor
111410661|NCT04603937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111410662|NCT02392286|Prednisone|prednisone|mesh-list
111410663|NCT02392286|Methylprednisolone|methylprednisolone|mesh-list
110833032|NCT01224509|Mifepristone|mifepristone|mesh-list
111410664|NCT02392286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111410665|NCT02392286|Glucocorticoids|glucocorticoids|mesh-ancestor
111410666|NCT02392286|Hormones|hormones|mesh-ancestor
111410667|NCT02392286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111410668|NCT02392286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111410669|NCT02392286|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111410670|NCT02392286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111410671|NCT02392286|Antiemetics|antiemetics|mesh-ancestor
111410672|NCT02392286|Autonomic Agents|autonomic agents|mesh-ancestor
111410673|NCT02392286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111410674|NCT02392286|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111410675|NCT02392286|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111410676|NCT02392286|Protective Agents|protective agents|mesh-ancestor
111410677|NCT04586153|Meplazumab|meplazumab|mesh-list
111410678|NCT04586153|Antiviral Agents|antiviral agents|mesh-ancestor
111410679|NCT04586153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111410680|NCT05717738|Bevacizumab|bevacizumab|mesh-list
111410681|NCT05717738|Atezolizumab|atezolizumab|mesh-list
111410682|NCT05717738|Sorafenib|sorafenib|mesh-list
111410683|NCT05717738|Apatinib|apatinib|mesh-list
111410684|NCT05717738|Lenvatinib|lenvatinib|mesh-list
111410685|NCT05717738|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
111410686|NCT05717738|Antibodies|antibodies|mesh-list
111410687|NCT05717738|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111410688|NCT05717738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111410689|NCT05717738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111410690|NCT05717738|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111410691|NCT05717738|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111410692|NCT05717738|Growth Substances|growth substances|mesh-ancestor
111410693|NCT05717738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111410694|NCT05717738|Growth Inhibitors|growth inhibitors|mesh-ancestor
111410695|NCT05717738|Immunologic Factors|immunologic factors|mesh-ancestor
111410696|NCT05717738|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111410697|NCT05717738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111410698|NCT05717738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111410699|NCT02393378|Folic Acid|folic acid|mesh-list
111410700|NCT02393378|Adalimumab|adalimumab|mesh-list
111410701|NCT02393378|Methotrexate|methotrexate|mesh-list
111410702|NCT02393378|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111410703|NCT02393378|Abortifacient Agents|abortifacient agents|mesh-ancestor
111410704|NCT02393378|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111410705|NCT02393378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111410706|NCT02393378|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111410707|NCT02393378|Antimetabolites|antimetabolites|mesh-ancestor
111410708|NCT02393378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111410709|NCT02393378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111410710|NCT02393378|Dermatologic Agents|dermatologic agents|mesh-ancestor
111410711|NCT02393378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111410712|NCT02393378|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111410713|NCT02393378|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111410714|NCT02393378|Immunologic Factors|immunologic factors|mesh-ancestor
111410715|NCT02393378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111410716|NCT02393378|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111410717|NCT02393378|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111410718|NCT02393378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111410719|NCT02393378|Hematinics|hematinics|mesh-ancestor
111410720|NCT02393378|Vitamin B Complex|vitamin b complex|mesh-ancestor
111410721|NCT02393378|Vitamins|vitamins|mesh-ancestor
111410722|NCT02393378|Micronutrients|micronutrients|mesh-ancestor
111410723|NCT04949477|Acetaminophen|acetaminophen|mesh-list
111410724|NCT04949477|Dexmedetomidine|dexmedetomidine|mesh-list
111410725|NCT04949477|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111410726|NCT04949477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111410727|NCT04949477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111410728|NCT04949477|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111410729|NCT04949477|Analgesics|analgesics|mesh-ancestor
111410730|NCT04949477|Sensory System Agents|sensory system agents|mesh-ancestor
111410731|NCT04949477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111410732|NCT04949477|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111410733|NCT04949477|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111410734|NCT04949477|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111410735|NCT04949477|Adrenergic Agents|adrenergic agents|mesh-ancestor
111410736|NCT04949477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110833368|NCT01226771|Antiviral Agents|antiviral agents|mesh-ancestor
111410737|NCT04949477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111410738|NCT04949477|Antipyretics|antipyretics|mesh-ancestor
111410739|NCT05717582|Androgens|androgens|mesh-list
111410740|NCT05717582|Hormones|hormones|mesh-ancestor
111410741|NCT05717582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111410742|NCT05717582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111410743|NCT03101033|Betamethasone|betamethasone|mesh-list
111410744|NCT03101033|Betamethasone Valerate|betamethasone valerate|mesh-list
111410745|NCT03101033|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
111410746|NCT03101033|Betamethasone benzoate|betamethasone benzoate|mesh-list
111410747|NCT03101033|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
111410748|NCT03101033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111410749|NCT03101033|Glucocorticoids|glucocorticoids|mesh-ancestor
111410750|NCT03101033|Hormones|hormones|mesh-ancestor
111410751|NCT03101033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111410752|NCT03101033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111410753|NCT03101033|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111410754|NCT03101033|Respiratory System Agents|respiratory system agents|mesh-ancestor
111410755|NCT02069041|Leucovorin|leucovorin|mesh-list
111410756|NCT02069041|Fluorouracil|fluorouracil|mesh-list
111410757|NCT02069041|Oxaliplatin|oxaliplatin|mesh-list
111410758|NCT02069041|Ramucirumab|ramucirumab|mesh-list
111410759|NCT02069041|Antimetabolites|antimetabolites|mesh-ancestor
111410760|NCT02069041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111410761|NCT02069041|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111410762|NCT02069041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111410763|NCT02069041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111410764|NCT02069041|Immunologic Factors|immunologic factors|mesh-ancestor
111410765|NCT02069041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111410766|NCT02069041|Antidotes|antidotes|mesh-ancestor
111410767|NCT02069041|Protective Agents|protective agents|mesh-ancestor
111410768|NCT02069041|Vitamin B Complex|vitamin b complex|mesh-ancestor
111410769|NCT02069041|Vitamins|vitamins|mesh-ancestor
111410770|NCT02069041|Micronutrients|micronutrients|mesh-ancestor
111410771|NCT04920344|Cisplatin|cisplatin|mesh-list
111410772|NCT04920344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111410773|NCT03101111|Vaccines|vaccines|mesh-list
111410774|NCT03101111|Immunologic Factors|immunologic factors|mesh-ancestor
111410775|NCT03101111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111410776|NCT05423834|Tenofovir|tenofovir|mesh-list
111410777|NCT05423834|Entecavir|entecavir|mesh-list
111410778|NCT05423834|Antiviral Agents|antiviral agents|mesh-ancestor
111410779|NCT05423834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111410780|NCT05423834|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111410781|NCT05423834|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111410782|NCT05423834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111410783|NCT05423834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111410784|NCT05423834|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111410785|NCT05423834|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111410786|NCT03103061|Regadenoson|regadenoson|mesh-list
111410787|NCT03103061|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
111410788|NCT03103061|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
111410789|NCT03103061|Purinergic Agonists|purinergic agonists|mesh-ancestor
111410790|NCT03103061|Purinergic Agents|purinergic agents|mesh-ancestor
111410791|NCT03103061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111410792|NCT03103061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111410793|NCT03103061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111410794|NCT03105479|Vancomycin|vancomycin|mesh-list
111410795|NCT03105479|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111410796|NCT03105479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111410797|NCT00355862|Cyclosporine|cyclosporine|mesh-list
111410798|NCT00355862|Sirolimus|sirolimus|mesh-list
111410799|NCT00355862|Prednisolone|prednisolone|mesh-list
111410800|NCT00355862|Temsirolimus|temsirolimus|mesh-list
111410801|NCT00355862|Azathioprine|azathioprine|mesh-list
111410802|NCT00355862|MTOR Inhibitors|mtor inhibitors|mesh-list
111410803|NCT00355862|Tacrolimus|tacrolimus|mesh-list
111410804|NCT00355862|Cyclosporins|cyclosporins|mesh-list
111410805|NCT00355862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111410806|NCT00355862|Immunologic Factors|immunologic factors|mesh-ancestor
111410807|NCT00355862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110833750|NCT03812731|Fentanyl|fentanyl|mesh-list
111410808|NCT00355862|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111410809|NCT00355862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111410810|NCT00355862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111410811|NCT00355862|Antifungal Agents|antifungal agents|mesh-ancestor
111410812|NCT00355862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111410813|NCT00355862|Dermatologic Agents|dermatologic agents|mesh-ancestor
111410814|NCT00355862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111410815|NCT00355862|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111410816|NCT00355862|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111410817|NCT00355862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110833809|NCT04420975|Nivolumab|nivolumab|mesh-list
111410818|NCT00355862|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111410819|NCT00355862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111410820|NCT00355862|Glucocorticoids|glucocorticoids|mesh-ancestor
111410821|NCT00355862|Hormones|hormones|mesh-ancestor
111410822|NCT00355862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111410823|NCT00355862|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111410824|NCT00355862|Antimetabolites|antimetabolites|mesh-ancestor
111410825|NCT00355862|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111410826|NCT02049151|Cyclophosphamide|cyclophosphamide|mesh-list
111410827|NCT02049151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111410828|NCT02049151|Immunologic Factors|immunologic factors|mesh-ancestor
111410829|NCT02049151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111410830|NCT02049151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111410831|NCT02049151|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111410832|NCT02049151|Alkylating Agents|alkylating agents|mesh-ancestor
111410833|NCT02049151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111410834|NCT02049151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111410835|NCT02049151|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111410836|NCT02049307|Losartan|losartan|mesh-list
111410837|NCT02049307|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111410838|NCT02049307|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111410839|NCT02049307|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111410840|NCT02049307|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111410841|NCT02049307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111410842|NCT00355628|Fentanyl|fentanyl|mesh-list
111410843|NCT00355628|Citric Acid|citric acid|mesh-list
111410844|NCT00355628|Sodium Citrate|sodium citrate|mesh-list
111410845|NCT00355628|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111410846|NCT00355628|Narcotics|narcotics|mesh-ancestor
111410847|NCT00355628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111410848|NCT00355628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111410849|NCT00355628|Analgesics|analgesics|mesh-ancestor
111410850|NCT00355628|Sensory System Agents|sensory system agents|mesh-ancestor
111410851|NCT00355628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111410852|NCT00355628|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111410853|NCT00355628|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110092829|NCT01698788|BB 1101|bb 1101|mesh-list
111410854|NCT00355628|Anesthetics, General|anesthetics, general|mesh-ancestor
111410855|NCT00355628|Anesthetics|anesthetics|mesh-ancestor
111410856|NCT00355628|Anticoagulants|anticoagulants|mesh-ancestor
111410857|NCT00355628|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
111410858|NCT00355628|Chelating Agents|chelating agents|mesh-ancestor
111410859|NCT00355628|Sequestering Agents|sequestering agents|mesh-ancestor
111410860|NCT00355628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111410861|NCT02049385|Diazoxide|diazoxide|mesh-list
111410862|NCT02049385|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111410863|NCT02049385|Vasodilator Agents|vasodilator agents|mesh-ancestor
111410864|NCT03717155|Carboplatin|carboplatin|mesh-list
111410865|NCT03717155|Gemcitabine|gemcitabine|mesh-list
111410866|NCT03717155|Cetuximab|cetuximab|mesh-list
111410867|NCT03717155|Avelumab|avelumab|mesh-list
111410868|NCT03717155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111410869|NCT03717155|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111410870|NCT03717155|Antimetabolites|antimetabolites|mesh-ancestor
111410871|NCT03717155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111410872|NCT03717155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111410873|NCT03789097|Pembrolizumab|pembrolizumab|mesh-list
111410874|NCT03789097|Poly ICLC|poly iclc|mesh-list
111135274|NCT04812535|Immunologic Factors|immunologic factors|mesh-ancestor
111410875|NCT03789097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111410877|NCT03789097|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111410878|NCT03789097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110833973|NCT01303471|Remifentanil|remifentanil|mesh-list
111410879|NCT03789097|Interferon Inducers|interferon inducers|mesh-ancestor
111410880|NCT03789097|Immunologic Factors|immunologic factors|mesh-ancestor
111410881|NCT03789097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111410882|NCT03655613|Nivolumab|nivolumab|mesh-list
111410883|NCT03655613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111410884|NCT03655613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111410885|NCT03655613|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111410886|NCT03655613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111410887|NCT04820036|Insulin|insulin|mesh-list
111410888|NCT04820036|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111410889|NCT04820036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111410890|NCT03286829|Metoprolol|metoprolol|mesh-list
111410891|NCT03286829|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111410892|NCT03286829|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111410893|NCT03286829|Sympatholytics|sympatholytics|mesh-ancestor
111410894|NCT03286829|Autonomic Agents|autonomic agents|mesh-ancestor
111410895|NCT03286829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111410896|NCT03286829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111410897|NCT03286829|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
111410898|NCT03286829|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111410899|NCT03286829|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111410900|NCT03286829|Adrenergic Agents|adrenergic agents|mesh-ancestor
111410901|NCT03286829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111410902|NCT03286829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111410903|NCT02051335|Scopolamine|scopolamine|mesh-list
111410904|NCT02051335|Donepezil|donepezil|mesh-list
111410905|NCT02051335|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
111410906|NCT02051335|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111410907|NCT02051335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111410908|NCT02051335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110834173|NCT03795649|Hemostatics|hemostatics|mesh-ancestor
111410909|NCT02051335|Cholinergic Agents|cholinergic agents|mesh-ancestor
111410910|NCT02051335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111410911|NCT02051335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111410912|NCT02051335|Nootropic Agents|nootropic agents|mesh-ancestor
111410913|NCT02051335|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111410914|NCT02051335|Antiemetics|antiemetics|mesh-ancestor
111410915|NCT02051335|Autonomic Agents|autonomic agents|mesh-ancestor
111410916|NCT02051335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111410917|NCT02051335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111410918|NCT02051335|Mydriatics|mydriatics|mesh-ancestor
111410919|NCT02051335|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111410920|NCT02051335|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111410921|NCT02051335|Parasympatholytics|parasympatholytics|mesh-ancestor
111410922|NCT03290027|Tazarotene|tazarotene|mesh-list
111410923|NCT03290027|Dermatologic Agents|dermatologic agents|mesh-ancestor
111410924|NCT03290027|Keratolytic Agents|keratolytic agents|mesh-ancestor
111410925|NCT02300077|Fentanyl|fentanyl|mesh-list
111410926|NCT02300077|Morphine|morphine|mesh-list
111410927|NCT02300077|Methadone|methadone|mesh-list
111410928|NCT02300077|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111410929|NCT02300077|Narcotics|narcotics|mesh-ancestor
111410930|NCT02300077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111410931|NCT02300077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111410932|NCT02300077|Analgesics|analgesics|mesh-ancestor
111410933|NCT02300077|Sensory System Agents|sensory system agents|mesh-ancestor
111410934|NCT02300077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111410935|NCT02300077|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111410936|NCT02300077|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111410937|NCT02300077|Anesthetics, General|anesthetics, general|mesh-ancestor
111410938|NCT02300077|Anesthetics|anesthetics|mesh-ancestor
111410939|NCT02300077|Antitussive Agents|antitussive agents|mesh-ancestor
111410940|NCT02300077|Respiratory System Agents|respiratory system agents|mesh-ancestor
111410941|NCT05272826|Dexamethasone|dexamethasone|mesh-list
111410942|NCT05272826|Bortezomib|bortezomib|mesh-list
111410943|NCT05272826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111410944|NCT05272826|Antiemetics|antiemetics|mesh-ancestor
111410945|NCT05272826|Autonomic Agents|autonomic agents|mesh-ancestor
111410946|NCT05272826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111410947|NCT05272826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111410948|NCT05272826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111410949|NCT05272826|Glucocorticoids|glucocorticoids|mesh-ancestor
111410950|NCT05272826|Hormones|hormones|mesh-ancestor
111410951|NCT05272826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111410952|NCT05272826|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111410953|NCT05272826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111410954|NCT03458429|Lenograstim|lenograstim|mesh-list
111410955|NCT03458429|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111410956|NCT03458429|Immunologic Factors|immunologic factors|mesh-ancestor
111410957|NCT03458429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111410958|NCT03291197|Bupivacaine|bupivacaine|mesh-list
111410959|NCT03291197|Anesthetics, Local|anesthetics, local|mesh-ancestor
111410960|NCT03291197|Anesthetics|anesthetics|mesh-ancestor
111410961|NCT03291197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110148847|NCT00006103|Antidotes|antidotes|mesh-ancestor
111410962|NCT03291197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111410963|NCT03291197|Sensory System Agents|sensory system agents|mesh-ancestor
111410964|NCT03291197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111410965|NCT05638880|Empagliflozin|empagliflozin|mesh-list
111410966|NCT05638880|Valsartan|valsartan|mesh-list
111410967|NCT05638880|Levocetirizine|levocetirizine|mesh-list
111410968|NCT05638880|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110834559|NCT01230983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111410969|NCT05638880|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111410970|NCT05638880|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111410971|NCT05638880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111410972|NCT05638880|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111410973|NCT05638880|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111410974|NCT05638880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111410975|NCT05638880|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
111410976|NCT05638880|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111410977|NCT05638880|Histamine Antagonists|histamine antagonists|mesh-ancestor
111410978|NCT05638880|Histamine Agents|histamine agents|mesh-ancestor
111410979|NCT05638880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111410980|NCT00356096|Pramipexole|pramipexole|mesh-list
111410981|NCT00356096|Antioxidants|antioxidants|mesh-ancestor
111410982|NCT00356096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111410983|NCT00356096|Protective Agents|protective agents|mesh-ancestor
111410984|NCT00356096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111410985|NCT00356096|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111410986|NCT00356096|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111410987|NCT00356096|Dopamine Agonists|dopamine agonists|mesh-ancestor
111410988|NCT00356096|Dopamine Agents|dopamine agents|mesh-ancestor
111410989|NCT00356096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111410990|NCT05637086|Phenytoin|phenytoin|mesh-list
111410991|NCT05637086|Pentoxifylline|pentoxifylline|mesh-list
111410992|NCT05637086|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111410993|NCT05637086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111410994|NCT05637086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111410995|NCT05637086|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111410996|NCT05637086|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111410997|NCT05637086|Protective Agents|protective agents|mesh-ancestor
111410998|NCT05637086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111410999|NCT05637086|Vasodilator Agents|vasodilator agents|mesh-ancestor
111411000|NCT05637086|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111411001|NCT05637086|Antioxidants|antioxidants|mesh-ancestor
111411002|NCT05637086|Anticonvulsants|anticonvulsants|mesh-ancestor
110151130|NCT00000799|Cidofovir|cidofovir|mesh-list
111411003|NCT05637086|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111411004|NCT05637086|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111411005|NCT05637086|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111411006|NCT05637086|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
111411007|NCT05637086|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111411008|NCT03243461|Temozolomide|temozolomide|mesh-list
111411009|NCT03243461|Valproic Acid|valproic acid|mesh-list
111411010|NCT03243461|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111411011|NCT03243461|Alkylating Agents|alkylating agents|mesh-ancestor
111411012|NCT03243461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111411013|NCT03243461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111411014|NCT03243461|Anticonvulsants|anticonvulsants|mesh-ancestor
110151598|NCT00001075|Ritonavir|ritonavir|mesh-list
111411015|NCT03243461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111411016|NCT03243461|GABA Agents|gaba agents|mesh-ancestor
111411017|NCT03243461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111411018|NCT03243461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111411019|NCT03243461|Antimanic Agents|antimanic agents|mesh-ancestor
111411020|NCT03243461|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111411021|NCT03243461|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111411022|NCT03243461|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111411023|NCT03296345|Ketamine|ketamine|mesh-list
111411024|NCT03296345|Analgesics|analgesics|mesh-ancestor
111411025|NCT03296345|Sensory System Agents|sensory system agents|mesh-ancestor
111411026|NCT03296345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111411028|NCT03296345|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111411029|NCT03296345|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111411030|NCT03296345|Anesthetics, General|anesthetics, general|mesh-ancestor
111411031|NCT03296345|Anesthetics|anesthetics|mesh-ancestor
111411032|NCT03296345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111411033|NCT03296345|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111411034|NCT03296345|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111411035|NCT03296345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111411036|NCT03296345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111411037|NCT00421694|Bicalutamide|bicalutamide|mesh-list
111411038|NCT00421694|Androgen Antagonists|androgen antagonists|mesh-ancestor
111411039|NCT00421694|Hormone Antagonists|hormone antagonists|mesh-ancestor
111411040|NCT00421694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111411041|NCT00421694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111411042|NCT00421694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111411043|NCT00376181|Pioglitazone|pioglitazone|mesh-list
111411044|NCT00376181|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
111411045|NCT00376181|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111411046|NCT00376181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111411047|NCT00376181|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111411048|NCT00376181|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111411049|NCT00376181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111411050|NCT04736693|Zoledronic Acid|zoledronic acid|mesh-list
111411051|NCT04736693|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
111411052|NCT04736693|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111411053|NCT04736693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111411054|NCT04736693|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111411055|NCT04736693|Hormone Antagonists|hormone antagonists|mesh-ancestor
111411056|NCT04736693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111411057|NCT04736693|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111411058|NCT04736693|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111411059|NCT04652414|Prednisone|prednisone|mesh-list
111411060|NCT04652414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111411061|NCT04652414|Glucocorticoids|glucocorticoids|mesh-ancestor
111411062|NCT04652414|Hormones|hormones|mesh-ancestor
111411063|NCT04652414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111411064|NCT04652414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111411065|NCT04652414|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111411066|NCT04652414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111411067|NCT04630964|Niacin|niacin|mesh-list
111411068|NCT04630964|Psilocybin|psilocybin|mesh-list
111411069|NCT04630964|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111411070|NCT04630964|Antimetabolites|antimetabolites|mesh-ancestor
111411071|NCT04630964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111411072|NCT04630964|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111411073|NCT04630964|Vasodilator Agents|vasodilator agents|mesh-ancestor
111411074|NCT04630964|Vitamin B Complex|vitamin b complex|mesh-ancestor
111411075|NCT04630964|Vitamins|vitamins|mesh-ancestor
111411076|NCT04630964|Micronutrients|micronutrients|mesh-ancestor
111411077|NCT04630964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111411078|NCT04630964|Hallucinogens|hallucinogens|mesh-ancestor
111411079|NCT04630964|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111411080|NCT04736381|Mycophenolic Acid|mycophenolic acid|mesh-list
111411081|NCT04736381|Abatacept|abatacept|mesh-list
111411082|NCT04736381|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111411083|NCT04736381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110835050|NCT01135589|Micafungin|micafungin|mesh-list
111411084|NCT04736381|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111411085|NCT04736381|Antitubercular Agents|antitubercular agents|mesh-ancestor
111411086|NCT04736381|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111411087|NCT04736381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111411088|NCT04736381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111411089|NCT04736381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111411090|NCT04736381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111411091|NCT04736381|Immunologic Factors|immunologic factors|mesh-ancestor
111411092|NCT04736381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111411093|NCT04736381|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111411094|NCT04736381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111411095|NCT04736381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111411096|NCT03302741|Botulinum Toxins|botulinum toxins|mesh-list
111411097|NCT03302741|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111411098|NCT03302741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111411099|NCT03302741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111411100|NCT03302741|Cholinergic Agents|cholinergic agents|mesh-ancestor
111411101|NCT03302741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111411102|NCT03302741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111411104|NCT02792465|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111411105|NCT02792465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111411106|NCT02792465|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
111411107|NCT02792465|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111411108|NCT02792465|Hormone Antagonists|hormone antagonists|mesh-ancestor
111411109|NCT02792465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111411110|NCT02792465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111411111|NCT05573828|Parathyroid Hormone|parathyroid hormone|mesh-list
111411112|NCT05573828|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111411113|NCT05573828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111411114|NCT02769611|Ruboxistaurin|ruboxistaurin|mesh-list
111411115|NCT02769611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111411116|NCT02769611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111411117|NCT04525820|Vitamin D|vitamin d|mesh-list
111411118|NCT04525820|Ergocalciferols|ergocalciferols|mesh-list
111411119|NCT04525820|Cholecalciferol|cholecalciferol|mesh-list
111411120|NCT04525820|Vitamins|vitamins|mesh-list
111411121|NCT04525820|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111411122|NCT04525820|Micronutrients|micronutrients|mesh-ancestor
111411123|NCT04525820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111411124|NCT04525820|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111411125|NCT04525820|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111411126|NCT05570708|Psilocybin|psilocybin|mesh-list
111411127|NCT05570708|Hallucinogens|hallucinogens|mesh-ancestor
111411128|NCT05570708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111411129|NCT05570708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111411130|NCT03305159|Chlorhexidine|chlorhexidine|mesh-list
111411131|NCT03305159|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
111411132|NCT03305159|Povidone-Iodine|povidone-iodine|mesh-list
111411133|NCT03305159|Povidone|povidone|mesh-list
111411134|NCT03305159|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111411135|NCT03305159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111411136|NCT03305159|Disinfectants|disinfectants|mesh-ancestor
111411137|NCT03305159|Dermatologic Agents|dermatologic agents|mesh-ancestor
111411138|NCT03305159|Plasma Substitutes|plasma substitutes|mesh-ancestor
111411139|NCT03305159|Blood Substitutes|blood substitutes|mesh-ancestor
111411140|NCT05552144|Listerine|listerine|mesh-list
111411141|NCT05552144|Sodium Fluoride|sodium fluoride|mesh-list
111411142|NCT05552144|Cariostatic Agents|cariostatic agents|mesh-ancestor
111411143|NCT05552144|Protective Agents|protective agents|mesh-ancestor
111411144|NCT05552144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111411145|NCT05552144|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111411146|NCT05552144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111411147|NCT03308669|Topiramate|topiramate|mesh-list
111411148|NCT03308669|Lasmiditan|lasmiditan|mesh-list
111411149|NCT03308669|Anticonvulsants|anticonvulsants|mesh-ancestor
111411150|NCT03308669|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111411151|NCT03308669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111411152|NCT03308669|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111411153|NCT03308669|Serotonin Agents|serotonin agents|mesh-ancestor
111411154|NCT03308669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111411155|NCT03308669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111411156|NCT00356252|Carotenoids|carotenoids|mesh-list
111411157|NCT00356252|Antioxidants|antioxidants|mesh-ancestor
111411158|NCT00356252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111411159|NCT00356252|Protective Agents|protective agents|mesh-ancestor
111411160|NCT00356252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111411161|NCT02056171|Quetiapine Fumarate|quetiapine fumarate|mesh-list
111411162|NCT02056171|Antidepressive Agents|antidepressive agents|mesh-ancestor
110835347|NCT03791827|Antimetabolites|antimetabolites|mesh-ancestor
111411163|NCT02056171|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111411164|NCT02056171|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111411165|NCT02056171|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111411166|NCT02056171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111411167|NCT02056171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111411168|NCT03312023|Sofosbuvir|sofosbuvir|mesh-list
111411169|NCT03312023|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
111411170|NCT03312023|Ledipasvir|ledipasvir|mesh-list
111411171|NCT03312023|Antiviral Agents|antiviral agents|mesh-ancestor
111411172|NCT03312023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111411173|NCT02342197|Triptorelin Pamoate|triptorelin pamoate|mesh-list
111411174|NCT02342197|Luteolytic Agents|luteolytic agents|mesh-ancestor
111411175|NCT02342197|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111411176|NCT02342197|Contraceptive Agents|contraceptive agents|mesh-ancestor
111411177|NCT02342197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111411178|NCT02342197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111411179|NCT02342197|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111411180|NCT02342197|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111411181|NCT02342197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111411182|NCT02344225|Ibuprofen|ibuprofen|mesh-list
111411183|NCT02344225|Ketorolac|ketorolac|mesh-list
111411184|NCT02344225|Caffeine|caffeine|mesh-list
111411185|NCT02344225|Caffeine citrate|caffeine citrate|mesh-list
111411186|NCT02344225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111411187|NCT02344225|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111411188|NCT02344225|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111411189|NCT02344225|Analgesics|analgesics|mesh-ancestor
111411190|NCT02344225|Sensory System Agents|sensory system agents|mesh-ancestor
111411191|NCT02344225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111411192|NCT02344225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111411193|NCT02344225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111411194|NCT02344225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111411195|NCT02344225|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111411196|NCT02344225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111411197|NCT02344225|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111411198|NCT02344225|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111411199|NCT02344225|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
111411200|NCT02344225|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111411201|NCT02344225|Purinergic Agents|purinergic agents|mesh-ancestor
111411202|NCT02344225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111411203|NCT04319588|Anesthetics|anesthetics|mesh-list
111411204|NCT04319588|Anesthetics, Local|anesthetics, local|mesh-list
110835462|NCT04595591|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111411205|NCT04319588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111411206|NCT04319588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111411207|NCT04319588|Sensory System Agents|sensory system agents|mesh-ancestor
111411208|NCT04319588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111411209|NCT03769844|Molgramostim|molgramostim|mesh-list
111411210|NCT03769844|Sargramostim|sargramostim|mesh-list
111411211|NCT03769844|Immunologic Factors|immunologic factors|mesh-ancestor
111411212|NCT03769844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111411213|NCT03769844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111411214|NCT02347345|Sofosbuvir|sofosbuvir|mesh-list
111411215|NCT02347345|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
111411216|NCT02347345|Ledipasvir|ledipasvir|mesh-list
111411217|NCT02347345|Antiviral Agents|antiviral agents|mesh-ancestor
111411218|NCT02347345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111411219|NCT03319277|Opiate Alkaloids|opiate alkaloids|mesh-list
111411220|NCT03319277|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111411221|NCT03319277|Narcotics|narcotics|mesh-ancestor
111411222|NCT03319277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111411223|NCT03319277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111411224|NCT03319277|Analgesics|analgesics|mesh-ancestor
111411225|NCT03319277|Sensory System Agents|sensory system agents|mesh-ancestor
111411226|NCT03319277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111411227|NCT03768440|Ropivacaine|ropivacaine|mesh-list
111411228|NCT03768440|Anesthetics, Local|anesthetics, local|mesh-ancestor
111411229|NCT03768440|Anesthetics|anesthetics|mesh-ancestor
111411230|NCT03768440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111411231|NCT03768440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111411232|NCT03768440|Sensory System Agents|sensory system agents|mesh-ancestor
111411233|NCT03768440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111411234|NCT04624295|Aspirin|aspirin|mesh-list
111411235|NCT04624295|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111411236|NCT04624295|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111411237|NCT04624295|Analgesics|analgesics|mesh-ancestor
111411238|NCT04624295|Sensory System Agents|sensory system agents|mesh-ancestor
111411239|NCT04624295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111411240|NCT04624295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111411241|NCT04624295|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111411242|NCT04624295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111411243|NCT04624295|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111411244|NCT04624295|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111411245|NCT04624295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111411246|NCT04624295|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111411247|NCT04624295|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111411248|NCT04624295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111135662|NCT04885777|Lidocaine|lidocaine|mesh-list
111411249|NCT04624295|Antipyretics|antipyretics|mesh-ancestor
111411250|NCT03323801|Tretinoin|tretinoin|mesh-list
111411251|NCT03323801|Isotretinoin|isotretinoin|mesh-list
111411252|NCT03323801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111411253|NCT03323801|Keratolytic Agents|keratolytic agents|mesh-ancestor
111411254|NCT03323801|Dermatologic Agents|dermatologic agents|mesh-ancestor
111411255|NCT04450355|Nefopam|nefopam|mesh-list
111411256|NCT04450355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111411257|NCT04450355|Analgesics|analgesics|mesh-ancestor
111411258|NCT04450355|Sensory System Agents|sensory system agents|mesh-ancestor
111411259|NCT04450355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111411260|NCT04450355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111411261|NCT02349685|Anti-Infective Agents|anti-infective agents|mesh-list
111411262|NCT02349685|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111411263|NCT02352259|Bleomycin|bleomycin|mesh-list
111411264|NCT02352259|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111411265|NCT02352259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111411266|NCT03326999|Bupivacaine|bupivacaine|mesh-list
111411267|NCT03326999|Anesthetics, Local|anesthetics, local|mesh-ancestor
111411268|NCT03326999|Anesthetics|anesthetics|mesh-ancestor
111411269|NCT03326999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111411270|NCT03326999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111411271|NCT03326999|Sensory System Agents|sensory system agents|mesh-ancestor
111411272|NCT03326999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111411273|NCT02397265|Insulin|insulin|mesh-list
111411274|NCT02397265|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111411275|NCT02397265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111411276|NCT00356720|Azithromycin|azithromycin|mesh-list
111411277|NCT00356720|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111411278|NCT00356720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111411279|NCT04121780|Hormones|hormones|mesh-list
111411280|NCT04121780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111411281|NCT04121780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111411282|NCT00375869|Darbepoetin alfa|darbepoetin alfa|mesh-list
111411283|NCT00375869|Hematinics|hematinics|mesh-ancestor
111411284|NCT03198221|Picosulfate sodium|picosulfate sodium|mesh-list
111411285|NCT03198221|Magnesium Oxide|magnesium oxide|mesh-list
111411286|NCT03198221|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
111411287|NCT03198221|Citric Acid|citric acid|mesh-list
111411288|NCT03198221|Anticoagulants|anticoagulants|mesh-ancestor
111411289|NCT03198221|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
111411290|NCT03198221|Chelating Agents|chelating agents|mesh-ancestor
111411291|NCT03198221|Sequestering Agents|sequestering agents|mesh-ancestor
110835737|NCT05115201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111411292|NCT03198221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111411293|NCT03198221|Cathartics|cathartics|mesh-ancestor
111411294|NCT03198221|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111411295|NCT03198221|Antacids|antacids|mesh-ancestor
111411296|NCT03198221|Laxatives|laxatives|mesh-ancestor
111411297|NCT03203681|Methyltestosterone|methyltestosterone|mesh-list
111411298|NCT03203681|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
111411299|NCT03203681|Testosterone|testosterone|mesh-list
111411300|NCT03203681|Testosterone undecanoate|testosterone undecanoate|mesh-list
111411301|NCT03203681|Testosterone enanthate|testosterone enanthate|mesh-list
111411302|NCT03203681|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111411303|NCT03203681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111411304|NCT03203681|Anabolic Agents|anabolic agents|mesh-ancestor
111411305|NCT03203681|Hormones|hormones|mesh-ancestor
111411306|NCT03203681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111411307|NCT03203681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111411308|NCT03203681|Androgens|androgens|mesh-ancestor
111411309|NCT05993949|Dasatinib|dasatinib|mesh-list
111411310|NCT05993949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110835803|NCT02891850|Tadalafil|tadalafil|mesh-list
111411311|NCT05993949|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111411312|NCT05993949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111411313|NCT05993949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111411314|NCT05993858|Cetuximab|cetuximab|mesh-list
111411315|NCT05993858|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111411316|NCT05993858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111411317|NCT05993767|Tenofovir|tenofovir|mesh-list
111411318|NCT05993767|Emtricitabine|emtricitabine|mesh-list
111411319|NCT05993767|Dolutegravir|dolutegravir|mesh-list
111411320|NCT05993767|Antiviral Agents|antiviral agents|mesh-ancestor
111411321|NCT05993767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111411322|NCT05993767|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111411323|NCT05993767|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111411324|NCT05993767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111411325|NCT05993767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111411326|NCT05993767|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111411327|NCT05993767|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111411328|NCT05993767|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111411330|NCT05993611|Immunoglobulins|immunoglobulins|mesh-list
111411331|NCT05993611|Immunologic Factors|immunologic factors|mesh-ancestor
111411332|NCT05993611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111411333|NCT05993455|Panitumumab|panitumumab|mesh-list
111411334|NCT05993455|Sotorasib|sotorasib|mesh-list
111411335|NCT05993455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111411336|NCT05993455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111411337|NCT05993455|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111411338|NCT05993455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111411339|NCT05993234|Trastuzumab|trastuzumab|mesh-list
111411340|NCT05993234|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
111411341|NCT05993234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111411342|NCT05993234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111411343|NCT05993234|Immunoconjugates|immunoconjugates|mesh-ancestor
111411344|NCT05993234|Immunologic Factors|immunologic factors|mesh-ancestor
111411345|NCT05993234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111411346|NCT05993143|Ivermectin|ivermectin|mesh-list
111411347|NCT05993143|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111411348|NCT05993143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111411349|NCT05992987|Adenosine|adenosine|mesh-list
111411350|NCT05992987|Antibodies|antibodies|mesh-list
111411351|NCT05992987|Immunologic Factors|immunologic factors|mesh-ancestor
111411352|NCT05992987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111411353|NCT05992987|Analgesics|analgesics|mesh-ancestor
111411354|NCT05992987|Sensory System Agents|sensory system agents|mesh-ancestor
111411355|NCT05992987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111411356|NCT05992987|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111411357|NCT05992987|Vasodilator Agents|vasodilator agents|mesh-ancestor
111411358|NCT05992987|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
111411359|NCT05992987|Purinergic Agonists|purinergic agonists|mesh-ancestor
111411360|NCT05992987|Purinergic Agents|purinergic agents|mesh-ancestor
111411361|NCT05992987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111411362|NCT05992987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111411363|NCT05992922|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111411364|NCT05992922|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111411365|NCT05992896|Bupivacaine|bupivacaine|mesh-list
111411366|NCT05992896|Anesthetics, Local|anesthetics, local|mesh-ancestor
111411367|NCT05992896|Anesthetics|anesthetics|mesh-ancestor
111411368|NCT05992896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111411369|NCT05992896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111411370|NCT05992896|Sensory System Agents|sensory system agents|mesh-ancestor
111411371|NCT05992896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111411372|NCT05992883|Triamcinolone|triamcinolone|mesh-list
111411373|NCT05992883|Ketorolac|ketorolac|mesh-list
111411374|NCT05992883|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111411375|NCT05992883|Glucocorticoids|glucocorticoids|mesh-ancestor
111411376|NCT05992883|Hormones|hormones|mesh-ancestor
111411377|NCT05992883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111411378|NCT05992883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111411379|NCT05992883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111411380|NCT05992883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111411381|NCT05992883|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111411382|NCT05992883|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111411383|NCT05992883|Analgesics|analgesics|mesh-ancestor
111411384|NCT05992883|Sensory System Agents|sensory system agents|mesh-ancestor
111411385|NCT05992883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111411386|NCT05992883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111411387|NCT05992883|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111411388|NCT05992610|Paclitaxel|paclitaxel|mesh-list
111411389|NCT05992610|Carboplatin|carboplatin|mesh-list
111411390|NCT05992610|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111411391|NCT05992610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111411392|NCT05992610|Tubulin Modulators|tubulin modulators|mesh-ancestor
111411393|NCT05992610|Antimitotic Agents|antimitotic agents|mesh-ancestor
111411394|NCT05992610|Mitosis Modulators|mitosis modulators|mesh-ancestor
111411395|NCT05992610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111411396|NCT05992311|Montelukast|montelukast|mesh-list
111411397|NCT05992311|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111411398|NCT05992311|Respiratory System Agents|respiratory system agents|mesh-ancestor
111411399|NCT05992311|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
111411400|NCT05992311|Hormone Antagonists|hormone antagonists|mesh-ancestor
111411401|NCT05992311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111135802|NCT04872283|Oxycodone|oxycodone|mesh-list
111411402|NCT05992311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111411403|NCT05992311|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
111411404|NCT05992311|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111411405|NCT05992311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111411406|NCT05992220|Bevacizumab|bevacizumab|mesh-list
111411407|NCT05992220|Atezolizumab|atezolizumab|mesh-list
111411408|NCT05992220|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111411409|NCT05992220|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111411410|NCT05992220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111411411|NCT05992220|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111411412|NCT05992220|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111411413|NCT05992220|Growth Substances|growth substances|mesh-ancestor
111411414|NCT05992220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111411415|NCT05992220|Growth Inhibitors|growth inhibitors|mesh-ancestor
111411416|NCT05992220|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111411417|NCT05992220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111411418|NCT05992220|Immunologic Factors|immunologic factors|mesh-ancestor
111411419|NCT05992077|Sofosbuvir|sofosbuvir|mesh-list
111411420|NCT05992077|Antiviral Agents|antiviral agents|mesh-ancestor
111411421|NCT05992077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111411422|NCT05991908|Vidarabine|vidarabine|mesh-list
111411423|NCT05991908|Fludarabine|fludarabine|mesh-list
111411424|NCT05991908|Fludarabine phosphate|fludarabine phosphate|mesh-list
111411425|NCT05991908|Melphalan|melphalan|mesh-list
111411426|NCT05991908|Busulfan|busulfan|mesh-list
111411427|NCT05991908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111411428|NCT05991908|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111411429|NCT05991908|Antimetabolites|antimetabolites|mesh-ancestor
110836093|NCT03359850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111411430|NCT05991908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111411431|NCT05991908|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111411432|NCT05991908|Immunologic Factors|immunologic factors|mesh-ancestor
111411433|NCT05991908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111411434|NCT05991908|Antiviral Agents|antiviral agents|mesh-ancestor
111411435|NCT05991908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111411436|NCT05991908|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111411437|NCT05991908|Alkylating Agents|alkylating agents|mesh-ancestor
111411438|NCT05991908|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111411439|NCT05991856|Antihypertensive Agents|antihypertensive agents|mesh-list
111411440|NCT05991830|Anesthetics|anesthetics|mesh-list
111411441|NCT05991830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111411442|NCT05991830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111411443|NCT05991817|Anesthetics|anesthetics|mesh-list
111411444|NCT05991817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111411445|NCT05991817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111411446|NCT05990894|Methylprednisolone|methylprednisolone|mesh-list
111411447|NCT05990894|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111411448|NCT05990894|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111411449|NCT05990894|Prednisolone|prednisolone|mesh-list
111411450|NCT05990894|Prednisolone acetate|prednisolone acetate|mesh-list
111411451|NCT05990894|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111411452|NCT05990894|Prednisolone phosphate|prednisolone phosphate|mesh-list
111411453|NCT05990894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111411454|NCT05990894|Antiemetics|antiemetics|mesh-ancestor
111411455|NCT05990894|Autonomic Agents|autonomic agents|mesh-ancestor
111411456|NCT05990894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111411457|NCT05990894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111411458|NCT05990894|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111411459|NCT05990894|Glucocorticoids|glucocorticoids|mesh-ancestor
111411460|NCT05990894|Hormones|hormones|mesh-ancestor
111411461|NCT05990894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111411462|NCT05990894|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111411463|NCT05990894|Protective Agents|protective agents|mesh-ancestor
111411464|NCT05990894|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111411465|NCT05990894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111411466|NCT05989386|Povidone-Iodine|povidone-iodine|mesh-list
111411467|NCT05989386|Povidone|povidone|mesh-list
111411468|NCT05989386|Plasma Substitutes|plasma substitutes|mesh-ancestor
111411469|NCT05989386|Blood Substitutes|blood substitutes|mesh-ancestor
111411470|NCT05989386|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111411471|NCT05989386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111411472|NCT05989347|Dapagliflozin|dapagliflozin|mesh-list
111411473|NCT05989347|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111411474|NCT05989347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111411475|NCT05989347|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111411476|NCT05989347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111411477|NCT05989126|Aflibercept|aflibercept|mesh-list
110836312|NCT01310647|Hormones|hormones|mesh-ancestor
111411478|NCT05989126|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111411479|NCT05989126|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111411480|NCT05989126|Growth Substances|growth substances|mesh-ancestor
111411481|NCT05989126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111411482|NCT05989126|Growth Inhibitors|growth inhibitors|mesh-ancestor
111411483|NCT05989126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111411484|NCT05988983|Contraceptive Agents|contraceptive agents|mesh-list
111411485|NCT05988983|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111411486|NCT05988983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111411487|NCT05988814|Folfirinox|folfirinox|mesh-list
111411488|NCT05988814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111411489|NCT05988788|Sodium Hypochlorite|sodium hypochlorite|mesh-list
111411490|NCT05988788|Eusol|eusol|mesh-list
111411491|NCT05988788|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
111411492|NCT05988788|Disinfectants|disinfectants|mesh-ancestor
111411493|NCT05988788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111411494|NCT05988788|Antioxidants|antioxidants|mesh-ancestor
110836374|NCT04394481|Anesthetics|anesthetics|mesh-ancestor
111411495|NCT05988788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111411496|NCT05988788|Protective Agents|protective agents|mesh-ancestor
111411497|NCT05988788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111411498|NCT05988788|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
111411499|NCT05988788|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
111411500|NCT05988788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111411501|NCT05988788|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111411502|NCT05988710|Oxycodone|oxycodone|mesh-list
111411503|NCT05988710|Buprenorphine|buprenorphine|mesh-list
111411504|NCT05988710|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111411505|NCT05988710|Narcotics|narcotics|mesh-ancestor
111411506|NCT05988710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111411507|NCT05988710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111411508|NCT05988710|Analgesics|analgesics|mesh-ancestor
111411509|NCT05988710|Sensory System Agents|sensory system agents|mesh-ancestor
110836442|NCT01309789|Hormones|hormones|mesh-ancestor
111411510|NCT05988710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111411511|NCT05988710|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111411512|NCT05988697|Trametinib|trametinib|mesh-list
111411513|NCT05988697|Dabrafenib|dabrafenib|mesh-list
111411514|NCT05988697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111411515|NCT05988697|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111411516|NCT05988697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111411517|NCT05988697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111411518|NCT05988684|Metformin|metformin|mesh-list
111411519|NCT05988684|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111411520|NCT05988684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111411521|NCT05988671|Dexamethasone|dexamethasone|mesh-list
111411522|NCT05988671|Dexamethasone acetate|dexamethasone acetate|mesh-list
111411523|NCT05988671|Dexmedetomidine|dexmedetomidine|mesh-list
111411524|NCT05988671|BB 1101|bb 1101|mesh-list
111411525|NCT05988671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111411526|NCT05988671|Antiemetics|antiemetics|mesh-ancestor
111411527|NCT05988671|Autonomic Agents|autonomic agents|mesh-ancestor
111411528|NCT05988671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111411529|NCT05988671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111411530|NCT05988671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111411531|NCT05988671|Glucocorticoids|glucocorticoids|mesh-ancestor
111411532|NCT05988671|Hormones|hormones|mesh-ancestor
111411533|NCT05988671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111411534|NCT05988671|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111411535|NCT05988671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111411536|NCT05988671|Protease Inhibitors|protease inhibitors|mesh-ancestor
111411537|NCT05988671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111411538|NCT05988671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110836623|NCT02897648|beta-Lactams|beta-lactams|mesh-list
111411539|NCT05988671|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111411540|NCT05988671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111411541|NCT05988671|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111411542|NCT05988671|Analgesics|analgesics|mesh-ancestor
111411543|NCT05988671|Sensory System Agents|sensory system agents|mesh-ancestor
111411544|NCT05988671|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111411545|NCT05988671|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111411546|NCT05988671|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111411547|NCT05988671|Adrenergic Agents|adrenergic agents|mesh-ancestor
111411548|NCT05988671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111411549|NCT05988632|Insulin|insulin|mesh-list
111411550|NCT05988632|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111411551|NCT05988632|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111411552|NCT05988632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111411553|NCT05988463|Artesunate|artesunate|mesh-list
111411554|NCT05988463|Antimalarials|antimalarials|mesh-ancestor
111411555|NCT05988463|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111411556|NCT05988463|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111411557|NCT05988463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111411558|NCT05988463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111411559|NCT05988463|Antiviral Agents|antiviral agents|mesh-ancestor
111411560|NCT05988463|Schistosomicides|schistosomicides|mesh-ancestor
111411561|NCT05988463|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
111411562|NCT05988463|Anthelmintics|anthelmintics|mesh-ancestor
111411563|NCT05988177|Spiramycin|spiramycin|mesh-list
111411564|NCT05988177|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111411565|NCT05988177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111411566|NCT05988177|Coccidiostats|coccidiostats|mesh-ancestor
111411567|NCT05988177|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111411568|NCT05988177|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111411569|NCT05988034|Moxifloxacin|moxifloxacin|mesh-list
111411570|NCT05988034|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
111411571|NCT05988034|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111411572|NCT05988034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111411573|NCT05988034|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111411574|NCT05988034|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111411575|NCT05988034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111411576|NCT05988034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111411577|NCT05988034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111411578|NCT05988034|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111411579|NCT05988034|Contraceptive Agents|contraceptive agents|mesh-ancestor
111411580|NCT05988034|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111411581|NCT05988034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111411582|NCT05988034|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
111411583|NCT05988034|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111411584|NCT05988034|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111411585|NCT05987722|Glycyrrhetinic Acid|glycyrrhetinic acid|mesh-list
111411586|NCT05987722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111411587|NCT05987696|Cytarabine|cytarabine|mesh-list
111411588|NCT05987696|Cyclophosphamide|cyclophosphamide|mesh-list
111411589|NCT05987696|Fludarabine|fludarabine|mesh-list
111411590|NCT05987696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111411591|NCT05987696|Immunologic Factors|immunologic factors|mesh-ancestor
111411592|NCT05987696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111411593|NCT05987696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111411594|NCT05987696|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111411595|NCT05987696|Alkylating Agents|alkylating agents|mesh-ancestor
111411596|NCT05987696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111411597|NCT05987696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111411598|NCT05987696|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111411599|NCT05987696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111411600|NCT05987696|Antimetabolites|antimetabolites|mesh-ancestor
111411601|NCT05987696|Antiviral Agents|antiviral agents|mesh-ancestor
111411602|NCT05987696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111411603|NCT05987657|Progesterone|progesterone|mesh-list
111411604|NCT05987657|Progestins|progestins|mesh-ancestor
111411605|NCT05987657|Hormones|hormones|mesh-ancestor
111411606|NCT05987657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111411607|NCT05987657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111411608|NCT05987397|Ubiquinone|ubiquinone|mesh-list
111411609|NCT05987397|Idebenone|idebenone|mesh-list
111411610|NCT05987397|Antioxidants|antioxidants|mesh-ancestor
111411611|NCT05987397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111411612|NCT05987397|Protective Agents|protective agents|mesh-ancestor
111411613|NCT05987397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111411614|NCT05987397|Micronutrients|micronutrients|mesh-ancestor
111411615|NCT05987345|Antibodies|antibodies|mesh-list
111411616|NCT05987345|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111411617|NCT05987345|Immunologic Factors|immunologic factors|mesh-ancestor
111411618|NCT05987345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111411619|NCT05987176|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
111411620|NCT05987176|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110837004|NCT03464656|Protective Agents|protective agents|mesh-ancestor
111411621|NCT05987176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111411622|NCT05987124|Defibrotide|defibrotide|mesh-list
111411623|NCT05987124|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111411624|NCT05987124|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111411625|NCT05987124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111411626|NCT05987124|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111411627|NCT05986968|Aspirin|aspirin|mesh-list
111411628|NCT05986968|Ticagrelor|ticagrelor|mesh-list
111411629|NCT05986968|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111411630|NCT05986968|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111411632|NCT05986968|Sensory System Agents|sensory system agents|mesh-ancestor
111411633|NCT05986968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111411634|NCT05986968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111411635|NCT05986968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111411636|NCT05986968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111411637|NCT05986968|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111411638|NCT05986968|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111411639|NCT05986968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111411640|NCT05986968|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111411641|NCT05986968|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111411642|NCT05986968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111411643|NCT05986968|Antipyretics|antipyretics|mesh-ancestor
111411644|NCT05986968|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111411645|NCT05986968|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111411646|NCT05986968|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111411647|NCT05986968|Purinergic Agents|purinergic agents|mesh-ancestor
111411648|NCT05986968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111411649|NCT05986942|Fentanyl|fentanyl|mesh-list
111411650|NCT05986942|Dexmedetomidine|dexmedetomidine|mesh-list
111411651|NCT05986942|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111411652|NCT05986942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111411653|NCT05986942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111411654|NCT05986942|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111411655|NCT05986942|Analgesics|analgesics|mesh-ancestor
111411656|NCT05986942|Sensory System Agents|sensory system agents|mesh-ancestor
111411657|NCT05986942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111411658|NCT05986942|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111411659|NCT05986942|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111411660|NCT05986942|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111411661|NCT05986942|Adrenergic Agents|adrenergic agents|mesh-ancestor
111411662|NCT05986942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110837254|NCT04452370|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111411663|NCT05986942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111411664|NCT05986942|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111411665|NCT05986942|Narcotics|narcotics|mesh-ancestor
111411666|NCT05986942|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111411667|NCT05986942|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111411668|NCT05986942|Anesthetics, General|anesthetics, general|mesh-ancestor
111411669|NCT05986942|Anesthetics|anesthetics|mesh-ancestor
111411670|NCT05986838|Metformin|metformin|mesh-list
111411671|NCT05986838|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111411672|NCT05986838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111411673|NCT05986734|Immunoglobulins|immunoglobulins|mesh-list
111411674|NCT05986734|Immunologic Factors|immunologic factors|mesh-ancestor
111411675|NCT05986734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111411676|NCT05986591|Bromides|bromides|mesh-list
111411677|NCT05986591|Tiotropium Bromide|tiotropium bromide|mesh-list
111411678|NCT05986591|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111411679|NCT05986591|Autonomic Agents|autonomic agents|mesh-ancestor
111411680|NCT05986591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111411681|NCT05986591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111411682|NCT05986591|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111411683|NCT05986591|Respiratory System Agents|respiratory system agents|mesh-ancestor
111411684|NCT05986591|Parasympatholytics|parasympatholytics|mesh-ancestor
111411685|NCT05986591|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111411686|NCT05986591|Cholinergic Agents|cholinergic agents|mesh-ancestor
111411687|NCT05986591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111411688|NCT05986591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111411689|NCT05986591|Anticonvulsants|anticonvulsants|mesh-ancestor
111411690|NCT05986422|Methylprednisolone|methylprednisolone|mesh-list
110837381|NCT01142843|Propolis|propolis|mesh-list
111411691|NCT05986422|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111411692|NCT05986422|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111411693|NCT05986422|Prednisolone|prednisolone|mesh-list
111411694|NCT05986422|Prednisolone acetate|prednisolone acetate|mesh-list
111411695|NCT05986422|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111411696|NCT05986422|Prednisolone phosphate|prednisolone phosphate|mesh-list
111411697|NCT05986422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111411698|NCT05986422|Antiemetics|antiemetics|mesh-ancestor
111411699|NCT05986422|Autonomic Agents|autonomic agents|mesh-ancestor
111411700|NCT05986422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111411701|NCT05986422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111411702|NCT05986422|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111411703|NCT05986422|Glucocorticoids|glucocorticoids|mesh-ancestor
111411704|NCT05986422|Hormones|hormones|mesh-ancestor
111411705|NCT05986422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111411706|NCT05986422|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111411707|NCT05986422|Protective Agents|protective agents|mesh-ancestor
111411708|NCT05986422|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111411709|NCT05986422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111411710|NCT05986344|Copper|copper|mesh-list
111411711|NCT05986344|Contraceptive Agents|contraceptive agents|mesh-list
111411712|NCT05986344|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111411713|NCT05986344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111411714|NCT05986344|Trace Elements|trace elements|mesh-ancestor
111411715|NCT05986344|Micronutrients|micronutrients|mesh-ancestor
111411716|NCT05986266|Carbetocin|carbetocin|mesh-list
111411717|NCT05986266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111411718|NCT05986266|Oxytocics|oxytocics|mesh-ancestor
111411719|NCT05986266|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111411720|NCT05986201|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
111411721|NCT05986201|Hemostatics|hemostatics|mesh-list
111411722|NCT05986201|Coagulants|coagulants|mesh-ancestor
111411723|NCT05986084|Cabotegravir|cabotegravir|mesh-list
111411724|NCT05986084|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111411725|NCT05986084|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111411726|NCT05986084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110837497|NCT03440788|Immunotoxins|immunotoxins|mesh-ancestor
111411727|NCT05986084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111411728|NCT05986084|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111411729|NCT05986084|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111411730|NCT05986084|Antiviral Agents|antiviral agents|mesh-ancestor
111411731|NCT05986084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111411732|NCT05986071|Fulvestrant|fulvestrant|mesh-list
111411733|NCT05986071|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111411734|NCT05986071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111411735|NCT05986071|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
111411736|NCT05986071|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111411737|NCT05986071|Hormone Antagonists|hormone antagonists|mesh-ancestor
111411738|NCT05986071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111411739|NCT05986071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111411740|NCT05985798|Chlorotrianisene|chlorotrianisene|mesh-list
111411741|NCT05985798|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
111411742|NCT05985798|Estrogens|estrogens|mesh-ancestor
111411743|NCT05985798|Hormones|hormones|mesh-ancestor
111411744|NCT05985798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111411745|NCT05985798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111411746|NCT05985798|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111411747|NCT05985798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111411748|NCT05985343|Glycopyrrolate|glycopyrrolate|mesh-list
111411749|NCT05985343|Neostigmine|neostigmine|mesh-list
111411750|NCT05985343|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111411751|NCT05985343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111411752|NCT05985343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111411753|NCT05985343|Cholinergic Agents|cholinergic agents|mesh-ancestor
111411754|NCT05985343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111411755|NCT05985343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111411756|NCT05985343|Parasympathomimetics|parasympathomimetics|mesh-ancestor
111411757|NCT05985343|Autonomic Agents|autonomic agents|mesh-ancestor
111411758|NCT05985343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111411759|NCT05985343|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111411760|NCT05985343|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111411761|NCT05985343|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111411762|NCT05985278|Catalase|catalase|mesh-list
111411763|NCT05985278|Antioxidants|antioxidants|mesh-ancestor
111411764|NCT05985278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111411765|NCT05985278|Protective Agents|protective agents|mesh-ancestor
111411766|NCT05985278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111411767|NCT05985187|Docetaxel|docetaxel|mesh-list
111411768|NCT05985187|Trastuzumab|trastuzumab|mesh-list
111411769|NCT05985187|Pertuzumab|pertuzumab|mesh-list
111411770|NCT05985187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111411771|NCT05985187|Tubulin Modulators|tubulin modulators|mesh-ancestor
111411772|NCT05985187|Antimitotic Agents|antimitotic agents|mesh-ancestor
111411773|NCT05985187|Mitosis Modulators|mitosis modulators|mesh-ancestor
111411774|NCT05985187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110837599|NCT04678479|GABA Modulators|gaba modulators|mesh-ancestor
111411775|NCT05985187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111411776|NCT05985070|Vitamin D|vitamin d|mesh-list
111411777|NCT05985070|Cholecalciferol|cholecalciferol|mesh-list
111411778|NCT05985070|Vitamins|vitamins|mesh-ancestor
111136181|NCT04869709|Betamethasone benzoate|betamethasone benzoate|mesh-list
111411779|NCT05985070|Micronutrients|micronutrients|mesh-ancestor
111411780|NCT05985070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111411781|NCT05985070|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111411782|NCT05985070|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111411783|NCT05984511|Bevacizumab|bevacizumab|mesh-list
111411784|NCT05984511|Atezolizumab|atezolizumab|mesh-list
111411785|NCT05984511|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111411786|NCT05984511|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111411787|NCT05984511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111411788|NCT05984511|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111411789|NCT05984511|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111411790|NCT05984511|Growth Substances|growth substances|mesh-ancestor
111411791|NCT05984511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111411792|NCT05984511|Growth Inhibitors|growth inhibitors|mesh-ancestor
111411793|NCT05984511|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111411794|NCT05984511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111411795|NCT05984511|Immunologic Factors|immunologic factors|mesh-ancestor
111411796|NCT05984381|Dapsone|dapsone|mesh-list
111411797|NCT05984381|Prednisolone|prednisolone|mesh-list
111411798|NCT05984381|Methotrexate|methotrexate|mesh-list
111411799|NCT05984381|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111411800|NCT05984381|Abortifacient Agents|abortifacient agents|mesh-ancestor
111411801|NCT05984381|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111411802|NCT05984381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111411803|NCT05984381|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111411804|NCT05984381|Antimetabolites|antimetabolites|mesh-ancestor
111411805|NCT05984381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111411806|NCT05984381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111411807|NCT05984381|Dermatologic Agents|dermatologic agents|mesh-ancestor
111411808|NCT05984381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111411809|NCT05984381|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111411810|NCT05984381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111411811|NCT05984381|Immunologic Factors|immunologic factors|mesh-ancestor
111411812|NCT05984381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111411813|NCT05984381|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111411814|NCT05984381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111411815|NCT05984381|Glucocorticoids|glucocorticoids|mesh-ancestor
111411816|NCT05984381|Hormones|hormones|mesh-ancestor
111411817|NCT05984381|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111411818|NCT05984381|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111411819|NCT05984381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111411820|NCT05984381|Antimalarials|antimalarials|mesh-ancestor
111411821|NCT05984381|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111411822|NCT05984381|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111411823|NCT05984381|Leprostatic Agents|leprostatic agents|mesh-ancestor
111411824|NCT05984381|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111411825|NCT05983952|Antibodies|antibodies|mesh-list
111411826|NCT05983952|Immunologic Factors|immunologic factors|mesh-ancestor
111411827|NCT05983952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111411828|NCT05983237|Temozolomide|temozolomide|mesh-list
111411829|NCT05983237|Fluzoparib|fluzoparib|mesh-list
111411830|NCT05983237|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111411831|NCT05983237|Alkylating Agents|alkylating agents|mesh-ancestor
111411832|NCT05983237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111411833|NCT05983237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111411834|NCT05983237|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111411835|NCT05983237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111411836|NCT05983055|Dexamethasone|dexamethasone|mesh-list
111411837|NCT05983055|Dexamethasone acetate|dexamethasone acetate|mesh-list
111411838|NCT05983055|BB 1101|bb 1101|mesh-list
111411839|NCT05983055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111411840|NCT05983055|Antiemetics|antiemetics|mesh-ancestor
111411841|NCT05983055|Autonomic Agents|autonomic agents|mesh-ancestor
111411842|NCT05983055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111411843|NCT05983055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111411844|NCT05983055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111411845|NCT05983055|Glucocorticoids|glucocorticoids|mesh-ancestor
111411846|NCT05983055|Hormones|hormones|mesh-ancestor
111411847|NCT05983055|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110837965|NCT01145807|Terbinafine|terbinafine|mesh-list
111411848|NCT05983055|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111411849|NCT05983055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111411850|NCT05983055|Protease Inhibitors|protease inhibitors|mesh-ancestor
111411851|NCT05983055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111411852|NCT05983055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111411853|NCT05970380|Anesthetics|anesthetics|mesh-list
111411854|NCT05970380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111411855|NCT05970380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111411856|NCT05969756|Fluorides|fluorides|mesh-list
111411858|NCT05969756|Cariostatic Agents|cariostatic agents|mesh-ancestor
111411859|NCT05969756|Protective Agents|protective agents|mesh-ancestor
111411860|NCT05969756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111411861|NCT05962424|Ketamine|ketamine|mesh-list
111411862|NCT05962424|Analgesics|analgesics|mesh-ancestor
111411863|NCT05962424|Sensory System Agents|sensory system agents|mesh-ancestor
111411864|NCT05962424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111411865|NCT05962424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111411866|NCT05962424|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111411867|NCT05962424|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111411868|NCT05962424|Anesthetics, General|anesthetics, general|mesh-ancestor
111411869|NCT05962424|Anesthetics|anesthetics|mesh-ancestor
111411870|NCT05962424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111411871|NCT05962424|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110838093|NCT03779035|Capecitabine|capecitabine|mesh-list
111411872|NCT05962424|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111411873|NCT05962424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111411874|NCT05962424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111411875|NCT05959629|Sodium Hypochlorite|sodium hypochlorite|mesh-list
111411876|NCT05959629|Eusol|eusol|mesh-list
111411877|NCT05959629|Disinfectants|disinfectants|mesh-ancestor
111411878|NCT05959629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111411879|NCT05955222|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
111411880|NCT05955222|Vasodilator Agents|vasodilator agents|mesh-ancestor
111411881|NCT05955222|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
111411882|NCT05955222|Protective Agents|protective agents|mesh-ancestor
111411883|NCT05955222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111411884|NCT05946603|Fluorophosphate|fluorophosphate|mesh-list
111411885|NCT05946603|Cariostatic Agents|cariostatic agents|mesh-ancestor
111411886|NCT05946603|Protective Agents|protective agents|mesh-ancestor
111411887|NCT05946603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111411888|NCT05938387|Vaccines|vaccines|mesh-list
111411889|NCT05938387|Immunologic Factors|immunologic factors|mesh-ancestor
111411890|NCT05938387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111411891|NCT05920967|Dexamethasone|dexamethasone|mesh-list
111411892|NCT05920967|Dexamethasone acetate|dexamethasone acetate|mesh-list
111411893|NCT05920967|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
111411894|NCT05920967|BB 1101|bb 1101|mesh-list
111411895|NCT05920967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111411896|NCT05920967|Antiemetics|antiemetics|mesh-ancestor
111411897|NCT05920967|Autonomic Agents|autonomic agents|mesh-ancestor
111411898|NCT05920967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111411899|NCT05920967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111411900|NCT05920967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111411901|NCT05920967|Glucocorticoids|glucocorticoids|mesh-ancestor
111411902|NCT05920967|Hormones|hormones|mesh-ancestor
110838214|NCT03784066|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111411903|NCT05920967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111411904|NCT05920967|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111411905|NCT05920967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111411906|NCT05920967|Protease Inhibitors|protease inhibitors|mesh-ancestor
111411907|NCT05920967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111411908|NCT05920967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111411909|NCT05920343|Rivaroxaban|rivaroxaban|mesh-list
111411910|NCT05920343|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110838269|NCT03063203|Decitabine|decitabine|mesh-list
111411911|NCT05920343|Antithrombins|antithrombins|mesh-ancestor
111411912|NCT05920343|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111411913|NCT05920343|Protease Inhibitors|protease inhibitors|mesh-ancestor
111411914|NCT05920343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111411915|NCT05920343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111411916|NCT05920343|Anticoagulants|anticoagulants|mesh-ancestor
111411917|NCT05916287|Antihypertensive Agents|antihypertensive agents|mesh-list
111411918|NCT05913388|Pembrolizumab|pembrolizumab|mesh-list
111411919|NCT05913388|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111411920|NCT05913388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111411921|NCT05913388|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111411922|NCT05913388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111411923|NCT05911594|Solifenacin Succinate|solifenacin succinate|mesh-list
111411924|NCT05911594|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111411925|NCT05911594|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111411926|NCT05911594|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111411927|NCT05911594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111411928|NCT05911594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111411929|NCT05911594|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111411930|NCT05911594|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111136331|NCT04873531|Neostigmine|neostigmine|mesh-list
111411931|NCT05911594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111411932|NCT05911594|Cholinergic Agents|cholinergic agents|mesh-ancestor
111411933|NCT05911594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111411934|NCT05911594|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111411935|NCT05911594|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111411936|NCT05911594|Urological Agents|urological agents|mesh-ancestor
111411937|NCT05910970|Lenvatinib|lenvatinib|mesh-list
111411938|NCT05910970|Tislelizumab|tislelizumab|mesh-list
111411939|NCT05910970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111411940|NCT05910970|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111411941|NCT05910970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111411942|NCT05910970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111411943|NCT05910970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111411944|NCT05900882|Dexamethasone|dexamethasone|mesh-list
111411945|NCT05900882|Lenalidomide|lenalidomide|mesh-list
111411946|NCT05900882|Bortezomib|bortezomib|mesh-list
111411947|NCT05900882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111411948|NCT05900882|Antiemetics|antiemetics|mesh-ancestor
111411949|NCT05900882|Autonomic Agents|autonomic agents|mesh-ancestor
111411950|NCT05900882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111411951|NCT05900882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111411952|NCT05900882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111411953|NCT05900882|Glucocorticoids|glucocorticoids|mesh-ancestor
111411954|NCT05900882|Hormones|hormones|mesh-ancestor
111411955|NCT05900882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111411956|NCT05900882|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111411957|NCT05900882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111411958|NCT05900882|Immunologic Factors|immunologic factors|mesh-ancestor
111411959|NCT05900882|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111411960|NCT05900882|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111411961|NCT05900882|Growth Substances|growth substances|mesh-ancestor
111411962|NCT05900882|Growth Inhibitors|growth inhibitors|mesh-ancestor
111411963|NCT05887492|Pembrolizumab|pembrolizumab|mesh-list
111411964|NCT05887492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111411965|NCT05887492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111411966|NCT05887492|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111411967|NCT05887492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111411968|NCT05886244|Eculizumab|eculizumab|mesh-list
111411969|NCT05886244|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
111411970|NCT05886244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111411971|NCT05886244|Immunologic Factors|immunologic factors|mesh-ancestor
111411972|NCT05886244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111411973|NCT05883540|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
111411974|NCT05883540|Hallucinogens|hallucinogens|mesh-ancestor
111411975|NCT05883540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111411976|NCT05883540|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111411977|NCT05883540|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111411978|NCT05883540|Serotonin Agents|serotonin agents|mesh-ancestor
111411979|NCT05883540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111411980|NCT05883540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111411981|NCT05883540|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111411982|NCT05875857|Analgesics, Opioid|analgesics, opioid|mesh-list
111411983|NCT05875857|Narcotics|narcotics|mesh-ancestor
111411984|NCT05875857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111411985|NCT05875857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111411986|NCT05875857|Analgesics|analgesics|mesh-ancestor
111411987|NCT05875857|Sensory System Agents|sensory system agents|mesh-ancestor
111411988|NCT05875857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111411989|NCT05871424|Buprenorphine|buprenorphine|mesh-list
111411990|NCT05871424|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111411991|NCT05871424|Narcotics|narcotics|mesh-ancestor
111411992|NCT05871424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111411993|NCT05871424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111411994|NCT05871424|Analgesics|analgesics|mesh-ancestor
111411995|NCT05871424|Sensory System Agents|sensory system agents|mesh-ancestor
111411996|NCT05871424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111411997|NCT05871424|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111411998|NCT05862233|Cyclosporine|cyclosporine|mesh-list
111411999|NCT05862233|Cyclosporins|cyclosporins|mesh-list
111412000|NCT05862233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111412001|NCT05862233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111412002|NCT05862233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111412003|NCT05862233|Immunologic Factors|immunologic factors|mesh-ancestor
111412004|NCT05862233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111412005|NCT05862233|Antifungal Agents|antifungal agents|mesh-ancestor
111412006|NCT05862233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111412007|NCT05862233|Dermatologic Agents|dermatologic agents|mesh-ancestor
111412008|NCT05862233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111412009|NCT05862233|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111412010|NCT05861050|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111412011|NCT05861050|Obinutuzumab|obinutuzumab|mesh-list
111412012|NCT05861050|Lenalidomide|lenalidomide|mesh-list
111412013|NCT05861050|Venetoclax|venetoclax|mesh-list
111412014|NCT05861050|Antibodies|antibodies|mesh-list
111412015|NCT05861050|Immunoglobulins|immunoglobulins|mesh-list
111412016|NCT05861050|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111412017|NCT05861050|Antibodies, Bispecific|antibodies, bispecific|mesh-list
111412018|NCT05861050|Immunologic Factors|immunologic factors|mesh-ancestor
111412019|NCT05861050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111412020|NCT05861050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111412021|NCT05861050|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111412022|NCT05861050|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111412023|NCT05861050|Growth Substances|growth substances|mesh-ancestor
111412024|NCT05861050|Growth Inhibitors|growth inhibitors|mesh-ancestor
111412025|NCT05856851|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
111412026|NCT05856851|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111412027|NCT05856851|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111412028|NCT05856851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111412029|NCT05846880|Vitamin D|vitamin d|mesh-list
111412030|NCT05846880|Ergocalciferols|ergocalciferols|mesh-list
111412031|NCT05846880|Cholecalciferol|cholecalciferol|mesh-list
111412032|NCT05846880|Vitamins|vitamins|mesh-list
111412033|NCT05846880|Lenalidomide|lenalidomide|mesh-list
111412034|NCT05846880|Micronutrients|micronutrients|mesh-ancestor
111412035|NCT05846880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111412036|NCT05846880|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111412037|NCT05846880|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111412038|NCT05846880|Immunologic Factors|immunologic factors|mesh-ancestor
111412039|NCT05846880|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111412040|NCT05846880|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111412041|NCT05846880|Growth Substances|growth substances|mesh-ancestor
111412042|NCT05846880|Growth Inhibitors|growth inhibitors|mesh-ancestor
111412043|NCT05846880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111412044|NCT05846451|Oxycodone|oxycodone|mesh-list
111412045|NCT05846451|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111412046|NCT05846451|Narcotics|narcotics|mesh-ancestor
111412047|NCT05846451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111412048|NCT05846451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111412049|NCT05846451|Analgesics|analgesics|mesh-ancestor
111412050|NCT05846451|Sensory System Agents|sensory system agents|mesh-ancestor
111412051|NCT05846451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111412052|NCT05840861|Quetiapine Fumarate|quetiapine fumarate|mesh-list
111412053|NCT05840861|Vortioxetine|vortioxetine|mesh-list
111412054|NCT05840861|Antidepressive Agents|antidepressive agents|mesh-ancestor
111412055|NCT05840861|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111412056|NCT05840861|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111412057|NCT05840861|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111412058|NCT05840861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111412059|NCT05840861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111412060|NCT05840861|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110839006|NCT02061293|Diphenhydramine|diphenhydramine|mesh-list
111412061|NCT05840861|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111412062|NCT05840861|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111412063|NCT05840861|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111412064|NCT05840861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111412065|NCT05840861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111412066|NCT05840861|Serotonin Agents|serotonin agents|mesh-ancestor
111412067|NCT05840861|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111412068|NCT05840861|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111412069|NCT05840861|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111412070|NCT05840861|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111412071|NCT05837104|Vitamin B 6|vitamin b 6|mesh-list
111412072|NCT05837104|Pyridoxal|pyridoxal|mesh-list
111412073|NCT05837104|Pyridoxine|pyridoxine|mesh-list
111412074|NCT05837104|Vitamins|vitamins|mesh-ancestor
111412075|NCT05837104|Micronutrients|micronutrients|mesh-ancestor
111412076|NCT05837104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111412077|NCT05837104|Vitamin B Complex|vitamin b complex|mesh-ancestor
111412078|NCT05829655|Suvorexant|suvorexant|mesh-list
111412079|NCT05829655|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111412080|NCT05829655|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111412081|NCT05829655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111412082|NCT05829655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111412083|NCT05829655|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
110839204|NCT01322191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111412084|NCT05829655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111412085|NCT05829655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111412086|NCT05825625|Atezolizumab|atezolizumab|mesh-list
111412087|NCT05825625|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111412088|NCT05825625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111412089|NCT05825625|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111412090|NCT05825625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111412091|NCT05824559|Bevacizumab|bevacizumab|mesh-list
111412092|NCT05824559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111412093|NCT05824559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111412094|NCT05824559|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111412095|NCT05824559|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111412096|NCT05824559|Growth Substances|growth substances|mesh-ancestor
111412097|NCT05824559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111412098|NCT05824559|Growth Inhibitors|growth inhibitors|mesh-ancestor
111412099|NCT05815264|Vaccines|vaccines|mesh-list
111412100|NCT05815264|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
111412101|NCT05815264|Immunologic Factors|immunologic factors|mesh-ancestor
111412102|NCT05815264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111412103|NCT05815186|Sotorasib|sotorasib|mesh-list
111412104|NCT05815186|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111412105|NCT05815186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111412106|NCT05815186|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111412107|NCT05815186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111412108|NCT05814640|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
111412109|NCT05814640|Olanzapine|olanzapine|mesh-list
111412110|NCT05814640|Aripiprazole|aripiprazole|mesh-list
111412111|NCT05814640|Lithium Carbonate|lithium carbonate|mesh-list
110839351|NCT02528201|Celecoxib|celecoxib|mesh-list
111412112|NCT05814640|Vortioxetine|vortioxetine|mesh-list
111412113|NCT05814640|Sertraline|sertraline|mesh-list
111412114|NCT05814640|Fluoxetine|fluoxetine|mesh-list
111412115|NCT05814640|Antiemetics|antiemetics|mesh-ancestor
111412116|NCT05814640|Autonomic Agents|autonomic agents|mesh-ancestor
111412117|NCT05814640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111412118|NCT05814640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111412119|NCT05814640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111412120|NCT05814640|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111412121|NCT05814640|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111412122|NCT05814640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111412123|NCT05814640|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111412124|NCT05814640|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111412125|NCT05814640|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111412126|NCT05814640|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111412127|NCT05814640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111412128|NCT05814640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111412129|NCT05814640|Serotonin Agents|serotonin agents|mesh-ancestor
111412130|NCT05814640|Antidepressive Agents|antidepressive agents|mesh-ancestor
111412131|NCT05814640|Dopamine Agonists|dopamine agonists|mesh-ancestor
111412132|NCT05814640|Dopamine Agents|dopamine agents|mesh-ancestor
111412133|NCT05814640|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111412134|NCT05814640|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111412135|NCT05814640|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111412136|NCT05814640|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111412137|NCT05814640|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111412138|NCT05814640|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111412139|NCT05814640|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111412140|NCT05814640|Analgesics|analgesics|mesh-ancestor
111412141|NCT05814640|Sensory System Agents|sensory system agents|mesh-ancestor
111412142|NCT05814640|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111412143|NCT05814640|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111412144|NCT05814640|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111412145|NCT05814640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111412146|NCT05814640|Antimanic Agents|antimanic agents|mesh-ancestor
111412147|NCT05814640|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111412148|NCT05814640|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111412149|NCT05810597|Tirzepatide|tirzepatide|mesh-list
111412150|NCT05810597|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111412151|NCT05810597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111412152|NCT05810597|Incretins|incretins|mesh-ancestor
111412153|NCT05810597|Hormones|hormones|mesh-ancestor
111412154|NCT05810597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111412155|NCT05804162|Moxifloxacin|moxifloxacin|mesh-list
111412156|NCT05804162|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
111412158|NCT05804162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111412159|NCT05804162|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111412160|NCT05804162|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111412161|NCT05804162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111412162|NCT05804162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111412163|NCT05804162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111412164|NCT05804162|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111412165|NCT05804162|Contraceptive Agents|contraceptive agents|mesh-ancestor
111412166|NCT05804162|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111412167|NCT05804162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111412168|NCT05804162|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
111412169|NCT05804162|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111412170|NCT05804162|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111412171|NCT05804084|Acetazolamide|acetazolamide|mesh-list
111412172|NCT05804084|Anticonvulsants|anticonvulsants|mesh-ancestor
111412173|NCT05804084|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
111412174|NCT05804084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111412175|NCT05804084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111412176|NCT05804084|Diuretics|diuretics|mesh-ancestor
111412177|NCT05804084|Natriuretic Agents|natriuretic agents|mesh-ancestor
111412178|NCT05804084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111412179|NCT05803382|Capecitabine|capecitabine|mesh-list
111412180|NCT05803382|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111412181|NCT05803382|Antimetabolites|antimetabolites|mesh-ancestor
111412182|NCT05803382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111412183|NCT05803382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110507345|NCT02812992|Paclitaxel|paclitaxel|mesh-list
111412184|NCT05786547|Varenicline|varenicline|mesh-list
111412185|NCT05786547|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111412186|NCT05786547|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111412187|NCT05786547|Cholinergic Agents|cholinergic agents|mesh-ancestor
111412188|NCT05786547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111412189|NCT05786547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111412190|NCT05786547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111412191|NCT05771779|Vaccines|vaccines|mesh-list
111412192|NCT05771779|Immunologic Factors|immunologic factors|mesh-ancestor
111412193|NCT05771779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111412194|NCT05770531|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
111412195|NCT05770531|Immunoconjugates|immunoconjugates|mesh-ancestor
111412196|NCT05770531|Immunologic Factors|immunologic factors|mesh-ancestor
111412197|NCT05770531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111412198|NCT05765513|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111412199|NCT05761171|Cytarabine|cytarabine|mesh-list
111412200|NCT05761171|Prednisone|prednisone|mesh-list
111412201|NCT05761171|Prednisolone|prednisolone|mesh-list
111412202|NCT05761171|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111412203|NCT05761171|Methylprednisolone|methylprednisolone|mesh-list
111412204|NCT05761171|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111412205|NCT05761171|Prednisolone acetate|prednisolone acetate|mesh-list
111412206|NCT05761171|Hydrocortisone|hydrocortisone|mesh-list
110507513|NCT00861523|Histamine Agents|histamine agents|mesh-ancestor
111412207|NCT05761171|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
111412208|NCT05761171|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
111412209|NCT05761171|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
111412210|NCT05761171|Cortisone|cortisone|mesh-list
111412211|NCT05761171|Methotrexate|methotrexate|mesh-list
111412212|NCT05761171|Fludarabine|fludarabine|mesh-list
111412213|NCT05761171|Fludarabine phosphate|fludarabine phosphate|mesh-list
111412214|NCT05761171|Vincristine|vincristine|mesh-list
111412215|NCT05761171|Asparaginase|asparaginase|mesh-list
111412216|NCT05761171|Pegaspargase|pegaspargase|mesh-list
111412217|NCT05761171|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111412218|NCT05761171|Prednisolone phosphate|prednisolone phosphate|mesh-list
111412219|NCT05761171|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111412220|NCT05761171|Glucocorticoids|glucocorticoids|mesh-ancestor
111412221|NCT05761171|Hormones|hormones|mesh-ancestor
111412222|NCT05761171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110507604|NCT02807610|Anesthetics|anesthetics|mesh-ancestor
111412223|NCT05761171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111412224|NCT05761171|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111412225|NCT05761171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111412226|NCT05761171|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111412227|NCT05761171|Abortifacient Agents|abortifacient agents|mesh-ancestor
111412228|NCT05761171|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111412229|NCT05761171|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111412230|NCT05761171|Antimetabolites|antimetabolites|mesh-ancestor
111412231|NCT05761171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111412232|NCT05761171|Dermatologic Agents|dermatologic agents|mesh-ancestor
111412233|NCT05761171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111412234|NCT05761171|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111412235|NCT05761171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111412236|NCT05761171|Immunologic Factors|immunologic factors|mesh-ancestor
111412237|NCT05761171|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111412238|NCT05761171|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111412239|NCT05761171|Antiviral Agents|antiviral agents|mesh-ancestor
111412240|NCT05761171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111412241|NCT05761171|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111412242|NCT05761171|Tubulin Modulators|tubulin modulators|mesh-ancestor
111412243|NCT05761171|Antimitotic Agents|antimitotic agents|mesh-ancestor
111412244|NCT05761171|Mitosis Modulators|mitosis modulators|mesh-ancestor
111412245|NCT05761171|Antiemetics|antiemetics|mesh-ancestor
111412246|NCT05761171|Autonomic Agents|autonomic agents|mesh-ancestor
111412247|NCT05761171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111412248|NCT05761171|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111412249|NCT05761171|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111412250|NCT05761171|Protective Agents|protective agents|mesh-ancestor
111412251|NCT05759949|Fulvestrant|fulvestrant|mesh-list
111412252|NCT05759949|Palbociclib|palbociclib|mesh-list
111412253|NCT05759949|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111412254|NCT05759949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111412255|NCT05759949|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
111412256|NCT05759949|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111412257|NCT05759949|Hormone Antagonists|hormone antagonists|mesh-ancestor
111412258|NCT05759949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111412259|NCT05759949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111412260|NCT05759949|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111412261|NCT05759949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111412262|NCT05759949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111412263|NCT05758831|Rituximab|rituximab|mesh-list
111412264|NCT05758831|Ocrelizumab|ocrelizumab|mesh-list
110507842|NCT00957905|Antidotes|antidotes|mesh-ancestor
111412265|NCT05758831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111412266|NCT05758831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111412267|NCT05758831|Immunologic Factors|immunologic factors|mesh-ancestor
111412268|NCT05758831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111412269|NCT05758831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111412270|NCT05752916|Clopidogrel|clopidogrel|mesh-list
111412271|NCT05752916|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
111412272|NCT05752916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111412273|NCT05752916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111412274|NCT05752916|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111412275|NCT05752916|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111412276|NCT05752916|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111412277|NCT05752916|Purinergic Agents|purinergic agents|mesh-ancestor
111412278|NCT05752916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111412279|NCT05752409|Ketamine|ketamine|mesh-list
111412280|NCT05752409|Propofol|propofol|mesh-list
111412281|NCT05752409|Esketamine|esketamine|mesh-list
111412282|NCT05752409|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111412283|NCT05752409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111412284|NCT05752409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111412285|NCT05752409|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111412286|NCT05752409|Anesthetics, General|anesthetics, general|mesh-ancestor
111412287|NCT05752409|Anesthetics|anesthetics|mesh-ancestor
111412288|NCT05752409|Analgesics|analgesics|mesh-ancestor
111412289|NCT05752409|Sensory System Agents|sensory system agents|mesh-ancestor
111412290|NCT05752409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111412291|NCT05752409|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111412292|NCT05752409|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111412293|NCT05752409|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111412294|NCT05752409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111412295|NCT05752409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111412296|NCT05752409|Antidepressive Agents|antidepressive agents|mesh-ancestor
111412297|NCT05752409|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111412298|NCT05747794|Paclitaxel|paclitaxel|mesh-list
111412299|NCT05747794|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111412300|NCT05747794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111412301|NCT05747794|Tubulin Modulators|tubulin modulators|mesh-ancestor
111412302|NCT05747794|Antimitotic Agents|antimitotic agents|mesh-ancestor
111412303|NCT05747794|Mitosis Modulators|mitosis modulators|mesh-ancestor
111136700|NCT04858633|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111412304|NCT05747794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111412305|NCT05746819|Antipyretics|antipyretics|mesh-list
111412306|NCT05746819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111412307|NCT05746481|Carboplatin|carboplatin|mesh-list
111412308|NCT05746481|Pemetrexed|pemetrexed|mesh-list
111412309|NCT05746481|Atezolizumab|atezolizumab|mesh-list
111412310|NCT05746481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111412311|NCT05746481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111412312|NCT05746481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111412313|NCT05746481|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111412314|NCT05746481|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111412315|NCT05746481|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111412316|NCT05746481|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111412317|NCT05723562|Dostarlimab|dostarlimab|mesh-list
111412318|NCT05723562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111412319|NCT05721937|Abrocitinib|abrocitinib|mesh-list
111412320|NCT05721937|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111412321|NCT05721937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111412322|NCT05721937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111412323|NCT05715411|Methamphetamine|methamphetamine|mesh-list
111412324|NCT05715411|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111412325|NCT05715411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111412326|NCT05715411|Sympathomimetics|sympathomimetics|mesh-ancestor
111412327|NCT05715411|Autonomic Agents|autonomic agents|mesh-ancestor
111412328|NCT05715411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111412329|NCT05715411|Dopamine Agents|dopamine agents|mesh-ancestor
111412330|NCT05715411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111412331|NCT05715411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111412332|NCT05715411|Adrenergic Agents|adrenergic agents|mesh-ancestor
111412333|NCT05715411|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111412334|NCT05715411|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111412335|NCT05715411|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111412336|NCT05715411|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111412337|NCT05714384|Calcium|calcium|mesh-list
111412338|NCT05714384|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111412339|NCT05714384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111412340|NCT05713838|Durvalumab|durvalumab|mesh-list
111412341|NCT05713838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111412342|NCT05713838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111412343|NCT05696782|Durvalumab|durvalumab|mesh-list
111412344|NCT05696782|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111412345|NCT05696782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111412346|NCT05693766|Capecitabine|capecitabine|mesh-list
111412347|NCT05693766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111412348|NCT05693766|Antimetabolites|antimetabolites|mesh-ancestor
111412349|NCT05693766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111412350|NCT05693766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111412351|NCT05692960|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
111412352|NCT05692960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111412353|NCT05692960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111412354|NCT05687344|Nifedipine|nifedipine|mesh-list
111412355|NCT05687344|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111412356|NCT05687344|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111412357|NCT05687344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111412358|NCT05687344|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111412359|NCT05687344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110508689|NCT05465330|Anesthetics|anesthetics|mesh-ancestor
111412360|NCT05687344|Vasodilator Agents|vasodilator agents|mesh-ancestor
111412361|NCT05687344|Tocolytic Agents|tocolytic agents|mesh-ancestor
111412362|NCT05687344|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111412363|NCT05685719|Itraconazole|itraconazole|mesh-list
111412364|NCT05685719|Rifampin|rifampin|mesh-list
111412365|NCT05685719|Antifungal Agents|antifungal agents|mesh-ancestor
111412366|NCT05685719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111412367|NCT05685719|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111412368|NCT05685719|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111412369|NCT05685719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111412370|NCT05685719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111412371|NCT05685719|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111412372|NCT05685719|Hormone Antagonists|hormone antagonists|mesh-ancestor
111412373|NCT05685719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111412374|NCT05685719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111412375|NCT05685719|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111412376|NCT05685719|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111412377|NCT05685719|Antitubercular Agents|antitubercular agents|mesh-ancestor
111412378|NCT05685719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111412379|NCT05685719|Leprostatic Agents|leprostatic agents|mesh-ancestor
111412380|NCT05685719|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111412381|NCT05685719|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111412382|NCT05685719|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111412383|NCT05685719|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
111412384|NCT05685719|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
111412385|NCT05685719|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
111412386|NCT05685719|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111412387|NCT05676931|Docetaxel|docetaxel|mesh-list
111412388|NCT05676931|Quemliclustat|quemliclustat|mesh-list
111412389|NCT05676931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111412390|NCT05676931|Tubulin Modulators|tubulin modulators|mesh-ancestor
111412391|NCT05676931|Antimitotic Agents|antimitotic agents|mesh-ancestor
111412392|NCT05676931|Mitosis Modulators|mitosis modulators|mesh-ancestor
111412393|NCT05676931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111412394|NCT05676931|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111412395|NCT05676931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111412396|NCT05661955|Tislelizumab|tislelizumab|mesh-list
111412397|NCT05661955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111412398|NCT05661955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111412399|NCT05661669|Ketamine|ketamine|mesh-list
111412400|NCT05661669|Analgesics|analgesics|mesh-ancestor
111412401|NCT05661669|Sensory System Agents|sensory system agents|mesh-ancestor
111412402|NCT05661669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111412403|NCT05661669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111412404|NCT05661669|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111412405|NCT05661669|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111412406|NCT05661669|Anesthetics, General|anesthetics, general|mesh-ancestor
111412407|NCT05661669|Anesthetics|anesthetics|mesh-ancestor
111412408|NCT05661669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111412409|NCT05661669|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111412410|NCT05661669|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111412411|NCT05661669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111412412|NCT05661669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111412413|NCT05659381|Cisplatin|cisplatin|mesh-list
111412414|NCT05659381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111412415|NCT05657873|Immunomodulating Agents|immunomodulating agents|mesh-list
111412416|NCT05657873|Immunologic Factors|immunologic factors|mesh-ancestor
111412417|NCT05657873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111412418|NCT05653713|Lenograstim|lenograstim|mesh-list
111412419|NCT05653713|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111412420|NCT05653713|Immunologic Factors|immunologic factors|mesh-ancestor
111412421|NCT05653713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111412422|NCT05650879|Trastuzumab|trastuzumab|mesh-list
111412423|NCT05650879|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
111412424|NCT05650879|Maytansine|maytansine|mesh-list
111412425|NCT05650879|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
111412426|NCT05650879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111412427|NCT05650879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111412428|NCT05650879|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111412429|NCT05650879|Tubulin Modulators|tubulin modulators|mesh-ancestor
111412430|NCT05650879|Antimitotic Agents|antimitotic agents|mesh-ancestor
111412431|NCT05650879|Mitosis Modulators|mitosis modulators|mesh-ancestor
111412432|NCT05650879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111412433|NCT05650879|Immunotoxins|immunotoxins|mesh-ancestor
111412434|NCT05650879|Immunoconjugates|immunoconjugates|mesh-ancestor
111412435|NCT05650879|Immunologic Factors|immunologic factors|mesh-ancestor
111412436|NCT05650879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111412437|NCT05646082|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
111412438|NCT05646082|Dostarlimab|dostarlimab|mesh-list
111412439|NCT05646082|Antiviral Agents|antiviral agents|mesh-ancestor
111412440|NCT05646082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111412441|NCT05646082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111412442|NCT05645432|Pregnanolone|pregnanolone|mesh-list
111412443|NCT05645432|Brexanolone|brexanolone|mesh-list
111412444|NCT05645432|Anesthetics|anesthetics|mesh-ancestor
111412445|NCT05645432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110508983|NCT04512235|Cyclophosphamide|cyclophosphamide|mesh-list
111412446|NCT05645432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111412447|NCT05645432|Neurosteroids|neurosteroids|mesh-ancestor
111412448|NCT05645432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111412449|NCT05645432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111412450|NCT05645432|GABA Modulators|gaba modulators|mesh-ancestor
111412451|NCT05645432|GABA Agents|gaba agents|mesh-ancestor
111412452|NCT05644561|Ravulizumab|ravulizumab|mesh-list
111412453|NCT05644561|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
111412454|NCT05644561|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111412455|NCT05644561|Immunologic Factors|immunologic factors|mesh-ancestor
111412456|NCT05644561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111412457|NCT05641324|Dexamethasone|dexamethasone|mesh-list
111412458|NCT05641324|Lenalidomide|lenalidomide|mesh-list
111412459|NCT05641324|Daratumumab|daratumumab|mesh-list
111412460|NCT05641324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111412461|NCT05641324|Antiemetics|antiemetics|mesh-ancestor
111412462|NCT05641324|Autonomic Agents|autonomic agents|mesh-ancestor
111412463|NCT05641324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111412464|NCT05641324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111412465|NCT05641324|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111412466|NCT05641324|Glucocorticoids|glucocorticoids|mesh-ancestor
111412467|NCT05641324|Hormones|hormones|mesh-ancestor
111412468|NCT05641324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111412469|NCT05641324|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111412470|NCT05641324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111412471|NCT05641324|Immunologic Factors|immunologic factors|mesh-ancestor
111412472|NCT05641324|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111412473|NCT05641324|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111412474|NCT05641324|Growth Substances|growth substances|mesh-ancestor
111412475|NCT05641324|Growth Inhibitors|growth inhibitors|mesh-ancestor
111412476|NCT05634707|Temozolomide|temozolomide|mesh-list
111412477|NCT05634707|Fluoxetine|fluoxetine|mesh-list
111412478|NCT05634707|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111412479|NCT05634707|Alkylating Agents|alkylating agents|mesh-ancestor
111412480|NCT05634707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111412481|NCT05634707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111412482|NCT05634707|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111412483|NCT05634707|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111412484|NCT05634707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111412485|NCT05634707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111412486|NCT05634707|Serotonin Agents|serotonin agents|mesh-ancestor
111412487|NCT05634707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111412488|NCT05634707|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111412489|NCT05634707|Antidepressive Agents|antidepressive agents|mesh-ancestor
111412490|NCT05634707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111412491|NCT05634707|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111412492|NCT05634707|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111412493|NCT05634707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111412494|NCT05632133|Ibuprofen|ibuprofen|mesh-list
111412495|NCT05632133|Lacosamide|lacosamide|mesh-list
111412496|NCT05632133|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111412497|NCT05632133|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111412498|NCT05632133|Analgesics|analgesics|mesh-ancestor
111412499|NCT05632133|Sensory System Agents|sensory system agents|mesh-ancestor
111412500|NCT05632133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111412501|NCT05632133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111412502|NCT05632133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111412503|NCT05632133|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111412504|NCT05632133|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111412505|NCT05632133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111412506|NCT05632133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111412507|NCT05632133|Anticonvulsants|anticonvulsants|mesh-ancestor
111412508|NCT05632133|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111412509|NCT05632133|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111412510|NCT05632133|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111412511|NCT05621811|ATI 7505|ati 7505|mesh-list
111412512|NCT05621811|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
111412513|NCT05621811|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111412514|NCT05621811|Serotonin Agents|serotonin agents|mesh-ancestor
111412515|NCT05621811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111412516|NCT05621811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111412517|NCT05621811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111412518|NCT05618587|Lithium Carbonate|lithium carbonate|mesh-list
111412519|NCT05618587|Antidepressive Agents|antidepressive agents|mesh-ancestor
111412520|NCT05618587|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111412521|NCT05618587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111412522|NCT05618587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111412523|NCT05618587|Antimanic Agents|antimanic agents|mesh-ancestor
111136930|NCT04856137|Paclitaxel|paclitaxel|mesh-list
111412524|NCT05618587|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111412525|NCT05618587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111412526|NCT05618587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111412527|NCT05603429|Antioxidants|antioxidants|mesh-list
111412528|NCT05603429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111412529|NCT05603429|Protective Agents|protective agents|mesh-ancestor
111412530|NCT05603429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111412531|NCT05598905|Pregabalin|pregabalin|mesh-list
111412532|NCT05598905|Lacosamide|lacosamide|mesh-list
111412533|NCT05598905|Oxycodone|oxycodone|mesh-list
111412534|NCT05598905|Analgesics|analgesics|mesh-ancestor
111412535|NCT05598905|Sensory System Agents|sensory system agents|mesh-ancestor
111412536|NCT05598905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111412537|NCT05598905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111412538|NCT05598905|Anticonvulsants|anticonvulsants|mesh-ancestor
111412539|NCT05598905|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111412540|NCT05598905|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111412541|NCT05598905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111412542|NCT05598905|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111412543|NCT05598905|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111412544|NCT05598905|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111412545|NCT05598905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111412546|NCT05598905|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111412547|NCT05598905|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111412548|NCT05598905|Narcotics|narcotics|mesh-ancestor
111412549|NCT05598905|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111412550|NCT05598905|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111412551|NCT05586776|Chlorhexidine|chlorhexidine|mesh-list
111412552|NCT05586776|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
111412553|NCT05586776|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
111412554|NCT05586776|Mupirocin|mupirocin|mesh-list
111412555|NCT05586776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111412556|NCT05586776|Disinfectants|disinfectants|mesh-ancestor
111412557|NCT05586776|Dermatologic Agents|dermatologic agents|mesh-ancestor
111412558|NCT05586776|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111412559|NCT05586776|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111412560|NCT05586776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111412561|NCT05586776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111412562|NCT05584137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111412563|NCT05584137|Antibodies|antibodies|mesh-list
111412564|NCT05584137|Immunoglobulins|immunoglobulins|mesh-list
111412565|NCT05584137|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111412566|NCT05584137|Immunologic Factors|immunologic factors|mesh-ancestor
111412567|NCT05584137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111412568|NCT05584137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111412569|NCT05583552|Imetelstat|imetelstat|mesh-list
111412570|NCT05583552|Motesanib diphosphate|motesanib diphosphate|mesh-list
111412571|NCT05583552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111412572|NCT05583552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111412573|NCT05583552|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111412574|NCT05578872|Pembrolizumab|pembrolizumab|mesh-list
111412575|NCT05578872|Ipilimumab|ipilimumab|mesh-list
111412576|NCT05578872|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111412577|NCT05578872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111412578|NCT05578872|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111412579|NCT05578872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111412580|NCT05576207|Micronutrients|micronutrients|mesh-list
111412581|NCT05576207|Trace Elements|trace elements|mesh-list
111412582|NCT05576207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111412583|NCT05557591|Cemiplimab|cemiplimab|mesh-list
111412584|NCT05557591|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111412585|NCT05557591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111412586|NCT05555732|Carboplatin|carboplatin|mesh-list
111412587|NCT05555732|Pembrolizumab|pembrolizumab|mesh-list
111412588|NCT05555732|Pemetrexed|pemetrexed|mesh-list
111412589|NCT05555732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111412590|NCT05555732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111412591|NCT05555732|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111412592|NCT05555732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111412593|NCT05555732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111412594|NCT05555732|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111412595|NCT05555732|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111412596|NCT05543850|Pancrelipase|pancrelipase|mesh-list
111412597|NCT05543850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111412598|NCT05539989|Vaccines|vaccines|mesh-list
111412599|NCT05539989|BCG Vaccine|bcg vaccine|mesh-list
111412600|NCT05539989|Immunologic Factors|immunologic factors|mesh-ancestor
111412601|NCT05539989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111412602|NCT05539989|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111412603|NCT05529147|Antihypertensive Agents|antihypertensive agents|mesh-list
111412604|NCT05526690|Metformin|metformin|mesh-list
111412605|NCT05526690|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111412606|NCT05526690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111412607|NCT05526430|Harmine|harmine|mesh-list
111412608|NCT05526430|Hallucinogens|hallucinogens|mesh-ancestor
111412609|NCT05526430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111412610|NCT05526430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111412611|NCT05526430|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
111412612|NCT05526430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111412613|NCT05526430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111412614|NCT05522673|Rolipram|rolipram|mesh-list
111412615|NCT05522673|Antidepressive Agents|antidepressive agents|mesh-ancestor
111412616|NCT05522673|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111412617|NCT05522673|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
111412618|NCT05522673|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111412619|NCT05522673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111412620|NCT05522673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111412621|NCT05521048|Doxycycline|doxycycline|mesh-list
111412622|NCT05521048|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111412623|NCT05521048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111412624|NCT05521048|Antimalarials|antimalarials|mesh-ancestor
111412625|NCT05521048|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111412626|NCT05521048|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111412627|NCT05520138|Abiraterone Acetate|abiraterone acetate|mesh-list
111412628|NCT05520138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111412629|NCT05520138|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111412630|NCT05520138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111412631|NCT05520138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111412632|NCT05520138|Hormone Antagonists|hormone antagonists|mesh-ancestor
111412633|NCT05520138|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110509059|NCT04373707|Nadroparin|nadroparin|mesh-list
111412634|NCT05520138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111412635|NCT05520138|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111412636|NCT05516849|Oxandrolone|oxandrolone|mesh-list
111412637|NCT05516849|Androgens|androgens|mesh-ancestor
111412638|NCT05516849|Hormones|hormones|mesh-ancestor
111412639|NCT05516849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111412640|NCT05516849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111412641|NCT05516849|Anabolic Agents|anabolic agents|mesh-ancestor
111412642|NCT05510427|Bevacizumab|bevacizumab|mesh-list
111412643|NCT05510427|Atezolizumab|atezolizumab|mesh-list
111412644|NCT05510427|Infigratinib|infigratinib|mesh-list
111412645|NCT05510427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111412646|NCT05510427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111412647|NCT05510427|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111412648|NCT05510427|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111412649|NCT05510427|Growth Substances|growth substances|mesh-ancestor
111412650|NCT05510427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111412651|NCT05510427|Growth Inhibitors|growth inhibitors|mesh-ancestor
111412652|NCT05510427|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111412653|NCT05510427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111412654|NCT05505292|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111412655|NCT05505292|Lifitegrast|lifitegrast|mesh-list
111412656|NCT05505292|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111412657|NCT05497726|Bevacizumab|bevacizumab|mesh-list
111412658|NCT05497726|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111412659|NCT05497726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111412660|NCT05497726|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111412661|NCT05497726|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111412662|NCT05497726|Growth Substances|growth substances|mesh-ancestor
111412663|NCT05497726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111412664|NCT05497726|Growth Inhibitors|growth inhibitors|mesh-ancestor
111412665|NCT05493501|Paclitaxel|paclitaxel|mesh-list
111412666|NCT05493501|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111412667|NCT05493501|Carboplatin|carboplatin|mesh-list
111412668|NCT05493501|Gemcitabine|gemcitabine|mesh-list
111412669|NCT05493501|Pemetrexed|pemetrexed|mesh-list
111412670|NCT05493501|Osimertinib|osimertinib|mesh-list
111412671|NCT05493501|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111412672|NCT05493501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111412673|NCT05493501|Tubulin Modulators|tubulin modulators|mesh-ancestor
111412674|NCT05493501|Antimitotic Agents|antimitotic agents|mesh-ancestor
111137076|NCT03040531|Hormones|hormones|mesh-ancestor
111412675|NCT05493501|Mitosis Modulators|mitosis modulators|mesh-ancestor
111412676|NCT05493501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111412677|NCT05493501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111412678|NCT05493501|Antimetabolites|antimetabolites|mesh-ancestor
111412679|NCT05493501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111412680|NCT05493501|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111412681|NCT05493501|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111412682|NCT05493501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111412683|NCT05486416|Propofol|propofol|mesh-list
111412684|NCT05486416|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111412685|NCT05486416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111412686|NCT05486416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111412687|NCT05486416|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111412688|NCT05486416|Anesthetics, General|anesthetics, general|mesh-ancestor
111412689|NCT05486416|Anesthetics|anesthetics|mesh-ancestor
111412690|NCT05478499|Deucravacitinib|deucravacitinib|mesh-list
111412691|NCT05478499|Dermatologic Agents|dermatologic agents|mesh-ancestor
111412692|NCT05478499|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111412693|NCT05478499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111412694|NCT05478499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111412695|NCT05478278|Moxifloxacin|moxifloxacin|mesh-list
111412696|NCT05478278|Psilocybin|psilocybin|mesh-list
111412697|NCT05478278|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111412698|NCT05478278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111412699|NCT05478278|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111412700|NCT05478278|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111412701|NCT05478278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111412702|NCT05478278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111412703|NCT05478278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110509065|NCT04335383|Antibodies|antibodies|mesh-list
111412704|NCT05478278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111412705|NCT05478278|Hallucinogens|hallucinogens|mesh-ancestor
111412706|NCT05478278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111412707|NCT05478174|Propofol|propofol|mesh-list
111412708|NCT05478174|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111412709|NCT05478174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111412710|NCT05478174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111412711|NCT05478174|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111412712|NCT05478174|Anesthetics, General|anesthetics, general|mesh-ancestor
111412713|NCT05478174|Anesthetics|anesthetics|mesh-ancestor
111412714|NCT05476094|Polyene phosphatidylcholine|polyene phosphatidylcholine|mesh-list
111412715|NCT05476094|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111412716|NCT05476094|Antimetabolites|antimetabolites|mesh-ancestor
111412717|NCT05476094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111412718|NCT05476094|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111412719|NCT05475210|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111412720|NCT05475210|(177)Lu-DOTA-EB-TATE|(177)lu-dota-eb-tate|mesh-list
111412721|NCT05475210|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111412722|NCT05475210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111412723|NCT05470283|Cyclophosphamide|cyclophosphamide|mesh-list
111412724|NCT05470283|Fludarabine|fludarabine|mesh-list
111412725|NCT05470283|Fludarabine phosphate|fludarabine phosphate|mesh-list
111412726|NCT05470283|Furosemide|furosemide|mesh-list
111412727|NCT05470283|Acetazolamide|acetazolamide|mesh-list
111412728|NCT05470283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111412729|NCT05470283|Immunologic Factors|immunologic factors|mesh-ancestor
111412730|NCT05470283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111412731|NCT05470283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111412732|NCT05470283|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111412733|NCT05470283|Alkylating Agents|alkylating agents|mesh-ancestor
111412734|NCT05470283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111412735|NCT05470283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111412736|NCT05470283|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111412737|NCT05470283|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111412738|NCT05470283|Antimetabolites|antimetabolites|mesh-ancestor
111412739|NCT05470283|Diuretics|diuretics|mesh-ancestor
111412740|NCT05470283|Natriuretic Agents|natriuretic agents|mesh-ancestor
111412741|NCT05470283|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
111412742|NCT05470283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111412743|NCT05470283|Anticonvulsants|anticonvulsants|mesh-ancestor
111412744|NCT05470283|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
111412745|NCT05470283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111412746|NCT05468203|Dapagliflozin|dapagliflozin|mesh-list
111412747|NCT05468203|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
111412748|NCT05468203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111412749|NCT05468203|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111412750|NCT05468203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111412751|NCT05461755|Tretinoin|tretinoin|mesh-list
111412752|NCT05461755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111412753|NCT05461755|Keratolytic Agents|keratolytic agents|mesh-ancestor
111412754|NCT05461755|Dermatologic Agents|dermatologic agents|mesh-ancestor
111412755|NCT05456256|Carboplatin|carboplatin|mesh-list
111412756|NCT05456256|Pemetrexed|pemetrexed|mesh-list
111412757|NCT05456256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111412758|NCT05456256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111412759|NCT05456256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111412760|NCT05456256|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111412761|NCT05456256|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111412762|NCT05453396|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
111412763|NCT05453396|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111412764|NCT05453396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111412765|NCT05451849|Cyclophosphamide|cyclophosphamide|mesh-list
111412766|NCT05451849|Fludarabine|fludarabine|mesh-list
111412767|NCT05451849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111412768|NCT05451849|Immunologic Factors|immunologic factors|mesh-ancestor
111412769|NCT05451849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111412770|NCT05451849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111412771|NCT05451849|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111412772|NCT05451849|Alkylating Agents|alkylating agents|mesh-ancestor
111412773|NCT05451849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111412774|NCT05451849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111412775|NCT05451849|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111412776|NCT05450965|Onvansertib|onvansertib|mesh-list
111412777|NCT05450965|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111412778|NCT05450965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111412779|NCT05450965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111412780|NCT05444582|Levonorgestrel|levonorgestrel|mesh-list
111412781|NCT05444582|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111412782|NCT05444582|Contraceptive Agents|contraceptive agents|mesh-ancestor
111412783|NCT05444582|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111412784|NCT05444582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111412785|NCT05444582|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111412786|NCT05444582|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111412787|NCT05444582|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111412788|NCT05442034|Mitogens|mitogens|mesh-list
111412789|NCT05442034|Mitosis Modulators|mitosis modulators|mesh-ancestor
111412790|NCT05442034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111412791|NCT05427981|Buprenorphine|buprenorphine|mesh-list
111412792|NCT05427981|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111412793|NCT05427981|Narcotics|narcotics|mesh-ancestor
111412794|NCT05427981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111412795|NCT05427981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111412796|NCT05427981|Analgesics|analgesics|mesh-ancestor
111412797|NCT05427981|Sensory System Agents|sensory system agents|mesh-ancestor
111412798|NCT05427981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111412799|NCT05427981|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111412800|NCT05425875|Dimercaprol|dimercaprol|mesh-list
111412801|NCT05425875|Chelating Agents|chelating agents|mesh-ancestor
111412802|NCT05425875|Sequestering Agents|sequestering agents|mesh-ancestor
111412803|NCT05425875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111412804|NCT05419011|Vaccines|vaccines|mesh-list
111412805|NCT05419011|Immunologic Factors|immunologic factors|mesh-ancestor
111412806|NCT05419011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111412807|NCT05414240|Ibudilast|ibudilast|mesh-list
111412808|NCT05414240|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111412809|NCT05414240|Autonomic Agents|autonomic agents|mesh-ancestor
111412810|NCT05414240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111412811|NCT05414240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111412812|NCT05414240|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111412813|NCT05414240|Respiratory System Agents|respiratory system agents|mesh-ancestor
111412814|NCT05414240|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111412815|NCT05414240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111412816|NCT05414240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111412817|NCT05414240|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111412818|NCT05414240|Vasodilator Agents|vasodilator agents|mesh-ancestor
111412819|NCT05401227|Ketamine|ketamine|mesh-list
111412820|NCT05401227|Analgesics|analgesics|mesh-ancestor
111412821|NCT05401227|Sensory System Agents|sensory system agents|mesh-ancestor
111412822|NCT05401227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111412823|NCT05401227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111412824|NCT05401227|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111412825|NCT05401227|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111412826|NCT05401227|Anesthetics, General|anesthetics, general|mesh-ancestor
111412827|NCT05401227|Anesthetics|anesthetics|mesh-ancestor
111412828|NCT05401227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111412829|NCT05401227|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111412830|NCT05401227|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111412831|NCT05401227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111412832|NCT05401227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111412833|NCT05398653|Cyclosporine|cyclosporine|mesh-list
111412834|NCT05398653|Cyclosporins|cyclosporins|mesh-list
111412835|NCT05398653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111412836|NCT05398653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111412837|NCT05398653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111412838|NCT05398653|Immunologic Factors|immunologic factors|mesh-ancestor
111412839|NCT05398653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111412840|NCT05398653|Antifungal Agents|antifungal agents|mesh-ancestor
111412841|NCT05398653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111412842|NCT05398653|Dermatologic Agents|dermatologic agents|mesh-ancestor
111412843|NCT05398653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111412844|NCT05398653|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111412845|NCT05397639|1-((2-bromophenyl)sulfonyl)-5-methoxy-3-((4-methyl-1-piperazinyl)methyl)-1H-indole dimesylate monohydrate|1-((2-bromophenyl)sulfonyl)-5-methoxy-3-((4-methyl-1-piperazinyl)methyl)-1h-indole dimesylate monohydrate|mesh-list
111412846|NCT05397639|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111412847|NCT05397639|Serotonin Agents|serotonin agents|mesh-ancestor
111412848|NCT05397639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111412849|NCT05397639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111412850|NCT05397639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111412852|NCT05378555|Analgesics|analgesics|mesh-ancestor
111412853|NCT05378555|Sensory System Agents|sensory system agents|mesh-ancestor
111412854|NCT05378555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111412855|NCT05378555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111412856|NCT05378555|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111412857|NCT05378555|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111412858|NCT05378555|Anesthetics, General|anesthetics, general|mesh-ancestor
111412859|NCT05378555|Anesthetics|anesthetics|mesh-ancestor
111412860|NCT05378555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111412861|NCT05378555|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111412862|NCT05378555|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111412863|NCT05378555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111412864|NCT05378555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111412865|NCT05361395|Carboplatin|carboplatin|mesh-list
111412866|NCT05361395|Etoposide|etoposide|mesh-list
111412867|NCT05361395|Atezolizumab|atezolizumab|mesh-list
111412868|NCT05361395|Durvalumab|durvalumab|mesh-list
111412869|NCT05361395|AMG 757|amg 757|mesh-list
111412870|NCT05361395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111412871|NCT05361395|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111412872|NCT05361395|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111412873|NCT05361395|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111412874|NCT05361395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111412875|NCT05361395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111412876|NCT05361395|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111412877|NCT05361395|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111412878|NCT05344469|Interferons|interferons|mesh-list
111412879|NCT05344469|Interferon-beta|interferon-beta|mesh-list
111412880|NCT05344469|Ofatumumab|ofatumumab|mesh-list
111412881|NCT05344469|Glatiramer Acetate|glatiramer acetate|mesh-list
111412882|NCT05344469|(T,G)-A-L|(t,g)-a-l|mesh-list
111412883|NCT05344469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111412884|NCT05344469|Antiviral Agents|antiviral agents|mesh-ancestor
111412885|NCT05344469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111412886|NCT05344469|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111412887|NCT05344469|Immunologic Factors|immunologic factors|mesh-ancestor
111412888|NCT05344469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111412889|NCT05344469|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111412890|NCT05344469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111412891|NCT05337137|Bevacizumab|bevacizumab|mesh-list
111412892|NCT05337137|Nivolumab|nivolumab|mesh-list
111412893|NCT05337137|Relatlimab|relatlimab|mesh-list
111412894|NCT05337137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111412895|NCT05337137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111412896|NCT05337137|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111412897|NCT05337137|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111412898|NCT05337137|Growth Substances|growth substances|mesh-ancestor
111412899|NCT05337137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111412900|NCT05337137|Growth Inhibitors|growth inhibitors|mesh-ancestor
111412901|NCT05337137|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111412902|NCT05337137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111412903|NCT05329766|Leucovorin|leucovorin|mesh-list
111412904|NCT05329766|Fluorouracil|fluorouracil|mesh-list
111412905|NCT05329766|Oxaliplatin|oxaliplatin|mesh-list
111412906|NCT05329766|Quemliclustat|quemliclustat|mesh-list
111412907|NCT05329766|Antimetabolites|antimetabolites|mesh-ancestor
111412908|NCT05329766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111412909|NCT05329766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111412910|NCT05329766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111412911|NCT05329766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111412912|NCT05329766|Immunologic Factors|immunologic factors|mesh-ancestor
111412913|NCT05329766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111412914|NCT05329766|Antidotes|antidotes|mesh-ancestor
111412915|NCT05329766|Protective Agents|protective agents|mesh-ancestor
111412916|NCT05329766|Vitamin B Complex|vitamin b complex|mesh-ancestor
111412917|NCT05329766|Vitamins|vitamins|mesh-ancestor
111412918|NCT05329766|Micronutrients|micronutrients|mesh-ancestor
111412919|NCT05329766|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111412920|NCT05329766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111412921|NCT05324852|Midazolam|midazolam|mesh-list
111412922|NCT05324852|Loxapine|loxapine|mesh-list
111412923|NCT05324852|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111412924|NCT05324852|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111412925|NCT05324852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111412926|NCT05324852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111412927|NCT05324852|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111412928|NCT05324852|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111412929|NCT05324852|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111412930|NCT05324852|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111412931|NCT05324852|Anesthetics, General|anesthetics, general|mesh-ancestor
111412932|NCT05324852|Anesthetics|anesthetics|mesh-ancestor
111412933|NCT05324852|GABA Modulators|gaba modulators|mesh-ancestor
111412934|NCT05324852|GABA Agents|gaba agents|mesh-ancestor
111412935|NCT05324852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111412936|NCT05324852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111412937|NCT05324852|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111412938|NCT05324852|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111412939|NCT05324852|Dopamine Agents|dopamine agents|mesh-ancestor
111412940|NCT05321420|Pirfenidone|pirfenidone|mesh-list
111412941|NCT05321420|Analgesics|analgesics|mesh-ancestor
111412942|NCT05321420|Sensory System Agents|sensory system agents|mesh-ancestor
111412943|NCT05321420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111412944|NCT05321420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111412945|NCT05321420|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111412946|NCT05321420|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111412947|NCT05321420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111412948|NCT05321420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111412949|NCT05321420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111412950|NCT05319756|Oxycodone|oxycodone|mesh-list
111412951|NCT05319756|Gabapentin|gabapentin|mesh-list
111412952|NCT05319756|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111412953|NCT05319756|Narcotics|narcotics|mesh-ancestor
111412954|NCT05319756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111412955|NCT05319756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111412956|NCT05319756|Analgesics|analgesics|mesh-ancestor
111412957|NCT05319756|Sensory System Agents|sensory system agents|mesh-ancestor
111412958|NCT05319756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111412959|NCT05319756|Anticonvulsants|anticonvulsants|mesh-ancestor
111412960|NCT05319756|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111412961|NCT05319756|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111412962|NCT05319756|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111412963|NCT05319756|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111412964|NCT05319756|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111412965|NCT05319756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111412966|NCT05319756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111412967|NCT05319756|Antimanic Agents|antimanic agents|mesh-ancestor
111412968|NCT05315648|Anesthetics|anesthetics|mesh-list
111412969|NCT05315648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111412970|NCT05315648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111412971|NCT05308901|Pembrolizumab|pembrolizumab|mesh-list
111412972|NCT05308901|Lenvatinib|lenvatinib|mesh-list
111412973|NCT05308901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111412974|NCT05308901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111412975|NCT05308901|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111412976|NCT05308901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111412977|NCT05308901|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111412978|NCT05308901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111412979|NCT05305105|Psilocybin|psilocybin|mesh-list
111412980|NCT05305105|Hallucinogens|hallucinogens|mesh-ancestor
111412981|NCT05305105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111412982|NCT05305105|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111412983|NCT05301608|Psilocybin|psilocybin|mesh-list
111412984|NCT05301608|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
111412985|NCT05301608|Hallucinogens|hallucinogens|mesh-ancestor
111412986|NCT05301608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111412987|NCT05301608|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111412988|NCT05301608|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111412989|NCT05301608|Serotonin Agents|serotonin agents|mesh-ancestor
110509163|NCT03709706|Pembrolizumab|pembrolizumab|mesh-list
111412990|NCT05301608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111412991|NCT05301608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111412992|NCT05301608|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111412993|NCT05301361|Methylphenidate|methylphenidate|mesh-list
111412994|NCT05301361|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111412995|NCT05301361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111412996|NCT05301361|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111412997|NCT05301361|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111412998|NCT05301361|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111412999|NCT05301361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111413000|NCT05301361|Dopamine Agents|dopamine agents|mesh-ancestor
111413001|NCT05301361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111413002|NCT05300035|Antibodies|antibodies|mesh-list
111413003|NCT05300035|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111413004|NCT05300035|Immunologic Factors|immunologic factors|mesh-ancestor
111413005|NCT05300035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111413006|NCT05290090|Rituximab|rituximab|mesh-list
111413007|NCT05290090|Lenalidomide|lenalidomide|mesh-list
111413008|NCT05290090|Zanubrutinib|zanubrutinib|mesh-list
111413009|NCT05290090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111413010|NCT05290090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111413011|NCT05290090|Immunologic Factors|immunologic factors|mesh-ancestor
111413012|NCT05290090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111413013|NCT05290090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111413014|NCT05290090|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111413015|NCT05290090|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111413016|NCT05290090|Growth Substances|growth substances|mesh-ancestor
111413017|NCT05290090|Growth Inhibitors|growth inhibitors|mesh-ancestor
111413018|NCT05290090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111413019|NCT05290090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111413020|NCT05290090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111413021|NCT05280340|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
111413022|NCT05280340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111413023|NCT05279898|Dexmedetomidine|dexmedetomidine|mesh-list
111413024|NCT05279898|Ketamine|ketamine|mesh-list
111413025|NCT05279898|Remifentanil|remifentanil|mesh-list
111413026|NCT05279898|Propofol|propofol|mesh-list
111413027|NCT05279898|Ropivacaine|ropivacaine|mesh-list
111413028|NCT05279898|Rocuronium|rocuronium|mesh-list
111413029|NCT05279898|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111413030|NCT05279898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111413031|NCT05279898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111413032|NCT05279898|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111413033|NCT05279898|Analgesics|analgesics|mesh-ancestor
111413034|NCT05279898|Sensory System Agents|sensory system agents|mesh-ancestor
111413035|NCT05279898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111413036|NCT05279898|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111413037|NCT05279898|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111413038|NCT05279898|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111413039|NCT05279898|Adrenergic Agents|adrenergic agents|mesh-ancestor
111413040|NCT05279898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111413041|NCT05279898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111413042|NCT05279898|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111413043|NCT05279898|Anesthetics, General|anesthetics, general|mesh-ancestor
111413044|NCT05279898|Anesthetics|anesthetics|mesh-ancestor
111413045|NCT05279898|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111413046|NCT05279898|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111413047|NCT05279898|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111413048|NCT05279898|Anesthetics, Local|anesthetics, local|mesh-ancestor
111413049|NCT05279898|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111413050|NCT05279898|Narcotics|narcotics|mesh-ancestor
111413051|NCT05279898|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
111413052|NCT05279898|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
111413053|NCT05279898|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111413054|NCT05277051|Dostarlimab|dostarlimab|mesh-list
111413055|NCT05277051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111413056|NCT05273567|Guanfacine|guanfacine|mesh-list
111413057|NCT05273567|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111413058|NCT05273567|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111413059|NCT05273567|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111413060|NCT05273567|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111413061|NCT05273567|Adrenergic Agents|adrenergic agents|mesh-ancestor
110509190|NCT03555188|Ondansetron|ondansetron|mesh-list
111413062|NCT05273567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111413063|NCT05273567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111413064|NCT05273567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111413065|NCT05266729|Polyene phosphatidylcholine|polyene phosphatidylcholine|mesh-list
111413066|NCT05266729|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111413067|NCT05266729|Antimetabolites|antimetabolites|mesh-ancestor
111413068|NCT05266729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111413069|NCT05266729|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111413070|NCT05257083|Dexamethasone|dexamethasone|mesh-list
111413071|NCT05257083|Cyclophosphamide|cyclophosphamide|mesh-list
111413072|NCT05257083|Fludarabine|fludarabine|mesh-list
111413073|NCT05257083|Lenalidomide|lenalidomide|mesh-list
111413074|NCT05257083|Bortezomib|bortezomib|mesh-list
111413075|NCT05257083|Daratumumab|daratumumab|mesh-list
111413076|NCT05257083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111413077|NCT05257083|Immunologic Factors|immunologic factors|mesh-ancestor
111413078|NCT05257083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111413079|NCT05257083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111413080|NCT05257083|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111413081|NCT05257083|Alkylating Agents|alkylating agents|mesh-ancestor
111413082|NCT05257083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111413083|NCT05257083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111413084|NCT05257083|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111413085|NCT05257083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111413086|NCT05257083|Antiemetics|antiemetics|mesh-ancestor
111413087|NCT05257083|Autonomic Agents|autonomic agents|mesh-ancestor
111413088|NCT05257083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111413089|NCT05257083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111413090|NCT05257083|Glucocorticoids|glucocorticoids|mesh-ancestor
111413091|NCT05257083|Hormones|hormones|mesh-ancestor
111413092|NCT05257083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111413093|NCT05257083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111413094|NCT05257083|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111413095|NCT05257083|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111413096|NCT05257083|Growth Substances|growth substances|mesh-ancestor
111413097|NCT05257083|Growth Inhibitors|growth inhibitors|mesh-ancestor
111413098|NCT05257018|Doxorubicin|doxorubicin|mesh-list
111413099|NCT05257018|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111413100|NCT05257018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111413101|NCT05257018|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111413102|NCT05257018|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111413103|NCT05257018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111413104|NCT05257018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111413105|NCT05255991|Treprostinil|treprostinil|mesh-list
111413106|NCT05255991|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111413107|NCT05254171|Paclitaxel|paclitaxel|mesh-list
111413108|NCT05254171|Gemcitabine|gemcitabine|mesh-list
111413109|NCT05254171|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111413110|NCT05254171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111413111|NCT05254171|Tubulin Modulators|tubulin modulators|mesh-ancestor
111413112|NCT05254171|Antimitotic Agents|antimitotic agents|mesh-ancestor
111413113|NCT05254171|Mitosis Modulators|mitosis modulators|mesh-ancestor
111413114|NCT05254171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111413115|NCT05254171|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111413116|NCT05254171|Antimetabolites|antimetabolites|mesh-ancestor
111413117|NCT05249426|Cetuximab|cetuximab|mesh-list
111413118|NCT05249426|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111413119|NCT05249426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111413120|NCT05243862|Atezolizumab|atezolizumab|mesh-list
111413121|NCT05243862|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111413122|NCT05243862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111413123|NCT05243862|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111413124|NCT05243862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111413125|NCT05233098|Technetium Tc 99m Aggregated Albumin|technetium tc 99m aggregated albumin|mesh-list
111413126|NCT05233098|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111413127|NCT05233098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111413128|NCT05223816|Nivolumab|nivolumab|mesh-list
111413129|NCT05223816|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111413130|NCT05223816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111413131|NCT05223816|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111413132|NCT05223816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111413133|NCT05216250|Botulinum Toxins|botulinum toxins|mesh-list
111413134|NCT05216250|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111413135|NCT05216250|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111413136|NCT05216250|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111413137|NCT05216250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111413138|NCT05216250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111413139|NCT05216250|Cholinergic Agents|cholinergic agents|mesh-ancestor
111413140|NCT05216250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111413141|NCT05216250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111413142|NCT05216250|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111413143|NCT05216250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111413144|NCT05211336|Prednisone|prednisone|mesh-list
111413145|NCT05211336|Lenalidomide|lenalidomide|mesh-list
111413146|NCT05211336|Venetoclax|venetoclax|mesh-list
111413147|NCT05211336|Obinutuzumab|obinutuzumab|mesh-list
111413148|NCT05211336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111413149|NCT05211336|Glucocorticoids|glucocorticoids|mesh-ancestor
111413150|NCT05211336|Hormones|hormones|mesh-ancestor
111413151|NCT05211336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111413152|NCT05211336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111413153|NCT05211336|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111413154|NCT05211336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111413155|NCT05211336|Immunologic Factors|immunologic factors|mesh-ancestor
111413156|NCT05211336|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111413157|NCT05211336|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111413158|NCT05211336|Growth Substances|growth substances|mesh-ancestor
111413159|NCT05211336|Growth Inhibitors|growth inhibitors|mesh-ancestor
111413160|NCT05211336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111413161|NCT05197426|Azacitidine|azacitidine|mesh-list
111413162|NCT05197426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111413163|NCT05197426|Antimetabolites|antimetabolites|mesh-ancestor
111413164|NCT05197426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111413165|NCT05197426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111413166|NCT05197426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111413167|NCT05186779|Progestins|progestins|mesh-list
111413168|NCT05186779|Hormones|hormones|mesh-ancestor
111413169|NCT05186779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111413170|NCT05186779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111413171|NCT05180825|Trametinib|trametinib|mesh-list
111413172|NCT05180825|Vinblastine|vinblastine|mesh-list
111413173|NCT05180825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111413174|NCT05180825|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111413175|NCT05180825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111413176|NCT05180825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111413177|NCT05180825|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111413178|NCT05180825|Tubulin Modulators|tubulin modulators|mesh-ancestor
111413179|NCT05180825|Antimitotic Agents|antimitotic agents|mesh-ancestor
111413180|NCT05180825|Mitosis Modulators|mitosis modulators|mesh-ancestor
111413181|NCT05179356|Dapagliflozin|dapagliflozin|mesh-list
111413182|NCT05179356|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111413183|NCT05179356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111413184|NCT05179356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111413185|NCT05179356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111413186|NCT05177146|Ketamine|ketamine|mesh-list
111413187|NCT05177146|Analgesics|analgesics|mesh-ancestor
111413188|NCT05177146|Sensory System Agents|sensory system agents|mesh-ancestor
111413189|NCT05177146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111413190|NCT05177146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111413191|NCT05177146|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111413192|NCT05177146|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111413193|NCT05177146|Anesthetics, General|anesthetics, general|mesh-ancestor
111413194|NCT05177146|Anesthetics|anesthetics|mesh-ancestor
111413195|NCT05177146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111413196|NCT05177146|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111413197|NCT05177146|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111413198|NCT05177146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110509197|NCT03555188|Dermatologic Agents|dermatologic agents|mesh-ancestor
111413199|NCT05177146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111413200|NCT05166421|Cilgavimab and tixagevimab drug combination|cilgavimab and tixagevimab drug combination|mesh-list
111413201|NCT05166421|Antiviral Agents|antiviral agents|mesh-ancestor
111413202|NCT05166421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111413203|NCT05156788|Lenvatinib|lenvatinib|mesh-list
111413204|NCT05156788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111413205|NCT05156788|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111413206|NCT05156788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111413207|NCT05156788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111413208|NCT05156268|Pembrolizumab|pembrolizumab|mesh-list
111413209|NCT05156268|Olaparib|olaparib|mesh-list
111413210|NCT05156268|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111413211|NCT05156268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111413212|NCT05156268|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111413213|NCT05156268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111413214|NCT05156268|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111413215|NCT05156268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111413216|NCT05154487|Fulvestrant|fulvestrant|mesh-list
111413217|NCT05154487|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111413218|NCT05154487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111413219|NCT05154487|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
111413220|NCT05154487|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111413221|NCT05154487|Hormone Antagonists|hormone antagonists|mesh-ancestor
111413222|NCT05154487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111413223|NCT05154487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111413224|NCT05154136|Itraconazole|itraconazole|mesh-list
111413225|NCT05154136|Antifungal Agents|antifungal agents|mesh-ancestor
111413226|NCT05154136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111413227|NCT05154136|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111413228|NCT05154136|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111413229|NCT05154136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111413230|NCT05154136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111413231|NCT05154136|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111413232|NCT05154136|Hormone Antagonists|hormone antagonists|mesh-ancestor
111413233|NCT05154136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111413234|NCT05154136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111413235|NCT05154136|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111413236|NCT05152576|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111413237|NCT05152576|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111413238|NCT05152576|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111413239|NCT05152576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111413240|NCT05152576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111413241|NCT05152576|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111413242|NCT05152576|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111413243|NCT05152576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111413244|NCT05152576|Cholinergic Agents|cholinergic agents|mesh-ancestor
111413245|NCT05152576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111413246|NCT05152147|Fluorouracil|fluorouracil|mesh-list
111413247|NCT05152147|Capecitabine|capecitabine|mesh-list
111413248|NCT05152147|Oxaliplatin|oxaliplatin|mesh-list
111413249|NCT05152147|Trastuzumab|trastuzumab|mesh-list
111413250|NCT05152147|Tislelizumab|tislelizumab|mesh-list
111413251|NCT05152147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111413252|NCT05152147|Antimetabolites|antimetabolites|mesh-ancestor
111413253|NCT05152147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111413254|NCT05152147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111413255|NCT05152147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111413256|NCT05152147|Immunologic Factors|immunologic factors|mesh-ancestor
110509203|NCT03547115|Venetoclax|venetoclax|mesh-list
111413257|NCT05152147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111413258|NCT05152147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111413259|NCT05147805|Treprostinil|treprostinil|mesh-list
111413260|NCT05147805|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111413261|NCT05142189|Docetaxel|docetaxel|mesh-list
111413262|NCT05142189|Cemiplimab|cemiplimab|mesh-list
111413263|NCT05142189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111413264|NCT05142189|Tubulin Modulators|tubulin modulators|mesh-ancestor
111413265|NCT05142189|Antimitotic Agents|antimitotic agents|mesh-ancestor
111413266|NCT05142189|Mitosis Modulators|mitosis modulators|mesh-ancestor
111413267|NCT05142189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111413268|NCT05142189|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111413269|NCT05141721|Leucovorin|leucovorin|mesh-list
111413270|NCT05141721|Bevacizumab|bevacizumab|mesh-list
111413271|NCT05141721|Ipilimumab|ipilimumab|mesh-list
111413272|NCT05141721|Atezolizumab|atezolizumab|mesh-list
111413273|NCT05141721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111413274|NCT05141721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111413275|NCT05141721|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111413276|NCT05141721|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111413277|NCT05141721|Growth Substances|growth substances|mesh-ancestor
111413278|NCT05141721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111413279|NCT05141721|Growth Inhibitors|growth inhibitors|mesh-ancestor
111413280|NCT05141721|Antidotes|antidotes|mesh-ancestor
111413281|NCT05141721|Protective Agents|protective agents|mesh-ancestor
111413282|NCT05141721|Vitamin B Complex|vitamin b complex|mesh-ancestor
111413283|NCT05141721|Vitamins|vitamins|mesh-ancestor
111413284|NCT05141721|Micronutrients|micronutrients|mesh-ancestor
111413285|NCT05141721|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111413286|NCT05141721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111413287|NCT05137938|Ketamine|ketamine|mesh-list
111413288|NCT05137938|Analgesics|analgesics|mesh-ancestor
111413289|NCT05137938|Sensory System Agents|sensory system agents|mesh-ancestor
111413290|NCT05137938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111413291|NCT05137938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111413292|NCT05137938|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111413293|NCT05137938|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111413294|NCT05137938|Anesthetics, General|anesthetics, general|mesh-ancestor
111413295|NCT05137938|Anesthetics|anesthetics|mesh-ancestor
111413296|NCT05137938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111413297|NCT05137938|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111413298|NCT05137938|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111413299|NCT05137938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111413300|NCT05137938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111413301|NCT05129358|Furosemide|furosemide|mesh-list
111413302|NCT05129358|Diuretics|diuretics|mesh-ancestor
111413303|NCT05129358|Natriuretic Agents|natriuretic agents|mesh-ancestor
111413304|NCT05129358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111413305|NCT05129358|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
111413306|NCT05129358|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111413307|NCT05129358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111413308|NCT05119296|Pembrolizumab|pembrolizumab|mesh-list
111413309|NCT05119296|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111413310|NCT05119296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111413311|NCT05119296|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111413312|NCT05119296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111413313|NCT05117554|Midazolam|midazolam|mesh-list
111413314|NCT05117554|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111413315|NCT05117554|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111413316|NCT05117554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111413317|NCT05117554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111413318|NCT05117554|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111413319|NCT05117554|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111413320|NCT05117554|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111413321|NCT05117554|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111413322|NCT05117554|Anesthetics, General|anesthetics, general|mesh-ancestor
111413323|NCT05117554|Anesthetics|anesthetics|mesh-ancestor
111413324|NCT05117554|GABA Modulators|gaba modulators|mesh-ancestor
111413325|NCT05117554|GABA Agents|gaba agents|mesh-ancestor
111413326|NCT05117554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111413327|NCT05117554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111413328|NCT05117125|Heparin|heparin|mesh-list
111413329|NCT05117125|Anticoagulants|anticoagulants|mesh-ancestor
111413330|NCT05117125|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111413331|NCT05117125|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111413332|NCT05117125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111413333|NCT05114460|Naloxone|naloxone|mesh-list
111413334|NCT05114460|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111413335|NCT05114460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111413336|NCT05114460|Sensory System Agents|sensory system agents|mesh-ancestor
111413337|NCT05114460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111413338|NCT05107453|Levobupivacaine|levobupivacaine|mesh-list
111413339|NCT05107453|Anesthetics, Local|anesthetics, local|mesh-ancestor
111413340|NCT05107453|Anesthetics|anesthetics|mesh-ancestor
111413341|NCT05107453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111413342|NCT05107453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111413343|NCT05107453|Sensory System Agents|sensory system agents|mesh-ancestor
111413344|NCT05107453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111413346|NCT05105841|Obinutuzumab|obinutuzumab|mesh-list
111413347|NCT05105841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111413348|NCT05105841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111413349|NCT05104723|Tofacitinib|tofacitinib|mesh-list
111413350|NCT05104723|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
111413351|NCT05104723|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111413352|NCT05104723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111413353|NCT05104723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111413354|NCT05099848|Leucovorin|leucovorin|mesh-list
111413355|NCT05099848|Fluorouracil|fluorouracil|mesh-list
111413356|NCT05099848|Oxaliplatin|oxaliplatin|mesh-list
111413357|NCT05099848|Apatinib|apatinib|mesh-list
111413358|NCT05099848|Antimetabolites|antimetabolites|mesh-ancestor
111413359|NCT05099848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111413360|NCT05099848|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111413361|NCT05099848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111413362|NCT05099848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111413363|NCT05099848|Immunologic Factors|immunologic factors|mesh-ancestor
111413364|NCT05099848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111413365|NCT05099848|Antidotes|antidotes|mesh-ancestor
111413366|NCT05099848|Protective Agents|protective agents|mesh-ancestor
111413367|NCT05099848|Vitamin B Complex|vitamin b complex|mesh-ancestor
111413368|NCT05099848|Vitamins|vitamins|mesh-ancestor
111413369|NCT05099848|Micronutrients|micronutrients|mesh-ancestor
111413370|NCT05099848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111413371|NCT05099848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111413372|NCT05098327|Pioglitazone|pioglitazone|mesh-list
111413373|NCT05098327|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111413374|NCT05098327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111413375|NCT05092373|Paclitaxel|paclitaxel|mesh-list
111413376|NCT05092373|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111413377|NCT05092373|Atezolizumab|atezolizumab|mesh-list
111413378|NCT05092373|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111413379|NCT05092373|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111413380|NCT05092373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111413381|NCT05092373|Tubulin Modulators|tubulin modulators|mesh-ancestor
111413382|NCT05092373|Antimitotic Agents|antimitotic agents|mesh-ancestor
111413383|NCT05092373|Mitosis Modulators|mitosis modulators|mesh-ancestor
111413384|NCT05092373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111413385|NCT05092373|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111413386|NCT05092373|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111413387|NCT05092373|Immunologic Factors|immunologic factors|mesh-ancestor
111413388|NCT05092373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111413389|NCT05082610|Pembrolizumab|pembrolizumab|mesh-list
111413390|NCT05082610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111413391|NCT05082610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111413392|NCT05082610|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111413393|NCT05082610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111413394|NCT05074589|Leucovorin|leucovorin|mesh-list
111413395|NCT05074589|Fluorouracil|fluorouracil|mesh-list
111413396|NCT05074589|Irinotecan|irinotecan|mesh-list
111413397|NCT05074589|Levoleucovorin|levoleucovorin|mesh-list
111413398|NCT05074589|Antimetabolites|antimetabolites|mesh-ancestor
111413399|NCT05074589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111413400|NCT05074589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111413401|NCT05074589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111413402|NCT05074589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111413403|NCT05074589|Immunologic Factors|immunologic factors|mesh-ancestor
111413404|NCT05074589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111413405|NCT05074589|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111413406|NCT05074589|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111413407|NCT05074589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111413408|NCT05074589|Antidotes|antidotes|mesh-ancestor
111413409|NCT05074589|Protective Agents|protective agents|mesh-ancestor
111413410|NCT05074589|Vitamin B Complex|vitamin b complex|mesh-ancestor
111413411|NCT05074589|Vitamins|vitamins|mesh-ancestor
111413412|NCT05074589|Micronutrients|micronutrients|mesh-ancestor
111413413|NCT05064085|Capecitabine|capecitabine|mesh-list
111413414|NCT05064085|Cemiplimab|cemiplimab|mesh-list
111413415|NCT05064085|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111413416|NCT05064085|Antimetabolites|antimetabolites|mesh-ancestor
111413417|NCT05064085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111413418|NCT05064085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111413419|NCT05064085|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111413420|NCT05061654|Tazobactam|tazobactam|mesh-list
111413421|NCT05061654|Ceftolozane|ceftolozane|mesh-list
111413422|NCT05061654|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
111413423|NCT05061654|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111413424|NCT05061654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111413425|NCT05061654|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
111413426|NCT05061654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111413427|NCT05061654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111413428|NCT05061654|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111413429|NCT05060965|Nicotine|nicotine|mesh-list
111413430|NCT05060965|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111413431|NCT05060965|Autonomic Agents|autonomic agents|mesh-ancestor
111413432|NCT05060965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111413433|NCT05060965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111413434|NCT05060965|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111413435|NCT05060965|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111413436|NCT05060965|Cholinergic Agents|cholinergic agents|mesh-ancestor
111413437|NCT05060965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111413438|NCT05060965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111413439|NCT05053126|Pregabalin|pregabalin|mesh-list
111413440|NCT05053126|Oxycodone|oxycodone|mesh-list
111413441|NCT05053126|Analgesics|analgesics|mesh-ancestor
111413442|NCT05053126|Sensory System Agents|sensory system agents|mesh-ancestor
111413443|NCT05053126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111413444|NCT05053126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111413445|NCT05053126|Anticonvulsants|anticonvulsants|mesh-ancestor
111413446|NCT05053126|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111413447|NCT05053126|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111413448|NCT05053126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111413449|NCT05053126|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111413450|NCT05053126|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111413451|NCT05053126|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111413452|NCT05053126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111413453|NCT05053126|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111413454|NCT05053126|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111413455|NCT05053126|Narcotics|narcotics|mesh-ancestor
111413456|NCT05051449|Ketamine|ketamine|mesh-list
111413457|NCT05051449|Analgesics|analgesics|mesh-ancestor
111413458|NCT05051449|Sensory System Agents|sensory system agents|mesh-ancestor
111413459|NCT05051449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111413460|NCT05051449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111413461|NCT05051449|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111413462|NCT05051449|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111413463|NCT05051449|Anesthetics, General|anesthetics, general|mesh-ancestor
111413464|NCT05051449|Anesthetics|anesthetics|mesh-ancestor
111413465|NCT05051449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111413466|NCT05051449|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111413467|NCT05051449|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111413468|NCT05051449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111413469|NCT05051449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111413470|NCT05049616|Nifedipine|nifedipine|mesh-list
111413471|NCT05049616|Diuretics|diuretics|mesh-list
111413472|NCT05049616|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
111413473|NCT05049616|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111413474|NCT05049616|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111413475|NCT05049616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111413476|NCT05049616|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111413477|NCT05049616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111413478|NCT05049616|Vasodilator Agents|vasodilator agents|mesh-ancestor
111413479|NCT05049616|Tocolytic Agents|tocolytic agents|mesh-ancestor
111413480|NCT05049616|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111413481|NCT05049616|Natriuretic Agents|natriuretic agents|mesh-ancestor
111413482|NCT05049616|Protease Inhibitors|protease inhibitors|mesh-ancestor
111413483|NCT05049616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111413484|NCT05049213|Povidone-Iodine|povidone-iodine|mesh-list
111413485|NCT05049213|Povidone|povidone|mesh-list
111413486|NCT05049213|Plasma Substitutes|plasma substitutes|mesh-ancestor
111413487|NCT05049213|Blood Substitutes|blood substitutes|mesh-ancestor
111413488|NCT05049213|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111413489|NCT05049213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111413490|NCT05032820|Lenalidomide|lenalidomide|mesh-list
111413491|NCT05032820|Immunologic Factors|immunologic factors|mesh-ancestor
111413492|NCT05032820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111413493|NCT05032820|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111413494|NCT05032820|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111413495|NCT05032820|Growth Substances|growth substances|mesh-ancestor
111413496|NCT05032820|Growth Inhibitors|growth inhibitors|mesh-ancestor
111413497|NCT05032820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111413498|NCT05030298|Temozolomide|temozolomide|mesh-list
111413499|NCT05030298|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111413500|NCT05030298|Alkylating Agents|alkylating agents|mesh-ancestor
111413501|NCT05030298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111413502|NCT05030298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111413503|NCT05025605|Dexmedetomidine|dexmedetomidine|mesh-list
111413504|NCT05025605|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111413505|NCT05025605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111413506|NCT05025605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111413507|NCT05025605|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111413508|NCT05025605|Analgesics|analgesics|mesh-ancestor
111413509|NCT05025605|Sensory System Agents|sensory system agents|mesh-ancestor
111413510|NCT05025605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111413511|NCT05025605|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111413512|NCT05025605|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111413513|NCT05025605|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111413514|NCT05025605|Adrenergic Agents|adrenergic agents|mesh-ancestor
111413515|NCT05025605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110509274|NCT03193853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111413516|NCT05025605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111413517|NCT05020600|Pregabalin|pregabalin|mesh-list
111413518|NCT05020600|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
111413519|NCT05020600|Amitriptyline|amitriptyline|mesh-list
111413520|NCT05020600|Analgesics|analgesics|mesh-ancestor
111413521|NCT05020600|Sensory System Agents|sensory system agents|mesh-ancestor
111413522|NCT05020600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111413523|NCT05020600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111413524|NCT05020600|Anticonvulsants|anticonvulsants|mesh-ancestor
111413525|NCT05020600|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111413526|NCT05020600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111413527|NCT05020600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111413528|NCT05020600|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111413529|NCT05020600|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111413530|NCT05020600|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111413531|NCT05020600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111413532|NCT05020600|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111413533|NCT05020600|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111413534|NCT05020600|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111413535|NCT05020600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111413536|NCT05020600|Antidepressive Agents|antidepressive agents|mesh-ancestor
111413537|NCT05020600|Dopamine Agents|dopamine agents|mesh-ancestor
111413538|NCT05020600|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
111413539|NCT05020600|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111413540|NCT05020600|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111413541|NCT05020600|Adrenergic Agents|adrenergic agents|mesh-ancestor
111413542|NCT05011266|Buprenorphine|buprenorphine|mesh-list
111413543|NCT05011266|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
111413544|NCT05011266|Naloxone|naloxone|mesh-list
111413545|NCT05011266|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111413546|NCT05011266|Narcotics|narcotics|mesh-ancestor
111413547|NCT05011266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111413548|NCT05011266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111413549|NCT05011266|Analgesics|analgesics|mesh-ancestor
111413550|NCT05011266|Sensory System Agents|sensory system agents|mesh-ancestor
111413551|NCT05011266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111413552|NCT05011266|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111413553|NCT05000450|Cyclophosphamide|cyclophosphamide|mesh-list
111413554|NCT05000450|Fludarabine|fludarabine|mesh-list
111413555|NCT05000450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111413556|NCT05000450|Immunologic Factors|immunologic factors|mesh-ancestor
111413557|NCT05000450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111413558|NCT05000450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111413559|NCT05000450|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111413560|NCT05000450|Alkylating Agents|alkylating agents|mesh-ancestor
111413561|NCT05000450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111413562|NCT05000450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111413563|NCT05000450|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111413564|NCT04998279|Lenograstim|lenograstim|mesh-list
111413565|NCT04998279|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111413566|NCT04998279|Immunologic Factors|immunologic factors|mesh-ancestor
111413567|NCT04998279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111413568|NCT04994509|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
111413569|NCT04994509|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
111413570|NCT04994509|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111413571|NCT04994509|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111413572|NCT04994509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111413573|NCT04994509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111413574|NCT04994509|Antiviral Agents|antiviral agents|mesh-ancestor
111413575|NCT04994509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111413576|NCT04994509|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111413577|NCT04994509|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111413578|NCT04973930|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
111413579|NCT04973930|Escitalopram|escitalopram|mesh-list
111413580|NCT04973930|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111413581|NCT04973930|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110509280|NCT03191084|Analgesics|analgesics|mesh-ancestor
111413582|NCT04973930|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111413583|NCT04973930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111413584|NCT04973930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111413585|NCT04973930|Serotonin Agents|serotonin agents|mesh-ancestor
111413586|NCT04973930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111413587|NCT04973930|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111413588|NCT04973930|Antidepressive Agents|antidepressive agents|mesh-ancestor
111413589|NCT04973930|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111413590|NCT04973930|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111413591|NCT04965077|Antibodies|antibodies|mesh-list
111413592|NCT04965077|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111413593|NCT04965077|Immunologic Factors|immunologic factors|mesh-ancestor
111413594|NCT04965077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111413595|NCT04964960|Paclitaxel|paclitaxel|mesh-list
111413596|NCT04964960|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111413597|NCT04964960|Carboplatin|carboplatin|mesh-list
111413598|NCT04964960|Pembrolizumab|pembrolizumab|mesh-list
111413599|NCT04964960|Pemetrexed|pemetrexed|mesh-list
111413600|NCT04964960|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111413601|NCT04964960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111413602|NCT04964960|Tubulin Modulators|tubulin modulators|mesh-ancestor
111413603|NCT04964960|Antimitotic Agents|antimitotic agents|mesh-ancestor
111413604|NCT04964960|Mitosis Modulators|mitosis modulators|mesh-ancestor
111413605|NCT04964960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111413606|NCT04964960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111413607|NCT04964960|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111413608|NCT04964960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111413609|NCT04964960|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111413610|NCT04964960|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111413611|NCT04956120|Dialysis Solutions|dialysis solutions|mesh-list
111413612|NCT04956120|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111413613|NCT04953962|Nivolumab|nivolumab|mesh-list
111413614|NCT04953962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111413615|NCT04953962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111413616|NCT04953962|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111413617|NCT04953962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111413618|NCT04939480|Atezolizumab|atezolizumab|mesh-list
111413619|NCT04939480|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111413620|NCT04939480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111413621|NCT04939480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111413622|NCT04939480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111413623|NCT04933617|Prednisone|prednisone|mesh-list
111413624|NCT04933617|Cyclophosphamide|cyclophosphamide|mesh-list
111413625|NCT04933617|Rituximab|rituximab|mesh-list
111413626|NCT04933617|Doxorubicin|doxorubicin|mesh-list
111413627|NCT04933617|Etoposide|etoposide|mesh-list
111413628|NCT04933617|Vincristine|vincristine|mesh-list
111413629|NCT04933617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111413630|NCT04933617|Immunologic Factors|immunologic factors|mesh-ancestor
111413631|NCT04933617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111413632|NCT04933617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111413633|NCT04933617|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111413634|NCT04933617|Alkylating Agents|alkylating agents|mesh-ancestor
111413635|NCT04933617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111413636|NCT04933617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111413637|NCT04933617|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111413638|NCT04933617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111413639|NCT04933617|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111413640|NCT04933617|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111413641|NCT04933617|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111413642|NCT04933617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111413643|NCT04933617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111413644|NCT04933617|Glucocorticoids|glucocorticoids|mesh-ancestor
111413645|NCT04933617|Hormones|hormones|mesh-ancestor
111413646|NCT04933617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111413647|NCT04933617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111413648|NCT04933617|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111413649|NCT04933617|Tubulin Modulators|tubulin modulators|mesh-ancestor
111413650|NCT04933617|Antimitotic Agents|antimitotic agents|mesh-ancestor
111413651|NCT04933617|Mitosis Modulators|mitosis modulators|mesh-ancestor
111413652|NCT04932434|Psilocybin|psilocybin|mesh-list
111413653|NCT04932434|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
111413654|NCT04932434|Hallucinogens|hallucinogens|mesh-ancestor
111413655|NCT04932434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111413656|NCT04932434|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111413657|NCT04932434|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111413658|NCT04932434|Serotonin Agents|serotonin agents|mesh-ancestor
111413659|NCT04932434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111413660|NCT04932434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111413661|NCT04932434|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111413662|NCT04927780|Leucovorin|leucovorin|mesh-list
111413663|NCT04927780|Fluorouracil|fluorouracil|mesh-list
111413664|NCT04927780|Oxaliplatin|oxaliplatin|mesh-list
111413665|NCT04927780|Irinotecan|irinotecan|mesh-list
111413666|NCT04927780|Calcium|calcium|mesh-list
111413667|NCT04927780|Levoleucovorin|levoleucovorin|mesh-list
111413668|NCT04927780|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111413669|NCT04927780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111413670|NCT04927780|Antimetabolites|antimetabolites|mesh-ancestor
111413671|NCT04927780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111413672|NCT04927780|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111413673|NCT04927780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111413674|NCT04927780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111413675|NCT04927780|Immunologic Factors|immunologic factors|mesh-ancestor
111413676|NCT04927780|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111413677|NCT04927780|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111413678|NCT04927780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111413679|NCT04927780|Antidotes|antidotes|mesh-ancestor
111413680|NCT04927780|Protective Agents|protective agents|mesh-ancestor
111413681|NCT04927780|Vitamin B Complex|vitamin b complex|mesh-ancestor
111413682|NCT04927780|Vitamins|vitamins|mesh-ancestor
111413683|NCT04927780|Micronutrients|micronutrients|mesh-ancestor
111413684|NCT04925557|Ocrelizumab|ocrelizumab|mesh-list
111413685|NCT04925557|Immunologic Factors|immunologic factors|mesh-ancestor
111413686|NCT04925557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111413687|NCT04921358|Docetaxel|docetaxel|mesh-list
111413688|NCT04921358|Tislelizumab|tislelizumab|mesh-list
111413689|NCT04921358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111413690|NCT04921358|Tubulin Modulators|tubulin modulators|mesh-ancestor
111413691|NCT04921358|Antimitotic Agents|antimitotic agents|mesh-ancestor
111413692|NCT04921358|Mitosis Modulators|mitosis modulators|mesh-ancestor
111413693|NCT04921358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111413694|NCT04921358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111413695|NCT04895761|Cyclophosphamide|cyclophosphamide|mesh-list
111413696|NCT04895761|Letrozole|letrozole|mesh-list
111413697|NCT04895761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111413698|NCT04895761|Immunologic Factors|immunologic factors|mesh-ancestor
111413699|NCT04895761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111413700|NCT04895761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111413701|NCT04895761|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111413702|NCT04895761|Alkylating Agents|alkylating agents|mesh-ancestor
111413703|NCT04895761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111413704|NCT04895761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111413705|NCT04895761|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111413706|NCT04895761|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111413707|NCT04895761|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111413708|NCT04895761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111413709|NCT04895761|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111413710|NCT04895761|Hormone Antagonists|hormone antagonists|mesh-ancestor
111413711|NCT04895761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111413712|NCT04892264|Dexamethasone|dexamethasone|mesh-list
111413713|NCT04892264|Dexamethasone acetate|dexamethasone acetate|mesh-list
111413714|NCT04892264|Lenalidomide|lenalidomide|mesh-list
111413715|NCT04892264|Daratumumab|daratumumab|mesh-list
111413716|NCT04892264|Ichthammol|ichthammol|mesh-list
111413717|NCT04892264|BB 1101|bb 1101|mesh-list
111413718|NCT04892264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111413719|NCT04892264|Antiemetics|antiemetics|mesh-ancestor
111413720|NCT04892264|Autonomic Agents|autonomic agents|mesh-ancestor
111413721|NCT04892264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111413722|NCT04892264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111413723|NCT04892264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111413724|NCT04892264|Glucocorticoids|glucocorticoids|mesh-ancestor
111413726|NCT04892264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111413727|NCT04892264|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111413728|NCT04892264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111413729|NCT04892264|Protease Inhibitors|protease inhibitors|mesh-ancestor
111413730|NCT04892264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111413731|NCT04892264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111413732|NCT04892264|Immunologic Factors|immunologic factors|mesh-ancestor
111413733|NCT04892264|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111413734|NCT04892264|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111413735|NCT04892264|Growth Substances|growth substances|mesh-ancestor
111413736|NCT04892264|Growth Inhibitors|growth inhibitors|mesh-ancestor
111413737|NCT04892264|Dermatologic Agents|dermatologic agents|mesh-ancestor
111413738|NCT04880863|Docetaxel|docetaxel|mesh-list
111413739|NCT04880863|Obinutuzumab|obinutuzumab|mesh-list
111413740|NCT04880863|Naptumomab estafenatox|naptumomab estafenatox|mesh-list
111413741|NCT04880863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111413742|NCT04880863|Tubulin Modulators|tubulin modulators|mesh-ancestor
111413743|NCT04880863|Antimitotic Agents|antimitotic agents|mesh-ancestor
111413744|NCT04880863|Mitosis Modulators|mitosis modulators|mesh-ancestor
111413745|NCT04880863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111413746|NCT04880863|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111413747|NCT04880863|Immunoconjugates|immunoconjugates|mesh-ancestor
111413748|NCT04880863|Immunologic Factors|immunologic factors|mesh-ancestor
111413749|NCT04880863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111413750|NCT04878029|Immunoconjugates|immunoconjugates|mesh-list
111413751|NCT04878029|Immunologic Factors|immunologic factors|mesh-ancestor
111413752|NCT04878029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111413753|NCT04871529|Carboplatin|carboplatin|mesh-list
111413754|NCT04871529|Gemcitabine|gemcitabine|mesh-list
111413755|NCT04871529|Avelumab|avelumab|mesh-list
111413756|NCT04871529|Immunoglobulins|immunoglobulins|mesh-list
111413757|NCT04871529|Immunoglobulin G|immunoglobulin g|mesh-list
111413758|NCT04871529|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111413759|NCT04871529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111413760|NCT04871529|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111413761|NCT04871529|Antimetabolites|antimetabolites|mesh-ancestor
111413762|NCT04871529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111413763|NCT04871529|Immunologic Factors|immunologic factors|mesh-ancestor
111413764|NCT04871529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111413765|NCT04871529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111413766|NCT04865887|Pembrolizumab|pembrolizumab|mesh-list
111413767|NCT04865887|Lenvatinib|lenvatinib|mesh-list
111413768|NCT04865887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111413769|NCT04865887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111413770|NCT04865887|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111413771|NCT04865887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111413772|NCT04865887|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111413773|NCT04865887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111413774|NCT04864444|Primaquine|primaquine|mesh-list
111413775|NCT04864444|Piperaquine|piperaquine|mesh-list
111413776|NCT04864444|Artenimol|artenimol|mesh-list
111413777|NCT04864444|Antimalarials|antimalarials|mesh-ancestor
111413778|NCT04864444|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111413779|NCT04864444|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111413780|NCT04864444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111413781|NCT04861987|Capecitabine|capecitabine|mesh-list
111413782|NCT04861987|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111413783|NCT04861987|Antimetabolites|antimetabolites|mesh-ancestor
111413784|NCT04861987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111413785|NCT04861987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111413786|NCT04853043|Cetuximab|cetuximab|mesh-list
111413787|NCT04853043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111413788|NCT04853043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111413789|NCT04834024|Antibodies|antibodies|mesh-list
111413790|NCT04834024|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111413791|NCT04834024|Immunologic Factors|immunologic factors|mesh-ancestor
111413792|NCT04834024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111413793|NCT04826133|Calcitriol|calcitriol|mesh-list
111413794|NCT04826133|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
111413795|NCT04826133|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111413796|NCT04826133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111413797|NCT04826133|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
111413798|NCT04826133|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111413799|NCT04826133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111413800|NCT04826133|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111413801|NCT04826133|Vitamins|vitamins|mesh-ancestor
111413802|NCT04826133|Micronutrients|micronutrients|mesh-ancestor
111413803|NCT04826133|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111413804|NCT04821817|Rocuronium|rocuronium|mesh-list
111413805|NCT04821817|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
111413806|NCT04821817|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
111413807|NCT04821817|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111413808|NCT04821817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111413809|NCT04821817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111413810|NCT04817241|Cytarabine|cytarabine|mesh-list
111413811|NCT04817241|Decitabine|decitabine|mesh-list
111413812|NCT04817241|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
111413813|NCT04817241|Daunorubicin|daunorubicin|mesh-list
111413814|NCT04817241|Venetoclax|venetoclax|mesh-list
111413815|NCT04817241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111413816|NCT04817241|Antimetabolites|antimetabolites|mesh-ancestor
111413817|NCT04817241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111413818|NCT04817241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111413819|NCT04817241|Antiviral Agents|antiviral agents|mesh-ancestor
111413820|NCT04817241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111413821|NCT04817241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111413822|NCT04817241|Immunologic Factors|immunologic factors|mesh-ancestor
111413823|NCT04817241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111413824|NCT04817241|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111413825|NCT04817241|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111413826|NCT04817241|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111413827|NCT04817241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111413828|NCT04792645|Memantine|memantine|mesh-list
111413829|NCT04792645|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111413830|NCT04792645|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111413831|NCT04792645|Dopamine Agents|dopamine agents|mesh-ancestor
111413832|NCT04792645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111413833|NCT04792645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111413834|NCT04792645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111413835|NCT04792645|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111413836|NCT04792645|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111413837|NCT04791228|Doxorubicin|doxorubicin|mesh-list
111413838|NCT04791228|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111413839|NCT04791228|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111413840|NCT04791228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111413841|NCT04791228|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111413842|NCT04791228|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111413843|NCT04791228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111413844|NCT04791228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111413845|NCT04768296|Topotecan|topotecan|mesh-list
111413846|NCT04768296|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111413847|NCT04768296|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111413848|NCT04768296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111413849|NCT04768296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111413850|NCT04768296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111413851|NCT04760626|Insulin|insulin|mesh-list
111413852|NCT04760626|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111413853|NCT04760626|Insulin Glargine|insulin glargine|mesh-list
111413854|NCT04760626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111413855|NCT04760626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111413856|NCT04757376|Denosumab|denosumab|mesh-list
111413857|NCT04757376|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111413858|NCT04757376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111413859|NCT04751500|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111413860|NCT04751500|Metronidazole|metronidazole|mesh-list
111413861|NCT04751500|Clindamycin|clindamycin|mesh-list
111413862|NCT04751500|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
111413863|NCT04751500|Misoprostol|misoprostol|mesh-list
111413864|NCT04751500|Mifepristone|mifepristone|mesh-list
111413865|NCT04751500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111413866|NCT04751500|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111413867|NCT04751500|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111413868|NCT04751500|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111413869|NCT04751500|Abortifacient Agents|abortifacient agents|mesh-ancestor
111413870|NCT04751500|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111413871|NCT04751500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111413872|NCT04751500|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111413873|NCT04751500|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111413874|NCT04751500|Oxytocics|oxytocics|mesh-ancestor
111413875|NCT04751500|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111413876|NCT04751500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111413877|NCT04751500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111413878|NCT04751500|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
111413879|NCT04751500|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111413880|NCT04751500|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111413881|NCT04751500|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111413882|NCT04751500|Contraceptive Agents|contraceptive agents|mesh-ancestor
111413883|NCT04751500|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
111413884|NCT04751500|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
111413885|NCT04751500|Hormone Antagonists|hormone antagonists|mesh-ancestor
111413886|NCT04751500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111413887|NCT04751500|Luteolytic Agents|luteolytic agents|mesh-ancestor
111413888|NCT04751500|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111413889|NCT04751500|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
111413890|NCT04751500|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
111413891|NCT04740931|Aflibercept|aflibercept|mesh-list
111413892|NCT04740931|Faricimab|faricimab|mesh-list
111413893|NCT04740931|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111413894|NCT04740931|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111413895|NCT04740931|Growth Substances|growth substances|mesh-ancestor
111413896|NCT04740931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111413897|NCT04740931|Growth Inhibitors|growth inhibitors|mesh-ancestor
111413898|NCT04740931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111413899|NCT04730037|Warfarin|warfarin|mesh-list
111413900|NCT04730037|Edoxaban|edoxaban|mesh-list
111413901|NCT04730037|Anticoagulants|anticoagulants|mesh-ancestor
111413902|NCT04730037|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111413903|NCT04730037|Antithrombins|antithrombins|mesh-ancestor
111413904|NCT04730037|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111413905|NCT04730037|Protease Inhibitors|protease inhibitors|mesh-ancestor
111413906|NCT04730037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111413907|NCT04730037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111413908|NCT04729725|Cemiplimab|cemiplimab|mesh-list
111413909|NCT04729725|Antibodies|antibodies|mesh-list
111413910|NCT04729725|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111413911|NCT04729725|Immunologic Factors|immunologic factors|mesh-ancestor
111413912|NCT04729725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111413913|NCT04729725|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111413914|NCT04729725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111413915|NCT04727242|Gemcitabine|gemcitabine|mesh-list
111413916|NCT04727242|Dacarbazine|dacarbazine|mesh-list
111413917|NCT04727242|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111413918|NCT04727242|Antimetabolites|antimetabolites|mesh-ancestor
111413919|NCT04727242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110509356|NCT02127073|Oxytocin|oxytocin|mesh-list
111413920|NCT04727242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111413921|NCT04727242|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111413922|NCT04727242|Alkylating Agents|alkylating agents|mesh-ancestor
111413923|NCT04723004|Bevacizumab|bevacizumab|mesh-list
111413924|NCT04723004|Sorafenib|sorafenib|mesh-list
111413925|NCT04723004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111413926|NCT04723004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111413927|NCT04723004|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111413928|NCT04723004|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111413929|NCT04723004|Growth Substances|growth substances|mesh-ancestor
111413930|NCT04723004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111413931|NCT04723004|Growth Inhibitors|growth inhibitors|mesh-ancestor
111413932|NCT04723004|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111413933|NCT04723004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111413934|NCT04723004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111413935|NCT04717414|Luspatercept|luspatercept|mesh-list
111413936|NCT04717414|Hematinics|hematinics|mesh-ancestor
111413937|NCT04706741|Prednisone|prednisone|mesh-list
111413938|NCT04706741|Prednisolone|prednisolone|mesh-list
111413939|NCT04706741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111413940|NCT04706741|Glucocorticoids|glucocorticoids|mesh-ancestor
111413941|NCT04706741|Hormones|hormones|mesh-ancestor
111413942|NCT04706741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111413943|NCT04706741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111413944|NCT04706741|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111413945|NCT04706741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111413946|NCT04698603|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
111413947|NCT04698603|Hallucinogens|hallucinogens|mesh-ancestor
111413948|NCT04698603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111413949|NCT04698603|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111413950|NCT04698603|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111413951|NCT04698603|Serotonin Agents|serotonin agents|mesh-ancestor
111413952|NCT04698603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111413953|NCT04698603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111413954|NCT04698603|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111413955|NCT04676334|Rucaparib|rucaparib|mesh-list
111413956|NCT04676334|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111413957|NCT04676334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111413958|NCT04676334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111413959|NCT04676334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111413960|NCT04669197|Hydroxychloroquine|hydroxychloroquine|mesh-list
111413961|NCT04669197|Paclitaxel|paclitaxel|mesh-list
111413962|NCT04669197|Gemcitabine|gemcitabine|mesh-list
111413963|NCT04669197|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111413964|NCT04669197|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111413965|NCT04669197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111413966|NCT04669197|Tubulin Modulators|tubulin modulators|mesh-ancestor
111413967|NCT04669197|Antimitotic Agents|antimitotic agents|mesh-ancestor
111413968|NCT04669197|Mitosis Modulators|mitosis modulators|mesh-ancestor
111413969|NCT04669197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111413970|NCT04669197|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111413971|NCT04669197|Antimetabolites|antimetabolites|mesh-ancestor
111413972|NCT04669197|Antimalarials|antimalarials|mesh-ancestor
111413973|NCT04669197|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111413974|NCT04669197|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111413975|NCT04669197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111413976|NCT04669197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111413977|NCT04669197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111413978|NCT04660812|Bevacizumab|bevacizumab|mesh-list
111413979|NCT04660812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111413980|NCT04660812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111413981|NCT04660812|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111413982|NCT04660812|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111413983|NCT04660812|Growth Substances|growth substances|mesh-ancestor
111413984|NCT04660812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111413985|NCT04660812|Growth Inhibitors|growth inhibitors|mesh-ancestor
111413986|NCT04651348|Antibodies|antibodies|mesh-list
111413987|NCT04651348|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111413988|NCT04651348|Immunologic Factors|immunologic factors|mesh-ancestor
111413989|NCT04651348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111413990|NCT04650581|Fulvestrant|fulvestrant|mesh-list
111413991|NCT04650581|Ipatasertib|ipatasertib|mesh-list
111413992|NCT04650581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111413993|NCT04650581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111413994|NCT04650581|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
111413995|NCT04650581|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111413996|NCT04650581|Hormone Antagonists|hormone antagonists|mesh-ancestor
111413997|NCT04650581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111413998|NCT04650581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111413999|NCT04650581|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111414000|NCT04650581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111414001|NCT04650581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111414002|NCT04640831|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
111414003|NCT04640831|Hallucinogens|hallucinogens|mesh-ancestor
111414004|NCT04640831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111414005|NCT04640831|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111414006|NCT04640831|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111414007|NCT04640831|Serotonin Agents|serotonin agents|mesh-ancestor
111414008|NCT04640831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111414009|NCT04640831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111414010|NCT04640831|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111414011|NCT04628338|Interferons|interferons|mesh-list
111414012|NCT04628338|Interferon-gamma|interferon-gamma|mesh-list
111414013|NCT04628338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111414014|NCT04628338|Antiviral Agents|antiviral agents|mesh-ancestor
111414015|NCT04628338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111414016|NCT04620603|Immunomodulating Agents|immunomodulating agents|mesh-list
111414017|NCT04620603|Immunologic Factors|immunologic factors|mesh-ancestor
111414018|NCT04620603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111414019|NCT04610398|Dexamethasone|dexamethasone|mesh-list
111414020|NCT04610398|Dexamethasone acetate|dexamethasone acetate|mesh-list
111414021|NCT04610398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111414022|NCT04610398|Antiemetics|antiemetics|mesh-ancestor
111414023|NCT04610398|Autonomic Agents|autonomic agents|mesh-ancestor
111414024|NCT04610398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111414025|NCT04610398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111414026|NCT04610398|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111414027|NCT04610398|Glucocorticoids|glucocorticoids|mesh-ancestor
111414028|NCT04610398|Hormones|hormones|mesh-ancestor
111414029|NCT04610398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111414030|NCT04610398|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111414031|NCT04610398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111414032|NCT04607460|Coal Tar|coal tar|mesh-list
111414033|NCT04607460|Keratolytic Agents|keratolytic agents|mesh-ancestor
111414034|NCT04607460|Dermatologic Agents|dermatologic agents|mesh-ancestor
111414035|NCT04606069|Regadenoson|regadenoson|mesh-list
111414036|NCT04606069|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
111414037|NCT04606069|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
111414038|NCT04606069|Purinergic Agonists|purinergic agonists|mesh-ancestor
111414039|NCT04606069|Purinergic Agents|purinergic agents|mesh-ancestor
111414040|NCT04606069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111414041|NCT04606069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111414042|NCT04606069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111414043|NCT04597411|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
111414044|NCT04597411|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111414045|NCT04597411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111414046|NCT04595981|Cisplatin|cisplatin|mesh-list
111414047|NCT04595981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111414048|NCT04590404|Nicotine|nicotine|mesh-list
111414049|NCT04590404|Varenicline|varenicline|mesh-list
111414050|NCT04590404|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111414051|NCT04590404|Autonomic Agents|autonomic agents|mesh-ancestor
111414052|NCT04590404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111414053|NCT04590404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111414054|NCT04590404|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111414055|NCT04590404|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111414056|NCT04590404|Cholinergic Agents|cholinergic agents|mesh-ancestor
111414057|NCT04590404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111414058|NCT04590404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111414059|NCT04576104|Metformin|metformin|mesh-list
111414060|NCT04576104|Megestrol|megestrol|mesh-list
111414061|NCT04576104|Megestrol Acetate|megestrol acetate|mesh-list
111414062|NCT04576104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111414063|NCT04576104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111414064|NCT04576104|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111414065|NCT04576104|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111414066|NCT04576104|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111414067|NCT04576104|Contraceptive Agents|contraceptive agents|mesh-ancestor
111414068|NCT04576104|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111414069|NCT04576104|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111414070|NCT04576104|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111414071|NCT04576104|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111414072|NCT04576104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111414073|NCT04576104|Appetite Stimulants|appetite stimulants|mesh-ancestor
111414074|NCT04576104|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111414075|NCT04575311|Quemliclustat|quemliclustat|mesh-list
111414076|NCT04575311|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111414077|NCT04575311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111414078|NCT04575311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111414079|NCT04575311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111414080|NCT04565730|Anesthetics|anesthetics|mesh-list
111414081|NCT04565730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111414082|NCT04565730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111414083|NCT04550494|Talazoparib|talazoparib|mesh-list
111414084|NCT04550494|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111414085|NCT04550494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111414086|NCT04550494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111414087|NCT04550494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111414088|NCT04549116|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111414089|NCT04549116|Progesterone|progesterone|mesh-list
111414090|NCT04549116|Progestins|progestins|mesh-ancestor
111414091|NCT04549116|Hormones|hormones|mesh-ancestor
111414092|NCT04549116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111414093|NCT04549116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111138504|NCT02400333|Ticagrelor|ticagrelor|mesh-list
111414094|NCT04544280|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
111414095|NCT04544280|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111414096|NCT04544280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111414097|NCT04544280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111414098|NCT04544280|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111414099|NCT04544280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111414100|NCT04544280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111414101|NCT04544280|Cholinergic Agents|cholinergic agents|mesh-ancestor
111414102|NCT04544280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111414103|NCT04523480|Methyltestosterone|methyltestosterone|mesh-list
111414104|NCT04523480|Testosterone|testosterone|mesh-list
111414105|NCT04523480|Testosterone undecanoate|testosterone undecanoate|mesh-list
111414106|NCT04523480|Testosterone enanthate|testosterone enanthate|mesh-list
111414107|NCT04523480|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
111414108|NCT04523480|Androgens|androgens|mesh-ancestor
111414109|NCT04523480|Hormones|hormones|mesh-ancestor
111414110|NCT04523480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111414111|NCT04523480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111414112|NCT04523480|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111414113|NCT04523480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111414114|NCT04523480|Anabolic Agents|anabolic agents|mesh-ancestor
111414115|NCT04521621|Pembrolizumab|pembrolizumab|mesh-list
111414116|NCT04521621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111414117|NCT04521621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111414118|NCT04521621|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111414119|NCT04521621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111414120|NCT04521569|Regadenoson|regadenoson|mesh-list
111414121|NCT04521569|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
111414122|NCT04521569|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
111414123|NCT04521569|Purinergic Agonists|purinergic agonists|mesh-ancestor
111414124|NCT04521569|Purinergic Agents|purinergic agents|mesh-ancestor
111414125|NCT04521569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111414126|NCT04521569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111414127|NCT04521569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111414128|NCT04506086|Blinatumomab|blinatumomab|mesh-list
111414129|NCT04506086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111414130|NCT04504825|Dexamethasone|dexamethasone|mesh-list
111414131|NCT04504825|Cyclophosphamide|cyclophosphamide|mesh-list
111414132|NCT04504825|Bortezomib|bortezomib|mesh-list
111414133|NCT04504825|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111414134|NCT04504825|Immunologic Factors|immunologic factors|mesh-ancestor
111414135|NCT04504825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111414136|NCT04504825|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111414137|NCT04504825|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111414138|NCT04504825|Alkylating Agents|alkylating agents|mesh-ancestor
111414139|NCT04504825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111414140|NCT04504825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111414141|NCT04504825|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111414142|NCT04504825|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111414143|NCT04504825|Antiemetics|antiemetics|mesh-ancestor
111414144|NCT04504825|Autonomic Agents|autonomic agents|mesh-ancestor
111414145|NCT04504825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111414146|NCT04504825|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111414147|NCT04504825|Glucocorticoids|glucocorticoids|mesh-ancestor
111414148|NCT04504825|Hormones|hormones|mesh-ancestor
111414149|NCT04504825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111414150|NCT04504825|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111414151|NCT04497142|Levetiracetam|levetiracetam|mesh-list
111414152|NCT04497142|Anticonvulsants|anticonvulsants|mesh-ancestor
111414153|NCT04497142|Nootropic Agents|nootropic agents|mesh-ancestor
111414154|NCT04495257|Nivolumab|nivolumab|mesh-list
111414155|NCT04495257|Ipilimumab|ipilimumab|mesh-list
111414156|NCT04495257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111414157|NCT04495257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111414158|NCT04495257|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111414159|NCT04495257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111414160|NCT04477759|Atezolizumab|atezolizumab|mesh-list
111414161|NCT04477759|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111414162|NCT04477759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111414163|NCT04477759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111414164|NCT04477759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111414165|NCT04477343|Nivolumab|nivolumab|mesh-list
111414166|NCT04477343|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111138580|NCT05554003|Temozolomide|temozolomide|mesh-list
111414167|NCT04477343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111414168|NCT04477343|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111414169|NCT04477343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111414170|NCT04464980|Naltrexone|naltrexone|mesh-list
111414171|NCT04464980|Buprenorphine|buprenorphine|mesh-list
111414172|NCT04464980|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111414173|NCT04464980|Narcotics|narcotics|mesh-ancestor
111414174|NCT04464980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111414175|NCT04464980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111414176|NCT04464980|Analgesics|analgesics|mesh-ancestor
111414177|NCT04464980|Sensory System Agents|sensory system agents|mesh-ancestor
111414178|NCT04464980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111414179|NCT04464980|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111414180|NCT04464980|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111414181|NCT04458545|Heroin|heroin|mesh-list
111414182|NCT04458545|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111414183|NCT04458545|Narcotics|narcotics|mesh-ancestor
111414184|NCT04458545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111414185|NCT04458545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111414186|NCT04458545|Analgesics|analgesics|mesh-ancestor
111414187|NCT04458545|Sensory System Agents|sensory system agents|mesh-ancestor
111414188|NCT04458545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111414189|NCT04454684|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
111414190|NCT04454684|Hallucinogens|hallucinogens|mesh-ancestor
111414191|NCT04454684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111414192|NCT04454684|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111414193|NCT04454684|Serotonin Agents|serotonin agents|mesh-ancestor
111414194|NCT04454684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111414195|NCT04454684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111414196|NCT04454684|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111414197|NCT04454684|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111414198|NCT04454684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111414199|NCT04454684|Adrenergic Agents|adrenergic agents|mesh-ancestor
111414200|NCT04414475|Dexamethasone|dexamethasone|mesh-list
111414201|NCT04414475|Bortezomib|bortezomib|mesh-list
111414202|NCT04414475|Pomalidomide|pomalidomide|mesh-list
111414203|NCT04414475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111414204|NCT04414475|Antiemetics|antiemetics|mesh-ancestor
111414205|NCT04414475|Autonomic Agents|autonomic agents|mesh-ancestor
111414206|NCT04414475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111414207|NCT04414475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111414208|NCT04414475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111414209|NCT04414475|Glucocorticoids|glucocorticoids|mesh-ancestor
111414210|NCT04414475|Hormones|hormones|mesh-ancestor
111414211|NCT04414475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111414212|NCT04414475|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111414213|NCT04414475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111414214|NCT04414475|Immunologic Factors|immunologic factors|mesh-ancestor
111414215|NCT04414475|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111414216|NCT04414475|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111414217|NCT04414475|Growth Substances|growth substances|mesh-ancestor
111414218|NCT04414475|Growth Inhibitors|growth inhibitors|mesh-ancestor
111414219|NCT04392622|Cisplatin|cisplatin|mesh-list
111414220|NCT04392622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111414221|NCT04374630|Paclitaxel|paclitaxel|mesh-list
111414222|NCT04374630|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111414223|NCT04374630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111414224|NCT04374630|Tubulin Modulators|tubulin modulators|mesh-ancestor
111414225|NCT04374630|Antimitotic Agents|antimitotic agents|mesh-ancestor
111414226|NCT04374630|Mitosis Modulators|mitosis modulators|mesh-ancestor
111414227|NCT04374630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111414228|NCT04354246|Pembrolizumab|pembrolizumab|mesh-list
111414229|NCT04354246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111414230|NCT04354246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111414231|NCT04354246|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111414232|NCT04354246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111414233|NCT04352166|Buprenorphine|buprenorphine|mesh-list
111414234|NCT04352166|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111414235|NCT04352166|Narcotics|narcotics|mesh-ancestor
111414236|NCT04352166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111414237|NCT04352166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111414238|NCT04352166|Analgesics|analgesics|mesh-ancestor
111414239|NCT04352166|Sensory System Agents|sensory system agents|mesh-ancestor
111414240|NCT04352166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111414241|NCT04352166|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111414242|NCT04351555|Carboplatin|carboplatin|mesh-list
111414243|NCT04351555|Pemetrexed|pemetrexed|mesh-list
111414244|NCT04351555|Osimertinib|osimertinib|mesh-list
111414245|NCT04351555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111414246|NCT04351555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111414247|NCT04351555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111414248|NCT04351555|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111414249|NCT04351555|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111414250|NCT04351555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111414251|NCT04316702|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
111414252|NCT04316702|Analgesics|analgesics|mesh-ancestor
111414253|NCT04316702|Sensory System Agents|sensory system agents|mesh-ancestor
111414254|NCT04316702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111414255|NCT04316702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111414256|NCT04316702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111414257|NCT04316702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111414258|NCT04316702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111414259|NCT04316702|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111414260|NCT04316702|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111414261|NCT04316702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111414262|NCT04316702|Antidepressive Agents|antidepressive agents|mesh-ancestor
111414263|NCT04316702|Dopamine Agents|dopamine agents|mesh-ancestor
111414264|NCT04314375|Budesonide|budesonide|mesh-list
111414265|NCT04314375|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111414266|NCT04314375|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111414267|NCT04314375|Autonomic Agents|autonomic agents|mesh-ancestor
111414268|NCT04314375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111414269|NCT04314375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111414270|NCT04314375|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111414271|NCT04314375|Respiratory System Agents|respiratory system agents|mesh-ancestor
111414272|NCT04314375|Glucocorticoids|glucocorticoids|mesh-ancestor
111414273|NCT04314375|Hormones|hormones|mesh-ancestor
111414274|NCT04314375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111414275|NCT04292457|Propofol|propofol|mesh-list
111414276|NCT04292457|Sevoflurane|sevoflurane|mesh-list
111414277|NCT04292457|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111414278|NCT04292457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111414279|NCT04292457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111414280|NCT04292457|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111414281|NCT04292457|Anesthetics, General|anesthetics, general|mesh-ancestor
111414282|NCT04292457|Anesthetics|anesthetics|mesh-ancestor
111414283|NCT04292457|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111414284|NCT04292457|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111414285|NCT04291599|Ketorolac|ketorolac|mesh-list
111414286|NCT04291599|Morphine|morphine|mesh-list
111414287|NCT04291599|Hydromorphone|hydromorphone|mesh-list
111414288|NCT04291599|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111414289|NCT04291599|Narcotics|narcotics|mesh-ancestor
111414290|NCT04291599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111414291|NCT04291599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111414292|NCT04291599|Analgesics|analgesics|mesh-ancestor
111414293|NCT04291599|Sensory System Agents|sensory system agents|mesh-ancestor
111414294|NCT04291599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111414295|NCT04291599|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111414296|NCT04291599|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111414297|NCT04291599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111414298|NCT04291599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111414299|NCT04291599|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111414300|NCT04291599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111414301|NCT04291599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111414302|NCT04274179|Lamotrigine|lamotrigine|mesh-list
111414303|NCT04274179|Valproic Acid|valproic acid|mesh-list
111414304|NCT04274179|Ethosuximide|ethosuximide|mesh-list
111414305|NCT04274179|Anticonvulsants|anticonvulsants|mesh-ancestor
111414306|NCT04274179|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111414307|NCT04274179|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111414308|NCT04274179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111414309|NCT04274179|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111414310|NCT04274179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111414311|NCT04274179|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111414312|NCT04274179|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111414313|NCT04274179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111414314|NCT04274179|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111414315|NCT04274179|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111414316|NCT04274179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111414317|NCT04274179|GABA Agents|gaba agents|mesh-ancestor
111414318|NCT04274179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111414319|NCT04274179|Antimanic Agents|antimanic agents|mesh-ancestor
111414320|NCT04273932|Lithium Carbonate|lithium carbonate|mesh-list
111414321|NCT04273932|Antidepressive Agents|antidepressive agents|mesh-ancestor
111414322|NCT04273932|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111414323|NCT04273932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111414324|NCT04273932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111414325|NCT04273932|Antimanic Agents|antimanic agents|mesh-ancestor
111414326|NCT04273932|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111414327|NCT04273932|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111414328|NCT04273932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111414329|NCT04272086|Bupivacaine|bupivacaine|mesh-list
111414330|NCT04272086|Anesthetics, Local|anesthetics, local|mesh-ancestor
111414331|NCT04272086|Anesthetics|anesthetics|mesh-ancestor
111414332|NCT04272086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111414333|NCT04272086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111414334|NCT04272086|Sensory System Agents|sensory system agents|mesh-ancestor
111414335|NCT04272086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111414336|NCT04256707|Docetaxel|docetaxel|mesh-list
111414337|NCT04256707|Pembrolizumab|pembrolizumab|mesh-list
111414338|NCT04256707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111414339|NCT04256707|Tubulin Modulators|tubulin modulators|mesh-ancestor
111414340|NCT04256707|Antimitotic Agents|antimitotic agents|mesh-ancestor
111414341|NCT04256707|Mitosis Modulators|mitosis modulators|mesh-ancestor
111414342|NCT04256707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111414343|NCT04256707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111414344|NCT04256707|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111414345|NCT04249427|Erenumab|erenumab|mesh-list
111414346|NCT04249427|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
111414347|NCT04249427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111414348|NCT04249427|Analgesics|analgesics|mesh-ancestor
111414349|NCT04249427|Sensory System Agents|sensory system agents|mesh-ancestor
111414350|NCT04249427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111414351|NCT04249427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111414352|NCT04233229|Insulin|insulin|mesh-list
111414353|NCT04233229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111414354|NCT04233229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111414355|NCT04232761|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
111414356|NCT04232761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111414357|NCT04230304|Daratumumab|daratumumab|mesh-list
111414358|NCT04230304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111414359|NCT04224272|Fulvestrant|fulvestrant|mesh-list
111414360|NCT04224272|Palbociclib|palbociclib|mesh-list
111414361|NCT04224272|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111414362|NCT04224272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111414363|NCT04224272|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
111414364|NCT04224272|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111414365|NCT04224272|Hormone Antagonists|hormone antagonists|mesh-ancestor
111414366|NCT04224272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111414367|NCT04224272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111414368|NCT04224272|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111414369|NCT04224272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111414370|NCT04224272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111414371|NCT04223856|Carboplatin|carboplatin|mesh-list
111414372|NCT04223856|Gemcitabine|gemcitabine|mesh-list
111414373|NCT04223856|Pembrolizumab|pembrolizumab|mesh-list
111414374|NCT04223856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111414375|NCT04223856|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111414376|NCT04223856|Antimetabolites|antimetabolites|mesh-ancestor
111414377|NCT04223856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111414378|NCT04223856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111414379|NCT04223856|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111414380|NCT04205552|Nivolumab|nivolumab|mesh-list
111414381|NCT04205552|Relatlimab|relatlimab|mesh-list
111414382|NCT04205552|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111414383|NCT04205552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111414384|NCT04205552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111414385|NCT04205552|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111414386|NCT04205552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111414387|NCT04200443|Temozolomide|temozolomide|mesh-list
111414388|NCT04200443|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111414389|NCT04200443|Alkylating Agents|alkylating agents|mesh-ancestor
111138806|NCT05123365|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111414390|NCT04200443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111414391|NCT04200443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111414392|NCT04192136|Niacinamide|niacinamide|mesh-list
111414393|NCT04192136|Niacin|niacin|mesh-list
111414394|NCT04192136|Nicotinic Acids|nicotinic acids|mesh-list
111414395|NCT04192136|Vitamin B Complex|vitamin b complex|mesh-ancestor
111414396|NCT04192136|Vitamins|vitamins|mesh-ancestor
111414397|NCT04192136|Micronutrients|micronutrients|mesh-ancestor
111414398|NCT04192136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111414399|NCT04192136|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111414400|NCT04192136|Antimetabolites|antimetabolites|mesh-ancestor
111414401|NCT04192136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111414402|NCT04192136|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111414403|NCT04192136|Vasodilator Agents|vasodilator agents|mesh-ancestor
111414404|NCT04181996|Colchicine|colchicine|mesh-list
111414405|NCT04181996|Gout Suppressants|gout suppressants|mesh-ancestor
111414406|NCT04181996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111414407|NCT04181996|Tubulin Modulators|tubulin modulators|mesh-ancestor
111414408|NCT04181996|Antimitotic Agents|antimitotic agents|mesh-ancestor
111414409|NCT04181996|Mitosis Modulators|mitosis modulators|mesh-ancestor
111414410|NCT04181996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111414411|NCT04181996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111414412|NCT04174365|Brexpiprazole|brexpiprazole|mesh-list
111414413|NCT04174365|Serotonin Agents|serotonin agents|mesh-ancestor
111414414|NCT04174365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111414415|NCT04174365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111414416|NCT04174365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111414417|NCT04174365|Dopamine Agonists|dopamine agonists|mesh-ancestor
111414418|NCT04174365|Dopamine Agents|dopamine agents|mesh-ancestor
111414419|NCT04173780|Atropine|atropine|mesh-list
111414420|NCT04173780|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111414421|NCT04173780|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111414422|NCT04173780|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111414423|NCT04173780|Autonomic Agents|autonomic agents|mesh-ancestor
111414424|NCT04173780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111414425|NCT04173780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111414426|NCT04173780|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111414427|NCT04173780|Respiratory System Agents|respiratory system agents|mesh-ancestor
111414428|NCT04173780|Mydriatics|mydriatics|mesh-ancestor
111414429|NCT04173780|Parasympatholytics|parasympatholytics|mesh-ancestor
111414430|NCT04173780|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111414431|NCT04173780|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111414432|NCT04173780|Cholinergic Agents|cholinergic agents|mesh-ancestor
111414433|NCT04173780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111414434|NCT04173780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111414435|NCT04167111|Vitamin D|vitamin d|mesh-list
111414436|NCT04167111|Cholecalciferol|cholecalciferol|mesh-list
111414437|NCT04167111|Vitamins|vitamins|mesh-ancestor
111414438|NCT04167111|Micronutrients|micronutrients|mesh-ancestor
111414439|NCT04167111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111414440|NCT04167111|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111414441|NCT04167111|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111414442|NCT04139304|Prednisone|prednisone|mesh-list
111414443|NCT04139304|Cortisone|cortisone|mesh-list
111414444|NCT04139304|Cyclophosphamide|cyclophosphamide|mesh-list
111414445|NCT04139304|Doxorubicin|doxorubicin|mesh-list
111414446|NCT04139304|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111414447|NCT04139304|Etoposide|etoposide|mesh-list
111414448|NCT04139304|Vincristine|vincristine|mesh-list
111414449|NCT04139304|Etoposide phosphate|etoposide phosphate|mesh-list
111414450|NCT04139304|Daunorubicin|daunorubicin|mesh-list
111414451|NCT04139304|Daratumumab|daratumumab|mesh-list
111414452|NCT04139304|Podophyllotoxin|podophyllotoxin|mesh-list
111414453|NCT04139304|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111414454|NCT04139304|Immunologic Factors|immunologic factors|mesh-ancestor
111414455|NCT04139304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111414456|NCT04139304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111414457|NCT04139304|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111414458|NCT04139304|Alkylating Agents|alkylating agents|mesh-ancestor
111414459|NCT04139304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111414460|NCT04139304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111414461|NCT04139304|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111414462|NCT04139304|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111414463|NCT04139304|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111414464|NCT04139304|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111414465|NCT04139304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111414466|NCT04139304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111414467|NCT04139304|Glucocorticoids|glucocorticoids|mesh-ancestor
111414468|NCT04139304|Hormones|hormones|mesh-ancestor
111414469|NCT04139304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111414470|NCT04139304|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111414471|NCT04139304|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111414472|NCT04139304|Tubulin Modulators|tubulin modulators|mesh-ancestor
111414473|NCT04139304|Antimitotic Agents|antimitotic agents|mesh-ancestor
111414474|NCT04139304|Mitosis Modulators|mitosis modulators|mesh-ancestor
111414475|NCT04139304|Keratolytic Agents|keratolytic agents|mesh-ancestor
111414476|NCT04139304|Dermatologic Agents|dermatologic agents|mesh-ancestor
111414477|NCT04135690|Sorafenib|sorafenib|mesh-list
111414478|NCT04135690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111414479|NCT04135690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111414480|NCT04135690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111414481|NCT04135690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111414482|NCT04126317|Aflibercept|aflibercept|mesh-list
111414483|NCT04126317|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111414484|NCT04126317|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111414485|NCT04126317|Growth Substances|growth substances|mesh-ancestor
111414486|NCT04126317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111414487|NCT04126317|Growth Inhibitors|growth inhibitors|mesh-ancestor
111414488|NCT04126317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111414489|NCT04123314|Psilocybin|psilocybin|mesh-list
111414490|NCT04123314|Hallucinogens|hallucinogens|mesh-ancestor
111414491|NCT04123314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111414492|NCT04123314|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111414493|NCT04109924|Trifluridine|trifluridine|mesh-list
111414494|NCT04109924|Bevacizumab|bevacizumab|mesh-list
111414495|NCT04109924|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111414496|NCT04109924|Irinotecan|irinotecan|mesh-list
111414497|NCT04109924|10-hydroxycamptothecin|10-hydroxycamptothecin|mesh-list
111414498|NCT04109924|Antibodies|antibodies|mesh-list
111414499|NCT04109924|Immunoglobulins|immunoglobulins|mesh-list
111414500|NCT04109924|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111414501|NCT04109924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111414502|NCT04109924|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111414503|NCT04109924|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111414504|NCT04109924|Growth Substances|growth substances|mesh-ancestor
111414505|NCT04109924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111414506|NCT04109924|Growth Inhibitors|growth inhibitors|mesh-ancestor
111414507|NCT04109924|Immunologic Factors|immunologic factors|mesh-ancestor
111414508|NCT04109924|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111414509|NCT04109924|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111414510|NCT04109924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111414511|NCT04109924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111414512|NCT04109924|Antimetabolites|antimetabolites|mesh-ancestor
111414513|NCT04109924|Antiviral Agents|antiviral agents|mesh-ancestor
111414514|NCT04109924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111414515|NCT04109924|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111414516|NCT04104672|Paclitaxel|paclitaxel|mesh-list
111414517|NCT04104672|Gemcitabine|gemcitabine|mesh-list
111414518|NCT04104672|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111414519|NCT04104672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111414520|NCT04104672|Tubulin Modulators|tubulin modulators|mesh-ancestor
111414521|NCT04104672|Antimitotic Agents|antimitotic agents|mesh-ancestor
111414522|NCT04104672|Mitosis Modulators|mitosis modulators|mesh-ancestor
111414523|NCT04104672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111414524|NCT04104672|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111414525|NCT04104672|Antimetabolites|antimetabolites|mesh-ancestor
111414526|NCT04097028|Trifluridine|trifluridine|mesh-list
111414527|NCT04097028|Oxaliplatin|oxaliplatin|mesh-list
111414528|NCT04097028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111414529|NCT04097028|Antimetabolites|antimetabolites|mesh-ancestor
111414530|NCT04097028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111414531|NCT04097028|Antiviral Agents|antiviral agents|mesh-ancestor
111414532|NCT04097028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111414533|NCT04093596|Cyclophosphamide|cyclophosphamide|mesh-list
111414534|NCT04093596|Fludarabine|fludarabine|mesh-list
111414535|NCT04093596|Nirogacestat|nirogacestat|mesh-list
111414536|NCT04093596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111414537|NCT04093596|Immunologic Factors|immunologic factors|mesh-ancestor
111414538|NCT04093596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111414539|NCT04093596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110509417|NCT01950520|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111414540|NCT04093596|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111414541|NCT04093596|Alkylating Agents|alkylating agents|mesh-ancestor
111414542|NCT04093596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111414543|NCT04093596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111414544|NCT04093596|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111414545|NCT04093596|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
111414546|NCT04093596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111414547|NCT04091750|Nivolumab|nivolumab|mesh-list
111414548|NCT04091750|Ipilimumab|ipilimumab|mesh-list
111414549|NCT04091750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111414550|NCT04091750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111414551|NCT04091750|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111414552|NCT04091750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111414553|NCT04066894|Neurotransmitter Agents|neurotransmitter agents|mesh-list
111414554|NCT04066894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111414555|NCT04066894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111414556|NCT04043195|Oxaliplatin|oxaliplatin|mesh-list
111414557|NCT04043195|Nivolumab|nivolumab|mesh-list
111414558|NCT04043195|Ipilimumab|ipilimumab|mesh-list
111414559|NCT04043195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111414560|NCT04043195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111414561|NCT04043195|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111414562|NCT04043195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111414563|NCT04038255|Nicotine|nicotine|mesh-list
111414564|NCT04038255|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111414565|NCT04038255|Autonomic Agents|autonomic agents|mesh-ancestor
111414566|NCT04038255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111414567|NCT04038255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111414568|NCT04038255|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111414569|NCT04038255|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111414570|NCT04038255|Cholinergic Agents|cholinergic agents|mesh-ancestor
111414571|NCT04038255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111414572|NCT04038255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111414573|NCT04031729|Aspirin|aspirin|mesh-list
111414574|NCT04031729|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111414575|NCT04031729|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111414576|NCT04031729|Analgesics|analgesics|mesh-ancestor
111414577|NCT04031729|Sensory System Agents|sensory system agents|mesh-ancestor
111414578|NCT04031729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111414579|NCT04031729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111414580|NCT04031729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111414581|NCT04031729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111414582|NCT04031729|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111414583|NCT04031729|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111414584|NCT04031729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111414585|NCT04031729|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111414586|NCT04031729|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111414587|NCT04031729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111414588|NCT04031729|Antipyretics|antipyretics|mesh-ancestor
111414589|NCT04024163|Benzonidazole|benzonidazole|mesh-list
111414590|NCT04024163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111414591|NCT04024163|Immunologic Factors|immunologic factors|mesh-ancestor
111414592|NCT04024163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111414593|NCT04024163|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
111414594|NCT04024163|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111414595|NCT04024163|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111414596|NCT04024163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111414597|NCT04023019|Thrombin|thrombin|mesh-list
111414598|NCT04023019|Hemostatics|hemostatics|mesh-ancestor
111414599|NCT04023019|Coagulants|coagulants|mesh-ancestor
111414600|NCT04014387|Zolpidem|zolpidem|mesh-list
111414601|NCT04014387|Suvorexant|suvorexant|mesh-list
111414602|NCT04014387|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111414603|NCT04014387|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111414604|NCT04014387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111414605|NCT04014387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111414606|NCT04014387|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
111414607|NCT04014387|GABA Agonists|gaba agonists|mesh-ancestor
111414608|NCT04014387|GABA Agents|gaba agents|mesh-ancestor
111414609|NCT04014387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111414610|NCT04014387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110509425|NCT01950520|Urological Agents|urological agents|mesh-ancestor
111414611|NCT04014387|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
111414612|NCT04005053|Acetylcysteine|acetylcysteine|mesh-list
111414613|NCT04005053|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111414614|NCT04005053|Antiviral Agents|antiviral agents|mesh-ancestor
111414615|NCT04005053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111414616|NCT04005053|Expectorants|expectorants|mesh-ancestor
111414617|NCT04005053|Respiratory System Agents|respiratory system agents|mesh-ancestor
111414618|NCT04005053|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111414619|NCT04005053|Antioxidants|antioxidants|mesh-ancestor
111414620|NCT04005053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111414621|NCT04005053|Protective Agents|protective agents|mesh-ancestor
111414622|NCT04005053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111414623|NCT04005053|Antidotes|antidotes|mesh-ancestor
111414624|NCT03984188|Theophylline|theophylline|mesh-list
111414625|NCT03984188|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111414626|NCT03984188|Autonomic Agents|autonomic agents|mesh-ancestor
111414627|NCT03984188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111414628|NCT03984188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111414629|NCT03984188|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111414630|NCT03984188|Respiratory System Agents|respiratory system agents|mesh-ancestor
111414631|NCT03984188|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111414632|NCT03984188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111414633|NCT03984188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111414634|NCT03984188|Vasodilator Agents|vasodilator agents|mesh-ancestor
111414635|NCT03984188|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
111414636|NCT03984188|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111414637|NCT03984188|Purinergic Agents|purinergic agents|mesh-ancestor
111414638|NCT03984188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111414639|NCT03982225|Polyene phosphatidylcholine|polyene phosphatidylcholine|mesh-list
111414640|NCT03982225|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111414641|NCT03982225|Antimetabolites|antimetabolites|mesh-ancestor
111414642|NCT03982225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111414643|NCT03982225|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111414644|NCT03981796|Paclitaxel|paclitaxel|mesh-list
111414645|NCT03981796|Carboplatin|carboplatin|mesh-list
111414646|NCT03981796|Niraparib|niraparib|mesh-list
111414647|NCT03981796|Dostarlimab|dostarlimab|mesh-list
111414648|NCT03981796|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111414649|NCT03981796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111414650|NCT03981796|Tubulin Modulators|tubulin modulators|mesh-ancestor
111414651|NCT03981796|Antimitotic Agents|antimitotic agents|mesh-ancestor
111414652|NCT03981796|Mitosis Modulators|mitosis modulators|mesh-ancestor
111414653|NCT03981796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111414654|NCT03981796|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111414655|NCT03981796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111414656|NCT03976375|Docetaxel|docetaxel|mesh-list
111414657|NCT03976375|Pembrolizumab|pembrolizumab|mesh-list
111414658|NCT03976375|Lenvatinib|lenvatinib|mesh-list
111414659|NCT03976375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111414660|NCT03976375|Tubulin Modulators|tubulin modulators|mesh-ancestor
111414661|NCT03976375|Antimitotic Agents|antimitotic agents|mesh-ancestor
111414662|NCT03976375|Mitosis Modulators|mitosis modulators|mesh-ancestor
111414663|NCT03976375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111414664|NCT03976375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111414665|NCT03976375|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111414666|NCT03976375|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111414667|NCT03976375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111414668|NCT03968406|Talazoparib|talazoparib|mesh-list
111414669|NCT03968406|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111414670|NCT03968406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111414671|NCT03968406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111414672|NCT03968406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111414673|NCT03967977|Carboplatin|carboplatin|mesh-list
111414674|NCT03967977|Gemcitabine|gemcitabine|mesh-list
111414675|NCT03967977|Tislelizumab|tislelizumab|mesh-list
111414676|NCT03967977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111414677|NCT03967977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111414678|NCT03967977|Antimetabolites|antimetabolites|mesh-ancestor
111414679|NCT03967977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111414680|NCT03967977|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111414681|NCT03962647|Letrozole|letrozole|mesh-list
111414682|NCT03962647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111414683|NCT03962647|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111414684|NCT03962647|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111414685|NCT03962647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111414686|NCT03962647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111414687|NCT03962647|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111414688|NCT03962647|Hormone Antagonists|hormone antagonists|mesh-ancestor
111414689|NCT03962647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111414690|NCT03962647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111414691|NCT03961698|Paclitaxel|paclitaxel|mesh-list
111414692|NCT03961698|Bevacizumab|bevacizumab|mesh-list
111414693|NCT03961698|Atezolizumab|atezolizumab|mesh-list
111139106|NCT02581189|Ritonavir|ritonavir|mesh-list
111414694|NCT03961698|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111414695|NCT03961698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111414696|NCT03961698|Tubulin Modulators|tubulin modulators|mesh-ancestor
111414697|NCT03961698|Antimitotic Agents|antimitotic agents|mesh-ancestor
111414698|NCT03961698|Mitosis Modulators|mitosis modulators|mesh-ancestor
111414699|NCT03961698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111414700|NCT03961698|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111414701|NCT03961698|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111414702|NCT03961698|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111414703|NCT03961698|Growth Substances|growth substances|mesh-ancestor
111414704|NCT03961698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111414705|NCT03961698|Growth Inhibitors|growth inhibitors|mesh-ancestor
111414706|NCT03961698|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111414707|NCT03945643|Sildenafil Citrate|sildenafil citrate|mesh-list
111414708|NCT03945643|Vasodilator Agents|vasodilator agents|mesh-ancestor
111414709|NCT03945643|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111414710|NCT03945643|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111414711|NCT03945643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111414712|NCT03945643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111414713|NCT03945643|Urological Agents|urological agents|mesh-ancestor
111414714|NCT03938389|Valsartan|valsartan|mesh-list
111414715|NCT03938389|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
111414716|NCT03938389|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111414717|NCT03938389|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111414718|NCT03938389|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111414719|NCT03938389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111414720|NCT03929666|Leucovorin|leucovorin|mesh-list
111414721|NCT03929666|Bevacizumab|bevacizumab|mesh-list
111414722|NCT03929666|Gemcitabine|gemcitabine|mesh-list
111414723|NCT03929666|Fluorouracil|fluorouracil|mesh-list
111414724|NCT03929666|Capecitabine|capecitabine|mesh-list
111414725|NCT03929666|Oxaliplatin|oxaliplatin|mesh-list
111414726|NCT03929666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111414727|NCT03929666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111414728|NCT03929666|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111414729|NCT03929666|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111414730|NCT03929666|Growth Substances|growth substances|mesh-ancestor
111414731|NCT03929666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111414732|NCT03929666|Growth Inhibitors|growth inhibitors|mesh-ancestor
111414733|NCT03929666|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111414734|NCT03929666|Antimetabolites|antimetabolites|mesh-ancestor
111414735|NCT03929666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111414736|NCT03929666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111414737|NCT03929666|Immunologic Factors|immunologic factors|mesh-ancestor
111414738|NCT03929666|Antidotes|antidotes|mesh-ancestor
111414739|NCT03929666|Protective Agents|protective agents|mesh-ancestor
111414740|NCT03929666|Vitamin B Complex|vitamin b complex|mesh-ancestor
111414741|NCT03929666|Vitamins|vitamins|mesh-ancestor
111414742|NCT03929666|Micronutrients|micronutrients|mesh-ancestor
111414743|NCT03926130|Mirikizumab|mirikizumab|mesh-list
111414744|NCT03926130|Ustekinumab|ustekinumab|mesh-list
111414745|NCT03926130|Dermatologic Agents|dermatologic agents|mesh-ancestor
111414746|NCT03926130|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111414747|NCT03926130|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111414748|NCT03926130|Analgesics|analgesics|mesh-ancestor
111414749|NCT03926130|Sensory System Agents|sensory system agents|mesh-ancestor
111414750|NCT03926130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111414751|NCT03926130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111414752|NCT03926130|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111414753|NCT03926130|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111414754|NCT03926130|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111414755|NCT03926130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111414756|NCT03908736|Picolinic acid|picolinic acid|mesh-list
111414757|NCT03908736|Iron Chelating Agents|iron chelating agents|mesh-ancestor
111414758|NCT03908736|Chelating Agents|chelating agents|mesh-ancestor
111414759|NCT03908736|Sequestering Agents|sequestering agents|mesh-ancestor
111414760|NCT03908736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111414761|NCT03905928|Nicotine|nicotine|mesh-list
111414762|NCT03905928|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111414763|NCT03905928|Autonomic Agents|autonomic agents|mesh-ancestor
111414764|NCT03905928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111414765|NCT03905928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111414766|NCT03905928|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111414767|NCT03905928|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111414768|NCT03905928|Cholinergic Agents|cholinergic agents|mesh-ancestor
111414769|NCT03905928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111414770|NCT03905928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111414771|NCT03887780|Rivaroxaban|rivaroxaban|mesh-list
111414772|NCT03887780|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111414773|NCT03887780|Antithrombins|antithrombins|mesh-ancestor
111414774|NCT03887780|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111414775|NCT03887780|Protease Inhibitors|protease inhibitors|mesh-ancestor
111414776|NCT03887780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111414777|NCT03887780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111414778|NCT03887780|Anticoagulants|anticoagulants|mesh-ancestor
111414779|NCT03879135|Factor VIII|factor viii|mesh-list
111414780|NCT03879135|Coagulants|coagulants|mesh-ancestor
111414781|NCT03872700|Fentanyl|fentanyl|mesh-list
111414782|NCT03872700|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111414783|NCT03872700|Narcotics|narcotics|mesh-ancestor
111414784|NCT03872700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111414785|NCT03872700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111414786|NCT03872700|Analgesics|analgesics|mesh-ancestor
111414787|NCT03872700|Sensory System Agents|sensory system agents|mesh-ancestor
111414788|NCT03872700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111414789|NCT03872700|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111414790|NCT03872700|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111414791|NCT03872700|Anesthetics, General|anesthetics, general|mesh-ancestor
111414792|NCT03872700|Anesthetics|anesthetics|mesh-ancestor
111414793|NCT03846310|Carboplatin|carboplatin|mesh-list
111414794|NCT03846310|Pembrolizumab|pembrolizumab|mesh-list
111414795|NCT03846310|Pemetrexed|pemetrexed|mesh-list
111414796|NCT03846310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111414797|NCT03846310|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111414798|NCT03846310|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111414799|NCT03846310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111414800|NCT03846310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111414801|NCT03846310|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111414802|NCT03846310|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111414803|NCT03818776|Durvalumab|durvalumab|mesh-list
111414804|NCT03818776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111414805|NCT03818776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111414806|NCT03796273|Ketoconazole|ketoconazole|mesh-list
111414807|NCT03796273|Antifungal Agents|antifungal agents|mesh-ancestor
111414808|NCT03796273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111414809|NCT03796273|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111414810|NCT03796273|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111414811|NCT03796273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111414812|NCT03796273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111414813|NCT03796273|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111414814|NCT03796273|Hormone Antagonists|hormone antagonists|mesh-ancestor
111414815|NCT03796273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111414816|NCT03796273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111414817|NCT03796273|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111414818|NCT03748823|Ravulizumab|ravulizumab|mesh-list
111414819|NCT03748823|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
111414820|NCT03748823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111414821|NCT03748823|Immunologic Factors|immunologic factors|mesh-ancestor
111414822|NCT03748823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111414823|NCT03742895|Olaparib|olaparib|mesh-list
111414824|NCT03742895|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111414825|NCT03742895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111414826|NCT03742895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111414827|NCT03742895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111414828|NCT03739931|Durvalumab|durvalumab|mesh-list
111414829|NCT03739931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111414830|NCT03739931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111414831|NCT03738800|Trifarotene|trifarotene|mesh-list
111414832|NCT03738800|Dermatologic Agents|dermatologic agents|mesh-ancestor
111414833|NCT03736889|Tislelizumab|tislelizumab|mesh-list
111414834|NCT03736889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111414835|NCT03736889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111414836|NCT03719326|Paclitaxel|paclitaxel|mesh-list
111414837|NCT03719326|Doxorubicin|doxorubicin|mesh-list
111414838|NCT03719326|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111414839|NCT03719326|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111414840|NCT03719326|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111414841|NCT03719326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111414842|NCT03719326|Tubulin Modulators|tubulin modulators|mesh-ancestor
111139253|NCT05865548|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111414844|NCT03719326|Mitosis Modulators|mitosis modulators|mesh-ancestor
111414845|NCT03719326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111414846|NCT03719326|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111414847|NCT03719326|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111414848|NCT03719326|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111414849|NCT03719326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111414850|NCT03717909|Valproic Acid|valproic acid|mesh-list
111414851|NCT03717909|Anticonvulsants|anticonvulsants|mesh-ancestor
111414852|NCT03717909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111414853|NCT03717909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111414854|NCT03717909|GABA Agents|gaba agents|mesh-ancestor
111414855|NCT03717909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111414856|NCT03717909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111414857|NCT03717909|Antimanic Agents|antimanic agents|mesh-ancestor
111414858|NCT03717909|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111414859|NCT03717909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111414860|NCT03717909|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111414861|NCT03715478|Dexamethasone|dexamethasone|mesh-list
111414862|NCT03715478|Pomalidomide|pomalidomide|mesh-list
111414863|NCT03715478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111414864|NCT03715478|Antiemetics|antiemetics|mesh-ancestor
111414865|NCT03715478|Autonomic Agents|autonomic agents|mesh-ancestor
111414866|NCT03715478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111414867|NCT03715478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111414868|NCT03715478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111414869|NCT03715478|Glucocorticoids|glucocorticoids|mesh-ancestor
111414870|NCT03715478|Hormones|hormones|mesh-ancestor
110509446|NCT01771107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111414871|NCT03715478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111414872|NCT03715478|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111414873|NCT03715478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111414874|NCT03715478|Immunologic Factors|immunologic factors|mesh-ancestor
111414875|NCT03715478|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111414876|NCT03715478|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111414877|NCT03715478|Growth Substances|growth substances|mesh-ancestor
111414878|NCT03715478|Growth Inhibitors|growth inhibitors|mesh-ancestor
111414879|NCT03709043|Ethanol|ethanol|mesh-list
111414880|NCT03709043|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111414881|NCT03709043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111414882|NCT03709043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111414883|NCT03709043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111414884|NCT03701581|4-Aminopyridine|4-aminopyridine|mesh-list
111414885|NCT03701581|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
111414886|NCT03701581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111414887|NCT03701581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111414888|NCT03700138|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111414889|NCT03700138|Immunologic Factors|immunologic factors|mesh-ancestor
111414890|NCT03700138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111414891|NCT03688464|Diphenhydramine|diphenhydramine|mesh-list
111414892|NCT03688464|Promethazine|promethazine|mesh-list
111414893|NCT03688464|Melatonin|melatonin|mesh-list
111414894|NCT03688464|Antioxidants|antioxidants|mesh-ancestor
111414895|NCT03688464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111414896|NCT03688464|Protective Agents|protective agents|mesh-ancestor
111414897|NCT03688464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111414898|NCT03688464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111414899|NCT03688464|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111414900|NCT03688464|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111414901|NCT03688464|Anesthetics, Local|anesthetics, local|mesh-ancestor
111414902|NCT03688464|Anesthetics|anesthetics|mesh-ancestor
111414903|NCT03688464|Sensory System Agents|sensory system agents|mesh-ancestor
111414904|NCT03688464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111414905|NCT03688464|Antiemetics|antiemetics|mesh-ancestor
111414906|NCT03688464|Autonomic Agents|autonomic agents|mesh-ancestor
111414907|NCT03688464|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111414908|NCT03688464|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111414909|NCT03688464|Histamine Antagonists|histamine antagonists|mesh-ancestor
111414910|NCT03688464|Histamine Agents|histamine agents|mesh-ancestor
111414911|NCT03688464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111414912|NCT03688464|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111414913|NCT03688464|Antipruritics|antipruritics|mesh-ancestor
111414914|NCT03688464|Dermatologic Agents|dermatologic agents|mesh-ancestor
111414915|NCT03684811|Gemcitabine|gemcitabine|mesh-list
111139328|NCT05866029|Denosumab|denosumab|mesh-list
111414916|NCT03684811|Nivolumab|nivolumab|mesh-list
111414917|NCT03684811|Azacitidine|azacitidine|mesh-list
111414918|NCT03684811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111414919|NCT03684811|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111414920|NCT03684811|Antimetabolites|antimetabolites|mesh-ancestor
111414921|NCT03684811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111414922|NCT03684811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111414923|NCT03684811|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111414924|NCT03684811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111414925|NCT03677973|Quemliclustat|quemliclustat|mesh-list
111414926|NCT03677973|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111414927|NCT03677973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111414928|NCT03677973|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111414929|NCT03677973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111414930|NCT03666065|Insulin|insulin|mesh-list
111414931|NCT03666065|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111414932|NCT03666065|Insulin Aspart|insulin aspart|mesh-list
111414933|NCT03666065|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111414934|NCT03666065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111414935|NCT03654716|Cytarabine|cytarabine|mesh-list
111414936|NCT03654716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111414937|NCT03654716|Antimetabolites|antimetabolites|mesh-ancestor
111414938|NCT03654716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111414939|NCT03654716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111414940|NCT03654716|Antiviral Agents|antiviral agents|mesh-ancestor
111414941|NCT03654716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111414942|NCT03654716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111414943|NCT03654716|Immunologic Factors|immunologic factors|mesh-ancestor
111414944|NCT03654716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111414945|NCT03646123|Doxorubicin|doxorubicin|mesh-list
111414946|NCT03646123|Nivolumab|nivolumab|mesh-list
111414947|NCT03646123|Dacarbazine|dacarbazine|mesh-list
111414948|NCT03646123|Brentuximab Vedotin|brentuximab vedotin|mesh-list
111414949|NCT03646123|Vinblastine|vinblastine|mesh-list
111414950|NCT03646123|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111414951|NCT03646123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111414952|NCT03646123|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111414953|NCT03646123|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111414954|NCT03646123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111414955|NCT03646123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111414956|NCT03646123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111414957|NCT03646123|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111414958|NCT03646123|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111414959|NCT03646123|Alkylating Agents|alkylating agents|mesh-ancestor
111414960|NCT03646123|Immunotoxins|immunotoxins|mesh-ancestor
111414961|NCT03646123|Immunoconjugates|immunoconjugates|mesh-ancestor
111414962|NCT03646123|Immunologic Factors|immunologic factors|mesh-ancestor
111414963|NCT03646123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111414964|NCT03646123|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111414965|NCT03646123|Tubulin Modulators|tubulin modulators|mesh-ancestor
111414966|NCT03646123|Antimitotic Agents|antimitotic agents|mesh-ancestor
111414967|NCT03646123|Mitosis Modulators|mitosis modulators|mesh-ancestor
111414968|NCT03629613|Antioxidants|antioxidants|mesh-list
111414969|NCT03629613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111414970|NCT03629613|Protective Agents|protective agents|mesh-ancestor
111414971|NCT03629613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111414972|NCT03617458|Metformin|metformin|mesh-list
111414973|NCT03617458|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111414974|NCT03617458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111414975|NCT03610971|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
111414976|NCT03610971|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111414977|NCT03610971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111414978|NCT03610971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111414979|NCT03606538|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
111414980|NCT03606538|Hallucinogens|hallucinogens|mesh-ancestor
111414981|NCT03606538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111414982|NCT03606538|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111414983|NCT03606538|Serotonin Agents|serotonin agents|mesh-ancestor
111414984|NCT03606538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111414985|NCT03606538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111414986|NCT03606538|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111414987|NCT03606538|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111414988|NCT03606538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111414989|NCT03606538|Adrenergic Agents|adrenergic agents|mesh-ancestor
111414990|NCT03605927|Sirolimus|sirolimus|mesh-list
111414991|NCT03605927|Tacrolimus|tacrolimus|mesh-list
111414992|NCT03605927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111414993|NCT03605927|Immunologic Factors|immunologic factors|mesh-ancestor
111414994|NCT03605927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111414995|NCT03605927|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111414996|NCT03605927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111414997|NCT03605927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111414998|NCT03605927|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111414999|NCT03605927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111415000|NCT03605927|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111415001|NCT03605927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111415002|NCT03605927|Antifungal Agents|antifungal agents|mesh-ancestor
111415003|NCT03586284|Valganciclovir|valganciclovir|mesh-list
111415004|NCT03586284|Ganciclovir|ganciclovir|mesh-list
111415005|NCT03586284|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
111415006|NCT03586284|Antiviral Agents|antiviral agents|mesh-ancestor
111415007|NCT03586284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111415008|NCT03586284|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111415009|NCT03586284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111415010|NCT03586284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111415011|NCT03583086|Nivolumab|nivolumab|mesh-list
111415012|NCT03583086|Vorolanib|vorolanib|mesh-list
111415013|NCT03583086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111415014|NCT03583086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111415015|NCT03583086|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111415016|NCT03583086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111415017|NCT03583086|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111415018|NCT03583086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111415019|NCT03557619|Venetoclax|venetoclax|mesh-list
111415020|NCT03557619|Levonorgestrel|levonorgestrel|mesh-list
111415021|NCT03557619|Ethinyl Estradiol|ethinyl estradiol|mesh-list
111415022|NCT03557619|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
111415023|NCT03557619|Estradiol|estradiol|mesh-list
111415024|NCT03557619|Estrogens|estrogens|mesh-ancestor
111415025|NCT03557619|Hormones|hormones|mesh-ancestor
111415026|NCT03557619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111415027|NCT03557619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111415028|NCT03557619|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111415029|NCT03557619|Contraceptive Agents|contraceptive agents|mesh-ancestor
111415030|NCT03557619|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111415031|NCT03557619|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111415032|NCT03557619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111415033|NCT03557619|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111415034|NCT03557619|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111415035|NCT03557619|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111415036|NCT03557619|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
111415037|NCT03534804|Pembrolizumab|pembrolizumab|mesh-list
111415038|NCT03534804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111415039|NCT03534804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111415040|NCT03534804|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111415041|NCT03534804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111415042|NCT03532477|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
111415043|NCT03532477|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111415044|NCT03532477|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111415045|NCT03532477|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111415046|NCT03532477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111415047|NCT03532477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111415048|NCT03532477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111415049|NCT03532477|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111415050|NCT03532477|Antidepressive Agents|antidepressive agents|mesh-ancestor
111415051|NCT03532477|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111415052|NCT03530267|Aflibercept|aflibercept|mesh-list
111415053|NCT03530267|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111415054|NCT03530267|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111415055|NCT03530267|Growth Substances|growth substances|mesh-ancestor
111415056|NCT03530267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111415057|NCT03530267|Growth Inhibitors|growth inhibitors|mesh-ancestor
111415058|NCT03530267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111415059|NCT03515837|Carboplatin|carboplatin|mesh-list
111415060|NCT03515837|Pembrolizumab|pembrolizumab|mesh-list
111415061|NCT03515837|Pemetrexed|pemetrexed|mesh-list
111415062|NCT03515837|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111415063|NCT03515837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111139477|NCT05163496|Psilocybin|psilocybin|mesh-list
111415064|NCT03515837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111415065|NCT03515837|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111415066|NCT03515837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111415068|NCT03515837|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111415069|NCT03515837|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111415070|NCT03493412|Verapamil|verapamil|mesh-list
111415071|NCT03493412|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111415072|NCT03493412|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111415073|NCT03493412|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111415074|NCT03493412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111415075|NCT03493412|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111415076|NCT03493412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111415077|NCT03493412|Vasodilator Agents|vasodilator agents|mesh-ancestor
111415078|NCT03474198|Levofloxacin|levofloxacin|mesh-list
111415079|NCT03474198|Rifampin|rifampin|mesh-list
111415080|NCT03474198|Isoniazid|isoniazid|mesh-list
111415081|NCT03474198|Linezolid|linezolid|mesh-list
111415082|NCT03474198|Pyrazinamide|pyrazinamide|mesh-list
111415083|NCT03474198|Ethambutol|ethambutol|mesh-list
111415084|NCT03474198|Rifapentine|rifapentine|mesh-list
111415085|NCT03474198|Bedaquiline|bedaquiline|mesh-list
111415086|NCT03474198|Clofazimine|clofazimine|mesh-list
111415087|NCT03474198|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111415088|NCT03474198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111415089|NCT03474198|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111415090|NCT03474198|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111415091|NCT03474198|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111415092|NCT03474198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111415093|NCT03474198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111415094|NCT03474198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111415095|NCT03474198|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111415096|NCT03474198|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111415097|NCT03474198|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111415098|NCT03474198|Antitubercular Agents|antitubercular agents|mesh-ancestor
111415099|NCT03474198|Leprostatic Agents|leprostatic agents|mesh-ancestor
111415100|NCT03474198|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111415101|NCT03474198|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111415102|NCT03474198|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111415103|NCT03474198|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
111415104|NCT03474198|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
111415105|NCT03474198|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
111415106|NCT03474198|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111415107|NCT03474198|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
111415108|NCT03474198|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111415109|NCT03474198|Antimetabolites|antimetabolites|mesh-ancestor
111415110|NCT03474198|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111415111|NCT03474198|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111415112|NCT03474198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111415113|NCT03421288|Leucovorin|leucovorin|mesh-list
111415114|NCT03421288|Docetaxel|docetaxel|mesh-list
111415115|NCT03421288|Fluorouracil|fluorouracil|mesh-list
111415116|NCT03421288|Oxaliplatin|oxaliplatin|mesh-list
111415117|NCT03421288|Atezolizumab|atezolizumab|mesh-list
111415118|NCT03421288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111415119|NCT03421288|Tubulin Modulators|tubulin modulators|mesh-ancestor
111415120|NCT03421288|Antimitotic Agents|antimitotic agents|mesh-ancestor
111415121|NCT03421288|Mitosis Modulators|mitosis modulators|mesh-ancestor
111415122|NCT03421288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111415123|NCT03421288|Antimetabolites|antimetabolites|mesh-ancestor
111415124|NCT03421288|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110509520|NCT00375609|Enoxaparin|enoxaparin|mesh-list
111415125|NCT03421288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111415126|NCT03421288|Immunologic Factors|immunologic factors|mesh-ancestor
111415127|NCT03421288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111415128|NCT03421288|Antidotes|antidotes|mesh-ancestor
111415129|NCT03421288|Protective Agents|protective agents|mesh-ancestor
111415130|NCT03421288|Vitamin B Complex|vitamin b complex|mesh-ancestor
111415131|NCT03421288|Vitamins|vitamins|mesh-ancestor
111415132|NCT03421288|Micronutrients|micronutrients|mesh-ancestor
111415133|NCT03421288|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111415134|NCT03421288|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111415135|NCT03418922|Nivolumab|nivolumab|mesh-list
111415136|NCT03418922|Lenvatinib|lenvatinib|mesh-list
111415137|NCT03418922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111139553|NCT04640779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111415138|NCT03418922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111415139|NCT03418922|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111415140|NCT03418922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111415141|NCT03418922|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111415142|NCT03418922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111415143|NCT03400826|Simvastatin|simvastatin|mesh-list
111415144|NCT03400826|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111415145|NCT03400826|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111415146|NCT03400826|Antimetabolites|antimetabolites|mesh-ancestor
111415147|NCT03400826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111415148|NCT03400826|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111415149|NCT03400826|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111415150|NCT03400826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111415151|NCT03400332|Nivolumab|nivolumab|mesh-list
111415152|NCT03400332|Ipilimumab|ipilimumab|mesh-list
111415153|NCT03400332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111415154|NCT03400332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111415155|NCT03400332|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111415156|NCT03400332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111415157|NCT03386578|Tenofovir|tenofovir|mesh-list
111415158|NCT03386578|Emtricitabine|emtricitabine|mesh-list
111415159|NCT03386578|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
111415160|NCT03386578|Antiviral Agents|antiviral agents|mesh-ancestor
111415161|NCT03386578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111415162|NCT03386578|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111415163|NCT03386578|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111415164|NCT03386578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111415165|NCT03386578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111415166|NCT03386578|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111415167|NCT03386578|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111415168|NCT03371017|Carboplatin|carboplatin|mesh-list
111415169|NCT03371017|Gemcitabine|gemcitabine|mesh-list
111415170|NCT03371017|Capecitabine|capecitabine|mesh-list
111415171|NCT03371017|Atezolizumab|atezolizumab|mesh-list
111415172|NCT03371017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111415173|NCT03371017|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111415174|NCT03371017|Antimetabolites|antimetabolites|mesh-ancestor
111415175|NCT03371017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111415176|NCT03371017|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111415177|NCT03371017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111415178|NCT03345576|Methyltestosterone|methyltestosterone|mesh-list
111415179|NCT03345576|Testosterone|testosterone|mesh-list
111415180|NCT03345576|Testosterone undecanoate|testosterone undecanoate|mesh-list
111415181|NCT03345576|Testosterone enanthate|testosterone enanthate|mesh-list
111415182|NCT03345576|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
111415183|NCT03345576|Androgens|androgens|mesh-ancestor
111415184|NCT03345576|Hormones|hormones|mesh-ancestor
111415185|NCT03345576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111415186|NCT03345576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111415187|NCT03345576|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111415188|NCT03345576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111415189|NCT03345576|Anabolic Agents|anabolic agents|mesh-ancestor
111415190|NCT03342027|Bupropion|bupropion|mesh-list
111415191|NCT03342027|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111415192|NCT03342027|Antidepressive Agents|antidepressive agents|mesh-ancestor
111415193|NCT03342027|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111415194|NCT03342027|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111415195|NCT03342027|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111415196|NCT03342027|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111415197|NCT03342027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111415198|NCT03342027|Dopamine Agents|dopamine agents|mesh-ancestor
111415199|NCT03342027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111415200|NCT03342027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111415201|NCT03342027|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111415202|NCT03342027|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111415203|NCT03342027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111415204|NCT03326245|Methylphenidate|methylphenidate|mesh-list
111415205|NCT03326245|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111415206|NCT03326245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111415207|NCT03326245|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111415208|NCT03326245|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111139637|NCT03913559|Antiviral Agents|antiviral agents|mesh-ancestor
111415209|NCT03326245|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111415210|NCT03326245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111415212|NCT03326245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111415213|NCT03245541|Durvalumab|durvalumab|mesh-list
111415214|NCT03245541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111415215|NCT03245541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111415216|NCT03245489|Aspirin|aspirin|mesh-list
111415217|NCT03245489|Pembrolizumab|pembrolizumab|mesh-list
111415218|NCT03245489|Clopidogrel|clopidogrel|mesh-list
111415219|NCT03245489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111415220|NCT03245489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111415221|NCT03245489|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111415222|NCT03245489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111415223|NCT03245489|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111415224|NCT03245489|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111415225|NCT03245489|Analgesics|analgesics|mesh-ancestor
111415226|NCT03245489|Sensory System Agents|sensory system agents|mesh-ancestor
111415227|NCT03245489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111415228|NCT03245489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111415229|NCT03245489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111415230|NCT03245489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111415231|NCT03245489|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111415232|NCT03245489|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111415233|NCT03245489|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111415234|NCT03245489|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111415235|NCT03245489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111415236|NCT03245489|Antipyretics|antipyretics|mesh-ancestor
111415237|NCT03245489|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111415238|NCT03245489|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111415239|NCT03245489|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111415240|NCT03245489|Purinergic Agents|purinergic agents|mesh-ancestor
111415241|NCT03245489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111415242|NCT03240809|Brodalumab|brodalumab|mesh-list
111415243|NCT03240809|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111415244|NCT03240809|Dermatologic Agents|dermatologic agents|mesh-ancestor
111415245|NCT03240809|Immunologic Factors|immunologic factors|mesh-ancestor
111415246|NCT03240809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111415247|NCT03192995|Cocaine|cocaine|mesh-list
111415248|NCT03192995|Anesthetics, Local|anesthetics, local|mesh-ancestor
111415249|NCT03192995|Anesthetics|anesthetics|mesh-ancestor
111415250|NCT03192995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111415251|NCT03192995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111415252|NCT03192995|Sensory System Agents|sensory system agents|mesh-ancestor
111415253|NCT03192995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111415254|NCT03192995|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111415255|NCT03192995|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111415256|NCT03192995|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111415257|NCT03192995|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111415258|NCT03192995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111415259|NCT03192995|Dopamine Agents|dopamine agents|mesh-ancestor
111415260|NCT03192995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111415261|NCT03190954|Raclopride|raclopride|mesh-list
111415262|NCT03190954|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111415263|NCT03190954|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111415264|NCT03190954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111415265|NCT03190954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111415266|NCT03190954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111415267|NCT03190954|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111415268|NCT03190954|Dopamine Agents|dopamine agents|mesh-ancestor
111415269|NCT03190954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111415270|NCT03190954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111415271|NCT03174977|Raltegravir Potassium|raltegravir potassium|mesh-list
111415272|NCT03174977|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111415273|NCT03174977|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111415274|NCT03174977|Antiviral Agents|antiviral agents|mesh-ancestor
111415275|NCT03174977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111415276|NCT03174977|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111415277|NCT03174977|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111415278|NCT03174977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111415279|NCT03174977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111415280|NCT03150511|Tesamorelin|tesamorelin|mesh-list
111139709|NCT03733132|Metformin|metformin|mesh-list
111415281|NCT03150511|Growth Substances|growth substances|mesh-ancestor
111415282|NCT03150511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111415283|NCT03149809|Solifenacin Succinate|solifenacin succinate|mesh-list
111415284|NCT03149809|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111415285|NCT03149809|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111415286|NCT03149809|Cholinergic Agents|cholinergic agents|mesh-ancestor
111415287|NCT03149809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111415288|NCT03149809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111415289|NCT03149809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111415290|NCT03149809|Urological Agents|urological agents|mesh-ancestor
111415291|NCT03121677|Poly I-C|poly i-c|mesh-list
111415292|NCT03121677|Rituximab|rituximab|mesh-list
111415293|NCT03121677|Nivolumab|nivolumab|mesh-list
111415294|NCT03121677|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
111415295|NCT03121677|Poly ICLC|poly iclc|mesh-list
111415296|NCT03121677|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111415297|NCT03121677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111415298|NCT03121677|Immunologic Factors|immunologic factors|mesh-ancestor
111415299|NCT03121677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111415300|NCT03121677|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111415301|NCT03121677|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111415302|NCT03121677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111415303|NCT03121677|Interferon Inducers|interferon inducers|mesh-ancestor
111415304|NCT03121677|Laxatives|laxatives|mesh-ancestor
111415305|NCT03121677|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111415306|NCT03121677|Antiviral Agents|antiviral agents|mesh-ancestor
111415307|NCT03121677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111415308|NCT03114527|Everolimus|everolimus|mesh-list
111415309|NCT03114527|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111415310|NCT03114527|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111415311|NCT03114527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111415312|NCT03114527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111415313|NCT03114527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111415314|NCT03114527|Immunologic Factors|immunologic factors|mesh-ancestor
111415315|NCT03114527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111415316|NCT03114527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111415317|NCT03110926|Leucovorin|leucovorin|mesh-list
111415318|NCT03110926|Paclitaxel|paclitaxel|mesh-list
111415319|NCT03110926|Carboplatin|carboplatin|mesh-list
111415320|NCT03110926|Oxaliplatin|oxaliplatin|mesh-list
111415321|NCT03110926|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111415322|NCT03110926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111415323|NCT03110926|Tubulin Modulators|tubulin modulators|mesh-ancestor
111415324|NCT03110926|Antimitotic Agents|antimitotic agents|mesh-ancestor
111415325|NCT03110926|Mitosis Modulators|mitosis modulators|mesh-ancestor
111415326|NCT03110926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111415327|NCT03110926|Antidotes|antidotes|mesh-ancestor
111415328|NCT03110926|Protective Agents|protective agents|mesh-ancestor
111415329|NCT03110926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111415330|NCT03110926|Vitamin B Complex|vitamin b complex|mesh-ancestor
111415331|NCT03110926|Vitamins|vitamins|mesh-ancestor
111415332|NCT03110926|Micronutrients|micronutrients|mesh-ancestor
111415333|NCT03092856|Axitinib|axitinib|mesh-list
111415334|NCT03092856|Antibodies|antibodies|mesh-list
111415335|NCT03092856|Immunologic Factors|immunologic factors|mesh-ancestor
111415336|NCT03092856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111415337|NCT03092856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111415338|NCT03092856|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111415339|NCT03092856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111415340|NCT03092856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111415341|NCT03088813|Irinotecan|irinotecan|mesh-list
111415342|NCT03088813|Topotecan|topotecan|mesh-list
111415343|NCT03088813|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111415344|NCT03088813|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111415345|NCT03088813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111415346|NCT03088813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111415347|NCT03088813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111415348|NCT03078010|Tazobactam|tazobactam|mesh-list
111415349|NCT03078010|Piperacillin|piperacillin|mesh-list
111415350|NCT03078010|Cefepime|cefepime|mesh-list
111415351|NCT03078010|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
111415352|NCT03078010|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111415353|NCT03078010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111415354|NCT03078010|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
111415355|NCT03078010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111415356|NCT03078010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111415357|NCT03075696|Obinutuzumab|obinutuzumab|mesh-list
111415358|NCT03075696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111415359|NCT03075696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111415360|NCT03043950|Panitumumab|panitumumab|mesh-list
111415361|NCT03043950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111415362|NCT03043950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111415363|NCT03035331|Pembrolizumab|pembrolizumab|mesh-list
111415364|NCT03035331|Vaccines|vaccines|mesh-list
111415365|NCT03035331|Immunologic Factors|immunologic factors|mesh-ancestor
111415366|NCT03035331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111415367|NCT03035331|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111415368|NCT03035331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111415369|NCT03035331|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111415370|NCT03035331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111415371|NCT02989636|Nivolumab|nivolumab|mesh-list
111415372|NCT02989636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111415373|NCT02989636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111415374|NCT02989636|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111415375|NCT02989636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111415376|NCT02944500|Liraglutide|liraglutide|mesh-list
111415377|NCT02944500|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111415378|NCT02944500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111415379|NCT02944500|Incretins|incretins|mesh-ancestor
111415380|NCT02944500|Hormones|hormones|mesh-ancestor
111415381|NCT02944500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111415382|NCT02935361|Atezolizumab|atezolizumab|mesh-list
111415383|NCT02935361|Guadecitabine|guadecitabine|mesh-list
111415384|NCT02935361|Azacitidine|azacitidine|mesh-list
111415385|NCT02935361|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111415386|NCT02935361|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111415387|NCT02935361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111415388|NCT02935361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111415389|NCT02935361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111415390|NCT02935361|Immunologic Factors|immunologic factors|mesh-ancestor
111415391|NCT02935361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111415392|NCT02935361|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111415393|NCT02935361|Antimetabolites|antimetabolites|mesh-ancestor
111415394|NCT02935361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111415395|NCT02932618|Factor VIII|factor viii|mesh-list
111415396|NCT02932618|Coagulants|coagulants|mesh-ancestor
111415397|NCT02923934|Nivolumab|nivolumab|mesh-list
111415398|NCT02923934|Ipilimumab|ipilimumab|mesh-list
111415399|NCT02923934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111415400|NCT02923934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111415401|NCT02923934|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111415402|NCT02923934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111415403|NCT02913313|Nivolumab|nivolumab|mesh-list
111415404|NCT02913313|Ipilimumab|ipilimumab|mesh-list
111415405|NCT02913313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111415406|NCT02913313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111415407|NCT02913313|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111415408|NCT02913313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111415409|NCT02908477|Docetaxel|docetaxel|mesh-list
111415410|NCT02908477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111415411|NCT02908477|Tubulin Modulators|tubulin modulators|mesh-ancestor
111415412|NCT02908477|Antimitotic Agents|antimitotic agents|mesh-ancestor
111415413|NCT02908477|Mitosis Modulators|mitosis modulators|mesh-ancestor
111415414|NCT02908477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111415415|NCT02892123|Paclitaxel|paclitaxel|mesh-list
111415416|NCT02892123|Vinorelbine|vinorelbine|mesh-list
111415417|NCT02892123|Capecitabine|capecitabine|mesh-list
111415418|NCT02892123|Tucatinib|tucatinib|mesh-list
111415419|NCT02892123|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111415420|NCT02892123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111415421|NCT02892123|Tubulin Modulators|tubulin modulators|mesh-ancestor
111415422|NCT02892123|Antimitotic Agents|antimitotic agents|mesh-ancestor
111415423|NCT02892123|Mitosis Modulators|mitosis modulators|mesh-ancestor
111415424|NCT02892123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111415425|NCT02892123|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111415426|NCT02892123|Antimetabolites|antimetabolites|mesh-ancestor
111415427|NCT02892123|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111415428|NCT02892123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111415429|NCT02754726|Paclitaxel|paclitaxel|mesh-list
111415430|NCT02754726|Gemcitabine|gemcitabine|mesh-list
111415431|NCT02754726|Nivolumab|nivolumab|mesh-list
111415432|NCT02754726|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111139859|NCT02168829|Aspirin|aspirin|mesh-list
111415433|NCT02754726|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111415434|NCT02754726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111415435|NCT02754726|Tubulin Modulators|tubulin modulators|mesh-ancestor
111415436|NCT02754726|Antimitotic Agents|antimitotic agents|mesh-ancestor
111415437|NCT02754726|Mitosis Modulators|mitosis modulators|mesh-ancestor
111415438|NCT02754726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110509609|NCT00617851|Vaccines|vaccines|mesh-list
111415439|NCT02754726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111415440|NCT02754726|Antimetabolites|antimetabolites|mesh-ancestor
111415441|NCT02754726|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111415442|NCT02754726|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111415443|NCT02733185|Vitamins|vitamins|mesh-list
111415444|NCT02733185|Edetic Acid|edetic acid|mesh-list
111415445|NCT02733185|Pentetic Acid|pentetic acid|mesh-list
111415446|NCT02733185|Micronutrients|micronutrients|mesh-ancestor
111415447|NCT02733185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111415448|NCT02733185|Anticoagulants|anticoagulants|mesh-ancestor
111415449|NCT02733185|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
111415450|NCT02733185|Chelating Agents|chelating agents|mesh-ancestor
111415451|NCT02733185|Sequestering Agents|sequestering agents|mesh-ancestor
111415452|NCT02733185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111415453|NCT02733185|Antidotes|antidotes|mesh-ancestor
111415454|NCT02733185|Protective Agents|protective agents|mesh-ancestor
111415455|NCT02733185|Iron Chelating Agents|iron chelating agents|mesh-ancestor
111415456|NCT02720445|Nicotine|nicotine|mesh-list
111415457|NCT02720445|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111415458|NCT02720445|Autonomic Agents|autonomic agents|mesh-ancestor
111415459|NCT02720445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111415460|NCT02720445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111415461|NCT02720445|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111415462|NCT02720445|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111415463|NCT02720445|Cholinergic Agents|cholinergic agents|mesh-ancestor
111415464|NCT02720445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111415465|NCT02720445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111415466|NCT02713997|Etanercept|etanercept|mesh-list
111415467|NCT02713997|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
111415468|NCT02713997|Protein C Inhibitor|protein c inhibitor|mesh-list
111415469|NCT02713997|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111415470|NCT02713997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111415471|NCT02713997|Analgesics|analgesics|mesh-ancestor
111415472|NCT02713997|Sensory System Agents|sensory system agents|mesh-ancestor
111415473|NCT02713997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111415474|NCT02713997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111415475|NCT02713997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111415476|NCT02713997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111415477|NCT02713997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111415478|NCT02713997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111415479|NCT02713997|Immunologic Factors|immunologic factors|mesh-ancestor
111415480|NCT02713997|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
111415481|NCT02713997|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111415482|NCT02713997|Protease Inhibitors|protease inhibitors|mesh-ancestor
111415483|NCT02713997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111415484|NCT02713997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111415485|NCT02703623|Prednisone|prednisone|mesh-list
111415486|NCT02703623|Cortisone|cortisone|mesh-list
111415487|NCT02703623|Carboplatin|carboplatin|mesh-list
111415488|NCT02703623|Ipilimumab|ipilimumab|mesh-list
111415489|NCT02703623|Abiraterone Acetate|abiraterone acetate|mesh-list
111415490|NCT02703623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111415491|NCT02703623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111415492|NCT02703623|Glucocorticoids|glucocorticoids|mesh-ancestor
111415493|NCT02703623|Hormones|hormones|mesh-ancestor
111415494|NCT02703623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111415495|NCT02703623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111415496|NCT02703623|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111415497|NCT02703623|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111415498|NCT02703623|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111415499|NCT02703623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111415500|NCT02703623|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111415501|NCT02703623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111415502|NCT02703623|Hormone Antagonists|hormone antagonists|mesh-ancestor
111415503|NCT02703623|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111415504|NCT02684227|Paclitaxel|paclitaxel|mesh-list
111415505|NCT02684227|Carboplatin|carboplatin|mesh-list
111415506|NCT02684227|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111415507|NCT02684227|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111415508|NCT02684227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111415509|NCT02684227|Tubulin Modulators|tubulin modulators|mesh-ancestor
111415510|NCT02684227|Antimitotic Agents|antimitotic agents|mesh-ancestor
111415511|NCT02684227|Mitosis Modulators|mitosis modulators|mesh-ancestor
111415512|NCT02684227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111415513|NCT02623972|Cyclophosphamide|cyclophosphamide|mesh-list
111415514|NCT02623972|Doxorubicin|doxorubicin|mesh-list
111415515|NCT02623972|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111415516|NCT02623972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111415517|NCT02623972|Immunologic Factors|immunologic factors|mesh-ancestor
111415518|NCT02623972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111415519|NCT02623972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111415520|NCT02623972|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111415521|NCT02623972|Alkylating Agents|alkylating agents|mesh-ancestor
111415522|NCT02623972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111415523|NCT02623972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111415524|NCT02623972|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111415525|NCT02623972|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111415526|NCT02623972|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111415527|NCT02623972|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111415528|NCT02623972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111415530|NCT02568618|Sensory System Agents|sensory system agents|mesh-ancestor
111415531|NCT02568618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111415532|NCT02568618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111415533|NCT02536300|Idelalisib|idelalisib|mesh-list
111415534|NCT02536300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111415535|NCT02536300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111415536|NCT02536300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111415537|NCT02525692|TIC10 compound|tic10 compound|mesh-list
111415538|NCT02525692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111415539|NCT02522715|Prednisone|prednisone|mesh-list
111415540|NCT02522715|Cortisone|cortisone|mesh-list
111415541|NCT02522715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111415542|NCT02522715|Glucocorticoids|glucocorticoids|mesh-ancestor
111415543|NCT02522715|Hormones|hormones|mesh-ancestor
111415544|NCT02522715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111415545|NCT02522715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111415546|NCT02522715|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111415547|NCT02522715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111415548|NCT02514382|Dexamethasone|dexamethasone|mesh-list
111415549|NCT02514382|Dexamethasone acetate|dexamethasone acetate|mesh-list
111415550|NCT02514382|Bortezomib|bortezomib|mesh-list
111415551|NCT02514382|Ichthammol|ichthammol|mesh-list
111415552|NCT02514382|BB 1101|bb 1101|mesh-list
111415553|NCT02514382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111415554|NCT02514382|Antiemetics|antiemetics|mesh-ancestor
111415555|NCT02514382|Autonomic Agents|autonomic agents|mesh-ancestor
111415556|NCT02514382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111415557|NCT02514382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111415558|NCT02514382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111415559|NCT02514382|Glucocorticoids|glucocorticoids|mesh-ancestor
111415560|NCT02514382|Hormones|hormones|mesh-ancestor
111415561|NCT02514382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110509630|NCT02806362|Ritonavir|ritonavir|mesh-list
111415562|NCT02514382|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111415563|NCT02514382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111415564|NCT02514382|Protease Inhibitors|protease inhibitors|mesh-ancestor
111415565|NCT02514382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111415566|NCT02514382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111415567|NCT02514382|Dermatologic Agents|dermatologic agents|mesh-ancestor
111415568|NCT02512718|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
111415569|NCT02512718|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
111415570|NCT02512718|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
111415571|NCT02512718|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111415572|NCT02511067|Ranibizumab|ranibizumab|mesh-list
111415573|NCT02511067|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111415574|NCT02511067|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111415575|NCT02511067|Growth Substances|growth substances|mesh-ancestor
111415576|NCT02511067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111415577|NCT02511067|Growth Inhibitors|growth inhibitors|mesh-ancestor
111415578|NCT02511067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111415579|NCT02500407|Atezolizumab|atezolizumab|mesh-list
111415580|NCT02500407|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111415581|NCT02500407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111415582|NCT02500407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111415583|NCT02500407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111415584|NCT02499354|Iron|iron|mesh-list
111415585|NCT02499354|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
111415586|NCT02499354|Trace Elements|trace elements|mesh-ancestor
111415587|NCT02499354|Micronutrients|micronutrients|mesh-ancestor
111415588|NCT02499354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111415589|NCT02499354|Hematinics|hematinics|mesh-ancestor
111415590|NCT02499354|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
111415591|NCT02499354|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111415592|NCT02488967|Paclitaxel|paclitaxel|mesh-list
111415593|NCT02488967|Cyclophosphamide|cyclophosphamide|mesh-list
111415594|NCT02488967|Carboplatin|carboplatin|mesh-list
111415595|NCT02488967|Doxorubicin|doxorubicin|mesh-list
111415596|NCT02488967|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111415597|NCT02488967|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111415598|NCT02488967|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111415599|NCT02488967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111415600|NCT02488967|Tubulin Modulators|tubulin modulators|mesh-ancestor
111415601|NCT02488967|Antimitotic Agents|antimitotic agents|mesh-ancestor
111415602|NCT02488967|Mitosis Modulators|mitosis modulators|mesh-ancestor
111415603|NCT02488967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111415604|NCT02488967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111415605|NCT02488967|Immunologic Factors|immunologic factors|mesh-ancestor
111415606|NCT02488967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111415607|NCT02488967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111415608|NCT02488967|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111415609|NCT02488967|Alkylating Agents|alkylating agents|mesh-ancestor
111415610|NCT02488967|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111415611|NCT02488967|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111415612|NCT02488967|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111415613|NCT02488967|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111415614|NCT02488967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111415615|NCT02458274|Dimercaprol|dimercaprol|mesh-list
111415616|NCT02458274|Chelating Agents|chelating agents|mesh-ancestor
111415617|NCT02458274|Sequestering Agents|sequestering agents|mesh-ancestor
111415618|NCT02458274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111415619|NCT02420613|Sirolimus|sirolimus|mesh-list
111415620|NCT02420613|Temsirolimus|temsirolimus|mesh-list
111415621|NCT02420613|Vorinostat|vorinostat|mesh-list
111415622|NCT02420613|MTOR Inhibitors|mtor inhibitors|mesh-list
111415623|NCT02420613|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111415624|NCT02420613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111415625|NCT02420613|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111415626|NCT02420613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111415627|NCT02420613|Antifungal Agents|antifungal agents|mesh-ancestor
111415628|NCT02420613|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111415629|NCT02420613|Immunologic Factors|immunologic factors|mesh-ancestor
111415630|NCT02420613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111415631|NCT02420613|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111415632|NCT02420613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111415633|NCT02420613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111415634|NCT02420613|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111415635|NCT02417285|Obinutuzumab|obinutuzumab|mesh-list
111415636|NCT02417285|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111415637|NCT02417285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111415638|NCT02409147|Nystatin|nystatin|mesh-list
111415639|NCT02409147|Prednisone|prednisone|mesh-list
111415640|NCT02409147|Thymoglobulin|thymoglobulin|mesh-list
111415641|NCT02409147|Basiliximab|basiliximab|mesh-list
111415642|NCT02409147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111415643|NCT02409147|Glucocorticoids|glucocorticoids|mesh-ancestor
111415644|NCT02409147|Hormones|hormones|mesh-ancestor
111415645|NCT02409147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111415646|NCT02409147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111415647|NCT02409147|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111415648|NCT02409147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111415649|NCT02409147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111415650|NCT02409147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111415651|NCT02409147|Immunologic Factors|immunologic factors|mesh-ancestor
111415652|NCT02409147|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111415653|NCT02409147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111415654|NCT02409147|Antifungal Agents|antifungal agents|mesh-ancestor
111415655|NCT02409147|Ionophores|ionophores|mesh-ancestor
111415656|NCT02409147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111415657|NCT02402439|Pancrelipase|pancrelipase|mesh-list
111415658|NCT02402439|Pancreatin|pancreatin|mesh-list
111415659|NCT02402439|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111415660|NCT02392026|Metronidazole|metronidazole|mesh-list
111415661|NCT02392026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111415662|NCT02392026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111415663|NCT02392026|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111415664|NCT02392026|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111415665|NCT02389036|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111415667|NCT02389036|Ceftriaxone|ceftriaxone|mesh-list
111415668|NCT02389036|Tobramycin|tobramycin|mesh-list
111415669|NCT02389036|Colistin|colistin|mesh-list
111415670|NCT02389036|Nystatin|nystatin|mesh-list
111415671|NCT02389036|Cefotaxime|cefotaxime|mesh-list
111415672|NCT02389036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111415673|NCT02389036|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111415674|NCT02389036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111415675|NCT02389036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111415676|NCT02389036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111415677|NCT02389036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111415678|NCT02389036|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111415679|NCT02389036|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111415680|NCT02389036|Antifungal Agents|antifungal agents|mesh-ancestor
111415681|NCT02389036|Ionophores|ionophores|mesh-ancestor
111415682|NCT02389036|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111415683|NCT02369523|Bupivacaine|bupivacaine|mesh-list
111415684|NCT02369523|Ropivacaine|ropivacaine|mesh-list
111415685|NCT02369523|Anesthetics, Local|anesthetics, local|mesh-ancestor
111415686|NCT02369523|Anesthetics|anesthetics|mesh-ancestor
111415687|NCT02369523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111415688|NCT02369523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111415689|NCT02369523|Sensory System Agents|sensory system agents|mesh-ancestor
111415690|NCT02369523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111415691|NCT02365649|Upadacitinib|upadacitinib|mesh-list
111415692|NCT02365649|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
111415693|NCT02365649|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111415694|NCT02365649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111415695|NCT02365649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111415696|NCT02365649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111415697|NCT02344355|Ascorbic Acid|ascorbic acid|mesh-list
111415698|NCT02344355|Temozolomide|temozolomide|mesh-list
111415699|NCT02344355|Vitamins|vitamins|mesh-ancestor
111415700|NCT02344355|Micronutrients|micronutrients|mesh-ancestor
111415701|NCT02344355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111415702|NCT02344355|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111415703|NCT02344355|Alkylating Agents|alkylating agents|mesh-ancestor
111415704|NCT02344355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111415705|NCT02344355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111415706|NCT02344355|Antioxidants|antioxidants|mesh-ancestor
111415707|NCT02344355|Protective Agents|protective agents|mesh-ancestor
111415708|NCT02339064|Apomorphine|apomorphine|mesh-list
111415709|NCT02339064|Emetics|emetics|mesh-ancestor
111415710|NCT02339064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111415711|NCT02339064|Autonomic Agents|autonomic agents|mesh-ancestor
111415712|NCT02339064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111415713|NCT02339064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111415714|NCT02339064|Dopamine Agonists|dopamine agonists|mesh-ancestor
111415715|NCT02339064|Dopamine Agents|dopamine agents|mesh-ancestor
111415716|NCT02339064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111415717|NCT02339064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111415718|NCT02289209|Pembrolizumab|pembrolizumab|mesh-list
111415719|NCT02289209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111415720|NCT02289209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111415721|NCT02289209|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111415722|NCT02289209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111415723|NCT02277717|Trastuzumab|trastuzumab|mesh-list
111415724|NCT02277717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111415725|NCT02277717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111415726|NCT02269280|Azacitidine|azacitidine|mesh-list
111415727|NCT02269280|Decitabine|decitabine|mesh-list
111415728|NCT02269280|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111415729|NCT02269280|Antimetabolites|antimetabolites|mesh-ancestor
111415730|NCT02269280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111415731|NCT02269280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111415732|NCT02269280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111415733|NCT02233829|Dopamine|dopamine|mesh-list
111415734|NCT02233829|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111415735|NCT02233829|Sympathomimetics|sympathomimetics|mesh-ancestor
111140148|NCT02380287|Antibodies|antibodies|mesh-list
111415736|NCT02233829|Autonomic Agents|autonomic agents|mesh-ancestor
111415737|NCT02233829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111415738|NCT02233829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111415739|NCT02233829|Dopamine Agents|dopamine agents|mesh-ancestor
111415740|NCT02233829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111415741|NCT02233829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111415742|NCT02233829|Protective Agents|protective agents|mesh-ancestor
111415743|NCT02207712|Ranibizumab|ranibizumab|mesh-list
111415744|NCT02207712|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111415745|NCT02207712|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111415746|NCT02207712|Growth Substances|growth substances|mesh-ancestor
111415747|NCT02207712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111415748|NCT02207712|Growth Inhibitors|growth inhibitors|mesh-ancestor
111415749|NCT02207712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111415750|NCT02187991|Paclitaxel|paclitaxel|mesh-list
111415751|NCT02187991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111415752|NCT02187991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111415753|NCT02187991|Tubulin Modulators|tubulin modulators|mesh-ancestor
111415754|NCT02187991|Antimitotic Agents|antimitotic agents|mesh-ancestor
111415755|NCT02187991|Mitosis Modulators|mitosis modulators|mesh-ancestor
111415756|NCT02187991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111415757|NCT02108860|Abatacept|abatacept|mesh-list
111415758|NCT02108860|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111415759|NCT02108860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111415760|NCT02108860|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111415761|NCT02108860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111415762|NCT02108860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111415763|NCT02108860|Immunologic Factors|immunologic factors|mesh-ancestor
111415764|NCT02108860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111415765|NCT02108860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111415766|NCT02079181|Fluorides|fluorides|mesh-list
111415767|NCT02079181|Cariostatic Agents|cariostatic agents|mesh-ancestor
111415768|NCT02079181|Protective Agents|protective agents|mesh-ancestor
111415769|NCT02079181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111415770|NCT02043457|Hormones|hormones|mesh-list
111415771|NCT02043457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111415772|NCT02043457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111415773|NCT01949662|Lorazepam|lorazepam|mesh-list
111415774|NCT01949662|Haloperidol|haloperidol|mesh-list
111415775|NCT01949662|Haloperidol decanoate|haloperidol decanoate|mesh-list
111415776|NCT01949662|Antiemetics|antiemetics|mesh-ancestor
111415777|NCT01949662|Autonomic Agents|autonomic agents|mesh-ancestor
111415778|NCT01949662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111415779|NCT01949662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111415780|NCT01949662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111415781|NCT01949662|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111415782|NCT01949662|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111415783|NCT01949662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111415784|NCT01949662|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111415785|NCT01949662|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111415786|NCT01949662|Dopamine Agents|dopamine agents|mesh-ancestor
111415787|NCT01949662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111415788|NCT01949662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111415789|NCT01949662|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111415790|NCT01949662|Anticonvulsants|anticonvulsants|mesh-ancestor
111415791|NCT01949662|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111415792|NCT01949662|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111415793|NCT01949662|GABA Modulators|gaba modulators|mesh-ancestor
111415794|NCT01949662|GABA Agents|gaba agents|mesh-ancestor
111415795|NCT01892722|Interferons|interferons|mesh-list
111415796|NCT01892722|Interferon-beta|interferon-beta|mesh-list
111415797|NCT01892722|Interferon beta-1a|interferon beta-1a|mesh-list
111415798|NCT01892722|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
111415799|NCT01892722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111415800|NCT01892722|Antiviral Agents|antiviral agents|mesh-ancestor
111415801|NCT01892722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111415802|NCT01892722|Immunologic Factors|immunologic factors|mesh-ancestor
111415803|NCT01892722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111415804|NCT01892722|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111415805|NCT01892722|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
111415806|NCT01892722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111415807|NCT01892722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111415808|NCT01860937|Cyclophosphamide|cyclophosphamide|mesh-list
111415809|NCT01860937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111415810|NCT01860937|Immunologic Factors|immunologic factors|mesh-ancestor
111415811|NCT01860937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111415812|NCT01860937|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111415813|NCT01860937|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111415814|NCT01860937|Alkylating Agents|alkylating agents|mesh-ancestor
111415815|NCT01860937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111415816|NCT01860937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111415817|NCT01860937|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111415819|NCT01770145|Carbidopa|carbidopa|mesh-list
111415820|NCT01770145|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
111415821|NCT01770145|Trimethobenzamide|trimethobenzamide|mesh-list
111415822|NCT01770145|Apomorphine|apomorphine|mesh-list
111415823|NCT01770145|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111415824|NCT01770145|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111415825|NCT01770145|Dopamine Agents|dopamine agents|mesh-ancestor
111415826|NCT01770145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111415827|NCT01770145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111415828|NCT01770145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111415829|NCT01770145|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
111415830|NCT01770145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111415831|NCT01770145|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111415832|NCT01770145|Immunologic Factors|immunologic factors|mesh-ancestor
111415833|NCT01770145|Dopamine Agonists|dopamine agonists|mesh-ancestor
111415834|NCT01770145|Emetics|emetics|mesh-ancestor
111415835|NCT01770145|Autonomic Agents|autonomic agents|mesh-ancestor
111415836|NCT01770145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111415837|NCT01770145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111415838|NCT01770145|Antiemetics|antiemetics|mesh-ancestor
111415839|NCT01758081|Vitamin D|vitamin d|mesh-list
111415840|NCT01758081|Ergocalciferols|ergocalciferols|mesh-list
111415841|NCT01758081|Cholecalciferol|cholecalciferol|mesh-list
111415842|NCT01758081|Vitamins|vitamins|mesh-list
111415843|NCT01758081|Micronutrients|micronutrients|mesh-ancestor
111415844|NCT01758081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111415845|NCT01758081|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111415846|NCT01758081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111415847|NCT01746836|Ponatinib|ponatinib|mesh-list
111415848|NCT01746836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111415849|NCT01746836|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111415850|NCT01746836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111415851|NCT01746836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111415852|NCT01726582|Leucovorin|leucovorin|mesh-list
111415853|NCT01726582|Paclitaxel|paclitaxel|mesh-list
111415854|NCT01726582|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111415855|NCT01726582|Gemcitabine|gemcitabine|mesh-list
111415856|NCT01726582|Fluorouracil|fluorouracil|mesh-list
111415857|NCT01726582|Capecitabine|capecitabine|mesh-list
111415858|NCT01726582|Oxaliplatin|oxaliplatin|mesh-list
111415859|NCT01726582|Irinotecan|irinotecan|mesh-list
111415860|NCT01726582|Cisplatin|cisplatin|mesh-list
111415861|NCT01726582|Folfirinox|folfirinox|mesh-list
111415862|NCT01726582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111415863|NCT01726582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111415864|NCT01726582|Tubulin Modulators|tubulin modulators|mesh-ancestor
111415865|NCT01726582|Antimitotic Agents|antimitotic agents|mesh-ancestor
111415866|NCT01726582|Mitosis Modulators|mitosis modulators|mesh-ancestor
111415867|NCT01726582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111415868|NCT01726582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111415869|NCT01726582|Antimetabolites|antimetabolites|mesh-ancestor
111415870|NCT01726582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111415871|NCT01726582|Immunologic Factors|immunologic factors|mesh-ancestor
111415872|NCT01726582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111415873|NCT01726582|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111415874|NCT01726582|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111415875|NCT01726582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111415876|NCT01726582|Antidotes|antidotes|mesh-ancestor
111415877|NCT01726582|Protective Agents|protective agents|mesh-ancestor
111415878|NCT01726582|Vitamin B Complex|vitamin b complex|mesh-ancestor
111415879|NCT01726582|Vitamins|vitamins|mesh-ancestor
111415880|NCT01726582|Micronutrients|micronutrients|mesh-ancestor
111415881|NCT01701986|Mycophenolic Acid|mycophenolic acid|mesh-list
111415882|NCT01701986|Rituximab|rituximab|mesh-list
111415883|NCT01701986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111415884|NCT01701986|Gemcitabine|gemcitabine|mesh-list
111415885|NCT01701986|Busulfan|busulfan|mesh-list
111415886|NCT01701986|Clofarabine|clofarabine|mesh-list
111415887|NCT01701986|Antibodies|antibodies|mesh-list
111415888|NCT01701986|Immunoglobulins|immunoglobulins|mesh-list
111415889|NCT01701986|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111415890|NCT01701986|Tacrolimus|tacrolimus|mesh-list
111415891|NCT01701986|Thymoglobulin|thymoglobulin|mesh-list
111415892|NCT01701986|Antilymphocyte Serum|antilymphocyte serum|mesh-list
111415893|NCT01701986|Immunologic Factors|immunologic factors|mesh-ancestor
111415894|NCT01701986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111415895|NCT01701986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111415896|NCT01701986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111415897|NCT01701986|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111415898|NCT01701986|Antimetabolites|antimetabolites|mesh-ancestor
111415899|NCT01701986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111415900|NCT01701986|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111415901|NCT01701986|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111415902|NCT01701986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111415903|NCT01701986|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111415904|NCT01701986|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111415905|NCT01701986|Antitubercular Agents|antitubercular agents|mesh-ancestor
111415906|NCT01701986|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111415907|NCT01701986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111415908|NCT01701986|Alkylating Agents|alkylating agents|mesh-ancestor
111415909|NCT01701986|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111415910|NCT01701986|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111415911|NCT01696734|Domperidone|domperidone|mesh-list
111415912|NCT01696734|Antiemetics|antiemetics|mesh-ancestor
111415913|NCT01696734|Autonomic Agents|autonomic agents|mesh-ancestor
111415914|NCT01696734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111415915|NCT01696734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111415916|NCT01696734|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111415917|NCT01696734|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111415918|NCT01696734|Dopamine Agents|dopamine agents|mesh-ancestor
111415919|NCT01696734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111415920|NCT01696734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111415921|NCT01687127|Folic Acid|folic acid|mesh-list
111415922|NCT01687127|Vitamin B Complex|vitamin b complex|mesh-list
111415923|NCT01687127|Calcium|calcium|mesh-list
111415924|NCT01687127|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111415925|NCT01687127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111415926|NCT01687127|Hematinics|hematinics|mesh-ancestor
111415927|NCT01687127|Vitamins|vitamins|mesh-ancestor
111415928|NCT01687127|Micronutrients|micronutrients|mesh-ancestor
111415929|NCT01565200|Trastuzumab|trastuzumab|mesh-list
111415930|NCT01565200|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
111415931|NCT01565200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111415932|NCT01565200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111415933|NCT01565200|Immunotoxins|immunotoxins|mesh-ancestor
111415934|NCT01565200|Immunoconjugates|immunoconjugates|mesh-ancestor
111415935|NCT01565200|Immunologic Factors|immunologic factors|mesh-ancestor
111415936|NCT01565200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111415937|NCT01565200|Tubulin Modulators|tubulin modulators|mesh-ancestor
111415938|NCT01565200|Antimitotic Agents|antimitotic agents|mesh-ancestor
111415939|NCT01565200|Mitosis Modulators|mitosis modulators|mesh-ancestor
111415940|NCT01565200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111415941|NCT01476787|Rituximab|rituximab|mesh-list
111415942|NCT01476787|Lenalidomide|lenalidomide|mesh-list
111415943|NCT01476787|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
111415944|NCT01476787|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111415945|NCT01476787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111415946|NCT01476787|Immunologic Factors|immunologic factors|mesh-ancestor
111415947|NCT01476787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111415948|NCT01476787|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111415949|NCT01476787|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111415950|NCT01476787|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111415951|NCT01476787|Growth Substances|growth substances|mesh-ancestor
111415952|NCT01476787|Growth Inhibitors|growth inhibitors|mesh-ancestor
111415953|NCT01476787|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111415954|NCT01476787|Alkylating Agents|alkylating agents|mesh-ancestor
111415955|NCT01476787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111415956|NCT01059786|Rituximab|rituximab|mesh-list
111415957|NCT01059786|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
111415958|NCT01059786|Pentostatin|pentostatin|mesh-list
111415959|NCT01059786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111415960|NCT01059786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111415961|NCT01059786|Immunologic Factors|immunologic factors|mesh-ancestor
111415962|NCT01059786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111415963|NCT01059786|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111415964|NCT01059786|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111415965|NCT01059786|Alkylating Agents|alkylating agents|mesh-ancestor
111415966|NCT01059786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111415967|NCT01059786|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
111415968|NCT01059786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111415969|NCT00993408|Selexipag|selexipag|mesh-list
111415970|NCT00993408|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111415971|NCT00871065|Sildenafil Citrate|sildenafil citrate|mesh-list
111415972|NCT00871065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111415973|NCT00871065|Vasodilator Agents|vasodilator agents|mesh-ancestor
111415974|NCT00871065|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111415975|NCT00871065|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111415976|NCT00871065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111415977|NCT00871065|Urological Agents|urological agents|mesh-ancestor
111415978|NCT00801489|Cytarabine|cytarabine|mesh-list
111415979|NCT00801489|Fludarabine|fludarabine|mesh-list
111415980|NCT00801489|Fludarabine phosphate|fludarabine phosphate|mesh-list
111415981|NCT00801489|Decitabine|decitabine|mesh-list
111415982|NCT00801489|Idarubicin|idarubicin|mesh-list
111415983|NCT00801489|Gemtuzumab|gemtuzumab|mesh-list
111415984|NCT00801489|Calicheamicins|calicheamicins|mesh-list
111415985|NCT00801489|Lenograstim|lenograstim|mesh-list
111415986|NCT00801489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111415987|NCT00801489|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111415988|NCT00801489|Antimetabolites|antimetabolites|mesh-ancestor
111415989|NCT00801489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111415990|NCT00801489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111415991|NCT00801489|Immunologic Factors|immunologic factors|mesh-ancestor
111415992|NCT00801489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111415993|NCT00801489|Antiviral Agents|antiviral agents|mesh-ancestor
111415994|NCT00801489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111415995|NCT00801489|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111415996|NCT00801489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111415997|NCT00801489|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111415998|NCT00801489|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111415999|NCT00801489|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111416000|NCT00801489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111416001|NCT00801489|Immunotoxins|immunotoxins|mesh-ancestor
111416002|NCT00801489|Immunoconjugates|immunoconjugates|mesh-ancestor
111416003|NCT00794339|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
111416004|NCT00794339|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111416005|NCT00794339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111416006|NCT00792662|Methylphenidate|methylphenidate|mesh-list
111416007|NCT00792662|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111416008|NCT00792662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111416009|NCT00792662|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111416010|NCT00792662|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111416011|NCT00792662|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111416012|NCT00792662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111416013|NCT00792662|Dopamine Agents|dopamine agents|mesh-ancestor
111416014|NCT00792662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111416015|NCT00786682|Hydroxychloroquine|hydroxychloroquine|mesh-list
111416016|NCT00786682|Docetaxel|docetaxel|mesh-list
111416017|NCT00786682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111416018|NCT00786682|Tubulin Modulators|tubulin modulators|mesh-ancestor
111416019|NCT00786682|Antimitotic Agents|antimitotic agents|mesh-ancestor
111416020|NCT00786682|Mitosis Modulators|mitosis modulators|mesh-ancestor
111416021|NCT00786682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111416022|NCT00786682|Antimalarials|antimalarials|mesh-ancestor
111416023|NCT00786682|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111416024|NCT00786682|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111416025|NCT00786682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111416026|NCT00786682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111416027|NCT00786682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111416028|NCT00675844|Dexelvucitabine|dexelvucitabine|mesh-list
111416029|NCT00675844|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111416030|NCT00675844|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111416031|NCT00675844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111416032|NCT00675844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111416033|NCT00675844|Antiviral Agents|antiviral agents|mesh-ancestor
111416034|NCT00675844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111416035|NCT00675844|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111416036|NCT00675844|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111416037|NCT00592280|Pancrelipase|pancrelipase|mesh-list
111416038|NCT00592280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111416039|NCT00571714|Ribavirin|ribavirin|mesh-list
111416040|NCT00571714|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
111416041|NCT00571714|Interferon-alpha|interferon-alpha|mesh-list
111416042|NCT00571714|Betaine|betaine|mesh-list
111416043|NCT00571714|Antimetabolites|antimetabolites|mesh-ancestor
111416044|NCT00571714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111416045|NCT00571714|Antiviral Agents|antiviral agents|mesh-ancestor
111416046|NCT00571714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111416047|NCT00571714|Immunologic Factors|immunologic factors|mesh-ancestor
111416048|NCT00571714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111416049|NCT00571714|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111416050|NCT00571714|Lipotropic Agents|lipotropic agents|mesh-ancestor
111416051|NCT00571714|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111416052|NCT00571714|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111416053|NCT00506662|Insulin|insulin|mesh-list
111416054|NCT00506662|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111416055|NCT00506662|Insulin Detemir|insulin detemir|mesh-list
111416056|NCT00506662|Isophane Insulin, Human|isophane insulin, human|mesh-list
111416057|NCT00506662|Insulin, Isophane|insulin, isophane|mesh-list
111416058|NCT00506662|Isophane insulin, beef|isophane insulin, beef|mesh-list
111416059|NCT00506662|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111416060|NCT00506662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111416061|NCT00455039|Lapatinib|lapatinib|mesh-list
111416062|NCT00455039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111416063|NCT00455039|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111416064|NCT00455039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111416065|NCT00455039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111416066|NCT00410956|Dexamethasone|dexamethasone|mesh-list
111416067|NCT00410956|Bevacizumab|bevacizumab|mesh-list
111416068|NCT00410956|Floxuridine|floxuridine|mesh-list
111416069|NCT00410956|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111416070|NCT00410956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111416071|NCT00410956|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111416072|NCT00410956|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111416073|NCT00410956|Growth Substances|growth substances|mesh-ancestor
111416074|NCT00410956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111416075|NCT00410956|Growth Inhibitors|growth inhibitors|mesh-ancestor
111416076|NCT00410956|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111416077|NCT00410956|Antiemetics|antiemetics|mesh-ancestor
111416078|NCT00410956|Autonomic Agents|autonomic agents|mesh-ancestor
111416079|NCT00410956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111416080|NCT00410956|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111416081|NCT00410956|Glucocorticoids|glucocorticoids|mesh-ancestor
111416082|NCT00410956|Hormones|hormones|mesh-ancestor
111416083|NCT00410956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111416084|NCT00410956|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111416085|NCT00410956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111416086|NCT00410956|Antimetabolites|antimetabolites|mesh-ancestor
111416087|NCT00410956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111416088|NCT00380159|Lamivudine|lamivudine|mesh-list
111416089|NCT00380159|Emtricitabine|emtricitabine|mesh-list
111416090|NCT00380159|Dexelvucitabine|dexelvucitabine|mesh-list
111416091|NCT00380159|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111416092|NCT00380159|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111416093|NCT00380159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111416094|NCT00380159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111416095|NCT00380159|Antiviral Agents|antiviral agents|mesh-ancestor
111416096|NCT00380159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111416097|NCT00380159|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111416098|NCT00380159|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111416099|NCT00338377|Cyclophosphamide|cyclophosphamide|mesh-list
111416100|NCT00338377|Fludarabine|fludarabine|mesh-list
111416101|NCT00338377|Fludarabine phosphate|fludarabine phosphate|mesh-list
111416102|NCT00338377|Interleukin-2|interleukin-2|mesh-list
111416103|NCT00338377|Mesna|mesna|mesh-list
111416104|NCT00338377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111416105|NCT00338377|Immunologic Factors|immunologic factors|mesh-ancestor
111416106|NCT00338377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111416107|NCT00338377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111416108|NCT00338377|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111416109|NCT00338377|Alkylating Agents|alkylating agents|mesh-ancestor
111416110|NCT00338377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111416111|NCT00338377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111416112|NCT00338377|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111416113|NCT00338377|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111416114|NCT00338377|Antimetabolites|antimetabolites|mesh-ancestor
111416115|NCT00338377|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111416116|NCT00338377|Analgesics|analgesics|mesh-ancestor
111416117|NCT00338377|Sensory System Agents|sensory system agents|mesh-ancestor
111416118|NCT00338377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111416119|NCT00338377|Protective Agents|protective agents|mesh-ancestor
111416120|NCT00161213|Gemcitabine|gemcitabine|mesh-list
111416121|NCT00161213|Imatinib Mesylate|imatinib mesylate|mesh-list
111416122|NCT00161213|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111416123|NCT00161213|Antimetabolites|antimetabolites|mesh-ancestor
111416124|NCT00161213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111416125|NCT00161213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111416126|NCT00161213|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111416127|NCT00161213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111416128|NCT00118131|Docetaxel|docetaxel|mesh-list
111416129|NCT00118131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111416130|NCT00118131|Tubulin Modulators|tubulin modulators|mesh-ancestor
111416131|NCT00118131|Antimitotic Agents|antimitotic agents|mesh-ancestor
111416132|NCT00118131|Mitosis Modulators|mitosis modulators|mesh-ancestor
111416133|NCT00118131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111416134|NCT00006436|Prednisone|prednisone|mesh-list
111416135|NCT00006436|Cyclophosphamide|cyclophosphamide|mesh-list
111416136|NCT00006436|Rituximab|rituximab|mesh-list
111416137|NCT00006436|Doxorubicin|doxorubicin|mesh-list
111416138|NCT00006436|Etoposide|etoposide|mesh-list
111416139|NCT00006436|Vincristine|vincristine|mesh-list
111416140|NCT00006436|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111416141|NCT00006436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111416142|NCT00006436|Immunologic Factors|immunologic factors|mesh-ancestor
111416143|NCT00006436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111416144|NCT00006436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111416145|NCT00006436|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111416146|NCT00006436|Alkylating Agents|alkylating agents|mesh-ancestor
111416147|NCT00006436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111416148|NCT00006436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111416149|NCT00006436|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111416150|NCT00006436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111416151|NCT00006436|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111416152|NCT00006436|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111416153|NCT00006436|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111416154|NCT00006436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111416155|NCT00006436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111416156|NCT00006436|Glucocorticoids|glucocorticoids|mesh-ancestor
111416157|NCT00006436|Hormones|hormones|mesh-ancestor
111416158|NCT00006436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111416159|NCT00006436|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111416160|NCT00006436|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111416161|NCT00006436|Tubulin Modulators|tubulin modulators|mesh-ancestor
111416162|NCT00006436|Antimitotic Agents|antimitotic agents|mesh-ancestor
111416163|NCT00006436|Mitosis Modulators|mitosis modulators|mesh-ancestor
111416164|NCT02399917|Azacitidine|azacitidine|mesh-list
111416165|NCT02399917|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111416166|NCT02399917|Antimetabolites|antimetabolites|mesh-ancestor
111416167|NCT02399917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111416168|NCT02399917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111416169|NCT02399917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111416170|NCT00356486|Ribavirin|ribavirin|mesh-list
111416171|NCT00356486|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
111416172|NCT00356486|Interferon-alpha|interferon-alpha|mesh-list
111416173|NCT00356486|Antimetabolites|antimetabolites|mesh-ancestor
111416174|NCT00356486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111416175|NCT00356486|Antiviral Agents|antiviral agents|mesh-ancestor
111416176|NCT00356486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111416177|NCT00356486|Immunologic Factors|immunologic factors|mesh-ancestor
111416178|NCT00356486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111416179|NCT03331835|Brodalumab|brodalumab|mesh-list
111416180|NCT03331835|Dermatologic Agents|dermatologic agents|mesh-ancestor
111416181|NCT02403895|Paclitaxel|paclitaxel|mesh-list
111416182|NCT02403895|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111416183|NCT02403895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111416184|NCT02403895|Tubulin Modulators|tubulin modulators|mesh-ancestor
111416185|NCT02403895|Antimitotic Agents|antimitotic agents|mesh-ancestor
111416186|NCT02403895|Mitosis Modulators|mitosis modulators|mesh-ancestor
111416187|NCT02403895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111416188|NCT03987776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
111416189|NCT02354833|Phenylephrine|phenylephrine|mesh-list
111416190|NCT02354833|Oxymetazoline|oxymetazoline|mesh-list
111416191|NCT02354833|Norepinephrine|norepinephrine|mesh-list
111416192|NCT02354833|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111416193|NCT02354833|Mydriatics|mydriatics|mesh-ancestor
111416194|NCT02354833|Autonomic Agents|autonomic agents|mesh-ancestor
111416195|NCT02354833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111416196|NCT02354833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111416197|NCT02354833|Sympathomimetics|sympathomimetics|mesh-ancestor
111140593|NCT04812379|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111416198|NCT02354833|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111416199|NCT02354833|Nasal Decongestants|nasal decongestants|mesh-ancestor
111416200|NCT02354833|Respiratory System Agents|respiratory system agents|mesh-ancestor
111416201|NCT02354833|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111416202|NCT02354833|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111416203|NCT02354833|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111416204|NCT02354833|Adrenergic Agents|adrenergic agents|mesh-ancestor
111416205|NCT02354833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111416206|NCT02354833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111416207|NCT02354833|Protective Agents|protective agents|mesh-ancestor
111416208|NCT03337724|Paclitaxel|paclitaxel|mesh-list
111416209|NCT03337724|Ipatasertib|ipatasertib|mesh-list
111416210|NCT03337724|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111416211|NCT03337724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111416212|NCT03337724|Tubulin Modulators|tubulin modulators|mesh-ancestor
111416213|NCT03337724|Antimitotic Agents|antimitotic agents|mesh-ancestor
111416214|NCT03337724|Mitosis Modulators|mitosis modulators|mesh-ancestor
111416215|NCT03337724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111416216|NCT03337724|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111416217|NCT03337724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111416218|NCT03838484|Nicotine|nicotine|mesh-list
111416219|NCT03838484|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111416220|NCT03838484|Autonomic Agents|autonomic agents|mesh-ancestor
111416221|NCT03838484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111416222|NCT03838484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111416223|NCT03838484|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111416224|NCT03838484|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111416225|NCT03838484|Cholinergic Agents|cholinergic agents|mesh-ancestor
111416226|NCT03838484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111416227|NCT03838484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111416228|NCT05721872|Arsenic Trioxide|arsenic trioxide|mesh-list
111416229|NCT05721872|Isoascorbic acid|isoascorbic acid|mesh-list
111416230|NCT05721872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111416231|NCT05721872|Antioxidants|antioxidants|mesh-ancestor
111416232|NCT05721872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111416233|NCT05721872|Protective Agents|protective agents|mesh-ancestor
111416234|NCT05721872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111416235|NCT02408965|Methylergonovine|methylergonovine|mesh-list
111416236|NCT02408965|Oxytocics|oxytocics|mesh-ancestor
111416237|NCT02408965|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111416238|NCT02408965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111416239|NCT03299426|Vaccines|vaccines|mesh-list
111416240|NCT03299426|Immunologic Factors|immunologic factors|mesh-ancestor
111416241|NCT03299426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111416242|NCT03216356|Cycloserine|cycloserine|mesh-list
111416243|NCT03216356|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111416244|NCT03216356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111416245|NCT03216356|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111416246|NCT03216356|Antitubercular Agents|antitubercular agents|mesh-ancestor
111416247|NCT03216356|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111416248|NCT03216356|Antimetabolites|antimetabolites|mesh-ancestor
111416249|NCT03216356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111416250|NCT02411929|Ertugliflozin|ertugliflozin|mesh-list
111416251|NCT02411929|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111416252|NCT02411929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111416253|NCT02411929|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111416254|NCT02411929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111416255|NCT00356954|Ascorbic Acid|ascorbic acid|mesh-list
111416256|NCT00356954|Antioxidants|antioxidants|mesh-ancestor
111416257|NCT00356954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111416258|NCT00356954|Protective Agents|protective agents|mesh-ancestor
111416259|NCT00356954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111416260|NCT00356954|Vitamins|vitamins|mesh-ancestor
111416261|NCT00356954|Micronutrients|micronutrients|mesh-ancestor
111416262|NCT02358889|Ranibizumab|ranibizumab|mesh-list
111416263|NCT02358889|hI-con1|hi-con1|mesh-list
111416264|NCT02358889|Immunoconjugates|immunoconjugates|mesh-list
111416265|NCT02358889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111416266|NCT02358889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111416267|NCT02358889|Growth Substances|growth substances|mesh-ancestor
111416268|NCT02358889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111416269|NCT02358889|Growth Inhibitors|growth inhibitors|mesh-ancestor
111416270|NCT02358889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111416271|NCT02358889|Immunologic Factors|immunologic factors|mesh-ancestor
111416272|NCT05721170|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
111416273|NCT05721170|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111416274|NCT05721170|Adrenergic Agents|adrenergic agents|mesh-ancestor
111416275|NCT05721170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111416276|NCT05721170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111416277|NCT05721170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111416278|NCT00358124|Metformin|metformin|mesh-list
111416279|NCT00358124|Insulin Glargine|insulin glargine|mesh-list
111416280|NCT00358124|Rosiglitazone|rosiglitazone|mesh-list
111416281|NCT00358124|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111416282|NCT00358124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111416283|NCT00358202|Ceftriaxone|ceftriaxone|mesh-list
111416284|NCT00358202|Cefepime|cefepime|mesh-list
111416285|NCT00358202|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111416286|NCT00358202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111416287|NCT02802566|Vitamins|vitamins|mesh-list
111416288|NCT02802566|Micronutrients|micronutrients|mesh-ancestor
111416289|NCT02802566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111416290|NCT04736225|Insulin|insulin|mesh-list
111416291|NCT04736225|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111416292|NCT04736225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111416293|NCT03344861|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
111416294|NCT03344861|Trioxsalen|trioxsalen|mesh-list
111416295|NCT03344861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111416296|NCT03344861|Dermatologic Agents|dermatologic agents|mesh-ancestor
111416297|NCT03344861|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111416298|NCT03348683|Propranolol|propranolol|mesh-list
111416299|NCT03348683|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111416300|NCT03348683|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111416301|NCT03348683|Adrenergic Agents|adrenergic agents|mesh-ancestor
111416302|NCT03348683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111416303|NCT03348683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111416304|NCT03348683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111416305|NCT03348683|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111416306|NCT03348683|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111416307|NCT03348683|Vasodilator Agents|vasodilator agents|mesh-ancestor
111416308|NCT04344782|Bevacizumab|bevacizumab|mesh-list
111416309|NCT04344782|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111416310|NCT04344782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111416311|NCT04344782|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111416312|NCT04344782|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111416313|NCT04344782|Growth Substances|growth substances|mesh-ancestor
111416314|NCT04344782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111416315|NCT04344782|Growth Inhibitors|growth inhibitors|mesh-ancestor
111416316|NCT00357188|Ritonavir|ritonavir|mesh-list
111416317|NCT00357188|Atazanavir Sulfate|atazanavir sulfate|mesh-list
111416318|NCT00357188|Efavirenz|efavirenz|mesh-list
111416319|NCT00357188|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111416320|NCT00357188|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111416321|NCT00357188|Protease Inhibitors|protease inhibitors|mesh-ancestor
111416322|NCT00357188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111416323|NCT00357188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111416324|NCT00357188|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111416325|NCT00357188|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111416326|NCT00357188|Antiviral Agents|antiviral agents|mesh-ancestor
111416327|NCT00357188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111416328|NCT00357188|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111416329|NCT00357188|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111416330|NCT00357188|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111416331|NCT00357188|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111416332|NCT00357188|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111416333|NCT00357188|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111416334|NCT00357188|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111416335|NCT00357188|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111416336|NCT00357188|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111416337|NCT02360215|Memantine|memantine|mesh-list
111416338|NCT02360215|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111416339|NCT02360215|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111416340|NCT02360215|Dopamine Agents|dopamine agents|mesh-ancestor
111416341|NCT02360215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111416342|NCT02360215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111416343|NCT02360215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111416344|NCT02360215|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111416345|NCT02360215|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111416346|NCT01349192|Chlorhexidine|chlorhexidine|mesh-list
111416347|NCT01349192|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
111416348|NCT01349192|Minocycline|minocycline|mesh-list
111416350|NCT01349192|Trimethoprim|trimethoprim|mesh-list
111416351|NCT01349192|Sulfamethoxazole|sulfamethoxazole|mesh-list
111416352|NCT01349192|Mupirocin|mupirocin|mesh-list
111416353|NCT01349192|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111416354|NCT01349192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111416355|NCT01349192|Disinfectants|disinfectants|mesh-ancestor
111416356|NCT01349192|Dermatologic Agents|dermatologic agents|mesh-ancestor
111416357|NCT01349192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111416358|NCT01349192|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111416359|NCT01349192|Antitubercular Agents|antitubercular agents|mesh-ancestor
111416360|NCT01349192|Leprostatic Agents|leprostatic agents|mesh-ancestor
111416361|NCT01349192|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111416362|NCT01349192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111416363|NCT01349192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111416364|NCT01349192|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111416365|NCT01349192|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111416366|NCT01349192|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
111416367|NCT01349192|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
111416368|NCT01349192|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
111416369|NCT01349192|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111416370|NCT01349192|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111416371|NCT01349192|Antimalarials|antimalarials|mesh-ancestor
111416372|NCT01349192|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111416373|NCT01349192|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111416374|NCT01349192|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111416375|NCT01349192|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111416376|NCT01349192|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
111416377|NCT01349192|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111416378|NCT01349192|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111416379|NCT02362321|Dexamethasone|dexamethasone|mesh-list
111416380|NCT02362321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111416381|NCT02362321|Antiemetics|antiemetics|mesh-ancestor
111416382|NCT02362321|Autonomic Agents|autonomic agents|mesh-ancestor
111416383|NCT02362321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111416384|NCT02362321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111416385|NCT02362321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111416386|NCT02362321|Glucocorticoids|glucocorticoids|mesh-ancestor
111416387|NCT02362321|Hormones|hormones|mesh-ancestor
111416388|NCT02362321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111416389|NCT02362321|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111416390|NCT02362321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111416391|NCT00354991|Losartan|losartan|mesh-list
111416392|NCT00354991|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
111416393|NCT00354991|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111416394|NCT00354991|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111416395|NCT00354991|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111416396|NCT00354991|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111416397|NCT00354991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111416398|NCT00354991|Diuretics|diuretics|mesh-ancestor
111416399|NCT00354991|Natriuretic Agents|natriuretic agents|mesh-ancestor
111416400|NCT00354991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111416401|NCT00354991|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
111416402|NCT00354991|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111416403|NCT02112578|Meclizine|meclizine|mesh-list
111416404|NCT02112578|Dimenhydrinate|dimenhydrinate|mesh-list
111416405|NCT02112578|Antiemetics|antiemetics|mesh-ancestor
111416406|NCT02112578|Autonomic Agents|autonomic agents|mesh-ancestor
111416407|NCT02112578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111416408|NCT02112578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111416409|NCT02112578|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111416410|NCT02112578|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111416411|NCT02112578|Histamine Antagonists|histamine antagonists|mesh-ancestor
111416412|NCT02112578|Histamine Agents|histamine agents|mesh-ancestor
111416413|NCT02112578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111416414|NCT02112578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111416415|NCT02112578|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111416416|NCT02112578|Cholinergic Agents|cholinergic agents|mesh-ancestor
111416417|NCT02112578|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111416418|NCT00358280|Bupivacaine|bupivacaine|mesh-list
111416419|NCT00358280|Ropivacaine|ropivacaine|mesh-list
111416420|NCT00358280|Anesthetics, Local|anesthetics, local|mesh-ancestor
111416421|NCT00358280|Anesthetics|anesthetics|mesh-ancestor
111140824|NCT02310789|Ivacaftor|ivacaftor|mesh-list
111416422|NCT00358280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111416423|NCT00358280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111416424|NCT00358280|Sensory System Agents|sensory system agents|mesh-ancestor
111416425|NCT00358280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111416426|NCT05719285|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111416427|NCT05719285|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
111416428|NCT05719285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111416429|NCT05719285|Antitubercular Agents|antitubercular agents|mesh-ancestor
111416430|NCT02363803|Lidocaine|lidocaine|mesh-list
111416431|NCT02363803|Anesthetics, Local|anesthetics, local|mesh-ancestor
111416432|NCT02363803|Anesthetics|anesthetics|mesh-ancestor
111416433|NCT02363803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111416434|NCT02363803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111416435|NCT02363803|Sensory System Agents|sensory system agents|mesh-ancestor
111416436|NCT02363803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111416437|NCT02363803|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111416438|NCT02363803|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111416439|NCT02363803|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111416440|NCT02363803|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111416441|NCT02363803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111416442|NCT03417193|Analgesics, Opioid|analgesics, opioid|mesh-list
111416443|NCT03417193|Anesthetics|anesthetics|mesh-list
111416444|NCT03417193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111416445|NCT03417193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111416446|NCT03417193|Narcotics|narcotics|mesh-ancestor
111416447|NCT03417193|Analgesics|analgesics|mesh-ancestor
111416448|NCT03417193|Sensory System Agents|sensory system agents|mesh-ancestor
111416449|NCT03417193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111416450|NCT02367859|Trametinib|trametinib|mesh-list
111416451|NCT02367859|Dabrafenib|dabrafenib|mesh-list
111416452|NCT02367859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111416453|NCT02367859|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111416454|NCT02367859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111416455|NCT02367859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111416456|NCT02368093|Dextromethorphan|dextromethorphan|mesh-list
111416457|NCT02368093|Antitussive Agents|antitussive agents|mesh-ancestor
111416458|NCT02368093|Respiratory System Agents|respiratory system agents|mesh-ancestor
111416459|NCT02368093|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111416460|NCT02368093|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111416461|NCT02368093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111416462|NCT02368093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111416463|NCT02368093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111416464|NCT03342937|Pembrolizumab|pembrolizumab|mesh-list
111416465|NCT03342937|Capecitabine|capecitabine|mesh-list
111416466|NCT03342937|Oxaliplatin|oxaliplatin|mesh-list
111416467|NCT03342937|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111416468|NCT03342937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111416469|NCT03342937|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111416470|NCT03342937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111416471|NCT03342937|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111416472|NCT03342937|Antimetabolites|antimetabolites|mesh-ancestor
111416473|NCT05718661|Methamphetamine|methamphetamine|mesh-list
111416474|NCT05718661|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111416475|NCT05718661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111416476|NCT05718661|Sympathomimetics|sympathomimetics|mesh-ancestor
111416477|NCT05718661|Autonomic Agents|autonomic agents|mesh-ancestor
111416478|NCT05718661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111416479|NCT05718661|Dopamine Agents|dopamine agents|mesh-ancestor
111416480|NCT05718661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111416481|NCT05718661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111416482|NCT05718661|Adrenergic Agents|adrenergic agents|mesh-ancestor
111416483|NCT05718661|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111416484|NCT05718661|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111416485|NCT05718661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111416486|NCT05718661|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111416487|NCT00354757|Rabeprazole|rabeprazole|mesh-list
111416488|NCT00354757|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111416489|NCT00354757|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111416490|NCT00354757|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111416491|NCT00354757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111416492|NCT00354757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111416493|NCT02376283|Clopidogrel|clopidogrel|mesh-list
111416494|NCT02376283|Ticagrelor|ticagrelor|mesh-list
111416496|NCT02376283|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111416497|NCT02376283|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111416498|NCT02376283|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111416499|NCT02376283|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111416500|NCT02376283|Purinergic Agents|purinergic agents|mesh-ancestor
111416501|NCT02376283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111416502|NCT02376283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111416503|NCT02376283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111416504|NCT00425347|Elotuzumab|elotuzumab|mesh-list
111416505|NCT00425347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111416506|NCT05718037|Vaccines|vaccines|mesh-list
111416507|NCT05718037|Immunologic Factors|immunologic factors|mesh-ancestor
111416508|NCT05718037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111416509|NCT05717881|Propolis|propolis|mesh-list
111416510|NCT05717881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111416511|NCT00355303|Misoprostol|misoprostol|mesh-list
111416512|NCT00355303|Dinoprostone|dinoprostone|mesh-list
111416513|NCT00355303|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111416514|NCT00355303|Abortifacient Agents|abortifacient agents|mesh-ancestor
111416515|NCT00355303|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111416516|NCT00355303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111416517|NCT00355303|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111416518|NCT00355303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111416519|NCT00355303|Oxytocics|oxytocics|mesh-ancestor
111416520|NCT05717569|Vitamin D|vitamin d|mesh-list
111416521|NCT05717569|Vitamins|vitamins|mesh-ancestor
111416522|NCT05717569|Micronutrients|micronutrients|mesh-ancestor
111416523|NCT05717569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111416524|NCT05717569|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111416525|NCT02385097|Ropivacaine|ropivacaine|mesh-list
111416526|NCT02385097|Chloroprocaine|chloroprocaine|mesh-list
111416527|NCT02385097|Anesthetics, Local|anesthetics, local|mesh-ancestor
111416528|NCT02385097|Anesthetics|anesthetics|mesh-ancestor
111416529|NCT02385097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111416530|NCT02385097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111416531|NCT02385097|Sensory System Agents|sensory system agents|mesh-ancestor
111416532|NCT02385097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111416533|NCT02387359|Plecanatide|plecanatide|mesh-list
111416534|NCT02387359|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
111416535|NCT02387359|Enzyme Activators|enzyme activators|mesh-ancestor
111416536|NCT02387359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111416537|NCT02387359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111416538|NCT00355459|Doxycycline|doxycycline|mesh-list
111416539|NCT00355459|Tetracycline|tetracycline|mesh-list
111416540|NCT00355459|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111416541|NCT00355459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111416542|NCT00355459|Antimalarials|antimalarials|mesh-ancestor
111416543|NCT00355459|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111416544|NCT00355459|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111416545|NCT00355459|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111416546|NCT00355459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111416547|NCT00355459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111416548|NCT02393677|Dexmedetomidine|dexmedetomidine|mesh-list
111416549|NCT02393677|Ropivacaine|ropivacaine|mesh-list
111416550|NCT02393677|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111416551|NCT02393677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111416552|NCT02393677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111416553|NCT02393677|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111416554|NCT02393677|Analgesics|analgesics|mesh-ancestor
111416555|NCT02393677|Sensory System Agents|sensory system agents|mesh-ancestor
111416556|NCT02393677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111416557|NCT02393677|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111416558|NCT02393677|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111416559|NCT02393677|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111416560|NCT02393677|Adrenergic Agents|adrenergic agents|mesh-ancestor
111416561|NCT02393677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111416562|NCT02393677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111416563|NCT02393677|Anesthetics, Local|anesthetics, local|mesh-ancestor
111416564|NCT02393677|Anesthetics|anesthetics|mesh-ancestor
111416565|NCT02394457|Cosyntropin|cosyntropin|mesh-list
111416566|NCT02394457|Hormones|hormones|mesh-ancestor
111416567|NCT02394457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111416568|NCT02394457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111416569|NCT00355771|Levocetirizine|levocetirizine|mesh-list
111416570|NCT00355771|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
111416571|NCT00355771|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111416572|NCT00355771|Histamine Antagonists|histamine antagonists|mesh-ancestor
111416573|NCT00355771|Histamine Agents|histamine agents|mesh-ancestor
111416574|NCT00355771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111416575|NCT00355771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111416576|NCT00355771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111416578|NCT05664139|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111416579|NCT05664139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111416580|NCT05664139|Tubulin Modulators|tubulin modulators|mesh-ancestor
111416581|NCT05664139|Antimitotic Agents|antimitotic agents|mesh-ancestor
111416582|NCT05664139|Mitosis Modulators|mitosis modulators|mesh-ancestor
111416583|NCT05664139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111416584|NCT03224351|Ivacaftor|ivacaftor|mesh-list
111416585|NCT03224351|VX-659|vx-659|mesh-list
111416586|NCT03224351|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
111416587|NCT03224351|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111416588|NCT03224351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111416589|NCT05658055|Amoxicillin|amoxicillin|mesh-list
111416590|NCT05658055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111416591|NCT05658055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111416592|NCT03906071|Docetaxel|docetaxel|mesh-list
111416593|NCT03906071|Nivolumab|nivolumab|mesh-list
111416594|NCT03906071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111416595|NCT03906071|Tubulin Modulators|tubulin modulators|mesh-ancestor
111416596|NCT03906071|Antimitotic Agents|antimitotic agents|mesh-ancestor
111416597|NCT03906071|Mitosis Modulators|mitosis modulators|mesh-ancestor
111416598|NCT03906071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111416599|NCT03906071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111416600|NCT03906071|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111416601|NCT01721876|Cytarabine|cytarabine|mesh-list
111416602|NCT01721876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111416603|NCT01721876|Antimetabolites|antimetabolites|mesh-ancestor
111416604|NCT01721876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111416605|NCT01721876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111416606|NCT01721876|Antiviral Agents|antiviral agents|mesh-ancestor
111416607|NCT01721876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111416608|NCT01721876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111416609|NCT01721876|Immunologic Factors|immunologic factors|mesh-ancestor
111416610|NCT01721876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111416611|NCT03224585|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
111416612|NCT03224585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111416613|NCT03423641|Antiviral Agents|antiviral agents|mesh-list
111416614|NCT03423641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111416615|NCT01112072|Riboflavin|riboflavin|mesh-list
111416616|NCT01112072|Vitamin B Complex|vitamin b complex|mesh-ancestor
111416617|NCT01112072|Vitamins|vitamins|mesh-ancestor
111416618|NCT01112072|Micronutrients|micronutrients|mesh-ancestor
111416619|NCT01112072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111416620|NCT01112072|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111416621|NCT01112072|Dermatologic Agents|dermatologic agents|mesh-ancestor
111416622|NCT04825795|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
111416623|NCT04825795|Protease Inhibitors|protease inhibitors|mesh-ancestor
111416624|NCT04825795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111416625|NCT04825795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111416626|NCT04825795|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111416627|NCT04825795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111416628|NCT03226223|Methamphetamine|methamphetamine|mesh-list
111416629|NCT03226223|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111416630|NCT03226223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111416631|NCT03226223|Sympathomimetics|sympathomimetics|mesh-ancestor
111416632|NCT03226223|Autonomic Agents|autonomic agents|mesh-ancestor
110509818|NCT02798250|Insulin|insulin|mesh-list
111416633|NCT03226223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111416634|NCT03226223|Dopamine Agents|dopamine agents|mesh-ancestor
111416635|NCT03226223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111416636|NCT03226223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111416637|NCT03226223|Adrenergic Agents|adrenergic agents|mesh-ancestor
111416638|NCT03226223|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111416639|NCT03226223|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111416640|NCT03226223|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111416641|NCT03226223|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111416642|NCT05620771|Bevacizumab|bevacizumab|mesh-list
111416643|NCT05620771|Atezolizumab|atezolizumab|mesh-list
111416644|NCT05620771|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111416645|NCT05620771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111416646|NCT05620771|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111416647|NCT05620771|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111416648|NCT05620771|Growth Substances|growth substances|mesh-ancestor
111416649|NCT05620771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111416650|NCT05620771|Growth Inhibitors|growth inhibitors|mesh-ancestor
111416651|NCT05620771|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111416652|NCT05620771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111416654|NCT05419297|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111416655|NCT05419297|Narcotics|narcotics|mesh-ancestor
111416656|NCT05419297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111416657|NCT05419297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111416658|NCT05419297|Analgesics|analgesics|mesh-ancestor
111416659|NCT05419297|Sensory System Agents|sensory system agents|mesh-ancestor
111416660|NCT05419297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111416661|NCT05419297|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111416662|NCT03226457|Empagliflozin|empagliflozin|mesh-list
111416663|NCT03226457|Furosemide|furosemide|mesh-list
111416664|NCT03226457|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111416665|NCT03226457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111416666|NCT03226457|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111416667|NCT03226457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111416668|NCT03226457|Diuretics|diuretics|mesh-ancestor
111416669|NCT03226457|Natriuretic Agents|natriuretic agents|mesh-ancestor
111416670|NCT03226457|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
111416671|NCT03226457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111416672|NCT00003159|Paclitaxel|paclitaxel|mesh-list
111416673|NCT00003159|Vinorelbine|vinorelbine|mesh-list
111416674|NCT00003159|Vinblastine|vinblastine|mesh-list
111416675|NCT00003159|Docetaxel|docetaxel|mesh-list
111416676|NCT00003159|Carboplatin|carboplatin|mesh-list
111416677|NCT00003159|Gemcitabine|gemcitabine|mesh-list
111416678|NCT00003159|Ifosfamide|ifosfamide|mesh-list
111416679|NCT00003159|Mitomycins|mitomycins|mesh-list
111416680|NCT00003159|Mitomycin|mitomycin|mesh-list
111416681|NCT00003159|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111416682|NCT00003159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111416683|NCT00003159|Tubulin Modulators|tubulin modulators|mesh-ancestor
111416684|NCT00003159|Antimitotic Agents|antimitotic agents|mesh-ancestor
111416685|NCT00003159|Mitosis Modulators|mitosis modulators|mesh-ancestor
111416686|NCT00003159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111416687|NCT00003159|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111416688|NCT00003159|Antimetabolites|antimetabolites|mesh-ancestor
111416689|NCT00003159|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111416690|NCT00003159|Alkylating Agents|alkylating agents|mesh-ancestor
111416691|NCT00003159|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111416692|NCT00003159|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111416693|NCT00003159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111416694|NCT03228017|Aspirin|aspirin|mesh-list
111416695|NCT03228017|Atorvastatin|atorvastatin|mesh-list
111416696|NCT03228017|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111416697|NCT03228017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111416698|NCT03228017|Analgesics|analgesics|mesh-ancestor
111416699|NCT03228017|Sensory System Agents|sensory system agents|mesh-ancestor
111416700|NCT03228017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111416701|NCT03228017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111416702|NCT03228017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111416703|NCT03228017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111416704|NCT03228017|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111416705|NCT03228017|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111416706|NCT03228017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111416707|NCT03228017|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111416708|NCT03228017|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111416709|NCT03228017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111416710|NCT03228017|Antipyretics|antipyretics|mesh-ancestor
111416711|NCT03228017|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111416712|NCT03228017|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111416713|NCT03228017|Antimetabolites|antimetabolites|mesh-ancestor
111416714|NCT03228017|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111416715|NCT03228017|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111416716|NCT00355927|Propofol|propofol|mesh-list
111416717|NCT00355927|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111416718|NCT00355927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111416719|NCT00355927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111416720|NCT00355927|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111416721|NCT00355927|Anesthetics, General|anesthetics, general|mesh-ancestor
111416722|NCT00355927|Anesthetics|anesthetics|mesh-ancestor
111416724|NCT00357422|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111416725|NCT00357422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111416726|NCT00357422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111416727|NCT00357422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111416728|NCT00356005|Azithromycin|azithromycin|mesh-list
111416729|NCT00356005|Artesunate|artesunate|mesh-list
111416730|NCT00356005|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111416731|NCT00356005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111416732|NCT00356005|Antimalarials|antimalarials|mesh-ancestor
111416733|NCT00356005|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111416734|NCT00356005|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111416735|NCT00356005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111416736|NCT00356005|Antiviral Agents|antiviral agents|mesh-ancestor
111416737|NCT00356005|Schistosomicides|schistosomicides|mesh-ancestor
111416738|NCT00356005|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
111416739|NCT00356005|Anthelmintics|anthelmintics|mesh-ancestor
111416740|NCT00376337|Micafungin|micafungin|mesh-list
111416741|NCT00376337|Antifungal Agents|antifungal agents|mesh-list
111416742|NCT00376337|Clotrimazole|clotrimazole|mesh-list
111416743|NCT00376337|Miconazole|miconazole|mesh-list
111416744|NCT00376337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111416745|NCT00376337|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111416746|NCT00376337|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111416747|NCT00376337|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111416748|NCT00376337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111416749|NCT00376337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111416750|NCT00376337|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111416751|NCT00376337|Hormone Antagonists|hormone antagonists|mesh-ancestor
111416752|NCT00376337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111416753|NCT00376337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111416754|NCT00376337|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111416755|NCT00376337|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111416756|NCT00003165|Doxorubicin|doxorubicin|mesh-list
111416757|NCT00003165|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111416758|NCT00003165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111416759|NCT00003165|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111416760|NCT00003165|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111416761|NCT00003165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111416762|NCT00003165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111416763|NCT05723510|Rivaroxaban|rivaroxaban|mesh-list
111416764|NCT05723510|Apixaban|apixaban|mesh-list
111416765|NCT05723510|Edoxaban|edoxaban|mesh-list
111416766|NCT05723510|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111416767|NCT05723510|Antithrombins|antithrombins|mesh-ancestor
111416768|NCT05723510|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111416769|NCT05723510|Protease Inhibitors|protease inhibitors|mesh-ancestor
111416770|NCT05723510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111416771|NCT05723510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111416772|NCT05723510|Anticoagulants|anticoagulants|mesh-ancestor
111416773|NCT00003171|Bryostatin 1|bryostatin 1|mesh-list
111416774|NCT00003171|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111416775|NCT00003171|Immunologic Factors|immunologic factors|mesh-ancestor
111416776|NCT00003171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111416777|NCT00003171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111416778|NCT00003183|Mitoxantrone|mitoxantrone|mesh-list
111416779|NCT00003183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111416780|NCT00003183|Analgesics|analgesics|mesh-ancestor
111416781|NCT00003183|Sensory System Agents|sensory system agents|mesh-ancestor
111416782|NCT00003183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111416783|NCT00003183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111416784|NCT00003183|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111416785|NCT00003183|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111416786|NCT00003183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111416787|NCT00003183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111416788|NCT02979223|Ascorbic Acid|ascorbic acid|mesh-list
111416789|NCT02979223|Magnesium citrate|magnesium citrate|mesh-list
111416790|NCT02979223|Picosulfate sodium|picosulfate sodium|mesh-list
111416791|NCT02979223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111416792|NCT02979223|Antioxidants|antioxidants|mesh-ancestor
111416793|NCT02979223|Protective Agents|protective agents|mesh-ancestor
111141190|NCT05485051|Chlorhexidine|chlorhexidine|mesh-list
111416794|NCT02979223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111416795|NCT02979223|Vitamins|vitamins|mesh-ancestor
111416796|NCT02979223|Micronutrients|micronutrients|mesh-ancestor
111416797|NCT02979223|Cathartics|cathartics|mesh-ancestor
111416798|NCT02979223|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111416799|NCT01805271|Everolimus|everolimus|mesh-list
111416800|NCT01805271|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111416801|NCT01805271|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111416802|NCT01805271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111416803|NCT01805271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111416804|NCT01805271|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111416805|NCT01805271|Immunologic Factors|immunologic factors|mesh-ancestor
111416806|NCT01805271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111416807|NCT01805271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111416808|NCT05723276|Psilocybin|psilocybin|mesh-list
111416809|NCT05723276|Hallucinogens|hallucinogens|mesh-ancestor
111416810|NCT05723276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111416811|NCT05723276|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111416812|NCT01768767|Ketamine|ketamine|mesh-list
111416813|NCT01768767|Analgesics|analgesics|mesh-ancestor
111416814|NCT01768767|Sensory System Agents|sensory system agents|mesh-ancestor
111416815|NCT01768767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111416816|NCT01768767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111416817|NCT01768767|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111416818|NCT01768767|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111416819|NCT01768767|Anesthetics, General|anesthetics, general|mesh-ancestor
111416820|NCT01768767|Anesthetics|anesthetics|mesh-ancestor
111416821|NCT01768767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111416822|NCT01768767|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111416823|NCT01768767|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111416824|NCT01768767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111416825|NCT01768767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111416826|NCT00376493|Metronidazole|metronidazole|mesh-list
111416827|NCT00376493|Doxycycline|doxycycline|mesh-list
111416828|NCT00376493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111416829|NCT00376493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111416830|NCT00376493|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111416831|NCT00376493|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111416832|NCT00376493|Antimalarials|antimalarials|mesh-ancestor
111416833|NCT00003195|Interferons|interferons|mesh-list
111416834|NCT00003195|Interferon-alpha|interferon-alpha|mesh-list
111416835|NCT00003195|Busulfan|busulfan|mesh-list
111416836|NCT00003195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111416837|NCT00003195|Antiviral Agents|antiviral agents|mesh-ancestor
111416838|NCT00003195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111416839|NCT00003195|Immunologic Factors|immunologic factors|mesh-ancestor
111416840|NCT00003195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111416841|NCT00003195|Alkylating Agents|alkylating agents|mesh-ancestor
111416842|NCT00003195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111416843|NCT00003195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111416844|NCT00003195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111416845|NCT00003195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111416846|NCT05716256|Urinastatin|urinastatin|mesh-list
111416847|NCT05716256|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
111416848|NCT05716256|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111416849|NCT05716256|Protease Inhibitors|protease inhibitors|mesh-ancestor
111416850|NCT05716256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111416851|NCT05716256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111416852|NCT00356083|Methadone|methadone|mesh-list
111416853|NCT00356083|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111416854|NCT00356083|Narcotics|narcotics|mesh-ancestor
111416855|NCT00356083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111416856|NCT00356083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111416857|NCT00356083|Analgesics|analgesics|mesh-ancestor
111416858|NCT00356083|Sensory System Agents|sensory system agents|mesh-ancestor
111416859|NCT00356083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111416860|NCT00356083|Antitussive Agents|antitussive agents|mesh-ancestor
111416861|NCT00356083|Respiratory System Agents|respiratory system agents|mesh-ancestor
111416862|NCT02977832|Alfuzosin|alfuzosin|mesh-list
111416863|NCT02977832|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111416864|NCT02977832|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111416865|NCT02977832|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111416866|NCT02977832|Adrenergic Agents|adrenergic agents|mesh-ancestor
111416867|NCT02977832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111416868|NCT02977832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111416869|NCT02977832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111416870|NCT02977832|Urological Agents|urological agents|mesh-ancestor
111416871|NCT04344236|Chlorhexidine|chlorhexidine|mesh-list
111416872|NCT04344236|Povidone-Iodine|povidone-iodine|mesh-list
111416873|NCT04344236|Povidone|povidone|mesh-list
111416874|NCT04344236|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111416875|NCT04344236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111416876|NCT04344236|Disinfectants|disinfectants|mesh-ancestor
111416877|NCT04344236|Plasma Substitutes|plasma substitutes|mesh-ancestor
111416878|NCT04344236|Blood Substitutes|blood substitutes|mesh-ancestor
111416879|NCT00355537|Testosterone|testosterone|mesh-list
111416880|NCT00355537|Androgens|androgens|mesh-ancestor
111416881|NCT00355537|Hormones|hormones|mesh-ancestor
111416882|NCT00355537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111416883|NCT00355537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111416884|NCT00003207|Doxorubicin|doxorubicin|mesh-list
111416885|NCT00003207|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111416886|NCT00003207|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111416887|NCT00003207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111416888|NCT00003207|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111416889|NCT00003207|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111416890|NCT00003207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111416891|NCT00003207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111416892|NCT00003387|Paclitaxel|paclitaxel|mesh-list
111416893|NCT00003387|Carboplatin|carboplatin|mesh-list
111416894|NCT00003387|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111416895|NCT00003387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111416896|NCT00003387|Tubulin Modulators|tubulin modulators|mesh-ancestor
111416897|NCT00003387|Antimitotic Agents|antimitotic agents|mesh-ancestor
111416898|NCT00003387|Mitosis Modulators|mitosis modulators|mesh-ancestor
111416899|NCT00003387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111416900|NCT01542021|Androgens|androgens|mesh-list
111416901|NCT01542021|Hormones|hormones|mesh-ancestor
111416902|NCT01542021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111416903|NCT01542021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111416904|NCT04706897|Lidocaine|lidocaine|mesh-list
111416905|NCT04706897|Dexmedetomidine|dexmedetomidine|mesh-list
111416906|NCT04706897|Ketamine|ketamine|mesh-list
111416907|NCT04706897|Anesthetics, Local|anesthetics, local|mesh-ancestor
111416908|NCT04706897|Anesthetics|anesthetics|mesh-ancestor
111416909|NCT04706897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111416910|NCT04706897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111416911|NCT04706897|Sensory System Agents|sensory system agents|mesh-ancestor
111416912|NCT04706897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111416913|NCT04706897|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111416914|NCT04706897|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111416915|NCT04706897|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111416916|NCT04706897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111416917|NCT04706897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111416918|NCT04706897|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111416919|NCT04706897|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111416920|NCT04706897|Analgesics|analgesics|mesh-ancestor
111416921|NCT04706897|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111416922|NCT04706897|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111416923|NCT04706897|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111416924|NCT04706897|Adrenergic Agents|adrenergic agents|mesh-ancestor
111416925|NCT04706897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111416926|NCT04706897|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111416927|NCT04706897|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111416928|NCT04706897|Anesthetics, General|anesthetics, general|mesh-ancestor
111416929|NCT04706897|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111416930|NCT04706897|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111416931|NCT00003213|Dexamethasone|dexamethasone|mesh-list
111416932|NCT00003213|Dexamethasone acetate|dexamethasone acetate|mesh-list
111416933|NCT00003213|Metoclopramide|metoclopramide|mesh-list
111416934|NCT00003213|Granisetron|granisetron|mesh-list
111416935|NCT00003213|BB 1101|bb 1101|mesh-list
111416936|NCT00003213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111416937|NCT00003213|Antiemetics|antiemetics|mesh-ancestor
111416938|NCT00003213|Autonomic Agents|autonomic agents|mesh-ancestor
111416939|NCT00003213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111416940|NCT00003213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111416941|NCT00003213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111416942|NCT00003213|Glucocorticoids|glucocorticoids|mesh-ancestor
111416943|NCT00003213|Hormones|hormones|mesh-ancestor
111416944|NCT00003213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111416945|NCT00003213|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111416946|NCT00003213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111416947|NCT00003213|Protease Inhibitors|protease inhibitors|mesh-ancestor
111416948|NCT00003213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111416949|NCT00003213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111416950|NCT00003213|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111416951|NCT00003213|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111416952|NCT00003213|Dopamine Agents|dopamine agents|mesh-ancestor
111416953|NCT00003213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111416954|NCT00003213|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111416955|NCT00003213|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111416956|NCT00003213|Serotonin Agents|serotonin agents|mesh-ancestor
111416958|NCT01445067|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
111416959|NCT01445067|Katacalcin|katacalcin|mesh-list
111416960|NCT01445067|Vasodilator Agents|vasodilator agents|mesh-ancestor
111416961|NCT01445067|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111416962|NCT01445067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111416963|NCT01445067|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111416964|NCT02978066|Anesthetics|anesthetics|mesh-list
111416965|NCT02978066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111416966|NCT02978066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111416967|NCT00003399|Dexamethasone|dexamethasone|mesh-list
111416968|NCT00003399|Paclitaxel|paclitaxel|mesh-list
111416969|NCT00003399|Etoposide|etoposide|mesh-list
111416970|NCT00003399|Cyclophosphamide|cyclophosphamide|mesh-list
111416971|NCT00003399|Melphalan|melphalan|mesh-list
111416972|NCT00003399|Carmustine|carmustine|mesh-list
111416973|NCT00003399|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111416974|NCT00003399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111416975|NCT00003399|Tubulin Modulators|tubulin modulators|mesh-ancestor
111416976|NCT00003399|Antimitotic Agents|antimitotic agents|mesh-ancestor
111416977|NCT00003399|Mitosis Modulators|mitosis modulators|mesh-ancestor
111416978|NCT00003399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111416979|NCT00003399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111416980|NCT00003399|Immunologic Factors|immunologic factors|mesh-ancestor
111416981|NCT00003399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111416982|NCT00003399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111416983|NCT00003399|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111416984|NCT00003399|Alkylating Agents|alkylating agents|mesh-ancestor
111416985|NCT00003399|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111416986|NCT00003399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111416987|NCT00003399|Antiemetics|antiemetics|mesh-ancestor
111416988|NCT00003399|Autonomic Agents|autonomic agents|mesh-ancestor
111416989|NCT00003399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111416990|NCT00003399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111416991|NCT00003399|Glucocorticoids|glucocorticoids|mesh-ancestor
111416992|NCT00003399|Hormones|hormones|mesh-ancestor
111416993|NCT00003399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111416994|NCT00003399|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111416995|NCT00003399|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111416996|NCT00003399|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111416997|NCT00003399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111416998|NCT03376061|Tranexamic Acid|tranexamic acid|mesh-list
111416999|NCT03376061|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111417000|NCT03376061|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111417001|NCT03376061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111417002|NCT03376061|Hemostatics|hemostatics|mesh-ancestor
111417003|NCT03376061|Coagulants|coagulants|mesh-ancestor
111417004|NCT03376295|Tiotropium Bromide|tiotropium bromide|mesh-list
111417005|NCT03376295|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111417006|NCT03376295|Autonomic Agents|autonomic agents|mesh-ancestor
111417007|NCT03376295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111417008|NCT03376295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111417009|NCT03376295|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111417010|NCT03376295|Respiratory System Agents|respiratory system agents|mesh-ancestor
111417011|NCT03376295|Parasympatholytics|parasympatholytics|mesh-ancestor
111417012|NCT03376295|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111417013|NCT03376295|Cholinergic Agents|cholinergic agents|mesh-ancestor
111417014|NCT03376295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111417015|NCT03376295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111417016|NCT00003219|Perillyl alcohol|perillyl alcohol|mesh-list
111417017|NCT00003219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111417018|NCT00003219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111417019|NCT00003219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111417020|NCT05715788|Nitric Oxide|nitric oxide|mesh-list
111417021|NCT05715788|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111417022|NCT05715788|Autonomic Agents|autonomic agents|mesh-ancestor
111417023|NCT05715788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111417024|NCT05715788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111417025|NCT05715788|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111417026|NCT05715788|Respiratory System Agents|respiratory system agents|mesh-ancestor
111417027|NCT05715788|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111417028|NCT05715788|Antioxidants|antioxidants|mesh-ancestor
111417029|NCT05715788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111417030|NCT05715788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111417031|NCT05715788|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
111417032|NCT05715788|Vasodilator Agents|vasodilator agents|mesh-ancestor
111417033|NCT05715788|Gasotransmitters|gasotransmitters|mesh-ancestor
111417034|NCT05715788|Protective Agents|protective agents|mesh-ancestor
111417035|NCT00003225|Irinotecan|irinotecan|mesh-list
111417036|NCT00003225|Amifostine|amifostine|mesh-list
111417037|NCT00003225|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111417038|NCT00003225|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111417039|NCT00003225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111417040|NCT00003225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111417041|NCT00003225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111417042|NCT00003225|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111417043|NCT00003225|Protective Agents|protective agents|mesh-ancestor
111417044|NCT00003225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111417045|NCT03838094|Calcium|calcium|mesh-list
111417046|NCT03838094|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111417047|NCT03838094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111417048|NCT03441269|Ibuprofen|ibuprofen|mesh-list
111417049|NCT03441269|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111417050|NCT03441269|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111417051|NCT03441269|Analgesics|analgesics|mesh-ancestor
111417052|NCT03441269|Sensory System Agents|sensory system agents|mesh-ancestor
111417053|NCT03441269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111417054|NCT03441269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111417055|NCT03441269|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111417056|NCT03441269|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111417057|NCT03441269|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111417058|NCT03441269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111417059|NCT03441269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111417060|NCT03252353|Octreotide|octreotide|mesh-list
111417061|NCT03252353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111417062|NCT03252353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111417063|NCT03252353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111417064|NCT00358358|Fluticasone|fluticasone|mesh-list
111417065|NCT00358358|Xhance|xhance|mesh-list
111417066|NCT00358358|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
111417067|NCT00358358|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
111417068|NCT00358358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111417069|NCT00358358|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111417070|NCT00358358|Autonomic Agents|autonomic agents|mesh-ancestor
111417071|NCT00358358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111417072|NCT00358358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111417073|NCT00358358|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111417074|NCT00358358|Respiratory System Agents|respiratory system agents|mesh-ancestor
111417075|NCT00358358|Dermatologic Agents|dermatologic agents|mesh-ancestor
111417076|NCT00358358|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111417077|NCT00358358|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111417078|NCT00358358|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111417079|NCT00358358|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111417080|NCT00358358|Adrenergic Agents|adrenergic agents|mesh-ancestor
111417081|NCT00358358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111417082|NCT00358358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111417083|NCT00358358|Glucocorticoids|glucocorticoids|mesh-ancestor
111417084|NCT00358358|Hormones|hormones|mesh-ancestor
111417085|NCT00358358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111417086|NCT00358358|Sympathomimetics|sympathomimetics|mesh-ancestor
111417087|NCT03441581|Eluxadoline|eluxadoline|mesh-list
111417088|NCT03441581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111417089|NCT02265510|Dexamethasone|dexamethasone|mesh-list
111417090|NCT02265510|Paclitaxel|paclitaxel|mesh-list
111417091|NCT02265510|Gemcitabine|gemcitabine|mesh-list
111417092|NCT02265510|Lenalidomide|lenalidomide|mesh-list
111417093|NCT02265510|Azacitidine|azacitidine|mesh-list
111417094|NCT02265510|Bortezomib|bortezomib|mesh-list
111417095|NCT02265510|Pomalidomide|pomalidomide|mesh-list
111417096|NCT02265510|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111417097|NCT02265510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111417098|NCT02265510|Tubulin Modulators|tubulin modulators|mesh-ancestor
111417099|NCT02265510|Antimitotic Agents|antimitotic agents|mesh-ancestor
111417100|NCT02265510|Mitosis Modulators|mitosis modulators|mesh-ancestor
111417101|NCT02265510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111417102|NCT02265510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111417103|NCT02265510|Antiemetics|antiemetics|mesh-ancestor
111417104|NCT02265510|Autonomic Agents|autonomic agents|mesh-ancestor
111417105|NCT02265510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111417106|NCT02265510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111417107|NCT02265510|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111417108|NCT02265510|Glucocorticoids|glucocorticoids|mesh-ancestor
111417109|NCT02265510|Hormones|hormones|mesh-ancestor
111417110|NCT02265510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111417111|NCT02265510|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111417112|NCT02265510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111417113|NCT02265510|Antimetabolites|antimetabolites|mesh-ancestor
111417114|NCT02265510|Immunologic Factors|immunologic factors|mesh-ancestor
111417115|NCT02265510|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111417116|NCT02265510|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111417117|NCT02265510|Growth Substances|growth substances|mesh-ancestor
111417118|NCT02265510|Growth Inhibitors|growth inhibitors|mesh-ancestor
111417119|NCT02265510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111417120|NCT03254147|Warfarin|warfarin|mesh-list
111417121|NCT03254147|Rivaroxaban|rivaroxaban|mesh-list
111417122|NCT03254147|Dabigatran|dabigatran|mesh-list
111417123|NCT03254147|Apixaban|apixaban|mesh-list
111417124|NCT03254147|Edoxaban|edoxaban|mesh-list
111417125|NCT03254147|Anticoagulants|anticoagulants|mesh-ancestor
111417126|NCT03254147|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111417127|NCT03254147|Antithrombins|antithrombins|mesh-ancestor
111417128|NCT03254147|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111417129|NCT03254147|Protease Inhibitors|protease inhibitors|mesh-ancestor
111417130|NCT03254147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111417131|NCT03254147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111417132|NCT03384329|Resveratrol|resveratrol|mesh-list
111417133|NCT03384329|Antioxidants|antioxidants|mesh-ancestor
111417134|NCT03384329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111417135|NCT03384329|Protective Agents|protective agents|mesh-ancestor
111417136|NCT03384329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111417137|NCT03384329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110509944|NCT02802072|Sensory System Agents|sensory system agents|mesh-ancestor
111417138|NCT03384329|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111417139|NCT03443063|Lemborexant|lemborexant|mesh-list
111417140|NCT03443063|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
111417141|NCT03443063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111417142|NCT03443063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111417143|NCT03443063|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111417144|NCT03443063|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111417145|NCT03443063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111417146|NCT03443063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111417147|NCT05327972|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
111417148|NCT05327972|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111417149|NCT05327972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111417150|NCT05327972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111417151|NCT05327972|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111417152|NCT05327972|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111417153|NCT05327972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111417154|NCT05327972|Cholinergic Agents|cholinergic agents|mesh-ancestor
111417155|NCT05327972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111417156|NCT03256253|Pregabalin|pregabalin|mesh-list
111417157|NCT03256253|Analgesics|analgesics|mesh-ancestor
111417158|NCT03256253|Sensory System Agents|sensory system agents|mesh-ancestor
111417159|NCT03256253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111417160|NCT03256253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111417161|NCT03256253|Anticonvulsants|anticonvulsants|mesh-ancestor
111417162|NCT03256253|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111417163|NCT03256253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111417164|NCT03256253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111417165|NCT03256253|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111417166|NCT03256253|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111417167|NCT03256253|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111417168|NCT03256253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111417169|NCT03256253|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111417170|NCT03256799|Ivacaftor|ivacaftor|mesh-list
111141576|NCT04524455|Hormones|hormones|mesh-ancestor
111417171|NCT03256799|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
111417172|NCT03256799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111417173|NCT03256799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111417174|NCT01238211|Cytarabine|cytarabine|mesh-list
111417175|NCT01238211|Daunorubicin|daunorubicin|mesh-list
111417176|NCT01238211|Dasatinib|dasatinib|mesh-list
111417177|NCT01238211|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111417178|NCT01238211|Antimetabolites|antimetabolites|mesh-ancestor
111417179|NCT01238211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111417180|NCT01238211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111417181|NCT01238211|Antiviral Agents|antiviral agents|mesh-ancestor
111417182|NCT01238211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111417183|NCT01238211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111417184|NCT01238211|Immunologic Factors|immunologic factors|mesh-ancestor
111417185|NCT01238211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111417186|NCT01238211|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111417187|NCT01238211|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111417188|NCT01238211|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111417189|NCT01238211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111417190|NCT01238211|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111417191|NCT04735445|Liver Extracts|liver extracts|mesh-list
111417192|NCT04735445|Hematinics|hematinics|mesh-ancestor
111417193|NCT00003231|Docetaxel|docetaxel|mesh-list
111417194|NCT00003231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111417195|NCT00003231|Tubulin Modulators|tubulin modulators|mesh-ancestor
111417196|NCT00003231|Antimitotic Agents|antimitotic agents|mesh-ancestor
111417197|NCT00003231|Mitosis Modulators|mitosis modulators|mesh-ancestor
111417198|NCT00003231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111417199|NCT00003405|Interferons|interferons|mesh-list
111417200|NCT00003405|Cytarabine|cytarabine|mesh-list
111417201|NCT00003405|Interferon-alpha|interferon-alpha|mesh-list
111417202|NCT00003405|Bromodeoxyuridine|bromodeoxyuridine|mesh-list
111417203|NCT00003405|5-bromouridine|5-bromouridine|mesh-list
111417204|NCT00003405|Idoxuridine|idoxuridine|mesh-list
111417205|NCT00003405|Mitoxantrone|mitoxantrone|mesh-list
111417206|NCT00003405|Idarubicin|idarubicin|mesh-list
111417207|NCT00003405|Isotretinoin|isotretinoin|mesh-list
111417208|NCT00003405|Amifostine|amifostine|mesh-list
111417209|NCT00003405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111417210|NCT00003405|Antiviral Agents|antiviral agents|mesh-ancestor
111417211|NCT00003405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111417212|NCT00003405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111417213|NCT00003405|Antimetabolites|antimetabolites|mesh-ancestor
111417214|NCT00003405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111417215|NCT00003405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111417216|NCT00003405|Immunologic Factors|immunologic factors|mesh-ancestor
111417217|NCT00003405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111417218|NCT00003405|Analgesics|analgesics|mesh-ancestor
111417219|NCT00003405|Sensory System Agents|sensory system agents|mesh-ancestor
111417220|NCT00003405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111417221|NCT00003405|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111417222|NCT00003405|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111417223|NCT00003405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111417224|NCT00003405|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111417225|NCT00003405|Dermatologic Agents|dermatologic agents|mesh-ancestor
111417226|NCT00003405|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111417227|NCT00003405|Protective Agents|protective agents|mesh-ancestor
111417228|NCT00003405|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111417229|NCT05131646|Axitinib|axitinib|mesh-list
111417230|NCT05131646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111417231|NCT05131646|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111417232|NCT05131646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111417233|NCT05131646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111417234|NCT00003411|Motexafin gadolinium|motexafin gadolinium|mesh-list
111417235|NCT00003411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111417236|NCT00003411|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111417237|NCT00003411|Dermatologic Agents|dermatologic agents|mesh-ancestor
111417238|NCT00003243|Aldesleukin|aldesleukin|mesh-list
111417239|NCT00003243|Cyclophosphamide|cyclophosphamide|mesh-list
111417240|NCT00003243|Doxorubicin|doxorubicin|mesh-list
111417241|NCT00003243|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111417242|NCT00003243|Etoposide|etoposide|mesh-list
111417243|NCT00003243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111417244|NCT00003243|Immunologic Factors|immunologic factors|mesh-ancestor
111417245|NCT00003243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111417246|NCT00003243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111417247|NCT00003243|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111417248|NCT00003243|Alkylating Agents|alkylating agents|mesh-ancestor
111417249|NCT00003243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111417250|NCT00003243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111417251|NCT00003243|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111417252|NCT00003243|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111417253|NCT00003243|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111417254|NCT00003243|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111417255|NCT00003243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111417256|NCT00003243|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111417257|NCT00003243|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111417258|NCT00003243|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111417259|NCT00003243|Antiviral Agents|antiviral agents|mesh-ancestor
111417260|NCT00003243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111417261|NCT04344158|Sorafenib|sorafenib|mesh-list
111417262|NCT04344158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111417263|NCT04344158|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111417264|NCT04344158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111417265|NCT04344158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111417266|NCT00003249|Ketoconazole|ketoconazole|mesh-list
111417267|NCT00003249|Carboxyamido-triazole|carboxyamido-triazole|mesh-list
111417268|NCT00003249|Antifungal Agents|antifungal agents|mesh-ancestor
111417269|NCT00003249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111417270|NCT00003249|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111417271|NCT00003249|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111417272|NCT00003249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111417273|NCT00003249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111417274|NCT00003249|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111417275|NCT00003249|Hormone Antagonists|hormone antagonists|mesh-ancestor
111417276|NCT00003249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111417277|NCT00003249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111417278|NCT00003249|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111417279|NCT00003249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111417280|NCT00003249|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111417281|NCT00003249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111417282|NCT00003249|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111417283|NCT00003255|Carboplatin|carboplatin|mesh-list
111417284|NCT00003255|Topotecan|topotecan|mesh-list
111417285|NCT00003255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111417286|NCT00003255|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111417287|NCT00003255|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111417288|NCT00003255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111417289|NCT00003255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111417290|NCT03269435|Metoclopramide|metoclopramide|mesh-list
111417291|NCT03269435|Bupivacaine|bupivacaine|mesh-list
111417292|NCT03269435|Anesthetics, Local|anesthetics, local|mesh-ancestor
111417293|NCT03269435|Anesthetics|anesthetics|mesh-ancestor
111417294|NCT03269435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111417295|NCT03269435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111417296|NCT03269435|Sensory System Agents|sensory system agents|mesh-ancestor
111417297|NCT03269435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111417298|NCT03269435|Antiemetics|antiemetics|mesh-ancestor
111417299|NCT03269435|Autonomic Agents|autonomic agents|mesh-ancestor
111417300|NCT03269435|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111417301|NCT03269435|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111417302|NCT03269435|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111417303|NCT03269435|Dopamine Agents|dopamine agents|mesh-ancestor
111417304|NCT03269435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111417305|NCT03269435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111417306|NCT00003261|Zidovudine|zidovudine|mesh-list
111417307|NCT00003261|Methotrexate|methotrexate|mesh-list
111417308|NCT00003261|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111417309|NCT00003261|Abortifacient Agents|abortifacient agents|mesh-ancestor
111417310|NCT00003261|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111417311|NCT00003261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111417312|NCT00003261|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111417313|NCT00003261|Antimetabolites|antimetabolites|mesh-ancestor
111417314|NCT00003261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111417315|NCT00003261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111417316|NCT00003261|Dermatologic Agents|dermatologic agents|mesh-ancestor
111417317|NCT00003261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111417318|NCT00003261|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111417319|NCT00003261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111417320|NCT00003261|Immunologic Factors|immunologic factors|mesh-ancestor
111417322|NCT00003261|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111417323|NCT00003261|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111417324|NCT00003261|Antiviral Agents|antiviral agents|mesh-ancestor
111417325|NCT00003261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111417326|NCT00003261|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111417327|NCT00003261|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111417328|NCT03279731|Liraglutide|liraglutide|mesh-list
111417329|NCT03279731|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111417330|NCT03279731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111417331|NCT03279731|Incretins|incretins|mesh-ancestor
111417332|NCT03279731|Hormones|hormones|mesh-ancestor
111417333|NCT03279731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111417334|NCT04477837|Rivaroxaban|rivaroxaban|mesh-list
111417335|NCT04477837|Apixaban|apixaban|mesh-list
111417336|NCT04477837|Edoxaban|edoxaban|mesh-list
111417337|NCT04477837|Dabigatran|dabigatran|mesh-list
111417338|NCT04477837|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111417339|NCT04477837|Antithrombins|antithrombins|mesh-ancestor
111417340|NCT04477837|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111417341|NCT04477837|Protease Inhibitors|protease inhibitors|mesh-ancestor
111417342|NCT04477837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111417343|NCT04477837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111417344|NCT04477837|Anticoagulants|anticoagulants|mesh-ancestor
111417345|NCT05267821|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
111417346|NCT05267821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111417347|NCT02264574|Obinutuzumab|obinutuzumab|mesh-list
111417348|NCT02264574|Chlorambucil|chlorambucil|mesh-list
111417349|NCT02264574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111417350|NCT02264574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111417351|NCT02264574|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111417352|NCT02264574|Alkylating Agents|alkylating agents|mesh-ancestor
111417353|NCT02264574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111417354|NCT04412863|Interferons|interferons|mesh-list
111417355|NCT04412863|Interferon-alpha|interferon-alpha|mesh-list
111417356|NCT04412863|Interferon alpha-2|interferon alpha-2|mesh-list
111417357|NCT04412863|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
111417358|NCT04412863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111417359|NCT04412863|Antiviral Agents|antiviral agents|mesh-ancestor
111417360|NCT04412863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111417361|NCT04412863|Immunologic Factors|immunologic factors|mesh-ancestor
111417362|NCT04412863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111417363|NCT03400475|Simvastatin|simvastatin|mesh-list
111417364|NCT03400475|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111417365|NCT03400475|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111417366|NCT03400475|Antimetabolites|antimetabolites|mesh-ancestor
111417367|NCT03400475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111417368|NCT03400475|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111417369|NCT03400475|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111417370|NCT03400475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111417371|NCT01641900|Eszopiclone|eszopiclone|mesh-list
111417372|NCT01641900|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111417373|NCT01641900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111417374|NCT01641900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111417375|NCT03834571|Paclitaxel|paclitaxel|mesh-list
111417376|NCT03834571|Cisplatin|cisplatin|mesh-list
111417377|NCT03834571|Carboplatin|carboplatin|mesh-list
111417378|NCT03834571|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111417379|NCT03834571|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111417380|NCT03834571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111417381|NCT03834571|Tubulin Modulators|tubulin modulators|mesh-ancestor
111417382|NCT03834571|Antimitotic Agents|antimitotic agents|mesh-ancestor
111417383|NCT03834571|Mitosis Modulators|mitosis modulators|mesh-ancestor
111417384|NCT03834571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111417385|NCT05088980|Lidocaine|lidocaine|mesh-list
111417386|NCT05088980|Anesthetics, Local|anesthetics, local|mesh-ancestor
111417387|NCT05088980|Anesthetics|anesthetics|mesh-ancestor
111417388|NCT05088980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111417389|NCT05088980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111417390|NCT05088980|Sensory System Agents|sensory system agents|mesh-ancestor
111417391|NCT05088980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111417392|NCT05088980|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111417393|NCT05088980|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111417394|NCT05088980|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111417395|NCT05088980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111417396|NCT05088980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111417398|NCT00376727|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111417399|NCT00376727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111417400|NCT05468606|Imiquimod|imiquimod|mesh-list
111417401|NCT05468606|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111417402|NCT05468606|Immunologic Factors|immunologic factors|mesh-ancestor
111417403|NCT05468606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111417404|NCT05468606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111417405|NCT05468606|Interferon Inducers|interferon inducers|mesh-ancestor
111417406|NCT04290871|Nitric Oxide|nitric oxide|mesh-list
111417407|NCT04290871|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111417408|NCT04290871|Autonomic Agents|autonomic agents|mesh-ancestor
111417409|NCT04290871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111417410|NCT04290871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111417411|NCT04290871|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111417412|NCT04290871|Respiratory System Agents|respiratory system agents|mesh-ancestor
111417413|NCT04290871|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111417414|NCT04290871|Antioxidants|antioxidants|mesh-ancestor
111417415|NCT04290871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111417416|NCT04290871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111417417|NCT04290871|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
111417418|NCT04290871|Vasodilator Agents|vasodilator agents|mesh-ancestor
111417419|NCT04290871|Gasotransmitters|gasotransmitters|mesh-ancestor
111417420|NCT04290871|Protective Agents|protective agents|mesh-ancestor
111417421|NCT03501979|Capecitabine|capecitabine|mesh-list
111417422|NCT03501979|Trastuzumab|trastuzumab|mesh-list
111417423|NCT03501979|Tucatinib|tucatinib|mesh-list
111417424|NCT03501979|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111417425|NCT03501979|Antimetabolites|antimetabolites|mesh-ancestor
111417426|NCT03501979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111417427|NCT03501979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111417428|NCT03501979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111417429|NCT03501979|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111417430|NCT03501979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111417431|NCT03465787|Quetiapine Fumarate|quetiapine fumarate|mesh-list
111417432|NCT03465787|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
111417433|NCT03465787|Antidepressive Agents|antidepressive agents|mesh-ancestor
111417434|NCT03465787|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111417435|NCT03465787|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111417436|NCT03465787|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111417437|NCT03465787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111417438|NCT03465787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111417439|NCT03465787|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
111417440|NCT03465787|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111417441|NCT03465787|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111417442|NCT03465787|Adrenergic Agents|adrenergic agents|mesh-ancestor
111417443|NCT03465787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111417444|NCT03465787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111417445|NCT03465787|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111417446|NCT03465787|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111417447|NCT03465787|Serotonin Agents|serotonin agents|mesh-ancestor
111417448|NCT03465787|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111417449|NCT03465787|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111417450|NCT03465787|Dopamine Agents|dopamine agents|mesh-ancestor
111417451|NCT05071352|Nefopam|nefopam|mesh-list
111417452|NCT05071352|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111417453|NCT05071352|Analgesics|analgesics|mesh-ancestor
111417454|NCT05071352|Sensory System Agents|sensory system agents|mesh-ancestor
111417455|NCT05071352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111417456|NCT05071352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111417457|NCT00376025|Antioxidants|antioxidants|mesh-list
111417458|NCT00376025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111417459|NCT00376025|Protective Agents|protective agents|mesh-ancestor
111417460|NCT00376025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111417461|NCT00376103|Temozolomide|temozolomide|mesh-list
111417462|NCT00376103|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111417463|NCT00376103|Alkylating Agents|alkylating agents|mesh-ancestor
111417464|NCT00376103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111417465|NCT00376103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111417466|NCT03836287|Bromides|bromides|mesh-list
111417467|NCT03836287|Anticonvulsants|anticonvulsants|mesh-ancestor
111417468|NCT03403517|Dexamethasone|dexamethasone|mesh-list
111417469|NCT03403517|Methylprednisolone|methylprednisolone|mesh-list
111417470|NCT03403517|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111417471|NCT03403517|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111417473|NCT03403517|Prednisolone acetate|prednisolone acetate|mesh-list
111417474|NCT03403517|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111417475|NCT03403517|Prednisolone phosphate|prednisolone phosphate|mesh-list
111417476|NCT03403517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111417477|NCT03403517|Antiemetics|antiemetics|mesh-ancestor
111417478|NCT03403517|Autonomic Agents|autonomic agents|mesh-ancestor
111417479|NCT03403517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111417480|NCT03403517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111417481|NCT03403517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111417482|NCT03403517|Glucocorticoids|glucocorticoids|mesh-ancestor
111417483|NCT03403517|Hormones|hormones|mesh-ancestor
111417484|NCT03403517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111417485|NCT03403517|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111417486|NCT03403517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111417487|NCT03403517|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111417488|NCT03403517|Protective Agents|protective agents|mesh-ancestor
111417489|NCT05247788|Ethanol|ethanol|mesh-list
111417490|NCT05247788|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111417491|NCT05247788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111417492|NCT05247788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111417493|NCT05247788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111417494|NCT02263326|Lamivudine|lamivudine|mesh-list
111417495|NCT02263326|Dolutegravir|dolutegravir|mesh-list
111417496|NCT02263326|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
111417497|NCT02263326|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111417498|NCT02263326|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111417499|NCT02263326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111417500|NCT02263326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111417501|NCT02263326|Antiviral Agents|antiviral agents|mesh-ancestor
111417502|NCT02263326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111417503|NCT02263326|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111417504|NCT02263326|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111417505|NCT02263326|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111417506|NCT05463848|Pembrolizumab|pembrolizumab|mesh-list
111417507|NCT05463848|Temozolomide|temozolomide|mesh-list
111417508|NCT05463848|Olaparib|olaparib|mesh-list
111417509|NCT05463848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111417510|NCT05463848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111417511|NCT05463848|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111417512|NCT05463848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111417513|NCT05463848|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111417514|NCT05463848|Alkylating Agents|alkylating agents|mesh-ancestor
111417515|NCT05463848|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111417516|NCT05463848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111417517|NCT05647512|Dexamethasone|dexamethasone|mesh-list
111417518|NCT05647512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111417519|NCT05647512|Antiemetics|antiemetics|mesh-ancestor
111417520|NCT05647512|Autonomic Agents|autonomic agents|mesh-ancestor
111417521|NCT05647512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111417522|NCT05647512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111417523|NCT05647512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111417524|NCT05647512|Glucocorticoids|glucocorticoids|mesh-ancestor
111417525|NCT05647512|Hormones|hormones|mesh-ancestor
111417526|NCT05647512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111417527|NCT05647512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111417528|NCT05647512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111417529|NCT00356395|Candesartan|candesartan|mesh-list
111417530|NCT00356395|Candesartan cilexetil|candesartan cilexetil|mesh-list
111417531|NCT00356395|Ramipril|ramipril|mesh-list
111417532|NCT00356395|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111417533|NCT00356395|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111417534|NCT00356395|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111417535|NCT00356395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111417536|NCT00356395|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
111417537|NCT00356395|Protease Inhibitors|protease inhibitors|mesh-ancestor
111417538|NCT00356395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111417539|NCT00356473|Atorvastatin|atorvastatin|mesh-list
111417540|NCT00356473|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111417541|NCT00356473|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110510002|NCT02801838|Analgesics|analgesics|mesh-ancestor
111417542|NCT00356473|Antimetabolites|antimetabolites|mesh-ancestor
111417543|NCT00356473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111417544|NCT00356473|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111417545|NCT00356473|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111417546|NCT00356473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111417547|NCT05461508|Amoxicillin|amoxicillin|mesh-list
111417548|NCT05461508|Fucoidan|fucoidan|mesh-list
111417549|NCT05461508|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111417550|NCT05461508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111417551|NCT05461508|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111417552|NCT05461508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111417553|NCT05461508|Anticoagulants|anticoagulants|mesh-ancestor
111417554|NCT05461508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111417555|NCT00356941|Docetaxel|docetaxel|mesh-list
111417556|NCT00356941|Oxaliplatin|oxaliplatin|mesh-list
111417557|NCT00356941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111417558|NCT00356941|Tubulin Modulators|tubulin modulators|mesh-ancestor
111417559|NCT00356941|Antimitotic Agents|antimitotic agents|mesh-ancestor
111417560|NCT00356941|Mitosis Modulators|mitosis modulators|mesh-ancestor
111417561|NCT00356941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111417562|NCT03450083|Benralizumab|benralizumab|mesh-list
111417563|NCT03450083|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111417564|NCT03450083|Respiratory System Agents|respiratory system agents|mesh-ancestor
111417565|NCT03580343|Tofacitinib|tofacitinib|mesh-list
111417566|NCT03580343|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
111417567|NCT03580343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111417568|NCT03580343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111417569|NCT03580343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111417570|NCT05445440|Leucovorin|leucovorin|mesh-list
111417571|NCT05445440|Sulfasalazine|sulfasalazine|mesh-list
111417572|NCT05445440|Methotrexate|methotrexate|mesh-list
111417573|NCT05445440|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111417574|NCT05445440|Abortifacient Agents|abortifacient agents|mesh-ancestor
111417575|NCT05445440|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111417576|NCT05445440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111417577|NCT05445440|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111417578|NCT05445440|Antimetabolites|antimetabolites|mesh-ancestor
111417579|NCT05445440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111417580|NCT05445440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111417581|NCT05445440|Dermatologic Agents|dermatologic agents|mesh-ancestor
111417582|NCT05445440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111417583|NCT05445440|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111417584|NCT05445440|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111417585|NCT05445440|Immunologic Factors|immunologic factors|mesh-ancestor
111417586|NCT05445440|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111417587|NCT05445440|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111417588|NCT05445440|Antidotes|antidotes|mesh-ancestor
111417589|NCT05445440|Protective Agents|protective agents|mesh-ancestor
111417590|NCT05445440|Vitamin B Complex|vitamin b complex|mesh-ancestor
111417591|NCT05445440|Vitamins|vitamins|mesh-ancestor
111417592|NCT05445440|Micronutrients|micronutrients|mesh-ancestor
111417593|NCT05445440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111417594|NCT05445440|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111417595|NCT05445440|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111417596|NCT05445440|Analgesics|analgesics|mesh-ancestor
111417597|NCT05445440|Sensory System Agents|sensory system agents|mesh-ancestor
111417598|NCT05445440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111417599|NCT05445440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111417600|NCT05445440|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111417601|NCT05041322|Buspirone|buspirone|mesh-list
111417602|NCT05041322|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111417603|NCT05041322|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111417604|NCT05041322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111417605|NCT05041322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111417606|NCT05041322|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111417607|NCT05041322|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111417608|NCT05041322|Serotonin Agents|serotonin agents|mesh-ancestor
111417609|NCT05041322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111417610|NCT05041322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111417611|NCT00422825|Imatinib Mesylate|imatinib mesylate|mesh-list
111417612|NCT00422825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111417613|NCT00422825|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111417614|NCT00422825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111417615|NCT00422825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111417616|NCT05229614|Pembrolizumab|pembrolizumab|mesh-list
111417617|NCT05229614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111417618|NCT05229614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111142018|NCT04424459|Analgesics, Opioid|analgesics, opioid|mesh-list
111417619|NCT05229614|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111417620|NCT05229614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111417621|NCT05445128|Plerixafor|plerixafor|mesh-list
111417622|NCT05445128|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111417623|NCT05445128|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111417624|NCT05445128|Antiviral Agents|antiviral agents|mesh-ancestor
111417625|NCT05445128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111417626|NCT02260986|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111417627|NCT02260986|Immunologic Factors|immunologic factors|mesh-ancestor
111417628|NCT02260986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111417629|NCT05210582|Afamelanotide|afamelanotide|mesh-list
111417630|NCT05210582|Dermatologic Agents|dermatologic agents|mesh-ancestor
111417631|NCT04995536|CPG-oligonucleotide|cpg-oligonucleotide|mesh-list
111417632|NCT04995536|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111417633|NCT04995536|Immunologic Factors|immunologic factors|mesh-ancestor
111417634|NCT04995536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111417635|NCT05647356|Bicalutamide|bicalutamide|mesh-list
111417636|NCT05647356|Androgen Antagonists|androgen antagonists|mesh-ancestor
111417637|NCT05647356|Hormone Antagonists|hormone antagonists|mesh-ancestor
111417638|NCT05647356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111417639|NCT05647356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111417640|NCT05647356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111417641|NCT05647278|Esomeprazole|esomeprazole|mesh-list
111417642|NCT05647278|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111417643|NCT05647278|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111417644|NCT05647278|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111417645|NCT05647278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111417646|NCT05647278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111417647|NCT00358748|Hydrocortisone|hydrocortisone|mesh-list
111417648|NCT00358748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111417649|NCT00359606|Tetrahydrouridine|tetrahydrouridine|mesh-list
111417650|NCT00359606|Antimetabolites|antimetabolites|mesh-ancestor
111417651|NCT00359606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111417652|NCT00359840|Darbepoetin alfa|darbepoetin alfa|mesh-list
111417653|NCT00359840|Hematinics|hematinics|mesh-ancestor
111417654|NCT02259582|Carboplatin|carboplatin|mesh-list
111417655|NCT02259582|Pemetrexed|pemetrexed|mesh-list
111417656|NCT02259582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111417657|NCT02259582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111417658|NCT02259582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111417659|NCT02259582|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111417660|NCT02259582|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111417661|NCT00360386|Clopidogrel|clopidogrel|mesh-list
111417662|NCT00360386|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111417663|NCT00360386|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111417664|NCT00360386|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111417665|NCT00360386|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111417666|NCT00360386|Purinergic Agents|purinergic agents|mesh-ancestor
111417667|NCT00360386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111417668|NCT00360386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111417669|NCT00360386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111417670|NCT02977208|Gabapentin|gabapentin|mesh-list
111417671|NCT02977208|Analgesics|analgesics|mesh-ancestor
111417672|NCT02977208|Sensory System Agents|sensory system agents|mesh-ancestor
111417673|NCT02977208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111417674|NCT02977208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111417675|NCT02977208|Anticonvulsants|anticonvulsants|mesh-ancestor
111417676|NCT02977208|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111417677|NCT02977208|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111417678|NCT02977208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111417679|NCT02977208|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111417680|NCT02977208|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111417681|NCT02977208|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111417682|NCT02977208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111417683|NCT02977208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111417684|NCT02977208|Antimanic Agents|antimanic agents|mesh-ancestor
111417685|NCT04866108|Capecitabine|capecitabine|mesh-list
111417686|NCT04866108|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111417687|NCT04866108|Antimetabolites|antimetabolites|mesh-ancestor
111417688|NCT04866108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111417689|NCT04866108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111417690|NCT04343768|Interferons|interferons|mesh-list
111417691|NCT04343768|Ritonavir|ritonavir|mesh-list
111417692|NCT04343768|Lopinavir|lopinavir|mesh-list
111417693|NCT04343768|Interferon-beta|interferon-beta|mesh-list
111417694|NCT04343768|Interferon beta-1a|interferon beta-1a|mesh-list
111417695|NCT04343768|Hydroxychloroquine|hydroxychloroquine|mesh-list
111417696|NCT04343768|Interferon beta-1b|interferon beta-1b|mesh-list
111417697|NCT04343768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111417698|NCT04343768|Antiviral Agents|antiviral agents|mesh-ancestor
111417699|NCT04343768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111417700|NCT04343768|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111417701|NCT04343768|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111417702|NCT04343768|Protease Inhibitors|protease inhibitors|mesh-ancestor
111417703|NCT04343768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111417704|NCT04343768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111417705|NCT04343768|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111417706|NCT04343768|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111417707|NCT04343768|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111417708|NCT04343768|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111417709|NCT04343768|Antimalarials|antimalarials|mesh-ancestor
111417710|NCT04343768|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111417711|NCT04343768|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111417712|NCT04343768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111417713|NCT04343768|Immunologic Factors|immunologic factors|mesh-ancestor
111417714|NCT04343768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111417715|NCT04343768|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111417716|NCT05925803|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111417717|NCT05925803|Immunologic Factors|immunologic factors|mesh-ancestor
111417718|NCT05925803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111417719|NCT05925790|Antibodies|antibodies|mesh-list
111417720|NCT05925790|Immunologic Factors|immunologic factors|mesh-ancestor
111417721|NCT05925790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111417722|NCT05925530|Durvalumab|durvalumab|mesh-list
111417723|NCT05925530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111417724|NCT05925530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111417725|NCT05925504|Luspatercept|luspatercept|mesh-list
111417726|NCT05925504|Hematinics|hematinics|mesh-ancestor
111417727|NCT05925491|Pembrolizumab|pembrolizumab|mesh-list
111417728|NCT05925491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111417729|NCT05925491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111417730|NCT05925491|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111417731|NCT05925491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111417732|NCT05925309|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111417733|NCT05925309|Meropenem|meropenem|mesh-list
111417734|NCT05925309|Imipenem|imipenem|mesh-list
111417735|NCT05925309|Cefaclor|cefaclor|mesh-list
111417736|NCT05925309|Sulfamethoxazole|sulfamethoxazole|mesh-list
111417737|NCT05925309|Sulperazone|sulperazone|mesh-list
111417738|NCT05925309|Methylprednisolone|methylprednisolone|mesh-list
111417739|NCT05925309|Glycyrrhizic Acid|glycyrrhizic acid|mesh-list
111417740|NCT05925309|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
111417741|NCT05925309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111417742|NCT05925309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111417743|NCT05925309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111417744|NCT05925309|Antiemetics|antiemetics|mesh-ancestor
111417745|NCT05925309|Autonomic Agents|autonomic agents|mesh-ancestor
111417746|NCT05925309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111417747|NCT05925309|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111417748|NCT05925309|Glucocorticoids|glucocorticoids|mesh-ancestor
111417749|NCT05925309|Hormones|hormones|mesh-ancestor
111417750|NCT05925309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111417751|NCT05925309|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111417752|NCT05925309|Protective Agents|protective agents|mesh-ancestor
111417753|NCT05925309|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
111417754|NCT05925309|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111417755|NCT05925283|Midazolam|midazolam|mesh-list
111417756|NCT05925283|Esketamine|esketamine|mesh-list
111417757|NCT05925283|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111417758|NCT05925283|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111417759|NCT05925283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111417760|NCT05925283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111417761|NCT05925283|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111417762|NCT05925283|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111417763|NCT05925283|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111417764|NCT05925283|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111417765|NCT05925283|Anesthetics, General|anesthetics, general|mesh-ancestor
111417766|NCT05925283|Anesthetics|anesthetics|mesh-ancestor
111417767|NCT05925283|GABA Modulators|gaba modulators|mesh-ancestor
111417768|NCT05925283|GABA Agents|gaba agents|mesh-ancestor
111142172|NCT05494307|Terbutaline|terbutaline|mesh-list
111417769|NCT05925283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111417770|NCT05925283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111417771|NCT05925283|Antidepressive Agents|antidepressive agents|mesh-ancestor
111417773|NCT05924971|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111417774|NCT05924971|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111417775|NCT05924971|Analgesics|analgesics|mesh-ancestor
111417776|NCT05924971|Sensory System Agents|sensory system agents|mesh-ancestor
111417777|NCT05924971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111417778|NCT05924971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111417779|NCT05924971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111417780|NCT05924971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111417781|NCT05924971|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111417782|NCT05924971|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111417783|NCT05924971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111417784|NCT05924971|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111417785|NCT05924971|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111417786|NCT05924971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111417787|NCT05924971|Antipyretics|antipyretics|mesh-ancestor
111417788|NCT05924893|Naltrexone|naltrexone|mesh-list
111417789|NCT05924893|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111417790|NCT05924893|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111417791|NCT05924893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111417792|NCT05924893|Sensory System Agents|sensory system agents|mesh-ancestor
111417793|NCT05924893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111417794|NCT05924165|Ketorolac|ketorolac|mesh-list
111417795|NCT05924165|Oxycodone|oxycodone|mesh-list
111417796|NCT05924165|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111417797|NCT05924165|Narcotics|narcotics|mesh-ancestor
111417798|NCT05924165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111417799|NCT05924165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111417800|NCT05924165|Analgesics|analgesics|mesh-ancestor
111417801|NCT05924165|Sensory System Agents|sensory system agents|mesh-ancestor
111417802|NCT05924165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111417803|NCT05924165|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111417804|NCT05924165|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111417805|NCT05924165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111417806|NCT05924165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111417807|NCT05924165|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111417808|NCT05924165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111417809|NCT05924165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111417810|NCT05924126|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111417811|NCT05924126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111417812|NCT05924100|Luspatercept|luspatercept|mesh-list
111417813|NCT05924100|Hematinics|hematinics|mesh-ancestor
111417814|NCT05923970|Vaccines|vaccines|mesh-list
111417815|NCT05923970|Antibodies|antibodies|mesh-list
111417816|NCT05923970|Immunoglobulins|immunoglobulins|mesh-list
111417817|NCT05923970|Immunologic Factors|immunologic factors|mesh-ancestor
111417818|NCT05923970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111417819|NCT05923879|Rituximab|rituximab|mesh-list
111417820|NCT05923879|Lenalidomide|lenalidomide|mesh-list
111417821|NCT05923879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111417822|NCT05923879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111417823|NCT05923879|Immunologic Factors|immunologic factors|mesh-ancestor
111417824|NCT05923879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111417825|NCT05923879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111417826|NCT05923879|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111417827|NCT05923879|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111417828|NCT05923879|Growth Substances|growth substances|mesh-ancestor
111417829|NCT05923879|Growth Inhibitors|growth inhibitors|mesh-ancestor
111417830|NCT05923021|Sertraline|sertraline|mesh-list
111417831|NCT05923021|Antidepressive Agents|antidepressive agents|mesh-ancestor
111417832|NCT05923021|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111417833|NCT05923021|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111417834|NCT05923021|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111417835|NCT05923021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111417836|NCT05923021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111417837|NCT05923021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111417838|NCT05923021|Serotonin Agents|serotonin agents|mesh-ancestor
111417839|NCT05923021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111417840|NCT05922930|Cyclophosphamide|cyclophosphamide|mesh-list
111417841|NCT05922930|Fludarabine|fludarabine|mesh-list
111417842|NCT05922930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111417843|NCT05922930|Immunologic Factors|immunologic factors|mesh-ancestor
111417844|NCT05922930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111142255|NCT05486819|Propofol|propofol|mesh-list
111417845|NCT05922930|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111417846|NCT05922930|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111417847|NCT05922930|Alkylating Agents|alkylating agents|mesh-ancestor
111417848|NCT05922930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111417849|NCT05922930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111417850|NCT05922930|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111417851|NCT05922904|Doxorubicin|doxorubicin|mesh-list
111417852|NCT05922904|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111417853|NCT05922904|Pembrolizumab|pembrolizumab|mesh-list
111417854|NCT05922904|Dacarbazine|dacarbazine|mesh-list
111417855|NCT05922904|Brentuximab Vedotin|brentuximab vedotin|mesh-list
111417856|NCT05922904|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111417857|NCT05922904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111417858|NCT05922904|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111417859|NCT05922904|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111417860|NCT05922904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111417861|NCT05922904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111417862|NCT05922904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111417863|NCT05922904|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111417864|NCT05922904|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111417865|NCT05922904|Alkylating Agents|alkylating agents|mesh-ancestor
111417866|NCT05922904|Immunotoxins|immunotoxins|mesh-ancestor
111417867|NCT05922904|Immunoconjugates|immunoconjugates|mesh-ancestor
111417868|NCT05922904|Immunologic Factors|immunologic factors|mesh-ancestor
111417869|NCT05922904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111417870|NCT05922839|Zanubrutinib|zanubrutinib|mesh-list
111417871|NCT05922839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111417872|NCT05922839|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111417873|NCT05922839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111417874|NCT05922839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111417875|NCT05922800|Gamma-oryzanol|gamma-oryzanol|mesh-list
111417876|NCT05922800|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111417877|NCT05922800|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111417878|NCT05922800|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111417879|NCT05922800|Antimetabolites|antimetabolites|mesh-ancestor
111417880|NCT05922800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111417881|NCT05922800|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111417882|NCT05922761|Fluticasone|fluticasone|mesh-list
111417884|NCT05922761|Azithromycin|azithromycin|mesh-list
111417885|NCT05922761|Prednisone|prednisone|mesh-list
111417886|NCT05922761|Montelukast|montelukast|mesh-list
111417887|NCT05922761|Belumosudil|belumosudil|mesh-list
111417888|NCT05922761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111417889|NCT05922761|Glucocorticoids|glucocorticoids|mesh-ancestor
111417890|NCT05922761|Hormones|hormones|mesh-ancestor
111417891|NCT05922761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111417892|NCT05922761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111417893|NCT05922761|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111417894|NCT05922761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111417895|NCT05922761|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111417896|NCT05922761|Autonomic Agents|autonomic agents|mesh-ancestor
111417897|NCT05922761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111417898|NCT05922761|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111417899|NCT05922761|Respiratory System Agents|respiratory system agents|mesh-ancestor
111417900|NCT05922761|Dermatologic Agents|dermatologic agents|mesh-ancestor
111417901|NCT05922761|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111417902|NCT05922761|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111417903|NCT05922761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111417904|NCT05922761|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
111417905|NCT05922761|Hormone Antagonists|hormone antagonists|mesh-ancestor
111417906|NCT05922761|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
111417907|NCT05922761|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111417908|NCT05922761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111417909|NCT05922761|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111417910|NCT05922761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111417911|NCT05922696|Vitamin D|vitamin d|mesh-list
111417912|NCT05922696|Cholecalciferol|cholecalciferol|mesh-list
111417913|NCT05922696|Vitamins|vitamins|mesh-ancestor
111417914|NCT05922696|Micronutrients|micronutrients|mesh-ancestor
111417915|NCT05922696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111417916|NCT05922696|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111417917|NCT05922696|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111417918|NCT05922605|Ketamine|ketamine|mesh-list
111417919|NCT05922605|Ropivacaine|ropivacaine|mesh-list
111142320|NCT02552225|Antidepressive Agents|antidepressive agents|mesh-ancestor
111417920|NCT05922605|Esketamine|esketamine|mesh-list
111417921|NCT05922605|Analgesics|analgesics|mesh-ancestor
111417922|NCT05922605|Sensory System Agents|sensory system agents|mesh-ancestor
111417923|NCT05922605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111417924|NCT05922605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111417925|NCT05922605|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111417926|NCT05922605|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111417927|NCT05922605|Anesthetics, General|anesthetics, general|mesh-ancestor
111417928|NCT05922605|Anesthetics|anesthetics|mesh-ancestor
111417929|NCT05922605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111417930|NCT05922605|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111417931|NCT05922605|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111417932|NCT05922605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111417933|NCT05922605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111417934|NCT05922605|Anesthetics, Local|anesthetics, local|mesh-ancestor
111417935|NCT05922605|Antidepressive Agents|antidepressive agents|mesh-ancestor
111417936|NCT05922605|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111417937|NCT05922501|Dexamethasone|dexamethasone|mesh-list
111417938|NCT05922501|Pomalidomide|pomalidomide|mesh-list
111417939|NCT05922501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111417940|NCT05922501|Antiemetics|antiemetics|mesh-ancestor
111417941|NCT05922501|Autonomic Agents|autonomic agents|mesh-ancestor
111417942|NCT05922501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111417943|NCT05922501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111417944|NCT05922501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111417945|NCT05922501|Glucocorticoids|glucocorticoids|mesh-ancestor
111417946|NCT05922501|Hormones|hormones|mesh-ancestor
111417947|NCT05922501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111417948|NCT05922501|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111417949|NCT05922501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111417950|NCT05922501|Immunologic Factors|immunologic factors|mesh-ancestor
111417951|NCT05922501|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111417952|NCT05922501|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111417953|NCT05922501|Growth Substances|growth substances|mesh-ancestor
111417954|NCT05922501|Growth Inhibitors|growth inhibitors|mesh-ancestor
111417955|NCT05922436|Clevidipine|clevidipine|mesh-list
111417956|NCT05922436|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111417957|NCT05922436|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111417958|NCT05922436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111417959|NCT05922436|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111417960|NCT05922436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111417961|NCT05922384|Etoposide|etoposide|mesh-list
111417962|NCT05922384|Melphalan|melphalan|mesh-list
111417963|NCT05922384|Carmustine|carmustine|mesh-list
111417964|NCT05922384|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111417965|NCT05922384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111417966|NCT05922384|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111417967|NCT05922384|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111417968|NCT05922384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111417969|NCT05922384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111417970|NCT05922384|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111417971|NCT05922384|Alkylating Agents|alkylating agents|mesh-ancestor
111417972|NCT05922384|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111417973|NCT05922384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111417974|NCT05922384|Immunologic Factors|immunologic factors|mesh-ancestor
111417975|NCT05922384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111417976|NCT05922358|Anti-Allergic Agents|anti-allergic agents|mesh-list
111417977|NCT05922345|Docetaxel|docetaxel|mesh-list
111417978|NCT05922345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111417979|NCT05922345|Tubulin Modulators|tubulin modulators|mesh-ancestor
111417980|NCT05922345|Antimitotic Agents|antimitotic agents|mesh-ancestor
111417981|NCT05922345|Mitosis Modulators|mitosis modulators|mesh-ancestor
111417982|NCT05922345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111417983|NCT05922306|Interferons|interferons|mesh-list
111417984|NCT05922306|Interferon-alpha|interferon-alpha|mesh-list
111417985|NCT05922306|Interferon alpha-2|interferon alpha-2|mesh-list
111417986|NCT05922306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111417987|NCT05922306|Antiviral Agents|antiviral agents|mesh-ancestor
111417988|NCT05922306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111417989|NCT05922306|Immunologic Factors|immunologic factors|mesh-ancestor
111417990|NCT05922306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111417991|NCT05922033|Insulin|insulin|mesh-list
111417992|NCT05922033|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111417993|NCT05922033|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111417994|NCT05922033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111417995|NCT05921942|Metformin|metformin|mesh-list
111142396|NCT05478785|Cisplatin|cisplatin|mesh-list
111417996|NCT05921942|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111417997|NCT05921942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111417998|NCT05921604|Gabapentin|gabapentin|mesh-list
111417999|NCT05921604|Baclofen|baclofen|mesh-list
111418000|NCT05921604|Analgesics|analgesics|mesh-ancestor
111418001|NCT05921604|Sensory System Agents|sensory system agents|mesh-ancestor
111418002|NCT05921604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110895241|NCT03553238|Idarubicin|idarubicin|mesh-list
111418003|NCT05921604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111418004|NCT05921604|Anticonvulsants|anticonvulsants|mesh-ancestor
111418005|NCT05921604|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111418006|NCT05921604|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111418007|NCT05921604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111418008|NCT05921604|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111418009|NCT05921604|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111418010|NCT05921604|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111418011|NCT05921604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111418012|NCT05921604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111418013|NCT05921604|Antimanic Agents|antimanic agents|mesh-ancestor
111418014|NCT05921604|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
111418015|NCT05921604|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111418016|NCT05921604|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
111418017|NCT05921604|GABA Agonists|gaba agonists|mesh-ancestor
111418018|NCT05921604|GABA Agents|gaba agents|mesh-ancestor
111418019|NCT05921370|Silodosin|silodosin|mesh-list
111418020|NCT05921370|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111418021|NCT05921370|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111418022|NCT05921370|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111418023|NCT05921370|Adrenergic Agents|adrenergic agents|mesh-ancestor
111418024|NCT05921370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111418025|NCT05921370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111418026|NCT05921370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111418027|NCT05921370|Urological Agents|urological agents|mesh-ancestor
111418028|NCT05921292|Lidocaine|lidocaine|mesh-list
111418029|NCT05921292|Anesthetics, Local|anesthetics, local|mesh-ancestor
111418030|NCT05921292|Anesthetics|anesthetics|mesh-ancestor
111418031|NCT05921292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111418032|NCT05921292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111418033|NCT05921292|Sensory System Agents|sensory system agents|mesh-ancestor
111418034|NCT05921292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111418035|NCT05921292|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111418036|NCT05921292|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111418037|NCT05921292|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111418038|NCT05921292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111418039|NCT05921292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111418040|NCT05921149|Paclitaxel|paclitaxel|mesh-list
111418041|NCT05921149|Carboplatin|carboplatin|mesh-list
111418042|NCT05921149|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111418043|NCT05921149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111418044|NCT05921149|Tubulin Modulators|tubulin modulators|mesh-ancestor
111418045|NCT05921149|Antimitotic Agents|antimitotic agents|mesh-ancestor
111418046|NCT05921149|Mitosis Modulators|mitosis modulators|mesh-ancestor
111418047|NCT05921149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111418048|NCT05921097|Histamine|histamine|mesh-list
111418049|NCT05921097|Histamine Agonists|histamine agonists|mesh-ancestor
111418050|NCT05921097|Histamine Agents|histamine agents|mesh-ancestor
111418051|NCT05921097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111418052|NCT05921097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111418053|NCT05921097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111418054|NCT05921071|Tranexamic Acid|tranexamic acid|mesh-list
111418055|NCT05921071|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111418056|NCT05921071|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111418057|NCT05921071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111418058|NCT05921071|Hemostatics|hemostatics|mesh-ancestor
111418059|NCT05921071|Coagulants|coagulants|mesh-ancestor
111418060|NCT05920980|Lidocaine|lidocaine|mesh-list
111418061|NCT05920980|Anesthetics, Local|anesthetics, local|mesh-ancestor
111418062|NCT05920980|Anesthetics|anesthetics|mesh-ancestor
111418063|NCT05920980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111418064|NCT05920980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111418065|NCT05920980|Sensory System Agents|sensory system agents|mesh-ancestor
111418066|NCT05920980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111418067|NCT05920980|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111418068|NCT05920980|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111418069|NCT05920980|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111418070|NCT05920980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111418071|NCT05920980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111418072|NCT05920928|Capecitabine|capecitabine|mesh-list
110510149|NCT00870337|Immunologic Factors|immunologic factors|mesh-ancestor
111418073|NCT05920928|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111418074|NCT05920928|Antimetabolites|antimetabolites|mesh-ancestor
111418075|NCT05920928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111418076|NCT05920928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111418077|NCT05920876|Antibodies, Bispecific|antibodies, bispecific|mesh-list
111418078|NCT05920876|Immunologic Factors|immunologic factors|mesh-ancestor
111418079|NCT05920876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111418080|NCT05920707|Vasopressins|vasopressins|mesh-list
111418081|NCT05920707|Arginine Vasopressin|arginine vasopressin|mesh-list
111418082|NCT05920707|Oxytocin|oxytocin|mesh-list
111418083|NCT05920707|Oxytocics|oxytocics|mesh-ancestor
111418084|NCT05920707|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111418085|NCT05920707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111418086|NCT05920707|Hemostatics|hemostatics|mesh-ancestor
111418087|NCT05920707|Coagulants|coagulants|mesh-ancestor
111418088|NCT05920707|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111418089|NCT05920707|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
111418090|NCT05920707|Natriuretic Agents|natriuretic agents|mesh-ancestor
111418091|NCT05920538|Nicardipine|nicardipine|mesh-list
111418092|NCT05920538|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111418093|NCT05920538|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111418094|NCT05920538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111418095|NCT05920538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111418096|NCT05920538|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111418097|NCT05920538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111418098|NCT05920538|Vasodilator Agents|vasodilator agents|mesh-ancestor
111418099|NCT05920512|Calcitriol|calcitriol|mesh-list
111418100|NCT05920512|Sirolimus|sirolimus|mesh-list
111418101|NCT05920512|Valproic Acid|valproic acid|mesh-list
111418102|NCT05920512|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111418103|NCT05920512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111418104|NCT05920512|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111418105|NCT05920512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111418106|NCT05920512|Antifungal Agents|antifungal agents|mesh-ancestor
111418107|NCT05920512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111418108|NCT05920512|Immunologic Factors|immunologic factors|mesh-ancestor
111418109|NCT05920512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111418110|NCT05920512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111418111|NCT05920512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111418112|NCT05920512|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111418113|NCT05920512|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
111418114|NCT05920512|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111418115|NCT05920512|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111418116|NCT05920512|Vitamins|vitamins|mesh-ancestor
111418117|NCT05920512|Micronutrients|micronutrients|mesh-ancestor
111418118|NCT05920512|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111418119|NCT05920512|Anticonvulsants|anticonvulsants|mesh-ancestor
111418120|NCT05920512|GABA Agents|gaba agents|mesh-ancestor
111418121|NCT05920512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111418122|NCT05920512|Antimanic Agents|antimanic agents|mesh-ancestor
111418123|NCT05920512|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111418124|NCT05920512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111418125|NCT05920512|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111418126|NCT05920356|Pembrolizumab|pembrolizumab|mesh-list
111418127|NCT05920356|Sotorasib|sotorasib|mesh-list
111418128|NCT05920356|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111418129|NCT05920356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111418130|NCT05920356|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111418131|NCT05920356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111418132|NCT05920187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
111418133|NCT05919992|Hydrocortisone|hydrocortisone|mesh-list
111418134|NCT05919992|Metyrapone|metyrapone|mesh-list
111418135|NCT05919992|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111418136|NCT05919992|Antimetabolites|antimetabolites|mesh-ancestor
111418137|NCT05919992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111418138|NCT05919992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111418139|NCT05919966|Chlorhexidine|chlorhexidine|mesh-list
111418140|NCT05919966|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111418141|NCT05919966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111418142|NCT05919966|Disinfectants|disinfectants|mesh-ancestor
111418143|NCT05919745|Acetaminophen|acetaminophen|mesh-list
111142548|NCT02301975|Xhance|xhance|mesh-list
111418144|NCT05919745|Ibuprofen|ibuprofen|mesh-list
111418145|NCT05919745|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111418147|NCT05919745|Sensory System Agents|sensory system agents|mesh-ancestor
111418148|NCT05919745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111418149|NCT05919745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111418150|NCT05919745|Antipyretics|antipyretics|mesh-ancestor
111418151|NCT05919745|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111418152|NCT05919745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111418153|NCT05919745|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111418154|NCT05919745|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111418155|NCT05919745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111418156|NCT05919745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111418157|NCT05919316|Mometasone Furoate|mometasone furoate|mesh-list
111418158|NCT05919316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111418159|NCT05919316|Dermatologic Agents|dermatologic agents|mesh-ancestor
111418160|NCT05919316|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111418161|NCT05918133|Paclitaxel|paclitaxel|mesh-list
111418162|NCT05918133|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111418163|NCT05918133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111418164|NCT05918133|Tubulin Modulators|tubulin modulators|mesh-ancestor
111418165|NCT05918133|Antimitotic Agents|antimitotic agents|mesh-ancestor
111418166|NCT05918133|Mitosis Modulators|mitosis modulators|mesh-ancestor
111418167|NCT05918133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111418168|NCT05918107|Carboplatin|carboplatin|mesh-list
111418169|NCT05918107|Pemetrexed|pemetrexed|mesh-list
111418170|NCT05918107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111418171|NCT05918107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111418172|NCT05918107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111418173|NCT05918107|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111418174|NCT05918107|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111418175|NCT05916950|Calcium|calcium|mesh-list
111418176|NCT05916950|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111418177|NCT05916950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111418178|NCT05900466|Metformin|metformin|mesh-list
111418179|NCT05900466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111418180|NCT05900466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111418181|NCT05897268|Lenvatinib|lenvatinib|mesh-list
111418182|NCT05897268|Tislelizumab|tislelizumab|mesh-list
111418183|NCT05897268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111418184|NCT05897268|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111418185|NCT05897268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111418186|NCT05897268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111418187|NCT05897268|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111418188|NCT05895773|Povidone-Iodine|povidone-iodine|mesh-list
111418189|NCT05895773|Glycyrrhizic Acid|glycyrrhizic acid|mesh-list
111418190|NCT05895773|Povidone|povidone|mesh-list
111418191|NCT05895773|Plasma Substitutes|plasma substitutes|mesh-ancestor
111418192|NCT05895773|Blood Substitutes|blood substitutes|mesh-ancestor
111418193|NCT05895773|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111418194|NCT05895773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111418195|NCT05895773|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111418196|NCT05895266|Midazolam|midazolam|mesh-list
111418197|NCT05895266|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111418198|NCT05895266|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111418199|NCT05895266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111418200|NCT05895266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111418201|NCT05895266|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111418202|NCT05895266|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111418203|NCT05895266|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111418204|NCT05895266|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111418205|NCT05895266|Anesthetics, General|anesthetics, general|mesh-ancestor
111418206|NCT05895266|Anesthetics|anesthetics|mesh-ancestor
111418207|NCT05895266|GABA Modulators|gaba modulators|mesh-ancestor
111418208|NCT05895266|GABA Agents|gaba agents|mesh-ancestor
111418209|NCT05895266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111418210|NCT05895266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111418211|NCT05895019|Propofol|propofol|mesh-list
111418212|NCT05895019|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111418213|NCT05895019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111418214|NCT05895019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111418215|NCT05895019|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111418216|NCT05895019|Anesthetics, General|anesthetics, general|mesh-ancestor
111418217|NCT05895019|Anesthetics|anesthetics|mesh-ancestor
111418218|NCT05893056|Lenvatinib|lenvatinib|mesh-list
111142619|NCT02366091|Antimetabolites|antimetabolites|mesh-ancestor
111418219|NCT05893056|Tislelizumab|tislelizumab|mesh-list
111418220|NCT05893056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111418221|NCT05893056|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111418222|NCT05893056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111418223|NCT05893056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111418224|NCT05893056|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111418225|NCT05891379|Immunosuppressive Agents|immunosuppressive agents|mesh-list
111418226|NCT05891379|Immunologic Factors|immunologic factors|mesh-ancestor
111418227|NCT05891379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111418228|NCT05888311|Charcoal|charcoal|mesh-list
111418229|NCT05888311|Antidotes|antidotes|mesh-ancestor
111418230|NCT05888311|Protective Agents|protective agents|mesh-ancestor
111418231|NCT05888311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111418232|NCT05883852|Cyclophosphamide|cyclophosphamide|mesh-list
111418233|NCT05883852|Carboplatin|carboplatin|mesh-list
111418234|NCT05883852|Docetaxel|docetaxel|mesh-list
111418235|NCT05883852|Trastuzumab|trastuzumab|mesh-list
111418236|NCT05883852|Epirubicin|epirubicin|mesh-list
111418237|NCT05883852|Pertuzumab|pertuzumab|mesh-list
111418238|NCT05883852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111418239|NCT05883852|Immunologic Factors|immunologic factors|mesh-ancestor
111418240|NCT05883852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111418241|NCT05883852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111418242|NCT05883852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111418243|NCT05883852|Alkylating Agents|alkylating agents|mesh-ancestor
111418244|NCT05883852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111418245|NCT05883852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111418246|NCT05883852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111418247|NCT05883852|Tubulin Modulators|tubulin modulators|mesh-ancestor
111418248|NCT05883852|Antimitotic Agents|antimitotic agents|mesh-ancestor
111418249|NCT05883852|Mitosis Modulators|mitosis modulators|mesh-ancestor
111418250|NCT05883852|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111418251|NCT05883852|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111418252|NCT05883852|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111418253|NCT05883852|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111418254|NCT05883852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111418255|NCT05857514|Indomethacin|indomethacin|mesh-list
111418256|NCT05857514|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111418257|NCT05857514|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111418258|NCT05857514|Analgesics|analgesics|mesh-ancestor
111418259|NCT05857514|Sensory System Agents|sensory system agents|mesh-ancestor
111418260|NCT05857514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111418261|NCT05857514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111418262|NCT05857514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111418263|NCT05857514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111418264|NCT05857514|Gout Suppressants|gout suppressants|mesh-ancestor
111418265|NCT05857514|Tocolytic Agents|tocolytic agents|mesh-ancestor
111418266|NCT05857514|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111418267|NCT05857514|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111418268|NCT05857514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111418269|NCT05857514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111418270|NCT05832892|Paclitaxel|paclitaxel|mesh-list
111418271|NCT05832892|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111418272|NCT05832892|Gemcitabine|gemcitabine|mesh-list
111418273|NCT05832892|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111418274|NCT05832892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111418275|NCT05832892|Tubulin Modulators|tubulin modulators|mesh-ancestor
111418276|NCT05832892|Antimitotic Agents|antimitotic agents|mesh-ancestor
111418277|NCT05832892|Mitosis Modulators|mitosis modulators|mesh-ancestor
111418278|NCT05832892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111418279|NCT05832892|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111418280|NCT05832892|Antimetabolites|antimetabolites|mesh-ancestor
111418281|NCT05832398|Leucovorin|leucovorin|mesh-list
111418282|NCT05832398|Fluorouracil|fluorouracil|mesh-list
111418283|NCT05832398|Oxaliplatin|oxaliplatin|mesh-list
111418284|NCT05832398|Irinotecan|irinotecan|mesh-list
111418285|NCT05832398|Antimetabolites|antimetabolites|mesh-ancestor
111418286|NCT05832398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111418287|NCT05832398|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111418288|NCT05832398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111418289|NCT05832398|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111418290|NCT05832398|Immunologic Factors|immunologic factors|mesh-ancestor
111418291|NCT05832398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111418292|NCT05832398|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111418293|NCT05832398|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111418294|NCT05832398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111418295|NCT05832398|Antidotes|antidotes|mesh-ancestor
111418296|NCT05832398|Protective Agents|protective agents|mesh-ancestor
111418297|NCT05832398|Vitamin B Complex|vitamin b complex|mesh-ancestor
111418299|NCT05832398|Micronutrients|micronutrients|mesh-ancestor
111418300|NCT05828147|Rituximab|rituximab|mesh-list
111418301|NCT05828147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111418302|NCT05828147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111418303|NCT05828147|Immunologic Factors|immunologic factors|mesh-ancestor
111418304|NCT05828147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111418305|NCT05828147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111418306|NCT05823987|Lenvatinib|lenvatinib|mesh-list
111418307|NCT05823987|Tislelizumab|tislelizumab|mesh-list
111418308|NCT05823987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111418309|NCT05823987|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111418310|NCT05823987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111418311|NCT05823987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111418312|NCT05823987|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111418313|NCT05823467|Trimethoprim|trimethoprim|mesh-list
111418314|NCT05823467|Sulfamethoxazole|sulfamethoxazole|mesh-list
111418315|NCT05823467|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111418316|NCT05823467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111418317|NCT05823467|Antimalarials|antimalarials|mesh-ancestor
111418318|NCT05823467|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111418319|NCT05823467|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111418320|NCT05823467|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111418321|NCT05823467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111418322|NCT05823467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111418323|NCT05823467|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111418324|NCT05823467|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
111418325|NCT05823467|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111418326|NCT05823337|Selenium|selenium|mesh-list
111418327|NCT05823337|Antioxidants|antioxidants|mesh-ancestor
111418328|NCT05823337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111418329|NCT05823337|Protective Agents|protective agents|mesh-ancestor
111418330|NCT05823337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111418331|NCT05823337|Trace Elements|trace elements|mesh-ancestor
111418332|NCT05823337|Micronutrients|micronutrients|mesh-ancestor
111418333|NCT05817591|Capsaicin|capsaicin|mesh-list
111418334|NCT05817591|Antipruritics|antipruritics|mesh-ancestor
111418335|NCT05817591|Dermatologic Agents|dermatologic agents|mesh-ancestor
111418336|NCT05817591|Sensory System Agents|sensory system agents|mesh-ancestor
111418337|NCT05817591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111418338|NCT05817591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111418339|NCT05803551|Ketamine|ketamine|mesh-list
111418340|NCT05803551|Analgesics|analgesics|mesh-ancestor
111418341|NCT05803551|Sensory System Agents|sensory system agents|mesh-ancestor
111418342|NCT05803551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111418343|NCT05803551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111418344|NCT05803551|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111418345|NCT05803551|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111418346|NCT05803551|Anesthetics, General|anesthetics, general|mesh-ancestor
111418347|NCT05803551|Anesthetics|anesthetics|mesh-ancestor
111418348|NCT05803551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111418349|NCT05803551|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111418350|NCT05803551|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111418351|NCT05803551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111418352|NCT05803551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111418353|NCT05796791|Ketamine|ketamine|mesh-list
111418354|NCT05796791|Analgesics|analgesics|mesh-ancestor
111418355|NCT05796791|Sensory System Agents|sensory system agents|mesh-ancestor
111418356|NCT05796791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111418357|NCT05796791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111418358|NCT05796791|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111418359|NCT05796791|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111418360|NCT05796791|Anesthetics, General|anesthetics, general|mesh-ancestor
111418361|NCT05796791|Anesthetics|anesthetics|mesh-ancestor
111418362|NCT05796791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111418363|NCT05796791|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111418364|NCT05796791|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111418365|NCT05796791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111418366|NCT05796791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111418367|NCT05770102|Atezolizumab|atezolizumab|mesh-list
111418368|NCT05770102|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111418369|NCT05770102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111418370|NCT05770102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111418371|NCT05770102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111418373|NCT05764733|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111418374|NCT05764733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111418375|NCT05759364|Papaverine|papaverine|mesh-list
111418376|NCT05759364|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111418377|NCT05759364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111418378|NCT05759364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111418379|NCT05759364|Vasodilator Agents|vasodilator agents|mesh-ancestor
111418380|NCT05759364|Urological Agents|urological agents|mesh-ancestor
111418381|NCT05753735|Amoxicillin|amoxicillin|mesh-list
111418382|NCT05753735|Tazobactam|tazobactam|mesh-list
111418383|NCT05753735|Piperacillin|piperacillin|mesh-list
111418384|NCT05753735|Clavulanic Acids|clavulanic acids|mesh-list
111418385|NCT05753735|Clavulanic Acid|clavulanic acid|mesh-list
111418386|NCT05753735|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
111418387|NCT05753735|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111418388|NCT05753735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111418389|NCT05753735|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
111418390|NCT05753735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111418391|NCT05753735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111418392|NCT05749926|Vaccines|vaccines|mesh-list
111418393|NCT05749926|Immunologic Factors|immunologic factors|mesh-ancestor
111418394|NCT05749926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111418395|NCT05730205|Etonogestrel|etonogestrel|mesh-list
111418396|NCT05730205|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111418397|NCT05730205|Contraceptive Agents|contraceptive agents|mesh-ancestor
111418398|NCT05730205|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111418399|NCT05730205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111418400|NCT05730205|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111418401|NCT05728736|Lemborexant|lemborexant|mesh-list
111418402|NCT05728736|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
111418403|NCT05728736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111418404|NCT05728736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111418405|NCT05728736|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111418406|NCT05728736|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111418407|NCT05728736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111418408|NCT05728736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111418409|NCT05725837|Fluoxetine|fluoxetine|mesh-list
111418410|NCT05725837|Paroxetine|paroxetine|mesh-list
111418411|NCT05725837|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111418412|NCT05725837|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111418413|NCT05725837|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111418414|NCT05725837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111418415|NCT05725837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111418416|NCT05725837|Serotonin Agents|serotonin agents|mesh-ancestor
111418417|NCT05725837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111418418|NCT05725837|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111418419|NCT05725837|Antidepressive Agents|antidepressive agents|mesh-ancestor
111418420|NCT05725837|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111418421|NCT05725837|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111418422|NCT05725837|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111418423|NCT05725837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111418424|NCT05714345|Cyclophosphamide|cyclophosphamide|mesh-list
111418425|NCT05714345|Fludarabine|fludarabine|mesh-list
111418426|NCT05714345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111418427|NCT05714345|Immunologic Factors|immunologic factors|mesh-ancestor
111418428|NCT05714345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111418429|NCT05714345|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111418430|NCT05714345|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111418431|NCT05714345|Alkylating Agents|alkylating agents|mesh-ancestor
111418432|NCT05714345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111418433|NCT05714345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111418434|NCT05714345|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111418435|NCT05706233|Analgesics|analgesics|mesh-list
111418436|NCT05706233|Sensory System Agents|sensory system agents|mesh-ancestor
111418437|NCT05706233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111418438|NCT05706233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111418439|NCT05705050|Aminophylline|aminophylline|mesh-list
111418440|NCT05705050|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111418441|NCT05705050|Autonomic Agents|autonomic agents|mesh-ancestor
111418442|NCT05705050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111418443|NCT05705050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111418444|NCT05705050|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111418445|NCT05705050|Respiratory System Agents|respiratory system agents|mesh-ancestor
111418446|NCT05705050|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111418447|NCT05705050|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111418448|NCT05705050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111418449|NCT05705050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111418450|NCT05705050|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
111418451|NCT05705050|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111418452|NCT05705050|Purinergic Agents|purinergic agents|mesh-ancestor
111418453|NCT05705050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111418454|NCT05705050|Protective Agents|protective agents|mesh-ancestor
111418455|NCT05693454|Tramadol|tramadol|mesh-list
111418456|NCT05693454|Levobupivacaine|levobupivacaine|mesh-list
111418457|NCT05693454|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111418458|NCT05693454|Narcotics|narcotics|mesh-ancestor
111418459|NCT05693454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111418460|NCT05693454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111418461|NCT05693454|Analgesics|analgesics|mesh-ancestor
111418462|NCT05693454|Sensory System Agents|sensory system agents|mesh-ancestor
111418463|NCT05693454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111418464|NCT05693454|Anesthetics, Local|anesthetics, local|mesh-ancestor
111418465|NCT05693454|Anesthetics|anesthetics|mesh-ancestor
111418466|NCT05681650|Paclitaxel|paclitaxel|mesh-list
111418467|NCT05681650|Cyclophosphamide|cyclophosphamide|mesh-list
111418468|NCT05681650|Fludarabine|fludarabine|mesh-list
111418469|NCT05681650|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111418470|NCT05681650|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111418471|NCT05681650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111418472|NCT05681650|Tubulin Modulators|tubulin modulators|mesh-ancestor
111418473|NCT05681650|Antimitotic Agents|antimitotic agents|mesh-ancestor
111418474|NCT05681650|Mitosis Modulators|mitosis modulators|mesh-ancestor
111418475|NCT05681650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111418476|NCT05681650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111418477|NCT05681650|Immunologic Factors|immunologic factors|mesh-ancestor
111418478|NCT05681650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111418479|NCT05681650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111418480|NCT05681650|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111418481|NCT05681650|Alkylating Agents|alkylating agents|mesh-ancestor
111418482|NCT05681650|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111418483|NCT05672108|Mitomycins|mitomycins|mesh-list
111418484|NCT05672108|Mitomycin|mitomycin|mesh-list
111418485|NCT05672108|Ethiodized Oil|ethiodized oil|mesh-list
111418486|NCT05672108|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111418487|NCT05672108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111418488|NCT05672108|Alkylating Agents|alkylating agents|mesh-ancestor
111418489|NCT05672108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111418490|NCT05672108|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111418491|NCT05672108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111418492|NCT05668429|Ibrexafungerp|ibrexafungerp|mesh-list
111418493|NCT05668429|Antifungal Agents|antifungal agents|mesh-ancestor
111418494|NCT05668429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111418495|NCT05648591|Iloperidone|iloperidone|mesh-list
111418496|NCT05648591|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111418497|NCT05648591|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111418498|NCT05648591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111418499|NCT05648591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111418500|NCT05648591|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111418501|NCT05624957|Lidocaine|lidocaine|mesh-list
111418502|NCT05624957|Epinephrine|epinephrine|mesh-list
111418503|NCT05624957|Racepinephrine|racepinephrine|mesh-list
111418504|NCT05624957|Epinephryl borate|epinephryl borate|mesh-list
111418505|NCT05624957|Anesthetics, Local|anesthetics, local|mesh-ancestor
111418506|NCT05624957|Anesthetics|anesthetics|mesh-ancestor
111418507|NCT05624957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111418508|NCT05624957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111418509|NCT05624957|Sensory System Agents|sensory system agents|mesh-ancestor
111418510|NCT05624957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111418511|NCT05624957|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111418512|NCT05624957|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111418513|NCT05624957|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111418514|NCT05624957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111418515|NCT05624957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111418516|NCT05624957|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111418517|NCT05624957|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111418518|NCT05624957|Adrenergic Agents|adrenergic agents|mesh-ancestor
111418519|NCT05624957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111418520|NCT05624957|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111418521|NCT05624957|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110510212|NCT00864019|Sertraline|sertraline|mesh-list
111418522|NCT05624957|Autonomic Agents|autonomic agents|mesh-ancestor
111418523|NCT05624957|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111418524|NCT05624957|Respiratory System Agents|respiratory system agents|mesh-ancestor
111418525|NCT05624957|Mydriatics|mydriatics|mesh-ancestor
111418526|NCT05624957|Sympathomimetics|sympathomimetics|mesh-ancestor
111418527|NCT05624957|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111418528|NCT05613426|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111418529|NCT05613426|Evolocumab|evolocumab|mesh-list
111418530|NCT05613426|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111418531|NCT05613426|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111418532|NCT05613426|Antimetabolites|antimetabolites|mesh-ancestor
111418533|NCT05613426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111418534|NCT05613426|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111418535|NCT05613426|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111418536|NCT05613426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111418537|NCT05613426|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
111418538|NCT05613426|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111418539|NCT05613426|Protease Inhibitors|protease inhibitors|mesh-ancestor
111418540|NCT05603065|Paclitaxel|paclitaxel|mesh-list
111418541|NCT05603065|Tislelizumab|tislelizumab|mesh-list
111418542|NCT05603065|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111418543|NCT05603065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111418544|NCT05603065|Tubulin Modulators|tubulin modulators|mesh-ancestor
111418545|NCT05603065|Antimitotic Agents|antimitotic agents|mesh-ancestor
111418546|NCT05603065|Mitosis Modulators|mitosis modulators|mesh-ancestor
111418547|NCT05603065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111418548|NCT05603065|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111418549|NCT05601700|Paclitaxel|paclitaxel|mesh-list
111418550|NCT05601700|Carboplatin|carboplatin|mesh-list
111418551|NCT05601700|Letrozole|letrozole|mesh-list
111418552|NCT05601700|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111418553|NCT05601700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111418554|NCT05601700|Tubulin Modulators|tubulin modulators|mesh-ancestor
111418555|NCT05601700|Antimitotic Agents|antimitotic agents|mesh-ancestor
111418556|NCT05601700|Mitosis Modulators|mitosis modulators|mesh-ancestor
111418557|NCT05601700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111418558|NCT05601700|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111418559|NCT05601700|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111418560|NCT05601700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111418561|NCT05601700|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111418562|NCT05601700|Hormone Antagonists|hormone antagonists|mesh-ancestor
111418563|NCT05601700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111418564|NCT05601700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111418565|NCT05572684|Pembrolizumab|pembrolizumab|mesh-list
111418566|NCT05572684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111418567|NCT05572684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111418568|NCT05572684|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111418569|NCT05572684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111418570|NCT05558150|Aceclofenac|aceclofenac|mesh-list
111418571|NCT05558150|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111418572|NCT05558150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111418573|NCT05558150|Analgesics|analgesics|mesh-ancestor
111418574|NCT05558150|Sensory System Agents|sensory system agents|mesh-ancestor
111418575|NCT05558150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111418576|NCT05558150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111418577|NCT05558150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111418578|NCT05558150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111418579|NCT05467748|Pembrolizumab|pembrolizumab|mesh-list
111418580|NCT05467748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111418581|NCT05467748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111418582|NCT05467748|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111418583|NCT05467748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111418584|NCT05460871|Pregabalin|pregabalin|mesh-list
111418585|NCT05460871|Analgesics|analgesics|mesh-ancestor
111418586|NCT05460871|Sensory System Agents|sensory system agents|mesh-ancestor
111418587|NCT05460871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111418588|NCT05460871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111418589|NCT05460871|Anticonvulsants|anticonvulsants|mesh-ancestor
111418590|NCT05460871|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111418591|NCT05460871|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111418592|NCT05460871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111418593|NCT05460871|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111418594|NCT05460871|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111418595|NCT05460871|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111418596|NCT05460871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111418597|NCT05460871|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111418598|NCT05457998|Flutemetamol|flutemetamol|mesh-list
111418599|NCT05457998|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111418600|NCT05457998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111418601|NCT05438316|Ramipril|ramipril|mesh-list
111418602|NCT05438316|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
111418603|NCT05438316|Protease Inhibitors|protease inhibitors|mesh-ancestor
111418604|NCT05438316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111418605|NCT05438316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111418606|NCT05438316|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111418607|NCT05426525|Empagliflozin|empagliflozin|mesh-list
111418608|NCT05426525|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111418609|NCT05426525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111418610|NCT05426525|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111418611|NCT05426525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111418612|NCT05403138|Daratumumab|daratumumab|mesh-list
111418613|NCT05403138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111418614|NCT05353140|Aspirin|aspirin|mesh-list
111418615|NCT05353140|Rivaroxaban|rivaroxaban|mesh-list
111418616|NCT05353140|Clopidogrel|clopidogrel|mesh-list
111418617|NCT05353140|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111418618|NCT05353140|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111418619|NCT05353140|Analgesics|analgesics|mesh-ancestor
111418620|NCT05353140|Sensory System Agents|sensory system agents|mesh-ancestor
111418621|NCT05353140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111418622|NCT05353140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111418623|NCT05353140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111418624|NCT05353140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111418625|NCT05353140|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111418626|NCT05353140|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111418627|NCT05353140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111418628|NCT05353140|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111418629|NCT05353140|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111418630|NCT05353140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111418631|NCT05353140|Antipyretics|antipyretics|mesh-ancestor
111418632|NCT05353140|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111418633|NCT05353140|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111418634|NCT05353140|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111418635|NCT05353140|Purinergic Agents|purinergic agents|mesh-ancestor
111418636|NCT05353140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111418637|NCT05353140|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111418638|NCT05353140|Antithrombins|antithrombins|mesh-ancestor
111418639|NCT05353140|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111418640|NCT05353140|Protease Inhibitors|protease inhibitors|mesh-ancestor
111418641|NCT05353140|Anticoagulants|anticoagulants|mesh-ancestor
111418642|NCT05351944|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
111418643|NCT05351944|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111418644|NCT05351944|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111418645|NCT05351944|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111418646|NCT05351944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111418647|NCT05351944|Adrenergic Agents|adrenergic agents|mesh-ancestor
111418648|NCT05351944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110510254|NCT00812331|Simeprevir|simeprevir|mesh-list
111418649|NCT05351944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111418650|NCT05346393|Terlipressin|terlipressin|mesh-list
111418651|NCT05346393|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111418652|NCT05346393|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111418653|NCT05340465|Iron|iron|mesh-list
111418654|NCT05340465|Dextrans|dextrans|mesh-list
111418655|NCT05340465|Darbepoetin alfa|darbepoetin alfa|mesh-list
111418656|NCT05340465|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
111418657|NCT05340465|Iron-Dextran Complex|iron-dextran complex|mesh-list
111418658|NCT05340465|Trace Elements|trace elements|mesh-ancestor
111418659|NCT05340465|Micronutrients|micronutrients|mesh-ancestor
111418660|NCT05340465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111418661|NCT05340465|Hematinics|hematinics|mesh-ancestor
111418662|NCT05340465|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
111418663|NCT05340465|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111418664|NCT05340465|Anticoagulants|anticoagulants|mesh-ancestor
111418665|NCT05340465|Plasma Substitutes|plasma substitutes|mesh-ancestor
111418666|NCT05340465|Blood Substitutes|blood substitutes|mesh-ancestor
111418667|NCT05303090|Lenvatinib|lenvatinib|mesh-list
111418668|NCT05303090|Tislelizumab|tislelizumab|mesh-list
111418669|NCT05303090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111418670|NCT05303090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111418671|NCT05303090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111418672|NCT05303090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111418673|NCT05303090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111418674|NCT05303064|Olanzapine|olanzapine|mesh-list
111418675|NCT05303064|Antiemetics|antiemetics|mesh-ancestor
111418676|NCT05303064|Autonomic Agents|autonomic agents|mesh-ancestor
111418677|NCT05303064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111418678|NCT05303064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111418679|NCT05303064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111418680|NCT05303064|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111418681|NCT05303064|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111418682|NCT05303064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111418683|NCT05303064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111418684|NCT05303064|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111418685|NCT05303064|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111418686|NCT05303064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111418687|NCT05303064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111418688|NCT05303064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111418689|NCT05303064|Serotonin Agents|serotonin agents|mesh-ancestor
111418690|NCT05259943|Psilocybin|psilocybin|mesh-list
111418691|NCT05259943|Hallucinogens|hallucinogens|mesh-ancestor
111418692|NCT05259943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111418693|NCT05259943|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111418694|NCT05243329|Psilocybin|psilocybin|mesh-list
111418695|NCT05243329|Hallucinogens|hallucinogens|mesh-ancestor
111418696|NCT05243329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111418697|NCT05243329|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111418698|NCT05237297|Celecoxib|celecoxib|mesh-list
111418699|NCT05237297|Naproxen|naproxen|mesh-list
111418700|NCT05237297|Aceclofenac|aceclofenac|mesh-list
111418701|NCT05237297|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111418702|NCT05237297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111418703|NCT05237297|Analgesics|analgesics|mesh-ancestor
111418704|NCT05237297|Sensory System Agents|sensory system agents|mesh-ancestor
111418705|NCT05237297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111418706|NCT05237297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111418707|NCT05237297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111418708|NCT05237297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111418709|NCT05237297|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111418710|NCT05237297|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111418711|NCT05237297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111418712|NCT05237297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111418713|NCT05237297|Gout Suppressants|gout suppressants|mesh-ancestor
111418714|NCT05216952|Misoprostol|misoprostol|mesh-list
111418715|NCT05216952|Ulipristal acetate|ulipristal acetate|mesh-list
111418716|NCT05216952|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111418717|NCT05216952|Abortifacient Agents|abortifacient agents|mesh-ancestor
111418718|NCT05216952|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111418719|NCT05216952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111418720|NCT05216952|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111418721|NCT05216952|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111418722|NCT05216952|Oxytocics|oxytocics|mesh-ancestor
111418723|NCT05216952|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111418724|NCT05216952|Contraceptive Agents|contraceptive agents|mesh-ancestor
111418725|NCT05216952|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111418726|NCT05213676|Nitric Oxide|nitric oxide|mesh-list
111418727|NCT05213676|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111418728|NCT05213676|Autonomic Agents|autonomic agents|mesh-ancestor
111418729|NCT05213676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111418730|NCT05213676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111418731|NCT05213676|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111418732|NCT05213676|Respiratory System Agents|respiratory system agents|mesh-ancestor
111418733|NCT05213676|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111418734|NCT05213676|Antioxidants|antioxidants|mesh-ancestor
111418735|NCT05213676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111418736|NCT05213676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111418737|NCT05213676|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
111418738|NCT05213676|Vasodilator Agents|vasodilator agents|mesh-ancestor
111418739|NCT05213676|Gasotransmitters|gasotransmitters|mesh-ancestor
111418740|NCT05213676|Protective Agents|protective agents|mesh-ancestor
111143158|NCT04261387|LUT014|lut014|mesh-list
111418741|NCT05206110|Ketorolac|ketorolac|mesh-list
111418742|NCT05206110|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
111418743|NCT05206110|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111418744|NCT05206110|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111418745|NCT05206110|Analgesics|analgesics|mesh-ancestor
111418746|NCT05206110|Sensory System Agents|sensory system agents|mesh-ancestor
111418747|NCT05206110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111418748|NCT05206110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111418749|NCT05206110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111418750|NCT05206110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111418751|NCT05206110|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111418752|NCT05206110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111418753|NCT05206110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111418754|NCT05144243|Azacitidine|azacitidine|mesh-list
111418755|NCT05144243|Venetoclax|venetoclax|mesh-list
111418756|NCT05144243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111418757|NCT05144243|Antimetabolites|antimetabolites|mesh-ancestor
111418758|NCT05144243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111418759|NCT05144243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111418760|NCT05144243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111418761|NCT05139238|Labetalol|labetalol|mesh-list
111418762|NCT05139238|Nifedipine|nifedipine|mesh-list
111418763|NCT05139238|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111418764|NCT05139238|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111418765|NCT05139238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111418766|NCT05139238|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111418767|NCT05139238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111418768|NCT05139238|Vasodilator Agents|vasodilator agents|mesh-ancestor
111418769|NCT05139238|Tocolytic Agents|tocolytic agents|mesh-ancestor
111418770|NCT05139238|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111418771|NCT05139238|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111418772|NCT05139238|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111418773|NCT05139238|Adrenergic Agents|adrenergic agents|mesh-ancestor
111418774|NCT05139238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111418775|NCT05139238|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111418776|NCT05139238|Sympathomimetics|sympathomimetics|mesh-ancestor
111418777|NCT05139238|Autonomic Agents|autonomic agents|mesh-ancestor
111418778|NCT05139238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111418779|NCT05139238|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111418780|NCT05139238|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111418781|NCT05138614|Analgesics, Opioid|analgesics, opioid|mesh-list
111418782|NCT05138614|Narcotics|narcotics|mesh-ancestor
111418783|NCT05138614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111418784|NCT05138614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111418785|NCT05138614|Analgesics|analgesics|mesh-ancestor
111418786|NCT05138614|Sensory System Agents|sensory system agents|mesh-ancestor
111418787|NCT05138614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111418788|NCT05132439|Metformin|metformin|mesh-list
111418789|NCT05132439|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111418790|NCT05132439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111418791|NCT05120141|Listerine|listerine|mesh-list
111418792|NCT05120141|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111418793|NCT05120141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111418794|NCT05103904|Lenvatinib|lenvatinib|mesh-list
111418795|NCT05103904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111418796|NCT05103904|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111418797|NCT05103904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111418798|NCT05103904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111418799|NCT05093582|Cromakalim|cromakalim|mesh-list
111418800|NCT05093582|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111418801|NCT05093582|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111418802|NCT05093582|Autonomic Agents|autonomic agents|mesh-ancestor
111418803|NCT05093582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111418804|NCT05093582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111418805|NCT05093582|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111418806|NCT05093582|Respiratory System Agents|respiratory system agents|mesh-ancestor
111418807|NCT05093582|Parasympatholytics|parasympatholytics|mesh-ancestor
111418808|NCT05093582|Vasodilator Agents|vasodilator agents|mesh-ancestor
111418809|NCT05090384|Prednisone|prednisone|mesh-list
111418810|NCT05090384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111418811|NCT05090384|Glucocorticoids|glucocorticoids|mesh-ancestor
111418812|NCT05090384|Hormones|hormones|mesh-ancestor
111418813|NCT05090384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111418814|NCT05090384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111418815|NCT05090384|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111418816|NCT05090384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111418817|NCT05089734|Docetaxel|docetaxel|mesh-list
111418818|NCT05089734|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
111418819|NCT05089734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111418820|NCT05089734|Tubulin Modulators|tubulin modulators|mesh-ancestor
111418821|NCT05089734|Antimitotic Agents|antimitotic agents|mesh-ancestor
111418822|NCT05089734|Mitosis Modulators|mitosis modulators|mesh-ancestor
111418823|NCT05089734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111418824|NCT05089734|Immunoconjugates|immunoconjugates|mesh-ancestor
111418825|NCT05089734|Immunologic Factors|immunologic factors|mesh-ancestor
111418826|NCT05089734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111418827|NCT05201183|Fludarabine|fludarabine|mesh-list
111418828|NCT05201183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111418829|NCT05062889|Leucovorin|leucovorin|mesh-list
111418830|NCT05062889|Trifluridine|trifluridine|mesh-list
111418831|NCT05062889|Fluorouracil|fluorouracil|mesh-list
111418832|NCT05062889|Capecitabine|capecitabine|mesh-list
111418833|NCT05062889|Oxaliplatin|oxaliplatin|mesh-list
111418834|NCT05062889|Irinotecan|irinotecan|mesh-list
111418835|NCT05062889|Levoleucovorin|levoleucovorin|mesh-list
111418836|NCT05062889|Antimetabolites|antimetabolites|mesh-ancestor
111418837|NCT05062889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111418838|NCT05062889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111418839|NCT05062889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111418840|NCT05062889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111418841|NCT05062889|Immunologic Factors|immunologic factors|mesh-ancestor
111418842|NCT05062889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111418843|NCT05062889|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111418844|NCT05062889|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111418845|NCT05062889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111418846|NCT05062889|Antidotes|antidotes|mesh-ancestor
111418847|NCT05062889|Protective Agents|protective agents|mesh-ancestor
111418848|NCT05062889|Vitamin B Complex|vitamin b complex|mesh-ancestor
111418849|NCT05062889|Vitamins|vitamins|mesh-ancestor
111418850|NCT05062889|Micronutrients|micronutrients|mesh-ancestor
111418851|NCT05062889|Antiviral Agents|antiviral agents|mesh-ancestor
111418852|NCT05062889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111418853|NCT05045703|Vitamin A|vitamin a|mesh-list
111418854|NCT05045703|Retinol palmitate|retinol palmitate|mesh-list
111418855|NCT05045703|Vitamins|vitamins|mesh-ancestor
111418856|NCT05045703|Micronutrients|micronutrients|mesh-ancestor
111418857|NCT05045703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111418858|NCT05045703|Antioxidants|antioxidants|mesh-ancestor
111418859|NCT05045703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111418860|NCT05045703|Protective Agents|protective agents|mesh-ancestor
111418861|NCT05045703|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
111418862|NCT05045703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111418863|NCT05005728|Carboplatin|carboplatin|mesh-list
111418864|NCT05005728|Docetaxel|docetaxel|mesh-list
111418865|NCT05005728|Olaparib|olaparib|mesh-list
111418866|NCT05005728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111418867|NCT05005728|Tubulin Modulators|tubulin modulators|mesh-ancestor
111418868|NCT05005728|Antimitotic Agents|antimitotic agents|mesh-ancestor
111418869|NCT05005728|Mitosis Modulators|mitosis modulators|mesh-ancestor
111418870|NCT05005728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111418871|NCT05005728|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111418872|NCT05005728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111418873|NCT04992507|Anesthetics|anesthetics|mesh-list
111418874|NCT04992507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111418875|NCT04992507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111418876|NCT04990037|Folfirinox|folfirinox|mesh-list
111418877|NCT04990037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111418878|NCT04949828|Pancrelipase|pancrelipase|mesh-list
111418879|NCT04949828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111418880|NCT04927884|Cyclophosphamide|cyclophosphamide|mesh-list
111418881|NCT04927884|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
111418882|NCT04927884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111418883|NCT04927884|Immunologic Factors|immunologic factors|mesh-ancestor
111418884|NCT04927884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111418885|NCT04927884|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111418886|NCT04927884|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111418887|NCT04927884|Alkylating Agents|alkylating agents|mesh-ancestor
111418888|NCT04927884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111418889|NCT04927884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111418890|NCT04927884|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111143289|NCT05332717|Antioxidants|antioxidants|mesh-ancestor
111418891|NCT04927884|Immunoconjugates|immunoconjugates|mesh-ancestor
111418892|NCT04868773|Trifluridine|trifluridine|mesh-list
111418893|NCT04868773|Antimetabolites|antimetabolites|mesh-ancestor
111418894|NCT04868773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111418895|NCT04868773|Antiviral Agents|antiviral agents|mesh-ancestor
111418896|NCT04868773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111418897|NCT04865029|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
111418898|NCT04865029|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
111418900|NCT04865029|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
111418901|NCT04865029|Progesterone|progesterone|mesh-list
111418902|NCT04865029|Estrogens|estrogens|mesh-ancestor
111418903|NCT04865029|Hormones|hormones|mesh-ancestor
111418904|NCT04865029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111418905|NCT04865029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111418906|NCT04865029|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111418907|NCT04865029|Contraceptive Agents|contraceptive agents|mesh-ancestor
111418908|NCT04865029|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111418909|NCT04865029|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111418910|NCT04865029|Progestins|progestins|mesh-ancestor
111418911|NCT04859660|Tamsulosin|tamsulosin|mesh-list
111418912|NCT04859660|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111418913|NCT04859660|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111418914|NCT04859660|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111418915|NCT04859660|Adrenergic Agents|adrenergic agents|mesh-ancestor
111418916|NCT04859660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111418917|NCT04859660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111418918|NCT04859660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111418919|NCT04859660|Urological Agents|urological agents|mesh-ancestor
111418920|NCT04806919|Progesterone|progesterone|mesh-list
111418921|NCT04806919|Progestins|progestins|mesh-ancestor
111418922|NCT04806919|Hormones|hormones|mesh-ancestor
111418923|NCT04806919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111418924|NCT04806919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111418925|NCT04805957|Sulforaphane|sulforaphane|mesh-list
111418926|NCT04805957|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
111418927|NCT04805957|Protective Agents|protective agents|mesh-ancestor
111418928|NCT04805957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111418929|NCT04805957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111418930|NCT04796779|Ferrous fumarate|ferrous fumarate|mesh-list
111418931|NCT04796779|Trace Elements|trace elements|mesh-ancestor
111418932|NCT04796779|Micronutrients|micronutrients|mesh-ancestor
111418933|NCT04796779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111418934|NCT04793815|Pembrolizumab|pembrolizumab|mesh-list
111418935|NCT04793815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111418936|NCT04793815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111418937|NCT04793815|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111418938|NCT04793815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111418939|NCT04762888|Edetic Acid|edetic acid|mesh-list
111418940|NCT04762888|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
111418941|NCT04762888|Chelating Agents|chelating agents|mesh-ancestor
111418942|NCT04762888|Sequestering Agents|sequestering agents|mesh-ancestor
111418943|NCT04762888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111418944|NCT04762888|Anticoagulants|anticoagulants|mesh-ancestor
111418945|NCT04762888|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
111418946|NCT04762888|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111418947|NCT04762134|Doxycycline|doxycycline|mesh-list
111418948|NCT04762134|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111418949|NCT04762134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111418950|NCT04762134|Antimalarials|antimalarials|mesh-ancestor
111418951|NCT04762134|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111418952|NCT04762134|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111418953|NCT04743934|Androgens|androgens|mesh-list
111418954|NCT04743934|Hormones|hormones|mesh-ancestor
111418955|NCT04743934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111418956|NCT04743934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111418957|NCT04736329|Telmisartan|telmisartan|mesh-list
111418958|NCT04736329|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111418959|NCT04736329|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111418960|NCT04736329|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111418961|NCT04736329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111418962|NCT04735068|Hydroxychloroquine|hydroxychloroquine|mesh-list
111418963|NCT04735068|Antimalarials|antimalarials|mesh-ancestor
111418964|NCT04735068|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111418965|NCT04735068|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111418966|NCT04735068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111418967|NCT04735068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111418968|NCT04735068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111418969|NCT04735068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111418970|NCT04721548|Minoxidil|minoxidil|mesh-list
111418971|NCT04721548|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111418972|NCT04721548|Vasodilator Agents|vasodilator agents|mesh-ancestor
111418974|NCT04717089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111418975|NCT04717089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111418976|NCT04712799|Xylometazoline|xylometazoline|mesh-list
111418977|NCT04712799|Nasal Decongestants|nasal decongestants|mesh-ancestor
111418978|NCT04712799|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111418979|NCT04712799|Respiratory System Agents|respiratory system agents|mesh-ancestor
111418980|NCT04712734|Iloperidone|iloperidone|mesh-list
111418981|NCT04712734|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111418982|NCT04712734|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111418983|NCT04712734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111418984|NCT04712734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111418985|NCT04712734|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111418986|NCT04687098|Idarubicin|idarubicin|mesh-list
111418987|NCT04687098|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111418988|NCT04687098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110510325|NCT02796378|Vitamins|vitamins|mesh-ancestor
111418989|NCT04687098|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111418990|NCT04687098|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111418991|NCT04687098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111418992|NCT04687098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111418993|NCT04683406|Oseltamivir|oseltamivir|mesh-list
111418994|NCT04683406|Antiviral Agents|antiviral agents|mesh-ancestor
111418995|NCT04683406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111418996|NCT04683406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111418997|NCT04683406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111418998|NCT04678401|Cyclophosphamide|cyclophosphamide|mesh-list
111418999|NCT04678401|Thiotepa|thiotepa|mesh-list
111419000|NCT04678401|Fludarabine|fludarabine|mesh-list
111419001|NCT04678401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111419002|NCT04678401|Immunologic Factors|immunologic factors|mesh-ancestor
111419003|NCT04678401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111419004|NCT04678401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111419005|NCT04678401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111419006|NCT04678401|Alkylating Agents|alkylating agents|mesh-ancestor
111419007|NCT04678401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111419008|NCT04678401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111419009|NCT04678401|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111419010|NCT04676087|Mogamulizumab|mogamulizumab|mesh-list
111419011|NCT04676087|Immunoglobulins|immunoglobulins|mesh-list
111419012|NCT04676087|Immunoglobulin G|immunoglobulin g|mesh-list
111419013|NCT04676087|Immunologic Factors|immunologic factors|mesh-ancestor
111419014|NCT04676087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111419015|NCT04676087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111419016|NCT04662086|Camostat|camostat|mesh-list
111419017|NCT04662086|Protease Inhibitors|protease inhibitors|mesh-ancestor
111419018|NCT04662086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111419019|NCT04662086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111419020|NCT04662086|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
111419021|NCT04662086|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111419022|NCT04662073|Camostat|camostat|mesh-list
111419023|NCT04662073|Protease Inhibitors|protease inhibitors|mesh-ancestor
111419024|NCT04662073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111419025|NCT04662073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111419026|NCT04662073|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
111419027|NCT04662073|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111419028|NCT04647877|Phenytoin|phenytoin|mesh-list
111419029|NCT04647877|Anticonvulsants|anticonvulsants|mesh-ancestor
111419030|NCT04647877|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111419031|NCT04647877|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111419032|NCT04647877|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111419033|NCT04647877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111419034|NCT04647877|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
111419035|NCT04647877|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111419036|NCT04632992|Maytansine|maytansine|mesh-list
111419037|NCT04632992|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
111419038|NCT04632992|Trastuzumab|trastuzumab|mesh-list
111419039|NCT04632992|Atezolizumab|atezolizumab|mesh-list
111419040|NCT04632992|Pertuzumab|pertuzumab|mesh-list
111419041|NCT04632992|Ipatasertib|ipatasertib|mesh-list
111419042|NCT04632992|Tucatinib|tucatinib|mesh-list
111419043|NCT04632992|Pralsetinib|pralsetinib|mesh-list
111419044|NCT04632992|Entrectinib|entrectinib|mesh-list
111419045|NCT04632992|Inavolisib|inavolisib|mesh-list
111419046|NCT04632992|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111143443|NCT05313997|Diclofenac|diclofenac|mesh-list
111419047|NCT04632992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111419048|NCT04632992|Tubulin Modulators|tubulin modulators|mesh-ancestor
111419049|NCT04632992|Antimitotic Agents|antimitotic agents|mesh-ancestor
111419050|NCT04632992|Mitosis Modulators|mitosis modulators|mesh-ancestor
111419051|NCT04632992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111419052|NCT04632992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111419053|NCT04632992|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111419055|NCT04632992|Immunoconjugates|immunoconjugates|mesh-ancestor
111419056|NCT04632992|Immunologic Factors|immunologic factors|mesh-ancestor
111419057|NCT04632992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111419058|NCT04632992|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111419059|NCT04632992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111419060|NCT04632992|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
111419061|NCT04617938|Analgesics, Opioid|analgesics, opioid|mesh-list
111419062|NCT04617938|Narcotics|narcotics|mesh-ancestor
111419063|NCT04617938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111419064|NCT04617938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111419065|NCT04617938|Analgesics|analgesics|mesh-ancestor
111419066|NCT04617938|Sensory System Agents|sensory system agents|mesh-ancestor
111419067|NCT04617938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111419068|NCT04608539|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
111419069|NCT04608539|Hematinics|hematinics|mesh-ancestor
111419070|NCT04586166|Imidacloprid|imidacloprid|mesh-list
111419071|NCT04586166|Cholinergic Agents|cholinergic agents|mesh-ancestor
111419072|NCT04586166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111419073|NCT04586166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111419074|NCT04586166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111419075|NCT04575597|Molnupiravir|molnupiravir|mesh-list
111419076|NCT04575597|Antiviral Agents|antiviral agents|mesh-ancestor
111419077|NCT04575597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111419078|NCT04562792|Daunorubicin|daunorubicin|mesh-list
111419079|NCT04562792|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111419080|NCT04562792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111419081|NCT04562792|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111419082|NCT04562792|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111419083|NCT04562792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111419084|NCT04562792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111419085|NCT04550377|Cannabidiol|cannabidiol|mesh-list
111419086|NCT04550377|Anticonvulsants|anticonvulsants|mesh-ancestor
111419087|NCT04544813|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
111419088|NCT04544813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111419089|NCT04501367|Dexamethasone|dexamethasone|mesh-list
111419090|NCT04501367|Dexamethasone acetate|dexamethasone acetate|mesh-list
111419091|NCT04501367|Prednisone|prednisone|mesh-list
111419092|NCT04501367|BB 1101|bb 1101|mesh-list
111419093|NCT04501367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111419094|NCT04501367|Antiemetics|antiemetics|mesh-ancestor
111419095|NCT04501367|Autonomic Agents|autonomic agents|mesh-ancestor
111419096|NCT04501367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111419097|NCT04501367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111419098|NCT04501367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111419099|NCT04501367|Glucocorticoids|glucocorticoids|mesh-ancestor
111419100|NCT04501367|Hormones|hormones|mesh-ancestor
111419101|NCT04501367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111419102|NCT04501367|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111419103|NCT04501367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111419104|NCT04501367|Protease Inhibitors|protease inhibitors|mesh-ancestor
111419105|NCT04501367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111419106|NCT04501367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111419107|NCT04491617|Analgesics, Opioid|analgesics, opioid|mesh-list
111419108|NCT04491617|Narcotics|narcotics|mesh-ancestor
111419109|NCT04491617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111419110|NCT04491617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111419111|NCT04491617|Analgesics|analgesics|mesh-ancestor
111419112|NCT04491617|Sensory System Agents|sensory system agents|mesh-ancestor
111419113|NCT04491617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111419114|NCT04490057|Bupropion|bupropion|mesh-list
111419115|NCT04490057|Nicotine|nicotine|mesh-list
111419116|NCT04490057|Varenicline|varenicline|mesh-list
111419117|NCT04490057|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111419118|NCT04490057|Autonomic Agents|autonomic agents|mesh-ancestor
111419119|NCT04490057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111419120|NCT04490057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111419121|NCT04490057|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111419122|NCT04490057|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111419123|NCT04490057|Cholinergic Agents|cholinergic agents|mesh-ancestor
111419125|NCT04490057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111419126|NCT04490057|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111419127|NCT04490057|Antidepressive Agents|antidepressive agents|mesh-ancestor
111419128|NCT04490057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111419129|NCT04490057|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111419130|NCT04490057|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111419131|NCT04490057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111419132|NCT04490057|Dopamine Agents|dopamine agents|mesh-ancestor
111419133|NCT04490057|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110510398|NCT00864799|Abortifacient Agents|abortifacient agents|mesh-ancestor
111419134|NCT04490057|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111419135|NCT04490057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111419136|NCT04487392|Estrogens|estrogens|mesh-list
111419137|NCT04487392|Hormones|hormones|mesh-ancestor
111419138|NCT04487392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111419139|NCT04487392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111419140|NCT04485546|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111419141|NCT04485546|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111419142|NCT04472416|Analgesics|analgesics|mesh-list
111419143|NCT04472416|Sensory System Agents|sensory system agents|mesh-ancestor
111419144|NCT04472416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111419145|NCT04472416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111419146|NCT04439136|Afatinib|afatinib|mesh-list
111419147|NCT04439136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111419148|NCT04439136|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111419149|NCT04439136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111419150|NCT04439136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111419151|NCT04439110|Trastuzumab|trastuzumab|mesh-list
111419152|NCT04439110|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
111419153|NCT04439110|Maytansine|maytansine|mesh-list
111419154|NCT04439110|Immunoconjugates|immunoconjugates|mesh-list
111419155|NCT04439110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111419156|NCT04439110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111419157|NCT04439110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111419158|NCT04439110|Tubulin Modulators|tubulin modulators|mesh-ancestor
111419159|NCT04439110|Antimitotic Agents|antimitotic agents|mesh-ancestor
111419160|NCT04439110|Mitosis Modulators|mitosis modulators|mesh-ancestor
111419161|NCT04439110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111419162|NCT04439110|Immunotoxins|immunotoxins|mesh-ancestor
111419163|NCT04439110|Immunologic Factors|immunologic factors|mesh-ancestor
111419164|NCT04439110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111419165|NCT04432831|Faricimab|faricimab|mesh-list
111419166|NCT04432831|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111419167|NCT04432831|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111419168|NCT04432831|Growth Substances|growth substances|mesh-ancestor
111419169|NCT04432831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111419170|NCT04432831|Growth Inhibitors|growth inhibitors|mesh-ancestor
111419171|NCT04432831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111419172|NCT04427293|Pembrolizumab|pembrolizumab|mesh-list
111419173|NCT04427293|Lenvatinib|lenvatinib|mesh-list
111419174|NCT04427293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111419175|NCT04427293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111419176|NCT04427293|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111419177|NCT04427293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111419178|NCT04427293|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111419179|NCT04427293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111419180|NCT04391842|Diclofenac|diclofenac|mesh-list
111419181|NCT04391842|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111419182|NCT04391842|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111419183|NCT04391842|Analgesics|analgesics|mesh-ancestor
111419184|NCT04391842|Sensory System Agents|sensory system agents|mesh-ancestor
111419185|NCT04391842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111419186|NCT04391842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111419187|NCT04391842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111419188|NCT04391842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111419189|NCT04391842|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111419190|NCT04391842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111419191|NCT04391842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111419192|NCT04383262|Fosamprenavir|fosamprenavir|mesh-list
111419193|NCT04383262|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111419194|NCT04383262|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111419195|NCT04383262|Protease Inhibitors|protease inhibitors|mesh-ancestor
111419196|NCT04383262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111419197|NCT04383262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111419198|NCT04383262|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111419199|NCT04383262|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111419200|NCT04383262|Antiviral Agents|antiviral agents|mesh-ancestor
111419201|NCT04383262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111419202|NCT04360681|Lofexidine|lofexidine|mesh-list
111419203|NCT04360681|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111419204|NCT04360681|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111419205|NCT04360681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111419206|NCT04360681|Sensory System Agents|sensory system agents|mesh-ancestor
111419207|NCT04360681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111419208|NCT04360681|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111419209|NCT04360681|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111419210|NCT04360681|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111419211|NCT04360681|Adrenergic Agents|adrenergic agents|mesh-ancestor
111419212|NCT04360681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111419213|NCT04360681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111419214|NCT04330248|Carbamazepine|carbamazepine|mesh-list
111419215|NCT04330248|Anticonvulsants|anticonvulsants|mesh-ancestor
111419216|NCT04330248|Antimanic Agents|antimanic agents|mesh-ancestor
111419217|NCT04330248|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111419218|NCT04330248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111419219|NCT04330248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111419220|NCT04330248|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111419221|NCT04330248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111419222|NCT04330248|Analgesics|analgesics|mesh-ancestor
111419223|NCT04330248|Sensory System Agents|sensory system agents|mesh-ancestor
111419224|NCT04330248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111419225|NCT04330248|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111419226|NCT04330248|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111419227|NCT04330248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111419228|NCT04330248|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111419229|NCT04330248|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111419230|NCT04328844|Pemetrexed|pemetrexed|mesh-list
111419231|NCT04328844|Avelumab|avelumab|mesh-list
111419232|NCT04328844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111419233|NCT04328844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111419234|NCT04328844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111419235|NCT04328844|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111419236|NCT04328844|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111419237|NCT04328844|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111419238|NCT04327024|Allopurinol|allopurinol|mesh-list
111419239|NCT04327024|Verinurad|verinurad|mesh-list
111419240|NCT04327024|Antimetabolites|antimetabolites|mesh-ancestor
111419241|NCT04327024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111419242|NCT04327024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111419243|NCT04327024|Gout Suppressants|gout suppressants|mesh-ancestor
111419244|NCT04327024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111419245|NCT04327024|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111419246|NCT04327024|Antioxidants|antioxidants|mesh-ancestor
111419247|NCT04327024|Protective Agents|protective agents|mesh-ancestor
111419248|NCT04327024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111419249|NCT04315272|Azithromycin|azithromycin|mesh-list
111419250|NCT04315272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111419251|NCT04315272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111419252|NCT04304352|Cyclophosphamide|cyclophosphamide|mesh-list
111419253|NCT04304352|Capecitabine|capecitabine|mesh-list
111419254|NCT04304352|Vinorelbine|vinorelbine|mesh-list
111419255|NCT04304352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111419256|NCT04304352|Immunologic Factors|immunologic factors|mesh-ancestor
111419257|NCT04304352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111419258|NCT04304352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111419259|NCT04304352|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111419260|NCT04304352|Alkylating Agents|alkylating agents|mesh-ancestor
111419261|NCT04304352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111419262|NCT04304352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111419263|NCT04304352|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111419264|NCT04304352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111419265|NCT04304352|Antimetabolites|antimetabolites|mesh-ancestor
111419266|NCT04304352|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111419267|NCT04304352|Tubulin Modulators|tubulin modulators|mesh-ancestor
111419268|NCT04304352|Antimitotic Agents|antimitotic agents|mesh-ancestor
111419269|NCT04304352|Mitosis Modulators|mitosis modulators|mesh-ancestor
111419270|NCT04297592|Doxycycline|doxycycline|mesh-list
111419271|NCT04297592|Cephalexin|cephalexin|mesh-list
111419272|NCT04297592|Cefadroxil|cefadroxil|mesh-list
111419273|NCT04297592|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111419274|NCT04297592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111419275|NCT04297592|Antimalarials|antimalarials|mesh-ancestor
111419276|NCT04297592|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111419277|NCT04297592|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111419278|NCT04294459|Acetaminophen|acetaminophen|mesh-list
111419279|NCT04294459|Diphenhydramine|diphenhydramine|mesh-list
111419280|NCT04294459|Promethazine|promethazine|mesh-list
111419281|NCT04294459|Methylprednisolone|methylprednisolone|mesh-list
111419282|NCT04294459|Ranitidine|ranitidine|mesh-list
111419283|NCT04294459|Montelukast|montelukast|mesh-list
111419284|NCT04294459|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111419285|NCT04294459|Analgesics|analgesics|mesh-ancestor
111419286|NCT04294459|Sensory System Agents|sensory system agents|mesh-ancestor
111419287|NCT04294459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111419288|NCT04294459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111419289|NCT04294459|Antipyretics|antipyretics|mesh-ancestor
111419290|NCT04294459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111419291|NCT04294459|Antiemetics|antiemetics|mesh-ancestor
111419292|NCT04294459|Autonomic Agents|autonomic agents|mesh-ancestor
111419293|NCT04294459|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111419294|NCT04294459|Glucocorticoids|glucocorticoids|mesh-ancestor
111419295|NCT04294459|Hormones|hormones|mesh-ancestor
111419296|NCT04294459|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111419297|NCT04294459|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111419298|NCT04294459|Protective Agents|protective agents|mesh-ancestor
111419299|NCT04294459|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111419300|NCT04294459|Respiratory System Agents|respiratory system agents|mesh-ancestor
111419301|NCT04294459|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
111419302|NCT04294459|Hormone Antagonists|hormone antagonists|mesh-ancestor
111419303|NCT04294459|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
111419304|NCT04294459|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111419305|NCT04294459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111419306|NCT04294459|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111419307|NCT04294459|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111419308|NCT04294459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111419309|NCT04294459|Anesthetics, Local|anesthetics, local|mesh-ancestor
111419310|NCT04294459|Anesthetics|anesthetics|mesh-ancestor
111419311|NCT04294459|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111419312|NCT04294459|Histamine Antagonists|histamine antagonists|mesh-ancestor
111419313|NCT04294459|Histamine Agents|histamine agents|mesh-ancestor
111419314|NCT04294459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111419315|NCT04294459|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111419316|NCT04294459|Antipruritics|antipruritics|mesh-ancestor
111419317|NCT04294459|Dermatologic Agents|dermatologic agents|mesh-ancestor
111419318|NCT04294459|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111419319|NCT04294459|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
111419320|NCT04291105|Cemiplimab|cemiplimab|mesh-list
111419321|NCT04291105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111419322|NCT04291105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111419323|NCT04268121|Cisplatin|cisplatin|mesh-list
111419324|NCT04268121|Etoposide|etoposide|mesh-list
111419325|NCT04268121|Etoposide phosphate|etoposide phosphate|mesh-list
111419326|NCT04268121|Carboplatin|carboplatin|mesh-list
111419327|NCT04268121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111419328|NCT04268121|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111419329|NCT04268121|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111419330|NCT04268121|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111419331|NCT04268121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111419332|NCT04268121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111419333|NCT04252612|Pramlintide|pramlintide|mesh-list
111419334|NCT04252612|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111419335|NCT04252612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111419336|NCT04225715|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
111419337|NCT04225715|Antiviral Agents|antiviral agents|mesh-ancestor
111419338|NCT04225715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111419339|NCT04210505|Povidone-Iodine|povidone-iodine|mesh-list
111419340|NCT04210505|Povidone|povidone|mesh-list
111419341|NCT04210505|Plasma Substitutes|plasma substitutes|mesh-ancestor
111419342|NCT04210505|Blood Substitutes|blood substitutes|mesh-ancestor
111419343|NCT04210505|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111419344|NCT04210505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111419345|NCT04195698|Upadacitinib|upadacitinib|mesh-list
111419346|NCT04195698|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
111419347|NCT04195698|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110510414|NCT04234776|Anesthetics|anesthetics|mesh-ancestor
111419348|NCT04195698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111419349|NCT04195698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111419350|NCT04195698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111419351|NCT04194528|Acetaminophen|acetaminophen|mesh-list
111419352|NCT04194528|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
111419353|NCT04194528|Oxycodone|oxycodone|mesh-list
111419354|NCT04194528|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111419355|NCT04194528|Analgesics|analgesics|mesh-ancestor
111419356|NCT04194528|Sensory System Agents|sensory system agents|mesh-ancestor
111419357|NCT04194528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111419358|NCT04194528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111419359|NCT04194528|Antipyretics|antipyretics|mesh-ancestor
111419360|NCT04194528|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111419361|NCT04194528|Narcotics|narcotics|mesh-ancestor
111419362|NCT04194528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111419363|NCT04194528|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111419364|NCT04194528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111419365|NCT04194528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111419366|NCT04189614|Cofetuzumab pelidotin|cofetuzumab pelidotin|mesh-list
111419367|NCT04189614|Immunoconjugates|immunoconjugates|mesh-ancestor
111419368|NCT04189614|Immunologic Factors|immunologic factors|mesh-ancestor
111419369|NCT04189614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111419370|NCT04179396|Rucaparib|rucaparib|mesh-list
111419371|NCT04179396|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111419372|NCT04179396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111419373|NCT04179396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111419374|NCT04179396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111419375|NCT04170348|Vitamin D|vitamin d|mesh-list
111419376|NCT04170348|Ergocalciferols|ergocalciferols|mesh-list
111419377|NCT04170348|Cholecalciferol|cholecalciferol|mesh-list
111419378|NCT04170348|Vitamins|vitamins|mesh-list
111419379|NCT04170348|Trientine|trientine|mesh-list
111419380|NCT04170348|Micronutrients|micronutrients|mesh-ancestor
111419381|NCT04170348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111419382|NCT04170348|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111419383|NCT04170348|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111419384|NCT04170348|Chelating Agents|chelating agents|mesh-ancestor
111419385|NCT04170348|Sequestering Agents|sequestering agents|mesh-ancestor
111419386|NCT04170348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111419387|NCT04166487|Paclitaxel|paclitaxel|mesh-list
111419388|NCT04166487|Carboplatin|carboplatin|mesh-list
111419389|NCT04166487|Pembrolizumab|pembrolizumab|mesh-list
111419390|NCT04166487|Pemetrexed|pemetrexed|mesh-list
111419391|NCT04166487|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111419392|NCT04166487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111419393|NCT04166487|Tubulin Modulators|tubulin modulators|mesh-ancestor
111419394|NCT04166487|Antimitotic Agents|antimitotic agents|mesh-ancestor
111419395|NCT04166487|Mitosis Modulators|mitosis modulators|mesh-ancestor
111419396|NCT04166487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111419397|NCT04166487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111419398|NCT04166487|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111419399|NCT04166487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111419400|NCT04166487|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111419401|NCT04166487|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111419402|NCT04158440|Paclitaxel|paclitaxel|mesh-list
111419403|NCT04158440|Docetaxel|docetaxel|mesh-list
111419404|NCT04158440|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111419405|NCT04158440|Cisplatin|cisplatin|mesh-list
111419406|NCT04158440|Carboplatin|carboplatin|mesh-list
111419407|NCT04158440|Pemetrexed|pemetrexed|mesh-list
111419408|NCT04158440|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111419409|NCT04158440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111419410|NCT04158440|Tubulin Modulators|tubulin modulators|mesh-ancestor
111419411|NCT04158440|Antimitotic Agents|antimitotic agents|mesh-ancestor
111419412|NCT04158440|Mitosis Modulators|mitosis modulators|mesh-ancestor
111419413|NCT04158440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111419414|NCT04158440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111419415|NCT04158440|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111419416|NCT04158440|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111419417|NCT04140162|Dexamethasone|dexamethasone|mesh-list
111419418|NCT04140162|Lenalidomide|lenalidomide|mesh-list
111419419|NCT04140162|Bortezomib|bortezomib|mesh-list
111419420|NCT04140162|Daratumumab|daratumumab|mesh-list
111419421|NCT04140162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111419422|NCT04140162|Antiemetics|antiemetics|mesh-ancestor
111419423|NCT04140162|Autonomic Agents|autonomic agents|mesh-ancestor
111419424|NCT04140162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111419425|NCT04140162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111419426|NCT04140162|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111419427|NCT04140162|Glucocorticoids|glucocorticoids|mesh-ancestor
111419428|NCT04140162|Hormones|hormones|mesh-ancestor
111419429|NCT04140162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111419430|NCT04140162|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111419431|NCT04140162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111419432|NCT04140162|Immunologic Factors|immunologic factors|mesh-ancestor
111419433|NCT04140162|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111419434|NCT04140162|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111419435|NCT04140162|Growth Substances|growth substances|mesh-ancestor
111419436|NCT04140162|Growth Inhibitors|growth inhibitors|mesh-ancestor
111419437|NCT04124939|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111419438|NCT04124939|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111419439|NCT04124939|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111419440|NCT04124939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111419441|NCT04124939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111419442|NCT04124939|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111419443|NCT04124939|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111419444|NCT04124939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111419445|NCT04124939|Cholinergic Agents|cholinergic agents|mesh-ancestor
111419446|NCT04124939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111419447|NCT04111978|Letrozole|letrozole|mesh-list
111419448|NCT04111978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111419449|NCT04111978|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111419450|NCT04111978|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111419451|NCT04111978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111419452|NCT04111978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111419453|NCT04111978|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111419454|NCT04111978|Hormone Antagonists|hormone antagonists|mesh-ancestor
111419455|NCT04111978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111419456|NCT04111978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111419457|NCT04085458|Factor VIII|factor viii|mesh-list
111419458|NCT04085458|Coagulants|coagulants|mesh-ancestor
111419459|NCT04077580|Methenamine|methenamine|mesh-list
111419460|NCT04077580|Methenamine hippurate|methenamine hippurate|mesh-list
111419461|NCT04077580|Methenamine mandelate|methenamine mandelate|mesh-list
111419462|NCT04077580|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111419463|NCT04077580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111419464|NCT04077580|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111419465|NCT04056910|Nivolumab|nivolumab|mesh-list
111419466|NCT04056910|Ivosidenib|ivosidenib|mesh-list
111419467|NCT04056910|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111419468|NCT04056910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111419469|NCT04056910|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111419470|NCT04056910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111419471|NCT04056910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111419472|NCT04054752|Vaccines|vaccines|mesh-list
111419473|NCT04054752|Immunologic Factors|immunologic factors|mesh-ancestor
111419474|NCT04054752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111419475|NCT04037527|Gemcitabine|gemcitabine|mesh-list
111419476|NCT04037527|Docetaxel|docetaxel|mesh-list
111419477|NCT04037527|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111419478|NCT04037527|Antimetabolites|antimetabolites|mesh-ancestor
111419479|NCT04037527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111419480|NCT04037527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111419481|NCT04037527|Tubulin Modulators|tubulin modulators|mesh-ancestor
111419482|NCT04037527|Antimitotic Agents|antimitotic agents|mesh-ancestor
111419483|NCT04037527|Mitosis Modulators|mitosis modulators|mesh-ancestor
111419484|NCT03974217|Decitabine|decitabine|mesh-list
111419485|NCT03974217|Talazoparib|talazoparib|mesh-list
111419486|NCT03974217|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111419487|NCT03974217|Antimetabolites|antimetabolites|mesh-ancestor
111419488|NCT03974217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111419489|NCT03974217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111419490|NCT03974217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110510417|NCT04234776|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111419491|NCT03974217|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111419492|NCT03971045|Cyclophosphamide|cyclophosphamide|mesh-list
111419493|NCT03971045|Pembrolizumab|pembrolizumab|mesh-list
111419494|NCT03971045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111419495|NCT03971045|Immunologic Factors|immunologic factors|mesh-ancestor
111419496|NCT03971045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111419497|NCT03971045|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111419498|NCT03971045|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111419499|NCT03971045|Alkylating Agents|alkylating agents|mesh-ancestor
111419500|NCT03971045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111419501|NCT03971045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111419502|NCT03971045|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111419503|NCT03971045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111419504|NCT03971045|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111419505|NCT03946800|Durvalumab|durvalumab|mesh-list
111419506|NCT03946800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111419507|NCT03946800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111419508|NCT03940235|Androgens|androgens|mesh-list
111419509|NCT03940235|Hormones|hormones|mesh-ancestor
111419510|NCT03940235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110510435|NCT04234776|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111419511|NCT03940235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111419512|NCT03935893|Cyclophosphamide|cyclophosphamide|mesh-list
111419513|NCT03935893|Fludarabine|fludarabine|mesh-list
111419514|NCT03935893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111419515|NCT03935893|Immunologic Factors|immunologic factors|mesh-ancestor
111419516|NCT03935893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111419517|NCT03935893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111419518|NCT03935893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111419519|NCT03935893|Alkylating Agents|alkylating agents|mesh-ancestor
111419520|NCT03935893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111419521|NCT03935893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111419522|NCT03935893|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111419523|NCT03916510|Capecitabine|capecitabine|mesh-list
111419524|NCT03916510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111419525|NCT03916510|Antimetabolites|antimetabolites|mesh-ancestor
111419526|NCT03916510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111419527|NCT03916510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111419528|NCT03905798|Lorazepam|lorazepam|mesh-list
111419529|NCT03905798|Anticonvulsants|anticonvulsants|mesh-ancestor
111419530|NCT03905798|Antiemetics|antiemetics|mesh-ancestor
111419531|NCT03905798|Autonomic Agents|autonomic agents|mesh-ancestor
111419532|NCT03905798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111419533|NCT03905798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111419534|NCT03905798|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111419535|NCT03905798|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111419536|NCT03905798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111419537|NCT03905798|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111419538|NCT03905798|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111419539|NCT03905798|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111419540|NCT03905798|GABA Modulators|gaba modulators|mesh-ancestor
111419541|NCT03905798|GABA Agents|gaba agents|mesh-ancestor
111419542|NCT03905798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111419543|NCT03905798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111419544|NCT03901482|Dihydroergotamine|dihydroergotamine|mesh-list
111419545|NCT03901482|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111419546|NCT03901482|Dopamine Agonists|dopamine agonists|mesh-ancestor
111419547|NCT03901482|Dopamine Agents|dopamine agents|mesh-ancestor
111419548|NCT03901482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111419549|NCT03901482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111419550|NCT03901482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111419551|NCT03901482|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111419552|NCT03901482|Analgesics|analgesics|mesh-ancestor
111419553|NCT03901482|Sensory System Agents|sensory system agents|mesh-ancestor
111419554|NCT03901482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111419555|NCT03900377|Rituximab|rituximab|mesh-list
111419556|NCT03900377|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111419557|NCT03900377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111419558|NCT03900377|Immunologic Factors|immunologic factors|mesh-ancestor
111419559|NCT03900377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111419560|NCT03900377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111419561|NCT03860844|Cytarabine|cytarabine|mesh-list
111419562|NCT03860844|Dexamethasone|dexamethasone|mesh-list
111419563|NCT03860844|Cyclophosphamide|cyclophosphamide|mesh-list
111419564|NCT03860844|Doxorubicin|doxorubicin|mesh-list
111419565|NCT03860844|Methotrexate|methotrexate|mesh-list
111419566|NCT03860844|Fludarabine|fludarabine|mesh-list
111419567|NCT03860844|Etoposide|etoposide|mesh-list
111419568|NCT03860844|Vincristine|vincristine|mesh-list
111419569|NCT03860844|Daunorubicin|daunorubicin|mesh-list
111419570|NCT03860844|Asparaginase|asparaginase|mesh-list
111419571|NCT03860844|Mitoxantrone|mitoxantrone|mesh-list
111419572|NCT03860844|Idarubicin|idarubicin|mesh-list
111419573|NCT03860844|Hydroxyurea|hydroxyurea|mesh-list
111419574|NCT03860844|Pegaspargase|pegaspargase|mesh-list
111419575|NCT03860844|Montelukast|montelukast|mesh-list
111419576|NCT03860844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111419577|NCT03860844|Immunologic Factors|immunologic factors|mesh-ancestor
111419578|NCT03860844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111419579|NCT03860844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111419580|NCT03860844|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111419581|NCT03860844|Alkylating Agents|alkylating agents|mesh-ancestor
111419582|NCT03860844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111419583|NCT03860844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111419584|NCT03860844|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111419585|NCT03860844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111419586|NCT03860844|Antiemetics|antiemetics|mesh-ancestor
111419587|NCT03860844|Autonomic Agents|autonomic agents|mesh-ancestor
111419588|NCT03860844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111419589|NCT03860844|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111419590|NCT03860844|Glucocorticoids|glucocorticoids|mesh-ancestor
111419591|NCT03860844|Hormones|hormones|mesh-ancestor
111419592|NCT03860844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111419593|NCT03860844|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111419594|NCT03860844|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111419595|NCT03860844|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111419596|NCT03860844|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111419597|NCT03860844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111419598|NCT03860844|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111419599|NCT03860844|Abortifacient Agents|abortifacient agents|mesh-ancestor
111419600|NCT03860844|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111419601|NCT03860844|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111419602|NCT03860844|Antimetabolites|antimetabolites|mesh-ancestor
111419603|NCT03860844|Dermatologic Agents|dermatologic agents|mesh-ancestor
111419604|NCT03860844|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111419605|NCT03860844|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111419606|NCT03860844|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111419607|NCT03860844|Antiviral Agents|antiviral agents|mesh-ancestor
111419608|NCT03860844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111419609|NCT03860844|Tubulin Modulators|tubulin modulators|mesh-ancestor
111419610|NCT03860844|Antimitotic Agents|antimitotic agents|mesh-ancestor
111419611|NCT03860844|Mitosis Modulators|mitosis modulators|mesh-ancestor
111419612|NCT03860844|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111419613|NCT03860844|Respiratory System Agents|respiratory system agents|mesh-ancestor
111419614|NCT03860844|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
111419615|NCT03860844|Hormone Antagonists|hormone antagonists|mesh-ancestor
111419616|NCT03860844|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
111419617|NCT03860844|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111419618|NCT03860844|Analgesics|analgesics|mesh-ancestor
111419619|NCT03860844|Sensory System Agents|sensory system agents|mesh-ancestor
111419620|NCT03860844|Antisickling Agents|antisickling agents|mesh-ancestor
111419621|NCT03853317|Avelumab|avelumab|mesh-list
111419622|NCT03853317|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111419623|NCT03853317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111419624|NCT03845010|Verapamil|verapamil|mesh-list
111419625|NCT03845010|Sotalol|sotalol|mesh-list
111419626|NCT03845010|Flecainide|flecainide|mesh-list
111419627|NCT03845010|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111419628|NCT03845010|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111419629|NCT03845010|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111419630|NCT03845010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111419631|NCT03845010|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111419632|NCT03845010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111419633|NCT03845010|Vasodilator Agents|vasodilator agents|mesh-ancestor
111419634|NCT03845010|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111419635|NCT03845010|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111419636|NCT03845010|Adrenergic Agents|adrenergic agents|mesh-ancestor
111419637|NCT03845010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111419638|NCT03845010|Sympatholytics|sympatholytics|mesh-ancestor
111419639|NCT03845010|Autonomic Agents|autonomic agents|mesh-ancestor
111419640|NCT03845010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111419641|NCT03845010|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111419642|NCT03845010|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111419643|NCT03829371|Dexamethasone|dexamethasone|mesh-list
111419644|NCT03829371|Prednisone|prednisone|mesh-list
111419645|NCT03829371|Lenalidomide|lenalidomide|mesh-list
111419646|NCT03829371|Melphalan|melphalan|mesh-list
111419647|NCT03829371|Bortezomib|bortezomib|mesh-list
111419648|NCT03829371|Daratumumab|daratumumab|mesh-list
111419649|NCT03829371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111419650|NCT03829371|Antiemetics|antiemetics|mesh-ancestor
111419651|NCT03829371|Autonomic Agents|autonomic agents|mesh-ancestor
111419652|NCT03829371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111419653|NCT03829371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111419654|NCT03829371|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111419655|NCT03829371|Glucocorticoids|glucocorticoids|mesh-ancestor
111419656|NCT03829371|Hormones|hormones|mesh-ancestor
111419657|NCT03829371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111419658|NCT03829371|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111419659|NCT03829371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111419660|NCT03829371|Immunologic Factors|immunologic factors|mesh-ancestor
111419661|NCT03829371|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111419662|NCT03829371|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111419663|NCT03829371|Growth Substances|growth substances|mesh-ancestor
111419664|NCT03829371|Growth Inhibitors|growth inhibitors|mesh-ancestor
111419665|NCT03829371|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111419666|NCT03829371|Alkylating Agents|alkylating agents|mesh-ancestor
111419667|NCT03829371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111419668|NCT03829371|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111419669|NCT03829371|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111419670|NCT03828227|Bevacizumab|bevacizumab|mesh-list
111419671|NCT03828227|Fluorouracil|fluorouracil|mesh-list
111419672|NCT03828227|Capecitabine|capecitabine|mesh-list
111419673|NCT03828227|Oxaliplatin|oxaliplatin|mesh-list
111419674|NCT03828227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111419675|NCT03828227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111419676|NCT03828227|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111419677|NCT03828227|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111419678|NCT03828227|Growth Substances|growth substances|mesh-ancestor
111419679|NCT03828227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111419680|NCT03828227|Growth Inhibitors|growth inhibitors|mesh-ancestor
111419681|NCT03828227|Antimetabolites|antimetabolites|mesh-ancestor
111419682|NCT03828227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111419683|NCT03828227|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111419684|NCT03828227|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111419685|NCT03828227|Immunologic Factors|immunologic factors|mesh-ancestor
111419686|NCT03785964|Nirogacestat|nirogacestat|mesh-list
111419687|NCT03785964|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
111419688|NCT03785964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111419689|NCT03785964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111419690|NCT03743428|Bevacizumab|bevacizumab|mesh-list
111419691|NCT03743428|Apatinib|apatinib|mesh-list
111419692|NCT03743428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111419693|NCT03743428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111419694|NCT03743428|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111419695|NCT03743428|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111419696|NCT03743428|Growth Substances|growth substances|mesh-ancestor
111419697|NCT03743428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111419698|NCT03743428|Growth Inhibitors|growth inhibitors|mesh-ancestor
111419699|NCT03743428|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111419700|NCT03743428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111419701|NCT03743428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111419702|NCT03739710|Docetaxel|docetaxel|mesh-list
111419703|NCT03739710|Ipilimumab|ipilimumab|mesh-list
111419704|NCT03739710|Dostarlimab|dostarlimab|mesh-list
111419705|NCT03739710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111419706|NCT03739710|Tubulin Modulators|tubulin modulators|mesh-ancestor
111419707|NCT03739710|Antimitotic Agents|antimitotic agents|mesh-ancestor
111419708|NCT03739710|Mitosis Modulators|mitosis modulators|mesh-ancestor
111419709|NCT03739710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111419710|NCT03739710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111419711|NCT03739710|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111419712|NCT03691064|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
111419713|NCT03691064|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111419714|NCT03691064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111419715|NCT03690921|Cisplatin|cisplatin|mesh-list
111419716|NCT03690921|Fluorouracil|fluorouracil|mesh-list
111419717|NCT03690921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111419718|NCT03690921|Antimetabolites|antimetabolites|mesh-ancestor
111419719|NCT03690921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111419720|NCT03690921|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111419721|NCT03690921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111419722|NCT03690921|Immunologic Factors|immunologic factors|mesh-ancestor
111419723|NCT03690921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111419724|NCT03637660|Penicillins|penicillins|mesh-list
111419725|NCT03637660|Penicillin G Benzathine|penicillin g benzathine|mesh-list
111419726|NCT03637660|Penicillin G|penicillin g|mesh-list
111419727|NCT03637660|Penicillin G Procaine|penicillin g procaine|mesh-list
111419728|NCT03637660|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111419729|NCT03637660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111419730|NCT03635489|Paclitaxel|paclitaxel|mesh-list
111419731|NCT03635489|Bevacizumab|bevacizumab|mesh-list
111419732|NCT03635489|Carboplatin|carboplatin|mesh-list
111419733|NCT03635489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111419734|NCT03635489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111419735|NCT03635489|Tubulin Modulators|tubulin modulators|mesh-ancestor
111419736|NCT03635489|Antimitotic Agents|antimitotic agents|mesh-ancestor
111419737|NCT03635489|Mitosis Modulators|mitosis modulators|mesh-ancestor
111419738|NCT03635489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111419739|NCT03635489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111419740|NCT03635489|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111419741|NCT03635489|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111419742|NCT03635489|Growth Substances|growth substances|mesh-ancestor
111419743|NCT03635489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111419744|NCT03635489|Growth Inhibitors|growth inhibitors|mesh-ancestor
111419745|NCT03631784|Paclitaxel|paclitaxel|mesh-list
111419746|NCT03631784|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111419747|NCT03631784|Carboplatin|carboplatin|mesh-list
111419748|NCT03631784|Pembrolizumab|pembrolizumab|mesh-list
111419749|NCT03631784|Pemetrexed|pemetrexed|mesh-list
111419750|NCT03631784|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111419751|NCT03631784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111419752|NCT03631784|Tubulin Modulators|tubulin modulators|mesh-ancestor
111419753|NCT03631784|Antimitotic Agents|antimitotic agents|mesh-ancestor
111419754|NCT03631784|Mitosis Modulators|mitosis modulators|mesh-ancestor
111419755|NCT03631784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111419756|NCT03631784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111419757|NCT03631784|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111419758|NCT03631784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111419759|NCT03631784|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111419760|NCT03631784|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111419761|NCT03617705|Ethanol|ethanol|mesh-list
111419762|NCT03617705|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111419763|NCT03617705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111419764|NCT03617705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111419765|NCT03617705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111419766|NCT03607422|Upadacitinib|upadacitinib|mesh-list
111419767|NCT03607422|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
111419768|NCT03607422|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111419769|NCT03607422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111419770|NCT03607422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111419771|NCT03607422|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111419772|NCT03576885|Nitric Oxide|nitric oxide|mesh-list
111419773|NCT03576885|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111419774|NCT03576885|Autonomic Agents|autonomic agents|mesh-ancestor
111419775|NCT03576885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111419776|NCT03576885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111419777|NCT03576885|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111419778|NCT03576885|Respiratory System Agents|respiratory system agents|mesh-ancestor
111419779|NCT03576885|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111419780|NCT03576885|Antioxidants|antioxidants|mesh-ancestor
111419781|NCT03576885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111419782|NCT03576885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111419783|NCT03576885|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
111419784|NCT03576885|Vasodilator Agents|vasodilator agents|mesh-ancestor
111419785|NCT03576885|Gasotransmitters|gasotransmitters|mesh-ancestor
111419786|NCT03576885|Protective Agents|protective agents|mesh-ancestor
111419787|NCT03576612|Valacyclovir|valacyclovir|mesh-list
111419788|NCT03576612|Acyclovir|acyclovir|mesh-list
111419789|NCT03576612|Nivolumab|nivolumab|mesh-list
111419790|NCT03576612|Temozolomide|temozolomide|mesh-list
111419791|NCT03576612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111419792|NCT03576612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111419793|NCT03576612|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111419794|NCT03576612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111419795|NCT03576612|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111419796|NCT03576612|Alkylating Agents|alkylating agents|mesh-ancestor
111419797|NCT03576612|Antiviral Agents|antiviral agents|mesh-ancestor
111419798|NCT03576612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111419799|NCT03576105|Photosensitizing Agents|photosensitizing agents|mesh-list
111419800|NCT03576105|Methylene Blue|methylene blue|mesh-list
111419801|NCT03576105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111419802|NCT03576105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111419803|NCT03576105|Dermatologic Agents|dermatologic agents|mesh-ancestor
111144184|NCT04214353|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
111419804|NCT03568318|Upadacitinib|upadacitinib|mesh-list
111419805|NCT03568318|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
110510595|NCT00617305|Tadalafil|tadalafil|mesh-list
111419806|NCT03568318|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111419807|NCT03568318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111419808|NCT03568318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111419809|NCT03568318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111419810|NCT03550794|Thiamine|thiamine|mesh-list
111419811|NCT03550794|Vitamins|vitamins|mesh-ancestor
111419812|NCT03550794|Micronutrients|micronutrients|mesh-ancestor
111419813|NCT03550794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111419814|NCT03550794|Vitamin B Complex|vitamin b complex|mesh-ancestor
111419815|NCT03495713|Nivolumab|nivolumab|mesh-list
111419816|NCT03495713|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111419817|NCT03495713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111419818|NCT03495713|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111419819|NCT03495713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111419820|NCT03491059|Nicotine|nicotine|mesh-list
111419821|NCT03491059|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111419822|NCT03491059|Autonomic Agents|autonomic agents|mesh-ancestor
111419823|NCT03491059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111419824|NCT03491059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111419825|NCT03491059|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111419826|NCT03491059|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111419827|NCT03491059|Cholinergic Agents|cholinergic agents|mesh-ancestor
111419828|NCT03491059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111419829|NCT03491059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111419830|NCT03459846|Durvalumab|durvalumab|mesh-list
111419831|NCT03459846|Olaparib|olaparib|mesh-list
111419832|NCT03459846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111419833|NCT03459846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111419834|NCT03459846|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111419835|NCT03459846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111419836|NCT03459846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111419837|NCT03456102|Pravastatin|pravastatin|mesh-list
111419838|NCT03456102|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111419839|NCT03456102|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111419840|NCT03456102|Antimetabolites|antimetabolites|mesh-ancestor
111419841|NCT03456102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111419842|NCT03456102|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111419843|NCT03456102|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111419844|NCT03456102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111419845|NCT03448666|Pembrolizumab|pembrolizumab|mesh-list
111419846|NCT03448666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111419847|NCT03448666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111419848|NCT03448666|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111419849|NCT03448666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111419850|NCT03439865|Ivacaftor|ivacaftor|mesh-list
111419851|NCT03439865|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
111419852|NCT03439865|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111419853|NCT03439865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111419854|NCT03436654|Prednisone|prednisone|mesh-list
111419855|NCT03436654|Abiraterone Acetate|abiraterone acetate|mesh-list
111419856|NCT03436654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111419857|NCT03436654|Glucocorticoids|glucocorticoids|mesh-ancestor
111419858|NCT03436654|Hormones|hormones|mesh-ancestor
111419859|NCT03436654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111419860|NCT03436654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111419861|NCT03436654|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111419862|NCT03436654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111419863|NCT03436654|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111419864|NCT03436654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111419865|NCT03436654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111419866|NCT03436654|Hormone Antagonists|hormone antagonists|mesh-ancestor
111419867|NCT03436654|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111419868|NCT03427125|Sevelamer|sevelamer|mesh-list
111419869|NCT03427125|Chelating Agents|chelating agents|mesh-ancestor
111419870|NCT03427125|Sequestering Agents|sequestering agents|mesh-ancestor
111419871|NCT03427125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111419872|NCT03359863|Pirfenidone|pirfenidone|mesh-list
111419873|NCT03359863|Analgesics|analgesics|mesh-ancestor
111419874|NCT03359863|Sensory System Agents|sensory system agents|mesh-ancestor
111419875|NCT03359863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111419876|NCT03359863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111419877|NCT03359863|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111419878|NCT03359863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111419879|NCT03359863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111419880|NCT03359863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111419881|NCT03359863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111419882|NCT03341273|Azithromycin|azithromycin|mesh-list
111419883|NCT03341273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111419884|NCT03341273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111419885|NCT03319901|Venetoclax|venetoclax|mesh-list
111419886|NCT03319901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111419887|NCT03307785|Paclitaxel|paclitaxel|mesh-list
111419888|NCT03307785|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111419889|NCT03307785|Bevacizumab|bevacizumab|mesh-list
111419890|NCT03307785|Carboplatin|carboplatin|mesh-list
111419891|NCT03307785|Pemetrexed|pemetrexed|mesh-list
111419892|NCT03307785|Niraparib|niraparib|mesh-list
111419893|NCT03307785|Dostarlimab|dostarlimab|mesh-list
111419894|NCT03307785|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111419895|NCT03307785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111419896|NCT03307785|Tubulin Modulators|tubulin modulators|mesh-ancestor
111419897|NCT03307785|Antimitotic Agents|antimitotic agents|mesh-ancestor
111419898|NCT03307785|Mitosis Modulators|mitosis modulators|mesh-ancestor
111419899|NCT03307785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111419900|NCT03307785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111419901|NCT03307785|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111419902|NCT03307785|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111419903|NCT03307785|Growth Substances|growth substances|mesh-ancestor
111419904|NCT03307785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111419905|NCT03307785|Growth Inhibitors|growth inhibitors|mesh-ancestor
111419906|NCT03307785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111419907|NCT03307785|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111419908|NCT03307785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111419909|NCT03307785|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111419910|NCT03301766|Lidocaine|lidocaine|mesh-list
111419911|NCT03301766|Anesthetics, Local|anesthetics, local|mesh-ancestor
111419912|NCT03301766|Anesthetics|anesthetics|mesh-ancestor
111419913|NCT03301766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111419914|NCT03301766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111419915|NCT03301766|Sensory System Agents|sensory system agents|mesh-ancestor
111419916|NCT03301766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111419917|NCT03301766|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111419918|NCT03301766|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111419919|NCT03301766|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111419920|NCT03301766|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111419921|NCT03301766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111419922|NCT03248167|Cannabidiol|cannabidiol|mesh-list
111419923|NCT03248167|Anticonvulsants|anticonvulsants|mesh-ancestor
111419924|NCT03243552|Levodopa|levodopa|mesh-list
111419925|NCT03243552|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111419926|NCT03243552|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111419927|NCT03243552|Dopamine Agents|dopamine agents|mesh-ancestor
111419928|NCT03243552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111419929|NCT03243552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111419930|NCT03243552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111419931|NCT03242278|Rivaroxaban|rivaroxaban|mesh-list
111419932|NCT03242278|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111419933|NCT03242278|Antithrombins|antithrombins|mesh-ancestor
111419934|NCT03242278|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111419935|NCT03242278|Protease Inhibitors|protease inhibitors|mesh-ancestor
111419936|NCT03242278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111419937|NCT03242278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111419938|NCT03242278|Anticoagulants|anticoagulants|mesh-ancestor
111419939|NCT03198728|Testosterone|testosterone|mesh-list
111419940|NCT03198728|Androgens|androgens|mesh-ancestor
111419941|NCT03198728|Hormones|hormones|mesh-ancestor
111419942|NCT03198728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111419943|NCT03198728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111419944|NCT03151811|Dexamethasone|dexamethasone|mesh-list
111419945|NCT03151811|Dexamethasone acetate|dexamethasone acetate|mesh-list
111419946|NCT03151811|Melphalan|melphalan|mesh-list
111419947|NCT03151811|Pomalidomide|pomalidomide|mesh-list
111419948|NCT03151811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111419949|NCT03151811|Antiemetics|antiemetics|mesh-ancestor
111419950|NCT03151811|Autonomic Agents|autonomic agents|mesh-ancestor
111144337|NCT02286843|Trastuzumab|trastuzumab|mesh-list
111419951|NCT03151811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111419952|NCT03151811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111419953|NCT03151811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111419954|NCT03151811|Glucocorticoids|glucocorticoids|mesh-ancestor
111419955|NCT03151811|Hormones|hormones|mesh-ancestor
111419956|NCT03151811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111419957|NCT03151811|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111419958|NCT03151811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111419959|NCT03151811|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111419960|NCT03151811|Alkylating Agents|alkylating agents|mesh-ancestor
111419961|NCT03151811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111419962|NCT03151811|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111419963|NCT03151811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111419964|NCT03151811|Immunologic Factors|immunologic factors|mesh-ancestor
111419965|NCT03151811|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111419966|NCT03151811|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111419967|NCT03151811|Growth Substances|growth substances|mesh-ancestor
111419968|NCT03151811|Growth Inhibitors|growth inhibitors|mesh-ancestor
111419969|NCT03144804|Lamivudine|lamivudine|mesh-list
111419970|NCT03144804|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111419971|NCT03144804|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111419972|NCT03144804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111419973|NCT03144804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111419974|NCT03144804|Antiviral Agents|antiviral agents|mesh-ancestor
111419975|NCT03144804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111419976|NCT03144804|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111419977|NCT03144804|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111419978|NCT03142334|Pembrolizumab|pembrolizumab|mesh-list
111419979|NCT03142334|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111419980|NCT03142334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111419981|NCT03142334|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111419982|NCT03142334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111419983|NCT03141034|Irinotecan|irinotecan|mesh-list
111419984|NCT03141034|Ramucirumab|ramucirumab|mesh-list
111419985|NCT03141034|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111419986|NCT03141034|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111419987|NCT03141034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111419988|NCT03141034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111419989|NCT03141034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111419990|NCT03126539|Sulforaphane|sulforaphane|mesh-list
111419991|NCT03126539|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
111419992|NCT03126539|Protective Agents|protective agents|mesh-ancestor
111419993|NCT03126539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111419994|NCT03126539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111419995|NCT03107923|Dobutamine|dobutamine|mesh-list
111419996|NCT03107923|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111419997|NCT03107923|Sympathomimetics|sympathomimetics|mesh-ancestor
111419998|NCT03107923|Autonomic Agents|autonomic agents|mesh-ancestor
111419999|NCT03107923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111420000|NCT03107923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111420001|NCT03107923|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
111420002|NCT03107923|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111420003|NCT03107923|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111420004|NCT03107923|Adrenergic Agents|adrenergic agents|mesh-ancestor
111420005|NCT03107923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111420006|NCT03107923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111420007|NCT03107923|Protective Agents|protective agents|mesh-ancestor
111420008|NCT03092817|Dexamethasone|dexamethasone|mesh-list
111420009|NCT03092817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111420010|NCT03092817|Antiemetics|antiemetics|mesh-ancestor
111420011|NCT03092817|Autonomic Agents|autonomic agents|mesh-ancestor
110510636|NCT00811395|Interferons|interferons|mesh-list
111420012|NCT03092817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111420013|NCT03092817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111420014|NCT03092817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111420015|NCT03092817|Glucocorticoids|glucocorticoids|mesh-ancestor
111420016|NCT03092817|Hormones|hormones|mesh-ancestor
111420017|NCT03092817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111420018|NCT03092817|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111420019|NCT03092817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111420020|NCT03043664|Pembrolizumab|pembrolizumab|mesh-list
111420021|NCT03043664|Lanreotide|lanreotide|mesh-list
111420022|NCT03043664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111420023|NCT03043664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111420024|NCT03043664|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111420025|NCT03043664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111420026|NCT02992522|Lenalidomide|lenalidomide|mesh-list
111420028|NCT02992522|Obinutuzumab|obinutuzumab|mesh-list
111420029|NCT02992522|Immunologic Factors|immunologic factors|mesh-ancestor
111420030|NCT02992522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111420031|NCT02992522|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111420032|NCT02992522|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111420033|NCT02992522|Growth Substances|growth substances|mesh-ancestor
111420034|NCT02992522|Growth Inhibitors|growth inhibitors|mesh-ancestor
111420035|NCT02992522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111420036|NCT02992522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111420037|NCT02969681|Ascorbic Acid|ascorbic acid|mesh-list
111420038|NCT02969681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111420039|NCT02969681|Vitamins|vitamins|mesh-ancestor
111420040|NCT02969681|Micronutrients|micronutrients|mesh-ancestor
111420041|NCT02969681|Antioxidants|antioxidants|mesh-ancestor
111420042|NCT02969681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111420043|NCT02969681|Protective Agents|protective agents|mesh-ancestor
111420044|NCT02956590|Pitavastatin|pitavastatin|mesh-list
111420045|NCT02956590|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111420046|NCT02956590|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111420047|NCT02956590|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111420048|NCT02956590|Antimetabolites|antimetabolites|mesh-ancestor
111420049|NCT02956590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111420050|NCT02956590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111420051|NCT02956590|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111420052|NCT02949700|Metformin|metformin|mesh-list
111420053|NCT02949700|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111420054|NCT02949700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111420055|NCT02947087|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
111420056|NCT02947087|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
111420057|NCT02947087|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111420058|NCT02947087|Protease Inhibitors|protease inhibitors|mesh-ancestor
111420059|NCT02947087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111420060|NCT02947087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111420061|NCT02864550|Doxycycline|doxycycline|mesh-list
111420062|NCT02864550|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111420063|NCT02864550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111420064|NCT02864550|Antimalarials|antimalarials|mesh-ancestor
111420065|NCT02864550|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111420066|NCT02864550|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111420067|NCT02841995|Belumosudil|belumosudil|mesh-list
111420068|NCT02841995|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111420069|NCT02841995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111420070|NCT02841995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111420071|NCT02702414|Pembrolizumab|pembrolizumab|mesh-list
111420072|NCT02702414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111420073|NCT02702414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111420074|NCT02702414|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111420075|NCT02702414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111420076|NCT02640534|Metformin|metformin|mesh-list
111420077|NCT02640534|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111420078|NCT02640534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111420079|NCT02628366|Dialysis Solutions|dialysis solutions|mesh-list
111420080|NCT02628366|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111420081|NCT02625480|Cyclophosphamide|cyclophosphamide|mesh-list
111420082|NCT02625480|Fludarabine|fludarabine|mesh-list
111420083|NCT02625480|Brexucabtagene autoleucel|brexucabtagene autoleucel|mesh-list
111420084|NCT02625480|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111420085|NCT02625480|Immunologic Factors|immunologic factors|mesh-ancestor
111420086|NCT02625480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111420087|NCT02625480|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111420088|NCT02625480|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111420089|NCT02625480|Alkylating Agents|alkylating agents|mesh-ancestor
111420090|NCT02625480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111420091|NCT02625480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111420092|NCT02625480|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111420093|NCT02625480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111420094|NCT02598726|Curcumin|curcumin|mesh-list
111420095|NCT02598726|Piperine|piperine|mesh-list
111420096|NCT02598726|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111420097|NCT02598726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111420098|NCT02598726|Analgesics|analgesics|mesh-ancestor
111420099|NCT02598726|Sensory System Agents|sensory system agents|mesh-ancestor
111420100|NCT02598726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111144485|NCT02494921|Tubulin Modulators|tubulin modulators|mesh-ancestor
111420101|NCT02598726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111420102|NCT02598726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111420103|NCT02598726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111420104|NCT02598726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111420105|NCT02598726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111420106|NCT02598726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111420107|NCT02598726|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111420108|NCT02586038|Thalidomide|thalidomide|mesh-list
111420109|NCT02586038|Dexamethasone|dexamethasone|mesh-list
111420110|NCT02586038|Cyclophosphamide|cyclophosphamide|mesh-list
111420112|NCT02586038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111420113|NCT02586038|Immunologic Factors|immunologic factors|mesh-ancestor
111420114|NCT02586038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111420115|NCT02586038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111420116|NCT02586038|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111420117|NCT02586038|Alkylating Agents|alkylating agents|mesh-ancestor
111420118|NCT02586038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111420119|NCT02586038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111420120|NCT02586038|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111420121|NCT02586038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111420122|NCT02586038|Antiemetics|antiemetics|mesh-ancestor
111420123|NCT02586038|Autonomic Agents|autonomic agents|mesh-ancestor
111420124|NCT02586038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111420125|NCT02586038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111420126|NCT02586038|Glucocorticoids|glucocorticoids|mesh-ancestor
111420127|NCT02586038|Hormones|hormones|mesh-ancestor
111420128|NCT02586038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111420129|NCT02586038|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111420130|NCT02586038|Leprostatic Agents|leprostatic agents|mesh-ancestor
111420131|NCT02586038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111420132|NCT02586038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111420133|NCT02586038|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111420134|NCT02586038|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111420135|NCT02586038|Growth Substances|growth substances|mesh-ancestor
111420136|NCT02586038|Growth Inhibitors|growth inhibitors|mesh-ancestor
111420137|NCT02586038|Protease Inhibitors|protease inhibitors|mesh-ancestor
111420138|NCT02586038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111420139|NCT02579811|Axitinib|axitinib|mesh-list
111420140|NCT02579811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111420141|NCT02579811|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111420142|NCT02579811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111420143|NCT02579811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111420144|NCT02554383|Amoxicillin|amoxicillin|mesh-list
111420145|NCT02554383|Clavulanic Acid|clavulanic acid|mesh-list
111420146|NCT02554383|Clavulanic Acids|clavulanic acids|mesh-list
111420147|NCT02554383|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
111420148|NCT02554383|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111420149|NCT02554383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111420150|NCT02554383|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
111420151|NCT02554383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111420152|NCT02554383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111420153|NCT02519439|Ganaxolone|ganaxolone|mesh-list
111420154|NCT02519439|Neurosteroids|neurosteroids|mesh-ancestor
111420155|NCT02519439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111420156|NCT02519439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111420157|NCT02519439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111420158|NCT02519439|GABA Modulators|gaba modulators|mesh-ancestor
111420159|NCT02519439|GABA Agents|gaba agents|mesh-ancestor
111420160|NCT02500797|Nivolumab|nivolumab|mesh-list
111420161|NCT02500797|Ipilimumab|ipilimumab|mesh-list
111420162|NCT02500797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111420163|NCT02500797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111420164|NCT02500797|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111420165|NCT02500797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111420166|NCT02359175|Acetaminophen|acetaminophen|mesh-list
111420167|NCT02359175|Fentanyl|fentanyl|mesh-list
111420168|NCT02359175|Analgesics, Opioid|analgesics, opioid|mesh-list
111420169|NCT02359175|Bupivacaine|bupivacaine|mesh-list
111420170|NCT02359175|Anesthetics, Local|anesthetics, local|mesh-ancestor
111420171|NCT02359175|Anesthetics|anesthetics|mesh-ancestor
111420172|NCT02359175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111420173|NCT02359175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111420174|NCT02359175|Sensory System Agents|sensory system agents|mesh-ancestor
111420175|NCT02359175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111420176|NCT02359175|Narcotics|narcotics|mesh-ancestor
111420177|NCT02359175|Analgesics|analgesics|mesh-ancestor
111420178|NCT02359175|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111420179|NCT02359175|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111420180|NCT02359175|Anesthetics, General|anesthetics, general|mesh-ancestor
111420181|NCT02359175|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111420182|NCT02359175|Antipyretics|antipyretics|mesh-ancestor
111420183|NCT02215980|Dexamethasone|dexamethasone|mesh-list
111420184|NCT02215980|Lenalidomide|lenalidomide|mesh-list
111420185|NCT02215980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111420186|NCT02215980|Antiemetics|antiemetics|mesh-ancestor
111420187|NCT02215980|Autonomic Agents|autonomic agents|mesh-ancestor
111420188|NCT02215980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111420189|NCT02215980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111420190|NCT02215980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111420191|NCT02215980|Glucocorticoids|glucocorticoids|mesh-ancestor
111420192|NCT02215980|Hormones|hormones|mesh-ancestor
111420193|NCT02215980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111420194|NCT02215980|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111420195|NCT02215980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111420196|NCT02215980|Immunologic Factors|immunologic factors|mesh-ancestor
111420197|NCT02215980|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111420198|NCT02215980|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111420199|NCT02215980|Growth Substances|growth substances|mesh-ancestor
111420200|NCT02215980|Growth Inhibitors|growth inhibitors|mesh-ancestor
111420201|NCT02101021|Paclitaxel|paclitaxel|mesh-list
111420202|NCT02101021|Gemcitabine|gemcitabine|mesh-list
111420203|NCT02101021|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
111420204|NCT02101021|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111420205|NCT02101021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111420206|NCT02101021|Tubulin Modulators|tubulin modulators|mesh-ancestor
111420207|NCT02101021|Antimitotic Agents|antimitotic agents|mesh-ancestor
111420208|NCT02101021|Mitosis Modulators|mitosis modulators|mesh-ancestor
111420209|NCT02101021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111420210|NCT02101021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111420211|NCT02101021|Antimetabolites|antimetabolites|mesh-ancestor
111420212|NCT02101021|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111420213|NCT02101021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111420214|NCT02088632|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
111420215|NCT02088632|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111420216|NCT02088632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111420217|NCT02088632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111420218|NCT02088632|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111420219|NCT02088632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111420220|NCT02088632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111420221|NCT02088632|Cholinergic Agents|cholinergic agents|mesh-ancestor
111420222|NCT02088632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111420223|NCT02031536|Everolimus|everolimus|mesh-list
111420224|NCT02031536|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111420225|NCT02031536|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111420226|NCT02031536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111420227|NCT02031536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111420228|NCT02031536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111420229|NCT02031536|Immunologic Factors|immunologic factors|mesh-ancestor
111420230|NCT02031536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111420231|NCT02031536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111420232|NCT02023996|Trastuzumab|trastuzumab|mesh-list
111420233|NCT02023996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111420234|NCT02023996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111420235|NCT02020720|Fluorides|fluorides|mesh-list
111420236|NCT02020720|Cariostatic Agents|cariostatic agents|mesh-ancestor
111420237|NCT02020720|Protective Agents|protective agents|mesh-ancestor
111420238|NCT02020720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111420239|NCT02020707|Paclitaxel|paclitaxel|mesh-list
111420240|NCT02020707|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111420241|NCT02020707|Bevacizumab|bevacizumab|mesh-list
111420242|NCT02020707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111420243|NCT02020707|Endothelial Growth Factors|endothelial growth factors|mesh-list
111420244|NCT02020707|Antibodies|antibodies|mesh-list
111420245|NCT02020707|Immunoglobulins|immunoglobulins|mesh-list
111420246|NCT02020707|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111420247|NCT02020707|Immunoglobulin G|immunoglobulin g|mesh-list
111420248|NCT02020707|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111420249|NCT02020707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111420250|NCT02020707|Tubulin Modulators|tubulin modulators|mesh-ancestor
111420251|NCT02020707|Antimitotic Agents|antimitotic agents|mesh-ancestor
111420253|NCT02020707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111420254|NCT02020707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111420255|NCT02020707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111420256|NCT02020707|Growth Substances|growth substances|mesh-ancestor
111420257|NCT02020707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111420258|NCT02020707|Growth Inhibitors|growth inhibitors|mesh-ancestor
111420259|NCT02020707|Immunologic Factors|immunologic factors|mesh-ancestor
111420260|NCT01968200|Enalapril|enalapril|mesh-list
111420261|NCT01968200|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
111420262|NCT01968200|Protease Inhibitors|protease inhibitors|mesh-ancestor
111420263|NCT01968200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111420264|NCT01968200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111420265|NCT01968200|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111420266|NCT01964430|Paclitaxel|paclitaxel|mesh-list
111420267|NCT01964430|Gemcitabine|gemcitabine|mesh-list
111420268|NCT01964430|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111420269|NCT01964430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111420270|NCT01964430|Tubulin Modulators|tubulin modulators|mesh-ancestor
111420271|NCT01964430|Antimitotic Agents|antimitotic agents|mesh-ancestor
111420272|NCT01964430|Mitosis Modulators|mitosis modulators|mesh-ancestor
111420273|NCT01964430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111420274|NCT01964430|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111420275|NCT01964430|Antimetabolites|antimetabolites|mesh-ancestor
111420276|NCT01934868|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111420277|NCT01898494|Cisplatin|cisplatin|mesh-list
111420278|NCT01898494|Carboplatin|carboplatin|mesh-list
111420279|NCT01898494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111420280|NCT01841359|Pramlintide|pramlintide|mesh-list
111420281|NCT01841359|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111420282|NCT01841359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111420283|NCT01824875|Capecitabine|capecitabine|mesh-list
111420284|NCT01824875|Temozolomide|temozolomide|mesh-list
111420285|NCT01824875|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111420286|NCT01824875|Antimetabolites|antimetabolites|mesh-ancestor
111420287|NCT01824875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111420288|NCT01824875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111420289|NCT01824875|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111420290|NCT01824875|Alkylating Agents|alkylating agents|mesh-ancestor
111420291|NCT01579734|Tamoxifen|tamoxifen|mesh-list
111420292|NCT01579734|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111420293|NCT01579734|Hormone Antagonists|hormone antagonists|mesh-ancestor
111420294|NCT01579734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111420295|NCT01579734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111420296|NCT01579734|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111420297|NCT01579734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111420298|NCT01579734|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111420299|NCT01579734|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111420300|NCT01579734|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111420301|NCT01566240|Paclitaxel|paclitaxel|mesh-list
111420302|NCT01566240|Carboplatin|carboplatin|mesh-list
111420303|NCT01566240|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111420304|NCT01566240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111420305|NCT01566240|Tubulin Modulators|tubulin modulators|mesh-ancestor
111420306|NCT01566240|Antimitotic Agents|antimitotic agents|mesh-ancestor
111420307|NCT01566240|Mitosis Modulators|mitosis modulators|mesh-ancestor
111420308|NCT01566240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111420309|NCT01390584|Prednisone|prednisone|mesh-list
111420310|NCT01390584|Cyclophosphamide|cyclophosphamide|mesh-list
111420311|NCT01390584|Dacarbazine|dacarbazine|mesh-list
111420312|NCT01390584|Doxorubicin|doxorubicin|mesh-list
111420313|NCT01390584|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111420314|NCT01390584|Etoposide|etoposide|mesh-list
111420315|NCT01390584|Vincristine|vincristine|mesh-list
111420316|NCT01390584|Etoposide phosphate|etoposide phosphate|mesh-list
111420317|NCT01390584|Bleomycin|bleomycin|mesh-list
111420318|NCT01390584|Vinblastine|vinblastine|mesh-list
111420319|NCT01390584|Podophyllotoxin|podophyllotoxin|mesh-list
111420320|NCT01390584|Procarbazine|procarbazine|mesh-list
111420321|NCT01390584|Imidazole|imidazole|mesh-list
111420322|NCT01390584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111420323|NCT01390584|Immunologic Factors|immunologic factors|mesh-ancestor
111420324|NCT01390584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111420325|NCT01390584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111420326|NCT01390584|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111420327|NCT01390584|Alkylating Agents|alkylating agents|mesh-ancestor
111420328|NCT01390584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111420329|NCT01390584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111420330|NCT01390584|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111420331|NCT01390584|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111420332|NCT01390584|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111420333|NCT01390584|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111420334|NCT01390584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111420335|NCT01390584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111420336|NCT01390584|Glucocorticoids|glucocorticoids|mesh-ancestor
111420337|NCT01390584|Hormones|hormones|mesh-ancestor
111420338|NCT01390584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111420339|NCT01390584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111420340|NCT01390584|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111420341|NCT01390584|Tubulin Modulators|tubulin modulators|mesh-ancestor
111420342|NCT01390584|Antimitotic Agents|antimitotic agents|mesh-ancestor
111420343|NCT01390584|Mitosis Modulators|mitosis modulators|mesh-ancestor
111420344|NCT01390584|Keratolytic Agents|keratolytic agents|mesh-ancestor
111420345|NCT01390584|Dermatologic Agents|dermatologic agents|mesh-ancestor
111420346|NCT01374841|Cyclophosphamide|cyclophosphamide|mesh-list
111420347|NCT01374841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111420348|NCT01374841|Immunologic Factors|immunologic factors|mesh-ancestor
111420349|NCT01374841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111420350|NCT01374841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111420351|NCT01374841|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111420352|NCT01374841|Alkylating Agents|alkylating agents|mesh-ancestor
111420353|NCT01374841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111420354|NCT01374841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111420355|NCT01374841|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111420356|NCT01216683|Rituximab|rituximab|mesh-list
111420357|NCT01216683|Lenalidomide|lenalidomide|mesh-list
111420358|NCT01216683|Bortezomib|bortezomib|mesh-list
111420359|NCT01216683|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
111420360|NCT01216683|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111420361|NCT01216683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111420362|NCT01216683|Immunologic Factors|immunologic factors|mesh-ancestor
111420363|NCT01216683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111420364|NCT01216683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111420365|NCT01216683|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111420366|NCT01216683|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111420367|NCT01216683|Growth Substances|growth substances|mesh-ancestor
111420368|NCT01216683|Growth Inhibitors|growth inhibitors|mesh-ancestor
111420369|NCT01216683|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111420370|NCT01216683|Alkylating Agents|alkylating agents|mesh-ancestor
111420371|NCT01216683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111420372|NCT01166113|Prednisone|prednisone|mesh-list
111420373|NCT01166113|Cyclophosphamide|cyclophosphamide|mesh-list
111420374|NCT01166113|Pomalidomide|pomalidomide|mesh-list
111420375|NCT01166113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111420376|NCT01166113|Immunologic Factors|immunologic factors|mesh-ancestor
111420377|NCT01166113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111420378|NCT01166113|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111420379|NCT01166113|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111420380|NCT01166113|Alkylating Agents|alkylating agents|mesh-ancestor
111420381|NCT01166113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111420382|NCT01166113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111420383|NCT01166113|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111420384|NCT01166113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111420385|NCT01166113|Glucocorticoids|glucocorticoids|mesh-ancestor
111420386|NCT01166113|Hormones|hormones|mesh-ancestor
111420387|NCT01166113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111420388|NCT01166113|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111420389|NCT01166113|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111420390|NCT01166113|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111420391|NCT01166113|Growth Substances|growth substances|mesh-ancestor
111420392|NCT01166113|Growth Inhibitors|growth inhibitors|mesh-ancestor
111420393|NCT01160107|Prednisone|prednisone|mesh-list
111420394|NCT01160107|Melphalan|melphalan|mesh-list
111420395|NCT01160107|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111420396|NCT01160107|Glucocorticoids|glucocorticoids|mesh-ancestor
111420397|NCT01160107|Hormones|hormones|mesh-ancestor
111420398|NCT01160107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111420399|NCT01160107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111420400|NCT01160107|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111420401|NCT01160107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111420402|NCT01160107|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111420404|NCT01160107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111420405|NCT01160107|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111420406|NCT01160107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111420407|NCT01160107|Immunologic Factors|immunologic factors|mesh-ancestor
111420408|NCT01145495|Rituximab|rituximab|mesh-list
111420409|NCT01145495|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111420410|NCT01145495|Lenalidomide|lenalidomide|mesh-list
111420411|NCT01145495|Antibodies|antibodies|mesh-list
111420412|NCT01145495|Immunoglobulins|immunoglobulins|mesh-list
111420413|NCT01145495|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111420414|NCT01145495|Immunologic Factors|immunologic factors|mesh-ancestor
111420415|NCT01145495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111420416|NCT01145495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111420417|NCT01145495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111420418|NCT01145495|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111420419|NCT01145495|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111420420|NCT01145495|Growth Substances|growth substances|mesh-ancestor
111420421|NCT01145495|Growth Inhibitors|growth inhibitors|mesh-ancestor
111420422|NCT01124695|Tamoxifen|tamoxifen|mesh-list
111420423|NCT01124695|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111420424|NCT01124695|Hormone Antagonists|hormone antagonists|mesh-ancestor
111420425|NCT01124695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111420426|NCT01124695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111420427|NCT01124695|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111420428|NCT01124695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111420429|NCT01124695|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111420430|NCT01124695|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111420431|NCT01124695|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111420432|NCT01084083|Paclitaxel|paclitaxel|mesh-list
111420433|NCT01084083|Cetuximab|cetuximab|mesh-list
111420434|NCT01084083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111420435|NCT01084083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111420436|NCT01084083|Tubulin Modulators|tubulin modulators|mesh-ancestor
111420437|NCT01084083|Antimitotic Agents|antimitotic agents|mesh-ancestor
111420438|NCT01084083|Mitosis Modulators|mitosis modulators|mesh-ancestor
111420439|NCT01084083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111420440|NCT01084083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111420441|NCT01079780|Irinotecan|irinotecan|mesh-list
111420442|NCT01079780|Cetuximab|cetuximab|mesh-list
111420443|NCT01079780|Ramucirumab|ramucirumab|mesh-list
111420444|NCT01079780|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111420445|NCT01079780|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111420446|NCT01079780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111420447|NCT01079780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111420448|NCT01079780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111420449|NCT01079780|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111420450|NCT01063179|Thalidomide|thalidomide|mesh-list
111420451|NCT01063179|Prednisone|prednisone|mesh-list
111420452|NCT01063179|Bortezomib|bortezomib|mesh-list
111420453|NCT01063179|Melphalan|melphalan|mesh-list
111420454|NCT01063179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111420455|NCT01063179|Glucocorticoids|glucocorticoids|mesh-ancestor
111420456|NCT01063179|Hormones|hormones|mesh-ancestor
111420457|NCT01063179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111420458|NCT01063179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111420459|NCT01063179|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111420460|NCT01063179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111420461|NCT01063179|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111420462|NCT01063179|Alkylating Agents|alkylating agents|mesh-ancestor
111420463|NCT01063179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111420464|NCT01063179|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111420465|NCT01063179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111420466|NCT01063179|Immunologic Factors|immunologic factors|mesh-ancestor
111420467|NCT01063179|Leprostatic Agents|leprostatic agents|mesh-ancestor
111420468|NCT01063179|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111420469|NCT01063179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111420470|NCT01063179|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111420471|NCT01063179|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111420472|NCT01063179|Growth Substances|growth substances|mesh-ancestor
111420473|NCT01063179|Growth Inhibitors|growth inhibitors|mesh-ancestor
111144858|NCT02444533|Anesthetics|anesthetics|mesh-ancestor
111420474|NCT01013961|Rituximab|rituximab|mesh-list
111420475|NCT01013961|Alemtuzumab|alemtuzumab|mesh-list
111420476|NCT01013961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111420477|NCT01013961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111420478|NCT01013961|Immunologic Factors|immunologic factors|mesh-ancestor
111420479|NCT01013961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111420480|NCT01013961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111420481|NCT00834093|Immunomodulating Agents|immunomodulating agents|mesh-list
111420482|NCT00834093|Immunologic Factors|immunologic factors|mesh-ancestor
111420483|NCT00834093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111420485|NCT00783510|Methotrexate|methotrexate|mesh-list
111420486|NCT00783510|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111420487|NCT00783510|Abortifacient Agents|abortifacient agents|mesh-ancestor
111420488|NCT00783510|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111420489|NCT00783510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111420490|NCT00783510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111420491|NCT00783510|Antimetabolites|antimetabolites|mesh-ancestor
111420492|NCT00783510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111420493|NCT00783510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111420494|NCT00783510|Dermatologic Agents|dermatologic agents|mesh-ancestor
111420495|NCT00783510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111420496|NCT00783510|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111420497|NCT00783510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111420498|NCT00783510|Immunologic Factors|immunologic factors|mesh-ancestor
111420499|NCT00783510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111420500|NCT00783510|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111420501|NCT00783510|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111420502|NCT00783510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111420503|NCT00779194|Sirolimus|sirolimus|mesh-list
111420504|NCT00779194|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111420505|NCT00779194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111420506|NCT00779194|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111420507|NCT00779194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111420508|NCT00779194|Antifungal Agents|antifungal agents|mesh-ancestor
111420509|NCT00779194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111420510|NCT00779194|Immunologic Factors|immunologic factors|mesh-ancestor
111420511|NCT00779194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111420512|NCT00665600|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111420513|NCT00665600|Albuterol|albuterol|mesh-list
111420514|NCT00665600|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111420515|NCT00665600|Autonomic Agents|autonomic agents|mesh-ancestor
111420516|NCT00665600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111420517|NCT00665600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111420518|NCT00665600|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111420519|NCT00665600|Respiratory System Agents|respiratory system agents|mesh-ancestor
111420520|NCT00665600|Tocolytic Agents|tocolytic agents|mesh-ancestor
111420521|NCT00665600|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111420522|NCT00665600|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111420523|NCT00665600|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111420524|NCT00665600|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111420525|NCT00665600|Adrenergic Agents|adrenergic agents|mesh-ancestor
111420526|NCT00665600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111420527|NCT00665600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111420528|NCT00606294|Misonidazole|misonidazole|mesh-list
111420529|NCT00606294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111420530|NCT00606294|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111420531|NCT00606294|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111420532|NCT00606294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111420533|NCT00551928|Prednisone|prednisone|mesh-list
111420534|NCT00551928|Lenalidomide|lenalidomide|mesh-list
111420535|NCT00551928|Melphalan|melphalan|mesh-list
111420536|NCT00551928|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111420537|NCT00551928|Glucocorticoids|glucocorticoids|mesh-ancestor
111420538|NCT00551928|Hormones|hormones|mesh-ancestor
111420539|NCT00551928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111420540|NCT00551928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111420541|NCT00551928|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111420542|NCT00551928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111420543|NCT00551928|Immunologic Factors|immunologic factors|mesh-ancestor
111420544|NCT00551928|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111420545|NCT00551928|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111420546|NCT00551928|Growth Substances|growth substances|mesh-ancestor
111420547|NCT00551928|Growth Inhibitors|growth inhibitors|mesh-ancestor
111420548|NCT00551928|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111420549|NCT00551928|Alkylating Agents|alkylating agents|mesh-ancestor
111144944|NCT02272803|Elotuzumab|elotuzumab|mesh-list
111420550|NCT00551928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111420551|NCT00551928|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111420552|NCT00551928|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111420553|NCT00330564|Sunitinib|sunitinib|mesh-list
111420554|NCT00330564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111420555|NCT00330564|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111420556|NCT00330564|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111420557|NCT00330564|Growth Substances|growth substances|mesh-ancestor
111420558|NCT00330564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111420559|NCT00330564|Growth Inhibitors|growth inhibitors|mesh-ancestor
111420560|NCT00330564|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111420561|NCT00330564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111420562|NCT00330564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111420563|NCT00316888|Cisplatin|cisplatin|mesh-list
111420564|NCT00316888|Fluorouracil|fluorouracil|mesh-list
111420565|NCT00316888|Cetuximab|cetuximab|mesh-list
111420566|NCT00316888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111420567|NCT00316888|Antimetabolites|antimetabolites|mesh-ancestor
111420568|NCT00316888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111420569|NCT00316888|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111420570|NCT00316888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111420571|NCT00316888|Immunologic Factors|immunologic factors|mesh-ancestor
111420572|NCT00316888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111420573|NCT00316888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111420574|NCT00309478|Tamoxifen|tamoxifen|mesh-list
111420575|NCT00309478|Cyclophosphamide|cyclophosphamide|mesh-list
111420576|NCT00309478|Fluorouracil|fluorouracil|mesh-list
111420577|NCT00309478|Methotrexate|methotrexate|mesh-list
111420578|NCT00309478|Goserelin|goserelin|mesh-list
111420579|NCT00309478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111420580|NCT00309478|Immunologic Factors|immunologic factors|mesh-ancestor
111420581|NCT00309478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111420582|NCT00309478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111420583|NCT00309478|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111420584|NCT00309478|Alkylating Agents|alkylating agents|mesh-ancestor
111420585|NCT00309478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111420586|NCT00309478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111420587|NCT00309478|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111420588|NCT00309478|Antimetabolites|antimetabolites|mesh-ancestor
111420589|NCT00309478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111420590|NCT00309478|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111420591|NCT00309478|Abortifacient Agents|abortifacient agents|mesh-ancestor
111420592|NCT00309478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111420593|NCT00309478|Dermatologic Agents|dermatologic agents|mesh-ancestor
111420594|NCT00309478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111420595|NCT00309478|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111420596|NCT00309478|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111420597|NCT00309478|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111420598|NCT00309478|Hormone Antagonists|hormone antagonists|mesh-ancestor
111420599|NCT00309478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111420600|NCT00309478|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111420601|NCT00309478|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111420602|NCT00309478|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111420603|NCT00309478|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111420604|NCT00295646|Tamoxifen|tamoxifen|mesh-list
111420605|NCT00295646|Zoledronic Acid|zoledronic acid|mesh-list
111420606|NCT00295646|Anastrozole|anastrozole|mesh-list
111420607|NCT00295646|Goserelin|goserelin|mesh-list
111420608|NCT00295646|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111420609|NCT00295646|Hormone Antagonists|hormone antagonists|mesh-ancestor
111420610|NCT00295646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111420611|NCT00295646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111420612|NCT00295646|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111420613|NCT00295646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111420614|NCT00295646|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111420615|NCT00295646|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111420616|NCT00295646|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111420617|NCT00295646|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111420618|NCT00295646|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111420619|NCT00295646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111420620|NCT00295646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111420621|NCT00274924|Prednisone|prednisone|mesh-list
111420622|NCT00274924|Cyclophosphamide|cyclophosphamide|mesh-list
111420623|NCT00274924|Ifosfamide|ifosfamide|mesh-list
111420624|NCT00274924|Rituximab|rituximab|mesh-list
111420625|NCT00274924|Carboplatin|carboplatin|mesh-list
111420626|NCT00274924|Doxorubicin|doxorubicin|mesh-list
111420627|NCT00274924|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111420628|NCT00274924|Etoposide|etoposide|mesh-list
111420629|NCT00274924|Vincristine|vincristine|mesh-list
111420630|NCT00274924|Podophyllotoxin|podophyllotoxin|mesh-list
111420631|NCT00274924|Lenograstim|lenograstim|mesh-list
111420632|NCT00274924|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111420633|NCT00274924|Immunologic Factors|immunologic factors|mesh-ancestor
111420634|NCT00274924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111420635|NCT00274924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111420636|NCT00274924|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111420637|NCT00274924|Alkylating Agents|alkylating agents|mesh-ancestor
111420638|NCT00274924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111420639|NCT00274924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111420640|NCT00274924|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111420641|NCT00274924|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111420642|NCT00274924|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111420643|NCT00274924|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111420644|NCT00274924|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111420645|NCT00274924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111420646|NCT00274924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111420647|NCT00274924|Glucocorticoids|glucocorticoids|mesh-ancestor
111420648|NCT00274924|Hormones|hormones|mesh-ancestor
111420649|NCT00274924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111420650|NCT00274924|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111420651|NCT00274924|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111420652|NCT00274924|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111420653|NCT00274924|Tubulin Modulators|tubulin modulators|mesh-ancestor
111420654|NCT00274924|Antimitotic Agents|antimitotic agents|mesh-ancestor
111420655|NCT00274924|Mitosis Modulators|mitosis modulators|mesh-ancestor
111420656|NCT00274924|Keratolytic Agents|keratolytic agents|mesh-ancestor
111420657|NCT00274924|Dermatologic Agents|dermatologic agents|mesh-ancestor
111420658|NCT00104884|Romidepsin|romidepsin|mesh-list
111420659|NCT00104884|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111420660|NCT00104884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111420661|NCT00104884|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111420662|NCT00104884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111420663|NCT00104884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111420664|NCT00096174|Cisplatin|cisplatin|mesh-list
111420665|NCT00096174|Cetuximab|cetuximab|mesh-list
111420666|NCT00096174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111420667|NCT00096174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111420668|NCT00080938|Temozolomide|temozolomide|mesh-list
111420669|NCT00080938|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111420670|NCT00080938|Alkylating Agents|alkylating agents|mesh-ancestor
111420671|NCT00080938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111420672|NCT00080938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111420673|NCT00074282|Cyclophosphamide|cyclophosphamide|mesh-list
111420674|NCT00074282|Rituximab|rituximab|mesh-list
111420675|NCT00074282|Alemtuzumab|alemtuzumab|mesh-list
111420676|NCT00074282|Pentostatin|pentostatin|mesh-list
111420677|NCT00074282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111420678|NCT00074282|Immunologic Factors|immunologic factors|mesh-ancestor
111420679|NCT00074282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111420680|NCT00074282|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111420681|NCT00074282|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111420682|NCT00074282|Alkylating Agents|alkylating agents|mesh-ancestor
111420683|NCT00074282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111420684|NCT00074282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111420685|NCT00074282|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111420686|NCT00074282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111420687|NCT00074282|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
111420688|NCT00074282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111420689|NCT00071981|Molgramostim|molgramostim|mesh-list
111420690|NCT00071981|Vaccines|vaccines|mesh-list
111420691|NCT00071981|Sargramostim|sargramostim|mesh-list
111420692|NCT00071981|Freund's Adjuvant|freund's adjuvant|mesh-list
111420693|NCT00071981|Immunologic Factors|immunologic factors|mesh-ancestor
111420694|NCT00071981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111420695|NCT00071981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111420696|NCT00071981|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111420697|NCT00070291|Cyclosporine|cyclosporine|mesh-list
111420698|NCT00070291|Cyclosporins|cyclosporins|mesh-list
111145083|NCT02462473|Olanzapine|olanzapine|mesh-list
111420699|NCT00070291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111420700|NCT00070291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111420701|NCT00070291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111420703|NCT00070291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111420704|NCT00070291|Antifungal Agents|antifungal agents|mesh-ancestor
111420705|NCT00070291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111420706|NCT00070291|Dermatologic Agents|dermatologic agents|mesh-ancestor
111420707|NCT00070291|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111420708|NCT00070291|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111420709|NCT00064350|Sorafenib|sorafenib|mesh-list
111420710|NCT00064350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111420711|NCT00064350|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111420712|NCT00064350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111420713|NCT00064350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111420714|NCT00060346|Prednisone|prednisone|mesh-list
111420715|NCT00060346|Cyclophosphamide|cyclophosphamide|mesh-list
111420716|NCT00060346|Rituximab|rituximab|mesh-list
111420717|NCT00060346|Doxorubicin|doxorubicin|mesh-list
111420718|NCT00060346|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111420719|NCT00060346|Vincristine|vincristine|mesh-list
111420720|NCT00060346|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111420721|NCT00060346|Immunologic Factors|immunologic factors|mesh-ancestor
111420722|NCT00060346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111420723|NCT00060346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111420724|NCT00060346|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111420725|NCT00060346|Alkylating Agents|alkylating agents|mesh-ancestor
111420726|NCT00060346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111420727|NCT00060346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111420728|NCT00060346|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111420729|NCT00060346|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111420730|NCT00060346|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111420731|NCT00060346|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111420732|NCT00060346|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111420733|NCT00060346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111420734|NCT00060346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111420735|NCT00060346|Glucocorticoids|glucocorticoids|mesh-ancestor
111420736|NCT00060346|Hormones|hormones|mesh-ancestor
111420737|NCT00060346|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111420738|NCT00060346|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111420739|NCT00060346|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111420740|NCT00060346|Tubulin Modulators|tubulin modulators|mesh-ancestor
111420741|NCT00060346|Antimitotic Agents|antimitotic agents|mesh-ancestor
111420742|NCT00060346|Mitosis Modulators|mitosis modulators|mesh-ancestor
111420743|NCT00057954|Cyclosporine|cyclosporine|mesh-list
111420744|NCT00057954|Mycophenolic Acid|mycophenolic acid|mesh-list
111420745|NCT00057954|Methotrexate|methotrexate|mesh-list
111420746|NCT00057954|Pentostatin|pentostatin|mesh-list
111420747|NCT00057954|Cyclosporins|cyclosporins|mesh-list
111420748|NCT00057954|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111420749|NCT00057954|Abortifacient Agents|abortifacient agents|mesh-ancestor
111420750|NCT00057954|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111420751|NCT00057954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111420752|NCT00057954|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111420753|NCT00057954|Antimetabolites|antimetabolites|mesh-ancestor
111420754|NCT00057954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111420755|NCT00057954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111420756|NCT00057954|Dermatologic Agents|dermatologic agents|mesh-ancestor
111420757|NCT00057954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111420758|NCT00057954|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111420759|NCT00057954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111420760|NCT00057954|Immunologic Factors|immunologic factors|mesh-ancestor
111420761|NCT00057954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111420762|NCT00057954|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111420763|NCT00057954|Antifungal Agents|antifungal agents|mesh-ancestor
111420764|NCT00057954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111420765|NCT00057954|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111420766|NCT00057954|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111420767|NCT00057954|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111420768|NCT00057954|Antitubercular Agents|antitubercular agents|mesh-ancestor
111420769|NCT00057954|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111420770|NCT00057954|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
111420771|NCT00049530|Interferons|interferons|mesh-list
111420772|NCT00049530|Interferon-alpha|interferon-alpha|mesh-list
111420773|NCT00049530|Interferon alpha-2|interferon alpha-2|mesh-list
111420774|NCT00049530|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
111420776|NCT00049530|Antiviral Agents|antiviral agents|mesh-ancestor
111420777|NCT00049530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111420778|NCT00049530|Immunologic Factors|immunologic factors|mesh-ancestor
111420779|NCT00049530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111420780|NCT00045305|Cyclosporine|cyclosporine|mesh-list
111420781|NCT00045305|Mycophenolic Acid|mycophenolic acid|mesh-list
111420782|NCT00045305|Methotrexate|methotrexate|mesh-list
111420783|NCT00045305|Pentostatin|pentostatin|mesh-list
111420784|NCT00045305|Methoxsalen|methoxsalen|mesh-list
111420785|NCT00045305|Cyclosporins|cyclosporins|mesh-list
111420786|NCT00045305|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111420787|NCT00045305|Abortifacient Agents|abortifacient agents|mesh-ancestor
110510705|NCT04114500|Estradiol|estradiol|mesh-list
111420788|NCT00045305|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111420789|NCT00045305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111420790|NCT00045305|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111420791|NCT00045305|Antimetabolites|antimetabolites|mesh-ancestor
111420792|NCT00045305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111420793|NCT00045305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111420794|NCT00045305|Dermatologic Agents|dermatologic agents|mesh-ancestor
111420795|NCT00045305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111420796|NCT00045305|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111420797|NCT00045305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111420798|NCT00045305|Immunologic Factors|immunologic factors|mesh-ancestor
111420799|NCT00045305|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111420800|NCT00045305|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111420801|NCT00045305|Antifungal Agents|antifungal agents|mesh-ancestor
111420802|NCT00045305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111420803|NCT00045305|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111420804|NCT00045305|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111420805|NCT00045305|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111420806|NCT00045305|Antitubercular Agents|antitubercular agents|mesh-ancestor
111420807|NCT00045305|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111420808|NCT00045305|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
111420809|NCT00045305|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111420810|NCT00033657|Paclitaxel|paclitaxel|mesh-list
111420811|NCT00033657|Camptothecin|camptothecin|mesh-list
111420812|NCT00033657|Cisplatin|cisplatin|mesh-list
111420813|NCT00033657|Irinotecan|irinotecan|mesh-list
111420814|NCT00033657|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111420815|NCT00033657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111420816|NCT00033657|Tubulin Modulators|tubulin modulators|mesh-ancestor
111420817|NCT00033657|Antimitotic Agents|antimitotic agents|mesh-ancestor
111420818|NCT00033657|Mitosis Modulators|mitosis modulators|mesh-ancestor
111420819|NCT00033657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111420820|NCT00033657|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111420821|NCT00033657|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111420822|NCT00033657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111420823|NCT00003389|Prednisone|prednisone|mesh-list
111420824|NCT00003389|Cyclophosphamide|cyclophosphamide|mesh-list
111420825|NCT00003389|Dacarbazine|dacarbazine|mesh-list
111420826|NCT00003389|Mechlorethamine|mechlorethamine|mesh-list
111420827|NCT00003389|Doxorubicin|doxorubicin|mesh-list
111420828|NCT00003389|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111420829|NCT00003389|Etoposide|etoposide|mesh-list
111420830|NCT00003389|Vincristine|vincristine|mesh-list
111420831|NCT00003389|Etoposide phosphate|etoposide phosphate|mesh-list
111420832|NCT00003389|Bleomycin|bleomycin|mesh-list
111420833|NCT00003389|Vinblastine|vinblastine|mesh-list
111420834|NCT00003389|Podophyllotoxin|podophyllotoxin|mesh-list
111420835|NCT00003389|Imidazole|imidazole|mesh-list
111420836|NCT00003389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111420837|NCT00003389|Immunologic Factors|immunologic factors|mesh-ancestor
111420838|NCT00003389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111420839|NCT00003389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111420840|NCT00003389|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111420841|NCT00003389|Alkylating Agents|alkylating agents|mesh-ancestor
111420842|NCT00003389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111420843|NCT00003389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111420844|NCT00003389|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111420845|NCT00003389|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111420846|NCT00003389|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111145232|NCT02438371|Tocolytic Agents|tocolytic agents|mesh-ancestor
111420847|NCT00003389|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111420848|NCT00003389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111420849|NCT00003389|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111420850|NCT00003389|Glucocorticoids|glucocorticoids|mesh-ancestor
111420851|NCT00003389|Hormones|hormones|mesh-ancestor
111420852|NCT00003389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111420853|NCT00003389|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111420854|NCT00003389|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111420855|NCT00003389|Tubulin Modulators|tubulin modulators|mesh-ancestor
111420856|NCT00003389|Antimitotic Agents|antimitotic agents|mesh-ancestor
111420857|NCT00003389|Mitosis Modulators|mitosis modulators|mesh-ancestor
111420858|NCT00003389|Keratolytic Agents|keratolytic agents|mesh-ancestor
111420859|NCT00003389|Dermatologic Agents|dermatologic agents|mesh-ancestor
111420860|NCT00003138|Epoetin Alfa|epoetin alfa|mesh-list
111420861|NCT00003138|Lenograstim|lenograstim|mesh-list
111420862|NCT00003138|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111420863|NCT00003138|Immunologic Factors|immunologic factors|mesh-ancestor
111420864|NCT00003138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111420865|NCT00003138|Hematinics|hematinics|mesh-ancestor
111420866|NCT00002525|Leucovorin|leucovorin|mesh-list
111420867|NCT00002525|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
111420868|NCT00002525|Tetrahydrofolates|tetrahydrofolates|mesh-list
111420869|NCT00002525|Fluorouracil|fluorouracil|mesh-list
111420870|NCT00002525|Calcium|calcium|mesh-list
111420871|NCT00002525|Levoleucovorin|levoleucovorin|mesh-list
111420872|NCT00002525|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111420873|NCT00002525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111420874|NCT00002525|Antimetabolites|antimetabolites|mesh-ancestor
111420875|NCT00002525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111420876|NCT00002525|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111420877|NCT00002525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111420878|NCT00002525|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111420879|NCT00002525|Immunologic Factors|immunologic factors|mesh-ancestor
111420880|NCT00002525|Antidotes|antidotes|mesh-ancestor
111420881|NCT00002525|Protective Agents|protective agents|mesh-ancestor
111420882|NCT00002525|Vitamin B Complex|vitamin b complex|mesh-ancestor
111420883|NCT00002525|Vitamins|vitamins|mesh-ancestor
111420884|NCT00002525|Micronutrients|micronutrients|mesh-ancestor
111420885|NCT05475522|Aminolevulinic Acid|aminolevulinic acid|mesh-list
111420886|NCT05475522|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111420887|NCT05475522|Dermatologic Agents|dermatologic agents|mesh-ancestor
111420888|NCT02259348|Aldesleukin|aldesleukin|mesh-list
111420889|NCT02259348|Cyclophosphamide|cyclophosphamide|mesh-list
111420890|NCT02259348|Melphalan|melphalan|mesh-list
111420891|NCT02259348|Mechlorethamine|mechlorethamine|mesh-list
111420892|NCT02259348|Thiotepa|thiotepa|mesh-list
111420893|NCT02259348|Rituximab|rituximab|mesh-list
111420894|NCT02259348|Fludarabine|fludarabine|mesh-list
111420895|NCT02259348|Fludarabine phosphate|fludarabine phosphate|mesh-list
111420896|NCT02259348|Interleukin-2|interleukin-2|mesh-list
111420897|NCT02259348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111420898|NCT02259348|Immunologic Factors|immunologic factors|mesh-ancestor
111420899|NCT02259348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111420900|NCT02259348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111420901|NCT02259348|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111420902|NCT02259348|Alkylating Agents|alkylating agents|mesh-ancestor
111420903|NCT02259348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111420904|NCT02259348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111420905|NCT02259348|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111420906|NCT02259348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111420907|NCT02259348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111420908|NCT02259348|Antimetabolites|antimetabolites|mesh-ancestor
111420909|NCT02259348|Antiviral Agents|antiviral agents|mesh-ancestor
111420910|NCT02259348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111420911|NCT02259348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111420912|NCT02259348|Analgesics|analgesics|mesh-ancestor
111420913|NCT02259348|Sensory System Agents|sensory system agents|mesh-ancestor
111420914|NCT02259348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111420915|NCT02259348|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111420916|NCT02259348|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111420917|NCT00357019|Isospaglumic acid|isospaglumic acid|mesh-list
111420918|NCT00357019|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111420919|NCT00357019|Autonomic Agents|autonomic agents|mesh-ancestor
111420920|NCT00357019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111420921|NCT00357019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111420922|NCT00357019|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111420923|NCT00357019|Respiratory System Agents|respiratory system agents|mesh-ancestor
111420924|NCT00357019|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111420925|NCT00357019|Histamine Antagonists|histamine antagonists|mesh-ancestor
111420926|NCT00357019|Histamine Agents|histamine agents|mesh-ancestor
111145306|NCT02265237|Antimetabolites|antimetabolites|mesh-ancestor
111420927|NCT00357019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110510714|NCT05755659|Antiemetics|antiemetics|mesh-ancestor
111420928|NCT00357019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111420930|NCT00357019|Protective Agents|protective agents|mesh-ancestor
111420931|NCT00357019|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111420932|NCT03994705|Cyclophosphamide|cyclophosphamide|mesh-list
111420933|NCT03994705|Fludarabine|fludarabine|mesh-list
111420934|NCT03994705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111420935|NCT03994705|Immunologic Factors|immunologic factors|mesh-ancestor
111420936|NCT03994705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111420937|NCT03994705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111420938|NCT03994705|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111420939|NCT03994705|Alkylating Agents|alkylating agents|mesh-ancestor
111420940|NCT03994705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111420941|NCT03994705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111420942|NCT03994705|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111420943|NCT03587207|Vaccines|vaccines|mesh-list
111420944|NCT03587207|Immunologic Factors|immunologic factors|mesh-ancestor
111420945|NCT03587207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111420946|NCT03592121|Phenylephrine|phenylephrine|mesh-list
111420947|NCT03592121|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111420948|NCT03592121|Mydriatics|mydriatics|mesh-ancestor
111420949|NCT03592121|Autonomic Agents|autonomic agents|mesh-ancestor
111420950|NCT03592121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111420951|NCT03592121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111420952|NCT03592121|Sympathomimetics|sympathomimetics|mesh-ancestor
111420953|NCT03592121|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111420954|NCT03592121|Nasal Decongestants|nasal decongestants|mesh-ancestor
111420955|NCT03592121|Respiratory System Agents|respiratory system agents|mesh-ancestor
111420956|NCT03592121|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111420957|NCT03592121|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111420958|NCT03592121|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111420959|NCT03592121|Adrenergic Agents|adrenergic agents|mesh-ancestor
111420960|NCT03592121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111420961|NCT03592121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111420962|NCT03592121|Protective Agents|protective agents|mesh-ancestor
111420963|NCT04332809|Gentamicins|gentamicins|mesh-list
111420964|NCT04332809|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111420965|NCT04332809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111420966|NCT04332809|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111420967|NCT04332809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111420968|NCT04332809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111420969|NCT03596723|Prednisolone|prednisolone|mesh-list
111420970|NCT03596723|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111420971|NCT03596723|Methylprednisolone|methylprednisolone|mesh-list
111420972|NCT03596723|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111420973|NCT03596723|Prednisolone acetate|prednisolone acetate|mesh-list
111420974|NCT03596723|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111420975|NCT03596723|Prednisolone phosphate|prednisolone phosphate|mesh-list
111420976|NCT03596723|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111420977|NCT03596723|Glucocorticoids|glucocorticoids|mesh-ancestor
111420978|NCT03596723|Hormones|hormones|mesh-ancestor
111420979|NCT03596723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111420980|NCT03596723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111420981|NCT03596723|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111420982|NCT03596723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111420983|NCT03596723|Antiemetics|antiemetics|mesh-ancestor
111420984|NCT03596723|Autonomic Agents|autonomic agents|mesh-ancestor
111420985|NCT03596723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111420986|NCT03596723|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111420987|NCT03596723|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111420988|NCT03596723|Protective Agents|protective agents|mesh-ancestor
111420989|NCT03463889|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
111420990|NCT03463889|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111420991|NCT03463889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111420992|NCT03472469|Acetaminophen|acetaminophen|mesh-list
111420993|NCT03472469|Ketorolac|ketorolac|mesh-list
111420994|NCT03472469|Naproxen|naproxen|mesh-list
111420995|NCT03472469|Celecoxib|celecoxib|mesh-list
111420996|NCT03472469|Lidocaine|lidocaine|mesh-list
111420997|NCT03472469|Pregabalin|pregabalin|mesh-list
111420998|NCT03472469|Gabapentin|gabapentin|mesh-list
111420999|NCT03472469|Tramadol|tramadol|mesh-list
111421000|NCT03472469|Anesthetics, Local|anesthetics, local|mesh-ancestor
111145390|NCT02256267|Rifampin|rifampin|mesh-list
111421001|NCT03472469|Anesthetics|anesthetics|mesh-ancestor
111421002|NCT03472469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111421003|NCT03472469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111421004|NCT03472469|Sensory System Agents|sensory system agents|mesh-ancestor
111421005|NCT03472469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111421006|NCT03472469|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111421007|NCT03472469|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111421008|NCT03472469|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111421009|NCT03472469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111421010|NCT03472469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111421011|NCT03472469|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111421013|NCT03472469|Antipyretics|antipyretics|mesh-ancestor
111421014|NCT03472469|Anticonvulsants|anticonvulsants|mesh-ancestor
111421015|NCT03472469|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111421016|NCT03472469|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111421017|NCT03472469|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111421018|NCT03472469|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111421019|NCT03472469|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111421020|NCT03472469|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111421021|NCT03472469|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111421022|NCT03472469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111421023|NCT03472469|Antimanic Agents|antimanic agents|mesh-ancestor
111421024|NCT03472469|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111421025|NCT03472469|Narcotics|narcotics|mesh-ancestor
111421026|NCT03472469|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111421027|NCT03472469|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111421028|NCT03472469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111421029|NCT03472469|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111421030|NCT03472469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111421031|NCT03472469|Gout Suppressants|gout suppressants|mesh-ancestor
111421032|NCT03472469|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111421033|NCT04926233|Bromides|bromides|mesh-list
111421034|NCT04926233|Tiotropium Bromide|tiotropium bromide|mesh-list
111421035|NCT04926233|Olodaterol|olodaterol|mesh-list
111421036|NCT04926233|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111421037|NCT04926233|Autonomic Agents|autonomic agents|mesh-ancestor
111421038|NCT04926233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111421039|NCT04926233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111421040|NCT04926233|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111421041|NCT04926233|Respiratory System Agents|respiratory system agents|mesh-ancestor
111421042|NCT04926233|Parasympatholytics|parasympatholytics|mesh-ancestor
111421043|NCT04926233|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111421044|NCT04926233|Cholinergic Agents|cholinergic agents|mesh-ancestor
111421045|NCT04926233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111421046|NCT04926233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111421047|NCT04926233|Anticonvulsants|anticonvulsants|mesh-ancestor
111421048|NCT04943159|Afamelanotide|afamelanotide|mesh-list
111421049|NCT04943159|Dermatologic Agents|dermatologic agents|mesh-ancestor
111421050|NCT04734665|Bevacizumab|bevacizumab|mesh-list
111421051|NCT04734665|Niraparib|niraparib|mesh-list
111421052|NCT04734665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111421053|NCT04734665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111421054|NCT04734665|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111421055|NCT04734665|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111421056|NCT04734665|Growth Substances|growth substances|mesh-ancestor
111421057|NCT04734665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111421058|NCT04734665|Growth Inhibitors|growth inhibitors|mesh-ancestor
111421059|NCT04734665|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111421060|NCT04734665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111421061|NCT04734665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111421062|NCT02258334|Vaccines|vaccines|mesh-list
111421063|NCT02258334|Immunologic Factors|immunologic factors|mesh-ancestor
111421064|NCT02258334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111421065|NCT03478163|Clindamycin|clindamycin|mesh-list
111421066|NCT03478163|Clindamycin palmitate|clindamycin palmitate|mesh-list
111421067|NCT03478163|Clindamycin phosphate|clindamycin phosphate|mesh-list
111421068|NCT03478163|Cefazolin|cefazolin|mesh-list
111421069|NCT03478163|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111421070|NCT03478163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111421071|NCT03478163|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111421072|NCT03478163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111421073|NCT03478163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111421074|NCT05646810|Lidocaine|lidocaine|mesh-list
111421075|NCT05646810|Anesthetics, Local|anesthetics, local|mesh-ancestor
111421076|NCT05646810|Anesthetics|anesthetics|mesh-ancestor
111421077|NCT05646810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111421078|NCT05646810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111421079|NCT05646810|Sensory System Agents|sensory system agents|mesh-ancestor
111421080|NCT05646810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111421081|NCT05646810|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111421082|NCT05646810|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111421083|NCT05646810|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111421084|NCT05646810|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111421085|NCT05646810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111421086|NCT04960202|Ritonavir|ritonavir|mesh-list
111421087|NCT04960202|Nirmatrelvir|nirmatrelvir|mesh-list
111421088|NCT04960202|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111421089|NCT04960202|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111421090|NCT04960202|Protease Inhibitors|protease inhibitors|mesh-ancestor
111421091|NCT04960202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111421092|NCT04960202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111421093|NCT04960202|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111421094|NCT04960202|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111421095|NCT04960202|Antiviral Agents|antiviral agents|mesh-ancestor
111421096|NCT04960202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111421097|NCT04960202|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111421098|NCT04960202|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111421099|NCT02959112|Indomethacin|indomethacin|mesh-list
111421100|NCT02959112|Epinephrine|epinephrine|mesh-list
111421101|NCT02959112|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111421102|NCT02959112|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111421103|NCT02959112|Adrenergic Agents|adrenergic agents|mesh-ancestor
111421104|NCT02959112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111421105|NCT02959112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111421106|NCT02959112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111421107|NCT02959112|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111421108|NCT02959112|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111421109|NCT02959112|Autonomic Agents|autonomic agents|mesh-ancestor
111421110|NCT02959112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111421111|NCT02959112|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111421112|NCT02959112|Respiratory System Agents|respiratory system agents|mesh-ancestor
111421113|NCT02959112|Mydriatics|mydriatics|mesh-ancestor
111421114|NCT02959112|Sympathomimetics|sympathomimetics|mesh-ancestor
111421115|NCT02959112|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111421116|NCT02959112|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111421117|NCT02959112|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111421118|NCT02959112|Analgesics|analgesics|mesh-ancestor
111421119|NCT02959112|Sensory System Agents|sensory system agents|mesh-ancestor
111421120|NCT02959112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111421121|NCT02959112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111421122|NCT02959112|Gout Suppressants|gout suppressants|mesh-ancestor
111421123|NCT02959112|Tocolytic Agents|tocolytic agents|mesh-ancestor
111421124|NCT02959112|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111421125|NCT02959112|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111421126|NCT02959112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111421127|NCT05377034|Bevacizumab|bevacizumab|mesh-list
111421128|NCT05377034|Atezolizumab|atezolizumab|mesh-list
111421129|NCT05377034|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111421130|NCT05377034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111421131|NCT05377034|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111421132|NCT05377034|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111421133|NCT05377034|Growth Substances|growth substances|mesh-ancestor
111421134|NCT05377034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111421135|NCT05377034|Growth Inhibitors|growth inhibitors|mesh-ancestor
111421136|NCT05377034|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111421137|NCT05377034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111421138|NCT03622619|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111421139|NCT03622619|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111421140|NCT03622619|Lubricant Eye Drops|lubricant eye drops|mesh-list
111421141|NCT03622619|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111421142|NCT03622619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111421143|NCT04428359|Vitamin D|vitamin d|mesh-list
111421144|NCT04428359|Vitamins|vitamins|mesh-ancestor
111421145|NCT04428359|Micronutrients|micronutrients|mesh-ancestor
111421146|NCT04428359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111421147|NCT04428359|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111421148|NCT02257632|Ranibizumab|ranibizumab|mesh-list
111421149|NCT02257632|Aflibercept|aflibercept|mesh-list
111421150|NCT02257632|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111421151|NCT02257632|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111421152|NCT02257632|Growth Substances|growth substances|mesh-ancestor
111421153|NCT02257632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111421154|NCT02257632|Growth Inhibitors|growth inhibitors|mesh-ancestor
111421155|NCT02257632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111421156|NCT05436054|Picosulfate sodium|picosulfate sodium|mesh-list
111421157|NCT05436054|Cathartics|cathartics|mesh-ancestor
111421158|NCT05436054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111421159|NCT01642914|Linaclotide|linaclotide|mesh-list
111421160|NCT01642914|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
111421161|NCT01642914|Enzyme Activators|enzyme activators|mesh-ancestor
111421162|NCT01642914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111421163|NCT01642914|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111421164|NCT04486352|Bevacizumab|bevacizumab|mesh-list
111421165|NCT04486352|Trastuzumab|trastuzumab|mesh-list
111421166|NCT04486352|Atezolizumab|atezolizumab|mesh-list
111421167|NCT04486352|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
111421168|NCT04486352|Letrozole|letrozole|mesh-list
111421169|NCT04486352|Maytansine|maytansine|mesh-list
111421170|NCT04486352|Talazoparib|talazoparib|mesh-list
111421171|NCT04486352|Ipatasertib|ipatasertib|mesh-list
111421172|NCT04486352|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111421173|NCT04486352|Inavolisib|inavolisib|mesh-list
111421174|NCT04486352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111421175|NCT04486352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111421176|NCT04486352|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111421177|NCT04486352|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111421178|NCT04486352|Growth Substances|growth substances|mesh-ancestor
111421179|NCT04486352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111421180|NCT04486352|Growth Inhibitors|growth inhibitors|mesh-ancestor
111421181|NCT04486352|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111421182|NCT04486352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111421183|NCT04486352|Immunologic Factors|immunologic factors|mesh-ancestor
111421184|NCT04486352|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111421185|NCT04486352|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111421186|NCT04486352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111421187|NCT04486352|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111421188|NCT04486352|Hormone Antagonists|hormone antagonists|mesh-ancestor
111421189|NCT04486352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111421190|NCT04486352|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111421191|NCT04486352|Tubulin Modulators|tubulin modulators|mesh-ancestor
111421192|NCT04486352|Antimitotic Agents|antimitotic agents|mesh-ancestor
111421193|NCT04486352|Mitosis Modulators|mitosis modulators|mesh-ancestor
111421194|NCT04486352|Immunotoxins|immunotoxins|mesh-ancestor
111421195|NCT04486352|Immunoconjugates|immunoconjugates|mesh-ancestor
111421196|NCT04486352|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111421197|NCT04486352|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111421198|NCT04486352|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
111421199|NCT01642602|Dexlansoprazole|dexlansoprazole|mesh-list
111421200|NCT01642602|Lansoprazole|lansoprazole|mesh-list
111421201|NCT01642602|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111421202|NCT01642602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111421203|NCT01642602|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111421204|NCT01642602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111421205|NCT01642602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111421206|NCT02256540|Resveratrol|resveratrol|mesh-list
111421207|NCT02256540|Estradiol|estradiol|mesh-list
111421208|NCT02256540|Estrogens|estrogens|mesh-ancestor
111421209|NCT02256540|Hormones|hormones|mesh-ancestor
111421210|NCT02256540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111421211|NCT02256540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111421212|NCT02256540|Antioxidants|antioxidants|mesh-ancestor
111421213|NCT02256540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111421214|NCT02256540|Protective Agents|protective agents|mesh-ancestor
111421215|NCT02256540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111421216|NCT02256540|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111421217|NCT05646264|Agomelatine|agomelatine|mesh-list
111421218|NCT05646264|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111421219|NCT05646264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111421220|NCT05646264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111421221|NCT01640184|Vitamin D|vitamin d|mesh-list
111421222|NCT01640184|Vitamins|vitamins|mesh-ancestor
111421223|NCT01640184|Micronutrients|micronutrients|mesh-ancestor
111421224|NCT01640184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111421225|NCT01640184|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111421226|NCT04904978|Listerine|listerine|mesh-list
111421227|NCT04904978|Sodium Fluoride|sodium fluoride|mesh-list
111421228|NCT04904978|Cariostatic Agents|cariostatic agents|mesh-ancestor
111145610|NCT04586985|Midazolam|midazolam|mesh-list
111421229|NCT04904978|Protective Agents|protective agents|mesh-ancestor
111421230|NCT04904978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111421231|NCT04904978|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111421232|NCT04904978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111421233|NCT03631433|Acetaminophen|acetaminophen|mesh-list
111421234|NCT03631433|Ibuprofen|ibuprofen|mesh-list
111421235|NCT03631433|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111421236|NCT03631433|Analgesics|analgesics|mesh-ancestor
111421237|NCT03631433|Sensory System Agents|sensory system agents|mesh-ancestor
111421238|NCT03631433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111421239|NCT03631433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111421240|NCT03631433|Antipyretics|antipyretics|mesh-ancestor
111421241|NCT03631433|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111421242|NCT03631433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111421243|NCT03631433|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111421244|NCT03631433|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111421245|NCT03631433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111421246|NCT03631433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111421247|NCT02973659|Oxybutynin|oxybutynin|mesh-list
111421248|NCT02973659|Parasympatholytics|parasympatholytics|mesh-ancestor
111421249|NCT02973659|Autonomic Agents|autonomic agents|mesh-ancestor
111421250|NCT02973659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111421251|NCT02973659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111421252|NCT02973659|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111421253|NCT02973659|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111421254|NCT02973659|Cholinergic Agents|cholinergic agents|mesh-ancestor
111421255|NCT02973659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111421256|NCT02973659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111421257|NCT02973659|Urological Agents|urological agents|mesh-ancestor
111421258|NCT04439396|Ketorolac|ketorolac|mesh-list
111421259|NCT04439396|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
111421260|NCT04439396|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111421261|NCT04439396|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111421262|NCT04439396|Analgesics|analgesics|mesh-ancestor
111421263|NCT04439396|Sensory System Agents|sensory system agents|mesh-ancestor
111421264|NCT04439396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111421265|NCT04439396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111421266|NCT04439396|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111421267|NCT04439396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111421268|NCT04439396|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111421269|NCT04439396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111421270|NCT04439396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111421271|NCT02255760|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111421272|NCT02255760|Immunologic Factors|immunologic factors|mesh-ancestor
111421273|NCT02255760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111421274|NCT00360464|Azithromycin|azithromycin|mesh-list
111421275|NCT00360464|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111421276|NCT00360464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111421277|NCT05651256|Botulinum Toxins|botulinum toxins|mesh-list
111421278|NCT05651256|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111421279|NCT05651256|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111421280|NCT05651256|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111421281|NCT05651256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111421282|NCT05651256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111421283|NCT05651256|Cholinergic Agents|cholinergic agents|mesh-ancestor
111421284|NCT05651256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111421285|NCT05651256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111421286|NCT05651256|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111421287|NCT05651256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111421288|NCT04297631|Tobramycin|tobramycin|mesh-list
111421289|NCT04297631|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111421290|NCT04297631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111421291|NCT04812470|Melphalan|melphalan|mesh-list
111421292|NCT04812470|Interleukin-2|interleukin-2|mesh-list
111421293|NCT04812470|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111421294|NCT04812470|Alkylating Agents|alkylating agents|mesh-ancestor
111421295|NCT04812470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111421296|NCT04812470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111421297|NCT04812470|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111421298|NCT04812470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111421299|NCT04812470|Immunologic Factors|immunologic factors|mesh-ancestor
111421300|NCT04812470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111421301|NCT04812470|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111421302|NCT04812470|Analgesics|analgesics|mesh-ancestor
111421303|NCT04812470|Sensory System Agents|sensory system agents|mesh-ancestor
111421304|NCT04812470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111421305|NCT02976194|Ranibizumab|ranibizumab|mesh-list
111421307|NCT02976194|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111421308|NCT02976194|Growth Substances|growth substances|mesh-ancestor
111421309|NCT02976194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111421310|NCT02976194|Growth Inhibitors|growth inhibitors|mesh-ancestor
111421311|NCT02976194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111421312|NCT00360776|Tipifarnib|tipifarnib|mesh-list
111421313|NCT00360776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111421314|NCT02976740|Immunologic Factors|immunologic factors|mesh-list
111421315|NCT02976740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111421316|NCT04342910|Paclitaxel|paclitaxel|mesh-list
111421317|NCT04342910|Irinotecan|irinotecan|mesh-list
111421318|NCT04342910|Apatinib|apatinib|mesh-list
111421319|NCT04342910|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111421320|NCT04342910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111421321|NCT04342910|Tubulin Modulators|tubulin modulators|mesh-ancestor
111421322|NCT04342910|Antimitotic Agents|antimitotic agents|mesh-ancestor
111421323|NCT04342910|Mitosis Modulators|mitosis modulators|mesh-ancestor
111421324|NCT04342910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111421325|NCT04342910|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111421326|NCT04342910|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111421327|NCT04342910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111421328|NCT04342910|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111421329|NCT04714073|Itraconazole|itraconazole|mesh-list
111421330|NCT04714073|Antifungal Agents|antifungal agents|mesh-ancestor
111421331|NCT04714073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111421332|NCT04714073|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111421333|NCT04714073|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111421334|NCT04714073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111421335|NCT04714073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111421336|NCT04714073|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111421337|NCT04714073|Hormone Antagonists|hormone antagonists|mesh-ancestor
111421338|NCT04714073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111421339|NCT04714073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111421340|NCT04714073|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111421341|NCT04342676|Panitumumab|panitumumab|mesh-list
111421342|NCT04342676|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111421343|NCT04342676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111421344|NCT01641822|Tobramycin|tobramycin|mesh-list
111421345|NCT01641822|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111421346|NCT01641822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111421347|NCT05364762|Cyclophosphamide|cyclophosphamide|mesh-list
111421348|NCT05364762|Tacrolimus|tacrolimus|mesh-list
111421349|NCT05364762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111421350|NCT05364762|Immunologic Factors|immunologic factors|mesh-ancestor
111421351|NCT05364762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111421352|NCT05364762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111421353|NCT05364762|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111421354|NCT05364762|Alkylating Agents|alkylating agents|mesh-ancestor
111421355|NCT05364762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111421356|NCT05364762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111421357|NCT05364762|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111421358|NCT05364762|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111421359|NCT05364762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111421360|NCT04871958|Insulin|insulin|mesh-list
111421361|NCT04871958|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111421362|NCT04871958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111421363|NCT04342598|Vitamin D|vitamin d|mesh-list
111421364|NCT04342598|Vitamins|vitamins|mesh-ancestor
111421365|NCT04342598|Micronutrients|micronutrients|mesh-ancestor
111421366|NCT04342598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111421367|NCT04342598|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111421368|NCT00360854|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111421369|NCT00360854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111421370|NCT00360854|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111421371|NCT00360854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111421372|NCT00360854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111421373|NCT05641818|Vitamin D|vitamin d|mesh-list
111421374|NCT05641818|Vitamins|vitamins|mesh-ancestor
111421375|NCT05641818|Micronutrients|micronutrients|mesh-ancestor
111421376|NCT05641818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111421377|NCT05641818|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111421378|NCT04762082|Tadalafil|tadalafil|mesh-list
111421379|NCT04762082|Vasodilator Agents|vasodilator agents|mesh-ancestor
111145752|NCT04254549|Rifaximin|rifaximin|mesh-list
111421380|NCT04762082|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111421381|NCT04762082|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111421382|NCT04762082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111421383|NCT04762082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111421384|NCT04762082|Urological Agents|urological agents|mesh-ancestor
111421385|NCT03514277|Bupivacaine|bupivacaine|mesh-list
111421386|NCT03514277|Anesthetics, Local|anesthetics, local|mesh-ancestor
111421387|NCT03514277|Anesthetics|anesthetics|mesh-ancestor
111421388|NCT03514277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111421389|NCT03514277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111421390|NCT03514277|Sensory System Agents|sensory system agents|mesh-ancestor
111421391|NCT03514277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111421393|NCT05334108|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111421394|NCT05334108|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111421395|NCT05334108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111421396|NCT05334108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111421397|NCT05334108|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111421398|NCT05334108|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111421399|NCT05334108|Dopamine Agents|dopamine agents|mesh-ancestor
111421400|NCT05334108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111421401|NCT05334108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111421402|NCT03984656|Lidocaine|lidocaine|mesh-list
111421403|NCT03984656|Anesthetics, Local|anesthetics, local|mesh-ancestor
111421404|NCT03984656|Anesthetics|anesthetics|mesh-ancestor
111421405|NCT03984656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111421406|NCT03984656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111421407|NCT03984656|Sensory System Agents|sensory system agents|mesh-ancestor
111421408|NCT03984656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111421409|NCT03984656|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111421410|NCT03984656|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111421411|NCT03984656|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111421412|NCT03984656|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111421413|NCT03984656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111421414|NCT05299944|Cannabidiol|cannabidiol|mesh-list
111421415|NCT05299944|Anticonvulsants|anticonvulsants|mesh-ancestor
111421416|NCT03655301|Metformin|metformin|mesh-list
111421417|NCT03655301|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111421418|NCT03655301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111421419|NCT04870866|Niacinamide|niacinamide|mesh-list
111421420|NCT04870866|Niacin|niacin|mesh-list
111421421|NCT04870866|Nicotinic Acids|nicotinic acids|mesh-list
111421422|NCT04870866|Vitamin B Complex|vitamin b complex|mesh-ancestor
111421423|NCT04870866|Vitamins|vitamins|mesh-ancestor
111421424|NCT04870866|Micronutrients|micronutrients|mesh-ancestor
111421425|NCT04870866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111421426|NCT04870866|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111421427|NCT04870866|Antimetabolites|antimetabolites|mesh-ancestor
111421428|NCT04870866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111421429|NCT04870866|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111421430|NCT04870866|Vasodilator Agents|vasodilator agents|mesh-ancestor
111421431|NCT03657407|Glycerol|glycerol|mesh-list
111421432|NCT03657407|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
111421433|NCT03657407|Protective Agents|protective agents|mesh-ancestor
111421434|NCT03657407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111421435|NCT01639560|Varenicline|varenicline|mesh-list
111421436|NCT01639560|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111421437|NCT01639560|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111421438|NCT01639560|Cholinergic Agents|cholinergic agents|mesh-ancestor
111421439|NCT01639560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111421440|NCT01639560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111421441|NCT01639560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111421442|NCT04243616|Paclitaxel|paclitaxel|mesh-list
111421443|NCT04243616|Cyclophosphamide|cyclophosphamide|mesh-list
111421444|NCT04243616|Carboplatin|carboplatin|mesh-list
111421445|NCT04243616|Doxorubicin|doxorubicin|mesh-list
111421446|NCT04243616|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111421447|NCT04243616|Cemiplimab|cemiplimab|mesh-list
111421448|NCT04243616|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111421449|NCT04243616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111421450|NCT04243616|Tubulin Modulators|tubulin modulators|mesh-ancestor
111421451|NCT04243616|Antimitotic Agents|antimitotic agents|mesh-ancestor
111421452|NCT04243616|Mitosis Modulators|mitosis modulators|mesh-ancestor
111421453|NCT04243616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111421454|NCT04243616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111421455|NCT04243616|Immunologic Factors|immunologic factors|mesh-ancestor
111421456|NCT04243616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111421457|NCT04243616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111421458|NCT04243616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111421459|NCT04243616|Alkylating Agents|alkylating agents|mesh-ancestor
111421460|NCT04243616|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111421461|NCT04243616|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111421462|NCT04243616|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111421463|NCT04243616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111421464|NCT04243616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111421465|NCT04243616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111421466|NCT03954314|Tranexamic Acid|tranexamic acid|mesh-list
111421467|NCT03954314|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111421468|NCT03954314|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111421469|NCT03954314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111421470|NCT03954314|Hemostatics|hemostatics|mesh-ancestor
111421471|NCT03954314|Coagulants|coagulants|mesh-ancestor
111421472|NCT03952130|Insulin|insulin|mesh-list
111421473|NCT03952130|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111421474|NCT03952130|Insulin Glargine|insulin glargine|mesh-list
111421475|NCT03952130|Insulin Lispro|insulin lispro|mesh-list
111421476|NCT03952130|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111421477|NCT03952130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111421478|NCT03661541|Squaric acid dibutyl ester|squaric acid dibutyl ester|mesh-list
111421479|NCT03661541|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111421480|NCT03661541|Immunologic Factors|immunologic factors|mesh-ancestor
111421481|NCT03661541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111421482|NCT03925532|Denosumab|denosumab|mesh-list
111421483|NCT03925532|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111421484|NCT03925532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111421485|NCT01640964|Terlipressin|terlipressin|mesh-list
111421486|NCT01640964|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111421487|NCT01640964|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111421488|NCT03663101|Lidocaine|lidocaine|mesh-list
111421489|NCT03663101|Botulinum Toxins|botulinum toxins|mesh-list
111421490|NCT03663101|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111421491|NCT03663101|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111421492|NCT03663101|Anesthetics, Local|anesthetics, local|mesh-ancestor
111421493|NCT03663101|Anesthetics|anesthetics|mesh-ancestor
111421494|NCT03663101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111421495|NCT03663101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111421496|NCT03663101|Sensory System Agents|sensory system agents|mesh-ancestor
111421497|NCT03663101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111421498|NCT03663101|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111421499|NCT03663101|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111421500|NCT03663101|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111421501|NCT03663101|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111421502|NCT03663101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111421503|NCT03663101|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111421504|NCT03663101|Cholinergic Agents|cholinergic agents|mesh-ancestor
111421505|NCT03663101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111421506|NCT03663101|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111421507|NCT05430048|Bisoprolol|bisoprolol|mesh-list
111421508|NCT05430048|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
111421509|NCT05430048|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111421510|NCT05430048|Sympatholytics|sympatholytics|mesh-ancestor
111421511|NCT05430048|Autonomic Agents|autonomic agents|mesh-ancestor
111421512|NCT05430048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111421513|NCT05430048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111421514|NCT05430048|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
111421515|NCT05430048|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111421516|NCT05430048|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111421517|NCT05430048|Adrenergic Agents|adrenergic agents|mesh-ancestor
111421518|NCT05430048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111421519|NCT05430048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111421520|NCT05430048|Hemostatics|hemostatics|mesh-ancestor
111421521|NCT05430048|Coagulants|coagulants|mesh-ancestor
111421522|NCT05430048|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
111421523|NCT05430048|Natriuretic Agents|natriuretic agents|mesh-ancestor
111421524|NCT02975570|Levofloxacin|levofloxacin|mesh-list
111421525|NCT02975570|Linezolid|linezolid|mesh-list
111421526|NCT02975570|Pyrazinamide|pyrazinamide|mesh-list
111421527|NCT02975570|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111421528|NCT02975570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111421529|NCT02975570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111421530|NCT02975570|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111421531|NCT02975570|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111421532|NCT02975570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111421533|NCT02975570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111421534|NCT02975570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111421535|NCT02975570|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111421536|NCT02975570|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111421537|NCT02975570|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111421538|NCT02975570|Antitubercular Agents|antitubercular agents|mesh-ancestor
111421539|NCT04184999|Dexamethasone|dexamethasone|mesh-list
111421540|NCT04184999|Prednisolone|prednisolone|mesh-list
111421541|NCT04184999|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111421542|NCT04184999|Methylprednisolone|methylprednisolone|mesh-list
111421543|NCT04184999|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111421544|NCT04184999|Prednisolone acetate|prednisolone acetate|mesh-list
111421545|NCT04184999|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111421546|NCT04184999|Prednisolone phosphate|prednisolone phosphate|mesh-list
111421547|NCT04184999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111421548|NCT04184999|Antiemetics|antiemetics|mesh-ancestor
111421549|NCT04184999|Autonomic Agents|autonomic agents|mesh-ancestor
111421550|NCT04184999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111421551|NCT04184999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111421552|NCT04184999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111421553|NCT04184999|Glucocorticoids|glucocorticoids|mesh-ancestor
111421554|NCT04184999|Hormones|hormones|mesh-ancestor
111421555|NCT04184999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111421556|NCT04184999|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111421557|NCT04184999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111421558|NCT04184999|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111421559|NCT04184999|Protective Agents|protective agents|mesh-ancestor
111421560|NCT03524339|Tamsulosin|tamsulosin|mesh-list
111421561|NCT03524339|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111421562|NCT03524339|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111421563|NCT03524339|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111421564|NCT03524339|Adrenergic Agents|adrenergic agents|mesh-ancestor
111421565|NCT03524339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111421566|NCT03524339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111421567|NCT03524339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111421568|NCT03524339|Urological Agents|urological agents|mesh-ancestor
111421569|NCT03667547|Raltegravir Potassium|raltegravir potassium|mesh-list
111421570|NCT03667547|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111421571|NCT03667547|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111421572|NCT03667547|Antiviral Agents|antiviral agents|mesh-ancestor
111421573|NCT03667547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111421574|NCT03667547|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111421575|NCT03667547|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111421576|NCT03667547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111421577|NCT03667547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111421578|NCT00361010|Levetiracetam|levetiracetam|mesh-list
111421579|NCT00361010|Anticonvulsants|anticonvulsants|mesh-ancestor
111421580|NCT00361010|Nootropic Agents|nootropic agents|mesh-ancestor
111421581|NCT00361088|Bortezomib|bortezomib|mesh-list
111421582|NCT00361088|Tipifarnib|tipifarnib|mesh-list
111421583|NCT00361088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111421584|NCT04172402|Gemcitabine|gemcitabine|mesh-list
111421585|NCT04172402|Nivolumab|nivolumab|mesh-list
111421586|NCT04172402|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111421587|NCT04172402|Antimetabolites|antimetabolites|mesh-ancestor
111421588|NCT04172402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111421589|NCT04172402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111421590|NCT04172402|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111421591|NCT04172402|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111421592|NCT04662242|Selenium|selenium|mesh-list
111421593|NCT04662242|Antioxidants|antioxidants|mesh-ancestor
111421594|NCT04662242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111421595|NCT04662242|Protective Agents|protective agents|mesh-ancestor
111421596|NCT04662242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111421597|NCT04662242|Trace Elements|trace elements|mesh-ancestor
111421598|NCT04662242|Micronutrients|micronutrients|mesh-ancestor
111421599|NCT04160546|Aspirin|aspirin|mesh-list
111421600|NCT04160546|Ponatinib|ponatinib|mesh-list
111421601|NCT04160546|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111421602|NCT04160546|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111421603|NCT04160546|Analgesics|analgesics|mesh-ancestor
111421604|NCT04160546|Sensory System Agents|sensory system agents|mesh-ancestor
111421605|NCT04160546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111421606|NCT04160546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111421607|NCT04160546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111421608|NCT04160546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111421609|NCT04160546|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111421610|NCT04160546|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111421611|NCT04160546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111421612|NCT04160546|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111421613|NCT04160546|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111421614|NCT04160546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111421615|NCT04160546|Antipyretics|antipyretics|mesh-ancestor
111421616|NCT04160546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111421617|NCT04160546|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111421618|NCT03675581|Nintedanib|nintedanib|mesh-list
111421619|NCT03675581|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
111421620|NCT03675581|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
111421621|NCT03675581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111421622|NCT03675581|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111421623|NCT03675581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111421624|NCT03675581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111421625|NCT03675581|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111421626|NCT03675581|Contraceptive Agents|contraceptive agents|mesh-ancestor
111421627|NCT03675581|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111421628|NCT03675581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111421629|NCT03675581|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
111421630|NCT03675581|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111421631|NCT03675581|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111421632|NCT03675581|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111421633|NCT03675581|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111421634|NCT03675581|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
111421635|NCT03675581|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
111421636|NCT03675581|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
111421637|NCT05142228|Erenumab|erenumab|mesh-list
111421638|NCT05142228|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
111421639|NCT05142228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111421640|NCT05142228|Analgesics|analgesics|mesh-ancestor
111421641|NCT05142228|Sensory System Agents|sensory system agents|mesh-ancestor
111421642|NCT05142228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111421643|NCT05142228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111421644|NCT00362102|Cetuximab|cetuximab|mesh-list
111421645|NCT00362102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111421646|NCT00362102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111421647|NCT05122026|Isoniazid|isoniazid|mesh-list
111421648|NCT05122026|Rifapentine|rifapentine|mesh-list
111421649|NCT05122026|Antitubercular Agents|antitubercular agents|mesh-ancestor
111421650|NCT05122026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111421651|NCT05122026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111421652|NCT05122026|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
111421653|NCT05122026|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111421654|NCT05122026|Antimetabolites|antimetabolites|mesh-ancestor
111421655|NCT05122026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111421656|NCT05122026|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111421657|NCT05122026|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111421658|NCT05122026|Leprostatic Agents|leprostatic agents|mesh-ancestor
111421659|NCT02958878|Tamsulosin|tamsulosin|mesh-list
111421660|NCT02958878|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111421661|NCT02958878|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111421662|NCT02958878|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111421663|NCT02958878|Adrenergic Agents|adrenergic agents|mesh-ancestor
111421664|NCT02958878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111421665|NCT02958878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111421666|NCT02958878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111421667|NCT02958878|Urological Agents|urological agents|mesh-ancestor
111421668|NCT02976116|Gefitinib|gefitinib|mesh-list
111421669|NCT02976116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111421670|NCT02976116|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111421671|NCT02976116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111421672|NCT02976116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111421673|NCT01600716|Botulinum Toxins|botulinum toxins|mesh-list
111421674|NCT01600716|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111421675|NCT01600716|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111421676|NCT01600716|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111421677|NCT01600716|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111421678|NCT01600716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111421679|NCT01600716|Cholinergic Agents|cholinergic agents|mesh-ancestor
111421680|NCT01600716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111421681|NCT01600716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111421682|NCT01600716|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111421683|NCT01600716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111421684|NCT02975258|Nitric Oxide|nitric oxide|mesh-list
111421685|NCT02975258|Methacholine Chloride|methacholine chloride|mesh-list
111421686|NCT02975258|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111421687|NCT02975258|Autonomic Agents|autonomic agents|mesh-ancestor
111421688|NCT02975258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111421689|NCT02975258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111421690|NCT02975258|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111421691|NCT02975258|Respiratory System Agents|respiratory system agents|mesh-ancestor
111421692|NCT02975258|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111421693|NCT02975258|Antioxidants|antioxidants|mesh-ancestor
111421694|NCT02975258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111421695|NCT02975258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111421696|NCT02975258|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
111421697|NCT02975258|Vasodilator Agents|vasodilator agents|mesh-ancestor
111421698|NCT02975258|Gasotransmitters|gasotransmitters|mesh-ancestor
111421699|NCT02975258|Protective Agents|protective agents|mesh-ancestor
111421700|NCT02975258|Miotics|miotics|mesh-ancestor
111421701|NCT02975258|Parasympathomimetics|parasympathomimetics|mesh-ancestor
111421702|NCT02975258|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
111421703|NCT02975258|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
111421704|NCT02975258|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111421705|NCT02975258|Cholinergic Agents|cholinergic agents|mesh-ancestor
111421706|NCT04844814|Prednisone|prednisone|mesh-list
111421707|NCT04844814|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
111421708|NCT04844814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111421709|NCT04844814|Glucocorticoids|glucocorticoids|mesh-ancestor
111421710|NCT04844814|Hormones|hormones|mesh-ancestor
111421711|NCT04844814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111421712|NCT04844814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111421713|NCT04844814|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111421714|NCT04844814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111421715|NCT04844814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111421716|NCT02975102|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111421717|NCT02975102|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111421718|NCT04833114|Carboplatin|carboplatin|mesh-list
111421719|NCT04833114|Etoposide|etoposide|mesh-list
111421720|NCT04833114|Rituximab|rituximab|mesh-list
111421721|NCT04833114|Ifosfamide|ifosfamide|mesh-list
111421722|NCT04833114|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
111421723|NCT04833114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111421724|NCT04833114|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111421725|NCT04833114|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111421726|NCT04833114|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111421727|NCT04833114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111421728|NCT04833114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111421729|NCT04833114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111421730|NCT04833114|Immunologic Factors|immunologic factors|mesh-ancestor
111421731|NCT04833114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111421732|NCT04833114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111421733|NCT04833114|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111421734|NCT04833114|Alkylating Agents|alkylating agents|mesh-ancestor
111421735|NCT04833114|Immunoconjugates|immunoconjugates|mesh-ancestor
111421736|NCT00376883|Pamidronate|pamidronate|mesh-list
111421737|NCT00376883|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111421738|NCT00376883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111421739|NCT05314673|Bevacizumab|bevacizumab|mesh-list
111421740|NCT05314673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111421741|NCT05314673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111421742|NCT05314673|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111421743|NCT05314673|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111421744|NCT05314673|Growth Substances|growth substances|mesh-ancestor
111421745|NCT05314673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111421746|NCT05314673|Growth Inhibitors|growth inhibitors|mesh-ancestor
111421747|NCT04112069|Insulin Lispro|insulin lispro|mesh-list
111421748|NCT04112069|Insulin Aspart|insulin aspart|mesh-list
111421749|NCT04112069|Pancrelipase|pancrelipase|mesh-list
111421750|NCT04112069|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111421751|NCT04112069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111421752|NCT04112069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111421753|NCT04098575|Empagliflozin|empagliflozin|mesh-list
111421754|NCT04098575|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111421755|NCT04098575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111421756|NCT04098575|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111421757|NCT04098575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111421758|NCT03776240|Trastuzumab|trastuzumab|mesh-list
111421759|NCT03776240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111421760|NCT03776240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111421761|NCT04832100|Pregabalin|pregabalin|mesh-list
111421762|NCT04832100|Imipramine|imipramine|mesh-list
111421763|NCT04832100|Analgesics|analgesics|mesh-ancestor
111421764|NCT04832100|Sensory System Agents|sensory system agents|mesh-ancestor
111421765|NCT04832100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111421766|NCT04832100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111421767|NCT04832100|Anticonvulsants|anticonvulsants|mesh-ancestor
111421768|NCT04832100|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111421769|NCT04832100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111421770|NCT04832100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111421771|NCT04832100|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111421772|NCT04832100|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111421773|NCT04832100|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111421774|NCT04832100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111421775|NCT04832100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111421776|NCT04832100|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
111421777|NCT04832100|Antidepressive Agents|antidepressive agents|mesh-ancestor
111421778|NCT04832100|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111421779|NCT04832100|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111421780|NCT04832100|Adrenergic Agents|adrenergic agents|mesh-ancestor
111421781|NCT04832100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111421782|NCT02976272|Bortezomib|bortezomib|mesh-list
111421783|NCT02976272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111421784|NCT00361790|Aripiprazole|aripiprazole|mesh-list
111421785|NCT00361790|Escitalopram|escitalopram|mesh-list
111421786|NCT00361790|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111421787|NCT00361790|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111421788|NCT00361790|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111421789|NCT00361790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111421790|NCT00361790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111421791|NCT00361790|Serotonin Agents|serotonin agents|mesh-ancestor
111421792|NCT00361790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111421793|NCT00361790|Antidepressive Agents|antidepressive agents|mesh-ancestor
111421794|NCT00361790|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111421795|NCT00361790|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111421796|NCT00361790|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111421797|NCT00361790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111421798|NCT00361790|Dopamine Agonists|dopamine agonists|mesh-ancestor
111421799|NCT00361790|Dopamine Agents|dopamine agents|mesh-ancestor
111421800|NCT00361790|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111421801|NCT00361790|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111421802|NCT00361790|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111421803|NCT00361790|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111421804|NCT00361790|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111421805|NCT00361790|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111421806|NCT04570332|Pembrolizumab|pembrolizumab|mesh-list
111421807|NCT04570332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111421808|NCT04570332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111421809|NCT04570332|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111421810|NCT04570332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111421811|NCT00361868|Metformin|metformin|mesh-list
111421812|NCT00361868|Rosiglitazone|rosiglitazone|mesh-list
111421813|NCT00361868|Fenofibrate|fenofibrate|mesh-list
111421814|NCT00361868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111421815|NCT00361868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111421816|NCT00361868|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111421817|NCT00361868|Antimetabolites|antimetabolites|mesh-ancestor
111421818|NCT00361868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111421819|NCT00361868|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111421820|NCT04564872|Linagliptin|linagliptin|mesh-list
111421821|NCT04564872|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111421822|NCT04564872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111421823|NCT04564872|Incretins|incretins|mesh-ancestor
111421824|NCT04564872|Hormones|hormones|mesh-ancestor
111421825|NCT04564872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111421826|NCT04564872|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111421827|NCT04564872|Protease Inhibitors|protease inhibitors|mesh-ancestor
111421828|NCT04564872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111421829|NCT04564872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111421831|NCT04343144|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111421832|NCT04343144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111421833|NCT04343144|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111421834|NCT04343144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111421835|NCT04075409|Padsevonil|padsevonil|mesh-list
111421836|NCT04075409|Anticonvulsants|anticonvulsants|mesh-ancestor
111421837|NCT03743246|Cyclophosphamide|cyclophosphamide|mesh-list
111421838|NCT03743246|Fludarabine|fludarabine|mesh-list
111421839|NCT03743246|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111421840|NCT03743246|Immunologic Factors|immunologic factors|mesh-ancestor
111421841|NCT03743246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111421842|NCT03743246|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111421843|NCT03743246|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111421844|NCT03743246|Alkylating Agents|alkylating agents|mesh-ancestor
111421845|NCT03743246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111421846|NCT03743246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111421847|NCT03743246|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111421848|NCT03703778|Ascorbic Acid|ascorbic acid|mesh-list
111421849|NCT03703778|Methyltestosterone|methyltestosterone|mesh-list
111421850|NCT03703778|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
111421851|NCT03703778|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
111421852|NCT03703778|Androgens|androgens|mesh-list
111421853|NCT03703778|Hormones|hormones|mesh-ancestor
111421854|NCT03703778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111421855|NCT03703778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111421856|NCT03703778|Antioxidants|antioxidants|mesh-ancestor
111421857|NCT03703778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111421858|NCT03703778|Protective Agents|protective agents|mesh-ancestor
111421859|NCT03703778|Vitamins|vitamins|mesh-ancestor
111421860|NCT03703778|Micronutrients|micronutrients|mesh-ancestor
111421861|NCT03703778|Estrogens|estrogens|mesh-ancestor
111421862|NCT03703778|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111421863|NCT03703778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111421864|NCT03703778|Anabolic Agents|anabolic agents|mesh-ancestor
111421865|NCT05346666|Midazolam|midazolam|mesh-list
111421866|NCT05346666|Phenobarbital|phenobarbital|mesh-list
111421867|NCT05346666|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111421868|NCT05346666|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111421869|NCT05346666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111421870|NCT05346666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111421871|NCT05346666|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111421872|NCT05346666|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111421873|NCT05346666|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111421874|NCT05346666|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111421875|NCT05346666|Anesthetics, General|anesthetics, general|mesh-ancestor
111421876|NCT05346666|Anesthetics|anesthetics|mesh-ancestor
111421877|NCT05346666|GABA Modulators|gaba modulators|mesh-ancestor
111421878|NCT05346666|GABA Agents|gaba agents|mesh-ancestor
111421879|NCT05346666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111421880|NCT05346666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111421881|NCT05346666|Anticonvulsants|anticonvulsants|mesh-ancestor
111421882|NCT05346666|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111421883|NCT05346666|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111421884|NCT05346666|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111421885|NCT05346666|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111421886|NCT05346666|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111421887|NCT00361166|Pimavanserin|pimavanserin|mesh-list
111421888|NCT00361166|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111421889|NCT00361166|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111421890|NCT00361166|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111421891|NCT00361166|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111421892|NCT00361166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111421893|NCT00361166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111421894|NCT00361166|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111421895|NCT00361166|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111421896|NCT00361166|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111421897|NCT00361166|Serotonin Agents|serotonin agents|mesh-ancestor
111421898|NCT00361166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111421899|NCT00361166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111421900|NCT03674294|Dexamethasone|dexamethasone|mesh-list
111421901|NCT03674294|Aprepitant|aprepitant|mesh-list
111421902|NCT03674294|Palonosetron|palonosetron|mesh-list
111421904|NCT03674294|Antiemetics|antiemetics|mesh-ancestor
111421905|NCT03674294|Autonomic Agents|autonomic agents|mesh-ancestor
111421906|NCT03674294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111421907|NCT03674294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111421908|NCT03674294|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111421909|NCT03674294|Glucocorticoids|glucocorticoids|mesh-ancestor
111421910|NCT03674294|Hormones|hormones|mesh-ancestor
111421911|NCT03674294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111421912|NCT03674294|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111421913|NCT03674294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111421914|NCT03674294|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
111421915|NCT03674294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111421916|NCT03674294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111421917|NCT03674294|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111421918|NCT03674294|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111421919|NCT03674294|Serotonin Agents|serotonin agents|mesh-ancestor
111421920|NCT00377273|Fluorouracil|fluorouracil|mesh-list
111421921|NCT00377273|Antimetabolites|antimetabolites|mesh-ancestor
111421922|NCT00377273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111421923|NCT00377273|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111421924|NCT00377273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111421925|NCT00377273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111421926|NCT00377273|Immunologic Factors|immunologic factors|mesh-ancestor
111421927|NCT00377273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111421928|NCT03706313|Bupivacaine|bupivacaine|mesh-list
111421929|NCT03706313|Anesthetics, Local|anesthetics, local|mesh-ancestor
111421930|NCT03706313|Anesthetics|anesthetics|mesh-ancestor
111421931|NCT03706313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111421932|NCT03706313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111421933|NCT03706313|Sensory System Agents|sensory system agents|mesh-ancestor
111421934|NCT03706313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111421935|NCT05369364|Dexamethasone|dexamethasone|mesh-list
111421936|NCT05369364|Zanubrutinib|zanubrutinib|mesh-list
111421937|NCT05369364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111421938|NCT05369364|Antiemetics|antiemetics|mesh-ancestor
111421939|NCT05369364|Autonomic Agents|autonomic agents|mesh-ancestor
111421940|NCT05369364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111421941|NCT05369364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111421942|NCT05369364|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111421943|NCT05369364|Glucocorticoids|glucocorticoids|mesh-ancestor
111421944|NCT05369364|Hormones|hormones|mesh-ancestor
111421945|NCT05369364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111421946|NCT05369364|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111421947|NCT05369364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111421948|NCT05369364|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111421949|NCT05369364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111421950|NCT05369364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111421951|NCT00361244|Irinotecan|irinotecan|mesh-list
111421952|NCT00361244|Cetuximab|cetuximab|mesh-list
111421953|NCT00361244|Sunitinib|sunitinib|mesh-list
111421954|NCT00361244|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111421955|NCT00361244|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111421956|NCT00361244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111421957|NCT00361244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111421958|NCT00361244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111421959|NCT00361244|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111421960|NCT00361244|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111421961|NCT00361244|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111421962|NCT00361244|Growth Substances|growth substances|mesh-ancestor
111421963|NCT00361244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111421964|NCT00361244|Growth Inhibitors|growth inhibitors|mesh-ancestor
111421965|NCT00361244|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111421966|NCT03381482|Anesthetics|anesthetics|mesh-list
111421967|NCT03381482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111421968|NCT03381482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111421969|NCT03545165|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
111421970|NCT03545165|177Lu-PSMA-617|177lu-psma-617|mesh-list
111421971|NCT03545165|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111421972|NCT03545165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110510818|NCT00877123|Vitamin D|vitamin d|mesh-list
111421973|NCT04968522|Methylphenidate|methylphenidate|mesh-list
111421974|NCT04968522|Dextroamphetamine|dextroamphetamine|mesh-list
111421975|NCT04968522|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111421976|NCT04968522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111421977|NCT04968522|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111421978|NCT04968522|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111421979|NCT04968522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111421980|NCT04968522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111421981|NCT04968522|Dopamine Agents|dopamine agents|mesh-ancestor
111421982|NCT04968522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111421983|NCT00361322|Clindamycin|clindamycin|mesh-list
111421984|NCT00361322|Clindamycin palmitate|clindamycin palmitate|mesh-list
111421985|NCT00361322|Clindamycin phosphate|clindamycin phosphate|mesh-list
111421986|NCT00361322|Salicylic Acid|salicylic acid|mesh-list
111421987|NCT00361322|Salicylates|salicylates|mesh-list
111421988|NCT00361322|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111421989|NCT00361322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111421990|NCT00361322|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111421991|NCT00361322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111421992|NCT00361322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111421993|NCT00361322|Antifungal Agents|antifungal agents|mesh-ancestor
111421994|NCT00361322|Keratolytic Agents|keratolytic agents|mesh-ancestor
111421995|NCT00361322|Dermatologic Agents|dermatologic agents|mesh-ancestor
111421996|NCT00361322|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111421997|NCT00361322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111421998|NCT00361322|Analgesics|analgesics|mesh-ancestor
111421999|NCT00361322|Sensory System Agents|sensory system agents|mesh-ancestor
111422000|NCT00361322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111422001|NCT00361322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111422002|NCT00361322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111422003|NCT00361322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111422004|NCT00361322|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111422005|NCT02974712|Fentanyl|fentanyl|mesh-list
111422006|NCT02974712|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111422007|NCT02974712|Narcotics|narcotics|mesh-ancestor
111422008|NCT02974712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111422009|NCT02974712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111422010|NCT02974712|Analgesics|analgesics|mesh-ancestor
111422011|NCT02974712|Sensory System Agents|sensory system agents|mesh-ancestor
111422012|NCT02974712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111422013|NCT02974712|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111422014|NCT02974712|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111422015|NCT02974712|Anesthetics, General|anesthetics, general|mesh-ancestor
111422016|NCT02974712|Anesthetics|anesthetics|mesh-ancestor
111422017|NCT02974556|Capecitabine|capecitabine|mesh-list
111422018|NCT02974556|Oxaliplatin|oxaliplatin|mesh-list
111422019|NCT02974556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111422020|NCT02974556|Antimetabolites|antimetabolites|mesh-ancestor
111422021|NCT02974556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111422022|NCT02974556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111422023|NCT04523142|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111422024|NCT04523142|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111422025|NCT03557333|Dihydroergotamine|dihydroergotamine|mesh-list
111422026|NCT03557333|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111422027|NCT03557333|Dopamine Agonists|dopamine agonists|mesh-ancestor
111422028|NCT03557333|Dopamine Agents|dopamine agents|mesh-ancestor
111422029|NCT03557333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111422030|NCT03557333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111422031|NCT03557333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111422032|NCT03557333|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111422033|NCT03557333|Analgesics|analgesics|mesh-ancestor
111422034|NCT03557333|Sensory System Agents|sensory system agents|mesh-ancestor
111422035|NCT03557333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111422036|NCT04957368|Midazolam|midazolam|mesh-list
111422037|NCT04957368|Nitrous Oxide|nitrous oxide|mesh-list
111422038|NCT04957368|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111422039|NCT04957368|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111422040|NCT04957368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111422041|NCT04957368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111422042|NCT04957368|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111422043|NCT04957368|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111422044|NCT04957368|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111422045|NCT04957368|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111422046|NCT04957368|Anesthetics, General|anesthetics, general|mesh-ancestor
111422047|NCT04957368|Anesthetics|anesthetics|mesh-ancestor
111422048|NCT04957368|GABA Modulators|gaba modulators|mesh-ancestor
111422049|NCT04957368|GABA Agents|gaba agents|mesh-ancestor
111422050|NCT04957368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111422051|NCT04957368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111422052|NCT04957368|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111422053|NCT04957368|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111422054|NCT04957368|Analgesics|analgesics|mesh-ancestor
111422055|NCT04957368|Sensory System Agents|sensory system agents|mesh-ancestor
111422056|NCT04957368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111422057|NCT04818450|Gabapentin|gabapentin|mesh-list
111422058|NCT04818450|Analgesics|analgesics|mesh-ancestor
111422059|NCT04818450|Sensory System Agents|sensory system agents|mesh-ancestor
111422060|NCT04818450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111422061|NCT04818450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111422062|NCT04818450|Anticonvulsants|anticonvulsants|mesh-ancestor
111422063|NCT04818450|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111422064|NCT04818450|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111422065|NCT04818450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111422066|NCT04818450|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111422067|NCT04818450|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111422068|NCT04818450|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111422069|NCT04818450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111422070|NCT04818450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111422071|NCT04818450|Antimanic Agents|antimanic agents|mesh-ancestor
111422072|NCT04841148|Hydroxychloroquine|hydroxychloroquine|mesh-list
111422073|NCT04841148|Palbociclib|palbociclib|mesh-list
111422074|NCT04841148|Avelumab|avelumab|mesh-list
111422075|NCT04841148|Antimalarials|antimalarials|mesh-ancestor
111422076|NCT04841148|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111422077|NCT04841148|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111422078|NCT04841148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111422079|NCT04841148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111422080|NCT04841148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111422081|NCT04841148|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111422082|NCT04841148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111422083|NCT04841148|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111422084|NCT04841148|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111422085|NCT05289804|Lidocaine|lidocaine|mesh-list
111422086|NCT05289804|Anesthetics, Local|anesthetics, local|mesh-list
111422087|NCT05289804|Prilocaine|prilocaine|mesh-list
111422088|NCT05289804|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
111422089|NCT05289804|Anesthetics|anesthetics|mesh-list
111422090|NCT05289804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111422091|NCT05289804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111422092|NCT05289804|Sensory System Agents|sensory system agents|mesh-ancestor
111422093|NCT05289804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111422094|NCT05289804|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111422095|NCT05289804|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111422096|NCT05289804|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111422097|NCT05289804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111422098|NCT05289804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111422099|NCT05289804|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
111422100|NCT05448872|Valsartan|valsartan|mesh-list
111422101|NCT05448872|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
111422102|NCT05448872|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111422103|NCT05448872|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111422104|NCT05448872|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111422105|NCT05448872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111422106|NCT04817826|Durvalumab|durvalumab|mesh-list
111422107|NCT04817826|Tremelimumab|tremelimumab|mesh-list
111422108|NCT04817826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111422109|NCT04817826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111422110|NCT00362258|Irbesartan|irbesartan|mesh-list
111422111|NCT00362258|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111422112|NCT00362258|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111422113|NCT00362258|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111422114|NCT00362258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111422115|NCT00362726|Rosiglitazone|rosiglitazone|mesh-list
111422116|NCT00362726|Ritonavir|ritonavir|mesh-list
111422117|NCT00362726|Atazanavir Sulfate|atazanavir sulfate|mesh-list
111422118|NCT00362726|Maleic acid|maleic acid|mesh-list
111422119|NCT00362726|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111422120|NCT00362726|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111422121|NCT00362726|Protease Inhibitors|protease inhibitors|mesh-ancestor
111422122|NCT00362726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111422123|NCT00362726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111422124|NCT00362726|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111422125|NCT00362726|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111422126|NCT00362726|Antiviral Agents|antiviral agents|mesh-ancestor
111422127|NCT00362726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111422128|NCT00362726|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111422129|NCT00362726|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111422130|NCT00362726|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111422131|NCT00362726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111422132|NCT04474470|Cetuximab|cetuximab|mesh-list
111422133|NCT04474470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111422134|NCT04474470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111422135|NCT05330754|Caffeine|caffeine|mesh-list
111422136|NCT05330754|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111422137|NCT05330754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111422138|NCT05330754|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111422139|NCT05330754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111422140|NCT05330754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111422141|NCT05330754|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
111422142|NCT05330754|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111422143|NCT05330754|Purinergic Agents|purinergic agents|mesh-ancestor
111422144|NCT05330754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111422145|NCT02271932|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111422146|NCT02271932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111422147|NCT04426968|Interferons|interferons|mesh-list
111422148|NCT04426968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111422149|NCT04426968|Antiviral Agents|antiviral agents|mesh-ancestor
111422150|NCT04426968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111422151|NCT04887948|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
111422152|NCT04887948|Immunologic Factors|immunologic factors|mesh-ancestor
111422153|NCT04887948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111422154|NCT03829488|Plasma-lyte 148|plasma-lyte 148|mesh-list
111422155|NCT03829488|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
111422156|NCT03829488|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111422157|NCT04049123|Insulin Lispro|insulin lispro|mesh-list
111422158|NCT04049123|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111422159|NCT04049123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111422160|NCT04051463|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111422161|NCT04051463|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111422162|NCT04184297|Tiotropium Bromide|tiotropium bromide|mesh-list
111422163|NCT04184297|Olodaterol|olodaterol|mesh-list
111422164|NCT04184297|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111422165|NCT04184297|Autonomic Agents|autonomic agents|mesh-ancestor
111422166|NCT04184297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111422167|NCT04184297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111422168|NCT04184297|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111422169|NCT04184297|Respiratory System Agents|respiratory system agents|mesh-ancestor
111422170|NCT04184297|Parasympatholytics|parasympatholytics|mesh-ancestor
111422171|NCT04184297|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111422172|NCT04184297|Cholinergic Agents|cholinergic agents|mesh-ancestor
111422173|NCT04184297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111422174|NCT04184297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111422175|NCT04031885|Paclitaxel|paclitaxel|mesh-list
111422176|NCT04031885|Docetaxel|docetaxel|mesh-list
111422177|NCT04031885|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111422178|NCT04031885|Capecitabine|capecitabine|mesh-list
111422179|NCT04031885|Fulvestrant|fulvestrant|mesh-list
111422180|NCT04031885|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111422181|NCT04031885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111422182|NCT04031885|Tubulin Modulators|tubulin modulators|mesh-ancestor
111422183|NCT04031885|Antimitotic Agents|antimitotic agents|mesh-ancestor
111422184|NCT04031885|Mitosis Modulators|mitosis modulators|mesh-ancestor
111422185|NCT04031885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111422186|NCT04031885|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111422187|NCT04031885|Antimetabolites|antimetabolites|mesh-ancestor
111422188|NCT04031885|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111422189|NCT04031885|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
111422190|NCT04031885|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111422191|NCT04031885|Hormone Antagonists|hormone antagonists|mesh-ancestor
111422192|NCT04031885|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111422193|NCT04031885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111422194|NCT01638000|Solifenacin Succinate|solifenacin succinate|mesh-list
111422195|NCT01638000|Mirabegron|mirabegron|mesh-list
111422196|NCT01638000|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111422197|NCT01638000|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111422198|NCT01638000|Cholinergic Agents|cholinergic agents|mesh-ancestor
111422199|NCT01638000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111146576|NCT02457247|Calcium Carbonate|calcium carbonate|mesh-list
111422200|NCT01638000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111422201|NCT01638000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111422202|NCT01638000|Urological Agents|urological agents|mesh-ancestor
111422203|NCT01638000|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
111422204|NCT01638000|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111422205|NCT01638000|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111422206|NCT01638000|Adrenergic Agents|adrenergic agents|mesh-ancestor
111422208|NCT04023695|Epinephrine|epinephrine|mesh-list
111422209|NCT04023695|Anesthetics, Local|anesthetics, local|mesh-ancestor
111422210|NCT04023695|Anesthetics|anesthetics|mesh-ancestor
111422211|NCT04023695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111422212|NCT04023695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111422213|NCT04023695|Sensory System Agents|sensory system agents|mesh-ancestor
111422214|NCT04023695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111422215|NCT04023695|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111422216|NCT04023695|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111422217|NCT04023695|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111422218|NCT04023695|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111422219|NCT04023695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111422220|NCT04023695|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111422221|NCT04023695|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111422222|NCT04023695|Adrenergic Agents|adrenergic agents|mesh-ancestor
111422223|NCT04023695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111422224|NCT04023695|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111422225|NCT04023695|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111422226|NCT04023695|Autonomic Agents|autonomic agents|mesh-ancestor
111422227|NCT04023695|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111422228|NCT04023695|Respiratory System Agents|respiratory system agents|mesh-ancestor
111422229|NCT04023695|Mydriatics|mydriatics|mesh-ancestor
111422230|NCT04023695|Sympathomimetics|sympathomimetics|mesh-ancestor
111422231|NCT04023695|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111422232|NCT04211909|Sofosbuvir|sofosbuvir|mesh-list
111422233|NCT04211909|Velpatasvir|velpatasvir|mesh-list
111422234|NCT04211909|Antiviral Agents|antiviral agents|mesh-ancestor
111422235|NCT04211909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111422236|NCT04223843|Tiotropium Bromide|tiotropium bromide|mesh-list
111422237|NCT04223843|Olodaterol|olodaterol|mesh-list
111422238|NCT04223843|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111422239|NCT04223843|Autonomic Agents|autonomic agents|mesh-ancestor
111422240|NCT04223843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111422241|NCT04223843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111422242|NCT04223843|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111422243|NCT04223843|Respiratory System Agents|respiratory system agents|mesh-ancestor
111422244|NCT04223843|Parasympatholytics|parasympatholytics|mesh-ancestor
111422245|NCT04223843|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111422246|NCT04223843|Cholinergic Agents|cholinergic agents|mesh-ancestor
111422247|NCT04223843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111422248|NCT04223843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111422249|NCT05722951|Metformin|metformin|mesh-list
111422250|NCT05722951|Levetiracetam|levetiracetam|mesh-list
111422251|NCT05722951|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111422252|NCT05722951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111422253|NCT05722951|Anticonvulsants|anticonvulsants|mesh-ancestor
111422254|NCT05722951|Nootropic Agents|nootropic agents|mesh-ancestor
111422255|NCT04838652|Pembrolizumab|pembrolizumab|mesh-list
111422256|NCT04838652|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111422257|NCT04838652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111422258|NCT04838652|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111422259|NCT04838652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111422260|NCT05722795|Imatinib Mesylate|imatinib mesylate|mesh-list
111422261|NCT05722795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111422262|NCT05722795|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111422263|NCT05722795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111422264|NCT05722795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111422265|NCT03778554|Metoprolol|metoprolol|mesh-list
111422266|NCT03778554|Carvedilol|carvedilol|mesh-list
111422267|NCT03778554|Nebivolol|nebivolol|mesh-list
111422268|NCT03778554|Bisoprolol|bisoprolol|mesh-list
111422269|NCT03778554|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111422270|NCT03778554|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111422271|NCT03778554|Sympatholytics|sympatholytics|mesh-ancestor
111422272|NCT03778554|Autonomic Agents|autonomic agents|mesh-ancestor
111422273|NCT03778554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111146655|NCT02428699|Cod Liver Oil|cod liver oil|mesh-list
111422274|NCT03778554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111422275|NCT03778554|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
111422277|NCT03778554|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111422278|NCT03778554|Adrenergic Agents|adrenergic agents|mesh-ancestor
111422279|NCT03778554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111422280|NCT03778554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111422281|NCT03778554|Antioxidants|antioxidants|mesh-ancestor
111422282|NCT03778554|Protective Agents|protective agents|mesh-ancestor
111422283|NCT03778554|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111422284|NCT03778554|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111422285|NCT03778554|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111422286|NCT03778554|Vasodilator Agents|vasodilator agents|mesh-ancestor
111422287|NCT03778554|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111422288|NCT03778554|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111422289|NCT03778554|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
111422290|NCT03778554|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111422291|NCT03778554|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111422292|NCT04810494|Lidocaine|lidocaine|mesh-list
111422293|NCT04810494|Anesthetics, Local|anesthetics, local|mesh-ancestor
111422294|NCT04810494|Anesthetics|anesthetics|mesh-ancestor
111422295|NCT04810494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111422296|NCT04810494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111422297|NCT04810494|Sensory System Agents|sensory system agents|mesh-ancestor
111422298|NCT04810494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111422299|NCT04810494|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111422300|NCT04810494|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111422301|NCT04810494|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111422302|NCT04810494|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111422303|NCT04810494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111422304|NCT05722405|Lenalidomide|lenalidomide|mesh-list
111422305|NCT05722405|Ixazomib|ixazomib|mesh-list
111422306|NCT05722405|Glycine|glycine|mesh-list
111422307|NCT05722405|Immunologic Factors|immunologic factors|mesh-ancestor
111422308|NCT05722405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111422309|NCT05722405|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111422310|NCT05722405|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111422311|NCT05722405|Growth Substances|growth substances|mesh-ancestor
111422312|NCT05722405|Growth Inhibitors|growth inhibitors|mesh-ancestor
111422313|NCT05722405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111422314|NCT05722405|Protease Inhibitors|protease inhibitors|mesh-ancestor
111422315|NCT05722405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111422316|NCT05722405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111422317|NCT05722405|Glycine Agents|glycine agents|mesh-ancestor
111422318|NCT05722405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111422319|NCT04259658|Calcium|calcium|mesh-list
111422320|NCT04259658|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111422321|NCT04259658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111422322|NCT02767531|Orlistat|orlistat|mesh-list
111422323|NCT02767531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111422324|NCT02767531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111422325|NCT02767531|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111422326|NCT02767531|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111422327|NCT04419246|Tranexamic Acid|tranexamic acid|mesh-list
111422328|NCT04419246|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111422329|NCT04419246|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111422330|NCT04419246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111422331|NCT04419246|Hemostatics|hemostatics|mesh-ancestor
111422332|NCT04419246|Coagulants|coagulants|mesh-ancestor
111422333|NCT02521753|Metformin|metformin|mesh-list
111422334|NCT02521753|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111422335|NCT02521753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111422336|NCT04229303|Voriconazole|voriconazole|mesh-list
111422337|NCT04229303|Antifungal Agents|antifungal agents|mesh-ancestor
111422338|NCT04229303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111422339|NCT04229303|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111422340|NCT04229303|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111422341|NCT04229303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111422342|NCT04229303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111422343|NCT04229303|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111422344|NCT04229303|Hormone Antagonists|hormone antagonists|mesh-ancestor
111422345|NCT04229303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111422346|NCT04229303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111422347|NCT04229303|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111422348|NCT05263986|Adagrasib|adagrasib|mesh-list
111422349|NCT05263986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111422350|NCT00357643|Vitamin D|vitamin d|mesh-list
111422351|NCT00357643|Calcium|calcium|mesh-list
111422352|NCT00357643|Vitamins|vitamins|mesh-ancestor
111422353|NCT00357643|Micronutrients|micronutrients|mesh-ancestor
111422354|NCT00357643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111422355|NCT00357643|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111422356|NCT00357643|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111422357|NCT00357721|Atazanavir Sulfate|atazanavir sulfate|mesh-list
111422358|NCT00357721|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111422359|NCT00357721|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111422360|NCT00357721|Protease Inhibitors|protease inhibitors|mesh-ancestor
111422361|NCT00357721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111422362|NCT00357721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111422363|NCT00357721|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111422364|NCT00357721|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111422365|NCT00357721|Antiviral Agents|antiviral agents|mesh-ancestor
111422366|NCT00357721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111422367|NCT03504410|Cytarabine|cytarabine|mesh-list
111422368|NCT03504410|Fludarabine|fludarabine|mesh-list
111422369|NCT03504410|Etoposide|etoposide|mesh-list
111422370|NCT03504410|Mitoxantrone|mitoxantrone|mesh-list
111422371|NCT03504410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111422372|NCT03504410|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111422373|NCT03504410|Antimetabolites|antimetabolites|mesh-ancestor
111422374|NCT03504410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111422375|NCT03504410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111422376|NCT03504410|Immunologic Factors|immunologic factors|mesh-ancestor
111422377|NCT03504410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111422378|NCT03504410|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111422379|NCT03504410|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111422380|NCT03504410|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111422381|NCT03504410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111422382|NCT03504410|Antiviral Agents|antiviral agents|mesh-ancestor
111422383|NCT03504410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111422384|NCT03504410|Analgesics|analgesics|mesh-ancestor
111422385|NCT03504410|Sensory System Agents|sensory system agents|mesh-ancestor
111422386|NCT03504410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111422387|NCT02464969|Apixaban|apixaban|mesh-list
111422388|NCT02464969|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111422389|NCT02464969|Antithrombins|antithrombins|mesh-ancestor
111422390|NCT02464969|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111422391|NCT02464969|Protease Inhibitors|protease inhibitors|mesh-ancestor
111422392|NCT02464969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111422393|NCT02464969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111422394|NCT02464969|Anticoagulants|anticoagulants|mesh-ancestor
111422395|NCT05392530|Macitentan|macitentan|mesh-list
111422396|NCT05392530|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
111422397|NCT05392530|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
111422398|NCT05392530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111422399|NCT05392530|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
111422400|NCT03498014|Analgesics, Opioid|analgesics, opioid|mesh-list
111422401|NCT03498014|Narcotics|narcotics|mesh-ancestor
111422402|NCT03498014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111422403|NCT03498014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111422404|NCT03498014|Analgesics|analgesics|mesh-ancestor
111422405|NCT03498014|Sensory System Agents|sensory system agents|mesh-ancestor
111422406|NCT03498014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111422407|NCT02460133|Ritonavir|ritonavir|mesh-list
111422408|NCT02460133|Ribavirin|ribavirin|mesh-list
111422409|NCT02460133|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111422410|NCT02460133|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111422411|NCT02460133|Protease Inhibitors|protease inhibitors|mesh-ancestor
111422412|NCT02460133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111422413|NCT02460133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111422414|NCT02460133|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111422415|NCT02460133|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111422416|NCT02460133|Antiviral Agents|antiviral agents|mesh-ancestor
111422417|NCT02460133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111422418|NCT02460133|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111422419|NCT02460133|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111422420|NCT02460133|Antimetabolites|antimetabolites|mesh-ancestor
111422421|NCT02220452|Anesthetics|anesthetics|mesh-list
111422422|NCT02220452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111422423|NCT02220452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111422424|NCT04256603|Gabapentin|gabapentin|mesh-list
111422425|NCT04256603|Analgesics|analgesics|mesh-ancestor
111422426|NCT04256603|Sensory System Agents|sensory system agents|mesh-ancestor
111422427|NCT04256603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111422428|NCT04256603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111422429|NCT04256603|Anticonvulsants|anticonvulsants|mesh-ancestor
111422430|NCT04256603|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111422431|NCT04256603|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111422432|NCT04256603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111422433|NCT04256603|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111422434|NCT04256603|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111422435|NCT04256603|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111422436|NCT04256603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111422437|NCT04256603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111422438|NCT04256603|Antimanic Agents|antimanic agents|mesh-ancestor
111422439|NCT05721079|Methoxsalen|methoxsalen|mesh-list
110510875|NCT00616603|Hormones|hormones|mesh-ancestor
111422440|NCT05721079|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111422441|NCT05721079|Dermatologic Agents|dermatologic agents|mesh-ancestor
111422442|NCT00362570|Temozolomide|temozolomide|mesh-list
111422443|NCT00362570|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111422444|NCT00362570|Alkylating Agents|alkylating agents|mesh-ancestor
111422445|NCT00362570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111422446|NCT00362570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111422447|NCT00357253|Capecitabine|capecitabine|mesh-list
111422448|NCT00357253|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111422449|NCT00357253|Antimetabolites|antimetabolites|mesh-ancestor
111422450|NCT00357253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111422451|NCT00357253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111422452|NCT02068430|Riboflavin|riboflavin|mesh-list
111422453|NCT02068430|Vitamin B Complex|vitamin b complex|mesh-ancestor
111422454|NCT02068430|Vitamins|vitamins|mesh-ancestor
111422455|NCT02068430|Micronutrients|micronutrients|mesh-ancestor
111422456|NCT02068430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111422457|NCT02068430|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111422458|NCT02068430|Dermatologic Agents|dermatologic agents|mesh-ancestor
111422459|NCT03138512|Nivolumab|nivolumab|mesh-list
111422460|NCT03138512|Ipilimumab|ipilimumab|mesh-list
111422461|NCT03138512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111422462|NCT03138512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111422463|NCT03138512|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111422464|NCT03138512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111422465|NCT03127592|Etodolac|etodolac|mesh-list
111422466|NCT03127592|Cyclobenzaprine|cyclobenzaprine|mesh-list
111422467|NCT03127592|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
111422468|NCT03127592|Antidepressive Agents|antidepressive agents|mesh-ancestor
111422469|NCT03127592|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111422470|NCT03127592|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
111422471|NCT03127592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111422472|NCT03127592|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111422473|NCT03127592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111422474|NCT03127592|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111422475|NCT03127592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111422476|NCT03127592|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111422477|NCT03127592|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111422478|NCT03127592|Analgesics|analgesics|mesh-ancestor
111422479|NCT03127592|Sensory System Agents|sensory system agents|mesh-ancestor
111422480|NCT03127592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111422481|NCT03127592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111422482|NCT03127592|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111422483|NCT03127592|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111422484|NCT03127592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111422485|NCT03127592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111422486|NCT02444234|Tedizolid|tedizolid|mesh-list
111422487|NCT02444234|Oxazolidinones|oxazolidinones|mesh-list
111422488|NCT02444234|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111422489|NCT02444234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111422490|NCT02444234|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111422491|NCT02444234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111422492|NCT02444234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111422493|NCT02444936|Vaccines|vaccines|mesh-list
111422494|NCT02444936|Immunologic Factors|immunologic factors|mesh-ancestor
111422495|NCT02444936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111422496|NCT02445326|Dexamethasone|dexamethasone|mesh-list
111422497|NCT02445326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111422498|NCT02445326|Antiemetics|antiemetics|mesh-ancestor
111422499|NCT02445326|Autonomic Agents|autonomic agents|mesh-ancestor
111422500|NCT02445326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111422501|NCT02445326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111422502|NCT02445326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111422503|NCT02445326|Glucocorticoids|glucocorticoids|mesh-ancestor
111422504|NCT02445326|Hormones|hormones|mesh-ancestor
111422505|NCT02445326|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111422506|NCT02445326|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111422507|NCT02445326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111422508|NCT04344457|Hydroxychloroquine|hydroxychloroquine|mesh-list
111422509|NCT04344457|Azithromycin|azithromycin|mesh-list
111422510|NCT04344457|Indomethacin|indomethacin|mesh-list
111422511|NCT04344457|Antimalarials|antimalarials|mesh-ancestor
111422512|NCT04344457|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111422513|NCT04344457|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111422514|NCT04344457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111422515|NCT04344457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111422516|NCT04344457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111422517|NCT04344457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111422518|NCT04344457|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111422519|NCT04344457|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111422520|NCT04344457|Analgesics|analgesics|mesh-ancestor
111422521|NCT04344457|Sensory System Agents|sensory system agents|mesh-ancestor
111422522|NCT04344457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111422523|NCT04344457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111422524|NCT04344457|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111422525|NCT04344457|Gout Suppressants|gout suppressants|mesh-ancestor
111422526|NCT04344457|Tocolytic Agents|tocolytic agents|mesh-ancestor
111422527|NCT04344457|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111422528|NCT04344457|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111422529|NCT04344457|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111422530|NCT05720533|Disitamab vedotin|disitamab vedotin|mesh-list
111422531|NCT05720533|Immunoconjugates|immunoconjugates|mesh-ancestor
111422532|NCT05720533|Immunologic Factors|immunologic factors|mesh-ancestor
111422533|NCT05720533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111422534|NCT02446496|Cefadroxil|cefadroxil|mesh-list
111422535|NCT02446496|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111422536|NCT02446496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111422537|NCT00355693|Propofol|propofol|mesh-list
111422538|NCT00355693|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111422539|NCT00355693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111422540|NCT00355693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111422541|NCT00355693|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111422542|NCT00355693|Anesthetics, General|anesthetics, general|mesh-ancestor
111422543|NCT00355693|Anesthetics|anesthetics|mesh-ancestor
111422544|NCT02448368|Verinurad|verinurad|mesh-list
111422545|NCT02448368|Gout Suppressants|gout suppressants|mesh-ancestor
111422546|NCT02448368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111422547|NCT02448914|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
111422548|NCT02448914|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111422549|NCT02448914|Immunologic Factors|immunologic factors|mesh-ancestor
111422550|NCT02448914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111422551|NCT02448914|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111422552|NCT02448914|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111422553|NCT02448914|Dopamine Agonists|dopamine agonists|mesh-ancestor
111422554|NCT02448914|Dopamine Agents|dopamine agents|mesh-ancestor
111422555|NCT02448914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111422556|NCT02448914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111422557|NCT03496662|Paclitaxel|paclitaxel|mesh-list
111422558|NCT03496662|Gemcitabine|gemcitabine|mesh-list
111422559|NCT03496662|Nivolumab|nivolumab|mesh-list
111422560|NCT03496662|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111422561|NCT03496662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111422562|NCT03496662|Tubulin Modulators|tubulin modulators|mesh-ancestor
111422563|NCT03496662|Antimitotic Agents|antimitotic agents|mesh-ancestor
111422564|NCT03496662|Mitosis Modulators|mitosis modulators|mesh-ancestor
111422565|NCT03496662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111422566|NCT03496662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111422567|NCT03496662|Antimetabolites|antimetabolites|mesh-ancestor
111422568|NCT03496662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111422569|NCT03496662|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111422570|NCT05002309|Antidepressive Agents|antidepressive agents|mesh-list
111146953|NCT02249949|Efatutazone|efatutazone|mesh-list
111422571|NCT05002309|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111422572|NCT05720065|Botulinum Toxins|botulinum toxins|mesh-list
111422573|NCT05720065|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111422574|NCT05720065|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111422575|NCT05720065|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111422576|NCT05720065|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111422577|NCT05720065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111422578|NCT05720065|Cholinergic Agents|cholinergic agents|mesh-ancestor
111422579|NCT05720065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110510893|NCT02790996|Vancomycin|vancomycin|mesh-list
111422580|NCT05720065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111422581|NCT05720065|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111422582|NCT05720065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111422583|NCT05719831|Amoxicillin|amoxicillin|mesh-list
111422584|NCT05719831|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111422585|NCT05719831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111422586|NCT01152541|Riboflavin|riboflavin|mesh-list
111422587|NCT01152541|Dextrans|dextrans|mesh-list
111422588|NCT01152541|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111422589|NCT01152541|Vitamin B Complex|vitamin b complex|mesh-ancestor
111422590|NCT01152541|Vitamins|vitamins|mesh-ancestor
111422591|NCT01152541|Micronutrients|micronutrients|mesh-ancestor
111422592|NCT01152541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111422593|NCT01152541|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111422594|NCT01152541|Dermatologic Agents|dermatologic agents|mesh-ancestor
111422595|NCT01152541|Anticoagulants|anticoagulants|mesh-ancestor
111422596|NCT01152541|Plasma Substitutes|plasma substitutes|mesh-ancestor
111422597|NCT01152541|Blood Substitutes|blood substitutes|mesh-ancestor
111422598|NCT01638546|Temozolomide|temozolomide|mesh-list
111422599|NCT01638546|Veliparib|veliparib|mesh-list
111422600|NCT01638546|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111422601|NCT01638546|Alkylating Agents|alkylating agents|mesh-ancestor
111422602|NCT01638546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111422603|NCT01638546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111422604|NCT01638546|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111422605|NCT01638546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111422606|NCT04948489|Norethindrone|norethindrone|mesh-list
111422607|NCT04948489|Norethindrone Acetate|norethindrone acetate|mesh-list
111422608|NCT04948489|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111422609|NCT04948489|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111422610|NCT04948489|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111422611|NCT04948489|Contraceptive Agents|contraceptive agents|mesh-ancestor
111422612|NCT04948489|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111422613|NCT04948489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111422614|NCT04948489|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111422615|NCT04948489|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111422616|NCT05723341|Morphine|morphine|mesh-list
111422617|NCT05723341|Bupivacaine|bupivacaine|mesh-list
111422618|NCT05723341|Anesthetics, Local|anesthetics, local|mesh-ancestor
111422619|NCT05723341|Anesthetics|anesthetics|mesh-ancestor
111422620|NCT05723341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111422621|NCT05723341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111422622|NCT05723341|Sensory System Agents|sensory system agents|mesh-ancestor
111422623|NCT05723341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111422624|NCT05723341|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111422625|NCT05723341|Narcotics|narcotics|mesh-ancestor
111422626|NCT05723341|Analgesics|analgesics|mesh-ancestor
111422627|NCT05718583|Butyric Acid|butyric acid|mesh-list
111422628|NCT05718583|Histamine Antagonists|histamine antagonists|mesh-ancestor
111422629|NCT05718583|Histamine Agents|histamine agents|mesh-ancestor
111422630|NCT05718583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111422631|NCT05718583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111422632|NCT05718583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111422633|NCT00363350|Rituximab|rituximab|mesh-list
111422634|NCT00363350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111422635|NCT00363350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111422636|NCT00363350|Immunologic Factors|immunologic factors|mesh-ancestor
111422637|NCT00363350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111422638|NCT00363350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111422639|NCT05717335|Thrombin|thrombin|mesh-list
111422640|NCT05717335|Hemostatics|hemostatics|mesh-ancestor
111422641|NCT05717335|Coagulants|coagulants|mesh-ancestor
111422642|NCT05717257|Dapagliflozin|dapagliflozin|mesh-list
111422643|NCT05717257|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111422644|NCT05717257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111422645|NCT05717257|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111422646|NCT05717257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111422647|NCT04341818|Vitamin D|vitamin d|mesh-list
111422648|NCT04341818|Ergocalciferols|ergocalciferols|mesh-list
111422649|NCT04341818|Cholecalciferol|cholecalciferol|mesh-list
111422650|NCT04341818|Vitamins|vitamins|mesh-list
111422651|NCT04341818|Micronutrients|micronutrients|mesh-ancestor
111422652|NCT04341818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111422653|NCT04341818|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111422654|NCT04341818|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111422655|NCT00362804|Tetrabenazine|tetrabenazine|mesh-list
111422656|NCT00362804|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111422657|NCT00362804|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111422658|NCT00362804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111422659|NCT00362804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111422660|NCT00362804|Adrenergic Agents|adrenergic agents|mesh-ancestor
111422661|NCT00362804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111422662|NCT00362804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111422663|NCT02451488|Sargramostim|sargramostim|mesh-list
111422664|NCT02451488|Immunologic Factors|immunologic factors|mesh-ancestor
111422665|NCT02451488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111422666|NCT03172494|Insulin|insulin|mesh-list
111422667|NCT03172494|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111422668|NCT03172494|Liraglutide|liraglutide|mesh-list
111422669|NCT03172494|Insulin, Long-Acting|insulin, long-acting|mesh-list
111422670|NCT03172494|Xultophy|xultophy|mesh-list
111422671|NCT03172494|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111422672|NCT03172494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111422673|NCT03172494|Incretins|incretins|mesh-ancestor
111422674|NCT03172494|Hormones|hormones|mesh-ancestor
111422675|NCT03172494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111422676|NCT02452346|Tosedostat|tosedostat|mesh-list
111422677|NCT02452346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111422678|NCT02452346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111422679|NCT02959255|Esomeprazole|esomeprazole|mesh-list
111422680|NCT02959255|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111422681|NCT02959255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111422682|NCT02959255|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111422683|NCT02959255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111422684|NCT02959255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111422685|NCT05716945|Fluorometholone|fluorometholone|mesh-list
111422686|NCT05716945|Dexamethasone|dexamethasone|mesh-list
111422687|NCT05716945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111422688|NCT05716945|Antiemetics|antiemetics|mesh-ancestor
111422689|NCT05716945|Autonomic Agents|autonomic agents|mesh-ancestor
111422690|NCT05716945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111422691|NCT05716945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111422692|NCT05716945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111422693|NCT05716945|Glucocorticoids|glucocorticoids|mesh-ancestor
111422694|NCT05716945|Hormones|hormones|mesh-ancestor
111422695|NCT05716945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111422696|NCT05716945|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111422697|NCT05716945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111422698|NCT05716945|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111422699|NCT03012620|Pembrolizumab|pembrolizumab|mesh-list
111422700|NCT03012620|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111422701|NCT03012620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111422702|NCT03012620|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111422703|NCT03012620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111422704|NCT05716867|Cystatins|cystatins|mesh-list
111422705|NCT05716867|Salivary Cystatins|salivary cystatins|mesh-list
111422706|NCT05716867|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
111422707|NCT05716867|Protease Inhibitors|protease inhibitors|mesh-ancestor
111422708|NCT05716867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111422709|NCT05716867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111422710|NCT04341584|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
111422711|NCT04341584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111422712|NCT01345136|Everolimus|everolimus|mesh-list
111422713|NCT01345136|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110510905|NCT02790684|Firuglipel|firuglipel|mesh-list
111422714|NCT01345136|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111422715|NCT01345136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111422716|NCT01345136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111422717|NCT01345136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111422718|NCT01345136|Immunologic Factors|immunologic factors|mesh-ancestor
111422719|NCT01345136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111422720|NCT01345136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111422721|NCT04341428|Lansoprazole|lansoprazole|mesh-list
111422722|NCT04341428|Dexlansoprazole|dexlansoprazole|mesh-list
111422723|NCT04341428|Fexuprazan|fexuprazan|mesh-list
111422724|NCT04341428|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111147105|NCT04771767|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111422725|NCT04341428|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111422726|NCT04341428|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111422727|NCT04341428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111422728|NCT04341428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111422729|NCT02453360|Bupivacaine|bupivacaine|mesh-list
111422730|NCT02453360|Anesthetics, Local|anesthetics, local|mesh-ancestor
111422731|NCT02453360|Anesthetics|anesthetics|mesh-ancestor
111422732|NCT02453360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111422733|NCT02453360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111422734|NCT02453360|Sensory System Agents|sensory system agents|mesh-ancestor
111422735|NCT02453360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111422736|NCT02453672|Bevacizumab|bevacizumab|mesh-list
111422737|NCT02453672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111422738|NCT02453672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111422739|NCT02453672|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111422740|NCT02453672|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111422741|NCT02453672|Growth Substances|growth substances|mesh-ancestor
111422742|NCT02453672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111422743|NCT02453672|Growth Inhibitors|growth inhibitors|mesh-ancestor
111422744|NCT03119064|Irinotecan|irinotecan|mesh-list
111422745|NCT03119064|Temozolomide|temozolomide|mesh-list
111422746|NCT03119064|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111422747|NCT03119064|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111422748|NCT03119064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111422749|NCT03119064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111422750|NCT03119064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111422751|NCT03119064|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111422752|NCT03119064|Alkylating Agents|alkylating agents|mesh-ancestor
111422753|NCT02453750|Bronchodilator Agents|bronchodilator agents|mesh-list
111422754|NCT02453750|Autonomic Agents|autonomic agents|mesh-ancestor
111422755|NCT02453750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111422756|NCT02453750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111422757|NCT02453750|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111422758|NCT02453750|Respiratory System Agents|respiratory system agents|mesh-ancestor
111422759|NCT03831295|Antibodies|antibodies|mesh-list
111422760|NCT03831295|Immunologic Factors|immunologic factors|mesh-ancestor
111422761|NCT03831295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111422762|NCT02454296|Lidocaine|lidocaine|mesh-list
111422763|NCT02454296|Anesthetics, Local|anesthetics, local|mesh-ancestor
111422764|NCT02454296|Anesthetics|anesthetics|mesh-ancestor
111422765|NCT02454296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111422766|NCT02454296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111422767|NCT02454296|Sensory System Agents|sensory system agents|mesh-ancestor
111422768|NCT02454296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111422769|NCT02454296|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111422770|NCT02454296|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111422771|NCT02454296|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111422772|NCT02454296|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111422773|NCT02454296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111422774|NCT03836833|Lamivudine|lamivudine|mesh-list
111422775|NCT03836833|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111422776|NCT03836833|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111422777|NCT03836833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111422778|NCT03836833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111422779|NCT03836833|Antiviral Agents|antiviral agents|mesh-ancestor
111422780|NCT03836833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111422781|NCT03836833|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111422782|NCT03836833|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111422783|NCT05710471|Aflibercept|aflibercept|mesh-list
111422784|NCT05710471|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111422785|NCT05710471|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111422786|NCT05710471|Growth Substances|growth substances|mesh-ancestor
111422787|NCT05710471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111422788|NCT05710471|Growth Inhibitors|growth inhibitors|mesh-ancestor
111422789|NCT05710471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111422790|NCT00358969|Guanfacine|guanfacine|mesh-list
111422791|NCT00358969|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111422792|NCT00358969|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111422793|NCT00358969|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111422794|NCT00358969|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111422795|NCT00358969|Adrenergic Agents|adrenergic agents|mesh-ancestor
111422796|NCT00358969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111422797|NCT00358969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111147183|NCT02210091|Factor VIII|factor viii|mesh-list
111422798|NCT00358969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111422799|NCT02896712|Modafinil|modafinil|mesh-list
111422800|NCT02896712|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111422801|NCT02896712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111422802|NCT02896712|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
111422803|NCT02896712|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111422804|NCT02896712|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111422805|NCT02896712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111422806|NCT05346601|Chiauranib|chiauranib|mesh-list
111422807|NCT05346601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111422808|NCT05346601|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111422809|NCT05346601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111422810|NCT05346601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111422811|NCT04344379|Azithromycin|azithromycin|mesh-list
111422812|NCT04344379|Hydroxychloroquine|hydroxychloroquine|mesh-list
111422813|NCT04344379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111422814|NCT04344379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111422815|NCT04344379|Antimalarials|antimalarials|mesh-ancestor
111422816|NCT04344379|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111422817|NCT04344379|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111422818|NCT04344379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111422819|NCT04344379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111422820|NCT04344379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111422821|NCT00359125|Mifepristone|mifepristone|mesh-list
111422822|NCT00359125|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
111422823|NCT00359125|Abortifacient Agents|abortifacient agents|mesh-ancestor
111422824|NCT00359125|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111422825|NCT00359125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111422826|NCT00359125|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111422827|NCT00359125|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111422828|NCT00359125|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111422829|NCT00359125|Contraceptive Agents|contraceptive agents|mesh-ancestor
111422830|NCT00359125|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
111422831|NCT00359125|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
111422832|NCT00359125|Hormone Antagonists|hormone antagonists|mesh-ancestor
111422833|NCT00359125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111422834|NCT00359125|Luteolytic Agents|luteolytic agents|mesh-ancestor
111422835|NCT00359125|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111422836|NCT00359125|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
111422837|NCT03042468|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
111422838|NCT03042468|177Lu-PSMA-617|177lu-psma-617|mesh-list
111422839|NCT03042468|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111422840|NCT03042468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111422841|NCT04450836|Trifluridine|trifluridine|mesh-list
111422842|NCT04450836|Antimetabolites|antimetabolites|mesh-ancestor
111422843|NCT04450836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111422844|NCT04450836|Antiviral Agents|antiviral agents|mesh-ancestor
110900098|NCT03095521|Menthol|menthol|mesh-list
111422845|NCT04450836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111422846|NCT05679193|Propranolol|propranolol|mesh-list
111422847|NCT05679193|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111422848|NCT05679193|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111422849|NCT05679193|Adrenergic Agents|adrenergic agents|mesh-ancestor
111422850|NCT05679193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111422851|NCT05679193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111422852|NCT05679193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111422853|NCT05679193|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111422854|NCT05679193|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111422855|NCT05679193|Vasodilator Agents|vasodilator agents|mesh-ancestor
111422856|NCT04795752|Cyclosporine|cyclosporine|mesh-list
111422857|NCT04795752|Cyclosporins|cyclosporins|mesh-list
111422858|NCT04795752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111422859|NCT04795752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111422860|NCT04795752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111422861|NCT04795752|Immunologic Factors|immunologic factors|mesh-ancestor
111422862|NCT04795752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111422863|NCT04795752|Antifungal Agents|antifungal agents|mesh-ancestor
111422864|NCT04795752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111422865|NCT04795752|Dermatologic Agents|dermatologic agents|mesh-ancestor
111422866|NCT04795752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111422867|NCT04795752|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111422868|NCT02977741|Olanzapine|olanzapine|mesh-list
111422869|NCT02977741|Antiemetics|antiemetics|mesh-ancestor
111422870|NCT02977741|Autonomic Agents|autonomic agents|mesh-ancestor
111147257|NCT02374021|Sulfasalazine|sulfasalazine|mesh-list
111422871|NCT02977741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111422872|NCT02977741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111422873|NCT02977741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111422874|NCT02977741|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111422875|NCT02977741|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111422876|NCT02977741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111422877|NCT02977741|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111422878|NCT02977741|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111422879|NCT02977741|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111422880|NCT02977741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111422881|NCT02977741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111422882|NCT02977741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111422883|NCT02977741|Serotonin Agents|serotonin agents|mesh-ancestor
111422884|NCT04334070|Clofazimine|clofazimine|mesh-list
111422885|NCT04334070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111422886|NCT04334070|Leprostatic Agents|leprostatic agents|mesh-ancestor
111422887|NCT04334070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111422888|NCT04334070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111422889|NCT05292001|Dextrans|dextrans|mesh-list
111422890|NCT05292001|Iron-Dextran Complex|iron-dextran complex|mesh-list
111422891|NCT05292001|Anticoagulants|anticoagulants|mesh-ancestor
111422892|NCT05292001|Plasma Substitutes|plasma substitutes|mesh-ancestor
111422893|NCT05292001|Blood Substitutes|blood substitutes|mesh-ancestor
111422894|NCT05292001|Hematinics|hematinics|mesh-ancestor
111422895|NCT01634178|Apremilast|apremilast|mesh-list
111422896|NCT01634178|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111422897|NCT01634178|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111422898|NCT01634178|Analgesics|analgesics|mesh-ancestor
111422899|NCT01634178|Sensory System Agents|sensory system agents|mesh-ancestor
111422900|NCT01634178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111422901|NCT01634178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111422902|NCT01634178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111422903|NCT01634178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111422904|NCT01634178|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
111422905|NCT01634178|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111422906|NCT01634178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111422907|NCT01634178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111422908|NCT00359359|Sagopilone|sagopilone|mesh-list
111422909|NCT00359359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111422910|NCT04782804|Capecitabine|capecitabine|mesh-list
111422911|NCT04782804|Tislelizumab|tislelizumab|mesh-list
111422912|NCT04782804|Antibodies|antibodies|mesh-list
111422913|NCT04782804|Immunologic Factors|immunologic factors|mesh-ancestor
111422914|NCT04782804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110510932|NCT00873769|Loxapine|loxapine|mesh-list
111422915|NCT04782804|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111422916|NCT04782804|Antimetabolites|antimetabolites|mesh-ancestor
111422917|NCT04782804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111422918|NCT04782804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111422919|NCT04782804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111422920|NCT04227288|Betamethasone|betamethasone|mesh-list
111422921|NCT04227288|Betamethasone Valerate|betamethasone valerate|mesh-list
111422922|NCT04227288|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
111422923|NCT04227288|Betamethasone benzoate|betamethasone benzoate|mesh-list
111422924|NCT04227288|Calcipotriene|calcipotriene|mesh-list
111422925|NCT04227288|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
111422926|NCT04227288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111422927|NCT04227288|Glucocorticoids|glucocorticoids|mesh-ancestor
111422928|NCT04227288|Hormones|hormones|mesh-ancestor
111422929|NCT04227288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111422930|NCT04227288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111422931|NCT04227288|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111422932|NCT04227288|Respiratory System Agents|respiratory system agents|mesh-ancestor
111422933|NCT04227288|Dermatologic Agents|dermatologic agents|mesh-ancestor
111422934|NCT02978443|Nivolumab|nivolumab|mesh-list
111422935|NCT02978443|Ipilimumab|ipilimumab|mesh-list
111422936|NCT02978443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111422937|NCT02978443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111422938|NCT02978443|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111422939|NCT02978443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111422940|NCT02465450|Lenabasum|lenabasum|mesh-list
111422941|NCT02465450|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
111422942|NCT02465450|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
111422943|NCT02465450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111147345|NCT02167893|Leuprolide|leuprolide|mesh-list
111422944|NCT02465450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111422945|NCT02465450|Hormones|hormones|mesh-ancestor
111422946|NCT02465450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111422947|NCT02465450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111422948|NCT00608972|Bevacizumab|bevacizumab|mesh-list
111422949|NCT00608972|Carboplatin|carboplatin|mesh-list
111422950|NCT00608972|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111422951|NCT00608972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111422952|NCT00608972|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111422953|NCT00608972|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111422954|NCT00608972|Growth Substances|growth substances|mesh-ancestor
111422955|NCT00608972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111422956|NCT00608972|Growth Inhibitors|growth inhibitors|mesh-ancestor
111422957|NCT02729714|Suvorexant|suvorexant|mesh-list
111422958|NCT02729714|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111422959|NCT02729714|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111422960|NCT02729714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111422961|NCT02729714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111422962|NCT02729714|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
111422963|NCT02729714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111422964|NCT02729714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111422965|NCT04802382|Fibrin fragment D|fibrin fragment d|mesh-list
111422966|NCT04802382|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111422967|NCT04802382|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111422968|NCT04802382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111422969|NCT04802382|Hemostatics|hemostatics|mesh-ancestor
111422970|NCT04802382|Coagulants|coagulants|mesh-ancestor
111422971|NCT05648916|Celecoxib|celecoxib|mesh-list
111422972|NCT05648916|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111422973|NCT05648916|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111422974|NCT05648916|Analgesics|analgesics|mesh-ancestor
111422975|NCT05648916|Sensory System Agents|sensory system agents|mesh-ancestor
111422976|NCT05648916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111422977|NCT05648916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111422978|NCT05648916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111422979|NCT05648916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111422980|NCT05648916|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111422981|NCT05648916|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111422982|NCT05648916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111422983|NCT05648916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111422984|NCT05458609|Naltrexone|naltrexone|mesh-list
111422985|NCT05458609|Lemborexant|lemborexant|mesh-list
111422986|NCT05458609|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111422987|NCT05458609|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111422988|NCT05458609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111422989|NCT05458609|Sensory System Agents|sensory system agents|mesh-ancestor
111422990|NCT05458609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111422991|NCT05458609|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
111422992|NCT05458609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111422993|NCT05458609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111422994|NCT05458609|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111422995|NCT05458609|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111422996|NCT05458609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111422997|NCT05648058|Diphenhydramine|diphenhydramine|mesh-list
111422998|NCT05648058|Promethazine|promethazine|mesh-list
111422999|NCT05648058|Nefopam|nefopam|mesh-list
111423000|NCT05648058|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111423001|NCT05648058|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111423002|NCT05648058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111423003|NCT05648058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111423004|NCT05648058|Anesthetics, Local|anesthetics, local|mesh-ancestor
111423005|NCT05648058|Anesthetics|anesthetics|mesh-ancestor
111423006|NCT05648058|Sensory System Agents|sensory system agents|mesh-ancestor
111423007|NCT05648058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111423008|NCT05648058|Antiemetics|antiemetics|mesh-ancestor
111423009|NCT05648058|Autonomic Agents|autonomic agents|mesh-ancestor
111423010|NCT05648058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111423011|NCT05648058|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111423012|NCT05648058|Histamine Antagonists|histamine antagonists|mesh-ancestor
111423013|NCT05648058|Histamine Agents|histamine agents|mesh-ancestor
111423014|NCT05648058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111423015|NCT05648058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111423016|NCT05648058|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111423017|NCT05648058|Antipruritics|antipruritics|mesh-ancestor
111423018|NCT05648058|Dermatologic Agents|dermatologic agents|mesh-ancestor
111423020|NCT05648058|Analgesics|analgesics|mesh-ancestor
111423021|NCT05649085|Cobalt|cobalt|mesh-list
111423022|NCT05649085|Chromium|chromium|mesh-list
111423023|NCT05649085|Trace Elements|trace elements|mesh-ancestor
111423024|NCT05649085|Micronutrients|micronutrients|mesh-ancestor
111423025|NCT05649085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111423026|NCT05210101|Sotrovimab|sotrovimab|mesh-list
111423027|NCT05210101|Antiviral Agents|antiviral agents|mesh-ancestor
111423028|NCT05210101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111423029|NCT02959411|Tolvaptan|tolvaptan|mesh-list
111423030|NCT02959411|Diuretics|diuretics|mesh-list
111423031|NCT02959411|Natriuretic Agents|natriuretic agents|mesh-ancestor
111423032|NCT02959411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111423033|NCT02959411|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
111423034|NCT02959411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111423035|NCT05426161|Botulinum Toxins|botulinum toxins|mesh-list
111423036|NCT05426161|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111423037|NCT05426161|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111423038|NCT05426161|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111423039|NCT05426161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111423040|NCT05426161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111423041|NCT05426161|Cholinergic Agents|cholinergic agents|mesh-ancestor
111423042|NCT05426161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111423043|NCT05426161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111423044|NCT05426161|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111423045|NCT05426161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111423046|NCT05630833|Nitrofurantoin|nitrofurantoin|mesh-list
111423047|NCT05630833|Gepotidacin|gepotidacin|mesh-list
111423048|NCT05630833|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111423049|NCT05630833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111423050|NCT05630833|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111423051|NCT05630833|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111423052|NCT05630833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111423053|NCT05630833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111423054|NCT05630833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111423055|NCT00359671|Docetaxel|docetaxel|mesh-list
111423056|NCT00359671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111423057|NCT00359671|Tubulin Modulators|tubulin modulators|mesh-ancestor
111423058|NCT00359671|Antimitotic Agents|antimitotic agents|mesh-ancestor
111423059|NCT00359671|Mitosis Modulators|mitosis modulators|mesh-ancestor
111423060|NCT00359671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111423061|NCT02977897|Octreotide|octreotide|mesh-list
111423062|NCT02977897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111423063|NCT02977897|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111423064|NCT02977897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111423065|NCT05114941|Immunoglobulins|immunoglobulins|mesh-list
111423066|NCT05114941|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111423067|NCT05114941|Antibodies|antibodies|mesh-list
111423068|NCT05114941|gamma-Globulins|gamma-globulins|mesh-list
111423069|NCT05114941|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
111423070|NCT05114941|Immunologic Factors|immunologic factors|mesh-ancestor
111423071|NCT05114941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111423072|NCT00359905|Tamsulosin|tamsulosin|mesh-list
111423073|NCT00359905|Silodosin|silodosin|mesh-list
111423074|NCT00359905|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111423075|NCT00359905|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111423076|NCT00359905|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111423077|NCT00359905|Adrenergic Agents|adrenergic agents|mesh-ancestor
111423078|NCT00359905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111423079|NCT00359905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111423080|NCT00359905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111423081|NCT00359905|Urological Agents|urological agents|mesh-ancestor
111423082|NCT05086939|Hyaluronic Acid|hyaluronic acid|mesh-list
111423083|NCT05086939|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111423084|NCT05086939|Immunologic Factors|immunologic factors|mesh-ancestor
111423085|NCT05086939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111423086|NCT05086939|Viscosupplements|viscosupplements|mesh-ancestor
111423087|NCT05086939|Protective Agents|protective agents|mesh-ancestor
111423088|NCT00358813|Casopitant|casopitant|mesh-list
111423089|NCT00358813|Antiemetics|antiemetics|mesh-ancestor
111423090|NCT00358813|Autonomic Agents|autonomic agents|mesh-ancestor
111423091|NCT00358813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111423092|NCT00358813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111423093|NCT00358813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111147480|NCT02164929|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111423094|NCT00358813|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
111423095|NCT00358813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111423096|NCT00358813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111423097|NCT04871191|Rituximab|rituximab|mesh-list
111423098|NCT04871191|Abatacept|abatacept|mesh-list
111423099|NCT04871191|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111423100|NCT04871191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111423101|NCT04871191|Immunologic Factors|immunologic factors|mesh-ancestor
111423102|NCT04871191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111423103|NCT04871191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111423104|NCT04871191|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111423105|NCT04871191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111423106|NCT04871191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111423107|NCT02976805|Bisacodyl|bisacodyl|mesh-list
111423108|NCT02976805|Cathartics|cathartics|mesh-ancestor
111423109|NCT02976805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111423110|NCT02976805|Laxatives|laxatives|mesh-ancestor
111423111|NCT04835623|Cyclosporine|cyclosporine|mesh-list
111423112|NCT04835623|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111423113|NCT04835623|Cyclosporins|cyclosporins|mesh-list
111423114|NCT04835623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111423115|NCT04835623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111423116|NCT04835623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111423117|NCT04835623|Immunologic Factors|immunologic factors|mesh-ancestor
111423118|NCT04835623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111423119|NCT04835623|Antifungal Agents|antifungal agents|mesh-ancestor
111423120|NCT04835623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111423121|NCT04835623|Dermatologic Agents|dermatologic agents|mesh-ancestor
111423122|NCT04835623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111423123|NCT04835623|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111423124|NCT04835623|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111423125|NCT04500613|Dexamethasone|dexamethasone|mesh-list
111423126|NCT04500613|Dexamethasone acetate|dexamethasone acetate|mesh-list
111423127|NCT04500613|Bupivacaine|bupivacaine|mesh-list
111423128|NCT04500613|BB 1101|bb 1101|mesh-list
111423129|NCT04500613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111423130|NCT04500613|Antiemetics|antiemetics|mesh-ancestor
111423131|NCT04500613|Autonomic Agents|autonomic agents|mesh-ancestor
111423132|NCT04500613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111423133|NCT04500613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111423134|NCT04500613|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111423135|NCT04500613|Glucocorticoids|glucocorticoids|mesh-ancestor
111423136|NCT04500613|Hormones|hormones|mesh-ancestor
111423137|NCT04500613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111423138|NCT04500613|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111423139|NCT04500613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111423140|NCT04500613|Protease Inhibitors|protease inhibitors|mesh-ancestor
111423141|NCT04500613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111423142|NCT04500613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111423143|NCT04500613|Anesthetics, Local|anesthetics, local|mesh-ancestor
111423144|NCT04500613|Anesthetics|anesthetics|mesh-ancestor
111423145|NCT04500613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111423146|NCT04500613|Sensory System Agents|sensory system agents|mesh-ancestor
111423147|NCT04833907|Prednisone|prednisone|mesh-list
111423148|NCT04833907|Levetiracetam|levetiracetam|mesh-list
111423149|NCT04833907|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111423150|NCT04833907|Glucocorticoids|glucocorticoids|mesh-ancestor
111423151|NCT04833907|Hormones|hormones|mesh-ancestor
111423152|NCT04833907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111423153|NCT04833907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111423154|NCT04833907|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111423155|NCT04833907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111423156|NCT04833907|Anticonvulsants|anticonvulsants|mesh-ancestor
111423157|NCT04833907|Nootropic Agents|nootropic agents|mesh-ancestor
111423158|NCT02976259|Dolutegravir|dolutegravir|mesh-list
111423159|NCT02976259|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111423160|NCT02976259|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111423161|NCT02976259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111423162|NCT02976259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111423163|NCT02976259|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111423164|NCT02976259|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111423165|NCT02976259|Antiviral Agents|antiviral agents|mesh-ancestor
111423166|NCT02976259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111423167|NCT00360295|Azithromycin|azithromycin|mesh-list
111423168|NCT00360295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111423169|NCT00360295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111423170|NCT02976727|Vitamin D|vitamin d|mesh-list
111423171|NCT02976727|Lidocaine|lidocaine|mesh-list
111423172|NCT02976727|Prilocaine|prilocaine|mesh-list
111423173|NCT02976727|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
111423174|NCT02976727|Calcipotriene|calcipotriene|mesh-list
111423175|NCT02976727|Vitamins|vitamins|mesh-ancestor
111423176|NCT02976727|Micronutrients|micronutrients|mesh-ancestor
111423177|NCT02976727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111423178|NCT02976727|Anesthetics, Local|anesthetics, local|mesh-ancestor
111423179|NCT02976727|Anesthetics|anesthetics|mesh-ancestor
111423180|NCT02976727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111423181|NCT02976727|Sensory System Agents|sensory system agents|mesh-ancestor
111423182|NCT02976727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111423183|NCT02976727|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111423184|NCT02976727|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111423185|NCT02976727|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111423186|NCT02976727|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111423187|NCT02976727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111423188|NCT02976727|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111423189|NCT02976727|Dermatologic Agents|dermatologic agents|mesh-ancestor
111423190|NCT02976727|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
111423191|NCT02977117|Dialysis Solutions|dialysis solutions|mesh-list
111423192|NCT02977117|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111423193|NCT00360607|Metronidazole|metronidazole|mesh-list
111423194|NCT00360607|Amikacin|amikacin|mesh-list
111423195|NCT00360607|Ceftazidime|ceftazidime|mesh-list
111423196|NCT00360607|Sulbactam|sulbactam|mesh-list
111423197|NCT00360607|Cefoperazone|cefoperazone|mesh-list
111423198|NCT00360607|Sulperazone|sulperazone|mesh-list
111423199|NCT00360607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111423200|NCT00360607|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111423201|NCT00360607|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111423202|NCT00360607|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111423203|NCT00360607|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
111423204|NCT00360607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111423205|NCT00360607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111423206|NCT00360607|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111423207|NCT00360763|Candesartan|candesartan|mesh-list
111423208|NCT00360763|Candesartan cilexetil|candesartan cilexetil|mesh-list
111423209|NCT00360763|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111423210|NCT00360763|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111423211|NCT00360763|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111423212|NCT00360763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111423213|NCT04032301|Ketamine|ketamine|mesh-list
111423214|NCT04032301|Analgesics|analgesics|mesh-ancestor
111423215|NCT04032301|Sensory System Agents|sensory system agents|mesh-ancestor
111423216|NCT04032301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111423217|NCT04032301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111423218|NCT04032301|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111423219|NCT04032301|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111423220|NCT04032301|Anesthetics, General|anesthetics, general|mesh-ancestor
111423221|NCT04032301|Anesthetics|anesthetics|mesh-ancestor
111423222|NCT04032301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111423223|NCT04032301|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111423224|NCT04032301|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111423225|NCT04032301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111423226|NCT04032301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111423227|NCT04010305|Dexmedetomidine|dexmedetomidine|mesh-list
111423228|NCT04010305|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111423229|NCT04010305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111423230|NCT04010305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111423231|NCT04010305|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111423232|NCT04010305|Analgesics|analgesics|mesh-ancestor
111423233|NCT04010305|Sensory System Agents|sensory system agents|mesh-ancestor
111423234|NCT04010305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111423235|NCT04010305|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111423236|NCT04010305|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111423237|NCT04010305|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111423238|NCT04010305|Adrenergic Agents|adrenergic agents|mesh-ancestor
111423239|NCT04010305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111423240|NCT04010305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111423241|NCT00361933|Valganciclovir|valganciclovir|mesh-list
111423242|NCT00361933|Antiviral Agents|antiviral agents|mesh-ancestor
111423243|NCT00361933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111423244|NCT04786093|Durvalumab|durvalumab|mesh-list
111423245|NCT04786093|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111423246|NCT04786093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111423247|NCT02976571|Bupivacaine|bupivacaine|mesh-list
111423248|NCT02976571|Anesthetics, Local|anesthetics, local|mesh-ancestor
111423249|NCT02976571|Anesthetics|anesthetics|mesh-ancestor
111423250|NCT02976571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111423251|NCT02976571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111423252|NCT02976571|Sensory System Agents|sensory system agents|mesh-ancestor
111423253|NCT02976571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111423254|NCT04731025|Vancomycin|vancomycin|mesh-list
111423255|NCT04731025|Gentamicins|gentamicins|mesh-list
111423256|NCT04731025|Cefazolin|cefazolin|mesh-list
111423257|NCT04731025|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111423258|NCT04731025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111423259|NCT04731025|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111423260|NCT04731025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110510961|NCT02787018|Autonomic Agents|autonomic agents|mesh-ancestor
111423261|NCT04731025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111423262|NCT04730635|Donepezil|donepezil|mesh-list
111423263|NCT04730635|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111423264|NCT04730635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111423265|NCT04730635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111423266|NCT04730635|Cholinergic Agents|cholinergic agents|mesh-ancestor
111423267|NCT04730635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111423268|NCT04730635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111423269|NCT04730635|Nootropic Agents|nootropic agents|mesh-ancestor
111423270|NCT04686799|Doxycycline|doxycycline|mesh-list
111423271|NCT04686799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111423272|NCT04686799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111423273|NCT04686799|Antimalarials|antimalarials|mesh-ancestor
111423274|NCT04686799|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111423275|NCT04686799|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111423276|NCT04676035|Vitamin K 1|vitamin k 1|mesh-list
111423277|NCT04676035|Vitamin K|vitamin k|mesh-list
111423278|NCT04676035|Midazolam|midazolam|mesh-list
111423279|NCT04676035|Omeprazole|omeprazole|mesh-list
111423280|NCT04676035|Warfarin|warfarin|mesh-list
111423281|NCT04676035|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111423282|NCT04676035|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111423283|NCT04676035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111423284|NCT04676035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111423285|NCT04676035|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111423286|NCT04676035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111423287|NCT04676035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111423288|NCT04676035|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111423289|NCT04676035|Anesthetics, General|anesthetics, general|mesh-ancestor
111423290|NCT04676035|Anesthetics|anesthetics|mesh-ancestor
111423291|NCT04676035|GABA Modulators|gaba modulators|mesh-ancestor
111423292|NCT04676035|GABA Agents|gaba agents|mesh-ancestor
111423293|NCT04676035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111423294|NCT04676035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111423295|NCT04676035|Anticoagulants|anticoagulants|mesh-ancestor
111423296|NCT04676035|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111423297|NCT04676035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111423298|NCT04676035|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111423299|NCT04676035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111423300|NCT04676035|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111423301|NCT04676035|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111423302|NCT04676035|Hemostatics|hemostatics|mesh-ancestor
111423303|NCT04676035|Coagulants|coagulants|mesh-ancestor
111423304|NCT04676035|Vitamins|vitamins|mesh-ancestor
111423305|NCT04676035|Micronutrients|micronutrients|mesh-ancestor
111423306|NCT03926299|Clobetasol|clobetasol|mesh-list
111423307|NCT03926299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111423308|NCT03926299|Glucocorticoids|glucocorticoids|mesh-ancestor
111423309|NCT03926299|Hormones|hormones|mesh-ancestor
111423310|NCT03926299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111423311|NCT03926299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111423312|NCT04359199|Cisplatin|cisplatin|mesh-list
111423313|NCT04359199|Pembrolizumab|pembrolizumab|mesh-list
111423314|NCT04359199|Nivolumab|nivolumab|mesh-list
111423315|NCT04359199|Cetuximab|cetuximab|mesh-list
111423316|NCT04359199|Durvalumab|durvalumab|mesh-list
111423317|NCT04359199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111423318|NCT04359199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111147707|NCT05379179|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111423319|NCT04359199|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111423320|NCT04359199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111423321|NCT03875911|Mitomycins|mitomycins|mesh-list
111423322|NCT03875911|Mitomycin|mitomycin|mesh-list
111423323|NCT03875911|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111423324|NCT03875911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111423325|NCT03875911|Alkylating Agents|alkylating agents|mesh-ancestor
111423326|NCT03875911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111423327|NCT03875911|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111423328|NCT03875911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111423329|NCT00361075|Estradiol|estradiol|mesh-list
111423330|NCT00361075|Estrogens|estrogens|mesh-list
111423331|NCT00361075|Progesterone|progesterone|mesh-list
111423332|NCT00361075|Hormones|hormones|mesh-ancestor
111423333|NCT00361075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111423334|NCT00361075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111423335|NCT00361075|Progestins|progestins|mesh-ancestor
111423336|NCT03844633|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
111423337|NCT03844633|Medroxyprogesterone|medroxyprogesterone|mesh-list
111423338|NCT03844633|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111423339|NCT03844633|Contraceptive Agents|contraceptive agents|mesh-ancestor
111423340|NCT03844633|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111423341|NCT03844633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111423342|NCT03844633|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111423343|NCT03844633|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
111423344|NCT03844633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111423345|NCT03844633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111423346|NCT03844633|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111423347|NCT03844633|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111423348|NCT03844633|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111423349|NCT00362089|Dronabinol|dronabinol|mesh-list
111423350|NCT00362089|Hallucinogens|hallucinogens|mesh-ancestor
111423351|NCT00362089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111423352|NCT00362089|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111423353|NCT00362089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111423354|NCT00362089|Analgesics|analgesics|mesh-ancestor
111423355|NCT00362089|Sensory System Agents|sensory system agents|mesh-ancestor
111423356|NCT00362089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111423357|NCT00362089|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
111423358|NCT00362089|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
111423359|NCT00362089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111423360|NCT00362089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111423361|NCT00362089|Hormones|hormones|mesh-ancestor
111423362|NCT00362089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111423363|NCT04666987|Liraglutide|liraglutide|mesh-list
111423364|NCT04666987|Xultophy|xultophy|mesh-list
111423365|NCT04666987|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111423366|NCT04666987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111423367|NCT04666987|Incretins|incretins|mesh-ancestor
111423368|NCT04666987|Hormones|hormones|mesh-ancestor
111423369|NCT04666987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111423370|NCT04318717|Pembrolizumab|pembrolizumab|mesh-list
111423371|NCT04318717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111423372|NCT04318717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111423373|NCT04318717|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111423374|NCT04318717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111423375|NCT03822637|Acetylcysteine|acetylcysteine|mesh-list
111423376|NCT03822637|Albuterol|albuterol|mesh-list
111423377|NCT03822637|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111423378|NCT03822637|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111423379|NCT03822637|Autonomic Agents|autonomic agents|mesh-ancestor
111423380|NCT03822637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111423381|NCT03822637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111423382|NCT03822637|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111423383|NCT03822637|Respiratory System Agents|respiratory system agents|mesh-ancestor
111423384|NCT03822637|Tocolytic Agents|tocolytic agents|mesh-ancestor
111423385|NCT03822637|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111423386|NCT03822637|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111423387|NCT03822637|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111423388|NCT03822637|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111423389|NCT03822637|Adrenergic Agents|adrenergic agents|mesh-ancestor
111423390|NCT03822637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110510972|NCT02787018|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111423391|NCT03822637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111423392|NCT03822637|Antiviral Agents|antiviral agents|mesh-ancestor
111423393|NCT03822637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111423394|NCT03822637|Expectorants|expectorants|mesh-ancestor
111423395|NCT03822637|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111423396|NCT03822637|Antioxidants|antioxidants|mesh-ancestor
111423397|NCT03822637|Protective Agents|protective agents|mesh-ancestor
111423398|NCT03822637|Antidotes|antidotes|mesh-ancestor
111423399|NCT05444101|Nicotine|nicotine|mesh-list
111423400|NCT05444101|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111423401|NCT05444101|Autonomic Agents|autonomic agents|mesh-ancestor
111423402|NCT05444101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111423403|NCT05444101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111423404|NCT05444101|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111423405|NCT05444101|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111423406|NCT05444101|Cholinergic Agents|cholinergic agents|mesh-ancestor
111423407|NCT05444101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111423408|NCT05444101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111423410|NCT02412306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111423411|NCT05616468|Cyclophosphamide|cyclophosphamide|mesh-list
111423412|NCT05616468|Fludarabine|fludarabine|mesh-list
111423413|NCT05616468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111423414|NCT05616468|Immunologic Factors|immunologic factors|mesh-ancestor
111423415|NCT05616468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111423416|NCT05616468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111423417|NCT05616468|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111423418|NCT05616468|Alkylating Agents|alkylating agents|mesh-ancestor
111423419|NCT05616468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111423420|NCT05616468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111423421|NCT05616468|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111423422|NCT03654768|Imatinib Mesylate|imatinib mesylate|mesh-list
111423423|NCT03654768|Dasatinib|dasatinib|mesh-list
111423424|NCT03654768|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
111423425|NCT03654768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111423426|NCT03654768|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111423427|NCT03654768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111423428|NCT03654768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111423429|NCT01352221|Ferric maltol|ferric maltol|mesh-list
111423430|NCT01352221|Hematinics|hematinics|mesh-ancestor
111423431|NCT05195034|Dexmedetomidine|dexmedetomidine|mesh-list
111423432|NCT05195034|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111423433|NCT05195034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111423434|NCT05195034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111423435|NCT05195034|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111423436|NCT05195034|Analgesics|analgesics|mesh-ancestor
111423437|NCT05195034|Sensory System Agents|sensory system agents|mesh-ancestor
111423438|NCT05195034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111423439|NCT05195034|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111423440|NCT05195034|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111423441|NCT05195034|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111423442|NCT05195034|Adrenergic Agents|adrenergic agents|mesh-ancestor
111423443|NCT05195034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111423444|NCT05195034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111423445|NCT05496894|Mitoxantrone|mitoxantrone|mesh-list
111423446|NCT05496894|Analgesics|analgesics|mesh-ancestor
111423447|NCT05496894|Sensory System Agents|sensory system agents|mesh-ancestor
111423448|NCT05496894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111423449|NCT05496894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111423450|NCT05496894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111423451|NCT05496894|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111423452|NCT05496894|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111423453|NCT05496894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110510998|NCT03412266|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111423454|NCT05496894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111423455|NCT02065362|Cyclophosphamide|cyclophosphamide|mesh-list
111423456|NCT02065362|Fludarabine|fludarabine|mesh-list
111423457|NCT02065362|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111423458|NCT02065362|Immunologic Factors|immunologic factors|mesh-ancestor
111423459|NCT02065362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111423460|NCT02065362|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111423461|NCT02065362|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111423462|NCT02065362|Alkylating Agents|alkylating agents|mesh-ancestor
111423463|NCT02065362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111423464|NCT02065362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111423465|NCT02065362|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111423466|NCT02021604|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
111423467|NCT02021604|Dopamine Agents|dopamine agents|mesh-ancestor
111423468|NCT02021604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111423469|NCT02021604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111423470|NCT02021604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111423471|NCT03518034|Testosterone|testosterone|mesh-list
111423472|NCT03518034|Androgens|androgens|mesh-ancestor
111423473|NCT03518034|Hormones|hormones|mesh-ancestor
111423474|NCT03518034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111423476|NCT04448886|Pembrolizumab|pembrolizumab|mesh-list
111423477|NCT04448886|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
111423478|NCT04448886|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111423479|NCT04448886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111423480|NCT04448886|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111423481|NCT04448886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111423482|NCT04448886|Immunoconjugates|immunoconjugates|mesh-ancestor
111423483|NCT04448886|Immunologic Factors|immunologic factors|mesh-ancestor
111423484|NCT04448886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111423485|NCT02389218|Sotalol|sotalol|mesh-list
111423486|NCT02389218|Flecainide|flecainide|mesh-list
111423487|NCT02389218|Propafenone|propafenone|mesh-list
111423488|NCT02389218|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111423489|NCT02389218|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111423490|NCT02389218|Adrenergic Agents|adrenergic agents|mesh-ancestor
111423491|NCT02389218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111423492|NCT02389218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111423493|NCT02389218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111423494|NCT02389218|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111423495|NCT02389218|Sympatholytics|sympatholytics|mesh-ancestor
111423496|NCT02389218|Autonomic Agents|autonomic agents|mesh-ancestor
111423497|NCT02389218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111423498|NCT02389218|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111423499|NCT02389218|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111423500|NCT02389218|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111423501|NCT01953120|Abatacept|abatacept|mesh-list
111423502|NCT01953120|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111423503|NCT01953120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111423504|NCT01953120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111423505|NCT01953120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111423506|NCT01953120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111423507|NCT01953120|Immunologic Factors|immunologic factors|mesh-ancestor
111423508|NCT01953120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111423509|NCT01953120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111423510|NCT01634100|Empagliflozin|empagliflozin|mesh-list
111423511|NCT01634100|Rifampin|rifampin|mesh-list
111423512|NCT01634100|Probenecid|probenecid|mesh-list
111423513|NCT01634100|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111423514|NCT01634100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111423515|NCT01634100|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111423516|NCT01634100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111423517|NCT01634100|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111423518|NCT01634100|Antitubercular Agents|antitubercular agents|mesh-ancestor
111423519|NCT01634100|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111423520|NCT01634100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111423521|NCT01634100|Leprostatic Agents|leprostatic agents|mesh-ancestor
111423522|NCT01634100|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111423523|NCT01634100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111423524|NCT01634100|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111423525|NCT01634100|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111423526|NCT01634100|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
111423527|NCT01634100|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
111423528|NCT01634100|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
111423529|NCT01634100|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111423530|NCT01634100|Uricosuric Agents|uricosuric agents|mesh-ancestor
111423531|NCT01634100|Gout Suppressants|gout suppressants|mesh-ancestor
111423532|NCT01634100|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111423533|NCT03661645|Dexamethasone|dexamethasone|mesh-list
111423534|NCT03661645|Dexamethasone acetate|dexamethasone acetate|mesh-list
111423535|NCT03661645|Methylprednisolone|methylprednisolone|mesh-list
111423536|NCT03661645|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111423537|NCT03661645|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111423538|NCT03661645|BB 1101|bb 1101|mesh-list
111423539|NCT03661645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111423540|NCT03661645|Antiemetics|antiemetics|mesh-ancestor
111423541|NCT03661645|Autonomic Agents|autonomic agents|mesh-ancestor
111423542|NCT03661645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111423543|NCT03661645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111423544|NCT03661645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111423545|NCT03661645|Glucocorticoids|glucocorticoids|mesh-ancestor
111423546|NCT03661645|Hormones|hormones|mesh-ancestor
111423547|NCT03661645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111423548|NCT03661645|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111423549|NCT03661645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111423550|NCT03661645|Protease Inhibitors|protease inhibitors|mesh-ancestor
111423551|NCT03661645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111423552|NCT03661645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111423553|NCT03661645|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111423554|NCT03661645|Protective Agents|protective agents|mesh-ancestor
111423555|NCT01633944|Buprenorphine|buprenorphine|mesh-list
111423556|NCT01633944|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111423557|NCT01633944|Narcotics|narcotics|mesh-ancestor
111423558|NCT01633944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111423559|NCT01633944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111423560|NCT01633944|Analgesics|analgesics|mesh-ancestor
111423561|NCT01633944|Sensory System Agents|sensory system agents|mesh-ancestor
111423562|NCT01633944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111423563|NCT01633944|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111423564|NCT04592419|Aflibercept|aflibercept|mesh-list
111423565|NCT04592419|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111423566|NCT04592419|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111423567|NCT04592419|Growth Substances|growth substances|mesh-ancestor
111423568|NCT04592419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111423569|NCT04592419|Growth Inhibitors|growth inhibitors|mesh-ancestor
111423570|NCT04592419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111423571|NCT00589316|Iodine|iodine|mesh-list
111423572|NCT00589316|Mycophenolic Acid|mycophenolic acid|mesh-list
111423573|NCT00589316|Cadexomer iodine|cadexomer iodine|mesh-list
111423574|NCT00589316|Cyclophosphamide|cyclophosphamide|mesh-list
111423575|NCT00589316|Fludarabine|fludarabine|mesh-list
111423576|NCT00589316|Fludarabine phosphate|fludarabine phosphate|mesh-list
111423577|NCT00589316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111423578|NCT00589316|Tacrolimus|tacrolimus|mesh-list
111423579|NCT00589316|Antibodies|antibodies|mesh-list
111423580|NCT00589316|Immunoglobulins|immunoglobulins|mesh-list
111423581|NCT00589316|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111423582|NCT00589316|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111423583|NCT00589316|Immunologic Factors|immunologic factors|mesh-ancestor
111423584|NCT00589316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111423585|NCT00589316|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111423586|NCT00589316|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111423587|NCT00589316|Alkylating Agents|alkylating agents|mesh-ancestor
111423588|NCT00589316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111423589|NCT00589316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111423590|NCT00589316|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111423591|NCT00589316|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111423592|NCT00589316|Antimetabolites|antimetabolites|mesh-ancestor
111423593|NCT00589316|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111423594|NCT00589316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111423595|NCT00589316|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111423596|NCT00589316|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111423597|NCT00589316|Antitubercular Agents|antitubercular agents|mesh-ancestor
111423598|NCT00589316|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111423599|NCT00589316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111423600|NCT00589316|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111423601|NCT00589316|Trace Elements|trace elements|mesh-ancestor
111423602|NCT00589316|Micronutrients|micronutrients|mesh-ancestor
111423603|NCT00362245|Amikacin|amikacin|mesh-list
111423604|NCT00362245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111423605|NCT00362245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111423606|NCT00361543|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
111423607|NCT00361543|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111423608|NCT00361543|Hormone Antagonists|hormone antagonists|mesh-ancestor
111423609|NCT00361543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111423610|NCT00361543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111423611|NCT00361543|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111423612|NCT00361543|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111423613|NCT00361543|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111423614|NCT00003417|Carmustine|carmustine|mesh-list
111423615|NCT00003417|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111423616|NCT00003417|Alkylating Agents|alkylating agents|mesh-ancestor
111423617|NCT00003417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111423618|NCT00003417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111423619|NCT04329429|Trastuzumab|trastuzumab|mesh-list
111423620|NCT04329429|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111148005|NCT01658813|Fluorouracil|fluorouracil|mesh-list
111423621|NCT04329429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111423622|NCT00003423|Cytarabine|cytarabine|mesh-list
111423623|NCT00003423|Dexamethasone|dexamethasone|mesh-list
111423624|NCT00003423|Prednisolone|prednisolone|mesh-list
111423625|NCT00003423|Cyclophosphamide|cyclophosphamide|mesh-list
111423626|NCT00003423|Methotrexate|methotrexate|mesh-list
111423627|NCT00003423|Etoposide|etoposide|mesh-list
111423628|NCT00003423|Vincristine|vincristine|mesh-list
111423629|NCT00003423|Daunorubicin|daunorubicin|mesh-list
111423630|NCT00003423|Asparaginase|asparaginase|mesh-list
111423631|NCT00003423|Mercaptopurine|mercaptopurine|mesh-list
111423632|NCT00003423|Thioguanine|thioguanine|mesh-list
111423633|NCT00003423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111423634|NCT00003423|Immunologic Factors|immunologic factors|mesh-ancestor
111423635|NCT00003423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111423636|NCT00003423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111423637|NCT00003423|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111423638|NCT00003423|Alkylating Agents|alkylating agents|mesh-ancestor
111423639|NCT00003423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111423640|NCT00003423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111423641|NCT00003423|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111423642|NCT00003423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111423643|NCT00003423|Antiemetics|antiemetics|mesh-ancestor
111423644|NCT00003423|Autonomic Agents|autonomic agents|mesh-ancestor
111423645|NCT00003423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111423646|NCT00003423|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111423647|NCT00003423|Glucocorticoids|glucocorticoids|mesh-ancestor
111423648|NCT00003423|Hormones|hormones|mesh-ancestor
111423649|NCT00003423|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111423650|NCT00003423|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111423651|NCT00003423|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111423652|NCT00003423|Abortifacient Agents|abortifacient agents|mesh-ancestor
111423653|NCT00003423|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111423654|NCT00003423|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111423655|NCT00003423|Antimetabolites|antimetabolites|mesh-ancestor
111423656|NCT00003423|Dermatologic Agents|dermatologic agents|mesh-ancestor
111423657|NCT00003423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111423658|NCT00003423|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111423659|NCT00003423|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111423660|NCT00003423|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111423661|NCT00003423|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111423662|NCT00003423|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111423663|NCT00003423|Antiviral Agents|antiviral agents|mesh-ancestor
111423664|NCT00003423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111423665|NCT00003423|Tubulin Modulators|tubulin modulators|mesh-ancestor
111423666|NCT00003423|Antimitotic Agents|antimitotic agents|mesh-ancestor
111423667|NCT00003423|Mitosis Modulators|mitosis modulators|mesh-ancestor
111423668|NCT00003423|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111423669|NCT00003273|Leucovorin|leucovorin|mesh-list
111423670|NCT00003273|Cyclophosphamide|cyclophosphamide|mesh-list
111423671|NCT00003273|Temozolomide|temozolomide|mesh-list
111423672|NCT00003273|Thiotepa|thiotepa|mesh-list
111423673|NCT00003273|Carboplatin|carboplatin|mesh-list
111423674|NCT00003273|Methotrexate|methotrexate|mesh-list
111423675|NCT00003273|Etoposide|etoposide|mesh-list
111423676|NCT00003273|Vincristine|vincristine|mesh-list
111423677|NCT00003273|Levoleucovorin|levoleucovorin|mesh-list
111423678|NCT00003273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111423679|NCT00003273|Immunologic Factors|immunologic factors|mesh-ancestor
111423680|NCT00003273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111423681|NCT00003273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111423682|NCT00003273|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111423683|NCT00003273|Alkylating Agents|alkylating agents|mesh-ancestor
111423684|NCT00003273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111423685|NCT00003273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111423686|NCT00003273|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111423687|NCT00003273|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111423688|NCT00003273|Abortifacient Agents|abortifacient agents|mesh-ancestor
111423689|NCT00003273|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111423690|NCT00003273|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111423691|NCT00003273|Antimetabolites|antimetabolites|mesh-ancestor
111423692|NCT00003273|Dermatologic Agents|dermatologic agents|mesh-ancestor
111423693|NCT00003273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111423694|NCT00003273|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111423695|NCT00003273|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111423696|NCT00003273|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111423697|NCT00003273|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111423698|NCT00003273|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111423699|NCT00003273|Antidotes|antidotes|mesh-ancestor
111423700|NCT00003273|Protective Agents|protective agents|mesh-ancestor
111423701|NCT00003273|Vitamin B Complex|vitamin b complex|mesh-ancestor
111423702|NCT00003273|Vitamins|vitamins|mesh-ancestor
111423703|NCT00003273|Micronutrients|micronutrients|mesh-ancestor
111423704|NCT00003273|Tubulin Modulators|tubulin modulators|mesh-ancestor
111423705|NCT00003273|Antimitotic Agents|antimitotic agents|mesh-ancestor
111423706|NCT00003273|Mitosis Modulators|mitosis modulators|mesh-ancestor
111423707|NCT04329585|Flumazenil|flumazenil|mesh-list
111423708|NCT04329585|Antidotes|antidotes|mesh-ancestor
111423709|NCT04329585|Protective Agents|protective agents|mesh-ancestor
111423710|NCT04329585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111423711|NCT04329585|GABA Modulators|gaba modulators|mesh-ancestor
111423712|NCT04329585|GABA Agents|gaba agents|mesh-ancestor
111423713|NCT04329585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111423714|NCT04329585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111423715|NCT00003279|Antibodies|antibodies|mesh-list
111423716|NCT00003279|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111423717|NCT00003279|BCG Vaccine|bcg vaccine|mesh-list
111423718|NCT00003279|Immunologic Factors|immunologic factors|mesh-ancestor
111423719|NCT00003279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111423720|NCT00003279|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111423721|NCT00383487|Calcitriol|calcitriol|mesh-list
111423722|NCT00383487|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
111423723|NCT00383487|Naproxen|naproxen|mesh-list
111423724|NCT00383487|Naproxen-n-butyl nitrate|naproxen-n-butyl nitrate|mesh-list
111423725|NCT00383487|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111423726|NCT00383487|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111423727|NCT00383487|Analgesics|analgesics|mesh-ancestor
111423728|NCT00383487|Sensory System Agents|sensory system agents|mesh-ancestor
111423729|NCT00383487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111423730|NCT00383487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111423731|NCT00383487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111423732|NCT00383487|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111423733|NCT00383487|Gout Suppressants|gout suppressants|mesh-ancestor
111423734|NCT00383487|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111423735|NCT00383487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111423736|NCT00383487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111423737|NCT00383487|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111423738|NCT00383487|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
111423739|NCT00383487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111423740|NCT00383487|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111423741|NCT00383487|Vitamins|vitamins|mesh-ancestor
111423742|NCT00383487|Micronutrients|micronutrients|mesh-ancestor
111423743|NCT00383487|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111423744|NCT00383487|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
111423745|NCT00003429|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
111423746|NCT00003429|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111423747|NCT00003429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111423748|NCT00003435|Antiviral Agents|antiviral agents|mesh-list
111423749|NCT00003435|Melphalan|melphalan|mesh-list
111423750|NCT00003435|Antilymphocyte Serum|antilymphocyte serum|mesh-list
111423751|NCT00003435|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111423752|NCT00003435|Alkylating Agents|alkylating agents|mesh-ancestor
111423753|NCT00003435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111423754|NCT00003435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111423755|NCT00003435|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111423756|NCT00003435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111423757|NCT00003435|Immunologic Factors|immunologic factors|mesh-ancestor
111423758|NCT00003435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111423759|NCT00003435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111423760|NCT00003441|Irofulven|irofulven|mesh-list
111423761|NCT00003441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111423762|NCT00003441|Alkylating Agents|alkylating agents|mesh-ancestor
111423763|NCT00003441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111423764|NCT00003441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111423765|NCT00002805|Cobalt|cobalt|mesh-list
111423766|NCT00002805|Cytarabine|cytarabine|mesh-list
111423767|NCT00002805|Hydrocortisone|hydrocortisone|mesh-list
111423768|NCT00002805|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
111423769|NCT00002805|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
111423770|NCT00002805|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
111423771|NCT00002805|Methotrexate|methotrexate|mesh-list
111423772|NCT00002805|Etoposide|etoposide|mesh-list
111423773|NCT00002805|Mitoxantrone|mitoxantrone|mesh-list
111423774|NCT00002805|Cladribine|cladribine|mesh-list
111148155|NCT02161185|GABA Modulators|gaba modulators|mesh-ancestor
111423775|NCT00002805|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111423776|NCT00002805|Abortifacient Agents|abortifacient agents|mesh-ancestor
111423777|NCT00002805|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111423778|NCT00002805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111423779|NCT00002805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111423780|NCT00002805|Antimetabolites|antimetabolites|mesh-ancestor
111423781|NCT00002805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111423782|NCT00002805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111423783|NCT00002805|Dermatologic Agents|dermatologic agents|mesh-ancestor
111423784|NCT00002805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111423785|NCT00002805|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111423786|NCT00002805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111423787|NCT00002805|Immunologic Factors|immunologic factors|mesh-ancestor
111423788|NCT00002805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111423789|NCT00002805|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111423790|NCT00002805|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111423791|NCT00002805|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111423792|NCT00002805|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111423793|NCT00002805|Antiviral Agents|antiviral agents|mesh-ancestor
111423794|NCT00002805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111423795|NCT00002805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111423796|NCT00002805|Analgesics|analgesics|mesh-ancestor
111423797|NCT00002805|Sensory System Agents|sensory system agents|mesh-ancestor
111423798|NCT00002805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111423799|NCT00002805|Trace Elements|trace elements|mesh-ancestor
111423800|NCT00002805|Micronutrients|micronutrients|mesh-ancestor
111423801|NCT00003297|Topotecan|topotecan|mesh-list
111423802|NCT00003297|Mitoxantrone|mitoxantrone|mesh-list
111423803|NCT00003297|Thiotepa|thiotepa|mesh-list
111423804|NCT00003297|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111423805|NCT00003297|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111423806|NCT00003297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111423807|NCT00003297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111423808|NCT00003297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111423809|NCT00003297|Analgesics|analgesics|mesh-ancestor
111423810|NCT00003297|Sensory System Agents|sensory system agents|mesh-ancestor
111423811|NCT00003297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111423812|NCT00003297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111423813|NCT00003297|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111423814|NCT00003297|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111423815|NCT00003297|Alkylating Agents|alkylating agents|mesh-ancestor
111423816|NCT00003297|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111423817|NCT00003297|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111423818|NCT00003297|Immunologic Factors|immunologic factors|mesh-ancestor
111423819|NCT00003447|Gemcitabine|gemcitabine|mesh-list
111423820|NCT00003447|Vinorelbine|vinorelbine|mesh-list
111423821|NCT00003447|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111423822|NCT00003447|Antimetabolites|antimetabolites|mesh-ancestor
111423823|NCT00003447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111423824|NCT00003447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111423825|NCT00003447|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111423826|NCT00003447|Tubulin Modulators|tubulin modulators|mesh-ancestor
111423827|NCT00003447|Antimitotic Agents|antimitotic agents|mesh-ancestor
111423828|NCT00003447|Mitosis Modulators|mitosis modulators|mesh-ancestor
111423829|NCT00003315|Amphotericin B|amphotericin b|mesh-list
111423830|NCT00003315|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
111423831|NCT00003315|Sargramostim|sargramostim|mesh-list
111423832|NCT00003315|Immunologic Factors|immunologic factors|mesh-ancestor
111423833|NCT00003315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111423834|NCT00003315|Amebicides|amebicides|mesh-ancestor
111423835|NCT00003315|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111423836|NCT00003315|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111423837|NCT00003315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111423838|NCT00003315|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111423839|NCT00003315|Antifungal Agents|antifungal agents|mesh-ancestor
111423840|NCT00002817|Sargramostim|sargramostim|mesh-list
111423841|NCT00002817|Immunologic Factors|immunologic factors|mesh-ancestor
111423842|NCT00002817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111423843|NCT00003465|Temozolomide|temozolomide|mesh-list
111423844|NCT00003465|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111423845|NCT00003465|Alkylating Agents|alkylating agents|mesh-ancestor
111423846|NCT00003465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111423847|NCT00003465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111423848|NCT00002823|Etoposide|etoposide|mesh-list
111423849|NCT00002823|Vinorelbine|vinorelbine|mesh-list
111423850|NCT00002823|Vinblastine|vinblastine|mesh-list
111423851|NCT00002823|Vindesine|vindesine|mesh-list
111423852|NCT00002823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111423853|NCT00002823|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111423854|NCT00002823|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111423855|NCT00002823|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111423856|NCT00002823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111423857|NCT00002823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111423858|NCT00002823|Tubulin Modulators|tubulin modulators|mesh-ancestor
111423859|NCT00002823|Antimitotic Agents|antimitotic agents|mesh-ancestor
111423860|NCT00002823|Mitosis Modulators|mitosis modulators|mesh-ancestor
111423861|NCT00361621|Prednisone|prednisone|mesh-list
111423862|NCT00361621|Cyclophosphamide|cyclophosphamide|mesh-list
111423863|NCT00361621|Rituximab|rituximab|mesh-list
111423864|NCT00361621|Doxorubicin|doxorubicin|mesh-list
111423865|NCT00361621|Vincristine|vincristine|mesh-list
111423866|NCT00361621|Bortezomib|bortezomib|mesh-list
111423867|NCT00361621|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111423868|NCT00361621|Immunologic Factors|immunologic factors|mesh-ancestor
111423869|NCT00361621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111423870|NCT00361621|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111423871|NCT00361621|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111423872|NCT00361621|Alkylating Agents|alkylating agents|mesh-ancestor
111423873|NCT00361621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111423874|NCT00361621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111423875|NCT00361621|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111423876|NCT00361621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111423877|NCT00361621|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111423878|NCT00361621|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111423879|NCT00361621|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111423880|NCT00361621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111423881|NCT00361621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111423882|NCT00361621|Glucocorticoids|glucocorticoids|mesh-ancestor
111423883|NCT00361621|Hormones|hormones|mesh-ancestor
111423884|NCT00361621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111423885|NCT00361621|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111423886|NCT00361621|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111423887|NCT00361621|Tubulin Modulators|tubulin modulators|mesh-ancestor
111423888|NCT00361621|Antimitotic Agents|antimitotic agents|mesh-ancestor
111423889|NCT00361621|Mitosis Modulators|mitosis modulators|mesh-ancestor
111423890|NCT00003327|Paclitaxel|paclitaxel|mesh-list
111423891|NCT00003327|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111423892|NCT00003327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111423893|NCT00003327|Tubulin Modulators|tubulin modulators|mesh-ancestor
111423894|NCT00003327|Antimitotic Agents|antimitotic agents|mesh-ancestor
111423895|NCT00003327|Mitosis Modulators|mitosis modulators|mesh-ancestor
111423896|NCT00003327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111423897|NCT00003339|Interleukin-12|interleukin-12|mesh-list
111423898|NCT00003339|Freund's Adjuvant|freund's adjuvant|mesh-list
111423899|NCT00003339|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111423900|NCT00003339|Immunologic Factors|immunologic factors|mesh-ancestor
111423901|NCT00003339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111423902|NCT00003339|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111423903|NCT00003339|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111423904|NCT00003339|Growth Substances|growth substances|mesh-ancestor
111423905|NCT00003339|Growth Inhibitors|growth inhibitors|mesh-ancestor
111423906|NCT00003339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111423907|NCT00002829|Interferons|interferons|mesh-list
111423908|NCT00002829|Interferon-alpha|interferon-alpha|mesh-list
111423909|NCT00002829|Cyclophosphamide|cyclophosphamide|mesh-list
111423910|NCT00002829|Etoposide|etoposide|mesh-list
111423911|NCT00002829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111423912|NCT00002829|Immunologic Factors|immunologic factors|mesh-ancestor
111423913|NCT00002829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111423914|NCT00002829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111423915|NCT00002829|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111423916|NCT00002829|Alkylating Agents|alkylating agents|mesh-ancestor
111423917|NCT00002829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111423918|NCT00002829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111423919|NCT00002829|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111423920|NCT00002829|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111423921|NCT00002829|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111423922|NCT00002829|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111423923|NCT00002829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111423924|NCT00002829|Antiviral Agents|antiviral agents|mesh-ancestor
111423925|NCT00002829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111423926|NCT03614221|Tacrolimus|tacrolimus|mesh-list
111423927|NCT03614221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111148307|NCT05346731|Olanzapine|olanzapine|mesh-list
111423928|NCT03614221|Immunologic Factors|immunologic factors|mesh-ancestor
111423929|NCT03614221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111423930|NCT03614221|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111423931|NCT03614221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111423932|NCT03614221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111423933|NCT00003345|Irinotecan|irinotecan|mesh-list
111423934|NCT00003345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111423935|NCT00003345|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111423936|NCT00003345|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111423937|NCT00003345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111423938|NCT00003345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111423939|NCT03596905|Plecanatide|plecanatide|mesh-list
111423940|NCT03596905|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
111423941|NCT03596905|Enzyme Activators|enzyme activators|mesh-ancestor
111423942|NCT03596905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111423943|NCT03596905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111423944|NCT00002835|Leucovorin|leucovorin|mesh-list
111423945|NCT00002835|Interferons|interferons|mesh-list
111423946|NCT00002835|Cytarabine|cytarabine|mesh-list
111423947|NCT00002835|Interferon-alpha|interferon-alpha|mesh-list
111423948|NCT00002835|Methylprednisolone|methylprednisolone|mesh-list
111423949|NCT00002835|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111423950|NCT00002835|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111423951|NCT00002835|Prednisolone|prednisolone|mesh-list
111423952|NCT00002835|Prednisolone acetate|prednisolone acetate|mesh-list
111423953|NCT00002835|Cyclophosphamide|cyclophosphamide|mesh-list
111423954|NCT00002835|Melphalan|melphalan|mesh-list
111423955|NCT00002835|Ifosfamide|ifosfamide|mesh-list
111423956|NCT00002835|Carmustine|carmustine|mesh-list
111423957|NCT00002835|Cisplatin|cisplatin|mesh-list
111423958|NCT00002835|Methotrexate|methotrexate|mesh-list
111423959|NCT00002835|Etoposide|etoposide|mesh-list
111423960|NCT00002835|Vincristine|vincristine|mesh-list
111423961|NCT00002835|Mitoxantrone|mitoxantrone|mesh-list
111423962|NCT00002835|Idarubicin|idarubicin|mesh-list
111423963|NCT00002835|Bleomycin|bleomycin|mesh-list
111423964|NCT00002835|Levoleucovorin|levoleucovorin|mesh-list
111423965|NCT00002835|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111423966|NCT00002835|Prednisolone phosphate|prednisolone phosphate|mesh-list
111423967|NCT00002835|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111423968|NCT00002835|Immunologic Factors|immunologic factors|mesh-ancestor
111423969|NCT00002835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111423970|NCT00002835|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111423971|NCT00002835|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111423972|NCT00002835|Alkylating Agents|alkylating agents|mesh-ancestor
111423973|NCT00002835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111423974|NCT00002835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111423975|NCT00002835|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111423976|NCT00002835|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111423977|NCT00002835|Abortifacient Agents|abortifacient agents|mesh-ancestor
111423978|NCT00002835|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111423979|NCT00002835|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111423980|NCT00002835|Antimetabolites|antimetabolites|mesh-ancestor
111423981|NCT00002835|Dermatologic Agents|dermatologic agents|mesh-ancestor
111423982|NCT00002835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111423983|NCT00002835|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111423984|NCT00002835|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111423985|NCT00002835|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111423986|NCT00002835|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111423987|NCT00002835|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111423988|NCT00002835|Antiviral Agents|antiviral agents|mesh-ancestor
111423989|NCT00002835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111423990|NCT00002835|Antidotes|antidotes|mesh-ancestor
111423991|NCT00002835|Protective Agents|protective agents|mesh-ancestor
111423992|NCT00002835|Vitamin B Complex|vitamin b complex|mesh-ancestor
111423993|NCT00002835|Vitamins|vitamins|mesh-ancestor
111423994|NCT00002835|Micronutrients|micronutrients|mesh-ancestor
111423995|NCT00002835|Tubulin Modulators|tubulin modulators|mesh-ancestor
111423996|NCT00002835|Antimitotic Agents|antimitotic agents|mesh-ancestor
111423997|NCT00002835|Mitosis Modulators|mitosis modulators|mesh-ancestor
111423998|NCT00002835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111423999|NCT00002835|Antiemetics|antiemetics|mesh-ancestor
111424000|NCT00002835|Autonomic Agents|autonomic agents|mesh-ancestor
111148385|NCT05254925|Emollients|emollients|mesh-ancestor
111424001|NCT00002835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111424002|NCT00002835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111424003|NCT00002835|Glucocorticoids|glucocorticoids|mesh-ancestor
111424004|NCT00002835|Hormones|hormones|mesh-ancestor
111424005|NCT00002835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111424006|NCT00002835|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111424007|NCT00002835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111424008|NCT00002835|Analgesics|analgesics|mesh-ancestor
111424009|NCT00002835|Sensory System Agents|sensory system agents|mesh-ancestor
111424010|NCT00002835|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111424011|NCT00003351|Irinotecan|irinotecan|mesh-list
111424012|NCT00003351|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111424013|NCT00003351|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111424014|NCT00003351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111424015|NCT00003351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111424016|NCT00003351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111424017|NCT00361153|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
111424018|NCT00361153|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111424019|NCT00361153|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111424020|NCT00361153|Antimetabolites|antimetabolites|mesh-ancestor
111424021|NCT00361153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111424022|NCT00361153|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111424023|NCT00002847|Interferons|interferons|mesh-list
111424024|NCT00002847|Interferon-alpha|interferon-alpha|mesh-list
111424025|NCT00002847|Aldesleukin|aldesleukin|mesh-list
111424026|NCT00002847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111424027|NCT00002847|Antiviral Agents|antiviral agents|mesh-ancestor
111424028|NCT00002847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111424029|NCT00002847|Immunologic Factors|immunologic factors|mesh-ancestor
111424030|NCT00002847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111424031|NCT00002847|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111424032|NCT00002847|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111424033|NCT03576001|Methyltestosterone|methyltestosterone|mesh-list
111424034|NCT03576001|Testosterone|testosterone|mesh-list
111424035|NCT03576001|Testosterone undecanoate|testosterone undecanoate|mesh-list
111424036|NCT03576001|Testosterone enanthate|testosterone enanthate|mesh-list
111424037|NCT03576001|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
111424038|NCT03576001|Androgens|androgens|mesh-ancestor
111424039|NCT03576001|Hormones|hormones|mesh-ancestor
111424040|NCT03576001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111424041|NCT03576001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111424042|NCT03576001|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111424043|NCT03576001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111424044|NCT03576001|Anabolic Agents|anabolic agents|mesh-ancestor
111424045|NCT04220827|Paclitaxel|paclitaxel|mesh-list
111424046|NCT04220827|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111424047|NCT04220827|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111424048|NCT04220827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111424049|NCT04220827|Tubulin Modulators|tubulin modulators|mesh-ancestor
111424050|NCT04220827|Antimitotic Agents|antimitotic agents|mesh-ancestor
111424051|NCT04220827|Mitosis Modulators|mitosis modulators|mesh-ancestor
111424052|NCT04220827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111424053|NCT00002865|Leucovorin|leucovorin|mesh-list
111424054|NCT00002865|Cobalt|cobalt|mesh-list
111424055|NCT00002865|Cytarabine|cytarabine|mesh-list
111424056|NCT00002865|Dexamethasone|dexamethasone|mesh-list
111424057|NCT00002865|Hydrocortisone|hydrocortisone|mesh-list
111424058|NCT00002865|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
111424059|NCT00002865|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
111424060|NCT00002865|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
111424061|NCT00002865|Cyclophosphamide|cyclophosphamide|mesh-list
111424062|NCT00002865|Ifosfamide|ifosfamide|mesh-list
111424063|NCT00002865|Doxorubicin|doxorubicin|mesh-list
111424064|NCT00002865|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111424065|NCT00002865|Methotrexate|methotrexate|mesh-list
111424066|NCT00002865|Etoposide|etoposide|mesh-list
111424067|NCT00002865|Vincristine|vincristine|mesh-list
111424068|NCT00002865|Levoleucovorin|levoleucovorin|mesh-list
111424069|NCT00002865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111424070|NCT00002865|Immunologic Factors|immunologic factors|mesh-ancestor
111424071|NCT00002865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111424072|NCT00002865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111424073|NCT00002865|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111424074|NCT00002865|Alkylating Agents|alkylating agents|mesh-ancestor
111424075|NCT00002865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111424076|NCT00002865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111424077|NCT00002865|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111424078|NCT00002865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110511079|NCT02785146|Calcium|calcium|mesh-list
111424079|NCT00002865|Antiemetics|antiemetics|mesh-ancestor
111424080|NCT00002865|Autonomic Agents|autonomic agents|mesh-ancestor
111424081|NCT00002865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111148454|NCT02116803|Hormone Antagonists|hormone antagonists|mesh-ancestor
111424082|NCT00002865|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111424083|NCT00002865|Glucocorticoids|glucocorticoids|mesh-ancestor
111424084|NCT00002865|Hormones|hormones|mesh-ancestor
111424085|NCT00002865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111424086|NCT00002865|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111424087|NCT00002865|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111424088|NCT00002865|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111424089|NCT00002865|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111424090|NCT00002865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111424091|NCT00002865|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111424092|NCT00002865|Abortifacient Agents|abortifacient agents|mesh-ancestor
111424093|NCT00002865|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111424094|NCT00002865|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111424095|NCT00002865|Antimetabolites|antimetabolites|mesh-ancestor
111424096|NCT00002865|Dermatologic Agents|dermatologic agents|mesh-ancestor
111424097|NCT00002865|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111424098|NCT00002865|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111424099|NCT00002865|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111424100|NCT00002865|Antiviral Agents|antiviral agents|mesh-ancestor
111424101|NCT00002865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111424102|NCT00002865|Antidotes|antidotes|mesh-ancestor
111424103|NCT00002865|Protective Agents|protective agents|mesh-ancestor
111424104|NCT00002865|Vitamin B Complex|vitamin b complex|mesh-ancestor
111424105|NCT00002865|Vitamins|vitamins|mesh-ancestor
111424106|NCT00002865|Micronutrients|micronutrients|mesh-ancestor
111424107|NCT00002865|Tubulin Modulators|tubulin modulators|mesh-ancestor
111424108|NCT00002865|Antimitotic Agents|antimitotic agents|mesh-ancestor
111424109|NCT00002865|Mitosis Modulators|mitosis modulators|mesh-ancestor
111424110|NCT00002865|Trace Elements|trace elements|mesh-ancestor
111424111|NCT00361309|Sunitinib|sunitinib|mesh-list
111424112|NCT00361309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111424113|NCT00361309|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111424114|NCT00361309|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111424115|NCT00361309|Growth Substances|growth substances|mesh-ancestor
111424116|NCT00361309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111424117|NCT00361309|Growth Inhibitors|growth inhibitors|mesh-ancestor
111424118|NCT00361309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111424119|NCT00361309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111424120|NCT00361309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111424121|NCT04154943|Cemiplimab|cemiplimab|mesh-list
111424122|NCT04154943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111424123|NCT04154943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111424124|NCT00361387|Methylphenidate|methylphenidate|mesh-list
111424125|NCT00361387|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111424126|NCT00361387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111424127|NCT00361387|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111424128|NCT00361387|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111424129|NCT00361387|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111424130|NCT00361387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111424131|NCT00361387|Dopamine Agents|dopamine agents|mesh-ancestor
111424132|NCT00361387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111424133|NCT04530487|Cyclosporine|cyclosporine|mesh-list
111424134|NCT04530487|Mycophenolic Acid|mycophenolic acid|mesh-list
111424135|NCT04530487|Fludarabine|fludarabine|mesh-list
111424136|NCT04530487|Fludarabine phosphate|fludarabine phosphate|mesh-list
111424137|NCT04530487|Etoposide|etoposide|mesh-list
111424138|NCT04530487|Etoposide phosphate|etoposide phosphate|mesh-list
111424139|NCT04530487|Melphalan|melphalan|mesh-list
111424140|NCT04530487|Mechlorethamine|mechlorethamine|mesh-list
111424141|NCT04530487|Thiotepa|thiotepa|mesh-list
111424142|NCT04530487|Podophyllotoxin|podophyllotoxin|mesh-list
111424143|NCT04530487|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
111424144|NCT04530487|Tacrolimus|tacrolimus|mesh-list
111424145|NCT04530487|Cyclosporins|cyclosporins|mesh-list
111424146|NCT04530487|Thymoglobulin|thymoglobulin|mesh-list
111424147|NCT04530487|Antilymphocyte Serum|antilymphocyte serum|mesh-list
111424148|NCT04530487|Immunoglobulins|immunoglobulins|mesh-list
111424149|NCT04530487|Antibodies|antibodies|mesh-list
111424150|NCT04530487|gamma-Globulins|gamma-globulins|mesh-list
111424151|NCT04530487|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111424152|NCT04530487|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
111424153|NCT04530487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111424154|NCT04530487|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111424155|NCT04530487|Antimetabolites|antimetabolites|mesh-ancestor
111424156|NCT04530487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111424157|NCT04530487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111424158|NCT04530487|Immunologic Factors|immunologic factors|mesh-ancestor
111424159|NCT04530487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111424160|NCT04530487|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111424161|NCT04530487|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111424163|NCT04530487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111424164|NCT04530487|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111424165|NCT04530487|Antifungal Agents|antifungal agents|mesh-ancestor
111424166|NCT04530487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111424167|NCT04530487|Dermatologic Agents|dermatologic agents|mesh-ancestor
111424168|NCT04530487|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111424169|NCT04530487|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111424170|NCT04530487|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111424171|NCT04530487|Antitubercular Agents|antitubercular agents|mesh-ancestor
111424172|NCT04530487|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111424173|NCT04530487|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111424174|NCT04530487|Alkylating Agents|alkylating agents|mesh-ancestor
111424175|NCT04530487|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111424176|NCT04530487|Keratolytic Agents|keratolytic agents|mesh-ancestor
111424177|NCT04530487|Tubulin Modulators|tubulin modulators|mesh-ancestor
111424178|NCT04530487|Antimitotic Agents|antimitotic agents|mesh-ancestor
111424179|NCT04530487|Mitosis Modulators|mitosis modulators|mesh-ancestor
111424180|NCT00003369|Tirapazamine|tirapazamine|mesh-list
111424181|NCT00003369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111424182|NCT04342351|Valsartan|valsartan|mesh-list
111424183|NCT04342351|Perindopril|perindopril|mesh-list
111424184|NCT04342351|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
111424185|NCT04342351|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111424186|NCT04342351|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111424187|NCT04342351|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111424188|NCT04342351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111424189|NCT04342351|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
111424190|NCT04342351|Protease Inhibitors|protease inhibitors|mesh-ancestor
111424191|NCT04342351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111424192|NCT04342273|Moxifloxacin|moxifloxacin|mesh-list
111424193|NCT04342273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111424194|NCT04342273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111424195|NCT04342273|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111424196|NCT04342273|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111424197|NCT04342273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111424198|NCT04342273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111424199|NCT04342273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111424200|NCT03504241|Mycophenolic Acid|mycophenolic acid|mesh-list
111424201|NCT03504241|Sirolimus|sirolimus|mesh-list
111424202|NCT03504241|Prednisone|prednisone|mesh-list
111424203|NCT03504241|Alemtuzumab|alemtuzumab|mesh-list
111424204|NCT03504241|Abatacept|abatacept|mesh-list
111424205|NCT03504241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111424206|NCT03504241|Glucocorticoids|glucocorticoids|mesh-ancestor
111424207|NCT03504241|Hormones|hormones|mesh-ancestor
111424208|NCT03504241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111424209|NCT03504241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111424210|NCT03504241|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111424211|NCT03504241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111424212|NCT03504241|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111424213|NCT03504241|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111424214|NCT03504241|Antitubercular Agents|antitubercular agents|mesh-ancestor
111424215|NCT03504241|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111424216|NCT03504241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111424217|NCT03504241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111424218|NCT03504241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111424219|NCT03504241|Antifungal Agents|antifungal agents|mesh-ancestor
111424220|NCT03504241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111424221|NCT03504241|Immunologic Factors|immunologic factors|mesh-ancestor
111424222|NCT03504241|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111424223|NCT03504241|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111424224|NCT03504241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111424225|NCT00003375|Vincristine|vincristine|mesh-list
111424226|NCT00003375|Lomustine|lomustine|mesh-list
111424227|NCT00003375|Procarbazine|procarbazine|mesh-list
111424228|NCT00003375|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111424229|NCT00003375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111424230|NCT00003375|Tubulin Modulators|tubulin modulators|mesh-ancestor
111424231|NCT00003375|Antimitotic Agents|antimitotic agents|mesh-ancestor
111424232|NCT00003375|Mitosis Modulators|mitosis modulators|mesh-ancestor
111424233|NCT00003375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111424234|NCT00003375|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111424236|NCT03499249|Acetylcysteine|acetylcysteine|mesh-list
111424237|NCT03499249|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111424238|NCT03499249|Antiviral Agents|antiviral agents|mesh-ancestor
111424239|NCT03499249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111424240|NCT03499249|Expectorants|expectorants|mesh-ancestor
111424241|NCT03499249|Respiratory System Agents|respiratory system agents|mesh-ancestor
111424242|NCT03499249|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111424243|NCT03499249|Antioxidants|antioxidants|mesh-ancestor
111424244|NCT03499249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111424245|NCT03499249|Protective Agents|protective agents|mesh-ancestor
111424246|NCT03499249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111424247|NCT03499249|Antidotes|antidotes|mesh-ancestor
111424248|NCT03498391|Ketamine|ketamine|mesh-list
111424249|NCT03498391|Propofol|propofol|mesh-list
111424250|NCT03498391|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111424251|NCT03498391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111424252|NCT03498391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111424253|NCT03498391|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111424254|NCT03498391|Anesthetics, General|anesthetics, general|mesh-ancestor
111424255|NCT03498391|Anesthetics|anesthetics|mesh-ancestor
111424256|NCT03498391|Analgesics|analgesics|mesh-ancestor
111424257|NCT03498391|Sensory System Agents|sensory system agents|mesh-ancestor
111424258|NCT03498391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111424259|NCT03498391|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111424260|NCT03498391|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111424261|NCT03498391|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111424262|NCT03498391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111424263|NCT03498391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111424264|NCT00003939|Trabectedin|trabectedin|mesh-list
111424265|NCT00003939|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111424266|NCT00003939|Alkylating Agents|alkylating agents|mesh-ancestor
111424267|NCT00003939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111424268|NCT00003939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111424269|NCT00003543|Fluorouracil|fluorouracil|mesh-list
111424270|NCT00003543|Vincristine|vincristine|mesh-list
111424271|NCT00003543|Carmustine|carmustine|mesh-list
111424272|NCT00003543|Streptozocin|streptozocin|mesh-list
111424273|NCT00003543|Antibodies|antibodies|mesh-list
111424274|NCT00003543|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111424275|NCT00003543|Immunologic Factors|immunologic factors|mesh-ancestor
111424276|NCT00003543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111424277|NCT00003543|Antimetabolites|antimetabolites|mesh-ancestor
111424278|NCT00003543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111424279|NCT00003543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111424280|NCT00003543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111424281|NCT00003543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111424282|NCT00003543|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111424283|NCT00003543|Tubulin Modulators|tubulin modulators|mesh-ancestor
111424284|NCT00003543|Antimitotic Agents|antimitotic agents|mesh-ancestor
111424285|NCT00003543|Mitosis Modulators|mitosis modulators|mesh-ancestor
111424286|NCT00003543|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111424287|NCT00003543|Alkylating Agents|alkylating agents|mesh-ancestor
111424288|NCT00003543|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111424289|NCT00003549|Cyclophosphamide|cyclophosphamide|mesh-list
111424290|NCT00003549|Fluorouracil|fluorouracil|mesh-list
111424291|NCT00003549|Methotrexate|methotrexate|mesh-list
111424292|NCT00003549|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111424293|NCT00003549|Immunologic Factors|immunologic factors|mesh-ancestor
111424294|NCT00003549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111424295|NCT00003549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111424296|NCT00003549|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111424297|NCT00003549|Alkylating Agents|alkylating agents|mesh-ancestor
111424298|NCT00003549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111424299|NCT00003549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111424300|NCT00003549|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111424301|NCT00003549|Antimetabolites|antimetabolites|mesh-ancestor
111424302|NCT00003549|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111424303|NCT00003549|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111424304|NCT00003549|Abortifacient Agents|abortifacient agents|mesh-ancestor
111424305|NCT00003549|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111424306|NCT00003549|Dermatologic Agents|dermatologic agents|mesh-ancestor
111424307|NCT00003549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111424308|NCT00003549|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111424309|NCT00003549|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111424310|NCT00002883|Fluorouracil|fluorouracil|mesh-list
111424311|NCT00002883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111424312|NCT00002883|Antimetabolites|antimetabolites|mesh-ancestor
111424313|NCT00002883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111424314|NCT00002883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111424315|NCT00002883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111424316|NCT00002883|Immunologic Factors|immunologic factors|mesh-ancestor
111424317|NCT00002883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111424318|NCT03492463|Nicotine|nicotine|mesh-list
111424319|NCT03492463|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111424320|NCT03492463|Autonomic Agents|autonomic agents|mesh-ancestor
111424321|NCT03492463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111424322|NCT03492463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111424323|NCT03492463|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111424324|NCT03492463|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111424325|NCT03492463|Cholinergic Agents|cholinergic agents|mesh-ancestor
111424326|NCT03492463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111424327|NCT03492463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111424328|NCT00003945|Topotecan|topotecan|mesh-list
111424329|NCT00003945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111424330|NCT00003945|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111424331|NCT00003945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111424332|NCT00003945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111424333|NCT00003945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111424334|NCT00003951|Exatecan|exatecan|mesh-list
111424335|NCT00003951|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111424336|NCT00003951|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111424337|NCT00003951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111424338|NCT00003951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111424339|NCT00003951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111424340|NCT00003957|Cytarabine|cytarabine|mesh-list
111424341|NCT00003957|Paclitaxel|paclitaxel|mesh-list
111424342|NCT00003957|Etoposide|etoposide|mesh-list
111424343|NCT00003957|Cyclophosphamide|cyclophosphamide|mesh-list
111424344|NCT00003957|Melphalan|melphalan|mesh-list
111424345|NCT00003957|Mitoxantrone|mitoxantrone|mesh-list
111424346|NCT00003957|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111424347|NCT00003957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111424348|NCT00003957|Tubulin Modulators|tubulin modulators|mesh-ancestor
111424349|NCT00003957|Antimitotic Agents|antimitotic agents|mesh-ancestor
111424350|NCT00003957|Mitosis Modulators|mitosis modulators|mesh-ancestor
111424351|NCT00003957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111424352|NCT00003957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111424353|NCT00003957|Immunologic Factors|immunologic factors|mesh-ancestor
111424354|NCT00003957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111424355|NCT00003957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111424356|NCT00003957|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111424357|NCT00003957|Alkylating Agents|alkylating agents|mesh-ancestor
111424358|NCT00003957|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111424359|NCT00003957|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111424360|NCT00003957|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111424361|NCT00003957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111424362|NCT00003957|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111424363|NCT00003957|Antimetabolites|antimetabolites|mesh-ancestor
111424364|NCT00003957|Antiviral Agents|antiviral agents|mesh-ancestor
111424365|NCT00003957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111424366|NCT00003957|Analgesics|analgesics|mesh-ancestor
111424367|NCT00003957|Sensory System Agents|sensory system agents|mesh-ancestor
111424368|NCT00003957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111424369|NCT00004833|Immunoglobulins|immunoglobulins|mesh-list
111424370|NCT00004833|Antibodies|antibodies|mesh-list
111424371|NCT00004833|gamma-Globulins|gamma-globulins|mesh-list
111424372|NCT00004833|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111424373|NCT00004833|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
111424374|NCT00004833|Immunologic Factors|immunologic factors|mesh-ancestor
111424375|NCT00004833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111424376|NCT00003555|Paclitaxel|paclitaxel|mesh-list
111424377|NCT00003555|Amifostine|amifostine|mesh-list
111424378|NCT00003555|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111424379|NCT00003555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111424380|NCT00003555|Tubulin Modulators|tubulin modulators|mesh-ancestor
111424381|NCT00003555|Antimitotic Agents|antimitotic agents|mesh-ancestor
111424382|NCT00003555|Mitosis Modulators|mitosis modulators|mesh-ancestor
111424383|NCT00003555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111424384|NCT00003555|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111424386|NCT00003555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111424387|NCT00003963|Rituximab|rituximab|mesh-list
111424388|NCT00003963|Vinorelbine|vinorelbine|mesh-list
111424389|NCT00003963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111424390|NCT00003963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111424391|NCT00003963|Immunologic Factors|immunologic factors|mesh-ancestor
111424392|NCT00003963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111424393|NCT00003963|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111424394|NCT00003963|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111424395|NCT00003963|Tubulin Modulators|tubulin modulators|mesh-ancestor
111424396|NCT00003963|Antimitotic Agents|antimitotic agents|mesh-ancestor
111424397|NCT00003963|Mitosis Modulators|mitosis modulators|mesh-ancestor
111424398|NCT00003963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111424399|NCT00004845|Naproxen|naproxen|mesh-list
111424400|NCT00004845|Rofecoxib|rofecoxib|mesh-list
111424401|NCT00004845|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111424402|NCT00004845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111424403|NCT00004845|Analgesics|analgesics|mesh-ancestor
111424404|NCT00004845|Sensory System Agents|sensory system agents|mesh-ancestor
111424405|NCT00004845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111424406|NCT00004845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111424407|NCT00004845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111424408|NCT00004845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111424409|NCT00004845|Gout Suppressants|gout suppressants|mesh-ancestor
111424410|NCT00004845|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111424411|NCT00004845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111424412|NCT00004845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111424413|NCT00004845|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111424414|NCT00003981|N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|mesh-list
111424415|NCT00003981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111424416|NCT00003981|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
111424417|NCT00003981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111424418|NCT00003981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111424419|NCT00003993|Aldesleukin|aldesleukin|mesh-list
111424420|NCT00003993|Bryostatin 1|bryostatin 1|mesh-list
111424421|NCT00003993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111424422|NCT00003993|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111424423|NCT00003993|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111424424|NCT00003993|Antiviral Agents|antiviral agents|mesh-ancestor
111424425|NCT00003993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111424426|NCT00003993|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111424427|NCT00003993|Immunologic Factors|immunologic factors|mesh-ancestor
110511106|NCT00913965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111424428|NCT00003993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111424429|NCT00004857|Fludarabine|fludarabine|mesh-list
111424430|NCT00004857|Fludarabine phosphate|fludarabine phosphate|mesh-list
111424431|NCT00004857|Alemtuzumab|alemtuzumab|mesh-list
111424432|NCT00004857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111424433|NCT00004857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111424434|NCT00004857|Antimetabolites|antimetabolites|mesh-ancestor
111424435|NCT00004857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111424436|NCT00004857|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111424437|NCT00004857|Immunologic Factors|immunologic factors|mesh-ancestor
111424438|NCT00004857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111424439|NCT00004857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111424440|NCT03476239|Blinatumomab|blinatumomab|mesh-list
111424441|NCT03476239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111424442|NCT00004863|Paclitaxel|paclitaxel|mesh-list
111424443|NCT00004863|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111424444|NCT00004863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111424445|NCT00004863|Tubulin Modulators|tubulin modulators|mesh-ancestor
111424446|NCT00004863|Antimitotic Agents|antimitotic agents|mesh-ancestor
111424447|NCT00004863|Mitosis Modulators|mitosis modulators|mesh-ancestor
111424448|NCT00004863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111424449|NCT00004875|Heparin|heparin|mesh-list
111424450|NCT00004875|Enoxaparin|enoxaparin|mesh-list
111424451|NCT00004875|Anticoagulants|anticoagulants|mesh-ancestor
111424452|NCT00004875|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111424453|NCT00004875|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111424454|NCT00004875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111424455|NCT00003561|Interferons|interferons|mesh-list
111424456|NCT00003561|Interferon-alpha|interferon-alpha|mesh-list
111424457|NCT00003561|Sargramostim|sargramostim|mesh-list
111424458|NCT00003561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111424459|NCT00003561|Antiviral Agents|antiviral agents|mesh-ancestor
111424460|NCT00003561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111424461|NCT00003561|Immunologic Factors|immunologic factors|mesh-ancestor
111424462|NCT00003561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111424463|NCT00003567|Temozolomide|temozolomide|mesh-list
111424464|NCT00003567|Carmustine|carmustine|mesh-list
111424465|NCT00003567|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
111424466|NCT00003567|Sargramostim|sargramostim|mesh-list
111424467|NCT00003567|Immunologic Factors|immunologic factors|mesh-ancestor
111424468|NCT00003567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111424469|NCT00003567|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111424470|NCT00003567|Alkylating Agents|alkylating agents|mesh-ancestor
111424471|NCT00003567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111424472|NCT00003567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111424473|NCT00003567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111424474|NCT00003573|Cyclophosphamide|cyclophosphamide|mesh-list
111424475|NCT00003573|Cisplatin|cisplatin|mesh-list
111424476|NCT00003573|Etoposide|etoposide|mesh-list
111424477|NCT00003573|Vincristine|vincristine|mesh-list
111424478|NCT00003573|Lenograstim|lenograstim|mesh-list
111424479|NCT00003573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111424480|NCT00003573|Immunologic Factors|immunologic factors|mesh-ancestor
111424481|NCT00003573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111424482|NCT00003573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111424483|NCT00003573|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111424484|NCT00003573|Alkylating Agents|alkylating agents|mesh-ancestor
111424485|NCT00003573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111424486|NCT00003573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111424487|NCT00003573|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111424488|NCT00003573|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111424489|NCT00003573|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111424490|NCT00003573|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111424491|NCT00003573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111424492|NCT00003573|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111424493|NCT00003573|Tubulin Modulators|tubulin modulators|mesh-ancestor
111424494|NCT00003573|Antimitotic Agents|antimitotic agents|mesh-ancestor
111424495|NCT00003573|Mitosis Modulators|mitosis modulators|mesh-ancestor
111424496|NCT03468985|Nivolumab|nivolumab|mesh-list
111424497|NCT03468985|Ipilimumab|ipilimumab|mesh-list
111424498|NCT03468985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111424499|NCT03468985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111424500|NCT03468985|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111424501|NCT03468985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111424502|NCT00003585|Interferons|interferons|mesh-list
111424503|NCT00003585|Interferon-alpha|interferon-alpha|mesh-list
111424504|NCT00003585|Aldesleukin|aldesleukin|mesh-list
111424505|NCT00003585|Fluorouracil|fluorouracil|mesh-list
111424506|NCT00003585|Isotretinoin|isotretinoin|mesh-list
111424507|NCT00003585|Antimetabolites|antimetabolites|mesh-ancestor
111424508|NCT00003585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111424509|NCT00003585|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111424510|NCT00003585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111424511|NCT00003585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111424512|NCT00003585|Immunologic Factors|immunologic factors|mesh-ancestor
111424513|NCT00003585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111424514|NCT00003585|Antiviral Agents|antiviral agents|mesh-ancestor
111424515|NCT00003585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111424516|NCT00003585|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111424517|NCT00003585|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111424518|NCT00003585|Dermatologic Agents|dermatologic agents|mesh-ancestor
111424519|NCT00003591|Paclitaxel|paclitaxel|mesh-list
111424520|NCT00003591|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111424521|NCT00003591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111424522|NCT00003591|Tubulin Modulators|tubulin modulators|mesh-ancestor
111424523|NCT00003591|Antimitotic Agents|antimitotic agents|mesh-ancestor
111424524|NCT00003591|Mitosis Modulators|mitosis modulators|mesh-ancestor
111424525|NCT00003591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111424526|NCT02975323|Carvedilol|carvedilol|mesh-list
111424527|NCT02975323|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111424528|NCT02975323|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111424529|NCT02975323|Adrenergic Agents|adrenergic agents|mesh-ancestor
111424530|NCT02975323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111424531|NCT02975323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111424532|NCT02975323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111424533|NCT02975323|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111424534|NCT02975323|Antioxidants|antioxidants|mesh-ancestor
111424535|NCT02975323|Protective Agents|protective agents|mesh-ancestor
111424536|NCT02975323|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111424537|NCT02975323|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111424538|NCT02975323|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111424539|NCT02975323|Vasodilator Agents|vasodilator agents|mesh-ancestor
111424540|NCT02975323|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111424541|NCT02975323|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111424542|NCT00003597|Carboplatin|carboplatin|mesh-list
111424543|NCT00003597|Etoposide|etoposide|mesh-list
111424544|NCT00003597|Ifosfamide|ifosfamide|mesh-list
111424545|NCT00003597|Lenograstim|lenograstim|mesh-list
111424546|NCT00003597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111424547|NCT00003597|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111424548|NCT00003597|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111424549|NCT00003597|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111424550|NCT00003597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111424551|NCT00003597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111424552|NCT00003597|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111424553|NCT00003597|Alkylating Agents|alkylating agents|mesh-ancestor
111424554|NCT00003597|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111424555|NCT00003597|Immunologic Factors|immunologic factors|mesh-ancestor
111424556|NCT00003597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111424557|NCT00004005|Leucovorin|leucovorin|mesh-list
111424558|NCT00004005|Fluorouracil|fluorouracil|mesh-list
111424559|NCT00004005|Irinotecan|irinotecan|mesh-list
111424560|NCT00004005|Calcium|calcium|mesh-list
111424561|NCT00004005|Levoleucovorin|levoleucovorin|mesh-list
111424562|NCT00004005|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111424563|NCT00004005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111424564|NCT00004005|Antimetabolites|antimetabolites|mesh-ancestor
111424565|NCT00004005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111424566|NCT00004005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111424567|NCT00004005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111424568|NCT00004005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111424569|NCT00004005|Immunologic Factors|immunologic factors|mesh-ancestor
111424570|NCT00004005|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111424571|NCT00004005|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111424572|NCT00004005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111424573|NCT00004005|Antidotes|antidotes|mesh-ancestor
111424574|NCT00004005|Protective Agents|protective agents|mesh-ancestor
111424575|NCT00004005|Vitamin B Complex|vitamin b complex|mesh-ancestor
111424576|NCT00004005|Vitamins|vitamins|mesh-ancestor
111424577|NCT00004005|Micronutrients|micronutrients|mesh-ancestor
111424578|NCT00003603|Dexamethasone|dexamethasone|mesh-list
111424579|NCT00003603|Prednisolone|prednisolone|mesh-list
111424580|NCT00003603|Cyclophosphamide|cyclophosphamide|mesh-list
111424581|NCT00003603|Melphalan|melphalan|mesh-list
111424582|NCT00003603|Lomustine|lomustine|mesh-list
111424583|NCT00003603|Idarubicin|idarubicin|mesh-list
111424584|NCT00003603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111424585|NCT00003603|Immunologic Factors|immunologic factors|mesh-ancestor
111424586|NCT00003603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111424587|NCT00003603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111424588|NCT00003603|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111424589|NCT00003603|Alkylating Agents|alkylating agents|mesh-ancestor
111424590|NCT00003603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111424591|NCT00003603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111424592|NCT00003603|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111424593|NCT00003603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111424594|NCT00003603|Antiemetics|antiemetics|mesh-ancestor
111424595|NCT00003603|Autonomic Agents|autonomic agents|mesh-ancestor
111424596|NCT00003603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111424597|NCT00003603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111424598|NCT00003603|Glucocorticoids|glucocorticoids|mesh-ancestor
111424599|NCT00003603|Hormones|hormones|mesh-ancestor
111424600|NCT00003603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111424601|NCT00003603|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111424602|NCT00003603|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111424603|NCT00003603|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111424604|NCT00003603|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111424605|NCT00003603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111424606|NCT00004887|Paclitaxel|paclitaxel|mesh-list
111424607|NCT00004887|Vinblastine|vinblastine|mesh-list
111424608|NCT00004887|Carboplatin|carboplatin|mesh-list
111424609|NCT00004887|Ifosfamide|ifosfamide|mesh-list
111424610|NCT00004887|Mitomycins|mitomycins|mesh-list
111424611|NCT00004887|Mitomycin|mitomycin|mesh-list
111424612|NCT00004887|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111424613|NCT00004887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111424614|NCT00004887|Tubulin Modulators|tubulin modulators|mesh-ancestor
111424615|NCT00004887|Antimitotic Agents|antimitotic agents|mesh-ancestor
111424616|NCT00004887|Mitosis Modulators|mitosis modulators|mesh-ancestor
111424617|NCT00004887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111424618|NCT00004887|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111424619|NCT00004887|Alkylating Agents|alkylating agents|mesh-ancestor
111424620|NCT00004887|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111424621|NCT00004887|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111424622|NCT00004887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111424623|NCT00004893|Interleukin-12|interleukin-12|mesh-list
111424624|NCT00004893|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111424625|NCT00004893|Immunologic Factors|immunologic factors|mesh-ancestor
111424626|NCT00004893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111424627|NCT00004893|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111424628|NCT00004893|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111424629|NCT00004893|Growth Substances|growth substances|mesh-ancestor
111424630|NCT00004893|Growth Inhibitors|growth inhibitors|mesh-ancestor
111424631|NCT00004893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111424632|NCT00004011|Paclitaxel|paclitaxel|mesh-list
111424633|NCT00004011|Carboplatin|carboplatin|mesh-list
111424634|NCT00004011|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111424635|NCT00004011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111424636|NCT00004011|Tubulin Modulators|tubulin modulators|mesh-ancestor
111424637|NCT00004011|Antimitotic Agents|antimitotic agents|mesh-ancestor
111424638|NCT00004011|Mitosis Modulators|mitosis modulators|mesh-ancestor
111424639|NCT00004011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111424640|NCT00004017|Antibodies|antibodies|mesh-list
111424641|NCT00004017|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111424642|NCT00004017|Immunologic Factors|immunologic factors|mesh-ancestor
111424643|NCT00004017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111424644|NCT00004905|Interferons|interferons|mesh-list
111424645|NCT00004905|Cytarabine|cytarabine|mesh-list
111424646|NCT00004905|Interferon-alpha|interferon-alpha|mesh-list
111424647|NCT00004905|Cyclophosphamide|cyclophosphamide|mesh-list
111424648|NCT00004905|Etoposide|etoposide|mesh-list
111424649|NCT00004905|Idarubicin|idarubicin|mesh-list
111424650|NCT00004905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111424651|NCT00004905|Immunologic Factors|immunologic factors|mesh-ancestor
111424652|NCT00004905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111424653|NCT00004905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111424654|NCT00004905|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111424655|NCT00004905|Alkylating Agents|alkylating agents|mesh-ancestor
111424656|NCT00004905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111424657|NCT00004905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111424658|NCT00004905|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111424659|NCT00004905|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111424660|NCT00004905|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111424661|NCT00004905|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111424662|NCT00004905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111424663|NCT00004905|Antiviral Agents|antiviral agents|mesh-ancestor
111424664|NCT00004905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111424665|NCT00004905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111424666|NCT00004905|Antimetabolites|antimetabolites|mesh-ancestor
111424667|NCT00004905|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111424668|NCT00004029|Sargramostim|sargramostim|mesh-list
111424669|NCT00004029|Vaccines|vaccines|mesh-list
111424670|NCT00004029|Immunologic Factors|immunologic factors|mesh-ancestor
111424671|NCT00004029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111424672|NCT00362323|Metformin|metformin|mesh-list
111424673|NCT00362323|Fenofibrate|fenofibrate|mesh-list
111424674|NCT00362323|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111424675|NCT00362323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111424676|NCT00362323|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111424677|NCT00362323|Antimetabolites|antimetabolites|mesh-ancestor
111424678|NCT00362323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111424679|NCT00362323|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111424680|NCT00004917|Epoetin Alfa|epoetin alfa|mesh-list
111424681|NCT00004917|Hematinics|hematinics|mesh-ancestor
111424682|NCT00421915|Etanercept|etanercept|mesh-list
111424683|NCT00421915|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111424684|NCT00421915|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111424685|NCT00421915|Analgesics|analgesics|mesh-ancestor
111424686|NCT00421915|Sensory System Agents|sensory system agents|mesh-ancestor
111424687|NCT00421915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111424688|NCT00421915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111424689|NCT00421915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111424690|NCT00421915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111424691|NCT00421915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111424692|NCT00421915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111424694|NCT00362713|Ipilimumab|ipilimumab|mesh-list
111424695|NCT00362713|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111424696|NCT00362713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111424697|NCT00362713|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111424698|NCT00362713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111424699|NCT00004047|Exatecan|exatecan|mesh-list
111424700|NCT00004047|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111424701|NCT00004047|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111424702|NCT00004047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111424703|NCT00004047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111424704|NCT00004047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111424705|NCT00003627|Fluorouracil|fluorouracil|mesh-list
111424706|NCT00003627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111424707|NCT00003627|Antimetabolites|antimetabolites|mesh-ancestor
111424708|NCT00003627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111424709|NCT00003627|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111424710|NCT00003627|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111424711|NCT00003627|Immunologic Factors|immunologic factors|mesh-ancestor
111424712|NCT00003627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111424713|NCT00004059|Fluorouracil|fluorouracil|mesh-list
111424714|NCT00004059|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
111424715|NCT00004059|Antimetabolites|antimetabolites|mesh-ancestor
111424716|NCT00004059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111424717|NCT00004059|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111424718|NCT00004059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111424719|NCT00004059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111424720|NCT00004059|Immunologic Factors|immunologic factors|mesh-ancestor
111424721|NCT00004059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111424722|NCT00004059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111424723|NCT00004059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111424724|NCT00003633|Prednisone|prednisone|mesh-list
111424725|NCT00003633|Docetaxel|docetaxel|mesh-list
111424726|NCT00003633|Mitoxantrone|mitoxantrone|mesh-list
111424727|NCT00003633|Estramustine|estramustine|mesh-list
111424728|NCT00003633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111424729|NCT00003633|Tubulin Modulators|tubulin modulators|mesh-ancestor
111424730|NCT00003633|Antimitotic Agents|antimitotic agents|mesh-ancestor
111424731|NCT00003633|Mitosis Modulators|mitosis modulators|mesh-ancestor
111424732|NCT00003633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111424733|NCT00003633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111424734|NCT00003633|Glucocorticoids|glucocorticoids|mesh-ancestor
111424735|NCT00003633|Hormones|hormones|mesh-ancestor
111424736|NCT00003633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111424737|NCT00003633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111424738|NCT00003633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111424739|NCT00003633|Analgesics|analgesics|mesh-ancestor
111424740|NCT00003633|Sensory System Agents|sensory system agents|mesh-ancestor
111424741|NCT00003633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111424742|NCT00003633|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111424743|NCT00003633|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111424744|NCT00003633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111424745|NCT00003633|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111424746|NCT00003633|Alkylating Agents|alkylating agents|mesh-ancestor
111424747|NCT00003639|Interferons|interferons|mesh-list
111424748|NCT00003639|Interferon-alpha|interferon-alpha|mesh-list
111424749|NCT00003639|Dexamethasone|dexamethasone|mesh-list
111424750|NCT00003639|Idarubicin|idarubicin|mesh-list
111424751|NCT00003639|Chlorambucil|chlorambucil|mesh-list
111424752|NCT00003639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111424753|NCT00003639|Antiemetics|antiemetics|mesh-ancestor
111424754|NCT00003639|Autonomic Agents|autonomic agents|mesh-ancestor
111424755|NCT00003639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111424756|NCT00003639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111424757|NCT00003639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111424758|NCT00003639|Glucocorticoids|glucocorticoids|mesh-ancestor
111424759|NCT00003639|Hormones|hormones|mesh-ancestor
111424760|NCT00003639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111424761|NCT00003639|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111424762|NCT00003639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111424763|NCT00003639|Antiviral Agents|antiviral agents|mesh-ancestor
111424764|NCT00003639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111424765|NCT00003639|Immunologic Factors|immunologic factors|mesh-ancestor
111424766|NCT00003639|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111424767|NCT00003639|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111424768|NCT00003639|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111424770|NCT00003639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111424771|NCT00003639|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111424772|NCT00003639|Alkylating Agents|alkylating agents|mesh-ancestor
111424773|NCT00004923|Docetaxel|docetaxel|mesh-list
111424774|NCT00004923|Irinotecan|irinotecan|mesh-list
111424775|NCT00004923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111424776|NCT00004923|Tubulin Modulators|tubulin modulators|mesh-ancestor
111424777|NCT00004923|Antimitotic Agents|antimitotic agents|mesh-ancestor
111424778|NCT00004923|Mitosis Modulators|mitosis modulators|mesh-ancestor
111424779|NCT00004923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111424780|NCT00004923|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111424781|NCT00004923|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111424782|NCT00004923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111424783|NCT00004071|Prednisone|prednisone|mesh-list
111424784|NCT00004071|Mitoxantrone|mitoxantrone|mesh-list
111424785|NCT00004071|Leflunomide|leflunomide|mesh-list
111424786|NCT00004071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111424787|NCT00004071|Glucocorticoids|glucocorticoids|mesh-ancestor
111424788|NCT00004071|Hormones|hormones|mesh-ancestor
111424789|NCT00004071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111424790|NCT00004071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111424791|NCT00004071|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111424792|NCT00004071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111424793|NCT00004071|Analgesics|analgesics|mesh-ancestor
111424794|NCT00004071|Sensory System Agents|sensory system agents|mesh-ancestor
111424795|NCT00004071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111424796|NCT00004071|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111424797|NCT00004071|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111424798|NCT00004071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111424799|NCT00004071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111424800|NCT00004071|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111424801|NCT00004071|Immunologic Factors|immunologic factors|mesh-ancestor
111424802|NCT00004077|Paclitaxel|paclitaxel|mesh-list
111424803|NCT00004077|Ifosfamide|ifosfamide|mesh-list
111424804|NCT00004077|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111424805|NCT00004077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111424806|NCT00004077|Tubulin Modulators|tubulin modulators|mesh-ancestor
111424807|NCT00004077|Antimitotic Agents|antimitotic agents|mesh-ancestor
111424808|NCT00004077|Mitosis Modulators|mitosis modulators|mesh-ancestor
111424809|NCT00004077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111424810|NCT00004077|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111424811|NCT00004077|Alkylating Agents|alkylating agents|mesh-ancestor
111424812|NCT00004083|Cisplatin|cisplatin|mesh-list
111424813|NCT00004083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111424814|NCT00004941|Infliximab|infliximab|mesh-list
111424815|NCT00004941|Antibodies|antibodies|mesh-list
111424816|NCT00004941|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111424817|NCT00004941|Immunologic Factors|immunologic factors|mesh-ancestor
111424818|NCT00004941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111424819|NCT00004941|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111424820|NCT00004941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111424821|NCT00004941|Dermatologic Agents|dermatologic agents|mesh-ancestor
111424822|NCT00004941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111424823|NCT00004941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111424824|NCT00003657|Carboplatin|carboplatin|mesh-list
111424825|NCT00003657|Etoposide|etoposide|mesh-list
111424826|NCT00003657|Ifosfamide|ifosfamide|mesh-list
111424827|NCT00003657|Amifostine|amifostine|mesh-list
111424828|NCT00003657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111424829|NCT00003657|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111424830|NCT00003657|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111424831|NCT00003657|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111424832|NCT00003657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111424833|NCT00003657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111424834|NCT00003657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111424835|NCT00003657|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111424836|NCT00003657|Alkylating Agents|alkylating agents|mesh-ancestor
111424837|NCT00003657|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111424838|NCT00003657|Protective Agents|protective agents|mesh-ancestor
111424839|NCT00004089|Paclitaxel|paclitaxel|mesh-list
111424840|NCT00004089|Fluorouracil|fluorouracil|mesh-list
111424841|NCT00004089|Hydroxyurea|hydroxyurea|mesh-list
111424842|NCT00004089|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111424843|NCT00004089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111424844|NCT00004089|Tubulin Modulators|tubulin modulators|mesh-ancestor
111424845|NCT00004089|Antimitotic Agents|antimitotic agents|mesh-ancestor
111424846|NCT00004089|Mitosis Modulators|mitosis modulators|mesh-ancestor
111424847|NCT00004089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111424848|NCT00004089|Antimetabolites|antimetabolites|mesh-ancestor
111424849|NCT00004089|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111424850|NCT00004089|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111424851|NCT00004089|Immunologic Factors|immunologic factors|mesh-ancestor
111424852|NCT00004089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111424853|NCT00004089|Antisickling Agents|antisickling agents|mesh-ancestor
111424854|NCT00004089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111424855|NCT00004089|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111424857|NCT00004095|Irinotecan|irinotecan|mesh-list
111424858|NCT00004095|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111424859|NCT00004095|Antimetabolites|antimetabolites|mesh-ancestor
111424860|NCT00004095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111424861|NCT00004095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111424862|NCT00004095|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111424863|NCT00004095|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111424864|NCT00004095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111424865|NCT00003663|Dexamethasone|dexamethasone|mesh-list
111424866|NCT00003663|Rituximab|rituximab|mesh-list
111424867|NCT00003663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111424868|NCT00003663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111424869|NCT00003663|Immunologic Factors|immunologic factors|mesh-ancestor
111424870|NCT00003663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111424871|NCT00003663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111424872|NCT00003663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111424873|NCT00003663|Antiemetics|antiemetics|mesh-ancestor
111424874|NCT00003663|Autonomic Agents|autonomic agents|mesh-ancestor
111424875|NCT00003663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111424876|NCT00003663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111424877|NCT00003663|Glucocorticoids|glucocorticoids|mesh-ancestor
111424878|NCT00003663|Hormones|hormones|mesh-ancestor
111424879|NCT00003663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111424880|NCT00003663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111424881|NCT00004107|Epratuzumab|epratuzumab|mesh-list
111424882|NCT00004107|Antibodies|antibodies|mesh-list
111424883|NCT00004107|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111424884|NCT00004107|Immunologic Factors|immunologic factors|mesh-ancestor
111424885|NCT00004107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111424886|NCT00004107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111424887|NCT00004107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111424888|NCT00004113|Temozolomide|temozolomide|mesh-list
111424889|NCT00004113|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111424890|NCT00004113|Alkylating Agents|alkylating agents|mesh-ancestor
111424891|NCT00004113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111424892|NCT00004113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111424893|NCT00003675|Topotecan|topotecan|mesh-list
111424894|NCT00003675|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111424895|NCT00003675|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111424896|NCT00003675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111424897|NCT00003675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111424898|NCT00003675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111424899|NCT00004137|Paclitaxel|paclitaxel|mesh-list
111424900|NCT00004137|Carboplatin|carboplatin|mesh-list
111424901|NCT00004137|Topotecan|topotecan|mesh-list
111424902|NCT00004137|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111424903|NCT00004137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111424904|NCT00004137|Tubulin Modulators|tubulin modulators|mesh-ancestor
111424905|NCT00004137|Antimitotic Agents|antimitotic agents|mesh-ancestor
111424906|NCT00004137|Mitosis Modulators|mitosis modulators|mesh-ancestor
111424907|NCT00004137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111424908|NCT00004137|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111424909|NCT00004137|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111424910|NCT00004137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111424911|NCT00003681|Epoetin Alfa|epoetin alfa|mesh-list
111424912|NCT00003681|Amifostine|amifostine|mesh-list
111424913|NCT00003681|Hematinics|hematinics|mesh-ancestor
111424914|NCT00003681|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111149279|NCT02507219|Analgesics|analgesics|mesh-ancestor
111424915|NCT00003681|Protective Agents|protective agents|mesh-ancestor
111424916|NCT00003681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111424917|NCT00005007|Etanercept|etanercept|mesh-list
111424918|NCT00005007|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111424919|NCT00005007|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111424920|NCT00005007|Analgesics|analgesics|mesh-ancestor
111424921|NCT00005007|Sensory System Agents|sensory system agents|mesh-ancestor
111424922|NCT00005007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111424923|NCT00005007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111424924|NCT00005007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111424925|NCT00005007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111424926|NCT00005007|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111424927|NCT00005007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111424928|NCT00005007|Immunologic Factors|immunologic factors|mesh-ancestor
111424929|NCT00384579|Botulinum Toxins|botulinum toxins|mesh-list
111424930|NCT00384579|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111424931|NCT00384579|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111424932|NCT00384579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111424933|NCT00384579|Cholinergic Agents|cholinergic agents|mesh-ancestor
111424934|NCT00384579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111424935|NCT00384579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111424936|NCT00004149|Arsenic Trioxide|arsenic trioxide|mesh-list
111424937|NCT00004149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111424938|NCT00384657|Iron|iron|mesh-list
111424939|NCT00384657|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
111424940|NCT00384657|Trace Elements|trace elements|mesh-ancestor
111424941|NCT00384657|Micronutrients|micronutrients|mesh-ancestor
111424942|NCT00384657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111424943|NCT00384657|Hematinics|hematinics|mesh-ancestor
111424944|NCT00005013|Sertraline|sertraline|mesh-list
111424945|NCT00005013|Antidepressive Agents|antidepressive agents|mesh-ancestor
111424946|NCT00005013|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111424947|NCT00005013|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111424948|NCT00005013|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111424949|NCT00005013|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111424950|NCT00005013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111424951|NCT00005013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111424952|NCT00005013|Serotonin Agents|serotonin agents|mesh-ancestor
111424953|NCT00005013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111424954|NCT00004161|Fenretinide|fenretinide|mesh-list
111424955|NCT00004161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111424956|NCT00004161|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
111424957|NCT00004161|Protective Agents|protective agents|mesh-ancestor
111424958|NCT00004161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111424959|NCT00004173|Paclitaxel|paclitaxel|mesh-list
111424960|NCT00004173|Oxaliplatin|oxaliplatin|mesh-list
111424961|NCT00004173|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111424962|NCT00004173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111424963|NCT00004173|Tubulin Modulators|tubulin modulators|mesh-ancestor
111424964|NCT00004173|Antimitotic Agents|antimitotic agents|mesh-ancestor
111424965|NCT00004173|Mitosis Modulators|mitosis modulators|mesh-ancestor
111424966|NCT00004173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111424967|NCT00005025|Ganciclovir|ganciclovir|mesh-list
111424968|NCT00005025|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
111424969|NCT00005025|Antiviral Agents|antiviral agents|mesh-ancestor
111424970|NCT00005025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111424971|NCT00005025|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111424972|NCT00005025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111424973|NCT00005025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111424974|NCT00004179|Prednisone|prednisone|mesh-list
111424975|NCT00004179|Cyclophosphamide|cyclophosphamide|mesh-list
111424976|NCT00004179|Rituximab|rituximab|mesh-list
111424977|NCT00004179|Doxorubicin|doxorubicin|mesh-list
111424978|NCT00004179|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111424979|NCT00004179|Vincristine|vincristine|mesh-list
111424980|NCT00004179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111424981|NCT00004179|Immunologic Factors|immunologic factors|mesh-ancestor
111424982|NCT00004179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111424983|NCT00004179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111424984|NCT00004179|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111424985|NCT00004179|Alkylating Agents|alkylating agents|mesh-ancestor
111424986|NCT00004179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111424987|NCT00004179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111424988|NCT00004179|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111424989|NCT00004179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111424990|NCT00004179|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111424991|NCT00004179|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111424992|NCT00004179|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111424993|NCT00004179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111424994|NCT00004179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111424995|NCT00004179|Glucocorticoids|glucocorticoids|mesh-ancestor
111424996|NCT00004179|Hormones|hormones|mesh-ancestor
111424997|NCT00004179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111424998|NCT00004179|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111424999|NCT00004179|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111425000|NCT00004179|Tubulin Modulators|tubulin modulators|mesh-ancestor
111425001|NCT00004179|Antimitotic Agents|antimitotic agents|mesh-ancestor
111425002|NCT00004179|Mitosis Modulators|mitosis modulators|mesh-ancestor
111425003|NCT00003687|Morphine|morphine|mesh-list
111425004|NCT00003687|Dextromethorphan|dextromethorphan|mesh-list
111425005|NCT00003687|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111425006|NCT00003687|Narcotics|narcotics|mesh-ancestor
111425007|NCT00003687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111425008|NCT00003687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111425009|NCT00003687|Analgesics|analgesics|mesh-ancestor
111425010|NCT00003687|Sensory System Agents|sensory system agents|mesh-ancestor
111425011|NCT00003687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111425012|NCT00003687|Antitussive Agents|antitussive agents|mesh-ancestor
111425013|NCT00003687|Respiratory System Agents|respiratory system agents|mesh-ancestor
111425014|NCT00003687|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111425015|NCT00003687|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111425016|NCT00003687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111425017|NCT00003687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111425018|NCT00003693|Dolastatin 10|dolastatin 10|mesh-list
111425019|NCT00003693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111425020|NCT00003693|Tubulin Modulators|tubulin modulators|mesh-ancestor
111425021|NCT00003693|Antimitotic Agents|antimitotic agents|mesh-ancestor
111425022|NCT00003693|Mitosis Modulators|mitosis modulators|mesh-ancestor
111425023|NCT00003693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111425024|NCT00005031|Irofulven|irofulven|mesh-list
111425025|NCT00005031|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111425026|NCT00005031|Alkylating Agents|alkylating agents|mesh-ancestor
111425027|NCT00005031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111425028|NCT00005031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111425029|NCT00005037|Temozolomide|temozolomide|mesh-list
111425030|NCT00005037|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111425031|NCT00005037|Alkylating Agents|alkylating agents|mesh-ancestor
111425032|NCT00005037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111425033|NCT00005037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111425034|NCT00004203|Oxaliplatin|oxaliplatin|mesh-list
111425035|NCT00004203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111479268|NCT05091346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111479269|NCT05091346|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111479270|NCT05091346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111479271|NCT05059873|Prednisone|prednisone|mesh-list
111479272|NCT05059873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111479273|NCT05059873|Glucocorticoids|glucocorticoids|mesh-ancestor
111479274|NCT05059873|Hormones|hormones|mesh-ancestor
111479275|NCT05059873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111479276|NCT05059873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111479277|NCT05059873|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111479278|NCT05059873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111479279|NCT05055024|Mazindol|mazindol|mesh-list
111479280|NCT05055024|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111479281|NCT05055024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111479282|NCT05055024|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111479283|NCT05055024|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111479284|NCT05055024|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111479285|NCT05055024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111479286|NCT05055024|Adrenergic Agents|adrenergic agents|mesh-ancestor
111479287|NCT05055024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111479288|NCT05055024|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111479289|NCT05055024|Dopamine Agents|dopamine agents|mesh-ancestor
111479290|NCT05047978|Caseins|caseins|mesh-list
111479291|NCT05047978|Chelating Agents|chelating agents|mesh-ancestor
111479292|NCT05047978|Sequestering Agents|sequestering agents|mesh-ancestor
111479293|NCT05047978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111479294|NCT05045664|Obinutuzumab|obinutuzumab|mesh-list
111479295|NCT05045664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111479296|NCT05045664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111479297|NCT05037552|Hemostatics|hemostatics|mesh-list
111425037|NCT00004209|Mitomycin|mitomycin|mesh-list
111425038|NCT00004209|Vinblastine|vinblastine|mesh-list
111425039|NCT00004209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111425040|NCT00004209|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111425041|NCT00004209|Alkylating Agents|alkylating agents|mesh-ancestor
111425042|NCT00004209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111425043|NCT00004209|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111425044|NCT00004209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111425045|NCT00004209|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111425046|NCT00004209|Tubulin Modulators|tubulin modulators|mesh-ancestor
111425047|NCT00004209|Antimitotic Agents|antimitotic agents|mesh-ancestor
111425048|NCT00004209|Mitosis Modulators|mitosis modulators|mesh-ancestor
111425049|NCT00005049|Carboplatin|carboplatin|mesh-list
111425050|NCT00005049|Floxuridine|floxuridine|mesh-list
111425051|NCT00005049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111425052|NCT00005049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111425053|NCT00005049|Antimetabolites|antimetabolites|mesh-ancestor
111425054|NCT00005049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111425055|NCT00004215|Cytarabine|cytarabine|mesh-list
111425056|NCT00004215|Daunorubicin|daunorubicin|mesh-list
111425057|NCT00004215|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111425058|NCT00004215|Antimetabolites|antimetabolites|mesh-ancestor
111425059|NCT00004215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111425060|NCT00004215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111425061|NCT00004215|Antiviral Agents|antiviral agents|mesh-ancestor
111425062|NCT00004215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111425063|NCT00004215|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111425064|NCT00004215|Immunologic Factors|immunologic factors|mesh-ancestor
111425065|NCT00004215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111425066|NCT00004215|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111425067|NCT00004215|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111425068|NCT00004215|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111425069|NCT00004215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111425070|NCT00004221|Paclitaxel|paclitaxel|mesh-list
111425071|NCT00004221|Cyclophosphamide|cyclophosphamide|mesh-list
111425072|NCT00004221|Carboplatin|carboplatin|mesh-list
111425073|NCT00004221|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111425074|NCT00004221|Topotecan|topotecan|mesh-list
111425075|NCT00004221|Lenograstim|lenograstim|mesh-list
111425076|NCT00004221|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111425077|NCT00004221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111425078|NCT00004221|Tubulin Modulators|tubulin modulators|mesh-ancestor
111425079|NCT00004221|Antimitotic Agents|antimitotic agents|mesh-ancestor
111425080|NCT00004221|Mitosis Modulators|mitosis modulators|mesh-ancestor
111425081|NCT00004221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111425082|NCT00004221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111425083|NCT00004221|Immunologic Factors|immunologic factors|mesh-ancestor
111425084|NCT00004221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111425085|NCT00004221|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111425086|NCT00004221|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111425087|NCT00004221|Alkylating Agents|alkylating agents|mesh-ancestor
111425088|NCT00004221|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111425089|NCT00004221|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111425090|NCT00004221|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111425091|NCT00004221|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111425092|NCT00004221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111425093|NCT00003711|Irinotecan|irinotecan|mesh-list
111425094|NCT00003711|Pemetrexed|pemetrexed|mesh-list
111425095|NCT00003711|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111425096|NCT00003711|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111425097|NCT00003711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111425098|NCT00003711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111425099|NCT00003711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111425100|NCT00003711|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111425101|NCT00003711|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111425102|NCT00004227|Cetuximab|cetuximab|mesh-list
111425103|NCT00004227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111425104|NCT00004227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111425105|NCT00003621|Etoposide|etoposide|mesh-list
111425106|NCT00003621|Carmustine|carmustine|mesh-list
111425107|NCT00003621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111425108|NCT00003621|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111149496|NCT01911442|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111425109|NCT00003621|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111425110|NCT00003621|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111425111|NCT00003621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111425112|NCT00003621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111425113|NCT00003621|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111425114|NCT00003621|Alkylating Agents|alkylating agents|mesh-ancestor
111425115|NCT00385359|Albuterol|albuterol|mesh-list
111425116|NCT00385359|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111425117|NCT00385359|Autonomic Agents|autonomic agents|mesh-ancestor
111425118|NCT00385359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111425119|NCT00385359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111425120|NCT00385359|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111425121|NCT00385359|Respiratory System Agents|respiratory system agents|mesh-ancestor
111425122|NCT00385359|Tocolytic Agents|tocolytic agents|mesh-ancestor
111425123|NCT00385359|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111425124|NCT00385359|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111425125|NCT00385359|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111425126|NCT00385359|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111425127|NCT00385359|Adrenergic Agents|adrenergic agents|mesh-ancestor
111425128|NCT00385359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111425129|NCT00385359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111425130|NCT00004233|Leucovorin|leucovorin|mesh-list
111425131|NCT00004233|Fluorouracil|fluorouracil|mesh-list
111425132|NCT00004233|Calcium|calcium|mesh-list
111425133|NCT00004233|Levoleucovorin|levoleucovorin|mesh-list
111425134|NCT00004233|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111425135|NCT00004233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111425136|NCT00004233|Antimetabolites|antimetabolites|mesh-ancestor
111425137|NCT00004233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111425138|NCT00004233|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111425139|NCT00004233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111425140|NCT00004233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111425141|NCT00004233|Immunologic Factors|immunologic factors|mesh-ancestor
111425142|NCT00004233|Antidotes|antidotes|mesh-ancestor
111425143|NCT00004233|Protective Agents|protective agents|mesh-ancestor
111425144|NCT00004233|Vitamin B Complex|vitamin b complex|mesh-ancestor
111425145|NCT00004233|Vitamins|vitamins|mesh-ancestor
111425146|NCT00004233|Micronutrients|micronutrients|mesh-ancestor
111425147|NCT00003717|Paclitaxel|paclitaxel|mesh-list
111425148|NCT00003717|Estramustine|estramustine|mesh-list
111425149|NCT00003717|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111425150|NCT00003717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111425151|NCT00003717|Tubulin Modulators|tubulin modulators|mesh-ancestor
111425152|NCT00003717|Antimitotic Agents|antimitotic agents|mesh-ancestor
111425153|NCT00003717|Mitosis Modulators|mitosis modulators|mesh-ancestor
111425154|NCT00003717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111425155|NCT00003717|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111425156|NCT00003717|Alkylating Agents|alkylating agents|mesh-ancestor
111425157|NCT00003717|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111425158|NCT00003723|Gemcitabine|gemcitabine|mesh-list
111425159|NCT00003723|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111425160|NCT00003723|Antimetabolites|antimetabolites|mesh-ancestor
111425161|NCT00003723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111425162|NCT00003723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111425163|NCT00005061|Bevacizumab|bevacizumab|mesh-list
111425164|NCT00005061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111425165|NCT00005061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111425166|NCT00005061|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111425167|NCT00005061|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111425168|NCT00005061|Growth Substances|growth substances|mesh-ancestor
111425169|NCT00005061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111425170|NCT00005061|Growth Inhibitors|growth inhibitors|mesh-ancestor
111425171|NCT00004245|Salicylates|salicylates|mesh-list
111425172|NCT00004245|Sodium Salicylate|sodium salicylate|mesh-list
111425173|NCT00004245|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
111425174|NCT00004245|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111425175|NCT00004245|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111425176|NCT00004245|Analgesics|analgesics|mesh-ancestor
111425177|NCT00004245|Sensory System Agents|sensory system agents|mesh-ancestor
111425178|NCT00004245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111425179|NCT00004245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111425180|NCT00004245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111425181|NCT00004245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111425182|NCT00004245|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111425183|NCT00004245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111425184|NCT00004245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111425185|NCT00004251|Letrozole|letrozole|mesh-list
111425186|NCT00004251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111425187|NCT00004251|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111425188|NCT00004251|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111425189|NCT00004251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111425190|NCT00004251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111425191|NCT00004251|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111425192|NCT00004251|Hormone Antagonists|hormone antagonists|mesh-ancestor
111425193|NCT00004251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111425194|NCT00004251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111425195|NCT00005067|Motexafin lutetium|motexafin lutetium|mesh-list
111425196|NCT00005067|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111425197|NCT00005067|Dermatologic Agents|dermatologic agents|mesh-ancestor
111425198|NCT00003729|Cytarabine|cytarabine|mesh-list
111425199|NCT00003729|Fludarabine|fludarabine|mesh-list
111425200|NCT00003729|Fludarabine phosphate|fludarabine phosphate|mesh-list
111425201|NCT00003729|Idarubicin|idarubicin|mesh-list
111425202|NCT00003729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111425203|NCT00003729|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111425204|NCT00003729|Antimetabolites|antimetabolites|mesh-ancestor
111425205|NCT00003729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111425206|NCT00003729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111425207|NCT00003729|Immunologic Factors|immunologic factors|mesh-ancestor
111425208|NCT00003729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111425209|NCT00003729|Antiviral Agents|antiviral agents|mesh-ancestor
111425210|NCT00003729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111425211|NCT00003729|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111425212|NCT00003729|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111425213|NCT00003729|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111425214|NCT00003729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111425215|NCT00004263|Cytarabine|cytarabine|mesh-list
111425216|NCT00004263|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
111425217|NCT00004263|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111425218|NCT00004263|Antimetabolites|antimetabolites|mesh-ancestor
111425219|NCT00004263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111425220|NCT00004263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111425221|NCT00004263|Antiviral Agents|antiviral agents|mesh-ancestor
111425222|NCT00004263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111425223|NCT00004263|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111425224|NCT00004263|Immunologic Factors|immunologic factors|mesh-ancestor
111425225|NCT00004263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111425226|NCT00004263|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111425227|NCT00004263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111425228|NCT00003735|Topotecan|topotecan|mesh-list
111425229|NCT00003735|10-hydroxycamptothecin|10-hydroxycamptothecin|mesh-list
111425230|NCT00003735|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111425231|NCT00003735|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111425232|NCT00003735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111425233|NCT00003735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111425234|NCT00003735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111425235|NCT00003735|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111425236|NCT00005073|Zoledronic Acid|zoledronic acid|mesh-list
111425237|NCT00005073|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111425238|NCT00005073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111425239|NCT00004275|Hormones|hormones|mesh-list
111425240|NCT00004275|Oxandrolone|oxandrolone|mesh-list
111425241|NCT00004275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111425242|NCT00004275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111425243|NCT00004275|Androgens|androgens|mesh-ancestor
111425244|NCT00004275|Anabolic Agents|anabolic agents|mesh-ancestor
111425245|NCT00003741|Antibodies|antibodies|mesh-list
111425246|NCT00003741|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111425247|NCT00003741|Immunologic Factors|immunologic factors|mesh-ancestor
111425248|NCT00003741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111425249|NCT00003747|Carboplatin|carboplatin|mesh-list
111425250|NCT00003747|Temozolomide|temozolomide|mesh-list
111425251|NCT00003747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111425252|NCT00003747|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111425253|NCT00003747|Alkylating Agents|alkylating agents|mesh-ancestor
111425254|NCT00003747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111425255|NCT00004311|Leuprolide|leuprolide|mesh-list
111425256|NCT00004311|Spironolactone|spironolactone|mesh-list
111425257|NCT00004311|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111425258|NCT00004311|Fertility Agents|fertility agents|mesh-ancestor
111425259|NCT00004311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111425260|NCT00004311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111425261|NCT00004311|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111425262|NCT00004311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111425263|NCT00004311|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
111425264|NCT00004311|Hormone Antagonists|hormone antagonists|mesh-ancestor
111425265|NCT00004311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111425266|NCT00004311|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
111425267|NCT00004311|Diuretics|diuretics|mesh-ancestor
111425268|NCT00004311|Natriuretic Agents|natriuretic agents|mesh-ancestor
111425269|NCT00004317|Leucovorin|leucovorin|mesh-list
111425270|NCT00004317|Pyrimethamine|pyrimethamine|mesh-list
111425271|NCT00004317|Sulfadiazine|sulfadiazine|mesh-list
111425272|NCT00004317|Spiramycin|spiramycin|mesh-list
111425273|NCT00004317|Calcium|calcium|mesh-list
111425274|NCT00004317|Levoleucovorin|levoleucovorin|mesh-list
111425275|NCT00004317|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111425276|NCT00004317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111425277|NCT00004317|Antidotes|antidotes|mesh-ancestor
111425278|NCT00004317|Protective Agents|protective agents|mesh-ancestor
111425279|NCT00004317|Vitamin B Complex|vitamin b complex|mesh-ancestor
111425280|NCT00004317|Vitamins|vitamins|mesh-ancestor
111425281|NCT00004317|Micronutrients|micronutrients|mesh-ancestor
111425282|NCT00004317|Antimalarials|antimalarials|mesh-ancestor
111425283|NCT00004317|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111425284|NCT00004317|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111425285|NCT00004317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111425286|NCT00004317|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111425287|NCT00004317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111425288|NCT00004317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111425289|NCT00004317|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111425290|NCT00004317|Coccidiostats|coccidiostats|mesh-ancestor
111425291|NCT00005091|Exatecan|exatecan|mesh-list
111425292|NCT00005091|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111425293|NCT00005091|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111425294|NCT00005091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111425295|NCT00005091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111425296|NCT00005091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111425297|NCT00004323|Cyclosporine|cyclosporine|mesh-list
111425298|NCT00004323|Methylprednisolone|methylprednisolone|mesh-list
111425299|NCT00004323|Cyclophosphamide|cyclophosphamide|mesh-list
111425300|NCT00004323|Methotrexate|methotrexate|mesh-list
111425301|NCT00004323|Cyclosporins|cyclosporins|mesh-list
111425302|NCT00004323|Antilymphocyte Serum|antilymphocyte serum|mesh-list
111425303|NCT00004323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111425304|NCT00004323|Immunologic Factors|immunologic factors|mesh-ancestor
111425305|NCT00004323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111425306|NCT00004323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111425307|NCT00004323|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111425308|NCT00004323|Alkylating Agents|alkylating agents|mesh-ancestor
111425309|NCT00004323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111425310|NCT00004323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111425311|NCT00004323|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111425312|NCT00004323|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111425313|NCT00004323|Abortifacient Agents|abortifacient agents|mesh-ancestor
111425314|NCT00004323|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111425315|NCT00004323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111425316|NCT00004323|Antimetabolites|antimetabolites|mesh-ancestor
111425317|NCT00004323|Dermatologic Agents|dermatologic agents|mesh-ancestor
111425318|NCT00004323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111425319|NCT00004323|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111425320|NCT00004323|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111425321|NCT00004323|Antifungal Agents|antifungal agents|mesh-ancestor
111425322|NCT00004323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111425323|NCT00004323|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111425324|NCT00004323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111425325|NCT00004323|Antiemetics|antiemetics|mesh-ancestor
111425326|NCT00004323|Autonomic Agents|autonomic agents|mesh-ancestor
111425327|NCT00004323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111425328|NCT00004323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111425329|NCT00004323|Glucocorticoids|glucocorticoids|mesh-ancestor
111425330|NCT00004323|Hormones|hormones|mesh-ancestor
111425331|NCT00004323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111425332|NCT00004323|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111425333|NCT00004323|Protective Agents|protective agents|mesh-ancestor
111425334|NCT00003753|Dexamethasone|dexamethasone|mesh-list
111425335|NCT00003753|Irinotecan|irinotecan|mesh-list
111425336|NCT00003753|Floxuridine|floxuridine|mesh-list
111425337|NCT00003753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111425338|NCT00003753|Antiemetics|antiemetics|mesh-ancestor
111425339|NCT00003753|Autonomic Agents|autonomic agents|mesh-ancestor
111425340|NCT00003753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111425341|NCT00003753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111425342|NCT00003753|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111425343|NCT00003753|Glucocorticoids|glucocorticoids|mesh-ancestor
111425344|NCT00003753|Hormones|hormones|mesh-ancestor
111425345|NCT00003753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111425346|NCT00003753|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111425347|NCT00003753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111425348|NCT00003753|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111425349|NCT00003753|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111425350|NCT00003753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111425351|NCT00003753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111425352|NCT00003753|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111425353|NCT00003753|Antimetabolites|antimetabolites|mesh-ancestor
111425354|NCT00003759|Valrubicin|valrubicin|mesh-list
111425355|NCT00003759|BCG Vaccine|bcg vaccine|mesh-list
111425356|NCT00003759|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111425357|NCT00003759|Immunologic Factors|immunologic factors|mesh-ancestor
111425358|NCT00003759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111425359|NCT00003759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111425360|NCT00003759|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111425361|NCT00003759|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111425362|NCT00003759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111425363|NCT00003759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111425364|NCT00003765|Carmustine|carmustine|mesh-list
111425365|NCT00003765|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
111425366|NCT00003765|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111425367|NCT00003765|Alkylating Agents|alkylating agents|mesh-ancestor
111425368|NCT00003765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111425369|NCT00003765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111425370|NCT00003765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111425371|NCT00003771|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
111425372|NCT00003771|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
111425373|NCT00003771|Norethindrone|norethindrone|mesh-list
111425374|NCT00003771|Norethindrone Acetate|norethindrone acetate|mesh-list
111425375|NCT00003771|Estradiol|estradiol|mesh-list
111425376|NCT00003771|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
111425377|NCT00003771|Estrogens|estrogens|mesh-ancestor
111425378|NCT00003771|Hormones|hormones|mesh-ancestor
111425379|NCT00003771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111425380|NCT00003771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111425381|NCT00003771|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111425382|NCT00003771|Contraceptive Agents|contraceptive agents|mesh-ancestor
111425383|NCT00003771|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111425384|NCT00003771|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111425385|NCT00003771|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111425386|NCT00003771|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111425387|NCT00003771|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111425388|NCT00004359|Methoxsalen|methoxsalen|mesh-list
111425389|NCT00004359|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111425390|NCT00004359|Dermatologic Agents|dermatologic agents|mesh-ancestor
111425391|NCT00004401|Immunoglobulins|immunoglobulins|mesh-list
111425392|NCT00004401|Antibodies|antibodies|mesh-list
111425393|NCT00004401|gamma-Globulins|gamma-globulins|mesh-list
111425394|NCT00004401|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111425395|NCT00004401|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
111425396|NCT00004401|Immunologic Factors|immunologic factors|mesh-ancestor
111425397|NCT00004401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111425398|NCT00003783|Leucovorin|leucovorin|mesh-list
111425399|NCT00003783|Cytarabine|cytarabine|mesh-list
111425400|NCT00003783|Dexamethasone|dexamethasone|mesh-list
111425401|NCT00003783|Prednisone|prednisone|mesh-list
111425402|NCT00003783|Cyclophosphamide|cyclophosphamide|mesh-list
111425403|NCT00003783|Methotrexate|methotrexate|mesh-list
111425404|NCT00003783|Etoposide|etoposide|mesh-list
111425405|NCT00003783|Vincristine|vincristine|mesh-list
111425406|NCT00003783|Daunorubicin|daunorubicin|mesh-list
111425407|NCT00003783|Asparaginase|asparaginase|mesh-list
111425408|NCT00003783|Mercaptopurine|mercaptopurine|mesh-list
111425409|NCT00003783|Idarubicin|idarubicin|mesh-list
111425410|NCT00003783|Levoleucovorin|levoleucovorin|mesh-list
111425411|NCT00003783|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111425412|NCT00003783|Immunologic Factors|immunologic factors|mesh-ancestor
111425413|NCT00003783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111425414|NCT00003783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111425415|NCT00003783|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111425416|NCT00003783|Alkylating Agents|alkylating agents|mesh-ancestor
111425417|NCT00003783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111425418|NCT00003783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111425419|NCT00003783|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111425420|NCT00003783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111425421|NCT00003783|Antiemetics|antiemetics|mesh-ancestor
111425422|NCT00003783|Autonomic Agents|autonomic agents|mesh-ancestor
111425423|NCT00003783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111425424|NCT00003783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111425425|NCT00003783|Glucocorticoids|glucocorticoids|mesh-ancestor
111425426|NCT00003783|Hormones|hormones|mesh-ancestor
111425427|NCT00003783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111425428|NCT00003783|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111425429|NCT00003783|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111425430|NCT00003783|Abortifacient Agents|abortifacient agents|mesh-ancestor
111425431|NCT00003783|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111425432|NCT00003783|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111425433|NCT00003783|Antimetabolites|antimetabolites|mesh-ancestor
111425434|NCT00003783|Dermatologic Agents|dermatologic agents|mesh-ancestor
111425435|NCT00003783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111425436|NCT00003783|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111425437|NCT00003783|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111425438|NCT00003783|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111425439|NCT00003783|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111425440|NCT00003783|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111425441|NCT00003783|Antiviral Agents|antiviral agents|mesh-ancestor
111425442|NCT00003783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111425443|NCT00003783|Antidotes|antidotes|mesh-ancestor
111425444|NCT00003783|Protective Agents|protective agents|mesh-ancestor
111425445|NCT00003783|Vitamin B Complex|vitamin b complex|mesh-ancestor
111425446|NCT00003783|Vitamins|vitamins|mesh-ancestor
111425447|NCT00003783|Micronutrients|micronutrients|mesh-ancestor
111425448|NCT00003783|Tubulin Modulators|tubulin modulators|mesh-ancestor
111425449|NCT00003783|Antimitotic Agents|antimitotic agents|mesh-ancestor
111425450|NCT00003783|Mitosis Modulators|mitosis modulators|mesh-ancestor
111425451|NCT00003783|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111425452|NCT00003789|Melphalan|melphalan|mesh-list
111425453|NCT00003789|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111425454|NCT00003789|Alkylating Agents|alkylating agents|mesh-ancestor
111425455|NCT00003789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111425456|NCT00003789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111425457|NCT00003789|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111425458|NCT00003789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111425459|NCT00003789|Immunologic Factors|immunologic factors|mesh-ancestor
111425460|NCT00003789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111425461|NCT00004407|Immunoglobulins|immunoglobulins|mesh-list
111425462|NCT00004407|Antibodies|antibodies|mesh-list
111425463|NCT00004407|gamma-Globulins|gamma-globulins|mesh-list
111425464|NCT00004407|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111425465|NCT00004407|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
111425466|NCT00004407|Immunologic Factors|immunologic factors|mesh-ancestor
111425467|NCT00004407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111425468|NCT00004419|Mitogens|mitogens|mesh-list
111425469|NCT00004419|Mitosis Modulators|mitosis modulators|mesh-ancestor
111425470|NCT00004419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111425471|NCT00004431|Baclofen|baclofen|mesh-list
111425472|NCT00004431|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
111425473|NCT00004431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111425474|NCT00004431|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111425475|NCT00004431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111425476|NCT00004431|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
111425477|NCT00004431|GABA Agonists|gaba agonists|mesh-ancestor
111425478|NCT00004431|GABA Agents|gaba agents|mesh-ancestor
111425479|NCT00004431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111425480|NCT00004431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111425481|NCT00384891|BCG Vaccine|bcg vaccine|mesh-list
111425482|NCT00384891|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111425483|NCT00384891|Immunologic Factors|immunologic factors|mesh-ancestor
111425484|NCT00384891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111425485|NCT00384969|Sorafenib|sorafenib|mesh-list
111425486|NCT00384969|Everolimus|everolimus|mesh-list
111425487|NCT00384969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111425488|NCT00384969|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111425489|NCT00384969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111425490|NCT00384969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111425491|NCT00384969|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111425492|NCT00384969|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111425493|NCT00384969|Immunologic Factors|immunologic factors|mesh-ancestor
111425494|NCT00384969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111425495|NCT00385437|Mirtazapine|mirtazapine|mesh-list
111425496|NCT00385437|Antidepressive Agents|antidepressive agents|mesh-ancestor
111425497|NCT00385437|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111425498|NCT00385437|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111425499|NCT00385437|Histamine Antagonists|histamine antagonists|mesh-ancestor
111425500|NCT00385437|Histamine Agents|histamine agents|mesh-ancestor
111425501|NCT00385437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111425502|NCT00385437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111425503|NCT00385437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111425504|NCT00385437|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111425505|NCT00385437|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111425506|NCT00385437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111425507|NCT00385437|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
111425508|NCT00385437|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111425509|NCT00385437|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111425510|NCT00385437|Adrenergic Agents|adrenergic agents|mesh-ancestor
111425511|NCT00385437|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111425512|NCT00385437|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111425513|NCT00385437|Serotonin Agents|serotonin agents|mesh-ancestor
111425514|NCT00385437|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111425515|NCT00004467|Acetylcysteine|acetylcysteine|mesh-list
111425516|NCT00004467|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111425517|NCT00004467|Antiviral Agents|antiviral agents|mesh-ancestor
111425518|NCT00004467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111425519|NCT00004467|Expectorants|expectorants|mesh-ancestor
111425520|NCT00004467|Respiratory System Agents|respiratory system agents|mesh-ancestor
111425521|NCT00004467|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111425522|NCT00004467|Antioxidants|antioxidants|mesh-ancestor
111425523|NCT00004467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111425524|NCT00004467|Protective Agents|protective agents|mesh-ancestor
111425525|NCT00004467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111425526|NCT00004467|Antidotes|antidotes|mesh-ancestor
111425527|NCT00004479|Midodrine|midodrine|mesh-list
111425528|NCT00004479|Sympathomimetics|sympathomimetics|mesh-ancestor
111425529|NCT00004479|Autonomic Agents|autonomic agents|mesh-ancestor
111425530|NCT00004479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111425531|NCT00004479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111425532|NCT00004479|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111425533|NCT00004479|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111425534|NCT00004479|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111425535|NCT00004479|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111425536|NCT00004479|Adrenergic Agents|adrenergic agents|mesh-ancestor
111425537|NCT00004479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111425538|NCT00004479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111425539|NCT00004485|Cyclosporine|cyclosporine|mesh-list
111425540|NCT00004485|Mycophenolic Acid|mycophenolic acid|mesh-list
111425541|NCT00004485|Fludarabine|fludarabine|mesh-list
111425542|NCT00004485|Cyclosporins|cyclosporins|mesh-list
111425543|NCT00004485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111425544|NCT00004485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111425545|NCT00004485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111425546|NCT00004485|Immunologic Factors|immunologic factors|mesh-ancestor
111425547|NCT00004485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111425548|NCT00004485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111425549|NCT00004485|Antifungal Agents|antifungal agents|mesh-ancestor
111425550|NCT00004485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111425551|NCT00004485|Dermatologic Agents|dermatologic agents|mesh-ancestor
111425552|NCT00004485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111425553|NCT00004485|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111425554|NCT00004485|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111425555|NCT00004485|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111425556|NCT00004485|Antitubercular Agents|antitubercular agents|mesh-ancestor
111425557|NCT00004485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111425558|NCT00385125|Rituximab|rituximab|mesh-list
111425559|NCT00385125|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
111425560|NCT00385125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110511271|NCT00590967|Cisplatin|cisplatin|mesh-list
111425561|NCT00385125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111425562|NCT00385125|Immunologic Factors|immunologic factors|mesh-ancestor
111425563|NCT00385125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111425564|NCT00385125|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111425565|NCT00385125|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111425566|NCT00385125|Alkylating Agents|alkylating agents|mesh-ancestor
111479298|NCT05037552|Coagulants|coagulants|mesh-ancestor
111425567|NCT00385125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111425568|NCT00003819|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
111425569|NCT00003819|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111425570|NCT00003819|Immunologic Factors|immunologic factors|mesh-ancestor
111425571|NCT00003819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111425572|NCT00003825|Pentosan Sulfuric Polyester|pentosan sulfuric polyester|mesh-list
111425573|NCT00003825|Anticoagulants|anticoagulants|mesh-ancestor
111425574|NCT00004551|Nicotine|nicotine|mesh-list
111425575|NCT00004551|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111425576|NCT00004551|Autonomic Agents|autonomic agents|mesh-ancestor
111425577|NCT00004551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111425578|NCT00004551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111425579|NCT00004551|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111425580|NCT00004551|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111425581|NCT00004551|Cholinergic Agents|cholinergic agents|mesh-ancestor
111425582|NCT00004551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111425583|NCT00004551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111425584|NCT02678312|Enalapril|enalapril|mesh-list
111425585|NCT02678312|Enalaprilat|enalaprilat|mesh-list
111425586|NCT02678312|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
111425587|NCT02678312|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
111425588|NCT02678312|Protease Inhibitors|protease inhibitors|mesh-ancestor
111425589|NCT02678312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111425590|NCT02678312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111425591|NCT02678312|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111425592|NCT02678312|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111425593|NCT00003843|Irinotecan|irinotecan|mesh-list
111425594|NCT00003843|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111425595|NCT00003843|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111425596|NCT00003843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111425597|NCT00003843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111425598|NCT00003843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111425599|NCT00003849|Rituximab|rituximab|mesh-list
111425600|NCT00003849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111425601|NCT00003849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111425602|NCT00003849|Immunologic Factors|immunologic factors|mesh-ancestor
111425603|NCT00003849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111425604|NCT00003849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111425605|NCT00004575|Miconazole|miconazole|mesh-list
111425606|NCT00004575|Bradykinin|bradykinin|mesh-list
111425607|NCT00004575|Kininogens|kininogens|mesh-list
111425608|NCT00004575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111425609|NCT00004575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111425610|NCT00004575|Antifungal Agents|antifungal agents|mesh-ancestor
111425611|NCT00004575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111425612|NCT00004575|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111425613|NCT00004575|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111425614|NCT00004575|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111425615|NCT00004575|Hormone Antagonists|hormone antagonists|mesh-ancestor
111425616|NCT00004575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111425617|NCT00004575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111425618|NCT00004575|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111425619|NCT00004575|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111425620|NCT00004575|Vasodilator Agents|vasodilator agents|mesh-ancestor
111425621|NCT00004575|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
111425622|NCT00004575|Protease Inhibitors|protease inhibitors|mesh-ancestor
111425623|NCT00004581|Ritonavir|ritonavir|mesh-list
111425624|NCT00004581|Lopinavir|lopinavir|mesh-list
111425625|NCT00004581|Nevirapine|nevirapine|mesh-list
111425626|NCT00004581|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111425627|NCT00004581|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111425628|NCT00004581|Protease Inhibitors|protease inhibitors|mesh-ancestor
111425629|NCT00004581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110511277|NCT00878371|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111425630|NCT00004581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111425631|NCT00004581|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111425632|NCT00004581|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111425633|NCT00004581|Antiviral Agents|antiviral agents|mesh-ancestor
111425634|NCT00004581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111425635|NCT00004581|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111425636|NCT00004581|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111425637|NCT00004581|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111425638|NCT00004581|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111425639|NCT00004581|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111425640|NCT00004581|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111425641|NCT00004257|Fluorouracil|fluorouracil|mesh-list
111425642|NCT00004257|Oxaliplatin|oxaliplatin|mesh-list
111425643|NCT00004257|Antimetabolites|antimetabolites|mesh-ancestor
111425644|NCT00004257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111425645|NCT00004257|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111425646|NCT00004257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111425647|NCT00004257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111425648|NCT00004257|Immunologic Factors|immunologic factors|mesh-ancestor
111425649|NCT00004257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111425650|NCT00004647|Mexiletine|mexiletine|mesh-list
111425651|NCT00004647|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111425652|NCT00004647|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111425653|NCT00004647|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111425654|NCT00004647|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111425655|NCT00004647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111425656|NCT02469116|Carboplatin|carboplatin|mesh-list
111425657|NCT02469116|Docetaxel|docetaxel|mesh-list
111425658|NCT02469116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111425659|NCT02469116|Tubulin Modulators|tubulin modulators|mesh-ancestor
111425660|NCT02469116|Antimitotic Agents|antimitotic agents|mesh-ancestor
111425661|NCT02469116|Mitosis Modulators|mitosis modulators|mesh-ancestor
111425662|NCT02469116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111425663|NCT00362960|Losartan|losartan|mesh-list
111425664|NCT00362960|Olmesartan|olmesartan|mesh-list
111425665|NCT00362960|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
111425666|NCT00362960|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111425667|NCT00362960|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111425668|NCT00362960|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111425669|NCT00362960|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111425670|NCT00362960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111425671|NCT00003867|Capecitabine|capecitabine|mesh-list
111425672|NCT00003867|Irinotecan|irinotecan|mesh-list
111425673|NCT00003867|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111425674|NCT00003867|Antimetabolites|antimetabolites|mesh-ancestor
111425675|NCT00003867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111425676|NCT00003867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111425677|NCT00003867|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111425678|NCT00003867|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111425679|NCT00003867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111425680|NCT00004665|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
111425681|NCT00004665|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111425682|NCT00004665|Immunologic Factors|immunologic factors|mesh-ancestor
111425683|NCT00004665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111425684|NCT00363584|Capecitabine|capecitabine|mesh-list
111425685|NCT00363584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111425686|NCT00363584|Antimetabolites|antimetabolites|mesh-ancestor
111425687|NCT00363584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111425688|NCT00363584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111425689|NCT00003873|Fluorouracil|fluorouracil|mesh-list
111425690|NCT00003873|Eniluracil|eniluracil|mesh-list
111425691|NCT00003873|Antimetabolites|antimetabolites|mesh-ancestor
111425692|NCT00003873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111425693|NCT00003873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111425694|NCT00003873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110511281|NCT00878371|Analgesics|analgesics|mesh-ancestor
111425695|NCT00003873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111425696|NCT00003873|Immunologic Factors|immunologic factors|mesh-ancestor
111425697|NCT00003873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111425698|NCT00003873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111425699|NCT00363116|Daclizumab|daclizumab|mesh-list
111425700|NCT00363116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111425701|NCT00363116|Immunologic Factors|immunologic factors|mesh-ancestor
111425702|NCT00363116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111425703|NCT00004689|Clarithromycin|clarithromycin|mesh-list
111425704|NCT00004689|Rifampin|rifampin|mesh-list
111425705|NCT00004689|Ethambutol|ethambutol|mesh-list
111425706|NCT00004689|Streptomycin|streptomycin|mesh-list
111425707|NCT00004689|Thioacetazone|thioacetazone|mesh-list
111425708|NCT00004689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111425709|NCT00004689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111425710|NCT00004689|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111425711|NCT00004689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111425712|NCT00004689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111425713|NCT00004689|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111425714|NCT00004689|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111425715|NCT00004689|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111425716|NCT00004689|Antitubercular Agents|antitubercular agents|mesh-ancestor
111425717|NCT00004689|Leprostatic Agents|leprostatic agents|mesh-ancestor
111425718|NCT00004689|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111425719|NCT00004689|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111425720|NCT00004689|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111425721|NCT00004689|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
111425722|NCT00004689|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
111425723|NCT00004689|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
111425724|NCT00004689|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111425726|NCT00004695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111425727|NCT00004695|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111425728|NCT00004695|Analgesics|analgesics|mesh-ancestor
111425729|NCT00004695|Sensory System Agents|sensory system agents|mesh-ancestor
111425730|NCT00004695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111425731|NCT00004695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111425732|NCT02570984|Omalizumab|omalizumab|mesh-list
111425733|NCT02570984|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111425734|NCT02570984|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111425735|NCT02570984|Respiratory System Agents|respiratory system agents|mesh-ancestor
111425736|NCT00004731|Ubiquinone|ubiquinone|mesh-list
111425737|NCT00004731|Coenzyme Q10|coenzyme q10|mesh-list
111425738|NCT00004731|Micronutrients|micronutrients|mesh-ancestor
111425739|NCT00004731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111425740|NCT00004731|Vitamins|vitamins|mesh-ancestor
111425741|NCT00003885|Arsenic Trioxide|arsenic trioxide|mesh-list
111425742|NCT00003885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111425743|NCT00003891|Lurtotecan|lurtotecan|mesh-list
111425744|NCT00003891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111425745|NCT02472314|Bupivacaine|bupivacaine|mesh-list
111425746|NCT02472314|Anesthetics, Local|anesthetics, local|mesh-ancestor
111425747|NCT02472314|Anesthetics|anesthetics|mesh-ancestor
111425748|NCT02472314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111425749|NCT02472314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111425750|NCT02472314|Sensory System Agents|sensory system agents|mesh-ancestor
111425751|NCT02472314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111425752|NCT00004755|Meglumine Antimoniate|meglumine antimoniate|mesh-list
111425753|NCT00004755|Allopurinol|allopurinol|mesh-list
111425754|NCT00004755|Antimetabolites|antimetabolites|mesh-ancestor
111425755|NCT00004755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111425756|NCT00004755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111425757|NCT00004755|Gout Suppressants|gout suppressants|mesh-ancestor
111425758|NCT00004755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111425759|NCT00004755|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111425760|NCT00004755|Antioxidants|antioxidants|mesh-ancestor
111425761|NCT00004755|Protective Agents|protective agents|mesh-ancestor
111425762|NCT00004755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111425763|NCT00004755|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111425764|NCT00004755|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111425765|NCT00004755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111425766|NCT00003897|Sargramostim|sargramostim|mesh-list
111425767|NCT00003897|Immunologic Factors|immunologic factors|mesh-ancestor
111425768|NCT00003897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111425769|NCT00003909|Motexafin gadolinium|motexafin gadolinium|mesh-list
110511288|NCT05753397|Ropivacaine|ropivacaine|mesh-list
111425770|NCT00003909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111425771|NCT00003909|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111425772|NCT00003909|Dermatologic Agents|dermatologic agents|mesh-ancestor
111425773|NCT00004767|Sodium Benzoate|sodium benzoate|mesh-list
111425774|NCT00004767|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
111425775|NCT00004767|Phenylacetic acid|phenylacetic acid|mesh-list
111425776|NCT00004767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111425777|NCT00004767|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111425778|NCT00004767|Antimetabolites|antimetabolites|mesh-ancestor
111425779|NCT00004767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111425780|NCT00004767|Antifungal Agents|antifungal agents|mesh-ancestor
111425781|NCT00004767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111425782|NCT00004785|Dexamethasone|dexamethasone|mesh-list
111425783|NCT00004785|Methylprednisolone|methylprednisolone|mesh-list
111425784|NCT00004785|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111425785|NCT00004785|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111425786|NCT00004785|Prednisolone|prednisolone|mesh-list
111425787|NCT00004785|Prednisolone acetate|prednisolone acetate|mesh-list
111425788|NCT00004785|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111425789|NCT00004785|Prednisolone phosphate|prednisolone phosphate|mesh-list
111425790|NCT00004785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111425791|NCT00004785|Antiemetics|antiemetics|mesh-ancestor
111425792|NCT00004785|Autonomic Agents|autonomic agents|mesh-ancestor
111425793|NCT00004785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111425794|NCT00004785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111425795|NCT00004785|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111425796|NCT00004785|Glucocorticoids|glucocorticoids|mesh-ancestor
111425797|NCT00004785|Hormones|hormones|mesh-ancestor
111425798|NCT00004785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111425799|NCT00004785|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111425800|NCT00004785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111425801|NCT00004785|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111425802|NCT00004785|Protective Agents|protective agents|mesh-ancestor
111425803|NCT00004815|Hormones|hormones|mesh-list
111425804|NCT00004815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111425805|NCT00004815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111425806|NCT02279823|Minoxidil|minoxidil|mesh-list
111425807|NCT02279823|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111425808|NCT02279823|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111425809|NCT02279823|Vasodilator Agents|vasodilator agents|mesh-ancestor
111425810|NCT04040361|Pembrolizumab|pembrolizumab|mesh-list
111425811|NCT04040361|Ramucirumab|ramucirumab|mesh-list
111425812|NCT04040361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111425813|NCT04040361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111425814|NCT04040361|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111425815|NCT04040361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111425816|NCT00386061|Rimonabant|rimonabant|mesh-list
111425817|NCT00386061|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111425818|NCT00386061|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
111425819|NCT00386061|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
111425820|NCT00386061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111425821|NCT00386061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111425822|NCT00386061|Hormones|hormones|mesh-ancestor
111425823|NCT00386061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111425824|NCT00386061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111425825|NCT00005571|Eculizumab|eculizumab|mesh-list
111425826|NCT00005571|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
111425827|NCT00005571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111425828|NCT00005571|Immunologic Factors|immunologic factors|mesh-ancestor
111425829|NCT00005571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111425830|NCT00005577|Gemcitabine|gemcitabine|mesh-list
111425831|NCT00005577|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111425832|NCT00005577|Antimetabolites|antimetabolites|mesh-ancestor
111425833|NCT00005577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111425834|NCT00005577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111425835|NCT00005583|Doxorubicin|doxorubicin|mesh-list
111425836|NCT00005583|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111425837|NCT00005583|Epirubicin|epirubicin|mesh-list
111425838|NCT00005583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111425839|NCT00005583|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111425840|NCT00005583|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111425841|NCT00005583|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111425842|NCT00005583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111425843|NCT00005583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111425844|NCT00005589|Cytarabine|cytarabine|mesh-list
111425845|NCT00005589|Cyclophosphamide|cyclophosphamide|mesh-list
111425846|NCT00005589|Melphalan|melphalan|mesh-list
111425847|NCT00005589|Carmustine|carmustine|mesh-list
111425848|NCT00005589|Rituximab|rituximab|mesh-list
111425849|NCT00005589|Etoposide|etoposide|mesh-list
111425850|NCT00005589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111425851|NCT00005589|Immunologic Factors|immunologic factors|mesh-ancestor
111425852|NCT00005589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111425853|NCT00005589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111425854|NCT00005589|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111425855|NCT00005589|Alkylating Agents|alkylating agents|mesh-ancestor
111425856|NCT00005589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111425857|NCT00005589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111425858|NCT00005589|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111425859|NCT00005589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111425860|NCT00005589|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111425861|NCT00005589|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111425862|NCT00005589|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111425863|NCT00005589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111425864|NCT00005589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111425865|NCT00005589|Antimetabolites|antimetabolites|mesh-ancestor
111425866|NCT00005589|Antiviral Agents|antiviral agents|mesh-ancestor
111425867|NCT00005589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111425868|NCT00005601|Cytarabine|cytarabine|mesh-list
111425869|NCT00005601|Dexamethasone|dexamethasone|mesh-list
111425870|NCT00005601|Rituximab|rituximab|mesh-list
111425871|NCT00005601|Sargramostim|sargramostim|mesh-list
111425872|NCT00005601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111425873|NCT00005601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111425874|NCT00005601|Immunologic Factors|immunologic factors|mesh-ancestor
111425875|NCT00005601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111425876|NCT00005601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111425877|NCT00005601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111425878|NCT00005601|Antiemetics|antiemetics|mesh-ancestor
111425879|NCT00005601|Autonomic Agents|autonomic agents|mesh-ancestor
111425880|NCT00005601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111425881|NCT00005601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111425882|NCT00005601|Glucocorticoids|glucocorticoids|mesh-ancestor
111425883|NCT00005601|Hormones|hormones|mesh-ancestor
111425884|NCT00005601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111425885|NCT00005601|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111425886|NCT00005601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111425887|NCT00005601|Antimetabolites|antimetabolites|mesh-ancestor
111425888|NCT00005601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111425889|NCT00005601|Antiviral Agents|antiviral agents|mesh-ancestor
111425890|NCT00005601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111425891|NCT00005601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111425892|NCT00005607|Leucovorin|leucovorin|mesh-list
111425893|NCT00005607|Fluorouracil|fluorouracil|mesh-list
111425894|NCT00005607|Irinotecan|irinotecan|mesh-list
111425895|NCT00005607|Calcium|calcium|mesh-list
111425896|NCT00005607|Levoleucovorin|levoleucovorin|mesh-list
111425897|NCT00005607|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111425898|NCT00005607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111425899|NCT00005607|Antimetabolites|antimetabolites|mesh-ancestor
111425900|NCT00005607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111425901|NCT00005607|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111425902|NCT00005607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111425903|NCT00005607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111425904|NCT00005607|Immunologic Factors|immunologic factors|mesh-ancestor
111425905|NCT00005607|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111425906|NCT00005607|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111425907|NCT00005607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111425908|NCT00005607|Antidotes|antidotes|mesh-ancestor
111425909|NCT00005607|Protective Agents|protective agents|mesh-ancestor
111425910|NCT00005607|Vitamin B Complex|vitamin b complex|mesh-ancestor
111425911|NCT00005607|Vitamins|vitamins|mesh-ancestor
111425912|NCT00005607|Micronutrients|micronutrients|mesh-ancestor
111425913|NCT00005613|Cyclophosphamide|cyclophosphamide|mesh-list
111425914|NCT00005613|Carmustine|carmustine|mesh-list
111425915|NCT00005613|Etoposide|etoposide|mesh-list
111425916|NCT00005613|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111425917|NCT00005613|Immunologic Factors|immunologic factors|mesh-ancestor
111425918|NCT00005613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111425919|NCT00005613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111425920|NCT00005613|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111425921|NCT00005613|Alkylating Agents|alkylating agents|mesh-ancestor
111425922|NCT00005613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111425923|NCT00005613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111425924|NCT00005613|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111425925|NCT00005613|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111425926|NCT00005613|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111425927|NCT00005613|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111425928|NCT00005613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111425929|NCT00005625|Trabectedin|trabectedin|mesh-list
111425930|NCT00005625|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111425931|NCT00005625|Alkylating Agents|alkylating agents|mesh-ancestor
111425932|NCT00005625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111425933|NCT00005625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111425934|NCT00005631|Rituximab|rituximab|mesh-list
111425935|NCT00005631|Carboplatin|carboplatin|mesh-list
111425936|NCT00005631|Etoposide|etoposide|mesh-list
111425937|NCT00005631|Ifosfamide|ifosfamide|mesh-list
111425938|NCT00005631|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111425939|NCT00005631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111425940|NCT00005631|Immunologic Factors|immunologic factors|mesh-ancestor
111425941|NCT00005631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111150316|NCT02473913|Silymarin|silymarin|mesh-list
111425942|NCT00005631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111425943|NCT00005631|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111425944|NCT00005631|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111425945|NCT00005631|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111425946|NCT00005631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111425947|NCT00005631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111425948|NCT00005631|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111425949|NCT00005631|Alkylating Agents|alkylating agents|mesh-ancestor
111425950|NCT00005637|Temozolomide|temozolomide|mesh-list
111425951|NCT00005637|Carmustine|carmustine|mesh-list
111425952|NCT00005637|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111425953|NCT00005637|Alkylating Agents|alkylating agents|mesh-ancestor
111425954|NCT00005637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111425955|NCT00005637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111425956|NCT00005643|Doxorubicin|doxorubicin|mesh-list
111425957|NCT00005643|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111425958|NCT00005643|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111425959|NCT00005643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111425960|NCT00005643|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111425961|NCT00005643|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111425962|NCT00005643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111425963|NCT00005643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111425964|NCT00005649|Paclitaxel|paclitaxel|mesh-list
111425965|NCT00005649|Capecitabine|capecitabine|mesh-list
111425966|NCT00005649|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111425967|NCT00005649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111425968|NCT00005649|Tubulin Modulators|tubulin modulators|mesh-ancestor
111425969|NCT00005649|Antimitotic Agents|antimitotic agents|mesh-ancestor
111425970|NCT00005649|Mitosis Modulators|mitosis modulators|mesh-ancestor
111425971|NCT00005649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111425972|NCT00005649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111425973|NCT00005649|Antimetabolites|antimetabolites|mesh-ancestor
111425974|NCT00005673|Capravirine|capravirine|mesh-list
111425975|NCT00005673|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111425976|NCT00005673|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111425977|NCT00005673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111425978|NCT00005673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111425979|NCT00005673|Antiviral Agents|antiviral agents|mesh-ancestor
111425980|NCT00005673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111425981|NCT00005673|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111425982|NCT00005673|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111425983|NCT02247349|Nivolumab|nivolumab|mesh-list
111425984|NCT02247349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111425985|NCT02247349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111425986|NCT02247349|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111425987|NCT02247349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111425988|NCT03390673|Bevacizumab|bevacizumab|mesh-list
111425989|NCT03390673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111425990|NCT03390673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111425991|NCT03390673|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111425992|NCT03390673|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111425993|NCT03390673|Growth Substances|growth substances|mesh-ancestor
111425994|NCT03390673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111425995|NCT03390673|Growth Inhibitors|growth inhibitors|mesh-ancestor
111425996|NCT02974933|Pemetrexed|pemetrexed|mesh-list
111425997|NCT02974933|Apatinib|apatinib|mesh-list
111425998|NCT02974933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111425999|NCT02974933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111426000|NCT02974933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111426001|NCT02974933|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111426002|NCT02974933|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111426003|NCT02974933|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111426004|NCT00005769|Hormones|hormones|mesh-list
111426005|NCT00005769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111426006|NCT00005769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111426007|NCT00005775|Amino-acid, glucose, and electrolyte solution|amino-acid, glucose, and electrolyte solution|mesh-list
111426008|NCT00005775|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
111426009|NCT00005775|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111426010|NCT00005787|Epoetin Alfa|epoetin alfa|mesh-list
111426011|NCT00005787|Flt3 ligand protein|flt3 ligand protein|mesh-list
111426012|NCT00005787|Sargramostim|sargramostim|mesh-list
111426013|NCT00005787|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111426014|NCT00005787|Immunologic Factors|immunologic factors|mesh-ancestor
111426015|NCT00005787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111426016|NCT00005787|Hematinics|hematinics|mesh-ancestor
111426017|NCT00005787|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111426018|NCT00005787|Protective Agents|protective agents|mesh-ancestor
111426019|NCT00005793|Cytarabine|cytarabine|mesh-list
111426020|NCT00005793|Etoposide|etoposide|mesh-list
111426021|NCT00005793|Daunorubicin|daunorubicin|mesh-list
111426022|NCT00005793|Topotecan|topotecan|mesh-list
111426023|NCT00005793|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111426024|NCT00005793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111426025|NCT00005793|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111426026|NCT00005793|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111426027|NCT00005793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111426028|NCT00005793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111426029|NCT00005793|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111426030|NCT00005793|Antimetabolites|antimetabolites|mesh-ancestor
111426031|NCT00005793|Antiviral Agents|antiviral agents|mesh-ancestor
111426032|NCT00005793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111426033|NCT00005793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111426034|NCT00005793|Immunologic Factors|immunologic factors|mesh-ancestor
111426035|NCT00005793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111426036|NCT00005793|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111426037|NCT00005793|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111426038|NCT00005799|Cyclosporine|cyclosporine|mesh-list
111426039|NCT00005799|Mycophenolic Acid|mycophenolic acid|mesh-list
111426040|NCT00005799|Fludarabine|fludarabine|mesh-list
111426041|NCT00005799|Fludarabine phosphate|fludarabine phosphate|mesh-list
111426042|NCT00005799|Cyclosporins|cyclosporins|mesh-list
111426043|NCT00005799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111426044|NCT00005799|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111426045|NCT00005799|Antimetabolites|antimetabolites|mesh-ancestor
111426046|NCT00005799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111426047|NCT00005799|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111426048|NCT00005799|Immunologic Factors|immunologic factors|mesh-ancestor
111426049|NCT00005799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111426050|NCT00005799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111426051|NCT00005799|Antifungal Agents|antifungal agents|mesh-ancestor
111426052|NCT00005799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111426053|NCT00005799|Dermatologic Agents|dermatologic agents|mesh-ancestor
111426054|NCT00005799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111426055|NCT00005799|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111426056|NCT00005799|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111426057|NCT00005799|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111426058|NCT00005799|Antitubercular Agents|antitubercular agents|mesh-ancestor
111426059|NCT00005799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111426060|NCT00386373|Imatinib Mesylate|imatinib mesylate|mesh-list
111426061|NCT00386373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111426062|NCT00386373|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111426063|NCT00386373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111426064|NCT00386373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111426065|NCT00005811|Topotecan|topotecan|mesh-list
111426066|NCT00005811|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111426067|NCT00005811|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111426068|NCT00005811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111426069|NCT00005811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111426070|NCT00005811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111426071|NCT02520518|Dapagliflozin|dapagliflozin|mesh-list
111426072|NCT02520518|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111426073|NCT02520518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111426074|NCT02520518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111426075|NCT02520518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111426076|NCT01689987|Sirolimus|sirolimus|mesh-list
111426077|NCT01689987|Hydroxychloroquine|hydroxychloroquine|mesh-list
111426078|NCT01689987|Dexamethasone|dexamethasone|mesh-list
111426079|NCT01689987|Dexamethasone acetate|dexamethasone acetate|mesh-list
111426080|NCT01689987|Cyclophosphamide|cyclophosphamide|mesh-list
111426081|NCT01689987|Ichthammol|ichthammol|mesh-list
111426082|NCT01689987|BB 1101|bb 1101|mesh-list
111426083|NCT01689987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111426084|NCT01689987|Immunologic Factors|immunologic factors|mesh-ancestor
111426085|NCT01689987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111426086|NCT01689987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111150467|NCT01896934|Antidepressive Agents|antidepressive agents|mesh-ancestor
111426087|NCT01689987|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111426088|NCT01689987|Alkylating Agents|alkylating agents|mesh-ancestor
111426089|NCT01689987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111426090|NCT01689987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111426091|NCT01689987|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111426092|NCT01689987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111426094|NCT01689987|Autonomic Agents|autonomic agents|mesh-ancestor
111426095|NCT01689987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111426096|NCT01689987|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111426097|NCT01689987|Glucocorticoids|glucocorticoids|mesh-ancestor
111426098|NCT01689987|Hormones|hormones|mesh-ancestor
111426099|NCT01689987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111426100|NCT01689987|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111426101|NCT01689987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111426102|NCT01689987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111426103|NCT01689987|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111426104|NCT01689987|Antifungal Agents|antifungal agents|mesh-ancestor
111426105|NCT01689987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110511336|NCT01716312|Omalizumab|omalizumab|mesh-list
111426106|NCT01689987|Antimalarials|antimalarials|mesh-ancestor
111426107|NCT01689987|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111426108|NCT01689987|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111426109|NCT01689987|Protease Inhibitors|protease inhibitors|mesh-ancestor
111426110|NCT01689987|Dermatologic Agents|dermatologic agents|mesh-ancestor
111426111|NCT01680939|Ibuprofen|ibuprofen|mesh-list
111426112|NCT01680939|Morphine|morphine|mesh-list
111426113|NCT01680939|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111426114|NCT01680939|Narcotics|narcotics|mesh-ancestor
111426115|NCT01680939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111426116|NCT01680939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111426117|NCT01680939|Analgesics|analgesics|mesh-ancestor
111426118|NCT01680939|Sensory System Agents|sensory system agents|mesh-ancestor
111426119|NCT01680939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111426120|NCT01680939|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111426121|NCT01680939|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111426122|NCT01680939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111426123|NCT01680939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111426124|NCT01680939|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111426125|NCT01680939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111426126|NCT01680939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111426127|NCT01689597|Morphine|morphine|mesh-list
111426128|NCT01689597|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111426129|NCT01689597|Narcotics|narcotics|mesh-ancestor
111426130|NCT01689597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111426131|NCT01689597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111426132|NCT01689597|Analgesics|analgesics|mesh-ancestor
111426133|NCT01689597|Sensory System Agents|sensory system agents|mesh-ancestor
111426134|NCT01689597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111426135|NCT02163733|Osimertinib|osimertinib|mesh-list
111426136|NCT02163733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111426137|NCT02163733|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111426138|NCT02163733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111426139|NCT02163733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111426140|NCT02483000|Biotin|biotin|mesh-list
111426141|NCT02483000|Cytarabine|cytarabine|mesh-list
111426142|NCT02483000|Etoposide|etoposide|mesh-list
111426143|NCT02483000|Podophyllotoxin|podophyllotoxin|mesh-list
111426144|NCT02483000|Etoposide phosphate|etoposide phosphate|mesh-list
111426145|NCT02483000|Melphalan|melphalan|mesh-list
111426146|NCT02483000|Mechlorethamine|mechlorethamine|mesh-list
111426147|NCT02483000|Carmustine|carmustine|mesh-list
111426148|NCT02483000|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
111426149|NCT02483000|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
111426150|NCT02483000|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111426151|NCT02483000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111426152|NCT02483000|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111426153|NCT02483000|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111426154|NCT02483000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111426155|NCT02483000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111426156|NCT02483000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111426157|NCT02483000|Antimetabolites|antimetabolites|mesh-ancestor
111426158|NCT02483000|Antiviral Agents|antiviral agents|mesh-ancestor
111426159|NCT02483000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111426160|NCT02483000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111426161|NCT02483000|Immunologic Factors|immunologic factors|mesh-ancestor
111426162|NCT02483000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111426163|NCT02483000|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111426164|NCT02483000|Alkylating Agents|alkylating agents|mesh-ancestor
111426165|NCT02483000|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111426166|NCT02483000|Chelating Agents|chelating agents|mesh-ancestor
111426167|NCT02483000|Sequestering Agents|sequestering agents|mesh-ancestor
111426168|NCT02483000|Keratolytic Agents|keratolytic agents|mesh-ancestor
111426169|NCT02483000|Dermatologic Agents|dermatologic agents|mesh-ancestor
111426170|NCT02483000|Tubulin Modulators|tubulin modulators|mesh-ancestor
111426171|NCT02483000|Antimitotic Agents|antimitotic agents|mesh-ancestor
111426172|NCT02483000|Mitosis Modulators|mitosis modulators|mesh-ancestor
111426173|NCT02483000|Vitamin B Complex|vitamin b complex|mesh-ancestor
111426174|NCT02483000|Vitamins|vitamins|mesh-ancestor
111426175|NCT02483000|Micronutrients|micronutrients|mesh-ancestor
111426176|NCT02420210|Dexamethasone|dexamethasone|mesh-list
111426177|NCT02420210|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
111426178|NCT02420210|Obinutuzumab|obinutuzumab|mesh-list
111426179|NCT02420210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111426180|NCT02420210|Antiemetics|antiemetics|mesh-ancestor
111426181|NCT02420210|Autonomic Agents|autonomic agents|mesh-ancestor
111426182|NCT02420210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111426183|NCT02420210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111426184|NCT02420210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111426185|NCT02420210|Glucocorticoids|glucocorticoids|mesh-ancestor
111426186|NCT02420210|Hormones|hormones|mesh-ancestor
111426187|NCT02420210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111426188|NCT02420210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111426189|NCT02420210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111426190|NCT02420210|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111426191|NCT02420210|Alkylating Agents|alkylating agents|mesh-ancestor
111426192|NCT02420210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111426193|NCT02420210|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111426194|NCT04829799|Ketorolac|ketorolac|mesh-list
111426195|NCT04829799|Lidocaine|lidocaine|mesh-list
111426196|NCT04829799|Phenylephrine|phenylephrine|mesh-list
111426197|NCT04829799|Oxymetazoline|oxymetazoline|mesh-list
111426198|NCT04829799|Anesthetics, Local|anesthetics, local|mesh-ancestor
111426199|NCT04829799|Anesthetics|anesthetics|mesh-ancestor
111426200|NCT04829799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111426201|NCT04829799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111426202|NCT04829799|Sensory System Agents|sensory system agents|mesh-ancestor
111426203|NCT04829799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111426204|NCT04829799|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111426205|NCT04829799|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111426206|NCT04829799|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111426207|NCT04829799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111426208|NCT04829799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111426209|NCT04829799|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111426210|NCT04829799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111426211|NCT04829799|Analgesics|analgesics|mesh-ancestor
111426212|NCT04829799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111426213|NCT04829799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111426214|NCT04829799|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111426215|NCT04829799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111426216|NCT04829799|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111426217|NCT04829799|Mydriatics|mydriatics|mesh-ancestor
111426218|NCT04829799|Autonomic Agents|autonomic agents|mesh-ancestor
111426219|NCT04829799|Sympathomimetics|sympathomimetics|mesh-ancestor
111426220|NCT04829799|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111426221|NCT04829799|Nasal Decongestants|nasal decongestants|mesh-ancestor
111426222|NCT04829799|Respiratory System Agents|respiratory system agents|mesh-ancestor
111426223|NCT04829799|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111426224|NCT04829799|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111426225|NCT04829799|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111426226|NCT04829799|Adrenergic Agents|adrenergic agents|mesh-ancestor
111426227|NCT04829799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111426228|NCT04829799|Protective Agents|protective agents|mesh-ancestor
111426229|NCT01789333|Riboflavin|riboflavin|mesh-list
111426230|NCT01789333|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111426231|NCT01789333|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111426232|NCT01789333|Vitamin B Complex|vitamin b complex|mesh-ancestor
111426233|NCT01789333|Vitamins|vitamins|mesh-ancestor
111426234|NCT01789333|Micronutrients|micronutrients|mesh-ancestor
111426235|NCT01789333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111426236|NCT01789333|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111426237|NCT01789333|Dermatologic Agents|dermatologic agents|mesh-ancestor
111426238|NCT02524106|Bococizumab|bococizumab|mesh-list
111426239|NCT02524106|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111426240|NCT02524106|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111426241|NCT02524106|Antimetabolites|antimetabolites|mesh-ancestor
111426242|NCT02524106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111426243|NCT02524106|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111426245|NCT01761877|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111426246|NCT01761877|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111426247|NCT01761877|Analgesics|analgesics|mesh-ancestor
111426248|NCT01761877|Sensory System Agents|sensory system agents|mesh-ancestor
111426249|NCT01761877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111426250|NCT01761877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111426251|NCT01761877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111426252|NCT01761877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111426253|NCT01761877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111426254|NCT01761877|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111426255|NCT01761877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111426256|NCT01761877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111426257|NCT02488070|Edetic Acid|edetic acid|mesh-list
111426258|NCT02488070|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
111426259|NCT02488070|Chelating Agents|chelating agents|mesh-ancestor
111426260|NCT02488070|Sequestering Agents|sequestering agents|mesh-ancestor
111426261|NCT02488070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111426262|NCT02488070|Anticoagulants|anticoagulants|mesh-ancestor
111426263|NCT02488070|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
111426264|NCT02488070|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111426265|NCT04116541|Trametinib|trametinib|mesh-list
111426266|NCT04116541|Dabrafenib|dabrafenib|mesh-list
111426267|NCT04116541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111426268|NCT04116541|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111426269|NCT04116541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111426270|NCT04116541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111426271|NCT03306979|Acetylcysteine|acetylcysteine|mesh-list
111426272|NCT03306979|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111426273|NCT03306979|Antiviral Agents|antiviral agents|mesh-ancestor
111426274|NCT03306979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111426275|NCT03306979|Expectorants|expectorants|mesh-ancestor
111426276|NCT03306979|Respiratory System Agents|respiratory system agents|mesh-ancestor
111426277|NCT03306979|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111426278|NCT03306979|Antioxidants|antioxidants|mesh-ancestor
111426279|NCT03306979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111426280|NCT03306979|Protective Agents|protective agents|mesh-ancestor
111426281|NCT03306979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111426282|NCT03306979|Antidotes|antidotes|mesh-ancestor
111426283|NCT00362869|Levofloxacin|levofloxacin|mesh-list
111426284|NCT00362869|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111426285|NCT00362869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111426286|NCT00362869|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111426287|NCT00362869|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111426288|NCT00362869|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111426289|NCT00362869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111426290|NCT00362869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111426291|NCT00362869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111426292|NCT00362869|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111426293|NCT00362869|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111426294|NCT03257215|Vitamin D|vitamin d|mesh-list
111426295|NCT03257215|Ergocalciferols|ergocalciferols|mesh-list
111426296|NCT03257215|Cholecalciferol|cholecalciferol|mesh-list
111426297|NCT03257215|Vitamins|vitamins|mesh-list
111426298|NCT03257215|Micronutrients|micronutrients|mesh-ancestor
111426299|NCT03257215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111426300|NCT03257215|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111426301|NCT03257215|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111426302|NCT02422940|4-Aminopyridine|4-aminopyridine|mesh-list
111426303|NCT02422940|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
111426304|NCT02422940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111426305|NCT02422940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111426306|NCT00588523|Temozolomide|temozolomide|mesh-list
111426307|NCT00588523|Busulfan|busulfan|mesh-list
111426308|NCT00588523|Thiotepa|thiotepa|mesh-list
111426309|NCT00588523|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111426310|NCT00588523|Alkylating Agents|alkylating agents|mesh-ancestor
111426311|NCT00588523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111426312|NCT00588523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111426313|NCT00588523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111426314|NCT00588523|Immunologic Factors|immunologic factors|mesh-ancestor
111426315|NCT00588523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111426316|NCT00588523|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111426317|NCT02974387|Loteprednol Etabonate|loteprednol etabonate|mesh-list
111426318|NCT02974387|Fluorometholone|fluorometholone|mesh-list
111426319|NCT02974387|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111426320|NCT02974387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111426322|NCT02974387|Hormones|hormones|mesh-ancestor
111426323|NCT02974387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111426324|NCT02974387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111426325|NCT00430183|Docetaxel|docetaxel|mesh-list
111426326|NCT00430183|Leuprolide|leuprolide|mesh-list
111426327|NCT00430183|Goserelin|goserelin|mesh-list
111426328|NCT00430183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111426329|NCT00430183|Tubulin Modulators|tubulin modulators|mesh-ancestor
111426330|NCT00430183|Antimitotic Agents|antimitotic agents|mesh-ancestor
111426331|NCT00430183|Mitosis Modulators|mitosis modulators|mesh-ancestor
111426332|NCT00430183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111426333|NCT00430183|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111426334|NCT00430183|Fertility Agents|fertility agents|mesh-ancestor
111426335|NCT00430183|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111426336|NCT00430183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111426337|NCT00430183|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111426338|NCT00362947|Parnaparin|parnaparin|mesh-list
111426339|NCT00362947|Anticoagulants|anticoagulants|mesh-ancestor
111426340|NCT00362947|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111426341|NCT00362947|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111426342|NCT00362947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111426343|NCT00363025|Daunorubicin|daunorubicin|mesh-list
111426344|NCT00363025|Idarubicin|idarubicin|mesh-list
111426345|NCT00363025|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111426346|NCT00363025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111426347|NCT00363025|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111426348|NCT00363025|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111426349|NCT00363025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111426350|NCT00363025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111426351|NCT02444143|Tacrolimus|tacrolimus|mesh-list
111426352|NCT02444143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111426353|NCT02444143|Immunologic Factors|immunologic factors|mesh-ancestor
111426354|NCT02444143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111426355|NCT02444143|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111426356|NCT02444143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111426357|NCT02444143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111426358|NCT03161431|Pembrolizumab|pembrolizumab|mesh-list
111426359|NCT03161431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111426360|NCT03161431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111426361|NCT03161431|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111426362|NCT03161431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111426363|NCT02445859|Cefuroxime|cefuroxime|mesh-list
111426364|NCT02445859|Cefuroxime axetil|cefuroxime axetil|mesh-list
111426365|NCT02445859|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111426366|NCT02445859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111426367|NCT02446483|Rabeprazole|rabeprazole|mesh-list
111426368|NCT02446483|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111426369|NCT02446483|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111426370|NCT02446483|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111426371|NCT02446483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111426372|NCT02446483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111426373|NCT00362635|Clevudine|clevudine|mesh-list
111426374|NCT00362635|Antiviral Agents|antiviral agents|mesh-ancestor
111426375|NCT00362635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111426376|NCT04744753|Calcium|calcium|mesh-list
111426377|NCT04744753|Ionophores|ionophores|mesh-list
111426378|NCT04744753|Calcium Ionophores|calcium ionophores|mesh-list
111426379|NCT04744753|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111426380|NCT04744753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111426381|NCT04744753|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110511357|NCT00880243|Immunologic Factors|immunologic factors|mesh-ancestor
111426382|NCT04744753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111426383|NCT02420041|Triamcinolone|triamcinolone|mesh-list
111426384|NCT02420041|Lidocaine|lidocaine|mesh-list
111426385|NCT02420041|Anesthetics, Local|anesthetics, local|mesh-ancestor
111426386|NCT02420041|Anesthetics|anesthetics|mesh-ancestor
111426387|NCT02420041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111426388|NCT02420041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111426389|NCT02420041|Sensory System Agents|sensory system agents|mesh-ancestor
111426390|NCT02420041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111426391|NCT02420041|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111426392|NCT02420041|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111150769|NCT02037165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111426393|NCT02420041|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111426394|NCT02420041|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111426395|NCT02420041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111426396|NCT02420041|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111426397|NCT02420041|Glucocorticoids|glucocorticoids|mesh-ancestor
111426398|NCT02420041|Hormones|hormones|mesh-ancestor
111426399|NCT02420041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111426400|NCT02421211|Sofosbuvir|sofosbuvir|mesh-list
111426401|NCT02421211|Ledipasvir|ledipasvir|mesh-list
111426402|NCT02421211|Simeprevir|simeprevir|mesh-list
111426403|NCT02421211|Antiviral Agents|antiviral agents|mesh-ancestor
111426404|NCT02421211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111426405|NCT02421211|Protease Inhibitors|protease inhibitors|mesh-ancestor
111426406|NCT02421211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111426407|NCT02421211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111426408|NCT00363259|Ribavirin|ribavirin|mesh-list
111426409|NCT00363259|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
111426410|NCT00363259|Antimetabolites|antimetabolites|mesh-ancestor
111426411|NCT00363259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111426412|NCT00363259|Antiviral Agents|antiviral agents|mesh-ancestor
111426413|NCT00363259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111426414|NCT03089905|Dexmedetomidine|dexmedetomidine|mesh-list
111426415|NCT03089905|Remifentanil|remifentanil|mesh-list
111426416|NCT03089905|Sevoflurane|sevoflurane|mesh-list
111426417|NCT03089905|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111426418|NCT03089905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111426419|NCT03089905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111426420|NCT03089905|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111426421|NCT03089905|Analgesics|analgesics|mesh-ancestor
111426422|NCT03089905|Sensory System Agents|sensory system agents|mesh-ancestor
111426423|NCT03089905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111426424|NCT03089905|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111426425|NCT03089905|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111426426|NCT03089905|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111426427|NCT03089905|Adrenergic Agents|adrenergic agents|mesh-ancestor
111426428|NCT03089905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111426429|NCT03089905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111426430|NCT03089905|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111426431|NCT03089905|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111426432|NCT03089905|Anesthetics, General|anesthetics, general|mesh-ancestor
111426433|NCT03089905|Anesthetics|anesthetics|mesh-ancestor
111426434|NCT03089905|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111426435|NCT03089905|Narcotics|narcotics|mesh-ancestor
111426436|NCT02424968|Cyclosporine|cyclosporine|mesh-list
111426437|NCT02424968|Mycophenolic Acid|mycophenolic acid|mesh-list
111426438|NCT02424968|Cyclosporins|cyclosporins|mesh-list
111426439|NCT02424968|Thymoglobulin|thymoglobulin|mesh-list
111426440|NCT02424968|Antilymphocyte Serum|antilymphocyte serum|mesh-list
111426441|NCT02424968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110511384|NCT00880321|Dabrafenib|dabrafenib|mesh-list
111426442|NCT02424968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111426443|NCT02424968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111426444|NCT02424968|Immunologic Factors|immunologic factors|mesh-ancestor
111426445|NCT02424968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111426446|NCT02424968|Antifungal Agents|antifungal agents|mesh-ancestor
111426447|NCT02424968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111426448|NCT02424968|Dermatologic Agents|dermatologic agents|mesh-ancestor
111426449|NCT02424968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111426450|NCT02424968|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111426451|NCT02424968|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111426452|NCT02424968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111426453|NCT02424968|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111426454|NCT02424968|Antitubercular Agents|antitubercular agents|mesh-ancestor
111426455|NCT02424968|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111426456|NCT02424799|GSK2646264|gsk2646264|mesh-list
111426457|NCT02424799|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111426458|NCT02424799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111426459|NCT02424799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111426460|NCT02492750|Dexamethasone|dexamethasone|mesh-list
111426461|NCT02492750|Dexamethasone acetate|dexamethasone acetate|mesh-list
111426462|NCT02492750|Lenalidomide|lenalidomide|mesh-list
111426463|NCT02492750|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
111426464|NCT02492750|Ichthammol|ichthammol|mesh-list
111426465|NCT02492750|BB 1101|bb 1101|mesh-list
111426466|NCT02492750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111426467|NCT02492750|Antiemetics|antiemetics|mesh-ancestor
111426468|NCT02492750|Autonomic Agents|autonomic agents|mesh-ancestor
111426469|NCT02492750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111426470|NCT02492750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111426471|NCT02492750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111426472|NCT02492750|Glucocorticoids|glucocorticoids|mesh-ancestor
111426473|NCT02492750|Hormones|hormones|mesh-ancestor
111426474|NCT02492750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111426475|NCT02492750|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111426476|NCT02492750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111426477|NCT02492750|Immunologic Factors|immunologic factors|mesh-ancestor
111426478|NCT02492750|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111426479|NCT02492750|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111426480|NCT02492750|Growth Substances|growth substances|mesh-ancestor
111426481|NCT02492750|Growth Inhibitors|growth inhibitors|mesh-ancestor
111426482|NCT02492750|Protease Inhibitors|protease inhibitors|mesh-ancestor
111426483|NCT02492750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111426484|NCT02492750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111426485|NCT02492750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111426486|NCT02492750|Dermatologic Agents|dermatologic agents|mesh-ancestor
111426487|NCT00363337|Aripiprazole|aripiprazole|mesh-list
111426488|NCT00363337|Antidepressive Agents|antidepressive agents|mesh-ancestor
111426489|NCT00363337|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111426490|NCT00363337|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111426491|NCT00363337|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111426492|NCT00363337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111426493|NCT00363337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111426494|NCT00363337|Dopamine Agonists|dopamine agonists|mesh-ancestor
111426495|NCT00363337|Dopamine Agents|dopamine agents|mesh-ancestor
111426496|NCT00363337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111426497|NCT00363337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111426498|NCT00363337|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111426499|NCT00363337|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111426500|NCT00363337|Serotonin Agents|serotonin agents|mesh-ancestor
111426501|NCT00363337|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111426502|NCT00363337|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111426503|NCT00363337|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111426504|NCT00363337|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111426505|NCT02493452|Plecanatide|plecanatide|mesh-list
111426506|NCT02493452|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
111426507|NCT02493452|Enzyme Activators|enzyme activators|mesh-ancestor
111426508|NCT02493452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111426509|NCT02493452|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111426510|NCT02429869|Everolimus|everolimus|mesh-list
111426511|NCT02429869|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111426512|NCT02429869|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111426513|NCT02429869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111426514|NCT02429869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111426515|NCT02429869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111426516|NCT02429869|Immunologic Factors|immunologic factors|mesh-ancestor
111426517|NCT02429869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111426518|NCT02429869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111426519|NCT02428478|Desipramine|desipramine|mesh-list
111426520|NCT02428478|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
111426521|NCT02428478|Antidepressive Agents|antidepressive agents|mesh-ancestor
111426522|NCT02428478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111426523|NCT02428478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111426524|NCT02428478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111426525|NCT02428478|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111426526|NCT02428478|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111426527|NCT02428478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111426528|NCT02428478|Adrenergic Agents|adrenergic agents|mesh-ancestor
111426529|NCT02428478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111426530|NCT02428478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111426531|NCT04341493|Hydroxychloroquine|hydroxychloroquine|mesh-list
111426532|NCT04341493|Nitazoxanide|nitazoxanide|mesh-list
111426533|NCT04341493|Antimalarials|antimalarials|mesh-ancestor
111426534|NCT04341493|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111426535|NCT04341493|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111426536|NCT04341493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111426537|NCT04341493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111426538|NCT04341493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111426539|NCT04341493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111426540|NCT02432287|Metformin|metformin|mesh-list
111426541|NCT02432287|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111426542|NCT02432287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111150921|NCT01891864|GP2015|gp2015|mesh-list
111426543|NCT02532998|Fludrocortisone|fludrocortisone|mesh-list
111426544|NCT02532998|Eplerenone|eplerenone|mesh-list
111426545|NCT02532998|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
111426546|NCT02532998|Hormone Antagonists|hormone antagonists|mesh-ancestor
111426547|NCT02532998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111426548|NCT02532998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111426549|NCT02532998|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
111426550|NCT02532998|Diuretics|diuretics|mesh-ancestor
111426551|NCT02532998|Natriuretic Agents|natriuretic agents|mesh-ancestor
111426552|NCT02532998|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111426553|NCT02532998|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111426554|NCT03026101|Nitroglycerin|nitroglycerin|mesh-list
111426555|NCT03026101|Vasodilator Agents|vasodilator agents|mesh-ancestor
111426556|NCT02453581|Artefenomel|artefenomel|mesh-list
111426557|NCT02453581|Antimalarials|antimalarials|mesh-ancestor
111426558|NCT02453581|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111426559|NCT02453581|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111426560|NCT02453581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111426561|NCT02533466|Listerine|listerine|mesh-list
111426562|NCT02533466|Fluorides|fluorides|mesh-list
111426563|NCT02533466|Sodium Fluoride|sodium fluoride|mesh-list
111426564|NCT02533466|Cariostatic Agents|cariostatic agents|mesh-ancestor
111426565|NCT02533466|Protective Agents|protective agents|mesh-ancestor
111426566|NCT02533466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111426567|NCT02533466|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111426568|NCT02533466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111426569|NCT02974244|Exenatide|exenatide|mesh-list
111426570|NCT02974244|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111426571|NCT02974244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111426572|NCT02974244|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111426573|NCT02974244|Incretins|incretins|mesh-ancestor
111426574|NCT02974244|Hormones|hormones|mesh-ancestor
111426575|NCT02974244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111426576|NCT02436031|Desipramine|desipramine|mesh-list
111426577|NCT02436031|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
111426578|NCT02436031|Antidepressive Agents|antidepressive agents|mesh-ancestor
111426579|NCT02436031|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111426580|NCT02436031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111426581|NCT02436031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111426582|NCT02436031|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111426583|NCT02436031|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111426584|NCT02436031|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111426585|NCT02436031|Adrenergic Agents|adrenergic agents|mesh-ancestor
111426586|NCT02436031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111426587|NCT02436031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111426588|NCT02454283|Vanoxerine|vanoxerine|mesh-list
111426589|NCT02454283|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111426590|NCT02454283|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111426591|NCT02454283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111426592|NCT02454283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111426593|NCT02454283|Dopamine Agents|dopamine agents|mesh-ancestor
111426594|NCT02454283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111426595|NCT02454283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111426596|NCT02437669|Hydromorphone|hydromorphone|mesh-list
111426597|NCT02437669|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111426598|NCT02437669|Narcotics|narcotics|mesh-ancestor
111426599|NCT02437669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111426600|NCT02437669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111426601|NCT02437669|Analgesics|analgesics|mesh-ancestor
111426602|NCT02437669|Sensory System Agents|sensory system agents|mesh-ancestor
111426603|NCT02437669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111426604|NCT02430818|Ketamine|ketamine|mesh-list
111426605|NCT02430818|Morphine|morphine|mesh-list
111426606|NCT02430818|Analgesics|analgesics|mesh-ancestor
111426607|NCT02430818|Sensory System Agents|sensory system agents|mesh-ancestor
111426608|NCT02430818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111426609|NCT02430818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111426610|NCT02430818|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111426611|NCT02430818|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111426612|NCT02430818|Anesthetics, General|anesthetics, general|mesh-ancestor
111426613|NCT02430818|Anesthetics|anesthetics|mesh-ancestor
111426614|NCT02430818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111426615|NCT02430818|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111426616|NCT02430818|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111426617|NCT02430818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111479299|NCT05028634|Vaccines|vaccines|mesh-list
111426618|NCT02430818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111426619|NCT02430818|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111426620|NCT02430818|Narcotics|narcotics|mesh-ancestor
111426621|NCT02455453|Estradiol|estradiol|mesh-list
111426622|NCT02455453|Estrogens|estrogens|mesh-ancestor
111426623|NCT02455453|Hormones|hormones|mesh-ancestor
111426624|NCT02455453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111426625|NCT02455453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111426626|NCT02533934|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
111426627|NCT02533934|Antiviral Agents|antiviral agents|mesh-ancestor
111426628|NCT02533934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111426629|NCT02519023|Acetaminophen|acetaminophen|mesh-list
111426630|NCT02519023|Ibuprofen|ibuprofen|mesh-list
111426631|NCT02519023|Epinephrine|epinephrine|mesh-list
111426632|NCT02519023|Oxycodone|oxycodone|mesh-list
111426633|NCT02519023|Bupivacaine|bupivacaine|mesh-list
111426634|NCT02519023|Anesthetics, Local|anesthetics, local|mesh-ancestor
111426635|NCT02519023|Anesthetics|anesthetics|mesh-ancestor
111426636|NCT02519023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111426637|NCT02519023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111426638|NCT02519023|Sensory System Agents|sensory system agents|mesh-ancestor
111426639|NCT02519023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111426640|NCT02519023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111426641|NCT02519023|Analgesics|analgesics|mesh-ancestor
111426642|NCT02519023|Antipyretics|antipyretics|mesh-ancestor
111426643|NCT02519023|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111426644|NCT02519023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111426645|NCT02519023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111426646|NCT02519023|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111426647|NCT02519023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111426648|NCT02519023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111426649|NCT02519023|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111426650|NCT02519023|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111426651|NCT02519023|Adrenergic Agents|adrenergic agents|mesh-ancestor
111426652|NCT02519023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111426653|NCT02519023|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111426654|NCT02519023|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111426655|NCT02519023|Autonomic Agents|autonomic agents|mesh-ancestor
111426656|NCT02519023|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111426657|NCT02519023|Respiratory System Agents|respiratory system agents|mesh-ancestor
111426658|NCT02519023|Mydriatics|mydriatics|mesh-ancestor
111426659|NCT02519023|Sympathomimetics|sympathomimetics|mesh-ancestor
111426660|NCT02519023|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111426661|NCT02519023|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111426662|NCT02519023|Narcotics|narcotics|mesh-ancestor
111426663|NCT02497040|Bupivacaine|bupivacaine|mesh-list
111426664|NCT02497040|Levobupivacaine|levobupivacaine|mesh-list
111426665|NCT02497040|Anesthetics, Local|anesthetics, local|mesh-ancestor
111426666|NCT02497040|Anesthetics|anesthetics|mesh-ancestor
111426667|NCT02497040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111426668|NCT02497040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111426669|NCT02497040|Sensory System Agents|sensory system agents|mesh-ancestor
111426670|NCT02497040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111426671|NCT02523235|Ropivacaine|ropivacaine|mesh-list
111426672|NCT02523235|Anesthetics, Local|anesthetics, local|mesh-ancestor
111426673|NCT02523235|Anesthetics|anesthetics|mesh-ancestor
111426674|NCT02523235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111426675|NCT02523235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111426676|NCT02523235|Sensory System Agents|sensory system agents|mesh-ancestor
111426677|NCT02523235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111426678|NCT02498522|Metformin|metformin|mesh-list
111426679|NCT02498522|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111426680|NCT02498522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111426681|NCT02919787|Irinotecan|irinotecan|mesh-list
111426682|NCT02919787|Fluorouracil|fluorouracil|mesh-list
111426683|NCT02919787|Oxaliplatin|oxaliplatin|mesh-list
111426684|NCT02919787|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111426685|NCT02919787|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111426686|NCT02919787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111426687|NCT02919787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111426688|NCT02919787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111426689|NCT02919787|Antimetabolites|antimetabolites|mesh-ancestor
111426690|NCT02919787|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111426691|NCT02919787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111426692|NCT02919787|Immunologic Factors|immunologic factors|mesh-ancestor
111426693|NCT02919787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111426694|NCT02459275|Metoclopramide|metoclopramide|mesh-list
111426695|NCT02459275|Antiemetics|antiemetics|mesh-ancestor
111426696|NCT02459275|Autonomic Agents|autonomic agents|mesh-ancestor
111426697|NCT02459275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111426698|NCT02459275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111426699|NCT02459275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111426700|NCT02459275|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111426701|NCT02459275|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111426702|NCT02459275|Dopamine Agents|dopamine agents|mesh-ancestor
111426703|NCT02459275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111426704|NCT02459275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111426705|NCT02524561|Estradiol|estradiol|mesh-list
111426706|NCT02524561|Progesterone|progesterone|mesh-list
111426707|NCT02524561|Estrogens|estrogens|mesh-ancestor
111426708|NCT02524561|Hormones|hormones|mesh-ancestor
111426709|NCT02524561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111426710|NCT02524561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111426711|NCT02524561|Progestins|progestins|mesh-ancestor
111426712|NCT02431598|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
111426713|NCT02431598|Chelating Agents|chelating agents|mesh-ancestor
111426714|NCT02431598|Sequestering Agents|sequestering agents|mesh-ancestor
111426715|NCT02431598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111426716|NCT04743739|Cyclosporine|cyclosporine|mesh-list
111426717|NCT04743739|Rituximab|rituximab|mesh-list
111426718|NCT04743739|Cyclosporins|cyclosporins|mesh-list
111426719|NCT04743739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111426720|NCT04743739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111426721|NCT04743739|Immunologic Factors|immunologic factors|mesh-ancestor
111426722|NCT04743739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111426723|NCT04743739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111426724|NCT04743739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111426725|NCT04743739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111426726|NCT04743739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111426727|NCT04743739|Antifungal Agents|antifungal agents|mesh-ancestor
111426728|NCT04743739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111426729|NCT04743739|Dermatologic Agents|dermatologic agents|mesh-ancestor
111426730|NCT04743739|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111426731|NCT02461693|Caffeine|caffeine|mesh-list
111426732|NCT02461693|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111426733|NCT02461693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111426734|NCT02461693|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111426735|NCT02461693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111426736|NCT02461693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111426737|NCT02461693|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
111426738|NCT02461693|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111426739|NCT02461693|Purinergic Agents|purinergic agents|mesh-ancestor
111426740|NCT02461693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111426741|NCT02525653|Paclitaxel|paclitaxel|mesh-list
111426742|NCT02525653|Gemcitabine|gemcitabine|mesh-list
111426743|NCT02525653|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111426744|NCT02525653|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111426745|NCT02525653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111426746|NCT02525653|Tubulin Modulators|tubulin modulators|mesh-ancestor
111426747|NCT02525653|Antimitotic Agents|antimitotic agents|mesh-ancestor
111426748|NCT02525653|Mitosis Modulators|mitosis modulators|mesh-ancestor
111426749|NCT02525653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111426750|NCT02525653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111426751|NCT02525653|Antimetabolites|antimetabolites|mesh-ancestor
111426752|NCT02431754|Tadalafil|tadalafil|mesh-list
111426753|NCT02431754|Vasodilator Agents|vasodilator agents|mesh-ancestor
111426754|NCT02431754|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111426755|NCT02431754|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111426756|NCT02431754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111426757|NCT02431754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111426758|NCT02431754|Urological Agents|urological agents|mesh-ancestor
111426759|NCT02500628|Metformin|metformin|mesh-list
111426760|NCT02500628|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111426761|NCT02500628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111426762|NCT02526667|Chlorhexidine|chlorhexidine|mesh-list
111426763|NCT02526667|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
111426764|NCT02526667|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111426765|NCT02526667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111426766|NCT02526667|Disinfectants|disinfectants|mesh-ancestor
111426767|NCT02526667|Dermatologic Agents|dermatologic agents|mesh-ancestor
111151141|NCT01650194|Glucocorticoids|glucocorticoids|mesh-ancestor
111426768|NCT02535806|Cytarabine|cytarabine|mesh-list
111426769|NCT02535806|Dexamethasone|dexamethasone|mesh-list
111426770|NCT02535806|Hydrocortisone|hydrocortisone|mesh-list
111426771|NCT02535806|Methotrexate|methotrexate|mesh-list
111426772|NCT02535806|Vincristine|vincristine|mesh-list
111426773|NCT02535806|Bortezomib|bortezomib|mesh-list
111426774|NCT02535806|Mitoxantrone|mitoxantrone|mesh-list
111426775|NCT02535806|Pegaspargase|pegaspargase|mesh-list
111426776|NCT02535806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111426777|NCT02535806|Antiemetics|antiemetics|mesh-ancestor
111426778|NCT02535806|Autonomic Agents|autonomic agents|mesh-ancestor
111426779|NCT02535806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111426780|NCT02535806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111426781|NCT02535806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111426782|NCT02535806|Glucocorticoids|glucocorticoids|mesh-ancestor
111426783|NCT02535806|Hormones|hormones|mesh-ancestor
111426784|NCT02535806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111426785|NCT02535806|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111426786|NCT02535806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111426787|NCT02535806|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111426788|NCT02535806|Abortifacient Agents|abortifacient agents|mesh-ancestor
111426789|NCT02535806|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111426790|NCT02535806|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111426791|NCT02535806|Antimetabolites|antimetabolites|mesh-ancestor
111426792|NCT02535806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111426793|NCT02535806|Dermatologic Agents|dermatologic agents|mesh-ancestor
111426794|NCT02535806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111426795|NCT02535806|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111426796|NCT02535806|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111426797|NCT02535806|Immunologic Factors|immunologic factors|mesh-ancestor
111426798|NCT02535806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111426799|NCT02535806|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111426800|NCT02535806|Antiviral Agents|antiviral agents|mesh-ancestor
111426801|NCT02535806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111426802|NCT02535806|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111426803|NCT02535806|Tubulin Modulators|tubulin modulators|mesh-ancestor
111426804|NCT02535806|Antimitotic Agents|antimitotic agents|mesh-ancestor
111426805|NCT02535806|Mitosis Modulators|mitosis modulators|mesh-ancestor
111426806|NCT02535806|Analgesics|analgesics|mesh-ancestor
111426807|NCT02535806|Sensory System Agents|sensory system agents|mesh-ancestor
111426808|NCT02535806|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111426809|NCT02535806|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111426810|NCT02536040|Fluorides|fluorides|mesh-list
111426811|NCT02536040|Cariostatic Agents|cariostatic agents|mesh-ancestor
111426812|NCT02536040|Protective Agents|protective agents|mesh-ancestor
111426813|NCT02536040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111426814|NCT02537444|Pembrolizumab|pembrolizumab|mesh-list
111426815|NCT02537444|Acalabrutinib|acalabrutinib|mesh-list
111426816|NCT02537444|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111426817|NCT02537444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111426818|NCT02537444|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111426819|NCT02537444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111426820|NCT02464033|Vitamin D|vitamin d|mesh-list
111426821|NCT02464033|Cholecalciferol|cholecalciferol|mesh-list
111426822|NCT02464033|Etanercept|etanercept|mesh-list
111426823|NCT02464033|Vitamins|vitamins|mesh-ancestor
111426824|NCT02464033|Micronutrients|micronutrients|mesh-ancestor
111426825|NCT02464033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111426826|NCT02464033|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111426827|NCT02464033|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111426828|NCT02464033|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111426829|NCT02464033|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111426830|NCT02464033|Analgesics|analgesics|mesh-ancestor
111426831|NCT02464033|Sensory System Agents|sensory system agents|mesh-ancestor
111426832|NCT02464033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111426833|NCT02464033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111426834|NCT02464033|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111426835|NCT02464033|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111426836|NCT02464033|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111426837|NCT02464033|Immunologic Factors|immunologic factors|mesh-ancestor
111426838|NCT02432456|Acetaminophen|acetaminophen|mesh-list
111426839|NCT02432456|Ibuprofen|ibuprofen|mesh-list
111426840|NCT02432456|Ketamine|ketamine|mesh-list
111426841|NCT02432456|Narcotics|narcotics|mesh-list
111426842|NCT02432456|Methocarbamol|methocarbamol|mesh-list
111426843|NCT02432456|Pantoprazole|pantoprazole|mesh-list
111426844|NCT02432456|Analgesics|analgesics|mesh-ancestor
111426845|NCT02432456|Sensory System Agents|sensory system agents|mesh-ancestor
111426846|NCT02432456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111426847|NCT02432456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111426848|NCT02432456|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111426849|NCT02432456|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111426850|NCT02432456|Anesthetics, General|anesthetics, general|mesh-ancestor
111426851|NCT02432456|Anesthetics|anesthetics|mesh-ancestor
111426852|NCT02432456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111426853|NCT02432456|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111426854|NCT02432456|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111426855|NCT02432456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111426856|NCT02432456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111426857|NCT02432456|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111426858|NCT02432456|Antipyretics|antipyretics|mesh-ancestor
110511422|NCT04230330|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111426859|NCT02432456|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111426860|NCT02432456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111426861|NCT02432456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111426862|NCT02432456|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111426863|NCT02432456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111426864|NCT02432456|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111426865|NCT02432456|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111426866|NCT02432456|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111426867|NCT02432456|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
111426868|NCT02432456|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111426869|NCT02531971|Fentanyl|fentanyl|mesh-list
111426870|NCT02531971|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111426871|NCT02531971|Narcotics|narcotics|mesh-ancestor
111426872|NCT02531971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111426873|NCT02531971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111426874|NCT02531971|Analgesics|analgesics|mesh-ancestor
111426875|NCT02531971|Sensory System Agents|sensory system agents|mesh-ancestor
111426876|NCT02531971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111426877|NCT02531971|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111426878|NCT02531971|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111426879|NCT02531971|Anesthetics, General|anesthetics, general|mesh-ancestor
111426880|NCT02531971|Anesthetics|anesthetics|mesh-ancestor
111426881|NCT02464657|Cytarabine|cytarabine|mesh-list
111426882|NCT02464657|Dexamethasone|dexamethasone|mesh-list
111426883|NCT02464657|Methylprednisolone|methylprednisolone|mesh-list
111426884|NCT02464657|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111426885|NCT02464657|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111426886|NCT02464657|Prednisolone|prednisolone|mesh-list
111426887|NCT02464657|Prednisolone acetate|prednisolone acetate|mesh-list
111426888|NCT02464657|Nivolumab|nivolumab|mesh-list
111426889|NCT02464657|Idarubicin|idarubicin|mesh-list
111426890|NCT02464657|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111426891|NCT02464657|Prednisolone phosphate|prednisolone phosphate|mesh-list
111426892|NCT02464657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111426893|NCT02464657|Antiemetics|antiemetics|mesh-ancestor
111426894|NCT02464657|Autonomic Agents|autonomic agents|mesh-ancestor
111426895|NCT02464657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111426896|NCT02464657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111426897|NCT02464657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111426898|NCT02464657|Glucocorticoids|glucocorticoids|mesh-ancestor
111426899|NCT02464657|Hormones|hormones|mesh-ancestor
111426900|NCT02464657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111426901|NCT02464657|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111426902|NCT02464657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111426903|NCT02464657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111426904|NCT02464657|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111426905|NCT02464657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111426906|NCT02464657|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111426907|NCT02464657|Antimetabolites|antimetabolites|mesh-ancestor
111426908|NCT02464657|Antiviral Agents|antiviral agents|mesh-ancestor
111426909|NCT02464657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111426910|NCT02464657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111426911|NCT02464657|Immunologic Factors|immunologic factors|mesh-ancestor
111426912|NCT02464657|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111426913|NCT02464657|Protective Agents|protective agents|mesh-ancestor
111426914|NCT02464657|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111426915|NCT02464657|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111426916|NCT02464657|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111426917|NCT02464657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111426918|NCT02535949|Tranexamic Acid|tranexamic acid|mesh-list
111426919|NCT02535949|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111426920|NCT02535949|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111426921|NCT02535949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111426922|NCT02535949|Hemostatics|hemostatics|mesh-ancestor
111426923|NCT02535949|Coagulants|coagulants|mesh-ancestor
111426924|NCT02536105|Methylphenidate|methylphenidate|mesh-list
111426925|NCT02536105|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111426926|NCT02536105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111426927|NCT02536105|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111426928|NCT02536105|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111426929|NCT02536105|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111426930|NCT02536105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111426931|NCT02536105|Dopamine Agents|dopamine agents|mesh-ancestor
111426932|NCT02536105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111426933|NCT02758951|Bevacizumab|bevacizumab|mesh-list
111426934|NCT02758951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111426935|NCT02758951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111426936|NCT02758951|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111426937|NCT02758951|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111426938|NCT02758951|Growth Substances|growth substances|mesh-ancestor
111426939|NCT02758951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111426940|NCT02758951|Growth Inhibitors|growth inhibitors|mesh-ancestor
111426941|NCT02436668|Paclitaxel|paclitaxel|mesh-list
111426942|NCT02436668|Gemcitabine|gemcitabine|mesh-list
111426943|NCT02436668|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111426944|NCT02436668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111426945|NCT02436668|Tubulin Modulators|tubulin modulators|mesh-ancestor
111426946|NCT02436668|Antimitotic Agents|antimitotic agents|mesh-ancestor
111426947|NCT02436668|Mitosis Modulators|mitosis modulators|mesh-ancestor
111426948|NCT02436668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111426949|NCT02436668|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111426950|NCT02436668|Antimetabolites|antimetabolites|mesh-ancestor
111426951|NCT02503982|Valganciclovir|valganciclovir|mesh-list
111426952|NCT02503982|Antiviral Agents|antiviral agents|mesh-ancestor
111426953|NCT02503982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111426954|NCT02438540|Metformin|metformin|mesh-list
111426955|NCT02438540|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111426956|NCT02438540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111426957|NCT02506634|Esomeprazole|esomeprazole|mesh-list
111426958|NCT02506634|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111426959|NCT02506634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111426960|NCT02506634|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111426961|NCT02506634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111426962|NCT02506634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111426963|NCT02506868|Darbepoetin alfa|darbepoetin alfa|mesh-list
111426964|NCT02506868|Hematinics|hematinics|mesh-ancestor
111426965|NCT02541422|Acetylcysteine|acetylcysteine|mesh-list
111426966|NCT02541422|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111426967|NCT02541422|Antiviral Agents|antiviral agents|mesh-ancestor
111426968|NCT02541422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111426969|NCT02541422|Expectorants|expectorants|mesh-ancestor
111426970|NCT02541422|Respiratory System Agents|respiratory system agents|mesh-ancestor
111426971|NCT02541422|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111426972|NCT02541422|Antioxidants|antioxidants|mesh-ancestor
111426973|NCT02541422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111426974|NCT02541422|Protective Agents|protective agents|mesh-ancestor
111426975|NCT02541422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111426976|NCT02541422|Antidotes|antidotes|mesh-ancestor
111426977|NCT02439164|Midazolam|midazolam|mesh-list
111426978|NCT02439164|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111426979|NCT02439164|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111426980|NCT02439164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111426981|NCT02439164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111426982|NCT02439164|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111426983|NCT02439164|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111426984|NCT02439164|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111426985|NCT02439164|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111426986|NCT02439164|Anesthetics, General|anesthetics, general|mesh-ancestor
111426987|NCT02439164|Anesthetics|anesthetics|mesh-ancestor
111426988|NCT02439164|GABA Modulators|gaba modulators|mesh-ancestor
111426989|NCT02439164|GABA Agents|gaba agents|mesh-ancestor
111426990|NCT02439164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111426991|NCT02439164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111426992|NCT02440178|Micafungin|micafungin|mesh-list
111426993|NCT02440178|Antifungal Agents|antifungal agents|mesh-ancestor
111426994|NCT02440178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111426995|NCT05078606|Anesthetics|anesthetics|mesh-list
111426996|NCT05078606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111426997|NCT05078606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111151368|NCT02279719|Sorafenib|sorafenib|mesh-list
111426998|NCT02546570|Oxytocin|oxytocin|mesh-list
111426999|NCT02546570|Oxytocics|oxytocics|mesh-ancestor
111427000|NCT02546570|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111427001|NCT02546570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111427002|NCT02548910|Sodium Citrate|sodium citrate|mesh-list
111427003|NCT02548910|Citric Acid|citric acid|mesh-list
111427004|NCT02548910|Anticoagulants|anticoagulants|mesh-ancestor
111427005|NCT02548910|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
111427006|NCT02548910|Chelating Agents|chelating agents|mesh-ancestor
111427007|NCT02548910|Sequestering Agents|sequestering agents|mesh-ancestor
111427008|NCT02548910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111427009|NCT02510144|Chlorhexidine|chlorhexidine|mesh-list
111427010|NCT02510144|Benzoyl Peroxide|benzoyl peroxide|mesh-list
111427011|NCT02510144|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111427012|NCT02510144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111427013|NCT02510144|Disinfectants|disinfectants|mesh-ancestor
111427014|NCT02510144|Dermatologic Agents|dermatologic agents|mesh-ancestor
111427015|NCT02538679|Epinephrine|epinephrine|mesh-list
111427016|NCT02538679|Racepinephrine|racepinephrine|mesh-list
111427017|NCT02538679|Bupivacaine|bupivacaine|mesh-list
111427018|NCT02538679|Epinephryl borate|epinephryl borate|mesh-list
111427019|NCT02538679|Anesthetics, Local|anesthetics, local|mesh-ancestor
111427020|NCT02538679|Anesthetics|anesthetics|mesh-ancestor
111427021|NCT02538679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111427022|NCT02538679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111427023|NCT02538679|Sensory System Agents|sensory system agents|mesh-ancestor
111427024|NCT02538679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111427025|NCT02538679|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111427026|NCT02538679|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111427027|NCT02538679|Adrenergic Agents|adrenergic agents|mesh-ancestor
111427028|NCT02538679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111427029|NCT02538679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111427030|NCT02538679|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111427031|NCT02538679|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111427032|NCT02538679|Autonomic Agents|autonomic agents|mesh-ancestor
111427033|NCT02538679|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111427034|NCT02538679|Respiratory System Agents|respiratory system agents|mesh-ancestor
111427035|NCT02538679|Mydriatics|mydriatics|mesh-ancestor
111427036|NCT02538679|Sympathomimetics|sympathomimetics|mesh-ancestor
111427037|NCT02538679|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111427038|NCT02511236|Nicotine|nicotine|mesh-list
111427039|NCT02511236|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111427040|NCT02511236|Autonomic Agents|autonomic agents|mesh-ancestor
111427041|NCT02511236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110511472|NCT02783040|Digoxin|digoxin|mesh-list
111427042|NCT02511236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111427043|NCT02511236|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111427044|NCT02511236|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111427045|NCT02511236|Cholinergic Agents|cholinergic agents|mesh-ancestor
111427046|NCT02511236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111427047|NCT02511236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111427048|NCT02551094|Colchicine|colchicine|mesh-list
111427049|NCT02551094|Gout Suppressants|gout suppressants|mesh-ancestor
111427050|NCT02551094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111427051|NCT02551094|Tubulin Modulators|tubulin modulators|mesh-ancestor
111427052|NCT02551094|Antimitotic Agents|antimitotic agents|mesh-ancestor
111427053|NCT02551094|Mitosis Modulators|mitosis modulators|mesh-ancestor
111427054|NCT02551094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111427055|NCT02551094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111427056|NCT02513498|Ixazomib|ixazomib|mesh-list
111427057|NCT02513498|Glycine|glycine|mesh-list
111427058|NCT02513498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111427059|NCT02513498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111427060|NCT02513498|Protease Inhibitors|protease inhibitors|mesh-ancestor
111427061|NCT02513498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111427062|NCT02513498|Glycine Agents|glycine agents|mesh-ancestor
111427063|NCT02513498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111427064|NCT02513498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111427065|NCT04787354|Capecitabine|capecitabine|mesh-list
111427066|NCT04787354|Oxaliplatin|oxaliplatin|mesh-list
111427067|NCT04787354|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111427068|NCT04787354|Antimetabolites|antimetabolites|mesh-ancestor
111427069|NCT04787354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111427070|NCT04787354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111427071|NCT02514044|Adderall|adderall|mesh-list
111427072|NCT02514044|Dextroamphetamine|dextroamphetamine|mesh-list
111427073|NCT02514044|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111427074|NCT02514044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111151435|NCT02278471|Diuretics|diuretics|mesh-ancestor
111427075|NCT02514044|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111427076|NCT02514044|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111427077|NCT02514044|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111427078|NCT02514044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111427079|NCT02514044|Dopamine Agents|dopamine agents|mesh-ancestor
111427080|NCT02514044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111427081|NCT02555228|Simethicone|simethicone|mesh-list
111427082|NCT02555228|Antifoaming Agents|antifoaming agents|mesh-ancestor
111427083|NCT02555228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111427084|NCT02555228|Emollients|emollients|mesh-ancestor
111427085|NCT02555228|Dermatologic Agents|dermatologic agents|mesh-ancestor
111427086|NCT02556788|Trifarotene|trifarotene|mesh-list
111427087|NCT02556788|Dermatologic Agents|dermatologic agents|mesh-ancestor
111427088|NCT02516150|Ethanol|ethanol|mesh-list
111427089|NCT02516150|Glucagon|glucagon|mesh-list
111427090|NCT02516150|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111427091|NCT02516150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111427092|NCT02516150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111427093|NCT02516150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111427094|NCT02516150|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111427095|NCT02516150|Hormones|hormones|mesh-ancestor
111427096|NCT02516150|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111427097|NCT04025060|Caffeine|caffeine|mesh-list
111427098|NCT04025060|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111427099|NCT04025060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111427100|NCT04025060|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111427101|NCT04025060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111427102|NCT04025060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111427103|NCT04025060|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
111427104|NCT04025060|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111427105|NCT04025060|Purinergic Agents|purinergic agents|mesh-ancestor
111427106|NCT04025060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111427107|NCT04542434|Niclosamide|niclosamide|mesh-list
111427108|NCT04542434|Anticestodal Agents|anticestodal agents|mesh-ancestor
111427109|NCT04542434|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
111427110|NCT04542434|Anthelmintics|anthelmintics|mesh-ancestor
111427111|NCT04542434|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111427112|NCT04542434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111427113|NCT04542434|Antinematodal Agents|antinematodal agents|mesh-ancestor
111427114|NCT04186286|Propranolol|propranolol|mesh-list
111427115|NCT04186286|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111427116|NCT04186286|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111427117|NCT04186286|Adrenergic Agents|adrenergic agents|mesh-ancestor
111427118|NCT04186286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111427119|NCT04186286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111427120|NCT04186286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111427121|NCT04186286|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111427122|NCT04186286|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111427123|NCT04186286|Vasodilator Agents|vasodilator agents|mesh-ancestor
111427124|NCT04341038|Methylprednisolone|methylprednisolone|mesh-list
111427125|NCT04341038|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111427126|NCT04341038|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111427127|NCT04341038|Prednisolone|prednisolone|mesh-list
111427128|NCT04341038|Prednisolone acetate|prednisolone acetate|mesh-list
111427129|NCT04341038|Tacrolimus|tacrolimus|mesh-list
111427130|NCT04341038|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111427131|NCT04341038|Prednisolone phosphate|prednisolone phosphate|mesh-list
111427132|NCT04341038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111427133|NCT04341038|Immunologic Factors|immunologic factors|mesh-ancestor
111427134|NCT04341038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111427135|NCT04341038|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111427136|NCT04341038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111427137|NCT04341038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111427138|NCT04341038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111427139|NCT04341038|Antiemetics|antiemetics|mesh-ancestor
111427140|NCT04341038|Autonomic Agents|autonomic agents|mesh-ancestor
111427141|NCT04341038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111427142|NCT04341038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111427143|NCT04341038|Glucocorticoids|glucocorticoids|mesh-ancestor
111427144|NCT04341038|Hormones|hormones|mesh-ancestor
111427145|NCT04341038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111427146|NCT04341038|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111427147|NCT04341038|Protective Agents|protective agents|mesh-ancestor
111427148|NCT04341038|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111427149|NCT04341038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111427150|NCT02561702|Mexiletine|mexiletine|mesh-list
111427152|NCT02561702|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111427153|NCT02561702|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111427154|NCT02561702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111427155|NCT02561702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111427156|NCT02563496|Chloroquine|chloroquine|mesh-list
111427157|NCT02563496|Tafenoquine|tafenoquine|mesh-list
111427158|NCT02563496|Amebicides|amebicides|mesh-ancestor
111427159|NCT02563496|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111427160|NCT02563496|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111427161|NCT02563496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111427162|NCT02563496|Antimalarials|antimalarials|mesh-ancestor
111427163|NCT02563496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111427164|NCT02540161|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111427165|NCT02540161|Immunologic Factors|immunologic factors|mesh-ancestor
111427166|NCT02540161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111427167|NCT02568644|Ketoprofen|ketoprofen|mesh-list
111427168|NCT02568644|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
111427169|NCT02568644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
111427170|NCT02568644|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111427171|NCT02568644|Analgesics|analgesics|mesh-ancestor
111427172|NCT02568644|Sensory System Agents|sensory system agents|mesh-ancestor
111427173|NCT02568644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111427174|NCT02568644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111427175|NCT02568644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111427176|NCT02568644|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111427177|NCT02568644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111427178|NCT02568644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111427179|NCT02541409|Interferons|interferons|mesh-list
111427180|NCT02541409|Ribavirin|ribavirin|mesh-list
111427181|NCT02541409|Interferon-alpha|interferon-alpha|mesh-list
111427182|NCT02541409|Interferon alpha-2|interferon alpha-2|mesh-list
111427183|NCT02541409|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
111427184|NCT02541409|Sofosbuvir|sofosbuvir|mesh-list
111427185|NCT02541409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111427186|NCT02541409|Antiviral Agents|antiviral agents|mesh-ancestor
111427187|NCT02541409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111427188|NCT02541409|Antimetabolites|antimetabolites|mesh-ancestor
111427189|NCT02541409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111427190|NCT02541409|Immunologic Factors|immunologic factors|mesh-ancestor
111427191|NCT02541409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111427192|NCT02569658|Tranexamic Acid|tranexamic acid|mesh-list
111427193|NCT02569658|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111427194|NCT02569658|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111427195|NCT02569658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111427196|NCT02569658|Hemostatics|hemostatics|mesh-ancestor
111427197|NCT02569658|Coagulants|coagulants|mesh-ancestor
111427198|NCT02541565|Prednisone|prednisone|mesh-list
111427199|NCT02541565|Cortisone|cortisone|mesh-list
111427200|NCT02541565|Cyclophosphamide|cyclophosphamide|mesh-list
111427201|NCT02541565|Rituximab|rituximab|mesh-list
111427202|NCT02541565|Doxorubicin|doxorubicin|mesh-list
111427203|NCT02541565|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111427204|NCT02541565|Pembrolizumab|pembrolizumab|mesh-list
111427205|NCT02541565|Vincristine|vincristine|mesh-list
111427206|NCT02541565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111427207|NCT02541565|Antibodies|antibodies|mesh-list
111427208|NCT02541565|Immunoglobulins|immunoglobulins|mesh-list
111427209|NCT02541565|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111427210|NCT02541565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111427211|NCT02541565|Immunologic Factors|immunologic factors|mesh-ancestor
111427212|NCT02541565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111427213|NCT02541565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111427214|NCT02541565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111427215|NCT02541565|Alkylating Agents|alkylating agents|mesh-ancestor
111427216|NCT02541565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111427217|NCT02541565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111427218|NCT02541565|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111427219|NCT02541565|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111427220|NCT02541565|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111427221|NCT02541565|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111427222|NCT02541565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111427223|NCT02541565|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111427224|NCT02541565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111427225|NCT02541565|Glucocorticoids|glucocorticoids|mesh-ancestor
111427226|NCT02541565|Hormones|hormones|mesh-ancestor
111151588|NCT02324270|Analgesics|analgesics|mesh-ancestor
111427227|NCT02541565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111427228|NCT02541565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111427229|NCT02541565|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111427230|NCT02541565|Tubulin Modulators|tubulin modulators|mesh-ancestor
111427231|NCT02541565|Antimitotic Agents|antimitotic agents|mesh-ancestor
111427232|NCT02541565|Mitosis Modulators|mitosis modulators|mesh-ancestor
111427233|NCT04707950|Tranexamic Acid|tranexamic acid|mesh-list
111427234|NCT04707950|Oxytocin|oxytocin|mesh-list
111427235|NCT04707950|Oxytocics|oxytocics|mesh-ancestor
111427236|NCT04707950|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111427237|NCT04707950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111427238|NCT04707950|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111427239|NCT04707950|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111427240|NCT04707950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111427241|NCT04707950|Hemostatics|hemostatics|mesh-ancestor
111427242|NCT04707950|Coagulants|coagulants|mesh-ancestor
111427243|NCT04044560|Blinatumomab|blinatumomab|mesh-list
111427244|NCT04044560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111427245|NCT03807440|Empagliflozin|empagliflozin|mesh-list
111427246|NCT03807440|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
111427247|NCT03807440|Linagliptin|linagliptin|mesh-list
111427248|NCT03807440|Metformin|metformin|mesh-list
111427249|NCT03807440|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
111427250|NCT03807440|Glucagon|glucagon|mesh-list
111427251|NCT03807440|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
111427252|NCT03807440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111427253|NCT03807440|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111427254|NCT03807440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111427255|NCT03807440|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111427256|NCT03807440|Hormones|hormones|mesh-ancestor
111427257|NCT03807440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111427258|NCT03807440|Incretins|incretins|mesh-ancestor
111427259|NCT03807440|Protease Inhibitors|protease inhibitors|mesh-ancestor
111427260|NCT03807440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111427261|NCT03256916|Nelfinavir|nelfinavir|mesh-list
111427262|NCT03256916|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111427263|NCT03256916|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111427264|NCT03256916|Protease Inhibitors|protease inhibitors|mesh-ancestor
111427265|NCT03256916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111427266|NCT03256916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111427267|NCT03256916|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111427268|NCT03256916|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111427269|NCT03256916|Antiviral Agents|antiviral agents|mesh-ancestor
111427270|NCT03256916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111427271|NCT02579876|Immunomodulating Agents|immunomodulating agents|mesh-list
111427272|NCT02579876|Immunologic Factors|immunologic factors|mesh-list
111427273|NCT02579876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111427274|NCT00364052|Valganciclovir|valganciclovir|mesh-list
111427275|NCT00364052|Ganciclovir|ganciclovir|mesh-list
111427276|NCT00364052|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
111427277|NCT00364052|Antiviral Agents|antiviral agents|mesh-ancestor
111427278|NCT00364052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111427279|NCT00364052|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111427280|NCT00364052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111427281|NCT00364052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111427282|NCT02582840|Dapagliflozin|dapagliflozin|mesh-list
111427283|NCT02582840|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111427284|NCT02582840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111427285|NCT02582840|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111427286|NCT02582840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111427287|NCT00364988|Pioglitazone|pioglitazone|mesh-list
111427288|NCT00364988|Losartan|losartan|mesh-list
111427289|NCT00364988|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111427290|NCT00364988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111427291|NCT00364988|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111427292|NCT00364988|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111427293|NCT00364988|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111427294|NCT00364988|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111427295|NCT00364988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111427296|NCT00365222|Temozolomide|temozolomide|mesh-list
111427297|NCT00365222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111427298|NCT00365222|Alkylating Agents|alkylating agents|mesh-ancestor
111427299|NCT00365222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111427300|NCT00365222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111427302|NCT03119012|Clopidogrel|clopidogrel|mesh-list
111427303|NCT03119012|Ticagrelor|ticagrelor|mesh-list
111427304|NCT03119012|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111427305|NCT03119012|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111427306|NCT03119012|Analgesics|analgesics|mesh-ancestor
111427307|NCT03119012|Sensory System Agents|sensory system agents|mesh-ancestor
111427308|NCT03119012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111427309|NCT03119012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111427310|NCT03119012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111427311|NCT03119012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111427312|NCT03119012|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111427313|NCT03119012|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111427314|NCT03119012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111427315|NCT03119012|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111427316|NCT03119012|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111427317|NCT03119012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111427318|NCT03119012|Antipyretics|antipyretics|mesh-ancestor
111427319|NCT03119012|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111427320|NCT03119012|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111427321|NCT03119012|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111427322|NCT03119012|Purinergic Agents|purinergic agents|mesh-ancestor
111427323|NCT03119012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111427324|NCT02584868|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
111427325|NCT02584868|Plasma Substitutes|plasma substitutes|mesh-ancestor
111427326|NCT02584868|Blood Substitutes|blood substitutes|mesh-ancestor
111427327|NCT02791568|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
111427328|NCT02791568|Hematinics|hematinics|mesh-ancestor
111427329|NCT02791568|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
111427330|NCT02791568|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111427331|NCT05248022|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
111427332|NCT05248022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111427333|NCT05248022|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111427334|NCT05248022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111427335|NCT05247554|Hydroxychloroquine|hydroxychloroquine|mesh-list
111427336|NCT05247554|Prednisone|prednisone|mesh-list
111427337|NCT05247554|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111427338|NCT05247554|Glucocorticoids|glucocorticoids|mesh-ancestor
111427339|NCT05247554|Hormones|hormones|mesh-ancestor
111427340|NCT05247554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111427341|NCT05247554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111427342|NCT05247554|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111427343|NCT05247554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111427344|NCT05247554|Antimalarials|antimalarials|mesh-ancestor
111427345|NCT05247554|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111427346|NCT05247554|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111427347|NCT05247554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111427348|NCT05247554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111427349|NCT05247554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111427350|NCT05247554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111427351|NCT02596022|Ketamine|ketamine|mesh-list
111427352|NCT02596022|Analgesics|analgesics|mesh-ancestor
111427353|NCT02596022|Sensory System Agents|sensory system agents|mesh-ancestor
111427354|NCT02596022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111427355|NCT02596022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111427356|NCT02596022|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111427357|NCT02596022|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111427358|NCT02596022|Anesthetics, General|anesthetics, general|mesh-ancestor
111427359|NCT02596022|Anesthetics|anesthetics|mesh-ancestor
111427360|NCT02596022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111427361|NCT02596022|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111427362|NCT02596022|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111427363|NCT02596022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111427364|NCT02596022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111427365|NCT00364442|Fluticasone|fluticasone|mesh-list
111427366|NCT00364442|Xhance|xhance|mesh-list
111427367|NCT00364442|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
111427368|NCT00364442|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111427369|NCT00364442|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111427370|NCT00364442|Autonomic Agents|autonomic agents|mesh-ancestor
111427371|NCT00364442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111427372|NCT00364442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111427373|NCT00364442|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111427374|NCT00364442|Respiratory System Agents|respiratory system agents|mesh-ancestor
111427375|NCT00364442|Dermatologic Agents|dermatologic agents|mesh-ancestor
111427376|NCT00364442|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111427377|NCT00364442|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111427378|NCT00364442|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111427379|NCT00364442|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111427380|NCT00364442|Adrenergic Agents|adrenergic agents|mesh-ancestor
111427381|NCT00364442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111427382|NCT00364442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111427383|NCT05371574|Clonidine|clonidine|mesh-list
111427384|NCT05371574|Analgesics|analgesics|mesh-ancestor
111427385|NCT05371574|Sensory System Agents|sensory system agents|mesh-ancestor
111427386|NCT05371574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111427387|NCT05371574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111427388|NCT05371574|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111427389|NCT05371574|Sympatholytics|sympatholytics|mesh-ancestor
111427390|NCT05371574|Autonomic Agents|autonomic agents|mesh-ancestor
111427391|NCT05371574|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111427392|NCT05371574|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111427393|NCT05371574|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111427394|NCT05371574|Adrenergic Agents|adrenergic agents|mesh-ancestor
111427395|NCT05371574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111427396|NCT05371574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111427397|NCT05371340|Quercetin|quercetin|mesh-list
111427398|NCT05371340|Antioxidants|antioxidants|mesh-ancestor
111427399|NCT05371340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111427400|NCT05371340|Protective Agents|protective agents|mesh-ancestor
111427401|NCT05371340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111427402|NCT02601170|Hyaluronic Acid|hyaluronic acid|mesh-list
111427403|NCT02601170|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111427404|NCT02601170|Immunologic Factors|immunologic factors|mesh-ancestor
111427405|NCT02601170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111427406|NCT02601170|Viscosupplements|viscosupplements|mesh-ancestor
111427407|NCT02601170|Protective Agents|protective agents|mesh-ancestor
111427408|NCT00366002|Darifenacin|darifenacin|mesh-list
111427409|NCT00366002|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111427410|NCT00366002|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111427411|NCT00366002|Cholinergic Agents|cholinergic agents|mesh-ancestor
111427412|NCT00366002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111427413|NCT00366002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111427414|NCT00366002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111427415|NCT00366002|Urological Agents|urological agents|mesh-ancestor
111427416|NCT00422240|Adapalene|adapalene|mesh-list
111427417|NCT00422240|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
111427418|NCT00422240|Benzoyl Peroxide|benzoyl peroxide|mesh-list
111427419|NCT00422240|Dermatologic Agents|dermatologic agents|mesh-ancestor
111427420|NCT00422240|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111427421|NCT00422240|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111427422|NCT00422240|Analgesics|analgesics|mesh-ancestor
111427423|NCT00422240|Sensory System Agents|sensory system agents|mesh-ancestor
111427424|NCT00422240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111427425|NCT00422240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111427426|NCT00422240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111427427|NCT00422240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111427428|NCT02605304|Ribavirin|ribavirin|mesh-list
111427429|NCT02605304|Sofosbuvir|sofosbuvir|mesh-list
111427430|NCT02605304|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
111427431|NCT02605304|Ledipasvir|ledipasvir|mesh-list
111427432|NCT02605304|Antimetabolites|antimetabolites|mesh-ancestor
111427433|NCT02605304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111427434|NCT02605304|Antiviral Agents|antiviral agents|mesh-ancestor
111427435|NCT02605304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111427436|NCT05365880|Lidocaine|lidocaine|mesh-list
111427437|NCT05365880|Anesthetics, Local|anesthetics, local|mesh-ancestor
111427438|NCT05365880|Anesthetics|anesthetics|mesh-ancestor
111427439|NCT05365880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111427440|NCT05365880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111427441|NCT05365880|Sensory System Agents|sensory system agents|mesh-ancestor
111427442|NCT05365880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111427443|NCT05365880|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111427444|NCT05365880|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111427445|NCT05365880|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111427446|NCT05365880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111427447|NCT05365880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111427448|NCT05362994|Sirolimus|sirolimus|mesh-list
111151811|NCT05646199|Metformin|metformin|mesh-list
111427449|NCT05362994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111427450|NCT05362994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111427451|NCT05362994|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111427452|NCT05362994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111427453|NCT05362994|Antifungal Agents|antifungal agents|mesh-ancestor
111427454|NCT05362994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111427455|NCT05362994|Immunologic Factors|immunologic factors|mesh-ancestor
111427456|NCT05362994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111427458|NCT02607254|Analgesics|analgesics|mesh-ancestor
111427459|NCT02607254|Sensory System Agents|sensory system agents|mesh-ancestor
111427460|NCT02607254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111427461|NCT02607254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111427462|NCT02607254|Anticonvulsants|anticonvulsants|mesh-ancestor
111427463|NCT02607254|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111427464|NCT02607254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111427465|NCT02607254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111427466|NCT02607254|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111427467|NCT02607254|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111427468|NCT02607254|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111427469|NCT02607254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111427470|NCT02607254|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111427471|NCT02611154|Testosterone|testosterone|mesh-list
111427472|NCT02611154|Androgens|androgens|mesh-ancestor
111427473|NCT02611154|Hormones|hormones|mesh-ancestor
111427474|NCT02611154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111427475|NCT02611154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111427476|NCT02617784|Oseltamivir|oseltamivir|mesh-list
111427477|NCT02617784|Antiviral Agents|antiviral agents|mesh-ancestor
111427478|NCT02617784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111427479|NCT02617784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111427480|NCT02617784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111427481|NCT00365612|Tenofovir|tenofovir|mesh-list
111427482|NCT00365612|Emtricitabine|emtricitabine|mesh-list
111427483|NCT00365612|Efavirenz|efavirenz|mesh-list
111427484|NCT00365612|Antiviral Agents|antiviral agents|mesh-ancestor
111427485|NCT00365612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111427486|NCT00365612|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111427487|NCT00365612|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111427488|NCT00365612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111427489|NCT00365612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111427490|NCT00365612|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111427491|NCT00365612|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111427492|NCT00365612|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111427493|NCT00365612|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111427494|NCT00365612|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111427495|NCT00365612|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111427496|NCT00365612|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111427497|NCT00365612|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111427498|NCT02974166|Ibuprofen|ibuprofen|mesh-list
111427499|NCT02974166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
111427500|NCT02974166|Cyclobenzaprine|cyclobenzaprine|mesh-list
111427501|NCT02974166|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111427502|NCT02974166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111427503|NCT02974166|Analgesics|analgesics|mesh-ancestor
111427504|NCT02974166|Sensory System Agents|sensory system agents|mesh-ancestor
111427505|NCT02974166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111427506|NCT02974166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111427507|NCT02974166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111427508|NCT02974166|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111427509|NCT02974166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111427510|NCT02974166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111427511|NCT02974166|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
111427512|NCT02974166|Antidepressive Agents|antidepressive agents|mesh-ancestor
111427513|NCT02974166|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111427514|NCT02974166|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
111427515|NCT02974166|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111427516|NCT02974166|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111427517|NCT02974166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111427518|NCT05731778|Listerine|listerine|mesh-list
111427519|NCT05731778|Fluorides|fluorides|mesh-list
111427520|NCT05731778|Sodium Fluoride|sodium fluoride|mesh-list
111427521|NCT05731778|Tin Fluorides|tin fluorides|mesh-list
111427522|NCT05731778|Cariostatic Agents|cariostatic agents|mesh-ancestor
111427523|NCT05731778|Protective Agents|protective agents|mesh-ancestor
111427524|NCT05731778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111427525|NCT05731778|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111427526|NCT05731778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111427527|NCT05477264|Tislelizumab|tislelizumab|mesh-list
111427528|NCT05477264|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111427529|NCT05477264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111427530|NCT00422318|Benzbromarone|benzbromarone|mesh-list
111427531|NCT00422318|Uricosuric Agents|uricosuric agents|mesh-ancestor
111427532|NCT00422318|Gout Suppressants|gout suppressants|mesh-ancestor
111427533|NCT00422318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111427534|NCT00364754|Tesmilifene|tesmilifene|mesh-list
111427535|NCT00364754|Histamine Antagonists|histamine antagonists|mesh-ancestor
111427536|NCT00364754|Histamine Agents|histamine agents|mesh-ancestor
111427537|NCT00364754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111427538|NCT00364754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111427539|NCT00364754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111427540|NCT00364754|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111427541|NCT00366236|Nitazoxanide|nitazoxanide|mesh-list
111427542|NCT00366236|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111427543|NCT00366236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111427544|NCT04741880|Lidocaine|lidocaine|mesh-list
111427545|NCT04741880|Anesthetics, Local|anesthetics, local|mesh-ancestor
111427546|NCT04741880|Anesthetics|anesthetics|mesh-ancestor
111427547|NCT04741880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111427548|NCT04741880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111427549|NCT04741880|Sensory System Agents|sensory system agents|mesh-ancestor
111427550|NCT04741880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111427551|NCT04741880|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111427552|NCT04741880|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111427553|NCT04741880|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111427554|NCT04741880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111427555|NCT04741880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111427556|NCT04742504|Benralizumab|benralizumab|mesh-list
111427557|NCT04742504|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111427558|NCT04742504|Respiratory System Agents|respiratory system agents|mesh-ancestor
111427559|NCT00365924|Teriparatide|teriparatide|mesh-list
111427560|NCT00365924|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111427561|NCT00365924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111427562|NCT00365924|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111427563|NCT05360030|Ketamine|ketamine|mesh-list
111427564|NCT05360030|Naloxone|naloxone|mesh-list
111427565|NCT05360030|Analgesics|analgesics|mesh-ancestor
110511594|NCT02782260|Dipyridamole|dipyridamole|mesh-list
111427566|NCT05360030|Sensory System Agents|sensory system agents|mesh-ancestor
111427567|NCT05360030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111427568|NCT05360030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111427569|NCT05360030|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111427570|NCT05360030|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111427571|NCT05360030|Anesthetics, General|anesthetics, general|mesh-ancestor
111427572|NCT05360030|Anesthetics|anesthetics|mesh-ancestor
111427573|NCT05360030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111427574|NCT05360030|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111427575|NCT05360030|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111427576|NCT05360030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111427577|NCT05360030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111427578|NCT05360030|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111427579|NCT04158362|Paclitaxel|paclitaxel|mesh-list
111427580|NCT04158362|Capecitabine|capecitabine|mesh-list
111427581|NCT04158362|Letrozole|letrozole|mesh-list
111427582|NCT04158362|Fulvestrant|fulvestrant|mesh-list
111427583|NCT04158362|Anastrozole|anastrozole|mesh-list
111427584|NCT04158362|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111427585|NCT04158362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111427586|NCT04158362|Tubulin Modulators|tubulin modulators|mesh-ancestor
111427587|NCT04158362|Antimitotic Agents|antimitotic agents|mesh-ancestor
111427588|NCT04158362|Mitosis Modulators|mitosis modulators|mesh-ancestor
111427589|NCT04158362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111427590|NCT04158362|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111427591|NCT04158362|Antimetabolites|antimetabolites|mesh-ancestor
111427592|NCT04158362|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111427593|NCT04158362|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111427594|NCT04158362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111427595|NCT04158362|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111427596|NCT04158362|Hormone Antagonists|hormone antagonists|mesh-ancestor
111427597|NCT04158362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111427598|NCT04158362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111427599|NCT04158362|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111427600|NCT04158362|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
111427601|NCT05272202|Propofol|propofol|mesh-list
111427602|NCT05272202|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111427603|NCT05272202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111427604|NCT05272202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111427605|NCT05272202|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111427606|NCT05272202|Anesthetics, General|anesthetics, general|mesh-ancestor
111427607|NCT05272202|Anesthetics|anesthetics|mesh-ancestor
111427608|NCT01575834|Denosumab|denosumab|mesh-list
111427609|NCT01575834|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111427610|NCT01575834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111427611|NCT05707442|Acetazolamide|acetazolamide|mesh-list
111427612|NCT05707442|Anticonvulsants|anticonvulsants|mesh-ancestor
111427613|NCT05707442|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
111427614|NCT05707442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111427615|NCT05707442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111427616|NCT05707442|Diuretics|diuretics|mesh-ancestor
111427617|NCT05707442|Natriuretic Agents|natriuretic agents|mesh-ancestor
111427618|NCT05707442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111427619|NCT04604132|Paclitaxel|paclitaxel|mesh-list
111427620|NCT04604132|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111427621|NCT04604132|Atezolizumab|atezolizumab|mesh-list
111427622|NCT04604132|Ramucirumab|ramucirumab|mesh-list
111427623|NCT04604132|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111427624|NCT04604132|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111427625|NCT04604132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111427626|NCT04604132|Tubulin Modulators|tubulin modulators|mesh-ancestor
111427627|NCT04604132|Antimitotic Agents|antimitotic agents|mesh-ancestor
111427628|NCT04604132|Mitosis Modulators|mitosis modulators|mesh-ancestor
111427629|NCT04604132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111427630|NCT04604132|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111427631|NCT04604132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111427632|NCT04604132|Immunologic Factors|immunologic factors|mesh-ancestor
111427633|NCT04604132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111427634|NCT05193188|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
111427635|NCT05193188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111427636|NCT05193188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111427637|NCT05193188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111427638|NCT04799262|Prednisone|prednisone|mesh-list
111427639|NCT04799262|Tofacitinib|tofacitinib|mesh-list
111427640|NCT04799262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111427641|NCT04799262|Glucocorticoids|glucocorticoids|mesh-ancestor
111427642|NCT04799262|Hormones|hormones|mesh-ancestor
111427643|NCT04799262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111427644|NCT04799262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111427645|NCT04799262|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111427646|NCT04799262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111427647|NCT04799262|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
111427648|NCT04799262|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111427649|NCT04799262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111427650|NCT04799262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111427651|NCT00851136|Bevacizumab|bevacizumab|mesh-list
111427652|NCT00851136|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111427653|NCT00851136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111427654|NCT00851136|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111427655|NCT00851136|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111427656|NCT00851136|Growth Substances|growth substances|mesh-ancestor
111427657|NCT00851136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111427658|NCT00851136|Growth Inhibitors|growth inhibitors|mesh-ancestor
111427659|NCT00366470|Cholecalciferol|cholecalciferol|mesh-list
111427660|NCT00366470|Vitamin D|vitamin d|mesh-list
111427661|NCT00366470|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111427662|NCT00366470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111427663|NCT00366470|Vitamins|vitamins|mesh-ancestor
111427664|NCT00366470|Micronutrients|micronutrients|mesh-ancestor
111427665|NCT00366470|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111427666|NCT04537286|Paclitaxel|paclitaxel|mesh-list
111427667|NCT04537286|Cisplatin|cisplatin|mesh-list
111427668|NCT04537286|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111427669|NCT04537286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111427670|NCT04537286|Tubulin Modulators|tubulin modulators|mesh-ancestor
111427671|NCT04537286|Antimitotic Agents|antimitotic agents|mesh-ancestor
111427672|NCT04537286|Mitosis Modulators|mitosis modulators|mesh-ancestor
111427673|NCT04537286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111427675|NCT02620904|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
111427676|NCT02620904|Abortifacient Agents|abortifacient agents|mesh-ancestor
111427677|NCT02620904|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111427678|NCT02620904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111427679|NCT02620904|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111427680|NCT02620904|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111427681|NCT02620904|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111427682|NCT02620904|Contraceptive Agents|contraceptive agents|mesh-ancestor
111427683|NCT02620904|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
111427684|NCT02620904|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
111427685|NCT02620904|Hormone Antagonists|hormone antagonists|mesh-ancestor
111427686|NCT02620904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111427687|NCT02620904|Luteolytic Agents|luteolytic agents|mesh-ancestor
111427688|NCT02620904|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111427689|NCT02620904|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
111427690|NCT00300768|Ivermectin|ivermectin|mesh-list
111427691|NCT00300768|Moxidectin|moxidectin|mesh-list
111427692|NCT00300768|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111427693|NCT00300768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111427694|NCT00300768|Anthelmintics|anthelmintics|mesh-ancestor
111427695|NCT00300768|Antinematodal Agents|antinematodal agents|mesh-ancestor
111427696|NCT02621060|Magnesium Oxide|magnesium oxide|mesh-list
111427697|NCT02621060|Antacids|antacids|mesh-ancestor
111427698|NCT02621060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111427699|NCT02621060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111427700|NCT04740554|Prednisone|prednisone|mesh-list
111427701|NCT04740554|Deflazacort|deflazacort|mesh-list
111427702|NCT04740554|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111427703|NCT04740554|Glucocorticoids|glucocorticoids|mesh-ancestor
111427704|NCT04740554|Hormones|hormones|mesh-ancestor
111427705|NCT04740554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111427706|NCT04740554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111427707|NCT04740554|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111427708|NCT04740554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111427709|NCT04740554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111427710|NCT04740554|Immunologic Factors|immunologic factors|mesh-ancestor
111427711|NCT02624180|Colchicine|colchicine|mesh-list
111427712|NCT02624180|Gout Suppressants|gout suppressants|mesh-ancestor
111427713|NCT02624180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111427714|NCT02624180|Tubulin Modulators|tubulin modulators|mesh-ancestor
111427715|NCT02624180|Antimitotic Agents|antimitotic agents|mesh-ancestor
111427716|NCT02624180|Mitosis Modulators|mitosis modulators|mesh-ancestor
111427717|NCT02624180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111427718|NCT02624180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111427719|NCT05068232|Carboplatin|carboplatin|mesh-list
111427720|NCT05068232|Etoposide|etoposide|mesh-list
111427721|NCT05068232|Durvalumab|durvalumab|mesh-list
111427722|NCT05068232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111427723|NCT05068232|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111427724|NCT05068232|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111427725|NCT05068232|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111427726|NCT05068232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111427727|NCT05068232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111427728|NCT05068232|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111427729|NCT04326764|Panobinostat|panobinostat|mesh-list
111427730|NCT04326764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111427731|NCT04326764|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111427732|NCT04326764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111427733|NCT04326764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111427734|NCT02628236|Aminolevulinic Acid|aminolevulinic acid|mesh-list
111427735|NCT02628236|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111427736|NCT02628236|Dermatologic Agents|dermatologic agents|mesh-ancestor
111427737|NCT02629094|Eplerenone|eplerenone|mesh-list
111427738|NCT02629094|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
111427739|NCT02629094|Hormone Antagonists|hormone antagonists|mesh-ancestor
111427740|NCT02629094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111427741|NCT02629094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111427742|NCT02629094|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
111427743|NCT02629094|Diuretics|diuretics|mesh-ancestor
111427744|NCT02629094|Natriuretic Agents|natriuretic agents|mesh-ancestor
111427745|NCT02629094|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111427746|NCT02630030|Ixazomib|ixazomib|mesh-list
111427747|NCT02630030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111427748|NCT02630030|Protease Inhibitors|protease inhibitors|mesh-ancestor
111427749|NCT02630030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111427750|NCT02630030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111427752|NCT04289792|Gemcitabine|gemcitabine|mesh-list
111427753|NCT04289792|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111427754|NCT04289792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111427755|NCT04289792|Tubulin Modulators|tubulin modulators|mesh-ancestor
111427756|NCT04289792|Antimitotic Agents|antimitotic agents|mesh-ancestor
111427757|NCT04289792|Mitosis Modulators|mitosis modulators|mesh-ancestor
111427758|NCT04289792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111427759|NCT04289792|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111427760|NCT04289792|Antimetabolites|antimetabolites|mesh-ancestor
111427761|NCT02631590|Gemcitabine|gemcitabine|mesh-list
111427762|NCT02631590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111427763|NCT02631590|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111427764|NCT02631590|Antimetabolites|antimetabolites|mesh-ancestor
111427765|NCT02631590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111427766|NCT02253654|Epoetin Alfa|epoetin alfa|mesh-list
111427767|NCT02253654|Hematinics|hematinics|mesh-ancestor
111427768|NCT02252406|Ranolazine|ranolazine|mesh-list
111427769|NCT02252406|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111427770|NCT02252406|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111427771|NCT02252406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111427772|NCT02252016|Grazoprevir|grazoprevir|mesh-list
111427773|NCT02252016|Antiviral Agents|antiviral agents|mesh-ancestor
111427774|NCT02252016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111427775|NCT04784442|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
111427776|NCT04784442|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111427777|NCT04784442|Antimetabolites|antimetabolites|mesh-ancestor
111427778|NCT04784442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111427779|NCT04784442|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111427780|NCT04784442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111427781|NCT04784442|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111427782|NCT04784442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111427783|NCT02706847|Upadacitinib|upadacitinib|mesh-list
111427784|NCT02706847|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
111427785|NCT02706847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111427786|NCT02706847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111427787|NCT02706847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111427788|NCT02706847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111427789|NCT02470741|Letrozole|letrozole|mesh-list
111427790|NCT02470741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111427791|NCT02470741|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111427792|NCT02470741|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111427793|NCT02470741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111427794|NCT02470741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111427795|NCT02470741|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111427796|NCT02470741|Hormone Antagonists|hormone antagonists|mesh-ancestor
111427797|NCT02470741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111427798|NCT02470741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111427799|NCT02544607|Ketamine|ketamine|mesh-list
111427800|NCT02544607|Analgesics|analgesics|mesh-ancestor
111427801|NCT02544607|Sensory System Agents|sensory system agents|mesh-ancestor
111427802|NCT02544607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111427803|NCT02544607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111427804|NCT02544607|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111427805|NCT02544607|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111427806|NCT02544607|Anesthetics, General|anesthetics, general|mesh-ancestor
111427807|NCT02544607|Anesthetics|anesthetics|mesh-ancestor
111427808|NCT02544607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111427809|NCT02544607|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111427810|NCT02544607|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111427811|NCT02544607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111427812|NCT02544607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111427813|NCT00363571|Acetazolamide|acetazolamide|mesh-list
111427814|NCT00363571|Anticonvulsants|anticonvulsants|mesh-ancestor
111427815|NCT00363571|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
111427816|NCT00363571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111427817|NCT00363571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111427818|NCT00363571|Diuretics|diuretics|mesh-ancestor
111152189|NCT02443883|Ramucirumab|ramucirumab|mesh-list
111427819|NCT00363571|Natriuretic Agents|natriuretic agents|mesh-ancestor
111427820|NCT00363571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111427821|NCT04744675|Triamcinolone|triamcinolone|mesh-list
111427822|NCT04744675|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
111427823|NCT04744675|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
111427824|NCT04744675|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
111427825|NCT04744675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111427826|NCT04744675|Glucocorticoids|glucocorticoids|mesh-ancestor
111427827|NCT04744675|Hormones|hormones|mesh-ancestor
111427828|NCT04744675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111427829|NCT04744675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111427830|NCT04744675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111427831|NCT04744675|Immunologic Factors|immunologic factors|mesh-ancestor
111427832|NCT04744675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111427833|NCT04744675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111427834|NCT02471521|Rocuronium|rocuronium|mesh-list
111427835|NCT02471521|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
111427836|NCT02471521|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
111427837|NCT02471521|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111427838|NCT02471521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111427839|NCT02471521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111427840|NCT02624479|Sodium thiosulfate|sodium thiosulfate|mesh-list
111427841|NCT02624479|Antidotes|antidotes|mesh-ancestor
111427842|NCT02624479|Protective Agents|protective agents|mesh-ancestor
111427843|NCT02624479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111427844|NCT02624479|Antioxidants|antioxidants|mesh-ancestor
111427845|NCT02624479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111427846|NCT02624479|Antitubercular Agents|antitubercular agents|mesh-ancestor
111427847|NCT02624479|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111427848|NCT02624479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111427849|NCT02624479|Chelating Agents|chelating agents|mesh-ancestor
111427850|NCT02624479|Sequestering Agents|sequestering agents|mesh-ancestor
111427851|NCT02472223|Povidone-Iodine|povidone-iodine|mesh-list
111427852|NCT02472223|Povidone|povidone|mesh-list
111427853|NCT02472223|Lubricant Eye Drops|lubricant eye drops|mesh-list
111427854|NCT02472223|Plasma Substitutes|plasma substitutes|mesh-ancestor
111427855|NCT02472223|Blood Substitutes|blood substitutes|mesh-ancestor
111427856|NCT02472223|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111427857|NCT02472223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111427858|NCT02472223|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
111427859|NCT02472223|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111427860|NCT02247960|Ciprofloxacin|ciprofloxacin|mesh-list
111427861|NCT02247960|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111427862|NCT02247960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111427863|NCT02247960|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111427864|NCT02247960|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111427865|NCT02247960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111427866|NCT02247960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111427867|NCT02247960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111427868|NCT02247960|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111427869|NCT02247960|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111427870|NCT02473783|Sertraline|sertraline|mesh-list
111427871|NCT02473783|Antidepressive Agents|antidepressive agents|mesh-ancestor
111427872|NCT02473783|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111427873|NCT02473783|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111427874|NCT02473783|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111427875|NCT02473783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111427876|NCT02473783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111427877|NCT02473783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111427878|NCT02473783|Serotonin Agents|serotonin agents|mesh-ancestor
111427879|NCT02473783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111427880|NCT02247804|Timolol|timolol|mesh-list
111427881|NCT02247804|Bimatoprost|bimatoprost|mesh-list
111427882|NCT02247804|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111427883|NCT02247804|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111427884|NCT02247804|Adrenergic Agents|adrenergic agents|mesh-ancestor
111427885|NCT02247804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111427886|NCT02247804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111427887|NCT02247804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111427888|NCT02247804|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111427889|NCT02247804|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111427890|NCT00366938|Lumiracoxib|lumiracoxib|mesh-list
111427891|NCT00366938|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111427892|NCT00366938|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111427893|NCT00366938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111427894|NCT00366938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111427895|NCT00366938|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111427896|NCT00366938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111427898|NCT00366938|Sensory System Agents|sensory system agents|mesh-ancestor
111427899|NCT00366938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111427900|NCT00366938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111427901|NCT00366938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111427902|NCT00366938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111427903|NCT05026320|Diclofenac|diclofenac|mesh-list
111427904|NCT05026320|Naproxen|naproxen|mesh-list
111427905|NCT05026320|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111427906|NCT05026320|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111427907|NCT05026320|Analgesics|analgesics|mesh-ancestor
111427908|NCT05026320|Sensory System Agents|sensory system agents|mesh-ancestor
111427909|NCT05026320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111427910|NCT05026320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111427911|NCT05026320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111427912|NCT05026320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111427913|NCT05026320|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111427914|NCT05026320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111427915|NCT05026320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111427916|NCT05026320|Gout Suppressants|gout suppressants|mesh-ancestor
111427917|NCT04068272|Bosentan|bosentan|mesh-list
111427918|NCT04068272|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111427919|NCT04068272|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
111427920|NCT04068272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111427921|NCT02243202|Canagliflozin|canagliflozin|mesh-list
111427922|NCT02243202|Phentermine|phentermine|mesh-list
111427923|NCT02243202|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111427924|NCT02243202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111427925|NCT02243202|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111427926|NCT02243202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111427927|NCT02243202|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111427928|NCT02243202|Appetite Depressants|appetite depressants|mesh-ancestor
111427929|NCT02243202|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111427930|NCT02243202|Sympathomimetics|sympathomimetics|mesh-ancestor
111427931|NCT02243202|Autonomic Agents|autonomic agents|mesh-ancestor
111427932|NCT02243202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111427933|NCT02243202|Adrenergic Agents|adrenergic agents|mesh-ancestor
111427934|NCT02243202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111427935|NCT04050410|Moxonidine|moxonidine|mesh-list
111427936|NCT04050410|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111427937|NCT02207946|Botulinum Toxins|botulinum toxins|mesh-list
111427938|NCT02207946|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111427939|NCT02207946|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111427940|NCT02207946|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
111427941|NCT02207946|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111427942|NCT02207946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111427943|NCT02207946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111427944|NCT02207946|Cholinergic Agents|cholinergic agents|mesh-ancestor
111427945|NCT02207946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111427946|NCT02207946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111427947|NCT02207946|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110511666|NCT04228926|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111427948|NCT02207946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111427949|NCT04235036|Rituximab|rituximab|mesh-list
111427950|NCT04235036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111427951|NCT04235036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111427952|NCT04235036|Immunologic Factors|immunologic factors|mesh-ancestor
111427953|NCT04235036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111427954|NCT04235036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111427955|NCT02560051|Ketoconazole|ketoconazole|mesh-list
111427956|NCT02560051|Docetaxel|docetaxel|mesh-list
111427957|NCT02560051|Doxorubicin|doxorubicin|mesh-list
111427958|NCT02560051|Estramustine|estramustine|mesh-list
111427959|NCT02560051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111427960|NCT02560051|Tubulin Modulators|tubulin modulators|mesh-ancestor
111427961|NCT02560051|Antimitotic Agents|antimitotic agents|mesh-ancestor
111427962|NCT02560051|Mitosis Modulators|mitosis modulators|mesh-ancestor
111427963|NCT02560051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111427964|NCT02560051|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111427965|NCT02560051|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111427966|NCT02560051|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111427967|NCT02560051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111427968|NCT02560051|Antifungal Agents|antifungal agents|mesh-ancestor
111427969|NCT02560051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111427970|NCT02560051|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111427971|NCT02560051|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111427972|NCT02560051|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111427973|NCT02560051|Hormone Antagonists|hormone antagonists|mesh-ancestor
111427974|NCT02560051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111427975|NCT02560051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111427976|NCT02560051|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111427977|NCT02560051|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111427978|NCT02560051|Alkylating Agents|alkylating agents|mesh-ancestor
111427979|NCT02560051|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111427980|NCT03786770|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111427981|NCT03786770|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111427982|NCT03786770|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111427983|NCT03786770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111427984|NCT03786770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111427985|NCT03786770|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111427986|NCT03786770|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111427987|NCT03786770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111427988|NCT03786770|Cholinergic Agents|cholinergic agents|mesh-ancestor
111427989|NCT03786770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111427990|NCT00367718|Bortezomib|bortezomib|mesh-list
111427991|NCT00367718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111427992|NCT02474407|Diazepam|diazepam|mesh-list
111427993|NCT02474407|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111427994|NCT02474407|Anticonvulsants|anticonvulsants|mesh-ancestor
111427995|NCT02474407|Antiemetics|antiemetics|mesh-ancestor
111427996|NCT02474407|Autonomic Agents|autonomic agents|mesh-ancestor
111427997|NCT02474407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111427998|NCT02474407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111427999|NCT02474407|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111428000|NCT02474407|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111428001|NCT02474407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111428002|NCT02474407|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
111428003|NCT02474407|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111428004|NCT02474407|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111428005|NCT02474407|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111428006|NCT02474407|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111428007|NCT02474407|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111428008|NCT02474407|Anesthetics, General|anesthetics, general|mesh-ancestor
111428009|NCT02474407|Anesthetics|anesthetics|mesh-ancestor
111428010|NCT02474407|GABA Modulators|gaba modulators|mesh-ancestor
111428011|NCT02474407|GABA Agents|gaba agents|mesh-ancestor
111428012|NCT02474407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111428013|NCT02474407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111428014|NCT05588492|Rifamycins|rifamycins|mesh-list
111428015|NCT05588492|Rifamycin SV|rifamycin sv|mesh-list
111428016|NCT05588492|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111428017|NCT05588492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111428018|NCT05588492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111428019|NCT03777956|Lacosamide|lacosamide|mesh-list
111428020|NCT03777956|Anticonvulsants|anticonvulsants|mesh-ancestor
111428021|NCT03777956|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111428022|NCT03777956|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111428023|NCT03777956|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111428024|NCT03777956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111428025|NCT02481505|Chloroprocaine|chloroprocaine|mesh-list
111428026|NCT02481505|Anesthetics, Local|anesthetics, local|mesh-ancestor
111428027|NCT02481505|Anesthetics|anesthetics|mesh-ancestor
111428028|NCT02481505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111428029|NCT02481505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111428030|NCT02481505|Sensory System Agents|sensory system agents|mesh-ancestor
111428031|NCT02481505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111428032|NCT02563093|Vaccines|vaccines|mesh-list
111428033|NCT02563093|Immunologic Factors|immunologic factors|mesh-ancestor
111428034|NCT02563093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111428035|NCT02564029|Lorazepam|lorazepam|mesh-list
111428036|NCT02564029|PF-06372865|pf-06372865|mesh-list
111428037|NCT02564029|Anticonvulsants|anticonvulsants|mesh-ancestor
111428038|NCT02564029|Antiemetics|antiemetics|mesh-ancestor
111428039|NCT02564029|Autonomic Agents|autonomic agents|mesh-ancestor
111428040|NCT02564029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111428041|NCT02564029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111428043|NCT02564029|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111428044|NCT02564029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111428045|NCT02564029|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111428046|NCT02564029|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111428047|NCT02564029|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111428048|NCT02564029|GABA Modulators|gaba modulators|mesh-ancestor
111428049|NCT02564029|GABA Agents|gaba agents|mesh-ancestor
111428050|NCT02564029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111428051|NCT02564029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111428052|NCT05588336|Morphine|morphine|mesh-list
111428053|NCT05588336|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111428054|NCT05588336|Narcotics|narcotics|mesh-ancestor
111428055|NCT05588336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111428056|NCT05588336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111428057|NCT05588336|Analgesics|analgesics|mesh-ancestor
111428058|NCT05588336|Sensory System Agents|sensory system agents|mesh-ancestor
111428059|NCT05588336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111428060|NCT02564497|Abatacept|abatacept|mesh-list
111428061|NCT02564497|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111428062|NCT02564497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111428063|NCT02564497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111428064|NCT02564497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111428065|NCT02564497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111428066|NCT02564497|Immunologic Factors|immunologic factors|mesh-ancestor
111428067|NCT02564497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111428068|NCT02564497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111428069|NCT02565901|Sirolimus|sirolimus|mesh-list
111428070|NCT02565901|Carboplatin|carboplatin|mesh-list
111428071|NCT02565901|Docetaxel|docetaxel|mesh-list
111428072|NCT02565901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111428073|NCT02565901|Tubulin Modulators|tubulin modulators|mesh-ancestor
111428074|NCT02565901|Antimitotic Agents|antimitotic agents|mesh-ancestor
111428075|NCT02565901|Mitosis Modulators|mitosis modulators|mesh-ancestor
111428076|NCT02565901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111428077|NCT02565901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111428078|NCT02565901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111428079|NCT02565901|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111428080|NCT02565901|Antifungal Agents|antifungal agents|mesh-ancestor
111428081|NCT02565901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111428082|NCT02565901|Immunologic Factors|immunologic factors|mesh-ancestor
111428083|NCT02565901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111428084|NCT03926624|Cytarabine|cytarabine|mesh-list
111428085|NCT03926624|Fludarabine|fludarabine|mesh-list
111428086|NCT03926624|Etoposide|etoposide|mesh-list
111428087|NCT03926624|Azacitidine|azacitidine|mesh-list
111428088|NCT03926624|Decitabine|decitabine|mesh-list
111428089|NCT03926624|Venetoclax|venetoclax|mesh-list
111428090|NCT03926624|Mitoxantrone|mitoxantrone|mesh-list
111428091|NCT03926624|Idarubicin|idarubicin|mesh-list
111428092|NCT03926624|Cladribine|cladribine|mesh-list
111428093|NCT03926624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111428094|NCT03926624|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111428095|NCT03926624|Antimetabolites|antimetabolites|mesh-ancestor
111428096|NCT03926624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111428097|NCT03926624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111428098|NCT03926624|Immunologic Factors|immunologic factors|mesh-ancestor
111428099|NCT03926624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111428100|NCT03926624|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111428101|NCT03926624|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111428102|NCT03926624|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111428103|NCT03926624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111428104|NCT03926624|Antiviral Agents|antiviral agents|mesh-ancestor
111428105|NCT03926624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111428106|NCT03926624|Analgesics|analgesics|mesh-ancestor
111428107|NCT03926624|Sensory System Agents|sensory system agents|mesh-ancestor
111428108|NCT03926624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111428109|NCT03926624|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111428110|NCT05588102|Fluvoxamine|fluvoxamine|mesh-list
111428111|NCT05588102|Citalopram|citalopram|mesh-list
111428112|NCT05588102|Fluoxetine|fluoxetine|mesh-list
111428113|NCT05588102|Paroxetine|paroxetine|mesh-list
111428114|NCT05588102|Sertraline|sertraline|mesh-list
111428115|NCT05588102|Escitalopram|escitalopram|mesh-list
111428116|NCT05588102|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
111428117|NCT05588102|Serotonin|serotonin|mesh-list
111428118|NCT05588102|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111428119|NCT05588102|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111428120|NCT05588102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111428121|NCT05588102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111428122|NCT05588102|Serotonin Agents|serotonin agents|mesh-ancestor
111428123|NCT05588102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111428124|NCT05588102|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111428125|NCT05588102|Antidepressive Agents|antidepressive agents|mesh-ancestor
111428126|NCT05588102|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111428127|NCT05588102|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111428128|NCT05588102|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111428129|NCT05588102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111428130|NCT05588102|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111428131|NCT05588102|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111428132|NCT05588102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111428133|NCT05588102|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111428134|NCT05588102|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111428135|NCT05588102|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111428136|NCT04744441|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111428137|NCT04744441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111428138|NCT03551210|Levofloxacin|levofloxacin|mesh-list
111428139|NCT03551210|Ofloxacin|ofloxacin|mesh-list
111428140|NCT03551210|Nemonoxacin|nemonoxacin|mesh-list
111428141|NCT03551210|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111428142|NCT03551210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111428143|NCT03551210|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111428144|NCT03551210|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111428145|NCT03551210|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111428146|NCT03551210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111428147|NCT03551210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111428148|NCT03551210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111428149|NCT03551210|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111428150|NCT03551210|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111428151|NCT02482675|Caseins|caseins|mesh-list
111428152|NCT02482675|Chelating Agents|chelating agents|mesh-ancestor
111428153|NCT02482675|Sequestering Agents|sequestering agents|mesh-ancestor
111428154|NCT02482675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111428155|NCT00364195|Tesmilifene|tesmilifene|mesh-list
111428156|NCT00364195|Histamine Antagonists|histamine antagonists|mesh-ancestor
111428157|NCT00364195|Histamine Agents|histamine agents|mesh-ancestor
111428158|NCT00364195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111428159|NCT00364195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111428160|NCT00364195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111428161|NCT00364195|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111428162|NCT02566369|Trifarotene|trifarotene|mesh-list
111428163|NCT02566369|Dermatologic Agents|dermatologic agents|mesh-ancestor
111428164|NCT02569723|Oxaliplatin|oxaliplatin|mesh-list
111428165|NCT02569723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111428166|NCT02570425|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
111428167|NCT02570425|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111428168|NCT02570425|Respiratory System Agents|respiratory system agents|mesh-ancestor
111428169|NCT02571439|Ropivacaine|ropivacaine|mesh-list
111428170|NCT02571439|Anesthetics, Local|anesthetics, local|mesh-ancestor
111428171|NCT02571439|Anesthetics|anesthetics|mesh-ancestor
111428172|NCT02571439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111428173|NCT02571439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111428174|NCT02571439|Sensory System Agents|sensory system agents|mesh-ancestor
111428175|NCT02571439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111428176|NCT02573857|Artefenomel|artefenomel|mesh-list
111428177|NCT02573857|Antimalarials|antimalarials|mesh-ancestor
111428178|NCT02573857|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111428179|NCT02573857|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111428180|NCT02573857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111428181|NCT03678428|Leucovorin|leucovorin|mesh-list
111428182|NCT03678428|Oxaliplatin|oxaliplatin|mesh-list
111428183|NCT03678428|Irinotecan|irinotecan|mesh-list
111428184|NCT03678428|Floxuridine|floxuridine|mesh-list
111428185|NCT03678428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111428186|NCT03678428|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111428187|NCT03678428|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111428188|NCT03678428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111428189|NCT03678428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111428190|NCT03678428|Antidotes|antidotes|mesh-ancestor
111428191|NCT03678428|Protective Agents|protective agents|mesh-ancestor
111428192|NCT03678428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111428193|NCT03678428|Vitamin B Complex|vitamin b complex|mesh-ancestor
111152586|NCT01817764|Xhance|xhance|mesh-list
111428194|NCT03678428|Vitamins|vitamins|mesh-ancestor
111428195|NCT03678428|Micronutrients|micronutrients|mesh-ancestor
111428196|NCT03678428|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111428197|NCT03678428|Antimetabolites|antimetabolites|mesh-ancestor
111428198|NCT02577601|Levonorgestrel|levonorgestrel|mesh-list
111428199|NCT02577601|Ethinyl Estradiol|ethinyl estradiol|mesh-list
111428200|NCT02577601|Ulipristal acetate|ulipristal acetate|mesh-list
111428201|NCT02577601|Contraceptives, Oral|contraceptives, oral|mesh-list
111428202|NCT02577601|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
111428203|NCT02577601|Estradiol|estradiol|mesh-list
111428204|NCT02577601|Estrogens|estrogens|mesh-ancestor
111428205|NCT02577601|Hormones|hormones|mesh-ancestor
111428206|NCT02577601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111428207|NCT02577601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111428208|NCT02577601|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111428209|NCT02577601|Contraceptive Agents|contraceptive agents|mesh-ancestor
111428210|NCT02577601|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111428211|NCT02577601|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111428212|NCT02577601|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111428213|NCT02577601|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111428214|NCT02577991|Triamcinolone|triamcinolone|mesh-list
111428215|NCT02577991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111428216|NCT02577991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111428217|NCT02577991|Glucocorticoids|glucocorticoids|mesh-ancestor
111428218|NCT02577991|Hormones|hormones|mesh-ancestor
111428219|NCT02577991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111428220|NCT02207634|Evolocumab|evolocumab|mesh-list
111428221|NCT02207634|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
111428222|NCT02207634|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111428223|NCT02207634|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111428224|NCT02207634|Antimetabolites|antimetabolites|mesh-ancestor
111428225|NCT02207634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111428226|NCT02207634|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111428227|NCT02207634|Protease Inhibitors|protease inhibitors|mesh-ancestor
111428228|NCT02207634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111428229|NCT02207634|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111428230|NCT02484859|Metoprolol|metoprolol|mesh-list
111428231|NCT02484859|Remifentanil|remifentanil|mesh-list
111428232|NCT02484859|Tramadol|tramadol|mesh-list
111428233|NCT02484859|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111428234|NCT02484859|Narcotics|narcotics|mesh-ancestor
111428235|NCT02484859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111428236|NCT02484859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111428237|NCT02484859|Analgesics|analgesics|mesh-ancestor
111428238|NCT02484859|Sensory System Agents|sensory system agents|mesh-ancestor
111428239|NCT02484859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111428240|NCT02484859|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111428241|NCT02484859|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111428242|NCT02484859|Sympatholytics|sympatholytics|mesh-ancestor
111428243|NCT02484859|Autonomic Agents|autonomic agents|mesh-ancestor
111428244|NCT02484859|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
111428245|NCT02484859|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111428246|NCT02484859|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111428247|NCT02484859|Adrenergic Agents|adrenergic agents|mesh-ancestor
111428248|NCT02484859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111428249|NCT02484859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111428250|NCT04341727|Azithromycin|azithromycin|mesh-list
111428251|NCT04341727|Hydroxychloroquine|hydroxychloroquine|mesh-list
111428252|NCT04341727|Chloroquine|chloroquine|mesh-list
111428253|NCT04341727|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
111428254|NCT04341727|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111428255|NCT04341727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111428256|NCT04341727|Antimalarials|antimalarials|mesh-ancestor
111428257|NCT04341727|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111428258|NCT04341727|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111428259|NCT04341727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111428260|NCT04341727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111428261|NCT04341727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111428262|NCT04341727|Amebicides|amebicides|mesh-ancestor
111428263|NCT04341727|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111428264|NCT04341727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111428265|NCT04341727|Analgesics|analgesics|mesh-ancestor
111428266|NCT04341727|Sensory System Agents|sensory system agents|mesh-ancestor
111428267|NCT04341727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111428268|NCT04341727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111428269|NCT04341727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111428270|NCT04341727|Filaricides|filaricides|mesh-ancestor
111428271|NCT04341727|Antinematodal Agents|antinematodal agents|mesh-ancestor
111428272|NCT04341727|Anthelmintics|anthelmintics|mesh-ancestor
111428273|NCT00367094|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
111428274|NCT00367094|Benazepril|benazepril|mesh-list
111428275|NCT00367094|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111428276|NCT00367094|Diuretics|diuretics|mesh-ancestor
111428277|NCT00367094|Natriuretic Agents|natriuretic agents|mesh-ancestor
111428278|NCT00367094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111428279|NCT00367094|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
111428280|NCT00367094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111428281|NCT00367094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111428282|NCT00367094|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
111428283|NCT00367094|Protease Inhibitors|protease inhibitors|mesh-ancestor
111428284|NCT00367094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111428285|NCT02581111|Naloxone|naloxone|mesh-list
111428286|NCT02581111|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111428287|NCT02581111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111428288|NCT02581111|Sensory System Agents|sensory system agents|mesh-ancestor
111428289|NCT02581111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111428290|NCT05587400|Dobutamine|dobutamine|mesh-list
111428291|NCT05587400|Nitric Oxide|nitric oxide|mesh-list
111428292|NCT05587400|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111428293|NCT05587400|Autonomic Agents|autonomic agents|mesh-ancestor
111428294|NCT05587400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111428295|NCT05587400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111428296|NCT05587400|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111428297|NCT05587400|Respiratory System Agents|respiratory system agents|mesh-ancestor
111428298|NCT05587400|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111428299|NCT05587400|Antioxidants|antioxidants|mesh-ancestor
111428300|NCT05587400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111428301|NCT05587400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110511712|NCT00634686|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111428302|NCT05587400|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
111428303|NCT05587400|Vasodilator Agents|vasodilator agents|mesh-ancestor
111428304|NCT05587400|Gasotransmitters|gasotransmitters|mesh-ancestor
111428305|NCT05587400|Protective Agents|protective agents|mesh-ancestor
111428306|NCT05587400|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111428307|NCT05587400|Sympathomimetics|sympathomimetics|mesh-ancestor
111428308|NCT05587400|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
111428309|NCT05587400|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111428310|NCT05587400|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111428311|NCT05587400|Adrenergic Agents|adrenergic agents|mesh-ancestor
111428312|NCT04339868|Terlipressin|terlipressin|mesh-list
111428313|NCT04339868|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111428314|NCT04339868|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111428315|NCT00367172|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
111428316|NCT00367172|Antiviral Agents|antiviral agents|mesh-ancestor
111428317|NCT00367172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111428318|NCT00367250|Trastuzumab|trastuzumab|mesh-list
111428319|NCT00367250|Cetuximab|cetuximab|mesh-list
111428320|NCT00367250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111428321|NCT00367250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111428322|NCT02489227|Adalimumab|adalimumab|mesh-list
111428323|NCT02489227|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111428324|NCT02489227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111428325|NCT02489227|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111428326|NCT02490631|Chlorhexidine|chlorhexidine|mesh-list
111428327|NCT02490631|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
111428328|NCT02490631|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111428329|NCT02490631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111428330|NCT02490631|Disinfectants|disinfectants|mesh-ancestor
111428331|NCT02490631|Dermatologic Agents|dermatologic agents|mesh-ancestor
111428332|NCT02207556|Doxycycline|doxycycline|mesh-list
111428333|NCT02207556|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111428334|NCT02207556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111428335|NCT02207556|Antimalarials|antimalarials|mesh-ancestor
111428336|NCT02207556|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111428337|NCT02207556|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111428338|NCT02572609|Ambroxol|ambroxol|mesh-list
111428339|NCT02572609|Expectorants|expectorants|mesh-ancestor
111428340|NCT02572609|Respiratory System Agents|respiratory system agents|mesh-ancestor
111428341|NCT02587117|Prednisolone|prednisolone|mesh-list
111428342|NCT02587117|Lycopene|lycopene|mesh-list
111428343|NCT02587117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111428344|NCT02587117|Glucocorticoids|glucocorticoids|mesh-ancestor
111428345|NCT02587117|Hormones|hormones|mesh-ancestor
111428346|NCT02587117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111428347|NCT02587117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111428348|NCT02587117|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111428349|NCT02587117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111428350|NCT02587117|Protective Agents|protective agents|mesh-ancestor
111428351|NCT02587117|Antioxidants|antioxidants|mesh-ancestor
111428352|NCT02587117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111428353|NCT02587117|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111428354|NCT02587117|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
111428355|NCT02587351|Metoprolol|metoprolol|mesh-list
111428356|NCT02587351|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111428357|NCT02587351|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111428358|NCT02587351|Sympatholytics|sympatholytics|mesh-ancestor
111428359|NCT02587351|Autonomic Agents|autonomic agents|mesh-ancestor
111428360|NCT02587351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111428361|NCT02587351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111428362|NCT02587351|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
111428363|NCT02587351|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111428364|NCT02587351|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111428365|NCT02587351|Adrenergic Agents|adrenergic agents|mesh-ancestor
111428366|NCT02587351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111428367|NCT02587351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111428368|NCT05553314|Carvedilol|carvedilol|mesh-list
111428369|NCT05553314|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111428370|NCT05553314|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111428371|NCT05553314|Adrenergic Agents|adrenergic agents|mesh-ancestor
111428372|NCT05553314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111428373|NCT05553314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111428374|NCT05553314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111428375|NCT05553314|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111428376|NCT05553314|Antioxidants|antioxidants|mesh-ancestor
111428377|NCT05553314|Protective Agents|protective agents|mesh-ancestor
111428378|NCT05553314|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111428379|NCT05553314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111428380|NCT05553314|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111428381|NCT05553314|Vasodilator Agents|vasodilator agents|mesh-ancestor
111428382|NCT05553314|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111428383|NCT05553314|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111428384|NCT00422396|Fenofibrate|fenofibrate|mesh-list
111428385|NCT00422396|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111428386|NCT00422396|Antimetabolites|antimetabolites|mesh-ancestor
111428387|NCT00422396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111428388|NCT00422396|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111428389|NCT00364273|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
111428390|NCT00364273|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111428391|NCT00364273|Autonomic Agents|autonomic agents|mesh-ancestor
111428392|NCT00364273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111428393|NCT00364273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111428394|NCT00364273|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111428395|NCT00364273|Respiratory System Agents|respiratory system agents|mesh-ancestor
111428396|NCT00364273|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111428397|NCT00364273|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111428398|NCT00364273|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111428399|NCT00364273|Adrenergic Agents|adrenergic agents|mesh-ancestor
111428400|NCT00364273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111428401|NCT00364273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111428402|NCT02495467|Nitroglycerin|nitroglycerin|mesh-list
111428403|NCT02495467|Vasodilator Agents|vasodilator agents|mesh-ancestor
111428404|NCT05249023|Butyric Acid|butyric acid|mesh-list
111428405|NCT05249023|Histamine Antagonists|histamine antagonists|mesh-ancestor
111428406|NCT05249023|Histamine Agents|histamine agents|mesh-ancestor
111428407|NCT05249023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111428408|NCT05249023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111428409|NCT05249023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111428410|NCT02495779|Tenofovir|tenofovir|mesh-list
111428411|NCT02495779|Emtricitabine|emtricitabine|mesh-list
111428412|NCT02495779|Antiviral Agents|antiviral agents|mesh-ancestor
111428413|NCT02495779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111428414|NCT02495779|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111428415|NCT02495779|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111428416|NCT02495779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111428417|NCT02495779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111428418|NCT02495779|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111428419|NCT02495779|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111428420|NCT05216497|Pentanedioic acid imidazolyl ethanamide|pentanedioic acid imidazolyl ethanamide|mesh-list
111428421|NCT05216497|Antiviral Agents|antiviral agents|mesh-ancestor
111428422|NCT05216497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111428423|NCT02502487|Ropivacaine|ropivacaine|mesh-list
111428424|NCT02502487|Tetracaine|tetracaine|mesh-list
111428425|NCT02502487|Anesthetics, Local|anesthetics, local|mesh-ancestor
111428426|NCT02502487|Anesthetics|anesthetics|mesh-ancestor
111428427|NCT02502487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111428428|NCT02502487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111428429|NCT02502487|Sensory System Agents|sensory system agents|mesh-ancestor
111428430|NCT02502487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111428431|NCT03238196|Fulvestrant|fulvestrant|mesh-list
111428432|NCT03238196|Palbociclib|palbociclib|mesh-list
111428433|NCT03238196|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111428434|NCT03238196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111428435|NCT03238196|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
111428436|NCT03238196|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111428437|NCT03238196|Hormone Antagonists|hormone antagonists|mesh-ancestor
111428438|NCT03238196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111428439|NCT03238196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111428440|NCT03238196|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111428441|NCT03238196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111428442|NCT03238196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111428443|NCT02632045|Fulvestrant|fulvestrant|mesh-list
111428444|NCT02632045|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111428445|NCT02632045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111428446|NCT02632045|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
111428447|NCT02632045|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111428448|NCT02632045|Hormone Antagonists|hormone antagonists|mesh-ancestor
111428449|NCT02632045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111428450|NCT02632045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111428451|NCT02503735|Sofosbuvir|sofosbuvir|mesh-list
111428452|NCT02503735|Ledipasvir|ledipasvir|mesh-list
111428453|NCT02503735|Antiviral Agents|antiviral agents|mesh-ancestor
111428454|NCT02503735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111428455|NCT04001881|Anesthetics|anesthetics|mesh-list
111428456|NCT04001881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111428457|NCT04001881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111428458|NCT03019640|Cytarabine|cytarabine|mesh-list
111428459|NCT03019640|Rituximab|rituximab|mesh-list
111428460|NCT03019640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111428461|NCT03019640|Etoposide|etoposide|mesh-list
111428462|NCT03019640|Lenalidomide|lenalidomide|mesh-list
111428463|NCT03019640|Etoposide phosphate|etoposide phosphate|mesh-list
111428464|NCT03019640|Melphalan|melphalan|mesh-list
111428465|NCT03019640|Mechlorethamine|mechlorethamine|mesh-list
111428466|NCT03019640|Carmustine|carmustine|mesh-list
111428467|NCT03019640|Podophyllotoxin|podophyllotoxin|mesh-list
111428468|NCT03019640|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
111428469|NCT03019640|Antibodies|antibodies|mesh-list
111428470|NCT03019640|Immunoglobulins|immunoglobulins|mesh-list
111428471|NCT03019640|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111428472|NCT03019640|Lenograstim|lenograstim|mesh-list
111428473|NCT03019640|Immunologic Factors|immunologic factors|mesh-ancestor
111428474|NCT03019640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111428475|NCT03019640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111428476|NCT03019640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111428477|NCT03019640|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111428478|NCT03019640|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111428479|NCT03019640|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111428480|NCT03019640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111428481|NCT03019640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111428482|NCT03019640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111428483|NCT03019640|Antimetabolites|antimetabolites|mesh-ancestor
111428484|NCT03019640|Antiviral Agents|antiviral agents|mesh-ancestor
111428485|NCT03019640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111428486|NCT03019640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111428487|NCT03019640|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111428488|NCT03019640|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111428489|NCT03019640|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111428490|NCT03019640|Growth Substances|growth substances|mesh-ancestor
111428491|NCT03019640|Growth Inhibitors|growth inhibitors|mesh-ancestor
111428492|NCT03019640|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111428493|NCT03019640|Alkylating Agents|alkylating agents|mesh-ancestor
111428494|NCT03019640|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111428495|NCT03019640|Keratolytic Agents|keratolytic agents|mesh-ancestor
111428496|NCT03019640|Dermatologic Agents|dermatologic agents|mesh-ancestor
111428497|NCT03019640|Tubulin Modulators|tubulin modulators|mesh-ancestor
111428498|NCT03019640|Antimitotic Agents|antimitotic agents|mesh-ancestor
111428499|NCT03019640|Mitosis Modulators|mitosis modulators|mesh-ancestor
111428500|NCT02136901|Hyaluronic Acid|hyaluronic acid|mesh-list
111428501|NCT02136901|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111428502|NCT02136901|Immunologic Factors|immunologic factors|mesh-ancestor
111428503|NCT02136901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111428504|NCT02136901|Viscosupplements|viscosupplements|mesh-ancestor
111428505|NCT02136901|Protective Agents|protective agents|mesh-ancestor
111428506|NCT02507011|Carvedilol|carvedilol|mesh-list
111428507|NCT02507011|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111428508|NCT02507011|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111428509|NCT02507011|Adrenergic Agents|adrenergic agents|mesh-ancestor
111428510|NCT02507011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111428511|NCT02507011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111428512|NCT02507011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111428513|NCT02507011|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111428514|NCT02507011|Antioxidants|antioxidants|mesh-ancestor
111428515|NCT02507011|Protective Agents|protective agents|mesh-ancestor
111428516|NCT02507011|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111428517|NCT02507011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111428518|NCT02507011|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111428519|NCT02507011|Vasodilator Agents|vasodilator agents|mesh-ancestor
111428520|NCT02507011|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111428521|NCT02507011|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111428522|NCT02977286|Methylnaltrexone|methylnaltrexone|mesh-list
111428523|NCT02977286|Naloxegol|naloxegol|mesh-list
111428524|NCT02977286|Bisacodyl|bisacodyl|mesh-list
111428525|NCT02977286|Magnesium citrate|magnesium citrate|mesh-list
111428526|NCT02977286|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
111428527|NCT02977286|Cathartics|cathartics|mesh-ancestor
111428528|NCT02977286|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111428529|NCT02977286|Laxatives|laxatives|mesh-ancestor
111428530|NCT02977286|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111428531|NCT02977286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111428532|NCT02977286|Sensory System Agents|sensory system agents|mesh-ancestor
111428533|NCT02977286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111428534|NCT02977286|Antidiarrheals|antidiarrheals|mesh-ancestor
111428535|NCT05345210|Amoxicillin|amoxicillin|mesh-list
111428536|NCT05345210|Clarithromycin|clarithromycin|mesh-list
111428537|NCT05345210|Tetracycline|tetracycline|mesh-list
111428538|NCT05345210|Furazolidone|furazolidone|mesh-list
111428539|NCT05345210|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111428540|NCT05345210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111428541|NCT05345210|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111428542|NCT05345210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111428543|NCT05345210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111428544|NCT05345210|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111428545|NCT05345210|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111428546|NCT05345210|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111428547|NCT05345210|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111428548|NCT05345210|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
111428549|NCT05345210|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111428550|NCT05345210|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111428551|NCT05345210|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
111428552|NCT02976896|Apatinib|apatinib|mesh-list
111428553|NCT02976896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111428554|NCT02976896|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111428555|NCT02976896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111428556|NCT02976896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111428557|NCT01810705|Asparaginase|asparaginase|mesh-list
111428558|NCT01810705|Eryaspase|eryaspase|mesh-list
111428559|NCT01810705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111428560|NCT02508103|Oxytocin|oxytocin|mesh-list
111428561|NCT02508103|Oxytocics|oxytocics|mesh-ancestor
111428562|NCT02508103|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111428563|NCT02508103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111428564|NCT02508259|Suramin|suramin|mesh-list
111428565|NCT02508259|Antinematodal Agents|antinematodal agents|mesh-ancestor
111428566|NCT02508259|Anthelmintics|anthelmintics|mesh-ancestor
111428567|NCT02508259|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111428568|NCT02508259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111428569|NCT02508259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111428570|NCT02508259|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
111428571|NCT02508259|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111428572|NCT02848820|Amoxicillin|amoxicillin|mesh-list
111428573|NCT02848820|Gentamicins|gentamicins|mesh-list
111428574|NCT02848820|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
111428575|NCT02848820|Clavulanic Acids|clavulanic acids|mesh-list
111428576|NCT02848820|Clavulanic Acid|clavulanic acid|mesh-list
111428577|NCT02848820|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111428578|NCT02848820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111428579|NCT02848820|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111428580|NCT02848820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111428581|NCT02848820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111428582|NCT02848820|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
111428584|NCT00534469|Aldesleukin|aldesleukin|mesh-list
111428585|NCT00534469|Etoposide|etoposide|mesh-list
111428586|NCT00534469|Idarubicin|idarubicin|mesh-list
111428587|NCT00534469|Busulfan|busulfan|mesh-list
111428588|NCT00534469|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111428589|NCT00534469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111428590|NCT00534469|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111428591|NCT00534469|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111428592|NCT00534469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111428593|NCT00534469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111428594|NCT00534469|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111428595|NCT00534469|Antimetabolites|antimetabolites|mesh-ancestor
111428596|NCT00534469|Antiviral Agents|antiviral agents|mesh-ancestor
111428597|NCT00534469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111428598|NCT00534469|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111428599|NCT00534469|Immunologic Factors|immunologic factors|mesh-ancestor
111428600|NCT00534469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111428601|NCT00534469|Alkylating Agents|alkylating agents|mesh-ancestor
111428602|NCT00534469|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111428603|NCT00534469|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111428604|NCT00534469|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111428605|NCT00534469|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111428606|NCT00534469|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111428607|NCT02240628|Lidocaine|lidocaine|mesh-list
111428608|NCT02240628|Tetracaine|tetracaine|mesh-list
111428609|NCT02240628|Anesthetics, Local|anesthetics, local|mesh-ancestor
111428610|NCT02240628|Anesthetics|anesthetics|mesh-ancestor
111428611|NCT02240628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111428612|NCT02240628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111428613|NCT02240628|Sensory System Agents|sensory system agents|mesh-ancestor
111428614|NCT02240628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111428615|NCT02240628|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111428616|NCT02240628|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111428617|NCT02240628|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111428618|NCT02240628|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111428619|NCT02240628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111428620|NCT02589067|Chlorhexidine|chlorhexidine|mesh-list
111428621|NCT02589067|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
111428622|NCT02589067|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111428623|NCT02589067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111428624|NCT02589067|Disinfectants|disinfectants|mesh-ancestor
111428625|NCT02589067|Dermatologic Agents|dermatologic agents|mesh-ancestor
111428626|NCT02511379|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111428627|NCT02511379|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111428628|NCT02207400|Listerine|listerine|mesh-list
111428629|NCT02207400|Fluorides|fluorides|mesh-list
111428630|NCT02207400|Sodium Fluoride|sodium fluoride|mesh-list
111428631|NCT02207400|Cariostatic Agents|cariostatic agents|mesh-ancestor
111428632|NCT02207400|Protective Agents|protective agents|mesh-ancestor
111428633|NCT02207400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111428634|NCT02207400|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111428635|NCT02207400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111428636|NCT02511535|Vaccines|vaccines|mesh-list
111428637|NCT02511535|Immunologic Factors|immunologic factors|mesh-ancestor
111428638|NCT02511535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111428639|NCT03545035|Rituximab|rituximab|mesh-list
111428640|NCT03545035|Idelalisib|idelalisib|mesh-list
111428641|NCT03545035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111428642|NCT03545035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111428643|NCT03545035|Immunologic Factors|immunologic factors|mesh-ancestor
111428644|NCT03545035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111428645|NCT03545035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111428646|NCT03545035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111428647|NCT03545035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111428648|NCT02589847|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111428649|NCT02589847|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
111428650|NCT02589847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111428651|NCT02589847|Antitubercular Agents|antitubercular agents|mesh-ancestor
111428652|NCT02592421|Dapagliflozin|dapagliflozin|mesh-list
111428653|NCT02592421|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111428654|NCT02592421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111428655|NCT02592421|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111428656|NCT02592421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111428657|NCT02512783|Lidocaine|lidocaine|mesh-list
111428658|NCT02512783|Propofol|propofol|mesh-list
111428659|NCT02512783|Anesthetics, Local|anesthetics, local|mesh-ancestor
111428660|NCT02512783|Anesthetics|anesthetics|mesh-ancestor
111428661|NCT02512783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111428662|NCT02512783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111428663|NCT02512783|Sensory System Agents|sensory system agents|mesh-ancestor
111428664|NCT02512783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111428665|NCT02512783|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111428666|NCT02512783|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111428667|NCT02512783|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111428668|NCT02512783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111428669|NCT02512783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111428670|NCT02512783|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111428671|NCT02512783|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111428672|NCT02512783|Anesthetics, General|anesthetics, general|mesh-ancestor
111428673|NCT02513095|Dantrolene|dantrolene|mesh-list
111428674|NCT02513095|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
111428675|NCT02513095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111428676|NCT02513095|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111428677|NCT02513095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111428678|NCT02513719|Everolimus|everolimus|mesh-list
111428679|NCT02513719|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111428680|NCT02513719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111428681|NCT02513719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111428682|NCT02513719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111428683|NCT02513719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111428684|NCT02513719|Immunologic Factors|immunologic factors|mesh-ancestor
111428685|NCT02513719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111428686|NCT02513719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111428687|NCT00363727|Ropinirole|ropinirole|mesh-list
111428688|NCT00363727|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111428689|NCT00363727|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111428690|NCT00363727|Dopamine Agonists|dopamine agonists|mesh-ancestor
111428691|NCT00363727|Dopamine Agents|dopamine agents|mesh-ancestor
111428692|NCT00363727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111428693|NCT00363727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111428694|NCT00363727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111428695|NCT04340869|Theobromine|theobromine|mesh-list
111428696|NCT04340869|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111428697|NCT04340869|Autonomic Agents|autonomic agents|mesh-ancestor
111428698|NCT04340869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111428699|NCT04340869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111428700|NCT04340869|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111428701|NCT04340869|Respiratory System Agents|respiratory system agents|mesh-ancestor
111428702|NCT04340869|Vasodilator Agents|vasodilator agents|mesh-ancestor
111428703|NCT00366067|Phenytoin|phenytoin|mesh-list
111428704|NCT00366067|Anticonvulsants|anticonvulsants|mesh-ancestor
110511776|NCT00958841|Hormones|hormones|mesh-ancestor
111428705|NCT00366067|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111428706|NCT00366067|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111428707|NCT00366067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111428708|NCT00366067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111428709|NCT00366067|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
111428710|NCT00366067|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111428711|NCT00364429|Lorazepam|lorazepam|mesh-list
111428712|NCT00364429|Risperidone|risperidone|mesh-list
111428713|NCT00364429|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111428714|NCT00364429|Serotonin Agents|serotonin agents|mesh-ancestor
111428715|NCT00364429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111428716|NCT00364429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111428717|NCT00364429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111428718|NCT00364429|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111428719|NCT00364429|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111428720|NCT00364429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111428721|NCT00364429|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111428722|NCT00364429|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111428723|NCT00364429|Dopamine Agents|dopamine agents|mesh-ancestor
111428724|NCT00364429|Anticonvulsants|anticonvulsants|mesh-ancestor
111428725|NCT00364429|Antiemetics|antiemetics|mesh-ancestor
111428726|NCT00364429|Autonomic Agents|autonomic agents|mesh-ancestor
111428727|NCT00364429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111428728|NCT00364429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111428729|NCT00364429|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111428730|NCT00364429|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111428731|NCT00364429|GABA Modulators|gaba modulators|mesh-ancestor
111428732|NCT00364429|GABA Agents|gaba agents|mesh-ancestor
111428733|NCT02593903|Trimethoprim|trimethoprim|mesh-list
111428734|NCT02593903|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
111428735|NCT02593903|Sulfamethoxazole|sulfamethoxazole|mesh-list
111428736|NCT02593903|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111428737|NCT02593903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111428738|NCT02593903|Antimalarials|antimalarials|mesh-ancestor
111428739|NCT02593903|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111428740|NCT02593903|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111428741|NCT02593903|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111428742|NCT02593903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111428743|NCT02593903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111428744|NCT02593903|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111428745|NCT02593903|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
111428746|NCT02593903|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111428747|NCT02593903|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111428748|NCT02596867|Propranolol|propranolol|mesh-list
111428749|NCT02596867|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111428750|NCT02596867|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111428751|NCT02596867|Adrenergic Agents|adrenergic agents|mesh-ancestor
111428752|NCT02596867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111428753|NCT02596867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111428754|NCT02596867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111428755|NCT02596867|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111428756|NCT02596867|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111428757|NCT02596867|Vasodilator Agents|vasodilator agents|mesh-ancestor
111428758|NCT02597101|Metformin|metformin|mesh-list
111428759|NCT02597101|Saxagliptin|saxagliptin|mesh-list
111428760|NCT02597101|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111428761|NCT02597101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111428762|NCT02597101|Incretins|incretins|mesh-ancestor
111428763|NCT02597101|Hormones|hormones|mesh-ancestor
110511784|NCT02937116|Etoposide|etoposide|mesh-list
111428764|NCT02597101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111428765|NCT02597101|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111428766|NCT02597101|Protease Inhibitors|protease inhibitors|mesh-ancestor
111428767|NCT02597101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111428768|NCT02597101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111428769|NCT02600611|Vancomycin|vancomycin|mesh-list
111428770|NCT02600611|Iclaprim|iclaprim|mesh-list
111428771|NCT02600611|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111428772|NCT02600611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111428773|NCT02600611|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111428774|NCT02600611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111428775|NCT02600611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111428776|NCT02600767|Lumefantrine|lumefantrine|mesh-list
111428777|NCT02600767|Artemether|artemether|mesh-list
111428778|NCT02600767|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
111428779|NCT02600767|Antimalarials|antimalarials|mesh-ancestor
111428780|NCT02600767|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111428781|NCT02600767|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111428782|NCT02600767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111428783|NCT00365287|Cyclosporine|cyclosporine|mesh-list
111428784|NCT00365287|Mycophenolic Acid|mycophenolic acid|mesh-list
111428785|NCT00365287|Cyclophosphamide|cyclophosphamide|mesh-list
111428786|NCT00365287|Fludarabine|fludarabine|mesh-list
111428787|NCT00365287|Fludarabine phosphate|fludarabine phosphate|mesh-list
111428788|NCT00365287|Cyclosporins|cyclosporins|mesh-list
111428789|NCT00365287|Antilymphocyte Serum|antilymphocyte serum|mesh-list
111428790|NCT00365287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111428791|NCT00365287|Immunologic Factors|immunologic factors|mesh-ancestor
111428792|NCT00365287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111428793|NCT00365287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111428794|NCT00365287|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111428795|NCT00365287|Alkylating Agents|alkylating agents|mesh-ancestor
111428796|NCT00365287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111428797|NCT00365287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111428798|NCT00365287|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111428799|NCT00365287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111428800|NCT00365287|Antimetabolites|antimetabolites|mesh-ancestor
111428801|NCT00365287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111428802|NCT00365287|Antifungal Agents|antifungal agents|mesh-ancestor
111428803|NCT00365287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111428804|NCT00365287|Dermatologic Agents|dermatologic agents|mesh-ancestor
111428805|NCT00365287|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111428806|NCT00365287|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111428807|NCT00365287|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111428808|NCT00365287|Antitubercular Agents|antitubercular agents|mesh-ancestor
111428809|NCT00365287|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111428811|NCT04743193|Anesthetics|anesthetics|mesh-ancestor
111428812|NCT04743193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111428813|NCT04743193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111428814|NCT04743193|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111428815|NCT04743193|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111428816|NCT04743193|Anesthetics, General|anesthetics, general|mesh-ancestor
111428817|NCT05572645|Trastuzumab|trastuzumab|mesh-list
111428818|NCT05572645|Pertuzumab|pertuzumab|mesh-list
111428819|NCT05572645|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111428820|NCT05572645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111428821|NCT02608177|Linagliptin|linagliptin|mesh-list
111428822|NCT02608177|Glipizide|glipizide|mesh-list
111428823|NCT02608177|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111428824|NCT02608177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111428825|NCT02608177|Incretins|incretins|mesh-ancestor
111428826|NCT02608177|Hormones|hormones|mesh-ancestor
111428827|NCT02608177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111428828|NCT02608177|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111428829|NCT02608177|Protease Inhibitors|protease inhibitors|mesh-ancestor
111428830|NCT02608177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111428831|NCT02608177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111428832|NCT02608489|Hyaluronic Acid|hyaluronic acid|mesh-list
111428833|NCT02608489|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111428834|NCT02608489|Immunologic Factors|immunologic factors|mesh-ancestor
111428835|NCT02608489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111428836|NCT02608489|Viscosupplements|viscosupplements|mesh-ancestor
111428837|NCT02608489|Protective Agents|protective agents|mesh-ancestor
111428838|NCT02611765|Penicillins|penicillins|mesh-list
111428839|NCT02611765|Penicillin G|penicillin g|mesh-list
111428840|NCT02611765|Penicillin G Benzathine|penicillin g benzathine|mesh-list
111428841|NCT02611765|Penicillin G Procaine|penicillin g procaine|mesh-list
111428842|NCT02611765|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111428843|NCT02611765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111428844|NCT02616523|Lidocaine|lidocaine|mesh-list
111428845|NCT02616523|Fentanyl|fentanyl|mesh-list
111428846|NCT02616523|Dexmedetomidine|dexmedetomidine|mesh-list
111428847|NCT02616523|Anesthetics, Local|anesthetics, local|mesh-ancestor
111428848|NCT02616523|Anesthetics|anesthetics|mesh-ancestor
111428849|NCT02616523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111428850|NCT02616523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111428851|NCT02616523|Sensory System Agents|sensory system agents|mesh-ancestor
111428852|NCT02616523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111428853|NCT02616523|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111428854|NCT02616523|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111428855|NCT02616523|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111428856|NCT02616523|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111428857|NCT02616523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111428858|NCT02616523|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111428859|NCT02616523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111428860|NCT02616523|Analgesics|analgesics|mesh-ancestor
111428861|NCT02616523|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111428862|NCT02616523|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111428863|NCT02616523|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111428864|NCT02616523|Adrenergic Agents|adrenergic agents|mesh-ancestor
111428865|NCT02616523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111428866|NCT02616523|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111428867|NCT02616523|Narcotics|narcotics|mesh-ancestor
111428868|NCT02616523|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111428869|NCT02616523|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111428870|NCT02616523|Anesthetics, General|anesthetics, general|mesh-ancestor
111428871|NCT05732155|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
111428872|NCT05732155|Hallucinogens|hallucinogens|mesh-ancestor
111428873|NCT05732155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111428874|NCT05732155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111428875|NCT05732155|Serotonin Agents|serotonin agents|mesh-ancestor
111428876|NCT05732155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111153236|NCT02421419|Anesthetics|anesthetics|mesh-ancestor
111428877|NCT05732155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111428878|NCT05732155|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111428879|NCT05732155|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111428880|NCT05732155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111428881|NCT05732155|Adrenergic Agents|adrenergic agents|mesh-ancestor
111428882|NCT05528419|Valsartan|valsartan|mesh-list
111428883|NCT05528419|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
111428884|NCT05528419|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111428885|NCT05528419|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111428886|NCT05528419|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111428887|NCT05528419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111428888|NCT05485831|Cannabidiol|cannabidiol|mesh-list
111428889|NCT05485831|Anticonvulsants|anticonvulsants|mesh-ancestor
111428890|NCT05480293|Ranibizumab|ranibizumab|mesh-list
111428891|NCT05480293|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111428892|NCT05480293|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111428893|NCT05480293|Growth Substances|growth substances|mesh-ancestor
111428894|NCT05480293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111428895|NCT05480293|Growth Inhibitors|growth inhibitors|mesh-ancestor
111428896|NCT05480293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111428897|NCT05449327|Rivaroxaban|rivaroxaban|mesh-list
111428898|NCT05449327|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111428899|NCT05449327|Antithrombins|antithrombins|mesh-ancestor
111428900|NCT05449327|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111428901|NCT05449327|Protease Inhibitors|protease inhibitors|mesh-ancestor
111428902|NCT05449327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111428903|NCT05449327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111428904|NCT05449327|Anticoagulants|anticoagulants|mesh-ancestor
111428905|NCT00365755|Cyclophosphamide|cyclophosphamide|mesh-list
111428906|NCT00365755|Melphalan|melphalan|mesh-list
111428907|NCT00365755|Carboplatin|carboplatin|mesh-list
111428908|NCT00365755|Etoposide|etoposide|mesh-list
111428909|NCT00365755|Vincristine|vincristine|mesh-list
111428910|NCT00365755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111428911|NCT00365755|Immunologic Factors|immunologic factors|mesh-ancestor
111428912|NCT00365755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111428913|NCT00365755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111428914|NCT00365755|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111428915|NCT00365755|Alkylating Agents|alkylating agents|mesh-ancestor
111428916|NCT00365755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111428917|NCT00365755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111428918|NCT00365755|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111428919|NCT00365755|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111428920|NCT00365755|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111428921|NCT00365755|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111428922|NCT00365755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111428923|NCT00365755|Tubulin Modulators|tubulin modulators|mesh-ancestor
111428924|NCT00365755|Antimitotic Agents|antimitotic agents|mesh-ancestor
111428925|NCT00365755|Mitosis Modulators|mitosis modulators|mesh-ancestor
111428926|NCT05730907|Simendan|simendan|mesh-list
111428927|NCT05730907|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111428928|NCT05730907|Vasodilator Agents|vasodilator agents|mesh-ancestor
111428929|NCT05730907|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
111428930|NCT05730907|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111428931|NCT05730907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111428932|NCT05730907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111428933|NCT05730907|Protective Agents|protective agents|mesh-ancestor
111428934|NCT05730907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111428935|NCT05355337|Pramipexole|pramipexole|mesh-list
111428936|NCT05355337|Antioxidants|antioxidants|mesh-ancestor
111428937|NCT05355337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111428938|NCT05355337|Protective Agents|protective agents|mesh-ancestor
111428939|NCT05355337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111428940|NCT05355337|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111428941|NCT05355337|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111428942|NCT05355337|Dopamine Agonists|dopamine agonists|mesh-ancestor
111428943|NCT05355337|Dopamine Agents|dopamine agents|mesh-ancestor
111428944|NCT05355337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111428945|NCT04340401|Capecitabine|capecitabine|mesh-list
111428946|NCT04340401|Oxaliplatin|oxaliplatin|mesh-list
111428947|NCT04340401|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111428948|NCT04340401|Antimetabolites|antimetabolites|mesh-ancestor
111428949|NCT04340401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111428950|NCT04340401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111428951|NCT04143607|Gefitinib|gefitinib|mesh-list
111428952|NCT04143607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111428953|NCT04143607|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111428954|NCT04143607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111428955|NCT04143607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111428956|NCT04802863|Imipenem|imipenem|mesh-list
111428957|NCT04802863|Cilastatin|cilastatin|mesh-list
111428958|NCT04802863|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111428959|NCT04802863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111428960|NCT04802863|Protease Inhibitors|protease inhibitors|mesh-ancestor
111428961|NCT04802863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111428962|NCT04802863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111428963|NCT04622839|Acetaminophen|acetaminophen|mesh-list
111428964|NCT04622839|Ibuprofen|ibuprofen|mesh-list
111428965|NCT04622839|Diclofenac|diclofenac|mesh-list
111428966|NCT04622839|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111428967|NCT04622839|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111428968|NCT04622839|Analgesics|analgesics|mesh-ancestor
111428969|NCT04622839|Sensory System Agents|sensory system agents|mesh-ancestor
111428970|NCT04622839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111428971|NCT04622839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111428972|NCT04622839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111428973|NCT04622839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111428974|NCT04622839|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111428975|NCT04622839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111428976|NCT04622839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111428977|NCT04622839|Antipyretics|antipyretics|mesh-ancestor
111428978|NCT02619799|Magnesium Sulfate|magnesium sulfate|mesh-list
111428979|NCT02619799|Midazolam|midazolam|mesh-list
111428980|NCT02619799|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111428981|NCT02619799|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111428982|NCT02619799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111428983|NCT02619799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111428984|NCT02619799|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111428985|NCT02619799|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111428986|NCT02619799|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111428987|NCT02619799|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111428988|NCT02619799|Anesthetics, General|anesthetics, general|mesh-ancestor
111428989|NCT02619799|Anesthetics|anesthetics|mesh-ancestor
111428990|NCT02619799|GABA Modulators|gaba modulators|mesh-ancestor
111428991|NCT02619799|GABA Agents|gaba agents|mesh-ancestor
111428992|NCT02619799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111428993|NCT02619799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111428994|NCT02619799|Analgesics|analgesics|mesh-ancestor
111428995|NCT02619799|Sensory System Agents|sensory system agents|mesh-ancestor
111428996|NCT02619799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111428997|NCT02619799|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111428998|NCT02619799|Anticonvulsants|anticonvulsants|mesh-ancestor
111428999|NCT02619799|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111429000|NCT02619799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111429001|NCT02619799|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111429002|NCT02619799|Tocolytic Agents|tocolytic agents|mesh-ancestor
111429003|NCT02619799|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111429004|NCT04741165|Bevacizumab|bevacizumab|mesh-list
111429005|NCT04741165|Lenvatinib|lenvatinib|mesh-list
111429006|NCT04741165|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111429007|NCT04741165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111429008|NCT04741165|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111429009|NCT04741165|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111429010|NCT04741165|Growth Substances|growth substances|mesh-ancestor
111429011|NCT04741165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111429012|NCT04741165|Growth Inhibitors|growth inhibitors|mesh-ancestor
111429013|NCT04741165|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111429014|NCT04741165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111429015|NCT04741165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111429016|NCT02625181|Promethazine|promethazine|mesh-list
111429017|NCT02625181|Diphenhydramine|diphenhydramine|mesh-list
111429018|NCT02625181|Meclizine|meclizine|mesh-list
111429019|NCT02625181|Dexamethasone|dexamethasone|mesh-list
111429020|NCT02625181|Fentanyl|fentanyl|mesh-list
111429021|NCT02625181|Sufentanil|sufentanil|mesh-list
111429022|NCT02625181|Scopolamine|scopolamine|mesh-list
111429023|NCT02625181|Oxymorphone|oxymorphone|mesh-list
111429024|NCT02625181|Meperidine|meperidine|mesh-list
111429025|NCT02625181|Droperidol|droperidol|mesh-list
111429026|NCT02625181|Ketamine|ketamine|mesh-list
111153388|NCT01621191|Dopamine Agents|dopamine agents|mesh-ancestor
111429027|NCT02625181|Morphine|morphine|mesh-list
111429028|NCT02625181|Remifentanil|remifentanil|mesh-list
111429029|NCT02625181|Oxycodone|oxycodone|mesh-list
111429030|NCT02625181|Methadone|methadone|mesh-list
111429031|NCT02625181|Hydromorphone|hydromorphone|mesh-list
111429032|NCT02625181|Hydrocodone|hydrocodone|mesh-list
111429033|NCT02625181|Alfentanil|alfentanil|mesh-list
111429034|NCT02625181|Haloperidol|haloperidol|mesh-list
111429035|NCT02625181|Ondansetron|ondansetron|mesh-list
111429036|NCT02625181|Aprepitant|aprepitant|mesh-list
111429037|NCT02625181|Metoclopramide|metoclopramide|mesh-list
111429038|NCT02625181|Palonosetron|palonosetron|mesh-list
111429039|NCT02625181|Granisetron|granisetron|mesh-list
111429040|NCT02625181|Ramosetron|ramosetron|mesh-list
111429041|NCT02625181|Tropisetron|tropisetron|mesh-list
111429042|NCT02625181|Dolasetron|dolasetron|mesh-list
111429043|NCT02625181|Anesthetics|anesthetics|mesh-list
111429044|NCT02625181|Propofol|propofol|mesh-list
111429045|NCT02625181|Sevoflurane|sevoflurane|mesh-list
111429046|NCT02625181|Desflurane|desflurane|mesh-list
111429047|NCT02625181|Isoflurane|isoflurane|mesh-list
111429048|NCT02625181|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
111429049|NCT02625181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111429050|NCT02625181|Antiemetics|antiemetics|mesh-ancestor
111429051|NCT02625181|Autonomic Agents|autonomic agents|mesh-ancestor
111429052|NCT02625181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111429053|NCT02625181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111429054|NCT02625181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111429055|NCT02625181|Glucocorticoids|glucocorticoids|mesh-ancestor
111429056|NCT02625181|Hormones|hormones|mesh-ancestor
111429057|NCT02625181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111429058|NCT02625181|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111429059|NCT02625181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111429060|NCT02625181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111429061|NCT02625181|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111429062|NCT02625181|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111429063|NCT02625181|Anesthetics, General|anesthetics, general|mesh-ancestor
111429064|NCT02625181|Analgesics|analgesics|mesh-ancestor
111429065|NCT02625181|Sensory System Agents|sensory system agents|mesh-ancestor
111429066|NCT02625181|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111429067|NCT02625181|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111429068|NCT02625181|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111429069|NCT02625181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111429070|NCT02625181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111429071|NCT02625181|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111429072|NCT02625181|Narcotics|narcotics|mesh-ancestor
111429073|NCT02625181|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111429074|NCT02625181|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111429075|NCT02625181|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111429076|NCT02625181|Antipruritics|antipruritics|mesh-ancestor
111429077|NCT02625181|Dermatologic Agents|dermatologic agents|mesh-ancestor
111429078|NCT02625181|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111429079|NCT02625181|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111429080|NCT02625181|Serotonin Agents|serotonin agents|mesh-ancestor
111429081|NCT02625181|Antitussive Agents|antitussive agents|mesh-ancestor
111429082|NCT02625181|Respiratory System Agents|respiratory system agents|mesh-ancestor
111429083|NCT02625181|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
111429084|NCT02625181|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111429085|NCT02625181|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111429086|NCT02625181|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111429087|NCT02625181|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111429088|NCT02625181|Dopamine Agents|dopamine agents|mesh-ancestor
111429089|NCT02625181|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111429090|NCT02625181|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111429091|NCT02625181|Mydriatics|mydriatics|mesh-ancestor
111429092|NCT02625181|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111429093|NCT02625181|Cholinergic Agents|cholinergic agents|mesh-ancestor
111429094|NCT02625181|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111429095|NCT02625181|Parasympatholytics|parasympatholytics|mesh-ancestor
111429096|NCT02625181|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111429097|NCT02625181|Histamine Antagonists|histamine antagonists|mesh-ancestor
111429098|NCT02625181|Histamine Agents|histamine agents|mesh-ancestor
111429099|NCT02625181|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111429100|NCT02625181|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111429101|NCT02625181|Anesthetics, Local|anesthetics, local|mesh-ancestor
111429102|NCT02630017|Methylphenidate|methylphenidate|mesh-list
111429103|NCT02630017|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111429104|NCT02630017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111429105|NCT02630017|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111429106|NCT02630017|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111429107|NCT02630017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111429108|NCT02630017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111429109|NCT02630017|Dopamine Agents|dopamine agents|mesh-ancestor
111429110|NCT02630017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111429111|NCT02630719|Timolol|timolol|mesh-list
111429112|NCT02630719|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111429113|NCT02630719|Lubricant Eye Drops|lubricant eye drops|mesh-list
111429114|NCT02630719|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111429115|NCT02630719|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111429116|NCT02630719|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111429117|NCT02630719|Adrenergic Agents|adrenergic agents|mesh-ancestor
111429118|NCT02630719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111429119|NCT02630719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111429120|NCT02630719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111429121|NCT02630719|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111429122|NCT02630719|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111429123|NCT02633371|Oxybutynin|oxybutynin|mesh-list
111429124|NCT02633371|Parasympatholytics|parasympatholytics|mesh-ancestor
111429125|NCT02633371|Autonomic Agents|autonomic agents|mesh-ancestor
111429126|NCT02633371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111429127|NCT02633371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111429128|NCT02633371|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111429129|NCT02633371|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111429130|NCT02633371|Cholinergic Agents|cholinergic agents|mesh-ancestor
111429131|NCT02633371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111429132|NCT02633371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111429133|NCT02633371|Urological Agents|urological agents|mesh-ancestor
111429134|NCT04159519|Budesonide|budesonide|mesh-list
111429135|NCT04159519|Albuterol|albuterol|mesh-list
111429136|NCT04159519|Formoterol Fumarate|formoterol fumarate|mesh-list
111429137|NCT04159519|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
111429138|NCT04159519|Benralizumab|benralizumab|mesh-list
111429139|NCT04159519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111429140|NCT04159519|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111429141|NCT04159519|Autonomic Agents|autonomic agents|mesh-ancestor
111429142|NCT04159519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111429143|NCT04159519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111429144|NCT04159519|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111429145|NCT04159519|Respiratory System Agents|respiratory system agents|mesh-ancestor
111429146|NCT04159519|Glucocorticoids|glucocorticoids|mesh-ancestor
111429147|NCT04159519|Hormones|hormones|mesh-ancestor
111429148|NCT04159519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111429149|NCT04159519|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111429150|NCT04159519|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111429151|NCT04159519|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111429152|NCT04159519|Adrenergic Agents|adrenergic agents|mesh-ancestor
111429153|NCT04159519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111429154|NCT04159519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111429155|NCT04159519|Tocolytic Agents|tocolytic agents|mesh-ancestor
111429156|NCT04159519|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111429157|NCT04913311|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
111429158|NCT04913311|Dimercaprol|dimercaprol|mesh-list
111429159|NCT04913311|Chelating Agents|chelating agents|mesh-ancestor
111429160|NCT04913311|Sequestering Agents|sequestering agents|mesh-ancestor
111429161|NCT04913311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111429162|NCT04913311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111429163|NCT04913311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111429164|NCT02634073|Lamivudine|lamivudine|mesh-list
111429165|NCT02634073|Sorbitol|sorbitol|mesh-list
111429166|NCT02634073|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111429167|NCT02634073|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111429168|NCT02634073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111429169|NCT02634073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111429170|NCT02634073|Antiviral Agents|antiviral agents|mesh-ancestor
111429171|NCT02634073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111429172|NCT02634073|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111429173|NCT02634073|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111429174|NCT02634073|Cathartics|cathartics|mesh-ancestor
111429175|NCT02634073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111429176|NCT00366691|Loteprednol Etabonate|loteprednol etabonate|mesh-list
111429177|NCT00366691|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111429178|NCT00367393|Pimecrolimus|pimecrolimus|mesh-list
111429179|NCT00367393|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111429180|NCT00367393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111429181|NCT00367393|Analgesics|analgesics|mesh-ancestor
111429182|NCT00367393|Sensory System Agents|sensory system agents|mesh-ancestor
111429183|NCT00367393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111429184|NCT00367393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111429185|NCT00367393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111429186|NCT00367393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111429187|NCT00367393|Dermatologic Agents|dermatologic agents|mesh-ancestor
111429188|NCT00367393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111429189|NCT00367393|Immunologic Factors|immunologic factors|mesh-ancestor
111429190|NCT00367393|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111429191|NCT00367393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111429192|NCT00367393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111429194|NCT00367471|Carboplatin|carboplatin|mesh-list
111429195|NCT00367471|Trastuzumab|trastuzumab|mesh-list
111429196|NCT00367471|Lapatinib|lapatinib|mesh-list
111429197|NCT00367471|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111429198|NCT00367471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111429199|NCT00367471|Tubulin Modulators|tubulin modulators|mesh-ancestor
111429200|NCT00367471|Antimitotic Agents|antimitotic agents|mesh-ancestor
111429201|NCT00367471|Mitosis Modulators|mitosis modulators|mesh-ancestor
111429202|NCT00367471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111429203|NCT00367471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111429204|NCT00367471|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111429205|NCT00367471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111429206|NCT02207244|Adalimumab|adalimumab|mesh-list
111429207|NCT02207244|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111429208|NCT02207244|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111429209|NCT02207244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111429210|NCT02207244|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111429211|NCT02207244|Immunologic Factors|immunologic factors|mesh-ancestor
111429212|NCT02207244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111429213|NCT02207088|Ritonavir|ritonavir|mesh-list
111429214|NCT02207088|Ribavirin|ribavirin|mesh-list
111429215|NCT02207088|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111429216|NCT02207088|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111429217|NCT02207088|Protease Inhibitors|protease inhibitors|mesh-ancestor
111429218|NCT02207088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111429219|NCT02207088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111429220|NCT02207088|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111429221|NCT02207088|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111429222|NCT02207088|Antiviral Agents|antiviral agents|mesh-ancestor
111429223|NCT02207088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111429224|NCT02207088|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111429225|NCT02207088|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111429226|NCT02207088|Antimetabolites|antimetabolites|mesh-ancestor
111429227|NCT02638597|Gemfibrozil|gemfibrozil|mesh-list
111429228|NCT02638597|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111429229|NCT02638597|Antimetabolites|antimetabolites|mesh-ancestor
111429230|NCT02638597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111429231|NCT02638597|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111429232|NCT02638597|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
111429233|NCT02638597|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111429234|NCT02638597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111429235|NCT02206620|Donepezil|donepezil|mesh-list
111429236|NCT02206620|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111429237|NCT02206620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111429238|NCT02206620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111429239|NCT02206620|Cholinergic Agents|cholinergic agents|mesh-ancestor
111429240|NCT02206620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111429241|NCT02206620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111429242|NCT02206620|Nootropic Agents|nootropic agents|mesh-ancestor
111429243|NCT02239926|Ranolazine|ranolazine|mesh-list
111429244|NCT02239926|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111429245|NCT02239926|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111429246|NCT02239926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111429247|NCT02239692|Picosulfate sodium|picosulfate sodium|mesh-list
111429248|NCT02239692|Cathartics|cathartics|mesh-ancestor
111429249|NCT02239692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111429250|NCT02641561|Indomethacin|indomethacin|mesh-list
111429251|NCT02641561|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111429252|NCT02641561|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111429253|NCT02641561|Analgesics|analgesics|mesh-ancestor
111429254|NCT02641561|Sensory System Agents|sensory system agents|mesh-ancestor
111429255|NCT02641561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111429256|NCT02641561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111429257|NCT02641561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111429258|NCT02641561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111429260|NCT02641561|Tocolytic Agents|tocolytic agents|mesh-ancestor
111429261|NCT02641561|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111429262|NCT02641561|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111429263|NCT02641561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111429264|NCT02641561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111429265|NCT02206152|Acetylcysteine|acetylcysteine|mesh-list
111429266|NCT02206152|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111429267|NCT02206152|Antiviral Agents|antiviral agents|mesh-ancestor
111429268|NCT02206152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111429269|NCT02206152|Expectorants|expectorants|mesh-ancestor
111429270|NCT02206152|Respiratory System Agents|respiratory system agents|mesh-ancestor
111429271|NCT02206152|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111429272|NCT02206152|Antioxidants|antioxidants|mesh-ancestor
111429273|NCT02206152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111429274|NCT02206152|Protective Agents|protective agents|mesh-ancestor
111429275|NCT02206152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111429276|NCT02206152|Antidotes|antidotes|mesh-ancestor
111429277|NCT00367081|Pyrimethamine|pyrimethamine|mesh-list
111429278|NCT00367081|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
111429279|NCT00367081|Sulfadiazine|sulfadiazine|mesh-list
111429280|NCT00367081|Antimalarials|antimalarials|mesh-ancestor
111429281|NCT00367081|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111429282|NCT00367081|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111429283|NCT00367081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111429284|NCT00367081|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111429285|NCT00367081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111429286|NCT00367081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111429287|NCT00367081|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111429288|NCT00367081|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111429289|NCT00367081|Coccidiostats|coccidiostats|mesh-ancestor
111429290|NCT04146571|Ensartinib|ensartinib|mesh-list
111429291|NCT04146571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111429292|NCT04146571|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111429293|NCT04146571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111429294|NCT04146571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111429295|NCT05342376|Dexmedetomidine|dexmedetomidine|mesh-list
111429296|NCT05342376|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111429297|NCT05342376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111429298|NCT05342376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111429299|NCT05342376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111429300|NCT05342376|Analgesics|analgesics|mesh-ancestor
111429301|NCT05342376|Sensory System Agents|sensory system agents|mesh-ancestor
111429302|NCT05342376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111429303|NCT05342376|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111429304|NCT05342376|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111429305|NCT05342376|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111429306|NCT05342376|Adrenergic Agents|adrenergic agents|mesh-ancestor
111429307|NCT05342376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111429308|NCT05342376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111429309|NCT02237196|Immunomodulating Agents|immunomodulating agents|mesh-list
111429310|NCT02237196|Immunologic Factors|immunologic factors|mesh-list
111429311|NCT02237196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111429312|NCT04776096|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
111429313|NCT04776096|Bepotastine besilate|bepotastine besilate|mesh-list
111429314|NCT04776096|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111429315|NCT04776096|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111429316|NCT04776096|Analgesics|analgesics|mesh-ancestor
111429317|NCT04776096|Sensory System Agents|sensory system agents|mesh-ancestor
111429318|NCT04776096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111429319|NCT04776096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111429320|NCT04776096|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111429321|NCT04776096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111429322|NCT04776096|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111429323|NCT04776096|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
111429324|NCT04776096|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111429325|NCT04776096|Histamine Antagonists|histamine antagonists|mesh-ancestor
111429326|NCT04776096|Histamine Agents|histamine agents|mesh-ancestor
111429327|NCT04776096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111429328|NCT04776096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111429329|NCT03260491|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
111429330|NCT03260491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111153685|NCT01785160|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111429331|NCT03260491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111429332|NCT03250273|Nivolumab|nivolumab|mesh-list
111429333|NCT03250273|Entinostat|entinostat|mesh-list
111429334|NCT03250273|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111429335|NCT03250273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111429336|NCT03250273|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111429337|NCT03250273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111429338|NCT03250273|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111429339|NCT03250273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111429340|NCT02203032|Ustekinumab|ustekinumab|mesh-list
111429341|NCT02203032|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111429342|NCT02203032|Dermatologic Agents|dermatologic agents|mesh-ancestor
111429343|NCT02203032|Immunologic Factors|immunologic factors|mesh-ancestor
111429344|NCT02203032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111429345|NCT02169414|Levodopa|levodopa|mesh-list
111429346|NCT02169414|Carbidopa|carbidopa|mesh-list
111429347|NCT02169414|Opicapone|opicapone|mesh-list
111429348|NCT02169414|Benserazide|benserazide|mesh-list
111429349|NCT02169414|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111429350|NCT02169414|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111429351|NCT02169414|Dopamine Agents|dopamine agents|mesh-ancestor
111429352|NCT02169414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111429353|NCT02169414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111429354|NCT02169414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111429355|NCT02169414|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
111429356|NCT02169414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111429357|NCT02169414|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
111429358|NCT03213457|Norethindrone|norethindrone|mesh-list
111429359|NCT03213457|Norethindrone Acetate|norethindrone acetate|mesh-list
111429360|NCT03213457|Estradiol|estradiol|mesh-list
111429361|NCT03213457|Estrogens|estrogens|mesh-ancestor
111429362|NCT03213457|Hormones|hormones|mesh-ancestor
111429363|NCT03213457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111429364|NCT03213457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111429365|NCT03213457|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111429366|NCT03213457|Contraceptive Agents|contraceptive agents|mesh-ancestor
111429367|NCT03213457|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111429368|NCT03213457|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111429369|NCT03213457|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111429370|NCT03213457|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111429371|NCT03213457|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111429372|NCT02201940|Sofosbuvir|sofosbuvir|mesh-list
111429373|NCT02201940|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
111429374|NCT02201940|Velpatasvir|velpatasvir|mesh-list
111429375|NCT02201940|Antiviral Agents|antiviral agents|mesh-ancestor
111429376|NCT02201940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111429377|NCT05588869|Cyclosporine|cyclosporine|mesh-list
111429378|NCT05588869|Cyclosporins|cyclosporins|mesh-list
111429379|NCT05588869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111429380|NCT05588869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111429381|NCT05588869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111429382|NCT05588869|Immunologic Factors|immunologic factors|mesh-ancestor
111429383|NCT05588869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111429384|NCT05588869|Antifungal Agents|antifungal agents|mesh-ancestor
111429385|NCT05588869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111429386|NCT05588869|Dermatologic Agents|dermatologic agents|mesh-ancestor
111429387|NCT05588869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111429388|NCT05588869|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111429389|NCT02169336|Dexmedetomidine|dexmedetomidine|mesh-list
111429390|NCT02169336|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111429391|NCT02169336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111429392|NCT02169336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111429393|NCT02169336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111429394|NCT02169336|Analgesics|analgesics|mesh-ancestor
111429395|NCT02169336|Sensory System Agents|sensory system agents|mesh-ancestor
111429396|NCT02169336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111429397|NCT02169336|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111429398|NCT02169336|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111429399|NCT02169336|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111429400|NCT02169336|Adrenergic Agents|adrenergic agents|mesh-ancestor
111429401|NCT02169336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111429402|NCT02169336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111429403|NCT03043807|Docetaxel|docetaxel|mesh-list
111429404|NCT03043807|Leuprolide|leuprolide|mesh-list
111429405|NCT03043807|Abiraterone Acetate|abiraterone acetate|mesh-list
111429406|NCT03043807|Bicalutamide|bicalutamide|mesh-list
111429407|NCT03043807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111429408|NCT03043807|Tubulin Modulators|tubulin modulators|mesh-ancestor
111429409|NCT03043807|Antimitotic Agents|antimitotic agents|mesh-ancestor
111429410|NCT03043807|Mitosis Modulators|mitosis modulators|mesh-ancestor
111429411|NCT03043807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111429412|NCT03043807|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111429413|NCT03043807|Fertility Agents|fertility agents|mesh-ancestor
111429414|NCT03043807|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111429415|NCT03043807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111429416|NCT03043807|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111429417|NCT03043807|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111429418|NCT03043807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111429419|NCT03043807|Hormone Antagonists|hormone antagonists|mesh-ancestor
111429420|NCT03043807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111429421|NCT03043807|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111429422|NCT03043807|Androgen Antagonists|androgen antagonists|mesh-ancestor
111429424|NCT02609828|Analgesics|analgesics|mesh-ancestor
111429425|NCT02609828|Sensory System Agents|sensory system agents|mesh-ancestor
111429426|NCT02609828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111429427|NCT02609828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111429428|NCT05588557|Bupivacaine|bupivacaine|mesh-list
111429429|NCT05588557|Anesthetics, Local|anesthetics, local|mesh-ancestor
111429430|NCT05588557|Anesthetics|anesthetics|mesh-ancestor
111429431|NCT05588557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111429432|NCT05588557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111429433|NCT05588557|Sensory System Agents|sensory system agents|mesh-ancestor
111429434|NCT05588557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111429435|NCT01632306|Leucovorin|leucovorin|mesh-list
111429436|NCT01632306|Paclitaxel|paclitaxel|mesh-list
111429437|NCT01632306|Gemcitabine|gemcitabine|mesh-list
111429438|NCT01632306|Fluorouracil|fluorouracil|mesh-list
111429439|NCT01632306|Oxaliplatin|oxaliplatin|mesh-list
111429440|NCT01632306|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111429441|NCT01632306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111429442|NCT01632306|Tubulin Modulators|tubulin modulators|mesh-ancestor
111429443|NCT01632306|Antimitotic Agents|antimitotic agents|mesh-ancestor
111429444|NCT01632306|Mitosis Modulators|mitosis modulators|mesh-ancestor
111429445|NCT01632306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111429446|NCT01632306|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110511899|NCT00630851|Donepezil|donepezil|mesh-list
111429447|NCT01632306|Antimetabolites|antimetabolites|mesh-ancestor
111429448|NCT01632306|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111429449|NCT01632306|Immunologic Factors|immunologic factors|mesh-ancestor
111429450|NCT01632306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111429451|NCT01632306|Antidotes|antidotes|mesh-ancestor
111429452|NCT01632306|Protective Agents|protective agents|mesh-ancestor
111429453|NCT01632306|Vitamin B Complex|vitamin b complex|mesh-ancestor
111429454|NCT01632306|Vitamins|vitamins|mesh-ancestor
111429455|NCT01632306|Micronutrients|micronutrients|mesh-ancestor
111429456|NCT02201784|Ropivacaine|ropivacaine|mesh-list
111429457|NCT02201784|Levobupivacaine|levobupivacaine|mesh-list
111429458|NCT02201784|Anesthetics, Local|anesthetics, local|mesh-ancestor
111429459|NCT02201784|Anesthetics|anesthetics|mesh-ancestor
111429460|NCT02201784|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111429461|NCT02201784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111429462|NCT02201784|Sensory System Agents|sensory system agents|mesh-ancestor
111429463|NCT02201784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111429464|NCT05587933|Parasympatholytics|parasympatholytics|mesh-list
111429465|NCT05587933|Autonomic Agents|autonomic agents|mesh-ancestor
111429466|NCT05587933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111429467|NCT05587933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111429468|NCT02018263|Cocaine|cocaine|mesh-list
111429469|NCT02018263|Nicotine|nicotine|mesh-list
111429470|NCT02018263|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111429471|NCT02018263|Autonomic Agents|autonomic agents|mesh-ancestor
111429472|NCT02018263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111429473|NCT02018263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111429474|NCT02018263|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111429475|NCT02018263|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111429476|NCT02018263|Cholinergic Agents|cholinergic agents|mesh-ancestor
111429477|NCT02018263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111429478|NCT02018263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111429479|NCT02018263|Anesthetics, Local|anesthetics, local|mesh-ancestor
111429480|NCT02018263|Anesthetics|anesthetics|mesh-ancestor
111429481|NCT02018263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111429482|NCT02018263|Sensory System Agents|sensory system agents|mesh-ancestor
111429483|NCT02018263|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111429484|NCT02018263|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111429485|NCT02018263|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111429486|NCT02018263|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111429487|NCT02018263|Dopamine Agents|dopamine agents|mesh-ancestor
111429488|NCT02168946|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111429489|NCT02168946|Meropenem|meropenem|mesh-list
111429490|NCT02168946|Vaborbactam|vaborbactam|mesh-list
111429491|NCT02168946|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
111429492|NCT02168946|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-list
111429493|NCT02168946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111429494|NCT02168946|Antitubercular Agents|antitubercular agents|mesh-ancestor
111429495|NCT02168946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111429496|NCT02168946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111429497|NCT02650856|Tranexamic Acid|tranexamic acid|mesh-list
111429498|NCT02650856|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111429499|NCT02650856|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111429500|NCT02650856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111429501|NCT02650856|Hemostatics|hemostatics|mesh-ancestor
111429502|NCT02650856|Coagulants|coagulants|mesh-ancestor
111429503|NCT02168478|Neomycin|neomycin|mesh-list
111429504|NCT02168478|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111429505|NCT02168478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111429506|NCT02168478|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111429507|NCT02168478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111429508|NCT02168478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111429509|NCT00367874|Buprenorphine|buprenorphine|mesh-list
111429510|NCT00367874|Valproic Acid|valproic acid|mesh-list
111429511|NCT00367874|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111429512|NCT00367874|Narcotics|narcotics|mesh-ancestor
111429513|NCT00367874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111429514|NCT00367874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111429515|NCT00367874|Analgesics|analgesics|mesh-ancestor
111429516|NCT00367874|Sensory System Agents|sensory system agents|mesh-ancestor
111429517|NCT00367874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111429518|NCT00367874|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111429519|NCT00367874|Anticonvulsants|anticonvulsants|mesh-ancestor
111429520|NCT00367874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110511901|NCT00630851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111429521|NCT00367874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111429522|NCT00367874|GABA Agents|gaba agents|mesh-ancestor
111429523|NCT00367874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111429524|NCT00367874|Antimanic Agents|antimanic agents|mesh-ancestor
111429525|NCT00367874|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111429526|NCT00367874|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111429527|NCT00367562|Valsartan|valsartan|mesh-list
111429528|NCT00367562|Enalapril|enalapril|mesh-list
111429529|NCT00367562|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111429530|NCT00367562|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111429531|NCT00367562|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111429532|NCT00367562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111429533|NCT00367562|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
111429534|NCT00367562|Protease Inhibitors|protease inhibitors|mesh-ancestor
111429535|NCT00367562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111429536|NCT02302976|Exenatide|exenatide|mesh-list
111429537|NCT02302976|Cocaine|cocaine|mesh-list
111429538|NCT02302976|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111429539|NCT02302976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111429540|NCT02302976|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111429541|NCT02302976|Incretins|incretins|mesh-ancestor
111429542|NCT02302976|Hormones|hormones|mesh-ancestor
111429543|NCT02302976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111429544|NCT02302976|Anesthetics, Local|anesthetics, local|mesh-ancestor
111429545|NCT02302976|Anesthetics|anesthetics|mesh-ancestor
111429546|NCT02302976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111429547|NCT02302976|Sensory System Agents|sensory system agents|mesh-ancestor
111429548|NCT02302976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111429549|NCT02302976|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111429550|NCT02302976|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111429551|NCT02302976|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111429552|NCT02302976|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111429553|NCT02302976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111429554|NCT02302976|Dopamine Agents|dopamine agents|mesh-ancestor
111429555|NCT02302976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111429556|NCT05073692|Liraglutide|liraglutide|mesh-list
111429557|NCT05073692|Empagliflozin|empagliflozin|mesh-list
111429558|NCT05073692|Exenatide|exenatide|mesh-list
111429559|NCT05073692|Glimepiride|glimepiride|mesh-list
111429560|NCT05073692|Linagliptin|linagliptin|mesh-list
111429561|NCT05073692|Saxagliptin|saxagliptin|mesh-list
111429562|NCT05073692|Alogliptin|alogliptin|mesh-list
111429563|NCT05073692|Glipizide|glipizide|mesh-list
111429564|NCT05073692|Glucagon|glucagon|mesh-list
111429565|NCT05073692|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
111429566|NCT05073692|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111429567|NCT05073692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111429568|NCT05073692|Incretins|incretins|mesh-ancestor
111429569|NCT05073692|Hormones|hormones|mesh-ancestor
111429570|NCT05073692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111429571|NCT05073692|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111429572|NCT05073692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111429573|NCT05073692|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111429574|NCT05073692|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111429575|NCT05073692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111429576|NCT05073692|Immunologic Factors|immunologic factors|mesh-ancestor
111429577|NCT05073692|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111429578|NCT05073692|Protease Inhibitors|protease inhibitors|mesh-ancestor
111429579|NCT05073692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111429580|NCT05073692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111429581|NCT02244164|Liraglutide|liraglutide|mesh-list
111429582|NCT02244164|Exenatide|exenatide|mesh-list
111429583|NCT02244164|Lixisenatide|lixisenatide|mesh-list
111429584|NCT02244164|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
111429585|NCT02244164|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111429586|NCT02244164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111429587|NCT02244164|Incretins|incretins|mesh-ancestor
111429588|NCT02244164|Hormones|hormones|mesh-ancestor
111429589|NCT02244164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111429590|NCT02244164|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111429591|NCT02244164|Protease Inhibitors|protease inhibitors|mesh-ancestor
111429592|NCT02244164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111429593|NCT02244164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111429594|NCT02152670|Raclopride|raclopride|mesh-list
111429595|NCT02152670|Methylphenidate|methylphenidate|mesh-list
111429596|NCT02152670|alpha-Methyltyrosine|alpha-methyltyrosine|mesh-list
111429597|NCT02152670|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111429598|NCT02152670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111429599|NCT02152670|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111429600|NCT02152670|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111429601|NCT02152670|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111429602|NCT02152670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111429603|NCT02152670|Dopamine Agents|dopamine agents|mesh-ancestor
111429604|NCT02152670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111429605|NCT02152670|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111429606|NCT02152670|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111429607|NCT02152670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111429608|NCT02152670|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111429609|NCT02152670|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111429610|NCT02152670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111429611|NCT02028806|Leucovorin|leucovorin|mesh-list
111429612|NCT02028806|Oxaliplatin|oxaliplatin|mesh-list
111429613|NCT02028806|Irinotecan|irinotecan|mesh-list
111429614|NCT02028806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111429615|NCT02028806|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111429616|NCT02028806|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111429617|NCT02028806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111429618|NCT02028806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111429619|NCT02028806|Antidotes|antidotes|mesh-ancestor
111429620|NCT02028806|Protective Agents|protective agents|mesh-ancestor
111429621|NCT02028806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111429622|NCT02028806|Vitamin B Complex|vitamin b complex|mesh-ancestor
111429623|NCT02028806|Vitamins|vitamins|mesh-ancestor
111429624|NCT02028806|Micronutrients|micronutrients|mesh-ancestor
111429625|NCT01756118|Dactolisib|dactolisib|mesh-list
111429626|NCT01756118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111429627|NCT04339712|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
111429628|NCT04339712|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111429629|NCT02656160|4-Aminopyridine|4-aminopyridine|mesh-list
111429630|NCT02656160|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
111429631|NCT02656160|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111429632|NCT02656160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111429633|NCT02657252|Polidocanol|polidocanol|mesh-list
111429634|NCT02657252|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
111429635|NCT02657252|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111429637|NCT04740086|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111429638|NCT04740086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111429639|NCT04739618|Pembrolizumab|pembrolizumab|mesh-list
111429640|NCT04739618|Ipilimumab|ipilimumab|mesh-list
111429641|NCT04739618|Sargramostim|sargramostim|mesh-list
111429642|NCT04739618|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111429643|NCT04739618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111429644|NCT04739618|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111429645|NCT04739618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111429646|NCT04739618|Immunologic Factors|immunologic factors|mesh-ancestor
111429647|NCT04739618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111429648|NCT02684942|Fentanyl|fentanyl|mesh-list
111429649|NCT02684942|Meperidine|meperidine|mesh-list
111429650|NCT02684942|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111429651|NCT02684942|Narcotics|narcotics|mesh-ancestor
111429652|NCT02684942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111429653|NCT02684942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111429654|NCT02684942|Analgesics|analgesics|mesh-ancestor
111429655|NCT02684942|Sensory System Agents|sensory system agents|mesh-ancestor
111429656|NCT02684942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111429657|NCT02684942|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111429658|NCT02684942|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111429659|NCT02684942|Anesthetics, General|anesthetics, general|mesh-ancestor
111429660|NCT02684942|Anesthetics|anesthetics|mesh-ancestor
111429661|NCT04739774|Itraconazole|itraconazole|mesh-list
111429662|NCT04739774|Antifungal Agents|antifungal agents|mesh-ancestor
111429663|NCT04739774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111429664|NCT04739774|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111429665|NCT04739774|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111429666|NCT04739774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111429667|NCT04739774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111429668|NCT04739774|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111429669|NCT04739774|Hormone Antagonists|hormone antagonists|mesh-ancestor
111429670|NCT04739774|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111429671|NCT04739774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111429672|NCT04739774|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111429673|NCT02660918|Bupivacaine|bupivacaine|mesh-list
111429674|NCT02660918|Anesthetics, Local|anesthetics, local|mesh-ancestor
111429675|NCT02660918|Anesthetics|anesthetics|mesh-ancestor
111429676|NCT02660918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111429677|NCT02660918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111429678|NCT02660918|Sensory System Agents|sensory system agents|mesh-ancestor
111429679|NCT02660918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111429680|NCT00367315|Lumiracoxib|lumiracoxib|mesh-list
111429681|NCT00367315|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111429682|NCT00367315|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111429683|NCT00367315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111429684|NCT00367315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111429685|NCT00367315|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111429686|NCT00367315|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111429687|NCT00367315|Analgesics|analgesics|mesh-ancestor
111429688|NCT00367315|Sensory System Agents|sensory system agents|mesh-ancestor
111429689|NCT00367315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111429690|NCT00367315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111429691|NCT00367315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111429692|NCT00367315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111429693|NCT01192555|Cyclophosphamide|cyclophosphamide|mesh-list
111429694|NCT01192555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111429695|NCT01192555|Immunologic Factors|immunologic factors|mesh-ancestor
111429696|NCT01192555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111429697|NCT01192555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111429698|NCT01192555|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111429699|NCT01192555|Alkylating Agents|alkylating agents|mesh-ancestor
111429700|NCT01192555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111429701|NCT01192555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111429702|NCT01192555|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111429703|NCT05441761|Dexamethasone|dexamethasone|mesh-list
111429704|NCT05441761|Gemcitabine|gemcitabine|mesh-list
111429705|NCT05441761|Mitoxantrone|mitoxantrone|mesh-list
111429706|NCT05441761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111429707|NCT05441761|Antiemetics|antiemetics|mesh-ancestor
111429708|NCT05441761|Autonomic Agents|autonomic agents|mesh-ancestor
111154054|NCT02360111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111429709|NCT05441761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111429710|NCT05441761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111429711|NCT05441761|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111429712|NCT05441761|Glucocorticoids|glucocorticoids|mesh-ancestor
111429713|NCT05441761|Hormones|hormones|mesh-ancestor
111429714|NCT05441761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111429715|NCT05441761|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111429716|NCT05441761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111429717|NCT05441761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111429718|NCT05441761|Antimetabolites|antimetabolites|mesh-ancestor
111429719|NCT05441761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111429720|NCT05441761|Analgesics|analgesics|mesh-ancestor
111429721|NCT05441761|Sensory System Agents|sensory system agents|mesh-ancestor
111429722|NCT05441761|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111429723|NCT05441761|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111429724|NCT05441761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111429725|NCT05587621|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
111429726|NCT05587621|Ezetimibe|ezetimibe|mesh-list
111429727|NCT05587621|Evolocumab|evolocumab|mesh-list
111429728|NCT05587621|Alirocumab|alirocumab|mesh-list
111429729|NCT05587621|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111429730|NCT05587621|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111429731|NCT05587621|Antimetabolites|antimetabolites|mesh-ancestor
111429732|NCT05587621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111429733|NCT05587621|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111429734|NCT05587621|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
111429735|NCT05587621|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111429736|NCT05587621|Protease Inhibitors|protease inhibitors|mesh-ancestor
111429737|NCT05587621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111429738|NCT05587621|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111429739|NCT05587621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111429740|NCT04739215|Dapagliflozin|dapagliflozin|mesh-list
111429741|NCT04739215|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111429742|NCT04739215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111429743|NCT04739215|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111429744|NCT04739215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111429745|NCT02688829|Sirolimus|sirolimus|mesh-list
111429746|NCT02688829|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111429747|NCT02688829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111429748|NCT02688829|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111429749|NCT02688829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111429750|NCT02688829|Antifungal Agents|antifungal agents|mesh-ancestor
111429751|NCT02688829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111429752|NCT02688829|Immunologic Factors|immunologic factors|mesh-ancestor
111429753|NCT02688829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111429754|NCT02688842|Sirolimus|sirolimus|mesh-list
111429755|NCT02688842|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111429756|NCT02688842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111429757|NCT02688842|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111429758|NCT02688842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111429759|NCT02688842|Antifungal Agents|antifungal agents|mesh-ancestor
111429760|NCT02688842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111429761|NCT02688842|Immunologic Factors|immunologic factors|mesh-ancestor
111429762|NCT02688842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111429763|NCT02689063|Acetaminophen|acetaminophen|mesh-list
111429764|NCT02689063|Ibuprofen|ibuprofen|mesh-list
111429765|NCT02689063|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111429766|NCT02689063|Analgesics|analgesics|mesh-ancestor
111429767|NCT02689063|Sensory System Agents|sensory system agents|mesh-ancestor
111429768|NCT02689063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111429769|NCT02689063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111429770|NCT02689063|Antipyretics|antipyretics|mesh-ancestor
111429771|NCT02689063|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111429772|NCT02689063|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111429773|NCT02689063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111429774|NCT02689063|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111429775|NCT02689063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111429776|NCT02689063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111429777|NCT02690935|Immunomodulating Agents|immunomodulating agents|mesh-list
111429778|NCT02690935|Immunologic Factors|immunologic factors|mesh-ancestor
111429779|NCT02690935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111429780|NCT00367861|Imatinib Mesylate|imatinib mesylate|mesh-list
111429781|NCT00367861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111429782|NCT00367861|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111429783|NCT00367861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111429784|NCT00367861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111429785|NCT02666846|Ibuprofen|ibuprofen|mesh-list
111429786|NCT02666846|Diclofenac|diclofenac|mesh-list
111429787|NCT02666846|Salicylates|salicylates|mesh-list
111429788|NCT02666846|Methyl salicylate|methyl salicylate|mesh-list
111429789|NCT02666846|Menthol|menthol|mesh-list
111429790|NCT02666846|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111429791|NCT02666846|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111429792|NCT02666846|Analgesics|analgesics|mesh-ancestor
111429793|NCT02666846|Sensory System Agents|sensory system agents|mesh-ancestor
111429794|NCT02666846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111429795|NCT02666846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111429796|NCT02666846|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111429797|NCT02666846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111429798|NCT02666846|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111429799|NCT02666846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111429800|NCT02666846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111429801|NCT02666846|Antipruritics|antipruritics|mesh-ancestor
111429802|NCT02666846|Dermatologic Agents|dermatologic agents|mesh-ancestor
111429803|NCT02643979|Ketamine|ketamine|mesh-list
111429804|NCT02643979|Propofol|propofol|mesh-list
111429805|NCT02643979|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111429806|NCT02643979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111429807|NCT02643979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111429808|NCT02643979|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111429809|NCT02643979|Anesthetics, General|anesthetics, general|mesh-ancestor
111429810|NCT02643979|Anesthetics|anesthetics|mesh-ancestor
111429811|NCT02643979|Analgesics|analgesics|mesh-ancestor
111429812|NCT02643979|Sensory System Agents|sensory system agents|mesh-ancestor
111429813|NCT02643979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111429814|NCT02643979|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111429815|NCT02643979|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111429816|NCT02643979|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111429817|NCT02643979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111429818|NCT02643979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111429819|NCT05587231|Fluorometholone|fluorometholone|mesh-list
111429820|NCT05587231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111429821|NCT05587231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111429822|NCT05587231|Glucocorticoids|glucocorticoids|mesh-ancestor
111429823|NCT05587231|Hormones|hormones|mesh-ancestor
111429824|NCT05587231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111429825|NCT05587231|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111429826|NCT02667704|Nintedanib|nintedanib|mesh-list
111429827|NCT02667704|Bosentan|bosentan|mesh-list
111429828|NCT02667704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111429829|NCT02667704|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111429830|NCT02667704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111429831|NCT02667704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111429832|NCT02667704|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111429833|NCT02667704|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
111429834|NCT02645617|Imidacloprid|imidacloprid|mesh-list
111429835|NCT02645617|Cholinergic Agents|cholinergic agents|mesh-ancestor
111429836|NCT02645617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111429837|NCT02645617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111429838|NCT02645617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111429839|NCT02694601|Caffeine|caffeine|mesh-list
111429840|NCT02694601|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111429841|NCT02694601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111429842|NCT02694601|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111429843|NCT02694601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111429844|NCT02694601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111429845|NCT02694601|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
111429846|NCT02694601|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111429847|NCT02694601|Purinergic Agents|purinergic agents|mesh-ancestor
111429848|NCT02694601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111429849|NCT02690948|Pembrolizumab|pembrolizumab|mesh-list
111429850|NCT02690948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111429851|NCT02690948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111429852|NCT02690948|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111429853|NCT02690948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111429854|NCT02698735|Gentamicins|gentamicins|mesh-list
111429855|NCT02698735|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111429856|NCT02698735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111429857|NCT02698735|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111429859|NCT02698735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111429860|NCT02691416|Propofol|propofol|mesh-list
111429861|NCT02691416|Sevoflurane|sevoflurane|mesh-list
111429862|NCT02691416|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111429863|NCT02691416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111429864|NCT02691416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111429865|NCT02691416|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111429866|NCT02691416|Anesthetics, General|anesthetics, general|mesh-ancestor
111429867|NCT02691416|Anesthetics|anesthetics|mesh-ancestor
111429868|NCT02691416|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111429869|NCT02691416|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111429870|NCT02650999|Pembrolizumab|pembrolizumab|mesh-list
111429871|NCT02650999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111429872|NCT02650999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111429873|NCT02650999|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111429874|NCT02650999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111429875|NCT05502211|Lidocaine|lidocaine|mesh-list
111429876|NCT05502211|Fentanyl|fentanyl|mesh-list
111429877|NCT05502211|Anesthetics, Local|anesthetics, local|mesh-ancestor
111429878|NCT05502211|Anesthetics|anesthetics|mesh-ancestor
111429879|NCT05502211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111429880|NCT05502211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111429881|NCT05502211|Sensory System Agents|sensory system agents|mesh-ancestor
111429882|NCT05502211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111429883|NCT05502211|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111429884|NCT05502211|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111429885|NCT05502211|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111429886|NCT05502211|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111429887|NCT05502211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111429888|NCT05502211|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111429889|NCT05502211|Narcotics|narcotics|mesh-ancestor
111429890|NCT05502211|Analgesics|analgesics|mesh-ancestor
111429891|NCT05502211|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111429892|NCT05502211|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111429893|NCT05502211|Anesthetics, General|anesthetics, general|mesh-ancestor
111429894|NCT02674412|Buspirone|buspirone|mesh-list
111429895|NCT02674412|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111429896|NCT02674412|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111429897|NCT02674412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111429898|NCT02674412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111429899|NCT02674412|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111429900|NCT02674412|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111429901|NCT02674412|Serotonin Agents|serotonin agents|mesh-ancestor
111429902|NCT02674412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111429903|NCT02674412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111429904|NCT04708106|Menthol|menthol|mesh-list
111429905|NCT04708106|Antipruritics|antipruritics|mesh-ancestor
111429906|NCT04708106|Dermatologic Agents|dermatologic agents|mesh-ancestor
111429907|NCT02697188|Methyltestosterone|methyltestosterone|mesh-list
111429908|NCT02697188|Testosterone|testosterone|mesh-list
111429909|NCT02697188|Testosterone undecanoate|testosterone undecanoate|mesh-list
111429910|NCT02697188|Testosterone enanthate|testosterone enanthate|mesh-list
111429911|NCT02697188|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
111429912|NCT02697188|Androgens|androgens|mesh-ancestor
111429913|NCT02697188|Hormones|hormones|mesh-ancestor
111429914|NCT02697188|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111429915|NCT02697188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111429916|NCT02697188|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111429917|NCT02697188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111429918|NCT02697188|Anabolic Agents|anabolic agents|mesh-ancestor
111429919|NCT04707560|Heparin|heparin|mesh-list
111429920|NCT04707560|Anticoagulants|anticoagulants|mesh-ancestor
111429921|NCT04707560|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111429922|NCT04707560|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111429923|NCT04707560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111429924|NCT02653183|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
111429925|NCT02653183|Laxatives|laxatives|mesh-ancestor
111429926|NCT02653183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111429927|NCT02701400|Durvalumab|durvalumab|mesh-list
111429928|NCT02701400|Ipilimumab|ipilimumab|mesh-list
111429929|NCT02701400|Tremelimumab|tremelimumab|mesh-list
111429930|NCT02701400|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111429931|NCT02701400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111429932|NCT02701400|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111429933|NCT02701400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111429934|NCT05403710|Botulinum Toxins|botulinum toxins|mesh-list
111429935|NCT05403710|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111429936|NCT05403710|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111429937|NCT05403710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111429938|NCT05403710|Cholinergic Agents|cholinergic agents|mesh-ancestor
111429939|NCT05403710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111429940|NCT05403710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111429941|NCT02703350|Insulin Lispro|insulin lispro|mesh-list
111429942|NCT02703350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111429943|NCT02703350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111429944|NCT05470465|Oxycodone|oxycodone|mesh-list
111429945|NCT05470465|Paroxetine|paroxetine|mesh-list
111429946|NCT05470465|Escitalopram|escitalopram|mesh-list
111429947|NCT05470465|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111429948|NCT05470465|Narcotics|narcotics|mesh-ancestor
111429949|NCT05470465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111429950|NCT05470465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111429951|NCT05470465|Analgesics|analgesics|mesh-ancestor
111429952|NCT05470465|Sensory System Agents|sensory system agents|mesh-ancestor
111429953|NCT05470465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111429954|NCT05470465|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111429955|NCT05470465|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111429956|NCT05470465|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111429957|NCT05470465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111429958|NCT05470465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111429959|NCT05470465|Serotonin Agents|serotonin agents|mesh-ancestor
111429960|NCT05470465|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111429961|NCT05470465|Antidepressive Agents|antidepressive agents|mesh-ancestor
111429962|NCT05470465|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111429963|NCT05470465|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111429964|NCT05470465|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111429965|NCT05470465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111429966|NCT00368030|Eszopiclone|eszopiclone|mesh-list
111429967|NCT00368030|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111429968|NCT00368030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111429969|NCT00368030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111429970|NCT02656069|Glucagon|glucagon|mesh-list
111429971|NCT02656069|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
111429972|NCT02656069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111429973|NCT02656069|Hormones|hormones|mesh-ancestor
111429974|NCT02656069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111429975|NCT02656069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111429976|NCT02656069|Incretins|incretins|mesh-ancestor
111429977|NCT05351762|Paclitaxel|paclitaxel|mesh-list
111429978|NCT05351762|Nimotuzumab|nimotuzumab|mesh-list
111429979|NCT05351762|Nedaplatin|nedaplatin|mesh-list
111429980|NCT05351762|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111429981|NCT05351762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111429982|NCT05351762|Tubulin Modulators|tubulin modulators|mesh-ancestor
111429983|NCT05351762|Antimitotic Agents|antimitotic agents|mesh-ancestor
111429984|NCT05351762|Mitosis Modulators|mitosis modulators|mesh-ancestor
111429985|NCT05351762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111429986|NCT05351762|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111429987|NCT02708641|Pembrolizumab|pembrolizumab|mesh-list
111429988|NCT02708641|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111429989|NCT02708641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111429990|NCT02708641|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111429991|NCT02708641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111429992|NCT02710981|Sildenafil Citrate|sildenafil citrate|mesh-list
111429993|NCT02710981|Clomiphene|clomiphene|mesh-list
111429994|NCT02710981|Enclomiphene|enclomiphene|mesh-list
111429995|NCT02710981|Zuclomiphene|zuclomiphene|mesh-list
111429996|NCT02710981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111429997|NCT02710981|Vasodilator Agents|vasodilator agents|mesh-ancestor
111429998|NCT02710981|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111429999|NCT02710981|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111430000|NCT02710981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111430001|NCT02710981|Urological Agents|urological agents|mesh-ancestor
111430002|NCT02710981|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111430003|NCT02710981|Hormone Antagonists|hormone antagonists|mesh-ancestor
111430004|NCT02710981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111430005|NCT02710981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111430006|NCT02710981|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111430007|NCT02710981|Fertility Agents|fertility agents|mesh-ancestor
111430008|NCT02710981|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111430009|NCT02710981|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111430010|NCT02710981|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111430011|NCT04193228|Carbon Fiber|carbon fiber|mesh-list
111430012|NCT04193228|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111430013|NCT04193228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111430014|NCT04738838|Oxytocin|oxytocin|mesh-list
111430015|NCT04738838|Oxytocics|oxytocics|mesh-ancestor
111430016|NCT04738838|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111430017|NCT04738838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111430018|NCT04739917|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
111430019|NCT04739917|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111430020|NCT04739917|Immunologic Factors|immunologic factors|mesh-ancestor
111430021|NCT04739917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111430022|NCT02659501|Acetaminophen|acetaminophen|mesh-list
111430023|NCT02659501|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
111430024|NCT02659501|Epinephrine|epinephrine|mesh-list
111430025|NCT02659501|Diazepam|diazepam|mesh-list
111430026|NCT02659501|Morphine|morphine|mesh-list
111430027|NCT02659501|Hydrocodone|hydrocodone|mesh-list
111430028|NCT02659501|Bupivacaine|bupivacaine|mesh-list
111430029|NCT02659501|Anesthetics, Local|anesthetics, local|mesh-ancestor
111430030|NCT02659501|Anesthetics|anesthetics|mesh-ancestor
111430031|NCT02659501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111430032|NCT02659501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111430033|NCT02659501|Sensory System Agents|sensory system agents|mesh-ancestor
111430034|NCT02659501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111430035|NCT02659501|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111430036|NCT02659501|Narcotics|narcotics|mesh-ancestor
111430037|NCT02659501|Analgesics|analgesics|mesh-ancestor
111430038|NCT02659501|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111430039|NCT02659501|Antipyretics|antipyretics|mesh-ancestor
111430040|NCT02659501|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111430041|NCT02659501|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111430042|NCT02659501|Adrenergic Agents|adrenergic agents|mesh-ancestor
111430043|NCT02659501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111430044|NCT02659501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111430045|NCT02659501|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111430046|NCT02659501|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111430047|NCT02659501|Autonomic Agents|autonomic agents|mesh-ancestor
111430048|NCT02659501|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111430049|NCT02659501|Respiratory System Agents|respiratory system agents|mesh-ancestor
111430050|NCT02659501|Mydriatics|mydriatics|mesh-ancestor
111430051|NCT02659501|Sympathomimetics|sympathomimetics|mesh-ancestor
111430052|NCT02659501|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111430053|NCT02659501|Antitussive Agents|antitussive agents|mesh-ancestor
111430054|NCT02659501|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111430055|NCT02659501|Anticonvulsants|anticonvulsants|mesh-ancestor
111430056|NCT02659501|Antiemetics|antiemetics|mesh-ancestor
111430057|NCT02659501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111430058|NCT02659501|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111430059|NCT02659501|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
111430060|NCT02659501|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111430061|NCT02659501|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111430062|NCT02659501|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111430063|NCT02659501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111430064|NCT02659501|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111430065|NCT02659501|Anesthetics, General|anesthetics, general|mesh-ancestor
111430066|NCT02659501|GABA Modulators|gaba modulators|mesh-ancestor
111430067|NCT02659501|GABA Agents|gaba agents|mesh-ancestor
111430068|NCT02659501|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111430069|NCT02659501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111430070|NCT02659501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111430071|NCT00367939|Amlodipine|amlodipine|mesh-list
111430072|NCT00367939|Valsartan|valsartan|mesh-list
111430073|NCT00367939|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111430074|NCT00367939|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111430075|NCT00367939|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111430076|NCT00367939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111430077|NCT00367939|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111430078|NCT00367939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111430079|NCT00367939|Vasodilator Agents|vasodilator agents|mesh-ancestor
111430080|NCT00367939|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111430081|NCT00367939|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111430082|NCT02720107|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
111430083|NCT02720107|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
111430084|NCT02720107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111430085|NCT02720107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111430086|NCT02720107|Immunologic Factors|immunologic factors|mesh-ancestor
111430087|NCT02720107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111430089|NCT02722837|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
111430090|NCT02722837|Velpatasvir|velpatasvir|mesh-list
111430091|NCT02722837|Antiviral Agents|antiviral agents|mesh-ancestor
111430092|NCT02722837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111430093|NCT02710526|Buprenorphine|buprenorphine|mesh-list
111430094|NCT02710526|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111430095|NCT02710526|Narcotics|narcotics|mesh-ancestor
111430096|NCT02710526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111430097|NCT02710526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111430098|NCT02710526|Analgesics|analgesics|mesh-ancestor
111430099|NCT02710526|Sensory System Agents|sensory system agents|mesh-ancestor
111430100|NCT02710526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111430101|NCT02710526|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111430102|NCT02664961|Bevacizumab|bevacizumab|mesh-list
111430103|NCT02664961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111430104|NCT02664961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111430105|NCT02664961|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111430106|NCT02664961|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111430107|NCT02664961|Growth Substances|growth substances|mesh-ancestor
111430108|NCT02664961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111430109|NCT02664961|Growth Inhibitors|growth inhibitors|mesh-ancestor
111430110|NCT02665273|Bupivacaine|bupivacaine|mesh-list
111430111|NCT02665273|Anesthetics, Local|anesthetics, local|mesh-ancestor
111430112|NCT02665273|Anesthetics|anesthetics|mesh-ancestor
111430113|NCT02665273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111430114|NCT02665273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111430115|NCT02665273|Sensory System Agents|sensory system agents|mesh-ancestor
111430116|NCT02665273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111430117|NCT02713178|Bupivacaine|bupivacaine|mesh-list
111430118|NCT02713178|Anesthetics, Local|anesthetics, local|mesh-ancestor
111430119|NCT02713178|Anesthetics|anesthetics|mesh-ancestor
111430120|NCT02713178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111430121|NCT02713178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111430122|NCT02713178|Sensory System Agents|sensory system agents|mesh-ancestor
111430123|NCT02713178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111430124|NCT04130438|Nebivolol|nebivolol|mesh-list
111430125|NCT04130438|Diltiazem|diltiazem|mesh-list
111430126|NCT04130438|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111430127|NCT04130438|Vasodilator Agents|vasodilator agents|mesh-ancestor
111430128|NCT04130438|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
111430129|NCT04130438|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111430130|NCT04130438|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111430131|NCT04130438|Adrenergic Agents|adrenergic agents|mesh-ancestor
111430132|NCT04130438|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111430133|NCT04130438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111430134|NCT04130438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111430135|NCT04130438|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111430136|NCT04130438|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111430137|NCT04130438|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111430138|NCT04048850|Grazoprevir|grazoprevir|mesh-list
111430139|NCT04048850|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
111430140|NCT04048850|Antiviral Agents|antiviral agents|mesh-ancestor
111430141|NCT04048850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111430142|NCT05261672|Midazolam|midazolam|mesh-list
111430143|NCT05261672|Bupivacaine|bupivacaine|mesh-list
111430144|NCT05261672|Anesthetics, Local|anesthetics, local|mesh-ancestor
111430145|NCT05261672|Anesthetics|anesthetics|mesh-ancestor
111430146|NCT05261672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111430147|NCT05261672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111430148|NCT05261672|Sensory System Agents|sensory system agents|mesh-ancestor
111430149|NCT05261672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111430150|NCT05261672|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111430151|NCT05261672|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111430152|NCT05261672|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111430153|NCT05261672|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111430154|NCT05261672|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111430155|NCT05261672|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111430156|NCT05261672|Anesthetics, General|anesthetics, general|mesh-ancestor
111430157|NCT05261672|GABA Modulators|gaba modulators|mesh-ancestor
111430159|NCT05261672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111430160|NCT05261672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111430161|NCT02714504|Voriconazole|voriconazole|mesh-list
111430162|NCT02714504|Posaconazole|posaconazole|mesh-list
111430163|NCT02714504|Antifungal Agents|antifungal agents|mesh-ancestor
111430164|NCT02714504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111430165|NCT02714504|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111430166|NCT02714504|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111430167|NCT02714504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111430168|NCT02714504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111430169|NCT02714504|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111430170|NCT02714504|Hormone Antagonists|hormone antagonists|mesh-ancestor
111430171|NCT02714504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111430172|NCT02714504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111430173|NCT02714504|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111430174|NCT02714504|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
111430175|NCT02714504|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111430176|NCT02714504|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111430177|NCT05221502|Bedaquiline|bedaquiline|mesh-list
111430178|NCT05221502|Diarylquinolines|diarylquinolines|mesh-list
111430179|NCT05221502|Antitubercular Agents|antitubercular agents|mesh-ancestor
111430180|NCT05221502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111430181|NCT05221502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111430182|NCT00368576|Darapladib|darapladib|mesh-list
111430183|NCT00368576|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
111430184|NCT00368576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111430185|NCT00368576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111430186|NCT02730247|Paclitaxel|paclitaxel|mesh-list
111430187|NCT02730247|Ramucirumab|ramucirumab|mesh-list
111430188|NCT02730247|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111430189|NCT02730247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111430190|NCT02730247|Tubulin Modulators|tubulin modulators|mesh-ancestor
111430191|NCT02730247|Antimitotic Agents|antimitotic agents|mesh-ancestor
111430192|NCT02730247|Mitosis Modulators|mitosis modulators|mesh-ancestor
111430193|NCT02730247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111430194|NCT03889106|Ribavirin|ribavirin|mesh-list
111430195|NCT03889106|Antimetabolites|antimetabolites|mesh-ancestor
111430196|NCT03889106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111430197|NCT03889106|Antiviral Agents|antiviral agents|mesh-ancestor
111430198|NCT03889106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111430199|NCT00368329|Carboplatin|carboplatin|mesh-list
111430200|NCT00368329|Fluorouracil|fluorouracil|mesh-list
111430201|NCT00368329|Capecitabine|capecitabine|mesh-list
111430202|NCT00368329|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
111430203|NCT00368329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111430204|NCT00368329|Antimetabolites|antimetabolites|mesh-ancestor
111430205|NCT00368329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111430206|NCT00368329|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111430207|NCT00368329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111430208|NCT00368329|Immunologic Factors|immunologic factors|mesh-ancestor
111430209|NCT00368329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111430210|NCT00368329|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111430211|NCT02670343|Methyltestosterone|methyltestosterone|mesh-list
111430212|NCT02670343|Testosterone|testosterone|mesh-list
111430213|NCT02670343|Testosterone undecanoate|testosterone undecanoate|mesh-list
111430214|NCT02670343|Testosterone enanthate|testosterone enanthate|mesh-list
111430215|NCT02670343|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
111430216|NCT02670343|Androgens|androgens|mesh-ancestor
111430217|NCT02670343|Hormones|hormones|mesh-ancestor
111430218|NCT02670343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111430219|NCT02670343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111430220|NCT02670343|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111430221|NCT02670343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111430222|NCT02670343|Anabolic Agents|anabolic agents|mesh-ancestor
111430223|NCT03697850|Atezolizumab|atezolizumab|mesh-list
111430224|NCT03697850|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111430225|NCT03697850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111430226|NCT03697850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111430227|NCT03697850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111430228|NCT02730884|ON 01910|on 01910|mesh-list
111430229|NCT02730884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111430230|NCT02730884|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111430231|NCT02730884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111430232|NCT02730884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111430233|NCT02732587|Saracatinib|saracatinib|mesh-list
111430234|NCT02732587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111430235|NCT02732587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111430236|NCT02732587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111430237|NCT02731820|Vitamin D|vitamin d|mesh-list
111430238|NCT02731820|Cholecalciferol|cholecalciferol|mesh-list
111430239|NCT02731820|Potassium Citrate|potassium citrate|mesh-list
111430240|NCT02731820|Calcium Carbonate|calcium carbonate|mesh-list
111430241|NCT02731820|Calcium|calcium|mesh-list
111430242|NCT02731820|Vitamins|vitamins|mesh-ancestor
111430243|NCT02731820|Micronutrients|micronutrients|mesh-ancestor
111430244|NCT02731820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111430245|NCT02731820|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111430246|NCT02731820|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111430247|NCT02731820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111430248|NCT02731820|Antacids|antacids|mesh-ancestor
111430249|NCT02731820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111430250|NCT02731820|Diuretics|diuretics|mesh-ancestor
111430251|NCT02731820|Natriuretic Agents|natriuretic agents|mesh-ancestor
111430252|NCT02731820|Expectorants|expectorants|mesh-ancestor
111430253|NCT02731820|Respiratory System Agents|respiratory system agents|mesh-ancestor
111430254|NCT02732899|Sirolimus|sirolimus|mesh-list
111430255|NCT02732899|Aflibercept|aflibercept|mesh-list
111430256|NCT02732899|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111430257|NCT02732899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111430258|NCT02732899|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111430259|NCT02732899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111430260|NCT02732899|Antifungal Agents|antifungal agents|mesh-ancestor
111430261|NCT02732899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111430262|NCT02732899|Immunologic Factors|immunologic factors|mesh-ancestor
111430263|NCT02732899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111430264|NCT02732899|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111430265|NCT02732899|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111430266|NCT02732899|Growth Substances|growth substances|mesh-ancestor
111430267|NCT02732899|Growth Inhibitors|growth inhibitors|mesh-ancestor
111430268|NCT02733757|Clonidine|clonidine|mesh-list
111430269|NCT02733757|Analgesics|analgesics|mesh-ancestor
111430270|NCT02733757|Sensory System Agents|sensory system agents|mesh-ancestor
111430271|NCT02733757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111430272|NCT02733757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111430273|NCT02733757|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111430274|NCT02733757|Sympatholytics|sympatholytics|mesh-ancestor
111430275|NCT02733757|Autonomic Agents|autonomic agents|mesh-ancestor
111430276|NCT02733757|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111430277|NCT02733757|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111430278|NCT02733757|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111430279|NCT02733757|Adrenergic Agents|adrenergic agents|mesh-ancestor
111430280|NCT02733757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111430281|NCT02733757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111430282|NCT00368264|Infliximab|infliximab|mesh-list
111430283|NCT00368264|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111430284|NCT00368264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111430285|NCT00368264|Dermatologic Agents|dermatologic agents|mesh-ancestor
111430286|NCT00368264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111430287|NCT00368264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111430288|NCT02734147|Ascorbic Acid|ascorbic acid|mesh-list
111430289|NCT02734147|Antioxidants|antioxidants|mesh-ancestor
111430290|NCT02734147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111430291|NCT02734147|Protective Agents|protective agents|mesh-ancestor
111430292|NCT02734147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111430293|NCT02734147|Vitamins|vitamins|mesh-ancestor
111430294|NCT02734147|Micronutrients|micronutrients|mesh-ancestor
111430295|NCT00368342|Azithromycin|azithromycin|mesh-list
111430296|NCT00368342|Clarithromycin|clarithromycin|mesh-list
111430297|NCT00368342|Erythromycin|erythromycin|mesh-list
111430298|NCT00368342|Erythromycin Estolate|erythromycin estolate|mesh-list
111430299|NCT00368342|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
111430300|NCT00368342|Erythromycin stearate|erythromycin stearate|mesh-list
111430301|NCT00368342|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111430302|NCT00368342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111430303|NCT00368342|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111430304|NCT00368342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111430305|NCT00368342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111430306|NCT00368342|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111430307|NCT00368342|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111430308|NCT00368342|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111430310|NCT03609008|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111430311|NCT03609008|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111430312|NCT03609008|Autonomic Agents|autonomic agents|mesh-ancestor
111430313|NCT03609008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111430314|NCT03609008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111430315|NCT03609008|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111430316|NCT03609008|Respiratory System Agents|respiratory system agents|mesh-ancestor
111430317|NCT03609008|Parasympatholytics|parasympatholytics|mesh-ancestor
111430318|NCT03609008|Vasodilator Agents|vasodilator agents|mesh-ancestor
111430319|NCT02734238|Methyltestosterone|methyltestosterone|mesh-list
111430320|NCT02734238|Testosterone|testosterone|mesh-list
111430321|NCT02734238|Testosterone undecanoate|testosterone undecanoate|mesh-list
111430322|NCT02734238|Testosterone enanthate|testosterone enanthate|mesh-list
111430323|NCT02734238|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
111430324|NCT02734238|Androgens|androgens|mesh-ancestor
111430325|NCT02734238|Hormones|hormones|mesh-ancestor
111430326|NCT02734238|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111430327|NCT02734238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111430328|NCT02734238|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111430329|NCT02734238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111430330|NCT02734238|Anabolic Agents|anabolic agents|mesh-ancestor
111430331|NCT04707547|Nivolumab|nivolumab|mesh-list
111430332|NCT04707547|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111430333|NCT04707547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111430334|NCT04707547|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111430335|NCT04707547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111430336|NCT02736175|Dexamethasone|dexamethasone|mesh-list
111430337|NCT02736175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111430338|NCT02736175|Antiemetics|antiemetics|mesh-ancestor
111430339|NCT02736175|Autonomic Agents|autonomic agents|mesh-ancestor
111430340|NCT02736175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111430341|NCT02736175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111430342|NCT02736175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111430343|NCT02736175|Glucocorticoids|glucocorticoids|mesh-ancestor
111430344|NCT02736175|Hormones|hormones|mesh-ancestor
111430345|NCT02736175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111430346|NCT02736175|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111430347|NCT02736175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111430348|NCT00369356|Prednisone|prednisone|mesh-list
111430349|NCT00369356|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111430350|NCT00369356|Glucocorticoids|glucocorticoids|mesh-ancestor
111430351|NCT00369356|Hormones|hormones|mesh-ancestor
111430352|NCT00369356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111430353|NCT00369356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111430354|NCT00369356|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111430355|NCT00369356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111430356|NCT04947085|Ketamine|ketamine|mesh-list
111430357|NCT04947085|Analgesics|analgesics|mesh-ancestor
111430358|NCT04947085|Sensory System Agents|sensory system agents|mesh-ancestor
111430359|NCT04947085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111430360|NCT04947085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111430361|NCT04947085|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111430362|NCT04947085|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111430363|NCT04947085|Anesthetics, General|anesthetics, general|mesh-ancestor
111430364|NCT04947085|Anesthetics|anesthetics|mesh-ancestor
111430365|NCT04947085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111430366|NCT04947085|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111430367|NCT04947085|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111430368|NCT04947085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110512044|NCT00879541|Factor VIII|factor viii|mesh-list
111430369|NCT04947085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111430370|NCT03357224|Atezolizumab|atezolizumab|mesh-list
111430371|NCT03357224|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111430372|NCT03357224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111430373|NCT03357224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111430374|NCT03357224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111430375|NCT02679469|Nalmefene|nalmefene|mesh-list
111430376|NCT02679469|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111430377|NCT02679469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111430378|NCT02679469|Sensory System Agents|sensory system agents|mesh-ancestor
111430379|NCT02679469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111430380|NCT02681809|Fibrinolysin|fibrinolysin|mesh-list
111430381|NCT02681809|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111154766|NCT02001987|Methotrexate|methotrexate|mesh-list
111430382|NCT02681809|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111430383|NCT02681809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111430385|NCT05445661|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
111430386|NCT05445661|Diuretics|diuretics|mesh-ancestor
111430387|NCT05445661|Natriuretic Agents|natriuretic agents|mesh-ancestor
111430388|NCT05445661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111430389|NCT04805125|Vaccines|vaccines|mesh-list
111430390|NCT04805125|Immunologic Factors|immunologic factors|mesh-ancestor
111430391|NCT04805125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111430392|NCT00368017|Pioglitazone|pioglitazone|mesh-list
111430393|NCT00368017|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111430394|NCT00368017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111430395|NCT00367627|Albendazole|albendazole|mesh-list
111430396|NCT00367627|Anthelmintics|anthelmintics|mesh-ancestor
111430397|NCT00367627|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111430398|NCT00367627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111430399|NCT00367627|Anticestodal Agents|anticestodal agents|mesh-ancestor
111430400|NCT00367627|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
111430401|NCT00367627|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111430402|NCT00367627|Tubulin Modulators|tubulin modulators|mesh-ancestor
111430403|NCT00367627|Antimitotic Agents|antimitotic agents|mesh-ancestor
111430404|NCT00367627|Mitosis Modulators|mitosis modulators|mesh-ancestor
111430405|NCT00367627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111430406|NCT00367627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111430407|NCT05443789|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
111430408|NCT05443789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111430409|NCT05443789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111430410|NCT05424523|Omalizumab|omalizumab|mesh-list
111430411|NCT05424523|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111430412|NCT05424523|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111430413|NCT05424523|Respiratory System Agents|respiratory system agents|mesh-ancestor
111430414|NCT05442931|Magnesium Sulfate|magnesium sulfate|mesh-list
111430415|NCT05442931|Pregabalin|pregabalin|mesh-list
111430416|NCT05442931|Nitroglycerin|nitroglycerin|mesh-list
111430417|NCT05442931|Analgesics|analgesics|mesh-ancestor
111430418|NCT05442931|Sensory System Agents|sensory system agents|mesh-ancestor
111430419|NCT05442931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111430420|NCT05442931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111430421|NCT05442931|Anticonvulsants|anticonvulsants|mesh-ancestor
111430422|NCT05442931|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111430423|NCT05442931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111430424|NCT05442931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111430425|NCT05442931|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111430426|NCT05442931|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111430427|NCT05442931|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111430428|NCT05442931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111430429|NCT05442931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111430430|NCT05442931|Anesthetics|anesthetics|mesh-ancestor
111430431|NCT05442931|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111430432|NCT05442931|Tocolytic Agents|tocolytic agents|mesh-ancestor
111430433|NCT05442931|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111430434|NCT05442931|Vasodilator Agents|vasodilator agents|mesh-ancestor
111430435|NCT05439499|Letrozole|letrozole|mesh-list
111430436|NCT05439499|Anastrozole|anastrozole|mesh-list
111430437|NCT05439499|Goserelin|goserelin|mesh-list
111430438|NCT05439499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111430439|NCT05439499|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111430440|NCT05439499|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111430441|NCT05439499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111430442|NCT05439499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111430443|NCT05439499|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111430444|NCT05439499|Hormone Antagonists|hormone antagonists|mesh-ancestor
111430445|NCT05439499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111430446|NCT05439499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111430447|NCT05439499|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111430448|NCT04003987|Bupivacaine|bupivacaine|mesh-list
111430449|NCT04003987|Anesthetics, Local|anesthetics, local|mesh-ancestor
111430450|NCT04003987|Anesthetics|anesthetics|mesh-ancestor
111430451|NCT04003987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111430452|NCT04003987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111430453|NCT04003987|Sensory System Agents|sensory system agents|mesh-ancestor
111430454|NCT04003987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111430455|NCT05448001|Lansoprazole|lansoprazole|mesh-list
111430456|NCT05448001|Dexlansoprazole|dexlansoprazole|mesh-list
111430457|NCT05448001|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111430459|NCT05448001|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111430460|NCT05448001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111430461|NCT05448001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111430462|NCT05447455|Anesthetics|anesthetics|mesh-list
111430463|NCT05447455|Anesthetics, Local|anesthetics, local|mesh-list
111430464|NCT05447455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111430465|NCT05447455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111430466|NCT05447455|Sensory System Agents|sensory system agents|mesh-ancestor
111430467|NCT05447455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111430468|NCT00369733|Darbepoetin alfa|darbepoetin alfa|mesh-list
111430469|NCT00369733|Hematinics|hematinics|mesh-ancestor
111430470|NCT00368719|Tacrolimus|tacrolimus|mesh-list
111430471|NCT00368719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111430472|NCT00368719|Immunologic Factors|immunologic factors|mesh-ancestor
111430473|NCT00368719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111430474|NCT00368719|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111430475|NCT00368719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111430476|NCT00368719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111430477|NCT00369811|Fentanyl|fentanyl|mesh-list
111430478|NCT00369811|Oxycodone|oxycodone|mesh-list
111430479|NCT00369811|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111430480|NCT00369811|Narcotics|narcotics|mesh-ancestor
111430481|NCT00369811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111430482|NCT00369811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111430483|NCT00369811|Analgesics|analgesics|mesh-ancestor
111430484|NCT00369811|Sensory System Agents|sensory system agents|mesh-ancestor
111430485|NCT00369811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111430486|NCT00369811|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111430487|NCT00369811|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111430488|NCT00369811|Anesthetics, General|anesthetics, general|mesh-ancestor
111430489|NCT00369811|Anesthetics|anesthetics|mesh-ancestor
111430490|NCT03615547|Clomiphene|clomiphene|mesh-list
111430491|NCT03615547|Enclomiphene|enclomiphene|mesh-list
111430492|NCT03615547|Zuclomiphene|zuclomiphene|mesh-list
111430493|NCT03615547|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111430494|NCT03615547|Hormone Antagonists|hormone antagonists|mesh-ancestor
111430495|NCT03615547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111430496|NCT03615547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111430497|NCT03615547|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111430498|NCT03615547|Fertility Agents|fertility agents|mesh-ancestor
111430499|NCT03615547|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111430500|NCT03615547|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111430501|NCT03615547|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111430502|NCT03105128|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111430503|NCT03105128|Immunologic Factors|immunologic factors|mesh-ancestor
111430504|NCT03105128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111430505|NCT03122509|Durvalumab|durvalumab|mesh-list
111430506|NCT03122509|Tremelimumab|tremelimumab|mesh-list
111430507|NCT03122509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111430508|NCT03122509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111430509|NCT03113695|Lenalidomide|lenalidomide|mesh-list
111430510|NCT03113695|Obinutuzumab|obinutuzumab|mesh-list
111430511|NCT03113695|Immunologic Factors|immunologic factors|mesh-ancestor
111430512|NCT03113695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111430513|NCT03113695|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111430514|NCT03113695|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111430515|NCT03113695|Growth Substances|growth substances|mesh-ancestor
111430516|NCT03113695|Growth Inhibitors|growth inhibitors|mesh-ancestor
111430517|NCT03113695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111430518|NCT03113695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111430519|NCT05315947|Brivaracetam|brivaracetam|mesh-list
111430520|NCT05315947|Anticonvulsants|anticonvulsants|mesh-ancestor
111430521|NCT00369434|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
111430522|NCT00369434|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111430523|NCT00369434|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111430524|NCT00369434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111430525|NCT00369434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111430526|NCT00369434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110512136|NCT02606409|Anesthetics|anesthetics|mesh-ancestor
111430527|NCT00369434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111430528|NCT00369434|Antidepressive Agents|antidepressive agents|mesh-ancestor
111430529|NCT00369434|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111430530|NCT05444738|Oxytocin|oxytocin|mesh-list
111430531|NCT05444738|Oxytocics|oxytocics|mesh-ancestor
111430532|NCT05444738|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111430533|NCT05444738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111430535|NCT05243953|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111430536|NCT05243953|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111430537|NCT05243953|Autonomic Agents|autonomic agents|mesh-ancestor
111430538|NCT05243953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111430539|NCT05243953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111430540|NCT05243953|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111430541|NCT05243953|Respiratory System Agents|respiratory system agents|mesh-ancestor
111430542|NCT05243953|Parasympatholytics|parasympatholytics|mesh-ancestor
111430543|NCT05243953|Vasodilator Agents|vasodilator agents|mesh-ancestor
111430544|NCT02757313|Dronabinol|dronabinol|mesh-list
111430545|NCT02757313|Hallucinogens|hallucinogens|mesh-ancestor
111430546|NCT02757313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111430547|NCT02757313|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111430548|NCT02757313|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111430549|NCT02757313|Analgesics|analgesics|mesh-ancestor
111430550|NCT02757313|Sensory System Agents|sensory system agents|mesh-ancestor
111430551|NCT02757313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111430552|NCT02757313|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
111430553|NCT02757313|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
111430554|NCT02757313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111430555|NCT02757313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111430556|NCT02757313|Hormones|hormones|mesh-ancestor
111430557|NCT02757313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111430558|NCT02514278|Capecitabine|capecitabine|mesh-list
111430559|NCT02514278|Folfirinox|folfirinox|mesh-list
111430560|NCT02514278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111430561|NCT02514278|Antimetabolites|antimetabolites|mesh-ancestor
111430562|NCT02514278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111430563|NCT02514278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111430564|NCT02379806|Enoxaparin|enoxaparin|mesh-list
111430565|NCT02379806|Anticoagulants|anticoagulants|mesh-ancestor
111430566|NCT02379806|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111430567|NCT02379806|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111430568|NCT02379806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111430569|NCT02358356|Capecitabine|capecitabine|mesh-list
111430570|NCT02358356|Temozolomide|temozolomide|mesh-list
111430571|NCT02358356|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111430572|NCT02358356|Antimetabolites|antimetabolites|mesh-ancestor
111430573|NCT02358356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111430574|NCT02358356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111430575|NCT02358356|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111430576|NCT02358356|Alkylating Agents|alkylating agents|mesh-ancestor
111430577|NCT04700761|Analgesics, Opioid|analgesics, opioid|mesh-list
111430578|NCT04700761|Anesthetics|anesthetics|mesh-list
111430579|NCT04700761|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111430580|NCT04700761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111430581|NCT04700761|Narcotics|narcotics|mesh-ancestor
111430582|NCT04700761|Analgesics|analgesics|mesh-ancestor
111430583|NCT04700761|Sensory System Agents|sensory system agents|mesh-ancestor
111430584|NCT04700761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111430585|NCT02315768|Obinutuzumab|obinutuzumab|mesh-list
111430586|NCT02315768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111430587|NCT02315768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111430588|NCT02162810|Prednisolone|prednisolone|mesh-list
111430589|NCT02162810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111430590|NCT02162810|Glucocorticoids|glucocorticoids|mesh-ancestor
111430591|NCT02162810|Hormones|hormones|mesh-ancestor
111430592|NCT02162810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111430593|NCT02162810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111430594|NCT02162810|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111430595|NCT02162810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111430596|NCT00368498|Teicoplanin|teicoplanin|mesh-list
111430597|NCT00368498|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111430598|NCT00368498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111430599|NCT05172817|Adalimumab|adalimumab|mesh-list
111430600|NCT05172817|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111430601|NCT05172817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111430602|NCT05172817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111430603|NCT05145907|Pembrolizumab|pembrolizumab|mesh-list
111430604|NCT05145907|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111430605|NCT05145907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111154962|NCT01999179|Apixaban|apixaban|mesh-list
111430606|NCT05145907|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111430607|NCT05145907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111430608|NCT04545151|Verapamil|verapamil|mesh-list
111430609|NCT04545151|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111430610|NCT04545151|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111430611|NCT04545151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111430612|NCT04545151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111430613|NCT04545151|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111430614|NCT04545151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111430615|NCT04545151|Vasodilator Agents|vasodilator agents|mesh-ancestor
111430616|NCT00961142|Fludarabine|fludarabine|mesh-list
111430617|NCT00961142|Melphalan|melphalan|mesh-list
111430618|NCT00961142|Thiotepa|thiotepa|mesh-list
111430619|NCT00961142|Thymoglobulin|thymoglobulin|mesh-list
111430620|NCT00961142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111430621|NCT00961142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111430622|NCT00961142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111430623|NCT00961142|Immunologic Factors|immunologic factors|mesh-ancestor
111430624|NCT00961142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111430625|NCT00961142|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111430626|NCT00961142|Alkylating Agents|alkylating agents|mesh-ancestor
111430627|NCT00961142|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111430628|NCT04523701|SMOFlipid|smoflipid|mesh-list
111430629|NCT04523701|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
111430630|NCT04523701|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
111430631|NCT04523701|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111430632|NCT04338373|Atropine|atropine|mesh-list
111430633|NCT04338373|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111430634|NCT04338373|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111430635|NCT04338373|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111430636|NCT04338373|Autonomic Agents|autonomic agents|mesh-ancestor
111430637|NCT04338373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111430638|NCT04338373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110512179|NCT04038307|Acetaminophen|acetaminophen|mesh-list
111430639|NCT04338373|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111430640|NCT04338373|Respiratory System Agents|respiratory system agents|mesh-ancestor
111430641|NCT04338373|Mydriatics|mydriatics|mesh-ancestor
111430642|NCT04338373|Parasympatholytics|parasympatholytics|mesh-ancestor
111430643|NCT04338373|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111430644|NCT04338373|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111430645|NCT04338373|Cholinergic Agents|cholinergic agents|mesh-ancestor
111430646|NCT04338373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111430647|NCT04338373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111430648|NCT00369031|polysaccharide-K|polysaccharide-k|mesh-list
111430649|NCT00369031|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111430650|NCT00369031|Immunologic Factors|immunologic factors|mesh-ancestor
111430651|NCT00369031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111430652|NCT00369031|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111430653|NCT00369031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111430654|NCT00369031|Antiviral Agents|antiviral agents|mesh-ancestor
111430655|NCT00369031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111430656|NCT00369031|Interferon Inducers|interferon inducers|mesh-ancestor
111430657|NCT00369031|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111430658|NCT00369031|Protective Agents|protective agents|mesh-ancestor
111430659|NCT05443178|Isoniazid|isoniazid|mesh-list
111430660|NCT05443178|Ethambutol|ethambutol|mesh-list
111430661|NCT05443178|Chloroquine|chloroquine|mesh-list
111430662|NCT05443178|Antitubercular Agents|antitubercular agents|mesh-ancestor
111430663|NCT05443178|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111430664|NCT05443178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111430665|NCT05443178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111430666|NCT05443178|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
111430667|NCT05443178|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111430668|NCT05443178|Antimetabolites|antimetabolites|mesh-ancestor
111430669|NCT05443178|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111430670|NCT05443178|Amebicides|amebicides|mesh-ancestor
111430671|NCT05443178|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111430672|NCT05443178|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111430673|NCT05443178|Antimalarials|antimalarials|mesh-ancestor
111430674|NCT05443178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111430675|NCT05061901|Lisinopril|lisinopril|mesh-list
111430676|NCT05061901|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
111430677|NCT05061901|Protease Inhibitors|protease inhibitors|mesh-ancestor
111430678|NCT05061901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111430679|NCT05061901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111430680|NCT05061901|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111430681|NCT05061901|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111430682|NCT05061901|Protective Agents|protective agents|mesh-ancestor
111430683|NCT05061901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111430685|NCT04338919|Ticagrelor|ticagrelor|mesh-list
111430686|NCT04338919|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111430687|NCT04338919|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111430688|NCT04338919|Analgesics|analgesics|mesh-ancestor
111430689|NCT04338919|Sensory System Agents|sensory system agents|mesh-ancestor
111430690|NCT04338919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111430691|NCT04338919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111430692|NCT04338919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111430693|NCT04338919|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111430694|NCT04338919|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111430695|NCT04338919|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111430696|NCT04338919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111430697|NCT04338919|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111430698|NCT04338919|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111430699|NCT04338919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111430700|NCT04338919|Antipyretics|antipyretics|mesh-ancestor
111430701|NCT04338919|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111430702|NCT04338919|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111430703|NCT04338919|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111430704|NCT04338919|Purinergic Agents|purinergic agents|mesh-ancestor
111430705|NCT04338919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111430706|NCT05451290|Gemcitabine|gemcitabine|mesh-list
111430707|NCT05451290|Tegafur|tegafur|mesh-list
111430708|NCT05451290|Oxaliplatin|oxaliplatin|mesh-list
111430709|NCT05451290|Apatinib|apatinib|mesh-list
111430710|NCT05451290|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111430711|NCT05451290|Antimetabolites|antimetabolites|mesh-ancestor
111430712|NCT05451290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111430713|NCT05451290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111430714|NCT05451290|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111430715|NCT05451290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111430716|NCT00369889|Bevacizumab|bevacizumab|mesh-list
111430717|NCT00369889|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111430718|NCT00369889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111430719|NCT00369889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111430720|NCT00369889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111430721|NCT00369889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111430722|NCT00369889|Growth Substances|growth substances|mesh-ancestor
111430723|NCT00369889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111430724|NCT00369889|Growth Inhibitors|growth inhibitors|mesh-ancestor
111430725|NCT00369889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111430726|NCT00369889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111430727|NCT00369889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111430728|NCT00369044|Prednisone|prednisone|mesh-list
111430729|NCT00369044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111430730|NCT00369044|Glucocorticoids|glucocorticoids|mesh-ancestor
111430731|NCT00369044|Hormones|hormones|mesh-ancestor
111430732|NCT00369044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111430733|NCT00369044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111430734|NCT00369044|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111430735|NCT00369044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111430736|NCT00370045|Bivalirudin|bivalirudin|mesh-list
111430737|NCT00370045|Eptifibatide|eptifibatide|mesh-list
111430738|NCT00370045|Antithrombins|antithrombins|mesh-ancestor
111430739|NCT00370045|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111430740|NCT00370045|Protease Inhibitors|protease inhibitors|mesh-ancestor
111430741|NCT00370045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111430742|NCT00370045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111430743|NCT00370045|Anticoagulants|anticoagulants|mesh-ancestor
111430744|NCT00370045|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111430745|NCT05451056|Sotorasib|sotorasib|mesh-list
111430746|NCT05451056|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111430747|NCT05451056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111430748|NCT05451056|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111430749|NCT05451056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111430750|NCT05441150|Ketamine|ketamine|mesh-list
111430751|NCT05441150|Analgesics|analgesics|mesh-ancestor
111430752|NCT05441150|Sensory System Agents|sensory system agents|mesh-ancestor
111430753|NCT05441150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111430754|NCT05441150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111430755|NCT05441150|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111430756|NCT05441150|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111430758|NCT05441150|Anesthetics|anesthetics|mesh-ancestor
111430759|NCT05441150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111430760|NCT05441150|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111430761|NCT05441150|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111430762|NCT05441150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111430763|NCT05441150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111430764|NCT04270214|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111430765|NCT04270214|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111430766|NCT04270214|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111430767|NCT04270214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111430768|NCT04270214|Cholinergic Agents|cholinergic agents|mesh-ancestor
111430769|NCT04270214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111430770|NCT04270214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111430771|NCT05438810|Fulvestrant|fulvestrant|mesh-list
111430772|NCT05438810|Goserelin|goserelin|mesh-list
111430773|NCT05438810|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111430774|NCT05438810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111430775|NCT05438810|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
111430776|NCT05438810|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111430777|NCT05438810|Hormone Antagonists|hormone antagonists|mesh-ancestor
111430778|NCT05438810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111430779|NCT05438810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111430780|NCT05451121|Dexmedetomidine|dexmedetomidine|mesh-list
111430781|NCT05451121|Propofol|propofol|mesh-list
111430782|NCT05451121|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111430783|NCT05451121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111430784|NCT05451121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111430785|NCT05451121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111430786|NCT05451121|Analgesics|analgesics|mesh-ancestor
111430787|NCT05451121|Sensory System Agents|sensory system agents|mesh-ancestor
111430788|NCT05451121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111430789|NCT05451121|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111430790|NCT05451121|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111430791|NCT05451121|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111430792|NCT05451121|Adrenergic Agents|adrenergic agents|mesh-ancestor
111430793|NCT05451121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111430794|NCT05451121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111430795|NCT05451121|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111430796|NCT05451121|Anesthetics, General|anesthetics, general|mesh-ancestor
111430797|NCT05451121|Anesthetics|anesthetics|mesh-ancestor
111430798|NCT04967443|Prazosin|prazosin|mesh-list
111430799|NCT04967443|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111430800|NCT04967443|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111430801|NCT04967443|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111430802|NCT04967443|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111430803|NCT04967443|Adrenergic Agents|adrenergic agents|mesh-ancestor
111430804|NCT04967443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111430805|NCT04967443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111430806|NCT04967443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111430807|NCT04697017|Salicylic Acid|salicylic acid|mesh-list
111430808|NCT04697017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111430809|NCT04697017|Antifungal Agents|antifungal agents|mesh-ancestor
111430810|NCT04697017|Keratolytic Agents|keratolytic agents|mesh-ancestor
111430811|NCT04697017|Dermatologic Agents|dermatologic agents|mesh-ancestor
111430812|NCT02230956|Botulinum Toxins|botulinum toxins|mesh-list
111430813|NCT02230956|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111430814|NCT02230956|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111430815|NCT02230956|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111430816|NCT02230956|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111430817|NCT02230956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111430818|NCT02230956|Cholinergic Agents|cholinergic agents|mesh-ancestor
111430819|NCT02230956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111430820|NCT02230956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111430821|NCT02230956|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111430822|NCT02230956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111430823|NCT05450042|Paclitaxel|paclitaxel|mesh-list
111430824|NCT05450042|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111430825|NCT05450042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111430826|NCT05450042|Tubulin Modulators|tubulin modulators|mesh-ancestor
111430827|NCT05450042|Antimitotic Agents|antimitotic agents|mesh-ancestor
111430828|NCT05450042|Mitosis Modulators|mitosis modulators|mesh-ancestor
111430829|NCT05450042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111430830|NCT05447936|Vitamin D|vitamin d|mesh-list
111430831|NCT05447936|Vitamins|vitamins|mesh-ancestor
111430832|NCT05447936|Micronutrients|micronutrients|mesh-ancestor
111430833|NCT05447936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111430834|NCT05447936|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111430835|NCT04739384|Ticagrelor|ticagrelor|mesh-list
111430836|NCT04739384|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111430837|NCT04739384|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111430838|NCT04739384|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111430839|NCT04739384|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111430840|NCT04739384|Purinergic Agents|purinergic agents|mesh-ancestor
111430841|NCT04739384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111430842|NCT04739384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111430843|NCT04739384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111430844|NCT04704596|Anesthetics|anesthetics|mesh-list
111430845|NCT04704596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111430846|NCT04704596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111430847|NCT05450497|Dexmedetomidine|dexmedetomidine|mesh-list
111430848|NCT05450497|Propofol|propofol|mesh-list
111430849|NCT05450497|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111430850|NCT05450497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111430851|NCT05450497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111430852|NCT05450497|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111430853|NCT05450497|Analgesics|analgesics|mesh-ancestor
111430854|NCT05450497|Sensory System Agents|sensory system agents|mesh-ancestor
111430855|NCT05450497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111430856|NCT05450497|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111430857|NCT05450497|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111430858|NCT05450497|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111430859|NCT05450497|Adrenergic Agents|adrenergic agents|mesh-ancestor
111430860|NCT05450497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111430861|NCT05450497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111430862|NCT05450497|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111430863|NCT05450497|Anesthetics, General|anesthetics, general|mesh-ancestor
111430864|NCT05450497|Anesthetics|anesthetics|mesh-ancestor
111430865|NCT02230332|Alendronate|alendronate|mesh-list
111430866|NCT02230332|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111430867|NCT02230332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111430868|NCT05449028|Bismuth|bismuth|mesh-list
111430869|NCT05449028|Antacids|antacids|mesh-ancestor
111430870|NCT05449028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111430871|NCT05449028|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111430872|NCT04845139|Nivolumab|nivolumab|mesh-list
111430873|NCT04845139|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111430874|NCT04845139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111430875|NCT04845139|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111430876|NCT04845139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111430877|NCT04738526|Lithium Carbonate|lithium carbonate|mesh-list
111430878|NCT04738526|Antidepressive Agents|antidepressive agents|mesh-ancestor
111430879|NCT04738526|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111430880|NCT04738526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111430881|NCT04738526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111430882|NCT04738526|Antimanic Agents|antimanic agents|mesh-ancestor
111430883|NCT04738526|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111430884|NCT04738526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111430885|NCT04738526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111430886|NCT05449483|Paclitaxel|paclitaxel|mesh-list
111430887|NCT05449483|Tislelizumab|tislelizumab|mesh-list
111430888|NCT05449483|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111430889|NCT05449483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111430890|NCT05449483|Tubulin Modulators|tubulin modulators|mesh-ancestor
111430891|NCT05449483|Antimitotic Agents|antimitotic agents|mesh-ancestor
111430892|NCT05449483|Mitosis Modulators|mitosis modulators|mesh-ancestor
111430893|NCT05449483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111430894|NCT05449483|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111430895|NCT05448404|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
111430896|NCT05448404|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111430897|NCT05448404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111430898|NCT04793659|Fasudil|fasudil|mesh-list
111430899|NCT04793659|1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine|1-(5-isoquinolinesulfonyl)-2-methylpiperazine|mesh-list
110512221|NCT05333744|Prednisone|prednisone|mesh-list
111430900|NCT04793659|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111430901|NCT04793659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111430902|NCT04793659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111430903|NCT04793659|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111430904|NCT04793659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111430905|NCT04793659|Vasodilator Agents|vasodilator agents|mesh-ancestor
111430906|NCT04793659|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111430907|NCT04793659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111430909|NCT05448937|Zinc Oxide|zinc oxide|mesh-list
111430910|NCT05448937|Dermatologic Agents|dermatologic agents|mesh-ancestor
111430911|NCT05448937|Sunscreening Agents|sunscreening agents|mesh-ancestor
111430912|NCT05448937|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111430913|NCT05448937|Protective Agents|protective agents|mesh-ancestor
111430914|NCT05448937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111430915|NCT05448937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111430916|NCT00370201|Colchicine|colchicine|mesh-list
111430917|NCT00370201|Gout Suppressants|gout suppressants|mesh-ancestor
111430918|NCT00370201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111430919|NCT00370201|Tubulin Modulators|tubulin modulators|mesh-ancestor
111430920|NCT00370201|Antimitotic Agents|antimitotic agents|mesh-ancestor
111430921|NCT00370201|Mitosis Modulators|mitosis modulators|mesh-ancestor
111430922|NCT00370201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111430923|NCT00370201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111430924|NCT05448781|Paclitaxel|paclitaxel|mesh-list
111430925|NCT05448781|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111430926|NCT05448781|Carboplatin|carboplatin|mesh-list
111430927|NCT05448781|Pemetrexed|pemetrexed|mesh-list
111430928|NCT05448781|Endostatins|endostatins|mesh-list
111430929|NCT05448781|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111430930|NCT05448781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111430931|NCT05448781|Tubulin Modulators|tubulin modulators|mesh-ancestor
111430932|NCT05448781|Antimitotic Agents|antimitotic agents|mesh-ancestor
111430933|NCT05448781|Mitosis Modulators|mitosis modulators|mesh-ancestor
111430934|NCT05448781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111430935|NCT05448781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111430936|NCT05448781|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111430937|NCT05448781|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111430938|NCT05448781|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111430939|NCT05448781|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111430940|NCT05448781|Growth Substances|growth substances|mesh-ancestor
111430941|NCT05448781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111430942|NCT05448781|Growth Inhibitors|growth inhibitors|mesh-ancestor
111430943|NCT03134755|Mometasone Furoate|mometasone furoate|mesh-list
111430944|NCT03134755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111430945|NCT03134755|Dermatologic Agents|dermatologic agents|mesh-ancestor
111430946|NCT03134755|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111430947|NCT04475432|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111430948|NCT04475432|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111430949|NCT00370825|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
111430950|NCT00370825|Miltefosine|miltefosine|mesh-list
111430951|NCT00370825|Antifungal Agents|antifungal agents|mesh-ancestor
111430952|NCT00370825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111430953|NCT00370825|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111430954|NCT00370825|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111430955|NCT00370825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111430956|NCT04450316|Naltrexone|naltrexone|mesh-list
111430957|NCT04450316|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111430958|NCT04450316|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111430959|NCT04450316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111430960|NCT04450316|Sensory System Agents|sensory system agents|mesh-ancestor
111430961|NCT04450316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111430962|NCT02535247|Pembrolizumab|pembrolizumab|mesh-list
111430963|NCT02535247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111430964|NCT02535247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111430965|NCT02535247|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111430966|NCT02535247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111430967|NCT04417920|Mitomycins|mitomycins|mesh-list
111430968|NCT04417920|Mitomycin|mitomycin|mesh-list
111430969|NCT04417920|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111430970|NCT04417920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111430971|NCT04417920|Alkylating Agents|alkylating agents|mesh-ancestor
111430972|NCT04417920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111430973|NCT04417920|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111430974|NCT04417920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111430975|NCT02626130|Tremelimumab|tremelimumab|mesh-list
111155339|NCT05813106|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111430976|NCT02626130|Ipilimumab|ipilimumab|mesh-list
111430977|NCT02626130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110512285|NCT04249154|Fertility Agents|fertility agents|mesh-ancestor
111430978|NCT02626130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111430979|NCT02626130|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111430980|NCT02626130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111430981|NCT02618720|Ornidazole|ornidazole|mesh-list
111430982|NCT02618720|Amebicides|amebicides|mesh-ancestor
111430983|NCT02618720|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111430984|NCT02618720|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111430985|NCT02618720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111430986|NCT02618720|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
111430987|NCT03758989|Prednisone|prednisone|mesh-list
111430988|NCT03758989|Cyclophosphamide|cyclophosphamide|mesh-list
111430989|NCT03758989|Rituximab|rituximab|mesh-list
111430990|NCT03758989|Doxorubicin|doxorubicin|mesh-list
111430991|NCT03758989|Vincristine|vincristine|mesh-list
111430992|NCT03758989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111430993|NCT03758989|Immunologic Factors|immunologic factors|mesh-ancestor
111430994|NCT03758989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111430995|NCT03758989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111430996|NCT03758989|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111430997|NCT03758989|Alkylating Agents|alkylating agents|mesh-ancestor
111430998|NCT03758989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111430999|NCT03758989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111431000|NCT03758989|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111431001|NCT03758989|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111431002|NCT03758989|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111431003|NCT03758989|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111431004|NCT03758989|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111431005|NCT03758989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111431006|NCT03758989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111431007|NCT03758989|Glucocorticoids|glucocorticoids|mesh-ancestor
111431008|NCT03758989|Hormones|hormones|mesh-ancestor
111431009|NCT03758989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111431010|NCT03758989|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111431011|NCT03758989|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111431012|NCT03758989|Tubulin Modulators|tubulin modulators|mesh-ancestor
111431013|NCT03758989|Antimitotic Agents|antimitotic agents|mesh-ancestor
111431014|NCT03758989|Mitosis Modulators|mitosis modulators|mesh-ancestor
111431015|NCT02042989|Vorinostat|vorinostat|mesh-list
111431016|NCT02042989|Ixazomib|ixazomib|mesh-list
111431017|NCT02042989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111431018|NCT02042989|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111431019|NCT02042989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111431020|NCT02042989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111431021|NCT02042989|Protease Inhibitors|protease inhibitors|mesh-ancestor
111431022|NCT04093531|Ustekinumab|ustekinumab|mesh-list
111431023|NCT04093531|Dermatologic Agents|dermatologic agents|mesh-ancestor
111431024|NCT05208944|Cemiplimab|cemiplimab|mesh-list
111431025|NCT05208944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111431026|NCT05208944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111431027|NCT01809379|Cisplatin|cisplatin|mesh-list
111431028|NCT01809379|Doxorubicin|doxorubicin|mesh-list
111431029|NCT01809379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111431030|NCT01809379|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111431031|NCT01809379|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111431032|NCT01809379|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111431033|NCT01809379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111431034|NCT01809379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111431035|NCT02229396|Dapagliflozin|dapagliflozin|mesh-list
111431036|NCT02229396|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111431037|NCT02229396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111431038|NCT02229396|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111431039|NCT02229396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111431040|NCT05202158|Gentamicins|gentamicins|mesh-list
111431041|NCT05202158|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111431042|NCT05202158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111431043|NCT05202158|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111431044|NCT05202158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111431045|NCT05202158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111431046|NCT00370370|Triamcinolone|triamcinolone|mesh-list
111431047|NCT00370370|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
111431048|NCT00370370|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
111431049|NCT00370370|Bevacizumab|bevacizumab|mesh-list
111431050|NCT00370370|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
111431051|NCT00370370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111431053|NCT00370370|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111431054|NCT00370370|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111431055|NCT00370370|Growth Substances|growth substances|mesh-ancestor
111431056|NCT00370370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111431057|NCT00370370|Growth Inhibitors|growth inhibitors|mesh-ancestor
111431058|NCT00370370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111431059|NCT00370370|Glucocorticoids|glucocorticoids|mesh-ancestor
111431060|NCT00370370|Hormones|hormones|mesh-ancestor
111431061|NCT00370370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111431062|NCT00370370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111431063|NCT00370370|Immunologic Factors|immunologic factors|mesh-ancestor
111431064|NCT00370370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111431065|NCT00370370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111431066|NCT02197416|Dabigatran|dabigatran|mesh-list
111431067|NCT02197416|Antithrombins|antithrombins|mesh-ancestor
111431068|NCT02197416|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111431069|NCT02197416|Protease Inhibitors|protease inhibitors|mesh-ancestor
111431070|NCT02197416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111431071|NCT02197416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111431072|NCT02197416|Anticoagulants|anticoagulants|mesh-ancestor
111431073|NCT00370591|Fluticasone|fluticasone|mesh-list
111431074|NCT00370591|Xhance|xhance|mesh-list
111431075|NCT00370591|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
111431076|NCT00370591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111431077|NCT00370591|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111431078|NCT00370591|Autonomic Agents|autonomic agents|mesh-ancestor
111431079|NCT00370591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111431080|NCT00370591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111431081|NCT00370591|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111431082|NCT00370591|Respiratory System Agents|respiratory system agents|mesh-ancestor
111431083|NCT00370591|Dermatologic Agents|dermatologic agents|mesh-ancestor
111431084|NCT00370591|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111431085|NCT00370591|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111431086|NCT00370591|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111431087|NCT00370591|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111431088|NCT00370591|Adrenergic Agents|adrenergic agents|mesh-ancestor
111431089|NCT00370591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111431090|NCT00370591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111431091|NCT03956173|Hypoglycemic Agents|hypoglycemic agents|mesh-list
111431092|NCT03956173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111431093|NCT00371527|Ipratropium|ipratropium|mesh-list
111431094|NCT00371527|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111431095|NCT00371527|Autonomic Agents|autonomic agents|mesh-ancestor
111431096|NCT00371527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111431097|NCT00371527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111431098|NCT00371527|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111431099|NCT00371527|Respiratory System Agents|respiratory system agents|mesh-ancestor
111431100|NCT00371527|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111431101|NCT00371527|Cholinergic Agents|cholinergic agents|mesh-ancestor
111431102|NCT00371527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110512365|NCT04227912|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111431103|NCT00371527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111431104|NCT00392756|Hormones|hormones|mesh-list
111431105|NCT00392756|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111431106|NCT00392756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111431107|NCT04027322|Dexamethasone|dexamethasone|mesh-list
111431108|NCT04027322|Budesonide|budesonide|mesh-list
111431109|NCT04027322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111431110|NCT04027322|Antiemetics|antiemetics|mesh-ancestor
111431111|NCT04027322|Autonomic Agents|autonomic agents|mesh-ancestor
111431112|NCT04027322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111431113|NCT04027322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111431114|NCT04027322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111431115|NCT04027322|Glucocorticoids|glucocorticoids|mesh-ancestor
111431116|NCT04027322|Hormones|hormones|mesh-ancestor
111431117|NCT04027322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111431118|NCT04027322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111431119|NCT04027322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111431120|NCT04027322|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111431121|NCT04027322|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111431122|NCT04027322|Respiratory System Agents|respiratory system agents|mesh-ancestor
111431123|NCT03845257|Dimercaprol|dimercaprol|mesh-list
111431124|NCT03845257|Chelating Agents|chelating agents|mesh-ancestor
111431125|NCT03845257|Sequestering Agents|sequestering agents|mesh-ancestor
111431126|NCT03845257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111431127|NCT00371072|Mitomycins|mitomycins|mesh-list
111431128|NCT00371072|Mitomycin|mitomycin|mesh-list
111431129|NCT00371072|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111431130|NCT00371072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111431131|NCT00371072|Alkylating Agents|alkylating agents|mesh-ancestor
111431132|NCT00371072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111431133|NCT00371072|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111431134|NCT00371072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111431135|NCT05454332|Caffeine|caffeine|mesh-list
111431136|NCT05454332|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111431137|NCT05454332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111431138|NCT05454332|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111431139|NCT05454332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111431140|NCT05454332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111431141|NCT05454332|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
111431142|NCT05454332|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111431143|NCT05454332|Purinergic Agents|purinergic agents|mesh-ancestor
111431144|NCT05454332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111431145|NCT03924518|Granisetron|granisetron|mesh-list
111431146|NCT03924518|Serotonin|serotonin|mesh-list
111431147|NCT03924518|Antiemetics|antiemetics|mesh-ancestor
111431148|NCT03924518|Autonomic Agents|autonomic agents|mesh-ancestor
111431149|NCT03924518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111431150|NCT03924518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111431151|NCT03924518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111431152|NCT03924518|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111431153|NCT03924518|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111431154|NCT03924518|Serotonin Agents|serotonin agents|mesh-ancestor
111431155|NCT03924518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111431156|NCT03924518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111431157|NCT03924518|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111431158|NCT05454085|Bisphenol A|bisphenol a|mesh-list
111431159|NCT05454085|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
111431160|NCT05454085|Estrogens|estrogens|mesh-ancestor
111431161|NCT05454085|Hormones|hormones|mesh-ancestor
111431162|NCT05454085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111431163|NCT05454085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111431164|NCT05454085|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111431165|NCT05454085|Antioxidants|antioxidants|mesh-ancestor
111431166|NCT05454085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111431167|NCT05454085|Protective Agents|protective agents|mesh-ancestor
111431168|NCT03886922|Cromakalim|cromakalim|mesh-list
111431169|NCT03886922|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111431170|NCT03886922|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111431171|NCT03886922|Autonomic Agents|autonomic agents|mesh-ancestor
111431172|NCT03886922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111431173|NCT03886922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111431174|NCT03886922|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111431175|NCT03886922|Respiratory System Agents|respiratory system agents|mesh-ancestor
111431176|NCT03886922|Parasympatholytics|parasympatholytics|mesh-ancestor
111431177|NCT03886922|Vasodilator Agents|vasodilator agents|mesh-ancestor
111431178|NCT05453552|Cyclophosphamide|cyclophosphamide|mesh-list
111431179|NCT05453552|Busulfan|busulfan|mesh-list
111431180|NCT05453552|Fludarabine|fludarabine|mesh-list
111431181|NCT05453552|Decitabine|decitabine|mesh-list
111431182|NCT05453552|Lenograstim|lenograstim|mesh-list
111431183|NCT05453552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111431184|NCT05453552|Immunologic Factors|immunologic factors|mesh-ancestor
111431185|NCT05453552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111431186|NCT05453552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111431187|NCT05453552|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111431188|NCT05453552|Alkylating Agents|alkylating agents|mesh-ancestor
111431189|NCT05453552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111431190|NCT05453552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111431191|NCT05453552|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111431192|NCT05453552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111431193|NCT05453552|Antimetabolites|antimetabolites|mesh-ancestor
111431194|NCT05453552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111431195|NCT05453552|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111431196|NCT03787082|Chlorhexidine|chlorhexidine|mesh-list
111431197|NCT03787082|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
111431198|NCT03787082|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111431199|NCT03787082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111155566|NCT05259046|Vitamin K 2|vitamin k 2|mesh-list
111431200|NCT03787082|Disinfectants|disinfectants|mesh-ancestor
111431201|NCT03787082|Dermatologic Agents|dermatologic agents|mesh-ancestor
111431202|NCT02165202|Rilpivirine|rilpivirine|mesh-list
111431203|NCT02165202|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111431204|NCT02165202|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111431205|NCT02165202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111431206|NCT02165202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111431207|NCT02165202|Antiviral Agents|antiviral agents|mesh-ancestor
111431208|NCT02165202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111431209|NCT02165202|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111431210|NCT02165202|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111431211|NCT01628874|Lidocaine|lidocaine|mesh-list
111431212|NCT01628874|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
111431213|NCT01628874|Anesthetics, Local|anesthetics, local|mesh-ancestor
111431214|NCT01628874|Anesthetics|anesthetics|mesh-ancestor
111431215|NCT01628874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111431216|NCT01628874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111431217|NCT01628874|Sensory System Agents|sensory system agents|mesh-ancestor
111431218|NCT01628874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111431219|NCT01628874|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111431220|NCT01628874|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111431221|NCT01628874|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111431222|NCT01628874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111431223|NCT01628874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111431224|NCT01628874|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
111431225|NCT04891718|Nivolumab|nivolumab|mesh-list
111431226|NCT04891718|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111431227|NCT04891718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111431228|NCT04891718|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111431229|NCT04891718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111431230|NCT03770689|Capecitabine|capecitabine|mesh-list
111431231|NCT03770689|Peposertib|peposertib|mesh-list
111431232|NCT03770689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111431233|NCT03770689|Antimetabolites|antimetabolites|mesh-ancestor
111431234|NCT03770689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111431235|NCT03770689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111431236|NCT03770689|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111431237|NCT03770689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111431238|NCT00371306|Metformin|metformin|mesh-list
111431239|NCT00371306|Glyburide|glyburide|mesh-list
111431240|NCT00371306|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111431241|NCT00371306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111431242|NCT02196714|Glycopyrrolate|glycopyrrolate|mesh-list
111431243|NCT02196714|Formoterol Fumarate|formoterol fumarate|mesh-list
111431244|NCT02196714|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111431245|NCT02196714|Autonomic Agents|autonomic agents|mesh-ancestor
111431246|NCT02196714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111431247|NCT02196714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111431248|NCT02196714|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111431249|NCT02196714|Respiratory System Agents|respiratory system agents|mesh-ancestor
111431250|NCT02196714|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111431251|NCT02196714|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111431252|NCT02196714|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111431253|NCT02196714|Adrenergic Agents|adrenergic agents|mesh-ancestor
111431254|NCT02196714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111431255|NCT02196714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111431256|NCT02196714|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111431257|NCT02196714|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111431258|NCT02196714|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111431259|NCT02196714|Cholinergic Agents|cholinergic agents|mesh-ancestor
111431260|NCT05453929|Rocuronium|rocuronium|mesh-list
111431261|NCT05453929|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
111431262|NCT05453929|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
111431263|NCT05453929|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111431264|NCT05453929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111431265|NCT05453929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111431266|NCT00370760|Dexamethasone|dexamethasone|mesh-list
111431267|NCT00370760|Colchicine|colchicine|mesh-list
111431268|NCT00370760|Heparin|heparin|mesh-list
111431269|NCT00370760|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
111431270|NCT00370760|Tinzaparin|tinzaparin|mesh-list
111431271|NCT00370760|Dalteparin|dalteparin|mesh-list
111431272|NCT00370760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111431273|NCT00370760|Antiemetics|antiemetics|mesh-ancestor
111155635|NCT05024552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111431274|NCT00370760|Autonomic Agents|autonomic agents|mesh-ancestor
111431275|NCT00370760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111431276|NCT00370760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111431277|NCT00370760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111431278|NCT00370760|Glucocorticoids|glucocorticoids|mesh-ancestor
111431279|NCT00370760|Hormones|hormones|mesh-ancestor
110512428|NCT04824144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111431280|NCT00370760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111431281|NCT00370760|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111431282|NCT00370760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111431283|NCT00370760|Anticoagulants|anticoagulants|mesh-ancestor
111431284|NCT00370760|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111431285|NCT00370760|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111431286|NCT00370760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111431287|NCT00370760|Gout Suppressants|gout suppressants|mesh-ancestor
111431288|NCT00370760|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111431289|NCT00370760|Tubulin Modulators|tubulin modulators|mesh-ancestor
111431290|NCT00370760|Antimitotic Agents|antimitotic agents|mesh-ancestor
111431291|NCT00370760|Mitosis Modulators|mitosis modulators|mesh-ancestor
111431292|NCT05203562|Letrozole|letrozole|mesh-list
111431293|NCT05203562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111431294|NCT05203562|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111431295|NCT05203562|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111431296|NCT05203562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111431297|NCT05203562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111431298|NCT05203562|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111431299|NCT05203562|Hormone Antagonists|hormone antagonists|mesh-ancestor
111431300|NCT05203562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111431301|NCT05203562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111431302|NCT04766762|Flunarizine|flunarizine|mesh-list
111431303|NCT04766762|Anticonvulsants|anticonvulsants|mesh-ancestor
111431304|NCT04766762|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111431305|NCT04766762|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111431306|NCT04766762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111431307|NCT04766762|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111431308|NCT04766762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111431309|NCT04766762|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111431310|NCT04766762|Histamine Antagonists|histamine antagonists|mesh-ancestor
111431311|NCT04766762|Histamine Agents|histamine agents|mesh-ancestor
111431312|NCT04766762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111431313|NCT04766762|Vasodilator Agents|vasodilator agents|mesh-ancestor
111431314|NCT04330040|Olaparib|olaparib|mesh-list
111431315|NCT04330040|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111431316|NCT04330040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111431317|NCT04330040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111431318|NCT04330040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111431319|NCT02737891|Metoprolol|metoprolol|mesh-list
111431320|NCT02737891|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111431321|NCT02737891|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111431322|NCT02737891|Sympatholytics|sympatholytics|mesh-ancestor
111431323|NCT02737891|Autonomic Agents|autonomic agents|mesh-ancestor
111431324|NCT02737891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111431325|NCT02737891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111431326|NCT02737891|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
111431327|NCT02737891|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111431328|NCT02737891|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111431329|NCT02737891|Adrenergic Agents|adrenergic agents|mesh-ancestor
111431330|NCT02737891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111431331|NCT02737891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111431332|NCT05055050|Imiquimod|imiquimod|mesh-list
111431333|NCT05055050|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111431334|NCT05055050|Immunologic Factors|immunologic factors|mesh-ancestor
111431335|NCT05055050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111431336|NCT05055050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111431337|NCT05055050|Interferon Inducers|interferon inducers|mesh-ancestor
111431338|NCT02196558|Quetmolimab|quetmolimab|mesh-list
111431339|NCT02196558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111431340|NCT04809662|Imiquimod|imiquimod|mesh-list
111431341|NCT04809662|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111431342|NCT04809662|Immunologic Factors|immunologic factors|mesh-ancestor
111431343|NCT04809662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111431344|NCT04809662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111431345|NCT04809662|Interferon Inducers|interferon inducers|mesh-ancestor
111431346|NCT02196324|Serlopitant|serlopitant|mesh-list
111155708|NCT04558918|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
111431347|NCT02196324|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
111431348|NCT02196324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111431349|NCT02196324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111431350|NCT02196324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111431351|NCT05450419|Vitamin D|vitamin d|mesh-list
111431352|NCT05450419|Cholecalciferol|cholecalciferol|mesh-list
111431353|NCT05450419|Vitamins|vitamins|mesh-ancestor
111431354|NCT05450419|Micronutrients|micronutrients|mesh-ancestor
111431355|NCT05450419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111431356|NCT05450419|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111431357|NCT05450419|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111431358|NCT05443009|Lidocaine|lidocaine|mesh-list
111431359|NCT05443009|Carticaine|carticaine|mesh-list
111431360|NCT05443009|Anesthetics, Local|anesthetics, local|mesh-ancestor
111431361|NCT05443009|Anesthetics|anesthetics|mesh-ancestor
111431362|NCT05443009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111431363|NCT05443009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111431364|NCT05443009|Sensory System Agents|sensory system agents|mesh-ancestor
111431365|NCT05443009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111431366|NCT05443009|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111431367|NCT05443009|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111431368|NCT05443009|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111431369|NCT05443009|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111431370|NCT05443009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111431371|NCT00370669|Triamcinolone|triamcinolone|mesh-list
111431372|NCT00370669|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
111431373|NCT00370669|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
111431374|NCT00370669|Bevacizumab|bevacizumab|mesh-list
111431375|NCT00370669|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
111431376|NCT00370669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111431377|NCT00370669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111431378|NCT00370669|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111431379|NCT00370669|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111431380|NCT00370669|Growth Substances|growth substances|mesh-ancestor
111431381|NCT00370669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111431382|NCT00370669|Growth Inhibitors|growth inhibitors|mesh-ancestor
111431383|NCT00370669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111431384|NCT00370669|Glucocorticoids|glucocorticoids|mesh-ancestor
111431385|NCT00370669|Hormones|hormones|mesh-ancestor
111431386|NCT00370669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111431387|NCT00370669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111431388|NCT00370669|Immunologic Factors|immunologic factors|mesh-ancestor
111431389|NCT00370669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111431390|NCT00370669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111431391|NCT05378971|Pomalidomide|pomalidomide|mesh-list
111431392|NCT05378971|Immunologic Factors|immunologic factors|mesh-ancestor
110512454|NCT05158686|Paclitaxel|paclitaxel|mesh-list
111431393|NCT05378971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111431394|NCT05378971|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111431395|NCT05378971|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111431396|NCT05378971|Growth Substances|growth substances|mesh-ancestor
111431397|NCT05378971|Growth Inhibitors|growth inhibitors|mesh-ancestor
111431398|NCT05378971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111431399|NCT02740543|Fluticasone|fluticasone|mesh-list
111431400|NCT02740543|Xhance|xhance|mesh-list
111431401|NCT02740543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111431402|NCT02740543|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111431403|NCT02740543|Autonomic Agents|autonomic agents|mesh-ancestor
111431404|NCT02740543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111431405|NCT02740543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111431406|NCT02740543|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111431407|NCT02740543|Respiratory System Agents|respiratory system agents|mesh-ancestor
111431408|NCT02740543|Dermatologic Agents|dermatologic agents|mesh-ancestor
111431409|NCT02740543|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111431410|NCT00370747|Ecabet|ecabet|mesh-list
111431411|NCT00370747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111431412|NCT00370747|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111431413|NCT00370747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111431414|NCT00370747|Protease Inhibitors|protease inhibitors|mesh-ancestor
111431415|NCT00370747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111431416|NCT00370747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111431417|NCT00370747|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
111431418|NCT00370747|Protective Agents|protective agents|mesh-ancestor
111431419|NCT00370747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111431420|NCT00370747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111431421|NCT02752256|Plasminogen|plasminogen|mesh-list
111431422|NCT02752256|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
111431423|NCT02752256|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111431424|NCT02752256|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111431425|NCT02752256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111431426|NCT02227446|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111431427|NCT02227446|Vancomycin|vancomycin|mesh-list
111431428|NCT02227446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111431429|NCT04738058|Lactoferrin|lactoferrin|mesh-list
111431430|NCT04738058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111431431|NCT02227368|Ticagrelor|ticagrelor|mesh-list
111431432|NCT02227368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111431433|NCT02227368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111431434|NCT02227368|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111431435|NCT02227368|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111431436|NCT02227368|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111431437|NCT02227368|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111431438|NCT02227368|Purinergic Agents|purinergic agents|mesh-ancestor
111431439|NCT02227368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111431440|NCT02162862|Bupropion|bupropion|mesh-list
111431441|NCT02162862|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111431442|NCT02162862|Antidepressive Agents|antidepressive agents|mesh-ancestor
111431443|NCT02162862|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111431444|NCT02162862|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111431445|NCT02162862|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111431446|NCT02162862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111431447|NCT02162862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111431448|NCT02162862|Dopamine Agents|dopamine agents|mesh-ancestor
111431449|NCT02162862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111431450|NCT02162862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111431451|NCT02162862|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111431452|NCT02162862|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111431453|NCT02162862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111431454|NCT05277727|Fucoidan|fucoidan|mesh-list
111431455|NCT05277727|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111431456|NCT05277727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111431457|NCT05277727|Anticoagulants|anticoagulants|mesh-ancestor
111431458|NCT05277727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111431459|NCT02226198|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111431460|NCT02226198|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111431461|NCT02226198|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111431462|NCT02226198|Antimetabolites|antimetabolites|mesh-ancestor
111431463|NCT02226198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111431464|NCT02226198|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111431465|NCT02226198|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111431466|NCT02226198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111431467|NCT02754518|Valsartan|valsartan|mesh-list
111431468|NCT02754518|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
111431469|NCT02754518|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111431470|NCT02754518|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111431471|NCT02754518|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111431472|NCT02754518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111431473|NCT02751385|Nintedanib|nintedanib|mesh-list
111431474|NCT02751385|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
111431475|NCT02751385|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
111431476|NCT02751385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111431477|NCT02751385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111431478|NCT02751385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111431479|NCT02751385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111431480|NCT02751385|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111431481|NCT02751385|Contraceptive Agents|contraceptive agents|mesh-ancestor
111431482|NCT02751385|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111431483|NCT02751385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111431484|NCT02751385|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
111431485|NCT02751385|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111431486|NCT02751385|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111431487|NCT02751385|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111431488|NCT02751385|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111431489|NCT02751385|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
111431490|NCT02751385|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
111431491|NCT02751385|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
111431492|NCT05349032|Curcumin|curcumin|mesh-list
111431493|NCT05349032|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111431494|NCT05349032|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111431495|NCT05349032|Analgesics|analgesics|mesh-ancestor
111431496|NCT05349032|Sensory System Agents|sensory system agents|mesh-ancestor
111431497|NCT05349032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111431498|NCT05349032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111431499|NCT05349032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111431500|NCT05349032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111431501|NCT05349032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111431502|NCT05349032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111431503|NCT05349032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111431504|NCT05057689|Fentanyl|fentanyl|mesh-list
111431505|NCT05057689|Midazolam|midazolam|mesh-list
111431506|NCT05057689|Dexmedetomidine|dexmedetomidine|mesh-list
111431507|NCT05057689|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111431508|NCT05057689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111431509|NCT05057689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111431510|NCT05057689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111431511|NCT05057689|Analgesics|analgesics|mesh-ancestor
111431512|NCT05057689|Sensory System Agents|sensory system agents|mesh-ancestor
111431513|NCT05057689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111431514|NCT05057689|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111431515|NCT05057689|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111431516|NCT05057689|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111431517|NCT05057689|Adrenergic Agents|adrenergic agents|mesh-ancestor
111431518|NCT05057689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111431519|NCT05057689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111431520|NCT05057689|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111431521|NCT05057689|Narcotics|narcotics|mesh-ancestor
111431522|NCT05057689|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111431523|NCT05057689|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111431524|NCT05057689|Anesthetics, General|anesthetics, general|mesh-ancestor
111431525|NCT05057689|Anesthetics|anesthetics|mesh-ancestor
111431526|NCT05057689|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111431527|NCT05057689|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111431528|NCT05057689|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111431529|NCT05057689|GABA Modulators|gaba modulators|mesh-ancestor
111431530|NCT05057689|GABA Agents|gaba agents|mesh-ancestor
111431531|NCT04737980|Dexamethasone|dexamethasone|mesh-list
111431532|NCT04737980|Bupivacaine|bupivacaine|mesh-list
111431533|NCT04737980|Ropivacaine|ropivacaine|mesh-list
111431534|NCT04737980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111431535|NCT04737980|Antiemetics|antiemetics|mesh-ancestor
111431536|NCT04737980|Autonomic Agents|autonomic agents|mesh-ancestor
111431537|NCT04737980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111431538|NCT04737980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111431539|NCT04737980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111431540|NCT04737980|Glucocorticoids|glucocorticoids|mesh-ancestor
111431541|NCT04737980|Hormones|hormones|mesh-ancestor
111431542|NCT04737980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111431543|NCT04737980|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111431544|NCT04737980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111431545|NCT04737980|Anesthetics, Local|anesthetics, local|mesh-ancestor
111431546|NCT04737980|Anesthetics|anesthetics|mesh-ancestor
111431547|NCT04737980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111431548|NCT04737980|Sensory System Agents|sensory system agents|mesh-ancestor
111431549|NCT00371696|Acetaminophen|acetaminophen|mesh-list
111431550|NCT00371696|Diclofenac|diclofenac|mesh-list
111431551|NCT00371696|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111431552|NCT00371696|Analgesics|analgesics|mesh-ancestor
111431553|NCT00371696|Sensory System Agents|sensory system agents|mesh-ancestor
111431554|NCT00371696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111431555|NCT00371696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111431556|NCT00371696|Antipyretics|antipyretics|mesh-ancestor
111431557|NCT00371696|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111431558|NCT00371696|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111431559|NCT00371696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111431560|NCT00371696|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111431561|NCT00371696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111431562|NCT00371696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111431563|NCT02756624|Cetirizine|cetirizine|mesh-list
111431564|NCT02756624|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111431565|NCT02756624|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
111431566|NCT02756624|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111155934|NCT03897621|Tranexamic Acid|tranexamic acid|mesh-list
111431567|NCT02756624|Histamine Antagonists|histamine antagonists|mesh-ancestor
111431568|NCT02756624|Histamine Agents|histamine agents|mesh-ancestor
111431569|NCT02756624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111431570|NCT02756624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110512501|NCT04951362|Ivermectin|ivermectin|mesh-list
111431571|NCT02756624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111431572|NCT02958800|Olanzapine|olanzapine|mesh-list
111431573|NCT02958800|Risperidone|risperidone|mesh-list
111431574|NCT02958800|Quetiapine Fumarate|quetiapine fumarate|mesh-list
111431575|NCT02958800|Antipsychotic Agents|antipsychotic agents|mesh-list
111431576|NCT02958800|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111431577|NCT02958800|Serotonin Agents|serotonin agents|mesh-ancestor
111431578|NCT02958800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111431579|NCT02958800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111431580|NCT02958800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111431581|NCT02958800|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111431582|NCT02958800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111431583|NCT02958800|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111431584|NCT02958800|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111431585|NCT02958800|Dopamine Agents|dopamine agents|mesh-ancestor
111431586|NCT02958800|Antiemetics|antiemetics|mesh-ancestor
111431587|NCT02958800|Autonomic Agents|autonomic agents|mesh-ancestor
111431588|NCT02958800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111431589|NCT02958800|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111431590|NCT02958800|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111431591|NCT02958800|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111431592|NCT02958800|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111431593|NCT02958800|Antidepressive Agents|antidepressive agents|mesh-ancestor
111431594|NCT00372086|Rosiglitazone|rosiglitazone|mesh-list
111431595|NCT00372086|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111431596|NCT00372086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111431597|NCT04738045|Ritonavir|ritonavir|mesh-list
111431598|NCT04738045|Lopinavir|lopinavir|mesh-list
111431599|NCT04738045|Remdesivir|remdesivir|mesh-list
111431600|NCT04738045|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111431601|NCT04738045|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111431602|NCT04738045|Protease Inhibitors|protease inhibitors|mesh-ancestor
111431603|NCT04738045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111431604|NCT04738045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111431605|NCT04738045|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111431606|NCT04738045|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111431607|NCT04738045|Antiviral Agents|antiviral agents|mesh-ancestor
111431608|NCT04738045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111431609|NCT04738045|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111431610|NCT04738045|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111431611|NCT04738045|Antimetabolites|antimetabolites|mesh-ancestor
111431612|NCT02226120|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
111431613|NCT02226120|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111431614|NCT02226120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111431615|NCT04587973|Dexmedetomidine|dexmedetomidine|mesh-list
111431616|NCT04587973|Ropivacaine|ropivacaine|mesh-list
111431617|NCT04587973|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111431618|NCT04587973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111431619|NCT04587973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111431620|NCT04587973|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111431621|NCT04587973|Analgesics|analgesics|mesh-ancestor
111431622|NCT04587973|Sensory System Agents|sensory system agents|mesh-ancestor
111431623|NCT04587973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111431624|NCT04587973|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111431625|NCT04587973|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111431626|NCT04587973|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111431627|NCT04587973|Adrenergic Agents|adrenergic agents|mesh-ancestor
111431628|NCT04587973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111431629|NCT04587973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111431630|NCT04587973|Anesthetics, Local|anesthetics, local|mesh-ancestor
111431631|NCT04587973|Anesthetics|anesthetics|mesh-ancestor
111431632|NCT02753881|Doxorubicin|doxorubicin|mesh-list
111431633|NCT02753881|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111431634|NCT02753881|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111431635|NCT02753881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111431636|NCT02753881|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111431637|NCT02753881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111431638|NCT02753881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111431639|NCT02753881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111431640|NCT00425360|Gemcitabine|gemcitabine|mesh-list
111431641|NCT00425360|Capecitabine|capecitabine|mesh-list
111431642|NCT00425360|Sargramostim|sargramostim|mesh-list
111431643|NCT00425360|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111431644|NCT00425360|Antimetabolites|antimetabolites|mesh-ancestor
111431645|NCT00425360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111431646|NCT00425360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111431647|NCT00425360|Immunologic Factors|immunologic factors|mesh-ancestor
111431648|NCT00425360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111431649|NCT04337606|Decitabine|decitabine|mesh-list
111431650|NCT04337606|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111431651|NCT04337606|Antimetabolites|antimetabolites|mesh-ancestor
111431652|NCT04337606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111431653|NCT04337606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111431654|NCT04337606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111431655|NCT01190306|Riboflavin|riboflavin|mesh-list
111431656|NCT01190306|Vitamin B Complex|vitamin b complex|mesh-ancestor
111431657|NCT01190306|Vitamins|vitamins|mesh-ancestor
111431658|NCT01190306|Micronutrients|micronutrients|mesh-ancestor
111431659|NCT01190306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111431660|NCT01190306|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111431661|NCT01190306|Dermatologic Agents|dermatologic agents|mesh-ancestor
111431662|NCT02759575|Pembrolizumab|pembrolizumab|mesh-list
111431663|NCT02759575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111431664|NCT02759575|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111431665|NCT02759575|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111431666|NCT02759575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111431667|NCT05320718|Ropivacaine|ropivacaine|mesh-list
111431668|NCT05320718|Anesthetics, Local|anesthetics, local|mesh-ancestor
111431669|NCT05320718|Anesthetics|anesthetics|mesh-ancestor
111431670|NCT05320718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111431671|NCT05320718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111431672|NCT05320718|Sensory System Agents|sensory system agents|mesh-ancestor
111431673|NCT05320718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111431674|NCT02739698|Paclitaxel|paclitaxel|mesh-list
111431675|NCT02739698|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111431676|NCT02739698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111431677|NCT02739698|Tubulin Modulators|tubulin modulators|mesh-ancestor
111431678|NCT02739698|Antimitotic Agents|antimitotic agents|mesh-ancestor
111431679|NCT02739698|Mitosis Modulators|mitosis modulators|mesh-ancestor
111431680|NCT02739698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111431681|NCT04336904|Favipiravir|favipiravir|mesh-list
111431682|NCT04336904|Antiviral Agents|antiviral agents|mesh-ancestor
111431683|NCT04336904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111431684|NCT02767934|Pembrolizumab|pembrolizumab|mesh-list
111431685|NCT02767934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111431686|NCT02767934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111431687|NCT02767934|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111431688|NCT02767934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111431689|NCT02194998|Ritonavir|ritonavir|mesh-list
111431690|NCT02194998|Ribavirin|ribavirin|mesh-list
111431691|NCT02194998|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111431692|NCT02194998|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111431693|NCT02194998|Protease Inhibitors|protease inhibitors|mesh-ancestor
111431694|NCT02194998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111431695|NCT02194998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111431696|NCT02194998|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111431697|NCT02194998|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111431698|NCT02194998|Antiviral Agents|antiviral agents|mesh-ancestor
111431699|NCT02194998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111431700|NCT02194998|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111431701|NCT02194998|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111431702|NCT02194998|Antimetabolites|antimetabolites|mesh-ancestor
111431703|NCT02194062|Fluticasone|fluticasone|mesh-list
111431704|NCT02194062|Xhance|xhance|mesh-list
111431705|NCT02194062|Budesonide|budesonide|mesh-list
111431706|NCT02194062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111431707|NCT02194062|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111431708|NCT02194062|Autonomic Agents|autonomic agents|mesh-ancestor
111431709|NCT02194062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111431710|NCT02194062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111431711|NCT02194062|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111431712|NCT02194062|Respiratory System Agents|respiratory system agents|mesh-ancestor
111431713|NCT02194062|Dermatologic Agents|dermatologic agents|mesh-ancestor
111431714|NCT02194062|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111431715|NCT02194062|Glucocorticoids|glucocorticoids|mesh-ancestor
111431716|NCT02194062|Hormones|hormones|mesh-ancestor
111431717|NCT02194062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111431719|NCT02768558|Etoposide|etoposide|mesh-list
111431720|NCT02768558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111431721|NCT02768558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111431722|NCT02768558|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111431723|NCT02768558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111431724|NCT02768558|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111431725|NCT02768558|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111431726|NCT02768558|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111431727|NCT02768558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111431728|NCT02192970|Bevacizumab|bevacizumab|mesh-list
111431729|NCT02192970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111431730|NCT02192970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111431731|NCT02192970|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111431732|NCT02192970|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111431733|NCT02192970|Growth Substances|growth substances|mesh-ancestor
111431734|NCT02192970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111431735|NCT02192970|Growth Inhibitors|growth inhibitors|mesh-ancestor
111431736|NCT05457296|Hydrocortisone|hydrocortisone|mesh-list
111431737|NCT05457296|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111431738|NCT05456438|Tea Tree Oil|tea tree oil|mesh-list
111431739|NCT05456438|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111431740|NCT05456438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111431741|NCT02744846|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111431742|NCT02744846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111431743|NCT02762071|Bupivacaine|bupivacaine|mesh-list
111431744|NCT02762071|Anesthetics, Local|anesthetics, local|mesh-ancestor
111431745|NCT02762071|Anesthetics|anesthetics|mesh-ancestor
111431746|NCT02762071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111431747|NCT02762071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111431748|NCT02762071|Sensory System Agents|sensory system agents|mesh-ancestor
111431749|NCT02762071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111431750|NCT04336891|Methyltestosterone|methyltestosterone|mesh-list
111431751|NCT04336891|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
111431752|NCT04336891|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
111431753|NCT04336891|Estradiol|estradiol|mesh-list
111431754|NCT04336891|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
111431755|NCT04336891|Testosterone|testosterone|mesh-list
111431756|NCT04336891|Testosterone undecanoate|testosterone undecanoate|mesh-list
111431757|NCT04336891|Testosterone enanthate|testosterone enanthate|mesh-list
111431758|NCT04336891|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
111431759|NCT04336891|Estrogens|estrogens|mesh-ancestor
111431760|NCT04336891|Hormones|hormones|mesh-ancestor
111431761|NCT04336891|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111431762|NCT04336891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111431763|NCT04336891|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111431764|NCT04336891|Contraceptive Agents|contraceptive agents|mesh-ancestor
111431765|NCT04336891|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111431766|NCT04336891|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111431767|NCT04336891|Androgens|androgens|mesh-ancestor
111431768|NCT04336891|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111431769|NCT04336891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111431770|NCT04336891|Anabolic Agents|anabolic agents|mesh-ancestor
111431771|NCT04337918|Nitric Oxide|nitric oxide|mesh-list
111431772|NCT04337918|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111431773|NCT04337918|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111431774|NCT04337918|Autonomic Agents|autonomic agents|mesh-ancestor
111431775|NCT04337918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111431776|NCT04337918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111431777|NCT04337918|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111431778|NCT04337918|Respiratory System Agents|respiratory system agents|mesh-ancestor
111431779|NCT04337918|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111431780|NCT04337918|Antioxidants|antioxidants|mesh-ancestor
111431781|NCT04337918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111431782|NCT04337918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111431783|NCT04337918|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
111431784|NCT04337918|Vasodilator Agents|vasodilator agents|mesh-ancestor
111431785|NCT04337918|Gasotransmitters|gasotransmitters|mesh-ancestor
111431786|NCT04337918|Protective Agents|protective agents|mesh-ancestor
111431787|NCT02747186|Lidocaine|lidocaine|mesh-list
111431788|NCT02747186|Anesthetics, Local|anesthetics, local|mesh-ancestor
111431789|NCT02747186|Anesthetics|anesthetics|mesh-ancestor
111431790|NCT02747186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111431791|NCT02747186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111431792|NCT02747186|Sensory System Agents|sensory system agents|mesh-ancestor
111431793|NCT02747186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111431795|NCT02747186|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111431796|NCT02747186|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111431797|NCT02747186|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111431798|NCT02747186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111431799|NCT02766517|Capsaicin|capsaicin|mesh-list
111431800|NCT02766517|Antipruritics|antipruritics|mesh-ancestor
111431801|NCT02766517|Dermatologic Agents|dermatologic agents|mesh-ancestor
111431802|NCT02766517|Sensory System Agents|sensory system agents|mesh-ancestor
111431803|NCT02766517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111431804|NCT02766517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111431805|NCT04336046|Bupivacaine|bupivacaine|mesh-list
111431806|NCT04336046|Anesthetics, Local|anesthetics, local|mesh-ancestor
111431807|NCT04336046|Anesthetics|anesthetics|mesh-ancestor
111431808|NCT04336046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111431809|NCT04336046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111431810|NCT04336046|Sensory System Agents|sensory system agents|mesh-ancestor
111431811|NCT04336046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111431812|NCT05348239|Copper|copper|mesh-list
111431813|NCT05348239|Chlorophyllin|chlorophyllin|mesh-list
111431814|NCT05348239|Trace Elements|trace elements|mesh-ancestor
111431815|NCT05348239|Micronutrients|micronutrients|mesh-ancestor
111431816|NCT05348239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111431817|NCT05348239|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
111431818|NCT05348239|Protective Agents|protective agents|mesh-ancestor
111431819|NCT02766673|Albuterol|albuterol|mesh-list
111431820|NCT02766673|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111431821|NCT02766673|Autonomic Agents|autonomic agents|mesh-ancestor
111431822|NCT02766673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111431823|NCT02766673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111431824|NCT02766673|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111431825|NCT02766673|Respiratory System Agents|respiratory system agents|mesh-ancestor
111431826|NCT02766673|Tocolytic Agents|tocolytic agents|mesh-ancestor
111431827|NCT02766673|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111431828|NCT02766673|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111431829|NCT02766673|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111431830|NCT02766673|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111431831|NCT02766673|Adrenergic Agents|adrenergic agents|mesh-ancestor
111431832|NCT02766673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111431833|NCT02766673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111431834|NCT00372008|Testosterone|testosterone|mesh-list
111431835|NCT00372008|Androgens|androgens|mesh-ancestor
111431836|NCT00372008|Hormones|hormones|mesh-ancestor
111431837|NCT00372008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111431838|NCT00372008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111431839|NCT02973763|Aflutinib|aflutinib|mesh-list
111431840|NCT02973763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111431841|NCT02973763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111431842|NCT02973763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111431843|NCT04337593|Pegaspargase|pegaspargase|mesh-list
111431844|NCT04337593|Basiliximab|basiliximab|mesh-list
111431845|NCT04337593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111431846|NCT04337593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111431847|NCT04337593|Immunologic Factors|immunologic factors|mesh-ancestor
111431848|NCT04337593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111431849|NCT05339581|Pembrolizumab|pembrolizumab|mesh-list
111431850|NCT05339581|Tislelizumab|tislelizumab|mesh-list
111431851|NCT05339581|Lenvatinib|lenvatinib|mesh-list
111431852|NCT05339581|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111431853|NCT05339581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111431854|NCT05339581|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111431855|NCT05339581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111431856|NCT05339581|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111431857|NCT05339581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111431858|NCT04064684|Budesonide|budesonide|mesh-list
111431859|NCT04064684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111431860|NCT04064684|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111431861|NCT04064684|Autonomic Agents|autonomic agents|mesh-ancestor
111431862|NCT04064684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111431863|NCT04064684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111431864|NCT04064684|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111431865|NCT04064684|Respiratory System Agents|respiratory system agents|mesh-ancestor
111431866|NCT04064684|Glucocorticoids|glucocorticoids|mesh-ancestor
111431867|NCT04064684|Hormones|hormones|mesh-ancestor
111431868|NCT04064684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111431870|NCT02192190|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111431871|NCT02192190|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111431872|NCT02192190|Analgesics|analgesics|mesh-ancestor
111431873|NCT02192190|Sensory System Agents|sensory system agents|mesh-ancestor
111431874|NCT02192190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111431875|NCT02192190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111431876|NCT02192190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111431877|NCT02192190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111431878|NCT02192190|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111431879|NCT02192190|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111431880|NCT02192190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111431881|NCT02192190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111431882|NCT02748889|Carboplatin|carboplatin|mesh-list
111431883|NCT02748889|Etoposide|etoposide|mesh-list
111431884|NCT02748889|Atezolizumab|atezolizumab|mesh-list
111431885|NCT02748889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111431886|NCT02748889|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111431887|NCT02748889|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111431888|NCT02748889|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111431889|NCT02748889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111431890|NCT02748889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111431891|NCT02748889|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111431892|NCT02748889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111431893|NCT04654988|Prednisone|prednisone|mesh-list
111431894|NCT04654988|Azathioprine|azathioprine|mesh-list
111431895|NCT04654988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111431896|NCT04654988|Glucocorticoids|glucocorticoids|mesh-ancestor
111431897|NCT04654988|Hormones|hormones|mesh-ancestor
111431898|NCT04654988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111431899|NCT04654988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111431900|NCT04654988|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111431901|NCT04654988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111431902|NCT04654988|Antimetabolites|antimetabolites|mesh-ancestor
111431903|NCT04654988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111431904|NCT04654988|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111431905|NCT04654988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111431906|NCT04654988|Immunologic Factors|immunologic factors|mesh-ancestor
111431907|NCT04654988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111431908|NCT02224560|Cannabidiol|cannabidiol|mesh-list
111431909|NCT02224560|Anticonvulsants|anticonvulsants|mesh-ancestor
111431910|NCT00372710|Zoledronic Acid|zoledronic acid|mesh-list
111431911|NCT00372710|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111431912|NCT00372710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111431913|NCT02973776|Clobetasol|clobetasol|mesh-list
111431914|NCT02973776|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
111431915|NCT02973776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111431916|NCT02973776|Glucocorticoids|glucocorticoids|mesh-ancestor
111431917|NCT02973776|Hormones|hormones|mesh-ancestor
111431918|NCT02973776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111431919|NCT02973776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111431920|NCT02161458|Dexetimide|dexetimide|mesh-list
111431921|NCT02161458|Citalopram|citalopram|mesh-list
111431922|NCT02161458|Escitalopram|escitalopram|mesh-list
111431923|NCT02161458|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111431924|NCT02161458|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111431925|NCT02161458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111431926|NCT02161458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111431927|NCT02161458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111431928|NCT02161458|Serotonin Agents|serotonin agents|mesh-ancestor
111431929|NCT02161458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111431930|NCT02161458|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111431931|NCT02161458|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111431932|NCT02161458|Parasympatholytics|parasympatholytics|mesh-ancestor
111431933|NCT02161458|Autonomic Agents|autonomic agents|mesh-ancestor
111431934|NCT02161458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111431935|NCT02161458|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111431936|NCT02161458|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111431937|NCT02161458|Cholinergic Agents|cholinergic agents|mesh-ancestor
111431938|NCT02161458|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111431939|NCT02161458|Antidepressive Agents|antidepressive agents|mesh-ancestor
111431940|NCT02161458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111431941|NCT04507022|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
111431942|NCT04507022|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
111431943|NCT04507022|Estradiol|estradiol|mesh-list
111431944|NCT04507022|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
111431945|NCT04507022|Progesterone|progesterone|mesh-list
111431946|NCT04507022|Aromatase Inhibitors|aromatase inhibitors|mesh-list
111431947|NCT04507022|Estrogens|estrogens|mesh-ancestor
111431948|NCT04507022|Hormones|hormones|mesh-ancestor
111431949|NCT04507022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111431950|NCT04507022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111431951|NCT04507022|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111431952|NCT04507022|Contraceptive Agents|contraceptive agents|mesh-ancestor
111431953|NCT04507022|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111431954|NCT04507022|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111431955|NCT04507022|Progestins|progestins|mesh-ancestor
111431956|NCT04507022|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111431957|NCT04507022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111431958|NCT04507022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111431959|NCT04507022|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111431960|NCT04507022|Hormone Antagonists|hormone antagonists|mesh-ancestor
111431961|NCT00372788|Pemetrexed|pemetrexed|mesh-list
111431962|NCT00372788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111431963|NCT00372788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111431964|NCT00372788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111431965|NCT00372788|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111431966|NCT00372788|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111431967|NCT00372476|Imatinib Mesylate|imatinib mesylate|mesh-list
111431968|NCT00372476|Vinorelbine|vinorelbine|mesh-list
111431969|NCT00372476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111431970|NCT00372476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111431971|NCT00372476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111431972|NCT00372476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111431973|NCT00372476|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110909202|NCT02068170|Antiemetics|antiemetics|mesh-ancestor
111431974|NCT00372476|Tubulin Modulators|tubulin modulators|mesh-ancestor
111431975|NCT00372476|Antimitotic Agents|antimitotic agents|mesh-ancestor
111431976|NCT00372476|Mitosis Modulators|mitosis modulators|mesh-ancestor
111431977|NCT04737967|Memantine|memantine|mesh-list
111431978|NCT04737967|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
111431979|NCT04737967|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111431980|NCT04737967|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111431981|NCT04737967|Dopamine Agents|dopamine agents|mesh-ancestor
111431982|NCT04737967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111431983|NCT04737967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111431984|NCT04737967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111431985|NCT04737967|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111431986|NCT04737967|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111431987|NCT04737967|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111431988|NCT04737967|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111431989|NCT04737967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111431990|NCT04737967|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111431991|NCT04737967|Antidepressive Agents|antidepressive agents|mesh-ancestor
111431992|NCT04737967|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111431993|NCT04766918|Hyaluronic Acid|hyaluronic acid|mesh-list
111431994|NCT04766918|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111431995|NCT04766918|Immunologic Factors|immunologic factors|mesh-ancestor
111431996|NCT04766918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111431997|NCT04766918|Viscosupplements|viscosupplements|mesh-ancestor
111431998|NCT04766918|Protective Agents|protective agents|mesh-ancestor
111431999|NCT03365414|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111432000|NCT04233476|Arginyl-glycyl-aspartic acid|arginyl-glycyl-aspartic acid|mesh-list
111432001|NCT04233476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111432002|NCT00371995|Amphotericin B|amphotericin b|mesh-list
111432003|NCT00371995|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
111432004|NCT00371995|Miltefosine|miltefosine|mesh-list
111432005|NCT00371995|Amebicides|amebicides|mesh-ancestor
111432006|NCT00371995|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111432007|NCT00371995|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111432008|NCT00371995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111432009|NCT00371995|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111432010|NCT00371995|Antifungal Agents|antifungal agents|mesh-ancestor
111432011|NCT00371995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111432012|NCT04193306|Alirocumab|alirocumab|mesh-list
111432013|NCT04193306|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
111432014|NCT04193306|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111432015|NCT04193306|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111432016|NCT04193306|Antimetabolites|antimetabolites|mesh-ancestor
111432017|NCT04193306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111432018|NCT04193306|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111432019|NCT04193306|Protease Inhibitors|protease inhibitors|mesh-ancestor
111432020|NCT04193306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111432021|NCT04193306|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111432022|NCT00372307|Pimecrolimus|pimecrolimus|mesh-list
111432023|NCT00372307|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111432024|NCT00372307|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111432025|NCT00372307|Analgesics|analgesics|mesh-ancestor
111432026|NCT00372307|Sensory System Agents|sensory system agents|mesh-ancestor
111432027|NCT00372307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111432028|NCT00372307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111432029|NCT00372307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111432030|NCT00372307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111432031|NCT00372307|Dermatologic Agents|dermatologic agents|mesh-ancestor
111432032|NCT00372307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111432033|NCT00372307|Immunologic Factors|immunologic factors|mesh-ancestor
111432034|NCT00372307|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111432035|NCT00372307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111432036|NCT00372307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111432037|NCT04647110|Crizotinib|crizotinib|mesh-list
111432038|NCT04647110|Ceritinib|ceritinib|mesh-list
111432039|NCT04647110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111432040|NCT04647110|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111432041|NCT04647110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111432042|NCT04647110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111432043|NCT04061330|Ketamine|ketamine|mesh-list
111432044|NCT04061330|Morphine|morphine|mesh-list
111432045|NCT04061330|Analgesics|analgesics|mesh-ancestor
111432046|NCT04061330|Sensory System Agents|sensory system agents|mesh-ancestor
111432047|NCT04061330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111432048|NCT04061330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111432049|NCT04061330|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111432050|NCT04061330|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111432051|NCT04061330|Anesthetics, General|anesthetics, general|mesh-ancestor
111432052|NCT04061330|Anesthetics|anesthetics|mesh-ancestor
111432053|NCT04061330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111432054|NCT04061330|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111432055|NCT04061330|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111432056|NCT04061330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111432057|NCT04061330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111432058|NCT04061330|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111432059|NCT04061330|Narcotics|narcotics|mesh-ancestor
111432060|NCT00372632|Pyrimethamine|pyrimethamine|mesh-list
111432061|NCT00372632|Sulfadoxine|sulfadoxine|mesh-list
111432062|NCT00372632|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
111432063|NCT00372632|Antimalarials|antimalarials|mesh-ancestor
111432064|NCT00372632|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111432065|NCT00372632|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111432066|NCT00372632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111432067|NCT00372632|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111432068|NCT00372632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111432069|NCT00372632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111432070|NCT00372632|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111432071|NCT04792021|Acetylcysteine|acetylcysteine|mesh-list
111432072|NCT04792021|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111432073|NCT04792021|Antiviral Agents|antiviral agents|mesh-ancestor
111432074|NCT04792021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111432075|NCT04792021|Expectorants|expectorants|mesh-ancestor
111432076|NCT04792021|Respiratory System Agents|respiratory system agents|mesh-ancestor
111432077|NCT04792021|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111432078|NCT04792021|Antioxidants|antioxidants|mesh-ancestor
111432079|NCT04792021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111432080|NCT04792021|Protective Agents|protective agents|mesh-ancestor
111432081|NCT04792021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111432082|NCT04792021|Antidotes|antidotes|mesh-ancestor
111432083|NCT04333927|Immunomodulating Agents|immunomodulating agents|mesh-list
111432084|NCT04333927|Immunologic Factors|immunologic factors|mesh-ancestor
111432085|NCT04333927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111432086|NCT04334005|Vitamin D|vitamin d|mesh-list
111432087|NCT04334005|Vitamins|vitamins|mesh-ancestor
111432088|NCT04334005|Micronutrients|micronutrients|mesh-ancestor
111432089|NCT04334005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111432090|NCT04334005|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111432091|NCT00966914|Paclitaxel|paclitaxel|mesh-list
111432092|NCT00966914|Docetaxel|docetaxel|mesh-list
111432093|NCT00966914|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111432094|NCT00966914|Cisplatin|cisplatin|mesh-list
111432095|NCT00966914|2,2'-dithiodiethanesulfonic acid|2,2'-dithiodiethanesulfonic acid|mesh-list
111432096|NCT00966914|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111432097|NCT00966914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111432098|NCT00966914|Tubulin Modulators|tubulin modulators|mesh-ancestor
111432099|NCT00966914|Antimitotic Agents|antimitotic agents|mesh-ancestor
111432100|NCT00966914|Mitosis Modulators|mitosis modulators|mesh-ancestor
111432101|NCT00966914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111432102|NCT00966914|Protective Agents|protective agents|mesh-ancestor
111432103|NCT00966914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111432104|NCT04432285|Botulinum Toxins|botulinum toxins|mesh-list
110512591|NCT02775006|Docetaxel|docetaxel|mesh-list
111432105|NCT04432285|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111432106|NCT04432285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111432107|NCT04432285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111432108|NCT04432285|Cholinergic Agents|cholinergic agents|mesh-ancestor
111432109|NCT04432285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111432110|NCT04432285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111432111|NCT04430959|Candesartan|candesartan|mesh-list
111432112|NCT04430959|Candesartan cilexetil|candesartan cilexetil|mesh-list
111432113|NCT04430959|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111432114|NCT04430959|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111432115|NCT04430959|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111432116|NCT04430959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111432117|NCT04737655|Beclomethasone|beclomethasone|mesh-list
111432118|NCT04737655|Glycopyrrolate|glycopyrrolate|mesh-list
111432119|NCT04737655|Formoterol Fumarate|formoterol fumarate|mesh-list
111432120|NCT04737655|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111432121|NCT04737655|Autonomic Agents|autonomic agents|mesh-ancestor
111432122|NCT04737655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111432123|NCT04737655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111432124|NCT04737655|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111432125|NCT04737655|Respiratory System Agents|respiratory system agents|mesh-ancestor
111432126|NCT04737655|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111432127|NCT04737655|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111432128|NCT04737655|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111432129|NCT04737655|Adrenergic Agents|adrenergic agents|mesh-ancestor
111432130|NCT04737655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111432131|NCT04737655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111432132|NCT04737655|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111432133|NCT04737655|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111432134|NCT04737655|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111432135|NCT04737655|Cholinergic Agents|cholinergic agents|mesh-ancestor
111432136|NCT04737655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111432137|NCT04737655|Glucocorticoids|glucocorticoids|mesh-ancestor
111432138|NCT04737655|Hormones|hormones|mesh-ancestor
111432139|NCT04737655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111432140|NCT05063396|Analgesics, Opioid|analgesics, opioid|mesh-list
111432141|NCT05063396|Anesthetics|anesthetics|mesh-list
111432142|NCT05063396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111432143|NCT05063396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111432144|NCT05063396|Narcotics|narcotics|mesh-ancestor
111432145|NCT05063396|Analgesics|analgesics|mesh-ancestor
111432146|NCT05063396|Sensory System Agents|sensory system agents|mesh-ancestor
111432147|NCT05063396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111432148|NCT05055752|Aspirin|aspirin|mesh-list
111432149|NCT05055752|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111432150|NCT05055752|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111432151|NCT05055752|Analgesics|analgesics|mesh-ancestor
111432152|NCT05055752|Sensory System Agents|sensory system agents|mesh-ancestor
111432153|NCT05055752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111432154|NCT05055752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111432155|NCT05055752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111432156|NCT05055752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111432157|NCT05055752|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111432158|NCT05055752|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111432159|NCT05055752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111432160|NCT05055752|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111432161|NCT05055752|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111432162|NCT05055752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111432163|NCT05055752|Antipyretics|antipyretics|mesh-ancestor
111432164|NCT04209140|Lithium Carbonate|lithium carbonate|mesh-list
111432165|NCT04209140|Antidepressive Agents|antidepressive agents|mesh-ancestor
111432167|NCT04209140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111432168|NCT04209140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111432169|NCT04209140|Antimanic Agents|antimanic agents|mesh-ancestor
111432170|NCT04209140|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111432171|NCT04209140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111432172|NCT04209140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111432173|NCT00372541|Ceftriaxone|ceftriaxone|mesh-list
111432174|NCT00372541|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111432175|NCT00372541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111432176|NCT04762381|Dexamethasone|dexamethasone|mesh-list
111432177|NCT04762381|Glucocorticoids|glucocorticoids|mesh-list
111432178|NCT04762381|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
111432179|NCT04762381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111432180|NCT04762381|Antiemetics|antiemetics|mesh-ancestor
111432181|NCT04762381|Autonomic Agents|autonomic agents|mesh-ancestor
111432182|NCT04762381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111432183|NCT04762381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111432184|NCT04762381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111432185|NCT04762381|Hormones|hormones|mesh-ancestor
111432186|NCT04762381|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111432187|NCT04762381|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111432188|NCT04762381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111432189|NCT01547468|Analgesics, Opioid|analgesics, opioid|mesh-list
111432190|NCT01547468|Narcotics|narcotics|mesh-ancestor
111432191|NCT01547468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111432192|NCT01547468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111432193|NCT01547468|Analgesics|analgesics|mesh-ancestor
111432194|NCT01547468|Sensory System Agents|sensory system agents|mesh-ancestor
111432195|NCT01547468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111432196|NCT04333628|Chloroquine|chloroquine|mesh-list
111432197|NCT04333628|Amebicides|amebicides|mesh-ancestor
111432198|NCT04333628|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111432199|NCT04333628|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111432200|NCT04333628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111432201|NCT04333628|Antimalarials|antimalarials|mesh-ancestor
111432202|NCT04333628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111432203|NCT00373412|Vaccines|vaccines|mesh-list
111432204|NCT00373412|Immunologic Factors|immunologic factors|mesh-ancestor
111432205|NCT00373412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111432206|NCT00373178|Metformin|metformin|mesh-list
111432207|NCT00373178|Rosiglitazone|rosiglitazone|mesh-list
111432208|NCT00373178|Hypoglycemic Agents|hypoglycemic agents|mesh-list
111432209|NCT00373178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111432210|NCT03254732|Pembrolizumab|pembrolizumab|mesh-list
111432211|NCT03254732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111432212|NCT03254732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111432213|NCT03254732|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111432214|NCT03254732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111432215|NCT02923466|Interferon-beta|interferon-beta|mesh-list
111432216|NCT02923466|Avelumab|avelumab|mesh-list
111432217|NCT02923466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111432218|NCT02923466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111432219|NCT02923466|Antiviral Agents|antiviral agents|mesh-ancestor
111432220|NCT02923466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111432221|NCT02923466|Immunologic Factors|immunologic factors|mesh-ancestor
111432222|NCT02923466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111432223|NCT00813566|Deoxyglucose|deoxyglucose|mesh-list
111432224|NCT00813566|Antimetabolites|antimetabolites|mesh-ancestor
111432225|NCT00813566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111432226|NCT00813566|Antiviral Agents|antiviral agents|mesh-ancestor
111432227|NCT00813566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111432228|NCT02885012|Ambrisentan|ambrisentan|mesh-list
111432229|NCT02885012|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111432230|NCT00372853|Tremelimumab|tremelimumab|mesh-list
111432231|NCT00372853|Ipilimumab|ipilimumab|mesh-list
111432232|NCT00372853|Sunitinib|sunitinib|mesh-list
111432233|NCT00372853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111432234|NCT00372853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111432235|NCT00372853|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111432236|NCT00372853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111432237|NCT00372853|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111432238|NCT00372853|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111432239|NCT00372853|Growth Substances|growth substances|mesh-ancestor
111432240|NCT00372853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111432241|NCT00372853|Growth Inhibitors|growth inhibitors|mesh-ancestor
111432242|NCT00372853|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111432243|NCT00372853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111432244|NCT02885636|Albuterol|albuterol|mesh-list
111432245|NCT02885636|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111432246|NCT02885636|Autonomic Agents|autonomic agents|mesh-ancestor
111432247|NCT02885636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111432248|NCT02885636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111432249|NCT02885636|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111432250|NCT02885636|Respiratory System Agents|respiratory system agents|mesh-ancestor
111432251|NCT02885636|Tocolytic Agents|tocolytic agents|mesh-ancestor
111432252|NCT02885636|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111432253|NCT02885636|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111432254|NCT02885636|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111432255|NCT02885636|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111432256|NCT02885636|Adrenergic Agents|adrenergic agents|mesh-ancestor
111432257|NCT02885636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111432258|NCT02885636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111432259|NCT00373087|Entacapone|entacapone|mesh-list
111432260|NCT00373087|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111432261|NCT00373087|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111432262|NCT00373087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111432263|NCT00373087|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
111432264|NCT00373087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111432265|NCT02892110|Varenicline|varenicline|mesh-list
111432266|NCT02892110|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111432267|NCT02892110|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111432268|NCT02892110|Cholinergic Agents|cholinergic agents|mesh-ancestor
111432269|NCT02892110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111432270|NCT02892110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111432271|NCT02892110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111432272|NCT02779166|Celecoxib|celecoxib|mesh-list
111432273|NCT02779166|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111432274|NCT02779166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111432275|NCT02779166|Analgesics|analgesics|mesh-ancestor
111432276|NCT02779166|Sensory System Agents|sensory system agents|mesh-ancestor
111432277|NCT02779166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111432278|NCT02779166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111432279|NCT02779166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111432280|NCT02779166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111432281|NCT02779166|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111432282|NCT02779166|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111432283|NCT02779166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111432284|NCT02779166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111432285|NCT00373165|Ganciclovir|ganciclovir|mesh-list
111432286|NCT00373165|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
111432287|NCT00373165|Antiviral Agents|antiviral agents|mesh-ancestor
111432288|NCT00373165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111432289|NCT00373165|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111432290|NCT00373165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111432291|NCT00373165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111432292|NCT04333550|Deferoxamine|deferoxamine|mesh-list
111432293|NCT04333550|Siderophores|siderophores|mesh-ancestor
111432294|NCT04333550|Iron Chelating Agents|iron chelating agents|mesh-ancestor
111432295|NCT04333550|Chelating Agents|chelating agents|mesh-ancestor
111432296|NCT04333550|Sequestering Agents|sequestering agents|mesh-ancestor
111432297|NCT04333550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111432298|NCT02827838|Durvalumab|durvalumab|mesh-list
111432299|NCT02827838|Immunoglobulins|immunoglobulins|mesh-list
111432300|NCT02827838|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111432301|NCT02827838|Immunoglobulin G|immunoglobulin g|mesh-list
111432302|NCT02827838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111432303|NCT02827838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111432304|NCT02827838|Immunologic Factors|immunologic factors|mesh-ancestor
111432305|NCT02827838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111432306|NCT02902172|Acetaminophen|acetaminophen|mesh-list
111432307|NCT02902172|Ibuprofen|ibuprofen|mesh-list
111432308|NCT02902172|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111432309|NCT02902172|Analgesics|analgesics|mesh-ancestor
111432310|NCT02902172|Sensory System Agents|sensory system agents|mesh-ancestor
111432311|NCT02902172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111432312|NCT02902172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111432313|NCT02902172|Antipyretics|antipyretics|mesh-ancestor
111432314|NCT02902172|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111156683|NCT01938573|Sirolimus|sirolimus|mesh-list
111432315|NCT02902172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111432316|NCT02902172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111432317|NCT02902172|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111432318|NCT02902172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111432319|NCT02902172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111432321|NCT04208347|Apatinib|apatinib|mesh-list
111432322|NCT04208347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111432323|NCT04208347|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111432324|NCT04208347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111432325|NCT04208347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111432326|NCT02777749|Bupivacaine|bupivacaine|mesh-list
111432327|NCT02777749|Anesthetics, Local|anesthetics, local|mesh-ancestor
111432328|NCT02777749|Anesthetics|anesthetics|mesh-ancestor
111432329|NCT02777749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111432330|NCT02777749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111432331|NCT02777749|Sensory System Agents|sensory system agents|mesh-ancestor
111432332|NCT02777749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111432333|NCT02785172|Clobetasol|clobetasol|mesh-list
111432334|NCT02785172|Halobetasol|halobetasol|mesh-list
111432335|NCT02785172|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111432336|NCT02785172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111432337|NCT02785172|Glucocorticoids|glucocorticoids|mesh-ancestor
111432338|NCT02785172|Hormones|hormones|mesh-ancestor
111432339|NCT02785172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111432340|NCT02785172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111432341|NCT02582125|Nivolumab|nivolumab|mesh-list
111432342|NCT02582125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111432343|NCT02582125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111432344|NCT02582125|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110512661|NCT02772354|Metoprolol|metoprolol|mesh-list
111432345|NCT02582125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111432346|NCT02785406|Suvorexant|suvorexant|mesh-list
111432347|NCT02785406|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111432348|NCT02785406|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111432349|NCT02785406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111432350|NCT02785406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111432351|NCT02785406|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
111432352|NCT02785406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111432353|NCT02785406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111432354|NCT02062489|Tamoxifen|tamoxifen|mesh-list
111432355|NCT02062489|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111432356|NCT02062489|Hormone Antagonists|hormone antagonists|mesh-ancestor
111432357|NCT02062489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111432358|NCT02062489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111432359|NCT02062489|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111432360|NCT02062489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111432361|NCT02062489|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111432362|NCT02062489|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111432363|NCT02062489|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111432364|NCT02780869|Thrombin|thrombin|mesh-list
111432365|NCT02780869|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
111432366|NCT02780869|Hemostatics|hemostatics|mesh-ancestor
111432367|NCT02780869|Coagulants|coagulants|mesh-ancestor
111432368|NCT02908490|Sildenafil Citrate|sildenafil citrate|mesh-list
111432369|NCT02908490|Vasodilator Agents|vasodilator agents|mesh-ancestor
111432370|NCT02908490|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111432371|NCT02908490|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111432372|NCT02908490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111432373|NCT02908490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111432374|NCT02908490|Urological Agents|urological agents|mesh-ancestor
111432375|NCT02911844|Fulvestrant|fulvestrant|mesh-list
111432376|NCT02911844|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111432377|NCT02911844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111432378|NCT02911844|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
111432379|NCT02911844|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111432380|NCT02911844|Hormone Antagonists|hormone antagonists|mesh-ancestor
111432381|NCT02911844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111432382|NCT02911844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111432383|NCT02790788|Methylprednisolone|methylprednisolone|mesh-list
111432384|NCT02790788|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111432385|NCT02790788|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111432386|NCT02790788|Prednisolone|prednisolone|mesh-list
111432387|NCT02790788|Prednisolone acetate|prednisolone acetate|mesh-list
111432388|NCT02790788|Hydrocortisone|hydrocortisone|mesh-list
111432389|NCT02790788|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
111432390|NCT02790788|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111432391|NCT02790788|Prednisolone phosphate|prednisolone phosphate|mesh-list
111432392|NCT02790788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111432393|NCT02790788|Antiemetics|antiemetics|mesh-ancestor
111432394|NCT02790788|Autonomic Agents|autonomic agents|mesh-ancestor
111432395|NCT02790788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111432396|NCT02790788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111432397|NCT02790788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111432398|NCT02790788|Glucocorticoids|glucocorticoids|mesh-ancestor
111432399|NCT02790788|Hormones|hormones|mesh-ancestor
111432400|NCT02790788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111432401|NCT02790788|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111432402|NCT02790788|Protective Agents|protective agents|mesh-ancestor
111432403|NCT02790788|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111432404|NCT02790788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111432405|NCT02888665|Doxorubicin|doxorubicin|mesh-list
111432406|NCT02888665|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111432407|NCT02888665|Pembrolizumab|pembrolizumab|mesh-list
111432408|NCT02888665|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111432409|NCT02888665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111432410|NCT02888665|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111432411|NCT02888665|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111432412|NCT02888665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111432413|NCT02888665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111432414|NCT02888665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111432415|NCT02888665|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111432416|NCT02781571|Sofosbuvir|sofosbuvir|mesh-list
111432417|NCT02781571|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
111432418|NCT02781571|Velpatasvir|velpatasvir|mesh-list
111432419|NCT02781571|Antiviral Agents|antiviral agents|mesh-ancestor
111432420|NCT02781571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111432421|NCT02918630|Nicotine|nicotine|mesh-list
111432422|NCT02918630|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111432423|NCT02918630|Autonomic Agents|autonomic agents|mesh-ancestor
111432424|NCT02918630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111432425|NCT02918630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111432426|NCT02918630|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111432427|NCT02918630|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111432428|NCT02918630|Cholinergic Agents|cholinergic agents|mesh-ancestor
111432429|NCT02918630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111432430|NCT02918630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111432431|NCT02781649|Ribavirin|ribavirin|mesh-list
111432432|NCT02781649|Sofosbuvir|sofosbuvir|mesh-list
111432433|NCT02781649|Grazoprevir|grazoprevir|mesh-list
111432434|NCT02781649|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
111432435|NCT02781649|Antimetabolites|antimetabolites|mesh-ancestor
111432436|NCT02781649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111432437|NCT02781649|Antiviral Agents|antiviral agents|mesh-ancestor
111432438|NCT02781649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111432439|NCT02794844|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
111432440|NCT02794844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111432441|NCT02794844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111432442|NCT02783443|Anesthetics|anesthetics|mesh-list
111432443|NCT02783443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111432444|NCT02783443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111432445|NCT00373568|Miltefosine|miltefosine|mesh-list
111432446|NCT00373568|Antifungal Agents|antifungal agents|mesh-ancestor
111432447|NCT00373568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111432448|NCT00373568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111432449|NCT00373568|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111432450|NCT00373568|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111432451|NCT03002012|Fluconazole|fluconazole|mesh-list
111432452|NCT03002012|Sertraline|sertraline|mesh-list
111432453|NCT03002012|Antidepressive Agents|antidepressive agents|mesh-ancestor
111432454|NCT03002012|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111432455|NCT03002012|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111432456|NCT03002012|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111432457|NCT03002012|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111432458|NCT03002012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111432459|NCT03002012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111432460|NCT03002012|Serotonin Agents|serotonin agents|mesh-ancestor
111432461|NCT03002012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111432462|NCT03002012|Antifungal Agents|antifungal agents|mesh-ancestor
111432463|NCT03002012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111432464|NCT03002012|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111432465|NCT03002012|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111432466|NCT03002012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111432467|NCT03002012|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111432468|NCT03002012|Hormone Antagonists|hormone antagonists|mesh-ancestor
111432469|NCT03002012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111432470|NCT03002012|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111432471|NCT03002012|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111432473|NCT00373646|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111432474|NCT00373646|Immunologic Factors|immunologic factors|mesh-ancestor
111432475|NCT00373646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111432476|NCT00373646|Leprostatic Agents|leprostatic agents|mesh-ancestor
111432477|NCT00373646|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111432478|NCT00373646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111432479|NCT00373646|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110512681|NCT02767752|Gemcitabine|gemcitabine|mesh-list
111432480|NCT00373646|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111432481|NCT00373646|Growth Substances|growth substances|mesh-ancestor
111432482|NCT00373646|Growth Inhibitors|growth inhibitors|mesh-ancestor
111432483|NCT00373646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111432484|NCT03001453|Epinephrine|epinephrine|mesh-list
111432485|NCT03001453|Bupivacaine|bupivacaine|mesh-list
111432486|NCT03001453|Anesthetics, Local|anesthetics, local|mesh-ancestor
111432487|NCT03001453|Anesthetics|anesthetics|mesh-ancestor
111432488|NCT03001453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111432489|NCT03001453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111432490|NCT03001453|Sensory System Agents|sensory system agents|mesh-ancestor
111432491|NCT03001453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111432492|NCT03001453|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111432493|NCT03001453|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111432494|NCT03001453|Adrenergic Agents|adrenergic agents|mesh-ancestor
111432495|NCT03001453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111432496|NCT03001453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111432497|NCT03001453|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111432498|NCT03001453|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111432499|NCT03001453|Autonomic Agents|autonomic agents|mesh-ancestor
111432500|NCT03001453|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111432501|NCT03001453|Respiratory System Agents|respiratory system agents|mesh-ancestor
111432502|NCT03001453|Mydriatics|mydriatics|mesh-ancestor
111432503|NCT03001453|Sympathomimetics|sympathomimetics|mesh-ancestor
111432504|NCT03001453|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111432505|NCT03001843|Ketamine|ketamine|mesh-list
111432506|NCT03001843|Narcotics|narcotics|mesh-list
111432507|NCT03001843|Analgesics|analgesics|mesh-ancestor
111432508|NCT03001843|Sensory System Agents|sensory system agents|mesh-ancestor
111432509|NCT03001843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111432510|NCT03001843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111432511|NCT03001843|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111432512|NCT03001843|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111432513|NCT03001843|Anesthetics, General|anesthetics, general|mesh-ancestor
111432514|NCT03001843|Anesthetics|anesthetics|mesh-ancestor
111432515|NCT03001843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111432516|NCT03001843|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111432517|NCT03001843|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111432518|NCT03001843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111432519|NCT03001843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111432520|NCT02785159|Tazarotene|tazarotene|mesh-list
111432521|NCT02785159|Dermatologic Agents|dermatologic agents|mesh-ancestor
111432522|NCT02785159|Keratolytic Agents|keratolytic agents|mesh-ancestor
111432523|NCT02786719|Cyclophosphamide|cyclophosphamide|mesh-list
111432524|NCT02786719|Doxorubicin|doxorubicin|mesh-list
111432525|NCT02786719|Etoposide|etoposide|mesh-list
111432526|NCT02786719|Vincristine|vincristine|mesh-list
111432527|NCT02786719|Topotecan|topotecan|mesh-list
111432528|NCT02786719|Sargramostim|sargramostim|mesh-list
111432529|NCT02786719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111432530|NCT02786719|Immunologic Factors|immunologic factors|mesh-ancestor
111432531|NCT02786719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111432532|NCT02786719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111432533|NCT02786719|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111432534|NCT02786719|Alkylating Agents|alkylating agents|mesh-ancestor
111432535|NCT02786719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111432536|NCT02786719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111432537|NCT02786719|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111432538|NCT02786719|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111432539|NCT02786719|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111432540|NCT02786719|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111432541|NCT02786719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111432542|NCT02786719|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111432543|NCT02786719|Tubulin Modulators|tubulin modulators|mesh-ancestor
111432544|NCT02786719|Antimitotic Agents|antimitotic agents|mesh-ancestor
111432545|NCT02786719|Mitosis Modulators|mitosis modulators|mesh-ancestor
111432546|NCT02786719|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111432548|NCT03003949|Progesterone|progesterone|mesh-list
111432549|NCT03003949|Estrogens|estrogens|mesh-ancestor
111432550|NCT03003949|Hormones|hormones|mesh-ancestor
110512690|NCT02835404|Nedaplatin|nedaplatin|mesh-list
111432551|NCT03003949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111432552|NCT03003949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111432553|NCT03003949|Progestins|progestins|mesh-ancestor
111432554|NCT03007225|Chlorotrianisene|chlorotrianisene|mesh-list
111432555|NCT03007225|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
111432556|NCT03007225|Estrogens|estrogens|mesh-ancestor
111432557|NCT03007225|Hormones|hormones|mesh-ancestor
111432558|NCT03007225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111432559|NCT03007225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111432560|NCT03007225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111432561|NCT03007225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111432562|NCT02800148|Azelaic acid|azelaic acid|mesh-list
111432563|NCT02800148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111432564|NCT02800148|Dermatologic Agents|dermatologic agents|mesh-ancestor
111432565|NCT02902081|Cannabidiol|cannabidiol|mesh-list
111432566|NCT02902081|Anticonvulsants|anticonvulsants|mesh-ancestor
111432567|NCT02791945|Acetylcysteine|acetylcysteine|mesh-list
111432568|NCT02791945|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111432569|NCT02791945|Antiviral Agents|antiviral agents|mesh-ancestor
111432570|NCT02791945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111432571|NCT02791945|Expectorants|expectorants|mesh-ancestor
111432572|NCT02791945|Respiratory System Agents|respiratory system agents|mesh-ancestor
111432573|NCT02791945|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111432574|NCT02791945|Antioxidants|antioxidants|mesh-ancestor
111432575|NCT02791945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111432576|NCT02791945|Protective Agents|protective agents|mesh-ancestor
111432577|NCT02791945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111432578|NCT02791945|Antidotes|antidotes|mesh-ancestor
111432579|NCT02793817|Loteprednol Etabonate|loteprednol etabonate|mesh-list
111432580|NCT02793817|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111432581|NCT00374192|Eszopiclone|eszopiclone|mesh-list
111432582|NCT00374192|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111432583|NCT00374192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111432584|NCT00374192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111432585|NCT02806544|Tamoxifen|tamoxifen|mesh-list
111432586|NCT02806544|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111432587|NCT02806544|Hormone Antagonists|hormone antagonists|mesh-ancestor
111432588|NCT02806544|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111432589|NCT02806544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111432590|NCT02806544|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111432591|NCT02806544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111432592|NCT02806544|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111432593|NCT02806544|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111432594|NCT02806544|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111432595|NCT00374348|Aripiprazole|aripiprazole|mesh-list
111432596|NCT00374348|Antidepressive Agents|antidepressive agents|mesh-ancestor
111432597|NCT00374348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111432598|NCT00374348|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111432599|NCT00374348|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111432600|NCT00374348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111432601|NCT00374348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111432602|NCT00374348|Dopamine Agonists|dopamine agonists|mesh-ancestor
111432603|NCT00374348|Dopamine Agents|dopamine agents|mesh-ancestor
111432604|NCT00374348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111432605|NCT00374348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111432606|NCT00374348|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111432607|NCT00374348|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111432608|NCT00374348|Serotonin Agents|serotonin agents|mesh-ancestor
111432609|NCT00374348|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111432610|NCT00374348|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111432611|NCT00374348|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111432612|NCT00374348|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111432613|NCT02933372|Varenicline|varenicline|mesh-list
111432614|NCT02933372|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111432615|NCT02933372|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111432616|NCT02933372|Cholinergic Agents|cholinergic agents|mesh-ancestor
111432617|NCT02933372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111432618|NCT02933372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111432619|NCT02933372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111432620|NCT02902237|Thromboplastin|thromboplastin|mesh-list
111432621|NCT02902237|Hemostatics|hemostatics|mesh-ancestor
111432622|NCT02902237|Coagulants|coagulants|mesh-ancestor
111432623|NCT02903407|Midazolam|midazolam|mesh-list
111432624|NCT02903407|Dexmedetomidine|dexmedetomidine|mesh-list
111432625|NCT02903407|Propofol|propofol|mesh-list
111432626|NCT02903407|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111432627|NCT02903407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111432628|NCT02903407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111432629|NCT02903407|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111432630|NCT02903407|Analgesics|analgesics|mesh-ancestor
111432631|NCT02903407|Sensory System Agents|sensory system agents|mesh-ancestor
111432632|NCT02903407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111432633|NCT02903407|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111432634|NCT02903407|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111432635|NCT02903407|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111432636|NCT02903407|Adrenergic Agents|adrenergic agents|mesh-ancestor
111432637|NCT02903407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111432638|NCT02903407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111432639|NCT02903407|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111432640|NCT02903407|Anesthetics, General|anesthetics, general|mesh-ancestor
111432641|NCT02903407|Anesthetics|anesthetics|mesh-ancestor
111432642|NCT02903407|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111432643|NCT02903407|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111432644|NCT02903407|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111432645|NCT02903407|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111432646|NCT02903407|GABA Modulators|gaba modulators|mesh-ancestor
111432647|NCT02903407|GABA Agents|gaba agents|mesh-ancestor
111432648|NCT02905981|Citric Acid|citric acid|mesh-list
111432649|NCT02905981|Sodium Citrate|sodium citrate|mesh-list
111432650|NCT02905981|Anticoagulants|anticoagulants|mesh-ancestor
111432651|NCT02905981|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
111432652|NCT02905981|Chelating Agents|chelating agents|mesh-ancestor
111432653|NCT02905981|Sequestering Agents|sequestering agents|mesh-ancestor
111432654|NCT02905981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111432655|NCT00374023|Vitamin A|vitamin a|mesh-list
111432656|NCT00374023|Vitamins|vitamins|mesh-ancestor
111432657|NCT00374023|Micronutrients|micronutrients|mesh-ancestor
111432658|NCT00374023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111432659|NCT02812238|Niacinamide|niacinamide|mesh-list
111432660|NCT02812238|Niacin|niacin|mesh-list
111432661|NCT02812238|Nicotinic Acids|nicotinic acids|mesh-list
111432662|NCT02812238|Vitamin B Complex|vitamin b complex|mesh-ancestor
111432663|NCT02812238|Vitamins|vitamins|mesh-ancestor
111432664|NCT02812238|Micronutrients|micronutrients|mesh-ancestor
111432665|NCT02812238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111432666|NCT02812238|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111432667|NCT02812238|Antimetabolites|antimetabolites|mesh-ancestor
111432668|NCT02812238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111432669|NCT02812238|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111432670|NCT02812238|Vasodilator Agents|vasodilator agents|mesh-ancestor
111432671|NCT03015961|Bupivacaine|bupivacaine|mesh-list
111432672|NCT03015961|Anesthetics, Local|anesthetics, local|mesh-ancestor
111432673|NCT03015961|Anesthetics|anesthetics|mesh-ancestor
111432674|NCT03015961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111432675|NCT03015961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111432676|NCT03015961|Sensory System Agents|sensory system agents|mesh-ancestor
111432677|NCT03015961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111432678|NCT03018223|Mycophenolic Acid|mycophenolic acid|mesh-list
111432679|NCT03018223|Sirolimus|sirolimus|mesh-list
111432680|NCT03018223|Cyclophosphamide|cyclophosphamide|mesh-list
111432681|NCT03018223|Busulfan|busulfan|mesh-list
111432682|NCT03018223|Fludarabine|fludarabine|mesh-list
111432683|NCT03018223|Lenograstim|lenograstim|mesh-list
111432684|NCT03018223|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111432685|NCT03018223|Immunologic Factors|immunologic factors|mesh-ancestor
111432686|NCT03018223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111432687|NCT03018223|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111432688|NCT03018223|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111432689|NCT03018223|Alkylating Agents|alkylating agents|mesh-ancestor
111432690|NCT03018223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111432691|NCT03018223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111432692|NCT03018223|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111432693|NCT03018223|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111432694|NCT03018223|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111432695|NCT03018223|Antitubercular Agents|antitubercular agents|mesh-ancestor
111432696|NCT03018223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111432697|NCT03018223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111432698|NCT03018223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111432699|NCT03018223|Antifungal Agents|antifungal agents|mesh-ancestor
111432700|NCT03018223|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111432701|NCT03018925|Golimumab|golimumab|mesh-list
111432702|NCT03018925|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111432703|NCT03018925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111432704|NCT03018925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111432705|NCT03018925|Immunologic Factors|immunologic factors|mesh-ancestor
111432706|NCT03018925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111432707|NCT03019783|Atazanavir Sulfate|atazanavir sulfate|mesh-list
111432708|NCT03019783|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111432709|NCT03019783|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111432710|NCT03019783|Protease Inhibitors|protease inhibitors|mesh-ancestor
111432711|NCT03019783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111432712|NCT03019783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111432713|NCT03019783|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111432714|NCT03019783|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111432715|NCT03019783|Antiviral Agents|antiviral agents|mesh-ancestor
111432716|NCT03019783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111432717|NCT03019939|Isavuconazole|isavuconazole|mesh-list
111432718|NCT03019939|Antifungal Agents|antifungal agents|mesh-ancestor
111432719|NCT03019939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111432720|NCT03020095|Ritonavir|ritonavir|mesh-list
111432721|NCT03020095|Ribavirin|ribavirin|mesh-list
111432722|NCT03020095|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111432723|NCT03020095|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111432724|NCT03020095|Protease Inhibitors|protease inhibitors|mesh-ancestor
111432725|NCT03020095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111432726|NCT03020095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111432727|NCT03020095|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111432728|NCT03020095|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111432729|NCT03020095|Antiviral Agents|antiviral agents|mesh-ancestor
111432730|NCT03020095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111432731|NCT03020095|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111432732|NCT03020095|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111432733|NCT03020095|Antimetabolites|antimetabolites|mesh-ancestor
111432734|NCT02934698|Ivacaftor|ivacaftor|mesh-list
111432735|NCT02934698|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
111432736|NCT02934698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111432737|NCT02934698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111432738|NCT03021343|Colchicine|colchicine|mesh-list
111432739|NCT03021343|Gout Suppressants|gout suppressants|mesh-ancestor
111432740|NCT03021343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111432741|NCT03021343|Tubulin Modulators|tubulin modulators|mesh-ancestor
111432742|NCT03021343|Antimitotic Agents|antimitotic agents|mesh-ancestor
111432743|NCT03021343|Mitosis Modulators|mitosis modulators|mesh-ancestor
111432744|NCT03021343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111432745|NCT03021343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111432746|NCT03025945|Nepafenac|nepafenac|mesh-list
111432747|NCT03025945|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111432748|NCT03025945|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111432749|NCT03025945|Analgesics|analgesics|mesh-ancestor
111432750|NCT03025945|Sensory System Agents|sensory system agents|mesh-ancestor
111432751|NCT03025945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111432752|NCT03025945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111432753|NCT03025945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111432754|NCT03025945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111432755|NCT02937506|Fentanyl|fentanyl|mesh-list
111432756|NCT02937506|Midazolam|midazolam|mesh-list
111432757|NCT02937506|Propofol|propofol|mesh-list
111432758|NCT02937506|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111432759|NCT02937506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111432760|NCT02937506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111432761|NCT02937506|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111432762|NCT02937506|Anesthetics, General|anesthetics, general|mesh-ancestor
111432763|NCT02937506|Anesthetics|anesthetics|mesh-ancestor
111432764|NCT02937506|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111432765|NCT02937506|Narcotics|narcotics|mesh-ancestor
111432766|NCT02937506|Analgesics|analgesics|mesh-ancestor
111432767|NCT02937506|Sensory System Agents|sensory system agents|mesh-ancestor
111432768|NCT02937506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111432769|NCT02937506|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111432770|NCT02937506|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111432771|NCT02937506|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111432772|NCT02937506|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111432773|NCT02937506|GABA Modulators|gaba modulators|mesh-ancestor
111432774|NCT02937506|GABA Agents|gaba agents|mesh-ancestor
111432775|NCT02937506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111432776|NCT02937506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111432777|NCT03026803|Capecitabine|capecitabine|mesh-list
111432778|NCT03026803|Oxaliplatin|oxaliplatin|mesh-list
111432779|NCT03026803|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111432780|NCT03026803|Antimetabolites|antimetabolites|mesh-ancestor
111432781|NCT03026803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111432782|NCT03026803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111432783|NCT03027661|Bupivacaine|bupivacaine|mesh-list
111432784|NCT03027661|Anesthetics, Local|anesthetics, local|mesh-ancestor
111432785|NCT03027661|Anesthetics|anesthetics|mesh-ancestor
111432786|NCT03027661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111432787|NCT03027661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111432788|NCT03027661|Sensory System Agents|sensory system agents|mesh-ancestor
111432789|NCT03027661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111432791|NCT03022526|Bupivacaine|bupivacaine|mesh-list
111432792|NCT03022526|Anesthetics, Local|anesthetics, local|mesh-ancestor
111432793|NCT03022526|Anesthetics|anesthetics|mesh-ancestor
111432794|NCT03022526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111432795|NCT03022526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111432796|NCT03022526|Sensory System Agents|sensory system agents|mesh-ancestor
111432797|NCT03022526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111432798|NCT03022526|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111432799|NCT03022526|Narcotics|narcotics|mesh-ancestor
111432800|NCT03022526|Analgesics|analgesics|mesh-ancestor
111432801|NCT03022526|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111432802|NCT03022526|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111432803|NCT03022526|Anesthetics, General|anesthetics, general|mesh-ancestor
111432804|NCT02794441|Dexamethasone|dexamethasone|mesh-list
111432805|NCT02794441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111432806|NCT02794441|Antiemetics|antiemetics|mesh-ancestor
111432807|NCT02794441|Autonomic Agents|autonomic agents|mesh-ancestor
111432808|NCT02794441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111432809|NCT02794441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111432810|NCT02794441|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111432811|NCT02794441|Glucocorticoids|glucocorticoids|mesh-ancestor
111432812|NCT02794441|Hormones|hormones|mesh-ancestor
111432813|NCT02794441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111432814|NCT02794441|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111432815|NCT02794441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111432816|NCT02941640|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
111432817|NCT02941640|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
111432818|NCT02941640|beta-Endorphin|beta-endorphin|mesh-list
111432819|NCT02941640|Hormones|hormones|mesh-ancestor
111432820|NCT02941640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111432821|NCT02941640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111432822|NCT02941640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111432823|NCT02941640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111432824|NCT02823080|Cetrorelix|cetrorelix|mesh-list
111432825|NCT02823080|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111432826|NCT02823080|Fertility Agents|fertility agents|mesh-ancestor
111432827|NCT02823080|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111432828|NCT02823080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111432829|NCT02823080|Hormone Antagonists|hormone antagonists|mesh-ancestor
111432830|NCT02823080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111432831|NCT03022916|Efinaconazole|efinaconazole|mesh-list
111432832|NCT03022916|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111432833|NCT03022916|Antifungal Agents|antifungal agents|mesh-ancestor
111432834|NCT03022916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111432835|NCT03031795|Ketorolac|ketorolac|mesh-list
111432836|NCT03031795|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111432837|NCT03031795|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111432838|NCT03031795|Analgesics|analgesics|mesh-ancestor
111432839|NCT03031795|Sensory System Agents|sensory system agents|mesh-ancestor
111432840|NCT03031795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111432841|NCT03031795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111432842|NCT03031795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111432843|NCT03031795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111432844|NCT03031795|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111432845|NCT03031795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111432846|NCT03031795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111432847|NCT02942654|Insulin Lispro|insulin lispro|mesh-list
111432848|NCT02942654|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111432849|NCT02942654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111432850|NCT02909959|Sulforaphane|sulforaphane|mesh-list
111432851|NCT02909959|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
111432852|NCT02909959|Protective Agents|protective agents|mesh-ancestor
111432853|NCT02909959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111432854|NCT02909959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111432855|NCT00373802|Phenylephrine|phenylephrine|mesh-list
111432856|NCT00373802|Oxymetazoline|oxymetazoline|mesh-list
111432857|NCT00373802|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111432858|NCT00373802|Mydriatics|mydriatics|mesh-ancestor
111432859|NCT00373802|Autonomic Agents|autonomic agents|mesh-ancestor
111432860|NCT00373802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111432861|NCT00373802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111432862|NCT00373802|Sympathomimetics|sympathomimetics|mesh-ancestor
111432863|NCT00373802|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111432864|NCT00373802|Nasal Decongestants|nasal decongestants|mesh-ancestor
111432865|NCT00373802|Respiratory System Agents|respiratory system agents|mesh-ancestor
111432866|NCT00373802|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111432867|NCT00373802|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111432868|NCT00373802|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111432869|NCT00373802|Adrenergic Agents|adrenergic agents|mesh-ancestor
111432870|NCT00373802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111432871|NCT00373802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111432872|NCT00373802|Protective Agents|protective agents|mesh-ancestor
111432873|NCT02945150|Grazoprevir|grazoprevir|mesh-list
111432874|NCT02945150|Antiviral Agents|antiviral agents|mesh-ancestor
111432875|NCT02945150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111432876|NCT03032965|Adenosine|adenosine|mesh-list
111432877|NCT03032965|Isoproterenol|isoproterenol|mesh-list
111432878|NCT03032965|Analgesics|analgesics|mesh-ancestor
111432879|NCT03032965|Sensory System Agents|sensory system agents|mesh-ancestor
111432880|NCT03032965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111432881|NCT03032965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111432882|NCT03032965|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111432883|NCT03032965|Vasodilator Agents|vasodilator agents|mesh-ancestor
111432884|NCT03032965|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
111432885|NCT03032965|Purinergic Agonists|purinergic agonists|mesh-ancestor
111432886|NCT03032965|Purinergic Agents|purinergic agents|mesh-ancestor
111432887|NCT03032965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111432888|NCT03032965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111432889|NCT03032965|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111432890|NCT03032965|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111432891|NCT03032965|Adrenergic Agents|adrenergic agents|mesh-ancestor
111432892|NCT03032965|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111432893|NCT03032965|Autonomic Agents|autonomic agents|mesh-ancestor
111432894|NCT03032965|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111432895|NCT03032965|Respiratory System Agents|respiratory system agents|mesh-ancestor
111432896|NCT03032965|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111432897|NCT03032965|Sympathomimetics|sympathomimetics|mesh-ancestor
111432898|NCT03032965|Protective Agents|protective agents|mesh-ancestor
111432899|NCT02948426|Interferon-gamma|interferon-gamma|mesh-list
111432900|NCT02948426|Antiviral Agents|antiviral agents|mesh-ancestor
111432901|NCT02948426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111432902|NCT03030638|Olodaterol|olodaterol|mesh-list
111432903|NCT03030638|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111432904|NCT03030638|Autonomic Agents|autonomic agents|mesh-ancestor
111432905|NCT03030638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111432906|NCT03030638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111432907|NCT03030638|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111432908|NCT03030638|Respiratory System Agents|respiratory system agents|mesh-ancestor
111432909|NCT02949674|Bupivacaine|bupivacaine|mesh-list
111432910|NCT02949674|Ropivacaine|ropivacaine|mesh-list
111432911|NCT02949674|Anesthetics, Local|anesthetics, local|mesh-ancestor
111432912|NCT02949674|Anesthetics|anesthetics|mesh-ancestor
111432913|NCT02949674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111432914|NCT02949674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111432915|NCT02949674|Sensory System Agents|sensory system agents|mesh-ancestor
111432916|NCT02949674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111432917|NCT03033511|Dexamethasone|dexamethasone|mesh-list
111157283|NCT02280044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111432918|NCT03033511|Dexamethasone acetate|dexamethasone acetate|mesh-list
111432919|NCT03033511|BB 1101|bb 1101|mesh-list
111432920|NCT03033511|Rovalpituzumab tesirine|rovalpituzumab tesirine|mesh-list
111432921|NCT03033511|Immunoconjugates|immunoconjugates|mesh-list
111432922|NCT03033511|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111432923|NCT03033511|Antiemetics|antiemetics|mesh-ancestor
111432924|NCT03033511|Autonomic Agents|autonomic agents|mesh-ancestor
111432925|NCT03033511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111432926|NCT03033511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111432927|NCT03033511|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111432928|NCT03033511|Glucocorticoids|glucocorticoids|mesh-ancestor
111432929|NCT03033511|Hormones|hormones|mesh-ancestor
111432930|NCT03033511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111432931|NCT03033511|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111432932|NCT03033511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111432933|NCT03033511|Protease Inhibitors|protease inhibitors|mesh-ancestor
111432934|NCT03033511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111432935|NCT03033511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111432936|NCT03033511|Immunologic Factors|immunologic factors|mesh-ancestor
111432937|NCT02951312|Glycopyrrolate|glycopyrrolate|mesh-list
111432938|NCT02951312|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111432939|NCT02951312|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111432940|NCT02951312|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111432941|NCT02951312|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111432942|NCT02951312|Cholinergic Agents|cholinergic agents|mesh-ancestor
111432943|NCT02951312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111432944|NCT02951312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111432945|NCT02951312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111432946|NCT03035929|Dexamethasone|dexamethasone|mesh-list
111432947|NCT03035929|Dexamethasone acetate|dexamethasone acetate|mesh-list
111432948|NCT03035929|BB 1101|bb 1101|mesh-list
111432949|NCT03035929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111432950|NCT03035929|Antiemetics|antiemetics|mesh-ancestor
111432951|NCT03035929|Autonomic Agents|autonomic agents|mesh-ancestor
111432952|NCT03035929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111432953|NCT03035929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111432954|NCT03035929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111432955|NCT03035929|Glucocorticoids|glucocorticoids|mesh-ancestor
111432956|NCT03035929|Hormones|hormones|mesh-ancestor
111432957|NCT03035929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111432958|NCT03035929|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111432959|NCT03035929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111432960|NCT03035929|Protease Inhibitors|protease inhibitors|mesh-ancestor
111432961|NCT03035929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111432962|NCT03035929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111432963|NCT02951702|Vancomycin|vancomycin|mesh-list
111432964|NCT02951702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111432965|NCT02951702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111432966|NCT02831816|Ethanol|ethanol|mesh-list
111432967|NCT02831816|Chlorhexidine|chlorhexidine|mesh-list
111432968|NCT02831816|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
111432969|NCT02831816|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111432970|NCT02831816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111432971|NCT02831816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111432972|NCT02831816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111432973|NCT02831816|Disinfectants|disinfectants|mesh-ancestor
111432974|NCT02831816|Dermatologic Agents|dermatologic agents|mesh-ancestor
111432975|NCT03036163|Macozinone|macozinone|mesh-list
111432976|NCT03036163|Antitubercular Agents|antitubercular agents|mesh-ancestor
111432977|NCT03036163|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111432978|NCT03036163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111432979|NCT02953886|Fluorides|fluorides|mesh-list
111432980|NCT02953886|Cariostatic Agents|cariostatic agents|mesh-ancestor
111432981|NCT02953886|Protective Agents|protective agents|mesh-ancestor
111432982|NCT02953886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111432983|NCT02802241|Peppermint oil|peppermint oil|mesh-list
111432984|NCT02802241|Antiemetics|antiemetics|mesh-ancestor
111432985|NCT02802241|Autonomic Agents|autonomic agents|mesh-ancestor
111432986|NCT02802241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111432987|NCT02802241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111432988|NCT02802241|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111432989|NCT02802241|Parasympatholytics|parasympatholytics|mesh-ancestor
111432990|NCT03035708|Varenicline|varenicline|mesh-list
111432991|NCT03035708|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111432992|NCT03035708|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111432993|NCT03035708|Cholinergic Agents|cholinergic agents|mesh-ancestor
111432994|NCT03035708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111432995|NCT03035708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111432996|NCT03035708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111432997|NCT00374426|Sertraline|sertraline|mesh-list
111432998|NCT00374426|Antidepressive Agents|antidepressive agents|mesh-ancestor
111432999|NCT00374426|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111433000|NCT00374426|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111433001|NCT00374426|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111433002|NCT00374426|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111433003|NCT00374426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111433004|NCT00374426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111433005|NCT00374426|Serotonin Agents|serotonin agents|mesh-ancestor
111433006|NCT00374426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111433007|NCT02916745|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
111433008|NCT02916745|Trioxsalen|trioxsalen|mesh-list
111433009|NCT02916745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111433010|NCT02916745|Dermatologic Agents|dermatologic agents|mesh-ancestor
111433011|NCT02916745|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111433012|NCT02954198|Mycophenolic Acid|mycophenolic acid|mesh-list
111433013|NCT02954198|Prednisone|prednisone|mesh-list
111433014|NCT02954198|Methylprednisolone|methylprednisolone|mesh-list
111433015|NCT02954198|Everolimus|everolimus|mesh-list
111433016|NCT02954198|Tacrolimus|tacrolimus|mesh-list
111433017|NCT02954198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111433018|NCT02954198|Glucocorticoids|glucocorticoids|mesh-ancestor
111433019|NCT02954198|Hormones|hormones|mesh-ancestor
111433020|NCT02954198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111433021|NCT02954198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111433022|NCT02954198|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111433023|NCT02954198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111433024|NCT02954198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111433025|NCT02954198|Immunologic Factors|immunologic factors|mesh-ancestor
111433026|NCT02954198|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111433027|NCT02954198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111433028|NCT02954198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111433029|NCT02954198|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111433030|NCT02954198|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111433031|NCT02954198|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111433032|NCT02954198|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111433033|NCT02954198|Antitubercular Agents|antitubercular agents|mesh-ancestor
111433034|NCT02954198|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111433035|NCT02954198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111433036|NCT02954198|Antiemetics|antiemetics|mesh-ancestor
111433037|NCT02954198|Autonomic Agents|autonomic agents|mesh-ancestor
111433038|NCT02954198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111433039|NCT02954198|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111433040|NCT02954198|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111433041|NCT02954198|Protective Agents|protective agents|mesh-ancestor
111433042|NCT02956070|Dexamethasone|dexamethasone|mesh-list
111433043|NCT02956070|Dexamethasone acetate|dexamethasone acetate|mesh-list
111433044|NCT02956070|BB 1101|bb 1101|mesh-list
111433045|NCT02956070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111433046|NCT02956070|Antiemetics|antiemetics|mesh-ancestor
111433047|NCT02956070|Autonomic Agents|autonomic agents|mesh-ancestor
111433048|NCT02956070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111433049|NCT02956070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111433050|NCT02956070|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111433051|NCT02956070|Glucocorticoids|glucocorticoids|mesh-ancestor
111433052|NCT02956070|Hormones|hormones|mesh-ancestor
111433053|NCT02956070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111433054|NCT02956070|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111433055|NCT02956070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111433056|NCT02956070|Protease Inhibitors|protease inhibitors|mesh-ancestor
111433057|NCT02956070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111433058|NCT02956070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111433059|NCT02956616|Ketorolac|ketorolac|mesh-list
111433060|NCT02956616|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111433061|NCT02956616|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111433062|NCT02956616|Analgesics|analgesics|mesh-ancestor
111433063|NCT02956616|Sensory System Agents|sensory system agents|mesh-ancestor
111433064|NCT02956616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111433065|NCT02956616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111433066|NCT02956616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111433067|NCT02956616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111433068|NCT02956616|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111433069|NCT02956616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111433070|NCT02956616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111433071|NCT02958956|Pioglitazone|pioglitazone|mesh-list
111433072|NCT02958956|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111433073|NCT02958956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111433074|NCT05829551|Ritonavir|ritonavir|mesh-list
111433075|NCT05829551|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111433076|NCT05829551|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111433077|NCT05829551|Protease Inhibitors|protease inhibitors|mesh-ancestor
111433078|NCT05829551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111433079|NCT05829551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111433080|NCT05829551|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111433081|NCT05829551|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111433082|NCT05829551|Antiviral Agents|antiviral agents|mesh-ancestor
111433083|NCT05829551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111433084|NCT05829551|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111433085|NCT05829551|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111433086|NCT05829460|Progestins|progestins|mesh-list
111433087|NCT05829460|Hormones|hormones|mesh-ancestor
111433088|NCT05829460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111433089|NCT05829460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111433090|NCT05829317|Magnesium Sulfate|magnesium sulfate|mesh-list
111433091|NCT05829317|Analgesics|analgesics|mesh-ancestor
111433092|NCT05829317|Sensory System Agents|sensory system agents|mesh-ancestor
111433093|NCT05829317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111433094|NCT05829317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111433095|NCT05829317|Anesthetics|anesthetics|mesh-ancestor
111433096|NCT05829317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111433097|NCT05829317|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111433098|NCT05829317|Anticonvulsants|anticonvulsants|mesh-ancestor
111433099|NCT05829317|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111433100|NCT05829317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111433101|NCT05829317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111433102|NCT05829317|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111433103|NCT05829317|Tocolytic Agents|tocolytic agents|mesh-ancestor
111433104|NCT05829317|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111433105|NCT05829148|Pregabalin|pregabalin|mesh-list
111433106|NCT05829148|Dexmedetomidine|dexmedetomidine|mesh-list
111433107|NCT05829148|Melatonin|melatonin|mesh-list
111433108|NCT05829148|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111433109|NCT05829148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111433110|NCT05829148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111433111|NCT05829148|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111433112|NCT05829148|Analgesics|analgesics|mesh-ancestor
111433113|NCT05829148|Sensory System Agents|sensory system agents|mesh-ancestor
111433114|NCT05829148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111433115|NCT05829148|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111433116|NCT05829148|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111433117|NCT05829148|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111433118|NCT05829148|Adrenergic Agents|adrenergic agents|mesh-ancestor
111433119|NCT05829148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111433120|NCT05829148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111433121|NCT05829148|Anticonvulsants|anticonvulsants|mesh-ancestor
111433122|NCT05829148|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111433123|NCT05829148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111433124|NCT05829148|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111433125|NCT05829148|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111433126|NCT05829148|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111433127|NCT05829148|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111433128|NCT05829148|Antioxidants|antioxidants|mesh-ancestor
111433129|NCT05829148|Protective Agents|protective agents|mesh-ancestor
111433130|NCT05829057|Interleukin-2|interleukin-2|mesh-list
111433131|NCT05829057|Antibodies|antibodies|mesh-list
111433132|NCT05829057|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111433133|NCT05829057|Immunologic Factors|immunologic factors|mesh-ancestor
111433134|NCT05829057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111433135|NCT05829057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111433136|NCT05829057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111433137|NCT05829057|Analgesics|analgesics|mesh-ancestor
111433138|NCT05829057|Sensory System Agents|sensory system agents|mesh-ancestor
111433139|NCT05829057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111433140|NCT05829044|Melatonin|melatonin|mesh-list
111433141|NCT05829044|Antioxidants|antioxidants|mesh-ancestor
111433142|NCT05829044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111433143|NCT05829044|Protective Agents|protective agents|mesh-ancestor
111433144|NCT05829044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111433145|NCT05829044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111433146|NCT05828836|Allopurinol|allopurinol|mesh-list
111157508|NCT02304302|Memantine|memantine|mesh-list
111433147|NCT05828836|Antimetabolites|antimetabolites|mesh-ancestor
111433148|NCT05828836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111433149|NCT05828836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111433150|NCT05828836|Gout Suppressants|gout suppressants|mesh-ancestor
111433151|NCT05828836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111433152|NCT05828836|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111433153|NCT05828836|Antioxidants|antioxidants|mesh-ancestor
111433154|NCT05828836|Protective Agents|protective agents|mesh-ancestor
111433155|NCT05828836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111433156|NCT05828810|Chlorhexidine|chlorhexidine|mesh-list
111433157|NCT05828810|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
111433158|NCT05828810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111433159|NCT05828810|Disinfectants|disinfectants|mesh-ancestor
111433160|NCT05828550|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111433161|NCT05828550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111433162|NCT05828381|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111433163|NCT05828381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111433164|NCT05828199|Dexmedetomidine|dexmedetomidine|mesh-list
111433165|NCT05828199|Ketamine|ketamine|mesh-list
111433166|NCT05828199|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111433167|NCT05828199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111433168|NCT05828199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111433169|NCT05828199|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111433170|NCT05828199|Analgesics|analgesics|mesh-ancestor
111433171|NCT05828199|Sensory System Agents|sensory system agents|mesh-ancestor
111433172|NCT05828199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111433173|NCT05828199|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111433174|NCT05828199|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111433175|NCT05828199|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111433176|NCT05828199|Adrenergic Agents|adrenergic agents|mesh-ancestor
111433177|NCT05828199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111433178|NCT05828199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111433179|NCT05828199|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111433180|NCT05828199|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111433181|NCT05828199|Anesthetics, General|anesthetics, general|mesh-ancestor
111433182|NCT05828199|Anesthetics|anesthetics|mesh-ancestor
111433183|NCT05828199|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111433184|NCT05828199|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111433185|NCT05827991|Minoxidil|minoxidil|mesh-list
111433186|NCT05827991|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111433187|NCT05827991|Vasodilator Agents|vasodilator agents|mesh-ancestor
111433188|NCT05827796|Paclitaxel|paclitaxel|mesh-list
111433189|NCT05827796|Gemcitabine|gemcitabine|mesh-list
111433190|NCT05827796|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111433191|NCT05827796|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111433192|NCT05827796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111433193|NCT05827796|Tubulin Modulators|tubulin modulators|mesh-ancestor
111433194|NCT05827796|Antimitotic Agents|antimitotic agents|mesh-ancestor
111433195|NCT05827796|Mitosis Modulators|mitosis modulators|mesh-ancestor
111433196|NCT05827796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111433197|NCT05827796|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111433198|NCT05827796|Antimetabolites|antimetabolites|mesh-ancestor
111433199|NCT05827770|Temozolomide|temozolomide|mesh-list
111433200|NCT05827770|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111433201|NCT05827770|Alkylating Agents|alkylating agents|mesh-ancestor
111433202|NCT05827770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111433203|NCT05827770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111433204|NCT05827497|Methotrexate|methotrexate|mesh-list
111433205|NCT05827497|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111433206|NCT05827497|Abortifacient Agents|abortifacient agents|mesh-ancestor
111433207|NCT05827497|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111433208|NCT05827497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111433209|NCT05827497|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111433210|NCT05827497|Antimetabolites|antimetabolites|mesh-ancestor
111433211|NCT05827497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111433212|NCT05827497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111433213|NCT05827497|Dermatologic Agents|dermatologic agents|mesh-ancestor
111433214|NCT05827497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111433215|NCT05827497|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111433216|NCT05827497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111433217|NCT05827497|Immunologic Factors|immunologic factors|mesh-ancestor
111433218|NCT05827497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111433219|NCT05827497|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111433220|NCT05827263|Salicylic Acid|salicylic acid|mesh-list
111433221|NCT05827263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111433222|NCT05827263|Antifungal Agents|antifungal agents|mesh-ancestor
111433223|NCT05827263|Keratolytic Agents|keratolytic agents|mesh-ancestor
111433224|NCT05827263|Dermatologic Agents|dermatologic agents|mesh-ancestor
111433225|NCT05825443|Paclitaxel|paclitaxel|mesh-list
111433226|NCT05825443|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111433227|NCT05825443|Cisplatin|cisplatin|mesh-list
111433228|NCT05825443|Carboplatin|carboplatin|mesh-list
111433229|NCT05825443|Pemetrexed|pemetrexed|mesh-list
111433230|NCT05825443|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111433231|NCT05825443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111433232|NCT05825443|Tubulin Modulators|tubulin modulators|mesh-ancestor
111433233|NCT05825443|Antimitotic Agents|antimitotic agents|mesh-ancestor
111433234|NCT05825443|Mitosis Modulators|mitosis modulators|mesh-ancestor
111433235|NCT05825443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111433236|NCT05825443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111433237|NCT05825443|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111433238|NCT05825443|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111433239|NCT05822934|Carboplatin|carboplatin|mesh-list
111433240|NCT05822934|Gemcitabine|gemcitabine|mesh-list
111433241|NCT05822934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111433242|NCT05822934|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111433243|NCT05822934|Antimetabolites|antimetabolites|mesh-ancestor
110512766|NCT00890552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111433244|NCT05822934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111433245|NCT05821972|Dexmedetomidine|dexmedetomidine|mesh-list
111433246|NCT05821972|Ketamine|ketamine|mesh-list
111433247|NCT05821972|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111433248|NCT05821972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111433249|NCT05821972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111433250|NCT05821972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111433251|NCT05821972|Analgesics|analgesics|mesh-ancestor
111433252|NCT05821972|Sensory System Agents|sensory system agents|mesh-ancestor
111433253|NCT05821972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111433254|NCT05821972|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111433255|NCT05821972|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111433256|NCT05821972|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111433257|NCT05821972|Adrenergic Agents|adrenergic agents|mesh-ancestor
111433258|NCT05821972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111433259|NCT05821972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111433260|NCT05821972|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111433261|NCT05821972|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111433262|NCT05821972|Anesthetics, General|anesthetics, general|mesh-ancestor
111433263|NCT05821972|Anesthetics|anesthetics|mesh-ancestor
111433264|NCT05821972|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111433265|NCT05821972|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111433266|NCT05774236|Dinoprostone|dinoprostone|mesh-list
111433267|NCT05774236|Oxytocics|oxytocics|mesh-ancestor
111433268|NCT05774236|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111433269|NCT05774236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111433270|NCT05748587|Iron|iron|mesh-list
111433271|NCT05748587|Deferoxamine|deferoxamine|mesh-list
111433272|NCT05748587|Trace Elements|trace elements|mesh-ancestor
111433273|NCT05748587|Micronutrients|micronutrients|mesh-ancestor
111433274|NCT05748587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111433275|NCT05748587|Siderophores|siderophores|mesh-ancestor
111433276|NCT05748587|Iron Chelating Agents|iron chelating agents|mesh-ancestor
111433277|NCT05748587|Chelating Agents|chelating agents|mesh-ancestor
111433278|NCT05748587|Sequestering Agents|sequestering agents|mesh-ancestor
111433279|NCT05748587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111433280|NCT05728814|Dostarlimab|dostarlimab|mesh-list
111433281|NCT05728814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111433282|NCT05707468|Hormones|hormones|mesh-list
111433283|NCT05707468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111433284|NCT05707468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111433285|NCT05698381|Acetic Acid|acetic acid|mesh-list
111433286|NCT05698381|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111433287|NCT05698381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111433288|NCT05683535|Atropine|atropine|mesh-list
111433289|NCT05683535|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111433290|NCT05683535|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111433291|NCT05683535|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111433292|NCT05683535|Autonomic Agents|autonomic agents|mesh-ancestor
111433293|NCT05683535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111433294|NCT05683535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111433295|NCT05683535|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111433296|NCT05683535|Respiratory System Agents|respiratory system agents|mesh-ancestor
111433297|NCT05683535|Mydriatics|mydriatics|mesh-ancestor
111433298|NCT05683535|Parasympatholytics|parasympatholytics|mesh-ancestor
111433299|NCT05683535|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111433300|NCT05683535|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111433301|NCT05683535|Cholinergic Agents|cholinergic agents|mesh-ancestor
111433302|NCT05683535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111433303|NCT05683535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111433304|NCT05678244|Acetaminophen|acetaminophen|mesh-list
111433305|NCT05678244|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111433306|NCT05678244|Analgesics|analgesics|mesh-ancestor
111433307|NCT05678244|Sensory System Agents|sensory system agents|mesh-ancestor
111433308|NCT05678244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111433309|NCT05678244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111433310|NCT05678244|Antipyretics|antipyretics|mesh-ancestor
111433311|NCT05676034|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
111433312|NCT05676034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111433313|NCT05675800|Psilocybin|psilocybin|mesh-list
111433314|NCT05675800|Hallucinogens|hallucinogens|mesh-ancestor
111433315|NCT05675800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111433316|NCT05675800|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111433317|NCT05675319|Dexamethasone|dexamethasone|mesh-list
111433318|NCT05675319|Dexamethasone acetate|dexamethasone acetate|mesh-list
111433319|NCT05675319|Lenalidomide|lenalidomide|mesh-list
111433320|NCT05675319|Bortezomib|bortezomib|mesh-list
111433321|NCT05675319|Daratumumab|daratumumab|mesh-list
111433322|NCT05675319|Pomalidomide|pomalidomide|mesh-list
111433323|NCT05675319|Ixazomib|ixazomib|mesh-list
111433324|NCT05675319|Elotuzumab|elotuzumab|mesh-list
111433325|NCT05675319|BB 1101|bb 1101|mesh-list
111433326|NCT05675319|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111433327|NCT05675319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111433328|NCT05675319|Antiemetics|antiemetics|mesh-ancestor
111433329|NCT05675319|Autonomic Agents|autonomic agents|mesh-ancestor
111433330|NCT05675319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111433331|NCT05675319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111433332|NCT05675319|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111433333|NCT05675319|Glucocorticoids|glucocorticoids|mesh-ancestor
111433334|NCT05675319|Hormones|hormones|mesh-ancestor
111433335|NCT05675319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111433336|NCT05675319|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111433337|NCT05675319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111433338|NCT05675319|Protease Inhibitors|protease inhibitors|mesh-ancestor
111433339|NCT05675319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111433340|NCT05675319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111433341|NCT05675319|Immunologic Factors|immunologic factors|mesh-ancestor
111433342|NCT05675319|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111433343|NCT05675319|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111433344|NCT05675319|Growth Substances|growth substances|mesh-ancestor
111433345|NCT05675319|Growth Inhibitors|growth inhibitors|mesh-ancestor
111433346|NCT05674487|Misoprostol|misoprostol|mesh-list
111433347|NCT05674487|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111433348|NCT05674487|Abortifacient Agents|abortifacient agents|mesh-ancestor
111433349|NCT05674487|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111433350|NCT05674487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111433351|NCT05674487|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111433352|NCT05674487|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111433353|NCT05674487|Oxytocics|oxytocics|mesh-ancestor
111433354|NCT05641376|Dexmedetomidine|dexmedetomidine|mesh-list
111433355|NCT05641376|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111433356|NCT05641376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111433357|NCT05641376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111433358|NCT05641376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111433359|NCT05641376|Analgesics|analgesics|mesh-ancestor
111433360|NCT05641376|Sensory System Agents|sensory system agents|mesh-ancestor
111433361|NCT05641376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110512814|NCT04248608|Analgesics|analgesics|mesh-ancestor
111433362|NCT05641376|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111433363|NCT05641376|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111433364|NCT05641376|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111433365|NCT05641376|Adrenergic Agents|adrenergic agents|mesh-ancestor
111433366|NCT05641376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111433367|NCT05641376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111433368|NCT05615311|Vitamin D|vitamin d|mesh-list
111433369|NCT05615311|Ergocalciferols|ergocalciferols|mesh-list
111433370|NCT05615311|Cholecalciferol|cholecalciferol|mesh-list
111433371|NCT05615311|Vitamins|vitamins|mesh-list
111433372|NCT05615311|Micronutrients|micronutrients|mesh-ancestor
111433373|NCT05615311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111433374|NCT05615311|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111433375|NCT05615311|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111433376|NCT05607615|Betadex|betadex|mesh-list
111433377|NCT05607615|Sequestering Agents|sequestering agents|mesh-ancestor
111433378|NCT05607615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111433379|NCT05593939|Niacinamide|niacinamide|mesh-list
111433381|NCT05593939|Nicotinic Acids|nicotinic acids|mesh-list
111433382|NCT05593939|Vitamin B Complex|vitamin b complex|mesh-ancestor
111433383|NCT05593939|Vitamins|vitamins|mesh-ancestor
111433384|NCT05593939|Micronutrients|micronutrients|mesh-ancestor
111433385|NCT05593939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111433386|NCT05593939|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111433387|NCT05593939|Antimetabolites|antimetabolites|mesh-ancestor
111433388|NCT05593939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111433389|NCT05593939|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111433390|NCT05593939|Vasodilator Agents|vasodilator agents|mesh-ancestor
111433391|NCT05577845|Ramosetron|ramosetron|mesh-list
111433392|NCT05577845|Antiemetics|antiemetics|mesh-ancestor
111433393|NCT05577845|Autonomic Agents|autonomic agents|mesh-ancestor
111433394|NCT05577845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111433395|NCT05577845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111433396|NCT05577845|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111433397|NCT05577845|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111433398|NCT05577845|Serotonin Agents|serotonin agents|mesh-ancestor
111433399|NCT05577845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111433400|NCT05577845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111433401|NCT05527912|Rituximab|rituximab|mesh-list
111433402|NCT05527912|Zanubrutinib|zanubrutinib|mesh-list
111433403|NCT05527912|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111433404|NCT05527912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111433405|NCT05527912|Immunologic Factors|immunologic factors|mesh-ancestor
111433406|NCT05527912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111433407|NCT05527912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111433408|NCT05527912|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111433409|NCT05527912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111433410|NCT05527912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111433411|NCT05504083|Benzbromarone|benzbromarone|mesh-list
111433412|NCT05504083|Uricosuric Agents|uricosuric agents|mesh-ancestor
111433413|NCT05504083|Gout Suppressants|gout suppressants|mesh-ancestor
111433414|NCT05504083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111433415|NCT05491187|Fentanyl|fentanyl|mesh-list
111433416|NCT05491187|Bupivacaine|bupivacaine|mesh-list
111433417|NCT05491187|Anesthetics, Local|anesthetics, local|mesh-ancestor
111433418|NCT05491187|Anesthetics|anesthetics|mesh-ancestor
111433419|NCT05491187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111433420|NCT05491187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111433421|NCT05491187|Sensory System Agents|sensory system agents|mesh-ancestor
111433422|NCT05491187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111433423|NCT05491187|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111433424|NCT05491187|Narcotics|narcotics|mesh-ancestor
111433425|NCT05491187|Analgesics|analgesics|mesh-ancestor
111433426|NCT05491187|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111433427|NCT05491187|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111433428|NCT05491187|Anesthetics, General|anesthetics, general|mesh-ancestor
111433429|NCT05480878|Nitazoxanide|nitazoxanide|mesh-list
111433430|NCT05480878|Escitalopram|escitalopram|mesh-list
111433431|NCT05480878|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111433432|NCT05480878|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110512817|NCT04783194|Dexamethasone|dexamethasone|mesh-list
111433433|NCT05480878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111433434|NCT05480878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111433435|NCT05480878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111433436|NCT05480878|Serotonin Agents|serotonin agents|mesh-ancestor
111433437|NCT05480878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111433438|NCT05480878|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111433439|NCT05480878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111433440|NCT05462730|Methylprednisolone|methylprednisolone|mesh-list
111433441|NCT05462730|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111433442|NCT05462730|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111433443|NCT05462730|Prednisolone|prednisolone|mesh-list
111433444|NCT05462730|Prednisolone acetate|prednisolone acetate|mesh-list
111433445|NCT05462730|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111433446|NCT05462730|Prednisolone phosphate|prednisolone phosphate|mesh-list
111433447|NCT05462730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111433448|NCT05462730|Antiemetics|antiemetics|mesh-ancestor
111433449|NCT05462730|Autonomic Agents|autonomic agents|mesh-ancestor
111433450|NCT05462730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111433451|NCT05462730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111433452|NCT05462730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111157817|NCT02299388|Hormones|hormones|mesh-ancestor
111433454|NCT05462730|Hormones|hormones|mesh-ancestor
111433455|NCT05462730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111433456|NCT05462730|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111433457|NCT05462730|Protective Agents|protective agents|mesh-ancestor
111433458|NCT05462730|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111433459|NCT05462730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111433460|NCT05462236|Pembrolizumab|pembrolizumab|mesh-list
111433461|NCT05462236|Irinotecan|irinotecan|mesh-list
111433462|NCT05462236|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111433463|NCT05462236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111433464|NCT05462236|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111433465|NCT05462236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111433466|NCT05462236|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111433467|NCT05462236|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111433468|NCT05462236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111433469|NCT05414331|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
111433470|NCT05414331|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111433471|NCT05414331|Adrenergic Agents|adrenergic agents|mesh-ancestor
111433472|NCT05414331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111433473|NCT05414331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111433474|NCT05414331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111433475|NCT05398367|Galactogogues|galactogogues|mesh-list
111433476|NCT05398367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111433477|NCT05383716|Pembrolizumab|pembrolizumab|mesh-list
111433478|NCT05383716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111433479|NCT05383716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111433480|NCT05383716|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111433481|NCT05383716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111433482|NCT05378945|Varenicline|varenicline|mesh-list
111433483|NCT05378945|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111433484|NCT05378945|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111433485|NCT05378945|Cholinergic Agents|cholinergic agents|mesh-ancestor
111433486|NCT05378945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111433487|NCT05378945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111433488|NCT05378945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111433489|NCT05362877|Salicylic Acid|salicylic acid|mesh-list
111433490|NCT05362877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111433491|NCT05362877|Antifungal Agents|antifungal agents|mesh-ancestor
111433492|NCT05362877|Keratolytic Agents|keratolytic agents|mesh-ancestor
111433493|NCT05362877|Dermatologic Agents|dermatologic agents|mesh-ancestor
111433494|NCT05358587|Anesthetics|anesthetics|mesh-list
111433495|NCT05358587|Anesthetics, Local|anesthetics, local|mesh-list
111433496|NCT05358587|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111433497|NCT05358587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111433498|NCT05358587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111433499|NCT05358587|Sensory System Agents|sensory system agents|mesh-ancestor
111433500|NCT05358587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111433501|NCT05330377|Cytarabine|cytarabine|mesh-list
111433502|NCT05330377|Mitoxantrone|mitoxantrone|mesh-list
111433503|NCT05330377|Cladribine|cladribine|mesh-list
111433504|NCT05330377|Lenograstim|lenograstim|mesh-list
111433505|NCT05330377|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111433506|NCT05330377|Antimetabolites|antimetabolites|mesh-ancestor
111433507|NCT05330377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111433508|NCT05330377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111433509|NCT05330377|Antiviral Agents|antiviral agents|mesh-ancestor
111433510|NCT05330377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111433511|NCT05330377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111433512|NCT05330377|Immunologic Factors|immunologic factors|mesh-ancestor
111433513|NCT05330377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111433514|NCT05330377|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111433515|NCT05330377|Analgesics|analgesics|mesh-ancestor
111433516|NCT05330377|Sensory System Agents|sensory system agents|mesh-ancestor
111433517|NCT05330377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111433518|NCT05330377|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111433519|NCT05330377|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111433520|NCT05330377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111433521|NCT05326087|Cetrorelix|cetrorelix|mesh-list
111433522|NCT05326087|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111433523|NCT05326087|Fertility Agents|fertility agents|mesh-ancestor
111433524|NCT05326087|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111433525|NCT05326087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111433526|NCT05326087|Hormone Antagonists|hormone antagonists|mesh-ancestor
111433527|NCT05326087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111433529|NCT05323435|Immunologic Factors|immunologic factors|mesh-ancestor
111433530|NCT05323435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111433531|NCT05322252|Misoprostol|misoprostol|mesh-list
111433532|NCT05322252|Mifepristone|mifepristone|mesh-list
111433533|NCT05322252|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111433534|NCT05322252|Abortifacient Agents|abortifacient agents|mesh-ancestor
111433535|NCT05322252|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111433536|NCT05322252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111433537|NCT05322252|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111433538|NCT05322252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111433539|NCT05322252|Oxytocics|oxytocics|mesh-ancestor
111433540|NCT05322252|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
111433541|NCT05322252|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111433542|NCT05322252|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111433543|NCT05322252|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111433544|NCT05322252|Contraceptive Agents|contraceptive agents|mesh-ancestor
111433545|NCT05322252|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
111433546|NCT05322252|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
111433547|NCT05322252|Hormone Antagonists|hormone antagonists|mesh-ancestor
111433548|NCT05322252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111433549|NCT05322252|Luteolytic Agents|luteolytic agents|mesh-ancestor
111433550|NCT05322252|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111433551|NCT05322252|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
111433552|NCT05293912|Antibodies, Bispecific|antibodies, bispecific|mesh-list
111433553|NCT05293912|Immunologic Factors|immunologic factors|mesh-ancestor
111433554|NCT05293912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111433555|NCT05288062|Dexamethasone|dexamethasone|mesh-list
111433556|NCT05288062|Dexamethasone acetate|dexamethasone acetate|mesh-list
111433557|NCT05288062|Lenalidomide|lenalidomide|mesh-list
111433558|NCT05288062|Pomalidomide|pomalidomide|mesh-list
111433559|NCT05288062|Ichthammol|ichthammol|mesh-list
111433560|NCT05288062|BB 1101|bb 1101|mesh-list
111433561|NCT05288062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111433562|NCT05288062|Antiemetics|antiemetics|mesh-ancestor
111433563|NCT05288062|Autonomic Agents|autonomic agents|mesh-ancestor
111433564|NCT05288062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111433565|NCT05288062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111433566|NCT05288062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111433567|NCT05288062|Glucocorticoids|glucocorticoids|mesh-ancestor
111433568|NCT05288062|Hormones|hormones|mesh-ancestor
111433569|NCT05288062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111433570|NCT05288062|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111433571|NCT05288062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111433572|NCT05288062|Protease Inhibitors|protease inhibitors|mesh-ancestor
111433573|NCT05288062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111433574|NCT05288062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111433575|NCT05288062|Immunologic Factors|immunologic factors|mesh-ancestor
111433576|NCT05288062|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111433577|NCT05288062|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111433578|NCT05288062|Growth Substances|growth substances|mesh-ancestor
111433579|NCT05288062|Growth Inhibitors|growth inhibitors|mesh-ancestor
111433580|NCT05288062|Dermatologic Agents|dermatologic agents|mesh-ancestor
111433581|NCT05246943|Fibrin fragment D|fibrin fragment d|mesh-list
111433582|NCT05246943|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111433583|NCT05246943|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111433584|NCT05246943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111433585|NCT05246943|Hemostatics|hemostatics|mesh-ancestor
111433586|NCT05246943|Coagulants|coagulants|mesh-ancestor
111433587|NCT05212454|Capecitabine|capecitabine|mesh-list
111433588|NCT05212454|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111433589|NCT05212454|Antimetabolites|antimetabolites|mesh-ancestor
111433590|NCT05212454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111433591|NCT05212454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111433592|NCT05157581|Methoxsalen|methoxsalen|mesh-list
111433593|NCT05157581|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111433594|NCT05157581|Dermatologic Agents|dermatologic agents|mesh-ancestor
111433595|NCT05096845|Vaccines|vaccines|mesh-list
111433596|NCT05096845|Immunologic Factors|immunologic factors|mesh-ancestor
111433597|NCT05096845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111433598|NCT05091866|Progesterone|progesterone|mesh-list
111433599|NCT05091866|Progestins|progestins|mesh-list
111433600|NCT05091866|Hormones|hormones|mesh-ancestor
111433601|NCT05091866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111433602|NCT05091866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111433603|NCT05084989|Vaccines|vaccines|mesh-list
111433604|NCT05084989|Immunologic Factors|immunologic factors|mesh-ancestor
111433605|NCT05084989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111433606|NCT05079828|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
111433607|NCT05079828|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111433608|NCT05079828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111433609|NCT05042700|Melatonin|melatonin|mesh-list
111433610|NCT05042700|Antioxidants|antioxidants|mesh-ancestor
111433611|NCT05042700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111433612|NCT05042700|Protective Agents|protective agents|mesh-ancestor
111433613|NCT05042700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111433614|NCT05042700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111433615|NCT05010954|Lansoprazole|lansoprazole|mesh-list
111433616|NCT05010954|Dexlansoprazole|dexlansoprazole|mesh-list
111433617|NCT05010954|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111433618|NCT05010954|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111433619|NCT05010954|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111433620|NCT05010954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111433621|NCT05010954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111433622|NCT05001724|Docetaxel|docetaxel|mesh-list
111433623|NCT05001724|Lenvatinib|lenvatinib|mesh-list
110512856|NCT00611923|Flutamide|flutamide|mesh-list
111433624|NCT05001724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111433625|NCT05001724|Tubulin Modulators|tubulin modulators|mesh-ancestor
111433626|NCT05001724|Antimitotic Agents|antimitotic agents|mesh-ancestor
111433627|NCT05001724|Mitosis Modulators|mitosis modulators|mesh-ancestor
111433628|NCT05001724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111433629|NCT05001724|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111433630|NCT05001724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111433631|NCT04996368|Tranexamic Acid|tranexamic acid|mesh-list
111433632|NCT04996368|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111433633|NCT04996368|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111433634|NCT04996368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111433635|NCT04996368|Hemostatics|hemostatics|mesh-ancestor
111433636|NCT04996368|Coagulants|coagulants|mesh-ancestor
111433637|NCT04994444|Nicotine|nicotine|mesh-list
111433638|NCT04994444|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111433639|NCT04994444|Autonomic Agents|autonomic agents|mesh-ancestor
111433640|NCT04994444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111433641|NCT04994444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111433642|NCT04994444|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111433643|NCT04994444|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111433644|NCT04994444|Cholinergic Agents|cholinergic agents|mesh-ancestor
111433645|NCT04994444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111433646|NCT04994444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111433647|NCT04987892|Tamsulosin|tamsulosin|mesh-list
111433648|NCT04987892|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111433649|NCT04987892|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111433650|NCT04987892|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111433651|NCT04987892|Adrenergic Agents|adrenergic agents|mesh-ancestor
111433652|NCT04987892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111433653|NCT04987892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111433654|NCT04987892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111433655|NCT04987892|Urological Agents|urological agents|mesh-ancestor
111433656|NCT05019222|Anesthetics|anesthetics|mesh-list
111433657|NCT05019222|Sevoflurane|sevoflurane|mesh-list
111433658|NCT05019222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111433659|NCT05019222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111433660|NCT05019222|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111433661|NCT05019222|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111433662|NCT05019222|Anesthetics, General|anesthetics, general|mesh-ancestor
111433663|NCT04966702|Ivermectin|ivermectin|mesh-list
111433664|NCT04966702|Albendazole|albendazole|mesh-list
111433665|NCT04966702|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111433666|NCT04966702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111433667|NCT04966702|Anthelmintics|anthelmintics|mesh-ancestor
111433668|NCT04966702|Anticestodal Agents|anticestodal agents|mesh-ancestor
111433669|NCT04966702|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
111433670|NCT04966702|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111433671|NCT04966702|Tubulin Modulators|tubulin modulators|mesh-ancestor
111433672|NCT04966702|Antimitotic Agents|antimitotic agents|mesh-ancestor
111433673|NCT04966702|Mitosis Modulators|mitosis modulators|mesh-ancestor
111433674|NCT04966702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111433675|NCT04966702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111433676|NCT04966663|Carboplatin|carboplatin|mesh-list
111433677|NCT04966663|Gemcitabine|gemcitabine|mesh-list
111433678|NCT04966663|Nivolumab|nivolumab|mesh-list
111433679|NCT04966663|Pemetrexed|pemetrexed|mesh-list
111433680|NCT04966663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111433681|NCT04966663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111433682|NCT04966663|Antimetabolites|antimetabolites|mesh-ancestor
111433683|NCT04966663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111433684|NCT04966663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111433685|NCT04966663|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111433686|NCT04966663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111433687|NCT04966663|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111433688|NCT04966663|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111433689|NCT04922593|Paliperidone Palmitate|paliperidone palmitate|mesh-list
111433690|NCT04922593|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111433691|NCT04922593|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111433692|NCT04922593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111433693|NCT04922593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111433694|NCT04922593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111433695|NCT04922593|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111433696|NCT04922593|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111433697|NCT04922593|Serotonin Agents|serotonin agents|mesh-ancestor
111433698|NCT04922593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111433699|NCT04922593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111433700|NCT04922593|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111433701|NCT04922593|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111433702|NCT04922593|Dopamine Agents|dopamine agents|mesh-ancestor
111433703|NCT04902950|Tranexamic Acid|tranexamic acid|mesh-list
111433704|NCT04902950|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111433705|NCT04902950|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111433706|NCT04902950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111433707|NCT04902950|Hemostatics|hemostatics|mesh-ancestor
111433708|NCT04902950|Coagulants|coagulants|mesh-ancestor
111433709|NCT04889118|Pembrolizumab|pembrolizumab|mesh-list
111433710|NCT04889118|Lenvatinib|lenvatinib|mesh-list
111433711|NCT04889118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111433712|NCT04889118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111433713|NCT04889118|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111433714|NCT04889118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111433715|NCT04889118|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111433716|NCT04889118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111433717|NCT04819971|Docetaxel|docetaxel|mesh-list
111433718|NCT04819971|Oxaliplatin|oxaliplatin|mesh-list
111433719|NCT04819971|Trastuzumab|trastuzumab|mesh-list
111433720|NCT04819971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111433721|NCT04819971|Tubulin Modulators|tubulin modulators|mesh-ancestor
111433722|NCT04819971|Antimitotic Agents|antimitotic agents|mesh-ancestor
111433723|NCT04819971|Mitosis Modulators|mitosis modulators|mesh-ancestor
111433724|NCT04819971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111433725|NCT04819971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111433726|NCT04724148|Fentanyl|fentanyl|mesh-list
111433727|NCT04724148|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111433728|NCT04724148|Narcotics|narcotics|mesh-ancestor
111433729|NCT04724148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111433730|NCT04724148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111433731|NCT04724148|Analgesics|analgesics|mesh-ancestor
111433732|NCT04724148|Sensory System Agents|sensory system agents|mesh-ancestor
111433733|NCT04724148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111433734|NCT04724148|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111433735|NCT04724148|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111433736|NCT04724148|Anesthetics, General|anesthetics, general|mesh-ancestor
111433737|NCT04724148|Anesthetics|anesthetics|mesh-ancestor
111433738|NCT04703803|Lidocaine|lidocaine|mesh-list
111433739|NCT04703803|Anesthetics, Local|anesthetics, local|mesh-ancestor
111433740|NCT04703803|Anesthetics|anesthetics|mesh-ancestor
111433741|NCT04703803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111433742|NCT04703803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111433743|NCT04703803|Sensory System Agents|sensory system agents|mesh-ancestor
111433744|NCT04703803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111433745|NCT04703803|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111433746|NCT04703803|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111433747|NCT04703803|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111433748|NCT04703803|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111433749|NCT04703803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111433750|NCT04681417|Carboplatin|carboplatin|mesh-list
111433751|NCT04681417|Etoposide|etoposide|mesh-list
111433752|NCT04681417|Etoposide phosphate|etoposide phosphate|mesh-list
111433753|NCT04681417|Vincristine|vincristine|mesh-list
111433754|NCT04681417|Melphalan|melphalan|mesh-list
111433755|NCT04681417|Topotecan|topotecan|mesh-list
111433756|NCT04681417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111433757|NCT04681417|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111433758|NCT04681417|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111433759|NCT04681417|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111433760|NCT04681417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111433761|NCT04681417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111433762|NCT04681417|Tubulin Modulators|tubulin modulators|mesh-ancestor
111433763|NCT04681417|Antimitotic Agents|antimitotic agents|mesh-ancestor
111433764|NCT04681417|Mitosis Modulators|mitosis modulators|mesh-ancestor
111433765|NCT04681417|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111433766|NCT04681417|Alkylating Agents|alkylating agents|mesh-ancestor
111433767|NCT04681417|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111433768|NCT04681417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111433769|NCT04681417|Immunologic Factors|immunologic factors|mesh-ancestor
111433770|NCT04681417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111433771|NCT04681417|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111433772|NCT04670978|Bevacizumab|bevacizumab|mesh-list
111433773|NCT04670978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111433774|NCT04670978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111433775|NCT04670978|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111433776|NCT04670978|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111433777|NCT04670978|Growth Substances|growth substances|mesh-ancestor
111433778|NCT04670978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111433779|NCT04670978|Growth Inhibitors|growth inhibitors|mesh-ancestor
111433780|NCT04639180|Apatinib|apatinib|mesh-list
111433781|NCT04639180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111433782|NCT04639180|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111433783|NCT04639180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111433784|NCT04639180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111433785|NCT04531943|Progesterone|progesterone|mesh-list
111433786|NCT04531943|Estrogens|estrogens|mesh-list
111433787|NCT04531943|Progestins|progestins|mesh-ancestor
111433788|NCT04531943|Hormones|hormones|mesh-ancestor
111433789|NCT04531943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111433790|NCT04531943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111433791|NCT04522973|Ethanol|ethanol|mesh-list
111433792|NCT04522973|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111433793|NCT04522973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111433794|NCT04522973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111433795|NCT04522973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111433796|NCT04520048|Acetylcholine|acetylcholine|mesh-list
111433797|NCT04520048|Vasodilator Agents|vasodilator agents|mesh-ancestor
111433798|NCT04520048|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111433799|NCT04520048|Cholinergic Agents|cholinergic agents|mesh-ancestor
111433800|NCT04520048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111433801|NCT04520048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111433802|NCT04520048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111433803|NCT04516850|Steroid delta-isomerase|steroid delta-isomerase|mesh-list
111433804|NCT04516850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111433805|NCT04516850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111433806|NCT04503460|Fluticasone|fluticasone|mesh-list
111433807|NCT04503460|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
111433808|NCT04503460|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
111433809|NCT04503460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111433810|NCT04503460|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111433811|NCT04503460|Autonomic Agents|autonomic agents|mesh-ancestor
111433812|NCT04503460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111433813|NCT04503460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111433814|NCT04503460|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111433815|NCT04503460|Respiratory System Agents|respiratory system agents|mesh-ancestor
111433816|NCT04503460|Dermatologic Agents|dermatologic agents|mesh-ancestor
111433817|NCT04503460|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111433818|NCT04503460|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111433819|NCT04503460|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111433820|NCT04503460|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111433821|NCT04503460|Adrenergic Agents|adrenergic agents|mesh-ancestor
111433822|NCT04503460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111433823|NCT04503460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111433824|NCT04503460|Glucocorticoids|glucocorticoids|mesh-ancestor
111433825|NCT04503460|Hormones|hormones|mesh-ancestor
111433826|NCT04503460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111433827|NCT04503460|Sympathomimetics|sympathomimetics|mesh-ancestor
111433828|NCT04460326|Insulin|insulin|mesh-list
111433829|NCT04460326|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111433830|NCT04460326|Insulin Glargine|insulin glargine|mesh-list
111433831|NCT04460326|Insulin Aspart|insulin aspart|mesh-list
111433832|NCT04460326|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111433833|NCT04460326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111433834|NCT04414748|Cetrorelix|cetrorelix|mesh-list
111433835|NCT04414748|Dydrogesterone|dydrogesterone|mesh-list
111433836|NCT04414748|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111433837|NCT04414748|Fertility Agents|fertility agents|mesh-ancestor
111433838|NCT04414748|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111433839|NCT04414748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111433840|NCT04414748|Hormone Antagonists|hormone antagonists|mesh-ancestor
111433841|NCT04414748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111433842|NCT04414748|Progestins|progestins|mesh-ancestor
111433843|NCT04414748|Hormones|hormones|mesh-ancestor
111433844|NCT04395196|Choline|choline|mesh-list
111433845|NCT04395196|Lipotropic Agents|lipotropic agents|mesh-ancestor
111433846|NCT04395196|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111433847|NCT04395196|Antimetabolites|antimetabolites|mesh-ancestor
111433848|NCT04395196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111433849|NCT04395196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111433850|NCT04395196|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111433851|NCT04395196|Nootropic Agents|nootropic agents|mesh-ancestor
111433852|NCT04233515|Anticoagulants|anticoagulants|mesh-list
111433853|NCT04169373|Upadacitinib|upadacitinib|mesh-list
111433854|NCT04169373|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
111433855|NCT04169373|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111433856|NCT04169373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111433857|NCT04169373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111433858|NCT04169373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111433859|NCT04167514|Protease Inhibitors|protease inhibitors|mesh-list
111433860|NCT04167514|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
111433861|NCT04167514|Protein C Inhibitor|protein c inhibitor|mesh-list
111433862|NCT04167514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111433863|NCT04167514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111433864|NCT04167514|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
111433865|NCT04167514|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111433866|NCT04150042|Vitamins|vitamins|mesh-list
111433867|NCT04150042|Ascorbic Acid|ascorbic acid|mesh-list
111433868|NCT04150042|Vitamin B 12|vitamin b 12|mesh-list
111433869|NCT04150042|Hydroxocobalamin|hydroxocobalamin|mesh-list
111433870|NCT04150042|Ethanol|ethanol|mesh-list
111433871|NCT04150042|Melphalan|melphalan|mesh-list
111433872|NCT04150042|Carmustine|carmustine|mesh-list
111433873|NCT04150042|Micronutrients|micronutrients|mesh-ancestor
111433874|NCT04150042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111433875|NCT04150042|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111433876|NCT04150042|Alkylating Agents|alkylating agents|mesh-ancestor
111433877|NCT04150042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111433878|NCT04150042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111433879|NCT04150042|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111433880|NCT04150042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111433881|NCT04150042|Immunologic Factors|immunologic factors|mesh-ancestor
111433882|NCT04150042|Antioxidants|antioxidants|mesh-ancestor
111433883|NCT04150042|Protective Agents|protective agents|mesh-ancestor
111433884|NCT04150042|Vitamin B Complex|vitamin b complex|mesh-ancestor
111433885|NCT04150042|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111433886|NCT04150042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111433887|NCT04150042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111433888|NCT04150042|Hematinics|hematinics|mesh-ancestor
111433889|NCT04141644|Ipilimumab|ipilimumab|mesh-list
111433890|NCT04141644|Osimertinib|osimertinib|mesh-list
111433891|NCT04141644|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111433892|NCT04141644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111433893|NCT04141644|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111433894|NCT04141644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111433895|NCT04141644|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111433896|NCT04141644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111433897|NCT04125927|Cysteamine|cysteamine|mesh-list
111433898|NCT04125927|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
111433899|NCT04125927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111433900|NCT04093024|Nintedanib|nintedanib|mesh-list
111433901|NCT04093024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111433902|NCT04093024|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111433903|NCT04093024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111433904|NCT04093024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111433905|NCT04091503|Temozolomide|temozolomide|mesh-list
111433906|NCT04091503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111433907|NCT04091503|Alkylating Agents|alkylating agents|mesh-ancestor
111433908|NCT04091503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111433909|NCT04091503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111433910|NCT04067752|Dialysis Solutions|dialysis solutions|mesh-list
111433911|NCT04067752|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111433912|NCT04044534|Insulin|insulin|mesh-list
111433913|NCT04044534|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111433914|NCT04044534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111433915|NCT04014790|KRN 7000|krn 7000|mesh-list
111433916|NCT04014790|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111433917|NCT04014790|Immunologic Factors|immunologic factors|mesh-ancestor
111433918|NCT04014790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111433919|NCT04014790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111433920|NCT03971474|Gemcitabine|gemcitabine|mesh-list
111433921|NCT03971474|Docetaxel|docetaxel|mesh-list
111433922|NCT03971474|Pembrolizumab|pembrolizumab|mesh-list
111433923|NCT03971474|Pemetrexed|pemetrexed|mesh-list
111433924|NCT03971474|Ramucirumab|ramucirumab|mesh-list
111433925|NCT03971474|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111433926|NCT03971474|Antibodies|antibodies|mesh-list
111433927|NCT03971474|Immunoglobulins|immunoglobulins|mesh-list
111433928|NCT03971474|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111433929|NCT03971474|Lexatumumab|lexatumumab|mesh-list
111433930|NCT03971474|Immunologic Factors|immunologic factors|mesh-ancestor
111433931|NCT03971474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111433932|NCT03971474|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111433933|NCT03971474|Antimetabolites|antimetabolites|mesh-ancestor
111433934|NCT03971474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111433935|NCT03971474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111433936|NCT03971474|Tubulin Modulators|tubulin modulators|mesh-ancestor
111433937|NCT03971474|Antimitotic Agents|antimitotic agents|mesh-ancestor
111433938|NCT03971474|Mitosis Modulators|mitosis modulators|mesh-ancestor
111433939|NCT03971474|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111433940|NCT03971474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111433941|NCT03971474|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111433942|NCT03971474|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111433943|NCT03965234|Cisplatin|cisplatin|mesh-list
111433944|NCT03965234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111433945|NCT03921060|Denosumab|denosumab|mesh-list
111433946|NCT03921060|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111433947|NCT03921060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111433948|NCT03859973|BI 425809|bi 425809|mesh-list
111433949|NCT03859973|Nootropic Agents|nootropic agents|mesh-ancestor
111433950|NCT03827070|Afatinib|afatinib|mesh-list
111433951|NCT03827070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111433952|NCT03827070|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111433953|NCT03827070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111433954|NCT03827070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111433955|NCT03820986|Pembrolizumab|pembrolizumab|mesh-list
111433956|NCT03820986|Lenvatinib|lenvatinib|mesh-list
111433957|NCT03820986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111433958|NCT03820986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111433959|NCT03820986|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111433960|NCT03820986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111433961|NCT03820986|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111433962|NCT03820986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111433963|NCT03805789|Protease Inhibitors|protease inhibitors|mesh-list
111433964|NCT03805789|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
111433965|NCT03805789|Protein C Inhibitor|protein c inhibitor|mesh-list
111433966|NCT03805789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111433967|NCT03805789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111433968|NCT03805789|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
111433969|NCT03805789|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111433970|NCT03748303|Pregnanolone|pregnanolone|mesh-list
111433971|NCT03748303|Anesthetics|anesthetics|mesh-ancestor
111433972|NCT03748303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110512897|NCT04038073|Antibodies|antibodies|mesh-list
111433973|NCT03748303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111433974|NCT03680053|Cetrorelix|cetrorelix|mesh-list
111433975|NCT03680053|Dydrogesterone|dydrogesterone|mesh-list
111433976|NCT03680053|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111433977|NCT03680053|Fertility Agents|fertility agents|mesh-ancestor
111433978|NCT03680053|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111433979|NCT03680053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111433980|NCT03680053|Hormone Antagonists|hormone antagonists|mesh-ancestor
111433981|NCT03680053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111433982|NCT03680053|Progestins|progestins|mesh-ancestor
111433983|NCT03680053|Hormones|hormones|mesh-ancestor
111433984|NCT03673007|Contraceptive Agents|contraceptive agents|mesh-list
111433985|NCT03673007|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111433986|NCT03673007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111433987|NCT03657602|Levonorgestrel|levonorgestrel|mesh-list
111433988|NCT03657602|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111433989|NCT03657602|Contraceptive Agents|contraceptive agents|mesh-ancestor
111433990|NCT03657602|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111433991|NCT03657602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111433992|NCT03657602|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111433993|NCT03657602|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111433994|NCT03657602|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111433995|NCT03656718|Nivolumab|nivolumab|mesh-list
111433996|NCT03656718|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111433997|NCT03656718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111433998|NCT03656718|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111433999|NCT03656718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111434000|NCT03632369|Xenon|xenon|mesh-list
111434001|NCT03632369|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111434002|NCT03632369|Anesthetics, General|anesthetics, general|mesh-ancestor
111434003|NCT03632369|Anesthetics|anesthetics|mesh-ancestor
111434004|NCT03632369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111434005|NCT03632369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111434006|NCT03625687|Antiviral Agents|antiviral agents|mesh-list
111434007|NCT03625687|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
111434008|NCT03625687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111434009|NCT03471364|Ketoconazole|ketoconazole|mesh-list
111434010|NCT03471364|Antifungal Agents|antifungal agents|mesh-ancestor
111434011|NCT03471364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111434012|NCT03471364|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111434013|NCT03471364|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111434014|NCT03471364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111434015|NCT03471364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111434016|NCT03471364|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111434017|NCT03471364|Hormone Antagonists|hormone antagonists|mesh-ancestor
111434018|NCT03471364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111434019|NCT03471364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111434020|NCT03471364|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111434021|NCT03469284|Methylene Blue|methylene blue|mesh-list
111434022|NCT03469284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111434023|NCT03469284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111434024|NCT03425331|Nivolumab|nivolumab|mesh-list
111434025|NCT03425331|Ipilimumab|ipilimumab|mesh-list
111434026|NCT03425331|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111434027|NCT03425331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111434028|NCT03425331|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111434029|NCT03425331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111434030|NCT03149211|UB-421|ub-421|mesh-list
111434031|NCT03149211|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110512901|NCT04739592|Vitamin D|vitamin d|mesh-list
111434032|NCT03149211|Antiviral Agents|antiviral agents|mesh-ancestor
111434033|NCT03149211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111434034|NCT03141671|Prednisone|prednisone|mesh-list
111434035|NCT03141671|Bicalutamide|bicalutamide|mesh-list
111434036|NCT03141671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111434037|NCT03141671|Glucocorticoids|glucocorticoids|mesh-ancestor
111434038|NCT03141671|Hormones|hormones|mesh-ancestor
111434039|NCT03141671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111434040|NCT03141671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111434041|NCT03141671|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111434042|NCT03141671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111434043|NCT03141671|Androgen Antagonists|androgen antagonists|mesh-ancestor
111434044|NCT03141671|Hormone Antagonists|hormone antagonists|mesh-ancestor
111434045|NCT03043430|Midazolam|midazolam|mesh-list
111434046|NCT03043430|Ketamine|ketamine|mesh-list
111434047|NCT03043430|Analgesics|analgesics|mesh-ancestor
111434048|NCT03043430|Sensory System Agents|sensory system agents|mesh-ancestor
111434049|NCT03043430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111434050|NCT03043430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111434051|NCT03043430|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111434052|NCT03043430|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111434053|NCT03043430|Anesthetics, General|anesthetics, general|mesh-ancestor
111158406|NCT02194465|Tadalafil|tadalafil|mesh-list
111434054|NCT03043430|Anesthetics|anesthetics|mesh-ancestor
111434055|NCT03043430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111434056|NCT03043430|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111434057|NCT03043430|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111434058|NCT03043430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111434059|NCT03043430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111434060|NCT03043430|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111434061|NCT03043430|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111434062|NCT03043430|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111434063|NCT03043430|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111434064|NCT03043430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111434065|NCT03043430|GABA Modulators|gaba modulators|mesh-ancestor
111434067|NCT03035890|Immunomodulating Agents|immunomodulating agents|mesh-list
111434068|NCT03035890|Immunologic Factors|immunologic factors|mesh-ancestor
111434069|NCT03035890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111434070|NCT03004261|Ganciclovir|ganciclovir|mesh-list
111434071|NCT03004261|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
111434072|NCT03004261|Foscarnet|foscarnet|mesh-list
111434073|NCT03004261|Antiviral Agents|antiviral agents|mesh-ancestor
111434074|NCT03004261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111434075|NCT03004261|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111434076|NCT03004261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111434077|NCT03004261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111434078|NCT03004261|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111434079|NCT02856425|Pembrolizumab|pembrolizumab|mesh-list
111434080|NCT02856425|Nintedanib|nintedanib|mesh-list
111434081|NCT02856425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111434082|NCT02856425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111434083|NCT02856425|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111434084|NCT02856425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111434085|NCT02856425|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111434086|NCT02856425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111434087|NCT02785952|Nivolumab|nivolumab|mesh-list
111434088|NCT02785952|Ipilimumab|ipilimumab|mesh-list
111434089|NCT02785952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111434090|NCT02785952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111434091|NCT02785952|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111434092|NCT02785952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111434093|NCT02567409|Cisplatin|cisplatin|mesh-list
111434094|NCT02567409|Gemcitabine|gemcitabine|mesh-list
111434095|NCT02567409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111434096|NCT02567409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111434097|NCT02567409|Antimetabolites|antimetabolites|mesh-ancestor
111434098|NCT02567409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111434099|NCT02443727|Oxytocin|oxytocin|mesh-list
111434100|NCT02443727|Oxytocics|oxytocics|mesh-ancestor
111434101|NCT02443727|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111434102|NCT02443727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111434103|NCT02429700|Paclitaxel|paclitaxel|mesh-list
111434104|NCT02429700|Etoposide|etoposide|mesh-list
111434105|NCT02429700|Carboplatin|carboplatin|mesh-list
111434106|NCT02429700|Bleomycin|bleomycin|mesh-list
111434107|NCT02429700|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111434108|NCT02429700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111434109|NCT02429700|Tubulin Modulators|tubulin modulators|mesh-ancestor
111434110|NCT02429700|Antimitotic Agents|antimitotic agents|mesh-ancestor
111434111|NCT02429700|Mitosis Modulators|mitosis modulators|mesh-ancestor
111434112|NCT02429700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111434113|NCT02429700|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111434114|NCT02429700|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111434115|NCT02429700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111434116|NCT02429700|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111434117|NCT02429687|Paclitaxel|paclitaxel|mesh-list
111434118|NCT02429687|Etoposide|etoposide|mesh-list
111434119|NCT02429687|Carboplatin|carboplatin|mesh-list
111434120|NCT02429687|Bleomycin|bleomycin|mesh-list
111434121|NCT02429687|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111434122|NCT02429687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111434123|NCT02429687|Tubulin Modulators|tubulin modulators|mesh-ancestor
111434124|NCT02429687|Antimitotic Agents|antimitotic agents|mesh-ancestor
111434125|NCT02429687|Mitosis Modulators|mitosis modulators|mesh-ancestor
111434126|NCT02429687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111434127|NCT02429687|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111434128|NCT02429687|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111434129|NCT02429687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111434130|NCT02429687|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111434131|NCT02194829|Paclitaxel|paclitaxel|mesh-list
111434132|NCT02194829|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111434133|NCT02194829|Gemcitabine|gemcitabine|mesh-list
111434134|NCT02194829|Adavosertib|adavosertib|mesh-list
111434135|NCT02194829|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111434136|NCT02194829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111434137|NCT02194829|Tubulin Modulators|tubulin modulators|mesh-ancestor
111434138|NCT02194829|Antimitotic Agents|antimitotic agents|mesh-ancestor
111434139|NCT02194829|Mitosis Modulators|mitosis modulators|mesh-ancestor
111434140|NCT02194829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111434141|NCT02194829|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111434142|NCT02194829|Antimetabolites|antimetabolites|mesh-ancestor
111434143|NCT02194829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111434144|NCT01370460|Tranexamic Acid|tranexamic acid|mesh-list
111434145|NCT01370460|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111434146|NCT01370460|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111434147|NCT01370460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111434148|NCT01370460|Hemostatics|hemostatics|mesh-ancestor
111434149|NCT01370460|Coagulants|coagulants|mesh-ancestor
111434150|NCT00621192|Meropenem|meropenem|mesh-list
111434151|NCT00621192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111434152|NCT00621192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111434153|NCT00364286|Dasatinib|dasatinib|mesh-list
111434154|NCT00364286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111434155|NCT00364286|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111434156|NCT00364286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111434157|NCT00364286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111434158|NCT00255346|Dasatinib|dasatinib|mesh-list
111434159|NCT00255346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111434160|NCT00255346|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111434161|NCT00255346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111434162|NCT00255346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111434163|NCT02834624|Poractant alfa|poractant alfa|mesh-list
111434164|NCT02834624|Calfactant|calfactant|mesh-list
111434165|NCT02834624|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
111434166|NCT02834624|Respiratory System Agents|respiratory system agents|mesh-ancestor
111434167|NCT02837744|Hemostatics|hemostatics|mesh-list
111434168|NCT02837744|Coagulants|coagulants|mesh-ancestor
111434169|NCT02918617|Fluorides|fluorides|mesh-list
111434170|NCT02918617|Cariostatic Agents|cariostatic agents|mesh-ancestor
111434171|NCT02918617|Protective Agents|protective agents|mesh-ancestor
110512923|NCT02771418|Propofol|propofol|mesh-list
111434172|NCT02918617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111434173|NCT02839772|Glycerol|glycerol|mesh-list
111434174|NCT02839772|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
111434175|NCT02839772|Protective Agents|protective agents|mesh-ancestor
111434176|NCT02839772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111434177|NCT03041636|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
111434178|NCT03041636|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111434179|NCT03041636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111434180|NCT03041636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111434181|NCT03043105|Thalidomide|thalidomide|mesh-list
111434182|NCT03043105|Prednisone|prednisone|mesh-list
111434183|NCT03043105|Cyclophosphamide|cyclophosphamide|mesh-list
111434184|NCT03043105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111434185|NCT03043105|Immunologic Factors|immunologic factors|mesh-ancestor
111434186|NCT03043105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111434187|NCT03043105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111434188|NCT03043105|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111434189|NCT03043105|Alkylating Agents|alkylating agents|mesh-ancestor
111434190|NCT03043105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111434191|NCT03043105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111434192|NCT03043105|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111434193|NCT03043105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111434194|NCT03043105|Glucocorticoids|glucocorticoids|mesh-ancestor
111434195|NCT03043105|Hormones|hormones|mesh-ancestor
111434196|NCT03043105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111434197|NCT03043105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111434198|NCT03043105|Leprostatic Agents|leprostatic agents|mesh-ancestor
111434199|NCT03043105|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111434200|NCT03043105|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111434201|NCT03043105|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111434202|NCT03043105|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111434203|NCT03043105|Growth Substances|growth substances|mesh-ancestor
111434204|NCT03043105|Growth Inhibitors|growth inhibitors|mesh-ancestor
111434205|NCT00374647|Mycophenolic Acid|mycophenolic acid|mesh-list
111434206|NCT00374647|Sirolimus|sirolimus|mesh-list
111158556|NCT02260934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111434207|NCT00374647|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111434208|NCT00374647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111434209|NCT00374647|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111434210|NCT00374647|Antitubercular Agents|antitubercular agents|mesh-ancestor
111434211|NCT00374647|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111434212|NCT00374647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111434213|NCT00374647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111434214|NCT00374647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111434215|NCT00374647|Antifungal Agents|antifungal agents|mesh-ancestor
111434216|NCT00374647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111434217|NCT00374647|Immunologic Factors|immunologic factors|mesh-ancestor
111434218|NCT00374647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111434220|NCT02964416|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111434221|NCT02964416|Narcotics|narcotics|mesh-ancestor
111434222|NCT02964416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111434223|NCT02964416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111434224|NCT02964416|Analgesics|analgesics|mesh-ancestor
111434225|NCT02964416|Sensory System Agents|sensory system agents|mesh-ancestor
111434226|NCT02964416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111434227|NCT02812771|Efinaconazole|efinaconazole|mesh-list
111434228|NCT02812771|Antifungal Agents|antifungal agents|mesh-ancestor
111434229|NCT02812771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111434230|NCT02969876|Vortioxetine|vortioxetine|mesh-list
111434231|NCT02969876|Antidepressive Agents|antidepressive agents|mesh-ancestor
111434232|NCT02969876|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111434233|NCT02969876|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111434234|NCT02969876|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111434235|NCT02969876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111434236|NCT02969876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111434237|NCT02969876|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110177278|NCT03150771|Aripiprazole|aripiprazole|mesh-list
111434238|NCT02969876|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111434239|NCT02969876|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111434240|NCT02969876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111434241|NCT02969876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111434242|NCT02969876|Serotonin Agents|serotonin agents|mesh-ancestor
111434243|NCT02969876|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111434244|NCT02969876|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111434245|NCT02969876|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111434246|NCT02969876|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111434247|NCT02970032|Heparin|heparin|mesh-list
111434248|NCT02970032|Calcium heparin|calcium heparin|mesh-list
111434249|NCT02970032|Anticoagulants|anticoagulants|mesh-ancestor
111434250|NCT02970032|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111434251|NCT02970032|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111434252|NCT02970032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111434253|NCT02813551|Torsemide|torsemide|mesh-list
111434254|NCT02813551|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111434255|NCT02813551|Diuretics|diuretics|mesh-ancestor
111434256|NCT02813551|Natriuretic Agents|natriuretic agents|mesh-ancestor
111434257|NCT02813551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111434258|NCT02813551|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
111434259|NCT02813551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111434260|NCT02813551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111434261|NCT02817763|Dipyrone|dipyrone|mesh-list
111434262|NCT02817763|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111434263|NCT02817763|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111434264|NCT02817763|Analgesics|analgesics|mesh-ancestor
111434265|NCT02817763|Sensory System Agents|sensory system agents|mesh-ancestor
111434266|NCT02817763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111434267|NCT02817763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111434268|NCT02817763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111434269|NCT02817763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111434270|NCT02817763|Antipyretics|antipyretics|mesh-ancestor
111434271|NCT02846792|Nivolumab|nivolumab|mesh-list
111434272|NCT02846792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111434273|NCT02846792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111434274|NCT02846792|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111434275|NCT02846792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111434276|NCT03053401|Anesthetics|anesthetics|mesh-list
111434277|NCT03053401|Anesthetics, Local|anesthetics, local|mesh-list
111434278|NCT03053401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111434279|NCT03053401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111434280|NCT03053401|Sensory System Agents|sensory system agents|mesh-ancestor
111434281|NCT03053401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111434282|NCT03054103|Midazolam|midazolam|mesh-list
111434283|NCT03054103|Ketamine|ketamine|mesh-list
111434284|NCT03054103|Analgesics|analgesics|mesh-ancestor
111434285|NCT03054103|Sensory System Agents|sensory system agents|mesh-ancestor
111434286|NCT03054103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111434287|NCT03054103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111434288|NCT03054103|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111434289|NCT03054103|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111434290|NCT03054103|Anesthetics, General|anesthetics, general|mesh-ancestor
111434291|NCT03054103|Anesthetics|anesthetics|mesh-ancestor
111434292|NCT03054103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111434293|NCT03054103|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111434294|NCT03054103|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111434295|NCT03054103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111434296|NCT03054103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111434297|NCT03054103|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111434298|NCT03054103|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111434299|NCT03054103|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111434300|NCT03054103|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111434301|NCT03054103|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111434302|NCT03054103|GABA Modulators|gaba modulators|mesh-ancestor
111434303|NCT03054103|GABA Agents|gaba agents|mesh-ancestor
111434304|NCT03043274|Cangrelor|cangrelor|mesh-list
111434305|NCT03043274|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111434306|NCT03043274|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111434307|NCT03043274|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111434308|NCT03043274|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111434309|NCT03043274|Purinergic Agents|purinergic agents|mesh-ancestor
111434310|NCT03043274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111434311|NCT03043274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111434312|NCT03043274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111434313|NCT03054805|Magnesium Oxide|magnesium oxide|mesh-list
111434314|NCT03054805|Antacids|antacids|mesh-ancestor
111434315|NCT03054805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111434316|NCT03054805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111434317|NCT00374101|Omeprazole|omeprazole|mesh-list
111434318|NCT00374101|Pantoprazole|pantoprazole|mesh-list
111434319|NCT00374101|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111434320|NCT00374101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111434321|NCT00374101|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111434322|NCT00374101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111434323|NCT00374101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111434324|NCT00373789|Botulinum Toxins|botulinum toxins|mesh-list
111434325|NCT00373789|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111434326|NCT00373789|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111434327|NCT00373789|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111434328|NCT00373789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111434329|NCT00373789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111434330|NCT00373789|Cholinergic Agents|cholinergic agents|mesh-ancestor
111434331|NCT00373789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111434332|NCT00373789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111434333|NCT00373789|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111434334|NCT00373789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111434335|NCT03062605|Povidone-Iodine|povidone-iodine|mesh-list
111434336|NCT03062605|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111434337|NCT03062605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111434338|NCT03050294|Desoximetasone|desoximetasone|mesh-list
111434339|NCT03050294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111434340|NCT03050294|Glucocorticoids|glucocorticoids|mesh-ancestor
111434341|NCT03050294|Hormones|hormones|mesh-ancestor
111434342|NCT03050294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111434343|NCT03050294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111434344|NCT02831569|Loxoprofen|loxoprofen|mesh-list
111434345|NCT02831569|Methocarbamol|methocarbamol|mesh-list
111434346|NCT02831569|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111434347|NCT02831569|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111434348|NCT02831569|Analgesics|analgesics|mesh-ancestor
111434349|NCT02831569|Sensory System Agents|sensory system agents|mesh-ancestor
111434350|NCT02831569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111434351|NCT02831569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111434352|NCT02831569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111434353|NCT02831569|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111434354|NCT02831569|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
111158730|NCT01604824|Alirocumab|alirocumab|mesh-list
111434355|NCT02831569|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111434357|NCT03065179|Ipilimumab|ipilimumab|mesh-list
111434358|NCT03065179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111434359|NCT03065179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111434360|NCT03065179|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111434361|NCT03065179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111434362|NCT02988050|Lidocaine|lidocaine|mesh-list
111434363|NCT02988050|Epinephrine|epinephrine|mesh-list
111434364|NCT02988050|Dexmedetomidine|dexmedetomidine|mesh-list
111434365|NCT02988050|Remifentanil|remifentanil|mesh-list
111434366|NCT02988050|Bupivacaine|bupivacaine|mesh-list
111434367|NCT02988050|Propofol|propofol|mesh-list
111434368|NCT02988050|Anesthetics, Local|anesthetics, local|mesh-ancestor
111434369|NCT02988050|Anesthetics|anesthetics|mesh-ancestor
111434370|NCT02988050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111434371|NCT02988050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111434372|NCT02988050|Sensory System Agents|sensory system agents|mesh-ancestor
110512963|NCT00884767|Leucovorin|leucovorin|mesh-list
111434373|NCT02988050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111434374|NCT02988050|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111434375|NCT02988050|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111434376|NCT02988050|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111434377|NCT02988050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111434378|NCT02988050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111434379|NCT02988050|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111434380|NCT02988050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111434381|NCT02988050|Analgesics|analgesics|mesh-ancestor
111434382|NCT02988050|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111434383|NCT02988050|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111434384|NCT02988050|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111434385|NCT02988050|Adrenergic Agents|adrenergic agents|mesh-ancestor
111434386|NCT02988050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111434387|NCT02988050|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111434388|NCT02988050|Anesthetics, General|anesthetics, general|mesh-ancestor
111434389|NCT02988050|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111434390|NCT02988050|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111434391|NCT02988050|Autonomic Agents|autonomic agents|mesh-ancestor
111434392|NCT02988050|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111434393|NCT02988050|Respiratory System Agents|respiratory system agents|mesh-ancestor
111434394|NCT02988050|Mydriatics|mydriatics|mesh-ancestor
111434395|NCT02988050|Sympathomimetics|sympathomimetics|mesh-ancestor
111434396|NCT02988050|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111434397|NCT02988050|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111434398|NCT02988050|Narcotics|narcotics|mesh-ancestor
111434399|NCT02988986|Tamoxifen|tamoxifen|mesh-list
111434400|NCT02988986|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111434401|NCT02988986|Hormone Antagonists|hormone antagonists|mesh-ancestor
111434402|NCT02988986|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111434403|NCT02988986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111434404|NCT02988986|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111434405|NCT02988986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111434406|NCT02988986|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111434407|NCT02988986|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111434408|NCT02988986|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111434409|NCT02832115|Lidocaine|lidocaine|mesh-list
111434410|NCT02832115|Nitroglycerin|nitroglycerin|mesh-list
111434411|NCT02832115|Anesthetics, Local|anesthetics, local|mesh-list
111434412|NCT02832115|Anesthetics|anesthetics|mesh-list
111434413|NCT02832115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111434414|NCT02832115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111434415|NCT02832115|Sensory System Agents|sensory system agents|mesh-ancestor
111434416|NCT02832115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111434417|NCT02832115|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111434418|NCT02832115|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111434419|NCT02832115|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111434420|NCT02832115|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111434421|NCT02832115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111434422|NCT02832115|Vasodilator Agents|vasodilator agents|mesh-ancestor
111434423|NCT03054506|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
111434424|NCT03054506|Laxatives|laxatives|mesh-ancestor
111434425|NCT03054506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111434426|NCT02935699|Diphenhydramine|diphenhydramine|mesh-list
111434427|NCT02935699|Promethazine|promethazine|mesh-list
111434428|NCT02935699|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111158778|NCT04863716|Analgesics|analgesics|mesh-ancestor
111434429|NCT02935699|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111434430|NCT02935699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111434431|NCT02935699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111434432|NCT02935699|Anesthetics, Local|anesthetics, local|mesh-ancestor
111434433|NCT02935699|Anesthetics|anesthetics|mesh-ancestor
111434434|NCT02935699|Sensory System Agents|sensory system agents|mesh-ancestor
111434435|NCT02935699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111434436|NCT02935699|Antiemetics|antiemetics|mesh-ancestor
111434437|NCT02935699|Autonomic Agents|autonomic agents|mesh-ancestor
111434438|NCT02935699|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111434439|NCT02935699|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111434440|NCT02935699|Histamine Antagonists|histamine antagonists|mesh-ancestor
111434441|NCT02935699|Histamine Agents|histamine agents|mesh-ancestor
111434442|NCT02935699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110512964|NCT00884767|Fluorouracil|fluorouracil|mesh-list
111434443|NCT02935699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111434444|NCT02935699|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111434445|NCT02935699|Antipruritics|antipruritics|mesh-ancestor
111434446|NCT02935699|Dermatologic Agents|dermatologic agents|mesh-ancestor
111434447|NCT02936479|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
111434448|NCT02936479|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
111434449|NCT02936479|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
111434450|NCT02936479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111434451|NCT02936479|Immunologic Factors|immunologic factors|mesh-ancestor
111434452|NCT02936479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111434453|NCT02841241|Esmolol|esmolol|mesh-list
111434454|NCT02841241|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
111434455|NCT02841241|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111434456|NCT02841241|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111434457|NCT02841241|Adrenergic Agents|adrenergic agents|mesh-ancestor
111434458|NCT02841241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111434459|NCT02841241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111434460|NCT02841241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111434461|NCT00374881|Phenylephrine|phenylephrine|mesh-list
111434462|NCT00374881|Oxymetazoline|oxymetazoline|mesh-list
111434463|NCT00374881|Morphine|morphine|mesh-list
111434464|NCT00374881|Sorbitol|sorbitol|mesh-list
111434465|NCT00374881|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111434466|NCT00374881|Narcotics|narcotics|mesh-ancestor
111434467|NCT00374881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111434468|NCT00374881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111434469|NCT00374881|Analgesics|analgesics|mesh-ancestor
111434470|NCT00374881|Sensory System Agents|sensory system agents|mesh-ancestor
111434471|NCT00374881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111434472|NCT00374881|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111434473|NCT00374881|Mydriatics|mydriatics|mesh-ancestor
111434474|NCT00374881|Autonomic Agents|autonomic agents|mesh-ancestor
111434475|NCT00374881|Sympathomimetics|sympathomimetics|mesh-ancestor
111434476|NCT00374881|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111434477|NCT00374881|Nasal Decongestants|nasal decongestants|mesh-ancestor
111434478|NCT00374881|Respiratory System Agents|respiratory system agents|mesh-ancestor
111434479|NCT00374881|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111434480|NCT00374881|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111434481|NCT00374881|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111434482|NCT00374881|Adrenergic Agents|adrenergic agents|mesh-ancestor
111434483|NCT00374881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111434484|NCT00374881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111434485|NCT00374881|Protective Agents|protective agents|mesh-ancestor
111434486|NCT00374881|Cathartics|cathartics|mesh-ancestor
111434487|NCT00374881|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111434488|NCT00374959|Ceftriaxone|ceftriaxone|mesh-list
111434489|NCT00374959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111434490|NCT00374959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111434491|NCT02846233|Metformin|metformin|mesh-list
111434492|NCT02846233|Empagliflozin|empagliflozin|mesh-list
111434493|NCT02846233|Dulaglutide|dulaglutide|mesh-list
111434494|NCT02846233|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
111434495|NCT02846233|rGLP-1 protein|rglp-1 protein|mesh-list
111434496|NCT02846233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111434497|NCT02846233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111434498|NCT02846233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111434499|NCT02846233|Incretins|incretins|mesh-ancestor
111434500|NCT02846233|Hormones|hormones|mesh-ancestor
111434501|NCT02846233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111434502|NCT02865590|Cimetidine|cimetidine|mesh-list
111434503|NCT02865590|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111434504|NCT02865590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111434505|NCT02865590|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
111434506|NCT02865590|Histamine Antagonists|histamine antagonists|mesh-ancestor
111434507|NCT02865590|Histamine Agents|histamine agents|mesh-ancestor
111434508|NCT02865590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111434509|NCT02865590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111434510|NCT02865590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111434511|NCT02865590|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111434512|NCT02865590|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111434513|NCT02865590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111434514|NCT02868242|Sofosbuvir|sofosbuvir|mesh-list
111434515|NCT02868242|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
111434516|NCT02868242|Ledipasvir|ledipasvir|mesh-list
111434517|NCT02868242|Antiviral Agents|antiviral agents|mesh-ancestor
111434518|NCT02868242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111434519|NCT03075553|Nivolumab|nivolumab|mesh-list
111434520|NCT03075553|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111434521|NCT03075553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111434522|NCT03075553|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111434523|NCT03075553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111434524|NCT03054740|Ethyl Chloride|ethyl chloride|mesh-list
111434525|NCT03054740|Anesthetics, Local|anesthetics, local|mesh-ancestor
111434526|NCT03054740|Anesthetics|anesthetics|mesh-ancestor
111434527|NCT03054740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111434528|NCT03054740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111434529|NCT03054740|Sensory System Agents|sensory system agents|mesh-ancestor
111434530|NCT03054740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111434531|NCT02997722|Ketamine|ketamine|mesh-list
111434532|NCT02997722|Analgesics|analgesics|mesh-ancestor
111434533|NCT02997722|Sensory System Agents|sensory system agents|mesh-ancestor
111434534|NCT02997722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111434535|NCT02997722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111434536|NCT02997722|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111434537|NCT02997722|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111434538|NCT02997722|Anesthetics, General|anesthetics, general|mesh-ancestor
111434539|NCT02997722|Anesthetics|anesthetics|mesh-ancestor
111434540|NCT02997722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111434541|NCT02997722|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111434542|NCT02997722|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111434543|NCT02997722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111434544|NCT02997722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111434545|NCT03108482|Celecoxib|celecoxib|mesh-list
111434546|NCT03108482|Tramadol|tramadol|mesh-list
111434547|NCT03108482|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111434548|NCT03108482|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111434549|NCT03108482|Analgesics|analgesics|mesh-ancestor
111434550|NCT03108482|Sensory System Agents|sensory system agents|mesh-ancestor
111434551|NCT03108482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111434552|NCT03108482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111434553|NCT03108482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111434554|NCT03108482|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111434555|NCT03108482|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111434556|NCT03108482|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111434557|NCT03108482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111434558|NCT03108482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111434559|NCT03108482|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111434560|NCT03108482|Narcotics|narcotics|mesh-ancestor
111434561|NCT03108482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111434562|NCT02850601|Dexamethasone|dexamethasone|mesh-list
111434563|NCT02850601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111434564|NCT02850601|Antiemetics|antiemetics|mesh-ancestor
111434565|NCT02850601|Autonomic Agents|autonomic agents|mesh-ancestor
111434566|NCT02850601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111434567|NCT02850601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111434568|NCT02850601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111434569|NCT02850601|Glucocorticoids|glucocorticoids|mesh-ancestor
111434570|NCT02850601|Hormones|hormones|mesh-ancestor
111434571|NCT02850601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111434572|NCT02850601|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111434573|NCT02850601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111434574|NCT03056456|Insulin Lispro|insulin lispro|mesh-list
111434575|NCT03056456|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111434576|NCT03056456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111434577|NCT03057704|Lidocaine|lidocaine|mesh-list
111434578|NCT03057704|Anesthetics, Local|anesthetics, local|mesh-ancestor
111434579|NCT03057704|Anesthetics|anesthetics|mesh-ancestor
111434580|NCT03057704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111434581|NCT03057704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111434582|NCT03057704|Sensory System Agents|sensory system agents|mesh-ancestor
111434583|NCT03057704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111434584|NCT03057704|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111434585|NCT03057704|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111434586|NCT03057704|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111434587|NCT03057704|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111434588|NCT03057704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111434590|NCT02874092|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111434591|NCT02874092|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111434592|NCT02874092|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111434593|NCT02874092|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111434594|NCT02874092|Purinergic Agents|purinergic agents|mesh-ancestor
111434595|NCT02874092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111434596|NCT02874092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111434597|NCT02874092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111434598|NCT02876900|Asenapine|asenapine|mesh-list
111434599|NCT02876900|Maleic acid|maleic acid|mesh-list
111434600|NCT02876900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111434601|NCT02876900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111434602|NCT02876900|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111434603|NCT02876900|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111434604|NCT02876900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111434605|NCT02876900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111434606|NCT02876900|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111434607|NCT02878382|Calcipotriene|calcipotriene|mesh-list
111434608|NCT02878382|Dermatologic Agents|dermatologic agents|mesh-ancestor
111434609|NCT03117140|Dexamethasone|dexamethasone|mesh-list
111434610|NCT03117140|Clonidine|clonidine|mesh-list
111434611|NCT03117140|Buprenorphine|buprenorphine|mesh-list
111434612|NCT03117140|Ropivacaine|ropivacaine|mesh-list
111434613|NCT03117140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111434614|NCT03117140|Antiemetics|antiemetics|mesh-ancestor
111434615|NCT03117140|Autonomic Agents|autonomic agents|mesh-ancestor
111434616|NCT03117140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111434617|NCT03117140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111434618|NCT03117140|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111434619|NCT03117140|Glucocorticoids|glucocorticoids|mesh-ancestor
111434620|NCT03117140|Hormones|hormones|mesh-ancestor
111434621|NCT03117140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111434622|NCT03117140|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111434623|NCT03117140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111434624|NCT03117140|Anesthetics, Local|anesthetics, local|mesh-ancestor
111434625|NCT03117140|Anesthetics|anesthetics|mesh-ancestor
111434626|NCT03117140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111434627|NCT03117140|Sensory System Agents|sensory system agents|mesh-ancestor
111434628|NCT03117140|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111434629|NCT03117140|Narcotics|narcotics|mesh-ancestor
111434630|NCT03117140|Analgesics|analgesics|mesh-ancestor
111434631|NCT03117140|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111434632|NCT03117140|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111434633|NCT03117140|Sympatholytics|sympatholytics|mesh-ancestor
111434634|NCT03117140|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111434635|NCT03117140|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111434636|NCT03117140|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111434637|NCT03117140|Adrenergic Agents|adrenergic agents|mesh-ancestor
111434638|NCT03117140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111434639|NCT03117140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111434640|NCT03118466|Cytarabine|cytarabine|mesh-list
111434641|NCT03118466|Etoposide|etoposide|mesh-list
111434642|NCT03118466|Mitoxantrone|mitoxantrone|mesh-list
111434643|NCT03118466|Lenalidomide|lenalidomide|mesh-list
111434644|NCT03118466|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111434645|NCT03118466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111434646|NCT03118466|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111434647|NCT03118466|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111434648|NCT03118466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111434649|NCT03118466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111434650|NCT03118466|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111434651|NCT03118466|Antimetabolites|antimetabolites|mesh-ancestor
111434652|NCT03118466|Antiviral Agents|antiviral agents|mesh-ancestor
111159015|NCT02164513|Xhance|xhance|mesh-list
111434654|NCT03118466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111434655|NCT03118466|Immunologic Factors|immunologic factors|mesh-ancestor
111434656|NCT03118466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111434657|NCT03118466|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111434658|NCT03118466|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111434659|NCT03118466|Growth Substances|growth substances|mesh-ancestor
111434660|NCT03118466|Growth Inhibitors|growth inhibitors|mesh-ancestor
111434661|NCT03118466|Analgesics|analgesics|mesh-ancestor
111434662|NCT03118466|Sensory System Agents|sensory system agents|mesh-ancestor
111434663|NCT03118466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111434664|NCT03068312|Ivacaftor|ivacaftor|mesh-list
111434665|NCT03068312|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
111434666|NCT03068312|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111434667|NCT03068312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111434668|NCT03119168|Simethicone|simethicone|mesh-list
111434669|NCT03119168|Antifoaming Agents|antifoaming agents|mesh-ancestor
111434670|NCT03119168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111434671|NCT03119168|Emollients|emollients|mesh-ancestor
111434672|NCT03119168|Dermatologic Agents|dermatologic agents|mesh-ancestor
111434673|NCT03070730|Atenolol|atenolol|mesh-list
111434674|NCT03070730|Droxidopa|droxidopa|mesh-list
111434675|NCT03070730|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111434676|NCT03070730|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111434677|NCT03070730|Sympatholytics|sympatholytics|mesh-ancestor
111434678|NCT03070730|Autonomic Agents|autonomic agents|mesh-ancestor
111434679|NCT03070730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111434680|NCT03070730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111434681|NCT03070730|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
111434682|NCT03070730|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111434683|NCT03070730|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111434684|NCT03070730|Adrenergic Agents|adrenergic agents|mesh-ancestor
111434685|NCT03070730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111434686|NCT03070730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111434687|NCT03070730|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111434688|NCT03070730|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111434689|NCT03121820|Memantine|memantine|mesh-list
111434690|NCT03121820|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111434691|NCT03121820|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111434692|NCT03121820|Dopamine Agents|dopamine agents|mesh-ancestor
111434693|NCT03121820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111434694|NCT03121820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111434695|NCT03121820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111434696|NCT03121820|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111434697|NCT03121820|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111434698|NCT03123614|Loteprednol Etabonate|loteprednol etabonate|mesh-list
111434699|NCT03123614|Prednisolone|prednisolone|mesh-list
111434700|NCT03123614|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111434701|NCT03123614|Methylprednisolone|methylprednisolone|mesh-list
111434702|NCT03123614|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111434703|NCT03123614|Prednisolone acetate|prednisolone acetate|mesh-list
111434704|NCT03123614|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111434705|NCT03123614|Prednisolone phosphate|prednisolone phosphate|mesh-list
111434706|NCT03123614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111434707|NCT03123614|Glucocorticoids|glucocorticoids|mesh-ancestor
111434708|NCT03123614|Hormones|hormones|mesh-ancestor
111434709|NCT03123614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111434710|NCT03123614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111434711|NCT03123614|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111434712|NCT03123614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111434713|NCT03123614|Antiemetics|antiemetics|mesh-ancestor
111434714|NCT03123614|Autonomic Agents|autonomic agents|mesh-ancestor
111434715|NCT03123614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111434716|NCT03123614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111434717|NCT03123614|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111434718|NCT03123614|Protective Agents|protective agents|mesh-ancestor
111434719|NCT03123614|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111434720|NCT03123848|Darunavir|darunavir|mesh-list
111434721|NCT03123848|Cobicistat|cobicistat|mesh-list
111434722|NCT03123848|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
111434723|NCT03123848|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111434724|NCT03123848|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111434725|NCT03123848|Protease Inhibitors|protease inhibitors|mesh-ancestor
111434726|NCT03123848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111159082|NCT04464512|Anesthetics|anesthetics|mesh-ancestor
111434727|NCT03123848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111434728|NCT03123848|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111434729|NCT03123848|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111434730|NCT03123848|Antiviral Agents|antiviral agents|mesh-ancestor
111434731|NCT03123848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111434732|NCT03123848|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111434733|NCT03123848|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111434734|NCT02946073|Buprenorphine|buprenorphine|mesh-list
111434735|NCT02946073|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111434736|NCT02946073|Narcotics|narcotics|mesh-ancestor
111434737|NCT02946073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111434738|NCT02946073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111434739|NCT02946073|Analgesics|analgesics|mesh-ancestor
111434740|NCT02946073|Sensory System Agents|sensory system agents|mesh-ancestor
111434741|NCT02946073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111434742|NCT02946073|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111434743|NCT03071744|Fentanyl|fentanyl|mesh-list
111434744|NCT03071744|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111434745|NCT03071744|Narcotics|narcotics|mesh-ancestor
111434746|NCT03071744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111434747|NCT03071744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111434748|NCT03071744|Analgesics|analgesics|mesh-ancestor
111434749|NCT03071744|Sensory System Agents|sensory system agents|mesh-ancestor
111434750|NCT03071744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111434751|NCT03071744|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111434752|NCT03071744|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111434753|NCT03071744|Anesthetics, General|anesthetics, general|mesh-ancestor
111434754|NCT03071744|Anesthetics|anesthetics|mesh-ancestor
111434755|NCT03074630|Dapagliflozin|dapagliflozin|mesh-list
111434756|NCT03074630|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111434757|NCT03074630|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111434758|NCT03074630|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111434759|NCT03074630|Antimetabolites|antimetabolites|mesh-ancestor
111434760|NCT03074630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111434761|NCT03074630|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111434762|NCT03074630|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111434763|NCT03074630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111434764|NCT03074630|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111434765|NCT03074630|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111434766|NCT03074630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111434767|NCT05404334|Androgens|androgens|mesh-list
111434768|NCT05404334|Hormones|hormones|mesh-ancestor
111434769|NCT05404334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111434770|NCT05404334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111434771|NCT00374894|Succimer|succimer|mesh-list
111434772|NCT00374894|Antidotes|antidotes|mesh-ancestor
111434773|NCT00374894|Protective Agents|protective agents|mesh-ancestor
111434774|NCT00374894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111434775|NCT00374894|Chelating Agents|chelating agents|mesh-ancestor
111434776|NCT00374894|Sequestering Agents|sequestering agents|mesh-ancestor
111434777|NCT00374894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111434778|NCT03088267|Amphetamine|amphetamine|mesh-list
111434779|NCT03088267|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111434780|NCT03088267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111434781|NCT03088267|Sympathomimetics|sympathomimetics|mesh-ancestor
111434782|NCT03088267|Autonomic Agents|autonomic agents|mesh-ancestor
111434783|NCT03088267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111434784|NCT03088267|Dopamine Agents|dopamine agents|mesh-ancestor
111434785|NCT03088267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111434786|NCT03088267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111434787|NCT03088267|Adrenergic Agents|adrenergic agents|mesh-ancestor
111434788|NCT03088267|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111434789|NCT03088267|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111434790|NCT03088267|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111434791|NCT03088267|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111434792|NCT03088345|Vasopressins|vasopressins|mesh-list
111434793|NCT03088345|Arginine Vasopressin|arginine vasopressin|mesh-list
111434794|NCT03088345|Hemostatics|hemostatics|mesh-ancestor
111434795|NCT03088345|Coagulants|coagulants|mesh-ancestor
111434796|NCT03088345|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111434797|NCT03088345|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
111434798|NCT03088345|Natriuretic Agents|natriuretic agents|mesh-ancestor
111434799|NCT03088345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111434800|NCT03127514|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
111434801|NCT03127514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111434802|NCT02858713|Betamethasone|betamethasone|mesh-list
111434803|NCT02858713|Betamethasone Valerate|betamethasone valerate|mesh-list
111434804|NCT02858713|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
111434805|NCT02858713|Betamethasone benzoate|betamethasone benzoate|mesh-list
111434806|NCT02858713|Calcipotriene|calcipotriene|mesh-list
111434807|NCT02858713|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
111434808|NCT02858713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111434809|NCT02858713|Glucocorticoids|glucocorticoids|mesh-ancestor
111434811|NCT02858713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111434812|NCT02858713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111434813|NCT02858713|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111434814|NCT02858713|Respiratory System Agents|respiratory system agents|mesh-ancestor
111434815|NCT02858713|Dermatologic Agents|dermatologic agents|mesh-ancestor
111434816|NCT00375050|Riluzole|riluzole|mesh-list
111434817|NCT00375050|Anticonvulsants|anticonvulsants|mesh-ancestor
111434818|NCT00375050|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111434819|NCT00375050|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111434820|NCT00375050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111434821|NCT00375050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111434822|NCT00375050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111434823|NCT00375050|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111434824|NCT00375050|Protective Agents|protective agents|mesh-ancestor
111434825|NCT02860507|Glycopyrrolate|glycopyrrolate|mesh-list
111434826|NCT02860507|Neostigmine|neostigmine|mesh-list
111434827|NCT02860507|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111434828|NCT02860507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111434829|NCT02860507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111434830|NCT02860507|Cholinergic Agents|cholinergic agents|mesh-ancestor
111434831|NCT02860507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111434832|NCT02860507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111434833|NCT02860507|Parasympathomimetics|parasympathomimetics|mesh-ancestor
111434834|NCT02860507|Autonomic Agents|autonomic agents|mesh-ancestor
111434835|NCT02860507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111434836|NCT02860507|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111434837|NCT02860507|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111434838|NCT02860507|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111434839|NCT03082196|Fluorides|fluorides|mesh-list
111434840|NCT03082196|Sodium Fluoride|sodium fluoride|mesh-list
111434841|NCT03082196|Fluorides, Topical|fluorides, topical|mesh-list
111434842|NCT03082196|Cariostatic Agents|cariostatic agents|mesh-ancestor
111434843|NCT03082196|Protective Agents|protective agents|mesh-ancestor
111434844|NCT03082196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111434845|NCT02861131|Neostigmine|neostigmine|mesh-list
111434846|NCT02861131|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111434847|NCT02861131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111434848|NCT02861131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111434849|NCT02861131|Cholinergic Agents|cholinergic agents|mesh-ancestor
111434850|NCT02861131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111434851|NCT02861131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111434852|NCT02861131|Parasympathomimetics|parasympathomimetics|mesh-ancestor
111434853|NCT02861131|Autonomic Agents|autonomic agents|mesh-ancestor
111434854|NCT02861131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111434855|NCT05057858|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
111434856|NCT05057858|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111434857|NCT05057858|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111434858|NCT05057858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111434859|NCT05057858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111434860|NCT05057858|Antiviral Agents|antiviral agents|mesh-ancestor
111434861|NCT05057858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111434862|NCT05057858|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111434863|NCT05057858|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111434864|NCT04707092|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111434865|NCT04707092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111434866|NCT02953561|Azacitidine|azacitidine|mesh-list
111434867|NCT02953561|Avelumab|avelumab|mesh-list
111434868|NCT02953561|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111434869|NCT02953561|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111434870|NCT02953561|Antimetabolites|antimetabolites|mesh-ancestor
111434871|NCT02953561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111434872|NCT02953561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111434873|NCT02953561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111434874|NCT02953561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111434875|NCT02953561|Immunologic Factors|immunologic factors|mesh-ancestor
111434876|NCT02953561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111434877|NCT03090620|Lorazepam|lorazepam|mesh-list
111434878|NCT03090620|Physostigmine|physostigmine|mesh-list
111434879|NCT03090620|Anticonvulsants|anticonvulsants|mesh-ancestor
111434880|NCT03090620|Antiemetics|antiemetics|mesh-ancestor
111434881|NCT03090620|Autonomic Agents|autonomic agents|mesh-ancestor
111434882|NCT03090620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111434883|NCT03090620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111434884|NCT03090620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111434885|NCT03090620|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111434886|NCT03090620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111434887|NCT03090620|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111434888|NCT03090620|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111434889|NCT03090620|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111434890|NCT03090620|GABA Modulators|gaba modulators|mesh-ancestor
111434891|NCT03090620|GABA Agents|gaba agents|mesh-ancestor
111434892|NCT03090620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111434893|NCT03090620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111434894|NCT03090620|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111434895|NCT03090620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111434896|NCT03090620|Cholinergic Agents|cholinergic agents|mesh-ancestor
111434897|NCT03090620|Miotics|miotics|mesh-ancestor
111434898|NCT02953873|Mycophenolic Acid|mycophenolic acid|mesh-list
111434899|NCT02953873|Prednisone|prednisone|mesh-list
111434900|NCT02953873|Methylprednisolone|methylprednisolone|mesh-list
111434901|NCT02953873|Tacrolimus|tacrolimus|mesh-list
111434902|NCT02953873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111434903|NCT02953873|Glucocorticoids|glucocorticoids|mesh-ancestor
111434904|NCT02953873|Hormones|hormones|mesh-ancestor
111434905|NCT02953873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111434906|NCT02953873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111434907|NCT02953873|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111434908|NCT02953873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111434909|NCT02953873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111434910|NCT02953873|Immunologic Factors|immunologic factors|mesh-ancestor
111434911|NCT02953873|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111434912|NCT02953873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111434913|NCT02953873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111434914|NCT02953873|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111434915|NCT02953873|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111434916|NCT02953873|Antitubercular Agents|antitubercular agents|mesh-ancestor
111434917|NCT02953873|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111434918|NCT02953873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111434919|NCT02953873|Antiemetics|antiemetics|mesh-ancestor
111434920|NCT02953873|Autonomic Agents|autonomic agents|mesh-ancestor
111434921|NCT02953873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111434922|NCT02953873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111434923|NCT02953873|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111434924|NCT02953873|Protective Agents|protective agents|mesh-ancestor
111434925|NCT03091478|Pembrolizumab|pembrolizumab|mesh-list
111434926|NCT03091478|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111434927|NCT03091478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111434928|NCT03091478|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111434929|NCT03091478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111434930|NCT02867605|Hyaluronic Acid|hyaluronic acid|mesh-list
111434931|NCT02867605|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111434932|NCT02867605|Immunologic Factors|immunologic factors|mesh-ancestor
111434933|NCT02867605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111434934|NCT02867605|Viscosupplements|viscosupplements|mesh-ancestor
111434935|NCT02867605|Protective Agents|protective agents|mesh-ancestor
111434936|NCT00375596|Ketotifen|ketotifen|mesh-list
111434937|NCT00375596|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
111434938|NCT00375596|Antipruritics|antipruritics|mesh-ancestor
111434939|NCT00375596|Dermatologic Agents|dermatologic agents|mesh-ancestor
111434940|NCT00375596|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111434941|NCT00375596|Histamine Antagonists|histamine antagonists|mesh-ancestor
111434942|NCT00375596|Histamine Agents|histamine agents|mesh-ancestor
111434943|NCT00375596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111434944|NCT00375596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111434945|NCT00375596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111434946|NCT00375596|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111434947|NCT03093272|Prednisone|prednisone|mesh-list
111434948|NCT03093272|Docetaxel|docetaxel|mesh-list
111434949|NCT03093272|Leuprolide|leuprolide|mesh-list
111434950|NCT03093272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111434951|NCT03093272|Tubulin Modulators|tubulin modulators|mesh-ancestor
111159306|NCT05221190|Anesthetics|anesthetics|mesh-ancestor
111434952|NCT03093272|Antimitotic Agents|antimitotic agents|mesh-ancestor
111434953|NCT03093272|Mitosis Modulators|mitosis modulators|mesh-ancestor
111434954|NCT03093272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111434955|NCT03093272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111434956|NCT03093272|Glucocorticoids|glucocorticoids|mesh-ancestor
111434957|NCT03093272|Hormones|hormones|mesh-ancestor
111434958|NCT03093272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111434959|NCT03093272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111434960|NCT03093272|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111434961|NCT03093272|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111434962|NCT03093272|Fertility Agents|fertility agents|mesh-ancestor
111434963|NCT03093272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111434964|NCT03100123|Aspirin|aspirin|mesh-list
111434965|NCT03100123|Heparin|heparin|mesh-list
111434966|NCT03100123|Enoxaparin|enoxaparin|mesh-list
111434967|NCT03100123|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
111434968|NCT03100123|Tinzaparin|tinzaparin|mesh-list
111434969|NCT03100123|Dalteparin|dalteparin|mesh-list
111434970|NCT03100123|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111434971|NCT03100123|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111434972|NCT03100123|Analgesics|analgesics|mesh-ancestor
111434973|NCT03100123|Sensory System Agents|sensory system agents|mesh-ancestor
111434974|NCT03100123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111434975|NCT03100123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111434976|NCT03100123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111434977|NCT03100123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111434978|NCT03100123|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111434979|NCT03100123|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111434980|NCT03100123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111434981|NCT03100123|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111434982|NCT03100123|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111434983|NCT03100123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111434984|NCT03100123|Antipyretics|antipyretics|mesh-ancestor
111434985|NCT03100123|Anticoagulants|anticoagulants|mesh-ancestor
111434986|NCT02957305|Misoprostol|misoprostol|mesh-list
111434987|NCT02957305|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111434988|NCT02957305|Abortifacient Agents|abortifacient agents|mesh-ancestor
111434989|NCT02957305|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111434990|NCT02957305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111434991|NCT02957305|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111434992|NCT02957305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111434993|NCT02957305|Oxytocics|oxytocics|mesh-ancestor
111434994|NCT04611152|Aflibercept|aflibercept|mesh-list
111434995|NCT04611152|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111434996|NCT04611152|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111434997|NCT04611152|Growth Substances|growth substances|mesh-ancestor
111434998|NCT04611152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111434999|NCT04611152|Growth Inhibitors|growth inhibitors|mesh-ancestor
111435000|NCT04611152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111435001|NCT03104725|Acetylcysteine|acetylcysteine|mesh-list
111435002|NCT03104725|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111435003|NCT03104725|Antiviral Agents|antiviral agents|mesh-ancestor
111435004|NCT03104725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111435005|NCT03104725|Expectorants|expectorants|mesh-ancestor
111435006|NCT03104725|Respiratory System Agents|respiratory system agents|mesh-ancestor
111435007|NCT03104725|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111435008|NCT03104725|Antioxidants|antioxidants|mesh-ancestor
111435009|NCT03104725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111435010|NCT03104725|Protective Agents|protective agents|mesh-ancestor
111435011|NCT03104725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111435012|NCT03104725|Antidotes|antidotes|mesh-ancestor
111435013|NCT03154658|Ropivacaine|ropivacaine|mesh-list
111435014|NCT03154658|Anesthetics, Local|anesthetics, local|mesh-ancestor
111435015|NCT03154658|Anesthetics|anesthetics|mesh-ancestor
111435016|NCT03154658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111435017|NCT03154658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111435018|NCT03154658|Sensory System Agents|sensory system agents|mesh-ancestor
111435019|NCT03154658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111435020|NCT03098420|Dexamethasone|dexamethasone|mesh-list
111435021|NCT03098420|Dexamethasone acetate|dexamethasone acetate|mesh-list
111435022|NCT03098420|Morphine|morphine|mesh-list
111435023|NCT03098420|Bupivacaine|bupivacaine|mesh-list
111159384|NCT03760484|Fidaxomicin|fidaxomicin|mesh-list
111435024|NCT03098420|Ropivacaine|ropivacaine|mesh-list
111435025|NCT03098420|BB 1101|bb 1101|mesh-list
111435026|NCT03098420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111435027|NCT03098420|Antiemetics|antiemetics|mesh-ancestor
111435028|NCT03098420|Autonomic Agents|autonomic agents|mesh-ancestor
111435029|NCT03098420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111435030|NCT03098420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111435031|NCT03098420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111435032|NCT03098420|Glucocorticoids|glucocorticoids|mesh-ancestor
111435033|NCT03098420|Hormones|hormones|mesh-ancestor
111435034|NCT03098420|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111435035|NCT03098420|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111435036|NCT03098420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111435037|NCT03098420|Protease Inhibitors|protease inhibitors|mesh-ancestor
111435038|NCT03098420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111435039|NCT03098420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111435040|NCT03098420|Anesthetics, Local|anesthetics, local|mesh-ancestor
111435041|NCT03098420|Anesthetics|anesthetics|mesh-ancestor
111435042|NCT03098420|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111435043|NCT03098420|Sensory System Agents|sensory system agents|mesh-ancestor
111435044|NCT03098420|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111435045|NCT03098420|Narcotics|narcotics|mesh-ancestor
111435046|NCT03098420|Analgesics|analgesics|mesh-ancestor
111435047|NCT02878057|Apatinib|apatinib|mesh-list
111435048|NCT02878057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111435049|NCT02878057|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111435050|NCT02878057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111435051|NCT02878057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111435052|NCT00422617|Alefacept|alefacept|mesh-list
111435053|NCT00422617|Dermatologic Agents|dermatologic agents|mesh-ancestor
111435054|NCT00422617|Immunologic Factors|immunologic factors|mesh-ancestor
111435055|NCT00422617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111435056|NCT03104738|Insulin|insulin|mesh-list
111435057|NCT03104738|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111435058|NCT03104738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111435059|NCT03163472|Anesthetics|anesthetics|mesh-list
111435060|NCT03163472|Anesthetics, Local|anesthetics, local|mesh-list
111435061|NCT03163472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111435062|NCT03163472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111435063|NCT03163472|Sensory System Agents|sensory system agents|mesh-ancestor
111435064|NCT03163472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111435065|NCT04468568|Terbutaline|terbutaline|mesh-list
111435066|NCT04468568|Atosiban|atosiban|mesh-list
111435067|NCT04468568|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111435068|NCT04468568|Autonomic Agents|autonomic agents|mesh-ancestor
111435069|NCT04468568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111435070|NCT04468568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111435071|NCT04468568|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111435072|NCT04468568|Respiratory System Agents|respiratory system agents|mesh-ancestor
111435073|NCT04468568|Sympathomimetics|sympathomimetics|mesh-ancestor
111435074|NCT04468568|Tocolytic Agents|tocolytic agents|mesh-ancestor
111435075|NCT04468568|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111435076|NCT04468568|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111435077|NCT04468568|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111435078|NCT04468568|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111435079|NCT04468568|Adrenergic Agents|adrenergic agents|mesh-ancestor
111435080|NCT04468568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111435081|NCT04468568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111435082|NCT04468568|Hormone Antagonists|hormone antagonists|mesh-ancestor
111435083|NCT04468568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111435084|NCT03168308|Glycopyrrolate|glycopyrrolate|mesh-list
111435085|NCT03168308|Neostigmine|neostigmine|mesh-list
111435086|NCT03168308|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111435087|NCT03168308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111435088|NCT03168308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111435089|NCT03168308|Cholinergic Agents|cholinergic agents|mesh-ancestor
111435090|NCT03168308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111435091|NCT03168308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111435092|NCT03168308|Parasympathomimetics|parasympathomimetics|mesh-ancestor
111435093|NCT03168308|Autonomic Agents|autonomic agents|mesh-ancestor
111435094|NCT03168308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111435095|NCT03168308|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111435096|NCT03168308|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111435097|NCT03168308|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111435098|NCT03109015|Sunitinib|sunitinib|mesh-list
111435099|NCT03109015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111435100|NCT03109015|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111435101|NCT03109015|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111435102|NCT03109015|Growth Substances|growth substances|mesh-ancestor
111435103|NCT03109015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111435104|NCT03109015|Growth Inhibitors|growth inhibitors|mesh-ancestor
111435105|NCT03109015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111435106|NCT03109015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111435107|NCT03109015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111435108|NCT03115177|Doxycycline|doxycycline|mesh-list
111435109|NCT03115177|Cefazolin|cefazolin|mesh-list
111435110|NCT03115177|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111435111|NCT03115177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111435112|NCT03115177|Antimalarials|antimalarials|mesh-ancestor
111435113|NCT03115177|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111435114|NCT03115177|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111435115|NCT03174158|Nicotine|nicotine|mesh-list
111435116|NCT03174158|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111435117|NCT03174158|Autonomic Agents|autonomic agents|mesh-ancestor
111435118|NCT03174158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111435119|NCT03174158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111435120|NCT03174158|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111435121|NCT03174158|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111435122|NCT03174158|Cholinergic Agents|cholinergic agents|mesh-ancestor
111435123|NCT03174158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111435124|NCT03174158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111435125|NCT03115801|Pembrolizumab|pembrolizumab|mesh-list
111435126|NCT03115801|Nivolumab|nivolumab|mesh-list
111435127|NCT03115801|Atezolizumab|atezolizumab|mesh-list
111435128|NCT03115801|Immunomodulating Agents|immunomodulating agents|mesh-list
111435129|NCT03115801|Immunologic Factors|immunologic factors|mesh-list
111435130|NCT03115801|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111435131|NCT03115801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111435132|NCT03115801|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111435133|NCT03115801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111435134|NCT03115801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111435135|NCT00422708|Anesthetics|anesthetics|mesh-list
111435136|NCT00422708|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111435137|NCT00422708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111435138|NCT03117517|Metformin|metformin|mesh-list
111435139|NCT03117517|Pioglitazone|pioglitazone|mesh-list
111435140|NCT03117517|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111435141|NCT03117517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111435142|NCT00375284|Pramipexole|pramipexole|mesh-list
111435143|NCT00375284|Antioxidants|antioxidants|mesh-ancestor
111435144|NCT00375284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111435145|NCT00375284|Protective Agents|protective agents|mesh-ancestor
111435146|NCT00375284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111435147|NCT00375284|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111435148|NCT00375284|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111435149|NCT00375284|Dopamine Agonists|dopamine agonists|mesh-ancestor
111435150|NCT00375284|Dopamine Agents|dopamine agents|mesh-ancestor
111435151|NCT00375284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111435152|NCT02966275|Glucagon|glucagon|mesh-list
111435153|NCT02966275|Pancrelipase|pancrelipase|mesh-list
111435154|NCT02966275|Pancreatin|pancreatin|mesh-list
111435155|NCT02966275|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
111435156|NCT02966275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111435157|NCT02966275|Hormones|hormones|mesh-ancestor
111435158|NCT02966275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111435159|NCT02966275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111435160|NCT02966275|Incretins|incretins|mesh-ancestor
111435161|NCT03795350|Beclomethasone|beclomethasone|mesh-list
111435162|NCT03795350|Glycopyrrolate|glycopyrrolate|mesh-list
111435163|NCT03795350|Bromides|bromides|mesh-list
111435164|NCT03795350|Formoterol Fumarate|formoterol fumarate|mesh-list
111435165|NCT03795350|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111435166|NCT03795350|Autonomic Agents|autonomic agents|mesh-ancestor
110513118|NCT02770794|Infliximab|infliximab|mesh-list
111435167|NCT03795350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111435168|NCT03795350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111435169|NCT03795350|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111435170|NCT03795350|Respiratory System Agents|respiratory system agents|mesh-ancestor
111435171|NCT03795350|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111435172|NCT03795350|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111435173|NCT03795350|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111435174|NCT03795350|Adrenergic Agents|adrenergic agents|mesh-ancestor
111435175|NCT03795350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111435176|NCT03795350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111435177|NCT03795350|Anticonvulsants|anticonvulsants|mesh-ancestor
111159522|NCT02986594|Anticoagulants|anticoagulants|mesh-ancestor
111435178|NCT03795350|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111435179|NCT03795350|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111435180|NCT03795350|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111435181|NCT03795350|Cholinergic Agents|cholinergic agents|mesh-ancestor
111435182|NCT03795350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111435183|NCT03795350|Glucocorticoids|glucocorticoids|mesh-ancestor
111435184|NCT03795350|Hormones|hormones|mesh-ancestor
111435185|NCT03795350|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111435186|NCT03118843|Velpatasvir|velpatasvir|mesh-list
111435187|NCT03118843|Antiviral Agents|antiviral agents|mesh-ancestor
111435188|NCT03118843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111435189|NCT02222922|Fluconazole|fluconazole|mesh-list
111435190|NCT02222922|Avelumab|avelumab|mesh-list
111435191|NCT02222922|Cofetuzumab pelidotin|cofetuzumab pelidotin|mesh-list
111435192|NCT02222922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111435193|NCT02222922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111435194|NCT02222922|Antifungal Agents|antifungal agents|mesh-ancestor
111435195|NCT02222922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111435196|NCT02222922|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111435197|NCT02222922|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111435198|NCT02222922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111435199|NCT02222922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111435200|NCT02222922|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111435201|NCT02222922|Hormone Antagonists|hormone antagonists|mesh-ancestor
111435202|NCT02222922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111435203|NCT02222922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111435204|NCT02222922|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111435205|NCT02222922|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111435206|NCT02222922|Immunoconjugates|immunoconjugates|mesh-ancestor
111435207|NCT02222922|Immunologic Factors|immunologic factors|mesh-ancestor
111435208|NCT03503942|Metformin|metformin|mesh-list
111435209|NCT03503942|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111435210|NCT03503942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111435211|NCT03122587|Dihydrotachysterol|dihydrotachysterol|mesh-list
111435212|NCT03122587|Vitamins|vitamins|mesh-ancestor
111435213|NCT03122587|Micronutrients|micronutrients|mesh-ancestor
111435214|NCT03122587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111435215|NCT03122587|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111435216|NCT02161146|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
111435217|NCT02161146|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111435218|NCT02161146|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111435219|NCT02161146|Analgesics|analgesics|mesh-ancestor
111435220|NCT02161146|Sensory System Agents|sensory system agents|mesh-ancestor
111435221|NCT02161146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111435222|NCT02161146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111435223|NCT02161146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111435224|NCT02161146|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111435225|NCT02161146|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111435226|NCT02161146|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
111435227|NCT02161146|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111435228|NCT02161146|Histamine Antagonists|histamine antagonists|mesh-ancestor
111435229|NCT02161146|Histamine Agents|histamine agents|mesh-ancestor
111435230|NCT02161146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111435231|NCT02161146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111435232|NCT03447782|Naltrexone|naltrexone|mesh-list
111435233|NCT03447782|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111435234|NCT03447782|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111435235|NCT03447782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111435236|NCT03447782|Sensory System Agents|sensory system agents|mesh-ancestor
111435237|NCT03447782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111435238|NCT03123055|Pembrolizumab|pembrolizumab|mesh-list
111435239|NCT03123055|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111435240|NCT03123055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111435241|NCT03123055|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111435242|NCT03123055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111435243|NCT02969317|Tiotropium Bromide|tiotropium bromide|mesh-list
111435244|NCT02969317|Olodaterol|olodaterol|mesh-list
111435245|NCT02969317|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111435246|NCT02969317|Autonomic Agents|autonomic agents|mesh-ancestor
111435247|NCT02969317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111435248|NCT02969317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111435249|NCT02969317|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111435250|NCT02969317|Respiratory System Agents|respiratory system agents|mesh-ancestor
111435251|NCT02969317|Parasympatholytics|parasympatholytics|mesh-ancestor
111435252|NCT02969317|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111435253|NCT02969317|Cholinergic Agents|cholinergic agents|mesh-ancestor
111435254|NCT02969317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111435255|NCT02969317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111435256|NCT00375362|Nitroglycerin|nitroglycerin|mesh-list
111435257|NCT00375362|Vasodilator Agents|vasodilator agents|mesh-ancestor
111435258|NCT05347082|Cholecalciferol|cholecalciferol|mesh-list
111435259|NCT05347082|Vitamin D|vitamin d|mesh-list
111435260|NCT05347082|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111435261|NCT05347082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111435262|NCT05347082|Vitamins|vitamins|mesh-ancestor
111435263|NCT05347082|Micronutrients|micronutrients|mesh-ancestor
111435264|NCT05347082|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111435265|NCT03087578|Mirabegron|mirabegron|mesh-list
111435266|NCT03087578|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
111435267|NCT03087578|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111435268|NCT03087578|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111435269|NCT03087578|Adrenergic Agents|adrenergic agents|mesh-ancestor
111435270|NCT03087578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111435271|NCT03087578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111435272|NCT03087578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111435273|NCT03087578|Urological Agents|urological agents|mesh-ancestor
111435274|NCT02807558|Azacitidine|azacitidine|mesh-list
111435275|NCT02807558|Daratumumab|daratumumab|mesh-list
111435276|NCT02807558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111435277|NCT02807558|Antimetabolites|antimetabolites|mesh-ancestor
111435278|NCT02807558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111435279|NCT02807558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111435280|NCT02807558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111435281|NCT05324384|Sirolimus|sirolimus|mesh-list
111435282|NCT05324384|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111435283|NCT05324384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111435284|NCT05324384|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111435285|NCT05324384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111435286|NCT05324384|Antifungal Agents|antifungal agents|mesh-ancestor
111435287|NCT05324384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111435288|NCT05324384|Immunologic Factors|immunologic factors|mesh-ancestor
111435289|NCT05324384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111435290|NCT02975557|Brimonidine Tartrate|brimonidine tartrate|mesh-list
111435291|NCT02975557|Lubricant Eye Drops|lubricant eye drops|mesh-list
111435292|NCT02975557|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111435293|NCT02975557|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111435294|NCT02975557|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111435295|NCT02975557|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111435296|NCT02975557|Adrenergic Agents|adrenergic agents|mesh-ancestor
111435297|NCT02975557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111435298|NCT02975557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111435299|NCT02975557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111435300|NCT02975557|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
111435301|NCT02975557|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111435302|NCT04736810|Gemcitabine|gemcitabine|mesh-list
111435303|NCT04736810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111435304|NCT04736810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111435305|NCT04736810|Antimetabolites|antimetabolites|mesh-ancestor
111435306|NCT04736810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111435307|NCT03132571|Naltrexone|naltrexone|mesh-list
111435308|NCT03132571|Bupropion|bupropion|mesh-list
111435309|NCT03132571|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111435310|NCT03132571|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111435311|NCT03132571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111435312|NCT03132571|Sensory System Agents|sensory system agents|mesh-ancestor
111435313|NCT03132571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111435314|NCT03132571|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111435315|NCT03132571|Antidepressive Agents|antidepressive agents|mesh-ancestor
111435316|NCT03132571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111435317|NCT03132571|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111435318|NCT03132571|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111435319|NCT03132571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111435320|NCT03132571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111435321|NCT03132571|Dopamine Agents|dopamine agents|mesh-ancestor
111435322|NCT03132571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111435323|NCT03132571|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111435324|NCT03132571|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111435325|NCT03132571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111435326|NCT05267054|Rituximab|rituximab|mesh-list
111435327|NCT05267054|Tislelizumab|tislelizumab|mesh-list
111435328|NCT05267054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111435329|NCT05267054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111435330|NCT05267054|Immunologic Factors|immunologic factors|mesh-ancestor
111435331|NCT05267054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111435332|NCT05267054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111435333|NCT02374424|Obinutuzumab|obinutuzumab|mesh-list
111435334|NCT02374424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111435335|NCT02374424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111435336|NCT02002130|Aluminum sulfate|aluminum sulfate|mesh-list
111435337|NCT02002130|gamma-Aminobutyric Acid|gamma-aminobutyric acid|mesh-list
111435338|NCT02002130|Butyric Acid|butyric acid|mesh-list
111435339|NCT02002130|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111435340|NCT02002130|Immunologic Factors|immunologic factors|mesh-ancestor
111435341|NCT02002130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111435342|NCT02002130|GABA Agents|gaba agents|mesh-ancestor
111435343|NCT02002130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111435344|NCT02002130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111435345|NCT02002130|Histamine Antagonists|histamine antagonists|mesh-ancestor
111435346|NCT02002130|Histamine Agents|histamine agents|mesh-ancestor
111435347|NCT01306994|Adenosine|adenosine|mesh-list
111435348|NCT01306994|Analgesics|analgesics|mesh-ancestor
111435349|NCT01306994|Sensory System Agents|sensory system agents|mesh-ancestor
111435350|NCT01306994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111435351|NCT01306994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111435352|NCT01306994|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111435353|NCT01306994|Vasodilator Agents|vasodilator agents|mesh-ancestor
111435354|NCT01306994|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
111435355|NCT01306994|Purinergic Agonists|purinergic agonists|mesh-ancestor
111435356|NCT01306994|Purinergic Agents|purinergic agents|mesh-ancestor
111435357|NCT01306994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111435358|NCT01306994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111435359|NCT02979301|Tamoxifen|tamoxifen|mesh-list
111435360|NCT02979301|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111435361|NCT02979301|Hormone Antagonists|hormone antagonists|mesh-ancestor
111435362|NCT02979301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111435363|NCT02979301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111435364|NCT02979301|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111435365|NCT02979301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111435366|NCT02979301|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111435367|NCT02979301|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111435368|NCT02979301|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111435369|NCT00375440|Tranexamic Acid|tranexamic acid|mesh-list
111435370|NCT00375440|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111435371|NCT00375440|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111435372|NCT00375440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111435373|NCT00375440|Hemostatics|hemostatics|mesh-ancestor
111435374|NCT00375440|Coagulants|coagulants|mesh-ancestor
111435375|NCT05113004|Mycophenolic Acid|mycophenolic acid|mesh-list
111435376|NCT05113004|Hydroxychloroquine|hydroxychloroquine|mesh-list
111435377|NCT05113004|Leflunomide|leflunomide|mesh-list
111435378|NCT05113004|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111435379|NCT05113004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111435380|NCT05113004|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111435381|NCT05113004|Antitubercular Agents|antitubercular agents|mesh-ancestor
111435382|NCT05113004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111435383|NCT05113004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111435384|NCT05113004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111435385|NCT05113004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111435386|NCT05113004|Antimalarials|antimalarials|mesh-ancestor
111435387|NCT05113004|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111435388|NCT05113004|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111435389|NCT05113004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111435390|NCT05113004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111435391|NCT05113004|Immunologic Factors|immunologic factors|mesh-ancestor
111435392|NCT05113004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111435393|NCT02983981|Desoximetasone|desoximetasone|mesh-list
111435394|NCT02983981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111435395|NCT02983981|Glucocorticoids|glucocorticoids|mesh-ancestor
111435396|NCT02983981|Hormones|hormones|mesh-ancestor
111435397|NCT02983981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111435398|NCT02983981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111435399|NCT00375583|Albendazole|albendazole|mesh-list
111435400|NCT00375583|Anthelmintics|anthelmintics|mesh-ancestor
111435401|NCT00375583|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111435402|NCT00375583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111435403|NCT00375583|Anticestodal Agents|anticestodal agents|mesh-ancestor
111435404|NCT00375583|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
111435405|NCT00375583|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111435406|NCT00375583|Tubulin Modulators|tubulin modulators|mesh-ancestor
111435407|NCT00375583|Antimitotic Agents|antimitotic agents|mesh-ancestor
111435408|NCT00375583|Mitosis Modulators|mitosis modulators|mesh-ancestor
111435409|NCT00375583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111435410|NCT00375583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111435411|NCT03143569|Heparin|heparin|mesh-list
111435412|NCT03143569|Calcium heparin|calcium heparin|mesh-list
111435413|NCT03143569|Anticoagulants|anticoagulants|mesh-ancestor
111435414|NCT03143569|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111435415|NCT03143569|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111435416|NCT03143569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111435417|NCT03149887|Bupivacaine|bupivacaine|mesh-list
111435418|NCT03149887|Anesthetics, Local|anesthetics, local|mesh-ancestor
111435419|NCT03149887|Anesthetics|anesthetics|mesh-ancestor
111435420|NCT03149887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111435421|NCT03149887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111435422|NCT03149887|Sensory System Agents|sensory system agents|mesh-ancestor
111435423|NCT03149887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111435424|NCT02988349|Listerine|listerine|mesh-list
111435425|NCT02988349|Sodium Fluoride|sodium fluoride|mesh-list
111435426|NCT02988349|Cariostatic Agents|cariostatic agents|mesh-ancestor
111435427|NCT02988349|Protective Agents|protective agents|mesh-ancestor
111435428|NCT02988349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111435429|NCT02988349|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111435430|NCT02988349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111435431|NCT02159352|Ritonavir|ritonavir|mesh-list
111435432|NCT02159352|Lopinavir|lopinavir|mesh-list
111435433|NCT02159352|Darunavir|darunavir|mesh-list
111435434|NCT02159352|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111435435|NCT02159352|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111435436|NCT02159352|Protease Inhibitors|protease inhibitors|mesh-ancestor
111435437|NCT02159352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111435438|NCT02159352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111435439|NCT02159352|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111435440|NCT02159352|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111435441|NCT02159352|Antiviral Agents|antiviral agents|mesh-ancestor
111435442|NCT02159352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111435443|NCT02159352|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111435444|NCT02159352|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111435445|NCT02187744|Carboplatin|carboplatin|mesh-list
111435446|NCT02187744|Docetaxel|docetaxel|mesh-list
111435447|NCT02187744|Trastuzumab|trastuzumab|mesh-list
111435448|NCT02187744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111435449|NCT02187744|Tubulin Modulators|tubulin modulators|mesh-ancestor
111435450|NCT02187744|Antimitotic Agents|antimitotic agents|mesh-ancestor
111435451|NCT02187744|Mitosis Modulators|mitosis modulators|mesh-ancestor
111435452|NCT02187744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111435453|NCT02187744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111435454|NCT03154333|Diacerein|diacerein|mesh-list
111435455|NCT03154333|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111435456|NCT04393441|Lubricant Eye Drops|lubricant eye drops|mesh-list
111435457|NCT04393441|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
111435458|NCT04393441|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111435459|NCT02995915|Bupropion|bupropion|mesh-list
111435460|NCT02995915|Nicotine|nicotine|mesh-list
111435461|NCT02995915|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111435462|NCT02995915|Autonomic Agents|autonomic agents|mesh-ancestor
111435463|NCT02995915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111435464|NCT02995915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111435465|NCT02995915|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111435466|NCT02995915|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111435467|NCT02995915|Cholinergic Agents|cholinergic agents|mesh-ancestor
111435468|NCT02995915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111435469|NCT02995915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111435470|NCT02995915|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111435471|NCT02995915|Antidepressive Agents|antidepressive agents|mesh-ancestor
111435472|NCT02995915|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111435473|NCT02995915|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111435474|NCT02995915|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111435475|NCT02995915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111435476|NCT02995915|Dopamine Agents|dopamine agents|mesh-ancestor
111435477|NCT02995915|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111435478|NCT02995915|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111435479|NCT02995915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111435480|NCT03163303|Nicotine|nicotine|mesh-list
111435481|NCT03163303|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111435482|NCT03163303|Autonomic Agents|autonomic agents|mesh-ancestor
111435483|NCT03163303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111435484|NCT03163303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111435485|NCT03163303|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111435486|NCT03163303|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111435487|NCT03163303|Cholinergic Agents|cholinergic agents|mesh-ancestor
111435488|NCT03163303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111435489|NCT03163303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111435490|NCT03000283|Conivaptan|conivaptan|mesh-list
111435491|NCT03000283|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
111435492|NCT03000283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111435493|NCT03000283|Natriuretic Agents|natriuretic agents|mesh-ancestor
111435494|NCT03000283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111435495|NCT03168295|Dapagliflozin|dapagliflozin|mesh-list
111435496|NCT03168295|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111435497|NCT03168295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111435498|NCT03168295|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111435499|NCT03168295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111435500|NCT03168841|Efinaconazole|efinaconazole|mesh-list
111435501|NCT03168841|Antifungal Agents|antifungal agents|mesh-ancestor
111435502|NCT03168841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111435503|NCT03865615|Oxytocin|oxytocin|mesh-list
111435504|NCT03865615|Oxytocics|oxytocics|mesh-ancestor
111435505|NCT03865615|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111435506|NCT03865615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111435507|NCT03185546|Nicotine|nicotine|mesh-list
111435508|NCT03185546|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111435509|NCT03185546|Autonomic Agents|autonomic agents|mesh-ancestor
111435510|NCT03185546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111435511|NCT03185546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111435512|NCT03185546|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111435513|NCT03185546|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111435514|NCT03185546|Cholinergic Agents|cholinergic agents|mesh-ancestor
111435515|NCT03185546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111435516|NCT03185546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111435517|NCT02186652|Pantoprazole|pantoprazole|mesh-list
111435518|NCT02186652|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111435519|NCT02186652|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111435520|NCT02186652|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111435521|NCT02186652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111435522|NCT02186652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111435523|NCT03606889|Bupivacaine|bupivacaine|mesh-list
111435524|NCT03606889|Anesthetics, Local|anesthetics, local|mesh-ancestor
111435525|NCT03606889|Anesthetics|anesthetics|mesh-ancestor
111435526|NCT03606889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111435527|NCT03606889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111435528|NCT03606889|Sensory System Agents|sensory system agents|mesh-ancestor
111435529|NCT03606889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111435530|NCT05363917|Folic Acid|folic acid|mesh-list
111435531|NCT05363917|Vitamin B Complex|vitamin b complex|mesh-list
111435532|NCT05363917|Hematinics|hematinics|mesh-ancestor
111435533|NCT05363917|Vitamins|vitamins|mesh-ancestor
111435534|NCT05363917|Micronutrients|micronutrients|mesh-ancestor
111435535|NCT05363917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111435536|NCT03187730|Nicotine|nicotine|mesh-list
111435537|NCT03187730|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111435538|NCT03187730|Autonomic Agents|autonomic agents|mesh-ancestor
111435539|NCT03187730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111435540|NCT03187730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111435541|NCT03187730|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111435542|NCT03187730|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111435543|NCT03187730|Cholinergic Agents|cholinergic agents|mesh-ancestor
111435544|NCT03187730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111435545|NCT03187730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111435546|NCT03261193|Bupivacaine|bupivacaine|mesh-list
111435547|NCT03261193|Anesthetics, Local|anesthetics, local|mesh-ancestor
111435548|NCT03261193|Anesthetics|anesthetics|mesh-ancestor
111435549|NCT03261193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111435550|NCT03261193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111435551|NCT03261193|Sensory System Agents|sensory system agents|mesh-ancestor
111435552|NCT03261193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111435553|NCT00375661|Interferons|interferons|mesh-list
111435554|NCT00375661|Ribavirin|ribavirin|mesh-list
111435555|NCT00375661|Interferon-alpha|interferon-alpha|mesh-list
111435557|NCT00375661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111435558|NCT00375661|Antiviral Agents|antiviral agents|mesh-ancestor
111435559|NCT00375661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111435560|NCT00375661|Antimetabolites|antimetabolites|mesh-ancestor
111435561|NCT00375661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111435562|NCT00375661|Immunologic Factors|immunologic factors|mesh-ancestor
111435563|NCT00375661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111435564|NCT04736186|Loperamide|loperamide|mesh-list
111435565|NCT04736186|Antidiarrheals|antidiarrheals|mesh-list
111435566|NCT04736186|Bentonite|bentonite|mesh-list
111435567|NCT04736186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111435568|NCT04736186|Antidotes|antidotes|mesh-ancestor
111435569|NCT04736186|Protective Agents|protective agents|mesh-ancestor
111435570|NCT04736186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111435571|NCT04941170|Bupivacaine|bupivacaine|mesh-list
111435572|NCT04941170|Anesthetics, Local|anesthetics, local|mesh-ancestor
111435573|NCT04941170|Anesthetics|anesthetics|mesh-ancestor
111435574|NCT04941170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111435575|NCT04941170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111435576|NCT04941170|Sensory System Agents|sensory system agents|mesh-ancestor
111435577|NCT04941170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111435578|NCT05357911|Digoxin|digoxin|mesh-list
111435579|NCT05357911|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111435580|NCT05357911|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111435581|NCT05357911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111435582|NCT05357911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111435583|NCT05357911|Protective Agents|protective agents|mesh-ancestor
111435584|NCT05357911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111435585|NCT03374839|Nivolumab|nivolumab|mesh-list
111435586|NCT03374839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111435587|NCT03374839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111435588|NCT03374839|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111435589|NCT03374839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111435590|NCT02221674|Tapentadol|tapentadol|mesh-list
111435591|NCT02221674|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111435592|NCT02221674|Narcotics|narcotics|mesh-ancestor
111435593|NCT02221674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111435594|NCT02221674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111435595|NCT02221674|Analgesics|analgesics|mesh-ancestor
111435596|NCT02221674|Sensory System Agents|sensory system agents|mesh-ancestor
111435597|NCT02221674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111435598|NCT02221674|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111435599|NCT02221674|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111435600|NCT02221674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111435601|NCT02221674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111435602|NCT02221674|Adrenergic Agents|adrenergic agents|mesh-ancestor
111435603|NCT02221674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111435604|NCT04736719|Warfarin|warfarin|mesh-list
111435605|NCT04736719|Apixaban|apixaban|mesh-list
111435606|NCT04736719|Anticoagulants|anticoagulants|mesh-ancestor
111435607|NCT04736719|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111435608|NCT04736719|Antithrombins|antithrombins|mesh-ancestor
111435609|NCT04736719|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111435610|NCT04736719|Protease Inhibitors|protease inhibitors|mesh-ancestor
111435611|NCT04736719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111435612|NCT04736719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111435613|NCT02221284|Alogliptin|alogliptin|mesh-list
111435614|NCT02221284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111435615|NCT02221284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111435616|NCT02221284|Incretins|incretins|mesh-ancestor
111435617|NCT02221284|Hormones|hormones|mesh-ancestor
111435618|NCT02221284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111435619|NCT02221284|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111435620|NCT02221284|Protease Inhibitors|protease inhibitors|mesh-ancestor
111435621|NCT02221284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111435622|NCT02221284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111435623|NCT04736108|Prednisolone|prednisolone|mesh-list
111435624|NCT04736108|Goserelin|goserelin|mesh-list
111435625|NCT04736108|Abiraterone Acetate|abiraterone acetate|mesh-list
111435626|NCT04736108|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111435627|NCT04736108|Glucocorticoids|glucocorticoids|mesh-ancestor
111435628|NCT04736108|Hormones|hormones|mesh-ancestor
111435629|NCT04736108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111435630|NCT04736108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111435631|NCT04736108|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111435632|NCT04736108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111435633|NCT04736108|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111435634|NCT04736108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110513186|NCT00889837|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111435635|NCT04736108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111435636|NCT04736108|Hormone Antagonists|hormone antagonists|mesh-ancestor
111435637|NCT04736108|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111435638|NCT02971033|Ezetimibe|ezetimibe|mesh-list
111435639|NCT02971033|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111435640|NCT02971033|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111435641|NCT02971033|Antimetabolites|antimetabolites|mesh-ancestor
111435642|NCT02971033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111435643|NCT02971033|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111435644|NCT05406674|Cisplatin|cisplatin|mesh-list
111435645|NCT05406674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111435646|NCT05341375|Anesthetics|anesthetics|mesh-list
111435647|NCT05341375|Esketamine|esketamine|mesh-list
111435648|NCT05341375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111435649|NCT05341375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111435650|NCT05341375|Antidepressive Agents|antidepressive agents|mesh-ancestor
111435651|NCT05341375|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111435652|NCT03196232|Pembrolizumab|pembrolizumab|mesh-list
111435653|NCT03196232|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111435654|NCT03196232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111435655|NCT03196232|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111435656|NCT03196232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111435657|NCT04356716|Sildenafil Citrate|sildenafil citrate|mesh-list
111435658|NCT04356716|Vasodilator Agents|vasodilator agents|mesh-ancestor
111435659|NCT04356716|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111435660|NCT04356716|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111435661|NCT04356716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111435662|NCT04356716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111435663|NCT04356716|Urological Agents|urological agents|mesh-ancestor
111435664|NCT03200587|Avelumab|avelumab|mesh-list
111435665|NCT03200587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111435666|NCT03200587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111435667|NCT03198884|Dolutegravir|dolutegravir|mesh-list
111435668|NCT03198884|Darunavir|darunavir|mesh-list
111435669|NCT03198884|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111435670|NCT03198884|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111435671|NCT03198884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111435672|NCT03198884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111435673|NCT03198884|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111435674|NCT03198884|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111435675|NCT03198884|Antiviral Agents|antiviral agents|mesh-ancestor
111435676|NCT03198884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111435677|NCT03198884|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111435678|NCT03198884|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111435679|NCT03198884|Protease Inhibitors|protease inhibitors|mesh-ancestor
111435680|NCT01801189|Pregabalin|pregabalin|mesh-list
111435681|NCT01801189|Analgesics|analgesics|mesh-ancestor
111435682|NCT01801189|Sensory System Agents|sensory system agents|mesh-ancestor
111435683|NCT01801189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111435684|NCT01801189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111435685|NCT01801189|Anticonvulsants|anticonvulsants|mesh-ancestor
111435686|NCT01801189|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111435687|NCT01801189|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111435688|NCT01801189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111435689|NCT01801189|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111435690|NCT01801189|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111435691|NCT01801189|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111435692|NCT01801189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111435693|NCT01801189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111435694|NCT04275362|Cimetidine|cimetidine|mesh-list
111435695|NCT04275362|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111435696|NCT04275362|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111435697|NCT04275362|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
111435698|NCT04275362|Histamine Antagonists|histamine antagonists|mesh-ancestor
111435699|NCT04275362|Histamine Agents|histamine agents|mesh-ancestor
111435700|NCT04275362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111435701|NCT04275362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111435702|NCT04275362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111435703|NCT04275362|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111435704|NCT04275362|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110912805|NCT02092506|Amoxicillin|amoxicillin|mesh-list
111435705|NCT04275362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111435706|NCT05178043|Nivolumab|nivolumab|mesh-list
111435707|NCT05178043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111435708|NCT05178043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111435709|NCT05178043|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111435710|NCT05178043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111435711|NCT00716755|Olanzapine|olanzapine|mesh-list
111435712|NCT00716755|Risperidone|risperidone|mesh-list
111435713|NCT00716755|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111435714|NCT00716755|Serotonin Agents|serotonin agents|mesh-ancestor
111435715|NCT00716755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111435716|NCT00716755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111435717|NCT00716755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111435718|NCT00716755|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111435719|NCT00716755|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111435720|NCT00716755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111435721|NCT00716755|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111435722|NCT00716755|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111435723|NCT00716755|Dopamine Agents|dopamine agents|mesh-ancestor
111435724|NCT00716755|Antiemetics|antiemetics|mesh-ancestor
111435725|NCT00716755|Autonomic Agents|autonomic agents|mesh-ancestor
111435726|NCT00716755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111435727|NCT00716755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111435728|NCT00716755|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111435729|NCT00716755|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111435730|NCT00716755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111435731|NCT05406050|Eldecalcitol|eldecalcitol|mesh-list
111435732|NCT05406050|Vitamin D|vitamin d|mesh-list
111435733|NCT05406050|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111435734|NCT05406050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111435735|NCT05406050|Vitamins|vitamins|mesh-ancestor
111435736|NCT05406050|Micronutrients|micronutrients|mesh-ancestor
111435737|NCT03202550|Oxycodone|oxycodone|mesh-list
111435738|NCT03202550|Lorazepam|lorazepam|mesh-list
111435739|NCT03202550|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111435740|NCT03202550|Narcotics|narcotics|mesh-ancestor
111435741|NCT03202550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111435742|NCT03202550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111435743|NCT03202550|Analgesics|analgesics|mesh-ancestor
111435744|NCT03202550|Sensory System Agents|sensory system agents|mesh-ancestor
111435745|NCT03202550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111435746|NCT03202550|Anticonvulsants|anticonvulsants|mesh-ancestor
111435747|NCT03202550|Antiemetics|antiemetics|mesh-ancestor
111435748|NCT03202550|Autonomic Agents|autonomic agents|mesh-ancestor
111435749|NCT03202550|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111435750|NCT03202550|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111435751|NCT03202550|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111435752|NCT03202550|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111435753|NCT03202550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111435754|NCT03202550|GABA Modulators|gaba modulators|mesh-ancestor
111435755|NCT03202550|GABA Agents|gaba agents|mesh-ancestor
111435756|NCT03202550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111435757|NCT03202550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111435758|NCT04088786|Irinotecan|irinotecan|mesh-list
111435759|NCT04088786|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111435760|NCT04088786|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111435761|NCT04088786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111435762|NCT04088786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111435763|NCT04088786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111435764|NCT00392821|Everolimus|everolimus|mesh-list
111435765|NCT00392821|Sorafenib|sorafenib|mesh-list
111435766|NCT00392821|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111435767|NCT00392821|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111435768|NCT00392821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111435769|NCT00392821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111435770|NCT00392821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111435771|NCT00392821|Immunologic Factors|immunologic factors|mesh-ancestor
111435772|NCT00392821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111435773|NCT00392821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111435774|NCT04708171|Anesthetics|anesthetics|mesh-list
111435775|NCT04708171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111435776|NCT04708171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111435777|NCT03290378|Tramadol|tramadol|mesh-list
111435778|NCT03290378|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111435779|NCT03290378|Narcotics|narcotics|mesh-ancestor
111435780|NCT03290378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111435781|NCT03290378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111435782|NCT03290378|Analgesics|analgesics|mesh-ancestor
111435783|NCT03290378|Sensory System Agents|sensory system agents|mesh-ancestor
111435784|NCT03290378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111435785|NCT02076217|Copper|copper|mesh-list
111435786|NCT02076217|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
111435787|NCT02076217|Contraceptive Agents|contraceptive agents|mesh-list
111435788|NCT02076217|Medroxyprogesterone|medroxyprogesterone|mesh-list
111435789|NCT02076217|Etonogestrel|etonogestrel|mesh-list
111435790|NCT02076217|Desogestrel|desogestrel|mesh-list
111435791|NCT02076217|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111435792|NCT02076217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111435793|NCT02076217|Trace Elements|trace elements|mesh-ancestor
111435794|NCT02076217|Micronutrients|micronutrients|mesh-ancestor
111435795|NCT02076217|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111435796|NCT02076217|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111435797|NCT02076217|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111435798|NCT02076217|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111435799|NCT02076217|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111435800|NCT02076217|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
111435801|NCT02076217|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111435802|NCT02076217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111435803|NCT02076217|Progestins|progestins|mesh-ancestor
111435804|NCT02076217|Hormones|hormones|mesh-ancestor
111435805|NCT02076217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111435806|NCT03291080|Tretinoin|tretinoin|mesh-list
111435807|NCT03291080|Isotretinoin|isotretinoin|mesh-list
111435808|NCT03291080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111435809|NCT03291080|Keratolytic Agents|keratolytic agents|mesh-ancestor
111435810|NCT03291080|Dermatologic Agents|dermatologic agents|mesh-ancestor
111435811|NCT04874545|Propofol|propofol|mesh-list
111435812|NCT04874545|Sevoflurane|sevoflurane|mesh-list
111435813|NCT04874545|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111435814|NCT04874545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111435815|NCT04874545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111435816|NCT04874545|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111435817|NCT04874545|Anesthetics, General|anesthetics, general|mesh-ancestor
111435818|NCT04874545|Anesthetics|anesthetics|mesh-ancestor
111435819|NCT04874545|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111435820|NCT04874545|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111435821|NCT03181009|Omalizumab|omalizumab|mesh-list
111435822|NCT03181009|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111435823|NCT03181009|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111435824|NCT03181009|Respiratory System Agents|respiratory system agents|mesh-ancestor
111435825|NCT04430569|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
111435826|NCT04430569|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111435827|NCT04430569|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111435828|NCT04430569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111435829|NCT03296072|Listerine|listerine|mesh-list
111435830|NCT03296072|Fluorides|fluorides|mesh-list
111435831|NCT03296072|Sodium Fluoride|sodium fluoride|mesh-list
111435832|NCT03296072|Tin Fluorides|tin fluorides|mesh-list
111435833|NCT03296072|Cariostatic Agents|cariostatic agents|mesh-ancestor
111435834|NCT03296072|Protective Agents|protective agents|mesh-ancestor
111435835|NCT03296072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111435836|NCT03296072|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111435837|NCT03296072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111435838|NCT03185065|Amantadine|amantadine|mesh-list
111435839|NCT03185065|Methylphenidate|methylphenidate|mesh-list
111435840|NCT03185065|Modafinil|modafinil|mesh-list
111435841|NCT03185065|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111435842|NCT03185065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111435843|NCT03185065|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111435844|NCT03185065|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111435845|NCT03185065|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110513198|NCT02770404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111435846|NCT03185065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111435847|NCT03185065|Dopamine Agents|dopamine agents|mesh-ancestor
111435848|NCT03185065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111435849|NCT03185065|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
111435850|NCT03185065|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111435851|NCT03185065|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111435852|NCT03185065|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111435853|NCT03185065|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111435854|NCT03185065|Antiviral Agents|antiviral agents|mesh-ancestor
111435855|NCT03185065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111435856|NCT03185065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111435857|NCT03185065|Analgesics|analgesics|mesh-ancestor
111435858|NCT03185065|Sensory System Agents|sensory system agents|mesh-ancestor
111435859|NCT03185065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111435860|NCT02220894|Paclitaxel|paclitaxel|mesh-list
111435861|NCT02220894|Carboplatin|carboplatin|mesh-list
111435862|NCT02220894|Pembrolizumab|pembrolizumab|mesh-list
111435863|NCT02220894|Pemetrexed|pemetrexed|mesh-list
111435864|NCT02220894|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111435865|NCT02220894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111435866|NCT02220894|Tubulin Modulators|tubulin modulators|mesh-ancestor
111435867|NCT02220894|Antimitotic Agents|antimitotic agents|mesh-ancestor
111435868|NCT02220894|Mitosis Modulators|mitosis modulators|mesh-ancestor
111435869|NCT02220894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111435870|NCT02220894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111435871|NCT02220894|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111435872|NCT02220894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111435873|NCT02220894|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111435874|NCT02220894|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111435875|NCT02159040|Azacitidine|azacitidine|mesh-list
111435876|NCT02159040|Deferasirox|deferasirox|mesh-list
111435877|NCT02159040|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111435878|NCT02159040|Antimetabolites|antimetabolites|mesh-ancestor
111435879|NCT02159040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111435880|NCT02159040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111435881|NCT02159040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111435882|NCT02159040|Iron Chelating Agents|iron chelating agents|mesh-ancestor
111435883|NCT02159040|Chelating Agents|chelating agents|mesh-ancestor
111435884|NCT02159040|Sequestering Agents|sequestering agents|mesh-ancestor
111435885|NCT03189589|Nemiralisib|nemiralisib|mesh-list
111435886|NCT03189589|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111435887|NCT03189589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111435888|NCT03189589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111435889|NCT03216902|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111435890|NCT03216902|Latanoprost|latanoprost|mesh-list
111435891|NCT03216902|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111435892|NCT03190213|Pembrolizumab|pembrolizumab|mesh-list
111435893|NCT03190213|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111435894|NCT03190213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111435895|NCT03190213|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111435896|NCT03190213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111435897|NCT01632150|Thalidomide|thalidomide|mesh-list
111435898|NCT01632150|Dexamethasone|dexamethasone|mesh-list
111435899|NCT01632150|Dexamethasone acetate|dexamethasone acetate|mesh-list
111435900|NCT01632150|Cyclophosphamide|cyclophosphamide|mesh-list
111435901|NCT01632150|Elotuzumab|elotuzumab|mesh-list
111435902|NCT01632150|BB 1101|bb 1101|mesh-list
111435903|NCT01632150|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111435904|NCT01632150|Immunologic Factors|immunologic factors|mesh-ancestor
111435905|NCT01632150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111435906|NCT01632150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111435907|NCT01632150|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111435908|NCT01632150|Alkylating Agents|alkylating agents|mesh-ancestor
111435909|NCT01632150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111435910|NCT01632150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111435911|NCT01632150|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111435912|NCT01632150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111435913|NCT01632150|Antiemetics|antiemetics|mesh-ancestor
111435914|NCT01632150|Autonomic Agents|autonomic agents|mesh-ancestor
111435915|NCT01632150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111435916|NCT01632150|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111435917|NCT01632150|Glucocorticoids|glucocorticoids|mesh-ancestor
111435918|NCT01632150|Hormones|hormones|mesh-ancestor
111435919|NCT01632150|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111435920|NCT01632150|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111435921|NCT01632150|Protease Inhibitors|protease inhibitors|mesh-ancestor
111435922|NCT01632150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111435923|NCT01632150|Leprostatic Agents|leprostatic agents|mesh-ancestor
111435924|NCT01632150|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111435925|NCT01632150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111435926|NCT01632150|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111435927|NCT01632150|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111435928|NCT01632150|Growth Substances|growth substances|mesh-ancestor
111435929|NCT01632150|Growth Inhibitors|growth inhibitors|mesh-ancestor
111435930|NCT02185014|Adalimumab|adalimumab|mesh-list
111435931|NCT02185014|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111435932|NCT02185014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111435933|NCT02185014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111435934|NCT03297944|Zolpidem|zolpidem|mesh-list
111435935|NCT03297944|Alprazolam|alprazolam|mesh-list
111435936|NCT03297944|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111435937|NCT03297944|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111435938|NCT03297944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111435939|NCT03297944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111435940|NCT03297944|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
111435941|NCT03297944|GABA Agonists|gaba agonists|mesh-ancestor
111435942|NCT03297944|GABA Agents|gaba agents|mesh-ancestor
111435943|NCT03297944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111435944|NCT03297944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111435945|NCT03297944|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111435946|NCT03297944|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111435947|NCT03297944|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111435948|NCT03297944|GABA Modulators|gaba modulators|mesh-ancestor
111435949|NCT04333004|Pembrolizumab|pembrolizumab|mesh-list
111435950|NCT04333004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111435951|NCT04333004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111435952|NCT04333004|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111435953|NCT04333004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111435954|NCT03219866|Budesonide|budesonide|mesh-list
111435955|NCT03219866|Tiotropium Bromide|tiotropium bromide|mesh-list
111435956|NCT03219866|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
111435957|NCT03219866|Ipratropium|ipratropium|mesh-list
111435958|NCT03219866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111435959|NCT03219866|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111435960|NCT03219866|Autonomic Agents|autonomic agents|mesh-ancestor
111435961|NCT03219866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111435962|NCT03219866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111435963|NCT03219866|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111435964|NCT03219866|Respiratory System Agents|respiratory system agents|mesh-ancestor
111435965|NCT03219866|Glucocorticoids|glucocorticoids|mesh-ancestor
111435966|NCT03219866|Hormones|hormones|mesh-ancestor
111435967|NCT03219866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111435968|NCT03219866|Parasympatholytics|parasympatholytics|mesh-ancestor
111435969|NCT03219866|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111435970|NCT03219866|Cholinergic Agents|cholinergic agents|mesh-ancestor
111435971|NCT03219866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111435972|NCT03219866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111435973|NCT03219866|Sympathomimetics|sympathomimetics|mesh-ancestor
111435974|NCT03300674|Lidocaine|lidocaine|mesh-list
111435975|NCT03300674|Hydromorphone|hydromorphone|mesh-list
111435976|NCT03300674|Anesthetics, Local|anesthetics, local|mesh-ancestor
111435977|NCT03300674|Anesthetics|anesthetics|mesh-ancestor
111435978|NCT03300674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111435979|NCT03300674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111435980|NCT03300674|Sensory System Agents|sensory system agents|mesh-ancestor
111435981|NCT03300674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111435982|NCT03300674|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111435983|NCT03300674|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111435984|NCT03300674|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111435985|NCT03300674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111435986|NCT03300674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111435987|NCT03300674|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111435988|NCT03300674|Narcotics|narcotics|mesh-ancestor
111435989|NCT03300674|Analgesics|analgesics|mesh-ancestor
111435990|NCT02158806|Aspirin|aspirin|mesh-list
111435991|NCT02158806|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111435992|NCT02158806|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111435993|NCT02158806|Analgesics|analgesics|mesh-ancestor
111435994|NCT02158806|Sensory System Agents|sensory system agents|mesh-ancestor
111435995|NCT02158806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111435996|NCT02158806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111435997|NCT02158806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111435998|NCT02158806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111435999|NCT02158806|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111436000|NCT02158806|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111436001|NCT02158806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111436002|NCT02158806|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111436003|NCT02158806|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111436004|NCT02158806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111436005|NCT02158806|Antipyretics|antipyretics|mesh-ancestor
111436006|NCT03197389|Pembrolizumab|pembrolizumab|mesh-list
111436007|NCT03197389|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111436008|NCT03197389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111436009|NCT03197389|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111436010|NCT03197389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111436011|NCT03198871|Acetaminophen|acetaminophen|mesh-list
111436012|NCT03198871|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111436013|NCT03198871|Analgesics|analgesics|mesh-ancestor
111436014|NCT03198871|Sensory System Agents|sensory system agents|mesh-ancestor
111436015|NCT03198871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111436016|NCT03198871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111436017|NCT03198871|Antipyretics|antipyretics|mesh-ancestor
111436018|NCT02157948|Denosumab|denosumab|mesh-list
111436019|NCT02157948|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111436020|NCT02157948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111436021|NCT03220958|Diphenhydramine|diphenhydramine|mesh-list
111436022|NCT03220958|Promethazine|promethazine|mesh-list
111436023|NCT03220958|Metoclopramide|metoclopramide|mesh-list
111436024|NCT03220958|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111436025|NCT03220958|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111436026|NCT03220958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111436027|NCT03220958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111436028|NCT03220958|Anesthetics, Local|anesthetics, local|mesh-ancestor
111436029|NCT03220958|Anesthetics|anesthetics|mesh-ancestor
111436030|NCT03220958|Sensory System Agents|sensory system agents|mesh-ancestor
111436031|NCT03220958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111436032|NCT03220958|Antiemetics|antiemetics|mesh-ancestor
111436033|NCT03220958|Autonomic Agents|autonomic agents|mesh-ancestor
111436034|NCT03220958|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111436035|NCT03220958|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111436036|NCT03220958|Histamine Antagonists|histamine antagonists|mesh-ancestor
111436037|NCT03220958|Histamine Agents|histamine agents|mesh-ancestor
111436038|NCT03220958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111436039|NCT03220958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111436040|NCT03220958|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111436041|NCT03220958|Antipruritics|antipruritics|mesh-ancestor
111436042|NCT03220958|Dermatologic Agents|dermatologic agents|mesh-ancestor
111436043|NCT03220958|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111436044|NCT03220958|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111436045|NCT03220958|Dopamine Agents|dopamine agents|mesh-ancestor
111436046|NCT02182830|Empagliflozin|empagliflozin|mesh-list
111436047|NCT02182830|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111436048|NCT02182830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111436049|NCT02182830|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111436050|NCT02182830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111436051|NCT03424681|Modafinil|modafinil|mesh-list
111436052|NCT03424681|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111436053|NCT03424681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111436054|NCT03424681|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
111436055|NCT03424681|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111436056|NCT03424681|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111436057|NCT03424681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111436058|NCT03303794|Bupivacaine|bupivacaine|mesh-list
111436059|NCT03303794|Anesthetics, Local|anesthetics, local|mesh-ancestor
111436060|NCT03303794|Anesthetics|anesthetics|mesh-ancestor
111436061|NCT03303794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111436062|NCT03303794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111436063|NCT03303794|Sensory System Agents|sensory system agents|mesh-ancestor
111436064|NCT03303794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111436065|NCT03305822|Insulin Lispro|insulin lispro|mesh-list
111436066|NCT03305822|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111436067|NCT03305822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111436068|NCT03435614|Analgesics|analgesics|mesh-list
111436069|NCT03435614|Narcotics|narcotics|mesh-list
111436070|NCT03435614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111436071|NCT03435614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111436072|NCT03435614|Sensory System Agents|sensory system agents|mesh-ancestor
111436073|NCT03435614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111436074|NCT03437564|Vortioxetine|vortioxetine|mesh-list
111436075|NCT03437564|Antidepressive Agents|antidepressive agents|mesh-ancestor
111436076|NCT03437564|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111436077|NCT03437564|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111436078|NCT03437564|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111436079|NCT03437564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111436080|NCT03437564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111436081|NCT03437564|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111436082|NCT03437564|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111436083|NCT03437564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111436084|NCT03437564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111436085|NCT03437564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111436087|NCT03437564|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111436088|NCT03437564|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111436089|NCT03437564|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111436090|NCT03437564|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111436091|NCT03438266|Hyaluronic Acid|hyaluronic acid|mesh-list
111436092|NCT03438266|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111436093|NCT03438266|Immunologic Factors|immunologic factors|mesh-ancestor
111436094|NCT03438266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111436095|NCT03438266|Viscosupplements|viscosupplements|mesh-ancestor
111436096|NCT03438266|Protective Agents|protective agents|mesh-ancestor
111436097|NCT03315104|Immunoglobulins|immunoglobulins|mesh-list
111436098|NCT03315104|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111436099|NCT03315104|gamma-Globulins|gamma-globulins|mesh-list
111436100|NCT03315104|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
111436101|NCT03315104|Immunologic Factors|immunologic factors|mesh-ancestor
111436102|NCT03315104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111436103|NCT03228914|Phenylephrine|phenylephrine|mesh-list
111436104|NCT03228914|Epinephrine|epinephrine|mesh-list
111436105|NCT03228914|Oxymetazoline|oxymetazoline|mesh-list
111436106|NCT03228914|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111436107|NCT03228914|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111436108|NCT03228914|Adrenergic Agents|adrenergic agents|mesh-ancestor
111436109|NCT03228914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111436110|NCT03228914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111436111|NCT03228914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111436112|NCT03228914|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111436113|NCT03228914|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111436114|NCT03228914|Autonomic Agents|autonomic agents|mesh-ancestor
111436115|NCT03228914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111436116|NCT03228914|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111436117|NCT03228914|Respiratory System Agents|respiratory system agents|mesh-ancestor
111436118|NCT03228914|Mydriatics|mydriatics|mesh-ancestor
111436119|NCT03228914|Sympathomimetics|sympathomimetics|mesh-ancestor
111436120|NCT03228914|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111436121|NCT03228914|Nasal Decongestants|nasal decongestants|mesh-ancestor
111436122|NCT03228914|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111436123|NCT03228914|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111436124|NCT03228914|Protective Agents|protective agents|mesh-ancestor
111436125|NCT03316976|Dexlansoprazole|dexlansoprazole|mesh-list
111436126|NCT03316976|Lansoprazole|lansoprazole|mesh-list
111436127|NCT03316976|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111436128|NCT03316976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111436129|NCT03316976|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111436130|NCT03316976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111436131|NCT03316976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111436132|NCT03234374|Bupivacaine|bupivacaine|mesh-list
111436133|NCT03234374|Anesthetics, Local|anesthetics, local|mesh-ancestor
111436134|NCT03234374|Anesthetics|anesthetics|mesh-ancestor
111436135|NCT03234374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111436136|NCT03234374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111436137|NCT03234374|Sensory System Agents|sensory system agents|mesh-ancestor
111436138|NCT03234374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111436139|NCT04332536|Codeine|codeine|mesh-list
111436140|NCT04332536|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111436141|NCT04332536|Narcotics|narcotics|mesh-ancestor
111436142|NCT04332536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111436143|NCT04332536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111436144|NCT04332536|Analgesics|analgesics|mesh-ancestor
111436145|NCT04332536|Sensory System Agents|sensory system agents|mesh-ancestor
111436146|NCT04332536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111436147|NCT04332536|Antitussive Agents|antitussive agents|mesh-ancestor
111436148|NCT04332536|Respiratory System Agents|respiratory system agents|mesh-ancestor
111436149|NCT03236168|Ivermectin|ivermectin|mesh-list
111436150|NCT03236168|Permethrin|permethrin|mesh-list
111436151|NCT03236168|Malathion|malathion|mesh-list
111436152|NCT03236168|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111436153|NCT03236168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111436154|NCT03236168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111436155|NCT03236168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111436156|NCT03236168|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111436157|NCT03236168|Cholinergic Agents|cholinergic agents|mesh-ancestor
111160508|NCT01588990|Antidotes|antidotes|mesh-ancestor
111436158|NCT03236168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111436159|NCT03236168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111436160|NCT03306589|Molgramostim|molgramostim|mesh-list
111436161|NCT03306589|Sargramostim|sargramostim|mesh-list
111436162|NCT03306589|Cantharidin|cantharidin|mesh-list
111436163|NCT03306589|Immunologic Factors|immunologic factors|mesh-ancestor
111436164|NCT03306589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111436165|NCT03306589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111436166|NCT03306589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111436167|NCT03306589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111436168|NCT03312517|Suvorexant|suvorexant|mesh-list
111436169|NCT03312517|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111436170|NCT03312517|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111436171|NCT03312517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111436172|NCT03312517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111436173|NCT03312517|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
111436174|NCT03312517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111436175|NCT03312517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111436176|NCT03315559|Nemiralisib|nemiralisib|mesh-list
111436177|NCT03315559|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111436178|NCT03315559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111436179|NCT03315559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111436180|NCT03239522|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111436181|NCT03239522|Glycine|glycine|mesh-list
111436182|NCT03239522|Glycine Agents|glycine agents|mesh-ancestor
111436183|NCT03239522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111436184|NCT03239522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111436185|NCT03239522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111436186|NCT03210337|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111436187|NCT03242408|Methyltestosterone|methyltestosterone|mesh-list
111436188|NCT03242408|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
111436189|NCT03242408|Testosterone|testosterone|mesh-list
111436190|NCT03242408|Testosterone undecanoate|testosterone undecanoate|mesh-list
111436191|NCT03242408|Testosterone enanthate|testosterone enanthate|mesh-list
111436192|NCT03242408|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111436193|NCT03242408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111436194|NCT03242408|Anabolic Agents|anabolic agents|mesh-ancestor
111436195|NCT03242408|Hormones|hormones|mesh-ancestor
111436196|NCT03242408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111436197|NCT03242408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111436198|NCT03242408|Androgens|androgens|mesh-ancestor
111436199|NCT03459794|Ivermectin|ivermectin|mesh-list
111436200|NCT03459794|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111436201|NCT03459794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111436202|NCT03211117|Docetaxel|docetaxel|mesh-list
111436203|NCT03211117|Doxorubicin|doxorubicin|mesh-list
111436204|NCT03211117|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111436205|NCT03211117|Pembrolizumab|pembrolizumab|mesh-list
111436206|NCT03211117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111436207|NCT03211117|Tubulin Modulators|tubulin modulators|mesh-ancestor
111436208|NCT03211117|Antimitotic Agents|antimitotic agents|mesh-ancestor
111436209|NCT03211117|Mitosis Modulators|mitosis modulators|mesh-ancestor
111436210|NCT03211117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111436211|NCT03211117|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111436212|NCT03211117|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111436213|NCT03211117|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111436214|NCT03211117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111436215|NCT03211117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111436216|NCT03211117|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111436217|NCT00376285|Fenofibrate|fenofibrate|mesh-list
111436218|NCT00376285|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111436219|NCT00376285|Antimetabolites|antimetabolites|mesh-ancestor
111436220|NCT00376285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111436221|NCT00376285|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111436222|NCT03460652|Serdexmethylphenidate and dexmethylphenidate|serdexmethylphenidate and dexmethylphenidate|mesh-list
111436223|NCT03460652|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111436224|NCT03460652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111436225|NCT03321097|Botulinum Toxins|botulinum toxins|mesh-list
111436226|NCT03321097|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111436227|NCT03321097|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111436228|NCT03321097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111436229|NCT03321097|Cholinergic Agents|cholinergic agents|mesh-ancestor
111436230|NCT03321097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111436231|NCT03321097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111436232|NCT03245762|Oxytocin|oxytocin|mesh-list
111436233|NCT03245762|Oxytocics|oxytocics|mesh-ancestor
111436234|NCT03245762|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111436235|NCT03245762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111436236|NCT03322657|Glycopyrrolate|glycopyrrolate|mesh-list
111436237|NCT03322657|Neostigmine|neostigmine|mesh-list
111436238|NCT03322657|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111436239|NCT03322657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111436240|NCT03322657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111436241|NCT03322657|Cholinergic Agents|cholinergic agents|mesh-ancestor
111436242|NCT03322657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111436243|NCT03322657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111436244|NCT03322657|Parasympathomimetics|parasympathomimetics|mesh-ancestor
111436245|NCT03322657|Autonomic Agents|autonomic agents|mesh-ancestor
111436246|NCT03322657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111436247|NCT03322657|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111436248|NCT03322657|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111436249|NCT03322657|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111436250|NCT03324451|Insulin|insulin|mesh-list
111436251|NCT03324451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111436252|NCT03324451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111436253|NCT03247790|Lasmiditan|lasmiditan|mesh-list
111436254|NCT03247790|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111436255|NCT03247790|Serotonin Agents|serotonin agents|mesh-ancestor
111436256|NCT03247790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111436257|NCT03247790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111436258|NCT03247790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111436259|NCT03249272|Adenosine|adenosine|mesh-list
111436260|NCT03249272|Regadenoson|regadenoson|mesh-list
111436261|NCT03249272|Analgesics|analgesics|mesh-ancestor
111436262|NCT03249272|Sensory System Agents|sensory system agents|mesh-ancestor
111436263|NCT03249272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111436264|NCT03249272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111436265|NCT03249272|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111436266|NCT03249272|Vasodilator Agents|vasodilator agents|mesh-ancestor
111436267|NCT03249272|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
111436268|NCT03249272|Purinergic Agonists|purinergic agonists|mesh-ancestor
111436269|NCT03249272|Purinergic Agents|purinergic agents|mesh-ancestor
111436270|NCT03249272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111436271|NCT03249272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111436272|NCT03249272|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
111436273|NCT03468920|Acetaminophen|acetaminophen|mesh-list
111436274|NCT03468920|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111436275|NCT03468920|Analgesics|analgesics|mesh-ancestor
111436276|NCT03468920|Sensory System Agents|sensory system agents|mesh-ancestor
111436277|NCT03468920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111436278|NCT03468920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111436279|NCT03468920|Antipyretics|antipyretics|mesh-ancestor
111436280|NCT02181816|Amlodipine|amlodipine|mesh-list
111436281|NCT02181816|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
111436282|NCT02181816|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111436283|NCT02181816|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111436284|NCT02181816|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111436285|NCT02181816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111436286|NCT02181816|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111436287|NCT02181816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111436288|NCT02181816|Vasodilator Agents|vasodilator agents|mesh-ancestor
111436289|NCT02181816|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111436290|NCT02181816|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111436291|NCT03256136|Carboplatin|carboplatin|mesh-list
111436292|NCT03256136|Nivolumab|nivolumab|mesh-list
111436293|NCT03256136|Pemetrexed|pemetrexed|mesh-list
111436294|NCT03256136|Ipilimumab|ipilimumab|mesh-list
111436295|NCT03256136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111436296|NCT03256136|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111436297|NCT03256136|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111436298|NCT03256136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111436299|NCT03256136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111436300|NCT03256136|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111436301|NCT03256136|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111436302|NCT03344510|Anesthetics|anesthetics|mesh-list
111436303|NCT03344510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111436304|NCT03344510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111436305|NCT03478982|Alprazolam|alprazolam|mesh-list
111436306|NCT03478982|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111436307|NCT03478982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111436308|NCT03478982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111436309|NCT03478982|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111436310|NCT03478982|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111436311|NCT03478982|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111436312|NCT03478982|GABA Modulators|gaba modulators|mesh-ancestor
111436313|NCT03478982|GABA Agents|gaba agents|mesh-ancestor
111436314|NCT03478982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111436315|NCT03478982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111436316|NCT03270332|Albuterol|albuterol|mesh-list
111436317|NCT03270332|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111436318|NCT03270332|Autonomic Agents|autonomic agents|mesh-ancestor
111436319|NCT03270332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111436320|NCT03270332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111436321|NCT03270332|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111436322|NCT03270332|Respiratory System Agents|respiratory system agents|mesh-ancestor
111436323|NCT03270332|Tocolytic Agents|tocolytic agents|mesh-ancestor
111436324|NCT03270332|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111436325|NCT03270332|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111436326|NCT03270332|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111436327|NCT03270332|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111436328|NCT03270332|Adrenergic Agents|adrenergic agents|mesh-ancestor
111436329|NCT03270332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111436330|NCT03270332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111436331|NCT03355820|Antibodies|antibodies|mesh-list
111436332|NCT03355820|Immunologic Factors|immunologic factors|mesh-ancestor
111436333|NCT03355820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111436334|NCT03357614|Amoxicillin|amoxicillin|mesh-list
111436335|NCT03357614|Ciprofloxacin|ciprofloxacin|mesh-list
111436336|NCT03357614|Clavulanic Acid|clavulanic acid|mesh-list
111436337|NCT03357614|Clavulanic Acids|clavulanic acids|mesh-list
111436338|NCT03357614|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
111436339|NCT03357614|Ertapenem|ertapenem|mesh-list
111436340|NCT03357614|Lactams|lactams|mesh-list
111436341|NCT03357614|Probenecid|probenecid|mesh-list
111436342|NCT03357614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111436343|NCT03357614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111436344|NCT03357614|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111436345|NCT03357614|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111436346|NCT03357614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111436347|NCT03357614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111436348|NCT03357614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111436349|NCT03357614|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111436350|NCT03357614|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111436351|NCT03357614|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
111436352|NCT03357614|Uricosuric Agents|uricosuric agents|mesh-ancestor
111436353|NCT03357614|Gout Suppressants|gout suppressants|mesh-ancestor
111436354|NCT03357614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111436355|NCT03275870|Hydroxychloroquine|hydroxychloroquine|mesh-list
111436356|NCT03275870|Antimalarials|antimalarials|mesh-ancestor
111436357|NCT03275870|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111436358|NCT03275870|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111436359|NCT03275870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111436360|NCT03275870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111436361|NCT03275870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111436362|NCT03275870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111436363|NCT02216214|Mirabegron|mirabegron|mesh-list
111436364|NCT02216214|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
111436365|NCT02216214|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111436366|NCT02216214|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111436367|NCT02216214|Adrenergic Agents|adrenergic agents|mesh-ancestor
111436368|NCT02216214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111436369|NCT02216214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111436370|NCT02216214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111436371|NCT02216214|Urological Agents|urological agents|mesh-ancestor
111436372|NCT00376376|Levofloxacin|levofloxacin|mesh-list
111436373|NCT00376376|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111436374|NCT00376376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111436375|NCT00376376|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111436376|NCT00376376|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111436377|NCT00376376|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111436378|NCT00376376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111436379|NCT00376376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111436380|NCT00376376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111436381|NCT00376376|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111436382|NCT00376376|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111436383|NCT02181504|Ranibizumab|ranibizumab|mesh-list
111436384|NCT02181504|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111436385|NCT02181504|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111436386|NCT02181504|Growth Substances|growth substances|mesh-ancestor
111436387|NCT02181504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111436388|NCT02181504|Growth Inhibitors|growth inhibitors|mesh-ancestor
111436389|NCT02181504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111436390|NCT02213094|Vitamins|vitamins|mesh-list
111436391|NCT02213094|Niacinamide|niacinamide|mesh-list
111436393|NCT02213094|Nicotinic Acids|nicotinic acids|mesh-list
111436394|NCT02213094|Vitamin B Complex|vitamin b complex|mesh-list
111436395|NCT02213094|Micronutrients|micronutrients|mesh-ancestor
111436396|NCT02213094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111436397|NCT02213094|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111436398|NCT02213094|Antimetabolites|antimetabolites|mesh-ancestor
111436399|NCT02213094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111436400|NCT02213094|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111436401|NCT02213094|Vasodilator Agents|vasodilator agents|mesh-ancestor
111436402|NCT01629966|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
111436403|NCT01629966|Antidepressive Agents|antidepressive agents|mesh-ancestor
111436404|NCT01629966|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111436405|NCT01629966|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111436406|NCT01629966|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111436407|NCT01629966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111436408|NCT01629966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111436409|NCT01629966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111436410|NCT01629966|Serotonin Agents|serotonin agents|mesh-ancestor
111436411|NCT01629966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111436412|NCT01629966|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111436413|NCT01629966|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111436414|NCT02177838|Cetuximab|cetuximab|mesh-list
111436415|NCT02177838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111436416|NCT02177838|Antibodies|antibodies|mesh-list
111436417|NCT02177838|Immunoglobulins|immunoglobulins|mesh-list
111436418|NCT02177838|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111436419|NCT02177838|Immunologic Factors|immunologic factors|mesh-ancestor
111436420|NCT02177838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111436421|NCT02177838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111436422|NCT03283436|Bupivacaine|bupivacaine|mesh-list
111436423|NCT03283436|Anesthetics, Local|anesthetics, local|mesh-ancestor
111436424|NCT03283436|Anesthetics|anesthetics|mesh-ancestor
111436425|NCT03283436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111436426|NCT03283436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111436427|NCT03283436|Sensory System Agents|sensory system agents|mesh-ancestor
111436428|NCT03283436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111436429|NCT00376064|Octreotide|octreotide|mesh-list
111436430|NCT00376064|Cabergoline|cabergoline|mesh-list
111436431|NCT00376064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111436432|NCT00376064|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111436433|NCT00376064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111436434|NCT00376064|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111436435|NCT00376064|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111436436|NCT00376064|Dopamine Agonists|dopamine agonists|mesh-ancestor
111436437|NCT00376064|Dopamine Agents|dopamine agents|mesh-ancestor
111436438|NCT00376064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111436439|NCT00376064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111436440|NCT00376064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111436441|NCT03581084|Acetylcysteine|acetylcysteine|mesh-list
111436442|NCT03581084|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111436443|NCT03581084|Antiviral Agents|antiviral agents|mesh-ancestor
111436444|NCT03581084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111436445|NCT03581084|Expectorants|expectorants|mesh-ancestor
111436446|NCT03581084|Respiratory System Agents|respiratory system agents|mesh-ancestor
111436447|NCT03581084|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111436448|NCT03581084|Antioxidants|antioxidants|mesh-ancestor
111436449|NCT03581084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111436450|NCT03581084|Protective Agents|protective agents|mesh-ancestor
111436451|NCT03581084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111436452|NCT03581084|Antidotes|antidotes|mesh-ancestor
111436453|NCT03383588|Epinephrine|epinephrine|mesh-list
111436454|NCT03383588|Fentanyl|fentanyl|mesh-list
111436455|NCT03383588|Morphine|morphine|mesh-list
111436456|NCT03383588|Bupivacaine|bupivacaine|mesh-list
111436457|NCT03383588|Anesthetics, Local|anesthetics, local|mesh-ancestor
111436458|NCT03383588|Anesthetics|anesthetics|mesh-ancestor
111436459|NCT03383588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111436460|NCT03383588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111436461|NCT03383588|Sensory System Agents|sensory system agents|mesh-ancestor
111436462|NCT03383588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111436463|NCT03383588|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111436464|NCT03383588|Narcotics|narcotics|mesh-ancestor
111436465|NCT03383588|Analgesics|analgesics|mesh-ancestor
111436466|NCT03383588|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111436467|NCT03383588|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111436468|NCT03383588|Anesthetics, General|anesthetics, general|mesh-ancestor
111436469|NCT03383588|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111436470|NCT03383588|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111436471|NCT03383588|Adrenergic Agents|adrenergic agents|mesh-ancestor
111436472|NCT03383588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111436473|NCT03383588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111436474|NCT03383588|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111436475|NCT03383588|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111436476|NCT03383588|Autonomic Agents|autonomic agents|mesh-ancestor
111436477|NCT03383588|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111436478|NCT03383588|Respiratory System Agents|respiratory system agents|mesh-ancestor
111436479|NCT03383588|Mydriatics|mydriatics|mesh-ancestor
111436480|NCT03383588|Sympathomimetics|sympathomimetics|mesh-ancestor
111436481|NCT03383588|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111436482|NCT03388268|Vancomycin|vancomycin|mesh-list
111436483|NCT03388268|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111436484|NCT03388268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111436485|NCT03393494|Adapalene|adapalene|mesh-list
111436486|NCT03393494|Benzoyl Peroxide|benzoyl peroxide|mesh-list
111436487|NCT03393494|Dermatologic Agents|dermatologic agents|mesh-ancestor
111436488|NCT03393494|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111436489|NCT03393494|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111436490|NCT03393494|Analgesics|analgesics|mesh-ancestor
111436491|NCT03393494|Sensory System Agents|sensory system agents|mesh-ancestor
111436492|NCT03393494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111436493|NCT03393494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111436494|NCT03393494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111436495|NCT03393494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111436496|NCT03588806|Oxycodone|oxycodone|mesh-list
111436497|NCT03588806|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111436498|NCT03588806|Narcotics|narcotics|mesh-ancestor
111436499|NCT03588806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111436500|NCT03588806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111436501|NCT03588806|Analgesics|analgesics|mesh-ancestor
111436502|NCT03588806|Sensory System Agents|sensory system agents|mesh-ancestor
111436503|NCT03588806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111436504|NCT02176356|Bimatoprost|bimatoprost|mesh-list
111436505|NCT02176356|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111436506|NCT02176356|Botulinum Toxins|botulinum toxins|mesh-list
111436507|NCT02176356|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111436508|NCT02176356|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111436509|NCT02176356|Hyaluronic Acid|hyaluronic acid|mesh-list
111436510|NCT02176356|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111436511|NCT02176356|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111436512|NCT02176356|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111436513|NCT02176356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111436514|NCT02176356|Cholinergic Agents|cholinergic agents|mesh-ancestor
111436515|NCT02176356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111436516|NCT02176356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111436517|NCT02176356|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111436518|NCT02176356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111436519|NCT02176356|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111436520|NCT02176356|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111436521|NCT02176356|Immunologic Factors|immunologic factors|mesh-ancestor
111436522|NCT02176356|Viscosupplements|viscosupplements|mesh-ancestor
111436523|NCT02176356|Protective Agents|protective agents|mesh-ancestor
111436524|NCT03591068|Fluticasone|fluticasone|mesh-list
111436525|NCT03591068|Xhance|xhance|mesh-list
111436526|NCT03591068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111436527|NCT03591068|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111436528|NCT03591068|Autonomic Agents|autonomic agents|mesh-ancestor
111436529|NCT03591068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111436530|NCT03591068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111436531|NCT03591068|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111436532|NCT03591068|Respiratory System Agents|respiratory system agents|mesh-ancestor
111436533|NCT03591068|Dermatologic Agents|dermatologic agents|mesh-ancestor
111436534|NCT03591068|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111436535|NCT03395990|Chloroprocaine|chloroprocaine|mesh-list
111436536|NCT03395990|Procaine|procaine|mesh-list
111436537|NCT03395990|Anesthetics, Local|anesthetics, local|mesh-ancestor
111436539|NCT03395990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111436540|NCT03395990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111436541|NCT03395990|Sensory System Agents|sensory system agents|mesh-ancestor
111436542|NCT03395990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111436543|NCT02175966|Ribavirin|ribavirin|mesh-list
111436544|NCT02175966|Sofosbuvir|sofosbuvir|mesh-list
111436545|NCT02175966|Antimetabolites|antimetabolites|mesh-ancestor
111436546|NCT02175966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111436547|NCT02175966|Antiviral Agents|antiviral agents|mesh-ancestor
111436548|NCT02175966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111436549|NCT02136576|Listerine|listerine|mesh-list
111436550|NCT02136576|Sodium Fluoride|sodium fluoride|mesh-list
111436551|NCT02136576|Cariostatic Agents|cariostatic agents|mesh-ancestor
111436552|NCT02136576|Protective Agents|protective agents|mesh-ancestor
111436553|NCT02136576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111436554|NCT02136576|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111436555|NCT02136576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111436556|NCT03398330|Oxycodone|oxycodone|mesh-list
111436557|NCT03398330|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111436558|NCT03398330|Narcotics|narcotics|mesh-ancestor
111436559|NCT03398330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111436560|NCT03398330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111436561|NCT03398330|Analgesics|analgesics|mesh-ancestor
111436562|NCT03398330|Sensory System Agents|sensory system agents|mesh-ancestor
111436563|NCT03398330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111436564|NCT00376766|Levetiracetam|levetiracetam|mesh-list
111436565|NCT00376766|Anticonvulsants|anticonvulsants|mesh-ancestor
111436566|NCT00376766|Nootropic Agents|nootropic agents|mesh-ancestor
111436567|NCT03403712|Dexamethasone|dexamethasone|mesh-list
111436568|NCT03403712|Palonosetron|palonosetron|mesh-list
111436569|NCT03403712|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111436570|NCT03403712|Antiemetics|antiemetics|mesh-ancestor
111436571|NCT03403712|Autonomic Agents|autonomic agents|mesh-ancestor
111436572|NCT03403712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111436573|NCT03403712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111436574|NCT03403712|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111436575|NCT03403712|Glucocorticoids|glucocorticoids|mesh-ancestor
111436576|NCT03403712|Hormones|hormones|mesh-ancestor
111436577|NCT03403712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111436578|NCT03403712|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111436579|NCT03403712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111436580|NCT03403712|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111436581|NCT03403712|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111436582|NCT03403712|Serotonin Agents|serotonin agents|mesh-ancestor
111436583|NCT03403712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111436584|NCT03403712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111436585|NCT03404648|Choline|choline|mesh-list
111436586|NCT03404648|Lipotropic Agents|lipotropic agents|mesh-ancestor
111436587|NCT03404648|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111436588|NCT03404648|Antimetabolites|antimetabolites|mesh-ancestor
111436589|NCT03404648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111436590|NCT03404648|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110513325|NCT00887107|Sorafenib|sorafenib|mesh-list
111436591|NCT03404648|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111436592|NCT03404648|Nootropic Agents|nootropic agents|mesh-ancestor
111436593|NCT03383198|Bupivacaine|bupivacaine|mesh-list
111436594|NCT03383198|Anesthetics, Local|anesthetics, local|mesh-ancestor
111436595|NCT03383198|Anesthetics|anesthetics|mesh-ancestor
111436596|NCT03383198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111436597|NCT03383198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111436598|NCT03383198|Sensory System Agents|sensory system agents|mesh-ancestor
111436599|NCT03383198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111436600|NCT03413618|Rivaroxaban|rivaroxaban|mesh-list
111436601|NCT03413618|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111436602|NCT03413618|Antithrombins|antithrombins|mesh-ancestor
111436603|NCT03413618|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111436604|NCT03413618|Protease Inhibitors|protease inhibitors|mesh-ancestor
111436605|NCT03413618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111436606|NCT03413618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111436607|NCT03413618|Anticoagulants|anticoagulants|mesh-ancestor
111436608|NCT03523988|Acetaminophen|acetaminophen|mesh-list
111436609|NCT03523988|Ibuprofen|ibuprofen|mesh-list
111436610|NCT03523988|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111160949|NCT02143141|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111436611|NCT03523988|Analgesics|analgesics|mesh-ancestor
111436612|NCT03523988|Sensory System Agents|sensory system agents|mesh-ancestor
111436613|NCT03523988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111436614|NCT03523988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111436615|NCT03523988|Antipyretics|antipyretics|mesh-ancestor
111436616|NCT03523988|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111436617|NCT03523988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111436618|NCT03523988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111436619|NCT03523988|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111436620|NCT03523988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111436621|NCT03523988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111436622|NCT03525548|Ivacaftor|ivacaftor|mesh-list
111436623|NCT03525548|Elexacaftor|elexacaftor|mesh-list
111436624|NCT03525548|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
111436625|NCT03525548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111436626|NCT03525548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111436627|NCT03528512|Fentanyl|fentanyl|mesh-list
111436628|NCT03528512|Midazolam|midazolam|mesh-list
111436629|NCT03528512|Ketamine|ketamine|mesh-list
111436630|NCT03528512|Analgesics|analgesics|mesh-ancestor
111436631|NCT03528512|Sensory System Agents|sensory system agents|mesh-ancestor
111436632|NCT03528512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111436633|NCT03528512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111436634|NCT03528512|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111436635|NCT03528512|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111436636|NCT03528512|Anesthetics, General|anesthetics, general|mesh-ancestor
111436637|NCT03528512|Anesthetics|anesthetics|mesh-ancestor
111436638|NCT03528512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111436639|NCT03528512|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111436640|NCT03528512|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111436641|NCT03528512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111436642|NCT03528512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111436643|NCT03528512|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111436644|NCT03528512|Narcotics|narcotics|mesh-ancestor
111436645|NCT03528512|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111436646|NCT03528512|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111436647|NCT03528512|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111436648|NCT03528512|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111436649|NCT03528512|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111436650|NCT03528512|GABA Modulators|gaba modulators|mesh-ancestor
111436651|NCT03528512|GABA Agents|gaba agents|mesh-ancestor
111436652|NCT02133924|Prednisone|prednisone|mesh-list
111436653|NCT02133924|Methylprednisolone|methylprednisolone|mesh-list
111436654|NCT02133924|Natalizumab|natalizumab|mesh-list
111436655|NCT02133924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111436656|NCT02133924|Glucocorticoids|glucocorticoids|mesh-ancestor
111436657|NCT02133924|Hormones|hormones|mesh-ancestor
111436658|NCT02133924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111436659|NCT02133924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111436660|NCT02133924|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111436661|NCT02133924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111436662|NCT02133924|Antiemetics|antiemetics|mesh-ancestor
111436663|NCT02133924|Autonomic Agents|autonomic agents|mesh-ancestor
111436664|NCT02133924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111436665|NCT02133924|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111436666|NCT02133924|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111436667|NCT02133924|Protective Agents|protective agents|mesh-ancestor
111436668|NCT02133924|Immunologic Factors|immunologic factors|mesh-ancestor
111436669|NCT03537404|Ritonavir|ritonavir|mesh-list
111436670|NCT03537404|Tenofovir|tenofovir|mesh-list
111436671|NCT03537404|Raltegravir Potassium|raltegravir potassium|mesh-list
111436672|NCT03537404|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111436673|NCT03537404|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111436674|NCT03537404|Protease Inhibitors|protease inhibitors|mesh-ancestor
111436675|NCT03537404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111436676|NCT03537404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111436677|NCT03537404|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111436678|NCT03537404|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111436679|NCT03537404|Antiviral Agents|antiviral agents|mesh-ancestor
111436680|NCT03537404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111436681|NCT03537404|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111436682|NCT03537404|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111436683|NCT03537404|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111436684|NCT03537404|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111436685|NCT03537404|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111436686|NCT03537404|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111436687|NCT03626714|Tacrolimus|tacrolimus|mesh-list
111436688|NCT03626714|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111436689|NCT03626714|Immunologic Factors|immunologic factors|mesh-ancestor
111436690|NCT03626714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111436691|NCT03626714|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111436692|NCT03626714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111436693|NCT03626714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111436694|NCT03538808|Varenicline|varenicline|mesh-list
111436695|NCT03538808|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111436696|NCT03538808|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111436697|NCT03538808|Cholinergic Agents|cholinergic agents|mesh-ancestor
111436698|NCT03538808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111436699|NCT03538808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111436700|NCT03538808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111436701|NCT00377000|Clindamycin|clindamycin|mesh-list
111436702|NCT00377000|Clindamycin palmitate|clindamycin palmitate|mesh-list
111436703|NCT00377000|Clindamycin phosphate|clindamycin phosphate|mesh-list
111436704|NCT00377000|Benzoyl Peroxide|benzoyl peroxide|mesh-list
111436705|NCT00377000|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111436706|NCT00377000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111436707|NCT00377000|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111436708|NCT00377000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111436709|NCT00377000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111436710|NCT00377000|Dermatologic Agents|dermatologic agents|mesh-ancestor
111436711|NCT02173548|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
111436712|NCT02173548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111436714|NCT04501640|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
111436715|NCT04501640|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111436716|NCT04501640|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111436717|NCT04501640|Adrenergic Agents|adrenergic agents|mesh-ancestor
111436718|NCT04501640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111436719|NCT04501640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111436720|NCT04501640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111436721|NCT04501640|Urological Agents|urological agents|mesh-ancestor
111436722|NCT04757610|Ranibizumab|ranibizumab|mesh-list
111436723|NCT04757610|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111436724|NCT04757610|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111436725|NCT04757610|Growth Substances|growth substances|mesh-ancestor
111436726|NCT04757610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111436727|NCT04757610|Growth Inhibitors|growth inhibitors|mesh-ancestor
111436728|NCT04757610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111436729|NCT03633344|Silicon|silicon|mesh-list
111436730|NCT03633344|Trace Elements|trace elements|mesh-ancestor
111436731|NCT03633344|Micronutrients|micronutrients|mesh-ancestor
111436732|NCT03633344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111436733|NCT02171130|Glucagon|glucagon|mesh-list
111436734|NCT02171130|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
111436735|NCT02171130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111436736|NCT02171130|Hormones|hormones|mesh-ancestor
111436737|NCT02171130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111436738|NCT02171130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111436739|NCT02171130|Incretins|incretins|mesh-ancestor
111436740|NCT04749810|Eculizumab|eculizumab|mesh-list
111436741|NCT04749810|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
111436742|NCT04749810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111436743|NCT04749810|Immunologic Factors|immunologic factors|mesh-ancestor
111436744|NCT04749810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111436745|NCT00377078|Lactoferrin|lactoferrin|mesh-list
111436746|NCT00377078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111436747|NCT04495712|Spironolactone|spironolactone|mesh-list
111436748|NCT04495712|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
111436749|NCT04495712|Hormone Antagonists|hormone antagonists|mesh-ancestor
111436750|NCT04495712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111436751|NCT04495712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111436752|NCT04495712|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
111436753|NCT04495712|Diuretics|diuretics|mesh-ancestor
111436754|NCT04495712|Natriuretic Agents|natriuretic agents|mesh-ancestor
111436755|NCT03553940|Vaccines|vaccines|mesh-list
111436756|NCT03553940|Immunologic Factors|immunologic factors|mesh-ancestor
111436757|NCT03553940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111436758|NCT04456634|Lumefantrine|lumefantrine|mesh-list
111436759|NCT04456634|Artemether|artemether|mesh-list
111436760|NCT04456634|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
111436761|NCT04456634|Antimalarials|antimalarials|mesh-ancestor
111436762|NCT04456634|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111436763|NCT04456634|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111436764|NCT04456634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111436765|NCT00377624|Hyaluronic Acid|hyaluronic acid|mesh-list
111436766|NCT00377624|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111436767|NCT00377624|Immunologic Factors|immunologic factors|mesh-ancestor
111436768|NCT00377624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111436769|NCT00377624|Viscosupplements|viscosupplements|mesh-ancestor
111436770|NCT00377624|Protective Agents|protective agents|mesh-ancestor
111436771|NCT03562988|Vitamins|vitamins|mesh-list
111436772|NCT03562988|Ascorbic Acid|ascorbic acid|mesh-list
111436773|NCT03562988|Micronutrients|micronutrients|mesh-ancestor
111436774|NCT03562988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111436775|NCT03562988|Antioxidants|antioxidants|mesh-ancestor
111436776|NCT03562988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111436777|NCT03562988|Protective Agents|protective agents|mesh-ancestor
111436778|NCT03644108|Guaifenesin|guaifenesin|mesh-list
111436779|NCT03644108|Expectorants|expectorants|mesh-ancestor
111436780|NCT03644108|Respiratory System Agents|respiratory system agents|mesh-ancestor
111436781|NCT04713956|Cyclophosphamide|cyclophosphamide|mesh-list
111436782|NCT04713956|Busulfan|busulfan|mesh-list
111436783|NCT04713956|Fludarabine|fludarabine|mesh-list
111436784|NCT04713956|Decitabine|decitabine|mesh-list
111436785|NCT04713956|Lenograstim|lenograstim|mesh-list
111436786|NCT04713956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111436787|NCT04713956|Immunologic Factors|immunologic factors|mesh-ancestor
111436788|NCT04713956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111436789|NCT04713956|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111436790|NCT04713956|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111436791|NCT04713956|Alkylating Agents|alkylating agents|mesh-ancestor
111436792|NCT04713956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111436793|NCT04713956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111436794|NCT04713956|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111436795|NCT04713956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111436796|NCT04713956|Antimetabolites|antimetabolites|mesh-ancestor
111436797|NCT04713956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111436798|NCT04713956|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111436799|NCT04425746|Afamelanotide|afamelanotide|mesh-list
111436800|NCT04425746|Dermatologic Agents|dermatologic agents|mesh-ancestor
111436801|NCT04392362|Adenosine|adenosine|mesh-list
111436802|NCT04392362|Analgesics|analgesics|mesh-ancestor
111436803|NCT04392362|Sensory System Agents|sensory system agents|mesh-ancestor
111436804|NCT04392362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111436805|NCT04392362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111436806|NCT04392362|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111436807|NCT04392362|Vasodilator Agents|vasodilator agents|mesh-ancestor
111436808|NCT04392362|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
111436809|NCT04392362|Purinergic Agonists|purinergic agonists|mesh-ancestor
111436810|NCT04392362|Purinergic Agents|purinergic agents|mesh-ancestor
111436811|NCT04392362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111436812|NCT04392362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111436813|NCT04734782|Antibodies|antibodies|mesh-list
111436814|NCT04734782|Immunologic Factors|immunologic factors|mesh-ancestor
111436815|NCT04734782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111436816|NCT04390022|Ivermectin|ivermectin|mesh-list
111436817|NCT04390022|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111436818|NCT04390022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111436819|NCT04370834|Immunoglobulins|immunoglobulins|mesh-list
111436820|NCT04370834|Immunoglobulin G|immunoglobulin g|mesh-list
111436821|NCT04370834|Immunologic Factors|immunologic factors|mesh-ancestor
111436822|NCT04370834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111436823|NCT03570476|Olaparib|olaparib|mesh-list
111436824|NCT03570476|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
111436825|NCT03570476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111436826|NCT03570476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111436827|NCT03570476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111436828|NCT03571724|Menthol|menthol|mesh-list
111436829|NCT03571724|Nicotine|nicotine|mesh-list
111436830|NCT03571724|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111436831|NCT03571724|Autonomic Agents|autonomic agents|mesh-ancestor
111436832|NCT03571724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111436833|NCT03571724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111436834|NCT03571724|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111436835|NCT03571724|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111436836|NCT03571724|Cholinergic Agents|cholinergic agents|mesh-ancestor
111436837|NCT03571724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111436838|NCT03571724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111436839|NCT03571724|Antipruritics|antipruritics|mesh-ancestor
111436840|NCT03571724|Dermatologic Agents|dermatologic agents|mesh-ancestor
111436841|NCT03572972|Warfarin|warfarin|mesh-list
111436842|NCT03572972|Rivaroxaban|rivaroxaban|mesh-list
111436843|NCT03572972|Dabigatran|dabigatran|mesh-list
111436845|NCT03572972|Anticoagulants|anticoagulants|mesh-ancestor
111436846|NCT03572972|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111436847|NCT03572972|Antithrombins|antithrombins|mesh-ancestor
111436848|NCT03572972|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111436849|NCT03572972|Protease Inhibitors|protease inhibitors|mesh-ancestor
111436850|NCT03572972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111436851|NCT03572972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111436852|NCT04352660|Mitomycins|mitomycins|mesh-list
111436853|NCT04352660|Mitomycin|mitomycin|mesh-list
111436854|NCT04352660|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111436855|NCT04352660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111436856|NCT04352660|Alkylating Agents|alkylating agents|mesh-ancestor
111436857|NCT04352660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111436858|NCT04352660|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111436859|NCT04352660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111436860|NCT04342130|Morphine|morphine|mesh-list
111436861|NCT04342130|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111436862|NCT04342130|Narcotics|narcotics|mesh-ancestor
111436863|NCT04342130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111436864|NCT04342130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111436865|NCT04342130|Analgesics|analgesics|mesh-ancestor
111436866|NCT04342130|Sensory System Agents|sensory system agents|mesh-ancestor
111436867|NCT04342130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111436868|NCT04338074|Tranexamic Acid|tranexamic acid|mesh-list
111436869|NCT04338074|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111436870|NCT04338074|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111436871|NCT04338074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111436872|NCT04338074|Hemostatics|hemostatics|mesh-ancestor
111436873|NCT04338074|Coagulants|coagulants|mesh-ancestor
111436874|NCT03964220|Tiotropium Bromide|tiotropium bromide|mesh-list
111436875|NCT03964220|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111436876|NCT03964220|Autonomic Agents|autonomic agents|mesh-ancestor
111436877|NCT03964220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111436878|NCT03964220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111436879|NCT03964220|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111436880|NCT03964220|Respiratory System Agents|respiratory system agents|mesh-ancestor
111436881|NCT03964220|Parasympatholytics|parasympatholytics|mesh-ancestor
111436882|NCT03964220|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111436883|NCT03964220|Cholinergic Agents|cholinergic agents|mesh-ancestor
111436884|NCT03964220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111436885|NCT03964220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111436886|NCT04337138|Gemtuzumab|gemtuzumab|mesh-list
111436887|NCT04337138|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111436888|NCT04337138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111436889|NCT04337138|Immunotoxins|immunotoxins|mesh-ancestor
111436890|NCT04337138|Immunoconjugates|immunoconjugates|mesh-ancestor
111436891|NCT04337138|Immunologic Factors|immunologic factors|mesh-ancestor
111436892|NCT04337138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111436893|NCT00422773|Cetuximab|cetuximab|mesh-list
111436894|NCT00422773|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111436895|NCT00422773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111436896|NCT03329209|Vedolizumab|vedolizumab|mesh-list
111436897|NCT03329209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111436898|NCT03661346|Labetalol|labetalol|mesh-list
111436899|NCT03661346|Esmolol|esmolol|mesh-list
111436900|NCT03661346|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
111436901|NCT03661346|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111436902|NCT03661346|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111436903|NCT03661346|Adrenergic Agents|adrenergic agents|mesh-ancestor
111436904|NCT03661346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111436905|NCT03661346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111436906|NCT03661346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111436907|NCT03661346|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111436908|NCT03661346|Sympathomimetics|sympathomimetics|mesh-ancestor
111436909|NCT03661346|Autonomic Agents|autonomic agents|mesh-ancestor
111436910|NCT03661346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111436911|NCT03661346|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111436912|NCT03661346|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111436913|NCT03329911|Paclitaxel|paclitaxel|mesh-list
111436914|NCT03329911|Carboplatin|carboplatin|mesh-list
111436915|NCT03329911|Bevacizumab|bevacizumab|mesh-list
111436916|NCT03329911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111436917|NCT03329911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111436918|NCT03329911|Tubulin Modulators|tubulin modulators|mesh-ancestor
111161253|NCT04530149|Analgesics|analgesics|mesh-ancestor
111436919|NCT03329911|Antimitotic Agents|antimitotic agents|mesh-ancestor
111436920|NCT03329911|Mitosis Modulators|mitosis modulators|mesh-ancestor
111436921|NCT03329911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111436922|NCT03329911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111436923|NCT03329911|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111436924|NCT03329911|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111436925|NCT03329911|Growth Substances|growth substances|mesh-ancestor
111436926|NCT03329911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111436927|NCT03329911|Growth Inhibitors|growth inhibitors|mesh-ancestor
111436928|NCT04322396|Azithromycin|azithromycin|mesh-list
111436929|NCT04322396|Hydroxychloroquine|hydroxychloroquine|mesh-list
111436930|NCT04322396|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111436931|NCT04322396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111436932|NCT04322396|Antimalarials|antimalarials|mesh-ancestor
111436933|NCT04322396|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111436934|NCT04322396|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111436935|NCT04322396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111436936|NCT04322396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111436937|NCT04322396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111436938|NCT03961100|Entrectinib|entrectinib|mesh-list
111436939|NCT03961100|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111436940|NCT03961100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111436941|NCT03961100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111436942|NCT03336853|Hybenx|hybenx|mesh-list
111436943|NCT03336853|Dental Disinfectants|dental disinfectants|mesh-ancestor
111436944|NCT03336853|Disinfectants|disinfectants|mesh-ancestor
111436945|NCT03336853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111436946|NCT03225313|Bupivacaine|bupivacaine|mesh-list
111436947|NCT03225313|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111436948|NCT03225313|Anesthetics, Local|anesthetics, local|mesh-ancestor
111436949|NCT03225313|Anesthetics|anesthetics|mesh-ancestor
111436950|NCT03225313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111436951|NCT03225313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111436952|NCT03225313|Sensory System Agents|sensory system agents|mesh-ancestor
111436953|NCT03225313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111436954|NCT03949244|Latanoprost|latanoprost|mesh-list
111436955|NCT03949244|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
111436956|NCT03949244|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111436957|NCT03948386|Bupivacaine|bupivacaine|mesh-list
111436958|NCT03948386|Mepivacaine|mepivacaine|mesh-list
111436959|NCT03948386|Anesthetics, Local|anesthetics, local|mesh-ancestor
111436960|NCT03948386|Anesthetics|anesthetics|mesh-ancestor
111436961|NCT03948386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111436962|NCT03948386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111436963|NCT03948386|Sensory System Agents|sensory system agents|mesh-ancestor
111436964|NCT03948386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111436965|NCT03445195|Imipenem|imipenem|mesh-list
111436966|NCT03445195|Sulbactam|sulbactam|mesh-list
111436967|NCT03445195|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
111436968|NCT03445195|Durlobactam|durlobactam|mesh-list
111436969|NCT03445195|Cilastatin|cilastatin|mesh-list
111436970|NCT03445195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111436971|NCT03445195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111436972|NCT03445195|Protease Inhibitors|protease inhibitors|mesh-ancestor
111436973|NCT03445195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111436974|NCT03445195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111436975|NCT03445195|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
111436976|NCT04277936|Levetiracetam|levetiracetam|mesh-list
111436977|NCT04277936|Anticonvulsants|anticonvulsants|mesh-ancestor
111436978|NCT04277936|Nootropic Agents|nootropic agents|mesh-ancestor
111436979|NCT03670160|Clonidine|clonidine|mesh-list
111436980|NCT03670160|Phenobarbital|phenobarbital|mesh-list
111436981|NCT03670160|Analgesics|analgesics|mesh-ancestor
111436982|NCT03670160|Sensory System Agents|sensory system agents|mesh-ancestor
111436983|NCT03670160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111436984|NCT03670160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111436985|NCT03670160|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111436986|NCT03670160|Sympatholytics|sympatholytics|mesh-ancestor
111436987|NCT03670160|Autonomic Agents|autonomic agents|mesh-ancestor
111436988|NCT03670160|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111436989|NCT03670160|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111436990|NCT03670160|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111436991|NCT03670160|Adrenergic Agents|adrenergic agents|mesh-ancestor
111436992|NCT03670160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111436993|NCT03670160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111436994|NCT03670160|Anticonvulsants|anticonvulsants|mesh-ancestor
111436995|NCT03670160|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111436996|NCT03670160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111436997|NCT03670160|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111436998|NCT03670160|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111437000|NCT03670160|GABA Agents|gaba agents|mesh-ancestor
111437001|NCT03670160|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111437002|NCT03670160|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111437003|NCT03670160|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111437004|NCT00375895|Cyclosporine|cyclosporine|mesh-list
111437005|NCT00375895|Cyclosporins|cyclosporins|mesh-list
111437006|NCT00375895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111437007|NCT00375895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111437008|NCT00375895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111437009|NCT00375895|Immunologic Factors|immunologic factors|mesh-ancestor
111437010|NCT00375895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111437011|NCT00375895|Antifungal Agents|antifungal agents|mesh-ancestor
111437012|NCT00375895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111437013|NCT00375895|Dermatologic Agents|dermatologic agents|mesh-ancestor
111437014|NCT00375895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111437015|NCT00375895|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111437016|NCT03338803|Linagliptin|linagliptin|mesh-list
111437017|NCT03338803|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111437018|NCT03338803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111437019|NCT03338803|Incretins|incretins|mesh-ancestor
111437020|NCT03338803|Hormones|hormones|mesh-ancestor
111437021|NCT03338803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111437022|NCT03338803|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111437023|NCT03338803|Protease Inhibitors|protease inhibitors|mesh-ancestor
111437024|NCT03338803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111437025|NCT03338803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111437026|NCT00377936|Gemcitabine|gemcitabine|mesh-list
111437027|NCT00377936|Paclitaxel|paclitaxel|mesh-list
111437028|NCT00377936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111437029|NCT00377936|Antimetabolites|antimetabolites|mesh-ancestor
111437030|NCT00377936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111437031|NCT00377936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111437032|NCT00377936|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111437033|NCT00377936|Tubulin Modulators|tubulin modulators|mesh-ancestor
111437034|NCT00377936|Antimitotic Agents|antimitotic agents|mesh-ancestor
111437035|NCT00377936|Mitosis Modulators|mitosis modulators|mesh-ancestor
111437036|NCT03696758|Metoprolol|metoprolol|mesh-list
111437037|NCT03696758|Sildenafil Citrate|sildenafil citrate|mesh-list
111437038|NCT03696758|Vasodilator Agents|vasodilator agents|mesh-ancestor
111437039|NCT03696758|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111437040|NCT03696758|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111437041|NCT03696758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111437042|NCT03696758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111437043|NCT03696758|Urological Agents|urological agents|mesh-ancestor
111437044|NCT03696758|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111437045|NCT03696758|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111437046|NCT03696758|Sympatholytics|sympatholytics|mesh-ancestor
111437047|NCT03696758|Autonomic Agents|autonomic agents|mesh-ancestor
111437048|NCT03696758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111437049|NCT03696758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111437050|NCT03696758|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
111437051|NCT03696758|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111437052|NCT03696758|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111437053|NCT03696758|Adrenergic Agents|adrenergic agents|mesh-ancestor
111437054|NCT03696758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111437055|NCT03233737|Anesthetics|anesthetics|mesh-list
111437056|NCT03233737|Tetracaine|tetracaine|mesh-list
111437057|NCT03233737|Benzocaine|benzocaine|mesh-list
111437058|NCT03233737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111437059|NCT03233737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111437060|NCT03233737|Anesthetics, Local|anesthetics, local|mesh-ancestor
111437061|NCT03233737|Sensory System Agents|sensory system agents|mesh-ancestor
111437062|NCT03233737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111437063|NCT03711578|Tenalisib|tenalisib|mesh-list
111437064|NCT03711578|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
111437065|NCT03711578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111437066|NCT03711578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111437067|NCT03463915|Triamcinolone|triamcinolone|mesh-list
111437068|NCT03463915|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
111437069|NCT03463915|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
111437070|NCT03463915|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
111437071|NCT03463915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111437072|NCT03463915|Glucocorticoids|glucocorticoids|mesh-ancestor
111437073|NCT03463915|Hormones|hormones|mesh-ancestor
111437074|NCT03463915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111437075|NCT03463915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111437076|NCT03463915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111437077|NCT03463915|Immunologic Factors|immunologic factors|mesh-ancestor
111437078|NCT03463915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111437079|NCT03463915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111437080|NCT03473665|Celecoxib|celecoxib|mesh-list
111437081|NCT03473665|Diclofenac|diclofenac|mesh-list
111437082|NCT03473665|Indomethacin|indomethacin|mesh-list
111437083|NCT03473665|Meloxicam|meloxicam|mesh-list
111437084|NCT03473665|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111437085|NCT03473665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111437086|NCT03473665|Analgesics|analgesics|mesh-ancestor
111437087|NCT03473665|Sensory System Agents|sensory system agents|mesh-ancestor
111437088|NCT03473665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111437089|NCT03473665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111437090|NCT03473665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111437091|NCT03473665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111437092|NCT03473665|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111437093|NCT03473665|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111437094|NCT03473665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111437095|NCT03473665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111437096|NCT03473665|Gout Suppressants|gout suppressants|mesh-ancestor
111437097|NCT03473665|Tocolytic Agents|tocolytic agents|mesh-ancestor
111437098|NCT03473665|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111437099|NCT03717506|Clindamycin|clindamycin|mesh-list
111437100|NCT03717506|Clindamycin palmitate|clindamycin palmitate|mesh-list
111437101|NCT03717506|Clindamycin phosphate|clindamycin phosphate|mesh-list
111437102|NCT03717506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111437103|NCT03717506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111437104|NCT03717506|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111437105|NCT03717506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111437106|NCT03717506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111437107|NCT03861338|Buprenorphine|buprenorphine|mesh-list
111437108|NCT03861338|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111437109|NCT03861338|Narcotics|narcotics|mesh-ancestor
111437110|NCT03861338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111437111|NCT03861338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111437112|NCT03861338|Analgesics|analgesics|mesh-ancestor
111437113|NCT03861338|Sensory System Agents|sensory system agents|mesh-ancestor
111437114|NCT03861338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111437115|NCT03861338|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111437116|NCT00377780|Docetaxel|docetaxel|mesh-list
111437117|NCT00377780|Doxorubicin|doxorubicin|mesh-list
111437118|NCT00377780|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111437119|NCT00377780|Trastuzumab|trastuzumab|mesh-list
111437120|NCT00377780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111437121|NCT00377780|Tubulin Modulators|tubulin modulators|mesh-ancestor
111437122|NCT00377780|Antimitotic Agents|antimitotic agents|mesh-ancestor
111437123|NCT00377780|Mitosis Modulators|mitosis modulators|mesh-ancestor
111437124|NCT00377780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111437125|NCT00377780|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111437126|NCT00377780|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111437127|NCT00377780|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111437128|NCT00377780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111437129|NCT00377780|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111437130|NCT00376519|Cyclosporine|cyclosporine|mesh-list
111437131|NCT00376519|Mycophenolic Acid|mycophenolic acid|mesh-list
111437132|NCT00376519|Cyclophosphamide|cyclophosphamide|mesh-list
111437133|NCT00376519|Fludarabine|fludarabine|mesh-list
111437134|NCT00376519|Fludarabine phosphate|fludarabine phosphate|mesh-list
111437135|NCT00376519|Cyclosporins|cyclosporins|mesh-list
111437136|NCT00376519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111437137|NCT00376519|Immunologic Factors|immunologic factors|mesh-ancestor
111437138|NCT00376519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111437139|NCT00376519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111437140|NCT00376519|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111437141|NCT00376519|Alkylating Agents|alkylating agents|mesh-ancestor
111437142|NCT00376519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111437143|NCT00376519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111437144|NCT00376519|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111161478|NCT04260347|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111437145|NCT00376519|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111437146|NCT00376519|Antimetabolites|antimetabolites|mesh-ancestor
111437147|NCT00376519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111437148|NCT00376519|Antifungal Agents|antifungal agents|mesh-ancestor
111437149|NCT00376519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111437150|NCT00376519|Dermatologic Agents|dermatologic agents|mesh-ancestor
111437151|NCT00376519|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111437152|NCT00376519|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111437153|NCT00376519|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111437154|NCT00376519|Antitubercular Agents|antitubercular agents|mesh-ancestor
111437155|NCT00376519|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111437156|NCT00422864|Leucovorin|leucovorin|mesh-list
111437157|NCT00422864|Fluorouracil|fluorouracil|mesh-list
111437158|NCT00422864|Oxaliplatin|oxaliplatin|mesh-list
111437159|NCT00422864|Antimetabolites|antimetabolites|mesh-ancestor
111437160|NCT00422864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111437161|NCT00422864|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111437162|NCT00422864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111437163|NCT00422864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111437164|NCT00422864|Immunologic Factors|immunologic factors|mesh-ancestor
111437165|NCT00422864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111437166|NCT00422864|Antidotes|antidotes|mesh-ancestor
111437167|NCT00422864|Protective Agents|protective agents|mesh-ancestor
111437168|NCT00422864|Vitamin B Complex|vitamin b complex|mesh-ancestor
111437169|NCT00422864|Vitamins|vitamins|mesh-ancestor
111437170|NCT00422864|Micronutrients|micronutrients|mesh-ancestor
111437171|NCT03373591|Bupivacaine|bupivacaine|mesh-list
111437172|NCT03373591|Anesthetics, Local|anesthetics, local|mesh-ancestor
111437173|NCT03373591|Anesthetics|anesthetics|mesh-ancestor
111437174|NCT03373591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111437175|NCT03373591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111437176|NCT03373591|Sensory System Agents|sensory system agents|mesh-ancestor
111437177|NCT03373591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111437178|NCT03378973|Dexmedetomidine|dexmedetomidine|mesh-list
111437179|NCT03378973|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111437180|NCT03378973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111437181|NCT03378973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111437182|NCT03378973|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111437183|NCT03378973|Analgesics|analgesics|mesh-ancestor
111437184|NCT03378973|Sensory System Agents|sensory system agents|mesh-ancestor
111437185|NCT03378973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111437186|NCT03378973|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111437187|NCT03378973|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111437188|NCT03378973|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111437189|NCT03378973|Adrenergic Agents|adrenergic agents|mesh-ancestor
111437190|NCT03378973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111437191|NCT03378973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111437192|NCT04121078|Rifampin|rifampin|mesh-list
111437193|NCT04121078|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111437194|NCT04121078|Antitubercular Agents|antitubercular agents|mesh-ancestor
111437195|NCT04121078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111437196|NCT04121078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111437197|NCT04121078|Leprostatic Agents|leprostatic agents|mesh-ancestor
111437198|NCT04121078|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111437199|NCT04121078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111437200|NCT04121078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111437201|NCT04121078|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111437202|NCT04121078|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111437203|NCT04121078|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
111437204|NCT04121078|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
111437205|NCT04121078|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
111437206|NCT04121078|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111437207|NCT03248947|Buprenorphine|buprenorphine|mesh-list
111437208|NCT03248947|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
111437209|NCT03248947|Naloxone|naloxone|mesh-list
111437210|NCT03248947|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111437211|NCT03248947|Narcotics|narcotics|mesh-ancestor
111437212|NCT03248947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111437213|NCT03248947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111437214|NCT03248947|Analgesics|analgesics|mesh-ancestor
111437215|NCT03248947|Sensory System Agents|sensory system agents|mesh-ancestor
111437216|NCT03248947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111437217|NCT03248947|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111437218|NCT04114058|Bupivacaine|bupivacaine|mesh-list
111437219|NCT04114058|Anesthetics, Local|anesthetics, local|mesh-ancestor
111437220|NCT04114058|Anesthetics|anesthetics|mesh-ancestor
111437221|NCT04114058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111437222|NCT04114058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111437223|NCT04114058|Sensory System Agents|sensory system agents|mesh-ancestor
111437224|NCT04114058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111437225|NCT03862040|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111437226|NCT03862040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111437227|NCT00376831|Fentanyl|fentanyl|mesh-list
111437228|NCT00376831|Midazolam|midazolam|mesh-list
111437229|NCT00376831|Ketamine|ketamine|mesh-list
111437230|NCT00376831|Analgesics|analgesics|mesh-ancestor
111437231|NCT00376831|Sensory System Agents|sensory system agents|mesh-ancestor
111437232|NCT00376831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111437233|NCT00376831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111437234|NCT00376831|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111437235|NCT00376831|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111437236|NCT00376831|Anesthetics, General|anesthetics, general|mesh-ancestor
111437237|NCT00376831|Anesthetics|anesthetics|mesh-ancestor
111437238|NCT00376831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111437239|NCT00376831|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111437240|NCT00376831|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111437241|NCT00376831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111437242|NCT00376831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111437243|NCT00376831|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111437244|NCT00376831|Narcotics|narcotics|mesh-ancestor
111437245|NCT00376831|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111437246|NCT00376831|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111437247|NCT00376831|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111437248|NCT00376831|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111437249|NCT00376831|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111437250|NCT00376831|GABA Modulators|gaba modulators|mesh-ancestor
111437251|NCT00376831|GABA Agents|gaba agents|mesh-ancestor
111437252|NCT03857750|Rocuronium|rocuronium|mesh-list
111437253|NCT03857750|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
111437254|NCT03857750|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
111437255|NCT03857750|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111437256|NCT03857750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111437257|NCT03857750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111437258|NCT03828422|Calcium|calcium|mesh-list
111437259|NCT03828422|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111437260|NCT03828422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111437261|NCT03852524|Methylnaltrexone|methylnaltrexone|mesh-list
111437262|NCT03852524|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111437263|NCT03852524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111437264|NCT03852524|Sensory System Agents|sensory system agents|mesh-ancestor
111437265|NCT03852524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111437266|NCT04081610|Hyaluronic Acid|hyaluronic acid|mesh-list
111437267|NCT04081610|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111437268|NCT04081610|Immunologic Factors|immunologic factors|mesh-ancestor
111437269|NCT04081610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111437270|NCT04081610|Viscosupplements|viscosupplements|mesh-ancestor
111437271|NCT04081610|Protective Agents|protective agents|mesh-ancestor
111437272|NCT03840278|Pancrelipase|pancrelipase|mesh-list
111437273|NCT03840278|Pancreatin|pancreatin|mesh-list
111437274|NCT03840278|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111437275|NCT03838874|Bupivacaine|bupivacaine|mesh-list
111437276|NCT03838874|Mepivacaine|mepivacaine|mesh-list
111437277|NCT03838874|Anesthetics, Local|anesthetics, local|mesh-ancestor
111437278|NCT03838874|Anesthetics|anesthetics|mesh-ancestor
111437279|NCT03838874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111437280|NCT03838874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111437281|NCT03838874|Sensory System Agents|sensory system agents|mesh-ancestor
111437282|NCT03838874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111437283|NCT04045964|Nicotine|nicotine|mesh-list
111437284|NCT04045964|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111437285|NCT04045964|Autonomic Agents|autonomic agents|mesh-ancestor
111437286|NCT04045964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111437287|NCT04045964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111437288|NCT04045964|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111437289|NCT04045964|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111437290|NCT04045964|Cholinergic Agents|cholinergic agents|mesh-ancestor
111437291|NCT04045964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111437292|NCT04045964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111437293|NCT05314400|Liver Extracts|liver extracts|mesh-list
111437294|NCT05314400|Hematinics|hematinics|mesh-ancestor
111437295|NCT04039412|Levofloxacin|levofloxacin|mesh-list
111437296|NCT04039412|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111437297|NCT04039412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111437298|NCT04039412|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111437299|NCT04039412|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111437300|NCT04039412|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111437301|NCT04039412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111437302|NCT04039412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111437303|NCT04039412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111437304|NCT04039412|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111437305|NCT04039412|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111437306|NCT03831854|Lamotrigine|lamotrigine|mesh-list
111437307|NCT03831854|Ketamine|ketamine|mesh-list
111437308|NCT03831854|Analgesics|analgesics|mesh-ancestor
111437309|NCT03831854|Sensory System Agents|sensory system agents|mesh-ancestor
111437310|NCT03831854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111437311|NCT03831854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111437312|NCT03831854|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111437313|NCT03831854|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111437314|NCT03831854|Anesthetics, General|anesthetics, general|mesh-ancestor
111437315|NCT03831854|Anesthetics|anesthetics|mesh-ancestor
111437316|NCT03831854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111437317|NCT03831854|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111437318|NCT03831854|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111437319|NCT03831854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111437320|NCT03831854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111437321|NCT03831854|Anticonvulsants|anticonvulsants|mesh-ancestor
111437322|NCT03831854|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111437323|NCT03831854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111437324|NCT03831854|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111437325|NCT03831854|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111437326|NCT03831854|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111437327|NCT03831854|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111437328|NCT03831854|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111437329|NCT03806270|Midazolam|midazolam|mesh-list
111437330|NCT03806270|Hydroxyzine|hydroxyzine|mesh-list
111437331|NCT03806270|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111437332|NCT03806270|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111437333|NCT03806270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111437334|NCT03806270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111437335|NCT03806270|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111437336|NCT03806270|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111437337|NCT03806270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111437338|NCT03806270|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111437339|NCT03806270|Anesthetics, General|anesthetics, general|mesh-ancestor
111437340|NCT03806270|Anesthetics|anesthetics|mesh-ancestor
111437341|NCT03806270|GABA Modulators|gaba modulators|mesh-ancestor
111437342|NCT03806270|GABA Agents|gaba agents|mesh-ancestor
111437343|NCT03806270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111437344|NCT03806270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111437345|NCT03806270|Antipruritics|antipruritics|mesh-ancestor
111437346|NCT03806270|Dermatologic Agents|dermatologic agents|mesh-ancestor
111437347|NCT03806270|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111437348|NCT03806270|Histamine Antagonists|histamine antagonists|mesh-ancestor
111437349|NCT03806270|Histamine Agents|histamine agents|mesh-ancestor
111437350|NCT03497845|Vaccines|vaccines|mesh-list
111437351|NCT03497845|Immunologic Factors|immunologic factors|mesh-ancestor
111437352|NCT03497845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111437353|NCT04036292|Varenicline|varenicline|mesh-list
111437354|NCT04036292|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111437355|NCT04036292|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111437356|NCT04036292|Cholinergic Agents|cholinergic agents|mesh-ancestor
111437357|NCT04036292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111437358|NCT04036292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111437359|NCT04036292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111437360|NCT03501043|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111437361|NCT03501043|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111437362|NCT03501043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111437363|NCT03501043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111437364|NCT03501043|Cholinergic Agents|cholinergic agents|mesh-ancestor
111437365|NCT03501043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111437366|NCT03501043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111437367|NCT00377390|Omalizumab|omalizumab|mesh-list
111437368|NCT00377390|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111437369|NCT00377390|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111437370|NCT00377390|Respiratory System Agents|respiratory system agents|mesh-ancestor
111437371|NCT03820388|Propofol|propofol|mesh-list
111437373|NCT03820388|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111437374|NCT03820388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111437375|NCT03820388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111437376|NCT03820388|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111437377|NCT03820388|Anesthetics, General|anesthetics, general|mesh-ancestor
111437378|NCT03820388|Anesthetics|anesthetics|mesh-ancestor
111437379|NCT03264157|Vaccines|vaccines|mesh-list
111437380|NCT03264157|Immunologic Factors|immunologic factors|mesh-ancestor
111437381|NCT03264157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111437382|NCT04029584|Rifampin|rifampin|mesh-list
111437383|NCT04029584|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111437384|NCT04029584|Antitubercular Agents|antitubercular agents|mesh-ancestor
111437385|NCT04029584|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111437386|NCT04029584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111437387|NCT04029584|Leprostatic Agents|leprostatic agents|mesh-ancestor
111437388|NCT04029584|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111437389|NCT04029584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111437390|NCT04029584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111437391|NCT04029584|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111437392|NCT04029584|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111437393|NCT04029584|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
111437394|NCT04029584|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
111437395|NCT04029584|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
111437396|NCT04029584|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111437397|NCT04028960|Insulin|insulin|mesh-list
111437398|NCT04028960|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111437399|NCT04028960|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111437400|NCT04028960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111437401|NCT03502915|Nitrous Oxide|nitrous oxide|mesh-list
111437402|NCT03502915|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111437403|NCT03502915|Anesthetics, General|anesthetics, general|mesh-ancestor
111437404|NCT03502915|Anesthetics|anesthetics|mesh-ancestor
111437405|NCT03502915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111437406|NCT03502915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111437407|NCT03502915|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111437408|NCT03502915|Analgesics|analgesics|mesh-ancestor
111437409|NCT03502915|Sensory System Agents|sensory system agents|mesh-ancestor
111437410|NCT03502915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111437411|NCT03506347|Vancomycin|vancomycin|mesh-list
111437412|NCT03506347|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111437413|NCT03506347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111437414|NCT03266419|Rocuronium|rocuronium|mesh-list
111437415|NCT03266419|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
111437416|NCT03266419|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
111437417|NCT03266419|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111437418|NCT03266419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111437419|NCT03266419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111437420|NCT00377468|Dronabinol|dronabinol|mesh-list
111437421|NCT00377468|Hallucinogens|hallucinogens|mesh-ancestor
111437422|NCT00377468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111437423|NCT00377468|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111437424|NCT00377468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111437425|NCT00377468|Analgesics|analgesics|mesh-ancestor
111437426|NCT00377468|Sensory System Agents|sensory system agents|mesh-ancestor
111437427|NCT00377468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111437428|NCT00377468|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
111437429|NCT00377468|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
111437430|NCT00377468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111437431|NCT00377468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111437432|NCT00377468|Hormones|hormones|mesh-ancestor
111437433|NCT00377468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111437434|NCT03799484|Lidocaine|lidocaine|mesh-list
111437435|NCT03799484|Prilocaine|prilocaine|mesh-list
111437436|NCT03799484|Petrolatum|petrolatum|mesh-list
111437437|NCT03799484|Botulinum Toxins|botulinum toxins|mesh-list
111437438|NCT03799484|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111437439|NCT03799484|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111437440|NCT03799484|Anesthetics, Local|anesthetics, local|mesh-ancestor
111437441|NCT03799484|Anesthetics|anesthetics|mesh-ancestor
110513607|NCT00923169|Mitogens|mitogens|mesh-list
111437442|NCT03799484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111437443|NCT03799484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111437444|NCT03799484|Sensory System Agents|sensory system agents|mesh-ancestor
111437445|NCT03799484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111161784|NCT03774875|Analgesics|analgesics|mesh-ancestor
111437446|NCT03799484|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111437447|NCT03799484|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111437448|NCT03799484|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111437449|NCT03799484|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111437450|NCT03799484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111437451|NCT03799484|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111437452|NCT03799484|Cholinergic Agents|cholinergic agents|mesh-ancestor
111437453|NCT03799484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111437454|NCT03799484|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111437455|NCT03799484|Emollients|emollients|mesh-ancestor
111437456|NCT03799484|Dermatologic Agents|dermatologic agents|mesh-ancestor
111437457|NCT00377546|Ketorolac|ketorolac|mesh-list
111437458|NCT00377546|Nepafenac|nepafenac|mesh-list
111437459|NCT00377546|Bromfenac|bromfenac|mesh-list
111437460|NCT00377546|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111437461|NCT00377546|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111437462|NCT00377546|Analgesics|analgesics|mesh-ancestor
111437463|NCT00377546|Sensory System Agents|sensory system agents|mesh-ancestor
111437464|NCT00377546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111437465|NCT00377546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111437466|NCT00377546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111437467|NCT00377546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111437468|NCT00377546|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111437469|NCT00377546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111437470|NCT00377546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111437471|NCT04290494|Plasminogen|plasminogen|mesh-list
111437472|NCT04290494|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111437473|NCT04290494|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111437474|NCT04290494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111437475|NCT04005404|Ropivacaine|ropivacaine|mesh-list
111437476|NCT04005404|Anesthetics, Local|anesthetics, local|mesh-ancestor
111437477|NCT04005404|Anesthetics|anesthetics|mesh-ancestor
111437478|NCT04005404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111437479|NCT04005404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111437480|NCT04005404|Sensory System Agents|sensory system agents|mesh-ancestor
111437481|NCT04005404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111437482|NCT03232892|Trametinib|trametinib|mesh-list
111437483|NCT03232892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111437484|NCT03232892|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111437485|NCT03232892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110513749|NCT04114149|Narcotics|narcotics|mesh-ancestor
111437486|NCT03232892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111437487|NCT03510481|Lumefantrine|lumefantrine|mesh-list
111437488|NCT03510481|Artemether|artemether|mesh-list
111437489|NCT03510481|Antimalarials|antimalarials|mesh-ancestor
111437490|NCT03510481|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111437491|NCT03510481|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111437492|NCT03510481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111437493|NCT03109418|Ketamine|ketamine|mesh-list
111437494|NCT03109418|Analgesics|analgesics|mesh-ancestor
111437495|NCT03109418|Sensory System Agents|sensory system agents|mesh-ancestor
111437496|NCT03109418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111437497|NCT03109418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111437498|NCT03109418|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111437499|NCT03109418|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111437500|NCT03109418|Anesthetics, General|anesthetics, general|mesh-ancestor
111437501|NCT03109418|Anesthetics|anesthetics|mesh-ancestor
111437502|NCT03109418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111437503|NCT03109418|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111437504|NCT03109418|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111437505|NCT03109418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111437506|NCT03109418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111437507|NCT03404167|Zoliflodacin|zoliflodacin|mesh-list
111437508|NCT03404167|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111437509|NCT03404167|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111437510|NCT03404167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111437511|NCT03404167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111437512|NCT03404167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111437513|NCT03771560|Leucovorin|leucovorin|mesh-list
111437514|NCT03771560|Folic Acid|folic acid|mesh-list
111437515|NCT03771560|Levoleucovorin|levoleucovorin|mesh-list
111437516|NCT03771560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111437517|NCT03771560|Antidotes|antidotes|mesh-ancestor
111437518|NCT03771560|Protective Agents|protective agents|mesh-ancestor
111437519|NCT03771560|Vitamin B Complex|vitamin b complex|mesh-ancestor
111437520|NCT03771560|Vitamins|vitamins|mesh-ancestor
111161866|NCT04813991|Narcotics|narcotics|mesh-ancestor
111437521|NCT03771560|Micronutrients|micronutrients|mesh-ancestor
111437522|NCT03771560|Hematinics|hematinics|mesh-ancestor
111437523|NCT03767738|Aflibercept|aflibercept|mesh-list
111437524|NCT03767738|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111437525|NCT03767738|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111437526|NCT03767738|Growth Substances|growth substances|mesh-ancestor
111437527|NCT03767738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111437528|NCT03767738|Growth Inhibitors|growth inhibitors|mesh-ancestor
110513879|NCT02758470|Diuretics|diuretics|mesh-ancestor
111437529|NCT03767738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111437530|NCT02973620|Simendan|simendan|mesh-list
111437531|NCT02973620|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111437532|NCT02973620|Vasodilator Agents|vasodilator agents|mesh-ancestor
111437533|NCT02973620|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
111437534|NCT02973620|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111437535|NCT02973620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111437536|NCT02973620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111437537|NCT02973620|Protective Agents|protective agents|mesh-ancestor
111437538|NCT02973620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111437539|NCT05313386|Dexmedetomidine|dexmedetomidine|mesh-list
111437540|NCT05313386|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111437541|NCT05313386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111437542|NCT05313386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111437543|NCT05313386|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111437544|NCT05313386|Analgesics|analgesics|mesh-ancestor
110513950|NCT04612530|Nivolumab|nivolumab|mesh-list
111437545|NCT05313386|Sensory System Agents|sensory system agents|mesh-ancestor
111437546|NCT05313386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111437547|NCT05313386|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111437548|NCT05313386|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111437549|NCT05313386|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111437550|NCT05313386|Adrenergic Agents|adrenergic agents|mesh-ancestor
111437551|NCT05313386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111437552|NCT05313386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111437553|NCT04018664|Nalbuphine|nalbuphine|mesh-list
111437554|NCT04018664|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111437555|NCT04018664|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111437556|NCT04018664|Narcotics|narcotics|mesh-ancestor
111437557|NCT04018664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111437558|NCT04018664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111437559|NCT04018664|Analgesics|analgesics|mesh-ancestor
111437560|NCT04018664|Sensory System Agents|sensory system agents|mesh-ancestor
111437561|NCT04018664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111437562|NCT03031340|Pregabalin|pregabalin|mesh-list
111437563|NCT03031340|Analgesics|analgesics|mesh-ancestor
111437564|NCT03031340|Sensory System Agents|sensory system agents|mesh-ancestor
111437565|NCT03031340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111437566|NCT03031340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111437567|NCT03031340|Anticonvulsants|anticonvulsants|mesh-ancestor
111437568|NCT03031340|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111437569|NCT03031340|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111437570|NCT03031340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111437571|NCT03031340|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111437572|NCT03031340|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111437573|NCT03031340|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111437574|NCT03031340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111437575|NCT03031340|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111437576|NCT03405259|Fluorides|fluorides|mesh-list
111437577|NCT03405259|Fluorides, Topical|fluorides, topical|mesh-list
111437578|NCT03405259|Cariostatic Agents|cariostatic agents|mesh-ancestor
111437579|NCT03405259|Protective Agents|protective agents|mesh-ancestor
111437580|NCT03405259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111437581|NCT03513757|Lidocaine|lidocaine|mesh-list
111437582|NCT03513757|Glycopyrrolate|glycopyrrolate|mesh-list
111437583|NCT03513757|Dexmedetomidine|dexmedetomidine|mesh-list
111437584|NCT03513757|Nitrous Oxide|nitrous oxide|mesh-list
111437585|NCT03513757|Propofol|propofol|mesh-list
111437586|NCT03513757|Sevoflurane|sevoflurane|mesh-list
111437587|NCT03513757|Anesthetics, Local|anesthetics, local|mesh-ancestor
111437588|NCT03513757|Anesthetics|anesthetics|mesh-ancestor
111437589|NCT03513757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111437590|NCT03513757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111437591|NCT03513757|Sensory System Agents|sensory system agents|mesh-ancestor
111437592|NCT03513757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111437593|NCT03513757|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111161954|NCT03027934|Ticagrelor|ticagrelor|mesh-list
111437594|NCT03513757|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111437595|NCT03513757|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111437596|NCT03513757|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111437597|NCT03513757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111437598|NCT03513757|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111437599|NCT03513757|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111437600|NCT03513757|Analgesics|analgesics|mesh-ancestor
111437601|NCT03513757|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111437602|NCT03513757|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111437603|NCT03513757|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111437604|NCT03513757|Adrenergic Agents|adrenergic agents|mesh-ancestor
111437605|NCT03513757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111437606|NCT03513757|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111437607|NCT03513757|Anesthetics, General|anesthetics, general|mesh-ancestor
111437608|NCT03513757|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111437609|NCT03513757|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111437610|NCT03513757|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111437611|NCT03513757|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111437612|NCT03513757|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111437613|NCT03513757|Cholinergic Agents|cholinergic agents|mesh-ancestor
111437614|NCT03760640|Insulin Lispro|insulin lispro|mesh-list
111437615|NCT03760640|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111437616|NCT03760640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111437617|NCT03275623|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111437618|NCT03275623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111437619|NCT03756038|Lorazepam|lorazepam|mesh-list
111437620|NCT03756038|Anticonvulsants|anticonvulsants|mesh-ancestor
111437621|NCT03756038|Antiemetics|antiemetics|mesh-ancestor
111437622|NCT03756038|Autonomic Agents|autonomic agents|mesh-ancestor
111437623|NCT03756038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111437624|NCT03756038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111437625|NCT03756038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111437626|NCT03756038|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111437627|NCT03756038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111437628|NCT03756038|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111437629|NCT03756038|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111437630|NCT03756038|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111437631|NCT03756038|GABA Modulators|gaba modulators|mesh-ancestor
111437632|NCT03756038|GABA Agents|gaba agents|mesh-ancestor
111437633|NCT03756038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111437634|NCT03756038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111437635|NCT03754556|Levonorgestrel|levonorgestrel|mesh-list
111437636|NCT03754556|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111437637|NCT03754556|Contraceptive Agents|contraceptive agents|mesh-ancestor
111437638|NCT03754556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111437639|NCT03754556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111437640|NCT03754556|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111437641|NCT03754556|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111437642|NCT03754556|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111437643|NCT03521479|Squaric acid dibutyl ester|squaric acid dibutyl ester|mesh-list
111437644|NCT03521479|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111437645|NCT03521479|Immunologic Factors|immunologic factors|mesh-ancestor
111437646|NCT03521479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111437647|NCT01495988|Bevacizumab|bevacizumab|mesh-list
111437648|NCT01495988|Vemurafenib|vemurafenib|mesh-list
111437649|NCT01495988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111437650|NCT01495988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111437651|NCT01495988|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111437652|NCT01495988|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111437653|NCT01495988|Growth Substances|growth substances|mesh-ancestor
111437654|NCT01495988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111437655|NCT01495988|Growth Inhibitors|growth inhibitors|mesh-ancestor
111437656|NCT01495988|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111437657|NCT01495988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111437658|NCT01495988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111437659|NCT02934932|Brexpiprazole|brexpiprazole|mesh-list
111437660|NCT02934932|Serotonin Agents|serotonin agents|mesh-ancestor
111437661|NCT02934932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111437662|NCT02934932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111437663|NCT02934932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111437664|NCT02934932|Dopamine Agonists|dopamine agonists|mesh-ancestor
111437665|NCT02934932|Dopamine Agents|dopamine agents|mesh-ancestor
111437666|NCT03415243|Acetaminophen|acetaminophen|mesh-list
111437667|NCT03415243|Phenylephrine|phenylephrine|mesh-list
111437668|NCT03415243|Oxymetazoline|oxymetazoline|mesh-list
111437669|NCT03415243|Dextromethorphan|dextromethorphan|mesh-list
111437670|NCT03415243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111437671|NCT03415243|Analgesics|analgesics|mesh-ancestor
111437672|NCT03415243|Sensory System Agents|sensory system agents|mesh-ancestor
111437673|NCT03415243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111437674|NCT03415243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111437675|NCT03415243|Antipyretics|antipyretics|mesh-ancestor
111437676|NCT03415243|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111437677|NCT03415243|Mydriatics|mydriatics|mesh-ancestor
111437678|NCT03415243|Autonomic Agents|autonomic agents|mesh-ancestor
111437679|NCT03415243|Sympathomimetics|sympathomimetics|mesh-ancestor
111437680|NCT03415243|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111437681|NCT03415243|Nasal Decongestants|nasal decongestants|mesh-ancestor
111437682|NCT03415243|Respiratory System Agents|respiratory system agents|mesh-ancestor
111437683|NCT03415243|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111437684|NCT03415243|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111437685|NCT03415243|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111437686|NCT03415243|Adrenergic Agents|adrenergic agents|mesh-ancestor
111437687|NCT03415243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111437688|NCT03415243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111437689|NCT03415243|Protective Agents|protective agents|mesh-ancestor
111437690|NCT03415243|Antitussive Agents|antitussive agents|mesh-ancestor
111437691|NCT03415243|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111437692|NCT03415243|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111437693|NCT02892500|Betamethasone|betamethasone|mesh-list
111437694|NCT02892500|Betamethasone Valerate|betamethasone valerate|mesh-list
111437695|NCT02892500|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
111437696|NCT02892500|Betamethasone benzoate|betamethasone benzoate|mesh-list
111437697|NCT02892500|Bupivacaine|bupivacaine|mesh-list
111437698|NCT02892500|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
111437699|NCT02892500|Anesthetics, Local|anesthetics, local|mesh-ancestor
111437700|NCT02892500|Anesthetics|anesthetics|mesh-ancestor
111437701|NCT02892500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111437702|NCT02892500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111437703|NCT02892500|Sensory System Agents|sensory system agents|mesh-ancestor
111437704|NCT02892500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111437705|NCT02892500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111437706|NCT02892500|Glucocorticoids|glucocorticoids|mesh-ancestor
111437707|NCT02892500|Hormones|hormones|mesh-ancestor
111437708|NCT02892500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111437709|NCT02892500|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111437710|NCT02892500|Respiratory System Agents|respiratory system agents|mesh-ancestor
111437711|NCT00378872|Tranexamic Acid|tranexamic acid|mesh-list
111437712|NCT00378872|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111437713|NCT00378872|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111437714|NCT00378872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111437715|NCT00378872|Hemostatics|hemostatics|mesh-ancestor
111437716|NCT00378872|Coagulants|coagulants|mesh-ancestor
111437717|NCT00378404|Docetaxel|docetaxel|mesh-list
111437718|NCT00378404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111437719|NCT00378404|Tubulin Modulators|tubulin modulators|mesh-ancestor
111437720|NCT00378404|Antimitotic Agents|antimitotic agents|mesh-ancestor
111437721|NCT00378404|Mitosis Modulators|mitosis modulators|mesh-ancestor
111437722|NCT00378404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111437723|NCT03742154|Varenicline|varenicline|mesh-list
111437724|NCT03742154|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111437725|NCT03742154|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111437726|NCT03742154|Cholinergic Agents|cholinergic agents|mesh-ancestor
111437727|NCT03742154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111437728|NCT03742154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111437729|NCT03742154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111437730|NCT02734940|Lidocaine|lidocaine|mesh-list
111437731|NCT02734940|Fentanyl|fentanyl|mesh-list
111437732|NCT02734940|Ketamine|ketamine|mesh-list
111437733|NCT02734940|Dexmedetomidine|dexmedetomidine|mesh-list
111437734|NCT02734940|Morphine|morphine|mesh-list
111437735|NCT02734940|Anesthetics, Local|anesthetics, local|mesh-ancestor
111437736|NCT02734940|Anesthetics|anesthetics|mesh-ancestor
111437737|NCT02734940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111437738|NCT02734940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111437739|NCT02734940|Sensory System Agents|sensory system agents|mesh-ancestor
111437740|NCT02734940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111437741|NCT02734940|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111437742|NCT02734940|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111437743|NCT02734940|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111162080|NCT04443569|Lidocaine|lidocaine|mesh-list
111437744|NCT02734940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111437745|NCT02734940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111437746|NCT02734940|Analgesics|analgesics|mesh-ancestor
111437747|NCT02734940|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111437748|NCT02734940|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111437749|NCT02734940|Anesthetics, General|anesthetics, general|mesh-ancestor
111437750|NCT02734940|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111437751|NCT02734940|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111437752|NCT02734940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111437753|NCT02734940|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111437754|NCT02734940|Narcotics|narcotics|mesh-ancestor
111437755|NCT02734940|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111437756|NCT02734940|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111437757|NCT02734940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111437758|NCT02734940|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111437759|NCT02734940|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111437760|NCT02734940|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111437761|NCT02734940|Adrenergic Agents|adrenergic agents|mesh-ancestor
111437762|NCT00378092|Risperidone|risperidone|mesh-list
111437763|NCT00378092|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111437764|NCT00378092|Serotonin Agents|serotonin agents|mesh-ancestor
111437765|NCT00378092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111437766|NCT00378092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111437767|NCT00378092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111437768|NCT00378092|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111437769|NCT00378092|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111437770|NCT00378092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111437771|NCT00378092|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111437772|NCT00378092|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111437773|NCT00378092|Dopamine Agents|dopamine agents|mesh-ancestor
111437774|NCT01347632|Metronidazole|metronidazole|mesh-list
111437775|NCT01347632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111437776|NCT01347632|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111437777|NCT01347632|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111437778|NCT01347632|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111437779|NCT02679560|Bupivacaine|bupivacaine|mesh-list
111437780|NCT02679560|Ropivacaine|ropivacaine|mesh-list
111437781|NCT02679560|Anesthetics, Local|anesthetics, local|mesh-ancestor
111437782|NCT02679560|Anesthetics|anesthetics|mesh-ancestor
111437783|NCT02679560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111437784|NCT02679560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111437785|NCT02679560|Sensory System Agents|sensory system agents|mesh-ancestor
111437786|NCT02679560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111437787|NCT03723980|Propolis|propolis|mesh-list
111437788|NCT03723980|Calcium|calcium|mesh-list
111437789|NCT03723980|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111437790|NCT03723980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111437791|NCT03723980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111437792|NCT01240304|Gemcitabine|gemcitabine|mesh-list
111437793|NCT01240304|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111437794|NCT01240304|Antimetabolites|antimetabolites|mesh-ancestor
111437795|NCT01240304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111437796|NCT01240304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111437797|NCT02614586|Ondansetron|ondansetron|mesh-list
111437798|NCT02614586|Antiemetics|antiemetics|mesh-ancestor
111437799|NCT02614586|Autonomic Agents|autonomic agents|mesh-ancestor
111437800|NCT02614586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111437801|NCT02614586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111437802|NCT02614586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111437803|NCT02614586|Antipruritics|antipruritics|mesh-ancestor
111437804|NCT02614586|Dermatologic Agents|dermatologic agents|mesh-ancestor
111437805|NCT02614586|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111437806|NCT02614586|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111437807|NCT02614586|Serotonin Agents|serotonin agents|mesh-ancestor
111437808|NCT02614586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111437809|NCT02614586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111437810|NCT01211756|Oxytocin|oxytocin|mesh-list
111437811|NCT01211756|Oxytocics|oxytocics|mesh-ancestor
111437812|NCT01211756|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111437813|NCT01211756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111437814|NCT03591458|Amitriptyline|amitriptyline|mesh-list
111437815|NCT03591458|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
111437816|NCT03591458|Antidepressive Agents|antidepressive agents|mesh-ancestor
111437817|NCT03591458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111437818|NCT03591458|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111437819|NCT03591458|Analgesics|analgesics|mesh-ancestor
111437820|NCT03591458|Sensory System Agents|sensory system agents|mesh-ancestor
111437821|NCT03591458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111437822|NCT03591458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111437823|NCT03591458|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111437824|NCT03591458|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111437825|NCT03591458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111437826|NCT03591458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111437827|NCT03591458|Adrenergic Agents|adrenergic agents|mesh-ancestor
111437828|NCT03591458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111437830|NCT03565328|Niacin|niacin|mesh-list
111437831|NCT03565328|Nicotinic Acids|nicotinic acids|mesh-list
111437832|NCT03565328|Vitamin B Complex|vitamin b complex|mesh-ancestor
111437833|NCT03565328|Vitamins|vitamins|mesh-ancestor
111437834|NCT03565328|Micronutrients|micronutrients|mesh-ancestor
111437835|NCT03565328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111437836|NCT03565328|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111437837|NCT03565328|Antimetabolites|antimetabolites|mesh-ancestor
111437838|NCT03565328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111437839|NCT03565328|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111437840|NCT03565328|Vasodilator Agents|vasodilator agents|mesh-ancestor
111437841|NCT01206296|Gemcitabine|gemcitabine|mesh-list
111437842|NCT01206296|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111437843|NCT01206296|Antimetabolites|antimetabolites|mesh-ancestor
111437844|NCT01206296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111437845|NCT01206296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111437846|NCT02593682|Suvorexant|suvorexant|mesh-list
111437847|NCT02593682|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111437848|NCT02593682|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111437849|NCT02593682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111437850|NCT02593682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111437851|NCT02593682|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
111437852|NCT02593682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111437853|NCT02593682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111437854|NCT01200602|Megestrol|megestrol|mesh-list
111437855|NCT01200602|Megestrol Acetate|megestrol acetate|mesh-list
111437856|NCT01200602|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111437857|NCT01200602|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111437858|NCT01200602|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111437859|NCT01200602|Contraceptive Agents|contraceptive agents|mesh-ancestor
111437860|NCT01200602|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111437861|NCT01200602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111437862|NCT01200602|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111437863|NCT01200602|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111437864|NCT01200602|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111437865|NCT01200602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111437866|NCT01200602|Appetite Stimulants|appetite stimulants|mesh-ancestor
111437867|NCT01200602|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111437868|NCT01194908|Tamoxifen|tamoxifen|mesh-list
111437869|NCT01194908|Decitabine|decitabine|mesh-list
111437870|NCT01194908|Panobinostat|panobinostat|mesh-list
111437871|NCT01194908|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111437872|NCT01194908|Antimetabolites|antimetabolites|mesh-ancestor
111437873|NCT01194908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111437874|NCT01194908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111437875|NCT01194908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111437876|NCT01194908|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111437877|NCT01194908|Hormone Antagonists|hormone antagonists|mesh-ancestor
111437878|NCT01194908|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111437879|NCT01194908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111437880|NCT01194908|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111437881|NCT01194908|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111437882|NCT01194908|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111437883|NCT01194908|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111437884|NCT01194908|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111437885|NCT01163084|Leuprolide|leuprolide|mesh-list
111437886|NCT01163084|Goserelin|goserelin|mesh-list
111437887|NCT01163084|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111437888|NCT01163084|Fertility Agents|fertility agents|mesh-ancestor
111437889|NCT01163084|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111437890|NCT01163084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111437891|NCT01163084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111437892|NCT01163084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111437893|NCT01155518|Clomiphene|clomiphene|mesh-list
111437894|NCT01155518|Testosterone|testosterone|mesh-list
111437895|NCT01155518|Androgens|androgens|mesh-ancestor
111437896|NCT01155518|Hormones|hormones|mesh-ancestor
111437897|NCT01155518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111437898|NCT01155518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111437899|NCT01155518|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111437900|NCT01155518|Hormone Antagonists|hormone antagonists|mesh-ancestor
111437901|NCT01155518|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111437903|NCT01155518|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111437904|NCT01155518|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111437905|NCT01155518|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111437906|NCT03490916|Acetazolamide|acetazolamide|mesh-list
111437907|NCT03490916|Anticonvulsants|anticonvulsants|mesh-ancestor
111437908|NCT03490916|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
111437909|NCT03490916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111437910|NCT03490916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111437911|NCT03490916|Diuretics|diuretics|mesh-ancestor
111437912|NCT03490916|Natriuretic Agents|natriuretic agents|mesh-ancestor
111437913|NCT03490916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111437914|NCT03333746|Nivolumab|nivolumab|mesh-list
111437915|NCT03333746|Lenalidomide|lenalidomide|mesh-list
111437916|NCT03333746|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111437917|NCT03333746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111437918|NCT03333746|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111437919|NCT03333746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111437920|NCT03333746|Immunologic Factors|immunologic factors|mesh-ancestor
111437921|NCT03333746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111437922|NCT03333746|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111437923|NCT03333746|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111437924|NCT03333746|Growth Substances|growth substances|mesh-ancestor
111437925|NCT03333746|Growth Inhibitors|growth inhibitors|mesh-ancestor
111437926|NCT01139996|Clonidine|clonidine|mesh-list
111437927|NCT01139996|Analgesics|analgesics|mesh-ancestor
111437928|NCT01139996|Sensory System Agents|sensory system agents|mesh-ancestor
111437929|NCT01139996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111437930|NCT01139996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111437931|NCT01139996|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111437932|NCT01139996|Sympatholytics|sympatholytics|mesh-ancestor
111437933|NCT01139996|Autonomic Agents|autonomic agents|mesh-ancestor
111437934|NCT01139996|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111437935|NCT01139996|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111437936|NCT01139996|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111437937|NCT01139996|Adrenergic Agents|adrenergic agents|mesh-ancestor
111437938|NCT01139996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111437939|NCT01139996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111437940|NCT02417870|Aldesleukin|aldesleukin|mesh-list
111437941|NCT02417870|Interleukin-2|interleukin-2|mesh-list
111437942|NCT02417870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111437943|NCT02417870|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111437944|NCT02417870|Analgesics|analgesics|mesh-ancestor
111437945|NCT02417870|Sensory System Agents|sensory system agents|mesh-ancestor
111437946|NCT02417870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111437947|NCT02417870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111437948|NCT02417870|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111437949|NCT02417870|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111437950|NCT02417870|Antiviral Agents|antiviral agents|mesh-ancestor
111437951|NCT02417870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111437952|NCT01131884|Alendronate|alendronate|mesh-list
111437953|NCT01131884|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111437954|NCT01131884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111437955|NCT02389712|Lamotrigine|lamotrigine|mesh-list
111437956|NCT02389712|Fluoxetine|fluoxetine|mesh-list
111437957|NCT02389712|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111437958|NCT02389712|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111437959|NCT02389712|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111437960|NCT02389712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111437961|NCT02389712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111437962|NCT02389712|Serotonin Agents|serotonin agents|mesh-ancestor
111437963|NCT02389712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111437964|NCT02389712|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110515569|NCT02824406|Anticonvulsants|anticonvulsants|mesh-ancestor
111437965|NCT02389712|Antidepressive Agents|antidepressive agents|mesh-ancestor
111437966|NCT02389712|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111437967|NCT02389712|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111437968|NCT02389712|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111162301|NCT02184572|Vaccines|vaccines|mesh-list
111437969|NCT02389712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111437970|NCT02389712|Anticonvulsants|anticonvulsants|mesh-ancestor
111437971|NCT02389712|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111437972|NCT02389712|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111437973|NCT02389712|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111437974|NCT02389712|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111437975|NCT02389712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111437976|NCT02389712|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111437977|NCT02369744|Tamsulosin|tamsulosin|mesh-list
111437978|NCT02369744|Silodosin|silodosin|mesh-list
111437979|NCT02369744|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111437980|NCT02369744|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111437981|NCT02369744|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111437982|NCT02369744|Adrenergic Agents|adrenergic agents|mesh-ancestor
111437983|NCT02369744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110515729|NCT00915915|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111437984|NCT02369744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111437985|NCT02369744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111437986|NCT02369744|Urological Agents|urological agents|mesh-ancestor
111437987|NCT03577171|Entecavir|entecavir|mesh-list
111437988|NCT03577171|Antiviral Agents|antiviral agents|mesh-ancestor
111437989|NCT03577171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111437990|NCT02367170|Midazolam|midazolam|mesh-list
111437991|NCT02367170|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111437992|NCT02367170|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111437993|NCT02367170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111437994|NCT02367170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111437995|NCT02367170|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111437996|NCT02367170|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111437997|NCT02367170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111437998|NCT02367170|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111437999|NCT02367170|Anesthetics, General|anesthetics, general|mesh-ancestor
111438000|NCT02367170|Anesthetics|anesthetics|mesh-ancestor
111438001|NCT02367170|GABA Modulators|gaba modulators|mesh-ancestor
111438002|NCT02367170|GABA Agents|gaba agents|mesh-ancestor
111438003|NCT02367170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111438004|NCT02367170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111438005|NCT01078844|Memantine|memantine|mesh-list
111438006|NCT01078844|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111438007|NCT01078844|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111438008|NCT01078844|Dopamine Agents|dopamine agents|mesh-ancestor
110515853|NCT02823236|Hormones|hormones|mesh-ancestor
111438009|NCT01078844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111438010|NCT01078844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111438011|NCT01078844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111438012|NCT01078844|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111438013|NCT01078844|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111438014|NCT00376051|Citalopram|citalopram|mesh-list
111438015|NCT00376051|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111438016|NCT00376051|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111438017|NCT00376051|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111438018|NCT00376051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111438019|NCT00376051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111438020|NCT00376051|Serotonin Agents|serotonin agents|mesh-ancestor
111438021|NCT00376051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111438022|NCT00376051|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111438023|NCT00376051|Antidepressive Agents|antidepressive agents|mesh-ancestor
111438024|NCT00376051|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111438025|NCT01072526|Cyclosporine|cyclosporine|mesh-list
111438026|NCT01072526|Lubricant Eye Drops|lubricant eye drops|mesh-list
111438027|NCT01072526|Cyclosporins|cyclosporins|mesh-list
111438028|NCT01072526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111438029|NCT01072526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111438030|NCT01072526|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111438031|NCT01072526|Immunologic Factors|immunologic factors|mesh-ancestor
111438032|NCT01072526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111438033|NCT01072526|Antifungal Agents|antifungal agents|mesh-ancestor
111438034|NCT01072526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111438035|NCT01072526|Dermatologic Agents|dermatologic agents|mesh-ancestor
111438036|NCT01072526|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111438037|NCT01072526|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111438038|NCT01072526|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
111438039|NCT01072526|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111438040|NCT05312840|Carboplatin|carboplatin|mesh-list
111438041|NCT05312840|Gemcitabine|gemcitabine|mesh-list
111438042|NCT05312840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111438043|NCT05312840|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111438044|NCT05312840|Antimetabolites|antimetabolites|mesh-ancestor
111438045|NCT05312840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111438046|NCT00376129|Alefacept|alefacept|mesh-list
111438047|NCT00376129|Dermatologic Agents|dermatologic agents|mesh-ancestor
111438048|NCT00376129|Immunologic Factors|immunologic factors|mesh-ancestor
111438049|NCT00376129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111438050|NCT01035944|Chitosan|chitosan|mesh-list
111438051|NCT01035944|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111438052|NCT01035944|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111438053|NCT01035944|Antimetabolites|antimetabolites|mesh-ancestor
111438054|NCT01035944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111438055|NCT01035944|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111438056|NCT01035944|Chelating Agents|chelating agents|mesh-ancestor
111438057|NCT01035944|Sequestering Agents|sequestering agents|mesh-ancestor
111438058|NCT01035944|Hemostatics|hemostatics|mesh-ancestor
111438059|NCT01035944|Coagulants|coagulants|mesh-ancestor
111438060|NCT00378638|Bevacizumab|bevacizumab|mesh-list
111438061|NCT00378638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111438062|NCT00378638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111438063|NCT00378638|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111438064|NCT00378638|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111438065|NCT00378638|Growth Substances|growth substances|mesh-ancestor
111438066|NCT00378638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111438067|NCT00378638|Growth Inhibitors|growth inhibitors|mesh-ancestor
111438068|NCT03582553|Naringenin|naringenin|mesh-list
111438069|NCT03582553|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111438070|NCT03582553|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111438071|NCT03582553|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111438072|NCT03582553|Hormone Antagonists|hormone antagonists|mesh-ancestor
111438073|NCT03582553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111438074|NCT03582553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111438075|NCT01025492|Fenofibric acid|fenofibric acid|mesh-list
111438076|NCT01025492|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111438077|NCT01025492|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111438078|NCT01025492|Antimetabolites|antimetabolites|mesh-ancestor
111438079|NCT01025492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111438080|NCT01025492|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111438081|NCT04331834|Hydroxychloroquine|hydroxychloroquine|mesh-list
111438082|NCT04331834|Antimalarials|antimalarials|mesh-ancestor
111438083|NCT04331834|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111438084|NCT04331834|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111438085|NCT04331834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111438086|NCT04331834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111438087|NCT04331834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111438088|NCT04331834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111438089|NCT01023620|Pioglitazone|pioglitazone|mesh-list
111438090|NCT01023620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111438091|NCT01023620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111438092|NCT03595579|Bupropion|bupropion|mesh-list
111438093|NCT03595579|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111438094|NCT03595579|Antidepressive Agents|antidepressive agents|mesh-ancestor
111438095|NCT03595579|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111438096|NCT03595579|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111438097|NCT03595579|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111438098|NCT03595579|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111438099|NCT03595579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111438100|NCT03595579|Dopamine Agents|dopamine agents|mesh-ancestor
111438101|NCT03595579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111438102|NCT03595579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111438103|NCT03595579|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111438104|NCT03595579|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111438105|NCT03595579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111438106|NCT02200328|Metronidazole|metronidazole|mesh-list
111438107|NCT02200328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111438108|NCT02200328|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111438109|NCT02200328|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111438110|NCT02200328|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111438111|NCT04327843|Haloperidol|haloperidol|mesh-list
111438112|NCT04327843|Haloperidol decanoate|haloperidol decanoate|mesh-list
111438113|NCT04327843|Antiemetics|antiemetics|mesh-ancestor
111438114|NCT04327843|Autonomic Agents|autonomic agents|mesh-ancestor
111438115|NCT04327843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111438116|NCT04327843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111438117|NCT04327843|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111438118|NCT04327843|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111162451|NCT02178566|Treprostinil|treprostinil|mesh-list
111438120|NCT04327843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111438121|NCT04327843|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111438122|NCT04327843|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111438123|NCT04327843|Dopamine Agents|dopamine agents|mesh-ancestor
111438124|NCT04327843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111438125|NCT04327843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111438126|NCT04327843|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111438127|NCT02147834|Ranolazine|ranolazine|mesh-list
111438128|NCT02147834|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111438129|NCT02147834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111438130|NCT02147834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111438131|NCT00979550|Imiquimod|imiquimod|mesh-list
111438132|NCT00979550|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111438133|NCT00979550|Immunologic Factors|immunologic factors|mesh-ancestor
111438134|NCT00979550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111438135|NCT00979550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110516240|NCT00908089|Infliximab|infliximab|mesh-list
111438136|NCT00979550|Interferon Inducers|interferon inducers|mesh-ancestor
111438137|NCT00966992|Zoledronic Acid|zoledronic acid|mesh-list
111438138|NCT00966992|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111438139|NCT00966992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111438140|NCT00379730|Prednisolone|prednisolone|mesh-list
111438141|NCT00379730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111438142|NCT00379730|Glucocorticoids|glucocorticoids|mesh-ancestor
111438143|NCT00379730|Hormones|hormones|mesh-ancestor
111438144|NCT00379730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111438145|NCT00379730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111438146|NCT00379730|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111438147|NCT00379730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111438148|NCT02074904|Topiramate|topiramate|mesh-list
111438149|NCT02074904|Anticonvulsants|anticonvulsants|mesh-ancestor
111438150|NCT02074904|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111438151|NCT02074904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111438152|NCT02043860|Melphalan|melphalan|mesh-list
111438153|NCT02043860|Immunologic Factors|immunologic factors|mesh-ancestor
111438154|NCT02043860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111438155|NCT02043860|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111438156|NCT02043860|Alkylating Agents|alkylating agents|mesh-ancestor
111438157|NCT02043860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111438158|NCT02043860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111438159|NCT02043860|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111438160|NCT02043860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111438161|NCT01974284|Ethanol|ethanol|mesh-list
111438162|NCT01974284|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111438163|NCT01974284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111438164|NCT01974284|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111438165|NCT01974284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111438166|NCT00869414|Insulin|insulin|mesh-list
111438167|NCT00869414|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111438168|NCT00869414|Insulin Glargine|insulin glargine|mesh-list
111438169|NCT00869414|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111438170|NCT00869414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111438171|NCT00843986|Conivaptan|conivaptan|mesh-list
111438172|NCT00843986|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
111438173|NCT00843986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111438174|NCT00843986|Natriuretic Agents|natriuretic agents|mesh-ancestor
111438175|NCT00843986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111438176|NCT03608839|Dexamethasone|dexamethasone|mesh-list
111438177|NCT03608839|Dexamethasone acetate|dexamethasone acetate|mesh-list
111438178|NCT03608839|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111438179|NCT03608839|BB 1101|bb 1101|mesh-list
111438180|NCT03608839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111438181|NCT03608839|Antiemetics|antiemetics|mesh-ancestor
111438182|NCT03608839|Autonomic Agents|autonomic agents|mesh-ancestor
111438183|NCT03608839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111438184|NCT03608839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111438185|NCT03608839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111438186|NCT03608839|Glucocorticoids|glucocorticoids|mesh-ancestor
111438187|NCT03608839|Hormones|hormones|mesh-ancestor
110516568|NCT02744196|Antimetabolites|antimetabolites|mesh-ancestor
111438188|NCT03608839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111438189|NCT03608839|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111438190|NCT03608839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111438191|NCT03608839|Protease Inhibitors|protease inhibitors|mesh-ancestor
111438192|NCT03608839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111438193|NCT03608839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111438194|NCT00845702|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
111438195|NCT00845702|Chelating Agents|chelating agents|mesh-ancestor
111438196|NCT00845702|Sequestering Agents|sequestering agents|mesh-ancestor
111438197|NCT00845702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111438198|NCT03610399|Primaquine|primaquine|mesh-list
111438199|NCT03610399|Antimalarials|antimalarials|mesh-ancestor
111438200|NCT03610399|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111438201|NCT03610399|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111438202|NCT03610399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111438203|NCT03610633|Oxytocin|oxytocin|mesh-list
111438204|NCT03610633|Oxytocics|oxytocics|mesh-ancestor
111438205|NCT03610633|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111438206|NCT03610633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111438207|NCT00832520|Mirtazapine|mirtazapine|mesh-list
111438208|NCT00832520|Antidepressive Agents|antidepressive agents|mesh-ancestor
111438209|NCT00832520|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111438210|NCT00832520|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111438211|NCT00832520|Histamine Antagonists|histamine antagonists|mesh-ancestor
111438212|NCT00832520|Histamine Agents|histamine agents|mesh-ancestor
111438213|NCT00832520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111438214|NCT00832520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111438215|NCT00832520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111438216|NCT00832520|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111438217|NCT00832520|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111438218|NCT00832520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111438219|NCT00832520|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
111438220|NCT00832520|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111438221|NCT00832520|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111438222|NCT00832520|Adrenergic Agents|adrenergic agents|mesh-ancestor
111438223|NCT00832520|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111438224|NCT00832520|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111438225|NCT00832520|Serotonin Agents|serotonin agents|mesh-ancestor
111438226|NCT00832520|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111438227|NCT03545893|Ibuprofen|ibuprofen|mesh-list
111438228|NCT03545893|Oxycodone|oxycodone|mesh-list
111438229|NCT03545893|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111438230|NCT03545893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111438231|NCT03545893|Analgesics|analgesics|mesh-ancestor
111438232|NCT03545893|Sensory System Agents|sensory system agents|mesh-ancestor
111438233|NCT03545893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111438234|NCT03545893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111438235|NCT03545893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111438236|NCT03545893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111438237|NCT03545893|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111438238|NCT03545893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110516925|NCT04480190|Fluorouracil|fluorouracil|mesh-list
111438239|NCT03545893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111438240|NCT03545893|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111438241|NCT03545893|Narcotics|narcotics|mesh-ancestor
111438242|NCT03545893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111438243|NCT01877564|Metformin|metformin|mesh-list
111438244|NCT01877564|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111438245|NCT01877564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111438246|NCT00376987|Zinc Oxide|zinc oxide|mesh-list
111438247|NCT00376987|Dermatologic Agents|dermatologic agents|mesh-ancestor
111438248|NCT00376987|Sunscreening Agents|sunscreening agents|mesh-ancestor
111438249|NCT00376987|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111438250|NCT00376987|Protective Agents|protective agents|mesh-ancestor
111438251|NCT00376987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111438252|NCT01889420|Everolimus|everolimus|mesh-list
111438253|NCT01889420|Pomalidomide|pomalidomide|mesh-list
111438254|NCT01889420|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111438255|NCT01889420|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111438256|NCT01889420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111438257|NCT01889420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111438258|NCT01889420|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111438259|NCT01889420|Immunologic Factors|immunologic factors|mesh-ancestor
111438260|NCT01889420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111438261|NCT01889420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111438262|NCT01889420|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111438263|NCT01889420|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111438264|NCT01889420|Growth Substances|growth substances|mesh-ancestor
111438265|NCT01889420|Growth Inhibitors|growth inhibitors|mesh-ancestor
111438266|NCT00379028|Fluticasone|fluticasone|mesh-list
111438267|NCT00379028|Budesonide|budesonide|mesh-list
111438268|NCT00379028|Formoterol Fumarate|formoterol fumarate|mesh-list
111438269|NCT00379028|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
111438270|NCT00379028|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111438271|NCT00379028|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111438272|NCT00379028|Autonomic Agents|autonomic agents|mesh-ancestor
111438273|NCT00379028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111438274|NCT00379028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111438275|NCT00379028|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111438276|NCT00379028|Respiratory System Agents|respiratory system agents|mesh-ancestor
111438277|NCT00379028|Dermatologic Agents|dermatologic agents|mesh-ancestor
111438278|NCT00379028|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111438279|NCT00379028|Glucocorticoids|glucocorticoids|mesh-ancestor
111438280|NCT00379028|Hormones|hormones|mesh-ancestor
111438281|NCT00379028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111438282|NCT00379028|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111438283|NCT00379028|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111438284|NCT00379028|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111438285|NCT00379028|Adrenergic Agents|adrenergic agents|mesh-ancestor
111438286|NCT00379028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111438287|NCT00379028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111438288|NCT05286554|Triptorelin Pamoate|triptorelin pamoate|mesh-list
111438289|NCT05286554|Hormones|hormones|mesh-list
111438290|NCT05286554|Progesterone|progesterone|mesh-list
111438291|NCT05286554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111438292|NCT05286554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111438293|NCT05286554|Progestins|progestins|mesh-ancestor
111438294|NCT05286554|Luteolytic Agents|luteolytic agents|mesh-ancestor
111438295|NCT05286554|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111438296|NCT05286554|Contraceptive Agents|contraceptive agents|mesh-ancestor
111438297|NCT05286554|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111438298|NCT05286554|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111438299|NCT05286554|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111438300|NCT05286554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111438301|NCT00379262|Fluorouracil|fluorouracil|mesh-list
111438302|NCT00379262|Capecitabine|capecitabine|mesh-list
111438303|NCT00379262|Antimetabolites|antimetabolites|mesh-ancestor
111438304|NCT00379262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111438305|NCT00379262|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111438306|NCT00379262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111438307|NCT00379262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111438308|NCT00379262|Immunologic Factors|immunologic factors|mesh-ancestor
111438309|NCT00379262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111438310|NCT00793520|Milnacipran|milnacipran|mesh-list
111438311|NCT00793520|Levomilnacipran|levomilnacipran|mesh-list
111438312|NCT00793520|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111438313|NCT00793520|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111438314|NCT00793520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111438315|NCT00793520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111438316|NCT00793520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111438317|NCT00793520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111438318|NCT00793520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111438319|NCT00793520|Analgesics|analgesics|mesh-ancestor
111438320|NCT00793520|Sensory System Agents|sensory system agents|mesh-ancestor
111438321|NCT00793520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111438322|NCT00793520|Antidepressive Agents|antidepressive agents|mesh-ancestor
111438323|NCT00793520|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111438324|NCT03621085|Ketamine|ketamine|mesh-list
111438325|NCT03621085|Analgesics|analgesics|mesh-ancestor
111438326|NCT03621085|Sensory System Agents|sensory system agents|mesh-ancestor
111438327|NCT03621085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111438328|NCT03621085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111438329|NCT03621085|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111438330|NCT03621085|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111438331|NCT03621085|Anesthetics, General|anesthetics, general|mesh-ancestor
111438332|NCT03621085|Anesthetics|anesthetics|mesh-ancestor
111438333|NCT03621085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111438334|NCT03621085|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111438335|NCT03621085|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111438336|NCT03621085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111438337|NCT03621085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111438338|NCT00795236|Melatonin|melatonin|mesh-list
111438339|NCT00795236|Antioxidants|antioxidants|mesh-ancestor
111438340|NCT00795236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111438341|NCT00795236|Protective Agents|protective agents|mesh-ancestor
111438342|NCT00795236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111438343|NCT00795236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111438344|NCT00790478|Melatonin|melatonin|mesh-list
111438345|NCT00790478|Antioxidants|antioxidants|mesh-ancestor
111438346|NCT00790478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111438347|NCT00790478|Protective Agents|protective agents|mesh-ancestor
111438348|NCT00790478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111438349|NCT00790478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111438350|NCT04490239|Heparin|heparin|mesh-list
111438351|NCT04490239|Calcium heparin|calcium heparin|mesh-list
111438352|NCT04490239|Anticoagulants|anticoagulants|mesh-ancestor
111438353|NCT04490239|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111438354|NCT04490239|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111438355|NCT04490239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111438356|NCT00791336|Nelfinavir|nelfinavir|mesh-list
111438357|NCT00791336|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111438358|NCT00791336|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111438359|NCT00791336|Protease Inhibitors|protease inhibitors|mesh-ancestor
111438360|NCT00791336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111438361|NCT00791336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111438362|NCT00791336|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111438363|NCT00791336|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111438364|NCT00791336|Antiviral Agents|antiviral agents|mesh-ancestor
111438365|NCT00791336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111438366|NCT00771602|Rituximab|rituximab|mesh-list
111438367|NCT00771602|Alemtuzumab|alemtuzumab|mesh-list
111438368|NCT00771602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111438369|NCT00771602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111438370|NCT00771602|Immunologic Factors|immunologic factors|mesh-ancestor
111438371|NCT00771602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111438372|NCT00771602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111438373|NCT01804166|Infliximab|infliximab|mesh-list
111438374|NCT01804166|Golimumab|golimumab|mesh-list
111438375|NCT01804166|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111438376|NCT01804166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111438377|NCT01804166|Dermatologic Agents|dermatologic agents|mesh-ancestor
111438378|NCT01804166|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111438379|NCT01804166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111438380|NCT01804166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111438381|NCT01804166|Immunologic Factors|immunologic factors|mesh-ancestor
111438382|NCT01804166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111438383|NCT04459585|Dabigatran|dabigatran|mesh-list
111438384|NCT04459585|Antithrombins|antithrombins|mesh-ancestor
111438385|NCT04459585|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111438386|NCT04459585|Protease Inhibitors|protease inhibitors|mesh-ancestor
111438387|NCT04459585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111438388|NCT04459585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111438389|NCT04459585|Anticoagulants|anticoagulants|mesh-ancestor
111438390|NCT05080556|Carboplatin|carboplatin|mesh-list
111438391|NCT05080556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111438392|NCT01797380|Escitalopram|escitalopram|mesh-list
111438393|NCT01797380|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111438394|NCT01797380|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111438395|NCT01797380|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111438396|NCT01797380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111438397|NCT01797380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111438398|NCT01797380|Serotonin Agents|serotonin agents|mesh-ancestor
111438399|NCT01797380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111438400|NCT00732680|Botulinum Toxins|botulinum toxins|mesh-list
111438401|NCT00732680|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111438402|NCT00732680|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111438403|NCT00732680|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111438404|NCT00732680|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110517520|NCT05786885|Micronutrients|micronutrients|mesh-ancestor
111438405|NCT00732680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111438406|NCT00732680|Cholinergic Agents|cholinergic agents|mesh-ancestor
111438407|NCT00732680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111438408|NCT00732680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111438409|NCT00732680|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111438410|NCT00732680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111438411|NCT00726830|Morphine|morphine|mesh-list
111438412|NCT00726830|Oxycodone|oxycodone|mesh-list
111438413|NCT00726830|Methadone|methadone|mesh-list
111438414|NCT00726830|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111438415|NCT00726830|Narcotics|narcotics|mesh-ancestor
110517612|NCT05702827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111438416|NCT00726830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111438417|NCT00726830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111438419|NCT00726830|Sensory System Agents|sensory system agents|mesh-ancestor
111438420|NCT00726830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111438421|NCT00726830|Antitussive Agents|antitussive agents|mesh-ancestor
111438422|NCT00726830|Respiratory System Agents|respiratory system agents|mesh-ancestor
111438423|NCT00691652|Rituximab|rituximab|mesh-list
111438424|NCT00691652|Clofarabine|clofarabine|mesh-list
111438425|NCT00691652|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111438426|NCT00691652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111438427|NCT00691652|Immunologic Factors|immunologic factors|mesh-ancestor
110517689|NCT05503875|Adalimumab|adalimumab|mesh-list
111438428|NCT00691652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111438429|NCT00691652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111438430|NCT00691652|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111438431|NCT00691652|Antimetabolites|antimetabolites|mesh-ancestor
111438432|NCT00691652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111438433|NCT00691574|Melatonin|melatonin|mesh-list
111438434|NCT00691574|Antioxidants|antioxidants|mesh-ancestor
111438435|NCT00691574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111438436|NCT00691574|Protective Agents|protective agents|mesh-ancestor
111438437|NCT00691574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111438438|NCT00691574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111438439|NCT00685880|Betamethasone|betamethasone|mesh-list
111438440|NCT00685880|Betamethasone acetate phosphate|betamethasone acetate phosphate|mesh-list
111438441|NCT00685880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111438442|NCT00685880|Glucocorticoids|glucocorticoids|mesh-ancestor
111438443|NCT00685880|Hormones|hormones|mesh-ancestor
111438444|NCT00685880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111438445|NCT00685880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111438446|NCT00685880|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111438447|NCT00685880|Respiratory System Agents|respiratory system agents|mesh-ancestor
111438448|NCT00685880|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111438449|NCT00685880|Autonomic Agents|autonomic agents|mesh-ancestor
111438450|NCT00685880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111438451|NCT00681044|Melphalan|melphalan|mesh-list
111438452|NCT00681044|Immunologic Factors|immunologic factors|mesh-ancestor
111438453|NCT00681044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111438454|NCT00681044|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111438455|NCT00681044|Alkylating Agents|alkylating agents|mesh-ancestor
111438456|NCT00681044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111438457|NCT00681044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111438458|NCT00681044|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111438459|NCT00681044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111438460|NCT03632083|Contact Lens Solutions|contact lens solutions|mesh-list
111438461|NCT03632083|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111438462|NCT03632083|Disinfectants|disinfectants|mesh-ancestor
111438463|NCT03632083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111438464|NCT03633487|Guaifenesin|guaifenesin|mesh-list
111438465|NCT03633487|Expectorants|expectorants|mesh-ancestor
111438466|NCT03633487|Respiratory System Agents|respiratory system agents|mesh-ancestor
111438467|NCT00423020|Epoetin Alfa|epoetin alfa|mesh-list
111438468|NCT00423020|Hematinics|hematinics|mesh-ancestor
111438469|NCT01756586|Dexamethasone|dexamethasone|mesh-list
111438470|NCT01756586|Bupivacaine|bupivacaine|mesh-list
111438471|NCT01756586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111438472|NCT01756586|Antiemetics|antiemetics|mesh-ancestor
111438473|NCT01756586|Autonomic Agents|autonomic agents|mesh-ancestor
111438474|NCT01756586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111438475|NCT01756586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111438476|NCT01756586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111438477|NCT01756586|Glucocorticoids|glucocorticoids|mesh-ancestor
111438478|NCT01756586|Hormones|hormones|mesh-ancestor
111438479|NCT01756586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111438480|NCT01756586|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111438481|NCT01756586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111438482|NCT01756586|Anesthetics, Local|anesthetics, local|mesh-ancestor
111438483|NCT01756586|Anesthetics|anesthetics|mesh-ancestor
111438484|NCT01756586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111438485|NCT01756586|Sensory System Agents|sensory system agents|mesh-ancestor
111438486|NCT03636061|Varenicline|varenicline|mesh-list
111438487|NCT03636061|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111438488|NCT03636061|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111438489|NCT03636061|Cholinergic Agents|cholinergic agents|mesh-ancestor
111438490|NCT03636061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111438491|NCT03636061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111438492|NCT03636061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111438493|NCT00661466|Bupivacaine|bupivacaine|mesh-list
111438494|NCT00661466|Anesthetics, Local|anesthetics, local|mesh-ancestor
111438495|NCT00661466|Anesthetics|anesthetics|mesh-ancestor
111438496|NCT00661466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111438497|NCT00661466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111438498|NCT00661466|Sensory System Agents|sensory system agents|mesh-ancestor
111438499|NCT00661466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111438500|NCT00639626|Insulin Detemir|insulin detemir|mesh-list
111438501|NCT00639626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111438502|NCT00639626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111438503|NCT01718444|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
111438504|NCT01718444|Clomiphene|clomiphene|mesh-list
111438505|NCT01718444|Enclomiphene|enclomiphene|mesh-list
111438506|NCT01718444|Zuclomiphene|zuclomiphene|mesh-list
111438507|NCT01718444|Medroxyprogesterone|medroxyprogesterone|mesh-list
111438508|NCT01718444|Progestins|progestins|mesh-list
111438509|NCT01718444|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111438510|NCT01718444|Hormone Antagonists|hormone antagonists|mesh-ancestor
111438511|NCT01718444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111438512|NCT01718444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111438513|NCT01718444|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111438514|NCT01718444|Fertility Agents|fertility agents|mesh-ancestor
111438515|NCT01718444|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111438516|NCT01718444|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111438517|NCT01718444|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111438518|NCT01718444|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111438519|NCT01718444|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111438520|NCT01718444|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111438521|NCT01718444|Contraceptive Agents|contraceptive agents|mesh-ancestor
111438522|NCT01718444|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111438523|NCT01718444|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111438524|NCT01718444|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
111438525|NCT01718444|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111438526|NCT01718444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111438527|NCT01718444|Hormones|hormones|mesh-ancestor
111438528|NCT00638222|Carvedilol|carvedilol|mesh-list
111438529|NCT00638222|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111438530|NCT00638222|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111438531|NCT00638222|Adrenergic Agents|adrenergic agents|mesh-ancestor
111438532|NCT00638222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111438533|NCT00638222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111438534|NCT00638222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111438535|NCT00638222|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111438536|NCT00638222|Antioxidants|antioxidants|mesh-ancestor
111438537|NCT00638222|Protective Agents|protective agents|mesh-ancestor
111438538|NCT00638222|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111438539|NCT00638222|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111438540|NCT00638222|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111438541|NCT00638222|Vasodilator Agents|vasodilator agents|mesh-ancestor
111438542|NCT00638222|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111438543|NCT00638222|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111438544|NCT00634322|Leucovorin|leucovorin|mesh-list
111438545|NCT00634322|Antidotes|antidotes|mesh-ancestor
111438546|NCT00634322|Protective Agents|protective agents|mesh-ancestor
111438547|NCT00634322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111438548|NCT00634322|Vitamin B Complex|vitamin b complex|mesh-ancestor
111438549|NCT00634322|Vitamins|vitamins|mesh-ancestor
111438550|NCT00634322|Micronutrients|micronutrients|mesh-ancestor
111438551|NCT00379886|Thiopental|thiopental|mesh-list
111438552|NCT00379886|Propofol|propofol|mesh-list
111438553|NCT00379886|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111438554|NCT00379886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111438555|NCT00379886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111438556|NCT00379886|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111438557|NCT00379886|Anesthetics, General|anesthetics, general|mesh-ancestor
111438558|NCT00379886|Anesthetics|anesthetics|mesh-ancestor
111438559|NCT00379886|Anticonvulsants|anticonvulsants|mesh-ancestor
111438560|NCT00379886|GABA Modulators|gaba modulators|mesh-ancestor
111438561|NCT00379886|GABA Agents|gaba agents|mesh-ancestor
111438562|NCT00379886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111438563|NCT00379886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111438564|NCT01705106|Celecoxib|celecoxib|mesh-list
111438565|NCT01705106|Capecitabine|capecitabine|mesh-list
111438566|NCT01705106|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111438567|NCT01705106|Antimetabolites|antimetabolites|mesh-ancestor
111162912|NCT01543204|Etanercept|etanercept|mesh-list
110518260|NCT03164564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111438568|NCT01705106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111438569|NCT01705106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111438570|NCT01705106|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111438571|NCT01705106|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111438572|NCT01705106|Analgesics|analgesics|mesh-ancestor
111438573|NCT01705106|Sensory System Agents|sensory system agents|mesh-ancestor
111438574|NCT01705106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111438575|NCT01705106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111438576|NCT01705106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111438577|NCT01705106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111438578|NCT01705106|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111438579|NCT01705106|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111438580|NCT01705106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111438581|NCT00624650|Phenylephrine|phenylephrine|mesh-list
111438582|NCT00624650|Dobutamine|dobutamine|mesh-list
111438583|NCT00624650|Furosemide|furosemide|mesh-list
111438584|NCT00624650|Vasopressins|vasopressins|mesh-list
111438585|NCT00624650|Arginine Vasopressin|arginine vasopressin|mesh-list
111438586|NCT00624650|Epinephrine|epinephrine|mesh-list
111438587|NCT00624650|Racepinephrine|racepinephrine|mesh-list
111438588|NCT00624650|Oxymetazoline|oxymetazoline|mesh-list
111438589|NCT00624650|Norepinephrine|norepinephrine|mesh-list
111438590|NCT00624650|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
111438591|NCT00624650|Epinephryl borate|epinephryl borate|mesh-list
111438592|NCT00624650|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111438593|NCT00624650|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111438594|NCT00624650|Adrenergic Agents|adrenergic agents|mesh-ancestor
110165852|NCT00025441|Dactinomycin|dactinomycin|mesh-list
111438595|NCT00624650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111438596|NCT00624650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111438597|NCT00624650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111438598|NCT00624650|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111438599|NCT00624650|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111438600|NCT00624650|Autonomic Agents|autonomic agents|mesh-ancestor
111438601|NCT00624650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111438602|NCT00624650|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111438603|NCT00624650|Respiratory System Agents|respiratory system agents|mesh-ancestor
111438604|NCT00624650|Mydriatics|mydriatics|mesh-ancestor
111438605|NCT00624650|Sympathomimetics|sympathomimetics|mesh-ancestor
111438606|NCT00624650|Diuretics|diuretics|mesh-ancestor
111438607|NCT00624650|Natriuretic Agents|natriuretic agents|mesh-ancestor
111438608|NCT00624650|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
111438609|NCT00624650|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111438610|NCT00624650|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111438611|NCT00624650|Nasal Decongestants|nasal decongestants|mesh-ancestor
111438612|NCT00624650|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111438613|NCT00624650|Protective Agents|protective agents|mesh-ancestor
111438614|NCT00624650|Hemostatics|hemostatics|mesh-ancestor
111438615|NCT00624650|Coagulants|coagulants|mesh-ancestor
111438616|NCT00624650|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
111438617|NCT00624650|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
111438618|NCT00377065|Raltegravir Potassium|raltegravir potassium|mesh-list
111438619|NCT00377065|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111438620|NCT00377065|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111438621|NCT00377065|Antiviral Agents|antiviral agents|mesh-ancestor
111438622|NCT00377065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111438623|NCT00377065|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111438624|NCT00377065|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111438625|NCT00377065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111438626|NCT00377065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111438627|NCT00377143|Warfarin|warfarin|mesh-list
111438628|NCT00377143|Anticoagulants|anticoagulants|mesh-ancestor
111438629|NCT00610532|Probenecid|probenecid|mesh-list
111438630|NCT00610532|Phenytoin|phenytoin|mesh-list
111438631|NCT00610532|Anticonvulsants|anticonvulsants|mesh-ancestor
111438632|NCT00610532|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111438633|NCT00610532|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111438634|NCT00610532|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111438635|NCT00610532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111438636|NCT00610532|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
111438637|NCT00610532|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111438638|NCT00610532|Uricosuric Agents|uricosuric agents|mesh-ancestor
111438639|NCT00610532|Gout Suppressants|gout suppressants|mesh-ancestor
111438640|NCT00610532|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111438641|NCT03642457|Bupivacaine|bupivacaine|mesh-list
111438642|NCT03642457|Anesthetics, Local|anesthetics, local|mesh-ancestor
111438643|NCT03642457|Anesthetics|anesthetics|mesh-ancestor
111438644|NCT03642457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111438645|NCT03642457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111438646|NCT03642457|Sensory System Agents|sensory system agents|mesh-ancestor
111438647|NCT03642457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111438649|NCT00379418|Anticoagulants|anticoagulants|mesh-ancestor
111438650|NCT00379418|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111438651|NCT00379496|Antidepressive Agents|antidepressive agents|mesh-list
111438652|NCT00379496|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111438653|NCT00378716|Leucovorin|leucovorin|mesh-list
111438654|NCT00378716|Fluorouracil|fluorouracil|mesh-list
111438655|NCT00378716|Tegafur|tegafur|mesh-list
111438656|NCT00378716|Calcium|calcium|mesh-list
111438657|NCT00378716|Levoleucovorin|levoleucovorin|mesh-list
111438658|NCT00378716|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111438659|NCT00378716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111438660|NCT00378716|Antimetabolites|antimetabolites|mesh-ancestor
111438661|NCT00378716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111438662|NCT00378716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111438663|NCT00378716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111438664|NCT00378716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111438665|NCT00378716|Immunologic Factors|immunologic factors|mesh-ancestor
111438666|NCT00378716|Antidotes|antidotes|mesh-ancestor
111438667|NCT00378716|Protective Agents|protective agents|mesh-ancestor
111438668|NCT00378716|Vitamin B Complex|vitamin b complex|mesh-ancestor
111438669|NCT00378716|Vitamins|vitamins|mesh-ancestor
111438670|NCT00378716|Micronutrients|micronutrients|mesh-ancestor
111438671|NCT03644095|Phenylpropanolamine|phenylpropanolamine|mesh-list
111438672|NCT03644095|Guaifenesin|guaifenesin|mesh-list
111438673|NCT03644095|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
111438674|NCT03644095|Expectorants|expectorants|mesh-ancestor
111438675|NCT03644095|Respiratory System Agents|respiratory system agents|mesh-ancestor
111438676|NCT03644095|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111438677|NCT03644095|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111438678|NCT03644095|Adrenergic Agents|adrenergic agents|mesh-ancestor
111438679|NCT03644095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111438680|NCT03644095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111438681|NCT03644095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111438682|NCT03644095|Appetite Depressants|appetite depressants|mesh-ancestor
111438683|NCT03644095|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111438684|NCT03644095|Sympathomimetics|sympathomimetics|mesh-ancestor
111438685|NCT03644095|Autonomic Agents|autonomic agents|mesh-ancestor
111438686|NCT03644095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111438687|NCT03644095|Nasal Decongestants|nasal decongestants|mesh-ancestor
111438688|NCT03644095|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111438689|NCT01633814|Estradiol|estradiol|mesh-list
111438690|NCT01633814|Estrogens|estrogens|mesh-ancestor
111438691|NCT01633814|Hormones|hormones|mesh-ancestor
111438692|NCT01633814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111438693|NCT01633814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111438694|NCT04585490|Paclitaxel|paclitaxel|mesh-list
111438695|NCT04585490|Cisplatin|cisplatin|mesh-list
111438696|NCT04585490|Carboplatin|carboplatin|mesh-list
111438697|NCT04585490|Pemetrexed|pemetrexed|mesh-list
111438698|NCT04585490|Durvalumab|durvalumab|mesh-list
111438699|NCT04585490|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111438700|NCT04585490|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111438701|NCT04585490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111438702|NCT04585490|Tubulin Modulators|tubulin modulators|mesh-ancestor
111438703|NCT04585490|Antimitotic Agents|antimitotic agents|mesh-ancestor
111438704|NCT04585490|Mitosis Modulators|mitosis modulators|mesh-ancestor
111438705|NCT04585490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111438706|NCT04585490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111438707|NCT04585490|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111438708|NCT04585490|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111438709|NCT04585490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111438710|NCT04585490|Immunologic Factors|immunologic factors|mesh-ancestor
111438711|NCT04585490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111438712|NCT04714099|Cyclosporine|cyclosporine|mesh-list
111438713|NCT04714099|Cyclosporins|cyclosporins|mesh-list
111438714|NCT04714099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111438715|NCT04714099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111438716|NCT04714099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111438717|NCT04714099|Immunologic Factors|immunologic factors|mesh-ancestor
111438718|NCT04714099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111438719|NCT04714099|Antifungal Agents|antifungal agents|mesh-ancestor
111438720|NCT04714099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111438721|NCT04714099|Dermatologic Agents|dermatologic agents|mesh-ancestor
111438722|NCT04714099|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111438723|NCT04714099|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111438724|NCT04566770|Vaccines|vaccines|mesh-list
111438725|NCT04566770|Immunologic Factors|immunologic factors|mesh-ancestor
111438726|NCT04566770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110518999|NCT02733510|Hormones|hormones|mesh-ancestor
111438727|NCT04342663|Fluvoxamine|fluvoxamine|mesh-list
111438728|NCT04342663|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111438729|NCT04342663|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111438730|NCT04342663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111438731|NCT04342663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111438732|NCT04342663|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111438733|NCT04342663|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111438734|NCT04342663|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111438735|NCT04342663|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111438736|NCT04342663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111438737|NCT04342663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111438738|NCT04342663|Serotonin Agents|serotonin agents|mesh-ancestor
111438739|NCT04342663|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111438740|NCT04342663|Antidepressive Agents|antidepressive agents|mesh-ancestor
111438741|NCT04342663|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111438742|NCT04342663|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111438743|NCT04342663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111438744|NCT04342663|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111438745|NCT00589550|Interferons|interferons|mesh-list
111438746|NCT00589550|Interferon-alpha|interferon-alpha|mesh-list
111438747|NCT00589550|Interferon alpha-2|interferon alpha-2|mesh-list
111438748|NCT00589550|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
111438749|NCT00589550|Sorafenib|sorafenib|mesh-list
111438750|NCT00589550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111438751|NCT00589550|Antiviral Agents|antiviral agents|mesh-ancestor
111438752|NCT00589550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111438753|NCT00589550|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111438754|NCT00589550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111438755|NCT00589550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111438756|NCT00589550|Immunologic Factors|immunologic factors|mesh-ancestor
111438757|NCT00589550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111438758|NCT01636466|Everolimus|everolimus|mesh-list
111438759|NCT01636466|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111438760|NCT01636466|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111438761|NCT01636466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111438762|NCT01636466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111438763|NCT01636466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111438764|NCT01636466|Immunologic Factors|immunologic factors|mesh-ancestor
111438765|NCT01636466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111438766|NCT01636466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111438767|NCT00568802|Hydroxyurea|hydroxyurea|mesh-list
111438768|NCT00568802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111438769|NCT00568802|Antisickling Agents|antisickling agents|mesh-ancestor
111438770|NCT00568802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111438771|NCT00568802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111438772|NCT00568802|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111438773|NCT03949621|Vedolizumab|vedolizumab|mesh-list
111438774|NCT03949621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111438775|NCT04429880|Oxytocin|oxytocin|mesh-list
111438776|NCT04429880|Oxytocics|oxytocics|mesh-ancestor
111438777|NCT04429880|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111438778|NCT04429880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111438779|NCT01692158|Heparin|heparin|mesh-list
111438780|NCT01692158|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
111438781|NCT01692158|Tinzaparin|tinzaparin|mesh-list
111438782|NCT01692158|Dalteparin|dalteparin|mesh-list
111438783|NCT01692158|Anticoagulants|anticoagulants|mesh-ancestor
111438784|NCT01692158|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111438785|NCT01692158|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111438786|NCT01692158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111438787|NCT01570634|Antidiarrheals|antidiarrheals|mesh-list
111438788|NCT01570634|Loperamide|loperamide|mesh-list
111438789|NCT01570634|Calcium Aluminosilicate|calcium aluminosilicate|mesh-list
111438790|NCT01570634|Calcium|calcium|mesh-list
111438791|NCT01570634|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110519149|NCT02738346|Carboplatin|carboplatin|mesh-list
111438792|NCT01570634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111438793|NCT01570634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111438794|NCT03928327|Itraconazole|itraconazole|mesh-list
111438795|NCT03928327|Rifampin|rifampin|mesh-list
111438796|NCT03928327|Antifungal Agents|antifungal agents|mesh-ancestor
111438797|NCT03928327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111438798|NCT03928327|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111438799|NCT03928327|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111438800|NCT03928327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111438801|NCT03928327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111438802|NCT03928327|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111438803|NCT03928327|Hormone Antagonists|hormone antagonists|mesh-ancestor
111438804|NCT03928327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111438805|NCT03928327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111438806|NCT03928327|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111438807|NCT03928327|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111438808|NCT03928327|Antitubercular Agents|antitubercular agents|mesh-ancestor
111438809|NCT03928327|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111438810|NCT03928327|Leprostatic Agents|leprostatic agents|mesh-ancestor
111438811|NCT03928327|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111438812|NCT03928327|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111438813|NCT03928327|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111438814|NCT03928327|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
111438815|NCT03928327|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
111438816|NCT03928327|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
111438817|NCT03928327|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111438819|NCT01055756|Pseudoephedrine|pseudoephedrine|mesh-list
111438820|NCT01055756|Ephedrine|ephedrine|mesh-list
111438821|NCT01055756|Antipruritics|antipruritics|mesh-ancestor
111438822|NCT01055756|Dermatologic Agents|dermatologic agents|mesh-ancestor
111438823|NCT01055756|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111438824|NCT01055756|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
111438825|NCT01055756|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111438826|NCT01055756|Histamine Antagonists|histamine antagonists|mesh-ancestor
111438827|NCT01055756|Histamine Agents|histamine agents|mesh-ancestor
111438828|NCT01055756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111438829|NCT01055756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111438830|NCT01055756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111438831|NCT01055756|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111438832|NCT01055756|Autonomic Agents|autonomic agents|mesh-ancestor
111438833|NCT01055756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111438834|NCT01055756|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111438835|NCT01055756|Respiratory System Agents|respiratory system agents|mesh-ancestor
111438836|NCT01055756|Nasal Decongestants|nasal decongestants|mesh-ancestor
111438837|NCT01055756|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111438838|NCT01055756|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111438839|NCT01055756|Sympathomimetics|sympathomimetics|mesh-ancestor
111438840|NCT01055756|Adrenergic Agents|adrenergic agents|mesh-ancestor
111438841|NCT00652574|Dasatinib|dasatinib|mesh-list
111438842|NCT00652574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111438843|NCT00652574|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111438844|NCT00652574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111438845|NCT00652574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111438846|NCT01550510|Ascorbic Acid|ascorbic acid|mesh-list
111438847|NCT01550510|Irinotecan|irinotecan|mesh-list
111438848|NCT01550510|Camptothecin|camptothecin|mesh-list
111438849|NCT01550510|Vitamins|vitamins|mesh-ancestor
111438850|NCT01550510|Micronutrients|micronutrients|mesh-ancestor
111438851|NCT01550510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111438852|NCT01550510|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111438853|NCT01550510|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111438854|NCT01550510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111438855|NCT01550510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111438856|NCT01550510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111438857|NCT01550510|Antioxidants|antioxidants|mesh-ancestor
111438858|NCT01550510|Protective Agents|protective agents|mesh-ancestor
111438859|NCT01550510|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111438860|NCT04333225|Hydroxychloroquine|hydroxychloroquine|mesh-list
111438861|NCT04333225|Antimalarials|antimalarials|mesh-ancestor
111438862|NCT04333225|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111438863|NCT04333225|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111438864|NCT04333225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111438865|NCT04333225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111438866|NCT04333225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111438867|NCT04333225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111438868|NCT00556400|Contraceptive Agents|contraceptive agents|mesh-list
111438869|NCT00556400|Contraceptives, Oral|contraceptives, oral|mesh-list
111163207|NCT01502956|Cholinergic Agents|cholinergic agents|mesh-ancestor
111438870|NCT00556400|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
111438871|NCT00556400|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111438872|NCT00556400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111438873|NCT00556400|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111438874|NCT00521924|Cyclosporine|cyclosporine|mesh-list
111438875|NCT00521924|Chloroquine|chloroquine|mesh-list
111438876|NCT00521924|Sulfasalazine|sulfasalazine|mesh-list
111438877|NCT00521924|Infliximab|infliximab|mesh-list
111438878|NCT00521924|Methotrexate|methotrexate|mesh-list
111438879|NCT00521924|Antirheumatic Agents|antirheumatic agents|mesh-list
111438880|NCT00521924|Cyclosporins|cyclosporins|mesh-list
111438881|NCT00521924|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111438882|NCT00521924|Abortifacient Agents|abortifacient agents|mesh-ancestor
111438883|NCT00521924|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111438884|NCT00521924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111438885|NCT00521924|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111438886|NCT00521924|Antimetabolites|antimetabolites|mesh-ancestor
111438887|NCT00521924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111438888|NCT00521924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111438889|NCT00521924|Dermatologic Agents|dermatologic agents|mesh-ancestor
111438890|NCT00521924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111438891|NCT00521924|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111438892|NCT00521924|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111438893|NCT00521924|Immunologic Factors|immunologic factors|mesh-ancestor
111438894|NCT00521924|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111438895|NCT00521924|Antifungal Agents|antifungal agents|mesh-ancestor
111438896|NCT00521924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111438897|NCT00521924|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111438898|NCT00521924|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111438899|NCT00521924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111438900|NCT00521924|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111438901|NCT00521924|Amebicides|amebicides|mesh-ancestor
110519375|NCT05843565|Cobalt|cobalt|mesh-list
111438902|NCT00521924|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111438903|NCT00521924|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111438904|NCT00521924|Antimalarials|antimalarials|mesh-ancestor
111438905|NCT00521924|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111438906|NCT00521924|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111438907|NCT00521924|Analgesics|analgesics|mesh-ancestor
111438908|NCT00521924|Sensory System Agents|sensory system agents|mesh-ancestor
111438909|NCT00521924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111438910|NCT03927781|Pregabalin|pregabalin|mesh-list
111438911|NCT03927781|Analgesics|analgesics|mesh-ancestor
111438912|NCT03927781|Sensory System Agents|sensory system agents|mesh-ancestor
111438913|NCT03927781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111438914|NCT03927781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111438915|NCT03927781|Anticonvulsants|anticonvulsants|mesh-ancestor
111438916|NCT03927781|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111438917|NCT03927781|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111438918|NCT03927781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111438919|NCT03927781|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111438920|NCT03927781|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111438921|NCT03927781|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111438922|NCT03927781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111438923|NCT03927781|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111438924|NCT00379964|Caspofungin|caspofungin|mesh-list
111438925|NCT00379964|Antifungal Agents|antifungal agents|mesh-ancestor
111438926|NCT00379964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111438927|NCT00379964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111438928|NCT00379964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111438929|NCT01545518|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111438930|NCT01545518|Immunologic Factors|immunologic factors|mesh-ancestor
111438931|NCT01545518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111438932|NCT01526408|Famciclovir|famciclovir|mesh-list
111438933|NCT01526408|Antiviral Agents|antiviral agents|mesh-ancestor
111438934|NCT01526408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111438935|NCT01526408|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111438936|NCT01526408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110519432|NCT05765266|Hormones|hormones|mesh-ancestor
111438937|NCT01526408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111438938|NCT04713644|Propofol|propofol|mesh-list
111438939|NCT04713644|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111438940|NCT04713644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111438941|NCT04713644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111438942|NCT04713644|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111438943|NCT04713644|Anesthetics, General|anesthetics, general|mesh-ancestor
111163283|NCT04757636|Aflibercept|aflibercept|mesh-list
111438944|NCT04713644|Anesthetics|anesthetics|mesh-ancestor
111438945|NCT00000734|Zidovudine|zidovudine|mesh-list
111438946|NCT00000734|Trimethoprim|trimethoprim|mesh-list
111438947|NCT00000734|Sulfamethoxazole|sulfamethoxazole|mesh-list
111438948|NCT00000734|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
111438949|NCT00000734|Antimetabolites|antimetabolites|mesh-ancestor
111438950|NCT00000734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111438951|NCT00000734|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111438952|NCT00000734|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111438953|NCT00000734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111438954|NCT00000734|Antiviral Agents|antiviral agents|mesh-ancestor
111438955|NCT00000734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111438956|NCT00000734|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111438957|NCT00000734|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111438958|NCT00000734|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111438959|NCT00000734|Antimalarials|antimalarials|mesh-ancestor
111438960|NCT00000734|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111438961|NCT00000734|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111438962|NCT00000734|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111438963|NCT00000734|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111438964|NCT00000734|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
111438965|NCT00000734|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111438966|NCT00000734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111438967|NCT03663283|Bupivacaine|bupivacaine|mesh-list
111438968|NCT03663283|Anesthetics, Local|anesthetics, local|mesh-ancestor
111438969|NCT03663283|Anesthetics|anesthetics|mesh-ancestor
111438970|NCT03663283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111438971|NCT03663283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111438972|NCT03663283|Sensory System Agents|sensory system agents|mesh-ancestor
111438973|NCT03663283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110519497|NCT05538767|Emodepside|emodepside|mesh-list
111438974|NCT00000764|Interferons|interferons|mesh-list
111438975|NCT00000764|Interferon-alpha|interferon-alpha|mesh-list
111438976|NCT00000764|Interferon alpha-2|interferon alpha-2|mesh-list
111438977|NCT00000764|Isotretinoin|isotretinoin|mesh-list
111438978|NCT00000764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111438979|NCT00000764|Antiviral Agents|antiviral agents|mesh-ancestor
111438980|NCT00000764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111438981|NCT00000764|Immunologic Factors|immunologic factors|mesh-ancestor
111438982|NCT00000764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111438983|NCT00000764|Dermatologic Agents|dermatologic agents|mesh-ancestor
111438984|NCT03909763|Danazol|danazol|mesh-list
111438985|NCT03909763|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111438986|NCT03909763|Hormone Antagonists|hormone antagonists|mesh-ancestor
111438987|NCT03909763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111438988|NCT03909763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111438989|NCT00484718|Celecoxib|celecoxib|mesh-list
111438990|NCT00484718|Oxycodone|oxycodone|mesh-list
111438991|NCT00484718|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111438992|NCT00484718|Narcotics|narcotics|mesh-ancestor
111438993|NCT00484718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111438994|NCT00484718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111438995|NCT00484718|Analgesics|analgesics|mesh-ancestor
111438996|NCT00484718|Sensory System Agents|sensory system agents|mesh-ancestor
111438997|NCT00484718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111438998|NCT00484718|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111438999|NCT00484718|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111439000|NCT00484718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111439001|NCT00484718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111439002|NCT00484718|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111439003|NCT00484718|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111439004|NCT00484718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111439005|NCT00484718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111439006|NCT03665155|Daratumumab|daratumumab|mesh-list
111439007|NCT03665155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111439008|NCT00477230|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
111439009|NCT00448682|Leucovorin|leucovorin|mesh-list
111439010|NCT00448682|Docetaxel|docetaxel|mesh-list
111439011|NCT00448682|Oxaliplatin|oxaliplatin|mesh-list
111439012|NCT00448682|Floxuridine|floxuridine|mesh-list
111439013|NCT00448682|Levoleucovorin|levoleucovorin|mesh-list
111439014|NCT00448682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111439015|NCT00448682|Tubulin Modulators|tubulin modulators|mesh-ancestor
111439016|NCT00448682|Antimitotic Agents|antimitotic agents|mesh-ancestor
111439017|NCT00448682|Mitosis Modulators|mitosis modulators|mesh-ancestor
111439018|NCT00448682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111439019|NCT00448682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111439020|NCT00448682|Antidotes|antidotes|mesh-ancestor
111439021|NCT00448682|Protective Agents|protective agents|mesh-ancestor
111439022|NCT00448682|Vitamin B Complex|vitamin b complex|mesh-ancestor
111439024|NCT00448682|Micronutrients|micronutrients|mesh-ancestor
111439025|NCT00448682|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111439026|NCT00448682|Antimetabolites|antimetabolites|mesh-ancestor
111439027|NCT04713488|Vaccines|vaccines|mesh-list
111439028|NCT04713488|Immunologic Factors|immunologic factors|mesh-ancestor
111439029|NCT04713488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111439030|NCT03675451|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
111439031|NCT03675451|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111439032|NCT03675451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111439033|NCT00380120|Warfarin|warfarin|mesh-list
111439034|NCT00380120|Anticoagulants|anticoagulants|mesh-ancestor
111439035|NCT00000770|Zidovudine|zidovudine|mesh-list
111439036|NCT00000770|Nevirapine|nevirapine|mesh-list
111439037|NCT00000770|Didanosine|didanosine|mesh-list
111439038|NCT00000770|Antimetabolites|antimetabolites|mesh-ancestor
111439039|NCT00000770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111439040|NCT00000770|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111439041|NCT00000770|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111439042|NCT00000770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111439043|NCT00000770|Antiviral Agents|antiviral agents|mesh-ancestor
111439044|NCT00000770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111439045|NCT00000770|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111439046|NCT00000770|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111439047|NCT00000770|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111439048|NCT00000770|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111439049|NCT00368654|Methotrexate|methotrexate|mesh-list
111439050|NCT00368654|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111439051|NCT00368654|Abortifacient Agents|abortifacient agents|mesh-ancestor
111439052|NCT00368654|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111439053|NCT00368654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111439054|NCT00368654|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111439055|NCT00368654|Antimetabolites|antimetabolites|mesh-ancestor
111439056|NCT00368654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111439057|NCT00368654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111439058|NCT00368654|Dermatologic Agents|dermatologic agents|mesh-ancestor
111439059|NCT00368654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111439060|NCT00368654|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111439061|NCT00368654|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111439062|NCT00368654|Immunologic Factors|immunologic factors|mesh-ancestor
111439063|NCT00368654|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111439064|NCT00368654|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111439065|NCT00000776|Fluconazole|fluconazole|mesh-list
111439066|NCT00000776|Amphotericin B|amphotericin b|mesh-list
111439067|NCT00000776|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
111439068|NCT00000776|Flucytosine|flucytosine|mesh-list
111439069|NCT00000776|Dexamethasone|dexamethasone|mesh-list
111439070|NCT00000776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111439071|NCT00000776|Antiemetics|antiemetics|mesh-ancestor
111439072|NCT00000776|Autonomic Agents|autonomic agents|mesh-ancestor
111439073|NCT00000776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111439074|NCT00000776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111439075|NCT00000776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111439076|NCT00000776|Glucocorticoids|glucocorticoids|mesh-ancestor
111439077|NCT00000776|Hormones|hormones|mesh-ancestor
111439078|NCT00000776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111439079|NCT00000776|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111439080|NCT00000776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111439081|NCT00000776|Antifungal Agents|antifungal agents|mesh-ancestor
111439082|NCT00000776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111439083|NCT00000776|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111439084|NCT00000776|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111439085|NCT00000776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111439086|NCT00000776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111439087|NCT00000776|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111439088|NCT00000776|Hormone Antagonists|hormone antagonists|mesh-ancestor
111439089|NCT00000776|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111439090|NCT00000776|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111439091|NCT00000776|Amebicides|amebicides|mesh-ancestor
111439092|NCT00000776|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111439093|NCT00000776|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111439094|NCT00000776|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111439095|NCT00000776|Antimetabolites|antimetabolites|mesh-ancestor
111439096|NCT04283773|Antibodies|antibodies|mesh-list
111439097|NCT04283773|Immunoglobulins|immunoglobulins|mesh-list
111439098|NCT04283773|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111439099|NCT04283773|Immunologic Factors|immunologic factors|mesh-ancestor
111439100|NCT04283773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111439101|NCT00329732|Lidocaine|lidocaine|mesh-list
111439102|NCT00329732|Bupivacaine|bupivacaine|mesh-list
111439103|NCT00329732|Anesthetics, Local|anesthetics, local|mesh-ancestor
111439104|NCT00329732|Anesthetics|anesthetics|mesh-ancestor
111439105|NCT00329732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111439106|NCT00329732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111439107|NCT00329732|Sensory System Agents|sensory system agents|mesh-ancestor
111439108|NCT00329732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111439109|NCT00329732|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111439110|NCT00329732|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111439111|NCT00329732|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111439112|NCT00329732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111439113|NCT00329732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111439114|NCT00000782|Vaccines|vaccines|mesh-list
111439115|NCT00000782|Immunologic Factors|immunologic factors|mesh-ancestor
111439116|NCT00000782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111439117|NCT00000800|Zidovudine|zidovudine|mesh-list
111439118|NCT00000800|Methadone|methadone|mesh-list
111439119|NCT00000800|Antimetabolites|antimetabolites|mesh-ancestor
111439120|NCT00000800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111439121|NCT00000800|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111439122|NCT00000800|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111439123|NCT00000800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111439124|NCT00000800|Antiviral Agents|antiviral agents|mesh-ancestor
111439125|NCT00000800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111439126|NCT00000800|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111439127|NCT00000800|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111439128|NCT00000800|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111439129|NCT00000800|Narcotics|narcotics|mesh-ancestor
111439130|NCT00000800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111439131|NCT00000800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111439132|NCT00000800|Analgesics|analgesics|mesh-ancestor
111439133|NCT00000800|Sensory System Agents|sensory system agents|mesh-ancestor
111439134|NCT00000800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111439135|NCT00000800|Antitussive Agents|antitussive agents|mesh-ancestor
111439136|NCT00000800|Respiratory System Agents|respiratory system agents|mesh-ancestor
111439137|NCT03679975|Riluzole|riluzole|mesh-list
111439138|NCT03679975|Anticonvulsants|anticonvulsants|mesh-ancestor
111439139|NCT03679975|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111439140|NCT03679975|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111439141|NCT03679975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110519651|NCT05282706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111439142|NCT03679975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111439143|NCT03679975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111439144|NCT03679975|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111439145|NCT03679975|Protective Agents|protective agents|mesh-ancestor
111439146|NCT03887299|Disinfectants|disinfectants|mesh-list
111439147|NCT03887299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111439148|NCT03684265|Meloxicam|meloxicam|mesh-list
111439149|NCT03684265|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111439150|NCT03684265|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111439151|NCT03684265|Analgesics|analgesics|mesh-ancestor
111439152|NCT03684265|Sensory System Agents|sensory system agents|mesh-ancestor
111439153|NCT03684265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111439154|NCT03684265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111439155|NCT03684265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111439156|NCT03684265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111439157|NCT03684265|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111439158|NCT03684265|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111439159|NCT03684265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111439160|NCT03684265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111439161|NCT00218036|Dexetimide|dexetimide|mesh-list
111439162|NCT00218036|Modafinil|modafinil|mesh-list
111439163|NCT00218036|Citalopram|citalopram|mesh-list
111439164|NCT00218036|Escitalopram|escitalopram|mesh-list
111439165|NCT00218036|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111439166|NCT00218036|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111439167|NCT00218036|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111439168|NCT00218036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111439169|NCT00218036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111439170|NCT00218036|Serotonin Agents|serotonin agents|mesh-ancestor
111439171|NCT00218036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111439172|NCT00218036|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111439173|NCT00218036|Antidepressive Agents|antidepressive agents|mesh-ancestor
111439174|NCT00218036|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111439175|NCT00218036|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111439176|NCT00218036|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111439177|NCT00218036|Parasympatholytics|parasympatholytics|mesh-ancestor
111439178|NCT00218036|Autonomic Agents|autonomic agents|mesh-ancestor
111439179|NCT00218036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111439180|NCT00218036|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111439181|NCT00218036|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111439182|NCT00218036|Cholinergic Agents|cholinergic agents|mesh-ancestor
111439183|NCT00218036|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111439184|NCT00218036|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
111439185|NCT00218036|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111439186|NCT00218036|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111439187|NCT00233090|Modafinil|modafinil|mesh-list
111439188|NCT00233090|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111439189|NCT00233090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111439190|NCT00233090|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
111439191|NCT00233090|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110519705|NCT04639466|Vaccines|vaccines|mesh-list
111439192|NCT00233090|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111439193|NCT00233090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111439194|NCT02921906|Acetaminophen|acetaminophen|mesh-list
111439195|NCT02921906|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111439196|NCT02921906|Analgesics|analgesics|mesh-ancestor
111439197|NCT02921906|Sensory System Agents|sensory system agents|mesh-ancestor
111439198|NCT02921906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111439199|NCT02921906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111439200|NCT02921906|Antipyretics|antipyretics|mesh-ancestor
111439201|NCT00000812|Thalidomide|thalidomide|mesh-list
111439202|NCT00000812|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111439203|NCT00000812|Immunologic Factors|immunologic factors|mesh-ancestor
111439204|NCT00000812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111439205|NCT00000812|Leprostatic Agents|leprostatic agents|mesh-ancestor
111439206|NCT00000812|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111439207|NCT00000812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111439208|NCT00000812|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111439209|NCT00000812|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111439210|NCT00000812|Growth Substances|growth substances|mesh-ancestor
111439211|NCT00000812|Growth Inhibitors|growth inhibitors|mesh-ancestor
111439212|NCT00000812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111439213|NCT00000818|Zidovudine|zidovudine|mesh-list
111439214|NCT00000818|Antimetabolites|antimetabolites|mesh-ancestor
111439215|NCT00000818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111439216|NCT00000818|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111439217|NCT00000818|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111439218|NCT00000818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111439219|NCT00000818|Antiviral Agents|antiviral agents|mesh-ancestor
111439220|NCT00000818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111439221|NCT00000818|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111439222|NCT00000818|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111439223|NCT00177866|Celecoxib|celecoxib|mesh-list
111439224|NCT00177866|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111439225|NCT00177866|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111439226|NCT00177866|Analgesics|analgesics|mesh-ancestor
111439227|NCT00177866|Sensory System Agents|sensory system agents|mesh-ancestor
111439228|NCT00177866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111439229|NCT00177866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111439230|NCT00177866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111439231|NCT00177866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111439232|NCT00177866|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111439233|NCT00177866|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111439234|NCT00177866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111439235|NCT00177866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111439236|NCT00089414|Drospirenone|drospirenone|mesh-list
111439237|NCT00089414|Ethinyl Estradiol|ethinyl estradiol|mesh-list
111439238|NCT00089414|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
111439239|NCT00089414|Estradiol|estradiol|mesh-list
111439240|NCT00089414|Progesterone|progesterone|mesh-list
111439241|NCT00089414|Estrogens|estrogens|mesh-ancestor
111439242|NCT00089414|Hormones|hormones|mesh-ancestor
110519868|NCT04249622|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111439243|NCT00089414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111439244|NCT00089414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111439245|NCT00089414|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111439247|NCT00089414|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111439248|NCT00089414|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111439249|NCT00089414|Progestins|progestins|mesh-ancestor
111439250|NCT00089414|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111439251|NCT00089414|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111439252|NCT00089414|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
111439253|NCT00089414|Hormone Antagonists|hormone antagonists|mesh-ancestor
111439254|NCT00089414|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
111439255|NCT00089414|Diuretics|diuretics|mesh-ancestor
111439256|NCT00089414|Natriuretic Agents|natriuretic agents|mesh-ancestor
111439257|NCT00075608|Melphalan|melphalan|mesh-list
111439258|NCT00075608|Immunologic Factors|immunologic factors|mesh-ancestor
111439259|NCT00075608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111439260|NCT00075608|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111439261|NCT00075608|Alkylating Agents|alkylating agents|mesh-ancestor
111439262|NCT00075608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111439263|NCT00075608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111439264|NCT00075608|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111439265|NCT00075608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111439266|NCT03704467|Carboplatin|carboplatin|mesh-list
111439267|NCT03704467|Avelumab|avelumab|mesh-list
111439268|NCT03704467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111439269|NCT03704467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111439270|NCT00000842|Mitogens|mitogens|mesh-list
111439271|NCT00000842|Mitosis Modulators|mitosis modulators|mesh-ancestor
111439272|NCT00000842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111439273|NCT02145260|Dialysis Solutions|dialysis solutions|mesh-list
110520062|NCT03634228|Antimetabolites|antimetabolites|mesh-ancestor
111439274|NCT02145260|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111439275|NCT00000848|Indinavir|indinavir|mesh-list
111439276|NCT00000848|Saquinavir|saquinavir|mesh-list
111439277|NCT00000848|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111439278|NCT00000848|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111439279|NCT00000848|Protease Inhibitors|protease inhibitors|mesh-ancestor
111439280|NCT00000848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111439281|NCT00000848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111439282|NCT00000848|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111439283|NCT00000848|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111439284|NCT00000848|Antiviral Agents|antiviral agents|mesh-ancestor
111439285|NCT00000848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111439286|NCT00000848|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111439287|NCT00000848|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111439288|NCT01795586|Carboplatin|carboplatin|mesh-list
111439289|NCT01795586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111439290|NCT02212574|Cyclophosphamide|cyclophosphamide|mesh-list
111439291|NCT02212574|Lomustine|lomustine|mesh-list
111439292|NCT02212574|Vincristine|vincristine|mesh-list
111439293|NCT02212574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111439294|NCT02212574|Immunologic Factors|immunologic factors|mesh-ancestor
111439295|NCT02212574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111439296|NCT02212574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111439297|NCT02212574|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111439298|NCT02212574|Alkylating Agents|alkylating agents|mesh-ancestor
111439299|NCT02212574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111439300|NCT02212574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111439301|NCT02212574|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111439302|NCT02212574|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111439303|NCT02212574|Tubulin Modulators|tubulin modulators|mesh-ancestor
111439304|NCT02212574|Antimitotic Agents|antimitotic agents|mesh-ancestor
111439305|NCT02212574|Mitosis Modulators|mitosis modulators|mesh-ancestor
111439306|NCT00000854|Nandrolone Decanoate|nandrolone decanoate|mesh-list
111439307|NCT00000854|Nandrolone|nandrolone|mesh-list
111439308|NCT00000854|Nandrolone phenpropionate|nandrolone phenpropionate|mesh-list
111439309|NCT00000854|Androgens|androgens|mesh-ancestor
111439310|NCT00000854|Hormones|hormones|mesh-ancestor
111439311|NCT00000854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111439312|NCT00000854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111439313|NCT00000854|Anabolic Agents|anabolic agents|mesh-ancestor
111439314|NCT00000854|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111439315|NCT04298918|Trastuzumab|trastuzumab|mesh-list
111439316|NCT04298918|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
111439317|NCT04298918|Venetoclax|venetoclax|mesh-list
111439318|NCT04298918|Maytansine|maytansine|mesh-list
111439319|NCT04298918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111439320|NCT04298918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111163658|NCT02209181|Acetaminophen|acetaminophen|mesh-list
111439321|NCT04298918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111439322|NCT04298918|Tubulin Modulators|tubulin modulators|mesh-ancestor
111439323|NCT04298918|Antimitotic Agents|antimitotic agents|mesh-ancestor
111439324|NCT04298918|Mitosis Modulators|mitosis modulators|mesh-ancestor
111439325|NCT04298918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111439326|NCT04298918|Immunotoxins|immunotoxins|mesh-ancestor
111439327|NCT04298918|Immunoconjugates|immunoconjugates|mesh-ancestor
111439328|NCT04298918|Immunologic Factors|immunologic factors|mesh-ancestor
111439329|NCT04298918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111439330|NCT00001676|Fludarabine|fludarabine|mesh-list
111439331|NCT00001676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111439332|NCT03714919|Acetaminophen|acetaminophen|mesh-list
111439333|NCT03714919|Dexmedetomidine|dexmedetomidine|mesh-list
111439334|NCT03714919|Ketamine|ketamine|mesh-list
111439335|NCT03714919|Dextromethorphan|dextromethorphan|mesh-list
111439336|NCT03714919|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111439337|NCT03714919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111439338|NCT03714919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111439339|NCT03714919|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111439340|NCT03714919|Analgesics|analgesics|mesh-ancestor
111439341|NCT03714919|Sensory System Agents|sensory system agents|mesh-ancestor
111439342|NCT03714919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111439343|NCT03714919|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111439344|NCT03714919|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111439345|NCT03714919|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111439346|NCT03714919|Adrenergic Agents|adrenergic agents|mesh-ancestor
111439347|NCT03714919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111439348|NCT03714919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111439349|NCT03714919|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111439350|NCT03714919|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111439351|NCT03714919|Anesthetics, General|anesthetics, general|mesh-ancestor
111439352|NCT03714919|Anesthetics|anesthetics|mesh-ancestor
111439353|NCT03714919|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110520259|NCT02981173|Psilocybin|psilocybin|mesh-list
111439354|NCT03714919|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111439355|NCT03714919|Antipyretics|antipyretics|mesh-ancestor
111439356|NCT03714919|Antitussive Agents|antitussive agents|mesh-ancestor
111439357|NCT03714919|Respiratory System Agents|respiratory system agents|mesh-ancestor
111439358|NCT00000872|Lamivudine|lamivudine|mesh-list
111439359|NCT00000872|Zidovudine|zidovudine|mesh-list
111439360|NCT00000872|Nevirapine|nevirapine|mesh-list
111439361|NCT00000872|Abacavir|abacavir|mesh-list
111439362|NCT00000872|Stavudine|stavudine|mesh-list
111439363|NCT00000872|Nelfinavir|nelfinavir|mesh-list
111439364|NCT00000872|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111439365|NCT00000872|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111439366|NCT00000872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111439367|NCT00000872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111439368|NCT00000872|Antiviral Agents|antiviral agents|mesh-ancestor
111439369|NCT00000872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111439370|NCT00000872|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111439371|NCT00000872|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111439372|NCT00000872|Antimetabolites|antimetabolites|mesh-ancestor
111439373|NCT00000872|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111439374|NCT00000872|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111439375|NCT00000872|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111439376|NCT00000872|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111439377|NCT00000872|Protease Inhibitors|protease inhibitors|mesh-ancestor
111439378|NCT00000878|Lamivudine|lamivudine|mesh-list
111439379|NCT00000878|Zidovudine|zidovudine|mesh-list
111439380|NCT00000878|Stavudine|stavudine|mesh-list
111439381|NCT00000878|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110520312|NCT02513394|Palbociclib|palbociclib|mesh-list
111439382|NCT00000878|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111439383|NCT00000878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111439384|NCT00000878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111439385|NCT00000878|Antiviral Agents|antiviral agents|mesh-ancestor
111439386|NCT00000878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111439387|NCT00000878|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111439388|NCT00000878|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111439389|NCT00000878|Antimetabolites|antimetabolites|mesh-ancestor
111439390|NCT04204057|Tenalisib|tenalisib|mesh-list
111439391|NCT04204057|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
111439392|NCT04204057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111439393|NCT04204057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111439394|NCT00001736|Cysteamine|cysteamine|mesh-list
111439395|NCT00001736|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
111439396|NCT00001736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111439397|NCT00000884|polysaccharide-K|polysaccharide-k|mesh-list
111439398|NCT00000884|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111439399|NCT00000884|Immunologic Factors|immunologic factors|mesh-ancestor
111439400|NCT00000884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111439401|NCT00000884|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110520378|NCT01935921|Cetuximab|cetuximab|mesh-list
111439402|NCT00000884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111439403|NCT00000884|Antiviral Agents|antiviral agents|mesh-ancestor
111439404|NCT00000884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111439405|NCT00000884|Interferon Inducers|interferon inducers|mesh-ancestor
111439406|NCT00000884|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111439407|NCT00000884|Protective Agents|protective agents|mesh-ancestor
111439408|NCT00000896|Lamivudine|lamivudine|mesh-list
111439409|NCT00000896|Zidovudine|zidovudine|mesh-list
111439410|NCT00000896|Nevirapine|nevirapine|mesh-list
111439411|NCT00000896|Stavudine|stavudine|mesh-list
111439412|NCT00000896|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
111439413|NCT00000896|Indinavir|indinavir|mesh-list
111439414|NCT00000896|Interleukin-12|interleukin-12|mesh-list
111439415|NCT00000896|Sargramostim|sargramostim|mesh-list
111439416|NCT00000896|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111439417|NCT00000896|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111439418|NCT00000896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111439419|NCT00000896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111439420|NCT00000896|Antiviral Agents|antiviral agents|mesh-ancestor
111439421|NCT00000896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111439422|NCT00000896|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111439423|NCT00000896|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111439424|NCT00000896|Antimetabolites|antimetabolites|mesh-ancestor
111439425|NCT00000896|Immunologic Factors|immunologic factors|mesh-ancestor
111439426|NCT00000896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111439427|NCT00000896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111439428|NCT00000896|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111439429|NCT00000896|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111439430|NCT00000896|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111439431|NCT00000896|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111439432|NCT00000896|Protease Inhibitors|protease inhibitors|mesh-ancestor
111439433|NCT00000896|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111439434|NCT00000896|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111439435|NCT00000896|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111439436|NCT00000896|Growth Substances|growth substances|mesh-ancestor
111439437|NCT00000896|Growth Inhibitors|growth inhibitors|mesh-ancestor
111439438|NCT00001790|Micafungin|micafungin|mesh-list
111439439|NCT00001790|Antifungal Agents|antifungal agents|mesh-ancestor
111439440|NCT00001790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111439441|NCT00000902|Ritonavir|ritonavir|mesh-list
111439442|NCT00000902|Nelfinavir|nelfinavir|mesh-list
111439443|NCT00000902|Lamivudine|lamivudine|mesh-list
111439444|NCT00000902|Zidovudine|zidovudine|mesh-list
111439445|NCT00000902|Nevirapine|nevirapine|mesh-list
111439446|NCT00000902|Stavudine|stavudine|mesh-list
111439447|NCT00000902|Didanosine|didanosine|mesh-list
111439448|NCT00000902|Zalcitabine|zalcitabine|mesh-list
111439449|NCT00000902|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111439450|NCT00000902|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111439451|NCT00000902|Protease Inhibitors|protease inhibitors|mesh-ancestor
111439452|NCT00000902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111439453|NCT00000902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111439454|NCT00000902|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111439455|NCT00000902|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111439456|NCT00000902|Antiviral Agents|antiviral agents|mesh-ancestor
111439457|NCT00000902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111439458|NCT00000902|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111439459|NCT00000902|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111439460|NCT00000902|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111439461|NCT00000902|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111439462|NCT00000902|Antimetabolites|antimetabolites|mesh-ancestor
111439463|NCT00000902|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111439464|NCT00000902|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111439465|NCT04331600|Chloroquine|chloroquine|mesh-list
111439466|NCT04331600|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
111439467|NCT04331600|Amebicides|amebicides|mesh-ancestor
111439468|NCT04331600|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111439469|NCT04331600|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111439470|NCT04331600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111439471|NCT04331600|Antimalarials|antimalarials|mesh-ancestor
111439472|NCT04331600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111439473|NCT04331600|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111439474|NCT04331600|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111439475|NCT04331600|Analgesics|analgesics|mesh-ancestor
111439476|NCT04331600|Sensory System Agents|sensory system agents|mesh-ancestor
111439477|NCT04331600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111439478|NCT04331600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111439479|NCT04331600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111439480|NCT04331600|Filaricides|filaricides|mesh-ancestor
111439481|NCT04331600|Antinematodal Agents|antinematodal agents|mesh-ancestor
111439482|NCT04331600|Anthelmintics|anthelmintics|mesh-ancestor
111439483|NCT00000188|Selegiline|selegiline|mesh-list
111439484|NCT00000188|Antidepressive Agents|antidepressive agents|mesh-ancestor
111439485|NCT00000188|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111439486|NCT00000188|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111439487|NCT00000188|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111439488|NCT00000188|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
111439489|NCT00000188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111439490|NCT00000188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111439491|NCT00000188|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111439492|NCT00000188|Protective Agents|protective agents|mesh-ancestor
111439493|NCT00000188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111439494|NCT00000914|Ritonavir|ritonavir|mesh-list
111439495|NCT00000914|Nelfinavir|nelfinavir|mesh-list
111439496|NCT00000914|Indinavir|indinavir|mesh-list
111439497|NCT00000914|Efavirenz|efavirenz|mesh-list
111439498|NCT00000914|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111439499|NCT00000914|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111439500|NCT00000914|Protease Inhibitors|protease inhibitors|mesh-ancestor
111439501|NCT00000914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111439502|NCT00000914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111439503|NCT00000914|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111439504|NCT00000914|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111439505|NCT00000914|Antiviral Agents|antiviral agents|mesh-ancestor
111439506|NCT00000914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111439507|NCT00000914|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111439508|NCT00000914|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111439509|NCT00000914|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111439510|NCT00000914|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110520584|NCT00054561|Isotretinoin|isotretinoin|mesh-list
111439511|NCT00000914|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111439512|NCT00000914|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111439513|NCT00000914|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111439514|NCT00000914|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111439515|NCT00000914|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111439516|NCT00000920|Ritonavir|ritonavir|mesh-list
111439517|NCT00000920|Saquinavir|saquinavir|mesh-list
111439518|NCT00000920|Lamivudine|lamivudine|mesh-list
111439519|NCT00000920|Zidovudine|zidovudine|mesh-list
111439520|NCT00000920|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111439521|NCT00000920|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111439522|NCT00000920|Protease Inhibitors|protease inhibitors|mesh-ancestor
111439523|NCT00000920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111439524|NCT00000920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111439525|NCT00000920|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111439526|NCT00000920|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111439527|NCT00000920|Antiviral Agents|antiviral agents|mesh-ancestor
111439528|NCT00000920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111439529|NCT00000920|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111439530|NCT00000920|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111439531|NCT00000920|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111439532|NCT00000920|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111439533|NCT00000920|Antimetabolites|antimetabolites|mesh-ancestor
111439534|NCT00000938|Doxycycline|doxycycline|mesh-list
111439535|NCT00000938|Ceftriaxone|ceftriaxone|mesh-list
111439536|NCT00000938|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111439537|NCT00000938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111439538|NCT00000938|Antimalarials|antimalarials|mesh-ancestor
111439539|NCT00000938|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111439540|NCT00000938|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111439541|NCT00001862|Etanercept|etanercept|mesh-list
111439542|NCT00001862|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111439543|NCT00001862|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111439544|NCT00001862|Analgesics|analgesics|mesh-ancestor
111439545|NCT00001862|Sensory System Agents|sensory system agents|mesh-ancestor
110520774|NCT00003701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111439546|NCT00001862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111439547|NCT00001862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111439548|NCT00001862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111439549|NCT00001862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111439550|NCT00001862|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111439551|NCT00001862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111163906|NCT01896531|Leucovorin|leucovorin|mesh-list
111439552|NCT00001862|Immunologic Factors|immunologic factors|mesh-ancestor
111439553|NCT00000194|Cycloserine|cycloserine|mesh-list
111439554|NCT00000194|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111439555|NCT00000194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111439556|NCT00000194|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111439557|NCT00000194|Antitubercular Agents|antitubercular agents|mesh-ancestor
111439558|NCT00000194|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111439559|NCT00000194|Antimetabolites|antimetabolites|mesh-ancestor
111439560|NCT00000194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111439561|NCT00000200|Methadone|methadone|mesh-list
111439562|NCT00000200|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111439563|NCT00000200|Narcotics|narcotics|mesh-ancestor
111439564|NCT00000200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111439565|NCT00000200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111439566|NCT00000200|Analgesics|analgesics|mesh-ancestor
111439567|NCT00000200|Sensory System Agents|sensory system agents|mesh-ancestor
111439568|NCT00000200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111439569|NCT00000200|Antitussive Agents|antitussive agents|mesh-ancestor
111439570|NCT00000200|Respiratory System Agents|respiratory system agents|mesh-ancestor
111439571|NCT00000206|Buprenorphine|buprenorphine|mesh-list
111439572|NCT00000206|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111439573|NCT00000206|Narcotics|narcotics|mesh-ancestor
111439574|NCT00000206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111439575|NCT00000206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111439576|NCT00000206|Analgesics|analgesics|mesh-ancestor
111439577|NCT00000206|Sensory System Agents|sensory system agents|mesh-ancestor
111439578|NCT00000206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111439579|NCT00000206|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111439580|NCT00000944|Lamivudine|lamivudine|mesh-list
111439581|NCT00000944|Zidovudine|zidovudine|mesh-list
111439582|NCT00000944|Indinavir|indinavir|mesh-list
111439583|NCT00000944|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111439584|NCT00000944|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111439585|NCT00000944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111439586|NCT00000944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111439587|NCT00000944|Antiviral Agents|antiviral agents|mesh-ancestor
111439588|NCT00000944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111439589|NCT00000944|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111439590|NCT00000944|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111439591|NCT00000944|Antimetabolites|antimetabolites|mesh-ancestor
111439592|NCT00000944|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111439593|NCT00000944|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111439594|NCT00000944|Protease Inhibitors|protease inhibitors|mesh-ancestor
111439595|NCT00000950|Pyridoxine|pyridoxine|mesh-list
111439596|NCT00000950|Vitamin B 6|vitamin b 6|mesh-list
111439597|NCT00000950|Rifampin|rifampin|mesh-list
111439598|NCT00000950|Isoniazid|isoniazid|mesh-list
111439599|NCT00000950|Pyrazinamide|pyrazinamide|mesh-list
111439600|NCT00000950|Ethambutol|ethambutol|mesh-list
111439601|NCT00000950|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111439602|NCT00000950|Antitubercular Agents|antitubercular agents|mesh-ancestor
111439603|NCT00000950|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111439604|NCT00000950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111439605|NCT00000950|Leprostatic Agents|leprostatic agents|mesh-ancestor
111439606|NCT00000950|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111439607|NCT00000950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111439608|NCT00000950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111439609|NCT00000950|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111439610|NCT00000950|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111439611|NCT00000950|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
111439612|NCT00000950|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
111439613|NCT00000950|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
111439614|NCT00000950|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111439615|NCT00000950|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
111439616|NCT00000950|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111439617|NCT00000950|Antimetabolites|antimetabolites|mesh-ancestor
111439618|NCT00000950|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111439619|NCT00000950|Vitamin B Complex|vitamin b complex|mesh-ancestor
111439620|NCT00000950|Vitamins|vitamins|mesh-ancestor
111439621|NCT00000950|Micronutrients|micronutrients|mesh-ancestor
111439622|NCT00000950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111439623|NCT00000218|Carbamazepine|carbamazepine|mesh-list
111163955|NCT01884597|Ranibizumab|ranibizumab|mesh-list
110521092|NCT04004078|Clotrimazole|clotrimazole|mesh-list
111439624|NCT00000218|Anticonvulsants|anticonvulsants|mesh-ancestor
111439625|NCT00000218|Antimanic Agents|antimanic agents|mesh-ancestor
111439626|NCT00000218|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111439627|NCT00000218|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111439628|NCT00000218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111439629|NCT00000218|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111439630|NCT00000218|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111439631|NCT00000218|Analgesics|analgesics|mesh-ancestor
111439632|NCT00000218|Sensory System Agents|sensory system agents|mesh-ancestor
111439633|NCT00000218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111439634|NCT00000218|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111439635|NCT00000218|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111439636|NCT00000218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111439637|NCT00000218|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111439638|NCT00000218|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111439639|NCT00000224|Buprenorphine|buprenorphine|mesh-list
111439640|NCT00000224|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111439641|NCT00000224|Narcotics|narcotics|mesh-ancestor
111439642|NCT00000224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111439643|NCT00000224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111439644|NCT00000224|Analgesics|analgesics|mesh-ancestor
111439645|NCT00000224|Sensory System Agents|sensory system agents|mesh-ancestor
111439646|NCT00000224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111439647|NCT00000224|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111439648|NCT04332991|Hydroxychloroquine|hydroxychloroquine|mesh-list
111439649|NCT04332991|Antimalarials|antimalarials|mesh-ancestor
111439650|NCT04332991|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111439651|NCT04332991|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111439652|NCT04332991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111439653|NCT04332991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111439654|NCT04332991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111439655|NCT04332991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111439656|NCT00000230|Buprenorphine|buprenorphine|mesh-list
111439657|NCT00000230|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111439658|NCT00000230|Narcotics|narcotics|mesh-ancestor
111439659|NCT00000230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111439660|NCT00000230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111439661|NCT00000230|Analgesics|analgesics|mesh-ancestor
111439662|NCT00000230|Sensory System Agents|sensory system agents|mesh-ancestor
111439663|NCT00000230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111439664|NCT00000230|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111439665|NCT00000236|Buprenorphine|buprenorphine|mesh-list
111439666|NCT00000236|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
111439667|NCT00000236|Naloxone|naloxone|mesh-list
111439668|NCT00000236|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111439669|NCT00000236|Narcotics|narcotics|mesh-ancestor
111439670|NCT00000236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111439671|NCT00000236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111439672|NCT00000236|Analgesics|analgesics|mesh-ancestor
111439673|NCT00000236|Sensory System Agents|sensory system agents|mesh-ancestor
111439674|NCT00000236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111439675|NCT00000236|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111439676|NCT00000974|Pentamidine|pentamidine|mesh-list
111439677|NCT00000974|Antifungal Agents|antifungal agents|mesh-ancestor
111439678|NCT00000974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111439679|NCT00000974|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111439680|NCT00000974|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111439681|NCT00000974|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
111439682|NCT00000242|Carbamazepine|carbamazepine|mesh-list
111439683|NCT00000242|Anticonvulsants|anticonvulsants|mesh-ancestor
111439684|NCT00000242|Antimanic Agents|antimanic agents|mesh-ancestor
111439685|NCT00000242|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111439686|NCT00000242|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111439687|NCT00000242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111439688|NCT00000242|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111439689|NCT00000242|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111439690|NCT00000242|Analgesics|analgesics|mesh-ancestor
111439691|NCT00000242|Sensory System Agents|sensory system agents|mesh-ancestor
111439692|NCT00000242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111439693|NCT00000242|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111439694|NCT00000242|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111439695|NCT00000242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111439696|NCT00000242|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111439697|NCT00000242|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111439698|NCT00000980|Spiramycin|spiramycin|mesh-list
111439699|NCT00000980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111439700|NCT00000980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111439701|NCT00000980|Coccidiostats|coccidiostats|mesh-ancestor
111439702|NCT00000980|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111439703|NCT00000980|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111439704|NCT00000992|Itraconazole|itraconazole|mesh-list
111439705|NCT00000992|Antifungal Agents|antifungal agents|mesh-ancestor
111439706|NCT00000992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111439707|NCT00000992|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111439708|NCT00000992|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111439709|NCT00000992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111439710|NCT00000992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111439711|NCT00000992|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111439712|NCT00000992|Hormone Antagonists|hormone antagonists|mesh-ancestor
111439713|NCT00000992|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111439714|NCT00000992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111439715|NCT00000992|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111439716|NCT00000254|Nitrous Oxide|nitrous oxide|mesh-list
111439717|NCT00000254|Isoflurane|isoflurane|mesh-list
111439718|NCT00000254|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111439719|NCT00000254|Anesthetics, General|anesthetics, general|mesh-ancestor
111439720|NCT00000254|Anesthetics|anesthetics|mesh-ancestor
111439721|NCT00000254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111439722|NCT00000254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111439723|NCT00000254|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111439724|NCT00000254|Analgesics|analgesics|mesh-ancestor
111439725|NCT00000254|Sensory System Agents|sensory system agents|mesh-ancestor
111439726|NCT00000254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111439727|NCT00000260|Nitrous Oxide|nitrous oxide|mesh-list
111439728|NCT00000260|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111439729|NCT00000260|Anesthetics, General|anesthetics, general|mesh-ancestor
111439730|NCT00000260|Anesthetics|anesthetics|mesh-ancestor
111439731|NCT00000260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111439732|NCT00000260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111439733|NCT00000260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111439734|NCT00000260|Analgesics|analgesics|mesh-ancestor
111439735|NCT00000260|Sensory System Agents|sensory system agents|mesh-ancestor
111439736|NCT00000260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111439737|NCT00000266|Flupenthixol|flupenthixol|mesh-list
111439738|NCT00000266|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
111439739|NCT00000266|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111439740|NCT00000266|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111439741|NCT00000266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111439742|NCT00000266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111439743|NCT00000266|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111439744|NCT00000266|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111439745|NCT00000266|Dopamine Agents|dopamine agents|mesh-ancestor
111439746|NCT00000266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111439747|NCT00000266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111439748|NCT00001016|Leucovorin|leucovorin|mesh-list
111439749|NCT00001016|Trimetrexate|trimetrexate|mesh-list
111439750|NCT00001016|Calcium|calcium|mesh-list
111439751|NCT00001016|Levoleucovorin|levoleucovorin|mesh-list
111439752|NCT00001016|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111439753|NCT00001016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111439754|NCT00001016|Antidotes|antidotes|mesh-ancestor
111439755|NCT00001016|Protective Agents|protective agents|mesh-ancestor
111439756|NCT00001016|Vitamin B Complex|vitamin b complex|mesh-ancestor
111439757|NCT00001016|Vitamins|vitamins|mesh-ancestor
111439758|NCT00001016|Micronutrients|micronutrients|mesh-ancestor
111439759|NCT00001016|Antifungal Agents|antifungal agents|mesh-ancestor
111439760|NCT00001016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111439761|NCT00001016|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111439762|NCT00001016|Antimetabolites|antimetabolites|mesh-ancestor
111439763|NCT00001016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111439764|NCT00001016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111439765|NCT00001016|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111439766|NCT00001016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111439767|NCT03811951|Insulin|insulin|mesh-list
111439768|NCT03811951|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111439769|NCT03811951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111439770|NCT04332289|Deuterium Oxide|deuterium oxide|mesh-list
111439771|NCT04332289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111439772|NCT04332289|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111439773|NCT04332289|Protective Agents|protective agents|mesh-ancestor
111439774|NCT04332289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111439775|NCT00001022|Zidovudine|zidovudine|mesh-list
111439776|NCT00001022|Didanosine|didanosine|mesh-list
111439777|NCT00001022|Zalcitabine|zalcitabine|mesh-list
111439778|NCT00001022|Antimetabolites|antimetabolites|mesh-ancestor
111164119|NCT02137837|Everolimus|everolimus|mesh-list
111439779|NCT00001022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111439780|NCT00001022|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111439781|NCT00001022|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111439782|NCT00001022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111439783|NCT00001022|Antiviral Agents|antiviral agents|mesh-ancestor
111439784|NCT00001022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111439785|NCT00001022|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111439786|NCT00001022|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111439787|NCT05218148|Oxaliplatin|oxaliplatin|mesh-list
111439788|NCT05218148|Trastuzumab|trastuzumab|mesh-list
111439789|NCT05218148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111439790|NCT05218148|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111439791|NCT00001934|Daclizumab|daclizumab|mesh-list
111439792|NCT00001934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111439793|NCT00001934|Immunologic Factors|immunologic factors|mesh-ancestor
111439794|NCT00001934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111439795|NCT00000278|Disulfiram|disulfiram|mesh-list
111439796|NCT00000278|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111439797|NCT00000278|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
111439798|NCT00000278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111439799|NCT00000278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111439800|NCT00001028|Dapsone|dapsone|mesh-list
111439801|NCT00001028|Pentamidine|pentamidine|mesh-list
111439802|NCT00001028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111439803|NCT00001028|Antimalarials|antimalarials|mesh-ancestor
111439804|NCT00001028|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111439805|NCT00001028|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111439806|NCT00001028|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111439807|NCT00001028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111439808|NCT00001028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111439809|NCT00001028|Leprostatic Agents|leprostatic agents|mesh-ancestor
111439810|NCT00001028|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111439811|NCT00001028|Antifungal Agents|antifungal agents|mesh-ancestor
111439812|NCT00001028|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
111439813|NCT00001940|Voriconazole|voriconazole|mesh-list
111439814|NCT00001940|Antifungal Agents|antifungal agents|mesh-ancestor
111439815|NCT00001940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111439816|NCT00001940|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111439817|NCT00001940|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111439818|NCT00001940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111439819|NCT00001940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111439820|NCT00001940|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111439821|NCT00001940|Hormone Antagonists|hormone antagonists|mesh-ancestor
111439822|NCT00001940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111439823|NCT00001940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111439824|NCT00001940|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111439825|NCT03907033|Bupivacaine|bupivacaine|mesh-list
111439826|NCT03907033|Anesthetics, Local|anesthetics, local|mesh-ancestor
111439827|NCT03907033|Anesthetics|anesthetics|mesh-ancestor
111439828|NCT03907033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111439829|NCT03907033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111439830|NCT03907033|Sensory System Agents|sensory system agents|mesh-ancestor
111439831|NCT03907033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111439832|NCT00001034|Ganciclovir|ganciclovir|mesh-list
111439833|NCT00001034|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
111439834|NCT00001034|Antiviral Agents|antiviral agents|mesh-ancestor
111439835|NCT00001034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111439836|NCT00001034|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111439837|NCT00001034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111439838|NCT00001034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111439839|NCT03818815|Amoxicillin|amoxicillin|mesh-list
111439840|NCT03818815|Clavulanic Acid|clavulanic acid|mesh-list
111439841|NCT03818815|Clavulanic Acids|clavulanic acids|mesh-list
111439842|NCT03818815|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
111439843|NCT03818815|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111439844|NCT03818815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111439845|NCT03818815|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
111439846|NCT03818815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111439847|NCT03818815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111439848|NCT00001958|Hydroxyurea|hydroxyurea|mesh-list
111439849|NCT00001958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111439850|NCT00001958|Antisickling Agents|antisickling agents|mesh-ancestor
111439851|NCT00001958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111439852|NCT00001958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111439853|NCT00001958|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111439855|NCT00001964|Cyclosporins|cyclosporins|mesh-list
111439856|NCT00001964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111439857|NCT00001964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111439858|NCT00001964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111439859|NCT00001964|Immunologic Factors|immunologic factors|mesh-ancestor
111439860|NCT00001964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111439861|NCT00001964|Antifungal Agents|antifungal agents|mesh-ancestor
111439862|NCT00001964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111439863|NCT00001964|Dermatologic Agents|dermatologic agents|mesh-ancestor
111439864|NCT00001964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111439865|NCT00001964|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111439866|NCT03801265|Ropivacaine|ropivacaine|mesh-list
111439867|NCT03801265|Anesthetics, Local|anesthetics, local|mesh-ancestor
111439868|NCT03801265|Anesthetics|anesthetics|mesh-ancestor
111439869|NCT03801265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111439870|NCT03801265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111439871|NCT03801265|Sensory System Agents|sensory system agents|mesh-ancestor
111439872|NCT03801265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111439873|NCT00000290|Cocaine|cocaine|mesh-list
111439874|NCT00000290|Anesthetics, Local|anesthetics, local|mesh-ancestor
111439875|NCT00000290|Anesthetics|anesthetics|mesh-ancestor
111439876|NCT00000290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110521647|NCT00935467|Hormones|hormones|mesh-ancestor
111439877|NCT00000290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111439878|NCT00000290|Sensory System Agents|sensory system agents|mesh-ancestor
111439879|NCT00000290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111439880|NCT00000290|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111439881|NCT00000290|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111439882|NCT00000290|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111439883|NCT00000290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111439884|NCT00000290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111439885|NCT00000290|Dopamine Agents|dopamine agents|mesh-ancestor
111439886|NCT00000290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111439887|NCT00000212|Desipramine|desipramine|mesh-list
111439888|NCT00000212|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
111439889|NCT00000212|Antidepressive Agents|antidepressive agents|mesh-ancestor
111439890|NCT00000212|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111439891|NCT00000212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111439892|NCT00000212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111439893|NCT00000212|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111439894|NCT00000212|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111439895|NCT00000212|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111439896|NCT00000212|Adrenergic Agents|adrenergic agents|mesh-ancestor
111439897|NCT00000212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111439898|NCT00000212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111439899|NCT00000302|Buprenorphine|buprenorphine|mesh-list
111439900|NCT00000302|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111439901|NCT00000302|Narcotics|narcotics|mesh-ancestor
111439902|NCT00000302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111439903|NCT00000302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111439904|NCT00000302|Analgesics|analgesics|mesh-ancestor
111439905|NCT00000302|Sensory System Agents|sensory system agents|mesh-ancestor
111439906|NCT00000302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111439907|NCT00000302|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111439908|NCT00001052|Aluminum Hydroxide|aluminum hydroxide|mesh-list
111439909|NCT00001052|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111439910|NCT00001052|Immunologic Factors|immunologic factors|mesh-ancestor
111439911|NCT00001052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111439912|NCT00001052|Antacids|antacids|mesh-ancestor
111439913|NCT00001052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111439914|NCT00001052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111439915|NCT00001058|Ritonavir|ritonavir|mesh-list
111439916|NCT00001058|Indinavir|indinavir|mesh-list
111439917|NCT00001058|Clarithromycin|clarithromycin|mesh-list
111439918|NCT00001058|Ethambutol|ethambutol|mesh-list
111439919|NCT00001058|Rifabutin|rifabutin|mesh-list
111439920|NCT00001058|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111439921|NCT00001058|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111439922|NCT00001058|Protease Inhibitors|protease inhibitors|mesh-ancestor
111439923|NCT00001058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111439924|NCT00001058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111439925|NCT00001058|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111439926|NCT00001058|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111439927|NCT00001058|Antiviral Agents|antiviral agents|mesh-ancestor
111439928|NCT00001058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111439929|NCT00001058|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111439930|NCT00001058|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111439931|NCT00001058|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111439932|NCT00001058|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111439933|NCT00001058|Antitubercular Agents|antitubercular agents|mesh-ancestor
111439934|NCT00001058|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111439935|NCT00000308|Amphetamine|amphetamine|mesh-list
111439936|NCT00000308|Dextroamphetamine|dextroamphetamine|mesh-list
111439937|NCT00000308|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111439938|NCT00000308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111439939|NCT00000308|Sympathomimetics|sympathomimetics|mesh-ancestor
111439940|NCT00000308|Autonomic Agents|autonomic agents|mesh-ancestor
111439941|NCT00000308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111439942|NCT00000308|Dopamine Agents|dopamine agents|mesh-ancestor
111439943|NCT00000308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111439944|NCT00000308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111439945|NCT00000308|Adrenergic Agents|adrenergic agents|mesh-ancestor
111439946|NCT00000308|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111439947|NCT00000308|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111439948|NCT00000308|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111439949|NCT00000308|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111439950|NCT00001994|Atovaquone|atovaquone|mesh-list
111439951|NCT00001994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111439952|NCT00001994|Antimalarials|antimalarials|mesh-ancestor
111439953|NCT00001994|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111439954|NCT00001994|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111439955|NCT00001994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111439956|NCT00001994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111439957|NCT00000320|Buprenorphine|buprenorphine|mesh-list
111439958|NCT00000320|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111439959|NCT00000320|Narcotics|narcotics|mesh-ancestor
111439960|NCT00000320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111439961|NCT00000320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111439962|NCT00000320|Analgesics|analgesics|mesh-ancestor
111439963|NCT00000320|Sensory System Agents|sensory system agents|mesh-ancestor
111439964|NCT00000320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111439965|NCT00000320|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111439966|NCT00000326|Heroin|heroin|mesh-list
111439967|NCT00000326|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111439968|NCT00000326|Narcotics|narcotics|mesh-ancestor
111439969|NCT00000326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111439970|NCT00000326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111439971|NCT00000326|Analgesics|analgesics|mesh-ancestor
111439972|NCT00000326|Sensory System Agents|sensory system agents|mesh-ancestor
111439973|NCT00000326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111439974|NCT03978403|Zolmitriptan|zolmitriptan|mesh-list
111439975|NCT03978403|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111439976|NCT03978403|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111439977|NCT03978403|Serotonin Agents|serotonin agents|mesh-ancestor
111439978|NCT03978403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111439979|NCT03978403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111439980|NCT03978403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111439981|NCT00002000|Valacyclovir|valacyclovir|mesh-list
111439982|NCT00002000|Acyclovir|acyclovir|mesh-list
111439983|NCT00002000|Antiviral Agents|antiviral agents|mesh-ancestor
111439984|NCT00002000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111439985|NCT03979807|Bromides|bromides|mesh-list
111439986|NCT03979807|Tiotropium Bromide|tiotropium bromide|mesh-list
111439987|NCT03979807|Olodaterol|olodaterol|mesh-list
111439988|NCT03979807|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111439989|NCT03979807|Autonomic Agents|autonomic agents|mesh-ancestor
111439990|NCT03979807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111439991|NCT03979807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111439992|NCT03979807|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111439993|NCT03979807|Respiratory System Agents|respiratory system agents|mesh-ancestor
111439994|NCT03979807|Parasympatholytics|parasympatholytics|mesh-ancestor
111439995|NCT03979807|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111439996|NCT03979807|Cholinergic Agents|cholinergic agents|mesh-ancestor
111439997|NCT03979807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111439998|NCT03979807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111439999|NCT03979807|Anticonvulsants|anticonvulsants|mesh-ancestor
111440000|NCT00001082|Adefovir|adefovir|mesh-list
111440001|NCT00001082|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
111440002|NCT00001082|Antiviral Agents|antiviral agents|mesh-ancestor
111440003|NCT00001082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111440004|NCT00001082|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111440005|NCT00001082|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111440006|NCT00001082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111440007|NCT00001082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111440009|NCT00002006|Sargramostim|sargramostim|mesh-list
111440010|NCT00002006|Antimetabolites|antimetabolites|mesh-ancestor
111440011|NCT00002006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111440012|NCT00002006|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111440013|NCT00002006|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111440014|NCT00002006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111440015|NCT00002006|Antiviral Agents|antiviral agents|mesh-ancestor
111440016|NCT00002006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111440017|NCT00002006|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111440018|NCT00002006|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111440019|NCT00002006|Immunologic Factors|immunologic factors|mesh-ancestor
111440020|NCT00002006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111440021|NCT04169113|Opiate Alkaloids|opiate alkaloids|mesh-list
111440022|NCT04169113|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111440023|NCT04169113|Narcotics|narcotics|mesh-ancestor
111440024|NCT04169113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111440025|NCT04169113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111440026|NCT04169113|Analgesics|analgesics|mesh-ancestor
111440027|NCT04169113|Sensory System Agents|sensory system agents|mesh-ancestor
111440028|NCT04169113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111440029|NCT00002012|Interferons|interferons|mesh-list
111440030|NCT00002012|Interferon-alpha|interferon-alpha|mesh-list
111440031|NCT00002012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111440032|NCT00002012|Antiviral Agents|antiviral agents|mesh-ancestor
111440033|NCT00002012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111440034|NCT00002012|Immunologic Factors|immunologic factors|mesh-ancestor
111440035|NCT00002012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111440036|NCT00380276|Tarenflurbil|tarenflurbil|mesh-list
110522000|NCT02715024|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111440037|NCT00380276|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
111440038|NCT00380276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111440039|NCT00380276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111440040|NCT00380354|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|mesh-list
111440041|NCT00380354|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
111440042|NCT00380354|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111440043|NCT00380354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111440044|NCT00380354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111440045|NCT03799783|Dexmedetomidine|dexmedetomidine|mesh-list
111440046|NCT03799783|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111440047|NCT03799783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111440048|NCT03799783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111440049|NCT03799783|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111440050|NCT03799783|Analgesics|analgesics|mesh-ancestor
111440051|NCT03799783|Sensory System Agents|sensory system agents|mesh-ancestor
111440052|NCT03799783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111440053|NCT03799783|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111440054|NCT03799783|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111440055|NCT03799783|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111440056|NCT03799783|Adrenergic Agents|adrenergic agents|mesh-ancestor
110522093|NCT04258475|Calcium|calcium|mesh-list
111440057|NCT03799783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111440058|NCT03799783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111440059|NCT00001088|Bupivacaine|bupivacaine|mesh-list
111440060|NCT00001088|Anesthetics, Local|anesthetics, local|mesh-ancestor
111440061|NCT00001088|Anesthetics|anesthetics|mesh-ancestor
111440062|NCT00001088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111440063|NCT00001088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111440064|NCT00001088|Sensory System Agents|sensory system agents|mesh-ancestor
111440065|NCT00001088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111440066|NCT00001094|Lamivudine|lamivudine|mesh-list
111440067|NCT00001094|Zidovudine|zidovudine|mesh-list
111440068|NCT00001094|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
111440069|NCT00001094|Delavirdine|delavirdine|mesh-list
111440070|NCT00001094|Nelfinavir|nelfinavir|mesh-list
111440071|NCT00001094|Saquinavir|saquinavir|mesh-list
111440072|NCT00001094|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111440073|NCT00001094|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111440074|NCT00001094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111440075|NCT00001094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111440076|NCT00001094|Antiviral Agents|antiviral agents|mesh-ancestor
111440077|NCT00001094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111440079|NCT00001094|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111440080|NCT00001094|Antimetabolites|antimetabolites|mesh-ancestor
111440081|NCT00001094|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111440082|NCT00001094|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111440083|NCT00001094|Protease Inhibitors|protease inhibitors|mesh-ancestor
111440084|NCT00001094|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110522117|NCT04042116|Nivolumab|nivolumab|mesh-list
111440085|NCT00001094|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111440086|NCT00001100|Ganciclovir|ganciclovir|mesh-list
111440087|NCT00001100|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
111440088|NCT00001100|Antiviral Agents|antiviral agents|mesh-ancestor
111440089|NCT00001100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111440090|NCT00001100|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111440091|NCT00001100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111440092|NCT00001100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111440093|NCT00000332|Nimodipine|nimodipine|mesh-list
111440094|NCT00000332|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111440095|NCT00000332|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111440096|NCT00000332|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111440097|NCT00000332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111440098|NCT00000332|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111440099|NCT00000332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111440100|NCT00000332|Vasodilator Agents|vasodilator agents|mesh-ancestor
111440101|NCT00000338|Lisuride|lisuride|mesh-list
111440102|NCT00000338|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111440103|NCT00000338|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111440104|NCT00000338|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111440105|NCT00000338|Serotonin Agents|serotonin agents|mesh-ancestor
111440106|NCT00000338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110522164|NCT02792816|Artemether|artemether|mesh-list
111440107|NCT00000338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111440108|NCT00000338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111440109|NCT00000338|Dopamine Agonists|dopamine agonists|mesh-ancestor
111440110|NCT00000338|Dopamine Agents|dopamine agents|mesh-ancestor
111440111|NCT04085341|Sunitinib|sunitinib|mesh-list
111440112|NCT04085341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111440113|NCT04085341|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111440114|NCT04085341|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111440115|NCT04085341|Growth Substances|growth substances|mesh-ancestor
111440116|NCT04085341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111440117|NCT04085341|Growth Inhibitors|growth inhibitors|mesh-ancestor
111440118|NCT04085341|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111440119|NCT04085341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111440120|NCT04085341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111440121|NCT00002018|Interferons|interferons|mesh-list
111440122|NCT00002018|Interferon-alpha|interferon-alpha|mesh-list
111440123|NCT00002018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111440124|NCT00002018|Antiviral Agents|antiviral agents|mesh-ancestor
111440125|NCT00002018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111440126|NCT00002018|Immunologic Factors|immunologic factors|mesh-ancestor
111440127|NCT00002018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111440128|NCT00002024|Ganciclovir|ganciclovir|mesh-list
111440129|NCT00002024|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
111440130|NCT00002024|Antiviral Agents|antiviral agents|mesh-ancestor
111440131|NCT00002024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111440132|NCT00002024|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111440133|NCT00002024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111440134|NCT00002024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111440135|NCT00001106|Zidovudine|zidovudine|mesh-list
111440136|NCT00001106|Antimetabolites|antimetabolites|mesh-ancestor
111440137|NCT00001106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111440138|NCT00001106|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111440139|NCT00001106|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111440140|NCT00001106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111440141|NCT00001106|Antiviral Agents|antiviral agents|mesh-ancestor
111440142|NCT00001106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111440143|NCT00001106|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111440144|NCT00001106|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111440145|NCT00000344|Buprenorphine|buprenorphine|mesh-list
111440146|NCT00000344|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
111440147|NCT00000344|Naloxone|naloxone|mesh-list
111440148|NCT00000344|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111440149|NCT00000344|Narcotics|narcotics|mesh-ancestor
111440150|NCT00000344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111440151|NCT00000344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111440152|NCT00000344|Analgesics|analgesics|mesh-ancestor
111440153|NCT00000344|Sensory System Agents|sensory system agents|mesh-ancestor
111440154|NCT00000344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111440155|NCT00000344|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111440156|NCT04103515|Cimetidine|cimetidine|mesh-list
111440157|NCT04103515|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111440158|NCT04103515|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111440159|NCT04103515|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
111440160|NCT04103515|Histamine Antagonists|histamine antagonists|mesh-ancestor
111440161|NCT04103515|Histamine Agents|histamine agents|mesh-ancestor
111440162|NCT04103515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111440163|NCT04103515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111440164|NCT04103515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111440165|NCT04103515|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111440166|NCT04103515|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111440167|NCT04103515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111440168|NCT00002030|Pentamidine|pentamidine|mesh-list
111440169|NCT00002030|Antifungal Agents|antifungal agents|mesh-ancestor
111440170|NCT00002030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111440171|NCT00002030|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111440172|NCT00002030|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111440173|NCT00002030|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
111440174|NCT00001112|Interferons|interferons|mesh-list
111440175|NCT00001112|Zidovudine|zidovudine|mesh-list
111440176|NCT00001112|Interferon-gamma|interferon-gamma|mesh-list
111440177|NCT00001112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111440178|NCT00001112|Antiviral Agents|antiviral agents|mesh-ancestor
111440179|NCT00001112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111440180|NCT00001112|Antimetabolites|antimetabolites|mesh-ancestor
111440181|NCT00001112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111440182|NCT00001112|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111440183|NCT00001112|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111440184|NCT00001112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111440185|NCT00001112|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111440186|NCT00001112|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111440187|NCT00002036|Immune Sera|immune sera|mesh-list
111440188|NCT00002036|Immunologic Factors|immunologic factors|mesh-ancestor
111440189|NCT00002036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111440190|NCT03782701|Brimonidine Tartrate|brimonidine tartrate|mesh-list
111440191|NCT03782701|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111440192|NCT03782701|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111440193|NCT03782701|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111440194|NCT03782701|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110522331|NCT04235270|Tadalafil|tadalafil|mesh-list
111440195|NCT03782701|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111440196|NCT03782701|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111440197|NCT03782701|Adrenergic Agents|adrenergic agents|mesh-ancestor
111440198|NCT03782701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111440199|NCT03782701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111440200|NCT03782701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111440201|NCT00000374|Olanzapine|olanzapine|mesh-list
111440202|NCT00000374|Risperidone|risperidone|mesh-list
111440203|NCT00000374|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111440204|NCT00000374|Serotonin Agents|serotonin agents|mesh-ancestor
111440205|NCT00000374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111440206|NCT00000374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111440207|NCT00000374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111440208|NCT00000374|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111440209|NCT00000374|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111440210|NCT00000374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111440211|NCT00000374|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111440212|NCT00000374|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111440213|NCT00000374|Dopamine Agents|dopamine agents|mesh-ancestor
111440214|NCT00000374|Antiemetics|antiemetics|mesh-ancestor
111440215|NCT00000374|Autonomic Agents|autonomic agents|mesh-ancestor
111440216|NCT00000374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111440217|NCT00000374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111440218|NCT00000374|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111440219|NCT00000374|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111440220|NCT00000374|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111440221|NCT00002042|Epoetin Alfa|epoetin alfa|mesh-list
111440222|NCT00002042|Hematinics|hematinics|mesh-ancestor
111440223|NCT03789175|Niacinamide|niacinamide|mesh-list
111440224|NCT03789175|Niacin|niacin|mesh-list
111440225|NCT03789175|Nicotinic Acids|nicotinic acids|mesh-list
111440226|NCT03789175|Vitamin B Complex|vitamin b complex|mesh-ancestor
111440227|NCT03789175|Vitamins|vitamins|mesh-ancestor
111440228|NCT03789175|Micronutrients|micronutrients|mesh-ancestor
111440229|NCT03789175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111440230|NCT03789175|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111440231|NCT03789175|Antimetabolites|antimetabolites|mesh-ancestor
110522396|NCT00945919|Analgesics|analgesics|mesh-ancestor
111440232|NCT03789175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111440233|NCT03789175|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111440234|NCT03789175|Vasodilator Agents|vasodilator agents|mesh-ancestor
111440235|NCT00002048|Zidovudine|zidovudine|mesh-list
111440236|NCT00002048|Antimetabolites|antimetabolites|mesh-ancestor
111440237|NCT00002048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111440238|NCT00002048|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111440239|NCT00002048|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111440240|NCT00002048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111440241|NCT00002048|Antiviral Agents|antiviral agents|mesh-ancestor
111440242|NCT00002048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111440243|NCT00002048|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111440244|NCT00002048|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111440245|NCT00002054|Pentamidine|pentamidine|mesh-list
111440246|NCT00002054|Antifungal Agents|antifungal agents|mesh-ancestor
111440247|NCT00002054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111440248|NCT00002054|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111440249|NCT00002054|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111440250|NCT00002054|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
111440251|NCT00002060|Inosine Pranobex|inosine pranobex|mesh-list
111440252|NCT00002060|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111440253|NCT00002060|Immunologic Factors|immunologic factors|mesh-ancestor
111440254|NCT00002060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111440255|NCT00002060|Antiviral Agents|antiviral agents|mesh-ancestor
111440256|NCT00002060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111440257|NCT00002066|Thymopentin|thymopentin|mesh-list
111440258|NCT00002066|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111440259|NCT00002066|Immunologic Factors|immunologic factors|mesh-ancestor
111440260|NCT00002066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111440261|NCT00002072|Epoetin Alfa|epoetin alfa|mesh-list
111440262|NCT00002072|Hematinics|hematinics|mesh-ancestor
111440263|NCT00002078|Interferons|interferons|mesh-list
111440264|NCT00002078|Interferon-alpha|interferon-alpha|mesh-list
111440265|NCT00002078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111440266|NCT00002078|Antiviral Agents|antiviral agents|mesh-ancestor
111440267|NCT00002078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111440268|NCT00002078|Immunologic Factors|immunologic factors|mesh-ancestor
111440269|NCT00002078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111440270|NCT00000440|Naltrexone|naltrexone|mesh-list
111440271|NCT00000440|Sertraline|sertraline|mesh-list
111440272|NCT00000440|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111440273|NCT00000440|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111440274|NCT00000440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111440275|NCT00000440|Sensory System Agents|sensory system agents|mesh-ancestor
111440276|NCT00000440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111440277|NCT00000440|Antidepressive Agents|antidepressive agents|mesh-ancestor
111440278|NCT00000440|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111440279|NCT00000440|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111440280|NCT00000440|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111440281|NCT00000440|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111440282|NCT00000440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111440283|NCT00000440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111440284|NCT00000440|Serotonin Agents|serotonin agents|mesh-ancestor
111440285|NCT00002084|Valacyclovir|valacyclovir|mesh-list
111440286|NCT00002084|Acyclovir|acyclovir|mesh-list
111440287|NCT00002084|Antiviral Agents|antiviral agents|mesh-ancestor
111440288|NCT00002084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111440289|NCT00000446|Sertraline|sertraline|mesh-list
111440290|NCT00000446|Antidepressive Agents|antidepressive agents|mesh-ancestor
111440291|NCT00000446|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111440292|NCT00000446|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111440293|NCT00000446|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111440294|NCT00000446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111440295|NCT00000446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111440296|NCT00000446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111440297|NCT00000446|Serotonin Agents|serotonin agents|mesh-ancestor
111440298|NCT00000446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111440299|NCT04131517|Padsevonil|padsevonil|mesh-list
111440300|NCT04131517|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
111440301|NCT04131517|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
111440302|NCT04131517|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111440303|NCT04131517|Contraceptive Agents|contraceptive agents|mesh-ancestor
111440304|NCT04131517|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111440305|NCT04131517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111440306|NCT04131517|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
111440307|NCT04131517|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111440308|NCT04131517|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111440309|NCT04131517|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111440310|NCT04131517|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111440311|NCT04131517|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
111440312|NCT04131517|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
111440313|NCT04131517|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
111440314|NCT04131517|Anticonvulsants|anticonvulsants|mesh-ancestor
111440315|NCT00001256|Prednisone|prednisone|mesh-list
111440316|NCT00001256|Methotrexate|methotrexate|mesh-list
111440317|NCT00001256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111440318|NCT00001256|Glucocorticoids|glucocorticoids|mesh-ancestor
111440319|NCT00001256|Hormones|hormones|mesh-ancestor
111440320|NCT00001256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111440321|NCT00001256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111440322|NCT00001256|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111440323|NCT00001256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111440324|NCT00001256|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111440325|NCT00001256|Abortifacient Agents|abortifacient agents|mesh-ancestor
111440326|NCT00001256|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111440327|NCT00001256|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111440328|NCT00001256|Antimetabolites|antimetabolites|mesh-ancestor
111440329|NCT00001256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111440330|NCT00001256|Dermatologic Agents|dermatologic agents|mesh-ancestor
111440331|NCT00001256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111440332|NCT00001256|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111440333|NCT00001256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111440334|NCT00001256|Immunologic Factors|immunologic factors|mesh-ancestor
111440335|NCT00001256|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111440336|NCT00001256|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111440337|NCT00000452|Naltrexone|naltrexone|mesh-list
111440338|NCT00000452|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111440339|NCT00000452|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111440340|NCT00000452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111440341|NCT00000452|Sensory System Agents|sensory system agents|mesh-ancestor
111440342|NCT00000452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111440343|NCT00000458|Sertraline|sertraline|mesh-list
111440344|NCT00000458|Antidepressive Agents|antidepressive agents|mesh-ancestor
111440345|NCT00000458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111440346|NCT00000458|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111440347|NCT00000458|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111440348|NCT00000458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111440349|NCT00000458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111440350|NCT00000458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111440351|NCT00000458|Serotonin Agents|serotonin agents|mesh-ancestor
111440352|NCT00000458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111440353|NCT03782233|Bromides|bromides|mesh-list
111440354|NCT03782233|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111440355|NCT03782233|Rocuronium|rocuronium|mesh-list
111440356|NCT03782233|Anticonvulsants|anticonvulsants|mesh-ancestor
111440357|NCT03782233|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
111440358|NCT03782233|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
111440359|NCT03782233|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111440360|NCT03782233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111440361|NCT03782233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111440362|NCT00002090|Azithromycin|azithromycin|mesh-list
111440363|NCT00002090|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111440364|NCT00002090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111440365|NCT00002096|Zidovudine|zidovudine|mesh-list
111440366|NCT00002096|Didanosine|didanosine|mesh-list
111440367|NCT00002096|Ganciclovir|ganciclovir|mesh-list
111440368|NCT00002096|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
111440369|NCT00002096|Antimetabolites|antimetabolites|mesh-ancestor
111440370|NCT00002096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111440371|NCT00002096|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111440372|NCT00002096|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111440373|NCT00002096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111440374|NCT00002096|Antiviral Agents|antiviral agents|mesh-ancestor
111440375|NCT00002096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111164713|NCT02219477|Ritonavir|ritonavir|mesh-list
111440376|NCT00002096|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111440377|NCT00002096|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111440378|NCT00002102|Leucovorin|leucovorin|mesh-list
111440379|NCT00002102|Trimetrexate|trimetrexate|mesh-list
111440380|NCT00002102|Calcium|calcium|mesh-list
111440381|NCT00002102|Levoleucovorin|levoleucovorin|mesh-list
111440382|NCT00002102|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111440383|NCT00002102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111440384|NCT00002102|Antidotes|antidotes|mesh-ancestor
111440385|NCT00002102|Protective Agents|protective agents|mesh-ancestor
111440386|NCT00002102|Vitamin B Complex|vitamin b complex|mesh-ancestor
111440387|NCT00002102|Vitamins|vitamins|mesh-ancestor
111440388|NCT00002102|Micronutrients|micronutrients|mesh-ancestor
111440389|NCT00002102|Antifungal Agents|antifungal agents|mesh-ancestor
111440390|NCT00002102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111440391|NCT00002102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111440392|NCT00002102|Antimetabolites|antimetabolites|mesh-ancestor
111440393|NCT00002102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111440394|NCT00002102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111440395|NCT00002102|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111440396|NCT00002102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111440397|NCT00002108|Lamivudine|lamivudine|mesh-list
111440398|NCT00002108|Zidovudine|zidovudine|mesh-list
111440399|NCT00002108|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111440400|NCT00002108|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111440401|NCT00002108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111440402|NCT00002108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110522823|NCT06003218|Narcotics|narcotics|mesh-ancestor
111440403|NCT00002108|Antiviral Agents|antiviral agents|mesh-ancestor
111440404|NCT00002108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111440405|NCT00002108|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111440406|NCT00002108|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111440407|NCT00002108|Antimetabolites|antimetabolites|mesh-ancestor
111440408|NCT00381134|Losartan|losartan|mesh-list
111440409|NCT00381134|Spironolactone|spironolactone|mesh-list
111440410|NCT00381134|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111440411|NCT00381134|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111440412|NCT00381134|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111440413|NCT00381134|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111440414|NCT00381134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111440415|NCT00381134|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
111440416|NCT00381134|Hormone Antagonists|hormone antagonists|mesh-ancestor
111440417|NCT00381134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111440418|NCT00381134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111440419|NCT00381134|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
111440420|NCT00381134|Diuretics|diuretics|mesh-ancestor
111440421|NCT00381134|Natriuretic Agents|natriuretic agents|mesh-ancestor
111440422|NCT00000506|Phentermine|phentermine|mesh-list
111440423|NCT00000506|Fenfluramine|fenfluramine|mesh-list
111440424|NCT00000506|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111440425|NCT00000506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111440426|NCT00000506|Appetite Depressants|appetite depressants|mesh-ancestor
111440427|NCT00000506|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111440428|NCT00000506|Sympathomimetics|sympathomimetics|mesh-ancestor
111440429|NCT00000506|Autonomic Agents|autonomic agents|mesh-ancestor
111440430|NCT00000506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111440431|NCT00000506|Adrenergic Agents|adrenergic agents|mesh-ancestor
111440432|NCT00000506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111440433|NCT00000506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111440434|NCT00000506|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111440435|NCT00000506|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111440436|NCT00000506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111440437|NCT00000506|Serotonin Agents|serotonin agents|mesh-ancestor
111440438|NCT00000512|Niacin|niacin|mesh-list
111440439|NCT00000512|Nicotinic Acids|nicotinic acids|mesh-list
111440440|NCT00000512|Lovastatin|lovastatin|mesh-list
111440441|NCT00000512|L 647318|l 647318|mesh-list
111440442|NCT00000512|Dihydromevinolin|dihydromevinolin|mesh-list
111440443|NCT00000512|Colestipol|colestipol|mesh-list
111440444|NCT00000512|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111440445|NCT00000512|Antimetabolites|antimetabolites|mesh-ancestor
111440446|NCT00000512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111440447|NCT00000512|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111440448|NCT00000512|Vasodilator Agents|vasodilator agents|mesh-ancestor
111440449|NCT00000512|Vitamin B Complex|vitamin b complex|mesh-ancestor
111440450|NCT00000512|Vitamins|vitamins|mesh-ancestor
111440451|NCT00000512|Micronutrients|micronutrients|mesh-ancestor
111440452|NCT00000512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111164779|NCT01456936|Bupropion|bupropion|mesh-list
111440453|NCT00000512|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111440454|NCT00000512|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111440455|NCT00000512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111440456|NCT00000512|Sequestering Agents|sequestering agents|mesh-ancestor
111440458|NCT00380822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111440459|NCT00380822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111440460|NCT00380822|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111440461|NCT00380822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111440462|NCT00380822|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
111440463|NCT00000542|Amlodipine|amlodipine|mesh-list
111440464|NCT00000542|Lisinopril|lisinopril|mesh-list
111440465|NCT00000542|Chlorthalidone|chlorthalidone|mesh-list
111440466|NCT00000542|Doxazosin|doxazosin|mesh-list
111440467|NCT00000542|Pravastatin|pravastatin|mesh-list
111440468|NCT00000542|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
111440469|NCT00000542|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111440470|NCT00000542|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111440471|NCT00000542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111440472|NCT00000542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111440473|NCT00000542|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111440474|NCT00000542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111440475|NCT00000542|Vasodilator Agents|vasodilator agents|mesh-ancestor
111440476|NCT00000542|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111440477|NCT00000542|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111440478|NCT00000542|Antimetabolites|antimetabolites|mesh-ancestor
111440479|NCT00000542|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111440480|NCT00000542|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111440481|NCT00000542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110523100|NCT05661708|Chelating Agents|chelating agents|mesh-ancestor
111440482|NCT00000542|Protease Inhibitors|protease inhibitors|mesh-ancestor
111440483|NCT00000542|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111440484|NCT00000542|Protective Agents|protective agents|mesh-ancestor
111440485|NCT00000542|Diuretics|diuretics|mesh-ancestor
111440486|NCT00000542|Natriuretic Agents|natriuretic agents|mesh-ancestor
111440487|NCT00000542|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
111440488|NCT00000542|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111440489|NCT00000542|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111440490|NCT00000542|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111440491|NCT00000542|Adrenergic Agents|adrenergic agents|mesh-ancestor
111440492|NCT00000542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111440493|NCT00002120|Leucovorin|leucovorin|mesh-list
111440494|NCT00002120|Trimethoprim|trimethoprim|mesh-list
111440495|NCT00002120|Dapsone|dapsone|mesh-list
111440496|NCT00002120|Sulfamethoxazole|sulfamethoxazole|mesh-list
111440497|NCT00002120|Trimetrexate|trimetrexate|mesh-list
111440498|NCT00002120|Calcium|calcium|mesh-list
111440499|NCT00002120|Levoleucovorin|levoleucovorin|mesh-list
111440500|NCT00002120|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111440501|NCT00002120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111440502|NCT00002120|Antidotes|antidotes|mesh-ancestor
111440503|NCT00002120|Protective Agents|protective agents|mesh-ancestor
111440504|NCT00002120|Vitamin B Complex|vitamin b complex|mesh-ancestor
111440505|NCT00002120|Vitamins|vitamins|mesh-ancestor
111440506|NCT00002120|Micronutrients|micronutrients|mesh-ancestor
111440507|NCT00002120|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111440508|NCT00002120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111440509|NCT00002120|Antimalarials|antimalarials|mesh-ancestor
111440510|NCT00002120|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111440511|NCT00002120|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111440512|NCT00002120|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111440513|NCT00002120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111440514|NCT00002120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111440515|NCT00002120|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111440516|NCT00002120|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
111440517|NCT00002120|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111440518|NCT00002120|Leprostatic Agents|leprostatic agents|mesh-ancestor
111440519|NCT00002120|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111440520|NCT00002120|Antifungal Agents|antifungal agents|mesh-ancestor
111440521|NCT00002120|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111440522|NCT00002120|Antimetabolites|antimetabolites|mesh-ancestor
111440523|NCT00002120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111440524|NCT00002126|Lenograstim|lenograstim|mesh-list
111440525|NCT00002126|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111440526|NCT00002126|Immunologic Factors|immunologic factors|mesh-ancestor
111440527|NCT00002126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111440528|NCT03231397|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
111440529|NCT03231397|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110523222|NCT05307731|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
111440530|NCT03231397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111440532|NCT03189433|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
111440533|NCT03189433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111440534|NCT03189433|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111440535|NCT03189433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111440536|NCT00002132|Itraconazole|itraconazole|mesh-list
111440537|NCT00002132|Fluconazole|fluconazole|mesh-list
111440538|NCT00002132|Antifungal Agents|antifungal agents|mesh-ancestor
111440539|NCT00002132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111440540|NCT00002132|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111440541|NCT00002132|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111440542|NCT00002132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111440543|NCT00002132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111440544|NCT00002132|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111440545|NCT00002132|Hormone Antagonists|hormone antagonists|mesh-ancestor
111440546|NCT00002132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111440547|NCT00002132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111440548|NCT00002132|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111440549|NCT00002132|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111440550|NCT00002132|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111440551|NCT00002144|Foscarnet|foscarnet|mesh-list
111440552|NCT00002144|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
111440553|NCT00002144|Antiviral Agents|antiviral agents|mesh-ancestor
111440554|NCT00002144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111440555|NCT00002144|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111440556|NCT00002144|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111440557|NCT00002144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111440558|NCT00002144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111440559|NCT00000578|Beclomethasone|beclomethasone|mesh-list
111440560|NCT00000578|Theophylline|theophylline|mesh-list
111440561|NCT00000578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111440562|NCT00000578|Glucocorticoids|glucocorticoids|mesh-ancestor
111440563|NCT00000578|Hormones|hormones|mesh-ancestor
111440564|NCT00000578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111440565|NCT00000578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111440566|NCT00000578|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111440567|NCT00000578|Respiratory System Agents|respiratory system agents|mesh-ancestor
111440568|NCT00000578|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111440569|NCT00000578|Autonomic Agents|autonomic agents|mesh-ancestor
111440570|NCT00000578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111440571|NCT00000578|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111440572|NCT00000578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111440573|NCT00000578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111440574|NCT00000578|Vasodilator Agents|vasodilator agents|mesh-ancestor
111440575|NCT00000578|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110523385|NCT04951206|Clobetasol|clobetasol|mesh-list
111440576|NCT00000578|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111440577|NCT00000578|Purinergic Agents|purinergic agents|mesh-ancestor
111440578|NCT00000578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111440579|NCT03774745|Mifepristone|mifepristone|mesh-list
111440580|NCT03774745|Progesterone|progesterone|mesh-list
111440581|NCT03774745|Progestins|progestins|mesh-ancestor
111440582|NCT03774745|Hormones|hormones|mesh-ancestor
111440583|NCT03774745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111440584|NCT03774745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111440585|NCT03774745|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
111440586|NCT03774745|Abortifacient Agents|abortifacient agents|mesh-ancestor
111440587|NCT03774745|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111440588|NCT03774745|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111440589|NCT03774745|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111440590|NCT03774745|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111440591|NCT03774745|Contraceptive Agents|contraceptive agents|mesh-ancestor
111440592|NCT03774745|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
111440593|NCT03774745|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
111440594|NCT03774745|Hormone Antagonists|hormone antagonists|mesh-ancestor
111440595|NCT03774745|Luteolytic Agents|luteolytic agents|mesh-ancestor
111440596|NCT03774745|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111440597|NCT03774745|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
111440598|NCT00000584|Immunoglobulins|immunoglobulins|mesh-list
111440599|NCT00000584|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111440600|NCT00000584|Antibodies|antibodies|mesh-list
111440601|NCT00000584|Immunologic Factors|immunologic factors|mesh-ancestor
111440602|NCT00000584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111440603|NCT00000590|Immunoglobulins|immunoglobulins|mesh-list
111440604|NCT00000590|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111440605|NCT00000590|Antibodies|antibodies|mesh-list
111440606|NCT00000590|Immunologic Factors|immunologic factors|mesh-ancestor
111440607|NCT00000590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111440608|NCT00000614|Warfarin|warfarin|mesh-list
111440609|NCT00000614|Anticoagulants|anticoagulants|mesh-ancestor
111440610|NCT02973464|Valganciclovir|valganciclovir|mesh-list
111440611|NCT02973464|Ganciclovir|ganciclovir|mesh-list
111440612|NCT02973464|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
111440613|NCT02973464|Antiviral Agents|antiviral agents|mesh-ancestor
111440614|NCT02973464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111440615|NCT02973464|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111440616|NCT02973464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111440617|NCT02973464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111440618|NCT00000626|Doxorubicin|doxorubicin|mesh-list
111440619|NCT00000626|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111440620|NCT00000626|Bleomycin|bleomycin|mesh-list
111440621|NCT00000626|Dacarbazine|dacarbazine|mesh-list
111440622|NCT00000626|Vinblastine|vinblastine|mesh-list
111440623|NCT00000626|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111440624|NCT00000626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111440625|NCT00000626|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111440626|NCT00000626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111440627|NCT00000626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111440628|NCT00000626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111440629|NCT00000626|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111440630|NCT00000626|Alkylating Agents|alkylating agents|mesh-ancestor
111440631|NCT00000626|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110523749|NCT03615105|Melphalan|melphalan|mesh-list
111440632|NCT00000626|Tubulin Modulators|tubulin modulators|mesh-ancestor
111440633|NCT00000626|Antimitotic Agents|antimitotic agents|mesh-ancestor
111440634|NCT00000626|Mitosis Modulators|mitosis modulators|mesh-ancestor
111440635|NCT03109873|Metformin|metformin|mesh-list
111440636|NCT03109873|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111440637|NCT03109873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111440638|NCT04713254|Metoprolol|metoprolol|mesh-list
111440639|NCT04713254|Midazolam|midazolam|mesh-list
111440640|NCT04713254|Bupropion|bupropion|mesh-list
111440641|NCT04713254|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111440642|NCT04713254|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111440643|NCT04713254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111440644|NCT04713254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111440645|NCT04713254|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111440646|NCT04713254|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111440647|NCT04713254|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111440648|NCT04713254|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111440649|NCT04713254|Anesthetics, General|anesthetics, general|mesh-ancestor
111440650|NCT04713254|Anesthetics|anesthetics|mesh-ancestor
111440651|NCT04713254|GABA Modulators|gaba modulators|mesh-ancestor
111440652|NCT04713254|GABA Agents|gaba agents|mesh-ancestor
111440653|NCT04713254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111440654|NCT04713254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111440655|NCT04713254|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111440656|NCT04713254|Antidepressive Agents|antidepressive agents|mesh-ancestor
111440657|NCT04713254|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111440658|NCT04713254|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111440659|NCT04713254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111440660|NCT04713254|Dopamine Agents|dopamine agents|mesh-ancestor
111440661|NCT04713254|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111440662|NCT04713254|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111440663|NCT04713254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111440664|NCT04713254|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111440665|NCT04713254|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111440666|NCT04713254|Sympatholytics|sympatholytics|mesh-ancestor
111440667|NCT04713254|Autonomic Agents|autonomic agents|mesh-ancestor
110523997|NCT02705300|Vitamin E|vitamin e|mesh-list
111440668|NCT04713254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111440669|NCT04713254|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
111440670|NCT04713254|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111440671|NCT04713254|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111440672|NCT04713254|Adrenergic Agents|adrenergic agents|mesh-ancestor
111440673|NCT00002156|Ganciclovir|ganciclovir|mesh-list
111440674|NCT00002156|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
111440675|NCT00002156|Fomivirsen|fomivirsen|mesh-list
111440676|NCT00002156|Antiviral Agents|antiviral agents|mesh-ancestor
111440677|NCT00002156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111440678|NCT00002156|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111440679|NCT00002156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111440680|NCT00002156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111440681|NCT04092907|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111440682|NCT04092907|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111440683|NCT00002162|Lamivudine|lamivudine|mesh-list
111440684|NCT00002162|Zidovudine|zidovudine|mesh-list
111440685|NCT00002162|Stavudine|stavudine|mesh-list
111440686|NCT00002162|Didanosine|didanosine|mesh-list
111440687|NCT00002162|Zalcitabine|zalcitabine|mesh-list
111440688|NCT00002162|Saquinavir|saquinavir|mesh-list
111440689|NCT00002162|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111440690|NCT00002162|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110524180|NCT00795340|Cediranib|cediranib|mesh-list
111440691|NCT00002162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111440692|NCT00002162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111440693|NCT00002162|Antiviral Agents|antiviral agents|mesh-ancestor
111440694|NCT00002162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111440695|NCT00002162|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111440696|NCT00002162|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111440697|NCT00002162|Antimetabolites|antimetabolites|mesh-ancestor
111440698|NCT00002162|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111440699|NCT00002162|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111440700|NCT00002162|Protease Inhibitors|protease inhibitors|mesh-ancestor
111440701|NCT00002162|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110524296|NCT00944359|Zinc|zinc|mesh-list
111440702|NCT00002162|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111440703|NCT00000638|Pyridoxine|pyridoxine|mesh-list
111440704|NCT00000638|Vitamin B 6|vitamin b 6|mesh-list
111440705|NCT00000638|Rifampin|rifampin|mesh-list
111440706|NCT00000638|Isoniazid|isoniazid|mesh-list
111440707|NCT00000638|Pyrazinamide|pyrazinamide|mesh-list
111440708|NCT00000638|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111440709|NCT00000638|Antitubercular Agents|antitubercular agents|mesh-ancestor
111440710|NCT00000638|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111440711|NCT00000638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111440712|NCT00000638|Leprostatic Agents|leprostatic agents|mesh-ancestor
111440713|NCT00000638|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111440714|NCT00000638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111440715|NCT00000638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110524363|NCT03633110|Nivolumab|nivolumab|mesh-list
111440716|NCT00000638|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111440717|NCT00000638|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111440718|NCT00000638|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
111440719|NCT00000638|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
111440720|NCT00000638|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
111440721|NCT00000638|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111440722|NCT00000638|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
111440723|NCT00000638|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111440724|NCT00000638|Antimetabolites|antimetabolites|mesh-ancestor
111440725|NCT00000638|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111440726|NCT00000638|Vitamin B Complex|vitamin b complex|mesh-ancestor
111440727|NCT00000638|Vitamins|vitamins|mesh-ancestor
111440728|NCT00000638|Micronutrients|micronutrients|mesh-ancestor
111440729|NCT00000638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111440730|NCT00000650|Ditiocarb|ditiocarb|mesh-list
111440731|NCT00000650|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111440732|NCT00000650|Immunologic Factors|immunologic factors|mesh-ancestor
111440733|NCT00000650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111440734|NCT00000650|Antiviral Agents|antiviral agents|mesh-ancestor
111440735|NCT00000650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111440736|NCT00000650|Chelating Agents|chelating agents|mesh-ancestor
111440737|NCT00000650|Sequestering Agents|sequestering agents|mesh-ancestor
111440738|NCT00000650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111440739|NCT00000656|Zidovudine|zidovudine|mesh-list
111440740|NCT00000656|Didanosine|didanosine|mesh-list
111440741|NCT00000656|Antimetabolites|antimetabolites|mesh-ancestor
111440742|NCT00000656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111440743|NCT00000656|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111440744|NCT00000656|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111440745|NCT00000656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111440746|NCT00000656|Antiviral Agents|antiviral agents|mesh-ancestor
111440747|NCT00000656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111440748|NCT00000656|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111440749|NCT00000656|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111440750|NCT00000662|Zidovudine|zidovudine|mesh-list
111440751|NCT00000662|Antimetabolites|antimetabolites|mesh-ancestor
111440752|NCT00000662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111440753|NCT00000662|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111440754|NCT00000662|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111440755|NCT00000662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111440756|NCT00000662|Antiviral Agents|antiviral agents|mesh-ancestor
111440757|NCT00000662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111440758|NCT00000662|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111440759|NCT00000662|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111440760|NCT00002168|Lamivudine|lamivudine|mesh-list
111440761|NCT00002168|Zidovudine|zidovudine|mesh-list
111440762|NCT00002168|Stavudine|stavudine|mesh-list
111440763|NCT00002168|Didanosine|didanosine|mesh-list
111440764|NCT00002168|Indinavir|indinavir|mesh-list
111440765|NCT00002168|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111440766|NCT00002168|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111440767|NCT00002168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111440768|NCT00002168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111440769|NCT00002168|Antiviral Agents|antiviral agents|mesh-ancestor
110172252|NCT00049777|Tinzaparin|tinzaparin|mesh-list
111440770|NCT00002168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111440771|NCT00002168|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111440772|NCT00002168|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111440773|NCT00002168|Antimetabolites|antimetabolites|mesh-ancestor
111440774|NCT00002168|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111440775|NCT00002168|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111440776|NCT00002168|Protease Inhibitors|protease inhibitors|mesh-ancestor
111440777|NCT00001442|Paclitaxel|paclitaxel|mesh-list
111440778|NCT00001442|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111440779|NCT00001442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111440780|NCT00001442|Tubulin Modulators|tubulin modulators|mesh-ancestor
111440781|NCT00001442|Antimitotic Agents|antimitotic agents|mesh-ancestor
111440782|NCT00001442|Mitosis Modulators|mitosis modulators|mesh-ancestor
110524862|NCT02600247|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111440783|NCT00001442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111440784|NCT00002174|Thalidomide|thalidomide|mesh-list
111440785|NCT00002174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111440786|NCT00002174|Immunologic Factors|immunologic factors|mesh-ancestor
111440787|NCT00002174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111440788|NCT00002174|Leprostatic Agents|leprostatic agents|mesh-ancestor
111440789|NCT00002174|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111440790|NCT00002174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111440791|NCT00002174|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111440792|NCT00002174|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111440793|NCT00002174|Growth Substances|growth substances|mesh-ancestor
111440794|NCT00002174|Growth Inhibitors|growth inhibitors|mesh-ancestor
111440795|NCT00002174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111440796|NCT00000668|Ganciclovir|ganciclovir|mesh-list
111440797|NCT00000668|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
111440798|NCT00000668|Antiviral Agents|antiviral agents|mesh-ancestor
111440799|NCT00000668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111440800|NCT00000668|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111440801|NCT00000668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111440802|NCT00000668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111440803|NCT00000680|Zidovudine|zidovudine|mesh-list
111440804|NCT00000680|Aldesleukin|aldesleukin|mesh-list
111440805|NCT00000680|Antimetabolites|antimetabolites|mesh-ancestor
111440806|NCT00000680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111440807|NCT00000680|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111440808|NCT00000680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111440809|NCT00000680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111440810|NCT00000680|Antiviral Agents|antiviral agents|mesh-ancestor
111440811|NCT00000680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111440812|NCT00000680|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111440813|NCT00000680|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111440814|NCT00000680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111440815|NCT00000692|Miglustat|miglustat|mesh-list
111440816|NCT00000692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111440817|NCT00000692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111440818|NCT00000692|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111440819|NCT00000692|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111440820|NCT00000692|Antiviral Agents|antiviral agents|mesh-ancestor
111440821|NCT00000692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111440822|NCT00000692|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
111440823|NCT00000692|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111440824|NCT00000692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111440825|NCT00000698|Ganciclovir|ganciclovir|mesh-list
111440826|NCT00000698|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
111440827|NCT00000698|Antiviral Agents|antiviral agents|mesh-ancestor
111165151|NCT01490086|Dopamine Agents|dopamine agents|mesh-ancestor
111440828|NCT00000698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111440829|NCT00000698|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111440830|NCT00000698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111440831|NCT00000698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111440832|NCT03764449|Balovaptan|balovaptan|mesh-list
111440833|NCT03764449|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
111440834|NCT03764449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111440835|NCT03764449|Natriuretic Agents|natriuretic agents|mesh-ancestor
111440836|NCT03764449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111440837|NCT00002180|Tenofovir|tenofovir|mesh-list
111440838|NCT00002180|Antiviral Agents|antiviral agents|mesh-ancestor
111440839|NCT00002180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110525055|NCT05106296|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111440840|NCT00002180|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111440841|NCT00002180|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111440842|NCT00002180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111440843|NCT00002180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111440844|NCT00002180|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111440845|NCT00002180|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111440846|NCT00002186|Acyclovir|acyclovir|mesh-list
111440847|NCT00002186|Antiviral Agents|antiviral agents|mesh-ancestor
111440848|NCT00002186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111440849|NCT00001502|Carboplatin|carboplatin|mesh-list
111440850|NCT00001502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111440851|NCT00002192|Azithromycin|azithromycin|mesh-list
111440852|NCT00002192|Clarithromycin|clarithromycin|mesh-list
111440853|NCT00002192|Ethambutol|ethambutol|mesh-list
111440854|NCT00002192|Rifapentine|rifapentine|mesh-list
111440855|NCT00002192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111440856|NCT00002192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111440857|NCT00002192|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111440858|NCT00002192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111440859|NCT00002192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111440860|NCT00002192|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111440861|NCT00002192|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111440862|NCT00002192|Antitubercular Agents|antitubercular agents|mesh-ancestor
111440863|NCT00002192|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111440864|NCT00002192|Leprostatic Agents|leprostatic agents|mesh-ancestor
111440865|NCT00002198|Abacavir|abacavir|mesh-list
111440866|NCT00002198|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111440867|NCT00002198|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111440868|NCT00002198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111440869|NCT00002198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111440870|NCT00002198|Antiviral Agents|antiviral agents|mesh-ancestor
111440871|NCT00002198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111440872|NCT00002198|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111440873|NCT00002198|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111440874|NCT00000704|Zalcitabine|zalcitabine|mesh-list
111440875|NCT00000704|Antimetabolites|antimetabolites|mesh-ancestor
111440876|NCT00000704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111440877|NCT00000704|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111440878|NCT00000704|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111440879|NCT00000704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111440880|NCT00000704|Antiviral Agents|antiviral agents|mesh-ancestor
111440881|NCT00000704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111440882|NCT00000704|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111440883|NCT00000704|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111440884|NCT00000728|Zidovudine|zidovudine|mesh-list
111440885|NCT00000728|Aldesleukin|aldesleukin|mesh-list
111440886|NCT00000728|Antimetabolites|antimetabolites|mesh-ancestor
111440887|NCT00000728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111440888|NCT00000728|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111440889|NCT00000728|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111440890|NCT00000728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111440891|NCT00000728|Antiviral Agents|antiviral agents|mesh-ancestor
111440892|NCT00000728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111440893|NCT00000728|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111440894|NCT00000728|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111440895|NCT00000728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111440896|NCT00001520|Neostigmine|neostigmine|mesh-list
111440897|NCT00001520|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111440898|NCT00001520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111440899|NCT00001520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111440900|NCT00001520|Cholinergic Agents|cholinergic agents|mesh-ancestor
111440901|NCT00001520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111440902|NCT00001520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111165227|NCT01625845|Protective Agents|protective agents|mesh-ancestor
111440903|NCT00001520|Parasympathomimetics|parasympathomimetics|mesh-ancestor
111440905|NCT00001520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111440906|NCT00001526|Daclizumab|daclizumab|mesh-list
111440907|NCT00001526|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111440908|NCT00001526|Immunologic Factors|immunologic factors|mesh-ancestor
111440909|NCT00001526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111440910|NCT00002294|Fluconazole|fluconazole|mesh-list
111440911|NCT00002294|Antifungal Agents|antifungal agents|mesh-ancestor
111440912|NCT00002294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111440913|NCT00002294|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111440914|NCT00002294|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111440915|NCT00002294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111440916|NCT00002294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111440917|NCT00002294|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111440918|NCT00002294|Hormone Antagonists|hormone antagonists|mesh-ancestor
111440919|NCT00002294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111440920|NCT00002294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111440921|NCT00002294|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110525254|NCT04257461|Capecitabine|capecitabine|mesh-list
111440922|NCT00002294|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111440923|NCT03758365|Triamcinolone|triamcinolone|mesh-list
111440924|NCT03758365|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
111440925|NCT03758365|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
111440926|NCT03758365|Hydrocortisone|hydrocortisone|mesh-list
111440927|NCT03758365|Betamethasone|betamethasone|mesh-list
111440928|NCT03758365|Betamethasone Valerate|betamethasone valerate|mesh-list
111440929|NCT03758365|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
111440930|NCT03758365|Betamethasone benzoate|betamethasone benzoate|mesh-list
111440931|NCT03758365|Clobetasol|clobetasol|mesh-list
111440932|NCT03758365|Desonide|desonide|mesh-list
111440933|NCT03758365|Hydrocortisone-17-butyrate|hydrocortisone-17-butyrate|mesh-list
111440934|NCT03758365|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
111440935|NCT03758365|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
111440936|NCT03758365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111440937|NCT03758365|Glucocorticoids|glucocorticoids|mesh-ancestor
111440938|NCT03758365|Hormones|hormones|mesh-ancestor
111440939|NCT03758365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111440940|NCT03758365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111440941|NCT03758365|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111440942|NCT03758365|Immunologic Factors|immunologic factors|mesh-ancestor
111440943|NCT03758365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110525417|NCT02707458|Antioxidants|antioxidants|mesh-ancestor
111440944|NCT03758365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111440945|NCT03758365|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111440946|NCT03758365|Respiratory System Agents|respiratory system agents|mesh-ancestor
111440947|NCT03758365|Dermatologic Agents|dermatologic agents|mesh-ancestor
111440948|NCT00002300|Megestrol|megestrol|mesh-list
111440949|NCT00002300|Megestrol Acetate|megestrol acetate|mesh-list
111440950|NCT00002300|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111440951|NCT00002300|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111440952|NCT00002300|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111440953|NCT00002300|Contraceptive Agents|contraceptive agents|mesh-ancestor
111440954|NCT00002300|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111440955|NCT00002300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111440956|NCT00002300|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110525477|NCT05301205|Anticonvulsants|anticonvulsants|mesh-ancestor
111440957|NCT00002300|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111440958|NCT00002300|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111440959|NCT00002300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111440960|NCT00002300|Appetite Stimulants|appetite stimulants|mesh-ancestor
111440961|NCT00002300|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111440962|NCT00002306|Fluconazole|fluconazole|mesh-list
111440963|NCT00002306|Antifungal Agents|antifungal agents|mesh-ancestor
111440964|NCT00002306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111440965|NCT00002306|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111440966|NCT00002306|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111440967|NCT00002306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111440968|NCT00002306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111440969|NCT00002306|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111440970|NCT00002306|Hormone Antagonists|hormone antagonists|mesh-ancestor
111440971|NCT00002306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111440972|NCT00002306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111440973|NCT00002306|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111440974|NCT00002306|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111440975|NCT00002210|Delavirdine|delavirdine|mesh-list
111440976|NCT00002210|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111440977|NCT00002210|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111440978|NCT00002210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111440979|NCT00002210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111440980|NCT00002210|Antiviral Agents|antiviral agents|mesh-ancestor
111440981|NCT00002210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111440982|NCT00002210|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111440983|NCT00002210|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111440984|NCT00002216|Lamivudine|lamivudine|mesh-list
111440985|NCT00002216|Zidovudine|zidovudine|mesh-list
111440986|NCT00002216|Abacavir|abacavir|mesh-list
111440987|NCT00002216|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
111440988|NCT00002216|Nelfinavir|nelfinavir|mesh-list
111440989|NCT00002216|Amprenavir|amprenavir|mesh-list
111440990|NCT00002216|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110525682|NCT02597283|Sirolimus|sirolimus|mesh-list
111440991|NCT00002216|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111440992|NCT00002216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111440993|NCT00002216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111440994|NCT00002216|Antiviral Agents|antiviral agents|mesh-ancestor
111440995|NCT00002216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111440996|NCT00002216|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111440997|NCT00002216|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111440998|NCT00002216|Antimetabolites|antimetabolites|mesh-ancestor
111440999|NCT00002216|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111441000|NCT00002216|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111441001|NCT00002216|Protease Inhibitors|protease inhibitors|mesh-ancestor
111441002|NCT00002216|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111441003|NCT00002216|Antitubercular Agents|antitubercular agents|mesh-ancestor
111441004|NCT00002216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111441005|NCT00002222|Valganciclovir|valganciclovir|mesh-list
111441006|NCT00002222|Antiviral Agents|antiviral agents|mesh-ancestor
111441007|NCT00002222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111441008|NCT00002312|Zidovudine|zidovudine|mesh-list
111441009|NCT00002312|Delavirdine|delavirdine|mesh-list
111441010|NCT00002312|Antimetabolites|antimetabolites|mesh-ancestor
111441011|NCT00002312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111441012|NCT00002312|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111441013|NCT00002312|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111441014|NCT00002312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111441015|NCT00002312|Antiviral Agents|antiviral agents|mesh-ancestor
111441016|NCT00002312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111441017|NCT00002312|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111441018|NCT00002312|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111441019|NCT00002318|Doxorubicin|doxorubicin|mesh-list
111441020|NCT00002318|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111441021|NCT00002318|Bleomycin|bleomycin|mesh-list
111441022|NCT00002318|Vincristine|vincristine|mesh-list
111441023|NCT00002318|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111441024|NCT00002318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111441025|NCT00002318|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110525813|NCT04848714|Antivenins|antivenins|mesh-list
111441026|NCT00002318|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111441027|NCT00002318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111441028|NCT00002318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111441029|NCT00002318|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111441030|NCT00002318|Tubulin Modulators|tubulin modulators|mesh-ancestor
111441031|NCT00002318|Antimitotic Agents|antimitotic agents|mesh-ancestor
111441032|NCT00002318|Mitosis Modulators|mitosis modulators|mesh-ancestor
111441033|NCT00002228|Enfuvirtide|enfuvirtide|mesh-list
111441034|NCT00002228|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
111441035|NCT00002228|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
111441036|NCT00002228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111441037|NCT00002228|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111441038|NCT00002228|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111441039|NCT00002228|Antiviral Agents|antiviral agents|mesh-ancestor
111441040|NCT00002228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111441041|NCT04714177|Edaravone|edaravone|mesh-list
111441042|NCT04714177|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111441043|NCT04714177|Antioxidants|antioxidants|mesh-ancestor
111441044|NCT04714177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110525877|NCT00921557|Calcium Carbonate|calcium carbonate|mesh-list
111441045|NCT04714177|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111441046|NCT04714177|Protective Agents|protective agents|mesh-ancestor
111441047|NCT04714177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111165370|NCT02097823|Serotonin Agents|serotonin agents|mesh-ancestor
111441048|NCT00001628|Angiotensin II|angiotensin ii|mesh-list
111441049|NCT00001628|Giapreza|giapreza|mesh-list
111441050|NCT00001628|Angiotensinogen|angiotensinogen|mesh-list
111441051|NCT00001628|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-list
111441052|NCT00001628|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111441053|NCT00001628|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111441054|NCT00001628|Protease Inhibitors|protease inhibitors|mesh-ancestor
111441055|NCT00001628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110525942|NCT02775734|Acetylcysteine|acetylcysteine|mesh-list
111441056|NCT00001628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111441057|NCT00001628|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111441058|NCT00002234|Lamivudine|lamivudine|mesh-list
111441059|NCT00002234|Efavirenz|efavirenz|mesh-list
111441060|NCT00002234|Didanosine|didanosine|mesh-list
111441061|NCT00002234|Adefovir|adefovir|mesh-list
111441062|NCT00002234|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
111441063|NCT00002234|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111441064|NCT00002234|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111441065|NCT00002234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111441066|NCT00002234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110526044|NCT00743145|Naltrexone|naltrexone|mesh-list
111441067|NCT00002234|Antiviral Agents|antiviral agents|mesh-ancestor
111441068|NCT00002234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111441069|NCT00002234|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111441070|NCT00002234|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111441071|NCT00002234|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111441072|NCT00002234|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111441073|NCT00002234|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111441074|NCT00002234|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111441075|NCT00002234|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111441076|NCT00002234|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111441077|NCT00002234|Antimetabolites|antimetabolites|mesh-ancestor
111441078|NCT04070287|Antibodies|antibodies|mesh-list
111441079|NCT04070287|Immunoglobulins|immunoglobulins|mesh-list
111441080|NCT04070287|Immunologic Factors|immunologic factors|mesh-ancestor
111441081|NCT04070287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111441082|NCT00002324|Zidovudine|zidovudine|mesh-list
111441083|NCT00002324|Nevirapine|nevirapine|mesh-list
111441084|NCT00002324|Antimetabolites|antimetabolites|mesh-ancestor
111441085|NCT00002324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111441086|NCT00002324|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111441087|NCT00002324|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111441088|NCT00002324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111441089|NCT00002324|Antiviral Agents|antiviral agents|mesh-ancestor
111441090|NCT00002324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111441091|NCT00002324|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111441092|NCT00002324|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111441093|NCT00002324|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111441094|NCT00002324|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111441095|NCT00002330|Ganciclovir|ganciclovir|mesh-list
111441096|NCT00002330|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
111441097|NCT00002330|Antiviral Agents|antiviral agents|mesh-ancestor
111441098|NCT00002330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111441099|NCT00002330|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111441100|NCT00002330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111441101|NCT00002330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111441102|NCT03740659|Levofloxacin|levofloxacin|mesh-list
111441103|NCT03740659|Ofloxacin|ofloxacin|mesh-list
111441104|NCT03740659|Dexamethasone|dexamethasone|mesh-list
111441105|NCT03740659|Dexamethasone acetate|dexamethasone acetate|mesh-list
111441106|NCT03740659|BB 1101|bb 1101|mesh-list
110526227|NCT02774096|Anesthetics|anesthetics|mesh-ancestor
111441107|NCT03740659|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111441108|NCT03740659|Antiemetics|antiemetics|mesh-ancestor
111441109|NCT03740659|Autonomic Agents|autonomic agents|mesh-ancestor
111441110|NCT03740659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111441111|NCT03740659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111441112|NCT03740659|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111441113|NCT03740659|Glucocorticoids|glucocorticoids|mesh-ancestor
111441114|NCT03740659|Hormones|hormones|mesh-ancestor
110526316|NCT03521232|Niclosamide|niclosamide|mesh-list
111441115|NCT03740659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111441116|NCT03740659|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111441117|NCT03740659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111441118|NCT03740659|Protease Inhibitors|protease inhibitors|mesh-ancestor
111441119|NCT03740659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111441120|NCT03740659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111441121|NCT03740659|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111441122|NCT03740659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111441123|NCT03740659|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111441124|NCT03740659|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111441125|NCT03740659|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111441126|NCT03740659|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111441127|NCT03740659|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111441128|NCT00002336|Clarithromycin|clarithromycin|mesh-list
111441129|NCT00002336|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111441130|NCT00002336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111441131|NCT00002336|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111441132|NCT00002336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111441133|NCT00002336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111441134|NCT00002336|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111441135|NCT00002336|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111441136|NCT00001646|Voriconazole|voriconazole|mesh-list
111441137|NCT00001646|Amphotericin B|amphotericin b|mesh-list
111441138|NCT00001646|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
111441139|NCT00001646|Antifungal Agents|antifungal agents|mesh-ancestor
111441140|NCT00001646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111441141|NCT00001646|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110526391|NCT02773472|Morphine|morphine|mesh-list
111441142|NCT00001646|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111441143|NCT00001646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111441144|NCT00001646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111441145|NCT00001646|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111441146|NCT00001646|Hormone Antagonists|hormone antagonists|mesh-ancestor
111441147|NCT00001646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111441148|NCT00001646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111441149|NCT00001646|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110526465|NCT02696720|Lidocaine|lidocaine|mesh-list
111441150|NCT00001646|Amebicides|amebicides|mesh-ancestor
111441151|NCT00001646|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111441152|NCT00001646|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111441153|NCT00001646|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111441154|NCT00001658|Amoxicillin|amoxicillin|mesh-list
111441155|NCT00001658|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111441156|NCT00001658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111441157|NCT00002252|Octreotide|octreotide|mesh-list
111441158|NCT00002252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111441159|NCT00002252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111441160|NCT00002252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111441161|NCT00002348|Mitoguazone|mitoguazone|mesh-list
111441162|NCT00002348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111441163|NCT00002348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111441164|NCT00002348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111441165|NCT02721277|SMOFlipid|smoflipid|mesh-list
110526503|NCT00643149|Amoxicillin|amoxicillin|mesh-list
111441166|NCT02721277|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
111441167|NCT02721277|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
111441168|NCT02721277|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111441169|NCT00378235|Pseudomonas aeruginosa exotoxin A|pseudomonas aeruginosa exotoxin a|mesh-list
111441170|NCT00378235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111441171|NCT00002270|Interferons|interferons|mesh-list
111441172|NCT00002270|Interferon-alpha|interferon-alpha|mesh-list
111441173|NCT00002270|Interferon alpha-2|interferon alpha-2|mesh-list
111441174|NCT00002270|Zidovudine|zidovudine|mesh-list
111441175|NCT00002270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111441176|NCT00002270|Antiviral Agents|antiviral agents|mesh-ancestor
111441177|NCT00002270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111441178|NCT00002270|Immunologic Factors|immunologic factors|mesh-ancestor
111441179|NCT00002270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111441180|NCT00002270|Antimetabolites|antimetabolites|mesh-ancestor
111441181|NCT00002270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110526669|NCT00910221|Atorvastatin|atorvastatin|mesh-list
111441182|NCT00002270|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111441183|NCT00002270|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111441184|NCT00002270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111441185|NCT00002270|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111441186|NCT00002270|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111441187|NCT00002354|Stavudine|stavudine|mesh-list
111441188|NCT00002354|Indinavir|indinavir|mesh-list
111441189|NCT00002354|Antimetabolites|antimetabolites|mesh-ancestor
111441190|NCT00002354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111441191|NCT00002354|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111441192|NCT00002354|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111441193|NCT00002354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111441194|NCT00002354|Antiviral Agents|antiviral agents|mesh-ancestor
111441195|NCT00002354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111441196|NCT00002354|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111441197|NCT00002354|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111441198|NCT00002354|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111441199|NCT00002354|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111441200|NCT00002354|Protease Inhibitors|protease inhibitors|mesh-ancestor
111441201|NCT00002360|Didanosine|didanosine|mesh-list
111441203|NCT00002360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111441204|NCT00002360|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111441205|NCT00002360|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111441206|NCT00002360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111441207|NCT00002360|Antiviral Agents|antiviral agents|mesh-ancestor
111441208|NCT00002360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111441209|NCT00002360|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111441210|NCT00002360|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111441211|NCT00002276|Zidovudine|zidovudine|mesh-list
111441212|NCT00002276|Ibuprofen|ibuprofen|mesh-list
111441213|NCT00002276|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111441214|NCT00002276|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111441215|NCT00002276|Analgesics|analgesics|mesh-ancestor
111441216|NCT00002276|Sensory System Agents|sensory system agents|mesh-ancestor
111441217|NCT00002276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111441218|NCT00002276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111441219|NCT00002276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111441220|NCT00002276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111441221|NCT00002276|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111441222|NCT00002276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111441223|NCT00002276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111441224|NCT00002276|Antimetabolites|antimetabolites|mesh-ancestor
111441225|NCT00002276|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111441226|NCT00002276|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111441227|NCT00002276|Antiviral Agents|antiviral agents|mesh-ancestor
111441228|NCT00002276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111441229|NCT00002276|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111441230|NCT00002276|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111441231|NCT00378547|Acetaminophen|acetaminophen|mesh-list
111441232|NCT00378547|Dexamethasone|dexamethasone|mesh-list
111441233|NCT00378547|Dexamethasone acetate|dexamethasone acetate|mesh-list
111441234|NCT00378547|Pregabalin|pregabalin|mesh-list
111441235|NCT00378547|BB 1101|bb 1101|mesh-list
111441236|NCT00378547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111441237|NCT00378547|Antiemetics|antiemetics|mesh-ancestor
111441238|NCT00378547|Autonomic Agents|autonomic agents|mesh-ancestor
111441239|NCT00378547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111441240|NCT00378547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111441241|NCT00378547|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111441242|NCT00378547|Glucocorticoids|glucocorticoids|mesh-ancestor
111441243|NCT00378547|Hormones|hormones|mesh-ancestor
111441244|NCT00378547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111441245|NCT00378547|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111441246|NCT00378547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111441247|NCT00378547|Protease Inhibitors|protease inhibitors|mesh-ancestor
111441248|NCT00378547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111441249|NCT00378547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111441250|NCT00378547|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111441251|NCT00378547|Analgesics|analgesics|mesh-ancestor
111441252|NCT00378547|Sensory System Agents|sensory system agents|mesh-ancestor
111441253|NCT00378547|Antipyretics|antipyretics|mesh-ancestor
111441254|NCT00378547|Anticonvulsants|anticonvulsants|mesh-ancestor
111441255|NCT00378547|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111441256|NCT00378547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111441257|NCT00378547|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111441258|NCT00378547|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111441259|NCT00378547|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111441260|NCT00378547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111441261|NCT00378547|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111441262|NCT00002282|Fluconazole|fluconazole|mesh-list
111441263|NCT00002282|Clotrimazole|clotrimazole|mesh-list
111441264|NCT00002282|Miconazole|miconazole|mesh-list
111441265|NCT00002282|Antifungal Agents|antifungal agents|mesh-ancestor
111441266|NCT00002282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111441267|NCT00002282|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111441268|NCT00002282|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111441269|NCT00002282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111441270|NCT00002282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111441271|NCT00002282|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111441272|NCT00002282|Hormone Antagonists|hormone antagonists|mesh-ancestor
111441273|NCT00002282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111441274|NCT00002282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111441275|NCT00002282|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111441276|NCT00002282|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111441277|NCT00002282|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111441278|NCT00002282|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111441279|NCT02658877|Omalizumab|omalizumab|mesh-list
111441280|NCT02658877|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110527189|NCT00647049|Antimetabolites|antimetabolites|mesh-ancestor
111441281|NCT02658877|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111441282|NCT02658877|Respiratory System Agents|respiratory system agents|mesh-ancestor
111441283|NCT00002288|Zidovudine|zidovudine|mesh-list
111441284|NCT00002288|Antimetabolites|antimetabolites|mesh-ancestor
111441285|NCT00002288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111441286|NCT00002288|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111441287|NCT00002288|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111441288|NCT00002288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111441289|NCT00002288|Antiviral Agents|antiviral agents|mesh-ancestor
111441290|NCT00002288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111441291|NCT00002288|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111441292|NCT00002288|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111441293|NCT00002366|Ritonavir|ritonavir|mesh-list
111441294|NCT00002366|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111441295|NCT00002366|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111441296|NCT00002366|Protease Inhibitors|protease inhibitors|mesh-ancestor
111441297|NCT00002366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111441298|NCT00002366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111441299|NCT00002366|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111441300|NCT00002366|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111441301|NCT00002366|Antiviral Agents|antiviral agents|mesh-ancestor
111441302|NCT00002366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111441303|NCT00002366|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111441304|NCT00002366|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111441305|NCT00378313|Paclitaxel|paclitaxel|mesh-list
111441306|NCT00378313|Gemcitabine|gemcitabine|mesh-list
111441307|NCT00378313|Epirubicin|epirubicin|mesh-list
111441308|NCT00378313|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111441309|NCT00378313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111441310|NCT00378313|Tubulin Modulators|tubulin modulators|mesh-ancestor
111441311|NCT00378313|Antimitotic Agents|antimitotic agents|mesh-ancestor
111441312|NCT00378313|Mitosis Modulators|mitosis modulators|mesh-ancestor
111441313|NCT00378313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110527426|NCT00648141|Diclofenac|diclofenac|mesh-list
111441314|NCT00378313|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111441315|NCT00378313|Antimetabolites|antimetabolites|mesh-ancestor
111441316|NCT00378313|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111441317|NCT00378313|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111441318|NCT00378313|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111441319|NCT00378313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111441320|NCT00002372|Nelfinavir|nelfinavir|mesh-list
111441321|NCT00002372|Indinavir|indinavir|mesh-list
111441322|NCT00002372|Saquinavir|saquinavir|mesh-list
111441323|NCT00002372|Amprenavir|amprenavir|mesh-list
111441324|NCT00002372|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111441325|NCT00002372|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111441326|NCT00002372|Protease Inhibitors|protease inhibitors|mesh-ancestor
111441327|NCT00002372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111441328|NCT00002372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111441329|NCT00002372|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111441330|NCT00002372|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111441331|NCT00002372|Antiviral Agents|antiviral agents|mesh-ancestor
111441332|NCT00002372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111441333|NCT00002372|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111441334|NCT00002372|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111441335|NCT00002372|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111441336|NCT00002372|Antitubercular Agents|antitubercular agents|mesh-ancestor
111441337|NCT00002372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111441338|NCT00002378|Ritonavir|ritonavir|mesh-list
111441339|NCT00002378|Nelfinavir|nelfinavir|mesh-list
111441340|NCT00002378|Saquinavir|saquinavir|mesh-list
111441341|NCT00002378|Lamivudine|lamivudine|mesh-list
111441342|NCT00002378|Zidovudine|zidovudine|mesh-list
111441343|NCT00002378|Stavudine|stavudine|mesh-list
111441344|NCT00002378|Delavirdine|delavirdine|mesh-list
111441345|NCT00002378|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111441346|NCT00002378|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111441347|NCT00002378|Protease Inhibitors|protease inhibitors|mesh-ancestor
111441348|NCT00002378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111441349|NCT00002378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111441350|NCT00002378|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111441351|NCT00002378|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111441352|NCT00002378|Antiviral Agents|antiviral agents|mesh-ancestor
111441353|NCT00002378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110527671|NCT00955045|Istradefylline|istradefylline|mesh-list
111441354|NCT00002378|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111441355|NCT00002378|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111441356|NCT00002378|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111441357|NCT00002378|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111441358|NCT00002378|Antimetabolites|antimetabolites|mesh-ancestor
111441360|NCT02589145|Dexamethasone|dexamethasone|mesh-list
111441361|NCT02589145|Rituximab|rituximab|mesh-list
111441362|NCT02589145|Gemcitabine|gemcitabine|mesh-list
111441363|NCT02589145|Lenalidomide|lenalidomide|mesh-list
111441364|NCT02589145|Melphalan|melphalan|mesh-list
111441365|NCT02589145|Busulfan|busulfan|mesh-list
111441366|NCT02589145|Vorinostat|vorinostat|mesh-list
111441367|NCT02589145|Enoxaparin|enoxaparin|mesh-list
111441368|NCT02589145|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111441369|NCT02589145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111441370|NCT02589145|Immunologic Factors|immunologic factors|mesh-ancestor
111441371|NCT02589145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111441372|NCT02589145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111441373|NCT02589145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111441374|NCT02589145|Antiemetics|antiemetics|mesh-ancestor
111441375|NCT02589145|Autonomic Agents|autonomic agents|mesh-ancestor
111441376|NCT02589145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111441377|NCT02589145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111441378|NCT02589145|Glucocorticoids|glucocorticoids|mesh-ancestor
111441379|NCT02589145|Hormones|hormones|mesh-ancestor
111441380|NCT02589145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111441381|NCT02589145|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111441382|NCT02589145|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111441383|NCT02589145|Antimetabolites|antimetabolites|mesh-ancestor
111441384|NCT02589145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111441385|NCT02589145|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111441386|NCT02589145|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111441387|NCT02589145|Growth Substances|growth substances|mesh-ancestor
111441388|NCT02589145|Growth Inhibitors|growth inhibitors|mesh-ancestor
111441389|NCT02589145|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111441390|NCT02589145|Alkylating Agents|alkylating agents|mesh-ancestor
111441391|NCT02589145|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111441392|NCT02589145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111441393|NCT02589145|Anticoagulants|anticoagulants|mesh-ancestor
111441394|NCT02589145|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111441395|NCT02589145|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111441396|NCT02589145|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111441397|NCT02589145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111441398|NCT02589145|Vitamin B Complex|vitamin b complex|mesh-ancestor
111441399|NCT02589145|Vitamins|vitamins|mesh-ancestor
111441400|NCT02589145|Micronutrients|micronutrients|mesh-ancestor
111441401|NCT00002384|Cidofovir|cidofovir|mesh-list
111441402|NCT00002384|Antiviral Agents|antiviral agents|mesh-ancestor
111441403|NCT00002384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111441404|NCT00002384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110527947|NCT02759198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111441405|NCT00002384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111441406|NCT02568007|Cyproheptadine|cyproheptadine|mesh-list
111441407|NCT02568007|Antipruritics|antipruritics|mesh-ancestor
111441408|NCT02568007|Dermatologic Agents|dermatologic agents|mesh-ancestor
111441409|NCT02568007|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111441410|NCT02568007|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111441411|NCT02568007|Histamine Antagonists|histamine antagonists|mesh-ancestor
111441412|NCT02568007|Histamine Agents|histamine agents|mesh-ancestor
111441413|NCT02568007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111441414|NCT02568007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111441415|NCT02568007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111441416|NCT02568007|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111441417|NCT02568007|Serotonin Agents|serotonin agents|mesh-ancestor
111441418|NCT02568007|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111441419|NCT00002390|Abacavir|abacavir|mesh-list
111441420|NCT00002390|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111441421|NCT00002390|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111441422|NCT00002390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111441423|NCT00002390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111441424|NCT00002390|Antiviral Agents|antiviral agents|mesh-ancestor
111441425|NCT00002390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111165748|NCT01625377|Immunologic Factors|immunologic factors|mesh-ancestor
111441426|NCT00002390|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111441427|NCT00002390|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111441428|NCT00002396|Tenofovir|tenofovir|mesh-list
111441429|NCT00002396|Antiviral Agents|antiviral agents|mesh-ancestor
111441430|NCT00002396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111441431|NCT00002396|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110528084|NCT02705664|Amorolfine|amorolfine|mesh-list
111441432|NCT00002396|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111441433|NCT00002396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111441434|NCT00002396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111441435|NCT00002396|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111441436|NCT00002396|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111441437|NCT00002402|Aluminum Hydroxide|aluminum hydroxide|mesh-list
111441438|NCT00002402|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111441439|NCT00002402|Immunologic Factors|immunologic factors|mesh-ancestor
111441440|NCT00002402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111441441|NCT00002402|Antacids|antacids|mesh-ancestor
111441442|NCT00002402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111441443|NCT00002402|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111441444|NCT00002420|Stavudine|stavudine|mesh-list
111441445|NCT00002420|Didanosine|didanosine|mesh-list
111441446|NCT00002420|Delavirdine|delavirdine|mesh-list
111441447|NCT00002420|Emivirine|emivirine|mesh-list
111441448|NCT00002420|Hydroxyurea|hydroxyurea|mesh-list
111441449|NCT00002420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111441450|NCT00002420|Antisickling Agents|antisickling agents|mesh-ancestor
111441451|NCT00002420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111441452|NCT00002420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111441453|NCT00002420|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111441454|NCT00002420|Antimetabolites|antimetabolites|mesh-ancestor
111441455|NCT00002420|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111441456|NCT00002420|Antiviral Agents|antiviral agents|mesh-ancestor
111441457|NCT00002420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111441458|NCT00002420|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111441459|NCT00002420|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111441460|NCT00381368|Ibandronic Acid|ibandronic acid|mesh-list
111441461|NCT00381368|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111441462|NCT00381368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111441463|NCT04024501|Verinurad|verinurad|mesh-list
111441464|NCT04024501|Gout Suppressants|gout suppressants|mesh-ancestor
111441465|NCT04024501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111441466|NCT05709626|Aspirin|aspirin|mesh-list
111441467|NCT05709626|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111441468|NCT05709626|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111441469|NCT05709626|Analgesics|analgesics|mesh-ancestor
111441470|NCT05709626|Sensory System Agents|sensory system agents|mesh-ancestor
111441471|NCT05709626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111441472|NCT05709626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111441473|NCT05709626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111441474|NCT05709626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111441475|NCT05709626|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111441476|NCT05709626|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111441477|NCT05709626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111441478|NCT05709626|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111441479|NCT05709626|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111441480|NCT05709626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111441481|NCT05709626|Antipyretics|antipyretics|mesh-ancestor
111441482|NCT03538015|Carvedilol|carvedilol|mesh-list
111441483|NCT03538015|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111441484|NCT03538015|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111441485|NCT03538015|Adrenergic Agents|adrenergic agents|mesh-ancestor
111441486|NCT03538015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111441487|NCT03538015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111441488|NCT03538015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111441489|NCT03538015|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111441490|NCT03538015|Antioxidants|antioxidants|mesh-ancestor
111441491|NCT03538015|Protective Agents|protective agents|mesh-ancestor
111441492|NCT03538015|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111441493|NCT03538015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111441494|NCT03538015|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111441495|NCT03538015|Vasodilator Agents|vasodilator agents|mesh-ancestor
111441496|NCT03538015|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111441497|NCT03538015|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111441498|NCT03342157|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
111441499|NCT03342157|Sennosides|sennosides|mesh-list
111441500|NCT03342157|Antidiarrheals|antidiarrheals|mesh-ancestor
111441501|NCT03342157|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111441502|NCT03342157|Laxatives|laxatives|mesh-ancestor
111441503|NCT04331210|Diclofenac|diclofenac|mesh-list
111441504|NCT04331210|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111441505|NCT04331210|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111441506|NCT04331210|Analgesics|analgesics|mesh-ancestor
111441507|NCT04331210|Sensory System Agents|sensory system agents|mesh-ancestor
111441508|NCT04331210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111441509|NCT04331210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111441510|NCT04331210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111441511|NCT04331210|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111441512|NCT04331210|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111441513|NCT04331210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111441514|NCT04331210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111441515|NCT00002426|Adefovir|adefovir|mesh-list
111441516|NCT00002426|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
111441517|NCT00002426|Antiviral Agents|antiviral agents|mesh-ancestor
111441518|NCT00002426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111441519|NCT00002426|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111441520|NCT00002426|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111441521|NCT00002426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111441522|NCT00002426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111441523|NCT00002432|Foscarnet|foscarnet|mesh-list
111441524|NCT00002432|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
111441525|NCT00002432|Antiviral Agents|antiviral agents|mesh-ancestor
111441526|NCT00002432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111441527|NCT00002432|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111441528|NCT00002432|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111441529|NCT00002432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111441530|NCT00002432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111441531|NCT05701436|Leucovorin|leucovorin|mesh-list
111441532|NCT05701436|Doxorubicin|doxorubicin|mesh-list
111441533|NCT05701436|Fluorouracil|fluorouracil|mesh-list
111441534|NCT05701436|Oxaliplatin|oxaliplatin|mesh-list
111441535|NCT05701436|Raltitrexed|raltitrexed|mesh-list
111441536|NCT05701436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111441537|NCT05701436|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111441538|NCT05701436|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111441539|NCT05701436|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111441540|NCT05701436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111441541|NCT05701436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111441542|NCT05701436|Antimetabolites|antimetabolites|mesh-ancestor
111441543|NCT05701436|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111441544|NCT05701436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111441545|NCT05701436|Immunologic Factors|immunologic factors|mesh-ancestor
111441546|NCT05701436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111441547|NCT05701436|Antidotes|antidotes|mesh-ancestor
111441548|NCT05701436|Protective Agents|protective agents|mesh-ancestor
111441549|NCT05701436|Vitamin B Complex|vitamin b complex|mesh-ancestor
111441550|NCT05701436|Vitamins|vitamins|mesh-ancestor
111441551|NCT05701436|Micronutrients|micronutrients|mesh-ancestor
111441552|NCT05701436|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111441553|NCT02487277|Paclitaxel|paclitaxel|mesh-list
111441554|NCT02487277|Gemcitabine|gemcitabine|mesh-list
111441555|NCT02487277|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111441556|NCT02487277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111441557|NCT02487277|Tubulin Modulators|tubulin modulators|mesh-ancestor
111441558|NCT02487277|Antimitotic Agents|antimitotic agents|mesh-ancestor
111441559|NCT02487277|Mitosis Modulators|mitosis modulators|mesh-ancestor
111441560|NCT02487277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110528844|NCT02746250|Adrenergic Agents|adrenergic agents|mesh-ancestor
111441561|NCT02487277|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111441562|NCT02487277|Antimetabolites|antimetabolites|mesh-ancestor
111441563|NCT00002438|Itraconazole|itraconazole|mesh-list
111441564|NCT00002438|Antifungal Agents|antifungal agents|mesh-ancestor
111441565|NCT00002438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111441566|NCT00002438|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111441567|NCT00002438|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111441568|NCT00002438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111441569|NCT00002438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111441570|NCT00002438|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111441571|NCT00002438|Hormone Antagonists|hormone antagonists|mesh-ancestor
111441572|NCT00002438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111441573|NCT00002438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111441574|NCT00002438|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111441575|NCT00002444|Nitazoxanide|nitazoxanide|mesh-list
111441576|NCT00002444|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111441577|NCT00002444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111441578|NCT02436265|Dexamethasone|dexamethasone|mesh-list
111441579|NCT02436265|Ropivacaine|ropivacaine|mesh-list
111441580|NCT02436265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111441582|NCT02436265|Autonomic Agents|autonomic agents|mesh-ancestor
111441583|NCT02436265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111441584|NCT02436265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111441585|NCT02436265|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111441586|NCT02436265|Glucocorticoids|glucocorticoids|mesh-ancestor
111441587|NCT02436265|Hormones|hormones|mesh-ancestor
111441588|NCT02436265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111441589|NCT02436265|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111441590|NCT02436265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111441591|NCT02436265|Anesthetics, Local|anesthetics, local|mesh-ancestor
111441592|NCT02436265|Anesthetics|anesthetics|mesh-ancestor
111441593|NCT02436265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111441594|NCT02436265|Sensory System Agents|sensory system agents|mesh-ancestor
111441595|NCT05751746|Magnesium Sulfate|magnesium sulfate|mesh-list
111441596|NCT05751746|Analgesics|analgesics|mesh-ancestor
111441597|NCT05751746|Sensory System Agents|sensory system agents|mesh-ancestor
111441598|NCT05751746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111441599|NCT05751746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111441600|NCT05751746|Anesthetics|anesthetics|mesh-ancestor
111441601|NCT05751746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111441602|NCT05751746|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111441603|NCT05751746|Anticonvulsants|anticonvulsants|mesh-ancestor
111441604|NCT05751746|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111441605|NCT05751746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111441606|NCT05751746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111441607|NCT05751746|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111441608|NCT05751746|Tocolytic Agents|tocolytic agents|mesh-ancestor
111441609|NCT05751746|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111441610|NCT00002450|Tenofovir|tenofovir|mesh-list
111441611|NCT00002450|Antiviral Agents|antiviral agents|mesh-ancestor
111441612|NCT00002450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111441613|NCT00002450|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111441614|NCT00002450|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111441615|NCT00002450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111441616|NCT00002450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111441617|NCT00002450|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111441618|NCT00002450|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111441619|NCT03277183|Epoetin Alfa|epoetin alfa|mesh-list
111441620|NCT03277183|Hematinics|hematinics|mesh-ancestor
111441621|NCT00002456|Cyclosporine|cyclosporine|mesh-list
111441622|NCT00002456|Methotrexate|methotrexate|mesh-list
111441623|NCT00002456|Cyclosporins|cyclosporins|mesh-list
111441624|NCT00002456|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111441625|NCT00002456|Abortifacient Agents|abortifacient agents|mesh-ancestor
111441626|NCT00002456|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111441627|NCT00002456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111441628|NCT00002456|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111441629|NCT00002456|Antimetabolites|antimetabolites|mesh-ancestor
111441630|NCT00002456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111441631|NCT00002456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111441632|NCT00002456|Dermatologic Agents|dermatologic agents|mesh-ancestor
111441633|NCT00002456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111441634|NCT00002456|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111441635|NCT00002456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111441636|NCT00002456|Immunologic Factors|immunologic factors|mesh-ancestor
111441637|NCT00002456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111441638|NCT00002456|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111441639|NCT00002456|Antifungal Agents|antifungal agents|mesh-ancestor
111441640|NCT00002456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111441641|NCT00002456|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111441642|NCT01525927|Cisplatin|cisplatin|mesh-list
111441643|NCT01525927|Carboplatin|carboplatin|mesh-list
111441644|NCT01525927|Etoposide|etoposide|mesh-list
111441645|NCT01525927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111441646|NCT01525927|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111441647|NCT01525927|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111441648|NCT01525927|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111441649|NCT01525927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111441650|NCT01525927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111441651|NCT00002474|Cyclophosphamide|cyclophosphamide|mesh-list
111441652|NCT00002474|Carboplatin|carboplatin|mesh-list
111441653|NCT00002474|Mitoxantrone|mitoxantrone|mesh-list
111441654|NCT00002474|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111441655|NCT00002474|Immunologic Factors|immunologic factors|mesh-ancestor
111441656|NCT00002474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111441657|NCT00002474|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111441658|NCT00002474|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111441659|NCT00002474|Alkylating Agents|alkylating agents|mesh-ancestor
111441660|NCT00002474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111441661|NCT00002474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111441662|NCT00002474|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111441663|NCT00002474|Analgesics|analgesics|mesh-ancestor
111441664|NCT00002474|Sensory System Agents|sensory system agents|mesh-ancestor
111441665|NCT00002474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111441666|NCT00002474|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111441667|NCT00002474|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111441668|NCT00002474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111441669|NCT00002492|Doxorubicin|doxorubicin|mesh-list
111441670|NCT00002492|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111441671|NCT00002492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111441672|NCT00002492|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111441673|NCT00002492|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111441674|NCT00002492|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111441675|NCT00002492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111441676|NCT00002492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111441677|NCT05751512|Methotrexate|methotrexate|mesh-list
111441678|NCT05751512|Cetuximab|cetuximab|mesh-list
111441679|NCT05751512|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111441680|NCT05751512|Abortifacient Agents|abortifacient agents|mesh-ancestor
111441681|NCT05751512|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111441682|NCT05751512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111441683|NCT05751512|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111441684|NCT05751512|Antimetabolites|antimetabolites|mesh-ancestor
110529634|NCT02732132|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111441685|NCT05751512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111441686|NCT05751512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111441687|NCT05751512|Dermatologic Agents|dermatologic agents|mesh-ancestor
111441688|NCT05751512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111441689|NCT05751512|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111441690|NCT05751512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111441691|NCT05751512|Immunologic Factors|immunologic factors|mesh-ancestor
111441692|NCT05751512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111441693|NCT05751512|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111441694|NCT05751512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111441695|NCT02373865|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111441696|NCT02373865|Glimepiride|glimepiride|mesh-list
111441697|NCT02373865|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111441698|NCT02373865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111441699|NCT02373865|Incretins|incretins|mesh-ancestor
111441700|NCT02373865|Hormones|hormones|mesh-ancestor
111441701|NCT02373865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111441702|NCT02373865|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111441703|NCT02373865|Protease Inhibitors|protease inhibitors|mesh-ancestor
111441704|NCT02373865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111441705|NCT02373865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111441706|NCT02373865|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111441707|NCT02373865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111441708|NCT02373865|Immunologic Factors|immunologic factors|mesh-ancestor
111441709|NCT00002498|Cyclophosphamide|cyclophosphamide|mesh-list
111441710|NCT00002498|Fluorouracil|fluorouracil|mesh-list
111441711|NCT00002498|Methotrexate|methotrexate|mesh-list
111441712|NCT00002498|Mitoxantrone|mitoxantrone|mesh-list
111441713|NCT00002498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111441714|NCT00002498|Immunologic Factors|immunologic factors|mesh-ancestor
111441715|NCT00002498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111441716|NCT00002498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111441717|NCT00002498|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111441718|NCT00002498|Alkylating Agents|alkylating agents|mesh-ancestor
111441719|NCT00002498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111441720|NCT00002498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111441721|NCT00002498|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111441722|NCT00002498|Antimetabolites|antimetabolites|mesh-ancestor
111441723|NCT00002498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111441724|NCT00002498|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111441725|NCT00002498|Abortifacient Agents|abortifacient agents|mesh-ancestor
111441726|NCT00002498|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111441727|NCT00002498|Dermatologic Agents|dermatologic agents|mesh-ancestor
111441728|NCT00002498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111166044|NCT01627067|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111441729|NCT00002498|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111441730|NCT00002498|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111441731|NCT00002498|Analgesics|analgesics|mesh-ancestor
111441732|NCT00002498|Sensory System Agents|sensory system agents|mesh-ancestor
111441733|NCT00002498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111441734|NCT00002498|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111441735|NCT00002498|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111441736|NCT00002504|Interferons|interferons|mesh-list
111441737|NCT00002504|Interferon-alpha|interferon-alpha|mesh-list
111441738|NCT00002504|Aldesleukin|aldesleukin|mesh-list
111441739|NCT00002504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111441740|NCT00002504|Antiviral Agents|antiviral agents|mesh-ancestor
111441741|NCT00002504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111441742|NCT00002504|Immunologic Factors|immunologic factors|mesh-ancestor
111441743|NCT00002504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111441744|NCT00002504|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111441745|NCT00002504|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111441746|NCT02360059|Metformin|metformin|mesh-list
111441747|NCT02360059|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111441748|NCT02360059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111441749|NCT00002510|Cyclophosphamide|cyclophosphamide|mesh-list
111441750|NCT00002510|Etoposide|etoposide|mesh-list
111441751|NCT00002510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111441752|NCT00002510|Immunologic Factors|immunologic factors|mesh-ancestor
111441753|NCT00002510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111441754|NCT00002510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111441755|NCT00002510|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111441756|NCT00002510|Alkylating Agents|alkylating agents|mesh-ancestor
111441757|NCT00002510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110529928|NCT02717780|Remifentanil|remifentanil|mesh-list
111441758|NCT00002510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111441759|NCT00002510|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111441760|NCT00002510|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111441761|NCT00002510|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111441762|NCT00002510|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111441763|NCT00002510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111441764|NCT01500109|Acetaminophen|acetaminophen|mesh-list
111441765|NCT01500109|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111441766|NCT01500109|Analgesics|analgesics|mesh-ancestor
111441767|NCT01500109|Sensory System Agents|sensory system agents|mesh-ancestor
111441768|NCT01500109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111441769|NCT01500109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111441770|NCT01500109|Antipyretics|antipyretics|mesh-ancestor
111441771|NCT00002516|Cobalt|cobalt|mesh-list
111441772|NCT00002516|Dactinomycin|dactinomycin|mesh-list
111441773|NCT00002516|Cyclophosphamide|cyclophosphamide|mesh-list
111441774|NCT00002516|Ifosfamide|ifosfamide|mesh-list
111441775|NCT00002516|Doxorubicin|doxorubicin|mesh-list
111441776|NCT00002516|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111441777|NCT00002516|Etoposide|etoposide|mesh-list
111441778|NCT00002516|Vincristine|vincristine|mesh-list
111441779|NCT00002516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111441780|NCT00002516|Immunologic Factors|immunologic factors|mesh-ancestor
111441781|NCT00002516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111441782|NCT00002516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111441783|NCT00002516|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111441784|NCT00002516|Alkylating Agents|alkylating agents|mesh-ancestor
111441785|NCT00002516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111441786|NCT00002516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111441787|NCT00002516|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111441788|NCT00002516|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111441789|NCT00002516|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111441790|NCT00002516|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111441791|NCT00002516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111441792|NCT00002516|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111441793|NCT00002516|Tubulin Modulators|tubulin modulators|mesh-ancestor
111441794|NCT00002516|Antimitotic Agents|antimitotic agents|mesh-ancestor
111441795|NCT00002516|Mitosis Modulators|mitosis modulators|mesh-ancestor
111441796|NCT00002516|Trace Elements|trace elements|mesh-ancestor
110530169|NCT02650479|Hormones|hormones|mesh-ancestor
111441797|NCT00002516|Micronutrients|micronutrients|mesh-ancestor
111441798|NCT00002516|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111441799|NCT00002516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111441800|NCT00002516|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111441801|NCT00002516|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111441802|NCT00002522|Cyclophosphamide|cyclophosphamide|mesh-list
111441803|NCT00002522|Etoposide|etoposide|mesh-list
111166127|NCT01598987|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111441804|NCT00002522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111441805|NCT00002522|Immunologic Factors|immunologic factors|mesh-ancestor
111441806|NCT00002522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111441807|NCT00002522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111441808|NCT00002522|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111441809|NCT00002522|Alkylating Agents|alkylating agents|mesh-ancestor
111441810|NCT00002522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111441811|NCT00002522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111441812|NCT00002522|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111441813|NCT00002522|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111441814|NCT00002522|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111441815|NCT00002522|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111441816|NCT00002522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111441817|NCT00002528|Tamoxifen|tamoxifen|mesh-list
111441818|NCT00002528|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111441819|NCT00002528|Hormone Antagonists|hormone antagonists|mesh-ancestor
111441820|NCT00002528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111441821|NCT00002528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111441822|NCT00002528|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111441823|NCT00002528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111441824|NCT00002528|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111441825|NCT00002528|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111441826|NCT00002528|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111441827|NCT02341495|Vitamin D|vitamin d|mesh-list
111441828|NCT02341495|Cholecalciferol|cholecalciferol|mesh-list
111441829|NCT02341495|Azacitidine|azacitidine|mesh-list
111441830|NCT02341495|Deferasirox|deferasirox|mesh-list
111441831|NCT02341495|Vitamins|vitamins|mesh-ancestor
111441832|NCT02341495|Micronutrients|micronutrients|mesh-ancestor
111441833|NCT02341495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111441834|NCT02341495|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111441835|NCT02341495|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111441836|NCT02341495|Antimetabolites|antimetabolites|mesh-ancestor
111441837|NCT02341495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111441838|NCT02341495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111441839|NCT02341495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111441840|NCT02341495|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111441841|NCT02341495|Iron Chelating Agents|iron chelating agents|mesh-ancestor
111441842|NCT02341495|Chelating Agents|chelating agents|mesh-ancestor
111441843|NCT02341495|Sequestering Agents|sequestering agents|mesh-ancestor
111441844|NCT00002534|Cytarabine|cytarabine|mesh-list
111441845|NCT00002534|Methylprednisolone|methylprednisolone|mesh-list
111441846|NCT00002534|Cyclophosphamide|cyclophosphamide|mesh-list
111441847|NCT00002534|Thiotepa|thiotepa|mesh-list
111441848|NCT00002534|Antilymphocyte Serum|antilymphocyte serum|mesh-list
111441849|NCT00002534|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111441850|NCT00002534|Immunologic Factors|immunologic factors|mesh-ancestor
111441851|NCT00002534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111441852|NCT00002534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111441853|NCT00002534|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111441854|NCT00002534|Alkylating Agents|alkylating agents|mesh-ancestor
111441855|NCT00002534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111441856|NCT00002534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111441857|NCT00002534|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111441858|NCT00002534|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111441859|NCT00002534|Antimetabolites|antimetabolites|mesh-ancestor
111441860|NCT00002534|Antiviral Agents|antiviral agents|mesh-ancestor
111441861|NCT00002534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111441862|NCT00002534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111441863|NCT00002534|Antiemetics|antiemetics|mesh-ancestor
111441864|NCT00002534|Autonomic Agents|autonomic agents|mesh-ancestor
111441865|NCT00002534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111441866|NCT00002534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111441867|NCT00002534|Glucocorticoids|glucocorticoids|mesh-ancestor
111441868|NCT00002534|Hormones|hormones|mesh-ancestor
111441869|NCT00002534|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111441870|NCT00002534|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111441871|NCT00002534|Protective Agents|protective agents|mesh-ancestor
111441872|NCT00002546|Ifosfamide|ifosfamide|mesh-list
111441873|NCT00002546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111441874|NCT00002546|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111441875|NCT00002546|Alkylating Agents|alkylating agents|mesh-ancestor
111441876|NCT00002546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111441877|NCT00378625|Artesunate|artesunate|mesh-list
111441878|NCT00378625|Antimalarials|antimalarials|mesh-ancestor
111441879|NCT00378625|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111441880|NCT00378625|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111441881|NCT00378625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111441882|NCT00378625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111441883|NCT00378625|Antiviral Agents|antiviral agents|mesh-ancestor
111441884|NCT00378625|Schistosomicides|schistosomicides|mesh-ancestor
111441885|NCT00378625|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
111441886|NCT00378625|Anthelmintics|anthelmintics|mesh-ancestor
111441887|NCT04005391|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
111441888|NCT04005391|Contraceptive Agents|contraceptive agents|mesh-list
111441889|NCT04005391|Levonorgestrel|levonorgestrel|mesh-list
111441890|NCT04005391|Medroxyprogesterone|medroxyprogesterone|mesh-list
111441891|NCT04005391|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111441892|NCT04005391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111441893|NCT04005391|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111441894|NCT04005391|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110872683|NCT02911688|Tocotrienols|tocotrienols|mesh-list
111441895|NCT04005391|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111441896|NCT04005391|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111441897|NCT04005391|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111441898|NCT04005391|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
111441899|NCT04005391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111441900|NCT04005391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111441901|NCT00002552|Leucovorin|leucovorin|mesh-list
111441902|NCT00002552|Cytarabine|cytarabine|mesh-list
111441903|NCT00002552|Hydrocortisone|hydrocortisone|mesh-list
111441904|NCT00002552|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
111441905|NCT00002552|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
111441906|NCT00002552|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
111441907|NCT00002552|Cyclophosphamide|cyclophosphamide|mesh-list
111441908|NCT00002552|Carmustine|carmustine|mesh-list
111441909|NCT00002552|Methotrexate|methotrexate|mesh-list
111441910|NCT00002552|Etoposide|etoposide|mesh-list
111441911|NCT00002552|Sargramostim|sargramostim|mesh-list
111441912|NCT00002552|Levoleucovorin|levoleucovorin|mesh-list
111441913|NCT00002552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111441914|NCT00002552|Immunologic Factors|immunologic factors|mesh-ancestor
111441915|NCT00002552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111441916|NCT00002552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111441917|NCT00002552|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110872823|NCT02391688|Analgesics|analgesics|mesh-ancestor
111441918|NCT00002552|Alkylating Agents|alkylating agents|mesh-ancestor
111441919|NCT00002552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111441920|NCT00002552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111441921|NCT00002552|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111441922|NCT00002552|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111441923|NCT00002552|Abortifacient Agents|abortifacient agents|mesh-ancestor
111441924|NCT00002552|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111441925|NCT00002552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111441926|NCT00002552|Antimetabolites|antimetabolites|mesh-ancestor
111441927|NCT00002552|Dermatologic Agents|dermatologic agents|mesh-ancestor
111441928|NCT00002552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111441929|NCT00002552|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111441930|NCT00002552|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110872986|NCT03659084|Deferasirox|deferasirox|mesh-list
111441931|NCT00002552|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111441932|NCT00002552|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111441933|NCT00002552|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111441934|NCT00002552|Antiviral Agents|antiviral agents|mesh-ancestor
111441935|NCT00002552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111441936|NCT00002552|Antidotes|antidotes|mesh-ancestor
111441937|NCT00002552|Protective Agents|protective agents|mesh-ancestor
111441938|NCT00002552|Vitamin B Complex|vitamin b complex|mesh-ancestor
111441939|NCT00002552|Vitamins|vitamins|mesh-ancestor
111441940|NCT00002552|Micronutrients|micronutrients|mesh-ancestor
111441941|NCT00002552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111441942|NCT00378781|Minocycline|minocycline|mesh-list
111441943|NCT00378781|Heparin|heparin|mesh-list
110873094|NCT05672212|Sufentanil|sufentanil|mesh-list
111441944|NCT00378781|Anticoagulants|anticoagulants|mesh-ancestor
111441945|NCT00378781|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111441946|NCT00378781|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111441947|NCT00378781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111441948|NCT00378781|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111441949|NCT00378781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111441950|NCT00377923|Progesterone|progesterone|mesh-list
111441951|NCT00377923|Progestins|progestins|mesh-ancestor
111441952|NCT00377923|Hormones|hormones|mesh-ancestor
111441953|NCT00377923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111441954|NCT00377923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111441955|NCT00002570|Leucovorin|leucovorin|mesh-list
111441956|NCT00002570|Fluorouracil|fluorouracil|mesh-list
111441957|NCT00002570|Calcium|calcium|mesh-list
111441958|NCT00002570|Levoleucovorin|levoleucovorin|mesh-list
111441959|NCT00002570|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111441960|NCT00002570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111441961|NCT00002570|Antimetabolites|antimetabolites|mesh-ancestor
111441962|NCT00002570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111441963|NCT00002570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111441964|NCT00002570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111441965|NCT00002570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111441966|NCT00002570|Immunologic Factors|immunologic factors|mesh-ancestor
111441967|NCT00002570|Antidotes|antidotes|mesh-ancestor
111441968|NCT00002570|Protective Agents|protective agents|mesh-ancestor
111441969|NCT00002570|Vitamin B Complex|vitamin b complex|mesh-ancestor
111441970|NCT00002570|Vitamins|vitamins|mesh-ancestor
111441971|NCT00002570|Micronutrients|micronutrients|mesh-ancestor
111441972|NCT00002576|Prednisolone|prednisolone|mesh-list
111441973|NCT00002576|Cyclophosphamide|cyclophosphamide|mesh-list
111441974|NCT00002576|Doxorubicin|doxorubicin|mesh-list
111441975|NCT00002576|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111441976|NCT00002576|Vincristine|vincristine|mesh-list
111441977|NCT00002576|Mitoxantrone|mitoxantrone|mesh-list
111441978|NCT00002576|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111441979|NCT00002576|Immunologic Factors|immunologic factors|mesh-ancestor
111441980|NCT00002576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111441981|NCT00002576|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111441982|NCT00002576|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111441983|NCT00002576|Alkylating Agents|alkylating agents|mesh-ancestor
111441984|NCT00002576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111441985|NCT00002576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111441986|NCT00002576|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111441987|NCT00002576|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111441988|NCT00002576|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111441989|NCT00002576|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111441990|NCT00002576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111441991|NCT00002576|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111441992|NCT00002576|Tubulin Modulators|tubulin modulators|mesh-ancestor
111441993|NCT00002576|Antimitotic Agents|antimitotic agents|mesh-ancestor
111441994|NCT00002576|Mitosis Modulators|mitosis modulators|mesh-ancestor
111441995|NCT00002576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111441996|NCT00002576|Glucocorticoids|glucocorticoids|mesh-ancestor
111441997|NCT00002576|Hormones|hormones|mesh-ancestor
111441998|NCT00002576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111441999|NCT00002576|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111442000|NCT00002576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111442001|NCT00002576|Analgesics|analgesics|mesh-ancestor
111442002|NCT00002576|Sensory System Agents|sensory system agents|mesh-ancestor
111442003|NCT00002582|Tamoxifen|tamoxifen|mesh-list
111442004|NCT00002582|Cyclophosphamide|cyclophosphamide|mesh-list
111442005|NCT00002582|Doxorubicin|doxorubicin|mesh-list
111442006|NCT00002582|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111442007|NCT00002582|Fluorouracil|fluorouracil|mesh-list
111442008|NCT00002582|Methotrexate|methotrexate|mesh-list
111442009|NCT00002582|Leuprolide|leuprolide|mesh-list
111442010|NCT00002582|Goserelin|goserelin|mesh-list
111442011|NCT00002582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111442012|NCT00002582|Immunologic Factors|immunologic factors|mesh-ancestor
111442013|NCT00002582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111442014|NCT00002582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111442015|NCT00002582|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111442016|NCT00002582|Alkylating Agents|alkylating agents|mesh-ancestor
111442017|NCT00002582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111442018|NCT00002582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111442019|NCT00002582|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111442020|NCT00002582|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111442021|NCT00002582|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111442022|NCT00002582|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111442023|NCT00002582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111442024|NCT00002582|Antimetabolites|antimetabolites|mesh-ancestor
111442025|NCT00002582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111442026|NCT00002582|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111442027|NCT00002582|Abortifacient Agents|abortifacient agents|mesh-ancestor
111442028|NCT00002582|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111442029|NCT00002582|Dermatologic Agents|dermatologic agents|mesh-ancestor
111442030|NCT00002582|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111442031|NCT00002582|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111442032|NCT00002582|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111442033|NCT00002582|Hormone Antagonists|hormone antagonists|mesh-ancestor
111442034|NCT00002582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111442035|NCT00002582|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111442036|NCT00002582|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110873794|NCT01411267|Antimetabolites|antimetabolites|mesh-ancestor
111442037|NCT00002582|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111442038|NCT00002582|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111442039|NCT00002582|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111442040|NCT00002582|Fertility Agents|fertility agents|mesh-ancestor
111442041|NCT00002588|Etoposide|etoposide|mesh-list
111442042|NCT00002588|Topotecan|topotecan|mesh-list
111442043|NCT00002588|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111442044|NCT00002588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111442045|NCT00002588|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111442046|NCT00002588|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111442047|NCT00002588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111442048|NCT00002588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111442049|NCT00002588|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111442050|NCT02239627|Clonidine|clonidine|mesh-list
111442051|NCT02239627|Analgesics|analgesics|mesh-ancestor
111442052|NCT02239627|Sensory System Agents|sensory system agents|mesh-ancestor
111442053|NCT02239627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111442054|NCT02239627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111442055|NCT02239627|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111442056|NCT02239627|Sympatholytics|sympatholytics|mesh-ancestor
111442057|NCT02239627|Autonomic Agents|autonomic agents|mesh-ancestor
111442058|NCT02239627|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111442059|NCT02239627|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111442060|NCT02239627|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111442061|NCT02239627|Adrenergic Agents|adrenergic agents|mesh-ancestor
111442062|NCT02239627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111442063|NCT02239627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111442064|NCT05750576|Chlorhexidine|chlorhexidine|mesh-list
111442065|NCT05750576|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111442066|NCT05750576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111442067|NCT05750576|Disinfectants|disinfectants|mesh-ancestor
111442068|NCT00002594|Cyclophosphamide|cyclophosphamide|mesh-list
111442069|NCT00002594|Melphalan|melphalan|mesh-list
111442070|NCT00002594|Molgramostim|molgramostim|mesh-list
111442071|NCT00002594|Sargramostim|sargramostim|mesh-list
111442072|NCT00002594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111442073|NCT00002594|Immunologic Factors|immunologic factors|mesh-ancestor
111442074|NCT00002594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111442075|NCT00002594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111442076|NCT00002594|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111442077|NCT00002594|Alkylating Agents|alkylating agents|mesh-ancestor
111442078|NCT00002594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111442079|NCT00002594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111442080|NCT00002594|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111442081|NCT02234011|Ketamine|ketamine|mesh-list
111442082|NCT02234011|Analgesics|analgesics|mesh-ancestor
111442083|NCT02234011|Sensory System Agents|sensory system agents|mesh-ancestor
111442084|NCT02234011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111442085|NCT02234011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111442086|NCT02234011|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111442087|NCT02234011|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111442088|NCT02234011|Anesthetics, General|anesthetics, general|mesh-ancestor
111442089|NCT02234011|Anesthetics|anesthetics|mesh-ancestor
111442090|NCT02234011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111442091|NCT02234011|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110874268|NCT02372110|Caffeine|caffeine|mesh-list
111442092|NCT02234011|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111442093|NCT02234011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111442094|NCT02234011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111442095|NCT00002600|Cyclophosphamide|cyclophosphamide|mesh-list
111442096|NCT00002600|Carboplatin|carboplatin|mesh-list
111442097|NCT00002600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111442098|NCT00002600|Immunologic Factors|immunologic factors|mesh-ancestor
111442099|NCT00002600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111442100|NCT00002600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111442101|NCT00002600|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111442102|NCT00002600|Alkylating Agents|alkylating agents|mesh-ancestor
111442103|NCT00002600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111442104|NCT00002600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111442105|NCT00002600|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111442106|NCT02177773|Octreotide|octreotide|mesh-list
111442107|NCT02177773|Edotreotide|edotreotide|mesh-list
111442108|NCT02177773|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110874410|NCT03634137|Hormones|hormones|mesh-ancestor
111442109|NCT02177773|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111442110|NCT02177773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111442111|NCT02177773|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111442112|NCT02177773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111442113|NCT02144155|Oxytocin|oxytocin|mesh-list
111442114|NCT02144155|Oxytocics|oxytocics|mesh-ancestor
111442115|NCT02144155|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111442116|NCT02144155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111442117|NCT00002618|Leucovorin|leucovorin|mesh-list
111442118|NCT00002618|Cobalt|cobalt|mesh-list
111442119|NCT00002618|Cytarabine|cytarabine|mesh-list
111442120|NCT00002618|Prednisone|prednisone|mesh-list
111442121|NCT00002618|Doxorubicin|doxorubicin|mesh-list
111442122|NCT00002618|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111442123|NCT00002618|Methotrexate|methotrexate|mesh-list
111442124|NCT00002618|Vincristine|vincristine|mesh-list
111442125|NCT00002618|Mercaptopurine|mercaptopurine|mesh-list
111442126|NCT00002618|Levoleucovorin|levoleucovorin|mesh-list
111442127|NCT00002618|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111442128|NCT00002618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111442129|NCT00002618|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111442130|NCT00002618|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111442131|NCT00002618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111442132|NCT00002618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111442133|NCT00002618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111442134|NCT00002618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111442135|NCT00002618|Glucocorticoids|glucocorticoids|mesh-ancestor
111442136|NCT00002618|Hormones|hormones|mesh-ancestor
111442137|NCT00002618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111442138|NCT00002618|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111442139|NCT00002618|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111442140|NCT00002618|Abortifacient Agents|abortifacient agents|mesh-ancestor
111442141|NCT00002618|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111442142|NCT00002618|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111442143|NCT00002618|Antimetabolites|antimetabolites|mesh-ancestor
111442144|NCT00002618|Dermatologic Agents|dermatologic agents|mesh-ancestor
111442145|NCT00002618|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111442146|NCT00002618|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111442147|NCT00002618|Immunologic Factors|immunologic factors|mesh-ancestor
111442148|NCT00002618|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111442149|NCT00002618|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111442150|NCT00002618|Antiviral Agents|antiviral agents|mesh-ancestor
111442151|NCT00002618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111442152|NCT00002618|Antidotes|antidotes|mesh-ancestor
111442153|NCT00002618|Protective Agents|protective agents|mesh-ancestor
111442154|NCT00002618|Vitamin B Complex|vitamin b complex|mesh-ancestor
111442155|NCT00002618|Vitamins|vitamins|mesh-ancestor
111442156|NCT00002618|Micronutrients|micronutrients|mesh-ancestor
111442157|NCT00002618|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111442158|NCT00002618|Tubulin Modulators|tubulin modulators|mesh-ancestor
111442159|NCT00002618|Antimitotic Agents|antimitotic agents|mesh-ancestor
111442160|NCT00002618|Mitosis Modulators|mitosis modulators|mesh-ancestor
111442161|NCT00002618|Trace Elements|trace elements|mesh-ancestor
111442162|NCT02145169|Nitrous Oxide|nitrous oxide|mesh-list
111442163|NCT02145169|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111442164|NCT02145169|Anesthetics, General|anesthetics, general|mesh-ancestor
111442165|NCT02145169|Anesthetics|anesthetics|mesh-ancestor
111442166|NCT02145169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111442167|NCT02145169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111442168|NCT02145169|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111442169|NCT02145169|Analgesics|analgesics|mesh-ancestor
111442170|NCT02145169|Sensory System Agents|sensory system agents|mesh-ancestor
111442171|NCT02145169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111442172|NCT00002630|Cobalt|cobalt|mesh-list
111442173|NCT00002630|Cyclophosphamide|cyclophosphamide|mesh-list
111442174|NCT00002630|Melphalan|melphalan|mesh-list
111442175|NCT00002630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111442176|NCT00002630|Immunologic Factors|immunologic factors|mesh-ancestor
111442177|NCT00002630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111442178|NCT00002630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110874922|NCT02354170|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111442179|NCT00002630|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111442180|NCT00002630|Alkylating Agents|alkylating agents|mesh-ancestor
111442181|NCT00002630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111442182|NCT00002630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111442183|NCT00002630|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111442184|NCT00002630|Trace Elements|trace elements|mesh-ancestor
111442185|NCT00002630|Micronutrients|micronutrients|mesh-ancestor
111442186|NCT00002642|Cobalt|cobalt|mesh-list
111442187|NCT00002642|Etoposide|etoposide|mesh-list
111442188|NCT00002642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111442189|NCT00002642|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111442190|NCT00002642|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111442191|NCT00002642|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111442192|NCT00002642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111442193|NCT00002642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111442194|NCT00002642|Trace Elements|trace elements|mesh-ancestor
111442195|NCT00002642|Micronutrients|micronutrients|mesh-ancestor
111442196|NCT00002642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111442197|NCT03983941|Ropivacaine|ropivacaine|mesh-list
111442198|NCT03983941|Anesthetics, Local|anesthetics, local|mesh-ancestor
111442199|NCT03983941|Anesthetics|anesthetics|mesh-ancestor
111442200|NCT03983941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111442201|NCT03983941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111442202|NCT03983941|Sensory System Agents|sensory system agents|mesh-ancestor
111442203|NCT03983941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111442204|NCT04331054|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
111442205|NCT04331054|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111442206|NCT04331054|Respiratory System Agents|respiratory system agents|mesh-ancestor
111442208|NCT00002654|Trace Elements|trace elements|mesh-ancestor
111442209|NCT00002654|Micronutrients|micronutrients|mesh-ancestor
111442210|NCT00002654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111442211|NCT01426555|Zoledronic Acid|zoledronic acid|mesh-list
111442212|NCT01426555|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111442213|NCT01426555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111442214|NCT01434745|Simvastatin|simvastatin|mesh-list
111442215|NCT01434745|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111442216|NCT01434745|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111442217|NCT01434745|Antimetabolites|antimetabolites|mesh-ancestor
111442218|NCT01434745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111442219|NCT01434745|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111442220|NCT01434745|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111442221|NCT01434745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111442222|NCT01401049|Lidocaine|lidocaine|mesh-list
111442223|NCT01401049|Propofol|propofol|mesh-list
111442224|NCT01401049|Fospropofol|fospropofol|mesh-list
111442225|NCT01401049|Anesthetics, Local|anesthetics, local|mesh-ancestor
111442226|NCT01401049|Anesthetics|anesthetics|mesh-ancestor
111442227|NCT01401049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111442228|NCT01401049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111442229|NCT01401049|Sensory System Agents|sensory system agents|mesh-ancestor
111442230|NCT01401049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111442231|NCT01401049|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111442232|NCT01401049|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111442233|NCT01401049|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111442234|NCT01401049|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111442235|NCT01401049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111442236|NCT01401049|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111442237|NCT01401049|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111442238|NCT01401049|Anesthetics, General|anesthetics, general|mesh-ancestor
111442239|NCT00381758|Methylphenidate|methylphenidate|mesh-list
111442240|NCT00381758|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111442241|NCT00381758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111442242|NCT00381758|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111442243|NCT00381758|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111442244|NCT00381758|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111442245|NCT00381758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111442246|NCT00381758|Dopamine Agents|dopamine agents|mesh-ancestor
111442247|NCT00381758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111442248|NCT01402531|Bevacizumab|bevacizumab|mesh-list
111442249|NCT01402531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111442250|NCT01402531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111442251|NCT01402531|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111442252|NCT01402531|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111442253|NCT01402531|Growth Substances|growth substances|mesh-ancestor
111442254|NCT01402531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111442255|NCT01402531|Growth Inhibitors|growth inhibitors|mesh-ancestor
111442256|NCT00381836|Darbepoetin alfa|darbepoetin alfa|mesh-list
111442257|NCT00381836|Hematinics|hematinics|mesh-ancestor
111442258|NCT01971853|Analgesics|analgesics|mesh-list
111442259|NCT01971853|Sensory System Agents|sensory system agents|mesh-ancestor
111442260|NCT01971853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111442261|NCT01971853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111442263|NCT00002678|Prednisone|prednisone|mesh-list
111442264|NCT00002678|Melphalan|melphalan|mesh-list
111442265|NCT00002678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111442266|NCT00002678|Antiemetics|antiemetics|mesh-ancestor
111442267|NCT00002678|Autonomic Agents|autonomic agents|mesh-ancestor
111442268|NCT00002678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111442269|NCT00002678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111442270|NCT00002678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111442271|NCT00002678|Glucocorticoids|glucocorticoids|mesh-ancestor
111442272|NCT00002678|Hormones|hormones|mesh-ancestor
111442273|NCT00002678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111442274|NCT00002678|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111442275|NCT00002678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111442276|NCT00002678|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111442277|NCT00002678|Alkylating Agents|alkylating agents|mesh-ancestor
111442278|NCT00002678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111442279|NCT00002678|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111442280|NCT00002678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111442281|NCT00002678|Immunologic Factors|immunologic factors|mesh-ancestor
111442282|NCT01397695|Bevacizumab|bevacizumab|mesh-list
111442283|NCT01397695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111442284|NCT01397695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111442285|NCT01397695|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111442286|NCT01397695|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111442287|NCT01397695|Growth Substances|growth substances|mesh-ancestor
111442288|NCT01397695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111442289|NCT01397695|Growth Inhibitors|growth inhibitors|mesh-ancestor
111442290|NCT00002684|Paclitaxel|paclitaxel|mesh-list
111442291|NCT00002684|Ifosfamide|ifosfamide|mesh-list
111442292|NCT00002684|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111442293|NCT00002684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111442294|NCT00002684|Tubulin Modulators|tubulin modulators|mesh-ancestor
111442295|NCT00002684|Antimitotic Agents|antimitotic agents|mesh-ancestor
111442296|NCT00002684|Mitosis Modulators|mitosis modulators|mesh-ancestor
111442297|NCT00002684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111442298|NCT00002684|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111442299|NCT00002684|Alkylating Agents|alkylating agents|mesh-ancestor
111442300|NCT02972918|Simendan|simendan|mesh-list
111442301|NCT02972918|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111442302|NCT02972918|Vasodilator Agents|vasodilator agents|mesh-ancestor
111442303|NCT02972918|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
111442304|NCT02972918|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111442305|NCT02972918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111442306|NCT02972918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111442307|NCT02972918|Protective Agents|protective agents|mesh-ancestor
111442308|NCT02972918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111442309|NCT05600491|Temozolomide|temozolomide|mesh-list
111442310|NCT05600491|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111442311|NCT05600491|Alkylating Agents|alkylating agents|mesh-ancestor
111442312|NCT05600491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111442313|NCT05600491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111442314|NCT00002696|Cyclophosphamide|cyclophosphamide|mesh-list
111442315|NCT00002696|Doxorubicin|doxorubicin|mesh-list
111442316|NCT00002696|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111442317|NCT00002696|Fluorouracil|fluorouracil|mesh-list
111442318|NCT00002696|Methotrexate|methotrexate|mesh-list
111442319|NCT00002696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111442320|NCT00002696|Immunologic Factors|immunologic factors|mesh-ancestor
111442321|NCT00002696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111442322|NCT00002696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111442323|NCT00002696|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111442324|NCT00002696|Alkylating Agents|alkylating agents|mesh-ancestor
111442325|NCT00002696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111442326|NCT00002696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111442327|NCT00002696|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111442328|NCT00002696|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111442329|NCT00002696|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111442330|NCT00002696|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111442331|NCT00002696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110875704|NCT02344732|Hormones|hormones|mesh-ancestor
111442332|NCT00002696|Antimetabolites|antimetabolites|mesh-ancestor
111442333|NCT00002696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111442334|NCT00002696|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111442335|NCT00002696|Abortifacient Agents|abortifacient agents|mesh-ancestor
111442336|NCT00002696|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111442337|NCT00002696|Dermatologic Agents|dermatologic agents|mesh-ancestor
111442338|NCT00002696|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111442339|NCT00002696|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111442340|NCT00002702|Aldesleukin|aldesleukin|mesh-list
111442341|NCT00002702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111442342|NCT00002702|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111442343|NCT00002702|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111442344|NCT00002702|Antiviral Agents|antiviral agents|mesh-ancestor
111442345|NCT00002702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111442346|NCT01890577|Darbepoetin alfa|darbepoetin alfa|mesh-list
111442347|NCT01890577|Hematinics|hematinics|mesh-ancestor
111442348|NCT01315873|Bortezomib|bortezomib|mesh-list
111442349|NCT01315873|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
111442350|NCT01315873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111442351|NCT01315873|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111442352|NCT01315873|Alkylating Agents|alkylating agents|mesh-ancestor
111442353|NCT01315873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111442354|NCT01895959|Hyaluronic Acid|hyaluronic acid|mesh-list
111442355|NCT01895959|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111442356|NCT01895959|Immunologic Factors|immunologic factors|mesh-ancestor
111442357|NCT01895959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111442358|NCT01895959|Viscosupplements|viscosupplements|mesh-ancestor
111442359|NCT01895959|Protective Agents|protective agents|mesh-ancestor
111442360|NCT01303003|Dexamethasone|dexamethasone|mesh-list
111442361|NCT01303003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111442362|NCT01303003|Antiemetics|antiemetics|mesh-ancestor
111442363|NCT01303003|Autonomic Agents|autonomic agents|mesh-ancestor
111442364|NCT01303003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111442365|NCT01303003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111442366|NCT01303003|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111442367|NCT01303003|Glucocorticoids|glucocorticoids|mesh-ancestor
111442368|NCT01303003|Hormones|hormones|mesh-ancestor
111442369|NCT01303003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111442370|NCT01303003|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111442371|NCT01303003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111442372|NCT00002714|Prednisone|prednisone|mesh-list
111442373|NCT00002714|Doxorubicin|doxorubicin|mesh-list
111442374|NCT00002714|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111442375|NCT00002714|Bleomycin|bleomycin|mesh-list
111442376|NCT00002714|Etoposide|etoposide|mesh-list
111442377|NCT00002714|Vincristine|vincristine|mesh-list
111442378|NCT00002714|Vinblastine|vinblastine|mesh-list
111442379|NCT00002714|Mechlorethamine|mechlorethamine|mesh-list
111442380|NCT00002714|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111442381|NCT00002714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111442382|NCT00002714|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111442383|NCT00002714|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111442384|NCT00002714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111442385|NCT00002714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111442386|NCT00002714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111442387|NCT00002714|Glucocorticoids|glucocorticoids|mesh-ancestor
111442388|NCT00002714|Hormones|hormones|mesh-ancestor
111442389|NCT00002714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111442390|NCT00002714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111442391|NCT00002714|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111442392|NCT00002714|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111442393|NCT00002714|Tubulin Modulators|tubulin modulators|mesh-ancestor
111442394|NCT00002714|Antimitotic Agents|antimitotic agents|mesh-ancestor
111442395|NCT00002714|Mitosis Modulators|mitosis modulators|mesh-ancestor
111442396|NCT00002714|Alkylating Agents|alkylating agents|mesh-ancestor
111442397|NCT00002714|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111442398|NCT00002720|Tamoxifen|tamoxifen|mesh-list
111442399|NCT00002720|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111442400|NCT00002720|Hormone Antagonists|hormone antagonists|mesh-ancestor
111442401|NCT00002720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111442402|NCT00002720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111442403|NCT00002720|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111442404|NCT00002720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111442405|NCT00002720|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111442406|NCT00002720|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111442407|NCT00002720|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111442408|NCT01821859|Bevacizumab|bevacizumab|mesh-list
110876102|NCT03489863|Ticagrelor|ticagrelor|mesh-list
111442409|NCT01821859|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111442410|NCT01821859|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111166721|NCT02106884|Antimetabolites|antimetabolites|mesh-ancestor
111442411|NCT01821859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111442412|NCT01821859|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111442413|NCT01821859|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111442414|NCT01821859|Growth Substances|growth substances|mesh-ancestor
111442415|NCT01821859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111442416|NCT01821859|Growth Inhibitors|growth inhibitors|mesh-ancestor
111442417|NCT05600023|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111442418|NCT05600023|Nitrofurantoin|nitrofurantoin|mesh-list
111442419|NCT05600023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111442420|NCT05600023|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111442421|NCT01194427|Tamoxifen|tamoxifen|mesh-list
111442422|NCT01194427|Vorinostat|vorinostat|mesh-list
111442423|NCT01194427|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111442424|NCT01194427|Hormone Antagonists|hormone antagonists|mesh-ancestor
111442425|NCT01194427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111442426|NCT01194427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111442427|NCT01194427|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111442428|NCT01194427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111442429|NCT01194427|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111442430|NCT01194427|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111442431|NCT01194427|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111442432|NCT01194427|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111442433|NCT01194427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111442434|NCT01194427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111442435|NCT05599555|Vaccines|vaccines|mesh-list
111442436|NCT05599555|Immunologic Factors|immunologic factors|mesh-ancestor
111442437|NCT05599555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111442438|NCT00002738|Leucovorin|leucovorin|mesh-list
111442439|NCT00002738|Trimetrexate|trimetrexate|mesh-list
111442440|NCT00002738|Calcium|calcium|mesh-list
111442441|NCT00002738|Levoleucovorin|levoleucovorin|mesh-list
111442442|NCT00002738|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111442443|NCT00002738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111442444|NCT00002738|Antidotes|antidotes|mesh-ancestor
111442445|NCT00002738|Protective Agents|protective agents|mesh-ancestor
111442446|NCT00002738|Vitamin B Complex|vitamin b complex|mesh-ancestor
111442447|NCT00002738|Vitamins|vitamins|mesh-ancestor
111442448|NCT00002738|Micronutrients|micronutrients|mesh-ancestor
111442449|NCT00002738|Antifungal Agents|antifungal agents|mesh-ancestor
111442450|NCT00002738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111442451|NCT00002738|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111442452|NCT00002738|Antimetabolites|antimetabolites|mesh-ancestor
111442453|NCT00002738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111442454|NCT00002738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111442455|NCT00002738|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111442456|NCT00002738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111442457|NCT04706455|Hyaluronic Acid|hyaluronic acid|mesh-list
111442458|NCT04706455|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111442459|NCT04706455|Immunologic Factors|immunologic factors|mesh-ancestor
111442460|NCT04706455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111442461|NCT04706455|Viscosupplements|viscosupplements|mesh-ancestor
111442462|NCT04706455|Protective Agents|protective agents|mesh-ancestor
111442463|NCT00002744|Cobalt|cobalt|mesh-list
111442464|NCT00002744|Cytarabine|cytarabine|mesh-list
111442465|NCT00002744|Dexamethasone|dexamethasone|mesh-list
111442466|NCT00002744|Prednisone|prednisone|mesh-list
111442467|NCT00002744|Hydrocortisone|hydrocortisone|mesh-list
111442468|NCT00002744|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
111442469|NCT00002744|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
111442470|NCT00002744|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
111442471|NCT00002744|Cyclophosphamide|cyclophosphamide|mesh-list
111442472|NCT00002744|Doxorubicin|doxorubicin|mesh-list
111442473|NCT00002744|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111442474|NCT00002744|Methotrexate|methotrexate|mesh-list
111442475|NCT00002744|Vincristine|vincristine|mesh-list
111442476|NCT00002744|Daunorubicin|daunorubicin|mesh-list
111442477|NCT00002744|Asparaginase|asparaginase|mesh-list
111442478|NCT00002744|Mercaptopurine|mercaptopurine|mesh-list
111442479|NCT00002744|Pegaspargase|pegaspargase|mesh-list
111442480|NCT00002744|Thioguanine|thioguanine|mesh-list
111442481|NCT00002744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111442482|NCT00002744|Immunologic Factors|immunologic factors|mesh-ancestor
111442483|NCT00002744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111442484|NCT00002744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111442485|NCT00002744|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111442486|NCT00002744|Alkylating Agents|alkylating agents|mesh-ancestor
111442487|NCT00002744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111442488|NCT00002744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111442489|NCT00002744|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111442490|NCT00002744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111442491|NCT00002744|Antiemetics|antiemetics|mesh-ancestor
111442492|NCT00002744|Autonomic Agents|autonomic agents|mesh-ancestor
111442493|NCT00002744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111442494|NCT00002744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111442495|NCT00002744|Glucocorticoids|glucocorticoids|mesh-ancestor
111442496|NCT00002744|Hormones|hormones|mesh-ancestor
111442497|NCT00002744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111442498|NCT00002744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111442499|NCT00002744|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111442500|NCT00002744|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111442501|NCT00002744|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111442502|NCT00002744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111442503|NCT00002744|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111442504|NCT00002744|Abortifacient Agents|abortifacient agents|mesh-ancestor
111442505|NCT00002744|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111442506|NCT00002744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111442507|NCT00002744|Antimetabolites|antimetabolites|mesh-ancestor
111442508|NCT00002744|Dermatologic Agents|dermatologic agents|mesh-ancestor
111442509|NCT00002744|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111442510|NCT00002744|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111442511|NCT00002744|Antiviral Agents|antiviral agents|mesh-ancestor
111442512|NCT00002744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111442513|NCT00002744|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111442514|NCT00002744|Tubulin Modulators|tubulin modulators|mesh-ancestor
111442515|NCT00002744|Antimitotic Agents|antimitotic agents|mesh-ancestor
111442516|NCT00002744|Mitosis Modulators|mitosis modulators|mesh-ancestor
111442517|NCT00002744|Trace Elements|trace elements|mesh-ancestor
111442518|NCT00002744|Micronutrients|micronutrients|mesh-ancestor
111442519|NCT01788475|Dexamethasone|dexamethasone|mesh-list
111442520|NCT01788475|Dexamethasone acetate|dexamethasone acetate|mesh-list
111442521|NCT01788475|BB 1101|bb 1101|mesh-list
111442522|NCT01788475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111442523|NCT01788475|Antiemetics|antiemetics|mesh-ancestor
111442524|NCT01788475|Autonomic Agents|autonomic agents|mesh-ancestor
111442525|NCT01788475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111442526|NCT01788475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111442527|NCT01788475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111442528|NCT01788475|Glucocorticoids|glucocorticoids|mesh-ancestor
111442529|NCT01788475|Hormones|hormones|mesh-ancestor
111442530|NCT01788475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111442531|NCT01788475|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111442532|NCT01788475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111442533|NCT01788475|Protease Inhibitors|protease inhibitors|mesh-ancestor
111442534|NCT01788475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111442535|NCT01788475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111442536|NCT01183897|Immunomodulating Agents|immunomodulating agents|mesh-list
111442537|NCT01183897|Immunologic Factors|immunologic factors|mesh-ancestor
111442538|NCT01183897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111442539|NCT00381914|Vitamin D|vitamin d|mesh-list
111442540|NCT00381914|Ergocalciferols|ergocalciferols|mesh-list
111442541|NCT00381914|Cholecalciferol|cholecalciferol|mesh-list
111442542|NCT00381914|Vitamins|vitamins|mesh-list
111442543|NCT00381914|Micronutrients|micronutrients|mesh-ancestor
111442544|NCT00381914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111442545|NCT00381914|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111442546|NCT00381914|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111442547|NCT00423007|Bromfenac|bromfenac|mesh-list
111442548|NCT00423007|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111442549|NCT00423007|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111442550|NCT00423007|Analgesics|analgesics|mesh-ancestor
111442551|NCT00423007|Sensory System Agents|sensory system agents|mesh-ancestor
111442552|NCT00423007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111442553|NCT00423007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111442554|NCT00423007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111442555|NCT00423007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111442556|NCT00002750|Melphalan|melphalan|mesh-list
111442557|NCT00002750|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111442558|NCT00002750|Alkylating Agents|alkylating agents|mesh-ancestor
111442559|NCT00002750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111442560|NCT00002750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111442561|NCT00002750|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111442562|NCT00002750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111166865|NCT02044094|Sensory System Agents|sensory system agents|mesh-ancestor
111442563|NCT00002750|Immunologic Factors|immunologic factors|mesh-ancestor
111442564|NCT00002750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111442565|NCT00002756|Leucovorin|leucovorin|mesh-list
111442566|NCT00002756|Cytarabine|cytarabine|mesh-list
111442567|NCT00002756|Prednisone|prednisone|mesh-list
111442568|NCT00002756|Hydrocortisone|hydrocortisone|mesh-list
111442569|NCT00002756|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
111442570|NCT00002756|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
111442571|NCT00002756|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
111442572|NCT00002756|Cyclophosphamide|cyclophosphamide|mesh-list
111442573|NCT00002756|Methotrexate|methotrexate|mesh-list
111442574|NCT00002756|Etoposide|etoposide|mesh-list
111442575|NCT00002756|Vincristine|vincristine|mesh-list
111442576|NCT00002756|Daunorubicin|daunorubicin|mesh-list
111442577|NCT00002756|Asparaginase|asparaginase|mesh-list
111442578|NCT00002756|Mercaptopurine|mercaptopurine|mesh-list
111442579|NCT00002756|Levoleucovorin|levoleucovorin|mesh-list
111442580|NCT00002756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111442581|NCT00002756|Immunologic Factors|immunologic factors|mesh-ancestor
111442582|NCT00002756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111442583|NCT00002756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111442584|NCT00002756|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111442585|NCT00002756|Alkylating Agents|alkylating agents|mesh-ancestor
111442586|NCT00002756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111442587|NCT00002756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111442588|NCT00002756|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111442589|NCT00002756|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111442590|NCT00002756|Glucocorticoids|glucocorticoids|mesh-ancestor
111442591|NCT00002756|Hormones|hormones|mesh-ancestor
111442592|NCT00002756|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111442593|NCT00002756|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111442594|NCT00002756|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111442595|NCT00002756|Abortifacient Agents|abortifacient agents|mesh-ancestor
110877250|NCT03650582|Glucagon|glucagon|mesh-list
111442596|NCT00002756|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111442597|NCT00002756|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111442598|NCT00002756|Antimetabolites|antimetabolites|mesh-ancestor
111442599|NCT00002756|Dermatologic Agents|dermatologic agents|mesh-ancestor
111442600|NCT00002756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111442601|NCT00002756|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111442602|NCT00002756|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111442603|NCT00002756|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110877320|NCT03461003|Protease Inhibitors|protease inhibitors|mesh-ancestor
111442604|NCT00002756|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111442605|NCT00002756|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111442606|NCT00002756|Antiviral Agents|antiviral agents|mesh-ancestor
111442607|NCT00002756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111442608|NCT00002756|Antidotes|antidotes|mesh-ancestor
111442609|NCT00002756|Protective Agents|protective agents|mesh-ancestor
111442610|NCT00002756|Vitamin B Complex|vitamin b complex|mesh-ancestor
111442611|NCT00002756|Vitamins|vitamins|mesh-ancestor
111442612|NCT00002756|Micronutrients|micronutrients|mesh-ancestor
111442613|NCT00002756|Tubulin Modulators|tubulin modulators|mesh-ancestor
111442614|NCT00002756|Antimitotic Agents|antimitotic agents|mesh-ancestor
111442615|NCT00002756|Mitosis Modulators|mitosis modulators|mesh-ancestor
111442616|NCT00002756|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111442617|NCT01183429|Tretinoin|tretinoin|mesh-list
111442618|NCT01183429|Isotretinoin|isotretinoin|mesh-list
111442619|NCT01183429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111442620|NCT01183429|Keratolytic Agents|keratolytic agents|mesh-ancestor
111442621|NCT01183429|Dermatologic Agents|dermatologic agents|mesh-ancestor
111442622|NCT01157533|Vancomycin|vancomycin|mesh-list
111442623|NCT01157533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111442624|NCT01157533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111442625|NCT05749016|Paclitaxel|paclitaxel|mesh-list
111442626|NCT05749016|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111442627|NCT05749016|Carboplatin|carboplatin|mesh-list
111442628|NCT05749016|Pertuzumab|pertuzumab|mesh-list
111442629|NCT05749016|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111442630|NCT05749016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110877588|NCT05197101|Oxytocin|oxytocin|mesh-list
111442631|NCT05749016|Tubulin Modulators|tubulin modulators|mesh-ancestor
111442632|NCT05749016|Antimitotic Agents|antimitotic agents|mesh-ancestor
111442633|NCT05749016|Mitosis Modulators|mitosis modulators|mesh-ancestor
111442634|NCT05749016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111442635|NCT05749016|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111442636|NCT01756573|Bupivacaine|bupivacaine|mesh-list
111442637|NCT01756573|Anesthetics, Local|anesthetics, local|mesh-ancestor
111442638|NCT01756573|Anesthetics|anesthetics|mesh-ancestor
111442639|NCT01756573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111442640|NCT01756573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111442641|NCT01756573|Sensory System Agents|sensory system agents|mesh-ancestor
111442642|NCT01756573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110877644|NCT04820205|Ketamine|ketamine|mesh-list
111442644|NCT01126801|Estrogens|estrogens|mesh-ancestor
111442645|NCT01126801|Hormones|hormones|mesh-ancestor
111442646|NCT01126801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111442647|NCT01126801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111442648|NCT01702909|Interleukin-2|interleukin-2|mesh-list
111442649|NCT01702909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111442650|NCT01702909|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111442651|NCT01702909|Analgesics|analgesics|mesh-ancestor
111442652|NCT01702909|Sensory System Agents|sensory system agents|mesh-ancestor
111442653|NCT01702909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111442654|NCT01702909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111442655|NCT00002768|Cytarabine|cytarabine|mesh-list
111442656|NCT00002768|Methotrexate|methotrexate|mesh-list
111442657|NCT00002768|Etoposide|etoposide|mesh-list
111442658|NCT00002768|Busulfan|busulfan|mesh-list
111442659|NCT00002768|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111442660|NCT00002768|Abortifacient Agents|abortifacient agents|mesh-ancestor
111442661|NCT00002768|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111442662|NCT00002768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111442663|NCT00002768|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111442664|NCT00002768|Antimetabolites|antimetabolites|mesh-ancestor
111442665|NCT00002768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111442666|NCT00002768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111442667|NCT00002768|Dermatologic Agents|dermatologic agents|mesh-ancestor
111442668|NCT00002768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111442669|NCT00002768|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111442670|NCT00002768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111442671|NCT00002768|Immunologic Factors|immunologic factors|mesh-ancestor
111442672|NCT00002768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111442673|NCT00002768|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111442674|NCT00002768|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111442675|NCT00002768|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111442676|NCT00002768|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111442677|NCT00002768|Antiviral Agents|antiviral agents|mesh-ancestor
111442678|NCT00002768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111442679|NCT00002768|Alkylating Agents|alkylating agents|mesh-ancestor
111442680|NCT00002768|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111442681|NCT00002768|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111442682|NCT00002774|Cisplatin|cisplatin|mesh-list
111442683|NCT00002774|Fluorouracil|fluorouracil|mesh-list
111442684|NCT00002774|Tirapazamine|tirapazamine|mesh-list
111442685|NCT00002774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111442686|NCT00002774|Antimetabolites|antimetabolites|mesh-ancestor
111442687|NCT00002774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111442688|NCT00002774|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111442689|NCT00002774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111442690|NCT00002774|Immunologic Factors|immunologic factors|mesh-ancestor
111442691|NCT00002774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111442692|NCT00002780|Aldesleukin|aldesleukin|mesh-list
111442693|NCT00002780|Cyclophosphamide|cyclophosphamide|mesh-list
111442694|NCT00002780|Thiotepa|thiotepa|mesh-list
111442695|NCT00002780|Carboplatin|carboplatin|mesh-list
111442696|NCT00002780|Sargramostim|sargramostim|mesh-list
111442697|NCT00002780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111442698|NCT00002780|Immunologic Factors|immunologic factors|mesh-ancestor
111442699|NCT00002780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111442700|NCT00002780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111442701|NCT00002780|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111442702|NCT00002780|Alkylating Agents|alkylating agents|mesh-ancestor
111442703|NCT00002780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111442704|NCT00002780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111442705|NCT00002780|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111442706|NCT00002780|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111442707|NCT00002780|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111442708|NCT00002780|Antiviral Agents|antiviral agents|mesh-ancestor
111442709|NCT00002780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111442710|NCT01692691|Dacarbazine|dacarbazine|mesh-list
111442711|NCT01692691|Carmustine|carmustine|mesh-list
111442712|NCT01692691|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111442713|NCT01692691|Alkylating Agents|alkylating agents|mesh-ancestor
111442714|NCT01692691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111442715|NCT01692691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111442716|NCT01127503|alpha-Methyltyrosine|alpha-methyltyrosine|mesh-list
111442717|NCT01127503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111442718|NCT01127503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111442719|NCT01122511|Dexamethasone|dexamethasone|mesh-list
111442720|NCT01122511|Ranibizumab|ranibizumab|mesh-list
111442721|NCT01122511|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111442722|NCT01122511|Antiemetics|antiemetics|mesh-ancestor
110878214|NCT03259425|Nivolumab|nivolumab|mesh-list
111442723|NCT01122511|Autonomic Agents|autonomic agents|mesh-ancestor
111442724|NCT01122511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111442725|NCT01122511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111442726|NCT01122511|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111442727|NCT01122511|Glucocorticoids|glucocorticoids|mesh-ancestor
111442728|NCT01122511|Hormones|hormones|mesh-ancestor
111442729|NCT01122511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111442730|NCT01122511|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111442731|NCT01122511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111442732|NCT01122511|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111442733|NCT01122511|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111442734|NCT01122511|Growth Substances|growth substances|mesh-ancestor
111442735|NCT01122511|Growth Inhibitors|growth inhibitors|mesh-ancestor
111442736|NCT05535218|Pembrolizumab|pembrolizumab|mesh-list
111442737|NCT05535218|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
111442738|NCT05535218|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111442739|NCT05535218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111442740|NCT05535218|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111442741|NCT05535218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111442742|NCT05535218|Immunoconjugates|immunoconjugates|mesh-ancestor
111442743|NCT05535218|Immunologic Factors|immunologic factors|mesh-ancestor
111442744|NCT05535218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111442745|NCT05531708|Cyclophosphamide|cyclophosphamide|mesh-list
111442746|NCT05531708|Fludarabine|fludarabine|mesh-list
111442747|NCT05531708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111442748|NCT05531708|Immunologic Factors|immunologic factors|mesh-ancestor
111442749|NCT05531708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111442750|NCT05531708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111442751|NCT05531708|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111442752|NCT05531708|Alkylating Agents|alkylating agents|mesh-ancestor
110878462|NCT03646916|Hormones|hormones|mesh-ancestor
110878482|NCT03645200|Apatinib|apatinib|mesh-list
111442753|NCT05531708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111442754|NCT05531708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111442755|NCT05531708|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111442756|NCT01663285|Gemcitabine|gemcitabine|mesh-list
110878547|NCT03404843|Fasudil|fasudil|mesh-list
111442757|NCT01663285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111442758|NCT01663285|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111442759|NCT01663285|Antimetabolites|antimetabolites|mesh-ancestor
111442760|NCT01663285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111442761|NCT00002786|Aldesleukin|aldesleukin|mesh-list
111442762|NCT00002786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111442763|NCT00002786|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111442764|NCT00002786|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111442765|NCT00002786|Antiviral Agents|antiviral agents|mesh-ancestor
111442766|NCT00002786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111442767|NCT00378937|Acetaminophen|acetaminophen|mesh-list
111442768|NCT00378937|Morphine|morphine|mesh-list
111442769|NCT00378937|Oxycodone|oxycodone|mesh-list
111442770|NCT00378937|Codeine|codeine|mesh-list
111442771|NCT00378937|Dextropropoxyphene|dextropropoxyphene|mesh-list
111442772|NCT00378937|Levopropoxyphene|levopropoxyphene|mesh-list
111442773|NCT00378937|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111442774|NCT00378937|Narcotics|narcotics|mesh-ancestor
111442775|NCT00378937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111442776|NCT00378937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111442777|NCT00378937|Analgesics|analgesics|mesh-ancestor
111442778|NCT00378937|Sensory System Agents|sensory system agents|mesh-ancestor
111442779|NCT00378937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111442780|NCT00378937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111442781|NCT00378937|Antipyretics|antipyretics|mesh-ancestor
111442782|NCT00378937|Antitussive Agents|antitussive agents|mesh-ancestor
111442783|NCT00378937|Respiratory System Agents|respiratory system agents|mesh-ancestor
111442784|NCT00002792|Cyclosporine|cyclosporine|mesh-list
111442785|NCT00002792|Cyclophosphamide|cyclophosphamide|mesh-list
111442786|NCT00002792|Busulfan|busulfan|mesh-list
111442787|NCT00002792|Methotrexate|methotrexate|mesh-list
111442788|NCT00002792|Tacrolimus|tacrolimus|mesh-list
111442789|NCT00002792|Cyclosporins|cyclosporins|mesh-list
111442790|NCT00002792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111442791|NCT00002792|Immunologic Factors|immunologic factors|mesh-ancestor
111442792|NCT00002792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111442793|NCT00002792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111442794|NCT00002792|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111442795|NCT00002792|Alkylating Agents|alkylating agents|mesh-ancestor
111442796|NCT00002792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111442797|NCT00002792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111442798|NCT00002792|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111442799|NCT00002792|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111442800|NCT00002792|Abortifacient Agents|abortifacient agents|mesh-ancestor
111442801|NCT00002792|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111442802|NCT00002792|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111442804|NCT00002792|Dermatologic Agents|dermatologic agents|mesh-ancestor
111442805|NCT00002792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111442806|NCT00002792|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110878917|NCT03274687|Androgens|androgens|mesh-list
111442807|NCT00002792|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111442808|NCT00002792|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111442809|NCT00002792|Antifungal Agents|antifungal agents|mesh-ancestor
111442810|NCT00002792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111442811|NCT01090141|Micafungin|micafungin|mesh-list
111442812|NCT01090141|Antifungal Agents|antifungal agents|mesh-ancestor
111442813|NCT01090141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111442814|NCT01048723|Everolimus|everolimus|mesh-list
111442815|NCT01048723|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111442816|NCT01048723|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111442817|NCT01048723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110878939|NCT03274453|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111442818|NCT01048723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111442819|NCT01048723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111442820|NCT01048723|Immunologic Factors|immunologic factors|mesh-ancestor
111442821|NCT01048723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111442822|NCT01048723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111442823|NCT05513612|Cyclophosphamide|cyclophosphamide|mesh-list
111442824|NCT05513612|Fludarabine|fludarabine|mesh-list
111442825|NCT05513612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111442826|NCT05513612|Immunologic Factors|immunologic factors|mesh-ancestor
111442827|NCT05513612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111442828|NCT05513612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111442829|NCT05513612|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111442830|NCT05513612|Alkylating Agents|alkylating agents|mesh-ancestor
110879021|NCT02236572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111442831|NCT05513612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111442832|NCT05513612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111442833|NCT05513612|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111442834|NCT05594407|Lidocaine|lidocaine|mesh-list
111442835|NCT05594407|Dexmedetomidine|dexmedetomidine|mesh-list
111442836|NCT05594407|Ketamine|ketamine|mesh-list
111442837|NCT05594407|Remifentanil|remifentanil|mesh-list
111442838|NCT05594407|Anesthetics, Local|anesthetics, local|mesh-ancestor
111442839|NCT05594407|Anesthetics|anesthetics|mesh-ancestor
111442840|NCT05594407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110879114|NCT03627546|Sofosbuvir|sofosbuvir|mesh-list
111442841|NCT05594407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111442842|NCT05594407|Sensory System Agents|sensory system agents|mesh-ancestor
111442843|NCT05594407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111442844|NCT05594407|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111442845|NCT05594407|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111442846|NCT05594407|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111442847|NCT05594407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111442848|NCT05594407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111442849|NCT05594407|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111442850|NCT05594407|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111442851|NCT05594407|Analgesics|analgesics|mesh-ancestor
111442852|NCT05594407|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111442853|NCT05594407|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111442854|NCT05594407|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111442855|NCT05594407|Adrenergic Agents|adrenergic agents|mesh-ancestor
111442856|NCT05594407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111442857|NCT05594407|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111442858|NCT05594407|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111442859|NCT05594407|Anesthetics, General|anesthetics, general|mesh-ancestor
111442860|NCT05594407|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111442861|NCT05594407|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111442862|NCT05594407|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111442863|NCT05594407|Narcotics|narcotics|mesh-ancestor
111442864|NCT00379717|Docetaxel|docetaxel|mesh-list
111442865|NCT00379717|Cisplatin|cisplatin|mesh-list
111442866|NCT00379717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111442867|NCT00379717|Tubulin Modulators|tubulin modulators|mesh-ancestor
111442868|NCT00379717|Antimitotic Agents|antimitotic agents|mesh-ancestor
111442869|NCT00379717|Mitosis Modulators|mitosis modulators|mesh-ancestor
111167167|NCT05886127|Hemostatics|hemostatics|mesh-list
111442870|NCT00379717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111442871|NCT04706377|Vitamin B 12|vitamin b 12|mesh-list
111442872|NCT04706377|Vitamins|vitamins|mesh-ancestor
111442873|NCT04706377|Micronutrients|micronutrients|mesh-ancestor
111442874|NCT04706377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111442875|NCT04706377|Vitamin B Complex|vitamin b complex|mesh-ancestor
111442876|NCT01583647|Niacin|niacin|mesh-list
111442877|NCT01583647|Niacinamide|niacinamide|mesh-list
111442878|NCT01583647|Nicotinic Acids|nicotinic acids|mesh-list
111442879|NCT01583647|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111442880|NCT01583647|Antimetabolites|antimetabolites|mesh-ancestor
111442881|NCT01583647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111442882|NCT01583647|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111442883|NCT01583647|Vasodilator Agents|vasodilator agents|mesh-ancestor
111442884|NCT01583647|Vitamin B Complex|vitamin b complex|mesh-ancestor
111442885|NCT01583647|Vitamins|vitamins|mesh-ancestor
111442886|NCT01583647|Micronutrients|micronutrients|mesh-ancestor
111442887|NCT01583647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111442888|NCT04403516|Dexamethasone|dexamethasone|mesh-list
111442889|NCT04403516|Prednisolone|prednisolone|mesh-list
111442890|NCT04403516|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111442891|NCT04403516|Methylprednisolone|methylprednisolone|mesh-list
111442892|NCT04403516|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111442893|NCT04403516|Prednisolone acetate|prednisolone acetate|mesh-list
111442894|NCT04403516|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111442895|NCT04403516|Prednisolone phosphate|prednisolone phosphate|mesh-list
111442896|NCT04403516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111442897|NCT04403516|Antiemetics|antiemetics|mesh-ancestor
111442898|NCT04403516|Autonomic Agents|autonomic agents|mesh-ancestor
111442899|NCT04403516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111442900|NCT04403516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111442901|NCT04403516|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111442902|NCT04403516|Glucocorticoids|glucocorticoids|mesh-ancestor
111442903|NCT04403516|Hormones|hormones|mesh-ancestor
111442904|NCT04403516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110879317|NCT05071794|Propofol|propofol|mesh-list
111442905|NCT04403516|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111442906|NCT04403516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111442907|NCT04403516|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111442908|NCT04403516|Protective Agents|protective agents|mesh-ancestor
111442909|NCT01555489|Ascorbic Acid|ascorbic acid|mesh-list
111442910|NCT01555489|Vitamins|vitamins|mesh-ancestor
111442911|NCT01555489|Micronutrients|micronutrients|mesh-ancestor
111442912|NCT01555489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111442913|NCT01555489|Antioxidants|antioxidants|mesh-ancestor
111442914|NCT01555489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111442915|NCT01555489|Protective Agents|protective agents|mesh-ancestor
111442916|NCT05243654|Metformin|metformin|mesh-list
111442917|NCT05243654|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111442918|NCT05243654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111442919|NCT01035073|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
111442920|NCT01035073|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111442921|NCT01035073|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111442922|NCT01035073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111442923|NCT01035073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111442924|NCT01035073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111442925|NCT01035073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111442926|NCT01035073|Analgesics|analgesics|mesh-ancestor
111442927|NCT01035073|Sensory System Agents|sensory system agents|mesh-ancestor
111442928|NCT01035073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111442929|NCT01035073|Antidepressive Agents|antidepressive agents|mesh-ancestor
111442930|NCT01035073|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111442931|NCT01035073|Dopamine Agents|dopamine agents|mesh-ancestor
111442932|NCT04331743|Mitoxantrone|mitoxantrone|mesh-list
111442933|NCT04331743|Analgesics|analgesics|mesh-ancestor
111442934|NCT04331743|Sensory System Agents|sensory system agents|mesh-ancestor
111442935|NCT04331743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111442936|NCT04331743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111442937|NCT04331743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111442938|NCT04331743|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111442939|NCT04331743|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111442940|NCT04331743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111442941|NCT04331743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111442942|NCT05296759|Gabapentin|gabapentin|mesh-list
111167246|NCT05802056|Hematinics|hematinics|mesh-ancestor
111442943|NCT05296759|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
111442944|NCT05296759|Botulinum Toxins|botulinum toxins|mesh-list
111442945|NCT05296759|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111442946|NCT05296759|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111442947|NCT05296759|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111442948|NCT05296759|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111442949|NCT05296759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111442950|NCT05296759|Cholinergic Agents|cholinergic agents|mesh-ancestor
111442951|NCT05296759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111442952|NCT05296759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111442953|NCT05296759|Analgesics|analgesics|mesh-ancestor
111442954|NCT05296759|Sensory System Agents|sensory system agents|mesh-ancestor
111442955|NCT05296759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111442956|NCT05296759|Anticonvulsants|anticonvulsants|mesh-ancestor
111442957|NCT05296759|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111442958|NCT05296759|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111442959|NCT05296759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111442960|NCT05296759|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111442961|NCT05296759|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111442962|NCT05296759|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111442963|NCT05296759|Antimanic Agents|antimanic agents|mesh-ancestor
110879571|NCT04446390|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111442964|NCT05296759|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111442965|NCT05296759|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111442966|NCT05296759|Antidepressive Agents|antidepressive agents|mesh-ancestor
111442967|NCT05296759|Dopamine Agents|dopamine agents|mesh-ancestor
111442968|NCT05296759|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111442969|NCT05546047|Tacrolimus|tacrolimus|mesh-list
111442970|NCT05546047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111442971|NCT05546047|Immunologic Factors|immunologic factors|mesh-ancestor
111442972|NCT05546047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111442973|NCT05546047|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111442974|NCT05546047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111442975|NCT05546047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111442976|NCT01532635|Mycophenolic Acid|mycophenolic acid|mesh-list
111442977|NCT01532635|Cyclophosphamide|cyclophosphamide|mesh-list
111442978|NCT01532635|Tacrolimus|tacrolimus|mesh-list
111442979|NCT01532635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111442980|NCT01532635|Immunologic Factors|immunologic factors|mesh-ancestor
111442981|NCT01532635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111442982|NCT01532635|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111442983|NCT01532635|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111442984|NCT01532635|Alkylating Agents|alkylating agents|mesh-ancestor
111442985|NCT01532635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110879653|NCT03646526|Amitriptyline|amitriptyline|mesh-list
111442986|NCT01532635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111442987|NCT01532635|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111442988|NCT01532635|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111442989|NCT01532635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111442990|NCT01532635|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111442991|NCT01532635|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111442992|NCT01532635|Antitubercular Agents|antitubercular agents|mesh-ancestor
111442993|NCT01532635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111442994|NCT01532635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111442995|NCT00986947|Rituximab|rituximab|mesh-list
111442996|NCT00986947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111442997|NCT00986947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111442998|NCT00986947|Immunologic Factors|immunologic factors|mesh-ancestor
111442999|NCT00986947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111443000|NCT00986947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111443001|NCT00539617|Leucovorin|leucovorin|mesh-list
111443002|NCT00539617|Fluorouracil|fluorouracil|mesh-list
111443003|NCT00539617|Oxaliplatin|oxaliplatin|mesh-list
111443004|NCT00539617|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111443005|NCT00539617|Antimetabolites|antimetabolites|mesh-ancestor
111443006|NCT00539617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111443007|NCT00539617|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111443008|NCT00539617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111443009|NCT00539617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111443010|NCT00539617|Immunologic Factors|immunologic factors|mesh-ancestor
110879795|NCT03372083|Deferasirox|deferasirox|mesh-list
111443011|NCT00539617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111443012|NCT00539617|Antidotes|antidotes|mesh-ancestor
111443013|NCT00539617|Protective Agents|protective agents|mesh-ancestor
111443014|NCT00539617|Vitamin B Complex|vitamin b complex|mesh-ancestor
111443015|NCT00539617|Vitamins|vitamins|mesh-ancestor
111443016|NCT00539617|Micronutrients|micronutrients|mesh-ancestor
111443017|NCT00539617|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111443018|NCT00539617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111167319|NCT05741086|Atorvastatin|atorvastatin|mesh-list
111443019|NCT05467514|Liraglutide|liraglutide|mesh-list
111443020|NCT05467514|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111443021|NCT05467514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111443022|NCT05467514|Incretins|incretins|mesh-ancestor
111443024|NCT05467514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111443025|NCT00976339|Vitamin D|vitamin d|mesh-list
111443026|NCT00976339|Cholecalciferol|cholecalciferol|mesh-list
111443027|NCT00976339|Vitamins|vitamins|mesh-ancestor
111443028|NCT00976339|Micronutrients|micronutrients|mesh-ancestor
111443029|NCT00976339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111443030|NCT00976339|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110879858|NCT04664829|Capecitabine|capecitabine|mesh-list
111443031|NCT00976339|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111443032|NCT04579640|Vitamin D|vitamin d|mesh-list
111443033|NCT04579640|Vitamins|vitamins|mesh-ancestor
111443034|NCT04579640|Micronutrients|micronutrients|mesh-ancestor
111443035|NCT04579640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111443036|NCT04579640|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111443037|NCT00523939|Cytarabine|cytarabine|mesh-list
111443038|NCT00523939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111443039|NCT00523939|Antimetabolites|antimetabolites|mesh-ancestor
111443040|NCT00523939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111443041|NCT00523939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111443042|NCT00523939|Antiviral Agents|antiviral agents|mesh-ancestor
111443043|NCT00523939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111443044|NCT00523939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111443045|NCT00523939|Immunologic Factors|immunologic factors|mesh-ancestor
111443046|NCT00523939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111443047|NCT00382538|Mifepristone|mifepristone|mesh-list
111443048|NCT00382538|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
111443049|NCT00382538|Abortifacient Agents|abortifacient agents|mesh-ancestor
111443050|NCT00382538|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111443051|NCT00382538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111443052|NCT00382538|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111443053|NCT00382538|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111443054|NCT00382538|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111443055|NCT00382538|Contraceptive Agents|contraceptive agents|mesh-ancestor
111443056|NCT00382538|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
111443057|NCT00382538|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
111443058|NCT00382538|Hormone Antagonists|hormone antagonists|mesh-ancestor
111443059|NCT00382538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111443060|NCT00382538|Luteolytic Agents|luteolytic agents|mesh-ancestor
111443061|NCT00382538|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111443062|NCT00382538|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
111443063|NCT00954187|Pregabalin|pregabalin|mesh-list
111443064|NCT00954187|Gabapentin|gabapentin|mesh-list
111443065|NCT00954187|Analgesics|analgesics|mesh-ancestor
111443066|NCT00954187|Sensory System Agents|sensory system agents|mesh-ancestor
111443067|NCT00954187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111443068|NCT00954187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111443069|NCT00954187|Anticonvulsants|anticonvulsants|mesh-ancestor
111443070|NCT00954187|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111443071|NCT00954187|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111443072|NCT00954187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111443073|NCT00954187|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111443074|NCT00954187|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111443075|NCT00954187|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111443076|NCT00954187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111443077|NCT00954187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111443078|NCT00954187|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111443079|NCT00954187|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111443080|NCT00954187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111443081|NCT00954187|Antimanic Agents|antimanic agents|mesh-ancestor
111443082|NCT00947791|Midazolam|midazolam|mesh-list
111443083|NCT00947791|Ketamine|ketamine|mesh-list
111443084|NCT00947791|Analgesics|analgesics|mesh-ancestor
111443085|NCT00947791|Sensory System Agents|sensory system agents|mesh-ancestor
111443086|NCT00947791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111443087|NCT00947791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111443088|NCT00947791|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111443089|NCT00947791|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110880177|NCT03368807|Insulin Lispro|insulin lispro|mesh-list
111443090|NCT00947791|Anesthetics, General|anesthetics, general|mesh-ancestor
111443091|NCT00947791|Anesthetics|anesthetics|mesh-ancestor
111443092|NCT00947791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111443093|NCT00947791|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111443094|NCT00947791|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111443095|NCT00947791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111443096|NCT00947791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111443097|NCT00947791|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111443098|NCT00947791|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110880227|NCT05178511|Ensartinib|ensartinib|mesh-list
111443099|NCT00947791|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111443100|NCT00947791|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111443101|NCT00947791|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111443102|NCT00947791|GABA Modulators|gaba modulators|mesh-ancestor
111443103|NCT00947791|GABA Agents|gaba agents|mesh-ancestor
111443104|NCT05136326|Capecitabine|capecitabine|mesh-list
111443105|NCT05136326|Temozolomide|temozolomide|mesh-list
111443106|NCT05136326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111443107|NCT05136326|Antimetabolites|antimetabolites|mesh-ancestor
111443108|NCT05136326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111443109|NCT05136326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111443110|NCT05136326|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111443111|NCT05136326|Alkylating Agents|alkylating agents|mesh-ancestor
111443112|NCT05387941|Dexamethasone|dexamethasone|mesh-list
111443113|NCT05387941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111443114|NCT05387941|Antiemetics|antiemetics|mesh-ancestor
111443115|NCT05387941|Autonomic Agents|autonomic agents|mesh-ancestor
111443116|NCT05387941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111443117|NCT05387941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111443118|NCT05387941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111443119|NCT05387941|Glucocorticoids|glucocorticoids|mesh-ancestor
111443120|NCT05387941|Hormones|hormones|mesh-ancestor
111443121|NCT05387941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110880474|NCT05229653|Anesthetics|anesthetics|mesh-ancestor
111443122|NCT05387941|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111443123|NCT05387941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111443124|NCT00379015|Cyclophosphamide|cyclophosphamide|mesh-list
111443125|NCT00379015|Docetaxel|docetaxel|mesh-list
111443126|NCT00379015|Trastuzumab|trastuzumab|mesh-list
111443127|NCT00379015|Epirubicin|epirubicin|mesh-list
111443128|NCT00379015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111443129|NCT00379015|Immunologic Factors|immunologic factors|mesh-ancestor
111443130|NCT00379015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111443131|NCT00379015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111443132|NCT00379015|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111443133|NCT00379015|Alkylating Agents|alkylating agents|mesh-ancestor
111443134|NCT00379015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111443135|NCT00379015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111443136|NCT00379015|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111443137|NCT00379015|Tubulin Modulators|tubulin modulators|mesh-ancestor
111443138|NCT00379015|Antimitotic Agents|antimitotic agents|mesh-ancestor
111443139|NCT00379015|Mitosis Modulators|mitosis modulators|mesh-ancestor
111443140|NCT00379015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111443141|NCT00379015|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111443142|NCT00379015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111443143|NCT00379015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111443144|NCT00379015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111443145|NCT00911053|Melatonin|melatonin|mesh-list
111443146|NCT00911053|Antioxidants|antioxidants|mesh-ancestor
111443147|NCT00911053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111443148|NCT00911053|Protective Agents|protective agents|mesh-ancestor
111443149|NCT00911053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111443150|NCT00911053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111443151|NCT04713410|Prednisolone|prednisolone|mesh-list
111443152|NCT04713410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111443153|NCT04713410|Glucocorticoids|glucocorticoids|mesh-ancestor
111443154|NCT04713410|Hormones|hormones|mesh-ancestor
111443155|NCT04713410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111443156|NCT04713410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110880628|NCT04906889|Analgesics|analgesics|mesh-ancestor
111443157|NCT04713410|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111443158|NCT04713410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111443159|NCT04713332|Vitamin E|vitamin e|mesh-list
111443160|NCT04713332|Tocopherols|tocopherols|mesh-list
111443161|NCT04713332|alpha-Tocopherol|alpha-tocopherol|mesh-list
111443162|NCT04713332|Vitamins|vitamins|mesh-ancestor
111443163|NCT04713332|Micronutrients|micronutrients|mesh-ancestor
111443164|NCT04713332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111443165|NCT04713332|Antioxidants|antioxidants|mesh-ancestor
111443166|NCT04713332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111443167|NCT04713332|Protective Agents|protective agents|mesh-ancestor
111443168|NCT00476827|Paclitaxel|paclitaxel|mesh-list
111443169|NCT00476827|Vinorelbine|vinorelbine|mesh-list
111443170|NCT00476827|Docetaxel|docetaxel|mesh-list
111443171|NCT00476827|Bevacizumab|bevacizumab|mesh-list
111443172|NCT00476827|Gemcitabine|gemcitabine|mesh-list
111443173|NCT00476827|Irinotecan|irinotecan|mesh-list
111443174|NCT00476827|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111443175|NCT00476827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111443176|NCT00476827|Tubulin Modulators|tubulin modulators|mesh-ancestor
111443177|NCT00476827|Antimitotic Agents|antimitotic agents|mesh-ancestor
111443178|NCT00476827|Mitosis Modulators|mitosis modulators|mesh-ancestor
111443179|NCT00476827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111443180|NCT00476827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111443181|NCT00476827|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111443182|NCT00476827|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111443183|NCT00476827|Growth Substances|growth substances|mesh-ancestor
111443184|NCT00476827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111443185|NCT00476827|Growth Inhibitors|growth inhibitors|mesh-ancestor
111443186|NCT00476827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111443187|NCT00476827|Antimetabolites|antimetabolites|mesh-ancestor
111443188|NCT00476827|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111443189|NCT00476827|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111443190|NCT00476827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111443191|NCT00459121|Paclitaxel|paclitaxel|mesh-list
111443192|NCT00459121|Carboplatin|carboplatin|mesh-list
111443193|NCT00459121|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111443194|NCT00459121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111443195|NCT00459121|Tubulin Modulators|tubulin modulators|mesh-ancestor
111443196|NCT00459121|Antimitotic Agents|antimitotic agents|mesh-ancestor
111443197|NCT00459121|Mitosis Modulators|mitosis modulators|mesh-ancestor
111443198|NCT00459121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111443199|NCT00904423|Vitamin D|vitamin d|mesh-list
111443200|NCT00904423|Vitamins|vitamins|mesh-ancestor
111443201|NCT00904423|Micronutrients|micronutrients|mesh-ancestor
111443202|NCT00904423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111443203|NCT00904423|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111443204|NCT05328895|Betahistine|betahistine|mesh-list
111443205|NCT05328895|Vasodilator Agents|vasodilator agents|mesh-ancestor
111443206|NCT05328895|Histamine Agonists|histamine agonists|mesh-ancestor
111443207|NCT05328895|Histamine Agents|histamine agents|mesh-ancestor
111443208|NCT05328895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111443209|NCT05328895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111443210|NCT05328895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111443211|NCT00879619|Prednisone|prednisone|mesh-list
111443212|NCT00879619|Cortisone|cortisone|mesh-list
111443213|NCT00879619|Docetaxel|docetaxel|mesh-list
111443214|NCT00879619|Sunitinib|sunitinib|mesh-list
111443215|NCT00879619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111443216|NCT00879619|Tubulin Modulators|tubulin modulators|mesh-ancestor
111443217|NCT00879619|Antimitotic Agents|antimitotic agents|mesh-ancestor
111443218|NCT00879619|Mitosis Modulators|mitosis modulators|mesh-ancestor
111443219|NCT00879619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111443220|NCT00879619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111443221|NCT00879619|Glucocorticoids|glucocorticoids|mesh-ancestor
111443222|NCT00879619|Hormones|hormones|mesh-ancestor
111443223|NCT00879619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111443224|NCT00879619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111443225|NCT00879619|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111443226|NCT00879619|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111443227|NCT00879619|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111443228|NCT00879619|Growth Substances|growth substances|mesh-ancestor
111443229|NCT00879619|Growth Inhibitors|growth inhibitors|mesh-ancestor
111443230|NCT00879619|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111443231|NCT00879619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111443232|NCT00822679|Eszopiclone|eszopiclone|mesh-list
111443233|NCT00822679|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111443234|NCT00822679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111443235|NCT00822679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111443236|NCT00323635|Tolterodine Tartrate|tolterodine tartrate|mesh-list
111443237|NCT00323635|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111443238|NCT00323635|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111443239|NCT00323635|Cholinergic Agents|cholinergic agents|mesh-ancestor
111443240|NCT00323635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111443241|NCT00323635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111443242|NCT00323635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111167543|NCT05345717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111443243|NCT00323635|Urological Agents|urological agents|mesh-ancestor
111443244|NCT00314353|Bevacizumab|bevacizumab|mesh-list
111443245|NCT00314353|Capecitabine|capecitabine|mesh-list
111443246|NCT00314353|Oxaliplatin|oxaliplatin|mesh-list
111443247|NCT00314353|Irinotecan|irinotecan|mesh-list
111443248|NCT00314353|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111443249|NCT00314353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111443250|NCT00314353|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111443251|NCT00314353|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111443252|NCT00314353|Growth Substances|growth substances|mesh-ancestor
111443253|NCT00314353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111443254|NCT00314353|Growth Inhibitors|growth inhibitors|mesh-ancestor
111443255|NCT00314353|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111443256|NCT00314353|Antimetabolites|antimetabolites|mesh-ancestor
111443257|NCT00314353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111443258|NCT00314353|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111443259|NCT00314353|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111443260|NCT00314353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111443261|NCT00279409|Aripiprazole|aripiprazole|mesh-list
110881344|NCT02889809|Xhance|xhance|mesh-list
111443262|NCT00279409|Antidepressive Agents|antidepressive agents|mesh-ancestor
111443263|NCT00279409|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111443264|NCT00279409|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111443265|NCT00279409|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111443266|NCT00279409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111443267|NCT00279409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111443268|NCT00279409|Dopamine Agonists|dopamine agonists|mesh-ancestor
111443269|NCT00279409|Dopamine Agents|dopamine agents|mesh-ancestor
110881403|NCT04180397|Furosemide|furosemide|mesh-list
111443270|NCT00279409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111443271|NCT00279409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111443272|NCT00279409|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111443273|NCT00279409|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111443274|NCT00279409|Serotonin Agents|serotonin agents|mesh-ancestor
111443275|NCT00279409|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110881513|NCT01667133|Ponatinib|ponatinib|mesh-list
111443276|NCT00279409|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111443277|NCT00279409|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111443278|NCT00279409|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111443279|NCT00379249|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111443280|NCT00379249|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111443281|NCT00379249|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110881588|NCT00967746|Progestins|progestins|mesh-ancestor
111443282|NCT00379249|Antimetabolites|antimetabolites|mesh-ancestor
111443283|NCT00379249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111443284|NCT00379249|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111443285|NCT00379249|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111443286|NCT00379249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111443287|NCT00801931|Cyclophosphamide|cyclophosphamide|mesh-list
111443288|NCT00801931|Melphalan|melphalan|mesh-list
111443289|NCT00801931|Busulfan|busulfan|mesh-list
111443290|NCT00801931|Thiotepa|thiotepa|mesh-list
111443291|NCT00801931|Fludarabine|fludarabine|mesh-list
111443292|NCT00801931|Alemtuzumab|alemtuzumab|mesh-list
111443293|NCT00801931|Phenytoin|phenytoin|mesh-list
111443294|NCT00801931|Fosphenytoin|fosphenytoin|mesh-list
111443295|NCT00801931|Thymoglobulin|thymoglobulin|mesh-list
111443296|NCT00801931|Antilymphocyte Serum|antilymphocyte serum|mesh-list
111443297|NCT00801931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111443298|NCT00801931|Immunologic Factors|immunologic factors|mesh-ancestor
111443299|NCT00801931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111443300|NCT00801931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111443301|NCT00801931|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111443302|NCT00801931|Alkylating Agents|alkylating agents|mesh-ancestor
111443303|NCT00801931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111443304|NCT00801931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111443305|NCT00801931|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111443306|NCT00801931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111443307|NCT00801931|Anticonvulsants|anticonvulsants|mesh-ancestor
111443308|NCT00801931|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111443309|NCT00801931|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111443310|NCT00801931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111443311|NCT00801931|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
111443312|NCT00801931|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111443313|NCT00780481|Bradykinin|bradykinin|mesh-list
111443314|NCT00780481|Kininogens|kininogens|mesh-list
111443315|NCT00780481|Vasodilator Agents|vasodilator agents|mesh-ancestor
111443316|NCT00780481|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
111443317|NCT00780481|Protease Inhibitors|protease inhibitors|mesh-ancestor
111443318|NCT00780481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111443319|NCT00780481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111443320|NCT05345990|Immunoglobulins|immunoglobulins|mesh-list
111443321|NCT05345990|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111443322|NCT05345990|Antibodies|antibodies|mesh-list
111443323|NCT05345990|Immunologic Factors|immunologic factors|mesh-ancestor
111443324|NCT05345990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111443325|NCT00019747|Thalidomide|thalidomide|mesh-list
111443326|NCT00019747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111443327|NCT00019747|Immunologic Factors|immunologic factors|mesh-ancestor
111443328|NCT00019747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111443329|NCT00019747|Leprostatic Agents|leprostatic agents|mesh-ancestor
111443330|NCT00019747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111443331|NCT00019747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111443332|NCT00019747|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111443333|NCT00019747|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111443334|NCT00019747|Growth Substances|growth substances|mesh-ancestor
111443335|NCT00019747|Growth Inhibitors|growth inhibitors|mesh-ancestor
111443336|NCT00019747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111443337|NCT05048719|Dulaglutide|dulaglutide|mesh-list
110882051|NCT03631953|Trametinib|trametinib|mesh-list
111443338|NCT05048719|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111443339|NCT05048719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111443340|NCT00759577|Solifenacin Succinate|solifenacin succinate|mesh-list
111443341|NCT00759577|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111443342|NCT00759577|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111443343|NCT00759577|Cholinergic Agents|cholinergic agents|mesh-ancestor
111443344|NCT00759577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111443345|NCT00759577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111443346|NCT00759577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111443347|NCT00759577|Urological Agents|urological agents|mesh-ancestor
111443348|NCT00746239|Dexetimide|dexetimide|mesh-list
111443349|NCT00746239|Citalopram|citalopram|mesh-list
111443350|NCT00746239|Escitalopram|escitalopram|mesh-list
111443351|NCT00746239|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111443352|NCT00746239|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111443353|NCT00746239|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111443354|NCT00746239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111443355|NCT00746239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111443356|NCT00746239|Serotonin Agents|serotonin agents|mesh-ancestor
111443357|NCT00746239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111443358|NCT00746239|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111443359|NCT00746239|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111443360|NCT00746239|Parasympatholytics|parasympatholytics|mesh-ancestor
111443361|NCT00746239|Autonomic Agents|autonomic agents|mesh-ancestor
111443362|NCT00746239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111443363|NCT00746239|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111443364|NCT00746239|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111443365|NCT00746239|Cholinergic Agents|cholinergic agents|mesh-ancestor
111443366|NCT00746239|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111443367|NCT00746239|Antidepressive Agents|antidepressive agents|mesh-ancestor
111443368|NCT00746239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111443369|NCT04977674|Naltrexone|naltrexone|mesh-list
111443370|NCT04977674|Ketamine|ketamine|mesh-list
111443371|NCT04977674|Analgesics|analgesics|mesh-ancestor
111443372|NCT04977674|Sensory System Agents|sensory system agents|mesh-ancestor
111443373|NCT04977674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111443374|NCT04977674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111443375|NCT04977674|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111443376|NCT04977674|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111443377|NCT04977674|Anesthetics, General|anesthetics, general|mesh-ancestor
111443378|NCT04977674|Anesthetics|anesthetics|mesh-ancestor
111443379|NCT04977674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110882280|NCT03336333|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111443380|NCT04977674|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111443381|NCT04977674|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111443382|NCT04977674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111443383|NCT04977674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111443384|NCT04977674|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111443385|NCT04977674|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111443386|NCT04965038|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
111443387|NCT04965038|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111443388|NCT04965038|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111443389|NCT04965038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111443390|NCT00402883|Folic Acid|folic acid|mesh-list
111443391|NCT00402883|Vitamin B 12|vitamin b 12|mesh-list
111443392|NCT00402883|Bevacizumab|bevacizumab|mesh-list
111443393|NCT00402883|Carboplatin|carboplatin|mesh-list
111443394|NCT00402883|Pemetrexed|pemetrexed|mesh-list
111443395|NCT00402883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110882425|NCT03688230|Cetuximab|cetuximab|mesh-list
111443396|NCT00402883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111167721|NCT04677543|Amikacin|amikacin|mesh-list
111443397|NCT00402883|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111443398|NCT00402883|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111443399|NCT00402883|Growth Substances|growth substances|mesh-ancestor
111443400|NCT00402883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111443401|NCT00402883|Growth Inhibitors|growth inhibitors|mesh-ancestor
111443402|NCT00402883|Vitamins|vitamins|mesh-ancestor
111443403|NCT00402883|Micronutrients|micronutrients|mesh-ancestor
111443404|NCT00402883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111443405|NCT00402883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110882491|NCT03636685|Pemetrexed|pemetrexed|mesh-list
111443406|NCT00402883|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111443407|NCT00402883|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111443408|NCT00402883|Hematinics|hematinics|mesh-ancestor
111443409|NCT00402883|Vitamin B Complex|vitamin b complex|mesh-ancestor
111443410|NCT04939844|Lenalidomide|lenalidomide|mesh-list
111443411|NCT04939844|Bortezomib|bortezomib|mesh-list
111443412|NCT04939844|Immunologic Factors|immunologic factors|mesh-ancestor
111443413|NCT04939844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111443414|NCT04939844|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111443415|NCT04939844|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111443416|NCT04939844|Growth Substances|growth substances|mesh-ancestor
111443417|NCT04939844|Growth Inhibitors|growth inhibitors|mesh-ancestor
111443418|NCT04939844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111443419|NCT05295212|Atezolizumab|atezolizumab|mesh-list
111443420|NCT05295212|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111443421|NCT05295212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111443422|NCT05295212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111443423|NCT05295212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111443424|NCT05286320|Pembrolizumab|pembrolizumab|mesh-list
111443425|NCT05286320|Lenvatinib|lenvatinib|mesh-list
111443426|NCT05286320|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111443427|NCT05286320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111443428|NCT05286320|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111443429|NCT05286320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111443430|NCT05286320|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111443431|NCT05286320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111443432|NCT00728845|Hydroxychloroquine|hydroxychloroquine|mesh-list
111443433|NCT00728845|Paclitaxel|paclitaxel|mesh-list
111443434|NCT00728845|Bevacizumab|bevacizumab|mesh-list
111443435|NCT00728845|Carboplatin|carboplatin|mesh-list
111443436|NCT00728845|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111443437|NCT00728845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111443438|NCT00728845|Tubulin Modulators|tubulin modulators|mesh-ancestor
111443439|NCT00728845|Antimitotic Agents|antimitotic agents|mesh-ancestor
111443440|NCT00728845|Mitosis Modulators|mitosis modulators|mesh-ancestor
111443441|NCT00728845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111443442|NCT00728845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111443443|NCT00728845|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111443444|NCT00728845|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111443445|NCT00728845|Growth Substances|growth substances|mesh-ancestor
111443446|NCT00728845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111443447|NCT00728845|Growth Inhibitors|growth inhibitors|mesh-ancestor
111443448|NCT00728845|Antimalarials|antimalarials|mesh-ancestor
111443449|NCT00728845|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111443450|NCT00728845|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111443451|NCT00728845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111443452|NCT00728845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111443453|NCT00728845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111443454|NCT00726037|Denileukin diftitox|denileukin diftitox|mesh-list
111443455|NCT00726037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111443456|NCT00703885|Alprazolam|alprazolam|mesh-list
111443457|NCT00703885|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111443458|NCT00703885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111443459|NCT00703885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111443460|NCT00703885|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111443461|NCT00703885|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111443462|NCT00703885|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111443463|NCT00703885|GABA Modulators|gaba modulators|mesh-ancestor
111443464|NCT00703885|GABA Agents|gaba agents|mesh-ancestor
111443465|NCT00703885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111443466|NCT00703885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111443467|NCT00703339|Treprostinil|treprostinil|mesh-list
111443468|NCT00703339|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111443469|NCT04330586|Ciclesonide|ciclesonide|mesh-list
111443470|NCT04330586|Glucocorticoids|glucocorticoids|mesh-ancestor
111443471|NCT04330586|Hormones|hormones|mesh-ancestor
111443472|NCT04330586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111443473|NCT04330586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111443474|NCT04330586|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111443475|NCT00382694|Fludarabine|fludarabine|mesh-list
111443476|NCT00382694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111443477|NCT04508036|Fibrin fragment D|fibrin fragment d|mesh-list
111443478|NCT04508036|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111443479|NCT04508036|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111443480|NCT04508036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111443481|NCT04508036|Hemostatics|hemostatics|mesh-ancestor
111443482|NCT04508036|Coagulants|coagulants|mesh-ancestor
111443483|NCT04828057|Timolol|timolol|mesh-list
111443484|NCT04828057|Bimatoprost|bimatoprost|mesh-list
111443485|NCT04828057|Travoprost|travoprost|mesh-list
111443486|NCT04828057|Latanoprost|latanoprost|mesh-list
111443487|NCT04828057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111443488|NCT04828057|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111443489|NCT04828057|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111443490|NCT04828057|Adrenergic Agents|adrenergic agents|mesh-ancestor
111443491|NCT04828057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111443492|NCT04828057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111443493|NCT04828057|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111443494|NCT04828057|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111443495|NCT04828057|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
111443496|NCT04828057|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111443497|NCT02973451|Bupivacaine|bupivacaine|mesh-list
111443498|NCT02973451|Anesthetics, Local|anesthetics, local|mesh-ancestor
111443499|NCT02973451|Anesthetics|anesthetics|mesh-ancestor
111443500|NCT02973451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111443501|NCT02973451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111443502|NCT02973451|Sensory System Agents|sensory system agents|mesh-ancestor
111443503|NCT02973451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111443504|NCT00000199|Piracetam|piracetam|mesh-list
111443505|NCT00000199|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111443506|NCT00000199|Protective Agents|protective agents|mesh-ancestor
111443507|NCT00000199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111443508|NCT00000199|Nootropic Agents|nootropic agents|mesh-ancestor
111443509|NCT00668785|Ranibizumab|ranibizumab|mesh-list
111443510|NCT00668785|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111443511|NCT00668785|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111443512|NCT00668785|Growth Substances|growth substances|mesh-ancestor
111443513|NCT00668785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111443514|NCT00668785|Growth Inhibitors|growth inhibitors|mesh-ancestor
111443515|NCT00668785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111443516|NCT00655057|Citalopram|citalopram|mesh-list
111443517|NCT00655057|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111443518|NCT00655057|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111443519|NCT00655057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111443520|NCT00655057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111443521|NCT00655057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111443522|NCT00655057|Serotonin Agents|serotonin agents|mesh-ancestor
111443523|NCT00655057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111443524|NCT00655057|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111443525|NCT00655057|Antidepressive Agents|antidepressive agents|mesh-ancestor
111443526|NCT00655057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111443527|NCT00000211|Buprenorphine|buprenorphine|mesh-list
111443528|NCT00000211|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111443529|NCT00000211|Narcotics|narcotics|mesh-ancestor
111443530|NCT00000211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111443531|NCT00000211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111443532|NCT00000211|Analgesics|analgesics|mesh-ancestor
111443533|NCT00000211|Sensory System Agents|sensory system agents|mesh-ancestor
111443534|NCT00000211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111443535|NCT00000211|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111443536|NCT04358432|Ezetimibe|ezetimibe|mesh-list
111443537|NCT04358432|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111443538|NCT04358432|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111443539|NCT04358432|Antimetabolites|antimetabolites|mesh-ancestor
111443540|NCT04358432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111443541|NCT04358432|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111443542|NCT00000217|Carbamazepine|carbamazepine|mesh-list
111443543|NCT00000217|Anticonvulsants|anticonvulsants|mesh-ancestor
111443544|NCT00000217|Antimanic Agents|antimanic agents|mesh-ancestor
111443545|NCT00000217|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111443546|NCT00000217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111443547|NCT00000217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111443548|NCT00000217|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111443549|NCT00000217|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111443550|NCT00000217|Analgesics|analgesics|mesh-ancestor
111443551|NCT00000217|Sensory System Agents|sensory system agents|mesh-ancestor
111443552|NCT00000217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111443553|NCT00000217|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111443554|NCT00000217|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111443555|NCT00000217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111443556|NCT00000217|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111443557|NCT00000217|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111443558|NCT00000223|Buprenorphine|buprenorphine|mesh-list
111443559|NCT00000223|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111443560|NCT00000223|Narcotics|narcotics|mesh-ancestor
111443561|NCT00000223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111443562|NCT00000223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111443563|NCT00000223|Analgesics|analgesics|mesh-ancestor
111443564|NCT00000223|Sensory System Agents|sensory system agents|mesh-ancestor
111443565|NCT00000223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111443566|NCT00000223|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111443567|NCT00000229|Buprenorphine|buprenorphine|mesh-list
111443568|NCT00000229|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111443569|NCT00000229|Narcotics|narcotics|mesh-ancestor
111443570|NCT00000229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111443571|NCT00000229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111443572|NCT00000229|Analgesics|analgesics|mesh-ancestor
111443573|NCT00000229|Sensory System Agents|sensory system agents|mesh-ancestor
111443574|NCT00000229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111443575|NCT00000229|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111443576|NCT00000235|Buprenorphine|buprenorphine|mesh-list
111443577|NCT00000235|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111443578|NCT00000235|Narcotics|narcotics|mesh-ancestor
111443579|NCT00000235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111443580|NCT00000235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111443581|NCT00000235|Analgesics|analgesics|mesh-ancestor
111443582|NCT00000235|Sensory System Agents|sensory system agents|mesh-ancestor
111443583|NCT00000235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111443584|NCT00000235|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111443585|NCT00000241|Flupenthixol|flupenthixol|mesh-list
111443586|NCT00000241|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
111443587|NCT00000241|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111443588|NCT00000241|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111443589|NCT00000241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111443590|NCT00000241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111443591|NCT00000241|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111443592|NCT00000241|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111443593|NCT00000241|Dopamine Agents|dopamine agents|mesh-ancestor
111443594|NCT00000241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111443595|NCT00000241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111443596|NCT00000253|Nitrous Oxide|nitrous oxide|mesh-list
111443597|NCT00000253|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111443598|NCT00000253|Anesthetics, General|anesthetics, general|mesh-ancestor
111443599|NCT00000253|Anesthetics|anesthetics|mesh-ancestor
111443600|NCT00000253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111443601|NCT00000253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111443602|NCT00000253|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111443603|NCT00000253|Analgesics|analgesics|mesh-ancestor
111443604|NCT00000253|Sensory System Agents|sensory system agents|mesh-ancestor
111443605|NCT00000253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111443606|NCT00000259|Nitrous Oxide|nitrous oxide|mesh-list
111443607|NCT00000259|Sevoflurane|sevoflurane|mesh-list
111443608|NCT00000259|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111443609|NCT00000259|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111443610|NCT00000259|Anesthetics, General|anesthetics, general|mesh-ancestor
111443611|NCT00000259|Anesthetics|anesthetics|mesh-ancestor
111443612|NCT00000259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111443613|NCT00000259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111443614|NCT00000259|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111443615|NCT00000259|Analgesics|analgesics|mesh-ancestor
111443616|NCT00000259|Sensory System Agents|sensory system agents|mesh-ancestor
111443617|NCT00000259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111443618|NCT00379405|Ritonavir|ritonavir|mesh-list
111443619|NCT00379405|Saquinavir|saquinavir|mesh-list
111443620|NCT00379405|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111443621|NCT00379405|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111443622|NCT00379405|Protease Inhibitors|protease inhibitors|mesh-ancestor
111443623|NCT00379405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111443624|NCT00379405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111443625|NCT00379405|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111443626|NCT00379405|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111443627|NCT00379405|Antiviral Agents|antiviral agents|mesh-ancestor
111443628|NCT00379405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111443629|NCT00379405|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111443630|NCT00379405|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111443631|NCT00379483|Deferasirox|deferasirox|mesh-list
111443632|NCT00379483|Iron Chelating Agents|iron chelating agents|mesh-ancestor
111443633|NCT00379483|Chelating Agents|chelating agents|mesh-ancestor
111443634|NCT00379483|Sequestering Agents|sequestering agents|mesh-ancestor
111443635|NCT00379483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111443636|NCT00607477|Minoxidil|minoxidil|mesh-list
111443637|NCT00607477|Hydralazine|hydralazine|mesh-list
111443638|NCT00607477|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111443639|NCT00607477|Vasodilator Agents|vasodilator agents|mesh-ancestor
111443640|NCT04423861|Nitazoxanide|nitazoxanide|mesh-list
111443641|NCT04423861|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111443642|NCT04423861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111443643|NCT00000271|Desipramine|desipramine|mesh-list
111443644|NCT00000271|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
111443645|NCT00000271|Antidepressive Agents|antidepressive agents|mesh-ancestor
111443646|NCT00000271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111443647|NCT00000271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111443648|NCT00000271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111443649|NCT00000271|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111443650|NCT00000271|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111443651|NCT00000271|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111443652|NCT00000271|Adrenergic Agents|adrenergic agents|mesh-ancestor
111443653|NCT00000271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111443654|NCT00000271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111443655|NCT00000277|Mazindol|mazindol|mesh-list
111443656|NCT00000277|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111443657|NCT00000277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111443658|NCT00000277|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111443659|NCT00000277|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111443660|NCT00000277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111443661|NCT00000277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111443662|NCT00000277|Adrenergic Agents|adrenergic agents|mesh-ancestor
111443663|NCT00000277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111443664|NCT00000277|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111443665|NCT00000277|Dopamine Agents|dopamine agents|mesh-ancestor
111443666|NCT00599131|Docetaxel|docetaxel|mesh-list
111443667|NCT00599131|Fluorouracil|fluorouracil|mesh-list
111443668|NCT00599131|Cetuximab|cetuximab|mesh-list
111443669|NCT00599131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111443670|NCT00599131|Tubulin Modulators|tubulin modulators|mesh-ancestor
111443671|NCT00599131|Antimitotic Agents|antimitotic agents|mesh-ancestor
111443672|NCT00599131|Mitosis Modulators|mitosis modulators|mesh-ancestor
111443673|NCT00599131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111443674|NCT00599131|Antimetabolites|antimetabolites|mesh-ancestor
111443675|NCT00599131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111443676|NCT00599131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111443677|NCT00599131|Immunologic Factors|immunologic factors|mesh-ancestor
111443678|NCT00599131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111443679|NCT00599131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111443680|NCT04302350|Nitrous Oxide|nitrous oxide|mesh-list
111443681|NCT04302350|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111443682|NCT04302350|Anesthetics, General|anesthetics, general|mesh-ancestor
111443683|NCT04302350|Anesthetics|anesthetics|mesh-ancestor
111443684|NCT04302350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111443685|NCT04302350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111443686|NCT04302350|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111443687|NCT04302350|Analgesics|analgesics|mesh-ancestor
111443688|NCT04302350|Sensory System Agents|sensory system agents|mesh-ancestor
111443689|NCT04302350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111443690|NCT00584935|Rituximab|rituximab|mesh-list
111443691|NCT00584935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111443692|NCT00584935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111443693|NCT00584935|Immunologic Factors|immunologic factors|mesh-ancestor
111443694|NCT00584935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111443695|NCT00584935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111443696|NCT04295486|Aspirin|aspirin|mesh-list
111443697|NCT04295486|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111443698|NCT04295486|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111443699|NCT04295486|Analgesics|analgesics|mesh-ancestor
111443700|NCT04295486|Sensory System Agents|sensory system agents|mesh-ancestor
111443701|NCT04295486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111443702|NCT04295486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111443703|NCT04295486|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111443704|NCT04295486|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111443705|NCT04295486|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111443706|NCT04295486|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111443707|NCT04295486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111443708|NCT04295486|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111443709|NCT04295486|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111443710|NCT04295486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111443711|NCT04295486|Antipyretics|antipyretics|mesh-ancestor
111443712|NCT00000289|Ondansetron|ondansetron|mesh-list
111443713|NCT00000289|Antiemetics|antiemetics|mesh-ancestor
111443714|NCT00000289|Autonomic Agents|autonomic agents|mesh-ancestor
111443715|NCT00000289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111443716|NCT00000289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111443717|NCT00000289|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111443718|NCT00000289|Antipruritics|antipruritics|mesh-ancestor
111443719|NCT00000289|Dermatologic Agents|dermatologic agents|mesh-ancestor
111443720|NCT00000289|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111443721|NCT00000289|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111443722|NCT00000289|Serotonin Agents|serotonin agents|mesh-ancestor
111443723|NCT00000289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111443724|NCT00000289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111443725|NCT00000295|Progesterone|progesterone|mesh-list
111443726|NCT00000295|Progestins|progestins|mesh-ancestor
111443727|NCT00000295|Hormones|hormones|mesh-ancestor
111443728|NCT00000295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111443729|NCT00000295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111443730|NCT00000733|Ribavirin|ribavirin|mesh-list
111443731|NCT00000733|Antimetabolites|antimetabolites|mesh-ancestor
111443732|NCT00000733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111443733|NCT00000733|Antiviral Agents|antiviral agents|mesh-ancestor
111443734|NCT00000733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111443735|NCT04246723|Ritonavir|ritonavir|mesh-list
111443736|NCT04246723|Sofosbuvir|sofosbuvir|mesh-list
111443737|NCT04246723|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111443738|NCT04246723|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111443739|NCT04246723|Protease Inhibitors|protease inhibitors|mesh-ancestor
111443740|NCT04246723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111443741|NCT04246723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111443742|NCT04246723|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111443743|NCT04246723|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111443744|NCT04246723|Antiviral Agents|antiviral agents|mesh-ancestor
111443745|NCT04246723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111443746|NCT04246723|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111443747|NCT04246723|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111443748|NCT00000301|Amantadine|amantadine|mesh-list
111443749|NCT00000301|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111443750|NCT00000301|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111443751|NCT00000301|Antiviral Agents|antiviral agents|mesh-ancestor
111443752|NCT00000301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111443753|NCT00000301|Dopamine Agents|dopamine agents|mesh-ancestor
111443754|NCT00000301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111443755|NCT00000301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111443756|NCT00000301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111443757|NCT00000301|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111443758|NCT00000301|Analgesics|analgesics|mesh-ancestor
111443759|NCT00000301|Sensory System Agents|sensory system agents|mesh-ancestor
111443760|NCT00000301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111443761|NCT00000307|Naltrexone|naltrexone|mesh-list
111443762|NCT00000307|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111443763|NCT00000307|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111443764|NCT00000307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111443765|NCT00000307|Sensory System Agents|sensory system agents|mesh-ancestor
111443766|NCT00000307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111443767|NCT00000313|Fenfluramine|fenfluramine|mesh-list
111443768|NCT00000313|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111443769|NCT00000313|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111443770|NCT00000313|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111443771|NCT00000313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111443772|NCT00000313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111443773|NCT00000313|Serotonin Agents|serotonin agents|mesh-ancestor
111168062|NCT02601365|Molgramostim|molgramostim|mesh-list
111443774|NCT00000313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111443775|NCT00000319|Buprenorphine|buprenorphine|mesh-list
111443776|NCT00000319|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111443777|NCT00000319|Narcotics|narcotics|mesh-ancestor
111443778|NCT00000319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111443779|NCT00000319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111443780|NCT00000319|Analgesics|analgesics|mesh-ancestor
111443781|NCT00000319|Sensory System Agents|sensory system agents|mesh-ancestor
111443782|NCT00000319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111443783|NCT00000319|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111443784|NCT00000325|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
111443785|NCT00000325|Hormones|hormones|mesh-ancestor
111443786|NCT00000325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111443787|NCT00000325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111443788|NCT04181203|Leuprolide|leuprolide|mesh-list
111443789|NCT04181203|Goserelin|goserelin|mesh-list
111443790|NCT04181203|Triptorelin Pamoate|triptorelin pamoate|mesh-list
111443791|NCT04181203|Hormones|hormones|mesh-list
111443792|NCT04181203|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111443793|NCT04181203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111443794|NCT04181203|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111443795|NCT04181203|Fertility Agents|fertility agents|mesh-ancestor
111443796|NCT04181203|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111443797|NCT04181203|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111443798|NCT04181203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111443799|NCT04181203|Luteolytic Agents|luteolytic agents|mesh-ancestor
111443800|NCT04181203|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111443801|NCT04181203|Contraceptive Agents|contraceptive agents|mesh-ancestor
111443802|NCT04181203|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111443803|NCT03521102|Acetaminophen|acetaminophen|mesh-list
111443804|NCT03521102|Hydromorphone|hydromorphone|mesh-list
111443805|NCT03521102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111443806|NCT03521102|Analgesics|analgesics|mesh-ancestor
111443807|NCT03521102|Sensory System Agents|sensory system agents|mesh-ancestor
111443808|NCT03521102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110884919|NCT01315093|Tinzaparin|tinzaparin|mesh-list
111443809|NCT03521102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111443810|NCT03521102|Antipyretics|antipyretics|mesh-ancestor
111443811|NCT03521102|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111443812|NCT03521102|Narcotics|narcotics|mesh-ancestor
111443813|NCT03521102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111443814|NCT00000763|O-(Chloroacetylcarbamoyl)fumagillol|o-(chloroacetylcarbamoyl)fumagillol|mesh-list
111443815|NCT00000763|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111443816|NCT00000763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111443817|NCT00000763|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111443818|NCT00000763|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111443819|NCT00000763|Growth Substances|growth substances|mesh-ancestor
111443820|NCT00000763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111443821|NCT00000763|Growth Inhibitors|growth inhibitors|mesh-ancestor
111443822|NCT00380263|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
111443823|NCT00380263|Growth Substances|growth substances|mesh-ancestor
111443824|NCT00380263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111443825|NCT00380263|Vasodilator Agents|vasodilator agents|mesh-ancestor
111443826|NCT00380263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111443827|NCT00380263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111443828|NCT00000769|Interleukin-4|interleukin-4|mesh-list
111443829|NCT00000769|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111443830|NCT00000769|Immunologic Factors|immunologic factors|mesh-ancestor
111443831|NCT00000769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111443832|NCT00000769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111443833|NCT00000769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111443834|NCT05440591|Metformin|metformin|mesh-list
111443835|NCT05440591|Dapagliflozin|dapagliflozin|mesh-list
111443836|NCT05440591|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111443837|NCT05440591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111443838|NCT05440591|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111443839|NCT05440591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111443840|NCT04099303|Vaccines|vaccines|mesh-list
111443841|NCT04099303|Immunologic Factors|immunologic factors|mesh-ancestor
111443842|NCT04099303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111443843|NCT00379951|Ertapenem|ertapenem|mesh-list
111443844|NCT00379951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111443845|NCT00379951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111443846|NCT00000337|Selegiline|selegiline|mesh-list
111168140|NCT01330446|Modafinil|modafinil|mesh-list
111443847|NCT00000337|Antidepressive Agents|antidepressive agents|mesh-ancestor
111443849|NCT00000337|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111443850|NCT00000337|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111443851|NCT00000337|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
111443852|NCT00000337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111443853|NCT00000337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111443854|NCT00000337|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111443855|NCT00000337|Protective Agents|protective agents|mesh-ancestor
111443856|NCT00000337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111443857|NCT00000781|Zidovudine|zidovudine|mesh-list
111443858|NCT00000781|Nevirapine|nevirapine|mesh-list
111443859|NCT00000781|Didanosine|didanosine|mesh-list
111443860|NCT00000781|Zalcitabine|zalcitabine|mesh-list
111443861|NCT00000781|Antimetabolites|antimetabolites|mesh-ancestor
111443862|NCT00000781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111443863|NCT00000781|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111443864|NCT00000781|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111443865|NCT00000781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111443866|NCT00000781|Antiviral Agents|antiviral agents|mesh-ancestor
111443867|NCT00000781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111443868|NCT00000781|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111443869|NCT00000781|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111443870|NCT00000781|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111443871|NCT00000781|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111443872|NCT00000349|Flupenthixol|flupenthixol|mesh-list
111443873|NCT00000349|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
111443874|NCT00000349|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111443875|NCT00000349|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111443876|NCT00000349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111443877|NCT00000349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111443878|NCT00000349|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111443879|NCT00000349|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111443880|NCT00000349|Dopamine Agents|dopamine agents|mesh-ancestor
111443881|NCT00000349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111443882|NCT00000349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111443883|NCT00000805|Ganciclovir|ganciclovir|mesh-list
111443884|NCT00000805|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
111443885|NCT00000805|Antiviral Agents|antiviral agents|mesh-ancestor
111443886|NCT00000805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111443887|NCT00000805|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111443888|NCT00000805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111443889|NCT00000805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111443890|NCT00000355|Buprenorphine|buprenorphine|mesh-list
111443891|NCT00000355|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111443892|NCT00000355|Narcotics|narcotics|mesh-ancestor
111443893|NCT00000355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111443894|NCT00000355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111443895|NCT00000355|Analgesics|analgesics|mesh-ancestor
111443896|NCT00000355|Sensory System Agents|sensory system agents|mesh-ancestor
111443897|NCT00000355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111443898|NCT00000355|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111443899|NCT04022785|Azacitidine|azacitidine|mesh-list
111443900|NCT04022785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111443901|NCT04022785|Antimetabolites|antimetabolites|mesh-ancestor
111443902|NCT04022785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111443903|NCT04022785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110885446|NCT03426657|Durvalumab|durvalumab|mesh-list
111443904|NCT04022785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111443905|NCT00000361|Methotrexate|methotrexate|mesh-list
111443906|NCT00000361|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111443907|NCT00000361|Abortifacient Agents|abortifacient agents|mesh-ancestor
111443908|NCT00000361|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111443909|NCT00000361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111443910|NCT00000361|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111443911|NCT00000361|Antimetabolites|antimetabolites|mesh-ancestor
111443912|NCT00000361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111443913|NCT00000361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111443914|NCT00000361|Dermatologic Agents|dermatologic agents|mesh-ancestor
111443915|NCT00000361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111443916|NCT00000361|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111443917|NCT00000361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111443918|NCT00000361|Immunologic Factors|immunologic factors|mesh-ancestor
111443919|NCT00000361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111443920|NCT00000361|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111443921|NCT00000811|Azithromycin|azithromycin|mesh-list
111443922|NCT00000811|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
111443923|NCT00000811|Trimethoprim|trimethoprim|mesh-list
111443924|NCT00000811|Sulfamethoxazole|sulfamethoxazole|mesh-list
111443925|NCT00000811|Atovaquone|atovaquone|mesh-list
111443926|NCT00000811|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111443927|NCT00000811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111443928|NCT00000811|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111443929|NCT00000811|Antimalarials|antimalarials|mesh-ancestor
111443930|NCT00000811|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111443931|NCT00000811|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111443932|NCT00000811|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111443933|NCT00000811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111443934|NCT00000811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111443935|NCT00000811|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111443936|NCT00000811|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
110886360|NCT02232087|Glucocorticoids|glucocorticoids|mesh-ancestor
111443937|NCT00000811|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111443938|NCT00000373|Olanzapine|olanzapine|mesh-list
111443939|NCT00000373|Fluoxetine|fluoxetine|mesh-list
111443940|NCT00000373|Antiemetics|antiemetics|mesh-ancestor
111443941|NCT00000373|Autonomic Agents|autonomic agents|mesh-ancestor
111443942|NCT00000373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111443943|NCT00000373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111443944|NCT00000373|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111443945|NCT00000373|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111443946|NCT00000373|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111443947|NCT00000373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110886411|NCT02972502|Antiemetics|antiemetics|mesh-ancestor
111443948|NCT00000373|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111443949|NCT00000373|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111443950|NCT00000373|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111443951|NCT00000373|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111443952|NCT00000373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111443953|NCT00000373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111443954|NCT00000373|Serotonin Agents|serotonin agents|mesh-ancestor
111443955|NCT00000373|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111443956|NCT00000373|Antidepressive Agents|antidepressive agents|mesh-ancestor
111443957|NCT00000373|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111443958|NCT00000373|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111443959|NCT00000373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111443960|NCT00000823|Zidovudine|zidovudine|mesh-list
111443961|NCT00000823|Didanosine|didanosine|mesh-list
111443962|NCT00000823|Antimetabolites|antimetabolites|mesh-ancestor
111443963|NCT00000823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111443964|NCT00000823|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111443965|NCT00000823|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111443966|NCT00000823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111443967|NCT00000823|Antiviral Agents|antiviral agents|mesh-ancestor
111443968|NCT00000823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111443969|NCT00000823|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111443970|NCT00000823|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111443971|NCT00000379|Fluoxetine|fluoxetine|mesh-list
111443972|NCT00000379|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111443973|NCT00000379|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111443974|NCT00000379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111443975|NCT00000379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111443976|NCT00000379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111443977|NCT00000379|Serotonin Agents|serotonin agents|mesh-ancestor
111443978|NCT00000379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111443979|NCT00000379|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111443980|NCT00000379|Antidepressive Agents|antidepressive agents|mesh-ancestor
111443981|NCT00000379|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111443982|NCT00000379|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111443983|NCT00000379|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111443984|NCT00000379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111443985|NCT00000385|Lithium Carbonate|lithium carbonate|mesh-list
111443986|NCT00000385|Antidepressive Agents|antidepressive agents|mesh-ancestor
111443987|NCT00000385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111443988|NCT00000385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111443989|NCT00000385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111443990|NCT00000385|Antimanic Agents|antimanic agents|mesh-ancestor
111443991|NCT00000385|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111443992|NCT00000385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111443993|NCT00000385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111443994|NCT00002894|Paclitaxel|paclitaxel|mesh-list
111443995|NCT00002894|Carboplatin|carboplatin|mesh-list
111443996|NCT00002894|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111443997|NCT00002894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111443998|NCT00002894|Tubulin Modulators|tubulin modulators|mesh-ancestor
111443999|NCT00002894|Antimitotic Agents|antimitotic agents|mesh-ancestor
111444000|NCT00002894|Mitosis Modulators|mitosis modulators|mesh-ancestor
111444001|NCT00002894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111444002|NCT00000829|Vaccines|vaccines|mesh-list
111444003|NCT00000829|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
111444004|NCT00000829|Immunologic Factors|immunologic factors|mesh-ancestor
111444005|NCT00000829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111444006|NCT03282344|Nivolumab|nivolumab|mesh-list
111444007|NCT03282344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111444008|NCT03282344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111444009|NCT03282344|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111444010|NCT03282344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111444011|NCT00000403|Doxycycline|doxycycline|mesh-list
111444012|NCT00000403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111444013|NCT00000403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111444014|NCT00000403|Antimalarials|antimalarials|mesh-ancestor
111444015|NCT00000403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111444016|NCT00000403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111444017|NCT00000841|Lamivudine|lamivudine|mesh-list
111444018|NCT00000841|Zidovudine|zidovudine|mesh-list
111444019|NCT00000841|Stavudine|stavudine|mesh-list
111444020|NCT00000841|Indinavir|indinavir|mesh-list
111444021|NCT00000841|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111444022|NCT00000841|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111444023|NCT00000841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111444024|NCT00000841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111444025|NCT00000841|Antiviral Agents|antiviral agents|mesh-ancestor
111444026|NCT00000841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111444027|NCT00000841|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111444028|NCT00000841|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111444029|NCT00000841|Antimetabolites|antimetabolites|mesh-ancestor
111444030|NCT00000841|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111444031|NCT00000841|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111444032|NCT00000841|Protease Inhibitors|protease inhibitors|mesh-ancestor
111444033|NCT00000415|Calcium|calcium|mesh-list
111444034|NCT00000415|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111444035|NCT00000415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111444036|NCT00000847|polysaccharide-K|polysaccharide-k|mesh-list
111444037|NCT00000847|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111444038|NCT00000847|Immunologic Factors|immunologic factors|mesh-ancestor
111444039|NCT00000847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111444040|NCT00000847|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111444041|NCT00000847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111444042|NCT00000847|Antiviral Agents|antiviral agents|mesh-ancestor
111444043|NCT00000847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111444044|NCT00000847|Interferon Inducers|interferon inducers|mesh-ancestor
111444045|NCT00000847|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111444046|NCT00000847|Protective Agents|protective agents|mesh-ancestor
111444047|NCT04195568|Calcium Carbonate|calcium carbonate|mesh-list
111444048|NCT04195568|Antacids|antacids|mesh-ancestor
111444049|NCT04195568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111444050|NCT04195568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111444051|NCT00000439|Valproic Acid|valproic acid|mesh-list
111444052|NCT00000439|Anticonvulsants|anticonvulsants|mesh-ancestor
111444053|NCT00000439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111444054|NCT00000439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111444055|NCT00000439|GABA Agents|gaba agents|mesh-ancestor
111444056|NCT00000439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111444057|NCT00000439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111444058|NCT00000439|Antimanic Agents|antimanic agents|mesh-ancestor
111444059|NCT00000439|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111444060|NCT00000439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111444061|NCT00000439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111444062|NCT00002912|Etoposide|etoposide|mesh-list
111444063|NCT00002912|Mitoxantrone|mitoxantrone|mesh-list
111444064|NCT00002912|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111444065|NCT00002912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111444066|NCT00002912|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111444067|NCT00002912|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111444068|NCT00002912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111444069|NCT00002912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111444070|NCT00002912|Analgesics|analgesics|mesh-ancestor
111444071|NCT00002912|Sensory System Agents|sensory system agents|mesh-ancestor
111444072|NCT00002912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111444073|NCT00002912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111444074|NCT04183790|Ivacaftor|ivacaftor|mesh-list
111444075|NCT04183790|Elexacaftor|elexacaftor|mesh-list
111444076|NCT04183790|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
111444077|NCT04183790|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111444078|NCT04183790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111444079|NCT00000445|Naltrexone|naltrexone|mesh-list
111444080|NCT00000445|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111444081|NCT00000445|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111444082|NCT00000445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111444083|NCT00000445|Sensory System Agents|sensory system agents|mesh-ancestor
111444084|NCT00000445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111444085|NCT00000451|Naltrexone|naltrexone|mesh-list
111444086|NCT00000451|Sertraline|sertraline|mesh-list
111444087|NCT00000451|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111444088|NCT00000451|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111444089|NCT00000451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111444090|NCT00000451|Sensory System Agents|sensory system agents|mesh-ancestor
111444091|NCT00000451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111444092|NCT00000451|Antidepressive Agents|antidepressive agents|mesh-ancestor
111444093|NCT00000451|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111444094|NCT00000451|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111444095|NCT00000451|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111444096|NCT00000451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111444097|NCT00000451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111444098|NCT00000451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111444099|NCT00000451|Serotonin Agents|serotonin agents|mesh-ancestor
111444100|NCT00000865|Lamivudine|lamivudine|mesh-list
111444101|NCT00000865|Zidovudine|zidovudine|mesh-list
111444102|NCT00000865|Abacavir|abacavir|mesh-list
111444103|NCT00000865|Stavudine|stavudine|mesh-list
111444104|NCT00000865|Didanosine|didanosine|mesh-list
111444105|NCT00000865|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111444106|NCT00000865|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111444107|NCT00000865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111444108|NCT00000865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111444109|NCT00000865|Antiviral Agents|antiviral agents|mesh-ancestor
111444110|NCT00000865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111444111|NCT00000865|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111444112|NCT00000865|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111444113|NCT00000865|Antimetabolites|antimetabolites|mesh-ancestor
111444114|NCT00000469|Aspirin|aspirin|mesh-list
111444115|NCT00000469|Lovastatin|lovastatin|mesh-list
111444116|NCT00000469|L 647318|l 647318|mesh-list
111444117|NCT00000469|Dihydromevinolin|dihydromevinolin|mesh-list
111444118|NCT00000469|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111444119|NCT00000469|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111444120|NCT00000469|Analgesics|analgesics|mesh-ancestor
111444121|NCT00000469|Sensory System Agents|sensory system agents|mesh-ancestor
111444122|NCT00000469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111444123|NCT00000469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111444124|NCT00000469|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111444125|NCT00000469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111444126|NCT00000469|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111444127|NCT00000469|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111444128|NCT00000469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111444129|NCT00000469|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111444130|NCT00000469|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111444131|NCT00000469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111444132|NCT00000469|Antipyretics|antipyretics|mesh-ancestor
111444133|NCT00000469|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111444134|NCT00000469|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111444135|NCT00000469|Antimetabolites|antimetabolites|mesh-ancestor
111444136|NCT00000469|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111444137|NCT00000469|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111444138|NCT00000889|Aldesleukin|aldesleukin|mesh-list
111444139|NCT00000889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111444140|NCT00000889|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111444141|NCT00000889|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111444142|NCT00000889|Antiviral Agents|antiviral agents|mesh-ancestor
111444143|NCT00000889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111444144|NCT00000505|Plasminogen|plasminogen|mesh-list
111444145|NCT00000505|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
111444146|NCT00000505|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111168438|NCT01821963|Immunologic Factors|immunologic factors|mesh-ancestor
111444147|NCT00000505|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111444148|NCT00000505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111444149|NCT00000901|Lamivudine|lamivudine|mesh-list
111444150|NCT00000901|Stavudine|stavudine|mesh-list
111444151|NCT00000901|Indinavir|indinavir|mesh-list
111444152|NCT00000901|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111444153|NCT00000901|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111444154|NCT00000901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111444155|NCT00000901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111444156|NCT00000901|Antiviral Agents|antiviral agents|mesh-ancestor
111444157|NCT00000901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111444158|NCT00000901|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111444159|NCT00000901|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111444160|NCT00000901|Antimetabolites|antimetabolites|mesh-ancestor
111444161|NCT00000901|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111444162|NCT00000901|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111444163|NCT00000901|Protease Inhibitors|protease inhibitors|mesh-ancestor
111444164|NCT00000541|Vitamins|vitamins|mesh-list
111444165|NCT00000541|Folic Acid|folic acid|mesh-list
111444166|NCT00000541|Vitamin E|vitamin e|mesh-list
111444167|NCT00000541|Vitamin B 12|vitamin b 12|mesh-list
111444168|NCT00000541|Vitamin B 6|vitamin b 6|mesh-list
111444169|NCT00000541|Pyridoxal|pyridoxal|mesh-list
111444170|NCT00000541|Pyridoxine|pyridoxine|mesh-list
111444171|NCT00000541|Beta Carotene|beta carotene|mesh-list
111444172|NCT00000541|Vitamin B Complex|vitamin b complex|mesh-list
111444173|NCT00000541|Carotenoids|carotenoids|mesh-list
111444174|NCT00000541|Micronutrients|micronutrients|mesh-ancestor
111444175|NCT00000541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111444176|NCT00000541|Antioxidants|antioxidants|mesh-ancestor
111444177|NCT00000541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111444178|NCT00000541|Protective Agents|protective agents|mesh-ancestor
111444179|NCT00000541|Hematinics|hematinics|mesh-ancestor
111444180|NCT00000541|Provitamins|provitamins|mesh-ancestor
111444181|NCT00000913|Ritonavir|ritonavir|mesh-list
111444182|NCT00000913|Nelfinavir|nelfinavir|mesh-list
111444183|NCT00000913|Saquinavir|saquinavir|mesh-list
111444184|NCT00000913|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111444185|NCT00000913|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111444186|NCT00000913|Protease Inhibitors|protease inhibitors|mesh-ancestor
111444187|NCT00000913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111444188|NCT00000913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111444189|NCT00000913|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111444190|NCT00000913|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111444191|NCT00000913|Antiviral Agents|antiviral agents|mesh-ancestor
111444192|NCT00000913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111444193|NCT00000913|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111444194|NCT00000913|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111444195|NCT00000547|Enalapril|enalapril|mesh-list
111444196|NCT00000547|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
111444197|NCT00000547|Protease Inhibitors|protease inhibitors|mesh-ancestor
111444198|NCT00000547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111444199|NCT00000547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111444200|NCT00000547|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111444201|NCT00002930|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
111444202|NCT00002930|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111444203|NCT00002930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111444204|NCT00000577|Colchicine|colchicine|mesh-list
111444205|NCT00000577|Albuterol|albuterol|mesh-list
111444206|NCT00000577|Hormones|hormones|mesh-list
111444207|NCT00000577|Adrenergic Agents|adrenergic agents|mesh-list
111444208|NCT00000577|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-list
110887422|NCT03578822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111444209|NCT00000577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111444210|NCT00000577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111444211|NCT00000577|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111444212|NCT00000577|Autonomic Agents|autonomic agents|mesh-ancestor
111444213|NCT00000577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111444214|NCT00000577|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111444215|NCT00000577|Respiratory System Agents|respiratory system agents|mesh-ancestor
111444216|NCT00000577|Tocolytic Agents|tocolytic agents|mesh-ancestor
111444217|NCT00000577|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110887552|NCT03578042|Vasodilator Agents|vasodilator agents|mesh-ancestor
111444218|NCT00000577|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111444219|NCT00000577|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111444220|NCT00000577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111444221|NCT00000577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111444222|NCT00000577|Gout Suppressants|gout suppressants|mesh-ancestor
111444223|NCT00000577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111444224|NCT00000577|Tubulin Modulators|tubulin modulators|mesh-ancestor
111444225|NCT00000577|Antimitotic Agents|antimitotic agents|mesh-ancestor
111444226|NCT00000577|Mitosis Modulators|mitosis modulators|mesh-ancestor
111444227|NCT00000577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111444228|NCT03321799|Anti-Infective Agents|anti-infective agents|mesh-list
111444229|NCT03321799|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111444230|NCT03015896|Nivolumab|nivolumab|mesh-list
111444231|NCT03015896|Lenalidomide|lenalidomide|mesh-list
111444232|NCT03015896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111444233|NCT03015896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111444234|NCT03015896|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111444235|NCT03015896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111444236|NCT03015896|Immunologic Factors|immunologic factors|mesh-ancestor
111444237|NCT03015896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111444238|NCT03015896|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111444239|NCT03015896|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111444240|NCT03015896|Growth Substances|growth substances|mesh-ancestor
110887680|NCT03646266|Bromides|bromides|mesh-list
111444241|NCT03015896|Growth Inhibitors|growth inhibitors|mesh-ancestor
111444242|NCT02994836|Adalimumab|adalimumab|mesh-list
111444243|NCT02994836|Infliximab|infliximab|mesh-list
111444244|NCT02994836|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111444245|NCT02994836|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111444246|NCT02994836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111444247|NCT02994836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111444248|NCT02994836|Dermatologic Agents|dermatologic agents|mesh-ancestor
111444249|NCT02994836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111444250|NCT00000937|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111444251|NCT00000937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111444252|NCT00000613|Genistein|genistein|mesh-list
111444253|NCT00000613|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
111444254|NCT00000613|Protective Agents|protective agents|mesh-ancestor
111444255|NCT00000613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111444256|NCT00000613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111444257|NCT00000613|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111444258|NCT00000613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111444259|NCT00000613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111444260|NCT00000613|Phytoestrogens|phytoestrogens|mesh-ancestor
111444261|NCT00000613|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
111444262|NCT00000613|Estrogens|estrogens|mesh-ancestor
111444263|NCT00000613|Hormones|hormones|mesh-ancestor
111444264|NCT00000613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111444265|NCT02909348|Pembrolizumab|pembrolizumab|mesh-list
111444266|NCT02909348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111444267|NCT02909348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111444268|NCT02909348|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111444269|NCT02909348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111444270|NCT00000949|Aldesleukin|aldesleukin|mesh-list
111444271|NCT00000949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111444272|NCT00000949|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111444273|NCT00000949|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111444274|NCT00000949|Antiviral Agents|antiviral agents|mesh-ancestor
111444275|NCT00000949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111444276|NCT00002936|Etoposide|etoposide|mesh-list
111444277|NCT00002936|Altretamine|altretamine|mesh-list
111444278|NCT00002936|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111444279|NCT00002936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111444280|NCT00002936|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111444281|NCT00002936|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111444282|NCT00002936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111444283|NCT00002936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111444284|NCT00002936|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111444285|NCT00002936|Alkylating Agents|alkylating agents|mesh-ancestor
111444286|NCT00000649|Zidovudine|zidovudine|mesh-list
111444287|NCT00000649|Nevirapine|nevirapine|mesh-list
111444288|NCT00000649|Antimetabolites|antimetabolites|mesh-ancestor
111444289|NCT00000649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111444290|NCT00000649|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111444291|NCT00000649|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111444292|NCT00000649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111444293|NCT00000649|Antiviral Agents|antiviral agents|mesh-ancestor
111444294|NCT00000649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111444295|NCT00000649|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111444296|NCT00000649|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111444297|NCT00000649|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111444298|NCT00000649|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111444299|NCT00000961|Zidovudine|zidovudine|mesh-list
111444300|NCT00000961|Immune Sera|immune sera|mesh-list
111444301|NCT00000961|Antimetabolites|antimetabolites|mesh-ancestor
111444302|NCT00000961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111444303|NCT00000961|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111444304|NCT00000961|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111444305|NCT00000961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111444306|NCT00000961|Antiviral Agents|antiviral agents|mesh-ancestor
111444307|NCT00000961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111444308|NCT00000961|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111444309|NCT00000961|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111444310|NCT00000961|Immunologic Factors|immunologic factors|mesh-ancestor
111444311|NCT00000961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111444312|NCT04048304|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111444313|NCT04048304|Vancomycin|vancomycin|mesh-list
111444314|NCT04048304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111444315|NCT00000655|Trimethoprim|trimethoprim|mesh-list
111444316|NCT00000655|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
111444317|NCT00000655|Atovaquone|atovaquone|mesh-list
111444318|NCT00000655|Sulfamethoxazole|sulfamethoxazole|mesh-list
111444319|NCT00000655|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111444320|NCT00000655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111444321|NCT00000655|Antimalarials|antimalarials|mesh-ancestor
111444322|NCT00000655|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111444323|NCT00000655|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111444324|NCT00000655|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111444325|NCT00000655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111444326|NCT00000655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111444327|NCT00000655|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111444328|NCT00000655|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
111444329|NCT00000655|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111444330|NCT00000655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111444331|NCT00002948|Topotecan|topotecan|mesh-list
111444332|NCT00002948|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111444333|NCT00002948|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111444334|NCT00002948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111444335|NCT00002948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111444336|NCT00002948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111444337|NCT02594293|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
111444338|NCT02594293|Antiviral Agents|antiviral agents|mesh-ancestor
111444339|NCT02594293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111444340|NCT00000967|Interferons|interferons|mesh-list
111444341|NCT00000967|Interferon-alpha|interferon-alpha|mesh-list
111444342|NCT00000967|Interferon alpha-2|interferon alpha-2|mesh-list
111444343|NCT00000967|Zidovudine|zidovudine|mesh-list
111444344|NCT00000967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111444345|NCT00000967|Antiviral Agents|antiviral agents|mesh-ancestor
111444346|NCT00000967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111444347|NCT00000967|Immunologic Factors|immunologic factors|mesh-ancestor
111444348|NCT00000967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111444349|NCT00000967|Antimetabolites|antimetabolites|mesh-ancestor
111444350|NCT00000967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111444351|NCT00000967|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111444352|NCT00000967|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111444353|NCT00000967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111444354|NCT00000967|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111444355|NCT00000967|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111444356|NCT00000661|Zidovudine|zidovudine|mesh-list
111444357|NCT00000661|Oxazepam|oxazepam|mesh-list
111444358|NCT00000661|Antimetabolites|antimetabolites|mesh-ancestor
111444359|NCT00000661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111444360|NCT00000661|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111444361|NCT00000661|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111444362|NCT00000661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111444363|NCT00000661|Antiviral Agents|antiviral agents|mesh-ancestor
111444364|NCT00000661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111444365|NCT00000661|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111444366|NCT00000661|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111444367|NCT00000661|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111444368|NCT00000661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111444369|NCT00000661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111444370|NCT00000661|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111444371|NCT00000661|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111444372|NCT00000661|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111444373|NCT00000661|GABA Modulators|gaba modulators|mesh-ancestor
111168664|NCT04594239|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111444374|NCT00000661|GABA Agents|gaba agents|mesh-ancestor
111444375|NCT00000661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111444376|NCT00000979|Zidovudine|zidovudine|mesh-list
111444377|NCT00000979|Didanosine|didanosine|mesh-list
111444378|NCT00000979|Antimetabolites|antimetabolites|mesh-ancestor
111444379|NCT00000979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111444380|NCT00000979|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111444381|NCT00000979|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111444382|NCT00000979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111444383|NCT00000979|Antiviral Agents|antiviral agents|mesh-ancestor
111444384|NCT00000979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111444385|NCT00000979|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111444386|NCT00000979|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111444387|NCT00000991|Zidovudine|zidovudine|mesh-list
111444388|NCT00000991|Trimethoprim|trimethoprim|mesh-list
111444389|NCT00000991|Sulfamethoxazole|sulfamethoxazole|mesh-list
111444390|NCT00000991|Dapsone|dapsone|mesh-list
111444391|NCT00000991|Pentamidine|pentamidine|mesh-list
111444392|NCT00000991|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
111444393|NCT00000991|Antimetabolites|antimetabolites|mesh-ancestor
111444394|NCT00000991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111444395|NCT00000991|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111444396|NCT00000991|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111444397|NCT00000991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111444398|NCT00000991|Antiviral Agents|antiviral agents|mesh-ancestor
111444399|NCT00000991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111444400|NCT00000991|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111444401|NCT00000991|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111444402|NCT00000991|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111444403|NCT00000991|Antimalarials|antimalarials|mesh-ancestor
111444404|NCT00000991|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111444405|NCT00000991|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111444406|NCT00000991|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111444407|NCT00000991|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111444408|NCT00000991|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
111444409|NCT00000991|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111444410|NCT00000991|Leprostatic Agents|leprostatic agents|mesh-ancestor
111444411|NCT00000991|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111444412|NCT00000991|Antifungal Agents|antifungal agents|mesh-ancestor
111444413|NCT00000991|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
111444414|NCT00000673|Ganciclovir|ganciclovir|mesh-list
111444415|NCT00000673|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
111444416|NCT00000673|Antiviral Agents|antiviral agents|mesh-ancestor
111444417|NCT00000673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111444418|NCT00000673|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111444419|NCT00000673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111444420|NCT00000673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111444421|NCT00000685|Zidovudine|zidovudine|mesh-list
111444422|NCT00000685|Antimetabolites|antimetabolites|mesh-ancestor
111444423|NCT00000685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111444424|NCT00000685|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111444425|NCT00000685|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111444426|NCT00000685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111444427|NCT00000685|Antiviral Agents|antiviral agents|mesh-ancestor
111444428|NCT00000685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111444429|NCT00000685|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111444430|NCT00000685|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111444431|NCT00002972|Paclitaxel|paclitaxel|mesh-list
111444432|NCT00002972|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110216847|NCT00102219|Pemetrexed|pemetrexed|mesh-list
111444433|NCT00002972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111444434|NCT00002972|Tubulin Modulators|tubulin modulators|mesh-ancestor
111444435|NCT00002972|Antimitotic Agents|antimitotic agents|mesh-ancestor
111444436|NCT00002972|Mitosis Modulators|mitosis modulators|mesh-ancestor
111444437|NCT00002972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111444438|NCT00000691|Foscarnet|foscarnet|mesh-list
111444439|NCT00000691|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
111444440|NCT00000691|Antiviral Agents|antiviral agents|mesh-ancestor
111444441|NCT00000691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111444442|NCT00000691|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110605745|NCT00904852|Bevacizumab|bevacizumab|mesh-list
111444443|NCT00000691|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111444444|NCT00000691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111444445|NCT00000691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111444446|NCT00002984|Paclitaxel|paclitaxel|mesh-list
111444447|NCT00002984|Fluorouracil|fluorouracil|mesh-list
111444448|NCT00002984|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111444449|NCT00002984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111444450|NCT00002984|Tubulin Modulators|tubulin modulators|mesh-ancestor
111444451|NCT00002984|Antimitotic Agents|antimitotic agents|mesh-ancestor
111444452|NCT00002984|Mitosis Modulators|mitosis modulators|mesh-ancestor
111444453|NCT00002984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111444454|NCT00002984|Antimetabolites|antimetabolites|mesh-ancestor
111444455|NCT00002984|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111444456|NCT00002984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111444457|NCT00002984|Immunologic Factors|immunologic factors|mesh-ancestor
111444458|NCT00002984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111444459|NCT00002990|BCG Vaccine|bcg vaccine|mesh-list
111444460|NCT00002990|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111444461|NCT00002990|Immunologic Factors|immunologic factors|mesh-ancestor
111444462|NCT00002990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111444463|NCT00000997|Zalcitabine|zalcitabine|mesh-list
111444464|NCT00000997|Antimetabolites|antimetabolites|mesh-ancestor
110888361|NCT01336621|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111444465|NCT00000997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111444466|NCT00000997|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111444467|NCT00000997|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111444468|NCT00000997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111444469|NCT00000997|Antiviral Agents|antiviral agents|mesh-ancestor
111444470|NCT00000997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111444471|NCT00000997|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111444472|NCT00000997|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111444473|NCT00000697|Foscarnet|foscarnet|mesh-list
111444474|NCT00000697|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
111444475|NCT00000697|Antiviral Agents|antiviral agents|mesh-ancestor
111444476|NCT00000697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111444477|NCT00000697|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111444478|NCT00000697|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111444479|NCT00000697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111444480|NCT00000697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111444481|NCT00001009|Dextrans|dextrans|mesh-list
111444482|NCT00001009|Anticoagulants|anticoagulants|mesh-ancestor
111444483|NCT00001009|Plasma Substitutes|plasma substitutes|mesh-ancestor
111444484|NCT00001009|Blood Substitutes|blood substitutes|mesh-ancestor
111444485|NCT00000703|Leucovorin|leucovorin|mesh-list
111444486|NCT00000703|Cytarabine|cytarabine|mesh-list
111444487|NCT00000703|Zidovudine|zidovudine|mesh-list
111444488|NCT00000703|Dexamethasone|dexamethasone|mesh-list
111444489|NCT00000703|Cyclophosphamide|cyclophosphamide|mesh-list
111444490|NCT00000703|Doxorubicin|doxorubicin|mesh-list
111444491|NCT00000703|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111444492|NCT00000703|Methotrexate|methotrexate|mesh-list
111444493|NCT00000703|Vincristine|vincristine|mesh-list
111444494|NCT00000703|Bleomycin|bleomycin|mesh-list
111444495|NCT00000703|Allopurinol|allopurinol|mesh-list
111444496|NCT00000703|Levoleucovorin|levoleucovorin|mesh-list
111444497|NCT00000703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111444498|NCT00000703|Immunologic Factors|immunologic factors|mesh-ancestor
111444499|NCT00000703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111444500|NCT00000703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111444501|NCT00000703|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111444502|NCT00000703|Alkylating Agents|alkylating agents|mesh-ancestor
111444503|NCT00000703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111444504|NCT00000703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111444505|NCT00000703|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111444506|NCT00000703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111444507|NCT00000703|Antiemetics|antiemetics|mesh-ancestor
111444508|NCT00000703|Autonomic Agents|autonomic agents|mesh-ancestor
111444509|NCT00000703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111444510|NCT00000703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111444511|NCT00000703|Glucocorticoids|glucocorticoids|mesh-ancestor
111444512|NCT00000703|Hormones|hormones|mesh-ancestor
110888550|NCT01332617|Prednisolone|prednisolone|mesh-list
111444513|NCT00000703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111444514|NCT00000703|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111444515|NCT00000703|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111444516|NCT00000703|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111444517|NCT00000703|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111444518|NCT00000703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110888603|NCT01342939|Hormones|hormones|mesh-ancestor
111444519|NCT00000703|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111444520|NCT00000703|Abortifacient Agents|abortifacient agents|mesh-ancestor
111444521|NCT00000703|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111444522|NCT00000703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111444523|NCT00000703|Antimetabolites|antimetabolites|mesh-ancestor
111444524|NCT00000703|Dermatologic Agents|dermatologic agents|mesh-ancestor
111444525|NCT00000703|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111444526|NCT00000703|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111444527|NCT00000703|Antiviral Agents|antiviral agents|mesh-ancestor
111444528|NCT00000703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110888672|NCT01332929|Bevacizumab|bevacizumab|mesh-list
111444530|NCT00000703|Protective Agents|protective agents|mesh-ancestor
111444531|NCT00000703|Vitamin B Complex|vitamin b complex|mesh-ancestor
111444532|NCT00000703|Vitamins|vitamins|mesh-ancestor
111444533|NCT00000703|Micronutrients|micronutrients|mesh-ancestor
111444534|NCT00000703|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111444535|NCT00000703|Tubulin Modulators|tubulin modulators|mesh-ancestor
111444536|NCT00000703|Antimitotic Agents|antimitotic agents|mesh-ancestor
111444537|NCT00000703|Mitosis Modulators|mitosis modulators|mesh-ancestor
111444538|NCT00000703|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111444539|NCT00000703|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111444540|NCT00000703|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111444541|NCT00000703|Gout Suppressants|gout suppressants|mesh-ancestor
111444542|NCT00000703|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111444543|NCT00000703|Antioxidants|antioxidants|mesh-ancestor
111444544|NCT00001015|Ribavirin|ribavirin|mesh-list
111444545|NCT00001015|Antimetabolites|antimetabolites|mesh-ancestor
111444546|NCT00001015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111444547|NCT00001015|Antiviral Agents|antiviral agents|mesh-ancestor
111444548|NCT00001015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111444549|NCT00000709|Zidovudine|zidovudine|mesh-list
111444550|NCT00000709|Antimetabolites|antimetabolites|mesh-ancestor
111444551|NCT00000709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111444552|NCT00000709|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111444553|NCT00000709|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111444554|NCT00000709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111444555|NCT00000709|Antiviral Agents|antiviral agents|mesh-ancestor
111444556|NCT00000709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111444557|NCT00000709|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111444558|NCT00000709|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111444559|NCT00001027|Pentamidine|pentamidine|mesh-list
111444560|NCT00001027|Antifungal Agents|antifungal agents|mesh-ancestor
111444561|NCT00001027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111444562|NCT00001027|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111444563|NCT00001027|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111444564|NCT00001027|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
111444565|NCT00000727|Zidovudine|zidovudine|mesh-list
111444566|NCT00000727|Pyrimethamine|pyrimethamine|mesh-list
111444567|NCT00000727|Sulfadoxine|sulfadoxine|mesh-list
111444568|NCT00000727|Trimethoprim|trimethoprim|mesh-list
111444569|NCT00000727|Sulfamethoxazole|sulfamethoxazole|mesh-list
111444570|NCT00000727|Pentamidine|pentamidine|mesh-list
111444571|NCT00000727|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
111444572|NCT00000727|Antimetabolites|antimetabolites|mesh-ancestor
111444573|NCT00000727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110888868|NCT05353010|Tacrolimus|tacrolimus|mesh-list
111444574|NCT00000727|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111444575|NCT00000727|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111444576|NCT00000727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111444577|NCT00000727|Antiviral Agents|antiviral agents|mesh-ancestor
111444578|NCT00000727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111444579|NCT00000727|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111444580|NCT00000727|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111444581|NCT00000727|Antimalarials|antimalarials|mesh-ancestor
111444582|NCT00000727|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111444583|NCT00000727|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111444584|NCT00000727|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111444585|NCT00000727|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111444586|NCT00000727|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111444587|NCT00000727|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
111444588|NCT00000727|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111444589|NCT00000727|Antifungal Agents|antifungal agents|mesh-ancestor
111444590|NCT00000727|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
111444591|NCT00000727|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111444592|NCT00001039|Clarithromycin|clarithromycin|mesh-list
111444593|NCT00001039|Ethambutol|ethambutol|mesh-list
111444594|NCT00001039|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111444595|NCT00001039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111444596|NCT00001039|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111444597|NCT00001039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111444598|NCT00001039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111444599|NCT00001039|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111444600|NCT00001039|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111444601|NCT00001039|Antitubercular Agents|antitubercular agents|mesh-ancestor
111444602|NCT00001057|Zidovudine|zidovudine|mesh-list
111444603|NCT00001057|Didanosine|didanosine|mesh-list
111444604|NCT00001057|Antimetabolites|antimetabolites|mesh-ancestor
111444605|NCT00001057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111444606|NCT00001057|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111444607|NCT00001057|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111444608|NCT00001057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111444609|NCT00001057|Antiviral Agents|antiviral agents|mesh-ancestor
111444610|NCT00001057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111444611|NCT00001057|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111444612|NCT00001057|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111444613|NCT00002293|Nystatin|nystatin|mesh-list
111444614|NCT00002293|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111444615|NCT00002293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111444616|NCT00002293|Antifungal Agents|antifungal agents|mesh-ancestor
111444617|NCT00002293|Ionophores|ionophores|mesh-ancestor
111444618|NCT00002293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111444619|NCT00002293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111444620|NCT00002299|Interferons|interferons|mesh-list
111444621|NCT00002299|Interferon-beta|interferon-beta|mesh-list
111444622|NCT00002299|Ganciclovir|ganciclovir|mesh-list
111444623|NCT00002299|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
111444624|NCT00002299|Interferon beta-1b|interferon beta-1b|mesh-list
111444625|NCT00002299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111444626|NCT00002299|Antiviral Agents|antiviral agents|mesh-ancestor
111444627|NCT00002299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111444628|NCT00002299|Immunologic Factors|immunologic factors|mesh-ancestor
111444629|NCT00002299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111444630|NCT00002299|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111444631|NCT00002299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111444632|NCT00002299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111444633|NCT00002299|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111444634|NCT00001063|Zidovudine|zidovudine|mesh-list
111444635|NCT00001063|Stavudine|stavudine|mesh-list
111444636|NCT00001063|Didanosine|didanosine|mesh-list
111444637|NCT00001063|Antimetabolites|antimetabolites|mesh-ancestor
111444638|NCT00001063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111444639|NCT00001063|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111444640|NCT00001063|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111444641|NCT00001063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111444642|NCT00001063|Antiviral Agents|antiviral agents|mesh-ancestor
111444643|NCT00001063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111444644|NCT00001063|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111444645|NCT00001063|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111444646|NCT00002305|Fluconazole|fluconazole|mesh-list
111444647|NCT00002305|Amphotericin B|amphotericin b|mesh-list
111444648|NCT00002305|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
111444649|NCT00002305|Flucytosine|flucytosine|mesh-list
111444650|NCT00002305|Antifungal Agents|antifungal agents|mesh-ancestor
111444651|NCT00002305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111444652|NCT00002305|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111444653|NCT00002305|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111444654|NCT00002305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111444655|NCT00002305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111444656|NCT00002305|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111444657|NCT00002305|Hormone Antagonists|hormone antagonists|mesh-ancestor
111444658|NCT00002305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111444659|NCT00002305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111444660|NCT00002305|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111444661|NCT00002305|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111444662|NCT00002305|Amebicides|amebicides|mesh-ancestor
111444663|NCT00002305|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111444664|NCT00002305|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111444665|NCT00002305|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111444666|NCT00002305|Antimetabolites|antimetabolites|mesh-ancestor
111444667|NCT00001081|Nitazoxanide|nitazoxanide|mesh-list
111444668|NCT00001081|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111444669|NCT00001081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111444670|NCT00002311|Wobenzym|wobenzym|mesh-list
111444671|NCT00002311|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111444672|NCT00002311|Immunologic Factors|immunologic factors|mesh-ancestor
111444673|NCT00002311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111444674|NCT00002317|Leucovorin|leucovorin|mesh-list
111444675|NCT00002317|Trimetrexate|trimetrexate|mesh-list
111444676|NCT00002317|Calcium|calcium|mesh-list
111444677|NCT00002317|Levoleucovorin|levoleucovorin|mesh-list
111444678|NCT00002317|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110889075|NCT01345981|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111444679|NCT00002317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111444680|NCT00002317|Antidotes|antidotes|mesh-ancestor
111444681|NCT00002317|Protective Agents|protective agents|mesh-ancestor
111444682|NCT00002317|Vitamin B Complex|vitamin b complex|mesh-ancestor
111444683|NCT00002317|Vitamins|vitamins|mesh-ancestor
111444684|NCT00002317|Micronutrients|micronutrients|mesh-ancestor
111444685|NCT00002317|Antifungal Agents|antifungal agents|mesh-ancestor
111444686|NCT00002317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111444687|NCT00002317|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111444688|NCT00002317|Antimetabolites|antimetabolites|mesh-ancestor
111444689|NCT00002317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111444690|NCT00002317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111444691|NCT00002317|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111444692|NCT00002317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111444693|NCT00001123|Ribavirin|ribavirin|mesh-list
111444694|NCT00001123|Antimetabolites|antimetabolites|mesh-ancestor
111444695|NCT00001123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111444696|NCT00001123|Antiviral Agents|antiviral agents|mesh-ancestor
111444697|NCT00001123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111444698|NCT00002323|Zidovudine|zidovudine|mesh-list
111444699|NCT00002323|Nevirapine|nevirapine|mesh-list
111444700|NCT00002323|Antimetabolites|antimetabolites|mesh-ancestor
111444701|NCT00002323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111444702|NCT00002323|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111444703|NCT00002323|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111444704|NCT00002323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111444705|NCT00002323|Antiviral Agents|antiviral agents|mesh-ancestor
111444706|NCT00002323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111444707|NCT00002323|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111444708|NCT00002323|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111444709|NCT00002323|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111444710|NCT00002323|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111444711|NCT00380965|Nabilone|nabilone|mesh-list
111444712|NCT00380965|Antiemetics|antiemetics|mesh-ancestor
111444713|NCT00380965|Autonomic Agents|autonomic agents|mesh-ancestor
111444714|NCT00380965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111444715|NCT00380965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111444716|NCT00380965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111444717|NCT00380965|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111444718|NCT00380965|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111444719|NCT00380965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111444720|NCT00380965|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111444721|NCT00001135|Nevirapine|nevirapine|mesh-list
111444722|NCT00001135|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111444723|NCT00001135|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111444724|NCT00001135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110889220|NCT01348243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111444725|NCT00001135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111444726|NCT00001135|Antiviral Agents|antiviral agents|mesh-ancestor
111444727|NCT00001135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111444728|NCT00001135|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111444729|NCT00001135|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111444730|NCT00001135|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111444731|NCT00001135|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111444732|NCT00003002|Sargramostim|sargramostim|mesh-list
111444733|NCT00003002|Immunologic Factors|immunologic factors|mesh-ancestor
111444734|NCT00003002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111444735|NCT00001891|Dobutamine|dobutamine|mesh-list
111444736|NCT00001891|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111444737|NCT00001891|Sympathomimetics|sympathomimetics|mesh-ancestor
111444738|NCT00001891|Autonomic Agents|autonomic agents|mesh-ancestor
111444739|NCT00001891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111444740|NCT00001891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110889301|NCT03563534|Fluorides|fluorides|mesh-list
111444741|NCT00001891|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
111444742|NCT00001891|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111444743|NCT00001891|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111444744|NCT00001891|Adrenergic Agents|adrenergic agents|mesh-ancestor
111444745|NCT00001891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111444746|NCT00001891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111444747|NCT00001891|Protective Agents|protective agents|mesh-ancestor
111444748|NCT00383864|Interferons|interferons|mesh-list
111444749|NCT00383864|Ribavirin|ribavirin|mesh-list
111444750|NCT00383864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111444751|NCT00383864|Antiviral Agents|antiviral agents|mesh-ancestor
111444752|NCT00383864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111444753|NCT00383864|Antimetabolites|antimetabolites|mesh-ancestor
111444754|NCT00383864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111444755|NCT00001903|Immunoglobulins|immunoglobulins|mesh-list
111444756|NCT00001903|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111169037|NCT01812759|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111444757|NCT00001903|Antibodies|antibodies|mesh-list
111444758|NCT00001903|Immunologic Factors|immunologic factors|mesh-ancestor
111444759|NCT00001903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111444760|NCT00002335|Emtricitabine|emtricitabine|mesh-list
111444761|NCT00002335|Antiviral Agents|antiviral agents|mesh-ancestor
111444762|NCT00002335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111444763|NCT00002335|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111444764|NCT00002335|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111444765|NCT00002335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111444766|NCT00002335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111444767|NCT00002335|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111444768|NCT00002335|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111444769|NCT00002341|Itraconazole|itraconazole|mesh-list
111444770|NCT00002341|Antifungal Agents|antifungal agents|mesh-ancestor
111444771|NCT00002341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111444772|NCT00002341|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111444773|NCT00002341|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111444774|NCT00002341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111444775|NCT00002341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111444776|NCT00002341|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111444777|NCT00002341|Hormone Antagonists|hormone antagonists|mesh-ancestor
111444778|NCT00002341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111444779|NCT00002341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111444780|NCT00002341|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111444781|NCT00002347|Zidovudine|zidovudine|mesh-list
111444782|NCT00002347|Nevirapine|nevirapine|mesh-list
111444783|NCT00002347|Zalcitabine|zalcitabine|mesh-list
111444784|NCT00002347|Saquinavir|saquinavir|mesh-list
111444785|NCT00002347|Antimetabolites|antimetabolites|mesh-ancestor
111444786|NCT00002347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111444787|NCT00002347|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111444788|NCT00002347|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111444789|NCT00002347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111444790|NCT00002347|Antiviral Agents|antiviral agents|mesh-ancestor
111444791|NCT00002347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111444792|NCT00002347|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111444793|NCT00002347|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111444794|NCT00002347|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111444795|NCT00002347|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111444796|NCT00002347|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111444797|NCT00002347|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111444798|NCT00002347|Protease Inhibitors|protease inhibitors|mesh-ancestor
111444799|NCT00002347|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111444800|NCT00002347|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111444801|NCT00001237|Molgramostim|molgramostim|mesh-list
111444802|NCT00001237|Sargramostim|sargramostim|mesh-list
111444803|NCT00001237|Immunologic Factors|immunologic factors|mesh-ancestor
111444804|NCT00001237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111444805|NCT00001237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111444806|NCT00001933|Nefiracetam|nefiracetam|mesh-list
111444807|NCT00001933|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111444808|NCT00001933|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111444809|NCT00001933|Protective Agents|protective agents|mesh-ancestor
111444810|NCT00001933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111444811|NCT00001933|Nootropic Agents|nootropic agents|mesh-ancestor
111444812|NCT00001249|Antibodies|antibodies|mesh-list
111444813|NCT00001249|Immunologic Factors|immunologic factors|mesh-ancestor
111444814|NCT00001249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111444815|NCT00380575|Conivaptan|conivaptan|mesh-list
111444816|NCT00380575|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
111444817|NCT00380575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111444818|NCT00380575|Natriuretic Agents|natriuretic agents|mesh-ancestor
111444819|NCT00380575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111444820|NCT00001963|Chrysarobin|chrysarobin|mesh-list
111444821|NCT00001963|Nitric Oxide|nitric oxide|mesh-list
111444822|NCT00001963|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111444823|NCT00001963|Autonomic Agents|autonomic agents|mesh-ancestor
111444824|NCT00001963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111444825|NCT00001963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111444826|NCT00001963|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111444827|NCT00001963|Respiratory System Agents|respiratory system agents|mesh-ancestor
111444828|NCT00001963|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111444829|NCT00001963|Antioxidants|antioxidants|mesh-ancestor
111444830|NCT00001963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111444831|NCT00001963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111444832|NCT00001963|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
111444833|NCT00001963|Vasodilator Agents|vasodilator agents|mesh-ancestor
111444834|NCT00001963|Gasotransmitters|gasotransmitters|mesh-ancestor
111444835|NCT00001963|Protective Agents|protective agents|mesh-ancestor
111444836|NCT00001963|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111444837|NCT00001963|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111444839|NCT00001963|Sensory System Agents|sensory system agents|mesh-ancestor
111444840|NCT00001963|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111444841|NCT00001963|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111444842|NCT00002377|Valganciclovir|valganciclovir|mesh-list
111444843|NCT00002377|Ganciclovir|ganciclovir|mesh-list
111444844|NCT00002377|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
111444845|NCT00002377|Antiviral Agents|antiviral agents|mesh-ancestor
111444846|NCT00002377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111444847|NCT00002377|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111444848|NCT00002377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111444849|NCT00002377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111444850|NCT00001339|Doxorubicin|doxorubicin|mesh-list
111444851|NCT00001339|Etoposide|etoposide|mesh-list
111444852|NCT00001339|Vincristine|vincristine|mesh-list
111444853|NCT00001339|Mitotane|mitotane|mesh-list
111444854|NCT00001339|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111444855|NCT00001339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111444856|NCT00001339|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111444857|NCT00001339|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111444858|NCT00001339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111444859|NCT00001339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110889839|NCT01357681|Antioxidants|antioxidants|mesh-ancestor
111444860|NCT00001339|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111444861|NCT00001339|Tubulin Modulators|tubulin modulators|mesh-ancestor
111444862|NCT00001339|Antimitotic Agents|antimitotic agents|mesh-ancestor
111444863|NCT00001339|Mitosis Modulators|mitosis modulators|mesh-ancestor
111444864|NCT00001339|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111444865|NCT00001993|Miglustat|miglustat|mesh-list
111444866|NCT00001993|Zidovudine|zidovudine|mesh-list
111444867|NCT00001993|Antimetabolites|antimetabolites|mesh-ancestor
111444868|NCT00001993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111444869|NCT00001993|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111444870|NCT00001993|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111444871|NCT00001993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111444872|NCT00001993|Antiviral Agents|antiviral agents|mesh-ancestor
111444873|NCT00001993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111444874|NCT00001993|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111444875|NCT00001993|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111444876|NCT00001993|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
111444877|NCT00001993|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111444878|NCT00001993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111444879|NCT00001999|Ganciclovir|ganciclovir|mesh-list
111444880|NCT00001999|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
111444881|NCT00001999|Immunoglobulins|immunoglobulins|mesh-list
111444882|NCT00001999|Antibodies|antibodies|mesh-list
111444883|NCT00001999|Antiviral Agents|antiviral agents|mesh-ancestor
111444884|NCT00001999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111444885|NCT00001999|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111444886|NCT00001999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111444887|NCT00001999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111444888|NCT00001999|Immunologic Factors|immunologic factors|mesh-ancestor
111444889|NCT00001999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111444890|NCT00002383|Saquinavir|saquinavir|mesh-list
111444891|NCT00002383|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111444892|NCT00002383|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111444893|NCT00002383|Protease Inhibitors|protease inhibitors|mesh-ancestor
111444894|NCT00002383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110889897|NCT02053766|Analgesics|analgesics|mesh-ancestor
111444895|NCT00002383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111444896|NCT00002383|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111444897|NCT00002383|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111444898|NCT00002383|Antiviral Agents|antiviral agents|mesh-ancestor
111444899|NCT00002383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111444900|NCT00002383|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111444901|NCT00002383|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111444902|NCT00002389|Lamivudine|lamivudine|mesh-list
111444903|NCT00002389|Zidovudine|zidovudine|mesh-list
111444904|NCT00002389|Abacavir|abacavir|mesh-list
111444905|NCT00002389|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111169187|NCT02012959|Tolvaptan|tolvaptan|mesh-list
111444906|NCT00002389|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111444907|NCT00002389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111444908|NCT00002389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111444909|NCT00002389|Antiviral Agents|antiviral agents|mesh-ancestor
111444910|NCT00002389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111444911|NCT00002389|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111444912|NCT00002389|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111444913|NCT00002389|Antimetabolites|antimetabolites|mesh-ancestor
111444914|NCT00001357|Interleukin-2|interleukin-2|mesh-list
111444915|NCT00001357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111444916|NCT00001357|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111444917|NCT00001357|Analgesics|analgesics|mesh-ancestor
111444918|NCT00001357|Sensory System Agents|sensory system agents|mesh-ancestor
111444919|NCT00001357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111444920|NCT00001357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111444921|NCT00001381|Suramin|suramin|mesh-list
111444922|NCT00001381|Antinematodal Agents|antinematodal agents|mesh-ancestor
111444923|NCT00001381|Anthelmintics|anthelmintics|mesh-ancestor
111444924|NCT00001381|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111444925|NCT00001381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111444926|NCT00001381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111444927|NCT00001381|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
111444928|NCT00001381|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111444929|NCT00002011|Methoxsalen|methoxsalen|mesh-list
111444930|NCT00002011|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111444931|NCT00002011|Dermatologic Agents|dermatologic agents|mesh-ancestor
111444932|NCT00002017|Interleukin-2|interleukin-2|mesh-list
111444933|NCT00002017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111444934|NCT00002017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111444935|NCT00002017|Analgesics|analgesics|mesh-ancestor
111444936|NCT00002017|Sensory System Agents|sensory system agents|mesh-ancestor
111444937|NCT00002017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111444938|NCT00002017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111444939|NCT00002023|Zidovudine|zidovudine|mesh-list
111444940|NCT00002023|Antimetabolites|antimetabolites|mesh-ancestor
111444941|NCT00002023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111444942|NCT00002023|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111444943|NCT00002023|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111444944|NCT00002023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111444945|NCT00002023|Antiviral Agents|antiviral agents|mesh-ancestor
111444946|NCT00002023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111444947|NCT00002023|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111444948|NCT00002023|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111444949|NCT00002029|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
111444950|NCT00002029|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
111444951|NCT00002029|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
111444952|NCT00002029|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111444953|NCT00002035|Zidovudine|zidovudine|mesh-list
111444954|NCT00002035|Didanosine|didanosine|mesh-list
111444955|NCT00002035|Antimetabolites|antimetabolites|mesh-ancestor
111444956|NCT00002035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111444957|NCT00002035|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111444958|NCT00002035|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111444959|NCT00002035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111444960|NCT00002035|Antiviral Agents|antiviral agents|mesh-ancestor
111444961|NCT00002035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111444962|NCT00002035|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111444963|NCT00002035|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111444964|NCT00002041|Amphotericin B|amphotericin b|mesh-list
111444965|NCT00002041|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
111444966|NCT00002041|Amebicides|amebicides|mesh-ancestor
111444967|NCT00002041|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111444968|NCT00002041|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111444969|NCT00002041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111444970|NCT00002041|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111444971|NCT00002041|Antifungal Agents|antifungal agents|mesh-ancestor
111444972|NCT00002047|Zidovudine|zidovudine|mesh-list
111444973|NCT00002047|Antimetabolites|antimetabolites|mesh-ancestor
111444974|NCT00002047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111444975|NCT00002047|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111444976|NCT00002047|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111444977|NCT00002047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111444978|NCT00002047|Antiviral Agents|antiviral agents|mesh-ancestor
111169263|NCT02011945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111444979|NCT00002047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111444980|NCT00002047|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111444981|NCT00002047|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111444982|NCT00002053|Pentamidine|pentamidine|mesh-list
111444983|NCT00002053|Antifungal Agents|antifungal agents|mesh-ancestor
111444985|NCT00002053|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111444986|NCT00002053|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111444987|NCT00002053|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
111444988|NCT00002059|Inosine Pranobex|inosine pranobex|mesh-list
111444989|NCT00002059|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111444990|NCT00002059|Immunologic Factors|immunologic factors|mesh-ancestor
111444991|NCT00002059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111444992|NCT00002059|Antiviral Agents|antiviral agents|mesh-ancestor
111444993|NCT00002059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111444994|NCT00002065|Disulfiram|disulfiram|mesh-list
111444995|NCT00002065|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111444996|NCT00002065|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
111444997|NCT00002065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110890295|NCT05162573|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111444998|NCT00002065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111444999|NCT00002071|Epoetin Alfa|epoetin alfa|mesh-list
111445000|NCT00002071|Hematinics|hematinics|mesh-ancestor
111445001|NCT00002395|Topotecan|topotecan|mesh-list
111445002|NCT00002395|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111445003|NCT00002395|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111445004|NCT00002395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111445005|NCT00002395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111445006|NCT00002395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111445007|NCT00002401|Lamivudine|lamivudine|mesh-list
111445008|NCT00002401|Zidovudine|zidovudine|mesh-list
111445009|NCT00002401|Delavirdine|delavirdine|mesh-list
111445010|NCT00002401|Indinavir|indinavir|mesh-list
111445011|NCT00002401|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111445012|NCT00002401|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111445013|NCT00002401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111445014|NCT00002401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111445015|NCT00002401|Antiviral Agents|antiviral agents|mesh-ancestor
111445016|NCT00002401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111445017|NCT00002401|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111445018|NCT00002401|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111445019|NCT00002401|Antimetabolites|antimetabolites|mesh-ancestor
111445020|NCT00002401|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111445021|NCT00002401|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111445022|NCT00002401|Protease Inhibitors|protease inhibitors|mesh-ancestor
111445023|NCT00002407|Lamivudine|lamivudine|mesh-list
111445024|NCT00002407|Nevirapine|nevirapine|mesh-list
111445025|NCT00002407|Stavudine|stavudine|mesh-list
111445026|NCT00002407|Didanosine|didanosine|mesh-list
111445027|NCT00002407|Indinavir|indinavir|mesh-list
111445028|NCT00002407|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111445029|NCT00002407|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111445030|NCT00002407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111445031|NCT00002407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111445032|NCT00002407|Antiviral Agents|antiviral agents|mesh-ancestor
111445033|NCT00002407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111445034|NCT00002407|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111445035|NCT00002407|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111445036|NCT00002407|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111445037|NCT00002407|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111445038|NCT00002407|Antimetabolites|antimetabolites|mesh-ancestor
111445039|NCT00002407|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111445040|NCT00002407|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111445041|NCT00002407|Protease Inhibitors|protease inhibitors|mesh-ancestor
111445042|NCT00002413|Emivirine|emivirine|mesh-list
111445043|NCT00002413|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111445044|NCT00002413|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111445045|NCT00002413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111445046|NCT00002413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111445047|NCT00002413|Antiviral Agents|antiviral agents|mesh-ancestor
111445048|NCT00002413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111445049|NCT00002419|Efavirenz|efavirenz|mesh-list
111445050|NCT00002419|Abacavir|abacavir|mesh-list
111445051|NCT00002419|Adefovir|adefovir|mesh-list
111445052|NCT00002419|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
111445053|NCT00002419|Amprenavir|amprenavir|mesh-list
111445054|NCT00002419|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111445055|NCT00002419|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111445056|NCT00002419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111445057|NCT00002419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111445058|NCT00002419|Antiviral Agents|antiviral agents|mesh-ancestor
111445059|NCT00002419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111445060|NCT00002419|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111445061|NCT00002419|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111445062|NCT00002419|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111445063|NCT00002419|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111445064|NCT00002419|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111445065|NCT00002419|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111445067|NCT00002419|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111445068|NCT00002419|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111445069|NCT00002419|Antitubercular Agents|antitubercular agents|mesh-ancestor
111445070|NCT00002419|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111445071|NCT00002419|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111445072|NCT00002419|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111445073|NCT00002419|Protease Inhibitors|protease inhibitors|mesh-ancestor
111445074|NCT00381511|Heparin|heparin|mesh-list
111445075|NCT00381511|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
111445076|NCT00381511|Tinzaparin|tinzaparin|mesh-list
111445077|NCT00381511|Dalteparin|dalteparin|mesh-list
111445078|NCT00381511|Anticoagulants|anticoagulants|mesh-ancestor
111445079|NCT00381511|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111445080|NCT00381511|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111445081|NCT00381511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111445082|NCT00002425|Saquinavir|saquinavir|mesh-list
111445083|NCT00002425|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111445084|NCT00002425|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111445085|NCT00002425|Protease Inhibitors|protease inhibitors|mesh-ancestor
111445086|NCT00002425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111445087|NCT00002425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111445088|NCT00002425|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111445089|NCT00002425|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111445090|NCT00002425|Antiviral Agents|antiviral agents|mesh-ancestor
111445091|NCT00002425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111445092|NCT00002425|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111445093|NCT00002425|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111445094|NCT00002431|Chlorhexidine|chlorhexidine|mesh-list
111445095|NCT00002431|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
111445096|NCT00002431|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111445097|NCT00002431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111445098|NCT00002431|Disinfectants|disinfectants|mesh-ancestor
111445099|NCT00002431|Dermatologic Agents|dermatologic agents|mesh-ancestor
111445100|NCT00002077|Fluconazole|fluconazole|mesh-list
111445101|NCT00002077|Antifungal Agents|antifungal agents|mesh-ancestor
111445102|NCT00002077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111445103|NCT00002077|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111445104|NCT00002077|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111445105|NCT00002077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111445106|NCT00002077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111445107|NCT00002077|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111445108|NCT00002077|Hormone Antagonists|hormone antagonists|mesh-ancestor
111445109|NCT00002077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111445110|NCT00002077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111445111|NCT00002077|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111445112|NCT00002077|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111445113|NCT00002089|Azithromycin|azithromycin|mesh-list
111445114|NCT00002089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111445115|NCT00002089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111445116|NCT00002095|Ganciclovir|ganciclovir|mesh-list
111445117|NCT00002095|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
111445118|NCT00002095|Antiviral Agents|antiviral agents|mesh-ancestor
111445119|NCT00002095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111445120|NCT00002095|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111445121|NCT00002095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111445122|NCT00002095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111445123|NCT00002101|Clarithromycin|clarithromycin|mesh-list
111445124|NCT00002101|Ethambutol|ethambutol|mesh-list
111445125|NCT00002101|Rifabutin|rifabutin|mesh-list
111445126|NCT00002101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111445127|NCT00002101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111445128|NCT00002101|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111445129|NCT00002101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111445130|NCT00002101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111445131|NCT00002101|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111445132|NCT00002101|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111445133|NCT00002101|Antitubercular Agents|antitubercular agents|mesh-ancestor
111445134|NCT00002101|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111445136|NCT02335424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111445137|NCT02335424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111445138|NCT02335424|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111445139|NCT02335424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111445140|NCT00002107|Aldesleukin|aldesleukin|mesh-list
111445141|NCT00002107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111445142|NCT00002107|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111445143|NCT00002107|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111445144|NCT00002107|Antiviral Agents|antiviral agents|mesh-ancestor
111445145|NCT00002107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111445146|NCT00002113|Fluconazole|fluconazole|mesh-list
111445147|NCT00002113|Flucytosine|flucytosine|mesh-list
111445148|NCT00002113|Antifungal Agents|antifungal agents|mesh-ancestor
111445149|NCT00002113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111445150|NCT00002113|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111445151|NCT00002113|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111445152|NCT00002113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110890822|NCT01318369|Anticonvulsants|anticonvulsants|mesh-ancestor
111445153|NCT00002113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111445154|NCT00002113|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111445155|NCT00002113|Hormone Antagonists|hormone antagonists|mesh-ancestor
111445156|NCT00002113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111445157|NCT00002113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111445158|NCT00002113|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111445159|NCT00002113|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111445160|NCT00002113|Antimetabolites|antimetabolites|mesh-ancestor
111445161|NCT00002437|Cidofovir|cidofovir|mesh-list
111445162|NCT00002437|Probenecid|probenecid|mesh-list
111445163|NCT00002437|Uricosuric Agents|uricosuric agents|mesh-ancestor
111445164|NCT00002437|Gout Suppressants|gout suppressants|mesh-ancestor
111445165|NCT00002437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111445166|NCT00002437|Antiviral Agents|antiviral agents|mesh-ancestor
111445167|NCT00002437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111445168|NCT00002437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111445169|NCT00002437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111445170|NCT00002443|Zidovudine|zidovudine|mesh-list
111445171|NCT00002443|Indinavir|indinavir|mesh-list
111445172|NCT00002443|Antimetabolites|antimetabolites|mesh-ancestor
111445173|NCT00002443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111445174|NCT00002443|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111445175|NCT00002443|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111445176|NCT00002443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111445177|NCT00002443|Antiviral Agents|antiviral agents|mesh-ancestor
111445178|NCT00002443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111445179|NCT00002443|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111445180|NCT00002443|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111445181|NCT00002443|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111445182|NCT00002443|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111445183|NCT00002443|Protease Inhibitors|protease inhibitors|mesh-ancestor
111445184|NCT00001561|Immunoglobulins|immunoglobulins|mesh-list
111445185|NCT00001561|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111445186|NCT00001561|Antibodies|antibodies|mesh-list
111445187|NCT00001561|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
111445188|NCT00001561|Immunologic Factors|immunologic factors|mesh-ancestor
111445189|NCT00001561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111445190|NCT00002449|Aldesleukin|aldesleukin|mesh-list
111445191|NCT00002449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111445192|NCT00002449|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111445193|NCT00002449|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111445194|NCT00002449|Antiviral Agents|antiviral agents|mesh-ancestor
111445195|NCT00002449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111445196|NCT00003014|Carboplatin|carboplatin|mesh-list
111445197|NCT00003014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111445198|NCT00002125|Foscarnet|foscarnet|mesh-list
111445199|NCT00002125|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
111445200|NCT00002125|Antiviral Agents|antiviral agents|mesh-ancestor
111445201|NCT00002125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111445202|NCT00002125|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111445203|NCT00002125|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111445204|NCT00002125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111445205|NCT00002125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111445206|NCT00001579|Leucovorin|leucovorin|mesh-list
111445207|NCT00001579|Fluorouracil|fluorouracil|mesh-list
111445208|NCT00001579|Eniluracil|eniluracil|mesh-list
111445209|NCT00001579|Antimetabolites|antimetabolites|mesh-ancestor
111445210|NCT00001579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111445211|NCT00001579|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111445213|NCT00001579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111445214|NCT00001579|Immunologic Factors|immunologic factors|mesh-ancestor
111445215|NCT00001579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111445216|NCT00001579|Antidotes|antidotes|mesh-ancestor
111445217|NCT00001579|Protective Agents|protective agents|mesh-ancestor
111445218|NCT00001579|Vitamin B Complex|vitamin b complex|mesh-ancestor
111445219|NCT00001579|Vitamins|vitamins|mesh-ancestor
111445220|NCT00001579|Micronutrients|micronutrients|mesh-ancestor
111445221|NCT00001579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111445222|NCT00003020|Immunotoxins|immunotoxins|mesh-list
111445223|NCT00003020|Immunoconjugates|immunoconjugates|mesh-ancestor
111445224|NCT00003020|Immunologic Factors|immunologic factors|mesh-ancestor
111445225|NCT00003020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111445226|NCT00002131|Vesnarinone|vesnarinone|mesh-list
111445227|NCT00002131|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111445228|NCT00002131|Immunologic Factors|immunologic factors|mesh-ancestor
111445229|NCT00002131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111445230|NCT00002131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111445231|NCT00002131|Antiviral Agents|antiviral agents|mesh-ancestor
111445232|NCT00002131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111445233|NCT00002131|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111445234|NCT00002131|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111445235|NCT00002131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111445236|NCT00002131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111445237|NCT00002131|Protective Agents|protective agents|mesh-ancestor
111445238|NCT00380887|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
111445239|NCT00380887|Estrogens|estrogens|mesh-ancestor
111445240|NCT00380887|Hormones|hormones|mesh-ancestor
111445241|NCT00380887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111445242|NCT00380887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111445243|NCT00002461|Cyclophosphamide|cyclophosphamide|mesh-list
111445244|NCT00002461|Carmustine|carmustine|mesh-list
111445245|NCT00002461|Etoposide|etoposide|mesh-list
111445246|NCT00002461|Sargramostim|sargramostim|mesh-list
111445247|NCT00002461|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111445248|NCT00002461|Immunologic Factors|immunologic factors|mesh-ancestor
111445249|NCT00002461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111445250|NCT00002461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111445251|NCT00002461|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111445252|NCT00002461|Alkylating Agents|alkylating agents|mesh-ancestor
110891131|NCT03294109|Anesthetics|anesthetics|mesh-ancestor
111445253|NCT00002461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111445254|NCT00002461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111445255|NCT00002461|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111445256|NCT00002461|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111445257|NCT00002461|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111445258|NCT00002461|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111445259|NCT00002461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111445260|NCT00003026|Bicalutamide|bicalutamide|mesh-list
111445261|NCT00003026|Triptorelin Pamoate|triptorelin pamoate|mesh-list
111445262|NCT00003026|Flutamide|flutamide|mesh-list
111445263|NCT00003026|Androgen Antagonists|androgen antagonists|mesh-ancestor
111445264|NCT00003026|Hormone Antagonists|hormone antagonists|mesh-ancestor
111445265|NCT00003026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111445266|NCT00003026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111445267|NCT00003026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111445268|NCT00003026|Luteolytic Agents|luteolytic agents|mesh-ancestor
111445269|NCT00003026|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111445270|NCT00003026|Contraceptive Agents|contraceptive agents|mesh-ancestor
111445271|NCT00003026|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111445272|NCT00003026|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111445273|NCT00003026|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111445274|NCT00002143|Acitretin|acitretin|mesh-list
111445275|NCT00002143|Keratolytic Agents|keratolytic agents|mesh-ancestor
111445276|NCT00002143|Dermatologic Agents|dermatologic agents|mesh-ancestor
111445277|NCT00002149|Amoxicillin|amoxicillin|mesh-list
111445278|NCT00002149|Clavulanic Acid|clavulanic acid|mesh-list
111445279|NCT00002149|Clavulanic Acids|clavulanic acids|mesh-list
111445280|NCT00002149|Pseudoephedrine|pseudoephedrine|mesh-list
111445281|NCT00002149|Ephedrine|ephedrine|mesh-list
111445282|NCT00002149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111445283|NCT00002149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111445284|NCT00002149|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
111445285|NCT00002149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111445286|NCT00002149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111445287|NCT00002149|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111445288|NCT00002149|Autonomic Agents|autonomic agents|mesh-ancestor
111445289|NCT00002149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111445290|NCT00002149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111445291|NCT00002149|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111445292|NCT00002149|Respiratory System Agents|respiratory system agents|mesh-ancestor
111445293|NCT00002149|Nasal Decongestants|nasal decongestants|mesh-ancestor
111445294|NCT00002149|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111445295|NCT00002149|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111445296|NCT00002149|Sympathomimetics|sympathomimetics|mesh-ancestor
111445297|NCT00002149|Adrenergic Agents|adrenergic agents|mesh-ancestor
111445298|NCT00002149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111445299|NCT03868046|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
111445300|NCT03868046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111445301|NCT03868046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111445302|NCT03868046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111445303|NCT02973295|Silymarin|silymarin|mesh-list
111445304|NCT02973295|Antioxidants|antioxidants|mesh-ancestor
111445305|NCT02973295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111445306|NCT02973295|Protective Agents|protective agents|mesh-ancestor
111445307|NCT02973295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111445308|NCT00003032|Tamoxifen|tamoxifen|mesh-list
111445309|NCT00003032|Cyclophosphamide|cyclophosphamide|mesh-list
111445310|NCT00003032|Mitoxantrone|mitoxantrone|mesh-list
111445311|NCT00003032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111445312|NCT00003032|Immunologic Factors|immunologic factors|mesh-ancestor
111445313|NCT00003032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111445314|NCT00003032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111445315|NCT00003032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111445316|NCT00003032|Alkylating Agents|alkylating agents|mesh-ancestor
111445317|NCT00003032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111445318|NCT00003032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111445319|NCT00003032|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111445320|NCT00003032|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111445321|NCT00003032|Hormone Antagonists|hormone antagonists|mesh-ancestor
111445322|NCT00003032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111445323|NCT00003032|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111445324|NCT00003032|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111445325|NCT00003032|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111445326|NCT00003032|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111445327|NCT00003032|Analgesics|analgesics|mesh-ancestor
111445328|NCT00003032|Sensory System Agents|sensory system agents|mesh-ancestor
111445329|NCT00003032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111445330|NCT00003032|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111445331|NCT00003032|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111445332|NCT00003032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111445333|NCT00002155|Lamivudine|lamivudine|mesh-list
111445334|NCT00002155|Zidovudine|zidovudine|mesh-list
111445335|NCT00002155|Indinavir|indinavir|mesh-list
111445336|NCT00002155|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111445337|NCT00002155|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111445338|NCT00002155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111445339|NCT00002155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111445340|NCT00002155|Antiviral Agents|antiviral agents|mesh-ancestor
111445341|NCT00002155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111445342|NCT00002155|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111445343|NCT00002155|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111445344|NCT00002155|Antimetabolites|antimetabolites|mesh-ancestor
111445345|NCT00002155|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111445346|NCT00002155|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111445347|NCT00002155|Protease Inhibitors|protease inhibitors|mesh-ancestor
111445348|NCT00003038|Suramin|suramin|mesh-list
111445349|NCT00003038|Doxorubicin|doxorubicin|mesh-list
111445350|NCT00003038|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111445351|NCT00003038|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111445352|NCT00003038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111445353|NCT00003038|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111445354|NCT00003038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111445355|NCT00003038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111445356|NCT00003038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111445357|NCT00003038|Antinematodal Agents|antinematodal agents|mesh-ancestor
111445358|NCT00003038|Anthelmintics|anthelmintics|mesh-ancestor
111169640|NCT01837719|Atazanavir Sulfate|atazanavir sulfate|mesh-list
111445359|NCT00003038|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111445360|NCT00003038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111445361|NCT00003038|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
111445362|NCT00003038|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111445363|NCT00003044|Cisplatin|cisplatin|mesh-list
111445364|NCT00003044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111445365|NCT00002161|Adefovir|adefovir|mesh-list
111445366|NCT00002161|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
111445367|NCT00002161|Antiviral Agents|antiviral agents|mesh-ancestor
111445368|NCT00002161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111445369|NCT00002161|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111445370|NCT00002161|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111445371|NCT00002161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111445372|NCT00002161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111445373|NCT00002167|Tin etiopurpurin|tin etiopurpurin|mesh-list
111445374|NCT00002167|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111445375|NCT00002167|Dermatologic Agents|dermatologic agents|mesh-ancestor
111445376|NCT03805022|Doxorubicin|doxorubicin|mesh-list
111445377|NCT03805022|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111445378|NCT03805022|Ifosfamide|ifosfamide|mesh-list
111445379|NCT03805022|Isophosphamide mustard|isophosphamide mustard|mesh-list
111445380|NCT03805022|Dacarbazine|dacarbazine|mesh-list
111445381|NCT03805022|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111445382|NCT03805022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111445383|NCT03805022|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111445384|NCT03805022|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111445385|NCT03805022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111445386|NCT03805022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111445387|NCT03805022|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111445388|NCT03805022|Alkylating Agents|alkylating agents|mesh-ancestor
111445389|NCT05752435|Bleomycin|bleomycin|mesh-list
111445390|NCT05752435|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111445391|NCT05752435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111445392|NCT00003050|Tamoxifen|tamoxifen|mesh-list
111445393|NCT00003050|Paclitaxel|paclitaxel|mesh-list
111445394|NCT00003050|Cyclophosphamide|cyclophosphamide|mesh-list
111445395|NCT00003050|Doxorubicin|doxorubicin|mesh-list
111445396|NCT00003050|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111445397|NCT00003050|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111445398|NCT00003050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111445399|NCT00003050|Tubulin Modulators|tubulin modulators|mesh-ancestor
111445400|NCT00003050|Antimitotic Agents|antimitotic agents|mesh-ancestor
111445401|NCT00003050|Mitosis Modulators|mitosis modulators|mesh-ancestor
110891648|NCT01336608|Fluticasone|fluticasone|mesh-list
111445402|NCT00003050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111445403|NCT00003050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111445404|NCT00003050|Immunologic Factors|immunologic factors|mesh-ancestor
111445405|NCT00003050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111445406|NCT00003050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111445407|NCT00003050|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111445408|NCT00003050|Alkylating Agents|alkylating agents|mesh-ancestor
111445409|NCT00003050|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111445410|NCT00003050|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111445411|NCT00003050|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111445412|NCT00003050|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111445413|NCT00003050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111445414|NCT00003050|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111445415|NCT00003050|Hormone Antagonists|hormone antagonists|mesh-ancestor
110891786|NCT02072330|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111445416|NCT00003050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111445417|NCT00003050|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111445418|NCT00003050|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111445419|NCT00003050|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111445420|NCT00003050|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111445421|NCT00002179|Lamivudine|lamivudine|mesh-list
111445422|NCT00002179|Zidovudine|zidovudine|mesh-list
111445423|NCT00002179|Indinavir|indinavir|mesh-list
111445424|NCT00002179|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111445425|NCT00002179|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111445426|NCT00002179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111445427|NCT00002179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111445428|NCT00002179|Antiviral Agents|antiviral agents|mesh-ancestor
111445429|NCT00002179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111445430|NCT00002179|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111445431|NCT00002179|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111445432|NCT00002179|Antimetabolites|antimetabolites|mesh-ancestor
111445433|NCT00002179|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111445434|NCT00002179|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111445435|NCT00002179|Protease Inhibitors|protease inhibitors|mesh-ancestor
111445436|NCT00003056|Cyclosporine|cyclosporine|mesh-list
111445437|NCT00003056|Methotrexate|methotrexate|mesh-list
111445438|NCT00003056|Cyclosporins|cyclosporins|mesh-list
111445439|NCT00003056|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111445440|NCT00003056|Abortifacient Agents|abortifacient agents|mesh-ancestor
111445441|NCT00003056|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111445442|NCT00003056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111445443|NCT00003056|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111445444|NCT00003056|Antimetabolites|antimetabolites|mesh-ancestor
111445445|NCT00003056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111445446|NCT00003056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111445447|NCT00003056|Dermatologic Agents|dermatologic agents|mesh-ancestor
111445448|NCT00003056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111445449|NCT00003056|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111445450|NCT00003056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111445451|NCT00003056|Immunologic Factors|immunologic factors|mesh-ancestor
111445452|NCT00003056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111445453|NCT00003056|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111445454|NCT00003056|Antifungal Agents|antifungal agents|mesh-ancestor
111445455|NCT00003056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111445456|NCT00003056|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111445457|NCT00002185|Nelfinavir|nelfinavir|mesh-list
111445458|NCT00002185|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111445459|NCT00002185|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111445460|NCT00002185|Protease Inhibitors|protease inhibitors|mesh-ancestor
111445461|NCT00002185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110892042|NCT02930005|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111445462|NCT00002185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111445463|NCT00002185|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111445464|NCT00002185|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111445465|NCT00002185|Antiviral Agents|antiviral agents|mesh-ancestor
111445466|NCT00002185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111445467|NCT05752279|Plasma-lyte 148|plasma-lyte 148|mesh-list
111445468|NCT05752279|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
111445469|NCT05752279|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111445470|NCT00003062|Temozolomide|temozolomide|mesh-list
111445471|NCT00003062|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111445472|NCT00003062|Alkylating Agents|alkylating agents|mesh-ancestor
111445473|NCT00003062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110892114|NCT03628443|Mitogens|mitogens|mesh-list
111445474|NCT00003062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111445475|NCT00002191|Albendazole|albendazole|mesh-list
111445476|NCT00002191|Anthelmintics|anthelmintics|mesh-ancestor
111445477|NCT00002191|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111445478|NCT00002191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111445479|NCT00002191|Anticestodal Agents|anticestodal agents|mesh-ancestor
111445480|NCT00002191|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
111445481|NCT00002191|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111445482|NCT00002191|Tubulin Modulators|tubulin modulators|mesh-ancestor
111445483|NCT00002191|Antimitotic Agents|antimitotic agents|mesh-ancestor
111445484|NCT00002191|Mitosis Modulators|mitosis modulators|mesh-ancestor
111445485|NCT00002191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111445486|NCT00002191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111445487|NCT00383396|Cyclosporine|cyclosporine|mesh-list
111445488|NCT00383396|Cyclosporins|cyclosporins|mesh-list
111445489|NCT00383396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111445490|NCT00383396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111445491|NCT00383396|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111445492|NCT00383396|Immunologic Factors|immunologic factors|mesh-ancestor
111445493|NCT00383396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111445494|NCT00383396|Antifungal Agents|antifungal agents|mesh-ancestor
111445495|NCT00383396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111445496|NCT00383396|Dermatologic Agents|dermatologic agents|mesh-ancestor
111445497|NCT00383396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111445498|NCT00383396|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111445499|NCT00002197|Abacavir|abacavir|mesh-list
111445500|NCT00002197|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110892223|NCT01363609|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111445501|NCT00002197|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111445502|NCT00002197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111445503|NCT00002197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111445504|NCT00002197|Antiviral Agents|antiviral agents|mesh-ancestor
111445505|NCT00002197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111445506|NCT00002197|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111445507|NCT00002197|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111445508|NCT00003068|Cyclophosphamide|cyclophosphamide|mesh-list
111445509|NCT00003068|Thiotepa|thiotepa|mesh-list
111445510|NCT00003068|Mitoxantrone|mitoxantrone|mesh-list
111445511|NCT00003068|Amifostine|amifostine|mesh-list
110892293|NCT02077946|Hormones|hormones|mesh-ancestor
111445512|NCT00003068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111445513|NCT00003068|Immunologic Factors|immunologic factors|mesh-ancestor
111445514|NCT00003068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111445515|NCT00003068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111445516|NCT00003068|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111445517|NCT00003068|Alkylating Agents|alkylating agents|mesh-ancestor
111445518|NCT00003068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111445519|NCT00003068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111445520|NCT00003068|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111445521|NCT00003068|Analgesics|analgesics|mesh-ancestor
111445522|NCT00003068|Sensory System Agents|sensory system agents|mesh-ancestor
111445523|NCT00003068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111445524|NCT00003068|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111445525|NCT00003068|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111445526|NCT00003068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111445527|NCT00003068|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111445528|NCT00003068|Protective Agents|protective agents|mesh-ancestor
111445529|NCT00003080|Tamoxifen|tamoxifen|mesh-list
111445530|NCT00003080|Melphalan|melphalan|mesh-list
111445531|NCT00003080|Thiotepa|thiotepa|mesh-list
111445532|NCT00003080|Mitoxantrone|mitoxantrone|mesh-list
111445533|NCT00003080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111445534|NCT00003080|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111445535|NCT00003080|Alkylating Agents|alkylating agents|mesh-ancestor
111445536|NCT00003080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111445537|NCT00003080|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111445538|NCT00003080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111445539|NCT00003080|Immunologic Factors|immunologic factors|mesh-ancestor
111445540|NCT00003080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111445541|NCT00003080|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111445542|NCT00003080|Hormone Antagonists|hormone antagonists|mesh-ancestor
111445543|NCT00003080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111445544|NCT00003080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111445545|NCT00003080|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111445546|NCT00003080|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111445547|NCT00003080|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111445548|NCT00003080|Analgesics|analgesics|mesh-ancestor
111445549|NCT00003080|Sensory System Agents|sensory system agents|mesh-ancestor
111445550|NCT00003080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111445551|NCT00003080|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111445552|NCT00003080|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111445553|NCT00003080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111445554|NCT00002203|Lamivudine|lamivudine|mesh-list
111445555|NCT00002203|Zidovudine|zidovudine|mesh-list
111445556|NCT00002203|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
111445557|NCT00002203|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111445558|NCT00002203|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111445559|NCT00002203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111445560|NCT00002203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111445561|NCT00002203|Antiviral Agents|antiviral agents|mesh-ancestor
111445562|NCT00002203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111445563|NCT00002203|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111445564|NCT00002203|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111445565|NCT00002203|Antimetabolites|antimetabolites|mesh-ancestor
111445566|NCT01568918|Tamsulosin|tamsulosin|mesh-list
111445567|NCT01568918|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111445568|NCT01568918|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111445569|NCT01568918|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111445570|NCT01568918|Adrenergic Agents|adrenergic agents|mesh-ancestor
111445571|NCT01568918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111445572|NCT01568918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111445573|NCT01568918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111445574|NCT01568918|Urological Agents|urological agents|mesh-ancestor
111445575|NCT00003086|Cyclophosphamide|cyclophosphamide|mesh-list
111445576|NCT00003086|Carboplatin|carboplatin|mesh-list
111445577|NCT00003086|Doxorubicin|doxorubicin|mesh-list
111445578|NCT00003086|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111445579|NCT00003086|Fluorouracil|fluorouracil|mesh-list
111445580|NCT00003086|Melphalan|melphalan|mesh-list
111445581|NCT00003086|Ifosfamide|ifosfamide|mesh-list
111445582|NCT00003086|Thiotepa|thiotepa|mesh-list
111445583|NCT00003086|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
111445584|NCT00003086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111445585|NCT00003086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111445586|NCT00003086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111445587|NCT00003086|Immunologic Factors|immunologic factors|mesh-ancestor
111445588|NCT00003086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111445589|NCT00003086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111445590|NCT00003086|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111445591|NCT00003086|Alkylating Agents|alkylating agents|mesh-ancestor
111445592|NCT00003086|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111445593|NCT00003086|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111445594|NCT00003086|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111445595|NCT00003086|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111445596|NCT00003086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111445597|NCT00003086|Antimetabolites|antimetabolites|mesh-ancestor
111445598|NCT00003086|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111445599|NCT00003086|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111445600|NCT00003086|Analgesics|analgesics|mesh-ancestor
111445601|NCT00003086|Sensory System Agents|sensory system agents|mesh-ancestor
111445602|NCT00003086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111445603|NCT00003092|Paclitaxel|paclitaxel|mesh-list
111445604|NCT00003092|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111445605|NCT00003092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111445606|NCT00003092|Tubulin Modulators|tubulin modulators|mesh-ancestor
111445607|NCT00003092|Antimitotic Agents|antimitotic agents|mesh-ancestor
111445608|NCT00003092|Mitosis Modulators|mitosis modulators|mesh-ancestor
111445609|NCT00003092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111445610|NCT00381199|Amitriptyline|amitriptyline|mesh-list
111445611|NCT00381199|Nabilone|nabilone|mesh-list
111445612|NCT00381199|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
111445613|NCT00381199|Antidepressive Agents|antidepressive agents|mesh-ancestor
111445614|NCT00381199|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111445615|NCT00381199|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111445616|NCT00381199|Analgesics|analgesics|mesh-ancestor
111445617|NCT00381199|Sensory System Agents|sensory system agents|mesh-ancestor
111445618|NCT00381199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111445619|NCT00381199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110892634|NCT01366183|Carboplatin|carboplatin|mesh-list
111445620|NCT00381199|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111445621|NCT00381199|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111445622|NCT00381199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111445623|NCT00381199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111445624|NCT00381199|Adrenergic Agents|adrenergic agents|mesh-ancestor
111445625|NCT00381199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111445626|NCT00381199|Antiemetics|antiemetics|mesh-ancestor
111445627|NCT00381199|Autonomic Agents|autonomic agents|mesh-ancestor
111445628|NCT00381199|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111445629|NCT00381199|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111445630|NCT00381199|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111445631|NCT00381199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111445632|NCT00002509|Cyclophosphamide|cyclophosphamide|mesh-list
111445633|NCT00002509|Carboplatin|carboplatin|mesh-list
111445634|NCT00002509|Etoposide|etoposide|mesh-list
111445635|NCT00002509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111445636|NCT00002509|Immunologic Factors|immunologic factors|mesh-ancestor
111445637|NCT00002509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111445638|NCT00002509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111445639|NCT00002509|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111445640|NCT00002509|Alkylating Agents|alkylating agents|mesh-ancestor
111445641|NCT00002509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111445642|NCT00002509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111445643|NCT00002509|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111445644|NCT00002509|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111445645|NCT00002509|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111445646|NCT00002509|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111445647|NCT00002509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111445648|NCT00002515|Carboplatin|carboplatin|mesh-list
111445649|NCT00002515|Topotecan|topotecan|mesh-list
111445650|NCT00002515|Thiotepa|thiotepa|mesh-list
111445651|NCT00002515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111445652|NCT00002515|Immunologic Factors|immunologic factors|mesh-ancestor
111445653|NCT00002515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111445654|NCT00002515|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111445655|NCT00002515|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111445656|NCT00002515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111445657|NCT00002515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111445658|NCT00002515|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111445659|NCT00002515|Alkylating Agents|alkylating agents|mesh-ancestor
111445660|NCT00002515|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111169931|NCT01987453|Ledipasvir|ledipasvir|mesh-list
111445661|NCT00002515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111445662|NCT00002521|Cyclophosphamide|cyclophosphamide|mesh-list
111445663|NCT00002521|Etoposide|etoposide|mesh-list
111445664|NCT00002521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111445665|NCT00002521|Immunologic Factors|immunologic factors|mesh-ancestor
111445666|NCT00002521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111445667|NCT00002521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111445668|NCT00002521|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111445669|NCT00002521|Alkylating Agents|alkylating agents|mesh-ancestor
111445670|NCT00002521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110892881|NCT02084342|Hemostatics|hemostatics|mesh-ancestor
111445671|NCT00002521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111445672|NCT00002521|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111445673|NCT00002521|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111445674|NCT00002521|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111445675|NCT00002521|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111445676|NCT00002521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111445677|NCT00003110|Bleomycin|bleomycin|mesh-list
111445678|NCT00003110|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111445679|NCT00003110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111445680|NCT00002215|Nelfinavir|nelfinavir|mesh-list
111445681|NCT00002215|Emivirine|emivirine|mesh-list
111445682|NCT00002215|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111445683|NCT00002215|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111445684|NCT00002215|Protease Inhibitors|protease inhibitors|mesh-ancestor
111445685|NCT00002215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111445686|NCT00002215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111445687|NCT00002215|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111445688|NCT00002215|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111445689|NCT00002215|Antiviral Agents|antiviral agents|mesh-ancestor
111445690|NCT00002215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110893008|NCT05042947|beta-Endorphin|beta-endorphin|mesh-list
111445691|NCT00002215|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111445692|NCT00002215|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111445693|NCT00003116|Cyclosporine|cyclosporine|mesh-list
111445694|NCT00003116|Cyclophosphamide|cyclophosphamide|mesh-list
111445695|NCT00003116|Busulfan|busulfan|mesh-list
111445696|NCT00003116|Cyclosporins|cyclosporins|mesh-list
111445697|NCT00003116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111445698|NCT00003116|Immunologic Factors|immunologic factors|mesh-ancestor
111445699|NCT00003116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111445700|NCT00003116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111445701|NCT00003116|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111445702|NCT00003116|Alkylating Agents|alkylating agents|mesh-ancestor
111445703|NCT00003116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111445704|NCT00003116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111445705|NCT00003116|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111445706|NCT00003116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111445707|NCT00003116|Antifungal Agents|antifungal agents|mesh-ancestor
111445708|NCT00003116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111445709|NCT00003116|Dermatologic Agents|dermatologic agents|mesh-ancestor
111445710|NCT00003116|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111445711|NCT00002227|Lamivudine|lamivudine|mesh-list
111445712|NCT00002227|Efavirenz|efavirenz|mesh-list
111445713|NCT00002227|Stavudine|stavudine|mesh-list
110959243|NCT03526224|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110959244|NCT03526224|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110959245|NCT03526224|Analgesics|analgesics|mesh-ancestor
110959246|NCT03526224|Sensory System Agents|sensory system agents|mesh-ancestor
110959247|NCT03526224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110959248|NCT03526224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110959249|NCT03526224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110959251|NCT03639246|Doxorubicin|doxorubicin|mesh-list
110959252|NCT03639246|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110959253|NCT03639246|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110959254|NCT03639246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110959255|NCT03639246|Tubulin Modulators|tubulin modulators|mesh-ancestor
110959256|NCT03639246|Antimitotic Agents|antimitotic agents|mesh-ancestor
110959257|NCT03639246|Mitosis Modulators|mitosis modulators|mesh-ancestor
110959258|NCT03639246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110959259|NCT03639246|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110959260|NCT03639246|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110959261|NCT03639246|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110959262|NCT03639246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110959263|NCT00545324|Fluticasone|fluticasone|mesh-list
110959264|NCT00545324|Montelukast|montelukast|mesh-list
110959265|NCT00545324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110959266|NCT00545324|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110959267|NCT00545324|Autonomic Agents|autonomic agents|mesh-ancestor
111445714|NCT00002227|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111445715|NCT00002227|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111445716|NCT00002227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111445717|NCT00002227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111445718|NCT00002227|Antiviral Agents|antiviral agents|mesh-ancestor
111445719|NCT00002227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111445720|NCT00002227|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111445721|NCT00002227|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111445722|NCT00002227|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111445723|NCT00002227|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111445724|NCT00002227|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111445725|NCT00002227|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111445726|NCT00002227|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111445727|NCT00002227|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111445728|NCT00002227|Antimetabolites|antimetabolites|mesh-ancestor
111445729|NCT00002233|Lamivudine|lamivudine|mesh-list
111445730|NCT00002233|Abacavir|abacavir|mesh-list
111445731|NCT00002233|Indinavir|indinavir|mesh-list
111445732|NCT00002233|Amprenavir|amprenavir|mesh-list
111445733|NCT00002233|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111445734|NCT00002233|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111445735|NCT00002233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111445736|NCT00002233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111445737|NCT00002233|Antiviral Agents|antiviral agents|mesh-ancestor
111445738|NCT00002233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111445739|NCT00002233|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111445740|NCT00002233|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110893398|NCT03752307|Prednisone|prednisone|mesh-list
111445741|NCT00002233|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111445742|NCT00002233|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111445743|NCT00002233|Protease Inhibitors|protease inhibitors|mesh-ancestor
111445744|NCT00002233|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111445745|NCT00002233|Antitubercular Agents|antitubercular agents|mesh-ancestor
111445746|NCT00002233|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111445747|NCT00002527|Aspirin|aspirin|mesh-list
111445748|NCT00002527|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111445749|NCT00002527|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111445750|NCT00002527|Analgesics|analgesics|mesh-ancestor
111445751|NCT00002527|Sensory System Agents|sensory system agents|mesh-ancestor
111445752|NCT00002527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111445753|NCT00002527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111445754|NCT00002527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111445755|NCT00002527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111445756|NCT00002527|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111445757|NCT00002527|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111445758|NCT00002527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111445759|NCT00002527|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111445760|NCT00002527|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111445761|NCT00002527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111445762|NCT00002527|Antipyretics|antipyretics|mesh-ancestor
111445763|NCT00002533|Fluconazole|fluconazole|mesh-list
111445764|NCT00002533|Antifungal Agents|antifungal agents|mesh-ancestor
111445765|NCT00002533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111445766|NCT00002533|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110893453|NCT03125941|Glucocorticoids|glucocorticoids|mesh-ancestor
111445767|NCT00002533|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111445768|NCT00002533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111445769|NCT00002533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111445770|NCT00002533|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111445771|NCT00002533|Hormone Antagonists|hormone antagonists|mesh-ancestor
111445772|NCT00002533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111445773|NCT00002533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111445774|NCT00002533|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110893503|NCT02092532|Aflibercept|aflibercept|mesh-list
111445775|NCT00002533|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111445776|NCT00002539|Doxorubicin|doxorubicin|mesh-list
111445777|NCT00002539|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111445778|NCT00002539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111445779|NCT00002539|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111445780|NCT00002539|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111445781|NCT00002539|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111445782|NCT00002539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111445783|NCT00002539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111445784|NCT00381589|Bromides|bromides|mesh-list
111445785|NCT00381589|Ipratropium|ipratropium|mesh-list
111170058|NCT01625897|Risperidone|risperidone|mesh-list
111445786|NCT00381589|Anticonvulsants|anticonvulsants|mesh-ancestor
111445787|NCT00381589|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111445788|NCT00381589|Autonomic Agents|autonomic agents|mesh-ancestor
111445789|NCT00381589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111445790|NCT00381589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111445791|NCT00381589|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111445792|NCT00381589|Respiratory System Agents|respiratory system agents|mesh-ancestor
111445793|NCT00381589|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111445794|NCT00381589|Cholinergic Agents|cholinergic agents|mesh-ancestor
111445795|NCT00381589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111445796|NCT00381589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111445797|NCT00002239|Ritonavir|ritonavir|mesh-list
111445798|NCT00002239|Amprenavir|amprenavir|mesh-list
111445799|NCT00002239|Abacavir|abacavir|mesh-list
111445800|NCT00002239|Enfuvirtide|enfuvirtide|mesh-list
111445801|NCT00002239|Efavirenz|efavirenz|mesh-list
111445802|NCT00002239|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111445803|NCT00002239|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111445804|NCT00002239|Protease Inhibitors|protease inhibitors|mesh-ancestor
111445805|NCT00002239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111445806|NCT00002239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111445807|NCT00002239|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111445808|NCT00002239|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111445809|NCT00002239|Antiviral Agents|antiviral agents|mesh-ancestor
111445810|NCT00002239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111445811|NCT00002239|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111445812|NCT00002239|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111445813|NCT00002239|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111445814|NCT00002239|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111445815|NCT00002239|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111445816|NCT00002239|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111445817|NCT00002239|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111445818|NCT00002239|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111445819|NCT00002239|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111445820|NCT00002239|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
111445821|NCT00002239|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
111445822|NCT00002239|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111445823|NCT00002239|Antitubercular Agents|antitubercular agents|mesh-ancestor
111445824|NCT00002239|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111445825|NCT00383474|Bortezomib|bortezomib|mesh-list
111445826|NCT00383474|Tipifarnib|tipifarnib|mesh-list
111445827|NCT00383474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111445828|NCT00002245|Lamivudine|lamivudine|mesh-list
111445829|NCT00002245|Abacavir|abacavir|mesh-list
111445830|NCT00002245|Amprenavir|amprenavir|mesh-list
110893774|NCT02099240|Cefonicid|cefonicid|mesh-list
111445831|NCT00002245|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111445832|NCT00002245|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111445833|NCT00002245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111445834|NCT00002245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111445835|NCT00002245|Antiviral Agents|antiviral agents|mesh-ancestor
111445836|NCT00002245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111445837|NCT00002245|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111445838|NCT00002245|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111445839|NCT00002245|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111445840|NCT00002245|Antitubercular Agents|antitubercular agents|mesh-ancestor
111445841|NCT00002245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111445842|NCT00002245|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111445843|NCT00002245|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111445844|NCT00002245|Protease Inhibitors|protease inhibitors|mesh-ancestor
111445845|NCT00003128|Paclitaxel|paclitaxel|mesh-list
111445846|NCT00003128|Ifosfamide|ifosfamide|mesh-list
111445847|NCT00003128|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111445848|NCT00003128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111445849|NCT00003128|Tubulin Modulators|tubulin modulators|mesh-ancestor
111445850|NCT00003128|Antimitotic Agents|antimitotic agents|mesh-ancestor
111445851|NCT00003128|Mitosis Modulators|mitosis modulators|mesh-ancestor
111445852|NCT00003128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111445853|NCT00003128|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111445854|NCT00003128|Alkylating Agents|alkylating agents|mesh-ancestor
111445855|NCT04331197|Letrozole|letrozole|mesh-list
111170134|NCT02106455|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111445856|NCT04331197|Clomiphene|clomiphene|mesh-list
111445857|NCT04331197|Enclomiphene|enclomiphene|mesh-list
111445858|NCT04331197|Zuclomiphene|zuclomiphene|mesh-list
111445859|NCT04331197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111445860|NCT04331197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111445861|NCT04331197|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111445862|NCT04331197|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111445863|NCT04331197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111445864|NCT04331197|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111445865|NCT04331197|Hormone Antagonists|hormone antagonists|mesh-ancestor
111445866|NCT04331197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111445867|NCT04331197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111445868|NCT04331197|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111445869|NCT04331197|Fertility Agents|fertility agents|mesh-ancestor
110893973|NCT05189145|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
111445870|NCT04331197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111445871|NCT04331197|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111445872|NCT04331197|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111445873|NCT05751733|Sunitinib|sunitinib|mesh-list
111445874|NCT05751733|Imatinib Mesylate|imatinib mesylate|mesh-list
111445875|NCT05751733|Apatinib|apatinib|mesh-list
111445876|NCT05751733|Dasatinib|dasatinib|mesh-list
111445877|NCT05751733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111445878|NCT05751733|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111445879|NCT05751733|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111445880|NCT05751733|Growth Substances|growth substances|mesh-ancestor
110894032|NCT04964193|Cyproterone|cyproterone|mesh-list
111445881|NCT05751733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111445882|NCT05751733|Growth Inhibitors|growth inhibitors|mesh-ancestor
111445883|NCT05751733|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111445884|NCT05751733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111445885|NCT05751733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111445886|NCT00002798|Cytarabine|cytarabine|mesh-list
111445887|NCT00002798|Aldesleukin|aldesleukin|mesh-list
111445888|NCT00002798|Dexamethasone|dexamethasone|mesh-list
111445889|NCT00002798|Hydrocortisone|hydrocortisone|mesh-list
111445890|NCT00002798|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
111445891|NCT00002798|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
111445892|NCT00002798|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
111445893|NCT00002798|Cyclophosphamide|cyclophosphamide|mesh-list
111445894|NCT00002798|Busulfan|busulfan|mesh-list
111445895|NCT00002798|Methotrexate|methotrexate|mesh-list
111445896|NCT00002798|Fludarabine|fludarabine|mesh-list
111445897|NCT00002798|Fludarabine phosphate|fludarabine phosphate|mesh-list
111445898|NCT00002798|Etoposide|etoposide|mesh-list
111445899|NCT00002798|Etoposide phosphate|etoposide phosphate|mesh-list
111445900|NCT00002798|Daunorubicin|daunorubicin|mesh-list
111445901|NCT00002798|Asparaginase|asparaginase|mesh-list
111445902|NCT00002798|Interleukin-2|interleukin-2|mesh-list
111445903|NCT00002798|Idarubicin|idarubicin|mesh-list
111445904|NCT00002798|Thioguanine|thioguanine|mesh-list
111445905|NCT00002798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111445906|NCT00002798|Immunologic Factors|immunologic factors|mesh-ancestor
111445907|NCT00002798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111445908|NCT00002798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111445909|NCT00002798|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111445910|NCT00002798|Alkylating Agents|alkylating agents|mesh-ancestor
111445911|NCT00002798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111445912|NCT00002798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111445913|NCT00002798|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111445914|NCT00002798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111445915|NCT00002798|Antiemetics|antiemetics|mesh-ancestor
111445916|NCT00002798|Autonomic Agents|autonomic agents|mesh-ancestor
111445917|NCT00002798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111445918|NCT00002798|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111445919|NCT00002798|Glucocorticoids|glucocorticoids|mesh-ancestor
111445920|NCT00002798|Hormones|hormones|mesh-ancestor
111445921|NCT00002798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111445922|NCT00002798|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111445923|NCT00002798|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111445924|NCT00002798|Abortifacient Agents|abortifacient agents|mesh-ancestor
111445925|NCT00002798|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111445926|NCT00002798|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111445927|NCT00002798|Antimetabolites|antimetabolites|mesh-ancestor
111445928|NCT00002798|Dermatologic Agents|dermatologic agents|mesh-ancestor
111445929|NCT00002798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111445930|NCT00002798|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111445931|NCT00002798|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111445932|NCT00002798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111445933|NCT00002798|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111445934|NCT00002798|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111445935|NCT00002798|Antiviral Agents|antiviral agents|mesh-ancestor
111445936|NCT00002798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111445937|NCT00002798|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111445938|NCT00002798|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111445939|NCT00002798|Analgesics|analgesics|mesh-ancestor
111445940|NCT00002798|Sensory System Agents|sensory system agents|mesh-ancestor
111445941|NCT00002798|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111445942|NCT00002798|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111445943|NCT00002251|Ganciclovir|ganciclovir|mesh-list
111445944|NCT00002251|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
111445945|NCT00002251|Antiviral Agents|antiviral agents|mesh-ancestor
111445946|NCT00002251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111445947|NCT00002251|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111445948|NCT00002251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111445949|NCT00002251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111445950|NCT00002257|Ganciclovir|ganciclovir|mesh-list
111445951|NCT00002257|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
111445952|NCT00002257|Antiviral Agents|antiviral agents|mesh-ancestor
111445953|NCT00002257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111445954|NCT00002257|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111445955|NCT00002257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111445956|NCT00002257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111445957|NCT00003134|Irinotecan|irinotecan|mesh-list
111445958|NCT00003134|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111445959|NCT00003134|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111445960|NCT00003134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111445961|NCT00003134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111445962|NCT00003134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111445963|NCT00002545|Carmustine|carmustine|mesh-list
111445964|NCT00002545|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111445965|NCT00002545|Alkylating Agents|alkylating agents|mesh-ancestor
111445966|NCT00002545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111445967|NCT00002545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111445968|NCT00002804|Cobalt|cobalt|mesh-list
111445969|NCT00002804|Doxorubicin|doxorubicin|mesh-list
111445970|NCT00002804|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111445971|NCT00002804|Vincristine|vincristine|mesh-list
111445972|NCT00002804|Ifosfamide|ifosfamide|mesh-list
111445973|NCT00002804|Lenograstim|lenograstim|mesh-list
111445974|NCT00002804|Mesna|mesna|mesh-list
111445975|NCT00002804|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111445976|NCT00002804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111445977|NCT00002804|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111445978|NCT00002804|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111445979|NCT00002804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111445980|NCT00002804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111445981|NCT00002804|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111445982|NCT00002804|Immunologic Factors|immunologic factors|mesh-ancestor
111445983|NCT00002804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111445984|NCT00002804|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111445985|NCT00002804|Tubulin Modulators|tubulin modulators|mesh-ancestor
111445986|NCT00002804|Antimitotic Agents|antimitotic agents|mesh-ancestor
111445987|NCT00002804|Mitosis Modulators|mitosis modulators|mesh-ancestor
111445988|NCT00002804|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111445989|NCT00002804|Alkylating Agents|alkylating agents|mesh-ancestor
111445990|NCT00002804|Protective Agents|protective agents|mesh-ancestor
111445991|NCT00002804|Trace Elements|trace elements|mesh-ancestor
111445992|NCT00002804|Micronutrients|micronutrients|mesh-ancestor
111445993|NCT00002810|Melphalan|melphalan|mesh-list
111445994|NCT00002810|Immunologic Factors|immunologic factors|mesh-ancestor
110894529|NCT01345929|Levofloxacin|levofloxacin|mesh-list
111445995|NCT00002810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111445996|NCT00002810|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111445997|NCT00002810|Alkylating Agents|alkylating agents|mesh-ancestor
111445998|NCT00002810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111445999|NCT00002810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111446000|NCT00002810|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111446001|NCT00002810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111446002|NCT00003140|Letrozole|letrozole|mesh-list
111446003|NCT00003140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111446004|NCT00003140|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111446005|NCT00003140|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111446006|NCT00003140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111446007|NCT00003140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111446008|NCT00003140|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111446009|NCT00003140|Hormone Antagonists|hormone antagonists|mesh-ancestor
111446010|NCT00003140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111446011|NCT00003140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111446012|NCT00003392|Paclitaxel|paclitaxel|mesh-list
111170290|NCT01445548|Sirolimus|sirolimus|mesh-list
111446013|NCT00003392|Cyclophosphamide|cyclophosphamide|mesh-list
111446014|NCT00003392|Carboplatin|carboplatin|mesh-list
111446015|NCT00003392|Melphalan|melphalan|mesh-list
111446016|NCT00003392|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111446017|NCT00003392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111446018|NCT00003392|Tubulin Modulators|tubulin modulators|mesh-ancestor
111446019|NCT00003392|Antimitotic Agents|antimitotic agents|mesh-ancestor
111446020|NCT00003392|Mitosis Modulators|mitosis modulators|mesh-ancestor
111446021|NCT00003392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111446022|NCT00003392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111446023|NCT00003392|Immunologic Factors|immunologic factors|mesh-ancestor
111446024|NCT00003392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111446025|NCT00003392|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111446026|NCT00003392|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111446027|NCT00003392|Alkylating Agents|alkylating agents|mesh-ancestor
111446028|NCT00003392|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111446029|NCT00002551|Leucovorin|leucovorin|mesh-list
111446030|NCT00002551|Levamisole|levamisole|mesh-list
111446031|NCT00002551|Fluorouracil|fluorouracil|mesh-list
111446032|NCT00002551|Calcium|calcium|mesh-list
111446033|NCT00002551|Levoleucovorin|levoleucovorin|mesh-list
111446034|NCT00002551|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111446035|NCT00002551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111446036|NCT00002551|Antimetabolites|antimetabolites|mesh-ancestor
111446037|NCT00002551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110894651|NCT02108366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111446038|NCT00002551|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111446039|NCT00002551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111446040|NCT00002551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111446041|NCT00002551|Immunologic Factors|immunologic factors|mesh-ancestor
111446042|NCT00002551|Antidotes|antidotes|mesh-ancestor
111446043|NCT00002551|Protective Agents|protective agents|mesh-ancestor
111446044|NCT00002551|Vitamin B Complex|vitamin b complex|mesh-ancestor
111446045|NCT00002551|Vitamins|vitamins|mesh-ancestor
111446046|NCT00002551|Micronutrients|micronutrients|mesh-ancestor
111446047|NCT00002551|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111446048|NCT00002551|Antinematodal Agents|antinematodal agents|mesh-ancestor
111446049|NCT00002551|Anthelmintics|anthelmintics|mesh-ancestor
111446050|NCT00002551|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111446051|NCT00002551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111446052|NCT00002551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111446053|NCT00003146|Melphalan|melphalan|mesh-list
111446054|NCT00003146|Busulfan|busulfan|mesh-list
111446055|NCT00003146|Thiotepa|thiotepa|mesh-list
111446056|NCT00003146|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111446057|NCT00003146|Alkylating Agents|alkylating agents|mesh-ancestor
111446058|NCT00003146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110894757|NCT03817515|Sirolimus|sirolimus|mesh-list
111446059|NCT00003146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111446060|NCT00003146|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111446061|NCT00003146|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111446062|NCT00003146|Immunologic Factors|immunologic factors|mesh-ancestor
111446063|NCT00003146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111446064|NCT00003398|Cyclophosphamide|cyclophosphamide|mesh-list
111446065|NCT00003398|Thiotepa|thiotepa|mesh-list
111446066|NCT00003398|Antilymphocyte Serum|antilymphocyte serum|mesh-list
111446067|NCT00003398|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111446068|NCT00003398|Immunologic Factors|immunologic factors|mesh-ancestor
111446069|NCT00003398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111446070|NCT00003398|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111446071|NCT00003398|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111446072|NCT00003398|Alkylating Agents|alkylating agents|mesh-ancestor
110894822|NCT01376323|Protease Inhibitors|protease inhibitors|mesh-ancestor
111446073|NCT00003398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111446074|NCT00003398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111446075|NCT00003398|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111446076|NCT00002263|Zidovudine|zidovudine|mesh-list
111446077|NCT00002263|Sargramostim|sargramostim|mesh-list
111446078|NCT00002263|Antimetabolites|antimetabolites|mesh-ancestor
111446079|NCT00002263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111446080|NCT00002263|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111446081|NCT00002263|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111446082|NCT00002263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111446083|NCT00002263|Antiviral Agents|antiviral agents|mesh-ancestor
111446084|NCT00002263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111446085|NCT00002263|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111446086|NCT00002263|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111446087|NCT00002263|Immunologic Factors|immunologic factors|mesh-ancestor
110894915|NCT01376713|Ofatumumab|ofatumumab|mesh-list
111446088|NCT00002263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111446089|NCT00002816|Leucovorin|leucovorin|mesh-list
111446090|NCT00002816|Cobalt|cobalt|mesh-list
111446092|NCT00002816|Dexamethasone|dexamethasone|mesh-list
111446093|NCT00002816|Hydrocortisone|hydrocortisone|mesh-list
111446094|NCT00002816|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
111446095|NCT00002816|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
111446096|NCT00002816|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
111446097|NCT00002816|Methotrexate|methotrexate|mesh-list
111446098|NCT00002816|Etoposide|etoposide|mesh-list
111446099|NCT00002816|Vincristine|vincristine|mesh-list
111446100|NCT00002816|Asparaginase|asparaginase|mesh-list
111446101|NCT00002816|Ifosfamide|ifosfamide|mesh-list
111446102|NCT00002816|Idarubicin|idarubicin|mesh-list
111446103|NCT00002816|Pegaspargase|pegaspargase|mesh-list
111446104|NCT00002816|Thioguanine|thioguanine|mesh-list
111446105|NCT00002816|Levoleucovorin|levoleucovorin|mesh-list
111446106|NCT00002816|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111446107|NCT00002816|Antiemetics|antiemetics|mesh-ancestor
111446108|NCT00002816|Autonomic Agents|autonomic agents|mesh-ancestor
111446109|NCT00002816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111446110|NCT00002816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111446111|NCT00002816|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111446112|NCT00002816|Glucocorticoids|glucocorticoids|mesh-ancestor
111446113|NCT00002816|Hormones|hormones|mesh-ancestor
111446114|NCT00002816|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111446115|NCT00002816|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111446116|NCT00002816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111446117|NCT00002816|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111446118|NCT00002816|Abortifacient Agents|abortifacient agents|mesh-ancestor
111446119|NCT00002816|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111446120|NCT00002816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111446121|NCT00002816|Antimetabolites|antimetabolites|mesh-ancestor
111446122|NCT00002816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111446123|NCT00002816|Dermatologic Agents|dermatologic agents|mesh-ancestor
111446124|NCT00002816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111446125|NCT00002816|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111446126|NCT00002816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111446127|NCT00002816|Immunologic Factors|immunologic factors|mesh-ancestor
111446128|NCT00002816|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111446129|NCT00002816|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111446130|NCT00002816|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111446131|NCT00002816|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111446132|NCT00002816|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111446133|NCT00002816|Antiviral Agents|antiviral agents|mesh-ancestor
111446134|NCT00002816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111446135|NCT00002816|Antidotes|antidotes|mesh-ancestor
111446136|NCT00002816|Protective Agents|protective agents|mesh-ancestor
111446137|NCT00002816|Vitamin B Complex|vitamin b complex|mesh-ancestor
111446138|NCT00002816|Vitamins|vitamins|mesh-ancestor
111446139|NCT00002816|Micronutrients|micronutrients|mesh-ancestor
111446140|NCT00002816|Tubulin Modulators|tubulin modulators|mesh-ancestor
111446141|NCT00002816|Antimitotic Agents|antimitotic agents|mesh-ancestor
111446142|NCT00002816|Mitosis Modulators|mitosis modulators|mesh-ancestor
111446143|NCT00002816|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111446144|NCT00002816|Alkylating Agents|alkylating agents|mesh-ancestor
111446145|NCT00002816|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111446146|NCT00002816|Trace Elements|trace elements|mesh-ancestor
111446147|NCT00002269|Zidovudine|zidovudine|mesh-list
111446148|NCT00002269|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
111446149|NCT00002269|Antimetabolites|antimetabolites|mesh-ancestor
111446150|NCT00002269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111446151|NCT00002269|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111446152|NCT00002269|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111446153|NCT00002269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111446154|NCT00002269|Antiviral Agents|antiviral agents|mesh-ancestor
111446155|NCT00002269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111446156|NCT00002269|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111446157|NCT00002269|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111446158|NCT00002275|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
111446159|NCT00002275|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
111446160|NCT00002275|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
111446161|NCT00002275|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111446162|NCT00003152|Interferons|interferons|mesh-list
111446163|NCT00003152|Interferon-alpha|interferon-alpha|mesh-list
111446164|NCT00003152|Prednisone|prednisone|mesh-list
111446165|NCT00003152|Cyclophosphamide|cyclophosphamide|mesh-list
111446166|NCT00003152|Vincristine|vincristine|mesh-list
111446167|NCT00003152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111446168|NCT00003152|Immunologic Factors|immunologic factors|mesh-ancestor
111446169|NCT00003152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111446170|NCT00003152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111446171|NCT00003152|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111446172|NCT00003152|Alkylating Agents|alkylating agents|mesh-ancestor
111446173|NCT00003152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111446174|NCT00003152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111446175|NCT00003152|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111446176|NCT00003152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111446178|NCT00003152|Hormones|hormones|mesh-ancestor
111446179|NCT00003152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111446180|NCT00003152|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111446181|NCT00003152|Antiviral Agents|antiviral agents|mesh-ancestor
111446182|NCT00003152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111446183|NCT00003152|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111446184|NCT00003152|Tubulin Modulators|tubulin modulators|mesh-ancestor
111446185|NCT00003152|Antimitotic Agents|antimitotic agents|mesh-ancestor
111446186|NCT00003152|Mitosis Modulators|mitosis modulators|mesh-ancestor
111446187|NCT05751421|Meloxicam|meloxicam|mesh-list
111446188|NCT05751421|Bupivacaine|bupivacaine|mesh-list
111446189|NCT05751421|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111446190|NCT05751421|Anesthetics, Local|anesthetics, local|mesh-ancestor
111446191|NCT05751421|Anesthetics|anesthetics|mesh-ancestor
111446192|NCT05751421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111446193|NCT05751421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111446194|NCT05751421|Sensory System Agents|sensory system agents|mesh-ancestor
111446195|NCT05751421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111446196|NCT05751421|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111446197|NCT05751421|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111446198|NCT05751421|Analgesics|analgesics|mesh-ancestor
111446199|NCT05751421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111446200|NCT05751421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111446201|NCT05751421|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111446202|NCT05751421|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111446203|NCT05751421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111446204|NCT05751421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111446205|NCT00002822|Cyclophosphamide|cyclophosphamide|mesh-list
111446206|NCT00002822|Ifosfamide|ifosfamide|mesh-list
111446207|NCT00002822|Carboplatin|carboplatin|mesh-list
111446208|NCT00002822|Doxorubicin|doxorubicin|mesh-list
111446209|NCT00002822|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111446210|NCT00002822|Etoposide|etoposide|mesh-list
111446211|NCT00002822|Vincristine|vincristine|mesh-list
111446212|NCT00002822|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111446213|NCT00002822|Immunologic Factors|immunologic factors|mesh-ancestor
111446214|NCT00002822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111446215|NCT00002822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111446216|NCT00002822|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111446217|NCT00002822|Alkylating Agents|alkylating agents|mesh-ancestor
111446218|NCT00002822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111446219|NCT00002822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111446220|NCT00002822|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111446221|NCT00002822|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111446222|NCT00002822|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111446223|NCT00002822|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111446224|NCT00002822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111446225|NCT00002822|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111446226|NCT00002822|Tubulin Modulators|tubulin modulators|mesh-ancestor
111446227|NCT00002822|Antimitotic Agents|antimitotic agents|mesh-ancestor
111446228|NCT00002822|Mitosis Modulators|mitosis modulators|mesh-ancestor
111446229|NCT00002281|Zidovudine|zidovudine|mesh-list
111446230|NCT00002281|Epoetin Alfa|epoetin alfa|mesh-list
111446231|NCT00002281|Antimetabolites|antimetabolites|mesh-ancestor
111446232|NCT00002281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111446233|NCT00002281|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111446234|NCT00002281|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111446235|NCT00002281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111446236|NCT00002281|Antiviral Agents|antiviral agents|mesh-ancestor
111446237|NCT00002281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111446238|NCT00002281|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111446239|NCT00002281|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111446240|NCT00002281|Hematinics|hematinics|mesh-ancestor
111446241|NCT00002287|Zidovudine|zidovudine|mesh-list
111446242|NCT00002287|Antimetabolites|antimetabolites|mesh-ancestor
111446243|NCT00002287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111446244|NCT00002287|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111446245|NCT00002287|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111446246|NCT00002287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111446247|NCT00002287|Antiviral Agents|antiviral agents|mesh-ancestor
111446248|NCT00002287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111446249|NCT00002287|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111446250|NCT00002287|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111446251|NCT00002828|Fluorouracil|fluorouracil|mesh-list
111446252|NCT00002828|Raltitrexed|raltitrexed|mesh-list
111446253|NCT00002828|Antimetabolites|antimetabolites|mesh-ancestor
111446254|NCT00002828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111446255|NCT00002828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111446256|NCT00002828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111446257|NCT00002828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111446258|NCT00002828|Immunologic Factors|immunologic factors|mesh-ancestor
111446259|NCT00002828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111446260|NCT00002828|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111446261|NCT00002828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111446262|NCT00003410|Motexafin gadolinium|motexafin gadolinium|mesh-list
111446263|NCT00003410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110895748|NCT02853318|Cyclophosphamide|cyclophosphamide|mesh-list
111446264|NCT00003410|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111446265|NCT00003410|Dermatologic Agents|dermatologic agents|mesh-ancestor
111446266|NCT00384020|Paroxetine|paroxetine|mesh-list
111446267|NCT00384020|Escitalopram|escitalopram|mesh-list
111446268|NCT00384020|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111446269|NCT00384020|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111446270|NCT00384020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111446271|NCT00384020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111446272|NCT00384020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111446273|NCT00384020|Serotonin Agents|serotonin agents|mesh-ancestor
111446274|NCT00384020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110895818|NCT02126462|Antacids|antacids|mesh-ancestor
111446275|NCT00384020|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111446276|NCT00384020|Antidepressive Agents|antidepressive agents|mesh-ancestor
111446277|NCT00384020|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111446278|NCT00384020|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111446279|NCT00384020|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111446280|NCT00384020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111446281|NCT00002557|Leucovorin|leucovorin|mesh-list
111446282|NCT00002557|Doxorubicin|doxorubicin|mesh-list
111446283|NCT00002557|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111446284|NCT00002557|Etoposide|etoposide|mesh-list
111446285|NCT00002557|Methotrexate|methotrexate|mesh-list
111446286|NCT00002557|Calcium|calcium|mesh-list
111446287|NCT00002557|Levoleucovorin|levoleucovorin|mesh-list
111446288|NCT00002557|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111446289|NCT00002557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111446290|NCT00002557|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111446291|NCT00002557|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111446292|NCT00002557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111446293|NCT00002557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111446294|NCT00002557|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111446295|NCT00002557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111446296|NCT00002557|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111446297|NCT00002557|Abortifacient Agents|abortifacient agents|mesh-ancestor
111446298|NCT00002557|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111446299|NCT00002557|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111446300|NCT00002557|Antimetabolites|antimetabolites|mesh-ancestor
111446301|NCT00002557|Dermatologic Agents|dermatologic agents|mesh-ancestor
111446302|NCT00002557|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111446303|NCT00002557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111446304|NCT00002557|Immunologic Factors|immunologic factors|mesh-ancestor
111446305|NCT00002557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111446306|NCT00002557|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111446307|NCT00002557|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111446308|NCT00002557|Antidotes|antidotes|mesh-ancestor
111446309|NCT00002557|Protective Agents|protective agents|mesh-ancestor
111446310|NCT00002557|Vitamin B Complex|vitamin b complex|mesh-ancestor
111446311|NCT00002557|Vitamins|vitamins|mesh-ancestor
111446312|NCT00002557|Micronutrients|micronutrients|mesh-ancestor
111446313|NCT00003158|Paclitaxel|paclitaxel|mesh-list
111446314|NCT00003158|Etoposide|etoposide|mesh-list
111446315|NCT00003158|Carboplatin|carboplatin|mesh-list
111446316|NCT00003158|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111446317|NCT00003158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111446318|NCT00003158|Tubulin Modulators|tubulin modulators|mesh-ancestor
111446319|NCT00003158|Antimitotic Agents|antimitotic agents|mesh-ancestor
111446321|NCT00003158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111446322|NCT00003158|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111446323|NCT00003158|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111446324|NCT00003158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111446325|NCT00003416|Interferons|interferons|mesh-list
111446326|NCT00003416|Interferon-alpha|interferon-alpha|mesh-list
111446327|NCT00003416|Dexamethasone|dexamethasone|mesh-list
111446328|NCT00003416|Melphalan|melphalan|mesh-list
111446329|NCT00003416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111446330|NCT00003416|Antiemetics|antiemetics|mesh-ancestor
111446331|NCT00003416|Autonomic Agents|autonomic agents|mesh-ancestor
111446332|NCT00003416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111446333|NCT00003416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111446334|NCT00003416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111446335|NCT00003416|Glucocorticoids|glucocorticoids|mesh-ancestor
111446336|NCT00003416|Hormones|hormones|mesh-ancestor
111446337|NCT00003416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111446338|NCT00003416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111446339|NCT00003416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111446340|NCT00003416|Antiviral Agents|antiviral agents|mesh-ancestor
111446341|NCT00003416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111446342|NCT00003416|Immunologic Factors|immunologic factors|mesh-ancestor
111446343|NCT00003416|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111446344|NCT00003416|Alkylating Agents|alkylating agents|mesh-ancestor
110896204|NCT05801224|Antioxidants|antioxidants|mesh-ancestor
111446345|NCT00003416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111446346|NCT00003416|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111446347|NCT00003416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111446348|NCT00002569|Vincristine|vincristine|mesh-list
111446349|NCT00002569|Lomustine|lomustine|mesh-list
111446350|NCT00002569|Procarbazine|procarbazine|mesh-list
111446351|NCT00002569|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111446352|NCT00002569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111446353|NCT00002569|Tubulin Modulators|tubulin modulators|mesh-ancestor
111446354|NCT00002569|Antimitotic Agents|antimitotic agents|mesh-ancestor
111446355|NCT00002569|Mitosis Modulators|mitosis modulators|mesh-ancestor
111446356|NCT00002569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111446357|NCT00002569|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111446358|NCT00002569|Alkylating Agents|alkylating agents|mesh-ancestor
111446359|NCT00002840|Vincristine|vincristine|mesh-list
111446360|NCT00002840|Lomustine|lomustine|mesh-list
111446361|NCT00002840|Procarbazine|procarbazine|mesh-list
110896348|NCT05420402|Propofol|propofol|mesh-list
111446362|NCT00002840|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111446363|NCT00002840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111446364|NCT00002840|Tubulin Modulators|tubulin modulators|mesh-ancestor
111446365|NCT00002840|Antimitotic Agents|antimitotic agents|mesh-ancestor
111446366|NCT00002840|Mitosis Modulators|mitosis modulators|mesh-ancestor
111446367|NCT00002840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111446368|NCT00002840|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111446369|NCT00002840|Alkylating Agents|alkylating agents|mesh-ancestor
111446370|NCT00002846|Aldesleukin|aldesleukin|mesh-list
111446371|NCT00002846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111446372|NCT00002846|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111446373|NCT00002846|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111446374|NCT00002846|Antiviral Agents|antiviral agents|mesh-ancestor
111446375|NCT00002846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111446376|NCT05720767|Itraconazole|itraconazole|mesh-list
111446377|NCT05720767|Rifampin|rifampin|mesh-list
111446378|NCT05720767|Antifungal Agents|antifungal agents|mesh-ancestor
111446379|NCT05720767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111446380|NCT05720767|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111446381|NCT05720767|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111446382|NCT05720767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111446383|NCT05720767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111446384|NCT05720767|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111446385|NCT05720767|Hormone Antagonists|hormone antagonists|mesh-ancestor
111446386|NCT05720767|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111446387|NCT05720767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111446388|NCT05720767|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111446389|NCT05720767|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111446390|NCT05720767|Antitubercular Agents|antitubercular agents|mesh-ancestor
111446391|NCT05720767|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111446392|NCT05720767|Leprostatic Agents|leprostatic agents|mesh-ancestor
111446393|NCT05720767|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111446394|NCT05720767|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111446395|NCT05720767|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111446396|NCT05720767|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
111446397|NCT05720767|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
111446398|NCT05720767|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
111446399|NCT05720767|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111446401|NCT05751031|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111446402|NCT05751031|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111446403|NCT05751031|Antiviral Agents|antiviral agents|mesh-ancestor
111446404|NCT05751031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111446405|NCT05751031|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111446406|NCT05751031|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111446407|NCT05751031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111446408|NCT05751031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111446409|NCT00002852|Paclitaxel|paclitaxel|mesh-list
111446410|NCT00002852|Carboplatin|carboplatin|mesh-list
111446411|NCT00002852|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111446412|NCT00002852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111446413|NCT00002852|Tubulin Modulators|tubulin modulators|mesh-ancestor
111446414|NCT00002852|Antimitotic Agents|antimitotic agents|mesh-ancestor
111446415|NCT00002852|Mitosis Modulators|mitosis modulators|mesh-ancestor
111446416|NCT00002852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111446417|NCT00003422|Leucovorin|leucovorin|mesh-list
111446418|NCT00003422|Fluorouracil|fluorouracil|mesh-list
111446419|NCT00003422|Calcium|calcium|mesh-list
111446420|NCT00003422|Levoleucovorin|levoleucovorin|mesh-list
111446421|NCT00003422|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111446422|NCT00003422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111446423|NCT00003422|Antimetabolites|antimetabolites|mesh-ancestor
111446424|NCT00003422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111446425|NCT00003422|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111446426|NCT00003422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111446427|NCT00003422|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111446428|NCT00003422|Immunologic Factors|immunologic factors|mesh-ancestor
111446429|NCT00003422|Antidotes|antidotes|mesh-ancestor
111446430|NCT00003422|Protective Agents|protective agents|mesh-ancestor
111446431|NCT00003422|Vitamin B Complex|vitamin b complex|mesh-ancestor
111446432|NCT00003422|Vitamins|vitamins|mesh-ancestor
111446433|NCT00003422|Micronutrients|micronutrients|mesh-ancestor
111446434|NCT00003176|Temozolomide|temozolomide|mesh-list
111446435|NCT00003176|Carmustine|carmustine|mesh-list
111446436|NCT00003176|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111446437|NCT00003176|Alkylating Agents|alkylating agents|mesh-ancestor
111446438|NCT00003176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111446439|NCT00003176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111446440|NCT00002858|Cyclophosphamide|cyclophosphamide|mesh-list
111446441|NCT00002858|Doxorubicin|doxorubicin|mesh-list
111446442|NCT00002858|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111446443|NCT00002858|Etoposide|etoposide|mesh-list
111446444|NCT00002858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111446445|NCT00002858|Immunologic Factors|immunologic factors|mesh-ancestor
111446446|NCT00002858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111446447|NCT00002858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111446448|NCT00002858|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111446449|NCT00002858|Alkylating Agents|alkylating agents|mesh-ancestor
111446450|NCT00002858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111446451|NCT00002858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111446452|NCT00002858|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111446453|NCT00002858|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111446454|NCT00002858|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111446455|NCT00002858|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111446456|NCT00002858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111446457|NCT00002858|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111446458|NCT00002864|Tamoxifen|tamoxifen|mesh-list
111446459|NCT00002864|Octreotide|octreotide|mesh-list
111446460|NCT00002864|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111446461|NCT00002864|Hormone Antagonists|hormone antagonists|mesh-ancestor
111446462|NCT00002864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111446463|NCT00002864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111446464|NCT00002864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111446465|NCT00002864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111446466|NCT00002864|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111446467|NCT00002864|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111446468|NCT00002864|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111446469|NCT00002864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111446470|NCT00002870|Cyclophosphamide|cyclophosphamide|mesh-list
111446471|NCT00002870|Thiotepa|thiotepa|mesh-list
111446472|NCT00002870|Fluorouracil|fluorouracil|mesh-list
111446473|NCT00002870|Epirubicin|epirubicin|mesh-list
111446474|NCT00002870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111446475|NCT00002870|Immunologic Factors|immunologic factors|mesh-ancestor
111446476|NCT00002870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111446477|NCT00002870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111446478|NCT00002870|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111446479|NCT00002870|Alkylating Agents|alkylating agents|mesh-ancestor
111446480|NCT00002870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111446481|NCT00002870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111446482|NCT00002870|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111446483|NCT00002870|Antimetabolites|antimetabolites|mesh-ancestor
111446484|NCT00002870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111446485|NCT00002870|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111446486|NCT00002870|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111446487|NCT00002870|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111446488|NCT00002870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111446489|NCT00002581|Tamoxifen|tamoxifen|mesh-list
111446490|NCT00002581|Cyclophosphamide|cyclophosphamide|mesh-list
111446491|NCT00002581|Fluorouracil|fluorouracil|mesh-list
111446492|NCT00002581|Methotrexate|methotrexate|mesh-list
111446493|NCT00002581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111446494|NCT00002581|Immunologic Factors|immunologic factors|mesh-ancestor
111446495|NCT00002581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111446496|NCT00002581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111446497|NCT00002581|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111446498|NCT00002581|Alkylating Agents|alkylating agents|mesh-ancestor
111446499|NCT00002581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111446500|NCT00002581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111446501|NCT00002581|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111446502|NCT00002581|Antimetabolites|antimetabolites|mesh-ancestor
111446503|NCT00002581|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111446504|NCT00002581|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111446505|NCT00002581|Abortifacient Agents|abortifacient agents|mesh-ancestor
110896876|NCT04546399|Vitamins|vitamins|mesh-ancestor
111446506|NCT00002581|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111446507|NCT00002581|Dermatologic Agents|dermatologic agents|mesh-ancestor
111446508|NCT00002581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111446509|NCT00002581|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111446510|NCT00002581|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111446511|NCT00002581|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111446512|NCT00002581|Hormone Antagonists|hormone antagonists|mesh-ancestor
111446513|NCT00002581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111446514|NCT00002581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111446515|NCT00002581|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111446516|NCT00002581|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110896929|NCT04418479|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111446517|NCT00002581|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111446518|NCT00003182|Gemcitabine|gemcitabine|mesh-list
111446519|NCT00003182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111446520|NCT00003182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111446521|NCT00003182|Antimetabolites|antimetabolites|mesh-ancestor
111446522|NCT00003182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111446523|NCT00002587|Paclitaxel|paclitaxel|mesh-list
111446524|NCT00002587|Topotecan|topotecan|mesh-list
111446525|NCT00002587|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111446526|NCT00002587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111446527|NCT00002587|Tubulin Modulators|tubulin modulators|mesh-ancestor
111446528|NCT00002587|Antimitotic Agents|antimitotic agents|mesh-ancestor
111446529|NCT00002587|Mitosis Modulators|mitosis modulators|mesh-ancestor
111446530|NCT00002587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111446531|NCT00002587|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111446532|NCT00002587|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111446533|NCT00002587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111446534|NCT00002876|Etoposide|etoposide|mesh-list
111446535|NCT00002876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111446536|NCT00002876|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111446537|NCT00002876|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111446538|NCT00002876|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111446539|NCT00002876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111446540|NCT00002876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111446541|NCT00002593|Leucovorin|leucovorin|mesh-list
111446543|NCT00002593|Fluorouracil|fluorouracil|mesh-list
111446544|NCT00002593|Calcium|calcium|mesh-list
111446545|NCT00002593|Levoleucovorin|levoleucovorin|mesh-list
111446546|NCT00002593|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111446547|NCT00002593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111446548|NCT00002593|Antimetabolites|antimetabolites|mesh-ancestor
111446549|NCT00002593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111446550|NCT00002593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111446551|NCT00002593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110897049|NCT04014803|Antipyretics|antipyretics|mesh-ancestor
111446552|NCT00002593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111446553|NCT00002593|Immunologic Factors|immunologic factors|mesh-ancestor
111446554|NCT00002593|Antidotes|antidotes|mesh-ancestor
111446555|NCT00002593|Protective Agents|protective agents|mesh-ancestor
111446556|NCT00002593|Vitamin B Complex|vitamin b complex|mesh-ancestor
111446557|NCT00002593|Vitamins|vitamins|mesh-ancestor
111446558|NCT00002593|Micronutrients|micronutrients|mesh-ancestor
111446559|NCT00002593|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111446560|NCT00002593|Antinematodal Agents|antinematodal agents|mesh-ancestor
111446561|NCT00002593|Anthelmintics|anthelmintics|mesh-ancestor
111446562|NCT00002593|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111446563|NCT00002593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111446564|NCT00002593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111446565|NCT00003194|Cyclophosphamide|cyclophosphamide|mesh-list
111446566|NCT00003194|Thiotepa|thiotepa|mesh-list
111446567|NCT00003194|Carboplatin|carboplatin|mesh-list
111446568|NCT00003194|Etoposide|etoposide|mesh-list
111446569|NCT00003194|Topotecan|topotecan|mesh-list
111446570|NCT00003194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111446571|NCT00003194|Immunologic Factors|immunologic factors|mesh-ancestor
111446572|NCT00003194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111446573|NCT00003194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111446574|NCT00003194|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111446575|NCT00003194|Alkylating Agents|alkylating agents|mesh-ancestor
111446576|NCT00003194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111446577|NCT00003194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111446578|NCT00003194|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111446579|NCT00003194|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111446580|NCT00003194|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111446581|NCT00003194|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111446582|NCT00003194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111446583|NCT00003194|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111446584|NCT00002882|Interferons|interferons|mesh-list
111446585|NCT00002882|Interferon-alpha|interferon-alpha|mesh-list
111446586|NCT00002882|Interferon alpha-2|interferon alpha-2|mesh-list
111446587|NCT00002882|Aldesleukin|aldesleukin|mesh-list
111446588|NCT00002882|Cisplatin|cisplatin|mesh-list
111446589|NCT00002882|Interleukin-2|interleukin-2|mesh-list
111446590|NCT00002882|Dacarbazine|dacarbazine|mesh-list
111446591|NCT00002882|Vinblastine|vinblastine|mesh-list
111446592|NCT00002882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111446593|NCT00002882|Antiviral Agents|antiviral agents|mesh-ancestor
111446594|NCT00002882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111446595|NCT00002882|Immunologic Factors|immunologic factors|mesh-ancestor
111446596|NCT00002882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111446597|NCT00002882|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111446598|NCT00002882|Analgesics|analgesics|mesh-ancestor
111446599|NCT00002882|Sensory System Agents|sensory system agents|mesh-ancestor
110897236|NCT03475277|Anesthetics, General|anesthetics, general|mesh-ancestor
111446600|NCT00002882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111446601|NCT00002882|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111446602|NCT00002882|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111446603|NCT00002882|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111446604|NCT00002882|Alkylating Agents|alkylating agents|mesh-ancestor
111446605|NCT00002882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111446606|NCT00002882|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110897302|NCT03284307|Anesthetics|anesthetics|mesh-ancestor
111446607|NCT00002882|Tubulin Modulators|tubulin modulators|mesh-ancestor
111446608|NCT00002882|Antimitotic Agents|antimitotic agents|mesh-ancestor
111446609|NCT00002882|Mitosis Modulators|mitosis modulators|mesh-ancestor
111446610|NCT00002888|Paclitaxel|paclitaxel|mesh-list
111446611|NCT00002888|Fluorouracil|fluorouracil|mesh-list
111446612|NCT00002888|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111446613|NCT00002888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110959268|NCT00545324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111446614|NCT00002888|Tubulin Modulators|tubulin modulators|mesh-ancestor
111446615|NCT00002888|Antimitotic Agents|antimitotic agents|mesh-ancestor
111446616|NCT00002888|Mitosis Modulators|mitosis modulators|mesh-ancestor
111446617|NCT00002888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111446618|NCT00002888|Antimetabolites|antimetabolites|mesh-ancestor
111446619|NCT00002888|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111446620|NCT00002888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111446621|NCT00002888|Immunologic Factors|immunologic factors|mesh-ancestor
111446622|NCT00002888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111446623|NCT00002599|Cobalt|cobalt|mesh-list
111446624|NCT00002599|Interferons|interferons|mesh-list
111446625|NCT00002599|Interferon-alpha|interferon-alpha|mesh-list
111446626|NCT00002599|Prednisone|prednisone|mesh-list
111446627|NCT00002599|Methylprednisolone|methylprednisolone|mesh-list
111446628|NCT00002599|Cyclophosphamide|cyclophosphamide|mesh-list
111446629|NCT00002599|Melphalan|melphalan|mesh-list
111446630|NCT00002599|Carmustine|carmustine|mesh-list
111446631|NCT00002599|Doxorubicin|doxorubicin|mesh-list
111446632|NCT00002599|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111446633|NCT00002599|Vincristine|vincristine|mesh-list
111446634|NCT00002599|Sargramostim|sargramostim|mesh-list
111446635|NCT00002599|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111446636|NCT00002599|Immunologic Factors|immunologic factors|mesh-ancestor
111446637|NCT00002599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111446638|NCT00002599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111446639|NCT00002599|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111446640|NCT00002599|Alkylating Agents|alkylating agents|mesh-ancestor
111446641|NCT00002599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111446642|NCT00002599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111446643|NCT00002599|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110897487|NCT02473042|Hormones|hormones|mesh-ancestor
111446644|NCT00002599|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111446645|NCT00002599|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111446646|NCT00002599|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111446647|NCT00002599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111446648|NCT00002599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111446649|NCT00002599|Glucocorticoids|glucocorticoids|mesh-ancestor
111446650|NCT00002599|Hormones|hormones|mesh-ancestor
111446651|NCT00002599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111446652|NCT00002599|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111446653|NCT00002599|Antiviral Agents|antiviral agents|mesh-ancestor
111446654|NCT00002599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111446655|NCT00002599|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111446656|NCT00002599|Tubulin Modulators|tubulin modulators|mesh-ancestor
111446657|NCT00002599|Antimitotic Agents|antimitotic agents|mesh-ancestor
111446658|NCT00002599|Mitosis Modulators|mitosis modulators|mesh-ancestor
111446659|NCT00002599|Antiemetics|antiemetics|mesh-ancestor
111446660|NCT00002599|Autonomic Agents|autonomic agents|mesh-ancestor
111446661|NCT00002599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111446662|NCT00002599|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111446663|NCT00002599|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111446664|NCT00002599|Protective Agents|protective agents|mesh-ancestor
111446665|NCT00002599|Trace Elements|trace elements|mesh-ancestor
111446666|NCT00002599|Micronutrients|micronutrients|mesh-ancestor
111446667|NCT00003440|Paclitaxel|paclitaxel|mesh-list
111446668|NCT00003440|Trastuzumab|trastuzumab|mesh-list
111446669|NCT00003440|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111446670|NCT00003440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111446671|NCT00003440|Tubulin Modulators|tubulin modulators|mesh-ancestor
111446672|NCT00003440|Antimitotic Agents|antimitotic agents|mesh-ancestor
111446673|NCT00003440|Mitosis Modulators|mitosis modulators|mesh-ancestor
111446674|NCT00003440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111446675|NCT00003440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111446676|NCT00003200|Docetaxel|docetaxel|mesh-list
111446677|NCT00003200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111446678|NCT00003200|Tubulin Modulators|tubulin modulators|mesh-ancestor
111446679|NCT00003200|Antimitotic Agents|antimitotic agents|mesh-ancestor
111446680|NCT00003200|Mitosis Modulators|mitosis modulators|mesh-ancestor
111446681|NCT00003200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111446682|NCT00003446|Leucovorin|leucovorin|mesh-list
111446683|NCT00003446|Trimetrexate|trimetrexate|mesh-list
111446684|NCT00003446|Fluorouracil|fluorouracil|mesh-list
111446685|NCT00003446|Calcium|calcium|mesh-list
111446686|NCT00003446|Levoleucovorin|levoleucovorin|mesh-list
111446687|NCT00003446|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111446688|NCT00003446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111446689|NCT00003446|Antimetabolites|antimetabolites|mesh-ancestor
111446690|NCT00003446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111446691|NCT00003446|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111446692|NCT00003446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111446693|NCT00003446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111446694|NCT00003446|Immunologic Factors|immunologic factors|mesh-ancestor
111446695|NCT00003446|Antidotes|antidotes|mesh-ancestor
111446696|NCT00003446|Protective Agents|protective agents|mesh-ancestor
111446697|NCT00003446|Vitamin B Complex|vitamin b complex|mesh-ancestor
111446698|NCT00003446|Vitamins|vitamins|mesh-ancestor
111446699|NCT00003446|Micronutrients|micronutrients|mesh-ancestor
111446700|NCT00003446|Antifungal Agents|antifungal agents|mesh-ancestor
111446701|NCT00003446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111446702|NCT00003446|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111446703|NCT00003446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111446704|NCT00003938|Amphotericin B|amphotericin b|mesh-list
111446705|NCT00003938|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
111446706|NCT00003938|Amebicides|amebicides|mesh-ancestor
111446707|NCT00003938|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111446708|NCT00003938|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111446709|NCT00003938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111446710|NCT00003938|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111446711|NCT00003938|Antifungal Agents|antifungal agents|mesh-ancestor
111446712|NCT00003212|Doxorubicin|doxorubicin|mesh-list
111446713|NCT00003212|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111446714|NCT00003212|Ifosfamide|ifosfamide|mesh-list
111446715|NCT00003212|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111446716|NCT00003212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111446717|NCT00003212|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111446718|NCT00003212|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111446719|NCT00003212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111446720|NCT00003212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111446721|NCT00003212|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111446722|NCT00003212|Alkylating Agents|alkylating agents|mesh-ancestor
111446723|NCT00002611|Dactinomycin|dactinomycin|mesh-list
111446724|NCT00002611|Cyclophosphamide|cyclophosphamide|mesh-list
111446725|NCT00002611|Doxorubicin|doxorubicin|mesh-list
111446726|NCT00002611|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111446727|NCT00002611|Etoposide|etoposide|mesh-list
111446728|NCT00002611|Vincristine|vincristine|mesh-list
111446729|NCT00002611|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111446730|NCT00002611|Immunologic Factors|immunologic factors|mesh-ancestor
111446731|NCT00002611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111446732|NCT00002611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111446733|NCT00002611|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111446734|NCT00002611|Alkylating Agents|alkylating agents|mesh-ancestor
111446735|NCT00002611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111446736|NCT00002611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111446737|NCT00002611|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111446738|NCT00002611|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111446739|NCT00002611|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111446740|NCT00002611|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111446741|NCT00002611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111446742|NCT00002611|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111446743|NCT00002611|Tubulin Modulators|tubulin modulators|mesh-ancestor
111446744|NCT00002611|Antimitotic Agents|antimitotic agents|mesh-ancestor
111446745|NCT00002611|Mitosis Modulators|mitosis modulators|mesh-ancestor
111446746|NCT00002611|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111446747|NCT00002611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111446748|NCT00002611|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111446749|NCT00002611|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111446750|NCT00003944|Paclitaxel|paclitaxel|mesh-list
111446751|NCT00003944|Cyclophosphamide|cyclophosphamide|mesh-list
111446752|NCT00003944|Carboplatin|carboplatin|mesh-list
111446753|NCT00003944|Topotecan|topotecan|mesh-list
111446754|NCT00003944|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111446755|NCT00003944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111446756|NCT00003944|Tubulin Modulators|tubulin modulators|mesh-ancestor
111446757|NCT00003944|Antimitotic Agents|antimitotic agents|mesh-ancestor
111446758|NCT00003944|Mitosis Modulators|mitosis modulators|mesh-ancestor
111446759|NCT00003944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111446760|NCT00003944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111446761|NCT00003944|Immunologic Factors|immunologic factors|mesh-ancestor
111446762|NCT00003944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111446763|NCT00003944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111446764|NCT00003944|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111446765|NCT00003944|Alkylating Agents|alkylating agents|mesh-ancestor
111446766|NCT00003944|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111446767|NCT00003944|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111446768|NCT00003944|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111171029|NCT01946438|Immunologic Factors|immunologic factors|mesh-ancestor
111446769|NCT00003944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111446770|NCT00003950|Cyclosporine|cyclosporine|mesh-list
111446771|NCT00003950|Irinotecan|irinotecan|mesh-list
111446772|NCT00003950|Cyclosporins|cyclosporins|mesh-list
111446773|NCT00003950|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111446774|NCT00003950|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111446775|NCT00003950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111446776|NCT00003950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111446777|NCT00003950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111446778|NCT00003950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111446779|NCT00003950|Immunologic Factors|immunologic factors|mesh-ancestor
111446780|NCT00003950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111446781|NCT00003950|Antifungal Agents|antifungal agents|mesh-ancestor
111446782|NCT00003950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111446783|NCT00003950|Dermatologic Agents|dermatologic agents|mesh-ancestor
111446784|NCT00003950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111446785|NCT00003950|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111446786|NCT00003464|Temozolomide|temozolomide|mesh-list
111446787|NCT00003464|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111446788|NCT00003464|Alkylating Agents|alkylating agents|mesh-ancestor
110898258|NCT01356017|Vasodilator Agents|vasodilator agents|mesh-ancestor
111446789|NCT00003464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111446790|NCT00003464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111446791|NCT00003230|Paclitaxel|paclitaxel|mesh-list
111446792|NCT00003230|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111446793|NCT00003230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111446794|NCT00003230|Tubulin Modulators|tubulin modulators|mesh-ancestor
111446795|NCT00003230|Antimitotic Agents|antimitotic agents|mesh-ancestor
111446796|NCT00003230|Mitosis Modulators|mitosis modulators|mesh-ancestor
111446797|NCT00003230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111446798|NCT00003956|Leucovorin|leucovorin|mesh-list
111446799|NCT00003956|Fluorouracil|fluorouracil|mesh-list
111446800|NCT00003956|Calcium|calcium|mesh-list
111446801|NCT00003956|Levoleucovorin|levoleucovorin|mesh-list
111446802|NCT00003956|Lonafarnib|lonafarnib|mesh-list
111446803|NCT00003956|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111446804|NCT00003956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111446805|NCT00003956|Antimetabolites|antimetabolites|mesh-ancestor
111446806|NCT00003956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111446807|NCT00003956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111446808|NCT00003956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110898394|NCT03103087|Norethindrone|norethindrone|mesh-list
111446809|NCT00003956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111446810|NCT00003956|Immunologic Factors|immunologic factors|mesh-ancestor
111446811|NCT00003956|Antidotes|antidotes|mesh-ancestor
111446812|NCT00003956|Protective Agents|protective agents|mesh-ancestor
111446813|NCT00003956|Vitamin B Complex|vitamin b complex|mesh-ancestor
111446814|NCT00003956|Vitamins|vitamins|mesh-ancestor
111446815|NCT00003956|Micronutrients|micronutrients|mesh-ancestor
111446816|NCT00003956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111446817|NCT00002623|Carboplatin|carboplatin|mesh-list
111446818|NCT00002623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111446819|NCT00003962|Aldesleukin|aldesleukin|mesh-list
111446820|NCT00003962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111446821|NCT00003962|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111446822|NCT00003962|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111446823|NCT00003962|Antiviral Agents|antiviral agents|mesh-ancestor
111446824|NCT00003962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111446825|NCT00003968|Bryostatin 1|bryostatin 1|mesh-list
111446826|NCT00003968|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111446827|NCT00003968|Immunologic Factors|immunologic factors|mesh-ancestor
111446828|NCT00003968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111446829|NCT00003968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111446830|NCT00003974|Cyclophosphamide|cyclophosphamide|mesh-list
110898452|NCT02135354|Azithromycin|azithromycin|mesh-list
111446831|NCT00003974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111446832|NCT00003974|Immunologic Factors|immunologic factors|mesh-ancestor
111446833|NCT00003974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111446834|NCT00003974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111446835|NCT00003974|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111446836|NCT00003974|Alkylating Agents|alkylating agents|mesh-ancestor
111446837|NCT00003974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111446838|NCT00003974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111446839|NCT00003974|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111446840|NCT00002635|Lenograstim|lenograstim|mesh-list
111446841|NCT00002635|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111446842|NCT00002635|Immunologic Factors|immunologic factors|mesh-ancestor
111446843|NCT00002635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111446844|NCT00003242|Paclitaxel|paclitaxel|mesh-list
111446845|NCT00003242|Bryostatin 1|bryostatin 1|mesh-list
111446846|NCT00003242|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111446847|NCT00003242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111171105|NCT01914926|Adrenergic Agents|adrenergic agents|mesh-ancestor
111446848|NCT00003242|Tubulin Modulators|tubulin modulators|mesh-ancestor
111446849|NCT00003242|Antimitotic Agents|antimitotic agents|mesh-ancestor
111446850|NCT00003242|Mitosis Modulators|mitosis modulators|mesh-ancestor
111446851|NCT00003242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111446852|NCT00003242|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111446853|NCT00003242|Immunologic Factors|immunologic factors|mesh-ancestor
111446854|NCT00003242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111446856|NCT05664061|Xhance|xhance|mesh-list
111446857|NCT05664061|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110898573|NCT03549728|Lenograstim|lenograstim|mesh-list
111446858|NCT05664061|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
111446859|NCT05664061|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111446860|NCT05664061|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111446861|NCT05664061|Autonomic Agents|autonomic agents|mesh-ancestor
111446862|NCT05664061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111446863|NCT05664061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111446864|NCT05664061|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111446865|NCT05664061|Respiratory System Agents|respiratory system agents|mesh-ancestor
111446866|NCT05664061|Dermatologic Agents|dermatologic agents|mesh-ancestor
111446867|NCT05664061|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111446868|NCT05664061|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111446869|NCT05664061|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111446870|NCT05664061|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111446871|NCT05664061|Adrenergic Agents|adrenergic agents|mesh-ancestor
111446872|NCT05664061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111446873|NCT05664061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111446874|NCT05664061|Glucocorticoids|glucocorticoids|mesh-ancestor
111446875|NCT05664061|Hormones|hormones|mesh-ancestor
111446876|NCT05664061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111446877|NCT05664061|Sympathomimetics|sympathomimetics|mesh-ancestor
111446878|NCT00003248|Rituximab|rituximab|mesh-list
111446879|NCT00003248|Fludarabine|fludarabine|mesh-list
111446880|NCT00003248|Fludarabine phosphate|fludarabine phosphate|mesh-list
110898628|NCT02238210|Cholinergic Agents|cholinergic agents|mesh-ancestor
111446881|NCT00003248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111446882|NCT00003248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111446883|NCT00003248|Immunologic Factors|immunologic factors|mesh-ancestor
111446884|NCT00003248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111446885|NCT00003248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111446886|NCT00003248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111446887|NCT00003248|Antimetabolites|antimetabolites|mesh-ancestor
111446888|NCT00003248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111446889|NCT00003248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111446890|NCT05663905|Ambroxol|ambroxol|mesh-list
111446891|NCT05663905|Expectorants|expectorants|mesh-ancestor
111446892|NCT05663905|Respiratory System Agents|respiratory system agents|mesh-ancestor
111446893|NCT00002641|Doxorubicin|doxorubicin|mesh-list
111446894|NCT00002641|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111446895|NCT00002641|Ifosfamide|ifosfamide|mesh-list
111446896|NCT00002641|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111446897|NCT00002641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111446898|NCT00002641|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111446899|NCT00002641|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111446900|NCT00002641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111446901|NCT00002641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111446902|NCT00002641|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111446903|NCT00002641|Alkylating Agents|alkylating agents|mesh-ancestor
111446904|NCT00003992|Tamoxifen|tamoxifen|mesh-list
111446905|NCT00003992|Paclitaxel|paclitaxel|mesh-list
111446906|NCT00003992|Cyclophosphamide|cyclophosphamide|mesh-list
111446907|NCT00003992|Doxorubicin|doxorubicin|mesh-list
111446908|NCT00003992|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111446909|NCT00003992|Trastuzumab|trastuzumab|mesh-list
111446910|NCT00003992|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111446911|NCT00003992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111446912|NCT00003992|Tubulin Modulators|tubulin modulators|mesh-ancestor
111446913|NCT00003992|Antimitotic Agents|antimitotic agents|mesh-ancestor
111446914|NCT00003992|Mitosis Modulators|mitosis modulators|mesh-ancestor
111446915|NCT00003992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111446916|NCT00003992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111446917|NCT00003992|Immunologic Factors|immunologic factors|mesh-ancestor
111446918|NCT00003992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111446919|NCT00003992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111446920|NCT00003992|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111446921|NCT00003992|Alkylating Agents|alkylating agents|mesh-ancestor
111446922|NCT00003992|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111446923|NCT00003992|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111446924|NCT00003992|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111446925|NCT00003992|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111446926|NCT00003992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111446927|NCT00003992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111446928|NCT00003992|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111446929|NCT00003992|Hormone Antagonists|hormone antagonists|mesh-ancestor
111446930|NCT00003992|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110898944|NCT05417893|MTOR Inhibitors|mtor inhibitors|mesh-list
111446931|NCT00003992|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111446932|NCT00003992|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111446933|NCT00003992|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111446934|NCT00003992|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111446935|NCT00002647|Verteporfin|verteporfin|mesh-list
111446936|NCT00002647|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111446937|NCT00002647|Dermatologic Agents|dermatologic agents|mesh-ancestor
111446938|NCT00002653|Prednisone|prednisone|mesh-list
111446939|NCT00002653|Cyclophosphamide|cyclophosphamide|mesh-list
111446940|NCT00002653|Melphalan|melphalan|mesh-list
111446941|NCT00002653|Carmustine|carmustine|mesh-list
111446942|NCT00002653|Doxorubicin|doxorubicin|mesh-list
111446943|NCT00002653|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111446944|NCT00002653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110899010|NCT03412799|Paclitaxel|paclitaxel|mesh-list
111446945|NCT00002653|Immunologic Factors|immunologic factors|mesh-ancestor
111446946|NCT00002653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111446947|NCT00002653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111446948|NCT00002653|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111446949|NCT00002653|Alkylating Agents|alkylating agents|mesh-ancestor
111446950|NCT00002653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111446951|NCT00002653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111446952|NCT00002653|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110899065|NCT04631471|Vasodilator Agents|vasodilator agents|mesh-ancestor
111446953|NCT00002653|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111446954|NCT00002653|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111446955|NCT00002653|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111446956|NCT00002653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111446957|NCT00002653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111446958|NCT00002653|Glucocorticoids|glucocorticoids|mesh-ancestor
111446959|NCT00002653|Hormones|hormones|mesh-ancestor
111446960|NCT00002653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111446961|NCT00002653|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111446962|NCT00003254|Fluorouracil|fluorouracil|mesh-list
111446963|NCT00003254|Eniluracil|eniluracil|mesh-list
111446964|NCT00003254|Antimetabolites|antimetabolites|mesh-ancestor
111446965|NCT00003254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111446966|NCT00003254|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111446967|NCT00003254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111446968|NCT00003254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111446969|NCT00003254|Immunologic Factors|immunologic factors|mesh-ancestor
111446970|NCT00003254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111446971|NCT00003254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111446972|NCT00002659|Cisplatin|cisplatin|mesh-list
111446973|NCT00002659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111446974|NCT00003998|Paclitaxel|paclitaxel|mesh-list
111446975|NCT00003998|Docetaxel|docetaxel|mesh-list
111446976|NCT00003998|Carboplatin|carboplatin|mesh-list
111446977|NCT00003998|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111446978|NCT00003998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111446979|NCT00003998|Tubulin Modulators|tubulin modulators|mesh-ancestor
111446980|NCT00003998|Antimitotic Agents|antimitotic agents|mesh-ancestor
111446981|NCT00003998|Mitosis Modulators|mitosis modulators|mesh-ancestor
111446982|NCT00003998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111446983|NCT00004004|Procarbazine|procarbazine|mesh-list
111446984|NCT00004004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111446985|NCT00003260|Leucovorin|leucovorin|mesh-list
111446986|NCT00003260|Fluorouracil|fluorouracil|mesh-list
111446987|NCT00003260|Oxaliplatin|oxaliplatin|mesh-list
111446988|NCT00003260|Irinotecan|irinotecan|mesh-list
111446989|NCT00003260|Calcium|calcium|mesh-list
111446990|NCT00003260|Levoleucovorin|levoleucovorin|mesh-list
111446991|NCT00003260|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111446992|NCT00003260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111446993|NCT00003260|Antimetabolites|antimetabolites|mesh-ancestor
111446994|NCT00003260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111446995|NCT00003260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111446996|NCT00003260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111446997|NCT00003260|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111446998|NCT00003260|Immunologic Factors|immunologic factors|mesh-ancestor
111446999|NCT00003260|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111447000|NCT00003260|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111447001|NCT00003260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111447002|NCT00003260|Antidotes|antidotes|mesh-ancestor
111447003|NCT00003260|Protective Agents|protective agents|mesh-ancestor
111447004|NCT00003260|Vitamin B Complex|vitamin b complex|mesh-ancestor
111447005|NCT00003260|Vitamins|vitamins|mesh-ancestor
111447006|NCT00003260|Micronutrients|micronutrients|mesh-ancestor
111447007|NCT00002665|Leucovorin|leucovorin|mesh-list
111447008|NCT00002665|Cytarabine|cytarabine|mesh-list
111447009|NCT00002665|Dexamethasone|dexamethasone|mesh-list
111447010|NCT00002665|Prednisone|prednisone|mesh-list
111447011|NCT00002665|Cyclophosphamide|cyclophosphamide|mesh-list
111447012|NCT00002665|Doxorubicin|doxorubicin|mesh-list
111447013|NCT00002665|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111447014|NCT00002665|Methotrexate|methotrexate|mesh-list
111447015|NCT00002665|Etoposide|etoposide|mesh-list
111447016|NCT00002665|Vincristine|vincristine|mesh-list
111447017|NCT00002665|Daunorubicin|daunorubicin|mesh-list
111447018|NCT00002665|Asparaginase|asparaginase|mesh-list
111447019|NCT00002665|Mercaptopurine|mercaptopurine|mesh-list
111447020|NCT00002665|Thioguanine|thioguanine|mesh-list
111447021|NCT00002665|Levoleucovorin|levoleucovorin|mesh-list
111447022|NCT00002665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111447023|NCT00002665|Immunologic Factors|immunologic factors|mesh-ancestor
110899384|NCT04465916|Tenofovir|tenofovir|mesh-list
111447024|NCT00002665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111447025|NCT00002665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111447026|NCT00002665|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111447027|NCT00002665|Alkylating Agents|alkylating agents|mesh-ancestor
111447028|NCT00002665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111447029|NCT00002665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111447030|NCT00002665|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111447031|NCT00002665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111447032|NCT00002665|Antiemetics|antiemetics|mesh-ancestor
111447033|NCT00002665|Autonomic Agents|autonomic agents|mesh-ancestor
111447034|NCT00002665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111447035|NCT00002665|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111447036|NCT00002665|Glucocorticoids|glucocorticoids|mesh-ancestor
111447037|NCT00002665|Hormones|hormones|mesh-ancestor
111447038|NCT00002665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111447039|NCT00002665|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111447040|NCT00002665|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111447041|NCT00002665|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110899519|NCT02241018|Antibodies|antibodies|mesh-list
111447042|NCT00002665|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111447043|NCT00002665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111447044|NCT00002665|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111447045|NCT00002665|Abortifacient Agents|abortifacient agents|mesh-ancestor
111447046|NCT00002665|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111447047|NCT00002665|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111447048|NCT00002665|Antimetabolites|antimetabolites|mesh-ancestor
111447049|NCT00002665|Dermatologic Agents|dermatologic agents|mesh-ancestor
111447050|NCT00002665|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111447051|NCT00002665|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111447052|NCT00002665|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111447053|NCT00002665|Antiviral Agents|antiviral agents|mesh-ancestor
111447054|NCT00002665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111447055|NCT00002665|Antidotes|antidotes|mesh-ancestor
110899577|NCT02245932|Antioxidants|antioxidants|mesh-ancestor
111447056|NCT00002665|Protective Agents|protective agents|mesh-ancestor
111447057|NCT00002665|Vitamin B Complex|vitamin b complex|mesh-ancestor
111447058|NCT00002665|Vitamins|vitamins|mesh-ancestor
111447059|NCT00002665|Micronutrients|micronutrients|mesh-ancestor
111447060|NCT00002665|Tubulin Modulators|tubulin modulators|mesh-ancestor
111447061|NCT00002665|Antimitotic Agents|antimitotic agents|mesh-ancestor
111447062|NCT00002665|Mitosis Modulators|mitosis modulators|mesh-ancestor
111447063|NCT00003536|Methotrexate|methotrexate|mesh-list
110899636|NCT03568994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111447064|NCT00003536|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111447065|NCT00003536|Abortifacient Agents|abortifacient agents|mesh-ancestor
111447066|NCT00003536|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111447067|NCT00003536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111447068|NCT00003536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111447069|NCT00003536|Antimetabolites|antimetabolites|mesh-ancestor
111447070|NCT00003536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111447071|NCT00003536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111447072|NCT00003536|Dermatologic Agents|dermatologic agents|mesh-ancestor
111447073|NCT00003536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111447074|NCT00003536|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111447075|NCT00003536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111447076|NCT00003536|Immunologic Factors|immunologic factors|mesh-ancestor
111447077|NCT00003536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110899713|NCT00109928|Etoposide|etoposide|mesh-list
111447078|NCT00003536|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111447079|NCT00003542|Interferons|interferons|mesh-list
111447080|NCT00003542|Interferon-alpha|interferon-alpha|mesh-list
111447081|NCT00003542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111447082|NCT00003542|Antiviral Agents|antiviral agents|mesh-ancestor
110899759|NCT01065519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111447083|NCT00003542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111447084|NCT00003542|Immunologic Factors|immunologic factors|mesh-ancestor
111447085|NCT00003542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111447086|NCT00004010|Prednisone|prednisone|mesh-list
111447087|NCT00004010|Cyclophosphamide|cyclophosphamide|mesh-list
111447088|NCT00004010|Dacarbazine|dacarbazine|mesh-list
111447089|NCT00004010|Doxorubicin|doxorubicin|mesh-list
111447090|NCT00004010|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111447091|NCT00004010|Etoposide|etoposide|mesh-list
111447092|NCT00004010|Vincristine|vincristine|mesh-list
111447093|NCT00004010|Bleomycin|bleomycin|mesh-list
111447094|NCT00004010|Vinblastine|vinblastine|mesh-list
111447095|NCT00004010|Procarbazine|procarbazine|mesh-list
111447096|NCT00004010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111447097|NCT00004010|Immunologic Factors|immunologic factors|mesh-ancestor
111447098|NCT00004010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111447099|NCT00004010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111447100|NCT00004010|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111447101|NCT00004010|Alkylating Agents|alkylating agents|mesh-ancestor
111447102|NCT00004010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111447103|NCT00004010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111447104|NCT00004010|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111447105|NCT00004010|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111447106|NCT00004010|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111447107|NCT00004010|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111447108|NCT00004010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111447109|NCT00004010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111447110|NCT00004010|Glucocorticoids|glucocorticoids|mesh-ancestor
111447111|NCT00004010|Hormones|hormones|mesh-ancestor
111447112|NCT00004010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111447113|NCT00004010|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111447114|NCT00004010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111447115|NCT00004010|Tubulin Modulators|tubulin modulators|mesh-ancestor
111447116|NCT00004010|Antimitotic Agents|antimitotic agents|mesh-ancestor
111447117|NCT00004010|Mitosis Modulators|mitosis modulators|mesh-ancestor
111447118|NCT00004016|Interferons|interferons|mesh-list
111447119|NCT00004016|Interferon-gamma|interferon-gamma|mesh-list
111447120|NCT00004016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111447121|NCT00004016|Antiviral Agents|antiviral agents|mesh-ancestor
111447122|NCT00004016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111447123|NCT00004022|Aldesleukin|aldesleukin|mesh-list
111447124|NCT00004022|Muromonab-CD3|muromonab-cd3|mesh-list
111447125|NCT00004022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111447126|NCT00004022|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111447127|NCT00004022|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111447128|NCT00004022|Antiviral Agents|antiviral agents|mesh-ancestor
111447129|NCT00004022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111447130|NCT00004022|Immunologic Factors|immunologic factors|mesh-ancestor
111447131|NCT00004022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111447132|NCT00004022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111447133|NCT00381901|Trastuzumab|trastuzumab|mesh-list
111447134|NCT00381901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111447135|NCT00381901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111447136|NCT00003278|Dexamethasone|dexamethasone|mesh-list
111447137|NCT00003278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111447138|NCT00003278|Antiemetics|antiemetics|mesh-ancestor
111447139|NCT00003278|Autonomic Agents|autonomic agents|mesh-ancestor
111447140|NCT00003278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111447141|NCT00003278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111447142|NCT00003278|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111447143|NCT00003278|Glucocorticoids|glucocorticoids|mesh-ancestor
111447144|NCT00003278|Hormones|hormones|mesh-ancestor
111447145|NCT00003278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111447146|NCT00003278|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111447147|NCT00003278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111447148|NCT00004028|Carmustine|carmustine|mesh-list
111447149|NCT00004028|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111447150|NCT00004028|Alkylating Agents|alkylating agents|mesh-ancestor
110900000|NCT03545516|Sensory System Agents|sensory system agents|mesh-ancestor
111447151|NCT00004028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111447152|NCT00004028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111447153|NCT00003554|Prednisone|prednisone|mesh-list
111447154|NCT00003554|Rituximab|rituximab|mesh-list
111447155|NCT00003554|Melphalan|melphalan|mesh-list
111447156|NCT00003554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111447157|NCT00003554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111447158|NCT00003554|Immunologic Factors|immunologic factors|mesh-ancestor
111447159|NCT00003554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111447160|NCT00003554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111447161|NCT00003554|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111447162|NCT00003554|Glucocorticoids|glucocorticoids|mesh-ancestor
111447163|NCT00003554|Hormones|hormones|mesh-ancestor
111447164|NCT00003554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111447165|NCT00003554|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111447166|NCT00003554|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111447167|NCT00003554|Alkylating Agents|alkylating agents|mesh-ancestor
111447168|NCT00003554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111447169|NCT00003554|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111447170|NCT00003554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111447171|NCT00003284|Paclitaxel|paclitaxel|mesh-list
111447172|NCT00003284|Etoposide|etoposide|mesh-list
111447173|NCT00003284|Carboplatin|carboplatin|mesh-list
111447174|NCT00003284|Ifosfamide|ifosfamide|mesh-list
111447175|NCT00003284|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111447176|NCT00003284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111447177|NCT00003284|Tubulin Modulators|tubulin modulators|mesh-ancestor
111447178|NCT00003284|Antimitotic Agents|antimitotic agents|mesh-ancestor
111447179|NCT00003284|Mitosis Modulators|mitosis modulators|mesh-ancestor
111447180|NCT00003284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111447181|NCT00003284|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111447182|NCT00003284|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111447183|NCT00003284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111447184|NCT00003284|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111447185|NCT00003284|Alkylating Agents|alkylating agents|mesh-ancestor
111447186|NCT00384410|Nabilone|nabilone|mesh-list
111447187|NCT00384410|Antiemetics|antiemetics|mesh-ancestor
111447188|NCT00384410|Autonomic Agents|autonomic agents|mesh-ancestor
111447189|NCT00384410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111447190|NCT00384410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111447191|NCT00384410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111447192|NCT00384410|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111447193|NCT00384410|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111447194|NCT00384410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111447195|NCT00384410|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111447196|NCT00004040|Interferons|interferons|mesh-list
111447197|NCT00004040|Interferon-alpha|interferon-alpha|mesh-list
111447198|NCT00004040|Rituximab|rituximab|mesh-list
111447199|NCT00004040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111447200|NCT00004040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111447201|NCT00004040|Immunologic Factors|immunologic factors|mesh-ancestor
111447202|NCT00004040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111447203|NCT00004040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111447204|NCT00004040|Antiviral Agents|antiviral agents|mesh-ancestor
111447205|NCT00004040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111447206|NCT00004046|Exatecan|exatecan|mesh-list
111447207|NCT00004046|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111447208|NCT00004046|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111447209|NCT00004046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111447210|NCT00004046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111447211|NCT00004046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111447212|NCT00003560|Carboplatin|carboplatin|mesh-list
111447213|NCT00003560|Docetaxel|docetaxel|mesh-list
111447214|NCT00003560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111447215|NCT00003560|Tubulin Modulators|tubulin modulators|mesh-ancestor
111447216|NCT00003560|Antimitotic Agents|antimitotic agents|mesh-ancestor
111447217|NCT00003560|Mitosis Modulators|mitosis modulators|mesh-ancestor
110900389|NCT03567408|Bivalirudin|bivalirudin|mesh-list
111447218|NCT00003560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111447219|NCT00003290|Hormones|hormones|mesh-list
111447220|NCT00003290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111447221|NCT00003290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111447222|NCT05748925|Dapagliflozin|dapagliflozin|mesh-list
111447223|NCT05748925|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111447224|NCT05748925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111447225|NCT05748925|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111447226|NCT05748925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111447227|NCT00003572|Mycophenolic Acid|mycophenolic acid|mesh-list
111447228|NCT00003572|Tacrolimus|tacrolimus|mesh-list
111447229|NCT00003572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111171496|NCT01995071|Ribavirin|ribavirin|mesh-list
111447230|NCT00003572|Immunologic Factors|immunologic factors|mesh-ancestor
111447231|NCT00003572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111447232|NCT00003572|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111447233|NCT00003572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111447234|NCT00003572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111447235|NCT00003572|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111447236|NCT00003572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111447237|NCT00003572|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111447238|NCT00003572|Antitubercular Agents|antitubercular agents|mesh-ancestor
111447239|NCT00003572|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111447240|NCT00003572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111447241|NCT00002689|Dexamethasone|dexamethasone|mesh-list
111447242|NCT00002689|Fluorouracil|fluorouracil|mesh-list
111447243|NCT00002689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111447244|NCT00002689|Antiemetics|antiemetics|mesh-ancestor
111447245|NCT00002689|Autonomic Agents|autonomic agents|mesh-ancestor
111447246|NCT00002689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111447247|NCT00002689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111447248|NCT00002689|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111447249|NCT00002689|Glucocorticoids|glucocorticoids|mesh-ancestor
111447250|NCT00002689|Hormones|hormones|mesh-ancestor
111447251|NCT00002689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111447252|NCT00002689|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111447253|NCT00002689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111447254|NCT00002689|Antimetabolites|antimetabolites|mesh-ancestor
111447255|NCT00002689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111447256|NCT00002689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111447257|NCT00002689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111447258|NCT00002689|Immunologic Factors|immunologic factors|mesh-ancestor
111447259|NCT00003296|Doxorubicin|doxorubicin|mesh-list
111447260|NCT00003296|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111447261|NCT00003296|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111447262|NCT00003296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111447263|NCT00003296|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111447264|NCT00003296|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111447265|NCT00003296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111447266|NCT00003296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111447267|NCT00004064|Oregovomab|oregovomab|mesh-list
111447268|NCT00004064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111447269|NCT00004064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111447270|NCT00382057|Anastrozole|anastrozole|mesh-list
111447271|NCT00382057|Goserelin|goserelin|mesh-list
111447272|NCT00382057|Testosterone|testosterone|mesh-list
111447273|NCT00382057|Androgens|androgens|mesh-ancestor
111447274|NCT00382057|Hormones|hormones|mesh-ancestor
111447275|NCT00382057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111447276|NCT00382057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111447277|NCT00382057|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111447278|NCT00382057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111447279|NCT00382057|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111447280|NCT00382057|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111447281|NCT00382057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111447282|NCT00382057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111447283|NCT00382057|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111447284|NCT00382057|Hormone Antagonists|hormone antagonists|mesh-ancestor
111447285|NCT00003578|Cytarabine|cytarabine|mesh-list
111447286|NCT00003578|Prednisone|prednisone|mesh-list
111447287|NCT00003578|Cyclophosphamide|cyclophosphamide|mesh-list
111447288|NCT00003578|Melphalan|melphalan|mesh-list
111447289|NCT00003578|Carmustine|carmustine|mesh-list
111447290|NCT00003578|Doxorubicin|doxorubicin|mesh-list
111447291|NCT00003578|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111447292|NCT00003578|Etoposide|etoposide|mesh-list
111447293|NCT00003578|Vincristine|vincristine|mesh-list
111447294|NCT00003578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111447295|NCT00003578|Immunologic Factors|immunologic factors|mesh-ancestor
111447296|NCT00003578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111447297|NCT00003578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111447298|NCT00003578|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111447299|NCT00003578|Alkylating Agents|alkylating agents|mesh-ancestor
111447300|NCT00003578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111447301|NCT00003578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111447302|NCT00003578|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111447303|NCT00003578|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111447304|NCT00003578|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111447305|NCT00003578|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111447306|NCT00003578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111447307|NCT00003578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111447308|NCT00003578|Glucocorticoids|glucocorticoids|mesh-ancestor
111447309|NCT00003578|Hormones|hormones|mesh-ancestor
111447310|NCT00003578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111447311|NCT00003578|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111447312|NCT00003578|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111447313|NCT00003578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111447314|NCT00003578|Antimetabolites|antimetabolites|mesh-ancestor
111447315|NCT00003578|Antiviral Agents|antiviral agents|mesh-ancestor
111447316|NCT00003578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111447317|NCT00003578|Tubulin Modulators|tubulin modulators|mesh-ancestor
111447318|NCT00003578|Antimitotic Agents|antimitotic agents|mesh-ancestor
111447319|NCT00003578|Mitosis Modulators|mitosis modulators|mesh-ancestor
111447320|NCT00003584|Prednisone|prednisone|mesh-list
111447321|NCT00003584|Estramustine|estramustine|mesh-list
111447322|NCT00003584|Vinorelbine|vinorelbine|mesh-list
110900817|NCT02835690|Pembrolizumab|pembrolizumab|mesh-list
111447323|NCT00003584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111447324|NCT00003584|Glucocorticoids|glucocorticoids|mesh-ancestor
111447325|NCT00003584|Hormones|hormones|mesh-ancestor
111447326|NCT00003584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111447327|NCT00003584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111447328|NCT00003584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111447329|NCT00003584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111447330|NCT00003584|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111447331|NCT00003584|Tubulin Modulators|tubulin modulators|mesh-ancestor
111447332|NCT00003584|Antimitotic Agents|antimitotic agents|mesh-ancestor
111447333|NCT00003584|Mitosis Modulators|mitosis modulators|mesh-ancestor
111447334|NCT00003584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111447335|NCT00003584|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111447336|NCT00003584|Alkylating Agents|alkylating agents|mesh-ancestor
111447337|NCT00002701|Cytarabine|cytarabine|mesh-list
111447338|NCT00002701|Cyclophosphamide|cyclophosphamide|mesh-list
111447339|NCT00002701|Busulfan|busulfan|mesh-list
111447340|NCT00002701|Methotrexate|methotrexate|mesh-list
111447341|NCT00002701|Etoposide|etoposide|mesh-list
111447342|NCT00002701|Mitoxantrone|mitoxantrone|mesh-list
111447343|NCT00002701|Mercaptopurine|mercaptopurine|mesh-list
111447344|NCT00002701|Idarubicin|idarubicin|mesh-list
111447345|NCT00002701|Tretinoin|tretinoin|mesh-list
111447346|NCT00002701|Thioguanine|thioguanine|mesh-list
111447347|NCT00002701|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111447348|NCT00002701|Immunologic Factors|immunologic factors|mesh-ancestor
111447349|NCT00002701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111447350|NCT00002701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111447351|NCT00002701|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111447352|NCT00002701|Alkylating Agents|alkylating agents|mesh-ancestor
111447353|NCT00002701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111447354|NCT00002701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111447355|NCT00002701|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111447356|NCT00002701|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111447357|NCT00002701|Abortifacient Agents|abortifacient agents|mesh-ancestor
111447358|NCT00002701|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111447359|NCT00002701|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111447360|NCT00002701|Antimetabolites|antimetabolites|mesh-ancestor
111447361|NCT00002701|Dermatologic Agents|dermatologic agents|mesh-ancestor
111447362|NCT00002701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111447363|NCT00002701|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111447364|NCT00002701|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111447365|NCT00002701|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111447366|NCT00002701|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111447367|NCT00002701|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111447368|NCT00002701|Antiviral Agents|antiviral agents|mesh-ancestor
111447369|NCT00002701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111447370|NCT00002701|Analgesics|analgesics|mesh-ancestor
111447371|NCT00002701|Sensory System Agents|sensory system agents|mesh-ancestor
111447372|NCT00002701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111447373|NCT00002701|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111447374|NCT00002701|Keratolytic Agents|keratolytic agents|mesh-ancestor
111447375|NCT00004070|Interleukin-12|interleukin-12|mesh-list
111447376|NCT00004070|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111447377|NCT00004070|Immunologic Factors|immunologic factors|mesh-ancestor
111447378|NCT00004070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111447379|NCT00004070|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111447380|NCT00004070|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111447381|NCT00004070|Growth Substances|growth substances|mesh-ancestor
111447382|NCT00004070|Growth Inhibitors|growth inhibitors|mesh-ancestor
111447383|NCT00004070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111447384|NCT00004082|Carboplatin|carboplatin|mesh-list
111447385|NCT00004082|Gemcitabine|gemcitabine|mesh-list
111447386|NCT00004082|Docetaxel|docetaxel|mesh-list
111447387|NCT00004082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111447388|NCT00004082|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111447389|NCT00004082|Antimetabolites|antimetabolites|mesh-ancestor
111447390|NCT00004082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111447391|NCT00004082|Tubulin Modulators|tubulin modulators|mesh-ancestor
111447392|NCT00004082|Antimitotic Agents|antimitotic agents|mesh-ancestor
111447393|NCT00004082|Mitosis Modulators|mitosis modulators|mesh-ancestor
111447394|NCT00002707|Tamoxifen|tamoxifen|mesh-list
111447395|NCT00002707|Cyclophosphamide|cyclophosphamide|mesh-list
111447396|NCT00002707|Docetaxel|docetaxel|mesh-list
111447397|NCT00002707|Doxorubicin|doxorubicin|mesh-list
111447398|NCT00002707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111447399|NCT00002707|Immunologic Factors|immunologic factors|mesh-ancestor
111447400|NCT00002707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111447401|NCT00002707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111447402|NCT00002707|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111447403|NCT00002707|Alkylating Agents|alkylating agents|mesh-ancestor
111447404|NCT00002707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111447405|NCT00002707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111447406|NCT00002707|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111447407|NCT00002707|Tubulin Modulators|tubulin modulators|mesh-ancestor
111447408|NCT00002707|Antimitotic Agents|antimitotic agents|mesh-ancestor
111447409|NCT00002707|Mitosis Modulators|mitosis modulators|mesh-ancestor
111447410|NCT00002707|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111447411|NCT00002707|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111447412|NCT00002707|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111447413|NCT00002707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111447414|NCT00002707|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111447415|NCT00002707|Hormone Antagonists|hormone antagonists|mesh-ancestor
111447416|NCT00002707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111447417|NCT00002707|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111447418|NCT00002707|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111447419|NCT00002707|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111447420|NCT00002707|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111447421|NCT00003596|Fluorouracil|fluorouracil|mesh-list
111447422|NCT00003596|Mitomycins|mitomycins|mesh-list
111447423|NCT00003596|Mitomycin|mitomycin|mesh-list
111447424|NCT00003596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111447425|NCT00003596|Antimetabolites|antimetabolites|mesh-ancestor
111447426|NCT00003596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111447427|NCT00003596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111447428|NCT00003596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111447429|NCT00003596|Immunologic Factors|immunologic factors|mesh-ancestor
111447430|NCT00003596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111447431|NCT00003596|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111447432|NCT00003596|Alkylating Agents|alkylating agents|mesh-ancestor
111447433|NCT00003596|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111447434|NCT00003596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111447435|NCT00002719|Cytarabine|cytarabine|mesh-list
111447436|NCT00002719|Etoposide|etoposide|mesh-list
111447437|NCT00002719|Mitoxantrone|mitoxantrone|mesh-list
111447438|NCT00002719|Idarubicin|idarubicin|mesh-list
111447439|NCT00002719|Carmustine|carmustine|mesh-list
111447440|NCT00002719|Amsacrine|amsacrine|mesh-list
111447441|NCT00002719|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111447442|NCT00002719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111447443|NCT00002719|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111447444|NCT00002719|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111447445|NCT00002719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111447446|NCT00002719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111447447|NCT00002719|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111447448|NCT00002719|Antimetabolites|antimetabolites|mesh-ancestor
111447449|NCT00002719|Antiviral Agents|antiviral agents|mesh-ancestor
111447450|NCT00002719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111447451|NCT00002719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111447452|NCT00002719|Immunologic Factors|immunologic factors|mesh-ancestor
111447453|NCT00002719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111447454|NCT00002719|Analgesics|analgesics|mesh-ancestor
111447455|NCT00002719|Sensory System Agents|sensory system agents|mesh-ancestor
111447456|NCT00002719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111447457|NCT00002719|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111447458|NCT00002719|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111447459|NCT00002719|Alkylating Agents|alkylating agents|mesh-ancestor
111447460|NCT00003326|Paclitaxel|paclitaxel|mesh-list
111447461|NCT00003326|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111447462|NCT00003326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111447463|NCT00003326|Tubulin Modulators|tubulin modulators|mesh-ancestor
111447464|NCT00003326|Antimitotic Agents|antimitotic agents|mesh-ancestor
111447465|NCT00003326|Mitosis Modulators|mitosis modulators|mesh-ancestor
111447466|NCT00003326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111447467|NCT00002725|Bryostatin 1|bryostatin 1|mesh-list
111447468|NCT00002725|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111447469|NCT00002725|Immunologic Factors|immunologic factors|mesh-ancestor
111447470|NCT00002725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111447471|NCT00002725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111447473|NCT00003602|Etoposide|etoposide|mesh-list
111447474|NCT00003602|Mitoxantrone|mitoxantrone|mesh-list
111447475|NCT00003602|Idarubicin|idarubicin|mesh-list
111447476|NCT00003602|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111447477|NCT00003602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111447478|NCT00003602|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111447479|NCT00003602|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111447480|NCT00003602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111447481|NCT00003602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111447482|NCT00003602|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111447483|NCT00003602|Antimetabolites|antimetabolites|mesh-ancestor
111447484|NCT00003602|Antiviral Agents|antiviral agents|mesh-ancestor
111447485|NCT00003602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111447486|NCT00003602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111447487|NCT00003602|Immunologic Factors|immunologic factors|mesh-ancestor
111447488|NCT00003602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111447489|NCT00003602|Analgesics|analgesics|mesh-ancestor
111447490|NCT00003602|Sensory System Agents|sensory system agents|mesh-ancestor
111447491|NCT00003602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111447492|NCT00003602|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111447493|NCT04609423|Vitamin D|vitamin d|mesh-list
111447494|NCT04609423|Cod Liver Oil|cod liver oil|mesh-list
111447495|NCT04609423|Vitamins|vitamins|mesh-ancestor
111447496|NCT04609423|Micronutrients|micronutrients|mesh-ancestor
111447497|NCT04609423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111447498|NCT04609423|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111447499|NCT00003332|Gemcitabine|gemcitabine|mesh-list
111447500|NCT00003332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111447501|NCT00003332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111447502|NCT00003332|Antimetabolites|antimetabolites|mesh-ancestor
111447503|NCT00003332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111447504|NCT00004094|Paclitaxel|paclitaxel|mesh-list
111447505|NCT00004094|Carboplatin|carboplatin|mesh-list
111447506|NCT00004094|Fluorouracil|fluorouracil|mesh-list
111447507|NCT00004094|Hydroxyurea|hydroxyurea|mesh-list
111447508|NCT00004094|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110901604|NCT03094416|Omeprazole|omeprazole|mesh-list
111447509|NCT00004094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111447510|NCT00004094|Tubulin Modulators|tubulin modulators|mesh-ancestor
111447511|NCT00004094|Antimitotic Agents|antimitotic agents|mesh-ancestor
111447512|NCT00004094|Mitosis Modulators|mitosis modulators|mesh-ancestor
111447513|NCT00004094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111447514|NCT00004094|Antimetabolites|antimetabolites|mesh-ancestor
111447515|NCT00004094|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111447516|NCT00004094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111447517|NCT00004094|Immunologic Factors|immunologic factors|mesh-ancestor
111447518|NCT00004094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111447519|NCT00004094|Antisickling Agents|antisickling agents|mesh-ancestor
111447520|NCT00004094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111447521|NCT00004094|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111447522|NCT00004100|Gemcitabine|gemcitabine|mesh-list
111447523|NCT00004100|Vinorelbine|vinorelbine|mesh-list
111447524|NCT00004100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111447525|NCT00004100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111447526|NCT00004100|Antimetabolites|antimetabolites|mesh-ancestor
111447527|NCT00004100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111447528|NCT00004100|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111447529|NCT00004100|Tubulin Modulators|tubulin modulators|mesh-ancestor
111447530|NCT00004100|Antimitotic Agents|antimitotic agents|mesh-ancestor
111447531|NCT00004100|Mitosis Modulators|mitosis modulators|mesh-ancestor
111447532|NCT00002737|Interferons|interferons|mesh-list
111447533|NCT00002737|Interferon-alpha|interferon-alpha|mesh-list
111447534|NCT00002737|Isotretinoin|isotretinoin|mesh-list
111447535|NCT00002737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111447536|NCT00002737|Antiviral Agents|antiviral agents|mesh-ancestor
111447537|NCT00002737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111447538|NCT00002737|Immunologic Factors|immunologic factors|mesh-ancestor
111447539|NCT00002737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111447540|NCT00002737|Dermatologic Agents|dermatologic agents|mesh-ancestor
111447541|NCT00003338|Epratuzumab|epratuzumab|mesh-list
111447542|NCT00003338|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111447543|NCT00003338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111447544|NCT00003620|Alvocidib|alvocidib|mesh-list
111447545|NCT00003620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111447546|NCT00003620|Growth Inhibitors|growth inhibitors|mesh-ancestor
111447547|NCT00003620|Growth Substances|growth substances|mesh-ancestor
111447548|NCT00003620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111447549|NCT00003620|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111447550|NCT00003620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111447551|NCT00003620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111447552|NCT00003344|Irinotecan|irinotecan|mesh-list
111447553|NCT00003344|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111447554|NCT00003344|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111447555|NCT00003344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111447556|NCT00003344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111447557|NCT00003344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111447558|NCT00003626|Dolastatin 10|dolastatin 10|mesh-list
111447559|NCT00003626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111447560|NCT00003626|Tubulin Modulators|tubulin modulators|mesh-ancestor
111447561|NCT00003626|Antimitotic Agents|antimitotic agents|mesh-ancestor
111447562|NCT00003626|Mitosis Modulators|mitosis modulators|mesh-ancestor
111447563|NCT00003626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111447564|NCT00003632|Cytarabine|cytarabine|mesh-list
111447565|NCT00003632|Methotrexate|methotrexate|mesh-list
111447566|NCT00003632|Etoposide|etoposide|mesh-list
111447567|NCT00003632|Melphalan|melphalan|mesh-list
111447568|NCT00003632|Carmustine|carmustine|mesh-list
111447569|NCT00003632|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111447570|NCT00003632|Abortifacient Agents|abortifacient agents|mesh-ancestor
111447571|NCT00003632|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111447572|NCT00003632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111447573|NCT00003632|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111447574|NCT00003632|Antimetabolites|antimetabolites|mesh-ancestor
110901912|NCT02819310|Laxatives|laxatives|mesh-list
111447575|NCT00003632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111447576|NCT00003632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111447577|NCT00003632|Dermatologic Agents|dermatologic agents|mesh-ancestor
111447578|NCT00003632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111447579|NCT00003632|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111447580|NCT00003632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111447581|NCT00003632|Immunologic Factors|immunologic factors|mesh-ancestor
111447582|NCT00003632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111447583|NCT00003632|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111447584|NCT00003632|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111447585|NCT00003632|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111447586|NCT00003632|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111447587|NCT00003632|Antiviral Agents|antiviral agents|mesh-ancestor
111447588|NCT00003632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111447589|NCT00003632|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111447590|NCT00003632|Alkylating Agents|alkylating agents|mesh-ancestor
111447591|NCT00003632|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111447592|NCT00004112|Prednisone|prednisone|mesh-list
111447593|NCT00004112|Cyclophosphamide|cyclophosphamide|mesh-list
111447594|NCT00004112|Rituximab|rituximab|mesh-list
111447595|NCT00004112|Doxorubicin|doxorubicin|mesh-list
111447596|NCT00004112|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111447597|NCT00004112|Vincristine|vincristine|mesh-list
111447598|NCT00004112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111447599|NCT00004112|Immunologic Factors|immunologic factors|mesh-ancestor
111447600|NCT00004112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111447601|NCT00004112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111447602|NCT00004112|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111447603|NCT00004112|Alkylating Agents|alkylating agents|mesh-ancestor
111447604|NCT00004112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111447605|NCT00004112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111447606|NCT00004112|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111447607|NCT00004112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111447608|NCT00004112|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111447609|NCT00004112|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111447610|NCT00004112|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111447611|NCT00004112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111447612|NCT00004112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111447613|NCT00004112|Glucocorticoids|glucocorticoids|mesh-ancestor
111447614|NCT00004112|Hormones|hormones|mesh-ancestor
110902091|NCT03108521|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111447615|NCT00004112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111447616|NCT00004112|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111447617|NCT00004112|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111447618|NCT00004112|Tubulin Modulators|tubulin modulators|mesh-ancestor
111447619|NCT00004112|Antimitotic Agents|antimitotic agents|mesh-ancestor
111447620|NCT00004112|Mitosis Modulators|mitosis modulators|mesh-ancestor
111447621|NCT00003350|Paclitaxel|paclitaxel|mesh-list
111447622|NCT00003350|Doxorubicin|doxorubicin|mesh-list
111447623|NCT00003350|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110902158|NCT05198141|Letrozole|letrozole|mesh-list
111447624|NCT00003350|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111447625|NCT00003350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111447626|NCT00003350|Tubulin Modulators|tubulin modulators|mesh-ancestor
111447627|NCT00003350|Antimitotic Agents|antimitotic agents|mesh-ancestor
111447628|NCT00003350|Mitosis Modulators|mitosis modulators|mesh-ancestor
111447629|NCT00003350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111447630|NCT00003350|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111447631|NCT00003350|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111447632|NCT00003350|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111447633|NCT00003350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111447634|NCT05584267|Immunomodulating Agents|immunomodulating agents|mesh-list
111447635|NCT05584267|Immunologic Factors|immunologic factors|mesh-ancestor
111447636|NCT05584267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111447637|NCT00003356|Aldesleukin|aldesleukin|mesh-list
111447638|NCT00003356|Rituximab|rituximab|mesh-list
111447639|NCT00003356|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111447640|NCT00003356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111447641|NCT00003356|Immunologic Factors|immunologic factors|mesh-ancestor
111447642|NCT00003356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111447643|NCT00003356|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111447644|NCT00003356|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111447645|NCT00003356|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111447646|NCT00003356|Antiviral Agents|antiviral agents|mesh-ancestor
111447647|NCT00003356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111447648|NCT00003638|Cyclophosphamide|cyclophosphamide|mesh-list
111447649|NCT00003638|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
111447650|NCT00003638|Detox adjuvant|detox adjuvant|mesh-list
111447651|NCT00003638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111447652|NCT00003638|Immunologic Factors|immunologic factors|mesh-ancestor
111447653|NCT00003638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111447654|NCT00003638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111447655|NCT00003638|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111447656|NCT00003638|Alkylating Agents|alkylating agents|mesh-ancestor
111447657|NCT00003638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111447658|NCT00003638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111447659|NCT00003638|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111447660|NCT00003638|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111447661|NCT00004142|Fluorouracil|fluorouracil|mesh-list
111447662|NCT00004142|Floxuridine|floxuridine|mesh-list
111447663|NCT00004142|Antimetabolites|antimetabolites|mesh-ancestor
111447664|NCT00004142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111447665|NCT00004142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111447666|NCT00004142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111447667|NCT00004142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111447668|NCT00004142|Immunologic Factors|immunologic factors|mesh-ancestor
111447669|NCT00004142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111447670|NCT00002749|Carboplatin|carboplatin|mesh-list
111447671|NCT00002749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111447672|NCT00003362|Sargramostim|sargramostim|mesh-list
111447673|NCT00003362|Freund's Adjuvant|freund's adjuvant|mesh-list
111447674|NCT00003362|Immunologic Factors|immunologic factors|mesh-ancestor
111447675|NCT00003362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111447676|NCT00003362|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111447677|NCT00003650|Cytarabine|cytarabine|mesh-list
111447678|NCT00003650|Dexamethasone|dexamethasone|mesh-list
111447679|NCT00003650|Prednisone|prednisone|mesh-list
111447680|NCT00003650|Methylprednisolone|methylprednisolone|mesh-list
111447681|NCT00003650|Cyclophosphamide|cyclophosphamide|mesh-list
111447682|NCT00003650|Methotrexate|methotrexate|mesh-list
111447683|NCT00003650|Etoposide|etoposide|mesh-list
111447684|NCT00003650|Vincristine|vincristine|mesh-list
111447685|NCT00003650|Daunorubicin|daunorubicin|mesh-list
111447686|NCT00003650|Asparaginase|asparaginase|mesh-list
111447687|NCT00003650|Mitoxantrone|mitoxantrone|mesh-list
111447688|NCT00003650|Mercaptopurine|mercaptopurine|mesh-list
111447689|NCT00003650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111447690|NCT00003650|Immunologic Factors|immunologic factors|mesh-ancestor
111447691|NCT00003650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111447692|NCT00003650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111447693|NCT00003650|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111447694|NCT00003650|Alkylating Agents|alkylating agents|mesh-ancestor
110902395|NCT02260050|Epinastine|epinastine|mesh-list
111447695|NCT00003650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111447696|NCT00003650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111447697|NCT00003650|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111447698|NCT00003650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111447699|NCT00003650|Antiemetics|antiemetics|mesh-ancestor
111447700|NCT00003650|Autonomic Agents|autonomic agents|mesh-ancestor
111447701|NCT00003650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111447702|NCT00003650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111447703|NCT00003650|Glucocorticoids|glucocorticoids|mesh-ancestor
111447704|NCT00003650|Hormones|hormones|mesh-ancestor
111447705|NCT00003650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111447706|NCT00003650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111447707|NCT00003650|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111447708|NCT00003650|Abortifacient Agents|abortifacient agents|mesh-ancestor
111447709|NCT00003650|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111447710|NCT00003650|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111447711|NCT00003650|Antimetabolites|antimetabolites|mesh-ancestor
111447712|NCT00003650|Dermatologic Agents|dermatologic agents|mesh-ancestor
111447713|NCT00003650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111447714|NCT00003650|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111447715|NCT00003650|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111447716|NCT00003650|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111447717|NCT00003650|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111447718|NCT00003650|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111447719|NCT00003650|Antiviral Agents|antiviral agents|mesh-ancestor
111447720|NCT00003650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111447721|NCT00003650|Tubulin Modulators|tubulin modulators|mesh-ancestor
111447722|NCT00003650|Antimitotic Agents|antimitotic agents|mesh-ancestor
111447723|NCT00003650|Mitosis Modulators|mitosis modulators|mesh-ancestor
111447724|NCT00003650|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111447725|NCT00003650|Protective Agents|protective agents|mesh-ancestor
111447726|NCT00003650|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111447727|NCT00003650|Analgesics|analgesics|mesh-ancestor
111447728|NCT00003650|Sensory System Agents|sensory system agents|mesh-ancestor
111447729|NCT00002755|Tamoxifen|tamoxifen|mesh-list
111447730|NCT00002755|Cobalt|cobalt|mesh-list
111447731|NCT00002755|Cyclophosphamide|cyclophosphamide|mesh-list
111447732|NCT00002755|Thiotepa|thiotepa|mesh-list
111447733|NCT00002755|Doxorubicin|doxorubicin|mesh-list
111447734|NCT00002755|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111447735|NCT00002755|Fluorouracil|fluorouracil|mesh-list
111447736|NCT00002755|Methotrexate|methotrexate|mesh-list
111447737|NCT00002755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111447738|NCT00002755|Immunologic Factors|immunologic factors|mesh-ancestor
111447739|NCT00002755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111447740|NCT00002755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111447741|NCT00002755|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111447742|NCT00002755|Alkylating Agents|alkylating agents|mesh-ancestor
111447743|NCT00002755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111447744|NCT00002755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111447745|NCT00002755|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111447746|NCT00002755|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111447747|NCT00002755|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111447748|NCT00002755|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111447749|NCT00002755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111447750|NCT00002755|Antimetabolites|antimetabolites|mesh-ancestor
111447751|NCT00002755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111447752|NCT00002755|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111447753|NCT00002755|Abortifacient Agents|abortifacient agents|mesh-ancestor
111447754|NCT00002755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111447755|NCT00002755|Dermatologic Agents|dermatologic agents|mesh-ancestor
111447756|NCT00002755|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111447757|NCT00002755|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111447758|NCT00002755|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111447759|NCT00002755|Hormone Antagonists|hormone antagonists|mesh-ancestor
111447760|NCT00002755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111447761|NCT00002755|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111447762|NCT00002755|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111447763|NCT00002755|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111447764|NCT00002755|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111447765|NCT00002755|Trace Elements|trace elements|mesh-ancestor
111447766|NCT00002755|Micronutrients|micronutrients|mesh-ancestor
111447767|NCT00002761|Interferons|interferons|mesh-list
111447769|NCT00002761|Interferon-gamma|interferon-gamma|mesh-list
111447770|NCT00002761|Cyclosporine|cyclosporine|mesh-list
111447771|NCT00002761|Cyclophosphamide|cyclophosphamide|mesh-list
111447772|NCT00002761|Busulfan|busulfan|mesh-list
111447773|NCT00002761|Idarubicin|idarubicin|mesh-list
111447774|NCT00002761|Cyclosporins|cyclosporins|mesh-list
111447775|NCT00002761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111447776|NCT00002761|Immunologic Factors|immunologic factors|mesh-ancestor
111447777|NCT00002761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111447778|NCT00002761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111447779|NCT00002761|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111447780|NCT00002761|Alkylating Agents|alkylating agents|mesh-ancestor
111447781|NCT00002761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111447782|NCT00002761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111447783|NCT00002761|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111447784|NCT00002761|Antiviral Agents|antiviral agents|mesh-ancestor
111447785|NCT00002761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111447786|NCT00002761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111447787|NCT00002761|Antimetabolites|antimetabolites|mesh-ancestor
111447788|NCT00002761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111447789|NCT00002761|Antifungal Agents|antifungal agents|mesh-ancestor
111447790|NCT00002761|Dermatologic Agents|dermatologic agents|mesh-ancestor
111447791|NCT00002761|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111447792|NCT00002761|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111447793|NCT00002761|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111447794|NCT00002761|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111447795|NCT00382135|Tadalafil|tadalafil|mesh-list
111447796|NCT00382135|Vasodilator Agents|vasodilator agents|mesh-ancestor
111447797|NCT00382135|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111447798|NCT00382135|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111447799|NCT00382135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111447800|NCT00382135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111447801|NCT00382135|Urological Agents|urological agents|mesh-ancestor
111447802|NCT00003662|Cyclosporine|cyclosporine|mesh-list
111447803|NCT00003662|Methylprednisolone|methylprednisolone|mesh-list
111447804|NCT00003662|Cyclophosphamide|cyclophosphamide|mesh-list
111447805|NCT00003662|Melphalan|melphalan|mesh-list
111447806|NCT00003662|Busulfan|busulfan|mesh-list
111447807|NCT00003662|Cyclosporins|cyclosporins|mesh-list
111447808|NCT00003662|Antilymphocyte Serum|antilymphocyte serum|mesh-list
111447809|NCT00003662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111447810|NCT00003662|Immunologic Factors|immunologic factors|mesh-ancestor
111447811|NCT00003662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111447812|NCT00003662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111447813|NCT00003662|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111447814|NCT00003662|Alkylating Agents|alkylating agents|mesh-ancestor
111447815|NCT00003662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111447816|NCT00003662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111447817|NCT00003662|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111447818|NCT00003662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111447819|NCT00003662|Antifungal Agents|antifungal agents|mesh-ancestor
111447820|NCT00003662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111447821|NCT00003662|Dermatologic Agents|dermatologic agents|mesh-ancestor
111447822|NCT00003662|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111447823|NCT00003662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111447824|NCT00003662|Antiemetics|antiemetics|mesh-ancestor
111447825|NCT00003662|Autonomic Agents|autonomic agents|mesh-ancestor
111447826|NCT00003662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111447827|NCT00003662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111447828|NCT00003662|Glucocorticoids|glucocorticoids|mesh-ancestor
111447829|NCT00003662|Hormones|hormones|mesh-ancestor
111447830|NCT00003662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111447831|NCT00003662|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111447832|NCT00003662|Protective Agents|protective agents|mesh-ancestor
111447833|NCT00004154|Fenretinide|fenretinide|mesh-list
111447834|NCT00004154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111447835|NCT00004154|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
111447836|NCT00004154|Protective Agents|protective agents|mesh-ancestor
111447837|NCT00004154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111447838|NCT00002767|Interferons|interferons|mesh-list
111447839|NCT00002767|Interferon-alpha|interferon-alpha|mesh-list
111447840|NCT00002767|Detox adjuvant|detox adjuvant|mesh-list
111447841|NCT00002767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111447842|NCT00002767|Antiviral Agents|antiviral agents|mesh-ancestor
111447843|NCT00002767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111447844|NCT00002767|Immunologic Factors|immunologic factors|mesh-ancestor
111447845|NCT00002767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111447846|NCT00002767|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111447847|NCT00002773|Interferons|interferons|mesh-list
111447848|NCT00002773|Interferon-alpha|interferon-alpha|mesh-list
111447849|NCT00002773|Cyclophosphamide|cyclophosphamide|mesh-list
111447850|NCT00002773|Sargramostim|sargramostim|mesh-list
111447851|NCT00002773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111447852|NCT00002773|Immunologic Factors|immunologic factors|mesh-ancestor
111447853|NCT00002773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111447854|NCT00002773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111447855|NCT00002773|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111447856|NCT00002773|Alkylating Agents|alkylating agents|mesh-ancestor
111447857|NCT00002773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111447858|NCT00002773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111447859|NCT00002773|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111447860|NCT00002773|Antiviral Agents|antiviral agents|mesh-ancestor
111447861|NCT00002773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111447862|NCT00004160|Paclitaxel|paclitaxel|mesh-list
111447863|NCT00004160|Gemcitabine|gemcitabine|mesh-list
111447864|NCT00004160|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111447865|NCT00004160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111447866|NCT00004160|Tubulin Modulators|tubulin modulators|mesh-ancestor
111447867|NCT00004160|Antimitotic Agents|antimitotic agents|mesh-ancestor
111447868|NCT00004160|Mitosis Modulators|mitosis modulators|mesh-ancestor
111447869|NCT00004160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111447870|NCT00004160|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111447871|NCT00004160|Antimetabolites|antimetabolites|mesh-ancestor
111447872|NCT00003368|Irinotecan|irinotecan|mesh-list
111447873|NCT00003368|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111447874|NCT00003368|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111447875|NCT00003368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111447876|NCT00003368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111447877|NCT00003368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111447878|NCT00003674|Dalteparin|dalteparin|mesh-list
111447879|NCT00003674|Tinzaparin|tinzaparin|mesh-list
111447880|NCT00003674|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
111447881|NCT00003674|Anticoagulants|anticoagulants|mesh-ancestor
111447882|NCT00003674|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111447883|NCT00003674|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111447884|NCT00003674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111447885|NCT00003380|Doxorubicin|doxorubicin|mesh-list
111447886|NCT00003380|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111447887|NCT00003380|Etoposide|etoposide|mesh-list
111447888|NCT00003380|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111447889|NCT00003380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111447890|NCT00003380|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111447891|NCT00003380|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111447892|NCT00003380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111447893|NCT00003380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111447894|NCT00003380|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111447895|NCT00002779|Fludarabine|fludarabine|mesh-list
111447896|NCT00002779|Fludarabine phosphate|fludarabine phosphate|mesh-list
111447897|NCT00002779|Octreotide|octreotide|mesh-list
111447898|NCT00002779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111447899|NCT00002779|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111447900|NCT00002779|Antimetabolites|antimetabolites|mesh-ancestor
111447901|NCT00002779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111447902|NCT00002779|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111447903|NCT00002779|Immunologic Factors|immunologic factors|mesh-ancestor
111447904|NCT00002779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111447905|NCT00002779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111447906|NCT00002779|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111447907|NCT00003680|Tamoxifen|tamoxifen|mesh-list
111447908|NCT00003680|Cyclophosphamide|cyclophosphamide|mesh-list
111447909|NCT00003680|Thiotepa|thiotepa|mesh-list
111447910|NCT00003680|Fluorouracil|fluorouracil|mesh-list
111447911|NCT00003680|Methotrexate|methotrexate|mesh-list
111447912|NCT00003680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111447913|NCT00003680|Immunologic Factors|immunologic factors|mesh-ancestor
111447914|NCT00003680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111447915|NCT00003680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111447916|NCT00003680|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111447917|NCT00003680|Alkylating Agents|alkylating agents|mesh-ancestor
111447918|NCT00003680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111447919|NCT00003680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111447920|NCT00003680|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111447921|NCT00003680|Antimetabolites|antimetabolites|mesh-ancestor
111447922|NCT00003680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111447923|NCT00003680|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111447924|NCT00003680|Abortifacient Agents|abortifacient agents|mesh-ancestor
111447925|NCT00003680|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111447926|NCT00003680|Dermatologic Agents|dermatologic agents|mesh-ancestor
111447927|NCT00003680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111447928|NCT00003680|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111447929|NCT00003680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111447930|NCT00003680|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111447931|NCT00003680|Hormone Antagonists|hormone antagonists|mesh-ancestor
111447932|NCT00003680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111447933|NCT00003680|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111447934|NCT00003680|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111447935|NCT00003680|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110903209|NCT05955885|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111447936|NCT00003680|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111447937|NCT00002785|Leucovorin|leucovorin|mesh-list
111447938|NCT00002785|Cobalt|cobalt|mesh-list
111447939|NCT00002785|Cytarabine|cytarabine|mesh-list
111447940|NCT00002785|Cyclosporine|cyclosporine|mesh-list
111447941|NCT00002785|Dexamethasone|dexamethasone|mesh-list
111447942|NCT00002785|Prednisone|prednisone|mesh-list
111447943|NCT00002785|Methylprednisolone|methylprednisolone|mesh-list
111447944|NCT00002785|Hydrocortisone|hydrocortisone|mesh-list
111447945|NCT00002785|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
111447946|NCT00002785|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
111447947|NCT00002785|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
111447948|NCT00002785|Cyclophosphamide|cyclophosphamide|mesh-list
111447949|NCT00002785|Methotrexate|methotrexate|mesh-list
111447950|NCT00002785|Etoposide|etoposide|mesh-list
111447951|NCT00002785|Vincristine|vincristine|mesh-list
111447952|NCT00002785|Daunorubicin|daunorubicin|mesh-list
111447953|NCT00002785|Asparaginase|asparaginase|mesh-list
111447954|NCT00002785|Mercaptopurine|mercaptopurine|mesh-list
111447955|NCT00002785|Pegaspargase|pegaspargase|mesh-list
111447956|NCT00002785|Cyclosporins|cyclosporins|mesh-list
111447957|NCT00002785|Levoleucovorin|levoleucovorin|mesh-list
111447958|NCT00002785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111447959|NCT00002785|Immunologic Factors|immunologic factors|mesh-ancestor
111447960|NCT00002785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111447961|NCT00002785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111447962|NCT00002785|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111447963|NCT00002785|Alkylating Agents|alkylating agents|mesh-ancestor
111447964|NCT00002785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111447965|NCT00002785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111447966|NCT00002785|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111447967|NCT00002785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111447968|NCT00002785|Antiemetics|antiemetics|mesh-ancestor
111447969|NCT00002785|Autonomic Agents|autonomic agents|mesh-ancestor
111447970|NCT00002785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111447971|NCT00002785|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111447972|NCT00002785|Glucocorticoids|glucocorticoids|mesh-ancestor
111447973|NCT00002785|Hormones|hormones|mesh-ancestor
111447974|NCT00002785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111447975|NCT00002785|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111447976|NCT00002785|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111447977|NCT00002785|Abortifacient Agents|abortifacient agents|mesh-ancestor
111447978|NCT00002785|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111447979|NCT00002785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111447980|NCT00002785|Antimetabolites|antimetabolites|mesh-ancestor
111447981|NCT00002785|Dermatologic Agents|dermatologic agents|mesh-ancestor
111447982|NCT00002785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111447983|NCT00002785|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111447984|NCT00002785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111447985|NCT00002785|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111447986|NCT00002785|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111447987|NCT00002785|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111447988|NCT00002785|Antiviral Agents|antiviral agents|mesh-ancestor
111447989|NCT00002785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111447990|NCT00002785|Antidotes|antidotes|mesh-ancestor
111447991|NCT00002785|Protective Agents|protective agents|mesh-ancestor
111447992|NCT00002785|Vitamin B Complex|vitamin b complex|mesh-ancestor
111447993|NCT00002785|Vitamins|vitamins|mesh-ancestor
111447994|NCT00002785|Micronutrients|micronutrients|mesh-ancestor
111447995|NCT00002785|Tubulin Modulators|tubulin modulators|mesh-ancestor
111447996|NCT00002785|Antimitotic Agents|antimitotic agents|mesh-ancestor
111447997|NCT00002785|Mitosis Modulators|mitosis modulators|mesh-ancestor
111447998|NCT00002785|Antifungal Agents|antifungal agents|mesh-ancestor
111447999|NCT00002785|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111448000|NCT00002785|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111448001|NCT00002785|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111448002|NCT00002785|Trace Elements|trace elements|mesh-ancestor
111448003|NCT00004184|Aluminum Hydroxide|aluminum hydroxide|mesh-list
111448004|NCT00004184|Antibodies|antibodies|mesh-list
111448005|NCT00004184|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111448006|NCT00004184|Sargramostim|sargramostim|mesh-list
111448007|NCT00004184|Aluminum sulfate|aluminum sulfate|mesh-list
111448008|NCT00004184|Immunologic Factors|immunologic factors|mesh-ancestor
111448009|NCT00004184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111448010|NCT00004184|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111448011|NCT00004184|Antacids|antacids|mesh-ancestor
111448012|NCT00004184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111448013|NCT00004184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111448014|NCT00003386|Paclitaxel|paclitaxel|mesh-list
111448015|NCT00003386|Cyclophosphamide|cyclophosphamide|mesh-list
111448016|NCT00003386|Carboplatin|carboplatin|mesh-list
111448017|NCT00003386|Vaccines|vaccines|mesh-list
111448018|NCT00003386|BCG Vaccine|bcg vaccine|mesh-list
111448019|NCT00003386|Immunologic Factors|immunologic factors|mesh-ancestor
111448020|NCT00003386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111448021|NCT00003386|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111448022|NCT00003386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111448023|NCT00003386|Tubulin Modulators|tubulin modulators|mesh-ancestor
111448024|NCT00003386|Antimitotic Agents|antimitotic agents|mesh-ancestor
111448025|NCT00003386|Mitosis Modulators|mitosis modulators|mesh-ancestor
111448026|NCT00003386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111448027|NCT00003386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111448028|NCT00003386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111448029|NCT00003386|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111448030|NCT00003386|Alkylating Agents|alkylating agents|mesh-ancestor
111448031|NCT00003386|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111448032|NCT00003386|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111448033|NCT00384566|Metoprolol|metoprolol|mesh-list
111448034|NCT00384566|Carvedilol|carvedilol|mesh-list
111448035|NCT00384566|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111448036|NCT00384566|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111448037|NCT00384566|Sympatholytics|sympatholytics|mesh-ancestor
111448038|NCT00384566|Autonomic Agents|autonomic agents|mesh-ancestor
111448039|NCT00384566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111448040|NCT00384566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111448041|NCT00384566|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
111448042|NCT00384566|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111448043|NCT00384566|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111448044|NCT00384566|Adrenergic Agents|adrenergic agents|mesh-ancestor
111448045|NCT00384566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110903634|NCT04901377|Dienogest|dienogest|mesh-list
111448046|NCT00384566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111448047|NCT00384566|Antioxidants|antioxidants|mesh-ancestor
111448048|NCT00384566|Protective Agents|protective agents|mesh-ancestor
111448049|NCT00384566|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111448050|NCT00384566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111448051|NCT00384566|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111448052|NCT00384566|Vasodilator Agents|vasodilator agents|mesh-ancestor
111448053|NCT00384566|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111448054|NCT00384566|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111448055|NCT00004832|Amifampridine|amifampridine|mesh-list
111448056|NCT00004832|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111448057|NCT00004832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111448058|NCT00004832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111448059|NCT00004832|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
111448060|NCT00004832|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111448061|NCT00004832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111448062|NCT00002791|Doxorubicin|doxorubicin|mesh-list
111448063|NCT00002791|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111448064|NCT00002791|Ifosfamide|ifosfamide|mesh-list
110903695|NCT04704999|Artemether|artemether|mesh-list
111448065|NCT00002791|Dacarbazine|dacarbazine|mesh-list
111448066|NCT00002791|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111448067|NCT00002791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111448068|NCT00002791|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111448069|NCT00002791|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111448070|NCT00002791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111448071|NCT00002791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111448072|NCT00002791|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111448073|NCT00002791|Alkylating Agents|alkylating agents|mesh-ancestor
111448074|NCT00004190|Gemcitabine|gemcitabine|mesh-list
111448075|NCT00004190|Oxaliplatin|oxaliplatin|mesh-list
111448076|NCT00004190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111448078|NCT00004190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110903774|NCT04596657|Vitamin D|vitamin d|mesh-list
111448079|NCT00004190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111448080|NCT00004196|Interferons|interferons|mesh-list
111448081|NCT00004196|Interferon-alpha|interferon-alpha|mesh-list
111448082|NCT00004196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111448083|NCT00004196|Antiviral Agents|antiviral agents|mesh-ancestor
111448084|NCT00004196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111448085|NCT00004196|Immunologic Factors|immunologic factors|mesh-ancestor
111448086|NCT00004196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111448087|NCT00004838|Succimer|succimer|mesh-list
111448088|NCT00004838|Antidotes|antidotes|mesh-ancestor
111448089|NCT00004838|Protective Agents|protective agents|mesh-ancestor
111448090|NCT00004838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111448091|NCT00004838|Chelating Agents|chelating agents|mesh-ancestor
111448092|NCT00004838|Sequestering Agents|sequestering agents|mesh-ancestor
111448093|NCT00004838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111448094|NCT00004202|Paclitaxel|paclitaxel|mesh-list
111448095|NCT00004202|Carboplatin|carboplatin|mesh-list
111448096|NCT00004202|Efaproxiral|efaproxiral|mesh-list
111448097|NCT00004202|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111448098|NCT00004202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111448099|NCT00004202|Tubulin Modulators|tubulin modulators|mesh-ancestor
111448100|NCT00004202|Antimitotic Agents|antimitotic agents|mesh-ancestor
111448101|NCT00004202|Mitosis Modulators|mitosis modulators|mesh-ancestor
111448102|NCT00004202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111448103|NCT00004202|Antisickling Agents|antisickling agents|mesh-ancestor
111448104|NCT00003686|Pilocarpine|pilocarpine|mesh-list
111448105|NCT00003686|Miotics|miotics|mesh-ancestor
111448106|NCT00003686|Autonomic Agents|autonomic agents|mesh-ancestor
111448107|NCT00003686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111448108|NCT00003686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111448109|NCT00003686|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
111448110|NCT00003686|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111448111|NCT00003686|Cholinergic Agents|cholinergic agents|mesh-ancestor
111448112|NCT00003686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111448113|NCT00003686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111448114|NCT05495035|Dexamethasone|dexamethasone|mesh-list
111448115|NCT05495035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111448116|NCT05495035|Antiemetics|antiemetics|mesh-ancestor
111448117|NCT05495035|Autonomic Agents|autonomic agents|mesh-ancestor
111448118|NCT05495035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111448119|NCT05495035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111448120|NCT05495035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111448121|NCT05495035|Glucocorticoids|glucocorticoids|mesh-ancestor
111448122|NCT05495035|Hormones|hormones|mesh-ancestor
111448123|NCT05495035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111448124|NCT05495035|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111448125|NCT05495035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111448126|NCT00004856|Trastuzumab|trastuzumab|mesh-list
111448127|NCT00004856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111448128|NCT00004856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111448129|NCT00003698|Fosbretabulin|fosbretabulin|mesh-list
111448130|NCT00003698|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111448131|NCT00003698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111448132|NCT00004862|Cytarabine|cytarabine|mesh-list
111448133|NCT00004862|Fludarabine|fludarabine|mesh-list
111448134|NCT00004862|Fludarabine phosphate|fludarabine phosphate|mesh-list
111448135|NCT00004862|Oblimersen|oblimersen|mesh-list
111448136|NCT00004862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111448137|NCT00004862|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111448138|NCT00004862|Antimetabolites|antimetabolites|mesh-ancestor
111448139|NCT00004862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111448140|NCT00004862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111448141|NCT00004862|Immunologic Factors|immunologic factors|mesh-ancestor
111448142|NCT00004862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111448143|NCT00004862|Antiviral Agents|antiviral agents|mesh-ancestor
111448144|NCT00004862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111448145|NCT00004220|Gemcitabine|gemcitabine|mesh-list
111448146|NCT00004220|Oxaliplatin|oxaliplatin|mesh-list
111448147|NCT00004220|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111448148|NCT00004220|Antimetabolites|antimetabolites|mesh-ancestor
111448149|NCT00004220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111448150|NCT00004220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111448151|NCT00003704|Capecitabine|capecitabine|mesh-list
111448152|NCT00003704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111448153|NCT00003704|Antimetabolites|antimetabolites|mesh-ancestor
111448154|NCT00003704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111448155|NCT00003704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111448156|NCT00004868|Semaxinib|semaxinib|mesh-list
111448157|NCT00004868|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111448158|NCT00004868|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111448159|NCT00004868|Growth Substances|growth substances|mesh-ancestor
111448160|NCT00004868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111448161|NCT00004868|Growth Inhibitors|growth inhibitors|mesh-ancestor
111448162|NCT00004868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111448163|NCT00004868|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110904133|NCT02974621|Olaparib|olaparib|mesh-list
111448164|NCT00004868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111448165|NCT00004868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111448166|NCT00003710|Irinotecan|irinotecan|mesh-list
111448167|NCT00003710|Mitomycins|mitomycins|mesh-list
111448168|NCT00003710|Mitomycin|mitomycin|mesh-list
111448169|NCT00003710|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111448170|NCT00003710|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111448171|NCT00003710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111448172|NCT00003710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111448173|NCT00003710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111448174|NCT00003710|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111448175|NCT00003710|Alkylating Agents|alkylating agents|mesh-ancestor
111448176|NCT00003710|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111448177|NCT00004232|Cyclosporine|cyclosporine|mesh-list
111448178|NCT00004232|Prednisone|prednisone|mesh-list
111448179|NCT00004232|Methylprednisolone|methylprednisolone|mesh-list
111448180|NCT00004232|Cyclosporins|cyclosporins|mesh-list
111448181|NCT00004232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111448182|NCT00004232|Glucocorticoids|glucocorticoids|mesh-ancestor
111448183|NCT00004232|Hormones|hormones|mesh-ancestor
111448184|NCT00004232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111448185|NCT00004232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111448186|NCT00004232|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111448187|NCT00004232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111448188|NCT00004232|Immunologic Factors|immunologic factors|mesh-ancestor
111448189|NCT00004232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111448190|NCT00004232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111448191|NCT00004232|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111448192|NCT00004232|Antifungal Agents|antifungal agents|mesh-ancestor
111448193|NCT00004232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111448194|NCT00004232|Dermatologic Agents|dermatologic agents|mesh-ancestor
111448195|NCT00004232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111448196|NCT00004232|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111448197|NCT00004232|Antiemetics|antiemetics|mesh-ancestor
111448198|NCT00004232|Autonomic Agents|autonomic agents|mesh-ancestor
111448199|NCT00004232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111448200|NCT00004232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111448201|NCT00004232|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111448202|NCT00004232|Protective Agents|protective agents|mesh-ancestor
111448203|NCT00004874|Iodine|iodine|mesh-list
111448204|NCT00004874|Tositumomab I-131|tositumomab i-131|mesh-list
111448205|NCT00004874|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111448206|NCT00004874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111448207|NCT00004874|Trace Elements|trace elements|mesh-ancestor
111448208|NCT00004874|Micronutrients|micronutrients|mesh-ancestor
111448209|NCT00004874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111448210|NCT00004874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111448211|NCT00004244|Interferons|interferons|mesh-list
111448212|NCT00004244|Interferon-alpha|interferon-alpha|mesh-list
111448213|NCT00004244|Interleukin-12|interleukin-12|mesh-list
111448214|NCT00004244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110904376|NCT02146976|Propofol|propofol|mesh-list
111448215|NCT00004244|Antiviral Agents|antiviral agents|mesh-ancestor
111448216|NCT00004244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111448217|NCT00004244|Immunologic Factors|immunologic factors|mesh-ancestor
111448218|NCT00004244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111448219|NCT00004244|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111448220|NCT00004244|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111448221|NCT00004244|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111448222|NCT00004244|Growth Substances|growth substances|mesh-ancestor
111448223|NCT00004244|Growth Inhibitors|growth inhibitors|mesh-ancestor
111448224|NCT00004880|Vaccines|vaccines|mesh-list
111448225|NCT00004880|Immunologic Factors|immunologic factors|mesh-ancestor
111448226|NCT00004880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111172442|NCT01918033|Histamine Agents|histamine agents|mesh-ancestor
111448227|NCT00004250|Dactinomycin|dactinomycin|mesh-list
111448228|NCT00004250|Melphalan|melphalan|mesh-list
110904429|NCT01568411|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111448229|NCT00004250|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111448230|NCT00004250|Alkylating Agents|alkylating agents|mesh-ancestor
111448231|NCT00004250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111448232|NCT00004250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111448233|NCT00004250|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111448234|NCT00004250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111448235|NCT00004250|Immunologic Factors|immunologic factors|mesh-ancestor
111448236|NCT00004250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111448237|NCT00004250|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111448238|NCT00004250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111448239|NCT00004250|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111448240|NCT00004250|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111448241|NCT00004250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110904488|NCT01383395|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
111448242|NCT00004250|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111448243|NCT00003728|Leucovorin|leucovorin|mesh-list
111448244|NCT00003728|Cytarabine|cytarabine|mesh-list
111448245|NCT00003728|Dexamethasone|dexamethasone|mesh-list
111448246|NCT00003728|Methylprednisolone|methylprednisolone|mesh-list
111448247|NCT00003728|Prednisolone|prednisolone|mesh-list
111448248|NCT00003728|Hydrocortisone|hydrocortisone|mesh-list
111448249|NCT00003728|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
111448250|NCT00003728|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
111448251|NCT00003728|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
111448252|NCT00003728|Cyclophosphamide|cyclophosphamide|mesh-list
111448253|NCT00003728|Doxorubicin|doxorubicin|mesh-list
111448254|NCT00003728|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111448255|NCT00003728|Methotrexate|methotrexate|mesh-list
111448256|NCT00003728|Etoposide|etoposide|mesh-list
111448257|NCT00003728|Vincristine|vincristine|mesh-list
111448258|NCT00003728|Daunorubicin|daunorubicin|mesh-list
111448259|NCT00003728|Asparaginase|asparaginase|mesh-list
111448260|NCT00003728|Mitoxantrone|mitoxantrone|mesh-list
111448261|NCT00003728|Mercaptopurine|mercaptopurine|mesh-list
111448262|NCT00003728|Thioguanine|thioguanine|mesh-list
111448263|NCT00003728|Vindesine|vindesine|mesh-list
111448264|NCT00003728|Levoleucovorin|levoleucovorin|mesh-list
111448265|NCT00003728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111448266|NCT00003728|Immunologic Factors|immunologic factors|mesh-ancestor
111448267|NCT00003728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111448268|NCT00003728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111448269|NCT00003728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111448270|NCT00003728|Alkylating Agents|alkylating agents|mesh-ancestor
111448271|NCT00003728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111448272|NCT00003728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111448273|NCT00003728|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111448274|NCT00003728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111448275|NCT00003728|Antiemetics|antiemetics|mesh-ancestor
111448276|NCT00003728|Autonomic Agents|autonomic agents|mesh-ancestor
111448277|NCT00003728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111448278|NCT00003728|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111448279|NCT00003728|Glucocorticoids|glucocorticoids|mesh-ancestor
111448280|NCT00003728|Hormones|hormones|mesh-ancestor
111448281|NCT00003728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111448282|NCT00003728|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111448283|NCT00003728|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111448284|NCT00003728|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111448285|NCT00003728|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111448286|NCT00003728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111448287|NCT00003728|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111448288|NCT00003728|Abortifacient Agents|abortifacient agents|mesh-ancestor
111448289|NCT00003728|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111448290|NCT00003728|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111448291|NCT00003728|Antimetabolites|antimetabolites|mesh-ancestor
111448292|NCT00003728|Dermatologic Agents|dermatologic agents|mesh-ancestor
111448293|NCT00003728|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111448294|NCT00003728|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111448295|NCT00003728|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111448296|NCT00003728|Antiviral Agents|antiviral agents|mesh-ancestor
111448297|NCT00003728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111448298|NCT00003728|Antidotes|antidotes|mesh-ancestor
111448299|NCT00003728|Protective Agents|protective agents|mesh-ancestor
111448300|NCT00003728|Vitamin B Complex|vitamin b complex|mesh-ancestor
111448301|NCT00003728|Vitamins|vitamins|mesh-ancestor
111448302|NCT00003728|Micronutrients|micronutrients|mesh-ancestor
111448303|NCT00003728|Tubulin Modulators|tubulin modulators|mesh-ancestor
111172519|NCT02092961|Adalimumab|adalimumab|mesh-list
111448304|NCT00003728|Antimitotic Agents|antimitotic agents|mesh-ancestor
111448305|NCT00003728|Mitosis Modulators|mitosis modulators|mesh-ancestor
111448306|NCT00003728|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111448307|NCT00003728|Analgesics|analgesics|mesh-ancestor
111448308|NCT00003728|Sensory System Agents|sensory system agents|mesh-ancestor
111448309|NCT00004886|Docetaxel|docetaxel|mesh-list
111448310|NCT00004886|Dofequidar|dofequidar|mesh-list
111448311|NCT00004886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111448312|NCT00004886|Tubulin Modulators|tubulin modulators|mesh-ancestor
111448313|NCT00004886|Antimitotic Agents|antimitotic agents|mesh-ancestor
111448314|NCT00004886|Mitosis Modulators|mitosis modulators|mesh-ancestor
110904794|NCT01304511|Ganirelix|ganirelix|mesh-list
111448315|NCT00004886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111448316|NCT00003734|Triptorelin Pamoate|triptorelin pamoate|mesh-list
111448317|NCT00003734|Flutamide|flutamide|mesh-list
111448318|NCT00003734|Luteolytic Agents|luteolytic agents|mesh-ancestor
111448319|NCT00003734|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111448320|NCT00003734|Contraceptive Agents|contraceptive agents|mesh-ancestor
111448321|NCT00003734|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111448322|NCT00003734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110904858|NCT04833023|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111448323|NCT00003734|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111448324|NCT00003734|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111448325|NCT00003734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111448326|NCT00003734|Androgen Antagonists|androgen antagonists|mesh-ancestor
111448327|NCT00003734|Hormone Antagonists|hormone antagonists|mesh-ancestor
111448328|NCT00003734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111448329|NCT00003740|Trastuzumab|trastuzumab|mesh-list
111448330|NCT00003740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111448331|NCT00003740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111448332|NCT05477875|Acetaminophen|acetaminophen|mesh-list
111448333|NCT05477875|Dronabinol|dronabinol|mesh-list
111448334|NCT05477875|Codeine|codeine|mesh-list
111448335|NCT05477875|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111448336|NCT05477875|Analgesics|analgesics|mesh-ancestor
111448337|NCT05477875|Sensory System Agents|sensory system agents|mesh-ancestor
111448338|NCT05477875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111448339|NCT05477875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111448340|NCT05477875|Antipyretics|antipyretics|mesh-ancestor
111448341|NCT05477875|Hallucinogens|hallucinogens|mesh-ancestor
111448342|NCT05477875|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111448343|NCT05477875|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
111448344|NCT05477875|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
111448345|NCT05477875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111448346|NCT05477875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111448347|NCT05477875|Hormones|hormones|mesh-ancestor
111448348|NCT05477875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111448349|NCT05477875|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111448350|NCT05477875|Narcotics|narcotics|mesh-ancestor
111448351|NCT05477875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111448352|NCT05477875|Antitussive Agents|antitussive agents|mesh-ancestor
111448353|NCT05477875|Respiratory System Agents|respiratory system agents|mesh-ancestor
111448354|NCT00004256|Sargramostim|sargramostim|mesh-list
111448355|NCT00004256|Immunologic Factors|immunologic factors|mesh-ancestor
111448356|NCT00004256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111448357|NCT00004262|Motexafin gadolinium|motexafin gadolinium|mesh-list
111448358|NCT00004262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111448359|NCT00004262|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111448360|NCT00004262|Dermatologic Agents|dermatologic agents|mesh-ancestor
111448361|NCT00004892|Carmustine|carmustine|mesh-list
111448362|NCT00004892|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
111448363|NCT00004892|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111448364|NCT00004892|Alkylating Agents|alkylating agents|mesh-ancestor
111448365|NCT00004892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111448366|NCT00004892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111448367|NCT00004892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111448368|NCT00004268|Midodrine|midodrine|mesh-list
111448369|NCT00004268|Sympathomimetics|sympathomimetics|mesh-ancestor
111448370|NCT00004268|Autonomic Agents|autonomic agents|mesh-ancestor
111448371|NCT00004268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111448372|NCT00004268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111448373|NCT00004268|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111448374|NCT00004268|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111448375|NCT00004268|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111448376|NCT00004268|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111448377|NCT00004268|Adrenergic Agents|adrenergic agents|mesh-ancestor
111448378|NCT00004268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111448379|NCT00004268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111448380|NCT00004274|Estrogens|estrogens|mesh-list
111448381|NCT00004274|Hormones|hormones|mesh-ancestor
111448382|NCT00004274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111448383|NCT00004274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111448384|NCT00004904|Methylprednisolone|methylprednisolone|mesh-list
111448385|NCT00004904|Cyclophosphamide|cyclophosphamide|mesh-list
111448386|NCT00004904|Etoposide|etoposide|mesh-list
111448387|NCT00004904|Cladribine|cladribine|mesh-list
111448388|NCT00004904|Tacrolimus|tacrolimus|mesh-list
111448389|NCT00004904|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110905100|NCT04497987|Bamlanivimab|bamlanivimab|mesh-list
111448390|NCT00004904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111448391|NCT00004904|Immunologic Factors|immunologic factors|mesh-ancestor
111448392|NCT00004904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111448393|NCT00004904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111448394|NCT00004904|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111448395|NCT00004904|Alkylating Agents|alkylating agents|mesh-ancestor
111448396|NCT00004904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111448397|NCT00004904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111448398|NCT00004904|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111448399|NCT00004904|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111448400|NCT00004904|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111448401|NCT00004904|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111448402|NCT00004904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111448403|NCT00004904|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111448404|NCT00004904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111448405|NCT00004904|Antiemetics|antiemetics|mesh-ancestor
111448406|NCT00004904|Autonomic Agents|autonomic agents|mesh-ancestor
111448407|NCT00004904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111448408|NCT00004904|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111448409|NCT00004904|Glucocorticoids|glucocorticoids|mesh-ancestor
111448410|NCT00004904|Hormones|hormones|mesh-ancestor
111448411|NCT00004904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111448412|NCT00004904|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111448413|NCT00004904|Protective Agents|protective agents|mesh-ancestor
111448414|NCT00004286|Immunoglobulins|immunoglobulins|mesh-list
111448415|NCT00004286|Antibodies|antibodies|mesh-list
111448416|NCT00004286|gamma-Globulins|gamma-globulins|mesh-list
111448417|NCT00004286|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111448418|NCT00004286|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
111448419|NCT00004286|Immunologic Factors|immunologic factors|mesh-ancestor
111448420|NCT00004286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111448421|NCT00003746|Cladribine|cladribine|mesh-list
111448422|NCT00003746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111448423|NCT00003746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111448424|NCT00003746|Immunologic Factors|immunologic factors|mesh-ancestor
111448425|NCT00003746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111448426|NCT00003752|Bexarotene|bexarotene|mesh-list
111448427|NCT00003752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111448428|NCT00003758|Cytarabine|cytarabine|mesh-list
111448429|NCT00003758|Idarubicin|idarubicin|mesh-list
111448430|NCT00003758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111448431|NCT00003758|Antimetabolites|antimetabolites|mesh-ancestor
111448432|NCT00003758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111448433|NCT00003758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111448434|NCT00003758|Antiviral Agents|antiviral agents|mesh-ancestor
111448435|NCT00003758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111448436|NCT00003758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111448437|NCT00003758|Immunologic Factors|immunologic factors|mesh-ancestor
111448438|NCT00003758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111448439|NCT00003758|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111448440|NCT00003758|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111448441|NCT00003758|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111448442|NCT00003758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111448443|NCT00004310|Clomipramine|clomipramine|mesh-list
111448444|NCT00004310|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
111448445|NCT00004310|Antidepressive Agents|antidepressive agents|mesh-ancestor
111448446|NCT00004310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111448447|NCT00004310|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111448448|NCT00004310|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111448449|NCT00004310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111448450|NCT00004310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111448451|NCT00004310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111448452|NCT00004310|Serotonin Agents|serotonin agents|mesh-ancestor
110905409|NCT02154776|Letrozole|letrozole|mesh-list
111448453|NCT00004310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111448454|NCT00004922|Irinotecan|irinotecan|mesh-list
111448455|NCT00004922|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111448456|NCT00004922|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111448457|NCT00004922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111448458|NCT00004922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111448459|NCT00004922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111448461|NCT00004316|Antipruritics|antipruritics|mesh-ancestor
111448462|NCT00004316|Dermatologic Agents|dermatologic agents|mesh-ancestor
111448463|NCT00004316|Sensory System Agents|sensory system agents|mesh-ancestor
110905468|NCT02160236|Tenoxicam|tenoxicam|mesh-list
111448464|NCT00004316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111448465|NCT00004316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111448466|NCT00004928|Zoledronic Acid|zoledronic acid|mesh-list
111448467|NCT00004928|Calcitriol|calcitriol|mesh-list
111448468|NCT00004928|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111448469|NCT00004928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111448470|NCT00004928|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111448471|NCT00004928|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
111448472|NCT00004928|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111448473|NCT00004928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111448474|NCT00004928|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111448475|NCT00004928|Vitamins|vitamins|mesh-ancestor
111448476|NCT00004928|Micronutrients|micronutrients|mesh-ancestor
111448477|NCT00004328|Enalapril|enalapril|mesh-list
111448478|NCT00004328|Polystyrene sulfonic acid|polystyrene sulfonic acid|mesh-list
111448479|NCT00004328|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
111448480|NCT00004328|Protease Inhibitors|protease inhibitors|mesh-ancestor
111448481|NCT00004328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111448482|NCT00004328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111448483|NCT00004328|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111448484|NCT00004328|Chelating Agents|chelating agents|mesh-ancestor
111448485|NCT00004328|Sequestering Agents|sequestering agents|mesh-ancestor
111448486|NCT00004934|Paclitaxel|paclitaxel|mesh-list
111448487|NCT00004934|Carboplatin|carboplatin|mesh-list
111448488|NCT00004934|Epirubicin|epirubicin|mesh-list
111448489|NCT00004934|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111448490|NCT00004934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111448491|NCT00004934|Tubulin Modulators|tubulin modulators|mesh-ancestor
111448492|NCT00004934|Antimitotic Agents|antimitotic agents|mesh-ancestor
111448493|NCT00004934|Mitosis Modulators|mitosis modulators|mesh-ancestor
111448494|NCT00004934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111448495|NCT00004934|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111448496|NCT00004934|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111448497|NCT00004934|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111448498|NCT00004934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111448499|NCT00003776|Leucovorin|leucovorin|mesh-list
111448500|NCT00003776|Trimetrexate|trimetrexate|mesh-list
111448501|NCT00003776|Doxorubicin|doxorubicin|mesh-list
111448502|NCT00003776|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111448503|NCT00003776|Methotrexate|methotrexate|mesh-list
111448504|NCT00003776|Ifosfamide|ifosfamide|mesh-list
111448505|NCT00003776|Calcium|calcium|mesh-list
111448506|NCT00003776|Levoleucovorin|levoleucovorin|mesh-list
111448507|NCT00003776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111448508|NCT00003776|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111448509|NCT00003776|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111448510|NCT00003776|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111448511|NCT00003776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111448512|NCT00003776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111448513|NCT00003776|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111448514|NCT00003776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111448515|NCT00003776|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111448516|NCT00003776|Abortifacient Agents|abortifacient agents|mesh-ancestor
111448517|NCT00003776|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111448518|NCT00003776|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111448519|NCT00003776|Antimetabolites|antimetabolites|mesh-ancestor
111448520|NCT00003776|Dermatologic Agents|dermatologic agents|mesh-ancestor
111448521|NCT00003776|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111448522|NCT00003776|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111448523|NCT00003776|Immunologic Factors|immunologic factors|mesh-ancestor
110905715|NCT02166632|Bupivacaine|bupivacaine|mesh-list
111448524|NCT00003776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111448525|NCT00003776|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111448526|NCT00003776|Antidotes|antidotes|mesh-ancestor
111448527|NCT00003776|Protective Agents|protective agents|mesh-ancestor
111448528|NCT00003776|Vitamin B Complex|vitamin b complex|mesh-ancestor
111448529|NCT00003776|Vitamins|vitamins|mesh-ancestor
111448530|NCT00003776|Micronutrients|micronutrients|mesh-ancestor
111448531|NCT00003776|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111448532|NCT00003776|Alkylating Agents|alkylating agents|mesh-ancestor
111448533|NCT00003776|Antifungal Agents|antifungal agents|mesh-ancestor
111448534|NCT00003776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111448535|NCT00003788|Carmustine|carmustine|mesh-list
111448536|NCT00003788|Lomustine|lomustine|mesh-list
110905779|NCT03704181|Colchicine|colchicine|mesh-list
111448537|NCT00003788|Procarbazine|procarbazine|mesh-list
111448538|NCT00003788|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
111448539|NCT00003788|Trioxsalen|trioxsalen|mesh-list
111448540|NCT00003788|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111448541|NCT00003788|Alkylating Agents|alkylating agents|mesh-ancestor
111448542|NCT00003788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111448543|NCT00003788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111448544|NCT00003788|Dermatologic Agents|dermatologic agents|mesh-ancestor
111448545|NCT00003788|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111448546|NCT00004340|Calcitriol|calcitriol|mesh-list
111448547|NCT00004340|Hormones|hormones|mesh-list
111448548|NCT00004340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111448549|NCT00004340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111448550|NCT00004340|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111448551|NCT00004340|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
111448552|NCT00004340|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111448553|NCT00004340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111448554|NCT00004340|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111448555|NCT00004340|Vitamins|vitamins|mesh-ancestor
111448556|NCT00004340|Micronutrients|micronutrients|mesh-ancestor
111448557|NCT00004340|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111448558|NCT00004346|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
111448559|NCT00004346|Lovastatin|lovastatin|mesh-list
111448560|NCT00004346|L 647318|l 647318|mesh-list
111448561|NCT00004346|Dihydromevinolin|dihydromevinolin|mesh-list
111448562|NCT00004346|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111448563|NCT00004346|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111448564|NCT00004346|Antimetabolites|antimetabolites|mesh-ancestor
111448565|NCT00004346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111448566|NCT00004346|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111448567|NCT00004346|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111448568|NCT00004346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111448569|NCT00004346|Cathartics|cathartics|mesh-ancestor
111448570|NCT00004346|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111448571|NCT00384800|Thalidomide|thalidomide|mesh-list
111448572|NCT00384800|Tegafur|tegafur|mesh-list
111448573|NCT00384800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111448574|NCT00384800|Immunologic Factors|immunologic factors|mesh-ancestor
111448575|NCT00384800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111448576|NCT00384800|Leprostatic Agents|leprostatic agents|mesh-ancestor
111448577|NCT00384800|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111448578|NCT00384800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111448579|NCT00384800|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111448580|NCT00384800|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111448581|NCT00384800|Growth Substances|growth substances|mesh-ancestor
111448582|NCT00384800|Growth Inhibitors|growth inhibitors|mesh-ancestor
111448583|NCT00384800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111448584|NCT00384800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111448585|NCT00384800|Antimetabolites|antimetabolites|mesh-ancestor
111448586|NCT00384800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111448587|NCT00384878|Leucovorin|leucovorin|mesh-list
111448588|NCT00384878|Fluorouracil|fluorouracil|mesh-list
111448589|NCT00384878|Cetuximab|cetuximab|mesh-list
111448590|NCT00384878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111448591|NCT00384878|Antimetabolites|antimetabolites|mesh-ancestor
111448592|NCT00384878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111448593|NCT00384878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111448594|NCT00384878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111448595|NCT00384878|Immunologic Factors|immunologic factors|mesh-ancestor
111448596|NCT00384878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111448597|NCT00384878|Antidotes|antidotes|mesh-ancestor
111448598|NCT00384878|Protective Agents|protective agents|mesh-ancestor
111448599|NCT00384878|Vitamin B Complex|vitamin b complex|mesh-ancestor
111448600|NCT00384878|Vitamins|vitamins|mesh-ancestor
110906014|NCT02162264|Donepezil|donepezil|mesh-list
111448601|NCT00384878|Micronutrients|micronutrients|mesh-ancestor
111448602|NCT00384878|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111448603|NCT02972762|Propofol|propofol|mesh-list
111448604|NCT02972762|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111448605|NCT02972762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111448606|NCT02972762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111448607|NCT02972762|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111448608|NCT02972762|Anesthetics, General|anesthetics, general|mesh-ancestor
111448609|NCT02972762|Anesthetics|anesthetics|mesh-ancestor
111448610|NCT00004358|Calcitonin|calcitonin|mesh-list
111448611|NCT00004358|Salmon calcitonin|salmon calcitonin|mesh-list
111448612|NCT00004358|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
111448613|NCT00004358|Katacalcin|katacalcin|mesh-list
111448614|NCT00004358|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111448615|NCT00004358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111448616|NCT00004358|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111448617|NCT00004358|Vasodilator Agents|vasodilator agents|mesh-ancestor
111448618|NCT00004364|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
111448619|NCT00004364|Hemostatics|hemostatics|mesh-ancestor
111448620|NCT00004364|Coagulants|coagulants|mesh-ancestor
111448621|NCT00004364|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
111448622|NCT00004364|Natriuretic Agents|natriuretic agents|mesh-ancestor
111448623|NCT00004364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111448624|NCT00005000|Lamivudine|lamivudine|mesh-list
111448625|NCT00005000|Zidovudine|zidovudine|mesh-list
111448626|NCT00005000|Efavirenz|efavirenz|mesh-list
111448627|NCT00005000|Stavudine|stavudine|mesh-list
111448628|NCT00005000|Didanosine|didanosine|mesh-list
111448629|NCT00005000|Nelfinavir|nelfinavir|mesh-list
111448630|NCT00005000|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
111448631|NCT00005000|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111448632|NCT00005000|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111448633|NCT00005000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111448634|NCT00005000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111448635|NCT00005000|Antiviral Agents|antiviral agents|mesh-ancestor
111448636|NCT00005000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111448637|NCT00005000|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111448638|NCT00005000|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111448639|NCT00005000|Antimetabolites|antimetabolites|mesh-ancestor
111448640|NCT00005000|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111448641|NCT00005000|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111448642|NCT00005000|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111448643|NCT00005000|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111448644|NCT00005000|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111448645|NCT00005000|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111448646|NCT00005000|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111448647|NCT00005000|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111448648|NCT00005000|Protease Inhibitors|protease inhibitors|mesh-ancestor
111448649|NCT00005000|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111448650|NCT00005000|Immunologic Factors|immunologic factors|mesh-ancestor
111448651|NCT00005000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111448652|NCT00004376|Guanfacine|guanfacine|mesh-list
111448653|NCT00004376|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111448654|NCT00004376|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111448655|NCT00004376|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110906287|NCT03612713|Oxycodone|oxycodone|mesh-list
111448656|NCT00004376|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111448657|NCT00004376|Adrenergic Agents|adrenergic agents|mesh-ancestor
111448658|NCT00004376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111448659|NCT00004376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111448660|NCT00004376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111448661|NCT00005006|Alendronate|alendronate|mesh-list
111448662|NCT00005006|Teriparatide|teriparatide|mesh-list
111448663|NCT00005006|Hormones|hormones|mesh-list
111448664|NCT00005006|Parathyroid Hormone|parathyroid hormone|mesh-list
111448665|NCT00005006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111448666|NCT00005006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111448667|NCT00005006|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111448668|NCT00005006|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111448669|NCT00004382|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
111448670|NCT00004382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111448671|NCT00004382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111448672|NCT00005012|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
111448673|NCT00005012|Antiviral Agents|antiviral agents|mesh-ancestor
111448674|NCT00005012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111448675|NCT00004400|Testosterone|testosterone|mesh-list
111448676|NCT00004400|Androgens|androgens|mesh-ancestor
111448677|NCT00004400|Hormones|hormones|mesh-ancestor
111448678|NCT00004400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111448679|NCT00004400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111448680|NCT00003812|Paclitaxel|paclitaxel|mesh-list
111448681|NCT00003812|Etoposide|etoposide|mesh-list
111448682|NCT00003812|Carboplatin|carboplatin|mesh-list
111448683|NCT00003812|Topotecan|topotecan|mesh-list
111448684|NCT00003812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111448685|NCT00003812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111448686|NCT00003812|Tubulin Modulators|tubulin modulators|mesh-ancestor
111448687|NCT00003812|Antimitotic Agents|antimitotic agents|mesh-ancestor
111448688|NCT00003812|Mitosis Modulators|mitosis modulators|mesh-ancestor
111448689|NCT00003812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111448690|NCT00003812|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111448691|NCT00003812|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111448692|NCT00003812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111448693|NCT00003812|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111448694|NCT00005018|Efavirenz|efavirenz|mesh-list
111448695|NCT00005018|Abacavir|abacavir|mesh-list
111448696|NCT00005018|Didanosine|didanosine|mesh-list
111448697|NCT00005018|Hydroxyurea|hydroxyurea|mesh-list
111448698|NCT00005018|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111448699|NCT00005018|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111448700|NCT00005018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111448701|NCT00005018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111448702|NCT00005018|Antiviral Agents|antiviral agents|mesh-ancestor
111448703|NCT00005018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111448704|NCT00005018|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111448705|NCT00005018|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110906505|NCT02171390|Testosterone|testosterone|mesh-list
111448706|NCT00005018|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111448707|NCT00005018|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111448708|NCT00005018|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111448709|NCT00005018|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111448710|NCT00005018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111448711|NCT00005018|Antisickling Agents|antisickling agents|mesh-ancestor
111448712|NCT00005018|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111448713|NCT00005018|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111448714|NCT00005018|Antimetabolites|antimetabolites|mesh-ancestor
111448715|NCT00003824|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111448716|NCT00003824|Ciprofloxacin|ciprofloxacin|mesh-list
111448717|NCT00003824|Cephalexin|cephalexin|mesh-list
111448718|NCT00003824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111448719|NCT00003824|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111448720|NCT00003824|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111448721|NCT00003824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111448722|NCT00003824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111448723|NCT00003824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111448724|NCT00003824|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111448725|NCT00003824|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111448726|NCT00004406|Hormones|hormones|mesh-list
111448727|NCT00004406|Parathyroid Hormone|parathyroid hormone|mesh-list
111448728|NCT00004406|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111448729|NCT00004406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111448730|NCT00004406|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111448731|NCT00005024|Cyclophosphamide|cyclophosphamide|mesh-list
111448732|NCT00005024|Carboplatin|carboplatin|mesh-list
111448733|NCT00005024|Doxorubicin|doxorubicin|mesh-list
110906697|NCT02255942|Zinc|zinc|mesh-list
111448734|NCT00005024|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111448735|NCT00005024|Granisetron|granisetron|mesh-list
111448736|NCT00005024|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111448737|NCT00005024|Immunologic Factors|immunologic factors|mesh-ancestor
111448738|NCT00005024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111448739|NCT00005024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111448740|NCT00005024|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111448741|NCT00005024|Alkylating Agents|alkylating agents|mesh-ancestor
111448742|NCT00005024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111448743|NCT00005024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111448744|NCT00005024|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111448745|NCT00005024|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111448746|NCT00005024|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111448747|NCT00005024|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111448748|NCT00005024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111448749|NCT00005024|Antiemetics|antiemetics|mesh-ancestor
111448750|NCT00005024|Autonomic Agents|autonomic agents|mesh-ancestor
111448751|NCT00005024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111448752|NCT00005024|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111448753|NCT00005024|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111448754|NCT00005024|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111448755|NCT00005024|Serotonin Agents|serotonin agents|mesh-ancestor
111448756|NCT00005024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111448757|NCT00005030|Lonafarnib|lonafarnib|mesh-list
111448758|NCT00005030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111448759|NCT00005030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111448760|NCT00004424|Fentanyl|fentanyl|mesh-list
111448761|NCT00004424|Midazolam|midazolam|mesh-list
111448762|NCT00004424|Propofol|propofol|mesh-list
111448763|NCT00004424|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111448764|NCT00004424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111448765|NCT00004424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111448766|NCT00004424|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111448767|NCT00004424|Anesthetics, General|anesthetics, general|mesh-ancestor
111448768|NCT00004424|Anesthetics|anesthetics|mesh-ancestor
111448769|NCT00004424|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111448770|NCT00004424|Narcotics|narcotics|mesh-ancestor
111448771|NCT00004424|Analgesics|analgesics|mesh-ancestor
111448772|NCT00004424|Sensory System Agents|sensory system agents|mesh-ancestor
111448773|NCT00004424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111448774|NCT00004424|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111448775|NCT00004424|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111448776|NCT00004424|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111448777|NCT00004424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111448778|NCT00004424|GABA Modulators|gaba modulators|mesh-ancestor
111448779|NCT00004424|GABA Agents|gaba agents|mesh-ancestor
111448780|NCT00004424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111448781|NCT00004424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111448782|NCT00004430|Prednisolone|prednisolone|mesh-list
111448783|NCT00004430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111448784|NCT00004430|Glucocorticoids|glucocorticoids|mesh-ancestor
111448785|NCT00004430|Hormones|hormones|mesh-ancestor
111448786|NCT00004430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111448787|NCT00004430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111448788|NCT00004430|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111448789|NCT00004430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111448790|NCT00003842|Interleukin-4|interleukin-4|mesh-list
111448791|NCT00003842|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111448792|NCT00003842|Immunologic Factors|immunologic factors|mesh-ancestor
111448793|NCT00003842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111448794|NCT00003842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111448795|NCT00003842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111448796|NCT00005036|Leucovorin|leucovorin|mesh-list
111448797|NCT00005036|Fluorouracil|fluorouracil|mesh-list
111448798|NCT00005036|Oxaliplatin|oxaliplatin|mesh-list
111448799|NCT00005036|Irinotecan|irinotecan|mesh-list
111448800|NCT00005036|Calcium|calcium|mesh-list
111448801|NCT00005036|Levoleucovorin|levoleucovorin|mesh-list
111448802|NCT00005036|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111448803|NCT00005036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111448804|NCT00005036|Antimetabolites|antimetabolites|mesh-ancestor
110907083|NCT02178644|Antimetabolites|antimetabolites|mesh-ancestor
111448805|NCT00005036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111448806|NCT00005036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111448807|NCT00005036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111448808|NCT00005036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111448809|NCT00005036|Immunologic Factors|immunologic factors|mesh-ancestor
111448810|NCT00005036|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111448811|NCT00005036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111448812|NCT00005036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111448813|NCT00005036|Antidotes|antidotes|mesh-ancestor
111448814|NCT00005036|Protective Agents|protective agents|mesh-ancestor
111448815|NCT00005036|Vitamin B Complex|vitamin b complex|mesh-ancestor
111448816|NCT00005036|Vitamins|vitamins|mesh-ancestor
111448817|NCT00005036|Micronutrients|micronutrients|mesh-ancestor
111448818|NCT00004436|Prednisone|prednisone|mesh-list
111448819|NCT00004436|Leuprolide|leuprolide|mesh-list
111448820|NCT00004436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111448821|NCT00004436|Glucocorticoids|glucocorticoids|mesh-ancestor
111448822|NCT00004436|Hormones|hormones|mesh-ancestor
111448823|NCT00004436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111448824|NCT00004436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111448825|NCT00004436|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111448826|NCT00004436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111448827|NCT00004436|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111448828|NCT00004436|Fertility Agents|fertility agents|mesh-ancestor
111448829|NCT00004436|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111448830|NCT00005042|Semaxinib|semaxinib|mesh-list
111448831|NCT00005042|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111448832|NCT00005042|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111448833|NCT00005042|Growth Substances|growth substances|mesh-ancestor
111448834|NCT00005042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111448835|NCT00005042|Growth Inhibitors|growth inhibitors|mesh-ancestor
111448836|NCT00005042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111448837|NCT00005042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111448838|NCT00005042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111448839|NCT00005042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111448840|NCT00004442|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
111448841|NCT00004442|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
110907268|NCT02179268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111448843|NCT00004442|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
111448844|NCT00004442|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111448845|NCT00004442|Cathartics|cathartics|mesh-ancestor
111448846|NCT05444569|Liraglutide|liraglutide|mesh-list
111448847|NCT05444569|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111448848|NCT05444569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111448849|NCT05444569|Incretins|incretins|mesh-ancestor
111448850|NCT05444569|Hormones|hormones|mesh-ancestor
111448851|NCT05444569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111448852|NCT00004448|Prednisone|prednisone|mesh-list
111448853|NCT00004448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111448854|NCT00004448|Glucocorticoids|glucocorticoids|mesh-ancestor
111448855|NCT00004448|Hormones|hormones|mesh-ancestor
111448856|NCT00004448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111448857|NCT00004448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111448858|NCT00004448|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111448859|NCT00004448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111448860|NCT00003860|Carboplatin|carboplatin|mesh-list
111448861|NCT00003860|Etoposide|etoposide|mesh-list
111448862|NCT00003860|Ifosfamide|ifosfamide|mesh-list
111448863|NCT00003860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111448864|NCT00003860|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111448865|NCT00003860|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111448866|NCT00003860|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111448867|NCT00003860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111448868|NCT00003860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111448869|NCT00003860|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111448870|NCT00003860|Alkylating Agents|alkylating agents|mesh-ancestor
111448871|NCT00005048|Paclitaxel|paclitaxel|mesh-list
111448872|NCT00005048|Estramustine|estramustine|mesh-list
111448873|NCT00005048|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111448874|NCT00005048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111448875|NCT00005048|Tubulin Modulators|tubulin modulators|mesh-ancestor
111448876|NCT00005048|Antimitotic Agents|antimitotic agents|mesh-ancestor
111448877|NCT00005048|Mitosis Modulators|mitosis modulators|mesh-ancestor
111448878|NCT00005048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111448879|NCT00005048|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110907458|NCT02183012|Ibuprofen|ibuprofen|mesh-list
111448880|NCT00005048|Alkylating Agents|alkylating agents|mesh-ancestor
111448881|NCT00005048|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111448882|NCT04756765|Talazoparib|talazoparib|mesh-list
111448883|NCT04756765|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111448884|NCT04756765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111448885|NCT04756765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111448886|NCT04756765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111448887|NCT00004466|Atorvastatin|atorvastatin|mesh-list
111448888|NCT00004466|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111448889|NCT00004466|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111448890|NCT00004466|Antimetabolites|antimetabolites|mesh-ancestor
111448891|NCT00004466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111448892|NCT00004466|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111448893|NCT00004466|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111448894|NCT00004466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111448895|NCT00005054|Temozolomide|temozolomide|mesh-list
111448896|NCT00005054|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111448897|NCT00005054|Alkylating Agents|alkylating agents|mesh-ancestor
111448898|NCT00005054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111448899|NCT00005054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111448900|NCT00004478|Droxidopa|droxidopa|mesh-list
111448901|NCT00004478|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111448902|NCT00004478|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111448903|NCT00003878|Carmustine|carmustine|mesh-list
111448904|NCT00003878|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111448905|NCT00003878|Alkylating Agents|alkylating agents|mesh-ancestor
111448906|NCT00003878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111448907|NCT00003878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111448908|NCT00005060|Docetaxel|docetaxel|mesh-list
110907573|NCT02183402|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111448909|NCT00005060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111448910|NCT00005060|Tubulin Modulators|tubulin modulators|mesh-ancestor
111448911|NCT00005060|Antimitotic Agents|antimitotic agents|mesh-ancestor
111448912|NCT00005060|Mitosis Modulators|mitosis modulators|mesh-ancestor
111448913|NCT00005060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111448914|NCT00003884|Zoledronic Acid|zoledronic acid|mesh-list
111448915|NCT00003884|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111448916|NCT00003884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111448917|NCT00005066|Carmustine|carmustine|mesh-list
111448918|NCT00005066|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
111448919|NCT00005066|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111448920|NCT00005066|Alkylating Agents|alkylating agents|mesh-ancestor
111448921|NCT00005066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111448922|NCT00005066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111448923|NCT00005066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111448924|NCT04711915|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
111448925|NCT04711915|Hallucinogens|hallucinogens|mesh-ancestor
111448926|NCT04711915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111448927|NCT04711915|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111448928|NCT04711915|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111448929|NCT04711915|Serotonin Agents|serotonin agents|mesh-ancestor
111448930|NCT04711915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111448931|NCT04711915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111448932|NCT04711915|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111448933|NCT00005072|Interleukin-2|interleukin-2|mesh-list
111448934|NCT00005072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111448935|NCT00005072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111448936|NCT00005072|Analgesics|analgesics|mesh-ancestor
111448937|NCT00005072|Sensory System Agents|sensory system agents|mesh-ancestor
111448938|NCT00005072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111448939|NCT00005072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111448940|NCT00004496|Hormones|hormones|mesh-list
111448941|NCT00004496|alpha-MSH|alpha-msh|mesh-list
111448942|NCT00004496|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
111448943|NCT00004496|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
111448944|NCT00004496|beta-Endorphin|beta-endorphin|mesh-list
111448945|NCT00004496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111448946|NCT00004496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111448947|NCT00004496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111448948|NCT00004496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111448949|NCT00003902|Capecitabine|capecitabine|mesh-list
111448950|NCT00003902|Vinorelbine|vinorelbine|mesh-list
111448951|NCT00003902|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111448952|NCT00003902|Antimetabolites|antimetabolites|mesh-ancestor
111448953|NCT00003902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111448954|NCT00003902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111448955|NCT00003902|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111448956|NCT00003902|Tubulin Modulators|tubulin modulators|mesh-ancestor
111448957|NCT00003902|Antimitotic Agents|antimitotic agents|mesh-ancestor
111448958|NCT00003902|Mitosis Modulators|mitosis modulators|mesh-ancestor
111448959|NCT00003908|Carboplatin|carboplatin|mesh-list
111448960|NCT00003908|Docetaxel|docetaxel|mesh-list
111448961|NCT00003908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111448962|NCT00003908|Tubulin Modulators|tubulin modulators|mesh-ancestor
111448963|NCT00003908|Antimitotic Agents|antimitotic agents|mesh-ancestor
111448964|NCT00003908|Mitosis Modulators|mitosis modulators|mesh-ancestor
111448965|NCT00003908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111448966|NCT00382837|Epratuzumab|epratuzumab|mesh-list
111448967|NCT00382837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111448968|NCT00382837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111448969|NCT00003914|Dolastatin 10|dolastatin 10|mesh-list
111448970|NCT00003914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111448971|NCT00003914|Tubulin Modulators|tubulin modulators|mesh-ancestor
111448972|NCT00003914|Antimitotic Agents|antimitotic agents|mesh-ancestor
111448973|NCT00003914|Mitosis Modulators|mitosis modulators|mesh-ancestor
111448974|NCT00003914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111448975|NCT00005078|Paclitaxel|paclitaxel|mesh-list
111448976|NCT00005078|Carboplatin|carboplatin|mesh-list
111448977|NCT00005078|Tirapazamine|tirapazamine|mesh-list
111448978|NCT00005078|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111448979|NCT00005078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111448980|NCT00005078|Tubulin Modulators|tubulin modulators|mesh-ancestor
111448981|NCT00005078|Antimitotic Agents|antimitotic agents|mesh-ancestor
111448982|NCT00005078|Mitosis Modulators|mitosis modulators|mesh-ancestor
111448983|NCT00005078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111448984|NCT04698031|Aspirin|aspirin|mesh-list
111448985|NCT04698031|Clopidogrel|clopidogrel|mesh-list
111448986|NCT04698031|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111448987|NCT04698031|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111448988|NCT04698031|Analgesics|analgesics|mesh-ancestor
111448989|NCT04698031|Sensory System Agents|sensory system agents|mesh-ancestor
111448990|NCT04698031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111448991|NCT04698031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111448992|NCT04698031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111448993|NCT04698031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111448994|NCT04698031|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111448995|NCT04698031|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110907879|NCT02186600|Vitamin D|vitamin d|mesh-list
111448996|NCT04698031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111448997|NCT04698031|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111448998|NCT04698031|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111448999|NCT04698031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111449000|NCT04698031|Antipyretics|antipyretics|mesh-ancestor
111449001|NCT04698031|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111449002|NCT04698031|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111449003|NCT04698031|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111449004|NCT04698031|Purinergic Agents|purinergic agents|mesh-ancestor
111449005|NCT04698031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111449006|NCT00003920|Cyclosporine|cyclosporine|mesh-list
111449007|NCT00003920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111449008|NCT00003920|Antibodies|antibodies|mesh-list
111449009|NCT00003920|Immunoglobulins|immunoglobulins|mesh-list
111449010|NCT00003920|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111449011|NCT00003920|Cyclosporins|cyclosporins|mesh-list
111449012|NCT00003920|Immunologic Factors|immunologic factors|mesh-ancestor
111449013|NCT00003920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111449014|NCT00003920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111449015|NCT00003920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111449016|NCT00003920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111449017|NCT00003920|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111449018|NCT00003920|Antifungal Agents|antifungal agents|mesh-ancestor
111449019|NCT00003920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111449020|NCT00003920|Dermatologic Agents|dermatologic agents|mesh-ancestor
111449021|NCT00003920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111449022|NCT00003920|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111449023|NCT00003926|Melphalan|melphalan|mesh-list
111449024|NCT00003926|Busulfan|busulfan|mesh-list
111449025|NCT00003926|Thiotepa|thiotepa|mesh-list
111449026|NCT00003926|Lenograstim|lenograstim|mesh-list
111449027|NCT00003926|Amifostine|amifostine|mesh-list
111449028|NCT00003926|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111449029|NCT00003926|Immunologic Factors|immunologic factors|mesh-ancestor
111449030|NCT00003926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111449031|NCT00003926|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111449032|NCT00003926|Alkylating Agents|alkylating agents|mesh-ancestor
111449033|NCT00003926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111449034|NCT00003926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111449035|NCT00003926|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111449036|NCT00003926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111449037|NCT00003926|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111449038|NCT00003926|Protective Agents|protective agents|mesh-ancestor
111449039|NCT05122819|Anesthetics|anesthetics|mesh-list
111449040|NCT05122819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111449041|NCT05122819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111449042|NCT00005090|Cyclophosphamide|cyclophosphamide|mesh-list
111449043|NCT00005090|Dacarbazine|dacarbazine|mesh-list
111449044|NCT00005090|Carmustine|carmustine|mesh-list
111449045|NCT00005090|Doxorubicin|doxorubicin|mesh-list
111449046|NCT00005090|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111449047|NCT00005090|Etoposide|etoposide|mesh-list
111449048|NCT00005090|Bleomycin|bleomycin|mesh-list
111449049|NCT00005090|Vinblastine|vinblastine|mesh-list
111449050|NCT00005090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111449051|NCT00005090|Immunologic Factors|immunologic factors|mesh-ancestor
111449052|NCT00005090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111449053|NCT00005090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111449054|NCT00005090|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111449055|NCT00005090|Alkylating Agents|alkylating agents|mesh-ancestor
111449056|NCT00005090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111449057|NCT00005090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111449058|NCT00005090|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111449059|NCT00005090|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111449060|NCT00005090|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111449061|NCT00005090|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111449062|NCT00005090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111449063|NCT00005090|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111449064|NCT00005090|Tubulin Modulators|tubulin modulators|mesh-ancestor
111449065|NCT00005090|Antimitotic Agents|antimitotic agents|mesh-ancestor
111449066|NCT00005090|Mitosis Modulators|mitosis modulators|mesh-ancestor
111449067|NCT00004580|Ritonavir|ritonavir|mesh-list
111449068|NCT00004580|Lopinavir|lopinavir|mesh-list
111449069|NCT00004580|Nevirapine|nevirapine|mesh-list
111449070|NCT00004580|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111449071|NCT00004580|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111449072|NCT00004580|Protease Inhibitors|protease inhibitors|mesh-ancestor
111449073|NCT00004580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111449074|NCT00004580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111449075|NCT00004580|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111449076|NCT00004580|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111449077|NCT00004580|Antiviral Agents|antiviral agents|mesh-ancestor
111449078|NCT00004580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111449079|NCT00004580|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111449080|NCT00004580|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111449081|NCT00004580|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111449082|NCT00004580|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111449083|NCT00004580|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111449084|NCT00004580|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111449085|NCT00005096|Docetaxel|docetaxel|mesh-list
111449086|NCT00005096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111449087|NCT00005096|Tubulin Modulators|tubulin modulators|mesh-ancestor
111449088|NCT00005096|Antimitotic Agents|antimitotic agents|mesh-ancestor
111449089|NCT00005096|Mitosis Modulators|mitosis modulators|mesh-ancestor
111449090|NCT00005096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111449091|NCT00004640|Chlorhexidine|chlorhexidine|mesh-list
111449092|NCT00004640|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111449093|NCT00004640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111449094|NCT00004640|Disinfectants|disinfectants|mesh-ancestor
111449095|NCT05104099|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
111449096|NCT05104099|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111449097|NCT05104099|Dermatologic Agents|dermatologic agents|mesh-ancestor
111449098|NCT00004646|Prednisone|prednisone|mesh-list
111449099|NCT00004646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111449100|NCT00004646|Glucocorticoids|glucocorticoids|mesh-ancestor
111449101|NCT00004646|Hormones|hormones|mesh-ancestor
111449102|NCT00004646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111449103|NCT00004646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111449104|NCT00004646|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111449105|NCT00004646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111449106|NCT00005108|Estradiol|estradiol|mesh-list
111449107|NCT00005108|Progesterone|progesterone|mesh-list
111449108|NCT00005108|Estrogens|estrogens|mesh-ancestor
111449109|NCT00005108|Hormones|hormones|mesh-ancestor
111449110|NCT00005108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111449111|NCT00005108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111449112|NCT00005108|Progestins|progestins|mesh-ancestor
111449113|NCT00004652|Pimozide|pimozide|mesh-list
111449114|NCT00004652|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111449115|NCT00004652|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111449116|NCT00004652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111449117|NCT00004652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111449118|NCT00004652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111449119|NCT00004652|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111449120|NCT00004652|Dopamine Agents|dopamine agents|mesh-ancestor
111449121|NCT00004652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111449122|NCT00004652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111449123|NCT00004652|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111449124|NCT00005120|Calanolide A|calanolide a|mesh-list
111449125|NCT00005120|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111449126|NCT00005120|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111449127|NCT00005120|Antiviral Agents|antiviral agents|mesh-ancestor
111449128|NCT00005120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111449129|NCT00004664|Megestrol|megestrol|mesh-list
110908247|NCT02055690|Fosbretabulin|fosbretabulin|mesh-list
111449130|NCT00004664|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111449131|NCT00004664|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111449132|NCT00004664|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111449133|NCT00004664|Contraceptive Agents|contraceptive agents|mesh-ancestor
111449134|NCT00004664|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111449135|NCT00004664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111449136|NCT00004664|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111449137|NCT00004664|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111449138|NCT00004664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111449139|NCT00004664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111449140|NCT00004682|Immunoglobulins|immunoglobulins|mesh-list
111449141|NCT00004682|Antibodies|antibodies|mesh-list
111449142|NCT00004682|gamma-Globulins|gamma-globulins|mesh-list
111449143|NCT00004682|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111449144|NCT00004682|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
111449145|NCT00004682|Immunologic Factors|immunologic factors|mesh-ancestor
111449146|NCT00004682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111449147|NCT00004688|Mercaptopurine|mercaptopurine|mesh-list
111449148|NCT00004688|Carmustine|carmustine|mesh-list
111449149|NCT00004688|Streptozocin|streptozocin|mesh-list
111449150|NCT00004688|Antimetabolites|antimetabolites|mesh-ancestor
111449151|NCT00004688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111449152|NCT00004688|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111449153|NCT00004688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111449154|NCT00004688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111449155|NCT00004688|Immunologic Factors|immunologic factors|mesh-ancestor
111449156|NCT00004688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110908303|NCT02192060|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111449157|NCT00004688|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111449158|NCT00004688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111449159|NCT00004688|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111449160|NCT00004688|Alkylating Agents|alkylating agents|mesh-ancestor
111449161|NCT00004688|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111449162|NCT00004694|Heparin|heparin|mesh-list
111449163|NCT00004694|Anticoagulants|anticoagulants|mesh-ancestor
111449164|NCT00004694|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111449165|NCT00004694|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111449166|NCT00004694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111449167|NCT04608409|Paclitaxel|paclitaxel|mesh-list
111449168|NCT04608409|Lapatinib|lapatinib|mesh-list
111449169|NCT04608409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111449170|NCT04608409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111449171|NCT04608409|Tubulin Modulators|tubulin modulators|mesh-ancestor
111449172|NCT04608409|Antimitotic Agents|antimitotic agents|mesh-ancestor
111449173|NCT04608409|Mitosis Modulators|mitosis modulators|mesh-ancestor
111449174|NCT04608409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111449175|NCT04608409|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111449176|NCT04608409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111449177|NCT00004700|Mitogens|mitogens|mesh-list
111449178|NCT00004700|Mitosis Modulators|mitosis modulators|mesh-ancestor
111449179|NCT00004700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111449180|NCT00004730|Magnesium Sulfate|magnesium sulfate|mesh-list
111449181|NCT00004730|Analgesics|analgesics|mesh-ancestor
111449182|NCT00004730|Sensory System Agents|sensory system agents|mesh-ancestor
111449183|NCT00004730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111449184|NCT00004730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111449185|NCT00004730|Anesthetics|anesthetics|mesh-ancestor
111449186|NCT00004730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111449187|NCT00004730|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111449188|NCT00004730|Anticonvulsants|anticonvulsants|mesh-ancestor
111449189|NCT00004730|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111449190|NCT00004730|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111449191|NCT00004730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111449192|NCT00004730|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111449193|NCT00004730|Tocolytic Agents|tocolytic agents|mesh-ancestor
110908413|NCT03676413|Fluticasone|fluticasone|mesh-list
111449194|NCT00004730|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111449195|NCT00004736|Lamivudine|lamivudine|mesh-list
111449196|NCT00004736|Zidovudine|zidovudine|mesh-list
111449197|NCT00004736|Stavudine|stavudine|mesh-list
111449198|NCT00004736|Nelfinavir|nelfinavir|mesh-list
111449199|NCT00004736|Isoniazid|isoniazid|mesh-list
111449200|NCT00004736|Pyrazinamide|pyrazinamide|mesh-list
111449201|NCT00004736|Ethambutol|ethambutol|mesh-list
111449202|NCT00004736|Rifabutin|rifabutin|mesh-list
111449203|NCT00004736|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111449204|NCT00004736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111449205|NCT00004736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111449206|NCT00004736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111449207|NCT00004736|Antiviral Agents|antiviral agents|mesh-ancestor
111449208|NCT00004736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111449209|NCT00004736|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111449210|NCT00004736|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111449211|NCT00004736|Antimetabolites|antimetabolites|mesh-ancestor
111449212|NCT00004736|Antitubercular Agents|antitubercular agents|mesh-ancestor
111449213|NCT00004736|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111449214|NCT00004736|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
111449215|NCT00004736|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111449216|NCT00004736|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111449217|NCT00004736|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111449218|NCT00004736|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111449219|NCT00004736|Protease Inhibitors|protease inhibitors|mesh-ancestor
111449220|NCT00004736|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111449221|NCT00004748|Methotrexate|methotrexate|mesh-list
111449222|NCT00004748|Colchicine|colchicine|mesh-list
111449223|NCT00004748|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
111449224|NCT00004748|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111449225|NCT00004748|Abortifacient Agents|abortifacient agents|mesh-ancestor
111449226|NCT00004748|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111449227|NCT00004748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111449228|NCT00004748|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111449229|NCT00004748|Antimetabolites|antimetabolites|mesh-ancestor
111449230|NCT00004748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111449231|NCT00004748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111449232|NCT00004748|Dermatologic Agents|dermatologic agents|mesh-ancestor
111449233|NCT00004748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111449234|NCT00004748|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111449235|NCT00004748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111449236|NCT00004748|Immunologic Factors|immunologic factors|mesh-ancestor
111449237|NCT00004748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111449238|NCT00004748|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111449239|NCT00004748|Gout Suppressants|gout suppressants|mesh-ancestor
111449240|NCT00004748|Tubulin Modulators|tubulin modulators|mesh-ancestor
111449241|NCT00004748|Antimitotic Agents|antimitotic agents|mesh-ancestor
111449242|NCT00004748|Mitosis Modulators|mitosis modulators|mesh-ancestor
111449243|NCT00004748|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
111449244|NCT00004748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111449245|NCT04585477|Durvalumab|durvalumab|mesh-list
111449246|NCT04585477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111449247|NCT04585477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111449248|NCT00004754|Epoprostenol|epoprostenol|mesh-list
111449249|NCT00004754|Tezosentan|tezosentan|mesh-list
111449250|NCT00004754|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111449251|NCT00004754|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111449252|NCT00004754|Vasodilator Agents|vasodilator agents|mesh-ancestor
111449253|NCT00005576|Aldesleukin|aldesleukin|mesh-list
110908614|NCT02060916|PAZ320|paz320|mesh-list
111449254|NCT00005576|Interleukin-2|interleukin-2|mesh-list
111449255|NCT00005576|Dinutuximab|dinutuximab|mesh-list
111449256|NCT00005576|Isotretinoin|isotretinoin|mesh-list
111449257|NCT00005576|Antibodies|antibodies|mesh-list
111449258|NCT00005576|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111449259|NCT00005576|Sargramostim|sargramostim|mesh-list
111449260|NCT00005576|Immunologic Factors|immunologic factors|mesh-ancestor
111449261|NCT00005576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111449262|NCT00005576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111449263|NCT00005576|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111449264|NCT00005576|Analgesics|analgesics|mesh-ancestor
111449265|NCT00005576|Sensory System Agents|sensory system agents|mesh-ancestor
111449266|NCT00005576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111449267|NCT00005576|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111449268|NCT00005576|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111449269|NCT00005576|Antiviral Agents|antiviral agents|mesh-ancestor
111449270|NCT00005576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111449271|NCT00005576|Dermatologic Agents|dermatologic agents|mesh-ancestor
111449272|NCT04713163|Vaccines|vaccines|mesh-list
111449273|NCT04713163|Immunologic Factors|immunologic factors|mesh-ancestor
111449274|NCT04713163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111449275|NCT00004772|Immunoglobulins|immunoglobulins|mesh-list
111449276|NCT00004772|Antibodies|antibodies|mesh-list
111449277|NCT00004772|gamma-Globulins|gamma-globulins|mesh-list
111449278|NCT00004772|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111449279|NCT00004772|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
111449280|NCT00004772|Immunologic Factors|immunologic factors|mesh-ancestor
111449281|NCT00004772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111449282|NCT04712929|Fluconazole|fluconazole|mesh-list
111449283|NCT04712929|Antifungal Agents|antifungal agents|mesh-ancestor
111449284|NCT04712929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111449285|NCT04712929|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111449286|NCT04712929|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111449287|NCT04712929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111449288|NCT04712929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111449289|NCT04712929|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111449290|NCT04712929|Hormone Antagonists|hormone antagonists|mesh-ancestor
111449291|NCT04712929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111449292|NCT04712929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111449293|NCT04712929|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111449294|NCT04712929|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111449295|NCT00004784|Methotrexate|methotrexate|mesh-list
111449296|NCT00004784|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
111449297|NCT00004784|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111449298|NCT00004784|Abortifacient Agents|abortifacient agents|mesh-ancestor
111449299|NCT00004784|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111449300|NCT00004784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111449301|NCT00004784|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111449302|NCT00004784|Antimetabolites|antimetabolites|mesh-ancestor
111449303|NCT00004784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111449304|NCT00004784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111449305|NCT00004784|Dermatologic Agents|dermatologic agents|mesh-ancestor
111449306|NCT00004784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111449307|NCT00004784|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111449308|NCT00004784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111449309|NCT00004784|Immunologic Factors|immunologic factors|mesh-ancestor
111449310|NCT00004784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111449311|NCT00004784|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111449312|NCT00004784|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
111449313|NCT00004784|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111449314|NCT00004796|Lactulose|lactulose|mesh-list
111449315|NCT00004796|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111449316|NCT00004802|Dichlorphenamide|dichlorphenamide|mesh-list
111449317|NCT00004802|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
111449318|NCT00004802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111449319|NCT00004802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111449320|NCT00004808|Fluconazole|fluconazole|mesh-list
111449321|NCT00004808|Antifungal Agents|antifungal agents|mesh-ancestor
111449322|NCT00004808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111449323|NCT00004808|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111449324|NCT00004808|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111449325|NCT00004808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111449326|NCT00004808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111449327|NCT00004808|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111449328|NCT00004808|Hormone Antagonists|hormone antagonists|mesh-ancestor
111449329|NCT00004808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110908932|NCT01378091|Growth Substances|growth substances|mesh-ancestor
111449330|NCT00004808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111449331|NCT00004808|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111449332|NCT00004808|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111449333|NCT00004814|Glatiramer Acetate|glatiramer acetate|mesh-list
111449334|NCT00004814|(T,G)-A-L|(t,g)-a-l|mesh-list
111449335|NCT00004814|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111449336|NCT00004814|Immunologic Factors|immunologic factors|mesh-ancestor
111449337|NCT00004814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110909062|NCT02064504|Xhance|xhance|mesh-list
111449338|NCT00004814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111449339|NCT00004814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111449340|NCT00004826|Clozapine|clozapine|mesh-list
111449341|NCT00004826|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111449342|NCT00004826|Serotonin Agents|serotonin agents|mesh-ancestor
111449343|NCT00004826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111449344|NCT00004826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111449345|NCT00004826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111449346|NCT00004826|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111449347|NCT00004826|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111449348|NCT00004826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111449349|NCT00004826|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111449350|NCT00004826|GABA Antagonists|gaba antagonists|mesh-ancestor
111449351|NCT00004826|GABA Agents|gaba agents|mesh-ancestor
111449352|NCT04555603|Pembrolizumab|pembrolizumab|mesh-list
111449353|NCT04555603|Avelumab|avelumab|mesh-list
111449354|NCT04555603|Axitinib|axitinib|mesh-list
111449355|NCT04555603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111449356|NCT04555603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111449357|NCT04555603|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111449358|NCT04555603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111449359|NCT04555603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111449360|NCT04555603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111449361|NCT04552327|Diclofenac|diclofenac|mesh-list
111449362|NCT04552327|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111449363|NCT04552327|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110909154|NCT02068170|Sunitinib|sunitinib|mesh-list
111449364|NCT04552327|Analgesics|analgesics|mesh-ancestor
111449365|NCT04552327|Sensory System Agents|sensory system agents|mesh-ancestor
111449366|NCT04552327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111449367|NCT04552327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111449368|NCT04552327|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111449369|NCT04552327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111449370|NCT04552327|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111449371|NCT04552327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111449372|NCT04552327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111449373|NCT00004778|Dexamethasone|dexamethasone|mesh-list
111449374|NCT00004778|Betamethasone|betamethasone|mesh-list
111449375|NCT00004778|Hormones|hormones|mesh-list
111449376|NCT00004778|Thyrotropin-Releasing Hormone|thyrotropin-releasing hormone|mesh-list
111449377|NCT00004778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111449378|NCT00004778|Antiemetics|antiemetics|mesh-ancestor
111449379|NCT00004778|Autonomic Agents|autonomic agents|mesh-ancestor
111449380|NCT00004778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111449381|NCT00004778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111449382|NCT00004778|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111449383|NCT00004778|Glucocorticoids|glucocorticoids|mesh-ancestor
111449384|NCT00004778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111449385|NCT00004778|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111449386|NCT00004778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111449387|NCT00004778|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111449388|NCT00004778|Respiratory System Agents|respiratory system agents|mesh-ancestor
111449389|NCT00005612|Paclitaxel|paclitaxel|mesh-list
111449390|NCT00005612|Etoposide|etoposide|mesh-list
111449391|NCT00005612|Cyclophosphamide|cyclophosphamide|mesh-list
111449392|NCT00005612|Carboplatin|carboplatin|mesh-list
111449393|NCT00005612|Topotecan|topotecan|mesh-list
111449394|NCT00005612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111449395|NCT00005612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111449396|NCT00005612|Tubulin Modulators|tubulin modulators|mesh-ancestor
111449397|NCT00005612|Antimitotic Agents|antimitotic agents|mesh-ancestor
111449398|NCT00005612|Mitosis Modulators|mitosis modulators|mesh-ancestor
111449399|NCT00005612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111449400|NCT00005612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111449401|NCT00005612|Immunologic Factors|immunologic factors|mesh-ancestor
111449402|NCT00005612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111449403|NCT00005612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110909323|NCT02199392|Lenvatinib|lenvatinib|mesh-list
111449404|NCT00005612|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111449405|NCT00005612|Alkylating Agents|alkylating agents|mesh-ancestor
111449406|NCT00005612|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111449407|NCT00005612|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111449408|NCT00005612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111449409|NCT00005612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111449410|NCT00005612|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111449411|NCT00005618|Arsenic Trioxide|arsenic trioxide|mesh-list
111449412|NCT00005618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111449413|NCT00005624|Tacedinaline|tacedinaline|mesh-list
111449414|NCT00005624|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
111449415|NCT00005624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111449416|NCT00005624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111449417|NCT00005624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111449418|NCT00385502|Econazole|econazole|mesh-list
111449419|NCT00385502|Antifungal Agents|antifungal agents|mesh-ancestor
111449420|NCT00385502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111449421|NCT00385502|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111449422|NCT00385502|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111449423|NCT00385502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111449424|NCT00385502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111449425|NCT00385502|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111449426|NCT00385502|Hormone Antagonists|hormone antagonists|mesh-ancestor
111449427|NCT00385502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111449428|NCT00385502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111449429|NCT00005630|Sargramostim|sargramostim|mesh-list
111449430|NCT00005630|Immunologic Factors|immunologic factors|mesh-ancestor
111449431|NCT00005630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111449432|NCT00005636|Pemetrexed|pemetrexed|mesh-list
111449433|NCT00005636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111449434|NCT00005636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111449435|NCT00005636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111449436|NCT00005636|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111449437|NCT00005636|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111449438|NCT00005642|Semaxinib|semaxinib|mesh-list
111449439|NCT00005642|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111449440|NCT00005642|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111449441|NCT00005642|Growth Substances|growth substances|mesh-ancestor
111449442|NCT00005642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111449443|NCT00005642|Growth Inhibitors|growth inhibitors|mesh-ancestor
111449444|NCT00005642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111449445|NCT00005642|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111449446|NCT00005642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111449447|NCT00005642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111449449|NCT00005648|Tipifarnib|tipifarnib|mesh-list
111449450|NCT00005648|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111449451|NCT00005648|Antimetabolites|antimetabolites|mesh-ancestor
111449452|NCT00005648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111449453|NCT00005648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111449454|NCT00005654|Metformin|metformin|mesh-list
111449455|NCT00005654|Clomiphene|clomiphene|mesh-list
111449456|NCT00005654|Enclomiphene|enclomiphene|mesh-list
111449457|NCT00005654|Zuclomiphene|zuclomiphene|mesh-list
111449458|NCT00005654|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111449459|NCT00005654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111449460|NCT00005654|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111449461|NCT00005654|Hormone Antagonists|hormone antagonists|mesh-ancestor
111449462|NCT00005654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111449463|NCT00005654|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111449464|NCT00005654|Fertility Agents|fertility agents|mesh-ancestor
111449465|NCT00005654|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111449466|NCT00005654|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111449467|NCT00005654|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111449468|NCT00005684|Heparin|heparin|mesh-list
111449469|NCT00005684|Warfarin|warfarin|mesh-list
111449470|NCT00005684|Anticoagulants|anticoagulants|mesh-ancestor
111449471|NCT00005684|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111449472|NCT00005684|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111449473|NCT00005684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111449474|NCT00386282|Misoprostol|misoprostol|mesh-list
111449475|NCT00386282|Mifepristone|mifepristone|mesh-list
111449476|NCT00386282|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111449477|NCT00386282|Abortifacient Agents|abortifacient agents|mesh-ancestor
111449478|NCT00386282|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111449479|NCT00386282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111449480|NCT00386282|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111449481|NCT00386282|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111449482|NCT00386282|Oxytocics|oxytocics|mesh-ancestor
111449483|NCT00386282|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
111449484|NCT00386282|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111449485|NCT00386282|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111449486|NCT00386282|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111449487|NCT00386282|Contraceptive Agents|contraceptive agents|mesh-ancestor
111449488|NCT00386282|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
111449489|NCT00386282|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
111449490|NCT00386282|Hormone Antagonists|hormone antagonists|mesh-ancestor
111449491|NCT00386282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111449492|NCT00386282|Luteolytic Agents|luteolytic agents|mesh-ancestor
111449493|NCT00386282|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111449494|NCT00386282|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
111449495|NCT04456699|Leucovorin|leucovorin|mesh-list
111449496|NCT04456699|Bevacizumab|bevacizumab|mesh-list
111449497|NCT04456699|Fluorouracil|fluorouracil|mesh-list
111449498|NCT04456699|Capecitabine|capecitabine|mesh-list
111449499|NCT04456699|Olaparib|olaparib|mesh-list
111449500|NCT04456699|Levoleucovorin|levoleucovorin|mesh-list
111449501|NCT04456699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111449502|NCT04456699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111449503|NCT04456699|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111449504|NCT04456699|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111449505|NCT04456699|Growth Substances|growth substances|mesh-ancestor
111449506|NCT04456699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111449507|NCT04456699|Growth Inhibitors|growth inhibitors|mesh-ancestor
111449508|NCT04456699|Antimetabolites|antimetabolites|mesh-ancestor
111449509|NCT04456699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111449510|NCT04456699|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111449511|NCT04456699|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111449512|NCT04456699|Immunologic Factors|immunologic factors|mesh-ancestor
111449513|NCT04456699|Antidotes|antidotes|mesh-ancestor
111449514|NCT04456699|Protective Agents|protective agents|mesh-ancestor
111449515|NCT04456699|Vitamin B Complex|vitamin b complex|mesh-ancestor
111449516|NCT04456699|Vitamins|vitamins|mesh-ancestor
111173713|NCT05892705|Analgesics|analgesics|mesh-ancestor
111449517|NCT04456699|Micronutrients|micronutrients|mesh-ancestor
111449518|NCT04456699|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111449519|NCT04456699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111449520|NCT00385658|Simvastatin|simvastatin|mesh-list
111449521|NCT00385658|Ezetimibe|ezetimibe|mesh-list
111449522|NCT00385658|Fenofibrate|fenofibrate|mesh-list
111449523|NCT00385658|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111449524|NCT00385658|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111449525|NCT00385658|Antimetabolites|antimetabolites|mesh-ancestor
111449526|NCT00385658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111449527|NCT00385658|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111449528|NCT00385658|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111449529|NCT00385658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111449530|NCT00005762|Ritonavir|ritonavir|mesh-list
111449531|NCT00005762|Nelfinavir|nelfinavir|mesh-list
111449532|NCT00005762|Indinavir|indinavir|mesh-list
111449533|NCT00005762|Saquinavir|saquinavir|mesh-list
111449534|NCT00005762|Amprenavir|amprenavir|mesh-list
111449535|NCT00005762|Efavirenz|efavirenz|mesh-list
111449536|NCT00005762|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111449537|NCT00005762|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111449538|NCT00005762|Protease Inhibitors|protease inhibitors|mesh-ancestor
111449539|NCT00005762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111449540|NCT00005762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111449541|NCT00005762|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111449542|NCT00005762|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111449543|NCT00005762|Antiviral Agents|antiviral agents|mesh-ancestor
111449544|NCT00005762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111449545|NCT00005762|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111449546|NCT00005762|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111449547|NCT00005762|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111449548|NCT00005762|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111449549|NCT00005762|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111449550|NCT00005762|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111449551|NCT00005762|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111449552|NCT00005762|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110909849|NCT02208986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111449553|NCT00005762|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111449554|NCT00005762|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111449555|NCT00005762|Antitubercular Agents|antitubercular agents|mesh-ancestor
111449556|NCT00005762|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111449557|NCT00005768|Estrogens|estrogens|mesh-list
111449558|NCT00005768|Hormones|hormones|mesh-ancestor
111449559|NCT00005768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111449560|NCT00005768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111449561|NCT00005774|Pulmonary Surfactants|pulmonary surfactants|mesh-list
111449562|NCT00005774|Respiratory System Agents|respiratory system agents|mesh-ancestor
111449563|NCT00005786|Arsenic Trioxide|arsenic trioxide|mesh-list
111449564|NCT00005786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111449565|NCT00005792|Etoposide|etoposide|mesh-list
111449566|NCT00005792|Melphalan|melphalan|mesh-list
111449567|NCT00005792|Topotecan|topotecan|mesh-list
111449568|NCT00005792|Etoposide phosphate|etoposide phosphate|mesh-list
110909901|NCT02205398|Cetuximab|cetuximab|mesh-list
111449569|NCT00005792|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111449570|NCT00005792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111449571|NCT00005792|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111449572|NCT00005792|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111449573|NCT00005792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111449574|NCT00005792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111449575|NCT00005792|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111449576|NCT00005792|Alkylating Agents|alkylating agents|mesh-ancestor
111449577|NCT00005792|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111449578|NCT00005792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111449579|NCT00005792|Immunologic Factors|immunologic factors|mesh-ancestor
111449580|NCT00005792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111449581|NCT00005792|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111449582|NCT00005798|Cyclophosphamide|cyclophosphamide|mesh-list
111449583|NCT00005798|Thiotepa|thiotepa|mesh-list
110909968|NCT02205554|Tramadol|tramadol|mesh-list
111449584|NCT00005798|Carboplatin|carboplatin|mesh-list
111449585|NCT00005798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111449586|NCT00005798|Immunologic Factors|immunologic factors|mesh-ancestor
111449587|NCT00005798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111449588|NCT00005798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111449589|NCT00005798|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111449590|NCT00005798|Alkylating Agents|alkylating agents|mesh-ancestor
111449591|NCT00005798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111449592|NCT00005798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111449593|NCT00005798|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111449594|NCT00005810|Carboplatin|carboplatin|mesh-list
111449595|NCT00005810|Docetaxel|docetaxel|mesh-list
111449596|NCT00005810|Estramustine|estramustine|mesh-list
111449597|NCT00005810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111449598|NCT00005810|Tubulin Modulators|tubulin modulators|mesh-ancestor
111449599|NCT00005810|Antimitotic Agents|antimitotic agents|mesh-ancestor
111449600|NCT00005810|Mitosis Modulators|mitosis modulators|mesh-ancestor
110627541|NCT02597699|Dsuvia|dsuvia|mesh-list
111449601|NCT00005810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111449602|NCT00005810|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111449603|NCT00005810|Alkylating Agents|alkylating agents|mesh-ancestor
111449604|NCT00005810|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111449605|NCT00385970|Leucovorin|leucovorin|mesh-list
111449606|NCT00385970|polysaccharide-K|polysaccharide-k|mesh-list
111449607|NCT00385970|Tegafur|tegafur|mesh-list
111449608|NCT00385970|Calcium|calcium|mesh-list
111449609|NCT00385970|Levoleucovorin|levoleucovorin|mesh-list
111449610|NCT00385970|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111449611|NCT00385970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111449612|NCT00385970|Antidotes|antidotes|mesh-ancestor
111449613|NCT00385970|Protective Agents|protective agents|mesh-ancestor
111449614|NCT00385970|Vitamin B Complex|vitamin b complex|mesh-ancestor
111449615|NCT00385970|Vitamins|vitamins|mesh-ancestor
111449616|NCT00385970|Micronutrients|micronutrients|mesh-ancestor
111449617|NCT00385970|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111449618|NCT00385970|Antimetabolites|antimetabolites|mesh-ancestor
111449619|NCT00385970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111449620|NCT00385970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111449621|NCT00385970|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111449622|NCT00385970|Immunologic Factors|immunologic factors|mesh-ancestor
111449623|NCT00385970|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111449624|NCT00385970|Antiviral Agents|antiviral agents|mesh-ancestor
111449625|NCT00385970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111449626|NCT00385970|Interferon Inducers|interferon inducers|mesh-ancestor
111449627|NCT00385970|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111449628|NCT05006677|Vitamin K|vitamin k|mesh-list
111449629|NCT05006677|Anticoagulants|anticoagulants|mesh-list
111449630|NCT05006677|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
111449631|NCT05006677|Vitamins|vitamins|mesh-ancestor
111449632|NCT05006677|Micronutrients|micronutrients|mesh-ancestor
111449633|NCT05006677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111449634|NCT05006677|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111449635|NCT05006677|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111449636|NCT05006677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111449637|NCT05006677|Hemostatics|hemostatics|mesh-ancestor
111449638|NCT05006677|Coagulants|coagulants|mesh-ancestor
111449639|NCT00386126|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
111449640|NCT00386126|Hematinics|hematinics|mesh-ancestor
111449641|NCT04569890|Hydroxychloroquine|hydroxychloroquine|mesh-list
111449642|NCT04569890|Prednisone|prednisone|mesh-list
111449643|NCT04569890|Certolizumab Pegol|certolizumab pegol|mesh-list
111449644|NCT04569890|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111449645|NCT04569890|Glucocorticoids|glucocorticoids|mesh-ancestor
111449646|NCT04569890|Hormones|hormones|mesh-ancestor
111449647|NCT04569890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111449648|NCT04569890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111449649|NCT04569890|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111449650|NCT04569890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111449651|NCT04569890|Antimalarials|antimalarials|mesh-ancestor
111449652|NCT04569890|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111449653|NCT04569890|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111449654|NCT04569890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111449655|NCT04569890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111449656|NCT04569890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111449657|NCT04569890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111449658|NCT04569890|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111449659|NCT04569890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111449660|NCT04569890|Immunologic Factors|immunologic factors|mesh-ancestor
111449661|NCT00423163|Voriconazole|voriconazole|mesh-list
111449662|NCT00423163|Micafungin|micafungin|mesh-list
111449663|NCT00423163|Antifungal Agents|antifungal agents|mesh-ancestor
111449664|NCT00423163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111449665|NCT00423163|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110910187|NCT02213744|Gemcitabine|gemcitabine|mesh-list
111449666|NCT00423163|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111449667|NCT00423163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111449668|NCT00423163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111173863|NCT05676294|Serotonin Agents|serotonin agents|mesh-ancestor
111449669|NCT00423163|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111449670|NCT00423163|Hormone Antagonists|hormone antagonists|mesh-ancestor
111449671|NCT00423163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111449672|NCT00423163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111449673|NCT00423163|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111449675|NCT04379635|Carboplatin|carboplatin|mesh-list
111449676|NCT04379635|Pemetrexed|pemetrexed|mesh-list
111449677|NCT04379635|Tislelizumab|tislelizumab|mesh-list
111449678|NCT04379635|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111449679|NCT04379635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111449680|NCT04379635|Tubulin Modulators|tubulin modulators|mesh-ancestor
111449681|NCT04379635|Antimitotic Agents|antimitotic agents|mesh-ancestor
111449682|NCT04379635|Mitosis Modulators|mitosis modulators|mesh-ancestor
111449683|NCT04379635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111449684|NCT04379635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111449685|NCT04379635|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111449686|NCT04379635|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111449687|NCT04379635|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111449688|NCT04568876|Palmidrol|palmidrol|mesh-list
111449689|NCT04568876|Analgesics|analgesics|mesh-ancestor
111449690|NCT04568876|Sensory System Agents|sensory system agents|mesh-ancestor
111449691|NCT04568876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111449692|NCT04568876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111449693|NCT04568876|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111449694|NCT04568876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111449695|NCT04568876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111449696|NCT04568876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111449697|NCT04568876|Antiviral Agents|antiviral agents|mesh-ancestor
111449698|NCT04568876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111449699|NCT04568876|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
111449700|NCT04568876|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
111449701|NCT04568876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111449702|NCT04568876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111449703|NCT04568876|Hormones|hormones|mesh-ancestor
111449704|NCT04568876|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111449705|NCT02210702|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
111449706|NCT02210702|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
111449707|NCT02210702|Ethinyl Estradiol|ethinyl estradiol|mesh-list
111449708|NCT02210702|Norethindrone|norethindrone|mesh-list
111449709|NCT02210702|Norethindrone Acetate|norethindrone acetate|mesh-list
111449710|NCT02210702|Estradiol|estradiol|mesh-list
111449711|NCT02210702|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
111449712|NCT02210702|Estrogens|estrogens|mesh-ancestor
111449713|NCT02210702|Hormones|hormones|mesh-ancestor
111449714|NCT02210702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111449715|NCT02210702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111449716|NCT02210702|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111449717|NCT02210702|Contraceptive Agents|contraceptive agents|mesh-ancestor
111449718|NCT02210702|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111449719|NCT02210702|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111449720|NCT02210702|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111449721|NCT02210702|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111449722|NCT02210702|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111449723|NCT04568096|Tamoxifen|tamoxifen|mesh-list
111449724|NCT04568096|Tretinoin|tretinoin|mesh-list
111449725|NCT04568096|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111449726|NCT04568096|Hormone Antagonists|hormone antagonists|mesh-ancestor
111449727|NCT04568096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111449728|NCT04568096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111449729|NCT04568096|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111449730|NCT04568096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111449731|NCT04568096|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111449732|NCT04568096|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111449733|NCT04568096|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111449734|NCT04568096|Keratolytic Agents|keratolytic agents|mesh-ancestor
111449735|NCT04568096|Dermatologic Agents|dermatologic agents|mesh-ancestor
111449736|NCT04568018|Pulmonary Surfactants|pulmonary surfactants|mesh-list
111449737|NCT04568018|Respiratory System Agents|respiratory system agents|mesh-ancestor
111449738|NCT02278172|Vitamin D|vitamin d|mesh-list
111449739|NCT02278172|Ergocalciferols|ergocalciferols|mesh-list
111449740|NCT02278172|Cholecalciferol|cholecalciferol|mesh-list
111449741|NCT02278172|Vitamins|vitamins|mesh-list
111173933|NCT05600686|Keratolytic Agents|keratolytic agents|mesh-ancestor
111449742|NCT02278172|Micronutrients|micronutrients|mesh-ancestor
111449743|NCT02278172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111449744|NCT02278172|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111449745|NCT02278172|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111449746|NCT04971031|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111449747|NCT04971031|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111449748|NCT04566224|Pyrithione zinc|pyrithione zinc|mesh-list
111449749|NCT04566224|Keratolytic Agents|keratolytic agents|mesh-ancestor
111449750|NCT04566224|Dermatologic Agents|dermatologic agents|mesh-ancestor
111449752|NCT02210858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111449753|NCT04565678|Mitapivat|mitapivat|mesh-list
111449754|NCT04565678|Enzyme Activators|enzyme activators|mesh-ancestor
111449755|NCT04565678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111449756|NCT04564430|Clonidine|clonidine|mesh-list
111449757|NCT04564430|Analgesics|analgesics|mesh-ancestor
111449758|NCT04564430|Sensory System Agents|sensory system agents|mesh-ancestor
111449759|NCT04564430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111449760|NCT04564430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111449761|NCT04564430|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111449762|NCT04564430|Sympatholytics|sympatholytics|mesh-ancestor
111449763|NCT04564430|Autonomic Agents|autonomic agents|mesh-ancestor
111449764|NCT04564430|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111449765|NCT04564430|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111449766|NCT04564430|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111449767|NCT04564430|Adrenergic Agents|adrenergic agents|mesh-ancestor
111449768|NCT04564430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111449769|NCT04564430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111449770|NCT04564040|Acalabrutinib|acalabrutinib|mesh-list
111449771|NCT04564040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110910588|NCT02222636|Analgesics|analgesics|mesh-ancestor
111449772|NCT00005804|Cyclophosphamide|cyclophosphamide|mesh-list
111449773|NCT00005804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111449774|NCT00005804|Immunologic Factors|immunologic factors|mesh-ancestor
111449775|NCT00005804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111449776|NCT00005804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111449777|NCT00005804|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111449778|NCT00005804|Alkylating Agents|alkylating agents|mesh-ancestor
111449779|NCT00005804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111449780|NCT00005804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111449781|NCT00005804|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111449782|NCT04563962|Methamphetamine|methamphetamine|mesh-list
111449783|NCT04563962|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111449784|NCT04563962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111449785|NCT04563962|Sympathomimetics|sympathomimetics|mesh-ancestor
111449786|NCT04563962|Autonomic Agents|autonomic agents|mesh-ancestor
111449787|NCT04563962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111449788|NCT04563962|Dopamine Agents|dopamine agents|mesh-ancestor
111449789|NCT04563962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111449790|NCT04563962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111449791|NCT04563962|Adrenergic Agents|adrenergic agents|mesh-ancestor
111449792|NCT04563962|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111449793|NCT04563962|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111449794|NCT04563962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111449795|NCT04563962|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111449796|NCT02211482|Lamivudine|lamivudine|mesh-list
111449797|NCT02211482|Dolutegravir|dolutegravir|mesh-list
111449798|NCT02211482|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111449799|NCT02211482|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111449800|NCT02211482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111449801|NCT02211482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111449802|NCT02211482|Antiviral Agents|antiviral agents|mesh-ancestor
111449803|NCT02211482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111449804|NCT02211482|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111449805|NCT02211482|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111449806|NCT02211482|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111449807|NCT02211482|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111449808|NCT04929847|Emollients|emollients|mesh-list
111449809|NCT04929847|Dermatologic Agents|dermatologic agents|mesh-ancestor
111449810|NCT04561934|Fluorides|fluorides|mesh-list
111449811|NCT04561934|Cariostatic Agents|cariostatic agents|mesh-ancestor
111449812|NCT04561934|Protective Agents|protective agents|mesh-ancestor
111449813|NCT04561934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111449814|NCT04330495|Hydroxychloroquine|hydroxychloroquine|mesh-list
111449815|NCT04330495|Antimalarials|antimalarials|mesh-ancestor
111449816|NCT04330495|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111449817|NCT04330495|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111449818|NCT04330495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111449819|NCT04330495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111449820|NCT04330495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111449821|NCT04330495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111449822|NCT04563260|Palonosetron|palonosetron|mesh-list
111449823|NCT04563260|Antiemetics|antiemetics|mesh-ancestor
111449824|NCT04563260|Autonomic Agents|autonomic agents|mesh-ancestor
111449825|NCT04563260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111449826|NCT04563260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110910751|NCT02075970|Epoetin Alfa|epoetin alfa|mesh-list
111449827|NCT04563260|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111449828|NCT04563260|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111449829|NCT04563260|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111449830|NCT04563260|Serotonin Agents|serotonin agents|mesh-ancestor
111449831|NCT04563260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111449832|NCT04563260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111449833|NCT04173793|Ezetimibe|ezetimibe|mesh-list
111449834|NCT04173793|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111449835|NCT04173793|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111449836|NCT04173793|Antimetabolites|antimetabolites|mesh-ancestor
111449837|NCT04173793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111449838|NCT04173793|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111449839|NCT04561856|Dexamethasone|dexamethasone|mesh-list
111449840|NCT04561856|Dexamethasone acetate|dexamethasone acetate|mesh-list
111449841|NCT04561856|BB 1101|bb 1101|mesh-list
111449842|NCT04561856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111449843|NCT04561856|Antiemetics|antiemetics|mesh-ancestor
111449844|NCT04561856|Autonomic Agents|autonomic agents|mesh-ancestor
111449845|NCT04561856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111449846|NCT04561856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111449847|NCT04561856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111449848|NCT04561856|Glucocorticoids|glucocorticoids|mesh-ancestor
111449849|NCT04561856|Hormones|hormones|mesh-ancestor
111449850|NCT04561856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111449851|NCT04561856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111449852|NCT04561856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111449853|NCT04561856|Protease Inhibitors|protease inhibitors|mesh-ancestor
111449854|NCT04561856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111449855|NCT04561856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111449856|NCT00382681|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111449857|NCT04173403|Ezetimibe|ezetimibe|mesh-list
111449858|NCT04173403|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111449859|NCT04173403|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111449860|NCT04173403|Antimetabolites|antimetabolites|mesh-ancestor
111449861|NCT04173403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111449862|NCT04173403|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111449863|NCT03539887|Ketamine|ketamine|mesh-list
111449864|NCT03539887|Analgesics|analgesics|mesh-ancestor
111449865|NCT03539887|Sensory System Agents|sensory system agents|mesh-ancestor
111449866|NCT03539887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111449867|NCT03539887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111449868|NCT03539887|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111449869|NCT03539887|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111449870|NCT03539887|Anesthetics, General|anesthetics, general|mesh-ancestor
111449871|NCT03539887|Anesthetics|anesthetics|mesh-ancestor
111449872|NCT03539887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111449873|NCT03539887|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111449874|NCT03539887|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111449875|NCT03539887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111449876|NCT03539887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111449877|NCT04123717|Acetaminophen|acetaminophen|mesh-list
111449878|NCT04123717|Ibuprofen|ibuprofen|mesh-list
111449879|NCT04123717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111449880|NCT04123717|Analgesics|analgesics|mesh-ancestor
110910943|NCT02591953|Antiemetics|antiemetics|mesh-ancestor
111449881|NCT04123717|Sensory System Agents|sensory system agents|mesh-ancestor
111449882|NCT04123717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111449883|NCT04123717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111449884|NCT04123717|Antipyretics|antipyretics|mesh-ancestor
111449885|NCT04123717|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111449886|NCT04123717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111449887|NCT04123717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111449888|NCT04123717|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111449889|NCT04123717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111449890|NCT04123717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111449891|NCT03472495|Diltiazem|diltiazem|mesh-list
111174093|NCT05096117|ASP8062|asp8062|mesh-list
111449892|NCT03472495|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111449893|NCT03472495|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111449894|NCT03472495|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111449895|NCT03472495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111449896|NCT03472495|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111449897|NCT03472495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111449898|NCT03472495|Vasodilator Agents|vasodilator agents|mesh-ancestor
111449899|NCT04094701|Analgesics, Opioid|analgesics, opioid|mesh-list
111449900|NCT04094701|Narcotics|narcotics|mesh-ancestor
111449901|NCT04094701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111449902|NCT04094701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111449903|NCT04094701|Analgesics|analgesics|mesh-ancestor
111449904|NCT04094701|Sensory System Agents|sensory system agents|mesh-ancestor
111449905|NCT04094701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111449907|NCT03351361|Ipilimumab|ipilimumab|mesh-list
111449908|NCT03351361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111449909|NCT03351361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111449910|NCT03351361|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111449911|NCT03351361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111449912|NCT03234907|Vedolizumab|vedolizumab|mesh-list
111449913|NCT03234907|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111449914|NCT04330027|Mitogens|mitogens|mesh-list
111449915|NCT04330027|Mitosis Modulators|mitosis modulators|mesh-ancestor
111449916|NCT04330027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111449917|NCT00002893|Leucovorin|leucovorin|mesh-list
111449918|NCT00002893|Fluorouracil|fluorouracil|mesh-list
111449919|NCT00002893|Raltitrexed|raltitrexed|mesh-list
111449920|NCT00002893|Calcium|calcium|mesh-list
111449921|NCT00002893|Levoleucovorin|levoleucovorin|mesh-list
111449922|NCT00002893|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111449923|NCT00002893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111449924|NCT00002893|Antimetabolites|antimetabolites|mesh-ancestor
111449925|NCT00002893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111449926|NCT00002893|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111449927|NCT00002893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111449928|NCT00002893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111449929|NCT00002893|Immunologic Factors|immunologic factors|mesh-ancestor
111449930|NCT00002893|Antidotes|antidotes|mesh-ancestor
111449931|NCT00002893|Protective Agents|protective agents|mesh-ancestor
111449932|NCT00002893|Vitamin B Complex|vitamin b complex|mesh-ancestor
111449933|NCT00002893|Vitamins|vitamins|mesh-ancestor
111449934|NCT00002893|Micronutrients|micronutrients|mesh-ancestor
111449935|NCT00002893|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111449936|NCT00002893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111449937|NCT03905941|Metformin|metformin|mesh-list
111449938|NCT03905941|Contraceptive Agents|contraceptive agents|mesh-list
111449939|NCT03905941|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111449940|NCT03905941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111449941|NCT03905941|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111449942|NCT03818581|Suvorexant|suvorexant|mesh-list
111449943|NCT03818581|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111449944|NCT03818581|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111449945|NCT03818581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111449946|NCT03818581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111449947|NCT03818581|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
111449948|NCT03818581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111449949|NCT03818581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111449950|NCT00002905|Zidovudine|zidovudine|mesh-list
111449951|NCT00002905|Didanosine|didanosine|mesh-list
111449952|NCT00002905|Cyclophosphamide|cyclophosphamide|mesh-list
111449953|NCT00002905|Prednimustine|prednimustine|mesh-list
111449954|NCT00002905|Doxorubicin|doxorubicin|mesh-list
111449955|NCT00002905|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111449956|NCT00002905|Etoposide|etoposide|mesh-list
111449957|NCT00002905|Mitoxantrone|mitoxantrone|mesh-list
111449958|NCT00002905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111449959|NCT00002905|Immunologic Factors|immunologic factors|mesh-ancestor
111449960|NCT00002905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111449961|NCT00002905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111449962|NCT00002905|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111449963|NCT00002905|Alkylating Agents|alkylating agents|mesh-ancestor
111449964|NCT00002905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111449965|NCT00002905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111449966|NCT00002905|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111449967|NCT00002905|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111449968|NCT00002905|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111449969|NCT00002905|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111449970|NCT00002905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111449971|NCT00002905|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111449973|NCT00002905|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111449974|NCT00002905|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111449975|NCT00002905|Antiviral Agents|antiviral agents|mesh-ancestor
111449976|NCT00002905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111449977|NCT00002905|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111449978|NCT00002905|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111449979|NCT00002905|Analgesics|analgesics|mesh-ancestor
111449980|NCT00002905|Sensory System Agents|sensory system agents|mesh-ancestor
111449981|NCT00002905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111449982|NCT00002911|Marimastat|marimastat|mesh-list
111449983|NCT00002911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111449984|NCT00002911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111449985|NCT00002917|Paclitaxel|paclitaxel|mesh-list
111449986|NCT00002917|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111449987|NCT00002917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111449988|NCT00002917|Tubulin Modulators|tubulin modulators|mesh-ancestor
111449989|NCT00002917|Antimitotic Agents|antimitotic agents|mesh-ancestor
111449990|NCT00002917|Mitosis Modulators|mitosis modulators|mesh-ancestor
111449991|NCT00002917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111449992|NCT00383695|Capecitabine|capecitabine|mesh-list
111449993|NCT00383695|Oxaliplatin|oxaliplatin|mesh-list
111449994|NCT00383695|Cetuximab|cetuximab|mesh-list
111449995|NCT00383695|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111449996|NCT00383695|Antimetabolites|antimetabolites|mesh-ancestor
110911396|NCT02235194|Chromium|chromium|mesh-list
111449997|NCT00383695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111449998|NCT00383695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111449999|NCT00383695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111450000|NCT00383851|Temozolomide|temozolomide|mesh-list
111450001|NCT00383851|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
111450002|NCT00383851|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111450003|NCT00383851|Alkylating Agents|alkylating agents|mesh-ancestor
110911460|NCT02600923|Hormone Antagonists|hormone antagonists|mesh-ancestor
111450004|NCT00383851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111450005|NCT00383851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111450006|NCT00383851|Chelating Agents|chelating agents|mesh-ancestor
111450007|NCT00383851|Sequestering Agents|sequestering agents|mesh-ancestor
111450008|NCT00383851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111450009|NCT00383851|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111450010|NCT00383851|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111450011|NCT00383851|Growth Substances|growth substances|mesh-ancestor
111450012|NCT00383851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111450013|NCT00383851|Growth Inhibitors|growth inhibitors|mesh-ancestor
111450014|NCT00002923|KRN 5500|krn 5500|mesh-list
111450015|NCT00002923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111450016|NCT00002923|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111450017|NCT00002923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111450018|NCT00002923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111450019|NCT02636569|Diclofenac|diclofenac|mesh-list
111450020|NCT02636569|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111450021|NCT02636569|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111450022|NCT02636569|Analgesics|analgesics|mesh-ancestor
111450023|NCT02636569|Sensory System Agents|sensory system agents|mesh-ancestor
111450024|NCT02636569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111450025|NCT02636569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111450026|NCT02636569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111450027|NCT02636569|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111450028|NCT02636569|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111450029|NCT02636569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111450030|NCT02636569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111450031|NCT00002935|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
111450032|NCT00002935|Trioxsalen|trioxsalen|mesh-list
111450033|NCT00002935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111450034|NCT00002935|Dermatologic Agents|dermatologic agents|mesh-ancestor
111450035|NCT00002935|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111450036|NCT00002941|Cyclophosphamide|cyclophosphamide|mesh-list
111450037|NCT00002941|Carmustine|carmustine|mesh-list
111450038|NCT00002941|Etoposide|etoposide|mesh-list
111450039|NCT00002941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111450040|NCT00002941|Immunologic Factors|immunologic factors|mesh-ancestor
111450041|NCT00002941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111450042|NCT00002941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111450043|NCT00002941|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111450044|NCT00002941|Alkylating Agents|alkylating agents|mesh-ancestor
111450045|NCT00002941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111450046|NCT00002941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111450047|NCT00002941|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111450048|NCT00002941|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111450049|NCT00002941|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111450050|NCT00002941|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111450051|NCT00002941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111450053|NCT00002953|Cyclophosphamide|cyclophosphamide|mesh-list
111450054|NCT00002953|Epirubicin|epirubicin|mesh-list
111450055|NCT00002953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111450056|NCT00002953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111450057|NCT00002953|Tubulin Modulators|tubulin modulators|mesh-ancestor
111450058|NCT00002953|Antimitotic Agents|antimitotic agents|mesh-ancestor
111450059|NCT00002953|Mitosis Modulators|mitosis modulators|mesh-ancestor
111450060|NCT00002953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111450061|NCT00002953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111450062|NCT00002953|Immunologic Factors|immunologic factors|mesh-ancestor
111450063|NCT00002953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111450064|NCT00002953|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111450065|NCT00002953|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111450066|NCT00002953|Alkylating Agents|alkylating agents|mesh-ancestor
111450067|NCT00002953|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111450068|NCT00002953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111450069|NCT00002953|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111450070|NCT00002953|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111450071|NCT00002953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111450072|NCT03693781|Colchicine|colchicine|mesh-list
111450073|NCT03693781|Gout Suppressants|gout suppressants|mesh-ancestor
111450074|NCT03693781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111450075|NCT03693781|Tubulin Modulators|tubulin modulators|mesh-ancestor
111450076|NCT03693781|Antimitotic Agents|antimitotic agents|mesh-ancestor
111450077|NCT03693781|Mitosis Modulators|mitosis modulators|mesh-ancestor
111450078|NCT03693781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111450079|NCT03693781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111450080|NCT02283853|Interferons|interferons|mesh-list
110911714|NCT04539808|Hematinics|hematinics|mesh-ancestor
111450081|NCT02283853|Interferon-beta|interferon-beta|mesh-list
111450082|NCT02283853|Interferon beta-1a|interferon beta-1a|mesh-list
111450083|NCT02283853|Dimethyl Fumarate|dimethyl fumarate|mesh-list
111450084|NCT02283853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111450085|NCT02283853|Antiviral Agents|antiviral agents|mesh-ancestor
111450086|NCT02283853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111450087|NCT02283853|Dermatologic Agents|dermatologic agents|mesh-ancestor
111450088|NCT02283853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111450089|NCT02283853|Immunologic Factors|immunologic factors|mesh-ancestor
111450090|NCT02283853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111450091|NCT02283853|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111450092|NCT03668041|Gabapentin|gabapentin|mesh-list
111450093|NCT03668041|Trazodone|trazodone|mesh-list
111450094|NCT03668041|Eszopiclone|eszopiclone|mesh-list
111450095|NCT03668041|Analgesics|analgesics|mesh-ancestor
111450096|NCT03668041|Sensory System Agents|sensory system agents|mesh-ancestor
110911776|NCT04477018|Iron|iron|mesh-list
111450097|NCT03668041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111450098|NCT03668041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111450099|NCT03668041|Anticonvulsants|anticonvulsants|mesh-ancestor
111450100|NCT03668041|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111450101|NCT03668041|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111450102|NCT03668041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111450103|NCT03668041|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111450104|NCT03668041|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111450105|NCT03668041|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111450106|NCT03668041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111450107|NCT03668041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111450108|NCT03668041|Antimanic Agents|antimanic agents|mesh-ancestor
111450109|NCT03668041|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111450110|NCT03668041|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111450111|NCT03668041|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111450112|NCT03668041|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111450113|NCT03668041|Serotonin Agents|serotonin agents|mesh-ancestor
111450114|NCT03668041|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111450115|NCT03668041|Antidepressive Agents|antidepressive agents|mesh-ancestor
111450116|NCT00002965|Interferons|interferons|mesh-list
111450117|NCT00002965|Interferon-alpha|interferon-alpha|mesh-list
111450118|NCT00002965|Interferon alpha-2|interferon alpha-2|mesh-list
111450119|NCT00002965|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
111450120|NCT00002965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111450121|NCT00002965|Antiviral Agents|antiviral agents|mesh-ancestor
111450122|NCT00002965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111450123|NCT00002965|Immunologic Factors|immunologic factors|mesh-ancestor
111450124|NCT00002965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111450125|NCT00002971|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
111450126|NCT00002971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110911876|NCT04409509|Antibodies|antibodies|mesh-list
111450127|NCT00002971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111450128|NCT00002971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111450129|NCT00002977|Melphalan|melphalan|mesh-list
111450130|NCT00002977|Thiotepa|thiotepa|mesh-list
111450131|NCT00002977|Immunologic Factors|immunologic factors|mesh-ancestor
111450132|NCT00002977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111450133|NCT00002977|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111450134|NCT00002977|Alkylating Agents|alkylating agents|mesh-ancestor
111450135|NCT00002977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111450136|NCT00002977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111450137|NCT00002977|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111450138|NCT00002977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111450139|NCT00003391|Antibodies|antibodies|mesh-list
111450140|NCT00003391|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111450141|NCT00003391|Immunologic Factors|immunologic factors|mesh-ancestor
110911930|NCT01418222|Leucovorin|leucovorin|mesh-list
111450142|NCT00003391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111450143|NCT00003397|Dexamethasone|dexamethasone|mesh-list
111450144|NCT00003397|Paclitaxel|paclitaxel|mesh-list
111450145|NCT00003397|Etoposide|etoposide|mesh-list
111450146|NCT00003397|Cyclophosphamide|cyclophosphamide|mesh-list
111450147|NCT00003397|Rituximab|rituximab|mesh-list
111450148|NCT00003397|Gemcitabine|gemcitabine|mesh-list
111450149|NCT00003397|Melphalan|melphalan|mesh-list
111450150|NCT00003397|Carmustine|carmustine|mesh-list
111450151|NCT00003397|Sargramostim|sargramostim|mesh-list
111450152|NCT00003397|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110911990|NCT01408082|Hormones|hormones|mesh-ancestor
111450153|NCT00003397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111450154|NCT00003397|Tubulin Modulators|tubulin modulators|mesh-ancestor
111450155|NCT00003397|Antimitotic Agents|antimitotic agents|mesh-ancestor
111450156|NCT00003397|Mitosis Modulators|mitosis modulators|mesh-ancestor
111450157|NCT00003397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111450158|NCT00003397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111450159|NCT00003397|Immunologic Factors|immunologic factors|mesh-ancestor
111450160|NCT00003397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111450161|NCT00003397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111450162|NCT00003397|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111450163|NCT00003397|Alkylating Agents|alkylating agents|mesh-ancestor
111450164|NCT00003397|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111450165|NCT00003397|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111450166|NCT00003397|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111450167|NCT00003397|Antiemetics|antiemetics|mesh-ancestor
111450168|NCT00003397|Autonomic Agents|autonomic agents|mesh-ancestor
111450169|NCT00003397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111450170|NCT00003397|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111450171|NCT00003397|Glucocorticoids|glucocorticoids|mesh-ancestor
111450172|NCT00003397|Hormones|hormones|mesh-ancestor
110912055|NCT01569919|Micronutrients|micronutrients|mesh-ancestor
111450173|NCT00003397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111450174|NCT00003397|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111450175|NCT00003397|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111450176|NCT00003397|Antimetabolites|antimetabolites|mesh-ancestor
111450177|NCT00003397|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111450178|NCT00003397|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111450179|NCT00003397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111450180|NCT00003409|Motexafin gadolinium|motexafin gadolinium|mesh-list
111450181|NCT00003409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111450182|NCT00003409|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111450183|NCT00003409|Dermatologic Agents|dermatologic agents|mesh-ancestor
111450184|NCT00003415|Topotecan|topotecan|mesh-list
111450185|NCT00003415|Amifostine|amifostine|mesh-list
111450186|NCT00003415|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111450187|NCT00003415|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111450188|NCT00003415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111450189|NCT00003415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111450190|NCT00003415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111450191|NCT00003415|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111450192|NCT00003415|Protective Agents|protective agents|mesh-ancestor
111450193|NCT00003415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111450194|NCT00002989|Cyclophosphamide|cyclophosphamide|mesh-list
111450195|NCT00002989|Melphalan|melphalan|mesh-list
111450196|NCT00002989|Busulfan|busulfan|mesh-list
111450197|NCT00002989|Idarubicin|idarubicin|mesh-list
111450198|NCT00002989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111450199|NCT00002989|Immunologic Factors|immunologic factors|mesh-ancestor
111450200|NCT00002989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111450201|NCT00002989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111450202|NCT00002989|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111450203|NCT00002989|Alkylating Agents|alkylating agents|mesh-ancestor
111450204|NCT00002989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111450205|NCT00002989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110912239|NCT05375734|Tislelizumab|tislelizumab|mesh-list
111450206|NCT00002989|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111450207|NCT00002989|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111450208|NCT00002989|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111450209|NCT00002989|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111450210|NCT00002989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111450211|NCT00002995|Dactinomycin|dactinomycin|mesh-list
111450212|NCT00002995|Cyclophosphamide|cyclophosphamide|mesh-list
111450213|NCT00002995|Vincristine|vincristine|mesh-list
111450214|NCT00002995|Sargramostim|sargramostim|mesh-list
111450215|NCT00002995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111450216|NCT00002995|Immunologic Factors|immunologic factors|mesh-ancestor
111450217|NCT00002995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111450218|NCT00002995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111450219|NCT00002995|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111450220|NCT00002995|Alkylating Agents|alkylating agents|mesh-ancestor
111450221|NCT00002995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111450222|NCT00002995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111450223|NCT00002995|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111450224|NCT00002995|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111450225|NCT00002995|Tubulin Modulators|tubulin modulators|mesh-ancestor
111450226|NCT00002995|Antimitotic Agents|antimitotic agents|mesh-ancestor
111450227|NCT00002995|Mitosis Modulators|mitosis modulators|mesh-ancestor
111450228|NCT00002995|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111450229|NCT00002995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111450230|NCT00002995|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110912374|NCT01353248|Ribavirin|ribavirin|mesh-list
111450231|NCT00002995|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111450232|NCT00002995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111450233|NCT00002995|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111450234|NCT00003001|Leucovorin|leucovorin|mesh-list
111450235|NCT00003001|Gemcitabine|gemcitabine|mesh-list
111450236|NCT00003001|Fluorouracil|fluorouracil|mesh-list
111450237|NCT00003001|Calcium|calcium|mesh-list
111450238|NCT00003001|Levoleucovorin|levoleucovorin|mesh-list
111450239|NCT00003001|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111450240|NCT00003001|Antimetabolites|antimetabolites|mesh-ancestor
111450241|NCT00003001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111450242|NCT00003001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111450243|NCT00003001|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111450244|NCT00003001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111450245|NCT00003001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111450246|NCT00003001|Immunologic Factors|immunologic factors|mesh-ancestor
111450247|NCT00003001|Antidotes|antidotes|mesh-ancestor
111450248|NCT00003001|Protective Agents|protective agents|mesh-ancestor
111450249|NCT00003001|Vitamin B Complex|vitamin b complex|mesh-ancestor
111450250|NCT00003001|Vitamins|vitamins|mesh-ancestor
111450251|NCT00003001|Micronutrients|micronutrients|mesh-ancestor
111450252|NCT00003421|Prednisolone|prednisolone|mesh-list
111450253|NCT00003421|Doxorubicin|doxorubicin|mesh-list
111450254|NCT00003421|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111450255|NCT00003421|Bleomycin|bleomycin|mesh-list
111450256|NCT00003421|Etoposide|etoposide|mesh-list
111450257|NCT00003421|Vincristine|vincristine|mesh-list
111450258|NCT00003421|Dacarbazine|dacarbazine|mesh-list
111450259|NCT00003421|Vinblastine|vinblastine|mesh-list
111450260|NCT00003421|Procarbazine|procarbazine|mesh-list
111450261|NCT00003421|Chlorambucil|chlorambucil|mesh-list
111450262|NCT00003421|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111450263|NCT00003421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111450264|NCT00003421|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111450265|NCT00003421|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111450266|NCT00003421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111450267|NCT00003421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111450268|NCT00003421|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111450269|NCT00003421|Tubulin Modulators|tubulin modulators|mesh-ancestor
111450270|NCT00003421|Antimitotic Agents|antimitotic agents|mesh-ancestor
111450271|NCT00003421|Mitosis Modulators|mitosis modulators|mesh-ancestor
110912545|NCT02090790|Glucocorticoids|glucocorticoids|mesh-ancestor
111450272|NCT00003421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111450273|NCT00003421|Glucocorticoids|glucocorticoids|mesh-ancestor
111450274|NCT00003421|Hormones|hormones|mesh-ancestor
111450275|NCT00003421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111450276|NCT00003421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111450277|NCT00003421|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111450278|NCT00003421|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111450279|NCT00003421|Alkylating Agents|alkylating agents|mesh-ancestor
111450280|NCT00003427|Oxaliplatin|oxaliplatin|mesh-list
111450281|NCT00003427|Irinotecan|irinotecan|mesh-list
111450282|NCT00003427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111450283|NCT00003427|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111450284|NCT00003427|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111450285|NCT00003427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111450286|NCT00003427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111450287|NCT00003439|Interleukin-12|interleukin-12|mesh-list
111450288|NCT00003439|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111450289|NCT00003439|Immunologic Factors|immunologic factors|mesh-ancestor
111450290|NCT00003439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111450291|NCT00003439|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111450292|NCT00003439|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111450293|NCT00003439|Growth Substances|growth substances|mesh-ancestor
111450294|NCT00003439|Growth Inhibitors|growth inhibitors|mesh-ancestor
111450295|NCT00003439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111450296|NCT00003007|Interferons|interferons|mesh-list
111450297|NCT00003007|Interferon-alpha|interferon-alpha|mesh-list
111450298|NCT00003007|Dexamethasone|dexamethasone|mesh-list
110912664|NCT04475120|Lactoferrin|lactoferrin|mesh-list
111450299|NCT00003007|Cyclophosphamide|cyclophosphamide|mesh-list
111450300|NCT00003007|Melphalan|melphalan|mesh-list
111450301|NCT00003007|Sargramostim|sargramostim|mesh-list
111450302|NCT00003007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111450303|NCT00003007|Immunologic Factors|immunologic factors|mesh-ancestor
111450304|NCT00003007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111450305|NCT00003007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111450306|NCT00003007|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111450307|NCT00003007|Alkylating Agents|alkylating agents|mesh-ancestor
111450308|NCT00003007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110912742|NCT01133990|Vitamins|vitamins|mesh-ancestor
111450309|NCT00003007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111450310|NCT00003007|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111450311|NCT00003007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111450312|NCT00003007|Antiemetics|antiemetics|mesh-ancestor
111450313|NCT00003007|Autonomic Agents|autonomic agents|mesh-ancestor
111450314|NCT00003007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111450315|NCT00003007|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111450316|NCT00003007|Glucocorticoids|glucocorticoids|mesh-ancestor
111450317|NCT00003007|Hormones|hormones|mesh-ancestor
111450318|NCT00003007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111450319|NCT00003007|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111450320|NCT00003007|Antiviral Agents|antiviral agents|mesh-ancestor
111450321|NCT00003007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111450322|NCT01478035|Phenytoin|phenytoin|mesh-list
111450323|NCT01478035|Anticonvulsants|anticonvulsants|mesh-ancestor
111450324|NCT01478035|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111450325|NCT01478035|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111450326|NCT01478035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111450327|NCT01478035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111450328|NCT01478035|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
111450329|NCT01478035|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111450330|NCT00003013|Tamoxifen|tamoxifen|mesh-list
111450331|NCT00003013|Paclitaxel|paclitaxel|mesh-list
111450332|NCT00003013|Cyclophosphamide|cyclophosphamide|mesh-list
111450333|NCT00003013|Doxorubicin|doxorubicin|mesh-list
111450334|NCT00003013|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111450335|NCT00003013|Fluorouracil|fluorouracil|mesh-list
111450336|NCT00003013|Methotrexate|methotrexate|mesh-list
111450337|NCT00003013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111450338|NCT00003013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111450339|NCT00003013|Tubulin Modulators|tubulin modulators|mesh-ancestor
111450340|NCT00003013|Antimitotic Agents|antimitotic agents|mesh-ancestor
111450341|NCT00003013|Mitosis Modulators|mitosis modulators|mesh-ancestor
111450342|NCT00003013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111450343|NCT00003013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111450344|NCT00003013|Immunologic Factors|immunologic factors|mesh-ancestor
111450345|NCT00003013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110912994|NCT02093598|Sirolimus|sirolimus|mesh-list
111450346|NCT00003013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111450347|NCT00003013|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111450348|NCT00003013|Alkylating Agents|alkylating agents|mesh-ancestor
111450349|NCT00003013|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111450350|NCT00003013|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111450351|NCT00003013|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111450352|NCT00003013|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111450353|NCT00003013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111450354|NCT00003013|Antimetabolites|antimetabolites|mesh-ancestor
111450355|NCT00003013|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111450356|NCT00003013|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111450357|NCT00003013|Abortifacient Agents|abortifacient agents|mesh-ancestor
111450358|NCT00003013|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111450359|NCT00003013|Dermatologic Agents|dermatologic agents|mesh-ancestor
111450360|NCT00003013|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111450361|NCT00003013|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111450362|NCT00003013|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111450363|NCT00003013|Hormone Antagonists|hormone antagonists|mesh-ancestor
111450364|NCT00003013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111450365|NCT00003013|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111450366|NCT00003013|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111450367|NCT00003013|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111450368|NCT00003013|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111450369|NCT00003445|Docetaxel|docetaxel|mesh-list
111450370|NCT00003445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111450371|NCT00003445|Tubulin Modulators|tubulin modulators|mesh-ancestor
111450372|NCT00003445|Antimitotic Agents|antimitotic agents|mesh-ancestor
111450373|NCT00003445|Mitosis Modulators|mitosis modulators|mesh-ancestor
111450374|NCT00003445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111450375|NCT00003451|Interferons|interferons|mesh-list
111450376|NCT00003451|Interferon-alpha|interferon-alpha|mesh-list
111450377|NCT00003451|Interleukin-12|interleukin-12|mesh-list
111450378|NCT00003451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111450379|NCT00003451|Antiviral Agents|antiviral agents|mesh-ancestor
111450380|NCT00003451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111450381|NCT00003451|Immunologic Factors|immunologic factors|mesh-ancestor
111450382|NCT00003451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111450383|NCT00003451|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111450384|NCT00003451|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111450385|NCT00003451|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111450386|NCT00003451|Growth Substances|growth substances|mesh-ancestor
111450387|NCT00003451|Growth Inhibitors|growth inhibitors|mesh-ancestor
111450388|NCT00003463|Irinotecan|irinotecan|mesh-list
111450389|NCT00003463|Carmustine|carmustine|mesh-list
111450390|NCT00003463|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111450391|NCT00003463|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111450392|NCT00003463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111450393|NCT00003463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111450394|NCT00003463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111450395|NCT00003463|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111450396|NCT00003463|Alkylating Agents|alkylating agents|mesh-ancestor
111450397|NCT00003019|Methotrexate|methotrexate|mesh-list
111450398|NCT00003019|Vinblastine|vinblastine|mesh-list
111450399|NCT00003019|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111450400|NCT00003019|Abortifacient Agents|abortifacient agents|mesh-ancestor
111450401|NCT00003019|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111450402|NCT00003019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111450403|NCT00003019|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111450404|NCT00003019|Antimetabolites|antimetabolites|mesh-ancestor
111450405|NCT00003019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111450406|NCT00003019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111450407|NCT00003019|Dermatologic Agents|dermatologic agents|mesh-ancestor
111450408|NCT00003019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111450409|NCT00003019|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111450410|NCT00003019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111450411|NCT00003019|Immunologic Factors|immunologic factors|mesh-ancestor
111450412|NCT00003019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111450413|NCT00003019|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111450414|NCT00003019|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111450415|NCT00003019|Tubulin Modulators|tubulin modulators|mesh-ancestor
111450416|NCT00003019|Antimitotic Agents|antimitotic agents|mesh-ancestor
111450417|NCT00003019|Mitosis Modulators|mitosis modulators|mesh-ancestor
111450418|NCT00003493|Dexamethasone|dexamethasone|mesh-list
111450419|NCT00003493|Doxorubicin|doxorubicin|mesh-list
111450420|NCT00003493|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111450421|NCT00003493|Vincristine|vincristine|mesh-list
111450422|NCT00003493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111450423|NCT00003493|Antiemetics|antiemetics|mesh-ancestor
111450424|NCT00003493|Autonomic Agents|autonomic agents|mesh-ancestor
111450425|NCT00003493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111450426|NCT00003493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111450427|NCT00003493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111450428|NCT00003493|Glucocorticoids|glucocorticoids|mesh-ancestor
111450429|NCT00003493|Hormones|hormones|mesh-ancestor
111450430|NCT00003493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111450431|NCT00003493|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111450432|NCT00003493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111450433|NCT00003493|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111450434|NCT00003493|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111450435|NCT00003493|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111450436|NCT00003493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111450437|NCT00003493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111450438|NCT00003493|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111450439|NCT00003493|Tubulin Modulators|tubulin modulators|mesh-ancestor
111450440|NCT00003493|Antimitotic Agents|antimitotic agents|mesh-ancestor
111450441|NCT00003493|Mitosis Modulators|mitosis modulators|mesh-ancestor
111450442|NCT00003031|Voriconazole|voriconazole|mesh-list
111450443|NCT00003031|Amphotericin B|amphotericin b|mesh-list
111450444|NCT00003031|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
111450445|NCT00003031|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
111450446|NCT00003031|Deoxycholic Acid|deoxycholic acid|mesh-list
111450447|NCT00003031|Antifungal Agents|antifungal agents|mesh-ancestor
111450448|NCT00003031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111450449|NCT00003031|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111450450|NCT00003031|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111450451|NCT00003031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111450452|NCT00003031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111450453|NCT00003031|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111450454|NCT00003031|Hormone Antagonists|hormone antagonists|mesh-ancestor
111450455|NCT00003031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111450456|NCT00003031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111450457|NCT00003031|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111450458|NCT00003031|Amebicides|amebicides|mesh-ancestor
111450459|NCT00003031|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111450460|NCT00003031|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111450461|NCT00003031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110913278|NCT05627414|Antimetabolites|antimetabolites|mesh-ancestor
111450462|NCT00003031|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
111450463|NCT00003031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111450464|NCT00003517|Leuprolide|leuprolide|mesh-list
111450465|NCT00003517|Flutamide|flutamide|mesh-list
111450466|NCT00003517|Bicalutamide|bicalutamide|mesh-list
111450467|NCT00003517|Hormones|hormones|mesh-list
111450468|NCT00003517|Androgen Antagonists|androgen antagonists|mesh-list
111450469|NCT00003517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111450470|NCT00003517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111450471|NCT00003517|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111450472|NCT00003517|Fertility Agents|fertility agents|mesh-ancestor
111450473|NCT00003517|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111450474|NCT00003517|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111450475|NCT00003517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111450476|NCT00003517|Hormone Antagonists|hormone antagonists|mesh-ancestor
111450477|NCT00003037|Gemcitabine|gemcitabine|mesh-list
111450478|NCT00003037|Docetaxel|docetaxel|mesh-list
111450479|NCT00003037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111450480|NCT00003037|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111450481|NCT00003037|Antimetabolites|antimetabolites|mesh-ancestor
111450482|NCT00003037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111450483|NCT00003037|Tubulin Modulators|tubulin modulators|mesh-ancestor
111450484|NCT00003037|Antimitotic Agents|antimitotic agents|mesh-ancestor
111450485|NCT00003037|Mitosis Modulators|mitosis modulators|mesh-ancestor
111450486|NCT00002803|Cyclophosphamide|cyclophosphamide|mesh-list
111450487|NCT00002803|Doxorubicin|doxorubicin|mesh-list
111450488|NCT00002803|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111450489|NCT00002803|Vincristine|vincristine|mesh-list
111450490|NCT00002803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111450491|NCT00002803|Immunologic Factors|immunologic factors|mesh-ancestor
111450492|NCT00002803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111450493|NCT00002803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111450494|NCT00002803|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111450495|NCT00002803|Alkylating Agents|alkylating agents|mesh-ancestor
111450496|NCT00002803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111450497|NCT00002803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111450498|NCT00002803|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111450499|NCT00002803|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111450500|NCT00002803|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111450501|NCT00002803|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111450502|NCT00002803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111450503|NCT00002803|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111450504|NCT00002803|Tubulin Modulators|tubulin modulators|mesh-ancestor
111450505|NCT00002803|Antimitotic Agents|antimitotic agents|mesh-ancestor
111450506|NCT00002803|Mitosis Modulators|mitosis modulators|mesh-ancestor
111450507|NCT00383929|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
111450508|NCT00383929|Candesartan|candesartan|mesh-list
111450509|NCT00383929|Candesartan cilexetil|candesartan cilexetil|mesh-list
111450510|NCT00383929|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111450511|NCT00383929|Diuretics|diuretics|mesh-ancestor
111450512|NCT00383929|Natriuretic Agents|natriuretic agents|mesh-ancestor
111450513|NCT00383929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111450514|NCT00383929|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
111450515|NCT00383929|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111450516|NCT00383929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111450517|NCT00383929|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111450518|NCT00383929|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111450519|NCT00003541|Prednisone|prednisone|mesh-list
111450520|NCT00003541|Cyclophosphamide|cyclophosphamide|mesh-list
111450521|NCT00003541|Ifosfamide|ifosfamide|mesh-list
111450522|NCT00003541|Carboplatin|carboplatin|mesh-list
111450523|NCT00003541|Doxorubicin|doxorubicin|mesh-list
111450524|NCT00003541|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111450525|NCT00003541|Etoposide|etoposide|mesh-list
111450526|NCT00003541|Vincristine|vincristine|mesh-list
111450527|NCT00003541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111450528|NCT00003541|Immunologic Factors|immunologic factors|mesh-ancestor
111450529|NCT00003541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111450530|NCT00003541|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111450531|NCT00003541|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111450532|NCT00003541|Alkylating Agents|alkylating agents|mesh-ancestor
111450533|NCT00003541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111450534|NCT00003541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111450535|NCT00003541|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111450536|NCT00003541|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111450537|NCT00003541|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111450538|NCT00003541|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111450539|NCT00003541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111450540|NCT00003541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111450541|NCT00003541|Glucocorticoids|glucocorticoids|mesh-ancestor
111450542|NCT00003541|Hormones|hormones|mesh-ancestor
111450543|NCT00003541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111450544|NCT00003541|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111450545|NCT00003541|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111450546|NCT00003541|Tubulin Modulators|tubulin modulators|mesh-ancestor
111450547|NCT00003541|Antimitotic Agents|antimitotic agents|mesh-ancestor
111450548|NCT00003541|Mitosis Modulators|mitosis modulators|mesh-ancestor
111450549|NCT00002809|Cyclophosphamide|cyclophosphamide|mesh-list
111450550|NCT00002809|Methotrexate|methotrexate|mesh-list
111450551|NCT00002809|Tacrolimus|tacrolimus|mesh-list
111450552|NCT00002809|Antilymphocyte Serum|antilymphocyte serum|mesh-list
111450553|NCT00002809|Sargramostim|sargramostim|mesh-list
111450554|NCT00002809|Immunoglobulins|immunoglobulins|mesh-list
111450555|NCT00002809|Antibodies|antibodies|mesh-list
111450556|NCT00002809|gamma-Globulins|gamma-globulins|mesh-list
111450557|NCT00002809|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111450558|NCT00002809|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
111450559|NCT00002809|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111450560|NCT00002809|Immunologic Factors|immunologic factors|mesh-ancestor
111450561|NCT00002809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111450562|NCT00002809|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111450563|NCT00002809|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111450564|NCT00002809|Alkylating Agents|alkylating agents|mesh-ancestor
111450565|NCT00002809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111450566|NCT00002809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111450567|NCT00002809|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111450568|NCT00002809|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111450569|NCT00002809|Abortifacient Agents|abortifacient agents|mesh-ancestor
111450570|NCT00002809|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111450571|NCT00002809|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111450572|NCT00002809|Antimetabolites|antimetabolites|mesh-ancestor
111450573|NCT00002809|Dermatologic Agents|dermatologic agents|mesh-ancestor
111450574|NCT00002809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111450575|NCT00002809|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111450576|NCT00002809|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111450577|NCT00002809|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111450578|NCT00383539|Vaccines|vaccines|mesh-list
111450579|NCT00383539|Immunologic Factors|immunologic factors|mesh-ancestor
111450580|NCT00383539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111450581|NCT00002827|Cobalt|cobalt|mesh-list
111450582|NCT00002827|Doxorubicin|doxorubicin|mesh-list
111450583|NCT00002827|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111450584|NCT00002827|Bleomycin|bleomycin|mesh-list
111450585|NCT00002827|Etoposide|etoposide|mesh-list
111450586|NCT00002827|Dexrazoxane|dexrazoxane|mesh-list
111450587|NCT00002827|Vincristine|vincristine|mesh-list
111450588|NCT00002827|Razoxane|razoxane|mesh-list
111450589|NCT00002827|Lenograstim|lenograstim|mesh-list
111450590|NCT00002827|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110913656|NCT00884234|Botulinum Toxins|botulinum toxins|mesh-list
111450591|NCT00002827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111450592|NCT00002827|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111450593|NCT00002827|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111450594|NCT00002827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111450595|NCT00002827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111450596|NCT00002827|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111450597|NCT00002827|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111450598|NCT00002827|Immunologic Factors|immunologic factors|mesh-ancestor
111450599|NCT00002827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111450600|NCT00002827|Tubulin Modulators|tubulin modulators|mesh-ancestor
111450601|NCT00002827|Antimitotic Agents|antimitotic agents|mesh-ancestor
111450602|NCT00002827|Mitosis Modulators|mitosis modulators|mesh-ancestor
111450603|NCT00002827|Trace Elements|trace elements|mesh-ancestor
111450604|NCT00002827|Micronutrients|micronutrients|mesh-ancestor
111450605|NCT00002827|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111450606|NCT00002827|Protective Agents|protective agents|mesh-ancestor
111450607|NCT00384475|Ciclesonide|ciclesonide|mesh-list
111450608|NCT00384475|Glucocorticoids|glucocorticoids|mesh-ancestor
111450609|NCT00384475|Hormones|hormones|mesh-ancestor
111450610|NCT00384475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111450611|NCT00384475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111450612|NCT00384475|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111450613|NCT00003565|Docetaxel|docetaxel|mesh-list
111450614|NCT00003565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111450615|NCT00003565|Tubulin Modulators|tubulin modulators|mesh-ancestor
111450616|NCT00003565|Antimitotic Agents|antimitotic agents|mesh-ancestor
111450617|NCT00003565|Mitosis Modulators|mitosis modulators|mesh-ancestor
111450618|NCT00003565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111450619|NCT00003049|Leucovorin|leucovorin|mesh-list
111450620|NCT00003049|Fluorouracil|fluorouracil|mesh-list
111450621|NCT00003049|Calcium|calcium|mesh-list
111450622|NCT00003049|Levoleucovorin|levoleucovorin|mesh-list
111450623|NCT00003049|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111450624|NCT00003049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111450625|NCT00003049|Antimetabolites|antimetabolites|mesh-ancestor
111450626|NCT00003049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111450627|NCT00003049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111450628|NCT00003049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111450629|NCT00003049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111450630|NCT00003049|Immunologic Factors|immunologic factors|mesh-ancestor
111450631|NCT00003049|Antidotes|antidotes|mesh-ancestor
111450632|NCT00003049|Protective Agents|protective agents|mesh-ancestor
111450633|NCT00003049|Vitamin B Complex|vitamin b complex|mesh-ancestor
111450634|NCT00003049|Vitamins|vitamins|mesh-ancestor
111450635|NCT00003049|Micronutrients|micronutrients|mesh-ancestor
111450636|NCT00003055|Irinotecan|irinotecan|mesh-list
111450637|NCT00003055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111450638|NCT00003055|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111450639|NCT00003055|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111450640|NCT00003055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111450641|NCT00003055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111450642|NCT00002833|Cytarabine|cytarabine|mesh-list
111450643|NCT00002833|Cyclosporine|cyclosporine|mesh-list
111450644|NCT00002833|Methylprednisolone|methylprednisolone|mesh-list
111450645|NCT00002833|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111450646|NCT00002833|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111450647|NCT00002833|Prednisolone|prednisolone|mesh-list
111450648|NCT00002833|Prednisolone acetate|prednisolone acetate|mesh-list
111450649|NCT00002833|Fludarabine|fludarabine|mesh-list
111450650|NCT00002833|Fludarabine phosphate|fludarabine phosphate|mesh-list
111450651|NCT00002833|Idarubicin|idarubicin|mesh-list
111450652|NCT00002833|Cladribine|cladribine|mesh-list
111450653|NCT00002833|Cyclosporins|cyclosporins|mesh-list
111450654|NCT00002833|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111450655|NCT00002833|Prednisolone phosphate|prednisolone phosphate|mesh-list
111450656|NCT00002833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111450657|NCT00002833|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111450658|NCT00002833|Antimetabolites|antimetabolites|mesh-ancestor
111450659|NCT00002833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111450660|NCT00002833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111450661|NCT00002833|Immunologic Factors|immunologic factors|mesh-ancestor
111450662|NCT00002833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111450663|NCT00002833|Antiviral Agents|antiviral agents|mesh-ancestor
111450664|NCT00002833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111450665|NCT00002833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111450666|NCT00002833|Antifungal Agents|antifungal agents|mesh-ancestor
111450667|NCT00002833|Dermatologic Agents|dermatologic agents|mesh-ancestor
111450668|NCT00002833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111450669|NCT00002833|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111450670|NCT00002833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111450671|NCT00002833|Antiemetics|antiemetics|mesh-ancestor
111450672|NCT00002833|Autonomic Agents|autonomic agents|mesh-ancestor
111450673|NCT00002833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111450674|NCT00002833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111450675|NCT00002833|Glucocorticoids|glucocorticoids|mesh-ancestor
111450676|NCT00002833|Hormones|hormones|mesh-ancestor
111450677|NCT00002833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111450678|NCT00002833|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111450679|NCT00002833|Protective Agents|protective agents|mesh-ancestor
111450680|NCT00002833|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111450681|NCT00002833|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111450682|NCT00002833|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111450683|NCT00002833|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111450684|NCT00003061|Cytarabine|cytarabine|mesh-list
111450685|NCT00003061|Methotrexate|methotrexate|mesh-list
111450686|NCT00003061|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111450687|NCT00003061|Abortifacient Agents|abortifacient agents|mesh-ancestor
111450688|NCT00003061|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111450689|NCT00003061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111450690|NCT00003061|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111450691|NCT00003061|Antimetabolites|antimetabolites|mesh-ancestor
111450692|NCT00003061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111450693|NCT00003061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111450694|NCT00003061|Dermatologic Agents|dermatologic agents|mesh-ancestor
111450695|NCT00003061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111450696|NCT00003061|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111450697|NCT00003061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111450698|NCT00003061|Immunologic Factors|immunologic factors|mesh-ancestor
111450699|NCT00003061|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111450700|NCT00003061|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111450701|NCT00003061|Antiviral Agents|antiviral agents|mesh-ancestor
111450702|NCT00003061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111450703|NCT00003577|Cyclophosphamide|cyclophosphamide|mesh-list
111450704|NCT00003577|Fluorouracil|fluorouracil|mesh-list
111450705|NCT00003577|Methotrexate|methotrexate|mesh-list
111450706|NCT00003577|Epirubicin|epirubicin|mesh-list
111450707|NCT00003577|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111450708|NCT00003577|Immunologic Factors|immunologic factors|mesh-ancestor
111450709|NCT00003577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111450710|NCT00003577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111450711|NCT00003577|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111450712|NCT00003577|Alkylating Agents|alkylating agents|mesh-ancestor
111450713|NCT00003577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111450714|NCT00003577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111450715|NCT00003577|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111450716|NCT00003577|Antimetabolites|antimetabolites|mesh-ancestor
111450717|NCT00003577|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111450718|NCT00003577|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111450719|NCT00003577|Abortifacient Agents|abortifacient agents|mesh-ancestor
111450720|NCT00003577|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111450721|NCT00003577|Dermatologic Agents|dermatologic agents|mesh-ancestor
111450722|NCT00003577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111450723|NCT00003577|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111450724|NCT00003577|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111450725|NCT00003577|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111450726|NCT00003577|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111450727|NCT00003577|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111450728|NCT00002839|Fluorouracil|fluorouracil|mesh-list
111450729|NCT00002839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111450730|NCT00002839|Antimetabolites|antimetabolites|mesh-ancestor
111450731|NCT00002839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111450732|NCT00002839|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111450733|NCT00002839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111450734|NCT00002839|Immunologic Factors|immunologic factors|mesh-ancestor
111450735|NCT00002839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111450736|NCT00003583|Etoposide|etoposide|mesh-list
111450737|NCT00003583|Amifostine|amifostine|mesh-list
111450738|NCT00003583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111450739|NCT00003583|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111450740|NCT00003583|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111450741|NCT00003583|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111450742|NCT00003583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111450743|NCT00003583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111450744|NCT00003583|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111450745|NCT00003583|Protective Agents|protective agents|mesh-ancestor
111450746|NCT00003583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111450747|NCT00002845|Aldesleukin|aldesleukin|mesh-list
111450748|NCT00002845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111450749|NCT00002845|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111450750|NCT00002845|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111450751|NCT00002845|Antiviral Agents|antiviral agents|mesh-ancestor
111450752|NCT00002845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111450753|NCT00003067|Aldesleukin|aldesleukin|mesh-list
111450754|NCT00003067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111450755|NCT00003067|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111450756|NCT00003067|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111450757|NCT00003067|Antiviral Agents|antiviral agents|mesh-ancestor
111450758|NCT00003067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111450759|NCT00003589|Paclitaxel|paclitaxel|mesh-list
111450760|NCT00003589|Gemcitabine|gemcitabine|mesh-list
111450761|NCT00003589|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111450762|NCT00003589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111450763|NCT00003589|Tubulin Modulators|tubulin modulators|mesh-ancestor
111450764|NCT00003589|Antimitotic Agents|antimitotic agents|mesh-ancestor
111450765|NCT00003589|Mitosis Modulators|mitosis modulators|mesh-ancestor
111450766|NCT00003589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111450767|NCT00003589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111450768|NCT00003589|Antimetabolites|antimetabolites|mesh-ancestor
111450769|NCT00003595|Prednisone|prednisone|mesh-list
111450770|NCT00003595|Cyclophosphamide|cyclophosphamide|mesh-list
111450771|NCT00003595|Rituximab|rituximab|mesh-list
111450772|NCT00003595|Doxorubicin|doxorubicin|mesh-list
111450773|NCT00003595|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111450774|NCT00003595|Vincristine|vincristine|mesh-list
111450775|NCT00003595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111450776|NCT00003595|Immunologic Factors|immunologic factors|mesh-ancestor
111450777|NCT00003595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111450778|NCT00003595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111450779|NCT00003595|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111450780|NCT00003595|Alkylating Agents|alkylating agents|mesh-ancestor
111450781|NCT00003595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111450782|NCT00003595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111450783|NCT00003595|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111450784|NCT00003595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111450785|NCT00003595|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111450786|NCT00003595|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111450787|NCT00003595|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111450788|NCT00003595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111450789|NCT00003595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111450790|NCT00003595|Glucocorticoids|glucocorticoids|mesh-ancestor
111450791|NCT00003595|Hormones|hormones|mesh-ancestor
111450792|NCT00003595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111450793|NCT00003595|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111450794|NCT00003595|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110914436|NCT03629639|Metformin|metformin|mesh-list
111450795|NCT00003595|Tubulin Modulators|tubulin modulators|mesh-ancestor
111450796|NCT00003595|Antimitotic Agents|antimitotic agents|mesh-ancestor
111450797|NCT00003595|Mitosis Modulators|mitosis modulators|mesh-ancestor
111450798|NCT00003073|Cytarabine|cytarabine|mesh-list
111450799|NCT00003073|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111450800|NCT00003073|Antimetabolites|antimetabolites|mesh-ancestor
111450801|NCT00003073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111450802|NCT00003073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111450803|NCT00003073|Antiviral Agents|antiviral agents|mesh-ancestor
111450804|NCT00003073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111174989|NCT01743027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111450805|NCT00003073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111450806|NCT00003073|Immunologic Factors|immunologic factors|mesh-ancestor
111450807|NCT00003073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111450808|NCT00003079|Cytarabine|cytarabine|mesh-list
111450809|NCT00003079|Bryostatin 1|bryostatin 1|mesh-list
110914479|NCT05200793|Protease Inhibitors|protease inhibitors|mesh-ancestor
111450810|NCT00003079|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111450811|NCT00003079|Antimetabolites|antimetabolites|mesh-ancestor
111450812|NCT00003079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111450813|NCT00003079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111450814|NCT00003079|Antiviral Agents|antiviral agents|mesh-ancestor
111450815|NCT00003079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111450816|NCT00003079|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111450817|NCT00003079|Immunologic Factors|immunologic factors|mesh-ancestor
111450818|NCT00003079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111450819|NCT00003079|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111450820|NCT00002869|Interferons|interferons|mesh-list
111450821|NCT00002869|Cytarabine|cytarabine|mesh-list
111450822|NCT00002869|Interferon-alpha|interferon-alpha|mesh-list
111450823|NCT00002869|Hydroxyurea|hydroxyurea|mesh-list
111450824|NCT00002869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111450825|NCT00002869|Antiviral Agents|antiviral agents|mesh-ancestor
111450826|NCT00002869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111450827|NCT00002869|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111450828|NCT00002869|Antimetabolites|antimetabolites|mesh-ancestor
111450829|NCT00002869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111450830|NCT00002869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111450831|NCT00002869|Immunologic Factors|immunologic factors|mesh-ancestor
111450832|NCT00002869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111450833|NCT00002869|Antisickling Agents|antisickling agents|mesh-ancestor
111450834|NCT00002869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111450835|NCT00002869|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111450836|NCT00002875|Cyclophosphamide|cyclophosphamide|mesh-list
111450837|NCT00002875|Lomustine|lomustine|mesh-list
111450838|NCT00002875|Cisplatin|cisplatin|mesh-list
111450839|NCT00002875|Vincristine|vincristine|mesh-list
111450840|NCT00002875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111450841|NCT00002875|Immunologic Factors|immunologic factors|mesh-ancestor
111450842|NCT00002875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111450843|NCT00002875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111450844|NCT00002875|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111450845|NCT00002875|Alkylating Agents|alkylating agents|mesh-ancestor
111450846|NCT00002875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111450847|NCT00002875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111450848|NCT00002875|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111450849|NCT00002875|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111450850|NCT00002875|Tubulin Modulators|tubulin modulators|mesh-ancestor
111450851|NCT00002875|Antimitotic Agents|antimitotic agents|mesh-ancestor
111450852|NCT00002875|Mitosis Modulators|mitosis modulators|mesh-ancestor
111450853|NCT00003613|Carmustine|carmustine|mesh-list
111450854|NCT00003613|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
111450855|NCT00003613|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111450856|NCT00003613|Alkylating Agents|alkylating agents|mesh-ancestor
111450857|NCT00003613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111450858|NCT00003613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111450859|NCT00003613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111450860|NCT00002881|Suramin|suramin|mesh-list
111450861|NCT00002881|Hydrocortisone|hydrocortisone|mesh-list
111450862|NCT00002881|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
111450863|NCT00002881|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
111450864|NCT00002881|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
111450865|NCT00002881|Leuprolide|leuprolide|mesh-list
111450866|NCT00002881|Goserelin|goserelin|mesh-list
111450867|NCT00002881|Flutamide|flutamide|mesh-list
111450868|NCT00002881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111450869|NCT00002881|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111450870|NCT00002881|Fertility Agents|fertility agents|mesh-ancestor
111450871|NCT00002881|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111450872|NCT00002881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111450873|NCT00002881|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111450874|NCT00002881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110914710|NCT04365985|Naltrexone|naltrexone|mesh-list
111450875|NCT00002881|Androgen Antagonists|androgen antagonists|mesh-ancestor
111450876|NCT00002881|Hormone Antagonists|hormone antagonists|mesh-ancestor
111450877|NCT00002881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111450878|NCT00002881|Antinematodal Agents|antinematodal agents|mesh-ancestor
111450879|NCT00002881|Anthelmintics|anthelmintics|mesh-ancestor
111450880|NCT00002881|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111450881|NCT00002881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111450882|NCT00002881|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
111450883|NCT00002881|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111450884|NCT00003091|Interferons|interferons|mesh-list
111450885|NCT00003091|Interferon-alpha|interferon-alpha|mesh-list
111450886|NCT00003091|Aldesleukin|aldesleukin|mesh-list
111450887|NCT00003091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111450888|NCT00003091|Antiviral Agents|antiviral agents|mesh-ancestor
111450889|NCT00003091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111450890|NCT00003091|Immunologic Factors|immunologic factors|mesh-ancestor
111450891|NCT00003091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111450892|NCT00003091|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111450893|NCT00003091|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111450894|NCT00003619|Vitamin E|vitamin e|mesh-list
111450895|NCT00003619|Cytarabine|cytarabine|mesh-list
111450896|NCT00003619|Fludarabine|fludarabine|mesh-list
111450897|NCT00003619|Fludarabine phosphate|fludarabine phosphate|mesh-list
111450898|NCT00003619|Etoposide|etoposide|mesh-list
111450899|NCT00003619|Busulfan|busulfan|mesh-list
111450900|NCT00003619|Topotecan|topotecan|mesh-list
111450901|NCT00003619|Isotretinoin|isotretinoin|mesh-list
111450902|NCT00003619|Vitamins|vitamins|mesh-ancestor
111450903|NCT00003619|Micronutrients|micronutrients|mesh-ancestor
111450904|NCT00003619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111450905|NCT00003619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111450906|NCT00003619|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111450907|NCT00003619|Antimetabolites|antimetabolites|mesh-ancestor
111450908|NCT00003619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111450909|NCT00003619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111450910|NCT00003619|Immunologic Factors|immunologic factors|mesh-ancestor
111450911|NCT00003619|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111450912|NCT00003619|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111450913|NCT00003619|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111450914|NCT00003619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111450915|NCT00003619|Antiviral Agents|antiviral agents|mesh-ancestor
111450916|NCT00003619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111450917|NCT00003619|Alkylating Agents|alkylating agents|mesh-ancestor
111450918|NCT00003619|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111450919|NCT00003619|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111450920|NCT00003619|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110914985|NCT05156879|Hormones|hormones|mesh-ancestor
111450921|NCT00003619|Antioxidants|antioxidants|mesh-ancestor
111450922|NCT00003619|Protective Agents|protective agents|mesh-ancestor
111450923|NCT00003619|Dermatologic Agents|dermatologic agents|mesh-ancestor
111450924|NCT00002887|Etoposide|etoposide|mesh-list
111450925|NCT00002887|Vinorelbine|vinorelbine|mesh-list
111450926|NCT00002887|Hydroxyurea|hydroxyurea|mesh-list
111450927|NCT00002887|Vinblastine|vinblastine|mesh-list
111450928|NCT00002887|Vindesine|vindesine|mesh-list
111450929|NCT00002887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111450930|NCT00002887|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111450931|NCT00002887|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111450932|NCT00002887|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110632589|NCT00881088|PENTA|penta|mesh-list
111450933|NCT00002887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111450934|NCT00002887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111450935|NCT00002887|Tubulin Modulators|tubulin modulators|mesh-ancestor
111450936|NCT00002887|Antimitotic Agents|antimitotic agents|mesh-ancestor
111450937|NCT00002887|Mitosis Modulators|mitosis modulators|mesh-ancestor
111450938|NCT00002887|Antisickling Agents|antisickling agents|mesh-ancestor
111450939|NCT00002887|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111450940|NCT00003937|Cisplatin|cisplatin|mesh-list
111450941|NCT00003937|Doxorubicin|doxorubicin|mesh-list
111450942|NCT00003937|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111450943|NCT00003937|Methotrexate|methotrexate|mesh-list
111450944|NCT00003937|Etoposide|etoposide|mesh-list
111450945|NCT00003937|Ifosfamide|ifosfamide|mesh-list
111450946|NCT00003937|Dexrazoxane|dexrazoxane|mesh-list
111450947|NCT00003937|Razoxane|razoxane|mesh-list
111450948|NCT00003937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111450949|NCT00003937|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111450950|NCT00003937|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111450951|NCT00003937|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111450952|NCT00003937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111450953|NCT00003937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111450954|NCT00003937|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111450955|NCT00003937|Abortifacient Agents|abortifacient agents|mesh-ancestor
111450956|NCT00003937|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111450957|NCT00003937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111450958|NCT00003937|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111450959|NCT00003937|Antimetabolites|antimetabolites|mesh-ancestor
111450960|NCT00003937|Dermatologic Agents|dermatologic agents|mesh-ancestor
111450961|NCT00003937|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111450962|NCT00003937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111450963|NCT00003937|Immunologic Factors|immunologic factors|mesh-ancestor
111450964|NCT00003937|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111450965|NCT00003937|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111450966|NCT00003937|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111450967|NCT00003937|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111450968|NCT00003937|Alkylating Agents|alkylating agents|mesh-ancestor
111450969|NCT00003937|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110915213|NCT04917029|Analgesics|analgesics|mesh-ancestor
111450970|NCT00003937|Protective Agents|protective agents|mesh-ancestor
111450971|NCT00003937|Antimitotic Agents|antimitotic agents|mesh-ancestor
111450972|NCT00003937|Mitosis Modulators|mitosis modulators|mesh-ancestor
111450973|NCT00003625|Cyclosporine|cyclosporine|mesh-list
111450974|NCT00003625|Etoposide|etoposide|mesh-list
111450975|NCT00003625|Vincristine|vincristine|mesh-list
111450976|NCT00003625|Cyclosporins|cyclosporins|mesh-list
111450977|NCT00003625|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111450978|NCT00003625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111450979|NCT00003625|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111450980|NCT00003625|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111450981|NCT00003625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111450982|NCT00003625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111450983|NCT00003625|Tubulin Modulators|tubulin modulators|mesh-ancestor
111450984|NCT00003625|Antimitotic Agents|antimitotic agents|mesh-ancestor
111450985|NCT00003625|Mitosis Modulators|mitosis modulators|mesh-ancestor
111450986|NCT00003625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111450987|NCT00003625|Immunologic Factors|immunologic factors|mesh-ancestor
111450988|NCT00003625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111450989|NCT00003625|Antifungal Agents|antifungal agents|mesh-ancestor
111450990|NCT00003625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111450991|NCT00003625|Dermatologic Agents|dermatologic agents|mesh-ancestor
111450992|NCT00003625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111450993|NCT00003625|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111450994|NCT00003637|Fluorouracil|fluorouracil|mesh-list
111450995|NCT00003637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111450996|NCT00003637|Antimetabolites|antimetabolites|mesh-ancestor
111450997|NCT00003637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111450998|NCT00003637|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111450999|NCT00003637|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111451000|NCT00003637|Immunologic Factors|immunologic factors|mesh-ancestor
111451001|NCT00003637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111451002|NCT00003943|Paclitaxel|paclitaxel|mesh-list
111451003|NCT00003943|Cyclophosphamide|cyclophosphamide|mesh-list
111451004|NCT00003943|Carboplatin|carboplatin|mesh-list
111451005|NCT00003943|Topotecan|topotecan|mesh-list
110915403|NCT00486512|Antipyretics|antipyretics|mesh-ancestor
111451006|NCT00003943|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111451007|NCT00003943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111451008|NCT00003943|Tubulin Modulators|tubulin modulators|mesh-ancestor
111451009|NCT00003943|Antimitotic Agents|antimitotic agents|mesh-ancestor
111451010|NCT00003943|Mitosis Modulators|mitosis modulators|mesh-ancestor
111451011|NCT00003943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111451012|NCT00003943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111451013|NCT00003943|Immunologic Factors|immunologic factors|mesh-ancestor
111451014|NCT00003943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111451015|NCT00003943|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110915466|NCT02774590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111451016|NCT00003943|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111451017|NCT00003943|Alkylating Agents|alkylating agents|mesh-ancestor
111451018|NCT00003943|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111451019|NCT00003943|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111451020|NCT00003943|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111451021|NCT00003943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111451022|NCT00003955|Dactinomycin|dactinomycin|mesh-list
111451023|NCT00003955|Cyclophosphamide|cyclophosphamide|mesh-list
111451024|NCT00003955|Irinotecan|irinotecan|mesh-list
111451025|NCT00003955|Vincristine|vincristine|mesh-list
111451026|NCT00003955|Sargramostim|sargramostim|mesh-list
111451027|NCT00003955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111451028|NCT00003955|Immunologic Factors|immunologic factors|mesh-ancestor
111451029|NCT00003955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111451030|NCT00003955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110915537|NCT03314181|Hormones|hormones|mesh-ancestor
111451031|NCT00003955|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111451032|NCT00003955|Alkylating Agents|alkylating agents|mesh-ancestor
111451033|NCT00003955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111451034|NCT00003955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111451035|NCT00003955|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111451036|NCT00003955|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111451037|NCT00003955|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111451038|NCT00003955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111451039|NCT00003955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111451040|NCT00003955|Tubulin Modulators|tubulin modulators|mesh-ancestor
111451041|NCT00003955|Antimitotic Agents|antimitotic agents|mesh-ancestor
111451042|NCT00003955|Mitosis Modulators|mitosis modulators|mesh-ancestor
111451043|NCT00003955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111451044|NCT00003955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111451045|NCT00003955|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111451046|NCT00003955|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111451047|NCT00003955|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111451049|NCT00003103|Oblimersen|oblimersen|mesh-list
111451050|NCT00003103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111451051|NCT00003103|Tubulin Modulators|tubulin modulators|mesh-ancestor
111451052|NCT00003103|Antimitotic Agents|antimitotic agents|mesh-ancestor
111451053|NCT00003103|Mitosis Modulators|mitosis modulators|mesh-ancestor
111451054|NCT00003103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111451055|NCT00003109|Irinotecan|irinotecan|mesh-list
111451056|NCT00003109|Raltitrexed|raltitrexed|mesh-list
111451057|NCT00003109|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111451058|NCT00003109|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111451059|NCT00003109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111451060|NCT00003109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111451061|NCT00003109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111451062|NCT00003109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111451063|NCT00003109|Antimetabolites|antimetabolites|mesh-ancestor
111451064|NCT00003109|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111451065|NCT00003643|Paclitaxel|paclitaxel|mesh-list
111451066|NCT00003643|Etoposide|etoposide|mesh-list
111451067|NCT00003643|Bleomycin|bleomycin|mesh-list
111451068|NCT00003643|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111451069|NCT00003643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111451070|NCT00003643|Tubulin Modulators|tubulin modulators|mesh-ancestor
111451071|NCT00003643|Antimitotic Agents|antimitotic agents|mesh-ancestor
111451072|NCT00003643|Mitosis Modulators|mitosis modulators|mesh-ancestor
111451073|NCT00003643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111451074|NCT00003643|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111451075|NCT00003643|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111451076|NCT00003643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111451077|NCT00003643|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111451078|NCT00003961|Sargramostim|sargramostim|mesh-list
111451079|NCT00003961|Immunologic Factors|immunologic factors|mesh-ancestor
111451080|NCT00003961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111451081|NCT00003661|Cyclosporine|cyclosporine|mesh-list
111451082|NCT00003661|Methylprednisolone|methylprednisolone|mesh-list
111451083|NCT00003661|Melphalan|melphalan|mesh-list
111451084|NCT00003661|Busulfan|busulfan|mesh-list
111451085|NCT00003661|Cyclosporins|cyclosporins|mesh-list
111451086|NCT00003661|Antilymphocyte Serum|antilymphocyte serum|mesh-list
111451087|NCT00003661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111451088|NCT00003661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111451089|NCT00003661|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111451090|NCT00003661|Immunologic Factors|immunologic factors|mesh-ancestor
111451091|NCT00003661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111451092|NCT00003661|Antifungal Agents|antifungal agents|mesh-ancestor
111451093|NCT00003661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111451094|NCT00003661|Dermatologic Agents|dermatologic agents|mesh-ancestor
111451095|NCT00003661|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111451096|NCT00003661|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111451097|NCT00003661|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111451098|NCT00003661|Antiemetics|antiemetics|mesh-ancestor
111451099|NCT00003661|Autonomic Agents|autonomic agents|mesh-ancestor
111451100|NCT00003661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111451101|NCT00003661|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111451102|NCT00003661|Glucocorticoids|glucocorticoids|mesh-ancestor
111451103|NCT00003661|Hormones|hormones|mesh-ancestor
111451104|NCT00003661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111451105|NCT00003661|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111451106|NCT00003661|Protective Agents|protective agents|mesh-ancestor
111451107|NCT00003661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111451108|NCT00003661|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111451109|NCT00003661|Alkylating Agents|alkylating agents|mesh-ancestor
111451110|NCT00003661|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111451111|NCT00003967|Etoposide|etoposide|mesh-list
111451112|NCT00003967|Topotecan|topotecan|mesh-list
111451113|NCT00003967|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111451114|NCT00003967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111451115|NCT00003967|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111451116|NCT00003967|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111451117|NCT00003967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111451118|NCT00003967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111451119|NCT00003967|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111451120|NCT00003115|Hydromorphone|hydromorphone|mesh-list
111451121|NCT00003115|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111451122|NCT00003115|Narcotics|narcotics|mesh-ancestor
111451123|NCT00003115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111451124|NCT00003115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111451125|NCT00003115|Analgesics|analgesics|mesh-ancestor
111451126|NCT00003115|Sensory System Agents|sensory system agents|mesh-ancestor
111451127|NCT00003115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111451128|NCT00003667|Cyclophosphamide|cyclophosphamide|mesh-list
111451129|NCT00003667|Doxorubicin|doxorubicin|mesh-list
111451130|NCT00003667|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111451131|NCT00003667|Vincristine|vincristine|mesh-list
111451132|NCT00003667|Dexrazoxane|dexrazoxane|mesh-list
111451133|NCT00003667|Razoxane|razoxane|mesh-list
111451134|NCT00003667|Glycerol|glycerol|mesh-list
111451135|NCT00003667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111451136|NCT00003667|Immunologic Factors|immunologic factors|mesh-ancestor
111451137|NCT00003667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111451138|NCT00003667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111451139|NCT00003667|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111451140|NCT00003667|Alkylating Agents|alkylating agents|mesh-ancestor
111451141|NCT00003667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111451142|NCT00003667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111451143|NCT00003667|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111451144|NCT00003667|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111451145|NCT00003667|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111451146|NCT00003667|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111451147|NCT00003667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111451148|NCT00003667|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111451149|NCT00003667|Tubulin Modulators|tubulin modulators|mesh-ancestor
111451150|NCT00003667|Antimitotic Agents|antimitotic agents|mesh-ancestor
111451151|NCT00003667|Mitosis Modulators|mitosis modulators|mesh-ancestor
111451152|NCT00003667|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
111451153|NCT00003667|Protective Agents|protective agents|mesh-ancestor
111451154|NCT00003667|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111451155|NCT00003673|Gemtuzumab|gemtuzumab|mesh-list
111451156|NCT00003673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111451157|NCT00003673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111451158|NCT00003673|Immunotoxins|immunotoxins|mesh-ancestor
111451159|NCT00003673|Immunoconjugates|immunoconjugates|mesh-ancestor
111451160|NCT00003673|Immunologic Factors|immunologic factors|mesh-ancestor
111451161|NCT00003673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111451162|NCT00003679|Tamoxifen|tamoxifen|mesh-list
111451163|NCT00003679|Cyclophosphamide|cyclophosphamide|mesh-list
111451164|NCT00003679|Docetaxel|docetaxel|mesh-list
111451165|NCT00003679|Doxorubicin|doxorubicin|mesh-list
111451166|NCT00003679|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111451167|NCT00003679|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111451168|NCT00003679|Immunologic Factors|immunologic factors|mesh-ancestor
111451169|NCT00003679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111451170|NCT00003679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110916146|NCT04368364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111451171|NCT00003679|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111451172|NCT00003679|Alkylating Agents|alkylating agents|mesh-ancestor
111451173|NCT00003679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111451174|NCT00003679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111451175|NCT00003679|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111451176|NCT00003679|Tubulin Modulators|tubulin modulators|mesh-ancestor
111451177|NCT00003679|Antimitotic Agents|antimitotic agents|mesh-ancestor
111451178|NCT00003679|Mitosis Modulators|mitosis modulators|mesh-ancestor
111451179|NCT00003679|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111451180|NCT00003679|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111451181|NCT00003679|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111451182|NCT00003679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111451183|NCT00003679|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111451184|NCT00003679|Hormone Antagonists|hormone antagonists|mesh-ancestor
111451185|NCT00003679|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111451186|NCT00003679|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111451187|NCT00003679|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110916212|NCT02740127|Clonidine|clonidine|mesh-list
111451188|NCT00003679|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111175365|NCT01854710|Dopamine Agents|dopamine agents|mesh-ancestor
111451189|NCT00003679|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111451190|NCT00003985|KRN 7000|krn 7000|mesh-list
111451191|NCT00003985|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111451192|NCT00003985|Immunologic Factors|immunologic factors|mesh-ancestor
111451193|NCT00003985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111451194|NCT00003985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111451195|NCT00384553|Rituximab|rituximab|mesh-list
111451196|NCT00384553|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111451197|NCT00384553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111451198|NCT00384553|Immunologic Factors|immunologic factors|mesh-ancestor
111451199|NCT00384553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111451200|NCT00384553|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111451201|NCT00003991|Aldesleukin|aldesleukin|mesh-list
111451202|NCT00003991|Histamine|histamine|mesh-list
111451203|NCT00003991|Histamine phosphate|histamine phosphate|mesh-list
111451204|NCT00003991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111451205|NCT00003991|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111451206|NCT00003991|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111451207|NCT00003991|Antiviral Agents|antiviral agents|mesh-ancestor
111451208|NCT00003991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110916316|NCT02282774|Anesthetics|anesthetics|mesh-ancestor
111451209|NCT00003991|Histamine Agonists|histamine agonists|mesh-ancestor
111451210|NCT00003991|Histamine Agents|histamine agents|mesh-ancestor
111451211|NCT00003991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111451212|NCT00003991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111451213|NCT00003991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111451214|NCT00003997|Irofulven|irofulven|mesh-list
111451215|NCT00003997|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111451216|NCT00003997|Alkylating Agents|alkylating agents|mesh-ancestor
111451217|NCT00003997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111451218|NCT00003997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111451219|NCT00384631|Bevacizumab|bevacizumab|mesh-list
111451220|NCT00384631|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111451221|NCT00384631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111451222|NCT00384631|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111451223|NCT00384631|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111451224|NCT00384631|Growth Substances|growth substances|mesh-ancestor
111451225|NCT00384631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111451226|NCT00384631|Growth Inhibitors|growth inhibitors|mesh-ancestor
111451227|NCT00003127|Paclitaxel|paclitaxel|mesh-list
111451228|NCT00003127|Carboplatin|carboplatin|mesh-list
111451229|NCT00003127|Amifostine|amifostine|mesh-list
111451230|NCT00003127|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111451231|NCT00003127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111451232|NCT00003127|Tubulin Modulators|tubulin modulators|mesh-ancestor
111451233|NCT00003127|Antimitotic Agents|antimitotic agents|mesh-ancestor
111451234|NCT00003127|Mitosis Modulators|mitosis modulators|mesh-ancestor
111451235|NCT00003127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111451236|NCT00003127|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111451237|NCT00003127|Protective Agents|protective agents|mesh-ancestor
111451238|NCT00003127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111451239|NCT00004003|Gemcitabine|gemcitabine|mesh-list
111451240|NCT00004003|Fluorouracil|fluorouracil|mesh-list
111451241|NCT00004003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111451242|NCT00004003|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111451243|NCT00004003|Antimetabolites|antimetabolites|mesh-ancestor
111451244|NCT00004003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111451245|NCT00004003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111451246|NCT00004003|Immunologic Factors|immunologic factors|mesh-ancestor
111451247|NCT00004003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111451248|NCT00004009|Tipifarnib|tipifarnib|mesh-list
111451249|NCT00004009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111451250|NCT00003133|Paclitaxel|paclitaxel|mesh-list
111451251|NCT00003133|Gemcitabine|gemcitabine|mesh-list
111451252|NCT00003133|Doxorubicin|doxorubicin|mesh-list
111451253|NCT00003133|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111451254|NCT00003133|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111451255|NCT00003133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111451256|NCT00003133|Tubulin Modulators|tubulin modulators|mesh-ancestor
111451257|NCT00003133|Antimitotic Agents|antimitotic agents|mesh-ancestor
111451258|NCT00003133|Mitosis Modulators|mitosis modulators|mesh-ancestor
111451259|NCT00003133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111451260|NCT00003133|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111451261|NCT00003133|Antimetabolites|antimetabolites|mesh-ancestor
111451262|NCT00003133|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111451263|NCT00003133|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111451264|NCT00003133|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111451265|NCT00003133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111451266|NCT00003691|Paclitaxel|paclitaxel|mesh-list
111451267|NCT00003691|Doxorubicin|doxorubicin|mesh-list
111451268|NCT00003691|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111451269|NCT00003691|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111451270|NCT00003691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111451271|NCT00003691|Tubulin Modulators|tubulin modulators|mesh-ancestor
111451272|NCT00003691|Antimitotic Agents|antimitotic agents|mesh-ancestor
111451273|NCT00003691|Mitosis Modulators|mitosis modulators|mesh-ancestor
111451274|NCT00003691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111451275|NCT00003691|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111451276|NCT00003691|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111451277|NCT00003691|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111451278|NCT00003691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111451279|NCT00003139|Pilocarpine|pilocarpine|mesh-list
111451280|NCT00003139|Miotics|miotics|mesh-ancestor
111451281|NCT00003139|Autonomic Agents|autonomic agents|mesh-ancestor
111451282|NCT00003139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111451283|NCT00003139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111451284|NCT00003139|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
111451285|NCT00003139|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111451286|NCT00003139|Cholinergic Agents|cholinergic agents|mesh-ancestor
111451287|NCT00003139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111451288|NCT00003139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111451289|NCT00003697|Vadimezan|vadimezan|mesh-list
111451290|NCT00003697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111451291|NCT02972983|Daptomycin|daptomycin|mesh-list
111451292|NCT02972983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111451293|NCT02972983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111451294|NCT00003709|Carbendazim|carbendazim|mesh-list
111451295|NCT00003709|Antinematodal Agents|antinematodal agents|mesh-ancestor
111451296|NCT00003709|Anthelmintics|anthelmintics|mesh-ancestor
111451297|NCT00003709|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111451298|NCT00003709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111451299|NCT00003145|Cyclosporine|cyclosporine|mesh-list
111451300|NCT00003145|Mycophenolic Acid|mycophenolic acid|mesh-list
111451301|NCT00003145|Fludarabine|fludarabine|mesh-list
111451302|NCT00003145|Fludarabine phosphate|fludarabine phosphate|mesh-list
111451303|NCT00003145|Cyclosporins|cyclosporins|mesh-list
111451304|NCT00003145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111451305|NCT00003145|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111451306|NCT00003145|Antimetabolites|antimetabolites|mesh-ancestor
111451307|NCT00003145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111451308|NCT00003145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111451309|NCT00003145|Immunologic Factors|immunologic factors|mesh-ancestor
111451310|NCT00003145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111451311|NCT00003145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111451312|NCT00003145|Antifungal Agents|antifungal agents|mesh-ancestor
111451313|NCT00003145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111451314|NCT00003145|Dermatologic Agents|dermatologic agents|mesh-ancestor
111451315|NCT00003145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111451316|NCT00003145|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111451317|NCT00003145|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111451318|NCT00003145|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110916669|NCT03556098|Hormones|hormones|mesh-list
111451319|NCT00003145|Antitubercular Agents|antitubercular agents|mesh-ancestor
111451320|NCT00003145|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111451321|NCT00004039|Interferons|interferons|mesh-list
111451322|NCT00004039|Interferon-alpha|interferon-alpha|mesh-list
111451323|NCT00004039|Prednisone|prednisone|mesh-list
111451324|NCT00004039|Cyclophosphamide|cyclophosphamide|mesh-list
111451325|NCT00004039|Rituximab|rituximab|mesh-list
111451326|NCT00004039|Doxorubicin|doxorubicin|mesh-list
111451327|NCT00004039|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111451328|NCT00004039|Vincristine|vincristine|mesh-list
111451329|NCT00004039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111451330|NCT00004039|Immunologic Factors|immunologic factors|mesh-ancestor
110916769|NCT00359450|Taxane|taxane|mesh-list
111451331|NCT00004039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111451332|NCT00004039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111451333|NCT00004039|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111451334|NCT00004039|Alkylating Agents|alkylating agents|mesh-ancestor
111451335|NCT00004039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111451336|NCT00004039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111451337|NCT00004039|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111451338|NCT00004039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111451339|NCT00004039|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111451340|NCT00004039|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111451341|NCT00004039|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111451342|NCT00004039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111451343|NCT00004039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111451344|NCT00004039|Glucocorticoids|glucocorticoids|mesh-ancestor
111451346|NCT00004039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111451347|NCT00004039|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111451348|NCT00004039|Antiviral Agents|antiviral agents|mesh-ancestor
111451349|NCT00004039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110916880|NCT00057980|Celecoxib|celecoxib|mesh-list
111451350|NCT00004039|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111451351|NCT00004039|Tubulin Modulators|tubulin modulators|mesh-ancestor
111451352|NCT00004039|Antimitotic Agents|antimitotic agents|mesh-ancestor
111451353|NCT00004039|Mitosis Modulators|mitosis modulators|mesh-ancestor
111451354|NCT00003151|Amoxicillin|amoxicillin|mesh-list
111451355|NCT00003151|Metronidazole|metronidazole|mesh-list
111451356|NCT00003151|Clarithromycin|clarithromycin|mesh-list
111451357|NCT00003151|Tetracycline|tetracycline|mesh-list
110916918|NCT05037994|Prednisolone|prednisolone|mesh-list
111451358|NCT00003151|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
111451359|NCT00003151|Omeprazole|omeprazole|mesh-list
111451360|NCT00003151|Bismuth|bismuth|mesh-list
111451361|NCT00003151|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111451362|NCT00003151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111451363|NCT00003151|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111451364|NCT00003151|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111451365|NCT00003151|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111451366|NCT00003151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111451367|NCT00003151|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111451368|NCT00003151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111451369|NCT00003151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111451370|NCT00003151|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111451371|NCT00003151|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111451372|NCT00003151|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111451373|NCT00003151|Antacids|antacids|mesh-ancestor
111451374|NCT00004045|Exatecan|exatecan|mesh-list
111451375|NCT00004045|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111451376|NCT00004045|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111451377|NCT00004045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111451378|NCT00004045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111451379|NCT00004045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111451380|NCT00003715|Interferons|interferons|mesh-list
111451381|NCT00003715|Interferon-alpha|interferon-alpha|mesh-list
111451382|NCT00003715|Cyclophosphamide|cyclophosphamide|mesh-list
111451383|NCT00003715|Vaccines|vaccines|mesh-list
111451384|NCT00003715|BCG Vaccine|bcg vaccine|mesh-list
111451385|NCT00003715|Immunologic Factors|immunologic factors|mesh-ancestor
111451386|NCT00003715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111451387|NCT00003715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111451388|NCT00003715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111451389|NCT00003715|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111451390|NCT00003715|Alkylating Agents|alkylating agents|mesh-ancestor
111451391|NCT00003715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111451392|NCT00003715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111451393|NCT00003715|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111451394|NCT00003715|Antiviral Agents|antiviral agents|mesh-ancestor
111451395|NCT00003715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111451396|NCT00003715|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111451397|NCT00004051|Irinotecan|irinotecan|mesh-list
111451398|NCT00004051|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111451399|NCT00004051|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111451400|NCT00004051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111451401|NCT00004051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111451402|NCT00004051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111451403|NCT00003727|Interferons|interferons|mesh-list
111451404|NCT00003727|Interferon-alpha|interferon-alpha|mesh-list
111451405|NCT00003727|Cyclophosphamide|cyclophosphamide|mesh-list
111451406|NCT00003727|Melphalan|melphalan|mesh-list
111451407|NCT00003727|Carmustine|carmustine|mesh-list
111451408|NCT00003727|Gemcitabine|gemcitabine|mesh-list
111451409|NCT00003727|Etoposide|etoposide|mesh-list
111451410|NCT00003727|Sargramostim|sargramostim|mesh-list
111451411|NCT00003727|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111451412|NCT00003727|Immunologic Factors|immunologic factors|mesh-ancestor
111451413|NCT00003727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111451414|NCT00003727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111451415|NCT00003727|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111451416|NCT00003727|Alkylating Agents|alkylating agents|mesh-ancestor
111451417|NCT00003727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111451418|NCT00003727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111451419|NCT00003727|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111451420|NCT00003727|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111451421|NCT00003727|Antimetabolites|antimetabolites|mesh-ancestor
111451422|NCT00003727|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111451423|NCT00003727|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111451424|NCT00003727|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111451425|NCT00003727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111451426|NCT00003727|Antiviral Agents|antiviral agents|mesh-ancestor
111451427|NCT00003727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111451428|NCT00003157|Gemcitabine|gemcitabine|mesh-list
111451429|NCT00003157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111451430|NCT00003157|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111451431|NCT00003157|Antimetabolites|antimetabolites|mesh-ancestor
111451432|NCT00003157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111451433|NCT00004057|Paclitaxel|paclitaxel|mesh-list
111451434|NCT00004057|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111451435|NCT00004057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111451436|NCT00004057|Tubulin Modulators|tubulin modulators|mesh-ancestor
111451437|NCT00004057|Antimitotic Agents|antimitotic agents|mesh-ancestor
111451438|NCT00004057|Mitosis Modulators|mitosis modulators|mesh-ancestor
111451439|NCT00004057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111451440|NCT00004063|Interferons|interferons|mesh-list
111451441|NCT00004063|Interferon-alpha|interferon-alpha|mesh-list
111451442|NCT00004063|Gemcitabine|gemcitabine|mesh-list
111451443|NCT00004063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111451444|NCT00004063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111451445|NCT00004063|Antimetabolites|antimetabolites|mesh-ancestor
111451446|NCT00004063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111451447|NCT00004063|Antiviral Agents|antiviral agents|mesh-ancestor
111451448|NCT00004063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111451449|NCT00004063|Immunologic Factors|immunologic factors|mesh-ancestor
110917365|NCT02106468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111451450|NCT00004063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111451451|NCT00003733|Paclitaxel|paclitaxel|mesh-list
111451452|NCT00003733|Carboplatin|carboplatin|mesh-list
111451453|NCT00003733|Topotecan|topotecan|mesh-list
111451454|NCT00003733|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111451455|NCT00003733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111451456|NCT00003733|Tubulin Modulators|tubulin modulators|mesh-ancestor
111451457|NCT00003733|Antimitotic Agents|antimitotic agents|mesh-ancestor
111451458|NCT00003733|Mitosis Modulators|mitosis modulators|mesh-ancestor
111451459|NCT00003733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111451460|NCT00003733|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111451461|NCT00003733|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111451462|NCT00003733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111451463|NCT00003739|Lenograstim|lenograstim|mesh-list
111451464|NCT00003739|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111451465|NCT00003739|Immunologic Factors|immunologic factors|mesh-ancestor
111451466|NCT00003739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111451467|NCT00003745|Topotecan|topotecan|mesh-list
111451468|NCT00003745|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111451469|NCT00003745|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111451470|NCT00003745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111451471|NCT00003745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111451472|NCT00003745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111451473|NCT00003163|Cyclophosphamide|cyclophosphamide|mesh-list
111451474|NCT00003163|Melphalan|melphalan|mesh-list
111451475|NCT00003163|Sargramostim|sargramostim|mesh-list
111451476|NCT00003163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111451477|NCT00003163|Immunologic Factors|immunologic factors|mesh-ancestor
111451478|NCT00003163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111451479|NCT00003163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111451480|NCT00003163|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111451481|NCT00003163|Alkylating Agents|alkylating agents|mesh-ancestor
111451482|NCT00003163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111451483|NCT00003163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111451484|NCT00003163|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111451485|NCT00004081|Docetaxel|docetaxel|mesh-list
111451486|NCT00004081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111451487|NCT00004081|Tubulin Modulators|tubulin modulators|mesh-ancestor
111451488|NCT00004081|Antimitotic Agents|antimitotic agents|mesh-ancestor
111451489|NCT00004081|Mitosis Modulators|mitosis modulators|mesh-ancestor
111451490|NCT00004081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111451491|NCT00003751|Penicillamine|penicillamine|mesh-list
111451492|NCT00003751|Antidotes|antidotes|mesh-ancestor
111451493|NCT00003751|Protective Agents|protective agents|mesh-ancestor
111451494|NCT00003751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111451495|NCT00003751|Chelating Agents|chelating agents|mesh-ancestor
111451496|NCT00003751|Sequestering Agents|sequestering agents|mesh-ancestor
111451497|NCT00003751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111451498|NCT00003751|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111451499|NCT00004087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111451500|NCT00004087|Antibodies|antibodies|mesh-list
111451501|NCT00004087|Immunoglobulins|immunoglobulins|mesh-list
111451502|NCT00004087|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111451503|NCT00004087|Immunologic Factors|immunologic factors|mesh-ancestor
111451504|NCT00004087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111451505|NCT00004087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111451506|NCT00003757|Rituximab|rituximab|mesh-list
111451507|NCT00003757|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111451508|NCT00003757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111451509|NCT00003757|Immunologic Factors|immunologic factors|mesh-ancestor
111451510|NCT00003757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111451511|NCT00003757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111451512|NCT00003175|Fluorouracil|fluorouracil|mesh-list
111451513|NCT00003175|Antimetabolites|antimetabolites|mesh-ancestor
111451514|NCT00003175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111451515|NCT00003175|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111451516|NCT00003175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111451517|NCT00003175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111451518|NCT00003175|Immunologic Factors|immunologic factors|mesh-ancestor
111451519|NCT00003175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111451520|NCT00004099|Leucovorin|leucovorin|mesh-list
111451521|NCT00004099|Fluorouracil|fluorouracil|mesh-list
111451522|NCT00004099|Calcium|calcium|mesh-list
111451523|NCT00004099|Levoleucovorin|levoleucovorin|mesh-list
111451524|NCT00004099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111451525|NCT00004099|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111451526|NCT00004099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111451527|NCT00004099|Antimetabolites|antimetabolites|mesh-ancestor
111451528|NCT00004099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111451529|NCT00004099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111451530|NCT00004099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111451531|NCT00004099|Immunologic Factors|immunologic factors|mesh-ancestor
111451532|NCT00004099|Antidotes|antidotes|mesh-ancestor
111451533|NCT00004099|Protective Agents|protective agents|mesh-ancestor
111451534|NCT00004099|Vitamin B Complex|vitamin b complex|mesh-ancestor
111451535|NCT00004099|Vitamins|vitamins|mesh-ancestor
111451536|NCT00004099|Micronutrients|micronutrients|mesh-ancestor
111451537|NCT00003763|Folic Acid|folic acid|mesh-list
111451538|NCT00003763|Hematinics|hematinics|mesh-ancestor
111451539|NCT00003763|Vitamin B Complex|vitamin b complex|mesh-ancestor
111451540|NCT00003763|Vitamins|vitamins|mesh-ancestor
111451541|NCT00003763|Micronutrients|micronutrients|mesh-ancestor
111451542|NCT00003763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111451543|NCT00003181|Aldesleukin|aldesleukin|mesh-list
111451544|NCT00003181|Vinblastine|vinblastine|mesh-list
111451545|NCT00003181|Sargramostim|sargramostim|mesh-list
111451546|NCT00003181|Immunologic Factors|immunologic factors|mesh-ancestor
111451547|NCT00003181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111451548|NCT00003181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111451549|NCT00003181|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111451550|NCT00003181|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111451551|NCT00003181|Antiviral Agents|antiviral agents|mesh-ancestor
111451552|NCT00003181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111451553|NCT00003181|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111451554|NCT00003181|Tubulin Modulators|tubulin modulators|mesh-ancestor
111451555|NCT00003181|Antimitotic Agents|antimitotic agents|mesh-ancestor
111451556|NCT00003181|Mitosis Modulators|mitosis modulators|mesh-ancestor
111451557|NCT00003181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111451558|NCT00004105|Paclitaxel|paclitaxel|mesh-list
111451559|NCT00004105|Vinorelbine|vinorelbine|mesh-list
111451560|NCT00004105|Estramustine|estramustine|mesh-list
111451561|NCT00004105|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111451562|NCT00004105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111451563|NCT00004105|Tubulin Modulators|tubulin modulators|mesh-ancestor
111451564|NCT00004105|Antimitotic Agents|antimitotic agents|mesh-ancestor
111451565|NCT00004105|Mitosis Modulators|mitosis modulators|mesh-ancestor
111451566|NCT00004105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111451567|NCT00004105|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111451568|NCT00004105|Alkylating Agents|alkylating agents|mesh-ancestor
111451569|NCT00004105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111451570|NCT00003187|Cytarabine|cytarabine|mesh-list
111451571|NCT00003187|Cyclosporine|cyclosporine|mesh-list
111451572|NCT00003187|Methylprednisolone|methylprednisolone|mesh-list
111451573|NCT00003187|Cyclophosphamide|cyclophosphamide|mesh-list
111451574|NCT00003187|Methotrexate|methotrexate|mesh-list
111451575|NCT00003187|Cyclosporins|cyclosporins|mesh-list
111451576|NCT00003187|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111451577|NCT00003187|Immunologic Factors|immunologic factors|mesh-ancestor
111451578|NCT00003187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111451579|NCT00003187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111451580|NCT00003187|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111451581|NCT00003187|Alkylating Agents|alkylating agents|mesh-ancestor
111451582|NCT00003187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111451583|NCT00003187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111451584|NCT00003187|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111451585|NCT00003187|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111451586|NCT00003187|Abortifacient Agents|abortifacient agents|mesh-ancestor
111451587|NCT00003187|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111451588|NCT00003187|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111451589|NCT00003187|Antimetabolites|antimetabolites|mesh-ancestor
111451590|NCT00003187|Dermatologic Agents|dermatologic agents|mesh-ancestor
111451591|NCT00003187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111451592|NCT00003187|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111451593|NCT00003187|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111451594|NCT00003187|Antiviral Agents|antiviral agents|mesh-ancestor
111451595|NCT00003187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111451596|NCT00003187|Antifungal Agents|antifungal agents|mesh-ancestor
111451597|NCT00003187|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110917876|NCT02109354|Vaccines|vaccines|mesh-list
111451598|NCT00003187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111451599|NCT00003187|Antiemetics|antiemetics|mesh-ancestor
111451600|NCT00003187|Autonomic Agents|autonomic agents|mesh-ancestor
111451601|NCT00003187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111451602|NCT00003187|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111451603|NCT00003187|Glucocorticoids|glucocorticoids|mesh-ancestor
111451605|NCT00003187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111451606|NCT00003187|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111451607|NCT00003187|Protective Agents|protective agents|mesh-ancestor
111451608|NCT00003769|Perillyl alcohol|perillyl alcohol|mesh-list
111451609|NCT00003769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111451610|NCT00003769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111451611|NCT00003769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111451612|NCT00003775|Leflunomide|leflunomide|mesh-list
111451613|NCT00003775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111451614|NCT00003775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111451615|NCT00003775|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111451616|NCT00003775|Immunologic Factors|immunologic factors|mesh-ancestor
111451617|NCT00003775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111451618|NCT00004123|Doxorubicin|doxorubicin|mesh-list
111451619|NCT00004123|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110918006|NCT02115360|Katacalcin|katacalcin|mesh-list
111451620|NCT00004123|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111451621|NCT00004123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111451622|NCT00004123|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111451623|NCT00004123|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111451624|NCT00004123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111451625|NCT00004123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111451626|NCT00003781|Docetaxel|docetaxel|mesh-list
111451627|NCT00003781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111451628|NCT00003781|Tubulin Modulators|tubulin modulators|mesh-ancestor
111451629|NCT00003781|Antimitotic Agents|antimitotic agents|mesh-ancestor
111451630|NCT00003781|Mitosis Modulators|mitosis modulators|mesh-ancestor
111451631|NCT00003781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111451632|NCT00003193|Paclitaxel|paclitaxel|mesh-list
111451633|NCT00003193|Amifostine|amifostine|mesh-list
111451634|NCT00003193|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111451635|NCT00003193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111451636|NCT00003193|Tubulin Modulators|tubulin modulators|mesh-ancestor
111451637|NCT00003193|Antimitotic Agents|antimitotic agents|mesh-ancestor
111451638|NCT00003193|Mitosis Modulators|mitosis modulators|mesh-ancestor
111451639|NCT00003193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111451640|NCT00003193|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111451641|NCT00003193|Protective Agents|protective agents|mesh-ancestor
111451642|NCT00003193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111451643|NCT00004135|Cyclophosphamide|cyclophosphamide|mesh-list
111451644|NCT00004135|Fludarabine|fludarabine|mesh-list
111451645|NCT00004135|Fludarabine phosphate|fludarabine phosphate|mesh-list
111451646|NCT00004135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111451647|NCT00004135|Immunologic Factors|immunologic factors|mesh-ancestor
111451648|NCT00004135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111451649|NCT00004135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111451650|NCT00004135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111451651|NCT00004135|Alkylating Agents|alkylating agents|mesh-ancestor
111451652|NCT00004135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111451653|NCT00004135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111451654|NCT00004135|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111451655|NCT00004135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111451656|NCT00004135|Antimetabolites|antimetabolites|mesh-ancestor
111451657|NCT00004141|Dacarbazine|dacarbazine|mesh-list
111451658|NCT00004141|Molgramostim|molgramostim|mesh-list
111451659|NCT00004141|Sargramostim|sargramostim|mesh-list
111451660|NCT00004141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111451661|NCT00004141|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111451662|NCT00004141|Alkylating Agents|alkylating agents|mesh-ancestor
111451663|NCT00004141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111451664|NCT00004141|Immunologic Factors|immunologic factors|mesh-ancestor
111451665|NCT00004141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111451666|NCT02972905|Nemiralisib|nemiralisib|mesh-list
111451667|NCT02972905|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111451668|NCT02972905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111451669|NCT02972905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111451670|NCT00003799|Leucovorin|leucovorin|mesh-list
111451671|NCT00003799|Fluorouracil|fluorouracil|mesh-list
111451672|NCT00003799|Oxaliplatin|oxaliplatin|mesh-list
111451673|NCT00003799|Calcium|calcium|mesh-list
111451674|NCT00003799|Levoleucovorin|levoleucovorin|mesh-list
111451675|NCT00003799|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111451676|NCT00003799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111451677|NCT00003799|Antimetabolites|antimetabolites|mesh-ancestor
111451678|NCT00003799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111451679|NCT00003799|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111451680|NCT00003799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111451681|NCT00003799|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111451682|NCT00003799|Immunologic Factors|immunologic factors|mesh-ancestor
111451683|NCT00003799|Antidotes|antidotes|mesh-ancestor
111451684|NCT00003799|Protective Agents|protective agents|mesh-ancestor
111451685|NCT00003799|Vitamin B Complex|vitamin b complex|mesh-ancestor
111451686|NCT00003799|Vitamins|vitamins|mesh-ancestor
111451687|NCT00003799|Micronutrients|micronutrients|mesh-ancestor
111451688|NCT00003205|Bryostatin 1|bryostatin 1|mesh-list
111451689|NCT00003205|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111451690|NCT00003205|Immunologic Factors|immunologic factors|mesh-ancestor
111451691|NCT00003205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111451692|NCT00003205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111451693|NCT00003211|Cyclophosphamide|cyclophosphamide|mesh-list
111451694|NCT00003211|Vincristine|vincristine|mesh-list
111451695|NCT00003211|Amifostine|amifostine|mesh-list
111451696|NCT00003211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111451697|NCT00003211|Immunologic Factors|immunologic factors|mesh-ancestor
111451698|NCT00003211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111451699|NCT00003211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111451700|NCT00003211|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111451701|NCT00003211|Alkylating Agents|alkylating agents|mesh-ancestor
111451702|NCT00003211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111451703|NCT00003211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111451704|NCT00003211|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111451705|NCT00003211|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111451706|NCT00003211|Tubulin Modulators|tubulin modulators|mesh-ancestor
111451707|NCT00003211|Antimitotic Agents|antimitotic agents|mesh-ancestor
111451708|NCT00003211|Mitosis Modulators|mitosis modulators|mesh-ancestor
111451709|NCT00003211|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111451710|NCT00003211|Protective Agents|protective agents|mesh-ancestor
111451711|NCT00003805|Vancomycin|vancomycin|mesh-list
111451712|NCT00003805|Tazobactam|tazobactam|mesh-list
111451713|NCT00003805|Piperacillin|piperacillin|mesh-list
111451714|NCT00003805|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
111451715|NCT00003805|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111451716|NCT00003805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111451717|NCT00003805|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
111451718|NCT00003805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111451719|NCT00003805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111451720|NCT00004159|Paclitaxel|paclitaxel|mesh-list
111451721|NCT00004159|Gemcitabine|gemcitabine|mesh-list
111451722|NCT00004159|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111451723|NCT00004159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111451724|NCT00004159|Tubulin Modulators|tubulin modulators|mesh-ancestor
111451725|NCT00004159|Antimitotic Agents|antimitotic agents|mesh-ancestor
111451726|NCT00004159|Mitosis Modulators|mitosis modulators|mesh-ancestor
111175891|NCT01704261|Metformin|metformin|mesh-list
111451727|NCT00004159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111451728|NCT00004159|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111451729|NCT00004159|Antimetabolites|antimetabolites|mesh-ancestor
111451731|NCT00003811|Bleomycin|bleomycin|mesh-list
111451732|NCT00003811|Amifostine|amifostine|mesh-list
111451733|NCT00003811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111451734|NCT00003811|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111451735|NCT00003811|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111451736|NCT00003811|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111451737|NCT00003811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111451738|NCT00003811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111451739|NCT00003811|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111451740|NCT00003811|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111451741|NCT00003811|Protective Agents|protective agents|mesh-ancestor
111451742|NCT00003811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111451743|NCT00004177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111451744|NCT00004177|Antibodies|antibodies|mesh-list
110918570|NCT03652233|Nivolumab|nivolumab|mesh-list
111451745|NCT00004177|Immunoglobulins|immunoglobulins|mesh-list
111451746|NCT00004177|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111451747|NCT00004177|Immunologic Factors|immunologic factors|mesh-ancestor
111451748|NCT00004177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111451749|NCT00004177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111451750|NCT00003817|Ondansetron|ondansetron|mesh-list
111451751|NCT00003817|Granisetron|granisetron|mesh-list
111451752|NCT00003817|Tropisetron|tropisetron|mesh-list
111451753|NCT00003817|Dolasetron|dolasetron|mesh-list
111451754|NCT00003817|Antiemetics|antiemetics|mesh-ancestor
111451755|NCT00003817|Autonomic Agents|autonomic agents|mesh-ancestor
111451756|NCT00003817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110918625|NCT04654312|Diuretics|diuretics|mesh-ancestor
111451757|NCT00003817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111451758|NCT00003817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111451759|NCT00003817|Antipruritics|antipruritics|mesh-ancestor
111451760|NCT00003817|Dermatologic Agents|dermatologic agents|mesh-ancestor
111451761|NCT00003817|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111451762|NCT00003817|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111451763|NCT00003817|Serotonin Agents|serotonin agents|mesh-ancestor
111451764|NCT00003817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111451765|NCT00003817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111451766|NCT00003829|Cyclophosphamide|cyclophosphamide|mesh-list
111451767|NCT00003829|Fludarabine|fludarabine|mesh-list
111451768|NCT00003829|Fludarabine phosphate|fludarabine phosphate|mesh-list
111451769|NCT00003829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111451770|NCT00003829|Immunologic Factors|immunologic factors|mesh-ancestor
111451771|NCT00003829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111451772|NCT00003829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111451773|NCT00003829|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111451774|NCT00003829|Alkylating Agents|alkylating agents|mesh-ancestor
111451775|NCT00003829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111451776|NCT00003829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111451777|NCT00003829|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111451778|NCT00003829|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111451779|NCT00003829|Antimetabolites|antimetabolites|mesh-ancestor
111451780|NCT04329403|Adapalene|adapalene|mesh-list
111451781|NCT04329403|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111451782|NCT04329403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111451783|NCT04329403|Analgesics|analgesics|mesh-ancestor
111451784|NCT04329403|Sensory System Agents|sensory system agents|mesh-ancestor
111451785|NCT04329403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111451786|NCT04329403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111451787|NCT04329403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111451788|NCT04329403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111451789|NCT04329403|Dermatologic Agents|dermatologic agents|mesh-ancestor
111451790|NCT00003217|Cytarabine|cytarabine|mesh-list
111451791|NCT00003217|Dexamethasone|dexamethasone|mesh-list
111451792|NCT00003217|Cyclophosphamide|cyclophosphamide|mesh-list
111451793|NCT00003217|Doxorubicin|doxorubicin|mesh-list
111451794|NCT00003217|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111451795|NCT00003217|Methotrexate|methotrexate|mesh-list
111451796|NCT00003217|Vincristine|vincristine|mesh-list
111451797|NCT00003217|Lenograstim|lenograstim|mesh-list
111451798|NCT00003217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111451799|NCT00003217|Immunologic Factors|immunologic factors|mesh-ancestor
111451800|NCT00003217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111451801|NCT00003217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111175967|NCT03595930|Fluticasone|fluticasone|mesh-list
111451802|NCT00003217|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111451803|NCT00003217|Alkylating Agents|alkylating agents|mesh-ancestor
110918743|NCT02121366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111451804|NCT00003217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111451805|NCT00003217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111451806|NCT00003217|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111451807|NCT00003217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111451808|NCT00003217|Antiemetics|antiemetics|mesh-ancestor
111451809|NCT00003217|Autonomic Agents|autonomic agents|mesh-ancestor
111451810|NCT00003217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111451811|NCT00003217|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111451812|NCT00003217|Glucocorticoids|glucocorticoids|mesh-ancestor
111451814|NCT00003217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111451815|NCT00003217|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111451816|NCT00003217|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111451817|NCT00003217|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111451818|NCT00003217|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111451819|NCT00003217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111451820|NCT00003217|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111451821|NCT00003217|Abortifacient Agents|abortifacient agents|mesh-ancestor
111451822|NCT00003217|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111451823|NCT00003217|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111451824|NCT00003217|Antimetabolites|antimetabolites|mesh-ancestor
111451825|NCT00003217|Dermatologic Agents|dermatologic agents|mesh-ancestor
111451826|NCT00003217|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111451827|NCT00003217|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111451828|NCT00003217|Antiviral Agents|antiviral agents|mesh-ancestor
111451829|NCT00003217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111451830|NCT00003217|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111451831|NCT00003217|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111451832|NCT00003217|Tubulin Modulators|tubulin modulators|mesh-ancestor
111451833|NCT00003217|Antimitotic Agents|antimitotic agents|mesh-ancestor
111451834|NCT00003217|Mitosis Modulators|mitosis modulators|mesh-ancestor
111451835|NCT00004183|Capecitabine|capecitabine|mesh-list
111451836|NCT00004183|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111451837|NCT00004183|Antimetabolites|antimetabolites|mesh-ancestor
111451838|NCT00004183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111451839|NCT00004183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111451840|NCT00003223|Fenretinide|fenretinide|mesh-list
111451841|NCT00003223|Retinamide|retinamide|mesh-list
111451842|NCT00003223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111451843|NCT00003223|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
111451844|NCT00003223|Protective Agents|protective agents|mesh-ancestor
111451845|NCT00003223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111451846|NCT00004189|Cisplatin|cisplatin|mesh-list
111451847|NCT00004189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111451848|NCT00003229|Aldesleukin|aldesleukin|mesh-list
111451849|NCT00003229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111451850|NCT00003229|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111451851|NCT00003229|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111451852|NCT00003229|Antiviral Agents|antiviral agents|mesh-ancestor
111451853|NCT00003229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111451854|NCT00003835|Leucovorin|leucovorin|mesh-list
111451855|NCT00003835|Fluorouracil|fluorouracil|mesh-list
111451856|NCT00003835|Irinotecan|irinotecan|mesh-list
111451857|NCT00003835|Calcium|calcium|mesh-list
111451858|NCT00003835|Levoleucovorin|levoleucovorin|mesh-list
111451859|NCT00003835|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111451860|NCT00003835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111451861|NCT00003835|Antimetabolites|antimetabolites|mesh-ancestor
111451862|NCT00003835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111451863|NCT00003835|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111451864|NCT00003835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111451865|NCT00003835|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111451866|NCT00003835|Immunologic Factors|immunologic factors|mesh-ancestor
111451867|NCT00003835|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111451868|NCT00003835|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111451869|NCT00003835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111451870|NCT00003835|Antidotes|antidotes|mesh-ancestor
111451871|NCT00003835|Protective Agents|protective agents|mesh-ancestor
111451872|NCT00003835|Vitamin B Complex|vitamin b complex|mesh-ancestor
111451873|NCT00003835|Vitamins|vitamins|mesh-ancestor
111451874|NCT00003835|Micronutrients|micronutrients|mesh-ancestor
111451875|NCT00003847|Doxorubicin|doxorubicin|mesh-list
111451876|NCT00003847|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111451877|NCT00003847|Vincristine|vincristine|mesh-list
111451878|NCT00003847|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111451879|NCT00003847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111451880|NCT00003847|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111451881|NCT00003847|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111451882|NCT00003847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111451883|NCT00003847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111451884|NCT00003847|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111451885|NCT00003847|Tubulin Modulators|tubulin modulators|mesh-ancestor
111451886|NCT00003847|Antimitotic Agents|antimitotic agents|mesh-ancestor
111451887|NCT00003847|Mitosis Modulators|mitosis modulators|mesh-ancestor
111451888|NCT00004195|Eniluracil|eniluracil|mesh-list
111451889|NCT00004195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111451890|NCT00004195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111451891|NCT00003853|Esorubicin|esorubicin|mesh-list
111451892|NCT00003853|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111451893|NCT00003853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111451894|NCT00385021|Leucovorin|leucovorin|mesh-list
111451895|NCT00385021|Fluorouracil|fluorouracil|mesh-list
111451896|NCT00385021|Oxaliplatin|oxaliplatin|mesh-list
111451897|NCT00385021|Bevacizumab|bevacizumab|mesh-list
111451898|NCT00385021|Antimetabolites|antimetabolites|mesh-ancestor
111451899|NCT00385021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111451900|NCT00385021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111451901|NCT00385021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111451902|NCT00385021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111451903|NCT00385021|Immunologic Factors|immunologic factors|mesh-ancestor
111451904|NCT00385021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111451905|NCT00385021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111451906|NCT00385021|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111451907|NCT00385021|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111451908|NCT00385021|Growth Substances|growth substances|mesh-ancestor
111451909|NCT00385021|Growth Inhibitors|growth inhibitors|mesh-ancestor
111451910|NCT00385021|Antidotes|antidotes|mesh-ancestor
111451911|NCT00385021|Protective Agents|protective agents|mesh-ancestor
111451912|NCT00385021|Vitamin B Complex|vitamin b complex|mesh-ancestor
111451913|NCT00385021|Vitamins|vitamins|mesh-ancestor
111451914|NCT00385021|Micronutrients|micronutrients|mesh-ancestor
110919010|NCT04441112|Hormones|hormones|mesh-ancestor
111451915|NCT00004201|Carboplatin|carboplatin|mesh-list
111451916|NCT00004201|Gemcitabine|gemcitabine|mesh-list
111451917|NCT00004201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111451918|NCT00004201|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111451919|NCT00004201|Antimetabolites|antimetabolites|mesh-ancestor
111451920|NCT00004201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111451921|NCT00003241|Phenylacetic acid|phenylacetic acid|mesh-list
111451922|NCT00003241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111451923|NCT00003241|Antimetabolites|antimetabolites|mesh-ancestor
111451924|NCT00003241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111451925|NCT00003241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111451926|NCT00003859|Cyclophosphamide|cyclophosphamide|mesh-list
111451927|NCT00003859|Carboplatin|carboplatin|mesh-list
111451928|NCT00003859|Etoposide|etoposide|mesh-list
111451929|NCT00003859|Vincristine|vincristine|mesh-list
111451930|NCT00003859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111451931|NCT00003859|Immunologic Factors|immunologic factors|mesh-ancestor
111451932|NCT00003859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111451933|NCT00003859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111451934|NCT00003859|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111451935|NCT00003859|Alkylating Agents|alkylating agents|mesh-ancestor
111451936|NCT00003859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111451937|NCT00003859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111451938|NCT00003859|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111451939|NCT00003859|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111451940|NCT00003859|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111451941|NCT00003859|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111451942|NCT00003859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111451943|NCT00003859|Tubulin Modulators|tubulin modulators|mesh-ancestor
111451944|NCT00003859|Antimitotic Agents|antimitotic agents|mesh-ancestor
111451945|NCT00003859|Mitosis Modulators|mitosis modulators|mesh-ancestor
111451946|NCT00003865|Toremifene|toremifene|mesh-list
111451947|NCT00003865|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111451948|NCT00003865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111451949|NCT00003865|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111451950|NCT00003865|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111451951|NCT00003865|Hormone Antagonists|hormone antagonists|mesh-ancestor
111451952|NCT00003865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111451953|NCT00003865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111451954|NCT00003865|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111451955|NCT00004207|Daunorubicin|daunorubicin|mesh-list
111451956|NCT00004207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111451957|NCT00004207|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111451958|NCT00004207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111451959|NCT00004207|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111451960|NCT00004207|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111451961|NCT00004207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111451962|NCT00004219|Granisetron|granisetron|mesh-list
111451963|NCT00004219|Antiemetics|antiemetics|mesh-ancestor
111451964|NCT00004219|Autonomic Agents|autonomic agents|mesh-ancestor
111451965|NCT00004219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111451966|NCT00004219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111451967|NCT00004219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111451968|NCT00004219|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111451969|NCT00004219|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111451970|NCT00004219|Serotonin Agents|serotonin agents|mesh-ancestor
111451971|NCT00004219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111451972|NCT00004219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111451973|NCT00003877|Paclitaxel|paclitaxel|mesh-list
111451974|NCT00003877|Cyclophosphamide|cyclophosphamide|mesh-list
111451975|NCT00003877|Carboplatin|carboplatin|mesh-list
111451976|NCT00003877|Thiotepa|thiotepa|mesh-list
111451977|NCT00003877|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111451978|NCT00003877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111451979|NCT00003877|Tubulin Modulators|tubulin modulators|mesh-ancestor
111451980|NCT00003877|Antimitotic Agents|antimitotic agents|mesh-ancestor
111451981|NCT00003877|Mitosis Modulators|mitosis modulators|mesh-ancestor
111451982|NCT00003877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111451983|NCT00003877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111451984|NCT00003877|Immunologic Factors|immunologic factors|mesh-ancestor
111451985|NCT00003877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111451986|NCT00003877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111451987|NCT00003877|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111451988|NCT00003877|Alkylating Agents|alkylating agents|mesh-ancestor
111451989|NCT00003877|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111451990|NCT00003883|Itraconazole|itraconazole|mesh-list
111451991|NCT00003883|Fluconazole|fluconazole|mesh-list
111451992|NCT00003883|Antifungal Agents|antifungal agents|mesh-ancestor
111451993|NCT00003883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111451994|NCT00003883|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111451995|NCT00003883|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111451996|NCT00003883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111451997|NCT00003883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111451998|NCT00003883|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111451999|NCT00003883|Hormone Antagonists|hormone antagonists|mesh-ancestor
111452000|NCT00003883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110919356|NCT02128308|Levofloxacin|levofloxacin|mesh-list
111452001|NCT00003883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111452002|NCT00003883|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111452003|NCT00003883|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111452004|NCT00003883|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111452005|NCT04225819|Vitamin D|vitamin d|mesh-list
111452006|NCT04225819|Cholecalciferol|cholecalciferol|mesh-list
111452007|NCT04225819|Vitamins|vitamins|mesh-ancestor
111452008|NCT04225819|Micronutrients|micronutrients|mesh-ancestor
111452009|NCT04225819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111452010|NCT04225819|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111452011|NCT04225819|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111452012|NCT00003253|Paclitaxel|paclitaxel|mesh-list
110919415|NCT01674010|Vitamins|vitamins|mesh-ancestor
111452013|NCT00003253|Antineoplastic Agents|antineoplastic agents|mesh-list
111452014|NCT00003253|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111452015|NCT00003253|Tubulin Modulators|tubulin modulators|mesh-ancestor
111452016|NCT00003253|Antimitotic Agents|antimitotic agents|mesh-ancestor
111452017|NCT00003253|Mitosis Modulators|mitosis modulators|mesh-ancestor
111452018|NCT00003253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111452019|NCT00004237|Cyclophosphamide|cyclophosphamide|mesh-list
111452020|NCT00004237|Doxorubicin|doxorubicin|mesh-list
111452021|NCT00004237|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111452022|NCT00004237|Vinorelbine|vinorelbine|mesh-list
111452023|NCT00004237|Epirubicin|epirubicin|mesh-list
111452024|NCT00004237|Mitoxantrone|mitoxantrone|mesh-list
111452025|NCT00004237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111452026|NCT00004237|Immunologic Factors|immunologic factors|mesh-ancestor
111452027|NCT00004237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111452028|NCT00004237|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111452029|NCT00004237|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111452030|NCT00004237|Alkylating Agents|alkylating agents|mesh-ancestor
111452031|NCT00004237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111452032|NCT00004237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111452033|NCT00004237|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111452034|NCT00004237|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111452035|NCT00004237|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111452036|NCT00004237|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111452037|NCT00004237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110919549|NCT03038594|Hormones|hormones|mesh-list
111452038|NCT00004237|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111452039|NCT00004237|Tubulin Modulators|tubulin modulators|mesh-ancestor
111452040|NCT00004237|Antimitotic Agents|antimitotic agents|mesh-ancestor
111452041|NCT00004237|Mitosis Modulators|mitosis modulators|mesh-ancestor
111452042|NCT00004237|Analgesics|analgesics|mesh-ancestor
111452043|NCT00004237|Sensory System Agents|sensory system agents|mesh-ancestor
111452044|NCT00004237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111452045|NCT00003259|Vinorelbine|vinorelbine|mesh-list
111452046|NCT00003259|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111452047|NCT00003259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111452048|NCT00003259|Tubulin Modulators|tubulin modulators|mesh-ancestor
111452049|NCT00003259|Antimitotic Agents|antimitotic agents|mesh-ancestor
111452050|NCT00003259|Mitosis Modulators|mitosis modulators|mesh-ancestor
111452051|NCT00003259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111452052|NCT00003913|Methylprednisolone|methylprednisolone|mesh-list
111452053|NCT00003913|Cyclophosphamide|cyclophosphamide|mesh-list
111452054|NCT00003913|Busulfan|busulfan|mesh-list
111452055|NCT00003913|Antilymphocyte Serum|antilymphocyte serum|mesh-list
111452056|NCT00003913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111452057|NCT00003913|Immunologic Factors|immunologic factors|mesh-ancestor
111452058|NCT00003913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111452059|NCT00003913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111452060|NCT00003913|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111452061|NCT00003913|Alkylating Agents|alkylating agents|mesh-ancestor
111452062|NCT00003913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111452063|NCT00003913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111452064|NCT00003913|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111452065|NCT00003913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111452066|NCT00003913|Antiemetics|antiemetics|mesh-ancestor
111452067|NCT00003913|Autonomic Agents|autonomic agents|mesh-ancestor
111452068|NCT00003913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111452069|NCT00003913|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111452070|NCT00003913|Glucocorticoids|glucocorticoids|mesh-ancestor
111452071|NCT00003913|Hormones|hormones|mesh-ancestor
111452072|NCT00003913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111452073|NCT00003913|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111452074|NCT00003913|Protective Agents|protective agents|mesh-ancestor
111452075|NCT00004243|Docetaxel|docetaxel|mesh-list
111452076|NCT00004243|Oxaliplatin|oxaliplatin|mesh-list
111452077|NCT00004243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111452078|NCT00004243|Tubulin Modulators|tubulin modulators|mesh-ancestor
111452079|NCT00004243|Antimitotic Agents|antimitotic agents|mesh-ancestor
111452080|NCT00004243|Mitosis Modulators|mitosis modulators|mesh-ancestor
111452081|NCT00004243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111452082|NCT00004249|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
111452083|NCT00004249|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111452084|NCT00004249|Immunologic Factors|immunologic factors|mesh-ancestor
111452085|NCT00004249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111452086|NCT00003925|Leucovorin|leucovorin|mesh-list
110919881|NCT02129322|Sorafenib|sorafenib|mesh-list
111452087|NCT00003925|Gemcitabine|gemcitabine|mesh-list
111452088|NCT00003925|Tegafur|tegafur|mesh-list
111452089|NCT00003925|Calcium|calcium|mesh-list
111452090|NCT00003925|Levoleucovorin|levoleucovorin|mesh-list
111452091|NCT00003925|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111452092|NCT00003925|Antimetabolites|antimetabolites|mesh-ancestor
111452093|NCT00003925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111452094|NCT00003925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111452095|NCT00003925|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111452096|NCT00003925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111452097|NCT00003925|Antidotes|antidotes|mesh-ancestor
111452098|NCT00003925|Protective Agents|protective agents|mesh-ancestor
111452099|NCT00003925|Vitamin B Complex|vitamin b complex|mesh-ancestor
111452100|NCT00003925|Vitamins|vitamins|mesh-ancestor
111452101|NCT00003925|Micronutrients|micronutrients|mesh-ancestor
111452102|NCT00004255|Methylprednisolone|methylprednisolone|mesh-list
111452103|NCT00004255|Cyclophosphamide|cyclophosphamide|mesh-list
111176265|NCT04026880|Testosterone enanthate|testosterone enanthate|mesh-list
111452104|NCT00004255|Fludarabine|fludarabine|mesh-list
111452105|NCT00004255|Fludarabine phosphate|fludarabine phosphate|mesh-list
111452107|NCT00004255|Antilymphocyte Serum|antilymphocyte serum|mesh-list
111452108|NCT00004255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111452109|NCT00004255|Immunologic Factors|immunologic factors|mesh-ancestor
111452110|NCT00004255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111452111|NCT00004255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111452112|NCT00004255|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111452113|NCT00004255|Alkylating Agents|alkylating agents|mesh-ancestor
111452114|NCT00004255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111452115|NCT00004255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111452116|NCT00004255|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111452117|NCT00004255|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111452118|NCT00004255|Antimetabolites|antimetabolites|mesh-ancestor
111452119|NCT00004255|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111452120|NCT00004255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111452121|NCT00004255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111452122|NCT00004255|Antiemetics|antiemetics|mesh-ancestor
111452123|NCT00004255|Autonomic Agents|autonomic agents|mesh-ancestor
111452124|NCT00004255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111452125|NCT00004255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111452126|NCT00004255|Glucocorticoids|glucocorticoids|mesh-ancestor
111452127|NCT00004255|Hormones|hormones|mesh-ancestor
111452128|NCT00004255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111452129|NCT00004255|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111452130|NCT00004255|Protective Agents|protective agents|mesh-ancestor
111452131|NCT00004261|Antibodies|antibodies|mesh-list
111452132|NCT00004261|Immunologic Factors|immunologic factors|mesh-ancestor
111452133|NCT00004261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111452134|NCT00004297|Diazepam|diazepam|mesh-list
111452135|NCT00004297|Lorazepam|lorazepam|mesh-list
111452136|NCT00004297|Anticonvulsants|anticonvulsants|mesh-ancestor
111452137|NCT00004297|Antiemetics|antiemetics|mesh-ancestor
111452138|NCT00004297|Autonomic Agents|autonomic agents|mesh-ancestor
111452139|NCT00004297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111452140|NCT00004297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111452141|NCT00004297|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111452142|NCT00004297|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111452143|NCT00004297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111452144|NCT00004297|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111452145|NCT00004297|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111452146|NCT00004297|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111452147|NCT00004297|GABA Modulators|gaba modulators|mesh-ancestor
111452148|NCT00004297|GABA Agents|gaba agents|mesh-ancestor
111452149|NCT00004297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111452150|NCT00004297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111452151|NCT00004297|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111452152|NCT00004297|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
111452153|NCT00004297|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111452154|NCT00004297|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111452155|NCT00004297|Anesthetics, General|anesthetics, general|mesh-ancestor
111452156|NCT00004297|Anesthetics|anesthetics|mesh-ancestor
111452157|NCT00004855|Ritonavir|ritonavir|mesh-list
111452158|NCT00004855|Lopinavir|lopinavir|mesh-list
111452159|NCT00004855|Lamivudine|lamivudine|mesh-list
111452160|NCT00004855|Nevirapine|nevirapine|mesh-list
111452161|NCT00004855|Abacavir|abacavir|mesh-list
111452162|NCT00004855|Stavudine|stavudine|mesh-list
111452163|NCT00004855|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111452164|NCT00004855|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111452165|NCT00004855|Protease Inhibitors|protease inhibitors|mesh-ancestor
111452166|NCT00004855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111452167|NCT00004855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111452168|NCT00004855|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111452169|NCT00004855|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111452170|NCT00004855|Antiviral Agents|antiviral agents|mesh-ancestor
111452171|NCT00004855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111452172|NCT00004855|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111452173|NCT00004855|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111452174|NCT00004855|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111452175|NCT00004855|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111452176|NCT00004855|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111452177|NCT00004855|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111452178|NCT00004855|Antimetabolites|antimetabolites|mesh-ancestor
111452179|NCT00003289|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
111452180|NCT00003289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111452181|NCT00003289|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111452182|NCT00003289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110920229|NCT03549312|Velpatasvir|velpatasvir|mesh-list
111452183|NCT00003289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111452184|NCT00004861|Gemcitabine|gemcitabine|mesh-list
111452185|NCT00004861|Tacedinaline|tacedinaline|mesh-list
111452186|NCT00004861|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111452187|NCT00004861|Antimetabolites|antimetabolites|mesh-ancestor
111452188|NCT00004861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111452189|NCT00004861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111452190|NCT00004861|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111452191|NCT00004861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111452192|NCT00004315|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
111452193|NCT00004315|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
111452194|NCT00004315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111452195|NCT04074343|Irinotecan|irinotecan|mesh-list
111452196|NCT04074343|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111452197|NCT04074343|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111452198|NCT04074343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111452199|NCT04074343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111452200|NCT04074343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111452201|NCT00003301|Irinotecan|irinotecan|mesh-list
111452202|NCT00003301|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111452203|NCT00003301|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111452204|NCT00003301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111452205|NCT00003301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111452206|NCT00003301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111452207|NCT00003307|Amifostine|amifostine|mesh-list
111452208|NCT00003307|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111452209|NCT00003307|Protective Agents|protective agents|mesh-ancestor
111452210|NCT00003307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111452211|NCT00004327|Octreotide|octreotide|mesh-list
111452212|NCT00004327|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111452213|NCT00004327|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111452214|NCT00004327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111452215|NCT00003313|Paclitaxel|paclitaxel|mesh-list
111452216|NCT00003313|Carboplatin|carboplatin|mesh-list
111452217|NCT00003313|Amifostine|amifostine|mesh-list
111452218|NCT00003313|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111452219|NCT00003313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111452220|NCT00003313|Tubulin Modulators|tubulin modulators|mesh-ancestor
111452221|NCT00003313|Antimitotic Agents|antimitotic agents|mesh-ancestor
111452222|NCT00003313|Mitosis Modulators|mitosis modulators|mesh-ancestor
111452223|NCT00003313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111452224|NCT00003313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111452225|NCT00003313|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111452226|NCT00003313|Protective Agents|protective agents|mesh-ancestor
111452227|NCT00004867|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
111452228|NCT00004867|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111452229|NCT00004867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111452230|NCT00004873|Docetaxel|docetaxel|mesh-list
111452231|NCT00004873|Fluorouracil|fluorouracil|mesh-list
111452232|NCT00004873|Epirubicin|epirubicin|mesh-list
111452233|NCT00004873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111452234|NCT00004873|Tubulin Modulators|tubulin modulators|mesh-ancestor
111452235|NCT00004873|Antimitotic Agents|antimitotic agents|mesh-ancestor
111452236|NCT00004873|Mitosis Modulators|mitosis modulators|mesh-ancestor
111452237|NCT00004873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111452238|NCT00004873|Antimetabolites|antimetabolites|mesh-ancestor
111452239|NCT00004873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111452240|NCT00004873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111452241|NCT00004873|Immunologic Factors|immunologic factors|mesh-ancestor
111452242|NCT00004873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111452243|NCT00004873|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111452244|NCT00004873|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111452245|NCT00004873|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111452246|NCT00004873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111452247|NCT00004879|Panitumumab|panitumumab|mesh-list
111452248|NCT00004879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111452249|NCT00004879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111452250|NCT00004339|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
111452251|NCT00004339|Trientine|trientine|mesh-list
111452252|NCT00004339|Chelating Agents|chelating agents|mesh-ancestor
111452253|NCT00004339|Sequestering Agents|sequestering agents|mesh-ancestor
111452254|NCT00004339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111452255|NCT00004339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111452256|NCT00004339|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111452257|NCT00004339|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111452258|NCT00004339|Growth Substances|growth substances|mesh-ancestor
111452259|NCT00004339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111452260|NCT00004339|Growth Inhibitors|growth inhibitors|mesh-ancestor
111452261|NCT00004339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111452262|NCT00003331|Leucovorin|leucovorin|mesh-list
111452263|NCT00003331|Fluorouracil|fluorouracil|mesh-list
111452264|NCT00003331|Topotecan|topotecan|mesh-list
111452265|NCT00003331|Calcium|calcium|mesh-list
111452266|NCT00003331|Levoleucovorin|levoleucovorin|mesh-list
111452267|NCT00003331|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111452268|NCT00003331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111452269|NCT00003331|Antimetabolites|antimetabolites|mesh-ancestor
111452270|NCT00003331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111452271|NCT00003331|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111452272|NCT00003331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111452273|NCT00003331|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111452274|NCT00003331|Immunologic Factors|immunologic factors|mesh-ancestor
111452275|NCT00003331|Antidotes|antidotes|mesh-ancestor
111452276|NCT00003331|Protective Agents|protective agents|mesh-ancestor
111452277|NCT00003331|Vitamin B Complex|vitamin b complex|mesh-ancestor
111452278|NCT00003331|Vitamins|vitamins|mesh-ancestor
111452279|NCT00003331|Micronutrients|micronutrients|mesh-ancestor
111452280|NCT00003331|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111452281|NCT00003331|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111452282|NCT00003331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111452283|NCT00004885|Leucovorin|leucovorin|mesh-list
111452284|NCT00004885|Fluorouracil|fluorouracil|mesh-list
111452285|NCT00004885|Irinotecan|irinotecan|mesh-list
111452286|NCT00004885|Calcium|calcium|mesh-list
111452287|NCT00004885|Levoleucovorin|levoleucovorin|mesh-list
110920720|NCT01316419|Telmisartan|telmisartan|mesh-list
111452288|NCT00004885|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111452289|NCT00004885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111452290|NCT00004885|Antimetabolites|antimetabolites|mesh-ancestor
111452291|NCT00004885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111452292|NCT00004885|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111452293|NCT00004885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111452294|NCT00004885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111452295|NCT00004885|Immunologic Factors|immunologic factors|mesh-ancestor
111452296|NCT00004885|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111452297|NCT00004885|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111452298|NCT00004885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111452299|NCT00004885|Antidotes|antidotes|mesh-ancestor
111452300|NCT00004885|Protective Agents|protective agents|mesh-ancestor
111452301|NCT00004885|Vitamin B Complex|vitamin b complex|mesh-ancestor
111452302|NCT00004885|Vitamins|vitamins|mesh-ancestor
111452303|NCT00004885|Micronutrients|micronutrients|mesh-ancestor
111452304|NCT00004891|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
111452305|NCT00004891|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111452306|NCT00004891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111452307|NCT00003337|Epratuzumab|epratuzumab|mesh-list
111452308|NCT00003337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111452309|NCT00003337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111452310|NCT00003343|Prednisone|prednisone|mesh-list
111452311|NCT00003343|Mitoxantrone|mitoxantrone|mesh-list
111452312|NCT00003343|Prinomastat|prinomastat|mesh-list
111452313|NCT00003343|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111452314|NCT00003343|Glucocorticoids|glucocorticoids|mesh-ancestor
111452315|NCT00003343|Hormones|hormones|mesh-ancestor
111452316|NCT00003343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111452317|NCT00003343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111452318|NCT00003343|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111452319|NCT00003343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111452320|NCT00003343|Analgesics|analgesics|mesh-ancestor
111452321|NCT00003343|Sensory System Agents|sensory system agents|mesh-ancestor
111452322|NCT00003343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111452323|NCT00003343|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111452324|NCT00003343|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110250555|NCT00140166|Vitamins|vitamins|mesh-ancestor
111452325|NCT00003343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111452326|NCT00003343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111452327|NCT00003343|Matrix Metalloproteinase Inhibitors|matrix metalloproteinase inhibitors|mesh-ancestor
111452328|NCT00003343|Protease Inhibitors|protease inhibitors|mesh-ancestor
111452329|NCT00004903|Interferons|interferons|mesh-list
111452330|NCT00004903|Cytarabine|cytarabine|mesh-list
111176487|NCT04146610|Immunoconjugates|immunoconjugates|mesh-list
111452331|NCT00004903|Interferon-alpha|interferon-alpha|mesh-list
111452332|NCT00004903|Cyclophosphamide|cyclophosphamide|mesh-list
111452333|NCT00004903|Melphalan|melphalan|mesh-list
111452334|NCT00004903|Etoposide|etoposide|mesh-list
111452335|NCT00004903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111452336|NCT00004903|Immunologic Factors|immunologic factors|mesh-ancestor
111452337|NCT00004903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111452338|NCT00004903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111452339|NCT00004903|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111452340|NCT00004903|Alkylating Agents|alkylating agents|mesh-ancestor
111452341|NCT00004903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111452342|NCT00004903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111452343|NCT00004903|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111452344|NCT00004903|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111452345|NCT00004903|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111452346|NCT00004903|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111452347|NCT00004903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111452349|NCT00004903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111452350|NCT00004903|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111452351|NCT00004903|Antimetabolites|antimetabolites|mesh-ancestor
111452352|NCT00004357|Methylprednisolone|methylprednisolone|mesh-list
111452353|NCT00004357|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111452354|NCT00004357|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111452355|NCT00004357|Prednisolone|prednisolone|mesh-list
111452356|NCT00004357|Prednisolone acetate|prednisolone acetate|mesh-list
111452357|NCT00004357|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111452358|NCT00004357|Prednisolone phosphate|prednisolone phosphate|mesh-list
111452359|NCT00004357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111452360|NCT00004357|Antiemetics|antiemetics|mesh-ancestor
111452361|NCT00004357|Autonomic Agents|autonomic agents|mesh-ancestor
111452362|NCT00004357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111452363|NCT00004357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111452364|NCT00004357|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111452365|NCT00004357|Glucocorticoids|glucocorticoids|mesh-ancestor
111452366|NCT00004357|Hormones|hormones|mesh-ancestor
111452367|NCT00004357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111452368|NCT00004357|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111452369|NCT00004357|Protective Agents|protective agents|mesh-ancestor
111452370|NCT00004357|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111452371|NCT00004357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111452372|NCT00004363|Chlorpropamide|chlorpropamide|mesh-list
111452373|NCT00004363|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
111452374|NCT00004363|Hemostatics|hemostatics|mesh-ancestor
111452375|NCT00004363|Coagulants|coagulants|mesh-ancestor
111452376|NCT00004363|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
111452377|NCT00004363|Natriuretic Agents|natriuretic agents|mesh-ancestor
111452378|NCT00004363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111452379|NCT00004363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111452380|NCT04069117|Letrozole|letrozole|mesh-list
111452381|NCT04069117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111452382|NCT04069117|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111452383|NCT04069117|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111452384|NCT04069117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111452385|NCT04069117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111452386|NCT04069117|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111452387|NCT04069117|Hormone Antagonists|hormone antagonists|mesh-ancestor
111452388|NCT04069117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111452389|NCT04069117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111452390|NCT00004921|Paclitaxel|paclitaxel|mesh-list
111452391|NCT00004921|Cyclophosphamide|cyclophosphamide|mesh-list
111452392|NCT00004921|Carboplatin|carboplatin|mesh-list
111452393|NCT00004921|Melphalan|melphalan|mesh-list
111452394|NCT00004921|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111452395|NCT00004921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111452396|NCT00004921|Tubulin Modulators|tubulin modulators|mesh-ancestor
111452397|NCT00004921|Antimitotic Agents|antimitotic agents|mesh-ancestor
111452398|NCT00004921|Mitosis Modulators|mitosis modulators|mesh-ancestor
111452399|NCT00004921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111452400|NCT00004921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111452401|NCT00004921|Immunologic Factors|immunologic factors|mesh-ancestor
110921155|NCT03102658|Micafungin|micafungin|mesh-list
111452402|NCT00004921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111452403|NCT00004921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111452404|NCT00004921|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111452405|NCT00004921|Alkylating Agents|alkylating agents|mesh-ancestor
111452406|NCT00004921|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111452407|NCT00004933|Hydroxyurea|hydroxyurea|mesh-list
111452408|NCT00004933|Homoharringtonine|homoharringtonine|mesh-list
111452409|NCT00004933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111176562|NCT03920722|Immunologic Factors|immunologic factors|mesh-ancestor
111452410|NCT00004933|Antisickling Agents|antisickling agents|mesh-ancestor
110921176|NCT03521024|Ether|ether|mesh-list
111452411|NCT00004933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111452412|NCT00004933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111452413|NCT00004933|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111452414|NCT00004933|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111452415|NCT00004933|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111452417|NCT00004981|Zidovudine|zidovudine|mesh-list
111452418|NCT00004981|Abacavir|abacavir|mesh-list
111452419|NCT00004981|Dideoxynucleosides|dideoxynucleosides|mesh-list
111452420|NCT00004981|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
111452421|NCT00004981|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111452422|NCT00004981|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111452423|NCT00004981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111452424|NCT00004981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111452425|NCT00004981|Antiviral Agents|antiviral agents|mesh-ancestor
111452426|NCT00004981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111452427|NCT00004981|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111452428|NCT00004981|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111452429|NCT00004981|Antimetabolites|antimetabolites|mesh-ancestor
111452430|NCT00004993|Hormones|hormones|mesh-list
111452431|NCT00004993|Parathyroid Hormone|parathyroid hormone|mesh-list
111452432|NCT00004993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111452433|NCT00004993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111452434|NCT00004993|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111452435|NCT00004999|Lamivudine|lamivudine|mesh-list
111452436|NCT00004999|Zidovudine|zidovudine|mesh-list
111452437|NCT00004999|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
111452438|NCT00004999|Capravirine|capravirine|mesh-list
111452439|NCT00004999|Nelfinavir|nelfinavir|mesh-list
111452440|NCT00004999|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111452441|NCT00004999|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111452442|NCT00004999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111452443|NCT00004999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111452444|NCT00004999|Antiviral Agents|antiviral agents|mesh-ancestor
111452445|NCT00004999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111452446|NCT00004999|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111452447|NCT00004999|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111452448|NCT00004999|Antimetabolites|antimetabolites|mesh-ancestor
111452449|NCT00004999|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111452450|NCT00004999|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111452451|NCT00004999|Protease Inhibitors|protease inhibitors|mesh-ancestor
111452452|NCT00003361|Decitabine|decitabine|mesh-list
110921480|NCT05884866|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111452453|NCT00003361|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111452454|NCT00003361|Antimetabolites|antimetabolites|mesh-ancestor
111452455|NCT00003361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111452456|NCT00003361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111452457|NCT00003361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111452458|NCT00003367|Vitamin E|vitamin e|mesh-list
111452459|NCT00003367|Vitamins|vitamins|mesh-ancestor
111452460|NCT00003367|Micronutrients|micronutrients|mesh-ancestor
111452461|NCT00003367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111452462|NCT00003367|Antioxidants|antioxidants|mesh-ancestor
111452463|NCT00003367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111452464|NCT00003367|Protective Agents|protective agents|mesh-ancestor
111452465|NCT00003379|Paclitaxel|paclitaxel|mesh-list
111452466|NCT00003379|Cisplatin|cisplatin|mesh-list
111452467|NCT00003379|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111452468|NCT00003379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111452469|NCT00003379|Tubulin Modulators|tubulin modulators|mesh-ancestor
111452470|NCT00003379|Antimitotic Agents|antimitotic agents|mesh-ancestor
111452471|NCT00003379|Mitosis Modulators|mitosis modulators|mesh-ancestor
110921602|NCT05830799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111452472|NCT00003379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111452473|NCT00003385|Paclitaxel|paclitaxel|mesh-list
111452474|NCT00003385|Carboplatin|carboplatin|mesh-list
111452475|NCT00003385|Doxorubicin|doxorubicin|mesh-list
111452476|NCT00003385|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111452477|NCT00003385|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111452478|NCT00003385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111452479|NCT00003385|Tubulin Modulators|tubulin modulators|mesh-ancestor
111452480|NCT00003385|Antimitotic Agents|antimitotic agents|mesh-ancestor
111452481|NCT00003385|Mitosis Modulators|mitosis modulators|mesh-ancestor
111452482|NCT00003385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110921670|NCT05593458|Oxaliplatin|oxaliplatin|mesh-list
111452483|NCT00003385|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111452484|NCT00003385|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111452485|NCT00003385|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111452486|NCT00003385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111452487|NCT00004381|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
111452488|NCT00004381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111452489|NCT00004381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111452490|NCT00005005|Alendronate|alendronate|mesh-list
111452491|NCT00005005|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111452492|NCT00005005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111452493|NCT00004393|Risperidone|risperidone|mesh-list
111452494|NCT00004393|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111452495|NCT00004393|Serotonin Agents|serotonin agents|mesh-ancestor
111452496|NCT00004393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111452497|NCT00004393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111452498|NCT00004393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111452499|NCT00004393|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111452500|NCT00004393|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111452501|NCT00004393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111452502|NCT00004393|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111452503|NCT00004393|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111452504|NCT00004393|Dopamine Agents|dopamine agents|mesh-ancestor
111452505|NCT00004399|Magnesium Sulfate|magnesium sulfate|mesh-list
111452507|NCT00004399|Analgesics|analgesics|mesh-ancestor
111452508|NCT00004399|Sensory System Agents|sensory system agents|mesh-ancestor
111452509|NCT00004399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111452510|NCT00004399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111452511|NCT00004399|Anesthetics|anesthetics|mesh-ancestor
111452512|NCT00004399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111452513|NCT00004399|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111452514|NCT00004399|Anticonvulsants|anticonvulsants|mesh-ancestor
111452515|NCT00004399|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111452516|NCT00004399|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111452517|NCT00004399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111452518|NCT00004399|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111452519|NCT00004399|Tocolytic Agents|tocolytic agents|mesh-ancestor
111452520|NCT00004399|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111452521|NCT00004399|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111452522|NCT00004399|Vasodilator Agents|vasodilator agents|mesh-ancestor
111452523|NCT00004423|Aminosalicylic Acid|aminosalicylic acid|mesh-list
111452524|NCT00004423|Antitubercular Agents|antitubercular agents|mesh-ancestor
111452525|NCT00004423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111452526|NCT00004423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111452527|NCT00005017|Ritonavir|ritonavir|mesh-list
111452528|NCT00005017|Amprenavir|amprenavir|mesh-list
111452529|NCT00005017|Lamivudine|lamivudine|mesh-list
111452530|NCT00005017|Abacavir|abacavir|mesh-list
111452531|NCT00005017|Stavudine|stavudine|mesh-list
111452532|NCT00005017|Efavirenz|efavirenz|mesh-list
111452533|NCT00005017|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111452534|NCT00005017|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111452535|NCT00005017|Protease Inhibitors|protease inhibitors|mesh-ancestor
111452536|NCT00005017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111452537|NCT00005017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111452538|NCT00005017|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111452539|NCT00005017|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111452540|NCT00005017|Antiviral Agents|antiviral agents|mesh-ancestor
111452541|NCT00005017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111452542|NCT00005017|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111452543|NCT00005017|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111452544|NCT00005017|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111452545|NCT00005017|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110921992|NCT04123873|Analgesics|analgesics|mesh-ancestor
111452546|NCT00005017|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111452547|NCT00005017|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111452548|NCT00005017|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111452549|NCT00005017|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111452550|NCT00005017|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111452551|NCT00005017|Antimetabolites|antimetabolites|mesh-ancestor
111452552|NCT00005017|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111452553|NCT00005017|Antitubercular Agents|antitubercular agents|mesh-ancestor
111452554|NCT00005017|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111452555|NCT00005023|Sargramostim|sargramostim|mesh-list
111452556|NCT00005023|Immunologic Factors|immunologic factors|mesh-ancestor
111452557|NCT00005023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111452558|NCT00005029|Topotecan|topotecan|mesh-list
111452559|NCT00005029|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111452560|NCT00005029|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111452561|NCT00005029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111452562|NCT00005029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111452563|NCT00005029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111452565|NCT00005035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111452566|NCT00004429|Hormones|hormones|mesh-list
111452567|NCT00004429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111452568|NCT00004429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111452569|NCT00005041|Tipifarnib|tipifarnib|mesh-list
111452570|NCT00005041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111452571|NCT00004441|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
111452572|NCT00004441|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
111452573|NCT00004441|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
111452574|NCT00004441|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111452575|NCT00004441|Antiviral Agents|antiviral agents|mesh-ancestor
111452576|NCT00004441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111452577|NCT00004465|Shiga Toxins|shiga toxins|mesh-list
111452578|NCT00004465|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111452579|NCT00004465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111452580|NCT00004465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111452581|NCT00005569|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
111452582|NCT00005569|Protease Inhibitors|protease inhibitors|mesh-list
111452583|NCT00005569|Secretory Leukocyte Peptidase Inhibitor|secretory leukocyte peptidase inhibitor|mesh-list
111452584|NCT00005569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111452585|NCT00005569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111452586|NCT00005569|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111452587|NCT00005569|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111452588|NCT00005569|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111452589|NCT00005569|Antiviral Agents|antiviral agents|mesh-ancestor
111452590|NCT00005569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111452591|NCT00005569|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111452592|NCT00005575|Imipramine|imipramine|mesh-list
111452593|NCT00005575|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
111452594|NCT00005575|Antidepressive Agents|antidepressive agents|mesh-ancestor
111452595|NCT00005575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111452596|NCT00005575|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111452597|NCT00005575|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111452598|NCT00005575|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110922234|NCT02243709|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111452599|NCT00005575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111452600|NCT00005575|Adrenergic Agents|adrenergic agents|mesh-ancestor
111452601|NCT00005575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111452602|NCT00005575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111452603|NCT00005059|Paclitaxel|paclitaxel|mesh-list
111452604|NCT00005059|Carboplatin|carboplatin|mesh-list
111452605|NCT00005059|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111452606|NCT00005059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111452607|NCT00005059|Tubulin Modulators|tubulin modulators|mesh-ancestor
111452608|NCT00005059|Antimitotic Agents|antimitotic agents|mesh-ancestor
111452609|NCT00005059|Mitosis Modulators|mitosis modulators|mesh-ancestor
111452610|NCT00005059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111452611|NCT00005065|Paclitaxel|paclitaxel|mesh-list
111452612|NCT00005065|Carboplatin|carboplatin|mesh-list
111452613|NCT00005065|Motexafin gadolinium|motexafin gadolinium|mesh-list
111452614|NCT00005065|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111452615|NCT00005065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111452616|NCT00005065|Tubulin Modulators|tubulin modulators|mesh-ancestor
111452617|NCT00005065|Antimitotic Agents|antimitotic agents|mesh-ancestor
111452618|NCT00005065|Mitosis Modulators|mitosis modulators|mesh-ancestor
111452619|NCT00005065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111452620|NCT00005065|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111452621|NCT00005065|Dermatologic Agents|dermatologic agents|mesh-ancestor
111452622|NCT00386191|Clopidogrel|clopidogrel|mesh-list
111452623|NCT00386191|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110922360|NCT00751829|Vasodilator Agents|vasodilator agents|mesh-ancestor
111452624|NCT00386191|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111452625|NCT00386191|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111452626|NCT00386191|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111452627|NCT00386191|Purinergic Agents|purinergic agents|mesh-ancestor
111452628|NCT00386191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111452629|NCT00386191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111452630|NCT00386191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111452631|NCT00386269|Codeine|codeine|mesh-list
111176790|NCT01866657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111452632|NCT00386269|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111452633|NCT00386269|Narcotics|narcotics|mesh-ancestor
111452634|NCT00386269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111452635|NCT00386269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111452636|NCT00386269|Analgesics|analgesics|mesh-ancestor
111452637|NCT00386269|Sensory System Agents|sensory system agents|mesh-ancestor
111452638|NCT00386269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111452639|NCT00386269|Antitussive Agents|antitussive agents|mesh-ancestor
111452640|NCT00386269|Respiratory System Agents|respiratory system agents|mesh-ancestor
111452641|NCT00005581|Paclitaxel|paclitaxel|mesh-list
111452642|NCT00005581|Cyclophosphamide|cyclophosphamide|mesh-list
111452643|NCT00005581|Fluorouracil|fluorouracil|mesh-list
111452644|NCT00005581|Epirubicin|epirubicin|mesh-list
111452645|NCT00005581|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111452646|NCT00005581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111452647|NCT00005581|Tubulin Modulators|tubulin modulators|mesh-ancestor
111452648|NCT00005581|Antimitotic Agents|antimitotic agents|mesh-ancestor
111452649|NCT00005581|Mitosis Modulators|mitosis modulators|mesh-ancestor
111452650|NCT00005581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111452651|NCT00005581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111452652|NCT00005581|Immunologic Factors|immunologic factors|mesh-ancestor
111452653|NCT00005581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111452654|NCT00005581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110922553|NCT02299310|Valsartan|valsartan|mesh-list
111452655|NCT00005581|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111452656|NCT00005581|Alkylating Agents|alkylating agents|mesh-ancestor
111452657|NCT00005581|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111452658|NCT00005581|Antimetabolites|antimetabolites|mesh-ancestor
111452659|NCT00005581|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111452660|NCT00005581|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111452661|NCT00005581|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111452662|NCT00005581|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111452663|NCT00005581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111452664|NCT00005077|Oxaliplatin|oxaliplatin|mesh-list
111452665|NCT00005077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111452666|NCT00004489|Cholecalciferol|cholecalciferol|mesh-list
111452667|NCT00004489|Vitamin D|vitamin d|mesh-list
111452668|NCT00004489|Alendronate|alendronate|mesh-list
111452669|NCT00004489|Calcium Carbonate|calcium carbonate|mesh-list
111452670|NCT00004489|Calcium|calcium|mesh-list
111452671|NCT00004489|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111452672|NCT00004489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111452673|NCT00004489|Vitamins|vitamins|mesh-ancestor
111452674|NCT00004489|Micronutrients|micronutrients|mesh-ancestor
111452675|NCT00004489|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111452676|NCT00004489|Antacids|antacids|mesh-ancestor
111452677|NCT00004489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111452678|NCT00004489|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111452679|NCT00005593|Carboplatin|carboplatin|mesh-list
111452680|NCT00005593|Fludarabine|fludarabine|mesh-list
111452681|NCT00005593|Fludarabine phosphate|fludarabine phosphate|mesh-list
111452682|NCT00005593|Topotecan|topotecan|mesh-list
111452683|NCT00005593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111452684|NCT00005593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111452685|NCT00005593|Antimetabolites|antimetabolites|mesh-ancestor
111452686|NCT00005593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111452687|NCT00005593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111452688|NCT00005593|Immunologic Factors|immunologic factors|mesh-ancestor
111452689|NCT00005593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111452690|NCT00005593|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111452691|NCT00005593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111452692|NCT00005593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111452693|NCT00004495|Folic Acid|folic acid|mesh-list
111452694|NCT00004495|Pyridoxine|pyridoxine|mesh-list
111452695|NCT00004495|Vitamin B 12|vitamin b 12|mesh-list
111452696|NCT00004495|Hydroxocobalamin|hydroxocobalamin|mesh-list
111452697|NCT00004495|Hematinics|hematinics|mesh-ancestor
111452698|NCT00004495|Vitamin B Complex|vitamin b complex|mesh-ancestor
111452699|NCT00004495|Vitamins|vitamins|mesh-ancestor
111452700|NCT00004495|Micronutrients|micronutrients|mesh-ancestor
111452701|NCT00004495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111452702|NCT00005089|Prednisone|prednisone|mesh-list
111452703|NCT00005089|Cyclophosphamide|cyclophosphamide|mesh-list
111452704|NCT00005089|Rituximab|rituximab|mesh-list
111452705|NCT00005089|Doxorubicin|doxorubicin|mesh-list
111452706|NCT00005089|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111452707|NCT00005089|Vincristine|vincristine|mesh-list
111452708|NCT00005089|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111452709|NCT00005089|Immunologic Factors|immunologic factors|mesh-ancestor
111452710|NCT00005089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111452711|NCT00005089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111452712|NCT00005089|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111452713|NCT00005089|Alkylating Agents|alkylating agents|mesh-ancestor
111452714|NCT00005089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111452715|NCT00005089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111452716|NCT00005089|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111452717|NCT00005089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111452718|NCT00005089|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111452719|NCT00005089|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111452720|NCT00005089|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110922857|NCT02959437|Antimetabolites|antimetabolites|mesh-ancestor
111452721|NCT00005089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111452722|NCT00005089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111452723|NCT00005089|Glucocorticoids|glucocorticoids|mesh-ancestor
111452724|NCT00005089|Hormones|hormones|mesh-ancestor
111452725|NCT00005089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111452726|NCT00005089|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111452727|NCT00005089|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111452728|NCT00005089|Tubulin Modulators|tubulin modulators|mesh-ancestor
111452729|NCT00005089|Antimitotic Agents|antimitotic agents|mesh-ancestor
111452730|NCT00005089|Mitosis Modulators|mitosis modulators|mesh-ancestor
111452731|NCT00005599|Paclitaxel|paclitaxel|mesh-list
111452732|NCT00005599|Bryostatin 1|bryostatin 1|mesh-list
111452733|NCT00005599|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111452734|NCT00005599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111452735|NCT00005599|Tubulin Modulators|tubulin modulators|mesh-ancestor
111452736|NCT00005599|Antimitotic Agents|antimitotic agents|mesh-ancestor
111452737|NCT00005599|Mitosis Modulators|mitosis modulators|mesh-ancestor
110922924|NCT05891145|Anesthetics|anesthetics|mesh-ancestor
111452738|NCT00005599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111452739|NCT00005599|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111452740|NCT00005599|Immunologic Factors|immunologic factors|mesh-ancestor
111452741|NCT00005599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111452742|NCT00004567|Mycophenolic Acid|mycophenolic acid|mesh-list
111452743|NCT00004567|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111452744|NCT00004567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110922980|NCT05890768|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111452745|NCT00004567|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111452746|NCT00004567|Antitubercular Agents|antitubercular agents|mesh-ancestor
111452747|NCT00004567|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111452748|NCT00004567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111452749|NCT00004567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111452750|NCT00004567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111452751|NCT00005113|Cyclosporine|cyclosporine|mesh-list
111452752|NCT00005113|Sirolimus|sirolimus|mesh-list
111452753|NCT00005113|Tacrolimus|tacrolimus|mesh-list
111452754|NCT00005113|Cyclosporins|cyclosporins|mesh-list
111452755|NCT00005113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111452756|NCT00005113|Immunologic Factors|immunologic factors|mesh-ancestor
111452757|NCT00005113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111452758|NCT00005113|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111452759|NCT00005113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111452760|NCT00005113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111452761|NCT00005113|Antifungal Agents|antifungal agents|mesh-ancestor
111452762|NCT00005113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111452763|NCT00005113|Dermatologic Agents|dermatologic agents|mesh-ancestor
111452764|NCT00005113|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111452765|NCT00005113|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111452766|NCT00005113|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111452767|NCT00005113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111452768|NCT00004573|Ganciclovir|ganciclovir|mesh-list
111452769|NCT00004573|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
111452770|NCT00004573|Antiviral Agents|antiviral agents|mesh-ancestor
111452771|NCT00004573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111452772|NCT00004573|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111452773|NCT00004573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111452774|NCT00004573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111452775|NCT00005623|Cyproterone Acetate|cyproterone acetate|mesh-list
111452776|NCT00005623|Cyproterone|cyproterone|mesh-list
111452777|NCT00005623|Androgen Antagonists|androgen antagonists|mesh-ancestor
111452778|NCT00005623|Hormone Antagonists|hormone antagonists|mesh-ancestor
110923179|NCT05446727|Anesthetics, Local|anesthetics, local|mesh-ancestor
111452779|NCT00005623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111452780|NCT00005623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111452781|NCT00005623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111452782|NCT00005623|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
111452783|NCT00005623|Contraceptive Agents|contraceptive agents|mesh-ancestor
111452784|NCT00005623|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111176943|NCT01698801|Dexamethasone|dexamethasone|mesh-list
111452786|NCT00005119|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111452787|NCT00005119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111452788|NCT00004585|Lamivudine|lamivudine|mesh-list
111452789|NCT00004585|Zidovudine|zidovudine|mesh-list
111452790|NCT00004585|Efavirenz|efavirenz|mesh-list
111452791|NCT00004585|Abacavir|abacavir|mesh-list
110923251|NCT05156710|Rituximab|rituximab|mesh-list
111452792|NCT00004585|Dideoxynucleosides|dideoxynucleosides|mesh-list
111452793|NCT00004585|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
111452794|NCT00004585|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111452795|NCT00004585|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111452796|NCT00004585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111452797|NCT00004585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111452798|NCT00004585|Antiviral Agents|antiviral agents|mesh-ancestor
111452799|NCT00004585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111452800|NCT00004585|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111452801|NCT00004585|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111452802|NCT00004585|Antimetabolites|antimetabolites|mesh-ancestor
111452803|NCT00004585|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111452804|NCT00004585|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111452805|NCT00004585|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111452806|NCT00004585|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111452807|NCT00004585|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111452808|NCT00004585|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111452809|NCT00005635|Paclitaxel|paclitaxel|mesh-list
111452810|NCT00005635|Trastuzumab|trastuzumab|mesh-list
111452811|NCT00005635|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111452812|NCT00005635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111452813|NCT00005635|Tubulin Modulators|tubulin modulators|mesh-ancestor
111452814|NCT00005635|Antimitotic Agents|antimitotic agents|mesh-ancestor
111452815|NCT00005635|Mitosis Modulators|mitosis modulators|mesh-ancestor
111452816|NCT00005635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111452817|NCT00005635|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111452818|NCT00005641|Leucovorin|leucovorin|mesh-list
111452819|NCT00005641|Cyclosporine|cyclosporine|mesh-list
111452820|NCT00005641|Methylprednisolone|methylprednisolone|mesh-list
111452821|NCT00005641|Cyclophosphamide|cyclophosphamide|mesh-list
111452822|NCT00005641|Busulfan|busulfan|mesh-list
111452823|NCT00005641|Methotrexate|methotrexate|mesh-list
111452824|NCT00005641|Cyclosporins|cyclosporins|mesh-list
111452825|NCT00005641|Antilymphocyte Serum|antilymphocyte serum|mesh-list
111452826|NCT00005641|Levoleucovorin|levoleucovorin|mesh-list
111452827|NCT00005641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111452828|NCT00005641|Immunologic Factors|immunologic factors|mesh-ancestor
111452829|NCT00005641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111452830|NCT00005641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111452831|NCT00005641|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111452832|NCT00005641|Alkylating Agents|alkylating agents|mesh-ancestor
111452833|NCT00005641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111452834|NCT00005641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111452835|NCT00005641|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110923420|NCT04697862|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111452836|NCT00005641|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111452837|NCT00005641|Abortifacient Agents|abortifacient agents|mesh-ancestor
111452838|NCT00005641|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111452839|NCT00005641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111452840|NCT00005641|Antimetabolites|antimetabolites|mesh-ancestor
111452841|NCT00005641|Dermatologic Agents|dermatologic agents|mesh-ancestor
111452842|NCT00005641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111452843|NCT00005641|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111452844|NCT00005641|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111452845|NCT00005641|Antidotes|antidotes|mesh-ancestor
111452846|NCT00005641|Protective Agents|protective agents|mesh-ancestor
111452847|NCT00005641|Vitamin B Complex|vitamin b complex|mesh-ancestor
111452848|NCT00005641|Vitamins|vitamins|mesh-ancestor
111452849|NCT00005641|Micronutrients|micronutrients|mesh-ancestor
111452850|NCT00005641|Antifungal Agents|antifungal agents|mesh-ancestor
111452851|NCT00005641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111452852|NCT00005641|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111452853|NCT00005641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111452854|NCT00005641|Antiemetics|antiemetics|mesh-ancestor
111452855|NCT00005641|Autonomic Agents|autonomic agents|mesh-ancestor
111452856|NCT00005641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111452857|NCT00005641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111452858|NCT00005641|Glucocorticoids|glucocorticoids|mesh-ancestor
111452859|NCT00005641|Hormones|hormones|mesh-ancestor
111452860|NCT00005641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111452861|NCT00005641|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111452862|NCT00005647|Paclitaxel|paclitaxel|mesh-list
111452863|NCT00005647|Semaxinib|semaxinib|mesh-list
111452864|NCT00005647|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111452865|NCT00005647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111452866|NCT00005647|Tubulin Modulators|tubulin modulators|mesh-ancestor
111452867|NCT00005647|Antimitotic Agents|antimitotic agents|mesh-ancestor
111452868|NCT00005647|Mitosis Modulators|mitosis modulators|mesh-ancestor
111452869|NCT00005647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111452870|NCT00005647|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111452871|NCT00005647|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111452872|NCT00005647|Growth Substances|growth substances|mesh-ancestor
110923606|NCT03831113|Buprenorphine|buprenorphine|mesh-list
111452873|NCT00005647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111452874|NCT00005647|Growth Inhibitors|growth inhibitors|mesh-ancestor
111452875|NCT00005647|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111452876|NCT00005647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111452877|NCT00005665|Interferons|interferons|mesh-list
111452878|NCT00005665|Interferon-alpha|interferon-alpha|mesh-list
111452879|NCT00005665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111452880|NCT00005665|Antiviral Agents|antiviral agents|mesh-ancestor
111452881|NCT00005665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111452882|NCT00005665|Immunologic Factors|immunologic factors|mesh-ancestor
111452883|NCT00005665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111452884|NCT00004669|Hydrocortisone|hydrocortisone|mesh-list
111452885|NCT00004669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111452886|NCT00385411|Valproic Acid|valproic acid|mesh-list
111452887|NCT00385411|Anticonvulsants|anticonvulsants|mesh-ancestor
111452888|NCT00385411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111452889|NCT00385411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111452890|NCT00385411|GABA Agents|gaba agents|mesh-ancestor
111452891|NCT00385411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111452892|NCT00385411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111452893|NCT00385411|Antimanic Agents|antimanic agents|mesh-ancestor
111452894|NCT00385411|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111452895|NCT00385411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111452896|NCT00385411|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111452897|NCT00004699|Mitogens|mitogens|mesh-list
111452898|NCT00004699|Mitosis Modulators|mitosis modulators|mesh-ancestor
111452899|NCT00004699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111452900|NCT00004705|Amiloride|amiloride|mesh-list
111452901|NCT00004705|Diuretics|diuretics|mesh-ancestor
111452902|NCT00004705|Natriuretic Agents|natriuretic agents|mesh-ancestor
111452903|NCT00004705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111452904|NCT00004705|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
111452905|NCT00004705|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111452906|NCT00004705|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111452907|NCT00004705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111452908|NCT00004705|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
111452909|NCT00004705|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
111452910|NCT00004747|Immunoglobulins|immunoglobulins|mesh-list
111452911|NCT00004747|Antibodies|antibodies|mesh-list
111452912|NCT00004747|gamma-Globulins|gamma-globulins|mesh-list
111452913|NCT00004747|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111452914|NCT00004747|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
111452915|NCT00004747|Immunologic Factors|immunologic factors|mesh-ancestor
111452916|NCT00004747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111452917|NCT00004759|Methylprednisolone|methylprednisolone|mesh-list
111452918|NCT00004759|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111452919|NCT00004759|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111452920|NCT00004759|Prednisolone|prednisolone|mesh-list
111452921|NCT00004759|Prednisolone acetate|prednisolone acetate|mesh-list
111452922|NCT00004759|Tirilazad|tirilazad|mesh-list
111452923|NCT00004759|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111452924|NCT00004759|Prednisolone phosphate|prednisolone phosphate|mesh-list
111452925|NCT00004759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111452926|NCT00004759|Antiemetics|antiemetics|mesh-ancestor
111452927|NCT00004759|Autonomic Agents|autonomic agents|mesh-ancestor
111452928|NCT00004759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111452929|NCT00004759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111452930|NCT00004759|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111452931|NCT00004759|Glucocorticoids|glucocorticoids|mesh-ancestor
111452932|NCT00004759|Hormones|hormones|mesh-ancestor
111452933|NCT00004759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111452934|NCT00004759|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111177102|NCT03159598|Urethane|urethane|mesh-list
111452935|NCT00004759|Protective Agents|protective agents|mesh-ancestor
111452936|NCT00004759|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111452937|NCT00004759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111452938|NCT00004759|Antioxidants|antioxidants|mesh-ancestor
110923986|NCT02646124|Anesthetics|anesthetics|mesh-ancestor
111452939|NCT00004759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111452940|NCT00004771|Leuprolide|leuprolide|mesh-list
111452941|NCT00004771|Testosterone|testosterone|mesh-list
111452942|NCT00004771|Androgens|androgens|mesh-ancestor
111452943|NCT00004771|Hormones|hormones|mesh-ancestor
111452944|NCT00004771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111452945|NCT00004771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111452946|NCT00004771|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111452947|NCT00004771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111452948|NCT00004771|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111452949|NCT00004771|Fertility Agents|fertility agents|mesh-ancestor
111452950|NCT00004771|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111452951|NCT00004789|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
111452952|NCT00004789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111452953|NCT00004789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111452954|NCT00004795|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
111452955|NCT00004795|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111452956|NCT00004795|Immunologic Factors|immunologic factors|mesh-ancestor
111452957|NCT00004795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111452958|NCT00004807|Topiramate|topiramate|mesh-list
111452959|NCT00004807|Dextromethorphan|dextromethorphan|mesh-list
111452960|NCT00004807|Donepezil|donepezil|mesh-list
111452961|NCT00004807|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111452962|NCT00004807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111452963|NCT00004807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111452964|NCT00004807|Cholinergic Agents|cholinergic agents|mesh-ancestor
111452965|NCT00004807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111452966|NCT00004807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111452967|NCT00004807|Nootropic Agents|nootropic agents|mesh-ancestor
111452968|NCT00004807|Anticonvulsants|anticonvulsants|mesh-ancestor
111452969|NCT00004807|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111452970|NCT00004807|Antitussive Agents|antitussive agents|mesh-ancestor
111452971|NCT00004807|Respiratory System Agents|respiratory system agents|mesh-ancestor
111452972|NCT00004807|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111452973|NCT00004807|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111452974|NCT00004825|Insulin|insulin|mesh-list
111452975|NCT00004825|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111452976|NCT00004825|Mitogens|mitogens|mesh-list
111452977|NCT00004825|Mecasermin|mecasermin|mesh-list
111452978|NCT00004825|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111452979|NCT00004825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111452980|NCT00004825|Mitosis Modulators|mitosis modulators|mesh-ancestor
111452981|NCT00004825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111452982|NCT00004825|Growth Substances|growth substances|mesh-ancestor
111452983|NCT00385645|Atazanavir Sulfate|atazanavir sulfate|mesh-list
111452984|NCT00385645|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
111452985|NCT00385645|Zidovudine|zidovudine|mesh-list
111452986|NCT00385645|Lamivudine|lamivudine|mesh-list
111452987|NCT00385645|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111452988|NCT00385645|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111452989|NCT00385645|Protease Inhibitors|protease inhibitors|mesh-ancestor
111452990|NCT00385645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111452991|NCT00385645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111452992|NCT00385645|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111452993|NCT00385645|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111452994|NCT00385645|Antiviral Agents|antiviral agents|mesh-ancestor
111452995|NCT00385645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111452996|NCT00385645|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110924255|NCT02143362|Narcotics|narcotics|mesh-ancestor
111452997|NCT00385645|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111452998|NCT00385645|Antimetabolites|antimetabolites|mesh-ancestor
111452999|NCT00385957|Lamivudine|lamivudine|mesh-list
111453000|NCT00385957|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111453001|NCT00385957|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111453002|NCT00385957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111453003|NCT00385957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111453004|NCT00385957|Antiviral Agents|antiviral agents|mesh-ancestor
111453005|NCT00385957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111453006|NCT00385957|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111453007|NCT00385957|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111453008|NCT00005107|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
111453009|NCT00005107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111453010|NCT00005107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111453011|NCT00005773|Nitric Oxide|nitric oxide|mesh-list
111453012|NCT00005773|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111453013|NCT00005773|Autonomic Agents|autonomic agents|mesh-ancestor
111453014|NCT00005773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111453015|NCT00005773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111453016|NCT00005773|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111453017|NCT00005773|Respiratory System Agents|respiratory system agents|mesh-ancestor
111453018|NCT00005773|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111453019|NCT00005773|Antioxidants|antioxidants|mesh-ancestor
111453020|NCT00005773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111453021|NCT00005773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111453022|NCT00005773|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
111453023|NCT00005773|Vasodilator Agents|vasodilator agents|mesh-ancestor
111453024|NCT00005773|Gasotransmitters|gasotransmitters|mesh-ancestor
111453025|NCT00005773|Protective Agents|protective agents|mesh-ancestor
111453026|NCT00005779|Interleukin-12|interleukin-12|mesh-list
111453027|NCT00005779|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111453028|NCT00005779|Immunologic Factors|immunologic factors|mesh-ancestor
111453029|NCT00005779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111453030|NCT00005779|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111453031|NCT00005779|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111453032|NCT00005779|Growth Substances|growth substances|mesh-ancestor
111453033|NCT00005779|Growth Inhibitors|growth inhibitors|mesh-ancestor
111453034|NCT00005779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111453035|NCT00005791|Fluorouracil|fluorouracil|mesh-list
111453036|NCT00005791|Irinotecan|irinotecan|mesh-list
111453037|NCT00005791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111453038|NCT00005791|Antimetabolites|antimetabolites|mesh-ancestor
111453039|NCT00005791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111453040|NCT00005791|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111453041|NCT00005791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111453042|NCT00005791|Immunologic Factors|immunologic factors|mesh-ancestor
111453043|NCT00005791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111453044|NCT00005791|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111453045|NCT00005791|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111453046|NCT00005791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111453047|NCT00005797|Cyclophosphamide|cyclophosphamide|mesh-list
111453048|NCT00005797|Busulfan|busulfan|mesh-list
111453049|NCT00005797|Etoposide|etoposide|mesh-list
111453050|NCT00005797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111453051|NCT00005797|Immunologic Factors|immunologic factors|mesh-ancestor
111453052|NCT00005797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111453053|NCT00005797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111453054|NCT00005797|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111453055|NCT00005797|Alkylating Agents|alkylating agents|mesh-ancestor
111453056|NCT00005797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111453057|NCT00005797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111453058|NCT00005797|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111453059|NCT00005797|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111453060|NCT00005797|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111453061|NCT00005797|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111453062|NCT00005797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111453063|NCT00005815|Thalidomide|thalidomide|mesh-list
111453064|NCT00005815|Temozolomide|temozolomide|mesh-list
111453065|NCT00005815|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111453066|NCT00005815|Alkylating Agents|alkylating agents|mesh-ancestor
111453067|NCT00005815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111453068|NCT00005815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111453069|NCT00005815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111453070|NCT00005815|Immunologic Factors|immunologic factors|mesh-ancestor
111453071|NCT00005815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111453072|NCT00005815|Leprostatic Agents|leprostatic agents|mesh-ancestor
111453073|NCT00005815|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111453074|NCT00005815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111453075|NCT00005815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111453076|NCT00005815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111453077|NCT00005815|Growth Substances|growth substances|mesh-ancestor
111453078|NCT00005815|Growth Inhibitors|growth inhibitors|mesh-ancestor
111453079|NCT02132754|Pembrolizumab|pembrolizumab|mesh-list
111453080|NCT02132754|MK-4166|mk-4166|mesh-list
111453081|NCT02132754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111453082|NCT02132754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111453083|NCT02132754|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111453084|NCT02132754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111453085|NCT02151786|Lansoprazole|lansoprazole|mesh-list
111453086|NCT02151786|Dexlansoprazole|dexlansoprazole|mesh-list
111453087|NCT02151786|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111453088|NCT02151786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111453089|NCT02151786|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111453090|NCT02151786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111453091|NCT02151786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111453092|NCT02106156|Interferons|interferons|mesh-list
111453094|NCT02106156|Interferon-alpha|interferon-alpha|mesh-list
111453095|NCT02106156|Interferon alpha-2|interferon alpha-2|mesh-list
111453096|NCT02106156|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
111453097|NCT02106156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111453098|NCT02106156|Antiviral Agents|antiviral agents|mesh-ancestor
111453099|NCT02106156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111453100|NCT02106156|Antimetabolites|antimetabolites|mesh-ancestor
111453101|NCT02106156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111453102|NCT02106156|Immunologic Factors|immunologic factors|mesh-ancestor
110924741|NCT05063578|Lidocaine|lidocaine|mesh-list
111453103|NCT02106156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111453104|NCT02131272|Insulin|insulin|mesh-list
111453105|NCT02131272|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111453106|NCT02131272|Insulin Detemir|insulin detemir|mesh-list
111453107|NCT02131272|Isophane Insulin, Human|isophane insulin, human|mesh-list
111453108|NCT02131272|Insulin, Isophane|insulin, isophane|mesh-list
111453109|NCT02131272|Isophane insulin, beef|isophane insulin, beef|mesh-list
111453110|NCT02131272|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111453111|NCT02131272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111453112|NCT02130882|Benralizumab|benralizumab|mesh-list
111453113|NCT02130882|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111453114|NCT02130882|Respiratory System Agents|respiratory system agents|mesh-ancestor
111453115|NCT02149836|Ezogabine|ezogabine|mesh-list
111453116|NCT02149836|Anticonvulsants|anticonvulsants|mesh-ancestor
111453117|NCT02149836|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111453118|NCT02149836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111453119|NCT02130024|Ranibizumab|ranibizumab|mesh-list
111453120|NCT02130024|Aflibercept|aflibercept|mesh-list
111453121|NCT02130024|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111453122|NCT02130024|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111453123|NCT02130024|Growth Substances|growth substances|mesh-ancestor
111453124|NCT02130024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111453125|NCT02130024|Growth Inhibitors|growth inhibitors|mesh-ancestor
111453126|NCT02130024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111453127|NCT02105688|Grazoprevir|grazoprevir|mesh-list
111453128|NCT02105688|Antiviral Agents|antiviral agents|mesh-ancestor
111453129|NCT02105688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111453130|NCT02105454|Ribavirin|ribavirin|mesh-list
111453131|NCT02105454|Grazoprevir|grazoprevir|mesh-list
111453132|NCT02105454|Antimetabolites|antimetabolites|mesh-ancestor
111453133|NCT02105454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111453134|NCT02105454|Antiviral Agents|antiviral agents|mesh-ancestor
111453135|NCT02105454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111453136|NCT02104752|Curcumin|curcumin|mesh-list
111453137|NCT02104752|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111453138|NCT02104752|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111453139|NCT02104752|Analgesics|analgesics|mesh-ancestor
111453140|NCT02104752|Sensory System Agents|sensory system agents|mesh-ancestor
111453141|NCT02104752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111453142|NCT02104752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111453143|NCT02104752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111453144|NCT02104752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111453145|NCT02104752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111453146|NCT02104752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111453147|NCT02104752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111453148|NCT02128932|Insulin Glargine|insulin glargine|mesh-list
111453149|NCT02128932|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111453150|NCT02128932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111453151|NCT02128542|Sofosbuvir|sofosbuvir|mesh-list
111453152|NCT02128542|Antiviral Agents|antiviral agents|mesh-ancestor
111453153|NCT02128542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111453154|NCT02127372|Cisplatin|cisplatin|mesh-list
111453155|NCT02127372|Docetaxel|docetaxel|mesh-list
111453156|NCT02127372|Imatinib Mesylate|imatinib mesylate|mesh-list
111453157|NCT02127372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111453158|NCT02127372|Tubulin Modulators|tubulin modulators|mesh-ancestor
111453159|NCT02127372|Antimitotic Agents|antimitotic agents|mesh-ancestor
111453160|NCT02127372|Mitosis Modulators|mitosis modulators|mesh-ancestor
111453161|NCT02127372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111453162|NCT02127372|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111453163|NCT02127372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111177318|NCT01671982|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111453164|NCT02125734|Bromides|bromides|mesh-list
111453165|NCT02125734|Tiotropium Bromide|tiotropium bromide|mesh-list
111453166|NCT02125734|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111453167|NCT02125734|Autonomic Agents|autonomic agents|mesh-ancestor
111453168|NCT02125734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111453169|NCT02125734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111453170|NCT02125734|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111453171|NCT02125734|Respiratory System Agents|respiratory system agents|mesh-ancestor
111453172|NCT02125734|Parasympatholytics|parasympatholytics|mesh-ancestor
111453173|NCT02125734|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111453174|NCT02125734|Cholinergic Agents|cholinergic agents|mesh-ancestor
111453175|NCT02125734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111453176|NCT02125734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111453177|NCT02125734|Anticonvulsants|anticonvulsants|mesh-ancestor
111453178|NCT02124798|Belimumab|belimumab|mesh-list
111453179|NCT02124798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111453180|NCT02124798|Immunologic Factors|immunologic factors|mesh-ancestor
111453181|NCT02124798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111453182|NCT04735770|Levobupivacaine|levobupivacaine|mesh-list
111453183|NCT04735770|Anesthetics|anesthetics|mesh-ancestor
111453184|NCT04735770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111453185|NCT04735770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111453186|NCT04735770|Anesthetics, Local|anesthetics, local|mesh-ancestor
111453187|NCT04735770|Sensory System Agents|sensory system agents|mesh-ancestor
111453188|NCT04735770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111453189|NCT02146248|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
111453190|NCT02146248|Contraceptive Agents|contraceptive agents|mesh-list
111453191|NCT02146248|Medroxyprogesterone|medroxyprogesterone|mesh-list
111453192|NCT02146248|Contraceptives, Oral|contraceptives, oral|mesh-list
111453193|NCT02146248|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
110924929|NCT03292146|Denosumab|denosumab|mesh-list
111453194|NCT02146248|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111453195|NCT02146248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111453196|NCT02146248|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111453197|NCT02146248|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111453198|NCT02146248|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111453199|NCT02146248|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111453200|NCT02146248|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
111453201|NCT02146248|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111453202|NCT02146248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111453203|NCT02124564|Lacosamide|lacosamide|mesh-list
111453204|NCT02124564|Anticonvulsants|anticonvulsants|mesh-ancestor
111453205|NCT02124564|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111453206|NCT02124564|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111453207|NCT02124564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111453208|NCT02124564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111453209|NCT02100696|Etrolizumab|etrolizumab|mesh-list
110924944|NCT02314754|Oxytocics|oxytocics|mesh-ancestor
111453210|NCT02100696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111453211|NCT02100696|Immunologic Factors|immunologic factors|mesh-ancestor
111453212|NCT02100696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111453213|NCT02123472|Cephalexin|cephalexin|mesh-list
111453214|NCT02123472|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111453215|NCT02123472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111453216|NCT02145078|Gemcitabine|gemcitabine|mesh-list
111453217|NCT02145078|Docetaxel|docetaxel|mesh-list
111453218|NCT02145078|Pemetrexed|pemetrexed|mesh-list
111453219|NCT02145078|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111453220|NCT02145078|Antimetabolites|antimetabolites|mesh-ancestor
111453221|NCT02145078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111453222|NCT02145078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110925003|NCT04463264|Nitazoxanide|nitazoxanide|mesh-list
111453223|NCT02145078|Tubulin Modulators|tubulin modulators|mesh-ancestor
111453224|NCT02145078|Antimitotic Agents|antimitotic agents|mesh-ancestor
111453225|NCT02145078|Mitosis Modulators|mitosis modulators|mesh-ancestor
111453226|NCT02145078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111453227|NCT02145078|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111453228|NCT02145078|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111453229|NCT02100228|Vitamin K|vitamin k|mesh-list
111453230|NCT02100228|Heparin|heparin|mesh-list
111453231|NCT02100228|Apixaban|apixaban|mesh-list
111453232|NCT02100228|Vitamins|vitamins|mesh-ancestor
111453233|NCT02100228|Micronutrients|micronutrients|mesh-ancestor
111453234|NCT02100228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111453235|NCT02100228|Anticoagulants|anticoagulants|mesh-ancestor
111453236|NCT02100228|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111453237|NCT02100228|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111453238|NCT02100228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111453239|NCT02100228|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111453240|NCT02100228|Antithrombins|antithrombins|mesh-ancestor
111453241|NCT02100228|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111453242|NCT02100228|Protease Inhibitors|protease inhibitors|mesh-ancestor
111453243|NCT02100228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111453244|NCT02100228|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111453245|NCT02100228|Hemostatics|hemostatics|mesh-ancestor
111453246|NCT02100228|Coagulants|coagulants|mesh-ancestor
111453247|NCT02099838|Metformin|metformin|mesh-list
111453248|NCT02099838|Pioglitazone|pioglitazone|mesh-list
111453249|NCT02099838|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111453250|NCT02099838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111453251|NCT02099682|Lansoprazole|lansoprazole|mesh-list
111453252|NCT02099682|Dexlansoprazole|dexlansoprazole|mesh-list
111453253|NCT02099682|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111453254|NCT02099682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111453255|NCT02099682|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111453256|NCT02099682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111453257|NCT02099682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111453258|NCT02098746|Pioglitazone|pioglitazone|mesh-list
111453259|NCT02098746|Glimepiride|glimepiride|mesh-list
111453260|NCT02098746|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111453261|NCT02098746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111453262|NCT02098746|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111453263|NCT02098746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111453264|NCT02098746|Immunologic Factors|immunologic factors|mesh-ancestor
111453265|NCT02122770|Itraconazole|itraconazole|mesh-list
111453266|NCT02122770|Fluconazole|fluconazole|mesh-list
111453267|NCT02122770|Paclitaxel|paclitaxel|mesh-list
111453268|NCT02122770|Docetaxel|docetaxel|mesh-list
111453269|NCT02122770|Carboplatin|carboplatin|mesh-list
111453270|NCT02122770|Pevonedistat|pevonedistat|mesh-list
111453271|NCT02122770|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111453272|NCT02122770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111453273|NCT02122770|Tubulin Modulators|tubulin modulators|mesh-ancestor
111453274|NCT02122770|Antimitotic Agents|antimitotic agents|mesh-ancestor
111453275|NCT02122770|Mitosis Modulators|mitosis modulators|mesh-ancestor
111453276|NCT02122770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111453277|NCT02122770|Antifungal Agents|antifungal agents|mesh-ancestor
111453278|NCT02122770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111453279|NCT02122770|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111453280|NCT02122770|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111453281|NCT02122770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111453282|NCT02122770|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111453283|NCT02122770|Hormone Antagonists|hormone antagonists|mesh-ancestor
111453284|NCT02122770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111453285|NCT02122770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110925233|NCT02254668|Everolimus|everolimus|mesh-list
111453286|NCT02122770|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111453287|NCT02122770|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111453288|NCT02122770|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111453289|NCT02122380|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111453290|NCT02122380|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111453291|NCT02122380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111453292|NCT02122380|Incretins|incretins|mesh-ancestor
111453293|NCT02122380|Hormones|hormones|mesh-ancestor
111453294|NCT02122380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111453295|NCT02122380|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111453296|NCT02122380|Protease Inhibitors|protease inhibitors|mesh-ancestor
111453297|NCT02122380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111453298|NCT02122380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111453299|NCT02121756|Dipyridamole|dipyridamole|mesh-list
111453300|NCT02121756|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111453301|NCT02121756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111453302|NCT02121756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111453303|NCT02121756|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111453304|NCT02121756|Vasodilator Agents|vasodilator agents|mesh-ancestor
111453305|NCT02141490|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
110269097|NCT00185952|Nifedipine|nifedipine|mesh-list
111453306|NCT02141490|Hematinics|hematinics|mesh-ancestor
111453307|NCT02141490|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
111453308|NCT02141490|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111453309|NCT02097108|Raltegravir Potassium|raltegravir potassium|mesh-list
111453310|NCT02097108|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111453311|NCT02097108|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111453312|NCT02097108|Antiviral Agents|antiviral agents|mesh-ancestor
111453313|NCT02097108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111453314|NCT02097108|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111453315|NCT02097108|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111177466|NCT03025594|Mydriatics|mydriatics|mesh-ancestor
111453317|NCT02097108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111453318|NCT02096952|Methylphenidate|methylphenidate|mesh-list
111453319|NCT02096952|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111453320|NCT02096952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111453321|NCT02096952|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111453322|NCT02096952|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111453323|NCT02096952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111453324|NCT02096952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111453325|NCT02096952|Dopamine Agents|dopamine agents|mesh-ancestor
111453326|NCT02096952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111453327|NCT02120898|Imiquimod|imiquimod|mesh-list
111453328|NCT02120898|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111453329|NCT02120898|Immunologic Factors|immunologic factors|mesh-ancestor
111453330|NCT02120898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111453331|NCT02120898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111453332|NCT02120898|Interferon Inducers|interferon inducers|mesh-ancestor
111453333|NCT02120664|Corticosterone|corticosterone|mesh-list
111453334|NCT02120664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111453335|NCT01627860|Topiramate|topiramate|mesh-list
111453336|NCT01627860|Anticonvulsants|anticonvulsants|mesh-ancestor
111453337|NCT01627860|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111453338|NCT01627860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111453339|NCT01627782|Ketamine|ketamine|mesh-list
111453340|NCT01627782|Analgesics|analgesics|mesh-ancestor
111453341|NCT01627782|Sensory System Agents|sensory system agents|mesh-ancestor
111453342|NCT01627782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111453343|NCT01627782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111453344|NCT01627782|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111453345|NCT01627782|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111453346|NCT01627782|Anesthetics, General|anesthetics, general|mesh-ancestor
111453347|NCT01627782|Anesthetics|anesthetics|mesh-ancestor
111453348|NCT01627782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111453349|NCT01627782|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111453350|NCT01627782|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111453351|NCT01627782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111453352|NCT01627782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111453353|NCT02119650|Pemetrexed|pemetrexed|mesh-list
111453354|NCT02119650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110925465|NCT02324738|Antimalarials|antimalarials|mesh-ancestor
111453355|NCT02119650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111453356|NCT02119650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111453357|NCT02119650|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111453358|NCT02119650|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111453359|NCT02119416|Caffeine|caffeine|mesh-list
111453360|NCT02119416|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111453361|NCT02119416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111453362|NCT02119416|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111453363|NCT02119416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111453364|NCT02119416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111453365|NCT02119416|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
111453366|NCT02119416|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111453367|NCT02119416|Purinergic Agents|purinergic agents|mesh-ancestor
111453368|NCT02119416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111453369|NCT02140164|Minocycline|minocycline|mesh-list
111453370|NCT02140164|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111453371|NCT02140164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111453372|NCT02119260|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111453373|NCT02119104|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
111453374|NCT02119104|Immunologic Factors|immunologic factors|mesh-ancestor
111453375|NCT02119104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111453376|NCT02119026|Bevacizumab|bevacizumab|mesh-list
111453377|NCT02119026|Capecitabine|capecitabine|mesh-list
111453378|NCT02119026|Oxaliplatin|oxaliplatin|mesh-list
111453379|NCT02119026|Irinotecan|irinotecan|mesh-list
111453380|NCT02119026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111453381|NCT02119026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111453382|NCT02119026|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111453383|NCT02119026|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111453384|NCT02119026|Growth Substances|growth substances|mesh-ancestor
111453385|NCT02119026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111453386|NCT02119026|Growth Inhibitors|growth inhibitors|mesh-ancestor
111453387|NCT02119026|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111453388|NCT02119026|Antimetabolites|antimetabolites|mesh-ancestor
111453389|NCT02119026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111453390|NCT02119026|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111453391|NCT02119026|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111453392|NCT02119026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111453393|NCT02095158|Phenylephrine|phenylephrine|mesh-list
111453394|NCT02095158|Oxymetazoline|oxymetazoline|mesh-list
111453395|NCT02095158|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111453396|NCT02095158|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111453397|NCT02095158|Adrenergic Agents|adrenergic agents|mesh-ancestor
111453398|NCT02095158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111453399|NCT02095158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111453400|NCT02095158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111453401|NCT02095158|Sympathomimetics|sympathomimetics|mesh-ancestor
111453402|NCT02095158|Autonomic Agents|autonomic agents|mesh-ancestor
111453403|NCT02095158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111453404|NCT02095158|Nasal Decongestants|nasal decongestants|mesh-ancestor
111453405|NCT02095158|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111453406|NCT02095158|Respiratory System Agents|respiratory system agents|mesh-ancestor
111453407|NCT02095158|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111453408|NCT02095158|Mydriatics|mydriatics|mesh-ancestor
111453409|NCT02095158|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111453410|NCT02095158|Protective Agents|protective agents|mesh-ancestor
111453411|NCT02118714|Atrasentan|atrasentan|mesh-list
111453412|NCT02118714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111453413|NCT02118714|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
111453414|NCT02118714|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
111453415|NCT02118714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111453416|NCT02138916|Benralizumab|benralizumab|mesh-list
111453417|NCT02138916|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111453418|NCT02138916|Respiratory System Agents|respiratory system agents|mesh-ancestor
111453419|NCT02118012|Ribavirin|ribavirin|mesh-list
111453420|NCT02118012|Antimetabolites|antimetabolites|mesh-ancestor
111453421|NCT02118012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111453422|NCT02118012|Antiviral Agents|antiviral agents|mesh-ancestor
111453423|NCT02118012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111453424|NCT02138838|Cinacalcet|cinacalcet|mesh-list
111453425|NCT02138838|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111453426|NCT02138838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111453427|NCT02138838|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
111453428|NCT02138838|Hormone Antagonists|hormone antagonists|mesh-ancestor
110925778|NCT03492710|Immunoglobulins|immunoglobulins|mesh-list
111453429|NCT02138838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111453430|NCT02092350|Grazoprevir|grazoprevir|mesh-list
111453431|NCT02092350|Antiviral Agents|antiviral agents|mesh-ancestor
111453432|NCT02092350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111453433|NCT02138136|Lubiprostone|lubiprostone|mesh-list
111453434|NCT02138136|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
111453435|NCT02138136|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111453436|NCT02138136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111453437|NCT02116608|Povidone-Iodine|povidone-iodine|mesh-list
111453438|NCT02116608|Silver Nitrate|silver nitrate|mesh-list
111453439|NCT02116608|Hydrocortisone|hydrocortisone|mesh-list
111453440|NCT02116608|Hydrocortisone-17-butyrate|hydrocortisone-17-butyrate|mesh-list
111453441|NCT02116608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111453442|NCT02116608|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111453443|NCT02116608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111453444|NCT02116608|Dermatologic Agents|dermatologic agents|mesh-ancestor
111453445|NCT02092116|Romidepsin|romidepsin|mesh-list
111453446|NCT02092116|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111453447|NCT02092116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111453448|NCT02092116|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111453449|NCT02092116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111453450|NCT02092116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111453451|NCT02091414|Cyclosporine|cyclosporine|mesh-list
111453452|NCT02091414|Mycophenolic Acid|mycophenolic acid|mesh-list
111453453|NCT02091414|Cyclosporins|cyclosporins|mesh-list
111453454|NCT02091414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111453455|NCT02091414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111453456|NCT02091414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111453457|NCT02091414|Immunologic Factors|immunologic factors|mesh-ancestor
111453458|NCT02091414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111453459|NCT02091414|Antifungal Agents|antifungal agents|mesh-ancestor
111453460|NCT02091414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111453461|NCT02091414|Dermatologic Agents|dermatologic agents|mesh-ancestor
111453462|NCT02091414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111453463|NCT02091414|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111453464|NCT02091414|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111453465|NCT02091414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111453466|NCT02091414|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111453467|NCT02091414|Antitubercular Agents|antitubercular agents|mesh-ancestor
111453468|NCT02091414|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111453469|NCT04731558|Enoxaparin|enoxaparin|mesh-list
111453470|NCT04731558|Dalteparin|dalteparin|mesh-list
111453471|NCT04731558|Tinzaparin|tinzaparin|mesh-list
111453472|NCT04731558|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
111453473|NCT04731558|Anticoagulants|anticoagulants|mesh-ancestor
111453474|NCT04731558|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111453475|NCT04731558|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111453476|NCT04731558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111453477|NCT02116530|Dexamethasone|dexamethasone|mesh-list
111453478|NCT02116530|Cyclophosphamide|cyclophosphamide|mesh-list
111453479|NCT02116530|Doxorubicin|doxorubicin|mesh-list
111453480|NCT02116530|Ondansetron|ondansetron|mesh-list
111453481|NCT02116530|Olanzapine|olanzapine|mesh-list
111453482|NCT02116530|Aprepitant|aprepitant|mesh-list
111453483|NCT02116530|Fosaprepitant|fosaprepitant|mesh-list
111453484|NCT02116530|Palonosetron|palonosetron|mesh-list
111453485|NCT02116530|Granisetron|granisetron|mesh-list
111453486|NCT02116530|Antiemetics|antiemetics|mesh-list
111453487|NCT02116530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111453488|NCT02116530|Immunologic Factors|immunologic factors|mesh-ancestor
111453489|NCT02116530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111453490|NCT02116530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111453491|NCT02116530|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111453492|NCT02116530|Alkylating Agents|alkylating agents|mesh-ancestor
111453493|NCT02116530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111453494|NCT02116530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111453495|NCT02116530|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111453496|NCT02116530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111453497|NCT02116530|Autonomic Agents|autonomic agents|mesh-ancestor
111453498|NCT02116530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111453499|NCT02116530|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111453500|NCT02116530|Glucocorticoids|glucocorticoids|mesh-ancestor
111453501|NCT02116530|Hormones|hormones|mesh-ancestor
111453502|NCT02116530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111453503|NCT02116530|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111453504|NCT02116530|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111453505|NCT02116530|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111453506|NCT02116530|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111453507|NCT02116530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111453508|NCT02116530|Antipruritics|antipruritics|mesh-ancestor
111453509|NCT02116530|Dermatologic Agents|dermatologic agents|mesh-ancestor
111453510|NCT02116530|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111453511|NCT02116530|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111453512|NCT02116530|Serotonin Agents|serotonin agents|mesh-ancestor
111453513|NCT02116530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111453514|NCT02116530|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111453515|NCT02116530|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111453516|NCT02116530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111453517|NCT02116530|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111453518|NCT02116530|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111453519|NCT02116530|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111453520|NCT02116530|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111453521|NCT02116530|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
111453522|NCT02072226|Aspirin|aspirin|mesh-list
111453523|NCT02072226|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
111453524|NCT02072226|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111453525|NCT02072226|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111453526|NCT02072226|Analgesics|analgesics|mesh-ancestor
111453527|NCT02072226|Sensory System Agents|sensory system agents|mesh-ancestor
111453528|NCT02072226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111453529|NCT02072226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111453530|NCT02072226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111453531|NCT02072226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111453532|NCT02072226|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111453533|NCT02072226|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111453534|NCT02072226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111453535|NCT02072226|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111453536|NCT02072226|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111453537|NCT02072226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111177690|NCT01675648|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111453538|NCT02072226|Antipyretics|antipyretics|mesh-ancestor
111453539|NCT04730856|Tinzaparin|tinzaparin|mesh-list
111453540|NCT04730856|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
111453541|NCT04730856|Dalteparin|dalteparin|mesh-list
111453542|NCT04730856|Anticoagulants|anticoagulants|mesh-ancestor
111453543|NCT04730856|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111453544|NCT04730856|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111453545|NCT04730856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111453546|NCT02114892|Resveratrol|resveratrol|mesh-list
111453547|NCT02114892|Antioxidants|antioxidants|mesh-ancestor
111453548|NCT02114892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111453549|NCT02114892|Protective Agents|protective agents|mesh-ancestor
111453550|NCT02114892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111453551|NCT02114892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111453552|NCT02114892|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111453553|NCT02070744|Ivacaftor|ivacaftor|mesh-list
111453554|NCT02070744|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
111453555|NCT02070744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111453556|NCT02070744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111453557|NCT04741698|Propranolol|propranolol|mesh-list
111453558|NCT04741698|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111453559|NCT04741698|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111453560|NCT04741698|Adrenergic Agents|adrenergic agents|mesh-ancestor
111453561|NCT04741698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111453562|NCT04741698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111453563|NCT04741698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111453564|NCT04741698|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111453565|NCT04741698|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111453566|NCT04741698|Vasodilator Agents|vasodilator agents|mesh-ancestor
111453567|NCT02111850|Aldesleukin|aldesleukin|mesh-list
111453568|NCT02111850|Cyclophosphamide|cyclophosphamide|mesh-list
111453569|NCT02111850|Fludarabine|fludarabine|mesh-list
111453570|NCT02111850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111453571|NCT02111850|Immunologic Factors|immunologic factors|mesh-ancestor
111453572|NCT02111850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111453573|NCT02111850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111453574|NCT02111850|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111453575|NCT02111850|Alkylating Agents|alkylating agents|mesh-ancestor
111453576|NCT02111850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111453577|NCT02111850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111453578|NCT02111850|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111453579|NCT02111850|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111453580|NCT02111850|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111453581|NCT02111850|Antiviral Agents|antiviral agents|mesh-ancestor
111453582|NCT02111850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111453583|NCT02085252|Bicalutamide|bicalutamide|mesh-list
111453584|NCT02085252|Leuprolide|leuprolide|mesh-list
111453585|NCT02085252|Androgen Antagonists|androgen antagonists|mesh-ancestor
111453586|NCT02085252|Hormone Antagonists|hormone antagonists|mesh-ancestor
111453587|NCT02085252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111453588|NCT02085252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111453589|NCT02085252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111453590|NCT02085252|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111453591|NCT02085252|Fertility Agents|fertility agents|mesh-ancestor
111453592|NCT02085252|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111453593|NCT02085252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111453594|NCT02084238|Interleukin-2|interleukin-2|mesh-list
111453595|NCT02084238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111453596|NCT02084238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111453597|NCT02084238|Analgesics|analgesics|mesh-ancestor
110926318|NCT03613857|Clopidogrel|clopidogrel|mesh-list
111453598|NCT02084238|Sensory System Agents|sensory system agents|mesh-ancestor
111453599|NCT02084238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111453600|NCT02084238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111453601|NCT02084082|Metformin|metformin|mesh-list
111453602|NCT02084082|Linagliptin|linagliptin|mesh-list
111453603|NCT02084082|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111453604|NCT02084082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111453605|NCT02084082|Incretins|incretins|mesh-ancestor
111453606|NCT02084082|Hormones|hormones|mesh-ancestor
110926375|NCT01361308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111453607|NCT02084082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111453608|NCT02084082|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111453609|NCT02084082|Protease Inhibitors|protease inhibitors|mesh-ancestor
111453610|NCT02084082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111453611|NCT02084082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111453612|NCT02083926|Ketamine|ketamine|mesh-list
111177765|NCT03861988|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111453613|NCT02083926|Analgesics|analgesics|mesh-ancestor
111453614|NCT02083926|Sensory System Agents|sensory system agents|mesh-ancestor
111453615|NCT02083926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111453616|NCT02083926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111453617|NCT02083926|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111453618|NCT02083926|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111453619|NCT02083926|Anesthetics, General|anesthetics, general|mesh-ancestor
111453620|NCT02083926|Anesthetics|anesthetics|mesh-ancestor
111453621|NCT02083926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111453622|NCT02083926|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111453623|NCT02083926|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111453624|NCT02083926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111453625|NCT02083926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111453626|NCT02083380|Piperaquine|piperaquine|mesh-list
111453627|NCT02083380|Artefenomel|artefenomel|mesh-list
111453628|NCT02083380|Antimalarials|antimalarials|mesh-ancestor
111453629|NCT02083380|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110926450|NCT03046017|Lidocaine|lidocaine|mesh-list
111453630|NCT02083380|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111453631|NCT02083380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111453633|NCT02109744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111453634|NCT02109744|Antimetabolites|antimetabolites|mesh-ancestor
111453635|NCT02109744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111453636|NCT02109744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111453637|NCT02109744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111453638|NCT02066298|Mometasone Furoate|mometasone furoate|mesh-list
111453639|NCT02066298|Tiotropium Bromide|tiotropium bromide|mesh-list
111453640|NCT02066298|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111453641|NCT02066298|Autonomic Agents|autonomic agents|mesh-ancestor
111453642|NCT02066298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111453643|NCT02066298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111453644|NCT02066298|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111453645|NCT02066298|Respiratory System Agents|respiratory system agents|mesh-ancestor
111453646|NCT02066298|Parasympatholytics|parasympatholytics|mesh-ancestor
110926497|NCT00354835|Dactinomycin|dactinomycin|mesh-list
111453647|NCT02066298|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111453648|NCT02066298|Cholinergic Agents|cholinergic agents|mesh-ancestor
111453649|NCT02066298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111453650|NCT02066298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111453651|NCT02066298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111453652|NCT02066298|Dermatologic Agents|dermatologic agents|mesh-ancestor
111453653|NCT02066298|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111453654|NCT02082912|Cycloserine|cycloserine|mesh-list
111453655|NCT02082912|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111453656|NCT02082912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111453657|NCT02082912|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111453658|NCT02082912|Antitubercular Agents|antitubercular agents|mesh-ancestor
111453659|NCT02082912|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111453660|NCT02082912|Antimetabolites|antimetabolites|mesh-ancestor
111453661|NCT02082912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111453662|NCT02082522|Cisplatin|cisplatin|mesh-list
111453663|NCT02082522|Gemcitabine|gemcitabine|mesh-list
111453664|NCT02082522|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
111453665|NCT02082522|Hematoporphyrin Derivative|hematoporphyrin derivative|mesh-list
111453666|NCT02082522|Trioxsalen|trioxsalen|mesh-list
111453667|NCT02082522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111453668|NCT02082522|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111453669|NCT02082522|Antimetabolites|antimetabolites|mesh-ancestor
111453670|NCT02082522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111453671|NCT02082522|Dermatologic Agents|dermatologic agents|mesh-ancestor
111453672|NCT02082522|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111453673|NCT02082210|Ramucirumab|ramucirumab|mesh-list
111453674|NCT02082210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111453675|NCT02107014|Naltrexone|naltrexone|mesh-list
111453676|NCT02107014|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111453677|NCT02107014|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111453678|NCT02107014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111453679|NCT02107014|Sensory System Agents|sensory system agents|mesh-ancestor
111453680|NCT02107014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111453681|NCT01624974|Montelukast|montelukast|mesh-list
111453682|NCT01624974|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111453683|NCT01624974|Respiratory System Agents|respiratory system agents|mesh-ancestor
111453684|NCT01624974|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
111453685|NCT01624974|Hormone Antagonists|hormone antagonists|mesh-ancestor
111453686|NCT01624974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111177839|NCT01677442|Anesthetics|anesthetics|mesh-list
111453688|NCT01624974|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
111453689|NCT01624974|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111453690|NCT01624974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111453691|NCT01624662|Fluticasone|fluticasone|mesh-list
111453692|NCT01624662|Xhance|xhance|mesh-list
111453693|NCT01624662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111453694|NCT01624662|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111453695|NCT01624662|Autonomic Agents|autonomic agents|mesh-ancestor
111453696|NCT01624662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111453697|NCT01624662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111453698|NCT01624662|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111453699|NCT01624662|Respiratory System Agents|respiratory system agents|mesh-ancestor
111453700|NCT01624662|Dermatologic Agents|dermatologic agents|mesh-ancestor
111453701|NCT01624662|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111453702|NCT02106390|Vaccines|vaccines|mesh-list
111453703|NCT02106390|Immunologic Factors|immunologic factors|mesh-ancestor
111453704|NCT02106390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111453705|NCT02064894|Ibuprofen|ibuprofen|mesh-list
111453706|NCT02064894|Morphine|morphine|mesh-list
111453707|NCT02064894|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111453708|NCT02064894|Narcotics|narcotics|mesh-ancestor
111453709|NCT02064894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111453710|NCT02064894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111453711|NCT02064894|Analgesics|analgesics|mesh-ancestor
111453712|NCT02064894|Sensory System Agents|sensory system agents|mesh-ancestor
111453713|NCT02064894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111453714|NCT02064894|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111453715|NCT02064894|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111453716|NCT02064894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111453717|NCT02064894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111453718|NCT02064894|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111453719|NCT02064894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111453720|NCT02064894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111453721|NCT02064816|Interferon beta-1a|interferon beta-1a|mesh-list
111453722|NCT02064816|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111453723|NCT02064816|Immunologic Factors|immunologic factors|mesh-ancestor
111453724|NCT02064816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111453725|NCT02064816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111453726|NCT02064816|Antiviral Agents|antiviral agents|mesh-ancestor
111453727|NCT02064816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111453728|NCT01624194|Oxytocin|oxytocin|mesh-list
111453729|NCT01624194|Oxytocics|oxytocics|mesh-ancestor
111453730|NCT01624194|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111453731|NCT01624194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111453732|NCT02079636|Gemcitabine|gemcitabine|mesh-list
111453733|NCT02079636|Pembrolizumab|pembrolizumab|mesh-list
111453734|NCT02079636|Pemetrexed|pemetrexed|mesh-list
111453735|NCT02079636|Ramucirumab|ramucirumab|mesh-list
111453736|NCT02079636|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111453737|NCT02079636|Antimetabolites|antimetabolites|mesh-ancestor
111453738|NCT02079636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111453739|NCT02079636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111453740|NCT02079636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111453741|NCT02079636|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111453742|NCT02079636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111453743|NCT02079636|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111453744|NCT02079636|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111453745|NCT02079246|(2-(6-fluoro-1H-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|(2-(6-fluoro-1h-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|mesh-list
111453746|NCT02079246|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111453747|NCT02079246|Serotonin Agents|serotonin agents|mesh-ancestor
110926840|NCT05038072|Glucocorticoids|glucocorticoids|mesh-ancestor
111453748|NCT02079246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111453749|NCT02079246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111453750|NCT02079246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111453751|NCT02047110|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111453752|NCT02047110|Immunologic Factors|immunologic factors|mesh-ancestor
111453753|NCT02047110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111453754|NCT02045862|Solifenacin Succinate|solifenacin succinate|mesh-list
111453755|NCT02045862|Mirabegron|mirabegron|mesh-list
111453756|NCT02045862|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111453757|NCT02045862|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111453758|NCT02045862|Cholinergic Agents|cholinergic agents|mesh-ancestor
111453759|NCT02045862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111177916|NCT01693185|Narcotics|narcotics|mesh-ancestor
111453760|NCT02045862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110926884|NCT03092206|Antiviral Agents|antiviral agents|mesh-ancestor
111453761|NCT02045862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111453762|NCT02045862|Urological Agents|urological agents|mesh-ancestor
111453763|NCT02045862|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
111453764|NCT02045862|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111453765|NCT02045862|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111453766|NCT02045862|Adrenergic Agents|adrenergic agents|mesh-ancestor
111453767|NCT04182984|Mycophenolic Acid|mycophenolic acid|mesh-list
111453768|NCT04182984|Prednisone|prednisone|mesh-list
111453769|NCT04182984|Azathioprine|azathioprine|mesh-list
111453770|NCT04182984|Bromides|bromides|mesh-list
111453771|NCT04182984|Tacrolimus|tacrolimus|mesh-list
111453772|NCT04182984|Immunosuppressive Agents|immunosuppressive agents|mesh-list
111453773|NCT04182984|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
111453774|NCT04182984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111453775|NCT04182984|Glucocorticoids|glucocorticoids|mesh-ancestor
111453776|NCT04182984|Hormones|hormones|mesh-ancestor
111453777|NCT04182984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111453778|NCT04182984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111453779|NCT04182984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111453780|NCT04182984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111453781|NCT04182984|Immunologic Factors|immunologic factors|mesh-ancestor
111453782|NCT04182984|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111453783|NCT04182984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111453784|NCT04182984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111453785|NCT04182984|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111453786|NCT04182984|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111453787|NCT04182984|Antitubercular Agents|antitubercular agents|mesh-ancestor
111453788|NCT04182984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111453789|NCT04182984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111453790|NCT04182984|Anticonvulsants|anticonvulsants|mesh-ancestor
111453791|NCT04182984|Antimetabolites|antimetabolites|mesh-ancestor
111453792|NCT04182984|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111453793|NCT04182984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111453794|NCT04182984|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111453795|NCT04182984|Cholinergic Agents|cholinergic agents|mesh-ancestor
111453796|NCT04182984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111453797|NCT02044302|Morphine|morphine|mesh-list
111453798|NCT02044302|Narcotics|narcotics|mesh-list
111453799|NCT02044302|Analgesics|analgesics|mesh-list
111453800|NCT02044302|Bupivacaine|bupivacaine|mesh-list
111453801|NCT02044302|Botulinum Toxins|botulinum toxins|mesh-list
111453802|NCT02044302|Anesthetics, Local|anesthetics, local|mesh-ancestor
111453803|NCT02044302|Anesthetics|anesthetics|mesh-ancestor
111453804|NCT02044302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111453805|NCT02044302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111453806|NCT02044302|Sensory System Agents|sensory system agents|mesh-ancestor
111453807|NCT02044302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111453808|NCT02044302|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111453809|NCT02044302|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111453810|NCT02044302|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111453811|NCT02044302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111453812|NCT02044302|Cholinergic Agents|cholinergic agents|mesh-ancestor
111453813|NCT02044302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111453814|NCT02062944|Sirolimus|sirolimus|mesh-list
111453815|NCT02062944|Immunosuppressive Agents|immunosuppressive agents|mesh-list
111453816|NCT02062944|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111453817|NCT02062944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111453818|NCT02062944|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111453819|NCT02062944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111453820|NCT02062944|Antifungal Agents|antifungal agents|mesh-ancestor
111453821|NCT02062944|Immunologic Factors|immunologic factors|mesh-ancestor
111453822|NCT02062944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111453823|NCT02062632|Doxepin|doxepin|mesh-list
111453824|NCT02062632|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111453825|NCT02062632|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111453826|NCT02062632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111453827|NCT02062632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111453828|NCT02062632|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
111453829|NCT02062632|Antidepressive Agents|antidepressive agents|mesh-ancestor
111453830|NCT02062632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111453831|NCT02062632|Histamine Antagonists|histamine antagonists|mesh-ancestor
111453832|NCT02062632|Histamine Agents|histamine agents|mesh-ancestor
111453833|NCT02062632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111453834|NCT02062632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111453835|NCT02043366|Flurbiprofen|flurbiprofen|mesh-list
111453836|NCT02043366|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
111453837|NCT02043366|Sufentanil|sufentanil|mesh-list
111453838|NCT02043366|Remifentanil|remifentanil|mesh-list
111453839|NCT02043366|Butorphanol|butorphanol|mesh-list
111453840|NCT02043366|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111453841|NCT02043366|Narcotics|narcotics|mesh-ancestor
111453842|NCT02043366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111453843|NCT02043366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111453844|NCT02043366|Analgesics|analgesics|mesh-ancestor
111453845|NCT02043366|Sensory System Agents|sensory system agents|mesh-ancestor
111453846|NCT02043366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111453847|NCT02043366|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111453848|NCT02043366|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111453849|NCT02043366|Anesthetics, General|anesthetics, general|mesh-ancestor
111453850|NCT02043366|Anesthetics|anesthetics|mesh-ancestor
111453851|NCT02043366|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111453852|NCT02043366|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111453853|NCT02043366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111453854|NCT02043366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111453855|NCT02043366|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111453856|NCT02043366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111453857|NCT02043366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111453858|NCT02043366|Antitussive Agents|antitussive agents|mesh-ancestor
111453859|NCT02043366|Respiratory System Agents|respiratory system agents|mesh-ancestor
111453860|NCT02043366|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111453861|NCT02060370|Sunitinib|sunitinib|mesh-list
111453862|NCT02060370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111453863|NCT02060370|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111453864|NCT02060370|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111453865|NCT02060370|Growth Substances|growth substances|mesh-ancestor
111453866|NCT02060370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111453867|NCT02060370|Growth Inhibitors|growth inhibitors|mesh-ancestor
111453868|NCT02060370|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111453869|NCT02060370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111453870|NCT02060370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111453871|NCT01622088|Pramipexole|pramipexole|mesh-list
111453872|NCT01622088|Antioxidants|antioxidants|mesh-ancestor
111453873|NCT01622088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111453874|NCT01622088|Protective Agents|protective agents|mesh-ancestor
111453875|NCT01622088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111453876|NCT01622088|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111453877|NCT01622088|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111453878|NCT01622088|Dopamine Agonists|dopamine agonists|mesh-ancestor
111453879|NCT01622088|Dopamine Agents|dopamine agents|mesh-ancestor
111453880|NCT01622088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111453881|NCT02021292|Macitentan|macitentan|mesh-list
111453882|NCT02021292|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
111453883|NCT02021292|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
111453884|NCT02021292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111453885|NCT02021292|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
111453886|NCT02043132|Tranexamic Acid|tranexamic acid|mesh-list
111453887|NCT02043132|Antifibrinolytic Agents|antifibrinolytic agents|mesh-list
111453888|NCT02043132|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111453889|NCT02043132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111453890|NCT02043132|Hemostatics|hemostatics|mesh-ancestor
111453891|NCT02043132|Coagulants|coagulants|mesh-ancestor
111453892|NCT02059434|Tiotropium Bromide|tiotropium bromide|mesh-list
111453893|NCT02059434|LAS190792|las190792|mesh-list
111453894|NCT02059434|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111453895|NCT02059434|Autonomic Agents|autonomic agents|mesh-ancestor
111453896|NCT02059434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111453897|NCT02059434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111453898|NCT02059434|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111453899|NCT02059434|Respiratory System Agents|respiratory system agents|mesh-ancestor
111453900|NCT02059434|Parasympatholytics|parasympatholytics|mesh-ancestor
111453901|NCT02059434|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111453902|NCT02059434|Cholinergic Agents|cholinergic agents|mesh-ancestor
111453903|NCT02059434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111453904|NCT02059434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111453905|NCT02059434|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111453906|NCT02059434|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111453907|NCT02059434|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111453908|NCT02059434|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111178070|NCT01587651|Ticagrelor|ticagrelor|mesh-list
111453909|NCT02059434|Adrenergic Agents|adrenergic agents|mesh-ancestor
111453911|NCT02059278|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
111453912|NCT02059278|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111453913|NCT02020512|Bimatoprost|bimatoprost|mesh-list
111453914|NCT02020512|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111453915|NCT02019420|Linezolid|linezolid|mesh-list
111453916|NCT02019420|Tedizolid|tedizolid|mesh-list
111453917|NCT02019420|Tedizolid phosphate|tedizolid phosphate|mesh-list
111453918|NCT02019420|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111453919|NCT02019420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111453920|NCT02019420|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111453921|NCT02019420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111453922|NCT02019420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111453923|NCT02058966|Entacapone|entacapone|mesh-list
111453924|NCT02058966|Methamphetamine|methamphetamine|mesh-list
111453925|NCT02058966|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111453926|NCT02058966|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111453927|NCT02058966|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
111453928|NCT02058966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111453929|NCT02058966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111453930|NCT02058966|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111453931|NCT02058966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111453932|NCT02058966|Sympathomimetics|sympathomimetics|mesh-ancestor
111453933|NCT02058966|Autonomic Agents|autonomic agents|mesh-ancestor
111453934|NCT02058966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111453935|NCT02058966|Dopamine Agents|dopamine agents|mesh-ancestor
111453936|NCT02058966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111453937|NCT02058966|Adrenergic Agents|adrenergic agents|mesh-ancestor
111453938|NCT02058966|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111453939|NCT02058966|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111453940|NCT02058966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111453941|NCT02058966|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111453942|NCT02017860|Everolimus|everolimus|mesh-list
111453943|NCT02017860|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111453944|NCT02017860|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111453945|NCT02017860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111453946|NCT02017860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111453947|NCT02017860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111453948|NCT02017860|Immunologic Factors|immunologic factors|mesh-ancestor
111453949|NCT02017860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111453950|NCT02017860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111453951|NCT02040870|Ceritinib|ceritinib|mesh-list
111453952|NCT02040870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111453953|NCT02040870|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111453954|NCT02040870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111453955|NCT02040870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111453956|NCT04720716|Sorafenib|sorafenib|mesh-list
111453957|NCT04720716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111453958|NCT04720716|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111453959|NCT04720716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111453960|NCT04720716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111453961|NCT02039778|Temozolomide|temozolomide|mesh-list
111453962|NCT02039778|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111453963|NCT02039778|Alkylating Agents|alkylating agents|mesh-ancestor
111453964|NCT02039778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111453965|NCT02039778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111453966|NCT02015676|Paclitaxel|paclitaxel|mesh-list
111453967|NCT02015676|Trastuzumab|trastuzumab|mesh-list
110927150|NCT01077817|Alendronate|alendronate|mesh-list
111453968|NCT02015676|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111453969|NCT02015676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111453970|NCT02015676|Tubulin Modulators|tubulin modulators|mesh-ancestor
111453971|NCT02015676|Antimitotic Agents|antimitotic agents|mesh-ancestor
111453972|NCT02015676|Mitosis Modulators|mitosis modulators|mesh-ancestor
111453973|NCT02015676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111453974|NCT02015676|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111453975|NCT02058108|Telbivudine|telbivudine|mesh-list
111453976|NCT02058108|Antiviral Agents|antiviral agents|mesh-ancestor
111453977|NCT02058108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111453978|NCT02058108|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111453979|NCT02058108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111453980|NCT02058108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111453981|NCT04678362|Avelumab|avelumab|mesh-list
111453982|NCT04678362|Talazoparib|talazoparib|mesh-list
111453983|NCT04678362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111453984|NCT04678362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111453985|NCT04678362|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111453986|NCT04678362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111453987|NCT04678362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111453988|NCT04678050|Dexmedetomidine|dexmedetomidine|mesh-list
111453989|NCT04678050|Ketamine|ketamine|mesh-list
111453990|NCT04678050|Propofol|propofol|mesh-list
111453991|NCT04678050|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111453992|NCT04678050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111453993|NCT04678050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111453994|NCT04678050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111453995|NCT04678050|Analgesics|analgesics|mesh-ancestor
111453996|NCT04678050|Sensory System Agents|sensory system agents|mesh-ancestor
111453997|NCT04678050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111453998|NCT04678050|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111453999|NCT04678050|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111454000|NCT04678050|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111454001|NCT04678050|Adrenergic Agents|adrenergic agents|mesh-ancestor
111454002|NCT04678050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111454003|NCT04678050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111454004|NCT04678050|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111454005|NCT04678050|Anesthetics, General|anesthetics, general|mesh-ancestor
111454006|NCT04678050|Anesthetics|anesthetics|mesh-ancestor
111454007|NCT04678050|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110927174|NCT00103506|Doxorubicin|doxorubicin|mesh-list
111454008|NCT04678050|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111454009|NCT04678050|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111454010|NCT02038920|Vedolizumab|vedolizumab|mesh-list
111454011|NCT02038920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111454012|NCT01622868|Lapatinib|lapatinib|mesh-list
111454013|NCT01622868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111454014|NCT01622868|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111454015|NCT01622868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111454016|NCT01622868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111454017|NCT02014740|Metformin|metformin|mesh-list
111454018|NCT02014740|Liraglutide|liraglutide|mesh-list
111454019|NCT02014740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111454020|NCT02014740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111454021|NCT02014740|Incretins|incretins|mesh-ancestor
111454022|NCT02014740|Hormones|hormones|mesh-ancestor
111454023|NCT02014740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111454024|NCT02014584|Dutasteride|dutasteride|mesh-list
111454025|NCT02014584|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
111454026|NCT02014584|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111454027|NCT02014584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111454028|NCT02014584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111454029|NCT02014584|Hormone Antagonists|hormone antagonists|mesh-ancestor
111454030|NCT02014584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111454031|NCT02014584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111454032|NCT02037984|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
111454033|NCT02037984|Immunologic Factors|immunologic factors|mesh-ancestor
111454034|NCT02037984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111454035|NCT02036580|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111454036|NCT02036580|Immunologic Factors|immunologic factors|mesh-ancestor
111454037|NCT02036580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111454038|NCT02057250|Hydroxychloroquine|hydroxychloroquine|mesh-list
111454039|NCT02057250|Sulfasalazine|sulfasalazine|mesh-list
111454040|NCT02057250|Methotrexate|methotrexate|mesh-list
111454041|NCT02057250|Leflunomide|leflunomide|mesh-list
111454042|NCT02057250|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111454043|NCT02057250|Abortifacient Agents|abortifacient agents|mesh-ancestor
111454044|NCT02057250|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111454045|NCT02057250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110927216|NCT02765490|Simeprevir|simeprevir|mesh-list
111454046|NCT02057250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111454047|NCT02057250|Antimetabolites|antimetabolites|mesh-ancestor
111454048|NCT02057250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111454049|NCT02057250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111454050|NCT02057250|Dermatologic Agents|dermatologic agents|mesh-ancestor
111454051|NCT02057250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111454052|NCT02057250|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111454053|NCT02057250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111454054|NCT02057250|Immunologic Factors|immunologic factors|mesh-ancestor
111454055|NCT02057250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111454056|NCT02057250|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111454057|NCT02057250|Antimalarials|antimalarials|mesh-ancestor
111454058|NCT02057250|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111454059|NCT02057250|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111454060|NCT02057250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111454061|NCT02057250|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111454062|NCT02057250|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111454064|NCT02057250|Sensory System Agents|sensory system agents|mesh-ancestor
111454065|NCT02057250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111454066|NCT02057250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111454067|NCT02057250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111454068|NCT02036502|Dexamethasone|dexamethasone|mesh-list
111454069|NCT02036502|Pembrolizumab|pembrolizumab|mesh-list
111454070|NCT02036502|Lenalidomide|lenalidomide|mesh-list
111454071|NCT02036502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111454072|NCT02036502|Antiemetics|antiemetics|mesh-ancestor
111454073|NCT02036502|Autonomic Agents|autonomic agents|mesh-ancestor
111454074|NCT02036502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111454075|NCT02036502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111454076|NCT02036502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111454077|NCT02036502|Glucocorticoids|glucocorticoids|mesh-ancestor
111454078|NCT02036502|Hormones|hormones|mesh-ancestor
111454079|NCT02036502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111454080|NCT02036502|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111454081|NCT02036502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111454082|NCT02036502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111454083|NCT02036502|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111454084|NCT02036502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111454085|NCT02036502|Immunologic Factors|immunologic factors|mesh-ancestor
111454086|NCT02036502|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111454087|NCT02036502|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111454088|NCT02036502|Growth Substances|growth substances|mesh-ancestor
111454089|NCT02036502|Growth Inhibitors|growth inhibitors|mesh-ancestor
111454090|NCT02056626|Carvedilol|carvedilol|mesh-list
111454091|NCT02056626|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111454092|NCT02056626|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111454093|NCT02056626|Adrenergic Agents|adrenergic agents|mesh-ancestor
111454094|NCT02056626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111454095|NCT02056626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111454096|NCT02056626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111454097|NCT02056626|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111454098|NCT02056626|Antioxidants|antioxidants|mesh-ancestor
111454099|NCT02056626|Protective Agents|protective agents|mesh-ancestor
111454100|NCT02056626|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111454101|NCT02056626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111454102|NCT02056626|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111454103|NCT02056626|Vasodilator Agents|vasodilator agents|mesh-ancestor
111454104|NCT02056626|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111454105|NCT02056626|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111454106|NCT02056392|Moxifloxacin|moxifloxacin|mesh-list
111454107|NCT02056392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111454108|NCT02056392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111454109|NCT02056392|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111454110|NCT02056392|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111454111|NCT02056392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111454112|NCT02056392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111454113|NCT02056392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111454114|NCT02034552|Prednisone|prednisone|mesh-list
111454115|NCT02034552|Abiraterone Acetate|abiraterone acetate|mesh-list
111454116|NCT02034552|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
111454117|NCT02034552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111454118|NCT02034552|Glucocorticoids|glucocorticoids|mesh-ancestor
111454119|NCT02034552|Hormones|hormones|mesh-ancestor
111454120|NCT02034552|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111454121|NCT02034552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111454122|NCT02034552|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111454123|NCT02034552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111454124|NCT02034552|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111454125|NCT02034552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111454126|NCT02034552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111454127|NCT02034552|Hormone Antagonists|hormone antagonists|mesh-ancestor
111454128|NCT02034552|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111454129|NCT02011386|Golimumab|golimumab|mesh-list
111178289|NCT04761952|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111454130|NCT02011386|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111454131|NCT02011386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111454132|NCT02011386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111454133|NCT02011386|Immunologic Factors|immunologic factors|mesh-ancestor
111454134|NCT02011386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111454135|NCT02034162|Mebendazole|mebendazole|mesh-list
111454137|NCT02034162|Piperazine citrate|piperazine citrate|mesh-list
111454138|NCT02034162|DMP 777|dmp 777|mesh-list
111454139|NCT02034162|Antinematodal Agents|antinematodal agents|mesh-ancestor
111454140|NCT02034162|Anthelmintics|anthelmintics|mesh-ancestor
111454141|NCT02034162|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111454142|NCT02034162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111454143|NCT02034162|Tubulin Modulators|tubulin modulators|mesh-ancestor
111454144|NCT02034162|Antimitotic Agents|antimitotic agents|mesh-ancestor
111454145|NCT02034162|Mitosis Modulators|mitosis modulators|mesh-ancestor
111454146|NCT02034162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111454147|NCT02034162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111454148|NCT02034162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111454149|NCT02034006|Ranibizumab|ranibizumab|mesh-list
111454150|NCT02034006|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111454151|NCT02034006|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111454152|NCT02034006|Growth Substances|growth substances|mesh-ancestor
111454153|NCT02034006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111454154|NCT02034006|Growth Inhibitors|growth inhibitors|mesh-ancestor
110927313|NCT05014048|Vitamin D|vitamin d|mesh-list
111454155|NCT02034006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111454156|NCT02052960|Cisplatin|cisplatin|mesh-list
111454157|NCT02052960|Fluorouracil|fluorouracil|mesh-list
111454158|NCT02052960|Cetuximab|cetuximab|mesh-list
111454159|NCT02052960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111454160|NCT02052960|Antimetabolites|antimetabolites|mesh-ancestor
111454161|NCT02052960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111454162|NCT02052960|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111454163|NCT02052960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111454164|NCT02052960|Immunologic Factors|immunologic factors|mesh-ancestor
111454165|NCT02052960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111454166|NCT02052960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111454167|NCT02008890|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111454168|NCT02008890|Immunologic Factors|immunologic factors|mesh-ancestor
111454169|NCT02008890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111454170|NCT02052414|Gabapentin|gabapentin|mesh-list
111454171|NCT02052414|Analgesics|analgesics|mesh-ancestor
111454172|NCT02052414|Sensory System Agents|sensory system agents|mesh-ancestor
111454173|NCT02052414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111454174|NCT02052414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111454175|NCT02052414|Anticonvulsants|anticonvulsants|mesh-ancestor
111454176|NCT02052414|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111454177|NCT02052414|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111454178|NCT02052414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111454179|NCT02052414|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111454180|NCT02052414|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111454181|NCT02052414|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111454182|NCT02052414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110927357|NCT02159820|Antimetabolites|antimetabolites|mesh-ancestor
111454183|NCT02052414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111454184|NCT02052414|Antimanic Agents|antimanic agents|mesh-ancestor
111454185|NCT02031276|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111454186|NCT02031276|Immunologic Factors|immunologic factors|mesh-ancestor
111454187|NCT02031276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111454188|NCT01363440|Aflibercept|aflibercept|mesh-list
111454189|NCT01363440|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111454190|NCT01363440|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111454191|NCT01363440|Growth Substances|growth substances|mesh-ancestor
111454192|NCT01363440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111454193|NCT01363440|Growth Inhibitors|growth inhibitors|mesh-ancestor
111454194|NCT01363440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111454195|NCT02007096|Bupivacaine|bupivacaine|mesh-list
111454196|NCT02007096|Anesthetics, Local|anesthetics, local|mesh-ancestor
111454197|NCT02007096|Anesthetics|anesthetics|mesh-ancestor
111454198|NCT02007096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111454199|NCT02007096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111454200|NCT02007096|Sensory System Agents|sensory system agents|mesh-ancestor
111454201|NCT02007096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111454202|NCT02006706|Methylprednisolone|methylprednisolone|mesh-list
111454203|NCT02006706|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111454204|NCT02006706|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111454205|NCT02006706|Prednisolone|prednisolone|mesh-list
111454206|NCT02006706|Prednisolone acetate|prednisolone acetate|mesh-list
111454207|NCT02006706|Rituximab|rituximab|mesh-list
111454208|NCT02006706|Methotrexate|methotrexate|mesh-list
111454209|NCT02006706|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111454210|NCT02006706|Prednisolone phosphate|prednisolone phosphate|mesh-list
111454211|NCT02006706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111454212|NCT02006706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111454213|NCT02006706|Immunologic Factors|immunologic factors|mesh-ancestor
111454214|NCT02006706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111454215|NCT02006706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111454216|NCT02006706|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111454217|NCT02006706|Abortifacient Agents|abortifacient agents|mesh-ancestor
111454218|NCT02006706|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111454219|NCT02006706|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111454220|NCT02006706|Antimetabolites|antimetabolites|mesh-ancestor
111454221|NCT02006706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111454222|NCT02006706|Dermatologic Agents|dermatologic agents|mesh-ancestor
111454223|NCT02006706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111454224|NCT02006706|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111454225|NCT02006706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111454226|NCT02006706|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111454227|NCT02006706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111454228|NCT02006706|Antiemetics|antiemetics|mesh-ancestor
111454229|NCT02006706|Autonomic Agents|autonomic agents|mesh-ancestor
111454230|NCT02006706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111454231|NCT02006706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111454232|NCT02006706|Glucocorticoids|glucocorticoids|mesh-ancestor
111454233|NCT02006706|Hormones|hormones|mesh-ancestor
111454234|NCT02006706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111454235|NCT02006706|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111454236|NCT02006706|Protective Agents|protective agents|mesh-ancestor
111454237|NCT02006706|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111454238|NCT02049138|Upadacitinib|upadacitinib|mesh-list
111454239|NCT02049138|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
111454240|NCT02049138|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111454241|NCT02049138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111454242|NCT02049138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111454243|NCT02049138|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111454244|NCT02048904|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111454245|NCT02048904|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111454246|NCT02048904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111454247|NCT02048904|Incretins|incretins|mesh-ancestor
111454248|NCT02048904|Hormones|hormones|mesh-ancestor
111454249|NCT02048904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111454250|NCT02048904|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111454251|NCT02048904|Protease Inhibitors|protease inhibitors|mesh-ancestor
111454252|NCT02048904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111454253|NCT02048904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111454254|NCT02006628|Cannabidiol|cannabidiol|mesh-list
111454255|NCT02006628|Anticonvulsants|anticonvulsants|mesh-ancestor
111454256|NCT02029638|Acetaminophen|acetaminophen|mesh-list
111454257|NCT02029638|Diphenhydramine|diphenhydramine|mesh-list
111454258|NCT02029638|Promethazine|promethazine|mesh-list
111454259|NCT02029638|Mycophenolic Acid|mycophenolic acid|mesh-list
111454260|NCT02029638|Prednisone|prednisone|mesh-list
111454261|NCT02029638|Methylprednisolone|methylprednisolone|mesh-list
111454262|NCT02029638|Cyclophosphamide|cyclophosphamide|mesh-list
111454263|NCT02029638|Fludarabine|fludarabine|mesh-list
111454264|NCT02029638|Thymoglobulin|thymoglobulin|mesh-list
111454265|NCT02029638|Antilymphocyte Serum|antilymphocyte serum|mesh-list
111454266|NCT02029638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111454267|NCT02029638|Immunologic Factors|immunologic factors|mesh-ancestor
111454268|NCT02029638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111454269|NCT02029638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111454270|NCT02029638|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111454271|NCT02029638|Alkylating Agents|alkylating agents|mesh-ancestor
111454272|NCT02029638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111454273|NCT02029638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111454274|NCT02029638|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111454275|NCT02029638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111454276|NCT02029638|Glucocorticoids|glucocorticoids|mesh-ancestor
111454277|NCT02029638|Hormones|hormones|mesh-ancestor
111454278|NCT02029638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111454279|NCT02029638|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111454280|NCT02029638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111454281|NCT02029638|Analgesics|analgesics|mesh-ancestor
111454282|NCT02029638|Sensory System Agents|sensory system agents|mesh-ancestor
111454283|NCT02029638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111454284|NCT02029638|Antipyretics|antipyretics|mesh-ancestor
111454285|NCT02029638|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111454286|NCT02029638|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111454287|NCT02029638|Antitubercular Agents|antitubercular agents|mesh-ancestor
111454288|NCT02029638|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111454289|NCT02029638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111454290|NCT02029638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111454291|NCT02029638|Antiemetics|antiemetics|mesh-ancestor
111454292|NCT02029638|Autonomic Agents|autonomic agents|mesh-ancestor
111454293|NCT02029638|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111454294|NCT02029638|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111454295|NCT02029638|Protective Agents|protective agents|mesh-ancestor
111454296|NCT02029638|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111454297|NCT02029638|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111454298|NCT02029638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111454299|NCT02029638|Anesthetics, Local|anesthetics, local|mesh-ancestor
111454300|NCT02029638|Anesthetics|anesthetics|mesh-ancestor
111454301|NCT02029638|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111454302|NCT02029638|Histamine Antagonists|histamine antagonists|mesh-ancestor
111454303|NCT02029638|Histamine Agents|histamine agents|mesh-ancestor
111454304|NCT02029638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111454305|NCT02029638|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111454306|NCT02029638|Antipruritics|antipruritics|mesh-ancestor
111454307|NCT02029638|Dermatologic Agents|dermatologic agents|mesh-ancestor
111454308|NCT02047734|Interferons|interferons|mesh-list
111454309|NCT02047734|Interferon-beta|interferon-beta|mesh-list
111454310|NCT02047734|Interferon beta-1a|interferon beta-1a|mesh-list
111454311|NCT02047734|Ozanimod|ozanimod|mesh-list
111454312|NCT02047734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111454313|NCT02047734|Antiviral Agents|antiviral agents|mesh-ancestor
111454314|NCT02047734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111454315|NCT02047734|Immunologic Factors|immunologic factors|mesh-ancestor
111454316|NCT02047734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111454317|NCT02047734|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111454318|NCT02047734|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
111454319|NCT02047734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111454320|NCT02047734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111454321|NCT01994850|Brentuximab Vedotin|brentuximab vedotin|mesh-list
111454322|NCT01994850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111454323|NCT01994850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111454324|NCT01994850|Immunotoxins|immunotoxins|mesh-ancestor
111454325|NCT01994850|Immunoconjugates|immunoconjugates|mesh-ancestor
111454326|NCT01994850|Immunologic Factors|immunologic factors|mesh-ancestor
111454327|NCT01994850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111454328|NCT01994382|Rituximab|rituximab|mesh-list
111454329|NCT01994382|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111454330|NCT01994382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111454331|NCT01994382|Immunologic Factors|immunologic factors|mesh-ancestor
111454332|NCT01994382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111454333|NCT01994382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111454334|NCT02003898|Insulin|insulin|mesh-list
111454335|NCT02003898|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111454336|NCT02003898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111454337|NCT01994226|Naproxen|naproxen|mesh-list
111454338|NCT01994226|Colchicine|colchicine|mesh-list
111454339|NCT01994226|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111454340|NCT01994226|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111454341|NCT01994226|Analgesics|analgesics|mesh-ancestor
111454342|NCT01994226|Sensory System Agents|sensory system agents|mesh-ancestor
111454343|NCT01994226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111454344|NCT01994226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111454345|NCT01994226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111454346|NCT01994226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111454347|NCT01994226|Gout Suppressants|gout suppressants|mesh-ancestor
111454348|NCT01994226|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111454349|NCT01994226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111454350|NCT01994226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111454351|NCT01994226|Tubulin Modulators|tubulin modulators|mesh-ancestor
111454352|NCT01994226|Antimitotic Agents|antimitotic agents|mesh-ancestor
111454353|NCT01994226|Mitosis Modulators|mitosis modulators|mesh-ancestor
111454354|NCT01994226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111454355|NCT02002884|Botulinum Toxins|botulinum toxins|mesh-list
111454356|NCT02002884|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111454357|NCT02002884|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111454358|NCT02002884|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
111454359|NCT02002884|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111454360|NCT02002884|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111454361|NCT02002884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110927813|NCT02854527|Diuretics|diuretics|mesh-ancestor
111454362|NCT02002884|Cholinergic Agents|cholinergic agents|mesh-ancestor
111454363|NCT02002884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111454364|NCT02002884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111454365|NCT02002884|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111454366|NCT02002884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111454367|NCT02023866|Cysteamine|cysteamine|mesh-list
111454368|NCT02023866|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
111454369|NCT02023866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111454370|NCT01967940|Atazanavir Sulfate|atazanavir sulfate|mesh-list
111454371|NCT01967940|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
111454372|NCT01967940|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111454373|NCT01967940|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111454374|NCT01967940|Protease Inhibitors|protease inhibitors|mesh-ancestor
111454375|NCT01967940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111454376|NCT01967940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111454377|NCT01967940|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111454378|NCT01967940|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111454379|NCT01967940|Antiviral Agents|antiviral agents|mesh-ancestor
111454380|NCT01967940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111454381|NCT01990560|Mifepristone|mifepristone|mesh-list
111454382|NCT01990560|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
111454383|NCT01990560|Abortifacient Agents|abortifacient agents|mesh-ancestor
111454384|NCT01990560|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111454385|NCT01990560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111454386|NCT01990560|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111454387|NCT01990560|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111454388|NCT01990560|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111454389|NCT01990560|Contraceptive Agents|contraceptive agents|mesh-ancestor
111454390|NCT01990560|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
111454391|NCT01990560|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
111454392|NCT01990560|Hormone Antagonists|hormone antagonists|mesh-ancestor
111454393|NCT01990560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111454394|NCT01990560|Luteolytic Agents|luteolytic agents|mesh-ancestor
111454395|NCT01990560|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111454396|NCT01990560|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
111454397|NCT01967628|Vitamin D|vitamin d|mesh-list
111454398|NCT01967628|Cholecalciferol|cholecalciferol|mesh-list
111454399|NCT01967628|Vitamins|vitamins|mesh-ancestor
111454400|NCT01967628|Micronutrients|micronutrients|mesh-ancestor
111454401|NCT01967628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111454402|NCT01967628|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111454403|NCT01967628|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111454404|NCT01998906|Paclitaxel|paclitaxel|mesh-list
111454405|NCT01998906|Doxorubicin|doxorubicin|mesh-list
111454406|NCT01998906|Trastuzumab|trastuzumab|mesh-list
111454407|NCT01998906|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111454408|NCT01998906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111454409|NCT01998906|Tubulin Modulators|tubulin modulators|mesh-ancestor
111454410|NCT01998906|Antimitotic Agents|antimitotic agents|mesh-ancestor
111454411|NCT01998906|Mitosis Modulators|mitosis modulators|mesh-ancestor
111454412|NCT01998906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111454413|NCT01998906|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111454414|NCT01998906|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111454415|NCT01998906|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111454416|NCT01998906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111454417|NCT01998906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111454418|NCT01967550|Diclofenac|diclofenac|mesh-list
111454419|NCT01967550|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111454420|NCT01967550|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111454421|NCT01967550|Analgesics|analgesics|mesh-ancestor
111454422|NCT01967550|Sensory System Agents|sensory system agents|mesh-ancestor
111454423|NCT01967550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111454424|NCT01967550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111454425|NCT01967550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111454426|NCT01967550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111454427|NCT01967550|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111454428|NCT01967550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111454429|NCT01967550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111454430|NCT01989546|Talazoparib|talazoparib|mesh-list
111454431|NCT01989546|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111454432|NCT01989546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111454433|NCT01989546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111454434|NCT01989546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111454435|NCT01989468|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111454436|NCT01989468|Immunologic Factors|immunologic factors|mesh-ancestor
111454437|NCT01989468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111454438|NCT01989156|Menthol|menthol|mesh-list
111454439|NCT01989156|Antipruritics|antipruritics|mesh-ancestor
111454440|NCT01989156|Dermatologic Agents|dermatologic agents|mesh-ancestor
111454441|NCT01965834|Fenofibrate|fenofibrate|mesh-list
111454442|NCT01965834|Fenofibric acid|fenofibric acid|mesh-list
111454443|NCT01965834|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111454444|NCT01965834|Antimetabolites|antimetabolites|mesh-ancestor
111454445|NCT01965834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111454446|NCT01965834|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111454447|NCT01965834|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111454448|NCT01996332|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111454449|NCT01996332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111454450|NCT01996332|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111454451|NCT01996332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111454452|NCT01996332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111454453|NCT01987596|Lenograstim|lenograstim|mesh-list
111454454|NCT01987596|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111454455|NCT01987596|Immunologic Factors|immunologic factors|mesh-ancestor
111454456|NCT01987596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111454457|NCT01964898|Nicotine|nicotine|mesh-list
111454458|NCT01964898|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111454459|NCT01964898|Autonomic Agents|autonomic agents|mesh-ancestor
111454460|NCT01964898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111454461|NCT01964898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111454462|NCT01964898|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111454463|NCT01964898|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111454464|NCT01964898|Cholinergic Agents|cholinergic agents|mesh-ancestor
110928168|NCT03605199|Denosumab|denosumab|mesh-list
111454465|NCT01964898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111454466|NCT01964898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111454467|NCT01964352|Tiotropium Bromide|tiotropium bromide|mesh-list
111454468|NCT01964352|Olodaterol|olodaterol|mesh-list
111454469|NCT01964352|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111454470|NCT01964352|Autonomic Agents|autonomic agents|mesh-ancestor
111454471|NCT01964352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111454472|NCT01964352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111454473|NCT01964352|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111454474|NCT01964352|Respiratory System Agents|respiratory system agents|mesh-ancestor
111454475|NCT01964352|Parasympatholytics|parasympatholytics|mesh-ancestor
111454476|NCT01964352|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111454477|NCT01964352|Cholinergic Agents|cholinergic agents|mesh-ancestor
111454478|NCT01964352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111454479|NCT01964352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111454480|NCT01946412|Ivacaftor|ivacaftor|mesh-list
111454481|NCT01946412|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
111454482|NCT01946412|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111454483|NCT01946412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111454484|NCT01945866|Dexamethasone|dexamethasone|mesh-list
111454485|NCT01945866|Ranibizumab|ranibizumab|mesh-list
111454486|NCT01945866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111454487|NCT01945866|Antiemetics|antiemetics|mesh-ancestor
111454488|NCT01945866|Autonomic Agents|autonomic agents|mesh-ancestor
111454489|NCT01945866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111454490|NCT01945866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111454491|NCT01945866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111454492|NCT01945866|Glucocorticoids|glucocorticoids|mesh-ancestor
111454493|NCT01945866|Hormones|hormones|mesh-ancestor
111454494|NCT01945866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111454495|NCT01945866|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111454496|NCT01945866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111454497|NCT01945866|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111454498|NCT01945866|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111454499|NCT01945866|Growth Substances|growth substances|mesh-ancestor
111454500|NCT01945866|Growth Inhibitors|growth inhibitors|mesh-ancestor
111454501|NCT01986114|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
111454502|NCT01986114|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111454503|NCT01986114|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111454504|NCT01986114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111178667|NCT00084838|Leucovorin|leucovorin|mesh-list
111454506|NCT01986114|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111454507|NCT01986114|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
111454508|NCT01986114|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111454509|NCT01986114|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111454510|NCT01986114|Adrenergic Agents|adrenergic agents|mesh-ancestor
111454511|NCT01986114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111454512|NCT01986114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111454513|NCT01986114|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111454514|NCT01986114|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111454515|NCT01986114|Serotonin Agents|serotonin agents|mesh-ancestor
111454516|NCT01986114|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111454517|NCT01986114|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111454518|NCT01986114|Dopamine Agents|dopamine agents|mesh-ancestor
111454519|NCT01945242|Alogliptin|alogliptin|mesh-list
111454520|NCT01945242|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111454521|NCT01945242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111454522|NCT01945242|Incretins|incretins|mesh-ancestor
111454523|NCT01945242|Hormones|hormones|mesh-ancestor
111454524|NCT01945242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111454525|NCT01945242|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111454526|NCT01945242|Protease Inhibitors|protease inhibitors|mesh-ancestor
111454527|NCT01945242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111454528|NCT01945242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111454529|NCT01945086|Ustekinumab|ustekinumab|mesh-list
111454530|NCT01945086|Dermatologic Agents|dermatologic agents|mesh-ancestor
111454531|NCT04658160|Imidacloprid|imidacloprid|mesh-list
111454532|NCT04658160|Cholinergic Agents|cholinergic agents|mesh-ancestor
111454533|NCT04658160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110928382|NCT02164578|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111454534|NCT04658160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111454535|NCT04658160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111454536|NCT01963728|Insulin|insulin|mesh-list
111454537|NCT01963728|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111454538|NCT01963728|Insulin Glargine|insulin glargine|mesh-list
111454539|NCT01963728|Insulin, Isophane|insulin, isophane|mesh-list
111454540|NCT01963728|Isophane Insulin, Human|isophane insulin, human|mesh-list
111454541|NCT01963728|Isophane insulin, beef|isophane insulin, beef|mesh-list
111454542|NCT01963728|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111454543|NCT01963728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111454544|NCT01962948|Paclitaxel|paclitaxel|mesh-list
111454545|NCT01962948|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111454546|NCT01962948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111454547|NCT01962948|Tubulin Modulators|tubulin modulators|mesh-ancestor
111454548|NCT01962948|Antimitotic Agents|antimitotic agents|mesh-ancestor
111454549|NCT01962948|Mitosis Modulators|mitosis modulators|mesh-ancestor
111454550|NCT01962948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111454551|NCT01985334|Glycopyrrolate|glycopyrrolate|mesh-list
111454552|NCT01985334|Bromides|bromides|mesh-list
111454553|NCT01985334|Anticonvulsants|anticonvulsants|mesh-ancestor
111454554|NCT01985334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111454555|NCT01985334|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111454556|NCT01985334|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111454557|NCT01985334|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111454558|NCT01985334|Cholinergic Agents|cholinergic agents|mesh-ancestor
111454559|NCT01985334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111454560|NCT01985334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111454561|NCT01944774|Moxifloxacin|moxifloxacin|mesh-list
111454562|NCT01944774|Nemonoxacin|nemonoxacin|mesh-list
111454563|NCT01944774|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111454564|NCT01944774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111454565|NCT01944774|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111454566|NCT01944774|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111454567|NCT01944774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111454568|NCT01944774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110928566|NCT02746575|Metoprolol|metoprolol|mesh-list
111454569|NCT01944774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111454570|NCT01944462|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
111454571|NCT01944462|Immunologic Factors|immunologic factors|mesh-ancestor
111454572|NCT01944462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111454573|NCT01942590|Clenbuterol|clenbuterol|mesh-list
110928627|NCT02164812|Moxifloxacin|moxifloxacin|mesh-list
111454574|NCT01942590|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111454575|NCT01942590|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111454576|NCT01942590|Adrenergic Agents|adrenergic agents|mesh-ancestor
111454577|NCT01942590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111178750|NCT00084682|Romidepsin|romidepsin|mesh-list
111454578|NCT01942590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111454579|NCT01942590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111454580|NCT01942590|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111454581|NCT01942590|Autonomic Agents|autonomic agents|mesh-ancestor
111454582|NCT01942590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111454583|NCT01942590|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111454584|NCT01942590|Respiratory System Agents|respiratory system agents|mesh-ancestor
111454585|NCT01942590|Sympathomimetics|sympathomimetics|mesh-ancestor
111454586|NCT01984242|Bevacizumab|bevacizumab|mesh-list
111454587|NCT01984242|Atezolizumab|atezolizumab|mesh-list
111454588|NCT01984242|Sunitinib|sunitinib|mesh-list
111454589|NCT01984242|Antibodies|antibodies|mesh-list
111454590|NCT01984242|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111454591|NCT01984242|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111454592|NCT01984242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111454593|NCT01984242|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111454594|NCT01984242|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111454595|NCT01984242|Growth Substances|growth substances|mesh-ancestor
111454596|NCT01984242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111454597|NCT01984242|Growth Inhibitors|growth inhibitors|mesh-ancestor
111454598|NCT01984242|Immunologic Factors|immunologic factors|mesh-ancestor
111454599|NCT01984242|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111454600|NCT01984242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110928755|NCT00101166|Vaccines|vaccines|mesh-list
111454601|NCT01984242|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111454602|NCT01984242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111454603|NCT01960842|Levodopa|levodopa|mesh-list
111454604|NCT01960842|Carbidopa|carbidopa|mesh-list
111454605|NCT01960842|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
111454606|NCT01960842|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111454607|NCT01960842|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111454608|NCT01960842|Dopamine Agents|dopamine agents|mesh-ancestor
111454609|NCT01960842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111454610|NCT01960842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111454611|NCT01960842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111454612|NCT01960842|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
111454613|NCT01960842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111454614|NCT01960842|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111454615|NCT01960842|Immunologic Factors|immunologic factors|mesh-ancestor
111454616|NCT01960842|Dopamine Agonists|dopamine agonists|mesh-ancestor
111454617|NCT01984164|Candesartan|candesartan|mesh-list
111454618|NCT01984164|Candesartan cilexetil|candesartan cilexetil|mesh-list
111454619|NCT01984164|Lisinopril|lisinopril|mesh-list
111454620|NCT01984164|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111454621|NCT01984164|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110928815|NCT03601533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111454622|NCT01984164|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111454623|NCT01984164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111454624|NCT01984164|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
111454625|NCT01984164|Protease Inhibitors|protease inhibitors|mesh-ancestor
111454626|NCT01984164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111454627|NCT01984164|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111454628|NCT01984164|Protective Agents|protective agents|mesh-ancestor
111454629|NCT01984164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111454630|NCT01983774|Esomeprazole|esomeprazole|mesh-list
111454631|NCT01983774|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111454632|NCT01983774|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111454633|NCT01983774|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111454634|NCT01983774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111454635|NCT01983774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111454636|NCT01982682|Mycophenolic Acid|mycophenolic acid|mesh-list
111454637|NCT01982682|Cyclophosphamide|cyclophosphamide|mesh-list
111454638|NCT01982682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111454639|NCT01982682|Immunologic Factors|immunologic factors|mesh-ancestor
111454640|NCT01982682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111454641|NCT01982682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111454642|NCT01982682|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111454643|NCT01982682|Alkylating Agents|alkylating agents|mesh-ancestor
111454644|NCT01982682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111454645|NCT01982682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111454646|NCT01982682|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111454647|NCT01982682|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111454648|NCT01982682|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111454649|NCT01982682|Antitubercular Agents|antitubercular agents|mesh-ancestor
111454650|NCT01982682|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111178821|NCT03084250|Tenofovir|tenofovir|mesh-list
111454651|NCT01982682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111454652|NCT01982682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111454653|NCT01940484|Epoetin Alfa|epoetin alfa|mesh-list
111454654|NCT01940484|Hematinics|hematinics|mesh-ancestor
111454655|NCT01960296|Clopidogrel|clopidogrel|mesh-list
110928922|NCT03066466|Methotrexate|methotrexate|mesh-list
111454656|NCT01960296|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111454657|NCT01960296|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111454658|NCT01960296|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111454659|NCT01960296|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111454660|NCT01960296|Purinergic Agents|purinergic agents|mesh-ancestor
111454661|NCT01960296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111454662|NCT01960296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111454663|NCT01960296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111454664|NCT01939314|Bupivacaine|bupivacaine|mesh-list
111454665|NCT01939314|Anesthetics, Local|anesthetics, local|mesh-ancestor
111454666|NCT01939314|Anesthetics|anesthetics|mesh-ancestor
110646516|NCT03389750|Oxymorphone|oxymorphone|mesh-list
111454667|NCT01939314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111454668|NCT01939314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111454669|NCT01939314|Sensory System Agents|sensory system agents|mesh-ancestor
111454670|NCT01939314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111454671|NCT01939158|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
111454672|NCT01939158|Immunologic Factors|immunologic factors|mesh-ancestor
111454673|NCT01939158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111454674|NCT01939002|Interferons|interferons|mesh-list
111454675|NCT01939002|Interferon-beta|interferon-beta|mesh-list
111454676|NCT01939002|Interferon beta-1a|interferon beta-1a|mesh-list
111454677|NCT01939002|Naproxen|naproxen|mesh-list
111454678|NCT01939002|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
111454679|NCT01939002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
111454680|NCT01939002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111454681|NCT01939002|Antiviral Agents|antiviral agents|mesh-ancestor
111454682|NCT01939002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111454683|NCT01939002|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111454684|NCT01939002|Analgesics|analgesics|mesh-ancestor
111454685|NCT01939002|Sensory System Agents|sensory system agents|mesh-ancestor
111454686|NCT01939002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111454687|NCT01939002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111454688|NCT01939002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111454689|NCT01939002|Gout Suppressants|gout suppressants|mesh-ancestor
111454690|NCT01939002|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111454691|NCT01939002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111454692|NCT01939002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111454693|NCT01939002|Immunologic Factors|immunologic factors|mesh-ancestor
111454694|NCT01939002|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111454695|NCT01938846|Paclitaxel|paclitaxel|mesh-list
111454696|NCT01938846|Exemestane|exemestane|mesh-list
111454697|NCT01938846|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111454698|NCT01938846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111454699|NCT01938846|Tubulin Modulators|tubulin modulators|mesh-ancestor
111454700|NCT01938846|Antimitotic Agents|antimitotic agents|mesh-ancestor
111454701|NCT01938846|Mitosis Modulators|mitosis modulators|mesh-ancestor
111454702|NCT01938846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111454703|NCT01938846|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111454704|NCT01938846|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111454705|NCT01938846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111454706|NCT01938846|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111454707|NCT01938846|Hormone Antagonists|hormone antagonists|mesh-ancestor
111454708|NCT01938846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111454709|NCT01938846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111454710|NCT01960140|Simvastatin|simvastatin|mesh-list
111454711|NCT01960140|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111454712|NCT01960140|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111454713|NCT01960140|Antimetabolites|antimetabolites|mesh-ancestor
111454714|NCT01960140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110929163|NCT03602469|Anesthetics|anesthetics|mesh-ancestor
111454715|NCT01960140|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111454716|NCT01960140|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111454717|NCT01960140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111454718|NCT01959672|Calcium, Dietary|calcium, dietary|mesh-list
111454719|NCT01959672|Leucovorin|leucovorin|mesh-list
111454720|NCT01959672|Folic Acid|folic acid|mesh-list
111454721|NCT01959672|Nelfinavir|nelfinavir|mesh-list
111454722|NCT01959672|Gemcitabine|gemcitabine|mesh-list
111454723|NCT01959672|Fluorouracil|fluorouracil|mesh-list
111454724|NCT01959672|Oregovomab|oregovomab|mesh-list
111454725|NCT01959672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111454726|NCT01959672|Antibodies|antibodies|mesh-list
111454727|NCT01959672|Immunoglobulins|immunoglobulins|mesh-list
111454728|NCT01959672|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111454729|NCT01959672|Calcium|calcium|mesh-list
111454730|NCT01959672|Levoleucovorin|levoleucovorin|mesh-list
111454731|NCT01959672|Immunologic Factors|immunologic factors|mesh-ancestor
111454732|NCT01959672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111454733|NCT01959672|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111454734|NCT01959672|Antimetabolites|antimetabolites|mesh-ancestor
111454735|NCT01959672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111454736|NCT01959672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111454737|NCT01959672|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111454738|NCT01959672|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110929280|NCT03590769|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
111454739|NCT01959672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111454740|NCT01959672|Antidotes|antidotes|mesh-ancestor
111454741|NCT01959672|Protective Agents|protective agents|mesh-ancestor
111454742|NCT01959672|Vitamin B Complex|vitamin b complex|mesh-ancestor
111454743|NCT01959672|Vitamins|vitamins|mesh-ancestor
111454744|NCT01959672|Micronutrients|micronutrients|mesh-ancestor
111454745|NCT01959672|Hematinics|hematinics|mesh-ancestor
111454746|NCT01959672|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111454747|NCT01959672|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111454748|NCT01959672|Protease Inhibitors|protease inhibitors|mesh-ancestor
111454749|NCT01959672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111454750|NCT01959672|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111454751|NCT01959672|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111454752|NCT01959672|Antiviral Agents|antiviral agents|mesh-ancestor
111454753|NCT01959672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111454754|NCT01980888|Rituximab|rituximab|mesh-list
111454755|NCT01980888|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
111454756|NCT01980888|Idelalisib|idelalisib|mesh-list
111454757|NCT01980888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111454758|NCT01980888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111454759|NCT01980888|Immunologic Factors|immunologic factors|mesh-ancestor
111454760|NCT01980888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111454761|NCT01980888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111454762|NCT01980888|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111454763|NCT01980888|Alkylating Agents|alkylating agents|mesh-ancestor
111454764|NCT01980888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111454765|NCT01980888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111454766|NCT04650282|Lidocaine|lidocaine|mesh-list
111454767|NCT04650282|Anesthetics, Local|anesthetics, local|mesh-ancestor
111454768|NCT04650282|Anesthetics|anesthetics|mesh-ancestor
111454769|NCT04650282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111454770|NCT04650282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111454771|NCT04650282|Sensory System Agents|sensory system agents|mesh-ancestor
111454772|NCT04650282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111454773|NCT04650282|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111454774|NCT04650282|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111454775|NCT04650282|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111454776|NCT04650282|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111454777|NCT04650282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111454778|NCT01937364|Baclofen|baclofen|mesh-list
111454779|NCT01937364|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
111454780|NCT01937364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111454781|NCT01937364|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111454782|NCT01937364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111454783|NCT01937364|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
111454784|NCT01937364|GABA Agonists|gaba agonists|mesh-ancestor
111454785|NCT01937364|GABA Agents|gaba agents|mesh-ancestor
111454786|NCT01937364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111454787|NCT01937364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111454788|NCT01979952|Nintedanib|nintedanib|mesh-list
111454789|NCT01979952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111454790|NCT01979952|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111454791|NCT01979952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111454792|NCT01979952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111454793|NCT01999218|Metformin|metformin|mesh-list
111454794|NCT01999218|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111454795|NCT01999218|Glimepiride|glimepiride|mesh-list
111454796|NCT01999218|Ertugliflozin|ertugliflozin|mesh-list
111454797|NCT01999218|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111454798|NCT01999218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111454799|NCT01999218|Incretins|incretins|mesh-ancestor
111454800|NCT01999218|Hormones|hormones|mesh-ancestor
111454801|NCT01999218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111454802|NCT01999218|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111454803|NCT01999218|Protease Inhibitors|protease inhibitors|mesh-ancestor
111454804|NCT01999218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111454805|NCT01999218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111454806|NCT01999218|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111454807|NCT01999218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110929583|NCT04859764|Hormones|hormones|mesh-ancestor
111454808|NCT01999218|Immunologic Factors|immunologic factors|mesh-ancestor
111454809|NCT01999218|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111454810|NCT01936974|Bevacizumab|bevacizumab|mesh-list
111454811|NCT01936974|Carboplatin|carboplatin|mesh-list
111454812|NCT01936974|Gemcitabine|gemcitabine|mesh-list
111454813|NCT01936974|Oxaliplatin|oxaliplatin|mesh-list
111454814|NCT01936974|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111454815|NCT01936974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111454816|NCT01936974|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111454817|NCT01936974|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111454818|NCT01936974|Growth Substances|growth substances|mesh-ancestor
111454819|NCT01936974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111454820|NCT01936974|Growth Inhibitors|growth inhibitors|mesh-ancestor
111454821|NCT01936974|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111454822|NCT01936974|Antimetabolites|antimetabolites|mesh-ancestor
111454823|NCT01936974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111454824|NCT01959516|Glycopyrrolate|glycopyrrolate|mesh-list
111454825|NCT01959516|Tiotropium Bromide|tiotropium bromide|mesh-list
111454826|NCT01959516|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111454827|NCT01959516|Autonomic Agents|autonomic agents|mesh-ancestor
111454828|NCT01959516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111454829|NCT01959516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111454830|NCT01959516|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111454831|NCT01959516|Respiratory System Agents|respiratory system agents|mesh-ancestor
110929655|NCT02171754|Afatinib|afatinib|mesh-list
111454832|NCT01959516|Parasympatholytics|parasympatholytics|mesh-ancestor
111454833|NCT01959516|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111454834|NCT01959516|Cholinergic Agents|cholinergic agents|mesh-ancestor
111454835|NCT01959516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111454836|NCT01959516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111454837|NCT01959516|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111454838|NCT01959516|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111454839|NCT01979016|Emollients|emollients|mesh-list
111454840|NCT01979016|Dermatologic Agents|dermatologic agents|mesh-ancestor
111454841|NCT01935336|Ponatinib|ponatinib|mesh-list
111454842|NCT01935336|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
111454843|NCT01935336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111454844|NCT01935336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111454845|NCT01935336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111454846|NCT01935336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111454847|NCT01978236|Trametinib|trametinib|mesh-list
111454848|NCT01978236|Dabrafenib|dabrafenib|mesh-list
111454849|NCT01978236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111454850|NCT01978236|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111454851|NCT01978236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111454852|NCT01978236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111454853|NCT01934790|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
111454854|NCT01934790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111454855|NCT01934556|Ranibizumab|ranibizumab|mesh-list
111454856|NCT01934556|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111454857|NCT01934556|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111454858|NCT01934556|Growth Substances|growth substances|mesh-ancestor
111454859|NCT01934556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111454860|NCT01934556|Growth Inhibitors|growth inhibitors|mesh-ancestor
111454861|NCT01934556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111454862|NCT04411212|Lenograstim|lenograstim|mesh-list
111454863|NCT04411212|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111454864|NCT04411212|Immunologic Factors|immunologic factors|mesh-ancestor
111454865|NCT04411212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111454866|NCT01620138|Cabergoline|cabergoline|mesh-list
111454867|NCT01620138|Pasireotide|pasireotide|mesh-list
111454868|NCT01620138|Hormones|hormones|mesh-ancestor
111454869|NCT01620138|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111454870|NCT01620138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111454871|NCT01620138|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111454872|NCT01620138|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111454873|NCT01620138|Dopamine Agonists|dopamine agonists|mesh-ancestor
111454874|NCT01620138|Dopamine Agents|dopamine agents|mesh-ancestor
111454875|NCT01620138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111454876|NCT01620138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111179049|NCT03366298|Epinephrine|epinephrine|mesh-list
111454877|NCT01932996|Nicotine|nicotine|mesh-list
111454878|NCT01932996|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111454879|NCT01932996|Autonomic Agents|autonomic agents|mesh-ancestor
111454880|NCT01932996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111454881|NCT01932996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111454882|NCT01932996|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111454883|NCT01932996|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111454884|NCT01932996|Cholinergic Agents|cholinergic agents|mesh-ancestor
111454885|NCT01932996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111454886|NCT01932996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111454887|NCT01932762|Ribavirin|ribavirin|mesh-list
111454888|NCT01932762|Grazoprevir|grazoprevir|mesh-list
111454889|NCT01932762|Antimetabolites|antimetabolites|mesh-ancestor
111454890|NCT01932762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111454891|NCT01932762|Antiviral Agents|antiviral agents|mesh-ancestor
111454892|NCT01932762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111454893|NCT01977456|Eptifibatide|eptifibatide|mesh-list
111454894|NCT01977456|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111454895|NCT01957644|Azacitidine|azacitidine|mesh-list
110929800|NCT03537612|Morphine|morphine|mesh-list
111454896|NCT01957644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111454897|NCT01957644|Antimetabolites|antimetabolites|mesh-ancestor
111454898|NCT01957644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111454899|NCT01957644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111454900|NCT01957644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111454901|NCT01931202|Escitalopram|escitalopram|mesh-list
111454902|NCT01931202|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111454903|NCT01931202|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111454904|NCT01931202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111454905|NCT01931202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111454906|NCT01931202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111454907|NCT01931202|Serotonin Agents|serotonin agents|mesh-ancestor
111454908|NCT01931202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111454909|NCT01930890|Mycophenolic Acid|mycophenolic acid|mesh-list
111454910|NCT01930890|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111454911|NCT01930890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111454912|NCT01930890|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111454913|NCT01930890|Antitubercular Agents|antitubercular agents|mesh-ancestor
111454914|NCT01930890|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111454915|NCT01930890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111454916|NCT01930890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111454917|NCT01930890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111454918|NCT01930188|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111454919|NCT01930188|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111454920|NCT01930188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111454921|NCT01930188|Incretins|incretins|mesh-ancestor
111454922|NCT01930188|Hormones|hormones|mesh-ancestor
111454923|NCT01930188|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111454924|NCT01930188|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111454925|NCT01930188|Protease Inhibitors|protease inhibitors|mesh-ancestor
111454926|NCT01930188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111454927|NCT01930188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111454928|NCT01976364|Methotrexate|methotrexate|mesh-list
111454929|NCT01976364|Tofacitinib|tofacitinib|mesh-list
111454930|NCT01976364|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111454931|NCT01976364|Abortifacient Agents|abortifacient agents|mesh-ancestor
111454932|NCT01976364|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111454933|NCT01976364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111454934|NCT01976364|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111454935|NCT01976364|Antimetabolites|antimetabolites|mesh-ancestor
111454936|NCT01976364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111454937|NCT01976364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111454938|NCT01976364|Dermatologic Agents|dermatologic agents|mesh-ancestor
110929906|NCT03067792|Irinotecan|irinotecan|mesh-list
111454939|NCT01976364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111454940|NCT01976364|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111454941|NCT01976364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111454942|NCT01976364|Immunologic Factors|immunologic factors|mesh-ancestor
111454943|NCT01976364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111454944|NCT01976364|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111454945|NCT01976364|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
111454946|NCT01976364|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111454947|NCT01929876|Itraconazole|itraconazole|mesh-list
111454948|NCT01929876|Antifungal Agents|antifungal agents|mesh-ancestor
111454949|NCT01929876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111179122|NCT01842308|Melphalan|melphalan|mesh-list
111454950|NCT01929876|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111454951|NCT01929876|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111454952|NCT01929876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111454953|NCT01929876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111454954|NCT01929876|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111454955|NCT01929876|Hormone Antagonists|hormone antagonists|mesh-ancestor
111454956|NCT01929876|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111454957|NCT01929876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111454958|NCT01929876|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111454959|NCT01928940|Trametinib|trametinib|mesh-list
111454960|NCT01928940|Dabrafenib|dabrafenib|mesh-list
111454961|NCT01928940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111454962|NCT01928940|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111454963|NCT01928940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111454964|NCT01928940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111454965|NCT01954056|Hydrocortisone|hydrocortisone|mesh-list
111454966|NCT01954056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111454968|NCT01975272|Ferrous fumarate|ferrous fumarate|mesh-list
111454969|NCT01975272|Ferric Compounds|ferric compounds|mesh-list
111454970|NCT01975272|Trace Elements|trace elements|mesh-ancestor
111454971|NCT01975272|Micronutrients|micronutrients|mesh-ancestor
111454972|NCT01975272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111454973|NCT01975272|Hematinics|hematinics|mesh-ancestor
111454974|NCT03965039|Fluorides|fluorides|mesh-list
111454975|NCT03965039|Tin Fluorides|tin fluorides|mesh-list
111454976|NCT03965039|Fluorophosphate|fluorophosphate|mesh-list
111454977|NCT03965039|Cariostatic Agents|cariostatic agents|mesh-ancestor
111454978|NCT03965039|Protective Agents|protective agents|mesh-ancestor
111454979|NCT03965039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111454980|NCT03961295|Vedolizumab|vedolizumab|mesh-list
111454981|NCT03961295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111454982|NCT03935399|Oxytocin|oxytocin|mesh-list
111454983|NCT03935399|Oxytocics|oxytocics|mesh-ancestor
111454984|NCT03935399|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111454985|NCT03935399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111454986|NCT03571607|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
111454987|NCT03571607|Immunologic Factors|immunologic factors|mesh-ancestor
111454988|NCT03571607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111454989|NCT03993119|Anticoagulants|anticoagulants|mesh-list
111454990|NCT03910439|Avelumab|avelumab|mesh-list
111454991|NCT03910439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111454992|NCT03910439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111454993|NCT03895307|Anesthetics|anesthetics|mesh-list
111454994|NCT03895307|Anesthetics, Local|anesthetics, local|mesh-list
111454995|NCT03895307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111454996|NCT03895307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111454997|NCT03895307|Sensory System Agents|sensory system agents|mesh-ancestor
111454998|NCT03895307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111454999|NCT03888755|Icatibant|icatibant|mesh-list
111455000|NCT03888755|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111455001|NCT03888755|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111455002|NCT03888755|Analgesics|analgesics|mesh-ancestor
111455003|NCT03888755|Sensory System Agents|sensory system agents|mesh-ancestor
111455004|NCT03888755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111455005|NCT03888755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111455006|NCT03888755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111455007|NCT03888755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111455008|NCT03888755|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
111455009|NCT03888755|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
111455010|NCT03888755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111455011|NCT03888755|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
111455012|NCT03888755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111455013|NCT03888755|Immunologic Factors|immunologic factors|mesh-ancestor
111455014|NCT00378755|Bortezomib|bortezomib|mesh-list
111455015|NCT00378755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111455016|NCT00378833|Niacin|niacin|mesh-list
111455017|NCT00378833|Niacinamide|niacinamide|mesh-list
111455018|NCT00378833|Nicotinic Acids|nicotinic acids|mesh-list
111455019|NCT00378833|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111455020|NCT00378833|Antimetabolites|antimetabolites|mesh-ancestor
111455021|NCT00378833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111455022|NCT00378833|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111455023|NCT00378833|Vasodilator Agents|vasodilator agents|mesh-ancestor
111455024|NCT00378833|Vitamin B Complex|vitamin b complex|mesh-ancestor
111455025|NCT00378833|Vitamins|vitamins|mesh-ancestor
111455026|NCT00378833|Micronutrients|micronutrients|mesh-ancestor
111455027|NCT00378833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111455028|NCT02995967|Botulinum Toxins|botulinum toxins|mesh-list
111455029|NCT02995967|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111455030|NCT02995967|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111455031|NCT02995967|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111455032|NCT02995967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111455033|NCT02995967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111455034|NCT02995967|Cholinergic Agents|cholinergic agents|mesh-ancestor
111455035|NCT02995967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111455036|NCT02995967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111455037|NCT02995967|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111455038|NCT02995967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111455039|NCT03888365|Treprostinil|treprostinil|mesh-list
111455040|NCT03888365|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111455041|NCT00377975|Pioglitazone|pioglitazone|mesh-list
111455042|NCT00377975|Ephedrine|ephedrine|mesh-list
111455043|NCT00377975|Caffeine|caffeine|mesh-list
111455044|NCT00377975|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111455045|NCT00377975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111455046|NCT00377975|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111455047|NCT00377975|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111455048|NCT00377975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111455049|NCT00377975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111455050|NCT00377975|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
111455051|NCT00377975|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111455052|NCT00377975|Purinergic Agents|purinergic agents|mesh-ancestor
111455053|NCT00377975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111455054|NCT00377975|Sympathomimetics|sympathomimetics|mesh-ancestor
111455055|NCT00377975|Autonomic Agents|autonomic agents|mesh-ancestor
111455056|NCT00377975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111455057|NCT00377975|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111455058|NCT00377975|Adrenergic Agents|adrenergic agents|mesh-ancestor
111455059|NCT02994251|Gemcitabine|gemcitabine|mesh-list
111455060|NCT02994251|Doxorubicin|doxorubicin|mesh-list
111455061|NCT02994251|Mitomycins|mitomycins|mesh-list
111455062|NCT02994251|Mitomycin|mitomycin|mesh-list
111455063|NCT02994251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111455064|NCT02994251|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111455065|NCT02994251|Antimetabolites|antimetabolites|mesh-ancestor
111455066|NCT02994251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111455067|NCT02994251|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111455068|NCT02994251|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111455069|NCT02994251|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111455070|NCT02994251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111455071|NCT02994251|Alkylating Agents|alkylating agents|mesh-ancestor
111455072|NCT02994251|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111455073|NCT02936999|Vitamin D|vitamin d|mesh-list
111455074|NCT02936999|Cholecalciferol|cholecalciferol|mesh-list
111455075|NCT02936999|Vitamins|vitamins|mesh-ancestor
111455076|NCT02936999|Micronutrients|micronutrients|mesh-ancestor
111455077|NCT02936999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111455078|NCT02936999|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110930153|NCT00108810|Analgesics|analgesics|mesh-ancestor
111455079|NCT02936999|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111455080|NCT02826551|Bupivacaine|bupivacaine|mesh-list
111455081|NCT02826551|Anesthetics, Local|anesthetics, local|mesh-ancestor
111455082|NCT02826551|Anesthetics|anesthetics|mesh-ancestor
111455083|NCT02826551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111455084|NCT02826551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111455085|NCT02826551|Sensory System Agents|sensory system agents|mesh-ancestor
111455086|NCT02826551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111455087|NCT00378443|Prednisone|prednisone|mesh-list
111455088|NCT00378443|Losartan|losartan|mesh-list
111455089|NCT00378443|Cilazapril|cilazapril|mesh-list
111455090|NCT00378443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111455091|NCT00378443|Glucocorticoids|glucocorticoids|mesh-ancestor
111455092|NCT00378443|Hormones|hormones|mesh-ancestor
111455093|NCT00378443|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110930194|NCT02177370|Fenoterol|fenoterol|mesh-list
111455094|NCT00378443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111455095|NCT00378443|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111455096|NCT00378443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111455097|NCT00378443|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111455098|NCT00378443|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111455099|NCT00378443|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111179267|NCT03279250|Hormones|hormones|mesh-list
111455100|NCT00378443|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111455101|NCT00378443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111455102|NCT00378443|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
111455103|NCT00378443|Protease Inhibitors|protease inhibitors|mesh-ancestor
111455104|NCT00378443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111455105|NCT01340573|Interferons|interferons|mesh-list
111455106|NCT01340573|Ribavirin|ribavirin|mesh-list
111455107|NCT01340573|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
111455108|NCT01340573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111455109|NCT01340573|Antiviral Agents|antiviral agents|mesh-ancestor
111455110|NCT01340573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111455111|NCT01340573|Antimetabolites|antimetabolites|mesh-ancestor
110930254|NCT03537144|Tocolytic Agents|tocolytic agents|mesh-ancestor
111455112|NCT01340573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111455113|NCT01340885|Rivastigmine|rivastigmine|mesh-list
111455114|NCT01340885|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
111455115|NCT01340885|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111455116|NCT01340885|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111455117|NCT01340885|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111455118|NCT01340885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111455119|NCT01340885|Adrenergic Agents|adrenergic agents|mesh-ancestor
111455120|NCT01340885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111455121|NCT01340885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111455122|NCT01340885|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111455123|NCT01340885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111455124|NCT01340885|Cholinergic Agents|cholinergic agents|mesh-ancestor
111455125|NCT01340885|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111455126|NCT01340885|Protective Agents|protective agents|mesh-ancestor
111455127|NCT01326923|Cetuximab|cetuximab|mesh-list
111455128|NCT01326923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111455129|NCT01326923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111455130|NCT03855059|Dexamethasone|dexamethasone|mesh-list
111455131|NCT03855059|Dexamethasone acetate|dexamethasone acetate|mesh-list
111455132|NCT03855059|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
111455133|NCT03855059|BB 1101|bb 1101|mesh-list
111455134|NCT03855059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111455135|NCT03855059|Antiemetics|antiemetics|mesh-ancestor
111455136|NCT03855059|Autonomic Agents|autonomic agents|mesh-ancestor
111455137|NCT03855059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111455138|NCT03855059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111455139|NCT03855059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111455140|NCT03855059|Glucocorticoids|glucocorticoids|mesh-ancestor
111455141|NCT03855059|Hormones|hormones|mesh-ancestor
111455142|NCT03855059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111455143|NCT03855059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111455144|NCT03855059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111455145|NCT03855059|Protease Inhibitors|protease inhibitors|mesh-ancestor
111455146|NCT03855059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111455147|NCT03855059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111455148|NCT01301963|Plerixafor|plerixafor|mesh-list
111455149|NCT01301963|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111455150|NCT01301963|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111455151|NCT01301963|Antiviral Agents|antiviral agents|mesh-ancestor
111455152|NCT01301963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111455153|NCT01262339|Botulinum Toxins|botulinum toxins|mesh-list
111455154|NCT01262339|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111455155|NCT01262339|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111455156|NCT01262339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111455157|NCT01262339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111455158|NCT01262339|Cholinergic Agents|cholinergic agents|mesh-ancestor
111455159|NCT01262339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111455160|NCT01262339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111455161|NCT01262339|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111455162|NCT01262339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111455163|NCT02708849|Lamotrigine|lamotrigine|mesh-list
111455164|NCT02708849|Ketamine|ketamine|mesh-list
111455165|NCT02708849|Analgesics|analgesics|mesh-ancestor
111455166|NCT02708849|Sensory System Agents|sensory system agents|mesh-ancestor
111455167|NCT02708849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110930417|NCT02174328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111455168|NCT02708849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111455169|NCT02708849|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111455170|NCT02708849|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111455171|NCT02708849|Anesthetics, General|anesthetics, general|mesh-ancestor
111455172|NCT02708849|Anesthetics|anesthetics|mesh-ancestor
111455173|NCT02708849|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111455174|NCT02708849|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111455175|NCT02708849|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111455176|NCT02708849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111455177|NCT02708849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111455178|NCT02708849|Anticonvulsants|anticonvulsants|mesh-ancestor
111455179|NCT02708849|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111455180|NCT02708849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111455181|NCT02708849|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111455182|NCT02708849|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111455183|NCT02708849|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111455184|NCT02708849|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110930473|NCT04437654|Apixaban|apixaban|mesh-list
111455185|NCT02708849|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111455186|NCT01222871|Triamcinolone|triamcinolone|mesh-list
111455187|NCT01222871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111455188|NCT01222871|Glucocorticoids|glucocorticoids|mesh-ancestor
111455190|NCT01222871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111455191|NCT01222871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111455192|NCT01219673|Minocycline|minocycline|mesh-list
111455193|NCT01219673|Modafinil|modafinil|mesh-list
111455194|NCT01219673|Bupropion|bupropion|mesh-list
111455195|NCT01219673|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111455196|NCT01219673|Antidepressive Agents|antidepressive agents|mesh-ancestor
111455197|NCT01219673|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111455198|NCT01219673|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111455199|NCT01219673|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111455200|NCT01219673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111455201|NCT01219673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111455202|NCT01219673|Dopamine Agents|dopamine agents|mesh-ancestor
111455203|NCT01219673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111455204|NCT01219673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111455205|NCT01219673|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111455206|NCT01219673|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111455207|NCT01219673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111455208|NCT01219673|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111455209|NCT01219673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111455210|NCT01219673|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111455211|NCT01219673|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
111455212|NCT01219673|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111455213|NCT01219673|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111455214|NCT01216631|Methylprednisolone|methylprednisolone|mesh-list
111455215|NCT01216631|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111455216|NCT01216631|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111455217|NCT01216631|Prednisolone|prednisolone|mesh-list
111455218|NCT01216631|Prednisolone acetate|prednisolone acetate|mesh-list
111455219|NCT01216631|Infliximab|infliximab|mesh-list
111455220|NCT01216631|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111455221|NCT01216631|Prednisolone phosphate|prednisolone phosphate|mesh-list
111455222|NCT01216631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111455223|NCT01216631|Antiemetics|antiemetics|mesh-ancestor
111455224|NCT01216631|Autonomic Agents|autonomic agents|mesh-ancestor
111455225|NCT01216631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111455226|NCT01216631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111455227|NCT01216631|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111455228|NCT01216631|Glucocorticoids|glucocorticoids|mesh-ancestor
111455229|NCT01216631|Hormones|hormones|mesh-ancestor
111455230|NCT01216631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111455231|NCT01216631|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111455232|NCT01216631|Protective Agents|protective agents|mesh-ancestor
111455233|NCT01216631|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111455234|NCT01216631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111455235|NCT01216631|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111455236|NCT01216631|Dermatologic Agents|dermatologic agents|mesh-ancestor
111455237|NCT01216631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111455238|NCT02693717|Pemetrexed|pemetrexed|mesh-list
111455239|NCT02693717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111455240|NCT02693717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111455241|NCT02693717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111455242|NCT02693717|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111455243|NCT02693717|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111455244|NCT03860753|Pioglitazone|pioglitazone|mesh-list
111455245|NCT03860753|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111455246|NCT03860753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111455247|NCT02687165|Cycloserine|cycloserine|mesh-list
111455248|NCT02687165|Milnacipran|milnacipran|mesh-list
111455249|NCT02687165|Levomilnacipran|levomilnacipran|mesh-list
111455250|NCT02687165|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111455251|NCT02687165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111455252|NCT02687165|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111455253|NCT02687165|Antitubercular Agents|antitubercular agents|mesh-ancestor
111455254|NCT02687165|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111455255|NCT02687165|Antimetabolites|antimetabolites|mesh-ancestor
111455256|NCT02687165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111455257|NCT02687165|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111455258|NCT02687165|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111455259|NCT02687165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111455260|NCT02687165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111455261|NCT02687165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111455262|NCT02687165|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111455263|NCT02687165|Analgesics|analgesics|mesh-ancestor
111455264|NCT02687165|Sensory System Agents|sensory system agents|mesh-ancestor
111455265|NCT02687165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111455266|NCT02687165|Antidepressive Agents|antidepressive agents|mesh-ancestor
111455267|NCT02687165|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111455268|NCT01169753|Modafinil|modafinil|mesh-list
111455269|NCT01169753|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111455270|NCT01169753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111455271|NCT01169753|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
111455272|NCT01169753|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111455273|NCT01169753|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111455274|NCT01169753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111455275|NCT02654639|Bevacizumab|bevacizumab|mesh-list
111455276|NCT02654639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111455277|NCT02654639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111455278|NCT02654639|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111455279|NCT02654639|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111455280|NCT02654639|Growth Substances|growth substances|mesh-ancestor
111455281|NCT02654639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111455282|NCT02654639|Growth Inhibitors|growth inhibitors|mesh-ancestor
111455283|NCT02634827|Decitabine|decitabine|mesh-list
111455284|NCT02634827|Midostaurin|midostaurin|mesh-list
111455285|NCT02634827|Staurosporine|staurosporine|mesh-list
111455286|NCT02634827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111455287|NCT02634827|Antimetabolites|antimetabolites|mesh-ancestor
111455288|NCT02634827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111455289|NCT02634827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111455290|NCT02634827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111455291|NCT02634827|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111455292|NCT02506985|Warfarin|warfarin|mesh-list
111455293|NCT02506985|Rivaroxaban|rivaroxaban|mesh-list
111455294|NCT02506985|Anticoagulants|anticoagulants|mesh-ancestor
111455295|NCT02506985|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111455296|NCT02506985|Antithrombins|antithrombins|mesh-ancestor
111455297|NCT02506985|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111455298|NCT02506985|Protease Inhibitors|protease inhibitors|mesh-ancestor
111455299|NCT02506985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111455300|NCT02506985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111455301|NCT01150409|Hydrocortisone|hydrocortisone|mesh-list
110930805|NCT04116112|Labetalol|labetalol|mesh-list
111455302|NCT01150409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111455303|NCT01133639|Ketorolac|ketorolac|mesh-list
111455304|NCT01133639|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111455305|NCT01133639|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111455306|NCT01133639|Analgesics|analgesics|mesh-ancestor
111455307|NCT01133639|Sensory System Agents|sensory system agents|mesh-ancestor
111455308|NCT01133639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111455309|NCT01133639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111455310|NCT01133639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111455311|NCT01133639|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111455312|NCT01133639|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111455313|NCT01133639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111455314|NCT01133639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111455315|NCT00378911|Sunitinib|sunitinib|mesh-list
111455316|NCT00378911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111455317|NCT00378911|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111455318|NCT00378911|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111455319|NCT00378911|Growth Substances|growth substances|mesh-ancestor
111455320|NCT00378911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111455321|NCT00378911|Growth Inhibitors|growth inhibitors|mesh-ancestor
111455322|NCT00378911|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111455323|NCT00378911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111455324|NCT00378911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111455325|NCT03822377|Ticagrelor|ticagrelor|mesh-list
111455326|NCT03822377|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111455327|NCT03822377|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111455328|NCT03822377|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111455329|NCT03822377|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111455330|NCT03822377|Purinergic Agents|purinergic agents|mesh-ancestor
111455331|NCT03822377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111455332|NCT03822377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111455333|NCT03822377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111455334|NCT02501759|Pentetic Acid|pentetic acid|mesh-list
111455335|NCT02501759|Antidotes|antidotes|mesh-ancestor
111455336|NCT02501759|Protective Agents|protective agents|mesh-ancestor
111455337|NCT02501759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111455338|NCT02501759|Chelating Agents|chelating agents|mesh-ancestor
111455339|NCT02501759|Sequestering Agents|sequestering agents|mesh-ancestor
111455340|NCT02501759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111455341|NCT02501759|Iron Chelating Agents|iron chelating agents|mesh-ancestor
111455342|NCT02499887|Prednisone|prednisone|mesh-list
111455343|NCT02499887|Albuterol|albuterol|mesh-list
111455344|NCT02499887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111455345|NCT02499887|Glucocorticoids|glucocorticoids|mesh-ancestor
111455346|NCT02499887|Hormones|hormones|mesh-ancestor
111455347|NCT02499887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111455348|NCT02499887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110930910|NCT03062800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111455349|NCT02499887|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111455350|NCT02499887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111455351|NCT02499887|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111455352|NCT02499887|Autonomic Agents|autonomic agents|mesh-ancestor
111455353|NCT02499887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111455354|NCT02499887|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111455355|NCT02499887|Respiratory System Agents|respiratory system agents|mesh-ancestor
111455356|NCT02499887|Tocolytic Agents|tocolytic agents|mesh-ancestor
111455357|NCT02499887|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111455358|NCT02499887|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111455359|NCT02499887|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111455360|NCT02499887|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111455361|NCT02499887|Adrenergic Agents|adrenergic agents|mesh-ancestor
111455362|NCT02499887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111455363|NCT02499887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111455364|NCT02504099|Ritonavir|ritonavir|mesh-list
111455365|NCT02504099|Ribavirin|ribavirin|mesh-list
111455366|NCT02504099|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111455367|NCT02504099|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111455368|NCT02504099|Protease Inhibitors|protease inhibitors|mesh-ancestor
111455369|NCT02504099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110931054|NCT04740580|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111455370|NCT02504099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111455371|NCT02504099|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111455372|NCT02504099|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111455373|NCT02504099|Antiviral Agents|antiviral agents|mesh-ancestor
111455374|NCT02504099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111455375|NCT02504099|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111455376|NCT02504099|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111455377|NCT02504099|Antimetabolites|antimetabolites|mesh-ancestor
111455378|NCT02450591|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111455379|NCT02450591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111455380|NCT02450591|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111455381|NCT02450591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111455382|NCT02450591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111455383|NCT01094561|Secretin|secretin|mesh-list
111455384|NCT01094561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111455385|NCT01094561|Hormones|hormones|mesh-ancestor
111455386|NCT01094561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111455387|NCT01094561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111455388|NCT01074437|Prednisolone|prednisolone|mesh-list
111455389|NCT01074437|Propranolol|propranolol|mesh-list
111455390|NCT01074437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111455391|NCT01074437|Glucocorticoids|glucocorticoids|mesh-ancestor
111455392|NCT01074437|Hormones|hormones|mesh-ancestor
111455393|NCT01074437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111455394|NCT01074437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111455395|NCT01074437|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110959269|NCT00545324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111455396|NCT01074437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111455397|NCT01074437|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111455398|NCT01074437|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111455400|NCT01074437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111455401|NCT01074437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111455402|NCT01074437|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111455403|NCT01074437|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111455404|NCT01074437|Vasodilator Agents|vasodilator agents|mesh-ancestor
111455405|NCT03807245|Aluminum Hydroxide|aluminum hydroxide|mesh-list
111455406|NCT03807245|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111455407|NCT03807245|Immunologic Factors|immunologic factors|mesh-ancestor
111455408|NCT03807245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111455409|NCT03807245|Antacids|antacids|mesh-ancestor
111455410|NCT03807245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111455411|NCT03807245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111455412|NCT03796013|Entrectinib|entrectinib|mesh-list
111455413|NCT03796013|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111455414|NCT03796013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111455415|NCT03796013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111455416|NCT03793751|Dexmedetomidine|dexmedetomidine|mesh-list
111455417|NCT03793751|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111455418|NCT03793751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111455419|NCT03793751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111455420|NCT03793751|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111455421|NCT03793751|Analgesics|analgesics|mesh-ancestor
111455422|NCT03793751|Sensory System Agents|sensory system agents|mesh-ancestor
111455423|NCT03793751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111455424|NCT03793751|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111455425|NCT03793751|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111455426|NCT03793751|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111455427|NCT03793751|Adrenergic Agents|adrenergic agents|mesh-ancestor
111455428|NCT03793751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111455429|NCT03793751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111455430|NCT02351063|Angiotensin II|angiotensin ii|mesh-list
111455431|NCT02351063|Diuretics|diuretics|mesh-list
111455432|NCT02351063|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
111455433|NCT02351063|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
111455434|NCT02351063|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
111455435|NCT02351063|Natriuretic Agents|natriuretic agents|mesh-ancestor
111455436|NCT02351063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111455437|NCT02351063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111455438|NCT02351063|Protease Inhibitors|protease inhibitors|mesh-ancestor
111455439|NCT02351063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111455440|NCT02351063|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111455441|NCT02351063|Hormone Antagonists|hormone antagonists|mesh-ancestor
111455442|NCT02351063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111455443|NCT02351063|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
111455444|NCT01016561|Cisplatin|cisplatin|mesh-list
111455445|NCT01016561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111455446|NCT01009931|Dexamethasone|dexamethasone|mesh-list
111455447|NCT01009931|Dexamethasone acetate|dexamethasone acetate|mesh-list
111455448|NCT01009931|Choline magnesium trisalicylate|choline magnesium trisalicylate|mesh-list
111455449|NCT01009931|Choline|choline|mesh-list
111455450|NCT01009931|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
111455451|NCT01009931|BB 1101|bb 1101|mesh-list
111455452|NCT01009931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111455453|NCT01009931|Antiemetics|antiemetics|mesh-ancestor
111455454|NCT01009931|Autonomic Agents|autonomic agents|mesh-ancestor
111455455|NCT01009931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110931288|NCT02183376|Linagliptin|linagliptin|mesh-list
111455456|NCT01009931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111455457|NCT01009931|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111455458|NCT01009931|Glucocorticoids|glucocorticoids|mesh-ancestor
111455459|NCT01009931|Hormones|hormones|mesh-ancestor
111455460|NCT01009931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111455461|NCT01009931|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111455462|NCT01009931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111455463|NCT01009931|Protease Inhibitors|protease inhibitors|mesh-ancestor
111455464|NCT01009931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111455465|NCT01009931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111455466|NCT01009931|Lipotropic Agents|lipotropic agents|mesh-ancestor
111455467|NCT01009931|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111455468|NCT01009931|Antimetabolites|antimetabolites|mesh-ancestor
111455470|NCT01009931|Nootropic Agents|nootropic agents|mesh-ancestor
111455471|NCT01009931|Analgesics|analgesics|mesh-ancestor
111455472|NCT01009931|Sensory System Agents|sensory system agents|mesh-ancestor
111455473|NCT01009931|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111455474|NCT01009931|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111455475|NCT01009931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111455476|NCT03792191|Fentanyl|fentanyl|mesh-list
111455477|NCT03792191|Bupivacaine|bupivacaine|mesh-list
111455478|NCT03792191|Anesthetics, Local|anesthetics, local|mesh-ancestor
111455479|NCT03792191|Anesthetics|anesthetics|mesh-ancestor
111455480|NCT03792191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111455481|NCT03792191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111455482|NCT03792191|Sensory System Agents|sensory system agents|mesh-ancestor
111455483|NCT03792191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111455484|NCT03792191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111455485|NCT03792191|Narcotics|narcotics|mesh-ancestor
111455486|NCT03792191|Analgesics|analgesics|mesh-ancestor
111455487|NCT03792191|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111455488|NCT03792191|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111455489|NCT03792191|Anesthetics, General|anesthetics, general|mesh-ancestor
111455490|NCT00986999|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111455491|NCT00986999|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111455492|NCT00986999|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111455493|NCT00986999|Antimetabolites|antimetabolites|mesh-ancestor
111455494|NCT00986999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111455495|NCT00986999|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111455496|NCT00986999|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111455497|NCT00986999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111455498|NCT00983645|Cyclosporine|cyclosporine|mesh-list
111455499|NCT00983645|Tacrolimus|tacrolimus|mesh-list
111455500|NCT00983645|Cyclosporins|cyclosporins|mesh-list
111455501|NCT00983645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111455502|NCT00983645|Immunologic Factors|immunologic factors|mesh-ancestor
111455503|NCT00983645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111455504|NCT00983645|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111455505|NCT00983645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111455506|NCT00983645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111455507|NCT00983645|Antifungal Agents|antifungal agents|mesh-ancestor
111455508|NCT00983645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111455509|NCT00983645|Dermatologic Agents|dermatologic agents|mesh-ancestor
111455510|NCT00983645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111455511|NCT00978419|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111455512|NCT00978419|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111455513|NCT00978419|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111455514|NCT00978419|Antimetabolites|antimetabolites|mesh-ancestor
111455515|NCT00978419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111455516|NCT00978419|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111455517|NCT00978419|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111455518|NCT00978419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111455519|NCT00957827|Cephalexin|cephalexin|mesh-list
111455520|NCT00957827|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111455521|NCT00957827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111455522|NCT00962429|Thioctic Acid|thioctic acid|mesh-list
111455523|NCT00962429|Antioxidants|antioxidants|mesh-ancestor
111455524|NCT00962429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111455525|NCT00962429|Protective Agents|protective agents|mesh-ancestor
111455526|NCT00962429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111455527|NCT00962429|Vitamin B Complex|vitamin b complex|mesh-ancestor
111455528|NCT00962429|Vitamins|vitamins|mesh-ancestor
111455529|NCT00962429|Micronutrients|micronutrients|mesh-ancestor
111455530|NCT00949403|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
111455531|NCT00949403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111455532|NCT00920309|Sirolimus|sirolimus|mesh-list
111455533|NCT00920309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111455534|NCT00920309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111455535|NCT00920309|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111455536|NCT00920309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111455537|NCT00920309|Antifungal Agents|antifungal agents|mesh-ancestor
111455538|NCT00920309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111455539|NCT00920309|Immunologic Factors|immunologic factors|mesh-ancestor
111455540|NCT00920309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111455541|NCT02075411|Bupivacaine|bupivacaine|mesh-list
111455542|NCT02075411|Anesthetics, Local|anesthetics, local|mesh-ancestor
111455543|NCT02075411|Anesthetics|anesthetics|mesh-ancestor
111455544|NCT02075411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111455545|NCT02075411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111455547|NCT02075411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111455548|NCT03753113|Minoxidil|minoxidil|mesh-list
111455549|NCT03753113|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111455550|NCT03753113|Vasodilator Agents|vasodilator agents|mesh-ancestor
111455551|NCT02075021|Paclitaxel|paclitaxel|mesh-list
111455552|NCT02075021|Lenalidomide|lenalidomide|mesh-list
111455553|NCT02075021|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111455554|NCT02075021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111455555|NCT02075021|Tubulin Modulators|tubulin modulators|mesh-ancestor
111455556|NCT02075021|Antimitotic Agents|antimitotic agents|mesh-ancestor
111455557|NCT02075021|Mitosis Modulators|mitosis modulators|mesh-ancestor
111455558|NCT02075021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111455559|NCT02075021|Immunologic Factors|immunologic factors|mesh-ancestor
111455560|NCT02075021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111455561|NCT02075021|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111455562|NCT02075021|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111455563|NCT02075021|Growth Substances|growth substances|mesh-ancestor
111455564|NCT02075021|Growth Inhibitors|growth inhibitors|mesh-ancestor
111455565|NCT02057237|Mitotane|mitotane|mesh-list
111455566|NCT02057237|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111455567|NCT02057237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111455568|NCT00378677|Cyclosporine|cyclosporine|mesh-list
111455569|NCT00378677|Cyclosporins|cyclosporins|mesh-list
111455570|NCT00378677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111455571|NCT00378677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111455572|NCT00378677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111455573|NCT00378677|Immunologic Factors|immunologic factors|mesh-ancestor
111455574|NCT00378677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111455575|NCT00378677|Antifungal Agents|antifungal agents|mesh-ancestor
111455576|NCT00378677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111455577|NCT00378677|Dermatologic Agents|dermatologic agents|mesh-ancestor
111455578|NCT00378677|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111455579|NCT00378677|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111455580|NCT00850421|Botulinum Toxins|botulinum toxins|mesh-list
111455581|NCT00850421|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111455582|NCT00850421|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111455583|NCT00850421|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111455584|NCT00850421|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111455585|NCT00850421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111455586|NCT00850421|Cholinergic Agents|cholinergic agents|mesh-ancestor
111455587|NCT00850421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111455588|NCT00850421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111455589|NCT00850421|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111455590|NCT00850421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111455591|NCT02017379|Erythromycin|erythromycin|mesh-list
111455592|NCT02017379|Erythromycin Estolate|erythromycin estolate|mesh-list
111455593|NCT02017379|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
111455594|NCT02017379|Erythromycin stearate|erythromycin stearate|mesh-list
111455595|NCT02017379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111455596|NCT02017379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111455597|NCT02017379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111455598|NCT02017379|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111455599|NCT02017379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111455600|NCT02017379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111455601|NCT01997567|Ropivacaine|ropivacaine|mesh-list
111455602|NCT01997567|Anesthetics, Local|anesthetics, local|mesh-ancestor
111455603|NCT01997567|Anesthetics|anesthetics|mesh-ancestor
111455604|NCT01997567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111455605|NCT01997567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111455606|NCT01997567|Sensory System Agents|sensory system agents|mesh-ancestor
111455607|NCT01997567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111455608|NCT00825227|Modafinil|modafinil|mesh-list
111455609|NCT00825227|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111455610|NCT00825227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111455611|NCT00825227|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
111455612|NCT00825227|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111455613|NCT00825227|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111455614|NCT00825227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111455615|NCT01978535|Iron|iron|mesh-list
111455616|NCT01978535|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
111455617|NCT01978535|Trace Elements|trace elements|mesh-ancestor
111455618|NCT01978535|Micronutrients|micronutrients|mesh-ancestor
111455619|NCT01978535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111455620|NCT01978535|Hematinics|hematinics|mesh-ancestor
111455622|NCT00808769|Omeprazole, sodium bicarbonate drug combination|omeprazole, sodium bicarbonate drug combination|mesh-list
111455623|NCT00808769|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111455624|NCT00808769|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111455625|NCT00808769|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111455626|NCT00808769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111455627|NCT00808769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111455628|NCT00379067|Tamsulosin|tamsulosin|mesh-list
111455629|NCT00379067|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111455630|NCT00379067|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111455631|NCT00379067|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111455632|NCT00379067|Adrenergic Agents|adrenergic agents|mesh-ancestor
111455633|NCT00379067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111455634|NCT00379067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111455635|NCT00379067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111455636|NCT00379067|Urological Agents|urological agents|mesh-ancestor
111455637|NCT00378287|Rabeprazole|rabeprazole|mesh-list
111455638|NCT00378287|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111455639|NCT00378287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111455640|NCT00378287|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111455641|NCT00378287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111455642|NCT00378287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111455643|NCT01938833|Paclitaxel|paclitaxel|mesh-list
111455644|NCT01938833|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111455645|NCT01938833|Romidepsin|romidepsin|mesh-list
111455646|NCT01938833|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110931983|NCT03125902|Paclitaxel|paclitaxel|mesh-list
111455647|NCT01938833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111455648|NCT01938833|Tubulin Modulators|tubulin modulators|mesh-ancestor
111455649|NCT01938833|Antimitotic Agents|antimitotic agents|mesh-ancestor
111455650|NCT01938833|Mitosis Modulators|mitosis modulators|mesh-ancestor
111455651|NCT01938833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111455652|NCT01938833|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111455653|NCT01938833|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111455654|NCT01938833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111455655|NCT01893359|Riboflavin|riboflavin|mesh-list
111455656|NCT01893359|Dextrans|dextrans|mesh-list
111455657|NCT01893359|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111455658|NCT01893359|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111455659|NCT01893359|Vitamin B Complex|vitamin b complex|mesh-ancestor
111455660|NCT01893359|Vitamins|vitamins|mesh-ancestor
111455661|NCT01893359|Micronutrients|micronutrients|mesh-ancestor
111455662|NCT01893359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111455663|NCT01893359|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111455664|NCT01893359|Dermatologic Agents|dermatologic agents|mesh-ancestor
111455665|NCT01893359|Anticoagulants|anticoagulants|mesh-ancestor
111455666|NCT01893359|Plasma Substitutes|plasma substitutes|mesh-ancestor
111455667|NCT01893359|Blood Substitutes|blood substitutes|mesh-ancestor
111455668|NCT00795665|Bevacizumab|bevacizumab|mesh-list
111455669|NCT00795665|Carmustine|carmustine|mesh-list
111455670|NCT00795665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111455671|NCT00795665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111455672|NCT00795665|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111455673|NCT00795665|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111455674|NCT00795665|Growth Substances|growth substances|mesh-ancestor
111455675|NCT00795665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111455676|NCT00795665|Growth Inhibitors|growth inhibitors|mesh-ancestor
111455677|NCT00795665|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111455678|NCT00795665|Alkylating Agents|alkylating agents|mesh-ancestor
111455679|NCT00795665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111455680|NCT00791843|Hormones|hormones|mesh-list
111455681|NCT00791843|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
111455682|NCT00791843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111455683|NCT00791843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111455684|NCT01836809|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
111455685|NCT01836809|Natriuretic Agents|natriuretic agents|mesh-ancestor
111455686|NCT01836809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111455687|NCT00780455|Interferons|interferons|mesh-list
110932151|NCT02194764|Naltrexone|naltrexone|mesh-list
111455688|NCT00780455|Interferon-beta|interferon-beta|mesh-list
111455689|NCT00780455|Interferon beta-1b|interferon beta-1b|mesh-list
111455690|NCT00780455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111455691|NCT00780455|Antiviral Agents|antiviral agents|mesh-ancestor
111455692|NCT00780455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111179864|NCT01687101|Antipruritics|antipruritics|mesh-ancestor
111455693|NCT00780455|Immunologic Factors|immunologic factors|mesh-ancestor
111455694|NCT00780455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111455695|NCT00780455|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111455696|NCT00755261|Bevacizumab|bevacizumab|mesh-list
111455697|NCT00755261|Doxorubicin|doxorubicin|mesh-list
111455698|NCT00755261|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111455699|NCT00755261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111455700|NCT00755261|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110932199|NCT02194218|Antiviral Agents|antiviral agents|mesh-ancestor
111455701|NCT00755261|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111455702|NCT00755261|Growth Substances|growth substances|mesh-ancestor
111455703|NCT00755261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111455704|NCT00755261|Growth Inhibitors|growth inhibitors|mesh-ancestor
111455705|NCT00755261|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111455706|NCT00755261|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111455707|NCT00755261|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111455708|NCT00755261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111455709|NCT00755261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111455710|NCT03724877|Cholinergic Agents|cholinergic agents|mesh-list
111455711|NCT03724877|Muscarinic Antagonists|muscarinic antagonists|mesh-list
111455712|NCT03724877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111455713|NCT03724877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111455714|NCT03724877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111455715|NCT03724877|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111455716|NCT00746603|Simvastatin|simvastatin|mesh-list
111455717|NCT00746603|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111455718|NCT00746603|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111455719|NCT00746603|Antimetabolites|antimetabolites|mesh-ancestor
111455720|NCT00746603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111455721|NCT00746603|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111455722|NCT00746603|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111455723|NCT00746603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111455724|NCT04713527|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111455725|NCT04713527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111455726|NCT00716807|Nalbuphine|nalbuphine|mesh-list
111455727|NCT00716807|Naloxone|naloxone|mesh-list
111455728|NCT00716807|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111455729|NCT00716807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111455730|NCT00716807|Sensory System Agents|sensory system agents|mesh-ancestor
111455731|NCT00716807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111455732|NCT00716807|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111455733|NCT00716807|Narcotics|narcotics|mesh-ancestor
111455734|NCT00716807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111455735|NCT00716807|Analgesics|analgesics|mesh-ancestor
111455736|NCT03426137|Ketorolac|ketorolac|mesh-list
111455737|NCT03426137|Oxycodone|oxycodone|mesh-list
111455738|NCT03426137|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111455739|NCT03426137|Narcotics|narcotics|mesh-ancestor
111455740|NCT03426137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111455741|NCT03426137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111455742|NCT03426137|Analgesics|analgesics|mesh-ancestor
111455743|NCT03426137|Sensory System Agents|sensory system agents|mesh-ancestor
111455744|NCT03426137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111455745|NCT03426137|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111455746|NCT03426137|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111455747|NCT03426137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111455748|NCT03426137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111455749|NCT03426137|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111455750|NCT03426137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111455751|NCT03426137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111455752|NCT01760993|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
111455753|NCT01760993|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111455754|NCT01760993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111455755|NCT01760993|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111455756|NCT01760993|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111455757|NCT01760993|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111455758|NCT01760993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111455759|NCT01760993|Dopamine Agents|dopamine agents|mesh-ancestor
111455760|NCT01760993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111455761|NCT00669461|Lubiprostone|lubiprostone|mesh-list
111455762|NCT00669461|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
111455763|NCT00669461|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111455764|NCT00669461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110959270|NCT00545324|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111455766|NCT00673595|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111455767|NCT00673595|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111455768|NCT00673595|Cholinergic Agents|cholinergic agents|mesh-ancestor
111455769|NCT00673595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111455770|NCT00673595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111455771|NCT00673595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111455772|NCT03248141|Factor VIII|factor viii|mesh-list
111455773|NCT03248141|Coagulants|coagulants|mesh-ancestor
111455774|NCT00378365|Arsenic Trioxide|arsenic trioxide|mesh-list
111455775|NCT00378365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111455776|NCT05313425|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111455777|NCT05313425|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111455778|NCT01754987|Ascorbic Acid|ascorbic acid|mesh-list
111455779|NCT01754987|Sorafenib|sorafenib|mesh-list
111455780|NCT01754987|Vitamins|vitamins|mesh-ancestor
111455781|NCT01754987|Micronutrients|micronutrients|mesh-ancestor
111455782|NCT01754987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111455783|NCT01754987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111455784|NCT01754987|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111455785|NCT01754987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111455786|NCT01754987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111455787|NCT01754987|Antioxidants|antioxidants|mesh-ancestor
111455788|NCT01754987|Protective Agents|protective agents|mesh-ancestor
111455789|NCT00652457|Memantine|memantine|mesh-list
111455790|NCT00652457|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111455791|NCT00652457|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111455792|NCT00652457|Dopamine Agents|dopamine agents|mesh-ancestor
111455793|NCT00652457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111455794|NCT00652457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111455795|NCT00652457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111455796|NCT00652457|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110932380|NCT03687463|Decitabine|decitabine|mesh-list
111455797|NCT00652457|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111455798|NCT00625703|Linezolid|linezolid|mesh-list
111455799|NCT00625703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111455800|NCT00625703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111455801|NCT00625703|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111455802|NCT00625703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111455803|NCT00625703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111455804|NCT00616577|Ropivacaine|ropivacaine|mesh-list
111455805|NCT00616577|Anesthetics, Local|anesthetics, local|mesh-ancestor
111455806|NCT00616577|Anesthetics|anesthetics|mesh-ancestor
111455807|NCT00616577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111455808|NCT00616577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111455809|NCT00616577|Sensory System Agents|sensory system agents|mesh-ancestor
111455810|NCT00616577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111455811|NCT00616343|Zonisamide|zonisamide|mesh-list
111455812|NCT00616343|Anticonvulsants|anticonvulsants|mesh-ancestor
111455813|NCT00616343|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111455814|NCT00616343|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111455815|NCT00616343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111455816|NCT00616343|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111455817|NCT00616343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111455818|NCT05599919|Nitric Oxide|nitric oxide|mesh-list
111455819|NCT05599919|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111455820|NCT05599919|Autonomic Agents|autonomic agents|mesh-ancestor
111455821|NCT05599919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111455822|NCT05599919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111455823|NCT05599919|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111455824|NCT05599919|Respiratory System Agents|respiratory system agents|mesh-ancestor
111455825|NCT05599919|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111455826|NCT05599919|Antioxidants|antioxidants|mesh-ancestor
111455827|NCT05599919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111455828|NCT05599919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111455829|NCT05599919|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
111455830|NCT05599919|Vasodilator Agents|vasodilator agents|mesh-ancestor
111455831|NCT05599919|Gasotransmitters|gasotransmitters|mesh-ancestor
111455832|NCT05599919|Protective Agents|protective agents|mesh-ancestor
111455833|NCT01645709|Verapamil|verapamil|mesh-list
111455834|NCT01645709|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111455835|NCT01645709|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111455836|NCT01645709|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111455837|NCT01645709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111455838|NCT01645709|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111455839|NCT01645709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111455840|NCT01645709|Vasodilator Agents|vasodilator agents|mesh-ancestor
111455841|NCT00608465|Ramipril|ramipril|mesh-list
111455842|NCT00608465|Eplerenone|eplerenone|mesh-list
111455843|NCT00608465|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
111455844|NCT00608465|Protease Inhibitors|protease inhibitors|mesh-ancestor
110932422|NCT03969121|Palbociclib|palbociclib|mesh-list
111455845|NCT00608465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111455846|NCT00608465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111455847|NCT00608465|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111455848|NCT00608465|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
111455849|NCT00608465|Hormone Antagonists|hormone antagonists|mesh-ancestor
111455850|NCT00608465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111455851|NCT00608465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111455852|NCT00608465|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
111455853|NCT00608465|Diuretics|diuretics|mesh-ancestor
111455854|NCT00608465|Natriuretic Agents|natriuretic agents|mesh-ancestor
111455855|NCT00608777|Betamethasone|betamethasone|mesh-list
111455856|NCT00608777|Calcipotriene|calcipotriene|mesh-list
111455857|NCT00608777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111455858|NCT00608777|Glucocorticoids|glucocorticoids|mesh-ancestor
111455859|NCT00608777|Hormones|hormones|mesh-ancestor
111455860|NCT00608777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111455861|NCT00608777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111455862|NCT00608777|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111455863|NCT00608777|Respiratory System Agents|respiratory system agents|mesh-ancestor
111455864|NCT00608777|Dermatologic Agents|dermatologic agents|mesh-ancestor
111455865|NCT00379457|Dactinomycin|dactinomycin|mesh-list
111455866|NCT00379457|Cyclophosphamide|cyclophosphamide|mesh-list
111455867|NCT00379457|Ifosfamide|ifosfamide|mesh-list
111455868|NCT00379457|Carboplatin|carboplatin|mesh-list
111455869|NCT00379457|Doxorubicin|doxorubicin|mesh-list
111455870|NCT00379457|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111455871|NCT00379457|Etoposide|etoposide|mesh-list
111455872|NCT00379457|Vincristine|vincristine|mesh-list
111455873|NCT00379457|Topotecan|topotecan|mesh-list
111455874|NCT00379457|Vinorelbine|vinorelbine|mesh-list
111455875|NCT00379457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111455876|NCT00379457|Immunologic Factors|immunologic factors|mesh-ancestor
111455877|NCT00379457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111455878|NCT00379457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111455879|NCT00379457|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111455880|NCT00379457|Alkylating Agents|alkylating agents|mesh-ancestor
111455881|NCT00379457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111455882|NCT00379457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111455883|NCT00379457|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111455884|NCT00379457|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111455885|NCT00379457|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111455886|NCT00379457|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111455887|NCT00379457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111455888|NCT00379457|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111455889|NCT00379457|Tubulin Modulators|tubulin modulators|mesh-ancestor
111455890|NCT00379457|Antimitotic Agents|antimitotic agents|mesh-ancestor
111455891|NCT00379457|Mitosis Modulators|mitosis modulators|mesh-ancestor
110932463|NCT02201316|Serotonin Agents|serotonin agents|mesh-ancestor
111455892|NCT00379457|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111455893|NCT00379457|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111455894|NCT00379457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111455895|NCT00379457|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111455896|NCT00379457|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111455897|NCT01629329|Aspirin|aspirin|mesh-list
111455898|NCT01629329|Acetaminophen|acetaminophen|mesh-list
111455899|NCT01629329|Prochlorperazine|prochlorperazine|mesh-list
111455900|NCT01629329|Caffeine|caffeine|mesh-list
111455901|NCT01629329|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111455902|NCT01629329|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111455903|NCT01629329|Analgesics|analgesics|mesh-ancestor
111455904|NCT01629329|Sensory System Agents|sensory system agents|mesh-ancestor
111455905|NCT01629329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111455906|NCT01629329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111455907|NCT01629329|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111455908|NCT01629329|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111455909|NCT01629329|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111455910|NCT01629329|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111455911|NCT01629329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111455912|NCT01629329|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111455913|NCT01629329|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111455914|NCT01629329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111455915|NCT01629329|Antipyretics|antipyretics|mesh-ancestor
111455916|NCT01629329|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111455917|NCT01629329|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111455918|NCT01629329|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
111455919|NCT01629329|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111455920|NCT01629329|Purinergic Agents|purinergic agents|mesh-ancestor
111455921|NCT01629329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111455922|NCT01629329|Antiemetics|antiemetics|mesh-ancestor
111455923|NCT01629329|Autonomic Agents|autonomic agents|mesh-ancestor
111455924|NCT01629329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111455925|NCT01629329|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111455926|NCT01629329|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111455927|NCT01629329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111455928|NCT01629329|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111455929|NCT01629329|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111455930|NCT01629329|Dopamine Agents|dopamine agents|mesh-ancestor
111455931|NCT01606709|Leuprolide|leuprolide|mesh-list
111455932|NCT01606709|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111455933|NCT01606709|Fertility Agents|fertility agents|mesh-ancestor
111455934|NCT01606709|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111455935|NCT01606709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111455936|NCT01606709|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111455937|NCT01606709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111455938|NCT00423059|Bevacizumab|bevacizumab|mesh-list
111455939|NCT00423059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111455940|NCT00423059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111455941|NCT00423059|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111455942|NCT00423059|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110932527|NCT02198352|Olcegepant|olcegepant|mesh-list
111455943|NCT00423059|Growth Substances|growth substances|mesh-ancestor
111455944|NCT00423059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111455945|NCT00423059|Growth Inhibitors|growth inhibitors|mesh-ancestor
111455946|NCT00585611|Atorvastatin|atorvastatin|mesh-list
111455947|NCT00585611|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111455948|NCT00585611|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111455949|NCT00585611|Antimetabolites|antimetabolites|mesh-ancestor
111455950|NCT00585611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111455951|NCT00585611|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111455952|NCT00585611|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111455953|NCT00585611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111455954|NCT00379691|Phenylephrine|phenylephrine|mesh-list
111455955|NCT00379691|Oxymetazoline|oxymetazoline|mesh-list
111455956|NCT00379691|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111455957|NCT00379691|Mydriatics|mydriatics|mesh-ancestor
111455958|NCT00379691|Autonomic Agents|autonomic agents|mesh-ancestor
111455959|NCT00379691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111455960|NCT00379691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111455961|NCT00379691|Sympathomimetics|sympathomimetics|mesh-ancestor
111455962|NCT00379691|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111455963|NCT00379691|Nasal Decongestants|nasal decongestants|mesh-ancestor
110934178|NCT05214287|Nitrox|nitrox|mesh-list
111455964|NCT00379691|Respiratory System Agents|respiratory system agents|mesh-ancestor
111455965|NCT00379691|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111455966|NCT00379691|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111455967|NCT00379691|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111455968|NCT00379691|Adrenergic Agents|adrenergic agents|mesh-ancestor
111455969|NCT00379691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111455970|NCT00379691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111455971|NCT00379691|Protective Agents|protective agents|mesh-ancestor
111455972|NCT01685333|Epoetin Alfa|epoetin alfa|mesh-list
111455973|NCT01685333|Hematinics|hematinics|mesh-ancestor
111455974|NCT01556009|Aminolevulinic Acid|aminolevulinic acid|mesh-list
111455975|NCT01556009|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111455976|NCT01556009|Dermatologic Agents|dermatologic agents|mesh-ancestor
111455977|NCT00546455|Fenretinide|fenretinide|mesh-list
111455978|NCT00546455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111455979|NCT00546455|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
111455980|NCT00546455|Protective Agents|protective agents|mesh-ancestor
111455981|NCT00546455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111455982|NCT00000737|Megestrol|megestrol|mesh-list
111455983|NCT00000737|Megestrol Acetate|megestrol acetate|mesh-list
111455984|NCT00000737|Dronabinol|dronabinol|mesh-list
111455985|NCT00000737|Hallucinogens|hallucinogens|mesh-ancestor
111455986|NCT00000737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111455987|NCT00000737|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111455988|NCT00000737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111455989|NCT00000737|Analgesics|analgesics|mesh-ancestor
111455990|NCT00000737|Sensory System Agents|sensory system agents|mesh-ancestor
111455991|NCT00000737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111455992|NCT00000737|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
111455993|NCT00000737|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
111455994|NCT00000737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111455995|NCT00000737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111455996|NCT00000737|Hormones|hormones|mesh-ancestor
111455997|NCT00000737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111455998|NCT00000737|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111455999|NCT00000737|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111456000|NCT00000737|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111456001|NCT00000737|Contraceptive Agents|contraceptive agents|mesh-ancestor
110932575|NCT04059679|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111456002|NCT00000737|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111456003|NCT00000737|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111456004|NCT00000737|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111456005|NCT00000737|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111456006|NCT00000737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111456007|NCT00000737|Appetite Stimulants|appetite stimulants|mesh-ancestor
111456008|NCT00000737|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111456009|NCT00528437|Carboplatin|carboplatin|mesh-list
111456010|NCT00528437|Temozolomide|temozolomide|mesh-list
111456011|NCT00528437|Thiotepa|thiotepa|mesh-list
111456012|NCT00528437|Tretinoin|tretinoin|mesh-list
111456013|NCT00528437|Isotretinoin|isotretinoin|mesh-list
111456014|NCT00528437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111456015|NCT00528437|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111456016|NCT00528437|Alkylating Agents|alkylating agents|mesh-ancestor
111456017|NCT00528437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111456018|NCT00528437|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111456019|NCT00528437|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111456020|NCT00528437|Immunologic Factors|immunologic factors|mesh-ancestor
111456021|NCT00528437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111456022|NCT00528437|Keratolytic Agents|keratolytic agents|mesh-ancestor
111456023|NCT00528437|Dermatologic Agents|dermatologic agents|mesh-ancestor
111456024|NCT00000743|Zidovudine|zidovudine|mesh-list
111456025|NCT00000743|Antimetabolites|antimetabolites|mesh-ancestor
111456026|NCT00000743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111456027|NCT00000743|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111456028|NCT00000743|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111456029|NCT00000743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111456030|NCT00000743|Antiviral Agents|antiviral agents|mesh-ancestor
111456031|NCT00000743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111456032|NCT00000743|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111456033|NCT00000743|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111456034|NCT00506909|Oxytocin|oxytocin|mesh-list
111456035|NCT00506909|Oxytocics|oxytocics|mesh-ancestor
111456036|NCT00506909|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111456037|NCT00506909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111456039|NCT00500045|Nicotinic Acids|nicotinic acids|mesh-list
111456040|NCT00500045|Niacinamide|niacinamide|mesh-list
111456041|NCT00500045|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111456042|NCT00500045|Antimetabolites|antimetabolites|mesh-ancestor
111456043|NCT00500045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111456044|NCT00500045|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111456045|NCT00500045|Vasodilator Agents|vasodilator agents|mesh-ancestor
111456046|NCT00500045|Vitamin B Complex|vitamin b complex|mesh-ancestor
111456047|NCT00500045|Vitamins|vitamins|mesh-ancestor
111456048|NCT00500045|Micronutrients|micronutrients|mesh-ancestor
111456049|NCT00500045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111456050|NCT00000767|Vaccines|vaccines|mesh-list
111456051|NCT00000767|Immunologic Factors|immunologic factors|mesh-ancestor
111456052|NCT00000767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111456053|NCT05383547|Bortezomib|bortezomib|mesh-list
111456054|NCT05383547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111456055|NCT00456989|Docetaxel|docetaxel|mesh-list
111456056|NCT00456989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111456057|NCT00456989|Tubulin Modulators|tubulin modulators|mesh-ancestor
111456058|NCT00456989|Antimitotic Agents|antimitotic agents|mesh-ancestor
111456059|NCT00456989|Mitosis Modulators|mitosis modulators|mesh-ancestor
111456060|NCT00456989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111456061|NCT00000773|Atovaquone|atovaquone|mesh-list
111456062|NCT00000773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111456063|NCT00000773|Antimalarials|antimalarials|mesh-ancestor
111456064|NCT00000773|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111456065|NCT00000773|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111456066|NCT00000773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111456067|NCT00000773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111456069|NCT00428207|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111456070|NCT00428207|Insulin Aspart|insulin aspart|mesh-list
111456071|NCT00428207|Insulin, Long-Acting|insulin, long-acting|mesh-list
111456072|NCT00428207|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
111456073|NCT00428207|Insulin Lispro|insulin lispro|mesh-list
111456074|NCT00428207|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111456075|NCT00428207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111456076|NCT00000791|Zidovudine|zidovudine|mesh-list
111456077|NCT00000791|Antimetabolites|antimetabolites|mesh-ancestor
111456078|NCT00000791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111456079|NCT00000791|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111456080|NCT00000791|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111456081|NCT00000791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111456082|NCT00000791|Antiviral Agents|antiviral agents|mesh-ancestor
111456083|NCT00000791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111456084|NCT00000791|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111456085|NCT00000791|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111456086|NCT00379847|Conivaptan|conivaptan|mesh-list
111456087|NCT00379847|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
111456088|NCT00379847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111456089|NCT00379847|Natriuretic Agents|natriuretic agents|mesh-ancestor
111456090|NCT00379847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111456091|NCT00374543|Ziprasidone|ziprasidone|mesh-list
111456092|NCT00374543|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111456093|NCT00374543|Serotonin Agents|serotonin agents|mesh-ancestor
111456094|NCT00374543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110932664|NCT02203500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111456095|NCT00374543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111456096|NCT00374543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111456097|NCT00374543|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111456098|NCT00374543|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111456099|NCT00374543|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111456100|NCT00374543|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111456101|NCT00374543|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111456102|NCT00374543|Dopamine Agents|dopamine agents|mesh-ancestor
111456103|NCT00000803|Zidovudine|zidovudine|mesh-list
111456104|NCT00000803|Didanosine|didanosine|mesh-list
111456105|NCT00000803|Delavirdine|delavirdine|mesh-list
111456106|NCT00000803|Antimetabolites|antimetabolites|mesh-ancestor
111456107|NCT00000803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111456108|NCT00000803|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111456109|NCT00000803|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111456110|NCT00000803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111456111|NCT00000803|Antiviral Agents|antiviral agents|mesh-ancestor
111456112|NCT00000803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111456113|NCT00000803|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111456114|NCT00000803|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111456115|NCT00299195|Sulindac|sulindac|mesh-list
111456116|NCT00299195|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111456117|NCT00299195|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111456118|NCT00299195|Analgesics|analgesics|mesh-ancestor
111456119|NCT00299195|Sensory System Agents|sensory system agents|mesh-ancestor
111456120|NCT00299195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110932694|NCT02199522|Anesthetics|anesthetics|mesh-ancestor
111456121|NCT00299195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111456122|NCT00299195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111456123|NCT00299195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111456124|NCT00299195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111456125|NCT00299195|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111456126|NCT00299195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111456127|NCT00299195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111456128|NCT01351415|Bevacizumab|bevacizumab|mesh-list
111456129|NCT01351415|Docetaxel|docetaxel|mesh-list
111456130|NCT01351415|Pemetrexed|pemetrexed|mesh-list
111456131|NCT01351415|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111456132|NCT01351415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111456133|NCT01351415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111456134|NCT01351415|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111456135|NCT01351415|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111456136|NCT01351415|Growth Substances|growth substances|mesh-ancestor
110932703|NCT03532698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111456137|NCT01351415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111456138|NCT01351415|Growth Inhibitors|growth inhibitors|mesh-ancestor
111456139|NCT01351415|Tubulin Modulators|tubulin modulators|mesh-ancestor
111456140|NCT01351415|Antimitotic Agents|antimitotic agents|mesh-ancestor
111456141|NCT01351415|Mitosis Modulators|mitosis modulators|mesh-ancestor
111180318|NCT05839366|Remifentanil|remifentanil|mesh-list
111456142|NCT01351415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111456143|NCT01351415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111456144|NCT01351415|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111456145|NCT01351415|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111456146|NCT01351415|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111456148|NCT00281879|Cyclosporine|cyclosporine|mesh-list
111456149|NCT00281879|Mycophenolic Acid|mycophenolic acid|mesh-list
111456150|NCT00281879|Methylprednisolone|methylprednisolone|mesh-list
111456151|NCT00281879|Cyclophosphamide|cyclophosphamide|mesh-list
111456152|NCT00281879|Melphalan|melphalan|mesh-list
111456153|NCT00281879|Busulfan|busulfan|mesh-list
111456154|NCT00281879|Carmustine|carmustine|mesh-list
111456155|NCT00281879|Methotrexate|methotrexate|mesh-list
111456156|NCT00281879|Fludarabine|fludarabine|mesh-list
111456157|NCT00281879|Fludarabine phosphate|fludarabine phosphate|mesh-list
111456158|NCT00281879|Etoposide|etoposide|mesh-list
111456159|NCT00281879|Tacrolimus|tacrolimus|mesh-list
111456160|NCT00281879|Cyclosporins|cyclosporins|mesh-list
111456161|NCT00281879|Antilymphocyte Serum|antilymphocyte serum|mesh-list
111456162|NCT00281879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111456163|NCT00281879|Immunologic Factors|immunologic factors|mesh-ancestor
111456164|NCT00281879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111456165|NCT00281879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111456166|NCT00281879|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111456167|NCT00281879|Alkylating Agents|alkylating agents|mesh-ancestor
111456168|NCT00281879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111456169|NCT00281879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111456170|NCT00281879|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111456171|NCT00281879|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111456172|NCT00281879|Abortifacient Agents|abortifacient agents|mesh-ancestor
111456173|NCT00281879|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111456174|NCT00281879|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111456175|NCT00281879|Antimetabolites|antimetabolites|mesh-ancestor
111456176|NCT00281879|Dermatologic Agents|dermatologic agents|mesh-ancestor
111456177|NCT00281879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111456178|NCT00281879|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111456179|NCT00281879|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111456180|NCT00281879|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111456181|NCT00281879|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111456182|NCT00281879|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111456183|NCT00281879|Antiviral Agents|antiviral agents|mesh-ancestor
111456184|NCT00281879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111456185|NCT00281879|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110932760|NCT03690583|Zinc|zinc|mesh-list
111456186|NCT00281879|Antifungal Agents|antifungal agents|mesh-ancestor
111456187|NCT00281879|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111456188|NCT00281879|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111456189|NCT00281879|Antitubercular Agents|antitubercular agents|mesh-ancestor
111456190|NCT00281879|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111456191|NCT00281879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111456192|NCT00281879|Antiemetics|antiemetics|mesh-ancestor
111456193|NCT00281879|Autonomic Agents|autonomic agents|mesh-ancestor
111456194|NCT00281879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111456195|NCT00281879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111456196|NCT00281879|Glucocorticoids|glucocorticoids|mesh-ancestor
111456197|NCT00281879|Hormones|hormones|mesh-ancestor
111456198|NCT00281879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111456199|NCT00281879|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111456200|NCT00281879|Protective Agents|protective agents|mesh-ancestor
111456201|NCT00000809|Aluminum Hydroxide|aluminum hydroxide|mesh-list
111456202|NCT00000809|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111456203|NCT00000809|Immunologic Factors|immunologic factors|mesh-ancestor
111456204|NCT00000809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111456205|NCT00000809|Antacids|antacids|mesh-ancestor
111456206|NCT00000809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111456207|NCT00000809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111456208|NCT05091203|Vitamin D|vitamin d|mesh-list
111456209|NCT05091203|Vitamins|vitamins|mesh-ancestor
111456210|NCT05091203|Micronutrients|micronutrients|mesh-ancestor
111456211|NCT05091203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111456212|NCT05091203|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111456213|NCT00240227|Prazosin|prazosin|mesh-list
111456214|NCT00240227|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111456215|NCT00240227|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111456216|NCT00240227|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111180392|NCT05497804|Antiemetics|antiemetics|mesh-ancestor
111456217|NCT00240227|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111456218|NCT00240227|Adrenergic Agents|adrenergic agents|mesh-ancestor
111456219|NCT00240227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111456220|NCT00240227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111456221|NCT00240227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111456223|NCT00205049|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111456224|NCT00205049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111456225|NCT00205049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111456226|NCT00205049|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111456227|NCT00205049|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110932791|NCT02200146|Hormones|hormones|mesh-ancestor
111456228|NCT00205049|Protective Agents|protective agents|mesh-ancestor
111456229|NCT00205049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111456230|NCT00205049|Vasodilator Agents|vasodilator agents|mesh-ancestor
111456231|NCT00205049|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111456232|NCT00205049|Antioxidants|antioxidants|mesh-ancestor
111456233|NCT00000833|Ribavirin|ribavirin|mesh-list
111456234|NCT00000833|Didanosine|didanosine|mesh-list
111456235|NCT00000833|Antimetabolites|antimetabolites|mesh-ancestor
111456236|NCT00000833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111456237|NCT00000833|Antiviral Agents|antiviral agents|mesh-ancestor
111456238|NCT00000833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111456239|NCT00000833|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111456240|NCT00000833|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111456241|NCT00000833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111456242|NCT00000833|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111456243|NCT00000833|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111456244|NCT00000839|Didanosine|didanosine|mesh-list
111456245|NCT00000839|Antimetabolites|antimetabolites|mesh-ancestor
111456246|NCT00000839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111456247|NCT00000839|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111456248|NCT00000839|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111456249|NCT00000839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111456250|NCT00000839|Antiviral Agents|antiviral agents|mesh-ancestor
111456251|NCT00000839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111456252|NCT00000839|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111456253|NCT00000839|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111456254|NCT00133679|Sildenafil Citrate|sildenafil citrate|mesh-list
111456255|NCT00133679|Vasodilator Agents|vasodilator agents|mesh-ancestor
111456256|NCT00133679|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111456257|NCT00133679|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111456258|NCT00133679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111456259|NCT00133679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111456260|NCT00133679|Urological Agents|urological agents|mesh-ancestor
111456261|NCT00000875|Acetaminophen|acetaminophen|mesh-list
110932826|NCT03690115|Ponatinib|ponatinib|mesh-list
111456262|NCT00000875|Diphenhydramine|diphenhydramine|mesh-list
111456263|NCT00000875|Promethazine|promethazine|mesh-list
111456264|NCT00000875|Lamivudine|lamivudine|mesh-list
111456265|NCT00000875|Zidovudine|zidovudine|mesh-list
111456266|NCT00000875|Aldesleukin|aldesleukin|mesh-list
111456267|NCT00000875|Indinavir|indinavir|mesh-list
111456268|NCT00000875|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111456269|NCT00000875|Analgesics|analgesics|mesh-ancestor
111456270|NCT00000875|Sensory System Agents|sensory system agents|mesh-ancestor
111456271|NCT00000875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111456272|NCT00000875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111456273|NCT00000875|Antipyretics|antipyretics|mesh-ancestor
111456274|NCT00000875|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111456275|NCT00000875|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111456276|NCT00000875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111456277|NCT00000875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111456278|NCT00000875|Antiviral Agents|antiviral agents|mesh-ancestor
111456279|NCT00000875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111456280|NCT00000875|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111456281|NCT00000875|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111456282|NCT00000875|Antimetabolites|antimetabolites|mesh-ancestor
111456283|NCT00000875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111456284|NCT00000875|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111456285|NCT00000875|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111456286|NCT00000875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111456287|NCT00000875|Anesthetics, Local|anesthetics, local|mesh-ancestor
111456288|NCT00000875|Anesthetics|anesthetics|mesh-ancestor
111456289|NCT00000875|Antiemetics|antiemetics|mesh-ancestor
111456290|NCT00000875|Autonomic Agents|autonomic agents|mesh-ancestor
111456291|NCT00000875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111456292|NCT00000875|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111456293|NCT00000875|Histamine Antagonists|histamine antagonists|mesh-ancestor
111456294|NCT00000875|Histamine Agents|histamine agents|mesh-ancestor
111456295|NCT00000875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111456296|NCT00000875|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111456297|NCT00000875|Antipruritics|antipruritics|mesh-ancestor
111456298|NCT00000875|Dermatologic Agents|dermatologic agents|mesh-ancestor
111456299|NCT00000875|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111456300|NCT00000875|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111456301|NCT00000875|Protease Inhibitors|protease inhibitors|mesh-ancestor
111456302|NCT04941833|Desogestrel|desogestrel|mesh-list
111456303|NCT04941833|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110932866|NCT02200848|Lenalidomide|lenalidomide|mesh-list
111456304|NCT04941833|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111456305|NCT04941833|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111456306|NCT04941833|Contraceptive Agents|contraceptive agents|mesh-ancestor
111456307|NCT04941833|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111456308|NCT04941833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111456309|NCT04941833|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111456310|NCT04941833|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111456311|NCT04941833|Progestins|progestins|mesh-ancestor
111456312|NCT04941833|Hormones|hormones|mesh-ancestor
111456313|NCT04941833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111456314|NCT04841369|Vaccines|vaccines|mesh-list
111456315|NCT04841369|Immunologic Factors|immunologic factors|mesh-ancestor
111456316|NCT04841369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111456317|NCT00002975|Aminolevulinic Acid|aminolevulinic acid|mesh-list
111456318|NCT00002975|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111456319|NCT00002975|Dermatologic Agents|dermatologic agents|mesh-ancestor
111456320|NCT00521885|Enoxaparin|enoxaparin|mesh-list
111456321|NCT00521885|Fondaparinux|fondaparinux|mesh-list
111456322|NCT00521885|Anticoagulants|anticoagulants|mesh-ancestor
111456323|NCT00521885|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111456324|NCT00521885|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111456325|NCT00521885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111456326|NCT00521885|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111456327|NCT00521885|Antithrombins|antithrombins|mesh-ancestor
111456328|NCT00521885|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111456329|NCT00521885|Protease Inhibitors|protease inhibitors|mesh-ancestor
111456330|NCT00521885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111456331|NCT05239013|Nitroglycerin|nitroglycerin|mesh-list
111456332|NCT05239013|Vasodilator Agents|vasodilator agents|mesh-ancestor
111456333|NCT00000881|Cidofovir|cidofovir|mesh-list
111456334|NCT00000881|Probenecid|probenecid|mesh-list
111456335|NCT00000881|Uricosuric Agents|uricosuric agents|mesh-ancestor
111456336|NCT00000881|Gout Suppressants|gout suppressants|mesh-ancestor
111456337|NCT00000881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111456338|NCT00000881|Antiviral Agents|antiviral agents|mesh-ancestor
111456339|NCT00000881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111456340|NCT00000881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111456341|NCT00000881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111456342|NCT00000887|Lamivudine|lamivudine|mesh-list
111456343|NCT00000887|Zidovudine|zidovudine|mesh-list
111456344|NCT00000887|Nelfinavir|nelfinavir|mesh-list
111456345|NCT00000887|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111456346|NCT00000887|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110932910|NCT01515748|Docetaxel|docetaxel|mesh-list
111456347|NCT00000887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111456348|NCT00000887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111456349|NCT00000887|Antiviral Agents|antiviral agents|mesh-ancestor
111456350|NCT00000887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111456351|NCT00000887|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111456352|NCT00000887|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111456353|NCT00000887|Antimetabolites|antimetabolites|mesh-ancestor
111456354|NCT00000887|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111456355|NCT00000887|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111456356|NCT00000887|Protease Inhibitors|protease inhibitors|mesh-ancestor
111456357|NCT00000119|Heparin|heparin|mesh-list
111456358|NCT00000119|Anticoagulants|anticoagulants|mesh-ancestor
111456359|NCT00000119|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111456360|NCT00000119|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111456361|NCT00000119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111456362|NCT00000923|Lamivudine|lamivudine|mesh-list
111456363|NCT00000923|Zidovudine|zidovudine|mesh-list
111456364|NCT00000923|Stavudine|stavudine|mesh-list
111456365|NCT00000923|Didanosine|didanosine|mesh-list
111456366|NCT00000923|Aldesleukin|aldesleukin|mesh-list
111456367|NCT00000923|Indinavir|indinavir|mesh-list
111456368|NCT00000923|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111456369|NCT00000923|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111456370|NCT00000923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111456371|NCT00000923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111456372|NCT00000923|Antiviral Agents|antiviral agents|mesh-ancestor
111456373|NCT00000923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111456374|NCT00000923|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111456375|NCT00000923|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111456376|NCT00000923|Antimetabolites|antimetabolites|mesh-ancestor
111456377|NCT00000923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111456378|NCT00000923|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111456379|NCT00000923|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111456380|NCT00000923|Protease Inhibitors|protease inhibitors|mesh-ancestor
111456381|NCT00000161|Aspirin|aspirin|mesh-list
111456382|NCT00000161|Vitamins|vitamins|mesh-list
111456383|NCT00000161|Vitamin E|vitamin e|mesh-list
111456384|NCT00000161|Beta Carotene|beta carotene|mesh-list
111456385|NCT00000161|Carotenoids|carotenoids|mesh-list
111456386|NCT00000161|Micronutrients|micronutrients|mesh-ancestor
111456387|NCT00000161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111456388|NCT00000161|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111456389|NCT00000161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111456390|NCT00000161|Analgesics|analgesics|mesh-ancestor
111456391|NCT00000161|Sensory System Agents|sensory system agents|mesh-ancestor
111456392|NCT00000161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111456393|NCT00000161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111456394|NCT00000161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111456395|NCT00000161|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111456396|NCT00000161|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111456397|NCT00000161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111456398|NCT00000161|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111456399|NCT00000161|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111456400|NCT00000161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111456401|NCT00000161|Antipyretics|antipyretics|mesh-ancestor
111456402|NCT00000161|Antioxidants|antioxidants|mesh-ancestor
111456403|NCT00000161|Protective Agents|protective agents|mesh-ancestor
111456404|NCT00000161|Provitamins|provitamins|mesh-ancestor
111456405|NCT00000929|Nonoxynol|nonoxynol|mesh-list
111456406|NCT00000929|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
111456407|NCT00000929|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
111456408|NCT00000929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111456409|NCT00000929|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111456410|NCT00000929|Contraceptive Agents|contraceptive agents|mesh-ancestor
111456411|NCT00000929|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111456412|NCT00000929|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
111456413|NCT00000935|Immunoglobulins|immunoglobulins|mesh-list
111456414|NCT00000935|Antibodies|antibodies|mesh-list
111456415|NCT00000935|gamma-Globulins|gamma-globulins|mesh-list
111456416|NCT00000935|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111456417|NCT00000935|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
111456418|NCT00000935|Immunologic Factors|immunologic factors|mesh-ancestor
111456419|NCT00000935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111456420|NCT00000197|Propranolol|propranolol|mesh-list
111456421|NCT00000197|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111456422|NCT00000197|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111456423|NCT00000197|Adrenergic Agents|adrenergic agents|mesh-ancestor
111456424|NCT00000197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111456425|NCT00000197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111456426|NCT00000197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111456427|NCT00000197|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111456428|NCT00000197|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111456429|NCT00000197|Vasodilator Agents|vasodilator agents|mesh-ancestor
111456430|NCT00000947|Azithromycin|azithromycin|mesh-list
111456431|NCT00000947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111456432|NCT00000947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111456433|NCT00000203|Buprenorphine|buprenorphine|mesh-list
111456434|NCT00000203|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111456435|NCT00000203|Narcotics|narcotics|mesh-ancestor
111456436|NCT00000203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110935697|NCT05258474|Niacin|niacin|mesh-list
111456437|NCT00000203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111456438|NCT00000203|Analgesics|analgesics|mesh-ancestor
111456439|NCT00000203|Sensory System Agents|sensory system agents|mesh-ancestor
111456440|NCT00000203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111456441|NCT00000203|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111456442|NCT00000209|Buprenorphine|buprenorphine|mesh-list
111456443|NCT00000209|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111456444|NCT00000209|Narcotics|narcotics|mesh-ancestor
111456445|NCT00000209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111456446|NCT00000209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111456447|NCT00000209|Analgesics|analgesics|mesh-ancestor
111180627|NCT04631029|Etoposide|etoposide|mesh-list
111456448|NCT00000209|Sensory System Agents|sensory system agents|mesh-ancestor
111456449|NCT00000209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111456450|NCT00000209|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111456452|NCT00000215|Dopamine Agonists|dopamine agonists|mesh-ancestor
111456453|NCT00000215|Dopamine Agents|dopamine agents|mesh-ancestor
111456454|NCT00000215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111456455|NCT00000215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111456456|NCT00000215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111456457|NCT00000953|Acyclovir|acyclovir|mesh-list
111456458|NCT00000953|Sorivudine|sorivudine|mesh-list
111456459|NCT00000953|Antiviral Agents|antiviral agents|mesh-ancestor
111456460|NCT00000953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111456461|NCT00000953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110933015|NCT02220114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111456462|NCT00000953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111456463|NCT00000983|Zidovudine|zidovudine|mesh-list
111456464|NCT00000983|Antimetabolites|antimetabolites|mesh-ancestor
111456465|NCT00000983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111456466|NCT00000983|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111456467|NCT00000983|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111456468|NCT00000983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111456469|NCT00000983|Antiviral Agents|antiviral agents|mesh-ancestor
111456470|NCT00000983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111456471|NCT00000983|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110933031|NCT04971382|Analgesics|analgesics|mesh-ancestor
111456472|NCT00000983|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111456473|NCT00000227|Buprenorphine|buprenorphine|mesh-list
111456474|NCT00000227|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111456475|NCT00000227|Narcotics|narcotics|mesh-ancestor
111456476|NCT00000227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111456477|NCT00000227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111456478|NCT00000227|Analgesics|analgesics|mesh-ancestor
111456479|NCT00000227|Sensory System Agents|sensory system agents|mesh-ancestor
111456480|NCT00000227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111456481|NCT00000227|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111456482|NCT00000233|Buprenorphine|buprenorphine|mesh-list
111456483|NCT00000233|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111456484|NCT00000233|Narcotics|narcotics|mesh-ancestor
111456485|NCT00000233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111456486|NCT00000233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111456487|NCT00000233|Analgesics|analgesics|mesh-ancestor
111456488|NCT00000233|Sensory System Agents|sensory system agents|mesh-ancestor
111456489|NCT00000233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111456490|NCT00000233|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111456491|NCT00000239|Buprenorphine|buprenorphine|mesh-list
111456492|NCT00000239|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111456493|NCT00000239|Narcotics|narcotics|mesh-ancestor
111456494|NCT00000239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111456495|NCT00000239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111456496|NCT00000239|Analgesics|analgesics|mesh-ancestor
111456497|NCT00000239|Sensory System Agents|sensory system agents|mesh-ancestor
111456498|NCT00000239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111456499|NCT00000239|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111456500|NCT00000245|Desipramine|desipramine|mesh-list
111456501|NCT00000245|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
111456502|NCT00000245|Antidepressive Agents|antidepressive agents|mesh-ancestor
111456503|NCT00000245|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111456504|NCT00000245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111456505|NCT00000245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110933047|NCT04151680|Edoxaban|edoxaban|mesh-list
111456506|NCT00000245|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111456507|NCT00000245|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111456508|NCT00000245|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111456509|NCT00000245|Adrenergic Agents|adrenergic agents|mesh-ancestor
111456510|NCT00000245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111456511|NCT00000245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111456512|NCT00000263|Ethanol|ethanol|mesh-list
111456513|NCT00000263|Nitrous Oxide|nitrous oxide|mesh-list
111456514|NCT00000263|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111456515|NCT00000263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111456516|NCT00000263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111456517|NCT00000263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111456518|NCT00000263|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111456519|NCT00000263|Anesthetics, General|anesthetics, general|mesh-ancestor
111456520|NCT00000263|Anesthetics|anesthetics|mesh-ancestor
111456521|NCT00000263|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111456522|NCT00000263|Analgesics|analgesics|mesh-ancestor
111456523|NCT00000263|Sensory System Agents|sensory system agents|mesh-ancestor
111456524|NCT00000263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111456525|NCT00000269|Pergolide|pergolide|mesh-list
111456526|NCT00000269|Dopamine Agonists|dopamine agonists|mesh-ancestor
111456528|NCT00000269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111456529|NCT00000269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111456530|NCT00000269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111456531|NCT04030559|Niraparib|niraparib|mesh-list
111456532|NCT04030559|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111456533|NCT04030559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111456534|NCT04030559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111456535|NCT04030559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111456536|NCT03967223|Cyclophosphamide|cyclophosphamide|mesh-list
111456537|NCT03967223|Fludarabine|fludarabine|mesh-list
111456538|NCT03967223|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111456539|NCT03967223|Immunologic Factors|immunologic factors|mesh-ancestor
111456540|NCT03967223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111456541|NCT03967223|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111456542|NCT03967223|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110933103|NCT04962958|Leucovorin|leucovorin|mesh-list
111456543|NCT03967223|Alkylating Agents|alkylating agents|mesh-ancestor
111456544|NCT03967223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111456545|NCT03967223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111456546|NCT03967223|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111456547|NCT00000989|Zidovudine|zidovudine|mesh-list
111456548|NCT00000989|Ganciclovir|ganciclovir|mesh-list
111456549|NCT00000989|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
111456550|NCT00000989|Sargramostim|sargramostim|mesh-list
111456551|NCT00000989|Antimetabolites|antimetabolites|mesh-ancestor
111456552|NCT00000989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111456553|NCT00000989|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111456554|NCT00000989|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111456555|NCT00000989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111456556|NCT00000989|Antiviral Agents|antiviral agents|mesh-ancestor
111456557|NCT00000989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111456558|NCT00000989|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111456559|NCT00000989|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111456560|NCT00000989|Immunologic Factors|immunologic factors|mesh-ancestor
111456561|NCT00000989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111456562|NCT00000995|Zidovudine|zidovudine|mesh-list
111456563|NCT00000995|Ganciclovir|ganciclovir|mesh-list
111456564|NCT00000995|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
111456565|NCT00000995|Antimetabolites|antimetabolites|mesh-ancestor
111456566|NCT00000995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111456567|NCT00000995|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111456568|NCT00000995|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111456569|NCT00000995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111456570|NCT00000995|Antiviral Agents|antiviral agents|mesh-ancestor
111456571|NCT00000995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111456572|NCT00000995|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111456573|NCT00000995|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111456574|NCT00001025|Zidovudine|zidovudine|mesh-list
111456575|NCT00001025|Didanosine|didanosine|mesh-list
111456576|NCT00001025|Antimetabolites|antimetabolites|mesh-ancestor
111456577|NCT00001025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111456578|NCT00001025|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111456579|NCT00001025|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111456580|NCT00001025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111456581|NCT00001025|Antiviral Agents|antiviral agents|mesh-ancestor
111456582|NCT00001025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111456583|NCT00001025|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111456584|NCT00001025|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111456585|NCT03121001|Mycophenolic Acid|mycophenolic acid|mesh-list
111456586|NCT03121001|Sirolimus|sirolimus|mesh-list
111456587|NCT03121001|Cyclophosphamide|cyclophosphamide|mesh-list
111456588|NCT03121001|Fludarabine|fludarabine|mesh-list
111456589|NCT03121001|Thymoglobulin|thymoglobulin|mesh-list
111456590|NCT03121001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110933139|NCT02222142|Isoflurane|isoflurane|mesh-list
111456591|NCT03121001|Immunologic Factors|immunologic factors|mesh-ancestor
111456592|NCT03121001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111456593|NCT03121001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111456594|NCT03121001|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111456595|NCT03121001|Alkylating Agents|alkylating agents|mesh-ancestor
111456596|NCT03121001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111456597|NCT03121001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111456598|NCT03121001|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111456599|NCT03121001|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111456600|NCT03121001|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111456601|NCT03121001|Antitubercular Agents|antitubercular agents|mesh-ancestor
111456602|NCT03121001|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111456603|NCT03121001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111456604|NCT03121001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111456605|NCT03121001|Antifungal Agents|antifungal agents|mesh-ancestor
111456606|NCT03055247|Ibuprofen|ibuprofen|mesh-list
111456607|NCT03055247|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111456608|NCT03055247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111456609|NCT03055247|Analgesics|analgesics|mesh-ancestor
111456610|NCT03055247|Sensory System Agents|sensory system agents|mesh-ancestor
111456611|NCT03055247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111456612|NCT03055247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111456613|NCT03055247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111456614|NCT03055247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111456615|NCT03055247|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111456616|NCT03055247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111456617|NCT03055247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111456618|NCT00001049|Zidovudine|zidovudine|mesh-list
111456619|NCT00001049|Didanosine|didanosine|mesh-list
111456620|NCT00001049|Antimetabolites|antimetabolites|mesh-ancestor
111456621|NCT00001049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111456622|NCT00001049|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111456623|NCT00001049|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111456624|NCT00001049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111456625|NCT00001049|Antiviral Agents|antiviral agents|mesh-ancestor
111456626|NCT00001049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111456627|NCT00001049|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111456628|NCT00001049|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111456629|NCT00001055|polysaccharide-K|polysaccharide-k|mesh-list
111456630|NCT00001055|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111456631|NCT00001055|Immunologic Factors|immunologic factors|mesh-ancestor
111456632|NCT00001055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111456633|NCT00001055|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111456634|NCT00001055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111456635|NCT00001055|Antiviral Agents|antiviral agents|mesh-ancestor
111456636|NCT00001055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111456637|NCT00001055|Interferon Inducers|interferon inducers|mesh-ancestor
111456638|NCT00001055|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111456639|NCT00001055|Protective Agents|protective agents|mesh-ancestor
111456640|NCT00000275|Flupenthixol|flupenthixol|mesh-list
111456641|NCT00000275|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
111456642|NCT00000275|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111456643|NCT00000275|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111456644|NCT00000275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111456645|NCT00000275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111456646|NCT00000275|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111456647|NCT00000275|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111456648|NCT00000275|Dopamine Agents|dopamine agents|mesh-ancestor
111456649|NCT00000275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111456650|NCT00000275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111456651|NCT00001061|Ganciclovir|ganciclovir|mesh-list
111456652|NCT00001061|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
111456653|NCT00001061|Foscarnet|foscarnet|mesh-list
111456654|NCT00001061|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
111456655|NCT00001061|Antiviral Agents|antiviral agents|mesh-ancestor
111456656|NCT00001061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111456657|NCT00001061|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111456658|NCT00001061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111456659|NCT00001061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111456660|NCT00001061|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111456661|NCT00000281|Amantadine|amantadine|mesh-list
111456662|NCT00000281|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111456663|NCT00000281|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111456664|NCT00000281|Antiviral Agents|antiviral agents|mesh-ancestor
111456665|NCT00000281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111456666|NCT00000281|Dopamine Agents|dopamine agents|mesh-ancestor
111456667|NCT00000281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111456668|NCT00000281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111456669|NCT00000281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111456670|NCT00000281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111456671|NCT00000281|Analgesics|analgesics|mesh-ancestor
111456672|NCT00000281|Sensory System Agents|sensory system agents|mesh-ancestor
111456673|NCT00000281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111456674|NCT00001067|Lamivudine|lamivudine|mesh-list
111456675|NCT00001067|Zidovudine|zidovudine|mesh-list
111180841|NCT03822468|Letrozole|letrozole|mesh-list
111456676|NCT00001067|Stavudine|stavudine|mesh-list
111456677|NCT00001067|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111456678|NCT00001067|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111456679|NCT00001067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111456680|NCT00001067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111456681|NCT00001067|Antiviral Agents|antiviral agents|mesh-ancestor
111456682|NCT00001067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111456683|NCT00001067|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111456684|NCT00001067|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111456685|NCT00001067|Antimetabolites|antimetabolites|mesh-ancestor
111456686|NCT00001079|Methyltestosterone|methyltestosterone|mesh-list
111456687|NCT00001079|Megestrol|megestrol|mesh-list
111456688|NCT00001079|Megestrol Acetate|megestrol acetate|mesh-list
111456689|NCT00001079|Testosterone|testosterone|mesh-list
111456690|NCT00001079|Testosterone undecanoate|testosterone undecanoate|mesh-list
111456691|NCT00001079|Testosterone enanthate|testosterone enanthate|mesh-list
111456692|NCT00001079|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
111456693|NCT00001079|Androgens|androgens|mesh-ancestor
111456694|NCT00001079|Hormones|hormones|mesh-ancestor
111456695|NCT00001079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111456696|NCT00001079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111456697|NCT00001079|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111456698|NCT00001079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111456699|NCT00001079|Anabolic Agents|anabolic agents|mesh-ancestor
111456700|NCT00001079|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111456701|NCT00001079|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111456702|NCT00001079|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111456703|NCT00001079|Contraceptive Agents|contraceptive agents|mesh-ancestor
111456704|NCT00001079|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111456705|NCT00001079|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111456706|NCT00001079|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111456707|NCT00001079|Appetite Stimulants|appetite stimulants|mesh-ancestor
111456708|NCT00001079|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111456709|NCT00000293|Nefazodone|nefazodone|mesh-list
111456710|NCT00000293|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111456711|NCT00000293|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111456712|NCT00000293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111456713|NCT00000293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111456714|NCT00000293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111456715|NCT00000293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111456716|NCT00000293|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111456717|NCT00000293|Antidepressive Agents|antidepressive agents|mesh-ancestor
111456718|NCT00000293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111456719|NCT00000293|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111456720|NCT00000293|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111456721|NCT00000293|Serotonin Agents|serotonin agents|mesh-ancestor
111456722|NCT00001091|Ritonavir|ritonavir|mesh-list
111456723|NCT00001091|Nelfinavir|nelfinavir|mesh-list
111456724|NCT00001091|Lamivudine|lamivudine|mesh-list
111456725|NCT00001091|Nevirapine|nevirapine|mesh-list
111456726|NCT00001091|Stavudine|stavudine|mesh-list
111456727|NCT00001091|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111456728|NCT00001091|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111456729|NCT00001091|Protease Inhibitors|protease inhibitors|mesh-ancestor
111456730|NCT00001091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111456731|NCT00001091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111456732|NCT00001091|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111456733|NCT00001091|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111456734|NCT00001091|Antiviral Agents|antiviral agents|mesh-ancestor
111456735|NCT00001091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111456736|NCT00001091|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111456737|NCT00001091|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111456738|NCT00001091|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111456739|NCT00001091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111456740|NCT00001091|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111456741|NCT00001091|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111456742|NCT00001091|Antimetabolites|antimetabolites|mesh-ancestor
111456743|NCT00000299|Buprenorphine|buprenorphine|mesh-list
111456744|NCT00000299|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111456745|NCT00000299|Narcotics|narcotics|mesh-ancestor
111456746|NCT00000299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111456747|NCT00000299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111456748|NCT00000299|Analgesics|analgesics|mesh-ancestor
111456749|NCT00000299|Sensory System Agents|sensory system agents|mesh-ancestor
111456750|NCT00000299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111456751|NCT00000299|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111456752|NCT00000305|Dextroamphetamine|dextroamphetamine|mesh-list
111456753|NCT00000305|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111456754|NCT00000305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111456755|NCT00000305|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111456756|NCT00000305|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111456757|NCT00000305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111456758|NCT00000305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111456759|NCT00000305|Dopamine Agents|dopamine agents|mesh-ancestor
111456760|NCT00000305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111456761|NCT00000311|Buprenorphine|buprenorphine|mesh-list
111456763|NCT00000311|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111456764|NCT00000311|Narcotics|narcotics|mesh-ancestor
111456765|NCT00000311|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111456766|NCT00000311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111456767|NCT00000311|Analgesics|analgesics|mesh-ancestor
111456768|NCT00000311|Sensory System Agents|sensory system agents|mesh-ancestor
111456769|NCT00000311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111456770|NCT00000311|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111456771|NCT00000311|Antitussive Agents|antitussive agents|mesh-ancestor
111456772|NCT00000311|Respiratory System Agents|respiratory system agents|mesh-ancestor
111456773|NCT00000317|Risperidone|risperidone|mesh-list
111456774|NCT00000317|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111456775|NCT00000317|Serotonin Agents|serotonin agents|mesh-ancestor
111456776|NCT00000317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111456777|NCT00000317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111456778|NCT00000317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111456779|NCT00000317|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111456780|NCT00000317|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111456781|NCT00000317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111456782|NCT00000317|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111456783|NCT00000317|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111456784|NCT00000317|Dopamine Agents|dopamine agents|mesh-ancestor
111456785|NCT00001115|Acyclovir|acyclovir|mesh-list
111456786|NCT00001115|Antiviral Agents|antiviral agents|mesh-ancestor
111456787|NCT00001115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111456788|NCT00001757|Voriconazole|voriconazole|mesh-list
111456789|NCT00001757|Antifungal Agents|antifungal agents|mesh-ancestor
111456790|NCT00001757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111456791|NCT00001757|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111456792|NCT00001757|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111456793|NCT00001757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111456794|NCT00001757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111456795|NCT00001757|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111456796|NCT00001757|Hormone Antagonists|hormone antagonists|mesh-ancestor
110933301|NCT04542408|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111456797|NCT00001757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111456798|NCT00001757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111456799|NCT00001757|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111456800|NCT00001133|Ritonavir|ritonavir|mesh-list
111456801|NCT00001133|Indinavir|indinavir|mesh-list
111456802|NCT00001133|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111456803|NCT00001133|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111456804|NCT00001133|Protease Inhibitors|protease inhibitors|mesh-ancestor
111456805|NCT00001133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111456806|NCT00001133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111456807|NCT00001133|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111456808|NCT00001133|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111456809|NCT00001133|Antiviral Agents|antiviral agents|mesh-ancestor
111456810|NCT00001133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111456811|NCT00001133|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111456812|NCT00001133|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111456813|NCT00000329|Analgesics, Opioid|analgesics, opioid|mesh-list
111456814|NCT00000329|Narcotics|narcotics|mesh-ancestor
111456815|NCT00000329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111456816|NCT00000329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111456817|NCT00000329|Analgesics|analgesics|mesh-ancestor
111456818|NCT00000329|Sensory System Agents|sensory system agents|mesh-ancestor
111456819|NCT00000329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111456820|NCT00000335|Morphine|morphine|mesh-list
111456821|NCT00000335|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111456822|NCT00000335|Narcotics|narcotics|mesh-ancestor
111456823|NCT00000335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111456824|NCT00000335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111456825|NCT00000335|Analgesics|analgesics|mesh-ancestor
111456826|NCT00000335|Sensory System Agents|sensory system agents|mesh-ancestor
111456827|NCT00000335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111456828|NCT00000341|Buprenorphine|buprenorphine|mesh-list
111456829|NCT00000341|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111456830|NCT00000341|Narcotics|narcotics|mesh-ancestor
111456831|NCT00000341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111456832|NCT00000341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111456833|NCT00000341|Analgesics|analgesics|mesh-ancestor
111456834|NCT00000341|Sensory System Agents|sensory system agents|mesh-ancestor
111456835|NCT00000341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111456836|NCT00000341|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111456837|NCT00000347|Risperidone|risperidone|mesh-list
111456838|NCT00000347|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111456839|NCT00000347|Serotonin Agents|serotonin agents|mesh-ancestor
111456840|NCT00000347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111456841|NCT00000347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111456842|NCT00000347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111456843|NCT00000347|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111456844|NCT00000347|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111456845|NCT00000347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111456846|NCT00000347|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111456847|NCT00000347|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111456848|NCT00000347|Dopamine Agents|dopamine agents|mesh-ancestor
111456849|NCT00001835|Oxaliplatin|oxaliplatin|mesh-list
111456850|NCT00001835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111456851|NCT00001193|Melphalan|melphalan|mesh-list
111456852|NCT00001193|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111456853|NCT00001193|Alkylating Agents|alkylating agents|mesh-ancestor
111456854|NCT00001193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111456855|NCT00001193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111456856|NCT00001193|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111456857|NCT00001193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111456858|NCT00001193|Immunologic Factors|immunologic factors|mesh-ancestor
110933369|NCT02905188|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111456859|NCT00001193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111456860|NCT00000353|Buprenorphine|buprenorphine|mesh-list
111456861|NCT00000353|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
111456862|NCT00000353|Naloxone|naloxone|mesh-list
111456863|NCT00000353|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111456864|NCT00000353|Narcotics|narcotics|mesh-ancestor
111456865|NCT00000353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111456866|NCT00000353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111456867|NCT00000353|Analgesics|analgesics|mesh-ancestor
111456868|NCT00000353|Sensory System Agents|sensory system agents|mesh-ancestor
111456869|NCT00000353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111456870|NCT00000353|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111456871|NCT00000377|Nortriptyline|nortriptyline|mesh-list
111456872|NCT00000377|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
111456873|NCT00000377|Antidepressive Agents|antidepressive agents|mesh-ancestor
111456874|NCT00000377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111456875|NCT00000377|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111456876|NCT00000377|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111456877|NCT00000377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111456878|NCT00000377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111456879|NCT00000377|Adrenergic Agents|adrenergic agents|mesh-ancestor
111456880|NCT00000377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111456881|NCT00000377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111456882|NCT00001865|Daclizumab|daclizumab|mesh-list
111456883|NCT00001865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111456884|NCT00001865|Immunologic Factors|immunologic factors|mesh-ancestor
111456885|NCT00001865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111456886|NCT00000389|Fluvoxamine|fluvoxamine|mesh-list
111456887|NCT00000389|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111456888|NCT00000389|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111456889|NCT00000389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111456890|NCT00000389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111456891|NCT00000389|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111456892|NCT00000389|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111456893|NCT00000389|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111456894|NCT00000389|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111456895|NCT00000389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111456896|NCT00000389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111456897|NCT00000389|Serotonin Agents|serotonin agents|mesh-ancestor
111456898|NCT00000389|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111456899|NCT00000389|Antidepressive Agents|antidepressive agents|mesh-ancestor
111456900|NCT00000389|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111456901|NCT00000389|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111456902|NCT00000389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111456903|NCT00000389|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111456904|NCT00001877|Pentoxifylline|pentoxifylline|mesh-list
111456905|NCT00001877|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111456906|NCT00001877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111456907|NCT00001877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110933433|NCT03676621|Abortifacient Agents|abortifacient agents|mesh-ancestor
111456908|NCT00001877|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111456909|NCT00001877|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111456910|NCT00001877|Protective Agents|protective agents|mesh-ancestor
111456911|NCT00001877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111456912|NCT00001877|Vasodilator Agents|vasodilator agents|mesh-ancestor
111456913|NCT00001877|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111456914|NCT00001877|Antioxidants|antioxidants|mesh-ancestor
111456915|NCT00380939|Atorvastatin|atorvastatin|mesh-list
111456916|NCT00380939|Pravastatin|pravastatin|mesh-list
111456917|NCT00380939|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111456918|NCT00380939|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111456919|NCT00380939|Antimetabolites|antimetabolites|mesh-ancestor
111456920|NCT00380939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111456921|NCT00380939|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111456922|NCT00380939|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111456923|NCT00380939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111456924|NCT00001889|Dobutamine|dobutamine|mesh-list
111456925|NCT00001889|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111456926|NCT00001889|Sympathomimetics|sympathomimetics|mesh-ancestor
111456927|NCT00001889|Autonomic Agents|autonomic agents|mesh-ancestor
111456928|NCT00001889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111456929|NCT00001889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111456930|NCT00001889|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
111456931|NCT00001889|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111456932|NCT00001889|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111456933|NCT00001889|Adrenergic Agents|adrenergic agents|mesh-ancestor
111456934|NCT00001889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111456935|NCT00001889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111456936|NCT00001889|Protective Agents|protective agents|mesh-ancestor
111456937|NCT00001901|Etanercept|etanercept|mesh-list
111456938|NCT00001901|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111456939|NCT00001901|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111456940|NCT00001901|Analgesics|analgesics|mesh-ancestor
111456941|NCT00001901|Sensory System Agents|sensory system agents|mesh-ancestor
111456942|NCT00001901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111456943|NCT00001901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111456944|NCT00001901|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111456945|NCT00001901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111456946|NCT00001901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111456947|NCT00001901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111456948|NCT00001901|Immunologic Factors|immunologic factors|mesh-ancestor
111456949|NCT00000437|Naltrexone|naltrexone|mesh-list
111456950|NCT00000437|Nicotine|nicotine|mesh-list
111456951|NCT00000437|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111456952|NCT00000437|Autonomic Agents|autonomic agents|mesh-ancestor
111456953|NCT00000437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111456954|NCT00000437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111456955|NCT00000437|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111456956|NCT00000437|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111456957|NCT00000437|Cholinergic Agents|cholinergic agents|mesh-ancestor
111456958|NCT00000437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111456959|NCT00000437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111456960|NCT00000437|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111456961|NCT00000437|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111456962|NCT00000437|Sensory System Agents|sensory system agents|mesh-ancestor
111456963|NCT00000443|Ondansetron|ondansetron|mesh-list
111456964|NCT00000443|Antiemetics|antiemetics|mesh-ancestor
111456965|NCT00000443|Autonomic Agents|autonomic agents|mesh-ancestor
111456966|NCT00000443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111456967|NCT00000443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111456968|NCT00000443|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111456969|NCT00000443|Antipruritics|antipruritics|mesh-ancestor
111456970|NCT00000443|Dermatologic Agents|dermatologic agents|mesh-ancestor
111456971|NCT00000443|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111456972|NCT00000443|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111456973|NCT00000443|Serotonin Agents|serotonin agents|mesh-ancestor
111456974|NCT00000443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111456975|NCT00000443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111456976|NCT00000449|Naltrexone|naltrexone|mesh-list
111456977|NCT00000449|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111456978|NCT00000449|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111456979|NCT00000449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111456980|NCT00000449|Sensory System Agents|sensory system agents|mesh-ancestor
111456981|NCT00000449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111456982|NCT00000455|Naltrexone|naltrexone|mesh-list
111456983|NCT00000455|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111456984|NCT00000455|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111456985|NCT00000455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111456986|NCT00000455|Sensory System Agents|sensory system agents|mesh-ancestor
111456987|NCT00000455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111456988|NCT00001307|Capsaicin|capsaicin|mesh-list
111456989|NCT00001307|Antipruritics|antipruritics|mesh-ancestor
111456990|NCT00001307|Dermatologic Agents|dermatologic agents|mesh-ancestor
111456991|NCT00001307|Sensory System Agents|sensory system agents|mesh-ancestor
111456992|NCT00001307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111456993|NCT00001307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111456994|NCT04713761|Carboplatin|carboplatin|mesh-list
111456995|NCT04713761|Pemetrexed|pemetrexed|mesh-list
111456996|NCT04713761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111456997|NCT04713761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111456998|NCT04713761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111456999|NCT04713761|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111457000|NCT04713761|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111457001|NCT00001937|Fluconazole|fluconazole|mesh-list
111457002|NCT00001937|Antifungal Agents|antifungal agents|mesh-ancestor
111457003|NCT00001937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111457004|NCT00001937|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111457005|NCT00001937|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111457006|NCT00001937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111457007|NCT00001937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111457008|NCT00001937|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111457009|NCT00001937|Hormone Antagonists|hormone antagonists|mesh-ancestor
111457010|NCT00001937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111457011|NCT00001937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111457012|NCT00001937|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111457013|NCT00001937|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111457014|NCT00001325|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
111457015|NCT00001325|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111457016|NCT00001325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111457017|NCT04331327|Mitogens|mitogens|mesh-list
111457018|NCT04331327|Mitosis Modulators|mitosis modulators|mesh-ancestor
111457019|NCT04331327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111457020|NCT00001955|Celecoxib|celecoxib|mesh-list
111457021|NCT00001955|Etanercept|etanercept|mesh-list
111457022|NCT00001955|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111457023|NCT00001955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111457024|NCT00001955|Analgesics|analgesics|mesh-ancestor
111457025|NCT00001955|Sensory System Agents|sensory system agents|mesh-ancestor
111457026|NCT00001955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111457027|NCT00001955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111457028|NCT00001955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111457029|NCT00001955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111457030|NCT00001955|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111457031|NCT00001955|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111457032|NCT00001955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111457033|NCT00001955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111457034|NCT00001955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111457035|NCT00001955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111457036|NCT00001955|Immunologic Factors|immunologic factors|mesh-ancestor
111457037|NCT04943783|Atorvastatin|atorvastatin|mesh-list
111457038|NCT04943783|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111457039|NCT04943783|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111457040|NCT04943783|Antimetabolites|antimetabolites|mesh-ancestor
111457041|NCT04943783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111457042|NCT04943783|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111457043|NCT04943783|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111457044|NCT04943783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111457045|NCT00000605|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
111457046|NCT00000605|Medroxyprogesterone|medroxyprogesterone|mesh-list
111457047|NCT00000605|Hormones|hormones|mesh-list
111457048|NCT00000605|Estrogens|estrogens|mesh-list
111457049|NCT00000605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111457050|NCT00000605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111457051|NCT00000605|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111457052|NCT00000605|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111457053|NCT00000605|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111457054|NCT00000605|Contraceptive Agents|contraceptive agents|mesh-ancestor
111457055|NCT00000605|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111457056|NCT00000605|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111457057|NCT00000605|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111457058|NCT00000605|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
111457059|NCT00000605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111457060|NCT00000605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111457061|NCT00000617|Azithromycin|azithromycin|mesh-list
111457062|NCT00000617|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111457063|NCT00000617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111457064|NCT00000623|Decitabine|decitabine|mesh-list
111457065|NCT00000623|Sildenafil Citrate|sildenafil citrate|mesh-list
111457066|NCT00000623|Deferiprone|deferiprone|mesh-list
111457067|NCT00000623|Deferoxamine|deferoxamine|mesh-list
111457068|NCT00000623|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111457069|NCT00000623|Antimetabolites|antimetabolites|mesh-ancestor
111457070|NCT00000623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111457071|NCT00000623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111457072|NCT00000623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111457073|NCT00000623|Vasodilator Agents|vasodilator agents|mesh-ancestor
111457074|NCT00000623|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111457075|NCT00000623|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111457076|NCT00000623|Urological Agents|urological agents|mesh-ancestor
111457077|NCT00000623|Iron Chelating Agents|iron chelating agents|mesh-ancestor
111457078|NCT00000623|Chelating Agents|chelating agents|mesh-ancestor
111457079|NCT00000623|Sequestering Agents|sequestering agents|mesh-ancestor
111457080|NCT00000623|Siderophores|siderophores|mesh-ancestor
111457081|NCT00001991|Atovaquone|atovaquone|mesh-list
111457082|NCT00001991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111457083|NCT00001991|Antimalarials|antimalarials|mesh-ancestor
111457084|NCT00001991|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111457085|NCT00001991|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111457086|NCT00001991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111457087|NCT00001991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111457088|NCT00001997|Zidovudine|zidovudine|mesh-list
111457089|NCT00001997|Didanosine|didanosine|mesh-list
111457090|NCT00001997|Interleukin-2|interleukin-2|mesh-list
111457091|NCT00001997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111457092|NCT00001997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111457093|NCT00001997|Analgesics|analgesics|mesh-ancestor
111457094|NCT00001997|Sensory System Agents|sensory system agents|mesh-ancestor
111457095|NCT00001997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111457096|NCT00001997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111457097|NCT00001997|Antimetabolites|antimetabolites|mesh-ancestor
111457098|NCT00001997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111457099|NCT00001997|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111457100|NCT00001997|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111457101|NCT00001997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111457102|NCT00001997|Antiviral Agents|antiviral agents|mesh-ancestor
111457103|NCT00001997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111457104|NCT00001997|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111457105|NCT00001997|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111457106|NCT00002003|Etoposide|etoposide|mesh-list
111457107|NCT00002003|Mitoxantrone|mitoxantrone|mesh-list
111457108|NCT00002003|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111457109|NCT00002003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111457110|NCT00002003|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111457111|NCT00002003|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111457112|NCT00002003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111457113|NCT00002003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111457114|NCT00002003|Analgesics|analgesics|mesh-ancestor
111457115|NCT00002003|Sensory System Agents|sensory system agents|mesh-ancestor
111457116|NCT00002003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111457117|NCT00002003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111457118|NCT00002009|Sargramostim|sargramostim|mesh-list
111457119|NCT00002009|Immunologic Factors|immunologic factors|mesh-ancestor
111181313|NCT01091831|Hormones|hormones|mesh-ancestor
111457120|NCT00002009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111457121|NCT00000629|Zidovudine|zidovudine|mesh-list
111457122|NCT00000629|Valproic Acid|valproic acid|mesh-list
111457123|NCT00000629|Antimetabolites|antimetabolites|mesh-ancestor
111457124|NCT00000629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111457125|NCT00000629|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111457126|NCT00000629|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111457127|NCT00000629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111457128|NCT00000629|Antiviral Agents|antiviral agents|mesh-ancestor
111457129|NCT00000629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111457130|NCT00000629|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111457131|NCT00000629|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111457132|NCT00000629|Anticonvulsants|anticonvulsants|mesh-ancestor
111457133|NCT00000629|GABA Agents|gaba agents|mesh-ancestor
111457134|NCT00000629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111457135|NCT00000629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111457136|NCT00000629|Antimanic Agents|antimanic agents|mesh-ancestor
111457137|NCT00000629|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111457138|NCT00000629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111457139|NCT00000629|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111457140|NCT00000647|Interferons|interferons|mesh-list
111457141|NCT00000647|Interferon-alpha|interferon-alpha|mesh-list
111457142|NCT00000647|Zidovudine|zidovudine|mesh-list
111457143|NCT00000647|CD4 Immunoadhesins|cd4 immunoadhesins|mesh-list
111457144|NCT00000647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111457145|NCT00000647|Antiviral Agents|antiviral agents|mesh-ancestor
111457146|NCT00000647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111457147|NCT00000647|Immunologic Factors|immunologic factors|mesh-ancestor
111457148|NCT00000647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111457149|NCT00000647|Antimetabolites|antimetabolites|mesh-ancestor
111457150|NCT00000647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111457151|NCT00000647|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111457152|NCT00000647|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111457153|NCT00000647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111457154|NCT00000647|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111457155|NCT00000647|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111457156|NCT00000653|Zalcitabine|zalcitabine|mesh-list
111457157|NCT00000653|Antimetabolites|antimetabolites|mesh-ancestor
111457158|NCT00000653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111457159|NCT00000653|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111457160|NCT00000653|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111457161|NCT00000653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111457162|NCT00000653|Antiviral Agents|antiviral agents|mesh-ancestor
111457163|NCT00000653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111457164|NCT00000653|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111457165|NCT00000653|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111457166|NCT00001409|Interleukin-2|interleukin-2|mesh-list
111457167|NCT00001409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111457168|NCT00001409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111457169|NCT00001409|Analgesics|analgesics|mesh-ancestor
111457170|NCT00001409|Sensory System Agents|sensory system agents|mesh-ancestor
111457171|NCT00001409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111457172|NCT00001409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111457173|NCT00000659|Zidovudine|zidovudine|mesh-list
111457174|NCT00000659|Antimetabolites|antimetabolites|mesh-ancestor
111457175|NCT00000659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111457176|NCT00000659|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111457177|NCT00000659|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111457178|NCT00000659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111457179|NCT00000659|Antiviral Agents|antiviral agents|mesh-ancestor
111457180|NCT00000659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111457181|NCT00000659|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111457182|NCT00000659|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111457183|NCT00381017|Interferons|interferons|mesh-list
111457184|NCT00381017|Interferon-alpha|interferon-alpha|mesh-list
111457185|NCT00381017|Interferon alpha-2|interferon alpha-2|mesh-list
111457186|NCT00381017|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
111457187|NCT00381017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111457188|NCT00381017|Antiviral Agents|antiviral agents|mesh-ancestor
111457189|NCT00381017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111457190|NCT00381017|Immunologic Factors|immunologic factors|mesh-ancestor
111457191|NCT00381017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111457192|NCT00002015|Ganciclovir|ganciclovir|mesh-list
111457193|NCT00002015|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
111457194|NCT00002015|Antiviral Agents|antiviral agents|mesh-ancestor
111457195|NCT00002015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111457196|NCT00002015|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111457197|NCT00002015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111457198|NCT00002015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111457199|NCT00002021|Foscarnet|foscarnet|mesh-list
111457200|NCT00002021|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
111457201|NCT00002021|Antiviral Agents|antiviral agents|mesh-ancestor
111457202|NCT00002021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111457203|NCT00002021|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111457204|NCT00002021|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111457205|NCT00002021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111457206|NCT00002021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111457207|NCT00002027|Diclazuril|diclazuril|mesh-list
111457208|NCT00002027|Coccidiostats|coccidiostats|mesh-ancestor
111457209|NCT00002027|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111457210|NCT00002027|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111457211|NCT00002027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111457212|NCT00000695|Interferons|interferons|mesh-list
111457213|NCT00000695|Zidovudine|zidovudine|mesh-list
111457214|NCT00000695|Interferon-beta|interferon-beta|mesh-list
111457215|NCT00000695|Interferon beta-1b|interferon beta-1b|mesh-list
111457216|NCT00000695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111457217|NCT00000695|Antiviral Agents|antiviral agents|mesh-ancestor
111457218|NCT00000695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111457219|NCT00000695|Antimetabolites|antimetabolites|mesh-ancestor
111457220|NCT00000695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111457221|NCT00000695|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111457222|NCT00000695|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111457223|NCT00000695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111457224|NCT00000695|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111457225|NCT00000695|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111457226|NCT00000695|Immunologic Factors|immunologic factors|mesh-ancestor
111457227|NCT00000695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111457228|NCT00000695|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111457229|NCT00000701|Zidovudine|zidovudine|mesh-list
111457230|NCT00000701|Antimetabolites|antimetabolites|mesh-ancestor
111457231|NCT00000701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111457232|NCT00000701|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111457233|NCT00000701|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111457234|NCT00000701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111457235|NCT00000701|Antiviral Agents|antiviral agents|mesh-ancestor
111457236|NCT00000701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111457237|NCT00000701|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111457238|NCT00000701|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111457239|NCT00000713|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
111457240|NCT00000713|Antiviral Agents|antiviral agents|mesh-ancestor
111457241|NCT00000713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111457242|NCT00000725|Interferons|interferons|mesh-list
111457243|NCT00000725|Interferon-alpha|interferon-alpha|mesh-list
111457244|NCT00000725|Interferon alpha-2|interferon alpha-2|mesh-list
111457245|NCT00000725|Zidovudine|zidovudine|mesh-list
111457246|NCT00000725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111457247|NCT00000725|Antiviral Agents|antiviral agents|mesh-ancestor
111457248|NCT00000725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111457249|NCT00000725|Immunologic Factors|immunologic factors|mesh-ancestor
111457250|NCT00000725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111457251|NCT00000725|Antimetabolites|antimetabolites|mesh-ancestor
111457252|NCT00000725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111457253|NCT00000725|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111457254|NCT00000725|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111457255|NCT00000725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111457256|NCT00000725|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111457257|NCT00000725|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111457258|NCT00002033|Zidovudine|zidovudine|mesh-list
111457259|NCT00002033|Antimetabolites|antimetabolites|mesh-ancestor
111457260|NCT00002033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111457261|NCT00002033|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111457262|NCT00002033|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111457263|NCT00002033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111457264|NCT00002033|Antiviral Agents|antiviral agents|mesh-ancestor
111457265|NCT00002033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111457266|NCT00002033|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111457267|NCT00002033|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111457268|NCT00002039|Foscarnet|foscarnet|mesh-list
111457269|NCT00002039|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
111457270|NCT00002039|Antiviral Agents|antiviral agents|mesh-ancestor
111457271|NCT00002039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111181447|NCT01517373|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111457272|NCT00002039|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111457273|NCT00002039|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111457274|NCT00002039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111457275|NCT00002039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111457276|NCT00000731|Acetaminophen|acetaminophen|mesh-list
111457277|NCT00000731|Zidovudine|zidovudine|mesh-list
111457278|NCT00000731|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111457279|NCT00000731|Analgesics|analgesics|mesh-ancestor
111457280|NCT00000731|Sensory System Agents|sensory system agents|mesh-ancestor
111457281|NCT00000731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111457282|NCT00000731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111457283|NCT00000731|Antipyretics|antipyretics|mesh-ancestor
111457284|NCT00000731|Antimetabolites|antimetabolites|mesh-ancestor
111457285|NCT00000731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111457286|NCT00000731|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111457287|NCT00000731|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111457288|NCT00000731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111457289|NCT00000731|Antiviral Agents|antiviral agents|mesh-ancestor
111457290|NCT00000731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111457291|NCT00000731|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111457292|NCT00000731|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111457293|NCT00002045|Zidovudine|zidovudine|mesh-list
111457294|NCT00002045|Antimetabolites|antimetabolites|mesh-ancestor
111457295|NCT00002045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111457296|NCT00002045|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111457297|NCT00002045|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110933810|NCT05872893|Hormones|hormones|mesh-ancestor
111457298|NCT00002045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111457299|NCT00002045|Antiviral Agents|antiviral agents|mesh-ancestor
111457300|NCT00002045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111457301|NCT00002045|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111457302|NCT00002045|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111457303|NCT00002051|Thymopentin|thymopentin|mesh-list
111457304|NCT00002051|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111457305|NCT00002051|Immunologic Factors|immunologic factors|mesh-ancestor
111457306|NCT00002051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111457307|NCT00001499|Paclitaxel|paclitaxel|mesh-list
111457308|NCT00001499|Cisplatin|cisplatin|mesh-list
111457309|NCT00001499|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111457310|NCT00001499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111457311|NCT00001499|Tubulin Modulators|tubulin modulators|mesh-ancestor
111457312|NCT00001499|Antimitotic Agents|antimitotic agents|mesh-ancestor
111457313|NCT00001499|Mitosis Modulators|mitosis modulators|mesh-ancestor
111457314|NCT00001499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111457315|NCT00002057|Nystatin|nystatin|mesh-list
111457316|NCT00002057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111457317|NCT00002057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111457318|NCT00002057|Antifungal Agents|antifungal agents|mesh-ancestor
111457319|NCT00002057|Ionophores|ionophores|mesh-ancestor
111457320|NCT00002057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111457321|NCT00002057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111457322|NCT00002297|Inosine Pranobex|inosine pranobex|mesh-list
111457323|NCT00002297|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111457324|NCT00002297|Immunologic Factors|immunologic factors|mesh-ancestor
111457325|NCT00002297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111457326|NCT00002297|Antiviral Agents|antiviral agents|mesh-ancestor
111457327|NCT00002297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111457328|NCT00001535|Interleukin-2|interleukin-2|mesh-list
111457329|NCT00001535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111457330|NCT00001535|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111457331|NCT00001535|Analgesics|analgesics|mesh-ancestor
111457332|NCT00001535|Sensory System Agents|sensory system agents|mesh-ancestor
111457333|NCT00001535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111457334|NCT00001535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111457335|NCT00002303|Epoetin Alfa|epoetin alfa|mesh-list
111457336|NCT00002303|Hematinics|hematinics|mesh-ancestor
111457337|NCT00002063|Zidovudine|zidovudine|mesh-list
111457338|NCT00002063|Antimetabolites|antimetabolites|mesh-ancestor
111457339|NCT00002063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111457340|NCT00002063|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111457341|NCT00002063|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111457342|NCT00002063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111457343|NCT00002063|Antiviral Agents|antiviral agents|mesh-ancestor
111457344|NCT00002063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111457345|NCT00002063|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111457346|NCT00002063|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111457347|NCT00002069|Ditiocarb|ditiocarb|mesh-list
111457348|NCT00002069|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111457349|NCT00002069|Immunologic Factors|immunologic factors|mesh-ancestor
111457350|NCT00002069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111181521|NCT00636610|Bevacizumab|bevacizumab|mesh-list
111457352|NCT00002069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111457353|NCT00002069|Chelating Agents|chelating agents|mesh-ancestor
111457354|NCT00002069|Sequestering Agents|sequestering agents|mesh-ancestor
111457355|NCT00002069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111457356|NCT00001565|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
111457357|NCT00001565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111457358|NCT00002309|Azithromycin|azithromycin|mesh-list
111457359|NCT00002309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111457360|NCT00002309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111457361|NCT00002315|Acyclovir|acyclovir|mesh-list
111457362|NCT00002315|5-propynylarabinofuranosyluracil|5-propynylarabinofuranosyluracil|mesh-list
111457363|NCT00002315|Antiviral Agents|antiviral agents|mesh-ancestor
111457364|NCT00002315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111457365|NCT00002075|Fluconazole|fluconazole|mesh-list
111457366|NCT00002075|Amphotericin B|amphotericin b|mesh-list
111457367|NCT00002075|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
111457368|NCT00002075|Flucytosine|flucytosine|mesh-list
111457369|NCT00002075|Antifungal Agents|antifungal agents|mesh-ancestor
111457370|NCT00002075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111457371|NCT00002075|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111457372|NCT00002075|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111457373|NCT00002075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111457374|NCT00002075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111457375|NCT00002075|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111457376|NCT00002075|Hormone Antagonists|hormone antagonists|mesh-ancestor
111457377|NCT00002075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111457378|NCT00002075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111457379|NCT00002075|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111457380|NCT00002075|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111457381|NCT00002075|Amebicides|amebicides|mesh-ancestor
111457382|NCT00002075|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111457383|NCT00002075|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111457384|NCT00002075|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111457385|NCT00002075|Antimetabolites|antimetabolites|mesh-ancestor
111457386|NCT00001577|Melphalan|melphalan|mesh-list
111457387|NCT00001577|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111457388|NCT00001577|Alkylating Agents|alkylating agents|mesh-ancestor
111457389|NCT00001577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111457390|NCT00001577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111457391|NCT00001577|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111457392|NCT00001577|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111457393|NCT00001577|Immunologic Factors|immunologic factors|mesh-ancestor
111457394|NCT00001577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111457395|NCT00002081|Zidovudine|zidovudine|mesh-list
111457396|NCT00002081|Zalcitabine|zalcitabine|mesh-list
111457397|NCT00002081|Antimetabolites|antimetabolites|mesh-ancestor
111457398|NCT00002081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111457399|NCT00002081|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111457400|NCT00002081|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111457401|NCT00002081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111457402|NCT00002081|Antiviral Agents|antiviral agents|mesh-ancestor
111457403|NCT00002081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111457404|NCT00002081|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111457405|NCT00002081|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111457406|NCT00002093|Doxorubicin|doxorubicin|mesh-list
111457407|NCT00002093|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111457408|NCT00002093|Daunorubicin|daunorubicin|mesh-list
111457409|NCT00002093|Bleomycin|bleomycin|mesh-list
111457410|NCT00002093|Vincristine|vincristine|mesh-list
111457411|NCT00002093|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111457412|NCT00002093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111457413|NCT00002093|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111457414|NCT00002093|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111457415|NCT00002093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111457416|NCT00002093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111457417|NCT00002093|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111457418|NCT00002093|Tubulin Modulators|tubulin modulators|mesh-ancestor
111457419|NCT00002093|Antimitotic Agents|antimitotic agents|mesh-ancestor
111457420|NCT00002093|Mitosis Modulators|mitosis modulators|mesh-ancestor
111457421|NCT00002099|Didanosine|didanosine|mesh-list
111457422|NCT00002099|Lentinan|lentinan|mesh-list
111457423|NCT00002099|Antimetabolites|antimetabolites|mesh-ancestor
111457424|NCT00002099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111457425|NCT00002099|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111457426|NCT00002099|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111457427|NCT00002099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111457428|NCT00002099|Antiviral Agents|antiviral agents|mesh-ancestor
111457429|NCT00002099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111457430|NCT00002099|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111457431|NCT00002099|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111457432|NCT00002099|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111457433|NCT00002099|Immunologic Factors|immunologic factors|mesh-ancestor
111457434|NCT00002099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111457435|NCT00002099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111457436|NCT00002321|Aldesleukin|aldesleukin|mesh-list
111457437|NCT00002321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111457438|NCT00002321|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111457439|NCT00002321|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111457440|NCT00002321|Antiviral Agents|antiviral agents|mesh-ancestor
111457441|NCT00002321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111457442|NCT00002327|Cidofovir|cidofovir|mesh-list
111457443|NCT00002327|Antiviral Agents|antiviral agents|mesh-ancestor
111457444|NCT00002327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111457445|NCT00002327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111457446|NCT00002327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111457447|NCT00002333|Saquinavir|saquinavir|mesh-list
111457448|NCT00002333|Zalcitabine|zalcitabine|mesh-list
111457449|NCT00002333|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111457450|NCT00002333|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111457451|NCT00002333|Protease Inhibitors|protease inhibitors|mesh-ancestor
111457452|NCT00002333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111457453|NCT00002333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111457454|NCT00002333|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111457455|NCT00002333|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111457456|NCT00002333|Antiviral Agents|antiviral agents|mesh-ancestor
111457457|NCT00002333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111457458|NCT00002333|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111457459|NCT00002333|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111457460|NCT00002333|Antimetabolites|antimetabolites|mesh-ancestor
111457461|NCT00002333|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111457462|NCT00002333|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111457463|NCT00002339|Fluconazole|fluconazole|mesh-list
111457464|NCT00002339|Antifungal Agents|antifungal agents|mesh-ancestor
111457465|NCT00002339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111457466|NCT00002339|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111457467|NCT00002339|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111457468|NCT00002339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111457469|NCT00002339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111457470|NCT00002339|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111457471|NCT00002339|Hormone Antagonists|hormone antagonists|mesh-ancestor
111457472|NCT00002339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111457473|NCT00002339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111457474|NCT00002339|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111457475|NCT00002339|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111457476|NCT00002105|Doxorubicin|doxorubicin|mesh-list
111457477|NCT00002105|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111457478|NCT00002105|Bleomycin|bleomycin|mesh-list
111457479|NCT00002105|Vincristine|vincristine|mesh-list
111457480|NCT00002105|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111457481|NCT00002105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111457482|NCT00002105|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111457483|NCT00002105|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111457484|NCT00002105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111457485|NCT00002105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111457486|NCT00002105|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111457487|NCT00002105|Tubulin Modulators|tubulin modulators|mesh-ancestor
111457488|NCT00002105|Antimitotic Agents|antimitotic agents|mesh-ancestor
111457489|NCT00002105|Mitosis Modulators|mitosis modulators|mesh-ancestor
111457490|NCT00002345|Megestrol|megestrol|mesh-list
111457491|NCT00002345|Megestrol Acetate|megestrol acetate|mesh-list
111457492|NCT00002345|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111457493|NCT00002345|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111457494|NCT00002345|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111457495|NCT00002345|Contraceptive Agents|contraceptive agents|mesh-ancestor
111457496|NCT00002345|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111457497|NCT00002345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111457498|NCT00002345|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111457499|NCT00002345|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111457500|NCT00002345|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111457501|NCT00002345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111457502|NCT00002345|Appetite Stimulants|appetite stimulants|mesh-ancestor
111457503|NCT00002345|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111457504|NCT00002111|Saquinavir|saquinavir|mesh-list
111457505|NCT00002111|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110934009|NCT05476172|Norethindrone|norethindrone|mesh-list
111457506|NCT00002111|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111457507|NCT00002111|Protease Inhibitors|protease inhibitors|mesh-ancestor
111457508|NCT00002111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111457509|NCT00002111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111457510|NCT00002111|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111457511|NCT00002111|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111457512|NCT00002111|Antiviral Agents|antiviral agents|mesh-ancestor
111457513|NCT00002111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111457514|NCT00002111|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111457515|NCT00002111|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111457516|NCT00002351|Indinavir|indinavir|mesh-list
111457517|NCT00002351|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111457518|NCT00002351|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111457519|NCT00002351|Protease Inhibitors|protease inhibitors|mesh-ancestor
111457520|NCT00002351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111457521|NCT00002351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111457522|NCT00002351|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111457523|NCT00002351|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111457524|NCT00002351|Antiviral Agents|antiviral agents|mesh-ancestor
111457525|NCT00002351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111457526|NCT00002357|Zidovudine|zidovudine|mesh-list
111457527|NCT00002357|Antimetabolites|antimetabolites|mesh-ancestor
111457528|NCT00002357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111457529|NCT00002357|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111457530|NCT00002357|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111457531|NCT00002357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111457532|NCT00002357|Antiviral Agents|antiviral agents|mesh-ancestor
111457533|NCT00002357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111457534|NCT00002357|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111457535|NCT00002357|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111457536|NCT00002117|Zidovudine|zidovudine|mesh-list
111457537|NCT00002117|Zalcitabine|zalcitabine|mesh-list
111457538|NCT00002117|Antimetabolites|antimetabolites|mesh-ancestor
111457539|NCT00002117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111457540|NCT00002117|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111457541|NCT00002117|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111457542|NCT00002117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111457543|NCT00002117|Antiviral Agents|antiviral agents|mesh-ancestor
111457544|NCT00002117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111457545|NCT00002117|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111457546|NCT00002117|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111457547|NCT00002123|Didanosine|didanosine|mesh-list
111457548|NCT00002123|Delavirdine|delavirdine|mesh-list
111457549|NCT00002123|Antimetabolites|antimetabolites|mesh-ancestor
111457550|NCT00002123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111457551|NCT00002123|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111457552|NCT00002123|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111457553|NCT00002123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111457554|NCT00002123|Antiviral Agents|antiviral agents|mesh-ancestor
111457555|NCT00002123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111457556|NCT00002123|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111457557|NCT00002123|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111457558|NCT00381173|Cyclophosphamide|cyclophosphamide|mesh-list
111457559|NCT00381173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111457560|NCT00381173|Immunologic Factors|immunologic factors|mesh-ancestor
111457561|NCT00381173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111457562|NCT00381173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111457563|NCT00381173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111457564|NCT00381173|Alkylating Agents|alkylating agents|mesh-ancestor
111457565|NCT00381173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111457566|NCT00381173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111457567|NCT00381173|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111457568|NCT00002129|Vesnarinone|vesnarinone|mesh-list
111457569|NCT00002129|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111457570|NCT00002129|Immunologic Factors|immunologic factors|mesh-ancestor
111457571|NCT00002129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111457572|NCT00002129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111457573|NCT00002129|Antiviral Agents|antiviral agents|mesh-ancestor
111457574|NCT00002129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111457575|NCT00002129|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111457576|NCT00002129|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111457577|NCT00002129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111457578|NCT00002129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111457579|NCT00002129|Protective Agents|protective agents|mesh-ancestor
111457580|NCT00002135|Ganciclovir|ganciclovir|mesh-list
111457581|NCT00002135|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
111457582|NCT00002135|Antiviral Agents|antiviral agents|mesh-ancestor
111457583|NCT00002135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111457584|NCT00002135|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111457585|NCT00002135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111457586|NCT00002135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111457587|NCT00002141|Abacavir|abacavir|mesh-list
111457588|NCT00002141|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111457589|NCT00002141|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111457590|NCT00002141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111457591|NCT00002141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111457592|NCT00002141|Antiviral Agents|antiviral agents|mesh-ancestor
111457593|NCT00002141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111457594|NCT00002141|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111457595|NCT00002141|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111457596|NCT00002369|Lamivudine|lamivudine|mesh-list
111457597|NCT00002369|Zidovudine|zidovudine|mesh-list
111457598|NCT00002369|Stavudine|stavudine|mesh-list
111457599|NCT00002369|Indinavir|indinavir|mesh-list
111457600|NCT00002369|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111457601|NCT00002369|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111457602|NCT00002369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111457603|NCT00002369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111457604|NCT00002369|Antiviral Agents|antiviral agents|mesh-ancestor
111457605|NCT00002369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111457606|NCT00002369|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111457607|NCT00002369|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111457608|NCT00002369|Antimetabolites|antimetabolites|mesh-ancestor
111457609|NCT00002369|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111457610|NCT00002369|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111457611|NCT00002369|Protease Inhibitors|protease inhibitors|mesh-ancestor
111457612|NCT00002375|Nelfinavir|nelfinavir|mesh-list
111457613|NCT00002375|Indinavir|indinavir|mesh-list
111457614|NCT00002375|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111457615|NCT00002375|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111457616|NCT00002375|Protease Inhibitors|protease inhibitors|mesh-ancestor
111457617|NCT00002375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111457618|NCT00002375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111457619|NCT00002375|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111457620|NCT00002375|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111457621|NCT00002375|Antiviral Agents|antiviral agents|mesh-ancestor
111457622|NCT00002375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111457623|NCT00002381|Nevirapine|nevirapine|mesh-list
111457624|NCT00002381|Stavudine|stavudine|mesh-list
111457625|NCT00002381|Nelfinavir|nelfinavir|mesh-list
111457626|NCT00002381|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111457627|NCT00002381|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111457628|NCT00002381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111457629|NCT00002381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111457630|NCT00002381|Antiviral Agents|antiviral agents|mesh-ancestor
111457631|NCT00002381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111457632|NCT00002381|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111457633|NCT00002381|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111457634|NCT00002381|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111457635|NCT00002381|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111457636|NCT00002381|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111457637|NCT00002381|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111457638|NCT00002381|Protease Inhibitors|protease inhibitors|mesh-ancestor
111457639|NCT00002381|Antimetabolites|antimetabolites|mesh-ancestor
111457640|NCT00002387|Efavirenz|efavirenz|mesh-list
111457641|NCT00002387|Indinavir|indinavir|mesh-list
111457642|NCT00002387|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111457643|NCT00002387|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111457644|NCT00002387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111457645|NCT00002387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111457646|NCT00002387|Antiviral Agents|antiviral agents|mesh-ancestor
111457647|NCT00002387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111457648|NCT00002387|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111457649|NCT00002387|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111457650|NCT00002387|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111457651|NCT00002387|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111457652|NCT00002387|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111457653|NCT00002387|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111457654|NCT00002387|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111457655|NCT00002387|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111457656|NCT00002387|Protease Inhibitors|protease inhibitors|mesh-ancestor
111457657|NCT00002387|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111457658|NCT00002387|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111457659|NCT00002393|Efavirenz|efavirenz|mesh-list
111457660|NCT00002393|Indinavir|indinavir|mesh-list
111457661|NCT00002393|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111457662|NCT00002393|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111457663|NCT00002393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111457664|NCT00002393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111457665|NCT00002393|Antiviral Agents|antiviral agents|mesh-ancestor
111457666|NCT00002393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111457667|NCT00002393|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111457668|NCT00002393|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111457669|NCT00002393|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111457670|NCT00002393|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111457671|NCT00002393|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111457672|NCT00002393|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111457673|NCT00002393|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111457674|NCT00002393|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111457675|NCT00002393|Protease Inhibitors|protease inhibitors|mesh-ancestor
111457676|NCT00002393|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111457677|NCT00002393|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111457678|NCT00002399|Fluconazole|fluconazole|mesh-list
111457679|NCT00002399|Posaconazole|posaconazole|mesh-list
111457680|NCT00002399|Antifungal Agents|antifungal agents|mesh-ancestor
111457681|NCT00002399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111457682|NCT00002399|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111457683|NCT00002399|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111457684|NCT00002399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111457685|NCT00002399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111457686|NCT00002399|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111457687|NCT00002399|Hormone Antagonists|hormone antagonists|mesh-ancestor
111457688|NCT00002399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111457689|NCT00002399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111457690|NCT00002399|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111457691|NCT00002399|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111457692|NCT00002399|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
111457693|NCT00002399|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111457694|NCT00002399|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111457695|NCT00002405|Amprenavir|amprenavir|mesh-list
111457696|NCT00002405|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111457697|NCT00002405|Antitubercular Agents|antitubercular agents|mesh-ancestor
111457698|NCT00002405|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111457699|NCT00002405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110934217|NCT05108688|Mirtazapine|mirtazapine|mesh-list
111457700|NCT00002405|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111457701|NCT00002405|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111457702|NCT00002405|Protease Inhibitors|protease inhibitors|mesh-ancestor
111457703|NCT00002405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111457704|NCT00002405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111457705|NCT00002405|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111457706|NCT00002405|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111457707|NCT00002405|Antiviral Agents|antiviral agents|mesh-ancestor
111457708|NCT00002417|Amprenavir|amprenavir|mesh-list
111457709|NCT00002417|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111457710|NCT00002417|Antitubercular Agents|antitubercular agents|mesh-ancestor
111457711|NCT00002417|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111457712|NCT00002417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111457713|NCT00002417|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111457714|NCT00002417|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111457715|NCT00002417|Protease Inhibitors|protease inhibitors|mesh-ancestor
111457716|NCT00002417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111457717|NCT00002417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111457718|NCT00002417|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111457719|NCT00002417|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111457720|NCT00002417|Antiviral Agents|antiviral agents|mesh-ancestor
111457721|NCT00002423|Lamivudine|lamivudine|mesh-list
111457722|NCT00002423|Abacavir|abacavir|mesh-list
111457723|NCT00002423|Nelfinavir|nelfinavir|mesh-list
111181892|NCT01921192|Vitamins|vitamins|mesh-ancestor
111457724|NCT00002423|Indinavir|indinavir|mesh-list
111457725|NCT00002423|Amprenavir|amprenavir|mesh-list
111457726|NCT00002423|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111457727|NCT00002423|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111457728|NCT00002423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111457729|NCT00002423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111457730|NCT00002423|Antiviral Agents|antiviral agents|mesh-ancestor
111457731|NCT00002423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111457732|NCT00002423|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111457733|NCT00002423|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111457734|NCT00002423|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111457735|NCT00002423|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111457736|NCT00002423|Protease Inhibitors|protease inhibitors|mesh-ancestor
111457737|NCT00002423|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111457738|NCT00002423|Antitubercular Agents|antitubercular agents|mesh-ancestor
111457739|NCT00002423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111457740|NCT02973581|Acetaminophen|acetaminophen|mesh-list
111457741|NCT02973581|Dipyrone|dipyrone|mesh-list
111457742|NCT02973581|Lidocaine|lidocaine|mesh-list
111457743|NCT02973581|Bupivacaine|bupivacaine|mesh-list
111457744|NCT02973581|Proxymetacaine|proxymetacaine|mesh-list
111457745|NCT02973581|Anesthetics, Local|anesthetics, local|mesh-ancestor
111457746|NCT02973581|Anesthetics|anesthetics|mesh-ancestor
111457747|NCT02973581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111457748|NCT02973581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111457749|NCT02973581|Sensory System Agents|sensory system agents|mesh-ancestor
111457750|NCT02973581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111457751|NCT02973581|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111457752|NCT02973581|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111457753|NCT02973581|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111457754|NCT02973581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111457755|NCT02973581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111457756|NCT02973581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111457757|NCT02973581|Analgesics|analgesics|mesh-ancestor
111457758|NCT02973581|Antipyretics|antipyretics|mesh-ancestor
111457759|NCT02973581|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111457760|NCT02973581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111457761|NCT02973581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111457762|NCT00002435|Zidovudine|zidovudine|mesh-list
111457763|NCT00002435|Antimetabolites|antimetabolites|mesh-ancestor
111457764|NCT00002435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111457765|NCT00002435|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111457766|NCT00002435|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111457767|NCT00002435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111457768|NCT00002435|Antiviral Agents|antiviral agents|mesh-ancestor
111457769|NCT00002435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111457770|NCT00002435|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111457771|NCT00002435|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111457772|NCT00002447|Ritonavir|ritonavir|mesh-list
111457773|NCT00002447|Saquinavir|saquinavir|mesh-list
111457774|NCT00002447|Efavirenz|efavirenz|mesh-list
111457775|NCT00002447|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111457776|NCT00002447|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111457777|NCT00002447|Protease Inhibitors|protease inhibitors|mesh-ancestor
111457778|NCT00002447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111457779|NCT00002447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111457780|NCT00002447|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111457781|NCT00002447|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111457782|NCT00002447|Antiviral Agents|antiviral agents|mesh-ancestor
111457783|NCT00002447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111457784|NCT00002447|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111457785|NCT00002447|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111457786|NCT00002447|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111457787|NCT00002447|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111457788|NCT00002447|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111457789|NCT00002447|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111457790|NCT00002447|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111457791|NCT00002447|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111457792|NCT00002447|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111457793|NCT00002453|Tenofovir|tenofovir|mesh-list
111457794|NCT00002453|Antiviral Agents|antiviral agents|mesh-ancestor
111457795|NCT00002453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111457796|NCT00002453|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111457797|NCT00002453|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111181977|NCT00984568|Analgesics|analgesics|mesh-ancestor
111457798|NCT00002453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111457799|NCT00002453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111457800|NCT00002453|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111457801|NCT00002453|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111457803|NCT00002465|Megestrol Acetate|megestrol acetate|mesh-list
111457804|NCT00002465|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111457805|NCT00002465|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111457806|NCT00002465|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111457807|NCT00002465|Contraceptive Agents|contraceptive agents|mesh-ancestor
111457808|NCT00002465|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111457809|NCT00002465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111457810|NCT00002465|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111457811|NCT00002465|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111457812|NCT00002465|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111457813|NCT00002465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111457814|NCT00002465|Appetite Stimulants|appetite stimulants|mesh-ancestor
111457815|NCT00002465|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111457816|NCT00002471|Leucovorin|leucovorin|mesh-list
111457817|NCT00002471|Cytarabine|cytarabine|mesh-list
111457818|NCT00002471|Dexamethasone|dexamethasone|mesh-list
111457819|NCT00002471|Methylprednisolone|methylprednisolone|mesh-list
111457820|NCT00002471|Hydrocortisone|hydrocortisone|mesh-list
111457821|NCT00002471|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
111457822|NCT00002471|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
111457823|NCT00002471|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
111457824|NCT00002471|Cyclophosphamide|cyclophosphamide|mesh-list
111457825|NCT00002471|Thiotepa|thiotepa|mesh-list
111457826|NCT00002471|Methotrexate|methotrexate|mesh-list
111457827|NCT00002471|Etoposide|etoposide|mesh-list
111457828|NCT00002471|Vincristine|vincristine|mesh-list
111457829|NCT00002471|Daunorubicin|daunorubicin|mesh-list
111457830|NCT00002471|Asparaginase|asparaginase|mesh-list
111457831|NCT00002471|Levoleucovorin|levoleucovorin|mesh-list
111457832|NCT00002471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110934351|NCT04898387|Timolol|timolol|mesh-list
111457833|NCT00002471|Immunologic Factors|immunologic factors|mesh-ancestor
111457834|NCT00002471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111457835|NCT00002471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111457836|NCT00002471|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111457837|NCT00002471|Alkylating Agents|alkylating agents|mesh-ancestor
111457838|NCT00002471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111457839|NCT00002471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111457840|NCT00002471|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111457841|NCT00002471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111457842|NCT00002471|Antiemetics|antiemetics|mesh-ancestor
111457843|NCT00002471|Autonomic Agents|autonomic agents|mesh-ancestor
111457844|NCT00002471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111457845|NCT00002471|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111457846|NCT00002471|Glucocorticoids|glucocorticoids|mesh-ancestor
111457847|NCT00002471|Hormones|hormones|mesh-ancestor
111457848|NCT00002471|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111457849|NCT00002471|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111457850|NCT00002471|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111457851|NCT00002471|Abortifacient Agents|abortifacient agents|mesh-ancestor
111457852|NCT00002471|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111457853|NCT00002471|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111457854|NCT00002471|Antimetabolites|antimetabolites|mesh-ancestor
111457855|NCT00002471|Dermatologic Agents|dermatologic agents|mesh-ancestor
111457856|NCT00002471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111457857|NCT00002471|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111457858|NCT00002471|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111457859|NCT00002471|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111457860|NCT00002471|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111457861|NCT00002471|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111457862|NCT00002471|Antiviral Agents|antiviral agents|mesh-ancestor
111457863|NCT00002471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111457864|NCT00002471|Antidotes|antidotes|mesh-ancestor
111457865|NCT00002471|Protective Agents|protective agents|mesh-ancestor
111457866|NCT00002471|Vitamin B Complex|vitamin b complex|mesh-ancestor
111457867|NCT00002471|Vitamins|vitamins|mesh-ancestor
111457868|NCT00002471|Micronutrients|micronutrients|mesh-ancestor
111457869|NCT00002471|Tubulin Modulators|tubulin modulators|mesh-ancestor
111457870|NCT00002471|Antimitotic Agents|antimitotic agents|mesh-ancestor
111457871|NCT00002471|Mitosis Modulators|mitosis modulators|mesh-ancestor
111457872|NCT00002471|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111457873|NCT00002471|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111457874|NCT00002477|Cyclophosphamide|cyclophosphamide|mesh-list
111457875|NCT00002477|Carboplatin|carboplatin|mesh-list
111457876|NCT00002477|Doxorubicin|doxorubicin|mesh-list
111457877|NCT00002477|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111457878|NCT00002477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111457879|NCT00002477|Immunologic Factors|immunologic factors|mesh-ancestor
111457880|NCT00002477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111457881|NCT00002477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111457882|NCT00002477|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111457883|NCT00002477|Alkylating Agents|alkylating agents|mesh-ancestor
111457884|NCT00002477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111457885|NCT00002477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111457886|NCT00002477|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111457887|NCT00002477|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111457888|NCT00002477|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111457889|NCT00002477|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111457890|NCT00002477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111457891|NCT00002489|Leucovorin|leucovorin|mesh-list
111457892|NCT00002489|Dactinomycin|dactinomycin|mesh-list
111457893|NCT00002489|Cyclophosphamide|cyclophosphamide|mesh-list
111457894|NCT00002489|Carboplatin|carboplatin|mesh-list
111457895|NCT00002489|Doxorubicin|doxorubicin|mesh-list
111457896|NCT00002489|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111457897|NCT00002489|Methotrexate|methotrexate|mesh-list
111457898|NCT00002489|Etoposide|etoposide|mesh-list
111457899|NCT00002489|Vincristine|vincristine|mesh-list
111457900|NCT00002489|Levoleucovorin|levoleucovorin|mesh-list
111457901|NCT00002489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111457902|NCT00002489|Immunologic Factors|immunologic factors|mesh-ancestor
111457903|NCT00002489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111457904|NCT00002489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111457905|NCT00002489|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111457906|NCT00002489|Alkylating Agents|alkylating agents|mesh-ancestor
111457907|NCT00002489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111457908|NCT00002489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111457909|NCT00002489|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111457910|NCT00002489|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111457911|NCT00002489|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111457912|NCT00002489|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111457913|NCT00002489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111457914|NCT00002489|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111457915|NCT00002489|Abortifacient Agents|abortifacient agents|mesh-ancestor
111457916|NCT00002489|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111457917|NCT00002489|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111457918|NCT00002489|Antimetabolites|antimetabolites|mesh-ancestor
111457919|NCT00002489|Dermatologic Agents|dermatologic agents|mesh-ancestor
111457920|NCT00002489|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111457921|NCT00002489|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111457922|NCT00002489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111457923|NCT00002489|Antidotes|antidotes|mesh-ancestor
111457924|NCT00002489|Protective Agents|protective agents|mesh-ancestor
111457925|NCT00002489|Vitamin B Complex|vitamin b complex|mesh-ancestor
111457926|NCT00002489|Vitamins|vitamins|mesh-ancestor
111457927|NCT00002489|Micronutrients|micronutrients|mesh-ancestor
111457928|NCT00002489|Tubulin Modulators|tubulin modulators|mesh-ancestor
111457929|NCT00002489|Antimitotic Agents|antimitotic agents|mesh-ancestor
111457930|NCT00002489|Mitosis Modulators|mitosis modulators|mesh-ancestor
111457931|NCT00002489|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111457932|NCT00002489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111457933|NCT00002489|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111457934|NCT00002495|Doxorubicin|doxorubicin|mesh-list
111457935|NCT00002495|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111457936|NCT00002495|Vinblastine|vinblastine|mesh-list
111457937|NCT00002495|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111457938|NCT00002495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111457939|NCT00002495|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111457940|NCT00002495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111457941|NCT00002495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111457942|NCT00002495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111457943|NCT00002495|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111457944|NCT00002495|Tubulin Modulators|tubulin modulators|mesh-ancestor
111457945|NCT00002495|Antimitotic Agents|antimitotic agents|mesh-ancestor
111457946|NCT00002495|Mitosis Modulators|mitosis modulators|mesh-ancestor
111457947|NCT00002501|Cyclophosphamide|cyclophosphamide|mesh-list
111457948|NCT00002501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111457949|NCT00002501|Immunologic Factors|immunologic factors|mesh-ancestor
111457950|NCT00002501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111457951|NCT00002501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111457952|NCT00002501|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111457953|NCT00002501|Alkylating Agents|alkylating agents|mesh-ancestor
111457954|NCT00002501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111457955|NCT00002501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111457956|NCT00002501|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111457957|NCT00002147|Doxorubicin|doxorubicin|mesh-list
111457958|NCT00002147|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111457959|NCT00002147|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111457960|NCT00002147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111457961|NCT00002147|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111457962|NCT00002147|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111457963|NCT00002147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111457964|NCT00002147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111457965|NCT00002159|Itraconazole|itraconazole|mesh-list
111457966|NCT00002159|Amphotericin B|amphotericin b|mesh-list
111457967|NCT00002159|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
111457968|NCT00002159|Antifungal Agents|antifungal agents|mesh-ancestor
111457969|NCT00002159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111457970|NCT00002159|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111457971|NCT00002159|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111457972|NCT00002159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111457973|NCT00002159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111457974|NCT00002159|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111457975|NCT00002159|Hormone Antagonists|hormone antagonists|mesh-ancestor
111457976|NCT00002159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111457977|NCT00002159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111457978|NCT00002159|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111457979|NCT00002159|Amebicides|amebicides|mesh-ancestor
111457980|NCT00002159|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111457981|NCT00002159|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111457982|NCT00002159|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111457983|NCT00002165|Nelfinavir|nelfinavir|mesh-list
111457984|NCT00002165|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111457985|NCT00002165|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111457986|NCT00002165|Protease Inhibitors|protease inhibitors|mesh-ancestor
111457987|NCT00002165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111457988|NCT00002165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111457989|NCT00002165|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111457990|NCT00002165|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111457991|NCT00002165|Antiviral Agents|antiviral agents|mesh-ancestor
111457992|NCT00002165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111457993|NCT00002171|Nelfinavir|nelfinavir|mesh-list
111457994|NCT00002171|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111457995|NCT00002171|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111457996|NCT00002171|Protease Inhibitors|protease inhibitors|mesh-ancestor
111457997|NCT00002171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111457998|NCT00002171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111457999|NCT00002171|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111458000|NCT00002171|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111458001|NCT00002171|Antiviral Agents|antiviral agents|mesh-ancestor
111458002|NCT00002171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111458003|NCT00002177|Nelfinavir|nelfinavir|mesh-list
111458004|NCT00002177|Stavudine|stavudine|mesh-list
111458005|NCT00002177|Didanosine|didanosine|mesh-list
111458006|NCT00002177|Hydroxyurea|hydroxyurea|mesh-list
111458007|NCT00002177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111458008|NCT00002177|Antisickling Agents|antisickling agents|mesh-ancestor
111458009|NCT00002177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111458010|NCT00002177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111458011|NCT00002177|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111458012|NCT00002177|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111458013|NCT00002177|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111458014|NCT00002177|Protease Inhibitors|protease inhibitors|mesh-ancestor
111458015|NCT00002177|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111458016|NCT00002177|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111458017|NCT00002177|Antiviral Agents|antiviral agents|mesh-ancestor
111458018|NCT00002177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111458019|NCT00002177|Antimetabolites|antimetabolites|mesh-ancestor
111458020|NCT00002177|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111458021|NCT00002183|Lamivudine|lamivudine|mesh-list
111458022|NCT00002183|Zidovudine|zidovudine|mesh-list
111458023|NCT00002183|Abacavir|abacavir|mesh-list
111182193|NCT04274920|Calcium|calcium|mesh-list
111458024|NCT00002183|Amprenavir|amprenavir|mesh-list
111458025|NCT00002183|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111458026|NCT00002183|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111458027|NCT00002183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111458028|NCT00002183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111458029|NCT00002183|Antiviral Agents|antiviral agents|mesh-ancestor
111458030|NCT00002183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111458031|NCT00002183|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111458032|NCT00002183|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111458033|NCT00002183|Antimetabolites|antimetabolites|mesh-ancestor
111458034|NCT00002183|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111458035|NCT00002183|Antitubercular Agents|antitubercular agents|mesh-ancestor
111458036|NCT00002183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111458037|NCT00002183|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111458038|NCT00002183|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111458039|NCT00002183|Protease Inhibitors|protease inhibitors|mesh-ancestor
111458040|NCT00002189|Paclitaxel|paclitaxel|mesh-list
111458041|NCT00002189|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111458042|NCT00002189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111458043|NCT00002189|Tubulin Modulators|tubulin modulators|mesh-ancestor
111458044|NCT00002189|Antimitotic Agents|antimitotic agents|mesh-ancestor
111458045|NCT00002189|Mitosis Modulators|mitosis modulators|mesh-ancestor
111458046|NCT00002189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111458047|NCT00002195|Lamivudine|lamivudine|mesh-list
111458048|NCT00002195|Zidovudine|zidovudine|mesh-list
111458049|NCT00002195|Amprenavir|amprenavir|mesh-list
111458050|NCT00002195|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111458051|NCT00002195|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111458052|NCT00002195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111458053|NCT00002195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111458054|NCT00002195|Antiviral Agents|antiviral agents|mesh-ancestor
111458055|NCT00002195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111458056|NCT00002195|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111458057|NCT00002195|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111458058|NCT00002195|Antimetabolites|antimetabolites|mesh-ancestor
111458059|NCT00002195|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111458060|NCT00002195|Antitubercular Agents|antitubercular agents|mesh-ancestor
111458061|NCT00002195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111458062|NCT00002195|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111458063|NCT00002195|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111458064|NCT00002195|Protease Inhibitors|protease inhibitors|mesh-ancestor
111458065|NCT00002201|Ritonavir|ritonavir|mesh-list
111458066|NCT00002201|Nelfinavir|nelfinavir|mesh-list
111458067|NCT00002201|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111458068|NCT00002201|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111458069|NCT00002201|Protease Inhibitors|protease inhibitors|mesh-ancestor
111458070|NCT00002201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111458071|NCT00002201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111458072|NCT00002201|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111458073|NCT00002201|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111458074|NCT00002201|Antiviral Agents|antiviral agents|mesh-ancestor
111458075|NCT00002201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111458076|NCT00002201|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111458077|NCT00002201|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111458078|NCT00002213|Efavirenz|efavirenz|mesh-list
111458079|NCT00002213|Abacavir|abacavir|mesh-list
111458080|NCT00002213|Amprenavir|amprenavir|mesh-list
111458081|NCT00002213|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111458082|NCT00002213|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111458083|NCT00002213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111458084|NCT00002213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111458085|NCT00002213|Antiviral Agents|antiviral agents|mesh-ancestor
111458086|NCT00002213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111458087|NCT00002213|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111458088|NCT00002213|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111458089|NCT00002213|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111458090|NCT00002213|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111458091|NCT00002213|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111458092|NCT00002213|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111458093|NCT00002213|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111458094|NCT00002213|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111458095|NCT00002213|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111458096|NCT00002213|Antitubercular Agents|antitubercular agents|mesh-ancestor
111458097|NCT00002213|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111458098|NCT00002213|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111458099|NCT00002213|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110934606|NCT03869996|Cytarabine|cytarabine|mesh-list
111458100|NCT00002213|Protease Inhibitors|protease inhibitors|mesh-ancestor
111458101|NCT00381251|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
111458102|NCT00381251|Estrogens|estrogens|mesh-ancestor
111458104|NCT00381251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111458105|NCT00381251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111458106|NCT00002219|Nelfinavir|nelfinavir|mesh-list
111458107|NCT00002219|Adefovir|adefovir|mesh-list
111458108|NCT00002219|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
111458109|NCT00002219|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111458110|NCT00002219|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111458111|NCT00002219|Protease Inhibitors|protease inhibitors|mesh-ancestor
111458112|NCT00002219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111458113|NCT00002219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111458114|NCT00002219|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111458115|NCT00002219|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111458116|NCT00002219|Antiviral Agents|antiviral agents|mesh-ancestor
111458117|NCT00002219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111458118|NCT00002219|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111458119|NCT00002219|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111458120|NCT00002225|Efavirenz|efavirenz|mesh-list
111458121|NCT00002225|Stavudine|stavudine|mesh-list
111458122|NCT00002225|Didanosine|didanosine|mesh-list
111458123|NCT00002225|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111458124|NCT00002225|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111458125|NCT00002225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111458126|NCT00002225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111458127|NCT00002225|Antiviral Agents|antiviral agents|mesh-ancestor
111458128|NCT00002225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111458129|NCT00002225|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111458130|NCT00002225|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111458131|NCT00002225|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111458132|NCT00002225|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111458133|NCT00002225|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111458134|NCT00002225|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111458135|NCT00002225|Antimetabolites|antimetabolites|mesh-ancestor
111458136|NCT00002225|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111458137|NCT00002225|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111458138|NCT00002243|Calanolide A|calanolide a|mesh-list
111458139|NCT00002243|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111458140|NCT00002243|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111458141|NCT00002243|Antiviral Agents|antiviral agents|mesh-ancestor
111458142|NCT00002243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111458143|NCT00002249|Levofloxacin|levofloxacin|mesh-list
111458144|NCT00002249|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111458145|NCT00002249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111458146|NCT00002249|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111458147|NCT00002249|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111458148|NCT00002249|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111458149|NCT00002249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111458150|NCT00002249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111458151|NCT00002249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111458152|NCT00002249|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111458153|NCT00002249|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111458154|NCT00002255|Zidovudine|zidovudine|mesh-list
111458155|NCT00002255|Epoetin Alfa|epoetin alfa|mesh-list
111458156|NCT00002255|Antimetabolites|antimetabolites|mesh-ancestor
111458157|NCT00002255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111458158|NCT00002255|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111458159|NCT00002255|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111458160|NCT00002255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111458161|NCT00002255|Antiviral Agents|antiviral agents|mesh-ancestor
111458162|NCT00002255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111458163|NCT00002255|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111458164|NCT00002255|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111458165|NCT00002255|Hematinics|hematinics|mesh-ancestor
111458166|NCT00002261|Vaccines|vaccines|mesh-list
111458167|NCT00002261|Immunologic Factors|immunologic factors|mesh-ancestor
111458168|NCT00002261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111458169|NCT00002507|Mitomycins|mitomycins|mesh-list
111458170|NCT00002507|Mitomycin|mitomycin|mesh-list
111458171|NCT00002507|Porfiromycin|porfiromycin|mesh-list
111458172|NCT00002507|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111458173|NCT00002507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111458174|NCT00002507|Alkylating Agents|alkylating agents|mesh-ancestor
111458175|NCT00002507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111458176|NCT00002507|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111458177|NCT00002507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111458178|NCT00002519|Paclitaxel|paclitaxel|mesh-list
111458179|NCT00002519|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111458180|NCT00002519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111458181|NCT00002519|Tubulin Modulators|tubulin modulators|mesh-ancestor
111458182|NCT00002519|Antimitotic Agents|antimitotic agents|mesh-ancestor
111458183|NCT00002519|Mitosis Modulators|mitosis modulators|mesh-ancestor
111458184|NCT00002519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111458185|NCT00002267|Rifabutin|rifabutin|mesh-list
111458186|NCT00002267|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111458187|NCT00002267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111458188|NCT00002267|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111458189|NCT00002267|Antitubercular Agents|antitubercular agents|mesh-ancestor
111458190|NCT00002273|Ganciclovir|ganciclovir|mesh-list
111458191|NCT00002273|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
111458192|NCT00002273|Antiviral Agents|antiviral agents|mesh-ancestor
111458193|NCT00002273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111458194|NCT00002273|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111458195|NCT00002273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111458196|NCT00002273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111458197|NCT00002279|Zalcitabine|zalcitabine|mesh-list
111458198|NCT00002279|Antimetabolites|antimetabolites|mesh-ancestor
111458199|NCT00002279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111458200|NCT00002279|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111458201|NCT00002279|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111458202|NCT00002279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111458203|NCT00002279|Antiviral Agents|antiviral agents|mesh-ancestor
111458204|NCT00002279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111458205|NCT00002279|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111458206|NCT00002279|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111458207|NCT00002285|Zidovudine|zidovudine|mesh-list
111458208|NCT00002285|Antimetabolites|antimetabolites|mesh-ancestor
111458209|NCT00002285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111458210|NCT00002285|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111458211|NCT00002285|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111458212|NCT00002285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111458213|NCT00002285|Antiviral Agents|antiviral agents|mesh-ancestor
111458214|NCT00002285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111458215|NCT00002285|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111458216|NCT00002285|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111458217|NCT00002531|Leucovorin|leucovorin|mesh-list
111458218|NCT00002531|Cytarabine|cytarabine|mesh-list
111458219|NCT00002531|Dexamethasone|dexamethasone|mesh-list
111458220|NCT00002531|Prednisolone|prednisolone|mesh-list
111458221|NCT00002531|Cyclophosphamide|cyclophosphamide|mesh-list
111458222|NCT00002531|Ifosfamide|ifosfamide|mesh-list
111458223|NCT00002531|Doxorubicin|doxorubicin|mesh-list
111458224|NCT00002531|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111458225|NCT00002531|Methotrexate|methotrexate|mesh-list
111458226|NCT00002531|Etoposide|etoposide|mesh-list
111458227|NCT00002531|Vincristine|vincristine|mesh-list
111458228|NCT00002531|Daunorubicin|daunorubicin|mesh-list
111458229|NCT00002531|Asparaginase|asparaginase|mesh-list
111458230|NCT00002531|Mitoxantrone|mitoxantrone|mesh-list
111458231|NCT00002531|Mercaptopurine|mercaptopurine|mesh-list
111458232|NCT00002531|Thioguanine|thioguanine|mesh-list
111458233|NCT00002531|Vindesine|vindesine|mesh-list
111458234|NCT00002531|Teniposide|teniposide|mesh-list
111458235|NCT00002531|Levoleucovorin|levoleucovorin|mesh-list
111458236|NCT00002531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111458237|NCT00002531|Immunologic Factors|immunologic factors|mesh-ancestor
111458238|NCT00002531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111458239|NCT00002531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111458240|NCT00002531|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111458241|NCT00002531|Alkylating Agents|alkylating agents|mesh-ancestor
111458242|NCT00002531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111458243|NCT00002531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111458244|NCT00002531|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111458245|NCT00002531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111458246|NCT00002531|Antiemetics|antiemetics|mesh-ancestor
111458247|NCT00002531|Autonomic Agents|autonomic agents|mesh-ancestor
111458248|NCT00002531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111458249|NCT00002531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111458250|NCT00002531|Glucocorticoids|glucocorticoids|mesh-ancestor
111458251|NCT00002531|Hormones|hormones|mesh-ancestor
111458252|NCT00002531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111458253|NCT00002531|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111458254|NCT00002531|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111458255|NCT00002531|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111458256|NCT00002531|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111458257|NCT00002531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111458258|NCT00002531|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111458259|NCT00002531|Abortifacient Agents|abortifacient agents|mesh-ancestor
111458260|NCT00002531|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111458261|NCT00002531|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111458262|NCT00002531|Antimetabolites|antimetabolites|mesh-ancestor
111458263|NCT00002531|Dermatologic Agents|dermatologic agents|mesh-ancestor
111458264|NCT00002531|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111458265|NCT00002531|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111458266|NCT00002531|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111458267|NCT00002531|Antiviral Agents|antiviral agents|mesh-ancestor
111458268|NCT00002531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111458269|NCT00002531|Antidotes|antidotes|mesh-ancestor
111458270|NCT00002531|Protective Agents|protective agents|mesh-ancestor
111458271|NCT00002531|Vitamin B Complex|vitamin b complex|mesh-ancestor
111458272|NCT00002531|Vitamins|vitamins|mesh-ancestor
111458273|NCT00002531|Micronutrients|micronutrients|mesh-ancestor
111458274|NCT00002531|Tubulin Modulators|tubulin modulators|mesh-ancestor
111458275|NCT00002531|Antimitotic Agents|antimitotic agents|mesh-ancestor
111458276|NCT00002531|Mitosis Modulators|mitosis modulators|mesh-ancestor
111458277|NCT00002531|Analgesics|analgesics|mesh-ancestor
111458278|NCT00002531|Sensory System Agents|sensory system agents|mesh-ancestor
111458279|NCT00002537|Topotecan|topotecan|mesh-list
111458280|NCT00002537|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111458281|NCT00002537|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111458282|NCT00002537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111458283|NCT00002537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111458284|NCT00002537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111458285|NCT00002543|Gallium nitrate|gallium nitrate|mesh-list
111458286|NCT00002543|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111458287|NCT00002543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111458288|NCT00002543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111458289|NCT00002291|Pentamidine|pentamidine|mesh-list
111458290|NCT00002291|Antifungal Agents|antifungal agents|mesh-ancestor
111458291|NCT00002291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111458292|NCT00002291|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111458293|NCT00002291|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111458294|NCT00002291|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
111458295|NCT00002549|Cytarabine|cytarabine|mesh-list
111458296|NCT00002549|Cyclophosphamide|cyclophosphamide|mesh-list
111458297|NCT00002549|Busulfan|busulfan|mesh-list
111458298|NCT00002549|Etoposide|etoposide|mesh-list
111458299|NCT00002549|Daunorubicin|daunorubicin|mesh-list
111458300|NCT00002549|Mitoxantrone|mitoxantrone|mesh-list
111458301|NCT00002549|Idarubicin|idarubicin|mesh-list
111458302|NCT00002549|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111458303|NCT00002549|Immunologic Factors|immunologic factors|mesh-ancestor
111458304|NCT00002549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111458305|NCT00002549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111458306|NCT00002549|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111458307|NCT00002549|Alkylating Agents|alkylating agents|mesh-ancestor
111458308|NCT00002549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111458309|NCT00002549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111458310|NCT00002549|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111458311|NCT00002549|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111458312|NCT00002549|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111458313|NCT00002549|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111458314|NCT00002549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111458315|NCT00002549|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111458316|NCT00002549|Antimetabolites|antimetabolites|mesh-ancestor
111458317|NCT00002549|Antiviral Agents|antiviral agents|mesh-ancestor
111458318|NCT00002549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111458319|NCT00002549|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111458320|NCT00002549|Analgesics|analgesics|mesh-ancestor
111458321|NCT00002549|Sensory System Agents|sensory system agents|mesh-ancestor
111458322|NCT00002549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111458323|NCT00002555|Cobalt|cobalt|mesh-list
111458324|NCT00002555|Trace Elements|trace elements|mesh-ancestor
111458325|NCT00002555|Micronutrients|micronutrients|mesh-ancestor
111458326|NCT00002555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111458327|NCT00002561|Doxorubicin|doxorubicin|mesh-list
111458328|NCT00002561|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111458329|NCT00002561|Bleomycin|bleomycin|mesh-list
111458330|NCT00002561|Dacarbazine|dacarbazine|mesh-list
111458331|NCT00002561|Vinblastine|vinblastine|mesh-list
111182494|NCT03824002|Insulin|insulin|mesh-list
111458332|NCT00002561|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111458333|NCT00002561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111458334|NCT00002561|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111458335|NCT00002561|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111458336|NCT00002561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111458337|NCT00002561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111458338|NCT00002561|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111458339|NCT00002561|Alkylating Agents|alkylating agents|mesh-ancestor
111458340|NCT00002561|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111458341|NCT00002561|Tubulin Modulators|tubulin modulators|mesh-ancestor
111458342|NCT00002561|Antimitotic Agents|antimitotic agents|mesh-ancestor
111458343|NCT00002561|Mitosis Modulators|mitosis modulators|mesh-ancestor
111458344|NCT00002567|Etoposide|etoposide|mesh-list
111458345|NCT00002567|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111458346|NCT00002567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111458347|NCT00002567|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111458348|NCT00002567|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111458349|NCT00002567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111458350|NCT00002567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111458351|NCT00002579|Tamoxifen|tamoxifen|mesh-list
111458352|NCT00002579|Cyclophosphamide|cyclophosphamide|mesh-list
111458353|NCT00002579|Fluorouracil|fluorouracil|mesh-list
111458354|NCT00002579|Methotrexate|methotrexate|mesh-list
111458355|NCT00002579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111458356|NCT00002579|Immunologic Factors|immunologic factors|mesh-ancestor
111458357|NCT00002579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111458358|NCT00002579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111458359|NCT00002579|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111458360|NCT00002579|Alkylating Agents|alkylating agents|mesh-ancestor
111458361|NCT00002579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111458362|NCT00002579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111458363|NCT00002579|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111458364|NCT00002579|Antimetabolites|antimetabolites|mesh-ancestor
111458365|NCT00002579|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111458366|NCT00002579|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111458367|NCT00002579|Abortifacient Agents|abortifacient agents|mesh-ancestor
111458368|NCT00002579|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111458369|NCT00002579|Dermatologic Agents|dermatologic agents|mesh-ancestor
111458370|NCT00002579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111458371|NCT00002579|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111458372|NCT00002579|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111458373|NCT00002579|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111458374|NCT00002579|Hormone Antagonists|hormone antagonists|mesh-ancestor
111458375|NCT00002579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111458376|NCT00002579|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111458377|NCT00002579|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111458378|NCT00002579|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111458379|NCT00002579|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111458380|NCT00002585|NSC 366140|nsc 366140|mesh-list
111458381|NCT00002585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111458382|NCT00002609|Cytarabine|cytarabine|mesh-list
111458383|NCT00002609|Idarubicin|idarubicin|mesh-list
111458384|NCT00002609|Lintuzumab|lintuzumab|mesh-list
111458385|NCT00002609|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111458386|NCT00002609|Antimetabolites|antimetabolites|mesh-ancestor
111458387|NCT00002609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111458388|NCT00002609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111458389|NCT00002609|Antiviral Agents|antiviral agents|mesh-ancestor
111458390|NCT00002609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111458391|NCT00002609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111458392|NCT00002609|Immunologic Factors|immunologic factors|mesh-ancestor
111458393|NCT00002609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111458394|NCT00002609|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111458395|NCT00002609|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111458396|NCT00002609|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111458397|NCT00002609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111458398|NCT00002609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111458399|NCT00002615|Fluorouracil|fluorouracil|mesh-list
111458400|NCT00002615|Epirubicin|epirubicin|mesh-list
111458401|NCT00002615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111458402|NCT00002615|Antimetabolites|antimetabolites|mesh-ancestor
111458403|NCT00002615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111458404|NCT00002615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111458405|NCT00002615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111458406|NCT00002615|Immunologic Factors|immunologic factors|mesh-ancestor
111458407|NCT00002615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111458408|NCT00002615|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111458409|NCT00002615|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111458410|NCT00002615|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111458411|NCT00002615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111458412|NCT00002621|Interferons|interferons|mesh-list
111458413|NCT00002621|Interferon-alpha|interferon-alpha|mesh-list
111458414|NCT00002621|Interferon alpha-2|interferon alpha-2|mesh-list
111458415|NCT00002621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111458416|NCT00002621|Antiviral Agents|antiviral agents|mesh-ancestor
111458417|NCT00002621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111458418|NCT00002621|Immunologic Factors|immunologic factors|mesh-ancestor
111458419|NCT00002621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111458420|NCT00002627|Paclitaxel|paclitaxel|mesh-list
111458421|NCT00002627|Cyclophosphamide|cyclophosphamide|mesh-list
111458422|NCT00002627|Carboplatin|carboplatin|mesh-list
111458423|NCT00002627|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111458424|NCT00002627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111458425|NCT00002627|Tubulin Modulators|tubulin modulators|mesh-ancestor
111458426|NCT00002627|Antimitotic Agents|antimitotic agents|mesh-ancestor
111458427|NCT00002627|Mitosis Modulators|mitosis modulators|mesh-ancestor
111458428|NCT00002627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111458429|NCT00002627|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111458430|NCT00002627|Immunologic Factors|immunologic factors|mesh-ancestor
111458431|NCT00002627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111458432|NCT00002627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111458433|NCT00002627|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111458434|NCT00002627|Alkylating Agents|alkylating agents|mesh-ancestor
111458435|NCT00002627|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111458436|NCT00002633|Leuprolide|leuprolide|mesh-list
111458437|NCT00002633|Goserelin|goserelin|mesh-list
111458438|NCT00002633|Flutamide|flutamide|mesh-list
111458439|NCT00002633|Bicalutamide|bicalutamide|mesh-list
111458440|NCT00002633|Nilutamide|nilutamide|mesh-list
111458441|NCT00002633|Buserelin|buserelin|mesh-list
111458442|NCT00002633|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111458443|NCT00002633|Fertility Agents|fertility agents|mesh-ancestor
111458444|NCT00002633|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111458445|NCT00002633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111458446|NCT00002633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111458447|NCT00002633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111458448|NCT00002633|Androgen Antagonists|androgen antagonists|mesh-ancestor
111458449|NCT00002633|Hormone Antagonists|hormone antagonists|mesh-ancestor
111458450|NCT00002633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111458451|NCT00002639|Suramin|suramin|mesh-list
111458452|NCT00002639|Antinematodal Agents|antinematodal agents|mesh-ancestor
111458453|NCT00002639|Anthelmintics|anthelmintics|mesh-ancestor
111458454|NCT00002639|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111458455|NCT00002639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111458456|NCT00002639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111458457|NCT00002639|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
111458458|NCT00002639|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111458459|NCT00002657|Interferons|interferons|mesh-list
111458460|NCT00002657|Cytarabine|cytarabine|mesh-list
111458461|NCT00002657|Interferon-alpha|interferon-alpha|mesh-list
111458462|NCT00002657|Prednisone|prednisone|mesh-list
111458463|NCT00002657|Cyclophosphamide|cyclophosphamide|mesh-list
111458464|NCT00002657|Doxorubicin|doxorubicin|mesh-list
111458465|NCT00002657|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111458466|NCT00002657|Methotrexate|methotrexate|mesh-list
111458467|NCT00002657|Etoposide|etoposide|mesh-list
111458468|NCT00002657|Vincristine|vincristine|mesh-list
111458469|NCT00002657|Bleomycin|bleomycin|mesh-list
111458470|NCT00002657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111458471|NCT00002657|Immunologic Factors|immunologic factors|mesh-ancestor
111458472|NCT00002657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111458473|NCT00002657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111458474|NCT00002657|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111458475|NCT00002657|Alkylating Agents|alkylating agents|mesh-ancestor
111458476|NCT00002657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111458477|NCT00002657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111458478|NCT00002657|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111458479|NCT00002657|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111458480|NCT00002657|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111458481|NCT00002657|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111182653|NCT01456468|Tretinoin|tretinoin|mesh-list
111458482|NCT00002657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111458483|NCT00002657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111458484|NCT00002657|Glucocorticoids|glucocorticoids|mesh-ancestor
111458485|NCT00002657|Hormones|hormones|mesh-ancestor
111479300|NCT05028634|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
111458486|NCT00002657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111458487|NCT00002657|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111458488|NCT00002657|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111458489|NCT00002657|Abortifacient Agents|abortifacient agents|mesh-ancestor
111458490|NCT00002657|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111458491|NCT00002657|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111458492|NCT00002657|Antimetabolites|antimetabolites|mesh-ancestor
111458493|NCT00002657|Dermatologic Agents|dermatologic agents|mesh-ancestor
111458494|NCT00002657|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111458495|NCT00002657|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111458496|NCT00002657|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111458497|NCT00002657|Antiviral Agents|antiviral agents|mesh-ancestor
111458498|NCT00002657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111458499|NCT00002657|Tubulin Modulators|tubulin modulators|mesh-ancestor
111458500|NCT00002657|Antimitotic Agents|antimitotic agents|mesh-ancestor
111458501|NCT00002657|Mitosis Modulators|mitosis modulators|mesh-ancestor
111458502|NCT05673785|Prednisone|prednisone|mesh-list
111458503|NCT05673785|Cyclophosphamide|cyclophosphamide|mesh-list
111458504|NCT05673785|Doxorubicin|doxorubicin|mesh-list
111458505|NCT05673785|Brentuximab Vedotin|brentuximab vedotin|mesh-list
111458506|NCT05673785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111458507|NCT05673785|Immunologic Factors|immunologic factors|mesh-ancestor
111458508|NCT05673785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111458509|NCT05673785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111458510|NCT05673785|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111458511|NCT05673785|Alkylating Agents|alkylating agents|mesh-ancestor
111458512|NCT05673785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111458513|NCT05673785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111458514|NCT05673785|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111458515|NCT05673785|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111458516|NCT05673785|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111458517|NCT05673785|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111458518|NCT05673785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111458519|NCT05673785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111458520|NCT05673785|Glucocorticoids|glucocorticoids|mesh-ancestor
111458521|NCT05673785|Hormones|hormones|mesh-ancestor
111458522|NCT05673785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111458523|NCT05673785|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111458524|NCT05673785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111458525|NCT05673785|Immunotoxins|immunotoxins|mesh-ancestor
111458526|NCT05673785|Immunoconjugates|immunoconjugates|mesh-ancestor
111458527|NCT00381875|Sargramostim|sargramostim|mesh-list
111458528|NCT00381875|Freund's Adjuvant|freund's adjuvant|mesh-list
111458529|NCT00381875|Immunologic Factors|immunologic factors|mesh-ancestor
111458530|NCT00381875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111458531|NCT00381875|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111458532|NCT00002669|Interferons|interferons|mesh-list
111458533|NCT00002669|Interferon-alpha|interferon-alpha|mesh-list
111458534|NCT00002669|Aldesleukin|aldesleukin|mesh-list
111458535|NCT00002669|Dacarbazine|dacarbazine|mesh-list
111458536|NCT00002669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111458537|NCT00002669|Antiviral Agents|antiviral agents|mesh-ancestor
111458538|NCT00002669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111458539|NCT00002669|Immunologic Factors|immunologic factors|mesh-ancestor
111458540|NCT00002669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111458541|NCT00002669|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111458542|NCT00002669|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111458543|NCT00002669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111458544|NCT00002669|Alkylating Agents|alkylating agents|mesh-ancestor
111458545|NCT00002669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111458546|NCT00002675|Cyclophosphamide|cyclophosphamide|mesh-list
111458547|NCT00002675|Carboplatin|carboplatin|mesh-list
111458548|NCT00002675|Etoposide|etoposide|mesh-list
111458549|NCT00002675|Vincristine|vincristine|mesh-list
111458550|NCT00002675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111458551|NCT00002675|Immunologic Factors|immunologic factors|mesh-ancestor
111458552|NCT00002675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111458553|NCT00002675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111458554|NCT00002675|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111458555|NCT00002675|Alkylating Agents|alkylating agents|mesh-ancestor
111458556|NCT00002675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111458557|NCT00002675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111458558|NCT00002675|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111458559|NCT00002675|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111458560|NCT00002675|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111458561|NCT00002675|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111458562|NCT00002675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111458563|NCT00002675|Tubulin Modulators|tubulin modulators|mesh-ancestor
111458564|NCT00002675|Antimitotic Agents|antimitotic agents|mesh-ancestor
111458565|NCT00002675|Mitosis Modulators|mitosis modulators|mesh-ancestor
111458566|NCT00002681|Aldesleukin|aldesleukin|mesh-list
111458567|NCT00002681|Daclizumab|daclizumab|mesh-list
111458568|NCT00002681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111458569|NCT00002681|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111458570|NCT00002681|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111458571|NCT00002681|Antiviral Agents|antiviral agents|mesh-ancestor
111458572|NCT00002681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111458573|NCT00002681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111458574|NCT00002681|Immunologic Factors|immunologic factors|mesh-ancestor
111458575|NCT00002681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111458576|NCT02973113|Nivolumab|nivolumab|mesh-list
111458577|NCT02973113|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111458578|NCT02973113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111458579|NCT02973113|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111458580|NCT02973113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111458581|NCT00002687|Aldesleukin|aldesleukin|mesh-list
111458582|NCT00002687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111458583|NCT00002687|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111458584|NCT00002687|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111458585|NCT00002687|Antiviral Agents|antiviral agents|mesh-ancestor
111458586|NCT00002687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111458587|NCT00002693|Carboplatin|carboplatin|mesh-list
111458588|NCT00002693|Topotecan|topotecan|mesh-list
111458589|NCT00002693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111458590|NCT00002693|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111458591|NCT00002693|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111458592|NCT00002693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111458593|NCT00002693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111458594|NCT00002705|Topotecan|topotecan|mesh-list
111458595|NCT00002705|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111458596|NCT00002705|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111458597|NCT00002705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111458598|NCT00002705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111458599|NCT00002705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111458600|NCT00002711|Paclitaxel|paclitaxel|mesh-list
111458601|NCT00002711|Cisplatin|cisplatin|mesh-list
111458602|NCT00002711|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111458603|NCT00002711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111458604|NCT00002711|Tubulin Modulators|tubulin modulators|mesh-ancestor
111458605|NCT00002711|Antimitotic Agents|antimitotic agents|mesh-ancestor
111458606|NCT00002711|Mitosis Modulators|mitosis modulators|mesh-ancestor
111458607|NCT00002711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111458608|NCT00002717|Paclitaxel|paclitaxel|mesh-list
111458609|NCT00002717|Cisplatin|cisplatin|mesh-list
111458610|NCT00002717|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111458611|NCT00002717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111458612|NCT00002717|Tubulin Modulators|tubulin modulators|mesh-ancestor
111458613|NCT00002717|Antimitotic Agents|antimitotic agents|mesh-ancestor
111458614|NCT00002717|Mitosis Modulators|mitosis modulators|mesh-ancestor
111458615|NCT00002717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111458616|NCT00002723|Suramin|suramin|mesh-list
111458617|NCT00002723|Antinematodal Agents|antinematodal agents|mesh-ancestor
111458618|NCT00002723|Anthelmintics|anthelmintics|mesh-ancestor
111458619|NCT00002723|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111458620|NCT00002723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111458621|NCT00002723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111458622|NCT00002723|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
111458623|NCT00002723|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111458624|NCT00002735|Cobalt|cobalt|mesh-list
111458625|NCT00002735|Cisplatin|cisplatin|mesh-list
111458626|NCT00002735|Fluorouracil|fluorouracil|mesh-list
111458627|NCT00002735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111458628|NCT00002735|Antimetabolites|antimetabolites|mesh-ancestor
111458629|NCT00002735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111458630|NCT00002735|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111458631|NCT00002735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111458632|NCT00002735|Immunologic Factors|immunologic factors|mesh-ancestor
111458633|NCT00002735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111458634|NCT00002735|Trace Elements|trace elements|mesh-ancestor
111458635|NCT00002735|Micronutrients|micronutrients|mesh-ancestor
111458636|NCT00002747|Cobalt|cobalt|mesh-list
111458637|NCT00002747|Fluorouracil|fluorouracil|mesh-list
111458638|NCT00002747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111458639|NCT00002747|Antimetabolites|antimetabolites|mesh-ancestor
111458640|NCT00002747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111458641|NCT00002747|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111458642|NCT00002747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111458643|NCT00002747|Immunologic Factors|immunologic factors|mesh-ancestor
111458644|NCT00002747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111458645|NCT00002747|Trace Elements|trace elements|mesh-ancestor
111458646|NCT00002747|Micronutrients|micronutrients|mesh-ancestor
111458647|NCT02973035|Amlodipine|amlodipine|mesh-list
111458648|NCT02973035|Valsartan|valsartan|mesh-list
111458649|NCT02973035|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111458650|NCT02973035|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111458651|NCT02973035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110935164|NCT02228616|Lactulose|lactulose|mesh-list
111458652|NCT02973035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111458653|NCT02973035|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111458654|NCT02973035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111458655|NCT02973035|Vasodilator Agents|vasodilator agents|mesh-ancestor
111458656|NCT02973035|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111458657|NCT02973035|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111458658|NCT00002753|Antibodies|antibodies|mesh-list
111458659|NCT00002753|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111458660|NCT00002753|Immunologic Factors|immunologic factors|mesh-ancestor
111458661|NCT00002753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111458662|NCT00002759|Cyclosporine|cyclosporine|mesh-list
111458663|NCT00002759|Irinotecan|irinotecan|mesh-list
111458664|NCT00002759|Phenobarbital|phenobarbital|mesh-list
111458665|NCT00002759|Cyclosporins|cyclosporins|mesh-list
111458666|NCT00002759|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111458667|NCT00002759|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111458668|NCT00002759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111458669|NCT00002759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111458670|NCT00002759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111458671|NCT00002759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111458672|NCT00002759|Immunologic Factors|immunologic factors|mesh-ancestor
111458673|NCT00002759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111458674|NCT00002759|Antifungal Agents|antifungal agents|mesh-ancestor
111458675|NCT00002759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111458676|NCT00002759|Dermatologic Agents|dermatologic agents|mesh-ancestor
111458677|NCT00002759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111458678|NCT00002759|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111458679|NCT00002759|Anticonvulsants|anticonvulsants|mesh-ancestor
111458680|NCT00002759|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111458681|NCT00002759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111458682|NCT00002759|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111458683|NCT00002759|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111458684|NCT00002759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111458685|NCT00002759|GABA Modulators|gaba modulators|mesh-ancestor
111458686|NCT00002759|GABA Agents|gaba agents|mesh-ancestor
111458687|NCT00002759|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111458688|NCT00002759|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111458689|NCT00002759|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111458690|NCT00002765|Immunotoxins|immunotoxins|mesh-list
111458691|NCT00002765|Immunoconjugates|immunoconjugates|mesh-ancestor
111458692|NCT00002765|Immunologic Factors|immunologic factors|mesh-ancestor
111458693|NCT00002765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111458694|NCT00002771|Interferons|interferons|mesh-list
111458695|NCT00002771|Cytarabine|cytarabine|mesh-list
111458696|NCT00002771|Interferon-alpha|interferon-alpha|mesh-list
111458697|NCT00002771|Busulfan|busulfan|mesh-list
111458698|NCT00002771|Idarubicin|idarubicin|mesh-list
111458699|NCT00002771|Hydroxyurea|hydroxyurea|mesh-list
111458700|NCT00002771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111458701|NCT00002771|Antiviral Agents|antiviral agents|mesh-ancestor
111458702|NCT00002771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111458703|NCT00002771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111458704|NCT00002771|Antimetabolites|antimetabolites|mesh-ancestor
111458705|NCT00002771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111458706|NCT00002771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111458707|NCT00002771|Immunologic Factors|immunologic factors|mesh-ancestor
111458708|NCT00002771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111458709|NCT00002771|Alkylating Agents|alkylating agents|mesh-ancestor
111458710|NCT00002771|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111458711|NCT00002771|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111458712|NCT00002771|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111458713|NCT00002771|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111458714|NCT00002771|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111458715|NCT00002771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111458716|NCT00002771|Antisickling Agents|antisickling agents|mesh-ancestor
111458717|NCT00002771|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111458718|NCT00002777|Tamoxifen|tamoxifen|mesh-list
111458719|NCT00002777|Exemestane|exemestane|mesh-list
111458720|NCT00002777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111458721|NCT00002777|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111458722|NCT00002777|Hormone Antagonists|hormone antagonists|mesh-ancestor
111458723|NCT00002777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111458724|NCT00002777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111458725|NCT00002777|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111458726|NCT00002777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111458727|NCT00002777|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111458728|NCT00002777|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111458729|NCT00002777|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111458730|NCT00002777|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111458731|NCT00002777|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111458732|NCT00002777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111458733|NCT00002783|Leucovorin|leucovorin|mesh-list
111458734|NCT00002783|Fluorouracil|fluorouracil|mesh-list
111458735|NCT00002783|Floxuridine|floxuridine|mesh-list
111458736|NCT00002783|Calcium|calcium|mesh-list
111458737|NCT00002783|Levoleucovorin|levoleucovorin|mesh-list
111458738|NCT00002783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111458739|NCT00002783|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111458740|NCT00002783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111458741|NCT00002783|Antimetabolites|antimetabolites|mesh-ancestor
111458742|NCT00002783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111458743|NCT00002783|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111458744|NCT00002783|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111458745|NCT00002783|Immunologic Factors|immunologic factors|mesh-ancestor
111458746|NCT00002783|Antidotes|antidotes|mesh-ancestor
111458747|NCT00002783|Protective Agents|protective agents|mesh-ancestor
111458748|NCT00002783|Vitamin B Complex|vitamin b complex|mesh-ancestor
111458749|NCT00002783|Vitamins|vitamins|mesh-ancestor
111458750|NCT00002783|Micronutrients|micronutrients|mesh-ancestor
111458751|NCT00002789|Cyclosporine|cyclosporine|mesh-list
111458752|NCT00002789|Cyclophosphamide|cyclophosphamide|mesh-list
111458753|NCT00002789|Busulfan|busulfan|mesh-list
111458754|NCT00002789|Methotrexate|methotrexate|mesh-list
111458755|NCT00002789|Cyclosporins|cyclosporins|mesh-list
111458756|NCT00002789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111458757|NCT00002789|Immunologic Factors|immunologic factors|mesh-ancestor
111458758|NCT00002789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111458759|NCT00002789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111458760|NCT00002789|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111458761|NCT00002789|Alkylating Agents|alkylating agents|mesh-ancestor
111458762|NCT00002789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111458763|NCT00002789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111458764|NCT00002789|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111458765|NCT00002789|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111458766|NCT00002789|Abortifacient Agents|abortifacient agents|mesh-ancestor
111458767|NCT00002789|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111458768|NCT00002789|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111458769|NCT00002789|Antimetabolites|antimetabolites|mesh-ancestor
111458770|NCT00002789|Dermatologic Agents|dermatologic agents|mesh-ancestor
111458771|NCT00002789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111458772|NCT00002789|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111458773|NCT00002789|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111458774|NCT00002789|Antifungal Agents|antifungal agents|mesh-ancestor
111458775|NCT00002789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111458776|NCT00002789|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111458777|NCT00381953|Interferons|interferons|mesh-list
111458778|NCT00381953|Ribavirin|ribavirin|mesh-list
111458779|NCT00381953|Interferon-alpha|interferon-alpha|mesh-list
111458780|NCT00381953|Interferon alpha-2|interferon alpha-2|mesh-list
111458781|NCT00381953|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
111458782|NCT00381953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111458783|NCT00381953|Antiviral Agents|antiviral agents|mesh-ancestor
111458784|NCT00381953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111458785|NCT00381953|Antimetabolites|antimetabolites|mesh-ancestor
111458786|NCT00381953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111458787|NCT00381953|Immunologic Factors|immunologic factors|mesh-ancestor
111458788|NCT00381953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111458789|NCT00382343|Trimethoprim|trimethoprim|mesh-list
111458790|NCT00382343|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
111458791|NCT00382343|Sulfamethoxazole|sulfamethoxazole|mesh-list
111458792|NCT00382343|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111458793|NCT00382343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111458794|NCT00382343|Antimalarials|antimalarials|mesh-ancestor
111458795|NCT00382343|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111458796|NCT00382343|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111458797|NCT00382343|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111458798|NCT00382343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111458799|NCT00382343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111458800|NCT00382343|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111458801|NCT00382343|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
111458802|NCT00382343|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111458803|NCT00382343|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111458804|NCT05749445|Ritonavir|ritonavir|mesh-list
111458805|NCT05749445|Nirmatrelvir|nirmatrelvir|mesh-list
111458806|NCT05749445|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
111458807|NCT05749445|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111458808|NCT05749445|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111458809|NCT05749445|Protease Inhibitors|protease inhibitors|mesh-ancestor
111458810|NCT05749445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111458811|NCT05749445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111458812|NCT05749445|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111458813|NCT05749445|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111458814|NCT05749445|Antiviral Agents|antiviral agents|mesh-ancestor
111458815|NCT05749445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111458816|NCT05749445|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111458817|NCT05749445|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111458818|NCT05749367|Ropivacaine|ropivacaine|mesh-list
111458819|NCT05749367|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111458820|NCT05749367|Anesthetics, Local|anesthetics, local|mesh-ancestor
111458821|NCT05749367|Anesthetics|anesthetics|mesh-ancestor
111458822|NCT05749367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111458823|NCT05749367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111458824|NCT05749367|Sensory System Agents|sensory system agents|mesh-ancestor
111458825|NCT05749367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111458826|NCT05749289|Octreotide|octreotide|mesh-list
111458827|NCT05749289|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111458828|NCT05749289|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111458829|NCT05749289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111458830|NCT02972957|Azithromycin|azithromycin|mesh-list
111458831|NCT02972957|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111458832|NCT02972957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111458833|NCT05545319|Ritonavir|ritonavir|mesh-list
111458834|NCT05545319|Nirmatrelvir|nirmatrelvir|mesh-list
111458835|NCT05545319|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111458836|NCT05545319|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111458837|NCT05545319|Protease Inhibitors|protease inhibitors|mesh-ancestor
111458838|NCT05545319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111458839|NCT05545319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111458840|NCT05545319|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111458841|NCT05545319|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111458842|NCT05545319|Antiviral Agents|antiviral agents|mesh-ancestor
111458843|NCT05545319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111458844|NCT05545319|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111458845|NCT05545319|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111458846|NCT05523869|Topotecan|topotecan|mesh-list
111458847|NCT05523869|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111458848|NCT05523869|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111458849|NCT05523869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111458850|NCT05523869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111458851|NCT05523869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111458852|NCT05522465|Dexamethasone|dexamethasone|mesh-list
111458853|NCT05522465|Prednisone|prednisone|mesh-list
111458854|NCT05522465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111458855|NCT05522465|Antiemetics|antiemetics|mesh-ancestor
111458856|NCT05522465|Autonomic Agents|autonomic agents|mesh-ancestor
111458857|NCT05522465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111458858|NCT05522465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111458859|NCT05522465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111458860|NCT05522465|Glucocorticoids|glucocorticoids|mesh-ancestor
111458861|NCT05522465|Hormones|hormones|mesh-ancestor
111458862|NCT05522465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111458863|NCT05522465|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111458864|NCT05522465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111458865|NCT05215691|Morphine|morphine|mesh-list
111458866|NCT05215691|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111458867|NCT05215691|Narcotics|narcotics|mesh-ancestor
111458868|NCT05215691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111458869|NCT05215691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111458870|NCT05215691|Analgesics|analgesics|mesh-ancestor
111458871|NCT05215691|Sensory System Agents|sensory system agents|mesh-ancestor
111458872|NCT05215691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111458873|NCT05204147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111458874|NCT05204147|Antibodies|antibodies|mesh-list
111458875|NCT05204147|Immunoglobulins|immunoglobulins|mesh-list
111458876|NCT05204147|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111458877|NCT05204147|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
111458878|NCT05204147|Immunologic Factors|immunologic factors|mesh-ancestor
111458879|NCT05204147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111458880|NCT05204147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111458881|NCT05204147|Chelating Agents|chelating agents|mesh-ancestor
111458882|NCT05204147|Sequestering Agents|sequestering agents|mesh-ancestor
111458883|NCT05204147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111458884|NCT04824053|Selenium|selenium|mesh-list
111458885|NCT04824053|Caseins|caseins|mesh-list
111458886|NCT04824053|Antioxidants|antioxidants|mesh-ancestor
111458887|NCT04824053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111458888|NCT04824053|Protective Agents|protective agents|mesh-ancestor
111458889|NCT04824053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111458890|NCT04824053|Trace Elements|trace elements|mesh-ancestor
111458891|NCT04824053|Micronutrients|micronutrients|mesh-ancestor
111458892|NCT04824053|Chelating Agents|chelating agents|mesh-ancestor
111458893|NCT04824053|Sequestering Agents|sequestering agents|mesh-ancestor
111458894|NCT04811339|Bismuth|bismuth|mesh-list
111458895|NCT04811339|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
111458896|NCT04811339|Antacids|antacids|mesh-ancestor
111458897|NCT04811339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111458898|NCT04811339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111458899|NCT04811339|Antidiarrheals|antidiarrheals|mesh-ancestor
111458900|NCT04783415|Acalabrutinib|acalabrutinib|mesh-list
111458901|NCT04783415|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
111458902|NCT04783415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111458903|NCT04783415|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111458904|NCT04783415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111458905|NCT04783415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111458906|NCT04331093|Apatinib|apatinib|mesh-list
111458907|NCT04331093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111458908|NCT04331093|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111458909|NCT04331093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111458910|NCT04331093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111458911|NCT05124977|Anti-Infective Agents|anti-infective agents|mesh-list
111458912|NCT05124977|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111458913|NCT00382421|Aspirin|aspirin|mesh-list
111458914|NCT00382421|Amlodipine|amlodipine|mesh-list
111458915|NCT00382421|Bisoprolol|bisoprolol|mesh-list
111458916|NCT00382421|Molsidomine|molsidomine|mesh-list
111458917|NCT00382421|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111458918|NCT00382421|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111458919|NCT00382421|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111458920|NCT00382421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111458921|NCT00382421|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111458922|NCT00382421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111458923|NCT00382421|Vasodilator Agents|vasodilator agents|mesh-ancestor
111458924|NCT00382421|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111458925|NCT00382421|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111458926|NCT00382421|Analgesics|analgesics|mesh-ancestor
111458927|NCT00382421|Sensory System Agents|sensory system agents|mesh-ancestor
111458928|NCT00382421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111458929|NCT00382421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111458930|NCT00382421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111458931|NCT00382421|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111458932|NCT00382421|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111458933|NCT00382421|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111458934|NCT00382421|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111458935|NCT00382421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111458936|NCT00382421|Antipyretics|antipyretics|mesh-ancestor
111458937|NCT00382421|Sympatholytics|sympatholytics|mesh-ancestor
111458938|NCT00382421|Autonomic Agents|autonomic agents|mesh-ancestor
111458939|NCT00382421|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
111458940|NCT00382421|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111479301|NCT05028634|Immunologic Factors|immunologic factors|mesh-ancestor
111183105|NCT04393792|Povidone-Iodine|povidone-iodine|mesh-list
111458941|NCT00382421|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111458942|NCT00382421|Adrenergic Agents|adrenergic agents|mesh-ancestor
111458943|NCT00382421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111458944|NCT00382421|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
111458945|NCT05069831|Abrocitinib|abrocitinib|mesh-list
111458946|NCT05069831|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111458947|NCT05069831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111458948|NCT05069831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111458949|NCT05312255|Propranolol|propranolol|mesh-list
111458950|NCT05312255|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
111458951|NCT05312255|Adrenergic Agents|adrenergic agents|mesh-list
111458952|NCT05312255|Adrenergic Antagonists|adrenergic antagonists|mesh-list
111458953|NCT05312255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111458954|NCT05312255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111458955|NCT05312255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111458956|NCT05312255|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111458957|NCT05312255|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111458958|NCT05312255|Vasodilator Agents|vasodilator agents|mesh-ancestor
111458959|NCT05015621|Leucovorin|leucovorin|mesh-list
111458960|NCT05015621|Fluorouracil|fluorouracil|mesh-list
111458961|NCT05015621|Irinotecan|irinotecan|mesh-list
111458962|NCT05015621|Calcium|calcium|mesh-list
111458963|NCT05015621|Levoleucovorin|levoleucovorin|mesh-list
111458964|NCT05015621|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111458965|NCT05015621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111458966|NCT05015621|Antimetabolites|antimetabolites|mesh-ancestor
111458967|NCT05015621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111458968|NCT05015621|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111458969|NCT05015621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111458970|NCT05015621|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111458971|NCT05015621|Immunologic Factors|immunologic factors|mesh-ancestor
111458972|NCT05015621|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111458973|NCT05015621|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111458974|NCT05015621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111458975|NCT05015621|Antidotes|antidotes|mesh-ancestor
111458976|NCT05015621|Protective Agents|protective agents|mesh-ancestor
111458977|NCT05015621|Vitamin B Complex|vitamin b complex|mesh-ancestor
111458978|NCT05015621|Vitamins|vitamins|mesh-ancestor
111458979|NCT05015621|Micronutrients|micronutrients|mesh-ancestor
111458980|NCT05007509|Vaccines|vaccines|mesh-list
111458981|NCT05007509|Immunologic Factors|immunologic factors|mesh-ancestor
111458982|NCT05007509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111458983|NCT05289167|Cyclophosphamide|cyclophosphamide|mesh-list
111458984|NCT05289167|Bortezomib|bortezomib|mesh-list
111458985|NCT05289167|Abatacept|abatacept|mesh-list
111458986|NCT05289167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111458987|NCT05289167|Immunologic Factors|immunologic factors|mesh-ancestor
111458988|NCT05289167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111458989|NCT05289167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111458990|NCT05289167|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111458991|NCT05289167|Alkylating Agents|alkylating agents|mesh-ancestor
111458992|NCT05289167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110935500|NCT03480308|Dexamethasone|dexamethasone|mesh-list
111458993|NCT05289167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111458994|NCT05289167|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111458995|NCT05289167|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111458996|NCT05289167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111458997|NCT00382499|Lidocaine|lidocaine|mesh-list
111458998|NCT00382499|Anesthetics, Local|anesthetics, local|mesh-ancestor
111458999|NCT00382499|Anesthetics|anesthetics|mesh-ancestor
111459000|NCT00382499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111459001|NCT00382499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111459002|NCT00382499|Sensory System Agents|sensory system agents|mesh-ancestor
111459003|NCT00382499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111459004|NCT00382499|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111459005|NCT00382499|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111459006|NCT00382499|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111459007|NCT00382499|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111459008|NCT00382499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111459009|NCT04330547|Analgesics|analgesics|mesh-list
111459010|NCT04330547|Sensory System Agents|sensory system agents|mesh-ancestor
111459011|NCT04330547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111459012|NCT04330547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111459013|NCT00382889|Beclomethasone|beclomethasone|mesh-list
111459014|NCT00382889|Albuterol|albuterol|mesh-list
111459015|NCT00382889|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111459016|NCT00382889|Autonomic Agents|autonomic agents|mesh-ancestor
111459017|NCT00382889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111459018|NCT00382889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111459019|NCT00382889|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111459020|NCT00382889|Respiratory System Agents|respiratory system agents|mesh-ancestor
111459021|NCT00382889|Tocolytic Agents|tocolytic agents|mesh-ancestor
111459022|NCT00382889|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111459023|NCT00382889|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111459024|NCT00382889|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111459025|NCT00382889|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111459026|NCT00382889|Adrenergic Agents|adrenergic agents|mesh-ancestor
111459027|NCT00382889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111459028|NCT00382889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111459029|NCT00382889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111459030|NCT00382889|Glucocorticoids|glucocorticoids|mesh-ancestor
111459032|NCT00382889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111459033|NCT04482959|Carbetocin|carbetocin|mesh-list
111459034|NCT04482959|Oxytocics|oxytocics|mesh-ancestor
111459035|NCT04482959|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111459036|NCT04482959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111459037|NCT04571879|Lidocaine|lidocaine|mesh-list
111459038|NCT04571879|Midazolam|midazolam|mesh-list
111459039|NCT04571879|Anesthetics, Local|anesthetics, local|mesh-ancestor
111459040|NCT04571879|Anesthetics|anesthetics|mesh-ancestor
111459041|NCT04571879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111459042|NCT04571879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111459043|NCT04571879|Sensory System Agents|sensory system agents|mesh-ancestor
111459044|NCT04571879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111459045|NCT04571879|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111459046|NCT04571879|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111459047|NCT04571879|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111459048|NCT04571879|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111459049|NCT04571879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111459050|NCT04571879|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111459051|NCT04571879|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111459052|NCT04571879|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111459053|NCT04571879|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111459054|NCT04571879|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111459055|NCT04571879|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111459056|NCT04571879|Anesthetics, General|anesthetics, general|mesh-ancestor
111459057|NCT04571879|GABA Modulators|gaba modulators|mesh-ancestor
111459058|NCT04571879|GABA Agents|gaba agents|mesh-ancestor
111459059|NCT04571879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111459060|NCT04563533|Vaccines|vaccines|mesh-list
111459061|NCT04563533|Immunologic Factors|immunologic factors|mesh-ancestor
111459062|NCT04563533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111459063|NCT04332107|Azithromycin|azithromycin|mesh-list
111459064|NCT04332107|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111459065|NCT04332107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111459066|NCT04328285|Ritonavir|ritonavir|mesh-list
111459067|NCT04328285|Lopinavir|lopinavir|mesh-list
111459068|NCT04328285|Hydroxychloroquine|hydroxychloroquine|mesh-list
111459069|NCT04328285|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111459070|NCT04328285|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111459071|NCT04328285|Protease Inhibitors|protease inhibitors|mesh-ancestor
111459072|NCT04328285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111459073|NCT04328285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111459074|NCT04328285|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111459075|NCT04328285|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111459076|NCT04328285|Antiviral Agents|antiviral agents|mesh-ancestor
111459077|NCT04328285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111459078|NCT04328285|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111459079|NCT04328285|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111459080|NCT04328285|Antimalarials|antimalarials|mesh-ancestor
111459081|NCT04328285|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111459082|NCT04328285|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111459083|NCT04328285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111459084|NCT04928261|Trastuzumab|trastuzumab|mesh-list
111459085|NCT04928261|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111459086|NCT04928261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111459087|NCT04920539|Dronabinol|dronabinol|mesh-list
111459088|NCT04920539|Hallucinogens|hallucinogens|mesh-ancestor
111459089|NCT04920539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111459090|NCT04920539|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111459091|NCT04920539|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111459092|NCT04920539|Analgesics|analgesics|mesh-ancestor
111459093|NCT04920539|Sensory System Agents|sensory system agents|mesh-ancestor
111459094|NCT04920539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111459095|NCT04920539|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
111459096|NCT04920539|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
111459097|NCT04920539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111459098|NCT04920539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111459099|NCT04920539|Hormones|hormones|mesh-ancestor
111459100|NCT04920539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111459101|NCT04882241|Leucovorin|leucovorin|mesh-list
111459102|NCT04882241|Docetaxel|docetaxel|mesh-list
111459103|NCT04882241|Pembrolizumab|pembrolizumab|mesh-list
111459104|NCT04882241|Fluorouracil|fluorouracil|mesh-list
111459105|NCT04882241|Capecitabine|capecitabine|mesh-list
111459106|NCT04882241|Oxaliplatin|oxaliplatin|mesh-list
111459107|NCT04882241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111459108|NCT04882241|Tubulin Modulators|tubulin modulators|mesh-ancestor
111459109|NCT04882241|Antimitotic Agents|antimitotic agents|mesh-ancestor
111459110|NCT04882241|Mitosis Modulators|mitosis modulators|mesh-ancestor
111459111|NCT04882241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111459112|NCT04882241|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111459113|NCT04882241|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111459114|NCT04882241|Antimetabolites|antimetabolites|mesh-ancestor
111459115|NCT04882241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111459116|NCT04882241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111459117|NCT04882241|Immunologic Factors|immunologic factors|mesh-ancestor
111459118|NCT04882241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111459119|NCT04882241|Antidotes|antidotes|mesh-ancestor
111459120|NCT04882241|Protective Agents|protective agents|mesh-ancestor
111459121|NCT04882241|Vitamin B Complex|vitamin b complex|mesh-ancestor
111459122|NCT04882241|Vitamins|vitamins|mesh-ancestor
111459123|NCT04882241|Micronutrients|micronutrients|mesh-ancestor
111459124|NCT04481243|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
111459125|NCT04481243|Immunologic Factors|immunologic factors|mesh-ancestor
111459126|NCT04481243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111459127|NCT03575195|Rifaximin|rifaximin|mesh-list
111459128|NCT03575195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111459129|NCT03575195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111459130|NCT03575195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111459131|NCT00002897|Fluorouracil|fluorouracil|mesh-list
111459132|NCT00002897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111459133|NCT00002897|Antimetabolites|antimetabolites|mesh-ancestor
111459134|NCT00002897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111459135|NCT00002897|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111459136|NCT00002897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111459137|NCT00002897|Immunologic Factors|immunologic factors|mesh-ancestor
111459138|NCT00002897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111459139|NCT00002903|Docetaxel|docetaxel|mesh-list
111459140|NCT00002903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111459141|NCT00002903|Tubulin Modulators|tubulin modulators|mesh-ancestor
111459142|NCT00002903|Antimitotic Agents|antimitotic agents|mesh-ancestor
111459143|NCT00002903|Mitosis Modulators|mitosis modulators|mesh-ancestor
111459144|NCT00002903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111459145|NCT03375203|Zolpidem|zolpidem|mesh-list
111459146|NCT03375203|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111459147|NCT03375203|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111459148|NCT03375203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111459149|NCT03375203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111459150|NCT03375203|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
111459151|NCT03375203|GABA Agonists|gaba agonists|mesh-ancestor
111459152|NCT03375203|GABA Agents|gaba agents|mesh-ancestor
111459153|NCT03375203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111459154|NCT03375203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111459155|NCT00002909|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
111459156|NCT00002909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111459157|NCT00002915|Penclomedine|penclomedine|mesh-list
111459158|NCT00002915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111459159|NCT00002921|Suramin|suramin|mesh-list
111459160|NCT00002921|Hydrocortisone|hydrocortisone|mesh-list
111459161|NCT00002921|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
111459162|NCT00002921|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
111459163|NCT00002921|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
111459164|NCT00002921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111459165|NCT00002921|Antinematodal Agents|antinematodal agents|mesh-ancestor
111459166|NCT00002921|Anthelmintics|anthelmintics|mesh-ancestor
111459167|NCT00002921|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111183333|NCT04121416|Sufentanil|sufentanil|mesh-list
111459168|NCT00002921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111459169|NCT00002921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111459170|NCT00002921|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
111459171|NCT00002921|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111459172|NCT00383045|Naltrexone|naltrexone|mesh-list
111459173|NCT00383045|Buprenorphine|buprenorphine|mesh-list
111459174|NCT00383045|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111459175|NCT00383045|Narcotics|narcotics|mesh-ancestor
111459176|NCT00383045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111459177|NCT00383045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111459178|NCT00383045|Analgesics|analgesics|mesh-ancestor
111459179|NCT00383045|Sensory System Agents|sensory system agents|mesh-ancestor
111459180|NCT00383045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111459181|NCT00383045|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111459182|NCT00383045|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111459183|NCT00383591|Vaccines|vaccines|mesh-list
111459184|NCT00383591|Immunologic Factors|immunologic factors|mesh-ancestor
111459185|NCT00383591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111459186|NCT00002933|Irinotecan|irinotecan|mesh-list
111459187|NCT00002933|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111459188|NCT00002933|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111459189|NCT00002933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111459190|NCT00002933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111459191|NCT00002933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111459192|NCT00002939|Paclitaxel|paclitaxel|mesh-list
111459193|NCT00002939|Irinotecan|irinotecan|mesh-list
111459194|NCT00002939|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111459195|NCT00002939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111459196|NCT00002939|Tubulin Modulators|tubulin modulators|mesh-ancestor
111459197|NCT00002939|Antimitotic Agents|antimitotic agents|mesh-ancestor
111459198|NCT00002939|Mitosis Modulators|mitosis modulators|mesh-ancestor
111459199|NCT00002939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111459200|NCT00002939|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111459201|NCT00002939|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111459202|NCT00002939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111459203|NCT04009967|Pembrolizumab|pembrolizumab|mesh-list
111459204|NCT04009967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111459205|NCT04009967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111459206|NCT04009967|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111459207|NCT04009967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111459208|NCT03085823|Sirolimus|sirolimus|mesh-list
111459209|NCT03085823|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111459210|NCT03085823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111459211|NCT03085823|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111459212|NCT03085823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111459213|NCT03085823|Antifungal Agents|antifungal agents|mesh-ancestor
111459214|NCT03085823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111459215|NCT03085823|Immunologic Factors|immunologic factors|mesh-ancestor
111459216|NCT03085823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111459217|NCT00002945|Cytarabine|cytarabine|mesh-list
111459218|NCT00002945|Aldesleukin|aldesleukin|mesh-list
111459219|NCT00002945|Cyclophosphamide|cyclophosphamide|mesh-list
111459220|NCT00002945|Melphalan|melphalan|mesh-list
111459221|NCT00002945|Etoposide|etoposide|mesh-list
111459222|NCT00002945|Idarubicin|idarubicin|mesh-list
111459223|NCT00002945|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111459224|NCT00002945|Immunologic Factors|immunologic factors|mesh-ancestor
111459225|NCT00002945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111459226|NCT00002945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111459227|NCT00002945|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111459228|NCT00002945|Alkylating Agents|alkylating agents|mesh-ancestor
111459229|NCT00002945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111459230|NCT00002945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111459231|NCT00002945|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111459232|NCT00002945|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111459233|NCT00002945|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111459234|NCT00002945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111459235|NCT00002945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111459236|NCT00002945|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111459237|NCT00002945|Antimetabolites|antimetabolites|mesh-ancestor
111459238|NCT00002945|Antiviral Agents|antiviral agents|mesh-ancestor
111459239|NCT00002945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111459240|NCT00002945|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111459241|NCT00002945|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111183459|NCT02974738|Belzutifan|belzutifan|mesh-list
111459242|NCT00002945|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111459243|NCT00002951|Fluorouracil|fluorouracil|mesh-list
111459244|NCT00002951|Hydroxyurea|hydroxyurea|mesh-list
111459245|NCT00002951|Antimetabolites|antimetabolites|mesh-ancestor
111459246|NCT00002951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111459247|NCT00002951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111459248|NCT00002951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111459249|NCT00002951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111459250|NCT00002951|Immunologic Factors|immunologic factors|mesh-ancestor
111459251|NCT00002951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111459252|NCT00002951|Antisickling Agents|antisickling agents|mesh-ancestor
111459253|NCT00002951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111459254|NCT00002951|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111459255|NCT03058289|Pembrolizumab|pembrolizumab|mesh-list
111459256|NCT03058289|Ipilimumab|ipilimumab|mesh-list
111459257|NCT03058289|Antibodies|antibodies|mesh-list
111459258|NCT03058289|Immunoglobulins|immunoglobulins|mesh-list
111459259|NCT03058289|Immunologic Factors|immunologic factors|mesh-ancestor
111459260|NCT03058289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111459261|NCT03058289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111459262|NCT03058289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111459263|NCT03058289|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111459264|NCT03058289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111459265|NCT00002963|Aminolevulinic Acid|aminolevulinic acid|mesh-list
111459266|NCT00002963|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111459267|NCT00002963|Dermatologic Agents|dermatologic agents|mesh-ancestor
111459268|NCT00002969|Paclitaxel|paclitaxel|mesh-list
111459269|NCT00002969|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111459270|NCT00002969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111459271|NCT00002969|Tubulin Modulators|tubulin modulators|mesh-ancestor
111459272|NCT00002969|Antimitotic Agents|antimitotic agents|mesh-ancestor
111459273|NCT00002969|Mitosis Modulators|mitosis modulators|mesh-ancestor
111459274|NCT00002969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111459275|NCT00002987|Prednisolone|prednisolone|mesh-list
111459276|NCT00002987|Cyclophosphamide|cyclophosphamide|mesh-list
111459277|NCT00002987|Doxorubicin|doxorubicin|mesh-list
111459278|NCT00002987|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111459279|NCT00002987|Etoposide|etoposide|mesh-list
111459280|NCT00002987|Vincristine|vincristine|mesh-list
111459281|NCT00002987|Bleomycin|bleomycin|mesh-list
111459282|NCT00002987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111459283|NCT00002987|Immunologic Factors|immunologic factors|mesh-ancestor
111459284|NCT00002987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111459285|NCT00002987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111459286|NCT00002987|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111459287|NCT00002987|Alkylating Agents|alkylating agents|mesh-ancestor
111459288|NCT00002987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111459289|NCT00002987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111459290|NCT00002987|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111459291|NCT00002987|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111459292|NCT00002987|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111459293|NCT00002987|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111459294|NCT00002987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111459295|NCT00002987|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111459296|NCT00002987|Tubulin Modulators|tubulin modulators|mesh-ancestor
111459297|NCT00002987|Antimitotic Agents|antimitotic agents|mesh-ancestor
111459298|NCT00002987|Mitosis Modulators|mitosis modulators|mesh-ancestor
111459299|NCT00002987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111459300|NCT00002987|Glucocorticoids|glucocorticoids|mesh-ancestor
111459301|NCT00002987|Hormones|hormones|mesh-ancestor
111459302|NCT00002987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111459303|NCT00002987|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111459304|NCT02919683|Nivolumab|nivolumab|mesh-list
111459305|NCT02919683|Ipilimumab|ipilimumab|mesh-list
111459306|NCT02919683|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111459307|NCT02919683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111459308|NCT02919683|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110935878|NCT03473210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111459309|NCT02919683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111459310|NCT03933293|Ezetimibe|ezetimibe|mesh-list
111459311|NCT03933293|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111459312|NCT03933293|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111459313|NCT03933293|Antimetabolites|antimetabolites|mesh-ancestor
111459314|NCT03933293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111459315|NCT03933293|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111459316|NCT00002993|Doxorubicin|doxorubicin|mesh-list
111459317|NCT00002993|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111459318|NCT00002993|Mitomycins|mitomycins|mesh-list
111459319|NCT00002993|Mitomycin|mitomycin|mesh-list
111459320|NCT00002993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111459321|NCT00002993|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111459322|NCT00002993|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111459323|NCT00002993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111459324|NCT00002993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111459325|NCT00002993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111459326|NCT00002993|Alkylating Agents|alkylating agents|mesh-ancestor
110935891|NCT03473210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111459327|NCT00002993|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111459328|NCT01928082|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
111459329|NCT01928082|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
111459330|NCT01928082|Estradiol|estradiol|mesh-list
111459331|NCT01928082|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
111459332|NCT01928082|Estrogens|estrogens|mesh-ancestor
111459333|NCT01928082|Hormones|hormones|mesh-ancestor
111459334|NCT01928082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111459335|NCT01928082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111459336|NCT01928082|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111459337|NCT01928082|Contraceptive Agents|contraceptive agents|mesh-ancestor
111459338|NCT01928082|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111459339|NCT01928082|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111459340|NCT00002999|Fluorouracil|fluorouracil|mesh-list
111459341|NCT00002999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111459342|NCT00002999|Antimetabolites|antimetabolites|mesh-ancestor
111459343|NCT00002999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111459344|NCT00002999|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111459345|NCT00002999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111459346|NCT00002999|Immunologic Factors|immunologic factors|mesh-ancestor
111459347|NCT00002999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111459348|NCT00003005|Cordycepin|cordycepin|mesh-list
111459349|NCT00003005|Pentostatin|pentostatin|mesh-list
111459350|NCT00003005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111459351|NCT00003005|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
111459352|NCT00003005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110935925|NCT00308516|Antidotes|antidotes|mesh-ancestor
111459353|NCT00003005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111459354|NCT00003005|Antifungal Agents|antifungal agents|mesh-ancestor
111459355|NCT00003005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111459356|NCT03905603|Cosyntropin|cosyntropin|mesh-list
111459357|NCT03905603|Hormones|hormones|mesh-ancestor
111459358|NCT03905603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111459359|NCT03905603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111459360|NCT00003011|Marimastat|marimastat|mesh-list
111459361|NCT00003011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111459362|NCT00003011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111459363|NCT00003017|Interleukin-12|interleukin-12|mesh-list
110935943|NCT03474614|Vasodilator Agents|vasodilator agents|mesh-ancestor
111459364|NCT00003017|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111459365|NCT00003017|Immunologic Factors|immunologic factors|mesh-ancestor
111459366|NCT00003017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111459367|NCT00003017|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111459368|NCT00003017|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111459369|NCT00003017|Growth Substances|growth substances|mesh-ancestor
111459370|NCT00003017|Growth Inhibitors|growth inhibitors|mesh-ancestor
111459371|NCT00003017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111459372|NCT00003023|Vaccines|vaccines|mesh-list
111459373|NCT00003023|Antibodies|antibodies|mesh-list
111459374|NCT00003023|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111459375|NCT00003023|BCG Vaccine|bcg vaccine|mesh-list
111459376|NCT00003023|Immunologic Factors|immunologic factors|mesh-ancestor
111459377|NCT00003023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111459378|NCT00003023|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111459379|NCT03850067|Carboplatin|carboplatin|mesh-list
111459380|NCT03850067|Nivolumab|nivolumab|mesh-list
111459381|NCT03850067|Etoposide|etoposide|mesh-list
111459382|NCT03850067|Pulrodemstat besilate|pulrodemstat besilate|mesh-list
111459383|NCT03850067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111459384|NCT03850067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111459385|NCT03850067|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111459386|NCT03850067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110935967|NCT05052710|Anesthetics|anesthetics|mesh-ancestor
111459387|NCT03850067|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111459388|NCT03850067|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111459389|NCT03850067|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111459390|NCT03850067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111459391|NCT00003029|Fluorouracil|fluorouracil|mesh-list
111459392|NCT00003029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111459393|NCT00003029|Antimetabolites|antimetabolites|mesh-ancestor
111459394|NCT00003029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111183555|NCT01894477|Fludarabine phosphate|fludarabine phosphate|mesh-list
111459395|NCT00003029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111459396|NCT00003029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111459397|NCT00003029|Immunologic Factors|immunologic factors|mesh-ancestor
111459398|NCT00003029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111459400|NCT00003035|Paclitaxel|paclitaxel|mesh-list
111459401|NCT00003035|Doxorubicin|doxorubicin|mesh-list
111459402|NCT00003035|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111459403|NCT00003035|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111459404|NCT00003035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111459405|NCT00003035|Tubulin Modulators|tubulin modulators|mesh-ancestor
111459406|NCT00003035|Antimitotic Agents|antimitotic agents|mesh-ancestor
111459407|NCT00003035|Mitosis Modulators|mitosis modulators|mesh-ancestor
111459408|NCT00003035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111459409|NCT00003035|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111459410|NCT00003035|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111459411|NCT00003035|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111459412|NCT00003035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111459413|NCT00003035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111459414|NCT00003035|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111459415|NCT00003035|Hormone Antagonists|hormone antagonists|mesh-ancestor
111459416|NCT00003035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111459417|NCT00003035|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111459418|NCT00003035|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111459419|NCT00003035|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111459420|NCT00003035|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111459421|NCT00003041|NSC 366140|nsc 366140|mesh-list
111459422|NCT00003041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111459423|NCT00003053|Etoposide|etoposide|mesh-list
111459424|NCT00003053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111459425|NCT00003053|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111459426|NCT00003053|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111459427|NCT00003053|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111459428|NCT00003053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110935996|NCT02736578|Cetuximab|cetuximab|mesh-list
111459429|NCT00003053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111459430|NCT00003065|Paclitaxel|paclitaxel|mesh-list
111459431|NCT00003065|Topotecan|topotecan|mesh-list
111459432|NCT00003065|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111459433|NCT00003065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111459434|NCT00003065|Tubulin Modulators|tubulin modulators|mesh-ancestor
111459435|NCT00003065|Antimitotic Agents|antimitotic agents|mesh-ancestor
111459436|NCT00003065|Mitosis Modulators|mitosis modulators|mesh-ancestor
111459437|NCT00003065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111459438|NCT00003065|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111459439|NCT00003065|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111459440|NCT00003065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111459441|NCT04329611|Hydroxychloroquine|hydroxychloroquine|mesh-list
111459442|NCT04329611|Antimalarials|antimalarials|mesh-ancestor
111459443|NCT04329611|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111459444|NCT04329611|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111459445|NCT04329611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111459446|NCT04329611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110936020|NCT03473600|Glucocorticoids|glucocorticoids|mesh-ancestor
111459447|NCT04329611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111459448|NCT04329611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111459449|NCT00383357|Zolpidem|zolpidem|mesh-list
111459450|NCT00383357|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111459451|NCT00383357|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111459452|NCT00383357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111459453|NCT00383357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111459454|NCT00383357|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
111459455|NCT00383357|GABA Agonists|gaba agonists|mesh-ancestor
111459456|NCT00383357|GABA Agents|gaba agents|mesh-ancestor
111459457|NCT00383357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111459458|NCT00383357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111459459|NCT00003089|Paclitaxel|paclitaxel|mesh-list
111459460|NCT00003089|Carboplatin|carboplatin|mesh-list
111459461|NCT00003089|Amifostine|amifostine|mesh-list
111459462|NCT00003089|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111459463|NCT00003089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111459464|NCT00003089|Tubulin Modulators|tubulin modulators|mesh-ancestor
111459465|NCT00003089|Antimitotic Agents|antimitotic agents|mesh-ancestor
111459466|NCT00003089|Mitosis Modulators|mitosis modulators|mesh-ancestor
111459467|NCT00003089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111459468|NCT00003089|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111459469|NCT00003089|Protective Agents|protective agents|mesh-ancestor
111459470|NCT00003089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111459472|NCT00003101|Busulfan|busulfan|mesh-list
111459473|NCT00003101|Thiotepa|thiotepa|mesh-list
111459474|NCT00003101|Lomustine|lomustine|mesh-list
111459475|NCT00003101|Procarbazine|procarbazine|mesh-list
111459476|NCT00003101|Immunologic Factors|immunologic factors|mesh-ancestor
111459477|NCT00003101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111459478|NCT00003101|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111459479|NCT00003101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111459480|NCT00003101|Tubulin Modulators|tubulin modulators|mesh-ancestor
111459481|NCT00003101|Antimitotic Agents|antimitotic agents|mesh-ancestor
111459482|NCT00003101|Mitosis Modulators|mitosis modulators|mesh-ancestor
111459483|NCT00003101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111459484|NCT00003101|Alkylating Agents|alkylating agents|mesh-ancestor
111459485|NCT00003101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111459486|NCT00003101|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111459487|NCT00003101|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111459488|NCT00003107|Interleukin-12|interleukin-12|mesh-list
111459489|NCT00003107|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111459490|NCT00003107|Immunologic Factors|immunologic factors|mesh-ancestor
111459491|NCT00003107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111459492|NCT00003107|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111459493|NCT00003107|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111459494|NCT00003107|Growth Substances|growth substances|mesh-ancestor
111459495|NCT00003107|Growth Inhibitors|growth inhibitors|mesh-ancestor
111459496|NCT00003107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111459497|NCT00003113|Cyclophosphamide|cyclophosphamide|mesh-list
111459498|NCT00003113|Lomustine|lomustine|mesh-list
111459499|NCT00003113|Etoposide|etoposide|mesh-list
111459500|NCT00003113|Procarbazine|procarbazine|mesh-list
111459501|NCT00003113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111459502|NCT00003113|Immunologic Factors|immunologic factors|mesh-ancestor
111459503|NCT00003113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111459504|NCT00003113|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111459505|NCT00003113|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111459506|NCT00003113|Alkylating Agents|alkylating agents|mesh-ancestor
111459507|NCT00003113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111459508|NCT00003113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111459509|NCT00003113|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111459510|NCT00003113|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111459511|NCT00003113|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111459512|NCT00003113|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111459513|NCT00003113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111459514|NCT01545557|Lidocaine|lidocaine|mesh-list
111459515|NCT01545557|Hyaluronic Acid|hyaluronic acid|mesh-list
111459516|NCT01545557|Anesthetics, Local|anesthetics, local|mesh-ancestor
111459517|NCT01545557|Anesthetics|anesthetics|mesh-ancestor
111459518|NCT01545557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111459519|NCT01545557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111459520|NCT01545557|Sensory System Agents|sensory system agents|mesh-ancestor
111459521|NCT01545557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111459522|NCT01545557|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111459523|NCT01545557|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111459524|NCT01545557|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111459525|NCT01545557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111459526|NCT01545557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111459527|NCT01545557|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111459528|NCT01545557|Immunologic Factors|immunologic factors|mesh-ancestor
111459529|NCT01545557|Viscosupplements|viscosupplements|mesh-ancestor
111459530|NCT01545557|Protective Agents|protective agents|mesh-ancestor
111459531|NCT00003119|Cyclophosphamide|cyclophosphamide|mesh-list
111459532|NCT00003119|Carboplatin|carboplatin|mesh-list
111459533|NCT00003119|Doxorubicin|doxorubicin|mesh-list
111459534|NCT00003119|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111459535|NCT00003119|Etoposide|etoposide|mesh-list
111459536|NCT00003119|Sargramostim|sargramostim|mesh-list
111459537|NCT00003119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111459538|NCT00003119|Immunologic Factors|immunologic factors|mesh-ancestor
111459539|NCT00003119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111459540|NCT00003119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111459541|NCT00003119|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110936118|NCT03562533|Paclitaxel|paclitaxel|mesh-list
111459542|NCT00003119|Alkylating Agents|alkylating agents|mesh-ancestor
111459543|NCT00003119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111183710|NCT01452724|Lansoprazole|lansoprazole|mesh-list
111459544|NCT00003119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111459545|NCT00003119|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111459546|NCT00003119|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111459547|NCT00003119|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111459548|NCT00003119|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111459549|NCT00003119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111459550|NCT00003119|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111459551|NCT00003395|Arsenic Trioxide|arsenic trioxide|mesh-list
111459552|NCT00003395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111459553|NCT00003401|Dexamethasone|dexamethasone|mesh-list
111459554|NCT00003401|Paclitaxel|paclitaxel|mesh-list
111459555|NCT00003401|Etoposide|etoposide|mesh-list
111459556|NCT00003401|Cyclophosphamide|cyclophosphamide|mesh-list
111459557|NCT00003401|Gemcitabine|gemcitabine|mesh-list
111459558|NCT00003401|Melphalan|melphalan|mesh-list
111459559|NCT00003401|Carmustine|carmustine|mesh-list
111459560|NCT00003401|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111459561|NCT00003401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111459562|NCT00003401|Tubulin Modulators|tubulin modulators|mesh-ancestor
111459563|NCT00003401|Antimitotic Agents|antimitotic agents|mesh-ancestor
111459564|NCT00003401|Mitosis Modulators|mitosis modulators|mesh-ancestor
111459565|NCT00003401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111459566|NCT00003401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111459567|NCT00003401|Immunologic Factors|immunologic factors|mesh-ancestor
111459568|NCT00003401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111459569|NCT00003401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111459570|NCT00003401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111459571|NCT00003401|Alkylating Agents|alkylating agents|mesh-ancestor
111459572|NCT00003401|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111459573|NCT00003401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111459574|NCT00003401|Antiemetics|antiemetics|mesh-ancestor
111459575|NCT00003401|Autonomic Agents|autonomic agents|mesh-ancestor
111459576|NCT00003401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111459577|NCT00003401|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111459578|NCT00003401|Glucocorticoids|glucocorticoids|mesh-ancestor
111459579|NCT00003401|Hormones|hormones|mesh-ancestor
111459580|NCT00003401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111459581|NCT00003401|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111459582|NCT00003401|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111459583|NCT00003401|Antimetabolites|antimetabolites|mesh-ancestor
111459584|NCT00003401|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111459585|NCT00003401|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111459586|NCT00003401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111459587|NCT00003125|Aldesleukin|aldesleukin|mesh-list
111459588|NCT00003125|Vaccines|vaccines|mesh-list
111459589|NCT00003125|Sargramostim|sargramostim|mesh-list
111459590|NCT00003125|Immunologic Factors|immunologic factors|mesh-ancestor
111459591|NCT00003125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111459592|NCT00003125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111459593|NCT00003125|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111459594|NCT00003125|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111459595|NCT00003125|Antiviral Agents|antiviral agents|mesh-ancestor
111459596|NCT00003125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111459597|NCT00003131|Gemtuzumab|gemtuzumab|mesh-list
111459598|NCT00003131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111459599|NCT00003131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111459600|NCT00003131|Immunotoxins|immunotoxins|mesh-ancestor
111459601|NCT00003131|Immunoconjugates|immunoconjugates|mesh-ancestor
111459602|NCT00003131|Immunologic Factors|immunologic factors|mesh-ancestor
111459603|NCT00003131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111459604|NCT00384371|Botulinum Toxins|botulinum toxins|mesh-list
111459605|NCT00384371|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111459606|NCT00384371|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111459607|NCT00384371|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111459608|NCT00384371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111459609|NCT00384371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111459610|NCT00384371|Cholinergic Agents|cholinergic agents|mesh-ancestor
111459611|NCT00384371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111459612|NCT00384371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111459613|NCT00384371|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111459614|NCT00384371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111459615|NCT00423215|Insulin Glargine|insulin glargine|mesh-list
111459616|NCT00423215|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111459617|NCT00423215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111459618|NCT00003413|Paclitaxel|paclitaxel|mesh-list
111459619|NCT00003413|Melphalan|melphalan|mesh-list
111459620|NCT00003413|Carmustine|carmustine|mesh-list
111459621|NCT00003413|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111459622|NCT00003413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111459623|NCT00003413|Tubulin Modulators|tubulin modulators|mesh-ancestor
111459624|NCT00003413|Antimitotic Agents|antimitotic agents|mesh-ancestor
111459625|NCT00003413|Mitosis Modulators|mitosis modulators|mesh-ancestor
111459626|NCT00003413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111459627|NCT00003413|Immunologic Factors|immunologic factors|mesh-ancestor
111459628|NCT00003413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111459629|NCT00003413|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111459630|NCT00003413|Alkylating Agents|alkylating agents|mesh-ancestor
111459631|NCT00003413|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111459632|NCT00003413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111459633|NCT00003137|Irinotecan|irinotecan|mesh-list
111459634|NCT00003137|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111459635|NCT00003137|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111459636|NCT00003137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111459637|NCT00003137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111459638|NCT00003137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111459639|NCT00003419|Antiviral Agents|antiviral agents|mesh-list
111459640|NCT00003419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111459641|NCT00003425|Cyclophosphamide|cyclophosphamide|mesh-list
111459642|NCT00003425|Melphalan|melphalan|mesh-list
111459643|NCT00003425|Amifostine|amifostine|mesh-list
111459644|NCT00003425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111459645|NCT00003425|Immunologic Factors|immunologic factors|mesh-ancestor
111459646|NCT00003425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111459647|NCT00003425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111459648|NCT00003425|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111459649|NCT00003425|Alkylating Agents|alkylating agents|mesh-ancestor
111459650|NCT00003425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111459651|NCT00003425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111459652|NCT00003425|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111459653|NCT00003425|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111459654|NCT00003425|Protective Agents|protective agents|mesh-ancestor
111459655|NCT00330551|Risperidone|risperidone|mesh-list
111459656|NCT00330551|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111459657|NCT00330551|Serotonin Agents|serotonin agents|mesh-ancestor
111459658|NCT00330551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111459659|NCT00330551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111459660|NCT00330551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111459661|NCT00330551|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111459662|NCT00330551|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111459663|NCT00330551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111459664|NCT00330551|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111459665|NCT00330551|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111459666|NCT00330551|Dopamine Agents|dopamine agents|mesh-ancestor
111459667|NCT00001259|Leuprolide|leuprolide|mesh-list
111459668|NCT00001259|Estradiol|estradiol|mesh-list
111459669|NCT00001259|Progesterone|progesterone|mesh-list
111459670|NCT00001259|Estrogens|estrogens|mesh-ancestor
111459671|NCT00001259|Hormones|hormones|mesh-ancestor
111459672|NCT00001259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111459673|NCT00001259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111459674|NCT00001259|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111459675|NCT00001259|Progestins|progestins|mesh-ancestor
111459676|NCT00001259|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111459677|NCT00001259|Fertility Agents|fertility agents|mesh-ancestor
111459678|NCT00001259|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111459679|NCT00001259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111459680|NCT00003143|Amifostine|amifostine|mesh-list
111459681|NCT00003143|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111459682|NCT00003143|Protective Agents|protective agents|mesh-ancestor
111459683|NCT00003143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111459684|NCT00003431|Flt3 ligand protein|flt3 ligand protein|mesh-list
111459685|NCT00003431|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111459686|NCT00003431|Immunologic Factors|immunologic factors|mesh-ancestor
111459687|NCT00003431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111459688|NCT00003431|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111459689|NCT00003431|Protective Agents|protective agents|mesh-ancestor
111459690|NCT00003149|Interleukin-12|interleukin-12|mesh-list
111459691|NCT00003149|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111459692|NCT00003149|Immunologic Factors|immunologic factors|mesh-ancestor
111459693|NCT00003149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111459694|NCT00003149|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111459695|NCT00003149|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111459696|NCT00003149|Growth Substances|growth substances|mesh-ancestor
111459697|NCT00003149|Growth Inhibitors|growth inhibitors|mesh-ancestor
111459698|NCT00003149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111459699|NCT00003437|Cytarabine|cytarabine|mesh-list
111459700|NCT00003437|Dexamethasone|dexamethasone|mesh-list
111459701|NCT00003437|Prednisolone|prednisolone|mesh-list
111459702|NCT00003437|Cyclophosphamide|cyclophosphamide|mesh-list
111459703|NCT00003437|Doxorubicin|doxorubicin|mesh-list
111459704|NCT00003437|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111459705|NCT00003437|Methotrexate|methotrexate|mesh-list
111459706|NCT00003437|Vincristine|vincristine|mesh-list
111459707|NCT00003437|Daunorubicin|daunorubicin|mesh-list
111459708|NCT00003437|Asparaginase|asparaginase|mesh-list
111459709|NCT00003437|Mercaptopurine|mercaptopurine|mesh-list
111459710|NCT00003437|Pegaspargase|pegaspargase|mesh-list
111459711|NCT00003437|Thioguanine|thioguanine|mesh-list
111459712|NCT00003437|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111459713|NCT00003437|Immunologic Factors|immunologic factors|mesh-ancestor
111459714|NCT00003437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111459715|NCT00003437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111459716|NCT00003437|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111459717|NCT00003437|Alkylating Agents|alkylating agents|mesh-ancestor
111459718|NCT00003437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111459719|NCT00003437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111459720|NCT00003437|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111459721|NCT00003437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111459722|NCT00003437|Antiemetics|antiemetics|mesh-ancestor
111459723|NCT00003437|Autonomic Agents|autonomic agents|mesh-ancestor
111459724|NCT00003437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111459725|NCT00003437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111459726|NCT00003437|Glucocorticoids|glucocorticoids|mesh-ancestor
111459727|NCT00003437|Hormones|hormones|mesh-ancestor
111459728|NCT00003437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111459729|NCT00003437|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111459730|NCT00003437|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111459731|NCT00003437|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111459732|NCT00003437|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111459733|NCT00003437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111459734|NCT00003437|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111459735|NCT00003437|Abortifacient Agents|abortifacient agents|mesh-ancestor
111459736|NCT00003437|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111459737|NCT00003437|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111459738|NCT00003437|Antimetabolites|antimetabolites|mesh-ancestor
111459739|NCT00003437|Dermatologic Agents|dermatologic agents|mesh-ancestor
111459740|NCT00003437|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111459741|NCT00003437|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111459742|NCT00003437|Antiviral Agents|antiviral agents|mesh-ancestor
111459743|NCT00003437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111459744|NCT00003437|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111459745|NCT00003437|Tubulin Modulators|tubulin modulators|mesh-ancestor
111459746|NCT00003437|Antimitotic Agents|antimitotic agents|mesh-ancestor
111459747|NCT00003437|Mitosis Modulators|mitosis modulators|mesh-ancestor
111459748|NCT00003443|Bryostatin 1|bryostatin 1|mesh-list
111459749|NCT00003443|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111459750|NCT00003443|Immunologic Factors|immunologic factors|mesh-ancestor
111459751|NCT00003443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111459752|NCT00003443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111459753|NCT00003449|Dexamethasone|dexamethasone|mesh-list
111459754|NCT00003449|Paclitaxel|paclitaxel|mesh-list
111459755|NCT00003449|Gemcitabine|gemcitabine|mesh-list
111459756|NCT00003449|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111459757|NCT00003449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111459758|NCT00003449|Tubulin Modulators|tubulin modulators|mesh-ancestor
111459759|NCT00003449|Antimitotic Agents|antimitotic agents|mesh-ancestor
111459760|NCT00003449|Mitosis Modulators|mitosis modulators|mesh-ancestor
111459761|NCT00003449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111459762|NCT00003449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111459763|NCT00003449|Antiemetics|antiemetics|mesh-ancestor
111459764|NCT00003449|Autonomic Agents|autonomic agents|mesh-ancestor
111459765|NCT00003449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110936331|NCT04967326|Carbamazepine|carbamazepine|mesh-list
111459766|NCT00003449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111459767|NCT00003449|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111459768|NCT00003449|Glucocorticoids|glucocorticoids|mesh-ancestor
111459769|NCT00003449|Hormones|hormones|mesh-ancestor
111459770|NCT00003449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111459771|NCT00003449|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111459772|NCT00003449|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111459773|NCT00003449|Antimetabolites|antimetabolites|mesh-ancestor
111459774|NCT00002801|Leucovorin|leucovorin|mesh-list
111183952|NCT02556424|Hormones|hormones|mesh-ancestor
111459776|NCT00002801|Calcium|calcium|mesh-list
111459777|NCT00002801|Levoleucovorin|levoleucovorin|mesh-list
111459778|NCT00002801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111459779|NCT00002801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111459780|NCT00002801|Antidotes|antidotes|mesh-ancestor
111459781|NCT00002801|Protective Agents|protective agents|mesh-ancestor
111459782|NCT00002801|Vitamin B Complex|vitamin b complex|mesh-ancestor
111459783|NCT00002801|Vitamins|vitamins|mesh-ancestor
111459784|NCT00002801|Micronutrients|micronutrients|mesh-ancestor
111459785|NCT00002801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111459786|NCT00002801|Antimetabolites|antimetabolites|mesh-ancestor
111459787|NCT00002801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111459788|NCT00002801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111459789|NCT00002813|Vinorelbine|vinorelbine|mesh-list
111459790|NCT00002813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111459791|NCT00002813|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111459792|NCT00002813|Tubulin Modulators|tubulin modulators|mesh-ancestor
111459793|NCT00002813|Antimitotic Agents|antimitotic agents|mesh-ancestor
111459794|NCT00002813|Mitosis Modulators|mitosis modulators|mesh-ancestor
111459795|NCT00002813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111459796|NCT00002819|Paclitaxel|paclitaxel|mesh-list
111459797|NCT00002819|Cyclophosphamide|cyclophosphamide|mesh-list
111459798|NCT00002819|Carboplatin|carboplatin|mesh-list
111459799|NCT00002819|Mitoxantrone|mitoxantrone|mesh-list
111459800|NCT00002819|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111459801|NCT00002819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111459802|NCT00002819|Tubulin Modulators|tubulin modulators|mesh-ancestor
111459803|NCT00002819|Antimitotic Agents|antimitotic agents|mesh-ancestor
111459804|NCT00002819|Mitosis Modulators|mitosis modulators|mesh-ancestor
111459805|NCT00002819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111459806|NCT00002819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111459807|NCT00002819|Immunologic Factors|immunologic factors|mesh-ancestor
111459808|NCT00002819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111459809|NCT00002819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111459810|NCT00002819|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111459811|NCT00002819|Alkylating Agents|alkylating agents|mesh-ancestor
111459812|NCT00002819|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111459813|NCT00002819|Analgesics|analgesics|mesh-ancestor
111459814|NCT00002819|Sensory System Agents|sensory system agents|mesh-ancestor
111459815|NCT00002819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111459816|NCT00002819|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111459817|NCT00002819|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111459818|NCT00002819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111459819|NCT00002825|Docetaxel|docetaxel|mesh-list
111459820|NCT00002825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111459821|NCT00002825|Tubulin Modulators|tubulin modulators|mesh-ancestor
111459822|NCT00002825|Antimitotic Agents|antimitotic agents|mesh-ancestor
111459823|NCT00002825|Mitosis Modulators|mitosis modulators|mesh-ancestor
111459824|NCT00002825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111459825|NCT00002831|Cyclosporine|cyclosporine|mesh-list
111459826|NCT00002831|Methylprednisolone|methylprednisolone|mesh-list
111459827|NCT00002831|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110936391|NCT04966234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111459828|NCT00002831|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111459829|NCT00002831|Prednisolone|prednisolone|mesh-list
111459830|NCT00002831|Prednisolone acetate|prednisolone acetate|mesh-list
111459831|NCT00002831|Cyclophosphamide|cyclophosphamide|mesh-list
111459832|NCT00002831|Busulfan|busulfan|mesh-list
111459833|NCT00002831|Methotrexate|methotrexate|mesh-list
111459834|NCT00002831|Decitabine|decitabine|mesh-list
111459835|NCT00002831|Tacrolimus|tacrolimus|mesh-list
111459836|NCT00002831|Cyclosporins|cyclosporins|mesh-list
111459837|NCT00002831|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111459838|NCT00002831|Prednisolone phosphate|prednisolone phosphate|mesh-list
111459839|NCT00002831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111459840|NCT00002831|Immunologic Factors|immunologic factors|mesh-ancestor
111459841|NCT00002831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111459842|NCT00002831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111459843|NCT00002831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111459844|NCT00002831|Alkylating Agents|alkylating agents|mesh-ancestor
111459845|NCT00002831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111459846|NCT00002831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111459847|NCT00002831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111459848|NCT00002831|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111459849|NCT00002831|Abortifacient Agents|abortifacient agents|mesh-ancestor
111459850|NCT00002831|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111459851|NCT00002831|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111459852|NCT00002831|Antimetabolites|antimetabolites|mesh-ancestor
111459853|NCT00002831|Dermatologic Agents|dermatologic agents|mesh-ancestor
111459854|NCT00002831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111459855|NCT00002831|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111459856|NCT00002831|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111459857|NCT00002831|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111459858|NCT00002831|Antifungal Agents|antifungal agents|mesh-ancestor
111459859|NCT00002831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111459860|NCT00002831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111459861|NCT00002831|Antiemetics|antiemetics|mesh-ancestor
111459862|NCT00002831|Autonomic Agents|autonomic agents|mesh-ancestor
111459863|NCT00002831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111459864|NCT00002831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111459865|NCT00002831|Glucocorticoids|glucocorticoids|mesh-ancestor
111459866|NCT00002831|Hormones|hormones|mesh-ancestor
111459867|NCT00002831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111459868|NCT00002831|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111459869|NCT00002831|Protective Agents|protective agents|mesh-ancestor
111459870|NCT00002831|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111459871|NCT00002837|Paclitaxel|paclitaxel|mesh-list
111459872|NCT00002837|Cyclophosphamide|cyclophosphamide|mesh-list
111459873|NCT00002837|Doxorubicin|doxorubicin|mesh-list
111459874|NCT00002837|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111459875|NCT00002837|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111459876|NCT00002837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111459877|NCT00002837|Tubulin Modulators|tubulin modulators|mesh-ancestor
111459878|NCT00002837|Antimitotic Agents|antimitotic agents|mesh-ancestor
111459879|NCT00002837|Mitosis Modulators|mitosis modulators|mesh-ancestor
111459880|NCT00002837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111459881|NCT00002837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111459882|NCT00002837|Immunologic Factors|immunologic factors|mesh-ancestor
111459883|NCT00002837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111459884|NCT00002837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111459885|NCT00002837|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111459886|NCT00002837|Alkylating Agents|alkylating agents|mesh-ancestor
111459887|NCT00002837|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111459888|NCT00002837|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111459889|NCT00002837|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111459890|NCT00002837|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111459891|NCT00002837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111459892|NCT00003461|Antibodies|antibodies|mesh-list
111459893|NCT00003461|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111459894|NCT00003461|Immunologic Factors|immunologic factors|mesh-ancestor
111459895|NCT00003461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111459896|NCT00003467|Carmustine|carmustine|mesh-list
111459897|NCT00003467|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111459898|NCT00003467|Alkylating Agents|alkylating agents|mesh-ancestor
111459899|NCT00003467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111459900|NCT00003467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111459901|NCT00002849|Interferons|interferons|mesh-list
111459902|NCT00002849|Interferon-alpha|interferon-alpha|mesh-list
111459903|NCT00002849|Dexamethasone|dexamethasone|mesh-list
111459904|NCT00002849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111459905|NCT00002849|Antiemetics|antiemetics|mesh-ancestor
111459906|NCT00002849|Autonomic Agents|autonomic agents|mesh-ancestor
111459907|NCT00002849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111459908|NCT00002849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111459909|NCT00002849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111459910|NCT00002849|Glucocorticoids|glucocorticoids|mesh-ancestor
111459911|NCT00002849|Hormones|hormones|mesh-ancestor
111459912|NCT00002849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111459913|NCT00002849|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111459914|NCT00002849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111459915|NCT00002849|Antiviral Agents|antiviral agents|mesh-ancestor
111459916|NCT00002849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111459917|NCT00002849|Immunologic Factors|immunologic factors|mesh-ancestor
111459918|NCT00002855|Ketoconazole|ketoconazole|mesh-list
111459919|NCT00002855|Hydrocortisone|hydrocortisone|mesh-list
111459920|NCT00002855|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
111459921|NCT00002855|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
111459922|NCT00002855|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
111459923|NCT00002855|Doxorubicin|doxorubicin|mesh-list
111459924|NCT00002855|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111459925|NCT00002855|Bicalutamide|bicalutamide|mesh-list
111459926|NCT00002855|Vinblastine|vinblastine|mesh-list
111184086|NCT04757506|Naltrexone|naltrexone|mesh-list
111459927|NCT00002855|Flutamide|flutamide|mesh-list
111459928|NCT00002855|Estramustine|estramustine|mesh-list
111459929|NCT00002855|Nilutamide|nilutamide|mesh-list
111459930|NCT00002855|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111459931|NCT00002855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111459932|NCT00002855|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111459933|NCT00002855|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111459934|NCT00002855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111459935|NCT00002855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111459936|NCT00002855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111459937|NCT00002855|Antifungal Agents|antifungal agents|mesh-ancestor
111459938|NCT00002855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111459939|NCT00002855|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111459940|NCT00002855|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111459941|NCT00002855|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111459942|NCT00002855|Hormone Antagonists|hormone antagonists|mesh-ancestor
111459943|NCT00002855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111459944|NCT00002855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111459945|NCT00002855|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111459946|NCT00002855|Androgen Antagonists|androgen antagonists|mesh-ancestor
111459947|NCT00002855|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111459948|NCT00002855|Tubulin Modulators|tubulin modulators|mesh-ancestor
111459949|NCT00002855|Antimitotic Agents|antimitotic agents|mesh-ancestor
111459950|NCT00002855|Mitosis Modulators|mitosis modulators|mesh-ancestor
111459951|NCT00002855|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111459952|NCT00002855|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111459953|NCT00002855|Alkylating Agents|alkylating agents|mesh-ancestor
111459954|NCT00003173|Thiotepa|thiotepa|mesh-list
111459955|NCT00003173|Immunologic Factors|immunologic factors|mesh-ancestor
111459956|NCT00003173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111459957|NCT00003173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111459958|NCT00003173|Alkylating Agents|alkylating agents|mesh-ancestor
111459959|NCT00003173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111459960|NCT00003173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111459961|NCT00003173|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111459962|NCT00003173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111459963|NCT00003179|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
111459964|NCT00003179|Medroxyprogesterone|medroxyprogesterone|mesh-list
111459965|NCT00003179|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111459966|NCT00003179|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111459967|NCT00003179|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111459968|NCT00003179|Contraceptive Agents|contraceptive agents|mesh-ancestor
111459969|NCT00003179|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111459970|NCT00003179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111459971|NCT00003179|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111459972|NCT00003179|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111459973|NCT00003179|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
111459974|NCT00003179|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111459975|NCT00003179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111459976|NCT00002879|Cladribine|cladribine|mesh-list
111459977|NCT00002879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111459978|NCT00002879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111459979|NCT00002879|Immunologic Factors|immunologic factors|mesh-ancestor
111459980|NCT00002879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111459981|NCT00003185|Cyclophosphamide|cyclophosphamide|mesh-list
111459982|NCT00003185|Sargramostim|sargramostim|mesh-list
111459983|NCT00003185|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111459984|NCT00003185|Immunologic Factors|immunologic factors|mesh-ancestor
111459985|NCT00003185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111459986|NCT00003185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111459987|NCT00003185|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111459988|NCT00003185|Alkylating Agents|alkylating agents|mesh-ancestor
111459989|NCT00003185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111459990|NCT00003185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111459991|NCT00003185|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111459992|NCT00003557|Dolastatin 10|dolastatin 10|mesh-list
111459993|NCT00003557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111459994|NCT00003557|Tubulin Modulators|tubulin modulators|mesh-ancestor
111459995|NCT00003557|Antimitotic Agents|antimitotic agents|mesh-ancestor
111459996|NCT00003557|Mitosis Modulators|mitosis modulators|mesh-ancestor
111459997|NCT00003557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111459998|NCT00003935|Etoposide|etoposide|mesh-list
111459999|NCT00003935|Vincristine|vincristine|mesh-list
111460000|NCT00003935|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111460001|NCT00003935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111460002|NCT00003935|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111460003|NCT00003935|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111460004|NCT00003935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111460005|NCT00003935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111460006|NCT00003935|Tubulin Modulators|tubulin modulators|mesh-ancestor
111460007|NCT00003935|Antimitotic Agents|antimitotic agents|mesh-ancestor
111460008|NCT00003935|Mitosis Modulators|mitosis modulators|mesh-ancestor
111460009|NCT00003191|Fenretinide|fenretinide|mesh-list
111460010|NCT00003191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111460011|NCT00003191|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
111460012|NCT00003191|Protective Agents|protective agents|mesh-ancestor
111460013|NCT00003191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111460014|NCT00003941|Etoposide|etoposide|mesh-list
111460015|NCT00003941|Ifosfamide|ifosfamide|mesh-list
111460016|NCT00003941|Bleomycin|bleomycin|mesh-list
111460017|NCT00003941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111460018|NCT00003941|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111460019|NCT00003941|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111460020|NCT00003941|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111460021|NCT00003941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111460022|NCT00003941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111460023|NCT00003941|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111460024|NCT00003941|Alkylating Agents|alkylating agents|mesh-ancestor
111460025|NCT00003941|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111460026|NCT00384527|Vancomycin|vancomycin|mesh-list
111460027|NCT00384527|Nitazoxanide|nitazoxanide|mesh-list
111460028|NCT00384527|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111460029|NCT00384527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111460030|NCT00384527|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111460031|NCT00003569|Paclitaxel|paclitaxel|mesh-list
111460032|NCT00003569|Cisplatin|cisplatin|mesh-list
111460033|NCT00003569|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111460034|NCT00003569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111460035|NCT00003569|Tubulin Modulators|tubulin modulators|mesh-ancestor
110936578|NCT06015152|Tazarotene|tazarotene|mesh-list
111460036|NCT00003569|Antimitotic Agents|antimitotic agents|mesh-ancestor
111460037|NCT00003569|Mitosis Modulators|mitosis modulators|mesh-ancestor
111460038|NCT00003569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111460039|NCT00003953|Tamoxifen|tamoxifen|mesh-list
111460040|NCT00003953|Cyclophosphamide|cyclophosphamide|mesh-list
111460041|NCT00003953|Docetaxel|docetaxel|mesh-list
111460042|NCT00003953|Doxorubicin|doxorubicin|mesh-list
111460043|NCT00003953|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111460044|NCT00003953|Fluorouracil|fluorouracil|mesh-list
111460045|NCT00003953|Methotrexate|methotrexate|mesh-list
111460046|NCT00003953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111460047|NCT00003953|Immunologic Factors|immunologic factors|mesh-ancestor
111460048|NCT00003953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110936613|NCT06012669|Lactoferrin|lactoferrin|mesh-list
111460049|NCT00003953|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111460050|NCT00003953|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111460051|NCT00003953|Alkylating Agents|alkylating agents|mesh-ancestor
111460052|NCT00003953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111460053|NCT00003953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111460054|NCT00003953|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111460055|NCT00003953|Tubulin Modulators|tubulin modulators|mesh-ancestor
111460056|NCT00003953|Antimitotic Agents|antimitotic agents|mesh-ancestor
111460057|NCT00003953|Mitosis Modulators|mitosis modulators|mesh-ancestor
111460058|NCT00003953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111460059|NCT00003953|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111460060|NCT00003953|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111460061|NCT00003953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111460062|NCT00003953|Antimetabolites|antimetabolites|mesh-ancestor
111460063|NCT00003953|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111460064|NCT00003953|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111460065|NCT00003953|Abortifacient Agents|abortifacient agents|mesh-ancestor
111460066|NCT00003953|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111460067|NCT00003953|Dermatologic Agents|dermatologic agents|mesh-ancestor
111460068|NCT00003953|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111460069|NCT00003953|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111460070|NCT00003953|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111460071|NCT00003953|Hormone Antagonists|hormone antagonists|mesh-ancestor
111460072|NCT00003953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111460073|NCT00003953|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111460074|NCT00003953|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111460075|NCT00003953|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111460076|NCT00003953|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111460077|NCT00003959|Sargramostim|sargramostim|mesh-list
111460078|NCT00003959|Immunologic Factors|immunologic factors|mesh-ancestor
111460079|NCT00003959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111460081|NCT02972723|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111460082|NCT02972723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111460083|NCT00003203|Cyclophosphamide|cyclophosphamide|mesh-list
111460084|NCT00003203|Cisplatin|cisplatin|mesh-list
111460085|NCT00003203|Carboplatin|carboplatin|mesh-list
111460086|NCT00003203|Vincristine|vincristine|mesh-list
111460087|NCT00003203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111460088|NCT00003203|Immunologic Factors|immunologic factors|mesh-ancestor
111460089|NCT00003203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111460090|NCT00003203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111460091|NCT00003203|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111460092|NCT00003203|Alkylating Agents|alkylating agents|mesh-ancestor
111460093|NCT00003203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111460094|NCT00003203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111460095|NCT00003203|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111460096|NCT00003203|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111460097|NCT00003203|Tubulin Modulators|tubulin modulators|mesh-ancestor
111460098|NCT00003203|Antimitotic Agents|antimitotic agents|mesh-ancestor
111460099|NCT00003203|Mitosis Modulators|mitosis modulators|mesh-ancestor
111460100|NCT00003575|Etoposide|etoposide|mesh-list
111460101|NCT00003575|Ifosfamide|ifosfamide|mesh-list
111460102|NCT00003575|Interleukin-12|interleukin-12|mesh-list
110936637|NCT05995444|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111460103|NCT00003575|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111460104|NCT00003575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111460105|NCT00003575|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111460106|NCT00003575|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111460107|NCT00003575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111460108|NCT00003575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111460109|NCT00003575|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111460110|NCT00003575|Immunologic Factors|immunologic factors|mesh-ancestor
111460111|NCT00003575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111460112|NCT00003575|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111460113|NCT00003575|Alkylating Agents|alkylating agents|mesh-ancestor
111460114|NCT00003575|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111460115|NCT00003575|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111460116|NCT00003575|Growth Substances|growth substances|mesh-ancestor
111460117|NCT00003575|Growth Inhibitors|growth inhibitors|mesh-ancestor
111460118|NCT00003539|Paclitaxel|paclitaxel|mesh-list
111460119|NCT00003539|Trastuzumab|trastuzumab|mesh-list
111460120|NCT00003539|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111460121|NCT00003539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111460122|NCT00003539|Tubulin Modulators|tubulin modulators|mesh-ancestor
111460123|NCT00003539|Antimitotic Agents|antimitotic agents|mesh-ancestor
111460124|NCT00003539|Mitosis Modulators|mitosis modulators|mesh-ancestor
111460125|NCT00003539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111460126|NCT00003539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111460127|NCT00003209|Fluorouracil|fluorouracil|mesh-list
111460128|NCT00003209|Methotrexate|methotrexate|mesh-list
111460129|NCT00003209|Ifosfamide|ifosfamide|mesh-list
111460130|NCT00003209|Mitomycins|mitomycins|mesh-list
111460131|NCT00003209|Mitomycin|mitomycin|mesh-list
111460132|NCT00003209|Bleomycin|bleomycin|mesh-list
111460133|NCT00003209|Vinblastine|vinblastine|mesh-list
111460134|NCT00003209|Vindesine|vindesine|mesh-list
111460135|NCT00003209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111460136|NCT00003209|Antimetabolites|antimetabolites|mesh-ancestor
111460137|NCT00003209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111460138|NCT00003209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111460139|NCT00003209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111460140|NCT00003209|Immunologic Factors|immunologic factors|mesh-ancestor
111460141|NCT00003209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111460142|NCT00003209|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111460143|NCT00003209|Abortifacient Agents|abortifacient agents|mesh-ancestor
111460144|NCT00003209|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111460145|NCT00003209|Dermatologic Agents|dermatologic agents|mesh-ancestor
111460146|NCT00003209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111460147|NCT00003209|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111460148|NCT00003209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111460149|NCT00003209|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111460150|NCT00003209|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111460151|NCT00003209|Alkylating Agents|alkylating agents|mesh-ancestor
111460152|NCT00003209|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111460153|NCT00003209|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111460154|NCT00003209|Tubulin Modulators|tubulin modulators|mesh-ancestor
111460155|NCT00003209|Antimitotic Agents|antimitotic agents|mesh-ancestor
111460156|NCT00003209|Mitosis Modulators|mitosis modulators|mesh-ancestor
111460157|NCT00003587|Paclitaxel|paclitaxel|mesh-list
111460158|NCT00003587|Vinorelbine|vinorelbine|mesh-list
111460159|NCT00003587|Docetaxel|docetaxel|mesh-list
111460160|NCT00003587|Carboplatin|carboplatin|mesh-list
111460161|NCT00003587|Gemcitabine|gemcitabine|mesh-list
111460162|NCT00003587|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111460163|NCT00003587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111460164|NCT00003587|Tubulin Modulators|tubulin modulators|mesh-ancestor
111460165|NCT00003587|Antimitotic Agents|antimitotic agents|mesh-ancestor
111460166|NCT00003587|Mitosis Modulators|mitosis modulators|mesh-ancestor
111460167|NCT00003587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111460168|NCT00003587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111460169|NCT00003587|Antimetabolites|antimetabolites|mesh-ancestor
111460170|NCT00003215|Leucovorin|leucovorin|mesh-list
111460171|NCT00003215|Cytarabine|cytarabine|mesh-list
111460172|NCT00003215|Prednisone|prednisone|mesh-list
111460173|NCT00003215|Methylprednisolone|methylprednisolone|mesh-list
111460174|NCT00003215|Hydrocortisone|hydrocortisone|mesh-list
111460175|NCT00003215|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
111460176|NCT00003215|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
111460177|NCT00003215|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
111460178|NCT00003215|Cyclophosphamide|cyclophosphamide|mesh-list
111460179|NCT00003215|Melphalan|melphalan|mesh-list
111460180|NCT00003215|Doxorubicin|doxorubicin|mesh-list
111460181|NCT00003215|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111460182|NCT00003215|Methotrexate|methotrexate|mesh-list
111460183|NCT00003215|Etoposide|etoposide|mesh-list
111460184|NCT00003215|Vincristine|vincristine|mesh-list
111460185|NCT00003215|Mitoxantrone|mitoxantrone|mesh-list
111460186|NCT00003215|Levoleucovorin|levoleucovorin|mesh-list
111460187|NCT00003215|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111460188|NCT00003215|Immunologic Factors|immunologic factors|mesh-ancestor
111460189|NCT00003215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111460190|NCT00003215|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111460191|NCT00003215|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111460192|NCT00003215|Alkylating Agents|alkylating agents|mesh-ancestor
111460193|NCT00003215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111460194|NCT00003215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111460195|NCT00003215|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111460196|NCT00003215|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111460197|NCT00003215|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111460198|NCT00003215|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111460199|NCT00003215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111460200|NCT00003215|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111460201|NCT00003215|Glucocorticoids|glucocorticoids|mesh-ancestor
111460202|NCT00003215|Hormones|hormones|mesh-ancestor
111460203|NCT00003215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111460204|NCT00003215|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111460205|NCT00003215|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111460206|NCT00003215|Abortifacient Agents|abortifacient agents|mesh-ancestor
111460207|NCT00003215|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111460208|NCT00003215|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111460209|NCT00003215|Antimetabolites|antimetabolites|mesh-ancestor
111460210|NCT00003215|Dermatologic Agents|dermatologic agents|mesh-ancestor
111460211|NCT00003215|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111460212|NCT00003215|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111460213|NCT00003215|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111460214|NCT00003215|Antiviral Agents|antiviral agents|mesh-ancestor
111460215|NCT00003215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111460216|NCT00003215|Antidotes|antidotes|mesh-ancestor
111460217|NCT00003215|Protective Agents|protective agents|mesh-ancestor
111460218|NCT00003215|Vitamin B Complex|vitamin b complex|mesh-ancestor
111460219|NCT00003215|Vitamins|vitamins|mesh-ancestor
111460220|NCT00003215|Micronutrients|micronutrients|mesh-ancestor
111460221|NCT00003215|Tubulin Modulators|tubulin modulators|mesh-ancestor
111460222|NCT00003215|Antimitotic Agents|antimitotic agents|mesh-ancestor
111460223|NCT00003215|Mitosis Modulators|mitosis modulators|mesh-ancestor
111460224|NCT00003215|Antiemetics|antiemetics|mesh-ancestor
111460225|NCT00003215|Autonomic Agents|autonomic agents|mesh-ancestor
111184378|NCT02236312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111460226|NCT00003215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111460227|NCT00003215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111460228|NCT00003215|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111460229|NCT00003215|Analgesics|analgesics|mesh-ancestor
111460230|NCT00003215|Sensory System Agents|sensory system agents|mesh-ancestor
111460231|NCT00003995|Trastuzumab|trastuzumab|mesh-list
111460232|NCT00003995|Irinotecan|irinotecan|mesh-list
111460233|NCT00003995|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111460234|NCT00003995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111460235|NCT00003995|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111460236|NCT00003995|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111460237|NCT00003995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111460238|NCT00003995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111460239|NCT00003593|Cytarabine|cytarabine|mesh-list
111460240|NCT00003593|Hydrocortisone|hydrocortisone|mesh-list
111460241|NCT00003593|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
111460242|NCT00003593|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
111460243|NCT00003593|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
111460244|NCT00003593|Methotrexate|methotrexate|mesh-list
111460245|NCT00003593|Thioguanine|thioguanine|mesh-list
111460246|NCT00003593|Daunorubicin|daunorubicin|mesh-list
111460247|NCT00003593|Asparaginase|asparaginase|mesh-list
111460248|NCT00003593|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111460249|NCT00003593|Abortifacient Agents|abortifacient agents|mesh-ancestor
111460250|NCT00003593|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111460251|NCT00003593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111460252|NCT00003593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111460253|NCT00003593|Antimetabolites|antimetabolites|mesh-ancestor
111460254|NCT00003593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111460255|NCT00003593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111460256|NCT00003593|Dermatologic Agents|dermatologic agents|mesh-ancestor
111460257|NCT00003593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110936806|NCT05741658|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111460258|NCT00003593|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111460259|NCT00003593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111460260|NCT00003593|Immunologic Factors|immunologic factors|mesh-ancestor
111460261|NCT00003593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111460262|NCT00003593|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111460263|NCT00003593|Antiviral Agents|antiviral agents|mesh-ancestor
111460264|NCT00003593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111460265|NCT00003593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111460266|NCT00003593|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111460267|NCT00003593|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111460268|NCT00003593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111460269|NCT00003599|Vitamin E|vitamin e|mesh-list
111460270|NCT00003599|Tocopherols|tocopherols|mesh-list
111460271|NCT00003599|alpha-Tocopherol|alpha-tocopherol|mesh-list
111460272|NCT00003599|Isotretinoin|isotretinoin|mesh-list
111460273|NCT00003599|Vitamins|vitamins|mesh-ancestor
111460274|NCT00003599|Micronutrients|micronutrients|mesh-ancestor
111460275|NCT00003599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111460276|NCT00003599|Antioxidants|antioxidants|mesh-ancestor
111460277|NCT00003599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111460278|NCT00003599|Protective Agents|protective agents|mesh-ancestor
111460279|NCT00003599|Dermatologic Agents|dermatologic agents|mesh-ancestor
111460280|NCT00003605|Cyclophosphamide|cyclophosphamide|mesh-list
111460281|NCT00003605|Rituximab|rituximab|mesh-list
111460282|NCT00003605|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111460283|NCT00003605|Immunologic Factors|immunologic factors|mesh-ancestor
111460284|NCT00003605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111460285|NCT00003605|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111460286|NCT00003605|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111460287|NCT00003605|Alkylating Agents|alkylating agents|mesh-ancestor
111460288|NCT00003605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111460289|NCT00003605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111460290|NCT00003605|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111460291|NCT00003605|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111460292|NCT00003611|Acitretin|acitretin|mesh-list
111460293|NCT00003611|Keratolytic Agents|keratolytic agents|mesh-ancestor
111460294|NCT00003611|Dermatologic Agents|dermatologic agents|mesh-ancestor
111460295|NCT00003617|Clarithromycin|clarithromycin|mesh-list
111460296|NCT00003617|Tinidazole|tinidazole|mesh-list
111460297|NCT00003617|Chlorambucil|chlorambucil|mesh-list
111460298|NCT00003617|Omeprazole|omeprazole|mesh-list
111460299|NCT00003617|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111460300|NCT00003617|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111460301|NCT00003617|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111460302|NCT00003617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111460303|NCT00003617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111460304|NCT00003617|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111460305|NCT00003617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111460306|NCT00003617|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111184456|NCT02191930|Cyclophosphamide|cyclophosphamide|mesh-list
111460307|NCT00003617|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111460308|NCT00003617|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111460309|NCT00003617|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111460310|NCT00003617|Alkylating Agents|alkylating agents|mesh-ancestor
111460311|NCT00003617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111460312|NCT00003617|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
111460313|NCT00003617|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111460314|NCT00003617|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111460315|NCT00004001|Prednisone|prednisone|mesh-list
111460316|NCT00004001|Docetaxel|docetaxel|mesh-list
111460317|NCT00004001|Mitoxantrone|mitoxantrone|mesh-list
111460318|NCT00004001|Estramustine|estramustine|mesh-list
111460319|NCT00004001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111460320|NCT00004001|Tubulin Modulators|tubulin modulators|mesh-ancestor
111460321|NCT00004001|Antimitotic Agents|antimitotic agents|mesh-ancestor
111460322|NCT00004001|Mitosis Modulators|mitosis modulators|mesh-ancestor
111460323|NCT00004001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111460324|NCT00004001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111460325|NCT00004001|Glucocorticoids|glucocorticoids|mesh-ancestor
111460326|NCT00004001|Hormones|hormones|mesh-ancestor
111460327|NCT00004001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111460328|NCT00004001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111460329|NCT00004001|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111460330|NCT00004001|Analgesics|analgesics|mesh-ancestor
111460331|NCT00004001|Sensory System Agents|sensory system agents|mesh-ancestor
111460332|NCT00004001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111460333|NCT00004001|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111460334|NCT00004001|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111460335|NCT00004001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111460336|NCT00004001|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111460337|NCT00004001|Alkylating Agents|alkylating agents|mesh-ancestor
111460338|NCT00004013|Paclitaxel|paclitaxel|mesh-list
111460339|NCT00004013|Trastuzumab|trastuzumab|mesh-list
111460340|NCT00004013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111460341|NCT00004013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110936885|NCT05669352|Pembrolizumab|pembrolizumab|mesh-list
111460342|NCT00004013|Tubulin Modulators|tubulin modulators|mesh-ancestor
111460343|NCT00004013|Antimitotic Agents|antimitotic agents|mesh-ancestor
111460344|NCT00004013|Mitosis Modulators|mitosis modulators|mesh-ancestor
111460345|NCT00004013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111460346|NCT00004013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111460347|NCT00004025|Aldesleukin|aldesleukin|mesh-list
111460348|NCT00004025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111460349|NCT00004025|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111460350|NCT00004025|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111460351|NCT00004025|Antiviral Agents|antiviral agents|mesh-ancestor
111460352|NCT00004025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111460353|NCT00004037|Docetaxel|docetaxel|mesh-list
111460354|NCT00004037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111460355|NCT00004037|Tubulin Modulators|tubulin modulators|mesh-ancestor
111460356|NCT00004037|Antimitotic Agents|antimitotic agents|mesh-ancestor
111460357|NCT00004037|Mitosis Modulators|mitosis modulators|mesh-ancestor
111460358|NCT00004037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111460359|NCT00004043|Calcitriol|calcitriol|mesh-list
111460360|NCT00004043|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111460361|NCT00004043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111460362|NCT00004043|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
111460363|NCT00004043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111460364|NCT00004043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111460365|NCT00004043|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111460366|NCT00004043|Vitamins|vitamins|mesh-ancestor
111460367|NCT00004043|Micronutrients|micronutrients|mesh-ancestor
111460368|NCT00004043|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111460369|NCT00004055|Paclitaxel|paclitaxel|mesh-list
111460370|NCT00004055|Topotecan|topotecan|mesh-list
111460371|NCT00004055|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111460372|NCT00004055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111460373|NCT00004055|Tubulin Modulators|tubulin modulators|mesh-ancestor
111460374|NCT00004055|Antimitotic Agents|antimitotic agents|mesh-ancestor
111460375|NCT00004055|Mitosis Modulators|mitosis modulators|mesh-ancestor
111460376|NCT00004055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111460377|NCT00004055|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111460378|NCT00004055|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111460379|NCT00004055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111184529|NCT02317744|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111460380|NCT00004061|Cyclophosphamide|cyclophosphamide|mesh-list
111460381|NCT00004061|Ifosfamide|ifosfamide|mesh-list
111460382|NCT00004061|Etoposide|etoposide|mesh-list
111460383|NCT00004061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111460384|NCT00004061|Immunologic Factors|immunologic factors|mesh-ancestor
111460385|NCT00004061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111460386|NCT00004061|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111460387|NCT00004061|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111460388|NCT00004061|Alkylating Agents|alkylating agents|mesh-ancestor
111460389|NCT00004061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111460390|NCT00004061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111460391|NCT00004061|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111460392|NCT00004061|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111460393|NCT00004061|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111460394|NCT00004061|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111460395|NCT00004061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111460397|NCT00004067|Cyclophosphamide|cyclophosphamide|mesh-list
111460398|NCT00004067|Doxorubicin|doxorubicin|mesh-list
111460399|NCT00004067|Trastuzumab|trastuzumab|mesh-list
111460400|NCT00004067|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111460401|NCT00004067|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111460402|NCT00004067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111460403|NCT00004067|Tubulin Modulators|tubulin modulators|mesh-ancestor
111460404|NCT00004067|Antimitotic Agents|antimitotic agents|mesh-ancestor
111460405|NCT00004067|Mitosis Modulators|mitosis modulators|mesh-ancestor
111460406|NCT00004067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111460407|NCT00004067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111460408|NCT00004067|Immunologic Factors|immunologic factors|mesh-ancestor
111460409|NCT00004067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111460410|NCT00004067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111460411|NCT00004067|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111460412|NCT00004067|Alkylating Agents|alkylating agents|mesh-ancestor
111460413|NCT00004067|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111460414|NCT00004067|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111460415|NCT00004067|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111460416|NCT00004067|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111460417|NCT00004067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111460418|NCT00004067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111460419|NCT00004073|Suramin|suramin|mesh-list
111460420|NCT00004073|Antinematodal Agents|antinematodal agents|mesh-ancestor
111460421|NCT00004073|Anthelmintics|anthelmintics|mesh-ancestor
111460422|NCT00004073|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111460423|NCT00004073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111460424|NCT00004073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111460425|NCT00004073|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
111460426|NCT00004073|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111460427|NCT00004085|Antibodies|antibodies|mesh-list
111460428|NCT00004085|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111460429|NCT00004085|Immunologic Factors|immunologic factors|mesh-ancestor
111460430|NCT00004085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111460431|NCT00004091|Antibodies|antibodies|mesh-list
111460432|NCT00004091|Immunologic Factors|immunologic factors|mesh-ancestor
111460433|NCT00004091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111460434|NCT00004097|Paclitaxel|paclitaxel|mesh-list
111460435|NCT00004097|Gemcitabine|gemcitabine|mesh-list
111460436|NCT00004097|Fluorouracil|fluorouracil|mesh-list
111460437|NCT00004097|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111460438|NCT00004097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111460439|NCT00004097|Tubulin Modulators|tubulin modulators|mesh-ancestor
111460440|NCT00004097|Antimitotic Agents|antimitotic agents|mesh-ancestor
111460441|NCT00004097|Mitosis Modulators|mitosis modulators|mesh-ancestor
111460442|NCT00004097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111460443|NCT00004097|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111460444|NCT00004097|Antimetabolites|antimetabolites|mesh-ancestor
111460445|NCT00004097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111460446|NCT00004097|Immunologic Factors|immunologic factors|mesh-ancestor
111460447|NCT00004097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111460448|NCT00004103|Irinotecan|irinotecan|mesh-list
111460449|NCT00004103|Floxuridine|floxuridine|mesh-list
111460450|NCT00004103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111460451|NCT00004103|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111460452|NCT00004103|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111460453|NCT00004103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111460454|NCT00004103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111460455|NCT00004103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111460456|NCT00004103|Antimetabolites|antimetabolites|mesh-ancestor
111460457|NCT00004109|Doxorubicin|doxorubicin|mesh-list
111460458|NCT00004109|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111460459|NCT00004109|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111460460|NCT00004109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111460461|NCT00004109|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111460462|NCT00004109|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111460463|NCT00004109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111460464|NCT00004109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111460465|NCT00003239|Interferons|interferons|mesh-list
111460466|NCT00003239|Cytarabine|cytarabine|mesh-list
111460467|NCT00003239|Interferon-alpha|interferon-alpha|mesh-list
110937010|NCT05542394|Curcumin|curcumin|mesh-list
111460468|NCT00003239|Interferon alpha-2|interferon alpha-2|mesh-list
111460469|NCT00003239|Homoharringtonine|homoharringtonine|mesh-list
111460470|NCT00003239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111460471|NCT00003239|Antiviral Agents|antiviral agents|mesh-ancestor
111460472|NCT00003239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111460473|NCT00003239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111460474|NCT00003239|Antimetabolites|antimetabolites|mesh-ancestor
111460475|NCT00003239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111460476|NCT00003239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111460477|NCT00003239|Immunologic Factors|immunologic factors|mesh-ancestor
111460478|NCT00003239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111460479|NCT00003239|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111460480|NCT00003239|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111460481|NCT00003239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111460482|NCT00004115|Antibodies|antibodies|mesh-list
111460483|NCT00004115|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111460484|NCT00004115|Immunologic Factors|immunologic factors|mesh-ancestor
111460485|NCT00004115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111460486|NCT00003245|Irinotecan|irinotecan|mesh-list
111460487|NCT00003245|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111460488|NCT00003245|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111460489|NCT00003245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111460490|NCT00003245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111460491|NCT00003245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111460492|NCT00004127|Leucovorin|leucovorin|mesh-list
111460493|NCT00004127|Fluorouracil|fluorouracil|mesh-list
111460494|NCT00004127|Oxaliplatin|oxaliplatin|mesh-list
111460495|NCT00004127|Calcium|calcium|mesh-list
111460496|NCT00004127|Levoleucovorin|levoleucovorin|mesh-list
111460497|NCT00004127|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111460498|NCT00004127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111460499|NCT00004127|Antimetabolites|antimetabolites|mesh-ancestor
111460500|NCT00004127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111460501|NCT00004127|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111460502|NCT00004127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111460503|NCT00004127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111460504|NCT00004127|Immunologic Factors|immunologic factors|mesh-ancestor
111460505|NCT00004127|Antidotes|antidotes|mesh-ancestor
111460506|NCT00004127|Protective Agents|protective agents|mesh-ancestor
111460507|NCT00004127|Vitamin B Complex|vitamin b complex|mesh-ancestor
111460508|NCT00004127|Vitamins|vitamins|mesh-ancestor
111460509|NCT00004127|Micronutrients|micronutrients|mesh-ancestor
111460510|NCT00003251|Paclitaxel|paclitaxel|mesh-list
111460511|NCT00003251|Amifostine|amifostine|mesh-list
110937059|NCT05442216|Azacitidine|azacitidine|mesh-list
111460512|NCT00003251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111460513|NCT00003251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111460514|NCT00003251|Tubulin Modulators|tubulin modulators|mesh-ancestor
111460515|NCT00003251|Antimitotic Agents|antimitotic agents|mesh-ancestor
111460516|NCT00003251|Mitosis Modulators|mitosis modulators|mesh-ancestor
111460517|NCT00003251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111460518|NCT00003251|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111460519|NCT00003251|Protective Agents|protective agents|mesh-ancestor
111460520|NCT00003251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111460521|NCT00004139|Gemcitabine|gemcitabine|mesh-list
111460522|NCT00004139|Docetaxel|docetaxel|mesh-list
111460523|NCT00004139|Irinotecan|irinotecan|mesh-list
111460524|NCT00004139|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111460525|NCT00004139|Antimetabolites|antimetabolites|mesh-ancestor
111460526|NCT00004139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111460527|NCT00004139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111460528|NCT00004139|Tubulin Modulators|tubulin modulators|mesh-ancestor
111460529|NCT00004139|Antimitotic Agents|antimitotic agents|mesh-ancestor
111460530|NCT00004139|Mitosis Modulators|mitosis modulators|mesh-ancestor
111460531|NCT00004139|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111460532|NCT00004139|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111460533|NCT00004139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111184673|NCT00530062|Albuterol|albuterol|mesh-list
111460534|NCT00004145|Cyclophosphamide|cyclophosphamide|mesh-list
111460535|NCT00004145|Fludarabine|fludarabine|mesh-list
111460536|NCT00004145|Fludarabine phosphate|fludarabine phosphate|mesh-list
111460537|NCT00004145|Antilymphocyte Serum|antilymphocyte serum|mesh-list
111460538|NCT00004145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111460539|NCT00004145|Immunologic Factors|immunologic factors|mesh-ancestor
111460540|NCT00004145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111460541|NCT00004145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111460542|NCT00004145|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111460543|NCT00004145|Alkylating Agents|alkylating agents|mesh-ancestor
111460544|NCT00004145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111460545|NCT00004145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111460546|NCT00004145|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111460547|NCT00004145|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111460548|NCT00004145|Antimetabolites|antimetabolites|mesh-ancestor
111460549|NCT00003263|Interferons|interferons|mesh-list
111460550|NCT00003263|Interferon-alpha|interferon-alpha|mesh-list
111460551|NCT00003263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111460552|NCT00003263|Antiviral Agents|antiviral agents|mesh-ancestor
111460553|NCT00003263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111460554|NCT00003263|Immunologic Factors|immunologic factors|mesh-ancestor
111460555|NCT00003263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111460556|NCT00004157|Oprelvekin|oprelvekin|mesh-list
111460557|NCT00004157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111460558|NCT00003269|Cyclophosphamide|cyclophosphamide|mesh-list
111460559|NCT00003269|Etoposide|etoposide|mesh-list
111460560|NCT00003269|Sargramostim|sargramostim|mesh-list
111460561|NCT00003269|Amifostine|amifostine|mesh-list
111460562|NCT00003269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111460563|NCT00003269|Immunologic Factors|immunologic factors|mesh-ancestor
111460564|NCT00003269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111460565|NCT00003269|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111460566|NCT00003269|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111460567|NCT00003269|Alkylating Agents|alkylating agents|mesh-ancestor
111460568|NCT00003269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111460569|NCT00003269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111460570|NCT00003269|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110937063|NCT05442216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111460571|NCT00003269|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111460572|NCT00003269|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111460573|NCT00003269|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111460574|NCT00003269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111460575|NCT00003269|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111460576|NCT00003269|Protective Agents|protective agents|mesh-ancestor
111460577|NCT00004163|Trastuzumab|trastuzumab|mesh-list
111460578|NCT00004163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111460579|NCT00004163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111460580|NCT00003281|Paclitaxel|paclitaxel|mesh-list
111460581|NCT00003281|Topotecan|topotecan|mesh-list
111460582|NCT00003281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111460583|NCT00003281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111460584|NCT00003281|Tubulin Modulators|tubulin modulators|mesh-ancestor
111460585|NCT00003281|Antimitotic Agents|antimitotic agents|mesh-ancestor
111460586|NCT00003281|Mitosis Modulators|mitosis modulators|mesh-ancestor
111460587|NCT00003281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111460588|NCT00003281|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111460589|NCT00003281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111460590|NCT00003281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111460591|NCT00003287|Leucovorin|leucovorin|mesh-list
111460592|NCT00003287|Fluorouracil|fluorouracil|mesh-list
111460593|NCT00003287|Oxaliplatin|oxaliplatin|mesh-list
111460594|NCT00003287|Calcium|calcium|mesh-list
111460595|NCT00003287|Levoleucovorin|levoleucovorin|mesh-list
111460596|NCT00003287|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111460597|NCT00003287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111460598|NCT00003287|Antimetabolites|antimetabolites|mesh-ancestor
111460599|NCT00003287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111460600|NCT00003287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111460601|NCT00003287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111460602|NCT00003287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111460603|NCT00003287|Immunologic Factors|immunologic factors|mesh-ancestor
111460604|NCT00003287|Antidotes|antidotes|mesh-ancestor
111460605|NCT00003287|Protective Agents|protective agents|mesh-ancestor
111460606|NCT00003287|Vitamin B Complex|vitamin b complex|mesh-ancestor
111460607|NCT00003287|Vitamins|vitamins|mesh-ancestor
111460608|NCT00003287|Micronutrients|micronutrients|mesh-ancestor
111460609|NCT00004187|Capecitabine|capecitabine|mesh-list
111184747|NCT04205266|Hematinics|hematinics|mesh-ancestor
111460610|NCT00004187|Oxaliplatin|oxaliplatin|mesh-list
111460611|NCT00004187|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111460612|NCT00004187|Antimetabolites|antimetabolites|mesh-ancestor
111460613|NCT00004187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111460614|NCT00004187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111460615|NCT00384137|Tacrolimus|tacrolimus|mesh-list
111460616|NCT00384137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111460617|NCT00384137|Immunologic Factors|immunologic factors|mesh-ancestor
111460618|NCT00384137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111460619|NCT00384137|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111460620|NCT00384137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111460621|NCT00384137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111460622|NCT00384215|Insulin Glargine|insulin glargine|mesh-list
111460623|NCT00384215|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111460624|NCT00384215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111460625|NCT00003293|Procarbazine|procarbazine|mesh-list
111460626|NCT00003293|Leflunomide|leflunomide|mesh-list
111460627|NCT00003293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111460628|NCT00003293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111460629|NCT00003293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111460630|NCT00003293|Immunologic Factors|immunologic factors|mesh-ancestor
111460631|NCT00003293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111460632|NCT00003293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111460633|NCT00004199|Gemcitabine|gemcitabine|mesh-list
111460634|NCT00004199|Prinomastat|prinomastat|mesh-list
111460635|NCT00004199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111460636|NCT00004199|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111460637|NCT00004199|Antimetabolites|antimetabolites|mesh-ancestor
111460638|NCT00004199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111460639|NCT00004199|Matrix Metalloproteinase Inhibitors|matrix metalloproteinase inhibitors|mesh-ancestor
111460640|NCT00004199|Protease Inhibitors|protease inhibitors|mesh-ancestor
111460641|NCT00004199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111460642|NCT00003299|Paclitaxel|paclitaxel|mesh-list
111460643|NCT00003299|Etoposide|etoposide|mesh-list
111460644|NCT00003299|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111460645|NCT00003299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111460646|NCT00003299|Tubulin Modulators|tubulin modulators|mesh-ancestor
111460647|NCT00003299|Antimitotic Agents|antimitotic agents|mesh-ancestor
111460648|NCT00003299|Mitosis Modulators|mitosis modulators|mesh-ancestor
111460649|NCT00003299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111460650|NCT00003299|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111460651|NCT00003299|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111460652|NCT00003299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111460653|NCT00004205|Tamoxifen|tamoxifen|mesh-list
111460654|NCT00004205|Letrozole|letrozole|mesh-list
111460655|NCT00004205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111460656|NCT00004205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111460657|NCT00004205|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111460658|NCT00004205|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111460659|NCT00004205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111460660|NCT00004205|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111460661|NCT00004205|Hormone Antagonists|hormone antagonists|mesh-ancestor
111460662|NCT00004205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111460663|NCT00004205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111460664|NCT00004205|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111460665|NCT00004205|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111460666|NCT00004205|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111460667|NCT00004205|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111460668|NCT00003305|Leucovorin|leucovorin|mesh-list
111460669|NCT00003305|Calcium|calcium|mesh-list
111460670|NCT00003305|Levoleucovorin|levoleucovorin|mesh-list
111460671|NCT00003305|Aminopterin|aminopterin|mesh-list
111460672|NCT00003305|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111460673|NCT00003305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111460674|NCT00003305|Antidotes|antidotes|mesh-ancestor
111460675|NCT00003305|Protective Agents|protective agents|mesh-ancestor
111460676|NCT00003305|Vitamin B Complex|vitamin b complex|mesh-ancestor
111460677|NCT00003305|Vitamins|vitamins|mesh-ancestor
111460678|NCT00003305|Micronutrients|micronutrients|mesh-ancestor
111460679|NCT00003305|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111460680|NCT00003305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111460681|NCT00003305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111460682|NCT00003311|Cytarabine|cytarabine|mesh-list
111460683|NCT00003311|Dexamethasone|dexamethasone|mesh-list
111460684|NCT00003311|Cyclophosphamide|cyclophosphamide|mesh-list
111460685|NCT00003311|Doxorubicin|doxorubicin|mesh-list
111460686|NCT00003311|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111460687|NCT00003311|Methotrexate|methotrexate|mesh-list
111184829|NCT04777552|Diazepam|diazepam|mesh-list
111460688|NCT00003311|Vincristine|vincristine|mesh-list
111460689|NCT00003311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111460690|NCT00003311|Immunologic Factors|immunologic factors|mesh-ancestor
111460691|NCT00003311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111460692|NCT00003311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111460693|NCT00003311|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111460694|NCT00003311|Alkylating Agents|alkylating agents|mesh-ancestor
110937191|NCT05108870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111460695|NCT00003311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111460696|NCT00003311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111460697|NCT00003311|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111460698|NCT00003311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111460699|NCT00003311|Antiemetics|antiemetics|mesh-ancestor
111460700|NCT00003311|Autonomic Agents|autonomic agents|mesh-ancestor
111460701|NCT00003311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111460702|NCT00003311|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111460703|NCT00003311|Glucocorticoids|glucocorticoids|mesh-ancestor
111460704|NCT00003311|Hormones|hormones|mesh-ancestor
111460705|NCT00003311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111460706|NCT00003311|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111460707|NCT00003311|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111460708|NCT00003311|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111460709|NCT00003311|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111460710|NCT00003311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111460711|NCT00003311|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111460712|NCT00003311|Abortifacient Agents|abortifacient agents|mesh-ancestor
111460713|NCT00003311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111460714|NCT00003311|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111460715|NCT00003311|Antimetabolites|antimetabolites|mesh-ancestor
111460716|NCT00003311|Dermatologic Agents|dermatologic agents|mesh-ancestor
111460717|NCT00003311|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111460718|NCT00003311|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111460719|NCT00003311|Antiviral Agents|antiviral agents|mesh-ancestor
111460720|NCT00003311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111460721|NCT00003311|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111460722|NCT00003311|Tubulin Modulators|tubulin modulators|mesh-ancestor
111460723|NCT00003311|Antimitotic Agents|antimitotic agents|mesh-ancestor
111460724|NCT00003311|Mitosis Modulators|mitosis modulators|mesh-ancestor
111460725|NCT00003317|Paclitaxel|paclitaxel|mesh-list
111460726|NCT00003317|Carboplatin|carboplatin|mesh-list
111460727|NCT00003317|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111460728|NCT00003317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111460729|NCT00003317|Tubulin Modulators|tubulin modulators|mesh-ancestor
111460730|NCT00003317|Antimitotic Agents|antimitotic agents|mesh-ancestor
111460731|NCT00003317|Mitosis Modulators|mitosis modulators|mesh-ancestor
111460732|NCT00003317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111460733|NCT00004217|Cytarabine|cytarabine|mesh-list
111460734|NCT00004217|Daunorubicin|daunorubicin|mesh-list
111460735|NCT00004217|Sargramostim|sargramostim|mesh-list
111460736|NCT00004217|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111460737|NCT00004217|Antimetabolites|antimetabolites|mesh-ancestor
111460738|NCT00004217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111460739|NCT00004217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111460740|NCT00004217|Antiviral Agents|antiviral agents|mesh-ancestor
111460741|NCT00004217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111460742|NCT00004217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111460743|NCT00004217|Immunologic Factors|immunologic factors|mesh-ancestor
110937251|NCT04956432|Antioxidants|antioxidants|mesh-ancestor
111460744|NCT00004217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111460745|NCT00004217|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111460746|NCT00004217|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111460747|NCT00004217|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111460748|NCT00004217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111460749|NCT00003323|Flutamide|flutamide|mesh-list
111460750|NCT00003323|Finasteride|finasteride|mesh-list
111460751|NCT00003323|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
111460752|NCT00003323|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111460753|NCT00003323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111460754|NCT00003323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111460755|NCT00003323|Hormone Antagonists|hormone antagonists|mesh-ancestor
111460756|NCT00003323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111460757|NCT00003323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111460758|NCT00003323|Urological Agents|urological agents|mesh-ancestor
111460759|NCT00003323|Androgen Antagonists|androgen antagonists|mesh-ancestor
111460760|NCT00003323|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111460761|NCT00003323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111460763|NCT00004229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111460764|NCT00004229|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111460765|NCT00004229|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111460766|NCT00004229|Growth Substances|growth substances|mesh-ancestor
111460767|NCT00004229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111460768|NCT00004229|Growth Inhibitors|growth inhibitors|mesh-ancestor
111460769|NCT00004235|Docetaxel|docetaxel|mesh-list
111460770|NCT00004235|Irinotecan|irinotecan|mesh-list
111460771|NCT00004235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111460772|NCT00004235|Tubulin Modulators|tubulin modulators|mesh-ancestor
111460773|NCT00004235|Antimitotic Agents|antimitotic agents|mesh-ancestor
111460774|NCT00004235|Mitosis Modulators|mitosis modulators|mesh-ancestor
111460775|NCT00004235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111460776|NCT00004235|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111460777|NCT00004235|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111460778|NCT00004235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111460779|NCT00003335|Cyclosporine|cyclosporine|mesh-list
111460780|NCT00003335|Methylprednisolone|methylprednisolone|mesh-list
111460781|NCT00003335|Melphalan|melphalan|mesh-list
111460782|NCT00003335|Busulfan|busulfan|mesh-list
111460783|NCT00003335|Cyclosporins|cyclosporins|mesh-list
111460784|NCT00003335|Antilymphocyte Serum|antilymphocyte serum|mesh-list
111460785|NCT00003335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111460786|NCT00003335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111460787|NCT00003335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111460788|NCT00003335|Immunologic Factors|immunologic factors|mesh-ancestor
111460789|NCT00003335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111460790|NCT00003335|Antifungal Agents|antifungal agents|mesh-ancestor
111460791|NCT00003335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111460792|NCT00003335|Dermatologic Agents|dermatologic agents|mesh-ancestor
111460793|NCT00003335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111460794|NCT00003335|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111460795|NCT00003335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111460796|NCT00003335|Antiemetics|antiemetics|mesh-ancestor
111460797|NCT00003335|Autonomic Agents|autonomic agents|mesh-ancestor
111460798|NCT00003335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111460799|NCT00003335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111460800|NCT00003335|Glucocorticoids|glucocorticoids|mesh-ancestor
111460801|NCT00003335|Hormones|hormones|mesh-ancestor
110937301|NCT04766853|Glucocorticoids|glucocorticoids|mesh-ancestor
110937302|NCT04766853|Hormones|hormones|mesh-ancestor
111460802|NCT00003335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111460803|NCT00003335|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111460804|NCT00003335|Protective Agents|protective agents|mesh-ancestor
111460805|NCT00003335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111460806|NCT00003335|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111460807|NCT00003335|Alkylating Agents|alkylating agents|mesh-ancestor
111460808|NCT00003335|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111460809|NCT00003341|Epoetin Alfa|epoetin alfa|mesh-list
111460810|NCT00003341|Hematinics|hematinics|mesh-ancestor
111460811|NCT00004253|Paclitaxel|paclitaxel|mesh-list
111460812|NCT00004253|Carboplatin|carboplatin|mesh-list
111460813|NCT00004253|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111460814|NCT00004253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111460815|NCT00004253|Tubulin Modulators|tubulin modulators|mesh-ancestor
111460816|NCT00004253|Antimitotic Agents|antimitotic agents|mesh-ancestor
111460817|NCT00004253|Mitosis Modulators|mitosis modulators|mesh-ancestor
111460818|NCT00004253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111460819|NCT00004265|Paclitaxel|paclitaxel|mesh-list
111460820|NCT00004265|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111460821|NCT00004265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111460822|NCT00004265|Tubulin Modulators|tubulin modulators|mesh-ancestor
111460823|NCT00004265|Antimitotic Agents|antimitotic agents|mesh-ancestor
111460824|NCT00004265|Mitosis Modulators|mitosis modulators|mesh-ancestor
111460825|NCT00004265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111460826|NCT00003365|Curcumin|curcumin|mesh-list
111460827|NCT00003365|Sulindac|sulindac|mesh-list
111460828|NCT00003365|Quercetin|quercetin|mesh-list
111460829|NCT00003365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111460830|NCT00003365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111460831|NCT00003365|Analgesics|analgesics|mesh-ancestor
111460832|NCT00003365|Sensory System Agents|sensory system agents|mesh-ancestor
111460833|NCT00003365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111460834|NCT00003365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111460835|NCT00003365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111460836|NCT00003365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111460837|NCT00003365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111460838|NCT00003365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111460839|NCT00003365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111460840|NCT00003365|Antioxidants|antioxidants|mesh-ancestor
111460841|NCT00003365|Protective Agents|protective agents|mesh-ancestor
111460842|NCT00003365|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111460843|NCT00004829|Tobramycin|tobramycin|mesh-list
111460844|NCT00004829|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111460845|NCT00004829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111460846|NCT00004313|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
111460847|NCT00004313|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111460848|NCT00004313|Immunologic Factors|immunologic factors|mesh-ancestor
111460849|NCT00004313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111460850|NCT00004853|Lenograstim|lenograstim|mesh-list
111460851|NCT00004853|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111460852|NCT00004853|Immunologic Factors|immunologic factors|mesh-ancestor
111460853|NCT00004853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111460854|NCT00004865|Paclitaxel|paclitaxel|mesh-list
111460855|NCT00004865|Fluorouracil|fluorouracil|mesh-list
111460856|NCT00004865|Cetuximab|cetuximab|mesh-list
111460857|NCT00004865|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111460858|NCT00004865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111460859|NCT00004865|Tubulin Modulators|tubulin modulators|mesh-ancestor
111460860|NCT00004865|Antimitotic Agents|antimitotic agents|mesh-ancestor
111460861|NCT00004865|Mitosis Modulators|mitosis modulators|mesh-ancestor
111460862|NCT00004865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111460863|NCT00004865|Antimetabolites|antimetabolites|mesh-ancestor
111460864|NCT00004865|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111460865|NCT00004865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111460866|NCT00004865|Immunologic Factors|immunologic factors|mesh-ancestor
111460867|NCT00004865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111460868|NCT00004865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111460869|NCT00004361|Citric Acid|citric acid|mesh-list
111460870|NCT00004361|Sodium Citrate|sodium citrate|mesh-list
111460871|NCT00004361|Calcium|calcium|mesh-list
111460872|NCT00004361|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111460873|NCT00004361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111460874|NCT00004361|Anticoagulants|anticoagulants|mesh-ancestor
111460875|NCT00004361|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
111460876|NCT00004361|Chelating Agents|chelating agents|mesh-ancestor
111460877|NCT00004361|Sequestering Agents|sequestering agents|mesh-ancestor
111460878|NCT00004361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111460879|NCT00004373|Alprazolam|alprazolam|mesh-list
111460880|NCT00004373|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111460881|NCT00004373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111460882|NCT00004373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111460883|NCT00004373|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111460884|NCT00004373|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111460885|NCT00004373|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111460886|NCT00004373|GABA Modulators|gaba modulators|mesh-ancestor
111460887|NCT00004373|GABA Agents|gaba agents|mesh-ancestor
111460888|NCT00004373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111460889|NCT00004373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111460890|NCT00004871|Azacitidine|azacitidine|mesh-list
111460891|NCT00004871|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
111460892|NCT00004871|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111460893|NCT00004871|Antimetabolites|antimetabolites|mesh-ancestor
111460894|NCT00004871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111460895|NCT00004871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111460896|NCT00004871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111460897|NCT00004397|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
111460898|NCT00004397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111460899|NCT00004397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111460900|NCT00004883|Trastuzumab|trastuzumab|mesh-list
111460901|NCT00004883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111460902|NCT00004883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111460903|NCT00004403|Albendazole|albendazole|mesh-list
111460904|NCT00004403|Dexamethasone|dexamethasone|mesh-list
111460905|NCT00004403|Phenytoin|phenytoin|mesh-list
111460906|NCT00004403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111460907|NCT00004403|Antiemetics|antiemetics|mesh-ancestor
111460908|NCT00004403|Autonomic Agents|autonomic agents|mesh-ancestor
111460909|NCT00004403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111460910|NCT00004403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111460911|NCT00004403|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111460912|NCT00004403|Glucocorticoids|glucocorticoids|mesh-ancestor
111460913|NCT00004403|Hormones|hormones|mesh-ancestor
111460914|NCT00004403|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111460915|NCT00004403|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111460916|NCT00004403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111460918|NCT00004403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111460919|NCT00004403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111460920|NCT00004403|Anticestodal Agents|anticestodal agents|mesh-ancestor
111460921|NCT00004403|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
111460922|NCT00004403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111460923|NCT00004403|Tubulin Modulators|tubulin modulators|mesh-ancestor
111460924|NCT00004403|Antimitotic Agents|antimitotic agents|mesh-ancestor
111460925|NCT00004403|Mitosis Modulators|mitosis modulators|mesh-ancestor
111460926|NCT00004403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111460927|NCT00004403|Anticonvulsants|anticonvulsants|mesh-ancestor
111460928|NCT00004403|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111460929|NCT00004403|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111460930|NCT00004403|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111460931|NCT00004403|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
111460932|NCT00004403|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111460933|NCT00004889|Rituximab|rituximab|mesh-list
111460934|NCT00004889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111460935|NCT00004889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111460936|NCT00004889|Immunologic Factors|immunologic factors|mesh-ancestor
111460937|NCT00004889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111460938|NCT00004889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111460939|NCT00385307|Amibegron|amibegron|mesh-list
111460940|NCT00385307|Amibegron hydrochloride|amibegron hydrochloride|mesh-list
111460941|NCT00385307|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111460942|NCT00385307|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111460943|NCT00385307|Adrenergic Agents|adrenergic agents|mesh-ancestor
111460944|NCT00385307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111460945|NCT00385307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111460946|NCT00385307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111460947|NCT00385307|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
111460948|NCT00004901|Fluorouracil|fluorouracil|mesh-list
111460949|NCT00004901|Hydroxyurea|hydroxyurea|mesh-list
111460950|NCT00004901|Eniluracil|eniluracil|mesh-list
111460951|NCT00004901|Antimetabolites|antimetabolites|mesh-ancestor
111460952|NCT00004901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111460953|NCT00004901|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111460954|NCT00004901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111460955|NCT00004901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111460956|NCT00004901|Immunologic Factors|immunologic factors|mesh-ancestor
111460957|NCT00004901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111460958|NCT00004901|Antisickling Agents|antisickling agents|mesh-ancestor
111460959|NCT00004901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111460960|NCT00004901|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111460961|NCT00004433|Pergolide|pergolide|mesh-list
111460962|NCT00004433|Dopamine Agonists|dopamine agonists|mesh-ancestor
111460963|NCT00004433|Dopamine Agents|dopamine agents|mesh-ancestor
111460964|NCT00004433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111460965|NCT00004433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111460966|NCT00004433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111460967|NCT00004913|Leucovorin|leucovorin|mesh-list
111460968|NCT00004913|Docetaxel|docetaxel|mesh-list
111460969|NCT00004913|Fluorouracil|fluorouracil|mesh-list
111460970|NCT00004913|Calcium|calcium|mesh-list
111460971|NCT00004913|Levoleucovorin|levoleucovorin|mesh-list
111460972|NCT00004913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111460973|NCT00004913|Tubulin Modulators|tubulin modulators|mesh-ancestor
111460974|NCT00004913|Antimitotic Agents|antimitotic agents|mesh-ancestor
111460975|NCT00004913|Mitosis Modulators|mitosis modulators|mesh-ancestor
111460976|NCT00004913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111460977|NCT00004913|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111460978|NCT00004913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111460979|NCT00004913|Antimetabolites|antimetabolites|mesh-ancestor
111460980|NCT00004913|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111460981|NCT00004913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111460982|NCT00004913|Immunologic Factors|immunologic factors|mesh-ancestor
111460983|NCT00004913|Antidotes|antidotes|mesh-ancestor
111460984|NCT00004913|Protective Agents|protective agents|mesh-ancestor
111460985|NCT00004913|Vitamin B Complex|vitamin b complex|mesh-ancestor
111460986|NCT00004913|Vitamins|vitamins|mesh-ancestor
111460987|NCT00004913|Micronutrients|micronutrients|mesh-ancestor
111460988|NCT00004919|Irinotecan|irinotecan|mesh-list
111460989|NCT00004919|Amifostine|amifostine|mesh-list
111460990|NCT00004919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111460991|NCT00004919|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111460992|NCT00004919|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111460993|NCT00004919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111460994|NCT00004919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111460995|NCT00004919|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111460996|NCT00004919|Protective Agents|protective agents|mesh-ancestor
111460997|NCT00004919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111460998|NCT00004925|Doxorubicin|doxorubicin|mesh-list
111460999|NCT00004925|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111461000|NCT00004925|Trastuzumab|trastuzumab|mesh-list
111461001|NCT00004925|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111461002|NCT00004925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111461003|NCT00004925|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111461004|NCT00004925|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111461005|NCT00004925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111461006|NCT00004925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111461007|NCT00004925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111461008|NCT00004931|Leucovorin|leucovorin|mesh-list
111461009|NCT00004931|Fluorouracil|fluorouracil|mesh-list
111461010|NCT00004931|Oxaliplatin|oxaliplatin|mesh-list
111461011|NCT00004931|Calcium|calcium|mesh-list
111461012|NCT00004931|Levoleucovorin|levoleucovorin|mesh-list
111461013|NCT00004931|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111461014|NCT00004931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111461015|NCT00004931|Antimetabolites|antimetabolites|mesh-ancestor
111461016|NCT00004931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111461017|NCT00004931|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111461018|NCT00004931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111461019|NCT00004931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111461020|NCT00004931|Immunologic Factors|immunologic factors|mesh-ancestor
111461021|NCT00004931|Antidotes|antidotes|mesh-ancestor
111461022|NCT00004931|Protective Agents|protective agents|mesh-ancestor
111461023|NCT00004931|Vitamin B Complex|vitamin b complex|mesh-ancestor
111461024|NCT00004931|Vitamins|vitamins|mesh-ancestor
111461025|NCT00004931|Micronutrients|micronutrients|mesh-ancestor
111461026|NCT00004979|Paclitaxel|paclitaxel|mesh-list
111461027|NCT00004979|Topotecan|topotecan|mesh-list
111461028|NCT00004979|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111461029|NCT00004979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111461030|NCT00004979|Tubulin Modulators|tubulin modulators|mesh-ancestor
111461031|NCT00004979|Antimitotic Agents|antimitotic agents|mesh-ancestor
111461032|NCT00004979|Mitosis Modulators|mitosis modulators|mesh-ancestor
111461033|NCT00004979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111461034|NCT00004979|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111461035|NCT00004979|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111461036|NCT00004979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111461037|NCT00004985|Nelfinavir|nelfinavir|mesh-list
111461038|NCT00004985|Capravirine|capravirine|mesh-list
111461039|NCT00004985|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111461040|NCT00004985|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111461041|NCT00004985|Protease Inhibitors|protease inhibitors|mesh-ancestor
111461042|NCT00004985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111461043|NCT00004985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111461044|NCT00004985|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111461045|NCT00004985|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111461046|NCT00004985|Antiviral Agents|antiviral agents|mesh-ancestor
111461047|NCT00004985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111461048|NCT00004985|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111461049|NCT00004985|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111461050|NCT00004997|Leucovorin|leucovorin|mesh-list
111461051|NCT00004997|Antidotes|antidotes|mesh-ancestor
111461052|NCT00004997|Protective Agents|protective agents|mesh-ancestor
110937548|NCT04238754|Cannabidiol|cannabidiol|mesh-list
111461053|NCT00004997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111461054|NCT00004997|Vitamin B Complex|vitamin b complex|mesh-ancestor
111461055|NCT00004997|Vitamins|vitamins|mesh-ancestor
111461056|NCT00004997|Micronutrients|micronutrients|mesh-ancestor
111461057|NCT00005009|Vaccines|vaccines|mesh-list
111461058|NCT00005009|Immunologic Factors|immunologic factors|mesh-ancestor
111461059|NCT00005009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111461060|NCT00004583|Ritonavir|ritonavir|mesh-list
111461061|NCT00004583|Lopinavir|lopinavir|mesh-list
111461062|NCT00004583|Nelfinavir|nelfinavir|mesh-list
111461063|NCT00004583|Lamivudine|lamivudine|mesh-list
111461064|NCT00004583|Stavudine|stavudine|mesh-list
111461065|NCT00004583|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111461066|NCT00004583|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111185200|NCT01479465|Leucovorin|leucovorin|mesh-list
111461067|NCT00004583|Protease Inhibitors|protease inhibitors|mesh-ancestor
111461068|NCT00004583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111461069|NCT00004583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111461070|NCT00004583|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111461071|NCT00004583|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111461072|NCT00004583|Antiviral Agents|antiviral agents|mesh-ancestor
111461073|NCT00004583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111461074|NCT00004583|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111461075|NCT00004583|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111461076|NCT00004583|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111461077|NCT00004583|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111461078|NCT00004583|Antimetabolites|antimetabolites|mesh-ancestor
111461079|NCT00005015|Fluoxetine|fluoxetine|mesh-list
111461080|NCT00005015|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111461081|NCT00005015|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111461082|NCT00005015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111461083|NCT00005015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111461084|NCT00005015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111461085|NCT00005015|Serotonin Agents|serotonin agents|mesh-ancestor
111461086|NCT00005015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111461087|NCT00005015|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111461088|NCT00005015|Antidepressive Agents|antidepressive agents|mesh-ancestor
111461089|NCT00005015|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111461090|NCT00005015|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111461091|NCT00005015|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111461092|NCT00005015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111461093|NCT00004637|Vitamin E|vitamin e|mesh-list
111461094|NCT00004637|Vitamins|vitamins|mesh-ancestor
111461095|NCT00004637|Micronutrients|micronutrients|mesh-ancestor
111461096|NCT00004637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111461097|NCT00004637|Antioxidants|antioxidants|mesh-ancestor
111461098|NCT00004637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111461099|NCT00004637|Protective Agents|protective agents|mesh-ancestor
111461100|NCT00005021|Paclitaxel|paclitaxel|mesh-list
111461101|NCT00005021|Carboplatin|carboplatin|mesh-list
111461102|NCT00005021|Topotecan|topotecan|mesh-list
111461103|NCT00005021|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111461104|NCT00005021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111461105|NCT00005021|Tubulin Modulators|tubulin modulators|mesh-ancestor
111461106|NCT00005021|Antimitotic Agents|antimitotic agents|mesh-ancestor
111461107|NCT00005021|Mitosis Modulators|mitosis modulators|mesh-ancestor
111461108|NCT00005021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111461109|NCT00005021|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111461110|NCT00005021|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111461111|NCT00005021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111461112|NCT00004643|Cytarabine|cytarabine|mesh-list
111461113|NCT00004643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111461114|NCT00004643|Antimetabolites|antimetabolites|mesh-ancestor
111461115|NCT00004643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111461116|NCT00004643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111461117|NCT00004643|Antiviral Agents|antiviral agents|mesh-ancestor
111461118|NCT00004643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111461119|NCT00004643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111461120|NCT00004643|Immunologic Factors|immunologic factors|mesh-ancestor
111461121|NCT00004643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111461122|NCT00005033|Trastuzumab|trastuzumab|mesh-list
111461123|NCT00005033|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111461124|NCT00005033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111461125|NCT00005039|Vaccines|vaccines|mesh-list
111461126|NCT00005039|Immunologic Factors|immunologic factors|mesh-ancestor
111461127|NCT00005039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111461128|NCT00004685|Albuterol|albuterol|mesh-list
111461129|NCT00004685|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111461130|NCT00004685|Autonomic Agents|autonomic agents|mesh-ancestor
111461131|NCT00004685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111461132|NCT00004685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111461133|NCT00004685|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111461134|NCT00004685|Respiratory System Agents|respiratory system agents|mesh-ancestor
111461135|NCT00004685|Tocolytic Agents|tocolytic agents|mesh-ancestor
111461136|NCT00004685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111461137|NCT00004685|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111461138|NCT00004685|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111461139|NCT00004685|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111461140|NCT00004685|Adrenergic Agents|adrenergic agents|mesh-ancestor
111461141|NCT00004685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111461142|NCT00004685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111461143|NCT00005045|Carboxyamido-triazole|carboxyamido-triazole|mesh-list
111461144|NCT00005045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111461145|NCT00005045|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111461146|NCT00005045|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111461147|NCT00005045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111461148|NCT00005045|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111461149|NCT00005045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111461150|NCT00005051|Paclitaxel|paclitaxel|mesh-list
111461151|NCT00005051|Carboplatin|carboplatin|mesh-list
111461152|NCT00005051|Topotecan|topotecan|mesh-list
111461153|NCT00005051|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111461154|NCT00005051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111461155|NCT00005051|Tubulin Modulators|tubulin modulators|mesh-ancestor
111461156|NCT00005051|Antimitotic Agents|antimitotic agents|mesh-ancestor
111461157|NCT00005051|Mitosis Modulators|mitosis modulators|mesh-ancestor
111461158|NCT00005051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111461159|NCT00005051|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111461160|NCT00005051|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111461161|NCT00005051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111461162|NCT00004697|Choline|choline|mesh-list
111461163|NCT00004697|Lipotropic Agents|lipotropic agents|mesh-ancestor
111461164|NCT00004697|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111461165|NCT00004697|Antimetabolites|antimetabolites|mesh-ancestor
111461166|NCT00004697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111461167|NCT00004697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111461168|NCT00004697|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111461169|NCT00004697|Nootropic Agents|nootropic agents|mesh-ancestor
111461170|NCT00004727|Aspirin|aspirin|mesh-list
111461171|NCT00004727|Ticlopidine|ticlopidine|mesh-list
111461172|NCT00004727|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111461173|NCT00004727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111461174|NCT00004727|Analgesics|analgesics|mesh-ancestor
111461175|NCT00004727|Sensory System Agents|sensory system agents|mesh-ancestor
111461176|NCT00004727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111461177|NCT00004727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111461178|NCT00004727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111461179|NCT00004727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111461180|NCT00004727|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111461181|NCT00004727|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111461182|NCT00004727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111461183|NCT00004727|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111461184|NCT00004727|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111461185|NCT00004727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111461186|NCT00004727|Antipyretics|antipyretics|mesh-ancestor
111461187|NCT00004727|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111461188|NCT00004727|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111461189|NCT00004727|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111461190|NCT00004727|Purinergic Agents|purinergic agents|mesh-ancestor
111461191|NCT00004727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111461192|NCT00004727|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111461193|NCT00004727|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111461194|NCT00004733|Levodopa|levodopa|mesh-list
111461195|NCT00004733|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111461196|NCT00004733|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111461197|NCT00004733|Dopamine Agents|dopamine agents|mesh-ancestor
111461198|NCT00004733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111461199|NCT00004733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111461200|NCT00004733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111461201|NCT00004739|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
111461202|NCT00004739|Antiviral Agents|antiviral agents|mesh-ancestor
111461203|NCT00004739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111461204|NCT00005057|Ganciclovir|ganciclovir|mesh-list
111461205|NCT00005057|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
111461206|NCT00005057|Antiviral Agents|antiviral agents|mesh-ancestor
111461207|NCT00005057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111461208|NCT00005057|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111461209|NCT00005057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111461210|NCT00005057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111461211|NCT00004757|Acyclovir|acyclovir|mesh-list
111461212|NCT00004757|Antiviral Agents|antiviral agents|mesh-ancestor
111461213|NCT00004757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111461214|NCT00005069|Arsenic Trioxide|arsenic trioxide|mesh-list
111461215|NCT00005069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111461216|NCT00004763|Leuprolide|leuprolide|mesh-list
111461217|NCT00004763|Ethinyl Estradiol|ethinyl estradiol|mesh-list
111461218|NCT00004763|Norethindrone|norethindrone|mesh-list
111461219|NCT00004763|Norethindrone Acetate|norethindrone acetate|mesh-list
111461220|NCT00004763|Norinyl|norinyl|mesh-list
111461221|NCT00004763|Estradiol|estradiol|mesh-list
111461222|NCT00004763|Estrogens|estrogens|mesh-ancestor
111461223|NCT00004763|Hormones|hormones|mesh-ancestor
111461224|NCT00004763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111461225|NCT00004763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111461226|NCT00004763|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111461227|NCT00004763|Contraceptive Agents|contraceptive agents|mesh-ancestor
111461228|NCT00004763|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111461229|NCT00004763|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111461230|NCT00004763|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111461231|NCT00004763|Fertility Agents|fertility agents|mesh-ancestor
111461232|NCT00004763|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111461233|NCT00004763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111461234|NCT00004763|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111461235|NCT00004763|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111461236|NCT00004763|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111461237|NCT00004763|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
111461238|NCT00004787|Lenograstim|lenograstim|mesh-list
111461239|NCT00004787|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111461240|NCT00004787|Immunologic Factors|immunologic factors|mesh-ancestor
111461241|NCT00004787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111461242|NCT00005081|Carmustine|carmustine|mesh-list
111461243|NCT00005081|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
111461244|NCT00005081|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111461245|NCT00005081|Alkylating Agents|alkylating agents|mesh-ancestor
111461246|NCT00005081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111461247|NCT00005081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111461248|NCT00005081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111461249|NCT00005087|Paclitaxel|paclitaxel|mesh-list
111461250|NCT00005087|Cisplatin|cisplatin|mesh-list
111461251|NCT00005087|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111461252|NCT00005087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111461253|NCT00005087|Tubulin Modulators|tubulin modulators|mesh-ancestor
111461254|NCT00005087|Antimitotic Agents|antimitotic agents|mesh-ancestor
111461255|NCT00005087|Mitosis Modulators|mitosis modulators|mesh-ancestor
111461256|NCT00005087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111461257|NCT00004799|Vaccines|vaccines|mesh-list
111461258|NCT00004799|Immunologic Factors|immunologic factors|mesh-ancestor
111461259|NCT00004799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111461260|NCT00005093|Gemcitabine|gemcitabine|mesh-list
111461261|NCT00005093|Tacedinaline|tacedinaline|mesh-list
111461262|NCT00005093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111461263|NCT00005093|Antimetabolites|antimetabolites|mesh-ancestor
111461264|NCT00005093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111461265|NCT00005093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111461266|NCT00005093|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111461267|NCT00005093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111461268|NCT00004811|Itraconazole|itraconazole|mesh-list
111461269|NCT00004811|Antifungal Agents|antifungal agents|mesh-ancestor
111461270|NCT00004811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111461271|NCT00004811|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111461272|NCT00004811|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111461273|NCT00004811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111461274|NCT00004811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111461275|NCT00004811|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111461276|NCT00004811|Hormone Antagonists|hormone antagonists|mesh-ancestor
111461277|NCT00004811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111461278|NCT00004811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111461279|NCT00004811|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111461280|NCT00004817|Phenytoin|phenytoin|mesh-list
111461281|NCT00004817|Valproic Acid|valproic acid|mesh-list
111461282|NCT00004817|Anticonvulsants|anticonvulsants|mesh-ancestor
111461283|NCT00004817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111461284|NCT00004817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111461285|NCT00004817|GABA Agents|gaba agents|mesh-ancestor
111461286|NCT00004817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111461287|NCT00004817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111461288|NCT00004817|Antimanic Agents|antimanic agents|mesh-ancestor
111461289|NCT00004817|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111461290|NCT00004817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111461291|NCT00004817|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110937787|NCT03269136|Hormones|hormones|mesh-ancestor
111185429|NCT00153166|Pioglitazone|pioglitazone|mesh-list
111461292|NCT00004817|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111461293|NCT00004817|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111461294|NCT00004817|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111461295|NCT00004817|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
111461296|NCT00004817|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111461298|NCT00005117|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111461299|NCT00005117|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111461300|NCT00005117|Antimetabolites|antimetabolites|mesh-ancestor
111461301|NCT00005117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111461302|NCT00005117|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111461303|NCT00005117|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111461304|NCT00005117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111461305|NCT00385385|KRM 1648|krm 1648|mesh-list
111461306|NCT00385385|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111461307|NCT00385385|Antitubercular Agents|antitubercular agents|mesh-ancestor
111461308|NCT00385385|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111461309|NCT00385385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111461310|NCT00385385|Leprostatic Agents|leprostatic agents|mesh-ancestor
111461311|NCT00385463|Montelukast|montelukast|mesh-list
111461312|NCT00385463|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
111461313|NCT00385463|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111461314|NCT00385463|Respiratory System Agents|respiratory system agents|mesh-ancestor
111461315|NCT00385463|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
111461316|NCT00385463|Hormone Antagonists|hormone antagonists|mesh-ancestor
111461317|NCT00385463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111461318|NCT00385463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111461319|NCT00385463|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
111461320|NCT00385463|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111461321|NCT00385463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111461322|NCT00385463|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111461323|NCT00385463|Autonomic Agents|autonomic agents|mesh-ancestor
111461324|NCT00385463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111461325|NCT00385463|Glucocorticoids|glucocorticoids|mesh-ancestor
111461326|NCT00385463|Hormones|hormones|mesh-ancestor
111461327|NCT00385463|Sympathomimetics|sympathomimetics|mesh-ancestor
111461328|NCT00423371|Hyaluronic Acid|hyaluronic acid|mesh-list
111461329|NCT00423371|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111461330|NCT00423371|Immunologic Factors|immunologic factors|mesh-ancestor
111461331|NCT00423371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111461332|NCT00423371|Viscosupplements|viscosupplements|mesh-ancestor
111461333|NCT00423371|Protective Agents|protective agents|mesh-ancestor
111461334|NCT00005579|Dolastatin 10|dolastatin 10|mesh-list
111461335|NCT00005579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111461336|NCT00005579|Tubulin Modulators|tubulin modulators|mesh-ancestor
111461337|NCT00005579|Antimitotic Agents|antimitotic agents|mesh-ancestor
111461338|NCT00005579|Mitosis Modulators|mitosis modulators|mesh-ancestor
111461339|NCT00005579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111461340|NCT00005585|Leucovorin|leucovorin|mesh-list
111461341|NCT00005585|Cytarabine|cytarabine|mesh-list
111461342|NCT00005585|Dexamethasone|dexamethasone|mesh-list
111461343|NCT00005585|Cyclophosphamide|cyclophosphamide|mesh-list
111461344|NCT00005585|Methotrexate|methotrexate|mesh-list
111461345|NCT00005585|Vincristine|vincristine|mesh-list
111461346|NCT00005585|Daunorubicin|daunorubicin|mesh-list
111461347|NCT00005585|Asparaginase|asparaginase|mesh-list
111461348|NCT00005585|Mercaptopurine|mercaptopurine|mesh-list
111461349|NCT00005585|Pegaspargase|pegaspargase|mesh-list
111461350|NCT00005585|Thioguanine|thioguanine|mesh-list
111461351|NCT00005585|Levoleucovorin|levoleucovorin|mesh-list
111461352|NCT00005585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111461353|NCT00005585|Immunologic Factors|immunologic factors|mesh-ancestor
111461354|NCT00005585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111461355|NCT00005585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111461356|NCT00005585|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111461357|NCT00005585|Alkylating Agents|alkylating agents|mesh-ancestor
111461358|NCT00005585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111461359|NCT00005585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111461360|NCT00005585|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111461361|NCT00005585|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111461362|NCT00005585|Antiemetics|antiemetics|mesh-ancestor
111461363|NCT00005585|Autonomic Agents|autonomic agents|mesh-ancestor
111461364|NCT00005585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111461365|NCT00005585|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111461366|NCT00005585|Glucocorticoids|glucocorticoids|mesh-ancestor
111461367|NCT00005585|Hormones|hormones|mesh-ancestor
111461368|NCT00005585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111461369|NCT00005585|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111461370|NCT00005585|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111461371|NCT00005585|Abortifacient Agents|abortifacient agents|mesh-ancestor
111461372|NCT00005585|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111461373|NCT00005585|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111461374|NCT00005585|Antimetabolites|antimetabolites|mesh-ancestor
111461375|NCT00005585|Dermatologic Agents|dermatologic agents|mesh-ancestor
111461376|NCT00005585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111461377|NCT00005585|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111461378|NCT00005585|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111461379|NCT00005585|Antiviral Agents|antiviral agents|mesh-ancestor
111461380|NCT00005585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111461381|NCT00005585|Antidotes|antidotes|mesh-ancestor
111461382|NCT00005585|Protective Agents|protective agents|mesh-ancestor
111461383|NCT00005585|Vitamin B Complex|vitamin b complex|mesh-ancestor
111461385|NCT00005585|Micronutrients|micronutrients|mesh-ancestor
111461386|NCT00005585|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111461387|NCT00005585|Tubulin Modulators|tubulin modulators|mesh-ancestor
111461388|NCT00005585|Antimitotic Agents|antimitotic agents|mesh-ancestor
111461389|NCT00005585|Mitosis Modulators|mitosis modulators|mesh-ancestor
111461390|NCT00005585|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111461391|NCT00005585|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111461392|NCT00005585|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111461393|NCT00005591|Gemcitabine|gemcitabine|mesh-list
111461394|NCT00005591|Cetuximab|cetuximab|mesh-list
111461395|NCT00005591|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111461396|NCT00005591|Antimetabolites|antimetabolites|mesh-ancestor
111461397|NCT00005591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111461398|NCT00005591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111461399|NCT00005591|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111461400|NCT01926444|Trimebutine|trimebutine|mesh-list
111461401|NCT01926444|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111461402|NCT01926444|Parasympatholytics|parasympatholytics|mesh-ancestor
111461403|NCT01926444|Autonomic Agents|autonomic agents|mesh-ancestor
111461404|NCT01926444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111461405|NCT01926444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111461406|NCT00005597|Temozolomide|temozolomide|mesh-list
111461407|NCT00005597|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111461408|NCT00005597|Alkylating Agents|alkylating agents|mesh-ancestor
111461409|NCT00005597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111461410|NCT00005597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111461411|NCT04172844|Azacitidine|azacitidine|mesh-list
111461412|NCT04172844|Venetoclax|venetoclax|mesh-list
111461413|NCT04172844|Enzyme Inhibitors|enzyme inhibitors|mesh-list
111461414|NCT04172844|Pevonedistat|pevonedistat|mesh-list
111461415|NCT04172844|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111461416|NCT04172844|Antimetabolites|antimetabolites|mesh-ancestor
111461417|NCT04172844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111461418|NCT04172844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111461419|NCT00005603|Cytarabine|cytarabine|mesh-list
111461420|NCT00005603|Dexamethasone|dexamethasone|mesh-list
111461421|NCT00005603|Prednisone|prednisone|mesh-list
111461422|NCT00005603|Cyclophosphamide|cyclophosphamide|mesh-list
111461423|NCT00005603|Doxorubicin|doxorubicin|mesh-list
111461424|NCT00005603|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111461425|NCT00005603|Methotrexate|methotrexate|mesh-list
111461426|NCT00005603|Vincristine|vincristine|mesh-list
111461427|NCT00005603|Daunorubicin|daunorubicin|mesh-list
111461428|NCT00005603|Asparaginase|asparaginase|mesh-list
111461429|NCT00005603|Mercaptopurine|mercaptopurine|mesh-list
111461430|NCT00005603|Thioguanine|thioguanine|mesh-list
111461431|NCT00005603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111461432|NCT00005603|Immunologic Factors|immunologic factors|mesh-ancestor
111461433|NCT00005603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111461434|NCT00005603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111461435|NCT00005603|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111461436|NCT00005603|Alkylating Agents|alkylating agents|mesh-ancestor
111461437|NCT00005603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111461438|NCT00005603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111461439|NCT00005603|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111461440|NCT00005603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111461441|NCT00005603|Antiemetics|antiemetics|mesh-ancestor
111461442|NCT00005603|Autonomic Agents|autonomic agents|mesh-ancestor
111461443|NCT00005603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111461444|NCT00005603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111461445|NCT00005603|Glucocorticoids|glucocorticoids|mesh-ancestor
111461446|NCT00005603|Hormones|hormones|mesh-ancestor
111461447|NCT00005603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111461448|NCT00005603|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111461449|NCT00005603|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111461450|NCT00005603|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111461451|NCT00005603|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111461452|NCT00005603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111461453|NCT00005603|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111461454|NCT00005603|Abortifacient Agents|abortifacient agents|mesh-ancestor
111461455|NCT00005603|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111461456|NCT00005603|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111461457|NCT00005603|Antimetabolites|antimetabolites|mesh-ancestor
111461458|NCT00005603|Dermatologic Agents|dermatologic agents|mesh-ancestor
111461459|NCT00005603|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111461460|NCT00005603|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111461461|NCT00005603|Antiviral Agents|antiviral agents|mesh-ancestor
111461462|NCT00005603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111461463|NCT00005603|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111461464|NCT00005603|Tubulin Modulators|tubulin modulators|mesh-ancestor
111461465|NCT00005603|Antimitotic Agents|antimitotic agents|mesh-ancestor
111461466|NCT00005603|Mitosis Modulators|mitosis modulators|mesh-ancestor
111461467|NCT00005609|Rituximab|rituximab|mesh-list
111461468|NCT00005609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111461469|NCT00005609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111461470|NCT00005609|Immunologic Factors|immunologic factors|mesh-ancestor
111461471|NCT00005609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111461472|NCT00005609|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111461473|NCT00005615|Interferons|interferons|mesh-list
111461474|NCT00005615|Interferon-alpha|interferon-alpha|mesh-list
111461475|NCT00005615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111461476|NCT00005615|Antiviral Agents|antiviral agents|mesh-ancestor
111461477|NCT00005615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111461478|NCT00005615|Immunologic Factors|immunologic factors|mesh-ancestor
111461479|NCT00005615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111461480|NCT00005627|Carboplatin|carboplatin|mesh-list
111461481|NCT00005627|Docetaxel|docetaxel|mesh-list
111461482|NCT00005627|Estramustine|estramustine|mesh-list
111461483|NCT00005627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111461484|NCT00005627|Tubulin Modulators|tubulin modulators|mesh-ancestor
111461485|NCT00005627|Antimitotic Agents|antimitotic agents|mesh-ancestor
111461486|NCT00005627|Mitosis Modulators|mitosis modulators|mesh-ancestor
111461487|NCT00005627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111461488|NCT00005627|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111461489|NCT00005627|Alkylating Agents|alkylating agents|mesh-ancestor
111461490|NCT00005627|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111461491|NCT00005639|Azacitidine|azacitidine|mesh-list
111461492|NCT00005639|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
111461493|NCT00005639|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111461494|NCT00005639|Antimetabolites|antimetabolites|mesh-ancestor
111461495|NCT00005639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111461496|NCT00005639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111461497|NCT00005639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111461498|NCT00005663|Valacyclovir|valacyclovir|mesh-list
111461499|NCT00005663|Antiviral Agents|antiviral agents|mesh-ancestor
111461500|NCT00005663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111461501|NCT00385853|Temozolomide|temozolomide|mesh-list
111461502|NCT00385853|Vatalanib|vatalanib|mesh-list
111461503|NCT00385853|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111461504|NCT00385853|Alkylating Agents|alkylating agents|mesh-ancestor
111461505|NCT00385853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111461506|NCT00385853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111461507|NCT00385853|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111461508|NCT00385853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111461509|NCT00005765|Nicotine|nicotine|mesh-list
111461510|NCT00005765|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111461511|NCT00005765|Autonomic Agents|autonomic agents|mesh-ancestor
111461512|NCT00005765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111461513|NCT00005765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111461514|NCT00005765|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111461515|NCT00005765|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111461516|NCT00005765|Cholinergic Agents|cholinergic agents|mesh-ancestor
111461517|NCT00005765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111461518|NCT00005765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111461519|NCT00005777|Dexamethasone|dexamethasone|mesh-list
111461520|NCT00005777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111461521|NCT00005777|Antiemetics|antiemetics|mesh-ancestor
111461522|NCT00005777|Autonomic Agents|autonomic agents|mesh-ancestor
111461523|NCT00005777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111461524|NCT00005777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111461525|NCT00005777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111461526|NCT00005777|Glucocorticoids|glucocorticoids|mesh-ancestor
111461527|NCT00005777|Hormones|hormones|mesh-ancestor
111461528|NCT00005777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111461529|NCT00005777|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111461530|NCT00005777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111461531|NCT00385931|Valsartan|valsartan|mesh-list
111461532|NCT00385931|Simvastatin|simvastatin|mesh-list
111461533|NCT00385931|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111461534|NCT00385931|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111461535|NCT00385931|Antimetabolites|antimetabolites|mesh-ancestor
111461536|NCT00385931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111461537|NCT00385931|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111461538|NCT00385931|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111461539|NCT00385931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111461540|NCT00385931|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111461541|NCT00385931|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111461542|NCT00385931|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111461543|NCT00386399|Mitomycins|mitomycins|mesh-list
111461544|NCT00386399|Mitomycin|mitomycin|mesh-list
111461545|NCT00386399|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111461546|NCT00386399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111461547|NCT00386399|Alkylating Agents|alkylating agents|mesh-ancestor
111461548|NCT00386399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111461549|NCT00386399|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111461550|NCT00386399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111461551|NCT00005807|Epothilones|epothilones|mesh-list
111461552|NCT00005807|Tubulin Modulators|tubulin modulators|mesh-ancestor
111461553|NCT00005807|Antimitotic Agents|antimitotic agents|mesh-ancestor
111461554|NCT00005807|Mitosis Modulators|mitosis modulators|mesh-ancestor
111461555|NCT00005807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111461556|NCT00005807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111461557|NCT00005813|Antibodies|antibodies|mesh-list
111461558|NCT00005813|Antibodies, Bispecific|antibodies, bispecific|mesh-list
111461559|NCT00005813|Immunologic Factors|immunologic factors|mesh-ancestor
111461560|NCT00005813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111461561|NCT04567433|Hydrocortisone|hydrocortisone|mesh-list
111461562|NCT04567433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111461563|NCT00003647|Dacarbazine|dacarbazine|mesh-list
111461564|NCT00003647|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111461565|NCT00003647|Alkylating Agents|alkylating agents|mesh-ancestor
111461566|NCT00003647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111461567|NCT00003647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111461568|NCT05895526|Fluorides|fluorides|mesh-list
111461569|NCT05895526|Fluorides, Topical|fluorides, topical|mesh-list
111461570|NCT05895526|Cariostatic Agents|cariostatic agents|mesh-ancestor
111461571|NCT05895526|Protective Agents|protective agents|mesh-ancestor
111461572|NCT05895526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111461573|NCT05895513|Pimavanserin|pimavanserin|mesh-list
110655578|NCT00972426|Carteolol|carteolol|mesh-list
111461574|NCT05895513|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111461575|NCT05895513|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111461576|NCT05895513|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111461577|NCT05895513|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111461578|NCT05895513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111461579|NCT05895513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111461580|NCT05895513|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111461581|NCT05895513|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111461582|NCT05895513|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111461583|NCT05895513|Serotonin Agents|serotonin agents|mesh-ancestor
111461584|NCT05895513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111461585|NCT05895513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111461586|NCT05895448|Sofosbuvir|sofosbuvir|mesh-list
111461587|NCT05895448|Velpatasvir|velpatasvir|mesh-list
111461588|NCT05895448|Antiviral Agents|antiviral agents|mesh-ancestor
111461589|NCT05895448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111461590|NCT05895370|Interleukin-2|interleukin-2|mesh-list
111461591|NCT05895370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111461592|NCT05895370|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111461593|NCT05895370|Analgesics|analgesics|mesh-ancestor
110959271|NCT00545324|Respiratory System Agents|respiratory system agents|mesh-ancestor
111461594|NCT05895370|Sensory System Agents|sensory system agents|mesh-ancestor
111461595|NCT05895370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111461596|NCT05895370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111461597|NCT05895305|Paclitaxel|paclitaxel|mesh-list
111461598|NCT05895305|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111461599|NCT05895305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111461600|NCT05895305|Tubulin Modulators|tubulin modulators|mesh-ancestor
111461601|NCT05895305|Antimitotic Agents|antimitotic agents|mesh-ancestor
111461602|NCT05895305|Mitosis Modulators|mitosis modulators|mesh-ancestor
111461603|NCT05895305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111461604|NCT05895240|Urinastatin|urinastatin|mesh-list
111461605|NCT05895240|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
111461606|NCT05895240|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111461607|NCT05895240|Protease Inhibitors|protease inhibitors|mesh-ancestor
111461608|NCT05895240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111461609|NCT05895240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111461610|NCT05895136|Enoxaparin|enoxaparin|mesh-list
111461611|NCT05895136|Anticoagulants|anticoagulants|mesh-ancestor
111461612|NCT05895136|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111461613|NCT05895136|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111461614|NCT05895136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111461615|NCT05895123|Atorvastatin|atorvastatin|mesh-list
111461616|NCT05895123|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111461617|NCT05895123|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111461618|NCT05895123|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111461619|NCT05895123|Antimetabolites|antimetabolites|mesh-ancestor
111461620|NCT05895123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111461621|NCT05895123|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111461622|NCT05895123|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111461623|NCT05895123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111461624|NCT05894954|Hormones|hormones|mesh-list
111461625|NCT05894954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111461626|NCT05894954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111461627|NCT05894889|Paclitaxel|paclitaxel|mesh-list
111461628|NCT05894889|Carboplatin|carboplatin|mesh-list
111461629|NCT05894889|Pembrolizumab|pembrolizumab|mesh-list
111461630|NCT05894889|Pemetrexed|pemetrexed|mesh-list
111461631|NCT05894889|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111461632|NCT05894889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111461633|NCT05894889|Tubulin Modulators|tubulin modulators|mesh-ancestor
111461634|NCT05894889|Antimitotic Agents|antimitotic agents|mesh-ancestor
111461635|NCT05894889|Mitosis Modulators|mitosis modulators|mesh-ancestor
111461636|NCT05894889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111461637|NCT05894889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111461638|NCT05894889|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111461639|NCT05894889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111461640|NCT05894889|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111461641|NCT05894889|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111461642|NCT05894824|Ramucirumab|ramucirumab|mesh-list
111461643|NCT05894824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111461644|NCT05894486|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
111461645|NCT05894486|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111461646|NCT05894486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111461647|NCT05894447|Pembrolizumab|pembrolizumab|mesh-list
111461648|NCT05894447|Obinutuzumab|obinutuzumab|mesh-list
111461649|NCT05894447|Naptumomab estafenatox|naptumomab estafenatox|mesh-list
111461650|NCT05894447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111461651|NCT05894447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111461652|NCT05894447|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111461653|NCT05894447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111461654|NCT05894447|Immunoconjugates|immunoconjugates|mesh-ancestor
111461655|NCT05894447|Immunologic Factors|immunologic factors|mesh-ancestor
111461656|NCT05894447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111461657|NCT05894200|Fluorides|fluorides|mesh-list
111461658|NCT05894200|Cariostatic Agents|cariostatic agents|mesh-ancestor
111461659|NCT05894200|Protective Agents|protective agents|mesh-ancestor
111461660|NCT05894200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111461661|NCT05894057|Midazolam|midazolam|mesh-list
111461662|NCT05894057|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111461663|NCT05894057|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111461664|NCT05894057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111461665|NCT05894057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111461666|NCT05894057|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111461667|NCT05894057|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111461668|NCT05894057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111461669|NCT05894057|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111185817|NCT01472835|Fentanyl|fentanyl|mesh-list
111461670|NCT05894057|Anesthetics, General|anesthetics, general|mesh-ancestor
111461671|NCT05894057|Anesthetics|anesthetics|mesh-ancestor
111461672|NCT05894057|GABA Modulators|gaba modulators|mesh-ancestor
111461673|NCT05894057|GABA Agents|gaba agents|mesh-ancestor
111461674|NCT05894057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111461675|NCT05894057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111461676|NCT05893888|Cisplatin|cisplatin|mesh-list
111461677|NCT05893888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111461678|NCT05893810|Mupirocin|mupirocin|mesh-list
111461679|NCT05893810|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111461680|NCT05893810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111461681|NCT05893810|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111461682|NCT05893810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111461683|NCT05893810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111461684|NCT05893654|Melphalan|melphalan|mesh-list
111461685|NCT05893654|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111461686|NCT05893654|Alkylating Agents|alkylating agents|mesh-ancestor
111461687|NCT05893654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111461688|NCT05893654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111461689|NCT05893654|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111461690|NCT05893654|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111461691|NCT05893654|Immunologic Factors|immunologic factors|mesh-ancestor
111461692|NCT05893654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111461693|NCT05893511|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111461694|NCT05893511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111461695|NCT05893472|Venetoclax|venetoclax|mesh-list
111461696|NCT05893472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111461697|NCT05892913|Atropine|atropine|mesh-list
111461698|NCT05892913|Ephedrine|ephedrine|mesh-list
111461699|NCT05892913|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111461700|NCT05892913|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111461701|NCT05892913|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111461702|NCT05892913|Autonomic Agents|autonomic agents|mesh-ancestor
111461703|NCT05892913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111461704|NCT05892913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111461705|NCT05892913|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111461706|NCT05892913|Respiratory System Agents|respiratory system agents|mesh-ancestor
111461707|NCT05892913|Mydriatics|mydriatics|mesh-ancestor
111461708|NCT05892913|Parasympatholytics|parasympatholytics|mesh-ancestor
111461709|NCT05892913|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111461710|NCT05892913|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111461711|NCT05892913|Cholinergic Agents|cholinergic agents|mesh-ancestor
111461712|NCT05892913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111461713|NCT05892913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111461714|NCT05892913|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111461715|NCT05892913|Sympathomimetics|sympathomimetics|mesh-ancestor
111461716|NCT05892913|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111461717|NCT05892913|Adrenergic Agents|adrenergic agents|mesh-ancestor
111461718|NCT05887830|Nivolumab|nivolumab|mesh-list
111461719|NCT05887830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111461720|NCT05887830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111461721|NCT05887830|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111461722|NCT05887830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111461723|NCT05885230|Lidocaine|lidocaine|mesh-list
111461724|NCT05885230|Bupivacaine|bupivacaine|mesh-list
111461725|NCT05885230|Anesthetics, Local|anesthetics, local|mesh-ancestor
111461726|NCT05885230|Anesthetics|anesthetics|mesh-ancestor
111461727|NCT05885230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111461728|NCT05885230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111461729|NCT05885230|Sensory System Agents|sensory system agents|mesh-ancestor
111461730|NCT05885230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111461731|NCT05885230|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111461732|NCT05885230|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111461733|NCT05885230|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111461734|NCT05885230|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111461735|NCT05885230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111461736|NCT05877027|Diclofenac|diclofenac|mesh-list
111461737|NCT05877027|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111461738|NCT05877027|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111461739|NCT05877027|Analgesics|analgesics|mesh-ancestor
111461740|NCT05877027|Sensory System Agents|sensory system agents|mesh-ancestor
111461741|NCT05877027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111461742|NCT05877027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111461743|NCT05877027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111461744|NCT05877027|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111461745|NCT05877027|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111461746|NCT05877027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111461747|NCT05877027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111461748|NCT05861258|Minocycline|minocycline|mesh-list
111461749|NCT05861258|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111461750|NCT05861258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111461751|NCT05807204|Acetylcysteine|acetylcysteine|mesh-list
111461752|NCT05807204|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111461753|NCT05807204|Antiviral Agents|antiviral agents|mesh-ancestor
111461754|NCT05807204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111461755|NCT05807204|Expectorants|expectorants|mesh-ancestor
111461756|NCT05807204|Respiratory System Agents|respiratory system agents|mesh-ancestor
111461757|NCT05807204|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111461758|NCT05807204|Antioxidants|antioxidants|mesh-ancestor
111461759|NCT05807204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111461760|NCT05807204|Protective Agents|protective agents|mesh-ancestor
111461761|NCT05807204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111461762|NCT05807204|Antidotes|antidotes|mesh-ancestor
111461763|NCT05784571|Insulin|insulin|mesh-list
111461764|NCT05784571|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111461765|NCT05784571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111461766|NCT05779943|Furosemide|furosemide|mesh-list
111461767|NCT05779943|Fluorides|fluorides|mesh-list
111461768|NCT05779943|Diuretics|diuretics|mesh-ancestor
111461769|NCT05779943|Natriuretic Agents|natriuretic agents|mesh-ancestor
111461770|NCT05779943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111461771|NCT05779943|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
111461772|NCT05779943|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111461773|NCT05779943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111461774|NCT05779943|Cariostatic Agents|cariostatic agents|mesh-ancestor
111461775|NCT05779943|Protective Agents|protective agents|mesh-ancestor
111461776|NCT05767047|Apremilast|apremilast|mesh-list
111461777|NCT05767047|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111461778|NCT05767047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111461779|NCT05767047|Analgesics|analgesics|mesh-ancestor
111461780|NCT05767047|Sensory System Agents|sensory system agents|mesh-ancestor
111461781|NCT05767047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111461782|NCT05767047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111461783|NCT05767047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111461784|NCT05767047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111461785|NCT05767047|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
111461786|NCT05767047|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111461787|NCT05767047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111461788|NCT05767047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111461789|NCT05727098|Ketamine|ketamine|mesh-list
111461790|NCT05727098|Bupivacaine|bupivacaine|mesh-list
111461791|NCT05727098|Anesthetics, Local|anesthetics, local|mesh-list
111461792|NCT05727098|Anesthetics|anesthetics|mesh-list
111461793|NCT05727098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111461794|NCT05727098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111461795|NCT05727098|Sensory System Agents|sensory system agents|mesh-ancestor
111461796|NCT05727098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111461797|NCT05727098|Analgesics|analgesics|mesh-ancestor
111461798|NCT05727098|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111461799|NCT05727098|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111461800|NCT05727098|Anesthetics, General|anesthetics, general|mesh-ancestor
111461801|NCT05727098|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111461802|NCT05727098|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111461803|NCT05727098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111461804|NCT05727098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111461805|NCT05656352|Chrysarobin|chrysarobin|mesh-list
111461806|NCT05656352|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111461807|NCT05656352|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111461808|NCT05656352|Analgesics|analgesics|mesh-ancestor
111461809|NCT05656352|Sensory System Agents|sensory system agents|mesh-ancestor
111461810|NCT05656352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111461811|NCT05656352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111461812|NCT05656352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111461813|NCT05656352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111461814|NCT05632809|Durvalumab|durvalumab|mesh-list
111461815|NCT05632809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111461816|NCT05632809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111461817|NCT05610527|Etonogestrel|etonogestrel|mesh-list
111461818|NCT05610527|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111461819|NCT05610527|Contraceptive Agents|contraceptive agents|mesh-ancestor
111461820|NCT05610527|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111461821|NCT05610527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111461822|NCT05610527|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111461823|NCT05608369|Vorinostat|vorinostat|mesh-list
111461824|NCT05608369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111461825|NCT05608369|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111461826|NCT05608369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111461827|NCT05608369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111461828|NCT05590468|Niacinamide|niacinamide|mesh-list
111461829|NCT05590468|Niacin|niacin|mesh-list
111461830|NCT05590468|Nicotinic Acids|nicotinic acids|mesh-list
111461831|NCT05590468|Vitamin B Complex|vitamin b complex|mesh-ancestor
111461832|NCT05590468|Vitamins|vitamins|mesh-ancestor
111461833|NCT05590468|Micronutrients|micronutrients|mesh-ancestor
111461834|NCT05590468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111461835|NCT05590468|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111461836|NCT05590468|Antimetabolites|antimetabolites|mesh-ancestor
111461837|NCT05590468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111461838|NCT05590468|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111461839|NCT05590468|Vasodilator Agents|vasodilator agents|mesh-ancestor
111461840|NCT05565560|Apremilast|apremilast|mesh-list
111461841|NCT05565560|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111461842|NCT05565560|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111461843|NCT05565560|Analgesics|analgesics|mesh-ancestor
111461844|NCT05565560|Sensory System Agents|sensory system agents|mesh-ancestor
111461845|NCT05565560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111461846|NCT05565560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111461847|NCT05565560|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111461848|NCT05565560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111461849|NCT05565560|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
111461850|NCT05565560|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111461851|NCT05565560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111461852|NCT05565560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111461853|NCT05564546|Nitric Oxide|nitric oxide|mesh-list
111461854|NCT05564546|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111461855|NCT05564546|Autonomic Agents|autonomic agents|mesh-ancestor
111461856|NCT05564546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111461857|NCT05564546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111461858|NCT05564546|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111461859|NCT05564546|Respiratory System Agents|respiratory system agents|mesh-ancestor
111461860|NCT05564546|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111461861|NCT05564546|Antioxidants|antioxidants|mesh-ancestor
111461862|NCT05564546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111461863|NCT05564546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111461864|NCT05564546|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
111461865|NCT05564546|Vasodilator Agents|vasodilator agents|mesh-ancestor
111461866|NCT05564546|Gasotransmitters|gasotransmitters|mesh-ancestor
111461867|NCT05564546|Protective Agents|protective agents|mesh-ancestor
111461868|NCT05527808|Carboplatin|carboplatin|mesh-list
111461869|NCT05527808|Pemetrexed|pemetrexed|mesh-list
111461870|NCT05527808|Tislelizumab|tislelizumab|mesh-list
111461871|NCT05527808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111461872|NCT05527808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111461873|NCT05527808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111461874|NCT05527808|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111461875|NCT05527808|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111461876|NCT05527808|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111461877|NCT05496335|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111461878|NCT05496335|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111461879|NCT05496335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111461880|NCT05496335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111461881|NCT05496335|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111461882|NCT05496335|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111461883|NCT05496335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111461884|NCT05496335|Cholinergic Agents|cholinergic agents|mesh-ancestor
111461885|NCT05496335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111461886|NCT05480098|Brimonidine Tartrate|brimonidine tartrate|mesh-list
111461887|NCT05480098|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111461888|NCT05480098|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111461889|NCT05480098|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111461890|NCT05480098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111461891|NCT05480098|Adrenergic Agents|adrenergic agents|mesh-ancestor
111461892|NCT05480098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111479302|NCT05028634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111461893|NCT05480098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111461894|NCT05480098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111461895|NCT05426031|Protamines|protamines|mesh-list
111461896|NCT05426031|Heparin Antagonists|heparin antagonists|mesh-ancestor
111461897|NCT05426031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111461898|NCT05426031|Coagulants|coagulants|mesh-ancestor
111461899|NCT05423106|Tenofovir|tenofovir|mesh-list
111461900|NCT05423106|Entecavir|entecavir|mesh-list
111461901|NCT05423106|Antiviral Agents|antiviral agents|mesh-ancestor
111461902|NCT05423106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111461903|NCT05423106|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111461904|NCT05423106|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111461905|NCT05423106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111461906|NCT05423106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111461907|NCT05423106|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111461908|NCT05423106|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111461909|NCT05399277|Rivaroxaban|rivaroxaban|mesh-list
111461910|NCT05399277|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111461911|NCT05399277|Antithrombins|antithrombins|mesh-ancestor
111461912|NCT05399277|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111461913|NCT05399277|Protease Inhibitors|protease inhibitors|mesh-ancestor
111461914|NCT05399277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111461915|NCT05399277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111461916|NCT05399277|Anticoagulants|anticoagulants|mesh-ancestor
111461917|NCT05362409|Aminolevulinic Acid|aminolevulinic acid|mesh-list
111461918|NCT05362409|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111461919|NCT05362409|Dermatologic Agents|dermatologic agents|mesh-ancestor
111461920|NCT05319873|Carboplatin|carboplatin|mesh-list
111461921|NCT05319873|Docetaxel|docetaxel|mesh-list
111461922|NCT05319873|Trastuzumab|trastuzumab|mesh-list
111461923|NCT05319873|Fulvestrant|fulvestrant|mesh-list
111461924|NCT05319873|Pertuzumab|pertuzumab|mesh-list
111461925|NCT05319873|Tucatinib|tucatinib|mesh-list
111461926|NCT05319873|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
111461927|NCT05319873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111461928|NCT05319873|Antibodies|antibodies|mesh-list
111461929|NCT05319873|Immunoglobulins|immunoglobulins|mesh-list
111461930|NCT05319873|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111461931|NCT05319873|Immunologic Factors|immunologic factors|mesh-ancestor
111461932|NCT05319873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111461933|NCT05319873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111461934|NCT05319873|Tubulin Modulators|tubulin modulators|mesh-ancestor
111461935|NCT05319873|Antimitotic Agents|antimitotic agents|mesh-ancestor
111461936|NCT05319873|Mitosis Modulators|mitosis modulators|mesh-ancestor
111461937|NCT05319873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111461938|NCT05319873|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111461939|NCT05319873|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
111461940|NCT05319873|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111461941|NCT05319873|Hormone Antagonists|hormone antagonists|mesh-ancestor
111461942|NCT05319873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111461943|NCT05319873|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111461944|NCT05319873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111461945|NCT05249452|Hydroxyurea|hydroxyurea|mesh-list
111461946|NCT05249452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111461947|NCT05249452|Antisickling Agents|antisickling agents|mesh-ancestor
111461948|NCT05249452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111461949|NCT05249452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111461950|NCT05249452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111461951|NCT05188326|Azacitidine|azacitidine|mesh-list
111461952|NCT05188326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111461953|NCT05188326|Antimetabolites|antimetabolites|mesh-ancestor
111461954|NCT05188326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111461955|NCT05188326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111461956|NCT05188326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111461957|NCT05180942|Atorvastatin|atorvastatin|mesh-list
111461958|NCT05180942|Calcium|calcium|mesh-list
111461959|NCT05180942|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111461960|NCT05180942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111461961|NCT05180942|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111461962|NCT05180942|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111461963|NCT05180942|Antimetabolites|antimetabolites|mesh-ancestor
111461964|NCT05180942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111461965|NCT05180942|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111461966|NCT05180942|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111461967|NCT05180942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111461968|NCT05164653|Valsartan|valsartan|mesh-list
111461969|NCT05164653|Angiotensin II|angiotensin ii|mesh-list
111461970|NCT05164653|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
111461971|NCT05164653|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
111461972|NCT05164653|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
111461973|NCT05164653|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111461974|NCT05164653|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111461975|NCT05164653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111461976|NCT05164653|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111461977|NCT05164653|Protease Inhibitors|protease inhibitors|mesh-ancestor
111461978|NCT05164653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111461979|NCT05160896|Bevacizumab|bevacizumab|mesh-list
111461980|NCT05160896|Cetuximab|cetuximab|mesh-list
111461981|NCT05160896|Irinotecan|irinotecan|mesh-list
111461982|NCT05160896|Raltitrexed|raltitrexed|mesh-list
111461983|NCT05160896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111461984|NCT05160896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111461985|NCT05160896|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111461986|NCT05160896|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111461987|NCT05160896|Growth Substances|growth substances|mesh-ancestor
111461988|NCT05160896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111461989|NCT05160896|Growth Inhibitors|growth inhibitors|mesh-ancestor
111461990|NCT05160896|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111461991|NCT05160896|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111461992|NCT05160896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111461993|NCT05160896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111461994|NCT05160896|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111461995|NCT05160896|Antimetabolites|antimetabolites|mesh-ancestor
111461996|NCT05160896|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111461997|NCT05129670|Calcium Carbonate|calcium carbonate|mesh-list
111461998|NCT05129670|Antacids|antacids|mesh-ancestor
111461999|NCT05129670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111462000|NCT05129670|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111462001|NCT05128617|Paclitaxel|paclitaxel|mesh-list
111462002|NCT05128617|Cyclophosphamide|cyclophosphamide|mesh-list
111462003|NCT05128617|Epirubicin|epirubicin|mesh-list
111462004|NCT05128617|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111462005|NCT05128617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111462006|NCT05128617|Tubulin Modulators|tubulin modulators|mesh-ancestor
111462007|NCT05128617|Antimitotic Agents|antimitotic agents|mesh-ancestor
111462008|NCT05128617|Mitosis Modulators|mitosis modulators|mesh-ancestor
111462009|NCT05128617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111462010|NCT05128617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111462011|NCT05128617|Immunologic Factors|immunologic factors|mesh-ancestor
111462012|NCT05128617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111462013|NCT05128617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111462014|NCT05128617|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111462015|NCT05128617|Alkylating Agents|alkylating agents|mesh-ancestor
111462016|NCT05128617|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111462017|NCT05128617|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111462018|NCT05128617|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111462019|NCT05128617|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111462020|NCT05128617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111462021|NCT05107375|Vaccines|vaccines|mesh-list
111462022|NCT05107375|Immunologic Factors|immunologic factors|mesh-ancestor
111462023|NCT05107375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111462024|NCT05094128|Upadacitinib|upadacitinib|mesh-list
111462025|NCT05094128|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
111462026|NCT05094128|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111462027|NCT05094128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111462028|NCT05094128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111462029|NCT05094128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111462030|NCT05065957|Capecitabine|capecitabine|mesh-list
111462031|NCT05065957|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111462032|NCT05065957|Antimetabolites|antimetabolites|mesh-ancestor
111462033|NCT05065957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111462034|NCT05065957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111462035|NCT05031520|Metoprolol|metoprolol|mesh-list
111462036|NCT05031520|Nitroglycerin|nitroglycerin|mesh-list
111462037|NCT05031520|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111462038|NCT05031520|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111462039|NCT05031520|Sympatholytics|sympatholytics|mesh-ancestor
111462040|NCT05031520|Autonomic Agents|autonomic agents|mesh-ancestor
111462041|NCT05031520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111462042|NCT05031520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111462043|NCT05031520|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
111462044|NCT05031520|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111462045|NCT05031520|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111462046|NCT05031520|Adrenergic Agents|adrenergic agents|mesh-ancestor
111462047|NCT05031520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111462048|NCT05031520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111462049|NCT05031520|Vasodilator Agents|vasodilator agents|mesh-ancestor
111462050|NCT04989829|Omeprazole|omeprazole|mesh-list
111462051|NCT04989829|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111462052|NCT04989829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111462053|NCT04989829|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111462054|NCT04989829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111462055|NCT04989829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111462056|NCT04988035|Remdesivir|remdesivir|mesh-list
111462057|NCT04988035|Antimetabolites|antimetabolites|mesh-ancestor
111462058|NCT04988035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111462059|NCT04988035|Antiviral Agents|antiviral agents|mesh-ancestor
111462060|NCT04988035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111462061|NCT04939792|Vitamin D|vitamin d|mesh-list
111462062|NCT04939792|Ergocalciferols|ergocalciferols|mesh-list
111462063|NCT04939792|Cholecalciferol|cholecalciferol|mesh-list
111462064|NCT04939792|Vitamins|vitamins|mesh-list
111462065|NCT04939792|Micronutrients|micronutrients|mesh-ancestor
111462066|NCT04939792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111462067|NCT04939792|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111462068|NCT04939792|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111462069|NCT04850495|Prednisone|prednisone|mesh-list
111462070|NCT04850495|Cortisone|cortisone|mesh-list
111462071|NCT04850495|Cyclophosphamide|cyclophosphamide|mesh-list
111462072|NCT04850495|Rituximab|rituximab|mesh-list
111462073|NCT04850495|Doxorubicin|doxorubicin|mesh-list
111462074|NCT04850495|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111462075|NCT04850495|Vincristine|vincristine|mesh-list
111462076|NCT04850495|Zanubrutinib|zanubrutinib|mesh-list
111462077|NCT04850495|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111462078|NCT04850495|Antibodies|antibodies|mesh-list
111462079|NCT04850495|Immunoglobulins|immunoglobulins|mesh-list
111462080|NCT04850495|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111462081|NCT04850495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111462082|NCT04850495|Immunologic Factors|immunologic factors|mesh-ancestor
111462083|NCT04850495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111462084|NCT04850495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111462085|NCT04850495|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111462086|NCT04850495|Alkylating Agents|alkylating agents|mesh-ancestor
111462087|NCT04850495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111462088|NCT04850495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111462089|NCT04850495|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111462090|NCT04850495|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111462091|NCT04850495|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111462092|NCT04850495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111462093|NCT04850495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111462094|NCT04850495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111462095|NCT04850495|Glucocorticoids|glucocorticoids|mesh-ancestor
111462096|NCT04850495|Hormones|hormones|mesh-ancestor
111462097|NCT04850495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111462098|NCT04850495|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111462099|NCT04850495|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111462100|NCT04850495|Tubulin Modulators|tubulin modulators|mesh-ancestor
111462101|NCT04850495|Antimitotic Agents|antimitotic agents|mesh-ancestor
111462102|NCT04850495|Mitosis Modulators|mitosis modulators|mesh-ancestor
111462103|NCT04850495|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111462104|NCT04763135|Mirtazapine|mirtazapine|mesh-list
111462105|NCT04763135|Escitalopram|escitalopram|mesh-list
111462106|NCT04763135|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111462107|NCT04763135|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111462108|NCT04763135|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111462109|NCT04763135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111462110|NCT04763135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111462111|NCT04763135|Serotonin Agents|serotonin agents|mesh-ancestor
111462112|NCT04763135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111462113|NCT04763135|Antidepressive Agents|antidepressive agents|mesh-ancestor
111462114|NCT04763135|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111462115|NCT04763135|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111462116|NCT04763135|Histamine Antagonists|histamine antagonists|mesh-ancestor
111462117|NCT04763135|Histamine Agents|histamine agents|mesh-ancestor
111462118|NCT04763135|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111462119|NCT04763135|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111462120|NCT04763135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111462121|NCT04763135|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
111462122|NCT04763135|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111462123|NCT04763135|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111462124|NCT04763135|Adrenergic Agents|adrenergic agents|mesh-ancestor
111462125|NCT04763135|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111462126|NCT04763135|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111462127|NCT04763135|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111462128|NCT04762979|Fulvestrant|fulvestrant|mesh-list
111462129|NCT04762979|Aromatase Inhibitors|aromatase inhibitors|mesh-list
111462130|NCT04762979|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111462131|NCT04762979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111462132|NCT04762979|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
111462133|NCT04762979|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111462134|NCT04762979|Hormone Antagonists|hormone antagonists|mesh-ancestor
111462135|NCT04762979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111462136|NCT04762979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111462137|NCT04762979|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111462138|NCT04762979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111462139|NCT04762979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111462140|NCT04723134|Leucovorin|leucovorin|mesh-list
111462141|NCT04723134|Folic Acid|folic acid|mesh-list
111462142|NCT04723134|Calcium|calcium|mesh-list
111462143|NCT04723134|Levoleucovorin|levoleucovorin|mesh-list
111462144|NCT04723134|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111462145|NCT04723134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111462146|NCT04723134|Antidotes|antidotes|mesh-ancestor
111462147|NCT04723134|Protective Agents|protective agents|mesh-ancestor
111462148|NCT04723134|Vitamin B Complex|vitamin b complex|mesh-ancestor
111462149|NCT04723134|Vitamins|vitamins|mesh-ancestor
111462150|NCT04723134|Micronutrients|micronutrients|mesh-ancestor
111462151|NCT04723134|Hematinics|hematinics|mesh-ancestor
111462152|NCT04711135|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
111462153|NCT04711135|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110938648|NCT04430998|Chlorhexidine|chlorhexidine|mesh-list
111462154|NCT04711135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111462155|NCT04666272|Trametinib|trametinib|mesh-list
111462156|NCT04666272|Dabrafenib|dabrafenib|mesh-list
111462157|NCT04666272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111462158|NCT04666272|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111462159|NCT04666272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111462160|NCT04666272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111462161|NCT04649060|Dexamethasone|dexamethasone|mesh-list
111462162|NCT04649060|Melphalan|melphalan|mesh-list
111462163|NCT04649060|Daratumumab|daratumumab|mesh-list
111462164|NCT04649060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111462165|NCT04649060|Antiemetics|antiemetics|mesh-ancestor
111462166|NCT04649060|Autonomic Agents|autonomic agents|mesh-ancestor
111462167|NCT04649060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111462168|NCT04649060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111462169|NCT04649060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111462170|NCT04649060|Glucocorticoids|glucocorticoids|mesh-ancestor
111462171|NCT04649060|Hormones|hormones|mesh-ancestor
111462172|NCT04649060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111462173|NCT04649060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111462174|NCT04649060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111462175|NCT04649060|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111462176|NCT04649060|Alkylating Agents|alkylating agents|mesh-ancestor
111462177|NCT04649060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111462178|NCT04649060|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111462179|NCT04649060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111462180|NCT04649060|Immunologic Factors|immunologic factors|mesh-ancestor
111462181|NCT04608487|Cyclophosphamide|cyclophosphamide|mesh-list
111462182|NCT04608487|Fludarabine|fludarabine|mesh-list
111462183|NCT04608487|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
111462184|NCT04608487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111462185|NCT04608487|Immunologic Factors|immunologic factors|mesh-ancestor
111462186|NCT04608487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111462187|NCT04608487|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111462188|NCT04608487|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111462189|NCT04608487|Alkylating Agents|alkylating agents|mesh-ancestor
111462190|NCT04608487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111462191|NCT04608487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111462192|NCT04608487|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111479303|NCT05028075|Cobalt|cobalt|mesh-list
111462193|NCT04608487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111462194|NCT04602767|Phenylephrine|phenylephrine|mesh-list
111462195|NCT04602767|Vasopressins|vasopressins|mesh-list
111462196|NCT04602767|Arginine Vasopressin|arginine vasopressin|mesh-list
111462197|NCT04602767|Oxymetazoline|oxymetazoline|mesh-list
111462198|NCT04602767|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111462199|NCT04602767|Mydriatics|mydriatics|mesh-ancestor
111462200|NCT04602767|Autonomic Agents|autonomic agents|mesh-ancestor
111462201|NCT04602767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111462202|NCT04602767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111462203|NCT04602767|Sympathomimetics|sympathomimetics|mesh-ancestor
111462204|NCT04602767|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111462205|NCT04602767|Nasal Decongestants|nasal decongestants|mesh-ancestor
111462206|NCT04602767|Respiratory System Agents|respiratory system agents|mesh-ancestor
111462207|NCT04602767|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111462208|NCT04602767|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111462209|NCT04602767|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111462210|NCT04602767|Adrenergic Agents|adrenergic agents|mesh-ancestor
111462211|NCT04602767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111462212|NCT04602767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111462213|NCT04602767|Protective Agents|protective agents|mesh-ancestor
111462214|NCT04602767|Hemostatics|hemostatics|mesh-ancestor
111462215|NCT04602767|Coagulants|coagulants|mesh-ancestor
111462216|NCT04602767|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
111462217|NCT04602767|Natriuretic Agents|natriuretic agents|mesh-ancestor
111462218|NCT04581447|Metformin|metformin|mesh-list
111462219|NCT04581447|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111462220|NCT04581447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111462221|NCT04520685|Cannabidiol|cannabidiol|mesh-list
111462222|NCT04520685|Anticonvulsants|anticonvulsants|mesh-ancestor
111462223|NCT04519151|Pembrolizumab|pembrolizumab|mesh-list
111462224|NCT04519151|Lenvatinib|lenvatinib|mesh-list
111462225|NCT04519151|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111462226|NCT04519151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111462227|NCT04519151|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111462228|NCT04519151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111462229|NCT04519151|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111462230|NCT04519151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111462231|NCT04511650|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111462232|NCT04506372|Enzyme Inhibitors|enzyme inhibitors|mesh-list
111462233|NCT04506372|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
111462234|NCT04506372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111462235|NCT04506372|Protease Inhibitors|protease inhibitors|mesh-ancestor
111462236|NCT04497012|Iron|iron|mesh-list
111462237|NCT04497012|Trace Elements|trace elements|mesh-ancestor
111462238|NCT04497012|Micronutrients|micronutrients|mesh-ancestor
111462239|NCT04497012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111462240|NCT04484259|Aspirin|aspirin|mesh-list
111462241|NCT04484259|Clopidogrel|clopidogrel|mesh-list
111462242|NCT04484259|Ticagrelor|ticagrelor|mesh-list
111462243|NCT04484259|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111462244|NCT04484259|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111462245|NCT04484259|Analgesics|analgesics|mesh-ancestor
111462246|NCT04484259|Sensory System Agents|sensory system agents|mesh-ancestor
111462247|NCT04484259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111462248|NCT04484259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111462249|NCT04484259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111462250|NCT04484259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111462251|NCT04484259|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111462252|NCT04484259|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111462253|NCT04484259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111462254|NCT04484259|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111462255|NCT04484259|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111462256|NCT04484259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111462257|NCT04484259|Antipyretics|antipyretics|mesh-ancestor
111462258|NCT04484259|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111462259|NCT04484259|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111462260|NCT04484259|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111462261|NCT04484259|Purinergic Agents|purinergic agents|mesh-ancestor
111462262|NCT04484259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111462263|NCT04463693|Etonogestrel|etonogestrel|mesh-list
111462264|NCT04463693|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111462265|NCT04463693|Contraceptive Agents|contraceptive agents|mesh-ancestor
111462266|NCT04463693|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111462267|NCT04463693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111186415|NCT00049036|Prednisone|prednisone|mesh-list
111479304|NCT05028075|Trace Elements|trace elements|mesh-ancestor
111462268|NCT04463693|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111462269|NCT04392011|Midazolam|midazolam|mesh-list
111462270|NCT04392011|Dextromethorphan|dextromethorphan|mesh-list
111462271|NCT04392011|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111462272|NCT04392011|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111462273|NCT04392011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111462274|NCT04392011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111462275|NCT04392011|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111462276|NCT04392011|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111462277|NCT04392011|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111462278|NCT04392011|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111462279|NCT04392011|Anesthetics, General|anesthetics, general|mesh-ancestor
111462280|NCT04392011|Anesthetics|anesthetics|mesh-ancestor
111462281|NCT04392011|GABA Modulators|gaba modulators|mesh-ancestor
111462282|NCT04392011|GABA Agents|gaba agents|mesh-ancestor
111462283|NCT04392011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111462284|NCT04392011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111462285|NCT04392011|Antitussive Agents|antitussive agents|mesh-ancestor
111462286|NCT04392011|Respiratory System Agents|respiratory system agents|mesh-ancestor
110938781|NCT03050866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111462287|NCT04392011|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111462288|NCT04392011|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111462289|NCT04370301|Mycophenolic Acid|mycophenolic acid|mesh-list
111462290|NCT04370301|Cyclophosphamide|cyclophosphamide|mesh-list
111462291|NCT04370301|Melphalan|melphalan|mesh-list
111462292|NCT04370301|Mechlorethamine|mechlorethamine|mesh-list
111462293|NCT04370301|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
111462294|NCT04370301|Fludarabine|fludarabine|mesh-list
111462295|NCT04370301|Tacrolimus|tacrolimus|mesh-list
111462296|NCT04370301|Lenograstim|lenograstim|mesh-list
111462297|NCT04370301|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
111462298|NCT04370301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111462299|NCT04370301|Immunologic Factors|immunologic factors|mesh-ancestor
111462300|NCT04370301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111462301|NCT04370301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111462302|NCT04370301|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111462303|NCT04370301|Alkylating Agents|alkylating agents|mesh-ancestor
111462304|NCT04370301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111462305|NCT04370301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111462306|NCT04370301|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111462307|NCT04370301|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111462308|NCT04370301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111462309|NCT04370301|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111462310|NCT04370301|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111462311|NCT04370301|Antitubercular Agents|antitubercular agents|mesh-ancestor
111462312|NCT04370301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111462313|NCT04370301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111462314|NCT04370301|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111462315|NCT04370301|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111462316|NCT04348916|Pembrolizumab|pembrolizumab|mesh-list
111462317|NCT04348916|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111462318|NCT04348916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111462319|NCT04348916|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111462320|NCT04348916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111462321|NCT04299113|Vinorelbine|vinorelbine|mesh-list
111462322|NCT04299113|Mocetinostat|mocetinostat|mesh-list
111462323|NCT04299113|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111462324|NCT04299113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111462325|NCT04299113|Tubulin Modulators|tubulin modulators|mesh-ancestor
111462326|NCT04299113|Antimitotic Agents|antimitotic agents|mesh-ancestor
111462327|NCT04299113|Mitosis Modulators|mitosis modulators|mesh-ancestor
111462328|NCT04299113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111462329|NCT04299113|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111462330|NCT04299113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111462331|NCT04291001|Ulipristal acetate|ulipristal acetate|mesh-list
111462332|NCT04291001|Etonogestrel|etonogestrel|mesh-list
111462333|NCT04291001|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111462334|NCT04291001|Contraceptive Agents|contraceptive agents|mesh-ancestor
111462335|NCT04291001|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111462336|NCT04291001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111462337|NCT04291001|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111462338|NCT04285580|Bimatoprost|bimatoprost|mesh-list
111462339|NCT04285580|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111462340|NCT04272606|Tranexamic Acid|tranexamic acid|mesh-list
111462341|NCT04272606|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111462342|NCT04272606|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111479305|NCT05028075|Micronutrients|micronutrients|mesh-ancestor
111462343|NCT04272606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111462345|NCT04272606|Coagulants|coagulants|mesh-ancestor
111462346|NCT04245371|Lidocaine|lidocaine|mesh-list
111462347|NCT04245371|Anesthetics, Local|anesthetics, local|mesh-ancestor
111462348|NCT04245371|Anesthetics|anesthetics|mesh-ancestor
111462349|NCT04245371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111462350|NCT04245371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111462351|NCT04245371|Sensory System Agents|sensory system agents|mesh-ancestor
111462352|NCT04245371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111462353|NCT04245371|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111462354|NCT04245371|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111462355|NCT04245371|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111462356|NCT04245371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111462357|NCT04245371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111462358|NCT04231539|Nicotine|nicotine|mesh-list
111462359|NCT04231539|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111462360|NCT04231539|Autonomic Agents|autonomic agents|mesh-ancestor
111462361|NCT04231539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111462362|NCT04231539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111462363|NCT04231539|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111462364|NCT04231539|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111462365|NCT04231539|Cholinergic Agents|cholinergic agents|mesh-ancestor
111462366|NCT04231539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111462367|NCT04231539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111462368|NCT04200313|Pancrelipase|pancrelipase|mesh-list
111462369|NCT04200313|Pancreatin|pancreatin|mesh-list
111462370|NCT04200313|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111462371|NCT04200248|Aflibercept|aflibercept|mesh-list
111462372|NCT04200248|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111462373|NCT04200248|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111462374|NCT04200248|Growth Substances|growth substances|mesh-ancestor
111462375|NCT04200248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111462376|NCT04200248|Growth Inhibitors|growth inhibitors|mesh-ancestor
111462377|NCT04200248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111462378|NCT04137887|Vaccines|vaccines|mesh-list
111462379|NCT04137887|Immunologic Factors|immunologic factors|mesh-ancestor
111462380|NCT04137887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111462381|NCT04095273|Pembrolizumab|pembrolizumab|mesh-list
111462382|NCT04095273|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111462383|NCT04095273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111462384|NCT04095273|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111462385|NCT04095273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111462386|NCT03992131|Rucaparib|rucaparib|mesh-list
111462387|NCT03992131|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
111462388|NCT03992131|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111462389|NCT03992131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111462390|NCT03992131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111462391|NCT03992131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111462392|NCT03992131|Immunoconjugates|immunoconjugates|mesh-ancestor
111462393|NCT03992131|Immunologic Factors|immunologic factors|mesh-ancestor
111462394|NCT03992131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111462395|NCT03954366|Rucaparib|rucaparib|mesh-list
111462396|NCT03954366|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111462397|NCT03954366|Contraceptive Agents|contraceptive agents|mesh-list
111462398|NCT03954366|Contraceptives, Oral|contraceptives, oral|mesh-list
111462399|NCT03954366|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111462400|NCT03954366|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111462401|NCT03954366|Antimetabolites|antimetabolites|mesh-ancestor
111462402|NCT03954366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111462403|NCT03954366|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111462404|NCT03954366|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111462405|NCT03954366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111462406|NCT03954366|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111462407|NCT03954366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111462408|NCT03954366|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111462409|NCT03954366|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111462410|NCT03954366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111462411|NCT03923270|Durvalumab|durvalumab|mesh-list
111462412|NCT03923270|Olaparib|olaparib|mesh-list
111462413|NCT03923270|Tremelimumab|tremelimumab|mesh-list
111462414|NCT03923270|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111462415|NCT03923270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110959272|NCT00545324|Dermatologic Agents|dermatologic agents|mesh-ancestor
111462416|NCT03923270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111462417|NCT03923270|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111462418|NCT03923270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111462419|NCT03923270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111462420|NCT03923270|Immunologic Factors|immunologic factors|mesh-ancestor
111462421|NCT03923270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111462422|NCT03912220|Niacinamide|niacinamide|mesh-list
111462423|NCT03912220|Niacin|niacin|mesh-list
111462424|NCT03912220|Nicotinic Acids|nicotinic acids|mesh-list
111462425|NCT03912220|Vitamin B Complex|vitamin b complex|mesh-ancestor
111462426|NCT03912220|Vitamins|vitamins|mesh-ancestor
111462427|NCT03912220|Micronutrients|micronutrients|mesh-ancestor
111462428|NCT03912220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111462429|NCT03912220|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111462430|NCT03912220|Antimetabolites|antimetabolites|mesh-ancestor
111462431|NCT03912220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111462432|NCT03912220|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111462433|NCT03912220|Vasodilator Agents|vasodilator agents|mesh-ancestor
111462434|NCT03872791|Paclitaxel|paclitaxel|mesh-list
111462435|NCT03872791|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111462436|NCT03872791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111462437|NCT03872791|Tubulin Modulators|tubulin modulators|mesh-ancestor
111462438|NCT03872791|Antimitotic Agents|antimitotic agents|mesh-ancestor
111462439|NCT03872791|Mitosis Modulators|mitosis modulators|mesh-ancestor
111462440|NCT03872791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111462441|NCT03864042|Losartan|losartan|mesh-list
111462442|NCT03864042|Midazolam|midazolam|mesh-list
111462443|NCT03864042|Dextromethorphan|dextromethorphan|mesh-list
111462444|NCT03864042|Caffeine|caffeine|mesh-list
111462445|NCT03864042|Modafinil|modafinil|mesh-list
111462446|NCT03864042|Bupropion|bupropion|mesh-list
111462447|NCT03864042|Omeprazole|omeprazole|mesh-list
111462448|NCT03864042|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111462449|NCT03864042|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111462450|NCT03864042|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111462451|NCT03864042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111462452|NCT03864042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111462453|NCT03864042|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111462454|NCT03864042|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111462455|NCT03864042|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111462456|NCT03864042|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111462457|NCT03864042|Anesthetics, General|anesthetics, general|mesh-ancestor
111462458|NCT03864042|Anesthetics|anesthetics|mesh-ancestor
111462459|NCT03864042|GABA Modulators|gaba modulators|mesh-ancestor
111462460|NCT03864042|GABA Agents|gaba agents|mesh-ancestor
111462461|NCT03864042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111462462|NCT03864042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111462463|NCT03864042|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111462464|NCT03864042|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111462465|NCT03864042|Antimetabolites|antimetabolites|mesh-ancestor
111462466|NCT03864042|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111462467|NCT03864042|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111462468|NCT03864042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111462469|NCT03864042|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111462470|NCT03864042|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111462471|NCT03864042|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111462472|NCT03864042|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111462473|NCT03864042|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111462474|NCT03864042|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111462475|NCT03864042|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
111462476|NCT03864042|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111462477|NCT03864042|Purinergic Agents|purinergic agents|mesh-ancestor
111462478|NCT03864042|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111462479|NCT03864042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111462480|NCT03864042|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111462481|NCT03864042|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111462482|NCT03864042|Antidepressive Agents|antidepressive agents|mesh-ancestor
111462483|NCT03864042|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111462484|NCT03864042|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111462485|NCT03864042|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111462486|NCT03864042|Dopamine Agents|dopamine agents|mesh-ancestor
111462487|NCT03864042|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111462488|NCT03864042|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111462489|NCT03864042|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
111462490|NCT03864042|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111462491|NCT03864042|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111462492|NCT03864042|Antitussive Agents|antitussive agents|mesh-ancestor
111462493|NCT03864042|Respiratory System Agents|respiratory system agents|mesh-ancestor
111462494|NCT03864042|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111462495|NCT03864042|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111462496|NCT03737604|Bupivacaine|bupivacaine|mesh-list
111462497|NCT03737604|Ropivacaine|ropivacaine|mesh-list
111462498|NCT03737604|Anesthetics, Local|anesthetics, local|mesh-ancestor
111462499|NCT03737604|Anesthetics|anesthetics|mesh-ancestor
111462500|NCT03737604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111462501|NCT03737604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111462502|NCT03737604|Sensory System Agents|sensory system agents|mesh-ancestor
111462503|NCT03737604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111462504|NCT03676504|Cyclophosphamide|cyclophosphamide|mesh-list
111462505|NCT03676504|Fludarabine|fludarabine|mesh-list
111462506|NCT03676504|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111462507|NCT03676504|Immunologic Factors|immunologic factors|mesh-ancestor
111462508|NCT03676504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111462509|NCT03676504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111462510|NCT03676504|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111462511|NCT03676504|Alkylating Agents|alkylating agents|mesh-ancestor
111462512|NCT03676504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111462513|NCT03676504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111462514|NCT03676504|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111462516|NCT03600155|Ipilimumab|ipilimumab|mesh-list
111462517|NCT03600155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111462518|NCT03600155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111462519|NCT03600155|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111462520|NCT03600155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111462521|NCT03597594|Fludarabine|fludarabine|mesh-list
111462522|NCT03597594|Busulfan|busulfan|mesh-list
111462523|NCT03597594|Thiotepa|thiotepa|mesh-list
111462524|NCT03597594|Thymoglobulin|thymoglobulin|mesh-list
111462525|NCT03597594|Antilymphocyte Serum|antilymphocyte serum|mesh-list
111462526|NCT03597594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111462527|NCT03597594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111462528|NCT03597594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111462529|NCT03597594|Immunologic Factors|immunologic factors|mesh-ancestor
111462530|NCT03597594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111462531|NCT03597594|Alkylating Agents|alkylating agents|mesh-ancestor
111462532|NCT03597594|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111462533|NCT03597594|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111462534|NCT03563690|Celecoxib|celecoxib|mesh-list
111462535|NCT03563690|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111462536|NCT03563690|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111462537|NCT03563690|Analgesics|analgesics|mesh-ancestor
111462538|NCT03563690|Sensory System Agents|sensory system agents|mesh-ancestor
111462539|NCT03563690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111462540|NCT03563690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111462541|NCT03563690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111462542|NCT03563690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111462543|NCT03563690|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111462544|NCT03563690|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111462545|NCT03563690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111462546|NCT03563690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111462547|NCT03557008|Metronidazole|metronidazole|mesh-list
111462548|NCT03557008|Vancomycin|vancomycin|mesh-list
111462549|NCT03557008|Neomycin|neomycin|mesh-list
111462550|NCT03557008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111462551|NCT03557008|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111462552|NCT03557008|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111462553|NCT03557008|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111462554|NCT03557008|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111462555|NCT03557008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111462556|NCT03557008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111462557|NCT03404193|Decitabine|decitabine|mesh-list
111462558|NCT03404193|Venetoclax|venetoclax|mesh-list
111462559|NCT03404193|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111462560|NCT03404193|Antimetabolites|antimetabolites|mesh-ancestor
111462561|NCT03404193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111462562|NCT03404193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111462563|NCT03404193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111462564|NCT03395847|Pembrolizumab|pembrolizumab|mesh-list
111462565|NCT03395847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111462566|NCT03395847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111462567|NCT03395847|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111462568|NCT03395847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111462569|NCT03347617|Pembrolizumab|pembrolizumab|mesh-list
111462570|NCT03347617|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
111462571|NCT03347617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111462572|NCT03347617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111462573|NCT03347617|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111462574|NCT03347617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111462575|NCT03347617|Hematinics|hematinics|mesh-ancestor
111462576|NCT03347617|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
111462577|NCT03347617|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111462578|NCT03328273|Acalabrutinib|acalabrutinib|mesh-list
111462579|NCT03328273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111462580|NCT03178149|Tacrolimus|tacrolimus|mesh-list
111462581|NCT03178149|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111462582|NCT03178149|Immunologic Factors|immunologic factors|mesh-ancestor
111462583|NCT03178149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111462584|NCT03178149|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111462585|NCT03178149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111462586|NCT03178149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111462587|NCT03136029|Antioxidants|antioxidants|mesh-list
111462588|NCT03136029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111462589|NCT03136029|Protective Agents|protective agents|mesh-ancestor
111462590|NCT03136029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111462591|NCT03040999|Cisplatin|cisplatin|mesh-list
111462592|NCT03040999|Pembrolizumab|pembrolizumab|mesh-list
111462593|NCT03040999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111462594|NCT03040999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111462595|NCT03040999|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111462596|NCT03040999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111462597|NCT02990338|Dexamethasone|dexamethasone|mesh-list
111462598|NCT02990338|Pomalidomide|pomalidomide|mesh-list
111462599|NCT02990338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111462600|NCT02990338|Antiemetics|antiemetics|mesh-ancestor
111462601|NCT02990338|Autonomic Agents|autonomic agents|mesh-ancestor
111462602|NCT02990338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111462603|NCT02990338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111462604|NCT02990338|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111462605|NCT02990338|Glucocorticoids|glucocorticoids|mesh-ancestor
111462606|NCT02990338|Hormones|hormones|mesh-ancestor
111462607|NCT02990338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111462608|NCT02990338|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111462609|NCT02990338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111462610|NCT02990338|Immunologic Factors|immunologic factors|mesh-ancestor
111462611|NCT02990338|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111462612|NCT02990338|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111462613|NCT02990338|Growth Substances|growth substances|mesh-ancestor
111462614|NCT02990338|Growth Inhibitors|growth inhibitors|mesh-ancestor
111462615|NCT02787369|Idelalisib|idelalisib|mesh-list
111462616|NCT02787369|Ricolinostat|ricolinostat|mesh-list
111462617|NCT02787369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111462618|NCT02787369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110939117|NCT02522858|Mydriatics|mydriatics|mesh-ancestor
111462619|NCT02787369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111462620|NCT02787369|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111462621|NCT02366728|Temozolomide|temozolomide|mesh-list
111462622|NCT02366728|Basiliximab|basiliximab|mesh-list
111462623|NCT02366728|Immunologic Factors|immunologic factors|mesh-ancestor
111462624|NCT02366728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111462625|NCT02366728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111462626|NCT02366728|Alkylating Agents|alkylating agents|mesh-ancestor
111462627|NCT02366728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111462628|NCT02366728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111462629|NCT02366728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111462630|NCT02333370|Tamoxifen|tamoxifen|mesh-list
111462631|NCT02333370|Letrozole|letrozole|mesh-list
111462632|NCT02333370|Fulvestrant|fulvestrant|mesh-list
111462633|NCT02333370|Goserelin|goserelin|mesh-list
111462634|NCT02333370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111462635|NCT02333370|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111462636|NCT02333370|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111462637|NCT02333370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111462638|NCT02333370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111462639|NCT02333370|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111462640|NCT02333370|Hormone Antagonists|hormone antagonists|mesh-ancestor
111462641|NCT02333370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111462642|NCT02333370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111462643|NCT02333370|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111462644|NCT02333370|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111462645|NCT02333370|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111462646|NCT02333370|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111462647|NCT02333370|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
111462648|NCT02303444|Sorafenib|sorafenib|mesh-list
111462649|NCT02303444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111462650|NCT02303444|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111462651|NCT02303444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111462652|NCT02303444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111462653|NCT02246920|Fluticasone|fluticasone|mesh-list
111462654|NCT02246920|Xhance|xhance|mesh-list
111462655|NCT02246920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111462656|NCT02246920|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111462657|NCT02246920|Autonomic Agents|autonomic agents|mesh-ancestor
111462658|NCT02246920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111462659|NCT02246920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111462660|NCT02246920|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111462661|NCT02246920|Respiratory System Agents|respiratory system agents|mesh-ancestor
111462662|NCT02246920|Dermatologic Agents|dermatologic agents|mesh-ancestor
111462663|NCT02246920|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111462664|NCT01832402|Fentanyl|fentanyl|mesh-list
111462665|NCT01832402|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111462666|NCT01832402|Narcotics|narcotics|mesh-ancestor
111462667|NCT01832402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111462668|NCT01832402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111462669|NCT01832402|Analgesics|analgesics|mesh-ancestor
111462670|NCT01832402|Sensory System Agents|sensory system agents|mesh-ancestor
111462671|NCT01832402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111462672|NCT01832402|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111462673|NCT01832402|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111462674|NCT01832402|Anesthetics, General|anesthetics, general|mesh-ancestor
111462675|NCT01832402|Anesthetics|anesthetics|mesh-ancestor
111462676|NCT01661881|Cytarabine|cytarabine|mesh-list
111462677|NCT01661881|Rituximab|rituximab|mesh-list
111462678|NCT01661881|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
111462679|NCT01661881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111462680|NCT01661881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111462681|NCT01661881|Immunologic Factors|immunologic factors|mesh-ancestor
111462682|NCT01661881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111462683|NCT01661881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111462684|NCT01661881|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111462685|NCT01661881|Antimetabolites|antimetabolites|mesh-ancestor
111462686|NCT01661881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111462687|NCT01661881|Antiviral Agents|antiviral agents|mesh-ancestor
111462688|NCT01661881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111462689|NCT01661881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111462690|NCT01661881|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111462691|NCT01661881|Alkylating Agents|alkylating agents|mesh-ancestor
111462692|NCT01473628|Rituximab|rituximab|mesh-list
111462693|NCT01473628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111462694|NCT01473628|Antibodies|antibodies|mesh-list
111462695|NCT01473628|Immunoglobulins|immunoglobulins|mesh-list
111462696|NCT01473628|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111462697|NCT01473628|Immunologic Factors|immunologic factors|mesh-ancestor
111462698|NCT01473628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111462699|NCT01473628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111462700|NCT01473628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111462701|NCT01210625|Psyllium|psyllium|mesh-list
111462702|NCT01210625|Cathartics|cathartics|mesh-ancestor
111462703|NCT01210625|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111462704|NCT01009190|Carboplatin|carboplatin|mesh-list
111462705|NCT01009190|Rucaparib|rucaparib|mesh-list
111462706|NCT01009190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111462707|NCT01009190|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111462708|NCT01009190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111462709|NCT01009190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111462710|NCT00321555|Immunotoxins|immunotoxins|mesh-list
111462711|NCT00321555|Immunoconjugates|immunoconjugates|mesh-ancestor
111462712|NCT00321555|Immunologic Factors|immunologic factors|mesh-ancestor
111462713|NCT00321555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111462714|NCT00003653|Leuprolide|leuprolide|mesh-list
111462715|NCT00003653|Goserelin|goserelin|mesh-list
111462716|NCT00003653|Flutamide|flutamide|mesh-list
110959273|NCT00545324|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111462717|NCT00003653|Bicalutamide|bicalutamide|mesh-list
111462718|NCT00003653|Cyproterone Acetate|cyproterone acetate|mesh-list
111462719|NCT00003653|Nilutamide|nilutamide|mesh-list
111462720|NCT00003653|Buserelin|buserelin|mesh-list
111462721|NCT00003653|Cyproterone|cyproterone|mesh-list
111462722|NCT00003653|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111462723|NCT00003653|Fertility Agents|fertility agents|mesh-ancestor
111462724|NCT00003653|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111462725|NCT00003653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111462726|NCT00003653|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111462727|NCT00003653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111462728|NCT00003653|Androgen Antagonists|androgen antagonists|mesh-ancestor
111462729|NCT00003653|Hormone Antagonists|hormone antagonists|mesh-ancestor
111462730|NCT00003653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111462731|NCT00003653|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
111462732|NCT00003653|Contraceptive Agents|contraceptive agents|mesh-ancestor
111462733|NCT00003671|Leucovorin|leucovorin|mesh-list
111462734|NCT00003671|Cytarabine|cytarabine|mesh-list
111462735|NCT00003671|Dexamethasone|dexamethasone|mesh-list
111462736|NCT00003671|Cyclophosphamide|cyclophosphamide|mesh-list
111462737|NCT00003671|Methotrexate|methotrexate|mesh-list
111462738|NCT00003671|Vincristine|vincristine|mesh-list
111462739|NCT00003671|Daunorubicin|daunorubicin|mesh-list
111462740|NCT00003671|Asparaginase|asparaginase|mesh-list
111462741|NCT00003671|Mercaptopurine|mercaptopurine|mesh-list
111462742|NCT00003671|Thioguanine|thioguanine|mesh-list
111462743|NCT00003671|Levoleucovorin|levoleucovorin|mesh-list
111462744|NCT00003671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111462745|NCT00003671|Immunologic Factors|immunologic factors|mesh-ancestor
111462746|NCT00003671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111462747|NCT00003671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111462748|NCT00003671|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111462749|NCT00003671|Alkylating Agents|alkylating agents|mesh-ancestor
111462750|NCT00003671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111462751|NCT00003671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111462752|NCT00003671|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111462753|NCT00003671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111462754|NCT00003671|Antiemetics|antiemetics|mesh-ancestor
111462755|NCT00003671|Autonomic Agents|autonomic agents|mesh-ancestor
111462756|NCT00003671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111462757|NCT00003671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111462758|NCT00003671|Glucocorticoids|glucocorticoids|mesh-ancestor
111462759|NCT00003671|Hormones|hormones|mesh-ancestor
111462760|NCT00003671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111462761|NCT00003671|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111462762|NCT00003671|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111462763|NCT00003671|Abortifacient Agents|abortifacient agents|mesh-ancestor
111462764|NCT00003671|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111462765|NCT00003671|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111462766|NCT00003671|Antimetabolites|antimetabolites|mesh-ancestor
111462767|NCT00003671|Dermatologic Agents|dermatologic agents|mesh-ancestor
111462768|NCT00003671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111462769|NCT00003671|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111462770|NCT00003671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111462771|NCT00003671|Antiviral Agents|antiviral agents|mesh-ancestor
111462772|NCT00003671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111462773|NCT00003671|Antidotes|antidotes|mesh-ancestor
111462774|NCT00003671|Protective Agents|protective agents|mesh-ancestor
111462775|NCT00003671|Vitamin B Complex|vitamin b complex|mesh-ancestor
111462776|NCT00003671|Vitamins|vitamins|mesh-ancestor
111462777|NCT00003671|Micronutrients|micronutrients|mesh-ancestor
111462778|NCT00003671|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111462779|NCT00003671|Tubulin Modulators|tubulin modulators|mesh-ancestor
111462780|NCT00003671|Antimitotic Agents|antimitotic agents|mesh-ancestor
111462781|NCT00003671|Mitosis Modulators|mitosis modulators|mesh-ancestor
111462782|NCT00003671|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111462783|NCT00003671|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111462784|NCT00003671|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111462785|NCT00003677|Dolastatin 10|dolastatin 10|mesh-list
111462786|NCT00003677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111462787|NCT00003677|Tubulin Modulators|tubulin modulators|mesh-ancestor
111462788|NCT00003677|Antimitotic Agents|antimitotic agents|mesh-ancestor
111462789|NCT00003677|Mitosis Modulators|mitosis modulators|mesh-ancestor
111462790|NCT00003677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111462791|NCT00384605|N-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|n-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|mesh-list
111462792|NCT00384605|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
111462793|NCT00384605|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
111462794|NCT00384605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111462795|NCT00384605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111462796|NCT00384605|Hormones|hormones|mesh-ancestor
111462797|NCT00384605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111462798|NCT00384605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111462799|NCT00003683|Doxorubicin|doxorubicin|mesh-list
111462800|NCT00003683|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111462801|NCT00003683|Ifosfamide|ifosfamide|mesh-list
111462802|NCT00003683|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111462803|NCT00003683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111462804|NCT00003683|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111462805|NCT00003683|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111462806|NCT00003683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111462807|NCT00003683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111462808|NCT00003683|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111462809|NCT00003683|Alkylating Agents|alkylating agents|mesh-ancestor
111462810|NCT00003707|Gemcitabine|gemcitabine|mesh-list
111462811|NCT00003707|Tipifarnib|tipifarnib|mesh-list
111462812|NCT00003707|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111462813|NCT00003707|Antimetabolites|antimetabolites|mesh-ancestor
111462814|NCT00003707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111462815|NCT00003707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111462816|NCT00003719|Irinotecan|irinotecan|mesh-list
111462817|NCT00003719|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111462818|NCT00003719|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111462819|NCT00003719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111462820|NCT00003719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111462821|NCT00003719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111462822|NCT00003725|Valrubicin|valrubicin|mesh-list
111462823|NCT00003725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111462824|NCT00003725|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111462825|NCT00003725|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111462826|NCT00003725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111462827|NCT00003725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111462828|NCT00003731|Temozolomide|temozolomide|mesh-list
111462829|NCT00003731|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111462830|NCT00003731|Alkylating Agents|alkylating agents|mesh-ancestor
111462831|NCT00003731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111462832|NCT00003731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111462833|NCT00003743|Aldesleukin|aldesleukin|mesh-list
111462834|NCT00003743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111462835|NCT00003743|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111462836|NCT00003743|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111462837|NCT00003743|Antiviral Agents|antiviral agents|mesh-ancestor
111462838|NCT00003743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111462839|NCT00384917|Ketoconazole|ketoconazole|mesh-list
111462840|NCT00384917|Antifungal Agents|antifungal agents|mesh-ancestor
111462841|NCT00384917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111462842|NCT00384917|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111462843|NCT00384917|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111462844|NCT00384917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111462845|NCT00384917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111462846|NCT00384917|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111462847|NCT00384917|Hormone Antagonists|hormone antagonists|mesh-ancestor
111462848|NCT00384917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111462849|NCT00384917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111462850|NCT00384917|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111462851|NCT05444153|Empagliflozin|empagliflozin|mesh-list
111462852|NCT05444153|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111462853|NCT05444153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111462854|NCT05444153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111462855|NCT05444153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111462856|NCT00003797|Gemcitabine|gemcitabine|mesh-list
111462857|NCT00003797|Trastuzumab|trastuzumab|mesh-list
111462858|NCT00003797|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111462859|NCT00003797|Antimetabolites|antimetabolites|mesh-ancestor
111462860|NCT00003797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111462861|NCT00003797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111462862|NCT00003797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111462863|NCT00003803|Gemcitabine|gemcitabine|mesh-list
111186996|NCT05383170|Pembrolizumab|pembrolizumab|mesh-list
111462864|NCT00003803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111462865|NCT00003803|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111462866|NCT00003803|Antimetabolites|antimetabolites|mesh-ancestor
111462867|NCT00003803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111462868|NCT00003815|Cytarabine|cytarabine|mesh-list
111462869|NCT00003815|Prednisolone|prednisolone|mesh-list
111462870|NCT00003815|Cyclophosphamide|cyclophosphamide|mesh-list
111462871|NCT00003815|Melphalan|melphalan|mesh-list
111462872|NCT00003815|Carmustine|carmustine|mesh-list
111462873|NCT00003815|Doxorubicin|doxorubicin|mesh-list
111462874|NCT00003815|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111462875|NCT00003815|Etoposide|etoposide|mesh-list
111462876|NCT00003815|Vincristine|vincristine|mesh-list
111462877|NCT00003815|Bleomycin|bleomycin|mesh-list
111462878|NCT00003815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111462879|NCT00003815|Immunologic Factors|immunologic factors|mesh-ancestor
111462880|NCT00003815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111462881|NCT00003815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111462882|NCT00003815|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111462883|NCT00003815|Alkylating Agents|alkylating agents|mesh-ancestor
111462884|NCT00003815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111462885|NCT00003815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111462886|NCT00003815|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110939395|NCT02048943|Tubulin Modulators|tubulin modulators|mesh-ancestor
111462887|NCT00003815|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111462888|NCT00003815|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111462889|NCT00003815|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111462890|NCT00003815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111462891|NCT00003815|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111462892|NCT00003815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111462893|NCT00003815|Antimetabolites|antimetabolites|mesh-ancestor
111462894|NCT00003815|Antiviral Agents|antiviral agents|mesh-ancestor
111462895|NCT00003815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111462896|NCT00003815|Tubulin Modulators|tubulin modulators|mesh-ancestor
111462897|NCT00003815|Antimitotic Agents|antimitotic agents|mesh-ancestor
111462898|NCT00003815|Mitosis Modulators|mitosis modulators|mesh-ancestor
111462899|NCT00003815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111462900|NCT00003815|Glucocorticoids|glucocorticoids|mesh-ancestor
111462901|NCT00003815|Hormones|hormones|mesh-ancestor
111462902|NCT00003815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111462903|NCT00003815|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111462904|NCT00003821|Aminopterin|aminopterin|mesh-list
111462905|NCT00003821|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111462906|NCT00003821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111462907|NCT00003821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111462908|NCT00003827|Cytarabine|cytarabine|mesh-list
111462909|NCT00003827|Topotecan|topotecan|mesh-list
111462910|NCT00003827|Amifostine|amifostine|mesh-list
111462911|NCT00003827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111462912|NCT00003827|Antimetabolites|antimetabolites|mesh-ancestor
111462913|NCT00003827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111462914|NCT00003827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111462915|NCT00003827|Antiviral Agents|antiviral agents|mesh-ancestor
111462916|NCT00003827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111462917|NCT00003827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111462918|NCT00003827|Immunologic Factors|immunologic factors|mesh-ancestor
111462919|NCT00003827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111462920|NCT00003827|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111462921|NCT00003827|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111462922|NCT00003827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111462923|NCT00003827|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111462924|NCT00003827|Protective Agents|protective agents|mesh-ancestor
111462925|NCT00003851|Gemcitabine|gemcitabine|mesh-list
111462926|NCT00003851|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111462927|NCT00003851|Antimetabolites|antimetabolites|mesh-ancestor
111462928|NCT00003851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111462929|NCT00003851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111462930|NCT00003881|Paclitaxel|paclitaxel|mesh-list
111462931|NCT00003881|Carboplatin|carboplatin|mesh-list
111462932|NCT00003881|Trastuzumab|trastuzumab|mesh-list
111462933|NCT00003881|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111462934|NCT00003881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111462935|NCT00003881|Tubulin Modulators|tubulin modulators|mesh-ancestor
111462936|NCT00003881|Antimitotic Agents|antimitotic agents|mesh-ancestor
111462937|NCT00003881|Mitosis Modulators|mitosis modulators|mesh-ancestor
111187070|NCT05144542|Nicotine|nicotine|mesh-list
111462938|NCT00003881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111462939|NCT00003881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111462940|NCT00003893|Cyclophosphamide|cyclophosphamide|mesh-list
111462942|NCT00003893|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111462943|NCT00003893|Fluorouracil|fluorouracil|mesh-list
111462944|NCT00003893|Methotrexate|methotrexate|mesh-list
111462945|NCT00003893|Epirubicin|epirubicin|mesh-list
111462946|NCT00003893|Mitoxantrone|mitoxantrone|mesh-list
111462947|NCT00003893|Mitomycins|mitomycins|mesh-list
111462948|NCT00003893|Mitomycin|mitomycin|mesh-list
111462949|NCT00003893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111462950|NCT00003893|Immunologic Factors|immunologic factors|mesh-ancestor
111462951|NCT00003893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111462952|NCT00003893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111462953|NCT00003893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111462954|NCT00003893|Alkylating Agents|alkylating agents|mesh-ancestor
111462955|NCT00003893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111462956|NCT00003893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111462957|NCT00003893|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110939460|NCT02049255|Anesthetics|anesthetics|mesh-ancestor
111462958|NCT00003893|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111462959|NCT00003893|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111462960|NCT00003893|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111462961|NCT00003893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111462962|NCT00003893|Antimetabolites|antimetabolites|mesh-ancestor
111462963|NCT00003893|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111462964|NCT00003893|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111462965|NCT00003893|Abortifacient Agents|abortifacient agents|mesh-ancestor
111462966|NCT00003893|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111462967|NCT00003893|Dermatologic Agents|dermatologic agents|mesh-ancestor
111462968|NCT00003893|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111462969|NCT00003893|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111462970|NCT00003893|Analgesics|analgesics|mesh-ancestor
111462971|NCT00003893|Sensory System Agents|sensory system agents|mesh-ancestor
111462972|NCT00003893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111462973|NCT00003899|Paclitaxel|paclitaxel|mesh-list
111462974|NCT00003899|Cyclophosphamide|cyclophosphamide|mesh-list
111462975|NCT00003899|Melphalan|melphalan|mesh-list
111462976|NCT00003899|Thiotepa|thiotepa|mesh-list
111462977|NCT00003899|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111462978|NCT00003899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111462979|NCT00003899|Tubulin Modulators|tubulin modulators|mesh-ancestor
111462980|NCT00003899|Antimitotic Agents|antimitotic agents|mesh-ancestor
111462981|NCT00003899|Mitosis Modulators|mitosis modulators|mesh-ancestor
111462982|NCT00003899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111462983|NCT00003899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111462984|NCT00003899|Immunologic Factors|immunologic factors|mesh-ancestor
111462985|NCT00003899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111462986|NCT00003899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111462987|NCT00003899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111462988|NCT00003899|Alkylating Agents|alkylating agents|mesh-ancestor
111462989|NCT00003899|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111462990|NCT00003917|Topotecan|topotecan|mesh-list
111462991|NCT00003917|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111462992|NCT00003917|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111462993|NCT00003917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111462994|NCT00003917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111462995|NCT00003917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111462996|NCT00003923|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
111462997|NCT00003923|Trioxsalen|trioxsalen|mesh-list
111462998|NCT00003923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111462999|NCT00003923|Dermatologic Agents|dermatologic agents|mesh-ancestor
111463000|NCT00003923|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111463001|NCT00003929|Lomustine|lomustine|mesh-list
111463002|NCT00003929|Procarbazine|procarbazine|mesh-list
111463003|NCT00003929|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111463004|NCT00003929|Alkylating Agents|alkylating agents|mesh-ancestor
111463005|NCT00003929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111463006|NCT00003929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111463007|NCT02210663|Veliparib|veliparib|mesh-list
111463008|NCT02210663|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111463009|NCT02210663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111463010|NCT02210663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111463011|NCT02210663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111463012|NCT04568837|Dexamethasone|dexamethasone|mesh-list
111463013|NCT04568837|Dexamethasone acetate|dexamethasone acetate|mesh-list
111463014|NCT04568837|Prednisone|prednisone|mesh-list
111463015|NCT04568837|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
111463016|NCT04568837|BB 1101|bb 1101|mesh-list
111463017|NCT04568837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111463018|NCT04568837|Antiemetics|antiemetics|mesh-ancestor
111463019|NCT04568837|Autonomic Agents|autonomic agents|mesh-ancestor
111463020|NCT04568837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111463021|NCT04568837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111463022|NCT04568837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111463023|NCT04568837|Glucocorticoids|glucocorticoids|mesh-ancestor
111463024|NCT04568837|Hormones|hormones|mesh-ancestor
111463025|NCT04568837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111463026|NCT04568837|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111463027|NCT04568837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111463028|NCT04568837|Protease Inhibitors|protease inhibitors|mesh-ancestor
111463029|NCT04568837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111463030|NCT04568837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111463031|NCT02210819|Rivaroxaban|rivaroxaban|mesh-list
111463032|NCT02210819|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111463033|NCT02210819|Antithrombins|antithrombins|mesh-ancestor
111463034|NCT02210819|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111463035|NCT02210819|Protease Inhibitors|protease inhibitors|mesh-ancestor
111463036|NCT02210819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111463037|NCT02210819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111463038|NCT02210819|Anticoagulants|anticoagulants|mesh-ancestor
111463039|NCT04564469|Furosemide|furosemide|mesh-list
111463040|NCT04564469|Diuretics|diuretics|mesh-ancestor
111463041|NCT04564469|Natriuretic Agents|natriuretic agents|mesh-ancestor
111463042|NCT04564469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111463043|NCT04564469|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
111463044|NCT04564469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111463045|NCT04564469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111463046|NCT04564001|Infliximab|infliximab|mesh-list
111463047|NCT04564001|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111463048|NCT04564001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111463049|NCT04564001|Dermatologic Agents|dermatologic agents|mesh-ancestor
111463050|NCT04564001|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111463051|NCT04564001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111463052|NCT04568603|Islatravir|islatravir|mesh-list
111463053|NCT04568603|Methadone|methadone|mesh-list
111463054|NCT04568603|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111463055|NCT04568603|Narcotics|narcotics|mesh-ancestor
111463056|NCT04568603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111463057|NCT04568603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111463058|NCT04568603|Analgesics|analgesics|mesh-ancestor
111463059|NCT04568603|Sensory System Agents|sensory system agents|mesh-ancestor
111463060|NCT04568603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111463061|NCT04568603|Antitussive Agents|antitussive agents|mesh-ancestor
111463062|NCT04568603|Respiratory System Agents|respiratory system agents|mesh-ancestor
111463063|NCT04568603|Antiviral Agents|antiviral agents|mesh-ancestor
111463064|NCT04568603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111463065|NCT04568603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111463066|NCT04568603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111463067|NCT04568603|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111463068|NCT04568603|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111463069|NCT04568603|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111463070|NCT04563299|Prednisolone|prednisolone|mesh-list
111463071|NCT04563299|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111463072|NCT04563299|Methylprednisolone|methylprednisolone|mesh-list
111463073|NCT04563299|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111463074|NCT04563299|Prednisolone acetate|prednisolone acetate|mesh-list
111463075|NCT04563299|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111463076|NCT04563299|Prednisolone phosphate|prednisolone phosphate|mesh-list
111463077|NCT04563299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111463078|NCT04563299|Glucocorticoids|glucocorticoids|mesh-ancestor
111463079|NCT04563299|Hormones|hormones|mesh-ancestor
111463080|NCT04563299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111463081|NCT04563299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111463082|NCT04563299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111463083|NCT04563299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111463084|NCT04563299|Antiemetics|antiemetics|mesh-ancestor
111463085|NCT04563299|Autonomic Agents|autonomic agents|mesh-ancestor
111463086|NCT04563299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111463087|NCT04563299|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111463088|NCT04563299|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111463089|NCT04563299|Protective Agents|protective agents|mesh-ancestor
111463090|NCT04561817|Paclitaxel|paclitaxel|mesh-list
111187238|NCT04926571|Hormones|hormones|mesh-ancestor
111463091|NCT04561817|Ipatasertib|ipatasertib|mesh-list
111463092|NCT04561817|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111463093|NCT04561817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111463094|NCT04561817|Tubulin Modulators|tubulin modulators|mesh-ancestor
111463095|NCT04561817|Antimitotic Agents|antimitotic agents|mesh-ancestor
111463096|NCT04561817|Mitosis Modulators|mitosis modulators|mesh-ancestor
111463097|NCT04561817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111463098|NCT04561817|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111463099|NCT04561817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111463100|NCT02211833|Pemetrexed|pemetrexed|mesh-list
111463101|NCT02211833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111463102|NCT02211833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111463103|NCT02211833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111463104|NCT02211833|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111463105|NCT02211833|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111463106|NCT02211443|Antibodies|antibodies|mesh-list
111463107|NCT02211443|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111463108|NCT02211443|Immunologic Factors|immunologic factors|mesh-ancestor
111463109|NCT02211443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111463110|NCT02211521|Hyaluronic Acid|hyaluronic acid|mesh-list
111463111|NCT02211521|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111463112|NCT02211521|Immunologic Factors|immunologic factors|mesh-ancestor
111463113|NCT02211521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111463114|NCT02211521|Viscosupplements|viscosupplements|mesh-ancestor
111463115|NCT02211521|Protective Agents|protective agents|mesh-ancestor
111463116|NCT01597908|Trametinib|trametinib|mesh-list
111463117|NCT01597908|Vemurafenib|vemurafenib|mesh-list
111463118|NCT01597908|Dabrafenib|dabrafenib|mesh-list
111463119|NCT01597908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111463120|NCT01597908|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111463121|NCT01597908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111463122|NCT01597908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111463123|NCT01948908|Midazolam|midazolam|mesh-list
111463124|NCT01948908|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111463125|NCT01948908|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111463126|NCT01948908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111463127|NCT01948908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111463128|NCT01948908|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111463129|NCT01948908|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111463130|NCT01948908|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111463131|NCT01948908|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111463132|NCT01948908|Anesthetics, General|anesthetics, general|mesh-ancestor
111463133|NCT01948908|Anesthetics|anesthetics|mesh-ancestor
111463134|NCT01948908|GABA Modulators|gaba modulators|mesh-ancestor
111463135|NCT01948908|GABA Agents|gaba agents|mesh-ancestor
111463136|NCT01948908|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111463137|NCT01948908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111463138|NCT01925274|Irinotecan|irinotecan|mesh-list
111463139|NCT01925274|Cetuximab|cetuximab|mesh-list
111463140|NCT01925274|Gedatolisib|gedatolisib|mesh-list
111463141|NCT01925274|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111463142|NCT01925274|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111463143|NCT01925274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111463144|NCT01925274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111463145|NCT01925274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111463146|NCT01925274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111463147|NCT01925274|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111463148|NCT01948830|Ranibizumab|ranibizumab|mesh-list
111463149|NCT01948830|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111463150|NCT01948830|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111463151|NCT01948830|Growth Substances|growth substances|mesh-ancestor
111463152|NCT01948830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111463153|NCT01948830|Growth Inhibitors|growth inhibitors|mesh-ancestor
111463154|NCT01948830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111463155|NCT01972464|Progesterone|progesterone|mesh-list
111463156|NCT01972464|Progestins|progestins|mesh-ancestor
111463157|NCT01972464|Hormones|hormones|mesh-ancestor
111463158|NCT01972464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111463159|NCT01972464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111463160|NCT01924182|Morphine|morphine|mesh-list
111463161|NCT01924182|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111463162|NCT01924182|Narcotics|narcotics|mesh-ancestor
111463163|NCT01924182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111463164|NCT01924182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111463165|NCT01924182|Analgesics|analgesics|mesh-ancestor
111463166|NCT01924182|Sensory System Agents|sensory system agents|mesh-ancestor
111463167|NCT01924182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111463168|NCT01946880|Mycophenolic Acid|mycophenolic acid|mesh-list
111463169|NCT01946880|Hydroxychloroquine|hydroxychloroquine|mesh-list
111463170|NCT01946880|Chloroquine|chloroquine|mesh-list
111463171|NCT01946880|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
111463173|NCT01946880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111463174|NCT01946880|Glucocorticoids|glucocorticoids|mesh-ancestor
111463175|NCT01946880|Hormones|hormones|mesh-ancestor
111463176|NCT01946880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111463177|NCT01946880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111463178|NCT01946880|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111463179|NCT01946880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111463180|NCT01946880|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111463181|NCT01946880|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111463182|NCT01946880|Antitubercular Agents|antitubercular agents|mesh-ancestor
111463183|NCT01946880|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111463184|NCT01946880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111463185|NCT01946880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111463186|NCT01946880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111463187|NCT01946880|Antimalarials|antimalarials|mesh-ancestor
111463188|NCT01946880|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111463189|NCT01946880|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111463190|NCT01946880|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111463191|NCT01946880|Amebicides|amebicides|mesh-ancestor
111463192|NCT01946880|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111463193|NCT01946880|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111463194|NCT01946880|Analgesics|analgesics|mesh-ancestor
111463195|NCT01946880|Sensory System Agents|sensory system agents|mesh-ancestor
111463196|NCT01946880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111463197|NCT01946880|Filaricides|filaricides|mesh-ancestor
111463198|NCT01946880|Antinematodal Agents|antinematodal agents|mesh-ancestor
111463199|NCT01946880|Anthelmintics|anthelmintics|mesh-ancestor
111463200|NCT01972152|Glucagon|glucagon|mesh-list
111463201|NCT01972152|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111463202|NCT01972152|Hormones|hormones|mesh-ancestor
111463203|NCT01972152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111463204|NCT01972152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111463205|NCT01972074|Memantine|memantine|mesh-list
111463206|NCT01972074|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111463207|NCT01972074|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111463208|NCT01972074|Dopamine Agents|dopamine agents|mesh-ancestor
111463209|NCT01972074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111463210|NCT01972074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111463211|NCT01972074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111463212|NCT01972074|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111463213|NCT01972074|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111463214|NCT01618266|Dexamethasone|dexamethasone|mesh-list
111463215|NCT01618266|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111463216|NCT01618266|Antiemetics|antiemetics|mesh-ancestor
111463217|NCT01618266|Autonomic Agents|autonomic agents|mesh-ancestor
111463218|NCT01618266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111463219|NCT01618266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111463220|NCT01618266|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111463221|NCT01618266|Glucocorticoids|glucocorticoids|mesh-ancestor
111463222|NCT01618266|Hormones|hormones|mesh-ancestor
111463223|NCT01618266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111463224|NCT01618266|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111463225|NCT01618266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111463226|NCT01918332|Valsartan|valsartan|mesh-list
111463227|NCT01918332|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111463228|NCT01918332|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111463229|NCT01918332|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111463230|NCT01918332|Antimetabolites|antimetabolites|mesh-ancestor
111463231|NCT01918332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111463232|NCT01918332|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111463233|NCT01918332|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111463234|NCT01918332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111463235|NCT01918332|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111463236|NCT01918332|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111463237|NCT01918332|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111463238|NCT01922934|Topiramate|topiramate|mesh-list
111463239|NCT01922934|Phentermine|phentermine|mesh-list
111463240|NCT01922934|Anticonvulsants|anticonvulsants|mesh-ancestor
111463241|NCT01922934|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111463242|NCT01922934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111463243|NCT01922934|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111463244|NCT01922934|Appetite Depressants|appetite depressants|mesh-ancestor
111463245|NCT01922934|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111463246|NCT01922934|Sympathomimetics|sympathomimetics|mesh-ancestor
111463247|NCT01922934|Autonomic Agents|autonomic agents|mesh-ancestor
111463248|NCT01922934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111463249|NCT01922934|Adrenergic Agents|adrenergic agents|mesh-ancestor
111463250|NCT01922934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111463251|NCT01922934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111463252|NCT01921140|Olaparib|olaparib|mesh-list
111463253|NCT01921140|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111463254|NCT01921140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111463255|NCT01921140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111463256|NCT01921140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111463257|NCT01917006|Botulinum Toxins|botulinum toxins|mesh-list
111463258|NCT01917006|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111463259|NCT01917006|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111463260|NCT01917006|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111463261|NCT01917006|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111463262|NCT01917006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111463263|NCT01917006|Cholinergic Agents|cholinergic agents|mesh-ancestor
111463264|NCT01917006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111463265|NCT01917006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111463266|NCT01917006|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111463267|NCT01917006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111463268|NCT01916226|Cetirizine|cetirizine|mesh-list
111463269|NCT01916226|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111463270|NCT01916226|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
111463271|NCT01916226|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111463272|NCT01916226|Histamine Antagonists|histamine antagonists|mesh-ancestor
111463273|NCT01916226|Histamine Agents|histamine agents|mesh-ancestor
111463274|NCT01916226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111463275|NCT01916226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111463276|NCT01916226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111463277|NCT01915914|Fluticasone|fluticasone|mesh-list
111463279|NCT01915914|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111463280|NCT01915914|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111463281|NCT01915914|Autonomic Agents|autonomic agents|mesh-ancestor
111463282|NCT01915914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111463283|NCT01915914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111463284|NCT01915914|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111463285|NCT01915914|Respiratory System Agents|respiratory system agents|mesh-ancestor
111463286|NCT01915914|Dermatologic Agents|dermatologic agents|mesh-ancestor
111463287|NCT01915914|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111463288|NCT01968954|Bococizumab|bococizumab|mesh-list
111463289|NCT01968954|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111463290|NCT01968954|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111463291|NCT01968954|Antimetabolites|antimetabolites|mesh-ancestor
111463292|NCT01968954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111463293|NCT01968954|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111463294|NCT01919190|Bupivacaine|bupivacaine|mesh-list
111463295|NCT01919190|Anesthetics, Local|anesthetics, local|mesh-ancestor
111463296|NCT01919190|Anesthetics|anesthetics|mesh-ancestor
111463297|NCT01919190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111463298|NCT01919190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111463299|NCT01919190|Sensory System Agents|sensory system agents|mesh-ancestor
111463300|NCT01919190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111463301|NCT01620060|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
111463302|NCT01620060|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111463303|NCT01620060|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111463304|NCT01620060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111463305|NCT01620060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111463306|NCT01620060|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111463307|NCT01620060|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
111463308|NCT01620060|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111463309|NCT01620060|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111463310|NCT01620060|Adrenergic Agents|adrenergic agents|mesh-ancestor
111463311|NCT01620060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111463312|NCT01620060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111463313|NCT01620060|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111463314|NCT01620060|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111187448|NCT04275180|Argatroban|argatroban|mesh-list
111463315|NCT01620060|Serotonin Agents|serotonin agents|mesh-ancestor
111463316|NCT01620060|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111463317|NCT01620060|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111463318|NCT01620060|Dopamine Agents|dopamine agents|mesh-ancestor
111463319|NCT01914666|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
111463320|NCT01914666|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111463321|NCT01914666|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111463322|NCT01914666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111463323|NCT01914666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111463324|NCT01914666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111463325|NCT01914666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111463326|NCT01914666|Analgesics|analgesics|mesh-ancestor
111463327|NCT01914666|Sensory System Agents|sensory system agents|mesh-ancestor
111463328|NCT01914666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111463329|NCT01914666|Antidepressive Agents|antidepressive agents|mesh-ancestor
111463330|NCT01914666|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111463331|NCT01914666|Dopamine Agents|dopamine agents|mesh-ancestor
111463332|NCT01913340|Epoetin Alfa|epoetin alfa|mesh-list
111463333|NCT01913340|Hematinics|hematinics|mesh-ancestor
111463334|NCT01912872|Omalizumab|omalizumab|mesh-list
111463335|NCT01912872|Budesonide|budesonide|mesh-list
111463336|NCT01912872|Formoterol Fumarate|formoterol fumarate|mesh-list
111463337|NCT01912872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111463338|NCT01912872|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111463339|NCT01912872|Autonomic Agents|autonomic agents|mesh-ancestor
111463340|NCT01912872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111463341|NCT01912872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111463342|NCT01912872|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111463343|NCT01912872|Respiratory System Agents|respiratory system agents|mesh-ancestor
111463344|NCT01912872|Glucocorticoids|glucocorticoids|mesh-ancestor
111463345|NCT01912872|Hormones|hormones|mesh-ancestor
111463346|NCT01912872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111463347|NCT01912872|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111463348|NCT01912872|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111463349|NCT01912872|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111463350|NCT01912872|Adrenergic Agents|adrenergic agents|mesh-ancestor
111463351|NCT01912872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111463352|NCT01912872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111463353|NCT01912872|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111463354|NCT01911780|Amlodipine|amlodipine|mesh-list
111463355|NCT01911780|Telmisartan|telmisartan|mesh-list
111463356|NCT01911780|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
111463357|NCT01911780|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111463358|NCT01911780|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111463359|NCT01911780|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111463360|NCT01911780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111463361|NCT01911780|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111463362|NCT01911780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111463363|NCT01911780|Vasodilator Agents|vasodilator agents|mesh-ancestor
111463364|NCT01911780|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111463365|NCT01911780|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111463366|NCT01911780|Diuretics|diuretics|mesh-ancestor
111463367|NCT01911780|Natriuretic Agents|natriuretic agents|mesh-ancestor
111463368|NCT01911780|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
111463369|NCT01911546|Everolimus|everolimus|mesh-list
111463370|NCT01911546|Tacrolimus|tacrolimus|mesh-list
111463371|NCT01911546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111463372|NCT01911546|Immunologic Factors|immunologic factors|mesh-ancestor
111463373|NCT01911546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111463374|NCT01911546|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111463375|NCT01911546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111463376|NCT01911546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111463377|NCT01911546|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111463378|NCT01911546|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111463379|NCT01911546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111463380|NCT01908816|Ranibizumab|ranibizumab|mesh-list
111463381|NCT01908816|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111463382|NCT01908816|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111463383|NCT01908816|Growth Substances|growth substances|mesh-ancestor
111463384|NCT01908816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111463385|NCT01908816|Growth Inhibitors|growth inhibitors|mesh-ancestor
111463386|NCT01908816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111463387|NCT01908582|Rifampin|rifampin|mesh-list
111463388|NCT01908582|Evacetrapib|evacetrapib|mesh-list
111463389|NCT01908582|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111463390|NCT01908582|Antitubercular Agents|antitubercular agents|mesh-ancestor
111463391|NCT01908582|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111463392|NCT01908582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111463393|NCT01908582|Leprostatic Agents|leprostatic agents|mesh-ancestor
111463394|NCT01908582|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111463395|NCT01908582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111463396|NCT01908582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111463397|NCT01908582|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111463398|NCT01908582|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111463399|NCT01908582|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
111463400|NCT01908582|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
111463401|NCT01908582|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
111463402|NCT01908582|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111463403|NCT01908582|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111463404|NCT01908582|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111463405|NCT01908582|Antimetabolites|antimetabolites|mesh-ancestor
111463406|NCT01908582|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111463408|NCT01907100|Pemetrexed|pemetrexed|mesh-list
111463409|NCT01907100|Nintedanib|nintedanib|mesh-list
111463410|NCT01907100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111463411|NCT01907100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111463412|NCT01907100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111463413|NCT01907100|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111463414|NCT01907100|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111463415|NCT01907100|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111463416|NCT01889862|Dextrans|dextrans|mesh-list
111463417|NCT01889862|Anticoagulants|anticoagulants|mesh-ancestor
111463418|NCT01889862|Plasma Substitutes|plasma substitutes|mesh-ancestor
111463419|NCT01889862|Blood Substitutes|blood substitutes|mesh-ancestor
111463420|NCT01887288|Capecitabine|capecitabine|mesh-list
111463421|NCT01887288|Digoxin|digoxin|mesh-list
111463422|NCT01887288|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111463423|NCT01887288|Antimetabolites|antimetabolites|mesh-ancestor
111463424|NCT01887288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111463425|NCT01887288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111463426|NCT01887288|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111463427|NCT01887288|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111463428|NCT01887288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111463429|NCT01887288|Protective Agents|protective agents|mesh-ancestor
111463430|NCT01887288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111463431|NCT03405714|Brivaracetam|brivaracetam|mesh-list
111463432|NCT03405714|Anticonvulsants|anticonvulsants|mesh-ancestor
111463433|NCT01885182|Oxycodone|oxycodone|mesh-list
111463434|NCT01885182|Naloxone|naloxone|mesh-list
111463435|NCT01885182|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111463436|NCT01885182|Narcotics|narcotics|mesh-ancestor
111463437|NCT01885182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111463438|NCT01885182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111463439|NCT01885182|Analgesics|analgesics|mesh-ancestor
111463440|NCT01885182|Sensory System Agents|sensory system agents|mesh-ancestor
111463441|NCT01885182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111463442|NCT01885182|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111463443|NCT01885104|Bisacodyl|bisacodyl|mesh-list
111463444|NCT01885104|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
111463445|NCT01885104|Laxatives|laxatives|mesh-list
111463446|NCT01885104|Cathartics|cathartics|mesh-ancestor
111463447|NCT01885104|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111463448|NCT01906008|Minocycline|minocycline|mesh-list
111463449|NCT01906008|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111463450|NCT01906008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111463451|NCT01904760|Dexmedetomidine|dexmedetomidine|mesh-list
111463452|NCT01904760|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111463453|NCT01904760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111463454|NCT01904760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111463455|NCT01904760|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111463456|NCT01904760|Analgesics|analgesics|mesh-ancestor
111463457|NCT01904760|Sensory System Agents|sensory system agents|mesh-ancestor
111463458|NCT01904760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111463459|NCT01904760|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111463460|NCT01904760|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111187594|NCT03979599|Levobupivacaine|levobupivacaine|mesh-list
111463461|NCT01904760|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111463462|NCT01904760|Adrenergic Agents|adrenergic agents|mesh-ancestor
111463463|NCT01904760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111463464|NCT01904760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111463465|NCT01904058|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
111463466|NCT01904058|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
111463467|NCT01904058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111463469|NCT01881126|Bimatoprost|bimatoprost|mesh-list
111463470|NCT01881126|Travoprost|travoprost|mesh-list
111463471|NCT01881126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111463472|NCT01881126|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111463473|NCT01881126|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111463474|NCT01881126|Adrenergic Agents|adrenergic agents|mesh-ancestor
111463475|NCT01881126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111463476|NCT01881126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111463477|NCT01881126|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111463478|NCT01881126|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111463479|NCT01880736|Insulin|insulin|mesh-list
111463480|NCT01880736|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111463481|NCT01880736|Insulin, Long-Acting|insulin, long-acting|mesh-list
111463482|NCT01880736|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111463483|NCT01880736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111463484|NCT01880424|Linaclotide|linaclotide|mesh-list
111463485|NCT01880424|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
111463486|NCT01880424|Enzyme Activators|enzyme activators|mesh-ancestor
111463487|NCT01880424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111463488|NCT01880424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111463489|NCT01862874|Vaccines|vaccines|mesh-list
111463490|NCT01862874|Immunologic Factors|immunologic factors|mesh-ancestor
111463491|NCT01862874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111463492|NCT01903434|Evacetrapib|evacetrapib|mesh-list
111463493|NCT01903434|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111463494|NCT01903434|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111463495|NCT01903434|Antimetabolites|antimetabolites|mesh-ancestor
111463496|NCT01903434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111463497|NCT01903434|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111463498|NCT01903356|Linagliptin|linagliptin|mesh-list
111463499|NCT01903356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111463500|NCT01903356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111463501|NCT01903356|Incretins|incretins|mesh-ancestor
111463502|NCT01903356|Hormones|hormones|mesh-ancestor
111463503|NCT01903356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111463504|NCT01903356|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111463505|NCT01903356|Protease Inhibitors|protease inhibitors|mesh-ancestor
111463506|NCT01903356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111463507|NCT01903356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111463508|NCT01862640|Brexpiprazole|brexpiprazole|mesh-list
111463509|NCT01862640|Serotonin Agents|serotonin agents|mesh-ancestor
111463510|NCT01862640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111463511|NCT01862640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111463512|NCT01862640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111463513|NCT01862640|Dopamine Agonists|dopamine agonists|mesh-ancestor
111463514|NCT01862640|Dopamine Agents|dopamine agents|mesh-ancestor
111463515|NCT01902966|Propranolol|propranolol|mesh-list
111463516|NCT01902966|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111463517|NCT01902966|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111463518|NCT01902966|Adrenergic Agents|adrenergic agents|mesh-ancestor
111463519|NCT01902966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111463520|NCT01902966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111463521|NCT01902966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111463522|NCT01902966|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111463523|NCT01902966|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111463524|NCT01902966|Vasodilator Agents|vasodilator agents|mesh-ancestor
111463525|NCT01862328|Paclitaxel|paclitaxel|mesh-list
111463526|NCT01862328|Docetaxel|docetaxel|mesh-list
111463527|NCT01862328|Carboplatin|carboplatin|mesh-list
111463528|NCT01862328|Gemcitabine|gemcitabine|mesh-list
111463529|NCT01862328|Pevonedistat|pevonedistat|mesh-list
111463530|NCT01862328|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111463531|NCT01862328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111463532|NCT01862328|Tubulin Modulators|tubulin modulators|mesh-ancestor
111463533|NCT01862328|Antimitotic Agents|antimitotic agents|mesh-ancestor
111463534|NCT01862328|Mitosis Modulators|mitosis modulators|mesh-ancestor
111463535|NCT01862328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111463536|NCT01862328|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111463537|NCT01862328|Antimetabolites|antimetabolites|mesh-ancestor
111463538|NCT01862328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111463539|NCT01862250|Clonidine|clonidine|mesh-list
111463540|NCT01862250|Analgesics|analgesics|mesh-ancestor
111463542|NCT01862250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111463543|NCT01862250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111463544|NCT01862250|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111463545|NCT01862250|Sympatholytics|sympatholytics|mesh-ancestor
111463546|NCT01862250|Autonomic Agents|autonomic agents|mesh-ancestor
111463547|NCT01862250|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111463548|NCT01862250|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111463549|NCT01862250|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111463550|NCT01862250|Adrenergic Agents|adrenergic agents|mesh-ancestor
111463551|NCT01862250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111463552|NCT01862250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111463553|NCT01876446|Irinotecan|irinotecan|mesh-list
111463554|NCT01876446|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111463555|NCT01876446|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111463556|NCT01876446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111463557|NCT01876446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111463558|NCT01876446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111463559|NCT04414800|Fentanyl|fentanyl|mesh-list
111463560|NCT04414800|Ketamine|ketamine|mesh-list
111463561|NCT04414800|Analgesics|analgesics|mesh-ancestor
111463562|NCT04414800|Sensory System Agents|sensory system agents|mesh-ancestor
111463563|NCT04414800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110940076|NCT02798835|Protease Inhibitors|protease inhibitors|mesh-ancestor
111463564|NCT04414800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111463565|NCT04414800|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111463566|NCT04414800|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111463567|NCT04414800|Anesthetics, General|anesthetics, general|mesh-ancestor
111463568|NCT04414800|Anesthetics|anesthetics|mesh-ancestor
111463569|NCT04414800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111463570|NCT04414800|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111463571|NCT04414800|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111463572|NCT04414800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111463573|NCT04414800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111463574|NCT04414800|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111463575|NCT04414800|Narcotics|narcotics|mesh-ancestor
111463576|NCT04414800|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111463577|NCT01898442|Ticagrelor|ticagrelor|mesh-list
111463578|NCT01898442|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111463579|NCT01898442|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111463580|NCT01898442|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111463581|NCT01898442|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111463582|NCT01898442|Purinergic Agents|purinergic agents|mesh-ancestor
111463583|NCT01898442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111463584|NCT01898442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111463585|NCT01898442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111463586|NCT01898208|Anti-Infective Agents|anti-infective agents|mesh-list
111463587|NCT01898208|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111463588|NCT01898130|Bevacizumab|bevacizumab|mesh-list
111463589|NCT01898130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111463590|NCT01898130|Antibodies|antibodies|mesh-list
111463591|NCT01898130|Immunoglobulins|immunoglobulins|mesh-list
111463592|NCT01898130|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111463593|NCT01898130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111463594|NCT01898130|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111463595|NCT01898130|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111463596|NCT01898130|Growth Substances|growth substances|mesh-ancestor
111463597|NCT01898130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111463598|NCT01898130|Growth Inhibitors|growth inhibitors|mesh-ancestor
111463599|NCT01898130|Immunologic Factors|immunologic factors|mesh-ancestor
111463600|NCT01876368|Olmesartan|olmesartan|mesh-list
111463601|NCT01876368|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
111463602|NCT01876368|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
111463603|NCT01876368|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111463604|NCT01876368|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111463605|NCT01876368|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111463606|NCT01876368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111463607|NCT01873950|Quinidine|quinidine|mesh-list
111463608|NCT01873950|Quinidine gluconate|quinidine gluconate|mesh-list
111463609|NCT01873950|Verapamil|verapamil|mesh-list
111463610|NCT01873950|Dofetilide|dofetilide|mesh-list
111463611|NCT01873950|Ranolazine|ranolazine|mesh-list
111463612|NCT01873950|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111463613|NCT01873950|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111187741|NCT03772314|Sympathomimetics|sympathomimetics|mesh-ancestor
111463614|NCT01873950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111463615|NCT01873950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111463616|NCT01873950|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111463617|NCT01873950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111463618|NCT01873950|Vasodilator Agents|vasodilator agents|mesh-ancestor
111463619|NCT01873950|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111463620|NCT01873950|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111463621|NCT01873950|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111463622|NCT01873950|Adrenergic Agents|adrenergic agents|mesh-ancestor
111463623|NCT01873950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111463624|NCT01873950|Antimalarials|antimalarials|mesh-ancestor
111463625|NCT01873950|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111463626|NCT01873950|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111463627|NCT01873950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111463628|NCT01873950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111463629|NCT01873950|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111463630|NCT01873950|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111463631|NCT01873950|Cholinergic Agents|cholinergic agents|mesh-ancestor
111463632|NCT01873950|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111463633|NCT01873950|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111463634|NCT01873950|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111463635|NCT01873950|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
111463636|NCT01896726|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
111463637|NCT01896726|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
111463638|NCT01896726|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111463639|NCT01896726|Contraceptive Agents|contraceptive agents|mesh-ancestor
111463640|NCT01896726|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111463641|NCT01896726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111463642|NCT01896726|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
111463643|NCT01896726|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111463644|NCT01896726|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111463645|NCT01896726|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111463646|NCT01896726|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111463647|NCT01896726|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
111463648|NCT01896726|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
111463649|NCT01896726|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
111463650|NCT01856790|Liraglutide|liraglutide|mesh-list
111463651|NCT01856790|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111463652|NCT01856790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111463653|NCT01856790|Incretins|incretins|mesh-ancestor
111463654|NCT01856790|Hormones|hormones|mesh-ancestor
111463655|NCT01856790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111463656|NCT01856322|Sulindac|sulindac|mesh-list
111463657|NCT01856322|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111463658|NCT01856322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111463659|NCT01856322|Analgesics|analgesics|mesh-ancestor
111463660|NCT01856322|Sensory System Agents|sensory system agents|mesh-ancestor
111463661|NCT01856322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111463662|NCT01856322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111463663|NCT01856322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111463664|NCT01856322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111463665|NCT01856322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111463666|NCT01856322|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111463667|NCT01856322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111463668|NCT01856322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111463669|NCT01871532|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
111463670|NCT01871532|Hormones|hormones|mesh-ancestor
111463671|NCT01871532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111463672|NCT01871532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111463673|NCT01855074|Risperidone|risperidone|mesh-list
111463674|NCT01855074|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111463675|NCT01855074|Serotonin Agents|serotonin agents|mesh-ancestor
111463676|NCT01855074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111463677|NCT01855074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111463678|NCT01855074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111463679|NCT01855074|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111463680|NCT01855074|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111463681|NCT01855074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111463682|NCT01855074|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111463683|NCT01855074|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111463684|NCT01855074|Dopamine Agents|dopamine agents|mesh-ancestor
111463685|NCT01895322|Tolvaptan|tolvaptan|mesh-list
111463686|NCT01895322|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
111463687|NCT01895322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111463688|NCT01895322|Natriuretic Agents|natriuretic agents|mesh-ancestor
111463689|NCT01895322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111463690|NCT01894776|Maraviroc|maraviroc|mesh-list
111463691|NCT01894776|Rifabutin|rifabutin|mesh-list
111463692|NCT01894776|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
111463693|NCT01894776|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
111463694|NCT01894776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111463695|NCT01894776|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111463696|NCT01894776|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111463697|NCT01894776|Antiviral Agents|antiviral agents|mesh-ancestor
111463698|NCT01894776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111463699|NCT01894776|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
111463700|NCT01894776|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111463701|NCT01894776|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111463702|NCT01894776|Antitubercular Agents|antitubercular agents|mesh-ancestor
111463703|NCT01854918|Evolocumab|evolocumab|mesh-list
111463704|NCT01854918|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
111463705|NCT01854918|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111463706|NCT01854918|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111463707|NCT01854918|Antimetabolites|antimetabolites|mesh-ancestor
111463708|NCT01854918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111463709|NCT01854918|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111463710|NCT01854918|Protease Inhibitors|protease inhibitors|mesh-ancestor
111463711|NCT01854918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111463712|NCT01854918|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111463713|NCT01894152|Everolimus|everolimus|mesh-list
111463714|NCT01894152|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111463715|NCT01894152|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111463716|NCT01894152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111463717|NCT01894152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111463718|NCT01894152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111463719|NCT01894152|Immunologic Factors|immunologic factors|mesh-ancestor
111463720|NCT01894152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111463721|NCT01894152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111463722|NCT01854528|Interferons|interferons|mesh-list
111463723|NCT01854528|Ribavirin|ribavirin|mesh-list
111463724|NCT01854528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111463725|NCT01854528|Antiviral Agents|antiviral agents|mesh-ancestor
111463726|NCT01854528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111463727|NCT01854528|Antimetabolites|antimetabolites|mesh-ancestor
111463728|NCT01854528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111463729|NCT01853982|Tazobactam|tazobactam|mesh-list
111463730|NCT01853982|Piperacillin|piperacillin|mesh-list
111463731|NCT01853982|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
111463732|NCT01853982|Ceftolozane|ceftolozane|mesh-list
111463733|NCT01853982|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
111463734|NCT01853982|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111463735|NCT01853982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111463736|NCT01853982|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
111463737|NCT01853982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111463738|NCT01853982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111463739|NCT01853982|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111463740|NCT01853280|Methylphenidate|methylphenidate|mesh-list
111463741|NCT01853280|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111463742|NCT01853280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111463743|NCT01853280|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111463744|NCT01853280|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111463745|NCT01853280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111463746|NCT01853280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111463747|NCT01853280|Dopamine Agents|dopamine agents|mesh-ancestor
111463748|NCT01853280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111463749|NCT01891890|Lamotrigine|lamotrigine|mesh-list
111463750|NCT01891890|Oxcarbazepine|oxcarbazepine|mesh-list
111463751|NCT01891890|Levetiracetam|levetiracetam|mesh-list
111463752|NCT01891890|Anticonvulsants|anticonvulsants|mesh-ancestor
111463753|NCT01891890|Nootropic Agents|nootropic agents|mesh-ancestor
111463754|NCT01891890|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111463755|NCT01891890|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111463756|NCT01891890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111463757|NCT01891890|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111463758|NCT01891890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111463759|NCT01891890|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111463760|NCT01891890|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111463761|NCT01891890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111463762|NCT01891890|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111463763|NCT01891890|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111463764|NCT01891890|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111463765|NCT01891890|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111463766|NCT01891890|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111463767|NCT01852812|Montelukast|montelukast|mesh-list
111463768|NCT01852812|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111463769|NCT01852812|Respiratory System Agents|respiratory system agents|mesh-ancestor
111463770|NCT01852812|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
111463771|NCT01852812|Hormone Antagonists|hormone antagonists|mesh-ancestor
111463772|NCT01852812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111463773|NCT01852812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111463774|NCT01852812|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
111463775|NCT01852812|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111463776|NCT01852812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111463777|NCT01869192|Cyclophosphamide|cyclophosphamide|mesh-list
111463779|NCT01869192|Capecitabine|capecitabine|mesh-list
111463780|NCT01869192|Epirubicin|epirubicin|mesh-list
111463781|NCT01869192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111463782|NCT01869192|Immunologic Factors|immunologic factors|mesh-ancestor
111463783|NCT01869192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111463784|NCT01869192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111463785|NCT01869192|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111463786|NCT01869192|Alkylating Agents|alkylating agents|mesh-ancestor
111463787|NCT01869192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111463788|NCT01869192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111463789|NCT01869192|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111463790|NCT01869192|Tubulin Modulators|tubulin modulators|mesh-ancestor
111463791|NCT01869192|Antimitotic Agents|antimitotic agents|mesh-ancestor
111463792|NCT01869192|Mitosis Modulators|mitosis modulators|mesh-ancestor
111463793|NCT01869192|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111463794|NCT01869192|Antimetabolites|antimetabolites|mesh-ancestor
111463795|NCT01869192|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111463796|NCT01869192|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111463797|NCT01869192|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111463798|NCT01869192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111463799|NCT01851720|Fentanyl|fentanyl|mesh-list
111463800|NCT01851720|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111463801|NCT01851720|Narcotics|narcotics|mesh-ancestor
111463802|NCT01851720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111463803|NCT01851720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111463804|NCT01851720|Analgesics|analgesics|mesh-ancestor
111463805|NCT01851720|Sensory System Agents|sensory system agents|mesh-ancestor
111463806|NCT01851720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111463807|NCT01851720|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111463808|NCT01851720|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111463809|NCT01851720|Anesthetics, General|anesthetics, general|mesh-ancestor
111463810|NCT01851720|Anesthetics|anesthetics|mesh-ancestor
111463811|NCT01851330|Sofosbuvir|sofosbuvir|mesh-list
111463812|NCT01851330|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
111463813|NCT01851330|Ledipasvir|ledipasvir|mesh-list
111463814|NCT01851330|Antiviral Agents|antiviral agents|mesh-ancestor
111463815|NCT01851330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111463816|NCT01868022|Paclitaxel|paclitaxel|mesh-list
111463817|NCT01868022|Docetaxel|docetaxel|mesh-list
111463818|NCT01868022|Carboplatin|carboplatin|mesh-list
111463819|NCT01868022|Pemetrexed|pemetrexed|mesh-list
111463820|NCT01868022|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111463821|NCT01868022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111463822|NCT01868022|Tubulin Modulators|tubulin modulators|mesh-ancestor
111463823|NCT01868022|Antimitotic Agents|antimitotic agents|mesh-ancestor
111463824|NCT01868022|Mitosis Modulators|mitosis modulators|mesh-ancestor
111463825|NCT01868022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111463826|NCT01868022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111463827|NCT01868022|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111463828|NCT01868022|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111463829|NCT01850004|Dasatinib|dasatinib|mesh-list
111463830|NCT01850004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111463831|NCT01850004|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111463832|NCT01850004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111463833|NCT01850004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111463834|NCT01867710|Dexamethasone|dexamethasone|mesh-list
111463835|NCT01867710|Prednisone|prednisone|mesh-list
111463836|NCT01867710|Abiraterone Acetate|abiraterone acetate|mesh-list
111463837|NCT01867710|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111463838|NCT01867710|Antiemetics|antiemetics|mesh-ancestor
111463839|NCT01867710|Autonomic Agents|autonomic agents|mesh-ancestor
111463840|NCT01867710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111463841|NCT01867710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111463842|NCT01867710|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111463843|NCT01867710|Glucocorticoids|glucocorticoids|mesh-ancestor
111463844|NCT01867710|Hormones|hormones|mesh-ancestor
111463845|NCT01867710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111463846|NCT01867710|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111463847|NCT01867710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111463848|NCT01867710|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111463849|NCT01867710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111463850|NCT01867710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111463851|NCT01867710|Hormone Antagonists|hormone antagonists|mesh-ancestor
111463852|NCT01867710|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111463853|NCT01832766|Dronabinol|dronabinol|mesh-list
111463854|NCT01832766|Hallucinogens|hallucinogens|mesh-ancestor
111463855|NCT01832766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111463856|NCT01832766|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111463857|NCT01832766|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111463858|NCT01832766|Analgesics|analgesics|mesh-ancestor
111463859|NCT01832766|Sensory System Agents|sensory system agents|mesh-ancestor
111463860|NCT01832766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111463861|NCT01832766|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
111463862|NCT01832766|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
111463863|NCT01832766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111463864|NCT01832766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111463865|NCT01832766|Hormones|hormones|mesh-ancestor
111463866|NCT01832766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111463867|NCT01832532|Liraglutide|liraglutide|mesh-list
111463868|NCT01832532|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111463869|NCT01832532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111463870|NCT01832532|Incretins|incretins|mesh-ancestor
111463871|NCT01832532|Hormones|hormones|mesh-ancestor
111463872|NCT01832532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111463873|NCT04414956|Vitamin K|vitamin k|mesh-list
111463874|NCT04414956|Agglutinins|agglutinins|mesh-list
111463875|NCT04414956|Vitamins|vitamins|mesh-ancestor
111463876|NCT04414956|Micronutrients|micronutrients|mesh-ancestor
111463877|NCT04414956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111463878|NCT04414956|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111463879|NCT04414956|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111463880|NCT04414956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111463881|NCT04414956|Hemostatics|hemostatics|mesh-ancestor
111463882|NCT04414956|Coagulants|coagulants|mesh-ancestor
111463883|NCT04414956|Immunologic Factors|immunologic factors|mesh-ancestor
111463884|NCT01848990|Insulin|insulin|mesh-list
111463885|NCT01848990|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111463886|NCT01848990|Insulin Aspart|insulin aspart|mesh-list
111463887|NCT01848990|Insulin Lispro|insulin lispro|mesh-list
111463888|NCT01848990|Insulin glulisine|insulin glulisine|mesh-list
111463889|NCT01848990|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111463890|NCT01848990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111463891|NCT01867086|Carboplatin|carboplatin|mesh-list
111463892|NCT01867086|Vaccines|vaccines|mesh-list
111463893|NCT01867086|Immunologic Factors|immunologic factors|mesh-ancestor
111463894|NCT01867086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111463895|NCT01867086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111463896|NCT01848834|Pembrolizumab|pembrolizumab|mesh-list
111463897|NCT01848834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111463898|NCT01848834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111463899|NCT01848834|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111463900|NCT01848834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111463901|NCT04600362|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111463902|NCT04600362|Immunologic Factors|immunologic factors|mesh-ancestor
111463903|NCT04600362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111463904|NCT01848210|Troxerutin|troxerutin|mesh-list
111463905|NCT01848210|Anticoagulants|anticoagulants|mesh-ancestor
111463906|NCT01830816|Ixazomib|ixazomib|mesh-list
111188040|NCT02923115|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111463907|NCT01830816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111463908|NCT01830816|Protease Inhibitors|protease inhibitors|mesh-ancestor
111463909|NCT01830816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111463910|NCT01830816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111463911|NCT01846416|Atezolizumab|atezolizumab|mesh-list
111463912|NCT01846416|Antibodies|antibodies|mesh-list
111463913|NCT01846416|Immunologic Factors|immunologic factors|mesh-ancestor
111463914|NCT01846416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111463915|NCT01846416|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111463916|NCT01846416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111463917|NCT01846416|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111463918|NCT01846416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111463919|NCT04589754|Ifosfamide|ifosfamide|mesh-list
111463920|NCT04589754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111463921|NCT04589754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111463922|NCT04589754|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111463923|NCT04589754|Alkylating Agents|alkylating agents|mesh-ancestor
111463924|NCT01846104|Vaccines|vaccines|mesh-list
111463925|NCT01846104|Immunologic Factors|immunologic factors|mesh-ancestor
111463926|NCT01846104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111463927|NCT01803282|Leucovorin|leucovorin|mesh-list
111463928|NCT01803282|Paclitaxel|paclitaxel|mesh-list
111463929|NCT01803282|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111463930|NCT01803282|Bevacizumab|bevacizumab|mesh-list
111463931|NCT01803282|Carboplatin|carboplatin|mesh-list
111463932|NCT01803282|Gemcitabine|gemcitabine|mesh-list
111463933|NCT01803282|Oxaliplatin|oxaliplatin|mesh-list
111463934|NCT01803282|Irinotecan|irinotecan|mesh-list
111463935|NCT01803282|Pemetrexed|pemetrexed|mesh-list
111463936|NCT01803282|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111463937|NCT01803282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111463938|NCT01803282|Tubulin Modulators|tubulin modulators|mesh-ancestor
111463939|NCT01803282|Antimitotic Agents|antimitotic agents|mesh-ancestor
111463940|NCT01803282|Mitosis Modulators|mitosis modulators|mesh-ancestor
111463941|NCT01803282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111463942|NCT01803282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111463943|NCT01803282|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111463944|NCT01803282|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111463945|NCT01803282|Growth Substances|growth substances|mesh-ancestor
111463946|NCT01803282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111463947|NCT01803282|Growth Inhibitors|growth inhibitors|mesh-ancestor
111463948|NCT01803282|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111463949|NCT01803282|Antimetabolites|antimetabolites|mesh-ancestor
111463950|NCT01803282|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111463951|NCT01803282|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111463952|NCT01803282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111463953|NCT01803282|Antidotes|antidotes|mesh-ancestor
111463954|NCT01803282|Protective Agents|protective agents|mesh-ancestor
111463955|NCT01803282|Vitamin B Complex|vitamin b complex|mesh-ancestor
111463956|NCT01803282|Vitamins|vitamins|mesh-ancestor
111463957|NCT01803282|Micronutrients|micronutrients|mesh-ancestor
111463958|NCT01803282|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111463959|NCT01803282|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111463960|NCT01844778|Tobramycin|tobramycin|mesh-list
111463961|NCT01844778|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111463962|NCT01844778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111463963|NCT01802580|Fluocinonide|fluocinonide|mesh-list
111463964|NCT01802580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111463965|NCT01802580|Glucocorticoids|glucocorticoids|mesh-ancestor
111463966|NCT01802580|Hormones|hormones|mesh-ancestor
111463967|NCT01802580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111463968|NCT01802580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111463969|NCT01802580|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111463970|NCT01611090|Rituximab|rituximab|mesh-list
111463971|NCT01611090|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
111463972|NCT01611090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111463973|NCT01611090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111463974|NCT01611090|Immunologic Factors|immunologic factors|mesh-ancestor
111463975|NCT01611090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111463976|NCT01611090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111463977|NCT01611090|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111463978|NCT01611090|Alkylating Agents|alkylating agents|mesh-ancestor
111463979|NCT01611090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111463980|NCT01844700|Risperidone|risperidone|mesh-list
111463981|NCT01844700|Aripiprazole|aripiprazole|mesh-list
111463982|NCT01844700|Quetiapine Fumarate|quetiapine fumarate|mesh-list
111463983|NCT01844700|Ziprasidone|ziprasidone|mesh-list
111463984|NCT01844700|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111463985|NCT01844700|Serotonin Agents|serotonin agents|mesh-ancestor
111463986|NCT01844700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111463987|NCT01844700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111463988|NCT01844700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111463989|NCT01844700|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111463990|NCT01844700|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111463991|NCT01844700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111463992|NCT01844700|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111463993|NCT01844700|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111463994|NCT01844700|Dopamine Agents|dopamine agents|mesh-ancestor
111463995|NCT01844700|Antidepressive Agents|antidepressive agents|mesh-ancestor
111463996|NCT01844700|Dopamine Agonists|dopamine agonists|mesh-ancestor
111463997|NCT01844700|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111463998|NCT01844700|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111463999|NCT01844700|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111464000|NCT01844700|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111464001|NCT01844076|Quinacrine|quinacrine|mesh-list
111464002|NCT01844076|Capecitabine|capecitabine|mesh-list
111464003|NCT01844076|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111464004|NCT01844076|Antimetabolites|antimetabolites|mesh-ancestor
110940479|NCT02232594|Autonomic Agents|autonomic agents|mesh-ancestor
111464005|NCT01844076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111464006|NCT01844076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111464007|NCT01844076|Anticestodal Agents|anticestodal agents|mesh-ancestor
111464008|NCT01844076|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
111464009|NCT01844076|Anthelmintics|anthelmintics|mesh-ancestor
111464010|NCT01844076|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111464011|NCT01844076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111464012|NCT01844076|Antimalarials|antimalarials|mesh-ancestor
111464013|NCT01844076|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111464014|NCT01844076|Antinematodal Agents|antinematodal agents|mesh-ancestor
111464015|NCT01844076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111464016|NCT01826448|Vemurafenib|vemurafenib|mesh-list
111464017|NCT01826448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111464018|NCT01826448|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111464019|NCT01826448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111464020|NCT01826448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111464021|NCT01826370|Linagliptin|linagliptin|mesh-list
111464022|NCT01826370|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111464023|NCT01826370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111464024|NCT01826370|Incretins|incretins|mesh-ancestor
111464025|NCT01826370|Hormones|hormones|mesh-ancestor
111464026|NCT01826370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111464027|NCT01826370|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111464028|NCT01826370|Protease Inhibitors|protease inhibitors|mesh-ancestor
111464029|NCT01826370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111464030|NCT01826370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111464031|NCT01799226|Triclosan|triclosan|mesh-list
111464032|NCT01799226|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111464033|NCT01799226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111464034|NCT01799226|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
111464035|NCT01799226|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111464036|NCT01799226|Antimetabolites|antimetabolites|mesh-ancestor
111464037|NCT01799226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111464038|NCT01799226|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111464039|NCT01798992|Metoprolol|metoprolol|mesh-list
111464040|NCT01798992|Carvedilol|carvedilol|mesh-list
111464041|NCT01798992|Doxazosin|doxazosin|mesh-list
111464042|NCT01798992|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111464043|NCT01798992|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111464044|NCT01798992|Sympatholytics|sympatholytics|mesh-ancestor
111464045|NCT01798992|Autonomic Agents|autonomic agents|mesh-ancestor
111464046|NCT01798992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111464047|NCT01798992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111464048|NCT01798992|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
111464049|NCT01798992|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111464050|NCT01798992|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111464051|NCT01798992|Adrenergic Agents|adrenergic agents|mesh-ancestor
111464052|NCT01798992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111464053|NCT01798992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111464054|NCT01798992|Antioxidants|antioxidants|mesh-ancestor
111464055|NCT01798992|Protective Agents|protective agents|mesh-ancestor
111464056|NCT01798992|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111464057|NCT01798992|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111464058|NCT01798992|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111464059|NCT01798992|Vasodilator Agents|vasodilator agents|mesh-ancestor
111188191|NCT06018025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111464060|NCT01798992|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111464061|NCT01798992|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111464063|NCT01798056|Immunologic Factors|immunologic factors|mesh-ancestor
111464064|NCT01798056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111464065|NCT01824342|Denosumab|denosumab|mesh-list
111464066|NCT01824342|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111464067|NCT01824342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111464068|NCT01823328|Ketamine|ketamine|mesh-list
111464069|NCT01823328|Etomidate|etomidate|mesh-list
111464070|NCT01823328|Analgesics|analgesics|mesh-ancestor
111464071|NCT01823328|Sensory System Agents|sensory system agents|mesh-ancestor
111464072|NCT01823328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111464073|NCT01823328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110940484|NCT04858516|Trastuzumab|trastuzumab|mesh-list
111464074|NCT01823328|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111464075|NCT01823328|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111464076|NCT01823328|Anesthetics, General|anesthetics, general|mesh-ancestor
111464077|NCT01823328|Anesthetics|anesthetics|mesh-ancestor
111464078|NCT01823328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111464079|NCT01823328|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111464080|NCT01823328|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111464081|NCT01823328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111464082|NCT01823328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111464083|NCT01823328|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111464084|NCT01840410|Ranibizumab|ranibizumab|mesh-list
111464085|NCT01840410|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111464086|NCT01840410|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111464087|NCT01840410|Growth Substances|growth substances|mesh-ancestor
111464088|NCT01840410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111464089|NCT01840410|Growth Inhibitors|growth inhibitors|mesh-ancestor
111464090|NCT01840410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111464091|NCT01797432|Triamcinolone|triamcinolone|mesh-list
111464092|NCT01797432|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
111464093|NCT01797432|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
111464094|NCT01797432|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
111464095|NCT01797432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111464096|NCT01797432|Glucocorticoids|glucocorticoids|mesh-ancestor
111464097|NCT01797432|Hormones|hormones|mesh-ancestor
111464098|NCT01797432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111464099|NCT01797432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111464100|NCT01797432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111464101|NCT01797432|Immunologic Factors|immunologic factors|mesh-ancestor
111464102|NCT01797432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111464103|NCT01797432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111464104|NCT01797120|Everolimus|everolimus|mesh-list
111464105|NCT01797120|MTOR Inhibitors|mtor inhibitors|mesh-list
111464106|NCT01797120|Fulvestrant|fulvestrant|mesh-list
111464107|NCT01797120|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111464108|NCT01797120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111464109|NCT01797120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111464110|NCT01797120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111464111|NCT01797120|Immunologic Factors|immunologic factors|mesh-ancestor
111464112|NCT01797120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111464113|NCT01797120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111464114|NCT01797120|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111464115|NCT01797120|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
111464116|NCT01797120|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111464117|NCT01797120|Hormone Antagonists|hormone antagonists|mesh-ancestor
111464118|NCT01797120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111464119|NCT01796964|Aflibercept|aflibercept|mesh-list
111464120|NCT01796964|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111464121|NCT01796964|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111464122|NCT01796964|Growth Substances|growth substances|mesh-ancestor
111464123|NCT01796964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111464124|NCT01796964|Growth Inhibitors|growth inhibitors|mesh-ancestor
111464125|NCT01796964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111464126|NCT01794780|Fluticasone|fluticasone|mesh-list
111464127|NCT01794780|Budesonide|budesonide|mesh-list
111464128|NCT01794780|Theophylline|theophylline|mesh-list
111464129|NCT01794780|Formoterol Fumarate|formoterol fumarate|mesh-list
111464130|NCT01794780|Tiotropium Bromide|tiotropium bromide|mesh-list
111464131|NCT01794780|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
111464132|NCT01794780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111188286|NCT06017141|Fentanyl|fentanyl|mesh-list
111464133|NCT01794780|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111464134|NCT01794780|Autonomic Agents|autonomic agents|mesh-ancestor
111464135|NCT01794780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111464136|NCT01794780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111464137|NCT01794780|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111464138|NCT01794780|Respiratory System Agents|respiratory system agents|mesh-ancestor
111464139|NCT01794780|Dermatologic Agents|dermatologic agents|mesh-ancestor
111464140|NCT01794780|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111464141|NCT01794780|Glucocorticoids|glucocorticoids|mesh-ancestor
111464142|NCT01794780|Hormones|hormones|mesh-ancestor
111464143|NCT01794780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111464144|NCT01794780|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111464145|NCT01794780|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111464146|NCT01794780|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111464147|NCT01794780|Adrenergic Agents|adrenergic agents|mesh-ancestor
111464148|NCT01794780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111464149|NCT01794780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111464150|NCT01794780|Parasympatholytics|parasympatholytics|mesh-ancestor
111464151|NCT01794780|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111464152|NCT01794780|Cholinergic Agents|cholinergic agents|mesh-ancestor
111464153|NCT01794780|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111464154|NCT01794780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111464155|NCT01794780|Vasodilator Agents|vasodilator agents|mesh-ancestor
111464156|NCT01794780|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
111464157|NCT01794780|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111464158|NCT01794780|Purinergic Agents|purinergic agents|mesh-ancestor
111464159|NCT01838616|Oxycodone|oxycodone|mesh-list
111464160|NCT01838616|Tapentadol|tapentadol|mesh-list
111464161|NCT01838616|Naloxone|naloxone|mesh-list
111464162|NCT01838616|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111464163|NCT01838616|Narcotics|narcotics|mesh-ancestor
111464164|NCT01838616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111464165|NCT01838616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111464166|NCT01838616|Analgesics|analgesics|mesh-ancestor
111464167|NCT01838616|Sensory System Agents|sensory system agents|mesh-ancestor
111464168|NCT01838616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111464169|NCT01838616|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111464170|NCT01838616|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111464171|NCT01838616|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111464172|NCT01838616|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111464173|NCT01838616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111464174|NCT01838616|Adrenergic Agents|adrenergic agents|mesh-ancestor
111464175|NCT01838616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111464176|NCT01794000|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
111464177|NCT01794000|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111464178|NCT01609218|Charcoal|charcoal|mesh-list
111464179|NCT01609218|Antidotes|antidotes|mesh-ancestor
111464180|NCT01609218|Protective Agents|protective agents|mesh-ancestor
111464181|NCT01609218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111464182|NCT04580472|Clindamycin|clindamycin|mesh-list
111464183|NCT04580472|Clindamycin palmitate|clindamycin palmitate|mesh-list
111464184|NCT04580472|Clindamycin phosphate|clindamycin phosphate|mesh-list
111464185|NCT04580472|Cephalexin|cephalexin|mesh-list
111464186|NCT04580472|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111464187|NCT04580472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111464188|NCT04580472|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111464189|NCT04580472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111464190|NCT04580472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111464191|NCT01611558|Ipilimumab|ipilimumab|mesh-list
111464192|NCT01611558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111464193|NCT01611558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111464194|NCT01611558|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111464195|NCT01611558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111464196|NCT01818726|Deferasirox|deferasirox|mesh-list
111464197|NCT01818726|Iron Chelating Agents|iron chelating agents|mesh-ancestor
111464198|NCT01818726|Chelating Agents|chelating agents|mesh-ancestor
111464199|NCT01818726|Sequestering Agents|sequestering agents|mesh-ancestor
111464200|NCT01818726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111464201|NCT01818336|Amoxicillin|amoxicillin|mesh-list
111464202|NCT01818336|Penicillins|penicillins|mesh-list
111464203|NCT01818336|Penicillin G|penicillin g|mesh-list
111464204|NCT01818336|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111464205|NCT01818336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111464206|NCT01818258|Ritonavir|ritonavir|mesh-list
111464207|NCT01818258|Lopinavir|lopinavir|mesh-list
111464208|NCT01818258|Lamivudine|lamivudine|mesh-list
111464209|NCT01818258|Zidovudine|zidovudine|mesh-list
111464210|NCT01818258|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111464211|NCT01818258|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111464212|NCT01818258|Protease Inhibitors|protease inhibitors|mesh-ancestor
111464213|NCT01818258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111464214|NCT01818258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111464215|NCT01818258|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111464216|NCT01818258|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111464217|NCT01818258|Antiviral Agents|antiviral agents|mesh-ancestor
111464218|NCT01818258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111464219|NCT01818258|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111464220|NCT01818258|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111464221|NCT01818258|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111464222|NCT01818258|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111464223|NCT01818258|Antimetabolites|antimetabolites|mesh-ancestor
111464224|NCT01817790|Fluticasone|fluticasone|mesh-list
111464225|NCT01817790|Xhance|xhance|mesh-list
111464226|NCT01817790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111464227|NCT01817790|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111464228|NCT01817790|Autonomic Agents|autonomic agents|mesh-ancestor
111464229|NCT01817790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111464230|NCT01817790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111464231|NCT01817790|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111464232|NCT01817790|Respiratory System Agents|respiratory system agents|mesh-ancestor
111464233|NCT01817790|Dermatologic Agents|dermatologic agents|mesh-ancestor
111464234|NCT01817790|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111464235|NCT01793688|Ampicillin|ampicillin|mesh-list
111464236|NCT01793688|Sulbactam|sulbactam|mesh-list
111464237|NCT01793688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111464238|NCT01793688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111464239|NCT01793688|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
111464240|NCT01793688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111464241|NCT01793688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111464242|NCT01792830|Metformin|metformin|mesh-list
111464243|NCT01792830|Insulin Glargine|insulin glargine|mesh-list
111464244|NCT01792830|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111464245|NCT01792830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111464246|NCT01792518|Linagliptin|linagliptin|mesh-list
111464247|NCT01792518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111464248|NCT01792518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111464249|NCT01792518|Incretins|incretins|mesh-ancestor
111464250|NCT01792518|Hormones|hormones|mesh-ancestor
111464251|NCT01792518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111464252|NCT01792518|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111464253|NCT01792518|Protease Inhibitors|protease inhibitors|mesh-ancestor
111464254|NCT01792518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111464255|NCT01792518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111464256|NCT01792284|Insulin|insulin|mesh-list
111464257|NCT01792284|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111464258|NCT01792284|Insulin Lispro|insulin lispro|mesh-list
111464259|NCT01792284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111464260|NCT01792284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111464261|NCT04414566|Cisplatin|cisplatin|mesh-list
111464262|NCT04414566|Gemcitabine|gemcitabine|mesh-list
111464263|NCT04414566|Docetaxel|docetaxel|mesh-list
111464264|NCT04414566|Fluorouracil|fluorouracil|mesh-list
111464265|NCT04414566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111464266|NCT04414566|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111464267|NCT04414566|Antimetabolites|antimetabolites|mesh-ancestor
111464268|NCT04414566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111464269|NCT04414566|Tubulin Modulators|tubulin modulators|mesh-ancestor
111464270|NCT04414566|Antimitotic Agents|antimitotic agents|mesh-ancestor
111464271|NCT04414566|Mitosis Modulators|mitosis modulators|mesh-ancestor
111464272|NCT04414566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111464273|NCT04414566|Immunologic Factors|immunologic factors|mesh-ancestor
111464274|NCT04414566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111464275|NCT01791894|Arsenic Trioxide|arsenic trioxide|mesh-list
111464276|NCT01791894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111464277|NCT04592016|Diclofenac|diclofenac|mesh-list
111464278|NCT04592016|Coal Tar|coal tar|mesh-list
111464279|NCT04592016|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111464280|NCT04592016|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111464281|NCT04592016|Analgesics|analgesics|mesh-ancestor
111464282|NCT04592016|Sensory System Agents|sensory system agents|mesh-ancestor
111464283|NCT04592016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111464284|NCT04592016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111464285|NCT04592016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111464286|NCT04592016|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111464287|NCT04592016|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111464289|NCT04592016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111464290|NCT04592016|Keratolytic Agents|keratolytic agents|mesh-ancestor
111464291|NCT04592016|Dermatologic Agents|dermatologic agents|mesh-ancestor
111464292|NCT01837680|Insulin|insulin|mesh-list
111464293|NCT01837680|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111464294|NCT01837680|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111464295|NCT01837680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111464296|NCT01836276|Varenicline|varenicline|mesh-list
111464297|NCT01836276|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111464298|NCT01836276|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111464299|NCT01836276|Cholinergic Agents|cholinergic agents|mesh-ancestor
111464300|NCT01836276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111464301|NCT01836276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111464302|NCT01836276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111464303|NCT01790568|Methotrexate|methotrexate|mesh-list
111464304|NCT01790568|Vorinostat|vorinostat|mesh-list
111464305|NCT01790568|Tacrolimus|tacrolimus|mesh-list
111464306|NCT01790568|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111464307|NCT01790568|Abortifacient Agents|abortifacient agents|mesh-ancestor
111464308|NCT01790568|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111464309|NCT01790568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111464310|NCT01790568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111464311|NCT01790568|Antimetabolites|antimetabolites|mesh-ancestor
111464312|NCT01790568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111464313|NCT01790568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111464314|NCT01790568|Dermatologic Agents|dermatologic agents|mesh-ancestor
111464315|NCT01790568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111464316|NCT01790568|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111464317|NCT01790568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111464318|NCT01790568|Immunologic Factors|immunologic factors|mesh-ancestor
111464319|NCT01790568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111464320|NCT01790568|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111464321|NCT01790568|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111464322|NCT01790568|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111464323|NCT01836198|Clarithromycin|clarithromycin|mesh-list
111464324|NCT01836198|Ketoconazole|ketoconazole|mesh-list
111464325|NCT01836198|Gemfibrozil|gemfibrozil|mesh-list
111464326|NCT01836198|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111464327|NCT01836198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111464328|NCT01836198|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111464329|NCT01836198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111464330|NCT01836198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111464331|NCT01836198|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111464332|NCT01836198|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111464333|NCT01836198|Antifungal Agents|antifungal agents|mesh-ancestor
111464334|NCT01836198|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111464335|NCT01836198|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111464336|NCT01836198|Hormone Antagonists|hormone antagonists|mesh-ancestor
111464337|NCT01836198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111464338|NCT01836198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111464339|NCT01836198|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111464340|NCT01836198|Antimetabolites|antimetabolites|mesh-ancestor
111464341|NCT01836198|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111464342|NCT01836198|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
111464343|NCT01816074|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
111464344|NCT01816074|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111464345|NCT01816074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111464346|NCT01816074|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111464347|NCT01816074|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111464348|NCT01816074|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111464349|NCT01816074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111464350|NCT01816074|Dopamine Agents|dopamine agents|mesh-ancestor
111464351|NCT01816074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111464352|NCT01815918|Hydrocortisone|hydrocortisone|mesh-list
111464353|NCT01815918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111464354|NCT01789320|Triamcinolone|triamcinolone|mesh-list
111464355|NCT01789320|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
111464356|NCT01789320|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
111464357|NCT01789320|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
111464358|NCT01789320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111464359|NCT01789320|Glucocorticoids|glucocorticoids|mesh-ancestor
111464360|NCT01789320|Hormones|hormones|mesh-ancestor
111464361|NCT01789320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111464362|NCT01789320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111464363|NCT01789320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111464364|NCT01789320|Immunologic Factors|immunologic factors|mesh-ancestor
111464365|NCT01789320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111464366|NCT01789320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111464367|NCT01788228|Vaccines|vaccines|mesh-list
111464368|NCT01788228|Immunologic Factors|immunologic factors|mesh-ancestor
111464369|NCT01788228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111464370|NCT01607346|Ezogabine|ezogabine|mesh-list
111464371|NCT01607346|Anticonvulsants|anticonvulsants|mesh-ancestor
111464372|NCT01607346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111464373|NCT01607346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111464374|NCT01815138|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
111464375|NCT01815138|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111464376|NCT01815138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111464377|NCT01606800|Ribavirin|ribavirin|mesh-list
111464378|NCT01606800|Interferon alpha-2|interferon alpha-2|mesh-list
111464379|NCT01606800|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
111464380|NCT01606800|Antimetabolites|antimetabolites|mesh-ancestor
111464381|NCT01606800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111464382|NCT01606800|Antiviral Agents|antiviral agents|mesh-ancestor
111464383|NCT01606800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111464384|NCT01606800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111464385|NCT01814748|Metformin|metformin|mesh-list
111464386|NCT01814748|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111464387|NCT01814748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111464388|NCT01814670|Botulinum Toxins|botulinum toxins|mesh-list
111464389|NCT01814670|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111464390|NCT01814670|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111464391|NCT01814670|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111464392|NCT01814670|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111464393|NCT01814670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111464394|NCT01814670|Cholinergic Agents|cholinergic agents|mesh-ancestor
111464395|NCT01814670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111464396|NCT01814670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111464397|NCT01814670|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111464398|NCT01814670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111464399|NCT01814046|Aldesleukin|aldesleukin|mesh-list
111464400|NCT01814046|Cyclophosphamide|cyclophosphamide|mesh-list
111464401|NCT01814046|Fludarabine|fludarabine|mesh-list
111464402|NCT01814046|Interleukin-2|interleukin-2|mesh-list
111464403|NCT01814046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111464404|NCT01814046|Immunologic Factors|immunologic factors|mesh-ancestor
111464405|NCT01814046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111464406|NCT01814046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111464407|NCT01814046|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111464408|NCT01814046|Alkylating Agents|alkylating agents|mesh-ancestor
111464409|NCT01814046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111464410|NCT01814046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110940914|NCT04854460|Ivermectin|ivermectin|mesh-list
111464411|NCT01814046|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111464412|NCT01814046|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111464413|NCT01814046|Analgesics|analgesics|mesh-ancestor
111464414|NCT01814046|Sensory System Agents|sensory system agents|mesh-ancestor
111464415|NCT01814046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111464416|NCT01814046|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111464417|NCT01814046|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111464418|NCT01814046|Antiviral Agents|antiviral agents|mesh-ancestor
111464419|NCT01814046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111464420|NCT01813890|Tapentadol|tapentadol|mesh-list
111464421|NCT01813890|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111464422|NCT01813890|Narcotics|narcotics|mesh-ancestor
111464423|NCT01813890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111464424|NCT01813890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111464425|NCT01813890|Analgesics|analgesics|mesh-ancestor
111464426|NCT01813890|Sensory System Agents|sensory system agents|mesh-ancestor
111464427|NCT01813890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111464428|NCT01813890|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111464429|NCT01813890|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111464430|NCT01813890|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111464431|NCT01813890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111464432|NCT01813890|Adrenergic Agents|adrenergic agents|mesh-ancestor
111464433|NCT01813890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111464434|NCT01813422|Evolocumab|evolocumab|mesh-list
111464435|NCT01813422|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
111464436|NCT01813422|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111464438|NCT01813422|Antimetabolites|antimetabolites|mesh-ancestor
111464439|NCT01813422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111464440|NCT01813422|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111464441|NCT01813422|Protease Inhibitors|protease inhibitors|mesh-ancestor
111464442|NCT01813422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111464443|NCT01813422|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111464444|NCT01786668|Tofacitinib|tofacitinib|mesh-list
111464445|NCT01786668|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
111464446|NCT01786668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111464447|NCT01786668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111464448|NCT01786668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111464449|NCT04414254|Cefprozil|cefprozil|mesh-list
111464450|NCT04414254|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111464451|NCT04414254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111464452|NCT01770912|Triamcinolone|triamcinolone|mesh-list
111464453|NCT01770912|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
111464454|NCT01770912|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
111464455|NCT01770912|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
111464456|NCT01770912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111464457|NCT01770912|Glucocorticoids|glucocorticoids|mesh-ancestor
111464458|NCT01770912|Hormones|hormones|mesh-ancestor
111464459|NCT01770912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111464460|NCT01770912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111464461|NCT01770912|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111464462|NCT01770912|Immunologic Factors|immunologic factors|mesh-ancestor
111464463|NCT01770912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111464464|NCT01770912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111464465|NCT01811706|4-Aminopyridine|4-aminopyridine|mesh-list
111464466|NCT01811706|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
111464467|NCT01811706|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111464468|NCT01811706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111464469|NCT01811238|Oxycodone|oxycodone|mesh-list
111464470|NCT01811238|Naloxone|naloxone|mesh-list
111464471|NCT01811238|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111464472|NCT01811238|Narcotics|narcotics|mesh-ancestor
111464473|NCT01811238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111464474|NCT01811238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111464475|NCT01811238|Analgesics|analgesics|mesh-ancestor
111464476|NCT01811238|Sensory System Agents|sensory system agents|mesh-ancestor
111464477|NCT01811238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111464478|NCT01811238|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111464479|NCT01769508|Fluorouracil|fluorouracil|mesh-list
111464480|NCT01769508|Oxaliplatin|oxaliplatin|mesh-list
111464481|NCT01769508|Lapatinib|lapatinib|mesh-list
111464482|NCT01769508|Antimetabolites|antimetabolites|mesh-ancestor
111464483|NCT01769508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111464484|NCT01769508|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111464485|NCT01769508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111464486|NCT01769508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111464487|NCT01769508|Immunologic Factors|immunologic factors|mesh-ancestor
111464488|NCT01769508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111464489|NCT01769508|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111464490|NCT01769508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111464491|NCT01810380|Quetiapine Fumarate|quetiapine fumarate|mesh-list
111464492|NCT01810380|Brexpiprazole|brexpiprazole|mesh-list
111464493|NCT01810380|Antidepressive Agents|antidepressive agents|mesh-ancestor
111464494|NCT01810380|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111464495|NCT01810380|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111464496|NCT01810380|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111464497|NCT01810380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111464498|NCT01810380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111464499|NCT01810380|Serotonin Agents|serotonin agents|mesh-ancestor
111464500|NCT01810380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111464501|NCT01810380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111464502|NCT01810380|Dopamine Agonists|dopamine agonists|mesh-ancestor
111464503|NCT01810380|Dopamine Agents|dopamine agents|mesh-ancestor
111464504|NCT01810302|Nicardipine|nicardipine|mesh-list
111464505|NCT01810302|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111464506|NCT01810302|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111464507|NCT01810302|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111464508|NCT01810302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111464509|NCT01810302|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111464510|NCT01810302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111464512|NCT01783938|Nivolumab|nivolumab|mesh-list
111464513|NCT01783938|Ipilimumab|ipilimumab|mesh-list
111464514|NCT01783938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111464515|NCT01783938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111464516|NCT01783938|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111464517|NCT01783938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111464518|NCT01768572|Hydroxychloroquine|hydroxychloroquine|mesh-list
111464519|NCT01768572|Sulfasalazine|sulfasalazine|mesh-list
111464520|NCT01768572|Methotrexate|methotrexate|mesh-list
111464521|NCT01768572|Leflunomide|leflunomide|mesh-list
111464522|NCT01768572|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111464523|NCT01768572|Abortifacient Agents|abortifacient agents|mesh-ancestor
111464524|NCT01768572|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111464525|NCT01768572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111464526|NCT01768572|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111464527|NCT01768572|Antimetabolites|antimetabolites|mesh-ancestor
111464528|NCT01768572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111464529|NCT01768572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111464530|NCT01768572|Dermatologic Agents|dermatologic agents|mesh-ancestor
111464531|NCT01768572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111464532|NCT01768572|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111464533|NCT01768572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111464534|NCT01768572|Immunologic Factors|immunologic factors|mesh-ancestor
111464535|NCT01768572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111464536|NCT01768572|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111464537|NCT01768572|Antimalarials|antimalarials|mesh-ancestor
111464538|NCT01768572|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111464539|NCT01768572|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111464540|NCT01768572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111464541|NCT01768572|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111464542|NCT01768572|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111464543|NCT01768572|Analgesics|analgesics|mesh-ancestor
111464544|NCT01768572|Sensory System Agents|sensory system agents|mesh-ancestor
111464545|NCT01768572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111464546|NCT01768572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111464547|NCT01768572|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111464548|NCT01783548|Beclomethasone|beclomethasone|mesh-list
111464549|NCT01783548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111464550|NCT01783548|Glucocorticoids|glucocorticoids|mesh-ancestor
111464551|NCT01783548|Hormones|hormones|mesh-ancestor
111464552|NCT01783548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111464553|NCT01783548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111464554|NCT01783548|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111464555|NCT01783548|Respiratory System Agents|respiratory system agents|mesh-ancestor
111464556|NCT01809210|Carboplatin|carboplatin|mesh-list
111464557|NCT01809210|Gemcitabine|gemcitabine|mesh-list
111464558|NCT01809210|Pemetrexed|pemetrexed|mesh-list
111464559|NCT01809210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111464560|NCT01809210|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111464561|NCT01809210|Antimetabolites|antimetabolites|mesh-ancestor
111464562|NCT01809210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111464563|NCT01809210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111464564|NCT01809210|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111464565|NCT01809210|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111464566|NCT01809132|Zinc|zinc|mesh-list
111464567|NCT01809132|Methylprednisolone|methylprednisolone|mesh-list
111464568|NCT01809132|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111464569|NCT01809132|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111464570|NCT01809132|Prednisolone|prednisolone|mesh-list
111464571|NCT01809132|Prednisolone acetate|prednisolone acetate|mesh-list
111464572|NCT01809132|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
111464573|NCT01809132|Pentoxifylline|pentoxifylline|mesh-list
111464574|NCT01809132|Zinc Sulfate|zinc sulfate|mesh-list
111464575|NCT01809132|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111464576|NCT01809132|Prednisolone phosphate|prednisolone phosphate|mesh-list
111464577|NCT01809132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111464578|NCT01809132|Antiemetics|antiemetics|mesh-ancestor
111464579|NCT01809132|Autonomic Agents|autonomic agents|mesh-ancestor
111464580|NCT01809132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111464581|NCT01809132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111464582|NCT01809132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111464583|NCT01809132|Glucocorticoids|glucocorticoids|mesh-ancestor
111188718|NCT05592223|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111464584|NCT01809132|Hormones|hormones|mesh-ancestor
111464585|NCT01809132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111464586|NCT01809132|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111464587|NCT01809132|Protective Agents|protective agents|mesh-ancestor
111464588|NCT01809132|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111464589|NCT01809132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111464590|NCT01809132|Trace Elements|trace elements|mesh-ancestor
111464591|NCT01809132|Micronutrients|micronutrients|mesh-ancestor
111464592|NCT01809132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111464593|NCT01809132|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111464594|NCT01809132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111464595|NCT01809132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111464596|NCT01809132|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111464597|NCT01809132|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111464598|NCT01809132|Vasodilator Agents|vasodilator agents|mesh-ancestor
111464599|NCT01809132|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111464600|NCT01809132|Antioxidants|antioxidants|mesh-ancestor
111464601|NCT01809132|Astringents|astringents|mesh-ancestor
111464602|NCT01809132|Dermatologic Agents|dermatologic agents|mesh-ancestor
111464603|NCT01766778|Metformin|metformin|mesh-list
111464604|NCT01766778|Vildagliptin|vildagliptin|mesh-list
111464605|NCT01766778|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111464606|NCT01766778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111464607|NCT01766778|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111464608|NCT01766778|Protease Inhibitors|protease inhibitors|mesh-ancestor
111464609|NCT01766778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111464610|NCT01766778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111464611|NCT01808196|Losartan|losartan|mesh-list
111464612|NCT01808196|Angiotensin II|angiotensin ii|mesh-list
111464613|NCT01808196|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
111464614|NCT01808196|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111464615|NCT01808196|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111464616|NCT01808196|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111464617|NCT01808196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111464618|NCT01808196|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111464619|NCT01808118|Adalimumab|adalimumab|mesh-list
111464620|NCT01808118|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111464621|NCT01808118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111464622|NCT01808118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111464623|NCT01782690|Gemcitabine|gemcitabine|mesh-list
111464624|NCT01782690|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111464625|NCT01782690|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111464626|NCT01782690|Antimetabolites|antimetabolites|mesh-ancestor
111464627|NCT01782690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111464628|NCT01782690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111464629|NCT01782690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111464630|NCT01782690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111464631|NCT01766310|Folic Acid|folic acid|mesh-list
111464632|NCT01766310|Hematinics|hematinics|mesh-ancestor
111464633|NCT01766310|Vitamin B Complex|vitamin b complex|mesh-ancestor
111464634|NCT01766310|Vitamins|vitamins|mesh-ancestor
111464635|NCT01766310|Micronutrients|micronutrients|mesh-ancestor
111464636|NCT01766310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111464637|NCT01782222|Rotigotine|rotigotine|mesh-list
111464638|NCT01782222|Dopamine Agonists|dopamine agonists|mesh-ancestor
111464639|NCT01782222|Dopamine Agents|dopamine agents|mesh-ancestor
111464640|NCT01782222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111464641|NCT01782222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111464642|NCT01782222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111464643|NCT01807182|Aldesleukin|aldesleukin|mesh-list
111464644|NCT01807182|Cyclophosphamide|cyclophosphamide|mesh-list
111464645|NCT01807182|Fludarabine|fludarabine|mesh-list
111464646|NCT01807182|Fludarabine phosphate|fludarabine phosphate|mesh-list
111464647|NCT01807182|Interleukin-2|interleukin-2|mesh-list
111464648|NCT01807182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111464649|NCT01807182|Immunologic Factors|immunologic factors|mesh-ancestor
111464650|NCT01807182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111464651|NCT01807182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111464652|NCT01807182|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111464653|NCT01807182|Alkylating Agents|alkylating agents|mesh-ancestor
111464654|NCT01807182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111464655|NCT01807182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111464656|NCT01807182|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111464657|NCT01807182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111464658|NCT01807182|Antimetabolites|antimetabolites|mesh-ancestor
111464659|NCT01807182|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111464660|NCT01807182|Analgesics|analgesics|mesh-ancestor
111464661|NCT01807182|Sensory System Agents|sensory system agents|mesh-ancestor
111464662|NCT01807182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111464663|NCT01807182|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111464664|NCT01807182|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111464665|NCT01807182|Antiviral Agents|antiviral agents|mesh-ancestor
111464666|NCT01807182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111464667|NCT01765764|Bimatoprost|bimatoprost|mesh-list
111464668|NCT01765764|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111464669|NCT01765764|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111464670|NCT01780974|Thioctic Acid|thioctic acid|mesh-list
111464671|NCT01780974|Antioxidants|antioxidants|mesh-ancestor
111464672|NCT01780974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111464673|NCT01780974|Protective Agents|protective agents|mesh-ancestor
111464674|NCT01780974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111464675|NCT01780974|Vitamin B Complex|vitamin b complex|mesh-ancestor
111464676|NCT01780974|Vitamins|vitamins|mesh-ancestor
111464677|NCT01780974|Micronutrients|micronutrients|mesh-ancestor
111464678|NCT01780662|Gemcitabine|gemcitabine|mesh-list
111464679|NCT01780662|Brentuximab Vedotin|brentuximab vedotin|mesh-list
111464680|NCT01780662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111464681|NCT01780662|Antibodies|antibodies|mesh-list
110940546|NCT02234466|Dexamethasone|dexamethasone|mesh-list
111464682|NCT01780662|Immunoglobulins|immunoglobulins|mesh-list
111464683|NCT01780662|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111464684|NCT01780662|Immunoconjugates|immunoconjugates|mesh-list
111464685|NCT01780662|Immunologic Factors|immunologic factors|mesh-ancestor
111464686|NCT01780662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111464687|NCT01780662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111464688|NCT01780662|Antimetabolites|antimetabolites|mesh-ancestor
111464689|NCT01780662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111464690|NCT01780662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111464691|NCT01780662|Immunotoxins|immunotoxins|mesh-ancestor
111464692|NCT01780506|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
111464693|NCT01780506|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111464694|NCT01780506|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111464695|NCT01780506|Antiviral Agents|antiviral agents|mesh-ancestor
111464696|NCT01780506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111464697|NCT01762800|Fluticasone|fluticasone|mesh-list
111464699|NCT01762800|Bromides|bromides|mesh-list
111464700|NCT01762800|Tiotropium Bromide|tiotropium bromide|mesh-list
111464701|NCT01762800|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
111464702|NCT01762800|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
111464703|NCT01762800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111464704|NCT01762800|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111464705|NCT01762800|Autonomic Agents|autonomic agents|mesh-ancestor
111464706|NCT01762800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111464707|NCT01762800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111464708|NCT01762800|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111464709|NCT01762800|Respiratory System Agents|respiratory system agents|mesh-ancestor
111464710|NCT01762800|Dermatologic Agents|dermatologic agents|mesh-ancestor
111464711|NCT01762800|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111464712|NCT01762800|Parasympatholytics|parasympatholytics|mesh-ancestor
111464713|NCT01762800|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111464714|NCT01762800|Cholinergic Agents|cholinergic agents|mesh-ancestor
111464715|NCT01762800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111464716|NCT01762800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111464717|NCT01762800|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111464718|NCT01762800|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111464719|NCT01762800|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111464720|NCT01762800|Adrenergic Agents|adrenergic agents|mesh-ancestor
111464721|NCT01762800|Anticonvulsants|anticonvulsants|mesh-ancestor
111464722|NCT01762800|Glucocorticoids|glucocorticoids|mesh-ancestor
111464723|NCT01762800|Hormones|hormones|mesh-ancestor
111464724|NCT01762800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111464725|NCT01762800|Sympathomimetics|sympathomimetics|mesh-ancestor
111464726|NCT04562532|Sirolimus|sirolimus|mesh-list
111464727|NCT04562532|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111464728|NCT04562532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111464729|NCT04562532|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111464730|NCT04562532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111464731|NCT04562532|Antifungal Agents|antifungal agents|mesh-ancestor
111464732|NCT04562532|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111464733|NCT04562532|Immunologic Factors|immunologic factors|mesh-ancestor
111464734|NCT04562532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111188864|NCT05322707|Budesonide|budesonide|mesh-list
111464735|NCT01778010|Cocaine|cocaine|mesh-list
111464736|NCT01778010|Modafinil|modafinil|mesh-list
111464737|NCT01778010|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111464738|NCT01778010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111464739|NCT01778010|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
111464740|NCT01778010|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111464741|NCT01778010|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111464742|NCT01778010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111464743|NCT01778010|Anesthetics, Local|anesthetics, local|mesh-ancestor
111464744|NCT01778010|Anesthetics|anesthetics|mesh-ancestor
111464745|NCT01778010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111464746|NCT01778010|Sensory System Agents|sensory system agents|mesh-ancestor
111464747|NCT01778010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111464748|NCT01778010|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111464749|NCT01778010|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111464750|NCT01778010|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111464751|NCT01778010|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111464752|NCT01778010|Dopamine Agents|dopamine agents|mesh-ancestor
111464753|NCT01778010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111464754|NCT01777854|Omeprazole|omeprazole|mesh-list
111464755|NCT01777854|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111464756|NCT01777854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111464757|NCT01777854|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111464758|NCT01777854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111464759|NCT01777854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111464760|NCT01777620|Botulinum Toxins|botulinum toxins|mesh-list
111464761|NCT01777620|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111464762|NCT01777620|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111464763|NCT01777620|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111464764|NCT01777620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111464765|NCT01777620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111464766|NCT01777620|Cholinergic Agents|cholinergic agents|mesh-ancestor
111464767|NCT01777620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111464768|NCT01777620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111464769|NCT01777620|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111464770|NCT01777620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111464771|NCT01777542|Insulin|insulin|mesh-list
111464772|NCT01777542|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111464773|NCT01777542|Mitogens|mitogens|mesh-list
111464774|NCT01777542|Mecasermin|mecasermin|mesh-list
111464775|NCT01777542|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111464776|NCT01777542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111464777|NCT01777542|Mitosis Modulators|mitosis modulators|mesh-ancestor
111464778|NCT01777542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111464779|NCT01777542|Growth Substances|growth substances|mesh-ancestor
111464780|NCT01777152|Prednisone|prednisone|mesh-list
111464781|NCT01777152|Cyclophosphamide|cyclophosphamide|mesh-list
111464782|NCT01777152|Doxorubicin|doxorubicin|mesh-list
111464783|NCT01777152|Vincristine|vincristine|mesh-list
111464784|NCT01777152|Brentuximab Vedotin|brentuximab vedotin|mesh-list
111464785|NCT01777152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111464786|NCT01777152|Immunologic Factors|immunologic factors|mesh-ancestor
111464787|NCT01777152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111464788|NCT01777152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111464789|NCT01777152|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111464790|NCT01777152|Alkylating Agents|alkylating agents|mesh-ancestor
111464791|NCT01777152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111464792|NCT01777152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111464793|NCT01777152|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111464794|NCT01777152|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111464795|NCT01777152|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111464796|NCT01777152|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111464797|NCT01777152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111464798|NCT01777152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111464799|NCT01777152|Glucocorticoids|glucocorticoids|mesh-ancestor
111464800|NCT01777152|Hormones|hormones|mesh-ancestor
111464801|NCT01777152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111464802|NCT01777152|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110940563|NCT02234466|Serotonin Agents|serotonin agents|mesh-ancestor
111464803|NCT01777152|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111464804|NCT01777152|Tubulin Modulators|tubulin modulators|mesh-ancestor
111464805|NCT01777152|Antimitotic Agents|antimitotic agents|mesh-ancestor
111464806|NCT01777152|Mitosis Modulators|mitosis modulators|mesh-ancestor
111464807|NCT01777152|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111464808|NCT01777152|Immunotoxins|immunotoxins|mesh-ancestor
111464809|NCT01777152|Immunoconjugates|immunoconjugates|mesh-ancestor
111188938|NCT05142735|Acetylcysteine|acetylcysteine|mesh-list
111464811|NCT01775124|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111464812|NCT01775124|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111464813|NCT01775124|Growth Substances|growth substances|mesh-ancestor
111464814|NCT01775124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111464815|NCT01775124|Growth Inhibitors|growth inhibitors|mesh-ancestor
111464816|NCT01775124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111464817|NCT01733316|Cysteamine|cysteamine|mesh-list
111464818|NCT01733316|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
111464819|NCT01733316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111464820|NCT01732926|Rituximab|rituximab|mesh-list
111464821|NCT01732926|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
111464822|NCT01732926|Idelalisib|idelalisib|mesh-list
111464823|NCT01732926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111464824|NCT01732926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111464825|NCT01732926|Immunologic Factors|immunologic factors|mesh-ancestor
111464826|NCT01732926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111464827|NCT01732926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111464828|NCT01732926|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111464829|NCT01732926|Alkylating Agents|alkylating agents|mesh-ancestor
111464830|NCT01732926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111464831|NCT01732926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111464832|NCT01732770|Zoledronic Acid|zoledronic acid|mesh-list
111464833|NCT01732770|Denosumab|denosumab|mesh-list
111464834|NCT01732770|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111464835|NCT01732770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111464836|NCT01774968|Insulin|insulin|mesh-list
111464837|NCT01774968|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111464838|NCT01774968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111464839|NCT01732536|Mometasone Furoate|mometasone furoate|mesh-list
111464840|NCT01732536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111464841|NCT01732536|Dermatologic Agents|dermatologic agents|mesh-ancestor
111464842|NCT01732536|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111464843|NCT01755702|Acetaminophen|acetaminophen|mesh-list
111464844|NCT01755702|Ibuprofen|ibuprofen|mesh-list
111464845|NCT01755702|Caffeine|caffeine|mesh-list
111464846|NCT01755702|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111464847|NCT01755702|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111464848|NCT01755702|Analgesics|analgesics|mesh-ancestor
111464849|NCT01755702|Sensory System Agents|sensory system agents|mesh-ancestor
111464850|NCT01755702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111464851|NCT01755702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111464852|NCT01755702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111464853|NCT01755702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111464854|NCT01755702|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111464855|NCT01755702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111464856|NCT01755702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111464857|NCT01755702|Antipyretics|antipyretics|mesh-ancestor
111464858|NCT01755702|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110940727|NCT02233452|Methadone|methadone|mesh-list
111464859|NCT01755702|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111464860|NCT01755702|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
111464861|NCT01755702|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111464862|NCT01755702|Purinergic Agents|purinergic agents|mesh-ancestor
111464863|NCT01755702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111464864|NCT01732458|Ondansetron|ondansetron|mesh-list
111464865|NCT01732458|Aprepitant|aprepitant|mesh-list
111464866|NCT01732458|Fosaprepitant|fosaprepitant|mesh-list
111464867|NCT01732458|Antiemetics|antiemetics|mesh-ancestor
111464868|NCT01732458|Autonomic Agents|autonomic agents|mesh-ancestor
111464869|NCT01732458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111464870|NCT01732458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111464871|NCT01732458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111464872|NCT01732458|Antipruritics|antipruritics|mesh-ancestor
111464873|NCT01732458|Dermatologic Agents|dermatologic agents|mesh-ancestor
111464874|NCT01732458|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111464875|NCT01732458|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111464876|NCT01732458|Serotonin Agents|serotonin agents|mesh-ancestor
111464877|NCT01732458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111464878|NCT01732458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111464879|NCT01732458|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
111464880|NCT01708902|Metformin|metformin|mesh-list
111464881|NCT01708902|Linagliptin|linagliptin|mesh-list
111464882|NCT01708902|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111464883|NCT01708902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111464884|NCT01708902|Incretins|incretins|mesh-ancestor
111464885|NCT01708902|Hormones|hormones|mesh-ancestor
111464886|NCT01708902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111464887|NCT01708902|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111464888|NCT01708902|Protease Inhibitors|protease inhibitors|mesh-ancestor
111464889|NCT01708902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111464890|NCT01708902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111464891|NCT01755546|Buprenorphine|buprenorphine|mesh-list
111464892|NCT01755546|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111464893|NCT01755546|Narcotics|narcotics|mesh-ancestor
111464894|NCT01755546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111464895|NCT01755546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111464896|NCT01755546|Analgesics|analgesics|mesh-ancestor
111464897|NCT01755546|Sensory System Agents|sensory system agents|mesh-ancestor
111464898|NCT01755546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111464899|NCT01755546|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111464900|NCT04413864|Dexmedetomidine|dexmedetomidine|mesh-list
111464901|NCT04413864|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111464902|NCT04413864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111464903|NCT04413864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111464904|NCT04413864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111464905|NCT04413864|Analgesics|analgesics|mesh-ancestor
111464906|NCT04413864|Sensory System Agents|sensory system agents|mesh-ancestor
111464907|NCT04413864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111464908|NCT04413864|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111464909|NCT04413864|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111464910|NCT04413864|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111464911|NCT04413864|Adrenergic Agents|adrenergic agents|mesh-ancestor
111464912|NCT04413864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111464913|NCT04413864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111464915|NCT01755234|Sevoflurane|sevoflurane|mesh-list
111464916|NCT01755234|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111464917|NCT01755234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111464918|NCT01755234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111464919|NCT01755234|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111464920|NCT01755234|Anesthetics, General|anesthetics, general|mesh-ancestor
111464921|NCT01755234|Anesthetics|anesthetics|mesh-ancestor
111464922|NCT01755234|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111464923|NCT01755234|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111464924|NCT01730586|Paclitaxel|paclitaxel|mesh-list
111464925|NCT01730586|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111464926|NCT01730586|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111464927|NCT01730586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111464928|NCT01730586|Tubulin Modulators|tubulin modulators|mesh-ancestor
111464929|NCT01730586|Antimitotic Agents|antimitotic agents|mesh-ancestor
111464930|NCT01730586|Mitosis Modulators|mitosis modulators|mesh-ancestor
111464931|NCT01730586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111464932|NCT01755156|Metformin|metformin|mesh-list
111464933|NCT01755156|Insulin Glargine|insulin glargine|mesh-list
111464934|NCT01755156|Glimepiride|glimepiride|mesh-list
111464935|NCT01755156|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111464936|NCT01755156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111464937|NCT01755156|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111464938|NCT01755156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111464939|NCT01755156|Immunologic Factors|immunologic factors|mesh-ancestor
111464940|NCT01754376|Aldesleukin|aldesleukin|mesh-list
111464941|NCT01754376|Interleukin-2|interleukin-2|mesh-list
111464942|NCT01754376|Vemurafenib|vemurafenib|mesh-list
111464943|NCT01754376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111464944|NCT01754376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111464945|NCT01754376|Analgesics|analgesics|mesh-ancestor
111464946|NCT01754376|Sensory System Agents|sensory system agents|mesh-ancestor
111464947|NCT01754376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111464948|NCT01754376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111464949|NCT01754376|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111464950|NCT01754376|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111464951|NCT01754376|Antiviral Agents|antiviral agents|mesh-ancestor
111464952|NCT01754376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111464953|NCT01754376|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111464954|NCT01754376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111464955|NCT01754376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111464956|NCT01605396|Exemestane|exemestane|mesh-list
111464957|NCT01605396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111464958|NCT01605396|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111464959|NCT01605396|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111464960|NCT01605396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111464961|NCT01605396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111464962|NCT01605396|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111464963|NCT01605396|Hormone Antagonists|hormone antagonists|mesh-ancestor
111464964|NCT01605396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111464965|NCT01605396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111464966|NCT01730118|Mitogens|mitogens|mesh-list
111464967|NCT01730118|Mitosis Modulators|mitosis modulators|mesh-ancestor
111464968|NCT01730118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111464969|NCT01730040|Atorvastatin|atorvastatin|mesh-list
111464970|NCT01730040|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111464971|NCT01730040|Ezetimibe|ezetimibe|mesh-list
111464972|NCT01730040|Alirocumab|alirocumab|mesh-list
111464973|NCT01730040|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111464974|NCT01730040|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111464975|NCT01730040|Antimetabolites|antimetabolites|mesh-ancestor
111464976|NCT01730040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111464977|NCT01730040|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111464978|NCT01730040|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111464979|NCT01730040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111464980|NCT01730040|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
111464981|NCT01730040|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111464982|NCT01730040|Protease Inhibitors|protease inhibitors|mesh-ancestor
111464983|NCT01706328|Fluticasone|fluticasone|mesh-list
111464984|NCT01706328|Xhance|xhance|mesh-list
111464985|NCT01706328|Albuterol|albuterol|mesh-list
111464986|NCT01706328|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
111464987|NCT01706328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111464988|NCT01706328|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111464989|NCT01706328|Autonomic Agents|autonomic agents|mesh-ancestor
111464990|NCT01706328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111464991|NCT01706328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111464992|NCT01706328|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111464993|NCT01706328|Respiratory System Agents|respiratory system agents|mesh-ancestor
111464994|NCT01706328|Dermatologic Agents|dermatologic agents|mesh-ancestor
111464995|NCT01706328|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111464996|NCT01706328|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111464997|NCT01706328|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111464998|NCT01706328|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111464999|NCT01706328|Adrenergic Agents|adrenergic agents|mesh-ancestor
111465000|NCT01706328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111465001|NCT01706328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111465002|NCT01706328|Tocolytic Agents|tocolytic agents|mesh-ancestor
111465003|NCT01706328|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111465004|NCT01706250|Salicylic Acid|salicylic acid|mesh-list
111465005|NCT01706250|Salicylates|salicylates|mesh-list
111465006|NCT01706250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111465007|NCT01706250|Antifungal Agents|antifungal agents|mesh-ancestor
111465008|NCT01706250|Keratolytic Agents|keratolytic agents|mesh-ancestor
111465009|NCT01706250|Dermatologic Agents|dermatologic agents|mesh-ancestor
111465010|NCT01706250|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111465011|NCT01706250|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111465012|NCT01706250|Analgesics|analgesics|mesh-ancestor
111465013|NCT01706250|Sensory System Agents|sensory system agents|mesh-ancestor
111465014|NCT01706250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111465015|NCT01706250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111465016|NCT01706250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111465017|NCT01706250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111465018|NCT01706250|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111465019|NCT01706250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111465020|NCT01706250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111465021|NCT01729728|Tapentadol|tapentadol|mesh-list
111465022|NCT01729728|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111465023|NCT01729728|Narcotics|narcotics|mesh-ancestor
111465024|NCT01729728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111465025|NCT01729728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111465026|NCT01729728|Analgesics|analgesics|mesh-ancestor
111465027|NCT01729728|Sensory System Agents|sensory system agents|mesh-ancestor
111465028|NCT01729728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111465029|NCT01729728|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111465030|NCT01729728|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111465031|NCT01729728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111465032|NCT01729728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111465033|NCT01729728|Adrenergic Agents|adrenergic agents|mesh-ancestor
111465034|NCT01729728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111465035|NCT01728324|Ribavirin|ribavirin|mesh-list
111465036|NCT01728324|Antimetabolites|antimetabolites|mesh-ancestor
111465037|NCT01728324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111465038|NCT01728324|Antiviral Agents|antiviral agents|mesh-ancestor
111465039|NCT01728324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111465040|NCT01728246|Acetaminophen|acetaminophen|mesh-list
111465041|NCT01728246|Tramadol|tramadol|mesh-list
111465042|NCT01728246|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111465043|NCT01728246|Analgesics|analgesics|mesh-ancestor
111465044|NCT01728246|Sensory System Agents|sensory system agents|mesh-ancestor
111465045|NCT01728246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111465046|NCT01728246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111465047|NCT01728246|Antipyretics|antipyretics|mesh-ancestor
111465048|NCT01728246|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111465049|NCT01728246|Narcotics|narcotics|mesh-ancestor
111465050|NCT01728246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111465051|NCT04414020|Progesterone|progesterone|mesh-list
111465052|NCT04414020|Progestins|progestins|mesh-ancestor
111465053|NCT04414020|Hormones|hormones|mesh-ancestor
111465054|NCT04414020|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111465055|NCT04414020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111465056|NCT01705236|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
111465057|NCT01705236|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
111465058|NCT01705236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111465059|NCT01705236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111465060|NCT01705236|Immunologic Factors|immunologic factors|mesh-ancestor
111465061|NCT01705236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111465062|NCT01751802|Ecopipam|ecopipam|mesh-list
111465063|NCT01751802|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111465064|NCT01751802|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111465065|NCT01751802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111465066|NCT01751802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111465067|NCT01751802|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111465068|NCT01751802|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111465069|NCT01751802|Dopamine Agents|dopamine agents|mesh-ancestor
111465070|NCT01751802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110940769|NCT03041506|Anesthetics|anesthetics|mesh-ancestor
111465071|NCT01751802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111465072|NCT01703286|Glimepiride|glimepiride|mesh-list
111465073|NCT01703286|Linagliptin|linagliptin|mesh-list
111465074|NCT01703286|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111465075|NCT01703286|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111465076|NCT01703286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111465077|NCT01703286|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111465078|NCT01703286|Immunologic Factors|immunologic factors|mesh-ancestor
111465079|NCT01703286|Incretins|incretins|mesh-ancestor
111465080|NCT01703286|Hormones|hormones|mesh-ancestor
111465081|NCT01703286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111465082|NCT01703286|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111465083|NCT01703286|Protease Inhibitors|protease inhibitors|mesh-ancestor
111465084|NCT01703286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111465085|NCT01703286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111465086|NCT01727700|Aripiprazole|aripiprazole|mesh-list
111465087|NCT01727700|Antidepressive Agents|antidepressive agents|mesh-ancestor
111465088|NCT01727700|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111465089|NCT01727700|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111465090|NCT01727700|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111465091|NCT01727700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111465092|NCT01727700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111465093|NCT01727700|Dopamine Agonists|dopamine agonists|mesh-ancestor
111465094|NCT01727700|Dopamine Agents|dopamine agents|mesh-ancestor
111465095|NCT01727700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111465096|NCT01727700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111465097|NCT01727700|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111465098|NCT01727700|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111465099|NCT01727700|Serotonin Agents|serotonin agents|mesh-ancestor
111465100|NCT01727700|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111465101|NCT01727700|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111465102|NCT01727700|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111465103|NCT01727700|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111465104|NCT01725282|Quetiapine Fumarate|quetiapine fumarate|mesh-list
111465105|NCT01725282|Antidepressive Agents|antidepressive agents|mesh-ancestor
111465106|NCT01725282|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111465107|NCT01725282|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111465108|NCT01725282|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111465109|NCT01725282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111465110|NCT01725282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111465111|NCT01725126|Metformin|metformin|mesh-list
111465112|NCT01725126|Liraglutide|liraglutide|mesh-list
111465113|NCT01725126|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111465114|NCT01725126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111465115|NCT01725126|Incretins|incretins|mesh-ancestor
111465116|NCT01725126|Hormones|hormones|mesh-ancestor
111465117|NCT01725126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111465118|NCT01751724|Caffeine|caffeine|mesh-list
111465119|NCT01751724|Caffeine citrate|caffeine citrate|mesh-list
111465120|NCT01751724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111465121|NCT01751724|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111465122|NCT01751724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111465123|NCT01751724|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111465124|NCT01751724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111465125|NCT01751724|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
111465126|NCT01751724|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111465127|NCT01751724|Purinergic Agents|purinergic agents|mesh-ancestor
111465128|NCT01751724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111465129|NCT01751646|Vitamin D|vitamin d|mesh-list
111465130|NCT01751646|Ergocalciferols|ergocalciferols|mesh-list
111465131|NCT01751646|Cholecalciferol|cholecalciferol|mesh-list
111465132|NCT01751646|Vitamins|vitamins|mesh-list
111465133|NCT01751646|Micronutrients|micronutrients|mesh-ancestor
110940779|NCT03041506|Analgesics|analgesics|mesh-ancestor
111465134|NCT01751646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111465135|NCT01751646|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111465136|NCT01751646|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111465137|NCT01751568|Raltegravir Potassium|raltegravir potassium|mesh-list
111465138|NCT01751568|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111465139|NCT01751568|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111465140|NCT01751568|Antiviral Agents|antiviral agents|mesh-ancestor
111465141|NCT01751568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111465142|NCT01751568|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111465143|NCT01751568|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111465144|NCT01751568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111465145|NCT01751568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111465146|NCT01751178|Ethanol|ethanol|mesh-list
111465147|NCT01751178|Chlorhexidine|chlorhexidine|mesh-list
111465148|NCT01751178|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
111465149|NCT01751178|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111465150|NCT01751178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111465151|NCT01751178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111465152|NCT01751178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111465153|NCT01751178|Disinfectants|disinfectants|mesh-ancestor
111465154|NCT01751178|Dermatologic Agents|dermatologic agents|mesh-ancestor
111465155|NCT01606254|Paliperidone Palmitate|paliperidone palmitate|mesh-list
111465156|NCT01606254|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111465157|NCT01606254|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111465158|NCT01606254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111465159|NCT01606254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111465160|NCT01606254|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111465161|NCT01606254|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111465162|NCT01606254|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111465163|NCT01606254|Serotonin Agents|serotonin agents|mesh-ancestor
111465164|NCT01606254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111465165|NCT01606254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111465166|NCT01606254|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111465167|NCT01606254|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111465168|NCT01606254|Dopamine Agents|dopamine agents|mesh-ancestor
111465169|NCT01723254|Immunoglobulin E|immunoglobulin e|mesh-list
111465170|NCT01723254|Immunologic Factors|immunologic factors|mesh-ancestor
111465171|NCT01723254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111465172|NCT01722162|Bevacizumab|bevacizumab|mesh-list
111465173|NCT01722162|Capecitabine|capecitabine|mesh-list
111465174|NCT01722162|Levocetirizine|levocetirizine|mesh-list
111465175|NCT01722162|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111465176|NCT01722162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111465177|NCT01722162|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111465178|NCT01722162|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111465179|NCT01722162|Growth Substances|growth substances|mesh-ancestor
111465180|NCT01722162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111465181|NCT01722162|Growth Inhibitors|growth inhibitors|mesh-ancestor
111465182|NCT01722162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111465183|NCT01722162|Antimetabolites|antimetabolites|mesh-ancestor
111465184|NCT01722162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111465185|NCT01722162|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
111465186|NCT01722162|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111465187|NCT01722162|Histamine Antagonists|histamine antagonists|mesh-ancestor
111465188|NCT01722162|Histamine Agents|histamine agents|mesh-ancestor
111465189|NCT01722162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111465191|NCT01721772|Dacarbazine|dacarbazine|mesh-list
111465192|NCT01721772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111465193|NCT01721772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111465194|NCT01721772|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111465195|NCT01721772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111465196|NCT01721772|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111465197|NCT01721772|Alkylating Agents|alkylating agents|mesh-ancestor
111465198|NCT01702428|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
111465199|NCT01702428|Immunologic Factors|immunologic factors|mesh-ancestor
111465200|NCT01702428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111465201|NCT01701258|Amisulpride|amisulpride|mesh-list
111465202|NCT01701258|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111465203|NCT01701258|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111465204|NCT01701258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111465205|NCT01701258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111465206|NCT01701258|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111465207|NCT01701258|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111465208|NCT01701258|Dopamine Agents|dopamine agents|mesh-ancestor
111465209|NCT01701258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111465210|NCT01701258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111465211|NCT01701258|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111465212|NCT01701258|Antidepressive Agents|antidepressive agents|mesh-ancestor
111465213|NCT01700946|Cytarabine|cytarabine|mesh-list
111465214|NCT01700946|Aldesleukin|aldesleukin|mesh-list
111465215|NCT01700946|Dexamethasone|dexamethasone|mesh-list
111465216|NCT01700946|Hydrocortisone|hydrocortisone|mesh-list
111465217|NCT01700946|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
111465218|NCT01700946|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
111465219|NCT01700946|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
111465220|NCT01700946|Cyclophosphamide|cyclophosphamide|mesh-list
111465221|NCT01700946|Rituximab|rituximab|mesh-list
111465222|NCT01700946|Methotrexate|methotrexate|mesh-list
111465223|NCT01700946|Etoposide|etoposide|mesh-list
111465224|NCT01700946|Vincristine|vincristine|mesh-list
111465225|NCT01700946|Asparaginase|asparaginase|mesh-list
111465226|NCT01700946|Interleukin-2|interleukin-2|mesh-list
111465227|NCT01700946|Mitoxantrone|mitoxantrone|mesh-list
111465228|NCT01700946|Mercaptopurine|mercaptopurine|mesh-list
111465229|NCT01700946|Clofarabine|clofarabine|mesh-list
111465230|NCT01700946|Vinblastine|vinblastine|mesh-list
111465231|NCT01700946|Pegaspargase|pegaspargase|mesh-list
111465232|NCT01700946|Teniposide|teniposide|mesh-list
111465233|NCT01700946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111465234|NCT01700946|Immunologic Factors|immunologic factors|mesh-ancestor
111465235|NCT01700946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111465236|NCT01700946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111465237|NCT01700946|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111465238|NCT01700946|Alkylating Agents|alkylating agents|mesh-ancestor
111465239|NCT01700946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111465240|NCT01700946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111465241|NCT01700946|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111465242|NCT01700946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111465243|NCT01700946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111465244|NCT01700946|Antiemetics|antiemetics|mesh-ancestor
111465245|NCT01700946|Autonomic Agents|autonomic agents|mesh-ancestor
111465246|NCT01700946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111465247|NCT01700946|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111465248|NCT01700946|Glucocorticoids|glucocorticoids|mesh-ancestor
111465249|NCT01700946|Hormones|hormones|mesh-ancestor
110940882|NCT02262936|Hemostatics|hemostatics|mesh-ancestor
110940883|NCT02262936|Coagulants|coagulants|mesh-ancestor
111465250|NCT01700946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111465251|NCT01700946|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111465252|NCT01700946|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111465253|NCT01700946|Abortifacient Agents|abortifacient agents|mesh-ancestor
111465254|NCT01700946|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111465255|NCT01700946|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111465256|NCT01700946|Antimetabolites|antimetabolites|mesh-ancestor
111465257|NCT01700946|Dermatologic Agents|dermatologic agents|mesh-ancestor
111465258|NCT01700946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111465259|NCT01700946|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111465260|NCT01700946|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111465261|NCT01700946|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111465262|NCT01700946|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111465264|NCT01700946|Antiviral Agents|antiviral agents|mesh-ancestor
111465265|NCT01700946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111465266|NCT01700946|Tubulin Modulators|tubulin modulators|mesh-ancestor
111465267|NCT01700946|Antimitotic Agents|antimitotic agents|mesh-ancestor
111465268|NCT01700946|Mitosis Modulators|mitosis modulators|mesh-ancestor
111465269|NCT01700946|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111465270|NCT01700946|Analgesics|analgesics|mesh-ancestor
111465271|NCT01700946|Sensory System Agents|sensory system agents|mesh-ancestor
111465272|NCT01700946|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111465273|NCT01700946|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111465274|NCT01748994|Pioglitazone|pioglitazone|mesh-list
111465275|NCT01748994|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111465276|NCT01748994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111465277|NCT01721070|Ketoconazole|ketoconazole|mesh-list
111465278|NCT01721070|Sufentanil|sufentanil|mesh-list
111465279|NCT01721070|Dsuvia|dsuvia|mesh-list
111465280|NCT01721070|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111465281|NCT01721070|Narcotics|narcotics|mesh-ancestor
111465282|NCT01721070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111465283|NCT01721070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111465284|NCT01721070|Analgesics|analgesics|mesh-ancestor
111465285|NCT01721070|Sensory System Agents|sensory system agents|mesh-ancestor
111465286|NCT01721070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111465287|NCT01721070|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111465288|NCT01721070|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111465289|NCT01721070|Anesthetics, General|anesthetics, general|mesh-ancestor
111465290|NCT01721070|Anesthetics|anesthetics|mesh-ancestor
111465291|NCT01721070|Antifungal Agents|antifungal agents|mesh-ancestor
111465292|NCT01721070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111465293|NCT01721070|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111465294|NCT01721070|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111465295|NCT01721070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111465296|NCT01721070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111465297|NCT01721070|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111465298|NCT01721070|Hormone Antagonists|hormone antagonists|mesh-ancestor
111465299|NCT01721070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111465300|NCT01721070|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111465301|NCT01748292|Ranibizumab|ranibizumab|mesh-list
111465302|NCT01748292|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111465303|NCT01748292|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111465304|NCT01748292|Growth Substances|growth substances|mesh-ancestor
111465305|NCT01748292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111465306|NCT01748292|Growth Inhibitors|growth inhibitors|mesh-ancestor
111465307|NCT01748292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111465308|NCT01720602|Letrozole|letrozole|mesh-list
111465309|NCT01720602|Anastrozole|anastrozole|mesh-list
111465310|NCT01720602|Vorinostat|vorinostat|mesh-list
111465311|NCT01720602|Exemestane|exemestane|mesh-list
111465312|NCT01720602|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
111465313|NCT01720602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111465314|NCT01720602|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111465315|NCT01720602|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111465316|NCT01720602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111465317|NCT01720602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111465318|NCT01720602|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111465319|NCT01720602|Hormone Antagonists|hormone antagonists|mesh-ancestor
111465320|NCT01720602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111465321|NCT01720602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111465322|NCT01720602|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111465323|NCT01720602|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111465324|NCT01720602|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111465325|NCT01746732|Moxifloxacin|moxifloxacin|mesh-list
111465326|NCT01746732|Evacetrapib|evacetrapib|mesh-list
111465327|NCT01746732|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
111465328|NCT01746732|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111465329|NCT01746732|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111465330|NCT01746732|Antimetabolites|antimetabolites|mesh-ancestor
111465331|NCT01746732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111465332|NCT01746732|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111465333|NCT01746732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111189462|NCT03655002|Nivolumab|nivolumab|mesh-list
111465334|NCT01746732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111465335|NCT01746732|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111465336|NCT01746732|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111465337|NCT01746732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111465338|NCT01746732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111465339|NCT01746732|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111465340|NCT01746732|Contraceptive Agents|contraceptive agents|mesh-ancestor
111465341|NCT01746732|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111465342|NCT01746732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111465343|NCT01746732|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
111465344|NCT01746732|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111465345|NCT01746732|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111465346|NCT01720524|Sildenafil Citrate|sildenafil citrate|mesh-list
111465347|NCT01720524|Vasodilator Agents|vasodilator agents|mesh-ancestor
111465348|NCT01720524|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111465349|NCT01720524|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111465350|NCT01720524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111465351|NCT01720524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111465352|NCT01720524|Urological Agents|urological agents|mesh-ancestor
111465353|NCT01717638|Vaccines|vaccines|mesh-list
111465354|NCT01717638|Immunologic Factors|immunologic factors|mesh-ancestor
111465355|NCT01717638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111465356|NCT01745094|Solifenacin Succinate|solifenacin succinate|mesh-list
111465357|NCT01745094|Mirabegron|mirabegron|mesh-list
111465358|NCT01745094|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111465359|NCT01745094|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111465360|NCT01745094|Cholinergic Agents|cholinergic agents|mesh-ancestor
111465361|NCT01745094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111465362|NCT01745094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111465363|NCT01745094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111465364|NCT01745094|Urological Agents|urological agents|mesh-ancestor
111465365|NCT01745094|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
111465366|NCT01745094|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111465367|NCT01745094|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111465368|NCT01745094|Adrenergic Agents|adrenergic agents|mesh-ancestor
111465369|NCT01717326|Ribavirin|ribavirin|mesh-list
111465370|NCT01717326|Grazoprevir|grazoprevir|mesh-list
111465371|NCT01717326|Antimetabolites|antimetabolites|mesh-ancestor
111465372|NCT01717326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111465373|NCT01717326|Antiviral Agents|antiviral agents|mesh-ancestor
111465374|NCT01717326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111465375|NCT01744782|Cysteamine|cysteamine|mesh-list
111465376|NCT01744782|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
111465377|NCT01744782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111465378|NCT01604850|Sofosbuvir|sofosbuvir|mesh-list
111465379|NCT01604850|Antiviral Agents|antiviral agents|mesh-ancestor
111465380|NCT01604850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111465381|NCT01742286|Ceritinib|ceritinib|mesh-list
111465382|NCT01742286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111465383|NCT01742286|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111465384|NCT01742286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111465385|NCT01742286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111465386|NCT01716234|Posaconazole|posaconazole|mesh-list
111465387|NCT01716234|Antifungal Agents|antifungal agents|mesh-ancestor
111465388|NCT01716234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111465389|NCT01716234|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
111465390|NCT01716234|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111465391|NCT01716234|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111465392|NCT01716234|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111465393|NCT01716234|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111465394|NCT01716234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111465395|NCT01716234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111465396|NCT01716234|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111465397|NCT01716234|Hormone Antagonists|hormone antagonists|mesh-ancestor
111465398|NCT01716234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111465399|NCT01716234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111465400|NCT01716156|Ribavirin|ribavirin|mesh-list
111465401|NCT01716156|Grazoprevir|grazoprevir|mesh-list
111465402|NCT01716156|Antimetabolites|antimetabolites|mesh-ancestor
111465403|NCT01716156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111465404|NCT01716156|Antiviral Agents|antiviral agents|mesh-ancestor
111465405|NCT01716156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111465406|NCT01739790|Acetylcysteine|acetylcysteine|mesh-list
111465407|NCT01739790|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111465408|NCT01739790|Antiviral Agents|antiviral agents|mesh-ancestor
111465409|NCT01739790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111465411|NCT01739790|Respiratory System Agents|respiratory system agents|mesh-ancestor
111465412|NCT01739790|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111465413|NCT01739790|Antioxidants|antioxidants|mesh-ancestor
111465414|NCT01739790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111465415|NCT01739790|Protective Agents|protective agents|mesh-ancestor
110940966|NCT05252988|Loperamide|loperamide|mesh-list
111465416|NCT01739790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111465417|NCT01739790|Antidotes|antidotes|mesh-ancestor
111465418|NCT01696032|Paclitaxel|paclitaxel|mesh-list
111465419|NCT01696032|Carboplatin|carboplatin|mesh-list
111465420|NCT01696032|Gemcitabine|gemcitabine|mesh-list
111465421|NCT01696032|Doxorubicin|doxorubicin|mesh-list
111465422|NCT01696032|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111465423|NCT01696032|Topotecan|topotecan|mesh-list
111465424|NCT01696032|Guadecitabine|guadecitabine|mesh-list
111465425|NCT01696032|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111465426|NCT01696032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111465427|NCT01696032|Tubulin Modulators|tubulin modulators|mesh-ancestor
111465428|NCT01696032|Antimitotic Agents|antimitotic agents|mesh-ancestor
111465429|NCT01696032|Mitosis Modulators|mitosis modulators|mesh-ancestor
111465430|NCT01696032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111465431|NCT01696032|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111465432|NCT01696032|Antimetabolites|antimetabolites|mesh-ancestor
111465433|NCT01696032|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111465434|NCT01696032|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111465435|NCT01696032|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111465436|NCT01696032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111465437|NCT01696032|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111465438|NCT01695954|Ritonavir|ritonavir|mesh-list
111465439|NCT01695954|Darunavir|darunavir|mesh-list
111465440|NCT01695954|Efavirenz|efavirenz|mesh-list
111465441|NCT01695954|Pitavastatin|pitavastatin|mesh-list
111465442|NCT01695954|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111465443|NCT01695954|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111465444|NCT01695954|Protease Inhibitors|protease inhibitors|mesh-ancestor
111465445|NCT01695954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111465446|NCT01695954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110940975|NCT03038230|Antibodies|antibodies|mesh-list
111465447|NCT01695954|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111465448|NCT01695954|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111465449|NCT01695954|Antiviral Agents|antiviral agents|mesh-ancestor
111465450|NCT01695954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111465451|NCT01695954|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111465452|NCT01695954|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111465453|NCT01695954|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111465454|NCT01695954|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111465455|NCT01695954|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111465456|NCT01695954|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111465457|NCT01695954|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111465458|NCT01695954|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111465459|NCT01695954|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111465460|NCT01695954|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111465461|NCT01695954|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111465462|NCT01695954|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111465463|NCT01695954|Antimetabolites|antimetabolites|mesh-ancestor
111465464|NCT01695954|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111465465|NCT01694706|Omeprazole|omeprazole|mesh-list
111465466|NCT01694706|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111465467|NCT01694706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111465468|NCT01694706|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111465469|NCT01694706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111465470|NCT01694706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111465471|NCT01715298|Glycopyrrolate|glycopyrrolate|mesh-list
111465472|NCT01715298|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111465473|NCT01715298|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111465474|NCT01715298|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111465475|NCT01715298|Cholinergic Agents|cholinergic agents|mesh-ancestor
111465476|NCT01715298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111465477|NCT01715298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111465478|NCT01715298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111465479|NCT01739400|Macitentan|macitentan|mesh-list
111465480|NCT01739400|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
111465481|NCT01739400|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
111189611|NCT03362515|Natriuretic Agents|natriuretic agents|mesh-ancestor
111465482|NCT01739400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111465483|NCT01739400|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
111465484|NCT01712178|Adalimumab|adalimumab|mesh-list
111465485|NCT01712178|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111465486|NCT01712178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111465487|NCT01712178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111465488|NCT01693068|Dacarbazine|dacarbazine|mesh-list
111465489|NCT01693068|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111465490|NCT01693068|Alkylating Agents|alkylating agents|mesh-ancestor
111465491|NCT01693068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111465492|NCT01693068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111465493|NCT01691898|Rituximab|rituximab|mesh-list
111465494|NCT01691898|Obinutuzumab|obinutuzumab|mesh-list
111465495|NCT01691898|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
111465496|NCT01691898|Pinatuzumab vedotin|pinatuzumab vedotin|mesh-list
111465497|NCT01691898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111465498|NCT01691898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111465499|NCT01691898|Immunologic Factors|immunologic factors|mesh-ancestor
111465500|NCT01691898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111465501|NCT01691898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111465502|NCT01691898|Immunoconjugates|immunoconjugates|mesh-ancestor
111465503|NCT01737840|Pantoprazole|pantoprazole|mesh-list
111465504|NCT01737840|Ranitidine|ranitidine|mesh-list
111465505|NCT01737840|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
111465506|NCT01737840|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111465507|NCT01737840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111465508|NCT01737840|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111465509|NCT01737840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111465510|NCT01737840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111465511|NCT01737840|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
111465512|NCT01737840|Histamine Antagonists|histamine antagonists|mesh-ancestor
111465513|NCT01737840|Histamine Agents|histamine agents|mesh-ancestor
111465514|NCT01737840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111465515|NCT01737840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111465516|NCT01711866|Rotigotine|rotigotine|mesh-list
111465517|NCT01711866|Dopamine Agonists|dopamine agonists|mesh-ancestor
111465518|NCT01711866|Dopamine Agents|dopamine agents|mesh-ancestor
111465519|NCT01711866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111465520|NCT01711866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111465521|NCT01711866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111465522|NCT01691508|Prednisone|prednisone|mesh-list
111465523|NCT01691508|Prednisolone|prednisolone|mesh-list
111465524|NCT01691508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111465525|NCT01691508|Glucocorticoids|glucocorticoids|mesh-ancestor
111465526|NCT01691508|Hormones|hormones|mesh-ancestor
111465527|NCT01691508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111465528|NCT01691508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111465529|NCT01691508|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111465530|NCT01691508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111465531|NCT01682460|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111465532|NCT01682460|Lubricant Eye Drops|lubricant eye drops|mesh-list
111465533|NCT01682460|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111465534|NCT01709838|Deferasirox|deferasirox|mesh-list
111465535|NCT01709838|Iron Chelating Agents|iron chelating agents|mesh-ancestor
111465536|NCT01709838|Chelating Agents|chelating agents|mesh-ancestor
111465537|NCT01709838|Sequestering Agents|sequestering agents|mesh-ancestor
111465538|NCT01709838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111465539|NCT01688466|Pomalidomide|pomalidomide|mesh-list
111465540|NCT01688466|Immunologic Factors|immunologic factors|mesh-ancestor
111465541|NCT01688466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111465542|NCT01688466|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111465543|NCT01688466|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111465544|NCT01688466|Growth Substances|growth substances|mesh-ancestor
111465545|NCT01688466|Growth Inhibitors|growth inhibitors|mesh-ancestor
111465546|NCT01688466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111465547|NCT01682148|Botulinum Toxins|botulinum toxins|mesh-list
111465548|NCT01682148|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111465549|NCT01682148|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111465550|NCT01682148|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111465551|NCT01682148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111465552|NCT01682148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111465553|NCT01682148|Cholinergic Agents|cholinergic agents|mesh-ancestor
111465554|NCT01682148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111465555|NCT01682148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111465556|NCT01682148|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111465557|NCT01682148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111465558|NCT01681992|Vaccines|vaccines|mesh-list
111465559|NCT01681992|Immunologic Factors|immunologic factors|mesh-ancestor
111465560|NCT01681992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111465561|NCT01687998|Evacetrapib|evacetrapib|mesh-list
111465562|NCT01687998|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111465563|NCT01687998|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111465564|NCT01687998|Antimetabolites|antimetabolites|mesh-ancestor
111465565|NCT01687998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111465566|NCT01687998|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111465568|NCT01681212|Dacarbazine|dacarbazine|mesh-list
111465569|NCT01681212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111465570|NCT01681212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111465571|NCT01681212|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111465572|NCT01681212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111465573|NCT01681212|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111465574|NCT01681212|Alkylating Agents|alkylating agents|mesh-ancestor
111465575|NCT01687296|Fluticasone|fluticasone|mesh-list
111465576|NCT01687296|Xhance|xhance|mesh-list
111465577|NCT01687296|Prednisone|prednisone|mesh-list
111465578|NCT01687296|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111465579|NCT01687296|Albuterol|albuterol|mesh-list
111465580|NCT01687296|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111465581|NCT01687296|Glucocorticoids|glucocorticoids|mesh-ancestor
111465582|NCT01687296|Hormones|hormones|mesh-ancestor
111465583|NCT01687296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111465584|NCT01687296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111465585|NCT01687296|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111465586|NCT01687296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111465587|NCT01687296|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111465588|NCT01687296|Autonomic Agents|autonomic agents|mesh-ancestor
111465589|NCT01687296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111465590|NCT01687296|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111465591|NCT01687296|Respiratory System Agents|respiratory system agents|mesh-ancestor
111465592|NCT01687296|Dermatologic Agents|dermatologic agents|mesh-ancestor
111465593|NCT01687296|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111465594|NCT01687296|Tocolytic Agents|tocolytic agents|mesh-ancestor
111465595|NCT01687296|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111465596|NCT01687296|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111465597|NCT01687296|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111465598|NCT01687296|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111465599|NCT01687296|Adrenergic Agents|adrenergic agents|mesh-ancestor
111465600|NCT01687296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111465601|NCT01687296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111465602|NCT01568892|Dolutegravir|dolutegravir|mesh-list
111465603|NCT01568892|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111465604|NCT01568892|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111465605|NCT01568892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111465606|NCT01568892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111465607|NCT01568892|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111465608|NCT01568892|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111465609|NCT01568892|Antiviral Agents|antiviral agents|mesh-ancestor
111465610|NCT01568892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111465611|NCT01568112|Aspirin|aspirin|mesh-list
111465612|NCT01568112|Dimethyl Fumarate|dimethyl fumarate|mesh-list
111465613|NCT01568112|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111465614|NCT01568112|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111465615|NCT01568112|Analgesics|analgesics|mesh-ancestor
111465616|NCT01568112|Sensory System Agents|sensory system agents|mesh-ancestor
111465617|NCT01568112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111465618|NCT01568112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111465619|NCT01568112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111465620|NCT01568112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111465621|NCT01568112|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111465622|NCT01568112|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111465623|NCT01568112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111465624|NCT01568112|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111465625|NCT01568112|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111465626|NCT01568112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111465627|NCT01568112|Antipyretics|antipyretics|mesh-ancestor
111465628|NCT01568112|Dermatologic Agents|dermatologic agents|mesh-ancestor
111465629|NCT01568112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111465630|NCT01568112|Immunologic Factors|immunologic factors|mesh-ancestor
111465631|NCT01568034|Levodopa|levodopa|mesh-list
111465632|NCT01568034|Carbidopa|carbidopa|mesh-list
111465633|NCT01568034|Opicapone|opicapone|mesh-list
111465634|NCT01568034|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111465635|NCT01568034|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111465636|NCT01568034|Dopamine Agents|dopamine agents|mesh-ancestor
111465637|NCT01568034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111465638|NCT01568034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111465639|NCT01568034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111465640|NCT01568034|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
111465641|NCT01568034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111465642|NCT01568034|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
111465643|NCT01687218|Tenofovir|tenofovir|mesh-list
111465644|NCT01687218|Emtricitabine|emtricitabine|mesh-list
111465645|NCT01687218|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
111465646|NCT01687218|Glycerol|glycerol|mesh-list
111465647|NCT01687218|Antiviral Agents|antiviral agents|mesh-ancestor
111465648|NCT01687218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111465649|NCT01687218|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111465650|NCT01687218|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111465651|NCT01687218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111465652|NCT01687218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111465653|NCT01687218|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111465654|NCT01687218|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111465655|NCT01687218|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
111465656|NCT01687218|Protective Agents|protective agents|mesh-ancestor
111465657|NCT01687218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111465658|NCT01686828|Letrozole|letrozole|mesh-list
111465659|NCT01686828|Methyltestosterone|methyltestosterone|mesh-list
111465660|NCT01686828|Acyline|acyline|mesh-list
111465661|NCT01686828|Testosterone|testosterone|mesh-list
111465662|NCT01686828|Testosterone undecanoate|testosterone undecanoate|mesh-list
111465663|NCT01686828|Testosterone enanthate|testosterone enanthate|mesh-list
111465664|NCT01686828|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
111465665|NCT01686828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111465666|NCT01686828|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111465667|NCT01686828|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111465668|NCT01686828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111465669|NCT01686828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111465670|NCT01686828|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111465671|NCT01686828|Hormone Antagonists|hormone antagonists|mesh-ancestor
111465672|NCT01686828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111465673|NCT01686828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111465674|NCT01686828|Androgens|androgens|mesh-ancestor
111465675|NCT01686828|Hormones|hormones|mesh-ancestor
111465676|NCT01686828|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111465677|NCT01686828|Anabolic Agents|anabolic agents|mesh-ancestor
111465678|NCT01603602|Botulinum Toxins|botulinum toxins|mesh-list
111465679|NCT01603602|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111465680|NCT01603602|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111465681|NCT01603602|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111465682|NCT01603602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111465683|NCT01603602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111465684|NCT01603602|Cholinergic Agents|cholinergic agents|mesh-ancestor
111465685|NCT01603602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111465686|NCT01603602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111465687|NCT01603602|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111465688|NCT01603602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111465689|NCT01684878|Paclitaxel|paclitaxel|mesh-list
111465690|NCT01684878|Gemcitabine|gemcitabine|mesh-list
111465691|NCT01684878|Topotecan|topotecan|mesh-list
111465692|NCT01684878|Pertuzumab|pertuzumab|mesh-list
111465693|NCT01684878|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111465694|NCT01684878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111465695|NCT01684878|Tubulin Modulators|tubulin modulators|mesh-ancestor
111465696|NCT01684878|Antimitotic Agents|antimitotic agents|mesh-ancestor
111465697|NCT01684878|Mitosis Modulators|mitosis modulators|mesh-ancestor
111465698|NCT01684878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111465699|NCT01684878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111465700|NCT01684878|Antimetabolites|antimetabolites|mesh-ancestor
111465701|NCT01684878|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111465702|NCT01684878|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111465703|NCT01684878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111465704|NCT01684878|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111465705|NCT01684722|Vitamin D|vitamin d|mesh-list
111465706|NCT01684722|Ergocalciferols|ergocalciferols|mesh-list
111465707|NCT01684722|Cholecalciferol|cholecalciferol|mesh-list
111465708|NCT01684722|Vitamins|vitamins|mesh-list
111465709|NCT01684722|Micronutrients|micronutrients|mesh-ancestor
111465710|NCT01684722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111465711|NCT01684722|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111465712|NCT01684722|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111465713|NCT01592292|Adalimumab|adalimumab|mesh-list
111465714|NCT01592292|Infliximab|infliximab|mesh-list
111465715|NCT01592292|Etanercept|etanercept|mesh-list
111465716|NCT01592292|Rituximab|rituximab|mesh-list
111465717|NCT01592292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111465718|NCT01592292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111465719|NCT01592292|Immunologic Factors|immunologic factors|mesh-ancestor
111465720|NCT01592292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111465721|NCT01592292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111465722|NCT01592292|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111465723|NCT01592292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111465724|NCT01592292|Dermatologic Agents|dermatologic agents|mesh-ancestor
111465725|NCT01592292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111465726|NCT01592292|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111465727|NCT01592292|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111465728|NCT01592292|Analgesics|analgesics|mesh-ancestor
111465729|NCT01592292|Sensory System Agents|sensory system agents|mesh-ancestor
111465730|NCT01592292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111465731|NCT01592292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111465732|NCT01565850|Darunavir|darunavir|mesh-list
111465733|NCT01565850|Cobicistat|cobicistat|mesh-list
111465734|NCT01565850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111465735|NCT01565850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111465736|NCT01565850|Antiviral Agents|antiviral agents|mesh-ancestor
111465737|NCT01565850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111465738|NCT01565850|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111465739|NCT01565850|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111465740|NCT01565850|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111465741|NCT01565850|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111465742|NCT01565850|Protease Inhibitors|protease inhibitors|mesh-ancestor
111465743|NCT01565850|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111465744|NCT01565850|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111465745|NCT01565694|Solifenacin Succinate|solifenacin succinate|mesh-list
111465746|NCT01565694|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111465747|NCT01565694|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111465748|NCT01565694|Cholinergic Agents|cholinergic agents|mesh-ancestor
111465749|NCT01565694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111465750|NCT01565694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111465751|NCT01565694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111465752|NCT01565694|Urological Agents|urological agents|mesh-ancestor
111465753|NCT01543152|Cyclophosphamide|cyclophosphamide|mesh-list
111465754|NCT01543152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111465755|NCT01543152|Immunologic Factors|immunologic factors|mesh-ancestor
111465756|NCT01543152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111465757|NCT01543152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111465758|NCT01543152|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111465759|NCT01543152|Alkylating Agents|alkylating agents|mesh-ancestor
111465760|NCT01543152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111465761|NCT01543152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111465762|NCT01543152|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111465763|NCT01565148|Ranibizumab|ranibizumab|mesh-list
111465764|NCT01565148|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111465765|NCT01565148|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111465766|NCT01565148|Growth Substances|growth substances|mesh-ancestor
111465767|NCT01565148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111465768|NCT01565148|Growth Inhibitors|growth inhibitors|mesh-ancestor
111465769|NCT01565148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111465770|NCT04410354|Remdesivir|remdesivir|mesh-list
111465771|NCT04410354|Antimetabolites|antimetabolites|mesh-ancestor
111465772|NCT04410354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111465773|NCT04410354|Antiviral Agents|antiviral agents|mesh-ancestor
111465774|NCT04410354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111465775|NCT01564758|Linezolid|linezolid|mesh-list
111465776|NCT01564758|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111465777|NCT01564758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111465778|NCT01564758|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111465779|NCT01564758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111465780|NCT01564758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111465781|NCT01589094|Gemcitabine|gemcitabine|mesh-list
111465782|NCT01589094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111465783|NCT01589094|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111465784|NCT01589094|Antimetabolites|antimetabolites|mesh-ancestor
111465785|NCT01589094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111465786|NCT01563354|Everolimus|everolimus|mesh-list
111465787|NCT01563354|Pasireotide|pasireotide|mesh-list
111465788|NCT01563354|Somatostatin|somatostatin|mesh-list
111465789|NCT01563354|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111465790|NCT01563354|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111465791|NCT01563354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111465792|NCT01563354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111465793|NCT01563354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111465794|NCT01563354|Immunologic Factors|immunologic factors|mesh-ancestor
111465795|NCT01563354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111465796|NCT01563354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111465797|NCT01563354|Hormones|hormones|mesh-ancestor
111465798|NCT01563354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111465799|NCT03027960|Empagliflozin|empagliflozin|mesh-list
111465800|NCT03027960|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111465801|NCT03027960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111465802|NCT03027960|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111465803|NCT03027960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111465804|NCT01539642|Sufentanil|sufentanil|mesh-list
111465805|NCT01539642|Dsuvia|dsuvia|mesh-list
111465806|NCT01539642|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111465807|NCT01539642|Narcotics|narcotics|mesh-ancestor
111465808|NCT01539642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111465809|NCT01539642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111465810|NCT01539642|Analgesics|analgesics|mesh-ancestor
111465811|NCT01539642|Sensory System Agents|sensory system agents|mesh-ancestor
111465812|NCT01539642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111465813|NCT01539642|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111465814|NCT01539642|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111465815|NCT01539642|Anesthetics, General|anesthetics, general|mesh-ancestor
111465816|NCT01539642|Anesthetics|anesthetics|mesh-ancestor
111465817|NCT01538472|Cytarabine|cytarabine|mesh-list
111465818|NCT01538472|Rituximab|rituximab|mesh-list
111465819|NCT01538472|Melphalan|melphalan|mesh-list
111465820|NCT01538472|Carmustine|carmustine|mesh-list
111465821|NCT01538472|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111465822|NCT01538472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111465823|NCT01538472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111465824|NCT01538472|Immunologic Factors|immunologic factors|mesh-ancestor
111465825|NCT01538472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111465826|NCT01538472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111465827|NCT01538472|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111465828|NCT01538472|Antimetabolites|antimetabolites|mesh-ancestor
111465829|NCT01538472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111465830|NCT01538472|Antiviral Agents|antiviral agents|mesh-ancestor
111465831|NCT01538472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111465832|NCT01538472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111465833|NCT01538472|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111465834|NCT01538472|Alkylating Agents|alkylating agents|mesh-ancestor
111465835|NCT01538472|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111465836|NCT01562028|Bevacizumab|bevacizumab|mesh-list
111465837|NCT01562028|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111465838|NCT01562028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111465839|NCT01562028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111465840|NCT01562028|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111465841|NCT01562028|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111465842|NCT01562028|Growth Substances|growth substances|mesh-ancestor
111465843|NCT01562028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111465844|NCT01562028|Growth Inhibitors|growth inhibitors|mesh-ancestor
111465845|NCT01562028|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111465846|NCT01562028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111465847|NCT01562028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111465848|NCT04767828|Capecitabine|capecitabine|mesh-list
110941114|NCT03037606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111465849|NCT04767828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111465850|NCT04767828|Antimetabolites|antimetabolites|mesh-ancestor
111465851|NCT04767828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111465852|NCT04767828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111465853|NCT01585584|Protease Inhibitors|protease inhibitors|mesh-list
111465854|NCT01585584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111465855|NCT01585584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111465856|NCT01537068|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
111465857|NCT01537068|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111465858|NCT01537068|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111465859|NCT01537068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111465860|NCT01537068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111465861|NCT01537068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111465862|NCT01537068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111465863|NCT01537068|Antidepressive Agents|antidepressive agents|mesh-ancestor
111465864|NCT01537068|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111465865|NCT01585428|Aldesleukin|aldesleukin|mesh-list
111465866|NCT01585428|Cyclophosphamide|cyclophosphamide|mesh-list
111465867|NCT01585428|Fludarabine|fludarabine|mesh-list
111465868|NCT01585428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111465869|NCT01585428|Immunologic Factors|immunologic factors|mesh-ancestor
111465870|NCT01585428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111465871|NCT01585428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111465872|NCT01585428|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111465873|NCT01585428|Alkylating Agents|alkylating agents|mesh-ancestor
111465874|NCT01585428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111465875|NCT01585428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111465876|NCT01585428|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111465877|NCT01585428|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111465878|NCT01585428|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111465879|NCT01585428|Antiviral Agents|antiviral agents|mesh-ancestor
111465880|NCT01585428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111465881|NCT01585272|Rivastigmine|rivastigmine|mesh-list
111465882|NCT01585272|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111465883|NCT01585272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111465884|NCT01585272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111465885|NCT01585272|Cholinergic Agents|cholinergic agents|mesh-ancestor
111465886|NCT01585272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111465887|NCT01585272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111465888|NCT01585272|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111465889|NCT01585272|Protective Agents|protective agents|mesh-ancestor
111465890|NCT01560780|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
111465891|NCT01560780|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111465892|NCT01585038|Efavirenz|efavirenz|mesh-list
111465893|NCT01585038|Rilpivirine|rilpivirine|mesh-list
111465894|NCT01585038|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111465895|NCT01585038|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111465896|NCT01585038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111465897|NCT01585038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111465898|NCT01585038|Antiviral Agents|antiviral agents|mesh-ancestor
111465899|NCT01585038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111465900|NCT01585038|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111465901|NCT01585038|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111465902|NCT01585038|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111465903|NCT01585038|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111465904|NCT01585038|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111465905|NCT01585038|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111465906|NCT01585038|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111465907|NCT01585038|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111465908|NCT01559844|Ribavirin|ribavirin|mesh-list
111465909|NCT01559844|Sofosbuvir|sofosbuvir|mesh-list
111465910|NCT01559844|Antimetabolites|antimetabolites|mesh-ancestor
111465911|NCT01559844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111465912|NCT01559844|Antiviral Agents|antiviral agents|mesh-ancestor
111465913|NCT01559844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111465914|NCT01584648|Trametinib|trametinib|mesh-list
111465915|NCT01584648|Dabrafenib|dabrafenib|mesh-list
111465916|NCT01584648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111465917|NCT01584648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111465918|NCT01584648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111465919|NCT01584648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111465920|NCT01559454|Buprenorphine|buprenorphine|mesh-list
111465921|NCT01559454|Methadone|methadone|mesh-list
111465922|NCT01559454|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
111465923|NCT01559454|Naloxone|naloxone|mesh-list
111465924|NCT01559454|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111465925|NCT01559454|Narcotics|narcotics|mesh-ancestor
111465926|NCT01559454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111465927|NCT01559454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111465928|NCT01559454|Analgesics|analgesics|mesh-ancestor
111465929|NCT01559454|Sensory System Agents|sensory system agents|mesh-ancestor
111465930|NCT01559454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111465931|NCT01559454|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111465932|NCT01559454|Antitussive Agents|antitussive agents|mesh-ancestor
111465933|NCT01559454|Respiratory System Agents|respiratory system agents|mesh-ancestor
111465934|NCT01583166|Epinephrine|epinephrine|mesh-list
111465935|NCT01583166|Bupivacaine|bupivacaine|mesh-list
111465936|NCT01583166|Anesthetics, Local|anesthetics, local|mesh-ancestor
111465937|NCT01583166|Anesthetics|anesthetics|mesh-ancestor
111465938|NCT01583166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111465939|NCT01583166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111465940|NCT01583166|Sensory System Agents|sensory system agents|mesh-ancestor
111465941|NCT01583166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111465942|NCT01583166|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111465943|NCT01583166|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111465944|NCT01583166|Adrenergic Agents|adrenergic agents|mesh-ancestor
111465945|NCT01583166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111465946|NCT01583166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111465947|NCT01583166|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111465948|NCT01583166|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111465949|NCT01583166|Autonomic Agents|autonomic agents|mesh-ancestor
111465950|NCT01583166|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111465951|NCT01583166|Respiratory System Agents|respiratory system agents|mesh-ancestor
111465952|NCT01583166|Mydriatics|mydriatics|mesh-ancestor
111465953|NCT01583166|Sympathomimetics|sympathomimetics|mesh-ancestor
111465954|NCT01583166|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111465955|NCT01582854|Actovegin|actovegin|mesh-list
111465956|NCT01582854|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111465957|NCT01582854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111465958|NCT01582854|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111465959|NCT01582854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111465960|NCT01582854|Antioxidants|antioxidants|mesh-ancestor
111465961|NCT01582854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111465962|NCT01582854|Protective Agents|protective agents|mesh-ancestor
111465963|NCT01582854|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111465964|NCT01582308|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111465965|NCT01582308|Vildagliptin|vildagliptin|mesh-list
111465966|NCT01582308|Saxagliptin|saxagliptin|mesh-list
111465967|NCT01582308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111465968|NCT01582308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111465969|NCT01582308|Incretins|incretins|mesh-ancestor
111465970|NCT01582308|Hormones|hormones|mesh-ancestor
111465971|NCT01582308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111465972|NCT01582308|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111465973|NCT01582308|Protease Inhibitors|protease inhibitors|mesh-ancestor
111465974|NCT01582308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111465975|NCT01582308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111465976|NCT01558674|Torsemide|torsemide|mesh-list
111465977|NCT01558674|Furosemide|furosemide|mesh-list
111465978|NCT01558674|Diuretics|diuretics|mesh-ancestor
111465979|NCT01558674|Natriuretic Agents|natriuretic agents|mesh-ancestor
111465980|NCT01558674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111465981|NCT01558674|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
111465982|NCT01558674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111465983|NCT01558674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111465984|NCT01558674|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111465985|NCT01535040|Memantine|memantine|mesh-list
111465986|NCT01535040|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111465987|NCT01535040|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111465988|NCT01535040|Dopamine Agents|dopamine agents|mesh-ancestor
111465989|NCT01535040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111465990|NCT01535040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111465991|NCT01535040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111465992|NCT01535040|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111465993|NCT01535040|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111465994|NCT01534962|Ranolazine|ranolazine|mesh-list
111465995|NCT01534962|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111465996|NCT01534962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111465997|NCT01534962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111465998|NCT01582152|Bevacizumab|bevacizumab|mesh-list
111465999|NCT01582152|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111466000|NCT01582152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111466001|NCT01582152|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111466002|NCT01582152|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111466003|NCT01582152|Growth Substances|growth substances|mesh-ancestor
111466004|NCT01582152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111466005|NCT01582152|Growth Inhibitors|growth inhibitors|mesh-ancestor
111466006|NCT01557504|Metformin|metformin|mesh-list
111466007|NCT01557504|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111466008|NCT01557504|Hormones|hormones|mesh-list
111466009|NCT01557504|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111466010|NCT01557504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111466011|NCT01557504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111466012|NCT01557504|Incretins|incretins|mesh-ancestor
111466013|NCT01557504|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111466014|NCT01557504|Protease Inhibitors|protease inhibitors|mesh-ancestor
111466015|NCT01557504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111466016|NCT01557504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111466018|NCT01580670|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111466019|NCT01580670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111466020|NCT01580670|Dermatologic Agents|dermatologic agents|mesh-ancestor
111466021|NCT01580670|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111466022|NCT01580670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111466023|NCT01534260|Bortezomib|bortezomib|mesh-list
111466024|NCT01534260|Sorafenib|sorafenib|mesh-list
111466025|NCT01534260|Vorinostat|vorinostat|mesh-list
111466026|NCT01534260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111466027|NCT01534260|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111466028|NCT01534260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111466029|NCT01534260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111466030|NCT01534260|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111466031|NCT01534182|Interferons|interferons|mesh-list
111466032|NCT01534182|Interferon-beta|interferon-beta|mesh-list
111466033|NCT01534182|Glatiramer Acetate|glatiramer acetate|mesh-list
111466034|NCT01534182|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
111466035|NCT01534182|(T,G)-A-L|(t,g)-a-l|mesh-list
111466036|NCT01534182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111466037|NCT01534182|Antiviral Agents|antiviral agents|mesh-ancestor
111466038|NCT01534182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111466039|NCT01534182|Immunologic Factors|immunologic factors|mesh-ancestor
111466040|NCT01534182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111466041|NCT01534182|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
111466042|NCT01534182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111466043|NCT01534182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111466044|NCT01534182|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111466045|NCT01534182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111466046|NCT01579812|Metformin|metformin|mesh-list
111466047|NCT01579812|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111466048|NCT01579812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111466049|NCT01579578|Paclitaxel|paclitaxel|mesh-list
111466050|NCT01579578|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111466051|NCT01579578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111466052|NCT01579578|Tubulin Modulators|tubulin modulators|mesh-ancestor
111466053|NCT01579578|Antimitotic Agents|antimitotic agents|mesh-ancestor
111466054|NCT01579578|Mitosis Modulators|mitosis modulators|mesh-ancestor
111466055|NCT01579578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111466056|NCT01578486|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
111466057|NCT01578486|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111466058|NCT01578486|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111466059|NCT01578486|Analgesics|analgesics|mesh-ancestor
111466060|NCT01578486|Sensory System Agents|sensory system agents|mesh-ancestor
111466061|NCT01578486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111466062|NCT01578486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111466063|NCT01578486|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111466064|NCT01578486|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111466065|NCT01555164|Metformin|metformin|mesh-list
111466066|NCT01555164|Ranolazine|ranolazine|mesh-list
111466067|NCT01555164|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111466068|NCT01555164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111466069|NCT01555164|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111466070|NCT01555164|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111466071|NCT01555164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111466072|NCT03028428|Hyaluronic Acid|hyaluronic acid|mesh-list
111466073|NCT03028428|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111466074|NCT03028428|Immunologic Factors|immunologic factors|mesh-ancestor
111466075|NCT03028428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111466076|NCT03028428|Viscosupplements|viscosupplements|mesh-ancestor
111466077|NCT03028428|Protective Agents|protective agents|mesh-ancestor
111466078|NCT01578330|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
111466079|NCT01578330|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
111466080|NCT01578330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111466081|NCT01578330|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111466082|NCT01578330|Immunologic Factors|immunologic factors|mesh-ancestor
111466083|NCT01578330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111466084|NCT01577160|Paliperidone Palmitate|paliperidone palmitate|mesh-list
111466085|NCT01577160|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111466086|NCT01577160|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111466087|NCT01577160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111466088|NCT01577160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111466089|NCT01577160|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111466090|NCT01577160|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111466091|NCT01577160|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111466092|NCT01577160|Serotonin Agents|serotonin agents|mesh-ancestor
111466093|NCT01577160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111466094|NCT01577160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111466095|NCT01577160|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111466096|NCT01577160|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111466097|NCT01577160|Dopamine Agents|dopamine agents|mesh-ancestor
111466098|NCT01554618|Exenatide|exenatide|mesh-list
111466099|NCT01554618|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111466100|NCT01554618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111466101|NCT01554618|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111466102|NCT01554618|Incretins|incretins|mesh-ancestor
111466103|NCT01554618|Hormones|hormones|mesh-ancestor
111466104|NCT01554618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111466105|NCT01531998|Dexamethasone|dexamethasone|mesh-list
111466106|NCT01531998|Lenalidomide|lenalidomide|mesh-list
111466107|NCT01531998|Bortezomib|bortezomib|mesh-list
111466108|NCT01531998|Siltuximab|siltuximab|mesh-list
111466109|NCT01531998|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111466110|NCT01531998|Antiemetics|antiemetics|mesh-ancestor
111466111|NCT01531998|Autonomic Agents|autonomic agents|mesh-ancestor
111466112|NCT01531998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111466113|NCT01531998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111466114|NCT01531998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111466115|NCT01531998|Glucocorticoids|glucocorticoids|mesh-ancestor
111466116|NCT01531998|Hormones|hormones|mesh-ancestor
111466117|NCT01531998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111466118|NCT01531998|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111466119|NCT01531998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111466120|NCT01531998|Immunologic Factors|immunologic factors|mesh-ancestor
111466121|NCT01531998|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111466122|NCT01531998|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111466123|NCT01531998|Growth Substances|growth substances|mesh-ancestor
111466124|NCT01531998|Growth Inhibitors|growth inhibitors|mesh-ancestor
111466125|NCT01553916|Lithium Carbonate|lithium carbonate|mesh-list
111466126|NCT01553916|Antidepressive Agents|antidepressive agents|mesh-ancestor
111466127|NCT01553916|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111466128|NCT01553916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111466129|NCT01553916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111466130|NCT01553916|Antimanic Agents|antimanic agents|mesh-ancestor
111466131|NCT01553916|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111466132|NCT01553916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111466133|NCT01553916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111466134|NCT01553136|Varenicline|varenicline|mesh-list
111466135|NCT01553136|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111466136|NCT01553136|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111466137|NCT01553136|Cholinergic Agents|cholinergic agents|mesh-ancestor
111466138|NCT01553136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111466139|NCT01553136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111466140|NCT01553136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111466141|NCT01552902|Methylphenidate|methylphenidate|mesh-list
111466142|NCT01552902|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
111466143|NCT01552902|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111466144|NCT01552902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111466145|NCT01552902|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111466146|NCT01552902|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111466147|NCT01552902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111466148|NCT01552902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111466149|NCT01552902|Dopamine Agents|dopamine agents|mesh-ancestor
111466150|NCT01552902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111466151|NCT02072928|Botulinum Toxins|botulinum toxins|mesh-list
111466152|NCT02072928|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111466153|NCT02072928|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111466154|NCT02072928|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111466155|NCT02072928|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111466156|NCT02072928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111466157|NCT02072928|Cholinergic Agents|cholinergic agents|mesh-ancestor
111466158|NCT02072928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111466159|NCT02072928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111466160|NCT02072928|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111466161|NCT02072928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111466162|NCT01529346|Ibuprofen|ibuprofen|mesh-list
111466163|NCT01529346|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111466164|NCT01529346|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111466165|NCT01529346|Analgesics|analgesics|mesh-ancestor
111466166|NCT01529346|Sensory System Agents|sensory system agents|mesh-ancestor
111466167|NCT01529346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111466168|NCT01529346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111466169|NCT01529346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111466170|NCT01529346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111466171|NCT01529346|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111466172|NCT01529346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111466173|NCT01529346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111466174|NCT01529268|Cysteamine|cysteamine|mesh-list
111466175|NCT01529268|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
111466176|NCT01529268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111466177|NCT01529112|Lenvatinib|lenvatinib|mesh-list
111466178|NCT01529112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111466179|NCT01529112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111466180|NCT01529112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111466181|NCT01529112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111466182|NCT01575054|Botulinum Toxins|botulinum toxins|mesh-list
111466183|NCT01575054|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111466184|NCT01575054|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111466185|NCT01575054|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111466186|NCT01575054|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111466187|NCT01575054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111466188|NCT01575054|Cholinergic Agents|cholinergic agents|mesh-ancestor
111466189|NCT01575054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111466190|NCT01575054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111466191|NCT01575054|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110941144|NCT04850950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111466192|NCT01575054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111466193|NCT01528254|Metformin|metformin|mesh-list
111466194|NCT01528254|Vildagliptin|vildagliptin|mesh-list
111466195|NCT01528254|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111466196|NCT01528254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111466197|NCT01528254|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111466198|NCT01528254|Protease Inhibitors|protease inhibitors|mesh-ancestor
111466199|NCT01528254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111466200|NCT01528254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111466201|NCT01526148|Quetiapine Fumarate|quetiapine fumarate|mesh-list
111466202|NCT01526148|Lithium Carbonate|lithium carbonate|mesh-list
111466203|NCT01526148|Antidepressive Agents|antidepressive agents|mesh-ancestor
111466204|NCT01526148|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111466205|NCT01526148|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111466206|NCT01526148|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111466207|NCT01526148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111466208|NCT01526148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111466209|NCT01526148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111466210|NCT01526148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111466211|NCT01526148|Antimanic Agents|antimanic agents|mesh-ancestor
111466212|NCT01525602|Paclitaxel|paclitaxel|mesh-list
111466213|NCT01525602|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111466214|NCT01525602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111466215|NCT01525602|Tubulin Modulators|tubulin modulators|mesh-ancestor
111466216|NCT01525602|Antimitotic Agents|antimitotic agents|mesh-ancestor
111466217|NCT01525602|Mitosis Modulators|mitosis modulators|mesh-ancestor
111466218|NCT01525602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111466219|NCT01549002|Fentanyl|fentanyl|mesh-list
111466220|NCT01549002|Morphine|morphine|mesh-list
111466221|NCT01549002|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111466222|NCT01549002|Narcotics|narcotics|mesh-ancestor
111466223|NCT01549002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111466224|NCT01549002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111466225|NCT01549002|Analgesics|analgesics|mesh-ancestor
111466226|NCT01549002|Sensory System Agents|sensory system agents|mesh-ancestor
111466227|NCT01549002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111466228|NCT01549002|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111466229|NCT01549002|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111466230|NCT01549002|Anesthetics, General|anesthetics, general|mesh-ancestor
111466231|NCT01549002|Anesthetics|anesthetics|mesh-ancestor
111466232|NCT01548768|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
111466233|NCT01548768|Antirheumatic Agents|antirheumatic agents|mesh-list
111466234|NCT01548768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111466235|NCT01572792|Bromides|bromides|mesh-list
111466236|NCT01572792|Formoterol Fumarate|formoterol fumarate|mesh-list
111466237|NCT01572792|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111466238|NCT01572792|Autonomic Agents|autonomic agents|mesh-ancestor
111466239|NCT01572792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111466240|NCT01572792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111466241|NCT01572792|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111466242|NCT01572792|Respiratory System Agents|respiratory system agents|mesh-ancestor
111466243|NCT01572792|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111466244|NCT01572792|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111466245|NCT01572792|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111466246|NCT01572792|Adrenergic Agents|adrenergic agents|mesh-ancestor
111466247|NCT01572792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111466248|NCT01572792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111466249|NCT01572792|Anticonvulsants|anticonvulsants|mesh-ancestor
111466250|NCT01547598|Timolol|timolol|mesh-list
111466251|NCT01547598|Bimatoprost|bimatoprost|mesh-list
111466252|NCT01547598|Travoprost|travoprost|mesh-list
111466253|NCT01547598|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111466254|NCT01547598|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111466255|NCT01547598|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111466256|NCT01547598|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111466257|NCT01547598|Adrenergic Agents|adrenergic agents|mesh-ancestor
111466258|NCT01547598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111466259|NCT01547598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111466260|NCT01547598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111466261|NCT01547598|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111466262|NCT01547598|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111466263|NCT01547286|Methacholine Chloride|methacholine chloride|mesh-list
111466264|NCT01547286|Miotics|miotics|mesh-ancestor
111466265|NCT01547286|Autonomic Agents|autonomic agents|mesh-ancestor
111466266|NCT01547286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111466267|NCT01547286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111466268|NCT01547286|Parasympathomimetics|parasympathomimetics|mesh-ancestor
111466269|NCT01547286|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
111466270|NCT01547286|Respiratory System Agents|respiratory system agents|mesh-ancestor
111466271|NCT01547286|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
111466272|NCT01547286|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111466273|NCT01547286|Cholinergic Agents|cholinergic agents|mesh-ancestor
111466274|NCT01547286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111466275|NCT01547286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111466276|NCT01524978|Cetuximab|cetuximab|mesh-list
111466277|NCT01524978|Vemurafenib|vemurafenib|mesh-list
111466278|NCT01524978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111466279|NCT01524978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111466280|NCT01524978|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111466281|NCT01524978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111466282|NCT01524978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111466283|NCT01524198|Budesonide|budesonide|mesh-list
111466284|NCT01524198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111466285|NCT01524198|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111466286|NCT01524198|Autonomic Agents|autonomic agents|mesh-ancestor
111466287|NCT01524198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111466288|NCT01524198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111466289|NCT01524198|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111466290|NCT01524198|Respiratory System Agents|respiratory system agents|mesh-ancestor
111466291|NCT01524198|Glucocorticoids|glucocorticoids|mesh-ancestor
111466292|NCT01524198|Hormones|hormones|mesh-ancestor
111466293|NCT01524198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111466294|NCT01523886|Rocuronium|rocuronium|mesh-list
111466295|NCT01523886|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
111466296|NCT01523886|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
111466297|NCT01523886|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111466298|NCT01523886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111466299|NCT01523886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111466300|NCT01546038|Cytarabine|cytarabine|mesh-list
111466301|NCT01546038|Decitabine|decitabine|mesh-list
111466302|NCT01546038|Daunorubicin|daunorubicin|mesh-list
111466303|NCT01546038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111466304|NCT01546038|Antimetabolites|antimetabolites|mesh-ancestor
111479306|NCT05028075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111190442|NCT01766336|Inositol|inositol|mesh-list
111466305|NCT01546038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111466306|NCT01546038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111466307|NCT01546038|Antiviral Agents|antiviral agents|mesh-ancestor
111466308|NCT01546038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111466309|NCT01546038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111466310|NCT01546038|Immunologic Factors|immunologic factors|mesh-ancestor
111466311|NCT01546038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111466312|NCT01546038|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111466313|NCT01546038|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111466314|NCT01546038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111466315|NCT01546038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111466316|NCT01571232|Dexamethasone|dexamethasone|mesh-list
111466317|NCT01571232|Bevacizumab|bevacizumab|mesh-list
111466318|NCT01571232|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111466319|NCT01571232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111466320|NCT01571232|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111466321|NCT01571232|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111466322|NCT01571232|Growth Substances|growth substances|mesh-ancestor
111466323|NCT01571232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111466324|NCT01571232|Growth Inhibitors|growth inhibitors|mesh-ancestor
111466325|NCT01571232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111466326|NCT01571232|Antiemetics|antiemetics|mesh-ancestor
111466327|NCT01571232|Autonomic Agents|autonomic agents|mesh-ancestor
111466328|NCT01571232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111466329|NCT01571232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111466330|NCT01571232|Glucocorticoids|glucocorticoids|mesh-ancestor
111466331|NCT01571232|Hormones|hormones|mesh-ancestor
111466332|NCT01571232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111466333|NCT01571232|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111466334|NCT01522950|Atenolol|atenolol|mesh-list
111466335|NCT01522950|Nebivolol|nebivolol|mesh-list
111466336|NCT01522950|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111466337|NCT01522950|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111466338|NCT01522950|Sympatholytics|sympatholytics|mesh-ancestor
111466339|NCT01522950|Autonomic Agents|autonomic agents|mesh-ancestor
111466340|NCT01522950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111466341|NCT01522950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111466342|NCT01522950|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
111466343|NCT01522950|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111466344|NCT01522950|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111466345|NCT01522950|Adrenergic Agents|adrenergic agents|mesh-ancestor
111466346|NCT01522950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111466347|NCT01522950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111466348|NCT01522950|Vasodilator Agents|vasodilator agents|mesh-ancestor
111466349|NCT01522950|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
111466350|NCT01522950|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111466351|NCT01522950|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111466352|NCT01522404|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
111466353|NCT01522404|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111466354|NCT01522404|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111466355|NCT01522404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111466356|NCT01522404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111466357|NCT01522404|Adrenergic Agents|adrenergic agents|mesh-ancestor
111466358|NCT01522404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111466359|NCT01522404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111466360|NCT01543776|Abiraterone Acetate|abiraterone acetate|mesh-list
111466361|NCT01543776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111466362|NCT01543776|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111466363|NCT01543776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111466364|NCT01543776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111466365|NCT01543776|Hormone Antagonists|hormone antagonists|mesh-ancestor
111466366|NCT01543776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111466367|NCT01543776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111466368|NCT01543776|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111466369|NCT01518192|Doxycycline|doxycycline|mesh-list
111466370|NCT01518192|Cefuroxime|cefuroxime|mesh-list
111466371|NCT01518192|Cefuroxime axetil|cefuroxime axetil|mesh-list
111466372|NCT01518192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111466373|NCT01518192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111466374|NCT01518192|Antimalarials|antimalarials|mesh-ancestor
111466375|NCT01518192|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111466376|NCT01518192|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111466377|NCT01517802|Prednisone|prednisone|mesh-list
111466378|NCT01517802|Abiraterone Acetate|abiraterone acetate|mesh-list
111466379|NCT01517802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111466380|NCT01517802|Glucocorticoids|glucocorticoids|mesh-ancestor
111466381|NCT01517802|Hormones|hormones|mesh-ancestor
111466382|NCT01517802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111466383|NCT01517802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111466384|NCT01517802|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111466385|NCT01517802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111466386|NCT01517802|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111466387|NCT01517802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111466388|NCT01517802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111466389|NCT01517802|Hormone Antagonists|hormone antagonists|mesh-ancestor
111466390|NCT01517802|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111466391|NCT04714710|Canrenoic Acid|canrenoic acid|mesh-list
111466392|NCT04714710|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
111466393|NCT04714710|Hormone Antagonists|hormone antagonists|mesh-ancestor
111466394|NCT04714710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111466395|NCT04714710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111466396|NCT04714710|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
111466397|NCT04714710|Diuretics|diuretics|mesh-ancestor
111466398|NCT04714710|Natriuretic Agents|natriuretic agents|mesh-ancestor
111466399|NCT01520922|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
111466400|NCT01520922|Ofatumumab|ofatumumab|mesh-list
111466401|NCT01520922|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111466402|NCT01520922|Alkylating Agents|alkylating agents|mesh-ancestor
111466403|NCT01520922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111466404|NCT01520922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111466405|NCT01517412|Metformin|metformin|mesh-list
111466406|NCT01517412|Lixisenatide|lixisenatide|mesh-list
111466407|NCT01517412|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111466408|NCT01517412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111466409|NCT01489956|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
111466410|NCT01489956|Freund's Adjuvant|freund's adjuvant|mesh-list
111466411|NCT01489956|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
111466412|NCT01489956|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111466413|NCT01489956|Immunologic Factors|immunologic factors|mesh-ancestor
111466414|NCT01489956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111466415|NCT01516008|Tapentadol|tapentadol|mesh-list
111466416|NCT01516008|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111466417|NCT01516008|Narcotics|narcotics|mesh-ancestor
111466418|NCT01516008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111466419|NCT01516008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111466420|NCT01516008|Analgesics|analgesics|mesh-ancestor
111466421|NCT01516008|Sensory System Agents|sensory system agents|mesh-ancestor
111466422|NCT01516008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111466423|NCT01516008|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111466424|NCT01516008|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111466425|NCT01516008|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111466426|NCT01516008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111466427|NCT01516008|Adrenergic Agents|adrenergic agents|mesh-ancestor
111466428|NCT01516008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111466429|NCT01489254|Glatiramer Acetate|glatiramer acetate|mesh-list
111466430|NCT01489254|(T,G)-A-L|(t,g)-a-l|mesh-list
111466431|NCT01489254|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111466432|NCT01489254|Immunologic Factors|immunologic factors|mesh-ancestor
111466433|NCT01489254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111466434|NCT01489254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111466435|NCT01489254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111466436|NCT01489020|Immunomodulating Agents|immunomodulating agents|mesh-list
111466437|NCT01489020|Immunologic Factors|immunologic factors|mesh-ancestor
111466438|NCT01489020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111466439|NCT01514682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
111466440|NCT01514448|Everolimus|everolimus|mesh-list
111466441|NCT01514448|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111466442|NCT01514448|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111466443|NCT01514448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111466444|NCT01514448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111466445|NCT01514448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111466446|NCT01514448|Immunologic Factors|immunologic factors|mesh-ancestor
111466447|NCT01514448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111466448|NCT01514448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111466449|NCT01514370|Interferons|interferons|mesh-list
111466450|NCT01514370|Interferon-beta|interferon-beta|mesh-list
111466451|NCT01514370|Interferon beta-1a|interferon beta-1a|mesh-list
111466452|NCT01514370|Curcumin|curcumin|mesh-list
111479307|NCT05012631|Losartan|losartan|mesh-list
111466453|NCT01514370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111466454|NCT01514370|Antiviral Agents|antiviral agents|mesh-ancestor
111466455|NCT01514370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111466456|NCT01514370|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111466457|NCT01514370|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111466458|NCT01514370|Analgesics|analgesics|mesh-ancestor
111466459|NCT01514370|Sensory System Agents|sensory system agents|mesh-ancestor
111466460|NCT01514370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111466461|NCT01514370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111466462|NCT01514370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111466463|NCT01514370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111466464|NCT01514370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111466465|NCT01514370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111466466|NCT01514370|Immunologic Factors|immunologic factors|mesh-ancestor
111466467|NCT01514370|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111466468|NCT01519674|Insulin|insulin|mesh-list
111466469|NCT01519674|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111466470|NCT01519674|Metformin|metformin|mesh-list
111466471|NCT01519674|Insulin Aspart|insulin aspart|mesh-list
111466472|NCT01519674|Insulin, Long-Acting|insulin, long-acting|mesh-list
111466473|NCT01519674|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
111466474|NCT01519674|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111466475|NCT01519674|Biphasic Insulins|biphasic insulins|mesh-list
111466476|NCT01519674|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
111466477|NCT01519674|Insulin, Isophane|insulin, isophane|mesh-list
111466478|NCT01519674|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111466479|NCT01519674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111466480|NCT01519674|Incretins|incretins|mesh-ancestor
111466481|NCT01519674|Hormones|hormones|mesh-ancestor
111466482|NCT01519674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111466483|NCT01519674|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111466484|NCT01519674|Protease Inhibitors|protease inhibitors|mesh-ancestor
111466485|NCT01519674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111466486|NCT01519674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111466487|NCT01519518|Heparin|heparin|mesh-list
111466488|NCT01519518|Calcium heparin|calcium heparin|mesh-list
111466489|NCT01519518|Bivalirudin|bivalirudin|mesh-list
111466490|NCT01519518|Anticoagulants|anticoagulants|mesh-ancestor
111466491|NCT01519518|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111466492|NCT01519518|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111466493|NCT01519518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111466494|NCT01519518|Antithrombins|antithrombins|mesh-ancestor
111466495|NCT01519518|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111466496|NCT01519518|Protease Inhibitors|protease inhibitors|mesh-ancestor
111466497|NCT01519518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111466498|NCT01518972|Prazosin|prazosin|mesh-list
111466499|NCT01518972|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111466500|NCT01518972|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111466501|NCT01518972|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111466502|NCT01518972|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111466503|NCT01518972|Adrenergic Agents|adrenergic agents|mesh-ancestor
111466504|NCT01518972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111466505|NCT01518972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111466506|NCT01518972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111466507|NCT01513590|Insulin|insulin|mesh-list
111466508|NCT01513590|Insulin Aspart|insulin aspart|mesh-list
111466509|NCT01513590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111466510|NCT01513590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111466511|NCT04672512|Prednisone|prednisone|mesh-list
111466512|NCT04672512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111466513|NCT04672512|Glucocorticoids|glucocorticoids|mesh-ancestor
111466514|NCT04672512|Hormones|hormones|mesh-ancestor
111466515|NCT04672512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111466516|NCT04672512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111466517|NCT04672512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111466518|NCT04672512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111466519|NCT01512108|Liraglutide|liraglutide|mesh-list
111466520|NCT01512108|Hypoglycemic Agents|hypoglycemic agents|mesh-list
111466521|NCT01512108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111466522|NCT01512108|Incretins|incretins|mesh-ancestor
111466523|NCT01512108|Hormones|hormones|mesh-ancestor
111466524|NCT01512108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111466525|NCT01486758|Azithromycin|azithromycin|mesh-list
111466526|NCT01486758|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111190702|NCT01898728|Iodine|iodine|mesh-list
111466527|NCT01486758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111466528|NCT01463982|Capecitabine|capecitabine|mesh-list
111466529|NCT01463982|Irinotecan|irinotecan|mesh-list
111466530|NCT01463982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111466531|NCT01463982|Antimetabolites|antimetabolites|mesh-ancestor
111466532|NCT01463982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111466533|NCT01463982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111466534|NCT01463982|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111466535|NCT01463982|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111466536|NCT01463982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111466537|NCT01510158|Allopurinol|allopurinol|mesh-list
111466538|NCT01510158|Lesinurad|lesinurad|mesh-list
111466539|NCT01510158|Antimetabolites|antimetabolites|mesh-ancestor
111466540|NCT01510158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111466541|NCT01510158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111466542|NCT01510158|Gout Suppressants|gout suppressants|mesh-ancestor
111466543|NCT01510158|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111466544|NCT01510158|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111466545|NCT01510158|Antioxidants|antioxidants|mesh-ancestor
111466546|NCT01510158|Protective Agents|protective agents|mesh-ancestor
111466547|NCT01510158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111466548|NCT01510158|Uricosuric Agents|uricosuric agents|mesh-ancestor
111466549|NCT04080882|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111466550|NCT04080882|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111466551|NCT04080882|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111466552|NCT04080882|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111466553|NCT04080882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111466554|NCT04080882|Cholinergic Agents|cholinergic agents|mesh-ancestor
111466555|NCT04080882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111466556|NCT04080882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111466557|NCT04080882|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111466558|NCT04080882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111466559|NCT01484496|Belimumab|belimumab|mesh-list
111466560|NCT01484496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111466561|NCT01484496|Immunologic Factors|immunologic factors|mesh-ancestor
111466562|NCT01484496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111466563|NCT01509846|Vaccines|vaccines|mesh-list
111466564|NCT01509846|Immunologic Factors|immunologic factors|mesh-ancestor
111466565|NCT01509846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111466566|NCT01462344|Fluticasone|fluticasone|mesh-list
111466567|NCT01462344|Xhance|xhance|mesh-list
111466568|NCT01462344|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
111466569|NCT01462344|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111466570|NCT01462344|Autonomic Agents|autonomic agents|mesh-ancestor
111466571|NCT01462344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111466572|NCT01462344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111466573|NCT01462344|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111466574|NCT01462344|Respiratory System Agents|respiratory system agents|mesh-ancestor
111466575|NCT01462344|Glucocorticoids|glucocorticoids|mesh-ancestor
111466576|NCT01462344|Hormones|hormones|mesh-ancestor
111466577|NCT01462344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111466578|NCT01462344|Sympathomimetics|sympathomimetics|mesh-ancestor
111466579|NCT01462344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111466580|NCT01462344|Dermatologic Agents|dermatologic agents|mesh-ancestor
111466581|NCT01462344|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111466582|NCT01462266|Metformin|metformin|mesh-list
111466583|NCT01462266|Insulin Glargine|insulin glargine|mesh-list
111466584|NCT01462266|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111466585|NCT01462266|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111466586|NCT01462266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111466587|NCT01462266|Incretins|incretins|mesh-ancestor
111466588|NCT01462266|Hormones|hormones|mesh-ancestor
111466589|NCT01462266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111466590|NCT01462266|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111466591|NCT01462266|Protease Inhibitors|protease inhibitors|mesh-ancestor
111466592|NCT01462266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111466593|NCT01462266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111466594|NCT04087590|Glycopyrrolate|glycopyrrolate|mesh-list
111466595|NCT04087590|Formoterol Fumarate|formoterol fumarate|mesh-list
111466596|NCT04087590|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111466597|NCT04087590|Autonomic Agents|autonomic agents|mesh-ancestor
111466598|NCT04087590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111466599|NCT04087590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111466600|NCT04087590|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111190749|NCT00266110|Trastuzumab|trastuzumab|mesh-list
111466601|NCT04087590|Respiratory System Agents|respiratory system agents|mesh-ancestor
111466602|NCT04087590|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111466603|NCT04087590|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111466604|NCT04087590|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111466605|NCT04087590|Adrenergic Agents|adrenergic agents|mesh-ancestor
111466606|NCT04087590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111466607|NCT04087590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111466608|NCT04087590|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111466609|NCT04087590|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111466610|NCT04087590|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111466611|NCT04087590|Cholinergic Agents|cholinergic agents|mesh-ancestor
111466612|NCT01508676|Diclofenac|diclofenac|mesh-list
111466613|NCT01508676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
111466614|NCT01508676|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111466615|NCT01508676|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111466616|NCT01508676|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111466617|NCT01508676|Analgesics|analgesics|mesh-ancestor
111466618|NCT01508676|Sensory System Agents|sensory system agents|mesh-ancestor
111466619|NCT01508676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111466620|NCT01508676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111466621|NCT01508676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111466622|NCT01508676|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111466623|NCT01508676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111466624|NCT01508676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111466625|NCT02985372|Cytarabine|cytarabine|mesh-list
111466626|NCT02985372|Decitabine|decitabine|mesh-list
111466627|NCT02985372|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111466628|NCT02985372|Antimetabolites|antimetabolites|mesh-ancestor
111466629|NCT02985372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111466630|NCT02985372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111466631|NCT02985372|Antiviral Agents|antiviral agents|mesh-ancestor
111466632|NCT02985372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111466633|NCT02985372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111466634|NCT02985372|Immunologic Factors|immunologic factors|mesh-ancestor
111466635|NCT02985372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111466636|NCT02985372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111466637|NCT02985216|Pregabalin|pregabalin|mesh-list
111466638|NCT02985216|Analgesics|analgesics|mesh-ancestor
111466639|NCT02985216|Sensory System Agents|sensory system agents|mesh-ancestor
111466640|NCT02985216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111466641|NCT02985216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111466642|NCT02985216|Anticonvulsants|anticonvulsants|mesh-ancestor
111466643|NCT02985216|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111466644|NCT02985216|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111466645|NCT02985216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111466646|NCT02985216|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111466647|NCT02985216|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111466648|NCT02985216|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111466649|NCT02985216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111466650|NCT02985216|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111466651|NCT01461096|Vaccines|vaccines|mesh-list
111466652|NCT01461096|Immunologic Factors|immunologic factors|mesh-ancestor
111466653|NCT01461096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111466654|NCT01480674|Trastuzumab|trastuzumab|mesh-list
111466655|NCT01480674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111466656|NCT01480674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111466657|NCT01506882|Levetiracetam|levetiracetam|mesh-list
111466658|NCT01506882|Anticonvulsants|anticonvulsants|mesh-ancestor
111466659|NCT01506882|Nootropic Agents|nootropic agents|mesh-ancestor
111466660|NCT01506726|Salicylic Acid|salicylic acid|mesh-list
111466661|NCT01506726|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
111466662|NCT01506726|Salicylates|salicylates|mesh-list
111466663|NCT01506726|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111466664|NCT01506726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111466665|NCT01506726|Analgesics|analgesics|mesh-ancestor
111466666|NCT01506726|Sensory System Agents|sensory system agents|mesh-ancestor
111466667|NCT01506726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111466668|NCT01506726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111466669|NCT01506726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111466670|NCT01506726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111466671|NCT01506726|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111466672|NCT01506726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111466673|NCT01506726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111466674|NCT01506726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111466675|NCT01506726|Antifungal Agents|antifungal agents|mesh-ancestor
111466676|NCT01506726|Keratolytic Agents|keratolytic agents|mesh-ancestor
111466677|NCT01506726|Dermatologic Agents|dermatologic agents|mesh-ancestor
111466678|NCT01505868|Carboplatin|carboplatin|mesh-list
111466679|NCT01505868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111466680|NCT01505634|Ciprofloxacin|ciprofloxacin|mesh-list
111466681|NCT01505634|Imipenem|imipenem|mesh-list
111466682|NCT01505634|Relebactam|relebactam|mesh-list
111466683|NCT01505634|Cilastatin|cilastatin|mesh-list
111466684|NCT01505634|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111466685|NCT01505634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111466686|NCT01505634|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111466687|NCT01505634|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111466688|NCT01505634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111466689|NCT01505634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111466690|NCT01505634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111466691|NCT01505634|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111466692|NCT01505634|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111466693|NCT01505634|Protease Inhibitors|protease inhibitors|mesh-ancestor
111466694|NCT01505634|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
111466695|NCT01460628|Modafinil|modafinil|mesh-list
111466696|NCT01460628|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111466697|NCT01460628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111466698|NCT01460628|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
111466699|NCT01460628|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111466700|NCT01460628|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111466701|NCT01460628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111466702|NCT01480596|Belimumab|belimumab|mesh-list
111466703|NCT01480596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111466704|NCT01480596|Immunologic Factors|immunologic factors|mesh-ancestor
111466705|NCT01480596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111466706|NCT01459614|Gemcitabine|gemcitabine|mesh-list
111466707|NCT01459614|Docetaxel|docetaxel|mesh-list
111466708|NCT01459614|Capecitabine|capecitabine|mesh-list
111466709|NCT01459614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111466710|NCT01459614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111466711|NCT01459614|Antimetabolites|antimetabolites|mesh-ancestor
111466712|NCT01459614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111466713|NCT01459614|Tubulin Modulators|tubulin modulators|mesh-ancestor
111466714|NCT01459614|Antimitotic Agents|antimitotic agents|mesh-ancestor
111466715|NCT01459614|Mitosis Modulators|mitosis modulators|mesh-ancestor
111466716|NCT01458522|Lacosamide|lacosamide|mesh-list
111466717|NCT01458522|Fosphenytoin|fosphenytoin|mesh-list
111466718|NCT01458522|Anticonvulsants|anticonvulsants|mesh-ancestor
111466719|NCT01458522|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111466720|NCT01458522|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111466721|NCT01458522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111466722|NCT01458522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111466723|NCT03026946|Cyclosporine|cyclosporine|mesh-list
111466724|NCT03026946|Alitretinoin|alitretinoin|mesh-list
111466725|NCT03026946|Cyclosporins|cyclosporins|mesh-list
111466726|NCT03026946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111466727|NCT03026946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111466728|NCT03026946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111466729|NCT03026946|Immunologic Factors|immunologic factors|mesh-ancestor
111466730|NCT03026946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111466731|NCT03026946|Antifungal Agents|antifungal agents|mesh-ancestor
111466732|NCT03026946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111466733|NCT03026946|Dermatologic Agents|dermatologic agents|mesh-ancestor
111466734|NCT03026946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111466735|NCT03026946|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111466736|NCT03026946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111466737|NCT01458366|Carboplatin|carboplatin|mesh-list
111466738|NCT01458366|Etoposide|etoposide|mesh-list
111466739|NCT01458366|Etoposide phosphate|etoposide phosphate|mesh-list
111466740|NCT01458366|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
111466741|NCT01458366|Ofatumumab|ofatumumab|mesh-list
111466742|NCT01458366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111466743|NCT01458366|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111466744|NCT01458366|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111466745|NCT01458366|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111466746|NCT01458366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111466747|NCT01458366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111466748|NCT01458366|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111466749|NCT01458366|Alkylating Agents|alkylating agents|mesh-ancestor
111466750|NCT01458210|Dulaglutide|dulaglutide|mesh-list
111466751|NCT01458210|Moxifloxacin|moxifloxacin|mesh-list
111466752|NCT01458210|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
111466753|NCT01458210|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111466754|NCT01458210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111466755|NCT01458210|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111466756|NCT01458210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111466757|NCT01458210|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111466758|NCT01458210|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111466759|NCT01458210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111466760|NCT01458210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111466761|NCT01458210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111466762|NCT01458210|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111466763|NCT01458210|Contraceptive Agents|contraceptive agents|mesh-ancestor
111466764|NCT01458210|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111466765|NCT01458210|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
111466766|NCT01458210|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111466767|NCT01458210|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111466768|NCT01457118|Etirinotecan pegol|etirinotecan pegol|mesh-list
111466769|NCT01457118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111466770|NCT01457118|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111466771|NCT01457118|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111466772|NCT01457118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111466773|NCT01457118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111466774|NCT01501110|Acetylcysteine|acetylcysteine|mesh-list
111466775|NCT01501110|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111466776|NCT01501110|Antiviral Agents|antiviral agents|mesh-ancestor
111466777|NCT01501110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111466778|NCT01501110|Expectorants|expectorants|mesh-ancestor
111466779|NCT01501110|Respiratory System Agents|respiratory system agents|mesh-ancestor
111466780|NCT01501110|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111466781|NCT01501110|Antioxidants|antioxidants|mesh-ancestor
111466782|NCT01501110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111466783|NCT01501110|Protective Agents|protective agents|mesh-ancestor
111466784|NCT01501110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111466785|NCT01501110|Antidotes|antidotes|mesh-ancestor
111466786|NCT01500720|Topotecan|topotecan|mesh-list
111466787|NCT01500720|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111466788|NCT01500720|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111466789|NCT01500720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111466790|NCT01500720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111466791|NCT01500720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111466792|NCT01476696|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
111466793|NCT01476696|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111466794|NCT01455012|Rotigotine|rotigotine|mesh-list
111466795|NCT01455012|Dopamine Agonists|dopamine agonists|mesh-ancestor
111466796|NCT01455012|Dopamine Agents|dopamine agents|mesh-ancestor
111466797|NCT01455012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111466798|NCT01455012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111466799|NCT01455012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111466800|NCT01454778|Paclitaxel|paclitaxel|mesh-list
111466801|NCT01454778|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111466802|NCT01454778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111466803|NCT01454778|Tubulin Modulators|tubulin modulators|mesh-ancestor
111466804|NCT01454778|Antimitotic Agents|antimitotic agents|mesh-ancestor
111466805|NCT01454778|Mitosis Modulators|mitosis modulators|mesh-ancestor
111466806|NCT01454778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111466807|NCT01454076|Clarithromycin|clarithromycin|mesh-list
111466808|NCT01454076|Rifampin|rifampin|mesh-list
111466809|NCT01454076|Ketoconazole|ketoconazole|mesh-list
111466810|NCT01454076|Ixazomib|ixazomib|mesh-list
111466811|NCT01454076|Glycine|glycine|mesh-list
111466812|NCT01454076|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111466813|NCT01454076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111466814|NCT01454076|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111466815|NCT01454076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111466816|NCT01454076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111466817|NCT01454076|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111466818|NCT01454076|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111466819|NCT01454076|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111466820|NCT01454076|Antitubercular Agents|antitubercular agents|mesh-ancestor
111466821|NCT01454076|Leprostatic Agents|leprostatic agents|mesh-ancestor
111466822|NCT01454076|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111466823|NCT01454076|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111466824|NCT01454076|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111466825|NCT01454076|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
111466826|NCT01454076|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
111466827|NCT01454076|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
111466828|NCT01454076|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111466829|NCT01454076|Antifungal Agents|antifungal agents|mesh-ancestor
111466830|NCT01454076|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111466831|NCT01454076|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111466832|NCT01454076|Hormone Antagonists|hormone antagonists|mesh-ancestor
111466833|NCT01454076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111466834|NCT01454076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111466835|NCT01454076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111466836|NCT01454076|Protease Inhibitors|protease inhibitors|mesh-ancestor
111466837|NCT01454076|Glycine Agents|glycine agents|mesh-ancestor
111466838|NCT01454076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111466839|NCT01453998|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
111466840|NCT01453998|Immunologic Factors|immunologic factors|mesh-ancestor
111466841|NCT01453998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111466842|NCT01453374|Naltrexone|naltrexone|mesh-list
111466843|NCT01453374|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111466844|NCT01453374|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111466845|NCT01453374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111466846|NCT01453374|Sensory System Agents|sensory system agents|mesh-ancestor
111466847|NCT01453374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111466848|NCT01453140|Sirolimus|sirolimus|mesh-list
111466849|NCT01453140|Cyclophosphamide|cyclophosphamide|mesh-list
111466850|NCT01453140|Temsirolimus|temsirolimus|mesh-list
111466851|NCT01453140|Interleukin-2|interleukin-2|mesh-list
111466852|NCT01453140|Azacitidine|azacitidine|mesh-list
111466853|NCT01453140|MTOR Inhibitors|mtor inhibitors|mesh-list
111466854|NCT01453140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111466855|NCT01453140|Immunologic Factors|immunologic factors|mesh-ancestor
111466856|NCT01453140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111466857|NCT01453140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111466858|NCT01453140|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111466859|NCT01453140|Alkylating Agents|alkylating agents|mesh-ancestor
111466860|NCT01453140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111466861|NCT01453140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111466862|NCT01453140|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111466863|NCT01453140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111466864|NCT01453140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111466865|NCT01453140|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111466866|NCT01453140|Antifungal Agents|antifungal agents|mesh-ancestor
111466867|NCT01453140|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111466868|NCT01453140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111466869|NCT01453140|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111466870|NCT01453140|Analgesics|analgesics|mesh-ancestor
111466871|NCT01453140|Sensory System Agents|sensory system agents|mesh-ancestor
111466872|NCT01453140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111466873|NCT01453140|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111466874|NCT01453140|Antimetabolites|antimetabolites|mesh-ancestor
111466875|NCT01499940|Vitamin D|vitamin d|mesh-list
111466876|NCT01499940|Cholecalciferol|cholecalciferol|mesh-list
111466877|NCT01499940|Vitamins|vitamins|mesh-ancestor
111466878|NCT01499940|Micronutrients|micronutrients|mesh-ancestor
111466879|NCT01499940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111466880|NCT01499940|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111466881|NCT01499940|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111466882|NCT01499160|Everolimus|everolimus|mesh-list
111466883|NCT01499160|Letrozole|letrozole|mesh-list
111466884|NCT01499160|Lapatinib|lapatinib|mesh-list
111466885|NCT01499160|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111466886|NCT01499160|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111466887|NCT01499160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111466888|NCT01499160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111466889|NCT01499160|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111466890|NCT01499160|Immunologic Factors|immunologic factors|mesh-ancestor
111466891|NCT01499160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111466892|NCT01499160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111466893|NCT01499160|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111466894|NCT01499160|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111466895|NCT01499160|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111466896|NCT01499160|Hormone Antagonists|hormone antagonists|mesh-ancestor
111466897|NCT01499160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111466898|NCT01498068|Interferons|interferons|mesh-list
111466899|NCT01498068|Ribavirin|ribavirin|mesh-list
111466900|NCT01498068|Interferon-alpha|interferon-alpha|mesh-list
111466901|NCT01498068|Interferon alpha-2|interferon alpha-2|mesh-list
111466902|NCT01498068|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
111466903|NCT01498068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111466905|NCT01498068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111466906|NCT01498068|Antimetabolites|antimetabolites|mesh-ancestor
111466907|NCT01498068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111466908|NCT01498068|Immunologic Factors|immunologic factors|mesh-ancestor
111466909|NCT01498068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111466910|NCT01497366|Sofosbuvir|sofosbuvir|mesh-list
111466911|NCT01497366|Antiviral Agents|antiviral agents|mesh-ancestor
111466912|NCT01497366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111466913|NCT01475838|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
111466914|NCT01475838|Antiviral Agents|antiviral agents|mesh-ancestor
111466915|NCT01475838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111466916|NCT01475838|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111466917|NCT01475838|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111466918|NCT01451814|Nicotine|nicotine|mesh-list
111466919|NCT01451814|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111466920|NCT01451814|Autonomic Agents|autonomic agents|mesh-ancestor
111466921|NCT01451814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111466922|NCT01451814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111466923|NCT01451814|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111466924|NCT01451814|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111466925|NCT01451814|Cholinergic Agents|cholinergic agents|mesh-ancestor
111466926|NCT01451814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111466927|NCT01451814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111466928|NCT01496430|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
111466929|NCT01496430|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111466930|NCT01496430|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111466931|NCT01496430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111466932|NCT04408326|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
111466933|NCT04408326|Angiotensin II|angiotensin ii|mesh-list
111466934|NCT04408326|Giapreza|giapreza|mesh-list
111466935|NCT04408326|Angiotensinogen|angiotensinogen|mesh-list
111466936|NCT04408326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111466937|NCT04408326|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111466938|NCT04408326|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111466939|NCT04408326|Protease Inhibitors|protease inhibitors|mesh-ancestor
111466940|NCT04408326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111466941|NCT04408326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111466942|NCT01474746|Sertraline|sertraline|mesh-list
111466943|NCT01474746|Antidepressive Agents|antidepressive agents|mesh-ancestor
111466944|NCT01474746|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111466945|NCT01474746|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111466946|NCT01474746|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111466947|NCT01474746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111466948|NCT01474746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111466949|NCT01474746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111466950|NCT01474746|Serotonin Agents|serotonin agents|mesh-ancestor
111466951|NCT01474746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111466952|NCT01450800|Nitrofurantoin|nitrofurantoin|mesh-list
111466953|NCT01450800|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111466954|NCT01450800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111466955|NCT01450800|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111466956|NCT01474512|Ixekizumab|ixekizumab|mesh-list
111466957|NCT01474512|Dermatologic Agents|dermatologic agents|mesh-ancestor
111466958|NCT02985606|Caffeine|caffeine|mesh-list
111466959|NCT02985606|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111466960|NCT02985606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111466961|NCT02985606|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111466962|NCT02985606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111466963|NCT02985606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111466964|NCT02985606|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
111466965|NCT02985606|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111466966|NCT02985606|Purinergic Agents|purinergic agents|mesh-ancestor
111466967|NCT02985606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111466968|NCT01473732|Mycophenolic Acid|mycophenolic acid|mesh-list
111466969|NCT01473732|Everolimus|everolimus|mesh-list
111466970|NCT01473732|Tacrolimus|tacrolimus|mesh-list
111466971|NCT01473732|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111466972|NCT01473732|Immunologic Factors|immunologic factors|mesh-ancestor
111466973|NCT01473732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111466974|NCT01473732|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111466975|NCT01473732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111466976|NCT01473732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111466978|NCT01473732|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111466979|NCT01473732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111466980|NCT01473732|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111466981|NCT01473732|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111466982|NCT01473732|Antitubercular Agents|antitubercular agents|mesh-ancestor
111466983|NCT01473732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111466984|NCT01473732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111466985|NCT01450098|Evacetrapib|evacetrapib|mesh-list
111466986|NCT01450098|Propyl Gallate|propyl gallate|mesh-list
111466987|NCT01450098|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111466988|NCT01450098|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111466989|NCT01450098|Antimetabolites|antimetabolites|mesh-ancestor
111466990|NCT01450098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111466991|NCT01450098|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111466992|NCT01450098|Antioxidants|antioxidants|mesh-ancestor
111466993|NCT01450098|Protective Agents|protective agents|mesh-ancestor
111466994|NCT01450098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111466995|NCT01449630|Celecoxib|celecoxib|mesh-list
111466996|NCT01449630|LY3031207|ly3031207|mesh-list
111466997|NCT01449630|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111466998|NCT01449630|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111466999|NCT01449630|Analgesics|analgesics|mesh-ancestor
111467000|NCT01449630|Sensory System Agents|sensory system agents|mesh-ancestor
111467001|NCT01449630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111467002|NCT01449630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111467003|NCT01449630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111467004|NCT01449630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111467005|NCT01449630|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111467006|NCT01449630|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111467007|NCT01449630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111467008|NCT01449630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111467009|NCT01449630|Prostaglandin Antagonists|prostaglandin antagonists|mesh-ancestor
111467010|NCT01449630|Hormone Antagonists|hormone antagonists|mesh-ancestor
111467011|NCT01449630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111467012|NCT01473420|Epoetin Alfa|epoetin alfa|mesh-list
111467013|NCT01473420|Hematinics|hematinics|mesh-ancestor
111467014|NCT04674774|Lansoprazole|lansoprazole|mesh-list
111467015|NCT04674774|Dexlansoprazole|dexlansoprazole|mesh-list
111467016|NCT04674774|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111467017|NCT04674774|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111467018|NCT04674774|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111467019|NCT04674774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111467020|NCT04674774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111467021|NCT01492686|Edaravone|edaravone|mesh-list
111467022|NCT01492686|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111467023|NCT01492686|Antioxidants|antioxidants|mesh-ancestor
111467024|NCT01492686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111467025|NCT01492686|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111467026|NCT01492686|Protective Agents|protective agents|mesh-ancestor
111467027|NCT01492686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111467028|NCT01449006|Maraviroc|maraviroc|mesh-list
111467029|NCT01449006|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
111467030|NCT01449006|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
111467031|NCT01449006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111467032|NCT01449006|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111467033|NCT01449006|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111467034|NCT01449006|Antiviral Agents|antiviral agents|mesh-ancestor
111467035|NCT01449006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111467036|NCT01449006|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
111467037|NCT01491672|Everolimus|everolimus|mesh-list
111467038|NCT01491672|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111467039|NCT01491672|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111467040|NCT01491672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111467041|NCT01491672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111467042|NCT01491672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111467043|NCT01491672|Immunologic Factors|immunologic factors|mesh-ancestor
111467044|NCT01491672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111467045|NCT01491672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111467046|NCT01447446|Ribavirin|ribavirin|mesh-list
111467047|NCT01447446|Interferon-alpha|interferon-alpha|mesh-list
111467048|NCT01447446|Interferon alpha-2|interferon alpha-2|mesh-list
111467049|NCT01447446|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
111467050|NCT01447446|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
111467051|NCT01447446|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
111467052|NCT01447446|Antimetabolites|antimetabolites|mesh-ancestor
111467053|NCT01447446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111467054|NCT01447446|Antiviral Agents|antiviral agents|mesh-ancestor
111467055|NCT01447446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111467056|NCT01447446|Immunologic Factors|immunologic factors|mesh-ancestor
111467057|NCT01447446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111467058|NCT01447446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111467059|NCT01471782|Blinatumomab|blinatumomab|mesh-list
111467060|NCT01471782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111467061|NCT01490580|Atropine|atropine|mesh-list
111467062|NCT01490580|Sufentanil|sufentanil|mesh-list
111467063|NCT01490580|Propofol|propofol|mesh-list
111467064|NCT01490580|Atracurium|atracurium|mesh-list
111467065|NCT01490580|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111467066|NCT01490580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111467067|NCT01490580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111467068|NCT01490580|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111467069|NCT01490580|Anesthetics, General|anesthetics, general|mesh-ancestor
111467070|NCT01490580|Anesthetics|anesthetics|mesh-ancestor
111467071|NCT01490580|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111467072|NCT01490580|Narcotics|narcotics|mesh-ancestor
111467073|NCT01490580|Analgesics|analgesics|mesh-ancestor
111467074|NCT01490580|Sensory System Agents|sensory system agents|mesh-ancestor
111467075|NCT01490580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111467076|NCT01490580|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111467077|NCT01490580|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111467078|NCT01490580|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111467079|NCT01490580|Autonomic Agents|autonomic agents|mesh-ancestor
111467080|NCT01490580|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111467081|NCT01490580|Respiratory System Agents|respiratory system agents|mesh-ancestor
111467082|NCT01490580|Mydriatics|mydriatics|mesh-ancestor
111467083|NCT01490580|Parasympatholytics|parasympatholytics|mesh-ancestor
111467084|NCT01490580|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111467085|NCT01490580|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111467086|NCT01490580|Cholinergic Agents|cholinergic agents|mesh-ancestor
111467087|NCT01490580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111467088|NCT01490580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111467089|NCT01490580|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
111467090|NCT01490580|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
111467091|NCT01490580|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111467092|NCT01490580|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
111467093|NCT01490190|Ethinyl Estradiol|ethinyl estradiol|mesh-list
111467094|NCT01490190|Etonogestrel|etonogestrel|mesh-list
111467095|NCT01490190|NuvaRing|nuvaring|mesh-list
111467096|NCT01490190|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111467097|NCT01490190|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111467098|NCT01490190|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111467099|NCT01490190|Contraceptive Agents|contraceptive agents|mesh-ancestor
111467100|NCT01490190|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111467101|NCT01490190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111467102|NCT01490190|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111467103|NCT01490190|Estrogens|estrogens|mesh-ancestor
111467104|NCT01490190|Hormones|hormones|mesh-ancestor
111467105|NCT01490190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111467106|NCT01446042|Methyltestosterone|methyltestosterone|mesh-list
111467107|NCT01446042|Testosterone|testosterone|mesh-list
111467108|NCT01446042|Testosterone undecanoate|testosterone undecanoate|mesh-list
111467109|NCT01446042|Testosterone enanthate|testosterone enanthate|mesh-list
111467110|NCT01446042|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
111467111|NCT01446042|Androgens|androgens|mesh-ancestor
111467112|NCT01446042|Hormones|hormones|mesh-ancestor
111467113|NCT01446042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111467114|NCT01446042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111467115|NCT01446042|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111467116|NCT01446042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111467117|NCT01446042|Anabolic Agents|anabolic agents|mesh-ancestor
111467118|NCT01445886|Calcitriol|calcitriol|mesh-list
111467119|NCT01445886|Calcipotriene|calcipotriene|mesh-list
111467120|NCT01445886|Dermatologic Agents|dermatologic agents|mesh-ancestor
111467121|NCT01445886|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111467122|NCT01445886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111467123|NCT01445886|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
111467124|NCT01445886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111467125|NCT01445886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111191292|NCT00198328|Bleomycin|bleomycin|mesh-list
111467126|NCT01445886|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111467127|NCT01445886|Vitamins|vitamins|mesh-ancestor
111467128|NCT01445886|Micronutrients|micronutrients|mesh-ancestor
111467129|NCT01445886|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111467130|NCT01470612|Tofacitinib|tofacitinib|mesh-list
111467131|NCT01470612|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
111467132|NCT01470612|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111467133|NCT01470612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111467134|NCT01470612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111467135|NCT04073316|Warfarin|warfarin|mesh-list
111467136|NCT04073316|Rivaroxaban|rivaroxaban|mesh-list
111467137|NCT04073316|Anticoagulants|anticoagulants|mesh-ancestor
111467138|NCT04073316|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111467139|NCT04073316|Antithrombins|antithrombins|mesh-ancestor
111467140|NCT04073316|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111467141|NCT04073316|Protease Inhibitors|protease inhibitors|mesh-ancestor
111467142|NCT04073316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111467143|NCT04073316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111467144|NCT04089852|Nitrous Oxide|nitrous oxide|mesh-list
111467145|NCT04089852|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111467146|NCT04089852|Anesthetics, General|anesthetics, general|mesh-ancestor
111467147|NCT04089852|Anesthetics|anesthetics|mesh-ancestor
111467148|NCT04089852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111467149|NCT04089852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111467150|NCT04089852|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111467151|NCT04089852|Analgesics|analgesics|mesh-ancestor
111467152|NCT04089852|Sensory System Agents|sensory system agents|mesh-ancestor
111467153|NCT04089852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111467154|NCT03026244|Vitamin D|vitamin d|mesh-list
111467155|NCT03026244|Caseins|caseins|mesh-list
111467156|NCT03026244|Vitamins|vitamins|mesh-ancestor
111467157|NCT03026244|Micronutrients|micronutrients|mesh-ancestor
111467158|NCT03026244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111467159|NCT03026244|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111467160|NCT03026244|Chelating Agents|chelating agents|mesh-ancestor
111467161|NCT03026244|Sequestering Agents|sequestering agents|mesh-ancestor
111467162|NCT03026244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111467163|NCT01470144|Epoprostenol|epoprostenol|mesh-list
111467164|NCT01470144|Tezosentan|tezosentan|mesh-list
111467165|NCT01470144|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111467166|NCT01470144|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111467167|NCT01470144|Vasodilator Agents|vasodilator agents|mesh-ancestor
111467168|NCT01443858|Meclizine|meclizine|mesh-list
111467169|NCT01443858|Nicotine|nicotine|mesh-list
111467170|NCT01443858|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111467171|NCT01443858|Autonomic Agents|autonomic agents|mesh-ancestor
111467172|NCT01443858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111467173|NCT01443858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111467174|NCT01443858|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111467175|NCT01443858|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111467176|NCT01443858|Cholinergic Agents|cholinergic agents|mesh-ancestor
111467177|NCT01443858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111467178|NCT01443858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111467179|NCT01443858|Antiemetics|antiemetics|mesh-ancestor
111467180|NCT01443858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111467181|NCT01443858|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111467182|NCT01443858|Histamine Antagonists|histamine antagonists|mesh-ancestor
111467183|NCT01443858|Histamine Agents|histamine agents|mesh-ancestor
111467184|NCT01443858|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111467185|NCT01443858|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111467186|NCT01443078|Carboplatin|carboplatin|mesh-list
111467187|NCT01443078|Gemcitabine|gemcitabine|mesh-list
111467188|NCT01443078|Docetaxel|docetaxel|mesh-list
111467189|NCT01443078|Pemetrexed|pemetrexed|mesh-list
111467190|NCT01443078|Vinorelbine|vinorelbine|mesh-list
111467191|NCT01443078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111467192|NCT01443078|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111467193|NCT01443078|Antimetabolites|antimetabolites|mesh-ancestor
111467194|NCT01443078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111467195|NCT01443078|Tubulin Modulators|tubulin modulators|mesh-ancestor
111467196|NCT01443078|Antimitotic Agents|antimitotic agents|mesh-ancestor
111467197|NCT01443078|Mitosis Modulators|mitosis modulators|mesh-ancestor
111467198|NCT01443078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111467199|NCT01443078|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111467200|NCT01443078|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111467201|NCT01443078|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111467202|NCT01439880|Evolocumab|evolocumab|mesh-list
111191351|NCT00326872|Cediranib|cediranib|mesh-list
111467203|NCT01439880|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
111467204|NCT01439880|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111467206|NCT01439880|Antimetabolites|antimetabolites|mesh-ancestor
111467207|NCT01439880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111467208|NCT01439880|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111467209|NCT01439880|Protease Inhibitors|protease inhibitors|mesh-ancestor
111467210|NCT01439880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111467211|NCT01439880|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111467212|NCT01469364|Aztreonam|aztreonam|mesh-list
111467213|NCT01469364|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111467214|NCT01469364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111467215|NCT01439568|Carboplatin|carboplatin|mesh-list
111467216|NCT01439568|Etoposide|etoposide|mesh-list
111467217|NCT01439568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111467218|NCT01439568|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111467219|NCT01439568|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111467220|NCT01439568|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111467221|NCT01439568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111467222|NCT01439568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111467223|NCT01469052|Axitinib|axitinib|mesh-list
111467224|NCT01469052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111467225|NCT01469052|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111467226|NCT01469052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111467227|NCT01469052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111467228|NCT01468818|Cyclophosphamide|cyclophosphamide|mesh-list
111467229|NCT01468818|Fludarabine|fludarabine|mesh-list
111467230|NCT01468818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111467231|NCT01468818|Immunologic Factors|immunologic factors|mesh-ancestor
111467232|NCT01468818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111467233|NCT01468818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111467234|NCT01468818|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111467235|NCT01468818|Alkylating Agents|alkylating agents|mesh-ancestor
111467236|NCT01468818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111467237|NCT01468818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111467238|NCT01468818|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111467239|NCT01442376|Ondansetron|ondansetron|mesh-list
111467240|NCT01442376|Palonosetron|palonosetron|mesh-list
111467241|NCT01442376|Antiemetics|antiemetics|mesh-ancestor
111467242|NCT01442376|Autonomic Agents|autonomic agents|mesh-ancestor
111467243|NCT01442376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111467244|NCT01442376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111467245|NCT01442376|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111467246|NCT01442376|Antipruritics|antipruritics|mesh-ancestor
111467247|NCT01442376|Dermatologic Agents|dermatologic agents|mesh-ancestor
111467248|NCT01442376|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111467249|NCT01442376|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111467250|NCT01442376|Serotonin Agents|serotonin agents|mesh-ancestor
111467251|NCT01442376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111467252|NCT01442376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111467253|NCT01442064|Ranibizumab|ranibizumab|mesh-list
111467254|NCT01442064|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111467255|NCT01442064|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111467256|NCT01442064|Growth Substances|growth substances|mesh-ancestor
111467257|NCT01442064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111467258|NCT01442064|Growth Inhibitors|growth inhibitors|mesh-ancestor
111467259|NCT01442064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111467260|NCT01441596|Vinorelbine|vinorelbine|mesh-list
111467261|NCT01441596|Afatinib|afatinib|mesh-list
111467262|NCT01441596|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111467263|NCT01441596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111467264|NCT01441596|Tubulin Modulators|tubulin modulators|mesh-ancestor
111467265|NCT01441596|Antimitotic Agents|antimitotic agents|mesh-ancestor
111467266|NCT01441596|Mitosis Modulators|mitosis modulators|mesh-ancestor
111467267|NCT01441596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111467268|NCT01441596|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111467269|NCT01441596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111467270|NCT01441440|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
111467271|NCT01441440|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111467272|NCT01441440|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111467273|NCT01441440|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111467274|NCT01441440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111467275|NCT01441440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111467276|NCT01441440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111467277|NCT01441440|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111467278|NCT01441440|Antidepressive Agents|antidepressive agents|mesh-ancestor
111467280|NCT03026478|Betamethasone|betamethasone|mesh-list
111467281|NCT03026478|Betamethasone Valerate|betamethasone valerate|mesh-list
111467282|NCT03026478|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
111467283|NCT03026478|Betamethasone benzoate|betamethasone benzoate|mesh-list
111467284|NCT03026478|Clobetasol|clobetasol|mesh-list
111467285|NCT03026478|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
111467286|NCT03026478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111467287|NCT03026478|Glucocorticoids|glucocorticoids|mesh-ancestor
111467288|NCT03026478|Hormones|hormones|mesh-ancestor
110941239|NCT06059118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111467289|NCT03026478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111467290|NCT03026478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111467291|NCT03026478|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111467292|NCT03026478|Respiratory System Agents|respiratory system agents|mesh-ancestor
111467293|NCT04066764|Nadroparin|nadroparin|mesh-list
111467294|NCT04066764|Warfarin|warfarin|mesh-list
111467295|NCT04066764|Rivaroxaban|rivaroxaban|mesh-list
111467296|NCT04066764|Anticoagulants|anticoagulants|mesh-ancestor
111467297|NCT04066764|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111467298|NCT04066764|Antithrombins|antithrombins|mesh-ancestor
111467299|NCT04066764|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111467300|NCT04066764|Protease Inhibitors|protease inhibitors|mesh-ancestor
111467301|NCT04066764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111467302|NCT04066764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111467303|NCT04066764|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111467304|NCT04066764|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111467305|NCT01437540|Bromides|bromides|mesh-list
111467306|NCT01437540|Formoterol Fumarate|formoterol fumarate|mesh-list
111467307|NCT01437540|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111467308|NCT01437540|Autonomic Agents|autonomic agents|mesh-ancestor
111467309|NCT01437540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111467310|NCT01437540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111467311|NCT01437540|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111467312|NCT01437540|Respiratory System Agents|respiratory system agents|mesh-ancestor
111467313|NCT01437540|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111467314|NCT01437540|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111467315|NCT01437540|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111467316|NCT01437540|Adrenergic Agents|adrenergic agents|mesh-ancestor
111467317|NCT01437540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111467318|NCT01437540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111467319|NCT01437540|Anticonvulsants|anticonvulsants|mesh-ancestor
111467320|NCT01420536|Salicylic Acid|salicylic acid|mesh-list
111467321|NCT01420536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111467322|NCT01420536|Antifungal Agents|antifungal agents|mesh-ancestor
111467323|NCT01420536|Keratolytic Agents|keratolytic agents|mesh-ancestor
111467324|NCT01420536|Dermatologic Agents|dermatologic agents|mesh-ancestor
111467325|NCT01467492|Interferons|interferons|mesh-list
111467326|NCT01467492|Ribavirin|ribavirin|mesh-list
111467327|NCT01467492|Interferon-alpha|interferon-alpha|mesh-list
111467328|NCT01467492|Interferon alpha-2|interferon alpha-2|mesh-list
111467329|NCT01467492|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
111467330|NCT01467492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111467331|NCT01467492|Antiviral Agents|antiviral agents|mesh-ancestor
111467332|NCT01467492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111467333|NCT01467492|Antimetabolites|antimetabolites|mesh-ancestor
111467334|NCT01467492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111467335|NCT01467492|Immunologic Factors|immunologic factors|mesh-ancestor
111467336|NCT01467492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111467337|NCT01466790|Ribavirin|ribavirin|mesh-list
111467338|NCT01466790|Sofosbuvir|sofosbuvir|mesh-list
111467339|NCT01466790|Simeprevir|simeprevir|mesh-list
111467340|NCT01466790|Antimetabolites|antimetabolites|mesh-ancestor
111467341|NCT01466790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111467342|NCT01466790|Antiviral Agents|antiviral agents|mesh-ancestor
111467343|NCT01466790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111467344|NCT01466790|Protease Inhibitors|protease inhibitors|mesh-ancestor
111467345|NCT01466790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111467346|NCT01418352|Aripiprazole|aripiprazole|mesh-list
111467347|NCT01418352|Antidepressive Agents|antidepressive agents|mesh-ancestor
111467348|NCT01418352|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111467349|NCT01418352|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111467350|NCT01418352|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111467351|NCT01418352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111191488|NCT01522443|Analgesics|analgesics|mesh-ancestor
111467352|NCT01418352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111467353|NCT01418352|Dopamine Agonists|dopamine agonists|mesh-ancestor
111467354|NCT01418352|Dopamine Agents|dopamine agents|mesh-ancestor
111467355|NCT01418352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111467356|NCT01418352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111467357|NCT01418352|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111467358|NCT01418352|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111467359|NCT01418352|Serotonin Agents|serotonin agents|mesh-ancestor
111467360|NCT01418352|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111467361|NCT01418352|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111467362|NCT01418352|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111467363|NCT01418352|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111467364|NCT01436370|Vaccines|vaccines|mesh-list
111467365|NCT01436370|Immunologic Factors|immunologic factors|mesh-ancestor
111467366|NCT01436370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111467367|NCT01465464|Orantinib|orantinib|mesh-list
111467368|NCT01465464|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111467369|NCT01465464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111467370|NCT01465464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111467371|NCT01465386|Bortezomib|bortezomib|mesh-list
111467372|NCT01465386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111467373|NCT01465230|Lenalidomide|lenalidomide|mesh-list
111467374|NCT01465230|Immunologic Factors|immunologic factors|mesh-ancestor
111467375|NCT01465230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111467376|NCT01465230|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111467377|NCT01465230|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111467378|NCT01465230|Growth Substances|growth substances|mesh-ancestor
111467379|NCT01465230|Growth Inhibitors|growth inhibitors|mesh-ancestor
111467380|NCT01465230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111467381|NCT01435122|Axitinib|axitinib|mesh-list
111467382|NCT01435122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111467383|NCT01435122|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111467384|NCT01435122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111467385|NCT01435122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111467386|NCT01393626|Tofacitinib|tofacitinib|mesh-list
111467387|NCT01393626|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
111467388|NCT01393626|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111467389|NCT01393626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111467390|NCT01393626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111467391|NCT01393158|Apremilast|apremilast|mesh-list
111467392|NCT01393158|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111467393|NCT01393158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111467394|NCT01393158|Analgesics|analgesics|mesh-ancestor
111467395|NCT01393158|Sensory System Agents|sensory system agents|mesh-ancestor
111467396|NCT01393158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111467397|NCT01393158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111467398|NCT01393158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111467399|NCT01393158|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111467400|NCT01393158|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
111467401|NCT01393158|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111467402|NCT01393158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111467403|NCT01393158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111467404|NCT01413360|Vitamins|vitamins|mesh-list
111467405|NCT01413360|Ascorbic Acid|ascorbic acid|mesh-list
111467406|NCT01413360|Micronutrients|micronutrients|mesh-ancestor
111467407|NCT01413360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111467408|NCT01413360|Antioxidants|antioxidants|mesh-ancestor
111467409|NCT01413360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111467410|NCT01413360|Protective Agents|protective agents|mesh-ancestor
111467411|NCT03815448|Methotrexate|methotrexate|mesh-list
111467412|NCT03815448|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111467413|NCT03815448|Abortifacient Agents|abortifacient agents|mesh-ancestor
111467414|NCT03815448|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111467415|NCT03815448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111467416|NCT03815448|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111467417|NCT03815448|Antimetabolites|antimetabolites|mesh-ancestor
111467418|NCT03815448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111467419|NCT03815448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111467420|NCT03815448|Dermatologic Agents|dermatologic agents|mesh-ancestor
111467421|NCT03815448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111467422|NCT03815448|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111467423|NCT03815448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111467424|NCT03815448|Immunologic Factors|immunologic factors|mesh-ancestor
111467425|NCT03815448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111467426|NCT03815448|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111467427|NCT01392378|Acetaminophen|acetaminophen|mesh-list
111467428|NCT01392378|Ibuprofen|ibuprofen|mesh-list
111467429|NCT01392378|Vaccines|vaccines|mesh-list
111467430|NCT01392378|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
111467431|NCT01392378|Immunologic Factors|immunologic factors|mesh-ancestor
111467432|NCT01392378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111467433|NCT01392378|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111467434|NCT01392378|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111467435|NCT01392378|Analgesics|analgesics|mesh-ancestor
111467436|NCT01392378|Sensory System Agents|sensory system agents|mesh-ancestor
111467437|NCT01392378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111467438|NCT01392378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111467439|NCT01392378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111467440|NCT01392378|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111467441|NCT01392378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111467442|NCT01392378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111467443|NCT01392378|Antipyretics|antipyretics|mesh-ancestor
111467444|NCT01412424|Octreotide|octreotide|mesh-list
111467445|NCT01412424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111467446|NCT01412424|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111467447|NCT01412424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111467448|NCT01433250|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111467449|NCT01433250|Immunologic Factors|immunologic factors|mesh-ancestor
111467450|NCT01433250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111467451|NCT01432938|Dulaglutide|dulaglutide|mesh-list
111467452|NCT01432938|Warfarin|warfarin|mesh-list
111467453|NCT01432938|Anticoagulants|anticoagulants|mesh-ancestor
111467454|NCT01432938|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111467455|NCT01432938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111467456|NCT01392300|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
111467457|NCT01392300|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111467458|NCT01392300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111467459|NCT01392300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111467460|NCT01392300|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111467461|NCT01392300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111467462|NCT01392300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111467463|NCT01392300|Cholinergic Agents|cholinergic agents|mesh-ancestor
111467464|NCT01392300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111467465|NCT01432626|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
111467466|NCT01432626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111467467|NCT01432626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111467468|NCT01432626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111467469|NCT01432626|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111467470|NCT01391130|Sunitinib|sunitinib|mesh-list
111467471|NCT01391130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111467472|NCT01391130|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111467473|NCT01391130|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111467474|NCT01391130|Growth Substances|growth substances|mesh-ancestor
111467475|NCT01391130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111467476|NCT01391130|Growth Inhibitors|growth inhibitors|mesh-ancestor
111467477|NCT01391130|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111467478|NCT01391130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111467479|NCT01391130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111467480|NCT04046094|Ascorbic Acid|ascorbic acid|mesh-list
111467481|NCT04046094|Vitamins|vitamins|mesh-ancestor
111467482|NCT04046094|Micronutrients|micronutrients|mesh-ancestor
111467483|NCT04046094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111467484|NCT04046094|Antioxidants|antioxidants|mesh-ancestor
110941262|NCT06058962|Suramin|suramin|mesh-list
111467485|NCT04046094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111467486|NCT04046094|Protective Agents|protective agents|mesh-ancestor
111467487|NCT01410240|Hemostatics|hemostatics|mesh-list
111467488|NCT01410240|Coagulants|coagulants|mesh-ancestor
111467489|NCT01408914|Rifampin|rifampin|mesh-list
111467490|NCT01408914|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111467491|NCT01408914|Antitubercular Agents|antitubercular agents|mesh-ancestor
111467492|NCT01408914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111467493|NCT01408914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111467494|NCT01408914|Leprostatic Agents|leprostatic agents|mesh-ancestor
111467495|NCT01408914|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111467496|NCT01408914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111467497|NCT01408914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111467498|NCT01408914|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111467499|NCT01408914|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111467500|NCT01408914|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
111467501|NCT01408914|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
111467502|NCT01408914|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
111467503|NCT01408914|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111467505|NCT04044222|Etoposide|etoposide|mesh-list
111467506|NCT04044222|Etoposide phosphate|etoposide phosphate|mesh-list
111467507|NCT04044222|Ifosfamide|ifosfamide|mesh-list
111467508|NCT04044222|Isophosphamide mustard|isophosphamide mustard|mesh-list
111467509|NCT04044222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111467510|NCT04044222|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111467511|NCT04044222|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111467512|NCT04044222|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111467513|NCT04044222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111467514|NCT04044222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111467515|NCT04044222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111467516|NCT04044222|Alkylating Agents|alkylating agents|mesh-ancestor
111467517|NCT01390428|Grazoprevir|grazoprevir|mesh-list
111467518|NCT01390428|Antiviral Agents|antiviral agents|mesh-ancestor
111467519|NCT01390428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111467520|NCT01429584|Bupivacaine|bupivacaine|mesh-list
111467521|NCT01429584|Anesthetics, Local|anesthetics, local|mesh-ancestor
111467522|NCT01429584|Anesthetics|anesthetics|mesh-ancestor
111467523|NCT01429584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111467524|NCT01429584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111467525|NCT01429584|Sensory System Agents|sensory system agents|mesh-ancestor
111467526|NCT01429584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111467527|NCT01405950|Clonidine|clonidine|mesh-list
111467528|NCT01405950|Tizanidine|tizanidine|mesh-list
111467529|NCT01405950|Analgesics|analgesics|mesh-ancestor
111467530|NCT01405950|Sensory System Agents|sensory system agents|mesh-ancestor
111467531|NCT01405950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111467532|NCT01405950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111467533|NCT01405950|Anticonvulsants|anticonvulsants|mesh-ancestor
111467534|NCT01405950|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
111467535|NCT01405950|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111467536|NCT01405950|Parasympatholytics|parasympatholytics|mesh-ancestor
111467537|NCT01405950|Autonomic Agents|autonomic agents|mesh-ancestor
111467538|NCT01405950|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111467539|NCT01405950|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111467540|NCT01405950|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111467541|NCT01405950|Adrenergic Agents|adrenergic agents|mesh-ancestor
111467542|NCT01405950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111467543|NCT01405950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111467544|NCT01405950|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111467545|NCT01405950|Sympatholytics|sympatholytics|mesh-ancestor
111467546|NCT01405560|Ribavirin|ribavirin|mesh-list
111467547|NCT01405560|Antimetabolites|antimetabolites|mesh-ancestor
110941284|NCT06058702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111467548|NCT01405560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111467549|NCT01405560|Antiviral Agents|antiviral agents|mesh-ancestor
111467550|NCT01405560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111467551|NCT01428882|Midazolam|midazolam|mesh-list
111467552|NCT01428882|Propofol|propofol|mesh-list
111467553|NCT01428882|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111467554|NCT01428882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111467555|NCT01428882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111467556|NCT01428882|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111467557|NCT01428882|Anesthetics, General|anesthetics, general|mesh-ancestor
111467558|NCT01428882|Anesthetics|anesthetics|mesh-ancestor
111467559|NCT01428882|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111467560|NCT01428882|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111467561|NCT01428882|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111467562|NCT01428882|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111467563|NCT01428882|GABA Modulators|gaba modulators|mesh-ancestor
111467564|NCT01428882|GABA Agents|gaba agents|mesh-ancestor
111467565|NCT01428882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111467566|NCT01428882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111467567|NCT01428258|Coal Tar|coal tar|mesh-list
111467568|NCT01428258|Keratolytic Agents|keratolytic agents|mesh-ancestor
111467569|NCT01428258|Dermatologic Agents|dermatologic agents|mesh-ancestor
111467570|NCT01442688|Amoxicillin|amoxicillin|mesh-list
111467571|NCT01442688|Mesalamine|mesalamine|mesh-list
111467572|NCT01442688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111467573|NCT01442688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111467574|NCT01442688|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111467575|NCT01442688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111467576|NCT01442688|Analgesics|analgesics|mesh-ancestor
111467577|NCT01442688|Sensory System Agents|sensory system agents|mesh-ancestor
111467578|NCT01442688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111467579|NCT01442688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111467580|NCT01442688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111467581|NCT01442688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111467582|NCT03814200|Rifampin|rifampin|mesh-list
111467583|NCT03814200|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111467584|NCT03814200|Antitubercular Agents|antitubercular agents|mesh-ancestor
111467585|NCT03814200|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111467586|NCT03814200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111467587|NCT03814200|Leprostatic Agents|leprostatic agents|mesh-ancestor
111467588|NCT03814200|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111467589|NCT03814200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111467590|NCT03814200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111467591|NCT03814200|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111467592|NCT03814200|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111467593|NCT03814200|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
111467594|NCT03814200|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
111467595|NCT03814200|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
111467596|NCT03814200|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111467597|NCT01426854|Nepafenac|nepafenac|mesh-list
111467598|NCT01426854|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111467599|NCT01426854|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111467600|NCT01426854|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111467601|NCT01426854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111467602|NCT01426854|Analgesics|analgesics|mesh-ancestor
111467603|NCT01426854|Sensory System Agents|sensory system agents|mesh-ancestor
111467604|NCT01426854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111467605|NCT01426854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111467606|NCT01426854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111467607|NCT01426854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111467608|NCT01403610|Bevacizumab|bevacizumab|mesh-list
111467609|NCT01403610|Phosphoramide Mustards|phosphoramide mustards|mesh-list
111467610|NCT01403610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111467611|NCT01403610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111467612|NCT01403610|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111467613|NCT01403610|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111467614|NCT01403610|Growth Substances|growth substances|mesh-ancestor
111467615|NCT01403610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111467616|NCT01403610|Growth Inhibitors|growth inhibitors|mesh-ancestor
111467617|NCT01403610|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111467618|NCT01403610|Alkylating Agents|alkylating agents|mesh-ancestor
111467619|NCT01403610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111467620|NCT01402986|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111467621|NCT01402986|Immunologic Factors|immunologic factors|mesh-ancestor
111467622|NCT01402986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111467623|NCT01389102|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
111467624|NCT01389102|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
111467625|NCT01389102|Estradiol|estradiol|mesh-list
111467626|NCT01389102|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
111467627|NCT01389102|Estrogens|estrogens|mesh-ancestor
111467628|NCT01389102|Hormones|hormones|mesh-ancestor
111467629|NCT01389102|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111467630|NCT01389102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111467631|NCT01389102|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111467632|NCT01389102|Contraceptive Agents|contraceptive agents|mesh-ancestor
111467633|NCT01389102|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111467634|NCT01389102|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111467635|NCT01402284|Dexamethasone|dexamethasone|mesh-list
111467636|NCT01402284|Lenalidomide|lenalidomide|mesh-list
111467637|NCT01402284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111467638|NCT01402284|Antiemetics|antiemetics|mesh-ancestor
111467639|NCT01402284|Autonomic Agents|autonomic agents|mesh-ancestor
111467640|NCT01402284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111467641|NCT01402284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111467642|NCT01402284|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111467643|NCT01402284|Glucocorticoids|glucocorticoids|mesh-ancestor
111467644|NCT01402284|Hormones|hormones|mesh-ancestor
111467645|NCT01402284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111467646|NCT01402284|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111467647|NCT01402284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111467648|NCT01402284|Immunologic Factors|immunologic factors|mesh-ancestor
111467649|NCT01402284|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111467650|NCT01402284|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111467651|NCT01402284|Growth Substances|growth substances|mesh-ancestor
111467652|NCT01402284|Growth Inhibitors|growth inhibitors|mesh-ancestor
111467653|NCT01388790|Cetuximab|cetuximab|mesh-list
111467654|NCT01388790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111467655|NCT01388790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111467656|NCT01388478|Pramipexole|pramipexole|mesh-list
111467657|NCT01388478|Antioxidants|antioxidants|mesh-ancestor
111467658|NCT01388478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111467659|NCT01388478|Protective Agents|protective agents|mesh-ancestor
111467660|NCT01388478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111467661|NCT01388478|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111467662|NCT01388478|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111467663|NCT01388478|Dopamine Agonists|dopamine agonists|mesh-ancestor
111467664|NCT01388478|Dopamine Agents|dopamine agents|mesh-ancestor
111467665|NCT01388478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111467666|NCT01400958|Modafinil|modafinil|mesh-list
111467667|NCT01400958|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111467668|NCT01400958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111467669|NCT01400958|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
111467670|NCT01400958|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111467671|NCT01400958|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111467672|NCT01400958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111467673|NCT01400412|Ritonavir|ritonavir|mesh-list
111467674|NCT01400412|Darunavir|darunavir|mesh-list
111467675|NCT01400412|Tenofovir|tenofovir|mesh-list
111467676|NCT01400412|Emtricitabine|emtricitabine|mesh-list
111467677|NCT01400412|Maraviroc|maraviroc|mesh-list
111467678|NCT01400412|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111467679|NCT01400412|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111467680|NCT01400412|Protease Inhibitors|protease inhibitors|mesh-ancestor
111467681|NCT01400412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111467682|NCT01400412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111467683|NCT01400412|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111467684|NCT01400412|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111467685|NCT01400412|Antiviral Agents|antiviral agents|mesh-ancestor
111467686|NCT01400412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111467687|NCT01400412|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110941301|NCT06058663|Durvalumab|durvalumab|mesh-list
111467688|NCT01400412|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111467689|NCT01400412|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111467690|NCT01400412|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111467691|NCT01400412|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
111467692|NCT01400412|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
111467693|NCT01400412|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
111467694|NCT01422876|Linagliptin|linagliptin|mesh-list
111467695|NCT01422876|Empagliflozin|empagliflozin|mesh-list
111467696|NCT01422876|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111467697|NCT01422876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111467698|NCT01422876|Incretins|incretins|mesh-ancestor
111467699|NCT01422876|Hormones|hormones|mesh-ancestor
111467700|NCT01422876|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111467701|NCT01422876|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111467702|NCT01422876|Protease Inhibitors|protease inhibitors|mesh-ancestor
111467703|NCT01422876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111467704|NCT01422876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111467705|NCT01422876|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111467706|NCT01422720|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
111467707|NCT01422720|Anticonvulsants|anticonvulsants|mesh-ancestor
111467708|NCT01422720|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111467709|NCT01422720|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111467710|NCT01422720|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111467711|NCT01422720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111467712|NCT01387932|Doxorubicin|doxorubicin|mesh-list
111467713|NCT01387932|Ethiodized Oil|ethiodized oil|mesh-list
111467714|NCT01387932|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111467715|NCT01387932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111467716|NCT01387932|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111467717|NCT01387932|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111467718|NCT01387932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111467719|NCT01387932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111467720|NCT04413786|Oxytocin|oxytocin|mesh-list
111467721|NCT04413786|Oxytocics|oxytocics|mesh-ancestor
111467722|NCT04413786|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111467723|NCT04413786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111467724|NCT01422408|Fluocinonide|fluocinonide|mesh-list
111467725|NCT01422408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111467726|NCT01422408|Glucocorticoids|glucocorticoids|mesh-ancestor
111467727|NCT01422408|Hormones|hormones|mesh-ancestor
111467728|NCT01422408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111467729|NCT01422408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111467730|NCT01422408|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111467731|NCT01387542|Paliperidone Palmitate|paliperidone palmitate|mesh-list
111467732|NCT01387542|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111467733|NCT01387542|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111467734|NCT01387542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111467735|NCT01387542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111467736|NCT01387542|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111467737|NCT01387542|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111467738|NCT01387542|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111467739|NCT01387542|Serotonin Agents|serotonin agents|mesh-ancestor
111467740|NCT01387542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111467741|NCT01387542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111467742|NCT01387542|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111467743|NCT01387542|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111467744|NCT01387542|Dopamine Agents|dopamine agents|mesh-ancestor
111467745|NCT01387074|Botulinum Toxins|botulinum toxins|mesh-list
111467746|NCT01387074|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111467747|NCT01387074|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111467748|NCT01387074|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111467749|NCT01387074|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111467750|NCT01387074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111467751|NCT01387074|Cholinergic Agents|cholinergic agents|mesh-ancestor
111467752|NCT01387074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111467753|NCT01387074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111467754|NCT01387074|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111467755|NCT01387074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111467756|NCT01386606|Methyltestosterone|methyltestosterone|mesh-list
111467757|NCT01386606|Enclomiphene|enclomiphene|mesh-list
111467758|NCT01386606|Clomiphene|clomiphene|mesh-list
111467759|NCT01386606|Zuclomiphene|zuclomiphene|mesh-list
111467760|NCT01386606|Testosterone|testosterone|mesh-list
111467761|NCT01386606|Testosterone undecanoate|testosterone undecanoate|mesh-list
111467762|NCT01386606|Testosterone enanthate|testosterone enanthate|mesh-list
111467763|NCT01386606|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
111467764|NCT01386606|Androgens|androgens|mesh-ancestor
111467765|NCT01386606|Hormones|hormones|mesh-ancestor
111467766|NCT01386606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111467767|NCT01386606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111467768|NCT01386606|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111467769|NCT01386606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111467770|NCT01386606|Anabolic Agents|anabolic agents|mesh-ancestor
111467771|NCT01386606|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111467772|NCT01386606|Hormone Antagonists|hormone antagonists|mesh-ancestor
111467773|NCT01386606|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111467774|NCT01386606|Fertility Agents|fertility agents|mesh-ancestor
111467775|NCT01386606|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111467776|NCT01386606|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111467777|NCT01386606|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111467778|NCT01385748|Clonidine|clonidine|mesh-list
111467779|NCT01385748|Analgesics|analgesics|mesh-ancestor
111467780|NCT01385748|Sensory System Agents|sensory system agents|mesh-ancestor
111467781|NCT01385748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111467782|NCT01385748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111467783|NCT01385748|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111467784|NCT01385748|Sympatholytics|sympatholytics|mesh-ancestor
111467785|NCT01385748|Autonomic Agents|autonomic agents|mesh-ancestor
111467786|NCT01385748|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111467787|NCT01385748|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111467788|NCT01385748|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111467789|NCT01385748|Adrenergic Agents|adrenergic agents|mesh-ancestor
111467790|NCT01385748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111467791|NCT01385748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111467792|NCT01397448|Rabeprazole|rabeprazole|mesh-list
111467793|NCT01397448|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111467794|NCT01397448|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111467795|NCT01397448|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111467796|NCT01397448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111467797|NCT01397448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111467798|NCT01384734|Ritonavir|ritonavir|mesh-list
111467799|NCT01384734|Atazanavir Sulfate|atazanavir sulfate|mesh-list
111467800|NCT01384734|Tenofovir|tenofovir|mesh-list
111467801|NCT01384734|Raltegravir Potassium|raltegravir potassium|mesh-list
111467802|NCT01384734|Fostemsavir|fostemsavir|mesh-list
111467803|NCT01384734|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111467804|NCT01384734|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111467805|NCT01384734|Protease Inhibitors|protease inhibitors|mesh-ancestor
111467806|NCT01384734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111467807|NCT01384734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111467808|NCT01384734|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111467809|NCT01384734|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111467810|NCT01384734|Antiviral Agents|antiviral agents|mesh-ancestor
111467811|NCT01384734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111467812|NCT01384734|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111467813|NCT01384734|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111467814|NCT01384734|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111467815|NCT01384734|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111467816|NCT01384734|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111467817|NCT01384734|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111467818|NCT01384734|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
111467819|NCT01384734|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
111467820|NCT01396512|Vaccines|vaccines|mesh-list
111467821|NCT01396512|Immunologic Factors|immunologic factors|mesh-ancestor
111467822|NCT01396512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111467823|NCT01396434|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
111467824|NCT01396434|Immunologic Factors|immunologic factors|mesh-ancestor
111467825|NCT01396434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111467826|NCT01383954|Diclofenac|diclofenac|mesh-list
111467827|NCT01383954|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111467828|NCT01383954|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111467829|NCT01383954|Analgesics|analgesics|mesh-ancestor
111467830|NCT01383954|Sensory System Agents|sensory system agents|mesh-ancestor
111467831|NCT01383954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111467832|NCT01383954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111467833|NCT01383954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111467834|NCT01383954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111467835|NCT01383954|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111467836|NCT01383954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111467837|NCT01383954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111467838|NCT05365464|Progesterone|progesterone|mesh-list
111467839|NCT05365464|Progestins|progestins|mesh-ancestor
111467840|NCT05365464|Hormones|hormones|mesh-ancestor
111467841|NCT05365464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111467842|NCT05365464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111467843|NCT01383486|Naproxen|naproxen|mesh-list
111467844|NCT01383486|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111467845|NCT01383486|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111467846|NCT01383486|Analgesics|analgesics|mesh-ancestor
111467847|NCT01383486|Sensory System Agents|sensory system agents|mesh-ancestor
111467848|NCT01383486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111467849|NCT01383486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111467850|NCT01383486|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111467851|NCT01383486|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111467852|NCT01383486|Gout Suppressants|gout suppressants|mesh-ancestor
111467853|NCT01383486|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111467854|NCT01383486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111467855|NCT01383486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111467856|NCT04766736|Antibodies|antibodies|mesh-list
111467857|NCT04766736|Immunologic Factors|immunologic factors|mesh-ancestor
111467858|NCT04766736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111467859|NCT01396278|Fluticasone|fluticasone|mesh-list
111467860|NCT01396278|Xhance|xhance|mesh-list
111467861|NCT01396278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111467862|NCT01396278|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111467863|NCT01396278|Autonomic Agents|autonomic agents|mesh-ancestor
111467864|NCT01396278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111467865|NCT01396278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111467866|NCT01396278|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111467867|NCT01396278|Respiratory System Agents|respiratory system agents|mesh-ancestor
111467868|NCT01396278|Dermatologic Agents|dermatologic agents|mesh-ancestor
111467869|NCT01396278|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111467870|NCT05365074|Chloroprocaine|chloroprocaine|mesh-list
111467871|NCT05365074|Anesthetics, Local|anesthetics, local|mesh-ancestor
111467872|NCT05365074|Anesthetics|anesthetics|mesh-ancestor
111467873|NCT05365074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111467874|NCT05365074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111467875|NCT05365074|Sensory System Agents|sensory system agents|mesh-ancestor
111467876|NCT05365074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111467877|NCT01383096|Artefenomel|artefenomel|mesh-list
111467878|NCT01383096|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111467879|NCT01383096|Antimalarials|antimalarials|mesh-ancestor
111467880|NCT01383096|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111467881|NCT01383096|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111467882|NCT01383096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111467883|NCT01382940|Acetaminophen|acetaminophen|mesh-list
111467884|NCT01382940|Methylprednisolone|methylprednisolone|mesh-list
111467885|NCT01382940|Rituximab|rituximab|mesh-list
111467886|NCT01382940|Methotrexate|methotrexate|mesh-list
111467887|NCT01382940|Histamine Antagonists|histamine antagonists|mesh-list
111467888|NCT01382940|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
111467889|NCT01382940|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111467890|NCT01382940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111467891|NCT01382940|Immunologic Factors|immunologic factors|mesh-ancestor
111467892|NCT01382940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111467893|NCT01382940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111467894|NCT01382940|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111467895|NCT01382940|Abortifacient Agents|abortifacient agents|mesh-ancestor
111467896|NCT01382940|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111467897|NCT01382940|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111467898|NCT01382940|Antimetabolites|antimetabolites|mesh-ancestor
111467899|NCT01382940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111467900|NCT01382940|Dermatologic Agents|dermatologic agents|mesh-ancestor
111467901|NCT01382940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111467902|NCT01382940|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111467903|NCT01382940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111467904|NCT01382940|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111467905|NCT01382940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111467906|NCT01382940|Analgesics|analgesics|mesh-ancestor
111467907|NCT01382940|Sensory System Agents|sensory system agents|mesh-ancestor
111467908|NCT01382940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111467909|NCT01382940|Antipyretics|antipyretics|mesh-ancestor
111467910|NCT01382940|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111467911|NCT01382940|Antiemetics|antiemetics|mesh-ancestor
111467912|NCT01382940|Autonomic Agents|autonomic agents|mesh-ancestor
111467913|NCT01382940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111467914|NCT01382940|Glucocorticoids|glucocorticoids|mesh-ancestor
111467915|NCT01382940|Hormones|hormones|mesh-ancestor
111467916|NCT01382940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111467917|NCT01382940|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111467918|NCT01382940|Protective Agents|protective agents|mesh-ancestor
111467919|NCT01382940|Histamine Agents|histamine agents|mesh-ancestor
111467920|NCT01382940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111467921|NCT01381926|Exenatide|exenatide|mesh-list
111467922|NCT01381926|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111467923|NCT01381926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111467924|NCT01381926|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111467925|NCT01381926|Incretins|incretins|mesh-ancestor
111467926|NCT01381926|Hormones|hormones|mesh-ancestor
111467927|NCT01381926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111467928|NCT01395888|Fluticasone|fluticasone|mesh-list
111467929|NCT01395888|Xhance|xhance|mesh-list
111467930|NCT01395888|Tiotropium Bromide|tiotropium bromide|mesh-list
111467931|NCT01395888|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111467932|NCT01395888|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111467933|NCT01395888|Autonomic Agents|autonomic agents|mesh-ancestor
111467934|NCT01395888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111467935|NCT01395888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111467936|NCT01395888|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111467937|NCT01395888|Respiratory System Agents|respiratory system agents|mesh-ancestor
111467938|NCT01395888|Dermatologic Agents|dermatologic agents|mesh-ancestor
111467939|NCT01395888|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111467940|NCT01395888|Parasympatholytics|parasympatholytics|mesh-ancestor
111467941|NCT01395888|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111467942|NCT01395888|Cholinergic Agents|cholinergic agents|mesh-ancestor
111467943|NCT01395888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111467944|NCT01395888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111467945|NCT01381692|Sirolimus|sirolimus|mesh-list
111467946|NCT01381692|Dexamethasone|dexamethasone|mesh-list
111467947|NCT01381692|Dexamethasone acetate|dexamethasone acetate|mesh-list
111467948|NCT01381692|Rituximab|rituximab|mesh-list
111467949|NCT01381692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111467950|NCT01381692|Bortezomib|bortezomib|mesh-list
111467951|NCT01381692|Temsirolimus|temsirolimus|mesh-list
111467952|NCT01381692|MTOR Inhibitors|mtor inhibitors|mesh-list
111467953|NCT01381692|Antibodies|antibodies|mesh-list
111467954|NCT01381692|Immunoglobulins|immunoglobulins|mesh-list
111467955|NCT01381692|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111467956|NCT01381692|BB 1101|bb 1101|mesh-list
111467957|NCT01381692|Immunologic Factors|immunologic factors|mesh-ancestor
111467958|NCT01381692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111467959|NCT01381692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111467960|NCT01381692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111467961|NCT01381692|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111467962|NCT01381692|Antiemetics|antiemetics|mesh-ancestor
111467963|NCT01381692|Autonomic Agents|autonomic agents|mesh-ancestor
111467964|NCT01381692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111467965|NCT01381692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111467966|NCT01381692|Glucocorticoids|glucocorticoids|mesh-ancestor
111467967|NCT01381692|Hormones|hormones|mesh-ancestor
111467968|NCT01381692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111467969|NCT01381692|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111467970|NCT01381692|Protease Inhibitors|protease inhibitors|mesh-ancestor
111467971|NCT01381692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111467972|NCT01381692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111467973|NCT01381692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111467974|NCT01381692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111467975|NCT01381692|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111467976|NCT01381692|Antifungal Agents|antifungal agents|mesh-ancestor
111467977|NCT01381692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111467978|NCT01381692|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111467979|NCT01395030|Choline|choline|mesh-list
111467980|NCT01395030|Lipotropic Agents|lipotropic agents|mesh-ancestor
111467981|NCT01395030|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111467982|NCT01395030|Antimetabolites|antimetabolites|mesh-ancestor
111467983|NCT01395030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111467984|NCT01395030|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111467985|NCT01395030|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111467986|NCT01395030|Nootropic Agents|nootropic agents|mesh-ancestor
111467987|NCT01394952|Dulaglutide|dulaglutide|mesh-list
111467988|NCT01394952|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111467989|NCT01394952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111467990|NCT01394718|Acetaminophen|acetaminophen|mesh-list
111467991|NCT01394718|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111467992|NCT01394718|Analgesics|analgesics|mesh-ancestor
111467993|NCT01394718|Sensory System Agents|sensory system agents|mesh-ancestor
111467994|NCT01394718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111467995|NCT01394718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111467996|NCT01394718|Antipyretics|antipyretics|mesh-ancestor
111467997|NCT01394250|Lidocaine|lidocaine|mesh-list
111467998|NCT01394250|Anesthetics, Local|anesthetics, local|mesh-ancestor
111467999|NCT01394250|Anesthetics|anesthetics|mesh-ancestor
111468000|NCT01394250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111468001|NCT01394250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111468002|NCT01394250|Sensory System Agents|sensory system agents|mesh-ancestor
111468003|NCT01394250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111468004|NCT01394250|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111468005|NCT01394250|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111468006|NCT01394250|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111468007|NCT01394250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111468008|NCT01394250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111468009|NCT01380990|Busulfan|busulfan|mesh-list
111468010|NCT01380990|Alkylating Agents|alkylating agents|mesh-ancestor
111468011|NCT01380990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111468012|NCT01380990|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111468013|NCT01380990|Immunologic Factors|immunologic factors|mesh-ancestor
111468014|NCT01380990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111468015|NCT01380990|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111468016|NCT01380990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111468017|NCT01380990|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111468018|NCT05361330|Fluoxetine|fluoxetine|mesh-list
111468019|NCT05361330|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111468020|NCT05361330|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111468021|NCT05361330|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111468022|NCT05361330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111468023|NCT05361330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111468024|NCT05361330|Serotonin Agents|serotonin agents|mesh-ancestor
111468025|NCT05361330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111468026|NCT05361330|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111468027|NCT05361330|Antidepressive Agents|antidepressive agents|mesh-ancestor
111468028|NCT05361330|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111192192|NCT00398476|Xhance|xhance|mesh-list
111468029|NCT05361330|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111468030|NCT05361330|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111468032|NCT00214968|Modafinil|modafinil|mesh-list
111468033|NCT00214968|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111468034|NCT00214968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111468035|NCT00214968|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
111468036|NCT00214968|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111468037|NCT00214968|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111468038|NCT00214968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111468039|NCT03592212|Albuterol|albuterol|mesh-list
111468040|NCT03592212|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111468041|NCT03592212|Autonomic Agents|autonomic agents|mesh-ancestor
111468042|NCT03592212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111468043|NCT03592212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111468044|NCT03592212|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111468045|NCT03592212|Respiratory System Agents|respiratory system agents|mesh-ancestor
111468046|NCT03592212|Tocolytic Agents|tocolytic agents|mesh-ancestor
111468047|NCT03592212|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111468048|NCT03592212|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111468049|NCT03592212|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111468050|NCT03592212|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111468051|NCT03592212|Adrenergic Agents|adrenergic agents|mesh-ancestor
111468052|NCT03592212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111468053|NCT03592212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111468054|NCT03024450|Trastuzumab|trastuzumab|mesh-list
111468055|NCT03024450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111468056|NCT03024450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111468057|NCT04263090|Nivolumab|nivolumab|mesh-list
111468058|NCT04263090|ON 01910|on 01910|mesh-list
111468059|NCT04263090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111468060|NCT04263090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111468061|NCT04263090|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111468062|NCT04263090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111468063|NCT04263090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111468064|NCT04263090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111468065|NCT05630274|Moxifloxacin|moxifloxacin|mesh-list
111468066|NCT05630274|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111468067|NCT05630274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111468068|NCT05630274|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111468069|NCT05630274|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111468070|NCT05630274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111468071|NCT05630274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111468072|NCT05630274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111468073|NCT05632692|Menthol|menthol|mesh-list
111468074|NCT05632692|Antipruritics|antipruritics|mesh-ancestor
111468075|NCT05632692|Dermatologic Agents|dermatologic agents|mesh-ancestor
111468076|NCT03594162|Cyclophosphamide|cyclophosphamide|mesh-list
111468077|NCT03594162|Fludarabine|fludarabine|mesh-list
111468078|NCT03594162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111468079|NCT03594162|Immunologic Factors|immunologic factors|mesh-ancestor
111468080|NCT03594162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111468081|NCT03594162|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111468082|NCT03594162|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111468083|NCT03594162|Alkylating Agents|alkylating agents|mesh-ancestor
111468084|NCT03594162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111468085|NCT03594162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111468086|NCT03594162|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111468087|NCT04407312|Aspirin|aspirin|mesh-list
111468088|NCT04407312|Cilostazol|cilostazol|mesh-list
111468089|NCT04407312|Clopidogrel|clopidogrel|mesh-list
111468090|NCT04407312|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111468091|NCT04407312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111468092|NCT04407312|Analgesics|analgesics|mesh-ancestor
111468093|NCT04407312|Sensory System Agents|sensory system agents|mesh-ancestor
111468094|NCT04407312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111468095|NCT04407312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111468096|NCT04407312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111468097|NCT04407312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111468098|NCT04407312|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111468099|NCT04407312|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111468100|NCT04407312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111468101|NCT04407312|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111468102|NCT04407312|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111468103|NCT04407312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111468104|NCT04407312|Antipyretics|antipyretics|mesh-ancestor
111468105|NCT04407312|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111468106|NCT04407312|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111468107|NCT04407312|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111468108|NCT04407312|Purinergic Agents|purinergic agents|mesh-ancestor
111468109|NCT04407312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111468110|NCT04407312|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111468111|NCT04407312|Autonomic Agents|autonomic agents|mesh-ancestor
111468112|NCT04407312|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111468113|NCT04407312|Respiratory System Agents|respiratory system agents|mesh-ancestor
111468114|NCT04407312|Vasodilator Agents|vasodilator agents|mesh-ancestor
111468115|NCT04407312|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111468116|NCT04407312|Protective Agents|protective agents|mesh-ancestor
111468117|NCT04407312|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
111468118|NCT04407312|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111468119|NCT04326738|Midazolam|midazolam|mesh-list
111468120|NCT04326738|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111468121|NCT04326738|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111468122|NCT04326738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111468123|NCT04326738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111468124|NCT04326738|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111468125|NCT04326738|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111468126|NCT04326738|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111468127|NCT04326738|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111468128|NCT04326738|Anesthetics, General|anesthetics, general|mesh-ancestor
111468129|NCT04326738|Anesthetics|anesthetics|mesh-ancestor
111468130|NCT04326738|GABA Modulators|gaba modulators|mesh-ancestor
111468131|NCT04326738|GABA Agents|gaba agents|mesh-ancestor
111468132|NCT04326738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111468133|NCT04326738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111468134|NCT04347486|Atropine|atropine|mesh-list
111468135|NCT04347486|Neostigmine|neostigmine|mesh-list
111468136|NCT04347486|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111468137|NCT04347486|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111468138|NCT04347486|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111468139|NCT04347486|Autonomic Agents|autonomic agents|mesh-ancestor
111468140|NCT04347486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111468141|NCT04347486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111468142|NCT04347486|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111468143|NCT04347486|Respiratory System Agents|respiratory system agents|mesh-ancestor
111468144|NCT04347486|Mydriatics|mydriatics|mesh-ancestor
111468145|NCT04347486|Parasympatholytics|parasympatholytics|mesh-ancestor
111468146|NCT04347486|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110941371|NCT06057935|Pemetrexed|pemetrexed|mesh-list
111468147|NCT04347486|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111468148|NCT04347486|Cholinergic Agents|cholinergic agents|mesh-ancestor
111468149|NCT04347486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111468150|NCT04347486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111468151|NCT04347486|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111468152|NCT04347486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111468153|NCT04347486|Parasympathomimetics|parasympathomimetics|mesh-ancestor
111468154|NCT04407234|Acetaminophen|acetaminophen|mesh-list
111468155|NCT04407234|Tirzepatide|tirzepatide|mesh-list
111468156|NCT04407234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111468157|NCT04407234|Analgesics|analgesics|mesh-ancestor
111468158|NCT04407234|Sensory System Agents|sensory system agents|mesh-ancestor
111468159|NCT04407234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111468160|NCT04407234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111468161|NCT04407234|Antipyretics|antipyretics|mesh-ancestor
111468162|NCT04407234|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111468163|NCT04407234|Incretins|incretins|mesh-ancestor
111468164|NCT04407234|Hormones|hormones|mesh-ancestor
111468165|NCT04407234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111468166|NCT05632224|Aprepitant|aprepitant|mesh-list
111468167|NCT05632224|Granisetron|granisetron|mesh-list
111468168|NCT05632224|Antiemetics|antiemetics|mesh-ancestor
111468169|NCT05632224|Autonomic Agents|autonomic agents|mesh-ancestor
111468170|NCT05632224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111468171|NCT05632224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111468172|NCT05632224|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111468173|NCT05632224|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
111468174|NCT05632224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111468175|NCT05632224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111468176|NCT05632224|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111192310|NCT00406276|Docetaxel|docetaxel|mesh-list
111468177|NCT05632224|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111468178|NCT05632224|Serotonin Agents|serotonin agents|mesh-ancestor
111468179|NCT03024840|Propofol|propofol|mesh-list
111468180|NCT03024840|Sevoflurane|sevoflurane|mesh-list
111468181|NCT03024840|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111468182|NCT03024840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111468183|NCT03024840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111468184|NCT03024840|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111468185|NCT03024840|Anesthetics, General|anesthetics, general|mesh-ancestor
111468186|NCT03024840|Anesthetics|anesthetics|mesh-ancestor
111468187|NCT03024840|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111468188|NCT03024840|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111468189|NCT05631678|Itraconazole|itraconazole|mesh-list
111468190|NCT05631678|Rifampin|rifampin|mesh-list
111468191|NCT05631678|Antifungal Agents|antifungal agents|mesh-ancestor
111468192|NCT05631678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111468193|NCT05631678|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111468194|NCT05631678|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111468195|NCT05631678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111468196|NCT05631678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111468197|NCT05631678|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111468198|NCT05631678|Hormone Antagonists|hormone antagonists|mesh-ancestor
111468199|NCT05631678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111468200|NCT05631678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111468201|NCT05631678|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111468202|NCT05631678|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111468203|NCT05631678|Antitubercular Agents|antitubercular agents|mesh-ancestor
111468204|NCT05631678|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111468205|NCT05631678|Leprostatic Agents|leprostatic agents|mesh-ancestor
111468206|NCT05631678|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111468207|NCT05631678|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111468208|NCT05631678|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111468209|NCT05631678|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
111468210|NCT05631678|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
111468211|NCT05631678|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
111468212|NCT05631678|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111468213|NCT03599778|Apatinib|apatinib|mesh-list
111468214|NCT03599778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111468215|NCT03599778|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111468216|NCT03599778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111468217|NCT03599778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111468218|NCT04008264|Scopolamine|scopolamine|mesh-list
111468219|NCT04008264|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
111468220|NCT04008264|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111468221|NCT04008264|Antiemetics|antiemetics|mesh-ancestor
111468222|NCT04008264|Autonomic Agents|autonomic agents|mesh-ancestor
111468223|NCT04008264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111468224|NCT04008264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111468225|NCT04008264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111468226|NCT04008264|Mydriatics|mydriatics|mesh-ancestor
111468227|NCT04008264|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111468228|NCT04008264|Cholinergic Agents|cholinergic agents|mesh-ancestor
111468229|NCT04008264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111468230|NCT04008264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111468231|NCT04008264|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111468232|NCT04008264|Parasympatholytics|parasympatholytics|mesh-ancestor
111468233|NCT03595254|Nicotine|nicotine|mesh-list
111468234|NCT03595254|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111468235|NCT03595254|Autonomic Agents|autonomic agents|mesh-ancestor
111468236|NCT03595254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111468237|NCT03595254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111468238|NCT03595254|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111468239|NCT03595254|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111468240|NCT03595254|Cholinergic Agents|cholinergic agents|mesh-ancestor
111468241|NCT03595254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111468242|NCT03595254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111468243|NCT03599466|Lisinopril|lisinopril|mesh-list
111468244|NCT03599466|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
111468245|NCT03599466|Protease Inhibitors|protease inhibitors|mesh-ancestor
111468246|NCT03599466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111468247|NCT03599466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111468248|NCT03599466|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111468249|NCT03599466|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111468251|NCT03599466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111468252|NCT03986970|Tenofovir|tenofovir|mesh-list
111468253|NCT03986970|Emtricitabine|emtricitabine|mesh-list
111468254|NCT03986970|Antiviral Agents|antiviral agents|mesh-ancestor
111468255|NCT03986970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111468256|NCT03986970|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111468257|NCT03986970|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111468258|NCT03986970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111468259|NCT03986970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111468260|NCT03986970|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111468261|NCT03986970|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111468262|NCT03594396|Durvalumab|durvalumab|mesh-list
111468263|NCT03594396|Olaparib|olaparib|mesh-list
111468264|NCT03594396|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111468265|NCT03594396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111468266|NCT03594396|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111468267|NCT03594396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111468268|NCT03594396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111468269|NCT03594240|Folic Acid|folic acid|mesh-list
111468270|NCT03594240|Vitamin B Complex|vitamin b complex|mesh-list
111468271|NCT03594240|Vitamins|vitamins|mesh-ancestor
111468272|NCT03594240|Micronutrients|micronutrients|mesh-ancestor
111468273|NCT03594240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111468274|NCT03594240|Hematinics|hematinics|mesh-ancestor
111468275|NCT03976362|Paclitaxel|paclitaxel|mesh-list
111468276|NCT03976362|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111468277|NCT03976362|Carboplatin|carboplatin|mesh-list
111468278|NCT03976362|Pembrolizumab|pembrolizumab|mesh-list
111468279|NCT03976362|Olaparib|olaparib|mesh-list
111468280|NCT03976362|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111468281|NCT03976362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111468282|NCT03976362|Tubulin Modulators|tubulin modulators|mesh-ancestor
111468283|NCT03976362|Antimitotic Agents|antimitotic agents|mesh-ancestor
111468284|NCT03976362|Mitosis Modulators|mitosis modulators|mesh-ancestor
111468285|NCT03976362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111468286|NCT03976362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111468287|NCT03976362|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110448423|NCT02731378|Iron|iron|mesh-list
111468288|NCT03976362|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111468289|NCT03976362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111468290|NCT03598374|Folic Acid|folic acid|mesh-list
111468291|NCT03598374|Vitamin B Complex|vitamin b complex|mesh-list
111468292|NCT03598374|Inositol|inositol|mesh-list
111468293|NCT03598374|Hematinics|hematinics|mesh-ancestor
111468294|NCT03598374|Vitamins|vitamins|mesh-ancestor
111468295|NCT03598374|Micronutrients|micronutrients|mesh-ancestor
111468296|NCT03598374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111468297|NCT04407078|Neostigmine|neostigmine|mesh-list
111468298|NCT04407078|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111468299|NCT04407078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111468300|NCT04407078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111468301|NCT04407078|Cholinergic Agents|cholinergic agents|mesh-ancestor
111468302|NCT04407078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111468303|NCT04407078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111468304|NCT04407078|Parasympathomimetics|parasympathomimetics|mesh-ancestor
111468305|NCT04407078|Autonomic Agents|autonomic agents|mesh-ancestor
111468306|NCT04407078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111468307|NCT00217620|Sorafenib|sorafenib|mesh-list
111468308|NCT00217620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111468309|NCT00217620|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111468310|NCT00217620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111468311|NCT00217620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111468312|NCT00217464|Fulvestrant|fulvestrant|mesh-list
111468313|NCT00217464|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111468314|NCT00217464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111468315|NCT00217464|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
111468316|NCT00217464|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111468317|NCT00217464|Hormone Antagonists|hormone antagonists|mesh-ancestor
111468318|NCT00217464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111468319|NCT00217464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111468320|NCT03597282|Nivolumab|nivolumab|mesh-list
111468321|NCT03597282|Ipilimumab|ipilimumab|mesh-list
111468322|NCT03597282|Poly ICLC|poly iclc|mesh-list
111468323|NCT03597282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111468324|NCT03597282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111468325|NCT03597282|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111468326|NCT03597282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111468327|NCT03597282|Interferon Inducers|interferon inducers|mesh-ancestor
111468328|NCT03597282|Immunologic Factors|immunologic factors|mesh-ancestor
111468329|NCT03597282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111468330|NCT03593304|Vitamins|vitamins|mesh-list
111468331|NCT03593304|Vitamin B 12|vitamin b 12|mesh-list
111468332|NCT03593304|Pyridoxine|pyridoxine|mesh-list
111468333|NCT03593304|Pyridoxal|pyridoxal|mesh-list
111468334|NCT03593304|Vitamin B 6|vitamin b 6|mesh-list
111468335|NCT03593304|Vitamin B Complex|vitamin b complex|mesh-list
111468336|NCT03593304|Micronutrients|micronutrients|mesh-ancestor
111468337|NCT03593304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111468338|NCT00211536|Insulin|insulin|mesh-list
111468339|NCT00211536|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111468340|NCT00211536|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111468341|NCT00211536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111468342|NCT03596970|Everolimus|everolimus|mesh-list
111468343|NCT03596970|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111468344|NCT03596970|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111468345|NCT03596970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111468346|NCT03596970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111468347|NCT03596970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111468348|NCT03596970|Immunologic Factors|immunologic factors|mesh-ancestor
111468349|NCT03596970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111468350|NCT03596970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111468351|NCT03596892|Cyclophosphamide|cyclophosphamide|mesh-list
111468352|NCT03596892|Busulfan|busulfan|mesh-list
111468353|NCT03596892|Decitabine|decitabine|mesh-list
111468354|NCT03596892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111468355|NCT03596892|Immunologic Factors|immunologic factors|mesh-ancestor
111468356|NCT03596892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111468357|NCT03596892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111468358|NCT03596892|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111468359|NCT03596892|Alkylating Agents|alkylating agents|mesh-ancestor
111468360|NCT03596892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110941483|NCT06056895|Antibodies|antibodies|mesh-list
111468361|NCT03596892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111468362|NCT03596892|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111468363|NCT03596892|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111468364|NCT03596892|Antimetabolites|antimetabolites|mesh-ancestor
111468365|NCT03596892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111468366|NCT03592836|Furosemide|furosemide|mesh-list
111468367|NCT03592836|Diuretics|diuretics|mesh-list
111468368|NCT03592836|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
111468369|NCT03592836|Natriuretic Agents|natriuretic agents|mesh-ancestor
111468370|NCT03592836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111468371|NCT03592836|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111468372|NCT03592836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111468373|NCT03596502|Warfarin|warfarin|mesh-list
111468374|NCT03596502|Anticoagulants|anticoagulants|mesh-list
111468375|NCT04197570|Analgesics, Opioid|analgesics, opioid|mesh-list
111468376|NCT04197570|Analgesics|analgesics|mesh-list
111468377|NCT04197570|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
111468378|NCT04197570|Anesthetics|anesthetics|mesh-list
111468379|NCT04197570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111468380|NCT04197570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111468381|NCT04197570|Narcotics|narcotics|mesh-ancestor
111468382|NCT04197570|Sensory System Agents|sensory system agents|mesh-ancestor
111468383|NCT04197570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111468384|NCT04197882|Molgramostim|molgramostim|mesh-list
111468385|NCT04197882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111468386|NCT03024060|Aminolevulinic Acid|aminolevulinic acid|mesh-list
111468387|NCT03024060|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111468388|NCT03024060|Dermatologic Agents|dermatologic agents|mesh-ancestor
111468389|NCT03024216|Atezolizumab|atezolizumab|mesh-list
111468390|NCT03024216|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111468391|NCT03024216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111468392|NCT03024216|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111468393|NCT03024216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111468394|NCT03981744|Ustekinumab|ustekinumab|mesh-list
111468395|NCT03981744|Dermatologic Agents|dermatologic agents|mesh-ancestor
111468396|NCT03591900|Insulin|insulin|mesh-list
111468397|NCT03591900|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111468398|NCT03591900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111468399|NCT03591744|Dexamethasone|dexamethasone|mesh-list
111468400|NCT03591744|Dexamethasone acetate|dexamethasone acetate|mesh-list
111468401|NCT03591744|Doxorubicin|doxorubicin|mesh-list
111468402|NCT03591744|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111468403|NCT03591744|Lenalidomide|lenalidomide|mesh-list
111468404|NCT03591744|Bortezomib|bortezomib|mesh-list
111468405|NCT03591744|Daratumumab|daratumumab|mesh-list
111468406|NCT03591744|Ichthammol|ichthammol|mesh-list
111468407|NCT03591744|BB 1101|bb 1101|mesh-list
111468408|NCT03591744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111468409|NCT03591744|Antiemetics|antiemetics|mesh-ancestor
111468410|NCT03591744|Autonomic Agents|autonomic agents|mesh-ancestor
111468411|NCT03591744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111468412|NCT03591744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111468413|NCT03591744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111468414|NCT03591744|Glucocorticoids|glucocorticoids|mesh-ancestor
111468415|NCT03591744|Hormones|hormones|mesh-ancestor
111468416|NCT03591744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111468417|NCT03591744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111468418|NCT03591744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111468419|NCT03591744|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111468420|NCT03591744|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111468421|NCT03591744|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111468422|NCT03591744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111468423|NCT03591744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111468424|NCT03591744|Immunologic Factors|immunologic factors|mesh-ancestor
111468425|NCT03591744|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111468426|NCT03591744|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111468427|NCT03591744|Growth Substances|growth substances|mesh-ancestor
111468428|NCT03591744|Growth Inhibitors|growth inhibitors|mesh-ancestor
111468429|NCT03591744|Protease Inhibitors|protease inhibitors|mesh-ancestor
111468430|NCT03591744|Dermatologic Agents|dermatologic agents|mesh-ancestor
111468431|NCT04196946|Fentanyl|fentanyl|mesh-list
111468432|NCT04196946|Alfentanil|alfentanil|mesh-list
111468433|NCT04196946|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111468434|NCT04196946|Narcotics|narcotics|mesh-ancestor
111468435|NCT04196946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111468436|NCT04196946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111468437|NCT04196946|Analgesics|analgesics|mesh-ancestor
111468438|NCT04196946|Sensory System Agents|sensory system agents|mesh-ancestor
111468439|NCT04196946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111468440|NCT04196946|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111468441|NCT04196946|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111468442|NCT04196946|Anesthetics, General|anesthetics, general|mesh-ancestor
111468443|NCT04196946|Anesthetics|anesthetics|mesh-ancestor
111468444|NCT03023904|Nivolumab|nivolumab|mesh-list
111468445|NCT03023904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111468446|NCT03023904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111468447|NCT03023904|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111468448|NCT03023904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111468449|NCT04196010|Cytarabine|cytarabine|mesh-list
111468450|NCT04196010|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
111468451|NCT04196010|Mitoxantrone|mitoxantrone|mesh-list
111468452|NCT04196010|Cladribine|cladribine|mesh-list
111468453|NCT04196010|Lenograstim|lenograstim|mesh-list
111468454|NCT04196010|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111468455|NCT04196010|Antimetabolites|antimetabolites|mesh-ancestor
111468456|NCT04196010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111468457|NCT04196010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111468458|NCT04196010|Antiviral Agents|antiviral agents|mesh-ancestor
111468459|NCT04196010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111468460|NCT04196010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111468461|NCT04196010|Immunologic Factors|immunologic factors|mesh-ancestor
111468462|NCT04196010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111468463|NCT04196010|Analgesics|analgesics|mesh-ancestor
111468464|NCT04196010|Sensory System Agents|sensory system agents|mesh-ancestor
111468465|NCT04196010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111468466|NCT04196010|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111468467|NCT04196010|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111468468|NCT04196010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111468469|NCT04196010|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111468470|NCT04196400|Betamethasone|betamethasone|mesh-list
111468471|NCT04196400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111468472|NCT04196400|Glucocorticoids|glucocorticoids|mesh-ancestor
111468473|NCT04196400|Hormones|hormones|mesh-ancestor
111468474|NCT04196400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111468475|NCT04196400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111468476|NCT04196400|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111468477|NCT04196400|Respiratory System Agents|respiratory system agents|mesh-ancestor
111468478|NCT03023436|Fluorouracil|fluorouracil|mesh-list
111468479|NCT03023436|Capecitabine|capecitabine|mesh-list
111468480|NCT03023436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111468481|NCT03023436|Antimetabolites|antimetabolites|mesh-ancestor
111468482|NCT03023436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110942551|NCT05769309|Anesthetics|anesthetics|mesh-ancestor
111468483|NCT03023436|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111468484|NCT03023436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111468485|NCT03023436|Immunologic Factors|immunologic factors|mesh-ancestor
111468486|NCT03023436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111468487|NCT04195074|Tenofovir|tenofovir|mesh-list
111468488|NCT04195074|Entecavir|entecavir|mesh-list
111468489|NCT04195074|Antiviral Agents|antiviral agents|mesh-ancestor
111468490|NCT04195074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111468491|NCT04195074|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111468492|NCT04195074|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111468493|NCT04195074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111468494|NCT04195074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111468495|NCT04195074|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111468496|NCT04195074|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111468497|NCT03590262|Metformin|metformin|mesh-list
111468498|NCT03590262|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111468499|NCT03590262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111468500|NCT04029636|Xenon|xenon|mesh-list
111468501|NCT04029636|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111468502|NCT04029636|Anesthetics, General|anesthetics, general|mesh-ancestor
111468503|NCT04029636|Anesthetics|anesthetics|mesh-ancestor
111468504|NCT04029636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111468505|NCT04029636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111468506|NCT04194684|Paclitaxel|paclitaxel|mesh-list
111468507|NCT04194684|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111468508|NCT04194684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111468509|NCT04194684|Tubulin Modulators|tubulin modulators|mesh-ancestor
111468510|NCT04194684|Antimitotic Agents|antimitotic agents|mesh-ancestor
111468511|NCT04194684|Mitosis Modulators|mitosis modulators|mesh-ancestor
111468512|NCT04194684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111468513|NCT04194294|Lidocaine|lidocaine|mesh-list
111468514|NCT04194294|Anesthetics, Local|anesthetics, local|mesh-ancestor
111468515|NCT04194294|Anesthetics|anesthetics|mesh-ancestor
111468516|NCT04194294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111468517|NCT04194294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111468518|NCT04194294|Sensory System Agents|sensory system agents|mesh-ancestor
111468519|NCT04194294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111468520|NCT04194294|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111468521|NCT04194294|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111468522|NCT04194294|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111468523|NCT04194294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111468524|NCT04194294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111468525|NCT04029090|Edaravone|edaravone|mesh-list
111468526|NCT04029090|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111468527|NCT04029090|Antioxidants|antioxidants|mesh-ancestor
111468528|NCT04029090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111468529|NCT04029090|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111468530|NCT04029090|Protective Agents|protective agents|mesh-ancestor
111468531|NCT04029090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111468532|NCT04194216|Clindamycin|clindamycin|mesh-list
111468533|NCT04194216|Clindamycin palmitate|clindamycin palmitate|mesh-list
111468534|NCT04194216|Clindamycin phosphate|clindamycin phosphate|mesh-list
111468535|NCT04194216|Cephalexin|cephalexin|mesh-list
111468536|NCT04194216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111468537|NCT04194216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111468538|NCT04194216|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111468539|NCT04194216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111468540|NCT04194216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111468541|NCT04193982|Vitamin E|vitamin e|mesh-list
111468542|NCT04193982|Vitamins|vitamins|mesh-ancestor
111468543|NCT04193982|Micronutrients|micronutrients|mesh-ancestor
111468544|NCT04193982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111468545|NCT04193982|Antioxidants|antioxidants|mesh-ancestor
111468546|NCT04193982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111468547|NCT04193982|Protective Agents|protective agents|mesh-ancestor
111468548|NCT04028778|Gefitinib|gefitinib|mesh-list
111468549|NCT04028778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111468550|NCT04028778|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111468551|NCT04028778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111468552|NCT04028778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111468553|NCT04028856|Interferons|interferons|mesh-list
111468554|NCT04028856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111468555|NCT04028856|Antiviral Agents|antiviral agents|mesh-ancestor
111468556|NCT04028856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111468557|NCT03594474|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
111468558|NCT03594474|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
111468559|NCT03594474|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
111468560|NCT03594474|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111468562|NCT04193592|Analgesics|analgesics|mesh-ancestor
111468563|NCT04193592|Sensory System Agents|sensory system agents|mesh-ancestor
111468564|NCT04193592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111468565|NCT04193592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111468566|NCT04193592|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111468567|NCT04193592|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111468568|NCT04193592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111468569|NCT04193592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111468570|NCT04193592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111468571|NCT03933384|Tenofovir|tenofovir|mesh-list
111468572|NCT03933384|Entecavir|entecavir|mesh-list
111468573|NCT03933384|Antiviral Agents|antiviral agents|mesh-ancestor
111468574|NCT03933384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111468575|NCT03933384|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111468576|NCT03933384|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111468577|NCT03933384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111468578|NCT03933384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111468579|NCT03933384|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111468580|NCT03933384|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111468581|NCT04028466|Omeprazole|omeprazole|mesh-list
111468582|NCT04028466|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111468583|NCT04028466|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111468584|NCT04028466|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111468585|NCT04028466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111468586|NCT04028466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111468587|NCT04027764|Paclitaxel|paclitaxel|mesh-list
111468588|NCT04027764|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111468589|NCT04027764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111468590|NCT04027764|Tubulin Modulators|tubulin modulators|mesh-ancestor
111468591|NCT04027764|Antimitotic Agents|antimitotic agents|mesh-ancestor
111468592|NCT04027764|Mitosis Modulators|mitosis modulators|mesh-ancestor
111468593|NCT04027764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111468594|NCT04027530|Ertugliflozin|ertugliflozin|mesh-list
111468595|NCT04027530|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111468596|NCT04027530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111468597|NCT04027530|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111468598|NCT04027530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111468599|NCT03023358|Prednisone|prednisone|mesh-list
111468600|NCT03023358|Cyclophosphamide|cyclophosphamide|mesh-list
111468601|NCT03023358|Doxorubicin|doxorubicin|mesh-list
111468602|NCT03023358|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111468603|NCT03023358|Vincristine|vincristine|mesh-list
111468604|NCT03023358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111468605|NCT03023358|Immunologic Factors|immunologic factors|mesh-ancestor
111468606|NCT03023358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111468607|NCT03023358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111468608|NCT03023358|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111468609|NCT03023358|Alkylating Agents|alkylating agents|mesh-ancestor
111468610|NCT03023358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111468611|NCT03023358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111468612|NCT03023358|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111468613|NCT03023358|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111468614|NCT03023358|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111468615|NCT03023358|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111468616|NCT03023358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111468617|NCT03023358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111468618|NCT03023358|Glucocorticoids|glucocorticoids|mesh-ancestor
111468619|NCT03023358|Hormones|hormones|mesh-ancestor
111468620|NCT03023358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111468621|NCT03023358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111468622|NCT03023358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111468623|NCT03023358|Tubulin Modulators|tubulin modulators|mesh-ancestor
111468624|NCT03023358|Antimitotic Agents|antimitotic agents|mesh-ancestor
111468625|NCT03023358|Mitosis Modulators|mitosis modulators|mesh-ancestor
111468626|NCT04192812|Leuprolide|leuprolide|mesh-list
111468627|NCT04192812|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111468628|NCT04192812|Fertility Agents|fertility agents|mesh-ancestor
111468629|NCT04192812|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111468630|NCT04192812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111468631|NCT04192812|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111468632|NCT04192812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111468633|NCT04407000|Favipiravir|favipiravir|mesh-list
111468634|NCT04407000|Antiviral Agents|antiviral agents|mesh-ancestor
111468635|NCT04407000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111468636|NCT04192656|Methylprednisolone|methylprednisolone|mesh-list
111468637|NCT04192656|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111468638|NCT04192656|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111468639|NCT04192656|Prednisolone|prednisolone|mesh-list
111468640|NCT04192656|Prednisolone acetate|prednisolone acetate|mesh-list
111468641|NCT04192656|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111468642|NCT04192656|Prednisolone phosphate|prednisolone phosphate|mesh-list
111468643|NCT04192656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111468644|NCT04192656|Antiemetics|antiemetics|mesh-ancestor
111468645|NCT04192656|Autonomic Agents|autonomic agents|mesh-ancestor
111468646|NCT04192656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111468647|NCT04192656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111468648|NCT04192656|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111468649|NCT04192656|Glucocorticoids|glucocorticoids|mesh-ancestor
111468650|NCT04192656|Hormones|hormones|mesh-ancestor
111468651|NCT04192656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111468652|NCT04192656|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111468653|NCT04192656|Protective Agents|protective agents|mesh-ancestor
111468654|NCT04192656|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111468655|NCT04192656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111468656|NCT04191954|Fasudil|fasudil|mesh-list
111468657|NCT04191954|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111468658|NCT04191954|Lubricant Eye Drops|lubricant eye drops|mesh-list
111468659|NCT04191954|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111468660|NCT04191954|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111468661|NCT04191954|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111468662|NCT04191954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111468663|NCT04191954|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111468664|NCT04191954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111468665|NCT04191954|Vasodilator Agents|vasodilator agents|mesh-ancestor
111468666|NCT04191954|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111468667|NCT04191954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111468668|NCT04192032|Nicotine|nicotine|mesh-list
111468669|NCT04192032|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111468670|NCT04192032|Autonomic Agents|autonomic agents|mesh-ancestor
111468671|NCT04192032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111468672|NCT04192032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111468673|NCT04192032|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111468674|NCT04192032|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111468675|NCT04192032|Cholinergic Agents|cholinergic agents|mesh-ancestor
111468676|NCT04192032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111468677|NCT04192032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111468678|NCT03023982|Morphine|morphine|mesh-list
111468679|NCT03023982|Bupivacaine|bupivacaine|mesh-list
111468680|NCT03023982|Anesthetics, Local|anesthetics, local|mesh-ancestor
111468681|NCT03023982|Anesthetics|anesthetics|mesh-ancestor
111468682|NCT03023982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111468683|NCT03023982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111468684|NCT03023982|Sensory System Agents|sensory system agents|mesh-ancestor
111468685|NCT03023982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111468686|NCT03023982|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111468687|NCT03023982|Narcotics|narcotics|mesh-ancestor
111468688|NCT03023982|Analgesics|analgesics|mesh-ancestor
111468689|NCT04192110|Diuretics|diuretics|mesh-list
111468690|NCT04192110|Natriuretic Agents|natriuretic agents|mesh-ancestor
111468691|NCT04192110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111468692|NCT04025736|Tranexamic Acid|tranexamic acid|mesh-list
111468693|NCT04025736|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111468694|NCT04025736|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111468695|NCT04025736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111468696|NCT04025736|Hemostatics|hemostatics|mesh-ancestor
111468697|NCT04025736|Coagulants|coagulants|mesh-ancestor
111468698|NCT04190160|Xultophy|xultophy|mesh-list
111468699|NCT04190160|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111468700|NCT04190160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111468701|NCT04190160|Incretins|incretins|mesh-ancestor
111468702|NCT04190160|Hormones|hormones|mesh-ancestor
111468703|NCT04190160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111192839|NCT00381862|Hormones|hormones|mesh-ancestor
111468704|NCT04190004|Vasopressins|vasopressins|mesh-list
111468705|NCT04190004|Arginine Vasopressin|arginine vasopressin|mesh-list
111468706|NCT04190004|Hemostatics|hemostatics|mesh-ancestor
111468707|NCT04190004|Coagulants|coagulants|mesh-ancestor
111468708|NCT04190004|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111468709|NCT04190004|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
111468710|NCT04190004|Natriuretic Agents|natriuretic agents|mesh-ancestor
111468711|NCT04190004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111468712|NCT04406376|Prednisone|prednisone|mesh-list
111468713|NCT04406376|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111468714|NCT04406376|Glucocorticoids|glucocorticoids|mesh-ancestor
111468715|NCT04406376|Hormones|hormones|mesh-ancestor
111468716|NCT04406376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111468717|NCT04406376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111468718|NCT04406376|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111468719|NCT04406376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111468720|NCT04024800|Pembrolizumab|pembrolizumab|mesh-list
111468721|NCT04024800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111468722|NCT04024800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111468723|NCT04024800|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111468724|NCT04024800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111468725|NCT04406610|Immunomodulating Agents|immunomodulating agents|mesh-list
111468726|NCT04406610|Immunologic Factors|immunologic factors|mesh-ancestor
111468727|NCT04406610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111468728|NCT04023630|Rivaroxaban|rivaroxaban|mesh-list
111468729|NCT04023630|Clopidogrel|clopidogrel|mesh-list
111468730|NCT04023630|Ticagrelor|ticagrelor|mesh-list
111468731|NCT04023630|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111468732|NCT04023630|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111468733|NCT04023630|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111468734|NCT04023630|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111468735|NCT04023630|Purinergic Agents|purinergic agents|mesh-ancestor
111468736|NCT04023630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111468737|NCT04023630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111468738|NCT04023630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111468739|NCT04023630|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111468740|NCT04023630|Antithrombins|antithrombins|mesh-ancestor
111468741|NCT04023630|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111468742|NCT04023630|Protease Inhibitors|protease inhibitors|mesh-ancestor
111468743|NCT04023630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111468744|NCT04023630|Anticoagulants|anticoagulants|mesh-ancestor
111468745|NCT04199754|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111468746|NCT04022304|Isophane Insulin, Human|isophane insulin, human|mesh-list
111468747|NCT04022304|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111468748|NCT04022304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111468749|NCT04020666|Kallikreins|kallikreins|mesh-list
111468750|NCT04020666|Coagulants|coagulants|mesh-ancestor
111468751|NCT04020666|Fertility Agents, Male|fertility agents, male|mesh-ancestor
111468752|NCT04020666|Fertility Agents|fertility agents|mesh-ancestor
111468753|NCT04020666|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111468754|NCT04020666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111468755|NCT04021992|Rituximab|rituximab|mesh-list
111468756|NCT04021992|Gemcitabine|gemcitabine|mesh-list
111468757|NCT04021992|Doxorubicin|doxorubicin|mesh-list
111468758|NCT04021992|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111468759|NCT04021992|Vinorelbine|vinorelbine|mesh-list
111468760|NCT04021992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111468761|NCT04021992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111468762|NCT04021992|Immunologic Factors|immunologic factors|mesh-ancestor
111468763|NCT04021992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111468764|NCT04021992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111468765|NCT04021992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111468766|NCT04021992|Antimetabolites|antimetabolites|mesh-ancestor
111468767|NCT04021992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111468768|NCT04021992|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111468769|NCT04021992|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111468770|NCT04021992|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111468771|NCT04021992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111468772|NCT04021992|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111468773|NCT04021992|Tubulin Modulators|tubulin modulators|mesh-ancestor
111468774|NCT04021992|Antimitotic Agents|antimitotic agents|mesh-ancestor
111468775|NCT04021992|Mitosis Modulators|mitosis modulators|mesh-ancestor
111468776|NCT04020588|Minocycline|minocycline|mesh-list
111468777|NCT04020588|Celecoxib|celecoxib|mesh-list
111468778|NCT04020588|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111468779|NCT04020588|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111468780|NCT04020588|Analgesics|analgesics|mesh-ancestor
111468781|NCT04020588|Sensory System Agents|sensory system agents|mesh-ancestor
111468782|NCT04020588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111468783|NCT04020588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111468785|NCT04020588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111468786|NCT04020588|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111468787|NCT04020588|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111468788|NCT04020588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111468789|NCT04020588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111468790|NCT04020588|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111468791|NCT04020588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111468792|NCT04145856|Simethicone|simethicone|mesh-list
111468793|NCT04145856|Alverine|alverine|mesh-list
111468794|NCT04145856|Antifoaming Agents|antifoaming agents|mesh-ancestor
111468795|NCT04145856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111468796|NCT04145856|Emollients|emollients|mesh-ancestor
111468797|NCT04145856|Dermatologic Agents|dermatologic agents|mesh-ancestor
111468798|NCT04145856|Parasympatholytics|parasympatholytics|mesh-ancestor
111468799|NCT04145856|Autonomic Agents|autonomic agents|mesh-ancestor
111468800|NCT04145856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111468801|NCT04145856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111468802|NCT04140786|Gentamicins|gentamicins|mesh-list
111468803|NCT04140786|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111468804|NCT04140786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111468805|NCT04140786|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111468806|NCT04140786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111468807|NCT04140786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111468808|NCT04147650|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111468809|NCT04147650|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111468810|NCT04022226|Ketamine|ketamine|mesh-list
111468811|NCT04022226|Methohexital|methohexital|mesh-list
111468812|NCT04022226|Analgesics|analgesics|mesh-ancestor
111468813|NCT04022226|Sensory System Agents|sensory system agents|mesh-ancestor
111468814|NCT04022226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111468815|NCT04022226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111468816|NCT04022226|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111468817|NCT04022226|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111468818|NCT04022226|Anesthetics, General|anesthetics, general|mesh-ancestor
111468819|NCT04022226|Anesthetics|anesthetics|mesh-ancestor
111468820|NCT04022226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111468821|NCT04022226|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111468822|NCT04022226|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111468823|NCT04022226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111468824|NCT04022226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111468825|NCT04029012|Methoxyflurane|methoxyflurane|mesh-list
111468826|NCT04029012|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111468827|NCT04029012|Anesthetics, General|anesthetics, general|mesh-ancestor
111468828|NCT04029012|Anesthetics|anesthetics|mesh-ancestor
111468829|NCT04029012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111468830|NCT04029012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111468831|NCT04025658|Oxytocin|oxytocin|mesh-list
111468832|NCT04025658|Oxytocics|oxytocics|mesh-ancestor
111468833|NCT04025658|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111468834|NCT04025658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111468835|NCT05586438|Colistin|colistin|mesh-list
111468836|NCT05586438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111468837|NCT05586438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111468838|NCT04145232|Nivolumab|nivolumab|mesh-list
111468839|NCT04145232|Ipilimumab|ipilimumab|mesh-list
111468840|NCT04145232|Atezolizumab|atezolizumab|mesh-list
111468841|NCT04145232|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111468842|NCT04145232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111468843|NCT04145232|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111468844|NCT04145232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111468845|NCT04144920|Oxymetazoline|oxymetazoline|mesh-list
111468846|NCT04144920|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111468847|NCT04144920|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111468848|NCT04144920|Adrenergic Agents|adrenergic agents|mesh-ancestor
111468849|NCT04144920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111468850|NCT04144920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111468851|NCT04144920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111468852|NCT04144920|Sympathomimetics|sympathomimetics|mesh-ancestor
111468853|NCT04144920|Autonomic Agents|autonomic agents|mesh-ancestor
111468854|NCT04144920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111468855|NCT04144920|Nasal Decongestants|nasal decongestants|mesh-ancestor
111468856|NCT04144920|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111192992|NCT00385216|Nicotine|nicotine|mesh-list
111468857|NCT04144920|Respiratory System Agents|respiratory system agents|mesh-ancestor
111468858|NCT04026282|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
111468860|NCT04026282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111468861|NCT04026282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111468862|NCT04144218|Lacosamide|lacosamide|mesh-list
111468863|NCT04144218|Anticonvulsants|anticonvulsants|mesh-ancestor
111468864|NCT04144218|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111468865|NCT04144218|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111468866|NCT04144218|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111468867|NCT04144218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111468868|NCT05580822|Tenecteplase|tenecteplase|mesh-list
111468869|NCT05580822|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111468870|NCT05580822|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111468871|NCT05580822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111468872|NCT05580354|Tislelizumab|tislelizumab|mesh-list
111468873|NCT05580354|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111468874|NCT05580354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111468875|NCT04143906|Carboplatin|carboplatin|mesh-list
111468876|NCT04143906|Gemcitabine|gemcitabine|mesh-list
111468877|NCT04143906|Vinorelbine|vinorelbine|mesh-list
111468878|NCT04143906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111468879|NCT04143906|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111468880|NCT04143906|Antimetabolites|antimetabolites|mesh-ancestor
111468881|NCT04143906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111468882|NCT04143906|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111468883|NCT04143906|Tubulin Modulators|tubulin modulators|mesh-ancestor
111468884|NCT04143906|Antimitotic Agents|antimitotic agents|mesh-ancestor
111468885|NCT04143906|Mitosis Modulators|mitosis modulators|mesh-ancestor
111468886|NCT02708706|Hyaluronic Acid|hyaluronic acid|mesh-list
111468887|NCT02708706|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111468888|NCT02708706|Immunologic Factors|immunologic factors|mesh-ancestor
111468889|NCT02708706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111468890|NCT02708706|Viscosupplements|viscosupplements|mesh-ancestor
111468891|NCT02708706|Protective Agents|protective agents|mesh-ancestor
111468892|NCT05587608|Anesthetics|anesthetics|mesh-list
111468893|NCT05587608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111468894|NCT05587608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111468895|NCT02703714|Pembrolizumab|pembrolizumab|mesh-list
111468896|NCT02703714|Sargramostim|sargramostim|mesh-list
111468897|NCT02703714|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111468898|NCT02703714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111468899|NCT02703714|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111468900|NCT02703714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111468901|NCT02703714|Immunologic Factors|immunologic factors|mesh-ancestor
111468902|NCT02703714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111468903|NCT03945864|Anti-Infective Agents|anti-infective agents|mesh-list
111468904|NCT03945864|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111468905|NCT03904446|Methylergonovine|methylergonovine|mesh-list
111468906|NCT03904446|Oxytocics|oxytocics|mesh-ancestor
111468907|NCT03904446|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111468908|NCT03904446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111468909|NCT03916068|Vitamin E|vitamin e|mesh-list
111468910|NCT03916068|Pentoxifylline|pentoxifylline|mesh-list
111468911|NCT03916068|Vitamins|vitamins|mesh-ancestor
111468912|NCT03916068|Micronutrients|micronutrients|mesh-ancestor
111468913|NCT03916068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111468914|NCT03916068|Antioxidants|antioxidants|mesh-ancestor
111468915|NCT03916068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111468916|NCT03916068|Protective Agents|protective agents|mesh-ancestor
111468917|NCT03916068|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111468918|NCT03916068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111468919|NCT03916068|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111468920|NCT03916068|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111468921|NCT03916068|Vasodilator Agents|vasodilator agents|mesh-ancestor
111468922|NCT03916068|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111468923|NCT04143282|Metformin|metformin|mesh-list
111468924|NCT04143282|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111468925|NCT04143282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111468926|NCT04149678|Cyclosporine|cyclosporine|mesh-list
111468927|NCT04149678|Cyclosporins|cyclosporins|mesh-list
111468928|NCT04149678|Ozanimod|ozanimod|mesh-list
111468929|NCT04149678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111468930|NCT04149678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111468931|NCT04149678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111468932|NCT04149678|Immunologic Factors|immunologic factors|mesh-ancestor
111468933|NCT04149678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111468934|NCT04149678|Antifungal Agents|antifungal agents|mesh-ancestor
111468935|NCT04149678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111468936|NCT04149678|Dermatologic Agents|dermatologic agents|mesh-ancestor
111468937|NCT04149678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111468938|NCT04149678|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111468939|NCT04149678|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
111468941|NCT05581992|Omeprazole|omeprazole|mesh-list
111468942|NCT05581992|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111468943|NCT05581992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111468944|NCT05581992|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111468945|NCT05581992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111468946|NCT05581992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111468947|NCT05581992|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111468948|NCT05581992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111468949|NCT05581992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111468950|NCT03020940|Cefuroxime|cefuroxime|mesh-list
111468951|NCT03020940|Cefuroxime axetil|cefuroxime axetil|mesh-list
111468952|NCT03020940|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111468953|NCT03020940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111468954|NCT03645408|Exenatide|exenatide|mesh-list
111468955|NCT03645408|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111468956|NCT03645408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111468957|NCT03645408|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111468958|NCT03645408|Incretins|incretins|mesh-ancestor
111468959|NCT03645408|Hormones|hormones|mesh-ancestor
111468960|NCT03645408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111468961|NCT04141410|Simendan|simendan|mesh-list
111468962|NCT04141410|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111468963|NCT04141410|Vasodilator Agents|vasodilator agents|mesh-ancestor
111468964|NCT04141410|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
111468965|NCT04141410|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111468966|NCT04141410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111468967|NCT04141410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111468968|NCT04141410|Protective Agents|protective agents|mesh-ancestor
111468969|NCT04141410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111468970|NCT05586204|Vaccines|vaccines|mesh-list
111468971|NCT05586204|Immunologic Factors|immunologic factors|mesh-ancestor
111468972|NCT05586204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111468973|NCT04149444|Trifluridine|trifluridine|mesh-list
111468974|NCT04149444|Antimetabolites|antimetabolites|mesh-ancestor
111468975|NCT04149444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111468976|NCT04149444|Antiviral Agents|antiviral agents|mesh-ancestor
111468977|NCT04149444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111468978|NCT03020706|Magnesium Sulfate|magnesium sulfate|mesh-list
111468979|NCT03020706|Analgesics|analgesics|mesh-ancestor
111468980|NCT03020706|Sensory System Agents|sensory system agents|mesh-ancestor
111468981|NCT03020706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111468982|NCT03020706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111468983|NCT03020706|Anesthetics|anesthetics|mesh-ancestor
111468984|NCT03020706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111468985|NCT03020706|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111468986|NCT03020706|Anticonvulsants|anticonvulsants|mesh-ancestor
111468987|NCT03020706|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111468988|NCT03020706|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111468989|NCT03020706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111468990|NCT03020706|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111468991|NCT03020706|Tocolytic Agents|tocolytic agents|mesh-ancestor
111468992|NCT03020706|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111468993|NCT03900624|Dexamethasone|dexamethasone|mesh-list
111468994|NCT03900624|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111468995|NCT03900624|Antiemetics|antiemetics|mesh-ancestor
111468996|NCT03900624|Autonomic Agents|autonomic agents|mesh-ancestor
111468997|NCT03900624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111468998|NCT03900624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111468999|NCT03900624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111469000|NCT03900624|Glucocorticoids|glucocorticoids|mesh-ancestor
111469001|NCT03900624|Hormones|hormones|mesh-ancestor
111469002|NCT03900624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111469003|NCT03900624|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111469004|NCT03900624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111469005|NCT04149132|Nitric Oxide|nitric oxide|mesh-list
111469006|NCT04149132|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111469007|NCT04149132|Autonomic Agents|autonomic agents|mesh-ancestor
111469008|NCT04149132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111469009|NCT04149132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111469010|NCT04149132|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111469011|NCT04149132|Respiratory System Agents|respiratory system agents|mesh-ancestor
111469012|NCT04149132|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111469013|NCT04149132|Antioxidants|antioxidants|mesh-ancestor
111469014|NCT04149132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111469015|NCT04149132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111469016|NCT04149132|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
111469017|NCT04149132|Vasodilator Agents|vasodilator agents|mesh-ancestor
111469018|NCT04149132|Gasotransmitters|gasotransmitters|mesh-ancestor
111469019|NCT04149132|Protective Agents|protective agents|mesh-ancestor
111469020|NCT03908892|Tetracycline|tetracycline|mesh-list
111469021|NCT03908892|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111469022|NCT03908892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111469023|NCT03908892|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111469024|NCT03908892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111469025|NCT03908892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111469026|NCT04140318|Paclitaxel|paclitaxel|mesh-list
111469027|NCT04140318|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111469028|NCT04140318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111469029|NCT04140318|Tubulin Modulators|tubulin modulators|mesh-ancestor
111469030|NCT04140318|Antimitotic Agents|antimitotic agents|mesh-ancestor
111469031|NCT04140318|Mitosis Modulators|mitosis modulators|mesh-ancestor
111469032|NCT04140318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111469033|NCT03021330|Cytarabine|cytarabine|mesh-list
111469034|NCT03021330|Daunorubicin|daunorubicin|mesh-list
111469035|NCT03021330|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111469036|NCT03021330|Antimetabolites|antimetabolites|mesh-ancestor
111469037|NCT03021330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111469038|NCT03021330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111469039|NCT03021330|Antiviral Agents|antiviral agents|mesh-ancestor
111469040|NCT03021330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111469041|NCT03021330|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111469042|NCT03021330|Immunologic Factors|immunologic factors|mesh-ancestor
111469043|NCT03021330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111469044|NCT03021330|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111469045|NCT03021330|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111469046|NCT03021330|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111469047|NCT03021330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111469048|NCT04140006|Alendronate|alendronate|mesh-list
111469049|NCT04140006|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111469050|NCT04140006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111469051|NCT04146324|Nivolumab|nivolumab|mesh-list
111469052|NCT04146324|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111469053|NCT04146324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111469054|NCT04146324|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111469055|NCT04146324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111469056|NCT03588936|Nivolumab|nivolumab|mesh-list
111469057|NCT03588936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111469058|NCT03588936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111469059|NCT03588936|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111469060|NCT03588936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111469061|NCT03022500|Durvalumab|durvalumab|mesh-list
111469062|NCT03022500|Tremelimumab|tremelimumab|mesh-list
111469063|NCT03022500|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111469064|NCT03022500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111469065|NCT04148898|Bevacizumab|bevacizumab|mesh-list
111469066|NCT04148898|Osimertinib|osimertinib|mesh-list
111469067|NCT04148898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111469068|NCT04148898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111469069|NCT04148898|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111469070|NCT04148898|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111469071|NCT04148898|Growth Substances|growth substances|mesh-ancestor
111469072|NCT04148898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111469073|NCT04148898|Growth Inhibitors|growth inhibitors|mesh-ancestor
111469074|NCT04148898|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111469075|NCT04148898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111469076|NCT04148898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111469077|NCT04148820|Aspirin|aspirin|mesh-list
111469078|NCT04148820|Perindopril|perindopril|mesh-list
111469079|NCT04148820|Atorvastatin|atorvastatin|mesh-list
111469080|NCT04148820|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111469081|NCT04148820|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111469083|NCT04148820|Sensory System Agents|sensory system agents|mesh-ancestor
111469084|NCT04148820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111469085|NCT04148820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111469086|NCT04148820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111469087|NCT04148820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111469088|NCT04148820|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111469089|NCT04148820|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111469090|NCT04148820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111469091|NCT04148820|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111469092|NCT04148820|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111469093|NCT04148820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111469094|NCT04148820|Antipyretics|antipyretics|mesh-ancestor
111469095|NCT04148820|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111469096|NCT04148820|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111469097|NCT04148820|Antimetabolites|antimetabolites|mesh-ancestor
111469098|NCT04148820|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111469099|NCT04148820|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111469100|NCT04148820|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
111469101|NCT04148820|Protease Inhibitors|protease inhibitors|mesh-ancestor
111469102|NCT04148820|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111469103|NCT03941496|Azacitidine|azacitidine|mesh-list
111469104|NCT03941496|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111469105|NCT03941496|Antimetabolites|antimetabolites|mesh-ancestor
111469106|NCT03941496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111469107|NCT03941496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111469108|NCT03941496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111469109|NCT03580980|Acetaminophen|acetaminophen|mesh-list
111469110|NCT03580980|Ketamine|ketamine|mesh-list
111469111|NCT03580980|Morphine|morphine|mesh-list
111469112|NCT03580980|Levobupivacaine|levobupivacaine|mesh-list
111469113|NCT03580980|Analgesics|analgesics|mesh-ancestor
111469114|NCT03580980|Sensory System Agents|sensory system agents|mesh-ancestor
111469115|NCT03580980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111469116|NCT03580980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111469117|NCT03580980|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111469118|NCT03580980|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111469119|NCT03580980|Anesthetics, General|anesthetics, general|mesh-ancestor
111469120|NCT03580980|Anesthetics|anesthetics|mesh-ancestor
111469121|NCT03580980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111469122|NCT03580980|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111469123|NCT03580980|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111469124|NCT03580980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111469125|NCT03580980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111469126|NCT03580980|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111469127|NCT03580980|Narcotics|narcotics|mesh-ancestor
111469128|NCT03580980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111469129|NCT03580980|Antipyretics|antipyretics|mesh-ancestor
111469130|NCT03580980|Anesthetics, Local|anesthetics, local|mesh-ancestor
111469131|NCT03587220|Lidocaine|lidocaine|mesh-list
111469132|NCT03587220|Capsaicin|capsaicin|mesh-list
111469133|NCT03587220|Histamine|histamine|mesh-list
111469134|NCT03587220|Anesthetics, Local|anesthetics, local|mesh-ancestor
111469135|NCT03587220|Anesthetics|anesthetics|mesh-ancestor
111469136|NCT03587220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111469137|NCT03587220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111469138|NCT03587220|Sensory System Agents|sensory system agents|mesh-ancestor
111469139|NCT03587220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111469140|NCT03587220|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111469141|NCT03587220|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111469142|NCT03587220|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111469143|NCT03587220|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111469144|NCT03587220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111469145|NCT03587220|Antipruritics|antipruritics|mesh-ancestor
111469146|NCT03587220|Dermatologic Agents|dermatologic agents|mesh-ancestor
111469147|NCT03587220|Histamine Agonists|histamine agonists|mesh-ancestor
111469148|NCT03587220|Histamine Agents|histamine agents|mesh-ancestor
111469149|NCT03587220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111469150|NCT03586908|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111469151|NCT03586908|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111469152|NCT04147572|Tiotropium Bromide|tiotropium bromide|mesh-list
111469153|NCT04147572|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111469154|NCT04147572|Autonomic Agents|autonomic agents|mesh-ancestor
111469155|NCT04147572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111469156|NCT04147572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111469157|NCT04147572|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111469158|NCT04147572|Respiratory System Agents|respiratory system agents|mesh-ancestor
111469159|NCT04147572|Parasympatholytics|parasympatholytics|mesh-ancestor
111469160|NCT04147572|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111469161|NCT04147572|Cholinergic Agents|cholinergic agents|mesh-ancestor
111469162|NCT04147572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111469163|NCT04147572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111469164|NCT03580590|Diltiazem|diltiazem|mesh-list
111469165|NCT03580590|Tranexamic Acid|tranexamic acid|mesh-list
111469166|NCT03580590|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111469167|NCT03580590|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111469168|NCT03580590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111469169|NCT03580590|Hemostatics|hemostatics|mesh-ancestor
111469170|NCT03580590|Coagulants|coagulants|mesh-ancestor
111469171|NCT03580590|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111469172|NCT03580590|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111469173|NCT03580590|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111469174|NCT03580590|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111469175|NCT03580590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111469176|NCT03580590|Vasodilator Agents|vasodilator agents|mesh-ancestor
111469177|NCT03891576|Niraparib|niraparib|mesh-list
111469178|NCT03891576|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111469179|NCT03891576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111469180|NCT03891576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111469181|NCT03891576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111469182|NCT03586674|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
111469183|NCT03586674|Fenofibrate|fenofibrate|mesh-list
111469184|NCT03586674|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111469185|NCT03586674|Antimetabolites|antimetabolites|mesh-ancestor
111469186|NCT03586674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111469187|NCT03586674|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111469188|NCT03586674|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
111469189|NCT03586674|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111469190|NCT03346668|Gabapentin|gabapentin|mesh-list
111469191|NCT03346668|Analgesics|analgesics|mesh-ancestor
111469192|NCT03346668|Sensory System Agents|sensory system agents|mesh-ancestor
111469193|NCT03346668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111469194|NCT03346668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111469195|NCT03346668|Anticonvulsants|anticonvulsants|mesh-ancestor
111469196|NCT03346668|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111469197|NCT03346668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111469198|NCT03346668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111469199|NCT03346668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111469200|NCT03346668|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111469201|NCT03346668|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111469202|NCT03346668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111469203|NCT03346668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111469204|NCT03346668|Antimanic Agents|antimanic agents|mesh-ancestor
111469205|NCT03585738|Folic Acid|folic acid|mesh-list
111469206|NCT03585738|Vitamin B Complex|vitamin b complex|mesh-list
111469207|NCT03585738|Inositol|inositol|mesh-list
111469208|NCT03585738|Hematinics|hematinics|mesh-ancestor
111469209|NCT03585738|Vitamins|vitamins|mesh-ancestor
111469210|NCT03585738|Micronutrients|micronutrients|mesh-ancestor
111469211|NCT03585738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111469212|NCT03583164|Olorofim|olorofim|mesh-list
111469213|NCT03583164|Antifungal Agents|antifungal agents|mesh-ancestor
111469214|NCT03583164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111469215|NCT03589326|Cytarabine|cytarabine|mesh-list
111469216|NCT03589326|Dexamethasone|dexamethasone|mesh-list
111469217|NCT03589326|Prednisone|prednisone|mesh-list
111469218|NCT03589326|Methotrexate|methotrexate|mesh-list
111469219|NCT03589326|Vincristine|vincristine|mesh-list
111469220|NCT03589326|Imatinib Mesylate|imatinib mesylate|mesh-list
111469221|NCT03589326|Ponatinib|ponatinib|mesh-list
111469222|NCT03589326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111469223|NCT03589326|Antiemetics|antiemetics|mesh-ancestor
111469224|NCT03589326|Autonomic Agents|autonomic agents|mesh-ancestor
111469225|NCT03589326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111469226|NCT03589326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111469227|NCT03589326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111469228|NCT03589326|Glucocorticoids|glucocorticoids|mesh-ancestor
111469229|NCT03589326|Hormones|hormones|mesh-ancestor
111193360|NCT00529126|Autonomic Agents|autonomic agents|mesh-ancestor
111469230|NCT03589326|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111469231|NCT03589326|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111469232|NCT03589326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111469233|NCT03589326|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111469234|NCT03589326|Abortifacient Agents|abortifacient agents|mesh-ancestor
111469235|NCT03589326|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111469236|NCT03589326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111469237|NCT03589326|Antimetabolites|antimetabolites|mesh-ancestor
111469238|NCT03589326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111469239|NCT03589326|Dermatologic Agents|dermatologic agents|mesh-ancestor
111469240|NCT03589326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111469241|NCT03589326|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111469242|NCT03589326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111469243|NCT03589326|Immunologic Factors|immunologic factors|mesh-ancestor
111469244|NCT03589326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111469245|NCT03589326|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111469246|NCT03589326|Antiviral Agents|antiviral agents|mesh-ancestor
111469247|NCT03589326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111469248|NCT03589326|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111469249|NCT03589326|Tubulin Modulators|tubulin modulators|mesh-ancestor
111469250|NCT03589326|Antimitotic Agents|antimitotic agents|mesh-ancestor
111469251|NCT03589326|Mitosis Modulators|mitosis modulators|mesh-ancestor
111469252|NCT03589326|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111469253|NCT03583866|Candesartan|candesartan|mesh-list
111469254|NCT03583866|Candesartan cilexetil|candesartan cilexetil|mesh-list
111469255|NCT03583866|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111469256|NCT03583866|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111469257|NCT03583866|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111469258|NCT03583866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111469259|NCT03585426|Vancomycin|vancomycin|mesh-list
111469260|NCT03585426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111469261|NCT03585426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111469262|NCT03585036|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
111469263|NCT03585036|Tramadol|tramadol|mesh-list
111469264|NCT03585036|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111469265|NCT03585036|Narcotics|narcotics|mesh-ancestor
111469266|NCT03585036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111469267|NCT03585036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111469268|NCT03585036|Analgesics|analgesics|mesh-ancestor
111469269|NCT03585036|Sensory System Agents|sensory system agents|mesh-ancestor
111469270|NCT03585036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111469271|NCT03585036|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111469272|NCT03585036|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111469273|NCT03585036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111469274|NCT03585036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111469275|NCT03155568|Bupivacaine|bupivacaine|mesh-list
111469276|NCT03155568|Anesthetics, Local|anesthetics, local|mesh-ancestor
111469277|NCT03155568|Anesthetics|anesthetics|mesh-ancestor
111469278|NCT03155568|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111469279|NCT03155568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111469280|NCT03155568|Sensory System Agents|sensory system agents|mesh-ancestor
111469281|NCT03155568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111469282|NCT03155646|Clonidine|clonidine|mesh-list
111469283|NCT03155646|Dexmedetomidine|dexmedetomidine|mesh-list
111469284|NCT03155646|Levobupivacaine|levobupivacaine|mesh-list
111469285|NCT03155646|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111469286|NCT03155646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111469287|NCT03155646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111469288|NCT03155646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111469289|NCT03155646|Analgesics|analgesics|mesh-ancestor
111469290|NCT03155646|Sensory System Agents|sensory system agents|mesh-ancestor
111469291|NCT03155646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111469292|NCT03155646|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111469293|NCT03155646|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111469294|NCT03155646|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111469295|NCT03155646|Adrenergic Agents|adrenergic agents|mesh-ancestor
111469296|NCT03155646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111469297|NCT03155646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111469298|NCT03155646|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111469299|NCT03155646|Sympatholytics|sympatholytics|mesh-ancestor
111469300|NCT03155646|Autonomic Agents|autonomic agents|mesh-ancestor
111469301|NCT03155646|Anesthetics, Local|anesthetics, local|mesh-ancestor
111469302|NCT03155646|Anesthetics|anesthetics|mesh-ancestor
111469303|NCT03584178|Budesonide|budesonide|mesh-list
111469304|NCT03584178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111469305|NCT03584178|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111469306|NCT03584178|Autonomic Agents|autonomic agents|mesh-ancestor
111469307|NCT03584178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111469308|NCT03584178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111469309|NCT03584178|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111469310|NCT03584178|Respiratory System Agents|respiratory system agents|mesh-ancestor
111469311|NCT03584178|Glucocorticoids|glucocorticoids|mesh-ancestor
111469313|NCT03584178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111469314|NCT04405206|Capecitabine|capecitabine|mesh-list
111469315|NCT04405206|Oxaliplatin|oxaliplatin|mesh-list
111469316|NCT04405206|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111469317|NCT04405206|Antimetabolites|antimetabolites|mesh-ancestor
111469318|NCT04405206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111469319|NCT04405206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111469320|NCT03101046|Docetaxel|docetaxel|mesh-list
111469321|NCT03101046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111469322|NCT03101046|Tubulin Modulators|tubulin modulators|mesh-ancestor
111469323|NCT03101046|Antimitotic Agents|antimitotic agents|mesh-ancestor
111469324|NCT03101046|Mitosis Modulators|mitosis modulators|mesh-ancestor
111469325|NCT03101046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111469326|NCT03159936|Tofacitinib|tofacitinib|mesh-list
111469327|NCT03159936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111469328|NCT03159936|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
111469329|NCT03159936|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111469330|NCT03159936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111469331|NCT03156816|Colchicine|colchicine|mesh-list
111469332|NCT03156816|Gout Suppressants|gout suppressants|mesh-ancestor
111469333|NCT03156816|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111469334|NCT03156816|Tubulin Modulators|tubulin modulators|mesh-ancestor
111469335|NCT03156816|Antimitotic Agents|antimitotic agents|mesh-ancestor
111469336|NCT03156816|Mitosis Modulators|mitosis modulators|mesh-ancestor
111469337|NCT03156816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111469338|NCT03156816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111469339|NCT03583476|Amoxicillin|amoxicillin|mesh-list
111469340|NCT03583476|Metronidazole|metronidazole|mesh-list
111469341|NCT03583476|Clarithromycin|clarithromycin|mesh-list
111469342|NCT03583476|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
111469343|NCT03583476|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111469344|NCT03583476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111469345|NCT03583476|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111469346|NCT03583476|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111469347|NCT03583476|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111469348|NCT03583476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111469349|NCT03583476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111469350|NCT03583476|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111469351|NCT03583476|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111469352|NCT03583242|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
111469353|NCT03583242|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111469354|NCT03583242|Growth Substances|growth substances|mesh-ancestor
111469355|NCT03583242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111469356|NCT03583242|Growth Inhibitors|growth inhibitors|mesh-ancestor
111469357|NCT03583242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111469358|NCT05703126|N,N-dimethylarginine|n,n-dimethylarginine|mesh-list
111469359|NCT05703126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111469360|NCT05703126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111469361|NCT03159390|Phenylacetic acid|phenylacetic acid|mesh-list
111469362|NCT03159390|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111469363|NCT03159390|Antimetabolites|antimetabolites|mesh-ancestor
111469364|NCT03159390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111469365|NCT03159390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111469366|NCT03582306|Chlorophyllin|chlorophyllin|mesh-list
111469367|NCT03582306|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
111469368|NCT03582306|Protective Agents|protective agents|mesh-ancestor
111469369|NCT03582306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111469370|NCT03159234|Epinephrine|epinephrine|mesh-list
111469371|NCT03159234|Racepinephrine|racepinephrine|mesh-list
111469372|NCT03159234|Epinephryl borate|epinephryl borate|mesh-list
111469373|NCT03159234|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111469374|NCT03159234|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111469375|NCT03159234|Adrenergic Agents|adrenergic agents|mesh-ancestor
111469376|NCT03159234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111469377|NCT03159234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111469378|NCT03159234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111469379|NCT03159234|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111469380|NCT03159234|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111469382|NCT03159234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111469383|NCT03159234|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111469384|NCT03159234|Respiratory System Agents|respiratory system agents|mesh-ancestor
111469385|NCT03159234|Mydriatics|mydriatics|mesh-ancestor
111469386|NCT03159234|Sympathomimetics|sympathomimetics|mesh-ancestor
111469387|NCT03159234|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111469388|NCT05701332|Gemcitabine|gemcitabine|mesh-list
111469389|NCT05701332|BCG Vaccine|bcg vaccine|mesh-list
111469390|NCT05701332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111469391|NCT05701332|Antimetabolites|antimetabolites|mesh-ancestor
111469392|NCT05701332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111469393|NCT05701332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111469394|NCT05701332|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111469395|NCT05701332|Immunologic Factors|immunologic factors|mesh-ancestor
111469396|NCT05701332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111469397|NCT03581916|JNJ-64326067|jnj-64326067|mesh-list
111469398|NCT03581916|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111469399|NCT03581916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111469400|NCT05703048|Dexmedetomidine|dexmedetomidine|mesh-list
111469401|NCT05703048|Esmolol|esmolol|mesh-list
111469402|NCT05703048|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111469403|NCT05703048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111469404|NCT05703048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111469405|NCT05703048|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111469406|NCT05703048|Analgesics|analgesics|mesh-ancestor
111469407|NCT05703048|Sensory System Agents|sensory system agents|mesh-ancestor
111469408|NCT05703048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111469409|NCT05703048|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111469410|NCT05703048|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111469411|NCT05703048|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111469412|NCT05703048|Adrenergic Agents|adrenergic agents|mesh-ancestor
111469413|NCT05703048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111469414|NCT05703048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111469415|NCT05703048|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
111469416|NCT05703048|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111469417|NCT05703048|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111469418|NCT03158142|Atropine|atropine|mesh-list
111469419|NCT03158142|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111469420|NCT03158142|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111469421|NCT03158142|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111469422|NCT03158142|Autonomic Agents|autonomic agents|mesh-ancestor
110100546|NCT01755663|Metoprolol|metoprolol|mesh-list
111469423|NCT03158142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111469424|NCT03158142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111469425|NCT03158142|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111469426|NCT03158142|Respiratory System Agents|respiratory system agents|mesh-ancestor
111469427|NCT03158142|Mydriatics|mydriatics|mesh-ancestor
111469428|NCT03158142|Parasympatholytics|parasympatholytics|mesh-ancestor
111469429|NCT03158142|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111469430|NCT03158142|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111469431|NCT03158142|Cholinergic Agents|cholinergic agents|mesh-ancestor
111469432|NCT03158142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111469433|NCT03158142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111469434|NCT03028740|Cenicriviroc|cenicriviroc|mesh-list
111469435|NCT03028740|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
111469436|NCT03028740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111469437|NCT03028740|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111469438|NCT03028740|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111469439|NCT03028740|Antiviral Agents|antiviral agents|mesh-ancestor
111469440|NCT03028740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111469441|NCT03027648|Levonorgestrel|levonorgestrel|mesh-list
111469442|NCT03027648|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111469443|NCT03027648|Contraceptive Agents|contraceptive agents|mesh-ancestor
111469444|NCT03027648|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111469445|NCT03027648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111469446|NCT03027648|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111469447|NCT03027648|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111469448|NCT03027648|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111469449|NCT01671384|Valproic Acid|valproic acid|mesh-list
111469450|NCT01671384|Anticonvulsants|anticonvulsants|mesh-ancestor
111469451|NCT01671384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111469452|NCT01671384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111469453|NCT01671384|GABA Agents|gaba agents|mesh-ancestor
111469454|NCT01671384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111469455|NCT01671384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111469456|NCT01671384|Antimanic Agents|antimanic agents|mesh-ancestor
111469457|NCT01671384|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111469458|NCT01671384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111469459|NCT01671384|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111469460|NCT01671774|Zoledronic Acid|zoledronic acid|mesh-list
111469461|NCT01671774|Interleukin-2|interleukin-2|mesh-list
111469462|NCT01671774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111469463|NCT01671774|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111469464|NCT01671774|Analgesics|analgesics|mesh-ancestor
111469465|NCT01671774|Sensory System Agents|sensory system agents|mesh-ancestor
111469466|NCT01671774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111469467|NCT01671774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111469468|NCT01671774|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111469469|NCT01671852|Mometasone Furoate|mometasone furoate|mesh-list
111469470|NCT01671852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111469471|NCT01671852|Dermatologic Agents|dermatologic agents|mesh-ancestor
111469472|NCT01671852|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111469473|NCT01672086|Calcium Carbonate|calcium carbonate|mesh-list
111469474|NCT01672086|Antacids|antacids|mesh-ancestor
111469475|NCT01672086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111469476|NCT01672086|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111469477|NCT05547750|Vitamin K|vitamin k|mesh-list
111469478|NCT05547750|Vitamin K 2|vitamin k 2|mesh-list
111469479|NCT05547750|Vitamins|vitamins|mesh-ancestor
111469480|NCT05547750|Micronutrients|micronutrients|mesh-ancestor
111469481|NCT05547750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111469482|NCT05547750|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111469483|NCT05547750|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111469484|NCT05547750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111469485|NCT05547750|Hemostatics|hemostatics|mesh-ancestor
111469486|NCT05547750|Coagulants|coagulants|mesh-ancestor
111469487|NCT04296006|Amphetamine|amphetamine|mesh-list
111469488|NCT04296006|Dextroamphetamine|dextroamphetamine|mesh-list
111469489|NCT04296006|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111469490|NCT04296006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111469491|NCT04296006|Sympathomimetics|sympathomimetics|mesh-ancestor
111469492|NCT04296006|Autonomic Agents|autonomic agents|mesh-ancestor
111469493|NCT04296006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111469494|NCT04296006|Dopamine Agents|dopamine agents|mesh-ancestor
111469495|NCT04296006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111469496|NCT04296006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111469497|NCT04296006|Adrenergic Agents|adrenergic agents|mesh-ancestor
111469498|NCT04296006|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111469499|NCT04296006|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111469500|NCT04296006|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111469501|NCT04296006|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111469502|NCT01672476|Valsartan|valsartan|mesh-list
111469503|NCT01672476|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111469504|NCT01672476|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111469505|NCT01672476|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111469506|NCT01672476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111469507|NCT01672554|Quetiapine Fumarate|quetiapine fumarate|mesh-list
111469508|NCT01672554|Antidepressive Agents|antidepressive agents|mesh-ancestor
111469509|NCT01672554|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111469510|NCT01672554|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111469511|NCT01672554|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111469512|NCT01672554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111469513|NCT01672554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111469514|NCT05067582|alpha-Methyltyrosine|alpha-methyltyrosine|mesh-list
111469515|NCT05067582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111469516|NCT05067582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111469517|NCT05033808|Epirubicin|epirubicin|mesh-list
111469518|NCT05033808|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111469519|NCT05033808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111469520|NCT05033808|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111469521|NCT05033808|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111469522|NCT05033808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111469523|NCT05033808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111469524|NCT04026984|Rifamycins|rifamycins|mesh-list
111469525|NCT04026984|Rifamycin SV|rifamycin sv|mesh-list
111469526|NCT04026984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111469527|NCT04026984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111469528|NCT04026984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111193664|NCT03019666|Niacin|niacin|mesh-list
111469529|NCT03153072|Amiodarone|amiodarone|mesh-list
111469530|NCT03153072|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111469531|NCT03153072|Vasodilator Agents|vasodilator agents|mesh-ancestor
111469532|NCT03153072|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
111469533|NCT03153072|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111469534|NCT03153072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111469535|NCT03153072|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111469536|NCT03153072|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111469537|NCT03153072|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111469538|NCT03153072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111469539|NCT03153072|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111469540|NCT03153072|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111469541|NCT03153072|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111469542|NCT01673724|Pramipexole|pramipexole|mesh-list
111469543|NCT01673724|Bromocriptine|bromocriptine|mesh-list
111469544|NCT01673724|Antioxidants|antioxidants|mesh-ancestor
111469545|NCT01673724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111469546|NCT01673724|Protective Agents|protective agents|mesh-ancestor
111469547|NCT01673724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111469548|NCT01673724|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111469549|NCT01673724|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111469550|NCT01673724|Dopamine Agonists|dopamine agonists|mesh-ancestor
111469551|NCT01673724|Dopamine Agents|dopamine agents|mesh-ancestor
111469552|NCT01673724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111469553|NCT01673724|Hormone Antagonists|hormone antagonists|mesh-ancestor
111469554|NCT01673724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111469555|NCT04765098|Tamoxifen|tamoxifen|mesh-list
111469556|NCT04765098|Etoposide|etoposide|mesh-list
111469557|NCT04765098|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111469558|NCT04765098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111469559|NCT04765098|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111469560|NCT04765098|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111469561|NCT04765098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111469562|NCT04765098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111469563|NCT04765098|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111469564|NCT04765098|Hormone Antagonists|hormone antagonists|mesh-ancestor
111469565|NCT04765098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111469566|NCT04765098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111469567|NCT04765098|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111469568|NCT04765098|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111469569|NCT04765098|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111469570|NCT04765098|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111469571|NCT01674036|Venglustat|venglustat|mesh-list
111469572|NCT01674036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111469573|NCT01674036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111469574|NCT03378102|Interferon-gamma|interferon-gamma|mesh-list
111469575|NCT03378102|Antiviral Agents|antiviral agents|mesh-ancestor
111469576|NCT03378102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111469577|NCT03032328|Vitamin D|vitamin d|mesh-list
111469578|NCT03032328|Vitamins|vitamins|mesh-ancestor
111469579|NCT03032328|Micronutrients|micronutrients|mesh-ancestor
111469580|NCT03032328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111469581|NCT03032328|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111469582|NCT04747392|Teriparatide|teriparatide|mesh-list
111469583|NCT04747392|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111469584|NCT04747392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111469585|NCT04747392|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111469586|NCT01674192|Prucalopride|prucalopride|mesh-list
111469587|NCT01674192|Laxatives|laxatives|mesh-ancestor
111469588|NCT01674192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111469589|NCT01674192|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
111469590|NCT01674192|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111469591|NCT01674192|Serotonin Agents|serotonin agents|mesh-ancestor
111469592|NCT01674192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111469593|NCT01674192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111469594|NCT01674192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111469595|NCT01674270|Bicalutamide|bicalutamide|mesh-list
111469596|NCT01674270|Androgen Antagonists|androgen antagonists|mesh-ancestor
111469597|NCT01674270|Hormone Antagonists|hormone antagonists|mesh-ancestor
111469598|NCT01674270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111469599|NCT01674270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111469600|NCT01674270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111469601|NCT01674504|Montelukast|montelukast|mesh-list
111469602|NCT01674504|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111469603|NCT01674504|Respiratory System Agents|respiratory system agents|mesh-ancestor
111469604|NCT01674504|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
111469605|NCT01674504|Hormone Antagonists|hormone antagonists|mesh-ancestor
111469606|NCT01674504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111469607|NCT01674504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111469608|NCT01674504|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
111469609|NCT01674504|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111469610|NCT01674504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111469611|NCT05353062|Epinephrine|epinephrine|mesh-list
111469612|NCT05353062|Hemostatics|hemostatics|mesh-list
111469613|NCT05353062|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111469614|NCT05353062|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111469615|NCT05353062|Adrenergic Agents|adrenergic agents|mesh-ancestor
111469616|NCT05353062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111469617|NCT05353062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111469618|NCT05353062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111469619|NCT05353062|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111469620|NCT05353062|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111469621|NCT05353062|Autonomic Agents|autonomic agents|mesh-ancestor
111469622|NCT05353062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111469623|NCT05353062|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111469624|NCT05353062|Respiratory System Agents|respiratory system agents|mesh-ancestor
111469625|NCT05353062|Mydriatics|mydriatics|mesh-ancestor
111469626|NCT05353062|Sympathomimetics|sympathomimetics|mesh-ancestor
111469627|NCT05353062|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111469628|NCT05353062|Coagulants|coagulants|mesh-ancestor
111469629|NCT03152370|Leucovorin|leucovorin|mesh-list
111469630|NCT03152370|Folic Acid|folic acid|mesh-list
111469631|NCT03152370|Capecitabine|capecitabine|mesh-list
111469632|NCT03152370|Oxaliplatin|oxaliplatin|mesh-list
111469633|NCT03152370|Levoleucovorin|levoleucovorin|mesh-list
111469634|NCT03152370|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111469635|NCT03152370|Antimetabolites|antimetabolites|mesh-ancestor
111469636|NCT03152370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111469637|NCT03152370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111469638|NCT03152370|Antidotes|antidotes|mesh-ancestor
111469639|NCT03152370|Protective Agents|protective agents|mesh-ancestor
111469640|NCT03152370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111469641|NCT03152370|Vitamin B Complex|vitamin b complex|mesh-ancestor
111469642|NCT03152370|Vitamins|vitamins|mesh-ancestor
111469643|NCT03152370|Micronutrients|micronutrients|mesh-ancestor
111469644|NCT03152370|Hematinics|hematinics|mesh-ancestor
111469645|NCT02187120|Tranexamic Acid|tranexamic acid|mesh-list
111469646|NCT02187120|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111469647|NCT02187120|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111469648|NCT02187120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111469649|NCT02187120|Hemostatics|hemostatics|mesh-ancestor
111469650|NCT02187120|Coagulants|coagulants|mesh-ancestor
111469651|NCT01674738|Bevacizumab|bevacizumab|mesh-list
111469652|NCT01674738|Pemetrexed|pemetrexed|mesh-list
111469653|NCT01674738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111469654|NCT01674738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111469655|NCT01674738|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111469656|NCT01674738|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111469657|NCT01674738|Growth Substances|growth substances|mesh-ancestor
111469658|NCT01674738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111469659|NCT01674738|Growth Inhibitors|growth inhibitors|mesh-ancestor
111469660|NCT01674738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111469661|NCT01674738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111469662|NCT01674738|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111469663|NCT01674738|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111469664|NCT01675206|Vitamin K|vitamin k|mesh-list
111469665|NCT01675206|Vitamin K 2|vitamin k 2|mesh-list
111469666|NCT01675206|Vitamins|vitamins|mesh-ancestor
111469667|NCT01675206|Micronutrients|micronutrients|mesh-ancestor
111469668|NCT01675206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111469669|NCT01675206|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111469670|NCT01675206|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111469671|NCT01675206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111469672|NCT01675206|Hemostatics|hemostatics|mesh-ancestor
111469673|NCT01675206|Coagulants|coagulants|mesh-ancestor
111469674|NCT03150576|Paclitaxel|paclitaxel|mesh-list
111469675|NCT03150576|Carboplatin|carboplatin|mesh-list
111469676|NCT03150576|Olaparib|olaparib|mesh-list
111469677|NCT03150576|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111469678|NCT03150576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111469679|NCT03150576|Tubulin Modulators|tubulin modulators|mesh-ancestor
111469680|NCT03150576|Antimitotic Agents|antimitotic agents|mesh-ancestor
111469681|NCT03150576|Mitosis Modulators|mitosis modulators|mesh-ancestor
111469682|NCT03150576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111469683|NCT03150576|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111469684|NCT03150576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111469685|NCT04747080|Dexamethasone|dexamethasone|mesh-list
111469686|NCT04747080|Dexamethasone acetate|dexamethasone acetate|mesh-list
111469687|NCT04747080|BB 1101|bb 1101|mesh-list
111469688|NCT04747080|Tacrolimus|tacrolimus|mesh-list
111469689|NCT04747080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111469690|NCT04747080|Antiemetics|antiemetics|mesh-ancestor
111469691|NCT04747080|Autonomic Agents|autonomic agents|mesh-ancestor
111469692|NCT04747080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111469693|NCT04747080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111469694|NCT04747080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111469695|NCT04747080|Glucocorticoids|glucocorticoids|mesh-ancestor
111469696|NCT04747080|Hormones|hormones|mesh-ancestor
111469697|NCT04747080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111469698|NCT04747080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111469699|NCT04747080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111469700|NCT04747080|Protease Inhibitors|protease inhibitors|mesh-ancestor
111469701|NCT04747080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111469702|NCT04747080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111469703|NCT04747080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111469704|NCT04747080|Immunologic Factors|immunologic factors|mesh-ancestor
111469705|NCT04747080|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111469706|NCT01675362|Selenium|selenium|mesh-list
111469707|NCT01675362|Losartan|losartan|mesh-list
111469708|NCT01675362|Verapamil|verapamil|mesh-list
111469709|NCT01675362|Calcium Channel Blockers|calcium channel blockers|mesh-list
111469710|NCT01675362|Calcium|calcium|mesh-list
111469711|NCT01675362|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
111469712|NCT01675362|Antioxidants|antioxidants|mesh-list
111469713|NCT01675362|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111469714|NCT01675362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111469715|NCT01675362|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111469716|NCT01675362|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111469717|NCT01675362|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111469718|NCT01675362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111469719|NCT01675362|Protective Agents|protective agents|mesh-ancestor
111469720|NCT01675362|Trace Elements|trace elements|mesh-ancestor
111469721|NCT01675362|Micronutrients|micronutrients|mesh-ancestor
111469722|NCT01675362|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111469723|NCT01675362|Vasodilator Agents|vasodilator agents|mesh-ancestor
111469724|NCT01675518|ASP7991|asp7991|mesh-list
111469725|NCT01675518|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
111469726|NCT01675518|Hormone Antagonists|hormone antagonists|mesh-ancestor
111469727|NCT01675518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111469728|NCT01675518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111469729|NCT03158532|Nitroglycerin|nitroglycerin|mesh-list
111469730|NCT03158532|Vasodilator Agents|vasodilator agents|mesh-ancestor
111469731|NCT01675986|Pregabalin|pregabalin|mesh-list
111469732|NCT01675986|Hydroxyzine|hydroxyzine|mesh-list
111469733|NCT01675986|Analgesics|analgesics|mesh-ancestor
111469734|NCT01675986|Sensory System Agents|sensory system agents|mesh-ancestor
111469735|NCT01675986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111469736|NCT01675986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111469737|NCT01675986|Anticonvulsants|anticonvulsants|mesh-ancestor
111469738|NCT01675986|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111469739|NCT01675986|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111469740|NCT01675986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111469741|NCT01675986|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111469742|NCT01675986|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111469743|NCT01675986|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111469744|NCT01675986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111469745|NCT01675986|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111469746|NCT01675986|Antipruritics|antipruritics|mesh-ancestor
111469747|NCT01675986|Dermatologic Agents|dermatologic agents|mesh-ancestor
111469748|NCT01675986|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111469749|NCT01675986|Histamine Antagonists|histamine antagonists|mesh-ancestor
111469750|NCT01675986|Histamine Agents|histamine agents|mesh-ancestor
111469751|NCT01675986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111469752|NCT03875664|Bupivacaine|bupivacaine|mesh-list
111469753|NCT03875664|Anesthetics, Local|anesthetics, local|mesh-ancestor
111193877|NCT01430403|Dermatologic Agents|dermatologic agents|mesh-ancestor
111469754|NCT03875664|Anesthetics|anesthetics|mesh-ancestor
111469755|NCT03875664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111469756|NCT03875664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111469757|NCT03875664|Sensory System Agents|sensory system agents|mesh-ancestor
111469758|NCT03875664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111469759|NCT01670136|Sildenafil Citrate|sildenafil citrate|mesh-list
111469760|NCT01670136|Vasodilator Agents|vasodilator agents|mesh-ancestor
111469761|NCT01670136|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111469762|NCT01670136|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111469763|NCT01670136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111469764|NCT01670136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111469765|NCT01670136|Urological Agents|urological agents|mesh-ancestor
111469766|NCT03873480|Epinephrine|epinephrine|mesh-list
111469767|NCT03873480|Bupivacaine|bupivacaine|mesh-list
111469768|NCT03873480|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111469769|NCT03873480|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111469770|NCT03873480|Adrenergic Agents|adrenergic agents|mesh-ancestor
111469771|NCT03873480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111469772|NCT03873480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111469773|NCT03873480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111469774|NCT03873480|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111469775|NCT03873480|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111469776|NCT03873480|Autonomic Agents|autonomic agents|mesh-ancestor
111469777|NCT03873480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111469778|NCT03873480|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111469779|NCT03873480|Respiratory System Agents|respiratory system agents|mesh-ancestor
111469780|NCT03873480|Mydriatics|mydriatics|mesh-ancestor
111469781|NCT03873480|Sympathomimetics|sympathomimetics|mesh-ancestor
111469782|NCT03873480|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111469783|NCT03873480|Anesthetics, Local|anesthetics, local|mesh-ancestor
111469784|NCT03873480|Anesthetics|anesthetics|mesh-ancestor
111469785|NCT03873480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111469786|NCT03873480|Sensory System Agents|sensory system agents|mesh-ancestor
111469787|NCT04764084|Niraparib|niraparib|mesh-list
111469788|NCT04764084|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111469789|NCT04764084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111469790|NCT04764084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111469791|NCT04764084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111469792|NCT03866772|Misoprostol|misoprostol|mesh-list
111469793|NCT03866772|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111469794|NCT03866772|Abortifacient Agents|abortifacient agents|mesh-ancestor
111469795|NCT03866772|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111469796|NCT03866772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111469797|NCT03866772|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111469798|NCT03866772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111469799|NCT03866772|Oxytocics|oxytocics|mesh-ancestor
111469800|NCT03866538|Budesonide|budesonide|mesh-list
111469801|NCT03866538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111469802|NCT03866538|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111469803|NCT03866538|Autonomic Agents|autonomic agents|mesh-ancestor
111469804|NCT03866538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111469805|NCT03866538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111469806|NCT03866538|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111469807|NCT03866538|Respiratory System Agents|respiratory system agents|mesh-ancestor
111469808|NCT03866538|Glucocorticoids|glucocorticoids|mesh-ancestor
111469809|NCT03866538|Hormones|hormones|mesh-ancestor
111469810|NCT03866538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111469811|NCT01677390|Everolimus|everolimus|mesh-list
111469812|NCT01677390|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111469813|NCT01677390|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111469814|NCT01677390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111469815|NCT01677390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111469816|NCT01677390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111469817|NCT01677390|Immunologic Factors|immunologic factors|mesh-ancestor
111469818|NCT01677390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111469819|NCT01677390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111469820|NCT03749070|Silymarin|silymarin|mesh-list
111469821|NCT03749070|Antioxidants|antioxidants|mesh-ancestor
111469822|NCT03749070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111469823|NCT03749070|Protective Agents|protective agents|mesh-ancestor
111469824|NCT03749070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111469825|NCT03748134|Paclitaxel|paclitaxel|mesh-list
111469826|NCT03748134|Fluorouracil|fluorouracil|mesh-list
111469827|NCT03748134|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111193963|NCT00513370|Adalimumab|adalimumab|mesh-list
111469829|NCT03748134|Tubulin Modulators|tubulin modulators|mesh-ancestor
111469830|NCT03748134|Antimitotic Agents|antimitotic agents|mesh-ancestor
111469831|NCT03748134|Mitosis Modulators|mitosis modulators|mesh-ancestor
111469832|NCT03748134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111469833|NCT03748134|Antimetabolites|antimetabolites|mesh-ancestor
111469834|NCT03748134|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111469835|NCT03748134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111469836|NCT03748134|Immunologic Factors|immunologic factors|mesh-ancestor
111469837|NCT03748134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111469838|NCT01345656|Spironolactone|spironolactone|mesh-list
111469839|NCT01345656|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
111469840|NCT01345656|Hormone Antagonists|hormone antagonists|mesh-ancestor
111469841|NCT01345656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111469842|NCT01345656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111469843|NCT01345656|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
111469844|NCT01345656|Diuretics|diuretics|mesh-ancestor
111469845|NCT01345656|Natriuretic Agents|natriuretic agents|mesh-ancestor
111469846|NCT04763616|Cemiplimab|cemiplimab|mesh-list
111469847|NCT04763616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111469848|NCT04763616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111469849|NCT03652974|Valproic Acid|valproic acid|mesh-list
111469850|NCT03652974|Clozapine|clozapine|mesh-list
111469851|NCT03652974|Amisulpride|amisulpride|mesh-list
111469852|NCT03652974|Anticonvulsants|anticonvulsants|mesh-ancestor
111469853|NCT03652974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111469854|NCT03652974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111469855|NCT03652974|GABA Agents|gaba agents|mesh-ancestor
111469856|NCT03652974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111469857|NCT03652974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111469858|NCT03652974|Antimanic Agents|antimanic agents|mesh-ancestor
111469859|NCT03652974|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111469860|NCT03652974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111469861|NCT03652974|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111469862|NCT03652974|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111469863|NCT03652974|Serotonin Agents|serotonin agents|mesh-ancestor
111469864|NCT03652974|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111469865|NCT03652974|GABA Antagonists|gaba antagonists|mesh-ancestor
111469866|NCT03652974|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111469867|NCT03652974|Dopamine Agents|dopamine agents|mesh-ancestor
111469868|NCT03652974|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111469869|NCT03652974|Antidepressive Agents|antidepressive agents|mesh-ancestor
111469870|NCT03649152|Propagermanium|propagermanium|mesh-list
111469871|NCT03649152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111469872|NCT03649152|Interferon Inducers|interferon inducers|mesh-ancestor
111469873|NCT03649152|Immunologic Factors|immunologic factors|mesh-ancestor
111469874|NCT03649152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111469875|NCT03646188|Doxorubicin|doxorubicin|mesh-list
111469876|NCT03646188|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111469877|NCT03646188|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111469878|NCT03646188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111469879|NCT03646188|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111469880|NCT03646188|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111469881|NCT03646188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111469882|NCT03646188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111469883|NCT03642210|Levonorgestrel|levonorgestrel|mesh-list
111469884|NCT03642210|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111469885|NCT03642210|Contraceptive Agents|contraceptive agents|mesh-ancestor
111469886|NCT03642210|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111469887|NCT03642210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111469888|NCT03642210|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111469889|NCT03642210|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111469890|NCT03642210|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111469891|NCT02082678|Ondansetron|ondansetron|mesh-list
111469892|NCT02082678|Antiemetics|antiemetics|mesh-ancestor
111469893|NCT02082678|Autonomic Agents|autonomic agents|mesh-ancestor
111469894|NCT02082678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111469895|NCT02082678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111469896|NCT02082678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111469897|NCT02082678|Antipruritics|antipruritics|mesh-ancestor
111469898|NCT02082678|Dermatologic Agents|dermatologic agents|mesh-ancestor
111469899|NCT02082678|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111469900|NCT02082678|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111469901|NCT02082678|Serotonin Agents|serotonin agents|mesh-ancestor
111469902|NCT02082678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111469903|NCT02082678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111469904|NCT01677468|Doxorubicin|doxorubicin|mesh-list
111469905|NCT01677468|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111469906|NCT01677468|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
111469907|NCT01677468|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111469908|NCT01677468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111469909|NCT01677468|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111469910|NCT01677468|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111469911|NCT01677468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111469912|NCT01677468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111469913|NCT01677468|Hemostatics|hemostatics|mesh-ancestor
111469914|NCT01677468|Coagulants|coagulants|mesh-ancestor
111469915|NCT00003816|Cyclophosphamide|cyclophosphamide|mesh-list
111469916|NCT00003816|Melphalan|melphalan|mesh-list
111469917|NCT00003816|Busulfan|busulfan|mesh-list
111469918|NCT00003816|Thiotepa|thiotepa|mesh-list
111469919|NCT00003816|Carboplatin|carboplatin|mesh-list
111469920|NCT00003816|Fludarabine|fludarabine|mesh-list
111469921|NCT00003816|Fludarabine phosphate|fludarabine phosphate|mesh-list
111469922|NCT00003816|Etoposide|etoposide|mesh-list
111469923|NCT00003816|Antilymphocyte Serum|antilymphocyte serum|mesh-list
111469924|NCT00003816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111469925|NCT00003816|Immunologic Factors|immunologic factors|mesh-ancestor
111469926|NCT00003816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111469927|NCT00003816|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111469928|NCT00003816|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111469929|NCT00003816|Alkylating Agents|alkylating agents|mesh-ancestor
111469930|NCT00003816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111469931|NCT00003816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111469932|NCT00003816|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110108626|NCT01819870|Carvedilol|carvedilol|mesh-list
111469933|NCT00003816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111469934|NCT00003816|Antimetabolites|antimetabolites|mesh-ancestor
111469935|NCT00003816|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111469936|NCT00003816|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111469937|NCT00003816|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111469938|NCT00003816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111469939|NCT03618654|Metformin|metformin|mesh-list
111469940|NCT03618654|Durvalumab|durvalumab|mesh-list
111469941|NCT03618654|Immunoglobulins|immunoglobulins|mesh-list
111469942|NCT03618654|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111469943|NCT03618654|Immunoglobulin G|immunoglobulin g|mesh-list
111469944|NCT03618654|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111469945|NCT03618654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111469946|NCT03618654|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111469947|NCT03618654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111469948|NCT03618654|Immunologic Factors|immunologic factors|mesh-ancestor
111469949|NCT04763070|Ciprofloxacin|ciprofloxacin|mesh-list
111469950|NCT04763070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111469951|NCT04763070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111469952|NCT04763070|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111469953|NCT04763070|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111469954|NCT04763070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111469955|NCT04763070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111469956|NCT04763070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111469957|NCT04763070|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111469958|NCT04763070|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111469959|NCT03611556|Leucovorin|leucovorin|mesh-list
111469960|NCT03611556|Paclitaxel|paclitaxel|mesh-list
111469961|NCT03611556|Gemcitabine|gemcitabine|mesh-list
111469962|NCT03611556|Oxaliplatin|oxaliplatin|mesh-list
111469963|NCT03611556|Fluorouracil|fluorouracil|mesh-list
111469964|NCT03611556|Durvalumab|durvalumab|mesh-list
111469965|NCT03611556|Levoleucovorin|levoleucovorin|mesh-list
111469966|NCT03611556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111469967|NCT03611556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111469968|NCT03611556|Tubulin Modulators|tubulin modulators|mesh-ancestor
111469969|NCT03611556|Antimitotic Agents|antimitotic agents|mesh-ancestor
111469970|NCT03611556|Mitosis Modulators|mitosis modulators|mesh-ancestor
111469971|NCT03611556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111469972|NCT03611556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111469973|NCT03611556|Antimetabolites|antimetabolites|mesh-ancestor
111469974|NCT03611556|Antidotes|antidotes|mesh-ancestor
111469975|NCT03611556|Protective Agents|protective agents|mesh-ancestor
111469976|NCT03611556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111469977|NCT03611556|Vitamin B Complex|vitamin b complex|mesh-ancestor
111469978|NCT03611556|Vitamins|vitamins|mesh-ancestor
111194105|NCT01441635|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111469979|NCT03611556|Micronutrients|micronutrients|mesh-ancestor
111469980|NCT03611556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111469981|NCT03611556|Immunologic Factors|immunologic factors|mesh-ancestor
111469982|NCT03611556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111469983|NCT03609060|Dexamethasone|dexamethasone|mesh-list
111469984|NCT03609060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111469985|NCT03609060|Antiemetics|antiemetics|mesh-ancestor
111469986|NCT03609060|Autonomic Agents|autonomic agents|mesh-ancestor
111469987|NCT03609060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111469988|NCT03609060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111469989|NCT03609060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111469990|NCT03609060|Glucocorticoids|glucocorticoids|mesh-ancestor
111469991|NCT03609060|Hormones|hormones|mesh-ancestor
111469992|NCT03609060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111469993|NCT03609060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111469994|NCT03609060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111469995|NCT03704766|alpha-Defensins|alpha-defensins|mesh-list
111469996|NCT03704766|Defensins|defensins|mesh-list
111469997|NCT03704766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111469998|NCT03826992|Cytarabine|cytarabine|mesh-list
111469999|NCT03826992|Daunorubicin|daunorubicin|mesh-list
111470000|NCT03826992|Venetoclax|venetoclax|mesh-list
111470001|NCT03826992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111470002|NCT03826992|Antimetabolites|antimetabolites|mesh-ancestor
111470003|NCT03826992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111470004|NCT03826992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111470005|NCT03826992|Antiviral Agents|antiviral agents|mesh-ancestor
111470006|NCT03826992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111470007|NCT03826992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111470008|NCT03826992|Immunologic Factors|immunologic factors|mesh-ancestor
111470009|NCT03826992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111470010|NCT03826992|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111470011|NCT03826992|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111470012|NCT03826992|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111470013|NCT03826992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111470014|NCT00004092|Paclitaxel|paclitaxel|mesh-list
111470015|NCT00004092|Cyclophosphamide|cyclophosphamide|mesh-list
111470016|NCT00004092|Carboplatin|carboplatin|mesh-list
111470017|NCT00004092|Doxorubicin|doxorubicin|mesh-list
111470018|NCT00004092|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111470019|NCT00004092|Thiotepa|thiotepa|mesh-list
111470020|NCT00004092|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111470021|NCT00004092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111470022|NCT00004092|Tubulin Modulators|tubulin modulators|mesh-ancestor
111470023|NCT00004092|Antimitotic Agents|antimitotic agents|mesh-ancestor
111470024|NCT00004092|Mitosis Modulators|mitosis modulators|mesh-ancestor
111470025|NCT00004092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111470026|NCT00004092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111470027|NCT00004092|Immunologic Factors|immunologic factors|mesh-ancestor
111470028|NCT00004092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111470029|NCT00004092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111470030|NCT00004092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111470031|NCT00004092|Alkylating Agents|alkylating agents|mesh-ancestor
111470032|NCT00004092|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111470033|NCT00004092|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111470034|NCT00004092|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111470035|NCT00004092|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111470036|NCT00004092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111470037|NCT00004146|Carboxyamido-triazole|carboxyamido-triazole|mesh-list
111470038|NCT00004146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111470039|NCT00004146|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111470040|NCT00004146|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111470041|NCT00004146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111470042|NCT00004146|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111470043|NCT00004146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111470044|NCT00004500|Pulmonary Surfactants|pulmonary surfactants|mesh-list
111470045|NCT00004500|Respiratory System Agents|respiratory system agents|mesh-ancestor
111470046|NCT03825198|Dexamethasone|dexamethasone|mesh-list
111470047|NCT03825198|Ketorolac|ketorolac|mesh-list
111470048|NCT03825198|Sufentanil|sufentanil|mesh-list
111470049|NCT03825198|Morphine|morphine|mesh-list
111470050|NCT03825198|Bromides|bromides|mesh-list
111470051|NCT03825198|Propofol|propofol|mesh-list
111470052|NCT03825198|Sevoflurane|sevoflurane|mesh-list
111470053|NCT03825198|Levobupivacaine|levobupivacaine|mesh-list
111470054|NCT03825198|Rocuronium|rocuronium|mesh-list
111470055|NCT03825198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111470056|NCT03825198|Antiemetics|antiemetics|mesh-ancestor
111470057|NCT03825198|Autonomic Agents|autonomic agents|mesh-ancestor
111470058|NCT03825198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111470059|NCT03825198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111470060|NCT03825198|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111470062|NCT03825198|Hormones|hormones|mesh-ancestor
111470063|NCT03825198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111470064|NCT03825198|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111470065|NCT03825198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111470066|NCT03825198|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111470067|NCT03825198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111470068|NCT03825198|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111470069|NCT03825198|Anesthetics, General|anesthetics, general|mesh-ancestor
111470070|NCT03825198|Anesthetics|anesthetics|mesh-ancestor
111470071|NCT03825198|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111470072|NCT03825198|Narcotics|narcotics|mesh-ancestor
111470073|NCT03825198|Analgesics|analgesics|mesh-ancestor
111470074|NCT03825198|Sensory System Agents|sensory system agents|mesh-ancestor
111470075|NCT03825198|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111470076|NCT03825198|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111470077|NCT03825198|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111470078|NCT03825198|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111470079|NCT03825198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111470080|NCT03825198|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111470081|NCT03825198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111470082|NCT03825198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111470083|NCT03825198|Anticonvulsants|anticonvulsants|mesh-ancestor
111470084|NCT03825198|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
111470085|NCT03825198|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
111470086|NCT03825198|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111470087|NCT03825198|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111470088|NCT03825198|Anesthetics, Local|anesthetics, local|mesh-ancestor
111470089|NCT03824106|Vitamin D|vitamin d|mesh-list
111470090|NCT03824106|Vitamins|vitamins|mesh-ancestor
111470091|NCT03824106|Micronutrients|micronutrients|mesh-ancestor
111470092|NCT03824106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111470093|NCT03824106|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111470094|NCT03817320|Leucovorin|leucovorin|mesh-list
111470095|NCT03817320|Cytarabine|cytarabine|mesh-list
111470096|NCT03817320|Dexamethasone|dexamethasone|mesh-list
111470097|NCT03817320|Hydrocortisone|hydrocortisone|mesh-list
111470098|NCT03817320|Doxorubicin|doxorubicin|mesh-list
111470099|NCT03817320|Methotrexate|methotrexate|mesh-list
111470100|NCT03817320|Vincristine|vincristine|mesh-list
111470101|NCT03817320|Asparaginase|asparaginase|mesh-list
111470102|NCT03817320|Ixazomib|ixazomib|mesh-list
111470103|NCT03817320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111470104|NCT03817320|Antiemetics|antiemetics|mesh-ancestor
111470105|NCT03817320|Autonomic Agents|autonomic agents|mesh-ancestor
111470106|NCT03817320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111470107|NCT03817320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111470108|NCT03817320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111470109|NCT03817320|Glucocorticoids|glucocorticoids|mesh-ancestor
111470110|NCT03817320|Hormones|hormones|mesh-ancestor
111470111|NCT03817320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111470112|NCT03817320|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111470113|NCT03817320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111470114|NCT03817320|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111470115|NCT03817320|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111470116|NCT03817320|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111470117|NCT03817320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111470118|NCT03817320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111470119|NCT03817320|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111470120|NCT03817320|Abortifacient Agents|abortifacient agents|mesh-ancestor
111470121|NCT03817320|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111470122|NCT03817320|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111470123|NCT03817320|Antimetabolites|antimetabolites|mesh-ancestor
111470124|NCT03817320|Dermatologic Agents|dermatologic agents|mesh-ancestor
111470125|NCT03817320|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111470126|NCT03817320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111470127|NCT03817320|Immunologic Factors|immunologic factors|mesh-ancestor
111470128|NCT03817320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111470129|NCT03817320|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111470130|NCT03817320|Antiviral Agents|antiviral agents|mesh-ancestor
111470131|NCT03817320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111470132|NCT03817320|Antidotes|antidotes|mesh-ancestor
111470133|NCT03817320|Protective Agents|protective agents|mesh-ancestor
111470134|NCT03817320|Vitamin B Complex|vitamin b complex|mesh-ancestor
111470135|NCT03817320|Vitamins|vitamins|mesh-ancestor
111470136|NCT03817320|Micronutrients|micronutrients|mesh-ancestor
111470137|NCT03817320|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111470138|NCT03817320|Tubulin Modulators|tubulin modulators|mesh-ancestor
111470139|NCT03817320|Antimitotic Agents|antimitotic agents|mesh-ancestor
111470140|NCT03817320|Mitosis Modulators|mitosis modulators|mesh-ancestor
111470141|NCT03817320|Protease Inhibitors|protease inhibitors|mesh-ancestor
111470142|NCT03684018|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111470143|NCT03684018|Immunologic Factors|immunologic factors|mesh-ancestor
111470144|NCT03684018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111470145|NCT03580356|Omalizumab|omalizumab|mesh-list
111470146|NCT03580356|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111470147|NCT03580356|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111470148|NCT03580356|Respiratory System Agents|respiratory system agents|mesh-ancestor
111470149|NCT03575052|Pimavanserin|pimavanserin|mesh-list
111470150|NCT03575052|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111470151|NCT03575052|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111470152|NCT03575052|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111470153|NCT03575052|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111470154|NCT03575052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111470155|NCT03575052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111470156|NCT03575052|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111470157|NCT03575052|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111470158|NCT03575052|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111470159|NCT03575052|Serotonin Agents|serotonin agents|mesh-ancestor
111470160|NCT03575052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111470161|NCT03575052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111470162|NCT03556020|VIP-ELP fusion molecule PB1046|vip-elp fusion molecule pb1046|mesh-list
111470163|NCT03556020|Vasodilator Agents|vasodilator agents|mesh-ancestor
111470164|NCT01677546|Insulin|insulin|mesh-list
111470165|NCT01677546|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111470166|NCT01677546|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111470167|NCT01677546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111470168|NCT04403724|Fentanyl|fentanyl|mesh-list
111470169|NCT04403724|Morphine|morphine|mesh-list
111470170|NCT04403724|Bupivacaine|bupivacaine|mesh-list
111470171|NCT04403724|Anesthetics, Local|anesthetics, local|mesh-ancestor
111470172|NCT04403724|Anesthetics|anesthetics|mesh-ancestor
111470173|NCT04403724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111470174|NCT04403724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111470175|NCT04403724|Sensory System Agents|sensory system agents|mesh-ancestor
111470176|NCT04403724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111470177|NCT04403724|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111470178|NCT04403724|Narcotics|narcotics|mesh-ancestor
111470179|NCT04403724|Analgesics|analgesics|mesh-ancestor
111470180|NCT04403724|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111470181|NCT04403724|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111470182|NCT04403724|Anesthetics, General|anesthetics, general|mesh-ancestor
111470183|NCT04403568|Ursolic acid|ursolic acid|mesh-list
111470184|NCT04403568|Curcumin|curcumin|mesh-list
111470185|NCT04403568|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111470186|NCT04403568|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111470187|NCT04403568|Analgesics|analgesics|mesh-ancestor
111470188|NCT04403568|Sensory System Agents|sensory system agents|mesh-ancestor
111470189|NCT04403568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111470190|NCT04403568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111470191|NCT04403568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111470192|NCT04403568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111470193|NCT04403568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111470194|NCT04403568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111470195|NCT04403568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111470196|NCT04403568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111470197|NCT04403568|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111470198|NCT04403568|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111470199|NCT03564756|Ascorbic Acid|ascorbic acid|mesh-list
111470200|NCT03564756|Vitamins|vitamins|mesh-ancestor
111470201|NCT03564756|Micronutrients|micronutrients|mesh-ancestor
111470202|NCT03564756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111470203|NCT03564756|Antioxidants|antioxidants|mesh-ancestor
111470204|NCT03564756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111470205|NCT03564756|Protective Agents|protective agents|mesh-ancestor
111470206|NCT03462966|Rifaximin|rifaximin|mesh-list
111470207|NCT03462966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111470208|NCT03462966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111470209|NCT03462966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111470210|NCT03458598|Analgesics, Opioid|analgesics, opioid|mesh-list
111470211|NCT03458598|Narcotics|narcotics|mesh-ancestor
111470212|NCT03458598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111470214|NCT03458598|Analgesics|analgesics|mesh-ancestor
111470215|NCT03458598|Sensory System Agents|sensory system agents|mesh-ancestor
111470216|NCT03458598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111470217|NCT03791736|Octreotide|octreotide|mesh-list
111470218|NCT03791736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111470219|NCT03791736|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111470220|NCT03791736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111470221|NCT01679964|Raltegravir Potassium|raltegravir potassium|mesh-list
111470222|NCT01679964|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111470223|NCT01679964|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111470224|NCT01679964|Antiviral Agents|antiviral agents|mesh-ancestor
111470225|NCT01679964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111470226|NCT01679964|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111470227|NCT01679964|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111470228|NCT01679964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111470229|NCT01679964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111470230|NCT03524898|Paclitaxel|paclitaxel|mesh-list
111470231|NCT03524898|Gemcitabine|gemcitabine|mesh-list
111470232|NCT03524898|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111470233|NCT03524898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111470234|NCT03524898|Tubulin Modulators|tubulin modulators|mesh-ancestor
111470235|NCT03524898|Antimitotic Agents|antimitotic agents|mesh-ancestor
111470236|NCT03524898|Mitosis Modulators|mitosis modulators|mesh-ancestor
111470237|NCT03524898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111470238|NCT03524898|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111470239|NCT03524898|Antimetabolites|antimetabolites|mesh-ancestor
111470240|NCT03524820|Cetuximab|cetuximab|mesh-list
111470241|NCT03524820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111470242|NCT03524820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111470243|NCT03524508|Fluorouracil|fluorouracil|mesh-list
111470244|NCT03524508|Irinotecan|irinotecan|mesh-list
111470245|NCT03524508|Antimetabolites|antimetabolites|mesh-ancestor
111470246|NCT03524508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111470247|NCT03524508|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111470248|NCT03524508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111470249|NCT03524508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111470250|NCT03524508|Immunologic Factors|immunologic factors|mesh-ancestor
111470251|NCT03524508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111470252|NCT03524508|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111470253|NCT03524508|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111470254|NCT03524508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111470255|NCT03457818|Denosumab|denosumab|mesh-list
111470256|NCT03457818|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111470257|NCT03457818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111470258|NCT01676844|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111470259|NCT01676844|Potassium phosphate|potassium phosphate|mesh-list
111470260|NCT01676844|Cariostatic Agents|cariostatic agents|mesh-ancestor
111470261|NCT01676844|Protective Agents|protective agents|mesh-ancestor
111470262|NCT01676844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111470263|NCT04403334|Moxifloxacin|moxifloxacin|mesh-list
111470264|NCT04403334|Levofloxacin|levofloxacin|mesh-list
111470265|NCT04403334|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111470266|NCT04403334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111470267|NCT04403334|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111470268|NCT04403334|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111470269|NCT04403334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111470270|NCT04403334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111470271|NCT04403334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111470272|NCT04403334|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111470273|NCT04403334|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111470274|NCT04403334|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111470275|NCT03779646|Bisoprolol|bisoprolol|mesh-list
111470276|NCT03779646|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111470277|NCT03779646|Sympatholytics|sympatholytics|mesh-ancestor
111470278|NCT03779646|Autonomic Agents|autonomic agents|mesh-ancestor
111470279|NCT03779646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111470280|NCT03779646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111470281|NCT03779646|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
111470282|NCT03779646|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111470283|NCT03779646|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111470284|NCT03779646|Adrenergic Agents|adrenergic agents|mesh-ancestor
111470285|NCT03779646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111470286|NCT03779646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111470288|NCT03774732|Cisplatin|cisplatin|mesh-list
111470289|NCT03774732|Carboplatin|carboplatin|mesh-list
111470290|NCT03774732|Pembrolizumab|pembrolizumab|mesh-list
111470291|NCT03774732|Pemetrexed|pemetrexed|mesh-list
111470292|NCT03774732|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111470293|NCT03774732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111470294|NCT03774732|Tubulin Modulators|tubulin modulators|mesh-ancestor
111470295|NCT03774732|Antimitotic Agents|antimitotic agents|mesh-ancestor
111470296|NCT03774732|Mitosis Modulators|mitosis modulators|mesh-ancestor
111470297|NCT03774732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111470298|NCT03774732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111470299|NCT03774732|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111470300|NCT03774732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111470301|NCT03774732|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111470302|NCT03774732|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111470303|NCT05347134|Gemcitabine|gemcitabine|mesh-list
111470304|NCT05347134|Capecitabine|capecitabine|mesh-list
111470305|NCT05347134|Vinorelbine|vinorelbine|mesh-list
111470306|NCT05347134|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111470307|NCT05347134|Antimetabolites|antimetabolites|mesh-ancestor
111470308|NCT05347134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111470309|NCT05347134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111470310|NCT05347134|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111470311|NCT05347134|Tubulin Modulators|tubulin modulators|mesh-ancestor
111470312|NCT05347134|Antimitotic Agents|antimitotic agents|mesh-ancestor
111470313|NCT05347134|Mitosis Modulators|mitosis modulators|mesh-ancestor
111470314|NCT00089778|Aldesleukin|aldesleukin|mesh-list
111470315|NCT00089778|Interleukin-2|interleukin-2|mesh-list
111470316|NCT00089778|Mitogens|mitogens|mesh-list
111470317|NCT00089778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111470318|NCT00089778|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111470319|NCT00089778|Analgesics|analgesics|mesh-ancestor
111470320|NCT00089778|Sensory System Agents|sensory system agents|mesh-ancestor
111470321|NCT00089778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111470322|NCT00089778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111470323|NCT00089778|Mitosis Modulators|mitosis modulators|mesh-ancestor
111470324|NCT00089778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111470325|NCT00089778|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111470326|NCT00089778|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111470327|NCT00089778|Antiviral Agents|antiviral agents|mesh-ancestor
111470328|NCT00089778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111470329|NCT00089544|Thalidomide|thalidomide|mesh-list
111470330|NCT00089544|Doxorubicin|doxorubicin|mesh-list
111470331|NCT00089544|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111470332|NCT00089544|Ifosfamide|ifosfamide|mesh-list
111470333|NCT00089544|Isophosphamide mustard|isophosphamide mustard|mesh-list
111470334|NCT00089544|Dacarbazine|dacarbazine|mesh-list
111470335|NCT00089544|Imidazole|imidazole|mesh-list
111470336|NCT00089544|Lenograstim|lenograstim|mesh-list
111470337|NCT00089544|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111470338|NCT00089544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111470339|NCT00089544|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111470340|NCT00089544|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111470341|NCT00089544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111470342|NCT00089544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111470343|NCT00089544|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111470344|NCT00089544|Immunologic Factors|immunologic factors|mesh-ancestor
111470345|NCT00089544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111470346|NCT00089544|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111470347|NCT00089544|Alkylating Agents|alkylating agents|mesh-ancestor
111470348|NCT00089544|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111470349|NCT00089544|Leprostatic Agents|leprostatic agents|mesh-ancestor
111470350|NCT00089544|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111470351|NCT00089544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111470352|NCT00089544|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111470353|NCT00089544|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111470354|NCT00089544|Growth Substances|growth substances|mesh-ancestor
111470355|NCT00089544|Growth Inhibitors|growth inhibitors|mesh-ancestor
111470356|NCT00089076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111470357|NCT00089076|Ipilimumab|ipilimumab|mesh-list
111470358|NCT00089076|Antibodies|antibodies|mesh-list
111470359|NCT00089076|Immunoglobulins|immunoglobulins|mesh-list
111470360|NCT00089076|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111470361|NCT00089076|Immunologic Factors|immunologic factors|mesh-ancestor
111470362|NCT00089076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111470363|NCT00089076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111470364|NCT00089076|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111470365|NCT00089076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111470366|NCT03773562|Erenumab|erenumab|mesh-list
111470367|NCT03773562|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
111470368|NCT03773562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111470369|NCT03773562|Analgesics|analgesics|mesh-ancestor
111470370|NCT03773562|Sensory System Agents|sensory system agents|mesh-ancestor
111470371|NCT03773562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111470372|NCT03773562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111470373|NCT00088374|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
111470374|NCT00088374|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111470375|NCT00088374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111470376|NCT00087594|Ribavirin|ribavirin|mesh-list
111470377|NCT00087594|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
111470378|NCT00087594|Antimetabolites|antimetabolites|mesh-ancestor
111470379|NCT00087594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111470380|NCT00087594|Antiviral Agents|antiviral agents|mesh-ancestor
111470381|NCT00087594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111470382|NCT03770286|Fluorides|fluorides|mesh-list
111470383|NCT03770286|Fluorides, Topical|fluorides, topical|mesh-list
111470384|NCT03770286|Cariostatic Agents|cariostatic agents|mesh-ancestor
111470385|NCT03770286|Protective Agents|protective agents|mesh-ancestor
111470386|NCT03770286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111470387|NCT00087516|Metformin|metformin|mesh-list
111470388|NCT00087516|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111470389|NCT00087516|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111470390|NCT00087516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111470391|NCT00087516|Incretins|incretins|mesh-ancestor
111470392|NCT00087516|Hormones|hormones|mesh-ancestor
111470393|NCT00087516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111470394|NCT00087516|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111470395|NCT00087516|Protease Inhibitors|protease inhibitors|mesh-ancestor
111470396|NCT00087516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111470397|NCT00087516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111470398|NCT03768960|Daratumumab|daratumumab|mesh-list
111470399|NCT03768960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111470400|NCT00087126|Topotecan|topotecan|mesh-list
111470401|NCT00087126|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111470402|NCT00087126|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111470403|NCT00087126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111470404|NCT00087126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111470405|NCT00087126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111470406|NCT00086346|Cyclosporine|cyclosporine|mesh-list
111470407|NCT00086346|Sirolimus|sirolimus|mesh-list
111470408|NCT00086346|Tacrolimus|tacrolimus|mesh-list
111470409|NCT00086346|Cyclosporins|cyclosporins|mesh-list
111470410|NCT00086346|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111470411|NCT00086346|Immunologic Factors|immunologic factors|mesh-ancestor
111470412|NCT00086346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111470413|NCT00086346|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111470414|NCT00086346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111470415|NCT00086346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111470416|NCT00086346|Antifungal Agents|antifungal agents|mesh-ancestor
111470417|NCT00086346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111470418|NCT00086346|Dermatologic Agents|dermatologic agents|mesh-ancestor
111470419|NCT00086346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111470420|NCT00086346|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111470421|NCT00086346|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111470422|NCT00086346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111470423|NCT00085566|Everolimus|everolimus|mesh-list
111470424|NCT00085566|Gefitinib|gefitinib|mesh-list
111470425|NCT00085566|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111470426|NCT00085566|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111470427|NCT00085566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111470428|NCT00085566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111470429|NCT00085566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111470430|NCT00085566|Immunologic Factors|immunologic factors|mesh-ancestor
111470431|NCT00085566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111470432|NCT00085566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111470433|NCT00085098|Cyclophosphamide|cyclophosphamide|mesh-list
111470434|NCT00085098|Cisplatin|cisplatin|mesh-list
111470435|NCT00085098|Carboplatin|carboplatin|mesh-list
111470436|NCT00085098|Etoposide|etoposide|mesh-list
111470437|NCT00085098|Lenograstim|lenograstim|mesh-list
111470438|NCT00085098|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111470440|NCT00085098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111470441|NCT00085098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111470442|NCT00085098|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111470443|NCT00085098|Alkylating Agents|alkylating agents|mesh-ancestor
111470444|NCT00085098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111470445|NCT00085098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111470446|NCT00085098|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111470447|NCT00085098|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111470448|NCT00085098|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111470449|NCT00085098|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111470450|NCT00085098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111470451|NCT00085098|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111470452|NCT00084864|Calcitriol|calcitriol|mesh-list
111470453|NCT00084864|Dexamethasone|dexamethasone|mesh-list
111470454|NCT00084864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111470455|NCT00084864|Antiemetics|antiemetics|mesh-ancestor
111470456|NCT00084864|Autonomic Agents|autonomic agents|mesh-ancestor
111470457|NCT00084864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111470458|NCT00084864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111470459|NCT00084864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111470460|NCT00084864|Glucocorticoids|glucocorticoids|mesh-ancestor
111470461|NCT00084864|Hormones|hormones|mesh-ancestor
111470462|NCT00084864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111470463|NCT00084864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111470464|NCT00084864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111470465|NCT00084864|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111470466|NCT00084864|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
111470467|NCT00084864|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111470468|NCT00084864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111470469|NCT00084864|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111470470|NCT00084864|Vitamins|vitamins|mesh-ancestor
111470471|NCT00084864|Micronutrients|micronutrients|mesh-ancestor
111470472|NCT00084864|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111470473|NCT01677702|Lactoferrin|lactoferrin|mesh-list
111470474|NCT01677702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111470475|NCT01473108|Eplerenone|eplerenone|mesh-list
111470476|NCT01473108|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
111470477|NCT01473108|Hormone Antagonists|hormone antagonists|mesh-ancestor
111470478|NCT01473108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111470479|NCT01473108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111470480|NCT01473108|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
111470481|NCT01473108|Diuretics|diuretics|mesh-ancestor
111470482|NCT01473108|Natriuretic Agents|natriuretic agents|mesh-ancestor
111470483|NCT01473108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111470484|NCT00084318|Docetaxel|docetaxel|mesh-list
111470485|NCT00084318|Cetuximab|cetuximab|mesh-list
111470486|NCT00084318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111470487|NCT00084318|Tubulin Modulators|tubulin modulators|mesh-ancestor
111470488|NCT00084318|Antimitotic Agents|antimitotic agents|mesh-ancestor
111470489|NCT00084318|Mitosis Modulators|mitosis modulators|mesh-ancestor
111470490|NCT00084318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111470491|NCT00084318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111470492|NCT00083616|Panitumumab|panitumumab|mesh-list
111470493|NCT00083616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111470494|NCT00083616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111470495|NCT00083226|Doxorubicin|doxorubicin|mesh-list
111470496|NCT00083226|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111470497|NCT00083226|Bortezomib|bortezomib|mesh-list
111470498|NCT00083226|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111470499|NCT00083226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111470500|NCT00083226|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111470501|NCT00083226|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111470502|NCT00083226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111470503|NCT00083226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111470504|NCT00082758|Interleukin-2|interleukin-2|mesh-list
111470505|NCT00082758|Denileukin diftitox|denileukin diftitox|mesh-list
111470506|NCT00082758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111470507|NCT00082758|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111470508|NCT00082758|Analgesics|analgesics|mesh-ancestor
111470509|NCT00082758|Sensory System Agents|sensory system agents|mesh-ancestor
111470510|NCT00082758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111470511|NCT00082758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111470512|NCT03438318|Atezolizumab|atezolizumab|mesh-list
111470513|NCT03438318|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111470514|NCT03438318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111470515|NCT03438318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111470516|NCT03438318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111470517|NCT03087942|Indoleacetic Acids|indoleacetic acids|mesh-list
111470518|NCT03087942|Plant Growth Regulators|plant growth regulators|mesh-ancestor
111470519|NCT03087942|Growth Substances|growth substances|mesh-ancestor
111470520|NCT03087942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111470521|NCT01678092|Omalizumab|omalizumab|mesh-list
111470522|NCT01678092|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111470523|NCT01678092|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111470524|NCT01678092|Respiratory System Agents|respiratory system agents|mesh-ancestor
111470525|NCT04402320|Midazolam|midazolam|mesh-list
111470526|NCT04402320|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111470527|NCT04402320|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111470528|NCT04402320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111470529|NCT04402320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111470530|NCT04402320|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111470531|NCT04402320|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111470532|NCT04402320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111470533|NCT04402320|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111470534|NCT04402320|Anesthetics, General|anesthetics, general|mesh-ancestor
111470535|NCT04402320|Anesthetics|anesthetics|mesh-ancestor
111470536|NCT04402320|GABA Modulators|gaba modulators|mesh-ancestor
111470537|NCT04402320|GABA Agents|gaba agents|mesh-ancestor
111470538|NCT04402320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111470539|NCT04402320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111470540|NCT03436056|Pembrolizumab|pembrolizumab|mesh-list
111470541|NCT03436056|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111470542|NCT03436056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111470543|NCT03436056|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111470544|NCT03436056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111470545|NCT03088176|Trametinib|trametinib|mesh-list
111470546|NCT03088176|Dabrafenib|dabrafenib|mesh-list
111470547|NCT03088176|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
111470548|NCT03088176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111470549|NCT03088176|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111470550|NCT03088176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111470551|NCT03088176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111470552|NCT03088176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111470553|NCT01678404|Rituximab|rituximab|mesh-list
111470554|NCT01678404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111470555|NCT01678404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111470556|NCT01678404|Immunologic Factors|immunologic factors|mesh-ancestor
111470557|NCT01678404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111470558|NCT01678404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111470559|NCT03087864|Paclitaxel|paclitaxel|mesh-list
111470560|NCT03087864|Carboplatin|carboplatin|mesh-list
111470561|NCT03087864|Atezolizumab|atezolizumab|mesh-list
111470562|NCT03087864|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111470563|NCT03087864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111470564|NCT03087864|Tubulin Modulators|tubulin modulators|mesh-ancestor
111470565|NCT03087864|Antimitotic Agents|antimitotic agents|mesh-ancestor
111470566|NCT03087864|Mitosis Modulators|mitosis modulators|mesh-ancestor
111470567|NCT03087864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111470568|NCT03087864|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111470569|NCT03087864|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111470570|NCT01678716|Micronutrients|micronutrients|mesh-list
111470571|NCT01678716|Trace Elements|trace elements|mesh-list
111470572|NCT01678716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111470573|NCT00081510|Anastrozole|anastrozole|mesh-list
111470574|NCT00081510|Lonafarnib|lonafarnib|mesh-list
111470575|NCT00081510|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111470576|NCT00081510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111470577|NCT00081510|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111470578|NCT00081510|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111470579|NCT00081510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111470580|NCT00081510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111470581|NCT00081510|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111470582|NCT00081510|Hormone Antagonists|hormone antagonists|mesh-ancestor
111470583|NCT00081510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111470584|NCT00081510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111470585|NCT00088452|Lamotrigine|lamotrigine|mesh-list
111470586|NCT00088452|Valproic Acid|valproic acid|mesh-list
111470587|NCT00088452|Ethosuximide|ethosuximide|mesh-list
111470589|NCT00088452|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111470590|NCT00088452|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111470591|NCT00088452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111470592|NCT00088452|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111470593|NCT00088452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111470594|NCT00088452|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111470595|NCT00088452|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111470596|NCT00088452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111470597|NCT00088452|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111470598|NCT00088452|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111470599|NCT00088452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111470600|NCT00088452|GABA Agents|gaba agents|mesh-ancestor
111470601|NCT00088452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111470602|NCT00088452|Antimanic Agents|antimanic agents|mesh-ancestor
111470603|NCT01679106|Fentanyl|fentanyl|mesh-list
111470604|NCT01679106|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111470605|NCT01679106|Narcotics|narcotics|mesh-ancestor
111470606|NCT01679106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111470607|NCT01679106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111470608|NCT01679106|Analgesics|analgesics|mesh-ancestor
111470609|NCT01679106|Sensory System Agents|sensory system agents|mesh-ancestor
111470610|NCT01679106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111470611|NCT01679106|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111470612|NCT01679106|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111470613|NCT01679106|Anesthetics, General|anesthetics, general|mesh-ancestor
111470614|NCT01679106|Anesthetics|anesthetics|mesh-ancestor
111470615|NCT04403100|Ritonavir|ritonavir|mesh-list
111470616|NCT04403100|Lopinavir|lopinavir|mesh-list
111470617|NCT04403100|Hydroxychloroquine|hydroxychloroquine|mesh-list
111470618|NCT04403100|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111470619|NCT04403100|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111470620|NCT04403100|Protease Inhibitors|protease inhibitors|mesh-ancestor
111470621|NCT04403100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111470622|NCT04403100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111470623|NCT04403100|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111470624|NCT04403100|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111470625|NCT04403100|Antiviral Agents|antiviral agents|mesh-ancestor
111470626|NCT04403100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111470627|NCT04403100|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111470628|NCT04403100|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111470629|NCT04403100|Antimalarials|antimalarials|mesh-ancestor
111470630|NCT04403100|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111470631|NCT04403100|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111470632|NCT04403100|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111470633|NCT03086538|Pemetrexed|pemetrexed|mesh-list
111470634|NCT03086538|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111470635|NCT03086538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111470636|NCT03086538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111470637|NCT03086538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111470638|NCT03086538|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111470639|NCT03086538|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111470640|NCT03086538|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111470641|NCT03473730|Daratumumab|daratumumab|mesh-list
111470642|NCT03473730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111470643|NCT03081858|Paclitaxel|paclitaxel|mesh-list
111470644|NCT03081858|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111470645|NCT03081858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111470646|NCT03081858|Tubulin Modulators|tubulin modulators|mesh-ancestor
111470647|NCT03081858|Antimitotic Agents|antimitotic agents|mesh-ancestor
111470648|NCT03081858|Mitosis Modulators|mitosis modulators|mesh-ancestor
110120604|NCT01907165|Copper|copper|mesh-list
111470649|NCT03081858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111470650|NCT01679340|Oxaliplatin|oxaliplatin|mesh-list
111470651|NCT01679340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111470652|NCT01679574|Metformin|metformin|mesh-list
111470653|NCT01679574|Letrozole|letrozole|mesh-list
111470654|NCT01679574|Clomiphene|clomiphene|mesh-list
111470655|NCT01679574|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111470656|NCT01679574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111470657|NCT01679574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111470658|NCT01679574|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111470659|NCT01679574|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111470660|NCT01679574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111470661|NCT01679574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111470662|NCT01679574|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111470663|NCT01679574|Hormone Antagonists|hormone antagonists|mesh-ancestor
111470664|NCT01679574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111470665|NCT01679574|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111470666|NCT01679574|Fertility Agents|fertility agents|mesh-ancestor
111470667|NCT01679574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111470668|NCT01679574|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111470669|NCT01679574|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111470670|NCT01679652|Nebivolol|nebivolol|mesh-list
111470671|NCT01679652|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111470672|NCT01679652|Vasodilator Agents|vasodilator agents|mesh-ancestor
111470673|NCT01679652|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
111470674|NCT01679652|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111470675|NCT01679652|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111470676|NCT01679652|Adrenergic Agents|adrenergic agents|mesh-ancestor
111470677|NCT01679652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111470678|NCT01679652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111470679|NCT01679652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111470680|NCT04761744|Nivolumab|nivolumab|mesh-list
111470681|NCT04761744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111470682|NCT04761744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111470683|NCT04761744|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111470684|NCT04761744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111470685|NCT03089658|Avelumab|avelumab|mesh-list
111470686|NCT03089658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111470687|NCT03089658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111470688|NCT03417492|Sildenafil Citrate|sildenafil citrate|mesh-list
111470689|NCT03417492|Citric Acid|citric acid|mesh-list
111470690|NCT03417492|Sodium Citrate|sodium citrate|mesh-list
111470691|NCT03417492|Anticoagulants|anticoagulants|mesh-ancestor
111470692|NCT03417492|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
111470693|NCT03417492|Chelating Agents|chelating agents|mesh-ancestor
111470694|NCT03417492|Sequestering Agents|sequestering agents|mesh-ancestor
111470695|NCT03417492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111470696|NCT03417492|Vasodilator Agents|vasodilator agents|mesh-ancestor
111470697|NCT03417492|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111470698|NCT03417492|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111470699|NCT03417492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111470700|NCT03417492|Urological Agents|urological agents|mesh-ancestor
111470701|NCT03080766|Decitabine|decitabine|mesh-list
111470702|NCT03080766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111470703|NCT03080766|Antimetabolites|antimetabolites|mesh-ancestor
111470704|NCT03080766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111470705|NCT03080766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111470706|NCT03080766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111470707|NCT03088722|Contraceptive Agents|contraceptive agents|mesh-list
111470708|NCT03088722|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111470709|NCT03088722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111470710|NCT03088644|(18)F-JNJ-64413739|(18)f-jnj-64413739|mesh-list
111470711|NCT03088644|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111470712|NCT03088644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111470713|NCT03088254|Amlodipine|amlodipine|mesh-list
111470714|NCT03088254|Telmisartan|telmisartan|mesh-list
111470715|NCT03088254|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111470716|NCT03088254|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111470717|NCT03088254|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111470718|NCT03088254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111470719|NCT03088254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111470720|NCT03088254|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111470721|NCT03088254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111470722|NCT03088254|Vasodilator Agents|vasodilator agents|mesh-ancestor
111470723|NCT03088254|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111470724|NCT03088254|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111470725|NCT03088254|Antimetabolites|antimetabolites|mesh-ancestor
111470726|NCT03088254|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111470727|NCT03088254|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111470728|NCT03088254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111470729|NCT03088254|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111470730|NCT03088254|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111470731|NCT05684718|Itraconazole|itraconazole|mesh-list
111470732|NCT05684718|Rifabutin|rifabutin|mesh-list
111470733|NCT05684718|Antifungal Agents|antifungal agents|mesh-ancestor
111470734|NCT05684718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111470735|NCT05684718|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111470736|NCT05684718|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111470737|NCT05684718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111470738|NCT05684718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111470739|NCT05684718|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111470740|NCT05684718|Hormone Antagonists|hormone antagonists|mesh-ancestor
111470741|NCT05684718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111470742|NCT05684718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111470743|NCT05684718|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111470744|NCT05684718|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111470745|NCT05684718|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111470746|NCT05684718|Antitubercular Agents|antitubercular agents|mesh-ancestor
111470747|NCT05684484|Salicylic Acid|salicylic acid|mesh-list
111470748|NCT05684484|Salicylates|salicylates|mesh-list
111470749|NCT05684484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111470750|NCT05684484|Antifungal Agents|antifungal agents|mesh-ancestor
111470751|NCT05684484|Keratolytic Agents|keratolytic agents|mesh-ancestor
111470752|NCT05684484|Dermatologic Agents|dermatologic agents|mesh-ancestor
111470753|NCT05684484|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111470754|NCT05684484|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111470755|NCT05684484|Analgesics|analgesics|mesh-ancestor
111470756|NCT05684484|Sensory System Agents|sensory system agents|mesh-ancestor
111470757|NCT05684484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111470758|NCT05684484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111470759|NCT05684484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111470760|NCT05684484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111470761|NCT05684484|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111470762|NCT05684484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111470763|NCT05684484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111470764|NCT03086382|Lacosamide|lacosamide|mesh-list
111470765|NCT03086382|Anticonvulsants|anticonvulsants|mesh-ancestor
111470766|NCT03086382|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111470767|NCT03086382|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111470768|NCT03086382|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111470769|NCT03086382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111470770|NCT03086226|Itraconazole|itraconazole|mesh-list
111470771|NCT03086226|Antifungal Agents|antifungal agents|mesh-ancestor
111470772|NCT03086226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111470773|NCT03086226|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111470774|NCT03086226|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111470775|NCT03086226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111470776|NCT03086226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111470777|NCT03086226|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111470778|NCT03086226|Hormone Antagonists|hormone antagonists|mesh-ancestor
111470779|NCT03086226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111470780|NCT03086226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111470781|NCT03086226|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111470782|NCT03085992|Bevacizumab|bevacizumab|mesh-list
111470783|NCT03085992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111470784|NCT03085992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111470785|NCT03085992|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111470786|NCT03085992|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111470787|NCT03085992|Growth Substances|growth substances|mesh-ancestor
111470788|NCT03085992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111470789|NCT03085992|Growth Inhibitors|growth inhibitors|mesh-ancestor
111470790|NCT03086070|Omeprazole|omeprazole|mesh-list
111470791|NCT03086070|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111470792|NCT03086070|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111470793|NCT03086070|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111470794|NCT03086070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111470795|NCT03086070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111470796|NCT05688306|Oprelvekin|oprelvekin|mesh-list
111470797|NCT05688306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111470798|NCT03086148|Ketamine|ketamine|mesh-list
111470799|NCT03086148|Analgesics|analgesics|mesh-ancestor
111470800|NCT03086148|Sensory System Agents|sensory system agents|mesh-ancestor
111470801|NCT03086148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111470802|NCT03086148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111470803|NCT03086148|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111470804|NCT03086148|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111470805|NCT03086148|Anesthetics, General|anesthetics, general|mesh-ancestor
111470806|NCT03086148|Anesthetics|anesthetics|mesh-ancestor
111470807|NCT03086148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111194933|NCT03025113|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111470808|NCT03086148|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111470809|NCT03086148|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111470810|NCT03086148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111470811|NCT03086148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111470812|NCT03359538|Sirolimus|sirolimus|mesh-list
111470813|NCT03359538|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111470814|NCT03359538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111470815|NCT03359538|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111470816|NCT03359538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111470817|NCT03359538|Antifungal Agents|antifungal agents|mesh-ancestor
111470818|NCT03359538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111470819|NCT03359538|Immunologic Factors|immunologic factors|mesh-ancestor
111470820|NCT03359538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111470821|NCT05345808|Triamcinolone|triamcinolone|mesh-list
111470822|NCT05345808|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
111470823|NCT05345808|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
111470824|NCT05345808|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
111470825|NCT05345808|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111470826|NCT05345808|Glucocorticoids|glucocorticoids|mesh-ancestor
111470827|NCT05345808|Hormones|hormones|mesh-ancestor
111470828|NCT05345808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111470829|NCT05345808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111470830|NCT05345808|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111470831|NCT05345808|Immunologic Factors|immunologic factors|mesh-ancestor
111470832|NCT05345808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111470833|NCT05345808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111470834|NCT02336958|Ropivacaine|ropivacaine|mesh-list
111470835|NCT02336958|Prilocaine|prilocaine|mesh-list
111470836|NCT02336958|Anesthetics, Local|anesthetics, local|mesh-ancestor
111470837|NCT02336958|Anesthetics|anesthetics|mesh-ancestor
111470838|NCT02336958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110123868|NCT01935869|Petrolatum|petrolatum|mesh-list
111470839|NCT02336958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111470840|NCT02336958|Sensory System Agents|sensory system agents|mesh-ancestor
111470841|NCT02336958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111470842|NCT03085368|Trastuzumab|trastuzumab|mesh-list
111470843|NCT03085368|Lapatinib|lapatinib|mesh-list
111470844|NCT03085368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111470845|NCT03085368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111470846|NCT03085368|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111470847|NCT03085368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111470848|NCT03085368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111470849|NCT03085290|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111470850|NCT03085290|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111470851|NCT05687760|Calcium|calcium|mesh-list
111470852|NCT05687760|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111470853|NCT05687760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111470854|NCT03084978|Anesthetics|anesthetics|mesh-list
111470855|NCT03084978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111470856|NCT03084978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111470857|NCT03084588|Methadone|methadone|mesh-list
111470858|NCT03084588|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111470859|NCT03084588|Narcotics|narcotics|mesh-ancestor
111470860|NCT03084588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111470861|NCT03084588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111470862|NCT03084588|Analgesics|analgesics|mesh-ancestor
111470863|NCT03084588|Sensory System Agents|sensory system agents|mesh-ancestor
111470864|NCT03084588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111470865|NCT03084588|Antitussive Agents|antitussive agents|mesh-ancestor
111470866|NCT03084588|Respiratory System Agents|respiratory system agents|mesh-ancestor
111470867|NCT05345574|Dexmedetomidine|dexmedetomidine|mesh-list
111470868|NCT05345574|Remifentanil|remifentanil|mesh-list
111470869|NCT05345574|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111470870|NCT05345574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111470871|NCT05345574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111470872|NCT05345574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111470873|NCT05345574|Analgesics|analgesics|mesh-ancestor
111470874|NCT05345574|Sensory System Agents|sensory system agents|mesh-ancestor
111470875|NCT05345574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111470876|NCT05345574|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111470877|NCT05345574|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111470878|NCT05345574|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111470879|NCT05345574|Adrenergic Agents|adrenergic agents|mesh-ancestor
111470880|NCT05345574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111470881|NCT05345574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111470882|NCT05345574|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111470883|NCT05345574|Narcotics|narcotics|mesh-ancestor
111470884|NCT05598606|Zoledronic Acid|zoledronic acid|mesh-list
111470885|NCT05598606|Denosumab|denosumab|mesh-list
111470886|NCT05598606|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111470887|NCT05598606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111470888|NCT04400916|Tranexamic Acid|tranexamic acid|mesh-list
111470889|NCT04400916|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111470890|NCT04400916|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111470891|NCT04400916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111470892|NCT04400916|Hemostatics|hemostatics|mesh-ancestor
111470893|NCT04400916|Coagulants|coagulants|mesh-ancestor
111470894|NCT05571072|Analgesics, Opioid|analgesics, opioid|mesh-list
111470895|NCT05571072|Narcotics|narcotics|mesh-ancestor
111470896|NCT05571072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111470897|NCT05571072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111470898|NCT05571072|Analgesics|analgesics|mesh-ancestor
111470899|NCT05571072|Sensory System Agents|sensory system agents|mesh-ancestor
111470900|NCT05571072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111470901|NCT03832452|Moxifloxacin|moxifloxacin|mesh-list
111470902|NCT03832452|1-Deoxynojirimycin|1-deoxynojirimycin|mesh-list
111470903|NCT03832452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111470904|NCT03832452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111470905|NCT03832452|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111470906|NCT03832452|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111470907|NCT03832452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111470908|NCT03832452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111470909|NCT03832452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111470910|NCT03832452|Antiviral Agents|antiviral agents|mesh-ancestor
111470911|NCT04279938|Rituximab|rituximab|mesh-list
111470912|NCT04279938|Pembrolizumab|pembrolizumab|mesh-list
111470913|NCT04279938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111470914|NCT04279938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111470915|NCT04279938|Immunologic Factors|immunologic factors|mesh-ancestor
111470916|NCT04279938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111470917|NCT04279938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111470918|NCT04279938|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111470919|NCT04279938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111470920|NCT05686434|Osimertinib|osimertinib|mesh-list
111470921|NCT05686434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111470922|NCT05686434|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111470923|NCT05686434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111470924|NCT05686434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111470925|NCT03083184|Ethanol|ethanol|mesh-list
111470926|NCT03083184|Enoxaparin|enoxaparin|mesh-list
111470927|NCT03083184|Anticoagulants|anticoagulants|mesh-ancestor
111470928|NCT03083184|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111470929|NCT03083184|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111470930|NCT03083184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111470931|NCT03083184|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111470932|NCT03083184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111470933|NCT03083184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111470934|NCT03083184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111470935|NCT03338244|Azithromycin|azithromycin|mesh-list
111470936|NCT03338244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111470937|NCT03338244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111470938|NCT05512962|Triamcinolone|triamcinolone|mesh-list
111470939|NCT05512962|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
111470940|NCT05512962|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
111470941|NCT05512962|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
111470942|NCT05512962|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111470943|NCT05512962|Glucocorticoids|glucocorticoids|mesh-ancestor
111470944|NCT05512962|Hormones|hormones|mesh-ancestor
111470945|NCT05512962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111470946|NCT05512962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111470947|NCT05512962|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111470948|NCT05512962|Immunologic Factors|immunologic factors|mesh-ancestor
111470949|NCT05512962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111470950|NCT05512962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111470951|NCT03082092|Methylprednisolone|methylprednisolone|mesh-list
111470952|NCT03082092|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111470953|NCT03082092|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111470954|NCT03082092|Prednisolone|prednisolone|mesh-list
111470955|NCT03082092|Prednisolone acetate|prednisolone acetate|mesh-list
111470956|NCT03082092|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111470957|NCT03082092|Prednisolone phosphate|prednisolone phosphate|mesh-list
111470958|NCT03082092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111470959|NCT03082092|Antiemetics|antiemetics|mesh-ancestor
111470960|NCT03082092|Autonomic Agents|autonomic agents|mesh-ancestor
111470961|NCT03082092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111470962|NCT03082092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111470963|NCT03082092|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111470964|NCT03082092|Glucocorticoids|glucocorticoids|mesh-ancestor
111470965|NCT03082092|Hormones|hormones|mesh-ancestor
111470966|NCT03082092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111470967|NCT03082092|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111470968|NCT03082092|Protective Agents|protective agents|mesh-ancestor
111470969|NCT03082092|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111470970|NCT03082092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111470971|NCT04401852|Magnesium Sulfate|magnesium sulfate|mesh-list
111470972|NCT04401852|Analgesics|analgesics|mesh-ancestor
111470973|NCT04401852|Sensory System Agents|sensory system agents|mesh-ancestor
111470974|NCT04401852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111470975|NCT04401852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111470976|NCT04401852|Anesthetics|anesthetics|mesh-ancestor
111470977|NCT04401852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111470978|NCT04401852|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111470979|NCT04401852|Anticonvulsants|anticonvulsants|mesh-ancestor
111470980|NCT04401852|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111470981|NCT04401852|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111470982|NCT04401852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111470983|NCT04401852|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111470984|NCT04401852|Tocolytic Agents|tocolytic agents|mesh-ancestor
111470985|NCT04401852|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111470986|NCT03082482|Nicotine|nicotine|mesh-list
111470987|NCT03082482|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111470988|NCT03082482|Autonomic Agents|autonomic agents|mesh-ancestor
111470989|NCT03082482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111470990|NCT03082482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111470991|NCT03082482|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111470992|NCT03082482|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111470993|NCT03082482|Cholinergic Agents|cholinergic agents|mesh-ancestor
111470994|NCT03082482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111470995|NCT03082482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111470996|NCT03308916|Liver Extracts|liver extracts|mesh-list
111470997|NCT03308916|Hematinics|hematinics|mesh-ancestor
111470998|NCT03081702|Hydroxychloroquine|hydroxychloroquine|mesh-list
111470999|NCT03081702|Itraconazole|itraconazole|mesh-list
111471000|NCT03081702|Antimalarials|antimalarials|mesh-ancestor
111471001|NCT03081702|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111471002|NCT03081702|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111471003|NCT03081702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111471004|NCT03081702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111471005|NCT03081702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111471006|NCT03081702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111471007|NCT03081702|Antifungal Agents|antifungal agents|mesh-ancestor
111471008|NCT03081702|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111471009|NCT03081702|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111471010|NCT03081702|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111471011|NCT03081702|Hormone Antagonists|hormone antagonists|mesh-ancestor
111471012|NCT03081702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111471013|NCT03081702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111471014|NCT03081702|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111471015|NCT04399434|Insulin|insulin|mesh-list
111471016|NCT04399434|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111471017|NCT04399434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111471018|NCT04760574|Testosterone|testosterone|mesh-list
111471019|NCT04760574|Androgens|androgens|mesh-ancestor
111471020|NCT04760574|Hormones|hormones|mesh-ancestor
111471021|NCT04760574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111471022|NCT04760574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111471023|NCT03237390|Gemcitabine|gemcitabine|mesh-list
111471024|NCT03237390|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111471025|NCT03237390|Antimetabolites|antimetabolites|mesh-ancestor
111471026|NCT03237390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111471027|NCT03237390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111471028|NCT04400136|Lansoprazole|lansoprazole|mesh-list
111471029|NCT04400136|Dexlansoprazole|dexlansoprazole|mesh-list
111471030|NCT04400136|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111471031|NCT04400136|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111195163|NCT02985255|Docetaxel|docetaxel|mesh-list
111471032|NCT04400136|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111471033|NCT04400136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111471034|NCT04400136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111471035|NCT05338086|Vitamin D|vitamin d|mesh-list
111471036|NCT05338086|Denosumab|denosumab|mesh-list
111471037|NCT05338086|Calcium|calcium|mesh-list
111471038|NCT05338086|Vitamins|vitamins|mesh-ancestor
111471039|NCT05338086|Micronutrients|micronutrients|mesh-ancestor
111471040|NCT05338086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111471041|NCT05338086|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111471042|NCT05338086|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111471043|NCT04857840|Firibastat|firibastat|mesh-list
111471044|NCT04857840|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111471045|NCT04582968|Capecitabine|capecitabine|mesh-list
111471046|NCT04582968|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111471047|NCT04582968|Antimetabolites|antimetabolites|mesh-ancestor
111471048|NCT04582968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111471049|NCT04582968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111471050|NCT03261570|Digoxin|digoxin|mesh-list
111471051|NCT03261570|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
111471052|NCT03261570|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111471053|NCT03261570|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111471054|NCT03261570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111471055|NCT03261570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111471056|NCT03261570|Protective Agents|protective agents|mesh-ancestor
111471057|NCT03261570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111471058|NCT03261570|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111471059|NCT03261570|Cholinergic Agents|cholinergic agents|mesh-ancestor
111471060|NCT03261570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111471061|NCT03227562|Risperidone|risperidone|mesh-list
111471062|NCT03227562|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111471063|NCT03227562|Serotonin Agents|serotonin agents|mesh-ancestor
111471064|NCT03227562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111471065|NCT03227562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111471066|NCT03227562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111471067|NCT03227562|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111471068|NCT03227562|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111471069|NCT03227562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111471070|NCT03227562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111471071|NCT03227562|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111471072|NCT03227562|Dopamine Agents|dopamine agents|mesh-ancestor
111471073|NCT04278378|Folic Acid|folic acid|mesh-list
111471074|NCT04278378|Riboflavin|riboflavin|mesh-list
111471075|NCT04278378|Hematinics|hematinics|mesh-ancestor
111471076|NCT04278378|Vitamin B Complex|vitamin b complex|mesh-ancestor
111471077|NCT04278378|Vitamins|vitamins|mesh-ancestor
111471078|NCT04278378|Micronutrients|micronutrients|mesh-ancestor
111471079|NCT04278378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111471080|NCT04278378|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111471081|NCT04278378|Dermatologic Agents|dermatologic agents|mesh-ancestor
111471082|NCT04551144|Methyltestosterone|methyltestosterone|mesh-list
111471083|NCT04551144|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
111471084|NCT04551144|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
111471085|NCT04551144|Estradiol|estradiol|mesh-list
111471086|NCT04551144|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
111471087|NCT04551144|Testosterone|testosterone|mesh-list
111471088|NCT04551144|Testosterone undecanoate|testosterone undecanoate|mesh-list
111471089|NCT04551144|Testosterone enanthate|testosterone enanthate|mesh-list
111471090|NCT04551144|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
111471091|NCT04551144|Estrogens|estrogens|mesh-ancestor
111471092|NCT04551144|Hormones|hormones|mesh-ancestor
111471093|NCT04551144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111471094|NCT04551144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111471095|NCT04551144|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111471096|NCT04551144|Contraceptive Agents|contraceptive agents|mesh-ancestor
111471097|NCT04551144|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111471098|NCT04551144|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111471099|NCT04551144|Androgens|androgens|mesh-ancestor
111471100|NCT04551144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111471101|NCT04551144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111471102|NCT04551144|Anabolic Agents|anabolic agents|mesh-ancestor
111471103|NCT04785924|Imipenem|imipenem|mesh-list
111471104|NCT04785924|Relebactam|relebactam|mesh-list
111471105|NCT04785924|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111471106|NCT04785924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111471107|NCT04785924|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
111471108|NCT04785924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111479308|NCT05012631|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111471109|NCT04785924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111471110|NCT04451772|Upadacitinib|upadacitinib|mesh-list
111471111|NCT04451772|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
111471112|NCT04451772|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111471113|NCT04451772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111471114|NCT04451772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111471115|NCT04451772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111471116|NCT03831984|Bromfenac|bromfenac|mesh-list
111471117|NCT03831984|Hyaluronic Acid|hyaluronic acid|mesh-list
111471118|NCT03831984|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111471119|NCT03831984|Immunologic Factors|immunologic factors|mesh-ancestor
111471120|NCT03831984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111471121|NCT03831984|Viscosupplements|viscosupplements|mesh-ancestor
111471122|NCT03831984|Protective Agents|protective agents|mesh-ancestor
111471123|NCT03831984|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111471124|NCT03831984|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111471125|NCT03831984|Analgesics|analgesics|mesh-ancestor
111471126|NCT03831984|Sensory System Agents|sensory system agents|mesh-ancestor
111471127|NCT03831984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111471128|NCT03831984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111471129|NCT03831984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111471130|NCT02084706|Triamcinolone|triamcinolone|mesh-list
111471131|NCT02084706|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
111471132|NCT02084706|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
111471133|NCT02084706|Lidocaine|lidocaine|mesh-list
111471134|NCT02084706|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
111471135|NCT02084706|Anesthetics, Local|anesthetics, local|mesh-ancestor
111471136|NCT02084706|Anesthetics|anesthetics|mesh-ancestor
111471137|NCT02084706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111471138|NCT02084706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111471139|NCT02084706|Sensory System Agents|sensory system agents|mesh-ancestor
111471140|NCT02084706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111471141|NCT02084706|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111471142|NCT02084706|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111471143|NCT02084706|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111471144|NCT02084706|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111471145|NCT02084706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111471146|NCT02084706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111471147|NCT02084706|Glucocorticoids|glucocorticoids|mesh-ancestor
111471148|NCT02084706|Hormones|hormones|mesh-ancestor
111471149|NCT02084706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111471150|NCT02084706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111471151|NCT02084706|Immunologic Factors|immunologic factors|mesh-ancestor
111471152|NCT02084706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111471153|NCT04704024|Tenofovir|tenofovir|mesh-list
111471154|NCT04704024|Lamivudine|lamivudine|mesh-list
111471155|NCT04704024|Antiviral Agents|antiviral agents|mesh-ancestor
111471156|NCT04704024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111471157|NCT04704024|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111471158|NCT04704024|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111471159|NCT04704024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111471160|NCT04704024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111471161|NCT04704024|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111471162|NCT04704024|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111471163|NCT04433988|Pentoxifylline|pentoxifylline|mesh-list
111471164|NCT04433988|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111471165|NCT04433988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111471166|NCT04433988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111471167|NCT04433988|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111471168|NCT04433988|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111471169|NCT04433988|Protective Agents|protective agents|mesh-ancestor
111471170|NCT04433988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111471171|NCT04433988|Vasodilator Agents|vasodilator agents|mesh-ancestor
111471172|NCT04433988|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111471173|NCT04433988|Antioxidants|antioxidants|mesh-ancestor
111471174|NCT04685538|Tetracaine|tetracaine|mesh-list
111471175|NCT04685538|Chloroprocaine|chloroprocaine|mesh-list
111471176|NCT04685538|Anesthetics, Local|anesthetics, local|mesh-ancestor
111471177|NCT04685538|Anesthetics|anesthetics|mesh-ancestor
111471178|NCT04685538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111471179|NCT04685538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111471180|NCT04685538|Sensory System Agents|sensory system agents|mesh-ancestor
111471181|NCT04685538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111471182|NCT05121246|Palivizumab|palivizumab|mesh-list
111471183|NCT05121246|Antiviral Agents|antiviral agents|mesh-ancestor
111471184|NCT05121246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111471185|NCT04344678|Sildenafil Citrate|sildenafil citrate|mesh-list
111471186|NCT04344678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111471187|NCT04344678|Vasodilator Agents|vasodilator agents|mesh-ancestor
111471188|NCT04344678|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111471189|NCT04344678|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111471190|NCT04344678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111471191|NCT04344678|Urological Agents|urological agents|mesh-ancestor
111471192|NCT03249558|Morphine|morphine|mesh-list
111471193|NCT03249558|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
111471194|NCT03249558|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111471195|NCT03249558|Narcotics|narcotics|mesh-ancestor
111471196|NCT03249558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111471197|NCT03249558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111471198|NCT03249558|Analgesics|analgesics|mesh-ancestor
111471199|NCT03249558|Sensory System Agents|sensory system agents|mesh-ancestor
111471200|NCT03249558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111471201|NCT03249558|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111471202|NCT03249558|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111471203|NCT03249558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111471204|NCT03249558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111471205|NCT03249558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111471206|NCT03249558|Antidepressive Agents|antidepressive agents|mesh-ancestor
111471207|NCT03249558|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111471208|NCT03249558|Dopamine Agents|dopamine agents|mesh-ancestor
111471209|NCT03246828|Gliclazide|gliclazide|mesh-list
111471210|NCT03246828|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111471211|NCT03246828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111471212|NCT04316442|Immunoconjugates|immunoconjugates|mesh-list
111471213|NCT04316442|Immunologic Factors|immunologic factors|mesh-ancestor
111471214|NCT04316442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111471215|NCT03204786|Vasopressins|vasopressins|mesh-list
111471216|NCT03204786|Arginine Vasopressin|arginine vasopressin|mesh-list
111471217|NCT03204786|Hemostatics|hemostatics|mesh-ancestor
111471218|NCT03204786|Coagulants|coagulants|mesh-ancestor
111471219|NCT03204786|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111471220|NCT03204786|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
111471221|NCT03204786|Natriuretic Agents|natriuretic agents|mesh-ancestor
111471222|NCT03204786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111471223|NCT03204396|Dulaglutide|dulaglutide|mesh-list
111471224|NCT03204396|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111471225|NCT03204396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111471226|NCT02008656|Leucovorin|leucovorin|mesh-list
111471227|NCT02008656|Fluorouracil|fluorouracil|mesh-list
111471228|NCT02008656|Capecitabine|capecitabine|mesh-list
111471229|NCT02008656|Oxaliplatin|oxaliplatin|mesh-list
111471230|NCT02008656|Antimetabolites|antimetabolites|mesh-ancestor
111471231|NCT02008656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111471232|NCT02008656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111471233|NCT02008656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111471234|NCT02008656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111471235|NCT02008656|Immunologic Factors|immunologic factors|mesh-ancestor
111471236|NCT02008656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111471237|NCT02008656|Antidotes|antidotes|mesh-ancestor
111471238|NCT02008656|Protective Agents|protective agents|mesh-ancestor
110445999|NCT02768740|Hydrocortisone|hydrocortisone|mesh-list
111471239|NCT02008656|Vitamin B Complex|vitamin b complex|mesh-ancestor
111471240|NCT02008656|Vitamins|vitamins|mesh-ancestor
111471241|NCT02008656|Micronutrients|micronutrients|mesh-ancestor
111471242|NCT04300140|Nivolumab|nivolumab|mesh-list
111471243|NCT04300140|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111471244|NCT04300140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111471245|NCT04300140|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111471246|NCT04300140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111471247|NCT03174132|Lidocaine|lidocaine|mesh-list
111471248|NCT03174132|Hyaluronic Acid|hyaluronic acid|mesh-list
111471249|NCT03174132|Anesthetics, Local|anesthetics, local|mesh-ancestor
111471250|NCT03174132|Anesthetics|anesthetics|mesh-ancestor
111471251|NCT03174132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111471252|NCT03174132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111471253|NCT03174132|Sensory System Agents|sensory system agents|mesh-ancestor
111471254|NCT03174132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111471255|NCT03174132|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111471256|NCT03174132|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111471257|NCT03174132|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111195390|NCT03591471|Dipyridamole|dipyridamole|mesh-list
111471258|NCT03174132|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111471259|NCT03174132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111471260|NCT03174132|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111471261|NCT03174132|Immunologic Factors|immunologic factors|mesh-ancestor
111471262|NCT03174132|Viscosupplements|viscosupplements|mesh-ancestor
111471263|NCT03174132|Protective Agents|protective agents|mesh-ancestor
111471264|NCT03173976|Zoledronic Acid|zoledronic acid|mesh-list
111471265|NCT03173976|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111471266|NCT03173976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111471267|NCT01812252|Azacitidine|azacitidine|mesh-list
111471268|NCT01812252|Decitabine|decitabine|mesh-list
111471269|NCT01812252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111471270|NCT01812252|Antimetabolites|antimetabolites|mesh-ancestor
111471271|NCT01812252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111471272|NCT01812252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111471273|NCT01812252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111471274|NCT03818802|Niacinamide|niacinamide|mesh-list
111471275|NCT03818802|Niacin|niacin|mesh-list
111471276|NCT03818802|Nicotinic Acids|nicotinic acids|mesh-list
111471277|NCT03818802|Vitamin B Complex|vitamin b complex|mesh-ancestor
111471278|NCT03818802|Vitamins|vitamins|mesh-ancestor
111471279|NCT03818802|Micronutrients|micronutrients|mesh-ancestor
111471280|NCT03818802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111471281|NCT03818802|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111471282|NCT03818802|Antimetabolites|antimetabolites|mesh-ancestor
111471283|NCT03818802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111471284|NCT03818802|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111471285|NCT03818802|Vasodilator Agents|vasodilator agents|mesh-ancestor
111471286|NCT04398108|Margetuximab|margetuximab|mesh-list
111471287|NCT04398108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111471288|NCT01625286|Paclitaxel|paclitaxel|mesh-list
111471289|NCT01625286|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111471290|NCT01625286|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111471291|NCT01625286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111471292|NCT01625286|Tubulin Modulators|tubulin modulators|mesh-ancestor
111471293|NCT01625286|Antimitotic Agents|antimitotic agents|mesh-ancestor
111471294|NCT01625286|Mitosis Modulators|mitosis modulators|mesh-ancestor
111471295|NCT01625286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111471296|NCT05158062|Paclitaxel|paclitaxel|mesh-list
111471297|NCT05158062|Docetaxel|docetaxel|mesh-list
111471298|NCT05158062|Bevacizumab|bevacizumab|mesh-list
111471299|NCT05158062|Carboplatin|carboplatin|mesh-list
111471300|NCT05158062|Pembrolizumab|pembrolizumab|mesh-list
111471301|NCT05158062|Olaparib|olaparib|mesh-list
111471302|NCT05158062|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111471303|NCT05158062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111471304|NCT05158062|Tubulin Modulators|tubulin modulators|mesh-ancestor
111471305|NCT05158062|Antimitotic Agents|antimitotic agents|mesh-ancestor
111471306|NCT05158062|Mitosis Modulators|mitosis modulators|mesh-ancestor
111471307|NCT05158062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111471308|NCT05158062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111471309|NCT05158062|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111471310|NCT05158062|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111471311|NCT05158062|Growth Substances|growth substances|mesh-ancestor
111471312|NCT05158062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111471313|NCT05158062|Growth Inhibitors|growth inhibitors|mesh-ancestor
111471314|NCT05158062|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111471315|NCT05158062|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111471316|NCT05158062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111471317|NCT01076868|Primaquine|primaquine|mesh-list
111471318|NCT01076868|Antimalarials|antimalarials|mesh-ancestor
111471319|NCT01076868|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111471320|NCT01076868|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111471321|NCT01076868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111471322|NCT03193866|Interferons|interferons|mesh-list
111471323|NCT03193866|Interferon-beta|interferon-beta|mesh-list
111471324|NCT03193866|Rituximab|rituximab|mesh-list
111471325|NCT03193866|Alemtuzumab|alemtuzumab|mesh-list
111471326|NCT03193866|Glatiramer Acetate|glatiramer acetate|mesh-list
111471327|NCT03193866|Dimethyl Fumarate|dimethyl fumarate|mesh-list
111471328|NCT03193866|Natalizumab|natalizumab|mesh-list
111471329|NCT03193866|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
111471330|NCT03193866|(T,G)-A-L|(t,g)-a-l|mesh-list
111471331|NCT03193866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111471332|NCT03193866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111471333|NCT03193866|Immunologic Factors|immunologic factors|mesh-ancestor
111471334|NCT03193866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111471335|NCT03193866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111471336|NCT03193866|Antiviral Agents|antiviral agents|mesh-ancestor
111471337|NCT03193866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111471338|NCT03193866|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
111471339|NCT03193866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111471340|NCT03193866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111471341|NCT03193866|Dermatologic Agents|dermatologic agents|mesh-ancestor
111471342|NCT03193866|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111471343|NCT04195776|Tenofovir|tenofovir|mesh-list
111471344|NCT04195776|Antiviral Agents|antiviral agents|mesh-ancestor
111471345|NCT04195776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111471346|NCT04195776|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111471347|NCT04195776|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111471348|NCT04195776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111471349|NCT04195776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111471350|NCT04195776|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111471351|NCT04195776|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111471352|NCT03708588|Ticagrelor|ticagrelor|mesh-list
111471353|NCT03708588|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111471354|NCT03708588|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111471355|NCT03708588|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111471356|NCT03708588|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111471357|NCT03708588|Purinergic Agents|purinergic agents|mesh-ancestor
111471358|NCT03708588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111471359|NCT03708588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111471360|NCT03708588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111471361|NCT04130802|Dexamethasone|dexamethasone|mesh-list
111471362|NCT04130802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111471363|NCT04130802|Antiemetics|antiemetics|mesh-ancestor
111471364|NCT04130802|Autonomic Agents|autonomic agents|mesh-ancestor
111471365|NCT04130802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111471366|NCT04130802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111471367|NCT04130802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111471368|NCT04130802|Glucocorticoids|glucocorticoids|mesh-ancestor
111471369|NCT04130802|Hormones|hormones|mesh-ancestor
111471370|NCT04130802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111471371|NCT04130802|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111471372|NCT04130802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111471373|NCT03087162|Dexlansoprazole|dexlansoprazole|mesh-list
111471374|NCT03087162|Lansoprazole|lansoprazole|mesh-list
111471375|NCT03087162|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111471376|NCT03087162|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111471377|NCT03087162|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110130463|NCT01962181|Methylphenidate|methylphenidate|mesh-list
111471378|NCT03087162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111471379|NCT03087162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111471380|NCT03165942|Ethanol|ethanol|mesh-list
111471381|NCT03165942|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111471382|NCT03165942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111471383|NCT03165942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111471384|NCT03165942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111471385|NCT03163992|Pembrolizumab|pembrolizumab|mesh-list
111471386|NCT03163992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111471387|NCT03163992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111471388|NCT03163992|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111471389|NCT03163992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111471390|NCT04397328|Hydroxychloroquine|hydroxychloroquine|mesh-list
111471391|NCT04397328|Antimalarials|antimalarials|mesh-ancestor
111471392|NCT04397328|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111471393|NCT04397328|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111471394|NCT04397328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111471395|NCT04397328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111471396|NCT04397328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111471397|NCT04397328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111471398|NCT03162432|Vitamin D|vitamin d|mesh-list
111471399|NCT03162432|Cholecalciferol|cholecalciferol|mesh-list
111471400|NCT03162432|Vitamins|vitamins|mesh-ancestor
111471401|NCT03162432|Micronutrients|micronutrients|mesh-ancestor
111471402|NCT03162432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111471403|NCT03162432|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111471404|NCT03162432|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111471405|NCT03392376|Haloperidol|haloperidol|mesh-list
111471406|NCT03392376|Haloperidol decanoate|haloperidol decanoate|mesh-list
111471407|NCT03392376|Antiemetics|antiemetics|mesh-ancestor
111471408|NCT03392376|Autonomic Agents|autonomic agents|mesh-ancestor
111471409|NCT03392376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111471410|NCT03392376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111471411|NCT03392376|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111471412|NCT03392376|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111471413|NCT03392376|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111471414|NCT03392376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111471415|NCT03392376|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111471416|NCT03392376|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111471417|NCT03392376|Dopamine Agents|dopamine agents|mesh-ancestor
111471418|NCT03392376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111471419|NCT03392376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111471420|NCT03392376|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111471421|NCT05243628|Insulin|insulin|mesh-list
111471422|NCT05243628|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111471423|NCT05243628|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111471424|NCT05243628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111471425|NCT05249478|Fentanyl|fentanyl|mesh-list
111471426|NCT05249478|Bupivacaine|bupivacaine|mesh-list
111471427|NCT05249478|Anesthetics, Local|anesthetics, local|mesh-ancestor
111471428|NCT05249478|Anesthetics|anesthetics|mesh-ancestor
111471429|NCT05249478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111471430|NCT05249478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111471431|NCT05249478|Sensory System Agents|sensory system agents|mesh-ancestor
111471432|NCT05249478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111471433|NCT05249478|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111471434|NCT05249478|Narcotics|narcotics|mesh-ancestor
111471435|NCT05249478|Analgesics|analgesics|mesh-ancestor
111471436|NCT05249478|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111471437|NCT05249478|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111471438|NCT05249478|Anesthetics, General|anesthetics, general|mesh-ancestor
111471439|NCT05244252|Bupivacaine|bupivacaine|mesh-list
111471440|NCT05244252|Anesthetics, Local|anesthetics, local|mesh-ancestor
111471441|NCT05244252|Anesthetics|anesthetics|mesh-ancestor
111471442|NCT05244252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111471443|NCT05244252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111471444|NCT05244252|Sensory System Agents|sensory system agents|mesh-ancestor
111471445|NCT05244252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111471446|NCT03286842|Olaparib|olaparib|mesh-list
111471447|NCT03286842|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111471448|NCT03286842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111471449|NCT03286842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111471450|NCT03286842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111471451|NCT05240274|Metformin|metformin|mesh-list
111471452|NCT05240274|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111471453|NCT05240274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111471454|NCT05244018|Vitamin D|vitamin d|mesh-list
111471455|NCT05244018|Ergocalciferols|ergocalciferols|mesh-list
111471456|NCT05244018|Cholecalciferol|cholecalciferol|mesh-list
111471457|NCT05244018|Vitamins|vitamins|mesh-list
111471458|NCT05244018|Micronutrients|micronutrients|mesh-ancestor
111471459|NCT05244018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111471460|NCT05244018|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111471461|NCT05244018|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111471462|NCT02398500|Ranibizumab|ranibizumab|mesh-list
111471463|NCT02398500|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111471464|NCT02398500|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111471465|NCT02398500|Growth Substances|growth substances|mesh-ancestor
111471466|NCT02398500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111471467|NCT02398500|Growth Inhibitors|growth inhibitors|mesh-ancestor
111471468|NCT02398500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111471469|NCT02984514|Deoxyglucose|deoxyglucose|mesh-list
111471470|NCT02984514|Antimetabolites|antimetabolites|mesh-ancestor
111471471|NCT02984514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111471472|NCT02984514|Antiviral Agents|antiviral agents|mesh-ancestor
111471473|NCT02984514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111471474|NCT04276428|Insulin|insulin|mesh-list
111471475|NCT04276428|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111471476|NCT04276428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111471477|NCT05248932|Norepinephrine|norepinephrine|mesh-list
111471478|NCT05248932|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111471479|NCT05248932|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111471480|NCT05248932|Adrenergic Agents|adrenergic agents|mesh-ancestor
111471481|NCT05248932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111471482|NCT05248932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111471483|NCT05248932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111471484|NCT05248932|Sympathomimetics|sympathomimetics|mesh-ancestor
111195612|NCT04190745|Paclitaxel|paclitaxel|mesh-list
111471485|NCT05248932|Autonomic Agents|autonomic agents|mesh-ancestor
111471486|NCT05248932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111471487|NCT05248932|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111471488|NCT02395614|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111471489|NCT02395614|Gentamicins|gentamicins|mesh-list
111471490|NCT02395614|Cefazolin|cefazolin|mesh-list
111471491|NCT02395614|Bacitracin|bacitracin|mesh-list
111471492|NCT02395614|Chlorhexidine|chlorhexidine|mesh-list
111471493|NCT02395614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111471494|NCT02395614|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111471495|NCT02395614|Disinfectants|disinfectants|mesh-ancestor
111471496|NCT02395614|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111471497|NCT02395614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111471498|NCT02395614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111471499|NCT04396938|Lamotrigine|lamotrigine|mesh-list
111471500|NCT04396938|Anticonvulsants|anticonvulsants|mesh-ancestor
111471501|NCT04396938|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111471502|NCT04396938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111471503|NCT04396938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110446010|NCT00580047|Calcium, Dietary|calcium, dietary|mesh-list
111471504|NCT04396938|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111471505|NCT04396938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111471506|NCT04396938|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111471507|NCT04396938|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111471508|NCT04396938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111471509|NCT04396938|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111471510|NCT04396938|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111471511|NCT00639678|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111471512|NCT00639678|Immunologic Factors|immunologic factors|mesh-ancestor
111471513|NCT00639678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111471514|NCT02914158|Tamoxifen|tamoxifen|mesh-list
111471515|NCT02914158|Leuprolide|leuprolide|mesh-list
111471516|NCT02914158|Goserelin|goserelin|mesh-list
111471517|NCT02914158|Aromatase Inhibitors|aromatase inhibitors|mesh-list
111471518|NCT02914158|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111471519|NCT02914158|Hormone Antagonists|hormone antagonists|mesh-ancestor
111471520|NCT02914158|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111471521|NCT02914158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111471522|NCT02914158|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111471523|NCT02914158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111471524|NCT02914158|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111471525|NCT02914158|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111471526|NCT02914158|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111471527|NCT02914158|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111471528|NCT02914158|Fertility Agents|fertility agents|mesh-ancestor
111471529|NCT02914158|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111471530|NCT02914158|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111471531|NCT02914158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111471532|NCT02914158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111471533|NCT05241132|Paclitaxel|paclitaxel|mesh-list
111471534|NCT05241132|Cisplatin|cisplatin|mesh-list
111471535|NCT05241132|Tislelizumab|tislelizumab|mesh-list
111471536|NCT05241132|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111471537|NCT05241132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111471538|NCT05241132|Tubulin Modulators|tubulin modulators|mesh-ancestor
111471539|NCT05241132|Antimitotic Agents|antimitotic agents|mesh-ancestor
111471540|NCT05241132|Mitosis Modulators|mitosis modulators|mesh-ancestor
111471541|NCT05241132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111471542|NCT05241132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111471543|NCT05241054|Acetaminophen|acetaminophen|mesh-list
111471544|NCT05241054|Nitroglycerin|nitroglycerin|mesh-list
111471545|NCT05241054|Fentanyl|fentanyl|mesh-list
111471546|NCT05241054|Bupivacaine|bupivacaine|mesh-list
111471547|NCT05241054|Propofol|propofol|mesh-list
111471548|NCT05241054|Sevoflurane|sevoflurane|mesh-list
111471549|NCT05241054|Atracurium|atracurium|mesh-list
111471550|NCT05241054|Anesthetics, Local|anesthetics, local|mesh-ancestor
111471551|NCT05241054|Anesthetics|anesthetics|mesh-ancestor
111471552|NCT05241054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111471553|NCT05241054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111471554|NCT05241054|Sensory System Agents|sensory system agents|mesh-ancestor
111471555|NCT05241054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111471556|NCT05241054|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111471557|NCT05241054|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111471558|NCT05241054|Anesthetics, General|anesthetics, general|mesh-ancestor
111471559|NCT05241054|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110135499|NCT01998126|Nivolumab|nivolumab|mesh-list
111471560|NCT05241054|Narcotics|narcotics|mesh-ancestor
111471561|NCT05241054|Analgesics|analgesics|mesh-ancestor
111471562|NCT05241054|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111471563|NCT05241054|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111471564|NCT05241054|Antipyretics|antipyretics|mesh-ancestor
111471565|NCT05241054|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111471566|NCT05241054|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111471567|NCT05241054|Vasodilator Agents|vasodilator agents|mesh-ancestor
111471568|NCT05241054|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
111471569|NCT05241054|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
111471570|NCT05241054|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111471571|NCT05241054|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
111471572|NCT05241054|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111471573|NCT05241054|Cholinergic Agents|cholinergic agents|mesh-ancestor
111471574|NCT05241054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111471575|NCT05241054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111471576|NCT00638508|Ketorolac|ketorolac|mesh-list
111471577|NCT00638508|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
111471578|NCT00638508|Ropivacaine|ropivacaine|mesh-list
111471579|NCT00638508|Anesthetics, Local|anesthetics, local|mesh-ancestor
111471580|NCT00638508|Anesthetics|anesthetics|mesh-ancestor
111471581|NCT00638508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111471582|NCT00638508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111471583|NCT00638508|Sensory System Agents|sensory system agents|mesh-ancestor
111471584|NCT00638508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111471585|NCT00638508|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111471586|NCT00638508|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111471587|NCT00638508|Analgesics|analgesics|mesh-ancestor
111471588|NCT00638508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111471589|NCT00638508|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111471590|NCT00638508|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111471591|NCT00638508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111471592|NCT00638508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111471593|NCT00637806|Megestrol|megestrol|mesh-list
111471594|NCT00637806|Megestrol Acetate|megestrol acetate|mesh-list
111471595|NCT00637806|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111471596|NCT00637806|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111471597|NCT00637806|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111471598|NCT00637806|Contraceptive Agents|contraceptive agents|mesh-ancestor
111471599|NCT00637806|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111471600|NCT00637806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111471601|NCT00637806|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111471602|NCT00637806|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111471603|NCT00637806|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111471604|NCT00637806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111471605|NCT00637806|Appetite Stimulants|appetite stimulants|mesh-ancestor
111471606|NCT00637806|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111471607|NCT00637728|Megestrol|megestrol|mesh-list
111471608|NCT00637728|Megestrol Acetate|megestrol acetate|mesh-list
111471609|NCT00637728|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111471610|NCT00637728|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111471611|NCT00637728|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111471612|NCT00637728|Contraceptive Agents|contraceptive agents|mesh-ancestor
110138062|NCT04898075|Nicotine|nicotine|mesh-list
111471613|NCT00637728|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111471614|NCT00637728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111471615|NCT00637728|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111471616|NCT00637728|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111471617|NCT00637728|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111471618|NCT00637728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111471619|NCT00637728|Appetite Stimulants|appetite stimulants|mesh-ancestor
111471620|NCT00637728|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111471621|NCT01922466|Loxoprofen|loxoprofen|mesh-list
111471622|NCT01922466|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111471623|NCT01922466|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111471624|NCT01922466|Analgesics|analgesics|mesh-ancestor
111471625|NCT01922466|Sensory System Agents|sensory system agents|mesh-ancestor
111471626|NCT01922466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111471627|NCT01922466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111471628|NCT01922466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111471629|NCT01922466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111471630|NCT00637572|Megestrol|megestrol|mesh-list
111471631|NCT00637572|Megestrol Acetate|megestrol acetate|mesh-list
111471632|NCT00637572|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111471633|NCT00637572|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111471634|NCT00637572|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111471635|NCT00637572|Contraceptive Agents|contraceptive agents|mesh-ancestor
111471636|NCT00637572|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111471637|NCT00637572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111195761|NCT04024683|Anesthetics, Local|anesthetics, local|mesh-ancestor
111471638|NCT00637572|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111471639|NCT00637572|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111471640|NCT00637572|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111471641|NCT00637572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111471642|NCT00637572|Appetite Stimulants|appetite stimulants|mesh-ancestor
111471643|NCT00637572|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111471644|NCT00637416|Lansoprazole|lansoprazole|mesh-list
111471645|NCT00637416|Dexlansoprazole|dexlansoprazole|mesh-list
111471646|NCT00637416|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111471647|NCT00637416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111471648|NCT00637416|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111471649|NCT00637416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111471650|NCT00637416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111471651|NCT00636792|Rituximab|rituximab|mesh-list
111471652|NCT00636792|Bortezomib|bortezomib|mesh-list
111471653|NCT00636792|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
111471654|NCT00636792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111471655|NCT00636792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111471656|NCT00636792|Immunologic Factors|immunologic factors|mesh-ancestor
111471657|NCT00636792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111471658|NCT00636792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111471659|NCT00636792|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111471660|NCT00636792|Alkylating Agents|alkylating agents|mesh-ancestor
111471661|NCT00636792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111471662|NCT03153462|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
111471663|NCT03153462|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111471664|NCT03153462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111471665|NCT00636636|Gabapentin|gabapentin|mesh-list
111471666|NCT00636636|Analgesics|analgesics|mesh-ancestor
111471667|NCT00636636|Sensory System Agents|sensory system agents|mesh-ancestor
111471668|NCT00636636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111471669|NCT00636636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111471670|NCT00636636|Anticonvulsants|anticonvulsants|mesh-ancestor
111471671|NCT00636636|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111471672|NCT00636636|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111471673|NCT00636636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111471674|NCT00636636|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111471675|NCT00636636|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111471676|NCT00636636|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111471677|NCT00636636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111471678|NCT00636636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111471679|NCT00636636|Antimanic Agents|antimanic agents|mesh-ancestor
111471680|NCT05244954|Chloroquine|chloroquine|mesh-list
111471681|NCT05244954|Piperaquine|piperaquine|mesh-list
111471682|NCT05244954|Artenimol|artenimol|mesh-list
111471683|NCT05244954|Amebicides|amebicides|mesh-ancestor
111471684|NCT05244954|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111471685|NCT05244954|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111471686|NCT05244954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111471687|NCT05244954|Antimalarials|antimalarials|mesh-ancestor
111471688|NCT05244954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111471689|NCT01929252|Dexmedetomidine|dexmedetomidine|mesh-list
111471690|NCT01929252|Levobupivacaine|levobupivacaine|mesh-list
111471691|NCT01929252|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111471692|NCT01929252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111471693|NCT01929252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111471694|NCT01929252|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111471695|NCT01929252|Analgesics|analgesics|mesh-ancestor
111471696|NCT01929252|Sensory System Agents|sensory system agents|mesh-ancestor
111471697|NCT01929252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111471698|NCT01929252|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111471699|NCT01929252|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111471700|NCT01929252|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111471701|NCT01929252|Adrenergic Agents|adrenergic agents|mesh-ancestor
111471702|NCT01929252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111471703|NCT01929252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111471704|NCT01929252|Anesthetics, Local|anesthetics, local|mesh-ancestor
111471705|NCT01929252|Anesthetics|anesthetics|mesh-ancestor
111471706|NCT04275960|Selitrectinib|selitrectinib|mesh-list
111471707|NCT04275960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111471708|NCT04275960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111471709|NCT00634920|Cyclosporine|cyclosporine|mesh-list
111471710|NCT00634920|Mycophenolic Acid|mycophenolic acid|mesh-list
111471711|NCT00634920|Prednisolone|prednisolone|mesh-list
111471712|NCT00634920|Everolimus|everolimus|mesh-list
111471713|NCT00634920|Cyclosporins|cyclosporins|mesh-list
111471715|NCT00634920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111471716|NCT00634920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111471717|NCT00634920|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111471718|NCT00634920|Immunologic Factors|immunologic factors|mesh-ancestor
111471719|NCT00634920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111471720|NCT00634920|Antifungal Agents|antifungal agents|mesh-ancestor
111471721|NCT00634920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111471722|NCT00634920|Dermatologic Agents|dermatologic agents|mesh-ancestor
111471723|NCT00634920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111471724|NCT00634920|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111471725|NCT00634920|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111471726|NCT00634920|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111471727|NCT00634920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111471728|NCT00634920|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111471729|NCT00634920|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111471730|NCT00634920|Antitubercular Agents|antitubercular agents|mesh-ancestor
111471731|NCT00634920|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111471732|NCT00634920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111471733|NCT00634920|Glucocorticoids|glucocorticoids|mesh-ancestor
111471734|NCT00634920|Hormones|hormones|mesh-ancestor
111471735|NCT00634920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111471736|NCT00634920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111471737|NCT01923012|Vitamin K|vitamin k|mesh-list
111471738|NCT01923012|Vitamin K 2|vitamin k 2|mesh-list
111471739|NCT01923012|Vitamins|vitamins|mesh-ancestor
111471740|NCT01923012|Micronutrients|micronutrients|mesh-ancestor
111471741|NCT01923012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111471742|NCT01923012|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111471743|NCT01923012|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111471744|NCT01923012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111471745|NCT01923012|Hemostatics|hemostatics|mesh-ancestor
111471746|NCT01923012|Coagulants|coagulants|mesh-ancestor
111471747|NCT01923090|Finasteride|finasteride|mesh-list
111471748|NCT01923090|Dutasteride|dutasteride|mesh-list
111471749|NCT01923090|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
111471750|NCT01923090|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111471751|NCT01923090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111471752|NCT01923090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111471753|NCT01923090|Hormone Antagonists|hormone antagonists|mesh-ancestor
111471754|NCT01923090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111471755|NCT01923090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111471756|NCT01923090|Urological Agents|urological agents|mesh-ancestor
111471757|NCT01929330|Dutasteride|dutasteride|mesh-list
111471758|NCT01929330|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
111471759|NCT01929330|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111471760|NCT01929330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111471761|NCT01929330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111471762|NCT01929330|Hormone Antagonists|hormone antagonists|mesh-ancestor
111471763|NCT01929330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111471764|NCT01929330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111471765|NCT00634842|Insulin|insulin|mesh-list
111471766|NCT00634842|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111471767|NCT00634842|Insulin Detemir|insulin detemir|mesh-list
111471768|NCT00634842|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111471769|NCT00634842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111471770|NCT04396548|Midodrine|midodrine|mesh-list
111471771|NCT04396548|Anesthetics|anesthetics|mesh-list
111471772|NCT04396548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111471773|NCT04396548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111471774|NCT04396548|Sympathomimetics|sympathomimetics|mesh-ancestor
111471775|NCT04396548|Autonomic Agents|autonomic agents|mesh-ancestor
111471776|NCT04396548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111471777|NCT04396548|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111471778|NCT04396548|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111471779|NCT04396548|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111471780|NCT04396548|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111471781|NCT04396548|Adrenergic Agents|adrenergic agents|mesh-ancestor
111471782|NCT04396548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111471783|NCT04396548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111471784|NCT01929798|Pancrelipase|pancrelipase|mesh-list
111471785|NCT01929798|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111471786|NCT00633984|Cycloserine|cycloserine|mesh-list
111471787|NCT00633984|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111471788|NCT00633984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111471789|NCT00633984|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111471790|NCT00633984|Antitubercular Agents|antitubercular agents|mesh-ancestor
111471791|NCT00633984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111471792|NCT00633984|Antimetabolites|antimetabolites|mesh-ancestor
111471793|NCT00633984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111471794|NCT04395612|Niraparib|niraparib|mesh-list
111471795|NCT04395612|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111471796|NCT04395612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111471797|NCT04395612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111471798|NCT04395612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111471799|NCT01923558|Donepezil|donepezil|mesh-list
111471800|NCT01923558|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111471801|NCT01923558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111471802|NCT01923558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111471803|NCT01923558|Cholinergic Agents|cholinergic agents|mesh-ancestor
111471804|NCT01923558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111471805|NCT01923558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111471806|NCT01923558|Nootropic Agents|nootropic agents|mesh-ancestor
111471807|NCT01921218|Cyclosporine|cyclosporine|mesh-list
111471808|NCT01921218|Mycophenolic Acid|mycophenolic acid|mesh-list
111471809|NCT01921218|Prednisone|prednisone|mesh-list
111471810|NCT01921218|Abatacept|abatacept|mesh-list
111471811|NCT01921218|Tacrolimus|tacrolimus|mesh-list
111471812|NCT01921218|Cyclosporins|cyclosporins|mesh-list
111471813|NCT01921218|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
111471814|NCT01921218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111471815|NCT01921218|Glucocorticoids|glucocorticoids|mesh-ancestor
111471816|NCT01921218|Hormones|hormones|mesh-ancestor
111471817|NCT01921218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111471818|NCT01921218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111471819|NCT01921218|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111471820|NCT01921218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111471821|NCT01921218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111471822|NCT01921218|Immunologic Factors|immunologic factors|mesh-ancestor
111471823|NCT01921218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111471824|NCT01921218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111471825|NCT01921218|Antifungal Agents|antifungal agents|mesh-ancestor
111471826|NCT01921218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111471827|NCT01921218|Dermatologic Agents|dermatologic agents|mesh-ancestor
111471828|NCT01921218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111471829|NCT01921218|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111471830|NCT01921218|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111471831|NCT01921218|Antitubercular Agents|antitubercular agents|mesh-ancestor
111471832|NCT01921218|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111471833|NCT01921218|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111471834|NCT01921218|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111471835|NCT00633750|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111471836|NCT00633750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111471837|NCT00633750|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111471838|NCT00633750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111471839|NCT00633750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111471840|NCT00633360|Drospirenone|drospirenone|mesh-list
111471841|NCT00633360|Ethinyl Estradiol|ethinyl estradiol|mesh-list
111471842|NCT00633360|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
111471843|NCT00633360|Estradiol|estradiol|mesh-list
111471844|NCT00633360|Estrogens|estrogens|mesh-ancestor
111471845|NCT00633360|Hormones|hormones|mesh-ancestor
111471846|NCT00633360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111471847|NCT00633360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111471848|NCT00633360|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111471849|NCT00633360|Contraceptive Agents|contraceptive agents|mesh-ancestor
111471850|NCT00633360|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111471851|NCT00633360|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111471852|NCT00633360|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111471853|NCT00633360|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111471854|NCT00633360|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
111471855|NCT00633360|Hormone Antagonists|hormone antagonists|mesh-ancestor
111471856|NCT00633360|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
111471857|NCT00633360|Diuretics|diuretics|mesh-ancestor
111471858|NCT00633360|Natriuretic Agents|natriuretic agents|mesh-ancestor
111471859|NCT00988260|Ganirelix|ganirelix|mesh-list
111471860|NCT00988260|Hormone Antagonists|hormone antagonists|mesh-ancestor
111471861|NCT00988260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111471862|NCT00988260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111471863|NCT00633126|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
111471864|NCT00633126|Cephalosporins|cephalosporins|mesh-list
111471865|NCT00633126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111471866|NCT00633126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111471867|NCT00989664|Tositumomab I-131|tositumomab i-131|mesh-list
111471868|NCT00989664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111471869|NCT01923870|Enclomiphene|enclomiphene|mesh-list
111471870|NCT01923870|Clomiphene|clomiphene|mesh-list
111471871|NCT01923870|Zuclomiphene|zuclomiphene|mesh-list
111471872|NCT01923870|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111471873|NCT01923870|Hormone Antagonists|hormone antagonists|mesh-ancestor
111471874|NCT01923870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111471875|NCT01923870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111471876|NCT01923870|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111471877|NCT01923870|Fertility Agents|fertility agents|mesh-ancestor
111471878|NCT01923870|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111471879|NCT01923870|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111471880|NCT01923870|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111471881|NCT00632736|Ropinirole|ropinirole|mesh-list
111471882|NCT00632736|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111471883|NCT00632736|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111471884|NCT00632736|Dopamine Agonists|dopamine agonists|mesh-ancestor
111471885|NCT00632736|Dopamine Agents|dopamine agents|mesh-ancestor
111471886|NCT00632736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111471887|NCT00632736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111471888|NCT00632736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111471889|NCT01923948|Pregabalin|pregabalin|mesh-list
111471890|NCT01923948|Analgesics|analgesics|mesh-ancestor
111471891|NCT01923948|Sensory System Agents|sensory system agents|mesh-ancestor
111471892|NCT01923948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111471893|NCT01923948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111471894|NCT01923948|Anticonvulsants|anticonvulsants|mesh-ancestor
111471895|NCT01923948|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111471896|NCT01923948|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111471897|NCT01923948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111471898|NCT01923948|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111471899|NCT01923948|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111471900|NCT01923948|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111471901|NCT01923948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111471902|NCT01923948|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111471903|NCT00989196|Factor VIII|factor viii|mesh-list
111471904|NCT00989196|Coagulants|coagulants|mesh-ancestor
111471905|NCT00631488|Metformin|metformin|mesh-list
111471906|NCT00631488|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111471907|NCT00631488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111471908|NCT00631488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111471909|NCT00631488|Incretins|incretins|mesh-ancestor
111471910|NCT00631488|Hormones|hormones|mesh-ancestor
111471911|NCT00631488|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111471912|NCT00631488|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111471913|NCT00631488|Protease Inhibitors|protease inhibitors|mesh-ancestor
111471914|NCT00631488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111471915|NCT00631488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111471916|NCT01924104|Aspirin|aspirin|mesh-list
111471917|NCT01924104|Heparin|heparin|mesh-list
111471918|NCT01924104|Calcium heparin|calcium heparin|mesh-list
111471919|NCT01924104|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
111471920|NCT01924104|Tinzaparin|tinzaparin|mesh-list
111471921|NCT01924104|Dalteparin|dalteparin|mesh-list
111471922|NCT01924104|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111471923|NCT01924104|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111471924|NCT01924104|Analgesics|analgesics|mesh-ancestor
111471925|NCT01924104|Sensory System Agents|sensory system agents|mesh-ancestor
111471926|NCT01924104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111471927|NCT01924104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111471928|NCT01924104|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111471929|NCT01924104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111471930|NCT01924104|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111471931|NCT01924104|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111471932|NCT01924104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111471933|NCT01924104|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111471934|NCT01924104|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111471935|NCT01924104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111471936|NCT01924104|Antipyretics|antipyretics|mesh-ancestor
111196067|NCT06059885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111471937|NCT01924104|Anticoagulants|anticoagulants|mesh-ancestor
111471938|NCT00987402|Ethanol|ethanol|mesh-list
111471939|NCT00987402|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111471940|NCT00987402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111471941|NCT00987402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111471942|NCT00987402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111471943|NCT00630786|Panitumumab|panitumumab|mesh-list
111471944|NCT00630786|Conatumumab|conatumumab|mesh-list
111471945|NCT00630786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111471946|NCT00630786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111471947|NCT00630396|Minocycline|minocycline|mesh-list
111471948|NCT00630396|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111471949|NCT00630396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111471950|NCT00636480|Chlorhexidine|chlorhexidine|mesh-list
111471951|NCT00636480|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
111471952|NCT00636480|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111471953|NCT00636480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111471954|NCT00636480|Disinfectants|disinfectants|mesh-ancestor
111471955|NCT00636480|Dermatologic Agents|dermatologic agents|mesh-ancestor
111471956|NCT00630552|Conatumumab|conatumumab|mesh-list
111471957|NCT00630552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111471958|NCT00630552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111471959|NCT01925352|Mitogens|mitogens|mesh-list
111471960|NCT01925352|Mitosis Modulators|mitosis modulators|mesh-ancestor
111471961|NCT01925352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111471962|NCT01920204|Midostaurin|midostaurin|mesh-list
111471963|NCT01920204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111471964|NCT01920204|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111471965|NCT01920204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111471966|NCT01920204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111471967|NCT04275258|Analgesics, Opioid|analgesics, opioid|mesh-list
111471968|NCT04275258|Narcotics|narcotics|mesh-ancestor
111471969|NCT04275258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111471970|NCT04275258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111471971|NCT04275258|Analgesics|analgesics|mesh-ancestor
111471972|NCT04275258|Sensory System Agents|sensory system agents|mesh-ancestor
111471973|NCT04275258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111471974|NCT01925820|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
111471975|NCT01925820|Entecavir|entecavir|mesh-list
111471976|NCT01925820|Antiviral Agents|antiviral agents|mesh-ancestor
111471977|NCT01925820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111471978|NCT01925898|Midazolam|midazolam|mesh-list
111471979|NCT01925898|Ketamine|ketamine|mesh-list
111471980|NCT01925898|Analgesics|analgesics|mesh-ancestor
111471981|NCT01925898|Sensory System Agents|sensory system agents|mesh-ancestor
111471982|NCT01925898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111471983|NCT01925898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111471984|NCT01925898|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111471985|NCT01925898|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111471986|NCT01925898|Anesthetics, General|anesthetics, general|mesh-ancestor
111471987|NCT01925898|Anesthetics|anesthetics|mesh-ancestor
111471988|NCT01925898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111471989|NCT01925898|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111471990|NCT01925898|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111471991|NCT01925898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111471992|NCT01925898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111471993|NCT01925898|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111471994|NCT01925898|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111471995|NCT01925898|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111471996|NCT01925898|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111471997|NCT01925898|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111471998|NCT01925898|GABA Modulators|gaba modulators|mesh-ancestor
111471999|NCT01925898|GABA Agents|gaba agents|mesh-ancestor
111472000|NCT00983580|Aspirin|aspirin|mesh-list
111472001|NCT00983580|Eflornithine|eflornithine|mesh-list
111472002|NCT00983580|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111472003|NCT00983580|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111472004|NCT00983580|Analgesics|analgesics|mesh-ancestor
111472005|NCT00983580|Sensory System Agents|sensory system agents|mesh-ancestor
111472006|NCT00983580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111472007|NCT00983580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111472008|NCT00983580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111196154|NCT06057467|Anticoagulants|anticoagulants|mesh-list
111472009|NCT00983580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111472010|NCT00983580|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111472011|NCT00983580|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111472012|NCT00983580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111472013|NCT00983580|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111472014|NCT00983580|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111472015|NCT00983580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111472016|NCT00983580|Antipyretics|antipyretics|mesh-ancestor
111472017|NCT00983580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111472018|NCT00983580|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
111472019|NCT00983580|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111472020|NCT00983580|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111472021|NCT00983580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111472022|NCT00983580|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
111472023|NCT00982878|Maraviroc|maraviroc|mesh-list
111472024|NCT00982878|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
111472025|NCT00982878|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
111472026|NCT00982878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111472027|NCT00982878|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111472028|NCT00982878|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111472029|NCT00982878|Antiviral Agents|antiviral agents|mesh-ancestor
111472030|NCT00982878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111472031|NCT00982878|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
111472032|NCT00982488|Imatinib Mesylate|imatinib mesylate|mesh-list
111472033|NCT00982488|Dasatinib|dasatinib|mesh-list
111472034|NCT00982488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111472035|NCT00982488|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111472036|NCT00982488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111472037|NCT00982488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111472038|NCT00982020|Olanzapine|olanzapine|mesh-list
111472039|NCT00982020|Antiemetics|antiemetics|mesh-ancestor
111472040|NCT00982020|Autonomic Agents|autonomic agents|mesh-ancestor
111472041|NCT00982020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111472042|NCT00982020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111472043|NCT00982020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111472044|NCT00982020|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111472045|NCT00982020|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111472046|NCT00982020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111472047|NCT00982020|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111472048|NCT00982020|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111472049|NCT00982020|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111472050|NCT00982020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111472051|NCT00982020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111472052|NCT00982020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111472053|NCT00982020|Serotonin Agents|serotonin agents|mesh-ancestor
111472054|NCT01926132|Ascorbic Acid|ascorbic acid|mesh-list
111472055|NCT01926132|Antioxidants|antioxidants|mesh-ancestor
111472056|NCT01926132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111472057|NCT01926132|Protective Agents|protective agents|mesh-ancestor
111472058|NCT01926132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111472059|NCT01926132|Vitamins|vitamins|mesh-ancestor
111472060|NCT01926132|Micronutrients|micronutrients|mesh-ancestor
111472061|NCT01926210|Letrozole|letrozole|mesh-list
111472062|NCT01926210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111472063|NCT01926210|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111472064|NCT01926210|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111472065|NCT01926210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111472066|NCT01926210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111472067|NCT01926210|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111472068|NCT01926210|Hormone Antagonists|hormone antagonists|mesh-ancestor
111472069|NCT01926210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111472070|NCT01926210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111472071|NCT01926288|Entecavir|entecavir|mesh-list
111472072|NCT01926288|Maleic acid|maleic acid|mesh-list
111472073|NCT01926288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111472074|NCT01926288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111472075|NCT01926288|Antiviral Agents|antiviral agents|mesh-ancestor
111472076|NCT01926288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111472077|NCT00981084|Modafinil|modafinil|mesh-list
111472078|NCT00981084|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111472079|NCT00981084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111472080|NCT00981084|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
111472081|NCT00981084|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111472082|NCT00981084|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111472083|NCT00981084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111472084|NCT00980148|Azithromycin|azithromycin|mesh-list
111472085|NCT00980148|Doxycycline|doxycycline|mesh-list
111472086|NCT00980148|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111472087|NCT00980148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111472088|NCT00980148|Antimalarials|antimalarials|mesh-ancestor
111472089|NCT00980148|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111472090|NCT00980148|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111472091|NCT03064854|Paclitaxel|paclitaxel|mesh-list
111472092|NCT03064854|Carboplatin|carboplatin|mesh-list
111472093|NCT03064854|Gemcitabine|gemcitabine|mesh-list
111472094|NCT03064854|Pemetrexed|pemetrexed|mesh-list
111472095|NCT03064854|Spartalizumab|spartalizumab|mesh-list
111472096|NCT03064854|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111472097|NCT03064854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111472098|NCT03064854|Tubulin Modulators|tubulin modulators|mesh-ancestor
111472099|NCT03064854|Antimitotic Agents|antimitotic agents|mesh-ancestor
111472100|NCT03064854|Mitosis Modulators|mitosis modulators|mesh-ancestor
111472101|NCT03064854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111472102|NCT03064854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111472103|NCT03064854|Antimetabolites|antimetabolites|mesh-ancestor
111472104|NCT03064854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111472105|NCT03064854|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111472106|NCT03064854|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111472107|NCT03064854|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111472108|NCT03064854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111472109|NCT00983814|Carbidopa|carbidopa|mesh-list
111472110|NCT00983814|Droxidopa|droxidopa|mesh-list
111472111|NCT00983814|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111472112|NCT00983814|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111472113|NCT00983814|Dopamine Agents|dopamine agents|mesh-ancestor
111472114|NCT00983814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111472115|NCT00983814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111472116|NCT00983814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111472117|NCT00983814|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
111472118|NCT00983814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111472119|NCT01921920|Omeprazole|omeprazole|mesh-list
111472120|NCT01921920|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111472121|NCT01921920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111472122|NCT01921920|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111472123|NCT01921920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111472124|NCT01921920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111472125|NCT04275414|Bevacizumab|bevacizumab|mesh-list
111472126|NCT04275414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111472127|NCT04275414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111472128|NCT04275414|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111472129|NCT04275414|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111472130|NCT04275414|Growth Substances|growth substances|mesh-ancestor
111472131|NCT04275414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111472132|NCT04275414|Growth Inhibitors|growth inhibitors|mesh-ancestor
111472133|NCT04395768|Vitamin D|vitamin d|mesh-list
111472134|NCT04395768|Cholecalciferol|cholecalciferol|mesh-list
111472135|NCT04395768|Vitamins|vitamins|mesh-list
111472136|NCT04395768|Ascorbic Acid|ascorbic acid|mesh-list
111472137|NCT04395768|Vitamin B 12|vitamin b 12|mesh-list
111472138|NCT04395768|Azithromycin|azithromycin|mesh-list
111472139|NCT04395768|Hydroxychloroquine|hydroxychloroquine|mesh-list
111472140|NCT04395768|Micronutrients|micronutrients|mesh-ancestor
111472141|NCT04395768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111472142|NCT04395768|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111472143|NCT04395768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111472144|NCT04395768|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111472145|NCT04395768|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111472146|NCT04395768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111472147|NCT04395768|Antimalarials|antimalarials|mesh-ancestor
111472148|NCT04395768|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111472149|NCT04395768|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111472150|NCT04395768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111472151|NCT04395768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111472152|NCT04395768|Antioxidants|antioxidants|mesh-ancestor
111472153|NCT04395768|Protective Agents|protective agents|mesh-ancestor
111472154|NCT04395768|Vitamin B Complex|vitamin b complex|mesh-ancestor
111472155|NCT01927224|Nifurtimox|nifurtimox|mesh-list
111472156|NCT01927224|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
111472157|NCT01927224|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111472158|NCT01927224|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111472159|NCT01927224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111472160|NCT01922154|Ranibizumab|ranibizumab|mesh-list
111472161|NCT01922154|Mitomycin|mitomycin|mesh-list
111472162|NCT01922154|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111472163|NCT01922154|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111472164|NCT01922154|Growth Substances|growth substances|mesh-ancestor
111472165|NCT01922154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111472166|NCT01922154|Growth Inhibitors|growth inhibitors|mesh-ancestor
111472167|NCT01922154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111472168|NCT01922154|Alkylating Agents|alkylating agents|mesh-ancestor
111472169|NCT01922154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111472170|NCT01922154|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111472171|NCT01922154|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111472172|NCT01922154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111472173|NCT03423342|Niacinamide|niacinamide|mesh-list
111472175|NCT03423342|Nicotinic Acids|nicotinic acids|mesh-list
111472176|NCT03423342|Vitamin B Complex|vitamin b complex|mesh-ancestor
111472177|NCT03423342|Vitamins|vitamins|mesh-ancestor
111472178|NCT03423342|Micronutrients|micronutrients|mesh-ancestor
111472179|NCT03423342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111472180|NCT03423342|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111472181|NCT03423342|Antimetabolites|antimetabolites|mesh-ancestor
111472182|NCT03423342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111472183|NCT03423342|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111472184|NCT03423342|Vasodilator Agents|vasodilator agents|mesh-ancestor
111472185|NCT01928160|Carboplatin|carboplatin|mesh-list
111472186|NCT01928160|Pemetrexed|pemetrexed|mesh-list
111472187|NCT01928160|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111472188|NCT01928160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111472189|NCT01928160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111472190|NCT01928160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111472191|NCT01928160|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111472192|NCT01928160|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111472193|NCT01928160|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111472194|NCT01928316|Mizolastine|mizolastine|mesh-list
111472195|NCT01928316|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
111472196|NCT01928316|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111472197|NCT01928316|Histamine Antagonists|histamine antagonists|mesh-ancestor
111472198|NCT01928316|Histamine Agents|histamine agents|mesh-ancestor
111472199|NCT01928316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111472200|NCT01928316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111472201|NCT01928316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111472202|NCT03050736|Dianhydrogalactitol|dianhydrogalactitol|mesh-list
111472203|NCT03050736|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111472204|NCT03050736|Alkylating Agents|alkylating agents|mesh-ancestor
111472205|NCT03050736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111472206|NCT03050736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111472207|NCT04559646|Hemostatics|hemostatics|mesh-list
111472208|NCT04559646|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111472209|NCT04559646|Coagulants|coagulants|mesh-ancestor
111472210|NCT04550520|Glucagon|glucagon|mesh-list
111472211|NCT04550520|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111472212|NCT04550520|Hormones|hormones|mesh-ancestor
111472213|NCT04550520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111472214|NCT04550520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111472215|NCT01928628|Valsartan|valsartan|mesh-list
111472216|NCT01928628|Lercanidipine|lercanidipine|mesh-list
111472217|NCT01928628|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111472218|NCT01928628|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111472219|NCT01928628|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111472220|NCT01928628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111472221|NCT01928628|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111472222|NCT01928628|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111472223|NCT01928628|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111472224|NCT01928628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111472225|NCT01929096|Edaravone|edaravone|mesh-list
111472226|NCT01929096|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111472227|NCT01929096|Antioxidants|antioxidants|mesh-ancestor
111472228|NCT01929096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111472229|NCT01929096|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111472230|NCT01929096|Protective Agents|protective agents|mesh-ancestor
111472231|NCT01929096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111472232|NCT03059004|TEMPO|tempo|mesh-list
111472233|NCT03059004|Antioxidants|antioxidants|mesh-ancestor
111472234|NCT03059004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111472235|NCT03059004|Protective Agents|protective agents|mesh-ancestor
111472236|NCT03059004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111472237|NCT04554888|Doxepin|doxepin|mesh-list
111472238|NCT04554888|Histamine|histamine|mesh-list
111472239|NCT04554888|Histamine Agonists|histamine agonists|mesh-ancestor
111472240|NCT04554888|Histamine Agents|histamine agents|mesh-ancestor
111472241|NCT04554888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111472242|NCT04554888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111472243|NCT04554888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111472244|NCT04554888|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111472245|NCT04554888|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111472246|NCT04554888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111472247|NCT04554888|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
111472248|NCT04554888|Antidepressive Agents|antidepressive agents|mesh-ancestor
111472249|NCT04554888|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111472250|NCT04554888|Histamine Antagonists|histamine antagonists|mesh-ancestor
111472251|NCT05601960|Sunscreening Agents|sunscreening agents|mesh-list
111472252|NCT05601960|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111472253|NCT05601960|Protective Agents|protective agents|mesh-ancestor
111472254|NCT05601960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111472255|NCT05601960|Dermatologic Agents|dermatologic agents|mesh-ancestor
111472256|NCT05605002|Serotonin|serotonin|mesh-list
111472257|NCT05605002|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111472258|NCT05605002|Serotonin Agents|serotonin agents|mesh-ancestor
111472259|NCT05605002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111472260|NCT05605002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111472261|NCT05605002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111472262|NCT03238248|Azacitidine|azacitidine|mesh-list
111472263|NCT03238248|Pevonedistat|pevonedistat|mesh-list
111472264|NCT03238248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111472265|NCT03238248|Antimetabolites|antimetabolites|mesh-ancestor
111472266|NCT03238248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111472267|NCT03238248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111472268|NCT03238248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111472269|NCT04124016|Grape Seed Extract|grape seed extract|mesh-list
111472270|NCT04124016|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111472271|NCT04124016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111472272|NCT04124016|Antioxidants|antioxidants|mesh-ancestor
111472273|NCT04124016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111472274|NCT04124016|Protective Agents|protective agents|mesh-ancestor
111472275|NCT04124016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111472276|NCT04124094|Fluticasone|fluticasone|mesh-list
111472277|NCT04124094|Xhance|xhance|mesh-list
111472278|NCT04124094|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
111472279|NCT04124094|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
111472280|NCT04124094|Charcoal|charcoal|mesh-list
111472281|NCT04124094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111472282|NCT04124094|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111472283|NCT04124094|Autonomic Agents|autonomic agents|mesh-ancestor
111472284|NCT04124094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111472285|NCT04124094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111472286|NCT04124094|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111472287|NCT04124094|Respiratory System Agents|respiratory system agents|mesh-ancestor
111472288|NCT04124094|Dermatologic Agents|dermatologic agents|mesh-ancestor
111472289|NCT04124094|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111472290|NCT04124094|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111472291|NCT04124094|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111472292|NCT04124094|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111472293|NCT04124094|Adrenergic Agents|adrenergic agents|mesh-ancestor
111472294|NCT04124094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111472295|NCT04124094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111472296|NCT04124094|Glucocorticoids|glucocorticoids|mesh-ancestor
111472297|NCT04124094|Hormones|hormones|mesh-ancestor
111472298|NCT04124094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111472299|NCT04124094|Sympathomimetics|sympathomimetics|mesh-ancestor
111472300|NCT04124094|Antidotes|antidotes|mesh-ancestor
111472301|NCT04124094|Protective Agents|protective agents|mesh-ancestor
111472302|NCT03033576|Nivolumab|nivolumab|mesh-list
111472303|NCT03033576|Ipilimumab|ipilimumab|mesh-list
111472304|NCT03033576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111472305|NCT03033576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111472306|NCT03033576|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111472307|NCT03033576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111472308|NCT04123392|Cyclophosphamide|cyclophosphamide|mesh-list
111472309|NCT04123392|Busulfan|busulfan|mesh-list
111472310|NCT04123392|Decitabine|decitabine|mesh-list
111472311|NCT04123392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111472312|NCT04123392|Immunologic Factors|immunologic factors|mesh-ancestor
111472313|NCT04123392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111472314|NCT04123392|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111472315|NCT04123392|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111472316|NCT04123392|Alkylating Agents|alkylating agents|mesh-ancestor
111472317|NCT04123392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111472318|NCT04123392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111472319|NCT04123392|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111472320|NCT04123392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111472321|NCT04123392|Antimetabolites|antimetabolites|mesh-ancestor
111472322|NCT04123392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111472323|NCT04760262|Remifentanil|remifentanil|mesh-list
111472324|NCT04760262|Propofol|propofol|mesh-list
111472325|NCT04760262|Sevoflurane|sevoflurane|mesh-list
111472326|NCT04760262|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111472327|NCT04760262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111472328|NCT04760262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111472329|NCT04760262|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111472330|NCT04760262|Anesthetics, General|anesthetics, general|mesh-ancestor
111472331|NCT04760262|Anesthetics|anesthetics|mesh-ancestor
111472332|NCT04760262|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111472333|NCT04760262|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111472334|NCT04760262|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111472335|NCT04760262|Narcotics|narcotics|mesh-ancestor
111472336|NCT04760262|Analgesics|analgesics|mesh-ancestor
111472337|NCT04760262|Sensory System Agents|sensory system agents|mesh-ancestor
111472338|NCT04760262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111472339|NCT03047928|Nivolumab|nivolumab|mesh-list
111472340|NCT03047928|Vaccines|vaccines|mesh-list
111472341|NCT03047928|Immunologic Factors|immunologic factors|mesh-ancestor
111472342|NCT03047928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111472343|NCT03047928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111472344|NCT03047928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111472345|NCT03047928|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111472346|NCT03047928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111472347|NCT05607810|Aflibercept|aflibercept|mesh-list
111472348|NCT05607810|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111472349|NCT05607810|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111472350|NCT05607810|Growth Substances|growth substances|mesh-ancestor
111472351|NCT05607810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111472352|NCT05607810|Growth Inhibitors|growth inhibitors|mesh-ancestor
111472353|NCT05607810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111472354|NCT04126278|Dexamethasone|dexamethasone|mesh-list
111472355|NCT04126278|Cortisone|cortisone|mesh-list
111472356|NCT04126278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111472357|NCT04126278|Antiemetics|antiemetics|mesh-ancestor
111472358|NCT04126278|Autonomic Agents|autonomic agents|mesh-ancestor
111472359|NCT04126278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111472360|NCT04126278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111472361|NCT04126278|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111472362|NCT04126278|Glucocorticoids|glucocorticoids|mesh-ancestor
111472363|NCT04126278|Hormones|hormones|mesh-ancestor
111472364|NCT04126278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111472365|NCT04126278|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111472366|NCT04126278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111472367|NCT04127682|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111472368|NCT04127682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111472369|NCT04122066|Sofosbuvir|sofosbuvir|mesh-list
111472370|NCT04122066|Antiviral Agents|antiviral agents|mesh-ancestor
111472371|NCT04122066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111472372|NCT04121910|Itraconazole|itraconazole|mesh-list
111472373|NCT04121910|Antifungal Agents|antifungal agents|mesh-ancestor
111472374|NCT04121910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111472375|NCT04121910|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111472376|NCT04121910|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111472377|NCT04121910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111472378|NCT04121910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111472379|NCT04121910|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111472380|NCT04121910|Hormone Antagonists|hormone antagonists|mesh-ancestor
111472381|NCT04121910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111472382|NCT04121910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111472383|NCT04121910|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111472384|NCT04129788|Bisacodyl|bisacodyl|mesh-list
111472385|NCT04129788|Cathartics|cathartics|mesh-ancestor
111472386|NCT04129788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111472387|NCT04129788|Laxatives|laxatives|mesh-ancestor
111472388|NCT03831126|Betamethasone|betamethasone|mesh-list
111472389|NCT03831126|Betamethasone Valerate|betamethasone valerate|mesh-list
111472390|NCT03831126|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
111472391|NCT03831126|Betamethasone benzoate|betamethasone benzoate|mesh-list
111472392|NCT03831126|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
111472393|NCT03831126|Glucocorticoids|glucocorticoids|mesh-ancestor
111472394|NCT03831126|Hormones|hormones|mesh-ancestor
111472395|NCT03831126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111472396|NCT03831126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111472397|NCT03831126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111472398|NCT03831126|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111472399|NCT03831126|Respiratory System Agents|respiratory system agents|mesh-ancestor
111472400|NCT04073784|Gemcitabine|gemcitabine|mesh-list
111472401|NCT04073784|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111472402|NCT04073784|Antimetabolites|antimetabolites|mesh-ancestor
111472403|NCT04073784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111472404|NCT04073784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111472405|NCT05606796|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111472406|NCT05606796|Latanoprost|latanoprost|mesh-list
111472407|NCT05606796|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111472408|NCT04129710|Rituximab|rituximab|mesh-list
111472409|NCT04129710|Methotrexate|methotrexate|mesh-list
111472410|NCT04129710|Etoposide|etoposide|mesh-list
111472411|NCT04129710|Lenalidomide|lenalidomide|mesh-list
111472412|NCT04129710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111472413|NCT04129710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111472414|NCT04129710|Immunologic Factors|immunologic factors|mesh-ancestor
111472415|NCT04129710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111472416|NCT04129710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111472417|NCT04129710|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111472418|NCT04129710|Abortifacient Agents|abortifacient agents|mesh-ancestor
111472419|NCT04129710|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111472420|NCT04129710|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111472421|NCT04129710|Antimetabolites|antimetabolites|mesh-ancestor
111472422|NCT04129710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111472423|NCT04129710|Dermatologic Agents|dermatologic agents|mesh-ancestor
111472424|NCT04129710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111472425|NCT04129710|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111472426|NCT04129710|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111472427|NCT04129710|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111472428|NCT04129710|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111472429|NCT04129710|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111472430|NCT04129710|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111472431|NCT04129710|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111472432|NCT04129710|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111472433|NCT04129710|Growth Substances|growth substances|mesh-ancestor
111472434|NCT04129710|Growth Inhibitors|growth inhibitors|mesh-ancestor
111472435|NCT03200808|Methylene Blue|methylene blue|mesh-list
111472436|NCT03200808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111472437|NCT03200808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111472438|NCT04129008|Aspirin|aspirin|mesh-list
111472439|NCT04129008|Indobufen|indobufen|mesh-list
111472440|NCT04129008|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111472441|NCT04129008|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111472442|NCT04129008|Analgesics|analgesics|mesh-ancestor
111472443|NCT04129008|Sensory System Agents|sensory system agents|mesh-ancestor
111472444|NCT04129008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111472445|NCT04129008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111472446|NCT04129008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111472447|NCT04129008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111472448|NCT04129008|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111472449|NCT04129008|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111472450|NCT04129008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111472451|NCT04129008|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111472452|NCT04129008|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111472453|NCT04129008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111472454|NCT04129008|Antipyretics|antipyretics|mesh-ancestor
111472455|NCT04128462|Phenylacetic acid|phenylacetic acid|mesh-list
111472456|NCT04128462|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111472457|NCT04128462|Antimetabolites|antimetabolites|mesh-ancestor
111472458|NCT04128462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111472459|NCT04128462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111472460|NCT04120350|Rituximab|rituximab|mesh-list
111472461|NCT04120350|Methotrexate|methotrexate|mesh-list
111472462|NCT04120350|Lenalidomide|lenalidomide|mesh-list
111472463|NCT04120350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111472464|NCT04120350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111472465|NCT04120350|Immunologic Factors|immunologic factors|mesh-ancestor
111472466|NCT04120350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111472467|NCT04120350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111472468|NCT04120350|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111472469|NCT04120350|Abortifacient Agents|abortifacient agents|mesh-ancestor
111472470|NCT04120350|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111472471|NCT04120350|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111472472|NCT04120350|Antimetabolites|antimetabolites|mesh-ancestor
111472473|NCT04120350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111472474|NCT04120350|Dermatologic Agents|dermatologic agents|mesh-ancestor
111472475|NCT04120350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111472476|NCT04120350|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111472477|NCT04120350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111472478|NCT04120350|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111472479|NCT04120350|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111472480|NCT04120350|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111472481|NCT04120350|Growth Substances|growth substances|mesh-ancestor
111472482|NCT04120350|Growth Inhibitors|growth inhibitors|mesh-ancestor
111472483|NCT04394598|Capecitabine|capecitabine|mesh-list
111472484|NCT04394598|Irinotecan|irinotecan|mesh-list
111472485|NCT04394598|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111472486|NCT04394598|Antimetabolites|antimetabolites|mesh-ancestor
111472487|NCT04394598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111472488|NCT04394598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110446101|NCT02696590|Vitamin D|vitamin d|mesh-list
111472489|NCT04394598|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111472490|NCT04394598|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111472491|NCT04394598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111472492|NCT04127916|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
111472493|NCT04127916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111472494|NCT04127916|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111472495|NCT04127916|Alkylating Agents|alkylating agents|mesh-ancestor
111472496|NCT04127916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111472497|NCT05602428|Anesthetics|anesthetics|mesh-list
111472498|NCT05602428|Esketamine|esketamine|mesh-list
111472499|NCT05602428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111472500|NCT05602428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111472501|NCT05602428|Antidepressive Agents|antidepressive agents|mesh-ancestor
111472502|NCT05602428|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111472503|NCT02983890|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111472504|NCT02983890|Dicloxacillin|dicloxacillin|mesh-list
111472505|NCT02983890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111472506|NCT04127058|Iloperidone|iloperidone|mesh-list
111472507|NCT04127058|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111472508|NCT04127058|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111472509|NCT04127058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111472510|NCT04127058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111472511|NCT04127058|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111472512|NCT03012360|Ciprofloxacin|ciprofloxacin|mesh-list
111472513|NCT03012360|Ceftriaxone|ceftriaxone|mesh-list
111472514|NCT03012360|Linezolid|linezolid|mesh-list
111472515|NCT03012360|Imipenem|imipenem|mesh-list
111472516|NCT03012360|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111472517|NCT03012360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111472518|NCT03012360|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111472519|NCT03012360|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111472520|NCT03012360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111472521|NCT03012360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111472522|NCT03012360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111472523|NCT03012360|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111472524|NCT03012360|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111472525|NCT03012360|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111472526|NCT04120974|Insulin|insulin|mesh-list
111472527|NCT04120974|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111472528|NCT04120974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111472529|NCT04126668|Vorolanib|vorolanib|mesh-list
111472530|NCT04126668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111472531|NCT04126668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111472532|NCT04126668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111472533|NCT04758936|Clonidine|clonidine|mesh-list
111472534|NCT04758936|Dexmedetomidine|dexmedetomidine|mesh-list
111472535|NCT04758936|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111472536|NCT04758936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111472537|NCT04758936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111472538|NCT04758936|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111196688|NCT06032923|Niacin|niacin|mesh-list
111472539|NCT04758936|Analgesics|analgesics|mesh-ancestor
111472540|NCT04758936|Sensory System Agents|sensory system agents|mesh-ancestor
111472541|NCT04758936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111472542|NCT04758936|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111472543|NCT04758936|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111472544|NCT04758936|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111472545|NCT04758936|Adrenergic Agents|adrenergic agents|mesh-ancestor
111472546|NCT04758936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111472547|NCT04758936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111472548|NCT04758936|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111472549|NCT04758936|Sympatholytics|sympatholytics|mesh-ancestor
111472550|NCT04758936|Autonomic Agents|autonomic agents|mesh-ancestor
111472551|NCT04126044|Bevacizumab|bevacizumab|mesh-list
111472552|NCT04126044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111472553|NCT04126044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111472554|NCT04126044|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111472555|NCT04126044|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111472556|NCT04126044|Growth Substances|growth substances|mesh-ancestor
111472557|NCT04126044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111472558|NCT04126044|Growth Inhibitors|growth inhibitors|mesh-ancestor
111472559|NCT04758858|Glucagon|glucagon|mesh-list
111472560|NCT04758858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111472561|NCT04758858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111472562|NCT04758858|Hormones|hormones|mesh-ancestor
111472563|NCT04758858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111472564|NCT04125888|Immunomodulating Agents|immunomodulating agents|mesh-list
111472565|NCT04125888|Immunologic Factors|immunologic factors|mesh-ancestor
111472566|NCT04125888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111472567|NCT02975310|Anesthetics|anesthetics|mesh-list
111472568|NCT02975310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111472569|NCT02975310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111472570|NCT04394208|Silymarin|silymarin|mesh-list
111472571|NCT04394208|Antioxidants|antioxidants|mesh-ancestor
111472572|NCT04394208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111472573|NCT04394208|Protective Agents|protective agents|mesh-ancestor
111472574|NCT04394208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111472575|NCT03829566|Methylprednisolone|methylprednisolone|mesh-list
111472576|NCT03829566|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111472577|NCT03829566|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111472578|NCT03829566|Prednisolone|prednisolone|mesh-list
111472579|NCT03829566|Prednisolone acetate|prednisolone acetate|mesh-list
111472580|NCT03829566|Cyclophosphamide|cyclophosphamide|mesh-list
111472581|NCT03829566|Rituximab|rituximab|mesh-list
111472582|NCT03829566|Thymoglobulin|thymoglobulin|mesh-list
111472583|NCT03829566|Antilymphocyte Serum|antilymphocyte serum|mesh-list
111472584|NCT03829566|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111472585|NCT03829566|Prednisolone phosphate|prednisolone phosphate|mesh-list
111472586|NCT03829566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111472587|NCT03829566|Immunologic Factors|immunologic factors|mesh-ancestor
111472588|NCT03829566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111472589|NCT03829566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111472590|NCT03829566|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111472591|NCT03829566|Alkylating Agents|alkylating agents|mesh-ancestor
111472592|NCT03829566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111472593|NCT03829566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111472594|NCT03829566|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111472595|NCT03829566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111472596|NCT03829566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111472597|NCT03829566|Antiemetics|antiemetics|mesh-ancestor
111472598|NCT03829566|Autonomic Agents|autonomic agents|mesh-ancestor
111472599|NCT03829566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111472600|NCT03829566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111472601|NCT03829566|Glucocorticoids|glucocorticoids|mesh-ancestor
111472602|NCT03829566|Hormones|hormones|mesh-ancestor
111472603|NCT03829566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111472604|NCT03829566|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111472605|NCT03829566|Protective Agents|protective agents|mesh-ancestor
111472606|NCT03829566|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111472607|NCT03933306|Dexmedetomidine|dexmedetomidine|mesh-list
111472608|NCT03933306|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111472609|NCT03933306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111472610|NCT03933306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111472611|NCT03933306|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111472612|NCT03933306|Analgesics|analgesics|mesh-ancestor
111472613|NCT03933306|Sensory System Agents|sensory system agents|mesh-ancestor
111472614|NCT03933306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111472615|NCT03933306|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111472616|NCT03933306|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111472617|NCT03933306|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111472618|NCT03933306|Adrenergic Agents|adrenergic agents|mesh-ancestor
111472619|NCT03933306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111472620|NCT03933306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111472621|NCT04394442|Hydroxychloroquine|hydroxychloroquine|mesh-list
111472622|NCT04394442|Antimalarials|antimalarials|mesh-ancestor
111472623|NCT04394442|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111472624|NCT04394442|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111472625|NCT04394442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111472626|NCT04394442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111472627|NCT04394442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111472628|NCT04394442|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111472629|NCT02972424|Teriparatide|teriparatide|mesh-list
111472630|NCT02972424|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111472631|NCT02972424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111472632|NCT02972424|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111472633|NCT05608590|Ethiodized Oil|ethiodized oil|mesh-list
111472634|NCT05608590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111472635|NCT04393584|Leucovorin|leucovorin|mesh-list
111472636|NCT04393584|Docetaxel|docetaxel|mesh-list
111472637|NCT04393584|Oxaliplatin|oxaliplatin|mesh-list
111472638|NCT04393584|Irinotecan|irinotecan|mesh-list
111472639|NCT04393584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111472640|NCT04393584|Tubulin Modulators|tubulin modulators|mesh-ancestor
111472641|NCT04393584|Antimitotic Agents|antimitotic agents|mesh-ancestor
111472642|NCT04393584|Mitosis Modulators|mitosis modulators|mesh-ancestor
111472643|NCT04393584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111472644|NCT04393584|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111472645|NCT04393584|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111472646|NCT04393584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111472647|NCT04393584|Antidotes|antidotes|mesh-ancestor
111472648|NCT04393584|Protective Agents|protective agents|mesh-ancestor
111472649|NCT04393584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111472650|NCT04393584|Vitamin B Complex|vitamin b complex|mesh-ancestor
111472651|NCT04393584|Vitamins|vitamins|mesh-ancestor
111472652|NCT04393584|Micronutrients|micronutrients|mesh-ancestor
111472653|NCT02965950|Cyclophosphamide|cyclophosphamide|mesh-list
111472654|NCT02965950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111472655|NCT02965950|Immunologic Factors|immunologic factors|mesh-ancestor
111472656|NCT02965950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111472657|NCT02965950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111472658|NCT02965950|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111472659|NCT02965950|Alkylating Agents|alkylating agents|mesh-ancestor
111472660|NCT02965950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111472661|NCT02965950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111472662|NCT02965950|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111472663|NCT03828474|Acetazolamide|acetazolamide|mesh-list
111472664|NCT03828474|Anticonvulsants|anticonvulsants|mesh-ancestor
111472665|NCT03828474|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
111472666|NCT03828474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111472667|NCT03828474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111472668|NCT03828474|Diuretics|diuretics|mesh-ancestor
111472669|NCT03828474|Natriuretic Agents|natriuretic agents|mesh-ancestor
111472670|NCT03828474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111472671|NCT03828084|Decitabine|decitabine|mesh-list
111472672|NCT03828084|Tetrahydrouridine|tetrahydrouridine|mesh-list
111472673|NCT03828084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111472674|NCT03828084|Antimetabolites|antimetabolites|mesh-ancestor
111472675|NCT03828084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111472676|NCT03828084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111472677|NCT03828084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111472678|NCT04274166|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111472679|NCT04274166|Immunologic Factors|immunologic factors|mesh-ancestor
111472680|NCT04274166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111472681|NCT02983734|Cycloserine|cycloserine|mesh-list
111472682|NCT02983734|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111472683|NCT02983734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111472684|NCT02983734|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111472685|NCT02983734|Antitubercular Agents|antitubercular agents|mesh-ancestor
111472686|NCT02983734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111472687|NCT02983734|Antimetabolites|antimetabolites|mesh-ancestor
111479309|NCT05012631|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111196816|NCT06002490|Antipyretics|antipyretics|mesh-ancestor
111472688|NCT02983734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111472689|NCT03821454|Capecitabine|capecitabine|mesh-list
111472690|NCT03821454|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111472691|NCT03821454|Antimetabolites|antimetabolites|mesh-ancestor
111472692|NCT03821454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111472693|NCT03821454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111472694|NCT03820518|Calcitriol|calcitriol|mesh-list
111472695|NCT03820518|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111472696|NCT03820518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111472697|NCT03820518|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
111472698|NCT03820518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111472699|NCT03820518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111472700|NCT03820518|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111472701|NCT03820518|Vitamins|vitamins|mesh-ancestor
111472702|NCT03820518|Micronutrients|micronutrients|mesh-ancestor
111472703|NCT03820518|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111472704|NCT03820206|Tranexamic Acid|tranexamic acid|mesh-list
111472705|NCT03820206|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111472706|NCT03820206|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111472707|NCT03820206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111472708|NCT03820206|Hemostatics|hemostatics|mesh-ancestor
111472709|NCT03820206|Coagulants|coagulants|mesh-ancestor
111472710|NCT02955654|Aripiprazole|aripiprazole|mesh-list
111472711|NCT02955654|Antidepressive Agents|antidepressive agents|mesh-ancestor
111472712|NCT02955654|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111472713|NCT02955654|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111472714|NCT02955654|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111472715|NCT02955654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111472716|NCT02955654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111472717|NCT02955654|Dopamine Agonists|dopamine agonists|mesh-ancestor
111472718|NCT02955654|Dopamine Agents|dopamine agents|mesh-ancestor
111472719|NCT02955654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111472720|NCT02955654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111472721|NCT02955654|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111472722|NCT02955654|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111472723|NCT02955654|Serotonin Agents|serotonin agents|mesh-ancestor
111472724|NCT02955654|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111472725|NCT02955654|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111472726|NCT02955654|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111472727|NCT02955654|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111472728|NCT04392648|Dexamethasone|dexamethasone|mesh-list
111472729|NCT04392648|Cyclophosphamide|cyclophosphamide|mesh-list
111472730|NCT04392648|Bortezomib|bortezomib|mesh-list
111472731|NCT04392648|Pomalidomide|pomalidomide|mesh-list
111472732|NCT04392648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111472733|NCT04392648|Immunologic Factors|immunologic factors|mesh-ancestor
111472734|NCT04392648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111472735|NCT04392648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111472736|NCT04392648|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111472737|NCT04392648|Alkylating Agents|alkylating agents|mesh-ancestor
111472738|NCT04392648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111472739|NCT04392648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111472740|NCT04392648|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111472741|NCT04392648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111472742|NCT04392648|Antiemetics|antiemetics|mesh-ancestor
111472743|NCT04392648|Autonomic Agents|autonomic agents|mesh-ancestor
111472744|NCT04392648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111472745|NCT04392648|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111472746|NCT04392648|Glucocorticoids|glucocorticoids|mesh-ancestor
111472747|NCT04392648|Hormones|hormones|mesh-ancestor
111472748|NCT04392648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111472749|NCT04392648|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111472750|NCT04392648|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111472751|NCT04392648|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111472752|NCT04392648|Growth Substances|growth substances|mesh-ancestor
111472753|NCT04392648|Growth Inhibitors|growth inhibitors|mesh-ancestor
111472754|NCT03826602|Metformin|metformin|mesh-list
111472755|NCT03826602|Tucatinib|tucatinib|mesh-list
111472756|NCT03826602|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111472757|NCT03826602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111472758|NCT03826602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111472759|NCT03826602|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111472760|NCT03826602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111472761|NCT03826602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111472763|NCT01453920|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111472764|NCT01453920|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111472765|NCT01453920|Growth Substances|growth substances|mesh-ancestor
111472766|NCT01453920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111472767|NCT01453920|Growth Inhibitors|growth inhibitors|mesh-ancestor
111472768|NCT01453920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111472769|NCT03820908|Bisantrene|bisantrene|mesh-list
111472770|NCT03820908|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111472771|NCT03820908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111472772|NCT02953548|Cannabidiol|cannabidiol|mesh-list
111472773|NCT02953548|Anticonvulsants|anticonvulsants|mesh-ancestor
111472774|NCT03112044|Sofosbuvir|sofosbuvir|mesh-list
111472775|NCT03112044|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
111472776|NCT03112044|Velpatasvir|velpatasvir|mesh-list
111472777|NCT03112044|Antiviral Agents|antiviral agents|mesh-ancestor
111472778|NCT03112044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111472779|NCT02952222|Dexmedetomidine|dexmedetomidine|mesh-list
111472780|NCT02952222|Propofol|propofol|mesh-list
111472781|NCT02952222|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111472782|NCT02952222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111472783|NCT02952222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111472784|NCT02952222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111472785|NCT02952222|Analgesics|analgesics|mesh-ancestor
111472786|NCT02952222|Sensory System Agents|sensory system agents|mesh-ancestor
111472787|NCT02952222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111472788|NCT02952222|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111472789|NCT02952222|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111472790|NCT02952222|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111472791|NCT02952222|Adrenergic Agents|adrenergic agents|mesh-ancestor
111472792|NCT02952222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111472793|NCT02952222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111472794|NCT02952222|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111472795|NCT02952222|Anesthetics, General|anesthetics, general|mesh-ancestor
111472796|NCT02952222|Anesthetics|anesthetics|mesh-ancestor
111472797|NCT03826368|Cannabidiol|cannabidiol|mesh-list
111472798|NCT03826368|Anticonvulsants|anticonvulsants|mesh-ancestor
111472799|NCT04391478|Milrinone|milrinone|mesh-list
111472800|NCT04391478|Sildenafil Citrate|sildenafil citrate|mesh-list
111472801|NCT04391478|Vasodilator Agents|vasodilator agents|mesh-ancestor
111472802|NCT04391478|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111472803|NCT04391478|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111472804|NCT04391478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111472805|NCT04391478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111472806|NCT04391478|Urological Agents|urological agents|mesh-ancestor
111472807|NCT04391478|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111472808|NCT04391478|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111472809|NCT04391478|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
111472810|NCT04391478|Protective Agents|protective agents|mesh-ancestor
111472811|NCT04391478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111472812|NCT03828006|Red yeast rice|red yeast rice|mesh-list
111472813|NCT03828006|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111472814|NCT03828006|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111472815|NCT03828006|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111472816|NCT03828006|Antimetabolites|antimetabolites|mesh-ancestor
111472817|NCT03828006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111472818|NCT03828006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111472819|NCT03828006|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111472820|NCT04391868|Sildenafil Citrate|sildenafil citrate|mesh-list
111472821|NCT04391868|Citric Acid|citric acid|mesh-list
111472822|NCT04391868|Sodium Citrate|sodium citrate|mesh-list
111472823|NCT04391868|Anticoagulants|anticoagulants|mesh-ancestor
111472824|NCT04391868|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
111472825|NCT04391868|Chelating Agents|chelating agents|mesh-ancestor
111472826|NCT04391868|Sequestering Agents|sequestering agents|mesh-ancestor
111472827|NCT04391868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111472828|NCT04391868|Vasodilator Agents|vasodilator agents|mesh-ancestor
111472829|NCT04391868|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111472830|NCT04391868|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111472831|NCT04391868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111472832|NCT04391868|Urological Agents|urological agents|mesh-ancestor
111472833|NCT03829332|Pembrolizumab|pembrolizumab|mesh-list
111472834|NCT03829332|Lenvatinib|lenvatinib|mesh-list
111472835|NCT03829332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111472836|NCT03829332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111472837|NCT03829332|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111472838|NCT03829332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111472839|NCT03829332|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111472840|NCT03829332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111472841|NCT02983188|Antipsychotic Agents|antipsychotic agents|mesh-list
111472842|NCT02983188|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111472843|NCT02983188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111472844|NCT02983188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111472845|NCT02983188|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111472846|NCT01450176|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
111472847|NCT01450176|Bepotastine besilate|bepotastine besilate|mesh-list
111472848|NCT01450176|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111472849|NCT01450176|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111472850|NCT01450176|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111472851|NCT01450176|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111472852|NCT01450176|Analgesics|analgesics|mesh-ancestor
111472853|NCT01450176|Sensory System Agents|sensory system agents|mesh-ancestor
111472854|NCT01450176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111472855|NCT01450176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111472856|NCT01450176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111472857|NCT01450176|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111472858|NCT01450176|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111472859|NCT01450176|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
111472860|NCT01450176|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111472861|NCT01450176|Histamine Antagonists|histamine antagonists|mesh-ancestor
111472862|NCT01450176|Histamine Agents|histamine agents|mesh-ancestor
111472863|NCT01450176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111472864|NCT01450176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111472865|NCT01454622|Metformin|metformin|mesh-list
111472866|NCT01454622|Canagliflozin|canagliflozin|mesh-list
111472867|NCT01454622|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111472868|NCT01454622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111472869|NCT01454622|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111472870|NCT01454622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111472871|NCT01450410|Nicotinic Acids|nicotinic acids|mesh-list
111472872|NCT01450410|Niacin|niacin|mesh-list
111472873|NCT01450410|Niacinamide|niacinamide|mesh-list
111472874|NCT01450410|Vitamin B Complex|vitamin b complex|mesh-ancestor
111472875|NCT01450410|Vitamins|vitamins|mesh-ancestor
111472876|NCT01450410|Micronutrients|micronutrients|mesh-ancestor
111472877|NCT01450410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111472878|NCT01450410|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111472879|NCT01450410|Antimetabolites|antimetabolites|mesh-ancestor
111472880|NCT01450410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111472881|NCT01450410|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111472882|NCT01450410|Vasodilator Agents|vasodilator agents|mesh-ancestor
111472883|NCT01450566|Lidocaine|lidocaine|mesh-list
111472884|NCT01450566|Anesthetics, Local|anesthetics, local|mesh-ancestor
111472885|NCT01450566|Anesthetics|anesthetics|mesh-ancestor
111472886|NCT01450566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111472887|NCT01450566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111472888|NCT01450566|Sensory System Agents|sensory system agents|mesh-ancestor
111472889|NCT01450566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111472890|NCT01450566|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111472891|NCT01450566|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111472892|NCT01450566|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111472893|NCT01450566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111472894|NCT01450566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111472895|NCT02947386|Nivolumab|nivolumab|mesh-list
111472896|NCT02947386|Nimotuzumab|nimotuzumab|mesh-list
111472897|NCT02947386|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111472898|NCT02947386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111472899|NCT02947386|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111472900|NCT02947386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111472901|NCT03043014|Misoprostol|misoprostol|mesh-list
111472902|NCT03043014|Mifepristone|mifepristone|mesh-list
111472903|NCT03043014|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111472904|NCT03043014|Abortifacient Agents|abortifacient agents|mesh-ancestor
111472905|NCT03043014|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111472906|NCT03043014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111472907|NCT03043014|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111472908|NCT03043014|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111472909|NCT03043014|Oxytocics|oxytocics|mesh-ancestor
111472910|NCT03043014|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
111472911|NCT03043014|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111472912|NCT03043014|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111472913|NCT03043014|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111472914|NCT03043014|Contraceptive Agents|contraceptive agents|mesh-ancestor
111472915|NCT03043014|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
111472916|NCT03043014|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
111472917|NCT03043014|Hormone Antagonists|hormone antagonists|mesh-ancestor
111472918|NCT03043014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111472919|NCT03043014|Luteolytic Agents|luteolytic agents|mesh-ancestor
111472920|NCT03043014|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111472921|NCT03043014|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
111472923|NCT02983344|Ropivacaine|ropivacaine|mesh-list
111472924|NCT02983344|Anesthetics, Local|anesthetics, local|mesh-ancestor
111472925|NCT02983344|Anesthetics|anesthetics|mesh-ancestor
111472926|NCT02983344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111472927|NCT02983344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111472928|NCT02983344|Sensory System Agents|sensory system agents|mesh-ancestor
111472929|NCT02983344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111472930|NCT02983344|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111472931|NCT02983344|Narcotics|narcotics|mesh-ancestor
111472932|NCT02983344|Analgesics|analgesics|mesh-ancestor
111472933|NCT02983344|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111472934|NCT02983344|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111472935|NCT02983344|Anesthetics, General|anesthetics, general|mesh-ancestor
111472936|NCT03824340|Doxycycline|doxycycline|mesh-list
111472937|NCT03824340|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111472938|NCT03824340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111472939|NCT03824340|Antimalarials|antimalarials|mesh-ancestor
111472940|NCT03824340|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111472941|NCT03824340|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111472942|NCT01455246|Meropenem|meropenem|mesh-list
111472943|NCT01455246|Daptomycin|daptomycin|mesh-list
111472944|NCT01455246|Ceftazidime|ceftazidime|mesh-list
111472945|NCT01455246|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111472946|NCT01455246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111472947|NCT02934282|HBOC 201|hboc 201|mesh-list
111472948|NCT02934282|Blood Substitutes|blood substitutes|mesh-ancestor
111472949|NCT03823950|Lenograstim|lenograstim|mesh-list
111472950|NCT03823950|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111472951|NCT03823950|Immunologic Factors|immunologic factors|mesh-ancestor
111472952|NCT03823950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111472953|NCT01451268|Panobinostat|panobinostat|mesh-list
111472954|NCT01451268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111472955|NCT01451268|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111472956|NCT01451268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111472957|NCT01451268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111472958|NCT03823638|Mannitol|mannitol|mesh-list
111472959|NCT03823638|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
111472960|NCT03823638|Diuretics|diuretics|mesh-ancestor
111472961|NCT03823638|Natriuretic Agents|natriuretic agents|mesh-ancestor
111472962|NCT03823638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111472963|NCT02884908|Pregabalin|pregabalin|mesh-list
111472964|NCT02884908|Analgesics|analgesics|mesh-ancestor
111472965|NCT02884908|Sensory System Agents|sensory system agents|mesh-ancestor
111472966|NCT02884908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111472967|NCT02884908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111472968|NCT02884908|Anticonvulsants|anticonvulsants|mesh-ancestor
111472969|NCT02884908|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111472970|NCT02884908|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111472971|NCT02884908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111472972|NCT02884908|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111472973|NCT02884908|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111472974|NCT02884908|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111472975|NCT02884908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111472976|NCT02884908|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111472977|NCT01451580|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111472978|NCT01451580|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111472979|NCT01451580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111472980|NCT01451658|Propranolol|propranolol|mesh-list
111472981|NCT01451658|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111472982|NCT01451658|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111472983|NCT01451658|Adrenergic Agents|adrenergic agents|mesh-ancestor
111472984|NCT01451658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111472985|NCT01451658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111472986|NCT01451658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111472987|NCT01451658|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111472989|NCT01451658|Vasodilator Agents|vasodilator agents|mesh-ancestor
111472990|NCT02851056|Lenograstim|lenograstim|mesh-list
111472991|NCT02851056|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111472992|NCT02851056|Immunologic Factors|immunologic factors|mesh-ancestor
111472993|NCT02851056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111472994|NCT02935374|Amoxicillin|amoxicillin|mesh-list
111472995|NCT02935374|Clavulanic Acid|clavulanic acid|mesh-list
111472996|NCT02935374|Clavulanic Acids|clavulanic acids|mesh-list
111472997|NCT02935374|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111472998|NCT02935374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111472999|NCT02935374|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
111473000|NCT02935374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111473001|NCT02935374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111473002|NCT01452750|Lansoprazole|lansoprazole|mesh-list
111473003|NCT01452750|Dexlansoprazole|dexlansoprazole|mesh-list
111473004|NCT01452750|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111473005|NCT01452750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111473006|NCT01452750|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111473007|NCT01452750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111473008|NCT01452750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111473009|NCT01452828|Tedizolid|tedizolid|mesh-list
111473010|NCT01452828|Tedizolid phosphate|tedizolid phosphate|mesh-list
111473011|NCT01452828|Oxazolidinones|oxazolidinones|mesh-list
111473012|NCT01452828|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111473013|NCT01452828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111473014|NCT01452828|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111473015|NCT01452828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111473016|NCT01452828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111473017|NCT01452906|Omeprazole|omeprazole|mesh-list
111473018|NCT01452906|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111473019|NCT01452906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111473020|NCT01452906|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111473021|NCT01452906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111473022|NCT01452906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111473023|NCT03823248|Folic Acid|folic acid|mesh-list
111473024|NCT03823248|Vitamin B Complex|vitamin b complex|mesh-list
111473025|NCT03823248|Hematinics|hematinics|mesh-ancestor
111473026|NCT03823248|Vitamins|vitamins|mesh-ancestor
111473027|NCT03823248|Micronutrients|micronutrients|mesh-ancestor
111473028|NCT03823248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111473029|NCT03822936|Fluorouracil|fluorouracil|mesh-list
111473030|NCT03822936|Oxaliplatin|oxaliplatin|mesh-list
111473031|NCT03822936|Irinotecan|irinotecan|mesh-list
111473032|NCT03822936|Antimetabolites|antimetabolites|mesh-ancestor
111473033|NCT03822936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111473034|NCT03822936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111473035|NCT03822936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111473036|NCT03822936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111473037|NCT03822936|Immunologic Factors|immunologic factors|mesh-ancestor
111473038|NCT03822936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111473039|NCT03822936|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111473040|NCT03822936|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111473041|NCT03822936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111473042|NCT03822546|Nicotine|nicotine|mesh-list
111473043|NCT03822546|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111473044|NCT03822546|Autonomic Agents|autonomic agents|mesh-ancestor
111473045|NCT03822546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111473046|NCT03822546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111473047|NCT03822546|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111473048|NCT03822546|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111473049|NCT03822546|Cholinergic Agents|cholinergic agents|mesh-ancestor
111473050|NCT03822546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111473051|NCT03822546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111473052|NCT01453686|Hydrocortisone|hydrocortisone|mesh-list
111473053|NCT01453686|Clobetasol|clobetasol|mesh-list
111473054|NCT01453686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111473055|NCT01453686|Glucocorticoids|glucocorticoids|mesh-ancestor
111473056|NCT01453686|Hormones|hormones|mesh-ancestor
111473057|NCT01453686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111473058|NCT01453686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111473059|NCT01455870|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111473060|NCT01455870|Exenatide|exenatide|mesh-list
111473061|NCT01455870|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111473062|NCT01455870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111473063|NCT01455870|Incretins|incretins|mesh-ancestor
111473064|NCT01455870|Hormones|hormones|mesh-ancestor
111473065|NCT01455870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111473066|NCT01455870|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111473067|NCT01455870|Protease Inhibitors|protease inhibitors|mesh-ancestor
111473068|NCT01455870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111473069|NCT01455870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111473070|NCT01455870|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111473072|NCT01456260|Dexlansoprazole|dexlansoprazole|mesh-list
111473073|NCT01456260|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111473074|NCT01456260|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111473075|NCT01456260|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111473076|NCT01456260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111473077|NCT01456260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111473078|NCT01890408|Ropivacaine|ropivacaine|mesh-list
111473079|NCT01890408|Anesthetics, Local|anesthetics, local|mesh-ancestor
111473080|NCT01890408|Anesthetics|anesthetics|mesh-ancestor
111473081|NCT01890408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111473082|NCT01890408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111473083|NCT01890408|Sensory System Agents|sensory system agents|mesh-ancestor
111473084|NCT01890408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111473085|NCT04849650|Amisulpride|amisulpride|mesh-list
111473086|NCT04849650|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111473087|NCT04849650|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111473088|NCT04849650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111473089|NCT04849650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111473090|NCT04849650|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111473091|NCT04849650|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111473092|NCT04849650|Dopamine Agents|dopamine agents|mesh-ancestor
111473093|NCT04849650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111473094|NCT04849650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111473095|NCT04849650|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111473096|NCT04849650|Antidepressive Agents|antidepressive agents|mesh-ancestor
111473097|NCT01891500|Nitric Oxide|nitric oxide|mesh-list
111473098|NCT01891500|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111473099|NCT01891500|Autonomic Agents|autonomic agents|mesh-ancestor
111473100|NCT01891500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111473101|NCT01891500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111473102|NCT01891500|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111473103|NCT01891500|Respiratory System Agents|respiratory system agents|mesh-ancestor
111473104|NCT01891500|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111473105|NCT01891500|Antioxidants|antioxidants|mesh-ancestor
111473106|NCT01891500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111473107|NCT01891500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111473108|NCT01891500|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
111473109|NCT01891500|Vasodilator Agents|vasodilator agents|mesh-ancestor
111473110|NCT01891500|Gasotransmitters|gasotransmitters|mesh-ancestor
111473111|NCT01891500|Protective Agents|protective agents|mesh-ancestor
111473112|NCT02862132|Vedolizumab|vedolizumab|mesh-list
111473113|NCT02862132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111473114|NCT02859402|Fludarabine|fludarabine|mesh-list
111473115|NCT02859402|Busulfan|busulfan|mesh-list
111473116|NCT02859402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111473117|NCT02859402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111473118|NCT02859402|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111473119|NCT02859402|Immunologic Factors|immunologic factors|mesh-ancestor
111473120|NCT02859402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111473121|NCT02859402|Alkylating Agents|alkylating agents|mesh-ancestor
111473122|NCT02859402|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111473123|NCT02859402|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111473124|NCT04844268|Vaccines|vaccines|mesh-list
111473125|NCT04844268|Immunologic Factors|immunologic factors|mesh-ancestor
111473126|NCT04844268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111473127|NCT04842552|Hydralazine|hydralazine|mesh-list
111473128|NCT04842552|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111473129|NCT04842552|Vasodilator Agents|vasodilator agents|mesh-ancestor
111473130|NCT02535312|Cisplatin|cisplatin|mesh-list
111473131|NCT02535312|Pemetrexed|pemetrexed|mesh-list
111473132|NCT02535312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111473133|NCT02535312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111473134|NCT02535312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111473135|NCT02535312|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111473136|NCT02535312|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111473137|NCT01891812|Nitrous Oxide|nitrous oxide|mesh-list
111473138|NCT01891812|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111473139|NCT01891812|Anesthetics, General|anesthetics, general|mesh-ancestor
111473140|NCT01891812|Anesthetics|anesthetics|mesh-ancestor
111473141|NCT01891812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111473142|NCT01891812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111473143|NCT01891812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111473144|NCT01891812|Analgesics|analgesics|mesh-ancestor
111473145|NCT01891812|Sensory System Agents|sensory system agents|mesh-ancestor
111473146|NCT01891812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111473147|NCT04390464|Ravulizumab|ravulizumab|mesh-list
111473148|NCT04390464|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
111473149|NCT04390464|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111473150|NCT04390464|Immunologic Factors|immunologic factors|mesh-ancestor
111473151|NCT04390464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111473152|NCT01892748|Vitamin D|vitamin d|mesh-list
111473153|NCT01892748|Cholecalciferol|cholecalciferol|mesh-list
111473154|NCT01892748|Vitamins|vitamins|mesh-ancestor
111473155|NCT01892748|Micronutrients|micronutrients|mesh-ancestor
111473156|NCT01892748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111473157|NCT01892748|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111473158|NCT01892748|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111473159|NCT01893060|Chlorhexidine|chlorhexidine|mesh-list
111473160|NCT01893060|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
111473161|NCT01893060|Povidone-Iodine|povidone-iodine|mesh-list
111473162|NCT01893060|Povidone|povidone|mesh-list
111473163|NCT01893060|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111473164|NCT01893060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111473165|NCT01893060|Disinfectants|disinfectants|mesh-ancestor
111473166|NCT01893060|Dermatologic Agents|dermatologic agents|mesh-ancestor
111473167|NCT01893060|Plasma Substitutes|plasma substitutes|mesh-ancestor
111473168|NCT01893060|Blood Substitutes|blood substitutes|mesh-ancestor
111473169|NCT02848560|Xenon|xenon|mesh-list
111473170|NCT02848560|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111473171|NCT02848560|Anesthetics, General|anesthetics, general|mesh-ancestor
111473172|NCT02848560|Anesthetics|anesthetics|mesh-ancestor
111473173|NCT02848560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111473174|NCT02848560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111473175|NCT01457820|Allopurinol|allopurinol|mesh-list
111473176|NCT01457820|Antimetabolites|antimetabolites|mesh-ancestor
111473177|NCT01457820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111473178|NCT01457820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111473179|NCT01457820|Gout Suppressants|gout suppressants|mesh-ancestor
111473180|NCT01457820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111473181|NCT01457820|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111473182|NCT01457820|Antioxidants|antioxidants|mesh-ancestor
111473183|NCT01457820|Protective Agents|protective agents|mesh-ancestor
111473184|NCT01457820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111473185|NCT05020782|Belimumab|belimumab|mesh-list
111473186|NCT05020782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111473187|NCT05020782|Immunologic Factors|immunologic factors|mesh-ancestor
111473188|NCT05020782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111473189|NCT01893294|Gemcitabine|gemcitabine|mesh-list
111473190|NCT01893294|Fluorouracil|fluorouracil|mesh-list
111473191|NCT01893294|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111473192|NCT01893294|Antimetabolites|antimetabolites|mesh-ancestor
111473193|NCT01893294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111473194|NCT01893294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111473195|NCT01893294|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111473196|NCT01893294|Immunologic Factors|immunologic factors|mesh-ancestor
111473197|NCT01893294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111473198|NCT01458054|Ritonavir|ritonavir|mesh-list
111473199|NCT01458054|Omeprazole|omeprazole|mesh-list
111473200|NCT01458054|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111473201|NCT01458054|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111473202|NCT01458054|Protease Inhibitors|protease inhibitors|mesh-ancestor
111473203|NCT01458054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111473204|NCT01458054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111473205|NCT01458054|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111473206|NCT01458054|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111473207|NCT01458054|Antiviral Agents|antiviral agents|mesh-ancestor
111473208|NCT01458054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111473209|NCT01458054|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111473210|NCT01458054|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111473211|NCT01458054|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111473212|NCT01458054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111473213|NCT01458054|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111197348|NCT05781711|Metformin|metformin|mesh-list
111473214|NCT01893450|Pentoxifylline|pentoxifylline|mesh-list
111473215|NCT01893450|Bromocriptine|bromocriptine|mesh-list
111473216|NCT01893450|Methimazole|methimazole|mesh-list
111473217|NCT01893450|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111473218|NCT01893450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111473219|NCT01893450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111473220|NCT01893450|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111473221|NCT01893450|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111473222|NCT01893450|Protective Agents|protective agents|mesh-ancestor
111473223|NCT01893450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111473224|NCT01893450|Vasodilator Agents|vasodilator agents|mesh-ancestor
111473225|NCT01893450|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111473226|NCT01893450|Antioxidants|antioxidants|mesh-ancestor
111473227|NCT01893450|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111473228|NCT01893450|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111473229|NCT01893450|Hormone Antagonists|hormone antagonists|mesh-ancestor
110446196|NCT01706692|Antifungal Agents|antifungal agents|mesh-ancestor
111473230|NCT01893450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111473231|NCT01893450|Dopamine Agonists|dopamine agonists|mesh-ancestor
111473232|NCT01893450|Dopamine Agents|dopamine agents|mesh-ancestor
111473233|NCT01893450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111473234|NCT01893450|Antithyroid Agents|antithyroid agents|mesh-ancestor
111473235|NCT05027100|Irinotecan|irinotecan|mesh-list
111473236|NCT05027100|Tislelizumab|tislelizumab|mesh-list
111473237|NCT05027100|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111473238|NCT05027100|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111473239|NCT05027100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111473240|NCT05027100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111473241|NCT05027100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111473242|NCT05027100|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111473243|NCT01458600|Diclofenac|diclofenac|mesh-list
111473244|NCT01458600|Propranolol|propranolol|mesh-list
111473245|NCT01458600|Metoprolol|metoprolol|mesh-list
111473246|NCT01458600|Methimazole|methimazole|mesh-list
111473247|NCT01458600|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111473248|NCT01458600|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111473249|NCT01458600|Analgesics|analgesics|mesh-ancestor
111473250|NCT01458600|Sensory System Agents|sensory system agents|mesh-ancestor
111473251|NCT01458600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111473252|NCT01458600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111473253|NCT01458600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111473254|NCT01458600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111473255|NCT01458600|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111473256|NCT01458600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111473257|NCT01458600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111473258|NCT01458600|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111473259|NCT01458600|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111473260|NCT01458600|Adrenergic Agents|adrenergic agents|mesh-ancestor
111473261|NCT01458600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111473262|NCT01458600|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111473263|NCT01458600|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111473264|NCT01458600|Vasodilator Agents|vasodilator agents|mesh-ancestor
111473265|NCT01458600|Sympatholytics|sympatholytics|mesh-ancestor
111473266|NCT01458600|Autonomic Agents|autonomic agents|mesh-ancestor
111473267|NCT01458600|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
111473268|NCT01458600|Antithyroid Agents|antithyroid agents|mesh-ancestor
111473269|NCT01458600|Hormone Antagonists|hormone antagonists|mesh-ancestor
111473270|NCT01458600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111473271|NCT02832570|Sildenafil Citrate|sildenafil citrate|mesh-list
111473272|NCT02832570|Vasodilator Agents|vasodilator agents|mesh-ancestor
111473273|NCT02832570|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111473274|NCT02832570|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111473275|NCT02832570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111473276|NCT02832570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111473277|NCT02832570|Urological Agents|urological agents|mesh-ancestor
111473278|NCT02742324|Interferon-alpha|interferon-alpha|mesh-list
111473279|NCT02742324|Interferon alpha-2|interferon alpha-2|mesh-list
111473280|NCT02742324|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
111473281|NCT02742324|Antiviral Agents|antiviral agents|mesh-ancestor
111473282|NCT02742324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111473283|NCT02742324|Immunologic Factors|immunologic factors|mesh-ancestor
111473284|NCT02742324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111473285|NCT02742324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111473286|NCT01459146|Lumefantrine|lumefantrine|mesh-list
111473287|NCT01459146|Artemether|artemether|mesh-list
111473288|NCT01459146|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
111473289|NCT01459146|Albendazole|albendazole|mesh-list
111473290|NCT01459146|Praziquantel|praziquantel|mesh-list
111473291|NCT01459146|Antimalarials|antimalarials|mesh-ancestor
111473292|NCT01459146|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111473293|NCT01459146|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111473294|NCT01459146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111473296|NCT01459146|Anticestodal Agents|anticestodal agents|mesh-ancestor
111473297|NCT01459146|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
111473298|NCT01459146|Tubulin Modulators|tubulin modulators|mesh-ancestor
111473299|NCT01459146|Antimitotic Agents|antimitotic agents|mesh-ancestor
111473300|NCT01459146|Mitosis Modulators|mitosis modulators|mesh-ancestor
111473301|NCT01459146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111473302|NCT01459146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111473303|NCT05026398|Fenfluramine|fenfluramine|mesh-list
111473304|NCT05026398|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111473305|NCT05026398|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111473306|NCT05026398|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111473307|NCT05026398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111473308|NCT05026398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111473309|NCT05026398|Serotonin Agents|serotonin agents|mesh-ancestor
111473310|NCT05026398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111473311|NCT05586750|Atorvastatin|atorvastatin|mesh-list
111473312|NCT05586750|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111473313|NCT05586750|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111473314|NCT05586750|Antimetabolites|antimetabolites|mesh-ancestor
111473315|NCT05586750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111473316|NCT05586750|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111473317|NCT05586750|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111473318|NCT05586750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111473319|NCT02720094|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
111473320|NCT02720094|Cabotegravir|cabotegravir|mesh-list
111473321|NCT02720094|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111473322|NCT02720094|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111473323|NCT02720094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111473324|NCT02720094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111473325|NCT02720094|Antiviral Agents|antiviral agents|mesh-ancestor
111473326|NCT02720094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111473327|NCT02720094|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111473328|NCT02720094|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111473329|NCT02720094|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111473330|NCT02720094|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111473331|NCT02716974|Docetaxel|docetaxel|mesh-list
111473332|NCT02716974|Leuprolide|leuprolide|mesh-list
111473333|NCT02716974|Bicalutamide|bicalutamide|mesh-list
111473334|NCT02716974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111473335|NCT02716974|Tubulin Modulators|tubulin modulators|mesh-ancestor
111473336|NCT02716974|Antimitotic Agents|antimitotic agents|mesh-ancestor
111473337|NCT02716974|Mitosis Modulators|mitosis modulators|mesh-ancestor
111473338|NCT02716974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111473339|NCT02716974|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111473340|NCT02716974|Fertility Agents|fertility agents|mesh-ancestor
111473341|NCT02716974|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111473342|NCT02716974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111473343|NCT02716974|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111473344|NCT02716974|Androgen Antagonists|androgen antagonists|mesh-ancestor
111473345|NCT02716974|Hormone Antagonists|hormone antagonists|mesh-ancestor
111473346|NCT02716974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111473347|NCT01459380|Bevacizumab|bevacizumab|mesh-list
111473348|NCT01459380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111473349|NCT01459380|Carboplatin|carboplatin|mesh-list
111473350|NCT01459380|Doxorubicin|doxorubicin|mesh-list
111473351|NCT01459380|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111473352|NCT01459380|Veliparib|veliparib|mesh-list
111473353|NCT01459380|Endothelial Growth Factors|endothelial growth factors|mesh-list
111473354|NCT01459380|Antibodies|antibodies|mesh-list
111473355|NCT01459380|Immunoglobulins|immunoglobulins|mesh-list
111473356|NCT01459380|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111473357|NCT01459380|Immunoglobulin G|immunoglobulin g|mesh-list
111473358|NCT01459380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111473359|NCT01459380|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111473360|NCT01459380|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111473361|NCT01459380|Growth Substances|growth substances|mesh-ancestor
111473362|NCT01459380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111473363|NCT01459380|Growth Inhibitors|growth inhibitors|mesh-ancestor
111473364|NCT01459380|Immunologic Factors|immunologic factors|mesh-ancestor
111473365|NCT01459380|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111473366|NCT01459380|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111473367|NCT01459380|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111473368|NCT01459380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111473369|NCT01459380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111473370|NCT01459380|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111473371|NCT04346004|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
111473372|NCT04346004|Hematinics|hematinics|mesh-ancestor
111473373|NCT02680314|Methotrexate|methotrexate|mesh-list
111473374|NCT02680314|Misoprostol|misoprostol|mesh-list
111473375|NCT02680314|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111473376|NCT02680314|Abortifacient Agents|abortifacient agents|mesh-ancestor
111473377|NCT02680314|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111473378|NCT02680314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111473379|NCT02680314|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111473380|NCT02680314|Antimetabolites|antimetabolites|mesh-ancestor
111473381|NCT02680314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111473382|NCT02680314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111473383|NCT02680314|Dermatologic Agents|dermatologic agents|mesh-ancestor
111473384|NCT02680314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111473385|NCT02680314|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111473386|NCT02680314|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111473387|NCT02680314|Immunologic Factors|immunologic factors|mesh-ancestor
111473388|NCT02680314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111473389|NCT02680314|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111473390|NCT02680314|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111473391|NCT02680314|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111473392|NCT02680314|Oxytocics|oxytocics|mesh-ancestor
111473393|NCT02707692|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
111473394|NCT02707692|Immunologic Factors|immunologic factors|mesh-ancestor
111473395|NCT02707692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111473396|NCT02706678|Tacrolimus|tacrolimus|mesh-list
111473397|NCT02706678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111473398|NCT02706678|Immunologic Factors|immunologic factors|mesh-ancestor
111473399|NCT02706678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111473400|NCT02706678|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111473401|NCT02706678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111473402|NCT02706678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111473403|NCT02705196|Paclitaxel|paclitaxel|mesh-list
111473404|NCT02705196|Gemcitabine|gemcitabine|mesh-list
111473405|NCT02705196|Atezolizumab|atezolizumab|mesh-list
111473406|NCT02705196|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111473407|NCT02705196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111473408|NCT02705196|Tubulin Modulators|tubulin modulators|mesh-ancestor
111473409|NCT02705196|Antimitotic Agents|antimitotic agents|mesh-ancestor
111473410|NCT02705196|Mitosis Modulators|mitosis modulators|mesh-ancestor
110453458|NCT01176968|Diuretics|diuretics|mesh-ancestor
111473411|NCT02705196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111473412|NCT02705196|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111473413|NCT02705196|Antimetabolites|antimetabolites|mesh-ancestor
111473414|NCT02705196|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111473415|NCT02705196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111473416|NCT02703948|Lidocaine|lidocaine|mesh-list
111473417|NCT02703948|Anesthetics, Local|anesthetics, local|mesh-ancestor
111473418|NCT02703948|Anesthetics|anesthetics|mesh-ancestor
111473419|NCT02703948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111473420|NCT02703948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111473421|NCT02703948|Sensory System Agents|sensory system agents|mesh-ancestor
111473422|NCT02703948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111473423|NCT02703948|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111473424|NCT02703948|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111473425|NCT02703948|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111473426|NCT02703948|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111473427|NCT02703948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111473428|NCT02666742|Aspirin|aspirin|mesh-list
111473429|NCT02666742|Rivaroxaban|rivaroxaban|mesh-list
111473430|NCT02666742|Edoxaban|edoxaban|mesh-list
111473431|NCT02666742|Dabigatran|dabigatran|mesh-list
111473432|NCT02666742|Anticoagulants|anticoagulants|mesh-list
111473433|NCT02666742|Coagulants|coagulants|mesh-list
111473434|NCT02666742|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111473435|NCT02666742|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111473436|NCT02666742|Analgesics|analgesics|mesh-ancestor
111473437|NCT02666742|Sensory System Agents|sensory system agents|mesh-ancestor
111473438|NCT02666742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111473439|NCT02666742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111473440|NCT02666742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111473441|NCT02666742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111473442|NCT02666742|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111473443|NCT02666742|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111473444|NCT02666742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111473445|NCT02666742|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111473446|NCT02666742|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111473447|NCT02666742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111473448|NCT02666742|Antipyretics|antipyretics|mesh-ancestor
111473449|NCT02666742|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111473450|NCT02666742|Antithrombins|antithrombins|mesh-ancestor
111473451|NCT02666742|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111473452|NCT02666742|Protease Inhibitors|protease inhibitors|mesh-ancestor
111473453|NCT02684292|Pembrolizumab|pembrolizumab|mesh-list
111473454|NCT02684292|Brentuximab Vedotin|brentuximab vedotin|mesh-list
111473455|NCT02684292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111473456|NCT02684292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111473457|NCT02684292|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111473458|NCT02684292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111473459|NCT02684292|Immunotoxins|immunotoxins|mesh-ancestor
111473460|NCT02684292|Immunoconjugates|immunoconjugates|mesh-ancestor
111473461|NCT02684292|Immunologic Factors|immunologic factors|mesh-ancestor
111473462|NCT02684292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111473463|NCT05586516|Paclitaxel|paclitaxel|mesh-list
111473464|NCT05586516|Gemcitabine|gemcitabine|mesh-list
111473465|NCT05586516|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111473466|NCT05586516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111473467|NCT05586516|Tubulin Modulators|tubulin modulators|mesh-ancestor
111473468|NCT05586516|Antimitotic Agents|antimitotic agents|mesh-ancestor
111473469|NCT05586516|Mitosis Modulators|mitosis modulators|mesh-ancestor
110446244|NCT02767024|Adrenergic Agents|adrenergic agents|mesh-ancestor
111473470|NCT05586516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111473471|NCT05586516|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111473472|NCT05586516|Antimetabolites|antimetabolites|mesh-ancestor
111473473|NCT04390854|Clotrimazole|clotrimazole|mesh-list
111473474|NCT04390854|Miconazole|miconazole|mesh-list
111473475|NCT04390854|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111473476|NCT04390854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111473477|NCT04390854|Antifungal Agents|antifungal agents|mesh-ancestor
111473478|NCT04390854|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111473479|NCT04390854|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111473480|NCT04390854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111473481|NCT04390854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111473482|NCT04390854|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111473483|NCT04390854|Hormone Antagonists|hormone antagonists|mesh-ancestor
111473484|NCT04390854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111473485|NCT04390854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111473486|NCT04390854|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111473487|NCT04390854|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111473488|NCT02465736|Cisplatin|cisplatin|mesh-list
111473489|NCT02465736|Docetaxel|docetaxel|mesh-list
111473490|NCT02465736|Vinorelbine|vinorelbine|mesh-list
111473491|NCT02465736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111473492|NCT02465736|Tubulin Modulators|tubulin modulators|mesh-ancestor
111473493|NCT02465736|Antimitotic Agents|antimitotic agents|mesh-ancestor
111473494|NCT02465736|Mitosis Modulators|mitosis modulators|mesh-ancestor
111473495|NCT02465736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111473496|NCT02465736|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111473497|NCT02630316|Treprostinil|treprostinil|mesh-list
111473498|NCT02630316|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111473499|NCT02359968|Paclitaxel|paclitaxel|mesh-list
111473500|NCT02359968|Fluorouracil|fluorouracil|mesh-list
111473501|NCT02359968|Oxaliplatin|oxaliplatin|mesh-list
111473502|NCT02359968|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111473503|NCT02359968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111473504|NCT02359968|Tubulin Modulators|tubulin modulators|mesh-ancestor
111473505|NCT02359968|Antimitotic Agents|antimitotic agents|mesh-ancestor
111473506|NCT02359968|Mitosis Modulators|mitosis modulators|mesh-ancestor
111473507|NCT02359968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111473508|NCT02359968|Antimetabolites|antimetabolites|mesh-ancestor
111473509|NCT02359968|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111473510|NCT02359968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111473511|NCT02359968|Immunologic Factors|immunologic factors|mesh-ancestor
111473512|NCT02359968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111473513|NCT02624544|Desonide|desonide|mesh-list
111473514|NCT02624544|Esomeprazole|esomeprazole|mesh-list
111473515|NCT02624544|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111473516|NCT02624544|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111473517|NCT02624544|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111473518|NCT02624544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111473519|NCT02624544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111473520|NCT02624544|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111473521|NCT02603328|Atorvastatin|atorvastatin|mesh-list
111473522|NCT02603328|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111473523|NCT02603328|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111473524|NCT02603328|Antimetabolites|antimetabolites|mesh-ancestor
111473525|NCT02603328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111473526|NCT02603328|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111473527|NCT02603328|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111473528|NCT02603328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111473529|NCT02323698|Caffeine|caffeine|mesh-list
111473530|NCT02323698|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111473531|NCT02323698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111473532|NCT02323698|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111473533|NCT02323698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111473534|NCT02323698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111473535|NCT02323698|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
111473536|NCT02323698|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111473537|NCT02323698|Purinergic Agents|purinergic agents|mesh-ancestor
111473538|NCT02323698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111473539|NCT01451736|Risperidone|risperidone|mesh-list
111473540|NCT01451736|Paliperidone Palmitate|paliperidone palmitate|mesh-list
111473541|NCT01451736|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111473542|NCT01451736|Serotonin Agents|serotonin agents|mesh-ancestor
111473543|NCT01451736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111473544|NCT01451736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111473545|NCT01451736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111473546|NCT01451736|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111473547|NCT01451736|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111473548|NCT01451736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111473549|NCT01451736|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111473550|NCT01451736|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111473551|NCT01451736|Dopamine Agents|dopamine agents|mesh-ancestor
111473552|NCT01451736|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111473553|NCT01451736|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111473554|NCT01450956|Sevoflurane|sevoflurane|mesh-list
111473555|NCT01450956|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111473556|NCT01450956|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111473557|NCT01450956|Anesthetics, General|anesthetics, general|mesh-ancestor
111473558|NCT01450956|Anesthetics|anesthetics|mesh-ancestor
111473559|NCT01450956|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111473560|NCT01450956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111473561|NCT02300922|Antibodies|antibodies|mesh-list
111473562|NCT02300922|Immunologic Factors|immunologic factors|mesh-ancestor
111473563|NCT02300922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111473564|NCT01453530|Glycopyrrolate|glycopyrrolate|mesh-list
111473565|NCT01453530|Neostigmine|neostigmine|mesh-list
111473566|NCT01453530|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111473567|NCT01453530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111473568|NCT01453530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111473569|NCT01453530|Cholinergic Agents|cholinergic agents|mesh-ancestor
111473570|NCT01453530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111473571|NCT01453530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111473572|NCT01453530|Parasympathomimetics|parasympathomimetics|mesh-ancestor
111473573|NCT01453530|Autonomic Agents|autonomic agents|mesh-ancestor
111473574|NCT01453530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111473575|NCT01453530|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111473576|NCT01453530|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111473577|NCT01453530|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111473578|NCT02983422|Aminophylline|aminophylline|mesh-list
111473579|NCT02983422|Furosemide|furosemide|mesh-list
111473580|NCT02983422|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111473581|NCT02983422|Autonomic Agents|autonomic agents|mesh-ancestor
111473582|NCT02983422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111473583|NCT02983422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111473584|NCT02983422|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111473585|NCT02983422|Respiratory System Agents|respiratory system agents|mesh-ancestor
111473586|NCT02983422|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111473587|NCT02983422|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111473588|NCT02983422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111197730|NCT05640102|Zanubrutinib|zanubrutinib|mesh-list
111473589|NCT02983422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111473590|NCT02983422|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
111473591|NCT02983422|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111473592|NCT02983422|Purinergic Agents|purinergic agents|mesh-ancestor
111473593|NCT02983422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111473594|NCT02983422|Protective Agents|protective agents|mesh-ancestor
111473595|NCT02983422|Diuretics|diuretics|mesh-ancestor
111473596|NCT02983422|Natriuretic Agents|natriuretic agents|mesh-ancestor
111473597|NCT02983422|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
111473598|NCT02983422|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111473599|NCT05585814|Bevacizumab|bevacizumab|mesh-list
111473600|NCT05585814|Pembrolizumab|pembrolizumab|mesh-list
111473601|NCT05585814|Capecitabine|capecitabine|mesh-list
111473602|NCT05585814|Oxaliplatin|oxaliplatin|mesh-list
111473603|NCT05585814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111473604|NCT05585814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111473605|NCT05585814|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111473606|NCT05585814|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111473607|NCT05585814|Growth Substances|growth substances|mesh-ancestor
111473608|NCT05585814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111473609|NCT05585814|Growth Inhibitors|growth inhibitors|mesh-ancestor
111473610|NCT05585814|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111473611|NCT05585814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111473612|NCT05585814|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111473613|NCT05585814|Antimetabolites|antimetabolites|mesh-ancestor
111473614|NCT02013648|Cytarabine|cytarabine|mesh-list
111473615|NCT02013648|Daunorubicin|daunorubicin|mesh-list
111473616|NCT02013648|Dasatinib|dasatinib|mesh-list
111473617|NCT02013648|Idarubicin|idarubicin|mesh-list
111473618|NCT02013648|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111473619|NCT02013648|Antimetabolites|antimetabolites|mesh-ancestor
111473620|NCT02013648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111473621|NCT02013648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111473622|NCT02013648|Antiviral Agents|antiviral agents|mesh-ancestor
111473623|NCT02013648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111473624|NCT02013648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111473625|NCT02013648|Immunologic Factors|immunologic factors|mesh-ancestor
111473626|NCT02013648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111473627|NCT02013648|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111473628|NCT02013648|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111473629|NCT02013648|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111473630|NCT02013648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111473631|NCT02013648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111473632|NCT05585736|Mydriatics|mydriatics|mesh-list
111473633|NCT05585736|Autonomic Agents|autonomic agents|mesh-ancestor
111473634|NCT05585736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111473635|NCT05585736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111473636|NCT01989780|Paclitaxel|paclitaxel|mesh-list
111473637|NCT01989780|Bevacizumab|bevacizumab|mesh-list
111473638|NCT01989780|Letrozole|letrozole|mesh-list
111473639|NCT01989780|Fulvestrant|fulvestrant|mesh-list
111473640|NCT01989780|Anastrozole|anastrozole|mesh-list
111473641|NCT01989780|Exemestane|exemestane|mesh-list
111473642|NCT01989780|Goserelin|goserelin|mesh-list
111473643|NCT01989780|Leuprolide|leuprolide|mesh-list
111473644|NCT01989780|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111473645|NCT01989780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111473646|NCT01989780|Tubulin Modulators|tubulin modulators|mesh-ancestor
111473647|NCT01989780|Antimitotic Agents|antimitotic agents|mesh-ancestor
111473648|NCT01989780|Mitosis Modulators|mitosis modulators|mesh-ancestor
111473649|NCT01989780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111473650|NCT01989780|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111473651|NCT01989780|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111473652|NCT01989780|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111473653|NCT01989780|Growth Substances|growth substances|mesh-ancestor
111473654|NCT01989780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111473655|NCT01989780|Growth Inhibitors|growth inhibitors|mesh-ancestor
111473656|NCT01989780|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111473657|NCT01989780|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111473658|NCT01989780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111473659|NCT01989780|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111473660|NCT01989780|Hormone Antagonists|hormone antagonists|mesh-ancestor
111473661|NCT01989780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111473662|NCT01989780|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111473663|NCT01989780|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
111473664|NCT01989780|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111473666|NCT01989780|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111473667|NCT02549898|Cilostazol|cilostazol|mesh-list
111473668|NCT02549898|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
111473669|NCT02549898|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111473670|NCT02549898|Autonomic Agents|autonomic agents|mesh-ancestor
111473671|NCT02549898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111473672|NCT02549898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111473673|NCT02549898|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111473674|NCT02549898|Respiratory System Agents|respiratory system agents|mesh-ancestor
111473675|NCT02549898|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111473676|NCT02549898|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111473677|NCT02549898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111473678|NCT02549898|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111473679|NCT02549898|Vasodilator Agents|vasodilator agents|mesh-ancestor
111473680|NCT02549898|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111473681|NCT02549898|Protective Agents|protective agents|mesh-ancestor
111473682|NCT02549898|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
111473683|NCT02549898|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111473684|NCT02549898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111473685|NCT02549898|Hematinics|hematinics|mesh-ancestor
111473686|NCT02549898|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
111473687|NCT02549898|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111473688|NCT05585580|Paclitaxel|paclitaxel|mesh-list
111473689|NCT05585580|Lenvatinib|lenvatinib|mesh-list
111473690|NCT05585580|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111473691|NCT05585580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111473692|NCT05585580|Tubulin Modulators|tubulin modulators|mesh-ancestor
111473693|NCT05585580|Antimitotic Agents|antimitotic agents|mesh-ancestor
111473694|NCT05585580|Mitosis Modulators|mitosis modulators|mesh-ancestor
111473695|NCT05585580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111473696|NCT05585580|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111473697|NCT05585580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111473698|NCT02513784|Chlorhexidine|chlorhexidine|mesh-list
111473699|NCT02513784|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
111473700|NCT02513784|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111473701|NCT02513784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111473702|NCT02513784|Disinfectants|disinfectants|mesh-ancestor
111473703|NCT02513784|Dermatologic Agents|dermatologic agents|mesh-ancestor
111473704|NCT02283996|Methylprednisolone|methylprednisolone|mesh-list
111473705|NCT02283996|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111473706|NCT02283996|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111473707|NCT02283996|Prednisolone|prednisolone|mesh-list
111473708|NCT02283996|Prednisolone acetate|prednisolone acetate|mesh-list
111473709|NCT02283996|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111473710|NCT02283996|Prednisolone phosphate|prednisolone phosphate|mesh-list
111473711|NCT02283996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111473712|NCT02283996|Antiemetics|antiemetics|mesh-ancestor
111473713|NCT02283996|Autonomic Agents|autonomic agents|mesh-ancestor
111473714|NCT02283996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111473715|NCT02283996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111473716|NCT02283996|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111473717|NCT02283996|Glucocorticoids|glucocorticoids|mesh-ancestor
111473718|NCT02283996|Hormones|hormones|mesh-ancestor
111473719|NCT02283996|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111473720|NCT02283996|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111473721|NCT02283996|Protective Agents|protective agents|mesh-ancestor
111473722|NCT02283996|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111473723|NCT02283996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111473724|NCT02369484|Afatinib|afatinib|mesh-list
111473725|NCT02369484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111473726|NCT02369484|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111473727|NCT02369484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111473728|NCT02369484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111473729|NCT04390152|Ritonavir|ritonavir|mesh-list
111473730|NCT04390152|Lopinavir|lopinavir|mesh-list
111473731|NCT04390152|Azithromycin|azithromycin|mesh-list
111473732|NCT04390152|Hydroxychloroquine|hydroxychloroquine|mesh-list
111473733|NCT04390152|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111473734|NCT04390152|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111473735|NCT04390152|Protease Inhibitors|protease inhibitors|mesh-ancestor
111473736|NCT04390152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111473737|NCT04390152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111473738|NCT04390152|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111473739|NCT04390152|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111473740|NCT04390152|Antiviral Agents|antiviral agents|mesh-ancestor
111473741|NCT04390152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111473742|NCT04390152|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111473743|NCT04390152|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111473744|NCT04390152|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111473745|NCT04390152|Antimalarials|antimalarials|mesh-ancestor
111473746|NCT04390152|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111473747|NCT04390152|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111473748|NCT04390152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111473749|NCT02496780|Insulin|insulin|mesh-list
111473750|NCT02496780|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111473751|NCT02496780|Insulin Aspart|insulin aspart|mesh-list
111473752|NCT02496780|Insulin Detemir|insulin detemir|mesh-list
111473753|NCT02496780|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111473754|NCT02496780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111473755|NCT01953588|Fulvestrant|fulvestrant|mesh-list
111473756|NCT01953588|Anastrozole|anastrozole|mesh-list
111473757|NCT01953588|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111473758|NCT01953588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111473759|NCT01953588|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
111473760|NCT01953588|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111473761|NCT01953588|Hormone Antagonists|hormone antagonists|mesh-ancestor
111473762|NCT01953588|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111473763|NCT01953588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111473764|NCT01953588|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111473765|NCT01953588|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111473766|NCT01953588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111473767|NCT01953588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111473768|NCT01953510|Vaccines|vaccines|mesh-list
111473769|NCT01953510|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
111473770|NCT01953510|Immunologic Factors|immunologic factors|mesh-ancestor
111473771|NCT01953510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111473772|NCT01943994|Psilocybin|psilocybin|mesh-list
111473773|NCT01943994|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
111473774|NCT01943994|Nicotine|nicotine|mesh-list
111473775|NCT01943994|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111473776|NCT01943994|Autonomic Agents|autonomic agents|mesh-ancestor
111473777|NCT01943994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111473778|NCT01943994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111473779|NCT01943994|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111473780|NCT01943994|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111473781|NCT01943994|Cholinergic Agents|cholinergic agents|mesh-ancestor
111473782|NCT01943994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111473783|NCT01943994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111473784|NCT01943994|Hallucinogens|hallucinogens|mesh-ancestor
111473785|NCT01943994|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111473786|NCT01943994|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111473787|NCT01943994|Serotonin Agents|serotonin agents|mesh-ancestor
111473788|NCT01943994|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111473789|NCT02456532|Zolpidem|zolpidem|mesh-list
111473790|NCT02456532|Eszopiclone|eszopiclone|mesh-list
111473791|NCT02456532|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111473792|NCT02456532|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111473793|NCT02456532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111473794|NCT02456532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111473795|NCT02456532|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
111473796|NCT02456532|GABA Agonists|gaba agonists|mesh-ancestor
111473797|NCT02456532|GABA Agents|gaba agents|mesh-ancestor
111473798|NCT02456532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111473799|NCT02456532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111473800|NCT05578950|Itraconazole|itraconazole|mesh-list
111473801|NCT05578950|Terbinafine|terbinafine|mesh-list
111473802|NCT05578950|Antifungal Agents|antifungal agents|mesh-ancestor
111473803|NCT05578950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111473804|NCT05578950|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111473805|NCT05578950|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111473806|NCT05578950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111473807|NCT05578950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111473808|NCT05578950|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111473809|NCT05578950|Hormone Antagonists|hormone antagonists|mesh-ancestor
111473810|NCT05578950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111473811|NCT05578950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111473812|NCT05578950|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111473813|NCT05586126|Sevoflurane|sevoflurane|mesh-list
111473814|NCT05586126|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111197954|NCT05554341|Paclitaxel|paclitaxel|mesh-list
111473815|NCT05586126|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111473817|NCT05586126|Anesthetics|anesthetics|mesh-ancestor
111473818|NCT05586126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111473819|NCT05586126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111473820|NCT01893996|Adalimumab|adalimumab|mesh-list
111473821|NCT01893996|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111473822|NCT01893996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111473823|NCT01893996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111473824|NCT02442180|Methylprednisolone|methylprednisolone|mesh-list
111473825|NCT02442180|Prednisolone|prednisolone|mesh-list
111473826|NCT02442180|Lenograstim|lenograstim|mesh-list
111473827|NCT02442180|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111473828|NCT02442180|Immunologic Factors|immunologic factors|mesh-ancestor
111473829|NCT02442180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111473830|NCT02442180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111473831|NCT02442180|Antiemetics|antiemetics|mesh-ancestor
111473832|NCT02442180|Autonomic Agents|autonomic agents|mesh-ancestor
111473833|NCT02442180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111473834|NCT02442180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111473835|NCT02442180|Glucocorticoids|glucocorticoids|mesh-ancestor
111473836|NCT02442180|Hormones|hormones|mesh-ancestor
111473837|NCT02442180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111473838|NCT02442180|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111473839|NCT02442180|Protective Agents|protective agents|mesh-ancestor
111473840|NCT02442180|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111473841|NCT02442180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111473842|NCT01924260|Gemcitabine|gemcitabine|mesh-list
111473843|NCT01924260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111473844|NCT01924260|Antimetabolites|antimetabolites|mesh-ancestor
111473845|NCT01924260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111473846|NCT01924260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111473847|NCT02432742|Hyaluronic Acid|hyaluronic acid|mesh-list
111473848|NCT02432742|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111473849|NCT02432742|Immunologic Factors|immunologic factors|mesh-ancestor
111473850|NCT02432742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111473851|NCT02432742|Viscosupplements|viscosupplements|mesh-ancestor
111473852|NCT02432742|Protective Agents|protective agents|mesh-ancestor
111473853|NCT02086500|Tranexamic Acid|tranexamic acid|mesh-list
111473854|NCT02086500|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111473855|NCT02086500|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111473856|NCT02086500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111473857|NCT02086500|Hemostatics|hemostatics|mesh-ancestor
111473858|NCT02086500|Coagulants|coagulants|mesh-ancestor
111473859|NCT02104986|Cisplatin|cisplatin|mesh-list
111473860|NCT02104986|Ifosfamide|ifosfamide|mesh-list
111473861|NCT02104986|Bleomycin|bleomycin|mesh-list
111473862|NCT02104986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111473863|NCT02104986|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111473864|NCT02104986|Alkylating Agents|alkylating agents|mesh-ancestor
111473865|NCT02104986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111473866|NCT02104986|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111473867|NCT04757532|Methyltestosterone|methyltestosterone|mesh-list
111473868|NCT04757532|Anastrozole|anastrozole|mesh-list
111473869|NCT04757532|Chlorthalidone|chlorthalidone|mesh-list
111473870|NCT04757532|Bupropion|bupropion|mesh-list
111473871|NCT04757532|Testosterone|testosterone|mesh-list
111473872|NCT04757532|Testosterone undecanoate|testosterone undecanoate|mesh-list
111473873|NCT04757532|Testosterone enanthate|testosterone enanthate|mesh-list
111473874|NCT04757532|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
111473875|NCT04757532|Danazol|danazol|mesh-list
111473876|NCT04757532|Androgens|androgens|mesh-ancestor
111473877|NCT04757532|Hormones|hormones|mesh-ancestor
111473878|NCT04757532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111473879|NCT04757532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111473880|NCT04757532|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111473881|NCT04757532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111473882|NCT04757532|Anabolic Agents|anabolic agents|mesh-ancestor
111473883|NCT04757532|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111473884|NCT04757532|Antidepressive Agents|antidepressive agents|mesh-ancestor
111473885|NCT04757532|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111473886|NCT04757532|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111473887|NCT04757532|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111473888|NCT04757532|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111473889|NCT04757532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111473890|NCT04757532|Dopamine Agents|dopamine agents|mesh-ancestor
111473891|NCT04757532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111473892|NCT04757532|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111473893|NCT04757532|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111473894|NCT04757532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111473895|NCT04757532|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111473896|NCT04757532|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111473897|NCT04757532|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111473898|NCT04757532|Hormone Antagonists|hormone antagonists|mesh-ancestor
111473899|NCT04757532|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111473900|NCT04757532|Diuretics|diuretics|mesh-ancestor
111473901|NCT04757532|Natriuretic Agents|natriuretic agents|mesh-ancestor
111473902|NCT04757532|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
111473903|NCT02069730|Androgens|androgens|mesh-list
111473904|NCT02069730|Androgen Antagonists|androgen antagonists|mesh-list
111473905|NCT02069730|Hormones|hormones|mesh-ancestor
111473906|NCT02069730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111473907|NCT02069730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111473908|NCT02069730|Hormone Antagonists|hormone antagonists|mesh-ancestor
111473909|NCT02068092|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
111473910|NCT02068092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111473911|NCT02068092|Antioxidants|antioxidants|mesh-ancestor
111473912|NCT02068092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111473913|NCT02068092|Protective Agents|protective agents|mesh-ancestor
111473914|NCT02068092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111473915|NCT02068092|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111473916|NCT02063022|Dactinomycin|dactinomycin|mesh-list
111473917|NCT02063022|Cyclophosphamide|cyclophosphamide|mesh-list
111473918|NCT02063022|Melphalan|melphalan|mesh-list
111473919|NCT02063022|Busulfan|busulfan|mesh-list
111473920|NCT02063022|Ifosfamide|ifosfamide|mesh-list
111473921|NCT02063022|Isophosphamide mustard|isophosphamide mustard|mesh-list
111473922|NCT02063022|Doxorubicin|doxorubicin|mesh-list
111473923|NCT02063022|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111473924|NCT02063022|Etoposide|etoposide|mesh-list
111473925|NCT02063022|Etoposide phosphate|etoposide phosphate|mesh-list
111473926|NCT02063022|Vincristine|vincristine|mesh-list
111473927|NCT02063022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111473928|NCT02063022|Immunologic Factors|immunologic factors|mesh-ancestor
111473929|NCT02063022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111473930|NCT02063022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111473931|NCT02063022|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111473932|NCT02063022|Alkylating Agents|alkylating agents|mesh-ancestor
111473933|NCT02063022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111473934|NCT02063022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111473935|NCT02063022|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111473936|NCT02063022|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111473937|NCT02063022|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111473938|NCT02063022|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111473939|NCT02063022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111473940|NCT02063022|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111473941|NCT02063022|Tubulin Modulators|tubulin modulators|mesh-ancestor
111473942|NCT02063022|Antimitotic Agents|antimitotic agents|mesh-ancestor
111473943|NCT02063022|Mitosis Modulators|mitosis modulators|mesh-ancestor
111473944|NCT02063022|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111473945|NCT02063022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111473946|NCT02063022|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111473947|NCT02063022|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111473948|NCT01895010|Tropisetron|tropisetron|mesh-list
111473949|NCT01895010|Antiemetics|antiemetics|mesh-ancestor
111473950|NCT01895010|Autonomic Agents|autonomic agents|mesh-ancestor
111473951|NCT01895010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111473952|NCT01895010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111473953|NCT01895010|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111473954|NCT01895010|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111473955|NCT01895010|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111473956|NCT01895010|Serotonin Agents|serotonin agents|mesh-ancestor
111473957|NCT01895010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111473958|NCT01895010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111473959|NCT01896336|Zolpidem|zolpidem|mesh-list
111473960|NCT01896336|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111473961|NCT01896336|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111473962|NCT01896336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111473963|NCT01896336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111473964|NCT01896336|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
111473965|NCT01896336|GABA Agonists|gaba agonists|mesh-ancestor
111473966|NCT01896336|GABA Agents|gaba agents|mesh-ancestor
111473968|NCT01896336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111473969|NCT02087748|Diclofenac|diclofenac|mesh-list
111473970|NCT02087748|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111473971|NCT02087748|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111473972|NCT02087748|Analgesics|analgesics|mesh-ancestor
111473973|NCT02087748|Sensory System Agents|sensory system agents|mesh-ancestor
111473974|NCT02087748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111473975|NCT02087748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111473976|NCT02087748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111473977|NCT02087748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111473978|NCT02087748|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111473979|NCT02087748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111473980|NCT02087748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111473981|NCT01490502|Vitamin D|vitamin d|mesh-list
111473982|NCT01490502|Cholecalciferol|cholecalciferol|mesh-list
111473983|NCT01490502|Vitamins|vitamins|mesh-ancestor
111473984|NCT01490502|Micronutrients|micronutrients|mesh-ancestor
111473985|NCT01490502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111473986|NCT01490502|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111473987|NCT01490502|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111473988|NCT01428024|Hyaluronic Acid|hyaluronic acid|mesh-list
111473989|NCT01428024|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111473990|NCT01428024|Immunologic Factors|immunologic factors|mesh-ancestor
111473991|NCT01428024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111473992|NCT01428024|Viscosupplements|viscosupplements|mesh-ancestor
111473993|NCT01428024|Protective Agents|protective agents|mesh-ancestor
111473994|NCT01412190|Hyaluronic Acid|hyaluronic acid|mesh-list
111473995|NCT01412190|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111473996|NCT01412190|Immunologic Factors|immunologic factors|mesh-ancestor
111473997|NCT01412190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111473998|NCT01412190|Viscosupplements|viscosupplements|mesh-ancestor
111473999|NCT01412190|Protective Agents|protective agents|mesh-ancestor
111474000|NCT01331148|Vitamin D|vitamin d|mesh-list
111474001|NCT01331148|Cholecalciferol|cholecalciferol|mesh-list
111474002|NCT01331148|Vitamins|vitamins|mesh-ancestor
111474003|NCT01331148|Micronutrients|micronutrients|mesh-ancestor
111474004|NCT01331148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111474005|NCT01331148|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111474006|NCT01331148|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111474007|NCT00273624|Olanzapine|olanzapine|mesh-list
111474008|NCT00273624|Antiemetics|antiemetics|mesh-ancestor
111474009|NCT00273624|Autonomic Agents|autonomic agents|mesh-ancestor
111474010|NCT00273624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111474011|NCT00273624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111474012|NCT00273624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111474013|NCT00273624|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111474014|NCT00273624|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111474015|NCT00273624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111474016|NCT00273624|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111474017|NCT00273624|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111474018|NCT00273624|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111474019|NCT00273624|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111474020|NCT00273624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111474021|NCT00273624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111474022|NCT00273624|Serotonin Agents|serotonin agents|mesh-ancestor
111474023|NCT01253070|Cytarabine|cytarabine|mesh-list
111474024|NCT01253070|Sorafenib|sorafenib|mesh-list
111474025|NCT01253070|Daunorubicin|daunorubicin|mesh-list
111474026|NCT01253070|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111474027|NCT01253070|Antimetabolites|antimetabolites|mesh-ancestor
111474028|NCT01253070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111474029|NCT01253070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111474030|NCT01253070|Antiviral Agents|antiviral agents|mesh-ancestor
111474031|NCT01253070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111474032|NCT01253070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111474033|NCT01253070|Immunologic Factors|immunologic factors|mesh-ancestor
111474034|NCT01253070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111474035|NCT01253070|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111474036|NCT01253070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111474037|NCT01253070|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111474038|NCT01253070|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111474039|NCT01253070|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111474040|NCT01212822|Leucovorin|leucovorin|mesh-list
111474041|NCT01212822|Bevacizumab|bevacizumab|mesh-list
111474042|NCT01212822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111474043|NCT01212822|Fluorouracil|fluorouracil|mesh-list
111474044|NCT01212822|Oxaliplatin|oxaliplatin|mesh-list
111474045|NCT01212822|Antibodies|antibodies|mesh-list
111474046|NCT01212822|Immunoglobulins|immunoglobulins|mesh-list
111474047|NCT01212822|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111474048|NCT01212822|Levoleucovorin|levoleucovorin|mesh-list
111474049|NCT01212822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111474050|NCT01212822|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111474051|NCT01212822|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111474052|NCT01212822|Growth Substances|growth substances|mesh-ancestor
111474053|NCT01212822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111474054|NCT01212822|Growth Inhibitors|growth inhibitors|mesh-ancestor
111474055|NCT01212822|Immunologic Factors|immunologic factors|mesh-ancestor
111474056|NCT01212822|Antimetabolites|antimetabolites|mesh-ancestor
111474057|NCT01212822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111474058|NCT01212822|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111474059|NCT01212822|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111474060|NCT01212822|Antidotes|antidotes|mesh-ancestor
111474061|NCT01212822|Protective Agents|protective agents|mesh-ancestor
111474062|NCT01212822|Vitamin B Complex|vitamin b complex|mesh-ancestor
111474063|NCT01212822|Vitamins|vitamins|mesh-ancestor
111474064|NCT01212822|Micronutrients|micronutrients|mesh-ancestor
111474065|NCT00163566|Dihydrotestosterone|dihydrotestosterone|mesh-list
111474066|NCT00163566|Androgens|androgens|mesh-ancestor
111474067|NCT00163566|Hormones|hormones|mesh-ancestor
111474068|NCT00163566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111474069|NCT00163566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111474070|NCT04705662|Lactulose|lactulose|mesh-list
111474071|NCT04705662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111474072|NCT04782960|Bupivacaine|bupivacaine|mesh-list
111474073|NCT04782960|Anesthetics|anesthetics|mesh-list
111474074|NCT04782960|Anesthetics, Local|anesthetics, local|mesh-ancestor
111474075|NCT04782960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111474076|NCT04782960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111474077|NCT04782960|Sensory System Agents|sensory system agents|mesh-ancestor
111474078|NCT04782960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111474079|NCT01026012|Regadenoson|regadenoson|mesh-list
111474080|NCT01026012|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
111474081|NCT01026012|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
111474082|NCT01026012|Purinergic Agonists|purinergic agonists|mesh-ancestor
111474083|NCT01026012|Purinergic Agents|purinergic agents|mesh-ancestor
111474084|NCT01026012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111474085|NCT01026012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111474086|NCT01026012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111474087|NCT02088216|Acetylcysteine|acetylcysteine|mesh-list
111474088|NCT02088216|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111474089|NCT02088216|Antiviral Agents|antiviral agents|mesh-ancestor
111474090|NCT02088216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111474091|NCT02088216|Expectorants|expectorants|mesh-ancestor
111474092|NCT02088216|Respiratory System Agents|respiratory system agents|mesh-ancestor
111474093|NCT02088216|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111474094|NCT02088216|Antioxidants|antioxidants|mesh-ancestor
111474095|NCT02088216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111474096|NCT02088216|Protective Agents|protective agents|mesh-ancestor
111474097|NCT02088216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111474098|NCT02088216|Antidotes|antidotes|mesh-ancestor
111474099|NCT01014936|Tepotinib|tepotinib|mesh-list
111474100|NCT01014936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111474101|NCT01896180|Latanoprost|latanoprost|mesh-list
111474102|NCT01896180|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
111474103|NCT01896180|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111474104|NCT00981162|Everolimus|everolimus|mesh-list
111474105|NCT00981162|Sorafenib|sorafenib|mesh-list
111474106|NCT00981162|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111474107|NCT00981162|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111474108|NCT00981162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111474109|NCT00981162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111474110|NCT00981162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111474111|NCT00981162|Immunologic Factors|immunologic factors|mesh-ancestor
111474112|NCT00981162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111474113|NCT00981162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111474114|NCT00875004|Epoetin Alfa|epoetin alfa|mesh-list
111474115|NCT00875004|Hematinics|hematinics|mesh-ancestor
111474116|NCT05320692|Apatinib|apatinib|mesh-list
111474117|NCT05320692|Chlorotrianisene|chlorotrianisene|mesh-list
111474118|NCT05320692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111474119|NCT05320692|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111474120|NCT05320692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111474121|NCT05320692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111474122|NCT05320692|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
111474123|NCT05320692|Estrogens|estrogens|mesh-ancestor
111474124|NCT05320692|Hormones|hormones|mesh-ancestor
111474125|NCT05320692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111474126|NCT05320692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111474127|NCT05320692|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111474128|NCT01763580|Prednisolone|prednisolone|mesh-list
111474129|NCT01763580|Tacrolimus|tacrolimus|mesh-list
111474130|NCT01763580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111474131|NCT01763580|Immunologic Factors|immunologic factors|mesh-ancestor
111474132|NCT01763580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111474133|NCT01763580|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111474134|NCT01763580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111474135|NCT01763580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111474136|NCT01763580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111474137|NCT01763580|Glucocorticoids|glucocorticoids|mesh-ancestor
111474138|NCT01763580|Hormones|hormones|mesh-ancestor
111474139|NCT01763580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111474140|NCT01763580|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111474141|NCT01763580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111474142|NCT03969420|Cytarabine|cytarabine|mesh-list
111474143|NCT03969420|Alvocidib|alvocidib|mesh-list
111474144|NCT03969420|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111474145|NCT03969420|Antimetabolites|antimetabolites|mesh-ancestor
111474146|NCT03969420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111474147|NCT03969420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111474148|NCT03969420|Antiviral Agents|antiviral agents|mesh-ancestor
111474149|NCT03969420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111474150|NCT03969420|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111474151|NCT03969420|Immunologic Factors|immunologic factors|mesh-ancestor
111474152|NCT03969420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111474153|NCT03969420|Growth Inhibitors|growth inhibitors|mesh-ancestor
111474154|NCT03969420|Growth Substances|growth substances|mesh-ancestor
111474155|NCT03969420|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111474156|NCT03969420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111474157|NCT01740492|Ketamine|ketamine|mesh-list
111474158|NCT01740492|Analgesics|analgesics|mesh-ancestor
111474159|NCT01740492|Sensory System Agents|sensory system agents|mesh-ancestor
111474160|NCT01740492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111474161|NCT01740492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111474162|NCT01740492|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111474163|NCT01740492|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111474164|NCT01740492|Anesthetics, General|anesthetics, general|mesh-ancestor
111474165|NCT01740492|Anesthetics|anesthetics|mesh-ancestor
111474166|NCT01740492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111474167|NCT01740492|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111474168|NCT01740492|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111474169|NCT01740492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111474170|NCT01740492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111474171|NCT04780854|Metformin|metformin|mesh-list
111474172|NCT04780854|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111474173|NCT04780854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111474174|NCT04780152|Fluoxetine|fluoxetine|mesh-list
111474175|NCT04780152|Antidepressive Agents|antidepressive agents|mesh-list
111474176|NCT04780152|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111474177|NCT04780152|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111474178|NCT04780152|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111474179|NCT04780152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111474180|NCT04780152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111474181|NCT04780152|Serotonin Agents|serotonin agents|mesh-ancestor
111474182|NCT04780152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111474183|NCT04780152|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111474184|NCT04780152|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111474185|NCT04780152|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111474186|NCT04780152|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111474187|NCT04780152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111474188|NCT00644280|Ranibizumab|ranibizumab|mesh-list
111474189|NCT00644280|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111474190|NCT00644280|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111474191|NCT00644280|Growth Substances|growth substances|mesh-ancestor
111474192|NCT00644280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111474193|NCT00644280|Growth Inhibitors|growth inhibitors|mesh-ancestor
111474194|NCT00644280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111474196|NCT04779762|Dermatologic Agents|dermatologic agents|mesh-ancestor
111474197|NCT04777968|Fluorides|fluorides|mesh-list
111474198|NCT04777968|Cariostatic Agents|cariostatic agents|mesh-ancestor
111474199|NCT04777968|Protective Agents|protective agents|mesh-ancestor
111474200|NCT04777968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111474201|NCT01722708|Metronidazole|metronidazole|mesh-list
111474202|NCT01722708|Clindamycin|clindamycin|mesh-list
111474203|NCT01722708|Clindamycin palmitate|clindamycin palmitate|mesh-list
111474204|NCT01722708|Clindamycin phosphate|clindamycin phosphate|mesh-list
111474205|NCT01722708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111474206|NCT01722708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111474207|NCT01722708|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111474208|NCT01722708|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111474209|NCT01722708|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111474210|NCT01722708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111474211|NCT01722708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111474212|NCT01711632|Vemurafenib|vemurafenib|mesh-list
111474213|NCT01711632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111474214|NCT01711632|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111474215|NCT01711632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111474216|NCT01711632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111474217|NCT04756206|Dutasteride|dutasteride|mesh-list
111474218|NCT04756206|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
111474219|NCT04756206|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111474220|NCT04756206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111474221|NCT04756206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111474222|NCT04756206|Hormone Antagonists|hormone antagonists|mesh-ancestor
111474223|NCT04756206|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111474224|NCT04756206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111474225|NCT04779060|Dexamethasone|dexamethasone|mesh-list
111474226|NCT04779060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111474227|NCT04779060|Antiemetics|antiemetics|mesh-ancestor
111474228|NCT04779060|Autonomic Agents|autonomic agents|mesh-ancestor
111474229|NCT04779060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111474230|NCT04779060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111474231|NCT04779060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111474232|NCT04779060|Glucocorticoids|glucocorticoids|mesh-ancestor
111474233|NCT04779060|Hormones|hormones|mesh-ancestor
111474234|NCT04779060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111474235|NCT04779060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111474236|NCT04779060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111474237|NCT04778514|Contraceptive Agents|contraceptive agents|mesh-list
111474238|NCT04778514|Contraceptives, Oral|contraceptives, oral|mesh-list
111474239|NCT04778514|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
111474240|NCT04778514|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111474241|NCT04778514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111474242|NCT04778514|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111474243|NCT04777110|Esketamine|esketamine|mesh-list
111474244|NCT04777110|Antidepressive Agents|antidepressive agents|mesh-ancestor
111474245|NCT04777110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111474246|NCT01895400|Cilostazol|cilostazol|mesh-list
111474247|NCT01895400|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111474248|NCT01895400|Autonomic Agents|autonomic agents|mesh-ancestor
111474249|NCT01895400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111474250|NCT01895400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111474251|NCT01895400|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111474252|NCT01895400|Respiratory System Agents|respiratory system agents|mesh-ancestor
111474253|NCT01895400|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111474254|NCT01895400|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111474255|NCT01895400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111474256|NCT01895400|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111474257|NCT01895400|Vasodilator Agents|vasodilator agents|mesh-ancestor
111474258|NCT01895400|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111474259|NCT01895400|Protective Agents|protective agents|mesh-ancestor
111474260|NCT01895400|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
111474261|NCT01895400|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111474262|NCT01895400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111474263|NCT05171946|Vaccines|vaccines|mesh-list
110446355|NCT04316936|Antiemetics|antiemetics|mesh-ancestor
111474264|NCT05171946|Immunologic Factors|immunologic factors|mesh-ancestor
111474265|NCT05171946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111474266|NCT05605314|Cyclosporine|cyclosporine|mesh-list
111474267|NCT05605314|Cyclosporins|cyclosporins|mesh-list
111474268|NCT05605314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111474269|NCT05605314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111474270|NCT05605314|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111474271|NCT05605314|Immunologic Factors|immunologic factors|mesh-ancestor
111474272|NCT05605314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111474273|NCT05605314|Antifungal Agents|antifungal agents|mesh-ancestor
111474274|NCT05605314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111474275|NCT05605314|Dermatologic Agents|dermatologic agents|mesh-ancestor
111474276|NCT05605314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111474277|NCT05605314|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111474278|NCT05605158|Pioglitazone|pioglitazone|mesh-list
111474279|NCT05605158|Empagliflozin|empagliflozin|mesh-list
111474280|NCT05605158|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111474281|NCT05605158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111474282|NCT05605158|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111474283|NCT05605158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111474284|NCT04775238|Copper|copper|mesh-list
111474285|NCT04775238|Trace Elements|trace elements|mesh-ancestor
111474286|NCT04775238|Micronutrients|micronutrients|mesh-ancestor
111474287|NCT04775238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111474288|NCT05580042|Tofacitinib|tofacitinib|mesh-list
111474289|NCT05580042|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
111474290|NCT05580042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111474291|NCT05580042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111474292|NCT05580042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111474293|NCT04773756|Sofosbuvir|sofosbuvir|mesh-list
111474294|NCT04773756|Antiviral Agents|antiviral agents|mesh-ancestor
111474295|NCT04773756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111474296|NCT03012984|Dexmedetomidine|dexmedetomidine|mesh-list
111474297|NCT03012984|Morphine|morphine|mesh-list
111474298|NCT03012984|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111474299|NCT03012984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111474300|NCT03012984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111474301|NCT03012984|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111474302|NCT03012984|Analgesics|analgesics|mesh-ancestor
111474303|NCT03012984|Sensory System Agents|sensory system agents|mesh-ancestor
111474304|NCT03012984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111474305|NCT03012984|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111474306|NCT03012984|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111474307|NCT03012984|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111474308|NCT03012984|Adrenergic Agents|adrenergic agents|mesh-ancestor
111474309|NCT03012984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111474310|NCT03012984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111474311|NCT03012984|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111474312|NCT03012984|Narcotics|narcotics|mesh-ancestor
111474313|NCT02744430|Mirabegron|mirabegron|mesh-list
111474314|NCT02744430|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
111474315|NCT02744430|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111474316|NCT02744430|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111474317|NCT02744430|Adrenergic Agents|adrenergic agents|mesh-ancestor
111474318|NCT02744430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111474319|NCT02744430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111474320|NCT02744430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111474321|NCT02744430|Urological Agents|urological agents|mesh-ancestor
111474322|NCT00054756|Hormones|hormones|mesh-list
111474323|NCT00054756|Thyrotropin-Releasing Hormone|thyrotropin-releasing hormone|mesh-list
111474324|NCT00054756|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111474325|NCT00054756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111474326|NCT01896960|Fentanyl|fentanyl|mesh-list
111474327|NCT01896960|Bupivacaine|bupivacaine|mesh-list
111474328|NCT01896960|Anesthetics, Local|anesthetics, local|mesh-ancestor
111474329|NCT01896960|Anesthetics|anesthetics|mesh-ancestor
111474330|NCT01896960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111474331|NCT01896960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111474332|NCT01896960|Sensory System Agents|sensory system agents|mesh-ancestor
111474333|NCT01896960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111474334|NCT01896960|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111474335|NCT01896960|Narcotics|narcotics|mesh-ancestor
111474336|NCT01896960|Analgesics|analgesics|mesh-ancestor
111474337|NCT01896960|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111474338|NCT01896960|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111474339|NCT01896960|Anesthetics, General|anesthetics, general|mesh-ancestor
111474340|NCT00055692|Bevacizumab|bevacizumab|mesh-list
111474341|NCT00055692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111474342|NCT00055692|Antibodies|antibodies|mesh-list
111474343|NCT00055692|Immunoglobulins|immunoglobulins|mesh-list
111474344|NCT00055692|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111474345|NCT00055692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111474346|NCT00055692|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111474347|NCT00055692|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111474348|NCT00055692|Growth Substances|growth substances|mesh-ancestor
111474349|NCT00055692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111474350|NCT00055692|Growth Inhibitors|growth inhibitors|mesh-ancestor
111474351|NCT00055692|Immunologic Factors|immunologic factors|mesh-ancestor
111474353|NCT04772352|Gout Suppressants|gout suppressants|mesh-ancestor
111474354|NCT04772352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111474355|NCT00056472|Olanzapine|olanzapine|mesh-list
111474356|NCT00056472|Sertraline|sertraline|mesh-list
111474357|NCT00056472|Antiemetics|antiemetics|mesh-ancestor
111474358|NCT00056472|Autonomic Agents|autonomic agents|mesh-ancestor
111474359|NCT00056472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111474360|NCT00056472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111474361|NCT00056472|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111474362|NCT00056472|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111474363|NCT00056472|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111474364|NCT00056472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111474365|NCT00056472|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111474366|NCT00056472|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111474367|NCT00056472|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111474368|NCT00056472|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111474369|NCT00056472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111474370|NCT00056472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111474371|NCT00056472|Serotonin Agents|serotonin agents|mesh-ancestor
111474372|NCT00056472|Antidepressive Agents|antidepressive agents|mesh-ancestor
111474373|NCT00056550|Antithrombins|antithrombins|mesh-list
111474374|NCT00056550|Antithrombin III|antithrombin iii|mesh-list
111474375|NCT00056550|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111474376|NCT00056550|Protease Inhibitors|protease inhibitors|mesh-ancestor
111474377|NCT00056550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111474378|NCT00056550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111474379|NCT00056550|Anticoagulants|anticoagulants|mesh-ancestor
111474380|NCT04771884|Vancomycin|vancomycin|mesh-list
111474381|NCT04771884|Meropenem|meropenem|mesh-list
111474382|NCT04771884|Ceftriaxone|ceftriaxone|mesh-list
111474383|NCT04771884|Linezolid|linezolid|mesh-list
111474384|NCT04771884|Ceftazidime|ceftazidime|mesh-list
111474385|NCT04771884|Ceftizoxime|ceftizoxime|mesh-list
111474386|NCT04771884|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111474387|NCT04771884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111474388|NCT04771884|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111474389|NCT04771884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111474390|NCT04771884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111474391|NCT02538744|Doxazosin|doxazosin|mesh-list
111474392|NCT02538744|Cocaine|cocaine|mesh-list
111474393|NCT02538744|Modafinil|modafinil|mesh-list
111474394|NCT02538744|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111474395|NCT02538744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111474396|NCT02538744|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
111474397|NCT02538744|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111474398|NCT02538744|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111474399|NCT02538744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111474400|NCT02538744|Anesthetics, Local|anesthetics, local|mesh-ancestor
111474401|NCT02538744|Anesthetics|anesthetics|mesh-ancestor
111474402|NCT02538744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111474403|NCT02538744|Sensory System Agents|sensory system agents|mesh-ancestor
111474404|NCT02538744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111474405|NCT02538744|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111474406|NCT02538744|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111474407|NCT02538744|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111474408|NCT02538744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111474409|NCT02538744|Dopamine Agents|dopamine agents|mesh-ancestor
111474410|NCT02538744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111474411|NCT02538744|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111474412|NCT02538744|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111474413|NCT02538744|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111474414|NCT02538744|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111474415|NCT02538744|Adrenergic Agents|adrenergic agents|mesh-ancestor
111474416|NCT00060528|Metronidazole|metronidazole|mesh-list
111474417|NCT00060528|Molgramostim|molgramostim|mesh-list
111474418|NCT00060528|Sargramostim|sargramostim|mesh-list
111474419|NCT00060528|Immunologic Factors|immunologic factors|mesh-ancestor
111474420|NCT00060528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111474421|NCT00060528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111474422|NCT00060528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111474423|NCT00060528|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111474424|NCT00060528|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111474425|NCT00060528|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111474426|NCT04696224|Tranexamic Acid|tranexamic acid|mesh-list
111474427|NCT04696224|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111474428|NCT04696224|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111474429|NCT04696224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111474430|NCT04696224|Hemostatics|hemostatics|mesh-ancestor
111474431|NCT04696224|Coagulants|coagulants|mesh-ancestor
111474432|NCT04753008|Dopamine|dopamine|mesh-list
111474433|NCT04753008|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111474434|NCT04753008|Sympathomimetics|sympathomimetics|mesh-ancestor
111474435|NCT04753008|Autonomic Agents|autonomic agents|mesh-ancestor
111474436|NCT04753008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111474437|NCT04753008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111474438|NCT04753008|Dopamine Agents|dopamine agents|mesh-ancestor
111474439|NCT04753008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111474440|NCT04753008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111474441|NCT04753008|Protective Agents|protective agents|mesh-ancestor
111474442|NCT00063570|Gemcitabine|gemcitabine|mesh-list
111474443|NCT00063570|Pemetrexed|pemetrexed|mesh-list
111474444|NCT00063570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111474445|NCT00063570|Antimetabolites|antimetabolites|mesh-ancestor
111474446|NCT00063570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111474447|NCT00063570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111474448|NCT00063570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111474449|NCT00063570|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111474450|NCT00063570|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111474451|NCT01897038|Sorafenib|sorafenib|mesh-list
111474452|NCT01897038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111474453|NCT01897038|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111474454|NCT01897038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111474455|NCT01897038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111474456|NCT04770792|Chlorhexidine|chlorhexidine|mesh-list
111474457|NCT04770792|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
111474458|NCT04770792|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111474459|NCT04770792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111474460|NCT04770792|Disinfectants|disinfectants|mesh-ancestor
111474461|NCT04770792|Dermatologic Agents|dermatologic agents|mesh-ancestor
111474462|NCT00064038|Dexamethasone|dexamethasone|mesh-list
111474463|NCT00064038|Lenalidomide|lenalidomide|mesh-list
111474464|NCT00064038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111474465|NCT00064038|Antiemetics|antiemetics|mesh-ancestor
111474466|NCT00064038|Autonomic Agents|autonomic agents|mesh-ancestor
111474467|NCT00064038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111474468|NCT00064038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111474469|NCT00064038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111474470|NCT00064038|Glucocorticoids|glucocorticoids|mesh-ancestor
111474471|NCT00064038|Hormones|hormones|mesh-ancestor
111474472|NCT00064038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111474473|NCT00064038|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111474474|NCT00064038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111474475|NCT00064038|Immunologic Factors|immunologic factors|mesh-ancestor
111474476|NCT00064038|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111474477|NCT00064038|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111474478|NCT00064038|Growth Substances|growth substances|mesh-ancestor
111474479|NCT00064038|Growth Inhibitors|growth inhibitors|mesh-ancestor
111474480|NCT01960530|Dexamethasone|dexamethasone|mesh-list
111474481|NCT01960530|Hydrocortisone|hydrocortisone|mesh-list
111474482|NCT01960530|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
111474483|NCT01960530|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
111474484|NCT01960530|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
111474485|NCT01960530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111474486|NCT01960530|Antiemetics|antiemetics|mesh-ancestor
111474487|NCT01960530|Autonomic Agents|autonomic agents|mesh-ancestor
111474488|NCT01960530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111474489|NCT01960530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111474490|NCT01960530|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111474491|NCT01960530|Glucocorticoids|glucocorticoids|mesh-ancestor
111474492|NCT01960530|Hormones|hormones|mesh-ancestor
111474493|NCT01960530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111474494|NCT01960530|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111474495|NCT01960530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111474496|NCT01897428|Bepotastine besilate|bepotastine besilate|mesh-list
111474497|NCT01897428|Salicylates|salicylates|mesh-list
111474498|NCT01897428|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111474499|NCT01897428|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111474500|NCT01897428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111474501|NCT01897428|Analgesics|analgesics|mesh-ancestor
111474502|NCT01897428|Sensory System Agents|sensory system agents|mesh-ancestor
111474503|NCT01897428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111474504|NCT01897428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111474505|NCT01897428|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111474506|NCT01897428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111474507|NCT01897428|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111474508|NCT01897428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111474509|NCT01897428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111474510|NCT00024102|Doxorubicin|doxorubicin|mesh-list
111474511|NCT00024102|Capecitabine|capecitabine|mesh-list
111474512|NCT00024102|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111474513|NCT00024102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111474514|NCT00024102|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111474515|NCT00024102|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111474516|NCT00024102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111474517|NCT00024102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111474518|NCT00024102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111474519|NCT00024102|Antimetabolites|antimetabolites|mesh-ancestor
111474520|NCT00074802|Paroxetine|paroxetine|mesh-list
111474521|NCT00074802|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111474522|NCT00074802|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111474523|NCT00074802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111474524|NCT00074802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111474525|NCT00074802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111474526|NCT00074802|Serotonin Agents|serotonin agents|mesh-ancestor
111474527|NCT00074802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111474528|NCT00074802|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111474529|NCT00074802|Antidepressive Agents|antidepressive agents|mesh-ancestor
111474530|NCT00074802|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111474531|NCT00074802|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111474532|NCT00074802|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111474533|NCT00074802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111474534|NCT02505750|Capecitabine|capecitabine|mesh-list
111474535|NCT02505750|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111474536|NCT02505750|Antimetabolites|antimetabolites|mesh-ancestor
111474537|NCT02505750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111474538|NCT02505750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111474539|NCT00030264|Methotrexate|methotrexate|mesh-list
111474540|NCT00030264|Vinblastine|vinblastine|mesh-list
111474541|NCT00030264|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111474542|NCT00030264|Abortifacient Agents|abortifacient agents|mesh-ancestor
111474543|NCT00030264|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111474544|NCT00030264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111474545|NCT00030264|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111474546|NCT00030264|Antimetabolites|antimetabolites|mesh-ancestor
111474547|NCT00030264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111474548|NCT00030264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111474549|NCT00030264|Dermatologic Agents|dermatologic agents|mesh-ancestor
111474550|NCT00030264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111474551|NCT00030264|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111474552|NCT00030264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111474553|NCT00030264|Immunologic Factors|immunologic factors|mesh-ancestor
111474554|NCT00030264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111474555|NCT00030264|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111474556|NCT00030264|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111474557|NCT00030264|Tubulin Modulators|tubulin modulators|mesh-ancestor
111474558|NCT00030264|Antimitotic Agents|antimitotic agents|mesh-ancestor
111474559|NCT00030264|Mitosis Modulators|mitosis modulators|mesh-ancestor
111474560|NCT01897116|Hydroxychloroquine|hydroxychloroquine|mesh-list
111474561|NCT01897116|Vemurafenib|vemurafenib|mesh-list
111474562|NCT01897116|Antimalarials|antimalarials|mesh-ancestor
111474563|NCT01897116|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111474564|NCT01897116|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111474565|NCT01897116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111474566|NCT01897116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111474567|NCT01897116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111474568|NCT01897116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111474569|NCT01897116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111474570|NCT01897116|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111474571|NCT00036738|Cyclosporine|cyclosporine|mesh-list
111474572|NCT00036738|Mycophenolic Acid|mycophenolic acid|mesh-list
111474573|NCT00036738|Fludarabine|fludarabine|mesh-list
111474574|NCT00036738|Fludarabine phosphate|fludarabine phosphate|mesh-list
111474575|NCT00036738|Imatinib Mesylate|imatinib mesylate|mesh-list
111474576|NCT00036738|Dasatinib|dasatinib|mesh-list
111474577|NCT00036738|Cyclosporins|cyclosporins|mesh-list
111474578|NCT00036738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111474579|NCT00036738|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111474580|NCT00036738|Antimetabolites|antimetabolites|mesh-ancestor
111474581|NCT00036738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111474582|NCT00036738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111474583|NCT00036738|Immunologic Factors|immunologic factors|mesh-ancestor
111474584|NCT00036738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111474585|NCT00036738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111474586|NCT00036738|Antifungal Agents|antifungal agents|mesh-ancestor
111474587|NCT00036738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111474588|NCT00036738|Dermatologic Agents|dermatologic agents|mesh-ancestor
111474589|NCT00036738|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111474590|NCT00036738|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111474591|NCT00036738|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111474592|NCT00036738|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111474593|NCT00036738|Antitubercular Agents|antitubercular agents|mesh-ancestor
111474594|NCT00036738|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111474595|NCT00036738|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111474596|NCT00038610|Cytarabine|cytarabine|mesh-list
111474597|NCT00038610|Dexamethasone|dexamethasone|mesh-list
111474598|NCT00038610|Cyclophosphamide|cyclophosphamide|mesh-list
111474599|NCT00038610|Doxorubicin|doxorubicin|mesh-list
111474600|NCT00038610|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111474601|NCT00038610|Methotrexate|methotrexate|mesh-list
111474602|NCT00038610|Vincristine|vincristine|mesh-list
111474603|NCT00038610|Imatinib Mesylate|imatinib mesylate|mesh-list
111474604|NCT00038610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111474605|NCT00038610|Immunologic Factors|immunologic factors|mesh-ancestor
111474606|NCT00038610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111474607|NCT00038610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111474608|NCT00038610|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111474609|NCT00038610|Alkylating Agents|alkylating agents|mesh-ancestor
111474610|NCT00038610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111474611|NCT00038610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111474612|NCT00038610|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111474613|NCT00038610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111474614|NCT00038610|Antiemetics|antiemetics|mesh-ancestor
111474615|NCT00038610|Autonomic Agents|autonomic agents|mesh-ancestor
111474616|NCT00038610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111474617|NCT00038610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111474618|NCT00038610|Glucocorticoids|glucocorticoids|mesh-ancestor
111474619|NCT00038610|Hormones|hormones|mesh-ancestor
111474620|NCT00038610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111474621|NCT00038610|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111474622|NCT00038610|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111474623|NCT00038610|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111474624|NCT00038610|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111474625|NCT00038610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111474626|NCT00038610|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111474627|NCT00038610|Abortifacient Agents|abortifacient agents|mesh-ancestor
111474628|NCT00038610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111474629|NCT00038610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111474630|NCT00038610|Antimetabolites|antimetabolites|mesh-ancestor
111474631|NCT00038610|Dermatologic Agents|dermatologic agents|mesh-ancestor
111474632|NCT00038610|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111474633|NCT00038610|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111474634|NCT00038610|Antiviral Agents|antiviral agents|mesh-ancestor
111474635|NCT00038610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111474636|NCT00038610|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111474637|NCT00038610|Tubulin Modulators|tubulin modulators|mesh-ancestor
111474638|NCT00038610|Antimitotic Agents|antimitotic agents|mesh-ancestor
111474639|NCT00038610|Mitosis Modulators|mitosis modulators|mesh-ancestor
111474640|NCT00038610|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111474641|NCT00156936|Naltrexone|naltrexone|mesh-list
111474642|NCT00156936|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111474643|NCT00156936|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111474644|NCT00156936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111474645|NCT00156936|Sensory System Agents|sensory system agents|mesh-ancestor
111474646|NCT00156936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111474647|NCT00046566|Caseins|caseins|mesh-list
111474648|NCT00046566|Chelating Agents|chelating agents|mesh-ancestor
111474649|NCT00046566|Sequestering Agents|sequestering agents|mesh-ancestor
111474650|NCT00046566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111474651|NCT00079326|Trastuzumab|trastuzumab|mesh-list
111474652|NCT00079326|Epothilone B|epothilone b|mesh-list
111474653|NCT00079326|Epothilones|epothilones|mesh-list
111474654|NCT00079326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111474655|NCT00079326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111474656|NCT00079326|Tubulin Modulators|tubulin modulators|mesh-ancestor
111474657|NCT00079326|Antimitotic Agents|antimitotic agents|mesh-ancestor
111474658|NCT00079326|Mitosis Modulators|mitosis modulators|mesh-ancestor
111474659|NCT00079326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111474660|NCT02187354|Blinatumomab|blinatumomab|mesh-list
111474661|NCT02187354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111474662|NCT01898052|Anesthetics|anesthetics|mesh-list
111474663|NCT01898052|Levobupivacaine|levobupivacaine|mesh-list
111474664|NCT01898052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111474665|NCT01898052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111474666|NCT01898052|Anesthetics, Local|anesthetics, local|mesh-ancestor
111474667|NCT01898052|Sensory System Agents|sensory system agents|mesh-ancestor
111474668|NCT01898052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111474669|NCT00051168|Travoprost|travoprost|mesh-list
111474670|NCT00051168|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111474671|NCT00083382|Pamidronate|pamidronate|mesh-list
111474672|NCT00083382|Thalidomide|thalidomide|mesh-list
111474673|NCT00083382|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111474674|NCT00083382|Immunologic Factors|immunologic factors|mesh-ancestor
111474675|NCT00083382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111474676|NCT00083382|Leprostatic Agents|leprostatic agents|mesh-ancestor
111474677|NCT00083382|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111474678|NCT00083382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111474679|NCT00083382|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111474680|NCT00083382|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111474681|NCT00083382|Growth Substances|growth substances|mesh-ancestor
111474682|NCT00083382|Growth Inhibitors|growth inhibitors|mesh-ancestor
111474683|NCT00083382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111474684|NCT00083382|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111474685|NCT00167544|Hydrocortisone|hydrocortisone|mesh-list
111474686|NCT00167544|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111474687|NCT00167934|Valproic Acid|valproic acid|mesh-list
111474688|NCT00167934|Anticonvulsants|anticonvulsants|mesh-ancestor
111474689|NCT00167934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111474690|NCT00167934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111474691|NCT00167934|GABA Agents|gaba agents|mesh-ancestor
111474692|NCT00167934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111474693|NCT00167934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111474694|NCT00167934|Antimanic Agents|antimanic agents|mesh-ancestor
111474695|NCT00167934|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111474696|NCT00167934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111474697|NCT00167934|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111474698|NCT00168324|Dexamethasone|dexamethasone|mesh-list
111474699|NCT00168324|Dexamethasone acetate|dexamethasone acetate|mesh-list
111474700|NCT00168324|BB 1101|bb 1101|mesh-list
111474701|NCT00168324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111474702|NCT00168324|Antiemetics|antiemetics|mesh-ancestor
111474703|NCT00168324|Autonomic Agents|autonomic agents|mesh-ancestor
111474704|NCT00168324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111474705|NCT00168324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111474706|NCT00168324|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111474707|NCT00168324|Glucocorticoids|glucocorticoids|mesh-ancestor
111474708|NCT00168324|Hormones|hormones|mesh-ancestor
111474709|NCT00168324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111474710|NCT00168324|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111474711|NCT00168324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111474712|NCT00168324|Protease Inhibitors|protease inhibitors|mesh-ancestor
111474713|NCT00168324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111474714|NCT00168324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111474715|NCT02091882|Aripiprazole|aripiprazole|mesh-list
111474716|NCT02091882|Antidepressive Agents|antidepressive agents|mesh-ancestor
111474717|NCT02091882|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111474718|NCT02091882|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111474719|NCT02091882|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111474720|NCT02091882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111474721|NCT02091882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111474722|NCT02091882|Dopamine Agonists|dopamine agonists|mesh-ancestor
111474723|NCT02091882|Dopamine Agents|dopamine agents|mesh-ancestor
111474724|NCT02091882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111474725|NCT02091882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111474726|NCT02091882|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111474727|NCT02091882|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111474728|NCT02091882|Serotonin Agents|serotonin agents|mesh-ancestor
111474729|NCT02091882|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111474730|NCT02091882|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111474731|NCT02091882|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111474732|NCT02091882|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111474733|NCT00085254|Temozolomide|temozolomide|mesh-list
111474734|NCT00085254|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111474735|NCT00085254|Alkylating Agents|alkylating agents|mesh-ancestor
111474736|NCT00085254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111474737|NCT00085254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111474738|NCT00253890|Trazodone|trazodone|mesh-list
111474739|NCT00253890|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111474740|NCT00253890|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111474741|NCT00253890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111474742|NCT00253890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111474743|NCT00253890|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111474744|NCT00253890|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111474745|NCT00253890|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111474746|NCT00253890|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111474747|NCT00253890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111474748|NCT00253890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111474749|NCT00253890|Serotonin Agents|serotonin agents|mesh-ancestor
111474750|NCT00253890|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111474751|NCT00253890|Antidepressive Agents|antidepressive agents|mesh-ancestor
111474752|NCT00254592|Paclitaxel|paclitaxel|mesh-list
111474753|NCT00254592|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111474754|NCT00254592|Cyclophosphamide|cyclophosphamide|mesh-list
111474755|NCT00254592|Bevacizumab|bevacizumab|mesh-list
111474756|NCT00254592|Carboplatin|carboplatin|mesh-list
111474757|NCT00254592|Doxorubicin|doxorubicin|mesh-list
111474758|NCT00254592|Trastuzumab|trastuzumab|mesh-list
111474759|NCT00254592|Sargramostim|sargramostim|mesh-list
111474760|NCT00254592|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111474761|NCT00254592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111474762|NCT00254592|Tubulin Modulators|tubulin modulators|mesh-ancestor
111474763|NCT00254592|Antimitotic Agents|antimitotic agents|mesh-ancestor
111474764|NCT00254592|Mitosis Modulators|mitosis modulators|mesh-ancestor
111474765|NCT00254592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111474766|NCT00254592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111474767|NCT00254592|Immunologic Factors|immunologic factors|mesh-ancestor
111474768|NCT00254592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111474769|NCT00254592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111474770|NCT00254592|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111474771|NCT00254592|Alkylating Agents|alkylating agents|mesh-ancestor
111474772|NCT00254592|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111474773|NCT00254592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111474774|NCT00254592|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111474775|NCT00254592|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111474776|NCT00254592|Growth Substances|growth substances|mesh-ancestor
111474777|NCT00254592|Growth Inhibitors|growth inhibitors|mesh-ancestor
111474778|NCT00254592|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111474779|NCT00254592|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111474780|NCT00254592|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111474781|NCT00254592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111474782|NCT00255684|Cyclosporine|cyclosporine|mesh-list
111474783|NCT00255684|Mycophenolic Acid|mycophenolic acid|mesh-list
111474784|NCT00255684|Cyclophosphamide|cyclophosphamide|mesh-list
111474785|NCT00255684|Fludarabine|fludarabine|mesh-list
111474786|NCT00255684|Fludarabine phosphate|fludarabine phosphate|mesh-list
111474787|NCT00255684|Cyclosporins|cyclosporins|mesh-list
111474788|NCT00255684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111474789|NCT00255684|Immunologic Factors|immunologic factors|mesh-ancestor
111474790|NCT00255684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111474791|NCT00255684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111474792|NCT00255684|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111474793|NCT00255684|Alkylating Agents|alkylating agents|mesh-ancestor
111474794|NCT00255684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111474795|NCT00255684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111474796|NCT00255684|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111474797|NCT00255684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111474799|NCT00255684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111474800|NCT00255684|Antifungal Agents|antifungal agents|mesh-ancestor
111474801|NCT00255684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111474802|NCT00255684|Dermatologic Agents|dermatologic agents|mesh-ancestor
111474803|NCT00255684|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111474804|NCT00255684|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111474805|NCT00255684|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111474806|NCT00255684|Antitubercular Agents|antitubercular agents|mesh-ancestor
111474807|NCT00255684|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111474808|NCT00256776|Thalidomide|thalidomide|mesh-list
111474809|NCT00256776|Dexamethasone|dexamethasone|mesh-list
111474810|NCT00256776|Bortezomib|bortezomib|mesh-list
111474811|NCT00256776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111474812|NCT00256776|Antiemetics|antiemetics|mesh-ancestor
111474813|NCT00256776|Autonomic Agents|autonomic agents|mesh-ancestor
111474814|NCT00256776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111474815|NCT00256776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111474816|NCT00256776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111474817|NCT00256776|Glucocorticoids|glucocorticoids|mesh-ancestor
111474818|NCT00256776|Hormones|hormones|mesh-ancestor
111474819|NCT00256776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111474820|NCT00256776|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111474821|NCT00256776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111474822|NCT00256776|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111474823|NCT00256776|Immunologic Factors|immunologic factors|mesh-ancestor
111474824|NCT00256776|Leprostatic Agents|leprostatic agents|mesh-ancestor
111474825|NCT00256776|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111474826|NCT00256776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111474827|NCT00256776|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111474828|NCT00256776|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111474829|NCT00256776|Growth Substances|growth substances|mesh-ancestor
111474830|NCT00256776|Growth Inhibitors|growth inhibitors|mesh-ancestor
111474831|NCT00258180|Cyclophosphamide|cyclophosphamide|mesh-list
111474832|NCT00258180|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111474833|NCT00258180|Immunologic Factors|immunologic factors|mesh-ancestor
111474834|NCT00258180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111474835|NCT00258180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111474836|NCT00258180|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111474837|NCT00258180|Alkylating Agents|alkylating agents|mesh-ancestor
111474838|NCT00258180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111474839|NCT00258180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111474840|NCT00258180|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111474841|NCT00176202|Valproic Acid|valproic acid|mesh-list
111474842|NCT00176202|Anticonvulsants|anticonvulsants|mesh-list
111474843|NCT00176202|Risperidone|risperidone|mesh-list
111474844|NCT00176202|Antipsychotic Agents|antipsychotic agents|mesh-list
111474845|NCT00176202|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111474846|NCT00176202|Serotonin Agents|serotonin agents|mesh-ancestor
111474847|NCT00176202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111474848|NCT00176202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111474849|NCT00176202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111474850|NCT00176202|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111474851|NCT00176202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111474852|NCT00176202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111474853|NCT00176202|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111474854|NCT00176202|Dopamine Agents|dopamine agents|mesh-ancestor
111474855|NCT00176202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111474856|NCT00176202|GABA Agents|gaba agents|mesh-ancestor
111474857|NCT00176202|Antimanic Agents|antimanic agents|mesh-ancestor
111474858|NCT00176592|Glatiramer Acetate|glatiramer acetate|mesh-list
111474859|NCT00176592|Interferon beta-1b|interferon beta-1b|mesh-list
111474860|NCT00176592|(T,G)-A-L|(t,g)-a-l|mesh-list
111474861|NCT00176592|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111474862|NCT00176592|Immunologic Factors|immunologic factors|mesh-ancestor
111474863|NCT00176592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111474864|NCT00176592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111474865|NCT00176592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111474866|NCT00176826|Busulfan|busulfan|mesh-list
111474867|NCT00176826|Alkylating Agents|alkylating agents|mesh-ancestor
111474868|NCT00176826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111474869|NCT00176826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111474870|NCT00176826|Immunologic Factors|immunologic factors|mesh-ancestor
111474871|NCT00176826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111474872|NCT00176826|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111474874|NCT00176826|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111474875|NCT00176904|Cyclophosphamide|cyclophosphamide|mesh-list
111474876|NCT00176904|Busulfan|busulfan|mesh-list
111474877|NCT00176904|Antilymphocyte Serum|antilymphocyte serum|mesh-list
111474878|NCT00176904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111474879|NCT00176904|Immunologic Factors|immunologic factors|mesh-ancestor
111474880|NCT00176904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111474881|NCT00176904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111474882|NCT00176904|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111474883|NCT00176904|Alkylating Agents|alkylating agents|mesh-ancestor
111474884|NCT00176904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111474885|NCT00176904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111474886|NCT00176904|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111474887|NCT00179478|Interferons|interferons|mesh-list
111474888|NCT00179478|Interferon-beta|interferon-beta|mesh-list
111474889|NCT00179478|Interferon beta-1a|interferon beta-1a|mesh-list
111474890|NCT00179478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111474891|NCT00179478|Antiviral Agents|antiviral agents|mesh-ancestor
111474892|NCT00179478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111474893|NCT00179478|Immunologic Factors|immunologic factors|mesh-ancestor
111474894|NCT00179478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111474895|NCT00179478|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111474896|NCT00182754|Octreotide|octreotide|mesh-list
111474897|NCT00182754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111474898|NCT00182754|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111474899|NCT00182754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111474900|NCT00085410|Bortezomib|bortezomib|mesh-list
111474901|NCT00085410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111474902|NCT00186498|Memantine|memantine|mesh-list
111474903|NCT00186498|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111474904|NCT00186498|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111474905|NCT00186498|Dopamine Agents|dopamine agents|mesh-ancestor
111474906|NCT00186498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111474907|NCT00186498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111474908|NCT00186498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111474909|NCT00186498|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111474910|NCT00186498|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111474911|NCT00265200|Zoledronic Acid|zoledronic acid|mesh-list
111474912|NCT00265200|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111474913|NCT00265200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111474914|NCT00087672|Lenalidomide|lenalidomide|mesh-list
111474915|NCT00087672|Immunologic Factors|immunologic factors|mesh-ancestor
111474916|NCT00087672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111474917|NCT00087672|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111474918|NCT00087672|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111474919|NCT00087672|Growth Substances|growth substances|mesh-ancestor
111474920|NCT00087672|Growth Inhibitors|growth inhibitors|mesh-ancestor
111474921|NCT00087672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111474922|NCT00088218|Cytarabine|cytarabine|mesh-list
111474923|NCT00088218|Clofarabine|clofarabine|mesh-list
111474924|NCT00088218|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111474925|NCT00088218|Antimetabolites|antimetabolites|mesh-ancestor
111474926|NCT00088218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111474927|NCT00088218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111474928|NCT00088218|Antiviral Agents|antiviral agents|mesh-ancestor
111474929|NCT00088218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111474930|NCT00088218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111474931|NCT00088218|Immunologic Factors|immunologic factors|mesh-ancestor
111474932|NCT00088218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111474933|NCT00189228|Omalizumab|omalizumab|mesh-list
111474934|NCT00189228|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111474935|NCT00189228|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111474936|NCT00189228|Respiratory System Agents|respiratory system agents|mesh-ancestor
111474937|NCT00091260|Dexamethasone|dexamethasone|mesh-list
111474938|NCT00091260|Dexamethasone acetate|dexamethasone acetate|mesh-list
111474939|NCT00091260|Lenalidomide|lenalidomide|mesh-list
111474940|NCT00091260|BB 1101|bb 1101|mesh-list
111474941|NCT00091260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111474942|NCT00091260|Antiemetics|antiemetics|mesh-ancestor
111474943|NCT00091260|Autonomic Agents|autonomic agents|mesh-ancestor
111474944|NCT00091260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111474945|NCT00091260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111474946|NCT00091260|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111474947|NCT00091260|Glucocorticoids|glucocorticoids|mesh-ancestor
111474948|NCT00091260|Hormones|hormones|mesh-ancestor
111199093|NCT04981509|Growth Substances|growth substances|mesh-ancestor
111474949|NCT00091260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111474950|NCT00091260|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111474951|NCT00091260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111474952|NCT00091260|Protease Inhibitors|protease inhibitors|mesh-ancestor
111474953|NCT00091260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111474954|NCT00091260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111474955|NCT00091260|Immunologic Factors|immunologic factors|mesh-ancestor
111474956|NCT00091260|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111474957|NCT00091260|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111474958|NCT00091260|Growth Substances|growth substances|mesh-ancestor
111474959|NCT00091260|Growth Inhibitors|growth inhibitors|mesh-ancestor
111474961|NCT00193128|Capecitabine|capecitabine|mesh-list
111474962|NCT00193128|Oxaliplatin|oxaliplatin|mesh-list
111474963|NCT00193128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111474964|NCT00193128|Tubulin Modulators|tubulin modulators|mesh-ancestor
111474965|NCT00193128|Antimitotic Agents|antimitotic agents|mesh-ancestor
111474966|NCT00193128|Mitosis Modulators|mitosis modulators|mesh-ancestor
111474967|NCT00193128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111474968|NCT00193128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111474969|NCT00193128|Antimetabolites|antimetabolites|mesh-ancestor
111474970|NCT00193596|Paclitaxel|paclitaxel|mesh-list
111474971|NCT00193596|Etoposide|etoposide|mesh-list
111474972|NCT00193596|Carboplatin|carboplatin|mesh-list
111474973|NCT00193596|Gemcitabine|gemcitabine|mesh-list
111474974|NCT00193596|Irinotecan|irinotecan|mesh-list
111474975|NCT00193596|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111474976|NCT00193596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111474977|NCT00193596|Tubulin Modulators|tubulin modulators|mesh-ancestor
111474978|NCT00193596|Antimitotic Agents|antimitotic agents|mesh-ancestor
111474979|NCT00193596|Mitosis Modulators|mitosis modulators|mesh-ancestor
111474980|NCT00193596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111474981|NCT00193596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111474982|NCT00193596|Antimetabolites|antimetabolites|mesh-ancestor
111474983|NCT00193596|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111474984|NCT00193596|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111474985|NCT00193596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111474986|NCT00193596|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111474987|NCT00194532|Ciprofloxacin|ciprofloxacin|mesh-list
111474988|NCT00194532|Cefpodoxime|cefpodoxime|mesh-list
111474989|NCT00194532|Cefpodoxime proxetil|cefpodoxime proxetil|mesh-list
111474990|NCT00194532|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111474991|NCT00194532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111474992|NCT00194532|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111474993|NCT00194532|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111474994|NCT00194532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111474995|NCT00194532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111474996|NCT00194532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111474997|NCT00194532|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111474998|NCT00194532|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111474999|NCT00194610|Botulinum Toxins|botulinum toxins|mesh-list
111475000|NCT00194610|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111475001|NCT00194610|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111475002|NCT00194610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111475003|NCT00194610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111475004|NCT00194610|Cholinergic Agents|cholinergic agents|mesh-ancestor
111475005|NCT00194610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111475006|NCT00194610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111475007|NCT00194610|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111475008|NCT00194610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111475009|NCT00093756|Paclitaxel|paclitaxel|mesh-list
111475010|NCT00093756|Carboplatin|carboplatin|mesh-list
111475011|NCT00093756|Bortezomib|bortezomib|mesh-list
111475012|NCT00093756|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111475013|NCT00093756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111475014|NCT00093756|Tubulin Modulators|tubulin modulators|mesh-ancestor
111475015|NCT00093756|Antimitotic Agents|antimitotic agents|mesh-ancestor
111475016|NCT00093756|Mitosis Modulators|mitosis modulators|mesh-ancestor
111475017|NCT00093756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111475018|NCT04118556|Sirolimus|sirolimus|mesh-list
111475019|NCT04118556|Infliximab|infliximab|mesh-list
111475020|NCT04118556|Etanercept|etanercept|mesh-list
111475021|NCT04118556|Everolimus|everolimus|mesh-list
111475022|NCT04118556|Vedolizumab|vedolizumab|mesh-list
111475023|NCT04118556|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111475024|NCT04118556|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111475025|NCT04118556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111475026|NCT04118556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111475027|NCT04118556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111475028|NCT04118556|Immunologic Factors|immunologic factors|mesh-ancestor
111475029|NCT04118556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111475030|NCT04118556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111475031|NCT04118556|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111475032|NCT04118556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111475033|NCT04118556|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111475034|NCT04118556|Antifungal Agents|antifungal agents|mesh-ancestor
111475035|NCT04118556|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111475036|NCT04118556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111475037|NCT04118556|Dermatologic Agents|dermatologic agents|mesh-ancestor
111475038|NCT04118556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111475039|NCT04118556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111475040|NCT04118556|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111475041|NCT04118556|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111475042|NCT04118556|Analgesics|analgesics|mesh-ancestor
111475043|NCT04118556|Sensory System Agents|sensory system agents|mesh-ancestor
111475044|NCT04118556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111475045|NCT00267696|Bevacizumab|bevacizumab|mesh-list
111475046|NCT00267696|Carboplatin|carboplatin|mesh-list
111475047|NCT00267696|Gemcitabine|gemcitabine|mesh-list
111475048|NCT00267696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111475049|NCT00267696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111475050|NCT00267696|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111475051|NCT00267696|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111475052|NCT00267696|Growth Substances|growth substances|mesh-ancestor
111475053|NCT00267696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111475054|NCT00267696|Growth Inhibitors|growth inhibitors|mesh-ancestor
111475055|NCT00267696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111475056|NCT00267696|Antimetabolites|antimetabolites|mesh-ancestor
111475057|NCT00267696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111475058|NCT00195624|Cyclosporine|cyclosporine|mesh-list
111475059|NCT00195624|Alemtuzumab|alemtuzumab|mesh-list
111475060|NCT00195624|Cyclosporins|cyclosporins|mesh-list
111475061|NCT00195624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111475062|NCT00195624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111475063|NCT00195624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111475064|NCT00195624|Immunologic Factors|immunologic factors|mesh-ancestor
111475065|NCT00195624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111475066|NCT00195624|Antifungal Agents|antifungal agents|mesh-ancestor
111475067|NCT00195624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111475068|NCT00195624|Dermatologic Agents|dermatologic agents|mesh-ancestor
111475069|NCT00195624|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111475070|NCT00195624|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111475071|NCT00195624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111475072|NCT00195624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111475073|NCT00195702|Adalimumab|adalimumab|mesh-list
111475074|NCT00195702|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111475075|NCT00195702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111475076|NCT00195702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111475077|NCT00197184|Vaccines|vaccines|mesh-list
111475078|NCT00197184|Immunologic Factors|immunologic factors|mesh-ancestor
111475079|NCT00197184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111475080|NCT00098670|Rituximab|rituximab|mesh-list
111475081|NCT00098670|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111475082|NCT00098670|Alemtuzumab|alemtuzumab|mesh-list
111475083|NCT00098670|Fludarabine|fludarabine|mesh-list
111475084|NCT00098670|Fludarabine phosphate|fludarabine phosphate|mesh-list
111475085|NCT00098670|Antibodies|antibodies|mesh-list
111475086|NCT00098670|Immunoglobulins|immunoglobulins|mesh-list
111475087|NCT00098670|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111475088|NCT00098670|Immunologic Factors|immunologic factors|mesh-ancestor
111475089|NCT00098670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111475090|NCT00098670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111475091|NCT00098670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111475092|NCT00098670|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111475093|NCT00098670|Antimetabolites|antimetabolites|mesh-ancestor
111475094|NCT00098670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111475095|NCT00098670|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111475096|NCT00201864|Fulvestrant|fulvestrant|mesh-list
111475097|NCT00201864|Exemestane|exemestane|mesh-list
111475098|NCT00201864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111475099|NCT00201864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111475100|NCT00201864|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
111475101|NCT00201864|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111475102|NCT00201864|Hormone Antagonists|hormone antagonists|mesh-ancestor
111475103|NCT00201864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111475104|NCT00201864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111475105|NCT00201864|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111475106|NCT00201864|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111475107|NCT00201864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111475108|NCT00201864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111475109|NCT00202722|Remifentanil|remifentanil|mesh-list
111475110|NCT00202722|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111475111|NCT00202722|Narcotics|narcotics|mesh-ancestor
111475112|NCT00202722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111475113|NCT00202722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111475114|NCT00202722|Analgesics|analgesics|mesh-ancestor
111475115|NCT00202722|Sensory System Agents|sensory system agents|mesh-ancestor
111475116|NCT00202722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111475117|NCT00100698|Hormones|hormones|mesh-list
111475118|NCT00100698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111475119|NCT00100698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111475120|NCT00103116|Vaccines|vaccines|mesh-list
111475121|NCT00103116|Immunologic Factors|immunologic factors|mesh-ancestor
111475122|NCT00103116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111475123|NCT00205374|Cidofovir|cidofovir|mesh-list
111475124|NCT00205374|Antiviral Agents|antiviral agents|mesh-ancestor
111475125|NCT00205374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111475126|NCT00205374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111475127|NCT00205374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111475128|NCT00103194|Lapatinib|lapatinib|mesh-list
111475129|NCT00103194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111475130|NCT00103194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111475131|NCT00103194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111475132|NCT00103194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111475133|NCT00208026|Pimecrolimus|pimecrolimus|mesh-list
111475134|NCT00208026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111475135|NCT00208026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111475136|NCT00208026|Analgesics|analgesics|mesh-ancestor
111475137|NCT00208026|Sensory System Agents|sensory system agents|mesh-ancestor
111475138|NCT00208026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111475139|NCT00208026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111475140|NCT00208026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111475141|NCT00208026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111475142|NCT00208026|Dermatologic Agents|dermatologic agents|mesh-ancestor
111475143|NCT00208026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111475144|NCT00208026|Immunologic Factors|immunologic factors|mesh-ancestor
111475145|NCT00208026|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111475146|NCT00208026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111475147|NCT00208026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111475148|NCT00106392|Tacrolimus|tacrolimus|mesh-list
111475149|NCT00106392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111475150|NCT00106392|Immunologic Factors|immunologic factors|mesh-ancestor
111475151|NCT00106392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111475152|NCT00106392|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111475153|NCT00106392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111475154|NCT00106392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111475155|NCT00211692|Interferons|interferons|mesh-list
111475156|NCT00211692|Ribavirin|ribavirin|mesh-list
111475157|NCT00211692|Interferon-alpha|interferon-alpha|mesh-list
111475158|NCT00211692|Interferon alfacon-1|interferon alfacon-1|mesh-list
111475159|NCT00211692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111475160|NCT00211692|Antiviral Agents|antiviral agents|mesh-ancestor
111475161|NCT00211692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111475162|NCT00211692|Antimetabolites|antimetabolites|mesh-ancestor
111475163|NCT00211692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111475164|NCT00211692|Immunologic Factors|immunologic factors|mesh-ancestor
111475165|NCT00211692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111475166|NCT01899690|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111475167|NCT01899690|Clindamycin|clindamycin|mesh-list
111475168|NCT01899690|Cephalexin|cephalexin|mesh-list
111475169|NCT01899690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111475170|NCT01899690|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111475171|NCT01899690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111475172|NCT01899690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111475173|NCT01899846|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
111199321|NCT04893096|Felzartamab|felzartamab|mesh-list
111475174|NCT01899846|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
111475175|NCT01899846|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111475176|NCT01899846|Hormone Antagonists|hormone antagonists|mesh-ancestor
111475177|NCT01899846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111475178|NCT01899846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111475179|NCT01899846|Progestins|progestins|mesh-ancestor
111475180|NCT01899846|Hormones|hormones|mesh-ancestor
111475181|NCT00214890|Tenofovir|tenofovir|mesh-list
111475182|NCT00214890|Abacavir|abacavir|mesh-list
111475183|NCT00214890|Antiviral Agents|antiviral agents|mesh-ancestor
111475184|NCT00214890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111475185|NCT00214890|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111475186|NCT00214890|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111475187|NCT00214890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111475188|NCT00214890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111475189|NCT00214890|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111475190|NCT00214890|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111475191|NCT00216060|Risedronic Acid|risedronic acid|mesh-list
111475192|NCT00216060|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111475193|NCT00216060|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111475194|NCT00216060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111475195|NCT00216060|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111475196|NCT00216060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111475197|NCT00216060|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111475198|NCT00282282|Sirolimus|sirolimus|mesh-list
111475199|NCT00282282|Fludarabine|fludarabine|mesh-list
111475200|NCT00282282|Busulfan|busulfan|mesh-list
111475201|NCT00282282|Tacrolimus|tacrolimus|mesh-list
111475202|NCT00282282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111475203|NCT00282282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111475204|NCT00282282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111475205|NCT00282282|Immunologic Factors|immunologic factors|mesh-ancestor
111475206|NCT00282282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111475207|NCT00282282|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111475208|NCT00282282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111475209|NCT00282282|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111475210|NCT00282282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111475211|NCT00282282|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111475212|NCT00282282|Antifungal Agents|antifungal agents|mesh-ancestor
111475213|NCT00282282|Alkylating Agents|alkylating agents|mesh-ancestor
111475214|NCT00282282|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111475215|NCT00282282|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111475216|NCT00282828|Clonazepam|clonazepam|mesh-list
111475217|NCT00282828|Sertraline|sertraline|mesh-list
111475218|NCT00282828|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
111475219|NCT00282828|Antidepressive Agents|antidepressive agents|mesh-ancestor
111475220|NCT00282828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111475221|NCT00282828|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111475222|NCT00282828|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111475223|NCT00282828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111475224|NCT00282828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111475225|NCT00282828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111475226|NCT00282828|Serotonin Agents|serotonin agents|mesh-ancestor
111475227|NCT00282828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111475228|NCT00282828|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111475229|NCT00282828|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111475230|NCT00282828|Anticonvulsants|anticonvulsants|mesh-ancestor
111475231|NCT00282828|GABA Modulators|gaba modulators|mesh-ancestor
111475232|NCT00282828|GABA Agents|gaba agents|mesh-ancestor
111475233|NCT00112242|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
111475234|NCT00112242|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111475235|NCT00112242|Immunologic Factors|immunologic factors|mesh-ancestor
111475236|NCT00112242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111475237|NCT00223236|Choline|choline|mesh-list
111475238|NCT00223236|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
111475239|NCT00223236|Lipotropic Agents|lipotropic agents|mesh-ancestor
111475240|NCT00223236|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111475241|NCT00223236|Antimetabolites|antimetabolites|mesh-ancestor
111475242|NCT00223236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111475243|NCT00223236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111475244|NCT00223236|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111475245|NCT00223236|Nootropic Agents|nootropic agents|mesh-ancestor
111475246|NCT00223704|Icatibant|icatibant|mesh-list
111475247|NCT00223704|Aminocaproic Acid|aminocaproic acid|mesh-list
111199407|NCT04840602|Rituximab|rituximab|mesh-list
111475248|NCT00223704|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111475249|NCT00223704|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111475250|NCT00223704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111475251|NCT00223704|Hemostatics|hemostatics|mesh-ancestor
111475252|NCT00223704|Coagulants|coagulants|mesh-ancestor
111475253|NCT00223704|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111475254|NCT00223704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111475255|NCT00223704|Analgesics|analgesics|mesh-ancestor
111475256|NCT00223704|Sensory System Agents|sensory system agents|mesh-ancestor
111475257|NCT00223704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111475258|NCT00223704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111475259|NCT00223704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111475260|NCT00223704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111475261|NCT00223704|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
111475262|NCT00223704|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
111475263|NCT00223704|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
111475264|NCT00223704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111475265|NCT00223704|Immunologic Factors|immunologic factors|mesh-ancestor
111475266|NCT00224952|Carbamazepine|carbamazepine|mesh-list
111475267|NCT00224952|Valproic Acid|valproic acid|mesh-list
111475268|NCT00224952|Anticonvulsants|anticonvulsants|mesh-ancestor
111475269|NCT00224952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111475270|NCT00224952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111475271|NCT00224952|GABA Agents|gaba agents|mesh-ancestor
111475272|NCT00224952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110446480|NCT00865189|Immunologic Factors|immunologic factors|mesh-ancestor
111475273|NCT00224952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111475274|NCT00224952|Antimanic Agents|antimanic agents|mesh-ancestor
111475275|NCT00224952|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111475276|NCT00224952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111475277|NCT00224952|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111475278|NCT00224952|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111475279|NCT00224952|Analgesics|analgesics|mesh-ancestor
111475280|NCT00224952|Sensory System Agents|sensory system agents|mesh-ancestor
111475281|NCT00224952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111475282|NCT00224952|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111475283|NCT00224952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111475284|NCT00224952|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111475285|NCT00224952|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111475286|NCT00225420|Docetaxel|docetaxel|mesh-list
111475287|NCT00225420|Leuprolide|leuprolide|mesh-list
111475288|NCT00225420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111475289|NCT00225420|Tubulin Modulators|tubulin modulators|mesh-ancestor
111475290|NCT00225420|Antimitotic Agents|antimitotic agents|mesh-ancestor
111475291|NCT00225420|Mitosis Modulators|mitosis modulators|mesh-ancestor
111475292|NCT00225420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111475293|NCT00225420|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111475294|NCT00225420|Fertility Agents|fertility agents|mesh-ancestor
111475295|NCT00225420|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111475296|NCT00225420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111475297|NCT00225420|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111475298|NCT00225498|Olanzapine|olanzapine|mesh-list
111475299|NCT00225498|Risperidone|risperidone|mesh-list
111475300|NCT00225498|Ziprasidone|ziprasidone|mesh-list
111475301|NCT00225498|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111475302|NCT00225498|Serotonin Agents|serotonin agents|mesh-ancestor
111475303|NCT00225498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111475304|NCT00225498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111475305|NCT00225498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111475306|NCT00225498|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111475307|NCT00225498|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111475308|NCT00225498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111475309|NCT00225498|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111475310|NCT00225498|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111475311|NCT00225498|Dopamine Agents|dopamine agents|mesh-ancestor
111475312|NCT00225498|Antiemetics|antiemetics|mesh-ancestor
111475313|NCT00225498|Autonomic Agents|autonomic agents|mesh-ancestor
111475314|NCT00225498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111475315|NCT00225498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111475316|NCT00225498|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111475317|NCT00225498|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111475318|NCT00225498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111475319|NCT00225732|Ibuprofen|ibuprofen|mesh-list
111475320|NCT00225732|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111475321|NCT00225732|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111199475|NCT04799275|Glucocorticoids|glucocorticoids|mesh-ancestor
111475322|NCT00225732|Analgesics|analgesics|mesh-ancestor
111475323|NCT00225732|Sensory System Agents|sensory system agents|mesh-ancestor
111475324|NCT00225732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111475325|NCT00225732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111475326|NCT00225732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111475327|NCT00225732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111475328|NCT00225732|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111475329|NCT00225732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111475330|NCT00225732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111475331|NCT02096718|Afatinib|afatinib|mesh-list
111475332|NCT02096718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111475333|NCT02096718|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111475334|NCT02096718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111475335|NCT02096718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111475336|NCT02097732|Ipilimumab|ipilimumab|mesh-list
111475337|NCT02097732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111475338|NCT02097732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111475339|NCT02097732|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111475340|NCT02097732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111475341|NCT00286182|Epoetin Alfa|epoetin alfa|mesh-list
111475342|NCT00286182|Hematinics|hematinics|mesh-ancestor
111475343|NCT00226590|Paclitaxel|paclitaxel|mesh-list
111475344|NCT00226590|Carboplatin|carboplatin|mesh-list
111475345|NCT00226590|Gemcitabine|gemcitabine|mesh-list
111475346|NCT00226590|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111475347|NCT00226590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111475348|NCT00226590|Tubulin Modulators|tubulin modulators|mesh-ancestor
111475349|NCT00226590|Antimitotic Agents|antimitotic agents|mesh-ancestor
111475350|NCT00226590|Mitosis Modulators|mitosis modulators|mesh-ancestor
111475351|NCT00226590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111475352|NCT00226590|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111475353|NCT00226590|Antimetabolites|antimetabolites|mesh-ancestor
111475354|NCT00114114|Goserelin|goserelin|mesh-list
111475355|NCT00114114|Testosterone|testosterone|mesh-list
111475356|NCT00114114|Androgens|androgens|mesh-ancestor
111475357|NCT00114114|Hormones|hormones|mesh-ancestor
111475358|NCT00114114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111475359|NCT00114114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111475360|NCT00114114|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111475361|NCT00114114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111475362|NCT00227760|Cediranib|cediranib|mesh-list
111475363|NCT00227760|Maleic acid|maleic acid|mesh-list
111475364|NCT00227760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111475365|NCT00227760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111475366|NCT00227760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111475367|NCT00227760|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111475368|NCT00227994|Donepezil|donepezil|mesh-list
111475369|NCT00227994|Galantamine|galantamine|mesh-list
111475370|NCT00227994|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111475371|NCT00227994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111475372|NCT00227994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111475373|NCT00227994|Cholinergic Agents|cholinergic agents|mesh-ancestor
111475374|NCT00227994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111475375|NCT00227994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111475376|NCT00227994|Nootropic Agents|nootropic agents|mesh-ancestor
111475377|NCT00227994|Parasympathomimetics|parasympathomimetics|mesh-ancestor
111475378|NCT00227994|Autonomic Agents|autonomic agents|mesh-ancestor
111475379|NCT00227994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111475380|NCT00114504|Simvastatin|simvastatin|mesh-list
111475381|NCT00114504|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111475382|NCT00114504|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111475383|NCT00114504|Antimetabolites|antimetabolites|mesh-ancestor
111475384|NCT00114504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111475385|NCT00114504|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111475386|NCT00114504|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111475387|NCT00114504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111475388|NCT01898676|Valproic Acid|valproic acid|mesh-list
111475389|NCT01898676|Anticonvulsants|anticonvulsants|mesh-ancestor
111475390|NCT01898676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111475391|NCT01898676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111475392|NCT01898676|GABA Agents|gaba agents|mesh-ancestor
111475393|NCT01898676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111475394|NCT01898676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111199551|NCT04759586|Immunologic Factors|immunologic factors|mesh-ancestor
111475395|NCT01898676|Antimanic Agents|antimanic agents|mesh-ancestor
111475396|NCT01898676|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111475397|NCT01898676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111475398|NCT01898676|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111475399|NCT00288366|Aripiprazole|aripiprazole|mesh-list
111475400|NCT00288366|Ziprasidone|ziprasidone|mesh-list
111475401|NCT00288366|Antidepressive Agents|antidepressive agents|mesh-ancestor
111475402|NCT00288366|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111475403|NCT00288366|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111475404|NCT00288366|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111475405|NCT00288366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111475406|NCT00288366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111475407|NCT00288366|Dopamine Agonists|dopamine agonists|mesh-ancestor
111475408|NCT00288366|Dopamine Agents|dopamine agents|mesh-ancestor
111475409|NCT00288366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111475410|NCT00288366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111475411|NCT00288366|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111475412|NCT00288366|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111475413|NCT00288366|Serotonin Agents|serotonin agents|mesh-ancestor
111475414|NCT00288366|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111475415|NCT00288366|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111475416|NCT00288366|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111475417|NCT00288366|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111475418|NCT00288600|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111475419|NCT00288600|Immunoglobulins|immunoglobulins|mesh-list
111475420|NCT00288600|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111475421|NCT00288600|Antibodies|antibodies|mesh-list
111475422|NCT00288600|gamma-Globulins|gamma-globulins|mesh-list
111475423|NCT00288600|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
111475424|NCT00288600|Immunologic Factors|immunologic factors|mesh-ancestor
111475425|NCT00288600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111475426|NCT00290472|Sirolimus|sirolimus|mesh-list
111475427|NCT00290472|Temsirolimus|temsirolimus|mesh-list
111475428|NCT00290472|MTOR Inhibitors|mtor inhibitors|mesh-list
111475429|NCT00290472|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111475430|NCT00290472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111475431|NCT00290472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111475432|NCT00290472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111475433|NCT00290472|Immunologic Factors|immunologic factors|mesh-ancestor
111475434|NCT00290472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111475435|NCT00290472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111475436|NCT00290472|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111475437|NCT00290472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111475438|NCT00290472|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111475439|NCT00290472|Antifungal Agents|antifungal agents|mesh-ancestor
111475440|NCT04752852|Dexamethasone|dexamethasone|mesh-list
111475441|NCT04752852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111475442|NCT04752852|Antiemetics|antiemetics|mesh-ancestor
111475443|NCT04752852|Autonomic Agents|autonomic agents|mesh-ancestor
111475444|NCT04752852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111475445|NCT04752852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111475446|NCT04752852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111475447|NCT04752852|Glucocorticoids|glucocorticoids|mesh-ancestor
111475448|NCT04752852|Hormones|hormones|mesh-ancestor
111475449|NCT04752852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111475450|NCT04752852|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111475451|NCT04752852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111475452|NCT01899144|Albuterol|albuterol|mesh-list
111475453|NCT01899144|Procaterol|procaterol|mesh-list
111475454|NCT01899144|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111475455|NCT01899144|Autonomic Agents|autonomic agents|mesh-ancestor
111475456|NCT01899144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111475457|NCT01899144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111475458|NCT01899144|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111475459|NCT01899144|Respiratory System Agents|respiratory system agents|mesh-ancestor
111475460|NCT01899144|Tocolytic Agents|tocolytic agents|mesh-ancestor
111475461|NCT01899144|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111475462|NCT01899144|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111475463|NCT01899144|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111475464|NCT01899144|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111475465|NCT01899144|Adrenergic Agents|adrenergic agents|mesh-ancestor
111475466|NCT01899144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111475467|NCT01899144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111475468|NCT01899144|Sympathomimetics|sympathomimetics|mesh-ancestor
111475469|NCT00234078|Rebamipide|rebamipide|mesh-list
111475470|NCT00234078|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111475471|NCT00234078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111475473|NCT00234078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111475474|NCT00234078|Protective Agents|protective agents|mesh-ancestor
111475475|NCT00234078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111475476|NCT00234078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111475477|NCT00118404|Fluoxetine|fluoxetine|mesh-list
111475478|NCT00118404|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111475479|NCT00118404|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111475480|NCT00118404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111475481|NCT00118404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111475482|NCT00118404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111475483|NCT00118404|Serotonin Agents|serotonin agents|mesh-ancestor
111475484|NCT00118404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111475485|NCT00118404|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111475486|NCT00118404|Antidepressive Agents|antidepressive agents|mesh-ancestor
111475487|NCT00118404|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111475488|NCT00118404|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111475489|NCT00118404|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111475490|NCT00118404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111475491|NCT00121836|Bevacizumab|bevacizumab|mesh-list
111475492|NCT00121836|Capecitabine|capecitabine|mesh-list
111475493|NCT00121836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111475494|NCT00121836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111475495|NCT00121836|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111475496|NCT00121836|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111475497|NCT00121836|Growth Substances|growth substances|mesh-ancestor
111475498|NCT00121836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111475499|NCT00121836|Growth Inhibitors|growth inhibitors|mesh-ancestor
111475500|NCT00121836|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111475501|NCT00121836|Antimetabolites|antimetabolites|mesh-ancestor
111475502|NCT00121836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111475503|NCT00237666|Ziprasidone|ziprasidone|mesh-list
111475504|NCT00237666|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111475505|NCT00237666|Serotonin Agents|serotonin agents|mesh-ancestor
111475506|NCT00237666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111475507|NCT00237666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111475508|NCT00237666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111475509|NCT00237666|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111475510|NCT00237666|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111475511|NCT00237666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111475512|NCT00237666|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111475513|NCT00237666|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111475514|NCT00237666|Dopamine Agents|dopamine agents|mesh-ancestor
111475515|NCT00296322|Mitomycins|mitomycins|mesh-list
111475516|NCT00296322|Mitomycin|mitomycin|mesh-list
111475517|NCT00296322|Doxifluridine|doxifluridine|mesh-list
111475518|NCT00296322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111475519|NCT00296322|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111475520|NCT00296322|Alkylating Agents|alkylating agents|mesh-ancestor
111475521|NCT00296322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111475522|NCT00296322|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111475523|NCT00296322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111475524|NCT00296322|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111475525|NCT00296322|Antimetabolites|antimetabolites|mesh-ancestor
111475526|NCT00296322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111475527|NCT00296322|Immunologic Factors|immunologic factors|mesh-ancestor
111475528|NCT00296322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111475529|NCT00296322|Appetite Stimulants|appetite stimulants|mesh-ancestor
111475530|NCT00296322|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111475531|NCT00123162|Sildenafil Citrate|sildenafil citrate|mesh-list
111475532|NCT00123162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111475533|NCT00123162|Vasodilator Agents|vasodilator agents|mesh-ancestor
111475534|NCT00123162|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111475535|NCT00123162|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111475536|NCT00123162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111475537|NCT00123162|Urological Agents|urological agents|mesh-ancestor
111475538|NCT00123630|Omalizumab|omalizumab|mesh-list
111475539|NCT00123630|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111475540|NCT00123630|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111475541|NCT00123630|Respiratory System Agents|respiratory system agents|mesh-ancestor
111475542|NCT00124176|Albuterol|albuterol|mesh-list
111475543|NCT00124176|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111475544|NCT00124176|Autonomic Agents|autonomic agents|mesh-ancestor
111475545|NCT00124176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111475546|NCT00124176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111475547|NCT00124176|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111475548|NCT00124176|Respiratory System Agents|respiratory system agents|mesh-ancestor
111475549|NCT00124176|Tocolytic Agents|tocolytic agents|mesh-ancestor
111475550|NCT00124176|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111475551|NCT00124176|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111475552|NCT00124176|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111475553|NCT00124176|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111475554|NCT00124176|Adrenergic Agents|adrenergic agents|mesh-ancestor
111475555|NCT00124176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111475556|NCT00124176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111475558|NCT00240162|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111475559|NCT00240162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111475560|NCT00240162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111475561|NCT00299988|Immunoglobulins|immunoglobulins|mesh-list
111475562|NCT00299988|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111475563|NCT00299988|Antibodies|antibodies|mesh-list
111475564|NCT00299988|gamma-Globulins|gamma-globulins|mesh-list
111475565|NCT00299988|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
111475566|NCT00299988|Immunologic Factors|immunologic factors|mesh-ancestor
111475567|NCT00299988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111475568|NCT04226352|Dextromethorphan|dextromethorphan|mesh-list
111475569|NCT04226352|Antitussive Agents|antitussive agents|mesh-ancestor
111475570|NCT04226352|Respiratory System Agents|respiratory system agents|mesh-ancestor
111475571|NCT04226352|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111475572|NCT04226352|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111475573|NCT04226352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111475574|NCT04226352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111475575|NCT04226352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111475576|NCT00300456|Simvastatin|simvastatin|mesh-list
111475577|NCT00300456|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111475578|NCT00300456|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111475579|NCT00300456|Antimetabolites|antimetabolites|mesh-ancestor
111475580|NCT00300456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111475581|NCT00300456|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111475582|NCT00300456|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111475583|NCT00300456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111475584|NCT00125034|Oxaliplatin|oxaliplatin|mesh-list
111475585|NCT00125034|Cetuximab|cetuximab|mesh-list
111475586|NCT00125034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111475587|NCT00125034|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111475588|NCT02100930|Molgramostim|molgramostim|mesh-list
111475589|NCT02100930|Isotretinoin|isotretinoin|mesh-list
111475590|NCT02100930|Antibodies|antibodies|mesh-list
111475591|NCT02100930|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111475592|NCT02100930|Sargramostim|sargramostim|mesh-list
111475593|NCT02100930|Immunologic Factors|immunologic factors|mesh-ancestor
111475594|NCT02100930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111475595|NCT02100930|Dermatologic Agents|dermatologic agents|mesh-ancestor
111475596|NCT02100930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111475597|NCT02101008|Disulfiram|disulfiram|mesh-list
111475598|NCT02101008|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111475599|NCT02101008|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
111475600|NCT02101008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111475601|NCT02101008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111475602|NCT00241176|Aripiprazole|aripiprazole|mesh-list
111475603|NCT00241176|Antidepressive Agents|antidepressive agents|mesh-ancestor
111475604|NCT00241176|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111475605|NCT00241176|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111475606|NCT00241176|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111475607|NCT00241176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111475608|NCT00241176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111475609|NCT00241176|Dopamine Agonists|dopamine agonists|mesh-ancestor
111475610|NCT00241176|Dopamine Agents|dopamine agents|mesh-ancestor
111475611|NCT00241176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111475612|NCT00241176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111475613|NCT00241176|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111475614|NCT00241176|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111475615|NCT00241176|Serotonin Agents|serotonin agents|mesh-ancestor
111475616|NCT00241176|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111475617|NCT00241176|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111199790|NCT04622228|Carboplatin|carboplatin|mesh-list
111475618|NCT00241176|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111475619|NCT00241176|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111475620|NCT02102100|Menthol|menthol|mesh-list
111475621|NCT02102100|Nicotine|nicotine|mesh-list
111475622|NCT02102100|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111475623|NCT02102100|Autonomic Agents|autonomic agents|mesh-ancestor
111475624|NCT02102100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111475625|NCT02102100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111475626|NCT02102100|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111475627|NCT02102100|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111475628|NCT02102100|Cholinergic Agents|cholinergic agents|mesh-ancestor
111475629|NCT02102100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111475630|NCT02102100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111475631|NCT02102100|Antipruritics|antipruritics|mesh-ancestor
111475632|NCT02102100|Dermatologic Agents|dermatologic agents|mesh-ancestor
111475633|NCT02094534|Insulin|insulin|mesh-list
111475634|NCT02094534|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111475635|NCT02094534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111475636|NCT00242502|Bevacizumab|bevacizumab|mesh-list
111475637|NCT00242502|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111475638|NCT00242502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111475639|NCT00242502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111475640|NCT00242502|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111475641|NCT00242502|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111475642|NCT00242502|Growth Substances|growth substances|mesh-ancestor
111475643|NCT00242502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111475644|NCT00242502|Growth Inhibitors|growth inhibitors|mesh-ancestor
111475645|NCT00242502|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111475646|NCT00242502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111475647|NCT00242502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111475648|NCT04389060|Grape Seed Extract|grape seed extract|mesh-list
111475649|NCT04389060|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111475650|NCT04389060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111475651|NCT04389060|Antioxidants|antioxidants|mesh-ancestor
111475652|NCT04389060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111475653|NCT04389060|Protective Agents|protective agents|mesh-ancestor
111475654|NCT04389060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111475655|NCT01899066|Carboplatin|carboplatin|mesh-list
111475656|NCT01899066|Etoposide|etoposide|mesh-list
111475657|NCT01899066|Vincristine|vincristine|mesh-list
111475658|NCT01899066|Ranibizumab|ranibizumab|mesh-list
111475659|NCT01899066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111475660|NCT01899066|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111475661|NCT01899066|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111475662|NCT01899066|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111475663|NCT01899066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111475664|NCT01899066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111475665|NCT01899066|Tubulin Modulators|tubulin modulators|mesh-ancestor
111475666|NCT01899066|Antimitotic Agents|antimitotic agents|mesh-ancestor
111475667|NCT01899066|Mitosis Modulators|mitosis modulators|mesh-ancestor
111475668|NCT01899066|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111475669|NCT01899066|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111475670|NCT01899066|Growth Substances|growth substances|mesh-ancestor
111475671|NCT01899066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111475672|NCT01899066|Growth Inhibitors|growth inhibitors|mesh-ancestor
111475673|NCT00127218|Niacin|niacin|mesh-list
111475674|NCT00127218|Atorvastatin|atorvastatin|mesh-list
111475675|NCT00127218|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111475676|NCT00127218|Simvastatin|simvastatin|mesh-list
111475677|NCT00127218|Pravastatin|pravastatin|mesh-list
111475678|NCT00127218|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111475679|NCT00127218|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111475680|NCT00127218|Antimetabolites|antimetabolites|mesh-ancestor
111475681|NCT00127218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111475682|NCT00127218|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111475683|NCT00127218|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111475684|NCT00127218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111475685|NCT00127218|Vasodilator Agents|vasodilator agents|mesh-ancestor
111475686|NCT00127218|Vitamin B Complex|vitamin b complex|mesh-ancestor
111475687|NCT00127218|Vitamins|vitamins|mesh-ancestor
111475688|NCT00127218|Micronutrients|micronutrients|mesh-ancestor
111475689|NCT00127218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111475690|NCT00127530|4-Aminopyridine|4-aminopyridine|mesh-list
111475691|NCT00127530|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
111475692|NCT00127530|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111475693|NCT00127530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111475694|NCT00250926|Dexamethasone|dexamethasone|mesh-list
111475695|NCT00250926|Dexamethasone acetate|dexamethasone acetate|mesh-list
111475696|NCT00250926|Rituximab|rituximab|mesh-list
111475697|NCT00250926|Bortezomib|bortezomib|mesh-list
111475698|NCT00250926|BB 1101|bb 1101|mesh-list
111475699|NCT00250926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111475700|NCT00250926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111475701|NCT00250926|Immunologic Factors|immunologic factors|mesh-ancestor
111475702|NCT00250926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111475703|NCT00250926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111475704|NCT00250926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111475705|NCT00250926|Antiemetics|antiemetics|mesh-ancestor
111475706|NCT00250926|Autonomic Agents|autonomic agents|mesh-ancestor
111475707|NCT00250926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111475708|NCT00250926|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111475709|NCT00250926|Glucocorticoids|glucocorticoids|mesh-ancestor
111475710|NCT00250926|Hormones|hormones|mesh-ancestor
111475711|NCT00250926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111475712|NCT00250926|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111475713|NCT00250926|Protease Inhibitors|protease inhibitors|mesh-ancestor
111475714|NCT00250926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111475715|NCT00250926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111475716|NCT00303966|Sorafenib|sorafenib|mesh-list
111475717|NCT00303966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111475718|NCT00303966|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111475719|NCT00303966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111475720|NCT00303966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111475721|NCT00304746|Testosterone|testosterone|mesh-list
111475722|NCT00304746|Androgens|androgens|mesh-ancestor
111475723|NCT00304746|Hormones|hormones|mesh-ancestor
111475724|NCT00304746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111475725|NCT00304746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111475726|NCT00134004|Mycophenolic Acid|mycophenolic acid|mesh-list
111475727|NCT00134004|Cyclophosphamide|cyclophosphamide|mesh-list
111475728|NCT00134004|Fludarabine|fludarabine|mesh-list
111475729|NCT00134004|Fludarabine phosphate|fludarabine phosphate|mesh-list
111475730|NCT00134004|Tacrolimus|tacrolimus|mesh-list
111475731|NCT00134004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111475732|NCT00134004|Immunologic Factors|immunologic factors|mesh-ancestor
111475733|NCT00134004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111475734|NCT00134004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111475735|NCT00134004|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111475736|NCT00134004|Alkylating Agents|alkylating agents|mesh-ancestor
111475737|NCT00134004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111475738|NCT00134004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111475739|NCT00134004|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111475740|NCT00134004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111475741|NCT00134004|Antimetabolites|antimetabolites|mesh-ancestor
111475742|NCT00134004|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111475743|NCT00134004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111475744|NCT00134004|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111475745|NCT00134004|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111475746|NCT00134004|Antitubercular Agents|antitubercular agents|mesh-ancestor
111475747|NCT00134004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111475748|NCT00134004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111475749|NCT00135798|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
111475750|NCT00135798|Antiviral Agents|antiviral agents|mesh-ancestor
111475751|NCT00135798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111475752|NCT02103114|Antithrombin III|antithrombin iii|mesh-list
111475753|NCT02103114|Antithrombins|antithrombins|mesh-list
111475754|NCT02103114|Thrombin|thrombin|mesh-list
111475755|NCT02103114|Hemostatics|hemostatics|mesh-ancestor
111475756|NCT02103114|Coagulants|coagulants|mesh-ancestor
111475757|NCT02103114|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111475758|NCT02103114|Protease Inhibitors|protease inhibitors|mesh-ancestor
111475759|NCT02103114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111475760|NCT02103114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111475761|NCT02103114|Anticoagulants|anticoagulants|mesh-ancestor
111475762|NCT01790022|Methylprednisolone|methylprednisolone|mesh-list
111475763|NCT01790022|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111475764|NCT01790022|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111475765|NCT01790022|Prednisolone|prednisolone|mesh-list
111475766|NCT01790022|Prednisolone acetate|prednisolone acetate|mesh-list
111475767|NCT01790022|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111475768|NCT01790022|Prednisolone phosphate|prednisolone phosphate|mesh-list
111475769|NCT01790022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111475770|NCT01790022|Antiemetics|antiemetics|mesh-ancestor
111199929|NCT04553692|Growth Substances|growth substances|mesh-ancestor
111475772|NCT01790022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111475773|NCT01790022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111475774|NCT01790022|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111475775|NCT01790022|Glucocorticoids|glucocorticoids|mesh-ancestor
111475776|NCT01790022|Hormones|hormones|mesh-ancestor
111475777|NCT01790022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111475778|NCT01790022|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111475779|NCT01790022|Protective Agents|protective agents|mesh-ancestor
111475780|NCT01790022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111475781|NCT01790022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111475782|NCT00140556|Bevacizumab|bevacizumab|mesh-list
111475783|NCT00140556|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111475784|NCT00140556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111475785|NCT00140556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111475786|NCT00140556|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111475787|NCT00140556|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111475788|NCT00140556|Growth Substances|growth substances|mesh-ancestor
111475789|NCT00140556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111475790|NCT00140556|Growth Inhibitors|growth inhibitors|mesh-ancestor
111475791|NCT00140556|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111475792|NCT00140556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110446561|NCT00603759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111475793|NCT00140556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111475794|NCT00142116|Thalidomide|thalidomide|mesh-list
111475795|NCT00142116|Rituximab|rituximab|mesh-list
111475796|NCT00142116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111475797|NCT00142116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111475798|NCT00142116|Immunologic Factors|immunologic factors|mesh-ancestor
111475799|NCT00142116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111475800|NCT00142116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111475801|NCT00142116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111475802|NCT00142116|Leprostatic Agents|leprostatic agents|mesh-ancestor
111475803|NCT00142116|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111475804|NCT00142116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111475805|NCT00142116|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111475806|NCT00142116|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111475807|NCT00142116|Growth Substances|growth substances|mesh-ancestor
111475808|NCT00142116|Growth Inhibitors|growth inhibitors|mesh-ancestor
111475809|NCT05201430|Capecitabine|capecitabine|mesh-list
111475810|NCT05201430|Oxaliplatin|oxaliplatin|mesh-list
111475811|NCT05201430|Irinotecan|irinotecan|mesh-list
111475812|NCT05201430|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111475813|NCT05201430|Antimetabolites|antimetabolites|mesh-ancestor
111475814|NCT05201430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111475815|NCT05201430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111475816|NCT05201430|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111475817|NCT05201430|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111475818|NCT05201430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111475819|NCT00142506|Sildenafil Citrate|sildenafil citrate|mesh-list
111475820|NCT00142506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111475821|NCT00142506|Vasodilator Agents|vasodilator agents|mesh-ancestor
111475822|NCT00142506|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111475823|NCT00142506|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111475824|NCT00142506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111475825|NCT00142506|Urological Agents|urological agents|mesh-ancestor
111475826|NCT05266794|Selenium|selenium|mesh-list
111475827|NCT05266794|Thioctic Acid|thioctic acid|mesh-list
111475828|NCT05266794|Antioxidants|antioxidants|mesh-ancestor
111475829|NCT05266794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111475830|NCT05266794|Protective Agents|protective agents|mesh-ancestor
111475831|NCT05266794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111475832|NCT05266794|Trace Elements|trace elements|mesh-ancestor
111475833|NCT05266794|Micronutrients|micronutrients|mesh-ancestor
111475834|NCT05266794|Vitamin B Complex|vitamin b complex|mesh-ancestor
111475835|NCT05266794|Vitamins|vitamins|mesh-ancestor
111475836|NCT00142818|Naltrexone|naltrexone|mesh-list
111475837|NCT00142818|Modafinil|modafinil|mesh-list
111475838|NCT00142818|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111475839|NCT00142818|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111475840|NCT00142818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111475841|NCT00142818|Sensory System Agents|sensory system agents|mesh-ancestor
111475842|NCT00142818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111475843|NCT00142818|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111475844|NCT00142818|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
111475845|NCT00142818|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111475846|NCT00142818|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111475847|NCT00142818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111475848|NCT05266716|Methamphetamine|methamphetamine|mesh-list
111475849|NCT05266716|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111475850|NCT05266716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111475851|NCT05266716|Sympathomimetics|sympathomimetics|mesh-ancestor
111475852|NCT05266716|Autonomic Agents|autonomic agents|mesh-ancestor
111475853|NCT05266716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111475854|NCT05266716|Dopamine Agents|dopamine agents|mesh-ancestor
111475855|NCT05266716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111475856|NCT05266716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111475857|NCT05266716|Adrenergic Agents|adrenergic agents|mesh-ancestor
111475858|NCT05266716|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111475859|NCT05266716|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111475860|NCT05266716|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111475861|NCT05266716|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111475862|NCT05266560|Propofol|propofol|mesh-list
111475863|NCT05266560|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111475864|NCT05266560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111475865|NCT05266560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111475866|NCT05266560|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111475867|NCT05266560|Anesthetics, General|anesthetics, general|mesh-ancestor
111475868|NCT05266560|Anesthetics|anesthetics|mesh-ancestor
111475869|NCT00147966|Rituximab|rituximab|mesh-list
111475870|NCT00147966|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111475871|NCT00147966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111475872|NCT00147966|Immunologic Factors|immunologic factors|mesh-ancestor
111475873|NCT00147966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111475874|NCT00147966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111475875|NCT04528212|Glimepiride|glimepiride|mesh-list
111475876|NCT04528212|Curcumin|curcumin|mesh-list
111475877|NCT04528212|Fenofibrate|fenofibrate|mesh-list
111475878|NCT04528212|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111475879|NCT04528212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111475880|NCT04528212|Analgesics|analgesics|mesh-ancestor
111475881|NCT04528212|Sensory System Agents|sensory system agents|mesh-ancestor
111475882|NCT04528212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111475883|NCT04528212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111475884|NCT04528212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111475885|NCT04528212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111475886|NCT04528212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111475887|NCT04528212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111475888|NCT04528212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111475889|NCT04528212|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111475890|NCT04528212|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111475891|NCT04528212|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111475892|NCT04528212|Immunologic Factors|immunologic factors|mesh-ancestor
111475893|NCT04528212|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111475894|NCT04528212|Antimetabolites|antimetabolites|mesh-ancestor
111475895|NCT04528212|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111475896|NCT00148668|Carboplatin|carboplatin|mesh-list
111475897|NCT00148668|Docetaxel|docetaxel|mesh-list
111475898|NCT00148668|Trastuzumab|trastuzumab|mesh-list
111475899|NCT00148668|Vinorelbine|vinorelbine|mesh-list
111475900|NCT00148668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111475901|NCT00148668|Tubulin Modulators|tubulin modulators|mesh-ancestor
111475902|NCT00148668|Antimitotic Agents|antimitotic agents|mesh-ancestor
111475903|NCT00148668|Mitosis Modulators|mitosis modulators|mesh-ancestor
111475904|NCT00148668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111475905|NCT00148668|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111475906|NCT00148668|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111475907|NCT00149838|Antidepressive Agents|antidepressive agents|mesh-list
111475908|NCT00149838|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111475909|NCT00324870|Bevacizumab|bevacizumab|mesh-list
111475910|NCT00324870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111475911|NCT00324870|Vorinostat|vorinostat|mesh-list
111475912|NCT00324870|Antibodies|antibodies|mesh-list
111475913|NCT00324870|Immunoglobulins|immunoglobulins|mesh-list
111475914|NCT00324870|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111475915|NCT00324870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111475916|NCT00324870|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111475917|NCT00324870|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111475918|NCT00324870|Growth Substances|growth substances|mesh-ancestor
111475919|NCT00324870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111475920|NCT00324870|Growth Inhibitors|growth inhibitors|mesh-ancestor
111475921|NCT00324870|Immunologic Factors|immunologic factors|mesh-ancestor
111475922|NCT00324870|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111475923|NCT00324870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111475924|NCT00324870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111475925|NCT00151320|Rituximab|rituximab|mesh-list
111475926|NCT00151320|Bortezomib|bortezomib|mesh-list
111475927|NCT00151320|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111475928|NCT00151320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111475929|NCT00151320|Immunologic Factors|immunologic factors|mesh-ancestor
111475930|NCT00151320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111475931|NCT00151320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111475932|NCT00328614|Ascorbic Acid|ascorbic acid|mesh-list
111475933|NCT00328614|Goserelin|goserelin|mesh-list
111475934|NCT00328614|Methyltestosterone|methyltestosterone|mesh-list
111475935|NCT00328614|Bicalutamide|bicalutamide|mesh-list
111475936|NCT00328614|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
111475937|NCT00328614|Androgens|androgens|mesh-list
111475938|NCT00328614|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
111475939|NCT00328614|Ethylene|ethylene|mesh-list
111475940|NCT00328614|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111475941|NCT00328614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111475942|NCT00328614|Hormones|hormones|mesh-ancestor
111475943|NCT00328614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111475944|NCT00328614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111475945|NCT00328614|Antioxidants|antioxidants|mesh-ancestor
111475946|NCT00328614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111475947|NCT00328614|Protective Agents|protective agents|mesh-ancestor
111475948|NCT00328614|Vitamins|vitamins|mesh-ancestor
111475949|NCT00328614|Micronutrients|micronutrients|mesh-ancestor
111475950|NCT00328614|Estrogens|estrogens|mesh-ancestor
111475951|NCT00328614|Anabolic Agents|anabolic agents|mesh-ancestor
111475952|NCT00328614|Androgen Antagonists|androgen antagonists|mesh-ancestor
111475953|NCT00328614|Hormone Antagonists|hormone antagonists|mesh-ancestor
111475954|NCT00328614|Plant Growth Regulators|plant growth regulators|mesh-ancestor
111475955|NCT00328614|Growth Substances|growth substances|mesh-ancestor
111475956|NCT00328614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111475957|NCT00328614|Analgesics|analgesics|mesh-ancestor
111475958|NCT00328614|Sensory System Agents|sensory system agents|mesh-ancestor
111475959|NCT00328614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111475960|NCT00328770|Sirolimus|sirolimus|mesh-list
111475961|NCT00328770|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111475962|NCT00328770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111475963|NCT00328770|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111475964|NCT00328770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111475965|NCT00328770|Antifungal Agents|antifungal agents|mesh-ancestor
111475966|NCT00328770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111475967|NCT00328770|Immunologic Factors|immunologic factors|mesh-ancestor
111475968|NCT00328770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111475969|NCT04177680|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
111475970|NCT04177680|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111475971|NCT04177680|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111475972|NCT00330876|Pitavastatin|pitavastatin|mesh-list
111475973|NCT00330876|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111475974|NCT00330876|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111475975|NCT00330876|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111475976|NCT00330876|Antimetabolites|antimetabolites|mesh-ancestor
111475977|NCT00330876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111475978|NCT00330876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111475979|NCT00330876|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111475980|NCT00334074|Cytarabine|cytarabine|mesh-list
111475981|NCT00334074|Clofarabine|clofarabine|mesh-list
111475982|NCT00334074|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111475983|NCT00334074|Antimetabolites|antimetabolites|mesh-ancestor
111475984|NCT00334074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111475985|NCT00334074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111475986|NCT00334074|Antiviral Agents|antiviral agents|mesh-ancestor
111475987|NCT00334074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111475988|NCT00334074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111475989|NCT00334074|Immunologic Factors|immunologic factors|mesh-ancestor
111475990|NCT00334074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111475991|NCT00335478|Daptomycin|daptomycin|mesh-list
111475992|NCT00335478|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111475993|NCT00335478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111475994|NCT04345926|Propofol|propofol|mesh-list
111475995|NCT04345926|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111475996|NCT04345926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111475997|NCT04345926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111475998|NCT04345926|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111475999|NCT04345926|Anesthetics, General|anesthetics, general|mesh-ancestor
111476000|NCT04345926|Anesthetics|anesthetics|mesh-ancestor
111476001|NCT00337350|Rosiglitazone|rosiglitazone|mesh-list
111476002|NCT00337350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111476003|NCT00337350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111476005|NCT00338598|Glycine Agents|glycine agents|mesh-ancestor
111476006|NCT00338598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111476007|NCT00338598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111476008|NCT00338598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111476009|NCT00338988|Capecitabine|capecitabine|mesh-list
111476010|NCT00338988|Oxaliplatin|oxaliplatin|mesh-list
111476011|NCT00338988|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111476012|NCT00338988|Antimetabolites|antimetabolites|mesh-ancestor
111476013|NCT00338988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111476014|NCT00338988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111476015|NCT00343044|Bevacizumab|bevacizumab|mesh-list
111476016|NCT00343044|Topotecan|topotecan|mesh-list
111476017|NCT00343044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111476018|NCT00343044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111476019|NCT00343044|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111476020|NCT00343044|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111476021|NCT00343044|Growth Substances|growth substances|mesh-ancestor
111476022|NCT00343044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111476023|NCT00343044|Growth Inhibitors|growth inhibitors|mesh-ancestor
111476024|NCT00343044|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111476025|NCT00343044|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111476026|NCT00343044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111476027|NCT00343044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111476028|NCT00344370|Atorvastatin|atorvastatin|mesh-list
111476029|NCT00344370|Pitavastatin|pitavastatin|mesh-list
111476030|NCT00344370|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111476031|NCT00344370|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111476032|NCT00344370|Antimetabolites|antimetabolites|mesh-ancestor
111476033|NCT00344370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111476034|NCT00344370|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111476035|NCT00344370|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111476036|NCT00344370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111476037|NCT00344682|Memantine|memantine|mesh-list
111476038|NCT00344682|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111476039|NCT00344682|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111476040|NCT00344682|Dopamine Agents|dopamine agents|mesh-ancestor
111476041|NCT00344682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111476042|NCT00344682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111476043|NCT00344682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111476044|NCT00344682|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111476045|NCT00344682|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111476046|NCT00345384|Dexmedetomidine|dexmedetomidine|mesh-list
111476047|NCT00345384|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111476048|NCT00345384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111476049|NCT00345384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111476050|NCT00345384|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111476051|NCT00345384|Analgesics|analgesics|mesh-ancestor
111476052|NCT00345384|Sensory System Agents|sensory system agents|mesh-ancestor
111476053|NCT00345384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111476054|NCT00345384|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111476055|NCT00345384|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111476056|NCT00345384|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111476057|NCT00345384|Adrenergic Agents|adrenergic agents|mesh-ancestor
111476058|NCT00345384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111476059|NCT00345384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111476060|NCT01791114|Propranolol|propranolol|mesh-list
111476061|NCT01791114|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111476062|NCT01791114|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111476063|NCT01791114|Adrenergic Agents|adrenergic agents|mesh-ancestor
111476064|NCT01791114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111476065|NCT01791114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111476066|NCT01791114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111476067|NCT01791114|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111476068|NCT01791114|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111476069|NCT01791114|Vasodilator Agents|vasodilator agents|mesh-ancestor
111476070|NCT01791192|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
111476071|NCT01791192|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
111476072|NCT01791192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111476073|NCT01791192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111476074|NCT01791192|Immunologic Factors|immunologic factors|mesh-ancestor
111476075|NCT01791192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111476076|NCT00350142|Gemcitabine|gemcitabine|mesh-list
111476077|NCT00350142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111476078|NCT00350142|Antimetabolites|antimetabolites|mesh-ancestor
111476079|NCT00350142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111476080|NCT00350142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111476081|NCT00350532|Clonidine|clonidine|mesh-list
111476082|NCT00350532|Analgesics|analgesics|mesh-ancestor
111476083|NCT00350532|Sensory System Agents|sensory system agents|mesh-ancestor
111476084|NCT00350532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111476085|NCT00350532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111476086|NCT00350532|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111476087|NCT00350532|Sympatholytics|sympatholytics|mesh-ancestor
111476088|NCT00350532|Autonomic Agents|autonomic agents|mesh-ancestor
111476089|NCT00350532|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111476090|NCT00350532|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111476091|NCT00350532|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111476092|NCT00350532|Adrenergic Agents|adrenergic agents|mesh-ancestor
111476093|NCT00350532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111476094|NCT00350532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111476095|NCT00351000|Ziprasidone|ziprasidone|mesh-list
111476096|NCT00351000|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111476097|NCT00351000|Serotonin Agents|serotonin agents|mesh-ancestor
111476098|NCT00351000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111476099|NCT00351000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111476100|NCT00351000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111476101|NCT00351000|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111476102|NCT00351000|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111476103|NCT00351000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111476104|NCT00351000|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111476105|NCT00351000|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111476106|NCT00351000|Dopamine Agents|dopamine agents|mesh-ancestor
111476107|NCT00351936|Aripiprazole|aripiprazole|mesh-list
111476108|NCT00351936|Antidepressive Agents|antidepressive agents|mesh-ancestor
111476109|NCT00351936|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111476110|NCT00351936|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111476111|NCT00351936|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111476112|NCT00351936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111476113|NCT00351936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111476114|NCT00351936|Dopamine Agonists|dopamine agonists|mesh-ancestor
111476115|NCT00351936|Dopamine Agents|dopamine agents|mesh-ancestor
111476116|NCT00351936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111476117|NCT00351936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111476118|NCT00351936|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111476119|NCT00351936|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111476120|NCT00351936|Serotonin Agents|serotonin agents|mesh-ancestor
111476121|NCT00351936|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111476122|NCT00351936|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111476123|NCT00351936|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111476124|NCT00351936|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111476125|NCT00352794|Prednisone|prednisone|mesh-list
111476126|NCT00352794|Lenalidomide|lenalidomide|mesh-list
111476127|NCT00352794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111476128|NCT00352794|Glucocorticoids|glucocorticoids|mesh-ancestor
111476129|NCT00352794|Hormones|hormones|mesh-ancestor
111476130|NCT00352794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111476131|NCT00352794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111476132|NCT00352794|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111476133|NCT00352794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111476134|NCT00352794|Immunologic Factors|immunologic factors|mesh-ancestor
111476135|NCT00352794|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111476136|NCT00352794|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111476137|NCT00352794|Growth Substances|growth substances|mesh-ancestor
111476138|NCT00352794|Growth Inhibitors|growth inhibitors|mesh-ancestor
111476139|NCT00353418|Ribavirin|ribavirin|mesh-list
111476140|NCT00353418|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
111476141|NCT00353418|Antimetabolites|antimetabolites|mesh-ancestor
111476142|NCT00353418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111476143|NCT00353418|Antiviral Agents|antiviral agents|mesh-ancestor
111476144|NCT00353418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111476145|NCT00353652|Chlorthalidone|chlorthalidone|mesh-list
111476146|NCT00353652|Spironolactone|spironolactone|mesh-list
111476147|NCT00353652|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
111476148|NCT00353652|Hormone Antagonists|hormone antagonists|mesh-ancestor
111476149|NCT00353652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111476150|NCT00353652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111476151|NCT00353652|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
111476153|NCT00353652|Natriuretic Agents|natriuretic agents|mesh-ancestor
111476154|NCT00353652|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111476155|NCT00353652|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
111476156|NCT00353652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111476157|NCT00353652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111476158|NCT02982798|Metformin|metformin|mesh-list
111476159|NCT02982798|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111476160|NCT02982798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111476161|NCT02982798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111476162|NCT02982798|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111476163|NCT02982798|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111476164|NCT02982798|Antimetabolites|antimetabolites|mesh-ancestor
111476165|NCT02982798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111476166|NCT02982798|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111476167|NCT02982798|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111476168|NCT02982798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111476169|NCT03709914|Fosfomycin|fosfomycin|mesh-list
111476170|NCT03709914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111476171|NCT03709914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111476172|NCT01794078|Ambrisentan|ambrisentan|mesh-list
111476173|NCT01794078|Aminophylline|aminophylline|mesh-list
111476174|NCT01794078|Theophylline|theophylline|mesh-list
111476175|NCT01794078|Ethylene|ethylene|mesh-list
111476176|NCT01794078|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111476177|NCT01794078|Autonomic Agents|autonomic agents|mesh-ancestor
111476178|NCT01794078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111476179|NCT01794078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111476180|NCT01794078|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111476181|NCT01794078|Respiratory System Agents|respiratory system agents|mesh-ancestor
111476182|NCT01794078|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111476183|NCT01794078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111476184|NCT01794078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111476185|NCT01794078|Vasodilator Agents|vasodilator agents|mesh-ancestor
111476186|NCT01794078|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
111476187|NCT01794078|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111476188|NCT01794078|Purinergic Agents|purinergic agents|mesh-ancestor
111476189|NCT01794078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111476190|NCT01794078|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111476191|NCT01794078|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111476192|NCT01794078|Protective Agents|protective agents|mesh-ancestor
111476193|NCT01794078|Plant Growth Regulators|plant growth regulators|mesh-ancestor
111476194|NCT01794078|Growth Substances|growth substances|mesh-ancestor
111476195|NCT00354978|Leucovorin|leucovorin|mesh-list
111476196|NCT00354978|Bevacizumab|bevacizumab|mesh-list
111476197|NCT00354978|Fluorouracil|fluorouracil|mesh-list
111476198|NCT00354978|Irinotecan|irinotecan|mesh-list
111476199|NCT00354978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111476200|NCT00354978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111476201|NCT00354978|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111476202|NCT00354978|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111476203|NCT00354978|Growth Substances|growth substances|mesh-ancestor
111476204|NCT00354978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111476205|NCT00354978|Growth Inhibitors|growth inhibitors|mesh-ancestor
111476206|NCT00354978|Antimetabolites|antimetabolites|mesh-ancestor
111476207|NCT00354978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111476208|NCT00354978|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111476209|NCT00354978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111476210|NCT00354978|Immunologic Factors|immunologic factors|mesh-ancestor
111476211|NCT00354978|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111476212|NCT00354978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111476213|NCT00354978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111476214|NCT00354978|Antidotes|antidotes|mesh-ancestor
111476215|NCT00354978|Protective Agents|protective agents|mesh-ancestor
111476216|NCT00354978|Vitamin B Complex|vitamin b complex|mesh-ancestor
111476217|NCT00354978|Vitamins|vitamins|mesh-ancestor
111476218|NCT00354978|Micronutrients|micronutrients|mesh-ancestor
111476219|NCT00357162|Belinostat|belinostat|mesh-list
111476220|NCT00357162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111476221|NCT00357162|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111476222|NCT00357162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111476223|NCT00357162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111476224|NCT03549000|Spartalizumab|spartalizumab|mesh-list
111476225|NCT03549000|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111476226|NCT03549000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111476227|NCT03549000|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111476228|NCT03549000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111476229|NCT03984240|Midazolam|midazolam|mesh-list
111476230|NCT03984240|Dexmedetomidine|dexmedetomidine|mesh-list
111476231|NCT03984240|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111476232|NCT03984240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111476233|NCT03984240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111476234|NCT03984240|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111476235|NCT03984240|Analgesics|analgesics|mesh-ancestor
111476236|NCT03984240|Sensory System Agents|sensory system agents|mesh-ancestor
111476237|NCT03984240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111476238|NCT03984240|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111476239|NCT03984240|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111476240|NCT03984240|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111476241|NCT03984240|Adrenergic Agents|adrenergic agents|mesh-ancestor
111476242|NCT03984240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111476243|NCT03984240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111476244|NCT03984240|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111476245|NCT03984240|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111476246|NCT03984240|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111476247|NCT03984240|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111476248|NCT03984240|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111476249|NCT03984240|Anesthetics, General|anesthetics, general|mesh-ancestor
111476250|NCT03984240|Anesthetics|anesthetics|mesh-ancestor
111476251|NCT03984240|GABA Modulators|gaba modulators|mesh-ancestor
111476252|NCT03984240|GABA Agents|gaba agents|mesh-ancestor
111476253|NCT00359736|Sildenafil Citrate|sildenafil citrate|mesh-list
111476254|NCT00359736|Vasodilator Agents|vasodilator agents|mesh-ancestor
111476255|NCT00359736|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111476256|NCT00359736|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111476257|NCT00359736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111476258|NCT00359736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111476259|NCT00359736|Urological Agents|urological agents|mesh-ancestor
111476260|NCT00360126|Lamotrigine|lamotrigine|mesh-list
111476261|NCT00360126|Anticonvulsants|anticonvulsants|mesh-ancestor
111476262|NCT00360126|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111476263|NCT00360126|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111476264|NCT00360126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111476265|NCT00360126|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111476266|NCT00360126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111476267|NCT00360126|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111476268|NCT00360126|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111476269|NCT00360126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111476270|NCT00360126|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111476271|NCT00360126|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111476272|NCT00360360|Paclitaxel|paclitaxel|mesh-list
111476273|NCT00360360|Bevacizumab|bevacizumab|mesh-list
111476274|NCT00360360|Carboplatin|carboplatin|mesh-list
111476275|NCT00360360|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111476276|NCT00360360|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111476277|NCT00360360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111476278|NCT00360360|Tubulin Modulators|tubulin modulators|mesh-ancestor
111476279|NCT00360360|Antimitotic Agents|antimitotic agents|mesh-ancestor
111476280|NCT00360360|Mitosis Modulators|mitosis modulators|mesh-ancestor
111476281|NCT00360360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111476282|NCT00360360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111476283|NCT00360360|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111476284|NCT00360360|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111476285|NCT00360360|Growth Substances|growth substances|mesh-ancestor
111476286|NCT00360360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111476287|NCT00360360|Growth Inhibitors|growth inhibitors|mesh-ancestor
111476288|NCT00360360|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111476289|NCT00360360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111476290|NCT01552590|Tolvaptan|tolvaptan|mesh-list
111476291|NCT01552590|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
111476292|NCT01552590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111476293|NCT01552590|Natriuretic Agents|natriuretic agents|mesh-ancestor
111476294|NCT01552590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111476295|NCT00549978|Cilostazol|cilostazol|mesh-list
111476296|NCT00549978|Probucol|probucol|mesh-list
111476297|NCT00549978|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111476298|NCT00549978|Autonomic Agents|autonomic agents|mesh-ancestor
111476299|NCT00549978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111476300|NCT00549978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111476301|NCT00549978|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111476302|NCT00549978|Respiratory System Agents|respiratory system agents|mesh-ancestor
111476303|NCT00549978|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111476304|NCT00549978|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111476305|NCT00549978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111476306|NCT00549978|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111476307|NCT00549978|Vasodilator Agents|vasodilator agents|mesh-ancestor
111476308|NCT00549978|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111476309|NCT00549978|Protective Agents|protective agents|mesh-ancestor
111476310|NCT00549978|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
111476311|NCT00549978|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111476312|NCT00549978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111476313|NCT00549978|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111476314|NCT00549978|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111476315|NCT00549978|Antimetabolites|antimetabolites|mesh-ancestor
111476316|NCT00549978|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111476317|NCT00549978|Antioxidants|antioxidants|mesh-ancestor
111476318|NCT03983226|Carboplatin|carboplatin|mesh-list
111476319|NCT03983226|Gemcitabine|gemcitabine|mesh-list
111476320|NCT03983226|Doxorubicin|doxorubicin|mesh-list
111476321|NCT03983226|Niraparib|niraparib|mesh-list
111476322|NCT03983226|Taxane|taxane|mesh-list
111476323|NCT03983226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111476324|NCT03983226|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111476325|NCT03983226|Antimetabolites|antimetabolites|mesh-ancestor
110446620|NCT02761486|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111476326|NCT03983226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111476327|NCT03983226|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111476328|NCT03983226|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111476329|NCT03983226|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111476330|NCT03983226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111476331|NCT03983226|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111476332|NCT00360672|Lenalidomide|lenalidomide|mesh-list
111476333|NCT00360672|Immunologic Factors|immunologic factors|mesh-ancestor
111476334|NCT00360672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111476335|NCT00360672|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111476336|NCT00360672|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111476337|NCT00360672|Growth Substances|growth substances|mesh-ancestor
111476338|NCT00360672|Growth Inhibitors|growth inhibitors|mesh-ancestor
111476339|NCT00360672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111476340|NCT00360828|Irinotecan|irinotecan|mesh-list
111476341|NCT00360828|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111476342|NCT00360828|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111476343|NCT00360828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111476344|NCT00360828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111476345|NCT00360828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111476346|NCT00361140|Fludarabine|fludarabine|mesh-list
111476347|NCT00361140|Fludarabine phosphate|fludarabine phosphate|mesh-list
111476348|NCT00361140|Busulfan|busulfan|mesh-list
111476349|NCT00361140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111476350|NCT00361140|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111476351|NCT00361140|Antimetabolites|antimetabolites|mesh-ancestor
111476352|NCT00361140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111476353|NCT00361140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111476354|NCT00361140|Immunologic Factors|immunologic factors|mesh-ancestor
111476355|NCT00361140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111476356|NCT00361140|Alkylating Agents|alkylating agents|mesh-ancestor
111476357|NCT00361140|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111476358|NCT00361140|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111476359|NCT00362466|Imatinib Mesylate|imatinib mesylate|mesh-list
111476360|NCT00362466|Dasatinib|dasatinib|mesh-list
111476361|NCT00362466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111476362|NCT00362466|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111476363|NCT00362466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111476364|NCT00362466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111476365|NCT00305682|Mycophenolic Acid|mycophenolic acid|mesh-list
111476366|NCT00305682|Sirolimus|sirolimus|mesh-list
111476367|NCT00305682|Cyclophosphamide|cyclophosphamide|mesh-list
111476368|NCT00305682|Fludarabine|fludarabine|mesh-list
111476369|NCT00305682|Antilymphocyte Serum|antilymphocyte serum|mesh-list
111476370|NCT00305682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111476371|NCT00305682|Immunologic Factors|immunologic factors|mesh-ancestor
111476372|NCT00305682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111476373|NCT00305682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111476374|NCT00305682|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111476375|NCT00305682|Alkylating Agents|alkylating agents|mesh-ancestor
111476376|NCT00305682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111476377|NCT00305682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111476378|NCT00305682|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111476379|NCT00305682|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111476380|NCT00305682|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111476381|NCT00305682|Antitubercular Agents|antitubercular agents|mesh-ancestor
111476382|NCT00305682|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111476383|NCT00305682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111476384|NCT00305682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111476385|NCT00305682|Antifungal Agents|antifungal agents|mesh-ancestor
111476386|NCT00305760|Cyclophosphamide|cyclophosphamide|mesh-list
111476387|NCT00305760|Cetuximab|cetuximab|mesh-list
111476388|NCT00305760|Vaccines|vaccines|mesh-list
111476389|NCT00305760|Immunologic Factors|immunologic factors|mesh-ancestor
111476390|NCT00305760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111476391|NCT00305760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111476392|NCT00305760|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111476393|NCT00305760|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111476394|NCT00305760|Alkylating Agents|alkylating agents|mesh-ancestor
110446634|NCT00940017|Voriconazole|voriconazole|mesh-list
111476395|NCT00305760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111476396|NCT00305760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111476397|NCT00305760|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111476398|NCT00305760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111476399|NCT00309738|Simvastatin|simvastatin|mesh-list
111476400|NCT00309738|Pitavastatin|pitavastatin|mesh-list
111476401|NCT00309738|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111476402|NCT00309738|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111476403|NCT00309738|Antimetabolites|antimetabolites|mesh-ancestor
111476404|NCT00309738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111476405|NCT00309738|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111476406|NCT00309738|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111476407|NCT00309738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111476408|NCT00310050|Pemetrexed|pemetrexed|mesh-list
111476409|NCT00310050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111476410|NCT00310050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111476411|NCT00310050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111476412|NCT00310050|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111476413|NCT00310050|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111476414|NCT00363168|Ranibizumab|ranibizumab|mesh-list
111476415|NCT00363168|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111476416|NCT00363168|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111476417|NCT00363168|Growth Substances|growth substances|mesh-ancestor
111476418|NCT00363168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111476419|NCT00363168|Growth Inhibitors|growth inhibitors|mesh-ancestor
111476420|NCT00363168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111476421|NCT00365274|Prednisone|prednisone|mesh-list
111476422|NCT00365274|Cyclophosphamide|cyclophosphamide|mesh-list
111476423|NCT00365274|Doxorubicin|doxorubicin|mesh-list
111476424|NCT00365274|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111476425|NCT00365274|Vincristine|vincristine|mesh-list
111476426|NCT00365274|Brentuximab Vedotin|brentuximab vedotin|mesh-list
111476427|NCT00365274|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111476428|NCT00365274|Immunologic Factors|immunologic factors|mesh-ancestor
111476429|NCT00365274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111476430|NCT00365274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111476431|NCT00365274|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111476432|NCT00365274|Alkylating Agents|alkylating agents|mesh-ancestor
111476433|NCT00365274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111476434|NCT00365274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111476435|NCT00365274|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111476436|NCT00365274|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111476437|NCT00365274|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111476438|NCT00365274|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111476439|NCT00365274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111476440|NCT00365274|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111476441|NCT00365274|Glucocorticoids|glucocorticoids|mesh-ancestor
111476442|NCT00365274|Hormones|hormones|mesh-ancestor
111476443|NCT00365274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111476444|NCT00365274|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111476445|NCT00365274|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111476446|NCT00365274|Tubulin Modulators|tubulin modulators|mesh-ancestor
111476447|NCT00365274|Antimitotic Agents|antimitotic agents|mesh-ancestor
111476448|NCT00365274|Mitosis Modulators|mitosis modulators|mesh-ancestor
111476449|NCT00365274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111476450|NCT00365274|Immunotoxins|immunotoxins|mesh-ancestor
111476451|NCT00365274|Immunoconjugates|immunoconjugates|mesh-ancestor
111476452|NCT00311376|Botulinum Toxins|botulinum toxins|mesh-list
111476453|NCT00311376|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111476454|NCT00311376|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111476455|NCT00311376|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111476456|NCT00311376|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111476457|NCT00311376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111476458|NCT00311376|Cholinergic Agents|cholinergic agents|mesh-ancestor
111476459|NCT00311376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111476460|NCT00311376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111476461|NCT00311376|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111476462|NCT00311376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111476463|NCT02104830|Lenograstim|lenograstim|mesh-list
111476464|NCT02104830|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111476465|NCT02104830|Immunologic Factors|immunologic factors|mesh-ancestor
111476466|NCT02104830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111476467|NCT00313560|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111476468|NCT00313560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111476469|NCT00313560|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111476470|NCT00313560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111476471|NCT00313560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111476472|NCT00314106|Aldesleukin|aldesleukin|mesh-list
111476473|NCT00314106|Cyclophosphamide|cyclophosphamide|mesh-list
111476474|NCT00314106|Fludarabine|fludarabine|mesh-list
111476475|NCT00314106|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111476476|NCT00314106|Immunologic Factors|immunologic factors|mesh-ancestor
111476477|NCT00314106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111476478|NCT00314106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111476479|NCT00314106|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111476480|NCT00314106|Alkylating Agents|alkylating agents|mesh-ancestor
111476481|NCT00314106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111476482|NCT00314106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111476483|NCT00314106|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111476484|NCT00314106|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111476485|NCT00314106|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111476486|NCT00314106|Antiviral Agents|antiviral agents|mesh-ancestor
111476487|NCT00314106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111476488|NCT00316524|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
111476489|NCT00316524|Antiviral Agents|antiviral agents|mesh-ancestor
111476490|NCT00316524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111476491|NCT00318708|Fluticasone|fluticasone|mesh-list
111476493|NCT00318708|Clarithromycin|clarithromycin|mesh-list
111476494|NCT00318708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111476495|NCT00318708|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111476496|NCT00318708|Autonomic Agents|autonomic agents|mesh-ancestor
111476497|NCT00318708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111476498|NCT00318708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111476499|NCT00318708|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111476500|NCT00318708|Respiratory System Agents|respiratory system agents|mesh-ancestor
111476501|NCT00318708|Dermatologic Agents|dermatologic agents|mesh-ancestor
111476502|NCT00318708|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111476503|NCT00318708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111476504|NCT00318708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111476505|NCT00318708|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111476506|NCT00318708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111476507|NCT00318708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111476508|NCT00318708|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111476509|NCT00318708|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111476510|NCT00319644|Dimercaprol|dimercaprol|mesh-list
111476511|NCT00319644|Chelating Agents|chelating agents|mesh-ancestor
111476512|NCT00319644|Sequestering Agents|sequestering agents|mesh-ancestor
111476513|NCT00319644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111476514|NCT02448420|Trastuzumab|trastuzumab|mesh-list
111476515|NCT02448420|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
111476516|NCT02448420|Palbociclib|palbociclib|mesh-list
111476517|NCT02448420|Antibodies|antibodies|mesh-list
111476518|NCT02448420|Immunoconjugates|immunoconjugates|mesh-list
111476519|NCT02448420|Immunologic Factors|immunologic factors|mesh-ancestor
111200683|NCT04092283|Cisplatin|cisplatin|mesh-list
111476520|NCT02448420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111476521|NCT02448420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111476522|NCT02448420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111476523|NCT02448420|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111476524|NCT02448420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111476525|NCT02448420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111476526|NCT02448420|Tubulin Modulators|tubulin modulators|mesh-ancestor
111476527|NCT02448420|Antimitotic Agents|antimitotic agents|mesh-ancestor
111476528|NCT02448420|Mitosis Modulators|mitosis modulators|mesh-ancestor
111476529|NCT02448420|Immunotoxins|immunotoxins|mesh-ancestor
111476530|NCT02422446|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
111476531|NCT02422446|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110446647|NCT01129583|Botulinum Toxins|botulinum toxins|mesh-list
111476532|NCT02422446|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111476533|NCT02405676|Cytarabine|cytarabine|mesh-list
111476534|NCT02405676|Prednisone|prednisone|mesh-list
111476535|NCT02405676|Cyclophosphamide|cyclophosphamide|mesh-list
111476536|NCT02405676|Ifosfamide|ifosfamide|mesh-list
111476537|NCT02405676|Isophosphamide mustard|isophosphamide mustard|mesh-list
111476538|NCT02405676|Rituximab|rituximab|mesh-list
111476539|NCT02405676|Methotrexate|methotrexate|mesh-list
111476540|NCT02405676|Etoposide|etoposide|mesh-list
111476541|NCT02405676|Etoposide phosphate|etoposide phosphate|mesh-list
111476542|NCT02405676|Vincristine|vincristine|mesh-list
111476543|NCT02405676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111476544|NCT02405676|Immunologic Factors|immunologic factors|mesh-ancestor
111476545|NCT02405676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111476546|NCT02405676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111476547|NCT02405676|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111476548|NCT02405676|Alkylating Agents|alkylating agents|mesh-ancestor
111476549|NCT02405676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111476550|NCT02405676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111476551|NCT02405676|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111476552|NCT02405676|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111476553|NCT02405676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111476554|NCT02405676|Glucocorticoids|glucocorticoids|mesh-ancestor
111476555|NCT02405676|Hormones|hormones|mesh-ancestor
111476556|NCT02405676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111476557|NCT02405676|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111476558|NCT02405676|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111476559|NCT02405676|Abortifacient Agents|abortifacient agents|mesh-ancestor
111476560|NCT02405676|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111476561|NCT02405676|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111476562|NCT02405676|Antimetabolites|antimetabolites|mesh-ancestor
111476563|NCT02405676|Dermatologic Agents|dermatologic agents|mesh-ancestor
111476564|NCT02405676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111476565|NCT02405676|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111476566|NCT02405676|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111476567|NCT02405676|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111476568|NCT02405676|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111476569|NCT02405676|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111476570|NCT02405676|Antiviral Agents|antiviral agents|mesh-ancestor
111476571|NCT02405676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111476572|NCT02405676|Tubulin Modulators|tubulin modulators|mesh-ancestor
111476573|NCT02405676|Antimitotic Agents|antimitotic agents|mesh-ancestor
111476574|NCT02405676|Mitosis Modulators|mitosis modulators|mesh-ancestor
111476575|NCT00321594|Belinostat|belinostat|mesh-list
111476576|NCT00321594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111476577|NCT00321594|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111476578|NCT00321594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111476579|NCT00321594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111476580|NCT04751136|Cerebrolysin|cerebrolysin|mesh-list
111476581|NCT04751136|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111476582|NCT04751136|Protective Agents|protective agents|mesh-ancestor
111476583|NCT04751136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111476584|NCT04751136|Nootropic Agents|nootropic agents|mesh-ancestor
111476585|NCT00390234|Aflibercept|aflibercept|mesh-list
111476586|NCT00390234|Endothelial Growth Factors|endothelial growth factors|mesh-list
111476587|NCT00390234|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111476588|NCT00390234|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111476589|NCT00390234|Growth Substances|growth substances|mesh-ancestor
111476590|NCT00390234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111476591|NCT00390234|Growth Inhibitors|growth inhibitors|mesh-ancestor
111476592|NCT00390234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111476593|NCT00391716|Gabapentin|gabapentin|mesh-list
111476594|NCT00391716|Analgesics|analgesics|mesh-ancestor
111476595|NCT00391716|Sensory System Agents|sensory system agents|mesh-ancestor
111476596|NCT00391716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111476597|NCT00391716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111476599|NCT00391716|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111476600|NCT00391716|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111476601|NCT00391716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111476602|NCT00391716|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111476603|NCT00391716|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111476604|NCT00391716|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111476605|NCT00391716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111476606|NCT00391716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111476607|NCT00391716|Antimanic Agents|antimanic agents|mesh-ancestor
111476608|NCT00392496|Sunitinib|sunitinib|mesh-list
111476609|NCT00392496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111476610|NCT00392496|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111476611|NCT00392496|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111476612|NCT00392496|Growth Substances|growth substances|mesh-ancestor
111476613|NCT00392496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111476614|NCT00392496|Growth Inhibitors|growth inhibitors|mesh-ancestor
111476615|NCT00392496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111476616|NCT00392496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111476617|NCT00392496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111476618|NCT01958190|Sirolimus|sirolimus|mesh-list
111476619|NCT01958190|Tacrolimus|tacrolimus|mesh-list
111476620|NCT01958190|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111476621|NCT01958190|Immunologic Factors|immunologic factors|mesh-ancestor
111476622|NCT01958190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111476623|NCT01958190|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111476624|NCT01958190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111476625|NCT01958190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111476626|NCT01958190|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111476627|NCT01958190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111476628|NCT01958190|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111476629|NCT01958190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111476630|NCT01958190|Antifungal Agents|antifungal agents|mesh-ancestor
111476631|NCT00638898|Melphalan|melphalan|mesh-list
111476632|NCT00638898|Busulfan|busulfan|mesh-list
111476633|NCT00638898|Topotecan|topotecan|mesh-list
111476634|NCT00638898|Lenograstim|lenograstim|mesh-list
111476635|NCT00638898|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111476636|NCT00638898|Immunologic Factors|immunologic factors|mesh-ancestor
111476637|NCT00638898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111476638|NCT00638898|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111476639|NCT00638898|Alkylating Agents|alkylating agents|mesh-ancestor
111476640|NCT00638898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111476641|NCT00638898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111476642|NCT00638898|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111476643|NCT00638898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111476644|NCT00638898|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111476645|NCT00638898|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111476646|NCT00638898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111476647|NCT00393978|Topiramate|topiramate|mesh-list
111476648|NCT00393978|Quetiapine Fumarate|quetiapine fumarate|mesh-list
111476649|NCT00393978|Antidepressive Agents|antidepressive agents|mesh-ancestor
111476650|NCT00393978|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111476651|NCT00393978|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111476652|NCT00393978|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111476653|NCT00393978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111476654|NCT00393978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111476655|NCT00393978|Anticonvulsants|anticonvulsants|mesh-ancestor
111476656|NCT00393978|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111476657|NCT00396006|Protease Inhibitors|protease inhibitors|mesh-list
111476658|NCT00396006|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
111476659|NCT00396006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110446666|NCT01186328|Methotrexate|methotrexate|mesh-list
111476660|NCT00396006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111476661|NCT00396006|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
111476662|NCT00396006|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111476663|NCT00397020|Valproic Acid|valproic acid|mesh-list
111476664|NCT00397020|Quetiapine Fumarate|quetiapine fumarate|mesh-list
111476665|NCT00397020|Antidepressive Agents|antidepressive agents|mesh-ancestor
111476666|NCT00397020|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111476667|NCT00397020|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111476668|NCT00397020|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111476669|NCT00397020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111200834|NCT04006262|Nivolumab|nivolumab|mesh-list
111476670|NCT00397020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111476671|NCT00397020|Anticonvulsants|anticonvulsants|mesh-ancestor
111476672|NCT00397020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111476673|NCT00397020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111476674|NCT00397020|GABA Agents|gaba agents|mesh-ancestor
111476675|NCT00397020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111476676|NCT00397020|Antimanic Agents|antimanic agents|mesh-ancestor
111476677|NCT00397878|Saracatinib|saracatinib|mesh-list
111476678|NCT00397878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111476679|NCT00397878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111476680|NCT00397878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111476681|NCT00400686|Epoetin Alfa|epoetin alfa|mesh-list
111476682|NCT00400686|Hematinics|hematinics|mesh-ancestor
111476683|NCT05220462|Midazolam|midazolam|mesh-list
111476684|NCT05220462|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111476685|NCT05220462|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111476686|NCT05220462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111476687|NCT05220462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111476688|NCT05220462|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111476689|NCT05220462|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111476690|NCT05220462|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111476691|NCT05220462|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111476692|NCT05220462|Anesthetics, General|anesthetics, general|mesh-ancestor
111476693|NCT05220462|Anesthetics|anesthetics|mesh-ancestor
111476694|NCT05220462|GABA Modulators|gaba modulators|mesh-ancestor
111476695|NCT05220462|GABA Agents|gaba agents|mesh-ancestor
111476696|NCT05220462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111476697|NCT05220462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111476698|NCT00373386|Hormones|hormones|mesh-list
111476699|NCT00373386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111476700|NCT00373386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111476701|NCT00374088|Acetylcysteine|acetylcysteine|mesh-list
111476702|NCT00374088|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111476703|NCT00374088|Antiviral Agents|antiviral agents|mesh-ancestor
111476704|NCT00374088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111476705|NCT00374088|Expectorants|expectorants|mesh-ancestor
111476706|NCT00374088|Respiratory System Agents|respiratory system agents|mesh-ancestor
111476707|NCT00374088|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111476708|NCT00374088|Antioxidants|antioxidants|mesh-ancestor
111476709|NCT00374088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111476710|NCT00374088|Protective Agents|protective agents|mesh-ancestor
111476711|NCT00374088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111476712|NCT00374088|Antidotes|antidotes|mesh-ancestor
111476713|NCT00374244|Pimozide|pimozide|mesh-list
111476714|NCT00374244|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111476715|NCT00374244|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111476716|NCT00374244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111476717|NCT00374244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111476718|NCT00374244|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111476719|NCT00374244|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111476720|NCT00374244|Dopamine Agents|dopamine agents|mesh-ancestor
111476721|NCT00374244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111476722|NCT00374244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111476723|NCT00374244|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111476724|NCT00377832|Acetaminophen|acetaminophen|mesh-list
111476725|NCT00377832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111476726|NCT00377832|Analgesics|analgesics|mesh-ancestor
111476727|NCT00377832|Sensory System Agents|sensory system agents|mesh-ancestor
111476728|NCT00377832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111476729|NCT00377832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111476730|NCT00377832|Antipyretics|antipyretics|mesh-ancestor
111476731|NCT00401778|Everolimus|everolimus|mesh-list
111476732|NCT00401778|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111476733|NCT00401778|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111476734|NCT00401778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111476735|NCT00401778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111476736|NCT00401778|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111476737|NCT00401778|Immunologic Factors|immunologic factors|mesh-ancestor
111476738|NCT00401778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111476739|NCT00401778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111476740|NCT00402714|Pentostatin|pentostatin|mesh-list
111476741|NCT00402714|Methoxsalen|methoxsalen|mesh-list
111476742|NCT00402714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111476743|NCT00402714|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
111476744|NCT00402714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111476745|NCT00402714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111476746|NCT00402714|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111476747|NCT00402714|Dermatologic Agents|dermatologic agents|mesh-ancestor
111476748|NCT00405288|Hydrocortisone|hydrocortisone|mesh-list
111476749|NCT00405288|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
111476750|NCT00405288|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
111476751|NCT00405288|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
111476752|NCT00405288|Pramoxine|pramoxine|mesh-list
111476753|NCT00405288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111476754|NCT00405288|Anesthetics, Local|anesthetics, local|mesh-ancestor
111476755|NCT00405288|Anesthetics|anesthetics|mesh-ancestor
111476756|NCT00405288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111476757|NCT00405288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111476758|NCT00405288|Sensory System Agents|sensory system agents|mesh-ancestor
111476759|NCT00405288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111476760|NCT00381810|Acetaminophen|acetaminophen|mesh-list
111476761|NCT00381810|Diphenhydramine|diphenhydramine|mesh-list
111476762|NCT00381810|Promethazine|promethazine|mesh-list
111476763|NCT00381810|Methylprednisolone|methylprednisolone|mesh-list
111476764|NCT00381810|Rituximab|rituximab|mesh-list
111476765|NCT00381810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111476766|NCT00381810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111476767|NCT00381810|Immunologic Factors|immunologic factors|mesh-ancestor
111476768|NCT00381810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111476769|NCT00381810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111476770|NCT00381810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111476771|NCT00381810|Analgesics|analgesics|mesh-ancestor
111476772|NCT00381810|Sensory System Agents|sensory system agents|mesh-ancestor
111476773|NCT00381810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111476774|NCT00381810|Antipyretics|antipyretics|mesh-ancestor
111476775|NCT00381810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111476776|NCT00381810|Antiemetics|antiemetics|mesh-ancestor
111476777|NCT00381810|Autonomic Agents|autonomic agents|mesh-ancestor
111476778|NCT00381810|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111476779|NCT00381810|Glucocorticoids|glucocorticoids|mesh-ancestor
111476780|NCT00381810|Hormones|hormones|mesh-ancestor
111476781|NCT00381810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111476782|NCT00381810|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111476783|NCT00381810|Protective Agents|protective agents|mesh-ancestor
111476784|NCT00381810|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111476785|NCT00381810|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111476786|NCT00381810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111476787|NCT00381810|Anesthetics, Local|anesthetics, local|mesh-ancestor
111476788|NCT00381810|Anesthetics|anesthetics|mesh-ancestor
111476789|NCT00381810|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111476790|NCT00381810|Histamine Antagonists|histamine antagonists|mesh-ancestor
111476791|NCT00381810|Histamine Agents|histamine agents|mesh-ancestor
111476792|NCT00381810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111476793|NCT00381810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111476794|NCT00381810|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111476795|NCT00381810|Antipruritics|antipruritics|mesh-ancestor
111476796|NCT00381810|Dermatologic Agents|dermatologic agents|mesh-ancestor
111476797|NCT00458952|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
111476798|NCT00458952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111476799|NCT00458952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111476800|NCT00458952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111476801|NCT00458952|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111476802|NCT00459732|Zinc|zinc|mesh-list
111476803|NCT00459732|Zinc Sulfate|zinc sulfate|mesh-list
111476804|NCT00459732|Trace Elements|trace elements|mesh-ancestor
111476805|NCT00459732|Micronutrients|micronutrients|mesh-ancestor
111476806|NCT00459732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111476807|NCT00459732|Astringents|astringents|mesh-ancestor
111476808|NCT00459732|Dermatologic Agents|dermatologic agents|mesh-ancestor
111476809|NCT00459810|Paclitaxel|paclitaxel|mesh-list
111476810|NCT00459810|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
111476811|NCT00459810|Estradiol|estradiol|mesh-list
111476812|NCT00459810|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111476813|NCT00459810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111476814|NCT00459810|Tubulin Modulators|tubulin modulators|mesh-ancestor
111476815|NCT00459810|Antimitotic Agents|antimitotic agents|mesh-ancestor
111476816|NCT00459810|Mitosis Modulators|mitosis modulators|mesh-ancestor
111476817|NCT00459810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111476818|NCT00459810|Estrogens|estrogens|mesh-ancestor
111476819|NCT00459810|Hormones|hormones|mesh-ancestor
111476820|NCT00459810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111476821|NCT00459810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111476822|NCT00405522|Remifentanil|remifentanil|mesh-list
111476823|NCT00405522|Propofol|propofol|mesh-list
111476824|NCT00405522|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111476825|NCT00405522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111476826|NCT00405522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111476827|NCT00405522|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111476828|NCT00405522|Anesthetics, General|anesthetics, general|mesh-ancestor
111476829|NCT00405522|Anesthetics|anesthetics|mesh-ancestor
111476830|NCT00405522|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111476831|NCT00405522|Narcotics|narcotics|mesh-ancestor
111476832|NCT00405522|Analgesics|analgesics|mesh-ancestor
111476833|NCT00405522|Sensory System Agents|sensory system agents|mesh-ancestor
111476834|NCT00405522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111476835|NCT00461292|Botulinum Toxins|botulinum toxins|mesh-list
111476836|NCT00461292|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111476837|NCT00461292|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111476838|NCT00461292|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111476839|NCT00461292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111476840|NCT00461292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111476841|NCT00461292|Cholinergic Agents|cholinergic agents|mesh-ancestor
111476842|NCT00461292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111476843|NCT00461292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111476844|NCT00461292|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111476845|NCT00461292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111476847|NCT00382590|Azacitidine|azacitidine|mesh-list
111476848|NCT00382590|Valproic Acid|valproic acid|mesh-list
111476849|NCT00382590|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111476850|NCT00382590|Antimetabolites|antimetabolites|mesh-ancestor
111476851|NCT00382590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111476852|NCT00382590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111476853|NCT00382590|Antiviral Agents|antiviral agents|mesh-ancestor
111476854|NCT00382590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111476855|NCT00382590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111476856|NCT00382590|Immunologic Factors|immunologic factors|mesh-ancestor
111476857|NCT00382590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111476858|NCT00382590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111476859|NCT00382590|Anticonvulsants|anticonvulsants|mesh-ancestor
111476860|NCT00382590|GABA Agents|gaba agents|mesh-ancestor
111476861|NCT00382590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111476862|NCT00382590|Antimanic Agents|antimanic agents|mesh-ancestor
111476863|NCT00382590|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111476864|NCT00382590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111476865|NCT00382590|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111476866|NCT00382824|Ubiquinone|ubiquinone|mesh-list
111476867|NCT00382824|Coenzyme Q10|coenzyme q10|mesh-list
111476868|NCT00382824|Micronutrients|micronutrients|mesh-ancestor
111476869|NCT00382824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111476870|NCT00382824|Vitamins|vitamins|mesh-ancestor
111476871|NCT00462072|Infliximab|infliximab|mesh-list
111476872|NCT00462072|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111476873|NCT00462072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111476874|NCT00462072|Dermatologic Agents|dermatologic agents|mesh-ancestor
111476875|NCT00462072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111476876|NCT00462072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111476877|NCT00462228|Memantine|memantine|mesh-list
111476878|NCT00462228|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111476879|NCT00462228|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111476880|NCT00462228|Dopamine Agents|dopamine agents|mesh-ancestor
111476881|NCT00462228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111476882|NCT00462228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111476883|NCT00462228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111476884|NCT00462228|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111476885|NCT00462228|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111476886|NCT00408564|Gemcitabine|gemcitabine|mesh-list
111476887|NCT00408564|Capecitabine|capecitabine|mesh-list
111476888|NCT00408564|Oxaliplatin|oxaliplatin|mesh-list
111476889|NCT00408564|Cetuximab|cetuximab|mesh-list
111476890|NCT00408564|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111476891|NCT00408564|Antimetabolites|antimetabolites|mesh-ancestor
111476892|NCT00408564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111476893|NCT00408564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111476894|NCT00408564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111476895|NCT00383448|Cyclosporine|cyclosporine|mesh-list
111476896|NCT00383448|Melphalan|melphalan|mesh-list
111476897|NCT00383448|Alemtuzumab|alemtuzumab|mesh-list
111476898|NCT00383448|Hydroxyurea|hydroxyurea|mesh-list
111476899|NCT00383448|Clofarabine|clofarabine|mesh-list
111476900|NCT00383448|Cyclosporins|cyclosporins|mesh-list
111476901|NCT00383448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111476902|NCT00383448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111476903|NCT00383448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111476904|NCT00383448|Immunologic Factors|immunologic factors|mesh-ancestor
111476905|NCT00383448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111476906|NCT00383448|Antifungal Agents|antifungal agents|mesh-ancestor
111476907|NCT00383448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111476908|NCT00383448|Dermatologic Agents|dermatologic agents|mesh-ancestor
111476909|NCT00383448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111476910|NCT00383448|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111476911|NCT00383448|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111476912|NCT00383448|Alkylating Agents|alkylating agents|mesh-ancestor
111476913|NCT00383448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111476914|NCT00383448|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111476915|NCT00383448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111476916|NCT00383448|Antisickling Agents|antisickling agents|mesh-ancestor
111476917|NCT00383448|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111476918|NCT00383448|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111476919|NCT00383448|Antimetabolites|antimetabolites|mesh-ancestor
111476920|NCT00384774|Lasmiditan|lasmiditan|mesh-list
111476921|NCT00384774|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111476922|NCT00384774|Serotonin Agents|serotonin agents|mesh-ancestor
111476923|NCT00384774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111476924|NCT00384774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111476925|NCT00384774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111476926|NCT00410826|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111476927|NCT00410826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111476928|NCT00410826|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111476929|NCT00410826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111476930|NCT00410826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111476931|NCT00464646|Cyclophosphamide|cyclophosphamide|mesh-list
111476932|NCT00464646|Bevacizumab|bevacizumab|mesh-list
111476933|NCT00464646|Docetaxel|docetaxel|mesh-list
111476934|NCT00464646|Trastuzumab|trastuzumab|mesh-list
111476935|NCT00464646|Epirubicin|epirubicin|mesh-list
111476936|NCT00464646|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111476937|NCT00464646|Immunologic Factors|immunologic factors|mesh-ancestor
111476938|NCT00464646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111476939|NCT00464646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111476940|NCT00464646|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111476941|NCT00464646|Alkylating Agents|alkylating agents|mesh-ancestor
111476942|NCT00464646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111476943|NCT00464646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111476944|NCT00464646|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111476945|NCT00464646|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111476946|NCT00464646|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111476947|NCT00464646|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111476948|NCT00464646|Growth Substances|growth substances|mesh-ancestor
111476949|NCT00464646|Growth Inhibitors|growth inhibitors|mesh-ancestor
111476950|NCT00464646|Tubulin Modulators|tubulin modulators|mesh-ancestor
111476951|NCT00464646|Antimitotic Agents|antimitotic agents|mesh-ancestor
111476952|NCT00464646|Mitosis Modulators|mitosis modulators|mesh-ancestor
111476953|NCT00464646|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111476954|NCT00464646|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111476955|NCT00464646|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111476956|NCT00464646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111476957|NCT00385008|Naproxen|naproxen|mesh-list
111476958|NCT00385008|Sumatriptan|sumatriptan|mesh-list
111476959|NCT00385008|Eletriptan|eletriptan|mesh-list
111476960|NCT00385008|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111476961|NCT00385008|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111476962|NCT00385008|Analgesics|analgesics|mesh-ancestor
111476963|NCT00385008|Sensory System Agents|sensory system agents|mesh-ancestor
111476964|NCT00385008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111476965|NCT00385008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111476966|NCT00385008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111476967|NCT00385008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111476968|NCT00385008|Gout Suppressants|gout suppressants|mesh-ancestor
111476969|NCT00385008|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111476970|NCT00385008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111476971|NCT00385008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111476972|NCT00385008|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111476973|NCT00385008|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111476974|NCT00385008|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111476975|NCT00385008|Serotonin Agents|serotonin agents|mesh-ancestor
111476976|NCT00385008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111476977|NCT00410904|Pemetrexed|pemetrexed|mesh-list
111476978|NCT00410904|Cediranib|cediranib|mesh-list
111476979|NCT00410904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111476980|NCT00410904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111476981|NCT00410904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111476982|NCT00410904|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111476983|NCT00410904|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111476984|NCT00410904|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111476985|NCT00385788|Gemcitabine|gemcitabine|mesh-list
111476986|NCT00385788|Methotrexate|methotrexate|mesh-list
111476987|NCT00385788|Fludarabine phosphate|fludarabine phosphate|mesh-list
111476988|NCT00385788|Fludarabine|fludarabine|mesh-list
111476989|NCT00385788|Melphalan|melphalan|mesh-list
111476990|NCT00385788|Tacrolimus|tacrolimus|mesh-list
111476991|NCT00385788|Thymoglobulin|thymoglobulin|mesh-list
111476992|NCT00385788|Antilymphocyte Serum|antilymphocyte serum|mesh-list
111476993|NCT00385788|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111476994|NCT00385788|Antimetabolites|antimetabolites|mesh-ancestor
111476995|NCT00385788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111476996|NCT00385788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111476997|NCT00385788|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111476998|NCT00385788|Abortifacient Agents|abortifacient agents|mesh-ancestor
111476999|NCT00385788|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111477000|NCT00385788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111477001|NCT00385788|Dermatologic Agents|dermatologic agents|mesh-ancestor
111477002|NCT00385788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110446712|NCT00848497|Anabolic Agents|anabolic agents|mesh-ancestor
111477003|NCT00385788|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111477004|NCT00385788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111477005|NCT00385788|Immunologic Factors|immunologic factors|mesh-ancestor
111477006|NCT00385788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111477007|NCT00385788|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111477008|NCT00385788|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111477009|NCT00385788|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111477010|NCT00385788|Alkylating Agents|alkylating agents|mesh-ancestor
111477011|NCT00385788|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111477012|NCT00411684|Ulipristal acetate|ulipristal acetate|mesh-list
111477013|NCT00411684|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111477014|NCT00411684|Contraceptive Agents|contraceptive agents|mesh-ancestor
111477015|NCT00411684|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111477016|NCT00411684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111477017|NCT00411684|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111477018|NCT00412074|Vitamin D|vitamin d|mesh-list
111477019|NCT00412074|Ergocalciferols|ergocalciferols|mesh-list
111477020|NCT00412074|Cholecalciferol|cholecalciferol|mesh-list
111477021|NCT00412074|Vitamins|vitamins|mesh-list
111477022|NCT00412074|Micronutrients|micronutrients|mesh-ancestor
111477023|NCT00412074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111477024|NCT00412074|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111477025|NCT00412074|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111477026|NCT00412464|PENTA|penta|mesh-list
111477027|NCT00412464|Fondaparinux|fondaparinux|mesh-list
111477028|NCT00412464|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111477029|NCT00412464|Antithrombins|antithrombins|mesh-ancestor
111477030|NCT00412464|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111477031|NCT00412464|Protease Inhibitors|protease inhibitors|mesh-ancestor
111477032|NCT00412464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111477033|NCT00412464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111477034|NCT00412464|Anticoagulants|anticoagulants|mesh-ancestor
111477035|NCT00412464|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111477036|NCT00412464|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111477037|NCT00466752|Sorafenib|sorafenib|mesh-list
111477038|NCT00466752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111477039|NCT00466752|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111477040|NCT00466752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111477041|NCT00466752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111477042|NCT02115750|Etanercept|etanercept|mesh-list
111477043|NCT02115750|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111477044|NCT02115750|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111477045|NCT02115750|Analgesics|analgesics|mesh-ancestor
111477046|NCT02115750|Sensory System Agents|sensory system agents|mesh-ancestor
111477047|NCT02115750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111477048|NCT02115750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111477049|NCT02115750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111201222|NCT03899155|Nivolumab|nivolumab|mesh-list
111477050|NCT02115750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111477051|NCT02115750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111477052|NCT02115750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111477054|NCT00413166|Idarubicin|idarubicin|mesh-list
111477055|NCT00413166|Tretinoin|tretinoin|mesh-list
111477056|NCT00413166|Arsenic Trioxide|arsenic trioxide|mesh-list
111477057|NCT00413166|Gemtuzumab|gemtuzumab|mesh-list
111477058|NCT00413166|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111477059|NCT00413166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111477060|NCT00413166|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111477061|NCT00413166|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111477062|NCT00413166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111477063|NCT00413166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111477064|NCT00413166|Keratolytic Agents|keratolytic agents|mesh-ancestor
111477065|NCT00413166|Dermatologic Agents|dermatologic agents|mesh-ancestor
111477066|NCT00413166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111477067|NCT00413166|Immunotoxins|immunotoxins|mesh-ancestor
111477068|NCT00413166|Immunoconjugates|immunoconjugates|mesh-ancestor
111477069|NCT00413166|Immunologic Factors|immunologic factors|mesh-ancestor
111477070|NCT00413166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111477071|NCT00413400|Etanercept|etanercept|mesh-list
111477072|NCT00413400|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110446718|NCT02763592|Lidocaine|lidocaine|mesh-list
111477073|NCT00413400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111477074|NCT00413400|Analgesics|analgesics|mesh-ancestor
111477075|NCT00413400|Sensory System Agents|sensory system agents|mesh-ancestor
111477076|NCT00413400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111477077|NCT00413400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111477078|NCT00413400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111477079|NCT00413400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111477080|NCT00413400|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111477081|NCT00413400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111477082|NCT00413400|Immunologic Factors|immunologic factors|mesh-ancestor
111477083|NCT00413478|Azacitidine|azacitidine|mesh-list
111477084|NCT00413478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111477085|NCT00413478|Antimetabolites|antimetabolites|mesh-ancestor
111477086|NCT00413478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111477087|NCT00413478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111477088|NCT00413478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111477089|NCT00413634|Anagrelide|anagrelide|mesh-list
111477090|NCT00413634|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111477091|NCT00413634|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111477092|NCT00413634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111477093|NCT00413634|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111477094|NCT00387036|Fluticasone|fluticasone|mesh-list
111477095|NCT00387036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111477096|NCT00387036|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111477097|NCT00387036|Autonomic Agents|autonomic agents|mesh-ancestor
111477098|NCT00387036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111477099|NCT00387036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111477100|NCT00387036|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111477101|NCT00387036|Respiratory System Agents|respiratory system agents|mesh-ancestor
111477102|NCT00387036|Dermatologic Agents|dermatologic agents|mesh-ancestor
111477103|NCT00387036|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111477104|NCT00387660|Carboplatin|carboplatin|mesh-list
111477105|NCT00387660|Irinotecan|irinotecan|mesh-list
111477106|NCT00387660|Camptothecin|camptothecin|mesh-list
111477107|NCT00387660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111477108|NCT00387660|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111477109|NCT00387660|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111477110|NCT00387660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111477111|NCT00387660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111477112|NCT00387660|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111477113|NCT00472056|Cytarabine|cytarabine|mesh-list
111477114|NCT00472056|Rituximab|rituximab|mesh-list
111477115|NCT00472056|Etoposide|etoposide|mesh-list
111477116|NCT00472056|Melphalan|melphalan|mesh-list
111477117|NCT00472056|Carmustine|carmustine|mesh-list
111477118|NCT00472056|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111477119|NCT00472056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111477120|NCT00472056|Immunologic Factors|immunologic factors|mesh-ancestor
111477121|NCT00472056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111477122|NCT00472056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111477123|NCT00472056|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111477124|NCT00472056|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111477125|NCT00472056|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111477126|NCT00472056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111477127|NCT00472056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111477128|NCT00472056|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111477130|NCT00472056|Antiviral Agents|antiviral agents|mesh-ancestor
111477131|NCT00472056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111477132|NCT00472056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111477133|NCT00472056|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111477134|NCT00472056|Alkylating Agents|alkylating agents|mesh-ancestor
111477135|NCT00472056|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111477136|NCT00415506|Rituximab|rituximab|mesh-list
111477137|NCT00415506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111477138|NCT00415506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111477139|NCT00415506|Immunologic Factors|immunologic factors|mesh-ancestor
111477140|NCT00415506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111477141|NCT00415506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111477142|NCT00389532|Vaccines|vaccines|mesh-list
111477143|NCT00389532|Immunologic Factors|immunologic factors|mesh-ancestor
111477144|NCT00389532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111477145|NCT01957956|Temozolomide|temozolomide|mesh-list
110446720|NCT02763592|Anesthetics|anesthetics|mesh-ancestor
111477146|NCT01957956|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111477147|NCT01957956|Alkylating Agents|alkylating agents|mesh-ancestor
111477148|NCT01957956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111477149|NCT01957956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111477150|NCT00475878|Escitalopram|escitalopram|mesh-list
111477151|NCT00475878|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111477152|NCT00475878|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111477153|NCT00475878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111477154|NCT00475878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111477155|NCT00475878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111477156|NCT00475878|Serotonin Agents|serotonin agents|mesh-ancestor
111477157|NCT00475878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111477158|NCT01795170|Pyridoxine|pyridoxine|mesh-list
111477159|NCT01795170|Vitamin B Complex|vitamin b complex|mesh-ancestor
111477160|NCT01795170|Vitamins|vitamins|mesh-ancestor
111477161|NCT01795170|Micronutrients|micronutrients|mesh-ancestor
111477162|NCT01795170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111477163|NCT00477204|Simvastatin|simvastatin|mesh-list
111477164|NCT00477204|Ezetimibe|ezetimibe|mesh-list
111477165|NCT00477204|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
111477166|NCT00477204|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111477167|NCT00477204|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111477168|NCT00477204|Antimetabolites|antimetabolites|mesh-ancestor
111477169|NCT00477204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111477170|NCT00477204|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111477171|NCT00477204|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111477172|NCT00477204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111477173|NCT00528450|Idarubicin|idarubicin|mesh-list
111477174|NCT00528450|Arsenic Trioxide|arsenic trioxide|mesh-list
111477175|NCT00528450|Tretinoin|tretinoin|mesh-list
111477176|NCT00528450|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111477177|NCT00528450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111477178|NCT00528450|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111477179|NCT00528450|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111477180|NCT00528450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111477181|NCT00528450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111477182|NCT00528450|Keratolytic Agents|keratolytic agents|mesh-ancestor
111477183|NCT00528450|Dermatologic Agents|dermatologic agents|mesh-ancestor
111477184|NCT00478218|Dexamethasone|dexamethasone|mesh-list
111477185|NCT00478218|Cyclophosphamide|cyclophosphamide|mesh-list
111477186|NCT00478218|Lenalidomide|lenalidomide|mesh-list
111477187|NCT00478218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111477188|NCT00478218|Immunologic Factors|immunologic factors|mesh-ancestor
111477189|NCT00478218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111477190|NCT00478218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111477191|NCT00478218|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111477192|NCT00478218|Alkylating Agents|alkylating agents|mesh-ancestor
111477193|NCT00478218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111477194|NCT00478218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111477195|NCT00478218|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111477196|NCT00478218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111477197|NCT00478218|Antiemetics|antiemetics|mesh-ancestor
111477198|NCT00478218|Autonomic Agents|autonomic agents|mesh-ancestor
111477199|NCT00478218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111477200|NCT00478218|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111477201|NCT00478218|Glucocorticoids|glucocorticoids|mesh-ancestor
111477202|NCT00478218|Hormones|hormones|mesh-ancestor
111477203|NCT00478218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111477204|NCT00478218|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111477205|NCT00478218|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111477206|NCT00478218|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111477207|NCT00478218|Growth Substances|growth substances|mesh-ancestor
111477208|NCT00478218|Growth Inhibitors|growth inhibitors|mesh-ancestor
111477209|NCT00479154|Botulinum Toxins|botulinum toxins|mesh-list
111477210|NCT00479154|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111477211|NCT00479154|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111477212|NCT00479154|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111477213|NCT00479154|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111477214|NCT00479154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111477215|NCT00479154|Cholinergic Agents|cholinergic agents|mesh-ancestor
111477216|NCT00479154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111477217|NCT00479154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111477218|NCT00479154|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111477219|NCT00479154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111477220|NCT04270656|Insulin|insulin|mesh-list
111477221|NCT04270656|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111477222|NCT04270656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111477223|NCT00424554|Temozolomide|temozolomide|mesh-list
111477224|NCT00424554|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111477225|NCT00424554|Alkylating Agents|alkylating agents|mesh-ancestor
111477226|NCT00424554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111477227|NCT00424554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111477228|NCT00425802|Cyclosporine|cyclosporine|mesh-list
111477229|NCT00425802|Mycophenolic Acid|mycophenolic acid|mesh-list
111477230|NCT00425802|Cyclophosphamide|cyclophosphamide|mesh-list
111477231|NCT00425802|Rituximab|rituximab|mesh-list
111477232|NCT00425802|Fludarabine|fludarabine|mesh-list
111477233|NCT00425802|Fludarabine phosphate|fludarabine phosphate|mesh-list
111477234|NCT00425802|Cyclosporins|cyclosporins|mesh-list
111477235|NCT00425802|Antilymphocyte Serum|antilymphocyte serum|mesh-list
111477236|NCT00425802|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111477237|NCT00425802|Immunologic Factors|immunologic factors|mesh-ancestor
111477238|NCT00425802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111477239|NCT00425802|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111477240|NCT00425802|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111477241|NCT00425802|Alkylating Agents|alkylating agents|mesh-ancestor
111477242|NCT00425802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111477243|NCT00425802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111477244|NCT00425802|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111477245|NCT00425802|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111477246|NCT00425802|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111477247|NCT00425802|Antimetabolites|antimetabolites|mesh-ancestor
111477248|NCT00425802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111477249|NCT00425802|Antifungal Agents|antifungal agents|mesh-ancestor
111477250|NCT00425802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111477251|NCT00425802|Dermatologic Agents|dermatologic agents|mesh-ancestor
111477252|NCT00425802|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111477253|NCT00425802|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111477254|NCT00425802|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111477255|NCT00425802|Antitubercular Agents|antitubercular agents|mesh-ancestor
111477256|NCT00425802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111477257|NCT00530634|Gemcitabine|gemcitabine|mesh-list
111477258|NCT00530634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111477259|NCT00530634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110446748|NCT02882555|Capsaicin|capsaicin|mesh-list
111477260|NCT00530634|Antimetabolites|antimetabolites|mesh-ancestor
111477261|NCT00530634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111477262|NCT00531882|Pioglitazone|pioglitazone|mesh-list
111477263|NCT00531882|Ibuprofen|ibuprofen|mesh-list
111477264|NCT00531882|Simvastatin|simvastatin|mesh-list
111477265|NCT00531882|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111477266|NCT00531882|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111477267|NCT00531882|Analgesics|analgesics|mesh-ancestor
111477268|NCT00531882|Sensory System Agents|sensory system agents|mesh-ancestor
111477269|NCT00531882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111477270|NCT00531882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111477271|NCT00531882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111477272|NCT00531882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111477273|NCT00531882|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111477274|NCT00531882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111477275|NCT00531882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111477276|NCT00531882|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111477277|NCT00531882|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111477278|NCT00531882|Antimetabolites|antimetabolites|mesh-ancestor
111477279|NCT00531882|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111477280|NCT00531882|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111477281|NCT00531882|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111477282|NCT00428298|Valacyclovir|valacyclovir|mesh-list
111477283|NCT00428298|Antiviral Agents|antiviral agents|mesh-ancestor
111477284|NCT00428298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111477285|NCT00486018|Ranibizumab|ranibizumab|mesh-list
111477286|NCT00486018|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111477287|NCT00486018|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111477288|NCT00486018|Growth Substances|growth substances|mesh-ancestor
111477289|NCT00486018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111477290|NCT00486018|Growth Inhibitors|growth inhibitors|mesh-ancestor
111477291|NCT00486018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111477292|NCT00486642|Bicalutamide|bicalutamide|mesh-list
111477293|NCT00486642|Androgen Antagonists|androgen antagonists|mesh-ancestor
111477294|NCT00486642|Hormone Antagonists|hormone antagonists|mesh-ancestor
111477295|NCT00486642|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111477296|NCT00486642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111477297|NCT00486642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111477298|NCT00428922|Bevacizumab|bevacizumab|mesh-list
111477299|NCT00428922|Trastuzumab|trastuzumab|mesh-list
111477300|NCT00428922|Docetaxel|docetaxel|mesh-list
111477301|NCT00428922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111477302|NCT00428922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111477303|NCT00428922|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111477304|NCT00428922|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111477305|NCT00428922|Growth Substances|growth substances|mesh-ancestor
111477306|NCT00428922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111477307|NCT00428922|Growth Inhibitors|growth inhibitors|mesh-ancestor
111477308|NCT00428922|Tubulin Modulators|tubulin modulators|mesh-ancestor
111477309|NCT00428922|Antimitotic Agents|antimitotic agents|mesh-ancestor
111477310|NCT00428922|Mitosis Modulators|mitosis modulators|mesh-ancestor
111477311|NCT00428922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111477312|NCT00533442|Mycophenolic Acid|mycophenolic acid|mesh-list
111477313|NCT00533442|Sirolimus|sirolimus|mesh-list
111477314|NCT00533442|Tacrolimus|tacrolimus|mesh-list
111477315|NCT00533442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111477316|NCT00533442|Immunologic Factors|immunologic factors|mesh-ancestor
111477317|NCT00533442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111477318|NCT00533442|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111477319|NCT00533442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111477320|NCT00533442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111477321|NCT00533442|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111477322|NCT00533442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111477323|NCT00533442|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111477324|NCT00533442|Antitubercular Agents|antitubercular agents|mesh-ancestor
111477325|NCT00533442|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111477326|NCT00533442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111477327|NCT00533442|Antifungal Agents|antifungal agents|mesh-ancestor
111477328|NCT00533910|Rifaximin|rifaximin|mesh-list
111477329|NCT00533910|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111477330|NCT00533910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111477331|NCT00533910|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111477332|NCT01954524|Sildenafil Citrate|sildenafil citrate|mesh-list
111477333|NCT01954524|Vasodilator Agents|vasodilator agents|mesh-ancestor
111477334|NCT01954524|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111477335|NCT01954524|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111477336|NCT01954524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111477337|NCT01954524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111477338|NCT01954524|Urological Agents|urological agents|mesh-ancestor
111477339|NCT00535002|Yohimbine|yohimbine|mesh-list
111477340|NCT00535002|Mydriatics|mydriatics|mesh-ancestor
111477341|NCT00535002|Autonomic Agents|autonomic agents|mesh-ancestor
111477342|NCT00535002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111477343|NCT00535002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111477344|NCT00535002|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
111477345|NCT00535002|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111477346|NCT00535002|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111477347|NCT00535002|Adrenergic Agents|adrenergic agents|mesh-ancestor
111477348|NCT00535002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111477349|NCT00535002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111477350|NCT00535002|Urological Agents|urological agents|mesh-ancestor
111477351|NCT02117934|Vaccines|vaccines|mesh-list
111201522|NCT03739814|Immunotoxins|immunotoxins|mesh-ancestor
111477352|NCT02117934|Immunologic Factors|immunologic factors|mesh-ancestor
111477353|NCT02117934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111477354|NCT00429702|Diphenhydramine|diphenhydramine|mesh-list
111477355|NCT00429702|Promethazine|promethazine|mesh-list
111477356|NCT00429702|Dexamethasone|dexamethasone|mesh-list
111477357|NCT00429702|Lorazepam|lorazepam|mesh-list
111477358|NCT00429702|Ondansetron|ondansetron|mesh-list
111477359|NCT00429702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111477360|NCT00429702|Antiemetics|antiemetics|mesh-ancestor
111477361|NCT00429702|Autonomic Agents|autonomic agents|mesh-ancestor
111477362|NCT00429702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111477363|NCT00429702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111477364|NCT00429702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111477365|NCT00429702|Glucocorticoids|glucocorticoids|mesh-ancestor
111477366|NCT00429702|Hormones|hormones|mesh-ancestor
111477367|NCT00429702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111477368|NCT00429702|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111477369|NCT00429702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111477370|NCT00429702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111477371|NCT00429702|Antipruritics|antipruritics|mesh-ancestor
111477372|NCT00429702|Dermatologic Agents|dermatologic agents|mesh-ancestor
111477373|NCT00429702|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111477374|NCT00429702|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111477375|NCT00429702|Serotonin Agents|serotonin agents|mesh-ancestor
111477376|NCT00429702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111477377|NCT00429702|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111477378|NCT00429702|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111477379|NCT00429702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111477380|NCT00429702|Anesthetics, Local|anesthetics, local|mesh-ancestor
111477381|NCT00429702|Anesthetics|anesthetics|mesh-ancestor
111477382|NCT00429702|Sensory System Agents|sensory system agents|mesh-ancestor
111477383|NCT00429702|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111477384|NCT00429702|Histamine Antagonists|histamine antagonists|mesh-ancestor
111477385|NCT00429702|Histamine Agents|histamine agents|mesh-ancestor
111477386|NCT00429702|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111477387|NCT00429702|Anticonvulsants|anticonvulsants|mesh-ancestor
111477388|NCT00429702|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111477389|NCT00429702|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111477390|NCT00429702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111477391|NCT00429702|GABA Modulators|gaba modulators|mesh-ancestor
111477392|NCT00429702|GABA Agents|gaba agents|mesh-ancestor
111477393|NCT00535392|Levetiracetam|levetiracetam|mesh-list
111477394|NCT00535392|Anticonvulsants|anticonvulsants|mesh-ancestor
111477395|NCT00535392|Nootropic Agents|nootropic agents|mesh-ancestor
111477396|NCT00535782|Methotrexate|methotrexate|mesh-list
111477397|NCT00535782|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111477398|NCT00535782|Abortifacient Agents|abortifacient agents|mesh-ancestor
111477399|NCT00535782|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111477400|NCT00535782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111477401|NCT00535782|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111477402|NCT00535782|Antimetabolites|antimetabolites|mesh-ancestor
111477403|NCT00535782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111477404|NCT00535782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111477405|NCT00535782|Dermatologic Agents|dermatologic agents|mesh-ancestor
111477406|NCT00535782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111477407|NCT00535782|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111477408|NCT00535782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111477409|NCT00535782|Immunologic Factors|immunologic factors|mesh-ancestor
111477410|NCT00535782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111477411|NCT00535782|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111477412|NCT00431184|Pentazocine|pentazocine|mesh-list
111477413|NCT00431184|Lorazepam|lorazepam|mesh-list
111477414|NCT00431184|Anticonvulsants|anticonvulsants|mesh-ancestor
111477415|NCT00431184|Antiemetics|antiemetics|mesh-ancestor
111477416|NCT00431184|Autonomic Agents|autonomic agents|mesh-ancestor
111477417|NCT00431184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111477418|NCT00431184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111477419|NCT00431184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111477420|NCT00431184|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111477421|NCT00431184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111477422|NCT00431184|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111477423|NCT00431184|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111477424|NCT00431184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111477425|NCT00431184|GABA Modulators|gaba modulators|mesh-ancestor
111477426|NCT00431184|GABA Agents|gaba agents|mesh-ancestor
111201615|NCT03674424|Avelumab|avelumab|mesh-list
111477427|NCT00431184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111477428|NCT00431184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111477429|NCT00431184|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111477430|NCT00431184|Narcotics|narcotics|mesh-ancestor
111477431|NCT00431184|Analgesics|analgesics|mesh-ancestor
111477432|NCT00431184|Sensory System Agents|sensory system agents|mesh-ancestor
111477433|NCT00431184|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111477434|NCT00431184|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111477435|NCT00535938|Botulinum Toxins|botulinum toxins|mesh-list
111477436|NCT00535938|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111477437|NCT00535938|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111477438|NCT00535938|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111477439|NCT00535938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111477440|NCT00535938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111477441|NCT00535938|Cholinergic Agents|cholinergic agents|mesh-ancestor
111477442|NCT00535938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111477443|NCT00535938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111477444|NCT00535938|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111477445|NCT00535938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111477446|NCT01795794|Omeprazole|omeprazole|mesh-list
111477447|NCT01795794|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111477448|NCT01795794|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111477449|NCT01795794|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111477450|NCT01795794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111477451|NCT01795794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111477452|NCT01796028|Metformin|metformin|mesh-list
111477453|NCT01796028|Docetaxel|docetaxel|mesh-list
111477454|NCT01796028|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111477455|NCT01796028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111477456|NCT01796028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111477457|NCT01796028|Tubulin Modulators|tubulin modulators|mesh-ancestor
111477458|NCT01796028|Antimitotic Agents|antimitotic agents|mesh-ancestor
111477459|NCT01796028|Mitosis Modulators|mitosis modulators|mesh-ancestor
111477460|NCT01796028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111477461|NCT00491244|Interferons|interferons|mesh-list
111477462|NCT00491244|Ribavirin|ribavirin|mesh-list
111477463|NCT00491244|Interferon-alpha|interferon-alpha|mesh-list
111477464|NCT00491244|Interferon alpha-2|interferon alpha-2|mesh-list
111477465|NCT00491244|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
111477466|NCT00491244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111477467|NCT00491244|Antiviral Agents|antiviral agents|mesh-ancestor
111477468|NCT00491244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111477469|NCT00491244|Antimetabolites|antimetabolites|mesh-ancestor
111477470|NCT00491244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111477471|NCT00491244|Immunologic Factors|immunologic factors|mesh-ancestor
111477472|NCT00491244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111477473|NCT00492336|Rasagiline|rasagiline|mesh-list
111477474|NCT00492336|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
111477475|NCT00492336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111477476|NCT00492336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111477477|NCT00492336|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111477478|NCT00492336|Protective Agents|protective agents|mesh-ancestor
111477479|NCT00492336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111477480|NCT00538434|Reslizumab|reslizumab|mesh-list
111477481|NCT00538434|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111477482|NCT00538434|Respiratory System Agents|respiratory system agents|mesh-ancestor
111477483|NCT00538824|Thalidomide|thalidomide|mesh-list
111477484|NCT00538824|Dexamethasone|dexamethasone|mesh-list
111477485|NCT00538824|Lenalidomide|lenalidomide|mesh-list
111477486|NCT00538824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111477487|NCT00538824|Antiemetics|antiemetics|mesh-ancestor
111477488|NCT00538824|Autonomic Agents|autonomic agents|mesh-ancestor
111477489|NCT00538824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111477490|NCT00538824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111477491|NCT00538824|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111477492|NCT00538824|Glucocorticoids|glucocorticoids|mesh-ancestor
111477493|NCT00538824|Hormones|hormones|mesh-ancestor
111477494|NCT00538824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111477495|NCT00538824|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111477496|NCT00538824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111477497|NCT00538824|Immunologic Factors|immunologic factors|mesh-ancestor
111477498|NCT00538824|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111477499|NCT00538824|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111477500|NCT00538824|Growth Substances|growth substances|mesh-ancestor
111477501|NCT00538824|Growth Inhibitors|growth inhibitors|mesh-ancestor
111477502|NCT00538824|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111477503|NCT00538824|Leprostatic Agents|leprostatic agents|mesh-ancestor
111477504|NCT00538824|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111477505|NCT00538824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111477506|NCT00539526|Bimatoprost|bimatoprost|mesh-list
111477507|NCT00539526|Travoprost|travoprost|mesh-list
111477508|NCT00539526|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111477509|NCT00539526|Latanoprost|latanoprost|mesh-list
111477510|NCT00539526|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111477511|NCT00539526|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111477512|NCT01796106|Fluorides|fluorides|mesh-list
111477513|NCT01796106|Fluorides, Topical|fluorides, topical|mesh-list
111477514|NCT01796106|Cariostatic Agents|cariostatic agents|mesh-ancestor
111477515|NCT01796106|Protective Agents|protective agents|mesh-ancestor
111477516|NCT01796106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111477517|NCT00541242|Bimatoprost|bimatoprost|mesh-list
111477518|NCT00541242|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111477519|NCT00541242|Latanoprost|latanoprost|mesh-list
111477520|NCT00541242|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111477521|NCT00541242|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111477522|NCT00438204|Bevacizumab|bevacizumab|mesh-list
111477523|NCT00438204|Gemcitabine|gemcitabine|mesh-list
111477524|NCT00438204|Pemetrexed|pemetrexed|mesh-list
111477525|NCT00438204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111477526|NCT00438204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111477527|NCT00438204|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111477528|NCT00438204|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111477529|NCT00438204|Growth Substances|growth substances|mesh-ancestor
111477530|NCT00438204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111477531|NCT00438204|Growth Inhibitors|growth inhibitors|mesh-ancestor
111477532|NCT00438204|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111477533|NCT00438204|Antimetabolites|antimetabolites|mesh-ancestor
111477534|NCT00438204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111477535|NCT00438204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111477536|NCT00438204|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111477537|NCT00438204|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111477538|NCT00439296|Cytarabine|cytarabine|mesh-list
111477539|NCT00439296|Dexamethasone|dexamethasone|mesh-list
111477540|NCT00439296|Cyclophosphamide|cyclophosphamide|mesh-list
111477541|NCT00439296|Doxorubicin|doxorubicin|mesh-list
111477542|NCT00439296|Methotrexate|methotrexate|mesh-list
111477543|NCT00439296|Asparaginase|asparaginase|mesh-list
111477544|NCT00439296|Mercaptopurine|mercaptopurine|mesh-list
111477545|NCT00439296|Thioguanine|thioguanine|mesh-list
111477546|NCT00439296|Pegaspargase|pegaspargase|mesh-list
111477547|NCT00439296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111477548|NCT00439296|Immunologic Factors|immunologic factors|mesh-ancestor
111477549|NCT00439296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111477550|NCT00439296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111477551|NCT00439296|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111477552|NCT00439296|Alkylating Agents|alkylating agents|mesh-ancestor
111477553|NCT00439296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111477554|NCT00439296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111477555|NCT00439296|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111477556|NCT00439296|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111477557|NCT00439296|Antiemetics|antiemetics|mesh-ancestor
111477558|NCT00439296|Autonomic Agents|autonomic agents|mesh-ancestor
111477559|NCT00439296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111477560|NCT00439296|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111477561|NCT00439296|Glucocorticoids|glucocorticoids|mesh-ancestor
111477562|NCT00439296|Hormones|hormones|mesh-ancestor
111477563|NCT00439296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111477564|NCT00439296|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111477565|NCT00439296|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111477566|NCT00439296|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111477567|NCT00439296|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111477568|NCT00439296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111477569|NCT00439296|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111477570|NCT00439296|Abortifacient Agents|abortifacient agents|mesh-ancestor
111477571|NCT00439296|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111477572|NCT00439296|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111477573|NCT00439296|Antimetabolites|antimetabolites|mesh-ancestor
111477574|NCT00439296|Dermatologic Agents|dermatologic agents|mesh-ancestor
111477575|NCT00439296|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111477576|NCT00439296|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111477577|NCT00439296|Antiviral Agents|antiviral agents|mesh-ancestor
111477578|NCT00439296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111477579|NCT03117660|Vitamin A|vitamin a|mesh-list
111477580|NCT03117660|Vitamins|vitamins|mesh-ancestor
111477581|NCT03117660|Micronutrients|micronutrients|mesh-ancestor
111477582|NCT03117660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111477583|NCT00439374|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
111477585|NCT00439374|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111477586|NCT00439374|Hormone Antagonists|hormone antagonists|mesh-ancestor
111477587|NCT00439374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111477588|NCT00439374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111477589|NCT00439374|Progestins|progestins|mesh-ancestor
111477590|NCT00439374|Hormones|hormones|mesh-ancestor
111477591|NCT00439608|Paclitaxel|paclitaxel|mesh-list
111477592|NCT00439608|Carboplatin|carboplatin|mesh-list
111477593|NCT00439608|Cetuximab|cetuximab|mesh-list
111477594|NCT00439608|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111477595|NCT00439608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111477596|NCT00439608|Tubulin Modulators|tubulin modulators|mesh-ancestor
111477597|NCT00439608|Antimitotic Agents|antimitotic agents|mesh-ancestor
111477598|NCT00439608|Mitosis Modulators|mitosis modulators|mesh-ancestor
111477599|NCT00439608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111477600|NCT00439608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111477601|NCT04750122|Carboplatin|carboplatin|mesh-list
111477602|NCT04750122|Docetaxel|docetaxel|mesh-list
111477603|NCT04750122|Trastuzumab|trastuzumab|mesh-list
111477604|NCT04750122|Pertuzumab|pertuzumab|mesh-list
111477605|NCT04750122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111477606|NCT04750122|Tubulin Modulators|tubulin modulators|mesh-ancestor
111477607|NCT04750122|Antimitotic Agents|antimitotic agents|mesh-ancestor
111477608|NCT04750122|Mitosis Modulators|mitosis modulators|mesh-ancestor
111477609|NCT04750122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111477610|NCT04750122|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111477611|NCT00443352|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
111477612|NCT00443352|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111477613|NCT00443352|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111477614|NCT00443352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111477615|NCT00443352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111477616|NCT00443352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111477617|NCT00443352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111477618|NCT00443352|Analgesics|analgesics|mesh-ancestor
111477619|NCT00443352|Sensory System Agents|sensory system agents|mesh-ancestor
111477620|NCT00443352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111477621|NCT00443352|Antidepressive Agents|antidepressive agents|mesh-ancestor
111477622|NCT00443352|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111477623|NCT00443352|Dopamine Agents|dopamine agents|mesh-ancestor
111477624|NCT00445302|Plerixafor|plerixafor|mesh-list
111477625|NCT00445302|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111477626|NCT00445302|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111477627|NCT00445302|Antiviral Agents|antiviral agents|mesh-ancestor
111477628|NCT00445302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111477629|NCT00504504|Rituximab|rituximab|mesh-list
111477630|NCT00504504|Doxorubicin|doxorubicin|mesh-list
111477631|NCT00504504|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111477632|NCT00504504|Dacarbazine|dacarbazine|mesh-list
111477633|NCT00504504|Bleomycin|bleomycin|mesh-list
111477634|NCT00504504|Vinblastine|vinblastine|mesh-list
111477635|NCT00504504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111477636|NCT00504504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111477637|NCT00504504|Immunologic Factors|immunologic factors|mesh-ancestor
111477638|NCT00504504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111477639|NCT00504504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111477640|NCT00504504|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111477641|NCT00504504|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111477642|NCT00504504|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111477643|NCT00504504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111477644|NCT00504504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111477645|NCT00504504|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111477646|NCT00504504|Alkylating Agents|alkylating agents|mesh-ancestor
111477647|NCT00504504|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111477648|NCT00504504|Tubulin Modulators|tubulin modulators|mesh-ancestor
111477649|NCT00504504|Antimitotic Agents|antimitotic agents|mesh-ancestor
111477650|NCT00504504|Mitosis Modulators|mitosis modulators|mesh-ancestor
111477651|NCT00504660|Celecoxib|celecoxib|mesh-list
111477652|NCT00504660|Capecitabine|capecitabine|mesh-list
111477653|NCT00504660|Thioguanine|thioguanine|mesh-list
111477654|NCT00504660|Temozolomide|temozolomide|mesh-list
111477655|NCT00504660|Lomustine|lomustine|mesh-list
111477656|NCT00504660|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111477657|NCT00504660|Antimetabolites|antimetabolites|mesh-ancestor
111477658|NCT00504660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111477659|NCT00504660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111477660|NCT00504660|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111477661|NCT00504660|Alkylating Agents|alkylating agents|mesh-ancestor
111477662|NCT00504660|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111477663|NCT00504660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111477664|NCT00504660|Analgesics|analgesics|mesh-ancestor
111477665|NCT00504660|Sensory System Agents|sensory system agents|mesh-ancestor
111477666|NCT00504660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111477667|NCT00504660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111477668|NCT00504660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111477669|NCT00504660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111477670|NCT00504660|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111477671|NCT00504660|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111477672|NCT00504660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111477673|NCT00505518|Psychotropic Drugs|psychotropic drugs|mesh-list
111477674|NCT00544908|Dasatinib|dasatinib|mesh-list
111477675|NCT00544908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111477676|NCT00544908|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111477677|NCT00544908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111477678|NCT00544908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111477679|NCT00447330|Bevacizumab|bevacizumab|mesh-list
111477680|NCT00447330|Capecitabine|capecitabine|mesh-list
111477681|NCT00447330|Oxaliplatin|oxaliplatin|mesh-list
111477682|NCT00447330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111477683|NCT00447330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111477684|NCT00447330|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111477685|NCT00447330|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111477686|NCT00447330|Growth Substances|growth substances|mesh-ancestor
111477687|NCT00447330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111477688|NCT00447330|Growth Inhibitors|growth inhibitors|mesh-ancestor
111477689|NCT00447330|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111477690|NCT00447330|Antimetabolites|antimetabolites|mesh-ancestor
111477691|NCT00447330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111477692|NCT02115048|Letrozole|letrozole|mesh-list
111477693|NCT02115048|Afatinib|afatinib|mesh-list
111477694|NCT02115048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111477695|NCT02115048|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111477696|NCT02115048|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111477697|NCT02115048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111477698|NCT02115048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111477699|NCT02115048|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111477700|NCT02115048|Hormone Antagonists|hormone antagonists|mesh-ancestor
111477701|NCT02115048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111477702|NCT02115048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111477703|NCT02115048|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111477704|NCT00546156|Paclitaxel|paclitaxel|mesh-list
111477705|NCT00546156|Cyclophosphamide|cyclophosphamide|mesh-list
111477706|NCT00546156|Bevacizumab|bevacizumab|mesh-list
111477707|NCT00546156|Doxorubicin|doxorubicin|mesh-list
111477708|NCT00546156|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111477709|NCT00546156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111477710|NCT00546156|Tubulin Modulators|tubulin modulators|mesh-ancestor
111477711|NCT00546156|Antimitotic Agents|antimitotic agents|mesh-ancestor
111477712|NCT00546156|Mitosis Modulators|mitosis modulators|mesh-ancestor
111477713|NCT00546156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111477714|NCT00546156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111477715|NCT00546156|Immunologic Factors|immunologic factors|mesh-ancestor
111477716|NCT00546156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111477717|NCT00546156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111477718|NCT00546156|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111477719|NCT00546156|Alkylating Agents|alkylating agents|mesh-ancestor
111477720|NCT00546156|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111477721|NCT00546156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111477722|NCT00546156|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111477723|NCT00546156|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111477724|NCT00546156|Growth Substances|growth substances|mesh-ancestor
111477725|NCT00546156|Growth Inhibitors|growth inhibitors|mesh-ancestor
111477726|NCT00546156|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111477727|NCT00546156|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111477728|NCT00546156|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111477729|NCT00546156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111477730|NCT00449046|Fluticasone|fluticasone|mesh-list
111477731|NCT00449046|Xhance|xhance|mesh-list
111477732|NCT00449046|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
111477733|NCT00449046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111477734|NCT00449046|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111477735|NCT00449046|Autonomic Agents|autonomic agents|mesh-ancestor
111477736|NCT00449046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111477737|NCT00449046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111477738|NCT00449046|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111477739|NCT00449046|Respiratory System Agents|respiratory system agents|mesh-ancestor
111477740|NCT00449046|Dermatologic Agents|dermatologic agents|mesh-ancestor
111477741|NCT00449046|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111477742|NCT00449046|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111477743|NCT00449046|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111477744|NCT00449046|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111477745|NCT00449046|Adrenergic Agents|adrenergic agents|mesh-ancestor
111477746|NCT00449046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111477747|NCT00449046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111477749|NCT00449748|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111477750|NCT00449748|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111477751|NCT00449748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111477752|NCT00449748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111477753|NCT00449748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111477754|NCT00449748|Immunologic Factors|immunologic factors|mesh-ancestor
111477755|NCT00449748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111477756|NCT00449748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111477757|NCT00509496|Aldesleukin|aldesleukin|mesh-list
111477758|NCT00509496|Cyclophosphamide|cyclophosphamide|mesh-list
111477759|NCT00509496|Fludarabine|fludarabine|mesh-list
111477760|NCT00509496|Fludarabine phosphate|fludarabine phosphate|mesh-list
111477761|NCT00509496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111477762|NCT00509496|Immunologic Factors|immunologic factors|mesh-ancestor
111477763|NCT00509496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111477764|NCT00509496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111477765|NCT00509496|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111477766|NCT00509496|Alkylating Agents|alkylating agents|mesh-ancestor
111477767|NCT00509496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111477768|NCT00509496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111477769|NCT00509496|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111477770|NCT00509496|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111477771|NCT00509496|Antimetabolites|antimetabolites|mesh-ancestor
111477772|NCT00509496|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111477773|NCT00509496|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111477774|NCT00509496|Antiviral Agents|antiviral agents|mesh-ancestor
111477775|NCT00509496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111477776|NCT00548418|Bevacizumab|bevacizumab|mesh-list
111477777|NCT00548418|Topotecan|topotecan|mesh-list
111477778|NCT00548418|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111477779|NCT00548418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111477780|NCT00548418|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111477781|NCT00548418|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111477782|NCT00548418|Growth Substances|growth substances|mesh-ancestor
111477783|NCT00548418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111477784|NCT00548418|Growth Inhibitors|growth inhibitors|mesh-ancestor
111477785|NCT00548418|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111477786|NCT00548418|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111477787|NCT00548418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111477788|NCT00548418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111477789|NCT00511992|Paclitaxel|paclitaxel|mesh-list
111477790|NCT00511992|Bevacizumab|bevacizumab|mesh-list
111477791|NCT00511992|Cisplatin|cisplatin|mesh-list
111477792|NCT00511992|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111477793|NCT00511992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111477794|NCT00511992|Tubulin Modulators|tubulin modulators|mesh-ancestor
111477795|NCT00511992|Antimitotic Agents|antimitotic agents|mesh-ancestor
111477796|NCT00511992|Mitosis Modulators|mitosis modulators|mesh-ancestor
111477797|NCT00511992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111477798|NCT00511992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111477799|NCT00511992|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111477800|NCT00511992|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111477801|NCT00511992|Growth Substances|growth substances|mesh-ancestor
111477802|NCT00511992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111477803|NCT00511992|Growth Inhibitors|growth inhibitors|mesh-ancestor
111477804|NCT00451698|Epoetin Alfa|epoetin alfa|mesh-list
111477805|NCT00451698|Hematinics|hematinics|mesh-ancestor
111477806|NCT00549042|Hydromorphone|hydromorphone|mesh-list
111477807|NCT00549042|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111477808|NCT00549042|Narcotics|narcotics|mesh-ancestor
111477809|NCT00549042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111477810|NCT00549042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111477812|NCT00549042|Sensory System Agents|sensory system agents|mesh-ancestor
111477813|NCT00549042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111477814|NCT00452868|Donepezil|donepezil|mesh-list
111477815|NCT00452868|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111477816|NCT00452868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111477817|NCT00452868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111477818|NCT00452868|Cholinergic Agents|cholinergic agents|mesh-ancestor
111477819|NCT00452868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111477820|NCT00452868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111477821|NCT00452868|Nootropic Agents|nootropic agents|mesh-ancestor
111477822|NCT00453336|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
111477823|NCT00453336|Trioxsalen|trioxsalen|mesh-list
111477824|NCT00453336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111477825|NCT00453336|Dermatologic Agents|dermatologic agents|mesh-ancestor
111477826|NCT00453336|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111477827|NCT00549822|Letrozole|letrozole|mesh-list
111477828|NCT00549822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111477829|NCT00549822|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111477830|NCT00549822|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111477831|NCT00549822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111477832|NCT00549822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111477833|NCT00549822|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111477834|NCT00549822|Hormone Antagonists|hormone antagonists|mesh-ancestor
111477835|NCT00549822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111477836|NCT00549822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111477837|NCT00550290|Cefazolin|cefazolin|mesh-list
111477838|NCT00550290|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111477839|NCT00550290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111477840|NCT01797198|Repaglinide|repaglinide|mesh-list
111477841|NCT01797198|Gemfibrozil|gemfibrozil|mesh-list
111477842|NCT01797198|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111477843|NCT01797198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111477844|NCT01797198|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111477845|NCT01797198|Antimetabolites|antimetabolites|mesh-ancestor
111477846|NCT01797198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111477847|NCT01797198|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111477848|NCT01797198|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
111477849|NCT01797198|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111477850|NCT01797198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111477851|NCT00552786|Acetylcysteine|acetylcysteine|mesh-list
111477852|NCT00552786|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111477853|NCT00552786|Antiviral Agents|antiviral agents|mesh-ancestor
111477854|NCT00552786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111477855|NCT00552786|Expectorants|expectorants|mesh-ancestor
111477856|NCT00552786|Respiratory System Agents|respiratory system agents|mesh-ancestor
111477857|NCT00552786|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111477858|NCT00552786|Antioxidants|antioxidants|mesh-ancestor
111477859|NCT00552786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111477860|NCT00552786|Protective Agents|protective agents|mesh-ancestor
111477861|NCT00552786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111477862|NCT00552786|Antidotes|antidotes|mesh-ancestor
111477863|NCT00517530|Obinutuzumab|obinutuzumab|mesh-list
111477864|NCT00517530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111477865|NCT00517530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111477866|NCT00518154|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
111477867|NCT00518154|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111477868|NCT00518154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111477869|NCT00518154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111477870|NCT00518154|Cholinergic Agents|cholinergic agents|mesh-ancestor
111477871|NCT00518154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111477872|NCT00518154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111477873|NCT00553098|Cyclosporine|cyclosporine|mesh-list
111477874|NCT00553098|Mycophenolic Acid|mycophenolic acid|mesh-list
111477875|NCT00553098|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111477876|NCT00553098|Alemtuzumab|alemtuzumab|mesh-list
111477877|NCT00553098|Fludarabine|fludarabine|mesh-list
111477878|NCT00553098|Fludarabine phosphate|fludarabine phosphate|mesh-list
111477879|NCT00553098|Antibodies|antibodies|mesh-list
111477880|NCT00553098|Immunoglobulins|immunoglobulins|mesh-list
111477881|NCT00553098|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111477882|NCT00553098|Cyclosporins|cyclosporins|mesh-list
111477883|NCT00553098|Immunologic Factors|immunologic factors|mesh-ancestor
111477884|NCT00553098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111202055|NCT03375307|Olaparib|olaparib|mesh-list
111477885|NCT00553098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111477886|NCT00553098|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111477887|NCT00553098|Antimetabolites|antimetabolites|mesh-ancestor
111477888|NCT00553098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111477889|NCT00553098|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111477890|NCT00553098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111477891|NCT00553098|Antifungal Agents|antifungal agents|mesh-ancestor
111477892|NCT00553098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111477893|NCT00553098|Dermatologic Agents|dermatologic agents|mesh-ancestor
111477894|NCT00553098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111477895|NCT00553098|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111477896|NCT00553098|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111477897|NCT00553098|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111477898|NCT00553098|Antitubercular Agents|antitubercular agents|mesh-ancestor
111477899|NCT00553098|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111477900|NCT00553410|Letrozole|letrozole|mesh-list
111477901|NCT00553410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111477902|NCT00553410|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111477903|NCT00553410|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111477904|NCT00553410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111477905|NCT00553410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111477906|NCT00553410|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111477907|NCT00553410|Hormone Antagonists|hormone antagonists|mesh-ancestor
111477908|NCT00553410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111477909|NCT00553410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111477910|NCT00554970|Budesonide|budesonide|mesh-list
111477911|NCT00554970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111477912|NCT00554970|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111477913|NCT00554970|Autonomic Agents|autonomic agents|mesh-ancestor
111477914|NCT00554970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111477915|NCT00554970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111477916|NCT00554970|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111477917|NCT00554970|Respiratory System Agents|respiratory system agents|mesh-ancestor
111477918|NCT00554970|Glucocorticoids|glucocorticoids|mesh-ancestor
111477919|NCT00554970|Hormones|hormones|mesh-ancestor
111477920|NCT00554970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111477921|NCT00524472|Insulin|insulin|mesh-list
111477922|NCT00524472|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111477923|NCT00524472|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111477924|NCT00524472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111477925|NCT00555048|Cyclophosphamide|cyclophosphamide|mesh-list
111477926|NCT00555048|Busulfan|busulfan|mesh-list
111477927|NCT00555048|Methotrexate|methotrexate|mesh-list
111477928|NCT00555048|Alemtuzumab|alemtuzumab|mesh-list
111477929|NCT00555048|Tacrolimus|tacrolimus|mesh-list
111477930|NCT00555048|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111477931|NCT00555048|Immunologic Factors|immunologic factors|mesh-ancestor
111477932|NCT00555048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111477933|NCT00555048|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111477934|NCT00555048|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111477935|NCT00555048|Alkylating Agents|alkylating agents|mesh-ancestor
111477936|NCT00555048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111477937|NCT00555048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111477938|NCT00555048|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111477939|NCT00555048|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111477940|NCT00555048|Abortifacient Agents|abortifacient agents|mesh-ancestor
111477941|NCT00555048|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111477942|NCT00555048|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111477943|NCT00555048|Antimetabolites|antimetabolites|mesh-ancestor
111477944|NCT00555048|Dermatologic Agents|dermatologic agents|mesh-ancestor
111477945|NCT00555048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111477946|NCT00555048|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111477947|NCT00555048|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111477948|NCT00555048|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111477949|NCT00555048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111477950|NCT00525798|Calcitonin|calcitonin|mesh-list
111477951|NCT00525798|Salmon calcitonin|salmon calcitonin|mesh-list
111477952|NCT00525798|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
111477953|NCT00525798|Katacalcin|katacalcin|mesh-list
111477954|NCT00525798|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111477955|NCT00525798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111477956|NCT00525798|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111477957|NCT00525798|Vasodilator Agents|vasodilator agents|mesh-ancestor
111477958|NCT00525876|Cyclophosphamide|cyclophosphamide|mesh-list
111477959|NCT00525876|Rituximab|rituximab|mesh-list
111477960|NCT00525876|Fludarabine|fludarabine|mesh-list
111477961|NCT00525876|Fludarabine phosphate|fludarabine phosphate|mesh-list
111477962|NCT00525876|Alemtuzumab|alemtuzumab|mesh-list
111477963|NCT00525876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111477964|NCT00525876|Immunologic Factors|immunologic factors|mesh-ancestor
111477965|NCT00525876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111477966|NCT00525876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111477967|NCT00525876|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111477968|NCT00525876|Alkylating Agents|alkylating agents|mesh-ancestor
111477969|NCT00525876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111477970|NCT00525876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111477971|NCT00525876|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111477972|NCT00525876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111477973|NCT00525876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111477974|NCT00525876|Antimetabolites|antimetabolites|mesh-ancestor
111477975|NCT00555750|Eszopiclone|eszopiclone|mesh-list
111477976|NCT00555750|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111477977|NCT00555750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111477978|NCT00555750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111477979|NCT00556140|Aripiprazole|aripiprazole|mesh-list
111477980|NCT00556140|Antidepressive Agents|antidepressive agents|mesh-ancestor
111477981|NCT00556140|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111477982|NCT00556140|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111477983|NCT00556140|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111477984|NCT00556140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111477985|NCT00556140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111477986|NCT00556140|Dopamine Agonists|dopamine agonists|mesh-ancestor
111477987|NCT00556140|Dopamine Agents|dopamine agents|mesh-ancestor
111477988|NCT00556140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111477989|NCT00556140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111477990|NCT00556140|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111477991|NCT00556140|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111477992|NCT00556140|Serotonin Agents|serotonin agents|mesh-ancestor
111477993|NCT00556140|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111477994|NCT00556140|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111477995|NCT00556140|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111477996|NCT00556140|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111477997|NCT00527124|Prednisone|prednisone|mesh-list
111477998|NCT00527124|Docetaxel|docetaxel|mesh-list
111477999|NCT00527124|Cediranib|cediranib|mesh-list
111478000|NCT00527124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111478001|NCT00527124|Tubulin Modulators|tubulin modulators|mesh-ancestor
111478002|NCT00527124|Antimitotic Agents|antimitotic agents|mesh-ancestor
111478003|NCT00527124|Mitosis Modulators|mitosis modulators|mesh-ancestor
111478004|NCT00527124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111478005|NCT00527124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111478006|NCT00527124|Glucocorticoids|glucocorticoids|mesh-ancestor
111478007|NCT00527124|Hormones|hormones|mesh-ancestor
111478008|NCT00527124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111478009|NCT00527124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111478010|NCT00527124|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111478011|NCT00527124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111478012|NCT00527124|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111478013|NCT00527592|Travoprost|travoprost|mesh-list
111478014|NCT00527592|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111478015|NCT00527592|Latanoprost|latanoprost|mesh-list
111478016|NCT00527592|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111478017|NCT00527592|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111478018|NCT00556452|Busulfan|busulfan|mesh-list
111478019|NCT00556452|Clofarabine|clofarabine|mesh-list
111478020|NCT00556452|Alkylating Agents|alkylating agents|mesh-ancestor
111478021|NCT00556452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111478022|NCT00556452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111478023|NCT00556452|Immunologic Factors|immunologic factors|mesh-ancestor
111478024|NCT00556452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111478025|NCT00556452|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111478026|NCT00556452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111478027|NCT00556452|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111478028|NCT00556452|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111478029|NCT00556452|Antimetabolites|antimetabolites|mesh-ancestor
111478030|NCT03158376|Gabapentin|gabapentin|mesh-list
111478031|NCT03158376|Analgesics|analgesics|mesh-ancestor
111478032|NCT03158376|Sensory System Agents|sensory system agents|mesh-ancestor
111478033|NCT03158376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111478034|NCT03158376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111478036|NCT03158376|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111478037|NCT03158376|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111478038|NCT03158376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111478039|NCT03158376|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111478040|NCT03158376|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111478041|NCT03158376|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111478042|NCT03158376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111478043|NCT03158376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111478044|NCT03158376|Antimanic Agents|antimanic agents|mesh-ancestor
111478045|NCT01797900|Paclitaxel|paclitaxel|mesh-list
111478046|NCT01797900|Cisplatin|cisplatin|mesh-list
111478047|NCT01797900|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111478048|NCT01797900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111478049|NCT01797900|Tubulin Modulators|tubulin modulators|mesh-ancestor
111478050|NCT01797900|Antimitotic Agents|antimitotic agents|mesh-ancestor
111478051|NCT01797900|Mitosis Modulators|mitosis modulators|mesh-ancestor
111478052|NCT01797900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111478053|NCT03572790|Prucalopride|prucalopride|mesh-list
111478054|NCT03572790|Laxatives|laxatives|mesh-ancestor
111478055|NCT03572790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111478056|NCT03572790|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
111478057|NCT03572790|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111478058|NCT03572790|Serotonin Agents|serotonin agents|mesh-ancestor
111478059|NCT03572790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111478060|NCT03572790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111478061|NCT03572790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111478062|NCT03428802|Pembrolizumab|pembrolizumab|mesh-list
111478063|NCT03428802|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111478064|NCT03428802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111478065|NCT03428802|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111478066|NCT03428802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111478067|NCT03379194|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111478068|NCT03379194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111478069|NCT02319486|Carboplatin|carboplatin|mesh-list
111478070|NCT02319486|Etoposide|etoposide|mesh-list
111478071|NCT02319486|Vincristine|vincristine|mesh-list
111478072|NCT02319486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111478073|NCT02319486|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111478074|NCT02319486|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111478075|NCT02319486|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111478076|NCT02319486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111478077|NCT02319486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111478078|NCT02319486|Tubulin Modulators|tubulin modulators|mesh-ancestor
111478079|NCT02319486|Antimitotic Agents|antimitotic agents|mesh-ancestor
110446985|NCT02759926|Analgesics|analgesics|mesh-ancestor
111478080|NCT02319486|Mitosis Modulators|mitosis modulators|mesh-ancestor
111478081|NCT03117972|Leucovorin|leucovorin|mesh-list
111478082|NCT03117972|Bevacizumab|bevacizumab|mesh-list
111478083|NCT03117972|Fluorouracil|fluorouracil|mesh-list
111478084|NCT03117972|Capecitabine|capecitabine|mesh-list
111478085|NCT03117972|Oxaliplatin|oxaliplatin|mesh-list
111478086|NCT03117972|Irinotecan|irinotecan|mesh-list
111478087|NCT03117972|Levoleucovorin|levoleucovorin|mesh-list
111478088|NCT03117972|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111478089|NCT03117972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111478090|NCT03117972|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111478091|NCT03117972|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111478092|NCT03117972|Growth Substances|growth substances|mesh-ancestor
111478093|NCT03117972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111478094|NCT03117972|Growth Inhibitors|growth inhibitors|mesh-ancestor
111478095|NCT03117972|Antimetabolites|antimetabolites|mesh-ancestor
111478096|NCT03117972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111478097|NCT03117972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111478098|NCT03117972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111478099|NCT03117972|Immunologic Factors|immunologic factors|mesh-ancestor
111478100|NCT03117972|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111478101|NCT03117972|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111478102|NCT03117972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111478103|NCT03117972|Antidotes|antidotes|mesh-ancestor
111478104|NCT03117972|Protective Agents|protective agents|mesh-ancestor
111478105|NCT03117972|Vitamin B Complex|vitamin b complex|mesh-ancestor
111478106|NCT03117972|Vitamins|vitamins|mesh-ancestor
111478107|NCT03117972|Micronutrients|micronutrients|mesh-ancestor
111478108|NCT05622162|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
111202300|NCT03117751|Hormones|hormones|mesh-ancestor
111478109|NCT05622162|18F-JK-PSMA-7|18f-jk-psma-7|mesh-list
111478110|NCT05622162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111478111|NCT00558012|Vitamin D|vitamin d|mesh-list
111478112|NCT00558012|Zoledronic Acid|zoledronic acid|mesh-list
111478113|NCT00558012|Calcium|calcium|mesh-list
111478114|NCT00558012|Vitamins|vitamins|mesh-ancestor
111478115|NCT00558012|Micronutrients|micronutrients|mesh-ancestor
111478116|NCT00558012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111478117|NCT00558012|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111478118|NCT00558012|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111478119|NCT00561834|Ranibizumab|ranibizumab|mesh-list
111478120|NCT00561834|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111478121|NCT00561834|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111478122|NCT00561834|Growth Substances|growth substances|mesh-ancestor
111478123|NCT00561834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111478124|NCT00561834|Growth Inhibitors|growth inhibitors|mesh-ancestor
111478125|NCT00561834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111478126|NCT04388202|Sertraline|sertraline|mesh-list
111478127|NCT04388202|Escitalopram|escitalopram|mesh-list
111478128|NCT04388202|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111478129|NCT04388202|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111478130|NCT04388202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111478131|NCT04388202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111478132|NCT04388202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111478133|NCT04388202|Serotonin Agents|serotonin agents|mesh-ancestor
111478134|NCT04388202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111478135|NCT04388202|Antidepressive Agents|antidepressive agents|mesh-ancestor
111478136|NCT04388202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111478137|NCT02128230|Thalidomide|thalidomide|mesh-list
111478138|NCT02128230|Dexamethasone|dexamethasone|mesh-list
111478139|NCT02128230|Dexamethasone acetate|dexamethasone acetate|mesh-list
111478140|NCT02128230|Cyclophosphamide|cyclophosphamide|mesh-list
111478141|NCT02128230|Melphalan|melphalan|mesh-list
111478142|NCT02128230|Cisplatin|cisplatin|mesh-list
111478143|NCT02128230|Doxorubicin|doxorubicin|mesh-list
111478144|NCT02128230|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111478145|NCT02128230|Etoposide|etoposide|mesh-list
111478146|NCT02128230|Etoposide phosphate|etoposide phosphate|mesh-list
111478147|NCT02128230|Lenalidomide|lenalidomide|mesh-list
111478148|NCT02128230|Lenograstim|lenograstim|mesh-list
111478149|NCT02128230|BB 1101|bb 1101|mesh-list
111478150|NCT02128230|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111478151|NCT02128230|Immunologic Factors|immunologic factors|mesh-ancestor
111478152|NCT02128230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111478153|NCT02128230|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111478154|NCT02128230|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111478155|NCT02128230|Alkylating Agents|alkylating agents|mesh-ancestor
111478156|NCT02128230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111478157|NCT02128230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111478158|NCT02128230|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111478159|NCT02128230|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111478160|NCT02128230|Antiemetics|antiemetics|mesh-ancestor
111478161|NCT02128230|Autonomic Agents|autonomic agents|mesh-ancestor
111478162|NCT02128230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111478163|NCT02128230|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111478164|NCT02128230|Glucocorticoids|glucocorticoids|mesh-ancestor
111478165|NCT02128230|Hormones|hormones|mesh-ancestor
111478166|NCT02128230|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111478167|NCT02128230|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111478168|NCT02128230|Protease Inhibitors|protease inhibitors|mesh-ancestor
111478169|NCT02128230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111478170|NCT02128230|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111478171|NCT02128230|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111478172|NCT02128230|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111478173|NCT02128230|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111478174|NCT02128230|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111478175|NCT02128230|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111478176|NCT02128230|Growth Substances|growth substances|mesh-ancestor
111478177|NCT02128230|Growth Inhibitors|growth inhibitors|mesh-ancestor
111478178|NCT02128230|Leprostatic Agents|leprostatic agents|mesh-ancestor
111478179|NCT02128230|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111478180|NCT02128230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111478181|NCT02128230|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111478182|NCT03416244|Nivolumab|nivolumab|mesh-list
111478183|NCT03416244|Ipilimumab|ipilimumab|mesh-list
111478184|NCT03416244|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111478185|NCT03416244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111478186|NCT03416244|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111478187|NCT03416244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111478188|NCT05560620|Caffeine|caffeine|mesh-list
111478189|NCT05560620|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111478190|NCT05560620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111478191|NCT05560620|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111478192|NCT05560620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111478193|NCT05560620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111478194|NCT05560620|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
111478195|NCT05560620|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111478196|NCT05560620|Purinergic Agents|purinergic agents|mesh-ancestor
111478197|NCT05560620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111478198|NCT04388124|Bosentan|bosentan|mesh-list
111478199|NCT04388124|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111478200|NCT04388124|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
111478201|NCT04388124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111478202|NCT03172416|Oxaliplatin|oxaliplatin|mesh-list
111478203|NCT03172416|Nivolumab|nivolumab|mesh-list
111478204|NCT03172416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111478205|NCT03172416|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111478206|NCT03172416|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111478207|NCT03172416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111478208|NCT05559996|Hyaluronic Acid|hyaluronic acid|mesh-list
111478209|NCT05559996|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111478210|NCT05559996|Immunologic Factors|immunologic factors|mesh-ancestor
111478211|NCT05559996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111478212|NCT05559996|Viscosupplements|viscosupplements|mesh-ancestor
111478213|NCT05559996|Protective Agents|protective agents|mesh-ancestor
111478214|NCT02812212|Diuretics|diuretics|mesh-list
111478215|NCT02812212|Natriuretic Agents|natriuretic agents|mesh-ancestor
111478216|NCT02812212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111478217|NCT05559450|Blinatumomab|blinatumomab|mesh-list
111478218|NCT05559450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111478219|NCT00564954|Methylphenidate|methylphenidate|mesh-list
111478220|NCT00564954|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
111478221|NCT00564954|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111478222|NCT00564954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111478223|NCT00564954|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111478224|NCT00564954|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111478225|NCT00564954|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111478226|NCT00564954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111478227|NCT00564954|Dopamine Agents|dopamine agents|mesh-ancestor
111478228|NCT00564954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111478229|NCT00565266|Beclomethasone|beclomethasone|mesh-list
111478230|NCT00565266|Bromides|bromides|mesh-list
111478231|NCT00565266|Tiotropium Bromide|tiotropium bromide|mesh-list
111478232|NCT00565266|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
111478233|NCT00565266|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111478234|NCT00565266|Autonomic Agents|autonomic agents|mesh-ancestor
111478235|NCT00565266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111478236|NCT00565266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111478237|NCT00565266|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111478238|NCT00565266|Respiratory System Agents|respiratory system agents|mesh-ancestor
111478239|NCT00565266|Parasympatholytics|parasympatholytics|mesh-ancestor
111478240|NCT00565266|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111478241|NCT00565266|Cholinergic Agents|cholinergic agents|mesh-ancestor
111478242|NCT00565266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111478243|NCT00565266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110447033|NCT02759224|Lafutidine|lafutidine|mesh-list
111478244|NCT00565266|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111478245|NCT00565266|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111478246|NCT00565266|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111478247|NCT00565266|Adrenergic Agents|adrenergic agents|mesh-ancestor
111478248|NCT00565266|Anticonvulsants|anticonvulsants|mesh-ancestor
111478249|NCT00565266|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111478250|NCT00565266|Glucocorticoids|glucocorticoids|mesh-ancestor
111478251|NCT00565266|Hormones|hormones|mesh-ancestor
111478252|NCT00565266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111478253|NCT00568386|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111478254|NCT00568386|Lubricant Eye Drops|lubricant eye drops|mesh-list
111478255|NCT00568386|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111478256|NCT01797978|Methylene Blue|methylene blue|mesh-list
111478257|NCT01797978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111478258|NCT01797978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111478259|NCT05363202|Fluticasone|fluticasone|mesh-list
111478260|NCT05363202|Xhance|xhance|mesh-list
111478261|NCT05363202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111478262|NCT05363202|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111478263|NCT05363202|Autonomic Agents|autonomic agents|mesh-ancestor
111478264|NCT05363202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111478265|NCT05363202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111478266|NCT05363202|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111478267|NCT05363202|Respiratory System Agents|respiratory system agents|mesh-ancestor
111478268|NCT05363202|Dermatologic Agents|dermatologic agents|mesh-ancestor
111478269|NCT05363202|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111478270|NCT05461092|Morphine|morphine|mesh-list
111478271|NCT05461092|Analgesics, Opioid|analgesics, opioid|mesh-list
111478272|NCT05461092|Bupivacaine|bupivacaine|mesh-list
111478273|NCT05461092|Anesthetics, Local|anesthetics, local|mesh-ancestor
111478274|NCT05461092|Anesthetics|anesthetics|mesh-ancestor
111478275|NCT05461092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111478276|NCT05461092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111478277|NCT05461092|Sensory System Agents|sensory system agents|mesh-ancestor
111478278|NCT05461092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111478279|NCT05461092|Narcotics|narcotics|mesh-ancestor
111478280|NCT05461092|Analgesics|analgesics|mesh-ancestor
111478281|NCT02129478|Olanzapine|olanzapine|mesh-list
111478282|NCT02129478|Antiemetics|antiemetics|mesh-ancestor
111478283|NCT02129478|Autonomic Agents|autonomic agents|mesh-ancestor
111478284|NCT02129478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111478285|NCT02129478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111478286|NCT02129478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111478287|NCT02129478|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111478288|NCT02129478|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111478289|NCT02129478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111478290|NCT02129478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111478291|NCT02129478|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110447055|NCT04586920|Itraconazole|itraconazole|mesh-list
111478292|NCT02129478|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111478293|NCT02129478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111478294|NCT02129478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111478295|NCT02129478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111478296|NCT02129478|Serotonin Agents|serotonin agents|mesh-ancestor
111478297|NCT02129556|Pembrolizumab|pembrolizumab|mesh-list
111478298|NCT02129556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111478299|NCT02129556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111478300|NCT02129556|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111478301|NCT02129556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111478302|NCT05362500|Tranylcypromine|tranylcypromine|mesh-list
111478303|NCT05362500|Glycolic acid|glycolic acid|mesh-list
111478304|NCT05362500|Tranexamic Acid|tranexamic acid|mesh-list
111478305|NCT05362500|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111478306|NCT05362500|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111478307|NCT05362500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111478308|NCT05362500|Hemostatics|hemostatics|mesh-ancestor
111478309|NCT05362500|Coagulants|coagulants|mesh-ancestor
111478310|NCT05362500|Keratolytic Agents|keratolytic agents|mesh-ancestor
111478311|NCT05362500|Dermatologic Agents|dermatologic agents|mesh-ancestor
111478312|NCT05362500|Antidepressive Agents|antidepressive agents|mesh-ancestor
111478313|NCT05362500|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111478314|NCT05362500|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
111478315|NCT05362500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111478316|NCT05362500|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111478317|NCT05362500|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111478318|NCT05362500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111478319|NCT05362500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111478320|NCT05161806|Aflibercept|aflibercept|mesh-list
111478321|NCT05161806|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111478322|NCT05161806|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111478323|NCT05161806|Growth Substances|growth substances|mesh-ancestor
111478324|NCT05161806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111478325|NCT05161806|Growth Inhibitors|growth inhibitors|mesh-ancestor
111478326|NCT05161806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111478327|NCT05362188|Niacinamide|niacinamide|mesh-list
111478328|NCT05362188|Niacin|niacin|mesh-list
111478329|NCT05362188|Nicotinic Acids|nicotinic acids|mesh-list
111478330|NCT05362188|Vitamin B Complex|vitamin b complex|mesh-ancestor
111478331|NCT05362188|Vitamins|vitamins|mesh-ancestor
111478332|NCT05362188|Micronutrients|micronutrients|mesh-ancestor
111478333|NCT05362188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111202516|NCT02883049|Hormones|hormones|mesh-ancestor
111478334|NCT05362188|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111478335|NCT05362188|Antimetabolites|antimetabolites|mesh-ancestor
111478336|NCT05362188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111478337|NCT05362188|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111478338|NCT05362188|Vasodilator Agents|vasodilator agents|mesh-ancestor
111478339|NCT05353374|Fusidic Acid|fusidic acid|mesh-list
111478340|NCT05353374|Petrolatum|petrolatum|mesh-list
111478341|NCT05353374|Emollients|emollients|mesh-ancestor
111478342|NCT05353374|Dermatologic Agents|dermatologic agents|mesh-ancestor
111478343|NCT05353374|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111478344|NCT05353374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111478345|NCT05353374|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111478346|NCT05353374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111478347|NCT05353374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111478348|NCT05214222|Paclitaxel|paclitaxel|mesh-list
111478349|NCT05214222|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111478350|NCT05214222|Cisplatin|cisplatin|mesh-list
111478351|NCT05214222|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111478352|NCT05214222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111478353|NCT05214222|Tubulin Modulators|tubulin modulators|mesh-ancestor
111478354|NCT05214222|Antimitotic Agents|antimitotic agents|mesh-ancestor
110447082|NCT02758990|Vitamins|vitamins|mesh-list
111478355|NCT05214222|Mitosis Modulators|mitosis modulators|mesh-ancestor
111478356|NCT05214222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111478357|NCT05198232|Aluminum hydroxide, magnesium hydroxide, simethicone drug combination|aluminum hydroxide, magnesium hydroxide, simethicone drug combination|mesh-list
111478358|NCT05198232|TEMPO|tempo|mesh-list
111478359|NCT05198232|Antioxidants|antioxidants|mesh-ancestor
111478360|NCT05198232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111478361|NCT05198232|Protective Agents|protective agents|mesh-ancestor
111478362|NCT05198232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111478363|NCT05198232|Antacids|antacids|mesh-ancestor
111478364|NCT05198232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111478365|NCT04747236|Gemcitabine|gemcitabine|mesh-list
111478366|NCT04747236|Azacitidine|azacitidine|mesh-list
111478367|NCT04747236|Romidepsin|romidepsin|mesh-list
111478368|NCT04747236|Belinostat|belinostat|mesh-list
111478369|NCT04747236|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111478370|NCT04747236|Antimetabolites|antimetabolites|mesh-ancestor
111478371|NCT04747236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111478372|NCT04747236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111478373|NCT04747236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111478374|NCT04747236|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111478375|NCT04747236|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111478376|NCT01797666|Pioglitazone|pioglitazone|mesh-list
111478377|NCT01797666|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111478378|NCT01797666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111478379|NCT05017194|Emodepside|emodepside|mesh-list
111478380|NCT05017194|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111478381|NCT05017194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111478382|NCT04501380|Rifamycins|rifamycins|mesh-list
111478383|NCT04501380|Rifamycin SV|rifamycin sv|mesh-list
111478384|NCT04501380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111478385|NCT04501380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111478386|NCT04501380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111478387|NCT04465734|Sorafenib|sorafenib|mesh-list
111478388|NCT04465734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111478389|NCT04465734|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111478390|NCT04465734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111478391|NCT04465734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111478392|NCT03856632|Liraglutide|liraglutide|mesh-list
111478393|NCT03856632|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
111478394|NCT03856632|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111478395|NCT03856632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111478396|NCT03856632|Incretins|incretins|mesh-ancestor
111478397|NCT03856632|Hormones|hormones|mesh-ancestor
111478398|NCT03856632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111478399|NCT04286178|Coenzyme Q10|coenzyme q10|mesh-list
111478400|NCT04286178|Micronutrients|micronutrients|mesh-ancestor
111478401|NCT04286178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111478402|NCT04286178|Vitamins|vitamins|mesh-ancestor
111478403|NCT04655976|Docetaxel|docetaxel|mesh-list
111478404|NCT04655976|Dostarlimab|dostarlimab|mesh-list
111478405|NCT04655976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111478406|NCT04655976|Tubulin Modulators|tubulin modulators|mesh-ancestor
111478407|NCT04655976|Antimitotic Agents|antimitotic agents|mesh-ancestor
111478408|NCT04655976|Mitosis Modulators|mitosis modulators|mesh-ancestor
111478409|NCT04655976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111478410|NCT01798602|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111478411|NCT01798602|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111478412|NCT01798602|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111478413|NCT01798602|Antimetabolites|antimetabolites|mesh-ancestor
111478414|NCT01798602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111478415|NCT01798602|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111478416|NCT01798602|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110458446|NCT04156984|Golimumab|golimumab|mesh-list
111478417|NCT01798602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111478418|NCT02783430|Ketamine|ketamine|mesh-list
111478419|NCT02783430|Milnacipran|milnacipran|mesh-list
111478420|NCT02783430|Levomilnacipran|levomilnacipran|mesh-list
111478421|NCT02783430|Analgesics|analgesics|mesh-ancestor
111478422|NCT02783430|Sensory System Agents|sensory system agents|mesh-ancestor
111478423|NCT02783430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111478424|NCT02783430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111478425|NCT02783430|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111478426|NCT02783430|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111478427|NCT02783430|Anesthetics, General|anesthetics, general|mesh-ancestor
111478428|NCT02783430|Anesthetics|anesthetics|mesh-ancestor
111478429|NCT02783430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111478430|NCT02783430|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111478431|NCT02783430|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111478432|NCT02783430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111478433|NCT02783430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111478434|NCT02783430|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111478435|NCT02783430|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111478436|NCT02783430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111478437|NCT02783430|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111478438|NCT02783430|Antidepressive Agents|antidepressive agents|mesh-ancestor
111478439|NCT02783430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111478440|NCT03642366|Tadalafil|tadalafil|mesh-list
111478441|NCT03642366|Vasodilator Agents|vasodilator agents|mesh-ancestor
111478442|NCT03642366|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111478443|NCT03642366|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111478444|NCT03642366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111478445|NCT03642366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111478446|NCT03642366|Urological Agents|urological agents|mesh-ancestor
111478447|NCT00604968|Doxorubicin|doxorubicin|mesh-list
111478448|NCT00604968|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111478449|NCT00604968|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111478450|NCT00604968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111478451|NCT00604968|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111478452|NCT00604968|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111478453|NCT00604968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111478454|NCT00604968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111478455|NCT00605202|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
111478456|NCT00605202|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111478457|NCT00605202|Diuretics|diuretics|mesh-ancestor
111478458|NCT00605202|Natriuretic Agents|natriuretic agents|mesh-ancestor
111478459|NCT00605202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110447109|NCT02758990|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111478460|NCT00605202|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
111478461|NCT00605202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111478462|NCT00605202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111478463|NCT03548454|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
111478464|NCT03548454|Desipramine|desipramine|mesh-list
111478465|NCT03548454|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111478466|NCT03548454|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111478467|NCT03548454|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111478468|NCT03548454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111478469|NCT03548454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111478470|NCT03548454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111478471|NCT03548454|Analgesics|analgesics|mesh-ancestor
111478472|NCT03548454|Sensory System Agents|sensory system agents|mesh-ancestor
111478473|NCT03548454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111478474|NCT03548454|Antidepressive Agents|antidepressive agents|mesh-ancestor
111478475|NCT03548454|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111478476|NCT03548454|Dopamine Agents|dopamine agents|mesh-ancestor
111478477|NCT03548454|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
111478478|NCT03548454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111478479|NCT03548454|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111478480|NCT03548454|Adrenergic Agents|adrenergic agents|mesh-ancestor
111478481|NCT00605904|Acamprosate|acamprosate|mesh-list
111478482|NCT00605904|Yohimbine|yohimbine|mesh-list
111478483|NCT00605904|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111478484|NCT00605904|Mydriatics|mydriatics|mesh-ancestor
111478485|NCT00605904|Autonomic Agents|autonomic agents|mesh-ancestor
111478486|NCT00605904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111478487|NCT00605904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111478488|NCT00605904|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
111478489|NCT00605904|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111478490|NCT00605904|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111478491|NCT00605904|Adrenergic Agents|adrenergic agents|mesh-ancestor
111478492|NCT00605904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111478493|NCT00605904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111478494|NCT00605904|Urological Agents|urological agents|mesh-ancestor
111478495|NCT01798914|Insulin|insulin|mesh-list
111478496|NCT01798914|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111478497|NCT01798914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111478498|NCT05194488|Botulinum Toxins|botulinum toxins|mesh-list
111478499|NCT05194488|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111478500|NCT05194488|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111478501|NCT05194488|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111478502|NCT05194488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111478503|NCT05194488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111478504|NCT05194488|Cholinergic Agents|cholinergic agents|mesh-ancestor
111478505|NCT05194488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111478506|NCT05194488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111478507|NCT05194488|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111478508|NCT05194488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111478509|NCT05175768|Niacinamide|niacinamide|mesh-list
111478510|NCT05175768|Niacin|niacin|mesh-list
111478511|NCT05175768|Nicotinic Acids|nicotinic acids|mesh-list
111478512|NCT05175768|Vitamin B Complex|vitamin b complex|mesh-ancestor
111478513|NCT05175768|Vitamins|vitamins|mesh-ancestor
111478514|NCT05175768|Micronutrients|micronutrients|mesh-ancestor
111478515|NCT05175768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111478516|NCT05175768|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111478517|NCT05175768|Antimetabolites|antimetabolites|mesh-ancestor
111478518|NCT05175768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110447148|NCT02752828|Insulin|insulin|mesh-list
111478519|NCT05175768|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111478520|NCT05175768|Vasodilator Agents|vasodilator agents|mesh-ancestor
111478521|NCT05097846|Amoxicillin|amoxicillin|mesh-list
111478522|NCT05097846|Doxycycline|doxycycline|mesh-list
111478523|NCT05097846|Furazolidone|furazolidone|mesh-list
111478524|NCT05097846|Esomeprazole|esomeprazole|mesh-list
111478525|NCT05097846|Bismuth|bismuth|mesh-list
111478526|NCT05097846|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111478527|NCT05097846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111478528|NCT05097846|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111478529|NCT05097846|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111478530|NCT05097846|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111478531|NCT05097846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111478532|NCT05097846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111478533|NCT05097846|Antimalarials|antimalarials|mesh-ancestor
111478534|NCT05097846|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111478535|NCT05097846|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111478536|NCT05097846|Antacids|antacids|mesh-ancestor
111478537|NCT05097846|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111478538|NCT05097846|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111478539|NCT05097846|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
111478540|NCT05097846|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
111478541|NCT00608634|Perillyl alcohol|perillyl alcohol|mesh-list
111478542|NCT00608634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111478543|NCT00608634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111478544|NCT00608634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111478545|NCT02897700|Cyclophosphamide|cyclophosphamide|mesh-list
111478546|NCT02897700|Doxorubicin|doxorubicin|mesh-list
111478547|NCT02897700|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111478548|NCT02897700|Fluorouracil|fluorouracil|mesh-list
111478549|NCT02897700|Methotrexate|methotrexate|mesh-list
111478550|NCT02897700|Epirubicin|epirubicin|mesh-list
111478551|NCT02897700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111478552|NCT02897700|Immunologic Factors|immunologic factors|mesh-ancestor
111478553|NCT02897700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111478554|NCT02897700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111478555|NCT02897700|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111478556|NCT02897700|Alkylating Agents|alkylating agents|mesh-ancestor
111478557|NCT02897700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111478558|NCT02897700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111478559|NCT02897700|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111478560|NCT02897700|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111478561|NCT02897700|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111478562|NCT02897700|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111478563|NCT02897700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111202746|NCT02598661|Imetelstat|imetelstat|mesh-list
111478564|NCT02897700|Antimetabolites|antimetabolites|mesh-ancestor
111478565|NCT02897700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111478566|NCT02897700|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111478567|NCT02897700|Abortifacient Agents|abortifacient agents|mesh-ancestor
111478568|NCT02897700|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111478569|NCT02897700|Dermatologic Agents|dermatologic agents|mesh-ancestor
111478570|NCT02897700|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111478571|NCT02897700|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111478572|NCT02889666|Cisplatin|cisplatin|mesh-list
111478573|NCT02889666|Carboplatin|carboplatin|mesh-list
111478574|NCT02889666|Gemcitabine|gemcitabine|mesh-list
111478575|NCT02889666|Docetaxel|docetaxel|mesh-list
111478576|NCT02889666|Oxaliplatin|oxaliplatin|mesh-list
111478577|NCT02889666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111478578|NCT02889666|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111478579|NCT02889666|Antimetabolites|antimetabolites|mesh-ancestor
111478580|NCT02889666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111478581|NCT02889666|Tubulin Modulators|tubulin modulators|mesh-ancestor
111478582|NCT02889666|Antimitotic Agents|antimitotic agents|mesh-ancestor
111478583|NCT02889666|Mitosis Modulators|mitosis modulators|mesh-ancestor
111478584|NCT00609804|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111478585|NCT00609804|Sorafenib|sorafenib|mesh-list
111478586|NCT00609804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111478587|NCT00609804|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111478588|NCT00609804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111478589|NCT00609804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111478590|NCT00610428|Prochlorperazine|prochlorperazine|mesh-list
111478591|NCT00610428|Antiemetics|antiemetics|mesh-ancestor
111478592|NCT00610428|Autonomic Agents|autonomic agents|mesh-ancestor
111478593|NCT00610428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111478594|NCT00610428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111478595|NCT00610428|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111478596|NCT00610428|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111478597|NCT00610428|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111478598|NCT00610428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111478599|NCT00610428|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111478600|NCT00610428|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111478601|NCT00610428|Dopamine Agents|dopamine agents|mesh-ancestor
111478602|NCT00610428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111478603|NCT00610428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111478604|NCT02446236|Rituximab|rituximab|mesh-list
111478605|NCT02446236|Lenalidomide|lenalidomide|mesh-list
111478606|NCT02446236|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111478607|NCT02446236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111478608|NCT02446236|Immunologic Factors|immunologic factors|mesh-ancestor
111478609|NCT02446236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111478610|NCT02446236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111478611|NCT02446236|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111478612|NCT02446236|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111478613|NCT02446236|Growth Substances|growth substances|mesh-ancestor
111478614|NCT02446236|Growth Inhibitors|growth inhibitors|mesh-ancestor
111478615|NCT00610740|Gemcitabine|gemcitabine|mesh-list
111478616|NCT00610740|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111478617|NCT00610740|Antimetabolites|antimetabolites|mesh-ancestor
111478618|NCT00610740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111478619|NCT00610740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111478620|NCT00611442|Lubiprostone|lubiprostone|mesh-list
111478621|NCT00611442|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
111478622|NCT00611442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110447160|NCT02753062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111478623|NCT00611442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111478624|NCT02136420|Promethazine|promethazine|mesh-list
111478625|NCT02136420|Diphenhydramine|diphenhydramine|mesh-list
111478626|NCT02136420|Antipruritics|antipruritics|mesh-ancestor
111478627|NCT02136420|Dermatologic Agents|dermatologic agents|mesh-ancestor
111478628|NCT02136420|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111478629|NCT02136420|Histamine Antagonists|histamine antagonists|mesh-ancestor
111478630|NCT02136420|Histamine Agents|histamine agents|mesh-ancestor
111478631|NCT02136420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111478632|NCT02136420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111478633|NCT02136420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111478634|NCT02136420|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111478635|NCT02136420|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111478636|NCT02136420|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111478637|NCT02136420|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111478638|NCT02136420|Anesthetics, Local|anesthetics, local|mesh-ancestor
111478639|NCT02136420|Anesthetics|anesthetics|mesh-ancestor
111478640|NCT02136420|Sensory System Agents|sensory system agents|mesh-ancestor
111478641|NCT02136420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111478642|NCT02136420|Antiemetics|antiemetics|mesh-ancestor
111478643|NCT02136420|Autonomic Agents|autonomic agents|mesh-ancestor
111478644|NCT02136420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111478645|NCT02136498|Varenicline|varenicline|mesh-list
111478646|NCT02136498|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111478647|NCT02136498|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111478648|NCT02136498|Cholinergic Agents|cholinergic agents|mesh-ancestor
111478649|NCT02136498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111478650|NCT02136498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111478651|NCT02136498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111478652|NCT00612222|Aldesleukin|aldesleukin|mesh-list
111478653|NCT00612222|Cyclophosphamide|cyclophosphamide|mesh-list
111478654|NCT00612222|Fludarabine|fludarabine|mesh-list
111478655|NCT00612222|Fludarabine phosphate|fludarabine phosphate|mesh-list
111478656|NCT00612222|Interleukin-2|interleukin-2|mesh-list
111478657|NCT00612222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111478658|NCT00612222|Immunologic Factors|immunologic factors|mesh-ancestor
111478659|NCT00612222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111478660|NCT00612222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111478661|NCT00612222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111478662|NCT00612222|Alkylating Agents|alkylating agents|mesh-ancestor
111478663|NCT00612222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111478664|NCT00612222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111478665|NCT00612222|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111478666|NCT00612222|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111478667|NCT00612222|Antimetabolites|antimetabolites|mesh-ancestor
111478668|NCT00612222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111478669|NCT00612222|Analgesics|analgesics|mesh-ancestor
111478670|NCT00612222|Sensory System Agents|sensory system agents|mesh-ancestor
111478671|NCT00612222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111478672|NCT00612222|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111478673|NCT00612222|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111478674|NCT00612222|Antiviral Agents|antiviral agents|mesh-ancestor
111478675|NCT00612222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111478676|NCT01711242|Capecitabine|capecitabine|mesh-list
111478677|NCT01711242|Oxaliplatin|oxaliplatin|mesh-list
111478678|NCT01711242|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111478679|NCT01711242|Antimetabolites|antimetabolites|mesh-ancestor
111478680|NCT01711242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111478681|NCT01711242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111478682|NCT04405908|Aluminum Hydroxide|aluminum hydroxide|mesh-list
111478683|NCT04405908|Aluminum sulfate|aluminum sulfate|mesh-list
111478684|NCT04405908|1018 oligonucleotide|1018 oligonucleotide|mesh-list
111478685|NCT04405908|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111478686|NCT04405908|Immunologic Factors|immunologic factors|mesh-ancestor
111478687|NCT04405908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111478688|NCT04405908|Antacids|antacids|mesh-ancestor
111478689|NCT04405908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111478690|NCT04405908|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111478691|NCT04331496|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111478692|NCT04304274|Morphine|morphine|mesh-list
111478693|NCT04304274|Ropivacaine|ropivacaine|mesh-list
111478694|NCT04304274|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111478695|NCT04304274|Narcotics|narcotics|mesh-ancestor
111478696|NCT04304274|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111478697|NCT04304274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111478698|NCT04304274|Analgesics|analgesics|mesh-ancestor
111478699|NCT04304274|Sensory System Agents|sensory system agents|mesh-ancestor
111478700|NCT04304274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111478701|NCT04304274|Anesthetics, Local|anesthetics, local|mesh-ancestor
111478702|NCT04304274|Anesthetics|anesthetics|mesh-ancestor
111478703|NCT02132832|Buspirone|buspirone|mesh-list
111478704|NCT02132832|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111478705|NCT02132832|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111478706|NCT02132832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111478707|NCT02132832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111478708|NCT02132832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111478709|NCT02132832|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111478710|NCT02132832|Serotonin Agents|serotonin agents|mesh-ancestor
111478711|NCT02132832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111478712|NCT02132832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111478713|NCT00614406|Celecoxib|celecoxib|mesh-list
111202892|NCT02194738|Nivolumab|nivolumab|mesh-list
111478714|NCT00614406|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111478715|NCT00614406|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111478716|NCT00614406|Analgesics|analgesics|mesh-ancestor
111478717|NCT00614406|Sensory System Agents|sensory system agents|mesh-ancestor
111478718|NCT00614406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111478719|NCT00614406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111478720|NCT00614406|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111478721|NCT00614406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111478722|NCT00614406|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111478723|NCT00614406|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111478724|NCT00614406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111478725|NCT00614406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111478726|NCT00614484|Paclitaxel|paclitaxel|mesh-list
111478727|NCT00614484|Carboplatin|carboplatin|mesh-list
111478728|NCT00614484|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111478729|NCT00614484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111478730|NCT00614484|Tubulin Modulators|tubulin modulators|mesh-ancestor
111478731|NCT00614484|Antimitotic Agents|antimitotic agents|mesh-ancestor
111478732|NCT00614484|Mitosis Modulators|mitosis modulators|mesh-ancestor
111478733|NCT00614484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111478734|NCT04159974|Durvalumab|durvalumab|mesh-list
111478735|NCT04159974|Tremelimumab|tremelimumab|mesh-list
111478736|NCT04159974|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111478737|NCT04159974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111478738|NCT04142502|Dexmedetomidine|dexmedetomidine|mesh-list
111478739|NCT04142502|Propofol|propofol|mesh-list
111478740|NCT04142502|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111478741|NCT04142502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111478742|NCT04142502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111478743|NCT04142502|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111478744|NCT04142502|Anesthetics, General|anesthetics, general|mesh-ancestor
111478745|NCT04142502|Anesthetics|anesthetics|mesh-ancestor
111478746|NCT04142502|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111478747|NCT04142502|Analgesics|analgesics|mesh-ancestor
111478748|NCT04142502|Sensory System Agents|sensory system agents|mesh-ancestor
111478749|NCT04142502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111478750|NCT04142502|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111478751|NCT04142502|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111478752|NCT04142502|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111478753|NCT04142502|Adrenergic Agents|adrenergic agents|mesh-ancestor
111478754|NCT04142502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111478755|NCT04142502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111478756|NCT00569010|Cytarabine|cytarabine|mesh-list
111478757|NCT00569010|Azacitidine|azacitidine|mesh-list
111478758|NCT00569010|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111478759|NCT00569010|Antimetabolites|antimetabolites|mesh-ancestor
111478760|NCT00569010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111478761|NCT00569010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111478762|NCT00569010|Antiviral Agents|antiviral agents|mesh-ancestor
111478763|NCT00569010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111478764|NCT00569010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111478765|NCT00569010|Immunologic Factors|immunologic factors|mesh-ancestor
111478766|NCT00569010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111478767|NCT00569010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111478768|NCT00616122|Cyclophosphamide|cyclophosphamide|mesh-list
111478769|NCT00616122|Methotrexate|methotrexate|mesh-list
111478770|NCT00616122|Sunitinib|sunitinib|mesh-list
111478771|NCT00616122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111478772|NCT00616122|Immunologic Factors|immunologic factors|mesh-ancestor
111478773|NCT00616122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111478774|NCT00616122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111478775|NCT00616122|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111478776|NCT00616122|Alkylating Agents|alkylating agents|mesh-ancestor
111478777|NCT00616122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111478778|NCT00616122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111478779|NCT00616122|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111478780|NCT00616122|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111478781|NCT00616122|Abortifacient Agents|abortifacient agents|mesh-ancestor
111478782|NCT00616122|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111478783|NCT00616122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111478784|NCT00616122|Antimetabolites|antimetabolites|mesh-ancestor
111478785|NCT00616122|Dermatologic Agents|dermatologic agents|mesh-ancestor
111478786|NCT00616122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111478787|NCT00616122|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111478788|NCT00616122|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111478789|NCT00616122|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111478790|NCT00616122|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111478791|NCT00616122|Growth Substances|growth substances|mesh-ancestor
111478792|NCT00616122|Growth Inhibitors|growth inhibitors|mesh-ancestor
111478793|NCT00616122|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111478794|NCT00617058|Metformin|metformin|mesh-list
111478795|NCT00617058|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111478796|NCT00617058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111478797|NCT00618540|Fludarabine|fludarabine|mesh-list
111478798|NCT00618540|Fludarabine phosphate|fludarabine phosphate|mesh-list
111478799|NCT00618540|Melphalan|melphalan|mesh-list
111478800|NCT00618540|Alemtuzumab|alemtuzumab|mesh-list
111478801|NCT00618540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111478802|NCT00618540|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111478803|NCT00618540|Antimetabolites|antimetabolites|mesh-ancestor
111478804|NCT00618540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111478805|NCT00618540|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111478806|NCT00618540|Immunologic Factors|immunologic factors|mesh-ancestor
111478807|NCT00618540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111478808|NCT00618540|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111478809|NCT00618540|Alkylating Agents|alkylating agents|mesh-ancestor
111478810|NCT00618540|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111478811|NCT00618540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111478812|NCT00570960|Dextrans|dextrans|mesh-list
111478813|NCT00570960|Anticoagulants|anticoagulants|mesh-ancestor
111478814|NCT00570960|Plasma Substitutes|plasma substitutes|mesh-ancestor
111478815|NCT00570960|Blood Substitutes|blood substitutes|mesh-ancestor
111478816|NCT00571428|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111478817|NCT00571428|Formoterol Fumarate|formoterol fumarate|mesh-list
111478818|NCT00571428|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111478819|NCT00571428|Autonomic Agents|autonomic agents|mesh-ancestor
111478820|NCT00571428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111478821|NCT00571428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111478822|NCT00571428|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111478823|NCT00571428|Respiratory System Agents|respiratory system agents|mesh-ancestor
111478824|NCT00571428|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111478825|NCT00571428|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111478826|NCT00571428|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111478827|NCT00571428|Adrenergic Agents|adrenergic agents|mesh-ancestor
111478828|NCT00571428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111478829|NCT00571428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111478830|NCT00571974|Aminolevulinic Acid|aminolevulinic acid|mesh-list
111478831|NCT00571974|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111478832|NCT00571974|Dermatologic Agents|dermatologic agents|mesh-ancestor
111478833|NCT00574236|Doxorubicin|doxorubicin|mesh-list
111478834|NCT00574236|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111478835|NCT00574236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111478836|NCT00574236|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111478837|NCT00574236|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111478838|NCT00574236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111478839|NCT00574236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111478840|NCT00574548|Vaccines|vaccines|mesh-list
111478841|NCT00574548|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
111478842|NCT00574548|Immunologic Factors|immunologic factors|mesh-ancestor
111478843|NCT00574548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111478844|NCT01168219|Methotrexate|methotrexate|mesh-list
111478845|NCT01168219|Fludarabine phosphate|fludarabine phosphate|mesh-list
111478846|NCT01168219|Azacitidine|azacitidine|mesh-list
111478847|NCT01168219|Fludarabine|fludarabine|mesh-list
111478848|NCT01168219|Busulfan|busulfan|mesh-list
111478849|NCT01168219|Tacrolimus|tacrolimus|mesh-list
111478850|NCT01168219|Antilymphocyte Serum|antilymphocyte serum|mesh-list
111478851|NCT01168219|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111478852|NCT01168219|Abortifacient Agents|abortifacient agents|mesh-ancestor
111478853|NCT01168219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111478854|NCT01168219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111478855|NCT01168219|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111478856|NCT01168219|Antimetabolites|antimetabolites|mesh-ancestor
111478857|NCT01168219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111478858|NCT01168219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111478859|NCT01168219|Dermatologic Agents|dermatologic agents|mesh-ancestor
111478860|NCT01168219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111478861|NCT01168219|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111478862|NCT01168219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111478863|NCT01168219|Immunologic Factors|immunologic factors|mesh-ancestor
111478864|NCT01168219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111478865|NCT01168219|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111478866|NCT01168219|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111478868|NCT01168219|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111478869|NCT01168219|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111478870|NCT01115803|Everolimus|everolimus|mesh-list
111478871|NCT01115803|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111478872|NCT01115803|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111478873|NCT01115803|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111478874|NCT01115803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111478875|NCT01115803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111478876|NCT01115803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111478877|NCT01115803|Immunologic Factors|immunologic factors|mesh-ancestor
111478878|NCT01115803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111478879|NCT01115803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111478880|NCT01115569|Hydrocodone|hydrocodone|mesh-list
111478881|NCT01115569|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111478882|NCT01115569|Narcotics|narcotics|mesh-ancestor
111478883|NCT01115569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111478884|NCT01115569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111478885|NCT01115569|Analgesics|analgesics|mesh-ancestor
111478886|NCT01115569|Sensory System Agents|sensory system agents|mesh-ancestor
111478887|NCT01115569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111478888|NCT01115569|Antitussive Agents|antitussive agents|mesh-ancestor
111478889|NCT01115569|Respiratory System Agents|respiratory system agents|mesh-ancestor
110447273|NCT02753140|Docetaxel|docetaxel|mesh-list
111478890|NCT01107886|Saxagliptin|saxagliptin|mesh-list
111478891|NCT01107886|Incretins|incretins|mesh-ancestor
111478892|NCT01107886|Hormones|hormones|mesh-ancestor
111478893|NCT01107886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111478894|NCT01107886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111478895|NCT01107886|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111478896|NCT01107886|Protease Inhibitors|protease inhibitors|mesh-ancestor
111478897|NCT01107886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111478898|NCT01107886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111478899|NCT01107886|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111478900|NCT01107457|Ixekizumab|ixekizumab|mesh-list
111478901|NCT01107457|Dermatologic Agents|dermatologic agents|mesh-ancestor
111478902|NCT05767008|Sunscreening Agents|sunscreening agents|mesh-list
111478903|NCT05767008|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111478904|NCT05767008|Protective Agents|protective agents|mesh-ancestor
111478905|NCT05767008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111478906|NCT05767008|Dermatologic Agents|dermatologic agents|mesh-ancestor
111478907|NCT05766605|Leucovorin|leucovorin|mesh-list
111478908|NCT05766605|Doxorubicin|doxorubicin|mesh-list
111478909|NCT05766605|Fluorouracil|fluorouracil|mesh-list
111478910|NCT05766605|Oxaliplatin|oxaliplatin|mesh-list
111478911|NCT05766605|Raltitrexed|raltitrexed|mesh-list
111478912|NCT05766605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111478913|NCT05766605|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111478914|NCT05766605|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111478915|NCT05766605|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111478916|NCT05766605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111478917|NCT05766605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111478918|NCT05766605|Antimetabolites|antimetabolites|mesh-ancestor
111478919|NCT05766605|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111478920|NCT05766605|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111478921|NCT05766605|Immunologic Factors|immunologic factors|mesh-ancestor
111478922|NCT05766605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111478923|NCT05766605|Antidotes|antidotes|mesh-ancestor
111478924|NCT05766605|Protective Agents|protective agents|mesh-ancestor
111478925|NCT05766605|Vitamin B Complex|vitamin b complex|mesh-ancestor
111478926|NCT05766605|Vitamins|vitamins|mesh-ancestor
111478927|NCT05766605|Micronutrients|micronutrients|mesh-ancestor
111478928|NCT05766605|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111478929|NCT05766436|Dexmedetomidine|dexmedetomidine|mesh-list
111478930|NCT05766436|Melatonin|melatonin|mesh-list
111478931|NCT05766436|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111478932|NCT05766436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111478933|NCT05766436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111478934|NCT05766436|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111478935|NCT05766436|Analgesics|analgesics|mesh-ancestor
111478936|NCT05766436|Sensory System Agents|sensory system agents|mesh-ancestor
111478937|NCT05766436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111478938|NCT05766436|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111478939|NCT05766436|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111478940|NCT05766436|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111478941|NCT05766436|Adrenergic Agents|adrenergic agents|mesh-ancestor
111478942|NCT05766436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111478943|NCT05766436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111478944|NCT05766436|Antioxidants|antioxidants|mesh-ancestor
111478945|NCT05766436|Protective Agents|protective agents|mesh-ancestor
111478946|NCT05766397|Methoxyflurane|methoxyflurane|mesh-list
111478947|NCT05766397|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111478948|NCT05766397|Anesthetics, General|anesthetics, general|mesh-ancestor
111478949|NCT05766397|Anesthetics|anesthetics|mesh-ancestor
111478950|NCT05766397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111478951|NCT05766397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111478952|NCT05766384|Xenon|xenon|mesh-list
111478953|NCT05766384|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111478954|NCT05766384|Anesthetics, General|anesthetics, general|mesh-ancestor
111478955|NCT05766384|Anesthetics|anesthetics|mesh-ancestor
111478956|NCT05766384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111478957|NCT05766384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111478958|NCT05766267|Moxifloxacin|moxifloxacin|mesh-list
111478959|NCT05766267|Rifampin|rifampin|mesh-list
111478960|NCT05766267|Isoniazid|isoniazid|mesh-list
111478961|NCT05766267|Pyrazinamide|pyrazinamide|mesh-list
111478962|NCT05766267|Ethambutol|ethambutol|mesh-list
111478963|NCT05766267|Rifabutin|rifabutin|mesh-list
111478964|NCT05766267|Bedaquiline|bedaquiline|mesh-list
111478965|NCT05766267|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111478966|NCT05766267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111478967|NCT05766267|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111478968|NCT05766267|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111478969|NCT05766267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111478970|NCT05766267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111478971|NCT05766267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111478972|NCT05766267|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111478973|NCT05766267|Antitubercular Agents|antitubercular agents|mesh-ancestor
111478974|NCT05766267|Leprostatic Agents|leprostatic agents|mesh-ancestor
111478975|NCT05766267|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111478976|NCT05766267|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111478977|NCT05766267|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111478978|NCT05766267|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
111478979|NCT05766267|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
111478980|NCT05766267|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
111478981|NCT05766267|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111478982|NCT05766267|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
111478983|NCT05766267|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111478984|NCT05766267|Antimetabolites|antimetabolites|mesh-ancestor
111478985|NCT05766267|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111478986|NCT05766176|Antibodies|antibodies|mesh-list
111478987|NCT05766176|Immunoglobulins|immunoglobulins|mesh-list
111478988|NCT05766176|Immunologic Factors|immunologic factors|mesh-ancestor
111478989|NCT05766176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111478990|NCT05766124|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
111478991|NCT05766124|Plasminogen|plasminogen|mesh-list
111478992|NCT05766124|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111478993|NCT05766124|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111478994|NCT05766124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111478995|NCT05766085|Dexamethasone|dexamethasone|mesh-list
111478996|NCT05766085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111478997|NCT05766085|Antiemetics|antiemetics|mesh-ancestor
111478998|NCT05766085|Autonomic Agents|autonomic agents|mesh-ancestor
111478999|NCT05766085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111479000|NCT05766085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111479001|NCT05766085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111479002|NCT05766085|Glucocorticoids|glucocorticoids|mesh-ancestor
111479003|NCT05766085|Hormones|hormones|mesh-ancestor
111479004|NCT05766085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111479005|NCT05766085|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111479006|NCT05766085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111479007|NCT05765825|Carboplatin|carboplatin|mesh-list
111479008|NCT05765825|Etoposide|etoposide|mesh-list
111479009|NCT05765825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111479010|NCT05765825|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111479011|NCT05765825|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111479012|NCT05765825|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111479013|NCT05765825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111479014|NCT05765825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111479015|NCT05765747|Celecoxib|celecoxib|mesh-list
111479016|NCT05765747|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111479017|NCT05765747|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111479018|NCT05765747|Analgesics|analgesics|mesh-ancestor
111479019|NCT05765747|Sensory System Agents|sensory system agents|mesh-ancestor
111479020|NCT05765747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111479021|NCT05765747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111479022|NCT05765747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111479023|NCT05765747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111479024|NCT05765747|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111479025|NCT05765747|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111479026|NCT05765747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111479027|NCT05765747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111479028|NCT05765617|Calcitriol|calcitriol|mesh-list
111479029|NCT05765617|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111479030|NCT05765617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111479031|NCT05765617|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
111479032|NCT05765617|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111479033|NCT05765617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111479034|NCT05765617|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111479035|NCT05765617|Vitamins|vitamins|mesh-ancestor
111479036|NCT05765617|Micronutrients|micronutrients|mesh-ancestor
111479037|NCT05765617|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111479038|NCT05765500|Leuprolide|leuprolide|mesh-list
111479039|NCT05765500|Relugolix|relugolix|mesh-list
111479040|NCT05765500|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111479041|NCT05765500|Fertility Agents|fertility agents|mesh-ancestor
111479042|NCT05765500|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111479043|NCT05765500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111479044|NCT05765500|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110447372|NCT04115644|Glucocorticoids|glucocorticoids|mesh-ancestor
111479045|NCT05765500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111479046|NCT05765500|Androgen Antagonists|androgen antagonists|mesh-ancestor
111479047|NCT05765500|Hormone Antagonists|hormone antagonists|mesh-ancestor
111479048|NCT05765500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111479049|NCT05765357|Trastuzumab|trastuzumab|mesh-list
111479050|NCT05765357|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111479051|NCT05765357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111479052|NCT05765240|Hyaluronic Acid|hyaluronic acid|mesh-list
111479053|NCT05765240|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111479054|NCT05765240|Immunologic Factors|immunologic factors|mesh-ancestor
111479055|NCT05765240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111479056|NCT05765240|Viscosupplements|viscosupplements|mesh-ancestor
111479057|NCT05765240|Protective Agents|protective agents|mesh-ancestor
111479058|NCT05765110|Dopamine|dopamine|mesh-list
111479059|NCT05765110|Dopamine Agonists|dopamine agonists|mesh-list
111479060|NCT05765110|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111479061|NCT05765110|Sympathomimetics|sympathomimetics|mesh-ancestor
111479062|NCT05765110|Autonomic Agents|autonomic agents|mesh-ancestor
111479063|NCT05765110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111479064|NCT05765110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111479065|NCT05765110|Dopamine Agents|dopamine agents|mesh-ancestor
111479066|NCT05765110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111479067|NCT05765110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111479068|NCT05765110|Protective Agents|protective agents|mesh-ancestor
111479069|NCT05765097|Pancrelipase|pancrelipase|mesh-list
111479070|NCT05765097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111479071|NCT05764811|Canagliflozin|canagliflozin|mesh-list
111479072|NCT05764811|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111479073|NCT05764811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111479074|NCT05764811|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111479075|NCT05764811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111479076|NCT05764798|Zolpidem|zolpidem|mesh-list
111479077|NCT05764798|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111479078|NCT05764798|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111479079|NCT05764798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111479080|NCT05764798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111479081|NCT05764798|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
111479082|NCT05764798|GABA Agonists|gaba agonists|mesh-ancestor
111479083|NCT05764798|GABA Agents|gaba agents|mesh-ancestor
111479084|NCT05764798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111479085|NCT05764798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111479086|NCT05764746|Artesunate|artesunate|mesh-list
111479087|NCT05764746|Lumefantrine|lumefantrine|mesh-list
111479088|NCT05764746|Artemether|artemether|mesh-list
111479089|NCT05764746|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
111479090|NCT05764746|Amodiaquine|amodiaquine|mesh-list
111479091|NCT05764746|Antimalarials|antimalarials|mesh-ancestor
111479092|NCT05764746|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111479093|NCT05764746|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111479094|NCT05764746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111479095|NCT05764746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111479096|NCT05764746|Antiviral Agents|antiviral agents|mesh-ancestor
111479097|NCT05764746|Schistosomicides|schistosomicides|mesh-ancestor
111479098|NCT05764746|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
111479099|NCT05764746|Anthelmintics|anthelmintics|mesh-ancestor
111479100|NCT05764707|Acetaminophen|acetaminophen|mesh-list
111479101|NCT05764707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111479102|NCT05764707|Analgesics|analgesics|mesh-ancestor
111479103|NCT05764707|Sensory System Agents|sensory system agents|mesh-ancestor
111479104|NCT05764707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111479105|NCT05764707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111479106|NCT05764707|Antipyretics|antipyretics|mesh-ancestor
111479107|NCT05763602|Povidone-Iodine|povidone-iodine|mesh-list
111479108|NCT05763602|Povidone|povidone|mesh-list
111479109|NCT05763602|Plasma Substitutes|plasma substitutes|mesh-ancestor
111479110|NCT05763602|Blood Substitutes|blood substitutes|mesh-ancestor
111479111|NCT05763602|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111479112|NCT05763602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111479113|NCT05757622|Remifentanil|remifentanil|mesh-list
111479114|NCT05757622|Propofol|propofol|mesh-list
111479115|NCT05757622|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111479116|NCT05757622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111479117|NCT05757622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111479118|NCT05757622|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111479119|NCT05757622|Anesthetics, General|anesthetics, general|mesh-ancestor
111479120|NCT05757622|Anesthetics|anesthetics|mesh-ancestor
111479121|NCT05757622|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111479122|NCT05757622|Narcotics|narcotics|mesh-ancestor
111479123|NCT05757622|Analgesics|analgesics|mesh-ancestor
111479124|NCT05757622|Sensory System Agents|sensory system agents|mesh-ancestor
111479125|NCT05757622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111479126|NCT05746650|Hormones|hormones|mesh-list
111479127|NCT05746650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111479128|NCT05746650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111479129|NCT05731726|Celecoxib|celecoxib|mesh-list
111479130|NCT05731726|Capecitabine|capecitabine|mesh-list
111479131|NCT05731726|Oxaliplatin|oxaliplatin|mesh-list
111479132|NCT05731726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111479133|NCT05731726|Antimetabolites|antimetabolites|mesh-ancestor
111479134|NCT05731726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111479135|NCT05731726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111479136|NCT05731726|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111479137|NCT05731726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111479138|NCT05731726|Analgesics|analgesics|mesh-ancestor
111479139|NCT05731726|Sensory System Agents|sensory system agents|mesh-ancestor
111479140|NCT05731726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111479141|NCT05731726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111479142|NCT05731726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111479143|NCT05731726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111479144|NCT05731726|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111479145|NCT05731726|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111479146|NCT05731726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111479147|NCT05715931|Leucovorin|leucovorin|mesh-list
111479148|NCT05715931|Docetaxel|docetaxel|mesh-list
111479149|NCT05715931|Oxaliplatin|oxaliplatin|mesh-list
111479150|NCT05715931|Trastuzumab|trastuzumab|mesh-list
111479151|NCT05715931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111479152|NCT05715931|Tubulin Modulators|tubulin modulators|mesh-ancestor
111479153|NCT05715931|Antimitotic Agents|antimitotic agents|mesh-ancestor
110959274|NCT00545324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110959275|NCT00545324|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110959276|NCT00545324|Hormone Antagonists|hormone antagonists|mesh-ancestor
110959277|NCT00545324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110959278|NCT00545324|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110959279|NCT00545324|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110959280|NCT02582242|Insulin Aspart|insulin aspart|mesh-list
110959281|NCT02582242|Biphasic Insulins|biphasic insulins|mesh-list
110959282|NCT02582242|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
110959283|NCT02582242|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110959284|NCT02582242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110959285|NCT05004038|BCG Vaccine|bcg vaccine|mesh-list
110959286|NCT05004038|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110959287|NCT05004038|Immunologic Factors|immunologic factors|mesh-ancestor
110959288|NCT05004038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110959289|NCT04217356|Hydroxyurea|hydroxyurea|mesh-list
111203347|NCT00089024|Vitamins|vitamins|mesh-ancestor
110942742|NCT05707208|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110942743|NCT05707208|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110942744|NCT05707208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110942745|NCT05704543|Buprenorphine|buprenorphine|mesh-list
110942746|NCT05704543|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110942747|NCT05704543|Narcotics|narcotics|mesh-ancestor
110942748|NCT05704543|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110942749|NCT05704543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110942750|NCT05704543|Analgesics|analgesics|mesh-ancestor
110942751|NCT05704543|Sensory System Agents|sensory system agents|mesh-ancestor
110942752|NCT05704543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110942753|NCT05704543|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110942754|NCT05694286|Hyaluronic Acid|hyaluronic acid|mesh-list
110942755|NCT05694286|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110942756|NCT05694286|Immunologic Factors|immunologic factors|mesh-ancestor
110942757|NCT05694286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110942758|NCT05694286|Viscosupplements|viscosupplements|mesh-ancestor
110942759|NCT05694286|Protective Agents|protective agents|mesh-ancestor
110942771|NCT05679401|Cyclophosphamide|cyclophosphamide|mesh-list
110942772|NCT05679401|Glucocorticoids|glucocorticoids|mesh-list
110942773|NCT05679401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110942774|NCT05679401|Immunologic Factors|immunologic factors|mesh-ancestor
110942775|NCT05679401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110942776|NCT05679401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110942777|NCT05679401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110942778|NCT05679401|Alkylating Agents|alkylating agents|mesh-ancestor
110942779|NCT05679401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110942780|NCT05679401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110942781|NCT05679401|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110942782|NCT05679401|Hormones|hormones|mesh-ancestor
110942783|NCT05679401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110660290|NCT00990678|Calcitriol|calcitriol|mesh-list
110943046|NCT05593341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110943048|NCT05593341|Sensory System Agents|sensory system agents|mesh-ancestor
110943049|NCT05593341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110943050|NCT05590312|Anesthetics|anesthetics|mesh-list
110943051|NCT05590312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110943052|NCT05590312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110943053|NCT05583617|Dexamethasone|dexamethasone|mesh-list
110943054|NCT05583617|Lenalidomide|lenalidomide|mesh-list
110943055|NCT05583617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110943056|NCT05583617|Antiemetics|antiemetics|mesh-ancestor
110943057|NCT05583617|Autonomic Agents|autonomic agents|mesh-ancestor
110943058|NCT05583617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110943059|NCT05583617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110943060|NCT05583617|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110943061|NCT05583617|Glucocorticoids|glucocorticoids|mesh-ancestor
110943062|NCT05583617|Hormones|hormones|mesh-ancestor
110943063|NCT05583617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110943064|NCT05583617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110943065|NCT05583617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110943066|NCT05583617|Immunologic Factors|immunologic factors|mesh-ancestor
110943067|NCT05583617|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110943068|NCT05583617|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110943069|NCT05583617|Growth Substances|growth substances|mesh-ancestor
110943070|NCT05583617|Growth Inhibitors|growth inhibitors|mesh-ancestor
110943071|NCT05583227|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110943072|NCT05583227|Immunologic Factors|immunologic factors|mesh-ancestor
110943073|NCT05583227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110943083|NCT05569512|Fludarabine|fludarabine|mesh-list
110943084|NCT05569512|Busulfan|busulfan|mesh-list
110943085|NCT05569512|Clofarabine|clofarabine|mesh-list
110943086|NCT05569512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110943087|NCT05569512|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110943088|NCT05569512|Antimetabolites|antimetabolites|mesh-ancestor
110943089|NCT05569512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110943090|NCT05569512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110943091|NCT05569512|Immunologic Factors|immunologic factors|mesh-ancestor
110943092|NCT05569512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110943093|NCT05569512|Alkylating Agents|alkylating agents|mesh-ancestor
110943094|NCT05569512|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110943095|NCT05569512|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110943306|NCT05478837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110943307|NCT05478837|Immunologic Factors|immunologic factors|mesh-ancestor
110943308|NCT05478837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110943309|NCT05478837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110943310|NCT05478837|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110943311|NCT05478837|Alkylating Agents|alkylating agents|mesh-ancestor
110943312|NCT05478837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110943313|NCT05478837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110943314|NCT05478837|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110943316|NCT05476952|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110943317|NCT05476952|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110943318|NCT05476952|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110943319|NCT05476952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110943320|NCT05476952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110943327|NCT05467176|Relugolix|relugolix|mesh-list
110943328|NCT05467176|Androgen Antagonists|androgen antagonists|mesh-ancestor
110660814|NCT00984464|Paclitaxel|paclitaxel|mesh-list
110943392|NCT05426174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110943404|NCT05414838|Vitamin D|vitamin d|mesh-list
110943405|NCT05414838|Curcumin|curcumin|mesh-list
110943458|NCT05383495|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110943459|NCT05383495|Anesthetics, General|anesthetics, general|mesh-ancestor
110943460|NCT05383495|Anesthetics|anesthetics|mesh-ancestor
110943461|NCT05383495|GABA Modulators|gaba modulators|mesh-ancestor
110943462|NCT05383495|GABA Agents|gaba agents|mesh-ancestor
110943463|NCT05383495|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110943526|NCT05343702|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110943527|NCT05343702|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110943528|NCT05343702|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110943529|NCT05343702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110943530|NCT05343702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110661035|NCT04003350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110943676|NCT05182164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110943697|NCT05169658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110943698|NCT05169658|Obinutuzumab|obinutuzumab|mesh-list
110943699|NCT05169658|Antibodies|antibodies|mesh-list
110943700|NCT05169658|Immunoglobulins|immunoglobulins|mesh-list
110943701|NCT05169658|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110943703|NCT05169658|Immunoconjugates|immunoconjugates|mesh-list
110943704|NCT05169658|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
110943743|NCT05113251|Tubulin Modulators|tubulin modulators|mesh-ancestor
110943744|NCT05113251|Antimitotic Agents|antimitotic agents|mesh-ancestor
110943745|NCT05113251|Mitosis Modulators|mitosis modulators|mesh-ancestor
110943746|NCT05113251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110943747|NCT05113251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110943748|NCT05113251|Immunologic Factors|immunologic factors|mesh-ancestor
110943749|NCT05113251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110943750|NCT05113251|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110943751|NCT05113251|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110943752|NCT05113251|Alkylating Agents|alkylating agents|mesh-ancestor
110943753|NCT05113251|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110943754|NCT05113251|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110943755|NCT05113251|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110943756|NCT05113251|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110943757|NCT05113251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110943758|NCT05113251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110943759|NCT05113251|Immunoconjugates|immunoconjugates|mesh-ancestor
110943771|NCT05111626|Nivolumab|nivolumab|mesh-list
110943772|NCT05111626|Bemarituzumab|bemarituzumab|mesh-list
110943773|NCT05111626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110943774|NCT05111626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110943775|NCT05111626|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110943776|NCT05111626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110944035|NCT05007106|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110944036|NCT05007106|Immunologic Factors|immunologic factors|mesh-ancestor
110944037|NCT05007106|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110944038|NCT05007106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110944040|NCT05006794|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
110944041|NCT05006794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110944042|NCT05006794|Tubulin Modulators|tubulin modulators|mesh-ancestor
110944043|NCT05006794|Antimitotic Agents|antimitotic agents|mesh-ancestor
110944044|NCT05006794|Mitosis Modulators|mitosis modulators|mesh-ancestor
110944045|NCT05006794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110944046|NCT05006794|Immunoconjugates|immunoconjugates|mesh-ancestor
110944047|NCT05006794|Immunologic Factors|immunologic factors|mesh-ancestor
111479154|NCT05715931|Mitosis Modulators|mitosis modulators|mesh-ancestor
110944048|NCT05006794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110944071|NCT04995029|Buprenorphine|buprenorphine|mesh-list
110944072|NCT04995029|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110944073|NCT04995029|Narcotics|narcotics|mesh-ancestor
110944074|NCT04995029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110944075|NCT04995029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110944076|NCT04995029|Analgesics|analgesics|mesh-ancestor
110944077|NCT04995029|Sensory System Agents|sensory system agents|mesh-ancestor
110944078|NCT04995029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110944079|NCT04995029|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110944080|NCT04994717|Blinatumomab|blinatumomab|mesh-list
110944081|NCT04994717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110944162|NCT04958785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110944163|NCT04958785|Tubulin Modulators|tubulin modulators|mesh-ancestor
110944164|NCT04958785|Antimitotic Agents|antimitotic agents|mesh-ancestor
110944165|NCT04958785|Mitosis Modulators|mitosis modulators|mesh-ancestor
110667125|NCT00450801|Cytarabine|cytarabine|mesh-list
110944180|NCT04956640|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110944181|NCT04956640|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110944185|NCT04938830|Palivizumab|palivizumab|mesh-list
110944186|NCT04938830|Antiviral Agents|antiviral agents|mesh-ancestor
110944187|NCT04938830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110944202|NCT04928846|Docetaxel|docetaxel|mesh-list
110944203|NCT04928846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110944204|NCT04928846|Tubulin Modulators|tubulin modulators|mesh-ancestor
110944205|NCT04928846|Antimitotic Agents|antimitotic agents|mesh-ancestor
110944206|NCT04928846|Mitosis Modulators|mitosis modulators|mesh-ancestor
110944207|NCT04928846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110944219|NCT04924075|Belzutifan|belzutifan|mesh-list
110944220|NCT04924075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110944584|NCT04730544|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110944585|NCT04730544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110945021|NCT04428151|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110945022|NCT04428151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110945024|NCT04428151|Antimitotic Agents|antimitotic agents|mesh-ancestor
110945025|NCT04428151|Mitosis Modulators|mitosis modulators|mesh-ancestor
110945026|NCT04428151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110945027|NCT04428151|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110447428|NCT02751034|Lidocaine|lidocaine|mesh-list
110945028|NCT04428151|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110945029|NCT04428151|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110945030|NCT04428151|Antimetabolites|antimetabolites|mesh-ancestor
110945031|NCT04428151|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110945032|NCT04428151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110945049|NCT04398706|Vaccines|vaccines|mesh-list
110945050|NCT04398706|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110945051|NCT04398706|Immunologic Factors|immunologic factors|mesh-ancestor
110945052|NCT04398706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110945053|NCT04389632|Carboplatin|carboplatin|mesh-list
110945054|NCT04389632|Pembrolizumab|pembrolizumab|mesh-list
110945055|NCT04389632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110945056|NCT04389632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110945057|NCT04389632|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110945058|NCT04389632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110945059|NCT04380636|Paclitaxel|paclitaxel|mesh-list
110945060|NCT04380636|Etoposide|etoposide|mesh-list
110945061|NCT04380636|Carboplatin|carboplatin|mesh-list
110945062|NCT04380636|Pembrolizumab|pembrolizumab|mesh-list
110945063|NCT04380636|Pemetrexed|pemetrexed|mesh-list
110945064|NCT04380636|Durvalumab|durvalumab|mesh-list
110945065|NCT04380636|Olaparib|olaparib|mesh-list
110945066|NCT04380636|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110945067|NCT04380636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110945068|NCT04380636|Tubulin Modulators|tubulin modulators|mesh-ancestor
110945187|NCT04301843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110945237|NCT04282031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110945239|NCT04282031|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110945240|NCT04282031|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110662830|NCT00539006|Xhance|xhance|mesh-list
110945651|NCT04078568|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110945652|NCT04078568|gamma-Globulins|gamma-globulins|mesh-list
110945653|NCT04078568|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110945654|NCT04078568|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110945655|NCT04078568|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110945656|NCT04078568|Analgesics|analgesics|mesh-ancestor
110945657|NCT04078568|Sensory System Agents|sensory system agents|mesh-ancestor
110945658|NCT04078568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110945659|NCT04078568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110945661|NCT04078568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110945662|NCT04078568|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110945663|NCT04078568|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110945664|NCT04078568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110945665|NCT04078568|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110945666|NCT04078568|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110945709|NCT04066348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110945710|NCT04066348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110945711|NCT04066348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110945712|NCT04066348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110945713|NCT04066348|Immunologic Factors|immunologic factors|mesh-ancestor
110945788|NCT03989414|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110945789|NCT03989414|Glucocorticoids|glucocorticoids|mesh-ancestor
110945790|NCT03989414|Hormones|hormones|mesh-ancestor
110945791|NCT03989414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110945792|NCT03989414|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110945793|NCT03989414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110946170|NCT03818061|Growth Substances|growth substances|mesh-ancestor
110946171|NCT03818061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110946172|NCT03818061|Growth Inhibitors|growth inhibitors|mesh-ancestor
110946173|NCT03818061|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110946174|NCT03818061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110669152|NCT01003314|Vaccines|vaccines|mesh-list
110946302|NCT03742414|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110946348|NCT03729869|Progesterone|progesterone|mesh-list
110946349|NCT03729869|Progestins|progestins|mesh-ancestor
110946384|NCT03713437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110946390|NCT03703960|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
110946391|NCT03703960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110946392|NCT03703960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110663890|NCT00790439|Anticoagulants|anticoagulants|mesh-ancestor
110946625|NCT03519295|Fluorouracil|fluorouracil|mesh-list
110946626|NCT03519295|Atezolizumab|atezolizumab|mesh-list
110946627|NCT03519295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110946628|NCT03519295|Tubulin Modulators|tubulin modulators|mesh-ancestor
110946629|NCT03519295|Antimitotic Agents|antimitotic agents|mesh-ancestor
110946630|NCT03519295|Mitosis Modulators|mitosis modulators|mesh-ancestor
110946631|NCT03519295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110946632|NCT03519295|Antimetabolites|antimetabolites|mesh-ancestor
110946633|NCT03519295|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110946634|NCT03519295|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110946635|NCT03519295|Immunologic Factors|immunologic factors|mesh-ancestor
110946636|NCT03519295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110946637|NCT03519295|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110946638|NCT03519295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110946639|NCT03515213|Fenofibrate|fenofibrate|mesh-list
110946640|NCT03515213|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110946641|NCT03515213|Antimetabolites|antimetabolites|mesh-ancestor
110946642|NCT03515213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110946643|NCT03515213|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110669618|NCT05721846|Nivolumab|nivolumab|mesh-list
110946871|NCT03326921|Vidarabine|vidarabine|mesh-list
110946872|NCT03326921|Fludarabine|fludarabine|mesh-list
110946873|NCT03326921|Fludarabine phosphate|fludarabine phosphate|mesh-list
110946874|NCT03326921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110946875|NCT03326921|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110947013|NCT03158389|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110947014|NCT03158389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110947015|NCT03158389|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110947016|NCT03158389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110947017|NCT03158389|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110947018|NCT03158389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110947019|NCT03158389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110947020|NCT03158389|Immunologic Factors|immunologic factors|mesh-ancestor
110947021|NCT03158389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110947022|NCT03158389|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110947023|NCT03158389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110947024|NCT03158389|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110947025|NCT03158389|Antifungal Agents|antifungal agents|mesh-ancestor
110947074|NCT03141177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110947075|NCT03141177|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110947076|NCT03141177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110947077|NCT03141177|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110947078|NCT03141177|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110947079|NCT03141177|Growth Substances|growth substances|mesh-ancestor
110947080|NCT03141177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110947081|NCT03141177|Growth Inhibitors|growth inhibitors|mesh-ancestor
110947082|NCT03141177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110947083|NCT03141177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110947084|NCT03140670|Rucaparib|rucaparib|mesh-list
110947085|NCT03140670|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110947086|NCT03140670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110947087|NCT03140670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110947088|NCT03140670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110664561|NCT03955939|GABA Agents|gaba agents|mesh-ancestor
110947293|NCT02945280|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110947294|NCT02945280|Antithrombins|antithrombins|mesh-ancestor
110947295|NCT02945280|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110947296|NCT02945280|Protease Inhibitors|protease inhibitors|mesh-ancestor
110947297|NCT02945280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110947298|NCT02945280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110947299|NCT02945280|Anticoagulants|anticoagulants|mesh-ancestor
110947300|NCT02944071|Paclitaxel|paclitaxel|mesh-list
110947301|NCT02944071|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110947302|NCT02944071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110947303|NCT02944071|Tubulin Modulators|tubulin modulators|mesh-ancestor
110947304|NCT02944071|Antimitotic Agents|antimitotic agents|mesh-ancestor
110947305|NCT02944071|Mitosis Modulators|mitosis modulators|mesh-ancestor
110947306|NCT02944071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110664791|NCT00385684|Antipyretics|antipyretics|mesh-ancestor
110947481|NCT02677493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110947519|NCT02633059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110947520|NCT02633059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110947521|NCT02633059|Protease Inhibitors|protease inhibitors|mesh-ancestor
110947522|NCT02633059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110947523|NCT02633059|Dermatologic Agents|dermatologic agents|mesh-ancestor
110947524|NCT02633059|Glycine Agents|glycine agents|mesh-ancestor
110947525|NCT02633059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110947531|NCT02630043|Oxaliplatin|oxaliplatin|mesh-list
110947533|NCT02630043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110947534|NCT02630043|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110947535|NCT02630043|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110947536|NCT02630043|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
110947537|NCT02630043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110947538|NCT02630043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110947539|NCT02614534|Mitomycins|mitomycins|mesh-list
110947540|NCT02614534|Mitomycin|mitomycin|mesh-list
110947541|NCT02614534|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110947542|NCT02614534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110947543|NCT02614534|Alkylating Agents|alkylating agents|mesh-ancestor
110947544|NCT02614534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110947545|NCT02614534|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110947546|NCT02614534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110947547|NCT02614066|Cyclophosphamide|cyclophosphamide|mesh-list
110947548|NCT02614066|Fludarabine|fludarabine|mesh-list
110947549|NCT02614066|Brexucabtagene autoleucel|brexucabtagene autoleucel|mesh-list
110947550|NCT02614066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110947551|NCT02614066|Immunologic Factors|immunologic factors|mesh-ancestor
110947552|NCT02614066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110947553|NCT02614066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110947554|NCT02614066|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110947555|NCT02614066|Alkylating Agents|alkylating agents|mesh-ancestor
110947556|NCT02614066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110947557|NCT02614066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110947558|NCT02614066|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110947559|NCT02614066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110947625|NCT02460692|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110947627|NCT02460692|Sensory System Agents|sensory system agents|mesh-ancestor
110947628|NCT02460692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110947629|NCT02460692|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
110947630|NCT02460692|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110947631|NCT02460692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110947632|NCT02460692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110947633|NCT02460692|Hormones|hormones|mesh-ancestor
110947634|NCT02460692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110947636|NCT02453282|Cisplatin|cisplatin|mesh-list
110947637|NCT02453282|Carboplatin|carboplatin|mesh-list
110947638|NCT02453282|Gemcitabine|gemcitabine|mesh-list
110947639|NCT02453282|Pemetrexed|pemetrexed|mesh-list
110947640|NCT02453282|Durvalumab|durvalumab|mesh-list
110947641|NCT02453282|Tremelimumab|tremelimumab|mesh-list
110947642|NCT02453282|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110947643|NCT02453282|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110947644|NCT02453282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110947653|NCT02453282|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110947654|NCT02453282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110947655|NCT02453282|Immunologic Factors|immunologic factors|mesh-ancestor
110947656|NCT02453282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110947660|NCT02408120|Insulin|insulin|mesh-list
110947661|NCT02408120|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110947662|NCT02408120|Insulin Glargine|insulin glargine|mesh-list
110947663|NCT02408120|Insulin Aspart|insulin aspart|mesh-list
110947664|NCT02408120|Insulin, Long-Acting|insulin, long-acting|mesh-list
110947665|NCT02408120|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
110947666|NCT02408120|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110947667|NCT02408120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110947668|NCT02403505|Vaccines|vaccines|mesh-list
110947669|NCT02403505|BCG Vaccine|bcg vaccine|mesh-list
110947670|NCT02403505|Immunologic Factors|immunologic factors|mesh-ancestor
110947671|NCT02403505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110947672|NCT02403505|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110947673|NCT02393183|Selenium|selenium|mesh-list
110947674|NCT02393183|Antioxidants|antioxidants|mesh-list
110947675|NCT02393183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110947676|NCT02393183|Protective Agents|protective agents|mesh-ancestor
110947677|NCT02393183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110947678|NCT02393183|Trace Elements|trace elements|mesh-ancestor
110947679|NCT02393183|Micronutrients|micronutrients|mesh-ancestor
110947680|NCT02391545|Rituximab|rituximab|mesh-list
110947681|NCT02391545|Obinutuzumab|obinutuzumab|mesh-list
110947682|NCT02391545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110947683|NCT02391545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110947684|NCT02391545|Immunologic Factors|immunologic factors|mesh-ancestor
110947685|NCT02391545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110947686|NCT02391545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110947701|NCT02295475|Warfarin|warfarin|mesh-list
110947702|NCT02295475|Apixaban|apixaban|mesh-list
110947703|NCT02295475|Anticoagulants|anticoagulants|mesh-ancestor
110947704|NCT02295475|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110947705|NCT02295475|Antithrombins|antithrombins|mesh-ancestor
110947706|NCT02295475|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110947707|NCT02295475|Protease Inhibitors|protease inhibitors|mesh-ancestor
110947708|NCT02295475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110947709|NCT02295475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110947773|NCT02139397|Bortezomib|bortezomib|mesh-list
110947774|NCT02139397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110947775|NCT02139397|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
110947776|NCT02139397|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110947777|NCT02139397|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110947778|NCT02139397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110947779|NCT02139397|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
110947780|NCT02139397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110947781|NCT02139397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110947782|NCT02117791|Riociguat|riociguat|mesh-list
110947783|NCT02117791|Enzyme Activators|enzyme activators|mesh-ancestor
110947784|NCT02117791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110677024|NCT03146962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110947890|NCT01920932|Cyclophosphamide|cyclophosphamide|mesh-list
110947891|NCT01920932|Dacarbazine|dacarbazine|mesh-list
110947892|NCT01920932|Doxorubicin|doxorubicin|mesh-list
110947893|NCT01920932|Etoposide|etoposide|mesh-list
110947894|NCT01920932|Brentuximab Vedotin|brentuximab vedotin|mesh-list
110947895|NCT01920932|Imidazole|imidazole|mesh-list
110947896|NCT01920932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110947897|NCT01920932|Immunologic Factors|immunologic factors|mesh-ancestor
110947898|NCT01920932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110947899|NCT01920932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110947900|NCT01920932|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110947901|NCT01920932|Alkylating Agents|alkylating agents|mesh-ancestor
110947902|NCT01920932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110947903|NCT01920932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110947904|NCT01920932|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110947905|NCT01920932|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110947906|NCT01920932|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110947907|NCT01920932|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110947908|NCT01920932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110947909|NCT01920932|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110947911|NCT01920932|Hormones|hormones|mesh-ancestor
110947912|NCT01920932|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110947913|NCT01920932|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110947914|NCT01920932|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110947915|NCT01920932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110947916|NCT01920932|Immunotoxins|immunotoxins|mesh-ancestor
110947917|NCT01920932|Immunoconjugates|immunoconjugates|mesh-ancestor
110947934|NCT01748149|Vemurafenib|vemurafenib|mesh-list
110947935|NCT01748149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110947936|NCT01748149|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110947937|NCT01748149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110947938|NCT01748149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110947939|NCT01597388|Fulvestrant|fulvestrant|mesh-list
110947940|NCT01597388|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110947941|NCT01597388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110947942|NCT01597388|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110947943|NCT01597388|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110947944|NCT01597388|Hormone Antagonists|hormone antagonists|mesh-ancestor
110947945|NCT01597388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110947946|NCT01597388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110947995|NCT01143766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110947997|NCT01143766|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110947998|NCT01143766|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110947999|NCT01143766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110948000|NCT01143766|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110948001|NCT01143766|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110948002|NCT01143766|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110948003|NCT01143766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110948004|NCT01143766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110948005|NCT01143766|Antimanic Agents|antimanic agents|mesh-ancestor
110948006|NCT01106898|Paclitaxel|paclitaxel|mesh-list
110948007|NCT01106898|Cyclophosphamide|cyclophosphamide|mesh-list
110948008|NCT01106898|Trastuzumab|trastuzumab|mesh-list
110948009|NCT01106898|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110948010|NCT01106898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110948011|NCT01106898|Tubulin Modulators|tubulin modulators|mesh-ancestor
110948012|NCT01106898|Antimitotic Agents|antimitotic agents|mesh-ancestor
110948013|NCT01106898|Mitosis Modulators|mitosis modulators|mesh-ancestor
110948014|NCT01106898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110948015|NCT01106898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110948016|NCT01106898|Immunologic Factors|immunologic factors|mesh-ancestor
110948017|NCT01106898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110948018|NCT01106898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110948019|NCT01106898|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110948020|NCT01106898|Alkylating Agents|alkylating agents|mesh-ancestor
110948030|NCT01059071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110948031|NCT01059071|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
110948032|NCT01059071|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110948033|NCT01059071|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110948034|NCT01059071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110948035|NCT01059071|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
110948036|NCT01001637|Curcumin|curcumin|mesh-list
110948037|NCT01001637|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110948038|NCT01001637|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110948039|NCT01001637|Analgesics|analgesics|mesh-ancestor
110948040|NCT01001637|Sensory System Agents|sensory system agents|mesh-ancestor
110948041|NCT01001637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110948042|NCT01001637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110948043|NCT01001637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110948044|NCT01001637|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110948045|NCT01001637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110948046|NCT01001637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110948047|NCT01001637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110948120|NCT00601003|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110948122|NCT00601003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110948123|NCT00601003|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
110948124|NCT00601003|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110948125|NCT00601003|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110948126|NCT00601003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110948127|NCT00575718|Nicotine|nicotine|mesh-list
110948128|NCT00575718|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110948129|NCT00575718|Autonomic Agents|autonomic agents|mesh-ancestor
110948130|NCT00575718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110948131|NCT00575718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110948132|NCT00575718|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110948133|NCT00575718|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110948134|NCT00575718|Cholinergic Agents|cholinergic agents|mesh-ancestor
110447470|NCT05382351|Tenofovir|tenofovir|mesh-list
110948135|NCT00575718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110948136|NCT00575718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110948137|NCT00571493|Cytarabine|cytarabine|mesh-list
110948138|NCT00571493|Etoposide|etoposide|mesh-list
110948139|NCT00571493|Etoposide phosphate|etoposide phosphate|mesh-list
110948140|NCT00571493|Bortezomib|bortezomib|mesh-list
110948141|NCT00571493|Melphalan|melphalan|mesh-list
110948142|NCT00571493|Carmustine|carmustine|mesh-list
110948143|NCT00571493|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110948144|NCT00571493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110948145|NCT00571493|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110948146|NCT00571493|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110948147|NCT00571493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110948148|NCT00571493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110948149|NCT00571493|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110948150|NCT00571493|Antimetabolites|antimetabolites|mesh-ancestor
110948151|NCT00571493|Antiviral Agents|antiviral agents|mesh-ancestor
110948152|NCT00571493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110948153|NCT00571493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110948154|NCT00571493|Immunologic Factors|immunologic factors|mesh-ancestor
110948155|NCT00571493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110948156|NCT00571493|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110948157|NCT00571493|Alkylating Agents|alkylating agents|mesh-ancestor
110948158|NCT00571493|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110948159|NCT00552461|Rituximab|rituximab|mesh-list
110948160|NCT00552461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110948161|NCT00552461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110948162|NCT00552461|Immunologic Factors|immunologic factors|mesh-ancestor
110948163|NCT00552461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110948164|NCT00552461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110660296|NCT00990678|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110660297|NCT00990678|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
110660298|NCT00990678|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110660299|NCT00990678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110660300|NCT00990678|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110660302|NCT00538590|Mitomycin|mitomycin|mesh-list
110660303|NCT00538590|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110660304|NCT00538590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110660305|NCT00538590|Alkylating Agents|alkylating agents|mesh-ancestor
110660306|NCT00538590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110660307|NCT00538590|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110660308|NCT00538590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110660309|NCT00990834|Simvastatin|simvastatin|mesh-list
110660310|NCT00990834|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110660311|NCT00990834|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110660312|NCT00990834|Antimetabolites|antimetabolites|mesh-ancestor
110660313|NCT00990834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110660314|NCT00990834|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110660315|NCT00990834|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110660316|NCT00990834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110660317|NCT00990990|Linezolid|linezolid|mesh-list
110660318|NCT00990990|Oxazolidinones|oxazolidinones|mesh-list
110660319|NCT00990990|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110660320|NCT00990990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110660321|NCT00990990|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110660322|NCT00990990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110660323|NCT00990990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110660324|NCT05589402|Lidocaine|lidocaine|mesh-list
110660325|NCT05589402|Anesthetics, Local|anesthetics, local|mesh-ancestor
110660326|NCT05589402|Anesthetics|anesthetics|mesh-ancestor
110660327|NCT05589402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110660328|NCT05589402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110660329|NCT05589402|Sensory System Agents|sensory system agents|mesh-ancestor
110660330|NCT05589402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110660331|NCT05589402|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110660332|NCT05589402|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110660333|NCT05589402|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110660334|NCT05589402|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110660335|NCT05589402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110660337|NCT00466947|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110660338|NCT00466947|Immunologic Factors|immunologic factors|mesh-ancestor
110660339|NCT00466947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110660340|NCT00537810|Sibutramine|sibutramine|mesh-list
110660341|NCT00537810|Antidepressive Agents|antidepressive agents|mesh-ancestor
110660342|NCT00537810|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110660343|NCT00537810|Appetite Depressants|appetite depressants|mesh-ancestor
110660344|NCT00537810|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110660345|NCT00989352|Rituximab|rituximab|mesh-list
110660346|NCT00989352|Methotrexate|methotrexate|mesh-list
110660347|NCT00989352|Lomustine|lomustine|mesh-list
110660348|NCT00989352|Procarbazine|procarbazine|mesh-list
110660349|NCT00989352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110660350|NCT00989352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110660351|NCT00989352|Immunologic Factors|immunologic factors|mesh-ancestor
110660352|NCT00989352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110660353|NCT00989352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110660354|NCT00989352|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110660355|NCT00989352|Abortifacient Agents|abortifacient agents|mesh-ancestor
110660356|NCT00989352|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110660357|NCT00989352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110660358|NCT00989352|Antimetabolites|antimetabolites|mesh-ancestor
110660359|NCT00989352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110660360|NCT00989352|Dermatologic Agents|dermatologic agents|mesh-ancestor
110660361|NCT00989352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110660362|NCT00989352|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110660363|NCT00989352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110660364|NCT00989352|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110660365|NCT00989352|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110660366|NCT00989352|Alkylating Agents|alkylating agents|mesh-ancestor
110660367|NCT05566626|Tropicamide|tropicamide|mesh-list
110660368|NCT05566626|Mydriatics|mydriatics|mesh-ancestor
110660369|NCT05566626|Autonomic Agents|autonomic agents|mesh-ancestor
110660370|NCT05566626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110660371|NCT05566626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110660372|NCT05566626|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110660373|NCT05566626|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110660374|NCT05566626|Cholinergic Agents|cholinergic agents|mesh-ancestor
110660375|NCT05566626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110660376|NCT05566626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110660377|NCT00989508|Perhexiline|perhexiline|mesh-list
110660378|NCT00989508|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110660379|NCT00989508|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110660380|NCT00989508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110660381|NCT00989508|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110660382|NCT00989508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110660383|NCT00989508|Vasodilator Agents|vasodilator agents|mesh-ancestor
110660384|NCT05360394|Paclitaxel|paclitaxel|mesh-list
110660385|NCT05360394|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110660386|NCT05360394|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110660387|NCT05360394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110660388|NCT05360394|Tubulin Modulators|tubulin modulators|mesh-ancestor
110660389|NCT05360394|Antimitotic Agents|antimitotic agents|mesh-ancestor
110660390|NCT05360394|Mitosis Modulators|mitosis modulators|mesh-ancestor
110660391|NCT05360394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110660392|NCT00090259|Losartan|losartan|mesh-list
110660393|NCT00090259|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110660394|NCT00090259|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110660395|NCT00090259|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110660396|NCT00090259|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110660397|NCT00090259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110660398|NCT00079183|Sirolimus|sirolimus|mesh-list
110660400|NCT00079183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110660401|NCT00079183|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110660402|NCT00079183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110660403|NCT00079183|Antifungal Agents|antifungal agents|mesh-ancestor
110660404|NCT00079183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110660405|NCT00079183|Immunologic Factors|immunologic factors|mesh-ancestor
110660406|NCT00079183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110660407|NCT01086085|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110660408|NCT01086085|Interferon-alpha|interferon-alpha|mesh-list
110660409|NCT01086085|Adefovir|adefovir|mesh-list
110660410|NCT01086085|Antiviral Agents|antiviral agents|mesh-ancestor
110660411|NCT01086085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110660412|NCT01086085|Immunologic Factors|immunologic factors|mesh-ancestor
110660413|NCT01086085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110660414|NCT01086085|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110660415|NCT01086085|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110660416|NCT01086085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110660417|NCT01086085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110660418|NCT01589419|Capecitabine|capecitabine|mesh-list
110660419|NCT01589419|Veliparib|veliparib|mesh-list
110660420|NCT01589419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110660421|NCT01589419|Antimetabolites|antimetabolites|mesh-ancestor
110660422|NCT01589419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110660423|NCT01589419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110660424|NCT01589419|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110660425|NCT01589419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110660426|NCT00676403|Pregabalin|pregabalin|mesh-list
110660427|NCT00676403|Analgesics|analgesics|mesh-ancestor
110660428|NCT00676403|Sensory System Agents|sensory system agents|mesh-ancestor
110660429|NCT00676403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110660430|NCT00676403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110660431|NCT00676403|Anticonvulsants|anticonvulsants|mesh-ancestor
110660432|NCT00676403|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110660433|NCT00676403|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110660434|NCT00676403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110660435|NCT00676403|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110660436|NCT00676403|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110660437|NCT00676403|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110660438|NCT00676403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110660439|NCT00676403|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110660440|NCT00078325|Modafinil|modafinil|mesh-list
110660441|NCT00078325|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110660442|NCT00078325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110660443|NCT00078325|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
110660444|NCT00078325|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110660445|NCT00078325|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110660446|NCT00078325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110660447|NCT03963193|Cisplatin|cisplatin|mesh-list
110660448|NCT03963193|Irinotecan|irinotecan|mesh-list
110660449|NCT03963193|Etoposide|etoposide|mesh-list
110660450|NCT03963193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110660451|NCT03963193|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110660452|NCT03963193|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110660453|NCT03963193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110660454|NCT03963193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110660455|NCT03963193|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110660456|NCT03963193|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110660457|NCT03961867|Docetaxel|docetaxel|mesh-list
110660458|NCT03961867|Oxaliplatin|oxaliplatin|mesh-list
110660459|NCT03961867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110660460|NCT03961867|Tubulin Modulators|tubulin modulators|mesh-ancestor
110660461|NCT03961867|Antimitotic Agents|antimitotic agents|mesh-ancestor
110660462|NCT03961867|Mitosis Modulators|mitosis modulators|mesh-ancestor
110660463|NCT03961867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110660464|NCT00077857|Docetaxel|docetaxel|mesh-list
110660465|NCT00077857|Capecitabine|capecitabine|mesh-list
110660466|NCT00077857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110660467|NCT00077857|Tubulin Modulators|tubulin modulators|mesh-ancestor
110660468|NCT00077857|Antimitotic Agents|antimitotic agents|mesh-ancestor
110660469|NCT00077857|Mitosis Modulators|mitosis modulators|mesh-ancestor
110660470|NCT00077857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110660471|NCT00077857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110660473|NCT00545402|Mycophenolic Acid|mycophenolic acid|mesh-list
110660474|NCT00545402|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110660475|NCT00545402|Tacrolimus|tacrolimus|mesh-list
110660476|NCT00545402|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110660477|NCT00545402|Immunologic Factors|immunologic factors|mesh-ancestor
110660478|NCT00545402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110660479|NCT00545402|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110660480|NCT00545402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110660481|NCT00545402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110660482|NCT00545402|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110660483|NCT00545402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110660484|NCT00545402|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110660485|NCT00545402|Antitubercular Agents|antitubercular agents|mesh-ancestor
110660486|NCT00545402|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110660487|NCT00545402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110660488|NCT00545402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110660489|NCT00545402|Glucocorticoids|glucocorticoids|mesh-ancestor
110660490|NCT00545402|Hormones|hormones|mesh-ancestor
110660491|NCT00545402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110660492|NCT00545402|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110660493|NCT00545402|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110660494|NCT00545402|Protective Agents|protective agents|mesh-ancestor
110660495|NCT03963115|Epinephrine|epinephrine|mesh-list
110660496|NCT03963115|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110660497|NCT03963115|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110660498|NCT03963115|Adrenergic Agents|adrenergic agents|mesh-ancestor
110660499|NCT03963115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110660500|NCT03963115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110660501|NCT03963115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110660502|NCT03963115|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110660503|NCT03963115|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110660504|NCT03963115|Autonomic Agents|autonomic agents|mesh-ancestor
110660505|NCT03963115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110660506|NCT03963115|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110660507|NCT03963115|Respiratory System Agents|respiratory system agents|mesh-ancestor
110660508|NCT03963115|Mydriatics|mydriatics|mesh-ancestor
110660509|NCT03963115|Sympathomimetics|sympathomimetics|mesh-ancestor
110660510|NCT03963115|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110307739|NCT00268697|Ezetimibe|ezetimibe|mesh-list
110660511|NCT01583023|Bupropion|bupropion|mesh-list
110660512|NCT01583023|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110660513|NCT01583023|Antidepressive Agents|antidepressive agents|mesh-ancestor
110660514|NCT01583023|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110660515|NCT01583023|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110660516|NCT01583023|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110660517|NCT01583023|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110660518|NCT01583023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110660519|NCT01583023|Dopamine Agents|dopamine agents|mesh-ancestor
110660520|NCT01583023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110660521|NCT01583023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110660522|NCT01583023|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110660523|NCT01583023|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110660524|NCT01583023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110660525|NCT00976976|Cisplatin|cisplatin|mesh-list
110660526|NCT00976976|Docetaxel|docetaxel|mesh-list
110660527|NCT00976976|Capecitabine|capecitabine|mesh-list
110660528|NCT00976976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110660529|NCT00976976|Tubulin Modulators|tubulin modulators|mesh-ancestor
110660530|NCT00976976|Antimitotic Agents|antimitotic agents|mesh-ancestor
110660531|NCT00976976|Mitosis Modulators|mitosis modulators|mesh-ancestor
110660532|NCT00976976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110660533|NCT00976976|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110660534|NCT00976976|Antimetabolites|antimetabolites|mesh-ancestor
110660535|NCT00977054|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110660536|NCT00977054|Interferon-alpha|interferon-alpha|mesh-list
110660537|NCT00977054|Ribavirin|ribavirin|mesh-list
110660538|NCT00977054|Interferon alpha-2|interferon alpha-2|mesh-list
110660539|NCT00977054|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
110660540|NCT00977054|Antiviral Agents|antiviral agents|mesh-ancestor
110660541|NCT00977054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110660542|NCT00977054|Immunologic Factors|immunologic factors|mesh-ancestor
110660543|NCT00977054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110660544|NCT00977054|Antimetabolites|antimetabolites|mesh-ancestor
110660545|NCT00977054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110660546|NCT00977054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110660547|NCT00977132|Lenalidomide|lenalidomide|mesh-list
110660548|NCT00977132|Immunologic Factors|immunologic factors|mesh-ancestor
110660549|NCT00977132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110660550|NCT00977132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110660551|NCT00977132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110660552|NCT00977132|Growth Substances|growth substances|mesh-ancestor
110660553|NCT00977132|Growth Inhibitors|growth inhibitors|mesh-ancestor
110660554|NCT00977132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110660555|NCT00545792|Bevacizumab|bevacizumab|mesh-list
110660556|NCT00545792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110660557|NCT00545792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110660558|NCT00545792|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110660559|NCT00545792|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110660560|NCT00545792|Growth Substances|growth substances|mesh-ancestor
110660561|NCT00545792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110660562|NCT00545792|Growth Inhibitors|growth inhibitors|mesh-ancestor
110660563|NCT00977288|Atorvastatin|atorvastatin|mesh-list
110660564|NCT00977288|Anacetrapib|anacetrapib|mesh-list
110660565|NCT00977288|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110660566|NCT00977288|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110660567|NCT00977288|Antimetabolites|antimetabolites|mesh-ancestor
110660568|NCT00977288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110660569|NCT00977288|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110660570|NCT00977288|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110660571|NCT00977288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110660572|NCT00966602|Ivacaftor|ivacaftor|mesh-list
110660573|NCT00966602|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
110660574|NCT00966602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110660575|NCT00966602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110660576|NCT00966680|Anesthetics|anesthetics|mesh-list
110660577|NCT00966680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110660578|NCT00966680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110660579|NCT00977444|Prednisolone|prednisolone|mesh-list
110660580|NCT00977444|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110660581|NCT00977444|Methylprednisolone|methylprednisolone|mesh-list
110660582|NCT00977444|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110660583|NCT00977444|Prednisolone acetate|prednisolone acetate|mesh-list
110660584|NCT00977444|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110307794|NCT00268814|Analgesics|analgesics|mesh-ancestor
110660585|NCT00977444|Prednisolone phosphate|prednisolone phosphate|mesh-list
110660586|NCT00977444|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110660587|NCT00977444|Glucocorticoids|glucocorticoids|mesh-ancestor
110660588|NCT00977444|Hormones|hormones|mesh-ancestor
110660589|NCT00977444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110660590|NCT00977444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110660591|NCT00977444|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110660592|NCT00977444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110660593|NCT00977444|Antiemetics|antiemetics|mesh-ancestor
110660594|NCT00977444|Autonomic Agents|autonomic agents|mesh-ancestor
110660595|NCT00977444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110660596|NCT00977444|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110660597|NCT00977444|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110660598|NCT00977444|Protective Agents|protective agents|mesh-ancestor
110660599|NCT00977600|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
110660600|NCT00977600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110660601|NCT00966836|Mycophenolic Acid|mycophenolic acid|mesh-list
110660602|NCT00966836|Valganciclovir|valganciclovir|mesh-list
110660603|NCT00966836|Everolimus|everolimus|mesh-list
110660604|NCT00966836|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110660605|NCT00966836|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110660606|NCT00966836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110660607|NCT00966836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110660608|NCT00966836|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110660609|NCT00966836|Immunologic Factors|immunologic factors|mesh-ancestor
110660610|NCT00966836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110660611|NCT00966836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110660612|NCT00966836|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110660613|NCT00966836|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110660614|NCT00966836|Antitubercular Agents|antitubercular agents|mesh-ancestor
110660615|NCT00966836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110660616|NCT00966836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110660617|NCT00966836|Antiviral Agents|antiviral agents|mesh-ancestor
110660618|NCT00967070|Nicotine|nicotine|mesh-list
110660619|NCT00967070|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110660620|NCT00967070|Autonomic Agents|autonomic agents|mesh-ancestor
110660621|NCT00967070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110660622|NCT00967070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110660623|NCT00967070|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110660624|NCT00967070|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110660625|NCT00967070|Cholinergic Agents|cholinergic agents|mesh-ancestor
110660626|NCT00967070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110660627|NCT00967070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110660629|NCT00977756|Lopinavir|lopinavir|mesh-list
110660630|NCT00977756|Atazanavir Sulfate|atazanavir sulfate|mesh-list
110660631|NCT00977756|Darunavir|darunavir|mesh-list
110660632|NCT00977756|Tenofovir|tenofovir|mesh-list
110660633|NCT00977756|Raltegravir Potassium|raltegravir potassium|mesh-list
110660634|NCT00977756|Maraviroc|maraviroc|mesh-list
110660635|NCT00977756|Etravirine|etravirine|mesh-list
110660636|NCT00977756|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110660637|NCT00977756|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110660638|NCT00977756|Protease Inhibitors|protease inhibitors|mesh-ancestor
110660639|NCT00977756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110660640|NCT00977756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110660641|NCT00977756|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110660642|NCT00977756|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110660643|NCT00977756|Antiviral Agents|antiviral agents|mesh-ancestor
110660644|NCT00977756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110660645|NCT00977756|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110660646|NCT00977756|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110660647|NCT00977756|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110660648|NCT00977756|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110660649|NCT00977756|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110660650|NCT00977756|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110660651|NCT00977756|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110660652|NCT00977756|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110660653|NCT00977756|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
110660654|NCT00967148|Tinzaparin|tinzaparin|mesh-list
110660655|NCT00967148|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
110660656|NCT00967148|Dalteparin|dalteparin|mesh-list
110660657|NCT00967148|Anticoagulants|anticoagulants|mesh-ancestor
110660658|NCT00967148|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110660659|NCT00967148|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110660660|NCT00967148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110660661|NCT04007588|Nivolumab|nivolumab|mesh-list
110660662|NCT04007588|Ipilimumab|ipilimumab|mesh-list
110660664|NCT04007588|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110660665|NCT04007588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110660666|NCT04007588|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110660667|NCT04007588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110660668|NCT04007588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110660669|NCT00978146|Hydroxyurea|hydroxyurea|mesh-list
110660670|NCT00978146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110660671|NCT00978146|Antisickling Agents|antisickling agents|mesh-ancestor
110660672|NCT00978146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110660673|NCT00978146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110660674|NCT00978146|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110660675|NCT00981968|Sitaxsentan|sitaxsentan|mesh-list
110660676|NCT00981968|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
110660677|NCT00981968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110660678|NCT00982046|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110660679|NCT00967382|Dalteparin|dalteparin|mesh-list
110660680|NCT00967382|Tinzaparin|tinzaparin|mesh-list
110660681|NCT00967382|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
110660682|NCT00967382|Anticoagulants|anticoagulants|mesh-ancestor
110660683|NCT00967382|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110660684|NCT00967382|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110660685|NCT00967382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110660686|NCT00982124|Zoledronic Acid|zoledronic acid|mesh-list
110660687|NCT00982124|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110660688|NCT00982124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110660689|NCT00982202|Pioglitazone|pioglitazone|mesh-list
110660690|NCT00982202|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110660691|NCT00982202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110660692|NCT00967538|Etanercept|etanercept|mesh-list
110660693|NCT00967538|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110660694|NCT00967538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110660695|NCT00967538|Analgesics|analgesics|mesh-ancestor
110660696|NCT00967538|Sensory System Agents|sensory system agents|mesh-ancestor
110660697|NCT00967538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110660698|NCT00967538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110660699|NCT00967538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110660700|NCT00967538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110660701|NCT00967538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110660702|NCT00967538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110660703|NCT00967538|Immunologic Factors|immunologic factors|mesh-ancestor
110660704|NCT00982358|Valsartan|valsartan|mesh-list
110660705|NCT00982358|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110660706|NCT00982358|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110660707|NCT00982358|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110660708|NCT00982358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110660709|NCT00982436|Carboplatin|carboplatin|mesh-list
110660711|NCT00982436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110660712|NCT00982436|Tubulin Modulators|tubulin modulators|mesh-ancestor
110660713|NCT00982436|Antimitotic Agents|antimitotic agents|mesh-ancestor
110660714|NCT00982436|Mitosis Modulators|mitosis modulators|mesh-ancestor
110660715|NCT00982436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110660716|NCT00545168|Permethrin|permethrin|mesh-list
110660717|NCT00545168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110660718|NCT00545168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110660719|NCT00984932|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110660720|NCT00984932|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110660721|NCT00984932|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110660722|NCT00984932|Antimetabolites|antimetabolites|mesh-ancestor
110660723|NCT00984932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110660724|NCT00984932|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110660725|NCT00984932|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110660726|NCT00984932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110660727|NCT00983138|Asparaginase|asparaginase|mesh-list
110660728|NCT00983138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110660729|NCT00544544|Riluzole|riluzole|mesh-list
110660730|NCT00544544|Anticonvulsants|anticonvulsants|mesh-ancestor
110660731|NCT00544544|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110660732|NCT00544544|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110660733|NCT00544544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110660734|NCT00544544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110660735|NCT00544544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110660736|NCT00544544|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110660737|NCT00544544|Protective Agents|protective agents|mesh-ancestor
110660739|NCT00979160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110660740|NCT00979160|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110660741|NCT00979160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110660742|NCT00979160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110660744|NCT00979316|BMS 708163|bms 708163|mesh-list
110660745|NCT00979316|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110660746|NCT00979316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110660747|NCT00979316|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110660748|NCT00979316|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110660749|NCT00979316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110660750|NCT00979316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110660751|NCT00979316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110660752|NCT00979316|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
110660753|NCT00983450|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
110660754|NCT00983450|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
110660755|NCT00983450|beta-Endorphin|beta-endorphin|mesh-list
110660756|NCT00983450|Hormones|hormones|mesh-ancestor
110660757|NCT00983450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110660758|NCT00983450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110660759|NCT00983450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110660760|NCT00983450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110660761|NCT00983996|Alendronate|alendronate|mesh-list
110660762|NCT00983996|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110660763|NCT00983996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110660764|NCT00985244|Azithromycin|azithromycin|mesh-list
110660765|NCT00985244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110660766|NCT00985244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110660767|NCT00979472|Solifenacin Succinate|solifenacin succinate|mesh-list
110660768|NCT00979472|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110660769|NCT00979472|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110660770|NCT00979472|Cholinergic Agents|cholinergic agents|mesh-ancestor
110660771|NCT00979472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110660772|NCT00979472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110660773|NCT00979472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110660774|NCT00979472|Urological Agents|urological agents|mesh-ancestor
110660775|NCT00984152|Efavirenz|efavirenz|mesh-list
110660776|NCT00984152|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110660777|NCT00984152|Raltegravir Potassium|raltegravir potassium|mesh-list
110660778|NCT00984152|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110660779|NCT00984152|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110660780|NCT00984152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110660781|NCT00984152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110660782|NCT00984152|Antiviral Agents|antiviral agents|mesh-ancestor
110660783|NCT00984152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110660784|NCT00984152|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110660785|NCT00984152|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110660786|NCT00984152|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110660787|NCT00984152|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110660788|NCT00984152|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110660789|NCT00984152|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110660790|NCT00984152|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110660791|NCT00984152|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110660792|NCT00984152|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110660793|NCT00984152|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110660794|NCT00985322|Ramipril|ramipril|mesh-list
110660795|NCT00985322|Antihypertensive Agents|antihypertensive agents|mesh-list
110660796|NCT00985322|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
110660797|NCT00985322|Protease Inhibitors|protease inhibitors|mesh-ancestor
110660798|NCT00985322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110660799|NCT00985322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110660800|NCT00984230|Lactoferrin|lactoferrin|mesh-list
110660801|NCT00984230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110660802|NCT00984386|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110660803|NCT00984386|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110660804|NCT00984386|Estradiol|estradiol|mesh-list
110660805|NCT00984386|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110660806|NCT00984386|Estrogens|estrogens|mesh-ancestor
110660807|NCT00984386|Hormones|hormones|mesh-ancestor
110335235|NCT05148546|Nivolumab|nivolumab|mesh-list
110660808|NCT00984386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110660809|NCT00984386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110660810|NCT00984386|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110660811|NCT00984386|Contraceptive Agents|contraceptive agents|mesh-ancestor
110660812|NCT00984386|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110660813|NCT00984386|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110660815|NCT00984464|Carboplatin|carboplatin|mesh-list
110660816|NCT00984464|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110660817|NCT00984464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110660818|NCT00984464|Tubulin Modulators|tubulin modulators|mesh-ancestor
110660819|NCT00984464|Antimitotic Agents|antimitotic agents|mesh-ancestor
110660820|NCT00984464|Mitosis Modulators|mitosis modulators|mesh-ancestor
110660821|NCT00984464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110660822|NCT00985556|Capecitabine|capecitabine|mesh-list
110660823|NCT00985556|Tegafur|tegafur|mesh-list
110660824|NCT00985556|Oxaliplatin|oxaliplatin|mesh-list
110660825|NCT00985556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110660826|NCT00985556|Antimetabolites|antimetabolites|mesh-ancestor
110660827|NCT00985556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110660828|NCT00985556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110660829|NCT04445246|Iloprost|iloprost|mesh-list
110660830|NCT04445246|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110660831|NCT04445246|Vasodilator Agents|vasodilator agents|mesh-ancestor
110660832|NCT00541346|Methylphenidate|methylphenidate|mesh-list
110660833|NCT00541346|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110660834|NCT00541346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110660835|NCT00541346|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110660836|NCT00541346|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110660837|NCT00541346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110660838|NCT00541346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110660839|NCT00541346|Dopamine Agents|dopamine agents|mesh-ancestor
110660840|NCT00541346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110660841|NCT00988520|Bromides|bromides|mesh-list
110660842|NCT00988520|Propofol|propofol|mesh-list
110660843|NCT00988520|Sevoflurane|sevoflurane|mesh-list
110660844|NCT00988520|Rocuronium|rocuronium|mesh-list
110660845|NCT00988520|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110660846|NCT00988520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110660847|NCT00988520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110660848|NCT00988520|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110660849|NCT00988520|Anesthetics, General|anesthetics, general|mesh-ancestor
110660850|NCT00988520|Anesthetics|anesthetics|mesh-ancestor
110660851|NCT00988520|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110660852|NCT00988520|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110660853|NCT00988520|Anticonvulsants|anticonvulsants|mesh-ancestor
110660854|NCT00988520|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110660855|NCT00988520|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110660856|NCT00988520|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110660857|NCT00988520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110660858|NCT05498090|Fenofibrate|fenofibrate|mesh-list
110660859|NCT05498090|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110660860|NCT05498090|Antimetabolites|antimetabolites|mesh-ancestor
110660861|NCT05498090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110660862|NCT05498090|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110660863|NCT00077623|Epoetin Alfa|epoetin alfa|mesh-list
110660864|NCT00077623|Hematinics|hematinics|mesh-ancestor
110660865|NCT00541034|Cyclophosphamide|cyclophosphamide|mesh-list
110660866|NCT00541034|Rituximab|rituximab|mesh-list
110660867|NCT00541034|Pentostatin|pentostatin|mesh-list
110660868|NCT00541034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110660869|NCT00541034|Immunologic Factors|immunologic factors|mesh-ancestor
110660870|NCT00541034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110660871|NCT00541034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110660872|NCT00541034|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110660873|NCT00541034|Alkylating Agents|alkylating agents|mesh-ancestor
110660874|NCT00541034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110660875|NCT00541034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110660876|NCT00541034|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110660877|NCT00541034|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110660878|NCT00541034|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
110660879|NCT00541034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110660880|NCT00540644|Prednisone|prednisone|mesh-list
110660881|NCT00540644|Cyclophosphamide|cyclophosphamide|mesh-list
110660882|NCT00540644|Lenalidomide|lenalidomide|mesh-list
110660883|NCT00540644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110660884|NCT00540644|Immunologic Factors|immunologic factors|mesh-ancestor
110660885|NCT00540644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110660886|NCT00540644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110660887|NCT00540644|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110660888|NCT00540644|Alkylating Agents|alkylating agents|mesh-ancestor
110660889|NCT00540644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110660890|NCT00540644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110660891|NCT00540644|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110660892|NCT00540644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110660893|NCT00540644|Glucocorticoids|glucocorticoids|mesh-ancestor
110660895|NCT00540644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110660896|NCT00540644|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110660897|NCT00540644|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110660898|NCT00540644|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110660899|NCT00540644|Growth Substances|growth substances|mesh-ancestor
110660900|NCT00540644|Growth Inhibitors|growth inhibitors|mesh-ancestor
110660901|NCT05450900|Biotin|biotin|mesh-list
110660902|NCT05450900|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
110660903|NCT05450900|Vitamins|vitamins|mesh-ancestor
110660904|NCT05450900|Micronutrients|micronutrients|mesh-ancestor
110660905|NCT05450900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110660906|NCT05450900|Vitamin B Complex|vitamin b complex|mesh-ancestor
110660907|NCT05450900|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110660908|NCT00988910|Contraceptive Agents|contraceptive agents|mesh-list
110660909|NCT00988910|Contraceptives, Oral|contraceptives, oral|mesh-list
110660910|NCT00988910|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
110660911|NCT00988910|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110660912|NCT00988910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110660913|NCT00988910|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110660914|NCT00986336|Topiramate|topiramate|mesh-list
110660915|NCT00986336|Risperidone|risperidone|mesh-list
110660916|NCT00986336|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110660918|NCT00986336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110660919|NCT00986336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110660920|NCT00986336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110660921|NCT00986336|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110660922|NCT00986336|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110660923|NCT00986336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110660924|NCT00986336|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110660925|NCT00986336|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110660926|NCT00986336|Dopamine Agents|dopamine agents|mesh-ancestor
110660927|NCT00986336|Anticonvulsants|anticonvulsants|mesh-ancestor
110660928|NCT00986336|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110660929|NCT00989300|Omeprazole|omeprazole|mesh-list
110660930|NCT00989300|Rabeprazole|rabeprazole|mesh-list
110660931|NCT00989300|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110660932|NCT00989300|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110660933|NCT00989300|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110660934|NCT00989300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110660935|NCT00989300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110660936|NCT01563614|Cytarabine|cytarabine|mesh-list
110660937|NCT01563614|Lomustine|lomustine|mesh-list
110660938|NCT01563614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110660939|NCT01563614|Antimetabolites|antimetabolites|mesh-ancestor
110660940|NCT01563614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110660941|NCT01563614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110660942|NCT01563614|Antiviral Agents|antiviral agents|mesh-ancestor
110660943|NCT01563614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110660944|NCT01563614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110660945|NCT01563614|Immunologic Factors|immunologic factors|mesh-ancestor
110660946|NCT01563614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110660947|NCT01563614|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110660948|NCT01563614|Alkylating Agents|alkylating agents|mesh-ancestor
110660949|NCT00543296|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
110660950|NCT00543296|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110660951|NCT00543296|Glucocorticoids|glucocorticoids|mesh-ancestor
110660952|NCT00543296|Hormones|hormones|mesh-ancestor
110660953|NCT00543296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110660954|NCT00543296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110660955|NCT00543062|Moxifloxacin|moxifloxacin|mesh-list
110660956|NCT00543062|Prochlorperazine|prochlorperazine|mesh-list
110660957|NCT00543062|Loxapine|loxapine|mesh-list
110660958|NCT00543062|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110335355|NCT00498251|Albuterol|albuterol|mesh-list
110660960|NCT00543062|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110660961|NCT00543062|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110660962|NCT00543062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110660963|NCT00543062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110660964|NCT00543062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110660965|NCT00543062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110660966|NCT00543062|Antiemetics|antiemetics|mesh-ancestor
110660967|NCT00543062|Autonomic Agents|autonomic agents|mesh-ancestor
110660968|NCT00543062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110660969|NCT00543062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110660970|NCT00543062|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110660971|NCT00543062|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110660972|NCT00543062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110660973|NCT00543062|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110660974|NCT00543062|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110660975|NCT00543062|Dopamine Agents|dopamine agents|mesh-ancestor
110660976|NCT00543062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110660977|NCT00986804|Decitabine|decitabine|mesh-list
110660978|NCT00986804|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110660979|NCT00986804|Antimetabolites|antimetabolites|mesh-ancestor
110660980|NCT00986804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110660981|NCT00986804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110660982|NCT00986804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110660983|NCT00676091|Vaccines|vaccines|mesh-list
110660984|NCT00676091|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110660985|NCT00676091|Immunologic Factors|immunologic factors|mesh-ancestor
110660986|NCT00676091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110660987|NCT02558933|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
110660988|NCT02558933|Antioxidants|antioxidants|mesh-ancestor
110660989|NCT02558933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110660990|NCT02558933|Protective Agents|protective agents|mesh-ancestor
110660991|NCT02558933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110660992|NCT02558933|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
110660993|NCT02558933|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110660994|NCT02558933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110660995|NCT02558933|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110660996|NCT00678041|Nitrofurantoin|nitrofurantoin|mesh-list
110660997|NCT00678041|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110660998|NCT00678041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110660999|NCT00678041|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110661000|NCT03903822|PF-06700841|pf-06700841|mesh-list
110661001|NCT03903822|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110661002|NCT03903822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110661003|NCT03903822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110661004|NCT04003350|Acetaminophen|acetaminophen|mesh-list
110661005|NCT04003350|Meloxicam|meloxicam|mesh-list
110661006|NCT04003350|Oxycodone|oxycodone|mesh-list
110661007|NCT04003350|Tramadol|tramadol|mesh-list
110661008|NCT04003350|Gabapentin|gabapentin|mesh-list
110661009|NCT04003350|Esomeprazole|esomeprazole|mesh-list
110661010|NCT04003350|Metaxalone|metaxalone|mesh-list
110661011|NCT04003350|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110661012|NCT04003350|Narcotics|narcotics|mesh-ancestor
110661013|NCT04003350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110661014|NCT04003350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110661015|NCT04003350|Analgesics|analgesics|mesh-ancestor
110661016|NCT04003350|Sensory System Agents|sensory system agents|mesh-ancestor
110661017|NCT04003350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110661018|NCT04003350|Anticonvulsants|anticonvulsants|mesh-ancestor
110661019|NCT04003350|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110661020|NCT04003350|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110661021|NCT04003350|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110661022|NCT04003350|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110661023|NCT04003350|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110661024|NCT04003350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110661025|NCT04003350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110661026|NCT04003350|Antimanic Agents|antimanic agents|mesh-ancestor
110661027|NCT04003350|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110661028|NCT04003350|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110661029|NCT04003350|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110661030|NCT04003350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110661031|NCT04003350|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110661032|NCT04003350|Antipyretics|antipyretics|mesh-ancestor
110308264|NCT00271349|Budesonide|budesonide|mesh-list
110661033|NCT04003350|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110661034|NCT04003350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110661036|NCT04003350|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110661037|NCT04003350|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110661038|NCT04003350|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110661039|NCT00748007|Rivastigmine|rivastigmine|mesh-list
110661040|NCT00748007|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
110661041|NCT00748007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110661042|NCT00748007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110661043|NCT00748007|Cholinergic Agents|cholinergic agents|mesh-ancestor
110661044|NCT00748007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110661045|NCT00748007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110661046|NCT00748007|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110661047|NCT00748007|Protective Agents|protective agents|mesh-ancestor
110661048|NCT00748163|Paclitaxel|paclitaxel|mesh-list
110661049|NCT00748163|Sunitinib|sunitinib|mesh-list
110661050|NCT00748163|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110661051|NCT00748163|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110661052|NCT00748163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110661053|NCT00748163|Tubulin Modulators|tubulin modulators|mesh-ancestor
110661054|NCT00748163|Antimitotic Agents|antimitotic agents|mesh-ancestor
110661055|NCT00748163|Mitosis Modulators|mitosis modulators|mesh-ancestor
110661056|NCT00748163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110661057|NCT00748163|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110661058|NCT00748163|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110661059|NCT00748163|Growth Substances|growth substances|mesh-ancestor
110661060|NCT00748163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110661061|NCT00748163|Growth Inhibitors|growth inhibitors|mesh-ancestor
110661062|NCT00748163|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110661063|NCT00748163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110661064|NCT00687401|Infliximab|infliximab|mesh-list
110661065|NCT00687401|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110661066|NCT00687401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110661067|NCT00687401|Dermatologic Agents|dermatologic agents|mesh-ancestor
110661068|NCT00687401|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110661069|NCT00687401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110661070|NCT00485693|Epinephrine|epinephrine|mesh-list
110661071|NCT00485693|Bupivacaine|bupivacaine|mesh-list
110661072|NCT00485693|Anesthetics, Local|anesthetics, local|mesh-ancestor
110661073|NCT00485693|Anesthetics|anesthetics|mesh-ancestor
110661074|NCT00485693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110661075|NCT00485693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110661076|NCT00485693|Sensory System Agents|sensory system agents|mesh-ancestor
110661077|NCT00485693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110661078|NCT00485693|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110661079|NCT00485693|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110661080|NCT00485693|Adrenergic Agents|adrenergic agents|mesh-ancestor
110661081|NCT00485693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110661082|NCT00485693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110661083|NCT00485693|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110661084|NCT00485693|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110661085|NCT00485693|Autonomic Agents|autonomic agents|mesh-ancestor
110661086|NCT00485693|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110661087|NCT00485693|Respiratory System Agents|respiratory system agents|mesh-ancestor
110661088|NCT00485693|Mydriatics|mydriatics|mesh-ancestor
110661089|NCT00485693|Sympathomimetics|sympathomimetics|mesh-ancestor
110661090|NCT00485693|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110661092|NCT00538902|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110661093|NCT00538902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110661094|NCT00538902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110661095|NCT00541970|Vaccines|vaccines|mesh-list
110661096|NCT00541970|Immunologic Factors|immunologic factors|mesh-ancestor
110661097|NCT00541970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110661098|NCT00687323|Temozolomide|temozolomide|mesh-list
110661099|NCT00687323|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110661100|NCT00687323|Alkylating Agents|alkylating agents|mesh-ancestor
110661101|NCT00687323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110661102|NCT00687323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110661103|NCT00989742|Doxycycline|doxycycline|mesh-list
110661104|NCT00989742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110661105|NCT00989742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110661106|NCT00989742|Antimalarials|antimalarials|mesh-ancestor
110661107|NCT00989742|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110661108|NCT00989742|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110661109|NCT05408208|Triamcinolone|triamcinolone|mesh-list
110661110|NCT05408208|Methotrexate|methotrexate|mesh-list
110683006|NCT00904631|Keratolytic Agents|keratolytic agents|mesh-ancestor
110661111|NCT05408208|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110661112|NCT05408208|Abortifacient Agents|abortifacient agents|mesh-ancestor
110661113|NCT05408208|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110661114|NCT05408208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110661115|NCT05408208|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110661116|NCT05408208|Antimetabolites|antimetabolites|mesh-ancestor
110661117|NCT05408208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110661118|NCT05408208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110661119|NCT05408208|Dermatologic Agents|dermatologic agents|mesh-ancestor
110661120|NCT05408208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110661121|NCT05408208|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110661122|NCT05408208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110661123|NCT05408208|Immunologic Factors|immunologic factors|mesh-ancestor
110661124|NCT05408208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110661125|NCT05408208|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110661126|NCT05408208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110661127|NCT05408208|Glucocorticoids|glucocorticoids|mesh-ancestor
110661129|NCT05408208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110661130|NCT00758693|Rituximab|rituximab|mesh-list
110661131|NCT00758693|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110661132|NCT00758693|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110661133|NCT00758693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110661134|NCT00758693|Immunologic Factors|immunologic factors|mesh-ancestor
110661135|NCT00758693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110661136|NCT00758693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110661137|NCT00758693|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110661138|NCT00758693|Alkylating Agents|alkylating agents|mesh-ancestor
110661139|NCT00758693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110661140|NCT00989820|Coal Tar|coal tar|mesh-list
110661141|NCT00989820|Keratolytic Agents|keratolytic agents|mesh-ancestor
110661142|NCT00989820|Dermatologic Agents|dermatologic agents|mesh-ancestor
110661143|NCT05357820|Itraconazole|itraconazole|mesh-list
110661144|NCT05357820|Rifampin|rifampin|mesh-list
110661145|NCT05357820|Antifungal Agents|antifungal agents|mesh-ancestor
110661146|NCT05357820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110661147|NCT05357820|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110661148|NCT05357820|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110661149|NCT05357820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110661150|NCT05357820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110661151|NCT05357820|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110661152|NCT05357820|Hormone Antagonists|hormone antagonists|mesh-ancestor
110661153|NCT05357820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110661154|NCT05357820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110661155|NCT05357820|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110661156|NCT05357820|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110661157|NCT05357820|Antitubercular Agents|antitubercular agents|mesh-ancestor
110661158|NCT05357820|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110661159|NCT05357820|Leprostatic Agents|leprostatic agents|mesh-ancestor
110661160|NCT05357820|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110661161|NCT05357820|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110661162|NCT05357820|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110661163|NCT05357820|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110661164|NCT05357820|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110661165|NCT05357820|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110661166|NCT05357820|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110661167|NCT00748787|Psyllium|psyllium|mesh-list
110661168|NCT00748787|Calcium polycarbophil|calcium polycarbophil|mesh-list
110661169|NCT00748787|Cathartics|cathartics|mesh-ancestor
110661170|NCT00748787|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110661171|NCT00748787|Antidiarrheals|antidiarrheals|mesh-ancestor
110661172|NCT05712044|Folic Acid|folic acid|mesh-list
110661173|NCT05712044|Vitamin B Complex|vitamin b complex|mesh-list
110661174|NCT05712044|Hematinics|hematinics|mesh-ancestor
110661175|NCT05712044|Vitamins|vitamins|mesh-ancestor
110661176|NCT05712044|Micronutrients|micronutrients|mesh-ancestor
110661177|NCT05712044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110661178|NCT00986960|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
110661179|NCT00986960|Hormones|hormones|mesh-ancestor
110661180|NCT00986960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110661181|NCT00986960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110661182|NCT05711966|Pulmonary Surfactants|pulmonary surfactants|mesh-list
110335583|NCT00503516|Megestrol|megestrol|mesh-list
110308398|NCT00272207|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110661183|NCT05711966|Respiratory System Agents|respiratory system agents|mesh-ancestor
110661184|NCT00759005|Hydrocortisone|hydrocortisone|mesh-list
110661185|NCT00759005|Propranolol|propranolol|mesh-list
110661186|NCT00759005|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110661187|NCT00759005|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110661188|NCT00759005|Adrenergic Agents|adrenergic agents|mesh-ancestor
110661189|NCT00759005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110661190|NCT00759005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110661191|NCT00759005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110661192|NCT00759005|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110661193|NCT00759005|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110661194|NCT00759005|Vasodilator Agents|vasodilator agents|mesh-ancestor
110661195|NCT00759005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110661196|NCT04360070|Ketamine|ketamine|mesh-list
110661197|NCT04360070|Analgesics|analgesics|mesh-ancestor
110661198|NCT04360070|Sensory System Agents|sensory system agents|mesh-ancestor
110661199|NCT04360070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110661200|NCT04360070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110661201|NCT04360070|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110661202|NCT04360070|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110661203|NCT04360070|Anesthetics, General|anesthetics, general|mesh-ancestor
110661204|NCT04360070|Anesthetics|anesthetics|mesh-ancestor
110661205|NCT04360070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110661206|NCT04360070|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110661207|NCT04360070|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110661208|NCT04360070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110661209|NCT04360070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110661210|NCT00748943|Chlorine dioxide|chlorine dioxide|mesh-list
110661211|NCT00748943|Dental Disinfectants|dental disinfectants|mesh-ancestor
110661212|NCT00748943|Disinfectants|disinfectants|mesh-ancestor
110661213|NCT00748943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110661214|NCT00749021|Ranibizumab|ranibizumab|mesh-list
110661215|NCT00749021|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110661216|NCT00749021|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110661217|NCT00749021|Growth Substances|growth substances|mesh-ancestor
110661218|NCT00749021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110661219|NCT00749021|Growth Inhibitors|growth inhibitors|mesh-ancestor
110661220|NCT00749021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110661221|NCT04048889|Ropivacaine|ropivacaine|mesh-list
110661222|NCT04048889|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110661223|NCT04048889|Anesthetics, Local|anesthetics, local|mesh-ancestor
110661224|NCT04048889|Anesthetics|anesthetics|mesh-ancestor
110661225|NCT04048889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110661226|NCT04048889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110661227|NCT04048889|Sensory System Agents|sensory system agents|mesh-ancestor
110661228|NCT04048889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110661229|NCT00987038|Midazolam|midazolam|mesh-list
110661230|NCT00987038|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110661231|NCT00987038|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110661232|NCT00987038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110661233|NCT00987038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110661234|NCT00987038|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110661235|NCT00987038|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110661236|NCT00987038|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110661237|NCT00987038|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110661238|NCT00987038|Anesthetics, General|anesthetics, general|mesh-ancestor
110661239|NCT00987038|Anesthetics|anesthetics|mesh-ancestor
110661240|NCT00987038|GABA Modulators|gaba modulators|mesh-ancestor
110661241|NCT00987038|GABA Agents|gaba agents|mesh-ancestor
110661242|NCT00987038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110661243|NCT00987038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110661244|NCT05711810|Ubiquinone|ubiquinone|mesh-list
110661245|NCT05711810|Coenzyme Q10|coenzyme q10|mesh-list
110661246|NCT05711810|Tocopherols|tocopherols|mesh-list
110661247|NCT05711810|Vitamin E|vitamin e|mesh-list
110661248|NCT05711810|alpha-Tocopherol|alpha-tocopherol|mesh-list
110661249|NCT05711810|Metoprolol|metoprolol|mesh-list
110661250|NCT05711810|Enalapril|enalapril|mesh-list
110661251|NCT05711810|Enalaprilat|enalaprilat|mesh-list
110661252|NCT05711810|Nifedipine|nifedipine|mesh-list
110661253|NCT05711810|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110661254|NCT05711810|Lansoprazole|lansoprazole|mesh-list
110661255|NCT05711810|Superoxide Dismutase|superoxide dismutase|mesh-list
110661256|NCT05711810|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110661257|NCT05711810|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110661258|NCT05711810|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110661259|NCT05711810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110661261|NCT05711810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110661262|NCT05711810|Analgesics|analgesics|mesh-ancestor
110661263|NCT05711810|Sensory System Agents|sensory system agents|mesh-ancestor
110661264|NCT05711810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110661265|NCT05711810|Antidepressive Agents|antidepressive agents|mesh-ancestor
110661266|NCT05711810|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110661267|NCT05711810|Dopamine Agents|dopamine agents|mesh-ancestor
110661268|NCT05711810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110661269|NCT05711810|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110661270|NCT05711810|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110661271|NCT05711810|Sympatholytics|sympatholytics|mesh-ancestor
110661272|NCT05711810|Autonomic Agents|autonomic agents|mesh-ancestor
110661273|NCT05711810|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110661274|NCT05711810|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110661275|NCT05711810|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110661276|NCT05711810|Adrenergic Agents|adrenergic agents|mesh-ancestor
110661277|NCT05711810|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110661278|NCT05711810|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110661279|NCT05711810|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110661280|NCT05711810|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110661281|NCT05711810|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110661282|NCT05711810|Vasodilator Agents|vasodilator agents|mesh-ancestor
110661283|NCT05711810|Tocolytic Agents|tocolytic agents|mesh-ancestor
110661284|NCT05711810|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110661285|NCT05711810|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110661286|NCT05711810|Protease Inhibitors|protease inhibitors|mesh-ancestor
110661287|NCT05711810|Micronutrients|micronutrients|mesh-ancestor
110661288|NCT05711810|Vitamins|vitamins|mesh-ancestor
110661289|NCT05711810|Antioxidants|antioxidants|mesh-ancestor
110661290|NCT05711810|Protective Agents|protective agents|mesh-ancestor
110661291|NCT05711810|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110661292|NCT00759083|Bivalirudin|bivalirudin|mesh-list
110661293|NCT00759083|Antithrombins|antithrombins|mesh-ancestor
110661294|NCT00759083|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110661295|NCT00759083|Protease Inhibitors|protease inhibitors|mesh-ancestor
110661296|NCT00759083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110661297|NCT00759083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110661298|NCT00759083|Anticoagulants|anticoagulants|mesh-ancestor
110661299|NCT00759239|Timolol|timolol|mesh-list
110661300|NCT00759239|Travoprost|travoprost|mesh-list
110661301|NCT00759239|Maleic acid|maleic acid|mesh-list
110661302|NCT00759239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110661303|NCT00759239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110661304|NCT00759239|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110661305|NCT00759239|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110661306|NCT00759239|Adrenergic Agents|adrenergic agents|mesh-ancestor
110661307|NCT00759239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110661308|NCT00759239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110661309|NCT00759239|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110661310|NCT00759239|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110661311|NCT03742908|Clindamycin|clindamycin|mesh-list
110661312|NCT03742908|Clindamycin palmitate|clindamycin palmitate|mesh-list
110661313|NCT03742908|Clindamycin phosphate|clindamycin phosphate|mesh-list
110661314|NCT03742908|Cefazolin|cefazolin|mesh-list
110661315|NCT03742908|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110661316|NCT03742908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110661317|NCT03742908|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110661318|NCT03742908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110661319|NCT03742908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110661320|NCT05357196|Gemcitabine|gemcitabine|mesh-list
110661321|NCT05357196|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110661322|NCT05357196|Antimetabolites|antimetabolites|mesh-ancestor
110661323|NCT05357196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110661324|NCT05357196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110661325|NCT05232630|Fenfluramine|fenfluramine|mesh-list
110661326|NCT05232630|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110661327|NCT05232630|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110661328|NCT05232630|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110661329|NCT05232630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110661330|NCT05232630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110661331|NCT05232630|Serotonin Agents|serotonin agents|mesh-ancestor
110661332|NCT05232630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110661334|NCT03902574|Serotonin Agents|serotonin agents|mesh-ancestor
110661335|NCT03902574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110661336|NCT03902574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110661337|NCT03902574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110661338|NCT03902574|Dopamine Agonists|dopamine agonists|mesh-ancestor
110661339|NCT03902574|Dopamine Agents|dopamine agents|mesh-ancestor
110661340|NCT01004874|Bevacizumab|bevacizumab|mesh-list
110661341|NCT01004874|Temozolomide|temozolomide|mesh-list
110661342|NCT01004874|Topotecan|topotecan|mesh-list
110661343|NCT01004874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110661344|NCT01004874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110661345|NCT01004874|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110661346|NCT01004874|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110661347|NCT01004874|Growth Substances|growth substances|mesh-ancestor
110661348|NCT01004874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110661349|NCT01004874|Growth Inhibitors|growth inhibitors|mesh-ancestor
110661350|NCT01004874|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110661351|NCT01004874|Alkylating Agents|alkylating agents|mesh-ancestor
110661352|NCT01004874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110661353|NCT01004874|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110661354|NCT01004874|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110661355|NCT01004874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110661356|NCT00987116|Prednisone|prednisone|mesh-list
110661357|NCT00987116|Azathioprine|azathioprine|mesh-list
110661358|NCT00987116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110661359|NCT00987116|Glucocorticoids|glucocorticoids|mesh-ancestor
110661360|NCT00987116|Hormones|hormones|mesh-ancestor
110661361|NCT00987116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110661362|NCT00987116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110661363|NCT00987116|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110661364|NCT00987116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110661365|NCT00987116|Antimetabolites|antimetabolites|mesh-ancestor
110661366|NCT00987116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110661367|NCT00987116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110661368|NCT00987116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110661369|NCT00987116|Immunologic Factors|immunologic factors|mesh-ancestor
110661370|NCT00987116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110661371|NCT05711732|Busulfan|busulfan|mesh-list
110661372|NCT05711732|Alkylating Agents|alkylating agents|mesh-ancestor
110661373|NCT05711732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110661374|NCT05711732|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110661375|NCT05711732|Immunologic Factors|immunologic factors|mesh-ancestor
110661376|NCT05711732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110661377|NCT05711732|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110661378|NCT05711732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110661379|NCT05711732|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110661380|NCT04004702|Levetiracetam|levetiracetam|mesh-list
110661381|NCT04004702|Anticonvulsants|anticonvulsants|mesh-ancestor
110661382|NCT04004702|Nootropic Agents|nootropic agents|mesh-ancestor
110661383|NCT00542828|Immunoglobulins|immunoglobulins|mesh-list
110661384|NCT00542828|Thymoglobulin|thymoglobulin|mesh-list
110661385|NCT00542828|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110661386|NCT00542828|Immunologic Factors|immunologic factors|mesh-ancestor
110661387|NCT00542828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110661388|NCT00542828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110661389|NCT04731974|Melatonin|melatonin|mesh-list
110661390|NCT04731974|Antioxidants|antioxidants|mesh-ancestor
110661391|NCT04731974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110661392|NCT04731974|Protective Agents|protective agents|mesh-ancestor
110661393|NCT04731974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110661394|NCT04731974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110661395|NCT00987662|Amlodipine|amlodipine|mesh-list
110661396|NCT00987662|Irbesartan|irbesartan|mesh-list
110661397|NCT00987662|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110661398|NCT00987662|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110661399|NCT00987662|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110661400|NCT00987662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110661401|NCT00987662|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110661402|NCT00987662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110661403|NCT00987662|Vasodilator Agents|vasodilator agents|mesh-ancestor
110661404|NCT00987662|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110661405|NCT00987662|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110661406|NCT04430426|Glycolic acid|glycolic acid|mesh-list
110661407|NCT04430426|Keratolytic Agents|keratolytic agents|mesh-ancestor
110661408|NCT04430426|Dermatologic Agents|dermatologic agents|mesh-ancestor
110661409|NCT00090103|Tamsulosin|tamsulosin|mesh-list
110661410|NCT00090103|Dutasteride|dutasteride|mesh-list
110661411|NCT00090103|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110661412|NCT00090103|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110661413|NCT00090103|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110661414|NCT00090103|Adrenergic Agents|adrenergic agents|mesh-ancestor
110661415|NCT00090103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110661416|NCT00090103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110661417|NCT00090103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110661418|NCT00090103|Urological Agents|urological agents|mesh-ancestor
110661419|NCT00090103|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
110661420|NCT00090103|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110661421|NCT00090103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110661422|NCT00090103|Hormone Antagonists|hormone antagonists|mesh-ancestor
110661423|NCT00090103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110661424|NCT01088659|Tenofovir|tenofovir|mesh-list
110661425|NCT01088659|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110661426|NCT01088659|Antiviral Agents|antiviral agents|mesh-ancestor
110661427|NCT01088659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110661428|NCT01088659|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110661429|NCT01088659|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110661430|NCT01088659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110661431|NCT01088659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110661432|NCT01088659|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110661433|NCT01088659|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110661434|NCT00087607|Ribavirin|ribavirin|mesh-list
110661435|NCT00087607|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110661436|NCT00087607|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110661437|NCT00087607|Antimetabolites|antimetabolites|mesh-ancestor
110661438|NCT00087607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110661439|NCT00087607|Antiviral Agents|antiviral agents|mesh-ancestor
110661440|NCT00087607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110661441|NCT01088737|Imiquimod|imiquimod|mesh-list
110661442|NCT01088737|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110661443|NCT01088737|Immunologic Factors|immunologic factors|mesh-ancestor
110661444|NCT01088737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110661445|NCT01088737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110661446|NCT01088737|Interferon Inducers|interferon inducers|mesh-ancestor
110661447|NCT00069823|Esomeprazole|esomeprazole|mesh-list
110661448|NCT00069823|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
110661449|NCT00069823|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110661450|NCT00069823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110661451|NCT00069823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110661452|NCT00069823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110661453|NCT01088815|Paclitaxel|paclitaxel|mesh-list
110661454|NCT01088815|Gemcitabine|gemcitabine|mesh-list
110661455|NCT01088815|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110661456|NCT01088815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110661457|NCT01088815|Tubulin Modulators|tubulin modulators|mesh-ancestor
110661458|NCT01088815|Antimitotic Agents|antimitotic agents|mesh-ancestor
110661459|NCT01088815|Mitosis Modulators|mitosis modulators|mesh-ancestor
110661460|NCT01088815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110661461|NCT01088815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110661462|NCT01088815|Antimetabolites|antimetabolites|mesh-ancestor
110661463|NCT00086515|Metformin|metformin|mesh-list
110661464|NCT00086515|Pioglitazone|pioglitazone|mesh-list
110661465|NCT00086515|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110661466|NCT00086515|Glipizide|glipizide|mesh-list
110661467|NCT00086515|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110661468|NCT00086515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110661469|NCT00086515|Incretins|incretins|mesh-ancestor
110661470|NCT00086515|Hormones|hormones|mesh-ancestor
110661471|NCT00086515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110661472|NCT00086515|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110661473|NCT00086515|Protease Inhibitors|protease inhibitors|mesh-ancestor
110661474|NCT00086515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110661475|NCT00086515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110661476|NCT00541658|Risedronic Acid|risedronic acid|mesh-list
110661477|NCT00541658|Etidronic Acid|etidronic acid|mesh-list
110661478|NCT00541658|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110661479|NCT00541658|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110661480|NCT00541658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110661481|NCT00541658|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110661482|NCT00541658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110661483|NCT00541658|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110661484|NCT04334174|Brentuximab Vedotin|brentuximab vedotin|mesh-list
110661485|NCT04334174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110661486|NCT04334174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110661487|NCT04334174|Immunotoxins|immunotoxins|mesh-ancestor
110661488|NCT04334174|Immunoconjugates|immunoconjugates|mesh-ancestor
110661489|NCT04334174|Immunologic Factors|immunologic factors|mesh-ancestor
110661490|NCT04334174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110661491|NCT04333706|Capecitabine|capecitabine|mesh-list
110661492|NCT04333706|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110661493|NCT04333706|Antimetabolites|antimetabolites|mesh-ancestor
110661494|NCT04333706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110661495|NCT04333706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110661496|NCT00987974|Atorvastatin|atorvastatin|mesh-list
110661497|NCT00987974|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110661498|NCT00987974|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110661499|NCT00987974|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110661500|NCT00987974|Antimetabolites|antimetabolites|mesh-ancestor
110661501|NCT00987974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110661502|NCT00987974|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110661503|NCT00987974|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110661504|NCT00987974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110661505|NCT03519074|Cisplatin|cisplatin|mesh-list
110661506|NCT03519074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110661507|NCT03905642|Amikacin|amikacin|mesh-list
110661508|NCT03905642|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110661509|NCT03905642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110661510|NCT04126538|Pirfenidone|pirfenidone|mesh-list
110661511|NCT04126538|Analgesics|analgesics|mesh-ancestor
110661512|NCT04126538|Sensory System Agents|sensory system agents|mesh-ancestor
110661513|NCT04126538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110661514|NCT04126538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110661515|NCT04126538|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110661516|NCT04126538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110661517|NCT04126538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110661518|NCT04126538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110661519|NCT04126538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110661520|NCT04004234|Manganese|manganese|mesh-list
110661521|NCT04004234|Paclitaxel|paclitaxel|mesh-list
110661522|NCT04004234|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110661523|NCT04004234|Gemcitabine|gemcitabine|mesh-list
110661524|NCT04004234|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
110661525|NCT04004234|Antibodies|antibodies|mesh-list
110661526|NCT04004234|Immunoglobulins|immunoglobulins|mesh-list
110661527|NCT04004234|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110661528|NCT04004234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110661529|NCT04004234|Tubulin Modulators|tubulin modulators|mesh-ancestor
110661530|NCT04004234|Antimitotic Agents|antimitotic agents|mesh-ancestor
110661531|NCT04004234|Mitosis Modulators|mitosis modulators|mesh-ancestor
110661532|NCT04004234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110661533|NCT04004234|Immunologic Factors|immunologic factors|mesh-ancestor
110661534|NCT04004234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110661535|NCT04004234|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110661537|NCT04004234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110661538|NCT04004234|Trace Elements|trace elements|mesh-ancestor
110661539|NCT04004234|Micronutrients|micronutrients|mesh-ancestor
110661540|NCT00990158|Vitamin K|vitamin k|mesh-list
110661541|NCT00990158|Vitamin K 1|vitamin k 1|mesh-list
110661542|NCT00990158|Vitamins|vitamins|mesh-ancestor
110661543|NCT00990158|Micronutrients|micronutrients|mesh-ancestor
110661544|NCT00990158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110661545|NCT00990158|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110661546|NCT00990158|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110661547|NCT00990158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110661548|NCT00990158|Hemostatics|hemostatics|mesh-ancestor
110661549|NCT00990158|Coagulants|coagulants|mesh-ancestor
110661550|NCT00412984|Warfarin|warfarin|mesh-list
110661551|NCT00412984|Apixaban|apixaban|mesh-list
110661552|NCT00412984|Anticoagulants|anticoagulants|mesh-ancestor
110661553|NCT00412984|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110661554|NCT00412984|Antithrombins|antithrombins|mesh-ancestor
110661555|NCT00412984|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110661556|NCT00412984|Protease Inhibitors|protease inhibitors|mesh-ancestor
110661557|NCT00412984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110661558|NCT00412984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110661560|NCT00539864|Agglutinins|agglutinins|mesh-ancestor
110308769|NCT00273533|Ramipril|ramipril|mesh-list
110661561|NCT00539864|Immunologic Factors|immunologic factors|mesh-ancestor
110661562|NCT00539864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110661563|NCT00539864|Coagulants|coagulants|mesh-ancestor
110661564|NCT04003376|Vitamin D|vitamin d|mesh-list
110661565|NCT04003376|Triamcinolone|triamcinolone|mesh-list
110661566|NCT04003376|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110661567|NCT04003376|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110661568|NCT04003376|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110661569|NCT04003376|Vitamins|vitamins|mesh-ancestor
110661570|NCT04003376|Micronutrients|micronutrients|mesh-ancestor
110661571|NCT04003376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110661572|NCT04003376|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110661573|NCT04003376|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110661574|NCT04003376|Glucocorticoids|glucocorticoids|mesh-ancestor
110661575|NCT04003376|Hormones|hormones|mesh-ancestor
110447592|NCT04217512|Pantoprazole|pantoprazole|mesh-list
110661576|NCT04003376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110661577|NCT04003376|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110661578|NCT04003376|Immunologic Factors|immunologic factors|mesh-ancestor
110661579|NCT04003376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110661580|NCT04003376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110661581|NCT04086212|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110661582|NCT04086212|Icodextrin|icodextrin|mesh-list
110661583|NCT04086212|Dialysis Solutions|dialysis solutions|mesh-list
110661584|NCT05404490|Bupivacaine|bupivacaine|mesh-list
110661585|NCT05404490|Anesthetics, Local|anesthetics, local|mesh-ancestor
110661586|NCT05404490|Anesthetics|anesthetics|mesh-ancestor
110661587|NCT05404490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110661588|NCT05404490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110661589|NCT05404490|Sensory System Agents|sensory system agents|mesh-ancestor
110661590|NCT05404490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110661591|NCT05359874|Bevacizumab|bevacizumab|mesh-list
110661592|NCT05359874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110661593|NCT05359874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110661594|NCT05359874|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110661595|NCT05359874|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110661596|NCT05359874|Growth Substances|growth substances|mesh-ancestor
110661597|NCT05359874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110661598|NCT05359874|Growth Inhibitors|growth inhibitors|mesh-ancestor
110661600|NCT00990392|Bacitracin|bacitracin|mesh-list
110661601|NCT00990392|Polymyxin B|polymyxin b|mesh-list
110661602|NCT00990392|Gramicidin|gramicidin|mesh-list
110661603|NCT00990392|Petrolatum|petrolatum|mesh-list
110661604|NCT00990392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110661605|NCT00990392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110661606|NCT00990392|Emollients|emollients|mesh-ancestor
110661607|NCT00990392|Dermatologic Agents|dermatologic agents|mesh-ancestor
110661608|NCT00990392|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110661609|NCT03367754|Pembrolizumab|pembrolizumab|mesh-list
110661610|NCT03367754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110661611|NCT03367754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110661612|NCT03367754|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110661613|NCT03367754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110661614|NCT03335072|Azithromycin|azithromycin|mesh-list
110661615|NCT03335072|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110661616|NCT03335072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110661617|NCT01034956|Calcium|calcium|mesh-list
110661618|NCT01034956|Hyaluronic Acid|hyaluronic acid|mesh-list
110661619|NCT01034956|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110661620|NCT01034956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110661621|NCT01034956|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110661622|NCT01034956|Immunologic Factors|immunologic factors|mesh-ancestor
110661623|NCT01034956|Viscosupplements|viscosupplements|mesh-ancestor
110661624|NCT01034956|Protective Agents|protective agents|mesh-ancestor
110661625|NCT01580878|Butenafine|butenafine|mesh-list
110661626|NCT01580878|Clotrimazole|clotrimazole|mesh-list
110661627|NCT01580878|Antifungal Agents|antifungal agents|mesh-ancestor
110661628|NCT01580878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110661629|NCT01580878|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110661630|NCT01580878|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110661631|NCT01580878|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110661632|NCT01580878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110661633|NCT01580878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110661634|NCT01580878|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110308855|NCT00274001|Nevirapine|nevirapine|mesh-list
110661636|NCT01580878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110661637|NCT01580878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110661638|NCT05589974|Verteporfin|verteporfin|mesh-list
110661639|NCT05589974|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110661640|NCT05589974|Dermatologic Agents|dermatologic agents|mesh-ancestor
110661641|NCT05589896|Mycophenolic Acid|mycophenolic acid|mesh-list
110661642|NCT05589896|Cyclophosphamide|cyclophosphamide|mesh-list
110661643|NCT05589896|Busulfan|busulfan|mesh-list
110661644|NCT05589896|Fludarabine|fludarabine|mesh-list
110661645|NCT05589896|Tacrolimus|tacrolimus|mesh-list
110661646|NCT05589896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110661647|NCT05589896|Immunologic Factors|immunologic factors|mesh-ancestor
110661648|NCT05589896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110661649|NCT05589896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110447598|NCT01079988|Cyclosporine|cyclosporine|mesh-list
110661650|NCT05589896|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110661651|NCT05589896|Alkylating Agents|alkylating agents|mesh-ancestor
110661652|NCT05589896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110661653|NCT05589896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110661654|NCT05589896|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110661655|NCT05589896|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110661656|NCT05589896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110661657|NCT05589896|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110661658|NCT05589896|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110661659|NCT05589896|Antitubercular Agents|antitubercular agents|mesh-ancestor
110661660|NCT05589896|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110661661|NCT05589896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110661662|NCT00673049|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110661663|NCT00673049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110661664|NCT00673049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110661665|NCT00673049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110661666|NCT00673049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110661667|NCT04003844|Aspirin|aspirin|mesh-list
110661668|NCT04003844|Immunoglobulins|immunoglobulins|mesh-list
110661669|NCT04003844|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110661670|NCT04003844|Antibodies|antibodies|mesh-list
110661671|NCT04003844|Immunoglobulin G|immunoglobulin g|mesh-list
110661672|NCT04003844|Immunologic Factors|immunologic factors|mesh-ancestor
110661673|NCT04003844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110661674|NCT04003844|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110661675|NCT04003844|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110661676|NCT04003844|Analgesics|analgesics|mesh-ancestor
110661677|NCT04003844|Sensory System Agents|sensory system agents|mesh-ancestor
110661678|NCT04003844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110661679|NCT04003844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110661680|NCT04003844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110661681|NCT04003844|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110661682|NCT04003844|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110661683|NCT04003844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110661684|NCT04003844|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110661685|NCT04003844|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110661686|NCT04003844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110661687|NCT04003844|Antipyretics|antipyretics|mesh-ancestor
110661688|NCT05589584|Acetylcysteine|acetylcysteine|mesh-list
110661689|NCT05589584|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110661691|NCT05589584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110661692|NCT05589584|Expectorants|expectorants|mesh-ancestor
110661693|NCT05589584|Respiratory System Agents|respiratory system agents|mesh-ancestor
110661694|NCT05589584|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110661695|NCT05589584|Antioxidants|antioxidants|mesh-ancestor
110661696|NCT05589584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110661697|NCT05589584|Protective Agents|protective agents|mesh-ancestor
110661698|NCT05589584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110661699|NCT05589584|Antidotes|antidotes|mesh-ancestor
110661700|NCT00412750|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110661701|NCT00412750|Telbivudine|telbivudine|mesh-list
110661702|NCT00412750|Antiviral Agents|antiviral agents|mesh-ancestor
110661703|NCT00412750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110661704|NCT00412750|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110661705|NCT00412750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110661706|NCT00412750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110661707|NCT05361278|Chlorhexidine|chlorhexidine|mesh-list
110661708|NCT05361278|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110661709|NCT05361278|Sodium Hypochlorite|sodium hypochlorite|mesh-list
110661710|NCT05361278|Eusol|eusol|mesh-list
110661711|NCT05361278|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110661712|NCT05361278|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110661713|NCT05361278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110661714|NCT05361278|Disinfectants|disinfectants|mesh-ancestor
110661715|NCT05361278|Dermatologic Agents|dermatologic agents|mesh-ancestor
110661716|NCT00764855|Propofol|propofol|mesh-list
110661717|NCT00764855|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110661718|NCT00764855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110661719|NCT00764855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110661720|NCT00764855|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110661721|NCT00764855|Anesthetics, General|anesthetics, general|mesh-ancestor
110661722|NCT00764855|Anesthetics|anesthetics|mesh-ancestor
110661723|NCT00759317|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
110661724|NCT00759317|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110661725|NCT00759317|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110661726|NCT00759317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110661727|NCT00759317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110661728|NCT00759317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110661729|NCT00759317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110661730|NCT00759317|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110661731|NCT00759317|Antidepressive Agents|antidepressive agents|mesh-ancestor
110661732|NCT00759317|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110661733|NCT00076999|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110661734|NCT01041040|Gemtuzumab|gemtuzumab|mesh-list
110661735|NCT01041040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110661736|NCT01041040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110661737|NCT01041040|Immunotoxins|immunotoxins|mesh-ancestor
110661738|NCT01041040|Immunoconjugates|immunoconjugates|mesh-ancestor
110661739|NCT01041040|Immunologic Factors|immunologic factors|mesh-ancestor
110661740|NCT01041040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110661741|NCT00765011|Cetuximab|cetuximab|mesh-list
110661742|NCT00765011|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110661743|NCT00765011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110661744|NCT00765167|Chlorhexidine|chlorhexidine|mesh-list
110661745|NCT00765167|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110661746|NCT00765167|Triclosan|triclosan|mesh-list
110661747|NCT00765167|Fluorides|fluorides|mesh-list
110661748|NCT00765167|Cariostatic Agents|cariostatic agents|mesh-ancestor
110661749|NCT00765167|Protective Agents|protective agents|mesh-ancestor
110661750|NCT00765167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110661751|NCT00765167|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110661752|NCT00765167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110661753|NCT00765167|Disinfectants|disinfectants|mesh-ancestor
110661754|NCT00765167|Dermatologic Agents|dermatologic agents|mesh-ancestor
110661755|NCT00765167|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
110661756|NCT00765167|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110661757|NCT00765167|Antimetabolites|antimetabolites|mesh-ancestor
110661758|NCT00765167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110661759|NCT00765167|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110661760|NCT00759551|Olmesartan|olmesartan|mesh-list
110661761|NCT00759551|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
110661762|NCT00759551|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110661763|NCT00759551|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110661764|NCT00759551|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110661765|NCT00759551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110661767|NCT03905096|BI 425809|bi 425809|mesh-list
110661768|NCT03905096|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110661769|NCT03905096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110661770|NCT03905096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110661771|NCT03905096|Cholinergic Agents|cholinergic agents|mesh-ancestor
110661772|NCT03905096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110661773|NCT03905096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110661774|NCT03905096|Nootropic Agents|nootropic agents|mesh-ancestor
110661775|NCT00412360|Cyclosporine|cyclosporine|mesh-list
110661776|NCT00412360|Mycophenolic Acid|mycophenolic acid|mesh-list
110661777|NCT00412360|Cyclophosphamide|cyclophosphamide|mesh-list
110661778|NCT00412360|Fludarabine|fludarabine|mesh-list
110661779|NCT00412360|Cyclosporins|cyclosporins|mesh-list
110661780|NCT00412360|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110661781|NCT00412360|Immunologic Factors|immunologic factors|mesh-ancestor
110661782|NCT00412360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110661783|NCT00412360|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110661784|NCT00412360|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110661785|NCT00412360|Alkylating Agents|alkylating agents|mesh-ancestor
110661786|NCT00412360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110661787|NCT00412360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110661788|NCT00412360|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110661789|NCT00412360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110661791|NCT00412360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110661792|NCT00412360|Dermatologic Agents|dermatologic agents|mesh-ancestor
110661793|NCT00412360|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110661794|NCT00412360|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110661795|NCT00412360|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110661796|NCT00412360|Antitubercular Agents|antitubercular agents|mesh-ancestor
110661797|NCT00412360|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110661798|NCT00761501|Naproxen|naproxen|mesh-list
110661799|NCT00761501|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110661800|NCT00761501|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110661801|NCT00761501|Analgesics|analgesics|mesh-ancestor
110661802|NCT00761501|Sensory System Agents|sensory system agents|mesh-ancestor
110661803|NCT00761501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110661804|NCT00761501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110661805|NCT00761501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110661806|NCT00761501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110661807|NCT00761501|Gout Suppressants|gout suppressants|mesh-ancestor
110661808|NCT00761501|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110661809|NCT00761501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110661810|NCT00761501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110661811|NCT01088893|Everolimus|everolimus|mesh-list
110661812|NCT01088893|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110661813|NCT01088893|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110661814|NCT01088893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110661815|NCT01088893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110661816|NCT01088893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110661817|NCT01088893|Immunologic Factors|immunologic factors|mesh-ancestor
110661818|NCT01088893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110661819|NCT01088893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110661820|NCT03026036|Raclopride|raclopride|mesh-list
110661821|NCT03026036|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110661822|NCT03026036|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110661823|NCT03026036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110661824|NCT03026036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110661825|NCT03026036|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110661826|NCT03026036|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110661827|NCT03026036|Dopamine Agents|dopamine agents|mesh-ancestor
110661828|NCT03026036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110661829|NCT03026036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110661830|NCT00990860|Doxorubicin|doxorubicin|mesh-list
110661831|NCT00990860|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110661832|NCT00990860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110661833|NCT00990860|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110661834|NCT00990860|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110661835|NCT00990860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110661836|NCT00990860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110661837|NCT01035190|Budesonide|budesonide|mesh-list
110661838|NCT01035190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110661839|NCT01035190|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110661840|NCT01035190|Autonomic Agents|autonomic agents|mesh-ancestor
110661841|NCT01035190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110661842|NCT01035190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110661843|NCT01035190|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110661844|NCT01035190|Respiratory System Agents|respiratory system agents|mesh-ancestor
110661845|NCT01035190|Glucocorticoids|glucocorticoids|mesh-ancestor
110661846|NCT01035190|Hormones|hormones|mesh-ancestor
110661847|NCT01035190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110661848|NCT00571103|Acamprosate|acamprosate|mesh-list
110661849|NCT00571103|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110661850|NCT00084799|Antibodies|antibodies|mesh-list
110661851|NCT00084799|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110661852|NCT00084799|Immunologic Factors|immunologic factors|mesh-ancestor
110661853|NCT00084799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110661854|NCT00765557|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
110661855|NCT00765557|Laxatives|laxatives|mesh-ancestor
110661856|NCT00765557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110661857|NCT01086553|Budesonide|budesonide|mesh-list
110661858|NCT01086553|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110661859|NCT01086553|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110661860|NCT01086553|Autonomic Agents|autonomic agents|mesh-ancestor
110661861|NCT01086553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110661862|NCT01086553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110661863|NCT01086553|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110661864|NCT01086553|Respiratory System Agents|respiratory system agents|mesh-ancestor
110661865|NCT01086553|Glucocorticoids|glucocorticoids|mesh-ancestor
110661866|NCT01086553|Hormones|hormones|mesh-ancestor
110447606|NCT01079988|Antimetabolites|antimetabolites|mesh-ancestor
110661867|NCT01086553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110661868|NCT01041508|Cyclosporine|cyclosporine|mesh-list
110661869|NCT01041508|Mycophenolic Acid|mycophenolic acid|mesh-list
110661870|NCT01041508|Clofarabine|clofarabine|mesh-list
110661871|NCT01041508|Cyclosporins|cyclosporins|mesh-list
110661872|NCT01041508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110661873|NCT01041508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110661874|NCT01041508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110661875|NCT01041508|Immunologic Factors|immunologic factors|mesh-ancestor
110661876|NCT01041508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110661877|NCT01041508|Antifungal Agents|antifungal agents|mesh-ancestor
110661878|NCT01041508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110661879|NCT01041508|Dermatologic Agents|dermatologic agents|mesh-ancestor
110661880|NCT01041508|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110661881|NCT01041508|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110661882|NCT01041508|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110661883|NCT01041508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110661884|NCT01041508|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110661885|NCT01041508|Antitubercular Agents|antitubercular agents|mesh-ancestor
110661886|NCT01041508|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110661887|NCT01041508|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110661888|NCT01041508|Antimetabolites|antimetabolites|mesh-ancestor
110661889|NCT00766025|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110661890|NCT00766025|Calcium|calcium|mesh-list
110661891|NCT00766025|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110661892|NCT00766025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110661893|NCT00766025|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110661894|NCT00766025|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110661895|NCT00766025|Antimetabolites|antimetabolites|mesh-ancestor
110661896|NCT00766025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110661897|NCT00766025|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110661898|NCT00766025|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110661899|NCT00766025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110661900|NCT00766181|Lidocaine|lidocaine|mesh-list
110661901|NCT00766181|Anesthetics, Local|anesthetics, local|mesh-ancestor
110661902|NCT00766181|Anesthetics|anesthetics|mesh-ancestor
110661903|NCT00766181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110661904|NCT00766181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110661905|NCT00766181|Sensory System Agents|sensory system agents|mesh-ancestor
110661906|NCT00766181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110661907|NCT00766181|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110661908|NCT00766181|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110661909|NCT00766181|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110661910|NCT00766181|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110661911|NCT00766181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110661912|NCT04048577|Natalizumab|natalizumab|mesh-list
110661913|NCT04048577|Immunologic Factors|immunologic factors|mesh-ancestor
110661914|NCT04048577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110661916|NCT00991250|Dacarbazine|dacarbazine|mesh-list
110661917|NCT00991250|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110661918|NCT00991250|Alkylating Agents|alkylating agents|mesh-ancestor
110661919|NCT00991250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110661920|NCT00991250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110661921|NCT00418522|Insulin|insulin|mesh-list
110661922|NCT00418522|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110661923|NCT00418522|Insulin Glargine|insulin glargine|mesh-list
110661924|NCT00418522|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110661925|NCT00418522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110661926|NCT00760175|Vaccines|vaccines|mesh-list
110661927|NCT00760175|Immunologic Factors|immunologic factors|mesh-ancestor
110661928|NCT00760175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110661929|NCT00766337|Sirolimus|sirolimus|mesh-list
110661930|NCT00766337|Temsirolimus|temsirolimus|mesh-list
110661931|NCT00766337|Ranibizumab|ranibizumab|mesh-list
110661932|NCT00766337|MTOR Inhibitors|mtor inhibitors|mesh-list
110661933|NCT00766337|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110683007|NCT00904631|Dermatologic Agents|dermatologic agents|mesh-ancestor
110661934|NCT00766337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110661935|NCT00766337|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110661936|NCT00766337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110661937|NCT00766337|Antifungal Agents|antifungal agents|mesh-ancestor
110661938|NCT00766337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110661939|NCT00766337|Immunologic Factors|immunologic factors|mesh-ancestor
110661940|NCT00766337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110661941|NCT00766337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110661942|NCT00766337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110661943|NCT00766337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110661944|NCT00766337|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110661945|NCT00766337|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110661946|NCT00766337|Growth Substances|growth substances|mesh-ancestor
110661947|NCT00766337|Growth Inhibitors|growth inhibitors|mesh-ancestor
110661948|NCT00991562|Lorvotuzumab mertansine|lorvotuzumab mertansine|mesh-list
110661949|NCT00991562|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
110661950|NCT00991562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110661951|NCT00991562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110661952|NCT00991562|Immunotoxins|immunotoxins|mesh-ancestor
110661953|NCT00991562|Immunoconjugates|immunoconjugates|mesh-ancestor
110661954|NCT00991562|Immunologic Factors|immunologic factors|mesh-ancestor
110661955|NCT00991562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110661956|NCT00991562|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110661957|NCT00991562|Tubulin Modulators|tubulin modulators|mesh-ancestor
110661958|NCT00991562|Antimitotic Agents|antimitotic agents|mesh-ancestor
110661959|NCT00991562|Mitosis Modulators|mitosis modulators|mesh-ancestor
110661960|NCT00991562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110661961|NCT00762671|Ebselen|ebselen|mesh-list
110661962|NCT00762671|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110661963|NCT00762671|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110661964|NCT00762671|Analgesics|analgesics|mesh-ancestor
110661965|NCT00762671|Sensory System Agents|sensory system agents|mesh-ancestor
110661966|NCT00762671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110661967|NCT00762671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110661968|NCT00762671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110661969|NCT00762671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110661970|NCT00762671|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110661971|NCT00762671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110661973|NCT00762671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110661974|NCT00762671|Protective Agents|protective agents|mesh-ancestor
110661975|NCT00762671|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110661976|NCT00762671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110661977|NCT00762671|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110661978|NCT02558387|Nintedanib|nintedanib|mesh-list
110661979|NCT02558387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110661980|NCT02558387|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110661981|NCT02558387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110661982|NCT02558387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110661983|NCT00766805|Propranolol|propranolol|mesh-list
110661984|NCT00766805|Isosorbide|isosorbide|mesh-list
110661985|NCT00766805|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
110661986|NCT00766805|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
110661987|NCT00766805|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110661988|NCT00766805|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110661989|NCT00766805|Adrenergic Agents|adrenergic agents|mesh-ancestor
110661990|NCT00766805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110661991|NCT00766805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110661992|NCT00766805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110661993|NCT00766805|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110661994|NCT00766805|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110661995|NCT00766805|Vasodilator Agents|vasodilator agents|mesh-ancestor
110661996|NCT00766805|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110661997|NCT00766805|Diuretics|diuretics|mesh-ancestor
110661998|NCT00766805|Natriuretic Agents|natriuretic agents|mesh-ancestor
110661999|NCT00766805|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
110662000|NCT00762749|Diphenhydramine|diphenhydramine|mesh-list
110662001|NCT00762749|Promethazine|promethazine|mesh-list
110662002|NCT00762749|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110662003|NCT00762749|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110662004|NCT00762749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110662005|NCT00762749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110662006|NCT00762749|Anesthetics, Local|anesthetics, local|mesh-ancestor
110662007|NCT00762749|Anesthetics|anesthetics|mesh-ancestor
110662008|NCT00762749|Sensory System Agents|sensory system agents|mesh-ancestor
110662009|NCT00762749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110662010|NCT00762749|Antiemetics|antiemetics|mesh-ancestor
110662011|NCT00762749|Autonomic Agents|autonomic agents|mesh-ancestor
110662012|NCT00762749|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110662013|NCT00762749|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110662014|NCT00762749|Histamine Antagonists|histamine antagonists|mesh-ancestor
110662015|NCT00762749|Histamine Agents|histamine agents|mesh-ancestor
110662016|NCT00762749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110662017|NCT00762749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110662018|NCT00762749|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110662019|NCT00762749|Antipruritics|antipruritics|mesh-ancestor
110662020|NCT00762749|Dermatologic Agents|dermatologic agents|mesh-ancestor
110662022|NCT00403546|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110662023|NCT00403546|Serotonin Agents|serotonin agents|mesh-ancestor
110662024|NCT00403546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110662025|NCT00403546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110662026|NCT00403546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110662027|NCT00403546|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110662028|NCT00403546|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110662029|NCT00403546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110662030|NCT00403546|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110662031|NCT00403546|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110662032|NCT00403546|Dopamine Agents|dopamine agents|mesh-ancestor
110662033|NCT00767117|Ritonavir|ritonavir|mesh-list
110662034|NCT00767117|Lopinavir|lopinavir|mesh-list
110662035|NCT00767117|Etravirine|etravirine|mesh-list
110662036|NCT00767117|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110662037|NCT00767117|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110662038|NCT00767117|Protease Inhibitors|protease inhibitors|mesh-ancestor
110662039|NCT00767117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110662040|NCT00767117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110662041|NCT00767117|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110662042|NCT00767117|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110662043|NCT00767117|Antiviral Agents|antiviral agents|mesh-ancestor
110662044|NCT00767117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110662045|NCT00767117|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110662046|NCT00767117|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110662047|NCT00767117|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110662048|NCT00767117|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110662049|NCT00762983|Loratadine|loratadine|mesh-list
110662050|NCT00762983|Antipruritics|antipruritics|mesh-ancestor
110662051|NCT00762983|Dermatologic Agents|dermatologic agents|mesh-ancestor
110662052|NCT00762983|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110662053|NCT00762983|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110662054|NCT00762983|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110662055|NCT00762983|Histamine Antagonists|histamine antagonists|mesh-ancestor
110662056|NCT00762983|Histamine Agents|histamine agents|mesh-ancestor
110662057|NCT00762983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110662058|NCT00762983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110662059|NCT00762983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110662060|NCT00403234|Buprenorphine|buprenorphine|mesh-list
110447635|NCT00636142|Infliximab|infliximab|mesh-list
110662061|NCT00403234|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110662062|NCT00403234|Narcotics|narcotics|mesh-ancestor
110662063|NCT00403234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110662064|NCT00403234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110662065|NCT00403234|Analgesics|analgesics|mesh-ancestor
110662066|NCT00403234|Sensory System Agents|sensory system agents|mesh-ancestor
110662067|NCT00403234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110662069|NCT04049201|Midazolam|midazolam|mesh-list
110662070|NCT04049201|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110662071|NCT04049201|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110662072|NCT04049201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110662073|NCT04049201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110662074|NCT04049201|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110662075|NCT04049201|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110662076|NCT04049201|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110662077|NCT04049201|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110662078|NCT04049201|Anesthetics, General|anesthetics, general|mesh-ancestor
110662079|NCT04049201|Anesthetics|anesthetics|mesh-ancestor
110662080|NCT04049201|GABA Modulators|gaba modulators|mesh-ancestor
110662081|NCT04049201|GABA Agents|gaba agents|mesh-ancestor
110662082|NCT04049201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110662083|NCT04049201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110662084|NCT00767663|Dipyridamole|dipyridamole|mesh-list
110662086|NCT00767663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110662087|NCT00767663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110662088|NCT00767663|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110662089|NCT00767663|Vasodilator Agents|vasodilator agents|mesh-ancestor
110662090|NCT00402688|Levofloxacin|levofloxacin|mesh-list
110662092|NCT00402688|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110662093|NCT00402688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110662094|NCT00402688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110662095|NCT00402688|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110662096|NCT00402688|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110662097|NCT00402688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110662098|NCT00402688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110662099|NCT00402688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110662100|NCT00402688|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110662101|NCT00402688|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110662102|NCT04049045|Empagliflozin|empagliflozin|mesh-list
110662103|NCT04049045|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110662104|NCT04049045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110662105|NCT04049045|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110662106|NCT04049045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110662107|NCT00763373|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110662108|NCT00763373|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
110662109|NCT00763373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110662110|NCT00763373|Antitubercular Agents|antitubercular agents|mesh-ancestor
110662111|NCT01035580|Curcumin|curcumin|mesh-list
110662112|NCT01035580|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110662113|NCT01035580|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110662114|NCT01035580|Analgesics|analgesics|mesh-ancestor
110662115|NCT01035580|Sensory System Agents|sensory system agents|mesh-ancestor
110662116|NCT01035580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110662117|NCT01035580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110662118|NCT01035580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110662119|NCT01035580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110662120|NCT01035580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110662121|NCT01035580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110677027|NCT03110978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110662122|NCT01035580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110662123|NCT00671879|Carisoprodol|carisoprodol|mesh-list
110662124|NCT00671879|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110662125|NCT00671879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110662126|NCT00671879|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110662127|NCT00671879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110447643|NCT02499562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110662128|NCT00402298|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
110662129|NCT00402298|Hallucinogens|hallucinogens|mesh-ancestor
110662130|NCT00402298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110662131|NCT00402298|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110662132|NCT00402298|Serotonin Agents|serotonin agents|mesh-ancestor
110662133|NCT00402298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110662134|NCT00402298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110662135|NCT00402298|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110662136|NCT00402298|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110662137|NCT00402298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110662138|NCT00402298|Adrenergic Agents|adrenergic agents|mesh-ancestor
110662139|NCT00767975|Rifampin|rifampin|mesh-list
110662141|NCT00767975|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110662142|NCT00767975|Antitubercular Agents|antitubercular agents|mesh-ancestor
110662143|NCT00767975|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110662144|NCT00767975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110662145|NCT00767975|Leprostatic Agents|leprostatic agents|mesh-ancestor
110662146|NCT00767975|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110662147|NCT00767975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110662148|NCT00767975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110662149|NCT00767975|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110662150|NCT00767975|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110662151|NCT00767975|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110662152|NCT00767975|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110662153|NCT00767975|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110662154|NCT00767975|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110662156|NCT00767975|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110662157|NCT00767975|Antimetabolites|antimetabolites|mesh-ancestor
110662158|NCT00767975|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110662159|NCT00768131|Paclitaxel|paclitaxel|mesh-list
110662160|NCT00768131|Carboplatin|carboplatin|mesh-list
110662161|NCT00768131|Cetuximab|cetuximab|mesh-list
110662162|NCT00768131|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110662163|NCT00768131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110662164|NCT00768131|Tubulin Modulators|tubulin modulators|mesh-ancestor
110662165|NCT00768131|Antimitotic Agents|antimitotic agents|mesh-ancestor
110662166|NCT00768131|Mitosis Modulators|mitosis modulators|mesh-ancestor
110662167|NCT00768131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110662168|NCT00768131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110662169|NCT00401830|Lacosamide|lacosamide|mesh-list
110662170|NCT00401830|Anticonvulsants|anticonvulsants|mesh-ancestor
110662171|NCT00401830|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110662172|NCT00401830|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110662173|NCT00401830|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110662174|NCT00401830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110662175|NCT00768209|Topiramate|topiramate|mesh-list
110662176|NCT00768209|Phentermine|phentermine|mesh-list
110662177|NCT00768209|Anticonvulsants|anticonvulsants|mesh-ancestor
110662178|NCT00768209|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110447650|NCT04304430|Protease Inhibitors|protease inhibitors|mesh-ancestor
110662179|NCT00768209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110662180|NCT00768209|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110662181|NCT00768209|Appetite Depressants|appetite depressants|mesh-ancestor
110662182|NCT00768209|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110662183|NCT00768209|Sympathomimetics|sympathomimetics|mesh-ancestor
110662184|NCT00768209|Autonomic Agents|autonomic agents|mesh-ancestor
110662185|NCT00768209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110662186|NCT00768209|Adrenergic Agents|adrenergic agents|mesh-ancestor
110662187|NCT00768209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110662188|NCT00768209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110662189|NCT00401752|Esomeprazole|esomeprazole|mesh-list
110662190|NCT00401752|Ranitidine|ranitidine|mesh-list
110662191|NCT00401752|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
110662192|NCT00401752|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110662193|NCT00401752|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110662194|NCT00401752|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110662195|NCT00401752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110677028|NCT03110978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110662196|NCT00401752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110662197|NCT00401752|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110662198|NCT00401752|Histamine Antagonists|histamine antagonists|mesh-ancestor
110662199|NCT00401752|Histamine Agents|histamine agents|mesh-ancestor
110662200|NCT00401752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110662201|NCT00401752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110662202|NCT00770471|Temozolomide|temozolomide|mesh-list
110662203|NCT00770471|Veliparib|veliparib|mesh-list
110662204|NCT00770471|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110662205|NCT00770471|Alkylating Agents|alkylating agents|mesh-ancestor
110662206|NCT00770471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110662207|NCT00770471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110662208|NCT00770471|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110662209|NCT00770471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110662210|NCT00539240|Antidepressive Agents|antidepressive agents|mesh-list
110662211|NCT00539240|Nortriptyline|nortriptyline|mesh-list
110662212|NCT00539240|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-list
110662213|NCT00539240|Rabeprazole|rabeprazole|mesh-list
110662214|NCT00539240|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110662215|NCT00539240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110662216|NCT00539240|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110662217|NCT00539240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110662218|NCT00539240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110662219|NCT00539240|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110662220|NCT00539240|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110662221|NCT00539240|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110662222|NCT00539240|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110662223|NCT00539240|Adrenergic Agents|adrenergic agents|mesh-ancestor
110662224|NCT00539240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110662225|NCT00539240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110662226|NCT00417976|Bevacizumab|bevacizumab|mesh-list
110662227|NCT00417976|Gemcitabine|gemcitabine|mesh-list
110662228|NCT00417976|Fluorouracil|fluorouracil|mesh-list
110336638|NCT00510393|Everolimus|everolimus|mesh-list
110662229|NCT00417976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110662230|NCT00417976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110662231|NCT00417976|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110662232|NCT00417976|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110447674|NCT02749162|Antiemetics|antiemetics|mesh-ancestor
110662233|NCT00417976|Growth Substances|growth substances|mesh-ancestor
110662234|NCT00417976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110309446|NCT00309699|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110662235|NCT00417976|Growth Inhibitors|growth inhibitors|mesh-ancestor
110662236|NCT00417976|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110662238|NCT00417976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110662239|NCT00417976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110662240|NCT00417976|Immunologic Factors|immunologic factors|mesh-ancestor
110662241|NCT00770705|Phenoxybenzamine|phenoxybenzamine|mesh-list
110662242|NCT00770705|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110662243|NCT00770705|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110662244|NCT00770705|Adrenergic Agents|adrenergic agents|mesh-ancestor
110662245|NCT00770705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110662246|NCT00770705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110662247|NCT00770705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110662248|NCT00770705|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110662249|NCT00770705|Vasodilator Agents|vasodilator agents|mesh-ancestor
110662250|NCT00991796|Paclitaxel|paclitaxel|mesh-list
110662251|NCT00991796|Carboplatin|carboplatin|mesh-list
110662252|NCT00991796|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110662253|NCT00991796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110662254|NCT00991796|Tubulin Modulators|tubulin modulators|mesh-ancestor
110662255|NCT00991796|Antimitotic Agents|antimitotic agents|mesh-ancestor
110662256|NCT00991796|Mitosis Modulators|mitosis modulators|mesh-ancestor
110662257|NCT00991796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110662258|NCT00673673|Bevacizumab|bevacizumab|mesh-list
110662259|NCT00673673|Fluorouracil|fluorouracil|mesh-list
110662260|NCT00673673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110662261|NCT00673673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110662262|NCT00673673|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110662263|NCT00673673|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110662264|NCT00673673|Growth Substances|growth substances|mesh-ancestor
110662265|NCT00673673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110662266|NCT00673673|Growth Inhibitors|growth inhibitors|mesh-ancestor
110662267|NCT00673673|Antimetabolites|antimetabolites|mesh-ancestor
110662268|NCT00673673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110662269|NCT00673673|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110662270|NCT00673673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110662271|NCT00673673|Immunologic Factors|immunologic factors|mesh-ancestor
110662272|NCT00763685|Etoricoxib|etoricoxib|mesh-list
110662273|NCT00763685|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110662274|NCT00763685|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110662275|NCT00763685|Analgesics|analgesics|mesh-ancestor
110662276|NCT00763685|Sensory System Agents|sensory system agents|mesh-ancestor
110662277|NCT00763685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110662278|NCT00763685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110662279|NCT00763685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110662280|NCT00763685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110662281|NCT00763685|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110662282|NCT00763685|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110662283|NCT00763685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110662284|NCT00763685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110662285|NCT04048655|Neostigmine|neostigmine|mesh-list
110662286|NCT04048655|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110662287|NCT04048655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110662288|NCT04048655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110662289|NCT04048655|Cholinergic Agents|cholinergic agents|mesh-ancestor
110662290|NCT04048655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110662291|NCT04048655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110662292|NCT04048655|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110662293|NCT04048655|Autonomic Agents|autonomic agents|mesh-ancestor
110662294|NCT04048655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110662295|NCT00768677|Topiramate|topiramate|mesh-list
110662296|NCT00768677|Anticonvulsants|anticonvulsants|mesh-ancestor
110662297|NCT00768677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110662298|NCT00768677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110662299|NCT02557451|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
110662300|NCT02557451|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110662301|NCT02557451|Growth Substances|growth substances|mesh-ancestor
110662302|NCT02557451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110662303|NCT02557451|Growth Inhibitors|growth inhibitors|mesh-ancestor
110662304|NCT02557451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110662305|NCT05408936|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
110662306|NCT05408936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110662307|NCT05408936|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110662308|NCT05408936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110662309|NCT02558153|Paclitaxel|paclitaxel|mesh-list
110662310|NCT02558153|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110662311|NCT02558153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110662312|NCT02558153|Tubulin Modulators|tubulin modulators|mesh-ancestor
110662313|NCT02558153|Antimitotic Agents|antimitotic agents|mesh-ancestor
110662314|NCT02558153|Mitosis Modulators|mitosis modulators|mesh-ancestor
110662315|NCT02558153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110662316|NCT00763763|Interferons|interferons|mesh-list
110662317|NCT00763763|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110662318|NCT00763763|Interferon-alpha|interferon-alpha|mesh-list
110662319|NCT00763763|Dexamethasone|dexamethasone|mesh-list
110662320|NCT00763763|Vincristine|vincristine|mesh-list
110662321|NCT00763763|Imatinib Mesylate|imatinib mesylate|mesh-list
110662322|NCT00763763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110662323|NCT00763763|Antiemetics|antiemetics|mesh-ancestor
110662324|NCT00763763|Autonomic Agents|autonomic agents|mesh-ancestor
110662325|NCT00763763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110662326|NCT00763763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110662327|NCT00763763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110662328|NCT00763763|Glucocorticoids|glucocorticoids|mesh-ancestor
110662329|NCT00763763|Hormones|hormones|mesh-ancestor
110662330|NCT00763763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110662331|NCT00763763|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110662332|NCT00763763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110662333|NCT00763763|Antiviral Agents|antiviral agents|mesh-ancestor
110662334|NCT00763763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110662335|NCT00763763|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110662336|NCT00763763|Tubulin Modulators|tubulin modulators|mesh-ancestor
110662337|NCT00763763|Antimitotic Agents|antimitotic agents|mesh-ancestor
110662338|NCT00763763|Mitosis Modulators|mitosis modulators|mesh-ancestor
110662339|NCT00763763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110662340|NCT00763763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110662341|NCT00763763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110662342|NCT00763763|Immunologic Factors|immunologic factors|mesh-ancestor
110662344|NCT01037140|Cholecalciferol|cholecalciferol|mesh-list
110662345|NCT01037140|Vitamins|vitamins|mesh-ancestor
110662346|NCT01037140|Micronutrients|micronutrients|mesh-ancestor
110662347|NCT01037140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110662348|NCT01037140|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110662349|NCT01037140|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110662350|NCT05357456|Epinephrine|epinephrine|mesh-list
110662351|NCT05357456|Racepinephrine|racepinephrine|mesh-list
110662352|NCT05357456|Epinephryl borate|epinephryl borate|mesh-list
110662353|NCT05357456|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110662354|NCT05357456|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110662355|NCT05357456|Adrenergic Agents|adrenergic agents|mesh-ancestor
110662356|NCT05357456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110662357|NCT05357456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110662358|NCT05357456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110662359|NCT05357456|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110662360|NCT05357456|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110662361|NCT05357456|Autonomic Agents|autonomic agents|mesh-ancestor
110662362|NCT05357456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110447705|NCT02041234|Orlistat|orlistat|mesh-list
110662363|NCT05357456|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110662364|NCT05357456|Respiratory System Agents|respiratory system agents|mesh-ancestor
110662365|NCT05357456|Mydriatics|mydriatics|mesh-ancestor
110662366|NCT05357456|Sympathomimetics|sympathomimetics|mesh-ancestor
110662367|NCT05357456|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110662368|NCT00069121|Leucovorin|leucovorin|mesh-list
110662369|NCT00069121|Fluorouracil|fluorouracil|mesh-list
110662370|NCT00069121|Capecitabine|capecitabine|mesh-list
110662371|NCT00069121|Oxaliplatin|oxaliplatin|mesh-list
110662372|NCT00069121|Antimetabolites|antimetabolites|mesh-ancestor
110662373|NCT00069121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110662374|NCT00069121|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110662375|NCT00069121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110662376|NCT00069121|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110662377|NCT00069121|Immunologic Factors|immunologic factors|mesh-ancestor
110662378|NCT00069121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110662379|NCT00069121|Antidotes|antidotes|mesh-ancestor
110662380|NCT00069121|Protective Agents|protective agents|mesh-ancestor
110662381|NCT00069121|Vitamin B Complex|vitamin b complex|mesh-ancestor
110662382|NCT00069121|Vitamins|vitamins|mesh-ancestor
110662383|NCT00069121|Micronutrients|micronutrients|mesh-ancestor
110662384|NCT00768911|Temozolomide|temozolomide|mesh-list
110662385|NCT00768911|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110662386|NCT00768911|Alkylating Agents|alkylating agents|mesh-ancestor
110662387|NCT00768911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110662388|NCT00768911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110662389|NCT00769145|Ranibizumab|ranibizumab|mesh-list
110662390|NCT00769145|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110662391|NCT00769145|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110662392|NCT00769145|Growth Substances|growth substances|mesh-ancestor
110662393|NCT00769145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110662394|NCT00769145|Growth Inhibitors|growth inhibitors|mesh-ancestor
110662395|NCT00769145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110662396|NCT00763997|Acetaminophen|acetaminophen|mesh-list
110662397|NCT00763997|Dipyrone|dipyrone|mesh-list
110662398|NCT00763997|Ibuprofen|ibuprofen|mesh-list
110662399|NCT00763997|Parecoxib|parecoxib|mesh-list
110662400|NCT00763997|Valdecoxib|valdecoxib|mesh-list
110662401|NCT00763997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110662402|NCT00763997|Analgesics|analgesics|mesh-ancestor
110662403|NCT00763997|Sensory System Agents|sensory system agents|mesh-ancestor
110662404|NCT00763997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110662405|NCT00763997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110662406|NCT00763997|Antipyretics|antipyretics|mesh-ancestor
110662407|NCT00763997|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110662408|NCT00763997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110662409|NCT00763997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110662410|NCT00763997|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110662411|NCT00763997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110662412|NCT00763997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110662413|NCT00763997|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110662414|NCT00771251|Golimumab|golimumab|mesh-list
110662415|NCT00771251|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110662416|NCT00771251|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110662417|NCT00771251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110662418|NCT00771251|Immunologic Factors|immunologic factors|mesh-ancestor
110662419|NCT00771251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110662420|NCT01420250|Bicalutamide|bicalutamide|mesh-list
110662421|NCT01420250|Hormones|hormones|mesh-list
110662422|NCT01420250|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
110662423|NCT01420250|Androgens|androgens|mesh-list
110662424|NCT01420250|Androgen Antagonists|androgen antagonists|mesh-list
110662425|NCT01420250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110662426|NCT01420250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110662427|NCT01420250|Hormone Antagonists|hormone antagonists|mesh-ancestor
110662428|NCT01420250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110662429|NCT00399568|Acetaminophen|acetaminophen|mesh-list
110662430|NCT00399568|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110662431|NCT00399568|Analgesics|analgesics|mesh-ancestor
110662432|NCT00399568|Sensory System Agents|sensory system agents|mesh-ancestor
110662433|NCT00399568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110662434|NCT00399568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110662435|NCT00399568|Antipyretics|antipyretics|mesh-ancestor
110662436|NCT05088356|Plerixafor|plerixafor|mesh-list
110662437|NCT05088356|Cyclophosphamide|cyclophosphamide|mesh-list
110662438|NCT05088356|Melphalan|melphalan|mesh-list
110662439|NCT05088356|Fludarabine|fludarabine|mesh-list
110662440|NCT05088356|Fludarabine phosphate|fludarabine phosphate|mesh-list
110662441|NCT05088356|Tacrolimus|tacrolimus|mesh-list
110662442|NCT05088356|Alkylating Agents|alkylating agents|mesh-list
110662443|NCT05088356|Lenograstim|lenograstim|mesh-list
110662444|NCT05088356|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110662445|NCT05088356|Immunologic Factors|immunologic factors|mesh-ancestor
110662446|NCT05088356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110662447|NCT05088356|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110662448|NCT05088356|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110662449|NCT05088356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110662450|NCT05088356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110662451|NCT05088356|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110662452|NCT05088356|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110662453|NCT05088356|Antimetabolites|antimetabolites|mesh-ancestor
110662454|NCT05088356|Antiviral Agents|antiviral agents|mesh-ancestor
110662455|NCT05088356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110662456|NCT05088356|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110662457|NCT05088356|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110662458|NCT05088356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110662459|NCT05088356|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110662460|NCT05088356|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110662462|NCT01039558|Lansoprazole|lansoprazole|mesh-list
110662463|NCT01039558|Dexlansoprazole|dexlansoprazole|mesh-list
110662464|NCT01039558|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110662465|NCT01039558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110662466|NCT01039558|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110662467|NCT01039558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110662468|NCT01039558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110662469|NCT01039558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110662470|NCT01039558|Protease Inhibitors|protease inhibitors|mesh-ancestor
110662471|NCT01039558|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110662472|NCT01039558|Protective Agents|protective agents|mesh-ancestor
110662473|NCT01039558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110662474|NCT01039558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110662475|NCT01324258|Gemcitabine|gemcitabine|mesh-list
110662476|NCT01324258|Trametinib|trametinib|mesh-list
110662477|NCT01324258|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110662478|NCT01324258|Antimetabolites|antimetabolites|mesh-ancestor
110662479|NCT01324258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110662480|NCT01324258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110662481|NCT01324258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110662482|NCT01324258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110662483|NCT00068419|Tamoxifen|tamoxifen|mesh-list
110662484|NCT00068419|Sulindac|sulindac|mesh-list
110662485|NCT00068419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110662486|NCT00068419|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110662487|NCT00068419|Hormone Antagonists|hormone antagonists|mesh-ancestor
110662488|NCT00068419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110662489|NCT00068419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110662490|NCT00068419|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110662491|NCT00068419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110662492|NCT00068419|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110662493|NCT00068419|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110662494|NCT00068419|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110662495|NCT00068419|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110662496|NCT00068419|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110662497|NCT00068419|Analgesics|analgesics|mesh-ancestor
110662498|NCT00068419|Sensory System Agents|sensory system agents|mesh-ancestor
110662499|NCT00068419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110662500|NCT00068419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110662501|NCT00068419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110662502|NCT00068419|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110662503|NCT00068419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110662504|NCT02557373|Vitamins|vitamins|mesh-list
110662505|NCT02557373|Vitamin A|vitamin a|mesh-list
110662506|NCT02557373|Retinol palmitate|retinol palmitate|mesh-list
110662507|NCT02557373|Micronutrients|micronutrients|mesh-ancestor
110662508|NCT02557373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110662509|NCT02557373|Antioxidants|antioxidants|mesh-ancestor
110662510|NCT02557373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110662511|NCT02557373|Protective Agents|protective agents|mesh-ancestor
110662512|NCT02557373|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110662513|NCT02557373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110662514|NCT01757626|Molgramostim|molgramostim|mesh-list
110662515|NCT01757626|Sargramostim|sargramostim|mesh-list
110662516|NCT01757626|Immunologic Factors|immunologic factors|mesh-ancestor
110662517|NCT01757626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110662518|NCT01757626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110662519|NCT04048811|Propofol|propofol|mesh-list
110662520|NCT04048811|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110662521|NCT04048811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110662522|NCT04048811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110662523|NCT04048811|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110662524|NCT04048811|Anesthetics, General|anesthetics, general|mesh-ancestor
110662525|NCT04048811|Anesthetics|anesthetics|mesh-ancestor
110662526|NCT01086631|Rituximab|rituximab|mesh-list
110662527|NCT01086631|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110662528|NCT01086631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110662529|NCT01086631|Immunologic Factors|immunologic factors|mesh-ancestor
110662531|NCT01086631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110662532|NCT00399490|Tanezumab|tanezumab|mesh-list
110662533|NCT00399490|Analgesics|analgesics|mesh-ancestor
110662534|NCT00399490|Sensory System Agents|sensory system agents|mesh-ancestor
110662535|NCT00399490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110662536|NCT00399490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110309771|NCT00280358|Xhance|xhance|mesh-list
110662537|NCT00398866|Triamcinolone|triamcinolone|mesh-list
110662538|NCT00398866|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110662539|NCT00398866|Bupivacaine|bupivacaine|mesh-list
110662540|NCT00398866|Hyaluronic Acid|hyaluronic acid|mesh-list
110662541|NCT00398866|Hylan|hylan|mesh-list
110662542|NCT00398866|Anesthetics, Local|anesthetics, local|mesh-ancestor
110662543|NCT00398866|Anesthetics|anesthetics|mesh-ancestor
110662544|NCT00398866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110662545|NCT00398866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110662546|NCT00398866|Sensory System Agents|sensory system agents|mesh-ancestor
110662547|NCT00398866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110662548|NCT00398866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110662549|NCT00398866|Glucocorticoids|glucocorticoids|mesh-ancestor
110662550|NCT00398866|Hormones|hormones|mesh-ancestor
110662551|NCT00398866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110662552|NCT00398866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110662553|NCT00398866|Immunologic Factors|immunologic factors|mesh-ancestor
110662554|NCT00398866|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110662555|NCT00398866|Viscosupplements|viscosupplements|mesh-ancestor
110662556|NCT00398866|Protective Agents|protective agents|mesh-ancestor
110662557|NCT00771563|Cisplatin|cisplatin|mesh-list
110662558|NCT00771563|Docetaxel|docetaxel|mesh-list
110662559|NCT00771563|Enoxaparin|enoxaparin|mesh-list
110662560|NCT00771563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110662561|NCT00771563|Tubulin Modulators|tubulin modulators|mesh-ancestor
110662562|NCT00771563|Antimitotic Agents|antimitotic agents|mesh-ancestor
110662563|NCT00771563|Mitosis Modulators|mitosis modulators|mesh-ancestor
110662564|NCT00771563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110662565|NCT00771563|Anticoagulants|anticoagulants|mesh-ancestor
110662566|NCT00771563|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110662567|NCT00771563|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110662568|NCT00775073|Bevacizumab|bevacizumab|mesh-list
110662569|NCT00775073|Everolimus|everolimus|mesh-list
110662570|NCT00775073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110662571|NCT00775073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110662572|NCT00775073|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110662573|NCT00775073|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110662574|NCT00775073|Growth Substances|growth substances|mesh-ancestor
110662575|NCT00775073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110662576|NCT00775073|Growth Inhibitors|growth inhibitors|mesh-ancestor
110662577|NCT00775073|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110662578|NCT00775073|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110662579|NCT00775073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110662580|NCT00775073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110662581|NCT00775073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110662582|NCT00775073|Immunologic Factors|immunologic factors|mesh-ancestor
110662583|NCT00398632|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110662584|NCT00398632|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110662585|NCT00398632|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110662586|NCT00398632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110662587|NCT00398632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110662588|NCT00398632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110662589|NCT00398632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110662590|NCT00398632|Analgesics|analgesics|mesh-ancestor
110662591|NCT00398632|Sensory System Agents|sensory system agents|mesh-ancestor
110662592|NCT00398632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110662593|NCT00398632|Antidepressive Agents|antidepressive agents|mesh-ancestor
110662594|NCT00398632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110662596|NCT01589146|Heparin|heparin|mesh-list
110662597|NCT01589146|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
110662598|NCT01589146|Tinzaparin|tinzaparin|mesh-list
110662599|NCT01589146|Dalteparin|dalteparin|mesh-list
110662600|NCT01589146|Anticoagulants|anticoagulants|mesh-ancestor
110662601|NCT01589146|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110662602|NCT01589146|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110662603|NCT01589146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110662604|NCT00775151|Amlodipine|amlodipine|mesh-list
110662605|NCT00775151|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110662606|NCT00775151|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110662607|NCT00775151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110662608|NCT00775151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110662609|NCT00775151|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110662610|NCT00775151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110662611|NCT00775151|Vasodilator Agents|vasodilator agents|mesh-ancestor
110662612|NCT04694300|Acetaminophen|acetaminophen|mesh-list
110662613|NCT04694300|Naproxen|naproxen|mesh-list
110662614|NCT04694300|Tramadol|tramadol|mesh-list
110662615|NCT04694300|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110662616|NCT04694300|Analgesics|analgesics|mesh-ancestor
110662617|NCT04694300|Sensory System Agents|sensory system agents|mesh-ancestor
110662618|NCT04694300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110662619|NCT04694300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110662620|NCT04694300|Antipyretics|antipyretics|mesh-ancestor
110662621|NCT04694300|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110662622|NCT04694300|Narcotics|narcotics|mesh-ancestor
110662623|NCT04694300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110662624|NCT04694300|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110662625|NCT04694300|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110662626|NCT04694300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110662627|NCT04694300|Gout Suppressants|gout suppressants|mesh-ancestor
110662628|NCT04694300|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110662629|NCT04694300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110662630|NCT04694300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110662631|NCT04642820|Methamphetamine|methamphetamine|mesh-list
110662632|NCT04642820|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110662633|NCT04642820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110662634|NCT04642820|Sympathomimetics|sympathomimetics|mesh-ancestor
110662635|NCT04642820|Autonomic Agents|autonomic agents|mesh-ancestor
110662636|NCT04642820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110662637|NCT04642820|Dopamine Agents|dopamine agents|mesh-ancestor
110662638|NCT04642820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110662639|NCT04642820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110662640|NCT04642820|Adrenergic Agents|adrenergic agents|mesh-ancestor
110662641|NCT04642820|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110662642|NCT04642820|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110662643|NCT04642820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110662644|NCT04642820|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110662645|NCT00771641|Cobalt|cobalt|mesh-list
110662646|NCT00771641|Trace Elements|trace elements|mesh-ancestor
110662647|NCT00771641|Micronutrients|micronutrients|mesh-ancestor
110662648|NCT00771641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110662649|NCT05408000|Propofol|propofol|mesh-list
110662650|NCT05408000|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110662651|NCT05408000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110662652|NCT05408000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110662653|NCT05408000|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110662654|NCT05408000|Anesthetics, General|anesthetics, general|mesh-ancestor
110662655|NCT05408000|Anesthetics|anesthetics|mesh-ancestor
110662656|NCT00771719|Ceftobiprole|ceftobiprole|mesh-list
110662657|NCT00771719|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
110662658|NCT00771719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110662659|NCT00771719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110662660|NCT00673361|Temozolomide|temozolomide|mesh-list
110662661|NCT00673361|Sorafenib|sorafenib|mesh-list
110662662|NCT00673361|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110662663|NCT00673361|Alkylating Agents|alkylating agents|mesh-ancestor
110662664|NCT00673361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110662665|NCT00673361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110662666|NCT00673361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110662667|NCT00673361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110662668|NCT00393718|Liraglutide|liraglutide|mesh-list
110662669|NCT00393718|Glyburide|glyburide|mesh-list
110662670|NCT00393718|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110662671|NCT00393718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110662673|NCT00393718|Hormones|hormones|mesh-ancestor
110662674|NCT00393718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110662675|NCT00669071|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
110662676|NCT00669071|Tretinoin|tretinoin|mesh-list
110662677|NCT00669071|Hydroquinone|hydroquinone|mesh-list
110662678|NCT00669071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110662679|NCT00669071|Keratolytic Agents|keratolytic agents|mesh-ancestor
110662680|NCT00669071|Dermatologic Agents|dermatologic agents|mesh-ancestor
110662681|NCT00669071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110662682|NCT00669071|Glucocorticoids|glucocorticoids|mesh-ancestor
110662683|NCT00669071|Hormones|hormones|mesh-ancestor
110662684|NCT00669071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110662685|NCT00669071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110662686|NCT00669071|Antioxidants|antioxidants|mesh-ancestor
110662687|NCT00669071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110662688|NCT00669071|Protective Agents|protective agents|mesh-ancestor
110309895|NCT00317070|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110662689|NCT00669071|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110662690|NCT00398320|Bevacizumab|bevacizumab|mesh-list
110662691|NCT00398320|Capecitabine|capecitabine|mesh-list
110662692|NCT00398320|Oxaliplatin|oxaliplatin|mesh-list
110662693|NCT00398320|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110662694|NCT00398320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110662695|NCT00398320|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110662696|NCT00398320|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110662697|NCT00398320|Growth Substances|growth substances|mesh-ancestor
110662698|NCT00398320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110662699|NCT00398320|Growth Inhibitors|growth inhibitors|mesh-ancestor
110662700|NCT00398320|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110662701|NCT00398320|Antimetabolites|antimetabolites|mesh-ancestor
110662702|NCT00398320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110662703|NCT00670007|Protease Inhibitors|protease inhibitors|mesh-list
110662704|NCT00670007|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
110662705|NCT00670007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110662706|NCT00670007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110662707|NCT00670007|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
110662708|NCT00670007|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110662709|NCT04003688|Magnesium Sulfate|magnesium sulfate|mesh-list
110662710|NCT04003688|Analgesics|analgesics|mesh-ancestor
110662711|NCT04003688|Sensory System Agents|sensory system agents|mesh-ancestor
110662712|NCT04003688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110662713|NCT04003688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110662714|NCT04003688|Anesthetics|anesthetics|mesh-ancestor
110662715|NCT04003688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110662716|NCT04003688|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110662717|NCT04003688|Anticonvulsants|anticonvulsants|mesh-ancestor
110662718|NCT04003688|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110662719|NCT04003688|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110662720|NCT04003688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110662721|NCT04003688|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110662722|NCT04003688|Tocolytic Agents|tocolytic agents|mesh-ancestor
110662723|NCT04003688|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110662724|NCT00779129|Cyclophosphamide|cyclophosphamide|mesh-list
110662725|NCT00779129|Doxorubicin|doxorubicin|mesh-list
110662726|NCT00779129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110662727|NCT00779129|Immunologic Factors|immunologic factors|mesh-ancestor
110662728|NCT00779129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110662729|NCT00779129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110662730|NCT00779129|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110662731|NCT00779129|Alkylating Agents|alkylating agents|mesh-ancestor
110662732|NCT00779129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110662733|NCT00779129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110662734|NCT00779129|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110662735|NCT00779129|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110662736|NCT00779129|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110662737|NCT00779129|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110662738|NCT00779129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110662739|NCT00772187|Fentanyl|fentanyl|mesh-list
110662740|NCT00772187|Morphine|morphine|mesh-list
110662741|NCT00772187|Anesthetics|anesthetics|mesh-ancestor
110662742|NCT00772187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110662743|NCT00772187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110662744|NCT00772187|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110662745|NCT00772187|Narcotics|narcotics|mesh-ancestor
110662746|NCT00772187|Analgesics|analgesics|mesh-ancestor
110662747|NCT00772187|Sensory System Agents|sensory system agents|mesh-ancestor
110662748|NCT00772187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110662749|NCT00772187|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110662750|NCT00772187|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110662751|NCT00772187|Anesthetics, General|anesthetics, general|mesh-ancestor
110662752|NCT00772265|Insulin|insulin|mesh-list
110662753|NCT00772265|Isophane Insulin, Human|isophane insulin, human|mesh-list
110662754|NCT00772265|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110662755|NCT00772265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110662756|NCT00779441|Zolpidem|zolpidem|mesh-list
110662757|NCT00779441|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110662758|NCT00779441|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110662759|NCT00779441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110662760|NCT00779441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110662761|NCT00779441|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
110662762|NCT00779441|GABA Agonists|gaba agonists|mesh-ancestor
110662763|NCT00779441|GABA Agents|gaba agents|mesh-ancestor
110662764|NCT00779441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110662765|NCT00779441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110662766|NCT02556437|Immunoglobulins|immunoglobulins|mesh-list
110662767|NCT02556437|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110662768|NCT02556437|Antibodies|antibodies|mesh-list
110662769|NCT02556437|Immunologic Factors|immunologic factors|mesh-ancestor
110662770|NCT02556437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110662771|NCT04946006|Oxytocin|oxytocin|mesh-list
110662772|NCT04946006|Oxytocics|oxytocics|mesh-ancestor
110662773|NCT04946006|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110662774|NCT04946006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110662775|NCT00775619|Carvedilol|carvedilol|mesh-list
110662776|NCT00775619|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110662777|NCT00775619|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110662778|NCT00775619|Adrenergic Agents|adrenergic agents|mesh-ancestor
110662779|NCT00775619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110662780|NCT00775619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110662781|NCT00775619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110662782|NCT00775619|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110662783|NCT00775619|Antioxidants|antioxidants|mesh-ancestor
110662784|NCT00775619|Protective Agents|protective agents|mesh-ancestor
110662785|NCT00775619|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110662786|NCT00775619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110662787|NCT00775619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110662788|NCT00775619|Vasodilator Agents|vasodilator agents|mesh-ancestor
110662789|NCT00775619|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110662790|NCT00775619|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110662791|NCT00775697|Montelukast|montelukast|mesh-list
110662792|NCT00775697|Leukotriene Antagonists|leukotriene antagonists|mesh-list
110662793|NCT00775697|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110662794|NCT00775697|Respiratory System Agents|respiratory system agents|mesh-ancestor
110662795|NCT00775697|Hormone Antagonists|hormone antagonists|mesh-ancestor
110662796|NCT00775697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110662797|NCT00775697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110662798|NCT00775697|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110662799|NCT00775697|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110662800|NCT00775697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110662801|NCT05357066|Nitrous Oxide|nitrous oxide|mesh-list
110662802|NCT05357066|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110662803|NCT05357066|Anesthetics, General|anesthetics, general|mesh-ancestor
110662804|NCT05357066|Anesthetics|anesthetics|mesh-ancestor
110662805|NCT05357066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110662806|NCT05357066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110662807|NCT05357066|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110662808|NCT05357066|Analgesics|analgesics|mesh-ancestor
110662809|NCT05357066|Sensory System Agents|sensory system agents|mesh-ancestor
110662810|NCT05357066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110662811|NCT02556905|Dexamethasone|dexamethasone|mesh-list
110662812|NCT02556905|Lenalidomide|lenalidomide|mesh-list
110662813|NCT02556905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110662814|NCT02556905|Antiemetics|antiemetics|mesh-ancestor
110662815|NCT02556905|Autonomic Agents|autonomic agents|mesh-ancestor
110662816|NCT02556905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110662817|NCT02556905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110923443|NCT04640545|Axitinib|axitinib|mesh-list
110662818|NCT02556905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110662820|NCT02556905|Hormones|hormones|mesh-ancestor
110662821|NCT02556905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110662822|NCT02556905|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110662823|NCT02556905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110662824|NCT02556905|Immunologic Factors|immunologic factors|mesh-ancestor
110662825|NCT02556905|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110662826|NCT02556905|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110662827|NCT02556905|Growth Substances|growth substances|mesh-ancestor
110662828|NCT02556905|Growth Inhibitors|growth inhibitors|mesh-ancestor
110662829|NCT00539006|Fluticasone|fluticasone|mesh-list
110662831|NCT00539006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110662832|NCT00539006|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110662833|NCT00539006|Autonomic Agents|autonomic agents|mesh-ancestor
110662834|NCT00539006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110662835|NCT00539006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110662836|NCT00539006|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110662837|NCT00539006|Respiratory System Agents|respiratory system agents|mesh-ancestor
110662838|NCT00539006|Dermatologic Agents|dermatologic agents|mesh-ancestor
110662839|NCT00539006|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110662840|NCT04047329|Anesthetics|anesthetics|mesh-list
110662841|NCT04047329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110662842|NCT04047329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110662843|NCT00779753|Amino-acid, glucose, and electrolyte solution|amino-acid, glucose, and electrolyte solution|mesh-list
110662844|NCT00779753|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
110662845|NCT00779753|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110662847|NCT00537056|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110662848|NCT00537056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110662849|NCT00537056|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110662850|NCT00537056|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110662851|NCT00537056|Growth Substances|growth substances|mesh-ancestor
110662852|NCT00537056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110662853|NCT00537056|Growth Inhibitors|growth inhibitors|mesh-ancestor
110662854|NCT00537056|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110662855|NCT00537056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110662856|NCT00537056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110662857|NCT00537056|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110662858|NCT00779831|Pseudoephedrine|pseudoephedrine|mesh-list
110662859|NCT00779831|Ephedrine|ephedrine|mesh-list
110662860|NCT00779831|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110662861|NCT00779831|Autonomic Agents|autonomic agents|mesh-ancestor
110662862|NCT00779831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110662863|NCT00779831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110662864|NCT00779831|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110662865|NCT00779831|Respiratory System Agents|respiratory system agents|mesh-ancestor
110662866|NCT00779831|Nasal Decongestants|nasal decongestants|mesh-ancestor
110662867|NCT00779831|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110662868|NCT00779831|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110662869|NCT00779831|Sympathomimetics|sympathomimetics|mesh-ancestor
110662870|NCT00779831|Adrenergic Agents|adrenergic agents|mesh-ancestor
110662871|NCT00779831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110662872|NCT00779831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110662873|NCT00535262|Selegiline|selegiline|mesh-list
110662874|NCT00535262|Antidepressive Agents|antidepressive agents|mesh-ancestor
110662875|NCT00535262|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110662876|NCT00535262|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110662877|NCT00535262|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110662878|NCT00535262|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
110662879|NCT00535262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110447785|NCT02748304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110662880|NCT00535262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110662881|NCT00535262|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110662882|NCT00535262|Protective Agents|protective agents|mesh-ancestor
110662883|NCT00535262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110662884|NCT00772499|Atenolol|atenolol|mesh-list
110662885|NCT00772499|Amlodipine|amlodipine|mesh-list
110662886|NCT00772499|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110662887|NCT00772499|Olmesartan|olmesartan|mesh-list
110662888|NCT00772499|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
110662889|NCT00772499|Hydralazine|hydralazine|mesh-list
110662890|NCT00772499|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110662891|NCT00772499|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110662892|NCT00772499|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110662893|NCT00772499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110662894|NCT00772499|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110662895|NCT00772499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110662896|NCT00772499|Vasodilator Agents|vasodilator agents|mesh-ancestor
110662897|NCT00772499|Diuretics|diuretics|mesh-ancestor
110662898|NCT00772499|Natriuretic Agents|natriuretic agents|mesh-ancestor
110662899|NCT00772499|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110662900|NCT00772499|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110662901|NCT00772499|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110662902|NCT00772499|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110662903|NCT00772499|Sympatholytics|sympatholytics|mesh-ancestor
110662904|NCT00772499|Autonomic Agents|autonomic agents|mesh-ancestor
110662905|NCT00772499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110662906|NCT00772499|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110662907|NCT00772499|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110662908|NCT00772499|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110662909|NCT00772499|Adrenergic Agents|adrenergic agents|mesh-ancestor
110662910|NCT00772499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110662911|NCT00989690|Docetaxel|docetaxel|mesh-list
110662912|NCT00989690|Pemetrexed|pemetrexed|mesh-list
110662913|NCT00989690|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110662914|NCT00989690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110662915|NCT00989690|Tubulin Modulators|tubulin modulators|mesh-ancestor
110662916|NCT00989690|Antimitotic Agents|antimitotic agents|mesh-ancestor
110662917|NCT00989690|Mitosis Modulators|mitosis modulators|mesh-ancestor
110662918|NCT00989690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110662919|NCT00989690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110662920|NCT00989690|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110662921|NCT00989690|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110662922|NCT00989690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110662924|NCT00074581|Lopinavir|lopinavir|mesh-list
110662925|NCT00074581|Atazanavir Sulfate|atazanavir sulfate|mesh-list
110662926|NCT00074581|Tenofovir|tenofovir|mesh-list
110662927|NCT00074581|Lamivudine|lamivudine|mesh-list
110662928|NCT00074581|Emtricitabine|emtricitabine|mesh-list
110662929|NCT00074581|Zidovudine|zidovudine|mesh-list
110662930|NCT00074581|Nevirapine|nevirapine|mesh-list
110662931|NCT00074581|Stavudine|stavudine|mesh-list
110662932|NCT00074581|Didanosine|didanosine|mesh-list
110662933|NCT00074581|Efavirenz|efavirenz|mesh-list
110662934|NCT00074581|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110662935|NCT00074581|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110662936|NCT00074581|Protease Inhibitors|protease inhibitors|mesh-ancestor
110662937|NCT00074581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110662938|NCT00074581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110662939|NCT00074581|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110662940|NCT00074581|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110662941|NCT00074581|Antiviral Agents|antiviral agents|mesh-ancestor
110662942|NCT00074581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110662943|NCT00074581|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110662944|NCT00074581|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110662945|NCT00074581|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110662946|NCT00074581|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110662947|NCT00074581|Antimetabolites|antimetabolites|mesh-ancestor
110662948|NCT00074581|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110662949|NCT00074581|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110662950|NCT00074581|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110662951|NCT00074581|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110662952|NCT00074581|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110662953|NCT00776477|Aspirin|aspirin|mesh-list
110662954|NCT00776477|Clopidogrel|clopidogrel|mesh-list
110662955|NCT00776477|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110662956|NCT00776477|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110662957|NCT00776477|Analgesics|analgesics|mesh-ancestor
110662958|NCT00776477|Sensory System Agents|sensory system agents|mesh-ancestor
110662959|NCT00776477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110662960|NCT00776477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110662961|NCT00776477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110662962|NCT00776477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110662963|NCT00776477|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110662964|NCT00776477|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110662965|NCT00776477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110662966|NCT00776477|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110662967|NCT00776477|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110662968|NCT00776477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110662969|NCT00776477|Antipyretics|antipyretics|mesh-ancestor
110023175|NCT00003426|Gemcitabine|gemcitabine|mesh-list
110662971|NCT00776477|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110662972|NCT00776477|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110662973|NCT00776477|Purinergic Agents|purinergic agents|mesh-ancestor
110662974|NCT00776477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110662975|NCT00772655|Rituximab|rituximab|mesh-list
110662976|NCT00772655|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110662977|NCT00772655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110662978|NCT00772655|Immunologic Factors|immunologic factors|mesh-ancestor
110662979|NCT00772655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110662980|NCT00772655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110662981|NCT00776633|Aspirin|aspirin|mesh-list
110662982|NCT00776633|Clopidogrel|clopidogrel|mesh-list
110662983|NCT00776633|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110662984|NCT00776633|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110662985|NCT00776633|Analgesics|analgesics|mesh-ancestor
110310202|NCT00318084|Esomeprazole|esomeprazole|mesh-list
110662986|NCT00776633|Sensory System Agents|sensory system agents|mesh-ancestor
110662987|NCT00776633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110662988|NCT00776633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110662989|NCT00776633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110662990|NCT00776633|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110662991|NCT00776633|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110662992|NCT00776633|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110662993|NCT00776633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110662994|NCT00776633|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110662995|NCT00776633|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110662996|NCT00776633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110662997|NCT00776633|Antipyretics|antipyretics|mesh-ancestor
110662998|NCT00776633|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110662999|NCT00776633|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110663000|NCT00776633|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110663001|NCT00776633|Purinergic Agents|purinergic agents|mesh-ancestor
110663002|NCT00776633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110663003|NCT01093963|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
110663004|NCT01093963|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110663005|NCT01093963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110663006|NCT01093963|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110663007|NCT01093963|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110663008|NCT01093963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110663009|NCT01093963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110663010|NCT01093963|Dopamine Agents|dopamine agents|mesh-ancestor
110447809|NCT00636298|Cetuximab|cetuximab|mesh-list
110663011|NCT01093963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110663012|NCT04256018|Mogamulizumab|mogamulizumab|mesh-list
110663013|NCT04256018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110663014|NCT03961087|Ubiquinone|ubiquinone|mesh-list
110663015|NCT03961087|Coenzyme Q10|coenzyme q10|mesh-list
110663016|NCT03961087|Meclofenoxate|meclofenoxate|mesh-list
110663017|NCT03961087|Micronutrients|micronutrients|mesh-ancestor
110663018|NCT03961087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110663019|NCT03961087|Vitamins|vitamins|mesh-ancestor
110663020|NCT03961087|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110663021|NCT03961087|Protective Agents|protective agents|mesh-ancestor
110663022|NCT03961087|Nootropic Agents|nootropic agents|mesh-ancestor
110663023|NCT03960775|Dexmedetomidine|dexmedetomidine|mesh-list
110663024|NCT03960775|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110663025|NCT03960775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110663026|NCT03960775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110663027|NCT03960775|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110663028|NCT03960775|Analgesics|analgesics|mesh-ancestor
110663029|NCT03960775|Sensory System Agents|sensory system agents|mesh-ancestor
110663030|NCT03960775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110663031|NCT03960775|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110663032|NCT03960775|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110663033|NCT03960775|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110663034|NCT03960775|Adrenergic Agents|adrenergic agents|mesh-ancestor
110663035|NCT03960775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110663036|NCT03960775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110663037|NCT00536978|Cytarabine|cytarabine|mesh-list
110663038|NCT00536978|Cyclophosphamide|cyclophosphamide|mesh-list
110663039|NCT00536978|Melphalan|melphalan|mesh-list
110663040|NCT00536978|Carmustine|carmustine|mesh-list
110663041|NCT00536978|Rituximab|rituximab|mesh-list
110663042|NCT00536978|Methotrexate|methotrexate|mesh-list
110663043|NCT00536978|Fludarabine|fludarabine|mesh-list
110663044|NCT00536978|Fludarabine phosphate|fludarabine phosphate|mesh-list
110663045|NCT00536978|Etoposide|etoposide|mesh-list
110663046|NCT00536978|Alemtuzumab|alemtuzumab|mesh-list
110663047|NCT00536978|Tacrolimus|tacrolimus|mesh-list
110663048|NCT00536978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110663049|NCT00536978|Immunologic Factors|immunologic factors|mesh-ancestor
110663050|NCT00536978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110663051|NCT00536978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110663052|NCT00536978|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110663053|NCT00536978|Alkylating Agents|alkylating agents|mesh-ancestor
110663054|NCT00536978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110663055|NCT00536978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110663056|NCT00536978|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110663057|NCT00536978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110663058|NCT00536978|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110663059|NCT00536978|Abortifacient Agents|abortifacient agents|mesh-ancestor
110663060|NCT00536978|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110663061|NCT00536978|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110663062|NCT00536978|Antimetabolites|antimetabolites|mesh-ancestor
110663063|NCT00536978|Dermatologic Agents|dermatologic agents|mesh-ancestor
110663064|NCT00536978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110663065|NCT00536978|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110663066|NCT00536978|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110663067|NCT00536978|Antiviral Agents|antiviral agents|mesh-ancestor
110663068|NCT00536978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110663069|NCT00536978|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110663070|NCT00536978|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110663071|NCT00536978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110663072|NCT00536978|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110663074|NCT03809611|Lipotropic Agents|lipotropic agents|mesh-ancestor
110663075|NCT03809611|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110663076|NCT03809611|Antimetabolites|antimetabolites|mesh-ancestor
110663077|NCT03809611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110663078|NCT03809611|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110663079|NCT03809611|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110663080|NCT03809611|Nootropic Agents|nootropic agents|mesh-ancestor
110663081|NCT05360342|Vitamins|vitamins|mesh-list
110663082|NCT05360342|Vitamin K|vitamin k|mesh-list
110663083|NCT05360342|Vitamin K 1|vitamin k 1|mesh-list
110663084|NCT05360342|Micronutrients|micronutrients|mesh-ancestor
110663085|NCT05360342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110663086|NCT05360342|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110663087|NCT05360342|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110663088|NCT05360342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110663089|NCT05360342|Hemostatics|hemostatics|mesh-ancestor
110663090|NCT05360342|Coagulants|coagulants|mesh-ancestor
110663091|NCT05290220|Lenvatinib|lenvatinib|mesh-list
110663092|NCT05290220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110663093|NCT05290220|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110663094|NCT05290220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110663095|NCT05290220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110663096|NCT04026230|Atorvastatin|atorvastatin|mesh-list
110663097|NCT04026230|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110663098|NCT04026230|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110663099|NCT04026230|Antimetabolites|antimetabolites|mesh-ancestor
110663100|NCT04026230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110663101|NCT04026230|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110663102|NCT04026230|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110663103|NCT04026230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110663104|NCT00536510|Niacin|niacin|mesh-list
110663105|NCT00536510|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110663106|NCT00536510|Antimetabolites|antimetabolites|mesh-ancestor
110663107|NCT00536510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110663108|NCT00536510|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110663109|NCT00536510|Vasodilator Agents|vasodilator agents|mesh-ancestor
110663110|NCT00536510|Vitamin B Complex|vitamin b complex|mesh-ancestor
110663111|NCT00536510|Vitamins|vitamins|mesh-ancestor
110663112|NCT00536510|Micronutrients|micronutrients|mesh-ancestor
110663113|NCT00536510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110663114|NCT04424264|Tenofovir|tenofovir|mesh-list
110663115|NCT04424264|Lamivudine|lamivudine|mesh-list
110663116|NCT04424264|Emtricitabine|emtricitabine|mesh-list
110663117|NCT04424264|Efavirenz|efavirenz|mesh-list
110663118|NCT04424264|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110663119|NCT04424264|Rifampin|rifampin|mesh-list
110663120|NCT04424264|Isoniazid|isoniazid|mesh-list
110663121|NCT04424264|Antiviral Agents|antiviral agents|mesh-ancestor
110663122|NCT04424264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110663123|NCT04424264|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110663124|NCT04424264|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110663125|NCT04424264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110663126|NCT04424264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110663127|NCT04424264|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110663128|NCT04424264|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110663129|NCT04424264|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110663130|NCT04424264|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110663131|NCT04424264|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110663132|NCT04424264|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110663133|NCT04424264|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110663134|NCT04424264|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110663135|NCT04424264|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110663136|NCT04424264|Antitubercular Agents|antitubercular agents|mesh-ancestor
110663137|NCT04424264|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110663138|NCT04424264|Leprostatic Agents|leprostatic agents|mesh-ancestor
110663139|NCT04424264|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110663140|NCT04424264|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110663141|NCT04424264|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110663142|NCT04424264|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
110663143|NCT04424264|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110663144|NCT04424264|Antimetabolites|antimetabolites|mesh-ancestor
110663145|NCT04424264|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110663146|NCT00398086|Paclitaxel|paclitaxel|mesh-list
110663147|NCT00398086|Gemcitabine|gemcitabine|mesh-list
110663148|NCT00398086|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110663149|NCT00398086|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110663150|NCT00398086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110663151|NCT00398086|Tubulin Modulators|tubulin modulators|mesh-ancestor
110663152|NCT00398086|Antimitotic Agents|antimitotic agents|mesh-ancestor
110663153|NCT00398086|Mitosis Modulators|mitosis modulators|mesh-ancestor
110663154|NCT00398086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110663155|NCT00398086|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110663156|NCT00398086|Antimetabolites|antimetabolites|mesh-ancestor
110663157|NCT04364360|Sulforaphane|sulforaphane|mesh-list
110663158|NCT04364360|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110663159|NCT04364360|Protective Agents|protective agents|mesh-ancestor
110663160|NCT04364360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110663161|NCT04364360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110663162|NCT00536198|Sertraline|sertraline|mesh-list
110663163|NCT00536198|Antidepressive Agents|antidepressive agents|mesh-ancestor
110663164|NCT00536198|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110663165|NCT00536198|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110663166|NCT00536198|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110663167|NCT00536198|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110663168|NCT00536198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110663169|NCT00536198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110663170|NCT00536198|Serotonin Agents|serotonin agents|mesh-ancestor
110663171|NCT00536198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110663172|NCT00393484|Lamivudine|lamivudine|mesh-list
110663173|NCT00393484|Entecavir|entecavir|mesh-list
110663174|NCT00393484|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110663175|NCT00393484|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110663176|NCT00393484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110663177|NCT00393484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110663178|NCT00393484|Antiviral Agents|antiviral agents|mesh-ancestor
110663179|NCT00393484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110663180|NCT00393484|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110663181|NCT00393484|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110663182|NCT00667823|Macitentan|macitentan|mesh-list
110663183|NCT00667823|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
110663184|NCT00667823|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
110663185|NCT00667823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110663186|NCT00667823|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
110663187|NCT00536120|Natalizumab|natalizumab|mesh-list
110663188|NCT00536120|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
110663189|NCT00536120|Immunologic Factors|immunologic factors|mesh-ancestor
110663190|NCT00536120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110663191|NCT00536120|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110663192|NCT00057811|Leucovorin|leucovorin|mesh-list
110663193|NCT00057811|Cytarabine|cytarabine|mesh-list
110663194|NCT00057811|Prednisone|prednisone|mesh-list
110663196|NCT00057811|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110663197|NCT00057811|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110663198|NCT00057811|Prednisolone|prednisolone|mesh-list
110663199|NCT00057811|Prednisolone acetate|prednisolone acetate|mesh-list
110663200|NCT00057811|Hydrocortisone|hydrocortisone|mesh-list
110663201|NCT00057811|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
110663202|NCT00057811|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
110663203|NCT00057811|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
110663204|NCT00057811|Cyclophosphamide|cyclophosphamide|mesh-list
110663205|NCT00057811|Rituximab|rituximab|mesh-list
110663206|NCT00057811|Doxorubicin|doxorubicin|mesh-list
110663207|NCT00057811|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110663208|NCT00057811|Methotrexate|methotrexate|mesh-list
110663210|NCT00057811|Vincristine|vincristine|mesh-list
110663211|NCT00057811|Etoposide phosphate|etoposide phosphate|mesh-list
110663212|NCT00057811|Rasburicase|rasburicase|mesh-list
110663213|NCT00057811|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110663214|NCT00057811|Prednisolone phosphate|prednisolone phosphate|mesh-list
110663215|NCT00057811|Levoleucovorin|levoleucovorin|mesh-list
110663216|NCT00057811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110663217|NCT00057811|Immunologic Factors|immunologic factors|mesh-ancestor
110663218|NCT00057811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110663219|NCT00057811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110663220|NCT00057811|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110663221|NCT00057811|Alkylating Agents|alkylating agents|mesh-ancestor
110663222|NCT00057811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110663223|NCT00057811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110663224|NCT00057811|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110663225|NCT00057811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110663226|NCT00057811|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110663227|NCT00057811|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110663228|NCT00057811|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110663229|NCT00057811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110663230|NCT00057811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110663231|NCT00057811|Glucocorticoids|glucocorticoids|mesh-ancestor
110663232|NCT00057811|Hormones|hormones|mesh-ancestor
110663233|NCT00057811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110663234|NCT00057811|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110663235|NCT00057811|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110663236|NCT00057811|Abortifacient Agents|abortifacient agents|mesh-ancestor
110663237|NCT00057811|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110663238|NCT00057811|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110663239|NCT00057811|Antimetabolites|antimetabolites|mesh-ancestor
110663240|NCT00057811|Dermatologic Agents|dermatologic agents|mesh-ancestor
110663241|NCT00057811|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110663242|NCT00057811|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110663243|NCT00057811|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110663244|NCT00057811|Antiviral Agents|antiviral agents|mesh-ancestor
110663245|NCT00057811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110663246|NCT00057811|Antidotes|antidotes|mesh-ancestor
110663247|NCT00057811|Protective Agents|protective agents|mesh-ancestor
110663248|NCT00057811|Vitamin B Complex|vitamin b complex|mesh-ancestor
110663249|NCT00057811|Vitamins|vitamins|mesh-ancestor
110663250|NCT00057811|Micronutrients|micronutrients|mesh-ancestor
110663251|NCT00057811|Tubulin Modulators|tubulin modulators|mesh-ancestor
110663252|NCT00057811|Antimitotic Agents|antimitotic agents|mesh-ancestor
110663253|NCT00057811|Mitosis Modulators|mitosis modulators|mesh-ancestor
110663254|NCT00057811|Antiemetics|antiemetics|mesh-ancestor
110663255|NCT00057811|Autonomic Agents|autonomic agents|mesh-ancestor
110663256|NCT00057811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110663257|NCT00057811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110663258|NCT00057811|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110663259|NCT00057811|Gout Suppressants|gout suppressants|mesh-ancestor
110663260|NCT03502148|Cisplatin|cisplatin|mesh-list
110663261|NCT03502148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110663262|NCT02530801|Bevacizumab|bevacizumab|mesh-list
110663263|NCT02530801|Fluorouracil|fluorouracil|mesh-list
110663264|NCT02530801|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110663265|NCT02530801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110663266|NCT02530801|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110663267|NCT02530801|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110663268|NCT02530801|Growth Substances|growth substances|mesh-ancestor
110663269|NCT02530801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110663270|NCT02530801|Growth Inhibitors|growth inhibitors|mesh-ancestor
110663271|NCT02530801|Antimetabolites|antimetabolites|mesh-ancestor
110923894|NCT01734928|Bortezomib|bortezomib|mesh-list
110663272|NCT02530801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110663273|NCT02530801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110663274|NCT02530801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110663275|NCT02530801|Immunologic Factors|immunologic factors|mesh-ancestor
110663276|NCT01091077|Naringenin|naringenin|mesh-list
110663277|NCT01091077|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110663278|NCT01091077|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110663279|NCT01091077|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110663280|NCT01091077|Hormone Antagonists|hormone antagonists|mesh-ancestor
110663281|NCT01091077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110663282|NCT01091077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110663283|NCT01094275|Omeprazole|omeprazole|mesh-list
110663284|NCT01094275|Clopidogrel|clopidogrel|mesh-list
110663285|NCT01094275|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110663286|NCT01094275|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110663287|NCT01094275|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110663288|NCT01094275|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110310501|NCT00284765|Analgesics|analgesics|mesh-ancestor
110663289|NCT01094275|Purinergic Agents|purinergic agents|mesh-ancestor
110663290|NCT01094275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110663291|NCT01094275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110663292|NCT01094275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110663293|NCT01094275|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110663294|NCT01094275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110663295|NCT01094275|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110663296|NCT01094275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110663297|NCT01089205|Metformin|metformin|mesh-list
110663298|NCT01089205|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110462772|NCT00876460|Docetaxel|docetaxel|mesh-list
110663299|NCT01089205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110663300|NCT02866682|Tacrolimus|tacrolimus|mesh-list
110663301|NCT02866682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110663302|NCT02866682|Immunologic Factors|immunologic factors|mesh-ancestor
110663303|NCT02866682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110663304|NCT02866682|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110663305|NCT02866682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110663306|NCT02866682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110663307|NCT01089439|Nitric Oxide|nitric oxide|mesh-list
110663308|NCT01089439|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110663309|NCT01089439|Autonomic Agents|autonomic agents|mesh-ancestor
110663310|NCT01089439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110663311|NCT01089439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110663312|NCT01089439|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110663313|NCT01089439|Respiratory System Agents|respiratory system agents|mesh-ancestor
110663314|NCT01089439|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110663315|NCT01089439|Antioxidants|antioxidants|mesh-ancestor
110663316|NCT01089439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110663317|NCT01089439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110663318|NCT01089439|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
110663319|NCT01089439|Vasodilator Agents|vasodilator agents|mesh-ancestor
110663320|NCT01089439|Gasotransmitters|gasotransmitters|mesh-ancestor
110663321|NCT01089439|Protective Agents|protective agents|mesh-ancestor
110663323|NCT00992030|Doxorubicin|doxorubicin|mesh-list
110663324|NCT00992030|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110663325|NCT00992030|Dacarbazine|dacarbazine|mesh-list
110663326|NCT00992030|Bleomycin|bleomycin|mesh-list
110663327|NCT00992030|Vinblastine|vinblastine|mesh-list
110663328|NCT00992030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110663329|NCT00992030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110663330|NCT00992030|Immunologic Factors|immunologic factors|mesh-ancestor
110663331|NCT00992030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110663332|NCT00992030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110663333|NCT00992030|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110663334|NCT00992030|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110663335|NCT00992030|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110663336|NCT00992030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110663337|NCT00992030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110663338|NCT00992030|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110663339|NCT00992030|Alkylating Agents|alkylating agents|mesh-ancestor
110663340|NCT00992030|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110663341|NCT00992030|Tubulin Modulators|tubulin modulators|mesh-ancestor
110663342|NCT00992030|Antimitotic Agents|antimitotic agents|mesh-ancestor
110663343|NCT00992030|Mitosis Modulators|mitosis modulators|mesh-ancestor
110663344|NCT01976390|Sirolimus|sirolimus|mesh-list
110663345|NCT01976390|Everolimus|everolimus|mesh-list
110663346|NCT01976390|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110663348|NCT01976390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110663349|NCT01976390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110663350|NCT01976390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110663351|NCT01976390|Immunologic Factors|immunologic factors|mesh-ancestor
110663352|NCT01976390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110663353|NCT01976390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110663354|NCT01976390|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110663355|NCT01976390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110663356|NCT01976390|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110663357|NCT01976390|Antifungal Agents|antifungal agents|mesh-ancestor
110663358|NCT00570713|Gemcitabine|gemcitabine|mesh-list
110663359|NCT00570713|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110663360|NCT00570713|Antimetabolites|antimetabolites|mesh-ancestor
110663361|NCT00570713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110663362|NCT00570713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110663363|NCT04002440|Candesartan cilexetil|candesartan cilexetil|mesh-list
110663364|NCT04002440|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110663365|NCT04002440|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110663366|NCT04002440|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110663367|NCT04002440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110663370|NCT00780377|Vasodilator Agents|vasodilator agents|mesh-ancestor
110663371|NCT00780377|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
110663372|NCT00780377|Protease Inhibitors|protease inhibitors|mesh-ancestor
110663373|NCT00780377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110663374|NCT00780377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110663375|NCT05219942|Insulin|insulin|mesh-list
110663376|NCT05219942|Insulin Glargine|insulin glargine|mesh-list
110663377|NCT05219942|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110663378|NCT05219942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110663379|NCT00669617|Fluticasone|fluticasone|mesh-list
110663380|NCT00669617|Xhance|xhance|mesh-list
110663381|NCT00669617|Albuterol|albuterol|mesh-list
110663382|NCT00669617|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110663383|NCT00669617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110663384|NCT00669617|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110663385|NCT00669617|Autonomic Agents|autonomic agents|mesh-ancestor
110663386|NCT00669617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110663387|NCT00669617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110663388|NCT00669617|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110663389|NCT00669617|Respiratory System Agents|respiratory system agents|mesh-ancestor
110663390|NCT00669617|Dermatologic Agents|dermatologic agents|mesh-ancestor
110663391|NCT00669617|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110663392|NCT00669617|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110663393|NCT00669617|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110663394|NCT00669617|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110663395|NCT00669617|Adrenergic Agents|adrenergic agents|mesh-ancestor
110663396|NCT00669617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110663397|NCT00669617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110663398|NCT00669617|Tocolytic Agents|tocolytic agents|mesh-ancestor
110663399|NCT00669617|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110663400|NCT03979352|Empagliflozin|empagliflozin|mesh-list
110663401|NCT03979352|Pancrelipase|pancrelipase|mesh-list
110663402|NCT03979352|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110663403|NCT03979352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110663404|NCT03979352|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110663405|NCT03979352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110663406|NCT03979352|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110663407|NCT00773201|Sotalol|sotalol|mesh-list
110663408|NCT00773201|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110663409|NCT00773201|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110663410|NCT00773201|Adrenergic Agents|adrenergic agents|mesh-ancestor
110663411|NCT00773201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110663412|NCT00773201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110663413|NCT00773201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110663414|NCT00773201|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110663415|NCT00773201|Sympatholytics|sympatholytics|mesh-ancestor
110663416|NCT00773201|Autonomic Agents|autonomic agents|mesh-ancestor
110663417|NCT00773201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110663418|NCT00777413|Minocycline|minocycline|mesh-list
110663419|NCT00777413|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110663420|NCT00777413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110663421|NCT05162690|Dapagliflozin|dapagliflozin|mesh-list
111479155|NCT05715931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110663422|NCT05162690|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110663423|NCT05162690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110663424|NCT05162690|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110663425|NCT05162690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110663426|NCT00992576|Hydromorphone|hydromorphone|mesh-list
110663427|NCT00992576|Naloxone|naloxone|mesh-list
110663428|NCT00992576|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110663429|NCT00992576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110663430|NCT00992576|Sensory System Agents|sensory system agents|mesh-ancestor
110663431|NCT00992576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110663432|NCT00992576|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110663433|NCT00992576|Narcotics|narcotics|mesh-ancestor
110663434|NCT00992576|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110663436|NCT00777569|Nicotine|nicotine|mesh-list
110663437|NCT00777569|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110663438|NCT00777569|Autonomic Agents|autonomic agents|mesh-ancestor
110310648|NCT00319488|Glucocorticoids|glucocorticoids|mesh-ancestor
110663439|NCT00777569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110663440|NCT00777569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110663441|NCT00777569|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110663442|NCT00777569|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110663443|NCT00777569|Cholinergic Agents|cholinergic agents|mesh-ancestor
110663444|NCT00777569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110663445|NCT00777569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110663446|NCT02556593|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110663447|NCT02556593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110663448|NCT02556593|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110663449|NCT02556593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110663450|NCT02556593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110663451|NCT00535730|Vaccines|vaccines|mesh-list
110663452|NCT00535730|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110663453|NCT00535730|Immunologic Factors|immunologic factors|mesh-ancestor
110663454|NCT00535730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110663455|NCT00992654|Maraviroc|maraviroc|mesh-list
110663456|NCT00992654|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110663457|NCT00992654|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110663458|NCT00992654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110663459|NCT00992654|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110663460|NCT00992654|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110663461|NCT00992654|Antiviral Agents|antiviral agents|mesh-ancestor
110663462|NCT00992654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110663463|NCT00992654|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
110663464|NCT00773591|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110663465|NCT00773591|Botulinum Toxins|botulinum toxins|mesh-list
110663466|NCT00773591|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110663467|NCT00773591|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110663468|NCT00773591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110663469|NCT00773591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110663470|NCT00773591|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110663471|NCT00773591|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110663472|NCT00773591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110663473|NCT00773591|Cholinergic Agents|cholinergic agents|mesh-ancestor
110663474|NCT00773591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110663475|NCT00995306|Capsaicin|capsaicin|mesh-list
110663476|NCT00995306|Antipruritics|antipruritics|mesh-ancestor
110663477|NCT00995306|Dermatologic Agents|dermatologic agents|mesh-ancestor
110663478|NCT00995306|Sensory System Agents|sensory system agents|mesh-ancestor
110663479|NCT00995306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110663480|NCT00995306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110663481|NCT00666965|Rotigotine|rotigotine|mesh-list
110663482|NCT00666965|Dopamine Agonists|dopamine agonists|mesh-ancestor
110663483|NCT00666965|Dopamine Agents|dopamine agents|mesh-ancestor
110663484|NCT00666965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110663485|NCT00666965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110663486|NCT00666965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110663487|NCT00781157|Phenylephrine|phenylephrine|mesh-list
110663488|NCT00781157|Oxymetazoline|oxymetazoline|mesh-list
110663489|NCT00781157|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110663490|NCT00781157|Mydriatics|mydriatics|mesh-ancestor
110663491|NCT00781157|Autonomic Agents|autonomic agents|mesh-ancestor
110663492|NCT00781157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110663493|NCT00781157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110663494|NCT00781157|Sympathomimetics|sympathomimetics|mesh-ancestor
110663496|NCT00781157|Nasal Decongestants|nasal decongestants|mesh-ancestor
110663497|NCT00781157|Respiratory System Agents|respiratory system agents|mesh-ancestor
110663498|NCT00781157|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110663499|NCT00781157|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110663500|NCT00781157|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110663501|NCT00781157|Adrenergic Agents|adrenergic agents|mesh-ancestor
110663502|NCT00781157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110663503|NCT00781157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110663504|NCT00781157|Protective Agents|protective agents|mesh-ancestor
110663505|NCT00777959|Sirolimus|sirolimus|mesh-list
110663506|NCT00777959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110663507|NCT00777959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110663508|NCT00777959|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110663509|NCT00777959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110663510|NCT00777959|Antifungal Agents|antifungal agents|mesh-ancestor
110663511|NCT00777959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110663512|NCT00777959|Immunologic Factors|immunologic factors|mesh-ancestor
110663513|NCT00777959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110663514|NCT00778037|Cyclobenzaprine|cyclobenzaprine|mesh-list
110663515|NCT00778037|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110663516|NCT00778037|Antidepressive Agents|antidepressive agents|mesh-ancestor
110663517|NCT00778037|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110663518|NCT00778037|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110663519|NCT00778037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110663520|NCT00778037|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110663521|NCT00778037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110663522|NCT00778037|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110663523|NCT00778037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110663524|NCT00778115|Simethicone|simethicone|mesh-list
110663526|NCT00778115|Antidiarrheals|antidiarrheals|mesh-list
110663527|NCT00778115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110663528|NCT00778115|Antifoaming Agents|antifoaming agents|mesh-ancestor
110663529|NCT00778115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110663530|NCT00778115|Emollients|emollients|mesh-ancestor
110663531|NCT00778115|Dermatologic Agents|dermatologic agents|mesh-ancestor
110663533|NCT00993122|Antimetabolites|antimetabolites|mesh-ancestor
110663534|NCT00993122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110663535|NCT00993122|Antiviral Agents|antiviral agents|mesh-ancestor
110663536|NCT00993122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110663537|NCT00778193|Aspirin|aspirin|mesh-list
110663538|NCT00778193|Celecoxib|celecoxib|mesh-list
110663539|NCT00778193|Naproxen|naproxen|mesh-list
110663540|NCT00778193|Clopidogrel|clopidogrel|mesh-list
110663541|NCT00778193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110663542|NCT00778193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110663543|NCT00778193|Analgesics|analgesics|mesh-ancestor
110663544|NCT00778193|Sensory System Agents|sensory system agents|mesh-ancestor
110663545|NCT00778193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110663546|NCT00778193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110663547|NCT00778193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110663548|NCT00778193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110663549|NCT00778193|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110663550|NCT00778193|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110663551|NCT00778193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110663552|NCT00778193|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110663553|NCT00778193|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110663554|NCT00778193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110663555|NCT00778193|Antipyretics|antipyretics|mesh-ancestor
110663556|NCT00778193|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110663557|NCT00778193|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110663558|NCT00778193|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110663559|NCT00778193|Purinergic Agents|purinergic agents|mesh-ancestor
110663560|NCT00778193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110663561|NCT00778193|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110663562|NCT00778193|Gout Suppressants|gout suppressants|mesh-ancestor
110663563|NCT00778271|Gabapentin|gabapentin|mesh-list
110663564|NCT00778271|Analgesics|analgesics|mesh-ancestor
110663565|NCT00778271|Sensory System Agents|sensory system agents|mesh-ancestor
110663566|NCT00778271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110663567|NCT00778271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110663568|NCT00778271|Anticonvulsants|anticonvulsants|mesh-ancestor
110663569|NCT00778271|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110663570|NCT00778271|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110924210|NCT01597492|Belimumab|belimumab|mesh-list
110663571|NCT00778271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110663572|NCT00778271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110663573|NCT00778271|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110663574|NCT00778271|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110663575|NCT00778271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110663576|NCT00778271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110663577|NCT00778271|Antimanic Agents|antimanic agents|mesh-ancestor
110663578|NCT00778349|Metformin|metformin|mesh-list
110663579|NCT00778349|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110663580|NCT00778349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110663581|NCT00995618|Tranilast|tranilast|mesh-list
110663582|NCT00995618|Febuxostat|febuxostat|mesh-list
110337990|NCT02276300|Imiquimod|imiquimod|mesh-list
110663584|NCT00995618|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110663585|NCT00995618|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110663586|NCT00995618|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110663587|NCT00995618|Analgesics|analgesics|mesh-ancestor
110663588|NCT00995618|Sensory System Agents|sensory system agents|mesh-ancestor
110663589|NCT00995618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110663590|NCT00995618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110663591|NCT00995618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110663592|NCT00995618|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110663593|NCT00995618|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110663594|NCT00995618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110663595|NCT00995618|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110663596|NCT00995618|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110663597|NCT00995618|Histamine Antagonists|histamine antagonists|mesh-ancestor
110663598|NCT00995618|Histamine Agents|histamine agents|mesh-ancestor
110663599|NCT00995618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110663600|NCT00995618|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110663601|NCT00995618|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110663602|NCT00778427|Metformin|metformin|mesh-list
110663603|NCT00778427|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110663604|NCT00778427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110663605|NCT03889886|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110663606|NCT03889886|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110663607|NCT00667355|Adalimumab|adalimumab|mesh-list
110663608|NCT00667355|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110663609|NCT00667355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110663610|NCT00667355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110663611|NCT00778505|Remifentanil|remifentanil|mesh-list
110663612|NCT00778505|Propofol|propofol|mesh-list
110663613|NCT00778505|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110663614|NCT00778505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110663615|NCT00778505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110663616|NCT00778505|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110663617|NCT00778505|Anesthetics, General|anesthetics, general|mesh-ancestor
110663618|NCT00778505|Anesthetics|anesthetics|mesh-ancestor
110663619|NCT00778505|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110663620|NCT00778505|Narcotics|narcotics|mesh-ancestor
110663621|NCT00778505|Analgesics|analgesics|mesh-ancestor
110663622|NCT00778505|Sensory System Agents|sensory system agents|mesh-ancestor
110663623|NCT00778505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110663624|NCT00532844|Vitamins|vitamins|mesh-list
110663625|NCT00532844|Ascorbic Acid|ascorbic acid|mesh-list
110663626|NCT00532844|Verapamil|verapamil|mesh-list
110663627|NCT00532844|Micronutrients|micronutrients|mesh-ancestor
110663628|NCT00532844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110663629|NCT00532844|Antioxidants|antioxidants|mesh-ancestor
110663630|NCT00532844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110663631|NCT00532844|Protective Agents|protective agents|mesh-ancestor
110663632|NCT00532844|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110663633|NCT00532844|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110663634|NCT00532844|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110663635|NCT00532844|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110663636|NCT00532844|Vasodilator Agents|vasodilator agents|mesh-ancestor
110663637|NCT00778583|Nitrofurantoin|nitrofurantoin|mesh-list
110663638|NCT00778583|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110663639|NCT00778583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110663640|NCT00778583|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110663641|NCT00778661|Amoxicillin|amoxicillin|mesh-list
110663642|NCT00778661|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110663643|NCT00778661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110663644|NCT00993356|Lanreotide|lanreotide|mesh-list
110663645|NCT00993356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110663646|NCT00781547|Hormones|hormones|mesh-list
110959290|NCT04217356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111479156|NCT05715931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110663647|NCT00781547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110663648|NCT00781547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110663649|NCT00778739|Cefprozil|cefprozil|mesh-list
110663650|NCT00778739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110663651|NCT00778739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110663652|NCT00781625|Methenamine hippurate|methenamine hippurate|mesh-list
110663653|NCT00781625|Methenamine|methenamine|mesh-list
110663654|NCT00781625|Methenamine mandelate|methenamine mandelate|mesh-list
110663655|NCT00781625|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110663656|NCT00781625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110663657|NCT00781625|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110663658|NCT00781781|Alemtuzumab|alemtuzumab|mesh-list
110663659|NCT00781781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110663660|NCT00781781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110663661|NCT00666263|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110663663|NCT00666263|Antibodies|antibodies|mesh-list
110663664|NCT00666263|gamma-Globulins|gamma-globulins|mesh-list
110663665|NCT00666263|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110663666|NCT00666263|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110663667|NCT00666263|Immunologic Factors|immunologic factors|mesh-ancestor
110663668|NCT00666263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110663669|NCT00667277|Bevacizumab|bevacizumab|mesh-list
110663670|NCT00667277|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110663671|NCT00667277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110663672|NCT00667277|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110663673|NCT00667277|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110663674|NCT00667277|Growth Substances|growth substances|mesh-ancestor
110663675|NCT00667277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110663676|NCT00667277|Growth Inhibitors|growth inhibitors|mesh-ancestor
110663677|NCT00774527|Cyclophosphamide|cyclophosphamide|mesh-list
110663678|NCT00774527|Fludarabine|fludarabine|mesh-list
110663679|NCT00774527|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110663680|NCT00774527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110663681|NCT00774527|Immunologic Factors|immunologic factors|mesh-ancestor
110663682|NCT00774527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110663683|NCT00774527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110663684|NCT00774527|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110663685|NCT00774527|Alkylating Agents|alkylating agents|mesh-ancestor
110663686|NCT00774527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110663687|NCT00774527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110663688|NCT00774527|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110663689|NCT00778973|Sertraline|sertraline|mesh-list
110663690|NCT00778973|Antidepressive Agents|antidepressive agents|mesh-ancestor
110663691|NCT00778973|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110663692|NCT00778973|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110663693|NCT00778973|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110663694|NCT00778973|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110663695|NCT00778973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110663696|NCT00778973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110663697|NCT00778973|Serotonin Agents|serotonin agents|mesh-ancestor
110663698|NCT00778973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110663699|NCT00774605|Varenicline|varenicline|mesh-list
110663700|NCT00774605|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110663702|NCT00774605|Cholinergic Agents|cholinergic agents|mesh-ancestor
110663703|NCT00774605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110663704|NCT00774605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110663705|NCT00774605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110663706|NCT00779051|Zolpidem|zolpidem|mesh-list
110663707|NCT00779051|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110663708|NCT00779051|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110663709|NCT00779051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110663710|NCT00779051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110663711|NCT00779051|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
110663712|NCT00779051|GABA Agonists|gaba agonists|mesh-ancestor
110663713|NCT00779051|GABA Agents|gaba agents|mesh-ancestor
110663714|NCT00779051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110663715|NCT00779051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110663716|NCT00774683|Raltegravir Potassium|raltegravir potassium|mesh-list
110663717|NCT00774683|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110663718|NCT00774683|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110663719|NCT00774683|Antiviral Agents|antiviral agents|mesh-ancestor
110663720|NCT00774683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110663721|NCT00774683|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110663722|NCT00774683|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110663723|NCT00774683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110663724|NCT00774683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110663726|NCT00782093|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110663727|NCT00782093|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110663728|NCT00782093|Growth Substances|growth substances|mesh-ancestor
110663729|NCT00782093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110663730|NCT00782093|Growth Inhibitors|growth inhibitors|mesh-ancestor
110663731|NCT00782093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110663732|NCT00784511|Vitamin D|vitamin d|mesh-list
110663734|NCT00784511|Cholecalciferol|cholecalciferol|mesh-list
110663735|NCT00784511|Vitamins|vitamins|mesh-list
110663736|NCT00784511|Micronutrients|micronutrients|mesh-ancestor
110663737|NCT00784511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110663738|NCT00784511|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110663739|NCT00784511|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110310948|NCT00320307|Abacavir|abacavir|mesh-list
110663741|NCT00784589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110663742|NCT00784589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110663743|NCT00784589|Immunologic Factors|immunologic factors|mesh-ancestor
110663744|NCT00784589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110663745|NCT00784589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110663746|NCT00784667|Cetuximab|cetuximab|mesh-list
110663747|NCT00784667|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110663748|NCT00784667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110663749|NCT00784667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110663750|NCT00784667|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110663751|NCT00784667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110663752|NCT00784667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110663753|NCT00784745|Dexamethasone|dexamethasone|mesh-list
110663754|NCT00784745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110663755|NCT00784745|Antiemetics|antiemetics|mesh-ancestor
110663756|NCT00784745|Autonomic Agents|autonomic agents|mesh-ancestor
110663757|NCT00784745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110663758|NCT00784745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110663759|NCT00784745|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110663760|NCT00784745|Glucocorticoids|glucocorticoids|mesh-ancestor
110663761|NCT00784745|Hormones|hormones|mesh-ancestor
110663762|NCT00784745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110663763|NCT00784745|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110663764|NCT00784745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110663765|NCT00993512|Bleomycin|bleomycin|mesh-list
110663766|NCT00993512|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110663767|NCT00993512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110663768|NCT00662129|Paclitaxel|paclitaxel|mesh-list
110663769|NCT00662129|Bevacizumab|bevacizumab|mesh-list
110663770|NCT00662129|Gemcitabine|gemcitabine|mesh-list
110663771|NCT00662129|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110663772|NCT00662129|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110663773|NCT00662129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110663774|NCT00662129|Tubulin Modulators|tubulin modulators|mesh-ancestor
110663775|NCT00662129|Antimitotic Agents|antimitotic agents|mesh-ancestor
110663776|NCT00662129|Mitosis Modulators|mitosis modulators|mesh-ancestor
110663777|NCT00662129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110663778|NCT00662129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110663779|NCT00662129|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110663780|NCT00662129|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110663781|NCT00662129|Growth Substances|growth substances|mesh-ancestor
110663782|NCT00662129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110663783|NCT00662129|Growth Inhibitors|growth inhibitors|mesh-ancestor
110663784|NCT00662129|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110663785|NCT00662129|Antimetabolites|antimetabolites|mesh-ancestor
110663786|NCT00993746|Lidocaine|lidocaine|mesh-list
110663787|NCT00993746|Bupivacaine|bupivacaine|mesh-list
110663788|NCT00993746|Anesthetics, Local|anesthetics, local|mesh-ancestor
110663789|NCT00993746|Anesthetics|anesthetics|mesh-ancestor
110663790|NCT00993746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110663791|NCT00993746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110663792|NCT00993746|Sensory System Agents|sensory system agents|mesh-ancestor
110663793|NCT00993746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110663794|NCT00993746|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110663795|NCT00993746|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110663796|NCT00993746|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111479157|NCT05715931|Antidotes|antidotes|mesh-ancestor
110663797|NCT00993746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110663798|NCT00993746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110663799|NCT00789971|Triamcinolone|triamcinolone|mesh-list
110663800|NCT00789971|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110663801|NCT00789971|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110663802|NCT00789971|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110663803|NCT00789971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110663804|NCT00789971|Glucocorticoids|glucocorticoids|mesh-ancestor
110663805|NCT00789971|Hormones|hormones|mesh-ancestor
110663806|NCT00789971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110663807|NCT00789971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110663808|NCT00789971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110663809|NCT00789971|Immunologic Factors|immunologic factors|mesh-ancestor
110663810|NCT00789971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110663811|NCT00789971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110663812|NCT00782405|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110663813|NCT00782405|Mirtazapine|mirtazapine|mesh-list
110663814|NCT00782405|Antidepressive Agents|antidepressive agents|mesh-ancestor
110663815|NCT00782405|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110663816|NCT00782405|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110663817|NCT00782405|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110663818|NCT00782405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110663819|NCT00782405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110663820|NCT00782405|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110663821|NCT00782405|Histamine Antagonists|histamine antagonists|mesh-ancestor
110663822|NCT00782405|Histamine Agents|histamine agents|mesh-ancestor
110663823|NCT00782405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110663824|NCT00782405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110663825|NCT00782405|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110663826|NCT00782405|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
110663827|NCT00782405|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110663828|NCT00782405|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110663829|NCT00782405|Adrenergic Agents|adrenergic agents|mesh-ancestor
110663830|NCT00782405|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110663831|NCT00782405|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110663832|NCT00782405|Serotonin Agents|serotonin agents|mesh-ancestor
110663833|NCT00782405|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110663834|NCT05343260|Propofol|propofol|mesh-list
110663835|NCT05343260|Sevoflurane|sevoflurane|mesh-list
110663836|NCT05343260|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110663837|NCT05343260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110663838|NCT05343260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110663839|NCT05343260|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110663840|NCT05343260|Anesthetics, General|anesthetics, general|mesh-ancestor
110663841|NCT05343260|Anesthetics|anesthetics|mesh-ancestor
110663842|NCT05343260|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110663843|NCT05343260|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110663844|NCT00664859|Atorvastatin|atorvastatin|mesh-list
110663845|NCT00664859|Fenofibrate|fenofibrate|mesh-list
110663846|NCT00664859|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110663847|NCT00664859|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110663848|NCT00664859|Antimetabolites|antimetabolites|mesh-ancestor
110663849|NCT00664859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110663850|NCT00664859|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110663851|NCT00664859|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110663852|NCT00664859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110663853|NCT00996788|Rebamipide|rebamipide|mesh-list
110663854|NCT00996788|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110663855|NCT00996788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110663856|NCT00996788|Antioxidants|antioxidants|mesh-ancestor
110663857|NCT00996788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110663858|NCT00996788|Protective Agents|protective agents|mesh-ancestor
110663859|NCT00996788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110663860|NCT00996788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110663861|NCT01564550|Insulin|insulin|mesh-list
110663862|NCT01564550|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110663863|NCT01564550|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110663864|NCT01564550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110663865|NCT00790439|Cyclosporine|cyclosporine|mesh-list
110663866|NCT00790439|Sirolimus|sirolimus|mesh-list
110663867|NCT00790439|Mycophenolic Acid|mycophenolic acid|mesh-list
110663868|NCT00790439|Heparin|heparin|mesh-list
110663869|NCT00790439|Calcium heparin|calcium heparin|mesh-list
110663870|NCT00790439|Dextrans|dextrans|mesh-list
110663871|NCT00790439|Tacrolimus|tacrolimus|mesh-list
110663872|NCT00790439|Cyclosporins|cyclosporins|mesh-list
110663873|NCT00790439|Basiliximab|basiliximab|mesh-list
110663874|NCT00790439|Daclizumab|daclizumab|mesh-list
110663875|NCT00790439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110663876|NCT00790439|Immunologic Factors|immunologic factors|mesh-ancestor
110663877|NCT00790439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110663878|NCT00790439|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110663879|NCT00790439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110663880|NCT00790439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110663881|NCT00790439|Antifungal Agents|antifungal agents|mesh-ancestor
110663882|NCT00790439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110663883|NCT00790439|Dermatologic Agents|dermatologic agents|mesh-ancestor
110663884|NCT00790439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110663885|NCT00790439|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110663886|NCT00790439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110663887|NCT00790439|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110663888|NCT00790439|Antitubercular Agents|antitubercular agents|mesh-ancestor
110311085|NCT00320697|Bupropion|bupropion|mesh-list
110663889|NCT00790439|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110663891|NCT00790439|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110663892|NCT00790439|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110663893|NCT00790439|Plasma Substitutes|plasma substitutes|mesh-ancestor
110663894|NCT00790439|Blood Substitutes|blood substitutes|mesh-ancestor
110663895|NCT00785603|Tramadol|tramadol|mesh-list
110663896|NCT00785603|Paroxetine|paroxetine|mesh-list
110663897|NCT00785603|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110663898|NCT00785603|Narcotics|narcotics|mesh-ancestor
110663899|NCT00785603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110663900|NCT00785603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110663901|NCT00785603|Analgesics|analgesics|mesh-ancestor
110663902|NCT00785603|Sensory System Agents|sensory system agents|mesh-ancestor
110663903|NCT00785603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110663904|NCT00785603|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110663905|NCT00785603|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110663906|NCT00785603|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110663907|NCT00785603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110663908|NCT00785603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110663909|NCT00785603|Serotonin Agents|serotonin agents|mesh-ancestor
110663910|NCT00785603|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110663911|NCT00785603|Antidepressive Agents|antidepressive agents|mesh-ancestor
110663912|NCT00785603|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110663913|NCT00785603|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110663914|NCT00785603|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110663915|NCT00785603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110663916|NCT00570401|Dasatinib|dasatinib|mesh-list
110663917|NCT00570401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110663918|NCT00570401|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110663919|NCT00570401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110663920|NCT00570401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110663921|NCT00532298|Vaccines|vaccines|mesh-list
110663922|NCT00532298|Immunologic Factors|immunologic factors|mesh-ancestor
110663923|NCT00532298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110663924|NCT04047017|Apatinib|apatinib|mesh-list
110663925|NCT04047017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110663926|NCT04047017|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110663927|NCT04047017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110663928|NCT04047017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110663929|NCT00997022|Sorafenib|sorafenib|mesh-list
110663930|NCT00997022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110663931|NCT00997022|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110663932|NCT00997022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110663933|NCT00997022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110663934|NCT00786149|Varenicline|varenicline|mesh-list
110663935|NCT00786149|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110663936|NCT00786149|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110663937|NCT00786149|Cholinergic Agents|cholinergic agents|mesh-ancestor
110663938|NCT00786149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110663939|NCT00786149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110663940|NCT00786149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110663941|NCT00410410|Abatacept|abatacept|mesh-list
110663942|NCT00410410|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110663943|NCT00410410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110663944|NCT00410410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110663945|NCT00410410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110663946|NCT00410410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111479158|NCT05715931|Protective Agents|protective agents|mesh-ancestor
110663947|NCT00410410|Immunologic Factors|immunologic factors|mesh-ancestor
110663948|NCT00410410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110663949|NCT00410410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110663950|NCT00782951|Morphine|morphine|mesh-list
110663951|NCT00782951|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110663952|NCT00782951|Narcotics|narcotics|mesh-ancestor
110663953|NCT00782951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110663954|NCT00782951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110663955|NCT00782951|Analgesics|analgesics|mesh-ancestor
110663956|NCT00782951|Sensory System Agents|sensory system agents|mesh-ancestor
110663957|NCT00782951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110663959|NCT02555813|Gemcitabine|gemcitabine|mesh-list
110663960|NCT02555813|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110663961|NCT02555813|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110663962|NCT02555813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110663963|NCT02555813|Tubulin Modulators|tubulin modulators|mesh-ancestor
110663964|NCT02555813|Antimitotic Agents|antimitotic agents|mesh-ancestor
110663965|NCT02555813|Mitosis Modulators|mitosis modulators|mesh-ancestor
110663966|NCT02555813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110663967|NCT02555813|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110663969|NCT00997412|Mycophenolic Acid|mycophenolic acid|mesh-list
110663970|NCT00997412|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110663971|NCT00997412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110663972|NCT00997412|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110663973|NCT00997412|Antitubercular Agents|antitubercular agents|mesh-ancestor
110663974|NCT00997412|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110663975|NCT00997412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110663976|NCT00997412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110663977|NCT00997412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110663978|NCT00783107|Cyclosporine|cyclosporine|mesh-list
110663979|NCT00783107|Cyclosporins|cyclosporins|mesh-list
110663980|NCT00783107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110663981|NCT00783107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110663982|NCT00783107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110663983|NCT00783107|Immunologic Factors|immunologic factors|mesh-ancestor
110663984|NCT00783107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110663985|NCT00783107|Antifungal Agents|antifungal agents|mesh-ancestor
110663986|NCT00783107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110663987|NCT00783107|Dermatologic Agents|dermatologic agents|mesh-ancestor
110663988|NCT00783107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110663989|NCT00783107|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110663990|NCT00534404|Nicotine|nicotine|mesh-list
110663991|NCT00534404|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110663992|NCT00534404|Autonomic Agents|autonomic agents|mesh-ancestor
110663993|NCT00534404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110663994|NCT00534404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110663995|NCT00534404|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110663996|NCT00534404|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110663997|NCT00534404|Cholinergic Agents|cholinergic agents|mesh-ancestor
110663998|NCT00534404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110663999|NCT00534404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110664000|NCT00393094|Bevacizumab|bevacizumab|mesh-list
110664001|NCT00393094|Irinotecan|irinotecan|mesh-list
110664002|NCT00393094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110664003|NCT00393094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110664004|NCT00393094|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110664005|NCT00393094|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110664006|NCT00393094|Growth Substances|growth substances|mesh-ancestor
110664007|NCT00393094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110664008|NCT00393094|Growth Inhibitors|growth inhibitors|mesh-ancestor
110664009|NCT00393094|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110664010|NCT00393094|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110664011|NCT00393094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110664012|NCT00393094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110664013|NCT00783653|Sunitinib|sunitinib|mesh-list
110664014|NCT00783653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110664015|NCT00783653|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110664016|NCT00783653|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110664017|NCT00783653|Growth Substances|growth substances|mesh-ancestor
110664018|NCT00783653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110664019|NCT00783653|Growth Inhibitors|growth inhibitors|mesh-ancestor
110664020|NCT00783653|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110664021|NCT00783653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110959291|NCT04217356|Antisickling Agents|antisickling agents|mesh-ancestor
110664022|NCT00783653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110664023|NCT00786305|Amikacin|amikacin|mesh-list
110664024|NCT00786305|Ceftazidime|ceftazidime|mesh-list
110664025|NCT00786305|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110664026|NCT00786305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110664027|NCT01044004|Modafinil|modafinil|mesh-list
110664028|NCT01044004|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110664029|NCT01044004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110664030|NCT01044004|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
110664031|NCT01044004|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110664032|NCT01044004|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110664033|NCT01044004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110664034|NCT00786383|Ramucirumab|ramucirumab|mesh-list
110664035|NCT00786383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110664036|NCT00790595|Sunitinib|sunitinib|mesh-list
110311230|NCT00322569|Pimecrolimus|pimecrolimus|mesh-list
110664037|NCT00790595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110664038|NCT00790595|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110664039|NCT00790595|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110664040|NCT00790595|Growth Substances|growth substances|mesh-ancestor
110664041|NCT00790595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110664042|NCT00790595|Growth Inhibitors|growth inhibitors|mesh-ancestor
110664043|NCT00790595|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110664044|NCT00790595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110664045|NCT00790595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110664046|NCT00783731|Midazolam|midazolam|mesh-list
110664047|NCT00783731|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110664048|NCT00783731|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110664049|NCT00783731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110664050|NCT00783731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110664051|NCT00783731|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110664052|NCT00783731|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110664053|NCT00783731|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110664054|NCT00783731|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110664055|NCT00783731|Anesthetics, General|anesthetics, general|mesh-ancestor
110664056|NCT00783731|Anesthetics|anesthetics|mesh-ancestor
110664057|NCT00783731|GABA Modulators|gaba modulators|mesh-ancestor
110664058|NCT00783731|GABA Agents|gaba agents|mesh-ancestor
110664059|NCT00783731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110664060|NCT00783731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110664061|NCT00409708|Methylphenidate|methylphenidate|mesh-list
110664062|NCT00409708|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110664063|NCT00409708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110664064|NCT00409708|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110664065|NCT00409708|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110664066|NCT00409708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110664067|NCT00409708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110664068|NCT00409708|Dopamine Agents|dopamine agents|mesh-ancestor
110664069|NCT00409708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110664070|NCT00790985|Naproxen|naproxen|mesh-list
110664071|NCT00790985|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110664072|NCT00790985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110664073|NCT00790985|Analgesics|analgesics|mesh-ancestor
110664074|NCT00790985|Sensory System Agents|sensory system agents|mesh-ancestor
110664075|NCT00790985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110664076|NCT00790985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110664077|NCT00790985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110664078|NCT00790985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110664079|NCT00790985|Gout Suppressants|gout suppressants|mesh-ancestor
110664080|NCT00790985|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110664081|NCT00790985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110664082|NCT00790985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110664083|NCT01324336|Mercaptopurine|mercaptopurine|mesh-list
110664084|NCT01324336|Antimetabolites|antimetabolites|mesh-ancestor
110664085|NCT01324336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110664086|NCT01324336|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110664087|NCT01324336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110664088|NCT01324336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110664089|NCT01324336|Immunologic Factors|immunologic factors|mesh-ancestor
110664090|NCT01324336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110664091|NCT01324336|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110664092|NCT01324336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111479159|NCT05715931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110664093|NCT01324492|Everolimus|everolimus|mesh-list
110664094|NCT01324492|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110664095|NCT01324492|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110664096|NCT01324492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110664097|NCT01324492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110664098|NCT01324492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110664099|NCT01324492|Immunologic Factors|immunologic factors|mesh-ancestor
110664100|NCT01324492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110664101|NCT01324492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110664102|NCT01039948|Gefitinib|gefitinib|mesh-list
110664103|NCT01039948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110664104|NCT01039948|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110664105|NCT01039948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110664106|NCT01039948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110664107|NCT00391846|Metoprolol|metoprolol|mesh-list
110664108|NCT00391846|Valsartan|valsartan|mesh-list
110664109|NCT00391846|Carvedilol|carvedilol|mesh-list
110664110|NCT00391846|Candesartan|candesartan|mesh-list
110664111|NCT00391846|Ramipril|ramipril|mesh-list
110664112|NCT00391846|Enalapril|enalapril|mesh-list
110664113|NCT00391846|Lisinopril|lisinopril|mesh-list
110664114|NCT00391846|Eplerenone|eplerenone|mesh-list
110664115|NCT00391846|Bisoprolol|bisoprolol|mesh-list
110664116|NCT00391846|Captopril|captopril|mesh-list
110664117|NCT00391846|Trandolapril|trandolapril|mesh-list
110664118|NCT00391846|Spironolactone|spironolactone|mesh-list
110664119|NCT00391846|Diuretics|diuretics|mesh-list
110664120|NCT00391846|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110664121|NCT00391846|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110664122|NCT00391846|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110664123|NCT00391846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110664124|NCT00391846|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110664125|NCT00391846|Sympatholytics|sympatholytics|mesh-ancestor
110664126|NCT00391846|Autonomic Agents|autonomic agents|mesh-ancestor
110664127|NCT00391846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110664128|NCT00391846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110664129|NCT00391846|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110664130|NCT00391846|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110664131|NCT00391846|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110664132|NCT00391846|Adrenergic Agents|adrenergic agents|mesh-ancestor
110664133|NCT00391846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110664134|NCT00391846|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110664135|NCT00391846|Hormone Antagonists|hormone antagonists|mesh-ancestor
110664136|NCT00391846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110664137|NCT00391846|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110664138|NCT00391846|Natriuretic Agents|natriuretic agents|mesh-ancestor
110664139|NCT00391846|Antioxidants|antioxidants|mesh-ancestor
110664140|NCT00391846|Protective Agents|protective agents|mesh-ancestor
110664141|NCT00391846|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110664142|NCT00391846|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110664143|NCT00391846|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110664144|NCT00391846|Vasodilator Agents|vasodilator agents|mesh-ancestor
110664145|NCT00391846|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110664146|NCT00391846|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110664147|NCT00391846|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110664148|NCT00391846|Protease Inhibitors|protease inhibitors|mesh-ancestor
110664149|NCT00391846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110664150|NCT00391846|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110664151|NCT00391768|Oseltamivir|oseltamivir|mesh-list
110664152|NCT00391768|Antiviral Agents|antiviral agents|mesh-ancestor
110664153|NCT00391768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110664154|NCT00391768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110664155|NCT00391768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110664157|NCT00391222|Risperidone|risperidone|mesh-list
110664158|NCT00391222|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110664159|NCT00391222|Serotonin Agents|serotonin agents|mesh-ancestor
110664160|NCT00391222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110664161|NCT00391222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110664162|NCT00391222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110664163|NCT00391222|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110664164|NCT00391222|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110664165|NCT00391222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110664166|NCT00391222|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110664167|NCT00391222|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110664168|NCT00391222|Dopamine Agents|dopamine agents|mesh-ancestor
111479160|NCT05715931|Vitamin B Complex|vitamin b complex|mesh-ancestor
110664169|NCT00391222|Antiemetics|antiemetics|mesh-ancestor
110664170|NCT00391222|Autonomic Agents|autonomic agents|mesh-ancestor
110664171|NCT00391222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110664172|NCT00391222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110664173|NCT00391222|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110664174|NCT00391222|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110664175|NCT00391222|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110664176|NCT00409006|Pemetrexed|pemetrexed|mesh-list
110664177|NCT00409006|Gefitinib|gefitinib|mesh-list
110664178|NCT00409006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110664179|NCT00409006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110664180|NCT00409006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110664181|NCT00409006|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110664182|NCT00409006|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110664183|NCT00409006|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110664184|NCT00997880|Calcium, Dietary|calcium, dietary|mesh-list
110664185|NCT00997880|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110664186|NCT00997880|Calcium|calcium|mesh-list
110664187|NCT00997880|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110664188|NCT00997880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110664189|NCT00997880|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110664190|NCT00997880|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110664191|NCT00997880|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110664192|NCT00997880|Antimetabolites|antimetabolites|mesh-ancestor
110664193|NCT00997880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110664194|NCT00997880|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110664195|NCT00997880|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110664196|NCT00997880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110664197|NCT00408928|Bortezomib|bortezomib|mesh-list
110664198|NCT00408928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110664199|NCT00997958|Mycophenolic Acid|mycophenolic acid|mesh-list
110664200|NCT00997958|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110664201|NCT00997958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110664202|NCT00997958|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110664203|NCT00997958|Antitubercular Agents|antitubercular agents|mesh-ancestor
110664204|NCT00997958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110664205|NCT00997958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110664206|NCT00997958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110664207|NCT00997958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110664208|NCT00998036|Sirolimus|sirolimus|mesh-list
110664209|NCT00998036|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110664210|NCT00998036|Temsirolimus|temsirolimus|mesh-list
110664211|NCT00998036|MTOR Inhibitors|mtor inhibitors|mesh-list
110664212|NCT00998036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110664213|NCT00998036|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110664214|NCT00998036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110664215|NCT00998036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110664216|NCT00998036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110664217|NCT00998036|Immunologic Factors|immunologic factors|mesh-ancestor
110664218|NCT00998036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110664219|NCT00998036|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110664220|NCT00998036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110664221|NCT00998036|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110664222|NCT00998036|Antifungal Agents|antifungal agents|mesh-ancestor
110664223|NCT05254808|Fosfomycin|fosfomycin|mesh-list
110664224|NCT05254808|Nitrofurantoin|nitrofurantoin|mesh-list
110664225|NCT05254808|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110664226|NCT05254808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110664227|NCT05254808|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110664228|NCT02275286|Trabectedin|trabectedin|mesh-list
110664229|NCT02275286|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110664230|NCT02275286|Alkylating Agents|alkylating agents|mesh-ancestor
110664231|NCT02275286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110664232|NCT02275286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110664233|NCT00998192|Paclitaxel|paclitaxel|mesh-list
110664234|NCT00998192|Carboplatin|carboplatin|mesh-list
110664235|NCT00998192|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110664236|NCT00998192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110664237|NCT00998192|Tubulin Modulators|tubulin modulators|mesh-ancestor
110664238|NCT00998192|Antimitotic Agents|antimitotic agents|mesh-ancestor
110664239|NCT00998192|Mitosis Modulators|mitosis modulators|mesh-ancestor
110664240|NCT00998192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110664241|NCT00994526|Vitamin E|vitamin e|mesh-list
110664242|NCT00994526|Calcium|calcium|mesh-list
110664243|NCT00994526|Vitamins|vitamins|mesh-ancestor
110664244|NCT00994526|Micronutrients|micronutrients|mesh-ancestor
110664245|NCT00994526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110664246|NCT00994526|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110664247|NCT00994526|Antioxidants|antioxidants|mesh-ancestor
110664248|NCT00994526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110664249|NCT00994526|Protective Agents|protective agents|mesh-ancestor
110664250|NCT00998504|Resveratrol|resveratrol|mesh-list
110664251|NCT00998504|Antioxidants|antioxidants|mesh-ancestor
110664252|NCT00998504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110664253|NCT00998504|Protective Agents|protective agents|mesh-ancestor
110664254|NCT00998504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110664255|NCT00998504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110664256|NCT00998504|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110664258|NCT00788684|Navitoclax|navitoclax|mesh-list
110664259|NCT00788684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110664260|NCT00788684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110664261|NCT00788684|Immunologic Factors|immunologic factors|mesh-ancestor
110664262|NCT00788684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110664263|NCT00788684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110664264|NCT00998972|Acetylcysteine|acetylcysteine|mesh-list
110447991|NCT01070784|Budesonide|budesonide|mesh-list
110664265|NCT00998972|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110664266|NCT00998972|Antiviral Agents|antiviral agents|mesh-ancestor
110664267|NCT00998972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110664268|NCT00998972|Expectorants|expectorants|mesh-ancestor
110664269|NCT00998972|Respiratory System Agents|respiratory system agents|mesh-ancestor
110664270|NCT00998972|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110664271|NCT00998972|Antioxidants|antioxidants|mesh-ancestor
110664272|NCT00998972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110664273|NCT00998972|Protective Agents|protective agents|mesh-ancestor
110664274|NCT00998972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110664275|NCT00998972|Antidotes|antidotes|mesh-ancestor
110664276|NCT00390910|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110664277|NCT00390910|Immunologic Factors|immunologic factors|mesh-ancestor
110664278|NCT00390910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110664279|NCT00998816|Pregabalin|pregabalin|mesh-list
110664280|NCT00998816|Analgesics|analgesics|mesh-ancestor
110664281|NCT00998816|Sensory System Agents|sensory system agents|mesh-ancestor
110664282|NCT00998816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110664283|NCT00998816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110664284|NCT00998816|Anticonvulsants|anticonvulsants|mesh-ancestor
110664285|NCT00998816|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110664286|NCT00998816|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110664287|NCT00998816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110664288|NCT00998816|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110664289|NCT00998816|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110664290|NCT00998816|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110664291|NCT00998816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110664292|NCT00998816|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110664293|NCT00533702|Dacarbazine|dacarbazine|mesh-list
110664294|NCT00533702|Ramucirumab|ramucirumab|mesh-list
110664295|NCT00533702|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110664296|NCT00533702|Imidazole|imidazole|mesh-list
110664297|NCT00533702|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110664298|NCT00533702|Alkylating Agents|alkylating agents|mesh-ancestor
110664299|NCT00533702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110664300|NCT00533702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110664301|NCT00533702|Immunologic Factors|immunologic factors|mesh-ancestor
110664302|NCT00533702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110664303|NCT00533702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110664304|NCT00408694|Bevacizumab|bevacizumab|mesh-list
110664305|NCT00408694|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110664306|NCT00408694|Cisplatin|cisplatin|mesh-list
110664307|NCT00408694|Fluorouracil|fluorouracil|mesh-list
110664308|NCT00408694|Endothelial Growth Factors|endothelial growth factors|mesh-list
110664309|NCT00408694|Antibodies|antibodies|mesh-list
110664310|NCT00408694|Immunoglobulins|immunoglobulins|mesh-list
110664311|NCT00408694|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110664312|NCT00408694|Immunoglobulin G|immunoglobulin g|mesh-list
110664313|NCT00408694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110664314|NCT00408694|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110664315|NCT00408694|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110664316|NCT00408694|Growth Substances|growth substances|mesh-ancestor
110664317|NCT00408694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111479161|NCT05715931|Vitamins|vitamins|mesh-ancestor
110664318|NCT00408694|Growth Inhibitors|growth inhibitors|mesh-ancestor
110664319|NCT00408694|Immunologic Factors|immunologic factors|mesh-ancestor
110664320|NCT00408694|Antimetabolites|antimetabolites|mesh-ancestor
110664321|NCT00408694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110664322|NCT00408694|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110664323|NCT00408694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110664324|NCT00999128|Rabeprazole|rabeprazole|mesh-list
110664325|NCT00999128|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110664326|NCT00999128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110664327|NCT00999128|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110664328|NCT00999128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110664329|NCT00999128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110664330|NCT00999206|Vaccines|vaccines|mesh-list
110664331|NCT00999206|Immunologic Factors|immunologic factors|mesh-ancestor
110338742|NCT05148377|Heparin|heparin|mesh-list
110664332|NCT00999206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110664334|NCT01043224|Calcipotriene|calcipotriene|mesh-list
110664335|NCT01043224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110664336|NCT01043224|Glucocorticoids|glucocorticoids|mesh-ancestor
110664337|NCT01043224|Hormones|hormones|mesh-ancestor
110664338|NCT01043224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110664339|NCT01043224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110664340|NCT01043224|Dermatologic Agents|dermatologic agents|mesh-ancestor
110664341|NCT01044238|Methylphenidate|methylphenidate|mesh-list
110664342|NCT01044238|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110664343|NCT01044238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110664344|NCT01044238|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110664345|NCT01044238|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110664346|NCT01044238|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110664347|NCT01044238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110664348|NCT01044238|Dopamine Agents|dopamine agents|mesh-ancestor
110664349|NCT01044238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110664350|NCT01043380|Atorvastatin|atorvastatin|mesh-list
110664352|NCT01043380|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110664353|NCT01043380|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110664354|NCT01043380|Antimetabolites|antimetabolites|mesh-ancestor
110664355|NCT01043380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110664356|NCT01043380|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110664357|NCT01043380|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110664358|NCT01043380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110664359|NCT01044394|Bisacodyl|bisacodyl|mesh-list
110664360|NCT01044394|Cathartics|cathartics|mesh-ancestor
110664361|NCT01044394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110664362|NCT01044394|Laxatives|laxatives|mesh-ancestor
110664363|NCT03474094|Atezolizumab|atezolizumab|mesh-list
110664364|NCT03474094|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110664365|NCT03474094|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110664366|NCT03474094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110664367|NCT03474094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110664368|NCT03474094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110664369|NCT03474094|Immunologic Factors|immunologic factors|mesh-ancestor
110664370|NCT03474094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110664371|NCT01043536|Temozolomide|temozolomide|mesh-list
110664372|NCT01043536|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110664373|NCT01043536|Alkylating Agents|alkylating agents|mesh-ancestor
110664374|NCT01043536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110664375|NCT01043536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110664376|NCT01004198|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110664377|NCT00056407|Dutasteride|dutasteride|mesh-list
110664378|NCT00056407|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
110664379|NCT00056407|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110664380|NCT00056407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110664381|NCT00056407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110664382|NCT00056407|Hormone Antagonists|hormone antagonists|mesh-ancestor
110664383|NCT00056407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110664384|NCT00056407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110664385|NCT00387790|Motexafin gadolinium|motexafin gadolinium|mesh-list
110664386|NCT00387790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110664387|NCT00387790|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110664388|NCT00387790|Dermatologic Agents|dermatologic agents|mesh-ancestor
110664389|NCT00073021|Mesalamine|mesalamine|mesh-list
110448011|NCT02694874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110664390|NCT00073021|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110664391|NCT00073021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110664392|NCT00073021|Analgesics|analgesics|mesh-ancestor
110664393|NCT00073021|Sensory System Agents|sensory system agents|mesh-ancestor
110664394|NCT00073021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110664395|NCT00073021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110664396|NCT00073021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110664397|NCT00073021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110664398|NCT01584115|Monophosphoryl lipid A|monophosphoryl lipid a|mesh-list
110664399|NCT01584115|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110664400|NCT01584115|Immunologic Factors|immunologic factors|mesh-ancestor
110664401|NCT01584115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110664402|NCT00395746|Liraglutide|liraglutide|mesh-list
110664403|NCT00395746|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110664404|NCT00395746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110664405|NCT00395746|Incretins|incretins|mesh-ancestor
110664406|NCT00395746|Hormones|hormones|mesh-ancestor
110664407|NCT00395746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110664408|NCT01004900|Timolol|timolol|mesh-list
110664409|NCT01004900|Brimonidine Tartrate|brimonidine tartrate|mesh-list
110664410|NCT01004900|Travoprost|travoprost|mesh-list
110664411|NCT01004900|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110664412|NCT01004900|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110664413|NCT01004900|Adrenergic Agents|adrenergic agents|mesh-ancestor
110664414|NCT01004900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110664415|NCT01004900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110664416|NCT01004900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110664417|NCT01004900|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110664418|NCT01004900|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110664419|NCT01004900|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110664420|NCT01004900|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110664421|NCT01004900|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110664422|NCT04001348|Diazepam|diazepam|mesh-list
110664423|NCT04001348|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110664424|NCT04001348|Anticonvulsants|anticonvulsants|mesh-ancestor
110664425|NCT04001348|Antiemetics|antiemetics|mesh-ancestor
110664426|NCT04001348|Autonomic Agents|autonomic agents|mesh-ancestor
110664427|NCT04001348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110664428|NCT04001348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110664429|NCT04001348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110664430|NCT04001348|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110664431|NCT04001348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110664432|NCT04001348|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110664433|NCT04001348|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110664434|NCT04001348|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110664435|NCT04001348|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110664436|NCT04001348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110664437|NCT04001348|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110664438|NCT04001348|Anesthetics, General|anesthetics, general|mesh-ancestor
110664439|NCT04001348|Anesthetics|anesthetics|mesh-ancestor
110664440|NCT04001348|GABA Modulators|gaba modulators|mesh-ancestor
110664441|NCT04001348|GABA Agents|gaba agents|mesh-ancestor
110664442|NCT04001348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110664443|NCT04001348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110664444|NCT00395512|Pioglitazone|pioglitazone|mesh-list
110664445|NCT00395512|Alogliptin|alogliptin|mesh-list
110664446|NCT00395512|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110664447|NCT00395512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110664448|NCT00395512|Incretins|incretins|mesh-ancestor
110664449|NCT00395512|Hormones|hormones|mesh-ancestor
110664450|NCT00395512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110664451|NCT00395512|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110664452|NCT00395512|Protease Inhibitors|protease inhibitors|mesh-ancestor
110664453|NCT00395512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110664454|NCT00395512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110664455|NCT03956017|Ubiquinone|ubiquinone|mesh-list
110664456|NCT03956017|Coenzyme Q10|coenzyme q10|mesh-list
110664457|NCT03956017|Micronutrients|micronutrients|mesh-ancestor
110664458|NCT03956017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110664459|NCT03956017|Vitamins|vitamins|mesh-ancestor
110664460|NCT00994916|Amifampridine|amifampridine|mesh-list
110664461|NCT00994916|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110664462|NCT00994916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110664463|NCT00994916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110664464|NCT00994916|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
110664465|NCT00994916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110664466|NCT00994916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110664467|NCT00999440|Methadone|methadone|mesh-list
110664468|NCT00999440|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110664469|NCT00999440|Narcotics|narcotics|mesh-ancestor
111479162|NCT05715931|Micronutrients|micronutrients|mesh-ancestor
110664470|NCT00999440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110664471|NCT00999440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110664472|NCT00999440|Analgesics|analgesics|mesh-ancestor
110664473|NCT00999440|Sensory System Agents|sensory system agents|mesh-ancestor
110664474|NCT00999440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110664475|NCT00999440|Antitussive Agents|antitussive agents|mesh-ancestor
110664476|NCT00999440|Respiratory System Agents|respiratory system agents|mesh-ancestor
110664477|NCT00054691|Gefitinib|gefitinib|mesh-list
110664478|NCT00054691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110664479|NCT00054691|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110664480|NCT00054691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110664481|NCT00054691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110664483|NCT02530879|Omeprazole|omeprazole|mesh-list
110664484|NCT02530879|Lansoprazole|lansoprazole|mesh-list
110664485|NCT02530879|Dexlansoprazole|dexlansoprazole|mesh-list
110664486|NCT02530879|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110664487|NCT02530879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110664488|NCT02530879|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110664489|NCT02530879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110664490|NCT02530879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110664491|NCT03957499|Dexamethasone|dexamethasone|mesh-list
110664492|NCT03957499|Magnesium Sulfate|magnesium sulfate|mesh-list
110664493|NCT03957499|Bupivacaine|bupivacaine|mesh-list
110664494|NCT03957499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110664495|NCT03957499|Antiemetics|antiemetics|mesh-ancestor
110664496|NCT03957499|Autonomic Agents|autonomic agents|mesh-ancestor
110664497|NCT03957499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110664498|NCT03957499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110664499|NCT03957499|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110664500|NCT03957499|Glucocorticoids|glucocorticoids|mesh-ancestor
110664501|NCT03957499|Hormones|hormones|mesh-ancestor
110664502|NCT03957499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110664503|NCT03957499|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110664504|NCT03957499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110664505|NCT03957499|Anesthetics, Local|anesthetics, local|mesh-ancestor
110664506|NCT03957499|Anesthetics|anesthetics|mesh-ancestor
110664507|NCT03957499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110664508|NCT03957499|Sensory System Agents|sensory system agents|mesh-ancestor
110664509|NCT03957499|Analgesics|analgesics|mesh-ancestor
110664510|NCT03957499|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110664511|NCT03957499|Anticonvulsants|anticonvulsants|mesh-ancestor
110664512|NCT03957499|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110664513|NCT03957499|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110664514|NCT03957499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110664515|NCT03957499|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110664516|NCT03957499|Tocolytic Agents|tocolytic agents|mesh-ancestor
110664517|NCT03957499|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110664518|NCT01040338|Nicotine|nicotine|mesh-list
110664519|NCT01040338|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110664520|NCT01040338|Autonomic Agents|autonomic agents|mesh-ancestor
110664521|NCT01040338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110664522|NCT01040338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110664523|NCT01040338|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110664524|NCT01040338|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110664525|NCT01040338|Cholinergic Agents|cholinergic agents|mesh-ancestor
110664526|NCT01040338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110664527|NCT01040338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110664528|NCT00066703|Tamoxifen|tamoxifen|mesh-list
110664529|NCT00066703|Triptorelin Pamoate|triptorelin pamoate|mesh-list
110664530|NCT00066703|Exemestane|exemestane|mesh-list
110664531|NCT00066703|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110664532|NCT00066703|Hormone Antagonists|hormone antagonists|mesh-ancestor
110664533|NCT00066703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110664534|NCT00066703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110664535|NCT00066703|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110664536|NCT00066703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110664537|NCT00066703|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110664538|NCT00066703|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110664539|NCT00066703|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110664540|NCT00066703|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110664541|NCT00066703|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110664542|NCT00066703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110664543|NCT00066703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110664544|NCT00066703|Luteolytic Agents|luteolytic agents|mesh-ancestor
110664545|NCT00066703|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110664546|NCT00066703|Contraceptive Agents|contraceptive agents|mesh-ancestor
110664547|NCT00066703|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110664548|NCT00066703|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110664549|NCT03955939|Midazolam|midazolam|mesh-list
110664550|NCT03955939|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110664551|NCT03955939|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110664552|NCT03955939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110664553|NCT03955939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110664554|NCT03955939|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110664555|NCT03955939|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110664556|NCT03955939|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110664557|NCT03955939|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110664558|NCT03955939|Anesthetics, General|anesthetics, general|mesh-ancestor
110664559|NCT03955939|Anesthetics|anesthetics|mesh-ancestor
110664560|NCT03955939|GABA Modulators|gaba modulators|mesh-ancestor
110664562|NCT03955939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110664563|NCT03955939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110664564|NCT01094821|ATI 7505|ati 7505|mesh-list
110664565|NCT01094821|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
110664566|NCT01094821|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110664567|NCT01094821|Serotonin Agents|serotonin agents|mesh-ancestor
110664568|NCT01094821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110664569|NCT01094821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110664570|NCT01094821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110664571|NCT00072475|Vatalanib|vatalanib|mesh-list
110664572|NCT00072475|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110664573|NCT00072475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110664574|NCT00072475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110664575|NCT01091701|Plasma-lyte 148|plasma-lyte 148|mesh-list
110664576|NCT01091701|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110664577|NCT01091701|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110664578|NCT00066469|Prednisone|prednisone|mesh-list
110664579|NCT00066469|Methylprednisolone|methylprednisolone|mesh-list
110664580|NCT00066469|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110664581|NCT00066469|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110664582|NCT00066469|Prednisolone|prednisolone|mesh-list
110664583|NCT00066469|Prednisolone acetate|prednisolone acetate|mesh-list
110664584|NCT00066469|Cyclophosphamide|cyclophosphamide|mesh-list
110664585|NCT00066469|Rituximab|rituximab|mesh-list
110664586|NCT00066469|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110664587|NCT00066469|Prednisolone phosphate|prednisolone phosphate|mesh-list
110664588|NCT00066469|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110664589|NCT00066469|Immunologic Factors|immunologic factors|mesh-ancestor
110664590|NCT00066469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110664591|NCT00066469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110664592|NCT00066469|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110664593|NCT00066469|Alkylating Agents|alkylating agents|mesh-ancestor
110664594|NCT00066469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110664595|NCT00066469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110664596|NCT00066469|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110664597|NCT00066469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110664598|NCT00066469|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110664599|NCT00066469|Glucocorticoids|glucocorticoids|mesh-ancestor
110664600|NCT00066469|Hormones|hormones|mesh-ancestor
110664601|NCT00066469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110664602|NCT00066469|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110664603|NCT00066469|Antiemetics|antiemetics|mesh-ancestor
110664604|NCT00066469|Autonomic Agents|autonomic agents|mesh-ancestor
110664605|NCT00066469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110664606|NCT00066469|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110664607|NCT00066469|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110664608|NCT00066469|Protective Agents|protective agents|mesh-ancestor
110664609|NCT01094977|Tranexamic Acid|tranexamic acid|mesh-list
110664610|NCT01094977|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110664611|NCT01094977|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110664612|NCT01094977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110664613|NCT01094977|Hemostatics|hemostatics|mesh-ancestor
110664614|NCT01094977|Coagulants|coagulants|mesh-ancestor
110664615|NCT01095133|Amiloride|amiloride|mesh-list
110664616|NCT01095133|Diuretics|diuretics|mesh-ancestor
110664617|NCT01095133|Natriuretic Agents|natriuretic agents|mesh-ancestor
110664618|NCT01095133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110664619|NCT01095133|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
110959292|NCT04217356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110664620|NCT01095133|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110664621|NCT01095133|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110664622|NCT01095133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110664623|NCT01095133|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
110664624|NCT01095133|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110664625|NCT00387088|Tiotropium Bromide|tiotropium bromide|mesh-list
110664626|NCT00387088|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110664627|NCT00387088|Autonomic Agents|autonomic agents|mesh-ancestor
110664628|NCT00387088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110664629|NCT00387088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110664630|NCT00387088|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110664631|NCT00387088|Respiratory System Agents|respiratory system agents|mesh-ancestor
110664632|NCT00387088|Parasympatholytics|parasympatholytics|mesh-ancestor
110664633|NCT00387088|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110664634|NCT00387088|Cholinergic Agents|cholinergic agents|mesh-ancestor
110664635|NCT00387088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110664636|NCT00387088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110664637|NCT01095211|Vitamin B Complex|vitamin b complex|mesh-list
110664638|NCT01095211|Vitamins|vitamins|mesh-ancestor
110664639|NCT01095211|Micronutrients|micronutrients|mesh-ancestor
110664640|NCT01095211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110664641|NCT01089985|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110664642|NCT01089985|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110664643|NCT00053365|Irofulven|irofulven|mesh-list
110664644|NCT00053365|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110664645|NCT00053365|Alkylating Agents|alkylating agents|mesh-ancestor
110664646|NCT00053365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110664647|NCT00053365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110664648|NCT00387010|Fentanyl|fentanyl|mesh-list
110664649|NCT00387010|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110664650|NCT00387010|Narcotics|narcotics|mesh-ancestor
110664651|NCT00387010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110664652|NCT00387010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110664653|NCT00387010|Analgesics|analgesics|mesh-ancestor
110664654|NCT00387010|Sensory System Agents|sensory system agents|mesh-ancestor
110664655|NCT00387010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110664656|NCT00387010|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110664657|NCT00387010|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110664658|NCT00387010|Anesthetics, General|anesthetics, general|mesh-ancestor
110664659|NCT00387010|Anesthetics|anesthetics|mesh-ancestor
110664660|NCT01092091|BCT-100|bct-100|mesh-list
110664661|NCT01092091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110664662|NCT00065065|Rosiglitazone|rosiglitazone|mesh-list
110664663|NCT00065065|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110664664|NCT00065065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110664665|NCT00386308|Tranexamic Acid|tranexamic acid|mesh-list
110664666|NCT00386308|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110664667|NCT00386308|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110664668|NCT00386308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110664669|NCT00386308|Hemostatics|hemostatics|mesh-ancestor
110664670|NCT00386308|Coagulants|coagulants|mesh-ancestor
110664671|NCT00064987|Hormones|hormones|mesh-list
110664672|NCT00064987|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
110664673|NCT00064987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110664674|NCT00064987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110664675|NCT00374140|Everolimus|everolimus|mesh-list
110664676|NCT00374140|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110664677|NCT00374140|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110664678|NCT00374140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110664679|NCT00374140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110664680|NCT00374140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110664681|NCT00374140|Immunologic Factors|immunologic factors|mesh-ancestor
110664682|NCT00374140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110664683|NCT00374140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110664685|NCT00665561|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
110664686|NCT00665561|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110664687|NCT00665561|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110664688|NCT00665561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110664689|NCT00665561|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110664690|NCT00665561|Antiviral Agents|antiviral agents|mesh-ancestor
110664691|NCT00665561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110664692|NCT00665561|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
110664693|NCT03955705|Nefopam|nefopam|mesh-list
110664694|NCT03955705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110664695|NCT03955705|Analgesics|analgesics|mesh-ancestor
110664696|NCT03955705|Sensory System Agents|sensory system agents|mesh-ancestor
110664697|NCT03955705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110664698|NCT03955705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110664699|NCT00786461|Silver Nitrate|silver nitrate|mesh-list
110664700|NCT00786461|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110664701|NCT00786461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110664702|NCT00786695|Esomeprazole|esomeprazole|mesh-list
110664703|NCT00786695|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110664704|NCT00786695|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110664705|NCT00786695|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110664706|NCT00786695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110448070|NCT02613013|Miotics|miotics|mesh-ancestor
110095093|NCT01712646|Oxytocin|oxytocin|mesh-list
110664707|NCT00786695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110664709|NCT00786851|Immunologic Factors|immunologic factors|mesh-ancestor
110664710|NCT00786851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110664711|NCT00786851|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110664712|NCT00786851|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110664713|NCT00786851|Growth Substances|growth substances|mesh-ancestor
110664714|NCT00786851|Growth Inhibitors|growth inhibitors|mesh-ancestor
110664715|NCT00786851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110664716|NCT00787007|Equol|equol|mesh-list
110664717|NCT00787007|Phytoestrogens|phytoestrogens|mesh-ancestor
110664718|NCT00787007|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
110664719|NCT00787007|Estrogens|estrogens|mesh-ancestor
110664720|NCT00787007|Hormones|hormones|mesh-ancestor
110664721|NCT00787007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110664722|NCT00787007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110664723|NCT00791141|Cetuximab|cetuximab|mesh-list
110664724|NCT00791141|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110664725|NCT00791141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110664726|NCT00386152|Epoetin Alfa|epoetin alfa|mesh-list
110664727|NCT00386152|Darbepoetin alfa|darbepoetin alfa|mesh-list
110664728|NCT00386152|Hematinics|hematinics|mesh-ancestor
110664729|NCT00787553|Cefazolin|cefazolin|mesh-list
110664730|NCT00787553|Tinidazole|tinidazole|mesh-list
110664731|NCT00787553|Imidazole|imidazole|mesh-list
110664732|NCT00787553|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110664733|NCT00787553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110664734|NCT00787553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110664735|NCT00787553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110664736|NCT00787553|Alkylating Agents|alkylating agents|mesh-ancestor
110664737|NCT00787553|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
110664738|NCT00787553|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110664739|NCT00787553|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110664740|NCT00795353|Alefacept|alefacept|mesh-list
110664741|NCT00795353|Dermatologic Agents|dermatologic agents|mesh-ancestor
110664742|NCT00795353|Immunologic Factors|immunologic factors|mesh-ancestor
110664743|NCT00795353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110664744|NCT00791297|Ulipristal acetate|ulipristal acetate|mesh-list
110664745|NCT00791297|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110664746|NCT00791297|Contraceptive Agents|contraceptive agents|mesh-ancestor
110664747|NCT00791297|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110664748|NCT00791297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110664749|NCT00791297|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110664750|NCT01045876|Dexamethasone|dexamethasone|mesh-list
110664751|NCT01045876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110664752|NCT01045876|Antiemetics|antiemetics|mesh-ancestor
110664753|NCT01045876|Autonomic Agents|autonomic agents|mesh-ancestor
110664754|NCT01045876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110664755|NCT01045876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110664756|NCT01045876|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110664757|NCT01045876|Glucocorticoids|glucocorticoids|mesh-ancestor
110664758|NCT01045876|Hormones|hormones|mesh-ancestor
110664759|NCT01045876|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110664760|NCT01045876|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110664761|NCT01045876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110664762|NCT00385762|Paroxetine|paroxetine|mesh-list
110664763|NCT00385762|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
110664764|NCT00385762|Serotonin|serotonin|mesh-list
110664765|NCT00385762|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110664766|NCT00385762|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110664767|NCT00385762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110664768|NCT00385762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110664769|NCT00385762|Serotonin Agents|serotonin agents|mesh-ancestor
110664770|NCT00385762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110664771|NCT00385762|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111479163|NCT05708183|Micronutrients|micronutrients|mesh-list
110664772|NCT00385762|Antidepressive Agents|antidepressive agents|mesh-ancestor
110664773|NCT00385762|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110664774|NCT00385762|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110664775|NCT00385762|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110664776|NCT00385762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110464244|NCT04139668|Naltrexone|naltrexone|mesh-list
110664777|NCT00385762|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110664778|NCT00385684|Acetaminophen|acetaminophen|mesh-list
110664779|NCT00385684|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
110664780|NCT00385684|Hydrocodone|hydrocodone|mesh-list
110664781|NCT00385684|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110664782|NCT00385684|Narcotics|narcotics|mesh-ancestor
110339213|NCT00526617|Veliparib|veliparib|mesh-list
110664783|NCT00385684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110664784|NCT00385684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110664785|NCT00385684|Analgesics|analgesics|mesh-ancestor
110311981|NCT00304200|Alkylating Agents|alkylating agents|mesh-ancestor
110664786|NCT00385684|Sensory System Agents|sensory system agents|mesh-ancestor
110664787|NCT00385684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110664788|NCT00385684|Antitussive Agents|antitussive agents|mesh-ancestor
110664789|NCT00385684|Respiratory System Agents|respiratory system agents|mesh-ancestor
110664790|NCT00385684|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110664792|NCT00385684|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110664793|NCT00385684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110664794|NCT00385684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110664795|NCT00661661|Tofacitinib|tofacitinib|mesh-list
110664796|NCT00661661|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
110664797|NCT00661661|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110664798|NCT00661661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110664799|NCT00661661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110664800|NCT00038467|Tamoxifen|tamoxifen|mesh-list
110664801|NCT00038467|Exemestane|exemestane|mesh-list
110664802|NCT00038467|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110664803|NCT00038467|Hormone Antagonists|hormone antagonists|mesh-ancestor
110664804|NCT00038467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110664805|NCT00038467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110664806|NCT00038467|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110664807|NCT00038467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110664808|NCT00038467|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110664809|NCT00038467|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110664810|NCT00038467|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110664811|NCT00038467|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110664812|NCT00038467|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110664813|NCT00038467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110664814|NCT00038467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110664815|NCT01095445|Ribavirin|ribavirin|mesh-list
110664816|NCT01095445|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110664817|NCT01095445|Antimetabolites|antimetabolites|mesh-ancestor
110664818|NCT01095445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110664819|NCT01095445|Antiviral Agents|antiviral agents|mesh-ancestor
110664820|NCT01095445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110664821|NCT00660179|Macitentan|macitentan|mesh-list
110664822|NCT00660179|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
110664823|NCT00660179|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
110664824|NCT00660179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110664825|NCT00660179|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
110664826|NCT00050167|Paclitaxel|paclitaxel|mesh-list
110664827|NCT00050167|Docetaxel|docetaxel|mesh-list
110664828|NCT00050167|Capecitabine|capecitabine|mesh-list
110664829|NCT00050167|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110664830|NCT00050167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110664831|NCT00050167|Tubulin Modulators|tubulin modulators|mesh-ancestor
110664832|NCT00050167|Antimitotic Agents|antimitotic agents|mesh-ancestor
110664833|NCT00050167|Mitosis Modulators|mitosis modulators|mesh-ancestor
110664834|NCT00050167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110664835|NCT00050167|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110664836|NCT00050167|Antimetabolites|antimetabolites|mesh-ancestor
110664837|NCT01096927|Amoxicillin|amoxicillin|mesh-list
110664838|NCT01096927|Clavulanic Acids|clavulanic acids|mesh-list
110664839|NCT01096927|Clavulanic Acid|clavulanic acid|mesh-list
110664840|NCT01096927|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110664841|NCT01096927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110664842|NCT01096927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110664843|NCT01096927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110664844|NCT01096927|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110664845|NCT00660023|Epoetin Alfa|epoetin alfa|mesh-list
110664846|NCT00660023|Hematinics|hematinics|mesh-ancestor
110664847|NCT02554955|Mycophenolic Acid|mycophenolic acid|mesh-list
110664848|NCT02554955|Daclizumab|daclizumab|mesh-list
110664849|NCT02554955|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110664850|NCT02554955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110664851|NCT02554955|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110664852|NCT02554955|Antitubercular Agents|antitubercular agents|mesh-ancestor
110664853|NCT02554955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110664854|NCT02554955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110664855|NCT02554955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110664856|NCT02554955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110664857|NCT02554955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110312062|NCT00324831|Hormones|hormones|mesh-ancestor
110664859|NCT02554955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110664861|NCT00062647|Cloxacillin|cloxacillin|mesh-list
110664862|NCT00062647|Oxacillin|oxacillin|mesh-list
110664863|NCT00062647|Telavancin|telavancin|mesh-list
110664864|NCT00062647|Nafcillin|nafcillin|mesh-list
110664865|NCT00062647|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110664866|NCT00062647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110664867|NCT00570323|Fulvestrant|fulvestrant|mesh-list
110664868|NCT00570323|Anastrozole|anastrozole|mesh-list
110664869|NCT00570323|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110664870|NCT00570323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110664871|NCT00570323|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110664872|NCT00570323|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110664873|NCT00570323|Hormone Antagonists|hormone antagonists|mesh-ancestor
110664874|NCT00570323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110664875|NCT00570323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110664876|NCT00570323|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110664877|NCT00570323|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110664878|NCT00570323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110664879|NCT00570323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110664880|NCT00791531|Methotrexate|methotrexate|mesh-list
110664881|NCT00791531|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110664882|NCT00791531|Abortifacient Agents|abortifacient agents|mesh-ancestor
110664883|NCT00791531|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110664884|NCT00791531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110664885|NCT00791531|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110664886|NCT00791531|Antimetabolites|antimetabolites|mesh-ancestor
110664887|NCT00791531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110664888|NCT00791531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110664889|NCT00791531|Dermatologic Agents|dermatologic agents|mesh-ancestor
110664890|NCT00791531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110664891|NCT00791531|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110664892|NCT00791531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110664893|NCT00791531|Immunologic Factors|immunologic factors|mesh-ancestor
110664894|NCT00791531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110664895|NCT00791531|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110664896|NCT00788099|Gemcitabine|gemcitabine|mesh-list
110664897|NCT00788099|Sorafenib|sorafenib|mesh-list
110664898|NCT00788099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110664899|NCT00788099|Antimetabolites|antimetabolites|mesh-ancestor
110664900|NCT00788099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110664901|NCT00788099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110664902|NCT00788099|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110664903|NCT00788099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110664904|NCT00795587|Mannitol|mannitol|mesh-list
110664905|NCT00795587|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110664906|NCT00795587|Diuretics|diuretics|mesh-ancestor
110664907|NCT00795587|Natriuretic Agents|natriuretic agents|mesh-ancestor
110664908|NCT00795587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110664909|NCT00661505|Epoetin Alfa|epoetin alfa|mesh-list
110664910|NCT00661505|Hematinics|hematinics|mesh-ancestor
110664911|NCT00788333|Trastuzumab|trastuzumab|mesh-list
110664912|NCT00788333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110664913|NCT00788333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110664914|NCT00795899|Paclitaxel|paclitaxel|mesh-list
110664915|NCT00795899|Cyclophosphamide|cyclophosphamide|mesh-list
110664916|NCT00795899|Trastuzumab|trastuzumab|mesh-list
110664917|NCT00795899|Epirubicin|epirubicin|mesh-list
110664918|NCT00795899|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110664919|NCT00795899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110664920|NCT00795899|Tubulin Modulators|tubulin modulators|mesh-ancestor
110664921|NCT00795899|Antimitotic Agents|antimitotic agents|mesh-ancestor
110664922|NCT00795899|Mitosis Modulators|mitosis modulators|mesh-ancestor
110023255|NCT00003576|Immunologic Factors|immunologic factors|mesh-ancestor
110664923|NCT00795899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110664924|NCT00795899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110664925|NCT00795899|Immunologic Factors|immunologic factors|mesh-ancestor
110664926|NCT00795899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110664927|NCT00795899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110664928|NCT00795899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110664929|NCT00795899|Alkylating Agents|alkylating agents|mesh-ancestor
110664930|NCT00795899|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110312129|NCT00304551|Antimetabolites|antimetabolites|mesh-ancestor
110664931|NCT00795899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110664932|NCT00795899|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110664933|NCT00795899|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110664934|NCT00795899|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110664935|NCT00795899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110664936|NCT00795977|Picibanil|picibanil|mesh-list
110664937|NCT00795977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110664938|NCT00796211|Nortriptyline|nortriptyline|mesh-list
110664939|NCT00796211|Calcipotriene|calcipotriene|mesh-list
110664940|NCT00796211|Dermatologic Agents|dermatologic agents|mesh-ancestor
110664941|NCT00796211|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110664942|NCT00796211|Antidepressive Agents|antidepressive agents|mesh-ancestor
110664943|NCT00796211|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110664944|NCT00796211|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110664945|NCT00796211|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110664946|NCT00796211|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110664947|NCT00796211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110664948|NCT00796211|Adrenergic Agents|adrenergic agents|mesh-ancestor
110664949|NCT00796211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110664950|NCT00796211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110664951|NCT00788567|Mycophenolic Acid|mycophenolic acid|mesh-list
110664952|NCT00788567|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110664953|NCT00788567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110664954|NCT00788567|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110664955|NCT00788567|Antitubercular Agents|antitubercular agents|mesh-ancestor
110664956|NCT00788567|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110664957|NCT00788567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110664958|NCT00788567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110664959|NCT00788567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110664960|NCT00662909|Mirabegron|mirabegron|mesh-list
110664961|NCT00662909|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
110664962|NCT00662909|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110664963|NCT00662909|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110664964|NCT00662909|Adrenergic Agents|adrenergic agents|mesh-ancestor
110664965|NCT00662909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110664966|NCT00662909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110664967|NCT00662909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110664968|NCT00662909|Urological Agents|urological agents|mesh-ancestor
110664969|NCT00050011|Zoledronic Acid|zoledronic acid|mesh-list
110664970|NCT00050011|Letrozole|letrozole|mesh-list
110664971|NCT00050011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110664972|NCT00050011|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110664973|NCT00050011|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110664974|NCT00050011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110664975|NCT00050011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110664976|NCT00050011|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110664977|NCT00050011|Hormone Antagonists|hormone antagonists|mesh-ancestor
110664978|NCT00050011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110664979|NCT00050011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110664980|NCT00050011|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110664982|NCT00661427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110664983|NCT00661427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110664984|NCT00049543|Gefitinib|gefitinib|mesh-list
110664985|NCT00049543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110664986|NCT00049543|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110664987|NCT00049543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110664988|NCT00049543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110664989|NCT03955393|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
110664990|NCT03955393|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110664991|NCT03955393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110664992|NCT01092481|Oxaliplatin|oxaliplatin|mesh-list
110664993|NCT01092481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110664995|NCT00035815|Mitosis Modulators|mitosis modulators|mesh-ancestor
110664996|NCT00035815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110664997|NCT00662831|Dalteparin|dalteparin|mesh-list
110664998|NCT00662831|Tinzaparin|tinzaparin|mesh-list
110664999|NCT00662831|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
110665000|NCT00662831|Anticoagulants|anticoagulants|mesh-ancestor
110665001|NCT00662831|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110665002|NCT00662831|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110665003|NCT00662831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110665004|NCT02555423|Anesthetics|anesthetics|mesh-list
110665005|NCT02555423|Levobupivacaine|levobupivacaine|mesh-list
110665006|NCT02555423|Anesthetics, Local|anesthetics, local|mesh-list
110665007|NCT02555423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110665008|NCT02555423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110665009|NCT02555423|Sensory System Agents|sensory system agents|mesh-ancestor
110665010|NCT02555423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110665012|NCT00792779|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110665013|NCT00792779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110665014|NCT00792779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110665015|NCT00792779|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110665016|NCT00792779|Anesthetics, General|anesthetics, general|mesh-ancestor
110665017|NCT00792779|Anesthetics|anesthetics|mesh-ancestor
110665018|NCT00662363|Lubiprostone|lubiprostone|mesh-list
110665019|NCT00662363|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
110665020|NCT00662363|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110665021|NCT00662363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110665022|NCT00796835|Paliperidone Palmitate|paliperidone palmitate|mesh-list
110665023|NCT00796835|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110665024|NCT00796835|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110665025|NCT00796835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110665026|NCT00796835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110665027|NCT00796835|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110665028|NCT00796835|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110665029|NCT00796835|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110665030|NCT00796835|Serotonin Agents|serotonin agents|mesh-ancestor
110665031|NCT00796835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110665032|NCT00796835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110665033|NCT00796835|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110665034|NCT00796835|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110665035|NCT00796835|Dopamine Agents|dopamine agents|mesh-ancestor
110665036|NCT00792857|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
110665037|NCT00792857|Vitamins|vitamins|mesh-ancestor
110665038|NCT00792857|Micronutrients|micronutrients|mesh-ancestor
110665039|NCT00792857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110665040|NCT00792857|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110665041|NCT02554175|Propofol|propofol|mesh-list
110665042|NCT02554175|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110665043|NCT02554175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110665044|NCT02554175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110665045|NCT02554175|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110665046|NCT02554175|Anesthetics, General|anesthetics, general|mesh-ancestor
110665047|NCT02554175|Anesthetics|anesthetics|mesh-ancestor
110665049|NCT00793091|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110665050|NCT00789503|Vitamin D|vitamin d|mesh-list
110665051|NCT00789503|Cholecalciferol|cholecalciferol|mesh-list
110665052|NCT00789503|Calcium|calcium|mesh-list
110665053|NCT00789503|Vitamins|vitamins|mesh-ancestor
110665054|NCT00789503|Micronutrients|micronutrients|mesh-ancestor
110665055|NCT00789503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110665056|NCT00789503|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110665057|NCT00789503|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110665058|NCT00797303|Bevacizumab|bevacizumab|mesh-list
110665059|NCT00797303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110665060|NCT00797303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110665061|NCT00797303|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110665062|NCT00797303|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110665063|NCT00797303|Growth Substances|growth substances|mesh-ancestor
110665064|NCT00797303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110665065|NCT00797303|Growth Inhibitors|growth inhibitors|mesh-ancestor
110665066|NCT00661193|Paclitaxel|paclitaxel|mesh-list
110665067|NCT00661193|Carboplatin|carboplatin|mesh-list
110665068|NCT00661193|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110665069|NCT00661193|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110665070|NCT00661193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110665072|NCT00661193|Antimitotic Agents|antimitotic agents|mesh-ancestor
110665073|NCT00661193|Mitosis Modulators|mitosis modulators|mesh-ancestor
110665074|NCT00661193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110665075|NCT00661193|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110665076|NCT00661193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110665077|NCT00801047|Remifentanil|remifentanil|mesh-list
110665078|NCT00801047|Bupivacaine|bupivacaine|mesh-list
110665079|NCT00801047|Anesthetics, Local|anesthetics, local|mesh-ancestor
110665080|NCT00801047|Anesthetics|anesthetics|mesh-ancestor
110665081|NCT00801047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110687679|NCT00943553|Decitabine|decitabine|mesh-list
110665082|NCT00801047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110665083|NCT00801047|Sensory System Agents|sensory system agents|mesh-ancestor
110665084|NCT00801047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110665085|NCT00801047|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110665086|NCT00801047|Narcotics|narcotics|mesh-ancestor
110665087|NCT00801047|Analgesics|analgesics|mesh-ancestor
110665088|NCT00801125|Natalizumab|natalizumab|mesh-list
110665089|NCT00801125|Immunologic Factors|immunologic factors|mesh-ancestor
110665090|NCT00801125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110665091|NCT00801281|Prednisone|prednisone|mesh-list
110665092|NCT00801281|Cyclophosphamide|cyclophosphamide|mesh-list
110665093|NCT00801281|Rituximab|rituximab|mesh-list
110665094|NCT00801281|Doxorubicin|doxorubicin|mesh-list
110665095|NCT00801281|Vincristine|vincristine|mesh-list
110665096|NCT00801281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110665097|NCT00801281|Immunologic Factors|immunologic factors|mesh-ancestor
110665098|NCT00801281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110665099|NCT00801281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110665100|NCT00801281|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110665101|NCT00801281|Alkylating Agents|alkylating agents|mesh-ancestor
110665102|NCT00801281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110665103|NCT00801281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110665104|NCT00801281|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110665105|NCT00801281|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110665106|NCT00801281|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110665107|NCT00801281|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110665108|NCT00801281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110665109|NCT00801281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110665110|NCT00801281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110665111|NCT00801281|Glucocorticoids|glucocorticoids|mesh-ancestor
110665112|NCT00801281|Hormones|hormones|mesh-ancestor
110665113|NCT00801281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110665114|NCT00801281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110665115|NCT00801281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110665116|NCT00801281|Tubulin Modulators|tubulin modulators|mesh-ancestor
110665117|NCT00801281|Antimitotic Agents|antimitotic agents|mesh-ancestor
110665118|NCT00801281|Mitosis Modulators|mitosis modulators|mesh-ancestor
110665119|NCT00801359|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110665120|NCT00801515|Maraviroc|maraviroc|mesh-list
110665121|NCT00801515|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110665122|NCT00801515|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110665123|NCT00801515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110665124|NCT00801515|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110665125|NCT00801515|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110665126|NCT00801515|Antiviral Agents|antiviral agents|mesh-ancestor
110665127|NCT00801515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110665128|NCT00801515|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
110665129|NCT00797693|Misoprostol|misoprostol|mesh-list
110665130|NCT00797693|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110665131|NCT00797693|Abortifacient Agents|abortifacient agents|mesh-ancestor
110665132|NCT00797693|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110665133|NCT00797693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110665134|NCT00797693|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110665135|NCT00797693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110665136|NCT00797693|Oxytocics|oxytocics|mesh-ancestor
110665138|NCT00797771|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110665139|NCT00797771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110665140|NCT00793559|Terlipressin|terlipressin|mesh-list
110665141|NCT00793559|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110665142|NCT00793559|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110665143|NCT00797927|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110665144|NCT00797927|Antipsychotic Agents|antipsychotic agents|mesh-list
110665145|NCT00797927|Antidepressive Agents|antidepressive agents|mesh-ancestor
110665146|NCT00797927|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110665148|NCT00797927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110665149|NCT00797927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110665150|NCT00798083|Lidocaine|lidocaine|mesh-list
110665151|NCT00798083|Ketamine|ketamine|mesh-list
110665152|NCT00798083|Amitriptyline|amitriptyline|mesh-list
110665153|NCT00798083|Anesthetics, Local|anesthetics, local|mesh-ancestor
110665154|NCT00798083|Anesthetics|anesthetics|mesh-ancestor
110665155|NCT00798083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110665156|NCT00798083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110665157|NCT00798083|Sensory System Agents|sensory system agents|mesh-ancestor
110665158|NCT00798083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110665159|NCT00798083|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110665160|NCT00798083|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110665161|NCT00798083|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110665162|NCT00798083|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110665163|NCT00798083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110665164|NCT00798083|Analgesics|analgesics|mesh-ancestor
110665165|NCT00798083|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110665166|NCT00798083|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110665167|NCT00798083|Anesthetics, General|anesthetics, general|mesh-ancestor
110665168|NCT00798083|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110665169|NCT00798083|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110665170|NCT00798083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110665171|NCT00798083|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110665172|NCT00798083|Antidepressive Agents|antidepressive agents|mesh-ancestor
110665173|NCT00798083|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110665174|NCT00798083|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110665175|NCT00798083|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110448131|NCT02736682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110665176|NCT00798083|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110665177|NCT00798083|Adrenergic Agents|adrenergic agents|mesh-ancestor
110665178|NCT00798395|Zopiclone|zopiclone|mesh-list
110665179|NCT00798395|Mirtazapine|mirtazapine|mesh-list
110665180|NCT00798395|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110665181|NCT00798395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110665182|NCT00798395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110665183|NCT00798395|Antidepressive Agents|antidepressive agents|mesh-ancestor
110665184|NCT00798395|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110665185|NCT00798395|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110665186|NCT00798395|Histamine Antagonists|histamine antagonists|mesh-ancestor
110665187|NCT00798395|Histamine Agents|histamine agents|mesh-ancestor
110665188|NCT00798395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110665189|NCT00798395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110665190|NCT00798395|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110665191|NCT00798395|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110665192|NCT00798395|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
110665193|NCT00798395|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110665194|NCT00798395|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110665195|NCT00798395|Adrenergic Agents|adrenergic agents|mesh-ancestor
110665196|NCT00798395|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110665197|NCT00798395|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110665198|NCT00798395|Serotonin Agents|serotonin agents|mesh-ancestor
110665199|NCT00798395|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110665201|NCT00801905|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110665202|NCT00801905|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110665203|NCT00801905|Analgesics|analgesics|mesh-ancestor
110665204|NCT00801905|Sensory System Agents|sensory system agents|mesh-ancestor
110665205|NCT00801905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110665206|NCT00801905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110665207|NCT00801905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110665208|NCT00801905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110665209|NCT00658541|Zolpidem|zolpidem|mesh-list
110665210|NCT00658541|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110665211|NCT00658541|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110665212|NCT00658541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110665213|NCT00658541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110665214|NCT00658541|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
110665215|NCT00658541|GABA Agonists|gaba agonists|mesh-ancestor
110665216|NCT00658541|GABA Agents|gaba agents|mesh-ancestor
110665217|NCT00658541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110665218|NCT00658541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110665219|NCT00048061|Vitamin D|vitamin d|mesh-list
110665220|NCT00048061|Ibandronic Acid|ibandronic acid|mesh-list
110665221|NCT00048061|Calcium|calcium|mesh-list
110665222|NCT00048061|Vitamins|vitamins|mesh-ancestor
110665223|NCT00048061|Micronutrients|micronutrients|mesh-ancestor
110665224|NCT00048061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110665225|NCT00048061|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110665226|NCT00048061|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110665228|NCT00802139|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
110665229|NCT00802139|Trace Elements|trace elements|mesh-ancestor
110665230|NCT00802139|Micronutrients|micronutrients|mesh-ancestor
110665231|NCT00802139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110687680|NCT00943553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110665232|NCT00802139|Hematinics|hematinics|mesh-ancestor
110312430|NCT00305331|Domperidone|domperidone|mesh-list
110665233|NCT00802217|Capsaicin|capsaicin|mesh-list
110665234|NCT00802217|Antipruritics|antipruritics|mesh-ancestor
110665235|NCT00802217|Dermatologic Agents|dermatologic agents|mesh-ancestor
110665236|NCT00802217|Sensory System Agents|sensory system agents|mesh-ancestor
110665237|NCT00802217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110665238|NCT00802217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110665239|NCT00802373|Solifenacin Succinate|solifenacin succinate|mesh-list
110665240|NCT00802373|Tolterodine Tartrate|tolterodine tartrate|mesh-list
110665241|NCT00802373|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110665242|NCT00802373|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110665243|NCT00802373|Cholinergic Agents|cholinergic agents|mesh-ancestor
110665244|NCT00802373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110665245|NCT00802373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110665246|NCT00802373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110665247|NCT00802373|Urological Agents|urological agents|mesh-ancestor
110665248|NCT03957109|Anesthetics|anesthetics|mesh-list
110665249|NCT03957109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110665250|NCT03957109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110665252|NCT00802451|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110665253|NCT00802451|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110665254|NCT00802451|Analgesics|analgesics|mesh-ancestor
110665255|NCT00802451|Sensory System Agents|sensory system agents|mesh-ancestor
110665256|NCT00802451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110665257|NCT00802451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110665258|NCT00802451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110665259|NCT00802451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110665260|NCT03956953|Deucravacitinib|deucravacitinib|mesh-list
110665261|NCT03956953|Dermatologic Agents|dermatologic agents|mesh-ancestor
110665262|NCT03956953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110665263|NCT03956953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110665264|NCT03956953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110665265|NCT00798473|Zoledronic Acid|zoledronic acid|mesh-list
110665266|NCT00798473|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110665267|NCT00798473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110665268|NCT04045769|Moxifloxacin|moxifloxacin|mesh-list
110665269|NCT04045769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110665270|NCT04045769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110665271|NCT04045769|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110665272|NCT04045769|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110665273|NCT04045769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110665274|NCT04045769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110665275|NCT04045769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110665276|NCT01097317|Carboplatin|carboplatin|mesh-list
110665277|NCT01097317|Vinorelbine|vinorelbine|mesh-list
110665278|NCT01097317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110665279|NCT01097317|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110665280|NCT01097317|Tubulin Modulators|tubulin modulators|mesh-ancestor
110665281|NCT01097317|Antimitotic Agents|antimitotic agents|mesh-ancestor
110665282|NCT01097317|Mitosis Modulators|mitosis modulators|mesh-ancestor
110665283|NCT01097317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110665284|NCT01095679|Baclofen|baclofen|mesh-list
110665285|NCT01095679|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110665286|NCT01095679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110665287|NCT01095679|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110665288|NCT01095679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110665289|NCT01095679|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
110665290|NCT01095679|GABA Agonists|gaba agonists|mesh-ancestor
110665291|NCT01095679|GABA Agents|gaba agents|mesh-ancestor
110665292|NCT01095679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110665293|NCT01095679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110665294|NCT00794261|Lenograstim|lenograstim|mesh-list
110665295|NCT00794261|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110665296|NCT00794261|Immunologic Factors|immunologic factors|mesh-ancestor
110665297|NCT00794261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110665299|NCT03953287|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110665300|NCT03953287|Analgesics|analgesics|mesh-ancestor
110665301|NCT03953287|Sensory System Agents|sensory system agents|mesh-ancestor
110665302|NCT03953287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110665303|NCT03953287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110665304|NCT03953287|Antipyretics|antipyretics|mesh-ancestor
110665305|NCT01097551|Phenylephrine|phenylephrine|mesh-list
110687681|NCT00943553|Antimetabolites|antimetabolites|mesh-ancestor
110665307|NCT01097551|Nitroglycerin|nitroglycerin|mesh-list
110665308|NCT01097551|Vasodilator Agents|vasodilator agents|mesh-ancestor
110665309|NCT01097551|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110665310|NCT01097551|Cholinergic Agents|cholinergic agents|mesh-ancestor
110665311|NCT01097551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110665312|NCT01097551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110665313|NCT01097551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110665314|NCT01097551|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110665315|NCT01097551|Mydriatics|mydriatics|mesh-ancestor
110665316|NCT01097551|Autonomic Agents|autonomic agents|mesh-ancestor
110665317|NCT01097551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110665318|NCT01097551|Sympathomimetics|sympathomimetics|mesh-ancestor
110665319|NCT01097551|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110665320|NCT01097551|Nasal Decongestants|nasal decongestants|mesh-ancestor
110665321|NCT01097551|Respiratory System Agents|respiratory system agents|mesh-ancestor
110665322|NCT01097551|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110665323|NCT01097551|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110665324|NCT01097551|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110665325|NCT01097551|Adrenergic Agents|adrenergic agents|mesh-ancestor
110665326|NCT01097551|Protective Agents|protective agents|mesh-ancestor
110665327|NCT00803309|Interferons|interferons|mesh-list
110665328|NCT00803309|Ribavirin|ribavirin|mesh-list
110665329|NCT00803309|Interferon-alpha|interferon-alpha|mesh-list
110665330|NCT00803309|Interferon alpha-2|interferon alpha-2|mesh-list
110665331|NCT00803309|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110665332|NCT00803309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110665333|NCT00803309|Antiviral Agents|antiviral agents|mesh-ancestor
110665334|NCT00803309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110665335|NCT00803309|Antimetabolites|antimetabolites|mesh-ancestor
110665336|NCT00803309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110665337|NCT00803309|Immunologic Factors|immunologic factors|mesh-ancestor
110665338|NCT00803309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110665339|NCT03953209|Spironolactone|spironolactone|mesh-list
110665340|NCT03953209|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110665341|NCT03953209|Hormone Antagonists|hormone antagonists|mesh-ancestor
110665342|NCT03953209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110665343|NCT03953209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110665344|NCT03953209|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110665345|NCT03953209|Diuretics|diuretics|mesh-ancestor
110665346|NCT03953209|Natriuretic Agents|natriuretic agents|mesh-ancestor
110665347|NCT01583959|Folic Acid|folic acid|mesh-list
110665348|NCT01583959|Hematinics|hematinics|mesh-ancestor
110665349|NCT01583959|Vitamin B Complex|vitamin b complex|mesh-ancestor
110665350|NCT01583959|Vitamins|vitamins|mesh-ancestor
110665351|NCT01583959|Micronutrients|micronutrients|mesh-ancestor
110665352|NCT01583959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110665353|NCT00803387|Travoprost|travoprost|mesh-list
110665354|NCT00803387|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110665355|NCT02553551|Vitamins|vitamins|mesh-list
110665356|NCT02553551|Micronutrients|micronutrients|mesh-ancestor
110665357|NCT02553551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110665358|NCT00803465|Fluticasone|fluticasone|mesh-list
110665359|NCT00803465|Xhance|xhance|mesh-list
110665360|NCT00803465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110665361|NCT00803465|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110665362|NCT00803465|Autonomic Agents|autonomic agents|mesh-ancestor
110665363|NCT00803465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110665364|NCT00803465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110665365|NCT00803465|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110665366|NCT00803465|Respiratory System Agents|respiratory system agents|mesh-ancestor
110665367|NCT00803465|Dermatologic Agents|dermatologic agents|mesh-ancestor
110665368|NCT00803465|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110665369|NCT00803699|Selenium|selenium|mesh-list
110665370|NCT00803699|Antioxidants|antioxidants|mesh-ancestor
110665371|NCT00803699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110665372|NCT00803699|Protective Agents|protective agents|mesh-ancestor
110665373|NCT00803699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110665375|NCT00803699|Micronutrients|micronutrients|mesh-ancestor
110665376|NCT00798785|Rituximab|rituximab|mesh-list
110665377|NCT00798785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110665378|NCT00798785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110665379|NCT00798785|Immunologic Factors|immunologic factors|mesh-ancestor
110665380|NCT00798785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110665381|NCT00798785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110665382|NCT01095991|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110448147|NCT02738632|Amlodipine|amlodipine|mesh-list
110665384|NCT01095991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110665385|NCT01095991|Incretins|incretins|mesh-ancestor
110665386|NCT01095991|Hormones|hormones|mesh-ancestor
110665387|NCT01095991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110665388|NCT01095991|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110665389|NCT01095991|Protease Inhibitors|protease inhibitors|mesh-ancestor
110665390|NCT01095991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110665391|NCT01095991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110665393|NCT00794807|Dermatologic Agents|dermatologic agents|mesh-ancestor
110665394|NCT00794807|Immunologic Factors|immunologic factors|mesh-ancestor
110665395|NCT00794807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110665396|NCT00794885|Folic Acid|folic acid|mesh-list
110665397|NCT00794885|Vitamin B Complex|vitamin b complex|mesh-list
110665398|NCT00794885|Enalapril|enalapril|mesh-list
110665399|NCT00794885|Enalaprilat|enalaprilat|mesh-list
110665400|NCT00794885|Maleic acid|maleic acid|mesh-list
110665401|NCT00794885|Hematinics|hematinics|mesh-ancestor
110665402|NCT00794885|Vitamins|vitamins|mesh-ancestor
110665403|NCT00794885|Micronutrients|micronutrients|mesh-ancestor
110665404|NCT00794885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110665405|NCT00794885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110665406|NCT00794885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110665407|NCT00794885|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110665408|NCT00794885|Protease Inhibitors|protease inhibitors|mesh-ancestor
110665409|NCT00794885|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110665410|NCT00803933|Pentamidine|pentamidine|mesh-list
110665411|NCT00803933|Pafuramidine|pafuramidine|mesh-list
110665412|NCT00803933|Antifungal Agents|antifungal agents|mesh-ancestor
110665413|NCT00803933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110665414|NCT00803933|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110665415|NCT00803933|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110665416|NCT00803933|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
110665417|NCT02553707|Ibandronic Acid|ibandronic acid|mesh-list
110665418|NCT02553707|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110665419|NCT02553707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110665420|NCT00799175|Ketorolac|ketorolac|mesh-list
110665421|NCT00799175|Epinephrine|epinephrine|mesh-list
110665422|NCT00799175|Ropivacaine|ropivacaine|mesh-list
110665423|NCT00799175|Anesthetics, Local|anesthetics, local|mesh-ancestor
110665424|NCT00799175|Anesthetics|anesthetics|mesh-ancestor
110665425|NCT00799175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110665426|NCT00799175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110665427|NCT00799175|Sensory System Agents|sensory system agents|mesh-ancestor
110665428|NCT00799175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110665429|NCT00799175|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110665430|NCT00799175|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110665431|NCT00799175|Adrenergic Agents|adrenergic agents|mesh-ancestor
110665432|NCT00799175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110665433|NCT00799175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110665434|NCT00799175|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110665435|NCT00799175|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110665436|NCT00799175|Autonomic Agents|autonomic agents|mesh-ancestor
110665437|NCT00799175|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110665438|NCT00799175|Respiratory System Agents|respiratory system agents|mesh-ancestor
110665439|NCT00799175|Mydriatics|mydriatics|mesh-ancestor
110665440|NCT00799175|Sympathomimetics|sympathomimetics|mesh-ancestor
110665441|NCT00799175|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110665442|NCT00799175|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110665443|NCT00799175|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110665444|NCT00799175|Analgesics|analgesics|mesh-ancestor
110665445|NCT00799175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110665446|NCT00799175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110665447|NCT00799175|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110665448|NCT00799175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110665449|NCT00656513|Pilocarpine|pilocarpine|mesh-list
110665450|NCT00656513|Miotics|miotics|mesh-ancestor
110665451|NCT00656513|Autonomic Agents|autonomic agents|mesh-ancestor
110665452|NCT00656513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110665453|NCT00656513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110665454|NCT00656513|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
110665455|NCT00656513|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110665456|NCT00656513|Cholinergic Agents|cholinergic agents|mesh-ancestor
110665457|NCT00656513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110665458|NCT00656513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110665459|NCT04017221|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
110665460|NCT04017221|Protease Inhibitors|protease inhibitors|mesh-ancestor
110665461|NCT04017221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110665462|NCT04017221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110665463|NCT04017221|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110665464|NCT04017221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110665465|NCT00804245|Choline|choline|mesh-list
110665466|NCT00804245|Lipotropic Agents|lipotropic agents|mesh-ancestor
110665467|NCT00804245|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110665468|NCT00804245|Antimetabolites|antimetabolites|mesh-ancestor
110665469|NCT00804245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110665470|NCT00804245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110665471|NCT00804245|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110665472|NCT00804245|Nootropic Agents|nootropic agents|mesh-ancestor
110665473|NCT00804401|Naproxen|naproxen|mesh-list
110665474|NCT00804401|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110665475|NCT00804401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110665476|NCT00804401|Analgesics|analgesics|mesh-ancestor
110665477|NCT00804401|Sensory System Agents|sensory system agents|mesh-ancestor
110665478|NCT00804401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110665479|NCT00804401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110665480|NCT00804401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110665481|NCT00804401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110665482|NCT00804401|Gout Suppressants|gout suppressants|mesh-ancestor
110665483|NCT00804401|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110665484|NCT00804401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110665485|NCT00804401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110665486|NCT00804791|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110665487|NCT00804791|Lubricant Eye Drops|lubricant eye drops|mesh-list
110665488|NCT00804791|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110665489|NCT02553083|Amoxicillin|amoxicillin|mesh-list
110665490|NCT02553083|Doxycycline|doxycycline|mesh-list
110665491|NCT02553083|Esomeprazole|esomeprazole|mesh-list
110665492|NCT02553083|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110665493|NCT02553083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110665494|NCT02553083|Antimalarials|antimalarials|mesh-ancestor
110665495|NCT02553083|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110665496|NCT02553083|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110665497|NCT02553083|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110665498|NCT02553083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110665499|NCT02553083|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110665500|NCT02553083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110677029|NCT03110978|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110676428|NCT04648020|Sympatholytics|sympatholytics|mesh-ancestor
110665501|NCT02553083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110665502|NCT00804947|Melphalan|melphalan|mesh-list
110665503|NCT00804947|Busulfan|busulfan|mesh-list
110665504|NCT00804947|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110665505|NCT00804947|Alkylating Agents|alkylating agents|mesh-ancestor
110665506|NCT00804947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110665507|NCT00804947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110665508|NCT00804947|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110665509|NCT00804947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110665510|NCT00804947|Immunologic Factors|immunologic factors|mesh-ancestor
110665511|NCT00804947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110665512|NCT00806663|Sunitinib|sunitinib|mesh-list
110665513|NCT00806663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110665514|NCT00806663|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110665515|NCT00806663|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110665516|NCT00806663|Growth Substances|growth substances|mesh-ancestor
110665517|NCT00806663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110665518|NCT00806663|Growth Inhibitors|growth inhibitors|mesh-ancestor
110665519|NCT00806663|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110665520|NCT00806663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110665521|NCT00806663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110665522|NCT00806741|Phenylephrine|phenylephrine|mesh-list
110665523|NCT00806741|Oxymetazoline|oxymetazoline|mesh-list
110665524|NCT00806741|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
110665525|NCT00806741|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110665526|NCT00806741|Mydriatics|mydriatics|mesh-ancestor
110665527|NCT00806741|Autonomic Agents|autonomic agents|mesh-ancestor
110665528|NCT00806741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110665529|NCT00806741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110665530|NCT00806741|Sympathomimetics|sympathomimetics|mesh-ancestor
110665531|NCT00806741|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110665532|NCT00806741|Nasal Decongestants|nasal decongestants|mesh-ancestor
110665533|NCT00806741|Respiratory System Agents|respiratory system agents|mesh-ancestor
110665534|NCT00806741|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110665535|NCT00806741|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110687682|NCT00943553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110665536|NCT00806741|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110665537|NCT00806741|Adrenergic Agents|adrenergic agents|mesh-ancestor
110665538|NCT00806741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110665539|NCT00806741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110665540|NCT00806741|Protective Agents|protective agents|mesh-ancestor
110665541|NCT00806741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110665542|NCT00806897|Insulin Detemir|insulin detemir|mesh-list
110665543|NCT00806897|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110665544|NCT00806897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110665545|NCT00805649|Dexamethasone|dexamethasone|mesh-list
110665546|NCT00805649|Bevacizumab|bevacizumab|mesh-list
110665547|NCT00805649|Temazepam|temazepam|mesh-list
110665548|NCT00805649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110665549|NCT00805649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110665550|NCT00805649|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110665551|NCT00805649|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110665552|NCT00805649|Growth Substances|growth substances|mesh-ancestor
110665553|NCT00805649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110665554|NCT00805649|Growth Inhibitors|growth inhibitors|mesh-ancestor
110665555|NCT00805649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110665556|NCT00805649|Antiemetics|antiemetics|mesh-ancestor
110665557|NCT00805649|Autonomic Agents|autonomic agents|mesh-ancestor
110665558|NCT00805649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110665559|NCT00805649|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110665560|NCT00805649|Glucocorticoids|glucocorticoids|mesh-ancestor
110665561|NCT00805649|Hormones|hormones|mesh-ancestor
110665562|NCT00805649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110665563|NCT00805649|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110665564|NCT00805649|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110665565|NCT00805649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110665566|NCT00805649|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110665567|NCT00805649|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110665568|NCT00805649|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110665569|NCT00805649|GABA Modulators|gaba modulators|mesh-ancestor
110665570|NCT00805649|GABA Agents|gaba agents|mesh-ancestor
110665571|NCT00805649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110665572|NCT00805649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110948224|NCT04428814|Ustekinumab|ustekinumab|mesh-list
110665573|NCT00807053|Ciclesonide|ciclesonide|mesh-list
110665574|NCT00807053|Glucocorticoids|glucocorticoids|mesh-ancestor
110665575|NCT00807053|Hormones|hormones|mesh-ancestor
110665576|NCT00807053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110665577|NCT00807053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110665578|NCT00807053|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110665579|NCT00809393|Tranexamic Acid|tranexamic acid|mesh-list
110665580|NCT00809393|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110665581|NCT00809393|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110665582|NCT00809393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110665583|NCT00809393|Hemostatics|hemostatics|mesh-ancestor
110665584|NCT00809393|Coagulants|coagulants|mesh-ancestor
110665585|NCT00658775|Esomeprazole|esomeprazole|mesh-list
110665586|NCT00658775|Rabeprazole|rabeprazole|mesh-list
110665587|NCT00658775|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110665588|NCT00658775|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110665589|NCT00658775|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110665590|NCT00658775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110665591|NCT00658775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110665592|NCT00488631|Golimumab|golimumab|mesh-list
110665593|NCT00488631|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110665594|NCT00488631|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110665595|NCT00488631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110665596|NCT00488631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110665597|NCT00488631|Immunologic Factors|immunologic factors|mesh-ancestor
110665598|NCT00488631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110665599|NCT00809549|Lenograstim|lenograstim|mesh-list
110665600|NCT00809549|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110665601|NCT00809549|Immunologic Factors|immunologic factors|mesh-ancestor
110665602|NCT00809549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110665603|NCT00809627|Caffeine|caffeine|mesh-list
110665604|NCT00809627|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110665605|NCT00809627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110665606|NCT00809627|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110665607|NCT00809627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110665608|NCT00809627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110665609|NCT00809627|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110665610|NCT00809627|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110665611|NCT00809627|Purinergic Agents|purinergic agents|mesh-ancestor
110665612|NCT00809627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110665613|NCT00809705|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
110665615|NCT00809705|Hormones|hormones|mesh-ancestor
110665616|NCT00809705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110665617|NCT00809705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110665618|NCT00655499|Irinotecan|irinotecan|mesh-list
110665619|NCT00655499|Panitumumab|panitumumab|mesh-list
110665620|NCT00655499|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110665621|NCT00655499|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110665622|NCT00655499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110665623|NCT00655499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110665624|NCT00655499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110665625|NCT00655499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110665626|NCT00800267|Timolol|timolol|mesh-list
110665627|NCT00800267|Latanoprost|latanoprost|mesh-list
110665628|NCT00800267|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110665629|NCT00800267|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110665630|NCT00800267|Adrenergic Agents|adrenergic agents|mesh-ancestor
110665631|NCT00800267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110665632|NCT00800267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110665633|NCT00800267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110665634|NCT00800267|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110665635|NCT00800267|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110665636|NCT00800267|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110665637|NCT00800267|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110665638|NCT00809939|Progesterone|progesterone|mesh-list
110665639|NCT00809939|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
110665640|NCT00809939|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
110665641|NCT00809939|Progestins|progestins|mesh-ancestor
110665642|NCT00809939|Hormones|hormones|mesh-ancestor
110665643|NCT00809939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110665644|NCT00809939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110665645|NCT00809939|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110665646|NCT00809939|Hormone Antagonists|hormone antagonists|mesh-ancestor
110665647|NCT00807443|Raltegravir Potassium|raltegravir potassium|mesh-list
110665648|NCT00807443|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110665649|NCT00807443|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110665650|NCT00807443|Antiviral Agents|antiviral agents|mesh-ancestor
110665651|NCT00807443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110665652|NCT00807443|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110665653|NCT00807443|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110665654|NCT00807443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110665655|NCT00807443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110665656|NCT00807521|Dexamethasone|dexamethasone|mesh-list
110665657|NCT00807521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110665658|NCT00807521|Antiemetics|antiemetics|mesh-ancestor
110665659|NCT00807521|Autonomic Agents|autonomic agents|mesh-ancestor
110665660|NCT00807521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110665661|NCT00807521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110665662|NCT00807521|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110665663|NCT00807521|Glucocorticoids|glucocorticoids|mesh-ancestor
110665664|NCT00807521|Hormones|hormones|mesh-ancestor
110665665|NCT00807521|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110665666|NCT00807521|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110665667|NCT00807521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110665668|NCT00800423|Timolol|timolol|mesh-list
110665669|NCT00800423|Brimonidine Tartrate|brimonidine tartrate|mesh-list
110665670|NCT00800423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110665671|NCT00800423|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110665672|NCT00800423|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110665673|NCT00800423|Adrenergic Agents|adrenergic agents|mesh-ancestor
110665674|NCT00800423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110665675|NCT00800423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110665676|NCT00800423|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110665677|NCT00800423|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110665678|NCT00800423|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110665679|NCT00800423|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110665680|NCT00800423|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110665681|NCT00651755|Prednisone|prednisone|mesh-list
110665682|NCT00651755|Cyclophosphamide|cyclophosphamide|mesh-list
110665683|NCT00651755|Rituximab|rituximab|mesh-list
110665684|NCT00651755|Doxorubicin|doxorubicin|mesh-list
110665685|NCT00651755|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110665686|NCT00651755|Vincristine|vincristine|mesh-list
110665687|NCT00651755|Ondansetron|ondansetron|mesh-list
110665689|NCT00651755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110665690|NCT00651755|Immunologic Factors|immunologic factors|mesh-ancestor
110665691|NCT00651755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110665692|NCT00651755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110665693|NCT00651755|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110665694|NCT00651755|Alkylating Agents|alkylating agents|mesh-ancestor
110665695|NCT00651755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110665696|NCT00651755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110665697|NCT00651755|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110665698|NCT00651755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110665699|NCT00651755|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110665700|NCT00651755|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110665701|NCT00651755|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110665702|NCT00651755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110665703|NCT00651755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110665704|NCT00651755|Glucocorticoids|glucocorticoids|mesh-ancestor
110665705|NCT00651755|Hormones|hormones|mesh-ancestor
110665706|NCT00651755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110665707|NCT00651755|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110665708|NCT00651755|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110665709|NCT00651755|Tubulin Modulators|tubulin modulators|mesh-ancestor
110665710|NCT00651755|Antimitotic Agents|antimitotic agents|mesh-ancestor
110665711|NCT00651755|Mitosis Modulators|mitosis modulators|mesh-ancestor
110665712|NCT00651755|Antiemetics|antiemetics|mesh-ancestor
110665713|NCT00651755|Autonomic Agents|autonomic agents|mesh-ancestor
110665714|NCT00651755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110665715|NCT00651755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110665716|NCT00651755|Antipruritics|antipruritics|mesh-ancestor
110665717|NCT00651755|Dermatologic Agents|dermatologic agents|mesh-ancestor
110665718|NCT00651755|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110665719|NCT00651755|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110665720|NCT00651755|Serotonin Agents|serotonin agents|mesh-ancestor
110665721|NCT00651755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110665722|NCT00651755|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110665723|NCT00807755|Carboplatin|carboplatin|mesh-list
110665724|NCT00807755|Etoposide|etoposide|mesh-list
110665725|NCT00807755|Everolimus|everolimus|mesh-list
110665726|NCT00807755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110665727|NCT00807755|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110665728|NCT00807755|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110665729|NCT00807755|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110665730|NCT00807755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110665731|NCT00807755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110665732|NCT00807755|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110665733|NCT00807755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110665734|NCT00807755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110665735|NCT00807755|Immunologic Factors|immunologic factors|mesh-ancestor
110665736|NCT00807755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110665737|NCT00813527|Fenofibrate|fenofibrate|mesh-list
110665738|NCT00813527|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110665739|NCT00813527|Antimetabolites|antimetabolites|mesh-ancestor
110665740|NCT00813527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110665741|NCT00813527|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110665742|NCT00810563|Bupivacaine|bupivacaine|mesh-list
110665743|NCT00810563|Anesthetics, Local|anesthetics, local|mesh-ancestor
110665744|NCT00810563|Anesthetics|anesthetics|mesh-ancestor
110665745|NCT00810563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110665746|NCT00810563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110665747|NCT00810563|Sensory System Agents|sensory system agents|mesh-ancestor
110665748|NCT00810563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110665750|NCT00808145|Gemcitabine|gemcitabine|mesh-list
110665751|NCT00808145|Sorafenib|sorafenib|mesh-list
110665752|NCT00808145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110665753|NCT00808145|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110665754|NCT00808145|Antimetabolites|antimetabolites|mesh-ancestor
110665755|NCT00808145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110665756|NCT00808145|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110665757|NCT00808145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110665758|NCT02552459|Sufentanil|sufentanil|mesh-list
110665759|NCT02552459|Dexmedetomidine|dexmedetomidine|mesh-list
110665760|NCT02552459|Dsuvia|dsuvia|mesh-list
110665762|NCT02552459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110665763|NCT02552459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110665764|NCT02552459|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110665766|NCT02552459|Sensory System Agents|sensory system agents|mesh-ancestor
110665767|NCT02552459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110665768|NCT02552459|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110665769|NCT02552459|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110665770|NCT02552459|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110665771|NCT02552459|Adrenergic Agents|adrenergic agents|mesh-ancestor
110665772|NCT02552459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110665773|NCT02552459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110665774|NCT02552459|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110665775|NCT02552459|Narcotics|narcotics|mesh-ancestor
110665776|NCT02552459|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110665777|NCT02552459|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110665778|NCT02552459|Anesthetics, General|anesthetics, general|mesh-ancestor
110665779|NCT02552459|Anesthetics|anesthetics|mesh-ancestor
110665780|NCT00810953|Pentamidine|pentamidine|mesh-list
110665781|NCT00810953|Antifungal Agents|antifungal agents|mesh-ancestor
110665782|NCT00810953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110665783|NCT00810953|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110665784|NCT00810953|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110665785|NCT00810953|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
110665786|NCT00811031|Prednisone|prednisone|mesh-list
110665787|NCT00811031|Docetaxel|docetaxel|mesh-list
110665788|NCT00811031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110665789|NCT00811031|Tubulin Modulators|tubulin modulators|mesh-ancestor
110665790|NCT00811031|Antimitotic Agents|antimitotic agents|mesh-ancestor
110665791|NCT00811031|Mitosis Modulators|mitosis modulators|mesh-ancestor
110665792|NCT00811031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110665793|NCT00811031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110665794|NCT00811031|Glucocorticoids|glucocorticoids|mesh-ancestor
110665795|NCT00811031|Hormones|hormones|mesh-ancestor
110665796|NCT00811031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110665797|NCT00811031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110665798|NCT00811031|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110665799|NCT02552537|Mannitol|mannitol|mesh-list
110665800|NCT02552537|Omeprazole|omeprazole|mesh-list
110665801|NCT02552537|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110665802|NCT02552537|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110665803|NCT02552537|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110665804|NCT02552537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110665805|NCT02552537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110665806|NCT02552537|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110665807|NCT02552537|Diuretics|diuretics|mesh-ancestor
110665808|NCT02552537|Natriuretic Agents|natriuretic agents|mesh-ancestor
110665809|NCT02552537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110665810|NCT00808223|Alefacept|alefacept|mesh-list
110665811|NCT00808223|Dermatologic Agents|dermatologic agents|mesh-ancestor
110665812|NCT00808223|Immunologic Factors|immunologic factors|mesh-ancestor
110665813|NCT00808223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110665814|NCT00811421|Pyrimethamine|pyrimethamine|mesh-list
110665815|NCT00811421|Sulfadoxine|sulfadoxine|mesh-list
110665816|NCT00811421|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
110665817|NCT00811421|Mefloquine|mefloquine|mesh-list
110665818|NCT00811421|Antimalarials|antimalarials|mesh-ancestor
110665819|NCT00811421|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110665820|NCT00811421|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110665821|NCT00811421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110665822|NCT00811421|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110665823|NCT00811421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110665824|NCT00811421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110665825|NCT00811421|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110665826|NCT00569777|Ketotifen|ketotifen|mesh-list
110665827|NCT00569777|Antipruritics|antipruritics|mesh-ancestor
110665828|NCT00569777|Dermatologic Agents|dermatologic agents|mesh-ancestor
110665829|NCT00569777|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110665830|NCT00569777|Histamine Antagonists|histamine antagonists|mesh-ancestor
110665831|NCT00569777|Histamine Agents|histamine agents|mesh-ancestor
110665832|NCT00569777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110665833|NCT00569777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110665834|NCT00569777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110665835|NCT00569777|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110665836|NCT00654095|Atorvastatin|atorvastatin|mesh-list
110665837|NCT00654095|Ezetimibe|ezetimibe|mesh-list
110665838|NCT00654095|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110665839|NCT00654095|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110313034|NCT04718714|Midazolam|midazolam|mesh-list
110665841|NCT00654095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110665842|NCT00654095|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110665843|NCT00654095|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110665844|NCT00654095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110665846|NCT00811967|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110665847|NCT00811967|Interferon-alpha|interferon-alpha|mesh-list
110665848|NCT00811967|Antimetabolites|antimetabolites|mesh-ancestor
110665849|NCT00811967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110665850|NCT00811967|Antiviral Agents|antiviral agents|mesh-ancestor
110665851|NCT00811967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110665852|NCT00811967|Immunologic Factors|immunologic factors|mesh-ancestor
110665853|NCT00811967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110665854|NCT04046159|Tamoxifen|tamoxifen|mesh-list
110665855|NCT04046159|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110665856|NCT04046159|Hormone Antagonists|hormone antagonists|mesh-ancestor
110665857|NCT04046159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110665858|NCT04046159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110665859|NCT04046159|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110665860|NCT04046159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110665861|NCT04046159|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110665862|NCT04046159|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110665863|NCT04046159|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110665864|NCT00653939|Paclitaxel|paclitaxel|mesh-list
110665865|NCT00653939|Fosbretabulin|fosbretabulin|mesh-list
110665866|NCT00653939|Combretastatin|combretastatin|mesh-list
110665867|NCT00653939|Bevacizumab|bevacizumab|mesh-list
110665868|NCT00653939|Carboplatin|carboplatin|mesh-list
110665869|NCT00653939|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110665870|NCT00653939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110665871|NCT00653939|Tubulin Modulators|tubulin modulators|mesh-ancestor
110665872|NCT00653939|Antimitotic Agents|antimitotic agents|mesh-ancestor
110665873|NCT00653939|Mitosis Modulators|mitosis modulators|mesh-ancestor
110448193|NCT00701233|Cholinergic Agents|cholinergic agents|mesh-ancestor
110665874|NCT00653939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110665875|NCT00653939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110665876|NCT00653939|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110665877|NCT00653939|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110665878|NCT00653939|Growth Substances|growth substances|mesh-ancestor
110665879|NCT00653939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110665880|NCT00653939|Growth Inhibitors|growth inhibitors|mesh-ancestor
110665881|NCT00812123|Cyclosporine|cyclosporine|mesh-list
110665882|NCT00812123|Sirolimus|sirolimus|mesh-list
110665883|NCT00812123|Mycophenolic Acid|mycophenolic acid|mesh-list
110665884|NCT00812123|Prednisone|prednisone|mesh-list
110665885|NCT00812123|Cyclosporins|cyclosporins|mesh-list
110665886|NCT00812123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110665887|NCT00812123|Glucocorticoids|glucocorticoids|mesh-ancestor
110665888|NCT00812123|Hormones|hormones|mesh-ancestor
110665889|NCT00812123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110665890|NCT00812123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110665891|NCT00812123|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110665892|NCT00812123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110665893|NCT00812123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110665894|NCT00812123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110665895|NCT00812123|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110665896|NCT00812123|Immunologic Factors|immunologic factors|mesh-ancestor
110665897|NCT00812123|Antifungal Agents|antifungal agents|mesh-ancestor
110665898|NCT00812123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110665899|NCT00812123|Dermatologic Agents|dermatologic agents|mesh-ancestor
110665900|NCT00812123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110665901|NCT00812123|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110665902|NCT00812123|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110665903|NCT00812123|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110665904|NCT00812123|Antitubercular Agents|antitubercular agents|mesh-ancestor
110665905|NCT00812123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110665906|NCT00646451|Pregabalin|pregabalin|mesh-list
110665908|NCT00646451|Sensory System Agents|sensory system agents|mesh-ancestor
110665909|NCT00646451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110665910|NCT00646451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110665911|NCT00646451|Anticonvulsants|anticonvulsants|mesh-ancestor
110340316|NCT02951234|Aspirin|aspirin|mesh-list
110665912|NCT00646451|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110665913|NCT00646451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110665914|NCT00646451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110665915|NCT00646451|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110665916|NCT00646451|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110665917|NCT00646451|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110665918|NCT00646451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110665919|NCT00646451|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110665921|NCT00809237|Gefitinib|gefitinib|mesh-list
110665922|NCT00809237|Antimalarials|antimalarials|mesh-ancestor
110665923|NCT00809237|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110665924|NCT00809237|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110665925|NCT00809237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110665926|NCT00809237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110665927|NCT00809237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110665928|NCT00809237|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110665929|NCT00809237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110665930|NCT00809237|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110665931|NCT00817583|Docetaxel|docetaxel|mesh-list
110665932|NCT00817583|Fluorouracil|fluorouracil|mesh-list
110665933|NCT00817583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110665934|NCT00817583|Tubulin Modulators|tubulin modulators|mesh-ancestor
110665935|NCT00817583|Antimitotic Agents|antimitotic agents|mesh-ancestor
110665936|NCT00817583|Mitosis Modulators|mitosis modulators|mesh-ancestor
110665937|NCT00817583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110665938|NCT00817583|Antimetabolites|antimetabolites|mesh-ancestor
110665939|NCT00817583|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110665940|NCT00817583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110665941|NCT00817583|Immunologic Factors|immunologic factors|mesh-ancestor
110665942|NCT00817583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110665943|NCT00817661|Vitamin A|vitamin a|mesh-list
110665944|NCT00817661|Vitamins|vitamins|mesh-ancestor
110665945|NCT00817661|Micronutrients|micronutrients|mesh-ancestor
110665946|NCT00817661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110665947|NCT00642707|Leronlimab|leronlimab|mesh-list
110665948|NCT00642707|Antibodies|antibodies|mesh-list
110665949|NCT00642707|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110665950|NCT00642707|Immunologic Factors|immunologic factors|mesh-ancestor
110665951|NCT00642707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110665952|NCT00642707|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110665953|NCT00642707|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110665954|NCT00642707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110665955|NCT00642707|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110665956|NCT00642707|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110665957|NCT00642707|Antiviral Agents|antiviral agents|mesh-ancestor
110665958|NCT00642707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110665959|NCT02551523|Dolutegravir|dolutegravir|mesh-list
110665960|NCT02551523|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
110665961|NCT02551523|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110665962|NCT02551523|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110665963|NCT02551523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110665964|NCT02551523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110665965|NCT02551523|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110665966|NCT02551523|Antiviral Agents|antiviral agents|mesh-ancestor
110665967|NCT02551523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110665968|NCT00817739|Leuprolide|leuprolide|mesh-list
110665969|NCT00817739|Flutamide|flutamide|mesh-list
110665970|NCT00817739|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110665971|NCT00817739|Fertility Agents|fertility agents|mesh-ancestor
110665972|NCT00817739|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110665973|NCT00817739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110665974|NCT00817739|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110665975|NCT00817739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110665976|NCT00817739|Androgen Antagonists|androgen antagonists|mesh-ancestor
110665977|NCT00817739|Hormone Antagonists|hormone antagonists|mesh-ancestor
110665978|NCT00817739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110665979|NCT00817895|Cisplatin|cisplatin|mesh-list
110665980|NCT00817895|Fluorouracil|fluorouracil|mesh-list
110665981|NCT00817895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110665982|NCT00817895|Antimetabolites|antimetabolites|mesh-ancestor
110665983|NCT00817895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110665984|NCT00817895|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110665985|NCT00817895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110665986|NCT00817895|Immunologic Factors|immunologic factors|mesh-ancestor
110665987|NCT00817895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110687683|NCT00943553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110313179|NCT00299351|Romidepsin|romidepsin|mesh-list
110665988|NCT00814229|Vaccines|vaccines|mesh-list
110665989|NCT00814229|Aluminum sulfate|aluminum sulfate|mesh-list
110665990|NCT00814229|Immunologic Factors|immunologic factors|mesh-ancestor
110665991|NCT00814229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110665992|NCT00814229|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110665993|NCT00568685|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
110665994|NCT00568685|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110665995|NCT00568685|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110665996|NCT00568685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110665997|NCT00568685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110665998|NCT00568685|Adrenergic Agents|adrenergic agents|mesh-ancestor
110665999|NCT00568685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110666000|NCT00568685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110666001|NCT00061945|Leucovorin|leucovorin|mesh-list
110666002|NCT00061945|Cytarabine|cytarabine|mesh-list
110666003|NCT00061945|Acyclovir|acyclovir|mesh-list
110666004|NCT00061945|Trimethoprim|trimethoprim|mesh-list
110666005|NCT00061945|Sulfamethoxazole|sulfamethoxazole|mesh-list
110666006|NCT00061945|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
110666007|NCT00061945|Dexamethasone|dexamethasone|mesh-list
110666008|NCT00061945|Cyclophosphamide|cyclophosphamide|mesh-list
110666009|NCT00061945|Methotrexate|methotrexate|mesh-list
110666010|NCT00061945|Vincristine|vincristine|mesh-list
110666011|NCT00061945|Imatinib Mesylate|imatinib mesylate|mesh-list
110666012|NCT00061945|Daunorubicin|daunorubicin|mesh-list
110666013|NCT00061945|Asparaginase|asparaginase|mesh-list
110666014|NCT00061945|Mercaptopurine|mercaptopurine|mesh-list
110666015|NCT00061945|Alemtuzumab|alemtuzumab|mesh-list
110666016|NCT00061945|Allopurinol|allopurinol|mesh-list
110666017|NCT00061945|Levoleucovorin|levoleucovorin|mesh-list
110666018|NCT00061945|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110666019|NCT00061945|Immunologic Factors|immunologic factors|mesh-ancestor
110666020|NCT00061945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110666021|NCT00061945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110666022|NCT00061945|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110666023|NCT00061945|Alkylating Agents|alkylating agents|mesh-ancestor
110666024|NCT00061945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110666025|NCT00061945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110666026|NCT00061945|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110666027|NCT00061945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110666028|NCT00061945|Antiemetics|antiemetics|mesh-ancestor
110666029|NCT00061945|Autonomic Agents|autonomic agents|mesh-ancestor
110666030|NCT00061945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110666031|NCT00061945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110666032|NCT00061945|Glucocorticoids|glucocorticoids|mesh-ancestor
110666034|NCT00061945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110666035|NCT00061945|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110666036|NCT00061945|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110666037|NCT00061945|Abortifacient Agents|abortifacient agents|mesh-ancestor
110666038|NCT00061945|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110666039|NCT00061945|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110666040|NCT00061945|Antimetabolites|antimetabolites|mesh-ancestor
110666041|NCT00061945|Dermatologic Agents|dermatologic agents|mesh-ancestor
110666042|NCT00061945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110666043|NCT00061945|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110666044|NCT00061945|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110666045|NCT00061945|Antiviral Agents|antiviral agents|mesh-ancestor
110666046|NCT00061945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110666047|NCT00061945|Antidotes|antidotes|mesh-ancestor
110666048|NCT00061945|Protective Agents|protective agents|mesh-ancestor
110666049|NCT00061945|Vitamin B Complex|vitamin b complex|mesh-ancestor
110666050|NCT00061945|Vitamins|vitamins|mesh-ancestor
110666051|NCT00061945|Micronutrients|micronutrients|mesh-ancestor
110666052|NCT00061945|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110666053|NCT00061945|Tubulin Modulators|tubulin modulators|mesh-ancestor
110666054|NCT00061945|Antimitotic Agents|antimitotic agents|mesh-ancestor
110666055|NCT00061945|Mitosis Modulators|mitosis modulators|mesh-ancestor
110666056|NCT00061945|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110666057|NCT00061945|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110666058|NCT00061945|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110666059|NCT00061945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110666060|NCT00061945|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110666061|NCT00061945|Gout Suppressants|gout suppressants|mesh-ancestor
110666062|NCT00061945|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110687684|NCT00943553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110666063|NCT00061945|Antioxidants|antioxidants|mesh-ancestor
110666064|NCT00061945|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110666065|NCT00061945|Antimalarials|antimalarials|mesh-ancestor
110666066|NCT00061945|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110666067|NCT00061945|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110666068|NCT00061945|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110666069|NCT00061945|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
110666070|NCT00061945|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110666071|NCT00061945|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110666072|NCT00817973|Caseins|caseins|mesh-list
110666073|NCT00817973|Chelating Agents|chelating agents|mesh-ancestor
110666074|NCT00817973|Sequestering Agents|sequestering agents|mesh-ancestor
110666075|NCT00817973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110666076|NCT01097941|Vaccines|vaccines|mesh-list
110666077|NCT01097941|Immunologic Factors|immunologic factors|mesh-ancestor
110666078|NCT01097941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110666079|NCT00642473|Metronidazole|metronidazole|mesh-list
110666080|NCT00642473|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110666081|NCT00642473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110666082|NCT00642473|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110666083|NCT00642473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110666084|NCT00642473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110666085|NCT00642473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110666086|NCT00642473|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110666087|NCT00642473|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110666088|NCT00642473|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110666089|NCT00645671|Loteprednol Etabonate|loteprednol etabonate|mesh-list
110666090|NCT00645671|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110666091|NCT00366340|Vaccines|vaccines|mesh-list
110666092|NCT00366340|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110666093|NCT00366340|Immunologic Factors|immunologic factors|mesh-ancestor
110666094|NCT00366340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110666095|NCT03992326|Cyclophosphamide|cyclophosphamide|mesh-list
110666096|NCT03992326|Fludarabine|fludarabine|mesh-list
110666097|NCT03992326|Interleukin-2|interleukin-2|mesh-list
110666098|NCT03992326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110666099|NCT03992326|Immunologic Factors|immunologic factors|mesh-ancestor
110666100|NCT03992326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110666101|NCT03992326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110666102|NCT03992326|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110666103|NCT03992326|Alkylating Agents|alkylating agents|mesh-ancestor
110666104|NCT03992326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110666105|NCT03992326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110666106|NCT03992326|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110677025|NCT03146962|Protective Agents|protective agents|mesh-ancestor
110666107|NCT03992326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110666108|NCT03992326|Analgesics|analgesics|mesh-ancestor
110666109|NCT03992326|Sensory System Agents|sensory system agents|mesh-ancestor
110666110|NCT03992326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110666111|NCT01045954|Insulin|insulin|mesh-list
110666112|NCT01045954|Insulin Glargine|insulin glargine|mesh-list
110666113|NCT01045954|Insulin Lispro|insulin lispro|mesh-list
110666114|NCT01045954|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110666115|NCT01045954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110666116|NCT01046032|Metformin|metformin|mesh-list
110666117|NCT01046032|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110666118|NCT01046032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110666119|NCT00061633|Vancomycin|vancomycin|mesh-list
110666120|NCT00061633|Penicillins|penicillins|mesh-list
110666121|NCT00061633|Telavancin|telavancin|mesh-list
110666122|NCT00061633|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110666123|NCT00061633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110666124|NCT00645593|Gemcitabine|gemcitabine|mesh-list
110666125|NCT00645593|Cetuximab|cetuximab|mesh-list
110666126|NCT00645593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110666127|NCT00645593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110666128|NCT00645593|Antimetabolites|antimetabolites|mesh-ancestor
110666129|NCT00645593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110666130|NCT00645593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110666131|NCT01093261|Hydrocortisone|hydrocortisone|mesh-list
110666132|NCT01093261|Fludrocortisone|fludrocortisone|mesh-list
110666133|NCT01093261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110666134|NCT02550977|Gestodene|gestodene|mesh-list
110666135|NCT02550977|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110666136|NCT02550977|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110666137|NCT02550977|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110666138|NCT02550977|Contraceptive Agents|contraceptive agents|mesh-ancestor
110666139|NCT02550977|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110666140|NCT02550977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110666141|NCT02550977|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110666142|NCT02550977|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110666143|NCT02550977|Progestins|progestins|mesh-ancestor
110666144|NCT02550977|Hormones|hormones|mesh-ancestor
110666145|NCT02550977|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110666146|NCT01045018|Mesalamine|mesalamine|mesh-list
110666147|NCT01045018|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110666148|NCT01045018|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110666149|NCT01045018|Analgesics|analgesics|mesh-ancestor
110666150|NCT01045018|Sensory System Agents|sensory system agents|mesh-ancestor
110666151|NCT01045018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110666152|NCT01045018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110666153|NCT01045018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110666154|NCT01045018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110666155|NCT01049464|Magnesium Sulfate|magnesium sulfate|mesh-list
110666156|NCT01049464|Analgesics|analgesics|mesh-ancestor
110666157|NCT01049464|Sensory System Agents|sensory system agents|mesh-ancestor
110666158|NCT01049464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110666159|NCT01049464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110666160|NCT01049464|Anesthetics|anesthetics|mesh-ancestor
110666161|NCT01049464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110666162|NCT01049464|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110666163|NCT01049464|Anticonvulsants|anticonvulsants|mesh-ancestor
110666164|NCT01049464|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110666165|NCT01049464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110666166|NCT01049464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110666167|NCT01049464|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110666168|NCT01049464|Tocolytic Agents|tocolytic agents|mesh-ancestor
110666169|NCT01049464|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110666170|NCT01046266|Cetuximab|cetuximab|mesh-list
110666171|NCT01046266|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110666172|NCT01046266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110666173|NCT00365794|Testosterone|testosterone|mesh-list
110666174|NCT00365794|Androgens|androgens|mesh-ancestor
110666175|NCT00365794|Hormones|hormones|mesh-ancestor
110666176|NCT00365794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110666177|NCT00365794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110666178|NCT01098019|Botulinum Toxins|botulinum toxins|mesh-list
110666179|NCT01098019|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110666180|NCT01098019|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
110948225|NCT04428814|Dermatologic Agents|dermatologic agents|mesh-ancestor
110948226|NCT03036514|Sufentanil|sufentanil|mesh-list
110666181|NCT01098019|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110666182|NCT01098019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110666183|NCT01098019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110666184|NCT01098019|Cholinergic Agents|cholinergic agents|mesh-ancestor
110666185|NCT01098019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110666186|NCT01098019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110666187|NCT01098019|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110666188|NCT01098019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110666189|NCT00365716|Vaccines|vaccines|mesh-list
110666190|NCT00365716|Immunologic Factors|immunologic factors|mesh-ancestor
110666191|NCT00365716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110666192|NCT01049542|Astressin|astressin|mesh-list
110666193|NCT01049542|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110666194|NCT01049542|Protective Agents|protective agents|mesh-ancestor
110666195|NCT01049542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110666196|NCT01049620|Capecitabine|capecitabine|mesh-list
110666197|NCT01049620|Oxaliplatin|oxaliplatin|mesh-list
110666198|NCT01049620|Everolimus|everolimus|mesh-list
110666199|NCT01049620|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110666200|NCT01049620|Antimetabolites|antimetabolites|mesh-ancestor
110666201|NCT01049620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110666202|NCT01049620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110666203|NCT01049620|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110666204|NCT01049620|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110666205|NCT01049620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110666206|NCT01049620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110666207|NCT01049620|Immunologic Factors|immunologic factors|mesh-ancestor
110666208|NCT01049620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110666210|NCT00059839|Doxorubicin|doxorubicin|mesh-list
110666211|NCT00059839|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110666212|NCT00059839|Methotrexate|methotrexate|mesh-list
110666213|NCT00059839|Vincristine|vincristine|mesh-list
110666214|NCT00059839|Mercaptopurine|mercaptopurine|mesh-list
110666215|NCT00059839|Vinblastine|vinblastine|mesh-list
110687685|NCT00453180|Acetylcysteine|acetylcysteine|mesh-list
110666216|NCT00059839|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110666217|NCT00059839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110666218|NCT00059839|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110666219|NCT00059839|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110666220|NCT00059839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110666221|NCT00059839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110666222|NCT00059839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110666223|NCT00059839|Glucocorticoids|glucocorticoids|mesh-ancestor
110666224|NCT00059839|Hormones|hormones|mesh-ancestor
110666225|NCT00059839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110666226|NCT00059839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110666227|NCT00059839|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110666228|NCT00059839|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110666229|NCT00059839|Abortifacient Agents|abortifacient agents|mesh-ancestor
110666230|NCT00059839|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110666231|NCT00059839|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110666232|NCT00059839|Antimetabolites|antimetabolites|mesh-ancestor
110666233|NCT00059839|Dermatologic Agents|dermatologic agents|mesh-ancestor
110666234|NCT00059839|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110666235|NCT00059839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110666236|NCT00059839|Immunologic Factors|immunologic factors|mesh-ancestor
110666237|NCT00059839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110666238|NCT00059839|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110666239|NCT00059839|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110666240|NCT00059839|Tubulin Modulators|tubulin modulators|mesh-ancestor
110666241|NCT00059839|Antimitotic Agents|antimitotic agents|mesh-ancestor
110666242|NCT00059839|Mitosis Modulators|mitosis modulators|mesh-ancestor
110666243|NCT00059215|Clopidogrel|clopidogrel|mesh-list
110666244|NCT00059215|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
110666245|NCT00059215|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110666246|NCT00059215|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110666247|NCT00059215|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110666248|NCT00059215|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110666249|NCT00059215|Purinergic Agents|purinergic agents|mesh-ancestor
110666250|NCT00059215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110666251|NCT00059215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110666252|NCT00059215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110666253|NCT00058825|Cyclosporine|cyclosporine|mesh-list
110666254|NCT00058825|Fludarabine|fludarabine|mesh-list
110666255|NCT00058825|Alemtuzumab|alemtuzumab|mesh-list
110666256|NCT00058825|Tacrolimus|tacrolimus|mesh-list
110666257|NCT00058825|Cyclosporins|cyclosporins|mesh-list
110666258|NCT00058825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110666259|NCT00058825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110666260|NCT00058825|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110666261|NCT00058825|Immunologic Factors|immunologic factors|mesh-ancestor
110666262|NCT00058825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110666263|NCT00058825|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110666264|NCT00058825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110666265|NCT00058825|Antifungal Agents|antifungal agents|mesh-ancestor
110666266|NCT00058825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110666267|NCT00058825|Dermatologic Agents|dermatologic agents|mesh-ancestor
110666268|NCT00058825|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110666269|NCT00058825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110666270|NCT02535052|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110666271|NCT02535052|Immunologic Factors|immunologic factors|mesh-ancestor
110666272|NCT02535052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110666273|NCT03953989|Ranolazine|ranolazine|mesh-list
110666274|NCT03953989|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110666275|NCT03953989|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110666276|NCT03953989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110666277|NCT01096225|Vaccines|vaccines|mesh-list
110666278|NCT01096225|Immunologic Factors|immunologic factors|mesh-ancestor
110666279|NCT01096225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110666280|NCT02535130|Amikacin|amikacin|mesh-list
110666281|NCT02535130|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110666282|NCT02535130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110666284|NCT01046500|Metformin|metformin|mesh-list
110666285|NCT01046500|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110666286|NCT01046500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110666287|NCT01046500|Vitamin B Complex|vitamin b complex|mesh-ancestor
110666288|NCT01046500|Vitamins|vitamins|mesh-ancestor
110666289|NCT01046500|Micronutrients|micronutrients|mesh-ancestor
110666290|NCT01046578|Letrozole|letrozole|mesh-list
110666291|NCT01046578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110666292|NCT01046578|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110666293|NCT01046578|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110666294|NCT01046578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110666295|NCT01046578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110666297|NCT01046578|Hormone Antagonists|hormone antagonists|mesh-ancestor
110666298|NCT01046578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110666299|NCT01046578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110666301|NCT00372424|Trastuzumab|trastuzumab|mesh-list
110666302|NCT00372424|Sunitinib|sunitinib|mesh-list
110666303|NCT00372424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110666304|NCT00372424|Tubulin Modulators|tubulin modulators|mesh-ancestor
110666305|NCT00372424|Antimitotic Agents|antimitotic agents|mesh-ancestor
110666306|NCT00372424|Mitosis Modulators|mitosis modulators|mesh-ancestor
110666307|NCT00372424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110666308|NCT00372424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110666309|NCT00372424|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110666310|NCT00372424|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110666311|NCT00372424|Growth Substances|growth substances|mesh-ancestor
110666312|NCT00372424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110666313|NCT00372424|Growth Inhibitors|growth inhibitors|mesh-ancestor
110666314|NCT00372424|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110666315|NCT00372424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110666316|NCT02530411|Fulvestrant|fulvestrant|mesh-list
110666317|NCT02530411|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110666318|NCT02530411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110666319|NCT02530411|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110666320|NCT02530411|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110666321|NCT02530411|Hormone Antagonists|hormone antagonists|mesh-ancestor
110666322|NCT02530411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110666323|NCT02530411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110666324|NCT01327027|Vasopressins|vasopressins|mesh-list
110666325|NCT01327027|Arginine Vasopressin|arginine vasopressin|mesh-list
110666326|NCT01327027|Hemostatics|hemostatics|mesh-ancestor
110666327|NCT01327027|Coagulants|coagulants|mesh-ancestor
110666328|NCT01327027|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110666329|NCT01327027|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
110666330|NCT01327027|Natriuretic Agents|natriuretic agents|mesh-ancestor
110666331|NCT01327027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110666332|NCT01093807|Enalapril|enalapril|mesh-list
110666333|NCT01093807|Enalaprilat|enalaprilat|mesh-list
110666334|NCT01093807|Lercanidipine|lercanidipine|mesh-list
110666335|NCT01093807|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110666336|NCT01093807|Protease Inhibitors|protease inhibitors|mesh-ancestor
110666337|NCT01093807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110666338|NCT01093807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110666339|NCT01093807|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110666340|NCT01093807|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110666341|NCT01093807|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110666342|NCT01093807|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110666343|NCT01093807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110666344|NCT00044083|Tolcapone|tolcapone|mesh-list
110666345|NCT00044083|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110666346|NCT00044083|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110666347|NCT00044083|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
110666348|NCT00044083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110666349|NCT00044083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110666350|NCT00058123|Poly ICLC|poly iclc|mesh-list
110666351|NCT00058123|Interferon Inducers|interferon inducers|mesh-ancestor
110666352|NCT00058123|Immunologic Factors|immunologic factors|mesh-ancestor
110666353|NCT00058123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110666354|NCT00022633|Paclitaxel|paclitaxel|mesh-list
110666355|NCT00022633|Gemcitabine|gemcitabine|mesh-list
110666356|NCT00022633|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110666357|NCT00022633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110666358|NCT00022633|Tubulin Modulators|tubulin modulators|mesh-ancestor
110666359|NCT00022633|Antimitotic Agents|antimitotic agents|mesh-ancestor
110666360|NCT00022633|Mitosis Modulators|mitosis modulators|mesh-ancestor
110666361|NCT00022633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110666362|NCT00022633|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110666363|NCT00022633|Antimetabolites|antimetabolites|mesh-ancestor
110666364|NCT00021541|Tipifarnib|tipifarnib|mesh-list
110666365|NCT00021541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110666366|NCT00021229|Imatinib Mesylate|imatinib mesylate|mesh-list
110666367|NCT00021229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110666368|NCT00021229|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110666369|NCT00021229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110666370|NCT00021229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110666372|NCT02688790|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110666373|NCT02688790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110666374|NCT00488475|Etanercept|etanercept|mesh-list
110666375|NCT00488475|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110666376|NCT00488475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110666377|NCT00488475|Analgesics|analgesics|mesh-ancestor
110666378|NCT00488475|Sensory System Agents|sensory system agents|mesh-ancestor
110666379|NCT00488475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110666380|NCT00488475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110666381|NCT00488475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110666382|NCT00488475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110666383|NCT00488475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110666384|NCT00488475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110666385|NCT00488475|Immunologic Factors|immunologic factors|mesh-ancestor
110666386|NCT01020279|Celecoxib|celecoxib|mesh-list
110666387|NCT01020279|Ketoprofen|ketoprofen|mesh-list
110666388|NCT01020279|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110666389|NCT01020279|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110666390|NCT01020279|Analgesics|analgesics|mesh-ancestor
110666391|NCT01020279|Sensory System Agents|sensory system agents|mesh-ancestor
110666392|NCT01020279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110666393|NCT01020279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110666394|NCT01020279|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110666395|NCT01020279|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110666396|NCT01020279|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110666397|NCT01020279|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110666398|NCT01020279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110666399|NCT01020279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110666400|NCT01020357|Caffeine|caffeine|mesh-list
110666401|NCT01020357|Caffeine citrate|caffeine citrate|mesh-list
110666402|NCT01020357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110666403|NCT01020357|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110448263|NCT02737696|Analgesics, Opioid|analgesics, opioid|mesh-list
110666404|NCT01020357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110666405|NCT01020357|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110666406|NCT01020357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110666407|NCT01020357|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110666408|NCT01020357|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110666409|NCT01020357|Purinergic Agents|purinergic agents|mesh-ancestor
110666410|NCT01020357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110666411|NCT00042991|Gefitinib|gefitinib|mesh-list
110666412|NCT00042991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110666413|NCT00042991|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110666414|NCT00042991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110666415|NCT00042991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110666416|NCT00466167|Pramipexole|pramipexole|mesh-list
110666417|NCT00466167|Antioxidants|antioxidants|mesh-ancestor
110666418|NCT00466167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110666419|NCT00466167|Protective Agents|protective agents|mesh-ancestor
110666420|NCT00466167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110666421|NCT00466167|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110666422|NCT00466167|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110666423|NCT00466167|Dopamine Agonists|dopamine agonists|mesh-ancestor
110666424|NCT00466167|Dopamine Agents|dopamine agents|mesh-ancestor
110666425|NCT00466167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110666426|NCT01017939|Prednisone|prednisone|mesh-list
110666427|NCT01017939|Abiraterone Acetate|abiraterone acetate|mesh-list
110666428|NCT01017939|Theophylline|theophylline|mesh-list
110666429|NCT01017939|Dextromethorphan|dextromethorphan|mesh-list
110666430|NCT01017939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110666431|NCT01017939|Glucocorticoids|glucocorticoids|mesh-ancestor
110666432|NCT01017939|Hormones|hormones|mesh-ancestor
110666433|NCT01017939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110666434|NCT01017939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110666435|NCT01017939|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110666437|NCT01017939|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110666438|NCT01017939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110666439|NCT01017939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110666440|NCT01017939|Hormone Antagonists|hormone antagonists|mesh-ancestor
110666441|NCT01017939|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110666442|NCT01017939|Antitussive Agents|antitussive agents|mesh-ancestor
110666443|NCT01017939|Respiratory System Agents|respiratory system agents|mesh-ancestor
110666444|NCT01017939|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110666445|NCT01017939|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110666446|NCT01017939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110666447|NCT01017939|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110666448|NCT01017939|Autonomic Agents|autonomic agents|mesh-ancestor
110666449|NCT01017939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110666450|NCT01017939|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110666451|NCT01017939|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110666452|NCT01017939|Vasodilator Agents|vasodilator agents|mesh-ancestor
110666453|NCT01017939|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110666454|NCT01017939|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110666455|NCT01017939|Purinergic Agents|purinergic agents|mesh-ancestor
110666456|NCT00480441|Dronabinol|dronabinol|mesh-list
110666457|NCT00480441|Hallucinogens|hallucinogens|mesh-ancestor
110666458|NCT00480441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110666459|NCT00480441|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110666460|NCT00480441|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110666461|NCT00480441|Analgesics|analgesics|mesh-ancestor
110666462|NCT00480441|Sensory System Agents|sensory system agents|mesh-ancestor
110666463|NCT00480441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110666464|NCT00480441|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
110666465|NCT00480441|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110666466|NCT00480441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110666467|NCT00480441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110666468|NCT00480441|Hormones|hormones|mesh-ancestor
110666469|NCT00480441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110666470|NCT01022463|Atenolol|atenolol|mesh-list
110666471|NCT01022463|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110666472|NCT01022463|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110666473|NCT01022463|Sympatholytics|sympatholytics|mesh-ancestor
110666474|NCT01022463|Autonomic Agents|autonomic agents|mesh-ancestor
110666475|NCT01022463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110666476|NCT01022463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110666477|NCT01022463|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110666478|NCT01022463|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110666479|NCT01022463|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110666480|NCT01022463|Adrenergic Agents|adrenergic agents|mesh-ancestor
110666481|NCT01022463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110666482|NCT01022463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110666483|NCT00488319|Paliperidone Palmitate|paliperidone palmitate|mesh-list
110666484|NCT00488319|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110666485|NCT00488319|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110666486|NCT00488319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110666487|NCT00488319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110666488|NCT00488319|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110666489|NCT00488319|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110666490|NCT00488319|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110666491|NCT00488319|Serotonin Agents|serotonin agents|mesh-ancestor
110666492|NCT00488319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110666493|NCT00488319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110666494|NCT00488319|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110666495|NCT00488319|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110666496|NCT00488319|Dopamine Agents|dopamine agents|mesh-ancestor
110666497|NCT01018251|Alovudine|alovudine|mesh-list
110666498|NCT01018251|Antiviral Agents|antiviral agents|mesh-ancestor
110666499|NCT01018251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110666500|NCT00463047|Fentanyl|fentanyl|mesh-list
110666501|NCT00463047|Oxycodone|oxycodone|mesh-list
110666502|NCT00463047|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110666503|NCT00463047|Narcotics|narcotics|mesh-ancestor
110666504|NCT00463047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110666505|NCT00463047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110666506|NCT00463047|Analgesics|analgesics|mesh-ancestor
110666507|NCT00463047|Sensory System Agents|sensory system agents|mesh-ancestor
110666509|NCT00463047|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110666510|NCT00463047|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110666511|NCT00463047|Anesthetics, General|anesthetics, general|mesh-ancestor
110666512|NCT00463047|Anesthetics|anesthetics|mesh-ancestor
110666513|NCT00487539|Golimumab|golimumab|mesh-list
110666514|NCT00487539|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110666515|NCT00487539|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110666516|NCT00487539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110666517|NCT00487539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110666518|NCT00487539|Immunologic Factors|immunologic factors|mesh-ancestor
110666519|NCT00487539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110666520|NCT00486837|Protease Inhibitors|protease inhibitors|mesh-list
110666521|NCT00486837|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
110666522|NCT00486837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110666523|NCT00486837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110666524|NCT00486837|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
110666525|NCT00486837|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110666526|NCT00486759|Bevacizumab|bevacizumab|mesh-list
110666527|NCT00486759|Rituximab|rituximab|mesh-list
110666528|NCT00486759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110666529|NCT00486759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110666530|NCT00486759|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110666531|NCT00486759|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110666532|NCT00486759|Growth Substances|growth substances|mesh-ancestor
110666533|NCT00486759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110666534|NCT00486759|Growth Inhibitors|growth inhibitors|mesh-ancestor
110666535|NCT00486759|Immunologic Factors|immunologic factors|mesh-ancestor
110666536|NCT00486759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110666537|NCT00486603|Hydroxychloroquine|hydroxychloroquine|mesh-list
110666538|NCT00486603|Temozolomide|temozolomide|mesh-list
110666539|NCT00486603|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110666540|NCT00486603|Alkylating Agents|alkylating agents|mesh-ancestor
110666541|NCT00486603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110666542|NCT00486603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110666543|NCT00486603|Antimalarials|antimalarials|mesh-ancestor
110666544|NCT00486603|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110666545|NCT00486603|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110666546|NCT00486603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110666547|NCT00486603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110666548|NCT00486603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110666549|NCT00474045|Insulin|insulin|mesh-list
110666550|NCT00474045|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110666551|NCT00474045|Insulin Aspart|insulin aspart|mesh-list
110666552|NCT00474045|Insulin Detemir|insulin detemir|mesh-list
110666553|NCT00474045|Insulin, Isophane|insulin, isophane|mesh-list
110666554|NCT00474045|Isophane Insulin, Human|isophane insulin, human|mesh-list
110666555|NCT00474045|Isophane insulin, beef|isophane insulin, beef|mesh-list
110666556|NCT00474045|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110666557|NCT00474045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110666558|NCT01020825|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
110666559|NCT01020825|Hemostatics|hemostatics|mesh-ancestor
110666560|NCT01020825|Coagulants|coagulants|mesh-ancestor
110666561|NCT01018485|Botulinum Toxins|botulinum toxins|mesh-list
110666562|NCT01018485|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110666563|NCT01018485|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110666564|NCT01018485|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110666565|NCT01018485|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110666566|NCT01018485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110666567|NCT01018485|Cholinergic Agents|cholinergic agents|mesh-ancestor
110666568|NCT01018485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110666569|NCT01018485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110666570|NCT01018485|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110666571|NCT01018485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110666572|NCT00462501|Leucovorin|leucovorin|mesh-list
110666573|NCT00462501|Bevacizumab|bevacizumab|mesh-list
110666574|NCT00462501|Fluorouracil|fluorouracil|mesh-list
110666575|NCT00462501|Oxaliplatin|oxaliplatin|mesh-list
110666576|NCT00462501|Calcium|calcium|mesh-list
110666577|NCT00462501|Levoleucovorin|levoleucovorin|mesh-list
110666578|NCT00462501|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110666579|NCT00462501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110666580|NCT00462501|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110666581|NCT00462501|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110666582|NCT00462501|Growth Substances|growth substances|mesh-ancestor
110666583|NCT00462501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110666584|NCT00462501|Growth Inhibitors|growth inhibitors|mesh-ancestor
110666585|NCT00462501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110666586|NCT00462501|Antimetabolites|antimetabolites|mesh-ancestor
110666587|NCT00462501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110666588|NCT00462501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110666589|NCT00462501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110666590|NCT00462501|Immunologic Factors|immunologic factors|mesh-ancestor
110666591|NCT00462501|Antidotes|antidotes|mesh-ancestor
110666592|NCT00462501|Protective Agents|protective agents|mesh-ancestor
110666593|NCT00462501|Vitamin B Complex|vitamin b complex|mesh-ancestor
110666594|NCT00462501|Vitamins|vitamins|mesh-ancestor
110666595|NCT00462501|Micronutrients|micronutrients|mesh-ancestor
110666596|NCT03996603|Estrogens|estrogens|mesh-list
110666597|NCT03996603|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
110666598|NCT03996603|Hormones|hormones|mesh-ancestor
110666599|NCT03996603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110666600|NCT03996603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110666601|NCT00462345|Rituximab|rituximab|mesh-list
110666602|NCT00462345|Methotrexate|methotrexate|mesh-list
110666603|NCT00462345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110666604|NCT00462345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110666605|NCT00462345|Immunologic Factors|immunologic factors|mesh-ancestor
110666606|NCT00462345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110666607|NCT00462345|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110666608|NCT00462345|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110666609|NCT00462345|Abortifacient Agents|abortifacient agents|mesh-ancestor
110666610|NCT00462345|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110666611|NCT00462345|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110666612|NCT00462345|Antimetabolites|antimetabolites|mesh-ancestor
110666613|NCT00462345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110666614|NCT00462345|Dermatologic Agents|dermatologic agents|mesh-ancestor
110666615|NCT00462345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110666616|NCT00462345|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110666617|NCT00462345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110666618|NCT00462345|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110666619|NCT01022541|Bevacizumab|bevacizumab|mesh-list
110666620|NCT01022541|Capecitabine|capecitabine|mesh-list
110666621|NCT01022541|Oxaliplatin|oxaliplatin|mesh-list
110666622|NCT01022541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110666623|NCT01022541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110666624|NCT01022541|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110666625|NCT01022541|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110666626|NCT01022541|Growth Substances|growth substances|mesh-ancestor
110666627|NCT01022541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110666628|NCT01022541|Growth Inhibitors|growth inhibitors|mesh-ancestor
110666629|NCT01022541|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110666630|NCT01022541|Antimetabolites|antimetabolites|mesh-ancestor
110666631|NCT01022541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110666632|NCT01047202|Vaccines|vaccines|mesh-list
110666633|NCT01047202|Immunologic Factors|immunologic factors|mesh-ancestor
110666634|NCT01047202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110666636|NCT01049854|Cyclophosphamide|cyclophosphamide|mesh-list
110666637|NCT01049854|Thiotepa|thiotepa|mesh-list
110666638|NCT01049854|Busulfan|busulfan|mesh-list
110666639|NCT01049854|Fludarabine phosphate|fludarabine phosphate|mesh-list
110666640|NCT01049854|Fludarabine|fludarabine|mesh-list
110666641|NCT01049854|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110666642|NCT01049854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110666643|NCT01049854|Immunologic Factors|immunologic factors|mesh-ancestor
110666644|NCT01049854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110666645|NCT01049854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110666646|NCT01049854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110666647|NCT01049854|Alkylating Agents|alkylating agents|mesh-ancestor
110666648|NCT01049854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110666649|NCT01049854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110666650|NCT01049854|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110666651|NCT01049854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110666652|NCT01049854|Antimetabolites|antimetabolites|mesh-ancestor
110666653|NCT01049854|Antiviral Agents|antiviral agents|mesh-ancestor
110666654|NCT01049854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110666655|NCT00453999|Oseltamivir|oseltamivir|mesh-list
110666656|NCT00453999|Peramivir|peramivir|mesh-list
110666657|NCT00453999|Antiviral Agents|antiviral agents|mesh-ancestor
110666658|NCT00453999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110666659|NCT00453999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110666660|NCT00453999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110666661|NCT00453921|Methylphenidate|methylphenidate|mesh-list
110666662|NCT00453921|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110666663|NCT00453921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110666664|NCT00453921|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110666665|NCT00453921|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110666666|NCT00453921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110666667|NCT00453921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110666668|NCT00453921|Dopamine Agents|dopamine agents|mesh-ancestor
110666669|NCT00453921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110666670|NCT00382720|Docetaxel|docetaxel|mesh-list
110313842|NCT00304382|Vaccines|vaccines|mesh-list
110666671|NCT00382720|Capecitabine|capecitabine|mesh-list
110666672|NCT00382720|Oxaliplatin|oxaliplatin|mesh-list
110666673|NCT00382720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110666674|NCT00382720|Tubulin Modulators|tubulin modulators|mesh-ancestor
110666675|NCT00382720|Antimitotic Agents|antimitotic agents|mesh-ancestor
110666676|NCT00382720|Mitosis Modulators|mitosis modulators|mesh-ancestor
110448283|NCT01126541|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110666677|NCT00382720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110666678|NCT00382720|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110666679|NCT00382720|Antimetabolites|antimetabolites|mesh-ancestor
110666680|NCT01025349|Bevacizumab|bevacizumab|mesh-list
110666681|NCT01025349|Docetaxel|docetaxel|mesh-list
110666682|NCT01025349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110666683|NCT01025349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110666684|NCT01025349|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110666685|NCT01025349|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110666686|NCT01025349|Growth Substances|growth substances|mesh-ancestor
110666687|NCT01025349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110666688|NCT01025349|Growth Inhibitors|growth inhibitors|mesh-ancestor
110666689|NCT01025349|Tubulin Modulators|tubulin modulators|mesh-ancestor
110666690|NCT01025349|Antimitotic Agents|antimitotic agents|mesh-ancestor
110666691|NCT01025349|Mitosis Modulators|mitosis modulators|mesh-ancestor
110666692|NCT01025349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110666693|NCT00453063|Mometasone Furoate|mometasone furoate|mesh-list
110666694|NCT00453063|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110666695|NCT00453063|Dermatologic Agents|dermatologic agents|mesh-ancestor
110666696|NCT00453063|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110666697|NCT00371566|Lapatinib|lapatinib|mesh-list
110666698|NCT00371566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110666699|NCT00371566|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110666700|NCT00371566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110666701|NCT00371566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110666702|NCT00371254|Dasatinib|dasatinib|mesh-list
110666703|NCT00371254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110666704|NCT00371254|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110666705|NCT00371254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110666706|NCT00371254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110666707|NCT00452673|Capecitabine|capecitabine|mesh-list
110666708|NCT00452673|Dasatinib|dasatinib|mesh-list
110666709|NCT00452673|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110666710|NCT00452673|Antimetabolites|antimetabolites|mesh-ancestor
110666711|NCT00452673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110666712|NCT00452673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110666713|NCT00452673|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110666714|NCT00452673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110666716|NCT00461253|Levonorgestrel|levonorgestrel|mesh-list
110666717|NCT00461253|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110666718|NCT00461253|Contraceptive Agents|contraceptive agents|mesh-ancestor
110666719|NCT00461253|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110666720|NCT00461253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110666721|NCT00461253|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110666722|NCT00461253|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110666723|NCT00461253|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110666724|NCT00461253|Trace Elements|trace elements|mesh-ancestor
110666725|NCT00461253|Micronutrients|micronutrients|mesh-ancestor
110666726|NCT00469833|Insulin|insulin|mesh-list
110666727|NCT00469833|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110666728|NCT00469833|Insulin Glargine|insulin glargine|mesh-list
110666729|NCT00469833|Insulin, Long-Acting|insulin, long-acting|mesh-list
110666730|NCT00469833|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110666731|NCT00469833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110666732|NCT00641537|Cladribine|cladribine|mesh-list
110666733|NCT00641537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110666734|NCT00641537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110666735|NCT00641537|Immunologic Factors|immunologic factors|mesh-ancestor
110666736|NCT00641537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110666737|NCT01025583|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110666738|NCT00814541|Dexamethasone|dexamethasone|mesh-list
110666739|NCT00814541|Doxorubicin|doxorubicin|mesh-list
110666740|NCT00814541|Bortezomib|bortezomib|mesh-list
110687686|NCT00453180|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110666741|NCT00814541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110313913|NCT00304616|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110666742|NCT00814541|Antiemetics|antiemetics|mesh-ancestor
110666743|NCT00814541|Autonomic Agents|autonomic agents|mesh-ancestor
110666744|NCT00814541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110666745|NCT00814541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110666746|NCT00814541|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110666747|NCT00814541|Glucocorticoids|glucocorticoids|mesh-ancestor
110666748|NCT00814541|Hormones|hormones|mesh-ancestor
110666749|NCT00814541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110666750|NCT00814541|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110666751|NCT00814541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110666752|NCT00814541|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110666753|NCT00814541|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110666754|NCT00814541|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110666755|NCT00814541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110666756|NCT00814541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110666757|NCT00814619|Capecitabine|capecitabine|mesh-list
110666758|NCT00814619|Panitumumab|panitumumab|mesh-list
110666759|NCT00814619|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110666760|NCT00814619|Antimetabolites|antimetabolites|mesh-ancestor
110666761|NCT00814619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110666762|NCT00814619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110666763|NCT00814619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110666764|NCT00641147|Curcumin|curcumin|mesh-list
110666765|NCT00641147|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110666766|NCT00641147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110666767|NCT00641147|Analgesics|analgesics|mesh-ancestor
110666768|NCT00641147|Sensory System Agents|sensory system agents|mesh-ancestor
110666769|NCT00641147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110666770|NCT00641147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110666771|NCT00641147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110666772|NCT00641147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110666773|NCT00641147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110666774|NCT00641147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110666775|NCT00641147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110666776|NCT00460239|Morphine|morphine|mesh-list
110666777|NCT00460239|Buprenorphine|buprenorphine|mesh-list
110666778|NCT00460239|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110666779|NCT00460239|Narcotics|narcotics|mesh-ancestor
110666780|NCT00460239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110666781|NCT00460239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110666782|NCT00460239|Analgesics|analgesics|mesh-ancestor
110666783|NCT00460239|Sensory System Agents|sensory system agents|mesh-ancestor
110666784|NCT00460239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110666785|NCT00460239|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110666787|NCT00640835|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
110666788|NCT00640835|Naloxone|naloxone|mesh-list
110666789|NCT00640835|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110666790|NCT00640835|Narcotics|narcotics|mesh-ancestor
110666791|NCT00640835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110666792|NCT00640835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110666793|NCT00640835|Analgesics|analgesics|mesh-ancestor
110666794|NCT00640835|Sensory System Agents|sensory system agents|mesh-ancestor
110666795|NCT00640835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110666796|NCT00640835|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110666797|NCT03839355|Warfarin|warfarin|mesh-list
110666798|NCT03839355|Apixaban|apixaban|mesh-list
110666799|NCT03839355|Anticoagulants|anticoagulants|mesh-ancestor
110666800|NCT03839355|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110666801|NCT03839355|Antithrombins|antithrombins|mesh-ancestor
110666802|NCT03839355|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110666803|NCT03839355|Protease Inhibitors|protease inhibitors|mesh-ancestor
110666804|NCT03839355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110666805|NCT03839355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110666806|NCT00640601|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110666807|NCT00640601|Antidepressive Agents|antidepressive agents|mesh-ancestor
110666808|NCT00640601|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110666809|NCT00640601|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110666810|NCT00640601|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110666811|NCT00640601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110448300|NCT00625469|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110666812|NCT00640601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110666814|NCT02551133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110666815|NCT02551133|Antiemetics|antiemetics|mesh-ancestor
110666816|NCT02551133|Autonomic Agents|autonomic agents|mesh-ancestor
110666817|NCT02551133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110666818|NCT02551133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110666819|NCT02551133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110666820|NCT02551133|Glucocorticoids|glucocorticoids|mesh-ancestor
110666821|NCT02551133|Hormones|hormones|mesh-ancestor
110666822|NCT02551133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110666823|NCT02551133|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110666824|NCT02551133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110666825|NCT00818285|Psychotropic Drugs|psychotropic drugs|mesh-list
110666826|NCT00452439|Vitamin D|vitamin d|mesh-list
110666827|NCT00452439|Risedronic Acid|risedronic acid|mesh-list
110666828|NCT00452439|Etidronic Acid|etidronic acid|mesh-list
110666829|NCT00452439|Calcium|calcium|mesh-list
110666830|NCT00452439|Vitamins|vitamins|mesh-ancestor
110666831|NCT00452439|Micronutrients|micronutrients|mesh-ancestor
110666832|NCT00452439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110666833|NCT00452439|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110666834|NCT00452439|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110666835|NCT00452439|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110666836|NCT00452439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110666837|NCT00452439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110666838|NCT01023087|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110666839|NCT01023087|Colistin|colistin|mesh-list
110666840|NCT01023087|Polymyxins|polymyxins|mesh-list
110666841|NCT01023087|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
110666842|NCT01023087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110666843|NCT01023087|Antitubercular Agents|antitubercular agents|mesh-ancestor
110666844|NCT00381940|Bortezomib|bortezomib|mesh-list
110666845|NCT00381940|Vinorelbine|vinorelbine|mesh-list
110666846|NCT00381940|Ifosfamide|ifosfamide|mesh-list
110666847|NCT00381940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110666848|NCT00381940|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110666849|NCT00381940|Tubulin Modulators|tubulin modulators|mesh-ancestor
110666850|NCT00381940|Antimitotic Agents|antimitotic agents|mesh-ancestor
110666851|NCT00381940|Mitosis Modulators|mitosis modulators|mesh-ancestor
110666852|NCT00381940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110666853|NCT00381940|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110666854|NCT00381940|Alkylating Agents|alkylating agents|mesh-ancestor
110666855|NCT00818675|Sirolimus|sirolimus|mesh-list
110666856|NCT00818675|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110666857|NCT00818675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110666858|NCT00818675|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110666859|NCT00818675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110666860|NCT00818675|Antifungal Agents|antifungal agents|mesh-ancestor
110666861|NCT00818675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110666862|NCT00818675|Immunologic Factors|immunologic factors|mesh-ancestor
110666863|NCT00818675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110666864|NCT00364156|Nicotine|nicotine|mesh-list
110666865|NCT00364156|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110666866|NCT00364156|Autonomic Agents|autonomic agents|mesh-ancestor
110666867|NCT00364156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110666868|NCT00364156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110666869|NCT00364156|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110666870|NCT00364156|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110666871|NCT00364156|Cholinergic Agents|cholinergic agents|mesh-ancestor
110666872|NCT00364156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110666873|NCT00364156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110666874|NCT00452361|Cyclosporine|cyclosporine|mesh-list
110666875|NCT00452361|Sirolimus|sirolimus|mesh-list
110666876|NCT00452361|Tacrolimus|tacrolimus|mesh-list
110666877|NCT00452361|Cyclosporins|cyclosporins|mesh-list
110666878|NCT00452361|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
110666879|NCT00452361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110666880|NCT00452361|Immunologic Factors|immunologic factors|mesh-ancestor
110666881|NCT00452361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110666882|NCT00452361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110666883|NCT00452361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110666884|NCT00452361|Antifungal Agents|antifungal agents|mesh-ancestor
110666885|NCT00452361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110666886|NCT00452361|Dermatologic Agents|dermatologic agents|mesh-ancestor
110666887|NCT00452361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110448305|NCT00637481|Atorvastatin|atorvastatin|mesh-list
110666888|NCT00452361|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110666889|NCT00452361|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110666891|NCT03334318|Allopurinol|allopurinol|mesh-list
110666892|NCT03334318|Antimetabolites|antimetabolites|mesh-ancestor
110666893|NCT03334318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110666894|NCT03334318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110666895|NCT03334318|Gout Suppressants|gout suppressants|mesh-ancestor
110314055|NCT00304850|Anesthetics|anesthetics|mesh-ancestor
110666896|NCT03334318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110666897|NCT03334318|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110666898|NCT03334318|Antioxidants|antioxidants|mesh-ancestor
110666899|NCT03334318|Protective Agents|protective agents|mesh-ancestor
110666900|NCT03334318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110666901|NCT00640289|Fibrinolysin|fibrinolysin|mesh-list
110666902|NCT00640289|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110666903|NCT00640289|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110666904|NCT00640289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110666906|NCT03877809|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110666907|NCT03877809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110666908|NCT03877809|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110666909|NCT03877809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110666910|NCT03877809|Antifungal Agents|antifungal agents|mesh-ancestor
110666911|NCT03877809|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110666912|NCT03877809|Immunologic Factors|immunologic factors|mesh-ancestor
110666913|NCT03877809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110666914|NCT01049932|Rilpivirine|rilpivirine|mesh-list
110666915|NCT01049932|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110666916|NCT01049932|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110666917|NCT01049932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110666918|NCT01049932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110666919|NCT01049932|Antiviral Agents|antiviral agents|mesh-ancestor
110666920|NCT01049932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110666921|NCT01049932|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110666922|NCT01049932|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110666923|NCT01047670|Hydrocortisone|hydrocortisone|mesh-list
110666924|NCT01047670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110666925|NCT00819065|Botulinum Toxins|botulinum toxins|mesh-list
110666926|NCT00819065|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110666927|NCT00819065|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110666928|NCT00819065|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110666929|NCT00819065|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110666930|NCT00819065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110666931|NCT00819065|Cholinergic Agents|cholinergic agents|mesh-ancestor
110666932|NCT00819065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110666933|NCT00819065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110666934|NCT00819065|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110666935|NCT00819065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110666936|NCT01047748|Digoxin|digoxin|mesh-list
110666937|NCT01047748|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110666938|NCT01047748|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110666939|NCT01047748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110666940|NCT01047748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110666941|NCT01047748|Protective Agents|protective agents|mesh-ancestor
110666942|NCT01047748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110666944|NCT00568451|Carboplatin|carboplatin|mesh-list
110666945|NCT00568451|Temozolomide|temozolomide|mesh-list
110666946|NCT00568451|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110666947|NCT00568451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110666948|NCT00568451|Tubulin Modulators|tubulin modulators|mesh-ancestor
110666949|NCT00568451|Antimitotic Agents|antimitotic agents|mesh-ancestor
110666950|NCT00568451|Mitosis Modulators|mitosis modulators|mesh-ancestor
110666951|NCT00568451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110666952|NCT00568451|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110666953|NCT00568451|Alkylating Agents|alkylating agents|mesh-ancestor
110666954|NCT00459537|Terbinafine|terbinafine|mesh-list
110666955|NCT00459537|Amorolfine|amorolfine|mesh-list
110666956|NCT00459537|Antifungal Agents|antifungal agents|mesh-ancestor
110666957|NCT00459537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110666958|NCT00459537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110666959|NCT00459537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110666960|NCT03866421|Liver Extracts|liver extracts|mesh-list
110666961|NCT03866421|Hematinics|hematinics|mesh-ancestor
110666962|NCT00819377|Milrinone|milrinone|mesh-list
110666963|NCT00819377|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110666964|NCT00819377|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110666965|NCT00819377|Vasodilator Agents|vasodilator agents|mesh-ancestor
110666966|NCT00819377|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110666967|NCT00819377|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110341366|NCT02937363|Vitamins|vitamins|mesh-ancestor
110666969|NCT00819377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110666970|NCT00819377|Protective Agents|protective agents|mesh-ancestor
110666971|NCT00819377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110666972|NCT01023165|Insulin Lispro|insulin lispro|mesh-list
110666973|NCT01023165|Insulin Aspart|insulin aspart|mesh-list
110666974|NCT01023165|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110314178|NCT00333021|PENTA|penta|mesh-list
110666975|NCT01023165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110666976|NCT01023243|Aspirin|aspirin|mesh-list
110666977|NCT01023243|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110666978|NCT01023243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110666979|NCT01023243|Analgesics|analgesics|mesh-ancestor
110666980|NCT01023243|Sensory System Agents|sensory system agents|mesh-ancestor
110666981|NCT01023243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110666982|NCT01023243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110666983|NCT01023243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110666984|NCT01023243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110666985|NCT01023243|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110666986|NCT01023243|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110666987|NCT01023243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110666988|NCT01023243|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110666989|NCT01023243|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110666990|NCT01023243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110666991|NCT01023243|Antipyretics|antipyretics|mesh-ancestor
110666992|NCT03762915|Minocycline|minocycline|mesh-list
110666993|NCT03762915|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110666994|NCT03762915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110666995|NCT00469209|Ascorbic Acid|ascorbic acid|mesh-list
110666996|NCT00469209|Bortezomib|bortezomib|mesh-list
110666997|NCT00469209|Melphalan|melphalan|mesh-list
110666998|NCT00469209|Arsenic Trioxide|arsenic trioxide|mesh-list
110666999|NCT00469209|Vitamins|vitamins|mesh-ancestor
110667000|NCT00469209|Micronutrients|micronutrients|mesh-ancestor
110667001|NCT00469209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110667002|NCT00469209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110667003|NCT00469209|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110667004|NCT00469209|Alkylating Agents|alkylating agents|mesh-ancestor
110667005|NCT00469209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110667006|NCT00469209|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110667007|NCT00469209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110667008|NCT00469209|Immunologic Factors|immunologic factors|mesh-ancestor
110667009|NCT00469209|Antioxidants|antioxidants|mesh-ancestor
110667010|NCT00469209|Protective Agents|protective agents|mesh-ancestor
110667011|NCT00635219|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110667012|NCT00635219|Vortioxetine|vortioxetine|mesh-list
110667013|NCT00635219|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110667014|NCT00635219|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110667015|NCT00635219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110667016|NCT00635219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110667017|NCT00635219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110667018|NCT00635219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110667019|NCT00635219|Analgesics|analgesics|mesh-ancestor
110667020|NCT00635219|Sensory System Agents|sensory system agents|mesh-ancestor
110667021|NCT00635219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110667022|NCT00635219|Antidepressive Agents|antidepressive agents|mesh-ancestor
110667023|NCT00635219|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110667024|NCT00635219|Dopamine Agents|dopamine agents|mesh-ancestor
110667025|NCT00635219|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110667026|NCT00635219|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110667027|NCT00635219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110667028|NCT00635219|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110667029|NCT00635219|Serotonin Agents|serotonin agents|mesh-ancestor
110667030|NCT00635219|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110667031|NCT00635219|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110667032|NCT00635219|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110667033|NCT00635219|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110667034|NCT01026129|Lidocaine|lidocaine|mesh-list
110667035|NCT01026129|Remifentanil|remifentanil|mesh-list
110667036|NCT01026129|Anesthetics, Local|anesthetics, local|mesh-ancestor
110667037|NCT01026129|Anesthetics|anesthetics|mesh-ancestor
110667038|NCT01026129|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110667039|NCT01026129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110667040|NCT01026129|Sensory System Agents|sensory system agents|mesh-ancestor
110667041|NCT01026129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110667042|NCT01026129|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110667043|NCT01026129|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110667044|NCT01026129|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110667045|NCT01026129|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110667046|NCT01026129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110667047|NCT01026129|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110667048|NCT01026129|Narcotics|narcotics|mesh-ancestor
110667049|NCT01026129|Analgesics|analgesics|mesh-ancestor
110667050|NCT01026285|Risperidone|risperidone|mesh-list
110667051|NCT01026285|Antipsychotic Agents|antipsychotic agents|mesh-list
110667052|NCT01026285|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110667053|NCT01026285|Serotonin Agents|serotonin agents|mesh-ancestor
110667054|NCT01026285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110667055|NCT01026285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110667056|NCT01026285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110667057|NCT01026285|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110667058|NCT01026285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110667059|NCT01026285|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110667060|NCT01026285|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110667061|NCT01026285|Dopamine Agents|dopamine agents|mesh-ancestor
110667062|NCT01026363|Vitamin D|vitamin d|mesh-list
110667063|NCT01026363|Ergocalciferols|ergocalciferols|mesh-list
110667064|NCT01026363|Cholecalciferol|cholecalciferol|mesh-list
110667065|NCT01026363|Calcitriol|calcitriol|mesh-list
110667066|NCT01026363|Vitamins|vitamins|mesh-list
110667067|NCT01026363|Micronutrients|micronutrients|mesh-ancestor
110667068|NCT01026363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110667069|NCT01026363|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110667070|NCT01026363|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110667071|NCT01026363|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
110667072|NCT01026363|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110667073|NCT01026363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110667074|NCT01026363|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110667075|NCT01023399|Artesunate|artesunate|mesh-list
110667076|NCT01023399|Amodiaquine|amodiaquine|mesh-list
110667077|NCT01023399|Antimalarials|antimalarials|mesh-ancestor
110667078|NCT01023399|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110667079|NCT01023399|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110667080|NCT01023399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110667081|NCT01023399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110667082|NCT01023399|Antiviral Agents|antiviral agents|mesh-ancestor
110667083|NCT01023399|Schistosomicides|schistosomicides|mesh-ancestor
110667084|NCT01023399|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110667085|NCT01023399|Anthelmintics|anthelmintics|mesh-ancestor
110667086|NCT00451191|Botulinum Toxins|botulinum toxins|mesh-list
110667087|NCT00451191|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110667088|NCT00451191|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110667089|NCT00451191|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110667090|NCT00451191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110667091|NCT00451191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110667092|NCT00451191|Cholinergic Agents|cholinergic agents|mesh-ancestor
110667093|NCT00451191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110667094|NCT00451191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110667095|NCT00451191|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110667096|NCT00451191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110667097|NCT00451035|Panobinostat|panobinostat|mesh-list
110667098|NCT00451035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110667099|NCT00451035|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110667100|NCT00451035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110667101|NCT00451035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110667102|NCT00468585|Bevacizumab|bevacizumab|mesh-list
110667103|NCT00468585|Capecitabine|capecitabine|mesh-list
110667104|NCT00468585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110667105|NCT00468585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110667106|NCT00468585|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110667107|NCT00468585|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110667108|NCT00468585|Growth Substances|growth substances|mesh-ancestor
110667109|NCT00468585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110667110|NCT00468585|Growth Inhibitors|growth inhibitors|mesh-ancestor
110667111|NCT00468585|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110667112|NCT00468585|Antimetabolites|antimetabolites|mesh-ancestor
110667113|NCT00468585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110667114|NCT01026597|Alirocumab|alirocumab|mesh-list
110667115|NCT01026597|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
110667116|NCT01026597|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110667117|NCT01026597|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110667118|NCT01026597|Antimetabolites|antimetabolites|mesh-ancestor
110667119|NCT01026597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110667120|NCT01026597|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110667121|NCT01026597|Protease Inhibitors|protease inhibitors|mesh-ancestor
110667122|NCT01026597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110667123|NCT01026597|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110667124|NCT00450801|Leucovorin|leucovorin|mesh-list
110667126|NCT00450801|Thalidomide|thalidomide|mesh-list
110667127|NCT00450801|Cyclophosphamide|cyclophosphamide|mesh-list
110667128|NCT00450801|Ifosfamide|ifosfamide|mesh-list
110667129|NCT00450801|Rituximab|rituximab|mesh-list
110667130|NCT00450801|Doxorubicin|doxorubicin|mesh-list
110667131|NCT00450801|Methotrexate|methotrexate|mesh-list
110667132|NCT00450801|Etoposide|etoposide|mesh-list
110667133|NCT00450801|Vincristine|vincristine|mesh-list
110667134|NCT00450801|Granisetron|granisetron|mesh-list
110667135|NCT00450801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110667136|NCT00450801|Immunologic Factors|immunologic factors|mesh-ancestor
110667137|NCT00450801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110667138|NCT00450801|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110667139|NCT00450801|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110667140|NCT00450801|Alkylating Agents|alkylating agents|mesh-ancestor
110667141|NCT00450801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110667142|NCT00450801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110667143|NCT00450801|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110667144|NCT00450801|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110667145|NCT00450801|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110667146|NCT00450801|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110667147|NCT00450801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110667148|NCT00450801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110667149|NCT00450801|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110667150|NCT00450801|Abortifacient Agents|abortifacient agents|mesh-ancestor
110667151|NCT00450801|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110667152|NCT00450801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110667153|NCT00450801|Antimetabolites|antimetabolites|mesh-ancestor
110667154|NCT00450801|Dermatologic Agents|dermatologic agents|mesh-ancestor
110667155|NCT00450801|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110667156|NCT00450801|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110667157|NCT00450801|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110667158|NCT00450801|Antiviral Agents|antiviral agents|mesh-ancestor
110667159|NCT00450801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110667160|NCT00450801|Antidotes|antidotes|mesh-ancestor
110667161|NCT00450801|Protective Agents|protective agents|mesh-ancestor
110667162|NCT00450801|Vitamin B Complex|vitamin b complex|mesh-ancestor
110667163|NCT00450801|Vitamins|vitamins|mesh-ancestor
110667164|NCT00450801|Micronutrients|micronutrients|mesh-ancestor
110667165|NCT00450801|Tubulin Modulators|tubulin modulators|mesh-ancestor
110667166|NCT00450801|Antimitotic Agents|antimitotic agents|mesh-ancestor
110667167|NCT00450801|Mitosis Modulators|mitosis modulators|mesh-ancestor
110667168|NCT00450801|Antiemetics|antiemetics|mesh-ancestor
110667169|NCT00450801|Autonomic Agents|autonomic agents|mesh-ancestor
110667170|NCT00450801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110667171|NCT00450801|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110667172|NCT00450801|Leprostatic Agents|leprostatic agents|mesh-ancestor
110667173|NCT00450801|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110667174|NCT00450801|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110667175|NCT00450801|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110667176|NCT00450801|Growth Substances|growth substances|mesh-ancestor
110667177|NCT00450801|Growth Inhibitors|growth inhibitors|mesh-ancestor
110667178|NCT00450801|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110667179|NCT00450801|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110667180|NCT00450801|Serotonin Agents|serotonin agents|mesh-ancestor
110667181|NCT00450801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110667182|NCT01023633|Oxaliplatin|oxaliplatin|mesh-list
110667183|NCT01023633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110667184|NCT00458211|Ziprasidone|ziprasidone|mesh-list
110667185|NCT00458211|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110667186|NCT00458211|Serotonin Agents|serotonin agents|mesh-ancestor
110667187|NCT00458211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110667188|NCT00458211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110667189|NCT00458211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110667190|NCT00458211|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110667191|NCT00458211|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110667192|NCT00458211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110667193|NCT00458211|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110667194|NCT00458211|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110667195|NCT00458211|Dopamine Agents|dopamine agents|mesh-ancestor
110667196|NCT00450723|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
110667197|NCT00450723|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110667198|NCT00450723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110667199|NCT00457821|Ivacaftor|ivacaftor|mesh-list
110667200|NCT00457821|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
110667201|NCT00457821|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110667202|NCT00457821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110667203|NCT00633893|Apixaban|apixaban|mesh-list
110667204|NCT00633893|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110667205|NCT00633893|Antithrombins|antithrombins|mesh-ancestor
110667206|NCT00633893|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110667207|NCT00633893|Protease Inhibitors|protease inhibitors|mesh-ancestor
110667208|NCT00633893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110667209|NCT00633893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110667210|NCT00633893|Anticoagulants|anticoagulants|mesh-ancestor
110667211|NCT02550665|Donepezil|donepezil|mesh-list
110667212|NCT02550665|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110667213|NCT02550665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110667214|NCT02550665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110667215|NCT02550665|Cholinergic Agents|cholinergic agents|mesh-ancestor
110667216|NCT02550665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110667217|NCT02550665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110667218|NCT02550665|Nootropic Agents|nootropic agents|mesh-ancestor
110667219|NCT00819845|Carvedilol|carvedilol|mesh-list
110667220|NCT00819845|Ramipril|ramipril|mesh-list
110667221|NCT00819845|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
110667222|NCT00819845|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110667223|NCT00819845|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110667224|NCT00819845|Adrenergic Agents|adrenergic agents|mesh-ancestor
110667225|NCT00819845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110667226|NCT00819845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110667227|NCT00819845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110667228|NCT00819845|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110667229|NCT00819845|Antioxidants|antioxidants|mesh-ancestor
110667230|NCT00819845|Protective Agents|protective agents|mesh-ancestor
110667231|NCT00819845|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110667232|NCT00819845|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110667233|NCT00819845|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110667234|NCT00819845|Vasodilator Agents|vasodilator agents|mesh-ancestor
110667235|NCT00819845|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110667236|NCT00819845|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110667237|NCT00819845|Protease Inhibitors|protease inhibitors|mesh-ancestor
110667238|NCT00819845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110678171|NCT04641338|Antipyretics|antipyretics|mesh-ancestor
110667239|NCT00457743|Sunitinib|sunitinib|mesh-list
110667240|NCT00457743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110667241|NCT00457743|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110667242|NCT00457743|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110667243|NCT00457743|Growth Substances|growth substances|mesh-ancestor
110667244|NCT00457743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110667245|NCT00457743|Growth Inhibitors|growth inhibitors|mesh-ancestor
110667246|NCT00457743|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110667247|NCT00457743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110667248|NCT00457743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110667249|NCT01023867|Donepezil|donepezil|mesh-list
110667250|NCT01023867|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110667251|NCT01023867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110667252|NCT01023867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110667253|NCT01023867|Cholinergic Agents|cholinergic agents|mesh-ancestor
110667254|NCT01023867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110667255|NCT01023867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110667256|NCT01023867|Nootropic Agents|nootropic agents|mesh-ancestor
110667257|NCT00820469|Rituximab|rituximab|mesh-list
110667258|NCT00820469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110667259|NCT00820469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110667260|NCT00820469|Immunologic Factors|immunologic factors|mesh-ancestor
110667261|NCT00820469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110667262|NCT00820469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110667263|NCT00815399|Metformin|metformin|mesh-list
110667264|NCT00815399|Pioglitazone|pioglitazone|mesh-list
110667265|NCT00815399|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110667266|NCT00815399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111479165|NCT05708183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110667267|NCT00644969|Varenicline|varenicline|mesh-list
110667268|NCT00644969|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110687688|NCT00453180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110687689|NCT00453180|Expectorants|expectorants|mesh-ancestor
110667269|NCT00644969|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110667270|NCT00644969|Cholinergic Agents|cholinergic agents|mesh-ancestor
110667271|NCT00644969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110667272|NCT00644969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110667273|NCT00644969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110667274|NCT00812435|Eptifibatide|eptifibatide|mesh-list
110667275|NCT00812435|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110667276|NCT00812513|Becaplermin|becaplermin|mesh-list
110667277|NCT00812513|Anticoagulants|anticoagulants|mesh-ancestor
110667278|NCT00812513|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
110667279|NCT00812513|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110667280|NCT00812513|Growth Substances|growth substances|mesh-ancestor
110667281|NCT00812513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110667282|NCT00820547|Cyclophosphamide|cyclophosphamide|mesh-list
110667283|NCT00820547|Bevacizumab|bevacizumab|mesh-list
110667285|NCT00820547|Fluorouracil|fluorouracil|mesh-list
110667286|NCT00820547|Epirubicin|epirubicin|mesh-list
110667287|NCT00820547|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110667288|NCT00820547|Immunologic Factors|immunologic factors|mesh-ancestor
110667289|NCT00820547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110667290|NCT00820547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110667291|NCT00820547|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110667292|NCT00820547|Alkylating Agents|alkylating agents|mesh-ancestor
110667293|NCT00820547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110667294|NCT00820547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110667295|NCT00820547|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110667296|NCT00820547|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110667297|NCT00820547|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110667298|NCT00820547|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110667299|NCT00820547|Growth Substances|growth substances|mesh-ancestor
110667300|NCT00820547|Growth Inhibitors|growth inhibitors|mesh-ancestor
110667301|NCT00820547|Tubulin Modulators|tubulin modulators|mesh-ancestor
110667302|NCT00820547|Antimitotic Agents|antimitotic agents|mesh-ancestor
110667303|NCT00820547|Mitosis Modulators|mitosis modulators|mesh-ancestor
110667304|NCT00820547|Antimetabolites|antimetabolites|mesh-ancestor
110667305|NCT00820547|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110667306|NCT00820547|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110667307|NCT00820547|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110667308|NCT00820547|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110667309|NCT00820547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110667310|NCT00815867|Epoetin Alfa|epoetin alfa|mesh-list
110667311|NCT00815867|Hematinics|hematinics|mesh-ancestor
110667312|NCT00815945|Carboplatin|carboplatin|mesh-list
110948227|NCT03036514|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110667314|NCT00815945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110667315|NCT00815945|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110667316|NCT00815945|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110667317|NCT00815945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110667318|NCT00815945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110667319|NCT00815945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110667320|NCT00812825|Prednisolone|prednisolone|mesh-list
110667321|NCT00812825|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110667322|NCT00812825|Glucocorticoids|glucocorticoids|mesh-ancestor
110667323|NCT00812825|Hormones|hormones|mesh-ancestor
110667324|NCT00812825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110667325|NCT00812825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110667326|NCT00812825|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110667327|NCT00812825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110667328|NCT00628355|Lidocaine|lidocaine|mesh-list
110667329|NCT00628355|Anesthetics, Local|anesthetics, local|mesh-ancestor
110667330|NCT00628355|Anesthetics|anesthetics|mesh-ancestor
110667331|NCT00628355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110667332|NCT00628355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110667333|NCT00628355|Sensory System Agents|sensory system agents|mesh-ancestor
110667334|NCT00628355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110667335|NCT00628355|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110667336|NCT00628355|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110667337|NCT00628355|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110667338|NCT00628355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110667339|NCT00628355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110667340|NCT00647699|Riboflavin|riboflavin|mesh-list
110667341|NCT00647699|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110667342|NCT00647699|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110341747|NCT02935764|Vitamins|vitamins|mesh-ancestor
110667343|NCT00647699|Vitamin B Complex|vitamin b complex|mesh-ancestor
110667345|NCT00647699|Micronutrients|micronutrients|mesh-ancestor
110667346|NCT00647699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110667347|NCT00647699|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110667348|NCT00647699|Dermatologic Agents|dermatologic agents|mesh-ancestor
110667349|NCT00813059|Bevacizumab|bevacizumab|mesh-list
110667350|NCT00813059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110667351|NCT00813059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110667352|NCT00813059|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110667353|NCT00813059|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110667354|NCT00813059|Growth Substances|growth substances|mesh-ancestor
110667355|NCT00813059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110667356|NCT00813059|Growth Inhibitors|growth inhibitors|mesh-ancestor
110667358|NCT00467649|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110667359|NCT00467649|Insulin Glargine|insulin glargine|mesh-list
110667360|NCT00467649|Insulin Aspart|insulin aspart|mesh-list
110667361|NCT00467649|Insulin Lispro|insulin lispro|mesh-list
110667362|NCT00467649|Insulin Detemir|insulin detemir|mesh-list
110667363|NCT00467649|Insulin glulisine|insulin glulisine|mesh-list
110667364|NCT00467649|Pramlintide|pramlintide|mesh-list
110667365|NCT00467649|Insulin, Short-Acting|insulin, short-acting|mesh-list
110667366|NCT00467649|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110667367|NCT00467649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110667368|NCT01023945|Ipragliflozin|ipragliflozin|mesh-list
110667369|NCT01023945|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110667370|NCT01023945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110667371|NCT01023945|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110667372|NCT01023945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110667373|NCT00450333|Epoetin Alfa|epoetin alfa|mesh-list
110667374|NCT00450333|Hematinics|hematinics|mesh-ancestor
110667375|NCT00643565|Bevacizumab|bevacizumab|mesh-list
110667376|NCT00643565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110667377|NCT00643565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110667378|NCT00643565|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110667379|NCT00643565|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110667380|NCT00643565|Growth Substances|growth substances|mesh-ancestor
110667381|NCT00643565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110667382|NCT00643565|Growth Inhibitors|growth inhibitors|mesh-ancestor
110667383|NCT00450255|Aflibercept|aflibercept|mesh-list
110667384|NCT00450255|Endothelial Growth Factors|endothelial growth factors|mesh-list
110667385|NCT00450255|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110667386|NCT00450255|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110667387|NCT00450255|Growth Substances|growth substances|mesh-ancestor
110667388|NCT00450255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110667389|NCT00450255|Growth Inhibitors|growth inhibitors|mesh-ancestor
110667390|NCT00450255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110667391|NCT00816335|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110667392|NCT00816335|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110667393|NCT00816335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110667394|NCT00813137|Endostar protein|endostar protein|mesh-list
110667395|NCT00813137|Endostatins|endostatins|mesh-list
110667396|NCT00813137|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110667397|NCT00813137|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110667398|NCT00813137|Growth Substances|growth substances|mesh-ancestor
110667399|NCT00813137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110667400|NCT00813137|Growth Inhibitors|growth inhibitors|mesh-ancestor
110667401|NCT00813137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110667402|NCT01024179|Sirolimus|sirolimus|mesh-list
110667403|NCT01024179|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110667404|NCT01024179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110667405|NCT01024179|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110667406|NCT01024179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110667407|NCT01024179|Antifungal Agents|antifungal agents|mesh-ancestor
110667408|NCT01024179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110667409|NCT01024179|Immunologic Factors|immunologic factors|mesh-ancestor
110667410|NCT01024179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110667411|NCT00821483|Frovatriptan|frovatriptan|mesh-list
110667412|NCT00821483|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110667413|NCT00821483|Serotonin Agents|serotonin agents|mesh-ancestor
110667414|NCT00821483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110667415|NCT00821483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111479166|NCT05594823|Furosemide|furosemide|mesh-list
110667416|NCT00821483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110667417|NCT02551367|Letrozole|letrozole|mesh-list
110667418|NCT02551367|Clomiphene|clomiphene|mesh-list
110667419|NCT02551367|Enclomiphene|enclomiphene|mesh-list
110667420|NCT02551367|Zuclomiphene|zuclomiphene|mesh-list
110667422|NCT02551367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110667423|NCT02551367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110667424|NCT02551367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110667425|NCT02551367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110667426|NCT02551367|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110667427|NCT02551367|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110667428|NCT02551367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110667430|NCT02551367|Hormone Antagonists|hormone antagonists|mesh-ancestor
110667431|NCT02551367|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110667432|NCT02551367|Fertility Agents|fertility agents|mesh-ancestor
110667433|NCT02551367|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110667434|NCT02551367|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110667435|NCT02551367|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110667436|NCT00813449|Dacarbazine|dacarbazine|mesh-list
110667437|NCT00813449|Endostar protein|endostar protein|mesh-list
110667438|NCT00813449|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110667439|NCT00813449|Alkylating Agents|alkylating agents|mesh-ancestor
110667440|NCT00813449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110667441|NCT00813449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110667442|NCT00813449|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110667443|NCT00813449|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110667444|NCT00813449|Growth Substances|growth substances|mesh-ancestor
110667445|NCT00813449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110667446|NCT00813449|Growth Inhibitors|growth inhibitors|mesh-ancestor
110667447|NCT00822029|Alendronate|alendronate|mesh-list
110667448|NCT00822029|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110667449|NCT00822029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110667450|NCT00467259|Testosterone|testosterone|mesh-list
110667451|NCT00467259|Androgens|androgens|mesh-ancestor
110667452|NCT00467259|Hormones|hormones|mesh-ancestor
110667453|NCT00467259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110667454|NCT00467259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110667455|NCT01022151|Aminophylline|aminophylline|mesh-list
110667456|NCT01022151|Doxapram|doxapram|mesh-list
110667457|NCT01022151|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110667458|NCT01022151|Autonomic Agents|autonomic agents|mesh-ancestor
110667459|NCT01022151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110667460|NCT01022151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110667461|NCT01022151|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110667462|NCT01022151|Respiratory System Agents|respiratory system agents|mesh-ancestor
110667463|NCT01022151|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110667464|NCT01022151|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110667465|NCT01022151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110667466|NCT01022151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110667467|NCT01022151|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110667468|NCT01022151|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110667469|NCT01022151|Purinergic Agents|purinergic agents|mesh-ancestor
110667470|NCT01022151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110667471|NCT01022151|Protective Agents|protective agents|mesh-ancestor
110667472|NCT01022151|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110667473|NCT01022229|Vitamins|vitamins|mesh-list
110667474|NCT01022229|Vitamin B 6|vitamin b 6|mesh-list
110667475|NCT01022229|Micronutrients|micronutrients|mesh-ancestor
110667476|NCT01022229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110667477|NCT01022229|Vitamin B Complex|vitamin b complex|mesh-ancestor
110667478|NCT00449787|Naproxen|naproxen|mesh-list
110667479|NCT00449787|Sumatriptan|sumatriptan|mesh-list
110667480|NCT00449787|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110667481|NCT00449787|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110667482|NCT00449787|Analgesics|analgesics|mesh-ancestor
110667483|NCT00449787|Sensory System Agents|sensory system agents|mesh-ancestor
110667484|NCT00449787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110667485|NCT00449787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110667486|NCT00449787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110667487|NCT00449787|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110667488|NCT00449787|Gout Suppressants|gout suppressants|mesh-ancestor
110667489|NCT00449787|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110667490|NCT00449787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110667491|NCT00449787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110667492|NCT00449787|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110023333|NCT00003624|Protective Agents|protective agents|mesh-ancestor
110667493|NCT00449787|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110667494|NCT00449787|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110667495|NCT00449787|Serotonin Agents|serotonin agents|mesh-ancestor
110667496|NCT00449787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110667497|NCT01566201|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
110667498|NCT01566201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110667499|NCT01566279|Everolimus|everolimus|mesh-list
110667500|NCT01566279|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110667501|NCT01566279|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110667502|NCT01566279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110667503|NCT01566279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110667505|NCT01566279|Immunologic Factors|immunologic factors|mesh-ancestor
110667506|NCT01566279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110667507|NCT01566279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110667508|NCT00449163|Leucovorin|leucovorin|mesh-list
110667509|NCT00449163|Bevacizumab|bevacizumab|mesh-list
110667510|NCT00449163|Irinotecan|irinotecan|mesh-list
110667511|NCT00449163|Floxuridine|floxuridine|mesh-list
110667512|NCT00449163|Levoleucovorin|levoleucovorin|mesh-list
110667513|NCT00449163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110667514|NCT00449163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110667515|NCT00449163|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110667516|NCT00449163|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110667517|NCT00449163|Growth Substances|growth substances|mesh-ancestor
110667518|NCT00449163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110667519|NCT00449163|Growth Inhibitors|growth inhibitors|mesh-ancestor
110667520|NCT00449163|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110667521|NCT00449163|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110667522|NCT00449163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110667523|NCT00449163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110667524|NCT00449163|Antidotes|antidotes|mesh-ancestor
110667525|NCT00449163|Protective Agents|protective agents|mesh-ancestor
110667526|NCT00449163|Vitamin B Complex|vitamin b complex|mesh-ancestor
110667527|NCT00449163|Vitamins|vitamins|mesh-ancestor
110667528|NCT00449163|Micronutrients|micronutrients|mesh-ancestor
110667529|NCT00449163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110667530|NCT00449163|Antimetabolites|antimetabolites|mesh-ancestor
110667531|NCT01026987|Plerixafor|plerixafor|mesh-list
110667532|NCT01026987|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110667533|NCT01026987|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110667534|NCT01026987|Antiviral Agents|antiviral agents|mesh-ancestor
110667535|NCT01026987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110667536|NCT00448539|Rufinamide|rufinamide|mesh-list
110667537|NCT00448539|Anticonvulsants|anticonvulsants|mesh-ancestor
110667538|NCT00448539|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110667539|NCT00448539|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110667540|NCT00448539|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110667541|NCT00448539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110667542|NCT00457665|Efavirenz|efavirenz|mesh-list
110667543|NCT00457665|Nelfinavir|nelfinavir|mesh-list
110667544|NCT00457665|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110667545|NCT00457665|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110667546|NCT00457665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110667547|NCT00457665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110667548|NCT00457665|Antiviral Agents|antiviral agents|mesh-ancestor
110667549|NCT00457665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110667550|NCT00457665|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110667551|NCT00457665|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110667552|NCT00457665|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110667553|NCT00457665|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110667554|NCT00457665|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110667555|NCT00457665|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110667556|NCT00457665|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110667557|NCT00457665|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110667558|NCT00457665|Protease Inhibitors|protease inhibitors|mesh-ancestor
110667559|NCT00457665|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110667560|NCT00457665|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110667561|NCT00447603|Losartan|losartan|mesh-list
110667562|NCT00447603|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110667563|NCT00447603|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110667564|NCT00447603|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110667565|NCT00447603|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110667566|NCT00447603|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110667567|NCT00447603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110667568|NCT00447603|Diuretics|diuretics|mesh-ancestor
110667569|NCT00447603|Natriuretic Agents|natriuretic agents|mesh-ancestor
110667570|NCT00447603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110667571|NCT00447603|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110667572|NCT00447603|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110667573|NCT00447057|Pemetrexed|pemetrexed|mesh-list
110667574|NCT00447057|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110667575|NCT00447057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110667576|NCT00447057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110667577|NCT00447057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110667578|NCT00447057|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110667579|NCT00447057|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110667580|NCT00447057|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110667581|NCT01027611|Lidocaine|lidocaine|mesh-list
110667582|NCT01027611|Proxymetacaine|proxymetacaine|mesh-list
110667583|NCT01027611|Propoxycaine|propoxycaine|mesh-list
110667584|NCT01027611|Anesthetics, Local|anesthetics, local|mesh-ancestor
110667585|NCT01027611|Anesthetics|anesthetics|mesh-ancestor
110667586|NCT01027611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110667587|NCT01027611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110667588|NCT01027611|Sensory System Agents|sensory system agents|mesh-ancestor
110667589|NCT01027611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110667590|NCT01027611|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110667591|NCT01027611|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110667592|NCT01027611|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110667593|NCT01027611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110667594|NCT01027611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110667595|NCT01024413|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110667596|NCT01024413|Gefitinib|gefitinib|mesh-list
110667597|NCT01024413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110667598|NCT01024413|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110667599|NCT01024413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110667600|NCT01024413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110667601|NCT00446511|Valsartan|valsartan|mesh-list
110667602|NCT00446511|Enalapril|enalapril|mesh-list
110667603|NCT00446511|Enalaprilat|enalaprilat|mesh-list
110667604|NCT00446511|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110667605|NCT00446511|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110667606|NCT00446511|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110667607|NCT00446511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110667608|NCT00446511|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110667609|NCT00446511|Protease Inhibitors|protease inhibitors|mesh-ancestor
110667610|NCT00446511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110667611|NCT01024491|Paroxetine|paroxetine|mesh-list
110667612|NCT01024491|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110667613|NCT01024491|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110667614|NCT01024491|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110667615|NCT01024491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110667616|NCT01024491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110667617|NCT01024491|Serotonin Agents|serotonin agents|mesh-ancestor
110667618|NCT01024491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110667619|NCT01024491|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110667620|NCT01024491|Antidepressive Agents|antidepressive agents|mesh-ancestor
110667621|NCT01024491|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110667622|NCT01024491|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110667623|NCT01024491|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110667624|NCT01024491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110667625|NCT00446199|Drospirenone|drospirenone|mesh-list
110667626|NCT00446199|Estradiol|estradiol|mesh-list
110667627|NCT00446199|Estrogens|estrogens|mesh-ancestor
110667628|NCT00446199|Hormones|hormones|mesh-ancestor
110667629|NCT00446199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110667630|NCT00446199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110667631|NCT00446199|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110667632|NCT00446199|Hormone Antagonists|hormone antagonists|mesh-ancestor
110667633|NCT00446199|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110667634|NCT00446199|Diuretics|diuretics|mesh-ancestor
110667635|NCT00446199|Natriuretic Agents|natriuretic agents|mesh-ancestor
110667636|NCT01027689|Alprazolam|alprazolam|mesh-list
110667637|NCT01027689|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110667638|NCT01027689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110667639|NCT01027689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110667640|NCT01027689|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110667641|NCT01027689|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110667642|NCT01027689|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110667643|NCT01027689|GABA Modulators|gaba modulators|mesh-ancestor
110667644|NCT01027689|GABA Agents|gaba agents|mesh-ancestor
110667645|NCT01027689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110667646|NCT01027689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110667647|NCT01024647|Certolizumab Pegol|certolizumab pegol|mesh-list
110667648|NCT01024647|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110667649|NCT01024647|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110667651|NCT01024647|Immunologic Factors|immunologic factors|mesh-ancestor
110667652|NCT01024647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110667653|NCT01024647|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110667654|NCT01027923|Cytarabine|cytarabine|mesh-list
110667655|NCT01027923|Plerixafor|plerixafor|mesh-list
110667656|NCT01027923|Etoposide|etoposide|mesh-list
110667657|NCT01027923|Mitoxantrone|mitoxantrone|mesh-list
110667658|NCT01027923|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110667659|NCT01027923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110667660|NCT01027923|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110667661|NCT01027923|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110667662|NCT01027923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110667663|NCT01027923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110667664|NCT01027923|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110667665|NCT01027923|Antimetabolites|antimetabolites|mesh-ancestor
110667666|NCT01027923|Antiviral Agents|antiviral agents|mesh-ancestor
110667667|NCT01027923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110667668|NCT01027923|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110667669|NCT01027923|Immunologic Factors|immunologic factors|mesh-ancestor
110667670|NCT01027923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110667671|NCT01027923|Analgesics|analgesics|mesh-ancestor
110667672|NCT01027923|Sensory System Agents|sensory system agents|mesh-ancestor
110667673|NCT01027923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110667674|NCT01027923|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110667675|NCT01027923|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110667676|NCT01565733|Insulin Aspart|insulin aspart|mesh-list
110667677|NCT01565733|Biphasic Insulins|biphasic insulins|mesh-list
110667678|NCT01565733|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
110667679|NCT01565733|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110667680|NCT01565733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110667681|NCT01027065|Tenofovir|tenofovir|mesh-list
110667682|NCT01027065|Entecavir|entecavir|mesh-list
110667683|NCT01027065|Antiviral Agents|antiviral agents|mesh-ancestor
110667684|NCT01027065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110667685|NCT01027065|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110667686|NCT01027065|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110667687|NCT01027065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110667688|NCT01027065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110948228|NCT03036514|Narcotics|narcotics|mesh-ancestor
110667689|NCT01027065|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110667690|NCT01027065|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110667691|NCT00456495|Ranibizumab|ranibizumab|mesh-list
110667692|NCT00456495|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110667693|NCT00456495|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110667694|NCT00456495|Growth Substances|growth substances|mesh-ancestor
110667695|NCT00456495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110667696|NCT00456495|Growth Inhibitors|growth inhibitors|mesh-ancestor
110667697|NCT00456495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110667698|NCT00445341|Alvocidib|alvocidib|mesh-list
110667699|NCT00445341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110667700|NCT00445341|Growth Inhibitors|growth inhibitors|mesh-ancestor
110667701|NCT00445341|Growth Substances|growth substances|mesh-ancestor
110667702|NCT00445341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110667703|NCT00445341|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110667704|NCT00445341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110667705|NCT00445341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110667706|NCT03846453|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110667707|NCT03846453|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110667708|NCT00444951|Vaccines|vaccines|mesh-list
110667709|NCT00444951|Immunologic Factors|immunologic factors|mesh-ancestor
110667710|NCT00444951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110667711|NCT00444795|Sunitinib|sunitinib|mesh-list
110667712|NCT00444795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110667713|NCT00444795|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110667714|NCT00444795|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110667715|NCT00444795|Growth Substances|growth substances|mesh-ancestor
110667716|NCT00444795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110667717|NCT00444795|Growth Inhibitors|growth inhibitors|mesh-ancestor
110667718|NCT00444795|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110667719|NCT00444795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110687690|NCT00453180|Respiratory System Agents|respiratory system agents|mesh-ancestor
110667720|NCT00444795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110667721|NCT03846219|Calcium, Dietary|calcium, dietary|mesh-list
110667722|NCT03846219|Calcium|calcium|mesh-list
110667723|NCT03846219|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110667724|NCT03846219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110667725|NCT03846219|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110667726|NCT00455325|Chloroquine|chloroquine|mesh-list
110667727|NCT00455325|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
110667728|NCT00455325|Amebicides|amebicides|mesh-ancestor
110667729|NCT00455325|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110667730|NCT00455325|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110667731|NCT00455325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110667732|NCT00455325|Antimalarials|antimalarials|mesh-ancestor
110667733|NCT00455325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110667734|NCT00455325|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110667735|NCT00455325|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110667736|NCT00455325|Analgesics|analgesics|mesh-ancestor
110667737|NCT00455325|Sensory System Agents|sensory system agents|mesh-ancestor
110667738|NCT00455325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110667739|NCT00455325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110667740|NCT00455325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110667741|NCT00455325|Filaricides|filaricides|mesh-ancestor
110667742|NCT00455325|Antinematodal Agents|antinematodal agents|mesh-ancestor
110667743|NCT00455325|Anthelmintics|anthelmintics|mesh-ancestor
110667744|NCT01028079|Aspirin|aspirin|mesh-list
110667745|NCT01028079|Ibuprofen|ibuprofen|mesh-list
110667746|NCT01028079|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110667747|NCT01028079|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110667748|NCT01028079|Analgesics|analgesics|mesh-ancestor
110667749|NCT01028079|Sensory System Agents|sensory system agents|mesh-ancestor
110667750|NCT01028079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110667751|NCT01028079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110667752|NCT01028079|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110667753|NCT01028079|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110667754|NCT01028079|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110667755|NCT01028079|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110667756|NCT01028079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110667757|NCT01028079|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110667758|NCT01028079|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110667759|NCT01028079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110667760|NCT01028079|Antipyretics|antipyretics|mesh-ancestor
110667761|NCT00443781|Anesthetics|anesthetics|mesh-list
110667762|NCT00443781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110667763|NCT00443781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110667764|NCT00443703|Ritonavir|ritonavir|mesh-list
110667765|NCT00443703|Lopinavir|lopinavir|mesh-list
110667766|NCT00443703|Raltegravir Potassium|raltegravir potassium|mesh-list
110667767|NCT00443703|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110667768|NCT00443703|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110667769|NCT00443703|Protease Inhibitors|protease inhibitors|mesh-ancestor
110667770|NCT00443703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110667771|NCT00443703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110667772|NCT00443703|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110667773|NCT00443703|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110448468|NCT00627354|Prednisone|prednisone|mesh-list
110667774|NCT00443703|Antiviral Agents|antiviral agents|mesh-ancestor
110667775|NCT00443703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110667776|NCT00443703|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110667777|NCT00443703|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110667778|NCT00443703|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110667779|NCT00443703|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110667780|NCT00381706|Leucovorin|leucovorin|mesh-list
110667781|NCT00381706|Cisplatin|cisplatin|mesh-list
110667782|NCT00381706|Fluorouracil|fluorouracil|mesh-list
110667783|NCT00381706|Oxaliplatin|oxaliplatin|mesh-list
110667784|NCT00381706|Irinotecan|irinotecan|mesh-list
110667785|NCT00381706|Cetuximab|cetuximab|mesh-list
110667786|NCT00381706|Epirubicin|epirubicin|mesh-list
110667787|NCT00381706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110667788|NCT00381706|Antimetabolites|antimetabolites|mesh-ancestor
110667789|NCT00381706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110667790|NCT00381706|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110667791|NCT00381706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110667792|NCT00381706|Immunologic Factors|immunologic factors|mesh-ancestor
110687691|NCT00453180|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110667793|NCT00381706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110667794|NCT00381706|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110667795|NCT00381706|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110667796|NCT00381706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110667797|NCT00381706|Antidotes|antidotes|mesh-ancestor
110667798|NCT00381706|Protective Agents|protective agents|mesh-ancestor
110667799|NCT00381706|Vitamin B Complex|vitamin b complex|mesh-ancestor
110667800|NCT00381706|Vitamins|vitamins|mesh-ancestor
110667801|NCT00381706|Micronutrients|micronutrients|mesh-ancestor
110667802|NCT00381706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110667803|NCT00381706|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110667804|NCT00381706|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110667805|NCT01045642|Omeprazole|omeprazole|mesh-list
110667806|NCT01045642|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110667807|NCT01045642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110667808|NCT01045642|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110667809|NCT01045642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110667810|NCT01045642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110667811|NCT05357430|Propofol|propofol|mesh-list
110667812|NCT05357430|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110667813|NCT05357430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110667814|NCT05357430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110667815|NCT05357430|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110667816|NCT05357430|Anesthetics, General|anesthetics, general|mesh-ancestor
110667817|NCT05357430|Anesthetics|anesthetics|mesh-ancestor
110667818|NCT00370552|Paclitaxel|paclitaxel|mesh-list
110667819|NCT00370552|Epothilones|epothilones|mesh-list
110667820|NCT00370552|Bevacizumab|bevacizumab|mesh-list
110667821|NCT00370552|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110667822|NCT00370552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110667823|NCT00370552|Tubulin Modulators|tubulin modulators|mesh-ancestor
110667824|NCT00370552|Antimitotic Agents|antimitotic agents|mesh-ancestor
110667825|NCT00370552|Mitosis Modulators|mitosis modulators|mesh-ancestor
110667826|NCT00370552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110667827|NCT00370552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110667828|NCT00370552|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110667829|NCT00370552|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110667830|NCT00370552|Growth Substances|growth substances|mesh-ancestor
110667831|NCT00370552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110667832|NCT00370552|Growth Inhibitors|growth inhibitors|mesh-ancestor
110667833|NCT00537030|Asparaginase|asparaginase|mesh-list
110667834|NCT00537030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110667835|NCT00381238|Rosiglitazone|rosiglitazone|mesh-list
110667836|NCT00381238|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110667837|NCT00381238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110667838|NCT04928820|Edetic Acid|edetic acid|mesh-list
110667839|NCT04928820|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
110667840|NCT04928820|Chelating Agents|chelating agents|mesh-ancestor
110667841|NCT04928820|Sequestering Agents|sequestering agents|mesh-ancestor
110667842|NCT04928820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110667843|NCT04928820|Anticoagulants|anticoagulants|mesh-ancestor
110667844|NCT04928820|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110667845|NCT04928820|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110667846|NCT04429152|Tenofovir|tenofovir|mesh-list
110667847|NCT04429152|Lamivudine|lamivudine|mesh-list
110667848|NCT04429152|Antiviral Agents|antiviral agents|mesh-ancestor
110667849|NCT04429152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110667850|NCT04429152|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110667851|NCT04429152|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110667852|NCT04429152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110667853|NCT04429152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110667854|NCT04429152|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110667855|NCT04429152|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110667856|NCT04001400|Rabeprazole|rabeprazole|mesh-list
110667857|NCT04001400|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110667858|NCT04001400|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110667859|NCT04001400|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110667860|NCT04001400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110667861|NCT04001400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110667862|NCT00380692|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
110667863|NCT00380692|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110667864|NCT00380692|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110667865|NCT00380692|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110667866|NCT00380692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110667867|NCT00380692|Adrenergic Agents|adrenergic agents|mesh-ancestor
110667868|NCT00380692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111479167|NCT05594823|Diuretics|diuretics|mesh-list
110667869|NCT00380692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110667870|NCT04285866|Durvalumab|durvalumab|mesh-list
110667871|NCT04285866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110667872|NCT04285866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110667873|NCT01047982|Folic Acid|folic acid|mesh-list
110667874|NCT01047982|Inositol|inositol|mesh-list
110667875|NCT01047982|Hematinics|hematinics|mesh-ancestor
110315038|NCT00322062|Vitamins|vitamins|mesh-ancestor
110667876|NCT01047982|Vitamin B Complex|vitamin b complex|mesh-ancestor
110667877|NCT01047982|Vitamins|vitamins|mesh-ancestor
110667878|NCT01047982|Micronutrients|micronutrients|mesh-ancestor
110667879|NCT01047982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110667880|NCT00536874|Gemcitabine|gemcitabine|mesh-list
110667881|NCT00536874|Oxaliplatin|oxaliplatin|mesh-list
110667882|NCT00536874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110667883|NCT00536874|Antimetabolites|antimetabolites|mesh-ancestor
110667884|NCT00536874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110667885|NCT00536874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110667886|NCT00991848|Lidocaine|lidocaine|mesh-list
110667887|NCT00991848|Anesthetics, Local|anesthetics, local|mesh-ancestor
110667888|NCT00991848|Anesthetics|anesthetics|mesh-ancestor
110667889|NCT00991848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110667890|NCT00991848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110667891|NCT00991848|Sensory System Agents|sensory system agents|mesh-ancestor
110667892|NCT00991848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110667893|NCT00991848|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110667894|NCT00991848|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110667895|NCT00991848|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110667896|NCT00991848|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110667897|NCT00991848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110667898|NCT05281068|Danazol|danazol|mesh-list
110667899|NCT05281068|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110667900|NCT05281068|Hormone Antagonists|hormone antagonists|mesh-ancestor
110667901|NCT05281068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110667902|NCT05281068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110667903|NCT00380068|Ambrisentan|ambrisentan|mesh-list
110667904|NCT00380068|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110667905|NCT00991926|Orlistat|orlistat|mesh-list
110667906|NCT00991926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110667907|NCT00991926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110667908|NCT00991926|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110667909|NCT00991926|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110667910|NCT04230954|Pembrolizumab|pembrolizumab|mesh-list
110667911|NCT04230954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110667912|NCT04230954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110667913|NCT04230954|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110667914|NCT04230954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110667915|NCT00536484|Fesoterodine|fesoterodine|mesh-list
110667916|NCT00536484|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110667917|NCT00536484|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110667918|NCT00536484|Cholinergic Agents|cholinergic agents|mesh-ancestor
110667919|NCT00536484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110667920|NCT00536484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110667921|NCT00536484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110667922|NCT00536484|Urological Agents|urological agents|mesh-ancestor
110667923|NCT00370396|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110667924|NCT00370396|Immunologic Factors|immunologic factors|mesh-ancestor
110667925|NCT00370396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110667926|NCT00992004|Turmeric extract|turmeric extract|mesh-list
110667927|NCT00992004|Antioxidants|antioxidants|mesh-ancestor
110667928|NCT00992004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110667929|NCT00992004|Protective Agents|protective agents|mesh-ancestor
110667930|NCT00992004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110667931|NCT03862716|Insulin|insulin|mesh-list
110667932|NCT03862716|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110667933|NCT03862716|Metformin|metformin|mesh-list
110667934|NCT03862716|Liraglutide|liraglutide|mesh-list
110667935|NCT03862716|Insulin, Long-Acting|insulin, long-acting|mesh-list
110667936|NCT03862716|Xultophy|xultophy|mesh-list
110667937|NCT03862716|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110667938|NCT03862716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110667939|NCT03862716|Incretins|incretins|mesh-ancestor
110667940|NCT03862716|Hormones|hormones|mesh-ancestor
110667941|NCT03862716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110667942|NCT00992082|Ketorolac|ketorolac|mesh-list
110667943|NCT00992082|Epinephrine|epinephrine|mesh-list
110667944|NCT00992082|Morphine|morphine|mesh-list
110667945|NCT00992082|Ropivacaine|ropivacaine|mesh-list
110667946|NCT00992082|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110667947|NCT00992082|Narcotics|narcotics|mesh-ancestor
110667948|NCT00992082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110667949|NCT00992082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110667950|NCT00992082|Analgesics|analgesics|mesh-ancestor
110667951|NCT00992082|Sensory System Agents|sensory system agents|mesh-ancestor
110667952|NCT00992082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110667953|NCT00992082|Anesthetics, Local|anesthetics, local|mesh-ancestor
110667954|NCT00992082|Anesthetics|anesthetics|mesh-ancestor
110667955|NCT00992082|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110667956|NCT00992082|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110667957|NCT00992082|Adrenergic Agents|adrenergic agents|mesh-ancestor
110667958|NCT00992082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110667959|NCT00992082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110667960|NCT00992082|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110667961|NCT00992082|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110667962|NCT00992082|Autonomic Agents|autonomic agents|mesh-ancestor
110667963|NCT00992082|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110667964|NCT00992082|Respiratory System Agents|respiratory system agents|mesh-ancestor
110667965|NCT00992082|Mydriatics|mydriatics|mesh-ancestor
110667966|NCT00992082|Sympathomimetics|sympathomimetics|mesh-ancestor
110667967|NCT00992082|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110667968|NCT00992082|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110667969|NCT00992082|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110667970|NCT00992082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110667971|NCT00992082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110667972|NCT00992082|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110667973|NCT00992082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110667974|NCT00455013|Mycophenolic Acid|mycophenolic acid|mesh-list
110667975|NCT00455013|Sirolimus|sirolimus|mesh-list
110667976|NCT00455013|Abatacept|abatacept|mesh-list
110667977|NCT00455013|Tacrolimus|tacrolimus|mesh-list
110667978|NCT00455013|Thymoglobulin|thymoglobulin|mesh-list
110667979|NCT00455013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110667980|NCT00455013|Immunologic Factors|immunologic factors|mesh-ancestor
110667981|NCT00455013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110667982|NCT00455013|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110667983|NCT00455013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110667984|NCT00455013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110667985|NCT00455013|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110667986|NCT00455013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110667987|NCT00455013|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110667988|NCT00455013|Antitubercular Agents|antitubercular agents|mesh-ancestor
110667989|NCT00455013|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110667990|NCT00455013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110667991|NCT00455013|Antifungal Agents|antifungal agents|mesh-ancestor
110667992|NCT00455013|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110667993|NCT00455013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110667994|NCT00455013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110667995|NCT00363298|Caffeine|caffeine|mesh-list
110667996|NCT00363298|Amphetamine|amphetamine|mesh-list
110667997|NCT00363298|Dextroamphetamine|dextroamphetamine|mesh-list
110667998|NCT00363298|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110667999|NCT00363298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110668000|NCT00363298|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110668001|NCT00363298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110668002|NCT00363298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110668003|NCT00363298|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110668004|NCT00363298|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110668005|NCT00363298|Purinergic Agents|purinergic agents|mesh-ancestor
110668006|NCT00363298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110668007|NCT00363298|Sympathomimetics|sympathomimetics|mesh-ancestor
110668008|NCT00363298|Autonomic Agents|autonomic agents|mesh-ancestor
110668009|NCT00363298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110668010|NCT00363298|Dopamine Agents|dopamine agents|mesh-ancestor
110668011|NCT00363298|Adrenergic Agents|adrenergic agents|mesh-ancestor
110668012|NCT00363298|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110668013|NCT00363298|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110668014|NCT00363298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110668015|NCT00363298|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110668016|NCT05254548|Flurbiprofen|flurbiprofen|mesh-list
110668017|NCT05254548|Midazolam|midazolam|mesh-list
110668018|NCT05254548|Omeprazole|omeprazole|mesh-list
110668019|NCT05254548|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110668020|NCT05254548|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110668021|NCT05254548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110668022|NCT05254548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110668023|NCT05254548|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110668024|NCT05254548|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110668025|NCT05254548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110668026|NCT05254548|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110668027|NCT05254548|Anesthetics, General|anesthetics, general|mesh-ancestor
110668028|NCT05254548|Anesthetics|anesthetics|mesh-ancestor
110668029|NCT05254548|GABA Modulators|gaba modulators|mesh-ancestor
110668030|NCT05254548|GABA Agents|gaba agents|mesh-ancestor
110668031|NCT05254548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110668032|NCT05254548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110668033|NCT05254548|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110668034|NCT05254548|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110668035|NCT05254548|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110668036|NCT05254548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110668037|NCT05254548|Analgesics|analgesics|mesh-ancestor
110668038|NCT05254548|Sensory System Agents|sensory system agents|mesh-ancestor
110668039|NCT05254548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110668040|NCT05254548|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110668041|NCT05254548|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110668042|NCT05254548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110668043|NCT05254548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110668044|NCT05254548|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110668045|NCT00363142|Ritonavir|ritonavir|mesh-list
110668046|NCT00363142|Fosamprenavir|fosamprenavir|mesh-list
110668047|NCT00363142|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110668048|NCT00363142|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110668049|NCT00363142|Protease Inhibitors|protease inhibitors|mesh-ancestor
110668050|NCT00363142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110668051|NCT00363142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110668052|NCT00363142|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110668053|NCT00363142|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110668054|NCT00363142|Antiviral Agents|antiviral agents|mesh-ancestor
110668055|NCT00363142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110668056|NCT00363142|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110668057|NCT00363142|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110668058|NCT05246982|Capecitabine|capecitabine|mesh-list
110668059|NCT05246982|Oxaliplatin|oxaliplatin|mesh-list
110668060|NCT05246982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110668061|NCT05246982|Antimetabolites|antimetabolites|mesh-ancestor
110668062|NCT05246982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110668063|NCT05246982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110668064|NCT04002024|Salicylic Acid|salicylic acid|mesh-list
110668065|NCT04002024|Salicylates|salicylates|mesh-list
110668066|NCT04002024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110678992|NCT06040034|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110668067|NCT04002024|Antifungal Agents|antifungal agents|mesh-ancestor
110668068|NCT04002024|Keratolytic Agents|keratolytic agents|mesh-ancestor
110668069|NCT04002024|Dermatologic Agents|dermatologic agents|mesh-ancestor
110668070|NCT04002024|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110668071|NCT04002024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110668072|NCT04002024|Analgesics|analgesics|mesh-ancestor
110668073|NCT04002024|Sensory System Agents|sensory system agents|mesh-ancestor
110668074|NCT04002024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110668075|NCT04002024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110668076|NCT04002024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110668077|NCT04002024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110668078|NCT04002024|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110668079|NCT04002024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110668080|NCT04002024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110668081|NCT01028313|Methylprednisolone|methylprednisolone|mesh-list
110668082|NCT01028313|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110668083|NCT01028313|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110668084|NCT01028313|Prednisolone|prednisolone|mesh-list
110668085|NCT01028313|Prednisolone acetate|prednisolone acetate|mesh-list
110668086|NCT01028313|Panobinostat|panobinostat|mesh-list
110668087|NCT01028313|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110668088|NCT01028313|Prednisolone phosphate|prednisolone phosphate|mesh-list
110668089|NCT01028313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110668090|NCT01028313|Antiemetics|antiemetics|mesh-ancestor
110668091|NCT01028313|Autonomic Agents|autonomic agents|mesh-ancestor
110668092|NCT01028313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110668093|NCT01028313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110668094|NCT01028313|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110668095|NCT01028313|Glucocorticoids|glucocorticoids|mesh-ancestor
110668096|NCT01028313|Hormones|hormones|mesh-ancestor
110668097|NCT01028313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110668098|NCT01028313|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110668099|NCT01028313|Protective Agents|protective agents|mesh-ancestor
110668100|NCT01028313|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110668101|NCT01028313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110668102|NCT01028313|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110668103|NCT01028313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110668104|NCT01028313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110668106|NCT04001712|Caffeine citrate|caffeine citrate|mesh-list
110668107|NCT04001712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110668108|NCT04001712|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110668109|NCT04001712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110668110|NCT04001712|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110668111|NCT04001712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110668112|NCT04001712|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110668113|NCT04001712|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110668114|NCT04001712|Purinergic Agents|purinergic agents|mesh-ancestor
110668115|NCT04001712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110668116|NCT01027377|Factor VIII|factor viii|mesh-list
110668117|NCT01027377|Coagulants|coagulants|mesh-ancestor
110668118|NCT00992160|Vestipitant|vestipitant|mesh-list
110668119|NCT00992160|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110668120|NCT00992160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110668121|NCT00992160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110668122|NCT00992160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110668123|NCT00379912|Azacitidine|azacitidine|mesh-list
110668124|NCT00379912|Epoetin Alfa|epoetin alfa|mesh-list
110668125|NCT00379912|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110668126|NCT00379912|Antimetabolites|antimetabolites|mesh-ancestor
110668127|NCT00379912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110668128|NCT00379912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110668129|NCT00379912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110668130|NCT00379912|Hematinics|hematinics|mesh-ancestor
110668131|NCT00379834|Timolol|timolol|mesh-list
110668132|NCT00379834|Dorzolamide|dorzolamide|mesh-list
110668133|NCT00379834|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110668134|NCT00379834|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110668135|NCT00379834|Adrenergic Agents|adrenergic agents|mesh-ancestor
110668136|NCT00379834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110668137|NCT00379834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110668138|NCT00379834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110948229|NCT03036514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110668139|NCT00379834|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110668140|NCT00379834|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110668141|NCT00379834|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110668142|NCT00379834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110668143|NCT02292706|Sofosbuvir|sofosbuvir|mesh-list
110668144|NCT02292706|Antiviral Agents|antiviral agents|mesh-ancestor
110668145|NCT02292706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110668146|NCT00992472|Prochlorperazine|prochlorperazine|mesh-list
110668147|NCT00992472|Antiemetics|antiemetics|mesh-ancestor
110668148|NCT00992472|Autonomic Agents|autonomic agents|mesh-ancestor
110668149|NCT00992472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110668150|NCT00992472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110668151|NCT00992472|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110668152|NCT00992472|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110668153|NCT00992472|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110668154|NCT00992472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110668155|NCT00992472|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110668156|NCT00992472|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110668157|NCT00992472|Dopamine Agents|dopamine agents|mesh-ancestor
110668158|NCT00992472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110668159|NCT00992472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110668160|NCT03453840|Lumefantrine|lumefantrine|mesh-list
110668161|NCT03453840|Artemether|artemether|mesh-list
110668162|NCT03453840|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
110668163|NCT03453840|Antimalarials|antimalarials|mesh-ancestor
110668164|NCT03453840|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110668165|NCT03453840|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110668166|NCT03453840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110668167|NCT03439254|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
110668168|NCT03439254|Cathartics|cathartics|mesh-ancestor
110668169|NCT03439254|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110668170|NCT05354700|Carboplatin|carboplatin|mesh-list
110668171|NCT05354700|Etoposide|etoposide|mesh-list
110668172|NCT05354700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110668173|NCT05354700|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110668174|NCT05354700|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110687692|NCT00453180|Antioxidants|antioxidants|mesh-ancestor
110668175|NCT05354700|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110668176|NCT05354700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110668177|NCT05354700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110668179|NCT03339258|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110668180|NCT03339258|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110315328|NCT00337545|Everolimus|everolimus|mesh-list
110668181|NCT03339258|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110668182|NCT03339258|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110668183|NCT03339258|Adrenergic Agents|adrenergic agents|mesh-ancestor
110668184|NCT03339258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110668185|NCT03339258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110668186|NCT03339258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110668187|NCT00992706|Doxorubicin|doxorubicin|mesh-list
110668188|NCT00992706|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110668189|NCT00992706|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110668190|NCT00992706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110668191|NCT00992706|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110668192|NCT00992706|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110668193|NCT00992706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110668194|NCT00992706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110668195|NCT00454779|Cisplatin|cisplatin|mesh-list
110668196|NCT00454779|Docetaxel|docetaxel|mesh-list
110668197|NCT00454779|Panitumumab|panitumumab|mesh-list
110668198|NCT00454779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110668199|NCT00454779|Tubulin Modulators|tubulin modulators|mesh-ancestor
110668200|NCT00454779|Antimitotic Agents|antimitotic agents|mesh-ancestor
110668201|NCT00454779|Mitosis Modulators|mitosis modulators|mesh-ancestor
110668202|NCT00454779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110668203|NCT00454779|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110668204|NCT00992862|Moexipril|moexipril|mesh-list
110668205|NCT00992862|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110668206|NCT00992862|Protease Inhibitors|protease inhibitors|mesh-ancestor
110668207|NCT00992862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110668208|NCT00992862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110668209|NCT00992862|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110668210|NCT00993096|Insulin|insulin|mesh-list
110668211|NCT00993096|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110668212|NCT00993096|Insulin Aspart|insulin aspart|mesh-list
110668213|NCT00993096|Insulin, Long-Acting|insulin, long-acting|mesh-list
110668214|NCT00993096|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
110668215|NCT00993096|Biphasic Insulins|biphasic insulins|mesh-list
110668216|NCT00993096|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
110668217|NCT00993096|Insulin, Isophane|insulin, isophane|mesh-list
110668218|NCT00993096|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110668219|NCT00993096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110668220|NCT00439569|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
110668221|NCT00439569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110668222|NCT03994107|Paclitaxel|paclitaxel|mesh-list
110668223|NCT03994107|Doxorubicin|doxorubicin|mesh-list
110668224|NCT03994107|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110668225|NCT03994107|Trastuzumab|trastuzumab|mesh-list
110668226|NCT03994107|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110668227|NCT03994107|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110668228|NCT03994107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110668229|NCT03994107|Tubulin Modulators|tubulin modulators|mesh-ancestor
110668230|NCT03994107|Antimitotic Agents|antimitotic agents|mesh-ancestor
110668231|NCT03994107|Mitosis Modulators|mitosis modulators|mesh-ancestor
110668232|NCT03994107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110668233|NCT03994107|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110668234|NCT03994107|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110668235|NCT03994107|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110668236|NCT03994107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110668237|NCT03994107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110668238|NCT03469713|Nivolumab|nivolumab|mesh-list
110668239|NCT03469713|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110668240|NCT03469713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110668241|NCT03469713|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110668242|NCT03469713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110668243|NCT00427635|Esomeprazole|esomeprazole|mesh-list
110668244|NCT00427635|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110668245|NCT00427635|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110668246|NCT00427635|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110668247|NCT00427635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110668248|NCT00427635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110668249|NCT00993642|Panobinostat|panobinostat|mesh-list
110668250|NCT00993642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110668251|NCT00993642|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110668252|NCT00993642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110668253|NCT00993642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110668254|NCT01028547|Dexamethasone|dexamethasone|mesh-list
110668256|NCT01028547|Antiemetics|antiemetics|mesh-ancestor
110668257|NCT01028547|Autonomic Agents|autonomic agents|mesh-ancestor
110668258|NCT01028547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110668259|NCT01028547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110668260|NCT01028547|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110668261|NCT01028547|Glucocorticoids|glucocorticoids|mesh-ancestor
110668262|NCT01028547|Hormones|hormones|mesh-ancestor
110668263|NCT01028547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110668264|NCT01028547|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110668265|NCT01028547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110668266|NCT01031355|Calcium, Dietary|calcium, dietary|mesh-list
110668267|NCT01031355|Tetrahydrofolates|tetrahydrofolates|mesh-list
110668268|NCT01031355|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110668269|NCT01031355|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110668270|NCT01031355|Calcium|calcium|mesh-list
110668271|NCT01031355|Estradiol|estradiol|mesh-list
110668272|NCT01031355|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110668273|NCT01031355|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110668274|NCT01031355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110668275|NCT01031355|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110668276|NCT01031355|Estrogens|estrogens|mesh-ancestor
110668277|NCT01031355|Hormones|hormones|mesh-ancestor
110668278|NCT01031355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110668279|NCT01031355|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110668280|NCT01031355|Contraceptive Agents|contraceptive agents|mesh-ancestor
110668281|NCT01031355|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110668282|NCT01031355|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110668283|NCT01031355|Vitamin B Complex|vitamin b complex|mesh-ancestor
110668284|NCT01031355|Vitamins|vitamins|mesh-ancestor
110668285|NCT01031355|Micronutrients|micronutrients|mesh-ancestor
110668286|NCT00993720|Liraglutide|liraglutide|mesh-list
110668287|NCT00993720|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110668288|NCT00993720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110668289|NCT00993720|Incretins|incretins|mesh-ancestor
110668290|NCT00993720|Hormones|hormones|mesh-ancestor
110668291|NCT00993720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110668292|NCT03891264|Cannabidiol|cannabidiol|mesh-list
110668293|NCT03891264|Anticonvulsants|anticonvulsants|mesh-ancestor
110668294|NCT00425607|Lonafarnib|lonafarnib|mesh-list
110668295|NCT00425607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110668296|NCT00425607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110668297|NCT00437073|Capecitabine|capecitabine|mesh-list
110668298|NCT00437073|Topotecan|topotecan|mesh-list
110668299|NCT00437073|Lapatinib|lapatinib|mesh-list
110668300|NCT00437073|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110668301|NCT00437073|Antimetabolites|antimetabolites|mesh-ancestor
110668302|NCT00437073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110668303|NCT00437073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110668304|NCT00437073|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110668305|NCT00437073|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110668306|NCT00437073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110668307|NCT00437073|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110668308|NCT00425373|Amlodipine|amlodipine|mesh-list
110668309|NCT00425373|Valsartan|valsartan|mesh-list
110668310|NCT00425373|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110668311|NCT00425373|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110668312|NCT00425373|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110668313|NCT00425373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110668314|NCT00425373|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110668315|NCT00425373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110668316|NCT00425373|Vasodilator Agents|vasodilator agents|mesh-ancestor
110668317|NCT00425373|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110668318|NCT00425373|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110668319|NCT01031589|Rilpivirine|rilpivirine|mesh-list
110668320|NCT01031589|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110668321|NCT01031589|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110668322|NCT01031589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110668323|NCT01031589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110668324|NCT01031589|Antiviral Agents|antiviral agents|mesh-ancestor
110668325|NCT01031589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110668326|NCT01031589|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110668327|NCT01031589|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110668328|NCT03894540|Paclitaxel|paclitaxel|mesh-list
110668329|NCT03894540|Pembrolizumab|pembrolizumab|mesh-list
110668330|NCT03894540|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110668331|NCT03894540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110668332|NCT03894540|Tubulin Modulators|tubulin modulators|mesh-ancestor
110668333|NCT03894540|Antimitotic Agents|antimitotic agents|mesh-ancestor
110668334|NCT03894540|Mitosis Modulators|mitosis modulators|mesh-ancestor
110668335|NCT03894540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110668336|NCT03894540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110668337|NCT03894540|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110668338|NCT00993876|Citalopram|citalopram|mesh-list
110668339|NCT00993876|Reboxetine|reboxetine|mesh-list
110668340|NCT00993876|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110668341|NCT00993876|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110668342|NCT00993876|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110668343|NCT00993876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110668344|NCT00993876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110668345|NCT00993876|Serotonin Agents|serotonin agents|mesh-ancestor
110668346|NCT00993876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110668347|NCT00993876|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110668348|NCT00993876|Antidepressive Agents|antidepressive agents|mesh-ancestor
110668349|NCT00993876|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110668350|NCT00993876|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110668351|NCT00993876|Adrenergic Agents|adrenergic agents|mesh-ancestor
110668352|NCT01646814|Aspirin|aspirin|mesh-list
110668353|NCT01646814|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110668354|NCT01646814|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110668355|NCT01646814|Analgesics|analgesics|mesh-ancestor
110668356|NCT01646814|Sensory System Agents|sensory system agents|mesh-ancestor
110668357|NCT01646814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110668358|NCT01646814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110668359|NCT01646814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110668360|NCT01646814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110668361|NCT01646814|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110668362|NCT01646814|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110668363|NCT01646814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110679287|NCT05628883|Sensory System Agents|sensory system agents|mesh-ancestor
110668364|NCT01646814|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110668365|NCT01646814|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110668366|NCT01646814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110668367|NCT01646814|Antipyretics|antipyretics|mesh-ancestor
110668368|NCT00994344|Ritonavir|ritonavir|mesh-list
110668369|NCT00994344|Lopinavir|lopinavir|mesh-list
110668370|NCT00994344|Darunavir|darunavir|mesh-list
110668371|NCT00994344|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110668372|NCT00994344|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110668373|NCT00994344|Protease Inhibitors|protease inhibitors|mesh-ancestor
110668374|NCT00994344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110668375|NCT00994344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110668376|NCT00994344|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110668377|NCT00994344|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110668378|NCT00994344|Antiviral Agents|antiviral agents|mesh-ancestor
110668379|NCT00994344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110668380|NCT00994344|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110668381|NCT00994344|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110668382|NCT00994500|Bortezomib|bortezomib|mesh-list
110668383|NCT00994500|Vorinostat|vorinostat|mesh-list
110668384|NCT00994500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110668385|NCT00994500|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110668386|NCT00994500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110668387|NCT00994500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110668388|NCT01416636|Treprostinil|treprostinil|mesh-list
110668389|NCT01416636|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110668390|NCT00999180|Botulinum Toxins|botulinum toxins|mesh-list
110668391|NCT00999180|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110668392|NCT00999180|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110668393|NCT00999180|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110668394|NCT00999180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110448520|NCT02733640|Histamine Antagonists|histamine antagonists|mesh-ancestor
110668395|NCT00999180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110668396|NCT00999180|Cholinergic Agents|cholinergic agents|mesh-ancestor
110668397|NCT00999180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110668398|NCT00999180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110668400|NCT00999180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110668401|NCT00999258|Sirolimus|sirolimus|mesh-list
110668402|NCT00999258|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110668403|NCT00999258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110668404|NCT00999258|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110668405|NCT00999258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110668406|NCT00999258|Antifungal Agents|antifungal agents|mesh-ancestor
110668407|NCT00999258|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110668408|NCT00999258|Immunologic Factors|immunologic factors|mesh-ancestor
110668409|NCT00999258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110668410|NCT00994734|Mifepristone|mifepristone|mesh-list
110668411|NCT00994734|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
110668412|NCT00994734|Abortifacient Agents|abortifacient agents|mesh-ancestor
110668413|NCT00994734|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110668414|NCT00994734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110668415|NCT00994734|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110668416|NCT00994734|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110668417|NCT00994734|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110668418|NCT00994734|Contraceptive Agents|contraceptive agents|mesh-ancestor
110668419|NCT00994734|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
110668420|NCT00994734|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
110668421|NCT00994734|Hormone Antagonists|hormone antagonists|mesh-ancestor
110668422|NCT00994734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110668423|NCT00994734|Luteolytic Agents|luteolytic agents|mesh-ancestor
110668424|NCT00994734|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110668425|NCT00994734|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
110668426|NCT00995826|Laninamivir|laninamivir|mesh-list
110668427|NCT00995826|Antiviral Agents|antiviral agents|mesh-ancestor
110668428|NCT00995826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110668429|NCT00994812|Metformin|metformin|mesh-list
110668430|NCT00994812|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110668431|NCT00994812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110668432|NCT00994968|Cyclophosphamide|cyclophosphamide|mesh-list
110668433|NCT00994968|Docetaxel|docetaxel|mesh-list
110668434|NCT00994968|Doxorubicin|doxorubicin|mesh-list
110668435|NCT00994968|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110668436|NCT00994968|Tegafur|tegafur|mesh-list
110668437|NCT00994968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110948230|NCT03036514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110668438|NCT00994968|Immunologic Factors|immunologic factors|mesh-ancestor
110668439|NCT00994968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110668440|NCT00994968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110668441|NCT00994968|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110668442|NCT00994968|Alkylating Agents|alkylating agents|mesh-ancestor
110668443|NCT00994968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110668444|NCT00994968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110668445|NCT00994968|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110668446|NCT00994968|Tubulin Modulators|tubulin modulators|mesh-ancestor
110668447|NCT00994968|Antimitotic Agents|antimitotic agents|mesh-ancestor
110668448|NCT00994968|Mitosis Modulators|mitosis modulators|mesh-ancestor
110668449|NCT00994968|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110668450|NCT00994968|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110668451|NCT00994968|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110668452|NCT00994968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110668453|NCT00994968|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110668454|NCT00994968|Antimetabolites|antimetabolites|mesh-ancestor
110668455|NCT03887442|Paclitaxel|paclitaxel|mesh-list
110668456|NCT03887442|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110668457|NCT03887442|Cetuximab|cetuximab|mesh-list
110668458|NCT03887442|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110668459|NCT03887442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110668460|NCT03887442|Tubulin Modulators|tubulin modulators|mesh-ancestor
110668461|NCT03887442|Antimitotic Agents|antimitotic agents|mesh-ancestor
110668462|NCT03887442|Mitosis Modulators|mitosis modulators|mesh-ancestor
110668463|NCT03887442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110448524|NCT02730676|Menthol|menthol|mesh-list
110668464|NCT03887442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110668465|NCT00996060|Hydralazine|hydralazine|mesh-list
110668466|NCT00996060|Valproic Acid|valproic acid|mesh-list
110668467|NCT00996060|Anticonvulsants|anticonvulsants|mesh-ancestor
110668468|NCT00996060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110668469|NCT00996060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110668471|NCT00996060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110668472|NCT00996060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110668473|NCT00996060|Antimanic Agents|antimanic agents|mesh-ancestor
110668474|NCT00996060|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110668475|NCT00996060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110668476|NCT00996060|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110668477|NCT00996060|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110668478|NCT00996060|Vasodilator Agents|vasodilator agents|mesh-ancestor
110668479|NCT00995046|Factor VIII|factor viii|mesh-list
110668480|NCT00995046|Coagulants|coagulants|mesh-ancestor
110668481|NCT00995124|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110668482|NCT04000932|Betamethasone dipropionate, betamethasone sodium phosphate drug combination|betamethasone dipropionate, betamethasone sodium phosphate drug combination|mesh-list
110668483|NCT04000932|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110668484|NCT04000932|Glucocorticoids|glucocorticoids|mesh-ancestor
110668485|NCT04000932|Hormones|hormones|mesh-ancestor
110668486|NCT04000932|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110668487|NCT04000932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110668488|NCT05170230|Terlipressin|terlipressin|mesh-list
110668489|NCT05170230|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110668490|NCT05170230|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110668491|NCT01000116|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
110668492|NCT01000116|Hemostatics|hemostatics|mesh-ancestor
110668493|NCT01000116|Coagulants|coagulants|mesh-ancestor
110668494|NCT00996684|Plasminogen|plasminogen|mesh-list
110668495|NCT00996684|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110668496|NCT00996684|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110668497|NCT00996684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110668498|NCT00996762|Lapatinib|lapatinib|mesh-list
110668499|NCT00996762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110668500|NCT00996762|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110668501|NCT00996762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110668502|NCT00996762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110668503|NCT05162196|Niraparib|niraparib|mesh-list
110668504|NCT05162196|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110668505|NCT05162196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110668506|NCT05162196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110668507|NCT05162196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110668508|NCT00997074|Ibuprofen|ibuprofen|mesh-list
110668509|NCT00997074|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
110668510|NCT00997074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
110668511|NCT00997074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110668512|NCT00997074|Analgesics|analgesics|mesh-ancestor
110948231|NCT03036514|Analgesics|analgesics|mesh-ancestor
110668513|NCT00997074|Sensory System Agents|sensory system agents|mesh-ancestor
110668514|NCT00997074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110668515|NCT00997074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110668516|NCT00997074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110668517|NCT00997074|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110668518|NCT00997074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110668519|NCT00997074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110668520|NCT05249712|Androgens|androgens|mesh-list
110668521|NCT05249712|Hormones|hormones|mesh-ancestor
110668522|NCT05249712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110668523|NCT05249712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110668524|NCT01000896|Paclitaxel|paclitaxel|mesh-list
110668525|NCT01000896|Carboplatin|carboplatin|mesh-list
110668526|NCT01000896|Saracatinib|saracatinib|mesh-list
110668527|NCT01000896|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110668528|NCT01000896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110668529|NCT01000896|Tubulin Modulators|tubulin modulators|mesh-ancestor
110668530|NCT01000896|Antimitotic Agents|antimitotic agents|mesh-ancestor
110668531|NCT01000896|Mitosis Modulators|mitosis modulators|mesh-ancestor
110668532|NCT01000896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110668533|NCT01000896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110668534|NCT00997542|Allopurinol|allopurinol|mesh-list
110668535|NCT00997542|Antimetabolites|antimetabolites|mesh-ancestor
110668536|NCT00997542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110668537|NCT00997542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110668538|NCT00997542|Gout Suppressants|gout suppressants|mesh-ancestor
110668539|NCT00997542|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110668540|NCT00997542|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110668541|NCT00997542|Antioxidants|antioxidants|mesh-ancestor
110668542|NCT00997542|Protective Agents|protective agents|mesh-ancestor
110668543|NCT00997542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110668544|NCT01001130|Fluticasone|fluticasone|mesh-list
110668545|NCT01001130|Xhance|xhance|mesh-list
110668546|NCT01001130|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110668547|NCT01001130|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110668548|NCT01001130|Autonomic Agents|autonomic agents|mesh-ancestor
110668549|NCT01001130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110668550|NCT01001130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110668551|NCT01001130|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110668552|NCT01001130|Respiratory System Agents|respiratory system agents|mesh-ancestor
110668553|NCT01001130|Dermatologic Agents|dermatologic agents|mesh-ancestor
110315714|NCT04715217|Cyclophosphamide|cyclophosphamide|mesh-list
110668554|NCT01001130|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110668556|NCT00424827|Fluorouracil|fluorouracil|mesh-list
110668557|NCT00424827|Cetuximab|cetuximab|mesh-list
110668558|NCT00424827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110668559|NCT00424827|Antimetabolites|antimetabolites|mesh-ancestor
110668560|NCT00424827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110668561|NCT00424827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110668562|NCT00424827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110668563|NCT00424827|Immunologic Factors|immunologic factors|mesh-ancestor
110668564|NCT00424827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110668565|NCT00424827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110668566|NCT01001364|Budesonide|budesonide|mesh-list
110668567|NCT01001364|Formoterol Fumarate|formoterol fumarate|mesh-list
110668568|NCT01001364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110668569|NCT01001364|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110668570|NCT01001364|Autonomic Agents|autonomic agents|mesh-ancestor
110668571|NCT01001364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110668572|NCT01001364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110668573|NCT01001364|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110668574|NCT01001364|Respiratory System Agents|respiratory system agents|mesh-ancestor
110668575|NCT01001364|Glucocorticoids|glucocorticoids|mesh-ancestor
110668576|NCT01001364|Hormones|hormones|mesh-ancestor
110668577|NCT01001364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110668578|NCT01001364|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110668579|NCT01001364|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110668580|NCT01001364|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110668581|NCT01001364|Adrenergic Agents|adrenergic agents|mesh-ancestor
110668582|NCT01001364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110668583|NCT01001364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110668584|NCT01031667|Cilostazol|cilostazol|mesh-list
110668585|NCT01031667|Probucol|probucol|mesh-list
110668586|NCT01031667|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110668587|NCT01031667|Autonomic Agents|autonomic agents|mesh-ancestor
110668588|NCT01031667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110668589|NCT01031667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110668590|NCT01031667|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110668591|NCT01031667|Respiratory System Agents|respiratory system agents|mesh-ancestor
110668592|NCT01031667|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110668593|NCT01031667|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110668594|NCT01031667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110668595|NCT01031667|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110668596|NCT01031667|Vasodilator Agents|vasodilator agents|mesh-ancestor
110668597|NCT01031667|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110668598|NCT01031667|Protective Agents|protective agents|mesh-ancestor
110668599|NCT01031667|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110668600|NCT01031667|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110668601|NCT01031667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110668602|NCT01031667|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110668603|NCT01031667|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110448538|NCT05433532|Venetoclax|venetoclax|mesh-list
110668604|NCT01031667|Antimetabolites|antimetabolites|mesh-ancestor
110668605|NCT01031667|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110668606|NCT01031667|Antioxidants|antioxidants|mesh-ancestor
110668607|NCT03995277|Biotin|biotin|mesh-list
110668608|NCT03995277|Vitamin B Complex|vitamin b complex|mesh-ancestor
110668609|NCT03995277|Vitamins|vitamins|mesh-ancestor
110668610|NCT03995277|Micronutrients|micronutrients|mesh-ancestor
110668611|NCT03995277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110668612|NCT04000386|Zinc Oxide|zinc oxide|mesh-list
110668613|NCT04000386|Dermatologic Agents|dermatologic agents|mesh-ancestor
110668614|NCT04000386|Sunscreening Agents|sunscreening agents|mesh-ancestor
110668615|NCT04000386|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110668616|NCT04000386|Protective Agents|protective agents|mesh-ancestor
110668617|NCT04000386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110668618|NCT00998088|Epoetin Alfa|epoetin alfa|mesh-list
110668619|NCT00998088|Hematinics|hematinics|mesh-ancestor
110668620|NCT00377962|Mycophenolic Acid|mycophenolic acid|mesh-list
110668621|NCT00377962|Everolimus|everolimus|mesh-list
110668622|NCT00377962|Azathioprine|azathioprine|mesh-list
110668623|NCT00377962|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
110668624|NCT00377962|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110668625|NCT00377962|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110668626|NCT00377962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110668627|NCT00377962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110315780|NCT00310583|Pregabalin|pregabalin|mesh-list
110668628|NCT00377962|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110668629|NCT00377962|Immunologic Factors|immunologic factors|mesh-ancestor
110668630|NCT00377962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110668631|NCT00377962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110668632|NCT00377962|Antimetabolites|antimetabolites|mesh-ancestor
110668633|NCT00377962|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110668634|NCT00377962|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110668635|NCT00377962|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110668636|NCT00377962|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110668637|NCT00377962|Antitubercular Agents|antitubercular agents|mesh-ancestor
110668638|NCT00377962|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110668639|NCT00377962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110668640|NCT00424749|Prednisone|prednisone|mesh-list
110668641|NCT00424749|Rituximab|rituximab|mesh-list
110668642|NCT00424749|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110668643|NCT00424749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110668644|NCT00424749|Immunologic Factors|immunologic factors|mesh-ancestor
110668645|NCT00424749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110668646|NCT00424749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110668647|NCT00424749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110668648|NCT00424749|Glucocorticoids|glucocorticoids|mesh-ancestor
110668649|NCT00424749|Hormones|hormones|mesh-ancestor
110668650|NCT00424749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110668651|NCT00424749|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110668652|NCT00424593|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110668653|NCT00424593|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110668654|NCT00424593|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110668655|NCT00424593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110668656|NCT00424593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110668657|NCT00424593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110668658|NCT00424593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110668659|NCT00424593|Analgesics|analgesics|mesh-ancestor
110668660|NCT00424593|Sensory System Agents|sensory system agents|mesh-ancestor
110668661|NCT00424593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110668662|NCT00424593|Antidepressive Agents|antidepressive agents|mesh-ancestor
110668663|NCT00424593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110668664|NCT00424593|Dopamine Agents|dopamine agents|mesh-ancestor
110668665|NCT00369382|Cyclosporine|cyclosporine|mesh-list
110668666|NCT00369382|Sirolimus|sirolimus|mesh-list
110668667|NCT00369382|Tacrolimus|tacrolimus|mesh-list
110668668|NCT00369382|Cyclosporins|cyclosporins|mesh-list
110668669|NCT00369382|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110668670|NCT00369382|Immunologic Factors|immunologic factors|mesh-ancestor
110668671|NCT00369382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110668672|NCT00369382|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110668673|NCT00369382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110668674|NCT00369382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110668675|NCT00369382|Antifungal Agents|antifungal agents|mesh-ancestor
110668676|NCT00369382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110668677|NCT00369382|Dermatologic Agents|dermatologic agents|mesh-ancestor
110668678|NCT00369382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110668679|NCT00369382|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110668680|NCT00369382|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110668681|NCT00369382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110668682|NCT00424515|Imatinib Mesylate|imatinib mesylate|mesh-list
110668683|NCT00424515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110668684|NCT00424515|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110668685|NCT00424515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110668686|NCT00424515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110668687|NCT00377260|Amoxicillin|amoxicillin|mesh-list
110668688|NCT00377260|Clavulanic Acid|clavulanic acid|mesh-list
110668689|NCT00377260|Clavulanic Acids|clavulanic acids|mesh-list
110668690|NCT00377260|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
110668691|NCT00377260|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110668692|NCT00377260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110668693|NCT00377260|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110668694|NCT00377260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110668695|NCT00377260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110668697|NCT00441441|Xhance|xhance|mesh-list
110668698|NCT00441441|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110668699|NCT00441441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110668700|NCT00441441|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110668701|NCT00441441|Autonomic Agents|autonomic agents|mesh-ancestor
110668702|NCT00441441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110668703|NCT00441441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110668704|NCT00441441|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110668705|NCT00441441|Respiratory System Agents|respiratory system agents|mesh-ancestor
110668706|NCT00441441|Dermatologic Agents|dermatologic agents|mesh-ancestor
110668707|NCT00441441|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110668708|NCT00441441|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110668709|NCT00441441|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110668710|NCT00441441|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110668711|NCT00441441|Adrenergic Agents|adrenergic agents|mesh-ancestor
110668712|NCT00441441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110668713|NCT00441441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110668715|NCT00436917|Letrozole|letrozole|mesh-list
110668716|NCT00436917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110668717|NCT00436917|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110668718|NCT00436917|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110668719|NCT00436917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110668720|NCT00436917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110668721|NCT00436917|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110668722|NCT00436917|Hormone Antagonists|hormone antagonists|mesh-ancestor
110668723|NCT00436917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110668724|NCT00436917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110668725|NCT00436917|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110668726|NCT00436605|Dasatinib|dasatinib|mesh-list
110668727|NCT00436605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110668728|NCT00436605|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110668729|NCT00436605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110668730|NCT00436605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110668731|NCT01034787|Tremelimumab|tremelimumab|mesh-list
110668732|NCT01034787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110668733|NCT01028781|Thalidomide|thalidomide|mesh-list
110668734|NCT01028781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110668735|NCT01028781|Immunologic Factors|immunologic factors|mesh-ancestor
110668736|NCT01028781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110668737|NCT01028781|Leprostatic Agents|leprostatic agents|mesh-ancestor
110668738|NCT01028781|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110668739|NCT01028781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110668740|NCT01028781|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110668741|NCT01028781|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110668742|NCT01028781|Growth Substances|growth substances|mesh-ancestor
110668743|NCT01028781|Growth Inhibitors|growth inhibitors|mesh-ancestor
110668744|NCT01028781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110668745|NCT01031901|Sirolimus|sirolimus|mesh-list
110668746|NCT01031901|Temsirolimus|temsirolimus|mesh-list
110668747|NCT01031901|MTOR Inhibitors|mtor inhibitors|mesh-list
110668748|NCT01031901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110668749|NCT01031901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110668750|NCT01031901|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110668751|NCT01031901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110668752|NCT01031901|Antifungal Agents|antifungal agents|mesh-ancestor
110668753|NCT01031901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110668754|NCT01031901|Immunologic Factors|immunologic factors|mesh-ancestor
110668755|NCT01031901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110668756|NCT01031901|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110668757|NCT01031901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110668758|NCT01031901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110668759|NCT00368992|Paclitaxel|paclitaxel|mesh-list
110668760|NCT00368992|Bevacizumab|bevacizumab|mesh-list
110668761|NCT00368992|Cetuximab|cetuximab|mesh-list
110668762|NCT00368992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110668763|NCT00368992|Antibodies|antibodies|mesh-list
110668764|NCT00368992|Immunoglobulins|immunoglobulins|mesh-list
110668765|NCT00368992|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110668766|NCT00368992|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110668767|NCT00368992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110668768|NCT00368992|Tubulin Modulators|tubulin modulators|mesh-ancestor
110668769|NCT00368992|Antimitotic Agents|antimitotic agents|mesh-ancestor
110668770|NCT00368992|Mitosis Modulators|mitosis modulators|mesh-ancestor
110668771|NCT00368992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110668772|NCT00368992|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110668773|NCT00368992|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110668774|NCT00368992|Growth Substances|growth substances|mesh-ancestor
110668775|NCT00368992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110668776|NCT00368992|Growth Inhibitors|growth inhibitors|mesh-ancestor
110668777|NCT00368992|Immunologic Factors|immunologic factors|mesh-ancestor
110668779|NCT00376246|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110668780|NCT00376246|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110668781|NCT00376246|Antimetabolites|antimetabolites|mesh-ancestor
110668782|NCT00376246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110668783|NCT00376246|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110668784|NCT01050088|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110668785|NCT00375934|Diclofenac|diclofenac|mesh-list
110668786|NCT00375934|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110668787|NCT00375934|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110668788|NCT00375934|Analgesics|analgesics|mesh-ancestor
110668789|NCT00375934|Sensory System Agents|sensory system agents|mesh-ancestor
110668790|NCT00375934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110668791|NCT00375934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110668792|NCT00375934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110668793|NCT00375934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110668794|NCT00375934|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110668795|NCT00375934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110668796|NCT00375934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110668797|NCT01052584|Chloroquine|chloroquine|mesh-list
110668798|NCT01052584|Lumefantrine|lumefantrine|mesh-list
110668799|NCT01052584|Artemether|artemether|mesh-list
110668800|NCT01052584|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
110668801|NCT01052584|Amebicides|amebicides|mesh-ancestor
110668802|NCT01052584|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110668803|NCT01052584|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110668804|NCT01052584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110668805|NCT01052584|Antimalarials|antimalarials|mesh-ancestor
110668806|NCT01052584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110668807|NCT02534506|Nivolumab|nivolumab|mesh-list
110668808|NCT02534506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110668809|NCT02534506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110668810|NCT02534506|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110668811|NCT02534506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110668812|NCT01050322|Gemcitabine|gemcitabine|mesh-list
110668813|NCT01050322|Capecitabine|capecitabine|mesh-list
110668814|NCT01050322|Vinorelbine|vinorelbine|mesh-list
110668815|NCT01050322|Lapatinib|lapatinib|mesh-list
110668816|NCT01050322|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110668817|NCT01050322|Antimetabolites|antimetabolites|mesh-ancestor
110668818|NCT01050322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110668819|NCT01050322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110668820|NCT01050322|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110668821|NCT01050322|Tubulin Modulators|tubulin modulators|mesh-ancestor
110668822|NCT01050322|Antimitotic Agents|antimitotic agents|mesh-ancestor
110668823|NCT01050322|Mitosis Modulators|mitosis modulators|mesh-ancestor
110668824|NCT01050322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110668825|NCT01050322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110668826|NCT00531960|Bevacizumab|bevacizumab|mesh-list
110668827|NCT00531960|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110668828|NCT00531960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110668829|NCT00531960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110668830|NCT00531960|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110668831|NCT00531960|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110668832|NCT00531960|Growth Substances|growth substances|mesh-ancestor
110668833|NCT00531960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110668834|NCT00531960|Growth Inhibitors|growth inhibitors|mesh-ancestor
110668835|NCT00531960|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110668836|NCT00531960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110668837|NCT00531960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110668838|NCT01001676|Paclitaxel|paclitaxel|mesh-list
110668839|NCT01001676|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110668840|NCT01001676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110668841|NCT01001676|Tubulin Modulators|tubulin modulators|mesh-ancestor
110668842|NCT01001676|Antimitotic Agents|antimitotic agents|mesh-ancestor
110668843|NCT01001676|Mitosis Modulators|mitosis modulators|mesh-ancestor
110668844|NCT01001676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110668845|NCT00816959|Bleomycin|bleomycin|mesh-list
110668846|NCT00816959|Dacarbazine|dacarbazine|mesh-list
110668847|NCT00816959|Vinblastine|vinblastine|mesh-list
110668848|NCT00816959|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110668849|NCT00816959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110668850|NCT00816959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110668851|NCT00816959|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110668853|NCT00816959|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110668854|NCT00816959|Tubulin Modulators|tubulin modulators|mesh-ancestor
110668855|NCT00816959|Antimitotic Agents|antimitotic agents|mesh-ancestor
110668856|NCT00816959|Mitosis Modulators|mitosis modulators|mesh-ancestor
110668857|NCT01001754|Ribavirin|ribavirin|mesh-list
110668858|NCT01001754|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110668859|NCT01001754|Antimetabolites|antimetabolites|mesh-ancestor
110668860|NCT01001754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110668861|NCT01001754|Antiviral Agents|antiviral agents|mesh-ancestor
110668862|NCT01001754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110668863|NCT00825851|Nicotine|nicotine|mesh-list
110668864|NCT00825851|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110668865|NCT00825851|Autonomic Agents|autonomic agents|mesh-ancestor
110668866|NCT00825851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110668867|NCT00825851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110668868|NCT00825851|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110668869|NCT00825851|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110668870|NCT00825851|Cholinergic Agents|cholinergic agents|mesh-ancestor
110668871|NCT00825851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110668872|NCT00825851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110668873|NCT00361504|Oxycodone|oxycodone|mesh-list
110668874|NCT00361504|Tapentadol|tapentadol|mesh-list
110668875|NCT00361504|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110668876|NCT00361504|Narcotics|narcotics|mesh-ancestor
110668877|NCT00361504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110668878|NCT00361504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110668879|NCT00361504|Analgesics|analgesics|mesh-ancestor
110668880|NCT00361504|Sensory System Agents|sensory system agents|mesh-ancestor
110668881|NCT00361504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110668882|NCT00361504|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110668883|NCT00361504|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110668884|NCT00361504|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110668885|NCT00361504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110668886|NCT00361504|Adrenergic Agents|adrenergic agents|mesh-ancestor
110668887|NCT00361504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110668888|NCT00361270|Complement Factor H|complement factor h|mesh-list
110668889|NCT00361270|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
110668890|NCT00361270|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110668891|NCT00361270|Immunologic Factors|immunologic factors|mesh-ancestor
110668892|NCT00361270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110668893|NCT00826163|Budesonide|budesonide|mesh-list
110668894|NCT00826163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110668895|NCT00826163|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110668896|NCT00826163|Autonomic Agents|autonomic agents|mesh-ancestor
110668897|NCT00826163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110668898|NCT00826163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110668899|NCT00826163|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110668900|NCT00826163|Respiratory System Agents|respiratory system agents|mesh-ancestor
110668901|NCT00826163|Glucocorticoids|glucocorticoids|mesh-ancestor
110668902|NCT00826163|Hormones|hormones|mesh-ancestor
110668903|NCT00826163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110668904|NCT00998166|Bevacizumab|bevacizumab|mesh-list
110668905|NCT00998166|Pemetrexed|pemetrexed|mesh-list
110668906|NCT00998166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110668907|NCT00998166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110668908|NCT00998166|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110668909|NCT00998166|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110668910|NCT00998166|Growth Substances|growth substances|mesh-ancestor
110668911|NCT00998166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110668912|NCT00998166|Growth Inhibitors|growth inhibitors|mesh-ancestor
110668913|NCT00998166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110668914|NCT00998166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110668915|NCT00998166|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110668916|NCT00998166|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110668917|NCT03990922|Morphine|morphine|mesh-list
110668918|NCT03990922|Ropivacaine|ropivacaine|mesh-list
110668919|NCT03990922|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110668920|NCT03990922|Narcotics|narcotics|mesh-ancestor
110668921|NCT03990922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110668922|NCT03990922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110668923|NCT03990922|Analgesics|analgesics|mesh-ancestor
110668924|NCT03990922|Sensory System Agents|sensory system agents|mesh-ancestor
110668925|NCT03990922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110668926|NCT03990922|Anesthetics, Local|anesthetics, local|mesh-ancestor
110668927|NCT03990922|Anesthetics|anesthetics|mesh-ancestor
110668928|NCT00822263|Acetylcysteine|acetylcysteine|mesh-list
110668929|NCT00822263|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110316090|NCT00339768|Omeprazole|omeprazole|mesh-list
110668930|NCT00822263|Antiviral Agents|antiviral agents|mesh-ancestor
110668931|NCT00822263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110668932|NCT00822263|Expectorants|expectorants|mesh-ancestor
110668933|NCT00822263|Respiratory System Agents|respiratory system agents|mesh-ancestor
110668934|NCT00822263|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110668935|NCT00822263|Antioxidants|antioxidants|mesh-ancestor
110668936|NCT00822263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110668937|NCT00822263|Protective Agents|protective agents|mesh-ancestor
110668938|NCT00822263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110668939|NCT00822263|Antidotes|antidotes|mesh-ancestor
110668940|NCT03992170|Daratumumab|daratumumab|mesh-list
110668941|NCT03992170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110668942|NCT00817037|Nifedipine|nifedipine|mesh-list
110668943|NCT00817037|Sitaxsentan|sitaxsentan|mesh-list
110668944|NCT00817037|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110668945|NCT00817037|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110448561|NCT02730442|Olorofim|olorofim|mesh-list
110668946|NCT00817037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110668947|NCT00817037|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110668948|NCT00817037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110668949|NCT00817037|Vasodilator Agents|vasodilator agents|mesh-ancestor
110668950|NCT00817037|Tocolytic Agents|tocolytic agents|mesh-ancestor
110668951|NCT00817037|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110668952|NCT00817037|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
110668953|NCT00998322|Gemcitabine|gemcitabine|mesh-list
110668954|NCT00998322|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110668955|NCT00998322|Antimetabolites|antimetabolites|mesh-ancestor
110668956|NCT00998322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110668957|NCT00998322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110668958|NCT00367744|Rosiglitazone|rosiglitazone|mesh-list
110668959|NCT00367744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110668960|NCT00367744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110668961|NCT01002300|Oxytocin|oxytocin|mesh-list
110668962|NCT01002300|Oxytocics|oxytocics|mesh-ancestor
110668963|NCT01002300|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110668964|NCT01002300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110668965|NCT00822419|Lidocaine|lidocaine|mesh-list
110668966|NCT00822419|Ketamine|ketamine|mesh-list
110668967|NCT00822419|Anesthetics, Local|anesthetics, local|mesh-ancestor
110668968|NCT00822419|Anesthetics|anesthetics|mesh-ancestor
110668969|NCT00822419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110668970|NCT00822419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110668971|NCT00822419|Sensory System Agents|sensory system agents|mesh-ancestor
110668972|NCT00822419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110668973|NCT00822419|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110668974|NCT00822419|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110668975|NCT00822419|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110668976|NCT00822419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110668977|NCT00822419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110668978|NCT00822419|Analgesics|analgesics|mesh-ancestor
110668979|NCT00822419|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110668980|NCT00822419|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110668981|NCT00822419|Anesthetics, General|anesthetics, general|mesh-ancestor
110668982|NCT00822419|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110668983|NCT00822419|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110668984|NCT00822419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110668985|NCT01002534|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
110668986|NCT01002534|Vasodilator Agents|vasodilator agents|mesh-ancestor
110668987|NCT01002534|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110668988|NCT01002534|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110668989|NCT01002534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110668990|NCT01002534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110668991|NCT01002534|Urological Agents|urological agents|mesh-ancestor
110668992|NCT00817271|Glucagon|glucagon|mesh-list
110668993|NCT00817271|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110668994|NCT00817271|Hormones|hormones|mesh-ancestor
110668995|NCT00817271|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110668996|NCT00817271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110668997|NCT01052896|Gabapentin|gabapentin|mesh-list
110668999|NCT01052896|Sensory System Agents|sensory system agents|mesh-ancestor
110669000|NCT01052896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110669001|NCT01052896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110669002|NCT01052896|Anticonvulsants|anticonvulsants|mesh-ancestor
110669003|NCT01052896|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110669004|NCT01052896|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110669005|NCT01052896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110669006|NCT01052896|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110669007|NCT01052896|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110669008|NCT01052896|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110669009|NCT01052896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110669010|NCT01052896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110448575|NCT02733874|Betamethasone|betamethasone|mesh-list
110669011|NCT01052896|Antimanic Agents|antimanic agents|mesh-ancestor
110669012|NCT01002690|Etoricoxib|etoricoxib|mesh-list
110669013|NCT01002690|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110669014|NCT01002690|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110669015|NCT01002690|Analgesics|analgesics|mesh-ancestor
110669016|NCT01002690|Sensory System Agents|sensory system agents|mesh-ancestor
110669017|NCT01002690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110669018|NCT01002690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110669019|NCT01002690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110669020|NCT01002690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110669021|NCT01002690|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110669022|NCT01002690|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110669023|NCT01002690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110669024|NCT01002690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110669025|NCT01048684|Mannitol|mannitol|mesh-list
110669026|NCT01048684|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110669027|NCT01048684|Diuretics|diuretics|mesh-ancestor
110669028|NCT01048684|Natriuretic Agents|natriuretic agents|mesh-ancestor
110669029|NCT01048684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110669030|NCT01002768|Insulin|insulin|mesh-list
110669031|NCT01002768|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110669032|NCT01002768|Insulin Glargine|insulin glargine|mesh-list
110669033|NCT01002768|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110669034|NCT01002768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110669035|NCT01050478|Paliperidone Palmitate|paliperidone palmitate|mesh-list
110669036|NCT01050478|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110669037|NCT01050478|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110669038|NCT01050478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110669039|NCT01050478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110669041|NCT01050478|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110669042|NCT01050478|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110669043|NCT01050478|Serotonin Agents|serotonin agents|mesh-ancestor
110669044|NCT01050478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110669045|NCT01050478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110669046|NCT01050478|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110669047|NCT01050478|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110669048|NCT01050478|Dopamine Agents|dopamine agents|mesh-ancestor
110669049|NCT00998556|Bromocriptine|bromocriptine|mesh-list
110669050|NCT00998556|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110669051|NCT00998556|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110669052|NCT00998556|Hormone Antagonists|hormone antagonists|mesh-ancestor
110669053|NCT00998556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110669054|NCT00998556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110669055|NCT00998556|Dopamine Agonists|dopamine agonists|mesh-ancestor
110669056|NCT00998556|Dopamine Agents|dopamine agents|mesh-ancestor
110669057|NCT00998556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110669058|NCT00998556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110669059|NCT01052974|Ropivacaine|ropivacaine|mesh-list
110669060|NCT01052974|Anesthetics, Local|anesthetics, local|mesh-ancestor
110669061|NCT01052974|Anesthetics|anesthetics|mesh-ancestor
110669062|NCT01052974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110669063|NCT01052974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110669064|NCT01052974|Sensory System Agents|sensory system agents|mesh-ancestor
110669065|NCT01052974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110669066|NCT00998634|Lithium Carbonate|lithium carbonate|mesh-list
110669067|NCT00998634|Antidepressive Agents|antidepressive agents|mesh-ancestor
110669068|NCT00998634|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110669069|NCT00998634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111479168|NCT05594823|Natriuretic Agents|natriuretic agents|mesh-ancestor
110669070|NCT00998634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110669071|NCT00998634|Antimanic Agents|antimanic agents|mesh-ancestor
110669072|NCT00998634|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110669073|NCT00998634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110669074|NCT00998634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110669075|NCT01003002|Levodopa|levodopa|mesh-list
110448586|NCT02730364|Acetaminophen|acetaminophen|mesh-list
110669076|NCT01003002|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110669077|NCT01003002|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110316227|NCT00347802|Travoprost|travoprost|mesh-list
110669078|NCT01003002|Dopamine Agents|dopamine agents|mesh-ancestor
110669079|NCT01003002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110669080|NCT01003002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110669081|NCT01003002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110669082|NCT01003158|Paclitaxel|paclitaxel|mesh-list
110669083|NCT01003158|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110669084|NCT01003158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110669085|NCT01003158|Tubulin Modulators|tubulin modulators|mesh-ancestor
110669086|NCT01003158|Antimitotic Agents|antimitotic agents|mesh-ancestor
110669087|NCT01003158|Mitosis Modulators|mitosis modulators|mesh-ancestor
110669088|NCT01003158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110669089|NCT03883386|Loratadine|loratadine|mesh-list
110669090|NCT03883386|Antipruritics|antipruritics|mesh-ancestor
110669091|NCT03883386|Dermatologic Agents|dermatologic agents|mesh-ancestor
110669092|NCT03883386|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110669093|NCT03883386|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110669094|NCT03883386|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110669095|NCT03883386|Histamine Antagonists|histamine antagonists|mesh-ancestor
110669096|NCT03883386|Histamine Agents|histamine agents|mesh-ancestor
110669097|NCT03883386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110669098|NCT03883386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110669099|NCT03883386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110669100|NCT00530946|Amlodipine|amlodipine|mesh-list
110669101|NCT00530946|Atorvastatin|atorvastatin|mesh-list
110669102|NCT00530946|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110669103|NCT00530946|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110669104|NCT00530946|Antimetabolites|antimetabolites|mesh-ancestor
110669105|NCT00530946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110669106|NCT00530946|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110669107|NCT00530946|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110669108|NCT00530946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110669109|NCT00530946|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110669110|NCT00530946|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110669111|NCT00530946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110669112|NCT00530946|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110669113|NCT00530946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110669114|NCT00530946|Vasodilator Agents|vasodilator agents|mesh-ancestor
110669115|NCT00424047|Dexamethasone|dexamethasone|mesh-list
110669116|NCT00424047|Dexamethasone acetate|dexamethasone acetate|mesh-list
110669117|NCT00424047|Lenalidomide|lenalidomide|mesh-list
110669118|NCT00424047|BB 1101|bb 1101|mesh-list
110669119|NCT00424047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110669120|NCT00424047|Antiemetics|antiemetics|mesh-ancestor
110669121|NCT00424047|Autonomic Agents|autonomic agents|mesh-ancestor
110669122|NCT00424047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110669123|NCT00424047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110669124|NCT00424047|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110669125|NCT00424047|Glucocorticoids|glucocorticoids|mesh-ancestor
110669126|NCT00424047|Hormones|hormones|mesh-ancestor
110669127|NCT00424047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110669128|NCT00424047|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110669129|NCT00424047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110669130|NCT00424047|Protease Inhibitors|protease inhibitors|mesh-ancestor
110669131|NCT00424047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110669132|NCT00424047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110669133|NCT00424047|Immunologic Factors|immunologic factors|mesh-ancestor
110669134|NCT00424047|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110669135|NCT00424047|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110669136|NCT00424047|Growth Substances|growth substances|mesh-ancestor
110669137|NCT00424047|Growth Inhibitors|growth inhibitors|mesh-ancestor
110669138|NCT00530790|Ropinirole|ropinirole|mesh-list
110669139|NCT00530790|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110669140|NCT00530790|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110669141|NCT00530790|Dopamine Agonists|dopamine agonists|mesh-ancestor
110669142|NCT00530790|Dopamine Agents|dopamine agents|mesh-ancestor
110669143|NCT00530790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110669144|NCT00530790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110669145|NCT00530790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110669146|NCT01032057|Gemcitabine|gemcitabine|mesh-list
110669147|NCT01032057|Capecitabine|capecitabine|mesh-list
110669148|NCT01032057|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110669149|NCT01032057|Antimetabolites|antimetabolites|mesh-ancestor
110669150|NCT01032057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110669151|NCT01032057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110669153|NCT01003314|Immunologic Factors|immunologic factors|mesh-ancestor
110669154|NCT01003314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110669155|NCT00530088|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
110669156|NCT00530088|Trioxsalen|trioxsalen|mesh-list
110669157|NCT00530088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110669158|NCT00530088|Dermatologic Agents|dermatologic agents|mesh-ancestor
110669159|NCT00530088|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110669160|NCT01006668|Propofol|propofol|mesh-list
110669161|NCT01006668|Sevoflurane|sevoflurane|mesh-list
110669162|NCT01006668|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110669163|NCT01006668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110669164|NCT01006668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110669165|NCT01006668|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110669166|NCT01006668|Anesthetics, General|anesthetics, general|mesh-ancestor
110669167|NCT01006668|Anesthetics|anesthetics|mesh-ancestor
110669168|NCT01006668|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110669169|NCT01006668|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110669170|NCT00360568|Levodopa|levodopa|mesh-list
110669171|NCT00360568|Carbidopa|carbidopa|mesh-list
110669172|NCT00360568|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
110669173|NCT00360568|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110669174|NCT00360568|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110669175|NCT00360568|Dopamine Agents|dopamine agents|mesh-ancestor
110669176|NCT00360568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110669177|NCT00360568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110669178|NCT00360568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110669179|NCT00360568|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
110669180|NCT00360568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110669181|NCT00360568|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110669182|NCT00360568|Immunologic Factors|immunologic factors|mesh-ancestor
110669183|NCT00360568|Dopamine Agonists|dopamine agonists|mesh-ancestor
110669184|NCT00436215|Bevacizumab|bevacizumab|mesh-list
110669185|NCT00436215|Sorafenib|sorafenib|mesh-list
110669186|NCT00436215|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110669187|NCT00436215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110669188|NCT00436215|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110669189|NCT00436215|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110669190|NCT00436215|Growth Substances|growth substances|mesh-ancestor
110669191|NCT00436215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110669192|NCT00436215|Growth Inhibitors|growth inhibitors|mesh-ancestor
110669193|NCT00436215|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110669194|NCT00436215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110669195|NCT00436215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110669196|NCT05734248|Hyaluronic Acid|hyaluronic acid|mesh-list
110669197|NCT05734248|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110669198|NCT05734248|Immunologic Factors|immunologic factors|mesh-ancestor
110669199|NCT05734248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110669200|NCT05734248|Viscosupplements|viscosupplements|mesh-ancestor
110669201|NCT05734248|Protective Agents|protective agents|mesh-ancestor
110669202|NCT00441363|Bromocriptine|bromocriptine|mesh-list
110669203|NCT00441363|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110669204|NCT00441363|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110669205|NCT00441363|Hormone Antagonists|hormone antagonists|mesh-ancestor
110669206|NCT00441363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110669207|NCT00441363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110669208|NCT00441363|Dopamine Agonists|dopamine agonists|mesh-ancestor
110669209|NCT00441363|Dopamine Agents|dopamine agents|mesh-ancestor
110669210|NCT00441363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110669211|NCT00441363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110669212|NCT00626795|Mupirocin|mupirocin|mesh-list
110669213|NCT00626795|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110669214|NCT00626795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110669215|NCT00626795|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110669216|NCT00626795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110669217|NCT00626795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110669218|NCT00826553|Midazolam|midazolam|mesh-list
110669219|NCT00826553|Dexmedetomidine|dexmedetomidine|mesh-list
110669220|NCT00826553|Lorazepam|lorazepam|mesh-list
110669221|NCT00826553|Propofol|propofol|mesh-list
110669223|NCT00826553|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110669224|NCT00826553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110669225|NCT00826553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110669226|NCT00826553|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110669227|NCT00826553|Analgesics|analgesics|mesh-ancestor
110669228|NCT00826553|Sensory System Agents|sensory system agents|mesh-ancestor
110669229|NCT00826553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110669230|NCT00826553|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110669231|NCT00826553|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110669232|NCT00826553|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110669233|NCT00826553|Adrenergic Agents|adrenergic agents|mesh-ancestor
110669234|NCT00826553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110669235|NCT00826553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110669236|NCT00826553|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110669237|NCT00826553|Anesthetics, General|anesthetics, general|mesh-ancestor
110669238|NCT00826553|Anesthetics|anesthetics|mesh-ancestor
110669239|NCT00826553|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110669240|NCT00826553|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110669241|NCT00826553|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110669242|NCT00826553|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110669243|NCT00826553|GABA Modulators|gaba modulators|mesh-ancestor
110669244|NCT00826553|GABA Agents|gaba agents|mesh-ancestor
110669245|NCT00826553|Anticonvulsants|anticonvulsants|mesh-ancestor
110669246|NCT00826553|Antiemetics|antiemetics|mesh-ancestor
110669247|NCT00826553|Autonomic Agents|autonomic agents|mesh-ancestor
110669248|NCT00826553|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110669249|NCT00626639|Cisplatin|cisplatin|mesh-list
110669250|NCT00626639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110669251|NCT00626561|Paclitaxel|paclitaxel|mesh-list
110669252|NCT00626561|Bevacizumab|bevacizumab|mesh-list
110669253|NCT00626561|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110669254|NCT00626561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110669255|NCT00626561|Tubulin Modulators|tubulin modulators|mesh-ancestor
110669256|NCT00626561|Antimitotic Agents|antimitotic agents|mesh-ancestor
110669257|NCT00626561|Mitosis Modulators|mitosis modulators|mesh-ancestor
110669258|NCT00626561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110669259|NCT00626561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110669260|NCT00626561|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110669261|NCT00626561|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110669262|NCT00626561|Growth Substances|growth substances|mesh-ancestor
110669263|NCT00626561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110669264|NCT00626561|Growth Inhibitors|growth inhibitors|mesh-ancestor
110669265|NCT03880266|Glycopyrrolate|glycopyrrolate|mesh-list
110669267|NCT03880266|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110669268|NCT03880266|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110669269|NCT03880266|Cholinergic Agents|cholinergic agents|mesh-ancestor
110669270|NCT03880266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110669271|NCT03880266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110669272|NCT03880266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110669273|NCT00423891|Entecavir|entecavir|mesh-list
110669274|NCT00423891|Antiviral Agents|antiviral agents|mesh-ancestor
110669275|NCT00423891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110669276|NCT00830609|Ribavirin|ribavirin|mesh-list
110669277|NCT00830609|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110669278|NCT00830609|Interferon-alpha|interferon-alpha|mesh-list
110669279|NCT00830609|Antimetabolites|antimetabolites|mesh-ancestor
110669280|NCT00830609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110669281|NCT00830609|Antiviral Agents|antiviral agents|mesh-ancestor
110669282|NCT00830609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110669283|NCT00830609|Immunologic Factors|immunologic factors|mesh-ancestor
110669284|NCT00830609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110669285|NCT00822809|Prednisolone|prednisolone|mesh-list
110669286|NCT00822809|Catumaxomab|catumaxomab|mesh-list
110669287|NCT00822809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110669288|NCT00822809|Glucocorticoids|glucocorticoids|mesh-ancestor
110669289|NCT00822809|Hormones|hormones|mesh-ancestor
110669290|NCT00822809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110669291|NCT00822809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110669292|NCT00822809|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110669293|NCT00822809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110669294|NCT00822809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110669295|NCT02549651|Durvalumab|durvalumab|mesh-list
110669296|NCT02549651|Tremelimumab|tremelimumab|mesh-list
110669297|NCT02549651|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110669299|NCT03999372|Hyaluronic Acid|hyaluronic acid|mesh-list
110669300|NCT03999372|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110669301|NCT03999372|Immunologic Factors|immunologic factors|mesh-ancestor
110669302|NCT03999372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110669303|NCT03999372|Viscosupplements|viscosupplements|mesh-ancestor
110669304|NCT03999372|Protective Agents|protective agents|mesh-ancestor
110669305|NCT05733468|Calcium, Dietary|calcium, dietary|mesh-list
110669306|NCT05733468|Calcium|calcium|mesh-list
110669307|NCT05733468|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110669308|NCT05733468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110669309|NCT05733468|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110669310|NCT00830843|Propofol|propofol|mesh-list
110669311|NCT00830843|Isoflurane|isoflurane|mesh-list
110669312|NCT00830843|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110669313|NCT00830843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110669314|NCT00830843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110669315|NCT00830843|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110669316|NCT00830843|Anesthetics, General|anesthetics, general|mesh-ancestor
110669317|NCT00830843|Anesthetics|anesthetics|mesh-ancestor
110669318|NCT00830843|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110669319|NCT00826787|Levetiracetam|levetiracetam|mesh-list
110669320|NCT00826787|Anticonvulsants|anticonvulsants|mesh-ancestor
110669321|NCT00826787|Nootropic Agents|nootropic agents|mesh-ancestor
110669322|NCT00823121|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
110669323|NCT00823121|Buserelin|buserelin|mesh-list
110669324|NCT00823121|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110669325|NCT00823121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110669326|NCT00823121|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110669327|NCT00823121|Fertility Agents|fertility agents|mesh-ancestor
110669328|NCT03687372|Hydrogen Peroxide|hydrogen peroxide|mesh-list
110669329|NCT03687372|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110669330|NCT03687372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110669331|NCT00626405|Paclitaxel|paclitaxel|mesh-list
110669332|NCT00626405|Bevacizumab|bevacizumab|mesh-list
110669333|NCT00626405|Carboplatin|carboplatin|mesh-list
110669334|NCT00626405|Temozolomide|temozolomide|mesh-list
110669335|NCT00626405|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110669336|NCT00626405|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110669337|NCT00626405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110669338|NCT00626405|Tubulin Modulators|tubulin modulators|mesh-ancestor
110669339|NCT00626405|Antimitotic Agents|antimitotic agents|mesh-ancestor
110669340|NCT00626405|Mitosis Modulators|mitosis modulators|mesh-ancestor
110669341|NCT00626405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110669342|NCT00626405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110669343|NCT00626405|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110680271|NCT04278404|Spironolactone|spironolactone|mesh-list
110669344|NCT00626405|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110669345|NCT00626405|Growth Substances|growth substances|mesh-ancestor
110669346|NCT00626405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110669347|NCT00626405|Growth Inhibitors|growth inhibitors|mesh-ancestor
110669348|NCT00626405|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110669349|NCT00626405|Alkylating Agents|alkylating agents|mesh-ancestor
110669350|NCT00826865|Levetiracetam|levetiracetam|mesh-list
110669351|NCT00826865|Anticonvulsants|anticonvulsants|mesh-ancestor
110669352|NCT00826865|Nootropic Agents|nootropic agents|mesh-ancestor
110669353|NCT00358150|Eliglustat|eliglustat|mesh-list
110669354|NCT00358150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110669355|NCT00358150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110669356|NCT05427630|Dronabinol|dronabinol|mesh-list
110669357|NCT05427630|Hallucinogens|hallucinogens|mesh-ancestor
110669358|NCT05427630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110669359|NCT05427630|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110669360|NCT05427630|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110669361|NCT05427630|Analgesics|analgesics|mesh-ancestor
110669362|NCT05427630|Sensory System Agents|sensory system agents|mesh-ancestor
110669363|NCT05427630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110669364|NCT05427630|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
110669365|NCT05427630|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110669366|NCT05427630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110669367|NCT05427630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110669368|NCT05427630|Hormones|hormones|mesh-ancestor
110669369|NCT05427630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110669370|NCT01050556|Folic Acid|folic acid|mesh-list
110669371|NCT01050556|Vitamin B Complex|vitamin b complex|mesh-list
110669372|NCT01050556|Hematinics|hematinics|mesh-ancestor
110669373|NCT01050556|Vitamins|vitamins|mesh-ancestor
110669374|NCT01050556|Micronutrients|micronutrients|mesh-ancestor
110669375|NCT01050556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110669377|NCT05889871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110669378|NCT05889871|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110669379|NCT05889871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110669380|NCT05889871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110669381|NCT05889455|Sildenafil Citrate|sildenafil citrate|mesh-list
110669382|NCT05889455|Vasodilator Agents|vasodilator agents|mesh-ancestor
110669383|NCT05889455|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110669384|NCT05889455|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110669385|NCT05889455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110669386|NCT05889455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110669387|NCT05889455|Urological Agents|urological agents|mesh-ancestor
110669389|NCT05889442|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110669390|NCT05889442|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110669391|NCT05889442|Autonomic Agents|autonomic agents|mesh-ancestor
110669392|NCT05889442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110669393|NCT05889442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110669394|NCT05889442|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110669395|NCT05889442|Respiratory System Agents|respiratory system agents|mesh-ancestor
110669396|NCT05889442|Parasympatholytics|parasympatholytics|mesh-ancestor
110669397|NCT05889442|Vasodilator Agents|vasodilator agents|mesh-ancestor
110669399|NCT05889390|Cyclophosphamide|cyclophosphamide|mesh-list
110669400|NCT05889390|Carboplatin|carboplatin|mesh-list
110669401|NCT05889390|Doxorubicin|doxorubicin|mesh-list
110669402|NCT05889390|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110669403|NCT05889390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110669404|NCT05889390|Tubulin Modulators|tubulin modulators|mesh-ancestor
110669405|NCT05889390|Antimitotic Agents|antimitotic agents|mesh-ancestor
110669406|NCT05889390|Mitosis Modulators|mitosis modulators|mesh-ancestor
110669407|NCT05889390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110669408|NCT05889390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110669409|NCT05889390|Immunologic Factors|immunologic factors|mesh-ancestor
110669410|NCT05889390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110669411|NCT05889390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110669412|NCT05889390|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110669413|NCT05889390|Alkylating Agents|alkylating agents|mesh-ancestor
110669414|NCT05889390|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110669415|NCT05889390|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110669416|NCT05889390|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110669417|NCT05889390|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110669418|NCT05889390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110948232|NCT03036514|Sensory System Agents|sensory system agents|mesh-ancestor
110669419|NCT05889338|Adalimumab|adalimumab|mesh-list
110669420|NCT05889338|Methotrexate|methotrexate|mesh-list
110669421|NCT05889338|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110669422|NCT05889338|Abortifacient Agents|abortifacient agents|mesh-ancestor
110669423|NCT05889338|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110669424|NCT05889338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110669425|NCT05889338|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110669426|NCT05889338|Antimetabolites|antimetabolites|mesh-ancestor
110669427|NCT05889338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110669428|NCT05889338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110669429|NCT05889338|Dermatologic Agents|dermatologic agents|mesh-ancestor
110669430|NCT05889338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110669431|NCT05889338|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110669432|NCT05889338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110669433|NCT05889338|Immunologic Factors|immunologic factors|mesh-ancestor
110669434|NCT05889338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110669435|NCT05889338|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110669436|NCT05889338|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110669437|NCT05889338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110669438|NCT05889143|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110669439|NCT05889143|Ezetimibe|ezetimibe|mesh-list
110669440|NCT05889143|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110669441|NCT05889143|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110669442|NCT05889143|Antimetabolites|antimetabolites|mesh-ancestor
110669443|NCT05889143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110669444|NCT05889143|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110669445|NCT05889143|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110669446|NCT05889143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110669447|NCT05889052|Pyrimethamine|pyrimethamine|mesh-list
110669448|NCT05889052|Sulfadoxine|sulfadoxine|mesh-list
110669449|NCT05889052|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
110669450|NCT05889052|Antimalarials|antimalarials|mesh-ancestor
110669451|NCT05889052|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110669452|NCT05889052|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110669453|NCT05889052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110669454|NCT05889052|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110669455|NCT05889052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110669456|NCT05889052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110669457|NCT05889052|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110669458|NCT05889026|Botulinum Toxins|botulinum toxins|mesh-list
110669459|NCT05889026|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110669460|NCT05889026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110669461|NCT05889026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110669462|NCT05889026|Cholinergic Agents|cholinergic agents|mesh-ancestor
110669463|NCT05889026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110669464|NCT05889026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110669466|NCT05888922|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110669467|NCT05888922|Vasodilator Agents|vasodilator agents|mesh-ancestor
110669468|NCT05888597|Menthol|menthol|mesh-list
110669469|NCT05888597|Antipruritics|antipruritics|mesh-ancestor
110669470|NCT05888597|Dermatologic Agents|dermatologic agents|mesh-ancestor
110669471|NCT05887947|Nicotine|nicotine|mesh-list
110669472|NCT05887947|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110669473|NCT05887947|Autonomic Agents|autonomic agents|mesh-ancestor
110669474|NCT05887947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110669475|NCT05887947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110669476|NCT05887947|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110669477|NCT05887947|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110669478|NCT05887947|Cholinergic Agents|cholinergic agents|mesh-ancestor
110669479|NCT05887947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110669480|NCT05887947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110669481|NCT05887908|Imipenem|imipenem|mesh-list
110669482|NCT05887908|Cefepime|cefepime|mesh-list
110669483|NCT05887908|Aztreonam|aztreonam|mesh-list
110669484|NCT05887908|Cilastatin|cilastatin|mesh-list
110669485|NCT05887908|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110669486|NCT05887908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110669487|NCT05887908|Protease Inhibitors|protease inhibitors|mesh-ancestor
110669488|NCT05887908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110669489|NCT05887908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110669490|NCT05887778|Dexamethasone|dexamethasone|mesh-list
110669491|NCT05887778|Dexamethasone acetate|dexamethasone acetate|mesh-list
110669492|NCT05887778|BB 1101|bb 1101|mesh-list
110669493|NCT05887778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110669494|NCT05887778|Antiemetics|antiemetics|mesh-ancestor
110669495|NCT05887778|Autonomic Agents|autonomic agents|mesh-ancestor
110669496|NCT05887778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110669497|NCT05887778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110669498|NCT05887778|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110669499|NCT05887778|Glucocorticoids|glucocorticoids|mesh-ancestor
110669500|NCT05887778|Hormones|hormones|mesh-ancestor
110669501|NCT05887778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110669502|NCT05887778|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110669503|NCT05887778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110669504|NCT05887778|Protease Inhibitors|protease inhibitors|mesh-ancestor
110669505|NCT05887778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110669506|NCT05887778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110669507|NCT05887765|Dexamethasone|dexamethasone|mesh-list
110669508|NCT05887765|Dexamethasone acetate|dexamethasone acetate|mesh-list
110669509|NCT05887765|BB 1101|bb 1101|mesh-list
110669510|NCT05887765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110669511|NCT05887765|Antiemetics|antiemetics|mesh-ancestor
110669512|NCT05887765|Autonomic Agents|autonomic agents|mesh-ancestor
110669513|NCT05887765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110669514|NCT05887765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110669515|NCT05887765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110669516|NCT05887765|Glucocorticoids|glucocorticoids|mesh-ancestor
110669517|NCT05887765|Hormones|hormones|mesh-ancestor
110669518|NCT05887765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110669519|NCT05887765|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110669520|NCT05887765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110669521|NCT05887765|Protease Inhibitors|protease inhibitors|mesh-ancestor
110669522|NCT05887765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110669523|NCT05887765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110669524|NCT05886712|Naloxone|naloxone|mesh-list
110669525|NCT05886712|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110669526|NCT05886712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110669527|NCT05886712|Sensory System Agents|sensory system agents|mesh-ancestor
110669528|NCT05886712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110669530|NCT05881382|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110316681|NCT00315848|Buprenorphine|buprenorphine|mesh-list
110669531|NCT05881382|Immunologic Factors|immunologic factors|mesh-ancestor
110669532|NCT05881382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110669533|NCT05874414|Trametinib|trametinib|mesh-list
110669534|NCT05874414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110669535|NCT05874414|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110669536|NCT05874414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110669537|NCT05874414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110669538|NCT05851677|Disitamab vedotin|disitamab vedotin|mesh-list
110669539|NCT05851677|Immunoconjugates|immunoconjugates|mesh-ancestor
110669540|NCT05851677|Immunologic Factors|immunologic factors|mesh-ancestor
110669541|NCT05851677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110669542|NCT05843708|Ciprofloxacin|ciprofloxacin|mesh-list
110669543|NCT05843708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110669544|NCT05843708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110669545|NCT05843708|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110669546|NCT05843708|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110669547|NCT05843708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110669548|NCT05843708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110669549|NCT05843708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110669550|NCT05843708|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110669551|NCT05843708|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110669552|NCT05805826|Vaccines|vaccines|mesh-list
110669553|NCT05805826|Immunologic Factors|immunologic factors|mesh-ancestor
110669554|NCT05805826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110669555|NCT05779020|Vaccines|vaccines|mesh-list
110669556|NCT05779020|Immunologic Factors|immunologic factors|mesh-ancestor
110669557|NCT05779020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110669558|NCT05774899|Venetoclax|venetoclax|mesh-list
110669559|NCT05774899|Lenvatinib|lenvatinib|mesh-list
110669560|NCT05774899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110669561|NCT05774899|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110669562|NCT05774899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110669563|NCT05774899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110669564|NCT05743946|Ivacaftor|ivacaftor|mesh-list
110669565|NCT05743946|Elexacaftor|elexacaftor|mesh-list
110669566|NCT05743946|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
110669567|NCT05743946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110669568|NCT05743946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110669569|NCT05742789|Propofol|propofol|mesh-list
110669570|NCT05742789|Sevoflurane|sevoflurane|mesh-list
110669571|NCT05742789|Isoflurane|isoflurane|mesh-list
110669572|NCT05742789|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110669573|NCT05742789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110669574|NCT05742789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110669575|NCT05742789|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110669576|NCT05742789|Anesthetics, General|anesthetics, general|mesh-ancestor
110669577|NCT05742789|Anesthetics|anesthetics|mesh-ancestor
110669578|NCT05742789|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110669579|NCT05742789|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110669580|NCT05741385|Metoprolol|metoprolol|mesh-list
110669581|NCT05741385|Midazolam|midazolam|mesh-list
110669582|NCT05741385|Caffeine|caffeine|mesh-list
110669583|NCT05741385|Omeprazole|omeprazole|mesh-list
110669584|NCT05741385|Warfarin|warfarin|mesh-list
110669585|NCT05741385|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110669586|NCT05741385|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110669587|NCT05741385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110669588|NCT05741385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110669589|NCT05741385|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110669590|NCT05741385|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110669591|NCT05741385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110669592|NCT05741385|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110669593|NCT05741385|Anesthetics, General|anesthetics, general|mesh-ancestor
110669594|NCT05741385|Anesthetics|anesthetics|mesh-ancestor
110669595|NCT05741385|GABA Modulators|gaba modulators|mesh-ancestor
110669596|NCT05741385|GABA Agents|gaba agents|mesh-ancestor
110669597|NCT05741385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110669598|NCT05741385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110669599|NCT05741385|Anticoagulants|anticoagulants|mesh-ancestor
110669600|NCT05741385|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110669601|NCT05741385|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110669602|NCT05741385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110669603|NCT05741385|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110669604|NCT05741385|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110669605|NCT05741385|Purinergic Agents|purinergic agents|mesh-ancestor
110669606|NCT05741385|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110669607|NCT05741385|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110669608|NCT05741385|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110669609|NCT05741385|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110669610|NCT05741385|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110669611|NCT05741385|Sympatholytics|sympatholytics|mesh-ancestor
110669612|NCT05741385|Autonomic Agents|autonomic agents|mesh-ancestor
110669613|NCT05741385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110669614|NCT05741385|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110669615|NCT05741385|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110669616|NCT05741385|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110669617|NCT05741385|Adrenergic Agents|adrenergic agents|mesh-ancestor
110669619|NCT05721846|Ipilimumab|ipilimumab|mesh-list
110669620|NCT05721846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110669621|NCT05721846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110669622|NCT05721846|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110669623|NCT05721846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110669624|NCT05696613|Rituximab|rituximab|mesh-list
110669625|NCT05696613|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
110669626|NCT05696613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110669627|NCT05696613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110669628|NCT05696613|Immunologic Factors|immunologic factors|mesh-ancestor
110669629|NCT05696613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110669630|NCT05696613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110669631|NCT05696613|Hormones|hormones|mesh-ancestor
110669632|NCT05696613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110669633|NCT05645146|Nicotine|nicotine|mesh-list
110669634|NCT05645146|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110669635|NCT05645146|Autonomic Agents|autonomic agents|mesh-ancestor
110669636|NCT05645146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110669637|NCT05645146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110669638|NCT05645146|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110669639|NCT05645146|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110669640|NCT05645146|Cholinergic Agents|cholinergic agents|mesh-ancestor
110669641|NCT05645146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110669642|NCT05645146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110669643|NCT05636111|Paclitaxel|paclitaxel|mesh-list
110669644|NCT05636111|Bevacizumab|bevacizumab|mesh-list
110669645|NCT05636111|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110669646|NCT05636111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110669647|NCT05636111|Tubulin Modulators|tubulin modulators|mesh-ancestor
110669648|NCT05636111|Antimitotic Agents|antimitotic agents|mesh-ancestor
110669649|NCT05636111|Mitosis Modulators|mitosis modulators|mesh-ancestor
110669650|NCT05636111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110669651|NCT05636111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110669652|NCT05636111|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110669653|NCT05636111|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110669654|NCT05636111|Growth Substances|growth substances|mesh-ancestor
110669655|NCT05636111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110669656|NCT05636111|Growth Inhibitors|growth inhibitors|mesh-ancestor
110669657|NCT05610072|Acetylcysteine|acetylcysteine|mesh-list
110669658|NCT05610072|Hydromorphone|hydromorphone|mesh-list
110669659|NCT05610072|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110669660|NCT05610072|Antiviral Agents|antiviral agents|mesh-ancestor
110669661|NCT05610072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110669662|NCT05610072|Expectorants|expectorants|mesh-ancestor
110669663|NCT05610072|Respiratory System Agents|respiratory system agents|mesh-ancestor
110669664|NCT05610072|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110669665|NCT05610072|Antioxidants|antioxidants|mesh-ancestor
110669666|NCT05610072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110669667|NCT05610072|Protective Agents|protective agents|mesh-ancestor
110669668|NCT05610072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110669669|NCT05610072|Antidotes|antidotes|mesh-ancestor
110669670|NCT05610072|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110669671|NCT05610072|Narcotics|narcotics|mesh-ancestor
110669672|NCT05610072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110669673|NCT05610072|Analgesics|analgesics|mesh-ancestor
110669674|NCT05610072|Sensory System Agents|sensory system agents|mesh-ancestor
110669675|NCT05610072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110669676|NCT05597085|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
110669677|NCT05597085|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110669678|NCT05597085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110669679|NCT05597085|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110669680|NCT05597085|Immunotoxins|immunotoxins|mesh-ancestor
110669681|NCT05597085|Immunoconjugates|immunoconjugates|mesh-ancestor
110669682|NCT05597085|Immunologic Factors|immunologic factors|mesh-ancestor
110669683|NCT05597085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110669684|NCT05577481|Antidepressive Agents|antidepressive agents|mesh-list
110669685|NCT05577481|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110669687|NCT05465135|Antimalarials|antimalarials|mesh-ancestor
110669688|NCT05465135|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110669689|NCT05465135|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110669690|NCT05465135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110669691|NCT05425732|Vaccines|vaccines|mesh-list
110669692|NCT05425732|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110669693|NCT05425732|Immunologic Factors|immunologic factors|mesh-ancestor
110669694|NCT05425732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110669695|NCT05389514|Cyclophosphamide|cyclophosphamide|mesh-list
110669696|NCT05389514|Gemcitabine|gemcitabine|mesh-list
110669697|NCT05389514|Pembrolizumab|pembrolizumab|mesh-list
110669698|NCT05389514|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110669699|NCT05389514|Immunologic Factors|immunologic factors|mesh-ancestor
110669700|NCT05389514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110669701|NCT05389514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110669702|NCT05389514|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110669703|NCT05389514|Alkylating Agents|alkylating agents|mesh-ancestor
110669704|NCT05389514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110669705|NCT05389514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110669706|NCT05389514|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110669707|NCT05389514|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110669708|NCT05389514|Antimetabolites|antimetabolites|mesh-ancestor
110669709|NCT05389514|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110669710|NCT05389514|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110669711|NCT05327777|Oxycodone|oxycodone|mesh-list
110669712|NCT05327777|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110669713|NCT05327777|Narcotics|narcotics|mesh-ancestor
110669714|NCT05327777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110669715|NCT05327777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110669716|NCT05327777|Analgesics|analgesics|mesh-ancestor
110669717|NCT05327777|Sensory System Agents|sensory system agents|mesh-ancestor
110669718|NCT05327777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110669719|NCT05309187|Pembrolizumab|pembrolizumab|mesh-list
110669720|NCT05309187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110669721|NCT05309187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110669722|NCT05309187|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110669723|NCT05309187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110669724|NCT05304546|Pembrolizumab|pembrolizumab|mesh-list
110669725|NCT05304546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110669726|NCT05304546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110669727|NCT05304546|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110669728|NCT05304546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110669729|NCT05261490|Doxorubicin|doxorubicin|mesh-list
110669730|NCT05261490|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110669731|NCT05261490|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110669732|NCT05261490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110669733|NCT05261490|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110669734|NCT05261490|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110669735|NCT05261490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110669736|NCT05261490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110669737|NCT05234099|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110669738|NCT05234099|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110669739|NCT05234099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110669740|NCT05180773|Bromocriptine|bromocriptine|mesh-list
110669741|NCT05180773|Rivaroxaban|rivaroxaban|mesh-list
110669742|NCT05180773|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110669743|NCT05180773|Antithrombins|antithrombins|mesh-ancestor
110669744|NCT05180773|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110669745|NCT05180773|Protease Inhibitors|protease inhibitors|mesh-ancestor
110669746|NCT05180773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110669747|NCT05180773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110669748|NCT05180773|Anticoagulants|anticoagulants|mesh-ancestor
110669749|NCT05180773|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110669750|NCT05180773|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110669751|NCT05180773|Hormone Antagonists|hormone antagonists|mesh-ancestor
110669752|NCT05180773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110669753|NCT05180773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110669754|NCT05180773|Dopamine Agonists|dopamine agonists|mesh-ancestor
111479169|NCT05594823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110316906|NCT00316745|Antidotes|antidotes|mesh-ancestor
110669756|NCT05180773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110669757|NCT05019430|Cocaine|cocaine|mesh-list
110669758|NCT05019430|Zolmitriptan|zolmitriptan|mesh-list
110669759|NCT05019430|Anesthetics, Local|anesthetics, local|mesh-ancestor
110669760|NCT05019430|Anesthetics|anesthetics|mesh-ancestor
110669761|NCT05019430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110669762|NCT05019430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110669763|NCT05019430|Sensory System Agents|sensory system agents|mesh-ancestor
110669764|NCT05019430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110669765|NCT05019430|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110669766|NCT05019430|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110669767|NCT05019430|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110669768|NCT05019430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110669769|NCT05019430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110669770|NCT05019430|Dopamine Agents|dopamine agents|mesh-ancestor
110669771|NCT05019430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110669772|NCT05019430|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110669773|NCT05019430|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110669774|NCT05019430|Serotonin Agents|serotonin agents|mesh-ancestor
110669775|NCT04957758|Varenicline|varenicline|mesh-list
110669776|NCT04957758|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110669777|NCT04957758|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110669778|NCT04957758|Cholinergic Agents|cholinergic agents|mesh-ancestor
110669779|NCT04957758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110669780|NCT04957758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110669781|NCT04957758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110669782|NCT04934722|Pembrolizumab|pembrolizumab|mesh-list
110669783|NCT04934722|Androgens|androgens|mesh-list
110669784|NCT04934722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110669785|NCT04934722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110669786|NCT04934722|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110669787|NCT04934722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110669788|NCT04934722|Hormones|hormones|mesh-ancestor
110669789|NCT04934722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110669790|NCT04934722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110669791|NCT04920383|Pembrolizumab|pembrolizumab|mesh-list
110669792|NCT04920383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110669793|NCT04920383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110669794|NCT04920383|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110669795|NCT04920383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110669796|NCT04899349|Metformin|metformin|mesh-list
110669797|NCT04899349|Dapagliflozin|dapagliflozin|mesh-list
110669798|NCT04899349|Fulvestrant|fulvestrant|mesh-list
110669799|NCT04899349|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110669800|NCT04899349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110669801|NCT04899349|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110669802|NCT04899349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110669803|NCT04899349|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110669804|NCT04899349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110669805|NCT04899349|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110669806|NCT04899349|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110669807|NCT04899349|Hormone Antagonists|hormone antagonists|mesh-ancestor
110669808|NCT04899349|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110669809|NCT04897841|Bupivacaine|bupivacaine|mesh-list
110669810|NCT04897841|Anesthetics, Local|anesthetics, local|mesh-ancestor
110669811|NCT04897841|Anesthetics|anesthetics|mesh-ancestor
110669812|NCT04897841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110669813|NCT04897841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110669814|NCT04897841|Sensory System Agents|sensory system agents|mesh-ancestor
110669815|NCT04897841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110669816|NCT04850599|Pomalidomide|pomalidomide|mesh-list
110669817|NCT04850599|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110669818|NCT04850599|Immunologic Factors|immunologic factors|mesh-ancestor
110669819|NCT04850599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110669820|NCT04850599|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110669821|NCT04850599|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110669822|NCT04850599|Growth Substances|growth substances|mesh-ancestor
110669823|NCT04850599|Growth Inhibitors|growth inhibitors|mesh-ancestor
110669824|NCT04850599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110683008|NCT00904631|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110669825|NCT04827134|Abacavir, dolutegravir, and lamivudine drug combination|abacavir, dolutegravir, and lamivudine drug combination|mesh-list
110669827|NCT04827134|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110669828|NCT04827134|Antiviral Agents|antiviral agents|mesh-ancestor
110669829|NCT04827134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110669831|NCT04736953|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110669832|NCT04736953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110669833|NCT04736953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110669834|NCT04736953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110669835|NCT04736953|Antifungal Agents|antifungal agents|mesh-ancestor
110669836|NCT04736953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110669837|NCT04736953|Immunologic Factors|immunologic factors|mesh-ancestor
110669838|NCT04736953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110669839|NCT04725617|Varenicline|varenicline|mesh-list
110669840|NCT04725617|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110669841|NCT04725617|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110669842|NCT04725617|Cholinergic Agents|cholinergic agents|mesh-ancestor
110669843|NCT04725617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110669844|NCT04725617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110669845|NCT04725617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110669846|NCT04707391|Vaccines|vaccines|mesh-list
110669847|NCT04707391|Immunologic Factors|immunologic factors|mesh-ancestor
110669848|NCT04707391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110669849|NCT04703075|Rifapentine|rifapentine|mesh-list
110669850|NCT04703075|Rifampin|rifampin|mesh-list
110669851|NCT04703075|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110669852|NCT04703075|Antitubercular Agents|antitubercular agents|mesh-ancestor
110669853|NCT04703075|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110669854|NCT04703075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110669855|NCT04703075|Leprostatic Agents|leprostatic agents|mesh-ancestor
110669856|NCT04703075|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110669857|NCT04703075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110669858|NCT04703075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110669859|NCT04703075|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110669860|NCT04703075|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110669861|NCT04703075|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110669862|NCT04703075|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110669863|NCT04703075|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110669864|NCT04703075|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110669865|NCT04702737|AMG 757|amg 757|mesh-list
110669866|NCT04702737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110669867|NCT04685421|Bupivacaine|bupivacaine|mesh-list
110669868|NCT04685421|Anesthetics, Local|anesthetics, local|mesh-ancestor
110669869|NCT04685421|Anesthetics|anesthetics|mesh-ancestor
110669870|NCT04685421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110669871|NCT04685421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110669872|NCT04685421|Sensory System Agents|sensory system agents|mesh-ancestor
110669873|NCT04685421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110669874|NCT04682158|Paclitaxel|paclitaxel|mesh-list
110669875|NCT04682158|Carboplatin|carboplatin|mesh-list
110669876|NCT04682158|Propranolol|propranolol|mesh-list
110669877|NCT04682158|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110669878|NCT04682158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110669879|NCT04682158|Tubulin Modulators|tubulin modulators|mesh-ancestor
110669880|NCT04682158|Antimitotic Agents|antimitotic agents|mesh-ancestor
110669881|NCT04682158|Mitosis Modulators|mitosis modulators|mesh-ancestor
110669882|NCT04682158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110669883|NCT04682158|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110669884|NCT04682158|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110669885|NCT04682158|Adrenergic Agents|adrenergic agents|mesh-ancestor
110669886|NCT04682158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110669887|NCT04682158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110669888|NCT04682158|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110669889|NCT04682158|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110669890|NCT04682158|Vasodilator Agents|vasodilator agents|mesh-ancestor
110669891|NCT04680975|Belumosudil|belumosudil|mesh-list
110669892|NCT04680975|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110669893|NCT04680975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110669894|NCT04680975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110669895|NCT04673786|Ustekinumab|ustekinumab|mesh-list
110669896|NCT04673786|Dermatologic Agents|dermatologic agents|mesh-ancestor
110669897|NCT04605978|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110669898|NCT04602533|Durvalumab|durvalumab|mesh-list
110095771|NCT01716416|Cetuximab|cetuximab|mesh-list
110669899|NCT04602533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110669901|NCT04597671|Durvalumab|durvalumab|mesh-list
110023715|NCT00003960|Hormones|hormones|mesh-ancestor
110669902|NCT04597671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110669903|NCT04597671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110669905|NCT04583969|Lenzilumab|lenzilumab|mesh-list
110669906|NCT04583969|Antimetabolites|antimetabolites|mesh-ancestor
110669907|NCT04583969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110669908|NCT04583969|Antiviral Agents|antiviral agents|mesh-ancestor
110669909|NCT04583969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110669910|NCT04583969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110669911|NCT04575857|Atorvastatin|atorvastatin|mesh-list
110669912|NCT04575857|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110669913|NCT04575857|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110669914|NCT04575857|Antimetabolites|antimetabolites|mesh-ancestor
110669915|NCT04575857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110669916|NCT04575857|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110669917|NCT04575857|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110669918|NCT04575857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110669919|NCT04561115|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110669920|NCT04561115|Immunologic Factors|immunologic factors|mesh-ancestor
110669921|NCT04561115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110669922|NCT04546425|Vaccines|vaccines|mesh-list
110669923|NCT04546425|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110669924|NCT04546425|Immunologic Factors|immunologic factors|mesh-ancestor
110669925|NCT04546425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110669926|NCT04502706|Rituximab|rituximab|mesh-list
110669927|NCT04502706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110669928|NCT04502706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110669929|NCT04502706|Immunologic Factors|immunologic factors|mesh-ancestor
110669930|NCT04502706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110669931|NCT04502706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110669932|NCT04486833|Cisplatin|cisplatin|mesh-list
110669933|NCT04486833|Carboplatin|carboplatin|mesh-list
110669934|NCT04486833|Osimertinib|osimertinib|mesh-list
110669935|NCT04486833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110669936|NCT04486833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110669937|NCT04486833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110669938|NCT04486833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110669939|NCT04468776|Zolpidem|zolpidem|mesh-list
110669940|NCT04468776|Trazodone|trazodone|mesh-list
110669941|NCT04468776|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110669942|NCT04468776|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110669943|NCT04468776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110669944|NCT04468776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110669945|NCT04468776|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
110669946|NCT04468776|GABA Agonists|gaba agonists|mesh-ancestor
110669947|NCT04468776|GABA Agents|gaba agents|mesh-ancestor
110669948|NCT04468776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110669949|NCT04468776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110669951|NCT04468776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110669952|NCT04468776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110669953|NCT04468776|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110669954|NCT04468776|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110669955|NCT04468776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110669956|NCT04468776|Serotonin Agents|serotonin agents|mesh-ancestor
110669957|NCT04468776|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110669958|NCT04468776|Antidepressive Agents|antidepressive agents|mesh-ancestor
110669959|NCT04456673|Cholinergic Agents|cholinergic agents|mesh-list
110669960|NCT04456673|Muscarinic Antagonists|muscarinic antagonists|mesh-list
110669961|NCT04456673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110669962|NCT04456673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110669963|NCT04456673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110669964|NCT04456673|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110669965|NCT04416269|Insulin|insulin|mesh-list
110669966|NCT04416269|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110669967|NCT04416269|Metformin|metformin|mesh-list
110669968|NCT04416269|Pioglitazone|pioglitazone|mesh-list
110669969|NCT04416269|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
110669970|NCT04416269|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110669971|NCT04416269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110669972|NCT04416269|Protease Inhibitors|protease inhibitors|mesh-ancestor
110669973|NCT04416269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110669974|NCT04416269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110669976|NCT04374461|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110669977|NCT04374461|Antiviral Agents|antiviral agents|mesh-ancestor
110669978|NCT04374461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110669979|NCT04374461|Expectorants|expectorants|mesh-ancestor
110669981|NCT04374461|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110669982|NCT04374461|Antioxidants|antioxidants|mesh-ancestor
110669983|NCT04374461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110669984|NCT04374461|Protective Agents|protective agents|mesh-ancestor
110669985|NCT04374461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110669986|NCT04374461|Antidotes|antidotes|mesh-ancestor
110669987|NCT04344860|Tranexamic Acid|tranexamic acid|mesh-list
110669988|NCT04344860|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110669989|NCT04344860|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110669990|NCT04344860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110669991|NCT04344860|Hemostatics|hemostatics|mesh-ancestor
110669992|NCT04344860|Coagulants|coagulants|mesh-ancestor
110669993|NCT04333420|Vilobelimab|vilobelimab|mesh-list
110669994|NCT04333420|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
110669995|NCT04333420|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110669996|NCT04333420|Immunologic Factors|immunologic factors|mesh-ancestor
110669997|NCT04333420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110669998|NCT04317534|Pembrolizumab|pembrolizumab|mesh-list
110669999|NCT04317534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110670000|NCT04317534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110670001|NCT04317534|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110670002|NCT04317534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110670003|NCT04247165|Paclitaxel|paclitaxel|mesh-list
110670004|NCT04247165|Gemcitabine|gemcitabine|mesh-list
110670005|NCT04247165|Nivolumab|nivolumab|mesh-list
110670006|NCT04247165|Ipilimumab|ipilimumab|mesh-list
110670007|NCT04247165|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110670008|NCT04247165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110670009|NCT04247165|Tubulin Modulators|tubulin modulators|mesh-ancestor
110670010|NCT04247165|Antimitotic Agents|antimitotic agents|mesh-ancestor
110670011|NCT04247165|Mitosis Modulators|mitosis modulators|mesh-ancestor
110670012|NCT04247165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110670013|NCT04247165|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110670014|NCT04247165|Antimetabolites|antimetabolites|mesh-ancestor
110670015|NCT04247165|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110670016|NCT04247165|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110670017|NCT04245865|Leucovorin|leucovorin|mesh-list
110670018|NCT04245865|Tocotrienols|tocotrienols|mesh-list
110670019|NCT04245865|Vitamin E|vitamin e|mesh-list
110670020|NCT04245865|Tocopherols|tocopherols|mesh-list
110670021|NCT04245865|Bevacizumab|bevacizumab|mesh-list
110670022|NCT04245865|Fluorouracil|fluorouracil|mesh-list
110670023|NCT04245865|Capecitabine|capecitabine|mesh-list
110670024|NCT04245865|Oxaliplatin|oxaliplatin|mesh-list
110670025|NCT04245865|Levoleucovorin|levoleucovorin|mesh-list
110448776|NCT00854581|Zidovudine|zidovudine|mesh-list
110670026|NCT04245865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110670027|NCT04245865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110670028|NCT04245865|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110670029|NCT04245865|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110670030|NCT04245865|Growth Substances|growth substances|mesh-ancestor
110670031|NCT04245865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110670032|NCT04245865|Growth Inhibitors|growth inhibitors|mesh-ancestor
110670033|NCT04245865|Antimetabolites|antimetabolites|mesh-ancestor
110670034|NCT04245865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110670035|NCT04245865|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110670036|NCT04245865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110670037|NCT04245865|Immunologic Factors|immunologic factors|mesh-ancestor
110670038|NCT04245865|Antidotes|antidotes|mesh-ancestor
110670039|NCT04245865|Protective Agents|protective agents|mesh-ancestor
110670040|NCT04245865|Vitamin B Complex|vitamin b complex|mesh-ancestor
110670041|NCT04245865|Vitamins|vitamins|mesh-ancestor
110670042|NCT04245865|Micronutrients|micronutrients|mesh-ancestor
110670043|NCT04245865|Antioxidants|antioxidants|mesh-ancestor
110670044|NCT04234867|Dapagliflozin|dapagliflozin|mesh-list
110670045|NCT04234867|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110670046|NCT04234867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110670047|NCT04234867|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110670048|NCT04234867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110670049|NCT04234048|Fenretinide|fenretinide|mesh-list
110670050|NCT04234048|Retinamide|retinamide|mesh-list
110670051|NCT04234048|Tretinoin|tretinoin|mesh-list
110670052|NCT04234048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110670053|NCT04234048|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110670054|NCT04234048|Protective Agents|protective agents|mesh-ancestor
110670055|NCT04234048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110670056|NCT04234048|Keratolytic Agents|keratolytic agents|mesh-ancestor
110670057|NCT04234048|Dermatologic Agents|dermatologic agents|mesh-ancestor
110670059|NCT04219280|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110670060|NCT04219280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110670061|NCT04219280|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110670062|NCT04219280|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110670063|NCT04219280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110670064|NCT04219280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110670065|NCT04219280|Dopamine Agents|dopamine agents|mesh-ancestor
110670066|NCT04219280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110670067|NCT04191096|Pembrolizumab|pembrolizumab|mesh-list
110670069|NCT04191096|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110670070|NCT04191096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110670071|NCT04191096|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110670072|NCT04191096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110670073|NCT04191096|Hormones|hormones|mesh-ancestor
110670074|NCT04191096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110670075|NCT04191096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110670076|NCT04177693|Letrozole|letrozole|mesh-list
110670077|NCT04177693|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
110670078|NCT04177693|Clomiphene|clomiphene|mesh-list
110670079|NCT04177693|Enclomiphene|enclomiphene|mesh-list
110670080|NCT04177693|Zuclomiphene|zuclomiphene|mesh-list
110670081|NCT04177693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110670082|NCT04177693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110670083|NCT04177693|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110670084|NCT04177693|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110670085|NCT04177693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110670086|NCT04177693|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110670087|NCT04177693|Hormone Antagonists|hormone antagonists|mesh-ancestor
110670088|NCT04177693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110670089|NCT04177693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110670090|NCT04177693|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110670091|NCT04177693|Fertility Agents|fertility agents|mesh-ancestor
110670092|NCT04177693|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110670093|NCT04177693|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110670094|NCT04177693|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110670095|NCT04177693|Antioxidants|antioxidants|mesh-ancestor
110670096|NCT04177693|Protective Agents|protective agents|mesh-ancestor
110670097|NCT04177693|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
110670098|NCT04177693|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110670099|NCT04177693|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110670100|NCT04118387|Acetazolamide|acetazolamide|mesh-list
110670101|NCT04118387|Zolpidem|zolpidem|mesh-list
110670102|NCT04118387|Buspirone|buspirone|mesh-list
110670103|NCT04118387|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110670104|NCT04118387|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110670105|NCT04118387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110670106|NCT04118387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110670107|NCT04118387|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
110670109|NCT04118387|GABA Agents|gaba agents|mesh-ancestor
110670110|NCT04118387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110670111|NCT04118387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110670112|NCT04118387|Anticonvulsants|anticonvulsants|mesh-ancestor
110670113|NCT04118387|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110670114|NCT04118387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110670115|NCT04118387|Diuretics|diuretics|mesh-ancestor
110670116|NCT04118387|Natriuretic Agents|natriuretic agents|mesh-ancestor
110670117|NCT04118387|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110670118|NCT04118387|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110670119|NCT04118387|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110670120|NCT04118387|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110670121|NCT04118387|Serotonin Agents|serotonin agents|mesh-ancestor
110670122|NCT04105335|Pembrolizumab|pembrolizumab|mesh-list
110670123|NCT04105335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110670124|NCT04105335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110670125|NCT04105335|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110670126|NCT04105335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110670127|NCT04072952|Palbociclib|palbociclib|mesh-list
110670147|NCT04006522|Atezolizumab|atezolizumab|mesh-list
110670148|NCT04006522|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110670149|NCT04006522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110670150|NCT04006522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110670151|NCT04006522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110670152|NCT03971734|Regadenoson|regadenoson|mesh-list
110670153|NCT03971734|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
110670154|NCT03971734|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
110670155|NCT03971734|Purinergic Agonists|purinergic agonists|mesh-ancestor
110670156|NCT03971734|Purinergic Agents|purinergic agents|mesh-ancestor
110670157|NCT03971734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110670158|NCT03971734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110670159|NCT03971734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110670160|NCT03922048|Bupivacaine|bupivacaine|mesh-list
110670161|NCT03922048|Anesthetics, Local|anesthetics, local|mesh-ancestor
110670162|NCT03922048|Anesthetics|anesthetics|mesh-ancestor
110670163|NCT03922048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110670164|NCT03922048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110670165|NCT03922048|Sensory System Agents|sensory system agents|mesh-ancestor
110670166|NCT03922048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110670167|NCT03914742|Temozolomide|temozolomide|mesh-list
110670168|NCT03914742|Pamiparib|pamiparib|mesh-list
110670169|NCT03914742|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
110670170|NCT03914742|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110670171|NCT03914742|Alkylating Agents|alkylating agents|mesh-ancestor
110670172|NCT03914742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110670173|NCT03914742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110670174|NCT03914742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110670175|NCT03891667|Disulfiram|disulfiram|mesh-list
110670176|NCT03891667|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110670177|NCT03891667|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
110670178|NCT03891667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110670179|NCT03891667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110670180|NCT03866174|Niacin|niacin|mesh-list
110670181|NCT03866174|Psilocybin|psilocybin|mesh-list
110670182|NCT03866174|Vitamins|vitamins|mesh-ancestor
110670183|NCT03866174|Micronutrients|micronutrients|mesh-ancestor
110670184|NCT03866174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110670185|NCT03866174|Vitamin B Complex|vitamin b complex|mesh-ancestor
110670186|NCT03866174|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110670187|NCT03866174|Antimetabolites|antimetabolites|mesh-ancestor
110670188|NCT03866174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110670189|NCT03866174|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110670190|NCT03866174|Vasodilator Agents|vasodilator agents|mesh-ancestor
110670191|NCT03866174|Hallucinogens|hallucinogens|mesh-ancestor
110670192|NCT03866174|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110670193|NCT03859869|Pancrelipase|pancrelipase|mesh-list
110670194|NCT03859869|Pancreatin|pancreatin|mesh-list
110670195|NCT03859869|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110670196|NCT03764098|Guanfacine|guanfacine|mesh-list
110670197|NCT03764098|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110670198|NCT03764098|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110670199|NCT03764098|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110670200|NCT03764098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110670201|NCT03764098|Adrenergic Agents|adrenergic agents|mesh-ancestor
110670202|NCT03764098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110670203|NCT03764098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110670205|NCT03740204|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110670206|NCT03740204|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110670207|NCT03740204|Estradiol|estradiol|mesh-list
110670208|NCT03740204|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110670209|NCT03740204|Progesterone|progesterone|mesh-list
110670210|NCT03740204|Estrogens|estrogens|mesh-ancestor
110670211|NCT03740204|Hormones|hormones|mesh-ancestor
110670212|NCT03740204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110670213|NCT03740204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110670214|NCT03740204|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110670215|NCT03740204|Contraceptive Agents|contraceptive agents|mesh-ancestor
110670216|NCT03740204|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110670217|NCT03740204|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110670218|NCT03740204|Progestins|progestins|mesh-ancestor
110670219|NCT03735563|Fentanyl|fentanyl|mesh-list
110670220|NCT03735563|Ketamine|ketamine|mesh-list
110670221|NCT03735563|Analgesics|analgesics|mesh-ancestor
110670222|NCT03735563|Sensory System Agents|sensory system agents|mesh-ancestor
110670223|NCT03735563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110670224|NCT03735563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110670225|NCT03735563|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110670226|NCT03735563|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110670227|NCT03735563|Anesthetics, General|anesthetics, general|mesh-ancestor
110670228|NCT03735563|Anesthetics|anesthetics|mesh-ancestor
110670229|NCT03735563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110670230|NCT03735563|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110670231|NCT03735563|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110670232|NCT03735563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110670233|NCT03735563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110670235|NCT03735563|Narcotics|narcotics|mesh-ancestor
110670236|NCT03735563|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110670237|NCT03715153|Bumetanide|bumetanide|mesh-list
110670238|NCT03715153|Diuretics|diuretics|mesh-ancestor
110670239|NCT03715153|Natriuretic Agents|natriuretic agents|mesh-ancestor
110670240|NCT03715153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110670241|NCT03715153|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110670242|NCT03715153|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110670243|NCT03715153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110670245|NCT03685773|Nicotinic Acids|nicotinic acids|mesh-list
110670246|NCT03685773|Niacinamide|niacinamide|mesh-list
110670247|NCT03685773|Diazoxide|diazoxide|mesh-list
110670248|NCT03685773|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110670249|NCT03685773|Antimetabolites|antimetabolites|mesh-ancestor
110670250|NCT03685773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110670251|NCT03685773|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110670252|NCT03685773|Vasodilator Agents|vasodilator agents|mesh-ancestor
110670253|NCT03685773|Vitamin B Complex|vitamin b complex|mesh-ancestor
110670254|NCT03685773|Vitamins|vitamins|mesh-ancestor
110670255|NCT03685773|Micronutrients|micronutrients|mesh-ancestor
110670256|NCT03685773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110670257|NCT03685773|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110670258|NCT03683277|Dexamethasone|dexamethasone|mesh-list
110670259|NCT03683277|Pomalidomide|pomalidomide|mesh-list
110670260|NCT03683277|Ixazomib|ixazomib|mesh-list
110670261|NCT03683277|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110670262|NCT03683277|Antiemetics|antiemetics|mesh-ancestor
110670263|NCT03683277|Autonomic Agents|autonomic agents|mesh-ancestor
110670264|NCT03683277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110670265|NCT03683277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110670266|NCT03683277|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110670267|NCT03683277|Glucocorticoids|glucocorticoids|mesh-ancestor
110670268|NCT03683277|Hormones|hormones|mesh-ancestor
110670269|NCT03683277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110670270|NCT03683277|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110670271|NCT03683277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110670272|NCT03683277|Immunologic Factors|immunologic factors|mesh-ancestor
110670273|NCT03683277|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110681176|NCT00262470|Adrenergic Agents|adrenergic agents|mesh-ancestor
110670274|NCT03683277|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110670275|NCT03683277|Growth Substances|growth substances|mesh-ancestor
110670276|NCT03683277|Growth Inhibitors|growth inhibitors|mesh-ancestor
110670277|NCT03683277|Protease Inhibitors|protease inhibitors|mesh-ancestor
110317436|NCT00346359|Antimetabolites|antimetabolites|mesh-ancestor
110670278|NCT03683277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110670279|NCT03683277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110670280|NCT03665207|Insulin|insulin|mesh-list
110670281|NCT03665207|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110670282|NCT03665207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110670283|NCT03660683|Dapagliflozin|dapagliflozin|mesh-list
110670284|NCT03660683|Saxagliptin|saxagliptin|mesh-list
110670285|NCT03660683|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110670286|NCT03660683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110670287|NCT03660683|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110670288|NCT03660683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110670289|NCT03660683|Incretins|incretins|mesh-ancestor
110670290|NCT03660683|Hormones|hormones|mesh-ancestor
110670291|NCT03660683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110670292|NCT03660683|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110670293|NCT03660683|Protease Inhibitors|protease inhibitors|mesh-ancestor
110670294|NCT03660683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110670295|NCT03569293|Upadacitinib|upadacitinib|mesh-list
110670296|NCT03569293|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
110670297|NCT03569293|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110670298|NCT03569293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110670299|NCT03569293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110670300|NCT03569293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110670301|NCT03566511|Diazoxide|diazoxide|mesh-list
110670302|NCT03566511|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110670303|NCT03566511|Vasodilator Agents|vasodilator agents|mesh-ancestor
110670305|NCT03464136|Ustekinumab|ustekinumab|mesh-list
110670306|NCT03464136|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110670307|NCT03464136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110670308|NCT03464136|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110670309|NCT03464136|Dermatologic Agents|dermatologic agents|mesh-ancestor
110670310|NCT03397706|Valganciclovir|valganciclovir|mesh-list
110670311|NCT03397706|Antiviral Agents|antiviral agents|mesh-ancestor
110670312|NCT03397706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110670313|NCT03382587|Aflibercept|aflibercept|mesh-list
110670314|NCT03382587|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110670315|NCT03382587|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110670316|NCT03382587|Growth Substances|growth substances|mesh-ancestor
110670317|NCT03382587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110670318|NCT03382587|Growth Inhibitors|growth inhibitors|mesh-ancestor
110670319|NCT03382587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110670320|NCT03325972|Dexmedetomidine|dexmedetomidine|mesh-list
110670321|NCT03325972|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110670322|NCT03325972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110670323|NCT03325972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110670324|NCT03325972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110670325|NCT03325972|Analgesics|analgesics|mesh-ancestor
110670326|NCT03325972|Sensory System Agents|sensory system agents|mesh-ancestor
110670327|NCT03325972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110670328|NCT03325972|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110670329|NCT03325972|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110670330|NCT03325972|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110670331|NCT03325972|Adrenergic Agents|adrenergic agents|mesh-ancestor
110670332|NCT03325972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110670333|NCT03325972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110670334|NCT03247712|Nivolumab|nivolumab|mesh-list
110670335|NCT03247712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110670336|NCT03247712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110670337|NCT03247712|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110670338|NCT03247712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110670339|NCT03198026|Obinutuzumab|obinutuzumab|mesh-list
110670340|NCT03198026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110670341|NCT03198026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110670342|NCT03125642|Cytarabine|cytarabine|mesh-list
110670343|NCT03125642|Cyclophosphamide|cyclophosphamide|mesh-list
110670344|NCT03125642|Melphalan|melphalan|mesh-list
110670345|NCT03125642|Carmustine|carmustine|mesh-list
110670346|NCT03125642|Etoposide|etoposide|mesh-list
110948233|NCT03036514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110670347|NCT03125642|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110670348|NCT03125642|Immunologic Factors|immunologic factors|mesh-ancestor
110670349|NCT03125642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110670350|NCT03125642|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110670351|NCT03125642|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110670352|NCT03125642|Alkylating Agents|alkylating agents|mesh-ancestor
110670353|NCT03125642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110670355|NCT03125642|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110670356|NCT03125642|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110670357|NCT03125642|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110670358|NCT03125642|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110448828|NCT02719834|Acetaminophen|acetaminophen|mesh-list
110670359|NCT03125642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110670360|NCT03125642|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110670361|NCT03125642|Antimetabolites|antimetabolites|mesh-ancestor
110670362|NCT03125642|Antiviral Agents|antiviral agents|mesh-ancestor
110670363|NCT03125642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110670365|NCT03048825|Spironolactone|spironolactone|mesh-list
110670366|NCT03048825|Gout Suppressants|gout suppressants|mesh-ancestor
110670367|NCT03048825|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110670368|NCT03048825|Tubulin Modulators|tubulin modulators|mesh-ancestor
110670369|NCT03048825|Antimitotic Agents|antimitotic agents|mesh-ancestor
110670370|NCT03048825|Mitosis Modulators|mitosis modulators|mesh-ancestor
110670371|NCT03048825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110670372|NCT03048825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110670373|NCT03048825|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110670374|NCT03048825|Hormone Antagonists|hormone antagonists|mesh-ancestor
110670375|NCT03048825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110670376|NCT03048825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110670377|NCT03048825|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110670378|NCT03048825|Diuretics|diuretics|mesh-ancestor
110670381|NCT03039413|Trace Elements|trace elements|mesh-ancestor
110670382|NCT03039413|Micronutrients|micronutrients|mesh-ancestor
110670383|NCT03039413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110670384|NCT03026790|Buprenorphine|buprenorphine|mesh-list
110670385|NCT03026790|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
110670386|NCT03026790|Naloxone|naloxone|mesh-list
110670387|NCT03026790|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110670388|NCT03026790|Narcotics|narcotics|mesh-ancestor
110670389|NCT03026790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110670390|NCT03026790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110670391|NCT03026790|Analgesics|analgesics|mesh-ancestor
110670392|NCT03026790|Sensory System Agents|sensory system agents|mesh-ancestor
110670393|NCT03026790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110670394|NCT03026790|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110670395|NCT02974725|Trametinib|trametinib|mesh-list
110670396|NCT02974725|Naporafenib|naporafenib|mesh-list
110670397|NCT02974725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110670398|NCT02974725|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110670399|NCT02974725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110670400|NCT02974725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110670401|NCT02955290|Pembrolizumab|pembrolizumab|mesh-list
110670402|NCT02955290|Nivolumab|nivolumab|mesh-list
110670403|NCT02955290|Vaccines|vaccines|mesh-list
110670404|NCT02955290|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
110670405|NCT02955290|Mitogens|mitogens|mesh-list
110670406|NCT02955290|Immunologic Factors|immunologic factors|mesh-ancestor
110670407|NCT02955290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110670408|NCT02955290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110670409|NCT02955290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110670410|NCT02955290|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110670411|NCT02955290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110670412|NCT02955290|Mitosis Modulators|mitosis modulators|mesh-ancestor
110670413|NCT02955290|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110670414|NCT02735707|Aspirin|aspirin|mesh-list
110670415|NCT02735707|Vitamins|vitamins|mesh-list
110670416|NCT02735707|Ascorbic Acid|ascorbic acid|mesh-list
110670417|NCT02735707|Interferons|interferons|mesh-list
110670418|NCT02735707|Ritonavir|ritonavir|mesh-list
110670419|NCT02735707|Lopinavir|lopinavir|mesh-list
110670420|NCT02735707|Interferon-beta|interferon-beta|mesh-list
110670421|NCT02735707|Oseltamivir|oseltamivir|mesh-list
110670422|NCT02735707|Interferon beta-1a|interferon beta-1a|mesh-list
110670423|NCT02735707|Antiviral Agents|antiviral agents|mesh-list
110670424|NCT02735707|Baloxavir|baloxavir|mesh-list
110670425|NCT02735707|Amoxicillin|amoxicillin|mesh-list
110670426|NCT02735707|Moxifloxacin|moxifloxacin|mesh-list
110670427|NCT02735707|Hydroxychloroquine|hydroxychloroquine|mesh-list
110670428|NCT02735707|Levofloxacin|levofloxacin|mesh-list
110670429|NCT02735707|Ivermectin|ivermectin|mesh-list
110670430|NCT02735707|Ceftriaxone|ceftriaxone|mesh-list
110670431|NCT02735707|Tazobactam|tazobactam|mesh-list
110670432|NCT02735707|Piperacillin|piperacillin|mesh-list
110670433|NCT02735707|Clavulanic Acid|clavulanic acid|mesh-list
110670434|NCT02735707|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
110670435|NCT02735707|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
110670437|NCT02735707|Dexamethasone|dexamethasone|mesh-list
110670438|NCT02735707|Hydrocortisone|hydrocortisone|mesh-list
110670439|NCT02735707|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
110670440|NCT02735707|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
110670441|NCT02735707|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
110670442|NCT02735707|Apremilast|apremilast|mesh-list
110670443|NCT02735707|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
110670444|NCT02735707|Losartan|losartan|mesh-list
110670445|NCT02735707|Valsartan|valsartan|mesh-list
110670446|NCT02735707|Telmisartan|telmisartan|mesh-list
110670447|NCT02735707|Candesartan|candesartan|mesh-list
110670448|NCT02735707|Ramipril|ramipril|mesh-list
110670449|NCT02735707|Olmesartan|olmesartan|mesh-list
110670450|NCT02735707|Enalapril|enalapril|mesh-list
110670451|NCT02735707|Lisinopril|lisinopril|mesh-list
110670452|NCT02735707|Irbesartan|irbesartan|mesh-list
110670453|NCT02735707|Perindopril|perindopril|mesh-list
110670454|NCT02735707|Captopril|captopril|mesh-list
110670455|NCT02735707|Trandolapril|trandolapril|mesh-list
110670456|NCT02735707|Clopidogrel|clopidogrel|mesh-list
110670457|NCT02735707|Ticagrelor|ticagrelor|mesh-list
110670458|NCT02735707|Simvastatin|simvastatin|mesh-list
110670459|NCT02735707|Enzyme Inhibitors|enzyme inhibitors|mesh-list
110670460|NCT02735707|Immunoglobulins|immunoglobulins|mesh-list
110670461|NCT02735707|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
110670462|NCT02735707|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
110670463|NCT02735707|Cysteamine|cysteamine|mesh-list
110670464|NCT02735707|Micronutrients|micronutrients|mesh-ancestor
110670465|NCT02735707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110670466|NCT02735707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110670467|NCT02735707|Antiemetics|antiemetics|mesh-ancestor
110670468|NCT02735707|Autonomic Agents|autonomic agents|mesh-ancestor
110670469|NCT02735707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110670470|NCT02735707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110670471|NCT02735707|Glucocorticoids|glucocorticoids|mesh-ancestor
110670472|NCT02735707|Hormones|hormones|mesh-ancestor
110670473|NCT02735707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110670474|NCT02735707|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110670475|NCT02735707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110670476|NCT02735707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110670477|NCT02735707|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110670478|NCT02735707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110670479|NCT02735707|Analgesics|analgesics|mesh-ancestor
110670480|NCT02735707|Sensory System Agents|sensory system agents|mesh-ancestor
110670481|NCT02735707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110670482|NCT02735707|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110670483|NCT02735707|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110670484|NCT02735707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110670485|NCT02735707|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110670486|NCT02735707|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110670487|NCT02735707|Antipyretics|antipyretics|mesh-ancestor
110670488|NCT02735707|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110670489|NCT02735707|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110670490|NCT02735707|Protease Inhibitors|protease inhibitors|mesh-ancestor
110670491|NCT02735707|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110670492|NCT02735707|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110670493|NCT02735707|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110670494|NCT02735707|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110670495|NCT02735707|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110670496|NCT02735707|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110670497|NCT02735707|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110670498|NCT02735707|Purinergic Agents|purinergic agents|mesh-ancestor
110670499|NCT02735707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110670500|NCT02735707|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110670501|NCT02735707|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110670502|NCT02735707|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110670503|NCT02735707|Antimetabolites|antimetabolites|mesh-ancestor
110670504|NCT02735707|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110670505|NCT02735707|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110670506|NCT02735707|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110670507|NCT02735707|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110670508|NCT02735707|Immunologic Factors|immunologic factors|mesh-ancestor
110317660|NCT00321074|Tacrolimus|tacrolimus|mesh-list
110670509|NCT02735707|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110670510|NCT02735707|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110670511|NCT02735707|Antimalarials|antimalarials|mesh-ancestor
110670512|NCT02735707|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110687693|NCT00453180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110670513|NCT02735707|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110670514|NCT02735707|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110670515|NCT02735707|Antioxidants|antioxidants|mesh-ancestor
110670516|NCT02735707|Protective Agents|protective agents|mesh-ancestor
110670517|NCT02735707|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110670518|NCT02735707|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110670519|NCT02735707|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110670520|NCT02735707|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
110670521|NCT02735707|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110670522|NCT02735707|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110670523|NCT02735707|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110670524|NCT02735707|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
110670525|NCT02697448|Propofol|propofol|mesh-list
110670526|NCT02697448|Sevoflurane|sevoflurane|mesh-list
110670527|NCT02697448|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110670528|NCT02697448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110670529|NCT02697448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110670530|NCT02697448|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110670531|NCT02697448|Anesthetics, General|anesthetics, general|mesh-ancestor
110670532|NCT02697448|Anesthetics|anesthetics|mesh-ancestor
110670533|NCT02697448|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110670534|NCT02697448|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110670535|NCT02647203|Fluorides|fluorides|mesh-list
110670536|NCT02647203|Cariostatic Agents|cariostatic agents|mesh-ancestor
110670537|NCT02647203|Protective Agents|protective agents|mesh-ancestor
110670538|NCT02647203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110670539|NCT02637973|Empagliflozin|empagliflozin|mesh-list
110670540|NCT02637973|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110670541|NCT02637973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110670542|NCT02637973|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110670543|NCT02637973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110670544|NCT02575794|Masoprocol|masoprocol|mesh-list
110670545|NCT02575794|Antioxidants|antioxidants|mesh-ancestor
110670546|NCT02575794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110670547|NCT02575794|Protective Agents|protective agents|mesh-ancestor
110670548|NCT02575794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110670549|NCT02575794|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
110670550|NCT02575794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110670551|NCT02575794|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110670552|NCT02575794|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110670553|NCT02575794|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110670554|NCT02575794|Analgesics|analgesics|mesh-ancestor
110670555|NCT02575794|Sensory System Agents|sensory system agents|mesh-ancestor
110670556|NCT02575794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110670557|NCT02575794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110670558|NCT02575794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110670559|NCT02546921|Immunoglobulin E|immunoglobulin e|mesh-list
110670560|NCT02546921|Immunologic Factors|immunologic factors|mesh-ancestor
110670561|NCT02546921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110670562|NCT02527681|Ceftobiprole|ceftobiprole|mesh-list
110670563|NCT02527681|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
110670564|NCT02527681|Cephalosporins|cephalosporins|mesh-list
110670565|NCT02527681|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110670566|NCT02527681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110670567|NCT02516696|Clarithromycin|clarithromycin|mesh-list
110670568|NCT02516696|Dexamethasone|dexamethasone|mesh-list
110670569|NCT02516696|Lenalidomide|lenalidomide|mesh-list
110670570|NCT02516696|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110670571|NCT02516696|Antiemetics|antiemetics|mesh-ancestor
110670572|NCT02516696|Autonomic Agents|autonomic agents|mesh-ancestor
110670573|NCT02516696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110670574|NCT02516696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110670575|NCT02516696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110670576|NCT02516696|Glucocorticoids|glucocorticoids|mesh-ancestor
110670577|NCT02516696|Hormones|hormones|mesh-ancestor
110670578|NCT02516696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110670579|NCT02516696|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110670580|NCT02516696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110670581|NCT02516696|Immunologic Factors|immunologic factors|mesh-ancestor
110670582|NCT02516696|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110670583|NCT02516696|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110670584|NCT02516696|Growth Substances|growth substances|mesh-ancestor
110317744|NCT00351975|Belinostat|belinostat|mesh-list
110670585|NCT02516696|Growth Inhibitors|growth inhibitors|mesh-ancestor
110670586|NCT02516696|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110670587|NCT02516696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110670588|NCT02516696|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110670589|NCT02516696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110670590|NCT02516696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110670591|NCT02516696|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110670592|NCT02516696|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110670593|NCT02513329|Bupivacaine|bupivacaine|mesh-list
110670594|NCT02513329|Anesthetics, Local|anesthetics, local|mesh-ancestor
110670595|NCT02513329|Anesthetics|anesthetics|mesh-ancestor
110670596|NCT02513329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110670597|NCT02513329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110670598|NCT02513329|Sensory System Agents|sensory system agents|mesh-ancestor
110670599|NCT02513329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110670600|NCT02425826|Thalidomide|thalidomide|mesh-list
110670602|NCT02425826|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110670603|NCT02425826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110670604|NCT02425826|Analgesics|analgesics|mesh-ancestor
110670605|NCT02425826|Sensory System Agents|sensory system agents|mesh-ancestor
110670606|NCT02425826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110670607|NCT02425826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110670608|NCT02425826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110670609|NCT02425826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110670610|NCT02425826|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
110670611|NCT02425826|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110670612|NCT02425826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110670613|NCT02425826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110670614|NCT02425826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110670615|NCT02425826|Immunologic Factors|immunologic factors|mesh-ancestor
110670616|NCT02425826|Leprostatic Agents|leprostatic agents|mesh-ancestor
110670617|NCT02425826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110670618|NCT02425826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110670619|NCT02425826|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110670620|NCT02425826|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110670621|NCT02425826|Growth Substances|growth substances|mesh-ancestor
110670622|NCT02425826|Growth Inhibitors|growth inhibitors|mesh-ancestor
110670623|NCT02425826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110670624|NCT02386774|Benoxinate|benoxinate|mesh-list
110670625|NCT02386774|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110670626|NCT02386774|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110670627|NCT02386774|Anesthetics, Local|anesthetics, local|mesh-ancestor
110670628|NCT02386774|Anesthetics|anesthetics|mesh-ancestor
110670629|NCT02386774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110670630|NCT02386774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110670631|NCT02386774|Sensory System Agents|sensory system agents|mesh-ancestor
110670632|NCT02386774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110670633|NCT02278120|Tamoxifen|tamoxifen|mesh-list
110670634|NCT02278120|Letrozole|letrozole|mesh-list
110670635|NCT02278120|Anastrozole|anastrozole|mesh-list
110670636|NCT02278120|Goserelin|goserelin|mesh-list
110670637|NCT02278120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110670638|NCT02278120|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110670639|NCT02278120|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110670640|NCT02278120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110670641|NCT02278120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110670642|NCT02278120|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110670643|NCT02278120|Hormone Antagonists|hormone antagonists|mesh-ancestor
110670644|NCT02278120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110670645|NCT02278120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110670646|NCT02278120|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110670647|NCT02278120|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110670648|NCT02278120|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110670649|NCT02278120|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110670650|NCT02274155|Antibodies|antibodies|mesh-list
110670651|NCT02274155|Immunologic Factors|immunologic factors|mesh-ancestor
110670652|NCT02274155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110670653|NCT02255357|Oxytocin|oxytocin|mesh-list
110670654|NCT02255357|Oxytocics|oxytocics|mesh-ancestor
110670655|NCT02255357|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110670656|NCT02255357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110670657|NCT02211131|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
110670658|NCT02211131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110670659|NCT02211131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110670660|NCT02155647|Avelumab|avelumab|mesh-list
110670661|NCT02155647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110670662|NCT02155647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110670664|NCT02057107|Cetuximab|cetuximab|mesh-list
110670665|NCT02057107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110670666|NCT02057107|Tubulin Modulators|tubulin modulators|mesh-ancestor
110670667|NCT02057107|Antimitotic Agents|antimitotic agents|mesh-ancestor
110670668|NCT02057107|Mitosis Modulators|mitosis modulators|mesh-ancestor
110670669|NCT02057107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110670670|NCT02057107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110670671|NCT01479075|Insulin|insulin|mesh-list
110670672|NCT01479075|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110670673|NCT01479075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110670674|NCT01479075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110670675|NCT01082679|Buprenorphine|buprenorphine|mesh-list
110670676|NCT01082679|Methadone|methadone|mesh-list
110670677|NCT01082679|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
110670678|NCT01082679|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110670679|NCT01082679|Narcotics|narcotics|mesh-ancestor
110670680|NCT01082679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110670681|NCT01082679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110670682|NCT01082679|Analgesics|analgesics|mesh-ancestor
110670683|NCT01082679|Sensory System Agents|sensory system agents|mesh-ancestor
110670684|NCT01082679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111479170|NCT05594823|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110670685|NCT01082679|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110670686|NCT01082679|Antitussive Agents|antitussive agents|mesh-ancestor
110670687|NCT01082679|Respiratory System Agents|respiratory system agents|mesh-ancestor
110670688|NCT00976963|Fosfomycin|fosfomycin|mesh-list
110670689|NCT00976963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110670690|NCT00976963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110670691|NCT00958633|Bupropion|bupropion|mesh-list
110670692|NCT00958633|Escitalopram|escitalopram|mesh-list
110670693|NCT00958633|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110670694|NCT00958633|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110670695|NCT00958633|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110670696|NCT00958633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110670697|NCT00958633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110670698|NCT00958633|Serotonin Agents|serotonin agents|mesh-ancestor
110670699|NCT00958633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110670700|NCT00958633|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110670701|NCT00958633|Antidepressive Agents|antidepressive agents|mesh-ancestor
110670702|NCT00958633|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110670703|NCT00958633|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110670704|NCT00958633|Dopamine Agents|dopamine agents|mesh-ancestor
110670705|NCT00958633|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110670706|NCT00958633|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110670707|NCT00958633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110670708|NCT00393783|Trastuzumab|trastuzumab|mesh-list
110670709|NCT00393783|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110670710|NCT00393783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110670711|NCT00074269|Cyclosporine|cyclosporine|mesh-list
110670712|NCT00074269|Methotrexate|methotrexate|mesh-list
110670713|NCT00074269|Fludarabine phosphate|fludarabine phosphate|mesh-list
110670714|NCT00074269|Fludarabine|fludarabine|mesh-list
110670715|NCT00074269|Melphalan|melphalan|mesh-list
110670716|NCT00074269|Cyclosporins|cyclosporins|mesh-list
110670717|NCT00074269|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110670718|NCT00074269|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110670719|NCT00074269|Abortifacient Agents|abortifacient agents|mesh-ancestor
110670720|NCT00074269|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110670721|NCT00074269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110670722|NCT00074269|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110670723|NCT00074269|Antimetabolites|antimetabolites|mesh-ancestor
110670724|NCT00074269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110670725|NCT00074269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110670726|NCT00074269|Dermatologic Agents|dermatologic agents|mesh-ancestor
110670727|NCT00074269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110670728|NCT00074269|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110670729|NCT00074269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110670730|NCT00074269|Immunologic Factors|immunologic factors|mesh-ancestor
110670731|NCT00074269|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110670732|NCT00074269|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110670733|NCT00074269|Antifungal Agents|antifungal agents|mesh-ancestor
110670734|NCT00074269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110670735|NCT00074269|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110670736|NCT00074269|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110670737|NCT00074269|Alkylating Agents|alkylating agents|mesh-ancestor
110670738|NCT00074269|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110670739|NCT00423735|Dasatinib|dasatinib|mesh-list
110670740|NCT00423735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110670741|NCT00423735|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110670742|NCT00423735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110670743|NCT00423735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110670744|NCT01032213|Magnesium Sulfate|magnesium sulfate|mesh-list
110670745|NCT01032213|Analgesics|analgesics|mesh-ancestor
110670746|NCT01032213|Sensory System Agents|sensory system agents|mesh-ancestor
110670747|NCT01032213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110670748|NCT01032213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110670749|NCT01032213|Anesthetics|anesthetics|mesh-ancestor
110670750|NCT01032213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110670751|NCT01032213|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110670752|NCT01032213|Anticonvulsants|anticonvulsants|mesh-ancestor
110670753|NCT01032213|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110670754|NCT01032213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110670755|NCT01032213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110670756|NCT01032213|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110670757|NCT01032213|Tocolytic Agents|tocolytic agents|mesh-ancestor
110670758|NCT01032213|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110670759|NCT00357994|Levodopa|levodopa|mesh-list
110670760|NCT00357994|Carbidopa|carbidopa|mesh-list
110023795|NCT00004056|Melphalan|melphalan|mesh-list
110670761|NCT00357994|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
110670762|NCT00357994|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110670763|NCT00357994|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110670764|NCT00357994|Dopamine Agents|dopamine agents|mesh-ancestor
110670765|NCT00357994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110670766|NCT00357994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110670767|NCT00357994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110670768|NCT00357994|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
110670769|NCT00357994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110670770|NCT00357994|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110670771|NCT00357994|Immunologic Factors|immunologic factors|mesh-ancestor
110670772|NCT00357994|Dopamine Agonists|dopamine agonists|mesh-ancestor
110670773|NCT00823433|Penicillins|penicillins|mesh-list
110670774|NCT00823433|Penicillin V|penicillin v|mesh-list
110670775|NCT00823433|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110670776|NCT00823433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110670777|NCT00423657|Vancomycin|vancomycin|mesh-list
110670778|NCT00423657|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
110670779|NCT00423657|Aztreonam|aztreonam|mesh-list
110670780|NCT00423657|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110670781|NCT00423657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110670782|NCT00831155|Nicotine|nicotine|mesh-list
110670783|NCT00831155|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110670784|NCT00831155|Autonomic Agents|autonomic agents|mesh-ancestor
110670785|NCT00831155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110670786|NCT00831155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110670787|NCT00831155|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110670788|NCT00831155|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110670789|NCT00831155|Cholinergic Agents|cholinergic agents|mesh-ancestor
110670790|NCT00831155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110670791|NCT00831155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110670792|NCT00827021|Epoetin Alfa|epoetin alfa|mesh-list
110670793|NCT00827021|Hematinics|hematinics|mesh-list
110670794|NCT01050712|Carbon Monoxide|carbon monoxide|mesh-list
110670795|NCT01050712|Antimetabolites|antimetabolites|mesh-ancestor
110670796|NCT01050712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110670797|NCT01050712|Gasotransmitters|gasotransmitters|mesh-ancestor
110670798|NCT01050712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110670799|NCT01050712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110670800|NCT02550119|Dexamethasone|dexamethasone|mesh-list
110670801|NCT02550119|Dexamethasone acetate|dexamethasone acetate|mesh-list
110670802|NCT02550119|Aprepitant|aprepitant|mesh-list
110670803|NCT02550119|Dolasetron|dolasetron|mesh-list
110670804|NCT02550119|Ichthammol|ichthammol|mesh-list
110670805|NCT02550119|BB 1101|bb 1101|mesh-list
110670806|NCT02550119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110670807|NCT02550119|Antiemetics|antiemetics|mesh-ancestor
110670808|NCT02550119|Autonomic Agents|autonomic agents|mesh-ancestor
110670809|NCT02550119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110670810|NCT02550119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110670811|NCT02550119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110670812|NCT02550119|Glucocorticoids|glucocorticoids|mesh-ancestor
110670813|NCT02550119|Hormones|hormones|mesh-ancestor
110670814|NCT02550119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110670815|NCT02550119|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110670816|NCT02550119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110670817|NCT02550119|Protease Inhibitors|protease inhibitors|mesh-ancestor
110670818|NCT02550119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110670819|NCT02550119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110670820|NCT02550119|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110670821|NCT02550119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110670822|NCT02550119|Dermatologic Agents|dermatologic agents|mesh-ancestor
110670823|NCT02550119|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110670824|NCT02550119|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110670825|NCT02550119|Serotonin Agents|serotonin agents|mesh-ancestor
110670826|NCT02548403|Simethicone|simethicone|mesh-list
110670827|NCT02548403|Antifoaming Agents|antifoaming agents|mesh-ancestor
110670828|NCT02548403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110670829|NCT02548403|Emollients|emollients|mesh-ancestor
110670830|NCT02548403|Dermatologic Agents|dermatologic agents|mesh-ancestor
110670831|NCT00367432|Levetiracetam|levetiracetam|mesh-list
110670832|NCT00367432|Anticonvulsants|anticonvulsants|mesh-ancestor
110670833|NCT00367432|Nootropic Agents|nootropic agents|mesh-ancestor
110448895|NCT02717884|Antimetabolites|antimetabolites|mesh-ancestor
110670835|NCT00623363|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110670836|NCT00623363|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110670837|NCT00623363|Serotonin Agents|serotonin agents|mesh-ancestor
110670838|NCT00623363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110670839|NCT00623363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110670840|NCT00623363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110670841|NCT00827177|Sorafenib|sorafenib|mesh-list
110670842|NCT00827177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110670843|NCT00827177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110670844|NCT00827177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110670845|NCT00827177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110670846|NCT00423267|Fluconazole|fluconazole|mesh-list
110670847|NCT00423267|Posaconazole|posaconazole|mesh-list
110670848|NCT00423267|Antifungal Agents|antifungal agents|mesh-ancestor
110670849|NCT00423267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110670850|NCT00423267|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110670851|NCT00423267|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110670852|NCT00423267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110670853|NCT00423267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110670854|NCT00423267|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110670855|NCT00423267|Hormone Antagonists|hormone antagonists|mesh-ancestor
110670856|NCT00423267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110670857|NCT00423267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110670858|NCT00423267|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110670859|NCT00423267|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110670860|NCT00423267|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
110670861|NCT00423267|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110670862|NCT00423267|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110670863|NCT02549261|Etoposide|etoposide|mesh-list
110670864|NCT02549261|Nimotuzumab|nimotuzumab|mesh-list
110670865|NCT02549261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110670866|NCT02549261|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110670867|NCT02549261|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110670868|NCT02549261|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110670869|NCT02549261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110670870|NCT02549261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110670871|NCT02549261|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110670872|NCT00357760|Aflibercept|aflibercept|mesh-list
110670873|NCT00357760|Endothelial Growth Factors|endothelial growth factors|mesh-list
110670874|NCT00357760|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110670875|NCT00357760|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110670876|NCT00357760|Growth Substances|growth substances|mesh-ancestor
110670877|NCT00357760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110670878|NCT00357760|Growth Inhibitors|growth inhibitors|mesh-ancestor
110670879|NCT00357760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110681772|NCT00345046|Antiemetics|antiemetics|mesh-ancestor
110670880|NCT00622739|Ziprasidone|ziprasidone|mesh-list
110670881|NCT00622739|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110670882|NCT00622739|Serotonin Agents|serotonin agents|mesh-ancestor
110670883|NCT00622739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110670884|NCT00622739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110670885|NCT00622739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110670886|NCT00622739|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110670887|NCT00622739|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110670888|NCT00622739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110670889|NCT00622739|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110670890|NCT00622739|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110670891|NCT00622739|Dopamine Agents|dopamine agents|mesh-ancestor
110670892|NCT03742336|Dabigatran|dabigatran|mesh-list
110670893|NCT03742336|Abrocitinib|abrocitinib|mesh-list
110670894|NCT03742336|Antithrombins|antithrombins|mesh-ancestor
110670895|NCT03742336|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110670896|NCT03742336|Protease Inhibitors|protease inhibitors|mesh-ancestor
110670897|NCT03742336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110670898|NCT03742336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110670899|NCT03742336|Anticoagulants|anticoagulants|mesh-ancestor
110670900|NCT03742336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110670901|NCT00435825|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110670902|NCT00435825|Antiviral Agents|antiviral agents|mesh-ancestor
110670903|NCT00435825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110670904|NCT00824057|Midazolam|midazolam|mesh-list
110670905|NCT00824057|Caffeine|caffeine|mesh-list
110670906|NCT00824057|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110670907|NCT00824057|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110670908|NCT00824057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110670909|NCT00824057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110670910|NCT00824057|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110670911|NCT00824057|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110670912|NCT00824057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110670913|NCT00824057|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110670914|NCT00824057|Anesthetics, General|anesthetics, general|mesh-ancestor
110670915|NCT00824057|Anesthetics|anesthetics|mesh-ancestor
110670916|NCT00824057|GABA Modulators|gaba modulators|mesh-ancestor
110670917|NCT00824057|GABA Agents|gaba agents|mesh-ancestor
110670918|NCT00824057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110670919|NCT00824057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110670920|NCT00824057|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110670921|NCT00824057|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110670922|NCT00824057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110670923|NCT00824057|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110670924|NCT00824057|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110670925|NCT00824057|Purinergic Agents|purinergic agents|mesh-ancestor
110670926|NCT01053208|Diphenhydramine|diphenhydramine|mesh-list
110670927|NCT01053208|Promethazine|promethazine|mesh-list
110670928|NCT01053208|Ibuprofen|ibuprofen|mesh-list
110670929|NCT01053208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110670930|NCT01053208|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110670931|NCT01053208|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110670932|NCT01053208|Analgesics|analgesics|mesh-ancestor
110670933|NCT01053208|Sensory System Agents|sensory system agents|mesh-ancestor
110670934|NCT01053208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110670935|NCT01053208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110670936|NCT01053208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110670937|NCT01053208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110670938|NCT01053208|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110670939|NCT01053208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110670940|NCT01053208|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110670941|NCT01053208|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110670942|NCT01053208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110670943|NCT01053208|Anesthetics, Local|anesthetics, local|mesh-ancestor
110670944|NCT01053208|Anesthetics|anesthetics|mesh-ancestor
110670945|NCT01053208|Antiemetics|antiemetics|mesh-ancestor
110670946|NCT01053208|Autonomic Agents|autonomic agents|mesh-ancestor
110670947|NCT01053208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110670948|NCT01053208|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110670949|NCT01053208|Histamine Antagonists|histamine antagonists|mesh-ancestor
110670950|NCT01053208|Histamine Agents|histamine agents|mesh-ancestor
110670951|NCT01053208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110670952|NCT01053208|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110670953|NCT01053208|Antipruritics|antipruritics|mesh-ancestor
110670954|NCT01053208|Dermatologic Agents|dermatologic agents|mesh-ancestor
110948234|NCT03036514|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110670956|NCT00423189|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110670957|NCT00423189|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110670958|NCT00423189|Growth Substances|growth substances|mesh-ancestor
110670959|NCT00423189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110670960|NCT00423189|Growth Inhibitors|growth inhibitors|mesh-ancestor
110318107|NCT00324077|Dasatinib|dasatinib|mesh-list
110670961|NCT00423189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110670962|NCT00831545|Temozolomide|temozolomide|mesh-list
110670963|NCT00831545|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110670964|NCT00831545|Alkylating Agents|alkylating agents|mesh-ancestor
110670965|NCT00831545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110670966|NCT00831545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110670967|NCT00824135|Mycophenolic Acid|mycophenolic acid|mesh-list
110670969|NCT00824135|Melphalan|melphalan|mesh-list
110670970|NCT00824135|Thiotepa|thiotepa|mesh-list
110670971|NCT00824135|Clofarabine|clofarabine|mesh-list
110670972|NCT00824135|Muromonab-CD3|muromonab-cd3|mesh-list
110670973|NCT00824135|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110670974|NCT00824135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110670975|NCT00824135|Immunologic Factors|immunologic factors|mesh-ancestor
110670976|NCT00824135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110670977|NCT00824135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110670978|NCT00824135|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110670979|NCT00824135|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110670980|NCT00824135|Antitubercular Agents|antitubercular agents|mesh-ancestor
110670981|NCT00824135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110670982|NCT00824135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110670983|NCT00824135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110670984|NCT00824135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110670985|NCT00824135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110670986|NCT00824135|Alkylating Agents|alkylating agents|mesh-ancestor
110670987|NCT00824135|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110670988|NCT00824135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110670989|NCT00824135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110670990|NCT00824135|Antimetabolites|antimetabolites|mesh-ancestor
110670991|NCT00422799|Rituximab|rituximab|mesh-list
110670992|NCT00422799|Bortezomib|bortezomib|mesh-list
110670993|NCT00422799|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110670994|NCT00422799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110670995|NCT00422799|Immunologic Factors|immunologic factors|mesh-ancestor
110670996|NCT00422799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110670997|NCT00422799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110670998|NCT00827411|Aspirin|aspirin|mesh-list
110670999|NCT00827411|Clopidogrel|clopidogrel|mesh-list
110671000|NCT00827411|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
110671001|NCT00827411|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110671002|NCT00827411|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110671003|NCT00827411|Analgesics|analgesics|mesh-ancestor
110671004|NCT00827411|Sensory System Agents|sensory system agents|mesh-ancestor
110671005|NCT00827411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110671006|NCT00827411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110671007|NCT00827411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110671008|NCT00827411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110671009|NCT00827411|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110671010|NCT00827411|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110671011|NCT00827411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110671012|NCT00827411|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110671013|NCT00827411|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110671014|NCT00827411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110671015|NCT00827411|Antipyretics|antipyretics|mesh-ancestor
110671016|NCT00827411|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110671017|NCT00827411|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110671018|NCT00827411|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110671019|NCT00827411|Purinergic Agents|purinergic agents|mesh-ancestor
110671020|NCT00827411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110671021|NCT00435045|Atorvastatin|atorvastatin|mesh-list
110671022|NCT00435045|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110671023|NCT00435045|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110671024|NCT00435045|Antimetabolites|antimetabolites|mesh-ancestor
110671025|NCT00435045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110671026|NCT00435045|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110671027|NCT00435045|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110671028|NCT00435045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110671029|NCT00441129|Insulin|insulin|mesh-list
110671030|NCT00441129|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110671031|NCT00441129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110671032|NCT00622505|Zoledronic Acid|zoledronic acid|mesh-list
110671033|NCT00622505|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110671034|NCT00622505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110671035|NCT00831857|Bevacizumab|bevacizumab|mesh-list
110671036|NCT00831857|89Zr-bevacizumab|89zr-bevacizumab|mesh-list
110671037|NCT00831857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110671038|NCT00831857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110671039|NCT00831857|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110671040|NCT00831857|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110671041|NCT00831857|Growth Substances|growth substances|mesh-ancestor
110671042|NCT00831857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110671043|NCT00831857|Growth Inhibitors|growth inhibitors|mesh-ancestor
110671044|NCT00831857|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110671045|NCT00831857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110671046|NCT00832013|Propofol|propofol|mesh-list
110671047|NCT00832013|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110671048|NCT00832013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110671049|NCT00832013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110671050|NCT00832013|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110671051|NCT00832013|Anesthetics, General|anesthetics, general|mesh-ancestor
110671052|NCT00832013|Anesthetics|anesthetics|mesh-ancestor
110671053|NCT00832481|Metformin|metformin|mesh-list
110671054|NCT00832481|Repaglinide|repaglinide|mesh-list
110671055|NCT00832481|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110671056|NCT00832481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110671057|NCT04044287|Misoprostol|misoprostol|mesh-list
110671058|NCT04044287|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110671059|NCT04044287|Abortifacient Agents|abortifacient agents|mesh-ancestor
110671060|NCT04044287|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110671061|NCT04044287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110671062|NCT04044287|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110671063|NCT04044287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110671064|NCT04044287|Oxytocics|oxytocics|mesh-ancestor
110671065|NCT00357370|Dapagliflozin|dapagliflozin|mesh-list
110671066|NCT00357370|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110671067|NCT00357370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110671068|NCT00357370|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110671069|NCT00357370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110671070|NCT00825071|Dexamethasone|dexamethasone|mesh-list
110671071|NCT00825071|Ondansetron|ondansetron|mesh-list
110671072|NCT00825071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110671073|NCT00825071|Antiemetics|antiemetics|mesh-ancestor
110671074|NCT00825071|Autonomic Agents|autonomic agents|mesh-ancestor
110671075|NCT00825071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110671076|NCT00825071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110671077|NCT00825071|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110671078|NCT00825071|Glucocorticoids|glucocorticoids|mesh-ancestor
110671079|NCT00825071|Hormones|hormones|mesh-ancestor
110671080|NCT00825071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110671081|NCT00825071|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110671082|NCT00825071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110671083|NCT00825071|Antipruritics|antipruritics|mesh-ancestor
110671084|NCT00825071|Dermatologic Agents|dermatologic agents|mesh-ancestor
110671085|NCT00825071|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110671086|NCT00825071|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110671087|NCT00825071|Serotonin Agents|serotonin agents|mesh-ancestor
110671088|NCT00825071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110671089|NCT00825071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110671090|NCT00574847|Escitalopram|escitalopram|mesh-list
110671091|NCT00574847|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110671092|NCT00574847|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110671093|NCT00574847|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110671094|NCT00574847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110671095|NCT00574847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110671096|NCT00574847|Serotonin Agents|serotonin agents|mesh-ancestor
110671097|NCT00574847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110671098|NCT00348790|Vatalanib|vatalanib|mesh-list
110671099|NCT00348790|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110671100|NCT00348790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110671101|NCT00348790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110671102|NCT00825149|Prednisone|prednisone|mesh-list
110671103|NCT00825149|Cyclophosphamide|cyclophosphamide|mesh-list
110671104|NCT00825149|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110671105|NCT00825149|Doxorubicin|doxorubicin|mesh-list
110671106|NCT00825149|Fludarabine|fludarabine|mesh-list
110671107|NCT00825149|Vincristine|vincristine|mesh-list
110671108|NCT00825149|Obinutuzumab|obinutuzumab|mesh-list
110671109|NCT00825149|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110671110|NCT00825149|Immunologic Factors|immunologic factors|mesh-ancestor
110671111|NCT00825149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110671112|NCT00825149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110671113|NCT00825149|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110671114|NCT00825149|Alkylating Agents|alkylating agents|mesh-ancestor
110671115|NCT00825149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110671116|NCT00825149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110671117|NCT00825149|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110671118|NCT00825149|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110671119|NCT00825149|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110671120|NCT00825149|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110671121|NCT00825149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110671122|NCT00825149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110671123|NCT00825149|Glucocorticoids|glucocorticoids|mesh-ancestor
110671124|NCT00825149|Hormones|hormones|mesh-ancestor
110671125|NCT00825149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110671126|NCT00825149|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110671127|NCT00825149|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110671128|NCT00825149|Tubulin Modulators|tubulin modulators|mesh-ancestor
110671129|NCT00825149|Antimitotic Agents|antimitotic agents|mesh-ancestor
110671130|NCT00825149|Mitosis Modulators|mitosis modulators|mesh-ancestor
110671131|NCT00825149|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110671132|NCT00360490|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
110671133|NCT00360490|Levonorgestrel|levonorgestrel|mesh-list
110448953|NCT02716792|Ibandronic Acid|ibandronic acid|mesh-list
110671134|NCT00360490|Medroxyprogesterone|medroxyprogesterone|mesh-list
110671135|NCT00360490|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110671136|NCT00360490|Contraceptive Agents|contraceptive agents|mesh-ancestor
110671137|NCT00360490|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110671138|NCT00360490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110671139|NCT00360490|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110671140|NCT00360490|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110671141|NCT00360490|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110671142|NCT00360490|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110671143|NCT00360490|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110671144|NCT00360490|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110671145|NCT00360490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110671146|NCT02549105|Lidocaine|lidocaine|mesh-list
110671147|NCT02549105|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
110671148|NCT02549105|Anesthetics, Local|anesthetics, local|mesh-ancestor
110671149|NCT02549105|Anesthetics|anesthetics|mesh-ancestor
110671150|NCT02549105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110671151|NCT02549105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110671152|NCT02549105|Sensory System Agents|sensory system agents|mesh-ancestor
110671153|NCT02549105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110671154|NCT02549105|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110671155|NCT02549105|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110671156|NCT02549105|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110671157|NCT02549105|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110671158|NCT02549105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110671159|NCT02549105|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
110671160|NCT00624377|Tiotropium Bromide|tiotropium bromide|mesh-list
110671161|NCT00624377|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110671162|NCT00624377|Autonomic Agents|autonomic agents|mesh-ancestor
110671163|NCT00624377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110671164|NCT00624377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110671165|NCT00624377|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110671166|NCT00624377|Respiratory System Agents|respiratory system agents|mesh-ancestor
110671167|NCT00624377|Parasympatholytics|parasympatholytics|mesh-ancestor
110671168|NCT00624377|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110671169|NCT00624377|Cholinergic Agents|cholinergic agents|mesh-ancestor
110671170|NCT00624377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110671171|NCT00624377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110671172|NCT02549963|Rivaroxaban|rivaroxaban|mesh-list
110671173|NCT02549963|Anticoagulants|anticoagulants|mesh-list
110671174|NCT02549963|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110671175|NCT02549963|Antithrombins|antithrombins|mesh-ancestor
110671176|NCT02549963|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110671177|NCT02549963|Protease Inhibitors|protease inhibitors|mesh-ancestor
110671178|NCT02549963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110671179|NCT02549963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110671180|NCT00624065|Carvedilol|carvedilol|mesh-list
110671181|NCT00624065|Lisinopril|lisinopril|mesh-list
110671182|NCT00624065|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110671183|NCT00624065|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110671184|NCT00624065|Adrenergic Agents|adrenergic agents|mesh-ancestor
110671185|NCT00624065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110671186|NCT00624065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110671187|NCT00624065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110671188|NCT00624065|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110671189|NCT00624065|Antioxidants|antioxidants|mesh-ancestor
110671190|NCT00624065|Protective Agents|protective agents|mesh-ancestor
110671191|NCT00624065|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110671192|NCT00624065|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110671193|NCT00624065|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110671194|NCT00624065|Vasodilator Agents|vasodilator agents|mesh-ancestor
110671195|NCT00624065|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110671196|NCT00624065|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110671197|NCT00624065|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110671198|NCT00624065|Protease Inhibitors|protease inhibitors|mesh-ancestor
110671199|NCT00624065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110671200|NCT00624065|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110671201|NCT00833339|Mifepristone|mifepristone|mesh-list
110671202|NCT00833339|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
110671203|NCT00833339|Abortifacient Agents|abortifacient agents|mesh-ancestor
110671204|NCT00833339|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110671205|NCT00833339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110671206|NCT00833339|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110671207|NCT00833339|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110671208|NCT00833339|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110671209|NCT00833339|Contraceptive Agents|contraceptive agents|mesh-ancestor
110671210|NCT00833339|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
110671211|NCT00833339|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
110671212|NCT00833339|Hormone Antagonists|hormone antagonists|mesh-ancestor
110671213|NCT00833339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110671214|NCT00833339|Luteolytic Agents|luteolytic agents|mesh-ancestor
110671215|NCT00833339|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110671216|NCT00833339|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
110671217|NCT00825617|Hormones|hormones|mesh-list
110671218|NCT00825617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110671219|NCT00825617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110671220|NCT00360334|Insulin Glargine|insulin glargine|mesh-list
110671221|NCT00360334|Exenatide|exenatide|mesh-list
110671222|NCT00360334|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110671223|NCT00360334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110671224|NCT00360334|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110671225|NCT00360334|Incretins|incretins|mesh-ancestor
110671226|NCT00360334|Hormones|hormones|mesh-ancestor
110671227|NCT00360334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110671228|NCT00422097|Epothilones|epothilones|mesh-list
110671229|NCT00422097|Famotidine|famotidine|mesh-list
110671230|NCT00422097|Tubulin Modulators|tubulin modulators|mesh-ancestor
110671231|NCT00422097|Antimitotic Agents|antimitotic agents|mesh-ancestor
110671232|NCT00422097|Mitosis Modulators|mitosis modulators|mesh-ancestor
110671233|NCT00422097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110671234|NCT00422097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110671235|NCT00422097|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110671236|NCT00422097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110671237|NCT00422097|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110671238|NCT00422097|Histamine Antagonists|histamine antagonists|mesh-ancestor
110671239|NCT00422097|Histamine Agents|histamine agents|mesh-ancestor
110671240|NCT00422097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110671241|NCT00422097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110671242|NCT01051102|Insulin|insulin|mesh-list
110671243|NCT01051102|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110671244|NCT01051102|Insulin Aspart|insulin aspart|mesh-list
110671245|NCT01051102|Insulin, Long-Acting|insulin, long-acting|mesh-list
110671246|NCT01051102|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
110671247|NCT01051102|Biphasic Insulins|biphasic insulins|mesh-list
110671248|NCT01051102|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
110682157|NCT00893477|Rituximab|rituximab|mesh-list
110671249|NCT01051102|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110671250|NCT01051102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110671251|NCT00348556|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
110671252|NCT00348556|Natriuretic Agents|natriuretic agents|mesh-ancestor
110671253|NCT00348556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110671254|NCT00434967|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110671255|NCT00434967|Candesartan|candesartan|mesh-list
110671256|NCT00434967|Candesartan cilexetil|candesartan cilexetil|mesh-list
110671257|NCT00434967|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110671258|NCT00434967|Diuretics|diuretics|mesh-ancestor
110671259|NCT00434967|Natriuretic Agents|natriuretic agents|mesh-ancestor
110671260|NCT00434967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110671261|NCT00434967|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110671262|NCT00434967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110448994|NCT00765310|Thioctic Acid|thioctic acid|mesh-list
110671263|NCT00434967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110671264|NCT00434967|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110671265|NCT00434967|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110671267|NCT00833729|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110671268|NCT00833729|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110671269|NCT00833729|Analgesics|analgesics|mesh-ancestor
110671270|NCT00833729|Sensory System Agents|sensory system agents|mesh-ancestor
110671271|NCT00833729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110671272|NCT00833729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110671273|NCT00833729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110671274|NCT00833729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110671275|NCT00833729|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110671276|NCT00833729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110671277|NCT00833729|Immunologic Factors|immunologic factors|mesh-ancestor
110671278|NCT00837239|Gemcitabine|gemcitabine|mesh-list
110671279|NCT00837239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110671280|NCT00837239|Antimetabolites|antimetabolites|mesh-ancestor
110671281|NCT00837239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111479171|NCT05594823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110671283|NCT00833807|Paclitaxel|paclitaxel|mesh-list
110671284|NCT00833807|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110671285|NCT00833807|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110671286|NCT00833807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110671287|NCT00833807|Tubulin Modulators|tubulin modulators|mesh-ancestor
110671288|NCT00833807|Antimitotic Agents|antimitotic agents|mesh-ancestor
110671289|NCT00833807|Mitosis Modulators|mitosis modulators|mesh-ancestor
110671290|NCT00833807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110671291|NCT00833963|Trastuzumab|trastuzumab|mesh-list
110671292|NCT00833963|Pertuzumab|pertuzumab|mesh-list
110671293|NCT00833963|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
110671294|NCT00833963|Maytansine|maytansine|mesh-list
110671295|NCT00833963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110671296|NCT00833963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110671297|NCT00833963|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110671298|NCT00833963|Tubulin Modulators|tubulin modulators|mesh-ancestor
110671299|NCT00833963|Antimitotic Agents|antimitotic agents|mesh-ancestor
110671300|NCT00833963|Mitosis Modulators|mitosis modulators|mesh-ancestor
110671301|NCT00833963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110671302|NCT00833963|Immunotoxins|immunotoxins|mesh-ancestor
110671303|NCT00833963|Immunoconjugates|immunoconjugates|mesh-ancestor
110671304|NCT00833963|Immunologic Factors|immunologic factors|mesh-ancestor
110671305|NCT00833963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110671306|NCT00837317|Phenol|phenol|mesh-list
110671307|NCT00837317|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110671308|NCT00837317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110671309|NCT00837317|Disinfectants|disinfectants|mesh-ancestor
110671310|NCT00837317|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
110671311|NCT00837317|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110671312|NCT04043897|Rifaximin|rifaximin|mesh-list
110671313|NCT04043897|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110671314|NCT04043897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110671315|NCT04043897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110671316|NCT00356590|Etanercept|etanercept|mesh-list
110671317|NCT00356590|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110671318|NCT00356590|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110671319|NCT00356590|Analgesics|analgesics|mesh-ancestor
110671320|NCT00356590|Sensory System Agents|sensory system agents|mesh-ancestor
110671321|NCT00356590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110671322|NCT00356590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110948235|NCT03036514|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110671323|NCT00356590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110671324|NCT00356590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110671325|NCT00356590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110671326|NCT00356590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110671327|NCT00356590|Immunologic Factors|immunologic factors|mesh-ancestor
110671328|NCT00828503|Valganciclovir|valganciclovir|mesh-list
110671329|NCT00828503|Everolimus|everolimus|mesh-list
110671330|NCT00828503|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110671331|NCT00828503|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110671332|NCT00828503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110671333|NCT00828503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110671334|NCT00828503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110671335|NCT00828503|Immunologic Factors|immunologic factors|mesh-ancestor
110671336|NCT00828503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110671337|NCT00828503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110671338|NCT00828503|Antiviral Agents|antiviral agents|mesh-ancestor
110671339|NCT00828503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110671340|NCT00834665|Molgramostim|molgramostim|mesh-list
110671341|NCT00834665|Sargramostim|sargramostim|mesh-list
110671342|NCT00834665|Immunologic Factors|immunologic factors|mesh-ancestor
110671343|NCT00834665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110671344|NCT00834665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110671345|NCT00837707|Aripiprazole|aripiprazole|mesh-list
110671346|NCT00837707|Antidepressive Agents|antidepressive agents|mesh-ancestor
110671347|NCT00837707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110671348|NCT00837707|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110671349|NCT00837707|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110671350|NCT00837707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110671351|NCT00837707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110671352|NCT00837707|Dopamine Agonists|dopamine agonists|mesh-ancestor
110671353|NCT00837707|Dopamine Agents|dopamine agents|mesh-ancestor
110671354|NCT00837707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110671355|NCT00837707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110671356|NCT00837707|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110671357|NCT00837707|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110671358|NCT00837707|Serotonin Agents|serotonin agents|mesh-ancestor
110671359|NCT00837707|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110671360|NCT00837707|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110671361|NCT00837707|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110671362|NCT00837707|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110671363|NCT01055938|Valproic Acid|valproic acid|mesh-list
110671364|NCT01055938|Anticonvulsants|anticonvulsants|mesh-ancestor
110671365|NCT01055938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110671366|NCT01055938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110671367|NCT01055938|GABA Agents|gaba agents|mesh-ancestor
110671368|NCT01055938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110671369|NCT01055938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110671370|NCT01055938|Antimanic Agents|antimanic agents|mesh-ancestor
110671371|NCT01055938|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110671372|NCT01055938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110671373|NCT01055938|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110671374|NCT00837785|Dimethyl Fumarate|dimethyl fumarate|mesh-list
110671375|NCT00837785|Dermatologic Agents|dermatologic agents|mesh-ancestor
110671376|NCT00837785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110671377|NCT00837785|Immunologic Factors|immunologic factors|mesh-ancestor
110671378|NCT00837785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110671379|NCT00356278|Cycloserine|cycloserine|mesh-list
110671381|NCT00356278|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110671382|NCT00356278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110671383|NCT00356278|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110671384|NCT00356278|Antitubercular Agents|antitubercular agents|mesh-ancestor
110671385|NCT00356278|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110671386|NCT00356278|Antimetabolites|antimetabolites|mesh-ancestor
110671387|NCT00356278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110671388|NCT00356278|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110671389|NCT00356278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110671390|NCT00356278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110671391|NCT00356278|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110671392|NCT00356278|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110671393|NCT00356278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110671394|NCT00356278|GABA Modulators|gaba modulators|mesh-ancestor
110671395|NCT00356278|GABA Agents|gaba agents|mesh-ancestor
110671396|NCT00356278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110948236|NCT03036514|Anesthetics, General|anesthetics, general|mesh-ancestor
110671397|NCT03991780|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
110671398|NCT03991780|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110671399|NCT03991780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110671400|NCT03991780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110671401|NCT00837941|Diphenhydramine|diphenhydramine|mesh-list
110671402|NCT00837941|Promethazine|promethazine|mesh-list
110671403|NCT00837941|Pregabalin|pregabalin|mesh-list
110671404|NCT00837941|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110671405|NCT00837941|Analgesics|analgesics|mesh-ancestor
110671406|NCT00837941|Sensory System Agents|sensory system agents|mesh-ancestor
110671407|NCT00837941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110671408|NCT00837941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110671410|NCT00837941|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110345802|NCT04943588|Antibodies|antibodies|mesh-list
110687694|NCT00453180|Protective Agents|protective agents|mesh-ancestor
110687695|NCT00453180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110671411|NCT00837941|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110671412|NCT00837941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110671413|NCT00837941|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110671414|NCT00837941|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110671415|NCT00837941|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110671416|NCT00837941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110671417|NCT00837941|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110671418|NCT00837941|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110671419|NCT00837941|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110671420|NCT00837941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110671421|NCT00837941|Antidepressive Agents|antidepressive agents|mesh-ancestor
110671422|NCT00837941|Dopamine Agents|dopamine agents|mesh-ancestor
110671423|NCT00837941|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110671424|NCT00837941|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110671425|NCT00837941|Anesthetics, Local|anesthetics, local|mesh-ancestor
110671426|NCT00837941|Anesthetics|anesthetics|mesh-ancestor
110671427|NCT00837941|Antiemetics|antiemetics|mesh-ancestor
110671428|NCT00837941|Autonomic Agents|autonomic agents|mesh-ancestor
110671429|NCT00837941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110671430|NCT00837941|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110671431|NCT00837941|Histamine Antagonists|histamine antagonists|mesh-ancestor
110671433|NCT00837941|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110671434|NCT00837941|Antipruritics|antipruritics|mesh-ancestor
110671435|NCT00837941|Dermatologic Agents|dermatologic agents|mesh-ancestor
110671436|NCT01053442|Fe(III)-EDTA|fe(iii)-edta|mesh-list
110671437|NCT01053442|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110671438|NCT01053442|Chelating Agents|chelating agents|mesh-ancestor
110671439|NCT01053442|Sequestering Agents|sequestering agents|mesh-ancestor
110671440|NCT01053442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110671441|NCT00356200|Fluphenazine|fluphenazine|mesh-list
110671442|NCT00356200|Fluphenazine depot|fluphenazine depot|mesh-list
110671443|NCT00356200|Fluphenazine enanthate|fluphenazine enanthate|mesh-list
110671444|NCT00356200|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110671445|NCT00356200|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110671446|NCT00356200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110671447|NCT00356200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110671448|NCT00356200|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110671449|NCT00356200|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110671450|NCT00356200|Dopamine Agents|dopamine agents|mesh-ancestor
110671451|NCT00356200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110671452|NCT00356200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110671453|NCT00356122|Bevacizumab|bevacizumab|mesh-list
110671454|NCT00356122|Docetaxel|docetaxel|mesh-list
110671455|NCT00356122|Oxaliplatin|oxaliplatin|mesh-list
110671456|NCT00356122|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110671457|NCT00356122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110671458|NCT00356122|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110671459|NCT00356122|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110671460|NCT00356122|Growth Substances|growth substances|mesh-ancestor
110671461|NCT00356122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110671462|NCT00356122|Growth Inhibitors|growth inhibitors|mesh-ancestor
110671463|NCT00356122|Tubulin Modulators|tubulin modulators|mesh-ancestor
110671464|NCT00356122|Antimitotic Agents|antimitotic agents|mesh-ancestor
110671465|NCT00356122|Mitosis Modulators|mitosis modulators|mesh-ancestor
110671466|NCT00356122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110671467|NCT00828815|Etravirine|etravirine|mesh-list
110671468|NCT00828815|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110671469|NCT00828815|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110671470|NCT00828815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110671471|NCT00828815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110671472|NCT00828815|Antiviral Agents|antiviral agents|mesh-ancestor
110671473|NCT00828815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110671474|NCT01053520|Navitoclax|navitoclax|mesh-list
110671475|NCT01053520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110671476|NCT00347932|Besifloxacin|besifloxacin|mesh-list
110671477|NCT00347932|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110671478|NCT00347932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110671479|NCT00347932|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110671480|NCT00347932|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110671481|NCT00347932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110318634|NCT04708353|Pregabalin|pregabalin|mesh-list
110671482|NCT00347932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110671483|NCT00347932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110671484|NCT00828971|Amoxicillin|amoxicillin|mesh-list
110671485|NCT00828971|Moxifloxacin|moxifloxacin|mesh-list
110671486|NCT00828971|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
110671487|NCT00828971|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110671488|NCT00828971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110671489|NCT00828971|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110671490|NCT00828971|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110671491|NCT00828971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110671492|NCT00828971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110671493|NCT00828971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110671494|NCT00828971|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110671495|NCT00828971|Contraceptive Agents|contraceptive agents|mesh-ancestor
110671496|NCT00828971|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110671497|NCT00828971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110671498|NCT00828971|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110671499|NCT00828971|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110671500|NCT00828971|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110671501|NCT00528996|Bromides|bromides|mesh-list
110671502|NCT00528996|Tiotropium Bromide|tiotropium bromide|mesh-list
110671503|NCT00528996|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110671504|NCT00528996|Autonomic Agents|autonomic agents|mesh-ancestor
110671505|NCT00528996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110671506|NCT00528996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110671507|NCT00528996|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110671508|NCT00528996|Respiratory System Agents|respiratory system agents|mesh-ancestor
110671509|NCT00528996|Parasympatholytics|parasympatholytics|mesh-ancestor
110671510|NCT00528996|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110671511|NCT00528996|Cholinergic Agents|cholinergic agents|mesh-ancestor
110671512|NCT00528996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110671513|NCT00528996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110671514|NCT00528996|Anticonvulsants|anticonvulsants|mesh-ancestor
110671515|NCT00359788|Albuterol|albuterol|mesh-list
110671516|NCT00359788|Tiotropium Bromide|tiotropium bromide|mesh-list
110671517|NCT00359788|Ipratropium|ipratropium|mesh-list
110671518|NCT00359788|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110671519|NCT00359788|Autonomic Agents|autonomic agents|mesh-ancestor
110671520|NCT00359788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110671521|NCT00359788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110671522|NCT00359788|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110671523|NCT00359788|Respiratory System Agents|respiratory system agents|mesh-ancestor
110671524|NCT00359788|Parasympatholytics|parasympatholytics|mesh-ancestor
110671525|NCT00359788|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110671526|NCT00359788|Cholinergic Agents|cholinergic agents|mesh-ancestor
110671527|NCT00359788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110671528|NCT00359788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110671529|NCT00359788|Tocolytic Agents|tocolytic agents|mesh-ancestor
110671530|NCT00359788|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110671531|NCT00359788|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110671532|NCT00359788|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110671533|NCT00359788|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110671534|NCT00359788|Adrenergic Agents|adrenergic agents|mesh-ancestor
110671535|NCT05416476|Anisodine|anisodine|mesh-list
110671536|NCT05416476|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110671537|NCT05416476|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110671538|NCT05416476|Analgesics|analgesics|mesh-ancestor
110671539|NCT05416476|Sensory System Agents|sensory system agents|mesh-ancestor
110671540|NCT05416476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110671541|NCT05416476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110671542|NCT05416476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110671543|NCT05416476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110671544|NCT05416476|Parasympatholytics|parasympatholytics|mesh-ancestor
110671545|NCT05416476|Autonomic Agents|autonomic agents|mesh-ancestor
110671546|NCT00623597|Ritonavir|ritonavir|mesh-list
110671547|NCT00623597|Saquinavir|saquinavir|mesh-list
110671548|NCT00623597|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110671549|NCT00623597|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110671550|NCT00623597|Protease Inhibitors|protease inhibitors|mesh-ancestor
110671551|NCT00623597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110671552|NCT00623597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110671553|NCT00623597|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110671554|NCT00623597|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110671555|NCT00623597|Antiviral Agents|antiviral agents|mesh-ancestor
110671556|NCT00623597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110687696|NCT00453180|Antidotes|antidotes|mesh-ancestor
110671557|NCT00623597|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110687697|NCT00943709|Insulin|insulin|mesh-list
110671558|NCT00623597|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110671559|NCT01056172|Ribavirin|ribavirin|mesh-list
110671560|NCT01056172|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110671561|NCT01056172|Interferon-alpha|interferon-alpha|mesh-list
110671562|NCT01056172|Antimetabolites|antimetabolites|mesh-ancestor
110671563|NCT01056172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110671564|NCT01056172|Antiviral Agents|antiviral agents|mesh-ancestor
110671565|NCT01056172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110671566|NCT01056172|Immunologic Factors|immunologic factors|mesh-ancestor
110671567|NCT01056172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110671568|NCT00838955|Sirolimus|sirolimus|mesh-list
110671569|NCT00838955|Temsirolimus|temsirolimus|mesh-list
110671570|NCT00838955|MTOR Inhibitors|mtor inhibitors|mesh-list
110671571|NCT00838955|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110671572|NCT00838955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110671573|NCT00838955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110671574|NCT00838955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110671575|NCT00838955|Immunologic Factors|immunologic factors|mesh-ancestor
110671576|NCT00838955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110671577|NCT00838955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110671578|NCT00838955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110671579|NCT00838955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110671580|NCT00838955|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110671581|NCT00838955|Antifungal Agents|antifungal agents|mesh-ancestor
110671582|NCT00347776|Azithromycin|azithromycin|mesh-list
110671583|NCT00347776|Tetracycline|tetracycline|mesh-list
110671584|NCT00347776|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110671585|NCT00347776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110671586|NCT00347776|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110671587|NCT00347776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110671588|NCT00347776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110671589|NCT04452136|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
110671590|NCT04452136|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110671591|NCT04452136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110671592|NCT00829205|Rituximab|rituximab|mesh-list
110671593|NCT00829205|Carboplatin|carboplatin|mesh-list
110671594|NCT00829205|Etoposide|etoposide|mesh-list
110671595|NCT00829205|Ifosfamide|ifosfamide|mesh-list
110671596|NCT00829205|Selenomethylselenocysteine|selenomethylselenocysteine|mesh-list
110671597|NCT00829205|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110671598|NCT00829205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110671599|NCT00829205|Immunologic Factors|immunologic factors|mesh-ancestor
110671600|NCT00829205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110671601|NCT00829205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110671602|NCT00829205|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110671603|NCT00829205|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110671604|NCT00829205|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110671605|NCT00829205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110671606|NCT00829205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110671607|NCT00829205|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110671608|NCT00829205|Alkylating Agents|alkylating agents|mesh-ancestor
110671609|NCT00829205|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110671610|NCT00829205|Protective Agents|protective agents|mesh-ancestor
110671611|NCT04944888|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
110671612|NCT04944888|Eliglustat|eliglustat|mesh-list
110671613|NCT04944888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110671614|NCT04944888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110671615|NCT04944888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110671616|NCT04944888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110671617|NCT00839111|Irinotecan|irinotecan|mesh-list
110671618|NCT00839111|Sorafenib|sorafenib|mesh-list
110671619|NCT00839111|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110671620|NCT00839111|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110671621|NCT00839111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110671622|NCT00839111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110671623|NCT00839111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110671624|NCT00839111|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110671625|NCT00836381|Tolterodine Tartrate|tolterodine tartrate|mesh-list
110671626|NCT00836381|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110671627|NCT00836381|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110671628|NCT00836381|Cholinergic Agents|cholinergic agents|mesh-ancestor
110671629|NCT00836381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110671630|NCT00836381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110318783|NCT00425997|Diuretics|diuretics|mesh-ancestor
110687698|NCT00943709|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110671631|NCT00836381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110671632|NCT00836381|Urological Agents|urological agents|mesh-ancestor
110671634|NCT02533336|Anthelmintics|anthelmintics|mesh-ancestor
110671635|NCT02533336|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110671636|NCT02533336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110671637|NCT05367960|BPN14770|bpn14770|mesh-list
110671638|NCT05367960|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
110671639|NCT05367960|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110671640|NCT05367960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110671641|NCT05367960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110671642|NCT01053910|Ramipril|ramipril|mesh-list
110671643|NCT01053910|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110671644|NCT01053910|Protease Inhibitors|protease inhibitors|mesh-ancestor
110671645|NCT01053910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110671646|NCT01053910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110671647|NCT01053910|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110671648|NCT00829595|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110671649|NCT00829595|Immunologic Factors|immunologic factors|mesh-ancestor
110671650|NCT00829595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110671651|NCT01008384|Vitamin D|vitamin d|mesh-list
110671652|NCT01008384|Cholecalciferol|cholecalciferol|mesh-list
110671653|NCT01008384|Vitamins|vitamins|mesh-ancestor
110671654|NCT01008384|Micronutrients|micronutrients|mesh-ancestor
110671655|NCT01008384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110671656|NCT01008384|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110671657|NCT01008384|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110671658|NCT02547155|Anesthetics|anesthetics|mesh-list
110671659|NCT02547155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110671660|NCT02547155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110671661|NCT00836849|Sertraline|sertraline|mesh-list
110671662|NCT00836849|Antidepressive Agents|antidepressive agents|mesh-ancestor
110671663|NCT00836849|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110671664|NCT00836849|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110671665|NCT00836849|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110671666|NCT00836849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110671667|NCT00836849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110671668|NCT00836849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110671669|NCT00836849|Serotonin Agents|serotonin agents|mesh-ancestor
110671670|NCT00836849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110671671|NCT00839345|Clopidogrel|clopidogrel|mesh-list
110671672|NCT00839345|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110671673|NCT00839345|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110671674|NCT00839345|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110671675|NCT00839345|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110671676|NCT00839345|Purinergic Agents|purinergic agents|mesh-ancestor
110671677|NCT00839345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110671678|NCT00839345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110671679|NCT00839345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110671680|NCT00839501|Acetazolamide|acetazolamide|mesh-list
110671681|NCT00839501|Anticonvulsants|anticonvulsants|mesh-ancestor
110671682|NCT00839501|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110671683|NCT00839501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110671684|NCT00839501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110671685|NCT00839501|Diuretics|diuretics|mesh-ancestor
110671686|NCT00839501|Natriuretic Agents|natriuretic agents|mesh-ancestor
110671687|NCT00839501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110671688|NCT00529542|Atorvastatin|atorvastatin|mesh-list
110671689|NCT00529542|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110671690|NCT00529542|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110682604|NCT00892385|Temozolomide|temozolomide|mesh-list
110671691|NCT00529542|Antimetabolites|antimetabolites|mesh-ancestor
110671692|NCT00529542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110671693|NCT00529542|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110671694|NCT00529542|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110671695|NCT00529542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110671696|NCT04043741|Sulfamethazine|sulfamethazine|mesh-list
110671697|NCT04043741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110671698|NCT00621959|Levocetirizine|levocetirizine|mesh-list
110671699|NCT00621959|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110671700|NCT00621959|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110671701|NCT00621959|Histamine Antagonists|histamine antagonists|mesh-ancestor
110671702|NCT00621959|Histamine Agents|histamine agents|mesh-ancestor
110318854|NCT00432432|Infliximab|infliximab|mesh-list
110671703|NCT00621959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110687699|NCT00943709|Insulin Glargine|insulin glargine|mesh-list
110671704|NCT00621959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110671705|NCT00621959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110671706|NCT00839657|Warfarin|warfarin|mesh-list
110671707|NCT00839657|Anticoagulants|anticoagulants|mesh-ancestor
110671708|NCT05259696|Cemiplimab|cemiplimab|mesh-list
110671709|NCT05259696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110671710|NCT05259696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110671711|NCT00830297|Isophane Insulin, Human|isophane insulin, human|mesh-list
110671712|NCT00830297|Insulin, Isophane|insulin, isophane|mesh-list
110671713|NCT00830297|Isophane insulin, beef|isophane insulin, beef|mesh-list
110671714|NCT00830297|Insulin, Long-Acting|insulin, long-acting|mesh-list
110671715|NCT00830297|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110671716|NCT00830297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110671717|NCT03877224|Dapagliflozin|dapagliflozin|mesh-list
110671718|NCT03877224|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110671719|NCT03877224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110671720|NCT03877224|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110671721|NCT03877224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110671722|NCT00840125|Docetaxel|docetaxel|mesh-list
110671723|NCT00840125|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110671724|NCT00840125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110671725|NCT00840125|Tubulin Modulators|tubulin modulators|mesh-ancestor
110671726|NCT00840125|Antimitotic Agents|antimitotic agents|mesh-ancestor
110671727|NCT00840125|Mitosis Modulators|mitosis modulators|mesh-ancestor
110671728|NCT00840125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110671729|NCT00840125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110671730|NCT00840125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110671731|NCT00830531|Bumetanide|bumetanide|mesh-list
110671732|NCT00830531|Diuretics|diuretics|mesh-ancestor
110671733|NCT00830531|Natriuretic Agents|natriuretic agents|mesh-ancestor
110671734|NCT00830531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110671735|NCT00830531|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110671736|NCT00830531|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110671737|NCT00830531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110671738|NCT05014542|Analgesics|analgesics|mesh-list
110671739|NCT05014542|Sensory System Agents|sensory system agents|mesh-ancestor
110671740|NCT05014542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110671741|NCT05014542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110671742|NCT04926324|Niraparib|niraparib|mesh-list
110671743|NCT04926324|Dostarlimab|dostarlimab|mesh-list
110671744|NCT04926324|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110671745|NCT04926324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110671746|NCT04926324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110671747|NCT04926324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110671748|NCT00621257|Vitamin D|vitamin d|mesh-list
110671749|NCT00621257|Ergocalciferols|ergocalciferols|mesh-list
110671750|NCT00621257|Cholecalciferol|cholecalciferol|mesh-list
110671751|NCT00621257|Vitamins|vitamins|mesh-list
110671752|NCT00621257|Micronutrients|micronutrients|mesh-ancestor
110671753|NCT00621257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110671754|NCT00621257|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110671755|NCT00621257|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110671756|NCT00840671|Cerebrolysin|cerebrolysin|mesh-list
110671757|NCT00840671|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110671758|NCT00840671|Protective Agents|protective agents|mesh-ancestor
110671759|NCT00840671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110948237|NCT03036514|Anesthetics|anesthetics|mesh-ancestor
110671760|NCT00840671|Nootropic Agents|nootropic agents|mesh-ancestor
110671761|NCT02546531|Gemcitabine|gemcitabine|mesh-list
110671762|NCT02546531|Pembrolizumab|pembrolizumab|mesh-list
110671763|NCT02546531|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110671764|NCT02546531|Antimetabolites|antimetabolites|mesh-ancestor
110671765|NCT02546531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110671766|NCT02546531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110671767|NCT02546531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110671768|NCT02546531|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110671769|NCT05205720|Ropivacaine|ropivacaine|mesh-list
110671770|NCT05205720|Anesthetics, Local|anesthetics, local|mesh-ancestor
110671771|NCT05205720|Anesthetics|anesthetics|mesh-ancestor
110671772|NCT05205720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110671773|NCT05205720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110671774|NCT05205720|Sensory System Agents|sensory system agents|mesh-ancestor
110671775|NCT05205720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110671776|NCT00841061|Ferrous fumarate|ferrous fumarate|mesh-list
110671777|NCT00841061|Trace Elements|trace elements|mesh-ancestor
110671778|NCT00841061|Micronutrients|micronutrients|mesh-ancestor
110671779|NCT00841061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110671781|NCT04042805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110449053|NCT02714842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110671782|NCT04042805|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110671783|NCT04042805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110671784|NCT04042805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110671785|NCT05643846|Bupivacaine|bupivacaine|mesh-list
110671786|NCT05643846|Anesthetics, Local|anesthetics, local|mesh-list
110671787|NCT05643846|Anesthetics|anesthetics|mesh-list
110671788|NCT05643846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110671789|NCT05643846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110671790|NCT05643846|Sensory System Agents|sensory system agents|mesh-ancestor
110671791|NCT05643846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110671792|NCT00841139|Perhexiline|perhexiline|mesh-list
110671793|NCT00841139|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110671794|NCT00841139|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110671795|NCT00841139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110023796|NCT00004056|Daunorubicin|daunorubicin|mesh-list
110671796|NCT00841139|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110671797|NCT00841139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110671798|NCT00841139|Vasodilator Agents|vasodilator agents|mesh-ancestor
110671800|NCT00844337|Gentamicins|gentamicins|mesh-list
110671801|NCT00844337|Penicillins|penicillins|mesh-list
110671802|NCT00844337|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110671803|NCT00844337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110671804|NCT00844337|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110671805|NCT00844337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110671806|NCT00844337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110671807|NCT00841373|Ranibizumab|ranibizumab|mesh-list
110671808|NCT00841373|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110671809|NCT00841373|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110671810|NCT00841373|Growth Substances|growth substances|mesh-ancestor
110671811|NCT00841373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110671812|NCT00841373|Growth Inhibitors|growth inhibitors|mesh-ancestor
110671813|NCT00841373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110671814|NCT00851513|Lidocaine|lidocaine|mesh-list
110671815|NCT00851513|Anesthetics, Local|anesthetics, local|mesh-ancestor
110671816|NCT00851513|Anesthetics|anesthetics|mesh-ancestor
110671817|NCT00851513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110671818|NCT00851513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110671819|NCT00851513|Sensory System Agents|sensory system agents|mesh-ancestor
110671820|NCT00851513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110671821|NCT00851513|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110671822|NCT00851513|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110671823|NCT00851513|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110671824|NCT00851513|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110671825|NCT00851513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110671826|NCT00841841|Acetaminophen|acetaminophen|mesh-list
110671827|NCT00841841|Dipyrone|dipyrone|mesh-list
110671828|NCT00841841|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110671829|NCT00841841|Analgesics|analgesics|mesh-ancestor
110671830|NCT00841841|Sensory System Agents|sensory system agents|mesh-ancestor
110671831|NCT00841841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110671832|NCT00841841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110671833|NCT00841841|Antipyretics|antipyretics|mesh-ancestor
110671834|NCT00841841|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110671835|NCT00841841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110671836|NCT00841841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110671837|NCT02545751|Thymalfasin|thymalfasin|mesh-list
110671838|NCT02545751|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110671839|NCT02545751|Immunologic Factors|immunologic factors|mesh-ancestor
110671840|NCT02545751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110671842|NCT00841919|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110671843|NCT00841919|Insulin Glargine|insulin glargine|mesh-list
110671844|NCT00841919|Insulin, Isophane|insulin, isophane|mesh-list
110671845|NCT00841919|Isophane Insulin, Human|isophane insulin, human|mesh-list
110671846|NCT00841919|Isophane insulin, beef|isophane insulin, beef|mesh-list
110671847|NCT00841919|Insulin Lispro|insulin lispro|mesh-list
110671848|NCT00841919|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110671849|NCT00841919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110671850|NCT00852059|Methylphenidate|methylphenidate|mesh-list
110671851|NCT00852059|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110687700|NCT00943709|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110671852|NCT00852059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110671853|NCT00852059|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110671854|NCT00852059|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110671855|NCT00852059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110671856|NCT00852059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110671857|NCT00852059|Dopamine Agents|dopamine agents|mesh-ancestor
110671858|NCT00852059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110671859|NCT00844727|Rofecoxib|rofecoxib|mesh-list
110671860|NCT00844727|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110671861|NCT00844727|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110671862|NCT00844727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110671863|NCT00844727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110671864|NCT00844727|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110671865|NCT00844727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110671866|NCT00844727|Analgesics|analgesics|mesh-ancestor
110671867|NCT00844727|Sensory System Agents|sensory system agents|mesh-ancestor
110671868|NCT00844727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110932411|NCT02201082|Amikacin|amikacin|mesh-list
110671869|NCT00844727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110671870|NCT00844727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110671871|NCT00844727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110671873|NCT00528528|Interferon-alpha|interferon-alpha|mesh-list
110671874|NCT00528528|Interferon alpha-2|interferon alpha-2|mesh-list
110671875|NCT00528528|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
110671876|NCT00528528|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110671877|NCT00528528|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110671878|NCT00528528|Antimetabolites|antimetabolites|mesh-ancestor
110671879|NCT00528528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110671880|NCT00528528|Antiviral Agents|antiviral agents|mesh-ancestor
110671881|NCT00528528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110671882|NCT00528528|Immunologic Factors|immunologic factors|mesh-ancestor
110671883|NCT00528528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110671884|NCT00528528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110671885|NCT00620555|Gabapentin|gabapentin|mesh-list
110671886|NCT00620555|Analgesics|analgesics|mesh-ancestor
110671887|NCT00620555|Sensory System Agents|sensory system agents|mesh-ancestor
110671888|NCT00620555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110671889|NCT00620555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110671890|NCT00620555|Anticonvulsants|anticonvulsants|mesh-ancestor
110671891|NCT00620555|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110671892|NCT00620555|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110671893|NCT00620555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110671894|NCT00620555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110671895|NCT00620555|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110671896|NCT00620555|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110671897|NCT00620555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110671898|NCT00620555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110671899|NCT00620555|Antimanic Agents|antimanic agents|mesh-ancestor
110671900|NCT00845351|Bexarotene|bexarotene|mesh-list
110671901|NCT00845351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110671902|NCT02546141|Caseins|caseins|mesh-list
110671903|NCT02546141|Chelating Agents|chelating agents|mesh-ancestor
110671904|NCT02546141|Sequestering Agents|sequestering agents|mesh-ancestor
110671905|NCT02546141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110671907|NCT00845819|Chlorhexidine|chlorhexidine|mesh-list
110671908|NCT00845819|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110671909|NCT00845819|Cadexomer iodine|cadexomer iodine|mesh-list
110671910|NCT00845819|Povidone-Iodine|povidone-iodine|mesh-list
110671911|NCT00845819|Nystatin|nystatin|mesh-list
110671912|NCT00845819|Povidone|povidone|mesh-list
110671913|NCT00845819|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110671914|NCT00845819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110671915|NCT00845819|Disinfectants|disinfectants|mesh-ancestor
110671916|NCT00845819|Dermatologic Agents|dermatologic agents|mesh-ancestor
110671917|NCT00845819|Trace Elements|trace elements|mesh-ancestor
110671918|NCT00845819|Micronutrients|micronutrients|mesh-ancestor
110671919|NCT00845819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110671920|NCT00845819|Plasma Substitutes|plasma substitutes|mesh-ancestor
110671921|NCT00845819|Blood Substitutes|blood substitutes|mesh-ancestor
110671922|NCT00845819|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110671923|NCT00845819|Antifungal Agents|antifungal agents|mesh-ancestor
110671924|NCT00845819|Ionophores|ionophores|mesh-ancestor
110671925|NCT00845819|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110671926|NCT00845819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110671927|NCT02546843|Rocuronium|rocuronium|mesh-list
110671928|NCT02546843|Atracurium|atracurium|mesh-list
110671929|NCT02546843|Cisatracurium|cisatracurium|mesh-list
110671930|NCT02546843|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110671931|NCT02546843|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110671932|NCT02546843|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110671933|NCT02546843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110671934|NCT02546843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110671935|NCT02546843|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
110671936|NCT02546843|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110671937|NCT02546843|Cholinergic Agents|cholinergic agents|mesh-ancestor
110671938|NCT02546843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110671939|NCT02546843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110671940|NCT03998982|Dexamethasone|dexamethasone|mesh-list
110671941|NCT03998982|Glycyrrhetinic Acid|glycyrrhetinic acid|mesh-list
110671942|NCT03998982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110671943|NCT03998982|Antiemetics|antiemetics|mesh-ancestor
110671944|NCT03998982|Autonomic Agents|autonomic agents|mesh-ancestor
110671945|NCT03998982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110671946|NCT03998982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110671947|NCT03998982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110671948|NCT03998982|Glucocorticoids|glucocorticoids|mesh-ancestor
110671949|NCT03998982|Hormones|hormones|mesh-ancestor
110671950|NCT03998982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110671951|NCT03998982|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110671952|NCT03998982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110671953|NCT00620321|Cytarabine|cytarabine|mesh-list
110671954|NCT00620321|Idarubicin|idarubicin|mesh-list
110671955|NCT00620321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110671956|NCT00620321|Antimetabolites|antimetabolites|mesh-ancestor
110671957|NCT00620321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110671958|NCT00620321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110671959|NCT00620321|Antiviral Agents|antiviral agents|mesh-ancestor
110671960|NCT00620321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110671961|NCT00620321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110671962|NCT00620321|Immunologic Factors|immunologic factors|mesh-ancestor
110671963|NCT00620321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110671964|NCT00620321|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110671965|NCT00620321|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110671966|NCT00620321|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110671967|NCT00620321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110671968|NCT00621023|Ascorbic Acid|ascorbic acid|mesh-list
110671969|NCT00621023|Decitabine|decitabine|mesh-list
110671970|NCT00621023|Arsenic Trioxide|arsenic trioxide|mesh-list
110671971|NCT00621023|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110671972|NCT00621023|Antimetabolites|antimetabolites|mesh-ancestor
110671973|NCT00621023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110671974|NCT00621023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110671975|NCT00621023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110671976|NCT00621023|Antioxidants|antioxidants|mesh-ancestor
110671977|NCT00621023|Protective Agents|protective agents|mesh-ancestor
110671978|NCT00621023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110671979|NCT00621023|Vitamins|vitamins|mesh-ancestor
110671980|NCT00621023|Micronutrients|micronutrients|mesh-ancestor
110671981|NCT00848861|Midazolam|midazolam|mesh-list
110671982|NCT00848861|Meperidine|meperidine|mesh-list
110671983|NCT00848861|Propofol|propofol|mesh-list
110671984|NCT00848861|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110671985|NCT00848861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110671986|NCT00848861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110671987|NCT00848861|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110671988|NCT00848861|Anesthetics, General|anesthetics, general|mesh-ancestor
110671989|NCT00848861|Anesthetics|anesthetics|mesh-ancestor
110671990|NCT00848861|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110671991|NCT00848861|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110671992|NCT00848861|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110671993|NCT00848861|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110671994|NCT00848861|GABA Modulators|gaba modulators|mesh-ancestor
110671995|NCT00848861|GABA Agents|gaba agents|mesh-ancestor
110671996|NCT00848861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110671997|NCT00848861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110671998|NCT00848861|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110671999|NCT00848861|Narcotics|narcotics|mesh-ancestor
110672000|NCT00848861|Analgesics|analgesics|mesh-ancestor
110672001|NCT00848861|Sensory System Agents|sensory system agents|mesh-ancestor
110672002|NCT00848861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110672003|NCT00852371|Pyrimethamine|pyrimethamine|mesh-list
110672004|NCT00852371|Piperaquine|piperaquine|mesh-list
110672005|NCT00852371|Sulfadoxine|sulfadoxine|mesh-list
110672006|NCT00852371|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
110672007|NCT00852371|Amodiaquine|amodiaquine|mesh-list
110672008|NCT00852371|Artenimol|artenimol|mesh-list
110672009|NCT00852371|Antimalarials|antimalarials|mesh-ancestor
110672010|NCT00852371|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110672011|NCT00852371|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110672012|NCT00852371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110672013|NCT00852371|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110672014|NCT00852371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110672015|NCT00852371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110672016|NCT00852371|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110672017|NCT00528372|Metformin|metformin|mesh-list
110672018|NCT00528372|Dapagliflozin|dapagliflozin|mesh-list
110672019|NCT00528372|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110672020|NCT00528372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110672021|NCT00528372|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110672022|NCT00528372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110672023|NCT01564680|Acetaminophen|acetaminophen|mesh-list
110672024|NCT01564680|Lornoxicam|lornoxicam|mesh-list
110672026|NCT01564680|Analgesics|analgesics|mesh-ancestor
110672027|NCT01564680|Sensory System Agents|sensory system agents|mesh-ancestor
110672028|NCT01564680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110672029|NCT01564680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110672030|NCT01564680|Antipyretics|antipyretics|mesh-ancestor
110672031|NCT01564680|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110672032|NCT01564680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110672033|NCT01564680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110672034|NCT01564836|Imatinib Mesylate|imatinib mesylate|mesh-list
110672035|NCT01564836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110672036|NCT01564836|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110672037|NCT01564836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110672038|NCT01564836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110672039|NCT00527982|Celecoxib|celecoxib|mesh-list
110672040|NCT00527982|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110672041|NCT00527982|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110672042|NCT00527982|Analgesics|analgesics|mesh-ancestor
110672043|NCT00527982|Sensory System Agents|sensory system agents|mesh-ancestor
110672044|NCT00527982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110672045|NCT00527982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110672046|NCT00527982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110672047|NCT00527982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110672048|NCT00527982|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110672049|NCT00527982|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110672050|NCT00527982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110672051|NCT00527982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110672052|NCT00527904|Naproxen|naproxen|mesh-list
110672053|NCT00527904|Esomeprazole|esomeprazole|mesh-list
110672054|NCT00527904|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110672055|NCT00527904|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110672056|NCT00527904|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110672057|NCT00527904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110672058|NCT00527904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110672059|NCT00527904|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110672060|NCT00527904|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110672061|NCT00527904|Analgesics|analgesics|mesh-ancestor
110672062|NCT00527904|Sensory System Agents|sensory system agents|mesh-ancestor
110672063|NCT00527904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110672064|NCT00527904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110672065|NCT00527904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110682978|NCT00904397|Analgesics|analgesics|mesh-ancestor
110672066|NCT00527904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110672067|NCT00527904|Gout Suppressants|gout suppressants|mesh-ancestor
110672068|NCT00527904|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110672069|NCT00619619|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
110672070|NCT00619619|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110672071|NCT00619619|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110672072|NCT00619619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110672073|NCT00619619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110672074|NCT00619619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110672075|NCT00619619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110672076|NCT00619619|Antidepressive Agents|antidepressive agents|mesh-ancestor
110672077|NCT00619619|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110672078|NCT00848939|Treprostinil|treprostinil|mesh-list
110672079|NCT00848939|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110319228|NCT00428883|Antioxidants|antioxidants|mesh-ancestor
110672080|NCT00842933|Prednisone|prednisone|mesh-list
110672081|NCT00842933|Methylprednisolone|methylprednisolone|mesh-list
110672082|NCT00842933|Hydrocortisone|hydrocortisone|mesh-list
110672083|NCT00842933|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
110672084|NCT00842933|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
110672085|NCT00842933|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
110672086|NCT00842933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110672087|NCT00842933|Glucocorticoids|glucocorticoids|mesh-ancestor
110672088|NCT00842933|Hormones|hormones|mesh-ancestor
110672089|NCT00842933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110672090|NCT00842933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110672091|NCT00842933|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110672092|NCT00842933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110672093|NCT00842933|Antiemetics|antiemetics|mesh-ancestor
110672094|NCT00842933|Autonomic Agents|autonomic agents|mesh-ancestor
110672095|NCT00842933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110672097|NCT00842933|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110672098|NCT00842933|Protective Agents|protective agents|mesh-ancestor
110672099|NCT00849095|Budesonide|budesonide|mesh-list
110672100|NCT00849095|Terbutaline|terbutaline|mesh-list
110672101|NCT00849095|Formoterol Fumarate|formoterol fumarate|mesh-list
110672102|NCT00849095|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
110672103|NCT00849095|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110672104|NCT00849095|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110672105|NCT00849095|Autonomic Agents|autonomic agents|mesh-ancestor
110672106|NCT00849095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110672107|NCT00849095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110672108|NCT00849095|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110672109|NCT00849095|Respiratory System Agents|respiratory system agents|mesh-ancestor
110672110|NCT00849095|Glucocorticoids|glucocorticoids|mesh-ancestor
110672111|NCT00849095|Hormones|hormones|mesh-ancestor
110672112|NCT00849095|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110672113|NCT00849095|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110672114|NCT00849095|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110672115|NCT00849095|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110672116|NCT00849095|Adrenergic Agents|adrenergic agents|mesh-ancestor
110672117|NCT00849095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110672118|NCT00849095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110672119|NCT00849095|Sympathomimetics|sympathomimetics|mesh-ancestor
110672120|NCT00849095|Tocolytic Agents|tocolytic agents|mesh-ancestor
110672121|NCT00849095|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110672122|NCT00527826|Fluticasone|fluticasone|mesh-list
110672123|NCT00527826|Xhance|xhance|mesh-list
110672124|NCT00527826|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110672125|NCT00527826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110672126|NCT00527826|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110672127|NCT00527826|Autonomic Agents|autonomic agents|mesh-ancestor
110672128|NCT00527826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110672129|NCT00527826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110672130|NCT00527826|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110672131|NCT00527826|Respiratory System Agents|respiratory system agents|mesh-ancestor
110672132|NCT00527826|Dermatologic Agents|dermatologic agents|mesh-ancestor
110672133|NCT00527826|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110672134|NCT00527826|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110672135|NCT00527826|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110672136|NCT00527826|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110672137|NCT00527826|Adrenergic Agents|adrenergic agents|mesh-ancestor
110948238|NCT04835896|Paclitaxel|paclitaxel|mesh-list
110672138|NCT00527826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110672139|NCT00527826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110672140|NCT00849329|Lapatinib|lapatinib|mesh-list
110672141|NCT00849329|Esomeprazole|esomeprazole|mesh-list
110672142|NCT00849329|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110672143|NCT00849329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110672144|NCT00849329|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110672145|NCT00849329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110672146|NCT00849329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110672147|NCT00849329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110672148|NCT00849329|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110672149|NCT03998670|Methamphetamine|methamphetamine|mesh-list
110672150|NCT03998670|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110672151|NCT03998670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110672152|NCT03998670|Sympathomimetics|sympathomimetics|mesh-ancestor
110672153|NCT03998670|Autonomic Agents|autonomic agents|mesh-ancestor
110672154|NCT03998670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110672155|NCT03998670|Dopamine Agents|dopamine agents|mesh-ancestor
110672156|NCT03998670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110672157|NCT03998670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110672158|NCT03998670|Adrenergic Agents|adrenergic agents|mesh-ancestor
110672159|NCT03998670|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110672160|NCT03998670|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110672161|NCT03998670|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110672162|NCT03998670|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110672163|NCT00852683|Pregabalin|pregabalin|mesh-list
110672164|NCT00852683|Analgesics|analgesics|mesh-ancestor
110672165|NCT00852683|Sensory System Agents|sensory system agents|mesh-ancestor
110672166|NCT00852683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110672167|NCT00852683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110672168|NCT00852683|Anticonvulsants|anticonvulsants|mesh-ancestor
110672169|NCT00852683|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110672170|NCT00852683|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110672171|NCT00852683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110672172|NCT00852683|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110672173|NCT00852683|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110672174|NCT00852683|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110672175|NCT00852683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110672176|NCT00852683|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110672177|NCT00619307|Interferon beta-1a|interferon beta-1a|mesh-list
110672178|NCT00619307|Ibuprofen|ibuprofen|mesh-list
110672179|NCT00619307|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110672180|NCT00619307|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110672181|NCT00619307|Analgesics|analgesics|mesh-ancestor
110672182|NCT00619307|Sensory System Agents|sensory system agents|mesh-ancestor
110672183|NCT00619307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110672184|NCT00619307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110672185|NCT00619307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110672186|NCT00619307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110672187|NCT00619307|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110672188|NCT00619307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110672189|NCT00619307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110672190|NCT00619307|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110672191|NCT00619307|Immunologic Factors|immunologic factors|mesh-ancestor
110672192|NCT00619307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110672193|NCT00619307|Antiviral Agents|antiviral agents|mesh-ancestor
110672194|NCT00619307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110672195|NCT00855881|Tegafur|tegafur|mesh-list
110672196|NCT00855881|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110672197|NCT00855881|Antimetabolites|antimetabolites|mesh-ancestor
110672198|NCT00855881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110672199|NCT00855881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110672200|NCT00619229|Alprostadil|alprostadil|mesh-list
110672201|NCT00619229|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110672202|NCT00619229|Vasodilator Agents|vasodilator agents|mesh-ancestor
110672203|NCT00619229|Urological Agents|urological agents|mesh-ancestor
110672204|NCT02546297|Budesonide|budesonide|mesh-list
110672205|NCT02546297|Bromides|bromides|mesh-list
110672206|NCT02546297|Formoterol Fumarate|formoterol fumarate|mesh-list
110672207|NCT02546297|Tiotropium Bromide|tiotropium bromide|mesh-list
110672208|NCT02546297|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
110672209|NCT02546297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110672210|NCT02546297|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110672211|NCT02546297|Autonomic Agents|autonomic agents|mesh-ancestor
110672212|NCT02546297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110672213|NCT02546297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110672214|NCT02546297|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110672215|NCT02546297|Respiratory System Agents|respiratory system agents|mesh-ancestor
110672216|NCT02546297|Glucocorticoids|glucocorticoids|mesh-ancestor
110672217|NCT02546297|Hormones|hormones|mesh-ancestor
110672218|NCT02546297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110672219|NCT02546297|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110672220|NCT02546297|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110672221|NCT02546297|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110672222|NCT02546297|Adrenergic Agents|adrenergic agents|mesh-ancestor
110672223|NCT02546297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110672224|NCT02546297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110672225|NCT02546297|Parasympatholytics|parasympatholytics|mesh-ancestor
110672226|NCT02546297|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110672227|NCT02546297|Cholinergic Agents|cholinergic agents|mesh-ancestor
110319374|NCT04703088|Antiemetics|antiemetics|mesh-ancestor
110672230|NCT00618995|Niacinamide|niacinamide|mesh-list
110672231|NCT00618995|Nicotinic Acids|nicotinic acids|mesh-list
110672232|NCT00618995|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110672233|NCT00618995|Antimetabolites|antimetabolites|mesh-ancestor
110672234|NCT00618995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110672235|NCT00618995|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110672236|NCT00618995|Vasodilator Agents|vasodilator agents|mesh-ancestor
110672237|NCT00618995|Vitamin B Complex|vitamin b complex|mesh-ancestor
110672238|NCT00618995|Vitamins|vitamins|mesh-ancestor
110672239|NCT00618995|Micronutrients|micronutrients|mesh-ancestor
110672240|NCT00618995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110672241|NCT03685344|Durvalumab|durvalumab|mesh-list
110672242|NCT03685344|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
110672243|NCT03685344|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111479172|NCT05594823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110672244|NCT03685344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110672245|NCT03685344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110672246|NCT03685344|Immunologic Factors|immunologic factors|mesh-ancestor
110672247|NCT03685344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110672248|NCT00856271|Losartan|losartan|mesh-list
110672249|NCT00856271|Olmesartan|olmesartan|mesh-list
110672250|NCT00856271|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
110672251|NCT00856271|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110672252|NCT00856271|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110672253|NCT00856271|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110672254|NCT00856271|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110672255|NCT00856271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110672256|NCT00856505|Mycophenolic Acid|mycophenolic acid|mesh-list
110672257|NCT00856505|Everolimus|everolimus|mesh-list
110672258|NCT00856505|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110672259|NCT00856505|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110672260|NCT00856505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110672261|NCT00856505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110672262|NCT00856505|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110672263|NCT00856505|Immunologic Factors|immunologic factors|mesh-ancestor
110672264|NCT00856505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110672265|NCT00856505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110672266|NCT00856505|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110672267|NCT00856505|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110672268|NCT00856505|Antitubercular Agents|antitubercular agents|mesh-ancestor
110672269|NCT00856505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110672270|NCT00856505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110672271|NCT02544893|Dexmedetomidine|dexmedetomidine|mesh-list
110672272|NCT02544893|Bupivacaine|bupivacaine|mesh-list
110672273|NCT02544893|Anesthetics, Local|anesthetics, local|mesh-ancestor
110672274|NCT02544893|Anesthetics|anesthetics|mesh-ancestor
110449096|NCT03998176|Antiviral Agents|antiviral agents|mesh-ancestor
110672275|NCT02544893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110672276|NCT02544893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110672277|NCT02544893|Sensory System Agents|sensory system agents|mesh-ancestor
110672278|NCT02544893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110672279|NCT02544893|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110672280|NCT02544893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110672281|NCT02544893|Analgesics|analgesics|mesh-ancestor
110672282|NCT02544893|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110672283|NCT02544893|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110672284|NCT02544893|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110672285|NCT02544893|Adrenergic Agents|adrenergic agents|mesh-ancestor
110672286|NCT02544893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110672287|NCT02544893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110683199|NCT00907985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110672288|NCT00520572|Etanercept|etanercept|mesh-list
110672289|NCT00520572|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110672290|NCT00520572|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110672291|NCT00520572|Analgesics|analgesics|mesh-ancestor
110672292|NCT00520572|Sensory System Agents|sensory system agents|mesh-ancestor
110672293|NCT00520572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110672294|NCT00520572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110672295|NCT00520572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110672296|NCT00520572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110672297|NCT00520572|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110672298|NCT00520572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110672299|NCT00520572|Immunologic Factors|immunologic factors|mesh-ancestor
110672300|NCT00853697|Methyltestosterone|methyltestosterone|mesh-list
110672301|NCT00853697|Testosterone|testosterone|mesh-list
110672302|NCT00853697|Testosterone undecanoate|testosterone undecanoate|mesh-list
110672303|NCT00853697|Testosterone enanthate|testosterone enanthate|mesh-list
110346697|NCT04385277|Vitamins|vitamins|mesh-ancestor
110672304|NCT00853697|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
110672305|NCT00853697|Dutasteride|dutasteride|mesh-list
110672306|NCT00853697|Androgens|androgens|mesh-ancestor
110672307|NCT00853697|Hormones|hormones|mesh-ancestor
110672308|NCT00853697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110672309|NCT00853697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110672310|NCT00853697|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110672311|NCT00853697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110672312|NCT00853697|Anabolic Agents|anabolic agents|mesh-ancestor
110672313|NCT00853697|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
110672314|NCT00853697|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110672315|NCT00853697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110672316|NCT00853697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110672317|NCT00853697|Hormone Antagonists|hormone antagonists|mesh-ancestor
110672318|NCT00861419|Niacinamide|niacinamide|mesh-list
110672319|NCT00861419|Bevacizumab|bevacizumab|mesh-list
110672320|NCT00861419|Sunitinib|sunitinib|mesh-list
110672321|NCT00861419|Trebananib|trebananib|mesh-list
110672322|NCT00861419|Sorafenib|sorafenib|mesh-list
110672323|NCT00861419|Motesanib diphosphate|motesanib diphosphate|mesh-list
110672324|NCT00861419|Imetelstat|imetelstat|mesh-list
110672325|NCT00861419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110672326|NCT00861419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110672327|NCT00861419|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110672328|NCT00861419|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110672329|NCT00861419|Growth Substances|growth substances|mesh-ancestor
110672330|NCT00861419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110672331|NCT00861419|Growth Inhibitors|growth inhibitors|mesh-ancestor
110672332|NCT00861419|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110672333|NCT00861419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110672334|NCT00861419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110672335|NCT00861419|Vitamin B Complex|vitamin b complex|mesh-ancestor
110672336|NCT00861419|Vitamins|vitamins|mesh-ancestor
110672337|NCT00861419|Micronutrients|micronutrients|mesh-ancestor
110672338|NCT00527514|Amlodipine|amlodipine|mesh-list
110672339|NCT00527514|Olmesartan|olmesartan|mesh-list
110672340|NCT00527514|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
110672341|NCT00527514|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110672342|NCT00527514|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110672343|NCT00527514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110672344|NCT00527514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110672345|NCT00527514|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110672346|NCT00527514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110672347|NCT00527514|Vasodilator Agents|vasodilator agents|mesh-ancestor
110672348|NCT00527514|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110672349|NCT00527514|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110672350|NCT03998826|Piroxicam|piroxicam|mesh-list
110672351|NCT03998826|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110672352|NCT03998826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110672353|NCT03998826|Analgesics|analgesics|mesh-ancestor
110672354|NCT03998826|Sensory System Agents|sensory system agents|mesh-ancestor
110672355|NCT03998826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110672356|NCT03998826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110672357|NCT03998826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110672358|NCT03998826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110672359|NCT03998826|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110672360|NCT03998826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110948239|NCT04835896|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110672361|NCT03998826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110672362|NCT00853931|Panitumumab|panitumumab|mesh-list
110672363|NCT00853931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110672364|NCT00853931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110672365|NCT00854009|BLI-489|bli-489|mesh-list
110672366|NCT00854009|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110672367|NCT00854009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110672368|NCT00854009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110672369|NCT00854009|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110672370|NCT00854009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110672371|NCT03998592|Vaccines|vaccines|mesh-list
110672372|NCT03998592|Immunologic Factors|immunologic factors|mesh-ancestor
110672373|NCT03998592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110672374|NCT00861731|Simvastatin|simvastatin|mesh-list
110672375|NCT00861731|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110672376|NCT00861731|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110672377|NCT00861731|Antimetabolites|antimetabolites|mesh-ancestor
110672378|NCT00861731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110672380|NCT00861731|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110672381|NCT00861731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110672382|NCT02544659|Pamidronate|pamidronate|mesh-list
110672383|NCT02544659|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110672384|NCT02544659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110672385|NCT00861887|Vancomycin|vancomycin|mesh-list
110672386|NCT00861887|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110672387|NCT00861887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110672388|NCT00857519|Carboplatin|carboplatin|mesh-list
110672389|NCT00857519|Melphalan|melphalan|mesh-list
110672390|NCT00857519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110672391|NCT00857519|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110672392|NCT00857519|Alkylating Agents|alkylating agents|mesh-ancestor
110672393|NCT00857519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110672394|NCT00857519|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110672395|NCT00857519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110672396|NCT00857519|Immunologic Factors|immunologic factors|mesh-ancestor
110672397|NCT00857519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110672398|NCT00618449|Azithromycin|azithromycin|mesh-list
110672399|NCT00618449|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110672400|NCT00618449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110672401|NCT00857597|Esomeprazole|esomeprazole|mesh-list
110672402|NCT00857597|Omeprazole|omeprazole|mesh-list
110672403|NCT00857597|Rabeprazole|rabeprazole|mesh-list
110672404|NCT00857597|Pantoprazole|pantoprazole|mesh-list
110672405|NCT00857597|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
110672406|NCT00857597|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110672407|NCT00857597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110672408|NCT00857597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110672409|NCT00857597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110672410|NCT00857753|Fentanyl|fentanyl|mesh-list
110672411|NCT00857753|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110672412|NCT00857753|Narcotics|narcotics|mesh-ancestor
110672413|NCT00857753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110672414|NCT00857753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110672415|NCT00857753|Analgesics|analgesics|mesh-ancestor
110672416|NCT00857753|Sensory System Agents|sensory system agents|mesh-ancestor
110672417|NCT00857753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110672418|NCT00857753|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110672419|NCT00857753|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110672420|NCT00857753|Anesthetics, General|anesthetics, general|mesh-ancestor
110672421|NCT00857753|Anesthetics|anesthetics|mesh-ancestor
110672422|NCT00854321|Rituximab|rituximab|mesh-list
110672423|NCT00854321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110672424|NCT00854321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110672425|NCT00854321|Immunologic Factors|immunologic factors|mesh-ancestor
110672426|NCT00854321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110672427|NCT00854321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110672428|NCT03684642|Metformin|metformin|mesh-list
110672429|NCT03684642|Dulaglutide|dulaglutide|mesh-list
110672430|NCT03684642|Efpeglenatide|efpeglenatide|mesh-list
110672431|NCT03684642|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110672432|NCT03684642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110672433|NCT00857831|Vitamin D|vitamin d|mesh-list
110672434|NCT00857831|Calcium|calcium|mesh-list
110672435|NCT00857831|Vitamins|vitamins|mesh-ancestor
110672436|NCT00857831|Micronutrients|micronutrients|mesh-ancestor
110672437|NCT00857831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110672438|NCT00857831|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110672439|NCT00857831|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110672440|NCT00862043|Sildenafil Citrate|sildenafil citrate|mesh-list
110672441|NCT00862043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110672442|NCT00862043|Vasodilator Agents|vasodilator agents|mesh-ancestor
110672443|NCT00862043|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110672444|NCT00862043|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110672445|NCT00862043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110672446|NCT00862043|Urological Agents|urological agents|mesh-ancestor
110672447|NCT00519636|Fluticasone|fluticasone|mesh-list
110672448|NCT00519636|Xhance|xhance|mesh-list
110672449|NCT00519636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110672450|NCT00519636|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110672451|NCT00519636|Autonomic Agents|autonomic agents|mesh-ancestor
110672452|NCT00519636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110672453|NCT00519636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110672454|NCT00519636|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110672455|NCT00519636|Respiratory System Agents|respiratory system agents|mesh-ancestor
110672456|NCT00519636|Dermatologic Agents|dermatologic agents|mesh-ancestor
110672457|NCT00519636|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110672458|NCT00857909|Amiloride|amiloride|mesh-list
110672459|NCT00857909|Spironolactone|spironolactone|mesh-list
110672460|NCT00857909|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110672461|NCT00857909|Hormone Antagonists|hormone antagonists|mesh-ancestor
110672462|NCT00857909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110672463|NCT00857909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110672464|NCT00857909|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110672465|NCT00857909|Diuretics|diuretics|mesh-ancestor
110672466|NCT00857909|Natriuretic Agents|natriuretic agents|mesh-ancestor
110672467|NCT00857909|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
110672468|NCT00857909|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110672469|NCT00857909|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110672470|NCT00857909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110672471|NCT00857909|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
110672472|NCT00857987|Expectorants|expectorants|mesh-list
110672473|NCT00857987|Respiratory System Agents|respiratory system agents|mesh-ancestor
110672474|NCT00854477|Capecitabine|capecitabine|mesh-list
110672475|NCT00854477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110672476|NCT00854477|Antimetabolites|antimetabolites|mesh-ancestor
110672477|NCT00854477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110672478|NCT00854477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110672479|NCT00854633|Lactoferrin|lactoferrin|mesh-list
110672480|NCT00854633|Talactoferrin alfa|talactoferrin alfa|mesh-list
110672481|NCT00854633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110672482|NCT00854633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110672483|NCT00618371|Raltegravir Potassium|raltegravir potassium|mesh-list
110672484|NCT00618371|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110672485|NCT00618371|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110672486|NCT00618371|Antiviral Agents|antiviral agents|mesh-ancestor
110672487|NCT00618371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110672488|NCT00618371|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110672489|NCT00618371|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110672490|NCT00618371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110672491|NCT00618371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110672492|NCT00858299|Valsartan|valsartan|mesh-list
110672493|NCT00858299|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110672494|NCT00858299|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110672495|NCT00858299|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110672496|NCT00858299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110672497|NCT00526890|Selenium|selenium|mesh-list
110672498|NCT00526890|Paclitaxel|paclitaxel|mesh-list
110672499|NCT00526890|Carboplatin|carboplatin|mesh-list
110672500|NCT00526890|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110672501|NCT00526890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110672502|NCT00526890|Tubulin Modulators|tubulin modulators|mesh-ancestor
110672503|NCT00526890|Antimitotic Agents|antimitotic agents|mesh-ancestor
110672504|NCT00526890|Mitosis Modulators|mitosis modulators|mesh-ancestor
110672505|NCT00526890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110672506|NCT00526890|Antioxidants|antioxidants|mesh-ancestor
110672507|NCT00526890|Protective Agents|protective agents|mesh-ancestor
110672508|NCT00526890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110672509|NCT00526890|Trace Elements|trace elements|mesh-ancestor
110672510|NCT00526890|Micronutrients|micronutrients|mesh-ancestor
110672511|NCT04041167|Thioctic Acid|thioctic acid|mesh-list
110672512|NCT04041167|Antioxidants|antioxidants|mesh-ancestor
110672513|NCT04041167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110672514|NCT04041167|Protective Agents|protective agents|mesh-ancestor
110672515|NCT04041167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110672516|NCT04041167|Vitamin B Complex|vitamin b complex|mesh-ancestor
110672517|NCT04041167|Vitamins|vitamins|mesh-ancestor
110672518|NCT04041167|Micronutrients|micronutrients|mesh-ancestor
110672519|NCT00858377|Complement Factor H|complement factor h|mesh-list
110672520|NCT00858377|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
110672521|NCT00858377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110672522|NCT00858377|Immunologic Factors|immunologic factors|mesh-ancestor
110672523|NCT00858377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110672524|NCT00854711|Nitric Oxide|nitric oxide|mesh-list
110672525|NCT00854711|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110672526|NCT00854711|Autonomic Agents|autonomic agents|mesh-ancestor
110672527|NCT00854711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110672528|NCT00854711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110672529|NCT00854711|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110672530|NCT00854711|Respiratory System Agents|respiratory system agents|mesh-ancestor
110672531|NCT00854711|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110672533|NCT00854711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110672534|NCT00854711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110672535|NCT00854711|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
110672536|NCT00854711|Vasodilator Agents|vasodilator agents|mesh-ancestor
110672537|NCT00854711|Gasotransmitters|gasotransmitters|mesh-ancestor
110672538|NCT00854711|Protective Agents|protective agents|mesh-ancestor
110672540|NCT00858455|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110672541|NCT00858455|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110672542|NCT00858455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110672543|NCT00858455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110672544|NCT00858455|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110672545|NCT00858455|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111479173|NCT05581797|Psilocybin|psilocybin|mesh-list
110672547|NCT00858455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110672548|NCT02544737|Apatinib|apatinib|mesh-list
110672549|NCT02544737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110672550|NCT02544737|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110672551|NCT02544737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110672552|NCT02544737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110672553|NCT00526656|Sunitinib|sunitinib|mesh-list
110672554|NCT00526656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110672555|NCT00526656|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110672556|NCT00526656|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110672557|NCT00526656|Growth Substances|growth substances|mesh-ancestor
110672558|NCT00526656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110672559|NCT00526656|Growth Inhibitors|growth inhibitors|mesh-ancestor
110672560|NCT00526656|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110672561|NCT00526656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110672562|NCT00526656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110672563|NCT00858767|Vitamin K 2|vitamin k 2|mesh-list
110672564|NCT00858767|Vitamin K|vitamin k|mesh-list
110672565|NCT00858767|Menaquinone 7|menaquinone 7|mesh-list
110672566|NCT00858767|Caseins|caseins|mesh-list
110672567|NCT00858767|Chelating Agents|chelating agents|mesh-ancestor
110672568|NCT00858767|Sequestering Agents|sequestering agents|mesh-ancestor
110672569|NCT00858767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110672570|NCT00858767|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110672571|NCT00858767|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110672572|NCT00858767|Hemostatics|hemostatics|mesh-ancestor
110672573|NCT00858767|Coagulants|coagulants|mesh-ancestor
110672574|NCT00858767|Vitamins|vitamins|mesh-ancestor
110672575|NCT00858767|Micronutrients|micronutrients|mesh-ancestor
110672576|NCT00858767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110672577|NCT00617903|Azelaic acid|azelaic acid|mesh-list
110672578|NCT00617903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110672579|NCT00617903|Dermatologic Agents|dermatologic agents|mesh-ancestor
110672580|NCT00526110|Docetaxel|docetaxel|mesh-list
110672581|NCT00526110|Fluorouracil|fluorouracil|mesh-list
110672582|NCT00526110|Oxaliplatin|oxaliplatin|mesh-list
110672583|NCT00526110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110672584|NCT00526110|Tubulin Modulators|tubulin modulators|mesh-ancestor
110672585|NCT00526110|Antimitotic Agents|antimitotic agents|mesh-ancestor
110672586|NCT00526110|Mitosis Modulators|mitosis modulators|mesh-ancestor
110672587|NCT00526110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110672588|NCT00526110|Antimetabolites|antimetabolites|mesh-ancestor
110672589|NCT00526110|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110672590|NCT00526110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110672591|NCT00526110|Immunologic Factors|immunologic factors|mesh-ancestor
110672592|NCT00526110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110672593|NCT00859079|Insulin|insulin|mesh-list
110672594|NCT00859079|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110672595|NCT00859079|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
110672596|NCT00859079|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110672597|NCT00859079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110672598|NCT00859079|Incretins|incretins|mesh-ancestor
110672599|NCT00859079|Hormones|hormones|mesh-ancestor
110672600|NCT00859079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110672601|NCT02544425|Dexamethasone|dexamethasone|mesh-list
110672602|NCT02544425|Etoposide|etoposide|mesh-list
110672603|NCT02544425|Melphalan|melphalan|mesh-list
110672604|NCT02544425|Busulfan|busulfan|mesh-list
110672605|NCT02544425|Asparaginase|asparaginase|mesh-list
110672606|NCT02544425|Ifosfamide|ifosfamide|mesh-list
110672607|NCT02544425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110672608|NCT02544425|Antiemetics|antiemetics|mesh-ancestor
110319750|NCT00430443|Annamycin|annamycin|mesh-list
110672609|NCT02544425|Autonomic Agents|autonomic agents|mesh-ancestor
110672610|NCT02544425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110672611|NCT02544425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110672612|NCT02544425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110672613|NCT02544425|Glucocorticoids|glucocorticoids|mesh-ancestor
110672614|NCT02544425|Hormones|hormones|mesh-ancestor
110672615|NCT02544425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110672616|NCT02544425|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110672617|NCT02544425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110672618|NCT02544425|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110672619|NCT02544425|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110672620|NCT02544425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110672621|NCT02544425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110672622|NCT02544425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110672623|NCT02544425|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110672624|NCT02544425|Alkylating Agents|alkylating agents|mesh-ancestor
110672625|NCT02544425|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110672626|NCT02544425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110672627|NCT02544425|Immunologic Factors|immunologic factors|mesh-ancestor
110672628|NCT00859235|Chlorhexidine|chlorhexidine|mesh-list
110672629|NCT00859235|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110672630|NCT00859235|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110672631|NCT00859235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110672632|NCT00859235|Disinfectants|disinfectants|mesh-ancestor
110672633|NCT00859235|Dermatologic Agents|dermatologic agents|mesh-ancestor
110672634|NCT04523688|Temozolomide|temozolomide|mesh-list
110672635|NCT04523688|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110672636|NCT04523688|Alkylating Agents|alkylating agents|mesh-ancestor
110672637|NCT04523688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110672638|NCT04523688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110672639|NCT00511836|Naltrexone|naltrexone|mesh-list
110672640|NCT00511836|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110672641|NCT00511836|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110672642|NCT00511836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110672643|NCT00511836|Sensory System Agents|sensory system agents|mesh-ancestor
110672644|NCT00511836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110672645|NCT00859703|Risedronic Acid|risedronic acid|mesh-list
110672646|NCT00859703|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110672647|NCT00859703|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110672648|NCT00859703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110672649|NCT00859703|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110672650|NCT00859703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110672651|NCT00859703|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110672652|NCT03998436|Esmolol|esmolol|mesh-list
110672653|NCT03998436|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110672654|NCT03998436|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110672655|NCT03998436|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110672656|NCT03998436|Adrenergic Agents|adrenergic agents|mesh-ancestor
110672657|NCT03998436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110672658|NCT03998436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110672659|NCT03998436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110672660|NCT00855101|Voriconazole|voriconazole|mesh-list
110672661|NCT00855101|Antifungal Agents|antifungal agents|mesh-ancestor
110672662|NCT00855101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110672663|NCT00855101|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110672664|NCT00855101|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110672665|NCT00855101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110672666|NCT00855101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110672667|NCT00855101|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110672668|NCT00855101|Hormone Antagonists|hormone antagonists|mesh-ancestor
110672669|NCT00855101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110672670|NCT00855101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110672671|NCT00855101|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110672673|NCT00573755|Letrozole|letrozole|mesh-list
110672674|NCT00573755|Anastrozole|anastrozole|mesh-list
110672675|NCT00573755|Exemestane|exemestane|mesh-list
110672676|NCT00573755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110672677|NCT00573755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110672678|NCT00573755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110672679|NCT00573755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110672680|NCT00573755|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110672681|NCT00573755|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110672682|NCT00573755|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110672683|NCT00573755|Hormone Antagonists|hormone antagonists|mesh-ancestor
110672684|NCT00573755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110672685|NCT00573755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110672686|NCT00573755|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110672688|NCT02544191|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110672689|NCT02544191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110672690|NCT00524316|Doxorubicin|doxorubicin|mesh-list
110672691|NCT00524316|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110672693|NCT00524316|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110672694|NCT00524316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110672695|NCT00524316|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110672696|NCT00524316|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110672697|NCT00524316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110672698|NCT00524316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110672699|NCT00524316|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110672700|NCT00524316|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110672701|NCT00524316|Growth Substances|growth substances|mesh-ancestor
110672702|NCT00524316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110672703|NCT00524316|Growth Inhibitors|growth inhibitors|mesh-ancestor
110672704|NCT00524316|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110672705|NCT03861936|Botulinum Toxins|botulinum toxins|mesh-list
110672706|NCT03861936|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110672707|NCT03861936|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110672708|NCT03861936|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110672709|NCT03861936|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110672710|NCT03861936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110672711|NCT03861936|Cholinergic Agents|cholinergic agents|mesh-ancestor
110672712|NCT03861936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110672713|NCT03861936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110672714|NCT03861936|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110672715|NCT03861936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110672716|NCT02544269|Bupivacaine|bupivacaine|mesh-list
110672717|NCT02544269|Ropivacaine|ropivacaine|mesh-list
110672718|NCT02544269|Anesthetics, Local|anesthetics, local|mesh-ancestor
110672719|NCT02544269|Anesthetics|anesthetics|mesh-ancestor
110672720|NCT02544269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110672721|NCT02544269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110672722|NCT02544269|Sensory System Agents|sensory system agents|mesh-ancestor
110672723|NCT02544269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110672724|NCT00434577|Vaccines|vaccines|mesh-list
110672725|NCT00434577|Immunologic Factors|immunologic factors|mesh-ancestor
110672726|NCT00434577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110672727|NCT00865085|Dexetimide|dexetimide|mesh-list
110672728|NCT00865085|Citalopram|citalopram|mesh-list
110672729|NCT00865085|Escitalopram|escitalopram|mesh-list
110672730|NCT00865085|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110672731|NCT00865085|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110672732|NCT00865085|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110672733|NCT00865085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110672734|NCT00865085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110672735|NCT00865085|Serotonin Agents|serotonin agents|mesh-ancestor
110672736|NCT00865085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110672737|NCT00865085|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110672738|NCT00865085|Antidepressive Agents|antidepressive agents|mesh-ancestor
110672739|NCT00865085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110672740|NCT00865085|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110672741|NCT00865085|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110672742|NCT00865085|Parasympatholytics|parasympatholytics|mesh-ancestor
110672743|NCT00865085|Autonomic Agents|autonomic agents|mesh-ancestor
110672744|NCT00865085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110672745|NCT00865085|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110672746|NCT00865085|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110672747|NCT00865085|Cholinergic Agents|cholinergic agents|mesh-ancestor
110672748|NCT00796068|Cyclosporine|cyclosporine|mesh-list
110672749|NCT00796068|Mycophenolic Acid|mycophenolic acid|mesh-list
110672750|NCT00796068|Fludarabine|fludarabine|mesh-list
110672751|NCT00796068|Fludarabine phosphate|fludarabine phosphate|mesh-list
110672752|NCT00796068|Treosulfan|treosulfan|mesh-list
110672753|NCT00796068|Busulfan|busulfan|mesh-list
110672754|NCT00796068|Cyclosporins|cyclosporins|mesh-list
110672755|NCT00796068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110672756|NCT00796068|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110347149|NCT04149574|Nivolumab|nivolumab|mesh-list
110672757|NCT00796068|Antimetabolites|antimetabolites|mesh-ancestor
110672758|NCT00796068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110672759|NCT00796068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110672760|NCT00796068|Immunologic Factors|immunologic factors|mesh-ancestor
110672761|NCT00796068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110672762|NCT00796068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110672763|NCT00796068|Antifungal Agents|antifungal agents|mesh-ancestor
110672764|NCT00796068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110672765|NCT00796068|Dermatologic Agents|dermatologic agents|mesh-ancestor
110672766|NCT00796068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110672767|NCT00796068|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110672768|NCT00796068|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110672769|NCT00796068|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110672770|NCT00796068|Antitubercular Agents|antitubercular agents|mesh-ancestor
110672771|NCT00796068|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110023797|NCT00004056|Asparaginase|asparaginase|mesh-list
110672772|NCT00796068|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110672773|NCT00796068|Alkylating Agents|alkylating agents|mesh-ancestor
110672774|NCT00796068|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110672776|NCT04732182|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110672777|NCT04732182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110672778|NCT04732182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110672779|NCT04732182|Cholinergic Agents|cholinergic agents|mesh-ancestor
110672780|NCT04732182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110672781|NCT04732182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110672782|NCT04732182|Nootropic Agents|nootropic agents|mesh-ancestor
110672783|NCT03783078|Pembrolizumab|pembrolizumab|mesh-list
110672784|NCT03783078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110672785|NCT03783078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110672786|NCT03783078|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110672787|NCT03783078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110672788|NCT01009476|Nicergoline|nicergoline|mesh-list
110672789|NCT01009476|Piracetam|piracetam|mesh-list
110672790|NCT01009476|Galantamine|galantamine|mesh-list
110672791|NCT01009476|Nootropic Agents|nootropic agents|mesh-list
110672792|NCT01009476|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110672793|NCT01009476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110672794|NCT01009476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110672795|NCT01009476|Cholinergic Agents|cholinergic agents|mesh-ancestor
110672796|NCT01009476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110672797|NCT01009476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110672798|NCT01009476|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110672799|NCT01009476|Autonomic Agents|autonomic agents|mesh-ancestor
110672800|NCT01009476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110672801|NCT01009476|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110672802|NCT01009476|Protective Agents|protective agents|mesh-ancestor
110672803|NCT01009476|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110672804|NCT01009476|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110672805|NCT01009476|Adrenergic Agents|adrenergic agents|mesh-ancestor
110672806|NCT01009476|Vasodilator Agents|vasodilator agents|mesh-ancestor
110672807|NCT00517296|Adalimumab|adalimumab|mesh-list
110672808|NCT00517296|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110672809|NCT00517296|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110672810|NCT00517296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110672811|NCT00516906|Chlorhexidine|chlorhexidine|mesh-list
110672812|NCT00516906|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110672813|NCT00516906|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110672814|NCT00516906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110672815|NCT00516906|Disinfectants|disinfectants|mesh-ancestor
110683718|NCT00934739|Dexamethasone|dexamethasone|mesh-list
110672816|NCT00516906|Dermatologic Agents|dermatologic agents|mesh-ancestor
110672817|NCT00523848|Thalidomide|thalidomide|mesh-list
110672818|NCT00523848|Doxorubicin|doxorubicin|mesh-list
110672819|NCT00523848|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110672820|NCT00523848|Bortezomib|bortezomib|mesh-list
110672821|NCT00523848|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110672822|NCT00523848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110672823|NCT00523848|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110672824|NCT00523848|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110672825|NCT00523848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110672826|NCT00523848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110672827|NCT00523848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110672828|NCT00523848|Immunologic Factors|immunologic factors|mesh-ancestor
110672829|NCT00523848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110672830|NCT00523848|Leprostatic Agents|leprostatic agents|mesh-ancestor
110672831|NCT00523848|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110319970|NCT00431145|Vitamins|vitamins|mesh-ancestor
110449135|NCT02712658|Terbutaline|terbutaline|mesh-list
110672832|NCT00523848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110672833|NCT00523848|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110672834|NCT00523848|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110672835|NCT00523848|Growth Substances|growth substances|mesh-ancestor
110672836|NCT00523848|Growth Inhibitors|growth inhibitors|mesh-ancestor
110672837|NCT00617669|Docetaxel|docetaxel|mesh-list
110672838|NCT00617669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110672839|NCT00617669|Tubulin Modulators|tubulin modulators|mesh-ancestor
110672840|NCT00617669|Antimitotic Agents|antimitotic agents|mesh-ancestor
110672841|NCT00617669|Mitosis Modulators|mitosis modulators|mesh-ancestor
110672842|NCT00617669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110672843|NCT04018157|Dexmedetomidine|dexmedetomidine|mesh-list
110672844|NCT04018157|Ketamine|ketamine|mesh-list
110672845|NCT04018157|Propofol|propofol|mesh-list
110672846|NCT04018157|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110672847|NCT04018157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110672848|NCT04018157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110672849|NCT04018157|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110672850|NCT04018157|Analgesics|analgesics|mesh-ancestor
110672851|NCT04018157|Sensory System Agents|sensory system agents|mesh-ancestor
110672852|NCT04018157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110672853|NCT04018157|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110672854|NCT04018157|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110672855|NCT04018157|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110672856|NCT04018157|Adrenergic Agents|adrenergic agents|mesh-ancestor
110672857|NCT04018157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110672858|NCT04018157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110672859|NCT04018157|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110672860|NCT04018157|Anesthetics, General|anesthetics, general|mesh-ancestor
110672861|NCT04018157|Anesthetics|anesthetics|mesh-ancestor
110672862|NCT04018157|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110672863|NCT04018157|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110672864|NCT04018157|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110672865|NCT00865241|Metformin|metformin|mesh-list
110672866|NCT00865241|Glyburide|glyburide|mesh-list
110672867|NCT00865241|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110672868|NCT00865241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110672869|NCT00863213|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
110672870|NCT00860639|Gemtuzumab|gemtuzumab|mesh-list
110672871|NCT00860639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110672872|NCT00860639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110672873|NCT00860639|Immunotoxins|immunotoxins|mesh-ancestor
110672874|NCT00860639|Immunoconjugates|immunoconjugates|mesh-ancestor
110672875|NCT00860639|Immunologic Factors|immunologic factors|mesh-ancestor
110672876|NCT00860639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110672877|NCT00863291|Buprenorphine|buprenorphine|mesh-list
110672878|NCT00863291|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110672879|NCT00863291|Narcotics|narcotics|mesh-ancestor
110672880|NCT00863291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110672881|NCT00863291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110672882|NCT00863291|Analgesics|analgesics|mesh-ancestor
110672883|NCT00863291|Sensory System Agents|sensory system agents|mesh-ancestor
110672884|NCT00863291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110672885|NCT00863291|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110672886|NCT00865319|Deoxyglucose|deoxyglucose|mesh-list
110672887|NCT00865319|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110672888|NCT00865319|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110672889|NCT00865319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110948240|NCT04835896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110672890|NCT00865319|Antimetabolites|antimetabolites|mesh-ancestor
110672891|NCT00865319|Antiviral Agents|antiviral agents|mesh-ancestor
110672892|NCT00865319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110672893|NCT00861029|Moxifloxacin|moxifloxacin|mesh-list
110672894|NCT00861029|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
110672895|NCT00861029|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110672896|NCT00861029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110672897|NCT00861029|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110672898|NCT00861029|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110672899|NCT00861029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110672900|NCT00861029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110672901|NCT00861029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110672902|NCT00861029|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110672903|NCT00861029|Contraceptive Agents|contraceptive agents|mesh-ancestor
110672904|NCT00861029|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110672905|NCT00861029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110320065|NCT00332072|Timolol|timolol|mesh-list
110672906|NCT00861029|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110672907|NCT00861029|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110672908|NCT00861029|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110672909|NCT00865397|Insulin Detemir|insulin detemir|mesh-list
110672910|NCT00865397|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110672911|NCT00865397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110672913|NCT00861107|Immunologic Factors|immunologic factors|mesh-ancestor
110672914|NCT00861107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110672915|NCT00510510|Glycopyrrolate|glycopyrrolate|mesh-list
110672916|NCT00510510|Bromides|bromides|mesh-list
110672917|NCT00510510|Anticonvulsants|anticonvulsants|mesh-ancestor
110672918|NCT00510510|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110672919|NCT00510510|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110672920|NCT00510510|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110672921|NCT00510510|Cholinergic Agents|cholinergic agents|mesh-ancestor
110672922|NCT00510510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110672923|NCT00510510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110672924|NCT00510510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110672925|NCT04685694|Misoprostol|misoprostol|mesh-list
110672926|NCT04685694|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110672927|NCT04685694|Abortifacient Agents|abortifacient agents|mesh-ancestor
110672928|NCT04685694|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110672929|NCT04685694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110672930|NCT04685694|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110672931|NCT04685694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110672932|NCT04685694|Oxytocics|oxytocics|mesh-ancestor
110672933|NCT00870311|Lithium Carbonate|lithium carbonate|mesh-list
110672934|NCT00870311|Antidepressive Agents|antidepressive agents|mesh-ancestor
110672935|NCT00870311|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110672936|NCT00870311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110672937|NCT00870311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110672938|NCT00870311|Antimanic Agents|antimanic agents|mesh-ancestor
110672939|NCT00870311|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110672940|NCT00870311|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110672941|NCT00870311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110672942|NCT00865631|Gabapentin|gabapentin|mesh-list
110672943|NCT00865631|Analgesics|analgesics|mesh-ancestor
110672944|NCT00865631|Sensory System Agents|sensory system agents|mesh-ancestor
110672945|NCT00865631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110672946|NCT00865631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110672947|NCT00865631|Anticonvulsants|anticonvulsants|mesh-ancestor
110672948|NCT00865631|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110672949|NCT00865631|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110672950|NCT00865631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110672951|NCT00865631|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110672952|NCT00865631|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110672953|NCT00865631|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110672954|NCT00865631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110672955|NCT00865631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110672956|NCT00865631|Antimanic Agents|antimanic agents|mesh-ancestor
110672957|NCT00863837|Terlipressin|terlipressin|mesh-list
110672958|NCT00863837|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
110672959|NCT00863837|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
110672960|NCT00863837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110672961|NCT00863837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110672962|NCT00863837|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110672963|NCT00863915|Ramipril|ramipril|mesh-list
110948241|NCT04835896|Tubulin Modulators|tubulin modulators|mesh-ancestor
110672964|NCT00863915|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110672965|NCT00863915|Protease Inhibitors|protease inhibitors|mesh-ancestor
110672966|NCT00863915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110672967|NCT00863915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110672968|NCT00863915|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110672969|NCT01009944|Atenolol|atenolol|mesh-list
110672970|NCT01009944|Lisinopril|lisinopril|mesh-list
110449142|NCT02712658|Sympathomimetics|sympathomimetics|mesh-ancestor
110672971|NCT01009944|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110672972|NCT01009944|Protease Inhibitors|protease inhibitors|mesh-ancestor
110672973|NCT01009944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110672974|NCT01009944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110672975|NCT01009944|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110672976|NCT01009944|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110672977|NCT01009944|Protective Agents|protective agents|mesh-ancestor
110672978|NCT01009944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110672979|NCT01009944|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110672980|NCT01009944|Sympatholytics|sympatholytics|mesh-ancestor
110672981|NCT01009944|Autonomic Agents|autonomic agents|mesh-ancestor
110672982|NCT01009944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110687701|NCT00943709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110672983|NCT01009944|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110672984|NCT01009944|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110672985|NCT01009944|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110672986|NCT01009944|Adrenergic Agents|adrenergic agents|mesh-ancestor
110672987|NCT01009944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110672988|NCT01010022|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
110672989|NCT01010022|Plasma Substitutes|plasma substitutes|mesh-ancestor
110672990|NCT01010022|Blood Substitutes|blood substitutes|mesh-ancestor
110672991|NCT00864071|Griseofulvin|griseofulvin|mesh-list
110672992|NCT00864071|Antifungal Agents|antifungal agents|mesh-ancestor
110672993|NCT00864071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110672994|NCT04264026|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
110672995|NCT04264026|Hallucinogens|hallucinogens|mesh-ancestor
110672996|NCT04264026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110672997|NCT04264026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110672998|NCT04264026|Serotonin Agents|serotonin agents|mesh-ancestor
110672999|NCT04264026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110673000|NCT04264026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110673001|NCT04264026|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110673002|NCT04264026|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110673003|NCT04264026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110673004|NCT04264026|Adrenergic Agents|adrenergic agents|mesh-ancestor
110673005|NCT00864149|Carvedilol|carvedilol|mesh-list
110673006|NCT00864149|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110673007|NCT00864149|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110673008|NCT00864149|Adrenergic Agents|adrenergic agents|mesh-ancestor
110673009|NCT00864149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110673010|NCT00864149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110673011|NCT00864149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110673012|NCT00864149|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110673013|NCT00864149|Antioxidants|antioxidants|mesh-ancestor
110673014|NCT00864149|Protective Agents|protective agents|mesh-ancestor
110673015|NCT00864149|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110673016|NCT00864149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110673017|NCT00864149|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110673018|NCT00864149|Vasodilator Agents|vasodilator agents|mesh-ancestor
110673019|NCT00864149|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110673020|NCT00864149|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110673021|NCT01010100|Acarbose|acarbose|mesh-list
110673022|NCT01010100|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
110673023|NCT01010100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110673024|NCT01010100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110673025|NCT01010100|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110673026|NCT01010100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110673027|NCT00870779|Aminolevulinic Acid|aminolevulinic acid|mesh-list
110673028|NCT00870779|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110673029|NCT00870779|Dermatologic Agents|dermatologic agents|mesh-ancestor
110673030|NCT01010178|Theophylline|theophylline|mesh-list
110673031|NCT01010178|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110673032|NCT01010178|Autonomic Agents|autonomic agents|mesh-ancestor
110673033|NCT01010178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110673034|NCT01010178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110673035|NCT01010178|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110673036|NCT01010178|Respiratory System Agents|respiratory system agents|mesh-ancestor
110673037|NCT01010178|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110673038|NCT01010178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110673039|NCT01010178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110673040|NCT01010178|Vasodilator Agents|vasodilator agents|mesh-ancestor
110673041|NCT01010178|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110673042|NCT01010178|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110673043|NCT01010178|Purinergic Agents|purinergic agents|mesh-ancestor
110673044|NCT01010178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110673045|NCT00617591|Dexamethasone|dexamethasone|mesh-list
110673046|NCT00617591|Doxorubicin|doxorubicin|mesh-list
110673047|NCT00617591|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110673048|NCT00617591|Lenalidomide|lenalidomide|mesh-list
110673049|NCT00617591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110673050|NCT00617591|Antiemetics|antiemetics|mesh-ancestor
110673051|NCT00617591|Autonomic Agents|autonomic agents|mesh-ancestor
110673052|NCT00617591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110673053|NCT00617591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110673054|NCT00617591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110673055|NCT00617591|Glucocorticoids|glucocorticoids|mesh-ancestor
110673056|NCT00617591|Hormones|hormones|mesh-ancestor
110673057|NCT00617591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110673058|NCT00617591|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110673059|NCT00617591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110673060|NCT00617591|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110673061|NCT00617591|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110673062|NCT00617591|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110673063|NCT00617591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110673064|NCT00617591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110673065|NCT00617591|Immunologic Factors|immunologic factors|mesh-ancestor
110673066|NCT00617591|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110673067|NCT00617591|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110673068|NCT00617591|Growth Substances|growth substances|mesh-ancestor
110673069|NCT00617591|Growth Inhibitors|growth inhibitors|mesh-ancestor
110673070|NCT00864305|Gabapentin|gabapentin|mesh-list
110673071|NCT00864305|Analgesics|analgesics|mesh-ancestor
110673072|NCT00864305|Sensory System Agents|sensory system agents|mesh-ancestor
110673073|NCT00864305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110673074|NCT00864305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110673075|NCT00864305|Anticonvulsants|anticonvulsants|mesh-ancestor
110673076|NCT00864305|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110673077|NCT00864305|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110673078|NCT00864305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110673079|NCT00864305|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110673080|NCT00864305|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110673081|NCT00864305|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110673082|NCT00864305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110673083|NCT00864305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110673084|NCT00864305|Antimanic Agents|antimanic agents|mesh-ancestor
110673085|NCT00510276|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
110673086|NCT00510276|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110673087|NCT00510276|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110673088|NCT00510276|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110673089|NCT00510276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110673090|NCT00510276|Adrenergic Agents|adrenergic agents|mesh-ancestor
110673091|NCT00510276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110673092|NCT00510276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110673093|NCT00864617|Nifedipine|nifedipine|mesh-list
110673094|NCT00864617|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110673095|NCT00864617|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110673096|NCT00864617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110673097|NCT00864617|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110673098|NCT00864617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110673099|NCT00864617|Vasodilator Agents|vasodilator agents|mesh-ancestor
110673100|NCT00864617|Tocolytic Agents|tocolytic agents|mesh-ancestor
110673101|NCT00864617|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110673102|NCT00865943|Dexetimide|dexetimide|mesh-list
110673103|NCT00865943|Citalopram|citalopram|mesh-list
110673104|NCT00865943|Escitalopram|escitalopram|mesh-list
110673105|NCT00865943|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110673106|NCT00865943|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110673107|NCT00865943|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110673108|NCT00865943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110673109|NCT00865943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110673110|NCT00865943|Serotonin Agents|serotonin agents|mesh-ancestor
110673111|NCT00865943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110673112|NCT00865943|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110673113|NCT00865943|Antidepressive Agents|antidepressive agents|mesh-ancestor
110673114|NCT00865943|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110673115|NCT00865943|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110673116|NCT00865943|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110673117|NCT00865943|Parasympatholytics|parasympatholytics|mesh-ancestor
110673118|NCT00865943|Autonomic Agents|autonomic agents|mesh-ancestor
110673119|NCT00865943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110673120|NCT00865943|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110673121|NCT00865943|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110673122|NCT00865943|Cholinergic Agents|cholinergic agents|mesh-ancestor
110673123|NCT00866021|Ritonavir|ritonavir|mesh-list
110673124|NCT00866021|Lopinavir|lopinavir|mesh-list
110673125|NCT00866021|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110673126|NCT00866021|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110673127|NCT00866021|Protease Inhibitors|protease inhibitors|mesh-ancestor
110673128|NCT00866021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110673129|NCT00866021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110673130|NCT00866021|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110673131|NCT00866021|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110673132|NCT00866021|Antiviral Agents|antiviral agents|mesh-ancestor
110673133|NCT00866021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110673134|NCT00866021|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110673135|NCT00866021|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110673137|NCT00871247|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
110673138|NCT00871247|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110673139|NCT00871247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110673140|NCT00871247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110673141|NCT00871247|Hormone Antagonists|hormone antagonists|mesh-ancestor
110673142|NCT00871247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110673143|NCT00871247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110673144|NCT00871247|Urological Agents|urological agents|mesh-ancestor
110673145|NCT04137120|Aflibercept|aflibercept|mesh-list
110673146|NCT04137120|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110673147|NCT04137120|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110673148|NCT04137120|Growth Substances|growth substances|mesh-ancestor
110673149|NCT04137120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110673150|NCT04137120|Growth Inhibitors|growth inhibitors|mesh-ancestor
110673151|NCT04137120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110673152|NCT00616655|Eszopiclone|eszopiclone|mesh-list
110673153|NCT00616655|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110673154|NCT00616655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110673155|NCT00616655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110673156|NCT00864773|Endothelial Growth Factors|endothelial growth factors|mesh-list
110673157|NCT00864773|Growth Substances|growth substances|mesh-ancestor
110673158|NCT00864773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110673159|NCT01010490|Dipivefrin|dipivefrin|mesh-list
110673160|NCT01010490|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110673161|NCT01010490|Adrenergic Agents|adrenergic agents|mesh-ancestor
110673162|NCT01010490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110673163|NCT01010490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110673164|NCT01010490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110673165|NCT00516048|Exenatide|exenatide|mesh-list
110673166|NCT00516048|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110673167|NCT00516048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110673168|NCT00516048|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110673169|NCT00516048|Incretins|incretins|mesh-ancestor
110673170|NCT00516048|Hormones|hormones|mesh-ancestor
110673171|NCT00516048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110673172|NCT00871949|Oxazolidinones|oxazolidinones|mesh-list
110673173|NCT00871949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110673174|NCT00871949|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110673175|NCT00871949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110673176|NCT00871949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110673177|NCT00865007|Ritonavir|ritonavir|mesh-list
110673178|NCT00865007|Lopinavir|lopinavir|mesh-list
110673179|NCT00865007|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110673180|NCT00865007|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110673181|NCT00865007|Protease Inhibitors|protease inhibitors|mesh-ancestor
110673182|NCT00865007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110673183|NCT00865007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110684091|NCT00936143|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110673184|NCT00865007|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110673185|NCT00865007|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110673186|NCT00865007|Antiviral Agents|antiviral agents|mesh-ancestor
110673187|NCT00865007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110673188|NCT00865007|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110673189|NCT00865007|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110673191|NCT00872417|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110673192|NCT00872417|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110673193|NCT00872417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110673194|NCT00872417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110673195|NCT00872417|Antiviral Agents|antiviral agents|mesh-ancestor
110673196|NCT00872417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110673197|NCT00872417|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110673198|NCT00872417|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110673199|NCT00876317|Etoricoxib|etoricoxib|mesh-list
110673200|NCT00876317|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110673201|NCT00876317|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110673202|NCT00876317|Analgesics|analgesics|mesh-ancestor
110673203|NCT00876317|Sensory System Agents|sensory system agents|mesh-ancestor
110673204|NCT00876317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110673205|NCT00876317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110673206|NCT00876317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110673207|NCT00876317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110673208|NCT00876317|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110673209|NCT00876317|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110673210|NCT00876317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110673211|NCT00876317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110673212|NCT00866645|Haloperidol|haloperidol|mesh-list
110673213|NCT00866645|Haloperidol decanoate|haloperidol decanoate|mesh-list
110673214|NCT00866645|Sulpiride|sulpiride|mesh-list
110673215|NCT00866645|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110673216|NCT00866645|Antiemetics|antiemetics|mesh-ancestor
110673217|NCT00866645|Autonomic Agents|autonomic agents|mesh-ancestor
110673218|NCT00866645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110673219|NCT00866645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110673220|NCT00866645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110673221|NCT00866645|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110673222|NCT00866645|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110673223|NCT00866645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110673224|NCT00866645|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110673225|NCT00866645|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110673226|NCT00866645|Dopamine Agents|dopamine agents|mesh-ancestor
110673227|NCT00866645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110673228|NCT00866645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110673229|NCT00866645|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110673230|NCT00866645|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110673231|NCT00866645|Antidepressive Agents|antidepressive agents|mesh-ancestor
110673232|NCT00872651|Timolol|timolol|mesh-list
110673233|NCT00872651|Travoprost|travoprost|mesh-list
110673234|NCT00872651|Latanoprost|latanoprost|mesh-list
110673235|NCT00872651|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110673236|NCT00872651|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110673237|NCT00872651|Adrenergic Agents|adrenergic agents|mesh-ancestor
110673238|NCT00872651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110673239|NCT00872651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110673240|NCT00872651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110673241|NCT00872651|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110673242|NCT00872651|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110673243|NCT00872651|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110673244|NCT00872651|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110673245|NCT00872963|Vaccines|vaccines|mesh-list
110673246|NCT00872963|Immunologic Factors|immunologic factors|mesh-ancestor
110673247|NCT00872963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110673248|NCT00873197|Granisetron|granisetron|mesh-list
110673249|NCT00873197|Antiemetics|antiemetics|mesh-ancestor
110673250|NCT00873197|Autonomic Agents|autonomic agents|mesh-ancestor
110673251|NCT00873197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110673252|NCT00873197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110673253|NCT00873197|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110673254|NCT00873197|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110673255|NCT00873197|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110673256|NCT00873197|Serotonin Agents|serotonin agents|mesh-ancestor
110948242|NCT04835896|Antimitotic Agents|antimitotic agents|mesh-ancestor
110673257|NCT00873197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110673258|NCT00873197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110673260|NCT00873353|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110673261|NCT00873353|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110673262|NCT00873353|Antimetabolites|antimetabolites|mesh-ancestor
110673263|NCT00873353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110673264|NCT00873353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110673265|NCT00873353|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110673266|NCT00873353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110673267|NCT00877097|Clodronic Acid|clodronic acid|mesh-list
110673268|NCT00877097|Trisequens|trisequens|mesh-list
110673269|NCT00877097|Norethindrone|norethindrone|mesh-list
110673270|NCT00877097|Estradiol|estradiol|mesh-list
110673271|NCT00877097|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110673272|NCT00877097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110673273|NCT00877097|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110673274|NCT00877097|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110673275|NCT00877097|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110320432|NCT00432315|Docetaxel|docetaxel|mesh-list
110673276|NCT00877097|Contraceptive Agents|contraceptive agents|mesh-ancestor
110687702|NCT00464178|Bortezomib|bortezomib|mesh-list
110673277|NCT00877097|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110673278|NCT00877097|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110673279|NCT00877097|Estrogens|estrogens|mesh-ancestor
110673281|NCT00877097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110673282|NCT00877097|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110673283|NCT00877175|Phenylephrine|phenylephrine|mesh-list
110673284|NCT00877175|Oxymetazoline|oxymetazoline|mesh-list
110673285|NCT00877175|Tropicamide|tropicamide|mesh-list
110673286|NCT00877175|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110673287|NCT00877175|Mydriatics|mydriatics|mesh-ancestor
110673288|NCT00877175|Autonomic Agents|autonomic agents|mesh-ancestor
110673289|NCT00877175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110673290|NCT00877175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110673291|NCT00877175|Sympathomimetics|sympathomimetics|mesh-ancestor
110673292|NCT00877175|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110673293|NCT00877175|Nasal Decongestants|nasal decongestants|mesh-ancestor
110673294|NCT00877175|Respiratory System Agents|respiratory system agents|mesh-ancestor
110673295|NCT00877175|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110673296|NCT00877175|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110673297|NCT00877175|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110673298|NCT00877175|Adrenergic Agents|adrenergic agents|mesh-ancestor
110673299|NCT00877175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110673300|NCT00877175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110673301|NCT00877175|Protective Agents|protective agents|mesh-ancestor
110673302|NCT00877175|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110673303|NCT00877175|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110673304|NCT00877175|Cholinergic Agents|cholinergic agents|mesh-ancestor
110673305|NCT00420927|Adalimumab|adalimumab|mesh-list
110673306|NCT00420927|Methotrexate|methotrexate|mesh-list
110673307|NCT00420927|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110673308|NCT00420927|Abortifacient Agents|abortifacient agents|mesh-ancestor
110673309|NCT00420927|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110673310|NCT00420927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110673311|NCT00420927|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110673312|NCT00420927|Antimetabolites|antimetabolites|mesh-ancestor
110673313|NCT00420927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110673314|NCT00420927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110673315|NCT00420927|Dermatologic Agents|dermatologic agents|mesh-ancestor
110673316|NCT00420927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110673317|NCT00420927|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110673318|NCT00420927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110673319|NCT00420927|Immunologic Factors|immunologic factors|mesh-ancestor
110673320|NCT00420927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110673321|NCT00420927|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110673322|NCT00420927|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110673323|NCT00420927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110673324|NCT00573443|Quinidine|quinidine|mesh-list
110673325|NCT00573443|Quinidine gluconate|quinidine gluconate|mesh-list
110673326|NCT00573443|Dextromethorphan|dextromethorphan|mesh-list
110673327|NCT00573443|Antitussive Agents|antitussive agents|mesh-ancestor
110673328|NCT00573443|Respiratory System Agents|respiratory system agents|mesh-ancestor
110673329|NCT00573443|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110673330|NCT00573443|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110684242|NCT00490698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110673331|NCT00573443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110673332|NCT00573443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110673333|NCT00573443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110673334|NCT00573443|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110673335|NCT00573443|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110673336|NCT00573443|Adrenergic Agents|adrenergic agents|mesh-ancestor
110673337|NCT00573443|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110673338|NCT00573443|Antimalarials|antimalarials|mesh-ancestor
110673339|NCT00573443|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110673340|NCT00573443|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110673341|NCT00573443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110673342|NCT00573443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110673343|NCT00573443|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110673344|NCT00573443|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110673345|NCT00573443|Cholinergic Agents|cholinergic agents|mesh-ancestor
110673346|NCT00573443|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110673347|NCT00573443|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110673348|NCT00573443|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110673349|NCT00573443|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110673350|NCT00573443|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110320488|NCT03279978|Anesthetics|anesthetics|mesh-ancestor
110673351|NCT05225831|Cyclophosphamide|cyclophosphamide|mesh-list
110673352|NCT05225831|Fludarabine|fludarabine|mesh-list
110673353|NCT05225831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110673354|NCT05225831|Immunologic Factors|immunologic factors|mesh-ancestor
110673355|NCT05225831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110673356|NCT05225831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110673357|NCT05225831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110673358|NCT05225831|Alkylating Agents|alkylating agents|mesh-ancestor
110673359|NCT05225831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110673360|NCT05225831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110673361|NCT05225831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110673363|NCT00873509|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110673364|NCT00873509|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110673365|NCT00873509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110673366|NCT00873509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110673367|NCT00873509|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110673368|NCT00873509|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110673369|NCT00873509|Serotonin Agents|serotonin agents|mesh-ancestor
110673370|NCT00873509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110673371|NCT00873509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110673372|NCT00877253|Carboplatin|carboplatin|mesh-list
110673373|NCT00877253|genexol-PM|genexol-pm|mesh-list
110673374|NCT00877253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110673375|NCT00877253|Tubulin Modulators|tubulin modulators|mesh-ancestor
110673376|NCT00877253|Antimitotic Agents|antimitotic agents|mesh-ancestor
110673377|NCT00877253|Mitosis Modulators|mitosis modulators|mesh-ancestor
110673378|NCT00877253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110673379|NCT05225753|Chrysarobin|chrysarobin|mesh-list
110673380|NCT05225753|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110673381|NCT05225753|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110673382|NCT05225753|Analgesics|analgesics|mesh-ancestor
110673383|NCT05225753|Sensory System Agents|sensory system agents|mesh-ancestor
110673384|NCT05225753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110673385|NCT05225753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110673386|NCT05225753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110673387|NCT05225753|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110673388|NCT00877409|Benzoyl Peroxide|benzoyl peroxide|mesh-list
110673389|NCT00877409|Dermatologic Agents|dermatologic agents|mesh-ancestor
110673390|NCT00874133|Domperidone|domperidone|mesh-list
110673391|NCT00874133|Antiemetics|antiemetics|mesh-ancestor
110673392|NCT00874133|Autonomic Agents|autonomic agents|mesh-ancestor
110673393|NCT00874133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110673394|NCT00874133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110673395|NCT00874133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110673396|NCT00874133|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110673397|NCT00874133|Dopamine Agents|dopamine agents|mesh-ancestor
110673398|NCT00874133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110673399|NCT00874133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110673400|NCT00867737|Fluticasone|fluticasone|mesh-list
110673401|NCT00867737|Budesonide|budesonide|mesh-list
110673402|NCT00867737|Formoterol Fumarate|formoterol fumarate|mesh-list
110948243|NCT04835896|Mitosis Modulators|mitosis modulators|mesh-ancestor
110673403|NCT00867737|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110673404|NCT00867737|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
110673405|NCT00867737|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
110673406|NCT00867737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110673407|NCT00867737|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110673408|NCT00867737|Autonomic Agents|autonomic agents|mesh-ancestor
110673409|NCT00867737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110673410|NCT00867737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110673411|NCT00867737|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110673412|NCT00867737|Respiratory System Agents|respiratory system agents|mesh-ancestor
110673413|NCT00867737|Dermatologic Agents|dermatologic agents|mesh-ancestor
110673414|NCT00867737|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110673415|NCT00867737|Glucocorticoids|glucocorticoids|mesh-ancestor
110673416|NCT00867737|Hormones|hormones|mesh-ancestor
110673417|NCT00867737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110673418|NCT00867737|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110673419|NCT00867737|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110673420|NCT00867737|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110673421|NCT00867737|Adrenergic Agents|adrenergic agents|mesh-ancestor
110673422|NCT00867737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110673423|NCT00867737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110673424|NCT00867737|Sympathomimetics|sympathomimetics|mesh-ancestor
110673425|NCT04551677|Vaccines|vaccines|mesh-list
110673426|NCT04551677|Immunologic Factors|immunologic factors|mesh-ancestor
110673427|NCT04551677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110673428|NCT04040465|Aspirin|aspirin|mesh-list
110673429|NCT04040465|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110673430|NCT04040465|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110673431|NCT04040465|Analgesics|analgesics|mesh-ancestor
110673432|NCT04040465|Sensory System Agents|sensory system agents|mesh-ancestor
110673433|NCT04040465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110673434|NCT04040465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110934008|NCT05476172|Dienogest|dienogest|mesh-list
110673435|NCT04040465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110673436|NCT04040465|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110673437|NCT04040465|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110673438|NCT04040465|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110673439|NCT04040465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110673440|NCT04040465|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110673441|NCT04040465|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110673442|NCT04040465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110673443|NCT04040465|Antipyretics|antipyretics|mesh-ancestor
110673444|NCT00420849|Dexamethasone|dexamethasone|mesh-list
110673445|NCT00420849|Lenalidomide|lenalidomide|mesh-list
110673446|NCT00420849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110673447|NCT00420849|Antiemetics|antiemetics|mesh-ancestor
110673448|NCT00420849|Autonomic Agents|autonomic agents|mesh-ancestor
110673449|NCT00420849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110673450|NCT00420849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110673451|NCT00420849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110673452|NCT00420849|Glucocorticoids|glucocorticoids|mesh-ancestor
110673453|NCT00420849|Hormones|hormones|mesh-ancestor
110673454|NCT00420849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110673455|NCT00420849|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110673456|NCT00420849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110673457|NCT00420849|Immunologic Factors|immunologic factors|mesh-ancestor
110673458|NCT00420849|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110673459|NCT00420849|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110673460|NCT00420849|Growth Substances|growth substances|mesh-ancestor
110673461|NCT00420849|Growth Inhibitors|growth inhibitors|mesh-ancestor
110673462|NCT00874523|Raltegravir Potassium|raltegravir potassium|mesh-list
110673463|NCT00874523|Atazanavir Sulfate|atazanavir sulfate|mesh-list
110673464|NCT00874523|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110673465|NCT00874523|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110673466|NCT00874523|Antiviral Agents|antiviral agents|mesh-ancestor
110673467|NCT00874523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110673468|NCT00874523|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110673469|NCT00874523|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110673470|NCT00874523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110673471|NCT00874523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110673472|NCT00874523|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110673473|NCT00874523|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110673474|NCT00874523|Protease Inhibitors|protease inhibitors|mesh-ancestor
110673475|NCT00874601|Valsartan|valsartan|mesh-list
110673476|NCT00874601|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110673477|NCT00874601|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110673478|NCT00874601|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110673479|NCT00874601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110673480|NCT00874679|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
110673481|NCT00874679|Vasodilator Agents|vasodilator agents|mesh-ancestor
110673482|NCT00874679|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110673483|NCT00874679|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110673484|NCT00874679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110673485|NCT00874679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110673486|NCT00874679|Urological Agents|urological agents|mesh-ancestor
110673487|NCT00617201|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
110673488|NCT00617201|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110673489|NCT00617201|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110673490|NCT00617201|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110673491|NCT00617201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110673492|NCT00617201|Adrenergic Agents|adrenergic agents|mesh-ancestor
110673493|NCT00617201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110673494|NCT00617201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110673495|NCT00420303|Etanercept|etanercept|mesh-list
110673496|NCT00420303|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110673497|NCT00420303|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110673498|NCT00420303|Analgesics|analgesics|mesh-ancestor
110673500|NCT00420303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110673501|NCT00420303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110673502|NCT00420303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110673503|NCT00420303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110673504|NCT00420303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110673505|NCT00420303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110673506|NCT00420303|Immunologic Factors|immunologic factors|mesh-ancestor
110673507|NCT00617123|Vorapaxar|vorapaxar|mesh-list
110673508|NCT00617123|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110673509|NCT00877955|Alprazolam|alprazolam|mesh-list
110673510|NCT00877955|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110673511|NCT00877955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110673512|NCT00877955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110673513|NCT00877955|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110673514|NCT00877955|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110673515|NCT00877955|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110673516|NCT00877955|GABA Modulators|gaba modulators|mesh-ancestor
110673517|NCT00877955|GABA Agents|gaba agents|mesh-ancestor
110673518|NCT00877955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110673519|NCT00877955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110673520|NCT00419757|Budesonide|budesonide|mesh-list
110673521|NCT00419757|Formoterol Fumarate|formoterol fumarate|mesh-list
110673522|NCT00419757|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
110673523|NCT00419757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110673524|NCT00419757|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110673525|NCT00419757|Autonomic Agents|autonomic agents|mesh-ancestor
110673526|NCT00419757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110673527|NCT00419757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110673528|NCT00419757|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110673529|NCT00419757|Respiratory System Agents|respiratory system agents|mesh-ancestor
110673530|NCT00419757|Glucocorticoids|glucocorticoids|mesh-ancestor
110673531|NCT00419757|Hormones|hormones|mesh-ancestor
110673532|NCT00419757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110673533|NCT00419757|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110673534|NCT00419757|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110673535|NCT00419757|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110673536|NCT00419757|Adrenergic Agents|adrenergic agents|mesh-ancestor
110673537|NCT00419757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110673538|NCT00419757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110673539|NCT00434109|Sunitinib|sunitinib|mesh-list
110673540|NCT00434109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110673541|NCT00434109|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110673542|NCT00434109|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110673543|NCT00434109|Growth Substances|growth substances|mesh-ancestor
110673544|NCT00434109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110673545|NCT00434109|Growth Inhibitors|growth inhibitors|mesh-ancestor
110673546|NCT00434109|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110673547|NCT00434109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110673548|NCT00434109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110673549|NCT00875069|Ethanol|ethanol|mesh-list
110673550|NCT00875069|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110673551|NCT00875069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110673552|NCT00875069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110673553|NCT00875069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110673554|NCT01029639|Insulin|insulin|mesh-list
110673555|NCT01029639|Insulin Aspart|insulin aspart|mesh-list
110673556|NCT01029639|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110673557|NCT01029639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110673558|NCT01029639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110673559|NCT00875147|Bevacizumab|bevacizumab|mesh-list
110673560|NCT00875147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110673561|NCT00875147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110673562|NCT00875147|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110673563|NCT00875147|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110673564|NCT00875147|Growth Substances|growth substances|mesh-ancestor
110673565|NCT00875147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110673566|NCT00875147|Growth Inhibitors|growth inhibitors|mesh-ancestor
110673567|NCT00433329|Bosentan|bosentan|mesh-list
110673568|NCT00433329|Sildenafil Citrate|sildenafil citrate|mesh-list
110673569|NCT00433329|Vasodilator Agents|vasodilator agents|mesh-ancestor
110673570|NCT00433329|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110673571|NCT00433329|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110673572|NCT00433329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110673573|NCT00433329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110673574|NCT00433329|Urological Agents|urological agents|mesh-ancestor
110673575|NCT00433329|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110673576|NCT00433329|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
110673578|NCT01035021|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110673579|NCT01035021|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110673580|NCT01035021|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110673581|NCT01035021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110673582|NCT01035021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110673583|NCT00878345|Pentobarbital|pentobarbital|mesh-list
110673584|NCT00878345|Dexmedetomidine|dexmedetomidine|mesh-list
110673585|NCT00878345|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110673586|NCT00878345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110673587|NCT00878345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110673588|NCT00878345|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110673589|NCT00878345|Analgesics|analgesics|mesh-ancestor
110673590|NCT00878345|Sensory System Agents|sensory system agents|mesh-ancestor
110673591|NCT00878345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110673592|NCT00878345|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110673593|NCT00878345|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110673594|NCT00878345|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110673595|NCT00878345|Adrenergic Agents|adrenergic agents|mesh-ancestor
110673596|NCT00878345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110673597|NCT00878345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110673598|NCT00878345|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110673599|NCT00878345|GABA Modulators|gaba modulators|mesh-ancestor
110673600|NCT00878345|GABA Agents|gaba agents|mesh-ancestor
110673601|NCT00433017|Ranibizumab|ranibizumab|mesh-list
110673602|NCT00433017|Verteporfin|verteporfin|mesh-list
110673603|NCT00433017|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110673604|NCT00433017|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110673605|NCT00433017|Growth Substances|growth substances|mesh-ancestor
110673606|NCT00433017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110673607|NCT00433017|Growth Inhibitors|growth inhibitors|mesh-ancestor
110673608|NCT00433017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110673609|NCT00433017|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110673610|NCT00433017|Dermatologic Agents|dermatologic agents|mesh-ancestor
110673611|NCT03726671|Choline|choline|mesh-list
110673612|NCT03726671|Lipotropic Agents|lipotropic agents|mesh-ancestor
110673613|NCT03726671|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110673614|NCT03726671|Antimetabolites|antimetabolites|mesh-ancestor
110673615|NCT03726671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110673616|NCT03726671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110673617|NCT03726671|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110673618|NCT03726671|Nootropic Agents|nootropic agents|mesh-ancestor
110673619|NCT00868283|Cerebrolysin|cerebrolysin|mesh-list
110673620|NCT00868283|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110673621|NCT00868283|Protective Agents|protective agents|mesh-ancestor
110673622|NCT00868283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110673623|NCT00868283|Nootropic Agents|nootropic agents|mesh-ancestor
110673624|NCT04039373|Mycophenolic Acid|mycophenolic acid|mesh-list
110673625|NCT04039373|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110673626|NCT04039373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110673627|NCT04039373|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110673628|NCT04039373|Antitubercular Agents|antitubercular agents|mesh-ancestor
110673629|NCT04039373|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110673630|NCT04039373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110673631|NCT04039373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110673632|NCT04039373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110673634|NCT00875537|Antipruritics|antipruritics|mesh-ancestor
110673635|NCT00875537|Dermatologic Agents|dermatologic agents|mesh-ancestor
110673636|NCT00875537|Sensory System Agents|sensory system agents|mesh-ancestor
110673637|NCT00875537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110673638|NCT00875537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110673639|NCT00875771|Bevacizumab|bevacizumab|mesh-list
110673640|NCT00875771|Capecitabine|capecitabine|mesh-list
110673641|NCT00875771|Irinotecan|irinotecan|mesh-list
110673642|NCT00875771|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110673643|NCT00875771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110673644|NCT00875771|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110673645|NCT00875771|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110673646|NCT00875771|Growth Substances|growth substances|mesh-ancestor
110673647|NCT00875771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110673648|NCT00875771|Growth Inhibitors|growth inhibitors|mesh-ancestor
110673649|NCT00875771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110673651|NCT00875771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110673652|NCT00875771|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110673653|NCT00875771|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110673654|NCT00875771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110673655|NCT00875849|Cetuximab|cetuximab|mesh-list
110673656|NCT00875849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110673657|NCT00875849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110673659|NCT00875927|Propolis|propolis|mesh-list
110673660|NCT00875927|Trace Elements|trace elements|mesh-ancestor
110673661|NCT00875927|Micronutrients|micronutrients|mesh-ancestor
110673662|NCT00875927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110023798|NCT00004056|Lenograstim|lenograstim|mesh-list
110673663|NCT00875927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110673665|NCT00878657|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110673666|NCT00878657|Antimetabolites|antimetabolites|mesh-ancestor
110673667|NCT00878657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110673668|NCT00878657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110673669|NCT00868829|Chromium|chromium|mesh-list
110673670|NCT00868829|Sirolimus|sirolimus|mesh-list
110673671|NCT00868829|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110673672|NCT00868829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110673673|NCT00868829|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110673674|NCT00868829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110673675|NCT00868829|Antifungal Agents|antifungal agents|mesh-ancestor
110673676|NCT00868829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110673677|NCT00868829|Immunologic Factors|immunologic factors|mesh-ancestor
110673678|NCT00868829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110673679|NCT00868829|Trace Elements|trace elements|mesh-ancestor
110673680|NCT00868829|Micronutrients|micronutrients|mesh-ancestor
110673681|NCT00868907|Risedronic Acid|risedronic acid|mesh-list
110673682|NCT00868907|Etidronic Acid|etidronic acid|mesh-list
110673683|NCT00868907|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110673684|NCT00868907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110673685|NCT00868907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110673686|NCT00868907|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110673687|NCT00868907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110673688|NCT00868907|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110673689|NCT00868985|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
110673690|NCT00868985|Laxatives|laxatives|mesh-ancestor
110673691|NCT00868985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110673692|NCT00869063|Diclofenac|diclofenac|mesh-list
110673693|NCT00869063|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110673694|NCT00869063|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110673695|NCT00869063|Analgesics|analgesics|mesh-ancestor
110673696|NCT00869063|Sensory System Agents|sensory system agents|mesh-ancestor
110673697|NCT00869063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110673698|NCT00869063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110673699|NCT00869063|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110673700|NCT00869063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110673701|NCT00869063|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110673702|NCT00869063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110673703|NCT00869063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110673704|NCT00869219|Nepafenac|nepafenac|mesh-list
110673705|NCT00869219|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110673706|NCT00869219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110673707|NCT00869219|Analgesics|analgesics|mesh-ancestor
110673708|NCT00869219|Sensory System Agents|sensory system agents|mesh-ancestor
110673709|NCT00869219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110673710|NCT00869219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110673711|NCT00869219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110673712|NCT00869219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110673713|NCT03994965|Pimavanserin|pimavanserin|mesh-list
110673714|NCT03994965|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110673715|NCT03994965|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110673716|NCT03994965|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110673717|NCT03994965|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110673718|NCT03994965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110673719|NCT03994965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110673720|NCT03994965|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110673721|NCT03994965|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110673722|NCT03994965|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110673723|NCT03994965|Serotonin Agents|serotonin agents|mesh-ancestor
110673724|NCT03994965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110673725|NCT03994965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110673726|NCT00531284|Dexamethasone|dexamethasone|mesh-list
110673727|NCT00531284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110673728|NCT00531284|Antiemetics|antiemetics|mesh-ancestor
110673729|NCT00531284|Autonomic Agents|autonomic agents|mesh-ancestor
110673730|NCT00531284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110673731|NCT00531284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110673732|NCT00531284|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110673733|NCT00531284|Glucocorticoids|glucocorticoids|mesh-ancestor
110673734|NCT00531284|Hormones|hormones|mesh-ancestor
110673735|NCT00531284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110673736|NCT00531284|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110673737|NCT00531284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110673738|NCT00531206|Ritonavir|ritonavir|mesh-list
110673739|NCT00531206|Tipranavir|tipranavir|mesh-list
110673740|NCT00531206|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110673741|NCT00531206|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110673742|NCT00531206|Protease Inhibitors|protease inhibitors|mesh-ancestor
110673743|NCT00531206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110673744|NCT00531206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110673745|NCT00531206|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110673746|NCT00531206|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110673747|NCT00531206|Antiviral Agents|antiviral agents|mesh-ancestor
110673748|NCT00531206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110673749|NCT00531206|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110673750|NCT00531206|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110673751|NCT00994994|Tranylcypromine|tranylcypromine|mesh-list
110673752|NCT00994994|Tranexamic Acid|tranexamic acid|mesh-list
110673753|NCT00994994|Antifibrinolytic Agents|antifibrinolytic agents|mesh-list
110673754|NCT00994994|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110673755|NCT00994994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110673756|NCT00994994|Hemostatics|hemostatics|mesh-ancestor
110673757|NCT00994994|Coagulants|coagulants|mesh-ancestor
110673758|NCT00994994|Antidepressive Agents|antidepressive agents|mesh-ancestor
110673759|NCT00994994|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110673760|NCT00994994|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
110673761|NCT00994994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110673762|NCT00994994|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110673763|NCT00994994|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110673764|NCT00994994|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110673765|NCT00994994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110673766|NCT00999752|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110673767|NCT00999752|Nebivolol|nebivolol|mesh-list
110673768|NCT00999752|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110673769|NCT00999752|Diuretics|diuretics|mesh-ancestor
110673770|NCT00999752|Natriuretic Agents|natriuretic agents|mesh-ancestor
110673771|NCT00999752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110673772|NCT00999752|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110673773|NCT00999752|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110673774|NCT00999752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110673775|NCT00999752|Vasodilator Agents|vasodilator agents|mesh-ancestor
110673776|NCT00999752|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
110673777|NCT00999752|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110673778|NCT00999752|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110673779|NCT00999752|Adrenergic Agents|adrenergic agents|mesh-ancestor
110673780|NCT00999752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110673781|NCT01005758|Cytarabine|cytarabine|mesh-list
110673782|NCT01005758|Dexamethasone|dexamethasone|mesh-list
110673783|NCT01005758|Prednisone|prednisone|mesh-list
110673784|NCT01005758|Methylprednisolone|methylprednisolone|mesh-list
110673785|NCT01005758|Prednisolone|prednisolone|mesh-list
110673786|NCT01005758|Hydrocortisone|hydrocortisone|mesh-list
110673787|NCT01005758|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
110673788|NCT01005758|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
110673789|NCT01005758|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
110673790|NCT01005758|Cyclophosphamide|cyclophosphamide|mesh-list
110673791|NCT01005758|Doxorubicin|doxorubicin|mesh-list
110673792|NCT01005758|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110673793|NCT01005758|Methotrexate|methotrexate|mesh-list
110673794|NCT01005758|Etoposide|etoposide|mesh-list
110673795|NCT01005758|Vincristine|vincristine|mesh-list
110673796|NCT01005758|Imatinib Mesylate|imatinib mesylate|mesh-list
110673797|NCT01005758|Mercaptopurine|mercaptopurine|mesh-list
110673798|NCT01005758|Pegaspargase|pegaspargase|mesh-list
110673799|NCT01005758|Etoposide phosphate|etoposide phosphate|mesh-list
110673800|NCT01005758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110673801|NCT01005758|Immunologic Factors|immunologic factors|mesh-ancestor
110687703|NCT00464178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110673802|NCT01005758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110673803|NCT01005758|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110673804|NCT01005758|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110673805|NCT01005758|Alkylating Agents|alkylating agents|mesh-ancestor
110673806|NCT01005758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110673807|NCT01005758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110673808|NCT01005758|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110673809|NCT01005758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110673810|NCT01005758|Antiemetics|antiemetics|mesh-ancestor
111479174|NCT05581797|Hallucinogens|hallucinogens|mesh-ancestor
110673811|NCT01005758|Autonomic Agents|autonomic agents|mesh-ancestor
110673812|NCT01005758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110673813|NCT01005758|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110673814|NCT01005758|Glucocorticoids|glucocorticoids|mesh-ancestor
110673816|NCT01005758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110673817|NCT01005758|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110673818|NCT01005758|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110673819|NCT01005758|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110673820|NCT01005758|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110673821|NCT01005758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110673822|NCT01005758|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110673823|NCT01005758|Abortifacient Agents|abortifacient agents|mesh-ancestor
110673824|NCT01005758|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110673825|NCT01005758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110673826|NCT01005758|Antimetabolites|antimetabolites|mesh-ancestor
110673827|NCT01005758|Dermatologic Agents|dermatologic agents|mesh-ancestor
110673828|NCT01005758|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110673829|NCT01005758|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110673830|NCT01005758|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110673831|NCT01005758|Antiviral Agents|antiviral agents|mesh-ancestor
110673832|NCT01005758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110673833|NCT01005758|Tubulin Modulators|tubulin modulators|mesh-ancestor
110673834|NCT01005758|Antimitotic Agents|antimitotic agents|mesh-ancestor
110673835|NCT01005758|Mitosis Modulators|mitosis modulators|mesh-ancestor
110673836|NCT01005758|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110673837|NCT01005758|Protective Agents|protective agents|mesh-ancestor
110673838|NCT01005758|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110673839|NCT00879047|Ethanol|ethanol|mesh-list
110673840|NCT00879047|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110673841|NCT00879047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110673842|NCT00879047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110673843|NCT00879047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110673844|NCT00999986|Cyclophosphamide|cyclophosphamide|mesh-list
110673845|NCT00999986|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110673846|NCT00999986|Immunologic Factors|immunologic factors|mesh-ancestor
110673847|NCT00999986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110673848|NCT00999986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110673849|NCT00999986|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110673850|NCT00999986|Alkylating Agents|alkylating agents|mesh-ancestor
110673851|NCT00999986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110673852|NCT00999986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110673853|NCT00999986|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110673854|NCT01000220|Omeprazole|omeprazole|mesh-list
110673855|NCT01000220|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110673856|NCT01000220|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110673857|NCT01000220|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110673858|NCT01000220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110673859|NCT01000220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110673860|NCT01006694|Antidepressive Agents|antidepressive agents|mesh-list
110673861|NCT01006694|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110673862|NCT01000298|Amoxicillin|amoxicillin|mesh-list
110673863|NCT01000298|Cefdinir|cefdinir|mesh-list
110673864|NCT01000298|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110673865|NCT01000298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110673866|NCT00614939|Saxagliptin|saxagliptin|mesh-list
110673867|NCT00614939|Incretins|incretins|mesh-ancestor
110673868|NCT00614939|Hormones|hormones|mesh-ancestor
110673869|NCT00614939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110673870|NCT00614939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110673871|NCT00614939|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110673872|NCT00614939|Protease Inhibitors|protease inhibitors|mesh-ancestor
110673873|NCT00614939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110673874|NCT00614939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110687704|NCT00316186|Carboplatin|carboplatin|mesh-list
110673875|NCT00614939|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110673876|NCT00879827|PENTA|penta|mesh-list
110673877|NCT00879827|Anticoagulants|anticoagulants|mesh-ancestor
110673878|NCT00879827|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110673879|NCT00879827|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110673880|NCT00879827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110673881|NCT01007084|Propranolol|propranolol|mesh-list
110673882|NCT01007084|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110673883|NCT01007084|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110673884|NCT01007084|Adrenergic Agents|adrenergic agents|mesh-ancestor
110673885|NCT01007084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110673886|NCT01007084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110673887|NCT01007084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110673888|NCT01007084|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110673889|NCT01007084|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110673890|NCT01007084|Vasodilator Agents|vasodilator agents|mesh-ancestor
110673891|NCT04040309|Lidocaine|lidocaine|mesh-list
110673892|NCT04040309|Anesthetics, Local|anesthetics, local|mesh-ancestor
110673893|NCT04040309|Anesthetics|anesthetics|mesh-ancestor
110673894|NCT04040309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110673895|NCT04040309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110673896|NCT04040309|Sensory System Agents|sensory system agents|mesh-ancestor
110673897|NCT04040309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110673898|NCT04040309|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110673899|NCT04040309|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110673900|NCT04040309|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110673901|NCT04040309|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110673902|NCT04040309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110673903|NCT01000688|Vildagliptin|vildagliptin|mesh-list
110673904|NCT01000688|Acarbose|acarbose|mesh-list
110673905|NCT01000688|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110673906|NCT01000688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110673907|NCT01000688|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110673908|NCT01000688|Protease Inhibitors|protease inhibitors|mesh-ancestor
110673909|NCT01000688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110673910|NCT01000688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110673911|NCT01000688|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
110673912|NCT00879983|Azithromycin|azithromycin|mesh-list
110673913|NCT00879983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110673914|NCT00879983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110673915|NCT00880061|Pseudomonas aeruginosa exotoxin A|pseudomonas aeruginosa exotoxin a|mesh-list
110673916|NCT00880061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110673917|NCT00869765|Cycloserine|cycloserine|mesh-list
110673918|NCT00869765|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110673919|NCT00869765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110673920|NCT00869765|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110673921|NCT00869765|Antitubercular Agents|antitubercular agents|mesh-ancestor
110673922|NCT00869765|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110673923|NCT00869765|Antimetabolites|antimetabolites|mesh-ancestor
110673924|NCT00869765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110673925|NCT00880373|Ibuprofen|ibuprofen|mesh-list
110673926|NCT00880373|Morphine|morphine|mesh-list
110673927|NCT00880373|Heroin|heroin|mesh-list
110673928|NCT00880373|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110673929|NCT00880373|Narcotics|narcotics|mesh-ancestor
110673930|NCT00880373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110673931|NCT00880373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110673932|NCT00880373|Analgesics|analgesics|mesh-ancestor
110673933|NCT00880373|Sensory System Agents|sensory system agents|mesh-ancestor
110673934|NCT00880373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110673935|NCT00880373|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110673936|NCT00880373|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110673937|NCT00880373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110673938|NCT00880373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110673939|NCT00880373|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110673940|NCT00880373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110673941|NCT00880373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110673942|NCT01007630|Rasagiline|rasagiline|mesh-list
110673943|NCT01007630|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
110673944|NCT01007630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110673945|NCT01007630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110673946|NCT01007630|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110673947|NCT01007630|Protective Agents|protective agents|mesh-ancestor
110673948|NCT01007630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110321097|NCT04699734|Lidocaine|lidocaine|mesh-list
110673950|NCT05883384|Chelating Agents|chelating agents|mesh-ancestor
110673951|NCT05883384|Sequestering Agents|sequestering agents|mesh-ancestor
110673952|NCT05883384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110673953|NCT05883358|Clonidine|clonidine|mesh-list
110673954|NCT05883358|Buprenorphine|buprenorphine|mesh-list
110673955|NCT05883358|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110673956|NCT05883358|Narcotics|narcotics|mesh-ancestor
110673957|NCT05883358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110673958|NCT05883358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110673959|NCT05883358|Analgesics|analgesics|mesh-ancestor
110673960|NCT05883358|Sensory System Agents|sensory system agents|mesh-ancestor
110023877|NCT00004110|Isotretinoin|isotretinoin|mesh-list
110673961|NCT05883358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110673962|NCT05883358|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110673963|NCT05883358|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110673964|NCT05883358|Sympatholytics|sympatholytics|mesh-ancestor
110673965|NCT05883358|Autonomic Agents|autonomic agents|mesh-ancestor
110673966|NCT05883358|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110673967|NCT05883358|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110673968|NCT05883358|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110673969|NCT05883358|Adrenergic Agents|adrenergic agents|mesh-ancestor
110673970|NCT05883358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110673971|NCT05883358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110673972|NCT05883345|Immunoglobulins|immunoglobulins|mesh-list
110673973|NCT05883345|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110673974|NCT05883345|Antibodies|antibodies|mesh-list
110673975|NCT05883345|Immunoglobulin G|immunoglobulin g|mesh-list
110673976|NCT05883345|Gastrins|gastrins|mesh-list
110673977|NCT05883345|Immunologic Factors|immunologic factors|mesh-ancestor
110673978|NCT05883345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110673979|NCT05883345|Hormones|hormones|mesh-ancestor
110673980|NCT05883345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110673981|NCT05883332|Nitrous Oxide|nitrous oxide|mesh-list
110673982|NCT05883332|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110673983|NCT05883332|Anesthetics, General|anesthetics, general|mesh-ancestor
110673984|NCT05883332|Anesthetics|anesthetics|mesh-ancestor
110673985|NCT05883332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110673986|NCT05883332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110673987|NCT05883332|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110673988|NCT05883332|Analgesics|analgesics|mesh-ancestor
110673989|NCT05883332|Sensory System Agents|sensory system agents|mesh-ancestor
110673990|NCT05883332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110673991|NCT05883176|Bevacizumab|bevacizumab|mesh-list
110673992|NCT05883176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110673993|NCT05883176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110673994|NCT05883176|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110673995|NCT05883176|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110673996|NCT05883176|Growth Substances|growth substances|mesh-ancestor
110673997|NCT05883176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110673998|NCT05883176|Growth Inhibitors|growth inhibitors|mesh-ancestor
110673999|NCT05883150|Midazolam|midazolam|mesh-list
110674000|NCT05883150|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110674001|NCT05883150|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110674002|NCT05883150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110674003|NCT05883150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110674004|NCT05883150|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110674005|NCT05883150|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110674006|NCT05883150|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110674007|NCT05883150|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110674008|NCT05883150|Anesthetics, General|anesthetics, general|mesh-ancestor
110674009|NCT05883150|Anesthetics|anesthetics|mesh-ancestor
110674010|NCT05883150|GABA Modulators|gaba modulators|mesh-ancestor
110674011|NCT05883150|GABA Agents|gaba agents|mesh-ancestor
110674012|NCT05883150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110674013|NCT05883150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110674014|NCT05883124|Rivastigmine|rivastigmine|mesh-list
110674015|NCT05883124|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110674016|NCT05883124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110674017|NCT05883124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110674018|NCT05883124|Cholinergic Agents|cholinergic agents|mesh-ancestor
110674019|NCT05883124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110674020|NCT05883124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110674021|NCT05883124|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110674022|NCT05883124|Protective Agents|protective agents|mesh-ancestor
110674023|NCT05883046|Performance-Enhancing Substances|performance-enhancing substances|mesh-list
110674024|NCT05883046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110674026|NCT05882864|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110674027|NCT05882864|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110674028|NCT05882864|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110674029|NCT05882864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110674030|NCT05882864|Glucocorticoids|glucocorticoids|mesh-ancestor
110674032|NCT05882864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110674033|NCT05882864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110674034|NCT05882864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110674035|NCT05882864|Immunologic Factors|immunologic factors|mesh-ancestor
110674036|NCT05882864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110023878|NCT00004110|Antibodies|antibodies|mesh-list
110674037|NCT05882864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110674038|NCT05882734|Cemiplimab|cemiplimab|mesh-list
110674039|NCT05882734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110674040|NCT05882734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110674041|NCT05882630|Carboplatin|carboplatin|mesh-list
110674042|NCT05882630|Etoposide|etoposide|mesh-list
110674043|NCT05882630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110674044|NCT05882630|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110674045|NCT05882630|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110674046|NCT05882630|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110674047|NCT05882630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110674048|NCT05882630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110674049|NCT05882604|Mesna|mesna|mesh-list
110674050|NCT05882604|Protective Agents|protective agents|mesh-ancestor
110674051|NCT05882604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110674052|NCT05881980|Itraconazole|itraconazole|mesh-list
110674053|NCT05881980|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
110674054|NCT05881980|Terbinafine|terbinafine|mesh-list
110674055|NCT05881980|Antifungal Agents|antifungal agents|mesh-ancestor
110674056|NCT05881980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110674057|NCT05881980|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110674058|NCT05881980|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110674059|NCT05881980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110674060|NCT05881980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110674061|NCT05881980|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110674062|NCT05881980|Hormone Antagonists|hormone antagonists|mesh-ancestor
110674063|NCT05881980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110674064|NCT05881980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110674065|NCT05881980|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110674066|NCT05881746|Liver Extracts|liver extracts|mesh-list
110674067|NCT05881746|Hematinics|hematinics|mesh-ancestor
110674068|NCT05881525|Paclitaxel|paclitaxel|mesh-list
110674069|NCT05881525|Cyclophosphamide|cyclophosphamide|mesh-list
110674070|NCT05881525|Fludarabine|fludarabine|mesh-list
110674071|NCT05881525|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110674072|NCT05881525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110674073|NCT05881525|Tubulin Modulators|tubulin modulators|mesh-ancestor
110674074|NCT05881525|Antimitotic Agents|antimitotic agents|mesh-ancestor
110674075|NCT05881525|Mitosis Modulators|mitosis modulators|mesh-ancestor
110674076|NCT05881525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110674077|NCT05881525|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110674078|NCT05881525|Immunologic Factors|immunologic factors|mesh-ancestor
110674079|NCT05881525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110674080|NCT05881525|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110674081|NCT05881525|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110674082|NCT05881525|Alkylating Agents|alkylating agents|mesh-ancestor
110674083|NCT05881525|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110674085|NCT05881187|Antifungal Agents|antifungal agents|mesh-list
110674086|NCT05881187|Clotrimazole|clotrimazole|mesh-list
110674087|NCT05881187|Miconazole|miconazole|mesh-list
110674088|NCT05881187|Vitamin B Complex|vitamin b complex|mesh-ancestor
110674089|NCT05881187|Vitamins|vitamins|mesh-ancestor
110674090|NCT05881187|Micronutrients|micronutrients|mesh-ancestor
110674091|NCT05881187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110674092|NCT05881187|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110674093|NCT05881187|Dermatologic Agents|dermatologic agents|mesh-ancestor
110674094|NCT05881187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110674095|NCT05881187|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110674096|NCT05881187|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110674097|NCT05881187|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110674098|NCT05881187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110674099|NCT05881187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110674100|NCT05881187|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110674102|NCT05881187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110674103|NCT05881187|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110674104|NCT05881187|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110674105|NCT05881135|Choline|choline|mesh-list
110674106|NCT05881135|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
110674107|NCT05881135|Lipotropic Agents|lipotropic agents|mesh-ancestor
110674108|NCT05881135|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110674109|NCT05881135|Antimetabolites|antimetabolites|mesh-ancestor
110674110|NCT05881135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110674111|NCT05881135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110449271|NCT02709304|Lidocaine|lidocaine|mesh-list
110674112|NCT05881135|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111479175|NCT05581797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110674113|NCT05881135|Nootropic Agents|nootropic agents|mesh-ancestor
110674114|NCT05880732|Magnesium Sulfate|magnesium sulfate|mesh-list
110674115|NCT05880732|Analgesics|analgesics|mesh-ancestor
110674116|NCT05880732|Sensory System Agents|sensory system agents|mesh-ancestor
110674117|NCT05880732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110674118|NCT05880732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110674119|NCT05880732|Anesthetics|anesthetics|mesh-ancestor
110674120|NCT05880732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110674121|NCT05880732|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110674122|NCT05880732|Anticonvulsants|anticonvulsants|mesh-ancestor
110674123|NCT05880732|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110674124|NCT05880732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110674125|NCT05880732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110674126|NCT05880732|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110674127|NCT05880732|Tocolytic Agents|tocolytic agents|mesh-ancestor
110674128|NCT05880732|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110674129|NCT05880693|Magnesium Sulfate|magnesium sulfate|mesh-list
110674130|NCT05880693|Dexmedetomidine|dexmedetomidine|mesh-list
110674131|NCT05880693|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110674132|NCT05880693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110674133|NCT05880693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110674134|NCT05880693|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110674135|NCT05880693|Analgesics|analgesics|mesh-ancestor
110674136|NCT05880693|Sensory System Agents|sensory system agents|mesh-ancestor
110674137|NCT05880693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110674138|NCT05880693|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110674139|NCT05880693|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110674140|NCT05880693|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110674141|NCT05880693|Adrenergic Agents|adrenergic agents|mesh-ancestor
110674142|NCT05880693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110674143|NCT05880693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110674144|NCT05880693|Anesthetics|anesthetics|mesh-ancestor
110674145|NCT05880693|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110674146|NCT05880693|Anticonvulsants|anticonvulsants|mesh-ancestor
110674147|NCT05880693|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110674148|NCT05880693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110674149|NCT05880693|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110674150|NCT05880693|Tocolytic Agents|tocolytic agents|mesh-ancestor
110674151|NCT05880693|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110674152|NCT05880355|Dapansutrile|dapansutrile|mesh-list
110674153|NCT05880355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110674154|NCT05880342|Methylphenidate|methylphenidate|mesh-list
110674156|NCT05880342|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110674157|NCT05880342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110674158|NCT05880342|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110674159|NCT05880342|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110674160|NCT05880342|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110674161|NCT05880342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110674162|NCT05880342|Dopamine Agents|dopamine agents|mesh-ancestor
110674163|NCT05880342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110674164|NCT05880342|Antidepressive Agents|antidepressive agents|mesh-ancestor
110674165|NCT05880342|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110674166|NCT05880342|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110674167|NCT05880342|Adrenergic Agents|adrenergic agents|mesh-ancestor
110674168|NCT05880186|Caffeine|caffeine|mesh-list
110674169|NCT05880186|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110674170|NCT05880186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110674171|NCT05880186|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110449273|NCT02709304|Anesthetics|anesthetics|mesh-ancestor
110674172|NCT05880186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110674173|NCT05880186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110674174|NCT05880186|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110674175|NCT05880186|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110674176|NCT05880186|Purinergic Agents|purinergic agents|mesh-ancestor
110674177|NCT05880186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110674179|NCT05880082|Carboplatin|carboplatin|mesh-list
110674180|NCT05880082|Tislelizumab|tislelizumab|mesh-list
110674181|NCT05880082|Nedaplatin|nedaplatin|mesh-list
110674182|NCT05880082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110674183|NCT05880082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110674184|NCT05880030|Vitamin D|vitamin d|mesh-list
110674185|NCT05880030|Cholecalciferol|cholecalciferol|mesh-list
110674186|NCT05880030|Vitamins|vitamins|mesh-ancestor
110674187|NCT05880030|Micronutrients|micronutrients|mesh-ancestor
110674188|NCT05880030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110674189|NCT05880030|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110674190|NCT05880030|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110674192|NCT05880017|Bupivacaine|bupivacaine|mesh-list
110674193|NCT05880017|Anesthetics, Local|anesthetics, local|mesh-ancestor
110674194|NCT05880017|Anesthetics|anesthetics|mesh-ancestor
110674195|NCT05880017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110674196|NCT05880017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110674197|NCT05880017|Sensory System Agents|sensory system agents|mesh-ancestor
110674198|NCT05880017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110674199|NCT05880017|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110674200|NCT05880017|Narcotics|narcotics|mesh-ancestor
110674201|NCT05880017|Analgesics|analgesics|mesh-ancestor
110674202|NCT05879796|Cisplatin|cisplatin|mesh-list
110674203|NCT05879796|Endostatins|endostatins|mesh-list
110674204|NCT05879796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110674205|NCT05879796|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110674206|NCT05879796|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110674207|NCT05879796|Growth Substances|growth substances|mesh-ancestor
110674208|NCT05879796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110674209|NCT05879796|Growth Inhibitors|growth inhibitors|mesh-ancestor
110674210|NCT05879653|Pembrolizumab|pembrolizumab|mesh-list
110674211|NCT05879653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110674212|NCT05879653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110674213|NCT05879653|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110674214|NCT05879653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110674215|NCT05879627|Exatecan|exatecan|mesh-list
110674216|NCT05879627|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110674217|NCT05879627|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110674218|NCT05879627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110674219|NCT05879627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110674220|NCT05879627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110674221|NCT05879536|Tramadol|tramadol|mesh-list
110674222|NCT05879536|Ondansetron|ondansetron|mesh-list
110674223|NCT05879536|Ropivacaine|ropivacaine|mesh-list
110674224|NCT05879536|Anesthetics, Local|anesthetics, local|mesh-ancestor
110674225|NCT05879536|Anesthetics|anesthetics|mesh-ancestor
110674226|NCT05879536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110674227|NCT05879536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110674228|NCT05879536|Sensory System Agents|sensory system agents|mesh-ancestor
110674229|NCT05879536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110674230|NCT05879536|Antiemetics|antiemetics|mesh-ancestor
110674231|NCT05879536|Autonomic Agents|autonomic agents|mesh-ancestor
110674232|NCT05879536|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110674233|NCT05879536|Antipruritics|antipruritics|mesh-ancestor
110674234|NCT05879536|Dermatologic Agents|dermatologic agents|mesh-ancestor
110674235|NCT05879536|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110674236|NCT05879536|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110674237|NCT05879536|Serotonin Agents|serotonin agents|mesh-ancestor
110674238|NCT05879536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110674239|NCT05879536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110674240|NCT05879536|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110674241|NCT05879536|Narcotics|narcotics|mesh-ancestor
110674242|NCT05879536|Analgesics|analgesics|mesh-ancestor
110674243|NCT05879367|Eflornithine|eflornithine|mesh-list
110674244|NCT05879367|Temozolomide|temozolomide|mesh-list
110674245|NCT05879367|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110674246|NCT05879367|Alkylating Agents|alkylating agents|mesh-ancestor
110674247|NCT05879367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110674248|NCT05879367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110674249|NCT05879367|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
110674250|NCT05879367|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110674251|NCT05879367|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110674252|NCT05879367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110674253|NCT05879367|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
110674254|NCT05879367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110674255|NCT05879276|Empagliflozin|empagliflozin|mesh-list
110674256|NCT05879276|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110674257|NCT05879276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110674258|NCT05879276|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110674259|NCT05879276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110674260|NCT05879237|Vitamin D|vitamin d|mesh-list
110674261|NCT05879237|Cholecalciferol|cholecalciferol|mesh-list
110674262|NCT05879237|Vitamins|vitamins|mesh-ancestor
110674263|NCT05879237|Micronutrients|micronutrients|mesh-ancestor
110674264|NCT05879237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110674265|NCT05879237|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110674266|NCT05879237|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110674267|NCT05879146|Nirogacestat|nirogacestat|mesh-list
110674268|NCT05879146|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
110674269|NCT05879146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110674270|NCT05879146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110674271|NCT05879068|Paclitaxel|paclitaxel|mesh-list
110674272|NCT05879068|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110674273|NCT05879068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110674274|NCT05879068|Tubulin Modulators|tubulin modulators|mesh-ancestor
110674275|NCT05879068|Antimitotic Agents|antimitotic agents|mesh-ancestor
110674276|NCT05879068|Mitosis Modulators|mitosis modulators|mesh-ancestor
110674277|NCT05879068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110674278|NCT05879029|Rabeprazole|rabeprazole|mesh-list
110674279|NCT05879029|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110674280|NCT05879029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110674281|NCT05879029|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110674282|NCT05879029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110674283|NCT05879029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110674284|NCT05878977|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
110674285|NCT05878977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110674286|NCT05878977|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110674287|NCT05878977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110674288|NCT05878964|Mitogens|mitogens|mesh-list
110674289|NCT05878964|Mitosis Modulators|mitosis modulators|mesh-ancestor
110674290|NCT05878964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110674291|NCT05878535|Metformin|metformin|mesh-list
110674292|NCT05878535|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110674293|NCT05878535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110674294|NCT05876806|Trametinib|trametinib|mesh-list
110674295|NCT05876806|Dabrafenib|dabrafenib|mesh-list
110674296|NCT05876806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110674297|NCT05876806|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110674298|NCT05876806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110674299|NCT05876806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110674300|NCT05876273|Pancrelipase|pancrelipase|mesh-list
110674301|NCT05876273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110674302|NCT05875506|Doxycycline|doxycycline|mesh-list
110674304|NCT05875506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110674305|NCT05875506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110674306|NCT05875506|Antimalarials|antimalarials|mesh-ancestor
110674307|NCT05875506|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110674308|NCT05875506|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110674309|NCT05875506|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110674310|NCT05875506|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110674311|NCT05875506|Antimetabolites|antimetabolites|mesh-ancestor
110674312|NCT05875506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110674313|NCT05875506|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110674314|NCT05875506|Chelating Agents|chelating agents|mesh-ancestor
110674315|NCT05875506|Sequestering Agents|sequestering agents|mesh-ancestor
110674316|NCT05875506|Hemostatics|hemostatics|mesh-ancestor
110674317|NCT05875506|Coagulants|coagulants|mesh-ancestor
110674318|NCT05875350|Anesthetics|anesthetics|mesh-list
110674319|NCT05875350|Anesthetics, Local|anesthetics, local|mesh-list
110674320|NCT05875350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110674321|NCT05875350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110674322|NCT05875350|Sensory System Agents|sensory system agents|mesh-ancestor
110674323|NCT05875350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110321455|NCT00446004|Omeprazole|omeprazole|mesh-list
110674324|NCT05871086|Ubiquinone|ubiquinone|mesh-list
110674325|NCT05871086|Coenzyme Q10|coenzyme q10|mesh-list
110674326|NCT05871086|Micronutrients|micronutrients|mesh-ancestor
110674327|NCT05871086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110674328|NCT05871086|Vitamins|vitamins|mesh-ancestor
110674329|NCT05864755|Bevacizumab|bevacizumab|mesh-list
110674330|NCT05864755|Durvalumab|durvalumab|mesh-list
110674331|NCT05864755|Tremelimumab|tremelimumab|mesh-list
110674332|NCT05864755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110674333|NCT05864755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110674334|NCT05864755|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110674335|NCT05864755|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110674336|NCT05864755|Growth Substances|growth substances|mesh-ancestor
110674337|NCT05864755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110674338|NCT05864755|Growth Inhibitors|growth inhibitors|mesh-ancestor
110674339|NCT05864404|Dexmedetomidine|dexmedetomidine|mesh-list
110674340|NCT05864404|Remifentanil|remifentanil|mesh-list
110674341|NCT05864404|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110674342|NCT05864404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110674343|NCT05864404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110674344|NCT05864404|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110674345|NCT05864404|Analgesics|analgesics|mesh-ancestor
110674346|NCT05864404|Sensory System Agents|sensory system agents|mesh-ancestor
110674347|NCT05864404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110674348|NCT05864404|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110674349|NCT05864404|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110674350|NCT05864404|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110674351|NCT05864404|Adrenergic Agents|adrenergic agents|mesh-ancestor
110674352|NCT05864404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110674353|NCT05864404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110674354|NCT05864404|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110674355|NCT05864404|Narcotics|narcotics|mesh-ancestor
110674356|NCT05856981|Pembrolizumab|pembrolizumab|mesh-list
110674357|NCT05856981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110674358|NCT05856981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110674359|NCT05856981|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110674360|NCT05856981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110674361|NCT05856357|Pyrimethamine|pyrimethamine|mesh-list
110674362|NCT05856357|Sulfadoxine|sulfadoxine|mesh-list
110674363|NCT05856357|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
110674364|NCT05856357|Antimalarials|antimalarials|mesh-ancestor
110674365|NCT05856357|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110674366|NCT05856357|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110674367|NCT05856357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110674368|NCT05856357|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110674369|NCT05856357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110674370|NCT05856357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110674371|NCT05856357|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110674372|NCT05846906|Sildenafil Citrate|sildenafil citrate|mesh-list
110674373|NCT05846906|Citric Acid|citric acid|mesh-list
110674374|NCT05846906|Sodium Citrate|sodium citrate|mesh-list
110674375|NCT05846906|Clomiphene|clomiphene|mesh-list
110674376|NCT05846906|Enclomiphene|enclomiphene|mesh-list
110674377|NCT05846906|Zuclomiphene|zuclomiphene|mesh-list
110674378|NCT05846906|Anticoagulants|anticoagulants|mesh-ancestor
110674379|NCT05846906|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110674380|NCT05846906|Chelating Agents|chelating agents|mesh-ancestor
110674381|NCT05846906|Sequestering Agents|sequestering agents|mesh-ancestor
110674382|NCT05846906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110674383|NCT05846906|Vasodilator Agents|vasodilator agents|mesh-ancestor
110674384|NCT05846906|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110674385|NCT05846906|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110674386|NCT05846906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110674387|NCT05846906|Urological Agents|urological agents|mesh-ancestor
110674388|NCT05846906|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110674389|NCT05846906|Hormone Antagonists|hormone antagonists|mesh-ancestor
110674390|NCT05846906|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110674391|NCT05846906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110674392|NCT05846906|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110674393|NCT05846906|Fertility Agents|fertility agents|mesh-ancestor
110674394|NCT05846906|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110674395|NCT05846906|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110674396|NCT05846906|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110674397|NCT05844462|Tadalafil|tadalafil|mesh-list
110674398|NCT05844462|Vasodilator Agents|vasodilator agents|mesh-ancestor
110674399|NCT05844462|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110674400|NCT05844462|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110687705|NCT00316186|Topotecan|topotecan|mesh-list
110674401|NCT05844462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110674402|NCT05844462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110674403|NCT05844462|Urological Agents|urological agents|mesh-ancestor
110674404|NCT05835245|Lenvatinib|lenvatinib|mesh-list
110674405|NCT05835245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110674406|NCT05835245|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110674407|NCT05835245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110674408|NCT05835245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110674409|NCT05832255|Psilocybin|psilocybin|mesh-list
110674410|NCT05832255|Hallucinogens|hallucinogens|mesh-ancestor
110674411|NCT05832255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110674412|NCT05832255|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111479176|NCT05581797|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110674414|NCT05826327|Esketamine|esketamine|mesh-list
110674415|NCT05826327|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110674416|NCT05826327|Narcotics|narcotics|mesh-ancestor
110674417|NCT05826327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110674418|NCT05826327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110674419|NCT05826327|Analgesics|analgesics|mesh-ancestor
110674420|NCT05826327|Sensory System Agents|sensory system agents|mesh-ancestor
110674421|NCT05826327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110674422|NCT05826327|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110674423|NCT05826327|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110674424|NCT05826327|Anesthetics, General|anesthetics, general|mesh-ancestor
110674425|NCT05826327|Anesthetics|anesthetics|mesh-ancestor
110674426|NCT05826327|Antidepressive Agents|antidepressive agents|mesh-ancestor
110674427|NCT05826327|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110674428|NCT05823116|Vancomycin|vancomycin|mesh-list
110674429|NCT05823116|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110674430|NCT05823116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110674431|NCT05817721|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
110674432|NCT05817721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110674433|NCT05817721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110674434|NCT05814991|Nitroglycerin|nitroglycerin|mesh-list
110674435|NCT05814991|Vasodilator Agents|vasodilator agents|mesh-ancestor
110674436|NCT05814367|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110674437|NCT05814367|Lubricant Eye Drops|lubricant eye drops|mesh-list
110674438|NCT05814367|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110674439|NCT05809011|Dexamethasone|dexamethasone|mesh-list
110674440|NCT05809011|Prednisone|prednisone|mesh-list
110674441|NCT05809011|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110674442|NCT05809011|Antiemetics|antiemetics|mesh-ancestor
110674443|NCT05809011|Autonomic Agents|autonomic agents|mesh-ancestor
110674444|NCT05809011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110674445|NCT05809011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110674446|NCT05809011|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110674447|NCT05809011|Glucocorticoids|glucocorticoids|mesh-ancestor
110674448|NCT05809011|Hormones|hormones|mesh-ancestor
110674449|NCT05809011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110674450|NCT05809011|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110674451|NCT05809011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110674452|NCT05801146|Botulinum Toxins|botulinum toxins|mesh-list
110685387|NCT04250064|Bevacizumab|bevacizumab|mesh-list
110674453|NCT05801146|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110674454|NCT05801146|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110674455|NCT05801146|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110674456|NCT05801146|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110674457|NCT05801146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110674458|NCT05801146|Cholinergic Agents|cholinergic agents|mesh-ancestor
110674459|NCT05801146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110674460|NCT05801146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110674461|NCT05801146|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110674462|NCT05801146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110674463|NCT05795647|Tocopherols|tocopherols|mesh-list
110674464|NCT05795647|Vitamin E|vitamin e|mesh-list
110674465|NCT05795647|Tocotrienols|tocotrienols|mesh-list
110674466|NCT05795647|alpha-Tocopherol|alpha-tocopherol|mesh-list
110674467|NCT05795647|Pentoxifylline|pentoxifylline|mesh-list
110674468|NCT05795647|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110674469|NCT05795647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110674470|NCT05795647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110674471|NCT05795647|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110674472|NCT05795647|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110674473|NCT05795647|Protective Agents|protective agents|mesh-ancestor
110674474|NCT05795647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110674475|NCT05795647|Vasodilator Agents|vasodilator agents|mesh-ancestor
110674476|NCT05795647|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110674479|NCT05795647|Micronutrients|micronutrients|mesh-ancestor
110674480|NCT05794399|Warfarin|warfarin|mesh-list
110674481|NCT05794399|Rivaroxaban|rivaroxaban|mesh-list
110674482|NCT05794399|Anticoagulants|anticoagulants|mesh-ancestor
110674483|NCT05794399|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110674484|NCT05794399|Antithrombins|antithrombins|mesh-ancestor
110674485|NCT05794399|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110674486|NCT05794399|Protease Inhibitors|protease inhibitors|mesh-ancestor
110674487|NCT05794399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110674488|NCT05794399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110674489|NCT05788510|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110674490|NCT05788510|Immunologic Factors|immunologic factors|mesh-ancestor
110674491|NCT05788510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110674492|NCT05764395|Pembrolizumab|pembrolizumab|mesh-list
110674493|NCT05764395|ON 01910|on 01910|mesh-list
110674494|NCT05764395|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110674495|NCT05764395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110674496|NCT05764395|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110674497|NCT05764395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110674498|NCT05764395|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110674499|NCT05764395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110674500|NCT05746546|Nicotine|nicotine|mesh-list
110674501|NCT05746546|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110674502|NCT05746546|Autonomic Agents|autonomic agents|mesh-ancestor
110674503|NCT05746546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110674504|NCT05746546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110674505|NCT05746546|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110674506|NCT05746546|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110674507|NCT05746546|Cholinergic Agents|cholinergic agents|mesh-ancestor
110674508|NCT05746546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110674509|NCT05746546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110674510|NCT05727371|Hylan|hylan|mesh-list
110674511|NCT05727371|Viscosupplements|viscosupplements|mesh-ancestor
110674512|NCT05727371|Protective Agents|protective agents|mesh-ancestor
110674513|NCT05727371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110674514|NCT05714306|Cyclophosphamide|cyclophosphamide|mesh-list
110674515|NCT05714306|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110674516|NCT05714306|Immunologic Factors|immunologic factors|mesh-ancestor
110674517|NCT05714306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110674518|NCT05714306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110674519|NCT05714306|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110674520|NCT05714306|Alkylating Agents|alkylating agents|mesh-ancestor
110674521|NCT05714306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110674522|NCT05714306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110674523|NCT05714306|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110674524|NCT05706259|Vitamin D|vitamin d|mesh-list
110674525|NCT05706259|Ergocalciferols|ergocalciferols|mesh-list
110674526|NCT05706259|Cholecalciferol|cholecalciferol|mesh-list
110674527|NCT05706259|Vitamins|vitamins|mesh-list
110674528|NCT05706259|Micronutrients|micronutrients|mesh-ancestor
110948244|NCT04835896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110685462|NCT01040559|Idarubicin|idarubicin|mesh-list
110674529|NCT05706259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110674530|NCT05706259|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110674531|NCT05706259|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110674532|NCT05704374|Pregabalin|pregabalin|mesh-list
110674533|NCT05704374|Analgesics|analgesics|mesh-ancestor
110674534|NCT05704374|Sensory System Agents|sensory system agents|mesh-ancestor
110674535|NCT05704374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110674536|NCT05704374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110674537|NCT05704374|Anticonvulsants|anticonvulsants|mesh-ancestor
110674538|NCT05704374|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110674539|NCT05704374|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110674540|NCT05704374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110674541|NCT05704374|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110674542|NCT05704374|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110674543|NCT05704374|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110674544|NCT05704374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110674545|NCT05704374|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110674546|NCT05704166|Pirfenidone|pirfenidone|mesh-list
110674547|NCT05704166|Analgesics|analgesics|mesh-ancestor
110674548|NCT05704166|Sensory System Agents|sensory system agents|mesh-ancestor
110674549|NCT05704166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110674550|NCT05704166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110674551|NCT05704166|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110348964|NCT01631617|Eusol|eusol|mesh-list
110674552|NCT05704166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110674553|NCT05704166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110674554|NCT05704166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110674555|NCT05704166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110674556|NCT05680558|Methoxsalen|methoxsalen|mesh-list
110674557|NCT05680558|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110674558|NCT05680558|Dermatologic Agents|dermatologic agents|mesh-ancestor
110674559|NCT05667324|Dexamethasone|dexamethasone|mesh-list
110674560|NCT05667324|Ropivacaine|ropivacaine|mesh-list
110674561|NCT05667324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110674562|NCT05667324|Antiemetics|antiemetics|mesh-ancestor
110674563|NCT05667324|Autonomic Agents|autonomic agents|mesh-ancestor
110674564|NCT05667324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110674565|NCT05667324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110674566|NCT05667324|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110674568|NCT05667324|Hormones|hormones|mesh-ancestor
110674569|NCT05667324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110674570|NCT05667324|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110674571|NCT05667324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110674572|NCT05667324|Anesthetics, Local|anesthetics, local|mesh-ancestor
110674573|NCT05667324|Anesthetics|anesthetics|mesh-ancestor
110674574|NCT05667324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110674575|NCT05667324|Sensory System Agents|sensory system agents|mesh-ancestor
110674576|NCT05663242|Anesthetics|anesthetics|mesh-list
110674577|NCT05663242|Propofol|propofol|mesh-list
110674578|NCT05663242|Sevoflurane|sevoflurane|mesh-list
110674579|NCT05663242|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110674580|NCT05663242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110674581|NCT05663242|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110674582|NCT05663242|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110674583|NCT05663242|Anesthetics, General|anesthetics, general|mesh-ancestor
110674584|NCT05663242|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110674585|NCT05663242|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110674586|NCT05661851|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110674587|NCT05661851|Lubricant Eye Drops|lubricant eye drops|mesh-list
110674588|NCT05661851|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110674589|NCT05656521|Dexamethasone|dexamethasone|mesh-list
110674590|NCT05656521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110674591|NCT05656521|Antiemetics|antiemetics|mesh-ancestor
110674592|NCT05656521|Autonomic Agents|autonomic agents|mesh-ancestor
110674593|NCT05656521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110674594|NCT05656521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110674595|NCT05656521|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110674596|NCT05656521|Glucocorticoids|glucocorticoids|mesh-ancestor
110674597|NCT05656521|Hormones|hormones|mesh-ancestor
110674598|NCT05656521|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110674599|NCT05656521|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110674600|NCT05656521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110674601|NCT05655013|Zoledronic Acid|zoledronic acid|mesh-list
110948245|NCT01668004|Golimumab|golimumab|mesh-list
110674602|NCT05655013|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110674603|NCT05655013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110674604|NCT05653271|Cyclophosphamide|cyclophosphamide|mesh-list
110674605|NCT05653271|Fludarabine|fludarabine|mesh-list
110674606|NCT05653271|Obinutuzumab|obinutuzumab|mesh-list
110674607|NCT05653271|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110674608|NCT05653271|Immunologic Factors|immunologic factors|mesh-ancestor
110674609|NCT05653271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110674610|NCT05653271|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110674611|NCT05653271|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110674612|NCT05653271|Alkylating Agents|alkylating agents|mesh-ancestor
110674613|NCT05653271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110674614|NCT05653271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110674615|NCT05653271|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110674616|NCT05653271|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110674617|NCT05644184|Vaccines|vaccines|mesh-list
110674618|NCT05644184|Immunologic Factors|immunologic factors|mesh-ancestor
110674619|NCT05644184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110674620|NCT05644041|Gemcitabine|gemcitabine|mesh-list
110674621|NCT05644041|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110674622|NCT05644041|Antimetabolites|antimetabolites|mesh-ancestor
110674623|NCT05644041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110674624|NCT05644041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110674625|NCT05633992|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110674626|NCT05633992|Immunologic Factors|immunologic factors|mesh-ancestor
110674627|NCT05633992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110674628|NCT05628623|Cytarabine|cytarabine|mesh-list
110674629|NCT05628623|Azacitidine|azacitidine|mesh-list
110674630|NCT05628623|Daunorubicin|daunorubicin|mesh-list
110674631|NCT05628623|Venetoclax|venetoclax|mesh-list
110674632|NCT05628623|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110674633|NCT05628623|Antimetabolites|antimetabolites|mesh-ancestor
110674634|NCT05628623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110674635|NCT05628623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110674636|NCT05628623|Antiviral Agents|antiviral agents|mesh-ancestor
110674637|NCT05628623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111479177|NCT05510544|Plerixafor|plerixafor|mesh-list
110674638|NCT05628623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110674639|NCT05628623|Immunologic Factors|immunologic factors|mesh-ancestor
110674640|NCT05628623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110674641|NCT05628623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110674642|NCT05628623|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110674643|NCT05628623|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110674644|NCT05628623|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110674645|NCT05616923|Trametinib|trametinib|mesh-list
110674646|NCT05616923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110674647|NCT05616923|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110674648|NCT05616923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110674649|NCT05616923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110674650|NCT05616013|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110674651|NCT05616013|Antibodies, Blocking|antibodies, blocking|mesh-list
110674652|NCT05616013|Immunologic Factors|immunologic factors|mesh-ancestor
110674653|NCT05616013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110674654|NCT05608200|Lenvatinib|lenvatinib|mesh-list
110674655|NCT05608200|Chlorotrianisene|chlorotrianisene|mesh-list
110674656|NCT05608200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110674657|NCT05608200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110674658|NCT05608200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110674659|NCT05608200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110674660|NCT05608200|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
110674661|NCT05608200|Estrogens|estrogens|mesh-ancestor
110674662|NCT05608200|Hormones|hormones|mesh-ancestor
110674663|NCT05608200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110674664|NCT05608200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110674665|NCT05608200|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110674666|NCT05606692|Propofol|propofol|mesh-list
110674667|NCT05606692|Sevoflurane|sevoflurane|mesh-list
110674668|NCT05606692|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110674669|NCT05606692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110674670|NCT05606692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110674671|NCT05606692|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110674672|NCT05606692|Anesthetics, General|anesthetics, general|mesh-ancestor
110674673|NCT05606692|Anesthetics|anesthetics|mesh-ancestor
110674674|NCT05606692|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110674675|NCT05606692|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110674676|NCT05601336|Metformin|metformin|mesh-list
110685605|NCT00303628|Antidotes|antidotes|mesh-ancestor
110674677|NCT05601336|Dapagliflozin|dapagliflozin|mesh-list
110674678|NCT05601336|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110674679|NCT05601336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110674680|NCT05601336|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110674681|NCT05601336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110674682|NCT05599243|Dutasteride|dutasteride|mesh-list
110674683|NCT05599243|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
110674684|NCT05599243|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110674685|NCT05599243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110674686|NCT05599243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110674687|NCT05599243|Hormone Antagonists|hormone antagonists|mesh-ancestor
110674688|NCT05599243|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110674689|NCT05599243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110674690|NCT05580666|Azithromycin|azithromycin|mesh-list
110674691|NCT05580666|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110674692|NCT05580666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110674693|NCT05557110|Blinatumomab|blinatumomab|mesh-list
110674694|NCT05557110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110674695|NCT05556889|Iodine|iodine|mesh-list
110674696|NCT05556889|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110674697|NCT05556889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110674698|NCT05556889|Trace Elements|trace elements|mesh-ancestor
110674699|NCT05556889|Micronutrients|micronutrients|mesh-ancestor
110674700|NCT05556889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110674701|NCT05544136|Carboplatin|carboplatin|mesh-list
110674702|NCT05544136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110674703|NCT05541471|Digoxin|digoxin|mesh-list
110674706|NCT05541471|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110674707|NCT05541471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110674708|NCT05541471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110674710|NCT05541471|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110674711|NCT05541471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110674712|NCT05541471|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110674713|NCT05541471|Anesthetics, General|anesthetics, general|mesh-ancestor
111479178|NCT05510544|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110674715|NCT05541471|GABA Modulators|gaba modulators|mesh-ancestor
110674716|NCT05541471|GABA Agents|gaba agents|mesh-ancestor
110674717|NCT05541471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110674718|NCT05541471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110674719|NCT05541471|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110674720|NCT05541471|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110674721|NCT05541471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110674722|NCT05541471|Protective Agents|protective agents|mesh-ancestor
110674723|NCT05504278|Carboplatin|carboplatin|mesh-list
110674724|NCT05504278|Pemetrexed|pemetrexed|mesh-list
110674725|NCT05504278|Cisplatin|cisplatin|mesh-list
110674726|NCT05504278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110674727|NCT05504278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110674728|NCT05504278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110674729|NCT05504278|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110674730|NCT05504278|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110674731|NCT05498792|Nivolumab|nivolumab|mesh-list
110674732|NCT05498792|Ipilimumab|ipilimumab|mesh-list
110674733|NCT05498792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110674734|NCT05498792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110674735|NCT05498792|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110674736|NCT05498792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110674737|NCT05490134|Naloxone|naloxone|mesh-list
110674738|NCT05490134|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110674739|NCT05490134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110674740|NCT05490134|Sensory System Agents|sensory system agents|mesh-ancestor
110674741|NCT05490134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110674742|NCT05479812|Pembrolizumab|pembrolizumab|mesh-list
110674743|NCT05479812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110674744|NCT05479812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110674745|NCT05479812|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110674746|NCT05479812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110674747|NCT05475613|Immunomodulating Agents|immunomodulating agents|mesh-list
110674748|NCT05475613|Immunologic Factors|immunologic factors|mesh-ancestor
110674749|NCT05475613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110674750|NCT05453968|Berotralstat|berotralstat|mesh-list
110674751|NCT05453968|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110674752|NCT05453968|Protease Inhibitors|protease inhibitors|mesh-ancestor
110948246|NCT01668004|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110685679|NCT00474786|Antifungal Agents|antifungal agents|mesh-ancestor
110674753|NCT05453968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110674754|NCT05453968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110674757|NCT05440201|Enoxaparin|enoxaparin|mesh-list
110674758|NCT05440201|Anticoagulants|anticoagulants|mesh-list
110674759|NCT05440201|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110674760|NCT05440201|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110674761|NCT05440201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110674762|NCT05422885|Dasatinib|dasatinib|mesh-list
110674763|NCT05422885|Quercetin|quercetin|mesh-list
110674764|NCT05422885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110674765|NCT05422885|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110674766|NCT05422885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110674767|NCT05422885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110674768|NCT05422885|Antioxidants|antioxidants|mesh-ancestor
110674769|NCT05422885|Protective Agents|protective agents|mesh-ancestor
110674770|NCT05422885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110674771|NCT05418049|Memantine|memantine|mesh-list
110674772|NCT05418049|Baclofen|baclofen|mesh-list
110674773|NCT05418049|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110674774|NCT05418049|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110674775|NCT05418049|Dopamine Agents|dopamine agents|mesh-ancestor
110674776|NCT05418049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110674777|NCT05418049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110674778|NCT05418049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110674779|NCT05418049|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110674780|NCT05418049|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110674781|NCT05418049|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110674782|NCT05418049|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110674783|NCT05418049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110674784|NCT05418049|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
110674785|NCT05418049|GABA Agonists|gaba agonists|mesh-ancestor
110674786|NCT05418049|GABA Agents|gaba agents|mesh-ancestor
110674787|NCT05414500|Brentuximab Vedotin|brentuximab vedotin|mesh-list
110674788|NCT05414500|Mogamulizumab|mogamulizumab|mesh-list
110674789|NCT05414500|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110674790|NCT05414500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110674791|NCT05414500|Immunotoxins|immunotoxins|mesh-ancestor
110674792|NCT05414500|Immunoconjugates|immunoconjugates|mesh-ancestor
110674793|NCT05414500|Immunologic Factors|immunologic factors|mesh-ancestor
110674794|NCT05414500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110674795|NCT05411484|Doxycycline|doxycycline|mesh-list
110674796|NCT05411484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110674797|NCT05411484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110674798|NCT05411484|Antimalarials|antimalarials|mesh-ancestor
110674799|NCT05411484|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110674800|NCT05411484|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110674801|NCT05369676|Ritonavir|ritonavir|mesh-list
110674802|NCT05369676|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110674803|NCT05369676|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110674804|NCT05369676|Protease Inhibitors|protease inhibitors|mesh-ancestor
110674805|NCT05369676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110674806|NCT05369676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110674807|NCT05369676|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110449401|NCT00607581|Glucocorticoids|glucocorticoids|mesh-ancestor
110674808|NCT05369676|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110674809|NCT05369676|Antiviral Agents|antiviral agents|mesh-ancestor
110674810|NCT05369676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110674811|NCT05369676|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110674812|NCT05369676|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110674813|NCT06014853|Abiraterone Acetate|abiraterone acetate|mesh-list
110674814|NCT06014853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110674815|NCT06014853|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110674816|NCT06014853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110674817|NCT06014853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110674818|NCT06014853|Hormone Antagonists|hormone antagonists|mesh-ancestor
110674819|NCT06014853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110674820|NCT06014853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110674821|NCT06014853|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110674822|NCT06014827|Osimertinib|osimertinib|mesh-list
110674823|NCT06014827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110674824|NCT06014827|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110674825|NCT06014827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110674826|NCT06014827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110674827|NCT06014801|Dialysis Solutions|dialysis solutions|mesh-list
110948247|NCT01668004|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110674828|NCT06014801|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110674829|NCT06014775|Antibodies|antibodies|mesh-list
110674830|NCT06014775|Immunologic Factors|immunologic factors|mesh-ancestor
110674831|NCT06014775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110674832|NCT06014749|Anesthetics|anesthetics|mesh-list
110674833|NCT06014749|Anesthetics, Local|anesthetics, local|mesh-list
110674834|NCT06014749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110674835|NCT06014749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110674836|NCT06014749|Sensory System Agents|sensory system agents|mesh-ancestor
110674837|NCT06014749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110674838|NCT06014606|Propranolol|propranolol|mesh-list
110674839|NCT06014606|Haloperidol|haloperidol|mesh-list
110674840|NCT06014606|Haloperidol decanoate|haloperidol decanoate|mesh-list
110674841|NCT06014606|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110674842|NCT06014606|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110674843|NCT06014606|Adrenergic Agents|adrenergic agents|mesh-ancestor
110674844|NCT06014606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110674845|NCT06014606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110674846|NCT06014606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110674847|NCT06014606|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110674848|NCT06014606|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110674849|NCT06014606|Vasodilator Agents|vasodilator agents|mesh-ancestor
110674850|NCT06014606|Antiemetics|antiemetics|mesh-ancestor
110674851|NCT06014606|Autonomic Agents|autonomic agents|mesh-ancestor
110674852|NCT06014606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110674853|NCT06014606|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110674854|NCT06014606|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110674855|NCT06014606|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110674856|NCT06014606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110674857|NCT06014606|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110674858|NCT06014606|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110674859|NCT06014606|Dopamine Agents|dopamine agents|mesh-ancestor
110674860|NCT06014606|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110674862|NCT06014528|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111479179|NCT05510544|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110674863|NCT06014528|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110674864|NCT06014528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110674865|NCT06014528|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110674866|NCT06014528|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110674867|NCT06014528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110674868|NCT06014528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110674870|NCT06014489|Azacitidine|azacitidine|mesh-list
110674871|NCT06014489|Venetoclax|venetoclax|mesh-list
110674872|NCT06014489|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110674873|NCT06014489|Antimetabolites|antimetabolites|mesh-ancestor
110674874|NCT06014489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110674875|NCT06014489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110674876|NCT06014489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110674877|NCT06014489|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110674878|NCT06014489|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110674879|NCT06014489|Antiviral Agents|antiviral agents|mesh-ancestor
110674880|NCT06014489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110474358|NCT00746941|Mefloquine|mefloquine|mesh-list
110674881|NCT06014489|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110674882|NCT06014489|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110674883|NCT06014138|Propofol|propofol|mesh-list
110674884|NCT06014138|Isoflurane|isoflurane|mesh-list
110674885|NCT06014138|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110674886|NCT06014138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110674887|NCT06014138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110674888|NCT06014138|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110674889|NCT06014138|Anesthetics, General|anesthetics, general|mesh-ancestor
110674890|NCT06014138|Anesthetics|anesthetics|mesh-ancestor
110674891|NCT06014138|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110674892|NCT06013956|Levodopa|levodopa|mesh-list
110674893|NCT06013956|Carbidopa|carbidopa|mesh-list
110674894|NCT06013956|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110674895|NCT06013956|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110674896|NCT06013956|Dopamine Agents|dopamine agents|mesh-ancestor
110674897|NCT06013956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110674898|NCT06013956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110674899|NCT06013956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110674900|NCT06013956|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
110674901|NCT06013956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110674902|NCT06013865|Empagliflozin|empagliflozin|mesh-list
110674903|NCT06013865|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110674904|NCT06013865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110674905|NCT06013865|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110674906|NCT06013865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110674907|NCT06013735|Listerine|listerine|mesh-list
110674908|NCT06013735|Fluorides|fluorides|mesh-list
110674909|NCT06013735|Sodium Fluoride|sodium fluoride|mesh-list
110674910|NCT06013735|Cariostatic Agents|cariostatic agents|mesh-ancestor
110674911|NCT06013735|Protective Agents|protective agents|mesh-ancestor
110674912|NCT06013735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110674913|NCT06013735|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110674914|NCT06013735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110674915|NCT06013540|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
110674916|NCT06013540|Tretinoin|tretinoin|mesh-list
110674917|NCT06013540|Hydroquinone|hydroquinone|mesh-list
110674918|NCT06013540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110674919|NCT06013540|Antioxidants|antioxidants|mesh-ancestor
110674920|NCT06013540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110674921|NCT06013540|Protective Agents|protective agents|mesh-ancestor
110674922|NCT06013540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110674923|NCT06013540|Keratolytic Agents|keratolytic agents|mesh-ancestor
110674924|NCT06013540|Dermatologic Agents|dermatologic agents|mesh-ancestor
110674925|NCT06013540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110674926|NCT06013540|Glucocorticoids|glucocorticoids|mesh-ancestor
110674927|NCT06013540|Hormones|hormones|mesh-ancestor
110674928|NCT06013540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110674929|NCT06013540|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110674930|NCT06013436|Cyclosporine|cyclosporine|mesh-list
110674931|NCT06013436|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110674932|NCT06013436|Cyclosporins|cyclosporins|mesh-list
110674939|NCT06013436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110674940|NCT06013436|Dermatologic Agents|dermatologic agents|mesh-ancestor
110674941|NCT06013436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110674942|NCT06013436|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110674943|NCT06013436|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110674944|NCT06013423|Cyclosporine|cyclosporine|mesh-list
110674945|NCT06013423|Mycophenolic Acid|mycophenolic acid|mesh-list
110674946|NCT06013423|Cyclophosphamide|cyclophosphamide|mesh-list
110674948|NCT06013423|Fludarabine|fludarabine|mesh-list
110674949|NCT06013423|Fludarabine phosphate|fludarabine phosphate|mesh-list
110674950|NCT06013423|Cyclosporins|cyclosporins|mesh-list
110674951|NCT06013423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110674952|NCT06013423|Immunologic Factors|immunologic factors|mesh-ancestor
110674953|NCT06013423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110674954|NCT06013423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110674955|NCT06013423|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110674956|NCT06013423|Alkylating Agents|alkylating agents|mesh-ancestor
110674957|NCT06013423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110674958|NCT06013423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110674959|NCT06013423|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110674960|NCT06013423|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110674961|NCT06013423|Antimetabolites|antimetabolites|mesh-ancestor
110674962|NCT06013423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110674963|NCT06013423|Antifungal Agents|antifungal agents|mesh-ancestor
110674964|NCT06013423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110674965|NCT06013423|Dermatologic Agents|dermatologic agents|mesh-ancestor
110674966|NCT06013423|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110674967|NCT06013423|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110674968|NCT06013423|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110674969|NCT06013423|Antitubercular Agents|antitubercular agents|mesh-ancestor
110674970|NCT06013423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110674978|NCT06013293|Zinc Oxide|zinc oxide|mesh-list
110674979|NCT06013293|Dermatologic Agents|dermatologic agents|mesh-ancestor
110674980|NCT06013293|Sunscreening Agents|sunscreening agents|mesh-ancestor
110674981|NCT06013293|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110674982|NCT06013293|Protective Agents|protective agents|mesh-ancestor
110674983|NCT06013293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110674984|NCT06013241|Mometasone Furoate|mometasone furoate|mesh-list
110674985|NCT06013241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110674986|NCT06013241|Dermatologic Agents|dermatologic agents|mesh-ancestor
110674987|NCT06013241|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110674988|NCT06013163|Orlistat|orlistat|mesh-list
110674989|NCT06013163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110674990|NCT06013163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110674991|NCT06013163|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110674992|NCT06013163|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110674993|NCT06013150|Epinephrine|epinephrine|mesh-list
110674994|NCT06013150|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110674995|NCT06013150|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110674996|NCT06013150|Adrenergic Agents|adrenergic agents|mesh-ancestor
110674997|NCT06013150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110674998|NCT06013150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110674999|NCT06013150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110675000|NCT06013150|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110675001|NCT06013150|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110675002|NCT06013150|Autonomic Agents|autonomic agents|mesh-ancestor
110675003|NCT06013150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110675004|NCT06013150|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110675005|NCT06013150|Respiratory System Agents|respiratory system agents|mesh-ancestor
110675006|NCT06013150|Mydriatics|mydriatics|mesh-ancestor
110675007|NCT06013150|Sympathomimetics|sympathomimetics|mesh-ancestor
110675008|NCT06013150|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110675010|NCT06013111|Fludarabine|fludarabine|mesh-list
110675011|NCT06013111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110675012|NCT06013111|Immunologic Factors|immunologic factors|mesh-ancestor
110675013|NCT06013111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110675014|NCT06013111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110675015|NCT06013111|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110675016|NCT06013111|Alkylating Agents|alkylating agents|mesh-ancestor
110675017|NCT06013111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110675018|NCT06013111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110675019|NCT06013111|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110675020|NCT06013020|Aspirin|aspirin|mesh-list
110675021|NCT06013020|Rivaroxaban|rivaroxaban|mesh-list
110675022|NCT06013020|Clopidogrel|clopidogrel|mesh-list
110675023|NCT06013020|Ticagrelor|ticagrelor|mesh-list
110675024|NCT06013020|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110675025|NCT06013020|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110675026|NCT06013020|Analgesics|analgesics|mesh-ancestor
110675027|NCT06013020|Sensory System Agents|sensory system agents|mesh-ancestor
110675028|NCT06013020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110675029|NCT06013020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110675030|NCT06013020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110675031|NCT06013020|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110675032|NCT06013020|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110675033|NCT06013020|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110675034|NCT06013020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110675035|NCT06013020|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110675036|NCT06013020|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110675037|NCT06013020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110675038|NCT06013020|Antipyretics|antipyretics|mesh-ancestor
110449411|NCT02707900|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110675039|NCT06013020|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110675040|NCT06013020|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110675041|NCT06013020|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110675042|NCT06013020|Purinergic Agents|purinergic agents|mesh-ancestor
110675043|NCT06013020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110675044|NCT06013020|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110675045|NCT06013020|Antithrombins|antithrombins|mesh-ancestor
110675046|NCT06013020|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110675047|NCT06013020|Protease Inhibitors|protease inhibitors|mesh-ancestor
110675048|NCT06013020|Anticoagulants|anticoagulants|mesh-ancestor
110675049|NCT06012929|TIC10 compound|tic10 compound|mesh-list
110675050|NCT06012929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110675052|NCT06012916|Antidepressive Agents|antidepressive agents|mesh-ancestor
110675053|NCT06012916|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110675054|NCT06008860|Azelastine|azelastine|mesh-list
110675055|NCT06008860|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110675056|NCT06008860|Autonomic Agents|autonomic agents|mesh-ancestor
110675057|NCT06008860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110675058|NCT06008860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110675059|NCT06008860|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110675060|NCT06008860|Respiratory System Agents|respiratory system agents|mesh-ancestor
110675061|NCT06008860|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
110675062|NCT06008860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110675063|NCT06008860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110675064|NCT06008860|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110675065|NCT06008860|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110675066|NCT06008860|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110675067|NCT06008860|Histamine Antagonists|histamine antagonists|mesh-ancestor
110675068|NCT06008860|Histamine Agents|histamine agents|mesh-ancestor
110675069|NCT06008860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110675070|NCT05997004|Glycopyrrolate|glycopyrrolate|mesh-list
110675071|NCT05997004|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110675073|NCT05997004|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110675074|NCT05997004|Cholinergic Agents|cholinergic agents|mesh-ancestor
110675075|NCT05997004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110675076|NCT05997004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110675077|NCT05997004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110675078|NCT05995301|Ropivacaine|ropivacaine|mesh-list
110675079|NCT05995301|Anesthetics, Local|anesthetics, local|mesh-ancestor
110675080|NCT05995301|Anesthetics|anesthetics|mesh-ancestor
110675081|NCT05995301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110675082|NCT05995301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110675083|NCT05995301|Sensory System Agents|sensory system agents|mesh-ancestor
110675084|NCT05995301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110675085|NCT05981131|BCG Vaccine|bcg vaccine|mesh-list
110675097|NCT05926570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110675098|NCT05923996|Botulinum Toxins|botulinum toxins|mesh-list
110675099|NCT05923996|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110675100|NCT05923996|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110675101|NCT05923996|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110675102|NCT05923996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110675103|NCT05923996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110675104|NCT05923996|Cholinergic Agents|cholinergic agents|mesh-ancestor
110675105|NCT05923996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110675106|NCT05923996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110675107|NCT05923996|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110675108|NCT05923996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110675109|NCT05919823|Xanomeline|xanomeline|mesh-list
110675110|NCT05919823|Trospium chloride|trospium chloride|mesh-list
110675111|NCT05919823|Parasympatholytics|parasympatholytics|mesh-ancestor
110675112|NCT05919823|Autonomic Agents|autonomic agents|mesh-ancestor
110675113|NCT05919823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110675114|NCT05919823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110675115|NCT05919823|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110675116|NCT05919823|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110675117|NCT05919823|Cholinergic Agents|cholinergic agents|mesh-ancestor
110675118|NCT05919823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110675119|NCT05919823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110675120|NCT05919823|Urological Agents|urological agents|mesh-ancestor
110675121|NCT05919823|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110675122|NCT05919823|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110675123|NCT05919823|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
110675124|NCT05919823|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110675133|NCT05907304|Trametinib|trametinib|mesh-list
110675134|NCT05907304|Naporafenib|naporafenib|mesh-list
110675135|NCT05907304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110675136|NCT05907304|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110675137|NCT05907304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110675138|NCT05907304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110675139|NCT05885542|Cannabidiol|cannabidiol|mesh-list
110675140|NCT05885542|Anticonvulsants|anticonvulsants|mesh-ancestor
110675141|NCT05839119|Gemcitabine|gemcitabine|mesh-list
110675142|NCT05839119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110675143|NCT05839119|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110675144|NCT05839119|Antimetabolites|antimetabolites|mesh-ancestor
110675145|NCT05839119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110675157|NCT05784246|Mirikizumab|mirikizumab|mesh-list
110675163|NCT05784246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110675164|NCT05784246|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110675166|NCT05784246|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110675167|NCT05784246|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110675168|NCT05782881|Glucagon|glucagon|mesh-list
110675169|NCT05782881|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
110675170|NCT05782881|Enzyme Inhibitors|enzyme inhibitors|mesh-list
110675171|NCT05782881|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
110675172|NCT05782881|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110675173|NCT05782881|Hormones|hormones|mesh-ancestor
110675174|NCT05782881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110675175|NCT05782881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110675176|NCT05782881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110675177|NCT05782881|Incretins|incretins|mesh-ancestor
110675178|NCT05782881|Protease Inhibitors|protease inhibitors|mesh-ancestor
110675184|NCT05759442|Metformin|metformin|mesh-list
110675185|NCT05759442|Acetic Acid|acetic acid|mesh-list
110675186|NCT05759442|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110675187|NCT05759442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110675188|NCT05759442|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110675189|NCT05759442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110675190|NCT05730218|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110675191|NCT05730218|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110675192|NCT05728346|Hyaluronic Acid|hyaluronic acid|mesh-list
110675193|NCT05728346|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110675194|NCT05728346|Immunologic Factors|immunologic factors|mesh-ancestor
110675195|NCT05728346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110675196|NCT05728346|Viscosupplements|viscosupplements|mesh-ancestor
110675197|NCT05728346|Protective Agents|protective agents|mesh-ancestor
110675198|NCT05631899|Cyclophosphamide|cyclophosphamide|mesh-list
110675200|NCT05631899|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110675201|NCT05631899|Paclitaxel|paclitaxel|mesh-list
110675202|NCT05631899|Antibodies|antibodies|mesh-list
110675203|NCT05631899|Immunoglobulins|immunoglobulins|mesh-list
110675204|NCT05631899|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110675205|NCT05631899|Antibodies, Blocking|antibodies, blocking|mesh-list
110675206|NCT05631899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110675207|NCT05631899|Immunologic Factors|immunologic factors|mesh-ancestor
110675208|NCT05631899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110675209|NCT05631899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110675210|NCT05631899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110675211|NCT05631899|Alkylating Agents|alkylating agents|mesh-ancestor
110675212|NCT05631899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110675213|NCT05631899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110675214|NCT05631899|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110675215|NCT05631899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110675216|NCT05631899|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110675217|NCT05631899|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110675218|NCT05631899|Tubulin Modulators|tubulin modulators|mesh-ancestor
110675219|NCT05631899|Antimitotic Agents|antimitotic agents|mesh-ancestor
110675220|NCT05631899|Mitosis Modulators|mitosis modulators|mesh-ancestor
110675221|NCT05631886|Cyclophosphamide|cyclophosphamide|mesh-list
110675222|NCT05631886|Ipilimumab|ipilimumab|mesh-list
110675223|NCT05631886|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110675224|NCT05631886|Paclitaxel|paclitaxel|mesh-list
110675226|NCT05631886|Immunoglobulins|immunoglobulins|mesh-list
110675227|NCT05631886|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110675228|NCT05631886|Antibodies, Blocking|antibodies, blocking|mesh-list
110675229|NCT05631886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110675230|NCT05631886|Immunologic Factors|immunologic factors|mesh-ancestor
110675231|NCT05631886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110675232|NCT05631886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110675233|NCT05631886|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110675239|NCT05631886|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110675240|NCT05631886|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110675241|NCT05631886|Tubulin Modulators|tubulin modulators|mesh-ancestor
110675242|NCT05631886|Antimitotic Agents|antimitotic agents|mesh-ancestor
110675243|NCT05631886|Mitosis Modulators|mitosis modulators|mesh-ancestor
110675245|NCT05601752|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110675246|NCT05601752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110675247|NCT05601752|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110675248|NCT05601752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110675249|NCT05556681|Sirolimus|sirolimus|mesh-list
110675250|NCT05556681|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110675251|NCT05556681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110675252|NCT05556681|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110675253|NCT05556681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110675254|NCT05556681|Antifungal Agents|antifungal agents|mesh-ancestor
110675255|NCT05556681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110675256|NCT05556681|Immunologic Factors|immunologic factors|mesh-ancestor
110675257|NCT05556681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110675263|NCT05534529|Rezafungin|rezafungin|mesh-list
110675264|NCT05534529|Antifungal Agents|antifungal agents|mesh-ancestor
110675265|NCT05534529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110675266|NCT05483010|Atorvastatin|atorvastatin|mesh-list
110675267|NCT05483010|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110675268|NCT05483010|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110675269|NCT05483010|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110675270|NCT05483010|Antimetabolites|antimetabolites|mesh-ancestor
110675271|NCT05483010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110675272|NCT05483010|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110675273|NCT05483010|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110675274|NCT05483010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110675275|NCT05368207|Pembrolizumab|pembrolizumab|mesh-list
110675276|NCT05368207|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110675277|NCT05368207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110675278|NCT05368207|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110675279|NCT05368207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110675280|NCT05364944|Octreotide|octreotide|mesh-list
110675281|NCT05364944|Lanreotide|lanreotide|mesh-list
110675282|NCT05364944|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110675283|NCT05364944|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110675284|NCT05364944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110675285|NCT05350774|Immunoglobulins|immunoglobulins|mesh-list
110675286|NCT05350774|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110675287|NCT05350774|Antibodies|antibodies|mesh-list
110675288|NCT05350774|gamma-Globulins|gamma-globulins|mesh-list
110675289|NCT05350774|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110675290|NCT05350774|Immunologic Factors|immunologic factors|mesh-ancestor
110675291|NCT05350774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110675292|NCT05341115|Leuprolide|leuprolide|mesh-list
110675293|NCT05341115|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110675294|NCT05341115|Fertility Agents|fertility agents|mesh-ancestor
110675295|NCT05341115|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110675296|NCT05341115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110675297|NCT05341115|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110675298|NCT05341115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110675299|NCT05285917|Hydroxyurea|hydroxyurea|mesh-list
110675300|NCT05285917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110675301|NCT05285917|Antisickling Agents|antisickling agents|mesh-ancestor
110675302|NCT05285917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110675303|NCT05285917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110675304|NCT05285917|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110675305|NCT05280704|Lidocaine|lidocaine|mesh-list
110675306|NCT05280704|Anesthetics, Local|anesthetics, local|mesh-ancestor
110675307|NCT05280704|Anesthetics|anesthetics|mesh-ancestor
110675308|NCT05280704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110675309|NCT05280704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110675310|NCT05280704|Sensory System Agents|sensory system agents|mesh-ancestor
110675311|NCT05280704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110675312|NCT05280704|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110675313|NCT05280704|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110675314|NCT05280704|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110675315|NCT05280704|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110675316|NCT05280704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110675317|NCT05271318|Pembrolizumab|pembrolizumab|mesh-list
110675318|NCT05271318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110675319|NCT05271318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110675320|NCT05271318|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110675321|NCT05271318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110675322|NCT05262855|FAPI-46|fapi-46|mesh-list
110675323|NCT05262855|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110675324|NCT05262855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110675325|NCT05253573|Nicotine|nicotine|mesh-list
110675326|NCT05253573|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110675327|NCT05253573|Autonomic Agents|autonomic agents|mesh-ancestor
110675328|NCT05253573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110675329|NCT05253573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110675330|NCT05253573|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110675331|NCT05253573|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110675332|NCT05253573|Cholinergic Agents|cholinergic agents|mesh-ancestor
110675333|NCT05253573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110675334|NCT05253573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110675335|NCT05233228|Nicotine|nicotine|mesh-list
110675336|NCT05233228|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110675337|NCT05233228|Autonomic Agents|autonomic agents|mesh-ancestor
110675338|NCT05233228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110675339|NCT05233228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110675340|NCT05233228|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110675341|NCT05233228|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110675342|NCT05233228|Cholinergic Agents|cholinergic agents|mesh-ancestor
110675343|NCT05233228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110675344|NCT05233228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110675345|NCT05220046|Psilocybin|psilocybin|mesh-list
110675346|NCT05220046|Hallucinogens|hallucinogens|mesh-ancestor
110675347|NCT05220046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110675348|NCT05220046|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110675349|NCT05176951|Treprostinil|treprostinil|mesh-list
110675350|NCT05176951|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110675351|NCT05119712|Terbinafine|terbinafine|mesh-list
110675352|NCT05119712|Antifungal Agents|antifungal agents|mesh-ancestor
110675353|NCT05119712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110675354|NCT05119712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110675355|NCT05119712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110675356|NCT05104047|Lobeline|lobeline|mesh-list
110675357|NCT05104047|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110675358|NCT05104047|Autonomic Agents|autonomic agents|mesh-ancestor
110675359|NCT05104047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110675360|NCT05104047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110675361|NCT05104047|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110675362|NCT05104047|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110675363|NCT05104047|Cholinergic Agents|cholinergic agents|mesh-ancestor
110675364|NCT05104047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110675365|NCT05104047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110675366|NCT05104047|Respiratory System Agents|respiratory system agents|mesh-ancestor
110675367|NCT05101629|Pembrolizumab|pembrolizumab|mesh-list
110675368|NCT05101629|Lenvatinib|lenvatinib|mesh-list
110675369|NCT05101629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110675370|NCT05101629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110675371|NCT05101629|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110675372|NCT05101629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110675373|NCT05101629|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110675374|NCT05101629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110675375|NCT05081479|Acetylcysteine|acetylcysteine|mesh-list
110675376|NCT05081479|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110675377|NCT05081479|Antiviral Agents|antiviral agents|mesh-ancestor
110675378|NCT05081479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110675379|NCT05081479|Expectorants|expectorants|mesh-ancestor
110675380|NCT05081479|Respiratory System Agents|respiratory system agents|mesh-ancestor
110675381|NCT05081479|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110675382|NCT05081479|Antioxidants|antioxidants|mesh-ancestor
110675383|NCT05081479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111479180|NCT05510544|Antiviral Agents|antiviral agents|mesh-ancestor
110675384|NCT05081479|Protective Agents|protective agents|mesh-ancestor
110675385|NCT05081479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110675387|NCT05059626|Bazedoxifene|bazedoxifene|mesh-list
110675388|NCT05059626|Simvastatin|simvastatin|mesh-list
110675389|NCT05059626|Estrogens|estrogens|mesh-list
110675390|NCT05059626|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110675391|NCT05059626|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110675392|NCT05059626|Antimetabolites|antimetabolites|mesh-ancestor
110675393|NCT05059626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110675394|NCT05059626|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110675395|NCT05059626|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110675396|NCT05059626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110675397|NCT05059626|Hormones|hormones|mesh-ancestor
110675398|NCT05059626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110675399|NCT05059626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110675400|NCT05059626|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110675401|NCT05059626|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110675402|NCT05059626|Hormone Antagonists|hormone antagonists|mesh-ancestor
110675403|NCT05059626|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110675404|NCT05042609|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110675405|NCT05042609|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110675406|NCT04985344|Propranolol|propranolol|mesh-list
110675407|NCT04985344|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110675408|NCT04985344|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110675409|NCT04985344|Adrenergic Agents|adrenergic agents|mesh-ancestor
110675410|NCT04985344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110675411|NCT04985344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110675412|NCT04985344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110675413|NCT04985344|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110675414|NCT04985344|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110675415|NCT04985344|Vasodilator Agents|vasodilator agents|mesh-ancestor
110675416|NCT04974970|Immunomodulating Agents|immunomodulating agents|mesh-list
110675417|NCT04974970|Immunologic Factors|immunologic factors|mesh-ancestor
110675418|NCT04974970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110675419|NCT04946370|Pembrolizumab|pembrolizumab|mesh-list
110675420|NCT04946370|Androgens|androgens|mesh-list
110675421|NCT04946370|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
110675422|NCT04946370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110675423|NCT04946370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110675424|NCT04946370|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110675425|NCT04946370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110675426|NCT04946370|Hormones|hormones|mesh-ancestor
110675427|NCT04946370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110675428|NCT04946370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110675429|NCT04946370|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110675430|NCT04920695|Nitric Oxide|nitric oxide|mesh-list
110675431|NCT04920695|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110675432|NCT04920695|Autonomic Agents|autonomic agents|mesh-ancestor
110675433|NCT04920695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110675434|NCT04920695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110675435|NCT04920695|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110675436|NCT04920695|Respiratory System Agents|respiratory system agents|mesh-ancestor
110675437|NCT04920695|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110675438|NCT04920695|Antioxidants|antioxidants|mesh-ancestor
110675439|NCT04920695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110675440|NCT04920695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110675441|NCT04920695|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
110675442|NCT04920695|Vasodilator Agents|vasodilator agents|mesh-ancestor
110675443|NCT04920695|Gasotransmitters|gasotransmitters|mesh-ancestor
110675444|NCT04920695|Protective Agents|protective agents|mesh-ancestor
110675445|NCT04865419|Voriconazole|voriconazole|mesh-list
110675446|NCT04865419|Antifungal Agents|antifungal agents|mesh-ancestor
110675447|NCT04865419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110675448|NCT04865419|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110675449|NCT04865419|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110675450|NCT04865419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110675451|NCT04865419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110675452|NCT04865419|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110675453|NCT04865419|Hormone Antagonists|hormone antagonists|mesh-ancestor
110687706|NCT00316186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110675461|NCT04808505|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110675462|NCT04808505|Antiviral Agents|antiviral agents|mesh-ancestor
110675463|NCT04808505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110675464|NCT04808505|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
110675465|NCT04808505|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110675466|NCT04808505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110675468|NCT04777357|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110675469|NCT04777357|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110675470|NCT04777357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110675471|NCT04777357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110675472|NCT04777357|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110675475|NCT04711343|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110675476|NCT04711343|Immunologic Factors|immunologic factors|mesh-ancestor
110675477|NCT04711343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110675483|NCT04646707|Lidocaine|lidocaine|mesh-list
110675484|NCT04646707|Bupivacaine|bupivacaine|mesh-list
110675485|NCT04646707|Anesthetics, Local|anesthetics, local|mesh-ancestor
110675486|NCT04646707|Anesthetics|anesthetics|mesh-ancestor
110675487|NCT04646707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110675488|NCT04646707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110675489|NCT04646707|Sensory System Agents|sensory system agents|mesh-ancestor
110675490|NCT04646707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110675491|NCT04646707|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110675492|NCT04646707|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110675493|NCT04646707|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110675494|NCT04646707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110675495|NCT04646707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110675496|NCT04646694|Ketamine|ketamine|mesh-list
110675497|NCT04646694|Analgesics|analgesics|mesh-ancestor
110675498|NCT04646694|Sensory System Agents|sensory system agents|mesh-ancestor
110675499|NCT04646694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110675500|NCT04646694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110675501|NCT04646694|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110675502|NCT04646694|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110675503|NCT04646694|Anesthetics, General|anesthetics, general|mesh-ancestor
110675504|NCT04646694|Anesthetics|anesthetics|mesh-ancestor
110675505|NCT04646694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110675506|NCT04646694|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110675507|NCT04646694|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110675508|NCT04646694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110682998|NCT00908921|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110675509|NCT04646694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110675510|NCT04595370|Dapagliflozin|dapagliflozin|mesh-list
110675511|NCT04595370|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110675512|NCT04595370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110675513|NCT04595370|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110675514|NCT04595370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110675515|NCT04543942|Ethanol|ethanol|mesh-list
110675516|NCT04543942|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110675517|NCT04543942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110675518|NCT04543942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110675519|NCT04543942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110349908|NCT02890186|Remifentanil|remifentanil|mesh-list
110675550|NCT04361708|Antimetabolites|antimetabolites|mesh-ancestor
110675551|NCT04361708|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110675552|NCT04361708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110675553|NCT04361708|Immunologic Factors|immunologic factors|mesh-ancestor
110675554|NCT04361708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110675555|NCT04361708|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110675556|NCT04361708|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110675557|NCT04361708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110675558|NCT04361708|Antidotes|antidotes|mesh-ancestor
110675559|NCT04361708|Protective Agents|protective agents|mesh-ancestor
110675560|NCT04361708|Vitamin B Complex|vitamin b complex|mesh-ancestor
110675561|NCT04361708|Vitamins|vitamins|mesh-ancestor
110675562|NCT04361708|Micronutrients|micronutrients|mesh-ancestor
110675563|NCT04345146|Bevacizumab|bevacizumab|mesh-list
110675564|NCT04345146|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110675565|NCT04345146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110675566|NCT04345146|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110675567|NCT04345146|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110675568|NCT04345146|Growth Substances|growth substances|mesh-ancestor
110675569|NCT04345146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110675570|NCT04345146|Growth Inhibitors|growth inhibitors|mesh-ancestor
110675571|NCT04336098|Paclitaxel|paclitaxel|mesh-list
110675573|NCT04336098|Pembrolizumab|pembrolizumab|mesh-list
110675574|NCT04336098|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110675575|NCT04336098|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110675576|NCT04336098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110675577|NCT04336098|Tubulin Modulators|tubulin modulators|mesh-ancestor
110675578|NCT04336098|Antimitotic Agents|antimitotic agents|mesh-ancestor
110675579|NCT04336098|Mitosis Modulators|mitosis modulators|mesh-ancestor
110675580|NCT04336098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110675581|NCT04336098|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110675582|NCT04336098|Antimetabolites|antimetabolites|mesh-ancestor
110675583|NCT04336098|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110675584|NCT04336098|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110675585|NCT04316494|Hydroxychloroquine|hydroxychloroquine|mesh-list
110675586|NCT04316494|Antimalarials|antimalarials|mesh-ancestor
110675587|NCT04316494|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110675588|NCT04316494|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110675589|NCT04316494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110675590|NCT04316494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110675591|NCT04316494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110675592|NCT04316494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110675593|NCT04253262|Rucaparib|rucaparib|mesh-list
110675594|NCT04253262|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110675595|NCT04253262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110675596|NCT04253262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110675597|NCT04253262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110675598|NCT04138277|Miglustat|miglustat|mesh-list
110675599|NCT04138277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110675600|NCT04138277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110675601|NCT04138277|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110675602|NCT04138277|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110675604|NCT04138277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110675605|NCT04138277|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
110675606|NCT04138277|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110675607|NCT04138277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110675608|NCT04129515|Pembrolizumab|pembrolizumab|mesh-list
110675609|NCT04129515|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110675610|NCT04129515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110948248|NCT01668004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110948249|NCT01668004|Immunologic Factors|immunologic factors|mesh-ancestor
110675611|NCT04129515|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110675612|NCT04129515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110675613|NCT04069052|Nitric Oxide|nitric oxide|mesh-list
110675614|NCT04069052|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110675615|NCT04069052|Autonomic Agents|autonomic agents|mesh-ancestor
110675616|NCT04069052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110675617|NCT04069052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110675618|NCT04069052|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110675619|NCT04069052|Respiratory System Agents|respiratory system agents|mesh-ancestor
110675620|NCT04069052|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110675621|NCT04069052|Antioxidants|antioxidants|mesh-ancestor
110675622|NCT04069052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110675623|NCT04069052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110675624|NCT04069052|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
110675625|NCT04069052|Vasodilator Agents|vasodilator agents|mesh-ancestor
110675626|NCT04069052|Gasotransmitters|gasotransmitters|mesh-ancestor
110675627|NCT04069052|Protective Agents|protective agents|mesh-ancestor
110675629|NCT03986034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110675630|NCT03968653|Carboplatin|carboplatin|mesh-list
110675631|NCT03968653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110675632|NCT03963414|Carboplatin|carboplatin|mesh-list
110675633|NCT03963414|Etoposide|etoposide|mesh-list
110675634|NCT03963414|Etoposide phosphate|etoposide phosphate|mesh-list
110675635|NCT03963414|Durvalumab|durvalumab|mesh-list
110675636|NCT03963414|Tremelimumab|tremelimumab|mesh-list
110675637|NCT03963414|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110675638|NCT03963414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110675639|NCT03963414|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110675640|NCT03963414|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110675641|NCT03963414|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110675642|NCT03963414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110675643|NCT03963414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110675644|NCT03963414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110675645|NCT03963414|Immunologic Factors|immunologic factors|mesh-ancestor
110675646|NCT03963414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110675647|NCT03949855|Rituximab|rituximab|mesh-list
110675648|NCT03949855|Belimumab|belimumab|mesh-list
110675649|NCT03949855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110675650|NCT03949855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110675651|NCT03949855|Immunologic Factors|immunologic factors|mesh-ancestor
110675652|NCT03949855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110675653|NCT03949855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110675654|NCT03949855|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110675655|NCT03861390|Prednisone|prednisone|mesh-list
110675656|NCT03861390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110675657|NCT03861390|Glucocorticoids|glucocorticoids|mesh-ancestor
110675658|NCT03861390|Hormones|hormones|mesh-ancestor
110675659|NCT03861390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110675660|NCT03861390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110675661|NCT03861390|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110675662|NCT03861390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110675663|NCT03829683|Ascorbic Acid|ascorbic acid|mesh-list
110675664|NCT03829683|Vitamins|vitamins|mesh-ancestor
110675665|NCT03829683|Micronutrients|micronutrients|mesh-ancestor
110675666|NCT03829683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110675667|NCT03829683|Antioxidants|antioxidants|mesh-ancestor
110675668|NCT03829683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110675669|NCT03829683|Protective Agents|protective agents|mesh-ancestor
110675670|NCT03723551|Afabicin|afabicin|mesh-list
110675671|NCT03723551|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110675672|NCT03723551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110675673|NCT03616587|Everolimus|everolimus|mesh-list
110675674|NCT03616587|Palbociclib|palbociclib|mesh-list
110675675|NCT03616587|Anastrozole|anastrozole|mesh-list
110675676|NCT03616587|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110687707|NCT00316186|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110675677|NCT03616587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110675678|NCT03616587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110675679|NCT03616587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110675680|NCT03616587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110675681|NCT03616587|Immunologic Factors|immunologic factors|mesh-ancestor
110675682|NCT03616587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110675683|NCT03616587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110675684|NCT03616587|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110675685|NCT03616587|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110686508|NCT00331006|Rituximab|rituximab|mesh-list
110675686|NCT03616587|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110675687|NCT03616587|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110675688|NCT03616587|Hormone Antagonists|hormone antagonists|mesh-ancestor
110675689|NCT03616587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110675690|NCT03609580|Tamsulosin|tamsulosin|mesh-list
110675691|NCT03609580|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110675692|NCT03609580|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110675693|NCT03609580|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110675694|NCT03609580|Adrenergic Agents|adrenergic agents|mesh-ancestor
110675695|NCT03609580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110675696|NCT03609580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110675697|NCT03609580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110675698|NCT03609580|Urological Agents|urological agents|mesh-ancestor
110675699|NCT03605342|Buprenorphine|buprenorphine|mesh-list
110675700|NCT03605342|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110675701|NCT03605342|Narcotics|narcotics|mesh-ancestor
110675702|NCT03605342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110675703|NCT03605342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110675704|NCT03605342|Analgesics|analgesics|mesh-ancestor
110675705|NCT03605342|Sensory System Agents|sensory system agents|mesh-ancestor
110675706|NCT03605342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110675707|NCT03605342|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110675708|NCT03530696|Palbociclib|palbociclib|mesh-list
110675709|NCT03530696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110675710|NCT03530696|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110675711|NCT03530696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110675712|NCT03530696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110675713|NCT03522961|Nitrofurantoin|nitrofurantoin|mesh-list
110675714|NCT03522961|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110675715|NCT03522961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110675716|NCT03522961|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110675717|NCT03520686|Paclitaxel|paclitaxel|mesh-list
110675718|NCT03520686|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110675719|NCT03520686|Cisplatin|cisplatin|mesh-list
110675720|NCT03520686|Carboplatin|carboplatin|mesh-list
110675721|NCT03520686|Pembrolizumab|pembrolizumab|mesh-list
110675722|NCT03520686|Pemetrexed|pemetrexed|mesh-list
110675723|NCT03520686|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110675724|NCT03520686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110675725|NCT03520686|Tubulin Modulators|tubulin modulators|mesh-ancestor
110675726|NCT03520686|Antimitotic Agents|antimitotic agents|mesh-ancestor
110675727|NCT03520686|Mitosis Modulators|mitosis modulators|mesh-ancestor
110675728|NCT03520686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110675729|NCT03520686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110675730|NCT03520686|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110675731|NCT03520686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110675732|NCT03520686|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110675733|NCT03520686|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110675734|NCT03450057|Dexamethasone|dexamethasone|mesh-list
110675735|NCT03450057|Daratumumab|daratumumab|mesh-list
110675736|NCT03450057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110675737|NCT03450057|Antiemetics|antiemetics|mesh-ancestor
110675738|NCT03450057|Autonomic Agents|autonomic agents|mesh-ancestor
110675739|NCT03450057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110675740|NCT03450057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110675741|NCT03450057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110675742|NCT03450057|Glucocorticoids|glucocorticoids|mesh-ancestor
110675743|NCT03450057|Hormones|hormones|mesh-ancestor
110675744|NCT03450057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110675745|NCT03450057|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110675746|NCT03450057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110675747|NCT03335839|Plasminogen|plasminogen|mesh-list
110675748|NCT03335839|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
110675749|NCT03335839|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110675750|NCT03335839|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110675751|NCT03335839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110675754|NCT03270059|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
110675755|NCT03270059|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110675756|NCT03198351|Teriflunomide|teriflunomide|mesh-list
110675757|NCT03198351|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110675758|NCT03198351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110675759|NCT03198351|Analgesics|analgesics|mesh-ancestor
110675760|NCT03198351|Sensory System Agents|sensory system agents|mesh-ancestor
110948250|NCT01668004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110675761|NCT03198351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110675762|NCT03198351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110675763|NCT03198351|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110675764|NCT03198351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110675765|NCT03198351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110675766|NCT03198351|Immunologic Factors|immunologic factors|mesh-ancestor
110675768|NCT03160040|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110675769|NCT03160040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110675770|NCT03107182|Diphenhydramine|diphenhydramine|mesh-list
110675771|NCT03107182|Promethazine|promethazine|mesh-list
110675772|NCT03107182|Dexamethasone|dexamethasone|mesh-list
110675773|NCT03107182|Paclitaxel|paclitaxel|mesh-list
110675774|NCT03107182|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110675775|NCT03107182|Carboplatin|carboplatin|mesh-list
110675776|NCT03107182|Nivolumab|nivolumab|mesh-list
110675777|NCT03107182|Hydroxyurea|hydroxyurea|mesh-list
110675778|NCT03107182|Famotidine|famotidine|mesh-list
110675779|NCT03107182|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110675780|NCT03107182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110675781|NCT03107182|Tubulin Modulators|tubulin modulators|mesh-ancestor
110675782|NCT03107182|Antimitotic Agents|antimitotic agents|mesh-ancestor
110675783|NCT03107182|Mitosis Modulators|mitosis modulators|mesh-ancestor
110675784|NCT03107182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110675785|NCT03107182|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110675786|NCT03107182|Antiemetics|antiemetics|mesh-ancestor
110675787|NCT03107182|Autonomic Agents|autonomic agents|mesh-ancestor
110675788|NCT03107182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110675789|NCT03107182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110675790|NCT03107182|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110675791|NCT03107182|Glucocorticoids|glucocorticoids|mesh-ancestor
110675792|NCT03107182|Hormones|hormones|mesh-ancestor
110675793|NCT03107182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110675794|NCT03107182|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110675795|NCT03107182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110675796|NCT03107182|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110675797|NCT03107182|Antisickling Agents|antisickling agents|mesh-ancestor
110675798|NCT03107182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110675799|NCT03107182|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110675800|NCT03107182|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110675801|NCT03107182|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110675802|NCT03107182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110675803|NCT03107182|Anesthetics, Local|anesthetics, local|mesh-ancestor
110675804|NCT03107182|Anesthetics|anesthetics|mesh-ancestor
110675805|NCT03107182|Sensory System Agents|sensory system agents|mesh-ancestor
110675806|NCT03107182|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110675807|NCT03107182|Histamine Antagonists|histamine antagonists|mesh-ancestor
110675808|NCT03107182|Histamine Agents|histamine agents|mesh-ancestor
110675809|NCT03107182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110675810|NCT03107182|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110675811|NCT03107182|Antipruritics|antipruritics|mesh-ancestor
110675812|NCT03107182|Dermatologic Agents|dermatologic agents|mesh-ancestor
110675813|NCT03107182|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110675814|NCT03107182|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110675815|NCT03037385|Pralsetinib|pralsetinib|mesh-list
110675816|NCT03037385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110675817|NCT02879318|Paclitaxel|paclitaxel|mesh-list
110675818|NCT02879318|Gemcitabine|gemcitabine|mesh-list
110675819|NCT02879318|Durvalumab|durvalumab|mesh-list
110675820|NCT02879318|Tremelimumab|tremelimumab|mesh-list
110675821|NCT02879318|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110675822|NCT02879318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110675823|NCT02879318|Tubulin Modulators|tubulin modulators|mesh-ancestor
110675824|NCT02879318|Antimitotic Agents|antimitotic agents|mesh-ancestor
110322956|NCT04699110|Purinergic Agonists|purinergic agonists|mesh-ancestor
110675825|NCT02879318|Mitosis Modulators|mitosis modulators|mesh-ancestor
110675826|NCT02879318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110675827|NCT02879318|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110675828|NCT02879318|Antimetabolites|antimetabolites|mesh-ancestor
110675829|NCT02879318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110675830|NCT02833701|Vitamins|vitamins|mesh-list
110675831|NCT02833701|Ascorbic Acid|ascorbic acid|mesh-list
110675832|NCT02833701|Bevacizumab|bevacizumab|mesh-list
110675833|NCT02833701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110675834|NCT02833701|Endothelial Growth Factors|endothelial growth factors|mesh-list
110675835|NCT02833701|Antibodies|antibodies|mesh-list
110675836|NCT02833701|Immunoglobulins|immunoglobulins|mesh-list
110675837|NCT02833701|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110675838|NCT02833701|Immunoglobulin G|immunoglobulin g|mesh-list
110675839|NCT02833701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110675840|NCT02833701|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110675841|NCT02833701|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110675842|NCT02833701|Growth Substances|growth substances|mesh-ancestor
110675843|NCT02833701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110675844|NCT02833701|Growth Inhibitors|growth inhibitors|mesh-ancestor
110675845|NCT02833701|Micronutrients|micronutrients|mesh-ancestor
110675846|NCT02833701|Immunologic Factors|immunologic factors|mesh-ancestor
110675847|NCT02833701|Antioxidants|antioxidants|mesh-ancestor
110675848|NCT02833701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110675849|NCT02833701|Protective Agents|protective agents|mesh-ancestor
110675850|NCT02767999|Fluoxetine|fluoxetine|mesh-list
110675851|NCT02767999|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110675852|NCT02767999|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110675853|NCT02767999|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110675854|NCT02767999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110675855|NCT02767999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110675856|NCT02767999|Serotonin Agents|serotonin agents|mesh-ancestor
110675857|NCT02767999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110675858|NCT02767999|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110675859|NCT02767999|Antidepressive Agents|antidepressive agents|mesh-ancestor
110675860|NCT02767999|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110675861|NCT02767999|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110675862|NCT02767999|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110675863|NCT02767999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110675864|NCT02675465|Miglustat|miglustat|mesh-list
110675865|NCT02675465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110675866|NCT02675465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110675867|NCT02675465|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110675868|NCT02675465|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110675869|NCT02675465|Antiviral Agents|antiviral agents|mesh-ancestor
110449574|NCT00935493|Guanfacine|guanfacine|mesh-list
110675870|NCT02675465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111479181|NCT05510544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110675871|NCT02675465|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
110675873|NCT02675465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110675874|NCT02670707|Cytarabine|cytarabine|mesh-list
110675875|NCT02670707|Prednisone|prednisone|mesh-list
110675876|NCT02670707|Vinblastine|vinblastine|mesh-list
110675877|NCT02670707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110675878|NCT02670707|Glucocorticoids|glucocorticoids|mesh-ancestor
110675879|NCT02670707|Hormones|hormones|mesh-ancestor
110675880|NCT02670707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110675881|NCT02670707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110675882|NCT02670707|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110675883|NCT02670707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110675884|NCT02670707|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110675885|NCT02670707|Antimetabolites|antimetabolites|mesh-ancestor
110675886|NCT02670707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110675887|NCT02670707|Antiviral Agents|antiviral agents|mesh-ancestor
110675888|NCT02670707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110675889|NCT02670707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110675890|NCT02670707|Immunologic Factors|immunologic factors|mesh-ancestor
110675891|NCT02670707|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110675892|NCT02670707|Tubulin Modulators|tubulin modulators|mesh-ancestor
110675893|NCT02670707|Antimitotic Agents|antimitotic agents|mesh-ancestor
110675894|NCT02670707|Mitosis Modulators|mitosis modulators|mesh-ancestor
110675895|NCT02658890|Nivolumab|nivolumab|mesh-list
110675896|NCT02658890|Ipilimumab|ipilimumab|mesh-list
110675897|NCT02658890|Linrodostat|linrodostat|mesh-list
110675898|NCT02658890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110675899|NCT02658890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110675900|NCT02658890|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110675901|NCT02658890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110675902|NCT02658890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110675903|NCT02597062|Dexamethasone|dexamethasone|mesh-list
110675908|NCT02597062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110675909|NCT02597062|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110675910|NCT02597062|Alkylating Agents|alkylating agents|mesh-ancestor
110675911|NCT02597062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110675912|NCT02597062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110675913|NCT02597062|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110675914|NCT02597062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110675915|NCT02597062|Antiemetics|antiemetics|mesh-ancestor
110675916|NCT02597062|Autonomic Agents|autonomic agents|mesh-ancestor
110675917|NCT02597062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110675918|NCT02597062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110675919|NCT02597062|Glucocorticoids|glucocorticoids|mesh-ancestor
110675921|NCT02597062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110675922|NCT02597062|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110675923|NCT02458014|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110675924|NCT02458014|Blinatumomab|blinatumomab|mesh-list
110675925|NCT02458014|Antibodies|antibodies|mesh-list
110675926|NCT02458014|Immunoglobulins|immunoglobulins|mesh-list
110675927|NCT02458014|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110675928|NCT02458014|Muromonab-CD3|muromonab-cd3|mesh-list
110675929|NCT02458014|Antibodies, Bispecific|antibodies, bispecific|mesh-list
110675930|NCT02458014|Immunologic Factors|immunologic factors|mesh-ancestor
110675931|NCT02458014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110675932|NCT02458014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110675933|NCT02458014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110675934|NCT02451982|Cyclophosphamide|cyclophosphamide|mesh-list
110675935|NCT02451982|Nivolumab|nivolumab|mesh-list
110675936|NCT02451982|Immunologic Factors|immunologic factors|mesh-ancestor
110675937|NCT02451982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110675938|NCT02451982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110675939|NCT02451982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110675940|NCT02451982|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110675941|NCT02451982|Alkylating Agents|alkylating agents|mesh-ancestor
110675942|NCT02451982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110675943|NCT02451982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110675944|NCT02451982|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110675945|NCT02451982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110675946|NCT02451982|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110675947|NCT02444741|Pembrolizumab|pembrolizumab|mesh-list
110675948|NCT02444741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110675949|NCT02444741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110675950|NCT02444741|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111479182|NCT05509699|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
110675951|NCT02444741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110675957|NCT02122185|Metformin|metformin|mesh-list
110675958|NCT02122185|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110675959|NCT02122185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110675960|NCT01528852|Chlorhexidine|chlorhexidine|mesh-list
110675961|NCT01528852|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110675962|NCT01528852|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110675963|NCT01528852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110675964|NCT01528852|Disinfectants|disinfectants|mesh-ancestor
110675965|NCT01528852|Dermatologic Agents|dermatologic agents|mesh-ancestor
110675966|NCT01248585|Dexamethasone|dexamethasone|mesh-list
110675967|NCT01248585|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110675968|NCT01248585|Antiemetics|antiemetics|mesh-ancestor
110675969|NCT01248585|Autonomic Agents|autonomic agents|mesh-ancestor
110675970|NCT01248585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110675971|NCT01248585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110675972|NCT01248585|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110675973|NCT01248585|Glucocorticoids|glucocorticoids|mesh-ancestor
110675974|NCT01248585|Hormones|hormones|mesh-ancestor
110675975|NCT01248585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110675976|NCT01248585|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110675977|NCT01248585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110675980|NCT00993655|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110675981|NCT00993655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110675982|NCT00993655|Tubulin Modulators|tubulin modulators|mesh-ancestor
110675983|NCT00993655|Antimitotic Agents|antimitotic agents|mesh-ancestor
110675984|NCT00993655|Mitosis Modulators|mitosis modulators|mesh-ancestor
110675985|NCT00993655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110675986|NCT00168701|Dimethyl Fumarate|dimethyl fumarate|mesh-list
110675987|NCT00168701|Dermatologic Agents|dermatologic agents|mesh-ancestor
110675988|NCT00168701|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110675989|NCT00168701|Immunologic Factors|immunologic factors|mesh-ancestor
110675990|NCT00168701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110675991|NCT05316493|Megestrol|megestrol|mesh-list
110675992|NCT05316493|Megestrol Acetate|megestrol acetate|mesh-list
110675993|NCT05316493|Contraceptive Agents|contraceptive agents|mesh-list
110675994|NCT05316493|Levonorgestrel|levonorgestrel|mesh-list
110675995|NCT05316493|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110675996|NCT05316493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110675997|NCT05316493|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110675998|NCT05316493|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110675999|NCT05316493|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110676000|NCT05316493|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110676001|NCT05316493|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110676002|NCT05316493|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110676003|NCT05316493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110676004|NCT05316493|Appetite Stimulants|appetite stimulants|mesh-ancestor
110676005|NCT05316493|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110676007|NCT05316467|Megestrol Acetate|megestrol acetate|mesh-list
110676008|NCT05316467|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110676009|NCT05316467|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110676010|NCT05316467|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110676011|NCT05316467|Contraceptive Agents|contraceptive agents|mesh-ancestor
110676012|NCT05316467|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110676013|NCT05316467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110676014|NCT05316467|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110676015|NCT05316467|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110676016|NCT05316467|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110676017|NCT05316467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110676018|NCT05316467|Appetite Stimulants|appetite stimulants|mesh-ancestor
110676019|NCT05316467|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110676020|NCT05304949|Ranibizumab|ranibizumab|mesh-list
110676021|NCT05304949|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110676022|NCT05304949|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110676023|NCT05304949|Growth Substances|growth substances|mesh-ancestor
110676024|NCT05304949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110676025|NCT05304949|Growth Inhibitors|growth inhibitors|mesh-ancestor
110676026|NCT05304949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110676027|NCT05294341|Norethindrone|norethindrone|mesh-list
110676028|NCT05294341|Norethindrone Acetate|norethindrone acetate|mesh-list
110676029|NCT05294341|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110676030|NCT05294341|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110676031|NCT05294341|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110676032|NCT05294341|Contraceptive Agents|contraceptive agents|mesh-ancestor
110676033|NCT05294341|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110676034|NCT05294341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110676035|NCT05294341|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110676036|NCT05294341|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110676038|NCT05293964|Palbociclib|palbociclib|mesh-list
110676039|NCT05293964|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110676040|NCT05293964|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110676041|NCT05293964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110676042|NCT05293964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110676043|NCT05293964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110676044|NCT05293964|Immunologic Factors|immunologic factors|mesh-ancestor
110676045|NCT05293964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110676046|NCT05293964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110676047|NCT05290207|Hypoglycemic Agents|hypoglycemic agents|mesh-list
110676048|NCT05290207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110676049|NCT05271240|Bevacizumab|bevacizumab|mesh-list
110676050|NCT05271240|Temozolomide|temozolomide|mesh-list
110676051|NCT05271240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110676052|NCT05271240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110676054|NCT05271240|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110676055|NCT05271240|Growth Substances|growth substances|mesh-ancestor
110676056|NCT05271240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110676057|NCT05271240|Growth Inhibitors|growth inhibitors|mesh-ancestor
110676058|NCT05271240|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110676059|NCT05271240|Alkylating Agents|alkylating agents|mesh-ancestor
110676060|NCT05271240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110676061|NCT05269459|Cannabidiol|cannabidiol|mesh-list
110676062|NCT05269459|Anticonvulsants|anticonvulsants|mesh-ancestor
110676063|NCT05264883|Azacitidine|azacitidine|mesh-list
110676064|NCT05264883|Decitabine|decitabine|mesh-list
110676065|NCT05264883|Venetoclax|venetoclax|mesh-list
110676066|NCT05264883|Aclarubicin|aclarubicin|mesh-list
110676067|NCT05264883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110676068|NCT05264883|Antimetabolites|antimetabolites|mesh-ancestor
110676069|NCT05264883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110676070|NCT05264883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110676071|NCT05264883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110676072|NCT05264883|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110676073|NCT05264883|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110676074|NCT05264883|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110676075|NCT05263453|Vemurafenib|vemurafenib|mesh-list
110676076|NCT05263453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110676077|NCT05263453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110676078|NCT05263453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110676079|NCT05263453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110676080|NCT05257629|Nicotine|nicotine|mesh-list
110676081|NCT05257629|Varenicline|varenicline|mesh-list
110676082|NCT05257629|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110676083|NCT05257629|Autonomic Agents|autonomic agents|mesh-ancestor
110676084|NCT05257629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110676085|NCT05257629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110676086|NCT05257629|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110676087|NCT05257629|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110676088|NCT05257629|Cholinergic Agents|cholinergic agents|mesh-ancestor
110676089|NCT05257629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110676090|NCT05257629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110676091|NCT05245669|Denosumab|denosumab|mesh-list
110676092|NCT05245669|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110676093|NCT05245669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110676094|NCT05233332|Vemurafenib|vemurafenib|mesh-list
110676095|NCT05233332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110676096|NCT05233332|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110676097|NCT05233332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110676098|NCT05233332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110676099|NCT05232084|Fentanyl|fentanyl|mesh-list
110676100|NCT05232084|Bupivacaine|bupivacaine|mesh-list
110676101|NCT05232084|Anesthetics, Local|anesthetics, local|mesh-ancestor
110676102|NCT05232084|Anesthetics|anesthetics|mesh-ancestor
110676103|NCT05232084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110676104|NCT05232084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110676105|NCT05232084|Sensory System Agents|sensory system agents|mesh-ancestor
110676106|NCT05232084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110676107|NCT05232084|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110676108|NCT05232084|Narcotics|narcotics|mesh-ancestor
110676109|NCT05232084|Analgesics|analgesics|mesh-ancestor
110676110|NCT05232084|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110676111|NCT05232084|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110676112|NCT05232084|Anesthetics, General|anesthetics, general|mesh-ancestor
110676113|NCT05195619|Cyclophosphamide|cyclophosphamide|mesh-list
110676115|NCT05195619|Immunologic Factors|immunologic factors|mesh-ancestor
110676116|NCT05195619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110676117|NCT05195619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110676118|NCT05195619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110676119|NCT05195619|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110676120|NCT05195619|Alkylating Agents|alkylating agents|mesh-ancestor
110676121|NCT05195619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110676122|NCT05195619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110676123|NCT05195619|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110676124|NCT05158517|Vedolizumab|vedolizumab|mesh-list
110676125|NCT05158517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110676126|NCT05139914|Dapagliflozin|dapagliflozin|mesh-list
110676127|NCT05139914|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110676128|NCT05139914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110676129|NCT05139914|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110676134|NCT05138835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110676135|NCT05138835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110676136|NCT05138835|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110676137|NCT05138835|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110676138|NCT05138835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110676139|NCT05138835|Cholinergic Agents|cholinergic agents|mesh-ancestor
110676140|NCT05138835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110676141|NCT05132231|Brodalumab|brodalumab|mesh-list
110676142|NCT05132231|Dermatologic Agents|dermatologic agents|mesh-ancestor
110676143|NCT05099107|Albuterol|albuterol|mesh-list
110676144|NCT05099107|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110676145|NCT05099107|Autonomic Agents|autonomic agents|mesh-ancestor
110676146|NCT05099107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110676147|NCT05099107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110676148|NCT05099107|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110676149|NCT05099107|Respiratory System Agents|respiratory system agents|mesh-ancestor
110676150|NCT05099107|Tocolytic Agents|tocolytic agents|mesh-ancestor
110676151|NCT05099107|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110676158|NCT05090280|Nafamostat|nafamostat|mesh-list
110676159|NCT05090280|Naltrexone|naltrexone|mesh-list
110676160|NCT05090280|Oxycodone|oxycodone|mesh-list
110676161|NCT05090280|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110676162|NCT05090280|Narcotics|narcotics|mesh-ancestor
110676163|NCT05090280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110676164|NCT05090280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110676165|NCT05090280|Analgesics|analgesics|mesh-ancestor
110676166|NCT05090280|Sensory System Agents|sensory system agents|mesh-ancestor
110676167|NCT05090280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110676168|NCT05090280|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110676169|NCT05090280|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110676170|NCT05090280|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110676171|NCT05090280|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110676172|NCT05090280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110676173|NCT05090280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110676174|NCT05090280|Anticoagulants|anticoagulants|mesh-ancestor
110676175|NCT05090280|Protease Inhibitors|protease inhibitors|mesh-ancestor
110676176|NCT05090280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110676177|NCT05090280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110676178|NCT05090280|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
110676179|NCT05090280|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110676180|NCT05090280|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
110676181|NCT05090280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110676182|NCT05090280|Immunologic Factors|immunologic factors|mesh-ancestor
110676183|NCT05078866|Vaccines|vaccines|mesh-list
110676184|NCT05078866|Immunologic Factors|immunologic factors|mesh-ancestor
110676185|NCT05078866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110676198|NCT04998786|Dexamethasone|dexamethasone|mesh-list
110676199|NCT04998786|Ixazomib|ixazomib|mesh-list
110676200|NCT04998786|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110676201|NCT04998786|Antiemetics|antiemetics|mesh-ancestor
110676202|NCT04998786|Autonomic Agents|autonomic agents|mesh-ancestor
110676203|NCT04998786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110676204|NCT04998786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110676205|NCT04998786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110676208|NCT04998786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110676209|NCT04998786|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110676210|NCT04998786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110676211|NCT04998786|Protease Inhibitors|protease inhibitors|mesh-ancestor
110676212|NCT04998786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110676213|NCT04998786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110676214|NCT04998500|Hormones|hormones|mesh-list
110676215|NCT04998500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110676216|NCT04998500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110676217|NCT04992624|Dronabinol|dronabinol|mesh-list
110676218|NCT04992624|Cannabidiol|cannabidiol|mesh-list
110676219|NCT04992624|Anticonvulsants|anticonvulsants|mesh-ancestor
110676220|NCT04992624|Hallucinogens|hallucinogens|mesh-ancestor
110676221|NCT04992624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110676222|NCT04992624|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110676223|NCT04992624|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110676224|NCT04992624|Analgesics|analgesics|mesh-ancestor
110676225|NCT04992624|Sensory System Agents|sensory system agents|mesh-ancestor
110676226|NCT04992624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110676227|NCT04992624|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
110676228|NCT04992624|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110676229|NCT04992624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110948251|NCT04835350|Pancrelipase|pancrelipase|mesh-list
110948252|NCT04835350|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110676230|NCT04992624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110676231|NCT04992624|Hormones|hormones|mesh-ancestor
110676232|NCT04992624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110676233|NCT04990258|Infliximab|infliximab|mesh-list
110676234|NCT04990258|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110676235|NCT04990258|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110676236|NCT04990258|Dermatologic Agents|dermatologic agents|mesh-ancestor
110676237|NCT04990258|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110676238|NCT04990258|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110676239|NCT04964089|Aflibercept|aflibercept|mesh-list
110676240|NCT04964089|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110676241|NCT04964089|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110676242|NCT04964089|Growth Substances|growth substances|mesh-ancestor
110676243|NCT04964089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110676244|NCT04964089|Growth Inhibitors|growth inhibitors|mesh-ancestor
110676245|NCT04964089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110676246|NCT04940299|Nivolumab|nivolumab|mesh-list
110676247|NCT04940299|Ipilimumab|ipilimumab|mesh-list
110676248|NCT04940299|Immunoglobulins|immunoglobulins|mesh-list
110676249|NCT04940299|Immunoglobulin G|immunoglobulin g|mesh-list
110676250|NCT04940299|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110676251|NCT04940299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110676252|NCT04940299|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110676253|NCT04940299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110676254|NCT04940299|Immunologic Factors|immunologic factors|mesh-ancestor
110676255|NCT04940299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110676256|NCT04931355|Cetrorelix|cetrorelix|mesh-list
110676257|NCT04931355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110676258|NCT04931355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110676259|NCT04931355|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110676260|NCT04931355|Fertility Agents|fertility agents|mesh-ancestor
110676261|NCT04931355|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110676262|NCT04931355|Hormone Antagonists|hormone antagonists|mesh-ancestor
110676263|NCT04924374|Pembrolizumab|pembrolizumab|mesh-list
110676264|NCT04924374|Atezolizumab|atezolizumab|mesh-list
110676265|NCT04924374|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110676266|NCT04924374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110676267|NCT04924374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110676268|NCT04924374|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110676269|NCT04924374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110676270|NCT04924374|Immunologic Factors|immunologic factors|mesh-ancestor
110676271|NCT04924374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110676272|NCT04918147|Acetaminophen|acetaminophen|mesh-list
110676273|NCT04918147|Diphenhydramine|diphenhydramine|mesh-list
110676274|NCT04918147|Promethazine|promethazine|mesh-list
110676275|NCT04918147|Prednisone|prednisone|mesh-list
110676276|NCT04918147|Methylprednisolone|methylprednisolone|mesh-list
110676277|NCT04918147|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110676278|NCT04918147|Elotuzumab|elotuzumab|mesh-list
110676279|NCT04918147|Famotidine|famotidine|mesh-list
110676280|NCT04918147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110676281|NCT04918147|Glucocorticoids|glucocorticoids|mesh-ancestor
110676282|NCT04918147|Hormones|hormones|mesh-ancestor
110676283|NCT04918147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110676284|NCT04918147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110676285|NCT04918147|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110676286|NCT04918147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110676287|NCT04918147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110676288|NCT04918147|Analgesics|analgesics|mesh-ancestor
110676289|NCT04918147|Sensory System Agents|sensory system agents|mesh-ancestor
110676290|NCT04918147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110676291|NCT04918147|Antipyretics|antipyretics|mesh-ancestor
110676292|NCT04918147|Antiemetics|antiemetics|mesh-ancestor
110676293|NCT04918147|Autonomic Agents|autonomic agents|mesh-ancestor
110676294|NCT04918147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110676295|NCT04918147|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110676296|NCT04918147|Protective Agents|protective agents|mesh-ancestor
110676297|NCT04918147|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110676298|NCT04918147|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110676299|NCT04918147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110676300|NCT04918147|Anesthetics, Local|anesthetics, local|mesh-ancestor
110676301|NCT04918147|Anesthetics|anesthetics|mesh-ancestor
110676302|NCT04918147|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110676303|NCT04918147|Histamine Antagonists|histamine antagonists|mesh-ancestor
110676304|NCT04918147|Histamine Agents|histamine agents|mesh-ancestor
110687099|NCT00385671|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110676305|NCT04918147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110676306|NCT04918147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110676307|NCT04918147|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110676308|NCT04918147|Antipruritics|antipruritics|mesh-ancestor
110676309|NCT04918147|Dermatologic Agents|dermatologic agents|mesh-ancestor
110676310|NCT04918147|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110676311|NCT04918147|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110676312|NCT04916197|Dexmedetomidine|dexmedetomidine|mesh-list
110676313|NCT04916197|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110676314|NCT04916197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110676315|NCT04916197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110676316|NCT04916197|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110676317|NCT04916197|Analgesics|analgesics|mesh-ancestor
110676318|NCT04916197|Sensory System Agents|sensory system agents|mesh-ancestor
110676319|NCT04916197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110676320|NCT04916197|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110676321|NCT04916197|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110676322|NCT04916197|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110676323|NCT04916197|Adrenergic Agents|adrenergic agents|mesh-ancestor
110676324|NCT04916197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110676325|NCT04916197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110676326|NCT04915768|Aluminum Hydroxide|aluminum hydroxide|mesh-list
110676327|NCT04915768|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110676328|NCT04915768|Immunologic Factors|immunologic factors|mesh-ancestor
110676329|NCT04915768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110676330|NCT04915768|Antacids|antacids|mesh-ancestor
110676331|NCT04915768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110676332|NCT04915768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110676333|NCT04902625|Naltrexone|naltrexone|mesh-list
110676334|NCT04902625|Bupropion|bupropion|mesh-list
110676335|NCT04902625|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110676336|NCT04902625|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110676337|NCT04902625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110676338|NCT04902625|Sensory System Agents|sensory system agents|mesh-ancestor
110676339|NCT04902625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110676340|NCT04902625|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110676341|NCT04902625|Antidepressive Agents|antidepressive agents|mesh-ancestor
110676342|NCT04902625|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110676343|NCT04902625|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110676344|NCT04902625|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110676345|NCT04902625|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110676346|NCT04902625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110676347|NCT04902625|Dopamine Agents|dopamine agents|mesh-ancestor
110676348|NCT04902625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110676349|NCT04902625|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110676350|NCT04902625|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110676351|NCT04902625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110676352|NCT04892303|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
110676353|NCT04892303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110676359|NCT04805775|Desflurane|desflurane|mesh-list
110676360|NCT04805775|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110676361|NCT04805775|Anesthetics, General|anesthetics, general|mesh-ancestor
110676362|NCT04805775|Anesthetics|anesthetics|mesh-ancestor
110676363|NCT04805775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110676364|NCT04805775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110676365|NCT04796194|Pembrolizumab|pembrolizumab|mesh-list
110676366|NCT04796194|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110676367|NCT04796194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110676368|NCT04796194|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110676369|NCT04796194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110676370|NCT04755647|Nitric Oxide|nitric oxide|mesh-list
110676371|NCT04755647|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110676372|NCT04755647|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110676373|NCT04755647|Autonomic Agents|autonomic agents|mesh-ancestor
110676374|NCT04755647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110676375|NCT04755647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110676376|NCT04755647|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110676377|NCT04755647|Respiratory System Agents|respiratory system agents|mesh-ancestor
110676378|NCT04755647|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110676379|NCT04755647|Antioxidants|antioxidants|mesh-ancestor
110948253|NCT01667926|Ketamine|ketamine|mesh-list
110948254|NCT01667926|Analgesics|analgesics|mesh-ancestor
110676380|NCT04755647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110676381|NCT04755647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110676382|NCT04755647|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
110676383|NCT04755647|Vasodilator Agents|vasodilator agents|mesh-ancestor
110676384|NCT04755647|Gasotransmitters|gasotransmitters|mesh-ancestor
110676385|NCT04755647|Protective Agents|protective agents|mesh-ancestor
110676390|NCT04699123|Pembrolizumab|pembrolizumab|mesh-list
110676391|NCT04699123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110676392|NCT04699123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110676393|NCT04699123|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110676394|NCT04699123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110676395|NCT04677972|Ebselen|ebselen|mesh-list
110676396|NCT04677972|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110676397|NCT04677972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110676398|NCT04677972|Analgesics|analgesics|mesh-ancestor
110676399|NCT04677972|Sensory System Agents|sensory system agents|mesh-ancestor
110676400|NCT04677972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110676401|NCT04677972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110676402|NCT04677972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110676403|NCT04677972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110676404|NCT04677972|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110676405|NCT04677972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110676406|NCT04677972|Antioxidants|antioxidants|mesh-ancestor
110676407|NCT04677972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110676408|NCT04677972|Protective Agents|protective agents|mesh-ancestor
110676409|NCT04677972|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110676410|NCT04677972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110676411|NCT04677972|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110676412|NCT04648046|Cyclophosphamide|cyclophosphamide|mesh-list
110676413|NCT04648046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110676414|NCT04648046|Immunologic Factors|immunologic factors|mesh-ancestor
110676415|NCT04648046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110676416|NCT04648046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110676417|NCT04648046|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110676418|NCT04648046|Alkylating Agents|alkylating agents|mesh-ancestor
110676419|NCT04648046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110676420|NCT04648046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110676421|NCT04648046|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110676422|NCT04648020|Clonidine|clonidine|mesh-list
110676423|NCT04648020|Analgesics|analgesics|mesh-ancestor
110676424|NCT04648020|Sensory System Agents|sensory system agents|mesh-ancestor
110676425|NCT04648020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110323554|NCT00467181|Fenoldopam|fenoldopam|mesh-list
110676426|NCT04648020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110676427|NCT04648020|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110676429|NCT04648020|Autonomic Agents|autonomic agents|mesh-ancestor
110676430|NCT04648020|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110676431|NCT04648020|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110676432|NCT04648020|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110676433|NCT04648020|Adrenergic Agents|adrenergic agents|mesh-ancestor
110676434|NCT04648020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110676435|NCT04648020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110676437|NCT04629651|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110676438|NCT04629651|Protease Inhibitors|protease inhibitors|mesh-ancestor
110676439|NCT04629651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110676440|NCT04629651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110676441|NCT04629651|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110676442|NCT04623398|Lithium Carbonate|lithium carbonate|mesh-list
110676443|NCT04623398|Antidepressive Agents|antidepressive agents|mesh-ancestor
110676444|NCT04623398|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110676445|NCT04623398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110676446|NCT04623398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110676447|NCT04623398|Antimanic Agents|antimanic agents|mesh-ancestor
110676448|NCT04623398|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110676449|NCT04623398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110676450|NCT04623398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110449628|NCT02724202|Curcumin|curcumin|mesh-list
110676452|NCT04614194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110676453|NCT04614194|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110676454|NCT04614194|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110676455|NCT04614194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110676456|NCT04614194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110676457|NCT04614194|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110676458|NCT04614194|Hormone Antagonists|hormone antagonists|mesh-ancestor
110676459|NCT04614194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110676460|NCT04614194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110676461|NCT04593654|Dalteparin|dalteparin|mesh-list
110676462|NCT04593654|Tinzaparin|tinzaparin|mesh-list
110676463|NCT04593654|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
110676464|NCT04593654|Anticoagulants|anticoagulants|mesh-ancestor
110676465|NCT04593654|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110676466|NCT04593654|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110676467|NCT04593654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110676468|NCT04591210|Angiotensin II|angiotensin ii|mesh-list
110676469|NCT04591210|Giapreza|giapreza|mesh-list
110676470|NCT04591210|Enzyme Inhibitors|enzyme inhibitors|mesh-list
110676471|NCT04591210|Angiotensinogen|angiotensinogen|mesh-list
110676472|NCT04591210|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
110676473|NCT04591210|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
110676474|NCT04591210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110676475|NCT04591210|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110676476|NCT04591210|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110676477|NCT04591210|Protease Inhibitors|protease inhibitors|mesh-ancestor
110676478|NCT04585893|Rituximab|rituximab|mesh-list
110676479|NCT04585893|Etoposide|etoposide|mesh-list
110676480|NCT04585893|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110676481|NCT04585893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110676482|NCT04585893|Immunologic Factors|immunologic factors|mesh-ancestor
110676483|NCT04585893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110676484|NCT04585893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110676485|NCT04585893|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110676486|NCT04585893|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110676487|NCT04585893|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110676488|NCT04585893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110676489|NCT04585893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110676490|NCT04573478|Atrasentan|atrasentan|mesh-list
110676491|NCT04573478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110676492|NCT04573478|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
110676493|NCT04573478|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
110676494|NCT04573478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110676495|NCT04547946|Trametinib|trametinib|mesh-list
110676496|NCT04547946|Dabrafenib|dabrafenib|mesh-list
110676497|NCT04547946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110676498|NCT04547946|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110676499|NCT04547946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110676500|NCT04547946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110676501|NCT04542824|Prednisone|prednisone|mesh-list
110676502|NCT04542824|Cyclophosphamide|cyclophosphamide|mesh-list
110676503|NCT04542824|Rituximab|rituximab|mesh-list
110676504|NCT04542824|Gemcitabine|gemcitabine|mesh-list
110676505|NCT04542824|Doxorubicin|doxorubicin|mesh-list
110676506|NCT04542824|Oxaliplatin|oxaliplatin|mesh-list
110676507|NCT04542824|Vincristine|vincristine|mesh-list
110676508|NCT04542824|Lenalidomide|lenalidomide|mesh-list
110676509|NCT04542824|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110676510|NCT04542824|Immunologic Factors|immunologic factors|mesh-ancestor
110676511|NCT04542824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110676512|NCT04542824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110676513|NCT04542824|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110676514|NCT04542824|Alkylating Agents|alkylating agents|mesh-ancestor
110676515|NCT04542824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110449640|NCT00605397|Trastuzumab|trastuzumab|mesh-list
110676516|NCT04542824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110676517|NCT04542824|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110676518|NCT04542824|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110676519|NCT04542824|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110676520|NCT04542824|Antimetabolites|antimetabolites|mesh-ancestor
110676521|NCT04542824|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110676522|NCT04542824|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110676523|NCT04542824|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110676524|NCT04542824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110676525|NCT04542824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110676526|NCT04542824|Glucocorticoids|glucocorticoids|mesh-ancestor
110676527|NCT04542824|Hormones|hormones|mesh-ancestor
110676528|NCT04542824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110676529|NCT04542824|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110676530|NCT04542824|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110676531|NCT04542824|Tubulin Modulators|tubulin modulators|mesh-ancestor
110676532|NCT04542824|Antimitotic Agents|antimitotic agents|mesh-ancestor
110682999|NCT00908921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110676534|NCT04542824|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110676535|NCT04542824|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110676536|NCT04542824|Growth Substances|growth substances|mesh-ancestor
110676537|NCT04542824|Growth Inhibitors|growth inhibitors|mesh-ancestor
110676538|NCT04535700|Pioglitazone|pioglitazone|mesh-list
110676539|NCT04535700|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110676540|NCT04535700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110676541|NCT04512911|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
110676542|NCT04510051|Cyclophosphamide|cyclophosphamide|mesh-list
110676543|NCT04510051|Fludarabine|fludarabine|mesh-list
110676544|NCT04510051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110676545|NCT04510051|Immunologic Factors|immunologic factors|mesh-ancestor
110676546|NCT04510051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110676547|NCT04510051|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110676548|NCT04510051|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110676549|NCT04510051|Alkylating Agents|alkylating agents|mesh-ancestor
110676550|NCT04510051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110676551|NCT04510051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110676552|NCT04510051|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110676553|NCT04471428|Docetaxel|docetaxel|mesh-list
110676554|NCT04471428|Atezolizumab|atezolizumab|mesh-list
110676555|NCT04471428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110676556|NCT04471428|Tubulin Modulators|tubulin modulators|mesh-ancestor
110676557|NCT04471428|Antimitotic Agents|antimitotic agents|mesh-ancestor
110676558|NCT04471428|Mitosis Modulators|mitosis modulators|mesh-ancestor
110676559|NCT04471428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110676560|NCT04471428|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110676561|NCT04471428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110676562|NCT04437225|Glycolic acid|glycolic acid|mesh-list
110676563|NCT04437225|Keratolytic Agents|keratolytic agents|mesh-ancestor
110676564|NCT04437225|Dermatologic Agents|dermatologic agents|mesh-ancestor
110676565|NCT04429555|Ibudilast|ibudilast|mesh-list
110676566|NCT04429555|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110676567|NCT04429555|Autonomic Agents|autonomic agents|mesh-ancestor
110676568|NCT04429555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110676569|NCT04429555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110676570|NCT04429555|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110676571|NCT04429555|Respiratory System Agents|respiratory system agents|mesh-ancestor
110676572|NCT04429555|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110323705|NCT00426296|Atazanavir Sulfate|atazanavir sulfate|mesh-list
110676573|NCT04429555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110676574|NCT04429555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110687709|NCT00316186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110676575|NCT04429555|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110676576|NCT04429555|Vasodilator Agents|vasodilator agents|mesh-ancestor
110676578|NCT04400474|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110676579|NCT04400474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110676580|NCT04400474|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110676581|NCT04400474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110676582|NCT04328337|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
110676583|NCT04328337|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
110676584|NCT04328337|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
110676585|NCT04328337|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110676587|NCT04319627|Calcium|calcium|mesh-list
110676588|NCT04319627|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110676589|NCT04319627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110676590|NCT04319627|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110676591|NCT04319627|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110676592|NCT04319627|Antimetabolites|antimetabolites|mesh-ancestor
110676593|NCT04319627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110676594|NCT04319627|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110676595|NCT04319627|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110676596|NCT04319627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110676597|NCT04305496|Fulvestrant|fulvestrant|mesh-list
110676598|NCT04305496|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110676599|NCT04305496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110676600|NCT04305496|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110676601|NCT04305496|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110676602|NCT04305496|Hormone Antagonists|hormone antagonists|mesh-ancestor
110948255|NCT01667926|Sensory System Agents|sensory system agents|mesh-ancestor
110676606|NCT04301934|Estrogens|estrogens|mesh-list
110676607|NCT04301934|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
110676608|NCT04301934|Hormones|hormones|mesh-ancestor
110676609|NCT04301934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110676610|NCT04301934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110676611|NCT04281017|Anesthetics|anesthetics|mesh-list
110676612|NCT04281017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110676613|NCT04281017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110676614|NCT04261036|Ascorbic Acid|ascorbic acid|mesh-list
110676615|NCT04261036|Antioxidants|antioxidants|mesh-ancestor
110676616|NCT04261036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110676617|NCT04261036|Protective Agents|protective agents|mesh-ancestor
110676618|NCT04261036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110676619|NCT04261036|Vitamins|vitamins|mesh-ancestor
110676620|NCT04261036|Micronutrients|micronutrients|mesh-ancestor
110676621|NCT04255407|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
110676622|NCT04155190|Veratrum Alkaloids|veratrum alkaloids|mesh-list
110676623|NCT04155190|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110676628|NCT04095832|Anesthetics|anesthetics|mesh-list
110676629|NCT04095832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110676630|NCT04095832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110676631|NCT04083365|Capecitabine|capecitabine|mesh-list
110676632|NCT04083365|Durvalumab|durvalumab|mesh-list
110676633|NCT04083365|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110676634|NCT04083365|Antimetabolites|antimetabolites|mesh-ancestor
110676635|NCT04083365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110676636|NCT04083365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110676637|NCT04083365|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110676638|NCT04072068|Edoxaban|edoxaban|mesh-list
110676639|NCT04072068|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110676640|NCT04072068|Antithrombins|antithrombins|mesh-ancestor
110676641|NCT04072068|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110676642|NCT04072068|Protease Inhibitors|protease inhibitors|mesh-ancestor
110676643|NCT04072068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110676644|NCT04072068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110676645|NCT04072068|Anticoagulants|anticoagulants|mesh-ancestor
110676646|NCT04036305|Lidocaine|lidocaine|mesh-list
110676647|NCT04036305|Bupivacaine|bupivacaine|mesh-list
110676648|NCT04036305|Anesthetics, Local|anesthetics, local|mesh-ancestor
110676649|NCT04036305|Anesthetics|anesthetics|mesh-ancestor
110676650|NCT04036305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110676651|NCT04036305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110676652|NCT04036305|Sensory System Agents|sensory system agents|mesh-ancestor
110676653|NCT04036305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110676654|NCT04036305|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110676655|NCT04036305|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110676656|NCT04036305|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110676657|NCT04036305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110676658|NCT04036305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110676660|NCT04021108|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110676661|NCT04021108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110676662|NCT04021108|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110676663|NCT04021108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110676664|NCT04019327|Temozolomide|temozolomide|mesh-list
110676665|NCT04019327|Talazoparib|talazoparib|mesh-list
110676666|NCT04019327|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110676667|NCT04019327|Alkylating Agents|alkylating agents|mesh-ancestor
110676668|NCT04019327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110676669|NCT04019327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110676670|NCT04019327|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110676671|NCT04019327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110676672|NCT03970655|Dexamethasone|dexamethasone|mesh-list
110676673|NCT03970655|Dexamethasone acetate|dexamethasone acetate|mesh-list
110676674|NCT03970655|Epinephrine|epinephrine|mesh-list
110676675|NCT03970655|Racepinephrine|racepinephrine|mesh-list
110676676|NCT03970655|Bupivacaine|bupivacaine|mesh-list
110676677|NCT03970655|Ropivacaine|ropivacaine|mesh-list
110687465|NCT00947063|Antipruritics|antipruritics|mesh-ancestor
110676678|NCT03970655|Epinephryl borate|epinephryl borate|mesh-list
110676679|NCT03970655|BB 1101|bb 1101|mesh-list
110676680|NCT03970655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110676681|NCT03970655|Antiemetics|antiemetics|mesh-ancestor
110676682|NCT03970655|Autonomic Agents|autonomic agents|mesh-ancestor
110676683|NCT03970655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110676684|NCT03970655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110676685|NCT03970655|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110676686|NCT03970655|Glucocorticoids|glucocorticoids|mesh-ancestor
110676687|NCT03970655|Hormones|hormones|mesh-ancestor
110676688|NCT03970655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110676689|NCT03970655|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110676690|NCT03970655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110676691|NCT03970655|Protease Inhibitors|protease inhibitors|mesh-ancestor
110676692|NCT03970655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110676693|NCT03970655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110676694|NCT03970655|Anesthetics, Local|anesthetics, local|mesh-ancestor
110676695|NCT03970655|Anesthetics|anesthetics|mesh-ancestor
110676696|NCT03970655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110676697|NCT03970655|Sensory System Agents|sensory system agents|mesh-ancestor
110676698|NCT03970655|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110676699|NCT03970655|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110676700|NCT03970655|Adrenergic Agents|adrenergic agents|mesh-ancestor
110676701|NCT03970655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110676702|NCT03970655|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110676703|NCT03970655|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110676704|NCT03970655|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110676705|NCT03970655|Respiratory System Agents|respiratory system agents|mesh-ancestor
110676706|NCT03970655|Mydriatics|mydriatics|mesh-ancestor
110676707|NCT03970655|Sympathomimetics|sympathomimetics|mesh-ancestor
110676708|NCT03970655|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110676709|NCT03916627|Cemiplimab|cemiplimab|mesh-list
110676710|NCT03916627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110676711|NCT03916627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110676712|NCT03912064|Ipilimumab|ipilimumab|mesh-list
110676713|NCT03912064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110676714|NCT03912064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110676715|NCT03912064|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110676716|NCT03912064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110676717|NCT03911453|Rucaparib|rucaparib|mesh-list
110676718|NCT03911453|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110676719|NCT03911453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110676720|NCT03911453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110676721|NCT03911453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110676722|NCT03870919|Palbociclib|palbociclib|mesh-list
110676723|NCT03870919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110676725|NCT03870919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110676726|NCT03870919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110676727|NCT03865290|Ondansetron|ondansetron|mesh-list
110676728|NCT03865290|Antiemetics|antiemetics|mesh-ancestor
110676729|NCT03865290|Autonomic Agents|autonomic agents|mesh-ancestor
110676730|NCT03865290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110676731|NCT03865290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110676732|NCT03865290|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110676733|NCT03865290|Antipruritics|antipruritics|mesh-ancestor
110676735|NCT03865290|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110676736|NCT03865290|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110676737|NCT03865290|Serotonin Agents|serotonin agents|mesh-ancestor
110676738|NCT03865290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110676739|NCT03865290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110676740|NCT03843359|Dostarlimab|dostarlimab|mesh-list
110676741|NCT03843359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110676742|NCT03840291|Edoxaban|edoxaban|mesh-list
110676743|NCT03840291|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110676744|NCT03840291|Antithrombins|antithrombins|mesh-ancestor
110676745|NCT03840291|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110676746|NCT03840291|Protease Inhibitors|protease inhibitors|mesh-ancestor
110676747|NCT03840291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110676748|NCT03840291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110676749|NCT03840291|Anticoagulants|anticoagulants|mesh-ancestor
110676750|NCT03837626|Amiloride|amiloride|mesh-list
110948256|NCT01667926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110676751|NCT03837626|Diuretics|diuretics|mesh-ancestor
110676752|NCT03837626|Natriuretic Agents|natriuretic agents|mesh-ancestor
110676753|NCT03837626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110676754|NCT03837626|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
110676755|NCT03837626|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110676756|NCT03837626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110676757|NCT03837626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110676758|NCT03837626|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
110676759|NCT03837626|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110676760|NCT03781219|Vemurafenib|vemurafenib|mesh-list
110676761|NCT03781219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110676762|NCT03781219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110676763|NCT03781219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110676764|NCT03781219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110676765|NCT03773237|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
110676766|NCT03773237|SMOFlipid|smoflipid|mesh-list
110676767|NCT03773237|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
110676768|NCT03773237|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
110676769|NCT03773237|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110676770|NCT03747484|Interferons|interferons|mesh-list
110676771|NCT03747484|Interferon-gamma|interferon-gamma|mesh-list
110676772|NCT03747484|Pembrolizumab|pembrolizumab|mesh-list
110676773|NCT03747484|Avelumab|avelumab|mesh-list
110676774|NCT03747484|Immunoglobulins|immunoglobulins|mesh-list
110676775|NCT03747484|Immunoglobulin G|immunoglobulin g|mesh-list
110676776|NCT03747484|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110676777|NCT03747484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110676778|NCT03747484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110676779|NCT03747484|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110676780|NCT03747484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110676781|NCT03747484|Antiviral Agents|antiviral agents|mesh-ancestor
110676782|NCT03747484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110676783|NCT03747484|Immunologic Factors|immunologic factors|mesh-ancestor
110676784|NCT03747484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110676785|NCT03694808|Vaccines|vaccines|mesh-list
110676786|NCT03694808|Immunologic Factors|immunologic factors|mesh-ancestor
110676787|NCT03694808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110676788|NCT03659539|Propofol|propofol|mesh-list
110676789|NCT03659539|Desflurane|desflurane|mesh-list
110676790|NCT03659539|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110676791|NCT03659539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110676792|NCT03659539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110676793|NCT03659539|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110676794|NCT03659539|Anesthetics, General|anesthetics, general|mesh-ancestor
110676795|NCT03659539|Anesthetics|anesthetics|mesh-ancestor
110323932|NCT00426998|Growth Inhibitors|growth inhibitors|mesh-ancestor
110676796|NCT03659539|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110676797|NCT03659136|Everolimus|everolimus|mesh-list
110676798|NCT03659136|Exemestane|exemestane|mesh-list
110676799|NCT03659136|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110676800|NCT03659136|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110676801|NCT03659136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110676802|NCT03659136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110676803|NCT03659136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110676804|NCT03659136|Immunologic Factors|immunologic factors|mesh-ancestor
110676805|NCT03659136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110676806|NCT03659136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110676808|NCT03659136|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110676809|NCT03659136|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110676810|NCT03659136|Hormone Antagonists|hormone antagonists|mesh-ancestor
110676811|NCT03659136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110676812|NCT03629418|Phenylephrine|phenylephrine|mesh-list
110676813|NCT03629418|Norepinephrine|norepinephrine|mesh-list
110676814|NCT03629418|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110676815|NCT03629418|Mydriatics|mydriatics|mesh-ancestor
110676816|NCT03629418|Autonomic Agents|autonomic agents|mesh-ancestor
110676817|NCT03629418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110676818|NCT03629418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110676819|NCT03629418|Sympathomimetics|sympathomimetics|mesh-ancestor
110676820|NCT03629418|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110676821|NCT03629418|Nasal Decongestants|nasal decongestants|mesh-ancestor
110676822|NCT03629418|Respiratory System Agents|respiratory system agents|mesh-ancestor
110676823|NCT03629418|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110676824|NCT03629418|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110676825|NCT03629418|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110683000|NCT00908921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110683001|NCT00908921|Immunologic Factors|immunologic factors|mesh-ancestor
110683002|NCT00904631|Salicylic Acid|salicylic acid|mesh-list
110683003|NCT00904631|Salicylates|salicylates|mesh-list
110683004|NCT00904631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110683005|NCT00904631|Antifungal Agents|antifungal agents|mesh-ancestor
110676826|NCT03629418|Adrenergic Agents|adrenergic agents|mesh-ancestor
110676827|NCT03629418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110676828|NCT03629418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110676829|NCT03629418|Protective Agents|protective agents|mesh-ancestor
110676830|NCT03606213|Vaccines|vaccines|mesh-list
110676831|NCT03606213|Immunologic Factors|immunologic factors|mesh-ancestor
110676832|NCT03606213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110676833|NCT03605719|Dexamethasone|dexamethasone|mesh-list
110676834|NCT03605719|Nivolumab|nivolumab|mesh-list
110676835|NCT03605719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110676836|NCT03605719|Antiemetics|antiemetics|mesh-ancestor
110676837|NCT03605719|Autonomic Agents|autonomic agents|mesh-ancestor
110676838|NCT03605719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110676839|NCT03605719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110676840|NCT03605719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110676841|NCT03605719|Glucocorticoids|glucocorticoids|mesh-ancestor
110676842|NCT03605719|Hormones|hormones|mesh-ancestor
110676843|NCT03605719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110676844|NCT03605719|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110676845|NCT03605719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110676846|NCT03605719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110676847|NCT03605719|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110676848|NCT03605719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110676849|NCT03514108|Metformin|metformin|mesh-list
110676850|NCT03514108|Hydralazine|hydralazine|mesh-list
110676851|NCT03514108|Isosorbide|isosorbide|mesh-list
110676852|NCT03514108|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
110676853|NCT03514108|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
110676854|NCT03514108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110676855|NCT03514108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110676856|NCT03514108|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110676857|NCT03514108|Diuretics|diuretics|mesh-ancestor
110676858|NCT03514108|Natriuretic Agents|natriuretic agents|mesh-ancestor
110676859|NCT03514108|Vasodilator Agents|vasodilator agents|mesh-ancestor
110676860|NCT03514108|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
110676861|NCT03514108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110676862|NCT03514108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110676863|NCT03390036|Triamcinolone|triamcinolone|mesh-list
110676864|NCT03390036|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110676865|NCT03390036|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110676866|NCT03390036|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110676867|NCT03390036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110676868|NCT03390036|Glucocorticoids|glucocorticoids|mesh-ancestor
110676869|NCT03390036|Hormones|hormones|mesh-ancestor
110676870|NCT03390036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110676871|NCT03390036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110676872|NCT03390036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110676873|NCT03390036|Immunologic Factors|immunologic factors|mesh-ancestor
110676874|NCT03390036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110676875|NCT03390036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110676876|NCT03379506|Grazoprevir|grazoprevir|mesh-list
110676877|NCT03379506|Antiviral Agents|antiviral agents|mesh-ancestor
110676878|NCT03379506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110676879|NCT03375788|Hormones|hormones|mesh-list
110676880|NCT03375788|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
110676881|NCT03375788|Tesamorelin|tesamorelin|mesh-list
110676882|NCT03375788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110676883|NCT03375788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110676884|NCT03375788|Growth Substances|growth substances|mesh-ancestor
110676885|NCT03366844|Pembrolizumab|pembrolizumab|mesh-list
110676886|NCT03366844|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110676887|NCT03366844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110676888|NCT03366844|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110676889|NCT03366844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110948257|NCT01667926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110948258|NCT01667926|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110948259|NCT01667926|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110948260|NCT01667926|Anesthetics, General|anesthetics, general|mesh-ancestor
110948261|NCT01667926|Anesthetics|anesthetics|mesh-ancestor
110948262|NCT01667926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110948263|NCT01667926|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110948264|NCT01667926|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110948265|NCT01667926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110948266|NCT01667926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110948268|NCT03039478|Vasodilator Agents|vasodilator agents|mesh-ancestor
110948269|NCT04832776|Bevacizumab|bevacizumab|mesh-list
110948270|NCT04832776|Cetuximab|cetuximab|mesh-list
110948271|NCT04832776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110948272|NCT04832776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110948273|NCT04832776|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110948274|NCT04832776|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110948275|NCT04832776|Growth Substances|growth substances|mesh-ancestor
110948276|NCT04832776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110948277|NCT04832776|Growth Inhibitors|growth inhibitors|mesh-ancestor
110948278|NCT04835116|Acetaminophen|acetaminophen|mesh-list
110948279|NCT04835116|Tramadol|tramadol|mesh-list
110948280|NCT04835116|Analgesics|analgesics|mesh-list
110948281|NCT04835116|Orphenadrine|orphenadrine|mesh-list
110948282|NCT04835116|Dimenhydrinate|dimenhydrinate|mesh-list
110948283|NCT04835116|Bupivacaine|bupivacaine|mesh-list
110948284|NCT04835116|Anesthetics, Local|anesthetics, local|mesh-ancestor
110948285|NCT04835116|Anesthetics|anesthetics|mesh-ancestor
110948286|NCT04835116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110948287|NCT04835116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110948288|NCT04835116|Sensory System Agents|sensory system agents|mesh-ancestor
110948289|NCT04835116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110948290|NCT04835116|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110948291|NCT04835116|Antipyretics|antipyretics|mesh-ancestor
110948292|NCT04835116|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110948293|NCT04835116|Narcotics|narcotics|mesh-ancestor
110948294|NCT04835116|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110948295|NCT04835116|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110948296|NCT04835116|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110948297|NCT04835116|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110948298|NCT04835116|Parasympatholytics|parasympatholytics|mesh-ancestor
110948299|NCT04835116|Autonomic Agents|autonomic agents|mesh-ancestor
110948300|NCT04835116|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110948301|NCT04835116|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110948302|NCT04835116|Cholinergic Agents|cholinergic agents|mesh-ancestor
110948303|NCT04835116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110948304|NCT04835116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110948305|NCT04835116|Cytochrome P-450 CYP2B6 Inhibitors|cytochrome p-450 cyp2b6 inhibitors|mesh-ancestor
110948306|NCT04835116|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110948307|NCT04835116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110948308|NCT04835116|Antiemetics|antiemetics|mesh-ancestor
110948309|NCT04835116|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110948310|NCT04835116|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110948311|NCT04835116|Histamine Antagonists|histamine antagonists|mesh-ancestor
110948312|NCT04835116|Histamine Agents|histamine agents|mesh-ancestor
110948313|NCT03036826|Meropenem|meropenem|mesh-list
110948314|NCT03036826|Tazobactam|tazobactam|mesh-list
110948315|NCT03036826|Piperacillin|piperacillin|mesh-list
110948316|NCT03036826|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
110948317|NCT03036826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110948318|NCT03036826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110948319|NCT03036826|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110948320|NCT03036826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110948321|NCT03036826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110948322|NCT03036046|Fluconazole|fluconazole|mesh-list
110948323|NCT03036046|Posaconazole|posaconazole|mesh-list
110948324|NCT03036046|Olorofim|olorofim|mesh-list
110948325|NCT03036046|Antifungal Agents|antifungal agents|mesh-ancestor
110948326|NCT03036046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110948327|NCT03036046|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110948328|NCT03036046|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110948329|NCT03036046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110948330|NCT03036046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110948331|NCT03036046|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110948332|NCT03036046|Hormone Antagonists|hormone antagonists|mesh-ancestor
110948333|NCT03036046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110948334|NCT03036046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110948335|NCT03036046|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110948336|NCT03036046|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110948337|NCT03036046|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
110948338|NCT03036046|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110948339|NCT03036046|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110948340|NCT04831528|Bevacizumab|bevacizumab|mesh-list
110948341|NCT04831528|Trastuzumab|trastuzumab|mesh-list
110948342|NCT04831528|Cetuximab|cetuximab|mesh-list
110948343|NCT04831528|Pertuzumab|pertuzumab|mesh-list
110948344|NCT04831528|Lapatinib|lapatinib|mesh-list
110948345|NCT04831528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110948346|NCT04831528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110948347|NCT04831528|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110948348|NCT04831528|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110948349|NCT04831528|Growth Substances|growth substances|mesh-ancestor
110948350|NCT04831528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110948351|NCT04831528|Growth Inhibitors|growth inhibitors|mesh-ancestor
110948352|NCT04831528|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110948353|NCT04831528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110948354|NCT04831528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110948355|NCT04824586|Insulin|insulin|mesh-list
110948356|NCT04824586|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110948357|NCT04824586|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110948358|NCT04824586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110948359|NCT04824898|Simvastatin|simvastatin|mesh-list
110948360|NCT04824898|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110948361|NCT04824898|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110948362|NCT04824898|Antimetabolites|antimetabolites|mesh-ancestor
110948363|NCT04824898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110948364|NCT04824898|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110948365|NCT04824898|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110948366|NCT04824898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110948367|NCT04824352|Apatinib|apatinib|mesh-list
110948368|NCT04824352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110948369|NCT04824352|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110948370|NCT04824352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110948371|NCT04824352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110948372|NCT04319614|Tranexamic Acid|tranexamic acid|mesh-list
110948373|NCT04319614|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110948374|NCT04319614|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110948375|NCT04319614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110948376|NCT04319614|Hemostatics|hemostatics|mesh-ancestor
110948377|NCT04319614|Coagulants|coagulants|mesh-ancestor
110948378|NCT01359904|Dialysis Solutions|dialysis solutions|mesh-list
110948379|NCT01359904|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110948380|NCT04823260|Niacinamide|niacinamide|mesh-list
110948381|NCT04823260|Niacin|niacin|mesh-list
110948382|NCT04823260|Nicotinic Acids|nicotinic acids|mesh-list
110948383|NCT04823260|Vitamin B Complex|vitamin b complex|mesh-ancestor
110948384|NCT04823260|Vitamins|vitamins|mesh-ancestor
110948385|NCT04823260|Micronutrients|micronutrients|mesh-ancestor
110948386|NCT04823260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110948387|NCT04823260|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110948388|NCT04823260|Antimetabolites|antimetabolites|mesh-ancestor
110948389|NCT04823260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110948390|NCT04823260|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110948391|NCT04823260|Vasodilator Agents|vasodilator agents|mesh-ancestor
110948392|NCT04816240|Midodrine|midodrine|mesh-list
110948393|NCT04816240|Sympathomimetics|sympathomimetics|mesh-ancestor
110948394|NCT04816240|Autonomic Agents|autonomic agents|mesh-ancestor
110948395|NCT04816240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110948396|NCT04816240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110948397|NCT04816240|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110948398|NCT04816240|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110948399|NCT04816240|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110948400|NCT04816240|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110948401|NCT04816240|Adrenergic Agents|adrenergic agents|mesh-ancestor
110948402|NCT04816240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110948403|NCT04816240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110948405|NCT04822012|Immunoglobulin G|immunoglobulin g|mesh-list
110948406|NCT04822012|Progesterone|progesterone|mesh-list
110948407|NCT04822012|Estrogens|estrogens|mesh-list
110948408|NCT04822012|Immunologic Factors|immunologic factors|mesh-ancestor
110948409|NCT04822012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110948410|NCT04822012|Progestins|progestins|mesh-ancestor
110948411|NCT04822012|Hormones|hormones|mesh-ancestor
110948412|NCT04822012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110948413|NCT05399732|Cyclosporine|cyclosporine|mesh-list
110948414|NCT05399732|Luspatercept|luspatercept|mesh-list
110948415|NCT05399732|Cyclosporins|cyclosporins|mesh-list
110948416|NCT05399732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110948417|NCT05399732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110948418|NCT05399732|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110948419|NCT05399732|Immunologic Factors|immunologic factors|mesh-ancestor
110948420|NCT05399732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110948421|NCT05399732|Antifungal Agents|antifungal agents|mesh-ancestor
110948422|NCT05399732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110948423|NCT05399732|Dermatologic Agents|dermatologic agents|mesh-ancestor
110948424|NCT05399732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110948425|NCT05399732|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110948426|NCT05399732|Hematinics|hematinics|mesh-ancestor
110948427|NCT05399576|Nicorandil|nicorandil|mesh-list
110948428|NCT05399576|Verapamil|verapamil|mesh-list
110948429|NCT05399576|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110948430|NCT05399576|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110948431|NCT05399576|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110948432|NCT05399576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110948433|NCT05399576|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110948434|NCT05399576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110948435|NCT05399576|Vasodilator Agents|vasodilator agents|mesh-ancestor
110948436|NCT05399576|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110948437|NCT05399576|Vitamin B Complex|vitamin b complex|mesh-ancestor
110948438|NCT05399576|Vitamins|vitamins|mesh-ancestor
110948439|NCT05399576|Micronutrients|micronutrients|mesh-ancestor
110948440|NCT05398718|Sotrovimab|sotrovimab|mesh-list
110948441|NCT05398718|Antiviral Agents|antiviral agents|mesh-ancestor
110948442|NCT05398718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110948443|NCT05255900|Metyrapone|metyrapone|mesh-list
110948444|NCT05255900|Antimetabolites|antimetabolites|mesh-ancestor
110948445|NCT05255900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110948446|NCT05255900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110948447|NCT04615286|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110948448|NCT04615286|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
110948449|NCT04615286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110948450|NCT04615286|Antitubercular Agents|antitubercular agents|mesh-ancestor
110948451|NCT05397938|Alendronate|alendronate|mesh-list
110948452|NCT05397938|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110948453|NCT05397938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110948454|NCT05133674|Tamoxifen|tamoxifen|mesh-list
110948455|NCT05133674|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110948456|NCT05133674|Hormone Antagonists|hormone antagonists|mesh-ancestor
110948457|NCT05133674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110948458|NCT05133674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110948459|NCT05133674|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110948460|NCT05133674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110948461|NCT05133674|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110948462|NCT05133674|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110948463|NCT05133674|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110948464|NCT02522936|Muramidase|muramidase|mesh-list
110948465|NCT02522936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110948466|NCT04525898|Methadone|methadone|mesh-list
110948467|NCT04525898|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110948468|NCT04525898|Narcotics|narcotics|mesh-ancestor
110948469|NCT04525898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110948470|NCT04525898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110948471|NCT04525898|Analgesics|analgesics|mesh-ancestor
110948473|NCT04525898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110948474|NCT04525898|Antitussive Agents|antitussive agents|mesh-ancestor
110948475|NCT04525898|Respiratory System Agents|respiratory system agents|mesh-ancestor
110948476|NCT04282070|Paclitaxel|paclitaxel|mesh-list
110948477|NCT04282070|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110948478|NCT04282070|Cisplatin|cisplatin|mesh-list
110948479|NCT04282070|Gemcitabine|gemcitabine|mesh-list
110948480|NCT04282070|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110948481|NCT04282070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110948482|NCT04282070|Tubulin Modulators|tubulin modulators|mesh-ancestor
110948483|NCT04282070|Antimitotic Agents|antimitotic agents|mesh-ancestor
110948484|NCT04282070|Mitosis Modulators|mitosis modulators|mesh-ancestor
110948485|NCT04282070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110948486|NCT04282070|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110948487|NCT04282070|Antimetabolites|antimetabolites|mesh-ancestor
110948488|NCT04347122|Tranexamic Acid|tranexamic acid|mesh-list
110948489|NCT04347122|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110948490|NCT04347122|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110948491|NCT04347122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110948492|NCT04347122|Hemostatics|hemostatics|mesh-ancestor
110948493|NCT04347122|Coagulants|coagulants|mesh-ancestor
110948494|NCT03467438|Polaprezinc|polaprezinc|mesh-list
110948495|NCT03467438|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110948496|NCT03467438|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110948497|NCT05397236|Dexamethasone|dexamethasone|mesh-list
110948498|NCT05397236|Bupivacaine|bupivacaine|mesh-list
110948499|NCT05397236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110948500|NCT05397236|Antiemetics|antiemetics|mesh-ancestor
110948501|NCT05397236|Autonomic Agents|autonomic agents|mesh-ancestor
110948502|NCT05397236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110948503|NCT05397236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110948504|NCT05397236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110948505|NCT05397236|Glucocorticoids|glucocorticoids|mesh-ancestor
110948506|NCT05397236|Hormones|hormones|mesh-ancestor
110948507|NCT05397236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110948508|NCT05397236|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110948509|NCT05397236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110948510|NCT05397236|Anesthetics, Local|anesthetics, local|mesh-ancestor
110948511|NCT05397236|Anesthetics|anesthetics|mesh-ancestor
110948512|NCT05397236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110948513|NCT05397236|Sensory System Agents|sensory system agents|mesh-ancestor
110948514|NCT05439278|Temozolomide|temozolomide|mesh-list
110948515|NCT05439278|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110948516|NCT05439278|Alkylating Agents|alkylating agents|mesh-ancestor
110948517|NCT05439278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110948518|NCT05439278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110948519|NCT03130010|Nefopam|nefopam|mesh-list
110948520|NCT03130010|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110948521|NCT03130010|Analgesics|analgesics|mesh-ancestor
110948522|NCT03130010|Sensory System Agents|sensory system agents|mesh-ancestor
110948523|NCT03130010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110948524|NCT03130010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110948525|NCT05396144|Nitrous Oxide|nitrous oxide|mesh-list
110948526|NCT05396144|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110948527|NCT05396144|Anesthetics, General|anesthetics, general|mesh-ancestor
110948528|NCT05396144|Anesthetics|anesthetics|mesh-ancestor
110948529|NCT05396144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110948530|NCT05396144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110948531|NCT05396144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110948532|NCT05396144|Analgesics|analgesics|mesh-ancestor
110948533|NCT05396144|Sensory System Agents|sensory system agents|mesh-ancestor
110948534|NCT05396144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110948535|NCT00157248|Dabigatran|dabigatran|mesh-list
110948536|NCT00157248|Antithrombins|antithrombins|mesh-ancestor
110948537|NCT00157248|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110948538|NCT00157248|Protease Inhibitors|protease inhibitors|mesh-ancestor
110948539|NCT00157248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110948540|NCT00157248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110948541|NCT00157248|Anticoagulants|anticoagulants|mesh-ancestor
110948542|NCT02504580|Bupivacaine|bupivacaine|mesh-list
110948543|NCT02504580|Anesthetics, Local|anesthetics, local|mesh-ancestor
110948544|NCT02504580|Anesthetics|anesthetics|mesh-ancestor
110948545|NCT02504580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110948546|NCT02504580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110948547|NCT02504580|Sensory System Agents|sensory system agents|mesh-ancestor
110948548|NCT02504580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110948550|NCT02235402|Bendroflumethiazide|bendroflumethiazide|mesh-list
110948551|NCT02235402|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110948552|NCT02235402|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110948553|NCT02235402|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110948554|NCT02235402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110948555|NCT02235402|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110948556|NCT02235402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110948557|NCT02235402|Diuretics|diuretics|mesh-ancestor
110948558|NCT02235402|Natriuretic Agents|natriuretic agents|mesh-ancestor
110948559|NCT02235402|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110948560|NCT02235480|Tazarotene|tazarotene|mesh-list
110948561|NCT02235480|Dermatologic Agents|dermatologic agents|mesh-ancestor
110948562|NCT02235480|Keratolytic Agents|keratolytic agents|mesh-ancestor
110948563|NCT02235558|Verapamil|verapamil|mesh-list
110948564|NCT02235558|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110948565|NCT02235558|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110948566|NCT02235558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110948567|NCT02235558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110948568|NCT02235558|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110948569|NCT02235558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110948570|NCT02235558|Vasodilator Agents|vasodilator agents|mesh-ancestor
110948571|NCT04214418|Hydroxychloroquine|hydroxychloroquine|mesh-list
110948572|NCT04214418|Atezolizumab|atezolizumab|mesh-list
110948573|NCT04214418|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110948574|NCT04214418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110948575|NCT04214418|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110948576|NCT04214418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110948577|NCT04214418|Antimalarials|antimalarials|mesh-ancestor
110948578|NCT04214418|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110948579|NCT04214418|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110948580|NCT04214418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110948581|NCT04214418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110948582|NCT04214418|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110948583|NCT02233920|Oxitropium|oxitropium|mesh-list
110948584|NCT02233920|Parasympatholytics|parasympatholytics|mesh-ancestor
110948585|NCT02233920|Autonomic Agents|autonomic agents|mesh-ancestor
110948586|NCT02233920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110948587|NCT02233920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110948588|NCT02235948|Folic Acid|folic acid|mesh-list
110948589|NCT02235948|Hematinics|hematinics|mesh-ancestor
110948590|NCT02235948|Vitamin B Complex|vitamin b complex|mesh-ancestor
110948591|NCT02235948|Vitamins|vitamins|mesh-ancestor
110948592|NCT02235948|Micronutrients|micronutrients|mesh-ancestor
110948593|NCT02235948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110948594|NCT02236026|Moxifloxacin|moxifloxacin|mesh-list
110948595|NCT02236026|ST 1435|st 1435|mesh-list
110948596|NCT02236026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110948597|NCT02236026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110948598|NCT02236026|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110948599|NCT02236026|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110948600|NCT02236026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110948601|NCT02236026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110948602|NCT02236026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110948603|NCT02236026|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110948604|NCT02236026|Contraceptive Agents|contraceptive agents|mesh-ancestor
110948605|NCT02236026|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110948606|NCT02236026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110948607|NCT02236026|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110948608|NCT02236182|Bromides|bromides|mesh-list
110948609|NCT02236182|Ipratropium|ipratropium|mesh-list
110948610|NCT02236182|Anticonvulsants|anticonvulsants|mesh-ancestor
110948611|NCT02236182|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110948612|NCT02236182|Autonomic Agents|autonomic agents|mesh-ancestor
110948613|NCT02236182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110948614|NCT02236182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110948615|NCT02236182|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110948616|NCT02236182|Respiratory System Agents|respiratory system agents|mesh-ancestor
110948617|NCT02236182|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110948618|NCT02236182|Cholinergic Agents|cholinergic agents|mesh-ancestor
110948619|NCT02236182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110948620|NCT02236182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110948621|NCT04453280|Antibodies|antibodies|mesh-list
110948622|NCT04453280|Immunologic Factors|immunologic factors|mesh-ancestor
110948623|NCT04453280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110948624|NCT01328756|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
110948625|NCT01328756|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110948626|NCT01328756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110948627|NCT01328756|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110948628|NCT01328756|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110948629|NCT01328756|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110948630|NCT01328756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110948631|NCT01328756|Dopamine Agents|dopamine agents|mesh-ancestor
110948632|NCT01328756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110948633|NCT03466502|Vancomycin|vancomycin|mesh-list
110948634|NCT03466502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110948635|NCT03466502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110948636|NCT05392634|Amoxicillin|amoxicillin|mesh-list
110948637|NCT05392634|Meropenem|meropenem|mesh-list
110948638|NCT05392634|Clavulanic Acids|clavulanic acids|mesh-list
110948639|NCT05392634|Clavulanic Acid|clavulanic acid|mesh-list
110948640|NCT05392634|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
110948641|NCT05392634|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110948642|NCT05392634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110948643|NCT05392634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110948644|NCT05392634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110948645|NCT05392634|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110948646|NCT01593228|Paclitaxel|paclitaxel|mesh-list
110948647|NCT01593228|Carboplatin|carboplatin|mesh-list
110948648|NCT01593228|Gemcitabine|gemcitabine|mesh-list
110948649|NCT01593228|Doxorubicin|doxorubicin|mesh-list
110948650|NCT01593228|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110948651|NCT01593228|Irinotecan|irinotecan|mesh-list
110948652|NCT01593228|Topotecan|topotecan|mesh-list
110948653|NCT01593228|Iniparib|iniparib|mesh-list
110948654|NCT01593228|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110948655|NCT01593228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110948656|NCT01593228|Tubulin Modulators|tubulin modulators|mesh-ancestor
110948657|NCT01593228|Antimitotic Agents|antimitotic agents|mesh-ancestor
110948658|NCT01593228|Mitosis Modulators|mitosis modulators|mesh-ancestor
110948659|NCT01593228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110948660|NCT01593228|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110948661|NCT01593228|Antimetabolites|antimetabolites|mesh-ancestor
110948662|NCT01593228|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110449701|NCT00606957|Vitamin D|vitamin d|mesh-list
110948663|NCT01593228|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110948664|NCT01593228|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110948665|NCT01593228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110948666|NCT01593228|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110948667|NCT01593228|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110948668|NCT02263638|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
110948669|NCT02263638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110948670|NCT02236260|Lidocaine|lidocaine|mesh-list
110948671|NCT02236260|Anesthetics, Local|anesthetics, local|mesh-ancestor
110948672|NCT02236260|Anesthetics|anesthetics|mesh-ancestor
110948673|NCT02236260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110948674|NCT02236260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110948675|NCT02236260|Sensory System Agents|sensory system agents|mesh-ancestor
110948676|NCT02236260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110948677|NCT02236260|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110948678|NCT02236260|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110948679|NCT02236260|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110948680|NCT02236260|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110948681|NCT02236260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110948682|NCT01555554|Propranolol|propranolol|mesh-list
110948683|NCT01555554|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110948684|NCT01555554|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110948685|NCT01555554|Adrenergic Agents|adrenergic agents|mesh-ancestor
110948686|NCT01555554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110948687|NCT01555554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110948688|NCT01555554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110948689|NCT01555554|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110948690|NCT01555554|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110948691|NCT01555554|Vasodilator Agents|vasodilator agents|mesh-ancestor
110948692|NCT01435044|Sofosbuvir|sofosbuvir|mesh-list
110948693|NCT01435044|Ribavirin|ribavirin|mesh-list
110948694|NCT01435044|Antiviral Agents|antiviral agents|mesh-ancestor
110948695|NCT01435044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110948696|NCT01435044|Antimetabolites|antimetabolites|mesh-ancestor
110023880|NCT00004110|Immunologic Factors|immunologic factors|mesh-ancestor
110948697|NCT01435044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110948699|NCT01434498|Ledipasvir|ledipasvir|mesh-list
110948700|NCT01434498|Antimetabolites|antimetabolites|mesh-ancestor
110948701|NCT01434498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110948702|NCT01434498|Antiviral Agents|antiviral agents|mesh-ancestor
110948703|NCT01434498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110948704|NCT03735966|Carboplatin|carboplatin|mesh-list
110948705|NCT03735966|Docetaxel|docetaxel|mesh-list
110948706|NCT03735966|Trastuzumab|trastuzumab|mesh-list
110948707|NCT03735966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110948708|NCT03735966|Tubulin Modulators|tubulin modulators|mesh-ancestor
110948709|NCT03735966|Antimitotic Agents|antimitotic agents|mesh-ancestor
110948710|NCT03735966|Mitosis Modulators|mitosis modulators|mesh-ancestor
110948711|NCT03735966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110948712|NCT03735966|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110948713|NCT01554696|Methotrexate|methotrexate|mesh-list
110660663|NCT04007588|Linrodostat|linrodostat|mesh-list
110948714|NCT01554696|Peficitinib|peficitinib|mesh-list
110948715|NCT01554696|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110948716|NCT01554696|Abortifacient Agents|abortifacient agents|mesh-ancestor
110948717|NCT01554696|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110948718|NCT01554696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110948719|NCT01554696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110948720|NCT01554696|Antimetabolites|antimetabolites|mesh-ancestor
110948721|NCT01554696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110948722|NCT01554696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110948723|NCT01554696|Dermatologic Agents|dermatologic agents|mesh-ancestor
110948724|NCT01554696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110948725|NCT01554696|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110948726|NCT01554696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110948727|NCT01554696|Immunologic Factors|immunologic factors|mesh-ancestor
110948728|NCT01554696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110948729|NCT01554696|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110948730|NCT02265276|Pioglitazone|pioglitazone|mesh-list
110948731|NCT02265276|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110948732|NCT02265276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110948733|NCT02263872|Minocycline|minocycline|mesh-list
110948734|NCT02263872|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110948735|NCT02263872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110948736|NCT02261376|DS-1971a|ds-1971a|mesh-list
110948737|NCT02261376|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110948738|NCT02261376|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110948739|NCT02261376|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110948740|NCT02261376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110948741|NCT01535508|Vitamin D|vitamin d|mesh-list
110948742|NCT01535508|Vitamins|vitamins|mesh-ancestor
110948743|NCT01535508|Micronutrients|micronutrients|mesh-ancestor
110948744|NCT01535508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110948745|NCT01535508|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110948746|NCT02626338|Cytarabine|cytarabine|mesh-list
110948747|NCT02626338|Fludarabine|fludarabine|mesh-list
110948748|NCT02626338|Fludarabine phosphate|fludarabine phosphate|mesh-list
110948749|NCT02626338|Etoposide|etoposide|mesh-list
110948750|NCT02626338|Etoposide phosphate|etoposide phosphate|mesh-list
110948751|NCT02626338|Mitoxantrone|mitoxantrone|mesh-list
110948752|NCT02626338|Idarubicin|idarubicin|mesh-list
110948753|NCT02626338|Crenolanib|crenolanib|mesh-list
110948754|NCT02626338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110948755|NCT02626338|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110948756|NCT02626338|Antimetabolites|antimetabolites|mesh-ancestor
110948757|NCT02626338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110948758|NCT02626338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110948759|NCT02626338|Immunologic Factors|immunologic factors|mesh-ancestor
110948760|NCT02626338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110948761|NCT02626338|Antiviral Agents|antiviral agents|mesh-ancestor
110948762|NCT02626338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110948763|NCT02626338|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110948764|NCT02626338|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110948765|NCT02626338|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110948766|NCT02626338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110948767|NCT02626338|Analgesics|analgesics|mesh-ancestor
110948768|NCT02626338|Sensory System Agents|sensory system agents|mesh-ancestor
110948769|NCT02626338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110948770|NCT02626338|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110948771|NCT01416402|Colchicine|colchicine|mesh-list
110948772|NCT01416402|Febuxostat|febuxostat|mesh-list
110948773|NCT01416402|Gout Suppressants|gout suppressants|mesh-ancestor
110948774|NCT01416402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110948775|NCT01416402|Tubulin Modulators|tubulin modulators|mesh-ancestor
110948776|NCT01416402|Antimitotic Agents|antimitotic agents|mesh-ancestor
110948777|NCT01416402|Mitosis Modulators|mitosis modulators|mesh-ancestor
110948778|NCT01416402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110948779|NCT01416402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110948780|NCT01414920|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110948781|NCT01414920|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110948782|NCT01414920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110948783|NCT01414920|Incretins|incretins|mesh-ancestor
110948784|NCT01414920|Hormones|hormones|mesh-ancestor
110948785|NCT01414920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110948786|NCT01414920|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110948787|NCT01414920|Protease Inhibitors|protease inhibitors|mesh-ancestor
110948788|NCT01414920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110660743|NCT00979316|Moxifloxacin|moxifloxacin|mesh-list
110948789|NCT01414920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110948790|NCT02263950|Artemether|artemether|mesh-list
110948791|NCT02263950|Antimalarials|antimalarials|mesh-ancestor
110948792|NCT02263950|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110948793|NCT02263950|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110948794|NCT02263950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110948796|NCT02261844|Antioxidants|antioxidants|mesh-ancestor
110948797|NCT02261844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110948798|NCT02261844|Protective Agents|protective agents|mesh-ancestor
110948799|NCT02261844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110948800|NCT02261844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110948801|NCT02261844|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110948802|NCT02261922|Ticagrelor|ticagrelor|mesh-list
110948803|NCT02261922|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
110948804|NCT02261922|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110948805|NCT02261922|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110948806|NCT02261922|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110948807|NCT02261922|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110948808|NCT02261922|Purinergic Agents|purinergic agents|mesh-ancestor
110948809|NCT02261922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110948810|NCT02261922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110948811|NCT02261922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110948812|NCT02264028|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110948813|NCT02264106|Pantoprazole|pantoprazole|mesh-list
110948814|NCT02264106|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110948815|NCT02264106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110948816|NCT02264106|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110948817|NCT02264106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110948818|NCT02264106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110948819|NCT02262156|Antidepressive Agents|antidepressive agents|mesh-list
110948820|NCT02262156|Serotonin|serotonin|mesh-list
110948821|NCT02262156|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
110948822|NCT02262156|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110948823|NCT02262156|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110948824|NCT02262156|Serotonin Agents|serotonin agents|mesh-ancestor
110948825|NCT02262156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110948826|NCT02262156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110948827|NCT02262156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110948828|NCT02262156|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110948829|NCT02262156|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110948830|NCT02612922|Nitazoxanide|nitazoxanide|mesh-list
110948831|NCT02612922|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110948832|NCT02612922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110948833|NCT01516476|Liraglutide|liraglutide|mesh-list
110948834|NCT01516476|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110948835|NCT01516476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110948836|NCT01516476|Incretins|incretins|mesh-ancestor
110948837|NCT01516476|Hormones|hormones|mesh-ancestor
110948838|NCT01516476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110948839|NCT01516086|Fluticasone|fluticasone|mesh-list
110948840|NCT01516086|Xhance|xhance|mesh-list
110948841|NCT01516086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110948842|NCT01516086|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110948843|NCT01516086|Autonomic Agents|autonomic agents|mesh-ancestor
110948844|NCT01516086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110948845|NCT01516086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110948846|NCT01516086|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110948847|NCT01516086|Respiratory System Agents|respiratory system agents|mesh-ancestor
110948848|NCT01516086|Dermatologic Agents|dermatologic agents|mesh-ancestor
110948849|NCT01516086|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110948850|NCT01497834|Asunaprevir|asunaprevir|mesh-list
110948851|NCT01497834|Protease Inhibitors|protease inhibitors|mesh-ancestor
110948852|NCT01497834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110948853|NCT01497834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110948854|NCT02265822|Midazolam|midazolam|mesh-list
110948855|NCT02265822|Melatonin|melatonin|mesh-list
110948856|NCT02265822|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110948857|NCT02265822|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110948858|NCT02265822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110948859|NCT02265822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110948860|NCT02265822|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110948861|NCT02265822|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110948862|NCT02265822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110948863|NCT02265822|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110948864|NCT02265822|Anesthetics, General|anesthetics, general|mesh-ancestor
110948865|NCT02265822|Anesthetics|anesthetics|mesh-ancestor
110948866|NCT02265822|GABA Modulators|gaba modulators|mesh-ancestor
110948867|NCT02265822|GABA Agents|gaba agents|mesh-ancestor
110948868|NCT02265822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110948869|NCT02265822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110948870|NCT02265822|Antioxidants|antioxidants|mesh-ancestor
110948871|NCT02265822|Protective Agents|protective agents|mesh-ancestor
110948872|NCT02607930|Lamivudine|lamivudine|mesh-list
110948873|NCT02607930|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110948874|NCT02607930|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110948875|NCT02607930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110948876|NCT02607930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110948877|NCT02607930|Antiviral Agents|antiviral agents|mesh-ancestor
110948878|NCT02607930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110948879|NCT02607930|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110948880|NCT02607930|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110948881|NCT02264184|Paroxetine|paroxetine|mesh-list
110948882|NCT02264184|Tamsulosin|tamsulosin|mesh-list
110948883|NCT02264184|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110948884|NCT02264184|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110948885|NCT02264184|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110948886|NCT02264184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110948887|NCT02264184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110948888|NCT02264184|Serotonin Agents|serotonin agents|mesh-ancestor
110948889|NCT02264184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110948890|NCT02264184|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110948891|NCT02264184|Antidepressive Agents|antidepressive agents|mesh-ancestor
110948892|NCT02264184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110948893|NCT02264184|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110948894|NCT02264184|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110948895|NCT02264184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110948896|NCT02264184|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110948897|NCT02264184|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110948898|NCT02264184|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110948899|NCT02264184|Adrenergic Agents|adrenergic agents|mesh-ancestor
110948900|NCT02264184|Urological Agents|urological agents|mesh-ancestor
110948901|NCT01260870|Paclitaxel|paclitaxel|mesh-list
110948902|NCT01260870|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110948903|NCT01260870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110948904|NCT01260870|Tubulin Modulators|tubulin modulators|mesh-ancestor
110948905|NCT01260870|Antimitotic Agents|antimitotic agents|mesh-ancestor
110948906|NCT01260870|Mitosis Modulators|mitosis modulators|mesh-ancestor
110948907|NCT01260870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110948908|NCT02266056|Rocuronium|rocuronium|mesh-list
110948909|NCT02266056|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110948910|NCT02266056|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110948911|NCT02266056|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110948912|NCT02266056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110948913|NCT02266056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110948914|NCT01482390|Ribavirin|ribavirin|mesh-list
110948915|NCT01482390|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110948916|NCT01482390|Antimetabolites|antimetabolites|mesh-ancestor
110948917|NCT01482390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110948918|NCT01482390|Antiviral Agents|antiviral agents|mesh-ancestor
110948919|NCT01482390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110948920|NCT01478178|Dianhydrogalactitol|dianhydrogalactitol|mesh-list
110024192|NCT00004368|Colchicine|colchicine|mesh-list
110948922|NCT01478178|Alkylating Agents|alkylating agents|mesh-ancestor
110948923|NCT01478178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110948924|NCT01478178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110948925|NCT01366014|Oxycodone|oxycodone|mesh-list
110948926|NCT01366014|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110948927|NCT01366014|Narcotics|narcotics|mesh-ancestor
110948928|NCT01366014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110948929|NCT01366014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110948930|NCT01366014|Analgesics|analgesics|mesh-ancestor
110948931|NCT01366014|Sensory System Agents|sensory system agents|mesh-ancestor
110948932|NCT01366014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110948933|NCT01361802|Ambroxol|ambroxol|mesh-list
110948934|NCT01361802|Expectorants|expectorants|mesh-ancestor
110948935|NCT01361802|Respiratory System Agents|respiratory system agents|mesh-ancestor
110948936|NCT01235754|Methyltestosterone|methyltestosterone|mesh-list
110948937|NCT01235754|Testosterone|testosterone|mesh-list
110948938|NCT01235754|Testosterone undecanoate|testosterone undecanoate|mesh-list
110948939|NCT01235754|Testosterone enanthate|testosterone enanthate|mesh-list
110948940|NCT01235754|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
110660894|NCT00540644|Hormones|hormones|mesh-ancestor
110948941|NCT01235754|Androgens|androgens|mesh-ancestor
110948942|NCT01235754|Hormones|hormones|mesh-ancestor
110948943|NCT01235754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110948944|NCT01235754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110948945|NCT01235754|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110948946|NCT01235754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110948947|NCT01235754|Anabolic Agents|anabolic agents|mesh-ancestor
110948948|NCT01234038|Paclitaxel|paclitaxel|mesh-list
110948949|NCT01234038|Carboplatin|carboplatin|mesh-list
110948950|NCT01234038|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110948951|NCT01234038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110948952|NCT01234038|Tubulin Modulators|tubulin modulators|mesh-ancestor
110948953|NCT01234038|Antimitotic Agents|antimitotic agents|mesh-ancestor
110948954|NCT01234038|Mitosis Modulators|mitosis modulators|mesh-ancestor
110948955|NCT01234038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110948956|NCT01233960|Remestemcel-l|remestemcel-l|mesh-list
110948957|NCT01233960|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110948958|NCT01233960|Antiviral Agents|antiviral agents|mesh-ancestor
110948959|NCT01233960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110948960|NCT01229982|Latanoprost|latanoprost|mesh-list
110948961|NCT01229982|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110948962|NCT01229982|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110948963|NCT01225380|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110948964|NCT01225380|Interferon-alpha|interferon-alpha|mesh-list
110948965|NCT01225380|Ribavirin|ribavirin|mesh-list
110948966|NCT01225380|Antiviral Agents|antiviral agents|mesh-ancestor
110948967|NCT01225380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110948968|NCT01225380|Immunologic Factors|immunologic factors|mesh-ancestor
110948969|NCT01225380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110948970|NCT01225380|Antimetabolites|antimetabolites|mesh-ancestor
110948971|NCT01225380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110948972|NCT01349868|Formoterol Fumarate|formoterol fumarate|mesh-list
110948973|NCT01349868|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110948974|NCT01349868|Autonomic Agents|autonomic agents|mesh-ancestor
110948975|NCT01349868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110948976|NCT01349868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110948977|NCT01349868|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110948978|NCT01349868|Respiratory System Agents|respiratory system agents|mesh-ancestor
110948979|NCT01349868|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110948980|NCT01349868|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110948981|NCT01349868|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110948982|NCT01349868|Adrenergic Agents|adrenergic agents|mesh-ancestor
110948983|NCT01349868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110948984|NCT01349868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110948985|NCT02266524|Tamsulosin|tamsulosin|mesh-list
110948986|NCT02266524|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110948987|NCT02266524|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110948988|NCT02266524|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110948989|NCT02266524|Adrenergic Agents|adrenergic agents|mesh-ancestor
110948990|NCT02266524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110948991|NCT02266524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110948992|NCT02266524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110948993|NCT02266524|Urological Agents|urological agents|mesh-ancestor
110948994|NCT01336686|Colchicine|colchicine|mesh-list
110948996|NCT01336686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110948997|NCT01336686|Tubulin Modulators|tubulin modulators|mesh-ancestor
110948998|NCT01336686|Antimitotic Agents|antimitotic agents|mesh-ancestor
110948999|NCT01336686|Mitosis Modulators|mitosis modulators|mesh-ancestor
110949000|NCT01336686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110949001|NCT01336686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110949002|NCT01455090|Ribavirin|ribavirin|mesh-list
110949003|NCT01455090|Asunaprevir|asunaprevir|mesh-list
110949004|NCT01455090|Antimetabolites|antimetabolites|mesh-ancestor
110949005|NCT01455090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110949006|NCT01455090|Antiviral Agents|antiviral agents|mesh-ancestor
110949007|NCT01455090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110949008|NCT01455090|Protease Inhibitors|protease inhibitors|mesh-ancestor
110949009|NCT01455090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110949010|NCT02056782|Heparin|heparin|mesh-list
110949011|NCT02056782|Anticoagulants|anticoagulants|mesh-ancestor
110949012|NCT02056782|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110949013|NCT02056782|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110949014|NCT02056782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110949015|NCT01198626|Moxifloxacin|moxifloxacin|mesh-list
110660959|NCT00543062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110949016|NCT01198626|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110949017|NCT01198626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110949018|NCT01198626|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110949019|NCT01198626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110949020|NCT01198626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110949021|NCT01198626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110949022|NCT01198626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110949023|NCT01194960|Docetaxel|docetaxel|mesh-list
110949024|NCT01194960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110949025|NCT01194960|Tubulin Modulators|tubulin modulators|mesh-ancestor
110949026|NCT01194960|Antimitotic Agents|antimitotic agents|mesh-ancestor
110949027|NCT01194960|Mitosis Modulators|mitosis modulators|mesh-ancestor
110949028|NCT01194960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110949029|NCT01331850|Ritonavir|ritonavir|mesh-list
110949030|NCT01331850|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110949031|NCT01331850|Interferon-alpha|interferon-alpha|mesh-list
110949032|NCT01331850|Ribavirin|ribavirin|mesh-list
110949033|NCT01331850|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110949034|NCT01331850|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110949035|NCT01331850|Protease Inhibitors|protease inhibitors|mesh-ancestor
110949036|NCT01331850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110949037|NCT01331850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110949038|NCT01331850|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110949039|NCT01331850|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110949040|NCT01331850|Antiviral Agents|antiviral agents|mesh-ancestor
110949041|NCT01331850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110949042|NCT01331850|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110949043|NCT01331850|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110949044|NCT01331850|Immunologic Factors|immunologic factors|mesh-ancestor
110949045|NCT01331850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110949046|NCT01331850|Antimetabolites|antimetabolites|mesh-ancestor
110949047|NCT02101034|Cetuximab|cetuximab|mesh-list
110949048|NCT02101034|Palbociclib|palbociclib|mesh-list
110949049|NCT02101034|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110949050|NCT02101034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110949051|NCT02101034|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110949052|NCT02101034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110949053|NCT02101034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110949054|NCT01328808|Acetaminophen|acetaminophen|mesh-list
110949055|NCT01328808|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110949056|NCT01328808|Analgesics|analgesics|mesh-ancestor
110949057|NCT01328808|Sensory System Agents|sensory system agents|mesh-ancestor
110949058|NCT01328808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110949059|NCT01328808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110949060|NCT01328808|Antipyretics|antipyretics|mesh-ancestor
110949061|NCT01968590|Vitamin D|vitamin d|mesh-list
110949062|NCT01968590|Cholecalciferol|cholecalciferol|mesh-list
110949063|NCT01968590|Vitamins|vitamins|mesh-ancestor
110949064|NCT01968590|Micronutrients|micronutrients|mesh-ancestor
110949065|NCT01968590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110949066|NCT01968590|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110949067|NCT01968590|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110949068|NCT01314222|Pregabalin|pregabalin|mesh-list
110949069|NCT01314222|Analgesics|analgesics|mesh-ancestor
110949070|NCT01314222|Sensory System Agents|sensory system agents|mesh-ancestor
110949071|NCT01314222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110949072|NCT01314222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110949073|NCT01314222|Anticonvulsants|anticonvulsants|mesh-ancestor
110949074|NCT01314222|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110949075|NCT01314222|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110449732|NCT04189198|Sensory System Agents|sensory system agents|mesh-ancestor
110949076|NCT01314222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110949077|NCT01314222|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110949078|NCT01314222|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110949079|NCT01314222|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110949080|NCT01314222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110949081|NCT01314222|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110949082|NCT05222828|Mepivacaine|mepivacaine|mesh-list
110949083|NCT05222828|Anesthetics, Local|anesthetics, local|mesh-ancestor
110949084|NCT05222828|Anesthetics|anesthetics|mesh-ancestor
110949085|NCT05222828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110949086|NCT05222828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110949087|NCT05222828|Sensory System Agents|sensory system agents|mesh-ancestor
110949088|NCT05222828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110949089|NCT01309932|Interferons|interferons|mesh-list
110949090|NCT01309932|Ribavirin|ribavirin|mesh-list
110949091|NCT01309932|Interferon-alpha|interferon-alpha|mesh-list
110949092|NCT01309932|Interferon alpha-2|interferon alpha-2|mesh-list
110949093|NCT01309932|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110949094|NCT01309932|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
110949095|NCT01309932|Protease Inhibitors|protease inhibitors|mesh-list
110949096|NCT01309932|Asunaprevir|asunaprevir|mesh-list
110949097|NCT01309932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110949098|NCT01309932|Antiviral Agents|antiviral agents|mesh-ancestor
110949099|NCT01309932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110949100|NCT01309932|Antimetabolites|antimetabolites|mesh-ancestor
110949101|NCT01309932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110949102|NCT01309932|Immunologic Factors|immunologic factors|mesh-ancestor
110949103|NCT01309932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110949104|NCT01309932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110949105|NCT01309932|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110949106|NCT01309932|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110949107|NCT01309932|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110949108|NCT01733888|Hydrogen Peroxide|hydrogen peroxide|mesh-list
110949109|NCT01733888|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110949110|NCT01733888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110949111|NCT01181622|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110949112|NCT01101594|Doxorubicin|doxorubicin|mesh-list
110949113|NCT01101594|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110949114|NCT01101594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110949115|NCT01101594|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110949116|NCT01101594|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110949117|NCT01101594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110949118|NCT01101594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110949119|NCT02269176|Losartan|losartan|mesh-list
110949120|NCT02269176|Telmisartan|telmisartan|mesh-list
110949121|NCT02269176|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110949122|NCT02269176|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110949123|NCT02269176|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110949124|NCT02269176|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110949125|NCT02269176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110949126|NCT01094262|Oxycodone|oxycodone|mesh-list
110949127|NCT01094262|Analgesics|analgesics|mesh-list
110949128|NCT01094262|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110949129|NCT01094262|Narcotics|narcotics|mesh-ancestor
110949130|NCT01094262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110949131|NCT01094262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110949132|NCT01094262|Sensory System Agents|sensory system agents|mesh-ancestor
110949133|NCT01094262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110949134|NCT04476186|Acyclovir|acyclovir|mesh-list
110949135|NCT04476186|Antiviral Agents|antiviral agents|mesh-ancestor
110949136|NCT04476186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110949137|NCT03440216|Meropenem|meropenem|mesh-list
110949138|NCT03440216|Ceftriaxone|ceftriaxone|mesh-list
110949139|NCT03440216|Temocillin|temocillin|mesh-list
110949140|NCT03440216|Penicillins|penicillins|mesh-list
110949141|NCT03440216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110949142|NCT03440216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110949143|NCT01166412|Levonorgestrel|levonorgestrel|mesh-list
110949144|NCT01166412|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110949145|NCT01166412|Contraceptive Agents|contraceptive agents|mesh-ancestor
110949146|NCT01166412|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110949147|NCT01166412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110949148|NCT01166412|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110449739|NCT00934791|Mycophenolic Acid|mycophenolic acid|mesh-list
110949149|NCT01166412|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110949150|NCT01166412|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110949152|NCT05370716|Analgesics|analgesics|mesh-ancestor
110949153|NCT05370716|Sensory System Agents|sensory system agents|mesh-ancestor
110949154|NCT05370716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110949155|NCT05370716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110949156|NCT05370716|Anticonvulsants|anticonvulsants|mesh-ancestor
110949157|NCT05370716|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110949158|NCT05370716|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110949159|NCT05370716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110949160|NCT05370716|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110949161|NCT05370716|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110949162|NCT05370716|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110949163|NCT05370716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110949164|NCT05370716|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110661128|NCT05408208|Hormones|hormones|mesh-ancestor
110949165|NCT01038804|Docetaxel|docetaxel|mesh-list
110949166|NCT01038804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110949167|NCT01038804|Tubulin Modulators|tubulin modulators|mesh-ancestor
110949168|NCT01038804|Antimitotic Agents|antimitotic agents|mesh-ancestor
110949169|NCT01038804|Mitosis Modulators|mitosis modulators|mesh-ancestor
110949170|NCT01038804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110949171|NCT05118776|Bevacizumab|bevacizumab|mesh-list
110949172|NCT05118776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110949173|NCT05118776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110949174|NCT05118776|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110949175|NCT05118776|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110949176|NCT05118776|Growth Substances|growth substances|mesh-ancestor
110949177|NCT05118776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110949178|NCT05118776|Growth Inhibitors|growth inhibitors|mesh-ancestor
110949179|NCT02269644|Azithromycin|azithromycin|mesh-list
110949180|NCT02269644|Linezolid|linezolid|mesh-list
110949181|NCT02269644|Dalbavancin|dalbavancin|mesh-list
110949182|NCT02269644|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110949183|NCT02269644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110949184|NCT02269644|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110949185|NCT02269644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110949186|NCT02269644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110949187|NCT03367988|Analgesics, Opioid|analgesics, opioid|mesh-list
110949188|NCT03367988|Anesthetics|anesthetics|mesh-list
110949189|NCT03367988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110949190|NCT03367988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110949191|NCT03367988|Narcotics|narcotics|mesh-ancestor
110949192|NCT03367988|Analgesics|analgesics|mesh-ancestor
110949193|NCT03367988|Sensory System Agents|sensory system agents|mesh-ancestor
110949194|NCT03367988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110949195|NCT03465488|Albendazole|albendazole|mesh-list
110949196|NCT03465488|Anthelmintics|anthelmintics|mesh-ancestor
110949197|NCT03465488|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110949198|NCT03465488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110949199|NCT03465488|Anticestodal Agents|anticestodal agents|mesh-ancestor
110949200|NCT03465488|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110949201|NCT03465488|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110949202|NCT03465488|Tubulin Modulators|tubulin modulators|mesh-ancestor
110949203|NCT03465488|Antimitotic Agents|antimitotic agents|mesh-ancestor
110949204|NCT03465488|Mitosis Modulators|mitosis modulators|mesh-ancestor
110949205|NCT03465488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110949206|NCT03465488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110949207|NCT02267304|Morphine|morphine|mesh-list
110949208|NCT02267304|Naloxone|naloxone|mesh-list
110949209|NCT02267304|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110949210|NCT02267304|Narcotics|narcotics|mesh-ancestor
110949211|NCT02267304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110949212|NCT02267304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110949213|NCT02267304|Analgesics|analgesics|mesh-ancestor
110949214|NCT02267304|Sensory System Agents|sensory system agents|mesh-ancestor
110949215|NCT02267304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110949216|NCT02267304|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110949217|NCT03465410|Tacrolimus|tacrolimus|mesh-list
110949218|NCT03465410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110949219|NCT03465410|Immunologic Factors|immunologic factors|mesh-ancestor
110949220|NCT03465410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110949221|NCT03465410|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110949222|NCT03465410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110449741|NCT00934791|Prednisone|prednisone|mesh-list
110449742|NCT00934791|Tacrolimus|tacrolimus|mesh-list
110949223|NCT03465410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110949224|NCT02522234|Lenograstim|lenograstim|mesh-list
110949225|NCT02522234|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110949226|NCT02522234|Immunologic Factors|immunologic factors|mesh-ancestor
110949227|NCT02522234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110949228|NCT00154284|Cyclosporine|cyclosporine|mesh-list
110949229|NCT00154284|Prednisone|prednisone|mesh-list
110949230|NCT00154284|Everolimus|everolimus|mesh-list
110949231|NCT00154284|Cyclosporins|cyclosporins|mesh-list
110949232|NCT00154284|Basiliximab|basiliximab|mesh-list
110949233|NCT00154284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110949234|NCT00154284|Glucocorticoids|glucocorticoids|mesh-ancestor
110949235|NCT00154284|Hormones|hormones|mesh-ancestor
110949236|NCT00154284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110949237|NCT00154284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110949238|NCT00154284|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110949239|NCT00154284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110949240|NCT00154284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110949241|NCT00154284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110949242|NCT00154284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110949243|NCT00154284|Immunologic Factors|immunologic factors|mesh-ancestor
110949244|NCT00154284|Antifungal Agents|antifungal agents|mesh-ancestor
110661260|NCT05711810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110949245|NCT00154284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110949246|NCT00154284|Dermatologic Agents|dermatologic agents|mesh-ancestor
110949247|NCT00154284|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110949248|NCT00154284|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110949249|NCT00154284|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110949250|NCT00154284|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110949251|NCT04973306|Tislelizumab|tislelizumab|mesh-list
110949252|NCT04973306|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110949253|NCT04973306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110949254|NCT01037166|Entecavir|entecavir|mesh-list
110949255|NCT01037166|Antiviral Agents|antiviral agents|mesh-ancestor
110949256|NCT01037166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110949257|NCT04491032|Anesthetics|anesthetics|mesh-list
110949258|NCT04491032|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110949259|NCT04491032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110949260|NCT02269800|Benzalkonium Compounds|benzalkonium compounds|mesh-list
110949261|NCT02269800|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110949262|NCT02269800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110949263|NCT04487756|Carboplatin|carboplatin|mesh-list
110949264|NCT04487756|Atezolizumab|atezolizumab|mesh-list
110949265|NCT04487756|Vaccines|vaccines|mesh-list
110949266|NCT04487756|Immunologic Factors|immunologic factors|mesh-ancestor
110949267|NCT04487756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110949268|NCT04487756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110949269|NCT04487756|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110949270|NCT04487756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110949271|NCT04487756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110949272|NCT01281462|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
110949273|NCT01281462|Cephalosporins|cephalosporins|mesh-list
110949274|NCT01281462|Avibactam|avibactam|mesh-list
110949275|NCT01281462|Doripenem|doripenem|mesh-list
110949276|NCT01281462|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110949277|NCT01281462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110949278|NCT01281462|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110949279|NCT01281462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110949280|NCT01281462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110949281|NCT04453124|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
110949282|NCT04453124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110949283|NCT01024062|Paclitaxel|paclitaxel|mesh-list
110949284|NCT01024062|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110949285|NCT01024062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110949286|NCT01024062|Tubulin Modulators|tubulin modulators|mesh-ancestor
110949287|NCT01024062|Antimitotic Agents|antimitotic agents|mesh-ancestor
110949288|NCT01024062|Mitosis Modulators|mitosis modulators|mesh-ancestor
110949289|NCT01024062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110949290|NCT04453436|Tenofovir|tenofovir|mesh-list
110949291|NCT04453436|Lamivudine|lamivudine|mesh-list
110949292|NCT04453436|Dolutegravir|dolutegravir|mesh-list
110949293|NCT04453436|Antiviral Agents|antiviral agents|mesh-ancestor
110949294|NCT04453436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110949295|NCT04453436|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110949296|NCT04453436|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110949297|NCT04453436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110949298|NCT04453436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110949299|NCT04453436|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110949300|NCT04453436|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110949301|NCT04453436|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110949302|NCT04453436|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110949303|NCT02267616|Etonogestrel|etonogestrel|mesh-list
110949304|NCT02267616|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110949305|NCT02267616|Contraceptive Agents|contraceptive agents|mesh-ancestor
110949306|NCT02267616|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110949307|NCT02267616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110949308|NCT02267616|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110949309|NCT05232734|Caffeine|caffeine|mesh-list
110949310|NCT05232734|Caffeine citrate|caffeine citrate|mesh-list
110949311|NCT05232734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110949312|NCT05232734|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110949313|NCT05232734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110949314|NCT05232734|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110949315|NCT05232734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110949316|NCT05232734|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110949317|NCT05232734|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110949318|NCT05232734|Purinergic Agents|purinergic agents|mesh-ancestor
110949319|NCT05232734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110949320|NCT03465098|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110949321|NCT03465098|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110949322|NCT03465098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110949324|NCT01023204|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110949325|NCT01023204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110949326|NCT01023204|Tubulin Modulators|tubulin modulators|mesh-ancestor
110949327|NCT01023204|Antimitotic Agents|antimitotic agents|mesh-ancestor
110949328|NCT01023204|Mitosis Modulators|mitosis modulators|mesh-ancestor
110949329|NCT01023204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110949330|NCT04460456|Pembrolizumab|pembrolizumab|mesh-list
110949331|NCT04460456|Cemiplimab|cemiplimab|mesh-list
110949332|NCT04460456|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110949333|NCT04460456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110949334|NCT04460456|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110949335|NCT04460456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110949336|NCT02268006|Capecitabine|capecitabine|mesh-list
110949337|NCT02268006|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110949338|NCT02268006|Antimetabolites|antimetabolites|mesh-ancestor
110949339|NCT02268006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110949340|NCT02268006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110949341|NCT03462212|Paclitaxel|paclitaxel|mesh-list
110949342|NCT03462212|Bevacizumab|bevacizumab|mesh-list
110949343|NCT03462212|Carboplatin|carboplatin|mesh-list
110949344|NCT03462212|Rucaparib|rucaparib|mesh-list
110949345|NCT03462212|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110949346|NCT03462212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110949347|NCT03462212|Tubulin Modulators|tubulin modulators|mesh-ancestor
110949348|NCT03462212|Antimitotic Agents|antimitotic agents|mesh-ancestor
110949349|NCT03462212|Mitosis Modulators|mitosis modulators|mesh-ancestor
110949350|NCT03462212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110949351|NCT03462212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110949352|NCT03462212|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110949353|NCT03462212|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110949354|NCT03462212|Growth Substances|growth substances|mesh-ancestor
110949355|NCT03462212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110949356|NCT03462212|Growth Inhibitors|growth inhibitors|mesh-ancestor
110949357|NCT03462212|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110949358|NCT03462212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110949359|NCT01016808|Morphine|morphine|mesh-list
110949360|NCT01016808|Oxycodone|oxycodone|mesh-list
110949361|NCT01016808|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110949362|NCT01016808|Narcotics|narcotics|mesh-ancestor
110949363|NCT01016808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110949364|NCT01016808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110949365|NCT01016808|Analgesics|analgesics|mesh-ancestor
110949366|NCT01016808|Sensory System Agents|sensory system agents|mesh-ancestor
110949367|NCT01016808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110949368|NCT01014078|Azithromycin|azithromycin|mesh-list
110949369|NCT01014078|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110949370|NCT01014078|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110949371|NCT01014078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110949372|NCT01014078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110949374|NCT02522078|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110949375|NCT02522078|Abortifacient Agents|abortifacient agents|mesh-ancestor
110949376|NCT02522078|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110949377|NCT02522078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110949378|NCT02522078|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110949379|NCT02522078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110949380|NCT02522078|Oxytocics|oxytocics|mesh-ancestor
110949381|NCT00911274|Mycophenolic Acid|mycophenolic acid|mesh-list
110949382|NCT00911274|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110949383|NCT00911274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110949384|NCT00911274|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110949385|NCT00911274|Antitubercular Agents|antitubercular agents|mesh-ancestor
110949386|NCT00911274|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110949387|NCT00911274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110949388|NCT00911274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110949389|NCT00911274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110949390|NCT03468296|Aflibercept|aflibercept|mesh-list
110949391|NCT03468296|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110949392|NCT03468296|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110661333|NCT03902574|Brexpiprazole|brexpiprazole|mesh-list
110949393|NCT03468296|Growth Substances|growth substances|mesh-ancestor
110949394|NCT03468296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110949395|NCT03468296|Growth Inhibitors|growth inhibitors|mesh-ancestor
110949396|NCT03468296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110949397|NCT01130142|Gemcitabine|gemcitabine|mesh-list
110949398|NCT01130142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110949399|NCT01130142|Antimetabolites|antimetabolites|mesh-ancestor
110949400|NCT01130142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110949401|NCT01130142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110949402|NCT03464864|Treprostinil|treprostinil|mesh-list
110949403|NCT03464864|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110949404|NCT03468140|Eculizumab|eculizumab|mesh-list
110949405|NCT03468140|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
110949406|NCT03468140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110949407|NCT03468140|Immunologic Factors|immunologic factors|mesh-ancestor
110949408|NCT03468140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110949409|NCT01009242|Methotrexate|methotrexate|mesh-list
110949410|NCT01009242|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110949411|NCT01009242|Abortifacient Agents|abortifacient agents|mesh-ancestor
110949412|NCT01009242|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110949413|NCT01009242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110949414|NCT01009242|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110949415|NCT01009242|Antimetabolites|antimetabolites|mesh-ancestor
110949416|NCT01009242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110949417|NCT01009242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110949418|NCT01009242|Dermatologic Agents|dermatologic agents|mesh-ancestor
110949419|NCT01009242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110949420|NCT01009242|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110949421|NCT01009242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110949422|NCT01009242|Immunologic Factors|immunologic factors|mesh-ancestor
110949423|NCT01009242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110949424|NCT01009242|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110949425|NCT03468062|Dexmedetomidine|dexmedetomidine|mesh-list
110949426|NCT03468062|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110949427|NCT03468062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110949428|NCT03468062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110949429|NCT03468062|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110949430|NCT03468062|Analgesics|analgesics|mesh-ancestor
110949431|NCT03468062|Sensory System Agents|sensory system agents|mesh-ancestor
110949432|NCT03468062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110949433|NCT03468062|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110949434|NCT03468062|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110949435|NCT03468062|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110949436|NCT03468062|Adrenergic Agents|adrenergic agents|mesh-ancestor
110949437|NCT03468062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110949438|NCT03468062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110949439|NCT03464552|Celecoxib|celecoxib|mesh-list
110949440|NCT03464552|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110949441|NCT03464552|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110949442|NCT03464552|Analgesics|analgesics|mesh-ancestor
110949443|NCT03464552|Sensory System Agents|sensory system agents|mesh-ancestor
110949444|NCT03464552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110938519|NCT05388188|Sufentanil|sufentanil|mesh-list
110949445|NCT03464552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110949446|NCT03464552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110949447|NCT03464552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110949448|NCT03464552|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110949449|NCT03464552|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110949450|NCT03464552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110949451|NCT03464552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110949452|NCT05628558|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
110949453|NCT05628558|Hemostatics|hemostatics|mesh-ancestor
110949454|NCT05628558|Coagulants|coagulants|mesh-ancestor
110949455|NCT05628558|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
110949456|NCT05628558|Natriuretic Agents|natriuretic agents|mesh-ancestor
110949457|NCT05628558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110949458|NCT01007292|Rituximab|rituximab|mesh-list
110949459|NCT01007292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110949460|NCT01007292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110949461|NCT01007292|Immunologic Factors|immunologic factors|mesh-ancestor
110949462|NCT01007292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110949463|NCT01007292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110949464|NCT03467984|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110949465|NCT03467984|Immunologic Factors|immunologic factors|mesh-ancestor
110949466|NCT03467984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110949467|NCT01005108|Gabapentin|gabapentin|mesh-list
110949468|NCT01005108|Analgesics|analgesics|mesh-ancestor
110949469|NCT01005108|Sensory System Agents|sensory system agents|mesh-ancestor
110949470|NCT01005108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110949471|NCT01005108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110949472|NCT01005108|Anticonvulsants|anticonvulsants|mesh-ancestor
110949473|NCT01005108|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110949474|NCT01005108|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110949475|NCT01005108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110949476|NCT01005108|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110949477|NCT01005108|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110949478|NCT01005108|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110949479|NCT01005108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110949480|NCT01005108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110949481|NCT01005108|Antimanic Agents|antimanic agents|mesh-ancestor
110949482|NCT00905346|Topiramate|topiramate|mesh-list
110949483|NCT00905346|Anticonvulsants|anticonvulsants|mesh-ancestor
110949484|NCT00905346|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110949485|NCT00905346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110949486|NCT00902928|Enoxaparin|enoxaparin|mesh-list
110949487|NCT00902928|Anticoagulants|anticoagulants|mesh-ancestor
110949488|NCT00902928|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110949489|NCT00902928|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110949490|NCT00902928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110949491|NCT01129674|Olanzapine|olanzapine|mesh-list
110949492|NCT01129674|Risperidone|risperidone|mesh-list
110949493|NCT01129674|Aripiprazole|aripiprazole|mesh-list
110949494|NCT01129674|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110949495|NCT01129674|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110949496|NCT01129674|Serotonin Agents|serotonin agents|mesh-ancestor
110949497|NCT01129674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110949498|NCT01129674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110949499|NCT01129674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110949500|NCT01129674|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110949501|NCT01129674|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110949502|NCT01129674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110949503|NCT01129674|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110949504|NCT01129674|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110949505|NCT01129674|Dopamine Agents|dopamine agents|mesh-ancestor
110949506|NCT01129674|Antiemetics|antiemetics|mesh-ancestor
110949507|NCT01129674|Autonomic Agents|autonomic agents|mesh-ancestor
110949508|NCT01129674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110949509|NCT01129674|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110949510|NCT01129674|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110949511|NCT01129674|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110949512|NCT01129674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110949513|NCT01129674|Antidepressive Agents|antidepressive agents|mesh-ancestor
110949514|NCT01129674|Dopamine Agonists|dopamine agonists|mesh-ancestor
110949515|NCT01129674|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110949516|NCT01129674|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110949517|NCT01129674|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110949518|NCT01129674|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110949519|NCT05045378|Midazolam|midazolam|mesh-list
110949520|NCT05045378|Ketamine|ketamine|mesh-list
110949521|NCT05045378|Analgesics|analgesics|mesh-ancestor
110949522|NCT05045378|Sensory System Agents|sensory system agents|mesh-ancestor
110949523|NCT05045378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110949524|NCT05045378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110949525|NCT05045378|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110949526|NCT05045378|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110949527|NCT05045378|Anesthetics, General|anesthetics, general|mesh-ancestor
110949528|NCT05045378|Anesthetics|anesthetics|mesh-ancestor
110949529|NCT05045378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110949530|NCT05045378|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110949531|NCT05045378|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110949532|NCT05045378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110949533|NCT05045378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110949534|NCT05045378|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110949535|NCT05045378|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110949536|NCT05045378|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110949537|NCT05045378|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110949538|NCT05045378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110949539|NCT05045378|GABA Modulators|gaba modulators|mesh-ancestor
110949540|NCT05045378|GABA Agents|gaba agents|mesh-ancestor
110949541|NCT05209152|Azacitidine|azacitidine|mesh-list
110949542|NCT05209152|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110949543|NCT05209152|Antimetabolites|antimetabolites|mesh-ancestor
110949544|NCT05209152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110949545|NCT05209152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110949546|NCT05209152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110949547|NCT03460964|Pilocarpine|pilocarpine|mesh-list
110949548|NCT03460964|Miotics|miotics|mesh-ancestor
110949549|NCT03460964|Autonomic Agents|autonomic agents|mesh-ancestor
110949550|NCT03460964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110949551|NCT03460964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110949552|NCT03460964|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
110949553|NCT03460964|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110949554|NCT03460964|Cholinergic Agents|cholinergic agents|mesh-ancestor
110949555|NCT03460964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110949556|NCT03460964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110949557|NCT03460808|Acetylcysteine|acetylcysteine|mesh-list
110949558|NCT03460808|Atorvastatin|atorvastatin|mesh-list
110949559|NCT03460808|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110949560|NCT03460808|Danazol|danazol|mesh-list
110449777|NCT02722954|Pembrolizumab|pembrolizumab|mesh-list
110949561|NCT03460808|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110949562|NCT03460808|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110949563|NCT03460808|Antimetabolites|antimetabolites|mesh-ancestor
110949564|NCT03460808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110949565|NCT03460808|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110949566|NCT03460808|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110949567|NCT03460808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110949568|NCT03460808|Antiviral Agents|antiviral agents|mesh-ancestor
110949569|NCT03460808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110949570|NCT03460808|Expectorants|expectorants|mesh-ancestor
110949571|NCT03460808|Respiratory System Agents|respiratory system agents|mesh-ancestor
110949572|NCT03460808|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110949573|NCT03460808|Antioxidants|antioxidants|mesh-ancestor
110949574|NCT03460808|Protective Agents|protective agents|mesh-ancestor
110949575|NCT03460808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110949576|NCT03460808|Antidotes|antidotes|mesh-ancestor
110949577|NCT03460808|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110949578|NCT03460808|Hormone Antagonists|hormone antagonists|mesh-ancestor
110949579|NCT03460808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110949580|NCT04946630|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
110949581|NCT04946630|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110949582|NCT04946630|Autonomic Agents|autonomic agents|mesh-ancestor
110949583|NCT04946630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110949584|NCT04946630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110949585|NCT04946630|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110949586|NCT04946630|Respiratory System Agents|respiratory system agents|mesh-ancestor
110949587|NCT04946630|Glucocorticoids|glucocorticoids|mesh-ancestor
110949588|NCT04946630|Hormones|hormones|mesh-ancestor
110949589|NCT04946630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110949590|NCT04946630|Sympathomimetics|sympathomimetics|mesh-ancestor
110949591|NCT00900900|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
110949592|NCT00900900|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110949593|NCT00900900|Immunologic Factors|immunologic factors|mesh-ancestor
110949594|NCT00900900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110949595|NCT03460730|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110949596|NCT03460730|Immunologic Factors|immunologic factors|mesh-ancestor
110949597|NCT03460730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110949598|NCT05627778|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
110949599|NCT05627778|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110949600|NCT05627778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110949601|NCT01120470|Prednisone|prednisone|mesh-list
110949602|NCT01120470|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110949603|NCT01120470|Glucocorticoids|glucocorticoids|mesh-ancestor
110949604|NCT01120470|Hormones|hormones|mesh-ancestor
110949605|NCT01120470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110949606|NCT01120470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110949607|NCT01120470|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110949608|NCT01120470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110949609|NCT01117584|Metformin|metformin|mesh-list
110949610|NCT01117584|Ipragliflozin|ipragliflozin|mesh-list
110949611|NCT01117584|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110949612|NCT01117584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110949613|NCT01117584|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110949614|NCT01117584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110949615|NCT03135054|Homoharringtonine|homoharringtonine|mesh-list
110949616|NCT03135054|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110949617|NCT03135054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110949618|NCT03135054|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110949619|NCT03135054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110949620|NCT03135054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110949621|NCT00991068|Lidocaine|lidocaine|mesh-list
110949622|NCT00991068|Tetracaine|tetracaine|mesh-list
110949623|NCT00991068|Anesthetics, Local|anesthetics, local|mesh-ancestor
110949624|NCT00991068|Anesthetics|anesthetics|mesh-ancestor
110949625|NCT00991068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110949626|NCT00991068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110949627|NCT00991068|Sensory System Agents|sensory system agents|mesh-ancestor
110949628|NCT00991068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110949629|NCT00991068|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110949630|NCT00991068|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110949631|NCT00991068|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110949632|NCT00991068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110949633|NCT00991068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110949634|NCT01114698|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
110949635|NCT01114698|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110949636|NCT01114698|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110949637|NCT01114698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110949638|NCT01114698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110949639|NCT01114698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110949640|NCT01114698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110949641|NCT01114698|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110949642|NCT01114698|Antidepressive Agents|antidepressive agents|mesh-ancestor
110949643|NCT01114698|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110949644|NCT01114308|Buprenorphine|buprenorphine|mesh-list
110949645|NCT01114308|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110949646|NCT01114308|Narcotics|narcotics|mesh-ancestor
110949647|NCT01114308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110949648|NCT01114308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110949649|NCT01114308|Analgesics|analgesics|mesh-ancestor
110949650|NCT01114308|Sensory System Agents|sensory system agents|mesh-ancestor
110949651|NCT01114308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110949652|NCT01114308|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110949653|NCT05469126|Clarithromycin|clarithromycin|mesh-list
110949654|NCT05469126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110949655|NCT05469126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110949656|NCT05469126|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110949657|NCT05469126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110949658|NCT05469126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110949659|NCT05469126|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110949660|NCT05469126|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110949661|NCT00887250|Losartan|losartan|mesh-list
110949662|NCT00887250|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110949663|NCT00887250|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110949664|NCT00887250|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110949665|NCT00887250|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110949666|NCT00887250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110949667|NCT00990912|Carboplatin|carboplatin|mesh-list
110949668|NCT00990912|Irinotecan|irinotecan|mesh-list
110949669|NCT00990912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110949670|NCT00990912|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110949671|NCT00990912|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110949672|NCT00990912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110949673|NCT00990912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110949674|NCT00973284|Mannitol|mannitol|mesh-list
110949675|NCT00973284|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110949676|NCT00973284|Diuretics|diuretics|mesh-ancestor
110949677|NCT00973284|Natriuretic Agents|natriuretic agents|mesh-ancestor
110949678|NCT00973284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110949679|NCT02599402|Nivolumab|nivolumab|mesh-list
110949680|NCT02599402|Ipilimumab|ipilimumab|mesh-list
110949681|NCT02599402|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110949682|NCT02599402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110949683|NCT02599402|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110949684|NCT02599402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110949685|NCT00879762|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
110661635|NCT01580878|Hormone Antagonists|hormone antagonists|mesh-ancestor
110949686|NCT00879762|Antiviral Agents|antiviral agents|mesh-ancestor
110949687|NCT00879762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110949688|NCT04768166|Miglustat|miglustat|mesh-list
110949689|NCT04768166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110949690|NCT04768166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110949691|NCT04768166|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110949692|NCT04768166|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110949693|NCT04768166|Antiviral Agents|antiviral agents|mesh-ancestor
110949694|NCT04768166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110949695|NCT04768166|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
110949696|NCT04768166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110949697|NCT04768166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110949698|NCT04822090|Immunoglobulins|immunoglobulins|mesh-list
110949699|NCT04822090|Antibodies|antibodies|mesh-list
110949700|NCT04822090|gamma-Globulins|gamma-globulins|mesh-list
110949701|NCT04822090|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110949702|NCT04822090|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110949703|NCT04822090|Immunologic Factors|immunologic factors|mesh-ancestor
110949704|NCT04822090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110949705|NCT03463382|Bupivacaine|bupivacaine|mesh-list
110949706|NCT03463382|Anesthetics, Local|anesthetics, local|mesh-ancestor
110949707|NCT03463382|Anesthetics|anesthetics|mesh-ancestor
110949708|NCT03463382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110949709|NCT03463382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110949710|NCT03463382|Sensory System Agents|sensory system agents|mesh-ancestor
110949711|NCT03463382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110949712|NCT05618236|Atropine|atropine|mesh-list
110949713|NCT05618236|Neostigmine|neostigmine|mesh-list
110949714|NCT05618236|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110949715|NCT05618236|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110949716|NCT05618236|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110949717|NCT05618236|Autonomic Agents|autonomic agents|mesh-ancestor
110949718|NCT05618236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110949719|NCT05618236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110949720|NCT05618236|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110949721|NCT05618236|Respiratory System Agents|respiratory system agents|mesh-ancestor
110949722|NCT05618236|Mydriatics|mydriatics|mesh-ancestor
110949723|NCT05618236|Parasympatholytics|parasympatholytics|mesh-ancestor
110949724|NCT05618236|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110949725|NCT05618236|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110949726|NCT05618236|Cholinergic Agents|cholinergic agents|mesh-ancestor
110949727|NCT05618236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110949728|NCT05618236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110949729|NCT05618236|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110949730|NCT05618236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110949731|NCT05618236|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110949732|NCT00872430|Laxatives|laxatives|mesh-list
110949733|NCT00872430|Cathartics|cathartics|mesh-list
110949734|NCT00872430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110949735|NCT00871182|Tiotropium Bromide|tiotropium bromide|mesh-list
110949736|NCT00871182|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110949737|NCT00871182|Autonomic Agents|autonomic agents|mesh-ancestor
110949738|NCT00871182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110949739|NCT00871182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110949740|NCT00871182|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110949742|NCT00871182|Parasympatholytics|parasympatholytics|mesh-ancestor
110949743|NCT00871182|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110949744|NCT00871182|Cholinergic Agents|cholinergic agents|mesh-ancestor
110949745|NCT00871182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110949746|NCT00871182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110949747|NCT04814056|Afatinib|afatinib|mesh-list
110949748|NCT04814056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110949749|NCT04814056|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110949750|NCT04814056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110949751|NCT04814056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110949752|NCT05627154|Citalopram|citalopram|mesh-list
110949753|NCT05627154|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110949754|NCT05627154|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110949755|NCT05627154|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110949756|NCT05627154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110949757|NCT05627154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110949758|NCT05627154|Serotonin Agents|serotonin agents|mesh-ancestor
110949759|NCT05627154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110949760|NCT05627154|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110949761|NCT05627154|Antidepressive Agents|antidepressive agents|mesh-ancestor
110949762|NCT05627154|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110949763|NCT03974854|Gemcitabine|gemcitabine|mesh-list
110949764|NCT03974854|Capecitabine|capecitabine|mesh-list
110949765|NCT03974854|Irinotecan|irinotecan|mesh-list
110949766|NCT03974854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110949767|NCT03974854|Antimetabolites|antimetabolites|mesh-ancestor
110949768|NCT03974854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110949769|NCT03974854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110949770|NCT03974854|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110949771|NCT03974854|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110949772|NCT03974854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110949773|NCT00957918|Nicotine|nicotine|mesh-list
110949774|NCT00957918|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110949775|NCT00957918|Autonomic Agents|autonomic agents|mesh-ancestor
110949776|NCT00957918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110949777|NCT00957918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110949778|NCT00957918|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110949779|NCT00957918|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110949780|NCT00957918|Cholinergic Agents|cholinergic agents|mesh-ancestor
110949781|NCT00957918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110949782|NCT00957918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110949783|NCT02734862|Fluconazole|fluconazole|mesh-list
110949784|NCT02734862|Caspofungin|caspofungin|mesh-list
110949785|NCT02734862|Rezafungin|rezafungin|mesh-list
110949786|NCT02734862|Antifungal Agents|antifungal agents|mesh-ancestor
110949787|NCT02734862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110949788|NCT02734862|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110949789|NCT02734862|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110949790|NCT02734862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110949791|NCT02734862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110949792|NCT02734862|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110949793|NCT02734862|Hormone Antagonists|hormone antagonists|mesh-ancestor
110949794|NCT02734862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110949795|NCT02734862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110949796|NCT02734862|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110949797|NCT02734862|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110949798|NCT00818844|Nepafenac|nepafenac|mesh-list
110949799|NCT00818844|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110949800|NCT00818844|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110949801|NCT00818844|Analgesics|analgesics|mesh-ancestor
110949802|NCT00818844|Sensory System Agents|sensory system agents|mesh-ancestor
110949803|NCT00818844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110949804|NCT00818844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110949805|NCT00818844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110949806|NCT00818844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110949807|NCT00862524|Gemcitabine|gemcitabine|mesh-list
110949808|NCT00862524|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110949809|NCT00862524|Antimetabolites|antimetabolites|mesh-ancestor
110949810|NCT00862524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110949811|NCT00862524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110949812|NCT00858702|Olmesartan|olmesartan|mesh-list
110949814|NCT00858702|Diuretics|diuretics|mesh-list
110949815|NCT00858702|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110949816|NCT00858702|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110949817|NCT00858702|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110949818|NCT00858702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110949819|NCT00858702|Natriuretic Agents|natriuretic agents|mesh-ancestor
110949820|NCT00858702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110949821|NCT00817986|Arbaclofen placarbil|arbaclofen placarbil|mesh-list
110949822|NCT00817986|Baclofen|baclofen|mesh-list
110949823|NCT00817986|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110949824|NCT00817986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110949825|NCT00817986|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110949826|NCT00817986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110949827|NCT00817986|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
110949828|NCT00817986|GABA Agonists|gaba agonists|mesh-ancestor
110949829|NCT00817986|GABA Agents|gaba agents|mesh-ancestor
110949830|NCT00817986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110949831|NCT00817986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110949832|NCT02598934|Ibandronic Acid|ibandronic acid|mesh-list
110949833|NCT02598934|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110949834|NCT02598934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110949835|NCT00817362|Trastuzumab|trastuzumab|mesh-list
110949836|NCT00817362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110949837|NCT00817362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110949838|NCT04176848|Durvalumab|durvalumab|mesh-list
110949839|NCT04176848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110949840|NCT04176848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110949841|NCT04163978|Budesonide|budesonide|mesh-list
110949842|NCT04163978|Nitric Oxide|nitric oxide|mesh-list
110949843|NCT04163978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110949844|NCT04163978|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110949845|NCT04163978|Autonomic Agents|autonomic agents|mesh-ancestor
110949846|NCT04163978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110949847|NCT04163978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110949848|NCT04163978|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110949849|NCT04163978|Respiratory System Agents|respiratory system agents|mesh-ancestor
110949850|NCT04163978|Glucocorticoids|glucocorticoids|mesh-ancestor
110949851|NCT04163978|Hormones|hormones|mesh-ancestor
110949852|NCT04163978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110949853|NCT04163978|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110949854|NCT04163978|Antioxidants|antioxidants|mesh-ancestor
110949855|NCT04163978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110949856|NCT04163978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110949857|NCT04163978|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
110949858|NCT04163978|Vasodilator Agents|vasodilator agents|mesh-ancestor
110949859|NCT04163978|Gasotransmitters|gasotransmitters|mesh-ancestor
110949860|NCT04163978|Protective Agents|protective agents|mesh-ancestor
110949861|NCT02598622|Acetylcarnitine|acetylcarnitine|mesh-list
110949862|NCT02598622|Vitamin B Complex|vitamin b complex|mesh-ancestor
110949863|NCT02598622|Vitamins|vitamins|mesh-ancestor
110949864|NCT02598622|Micronutrients|micronutrients|mesh-ancestor
110949865|NCT02598622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110949866|NCT02598622|Nootropic Agents|nootropic agents|mesh-ancestor
110949867|NCT03463070|Misoprostol|misoprostol|mesh-list
110949868|NCT03463070|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110949869|NCT03463070|Abortifacient Agents|abortifacient agents|mesh-ancestor
110949870|NCT03463070|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110949871|NCT03463070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110949872|NCT03463070|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110949873|NCT03463070|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110949874|NCT03463070|Oxytocics|oxytocics|mesh-ancestor
110949875|NCT00807612|Paclitaxel|paclitaxel|mesh-list
110949876|NCT00807612|Carboplatin|carboplatin|mesh-list
110949877|NCT00807612|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110949878|NCT00807612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110949879|NCT00807612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110949880|NCT00807612|Tubulin Modulators|tubulin modulators|mesh-ancestor
110949881|NCT00807612|Antimitotic Agents|antimitotic agents|mesh-ancestor
110949882|NCT00807612|Mitosis Modulators|mitosis modulators|mesh-ancestor
110949883|NCT00807612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110949884|NCT00807612|Immunologic Factors|immunologic factors|mesh-ancestor
110949885|NCT00807612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110949886|NCT00805350|SR 46349B|sr 46349b|mesh-list
110949887|NCT00805350|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110949889|NCT00805350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110949890|NCT00805350|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110949891|NCT00805350|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110949892|NCT00805350|Serotonin Agents|serotonin agents|mesh-ancestor
110949893|NCT00805350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110949894|NCT00805350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110949895|NCT03462836|Lidocaine|lidocaine|mesh-list
110949896|NCT03462836|Ketamine|ketamine|mesh-list
110949897|NCT03462836|Anesthetics, Local|anesthetics, local|mesh-ancestor
110949898|NCT03462836|Anesthetics|anesthetics|mesh-ancestor
110949899|NCT03462836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110949900|NCT03462836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110949901|NCT03462836|Sensory System Agents|sensory system agents|mesh-ancestor
110949902|NCT03462836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110949903|NCT03462836|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110949904|NCT03462836|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110949905|NCT03462836|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110949906|NCT03462836|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110949907|NCT03462836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110949908|NCT03462836|Analgesics|analgesics|mesh-ancestor
110949909|NCT03462836|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110309076|NCT00274820|Ascorbic Acid|ascorbic acid|mesh-list
110949910|NCT03462836|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110949911|NCT03462836|Anesthetics, General|anesthetics, general|mesh-ancestor
110949912|NCT03462836|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110949913|NCT03462836|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110949914|NCT03462836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110949915|NCT00849576|Insulin|insulin|mesh-list
110949916|NCT00849576|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110949917|NCT00849576|Insulin Lispro|insulin lispro|mesh-list
110949918|NCT00849576|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110949919|NCT00849576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110949920|NCT00841698|Paroxetine|paroxetine|mesh-list
110949921|NCT00841698|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110949922|NCT00841698|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110949923|NCT00841698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110949924|NCT00841698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110949925|NCT00841698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110949926|NCT00841698|Serotonin Agents|serotonin agents|mesh-ancestor
110949927|NCT00841698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110949928|NCT00841698|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110949929|NCT00841698|Antidepressive Agents|antidepressive agents|mesh-ancestor
110949930|NCT00841698|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110949931|NCT00841698|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110949932|NCT00841698|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110949933|NCT00841698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110949934|NCT04383002|Nitric Oxide|nitric oxide|mesh-list
110949935|NCT04383002|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110949936|NCT04383002|Autonomic Agents|autonomic agents|mesh-ancestor
110949937|NCT04383002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110949938|NCT04383002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110949939|NCT04383002|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110949940|NCT04383002|Respiratory System Agents|respiratory system agents|mesh-ancestor
110949941|NCT04383002|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110949942|NCT04383002|Antioxidants|antioxidants|mesh-ancestor
110949943|NCT04383002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110949944|NCT04383002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110949945|NCT04383002|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
110949946|NCT04383002|Vasodilator Agents|vasodilator agents|mesh-ancestor
110949947|NCT04383002|Gasotransmitters|gasotransmitters|mesh-ancestor
110949948|NCT04383002|Protective Agents|protective agents|mesh-ancestor
110949949|NCT00841542|Amlodipine|amlodipine|mesh-list
110949950|NCT00841542|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110949951|NCT00841542|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110949952|NCT00841542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110949953|NCT00841542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110949954|NCT00841542|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110949955|NCT00841542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110949956|NCT00841542|Vasodilator Agents|vasodilator agents|mesh-ancestor
110949957|NCT03623750|Cyclophosphamide|cyclophosphamide|mesh-list
110949958|NCT03623750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110949959|NCT03623750|Immunologic Factors|immunologic factors|mesh-ancestor
110949960|NCT03623750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110949961|NCT03623750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110949962|NCT03623750|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110949963|NCT03623750|Alkylating Agents|alkylating agents|mesh-ancestor
110949964|NCT03623750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110949965|NCT03623750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110949966|NCT03623750|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110949967|NCT00840840|Amoxicillin|amoxicillin|mesh-list
110949968|NCT00840840|Clavulanic Acid|clavulanic acid|mesh-list
110949969|NCT00840840|Clavulanic Acids|clavulanic acids|mesh-list
110949970|NCT00840840|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
110949971|NCT00840840|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110949972|NCT00840840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110949973|NCT00840840|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110949974|NCT00840840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110949975|NCT00840840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110949976|NCT03595982|Nifedipine|nifedipine|mesh-list
110949977|NCT03595982|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110949978|NCT03595982|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110949979|NCT03595982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110949980|NCT03595982|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110309188|NCT00277589|Iodine|iodine|mesh-list
110949981|NCT03595982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110949983|NCT03595982|Tocolytic Agents|tocolytic agents|mesh-ancestor
110949984|NCT03595982|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110949985|NCT00944970|Adenosine|adenosine|mesh-list
110949986|NCT00944970|Binodenoson|binodenoson|mesh-list
110949987|NCT00944970|Analgesics|analgesics|mesh-ancestor
110949988|NCT00944970|Sensory System Agents|sensory system agents|mesh-ancestor
110949989|NCT00944970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110949990|NCT00944970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110949991|NCT00944970|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110949992|NCT00944970|Vasodilator Agents|vasodilator agents|mesh-ancestor
110949993|NCT00944970|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
110949994|NCT00944970|Purinergic Agonists|purinergic agonists|mesh-ancestor
110949995|NCT00944970|Purinergic Agents|purinergic agents|mesh-ancestor
110949996|NCT00944970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110949997|NCT00944970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110949998|NCT00840216|Clarithromycin|clarithromycin|mesh-list
110949999|NCT00840216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110950000|NCT00840216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110950001|NCT00840216|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110950002|NCT00840216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110950003|NCT00840216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110950004|NCT00840216|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110950005|NCT00840216|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110950006|NCT03462446|Vitamin K|vitamin k|mesh-list
110950007|NCT03462446|Rivaroxaban|rivaroxaban|mesh-list
110950008|NCT03462446|Vitamins|vitamins|mesh-ancestor
110950009|NCT03462446|Micronutrients|micronutrients|mesh-ancestor
110950010|NCT03462446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110950011|NCT03462446|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110950012|NCT03462446|Antithrombins|antithrombins|mesh-ancestor
110950013|NCT03462446|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110950014|NCT03462446|Protease Inhibitors|protease inhibitors|mesh-ancestor
110950015|NCT03462446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110950016|NCT03462446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110950017|NCT03462446|Anticoagulants|anticoagulants|mesh-ancestor
110950018|NCT03462446|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110950019|NCT03462446|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110950020|NCT03462446|Hemostatics|hemostatics|mesh-ancestor
110950021|NCT03462446|Coagulants|coagulants|mesh-ancestor
110950022|NCT00944892|Fasinumab|fasinumab|mesh-list
110950023|NCT00944892|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110950024|NCT00944892|Analgesics|analgesics|mesh-ancestor
110950025|NCT00944892|Sensory System Agents|sensory system agents|mesh-ancestor
110950026|NCT00944892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110950027|NCT00944892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110950028|NCT00939276|Nepafenac|nepafenac|mesh-list
110950029|NCT00939276|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110950030|NCT00939276|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110950031|NCT00939276|Analgesics|analgesics|mesh-ancestor
110950032|NCT00939276|Sensory System Agents|sensory system agents|mesh-ancestor
110950033|NCT00939276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110950034|NCT00939276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110950036|NCT00939276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110950037|NCT03455426|Letrozole|letrozole|mesh-list
110950038|NCT03455426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110950039|NCT03455426|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110950040|NCT03455426|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110950041|NCT03455426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110950042|NCT03455426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110950043|NCT03455426|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110950044|NCT03455426|Hormone Antagonists|hormone antagonists|mesh-ancestor
110950045|NCT03455426|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110950046|NCT03455426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110950047|NCT00791154|Carboplatin|carboplatin|mesh-list
110950048|NCT00791154|Etoposide|etoposide|mesh-list
110950049|NCT00791154|Rilotumumab|rilotumumab|mesh-list
110950050|NCT00791154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110950051|NCT00791154|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110950052|NCT00791154|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110950053|NCT00791154|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110950054|NCT00791154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110950055|NCT00791154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110662085|NCT00767663|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110950056|NCT00791154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110950057|NCT00938652|Carboplatin|carboplatin|mesh-list
110950058|NCT00938652|Gemcitabine|gemcitabine|mesh-list
110950060|NCT00938652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110950061|NCT00938652|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110950062|NCT00938652|Antimetabolites|antimetabolites|mesh-ancestor
110950063|NCT00938652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110950064|NCT00938652|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110950065|NCT00938652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110950066|NCT00928590|Timolol|timolol|mesh-list
110950067|NCT00928590|Travoprost|travoprost|mesh-list
110950068|NCT00928590|Cloprostenol|cloprostenol|mesh-list
110950069|NCT00928590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110950070|NCT00928590|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110950071|NCT00928590|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110950072|NCT00928590|Adrenergic Agents|adrenergic agents|mesh-ancestor
110950073|NCT00928590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110950074|NCT00928590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110950075|NCT00928590|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110950076|NCT00928590|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110950077|NCT00928590|Luteolytic Agents|luteolytic agents|mesh-ancestor
110950078|NCT00928590|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110950079|NCT00928590|Contraceptive Agents|contraceptive agents|mesh-ancestor
110950080|NCT00928590|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110950081|NCT00928590|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110950082|NCT03512756|Sirolimus|sirolimus|mesh-list
110950083|NCT03512756|Gemcitabine|gemcitabine|mesh-list
110950084|NCT03512756|Capecitabine|capecitabine|mesh-list
110950085|NCT03512756|Phenytoin|phenytoin|mesh-list
110950086|NCT03512756|Methoxsalen|methoxsalen|mesh-list
110950087|NCT03512756|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110950088|NCT03512756|Antimetabolites|antimetabolites|mesh-ancestor
110950089|NCT03512756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110950090|NCT03512756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110950091|NCT03512756|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110950092|NCT03512756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110950093|NCT03512756|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110950094|NCT03512756|Antifungal Agents|antifungal agents|mesh-ancestor
110950095|NCT03512756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110950096|NCT03512756|Immunologic Factors|immunologic factors|mesh-ancestor
110950097|NCT03512756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110950098|NCT03512756|Anticonvulsants|anticonvulsants|mesh-ancestor
110950099|NCT03512756|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110950100|NCT03512756|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110950101|NCT03512756|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110950102|NCT03512756|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110950103|NCT03512756|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110950104|NCT03512756|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110950105|NCT03512756|Dermatologic Agents|dermatologic agents|mesh-ancestor
110950106|NCT04697940|Cyclophosphamide|cyclophosphamide|mesh-list
110950107|NCT04697940|Fludarabine|fludarabine|mesh-list
110950108|NCT04697940|Fludarabine phosphate|fludarabine phosphate|mesh-list
110950110|NCT04697940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110950111|NCT04697940|Immunologic Factors|immunologic factors|mesh-ancestor
110950112|NCT04697940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110950113|NCT04697940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110950114|NCT04697940|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110950115|NCT04697940|Alkylating Agents|alkylating agents|mesh-ancestor
110950116|NCT04697940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110950117|NCT04697940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110950118|NCT04697940|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110950119|NCT04697940|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110950120|NCT04697940|Antimetabolites|antimetabolites|mesh-ancestor
110950121|NCT04697940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110950122|NCT00836706|Clarithromycin|clarithromycin|mesh-list
110950123|NCT00836706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110950124|NCT00836706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110662091|NCT00402688|Ofloxacin|ofloxacin|mesh-list
110950125|NCT00836706|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110950126|NCT00836706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110950127|NCT00836706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110950128|NCT00836706|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110950129|NCT00836706|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110950130|NCT00836472|Metformin|metformin|mesh-list
110950131|NCT00836472|Glyburide|glyburide|mesh-list
110950132|NCT00836472|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110950133|NCT00836472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110950134|NCT04473846|Anesthetics|anesthetics|mesh-list
110950135|NCT04473846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110950136|NCT04473846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110950137|NCT03129698|Apatinib|apatinib|mesh-list
110950138|NCT03129698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110950139|NCT03129698|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110950140|NCT03129698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110950141|NCT03129698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110950142|NCT03355118|Anesthetics|anesthetics|mesh-list
110950143|NCT03355118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110950144|NCT03355118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110950145|NCT03263078|Propofol|propofol|mesh-list
110950146|NCT03263078|Sevoflurane|sevoflurane|mesh-list
110950147|NCT03263078|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110950148|NCT03263078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110950149|NCT03263078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110950150|NCT03263078|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110950151|NCT03263078|Anesthetics, General|anesthetics, general|mesh-ancestor
110950152|NCT03263078|Anesthetics|anesthetics|mesh-ancestor
110950153|NCT03263078|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110950154|NCT03263078|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110950155|NCT05349006|Azathioprine|azathioprine|mesh-list
110950156|NCT05349006|Antimetabolites|antimetabolites|mesh-ancestor
110950157|NCT05349006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110950158|NCT05349006|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110950159|NCT05349006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110950160|NCT05349006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110950161|NCT05349006|Immunologic Factors|immunologic factors|mesh-ancestor
110950162|NCT05349006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110950163|NCT05349006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110950164|NCT00785226|Sorafenib|sorafenib|mesh-list
110950165|NCT00785226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110950166|NCT00785226|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110950167|NCT00785226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110950168|NCT00785226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110950169|NCT02598388|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
110950170|NCT02598388|Antiviral Agents|antiviral agents|mesh-ancestor
110950171|NCT02598388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110950172|NCT03448640|Tropicamide|tropicamide|mesh-list
110950173|NCT03448640|Mydriatics|mydriatics|mesh-ancestor
110950174|NCT03448640|Autonomic Agents|autonomic agents|mesh-ancestor
110950175|NCT03448640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110950176|NCT03448640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110950177|NCT03448640|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110950178|NCT03448640|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110950179|NCT03448640|Cholinergic Agents|cholinergic agents|mesh-ancestor
110950180|NCT03448640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110950181|NCT03448640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110950183|NCT00836004|Clindamycin palmitate|clindamycin palmitate|mesh-list
110950184|NCT00836004|Clindamycin phosphate|clindamycin phosphate|mesh-list
110950185|NCT00836004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110950186|NCT00836004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110950187|NCT00836004|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110950188|NCT00836004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110950189|NCT00836004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110950190|NCT00917826|Valganciclovir|valganciclovir|mesh-list
110950191|NCT00917826|Ganciclovir|ganciclovir|mesh-list
110950192|NCT00917826|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
110950193|NCT00917826|Arginine butyrate|arginine butyrate|mesh-list
110950194|NCT00917826|Antiviral Agents|antiviral agents|mesh-ancestor
110950195|NCT00917826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110950196|NCT00917826|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110950197|NCT00917826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110950198|NCT00917826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110950199|NCT00917826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110950200|NCT03102320|Gemcitabine|gemcitabine|mesh-list
110950201|NCT03102320|Maytansine|maytansine|mesh-list
110950202|NCT03102320|Anetumab ravtansine|anetumab ravtansine|mesh-list
110662155|NCT00767975|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
110950203|NCT03102320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110950204|NCT03102320|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110950205|NCT03102320|Antimetabolites|antimetabolites|mesh-ancestor
110950206|NCT03102320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110950207|NCT03102320|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110950208|NCT03102320|Tubulin Modulators|tubulin modulators|mesh-ancestor
110950209|NCT03102320|Antimitotic Agents|antimitotic agents|mesh-ancestor
110950210|NCT03102320|Mitosis Modulators|mitosis modulators|mesh-ancestor
110950211|NCT03102320|Immunoconjugates|immunoconjugates|mesh-ancestor
110950212|NCT03102320|Immunologic Factors|immunologic factors|mesh-ancestor
110950213|NCT03102320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110950214|NCT00835692|Clarithromycin|clarithromycin|mesh-list
110950215|NCT00835692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110950216|NCT00835692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110950217|NCT00835692|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110950218|NCT00835692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110950219|NCT00835692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110950220|NCT00835692|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110950221|NCT00835692|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110950222|NCT00835614|Cefprozil|cefprozil|mesh-list
110950223|NCT00835614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110950224|NCT00835614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110950225|NCT00835536|Ribavirin|ribavirin|mesh-list
110950226|NCT00835536|Antimetabolites|antimetabolites|mesh-ancestor
110950227|NCT00835536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110950228|NCT00835536|Antiviral Agents|antiviral agents|mesh-ancestor
110950229|NCT00835536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110950230|NCT04561362|Pembrolizumab|pembrolizumab|mesh-list
110950231|NCT04561362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110950232|NCT04561362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110950233|NCT04561362|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110950234|NCT04561362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110950235|NCT04060628|Docetaxel|docetaxel|mesh-list
110950236|NCT04060628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110950237|NCT04060628|Tubulin Modulators|tubulin modulators|mesh-ancestor
110950238|NCT04060628|Antimitotic Agents|antimitotic agents|mesh-ancestor
110950239|NCT04060628|Mitosis Modulators|mitosis modulators|mesh-ancestor
110950240|NCT04060628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110950241|NCT04356664|Triptorelin Pamoate|triptorelin pamoate|mesh-list
110950242|NCT04356664|Luteolytic Agents|luteolytic agents|mesh-ancestor
110950243|NCT04356664|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110950244|NCT04356664|Contraceptive Agents|contraceptive agents|mesh-ancestor
110950245|NCT04356664|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110950246|NCT04356664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110950247|NCT04356664|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110950248|NCT04356664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110950249|NCT04356664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110950250|NCT04037072|Mitomycins|mitomycins|mesh-list
110950251|NCT04037072|Mitomycin|mitomycin|mesh-list
110950252|NCT04037072|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110950253|NCT04037072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110950254|NCT04037072|Alkylating Agents|alkylating agents|mesh-ancestor
110950255|NCT04037072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110950256|NCT04037072|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110950257|NCT04037072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110950259|NCT04819438|Anticonvulsants|anticonvulsants|mesh-ancestor
110950260|NCT04819438|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110950261|NCT04819438|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110950262|NCT04819438|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110950263|NCT04819438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110950264|NCT04819438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110950265|NCT04819438|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110950266|NCT04819438|Protective Agents|protective agents|mesh-ancestor
110950267|NCT05616910|Nitric Oxide|nitric oxide|mesh-list
110950268|NCT05616910|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110950269|NCT05616910|Autonomic Agents|autonomic agents|mesh-ancestor
110950270|NCT05616910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110950271|NCT05616910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110950272|NCT05616910|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110950273|NCT05616910|Respiratory System Agents|respiratory system agents|mesh-ancestor
110950274|NCT05616910|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110950275|NCT05616910|Antioxidants|antioxidants|mesh-ancestor
110662237|NCT00417976|Antimetabolites|antimetabolites|mesh-ancestor
110950276|NCT05616910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110950277|NCT05616910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110950278|NCT05616910|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
110950279|NCT05616910|Vasodilator Agents|vasodilator agents|mesh-ancestor
110950280|NCT05616910|Gasotransmitters|gasotransmitters|mesh-ancestor
110950281|NCT05616910|Protective Agents|protective agents|mesh-ancestor
110950282|NCT04537026|Dexamethasone|dexamethasone|mesh-list
110950283|NCT04537026|Dexamethasone acetate|dexamethasone acetate|mesh-list
110950284|NCT04537026|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
110950285|NCT04537026|BB 1101|bb 1101|mesh-list
110950286|NCT04537026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110950287|NCT04537026|Antiemetics|antiemetics|mesh-ancestor
110950288|NCT04537026|Autonomic Agents|autonomic agents|mesh-ancestor
110950289|NCT04537026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110950290|NCT04537026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110950291|NCT04537026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110950292|NCT04537026|Glucocorticoids|glucocorticoids|mesh-ancestor
110950293|NCT04537026|Hormones|hormones|mesh-ancestor
110950294|NCT04537026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110950295|NCT04537026|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110950296|NCT04537026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110950297|NCT04537026|Protease Inhibitors|protease inhibitors|mesh-ancestor
110950298|NCT04537026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110950299|NCT04537026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110950300|NCT04819828|Diclofenac|diclofenac|mesh-list
110950301|NCT04819828|Tamsulosin|tamsulosin|mesh-list
110950302|NCT04819828|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110950303|NCT04819828|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110950304|NCT04819828|Analgesics|analgesics|mesh-ancestor
110950305|NCT04819828|Sensory System Agents|sensory system agents|mesh-ancestor
110950306|NCT04819828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110950307|NCT04819828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110950308|NCT04819828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110950309|NCT04819828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110950310|NCT04819828|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110950311|NCT04819828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110950312|NCT04819828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110950313|NCT04819828|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110950314|NCT04819828|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110950315|NCT04819828|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110950316|NCT04819828|Adrenergic Agents|adrenergic agents|mesh-ancestor
110950317|NCT04819828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110950318|NCT04819828|Urological Agents|urological agents|mesh-ancestor
110950319|NCT02602288|Nicotine|nicotine|mesh-list
110950320|NCT02602288|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110950321|NCT02602288|Autonomic Agents|autonomic agents|mesh-ancestor
110950322|NCT02602288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110950323|NCT02602288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110950324|NCT02602288|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110950325|NCT02602288|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110950326|NCT02602288|Cholinergic Agents|cholinergic agents|mesh-ancestor
110950328|NCT02602288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110950329|NCT03745352|Azacitidine|azacitidine|mesh-list
110950330|NCT03745352|Enzyme Inhibitors|enzyme inhibitors|mesh-list
110950331|NCT03745352|Pevonedistat|pevonedistat|mesh-list
110950332|NCT03745352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110950333|NCT03745352|Antimetabolites|antimetabolites|mesh-ancestor
110950334|NCT03745352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110950335|NCT03745352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110950336|NCT03740126|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110950337|NCT03740126|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110950338|NCT03740126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110950339|NCT05617690|Propofol|propofol|mesh-list
110950340|NCT05617690|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110950341|NCT05617690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110950342|NCT05617690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110950343|NCT05617690|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110950344|NCT05617690|Anesthetics, General|anesthetics, general|mesh-ancestor
110950345|NCT05617690|Anesthetics|anesthetics|mesh-ancestor
110950346|NCT03448094|Resveratrol|resveratrol|mesh-list
110950347|NCT03448094|Antioxidants|antioxidants|mesh-ancestor
110950348|NCT03448094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110950349|NCT03448094|Protective Agents|protective agents|mesh-ancestor
110309529|NCT00279383|Thrombin|thrombin|mesh-list
110950350|NCT03448094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110950352|NCT03448094|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110950353|NCT04819204|Cetrorelix|cetrorelix|mesh-list
110950354|NCT04819204|Testosterone|testosterone|mesh-list
110950355|NCT04819204|Androgens|androgens|mesh-ancestor
110950356|NCT04819204|Hormones|hormones|mesh-ancestor
110950357|NCT04819204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110950358|NCT04819204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110950359|NCT04819204|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110950360|NCT04819204|Fertility Agents|fertility agents|mesh-ancestor
110950361|NCT04819204|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110950362|NCT04819204|Hormone Antagonists|hormone antagonists|mesh-ancestor
110950363|NCT02807454|Dexamethasone|dexamethasone|mesh-list
110950364|NCT02807454|Durvalumab|durvalumab|mesh-list
110950365|NCT02807454|Daratumumab|daratumumab|mesh-list
110950366|NCT02807454|Pomalidomide|pomalidomide|mesh-list
110950367|NCT02807454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110950368|NCT02807454|Antiemetics|antiemetics|mesh-ancestor
110950369|NCT02807454|Autonomic Agents|autonomic agents|mesh-ancestor
110950370|NCT02807454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110950371|NCT02807454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110950372|NCT02807454|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110950373|NCT02807454|Glucocorticoids|glucocorticoids|mesh-ancestor
110950374|NCT02807454|Hormones|hormones|mesh-ancestor
110950375|NCT02807454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110950376|NCT02807454|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110950377|NCT02807454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110950378|NCT02807454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110950379|NCT02807454|Immunologic Factors|immunologic factors|mesh-ancestor
110950380|NCT02807454|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110950381|NCT02807454|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110950382|NCT02807454|Growth Substances|growth substances|mesh-ancestor
110950383|NCT02807454|Growth Inhibitors|growth inhibitors|mesh-ancestor
110950384|NCT03718286|Alirocumab|alirocumab|mesh-list
110950385|NCT03718286|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
110950386|NCT03718286|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110950387|NCT03718286|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110950388|NCT03718286|Antimetabolites|antimetabolites|mesh-ancestor
110950389|NCT03718286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110950390|NCT03718286|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110950391|NCT03718286|Protease Inhibitors|protease inhibitors|mesh-ancestor
110950392|NCT03718286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110950393|NCT03718286|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110950394|NCT05320874|Antibodies|antibodies|mesh-list
110950395|NCT05320874|Antibodies, Bispecific|antibodies, bispecific|mesh-list
110950396|NCT05320874|Immunologic Factors|immunologic factors|mesh-ancestor
110950397|NCT05320874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110950398|NCT05320640|Decitabine|decitabine|mesh-list
110950399|NCT05320640|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
110950400|NCT05320640|Antibodies|antibodies|mesh-list
110950401|NCT05320640|Immunologic Factors|immunologic factors|mesh-ancestor
110950402|NCT05320640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110950403|NCT05320640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110950404|NCT05320640|Antimetabolites|antimetabolites|mesh-ancestor
110950405|NCT05320640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110950406|NCT05320640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110950407|NCT05320640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110950408|NCT05320640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110950409|NCT00835146|Ribavirin|ribavirin|mesh-list
110950410|NCT00835146|Antimetabolites|antimetabolites|mesh-ancestor
110950411|NCT00835146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110950412|NCT00835146|Antiviral Agents|antiviral agents|mesh-ancestor
110950413|NCT00835146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110950414|NCT04472910|Folfirinox|folfirinox|mesh-list
110950415|NCT04472910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110950416|NCT01479842|Rituximab|rituximab|mesh-list
110950417|NCT01479842|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110950418|NCT01479842|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
110950419|NCT01479842|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110950420|NCT01479842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110950421|NCT01479842|Immunologic Factors|immunologic factors|mesh-ancestor
110950422|NCT01479842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110950423|NCT01479842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110950424|NCT01479842|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110950425|NCT01479842|Alkylating Agents|alkylating agents|mesh-ancestor
110950426|NCT01479842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110950427|NCT01479842|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110950428|NCT01479842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110950430|NCT04818736|Immunologic Factors|immunologic factors|mesh-ancestor
110950431|NCT04818736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110950432|NCT03719430|Doxorubicin|doxorubicin|mesh-list
110950433|NCT03719430|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110950434|NCT03719430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110950435|NCT03719430|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110950436|NCT03719430|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110950437|NCT03719430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110950438|NCT03719430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110950439|NCT04811326|Latanoprost|latanoprost|mesh-list
110950440|NCT04811326|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110950441|NCT04811326|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110950442|NCT00834990|Valproic Acid|valproic acid|mesh-list
110950443|NCT00834990|Anticonvulsants|anticonvulsants|mesh-ancestor
110950444|NCT00834990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110950445|NCT00834990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110950446|NCT00834990|GABA Agents|gaba agents|mesh-ancestor
110950447|NCT00834990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110950448|NCT00834990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110950449|NCT00834990|Antimanic Agents|antimanic agents|mesh-ancestor
110950450|NCT00834990|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110950451|NCT00834990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110950452|NCT00834990|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110950453|NCT04479072|Aspirin|aspirin|mesh-list
110950454|NCT04479072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110950455|NCT04479072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110950456|NCT04479072|Analgesics|analgesics|mesh-ancestor
110950457|NCT04479072|Sensory System Agents|sensory system agents|mesh-ancestor
110950458|NCT04479072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110950459|NCT04479072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110950460|NCT04479072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110950461|NCT04479072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110950462|NCT04479072|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110950463|NCT04479072|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110950464|NCT04479072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110950465|NCT04479072|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110950466|NCT04479072|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110950467|NCT04479072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110950468|NCT04479072|Antipyretics|antipyretics|mesh-ancestor
110950469|NCT03036202|Epinephrine|epinephrine|mesh-list
110950470|NCT03036202|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110950471|NCT03036202|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110950472|NCT03036202|Adrenergic Agents|adrenergic agents|mesh-ancestor
110950473|NCT03036202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110950474|NCT03036202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110950475|NCT03036202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110950476|NCT03036202|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110950477|NCT03036202|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110950479|NCT03036202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110950480|NCT03036202|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110950481|NCT03036202|Respiratory System Agents|respiratory system agents|mesh-ancestor
110950482|NCT03036202|Mydriatics|mydriatics|mesh-ancestor
110950483|NCT03036202|Sympathomimetics|sympathomimetics|mesh-ancestor
110950484|NCT03036202|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110950485|NCT03245918|Aprepitant|aprepitant|mesh-list
110950486|NCT03245918|Fosaprepitant|fosaprepitant|mesh-list
110950487|NCT03245918|Antiemetics|antiemetics|mesh-ancestor
110950488|NCT03245918|Autonomic Agents|autonomic agents|mesh-ancestor
110950489|NCT03245918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110950490|NCT03245918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110950491|NCT03245918|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110950492|NCT03245918|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110950493|NCT03245918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110449869|NCT01119131|Vitamins|vitamins|mesh-ancestor
110950494|NCT03245918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110950495|NCT00834756|Azithromycin|azithromycin|mesh-list
110950496|NCT00834756|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110950497|NCT00834756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110950498|NCT00828854|Entinostat|entinostat|mesh-list
110950499|NCT00828854|Aromatase Inhibitors|aromatase inhibitors|mesh-list
110950500|NCT00828854|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110950501|NCT00828854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110950502|NCT00828854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110950503|NCT00828854|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110950504|NCT00828854|Hormone Antagonists|hormone antagonists|mesh-ancestor
110950505|NCT00828854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110950506|NCT00828854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110950507|NCT00828854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110950508|NCT00828854|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110950509|NCT00834522|Granisetron|granisetron|mesh-list
110950510|NCT00834522|Antiemetics|antiemetics|mesh-ancestor
110950511|NCT00834522|Autonomic Agents|autonomic agents|mesh-ancestor
110950512|NCT00834522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110950513|NCT00834522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110950514|NCT00834522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110950515|NCT00834522|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110950516|NCT00834522|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110950517|NCT00834522|Serotonin Agents|serotonin agents|mesh-ancestor
110950518|NCT00834522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110950519|NCT00834522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110950520|NCT00834444|Famciclovir|famciclovir|mesh-list
110950521|NCT00834444|Antiviral Agents|antiviral agents|mesh-ancestor
110950522|NCT00834444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110950523|NCT00834444|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110950524|NCT00834444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110950525|NCT00834444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110950526|NCT05174858|Hemostatics|hemostatics|mesh-list
110950527|NCT05174858|Coagulants|coagulants|mesh-ancestor
110950528|NCT00834132|Azithromycin|azithromycin|mesh-list
110950529|NCT00834132|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110950530|NCT00834132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110950531|NCT00833586|Terbinafine|terbinafine|mesh-list
110950532|NCT00833586|Antifungal Agents|antifungal agents|mesh-ancestor
110950533|NCT00833586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110950534|NCT00833586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110950535|NCT00833586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110950536|NCT02605954|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
110950537|NCT02605954|Antiviral Agents|antiviral agents|mesh-ancestor
110950538|NCT02605954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110950539|NCT03447470|Nivolumab|nivolumab|mesh-list
110950540|NCT03447470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110950541|NCT03447470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110950542|NCT03447470|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110950543|NCT03447470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110950544|NCT00765804|Dexamethasone|dexamethasone|mesh-list
110950545|NCT00765804|Citric Acid|citric acid|mesh-list
110950546|NCT00765804|Sodium Citrate|sodium citrate|mesh-list
110950547|NCT00765804|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110950548|NCT00765804|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110950549|NCT00765804|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
110950550|NCT00765804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110950551|NCT00765804|Antiemetics|antiemetics|mesh-ancestor
110950552|NCT00765804|Autonomic Agents|autonomic agents|mesh-ancestor
110950553|NCT00765804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110950554|NCT00765804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110950555|NCT00765804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110950556|NCT00765804|Glucocorticoids|glucocorticoids|mesh-ancestor
110950557|NCT00765804|Hormones|hormones|mesh-ancestor
110950558|NCT00765804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110950559|NCT00765804|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110950560|NCT00765804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110950561|NCT00765804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110950562|NCT00765804|Anticoagulants|anticoagulants|mesh-ancestor
110950563|NCT00765804|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110950564|NCT00765804|Chelating Agents|chelating agents|mesh-ancestor
110950565|NCT00765804|Sequestering Agents|sequestering agents|mesh-ancestor
110950566|NCT00764634|Vaccines|vaccines|mesh-list
110950567|NCT00764634|Immunologic Factors|immunologic factors|mesh-ancestor
110950568|NCT00764634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110950569|NCT03443726|Epinephrine|epinephrine|mesh-list
110950570|NCT03443726|Carticaine|carticaine|mesh-list
110950571|NCT03443726|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110950572|NCT03443726|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110950573|NCT03443726|Adrenergic Agents|adrenergic agents|mesh-ancestor
110950574|NCT03443726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110662530|NCT01086631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110950575|NCT03443726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110950576|NCT03443726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110950577|NCT03443726|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110950578|NCT03443726|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110950579|NCT03443726|Autonomic Agents|autonomic agents|mesh-ancestor
110950580|NCT03443726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110950581|NCT03443726|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110950582|NCT03443726|Respiratory System Agents|respiratory system agents|mesh-ancestor
110950583|NCT03443726|Mydriatics|mydriatics|mesh-ancestor
110950584|NCT03443726|Sympathomimetics|sympathomimetics|mesh-ancestor
110950585|NCT03443726|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110950586|NCT03443726|Anesthetics, Local|anesthetics, local|mesh-ancestor
110950587|NCT03443726|Anesthetics|anesthetics|mesh-ancestor
110950588|NCT03443726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110950589|NCT03443726|Sensory System Agents|sensory system agents|mesh-ancestor
110950590|NCT00760344|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110950591|NCT00760344|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110950592|NCT00760344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110950593|NCT00760344|Incretins|incretins|mesh-ancestor
110950594|NCT00760344|Hormones|hormones|mesh-ancestor
110950595|NCT00760344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110950596|NCT00760344|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110950597|NCT00760344|Protease Inhibitors|protease inhibitors|mesh-ancestor
110950598|NCT00760344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110950599|NCT00760344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110950600|NCT03443570|Rituximab|rituximab|mesh-list
110950601|NCT03443570|Bortezomib|bortezomib|mesh-list
110950602|NCT03443570|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110950603|NCT03443570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110950604|NCT03443570|Immunologic Factors|immunologic factors|mesh-ancestor
110950605|NCT03443570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110950606|NCT03443570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110950607|NCT02718404|Analgesics|analgesics|mesh-list
110950608|NCT02718404|Sensory System Agents|sensory system agents|mesh-ancestor
110950609|NCT02718404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110449915|NCT04829422|Lazertinib|lazertinib|mesh-list
110950610|NCT02718404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110950611|NCT03443492|Leucovorin|leucovorin|mesh-list
110950612|NCT03443492|Gemcitabine|gemcitabine|mesh-list
110950613|NCT03443492|Oxaliplatin|oxaliplatin|mesh-list
110950614|NCT03443492|Irinotecan|irinotecan|mesh-list
110950615|NCT03443492|Levoleucovorin|levoleucovorin|mesh-list
110950616|NCT03443492|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110950617|NCT03443492|Antimetabolites|antimetabolites|mesh-ancestor
110950618|NCT03443492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110950619|NCT03443492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110950620|NCT03443492|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110950621|NCT03443492|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110950622|NCT03443492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110950623|NCT03443492|Antidotes|antidotes|mesh-ancestor
110950624|NCT03443492|Protective Agents|protective agents|mesh-ancestor
110950625|NCT03443492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110950626|NCT03443492|Vitamin B Complex|vitamin b complex|mesh-ancestor
110950627|NCT03443492|Vitamins|vitamins|mesh-ancestor
110950628|NCT03443492|Micronutrients|micronutrients|mesh-ancestor
110950629|NCT00724698|Desloratadine|desloratadine|mesh-list
110950630|NCT00724698|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110950631|NCT00724698|Cholinergic Agents|cholinergic agents|mesh-ancestor
110950632|NCT00724698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110950633|NCT00724698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110950634|NCT00724698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110950635|NCT00724698|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110950636|NCT00724698|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110950637|NCT00724698|Histamine Antagonists|histamine antagonists|mesh-ancestor
110950638|NCT00724698|Histamine Agents|histamine agents|mesh-ancestor
110950639|NCT00722592|Doxorubicin|doxorubicin|mesh-list
110950640|NCT00722592|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110950641|NCT00722592|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110950642|NCT00722592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110950643|NCT00722592|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110950644|NCT00722592|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110950645|NCT00722592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110950646|NCT00722592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110950647|NCT00829998|Zaleplon|zaleplon|mesh-list
110950648|NCT00829998|Anticonvulsants|anticonvulsants|mesh-ancestor
110950649|NCT00829998|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110950650|NCT00829998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110950651|NCT00829998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110950652|NCT00829998|GABA Modulators|gaba modulators|mesh-ancestor
110950653|NCT00829998|GABA Agents|gaba agents|mesh-ancestor
110950654|NCT00829998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110950655|NCT00829998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110950656|NCT00722358|Asunaprevir|asunaprevir|mesh-list
110950657|NCT00722358|Protease Inhibitors|protease inhibitors|mesh-ancestor
110950658|NCT00722358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110950659|NCT00722358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110950660|NCT00719550|Capecitabine|capecitabine|mesh-list
110950661|NCT00719550|Epirubicin|epirubicin|mesh-list
110950662|NCT00719550|Rilotumumab|rilotumumab|mesh-list
110950663|NCT00719550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110950664|NCT00719550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110950665|NCT00719550|Antimetabolites|antimetabolites|mesh-ancestor
110950666|NCT00719550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110950667|NCT00719550|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110950668|NCT00719550|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110950669|NCT00719550|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110950670|NCT00719550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110950671|NCT00719550|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110950672|NCT03443180|Trypsin Inhibitors|trypsin inhibitors|mesh-list
110950673|NCT03443180|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110950674|NCT03443180|Protease Inhibitors|protease inhibitors|mesh-ancestor
110950675|NCT03443180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110950676|NCT03443180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110950677|NCT05016518|Propofol|propofol|mesh-list
110950678|NCT05016518|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110950679|NCT05016518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110950680|NCT05016518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110950681|NCT05016518|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110950682|NCT05016518|Anesthetics, General|anesthetics, general|mesh-ancestor
110950683|NCT05016518|Anesthetics|anesthetics|mesh-ancestor
110950684|NCT03446534|Amoxicillin|amoxicillin|mesh-list
110950685|NCT03446534|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110950686|NCT03446534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110950687|NCT00829764|Doxycycline|doxycycline|mesh-list
110950688|NCT00829764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110950689|NCT00829764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110950690|NCT00829764|Antimalarials|antimalarials|mesh-ancestor
110950691|NCT00829764|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110950692|NCT00829764|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110950693|NCT00718224|Enoxaparin|enoxaparin|mesh-list
110950694|NCT00718224|Semuloparin|semuloparin|mesh-list
110950695|NCT00718224|Anticoagulants|anticoagulants|mesh-ancestor
110950696|NCT00718224|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110950697|NCT00718224|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110950698|NCT00718224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110950699|NCT03129542|Midodrine|midodrine|mesh-list
110950700|NCT03129542|Sympathomimetics|sympathomimetics|mesh-ancestor
110950701|NCT03129542|Autonomic Agents|autonomic agents|mesh-ancestor
110950702|NCT03129542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110950703|NCT03129542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110950705|NCT03129542|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110950706|NCT03129542|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110950707|NCT03129542|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110950708|NCT03129542|Adrenergic Agents|adrenergic agents|mesh-ancestor
110950709|NCT03129542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110950710|NCT03129542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110950711|NCT03129074|Capecitabine|capecitabine|mesh-list
110950712|NCT03129074|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110950713|NCT03129074|Antimetabolites|antimetabolites|mesh-ancestor
110950714|NCT03129074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110950715|NCT03129074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110950716|NCT03449654|Liraglutide|liraglutide|mesh-list
110950717|NCT03449654|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110950718|NCT03449654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110950719|NCT03449654|Incretins|incretins|mesh-ancestor
110950720|NCT03449654|Hormones|hormones|mesh-ancestor
110950721|NCT03449654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110950722|NCT03388008|Mycophenolic Acid|mycophenolic acid|mesh-list
110950723|NCT03388008|Prednisone|prednisone|mesh-list
110950724|NCT03388008|Methylprednisolone|methylprednisolone|mesh-list
110950725|NCT03388008|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110950726|NCT03388008|Abatacept|abatacept|mesh-list
110950727|NCT03388008|Tacrolimus|tacrolimus|mesh-list
110950728|NCT03388008|Thymoglobulin|thymoglobulin|mesh-list
110950729|NCT03388008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110950730|NCT03388008|Glucocorticoids|glucocorticoids|mesh-ancestor
110950731|NCT03388008|Hormones|hormones|mesh-ancestor
110950732|NCT03388008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110950733|NCT03388008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110950734|NCT03388008|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110950735|NCT03388008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110950736|NCT03388008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110950737|NCT03388008|Immunologic Factors|immunologic factors|mesh-ancestor
110950738|NCT03388008|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110950739|NCT03388008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110950740|NCT03388008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110950741|NCT03388008|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110950742|NCT03388008|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110950743|NCT03388008|Antitubercular Agents|antitubercular agents|mesh-ancestor
110449925|NCT00612898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110950744|NCT03388008|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110950745|NCT03388008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110950746|NCT03388008|Antiemetics|antiemetics|mesh-ancestor
110950747|NCT03388008|Autonomic Agents|autonomic agents|mesh-ancestor
110950748|NCT03388008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110950749|NCT03388008|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110950750|NCT03388008|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110950751|NCT03388008|Protective Agents|protective agents|mesh-ancestor
110950752|NCT03388008|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110950753|NCT03388008|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110950754|NCT03388008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110950755|NCT00710580|Etanercept|etanercept|mesh-list
110950756|NCT00710580|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110950757|NCT00710580|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110950758|NCT00710580|Analgesics|analgesics|mesh-ancestor
110950759|NCT00710580|Sensory System Agents|sensory system agents|mesh-ancestor
110950760|NCT00710580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110950761|NCT00710580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110950762|NCT00710580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110950763|NCT00710580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110950764|NCT00710580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110950765|NCT00710580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110950766|NCT00710580|Immunologic Factors|immunologic factors|mesh-ancestor
110950767|NCT00829686|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
110950768|NCT00829686|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110950769|NCT00829686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110950770|NCT00829686|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110950771|NCT00829686|Antimalarials|antimalarials|mesh-ancestor
110950772|NCT00829686|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110950773|NCT00829686|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110950774|NCT00829530|Ramipril|ramipril|mesh-list
110950775|NCT00829530|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110950776|NCT00829530|Protease Inhibitors|protease inhibitors|mesh-ancestor
110950777|NCT00829530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110950778|NCT00829530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110950779|NCT00829530|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110950781|NCT01377194|Levomilnacipran|levomilnacipran|mesh-list
110950782|NCT01377194|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110950783|NCT01377194|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110950784|NCT01377194|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110950785|NCT01377194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110950786|NCT01377194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110950787|NCT01377194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110950788|NCT01377194|Antidepressive Agents|antidepressive agents|mesh-ancestor
110950789|NCT01377194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110950790|NCT01377194|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110950791|NCT01377194|Analgesics|analgesics|mesh-ancestor
110950792|NCT01377194|Sensory System Agents|sensory system agents|mesh-ancestor
110950793|NCT01377194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110950794|NCT00829452|Ramipril|ramipril|mesh-list
110950795|NCT00829452|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110950796|NCT00829452|Protease Inhibitors|protease inhibitors|mesh-ancestor
110950797|NCT00829452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110950798|NCT00829452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110950799|NCT00829452|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110662846|NCT00537056|Sunitinib|sunitinib|mesh-list
110950801|NCT00747318|Xhance|xhance|mesh-list
110950802|NCT00747318|Formoterol Fumarate|formoterol fumarate|mesh-list
110950803|NCT00747318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110950804|NCT00747318|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110950805|NCT00747318|Autonomic Agents|autonomic agents|mesh-ancestor
110950806|NCT00747318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110950807|NCT00747318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110950808|NCT00747318|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110950809|NCT00747318|Respiratory System Agents|respiratory system agents|mesh-ancestor
110950810|NCT00747318|Dermatologic Agents|dermatologic agents|mesh-ancestor
110950811|NCT00747318|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110950812|NCT00747318|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110950813|NCT00747318|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110950814|NCT00747318|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110950815|NCT00747318|Adrenergic Agents|adrenergic agents|mesh-ancestor
110449934|NCT01118663|Pentetic Acid|pentetic acid|mesh-list
110950816|NCT00747318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110950817|NCT00747318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110950818|NCT00744276|Danazol|danazol|mesh-list
110950819|NCT00744276|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110950820|NCT00744276|Hormone Antagonists|hormone antagonists|mesh-ancestor
110950821|NCT00744276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110950822|NCT00744276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110950823|NCT03438344|Vaccines|vaccines|mesh-list
110950824|NCT03438344|Immunologic Factors|immunologic factors|mesh-ancestor
110950825|NCT03438344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110950826|NCT04640402|Vaccines|vaccines|mesh-list
110950827|NCT04640402|Immunologic Factors|immunologic factors|mesh-ancestor
110950828|NCT04640402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110950829|NCT03445910|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
110950830|NCT03445910|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110950831|NCT03445910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110950832|NCT00646542|Vildagliptin|vildagliptin|mesh-list
110950833|NCT00646542|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110950834|NCT00646542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110950835|NCT00646542|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110950836|NCT00646542|Protease Inhibitors|protease inhibitors|mesh-ancestor
110950837|NCT00646542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110950838|NCT00646542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110950839|NCT03256344|Atezolizumab|atezolizumab|mesh-list
110950840|NCT03256344|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
110950841|NCT03256344|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110950842|NCT03256344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110950843|NCT03256344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110950844|NCT03256344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110950845|NCT02063139|Fluticasone|fluticasone|mesh-list
110950846|NCT02063139|Beclomethasone|beclomethasone|mesh-list
110950847|NCT02063139|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110950848|NCT02063139|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110950849|NCT02063139|Autonomic Agents|autonomic agents|mesh-ancestor
110939942|NCT04865380|Tranexamic Acid|tranexamic acid|mesh-list
110950850|NCT02063139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110950851|NCT02063139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110950852|NCT02063139|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110950853|NCT02063139|Respiratory System Agents|respiratory system agents|mesh-ancestor
110950854|NCT02063139|Dermatologic Agents|dermatologic agents|mesh-ancestor
110950855|NCT02063139|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110950857|NCT02063139|Hormones|hormones|mesh-ancestor
110950858|NCT02063139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110950859|NCT00690456|Metformin|metformin|mesh-list
110950860|NCT00690456|Rimonabant|rimonabant|mesh-list
110950861|NCT00690456|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110950862|NCT00690456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110950863|NCT00690456|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110950864|NCT00690456|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
110950865|NCT00690456|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110950866|NCT00690456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110950867|NCT00690456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110950868|NCT00690456|Hormones|hormones|mesh-ancestor
110950869|NCT00690456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110950870|NCT01370499|Serotonin|serotonin|mesh-list
110950871|NCT01370499|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
110950872|NCT01370499|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110950874|NCT01370499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110950875|NCT01370499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110950876|NCT01370499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110950877|NCT01370499|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110950878|NCT01370499|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110950879|NCT03445286|Fluorides|fluorides|mesh-list
110950880|NCT03445286|Cariostatic Agents|cariostatic agents|mesh-ancestor
110950881|NCT03445286|Protective Agents|protective agents|mesh-ancestor
110950882|NCT03445286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110950883|NCT00626106|Fulvestrant|fulvestrant|mesh-list
110950884|NCT00626106|Exemestane|exemestane|mesh-list
110950885|NCT00626106|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110449936|NCT01118663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110950886|NCT00626106|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110950887|NCT00626106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110950888|NCT00626106|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110950889|NCT00626106|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110950890|NCT00626106|Hormone Antagonists|hormone antagonists|mesh-ancestor
110950891|NCT00626106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110950892|NCT00626106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110950893|NCT00626106|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110950894|NCT00626106|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110950895|NCT00626106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110950896|NCT00626106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110950897|NCT00626106|Immunologic Factors|immunologic factors|mesh-ancestor
110950898|NCT02064465|Lamotrigine|lamotrigine|mesh-list
110950899|NCT02064465|Anticonvulsants|anticonvulsants|mesh-list
110950900|NCT02064465|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110950901|NCT02064465|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110950902|NCT02064465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110950903|NCT02064465|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110950904|NCT02064465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110950905|NCT02064465|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110950906|NCT02064465|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110950907|NCT02064465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110950908|NCT02064465|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110950909|NCT02064465|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110950910|NCT04530656|Vaccines|vaccines|mesh-list
110950911|NCT04530656|Immunologic Factors|immunologic factors|mesh-ancestor
110950912|NCT04530656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110950913|NCT00690066|Remestemcel-l|remestemcel-l|mesh-list
110950914|NCT00690066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110950915|NCT00690066|Antiviral Agents|antiviral agents|mesh-ancestor
110950916|NCT00690066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110950917|NCT01370265|Adenosine|adenosine|mesh-list
110950918|NCT01370265|Regadenoson|regadenoson|mesh-list
110950919|NCT01370265|Analgesics|analgesics|mesh-ancestor
110950920|NCT01370265|Sensory System Agents|sensory system agents|mesh-ancestor
110950921|NCT01370265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110950922|NCT01370265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110950923|NCT01370265|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110950924|NCT01370265|Vasodilator Agents|vasodilator agents|mesh-ancestor
110950925|NCT01370265|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
110950926|NCT01370265|Purinergic Agonists|purinergic agonists|mesh-ancestor
110950927|NCT01370265|Purinergic Agents|purinergic agents|mesh-ancestor
110950928|NCT01370265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110950929|NCT01370265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110950930|NCT01370265|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
110950932|NCT00734292|Xhance|xhance|mesh-list
110950933|NCT00734292|Formoterol Fumarate|formoterol fumarate|mesh-list
110950934|NCT00734292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110950935|NCT00734292|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110950936|NCT00734292|Autonomic Agents|autonomic agents|mesh-ancestor
110950937|NCT00734292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110950938|NCT00734292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110950939|NCT00734292|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110950940|NCT00734292|Respiratory System Agents|respiratory system agents|mesh-ancestor
110950941|NCT00734292|Dermatologic Agents|dermatologic agents|mesh-ancestor
110950942|NCT00734292|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110950943|NCT00734292|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110950944|NCT00734292|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110950945|NCT00734292|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110950946|NCT00734292|Adrenergic Agents|adrenergic agents|mesh-ancestor
110950947|NCT00734292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110950948|NCT00734292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110950950|NCT02064621|Amlodipine|amlodipine|mesh-list
110950951|NCT02064621|Candesartan|candesartan|mesh-list
110950952|NCT02064621|Candesartan cilexetil|candesartan cilexetil|mesh-list
110950953|NCT02064621|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110950954|NCT02064621|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110950955|NCT02064621|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110950956|NCT02064621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110950957|NCT02064621|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110950958|NCT02064621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110950959|NCT02064621|Vasodilator Agents|vasodilator agents|mesh-ancestor
110950960|NCT02064621|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110950961|NCT02064621|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110950962|NCT00684918|Obatoclax|obatoclax|mesh-list
110950963|NCT00684918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110950964|NCT00684918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110950965|NCT00726336|Tenofovir|tenofovir|mesh-list
110950966|NCT00726336|Dolutegravir|dolutegravir|mesh-list
110950967|NCT00726336|Antiviral Agents|antiviral agents|mesh-ancestor
110950968|NCT00726336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110950969|NCT00726336|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110950970|NCT00726336|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110950971|NCT00726336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110950972|NCT00726336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110950973|NCT00726336|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110950974|NCT00726336|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110950975|NCT00726336|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110950976|NCT00726336|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110950977|NCT02280720|Tryptophan|tryptophan|mesh-list
110950978|NCT02280720|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110950979|NCT02280720|Antidepressive Agents|antidepressive agents|mesh-ancestor
110950980|NCT02280720|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110950981|NCT02068131|Capecitabine|capecitabine|mesh-list
110950982|NCT02068131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110950983|NCT02068131|Antimetabolites|antimetabolites|mesh-ancestor
110950984|NCT02068131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110950985|NCT02068131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110950986|NCT02068209|Tramadol|tramadol|mesh-list
110950987|NCT02068209|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110950988|NCT02068209|Narcotics|narcotics|mesh-ancestor
110950989|NCT02068209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110950990|NCT02068209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110950991|NCT02068209|Analgesics|analgesics|mesh-ancestor
110950992|NCT02068209|Sensory System Agents|sensory system agents|mesh-ancestor
110950993|NCT02068209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110950994|NCT00680784|Ketoprofen|ketoprofen|mesh-list
110950995|NCT00680784|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110950996|NCT00680784|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110950997|NCT00680784|Analgesics|analgesics|mesh-ancestor
110950998|NCT00680784|Sensory System Agents|sensory system agents|mesh-ancestor
110950999|NCT00680784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110951000|NCT00680784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110951001|NCT00680784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110951002|NCT00680784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110951003|NCT00680784|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110951004|NCT00680784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110951005|NCT00680784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110951006|NCT02068287|Esmolol|esmolol|mesh-list
110951007|NCT02068287|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110951008|NCT02068287|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110951009|NCT02068287|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110951010|NCT02068287|Adrenergic Agents|adrenergic agents|mesh-ancestor
110951011|NCT02068287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110951012|NCT02068287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110951013|NCT02068287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110951014|NCT02280876|Andrographolide|andrographolide|mesh-list
110951015|NCT02280876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110951016|NCT02280876|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110951017|NCT02280876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110951018|NCT02280876|Analgesics|analgesics|mesh-ancestor
110951019|NCT02280876|Sensory System Agents|sensory system agents|mesh-ancestor
110951020|NCT02280876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110951021|NCT02280876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110951022|NCT02280876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110951023|NCT02280876|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110951024|NCT02280876|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110951025|NCT02280876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110951027|NCT02280876|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110951028|NCT00680472|Ketoprofen|ketoprofen|mesh-list
110951029|NCT00680472|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110951030|NCT00680472|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110951031|NCT00680472|Analgesics|analgesics|mesh-ancestor
110951032|NCT00680472|Sensory System Agents|sensory system agents|mesh-ancestor
110951033|NCT00680472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110951034|NCT00680472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110951035|NCT00680472|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110951036|NCT00680472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110951037|NCT00680472|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110951038|NCT00680472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110951039|NCT00680472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110951040|NCT03444662|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
110951041|NCT03444662|Nootropic Agents|nootropic agents|mesh-ancestor
110951042|NCT03444506|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
110951043|NCT03444506|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110951044|NCT03444506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110951045|NCT03444506|Analgesics|analgesics|mesh-ancestor
110951046|NCT03444506|Sensory System Agents|sensory system agents|mesh-ancestor
110951047|NCT03444506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110951048|NCT03444506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110951049|NCT03444506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110951050|NCT03444506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110951051|NCT03444506|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110951052|NCT03444506|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110951053|NCT03444506|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110951054|NCT03444506|Histamine Antagonists|histamine antagonists|mesh-ancestor
110951055|NCT03444506|Histamine Agents|histamine agents|mesh-ancestor
110951056|NCT03444506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110951057|NCT03444506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110951058|NCT02065947|Lidocaine|lidocaine|mesh-list
110951059|NCT02065947|Epinephrine|epinephrine|mesh-list
110951060|NCT02065947|Racepinephrine|racepinephrine|mesh-list
110951061|NCT02065947|Fentanyl|fentanyl|mesh-list
110951062|NCT02065947|Midazolam|midazolam|mesh-list
110951063|NCT02065947|Ketamine|ketamine|mesh-list
110951064|NCT02065947|Bupivacaine|bupivacaine|mesh-list
110951065|NCT02065947|Propofol|propofol|mesh-list
110951066|NCT02065947|Sevoflurane|sevoflurane|mesh-list
110951067|NCT02065947|Epinephryl borate|epinephryl borate|mesh-list
110951068|NCT02065947|Atracurium|atracurium|mesh-list
110951069|NCT02065947|Anesthetics, Local|anesthetics, local|mesh-ancestor
110951070|NCT02065947|Anesthetics|anesthetics|mesh-ancestor
110951071|NCT02065947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110951072|NCT02065947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110951073|NCT02065947|Sensory System Agents|sensory system agents|mesh-ancestor
110951074|NCT02065947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110951075|NCT02065947|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110951076|NCT02065947|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110951077|NCT02065947|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110951078|NCT02065947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110951079|NCT02065947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110951080|NCT02065947|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110951081|NCT02065947|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110951082|NCT02065947|Anesthetics, General|anesthetics, general|mesh-ancestor
110951083|NCT02065947|Analgesics|analgesics|mesh-ancestor
110951084|NCT02065947|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110951085|NCT02065947|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110951086|NCT02065947|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110951087|NCT02065947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110951088|NCT02065947|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110951089|NCT02065947|Narcotics|narcotics|mesh-ancestor
110951090|NCT02065947|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110951091|NCT02065947|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110951092|NCT02065947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110951093|NCT02065947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110951094|NCT02065947|GABA Modulators|gaba modulators|mesh-ancestor
110951095|NCT02065947|GABA Agents|gaba agents|mesh-ancestor
110951096|NCT02065947|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110951097|NCT02065947|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110951098|NCT02065947|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110449950|NCT01118351|Sunitinib|sunitinib|mesh-list
110951099|NCT02065947|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110951100|NCT02065947|Adrenergic Agents|adrenergic agents|mesh-ancestor
110951101|NCT02065947|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110951102|NCT02065947|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110951103|NCT02065947|Autonomic Agents|autonomic agents|mesh-ancestor
110951104|NCT02065947|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110951105|NCT02065947|Respiratory System Agents|respiratory system agents|mesh-ancestor
110951106|NCT02065947|Mydriatics|mydriatics|mesh-ancestor
110951107|NCT02065947|Sympathomimetics|sympathomimetics|mesh-ancestor
110951108|NCT02065947|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110951109|NCT02065947|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110951110|NCT02065947|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110951111|NCT02065947|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110951112|NCT02065947|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
110951113|NCT02065947|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110951114|NCT02065947|Cholinergic Agents|cholinergic agents|mesh-ancestor
110951115|NCT03436472|Dexmedetomidine|dexmedetomidine|mesh-list
110951116|NCT03436472|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110951117|NCT03436472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110951118|NCT03436472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110951119|NCT03436472|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110951120|NCT03436472|Analgesics|analgesics|mesh-ancestor
110951121|NCT03436472|Sensory System Agents|sensory system agents|mesh-ancestor
110951122|NCT03436472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110951123|NCT03436472|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110951124|NCT03436472|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110951125|NCT03436472|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110951126|NCT03436472|Adrenergic Agents|adrenergic agents|mesh-ancestor
110951127|NCT03436472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110951128|NCT03436472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110951129|NCT02066103|Paclitaxel|paclitaxel|mesh-list
110951130|NCT02066103|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110951131|NCT02066103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110951132|NCT02066103|Tubulin Modulators|tubulin modulators|mesh-ancestor
110951133|NCT02066103|Antimitotic Agents|antimitotic agents|mesh-ancestor
110951134|NCT02066103|Mitosis Modulators|mitosis modulators|mesh-ancestor
110951135|NCT02066103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110951136|NCT04809532|Tramadol|tramadol|mesh-list
110951137|NCT04809532|Bupivacaine|bupivacaine|mesh-list
110951138|NCT04809532|Anesthetics, Local|anesthetics, local|mesh-ancestor
110951139|NCT04809532|Anesthetics|anesthetics|mesh-ancestor
110951140|NCT04809532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110951141|NCT04809532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110951142|NCT04809532|Sensory System Agents|sensory system agents|mesh-ancestor
110951143|NCT04809532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110951144|NCT04809532|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110951145|NCT04809532|Narcotics|narcotics|mesh-ancestor
110951146|NCT04809532|Analgesics|analgesics|mesh-ancestor
110951147|NCT04809142|Gemcitabine|gemcitabine|mesh-list
110951148|NCT04809142|Capecitabine|capecitabine|mesh-list
110951149|NCT04809142|Oxaliplatin|oxaliplatin|mesh-list
110951150|NCT04809142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110951152|NCT04809142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110951153|NCT04809142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110951154|NCT02064777|Tacrolimus|tacrolimus|mesh-list
110951155|NCT02064777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110951156|NCT02064777|Immunologic Factors|immunologic factors|mesh-ancestor
110951157|NCT02064777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110951158|NCT02064777|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110951159|NCT02064777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110951160|NCT02064777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110951161|NCT02069145|Sorafenib|sorafenib|mesh-list
110951162|NCT02069145|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
110951163|NCT02069145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110951164|NCT02069145|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110951165|NCT02069145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110951166|NCT02069145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110951167|NCT02069145|Immunologic Factors|immunologic factors|mesh-ancestor
110951168|NCT02069145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110951169|NCT04830358|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110951170|NCT04830358|Immunologic Factors|immunologic factors|mesh-ancestor
110951171|NCT04830358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110951172|NCT03444272|Sofosbuvir|sofosbuvir|mesh-list
110951173|NCT03444272|Antiviral Agents|antiviral agents|mesh-ancestor
110951174|NCT03444272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110951175|NCT03347331|Befiradol|befiradol|mesh-list
110951176|NCT03347331|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110951177|NCT03347331|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110951178|NCT03347331|Serotonin Agents|serotonin agents|mesh-ancestor
110951179|NCT03347331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110951180|NCT03347331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110951181|NCT03347331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110951182|NCT05573373|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
110951183|NCT05573373|Antineoplastic Agents|antineoplastic agents|mesh-list
110951184|NCT05573373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110951185|NCT05573373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110951186|NCT03109652|Tranexamic Acid|tranexamic acid|mesh-list
110951187|NCT03109652|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110951188|NCT03109652|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110951189|NCT03109652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110951190|NCT03109652|Hemostatics|hemostatics|mesh-ancestor
110951191|NCT03109652|Coagulants|coagulants|mesh-ancestor
110951192|NCT02069301|Fluoxetine|fluoxetine|mesh-list
110951193|NCT02069301|Antidepressive Agents|antidepressive agents|mesh-list
110951194|NCT02069301|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110951195|NCT02069301|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110951196|NCT02069301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110951197|NCT02069301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110951198|NCT02069301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110951199|NCT02069301|Serotonin Agents|serotonin agents|mesh-ancestor
110951200|NCT02069301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110951201|NCT02069301|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110951202|NCT02069301|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110951203|NCT02069301|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110951204|NCT02069301|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110951205|NCT02069301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110951206|NCT03035656|Ropivacaine|ropivacaine|mesh-list
110951207|NCT03035656|Anesthetics, Local|anesthetics, local|mesh-ancestor
110951208|NCT03035656|Anesthetics|anesthetics|mesh-ancestor
110951209|NCT03035656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110951210|NCT03035656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110951211|NCT03035656|Sensory System Agents|sensory system agents|mesh-ancestor
110951212|NCT03035656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110951213|NCT03443960|Amitriptyline|amitriptyline|mesh-list
110951214|NCT03443960|Cyclobenzaprine|cyclobenzaprine|mesh-list
110951215|NCT03443960|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110951216|NCT03443960|Antidepressive Agents|antidepressive agents|mesh-ancestor
110951217|NCT03443960|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110951218|NCT03443960|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110951219|NCT03443960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110951220|NCT03443960|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110951221|NCT03443960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110951222|NCT03443960|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110951223|NCT03443960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110951224|NCT03443960|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110951225|NCT03443960|Analgesics|analgesics|mesh-ancestor
110951226|NCT03443960|Sensory System Agents|sensory system agents|mesh-ancestor
110951227|NCT03443960|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110951228|NCT03443960|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110951229|NCT03443960|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110951230|NCT03443960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110951231|NCT03443960|Adrenergic Agents|adrenergic agents|mesh-ancestor
110951232|NCT03443960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110951233|NCT05616754|Vaccines|vaccines|mesh-list
110951234|NCT05616754|Immunologic Factors|immunologic factors|mesh-ancestor
110951235|NCT05616754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110951236|NCT03440996|Listerine|listerine|mesh-list
110951237|NCT03440996|Sodium Fluoride|sodium fluoride|mesh-list
110951238|NCT03440996|Cariostatic Agents|cariostatic agents|mesh-ancestor
110951239|NCT03440996|Protective Agents|protective agents|mesh-ancestor
110951240|NCT03440996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110951241|NCT03440996|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110951242|NCT03440996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110951243|NCT04451174|Prednisone|prednisone|mesh-list
110663209|NCT00057811|Etoposide|etoposide|mesh-list
110951244|NCT04451174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110951245|NCT04451174|Glucocorticoids|glucocorticoids|mesh-ancestor
110951246|NCT04451174|Hormones|hormones|mesh-ancestor
110951247|NCT04451174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110951248|NCT04451174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110951249|NCT04451174|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110951250|NCT04451174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110951251|NCT04828642|Vitamins|vitamins|mesh-list
110951252|NCT04828642|Ascorbic Acid|ascorbic acid|mesh-list
110951253|NCT04828642|Vitamin E|vitamin e|mesh-list
110951254|NCT04828642|Tocopherols|tocopherols|mesh-list
110951255|NCT04828642|Micronutrients|micronutrients|mesh-ancestor
110951256|NCT04828642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110951257|NCT04828642|Antioxidants|antioxidants|mesh-ancestor
110951258|NCT04828642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110951259|NCT04828642|Protective Agents|protective agents|mesh-ancestor
110951260|NCT03433352|Methimazole|methimazole|mesh-list
110951261|NCT03433352|Propylthiouracil|propylthiouracil|mesh-list
110951262|NCT03433352|Antithyroid Agents|antithyroid agents|mesh-ancestor
110951263|NCT03433352|Hormone Antagonists|hormone antagonists|mesh-ancestor
110951264|NCT03433352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110951265|NCT03433352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110951266|NCT03433352|Antimetabolites|antimetabolites|mesh-ancestor
110951267|NCT03433352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110951268|NCT04828564|Ribavirin|ribavirin|mesh-list
110951269|NCT04828564|Favipiravir|favipiravir|mesh-list
110951270|NCT04828564|Antimetabolites|antimetabolites|mesh-ancestor
110951271|NCT04828564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110951272|NCT04828564|Antiviral Agents|antiviral agents|mesh-ancestor
110951273|NCT04828564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110951274|NCT03435302|Temozolomide|temozolomide|mesh-list
110951275|NCT03435302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110951276|NCT03435302|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110951277|NCT03435302|Alkylating Agents|alkylating agents|mesh-ancestor
110951278|NCT03435302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110951279|NCT04973150|Anesthetics|anesthetics|mesh-list
110951280|NCT04973150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110951281|NCT04973150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110951282|NCT03433196|Atorvastatin|atorvastatin|mesh-list
110951283|NCT03433196|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110951284|NCT03433196|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110951285|NCT03433196|Antimetabolites|antimetabolites|mesh-ancestor
110951286|NCT03433196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110951287|NCT03433196|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110951288|NCT03433196|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110951289|NCT03433196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110951290|NCT02792829|Lenvatinib|lenvatinib|mesh-list
110951291|NCT02792829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110951292|NCT02792829|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110951293|NCT02792829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110951294|NCT02792829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110951295|NCT02066571|Droxidopa|droxidopa|mesh-list
110951296|NCT02066571|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110951297|NCT02066571|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110951298|NCT02066649|Carvedilol|carvedilol|mesh-list
110951299|NCT02066649|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110951300|NCT02066649|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110951301|NCT02066649|Adrenergic Agents|adrenergic agents|mesh-ancestor
110951302|NCT02066649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110951303|NCT02066649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110951304|NCT02066649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110951305|NCT02066649|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110951306|NCT02066649|Antioxidants|antioxidants|mesh-ancestor
110951307|NCT02066649|Protective Agents|protective agents|mesh-ancestor
110951308|NCT02066649|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110951309|NCT02066649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110951310|NCT02066649|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110951311|NCT02066649|Vasodilator Agents|vasodilator agents|mesh-ancestor
110951312|NCT02066649|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110951313|NCT02066649|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110951314|NCT02070003|Analgesics, Opioid|analgesics, opioid|mesh-list
110951315|NCT02070003|Narcotics|narcotics|mesh-ancestor
110951316|NCT02070003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110951317|NCT02070003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110951318|NCT02070003|Analgesics|analgesics|mesh-ancestor
110951319|NCT02070003|Sensory System Agents|sensory system agents|mesh-ancestor
110951320|NCT02070003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110951321|NCT02070159|Clopidogrel|clopidogrel|mesh-list
110951322|NCT02070159|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
110951323|NCT02070159|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110951324|NCT02070159|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110951325|NCT02070159|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110951326|NCT02070159|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110951327|NCT02070159|Purinergic Agents|purinergic agents|mesh-ancestor
110951328|NCT02070159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110951329|NCT02070159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110951330|NCT02070159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110951331|NCT05619328|Vitamins|vitamins|mesh-list
110951332|NCT05619328|Vitamin B Complex|vitamin b complex|mesh-list
110951333|NCT05619328|Micronutrients|micronutrients|mesh-ancestor
110951334|NCT05619328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110951335|NCT05559099|Tecovirimat|tecovirimat|mesh-list
110951336|NCT05559099|Antiviral Agents|antiviral agents|mesh-ancestor
110951337|NCT05559099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110951338|NCT03432884|Moxifloxacin|moxifloxacin|mesh-list
110951339|NCT03432884|Zanubrutinib|zanubrutinib|mesh-list
110951340|NCT03432884|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110951341|NCT03432884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110951342|NCT03432884|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110951343|NCT03432884|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110951344|NCT03432884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110951345|NCT03432884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110951346|NCT03432884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110951347|NCT03432884|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110951348|NCT04827784|Anesthetics|anesthetics|mesh-list
110951349|NCT04827784|Anesthetics, Local|anesthetics, local|mesh-list
110951350|NCT04827784|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110951351|NCT04827784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110951352|NCT04827784|Sensory System Agents|sensory system agents|mesh-ancestor
110951353|NCT04827784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110951354|NCT03986996|Amoxicillin|amoxicillin|mesh-list
110951355|NCT03986996|Metronidazole|metronidazole|mesh-list
110951356|NCT03986996|Doxycycline|doxycycline|mesh-list
110951357|NCT03986996|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110951358|NCT03986996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110951359|NCT03986996|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110951360|NCT03986996|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110951361|NCT03986996|Antimalarials|antimalarials|mesh-ancestor
110951362|NCT04827472|Fexuprazan|fexuprazan|mesh-list
110951363|NCT04827472|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110951364|NCT04796428|Dapagliflozin|dapagliflozin|mesh-list
110951365|NCT04796428|Empagliflozin|empagliflozin|mesh-list
110951366|NCT04796428|Canagliflozin|canagliflozin|mesh-list
110951367|NCT04796428|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110951368|NCT04796428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110951369|NCT04796428|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110951370|NCT04796428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110951371|NCT03432728|Anesthetics|anesthetics|mesh-list
110024193|NCT00004368|Gout Suppressants|gout suppressants|mesh-ancestor
110951372|NCT03432728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110951373|NCT03432728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110951374|NCT04450160|Temozolomide|temozolomide|mesh-list
110951375|NCT04450160|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110951376|NCT04450160|Alkylating Agents|alkylating agents|mesh-ancestor
110951377|NCT04450160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110951378|NCT04450160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110951379|NCT03432572|Riboflavin|riboflavin|mesh-list
110951380|NCT03432572|Thiamine|thiamine|mesh-list
110951381|NCT03432572|Vitamin B Complex|vitamin b complex|mesh-ancestor
110951382|NCT03432572|Vitamins|vitamins|mesh-ancestor
110951383|NCT03432572|Micronutrients|micronutrients|mesh-ancestor
110951384|NCT03432572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110951385|NCT03432572|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110951386|NCT03432572|Dermatologic Agents|dermatologic agents|mesh-ancestor
110951387|NCT02260323|Antirheumatic Agents|antirheumatic agents|mesh-list
110951388|NCT02805504|Bupivacaine|bupivacaine|mesh-list
110951389|NCT02805504|Anesthetics, Local|anesthetics, local|mesh-ancestor
110951390|NCT02805504|Anesthetics|anesthetics|mesh-ancestor
110951391|NCT02805504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110663369|NCT00780377|Kininogens|kininogens|mesh-list
110951392|NCT02805504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110951393|NCT02805504|Sensory System Agents|sensory system agents|mesh-ancestor
110663435|NCT00992576|Analgesics|analgesics|mesh-ancestor
110951394|NCT02805504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110951396|NCT02783508|Nitrous Oxide|nitrous oxide|mesh-list
110951397|NCT02783508|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110951398|NCT02783508|Anesthetics, General|anesthetics, general|mesh-ancestor
110951399|NCT02783508|Anesthetics|anesthetics|mesh-ancestor
110951400|NCT02783508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110951401|NCT02783508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110951402|NCT02783508|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110951403|NCT02783508|Analgesics|analgesics|mesh-ancestor
110951404|NCT02783508|Sensory System Agents|sensory system agents|mesh-ancestor
110951405|NCT02783508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110951406|NCT02783508|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110951407|NCT02783508|Narcotics|narcotics|mesh-ancestor
110951408|NCT02783508|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110951409|NCT02071407|Midazolam|midazolam|mesh-list
110951410|NCT02071407|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110951411|NCT02071407|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110951412|NCT02071407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110951413|NCT02071407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110951414|NCT02071407|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110951415|NCT02071407|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110951416|NCT02071407|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110951417|NCT02071407|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110951418|NCT02071407|Anesthetics, General|anesthetics, general|mesh-ancestor
110951419|NCT02071407|Anesthetics|anesthetics|mesh-ancestor
110951420|NCT02071407|GABA Modulators|gaba modulators|mesh-ancestor
110951421|NCT02071407|GABA Agents|gaba agents|mesh-ancestor
110951422|NCT02071407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110951423|NCT02071407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110951424|NCT02281266|Entecavir|entecavir|mesh-list
110951425|NCT02281266|Thymalfasin|thymalfasin|mesh-list
110951426|NCT02281266|Antiviral Agents|antiviral agents|mesh-ancestor
110951427|NCT02281266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110951428|NCT02281266|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110951429|NCT02281266|Immunologic Factors|immunologic factors|mesh-ancestor
110951430|NCT02281266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110951431|NCT00625326|Calcipotriene|calcipotriene|mesh-list
110951432|NCT00625326|Dermatologic Agents|dermatologic agents|mesh-ancestor
110951433|NCT03434054|Losartan|losartan|mesh-list
110951434|NCT03434054|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110951435|NCT03434054|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110951436|NCT03434054|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110951437|NCT03434054|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110951438|NCT03434054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110951439|NCT03433976|Anesthetics|anesthetics|mesh-list
110951440|NCT03433976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110951441|NCT03433976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110951442|NCT04473144|Urinastatin|urinastatin|mesh-list
110951443|NCT04473144|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
110951444|NCT04473144|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110951445|NCT04473144|Protease Inhibitors|protease inhibitors|mesh-ancestor
110951446|NCT04473144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110951447|NCT04473144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110951448|NCT02605642|Infliximab|infliximab|mesh-list
110951449|NCT02605642|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110951450|NCT02605642|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110951451|NCT02605642|Dermatologic Agents|dermatologic agents|mesh-ancestor
110951452|NCT02605642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110951453|NCT02605642|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110951454|NCT00624858|Naltrexone|naltrexone|mesh-list
110951455|NCT00624858|Bupropion|bupropion|mesh-list
110951456|NCT00624858|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110951457|NCT00624858|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110951458|NCT00624858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110951459|NCT00624858|Sensory System Agents|sensory system agents|mesh-ancestor
110951460|NCT00624858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110951461|NCT00624858|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110951462|NCT00624858|Antidepressive Agents|antidepressive agents|mesh-ancestor
110951463|NCT00624858|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110951464|NCT00624858|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110951465|NCT00624858|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110951466|NCT00624858|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110951467|NCT00624858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110951468|NCT00624858|Dopamine Agents|dopamine agents|mesh-ancestor
110951469|NCT00624858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110951470|NCT00624858|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110951471|NCT00624858|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110951472|NCT00624858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110951473|NCT03128528|Empagliflozin|empagliflozin|mesh-list
110951474|NCT03128528|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110951475|NCT03128528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110951476|NCT03128528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110951477|NCT03128528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110951478|NCT02071641|Sunitinib|sunitinib|mesh-list
110951479|NCT02071641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110951480|NCT02071641|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110951481|NCT02071641|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110951482|NCT02071641|Growth Substances|growth substances|mesh-ancestor
110951483|NCT02071641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110951484|NCT02071641|Growth Inhibitors|growth inhibitors|mesh-ancestor
110951485|NCT02071641|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110951486|NCT02071641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110951487|NCT02071641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110951488|NCT02253810|Tranexamic Acid|tranexamic acid|mesh-list
110951489|NCT02253810|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110951490|NCT02253810|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110951491|NCT02253810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110951492|NCT02253810|Hemostatics|hemostatics|mesh-ancestor
110951493|NCT02253810|Coagulants|coagulants|mesh-ancestor
110951494|NCT03298893|Nivolumab|nivolumab|mesh-list
110951495|NCT03298893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110951496|NCT03298893|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110951497|NCT03298893|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110951498|NCT03298893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110951499|NCT00673062|Pseudoephedrine|pseudoephedrine|mesh-list
110951500|NCT00673062|Ephedrine|ephedrine|mesh-list
110951501|NCT00673062|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110951502|NCT00673062|Autonomic Agents|autonomic agents|mesh-ancestor
110951503|NCT00673062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110951504|NCT00673062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110951505|NCT00673062|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110951506|NCT00673062|Respiratory System Agents|respiratory system agents|mesh-ancestor
110951507|NCT00673062|Nasal Decongestants|nasal decongestants|mesh-ancestor
110951508|NCT00673062|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110951509|NCT00673062|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110951510|NCT00673062|Sympathomimetics|sympathomimetics|mesh-ancestor
110951511|NCT00673062|Adrenergic Agents|adrenergic agents|mesh-ancestor
110951512|NCT00673062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110951513|NCT00673062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110951514|NCT03559803|Cisplatin|cisplatin|mesh-list
110951515|NCT03559803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110951516|NCT03439358|Magnesium Sulfate|magnesium sulfate|mesh-list
110951517|NCT03439358|Analgesics|analgesics|mesh-ancestor
110951518|NCT03439358|Sensory System Agents|sensory system agents|mesh-ancestor
110951519|NCT03439358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110951520|NCT03439358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111203406|NCT01819129|Insulin|insulin|mesh-list
110951521|NCT03439358|Anesthetics|anesthetics|mesh-ancestor
110951522|NCT03439358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110951523|NCT03439358|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110951524|NCT03439358|Anticonvulsants|anticonvulsants|mesh-ancestor
110951525|NCT03439358|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110951526|NCT03439358|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110951527|NCT03439358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110951528|NCT03439358|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110951529|NCT03439358|Tocolytic Agents|tocolytic agents|mesh-ancestor
110951530|NCT03439358|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110951531|NCT02072031|Sunitinib|sunitinib|mesh-list
110951532|NCT02072031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110951533|NCT02072031|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110951534|NCT02072031|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110951535|NCT02072031|Growth Substances|growth substances|mesh-ancestor
110951536|NCT02072031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110951537|NCT02072031|Growth Inhibitors|growth inhibitors|mesh-ancestor
110951538|NCT02072031|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110951539|NCT02072031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110951540|NCT02072031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110663532|NCT00993122|Ribavirin|ribavirin|mesh-list
110951541|NCT05616442|Vitamin E|vitamin e|mesh-list
110951542|NCT05616442|Ketotifen|ketotifen|mesh-list
110951543|NCT05616442|Vitamins|vitamins|mesh-ancestor
110951544|NCT05616442|Micronutrients|micronutrients|mesh-ancestor
110951545|NCT05616442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110951546|NCT05616442|Antioxidants|antioxidants|mesh-ancestor
110951547|NCT05616442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110951548|NCT05616442|Protective Agents|protective agents|mesh-ancestor
110951549|NCT05616442|Antipruritics|antipruritics|mesh-ancestor
110951550|NCT05616442|Dermatologic Agents|dermatologic agents|mesh-ancestor
110951551|NCT05616442|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110951552|NCT05616442|Histamine Antagonists|histamine antagonists|mesh-ancestor
110951553|NCT05616442|Histamine Agents|histamine agents|mesh-ancestor
110951554|NCT05616442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110951555|NCT05616442|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110951556|NCT02065401|Magnesium Hydroxide|magnesium hydroxide|mesh-list
110951557|NCT02065401|Antacids|antacids|mesh-ancestor
110951558|NCT02065401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110951559|NCT02065401|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110951560|NCT00620256|Timolol|timolol|mesh-list
110951561|NCT00620256|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110951562|NCT00620256|Latanoprost|latanoprost|mesh-list
110951563|NCT00620256|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110951564|NCT00620256|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110951565|NCT00620256|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110951566|NCT00620256|Adrenergic Agents|adrenergic agents|mesh-ancestor
110951567|NCT00620256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110951568|NCT00620256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110951569|NCT00620256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110951570|NCT00620256|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110951571|NCT00620256|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110951572|NCT04805710|Rivaroxaban|rivaroxaban|mesh-list
110951573|NCT04805710|Clopidogrel|clopidogrel|mesh-list
110951574|NCT04805710|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110951575|NCT04805710|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110951576|NCT04805710|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110951577|NCT04805710|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110951578|NCT04805710|Purinergic Agents|purinergic agents|mesh-ancestor
110951579|NCT04805710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110951580|NCT04805710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110951581|NCT04805710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110951582|NCT04805710|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110951583|NCT04805710|Antithrombins|antithrombins|mesh-ancestor
110951584|NCT04805710|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110951585|NCT04805710|Protease Inhibitors|protease inhibitors|mesh-ancestor
110951586|NCT04805710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110951587|NCT04805710|Anticoagulants|anticoagulants|mesh-ancestor
110951588|NCT02076477|Docetaxel|docetaxel|mesh-list
110951589|NCT02076477|Pemetrexed|pemetrexed|mesh-list
110951590|NCT02076477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110951591|NCT02076477|Tubulin Modulators|tubulin modulators|mesh-ancestor
110951592|NCT02076477|Antimitotic Agents|antimitotic agents|mesh-ancestor
110951593|NCT02076477|Mitosis Modulators|mitosis modulators|mesh-ancestor
110951594|NCT02076477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110951595|NCT02076477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110951596|NCT02076477|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110951597|NCT02076477|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110951599|NCT04472832|Enzyme Activators|enzyme activators|mesh-ancestor
110951600|NCT04472832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110951601|NCT04879550|Antithrombins|antithrombins|mesh-list
110951602|NCT04879550|Antithrombin III|antithrombin iii|mesh-list
110951603|NCT04879550|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110951604|NCT04879550|Protease Inhibitors|protease inhibitors|mesh-ancestor
110951605|NCT04879550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110951606|NCT04879550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110951607|NCT04879550|Anticoagulants|anticoagulants|mesh-ancestor
110951608|NCT00613002|Testosterone|testosterone|mesh-list
110951609|NCT00613002|Androgens|androgens|mesh-ancestor
110951610|NCT00613002|Hormones|hormones|mesh-ancestor
110951611|NCT00613002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110951612|NCT00613002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110951613|NCT02076945|Lidocaine|lidocaine|mesh-list
110951614|NCT02076945|Bupivacaine|bupivacaine|mesh-list
110951615|NCT02076945|Anesthetics, Local|anesthetics, local|mesh-ancestor
110951616|NCT02076945|Anesthetics|anesthetics|mesh-ancestor
110663583|NCT00995618|Gout Suppressants|gout suppressants|mesh-ancestor
110951617|NCT02076945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110951618|NCT02076945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110951619|NCT02076945|Sensory System Agents|sensory system agents|mesh-ancestor
110951620|NCT02076945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110951621|NCT02076945|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110951622|NCT02076945|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110951623|NCT02076945|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110951624|NCT02076945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110951625|NCT02076945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110951626|NCT03438890|Chlorhexidine|chlorhexidine|mesh-list
110951627|NCT03438890|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110951628|NCT03438890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110951629|NCT03438890|Disinfectants|disinfectants|mesh-ancestor
110951630|NCT00668772|Tiotropium Bromide|tiotropium bromide|mesh-list
110951631|NCT00668772|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110951632|NCT00668772|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110951633|NCT00668772|Autonomic Agents|autonomic agents|mesh-ancestor
110951634|NCT00668772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110951635|NCT00668772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110951636|NCT00668772|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110951637|NCT00668772|Respiratory System Agents|respiratory system agents|mesh-ancestor
110951638|NCT00668772|Parasympatholytics|parasympatholytics|mesh-ancestor
110951639|NCT00668772|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110951640|NCT00668772|Cholinergic Agents|cholinergic agents|mesh-ancestor
110951641|NCT00668772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110951642|NCT00668772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110951643|NCT00668772|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110951644|NCT00668772|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110951645|NCT00668772|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110951646|NCT00668772|Adrenergic Agents|adrenergic agents|mesh-ancestor
110951647|NCT03438812|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
110951648|NCT03438812|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110951649|NCT03438812|Immunologic Factors|immunologic factors|mesh-ancestor
110951650|NCT03438812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110951651|NCT02077257|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110951652|NCT02077257|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110951653|NCT02077257|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110951654|NCT02077257|Antimetabolites|antimetabolites|mesh-ancestor
110951655|NCT02077257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110951656|NCT02077257|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110951657|NCT02077257|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110951658|NCT02077257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110951659|NCT02732912|Zopiclone|zopiclone|mesh-list
110951660|NCT02732912|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110951661|NCT02732912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110951662|NCT02732912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110951663|NCT02792517|Erenumab|erenumab|mesh-list
110951664|NCT02792517|Norgestimate|norgestimate|mesh-list
110951665|NCT02792517|Contraceptive Agents|contraceptive agents|mesh-list
110951666|NCT02792517|Contraceptives, Oral|contraceptives, oral|mesh-list
110951667|NCT02792517|Estradiol|estradiol|mesh-list
110951668|NCT02792517|Estrogens|estrogens|mesh-ancestor
110951669|NCT02792517|Hormones|hormones|mesh-ancestor
110951670|NCT02792517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110951671|NCT02792517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110951672|NCT02792517|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110951673|NCT02792517|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110951674|NCT02792517|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110951675|NCT02792517|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
110951676|NCT02792517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110951677|NCT02792517|Analgesics|analgesics|mesh-ancestor
110951678|NCT02792517|Sensory System Agents|sensory system agents|mesh-ancestor
110951679|NCT02792517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110951680|NCT02792517|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110951681|NCT03431714|Artesunate|artesunate|mesh-list
110951682|NCT03431714|Piperaquine|piperaquine|mesh-list
110951683|NCT03431714|Amodiaquine|amodiaquine|mesh-list
110951684|NCT03431714|Artenimol|artenimol|mesh-list
110951685|NCT03431714|Antimalarials|antimalarials|mesh-ancestor
110951686|NCT03431714|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110951687|NCT03431714|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110951688|NCT03431714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110951689|NCT03431714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110663662|NCT00666263|Immunoglobulins|immunoglobulins|mesh-list
110951690|NCT03431714|Antiviral Agents|antiviral agents|mesh-ancestor
110951691|NCT03431714|Schistosomicides|schistosomicides|mesh-ancestor
110951692|NCT03431714|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110951693|NCT03431714|Anthelmintics|anthelmintics|mesh-ancestor
110951694|NCT03433586|Aspirin|aspirin|mesh-list
110951695|NCT03433586|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110951696|NCT03433586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110951697|NCT03433586|Analgesics|analgesics|mesh-ancestor
110951698|NCT03433586|Sensory System Agents|sensory system agents|mesh-ancestor
110951699|NCT03433586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110951700|NCT03433586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110951701|NCT03433586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110951702|NCT03433586|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110951703|NCT03433586|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110951704|NCT03433586|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110951705|NCT03433586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110951706|NCT03433586|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110951707|NCT03433586|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110951708|NCT03433586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110951709|NCT03433586|Antipyretics|antipyretics|mesh-ancestor
110951710|NCT03431558|Lactoferrin|lactoferrin|mesh-list
110951711|NCT03431558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110951712|NCT02273622|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
110951713|NCT02273622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110951714|NCT02273622|Antioxidants|antioxidants|mesh-ancestor
110951715|NCT02273622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110951716|NCT02273622|Protective Agents|protective agents|mesh-ancestor
110951717|NCT02273622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110951718|NCT02273622|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110951719|NCT02077803|Metformin|metformin|mesh-list
110951720|NCT02077803|Canagliflozin|canagliflozin|mesh-list
110951721|NCT02077803|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110951722|NCT02077803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110951723|NCT02077803|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110951724|NCT02077803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110951725|NCT02072811|Cytarabine|cytarabine|mesh-list
110951726|NCT02072811|Daunorubicin|daunorubicin|mesh-list
110951727|NCT02072811|Mitoxantrone|mitoxantrone|mesh-list
110951728|NCT02072811|Cladribine|cladribine|mesh-list
110951729|NCT02072811|Lenograstim|lenograstim|mesh-list
110951730|NCT02072811|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110951731|NCT02072811|Antimetabolites|antimetabolites|mesh-ancestor
110951732|NCT02072811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110951733|NCT02072811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110951734|NCT02072811|Antiviral Agents|antiviral agents|mesh-ancestor
110951735|NCT02072811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110951736|NCT02072811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110951737|NCT02072811|Immunologic Factors|immunologic factors|mesh-ancestor
110951738|NCT02072811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110951739|NCT02072811|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110951740|NCT02072811|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110951741|NCT02072811|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110951742|NCT02072811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110951743|NCT02072811|Analgesics|analgesics|mesh-ancestor
110951744|NCT02072811|Sensory System Agents|sensory system agents|mesh-ancestor
110951745|NCT02072811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110951746|NCT02072811|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110951748|NCT02080377|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110951749|NCT02080377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110951750|NCT02072967|Rituximab|rituximab|mesh-list
110951751|NCT02072967|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110951752|NCT02072967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110951753|NCT02072967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110951754|NCT02072967|Immunologic Factors|immunologic factors|mesh-ancestor
110951755|NCT02072967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110951756|NCT02072967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110951757|NCT02072967|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110951758|NCT02072967|Alkylating Agents|alkylating agents|mesh-ancestor
110951759|NCT02072967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110951760|NCT02073357|Anesthetics|anesthetics|mesh-list
110663733|NCT00784511|Ergocalciferols|ergocalciferols|mesh-list
110951761|NCT02073357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110951762|NCT02073357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110951763|NCT02073669|Interferons|interferons|mesh-list
110951764|NCT02073669|Interferon-gamma|interferon-gamma|mesh-list
110951765|NCT02073669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110951766|NCT02073669|Antiviral Agents|antiviral agents|mesh-ancestor
110951767|NCT02073669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110951768|NCT03428282|Anesthetics|anesthetics|mesh-list
110951769|NCT03428282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110951770|NCT03428282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110951771|NCT00463242|Agomelatine|agomelatine|mesh-list
110951772|NCT00463242|Paroxetine|paroxetine|mesh-list
110951773|NCT00463242|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110951774|NCT00463242|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110951775|NCT00463242|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110951776|NCT00463242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110951777|NCT00463242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110951778|NCT00463242|Serotonin Agents|serotonin agents|mesh-ancestor
110951779|NCT00463242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110951780|NCT00463242|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110951781|NCT00463242|Antidepressive Agents|antidepressive agents|mesh-ancestor
110951782|NCT00463242|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110951783|NCT00463242|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110951784|NCT00463242|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110951785|NCT00463242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110951786|NCT00463242|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110951787|NCT00463242|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110951788|NCT02074137|Prednisone|prednisone|mesh-list
110951789|NCT02074137|Prednisolone|prednisolone|mesh-list
110951790|NCT02074137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110951791|NCT02074137|Glucocorticoids|glucocorticoids|mesh-ancestor
110951792|NCT02074137|Hormones|hormones|mesh-ancestor
110951793|NCT02074137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110951794|NCT02074137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110951795|NCT02074137|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110951796|NCT02074137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110951797|NCT00600288|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110951798|NCT00600288|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110951799|NCT00594984|Irinotecan|irinotecan|mesh-list
110951800|NCT00594984|Cetuximab|cetuximab|mesh-list
110951801|NCT00594984|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110951802|NCT00594984|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110951803|NCT00594984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110951804|NCT00594984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110951805|NCT00594984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110951806|NCT00594984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110951807|NCT01369485|Caffeine|caffeine|mesh-list
110951808|NCT01369485|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110951809|NCT01369485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110951810|NCT01369485|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110951811|NCT01369485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110951812|NCT01369485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110951813|NCT01369485|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110951814|NCT01369485|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110940926|NCT04854538|Hormones|hormones|mesh-ancestor
110951815|NCT01369485|Purinergic Agents|purinergic agents|mesh-ancestor
110951816|NCT01369485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110951817|NCT03422978|Dexmedetomidine|dexmedetomidine|mesh-list
110951818|NCT03422978|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110951819|NCT03422978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110951820|NCT03422978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110951821|NCT03422978|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110951822|NCT03422978|Analgesics|analgesics|mesh-ancestor
110951823|NCT03422978|Sensory System Agents|sensory system agents|mesh-ancestor
110951824|NCT03422978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110951825|NCT03422978|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110951826|NCT03422978|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110951827|NCT03422978|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110951828|NCT03422978|Adrenergic Agents|adrenergic agents|mesh-ancestor
110951829|NCT03422978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110951830|NCT03422978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110951832|NCT02278692|Vitamins|vitamins|mesh-ancestor
110951833|NCT02278692|Micronutrients|micronutrients|mesh-ancestor
110951834|NCT02278692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110951835|NCT02278692|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110951836|NCT02278692|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110951837|NCT02278692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110951838|NCT02278692|Hemostatics|hemostatics|mesh-ancestor
110951839|NCT02278692|Coagulants|coagulants|mesh-ancestor
110951840|NCT02281968|Naproxen|naproxen|mesh-list
110951841|NCT02281968|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110951842|NCT02281968|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110951843|NCT02281968|Analgesics|analgesics|mesh-ancestor
110951844|NCT02281968|Sensory System Agents|sensory system agents|mesh-ancestor
110951845|NCT02281968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110951846|NCT02281968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110951847|NCT02281968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110951848|NCT02281968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110951849|NCT02281968|Gout Suppressants|gout suppressants|mesh-ancestor
110951850|NCT02281968|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110951851|NCT02281968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110951852|NCT02281968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110951853|NCT02080845|Theobromine|theobromine|mesh-list
110951854|NCT02080845|Caffeine|caffeine|mesh-list
110951855|NCT02080845|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110951856|NCT02080845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110951857|NCT02080845|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110951858|NCT02080845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110951859|NCT02080845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110951860|NCT02080845|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110951861|NCT02080845|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110951862|NCT02080845|Purinergic Agents|purinergic agents|mesh-ancestor
110951863|NCT02080845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110951864|NCT02080845|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110951865|NCT02080845|Autonomic Agents|autonomic agents|mesh-ancestor
110951866|NCT02080845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110951867|NCT02080845|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110951868|NCT02080845|Respiratory System Agents|respiratory system agents|mesh-ancestor
110951869|NCT02080845|Vasodilator Agents|vasodilator agents|mesh-ancestor
110951870|NCT02284230|Liraglutide|liraglutide|mesh-list
110951871|NCT02284230|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110951872|NCT02284230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110951873|NCT02284230|Incretins|incretins|mesh-ancestor
110951874|NCT02284230|Hormones|hormones|mesh-ancestor
110951875|NCT02284230|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110951876|NCT02792088|Tenofovir|tenofovir|mesh-list
110951877|NCT02792088|Antiviral Agents|antiviral agents|mesh-ancestor
110951878|NCT02792088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110951879|NCT02792088|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110951880|NCT02792088|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110951881|NCT02792088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110951882|NCT02792088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110951883|NCT02792088|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110951884|NCT02792088|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110951885|NCT02074293|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110951886|NCT02074293|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110951887|NCT02074293|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110951888|NCT02074293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110951889|NCT02074293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110951890|NCT02074293|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110951891|NCT02074293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110951892|NCT02074293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110951893|NCT02074293|Cholinergic Agents|cholinergic agents|mesh-ancestor
110951894|NCT02074293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110951895|NCT00451152|Hydrocortisone|hydrocortisone|mesh-list
110951896|NCT00451152|Anecortave|anecortave|mesh-list
110951897|NCT00451152|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110951898|NCT00451152|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110951899|NCT00451152|Growth Substances|growth substances|mesh-ancestor
110951900|NCT00451152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110951901|NCT00451152|Growth Inhibitors|growth inhibitors|mesh-ancestor
110951902|NCT00451152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110951903|NCT00451152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110951904|NCT02078583|Fentanyl|fentanyl|mesh-list
110951905|NCT02078583|Remifentanil|remifentanil|mesh-list
110951906|NCT02078583|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110951907|NCT02078583|Narcotics|narcotics|mesh-ancestor
110951908|NCT02078583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110951909|NCT02078583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110951910|NCT02078583|Analgesics|analgesics|mesh-ancestor
110951911|NCT02078583|Sensory System Agents|sensory system agents|mesh-ancestor
110951912|NCT02078583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110951913|NCT02078583|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110951914|NCT02078583|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110951915|NCT02078583|Anesthetics, General|anesthetics, general|mesh-ancestor
110951916|NCT02078583|Anesthetics|anesthetics|mesh-ancestor
110951917|NCT03069638|Dexmedetomidine|dexmedetomidine|mesh-list
110951918|NCT03069638|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
110951919|NCT03069638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110951920|NCT03069638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110951921|NCT03069638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110951922|NCT03069638|Analgesics|analgesics|mesh-ancestor
110951923|NCT03069638|Sensory System Agents|sensory system agents|mesh-ancestor
110951924|NCT03069638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110951925|NCT03069638|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110951926|NCT03069638|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110951927|NCT03069638|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110951928|NCT03069638|Adrenergic Agents|adrenergic agents|mesh-ancestor
110951929|NCT03069638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110951930|NCT03069638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110951931|NCT02948660|Zolpidem|zolpidem|mesh-list
110951932|NCT02948660|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110951933|NCT02948660|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110951934|NCT02948660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110951935|NCT02948660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110951936|NCT02948660|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
110951937|NCT02948660|GABA Agonists|gaba agonists|mesh-ancestor
110951938|NCT02948660|GABA Agents|gaba agents|mesh-ancestor
110951939|NCT02948660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110951940|NCT02948660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110951941|NCT02074605|Interferons|interferons|mesh-list
110951942|NCT02074605|Interferon-alpha|interferon-alpha|mesh-list
110951943|NCT02074605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110951944|NCT02074605|Antiviral Agents|antiviral agents|mesh-ancestor
110951945|NCT02074605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110951946|NCT02074605|Immunologic Factors|immunologic factors|mesh-ancestor
110951947|NCT02074605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110951948|NCT00448422|Prulifloxacin|prulifloxacin|mesh-list
110951949|NCT00448422|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110951950|NCT00448422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110951951|NCT00448422|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110951952|NCT00448422|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110951953|NCT00448422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110951954|NCT00448422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110951955|NCT00448422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110951956|NCT00583830|Paclitaxel|paclitaxel|mesh-list
110951957|NCT00583830|Carboplatin|carboplatin|mesh-list
110951958|NCT00583830|Mapatumumab|mapatumumab|mesh-list
110951959|NCT00583830|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110951960|NCT00583830|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110951961|NCT00583830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110951962|NCT00583830|Tubulin Modulators|tubulin modulators|mesh-ancestor
110951963|NCT00583830|Antimitotic Agents|antimitotic agents|mesh-ancestor
110951964|NCT00583830|Mitosis Modulators|mitosis modulators|mesh-ancestor
111203407|NCT01819129|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110951965|NCT00583830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110951966|NCT00583830|Immunologic Factors|immunologic factors|mesh-ancestor
110951967|NCT00583830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110951968|NCT03430544|Cariprazine|cariprazine|mesh-list
110951969|NCT03430544|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110951970|NCT03430544|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110951971|NCT03430544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110951972|NCT03430544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110951973|NCT03430544|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110951974|NCT00583674|Cisplatin|cisplatin|mesh-list
110951975|NCT00583674|Capecitabine|capecitabine|mesh-list
110951976|NCT00583674|Trebananib|trebananib|mesh-list
110951977|NCT00583674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110951978|NCT00583674|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110951979|NCT00583674|Antimetabolites|antimetabolites|mesh-ancestor
110951980|NCT00583674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110951981|NCT00583674|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110951982|NCT00583674|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110951983|NCT00583674|Growth Substances|growth substances|mesh-ancestor
110951984|NCT00583674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110951985|NCT00583674|Growth Inhibitors|growth inhibitors|mesh-ancestor
110663958|NCT02555813|Paclitaxel|paclitaxel|mesh-list
110951986|NCT03422510|CXA-10|cxa-10|mesh-list
110951987|NCT03422510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110951988|NCT03430466|Fulvestrant|fulvestrant|mesh-list
110951989|NCT03430466|Tremelimumab|tremelimumab|mesh-list
110951990|NCT03430466|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110951991|NCT03430466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110951992|NCT03430466|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110951993|NCT03430466|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110951994|NCT03430466|Hormone Antagonists|hormone antagonists|mesh-ancestor
110951995|NCT03430466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110951996|NCT03430466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110951997|NCT02280174|Linagliptin|linagliptin|mesh-list
110951998|NCT02280174|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110951999|NCT02280174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110952000|NCT02280174|Incretins|incretins|mesh-ancestor
110952001|NCT02280174|Hormones|hormones|mesh-ancestor
110952002|NCT02280174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110952003|NCT02280174|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110952004|NCT02280174|Protease Inhibitors|protease inhibitors|mesh-ancestor
110952005|NCT02280174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110952006|NCT02280174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110952007|NCT00447564|Buprenorphine|buprenorphine|mesh-list
110952008|NCT00447564|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110952009|NCT00447564|Narcotics|narcotics|mesh-ancestor
110952010|NCT00447564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110952011|NCT00447564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110952012|NCT00447564|Analgesics|analgesics|mesh-ancestor
110952013|NCT00447564|Sensory System Agents|sensory system agents|mesh-ancestor
110952014|NCT00447564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110952015|NCT00447564|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110952016|NCT00576810|Picosulfate sodium|picosulfate sodium|mesh-list
110952017|NCT00576810|Cathartics|cathartics|mesh-ancestor
110952018|NCT00576810|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110952019|NCT00576342|Timolol|timolol|mesh-list
110952020|NCT00576342|Dorzolamide|dorzolamide|mesh-list
110952021|NCT00576342|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110952022|NCT00576342|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110952023|NCT00576342|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110952024|NCT00576342|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110952025|NCT00576342|Adrenergic Agents|adrenergic agents|mesh-ancestor
110952026|NCT00576342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110952027|NCT00576342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110952028|NCT00576342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110952029|NCT00576342|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110952030|NCT00576342|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110952031|NCT00576342|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110952032|NCT00576342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110952033|NCT02282280|Prilocaine|prilocaine|mesh-list
110952034|NCT02282280|Anesthetics, Local|anesthetics, local|mesh-ancestor
110952035|NCT02282280|Anesthetics|anesthetics|mesh-ancestor
110952036|NCT02282280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110952037|NCT02282280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110952038|NCT02282280|Sensory System Agents|sensory system agents|mesh-ancestor
110952040|NCT03429998|Evolocumab|evolocumab|mesh-list
110952041|NCT03429998|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110952042|NCT03429998|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
110952043|NCT03429998|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110952044|NCT03429998|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110952045|NCT03429998|Antimetabolites|antimetabolites|mesh-ancestor
110952046|NCT03429998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110952047|NCT03429998|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110952048|NCT03429998|Protease Inhibitors|protease inhibitors|mesh-ancestor
110952049|NCT03429998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110952050|NCT03429998|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110952051|NCT03429998|Immunologic Factors|immunologic factors|mesh-ancestor
110952052|NCT03429998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110952053|NCT00658008|Paroxetine|paroxetine|mesh-list
110952054|NCT00658008|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110952055|NCT00658008|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110952056|NCT00658008|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110952057|NCT00658008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110952058|NCT00658008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110952059|NCT00658008|Serotonin Agents|serotonin agents|mesh-ancestor
110952060|NCT00658008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110952061|NCT00658008|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110952062|NCT00658008|Antidepressive Agents|antidepressive agents|mesh-ancestor
110952063|NCT00658008|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110952064|NCT00658008|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110952065|NCT00658008|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110952066|NCT00658008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110952067|NCT03427502|Epinephrine|epinephrine|mesh-list
110952068|NCT03427502|Bupivacaine|bupivacaine|mesh-list
110952069|NCT03427502|Anesthetics, Local|anesthetics, local|mesh-ancestor
110952070|NCT03427502|Anesthetics|anesthetics|mesh-ancestor
110952071|NCT03427502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110952072|NCT03427502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110952073|NCT03427502|Sensory System Agents|sensory system agents|mesh-ancestor
110952074|NCT03427502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110952075|NCT03427502|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110952076|NCT03427502|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110952077|NCT03427502|Adrenergic Agents|adrenergic agents|mesh-ancestor
110952078|NCT03427502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110952079|NCT03427502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110952080|NCT03427502|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110952081|NCT03427502|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110952082|NCT03427502|Autonomic Agents|autonomic agents|mesh-ancestor
110952083|NCT03427502|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110952084|NCT03427502|Respiratory System Agents|respiratory system agents|mesh-ancestor
110952085|NCT03427502|Mydriatics|mydriatics|mesh-ancestor
110952086|NCT03427502|Sympathomimetics|sympathomimetics|mesh-ancestor
110952087|NCT03427502|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110952088|NCT00440388|Rituximab|rituximab|mesh-list
110952089|NCT00440388|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110952090|NCT00440388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110952091|NCT00440388|Immunologic Factors|immunologic factors|mesh-ancestor
110952092|NCT00440388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110952093|NCT00440388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110952094|NCT03422042|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110952095|NCT03422042|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
110952096|NCT03422042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110952097|NCT03422042|Antitubercular Agents|antitubercular agents|mesh-ancestor
110952098|NCT04449224|Etanercept|etanercept|mesh-list
110952099|NCT04449224|Abatacept|abatacept|mesh-list
110952100|NCT04449224|Tofacitinib|tofacitinib|mesh-list
110952101|NCT04449224|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110952102|NCT04449224|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110952103|NCT04449224|Analgesics|analgesics|mesh-ancestor
110952104|NCT04449224|Sensory System Agents|sensory system agents|mesh-ancestor
110952105|NCT04449224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110952106|NCT04449224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110952107|NCT04449224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110952108|NCT04449224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110952109|NCT04449224|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110952110|NCT04449224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110952111|NCT04449224|Immunologic Factors|immunologic factors|mesh-ancestor
110952112|NCT04449224|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110952113|NCT04449224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110952114|NCT04449224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110952115|NCT04449224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110952116|NCT04449224|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
110952117|NCT04449224|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110952118|NCT04449224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110952119|NCT00437112|Insulin|insulin|mesh-list
110952120|NCT00437112|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110952121|NCT00437112|Insulin Glargine|insulin glargine|mesh-list
110952122|NCT00437112|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110952123|NCT00437112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110952124|NCT00434850|Gusperimus|gusperimus|mesh-list
110952125|NCT00434850|Sirolimus|sirolimus|mesh-list
110952126|NCT00434850|Etanercept|etanercept|mesh-list
110952127|NCT00434850|Tacrolimus|tacrolimus|mesh-list
110952128|NCT00434850|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110952129|NCT00434850|Basiliximab|basiliximab|mesh-list
110952130|NCT00434850|Daclizumab|daclizumab|mesh-list
110952131|NCT00434850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110952132|NCT00434850|Immunologic Factors|immunologic factors|mesh-ancestor
110952133|NCT00434850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110952134|NCT00434850|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110952135|NCT00434850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110952136|NCT00434850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110952137|NCT00434850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110952138|NCT00434850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110952139|NCT00434850|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110952140|NCT00434850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110952141|NCT00434850|Antifungal Agents|antifungal agents|mesh-ancestor
110952142|NCT00434850|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110952143|NCT00434850|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110952144|NCT00434850|Analgesics|analgesics|mesh-ancestor
110952145|NCT00434850|Sensory System Agents|sensory system agents|mesh-ancestor
110952146|NCT00434850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110952147|NCT00434850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110952148|NCT00434850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110952149|NCT00434850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110952150|NCT00434850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110952151|NCT00434850|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110952152|NCT00434850|Protective Agents|protective agents|mesh-ancestor
110952153|NCT04449380|Interferons|interferons|mesh-list
110952154|NCT04449380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110952155|NCT04449380|Antiviral Agents|antiviral agents|mesh-ancestor
110952156|NCT04449380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110952157|NCT03128216|Bupivacaine|bupivacaine|mesh-list
110952158|NCT03128216|Ropivacaine|ropivacaine|mesh-list
110952159|NCT03128216|Anesthetics, Local|anesthetics, local|mesh-list
110952160|NCT03128216|Anesthetics|anesthetics|mesh-list
110952161|NCT03128216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110952162|NCT03128216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110952163|NCT03128216|Sensory System Agents|sensory system agents|mesh-ancestor
110952164|NCT03128216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110952165|NCT00566202|Escitalopram|escitalopram|mesh-list
110952166|NCT00566202|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110952167|NCT00566202|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110952168|NCT00566202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110952169|NCT00566202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110952170|NCT00566202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110952171|NCT00566202|Serotonin Agents|serotonin agents|mesh-ancestor
110952172|NCT00566202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110952173|NCT02280486|Glimepiride|glimepiride|mesh-list
110952174|NCT02280486|Saxagliptin|saxagliptin|mesh-list
110952175|NCT02280486|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110952176|NCT02280486|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110952177|NCT02280486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110952178|NCT02280486|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110952179|NCT02280486|Immunologic Factors|immunologic factors|mesh-ancestor
110952180|NCT02280486|Incretins|incretins|mesh-ancestor
110952181|NCT02280486|Hormones|hormones|mesh-ancestor
110952182|NCT02280486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110952183|NCT02280486|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110952184|NCT02280486|Protease Inhibitors|protease inhibitors|mesh-ancestor
110952185|NCT02280486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110952186|NCT02280486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110952187|NCT00434226|Paclitaxel|paclitaxel|mesh-list
110952188|NCT00434226|Bevacizumab|bevacizumab|mesh-list
110952189|NCT00434226|Carboplatin|carboplatin|mesh-list
110952191|NCT00434226|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110952192|NCT00434226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110952193|NCT00434226|Tubulin Modulators|tubulin modulators|mesh-ancestor
110952194|NCT00434226|Antimitotic Agents|antimitotic agents|mesh-ancestor
110952195|NCT00434226|Mitosis Modulators|mitosis modulators|mesh-ancestor
110952196|NCT00434226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110952197|NCT00434226|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110952198|NCT00434226|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110952199|NCT00434226|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110952200|NCT00434226|Growth Substances|growth substances|mesh-ancestor
110952201|NCT00434226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110952202|NCT00434226|Growth Inhibitors|growth inhibitors|mesh-ancestor
110952203|NCT00434226|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110952204|NCT00434226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110952205|NCT00430950|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110952206|NCT00430950|Olmesartan|olmesartan|mesh-list
110952207|NCT00430950|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
110952208|NCT00430950|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110952209|NCT00430950|Diuretics|diuretics|mesh-ancestor
110952210|NCT00430950|Natriuretic Agents|natriuretic agents|mesh-ancestor
110952211|NCT00430950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110450094|NCT02881619|Etodolac|etodolac|mesh-list
110952212|NCT00430950|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110952213|NCT00430950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110952214|NCT00430950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110952215|NCT00430950|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110952216|NCT00430950|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110952217|NCT00549744|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|mesh-list
110952218|NCT00549744|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
110952219|NCT00549744|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110952220|NCT00549744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110952221|NCT00549744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110952222|NCT02081391|Tapentadol|tapentadol|mesh-list
110952223|NCT02081391|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110952224|NCT02081391|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110952225|NCT02081391|Narcotics|narcotics|mesh-ancestor
110952226|NCT02081391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110952227|NCT02081391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110952228|NCT02081391|Analgesics|analgesics|mesh-ancestor
110952229|NCT02081391|Sensory System Agents|sensory system agents|mesh-ancestor
110952230|NCT02081391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110952231|NCT02081391|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110952232|NCT02081391|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110952233|NCT02081391|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110952234|NCT02081391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110952235|NCT02081391|Adrenergic Agents|adrenergic agents|mesh-ancestor
110952236|NCT02081391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110952237|NCT00549510|Lisinopril|lisinopril|mesh-list
110952238|NCT00549510|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110952239|NCT00549510|Protease Inhibitors|protease inhibitors|mesh-ancestor
110952240|NCT00549510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110952241|NCT00549510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110952242|NCT00549510|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110952243|NCT00549510|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110952244|NCT00549510|Protective Agents|protective agents|mesh-ancestor
110952245|NCT00549510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110952246|NCT00430092|Fluprednisolone|fluprednisolone|mesh-list
110952247|NCT00430092|Difluprednate|difluprednate|mesh-list
110952248|NCT00430092|Glucocorticoids|glucocorticoids|mesh-ancestor
110952249|NCT00430092|Hormones|hormones|mesh-ancestor
110952250|NCT00430092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110952251|NCT00430092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110952252|NCT00430092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110952253|NCT00427440|Rilotumumab|rilotumumab|mesh-list
110952254|NCT00427440|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110952255|NCT00427440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110952256|NCT00427440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110952257|NCT00427440|Immunologic Factors|immunologic factors|mesh-ancestor
110952258|NCT00427440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110952259|NCT00650832|Darunavir|darunavir|mesh-list
110941365|NCT06058234|Antibodies|antibodies|mesh-list
110952260|NCT00650832|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110952261|NCT00650832|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110952262|NCT00650832|Protease Inhibitors|protease inhibitors|mesh-ancestor
110952263|NCT00650832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110952264|NCT00650832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110952265|NCT00650832|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110952266|NCT00650832|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110952267|NCT00650832|Antiviral Agents|antiviral agents|mesh-ancestor
110952268|NCT00650832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110952269|NCT00425100|Fesoterodine|fesoterodine|mesh-list
110952270|NCT00425100|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110952271|NCT00425100|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110952272|NCT00425100|Cholinergic Agents|cholinergic agents|mesh-ancestor
110952273|NCT00425100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110952274|NCT00425100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110952275|NCT00425100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110952276|NCT00425100|Urological Agents|urological agents|mesh-ancestor
110952277|NCT00546780|Bortezomib|bortezomib|mesh-list
110952278|NCT00546780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110952279|NCT00420888|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110952280|NCT00420888|Naptumomab estafenatox|naptumomab estafenatox|mesh-list
110952281|NCT00420888|Immunoconjugates|immunoconjugates|mesh-list
110952282|NCT00420888|Immunologic Factors|immunologic factors|mesh-ancestor
110952283|NCT00420888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110952284|NCT00543582|Azacitidine|azacitidine|mesh-list
110664257|NCT00788684|Rituximab|rituximab|mesh-list
110952286|NCT00543582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110952287|NCT00543582|Antimetabolites|antimetabolites|mesh-ancestor
110952288|NCT00543582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110952289|NCT00543582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110952290|NCT00543582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110952291|NCT00543582|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110952292|NCT00542724|Insulin|insulin|mesh-list
110952293|NCT00542724|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110952294|NCT00542724|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110952295|NCT00542724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110952296|NCT00412932|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110952297|NCT00412932|Olmesartan|olmesartan|mesh-list
110952298|NCT00412932|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
110952299|NCT00412932|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110952300|NCT00412932|Diuretics|diuretics|mesh-ancestor
110952301|NCT00412932|Natriuretic Agents|natriuretic agents|mesh-ancestor
110952302|NCT00412932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110952303|NCT00412932|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110952304|NCT00412932|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110952305|NCT00412932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110952306|NCT00412932|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110952307|NCT00412932|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110952308|NCT00411528|Prednisone|prednisone|mesh-list
110952309|NCT00411528|Docetaxel|docetaxel|mesh-list
110952310|NCT00411528|Epothilone B|epothilone b|mesh-list
110952311|NCT00411528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110952312|NCT00411528|Tubulin Modulators|tubulin modulators|mesh-ancestor
110952313|NCT00411528|Antimitotic Agents|antimitotic agents|mesh-ancestor
110952314|NCT00411528|Mitosis Modulators|mitosis modulators|mesh-ancestor
110952315|NCT00411528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110952316|NCT00411528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110952317|NCT00411528|Glucocorticoids|glucocorticoids|mesh-ancestor
110952318|NCT00411528|Hormones|hormones|mesh-ancestor
110952319|NCT00411528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110952320|NCT00411528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110952321|NCT00411528|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110952322|NCT00384150|Galiximab|galiximab|mesh-list
110952323|NCT00384150|Rituximab|rituximab|mesh-list
110952324|NCT00384150|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110952325|NCT00384150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110952326|NCT00384150|Immunologic Factors|immunologic factors|mesh-ancestor
110952327|NCT00384150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110952328|NCT00384150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110952329|NCT00384150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110952330|NCT00532038|Ketoprofen|ketoprofen|mesh-list
110952331|NCT00532038|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110952332|NCT00532038|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110952333|NCT00532038|Analgesics|analgesics|mesh-ancestor
110952334|NCT00532038|Sensory System Agents|sensory system agents|mesh-ancestor
110952335|NCT00532038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110952336|NCT00532038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110952337|NCT00532038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110952338|NCT00532038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110952339|NCT00532038|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110952340|NCT00532038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110952341|NCT00532038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110952342|NCT00403416|Mycophenolic Acid|mycophenolic acid|mesh-list
110952343|NCT00403416|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110952344|NCT00403416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110952345|NCT00403416|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110952346|NCT00403416|Antitubercular Agents|antitubercular agents|mesh-ancestor
110952347|NCT00403416|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110952348|NCT00403416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110952349|NCT00403416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110952350|NCT00403416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110952351|NCT00401388|Allopurinol|allopurinol|mesh-list
110952352|NCT00401388|Antiemetics|antiemetics|mesh-list
110952353|NCT00401388|Loperamide|loperamide|mesh-list
110952354|NCT00401388|Antidiarrheals|antidiarrheals|mesh-list
110952355|NCT00401388|Antimetabolites|antimetabolites|mesh-ancestor
110952356|NCT00401388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110952357|NCT00401388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110664333|NCT01043224|Clobetasol|clobetasol|mesh-list
110952358|NCT00401388|Gout Suppressants|gout suppressants|mesh-ancestor
110952360|NCT00401388|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110952362|NCT00401388|Protective Agents|protective agents|mesh-ancestor
110952363|NCT00401388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110952364|NCT00401388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110952365|NCT00401388|Autonomic Agents|autonomic agents|mesh-ancestor
110952366|NCT00401388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110952367|NCT02282826|Acyclovir|acyclovir|mesh-list
110952368|NCT02282826|Antiviral Agents|antiviral agents|mesh-ancestor
110952369|NCT02282826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110952370|NCT00374166|Paroxetine|paroxetine|mesh-list
110952371|NCT00374166|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110952372|NCT00374166|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110952373|NCT00374166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110952374|NCT00374166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110952375|NCT00374166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110952376|NCT00374166|Serotonin Agents|serotonin agents|mesh-ancestor
110952377|NCT00374166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110952378|NCT00374166|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110952379|NCT00374166|Antidepressive Agents|antidepressive agents|mesh-ancestor
110952380|NCT00374166|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110952381|NCT00374166|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110952382|NCT00374166|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110952383|NCT00374166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110952384|NCT03559413|Imiquimod|imiquimod|mesh-list
110952385|NCT03559413|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110952386|NCT03559413|Immunologic Factors|immunologic factors|mesh-ancestor
110952387|NCT03559413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110952388|NCT03559413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110952389|NCT03559413|Interferon Inducers|interferon inducers|mesh-ancestor
110952390|NCT02078895|Botulinum Toxins|botulinum toxins|mesh-list
110952391|NCT02078895|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110952392|NCT02078895|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110952393|NCT02078895|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110952394|NCT02078895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110952395|NCT02078895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110952396|NCT02078895|Cholinergic Agents|cholinergic agents|mesh-ancestor
110952397|NCT02078895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110952398|NCT02078895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110952399|NCT02078895|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110952400|NCT02078895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110952401|NCT02078973|Tolvaptan|tolvaptan|mesh-list
110952402|NCT02078973|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
110952403|NCT02078973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110952404|NCT02078973|Natriuretic Agents|natriuretic agents|mesh-ancestor
110952405|NCT02078973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110952406|NCT00397254|Rizatriptan|rizatriptan|mesh-list
110952407|NCT00397254|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110952408|NCT00397254|Serotonin Agents|serotonin agents|mesh-ancestor
110952409|NCT00397254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111203408|NCT01819129|Insulin Glargine|insulin glargine|mesh-list
110952410|NCT00397254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110952411|NCT00397254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110952412|NCT01369641|Sodium thiosulfate|sodium thiosulfate|mesh-list
110952414|NCT01369641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110952415|NCT01369641|Antidotes|antidotes|mesh-ancestor
110952416|NCT01369641|Protective Agents|protective agents|mesh-ancestor
110952417|NCT01369641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110952418|NCT01369641|Antioxidants|antioxidants|mesh-ancestor
110952419|NCT01369641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110952420|NCT01369641|Antitubercular Agents|antitubercular agents|mesh-ancestor
110952421|NCT01369641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110952422|NCT01369641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110952423|NCT01369641|Chelating Agents|chelating agents|mesh-ancestor
110952424|NCT01369641|Sequestering Agents|sequestering agents|mesh-ancestor
110952425|NCT02283060|Tenofovir|tenofovir|mesh-list
110952426|NCT02283060|Emtricitabine|emtricitabine|mesh-list
110952427|NCT02283060|Efavirenz|efavirenz|mesh-list
110952428|NCT02283060|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110952429|NCT02283060|Cobicistat|cobicistat|mesh-list
110952430|NCT02283060|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110952431|NCT02283060|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110952432|NCT02283060|Elvitegravir|elvitegravir|mesh-list
110952433|NCT02283060|Antiviral Agents|antiviral agents|mesh-ancestor
110952434|NCT02283060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110952435|NCT02283060|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110952436|NCT02283060|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110952437|NCT02283060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110952438|NCT02283060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110952439|NCT02283060|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110952440|NCT02283060|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110952441|NCT02283060|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110952442|NCT02283060|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110952443|NCT02283060|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110952444|NCT02283060|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110952445|NCT02283060|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110952446|NCT02283060|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110952447|NCT02283060|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110952448|NCT02283060|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110952449|NCT03559725|Menthol|menthol|mesh-list
110952450|NCT03559725|Nicotine|nicotine|mesh-list
110952451|NCT03559725|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110952452|NCT03559725|Autonomic Agents|autonomic agents|mesh-ancestor
110952453|NCT03559725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110952454|NCT03559725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110952455|NCT03559725|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110952456|NCT03559725|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110952457|NCT03559725|Cholinergic Agents|cholinergic agents|mesh-ancestor
110952458|NCT03559725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110952459|NCT03559725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110952460|NCT03559725|Antipruritics|antipruritics|mesh-ancestor
110952461|NCT03559725|Dermatologic Agents|dermatologic agents|mesh-ancestor
110952462|NCT00529152|Deferiprone|deferiprone|mesh-list
110952463|NCT00529152|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110952464|NCT00529152|Chelating Agents|chelating agents|mesh-ancestor
110952465|NCT00529152|Sequestering Agents|sequestering agents|mesh-ancestor
110952466|NCT00529152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110952467|NCT00525330|Metformin|metformin|mesh-list
110952468|NCT00525330|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110952469|NCT00525330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110952470|NCT02287272|Cimetidine|cimetidine|mesh-list
110952471|NCT02287272|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110952472|NCT02287272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110952473|NCT02287272|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110952474|NCT02287272|Histamine Antagonists|histamine antagonists|mesh-ancestor
110952475|NCT02287272|Histamine Agents|histamine agents|mesh-ancestor
110952476|NCT02287272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110952477|NCT02287272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110952478|NCT02287272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110952479|NCT02287272|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110952480|NCT02287272|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110952481|NCT02287272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110952482|NCT00392574|Prulifloxacin|prulifloxacin|mesh-list
110952483|NCT00392574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110952484|NCT00392574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110952485|NCT00392574|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110952486|NCT00392574|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110952487|NCT00392574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110450109|NCT04303806|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110952488|NCT00392574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110952489|NCT00392574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110952490|NCT04470414|Antibodies|antibodies|mesh-list
110952491|NCT04470414|Immunoglobulin G|immunoglobulin g|mesh-list
110952492|NCT04470414|Immunologic Factors|immunologic factors|mesh-ancestor
110952493|NCT04470414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110952494|NCT00363636|Galiximab|galiximab|mesh-list
110952495|NCT00363636|Rituximab|rituximab|mesh-list
110952496|NCT00363636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110952497|NCT00363636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110952498|NCT00363636|Immunologic Factors|immunologic factors|mesh-ancestor
110952499|NCT00363636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110952500|NCT00363636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110952501|NCT00363636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110952502|NCT02605174|Lasmiditan|lasmiditan|mesh-list
110952503|NCT02605174|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110664482|NCT02530879|Esomeprazole|esomeprazole|mesh-list
110952505|NCT02605174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110952506|NCT02605174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110952507|NCT02605174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110952508|NCT00522834|Paclitaxel|paclitaxel|mesh-list
110952509|NCT00522834|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110952510|NCT00522834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110952511|NCT00522834|Tubulin Modulators|tubulin modulators|mesh-ancestor
110952512|NCT00522834|Antimitotic Agents|antimitotic agents|mesh-ancestor
110952513|NCT00522834|Mitosis Modulators|mitosis modulators|mesh-ancestor
110952514|NCT00522834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110952515|NCT02075619|Amlodipine|amlodipine|mesh-list
110952516|NCT02075619|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110952517|NCT02075619|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110952518|NCT02075619|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110952519|NCT02075619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110952520|NCT02075619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110952521|NCT02075619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110952522|NCT02075619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110952523|NCT02075619|Vasodilator Agents|vasodilator agents|mesh-ancestor
110952524|NCT02075619|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110952525|NCT02075619|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110952526|NCT02075619|Antimetabolites|antimetabolites|mesh-ancestor
110952527|NCT02075619|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110952528|NCT02075619|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110952529|NCT02075619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110952530|NCT00358878|Satavaptan|satavaptan|mesh-list
110952531|NCT00358878|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
110952532|NCT00358878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110952533|NCT00358878|Natriuretic Agents|natriuretic agents|mesh-ancestor
110952534|NCT00358878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110952535|NCT02283372|Paclitaxel|paclitaxel|mesh-list
110952536|NCT02283372|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110952537|NCT02283372|Gemcitabine|gemcitabine|mesh-list
110952538|NCT02283372|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110952539|NCT02283372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110952540|NCT02283372|Tubulin Modulators|tubulin modulators|mesh-ancestor
110952541|NCT02283372|Antimitotic Agents|antimitotic agents|mesh-ancestor
110952542|NCT02283372|Mitosis Modulators|mitosis modulators|mesh-ancestor
110952543|NCT02283372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110952544|NCT02283372|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110952545|NCT02283372|Antimetabolites|antimetabolites|mesh-ancestor
110952546|NCT00507936|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110952547|NCT00507936|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110952548|NCT00507936|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110952549|NCT00507936|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110952550|NCT00507936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110952551|NCT00507936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110952552|NCT00507936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110952553|NCT00507936|Analgesics|analgesics|mesh-ancestor
110952554|NCT00507936|Sensory System Agents|sensory system agents|mesh-ancestor
110952555|NCT00507936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110952556|NCT00507936|Antidepressive Agents|antidepressive agents|mesh-ancestor
110952557|NCT00507936|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110952559|NCT04427020|Caseins|caseins|mesh-list
110952560|NCT04427020|Chelating Agents|chelating agents|mesh-ancestor
110952561|NCT04427020|Sequestering Agents|sequestering agents|mesh-ancestor
110952562|NCT04427020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110952563|NCT02083575|Vitamins|vitamins|mesh-list
110952564|NCT02083575|Ascorbic Acid|ascorbic acid|mesh-list
110952565|NCT02083575|Deferiprone|deferiprone|mesh-list
110952566|NCT02083575|Micronutrients|micronutrients|mesh-ancestor
110952567|NCT02083575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110952568|NCT02083575|Antioxidants|antioxidants|mesh-ancestor
110952569|NCT02083575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110952570|NCT02083575|Protective Agents|protective agents|mesh-ancestor
110952571|NCT02083575|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110952572|NCT02083575|Chelating Agents|chelating agents|mesh-ancestor
110952573|NCT02083575|Sequestering Agents|sequestering agents|mesh-ancestor
110952574|NCT02286258|Calcium, Dietary|calcium, dietary|mesh-list
110952575|NCT02286258|Edetic Acid|edetic acid|mesh-list
110952576|NCT02286258|Calcium|calcium|mesh-list
110952577|NCT02286258|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110952578|NCT02286258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110952579|NCT02286258|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110952580|NCT02286258|Chelating Agents|chelating agents|mesh-ancestor
110952581|NCT02286258|Sequestering Agents|sequestering agents|mesh-ancestor
110952582|NCT02286258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110952583|NCT02286258|Anticoagulants|anticoagulants|mesh-ancestor
110952584|NCT02286258|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110952585|NCT02088411|Diclofenac|diclofenac|mesh-list
110952586|NCT02088411|Wobenzym|wobenzym|mesh-list
110952587|NCT02088411|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110952588|NCT02088411|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110952589|NCT02088411|Analgesics|analgesics|mesh-ancestor
110952590|NCT02088411|Sensory System Agents|sensory system agents|mesh-ancestor
110952591|NCT02088411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110952592|NCT02088411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110952593|NCT02088411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110952594|NCT02088411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110952595|NCT02088411|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110952596|NCT02088411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110952597|NCT02088411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110952598|NCT02088411|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110952599|NCT02088411|Immunologic Factors|immunologic factors|mesh-ancestor
110952600|NCT02082327|1-Deoxynojirimycin|1-deoxynojirimycin|mesh-list
110952601|NCT02082327|Antiviral Agents|antiviral agents|mesh-ancestor
110952602|NCT02082327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110952603|NCT02082327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110952604|NCT02082327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110952605|NCT02604550|Naproxen|naproxen|mesh-list
110952606|NCT02604550|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
110952607|NCT02604550|Ropivacaine|ropivacaine|mesh-list
110952608|NCT02604550|Anesthetics, Local|anesthetics, local|mesh-ancestor
110952609|NCT02604550|Anesthetics|anesthetics|mesh-ancestor
110952610|NCT02604550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110952611|NCT02604550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110952612|NCT02604550|Sensory System Agents|sensory system agents|mesh-ancestor
110450121|NCT02882087|Antimetabolites|antimetabolites|mesh-ancestor
110952613|NCT02604550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110952614|NCT02604550|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110952615|NCT02604550|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110952616|NCT02604550|Analgesics|analgesics|mesh-ancestor
110952617|NCT02604550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110952618|NCT02604550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110952619|NCT02604550|Gout Suppressants|gout suppressants|mesh-ancestor
110952620|NCT02604550|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110952621|NCT02604550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110952622|NCT02604550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110952623|NCT02604550|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110952624|NCT02604550|Narcotics|narcotics|mesh-ancestor
110952625|NCT02084043|Amikacin|amikacin|mesh-list
110952626|NCT02084043|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110952627|NCT02084043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110952628|NCT03530670|Midazolam|midazolam|mesh-list
110952629|NCT03530670|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110952630|NCT03530670|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110952631|NCT03530670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110952632|NCT03530670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110952633|NCT03530670|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110952634|NCT03530670|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110952635|NCT03530670|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110952636|NCT03530670|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110952637|NCT03530670|Anesthetics, General|anesthetics, general|mesh-ancestor
110952638|NCT03530670|Anesthetics|anesthetics|mesh-ancestor
110952639|NCT03530670|GABA Modulators|gaba modulators|mesh-ancestor
110952640|NCT03530670|GABA Agents|gaba agents|mesh-ancestor
110952641|NCT03530670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110952642|NCT03530670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110952643|NCT00120042|Misoprostol|misoprostol|mesh-list
110952644|NCT00120042|Oxytocin|oxytocin|mesh-list
110952645|NCT00120042|Oxytocics|oxytocics|mesh-ancestor
110952646|NCT00120042|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110952647|NCT00120042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110952648|NCT00120042|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110952649|NCT00120042|Abortifacient Agents|abortifacient agents|mesh-ancestor
110952650|NCT00120042|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110952651|NCT00120042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110952652|NCT02084355|Fentanyl|fentanyl|mesh-list
110952653|NCT02084355|Oxycodone|oxycodone|mesh-list
110952654|NCT02084355|Hydromorphone|hydromorphone|mesh-list
110952655|NCT02084355|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110952656|NCT02084355|Narcotics|narcotics|mesh-ancestor
110952657|NCT02084355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110952658|NCT02084355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110952659|NCT02084355|Analgesics|analgesics|mesh-ancestor
110952660|NCT02084355|Sensory System Agents|sensory system agents|mesh-ancestor
110952661|NCT02084355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110952662|NCT02084355|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110952663|NCT02084355|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110952664|NCT02084355|Anesthetics, General|anesthetics, general|mesh-ancestor
110952665|NCT02084355|Anesthetics|anesthetics|mesh-ancestor
110952666|NCT00353574|Darusentan|darusentan|mesh-list
110952667|NCT00353574|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
110952668|NCT00353574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110952669|NCT02082405|Dexamethasone|dexamethasone|mesh-list
110952670|NCT02082405|Cyclophosphamide|cyclophosphamide|mesh-list
110952671|NCT02082405|Bortezomib|bortezomib|mesh-list
110952672|NCT02082405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110952673|NCT02082405|Immunologic Factors|immunologic factors|mesh-ancestor
110952674|NCT02082405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110952675|NCT02082405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110952676|NCT02082405|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110952677|NCT02082405|Alkylating Agents|alkylating agents|mesh-ancestor
110952678|NCT02082405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110952679|NCT02082405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110952680|NCT02082405|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110952681|NCT02082405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110952682|NCT02082405|Antiemetics|antiemetics|mesh-ancestor
110952683|NCT02082405|Autonomic Agents|autonomic agents|mesh-ancestor
110952684|NCT02082405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110952685|NCT02082405|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110952686|NCT02082405|Glucocorticoids|glucocorticoids|mesh-ancestor
110952687|NCT02082405|Hormones|hormones|mesh-ancestor
110952688|NCT02082405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110952689|NCT02082405|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110952690|NCT04428268|Chloroquine|chloroquine|mesh-list
110952691|NCT04428268|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
110952692|NCT04428268|Losartan|losartan|mesh-list
110952693|NCT04428268|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110952694|NCT04428268|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110952695|NCT04428268|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110952696|NCT04428268|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110952697|NCT04428268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110952698|NCT04428268|Amebicides|amebicides|mesh-ancestor
110952699|NCT04428268|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110952700|NCT04428268|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110952701|NCT04428268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110952702|NCT04428268|Antimalarials|antimalarials|mesh-ancestor
110952703|NCT04428268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110952704|NCT04428268|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110952705|NCT04428268|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110952706|NCT04428268|Analgesics|analgesics|mesh-ancestor
111203409|NCT01819129|Insulin Aspart|insulin aspart|mesh-list
110952707|NCT04428268|Sensory System Agents|sensory system agents|mesh-ancestor
110952708|NCT04428268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110952709|NCT04428268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110952710|NCT04428268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110952711|NCT04428268|Filaricides|filaricides|mesh-ancestor
110952712|NCT04428268|Antinematodal Agents|antinematodal agents|mesh-ancestor
110952713|NCT04428268|Anthelmintics|anthelmintics|mesh-ancestor
110952714|NCT02084433|Anesthetics|anesthetics|mesh-list
110952715|NCT02084433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110952716|NCT02084433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110952717|NCT04427098|Enoxaparin|enoxaparin|mesh-list
110952718|NCT04427098|Enoxaparin sodium|enoxaparin sodium|mesh-list
110952719|NCT04427098|Anticoagulants|anticoagulants|mesh-ancestor
110952720|NCT04427098|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110952721|NCT04427098|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110952722|NCT04427098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110952723|NCT00352560|Irbesartan|irbesartan|mesh-list
110952724|NCT00352560|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110952725|NCT00352560|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110952726|NCT00352560|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110952727|NCT00352560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110664708|NCT00786851|Lenalidomide|lenalidomide|mesh-list
110952728|NCT00115050|Darunavir|darunavir|mesh-list
110952729|NCT00115050|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110952730|NCT00115050|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110952731|NCT00115050|Protease Inhibitors|protease inhibitors|mesh-ancestor
110952732|NCT00115050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110952733|NCT00115050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110952734|NCT00115050|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110952735|NCT00115050|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110952736|NCT00115050|Antiviral Agents|antiviral agents|mesh-ancestor
110952737|NCT00115050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110952738|NCT05616364|Dexmedetomidine|dexmedetomidine|mesh-list
110952739|NCT05616364|Tramadol|tramadol|mesh-list
110952740|NCT05616364|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110952741|NCT05616364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110952742|NCT05616364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110952743|NCT05616364|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110952744|NCT05616364|Analgesics|analgesics|mesh-ancestor
110952745|NCT05616364|Sensory System Agents|sensory system agents|mesh-ancestor
110952746|NCT05616364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110952747|NCT05616364|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110952748|NCT05616364|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110952749|NCT05616364|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110952750|NCT05616364|Adrenergic Agents|adrenergic agents|mesh-ancestor
110952751|NCT05616364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110952752|NCT05616364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110952753|NCT05616364|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110952754|NCT05616364|Narcotics|narcotics|mesh-ancestor
110952755|NCT00345618|Biotin|biotin|mesh-list
110952756|NCT00345618|Enoxaparin|enoxaparin|mesh-list
110952757|NCT00345618|Warfarin|warfarin|mesh-list
110952758|NCT00345618|Idraparinux|idraparinux|mesh-list
110952759|NCT00345618|Idrabiotaparinux|idrabiotaparinux|mesh-list
110952760|NCT00345618|Anticoagulants|anticoagulants|mesh-ancestor
110952761|NCT00345618|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110952762|NCT00345618|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110952763|NCT00345618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110952764|NCT00345618|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110952765|NCT00345618|Antithrombins|antithrombins|mesh-ancestor
110952766|NCT00345618|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110952767|NCT00345618|Protease Inhibitors|protease inhibitors|mesh-ancestor
110952768|NCT00345618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110952769|NCT00345618|Vitamin B Complex|vitamin b complex|mesh-ancestor
110952770|NCT00345618|Vitamins|vitamins|mesh-ancestor
110952771|NCT00345618|Micronutrients|micronutrients|mesh-ancestor
110952772|NCT00345618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110952773|NCT03611868|Pembrolizumab|pembrolizumab|mesh-list
110952774|NCT03611868|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110952775|NCT03611868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110952776|NCT03611868|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110952777|NCT03611868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110952778|NCT00116298|Lamivudine|lamivudine|mesh-list
110952779|NCT00116298|Efavirenz|efavirenz|mesh-list
110952780|NCT00116298|Stavudine|stavudine|mesh-list
110952781|NCT00116298|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110952782|NCT00116298|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110952783|NCT00116298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110952784|NCT00116298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110952785|NCT00116298|Antiviral Agents|antiviral agents|mesh-ancestor
110952786|NCT00116298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110952787|NCT00116298|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110952788|NCT00116298|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110952789|NCT00116298|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110952790|NCT00116298|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110952791|NCT00116298|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110952792|NCT00116298|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110952793|NCT00116298|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110952794|NCT00116298|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110952795|NCT00116298|Antimetabolites|antimetabolites|mesh-ancestor
110952796|NCT01866111|Cenobamate|cenobamate|mesh-list
110952797|NCT01866111|Anticonvulsants|anticonvulsants|mesh-ancestor
110952798|NCT02084589|Fentanyl|fentanyl|mesh-list
110952799|NCT02084589|Ropivacaine|ropivacaine|mesh-list
110952800|NCT02084589|Anesthetics, Local|anesthetics, local|mesh-ancestor
110952801|NCT02084589|Anesthetics|anesthetics|mesh-ancestor
110952802|NCT02084589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110952803|NCT02084589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110952804|NCT02084589|Sensory System Agents|sensory system agents|mesh-ancestor
110952805|NCT02084589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110952806|NCT02084589|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110952807|NCT02084589|Narcotics|narcotics|mesh-ancestor
110952808|NCT02084589|Analgesics|analgesics|mesh-ancestor
110952809|NCT02084589|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110952810|NCT02084589|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110952811|NCT02084589|Anesthetics, General|anesthetics, general|mesh-ancestor
110952812|NCT03557853|Golimumab|golimumab|mesh-list
110952813|NCT03557853|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110952814|NCT03557853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110952815|NCT03557853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110952816|NCT03557853|Immunologic Factors|immunologic factors|mesh-ancestor
110952817|NCT03557853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110952818|NCT04346290|Dexmedetomidine|dexmedetomidine|mesh-list
110952819|NCT04346290|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110952820|NCT04346290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110952821|NCT04346290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110952822|NCT04346290|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110952823|NCT04346290|Analgesics|analgesics|mesh-ancestor
110952824|NCT04346290|Sensory System Agents|sensory system agents|mesh-ancestor
110952825|NCT04346290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110952826|NCT04346290|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110952827|NCT04346290|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110952828|NCT04346290|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110952829|NCT04346290|Adrenergic Agents|adrenergic agents|mesh-ancestor
110952830|NCT04346290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110952831|NCT04346290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110952832|NCT04426552|Dexmedetomidine|dexmedetomidine|mesh-list
110952833|NCT04426552|Sevoflurane|sevoflurane|mesh-list
110952834|NCT04426552|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110952835|NCT04426552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110952836|NCT04426552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110952837|NCT04426552|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110952838|NCT04426552|Analgesics|analgesics|mesh-ancestor
110952839|NCT04426552|Sensory System Agents|sensory system agents|mesh-ancestor
110952840|NCT04426552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110952841|NCT04426552|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110952842|NCT04426552|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110952843|NCT04426552|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110952844|NCT04426552|Adrenergic Agents|adrenergic agents|mesh-ancestor
110952845|NCT04426552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110952846|NCT04426552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110952847|NCT04426552|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110952848|NCT04426552|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110952849|NCT04426552|Anesthetics, General|anesthetics, general|mesh-ancestor
110952850|NCT04426552|Anesthetics|anesthetics|mesh-ancestor
110952851|NCT04803370|Antibodies|antibodies|mesh-list
110952852|NCT04803370|Immunologic Factors|immunologic factors|mesh-ancestor
110952853|NCT04803370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110952854|NCT01369329|Ustekinumab|ustekinumab|mesh-list
110952855|NCT01369329|Dermatologic Agents|dermatologic agents|mesh-ancestor
110952856|NCT04802980|Paclitaxel|paclitaxel|mesh-list
110952857|NCT04802980|Carboplatin|carboplatin|mesh-list
110952858|NCT04802980|Gemcitabine|gemcitabine|mesh-list
110952859|NCT04802980|Capecitabine|capecitabine|mesh-list
110952860|NCT04802980|Oxaliplatin|oxaliplatin|mesh-list
110952861|NCT04802980|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110952862|NCT04802980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110952863|NCT04802980|Tubulin Modulators|tubulin modulators|mesh-ancestor
110952864|NCT04802980|Antimitotic Agents|antimitotic agents|mesh-ancestor
110952865|NCT04802980|Mitosis Modulators|mitosis modulators|mesh-ancestor
110952866|NCT04802980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110952867|NCT04802980|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110952868|NCT04802980|Antimetabolites|antimetabolites|mesh-ancestor
110952869|NCT02088645|Cholecystokinin|cholecystokinin|mesh-list
110952870|NCT02088645|Gastrins|gastrins|mesh-list
110952871|NCT02088645|Hormones|hormones|mesh-ancestor
110952872|NCT02088645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110952873|NCT02088645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110952874|NCT02088645|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
110952875|NCT02088645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110952876|NCT03558477|Esomeprazole|esomeprazole|mesh-list
110952877|NCT03558477|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110952878|NCT03558477|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110952879|NCT03558477|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110664858|NCT02554955|Immunologic Factors|immunologic factors|mesh-ancestor
110952880|NCT03558477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110952881|NCT03558477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110952882|NCT04792840|Letrozole|letrozole|mesh-list
110952883|NCT04792840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110952884|NCT04792840|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110952885|NCT04792840|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110952886|NCT04792840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110952887|NCT04792840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110952888|NCT04792840|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110952889|NCT04792840|Hormone Antagonists|hormone antagonists|mesh-ancestor
110952890|NCT04792840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110952891|NCT04792840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110952892|NCT02085213|Nitroglycerin|nitroglycerin|mesh-list
110952893|NCT02085213|Vasodilator Agents|vasodilator agents|mesh-ancestor
110952894|NCT02088801|Pyrithione zinc|pyrithione zinc|mesh-list
110952895|NCT02088801|Keratolytic Agents|keratolytic agents|mesh-ancestor
110952896|NCT02088801|Dermatologic Agents|dermatologic agents|mesh-ancestor
110952897|NCT02085291|Norepinephrine|norepinephrine|mesh-list
110952898|NCT02085291|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110952899|NCT02085291|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110952900|NCT02085291|Adrenergic Agents|adrenergic agents|mesh-ancestor
110952901|NCT02085291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110952902|NCT02085291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110952903|NCT02085291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110952904|NCT02085291|Sympathomimetics|sympathomimetics|mesh-ancestor
110952905|NCT02085291|Autonomic Agents|autonomic agents|mesh-ancestor
110952906|NCT02085291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110952907|NCT02085291|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110952908|NCT04792138|Phenobarbital|phenobarbital|mesh-list
110952909|NCT04792138|Anticonvulsants|anticonvulsants|mesh-ancestor
110952910|NCT04792138|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110952911|NCT04792138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110952912|NCT04792138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110952913|NCT04792138|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110952914|NCT04792138|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110952915|NCT04792138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110952916|NCT04792138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110952917|NCT04792138|GABA Modulators|gaba modulators|mesh-ancestor
110952918|NCT04792138|GABA Agents|gaba agents|mesh-ancestor
110952919|NCT04792138|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110952920|NCT04792138|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110952921|NCT04792138|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110952922|NCT04802122|Propofol|propofol|mesh-list
110952923|NCT04802122|Sevoflurane|sevoflurane|mesh-list
110952924|NCT04802122|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110952925|NCT04802122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110952926|NCT04802122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110952927|NCT04802122|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110952928|NCT04802122|Anesthetics, General|anesthetics, general|mesh-ancestor
110952929|NCT04802122|Anesthetics|anesthetics|mesh-ancestor
110952930|NCT04802122|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110942046|NCT05994820|Vaccines|vaccines|mesh-list
111203410|NCT01819129|Insulin, Long-Acting|insulin, long-acting|mesh-list
110952931|NCT04802122|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110952932|NCT04784728|Lidocaine|lidocaine|mesh-list
110952933|NCT04784728|Anesthetics, Local|anesthetics, local|mesh-ancestor
110952934|NCT04784728|Anesthetics|anesthetics|mesh-ancestor
110952935|NCT04784728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110952936|NCT04784728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110952937|NCT04784728|Sensory System Agents|sensory system agents|mesh-ancestor
110952938|NCT04784728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110952939|NCT04784728|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110952940|NCT04784728|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110952941|NCT04784728|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110952942|NCT04784728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110952943|NCT04784728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110952944|NCT02085603|Saracatinib|saracatinib|mesh-list
110952945|NCT02085603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110952946|NCT02085603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110952947|NCT02085603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110952948|NCT02090829|Oxytocin|oxytocin|mesh-list
110952949|NCT02090829|Oxytocics|oxytocics|mesh-ancestor
110952950|NCT02090829|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110952951|NCT02090829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110952952|NCT04801888|Vaccines|vaccines|mesh-list
110952953|NCT04801888|Immunologic Factors|immunologic factors|mesh-ancestor
110952955|NCT02089503|Ranibizumab|ranibizumab|mesh-list
110952956|NCT02089503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110952957|NCT02089503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110952958|NCT02089503|Growth Substances|growth substances|mesh-ancestor
110952959|NCT02089503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110952960|NCT02089503|Growth Inhibitors|growth inhibitors|mesh-ancestor
110952961|NCT02089503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110952962|NCT02091063|Ricolinostat|ricolinostat|mesh-list
110952963|NCT02091063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110952964|NCT02091063|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110952965|NCT02091063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110952966|NCT02091063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110952967|NCT02091219|Vitamin D|vitamin d|mesh-list
110952968|NCT02091219|Cholecalciferol|cholecalciferol|mesh-list
110952969|NCT02091219|Calcifediol|calcifediol|mesh-list
110952970|NCT02091219|Vitamins|vitamins|mesh-ancestor
110952971|NCT02091219|Micronutrients|micronutrients|mesh-ancestor
110952972|NCT02091219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110952973|NCT02091219|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110952974|NCT02091219|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110952975|NCT02091297|Acetaminophen|acetaminophen|mesh-list
110952976|NCT02091297|Morphine|morphine|mesh-list
110952977|NCT02091297|Ropivacaine|ropivacaine|mesh-list
110952978|NCT02091297|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110952979|NCT02091297|Narcotics|narcotics|mesh-ancestor
110952980|NCT02091297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110952981|NCT02091297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110952982|NCT02091297|Analgesics|analgesics|mesh-ancestor
110952983|NCT02091297|Sensory System Agents|sensory system agents|mesh-ancestor
110952984|NCT02091297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110952985|NCT02091297|Anesthetics, Local|anesthetics, local|mesh-ancestor
110952986|NCT02091297|Anesthetics|anesthetics|mesh-ancestor
110952987|NCT02091297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110952988|NCT02091297|Antipyretics|antipyretics|mesh-ancestor
110952989|NCT04791202|Methylprednisolone|methylprednisolone|mesh-list
110952990|NCT04791202|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110952991|NCT04791202|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110952992|NCT04791202|Prednisolone|prednisolone|mesh-list
110952993|NCT04791202|Prednisolone acetate|prednisolone acetate|mesh-list
110952994|NCT04791202|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110952995|NCT04791202|Prednisolone phosphate|prednisolone phosphate|mesh-list
110952996|NCT04791202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110952997|NCT04791202|Antiemetics|antiemetics|mesh-ancestor
110952998|NCT04791202|Autonomic Agents|autonomic agents|mesh-ancestor
110952999|NCT04791202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110953000|NCT04791202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110953001|NCT04791202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110953002|NCT04791202|Glucocorticoids|glucocorticoids|mesh-ancestor
110953003|NCT04791202|Hormones|hormones|mesh-ancestor
110953004|NCT04791202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110953005|NCT04791202|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110953006|NCT04791202|Protective Agents|protective agents|mesh-ancestor
110953007|NCT04791202|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110953008|NCT04791202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110953009|NCT04801342|Memantine|memantine|mesh-list
110953010|NCT04801342|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110953011|NCT04801342|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110953012|NCT04801342|Dopamine Agents|dopamine agents|mesh-ancestor
110953013|NCT04801342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110953014|NCT04801342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110953015|NCT04801342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110953016|NCT04801342|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110953017|NCT04801342|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110953018|NCT04801264|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
110953019|NCT04801264|177Lu-EB-PSMA-617|177lu-eb-psma-617|mesh-list
110953020|NCT04801264|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110953021|NCT04801264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110953022|NCT02590588|Idelalisib|idelalisib|mesh-list
110953023|NCT02590588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110953024|NCT02590588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110953025|NCT02590588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110953026|NCT02086227|Glucagon|glucagon|mesh-list
110953027|NCT02086227|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
110953028|NCT02086227|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110953029|NCT02086227|Hormones|hormones|mesh-ancestor
110953030|NCT02086227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110953031|NCT02086227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110953032|NCT02086227|Incretins|incretins|mesh-ancestor
110953033|NCT02086929|Trazodone|trazodone|mesh-list
110953034|NCT02086929|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
110953035|NCT02086929|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110953036|NCT02086929|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110953037|NCT02086929|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110953038|NCT02086929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110953039|NCT02086929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110953040|NCT02086929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110953041|NCT02086929|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110953042|NCT02086929|Antidepressive Agents|antidepressive agents|mesh-ancestor
110953043|NCT02086929|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110953044|NCT02086929|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110953045|NCT02086929|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110953046|NCT02086929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110953047|NCT02086929|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110953048|NCT02086929|Serotonin Agents|serotonin agents|mesh-ancestor
110953049|NCT02249013|Paclitaxel|paclitaxel|mesh-list
110953050|NCT02249013|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110953051|NCT02249013|Carboplatin|carboplatin|mesh-list
110953052|NCT02249013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110953053|NCT02249013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110953054|NCT02249013|Tubulin Modulators|tubulin modulators|mesh-ancestor
110953055|NCT02249013|Antimitotic Agents|antimitotic agents|mesh-ancestor
110953056|NCT02249013|Mitosis Modulators|mitosis modulators|mesh-ancestor
110953057|NCT02249013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110953058|NCT02249871|Omeprazole|omeprazole|mesh-list
110953059|NCT02249871|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110953060|NCT02249871|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110953061|NCT02249871|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110953062|NCT02249871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110953063|NCT02249871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110953064|NCT02087007|Cilostazol|cilostazol|mesh-list
110953065|NCT02087007|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110953066|NCT02087007|Autonomic Agents|autonomic agents|mesh-ancestor
110953067|NCT02087007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110953068|NCT02087007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110953069|NCT02087007|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110953070|NCT02087007|Respiratory System Agents|respiratory system agents|mesh-ancestor
110953071|NCT02087007|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110953072|NCT02087007|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110953073|NCT02087007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110953074|NCT02087007|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110953075|NCT02087007|Vasodilator Agents|vasodilator agents|mesh-ancestor
110953076|NCT02087007|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110953077|NCT02087007|Protective Agents|protective agents|mesh-ancestor
110953078|NCT02087007|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110953079|NCT02087007|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110953080|NCT02087007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110953081|NCT01434602|Everolimus|everolimus|mesh-list
110953082|NCT01434602|Sorafenib|sorafenib|mesh-list
110953083|NCT01434602|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110953084|NCT01434602|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110953085|NCT01434602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110953086|NCT01434602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110953087|NCT01434602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110953088|NCT01434602|Immunologic Factors|immunologic factors|mesh-ancestor
110953089|NCT01434602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110953090|NCT01434602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110953091|NCT02087475|Fluorouracil|fluorouracil|mesh-list
110953092|NCT02087475|Irinotecan|irinotecan|mesh-list
110953093|NCT02087475|Antimetabolites|antimetabolites|mesh-ancestor
110953094|NCT02087475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110953095|NCT02087475|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110953096|NCT02087475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110953097|NCT02087475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110953098|NCT02087475|Immunologic Factors|immunologic factors|mesh-ancestor
110953099|NCT02087475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110953100|NCT02087475|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110953101|NCT02087475|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110953102|NCT02087475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110953103|NCT05486949|Itraconazole|itraconazole|mesh-list
110953104|NCT05486949|Carbamazepine|carbamazepine|mesh-list
110953105|NCT05486949|Antifungal Agents|antifungal agents|mesh-ancestor
110953106|NCT05486949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110953107|NCT05486949|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110953108|NCT05486949|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110953109|NCT05486949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110953110|NCT05486949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110953111|NCT05486949|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110953112|NCT05486949|Hormone Antagonists|hormone antagonists|mesh-ancestor
110953113|NCT05486949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110953114|NCT05486949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110953115|NCT05486949|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110953116|NCT05486949|Anticonvulsants|anticonvulsants|mesh-ancestor
110953117|NCT05486949|Antimanic Agents|antimanic agents|mesh-ancestor
110953118|NCT05486949|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110953119|NCT05486949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110953120|NCT05486949|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110953121|NCT05486949|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110953122|NCT05486949|Analgesics|analgesics|mesh-ancestor
110953123|NCT05486949|Sensory System Agents|sensory system agents|mesh-ancestor
110953124|NCT05486949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110953125|NCT05486949|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110953126|NCT05486949|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110953127|NCT05486949|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110953128|NCT05486949|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110953129|NCT03558243|Hemostatics|hemostatics|mesh-list
110953130|NCT03558243|Coagulants|coagulants|mesh-ancestor
110953131|NCT03426956|Canagliflozin|canagliflozin|mesh-list
110953132|NCT03426956|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110953133|NCT03426956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110953134|NCT03426956|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110953135|NCT03426956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110953136|NCT03557229|Vitamins|vitamins|mesh-list
110953137|NCT03557229|Vitamin E|vitamin e|mesh-list
110953138|NCT03557229|Acetylcysteine|acetylcysteine|mesh-list
110953139|NCT03557229|Melatonin|melatonin|mesh-list
110953140|NCT03557229|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110953141|NCT03557229|Micronutrients|micronutrients|mesh-ancestor
110953142|NCT03557229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110953143|NCT03557229|Antioxidants|antioxidants|mesh-ancestor
110953144|NCT03557229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110953145|NCT03557229|Protective Agents|protective agents|mesh-ancestor
110953146|NCT03557229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110953147|NCT03557229|Antiviral Agents|antiviral agents|mesh-ancestor
110953148|NCT03557229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110953149|NCT03557229|Expectorants|expectorants|mesh-ancestor
110953150|NCT03557229|Respiratory System Agents|respiratory system agents|mesh-ancestor
110953151|NCT03557229|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110953152|NCT03557229|Antidotes|antidotes|mesh-ancestor
110953153|NCT02087631|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110953154|NCT02087631|Antidepressive Agents|antidepressive agents|mesh-ancestor
110953155|NCT02087631|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110953156|NCT02087631|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110953158|NCT02087631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110953159|NCT02087631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110953160|NCT00940940|Vaccines|vaccines|mesh-list
110953161|NCT00940940|Immunologic Factors|immunologic factors|mesh-ancestor
110953162|NCT00940940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110953163|NCT03557840|Temocillin|temocillin|mesh-list
110953164|NCT03557840|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110953165|NCT03557840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110953166|NCT02092701|Cholecalciferol|cholecalciferol|mesh-list
110953167|NCT02092701|Vitamin D|vitamin d|mesh-list
110953168|NCT02092701|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110953169|NCT02092701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110953170|NCT02092701|Vitamins|vitamins|mesh-ancestor
110953171|NCT02092701|Micronutrients|micronutrients|mesh-ancestor
110953172|NCT02092701|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110953173|NCT01767129|Quinidine|quinidine|mesh-list
110953174|NCT01767129|Dextromethorphan|dextromethorphan|mesh-list
110953175|NCT01767129|Antitussive Agents|antitussive agents|mesh-ancestor
110953176|NCT01767129|Respiratory System Agents|respiratory system agents|mesh-ancestor
110953177|NCT01767129|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110953178|NCT01767129|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110953179|NCT01767129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110953180|NCT01767129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110953181|NCT01767129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110953182|NCT01767129|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110953183|NCT01767129|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110953184|NCT01767129|Adrenergic Agents|adrenergic agents|mesh-ancestor
110953185|NCT01767129|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110953186|NCT01767129|Antimalarials|antimalarials|mesh-ancestor
110953187|NCT01767129|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110953188|NCT01767129|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110953189|NCT01767129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110953190|NCT01767129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110953191|NCT01767129|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110953192|NCT01767129|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110953193|NCT01767129|Cholinergic Agents|cholinergic agents|mesh-ancestor
110953194|NCT01767129|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110953195|NCT01767129|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110953196|NCT01767129|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110953197|NCT01767129|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110953198|NCT01767129|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110953199|NCT01309191|Minoxidil|minoxidil|mesh-list
110953200|NCT01309191|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110953201|NCT01309191|Vasodilator Agents|vasodilator agents|mesh-ancestor
110953202|NCT03420638|Epinephrine|epinephrine|mesh-list
110953203|NCT03420638|Bupivacaine|bupivacaine|mesh-list
110953204|NCT03420638|Anesthetics, Local|anesthetics, local|mesh-ancestor
110953205|NCT03420638|Anesthetics|anesthetics|mesh-ancestor
110953206|NCT03420638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110953207|NCT03420638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110953208|NCT03420638|Sensory System Agents|sensory system agents|mesh-ancestor
110953209|NCT03420638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110953210|NCT03420638|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110953211|NCT03420638|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110953212|NCT03420638|Adrenergic Agents|adrenergic agents|mesh-ancestor
110953213|NCT03420638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110953214|NCT03420638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110953215|NCT03420638|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110953216|NCT03420638|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110953217|NCT03420638|Autonomic Agents|autonomic agents|mesh-ancestor
110953218|NCT03420638|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110953219|NCT03420638|Respiratory System Agents|respiratory system agents|mesh-ancestor
110953220|NCT03420638|Mydriatics|mydriatics|mesh-ancestor
110953221|NCT03420638|Sympathomimetics|sympathomimetics|mesh-ancestor
110953222|NCT03420638|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110953223|NCT00715988|Methadone|methadone|mesh-list
110953224|NCT00715988|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110953225|NCT00715988|Narcotics|narcotics|mesh-ancestor
110953226|NCT00715988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110953227|NCT00715988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110953228|NCT00715988|Analgesics|analgesics|mesh-ancestor
110953229|NCT00715988|Sensory System Agents|sensory system agents|mesh-ancestor
110953230|NCT00715988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110953231|NCT00715988|Antitussive Agents|antitussive agents|mesh-ancestor
110953232|NCT00715988|Respiratory System Agents|respiratory system agents|mesh-ancestor
110953233|NCT02093091|Vitremer|vitremer|mesh-list
110953234|NCT02093091|Cariostatic Agents|cariostatic agents|mesh-ancestor
110953235|NCT02093091|Protective Agents|protective agents|mesh-ancestor
110953236|NCT02093091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110953237|NCT02791269|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110953238|NCT02791269|Antiviral Agents|antiviral agents|mesh-ancestor
110953239|NCT02791269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110953240|NCT03556917|Caffeine|caffeine|mesh-list
110953241|NCT03556917|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110953242|NCT03556917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110953243|NCT03556917|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110953244|NCT03556917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110953245|NCT03556917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110953246|NCT03556917|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110953247|NCT03556917|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110953248|NCT03556917|Purinergic Agents|purinergic agents|mesh-ancestor
110953249|NCT03556917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110953250|NCT02090439|Silodosin|silodosin|mesh-list
110953251|NCT02090439|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110953252|NCT02090439|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110953253|NCT02090439|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110953254|NCT02090439|Adrenergic Agents|adrenergic agents|mesh-ancestor
110953255|NCT02090439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110953256|NCT02090439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110953257|NCT02090439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110953258|NCT02090439|Urological Agents|urological agents|mesh-ancestor
110953259|NCT02696564|Losartan|losartan|mesh-list
110953260|NCT02696564|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110953261|NCT02696564|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110953262|NCT02696564|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110953263|NCT02696564|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110953264|NCT02696564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110953265|NCT02093403|Decitabine|decitabine|mesh-list
110953266|NCT02093403|Azacitidine|azacitidine|mesh-list
110953267|NCT02093403|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110953268|NCT02093403|Antimetabolites|antimetabolites|mesh-ancestor
110953269|NCT02093403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110953270|NCT02093403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110953271|NCT02093403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110953272|NCT03426176|Oxytocin|oxytocin|mesh-list
110953273|NCT03426176|Oxytocics|oxytocics|mesh-ancestor
110953274|NCT03426176|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110953275|NCT03426176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110953276|NCT02095899|Rufinamide|rufinamide|mesh-list
110953277|NCT02095899|Anticonvulsants|anticonvulsants|mesh-ancestor
110953278|NCT02095899|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110953279|NCT02095899|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110953280|NCT02095899|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110953281|NCT02095899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110953282|NCT03525002|Bromocriptine|bromocriptine|mesh-list
110953283|NCT03525002|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110953284|NCT03525002|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110953285|NCT03525002|Hormone Antagonists|hormone antagonists|mesh-ancestor
110953286|NCT03525002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110953287|NCT03525002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110953288|NCT03525002|Dopamine Agonists|dopamine agonists|mesh-ancestor
110953289|NCT03525002|Dopamine Agents|dopamine agents|mesh-ancestor
110953290|NCT03525002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110450190|NCT01107743|Vasodilator Agents|vasodilator agents|mesh-ancestor
110953291|NCT03525002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110953292|NCT03426020|Midazolam|midazolam|mesh-list
110953293|NCT03426020|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110953294|NCT03426020|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110953295|NCT03426020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110953296|NCT03426020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110953297|NCT03426020|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110953298|NCT03426020|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110953299|NCT03426020|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110953300|NCT03426020|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110953301|NCT03426020|Anesthetics, General|anesthetics, general|mesh-ancestor
110953302|NCT03426020|Anesthetics|anesthetics|mesh-ancestor
110953303|NCT03426020|GABA Modulators|gaba modulators|mesh-ancestor
110953304|NCT03426020|GABA Agents|gaba agents|mesh-ancestor
110953305|NCT03426020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110953306|NCT03426020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110953308|NCT03428906|Oxytocics|oxytocics|mesh-ancestor
110953309|NCT03428906|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110953310|NCT03428906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110953311|NCT02521298|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110953312|NCT02521298|Methylprednisolone|methylprednisolone|mesh-list
110953313|NCT02521298|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110953314|NCT02521298|Prednisolone|prednisolone|mesh-list
110953315|NCT02521298|Prednisolone acetate|prednisolone acetate|mesh-list
110953316|NCT02521298|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110953317|NCT02521298|Prednisolone phosphate|prednisolone phosphate|mesh-list
110953318|NCT02521298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110953319|NCT02521298|Antiemetics|antiemetics|mesh-ancestor
110953320|NCT02521298|Autonomic Agents|autonomic agents|mesh-ancestor
110953321|NCT02521298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110953322|NCT02521298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110953323|NCT02521298|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110953324|NCT02521298|Glucocorticoids|glucocorticoids|mesh-ancestor
110953325|NCT02521298|Hormones|hormones|mesh-ancestor
110953326|NCT02521298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110953327|NCT02521298|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110665306|NCT01097551|Acetylcholine|acetylcholine|mesh-list
110953328|NCT02521298|Protective Agents|protective agents|mesh-ancestor
110953329|NCT02521298|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110953330|NCT02521298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110953332|NCT00389870|Irinotecan|irinotecan|mesh-list
110953333|NCT00389870|Panitumumab|panitumumab|mesh-list
110953334|NCT00389870|Cyclosporins|cyclosporins|mesh-list
110953335|NCT00389870|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110953336|NCT00389870|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110953337|NCT00389870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110953338|NCT00389870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110953339|NCT00389870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110953340|NCT00389870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110953341|NCT00389870|Immunologic Factors|immunologic factors|mesh-ancestor
110953342|NCT00389870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110953343|NCT00389870|Antifungal Agents|antifungal agents|mesh-ancestor
110953344|NCT00389870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110953345|NCT00389870|Dermatologic Agents|dermatologic agents|mesh-ancestor
110953346|NCT00389870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110953347|NCT00389870|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110953348|NCT00389870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110953349|NCT03419858|Naloxone|naloxone|mesh-list
110953350|NCT03419858|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110953351|NCT03419858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110953352|NCT03419858|Sensory System Agents|sensory system agents|mesh-ancestor
110953353|NCT03419858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110953354|NCT03417206|Remifentanil|remifentanil|mesh-list
110953355|NCT03417206|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110953356|NCT03417206|Narcotics|narcotics|mesh-ancestor
110450206|NCT03739840|Padsevonil|padsevonil|mesh-list
110953357|NCT03417206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110953358|NCT03417206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110953359|NCT03417206|Analgesics|analgesics|mesh-ancestor
110953360|NCT03417206|Sensory System Agents|sensory system agents|mesh-ancestor
110953361|NCT03417206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110953362|NCT00003716|Rituximab|rituximab|mesh-list
110953363|NCT00003716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110953364|NCT00003716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110953365|NCT00003716|Immunologic Factors|immunologic factors|mesh-ancestor
110953366|NCT00003716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110953367|NCT00003716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110953368|NCT02593786|Nivolumab|nivolumab|mesh-list
110953369|NCT02593786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110953370|NCT02593786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110953371|NCT02593786|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110953372|NCT02593786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110953373|NCT03425708|Febuxostat|febuxostat|mesh-list
110953374|NCT03425708|Gout Suppressants|gout suppressants|mesh-ancestor
110953375|NCT03425708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110953376|NCT03425552|Paliperidone Palmitate|paliperidone palmitate|mesh-list
110953377|NCT03425552|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110953378|NCT03425552|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110953379|NCT03425552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110953380|NCT03425552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110953381|NCT03425552|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110953382|NCT03425552|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110953383|NCT03425552|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110953384|NCT03425552|Serotonin Agents|serotonin agents|mesh-ancestor
110953385|NCT03425552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110953386|NCT03425552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110953387|NCT03425552|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110953388|NCT03425552|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110953389|NCT03425552|Dopamine Agents|dopamine agents|mesh-ancestor
110953390|NCT04791046|Antihypertensive Agents|antihypertensive agents|mesh-list
110953391|NCT03425474|Propofol|propofol|mesh-list
110953392|NCT03425474|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110953393|NCT03425474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110953394|NCT03425474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110953395|NCT03425474|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110953396|NCT03425474|Anesthetics, General|anesthetics, general|mesh-ancestor
110953397|NCT03425474|Anesthetics|anesthetics|mesh-ancestor
110953398|NCT03419624|Metformin|metformin|mesh-list
110953399|NCT03419624|Dapagliflozin|dapagliflozin|mesh-list
110953400|NCT03419624|Exenatide|exenatide|mesh-list
110953401|NCT03419624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110953402|NCT03419624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110665383|NCT01095991|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110953403|NCT03419624|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110953404|NCT03419624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110953405|NCT03419624|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110953406|NCT03419624|Incretins|incretins|mesh-ancestor
110953407|NCT03419624|Hormones|hormones|mesh-ancestor
110953408|NCT03419624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110953409|NCT02096055|Idarubicin|idarubicin|mesh-list
110953410|NCT02096055|Cladribine|cladribine|mesh-list
110953411|NCT02096055|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
110953412|NCT02096055|Guadecitabine|guadecitabine|mesh-list
110953413|NCT02096055|Azacitidine|azacitidine|mesh-list
110953414|NCT02096055|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110953415|NCT02096055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110953416|NCT02096055|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110953417|NCT02096055|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110953418|NCT02096055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110953419|NCT02096055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110953420|NCT02096055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110953421|NCT02096055|Immunologic Factors|immunologic factors|mesh-ancestor
110953422|NCT02096055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110953423|NCT02096055|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110953424|NCT02096055|Antimetabolites|antimetabolites|mesh-ancestor
110953425|NCT03425162|Morphine|morphine|mesh-list
110953426|NCT03425162|Bupivacaine|bupivacaine|mesh-list
110953427|NCT03425162|Anesthetics, Local|anesthetics, local|mesh-ancestor
110953428|NCT03425162|Anesthetics|anesthetics|mesh-ancestor
110953429|NCT03425162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110953430|NCT03425162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110953431|NCT03425162|Sensory System Agents|sensory system agents|mesh-ancestor
110953432|NCT03425162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110953433|NCT03425162|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110953434|NCT03425162|Narcotics|narcotics|mesh-ancestor
110953435|NCT03425162|Analgesics|analgesics|mesh-ancestor
110953436|NCT02096133|Cholecalciferol|cholecalciferol|mesh-list
110953437|NCT02096133|Vitamin D|vitamin d|mesh-list
110953438|NCT02096133|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110953439|NCT02096133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110953440|NCT02096133|Vitamins|vitamins|mesh-ancestor
110953441|NCT02096133|Micronutrients|micronutrients|mesh-ancestor
110953442|NCT02096133|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110953443|NCT02096289|Thioridazine|thioridazine|mesh-list
110953444|NCT02096289|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110953445|NCT02096289|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110953446|NCT02096289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110953447|NCT02096289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110953448|NCT02096289|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110953449|NCT02096289|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110953450|NCT02096289|Dopamine Agents|dopamine agents|mesh-ancestor
110953451|NCT02096289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110953452|NCT02096289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110953453|NCT02090673|Exenatide|exenatide|mesh-list
110953454|NCT02090673|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110953455|NCT02090673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110953456|NCT02090673|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110953457|NCT02090673|Incretins|incretins|mesh-ancestor
110953458|NCT02090673|Hormones|hormones|mesh-ancestor
110953459|NCT02090673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110953460|NCT03556371|Acetylcysteine|acetylcysteine|mesh-list
110953461|NCT03556371|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110953462|NCT03556371|Antiviral Agents|antiviral agents|mesh-ancestor
110953463|NCT03556371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110953464|NCT03556371|Expectorants|expectorants|mesh-ancestor
110953465|NCT03556371|Respiratory System Agents|respiratory system agents|mesh-ancestor
110953466|NCT03556371|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110953467|NCT03556371|Antioxidants|antioxidants|mesh-ancestor
110953468|NCT03556371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110953469|NCT03556371|Protective Agents|protective agents|mesh-ancestor
110953470|NCT03556371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110953471|NCT03556371|Antidotes|antidotes|mesh-ancestor
110953472|NCT02827526|Ketamine|ketamine|mesh-list
110953473|NCT02827526|Analgesics|analgesics|mesh-ancestor
110953474|NCT02827526|Sensory System Agents|sensory system agents|mesh-ancestor
110953475|NCT02827526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110953476|NCT02827526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110953477|NCT02827526|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110953478|NCT02827526|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110953479|NCT02827526|Anesthetics, General|anesthetics, general|mesh-ancestor
110953480|NCT02827526|Anesthetics|anesthetics|mesh-ancestor
110953481|NCT02827526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110953482|NCT02827526|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110953483|NCT02827526|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110953484|NCT02827526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110953485|NCT02827526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110953486|NCT04799314|Tislelizumab|tislelizumab|mesh-list
110953487|NCT04799314|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
110953488|NCT04799314|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110953489|NCT04799314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110953490|NCT04799314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110953491|NCT03425084|Morphine|morphine|mesh-list
110953492|NCT03425084|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110953493|NCT03425084|Narcotics|narcotics|mesh-ancestor
110953494|NCT03425084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110953495|NCT03425084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110953496|NCT03425084|Analgesics|analgesics|mesh-ancestor
110953497|NCT03425084|Sensory System Agents|sensory system agents|mesh-ancestor
110953498|NCT03425084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110953499|NCT03424928|Thalidomide|thalidomide|mesh-list
110953500|NCT03424928|Pomalidomide|pomalidomide|mesh-list
110953501|NCT03424928|Immunologic Factors|immunologic factors|mesh-ancestor
110953502|NCT03424928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110953503|NCT03424928|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110953504|NCT03424928|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110953505|NCT03424928|Growth Substances|growth substances|mesh-ancestor
110953506|NCT03424928|Growth Inhibitors|growth inhibitors|mesh-ancestor
110953507|NCT03424928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110953508|NCT03424928|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110953509|NCT03424928|Leprostatic Agents|leprostatic agents|mesh-ancestor
110953510|NCT03424928|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110953511|NCT03424928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110953512|NCT04799002|Melphalan|melphalan|mesh-list
110953513|NCT04799002|Topotecan|topotecan|mesh-list
110953514|NCT04799002|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110953515|NCT04799002|Alkylating Agents|alkylating agents|mesh-ancestor
110953516|NCT04799002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110953517|NCT04799002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110953518|NCT04799002|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110953519|NCT04799002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110953520|NCT04799002|Immunologic Factors|immunologic factors|mesh-ancestor
110953521|NCT04799002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110953522|NCT04799002|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110953523|NCT04799002|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110953524|NCT04799002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110953525|NCT02098785|Caffeine|caffeine|mesh-list
110953526|NCT02098785|Caffeine citrate|caffeine citrate|mesh-list
110953527|NCT02098785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110953528|NCT02098785|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110953529|NCT02098785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110953530|NCT02098785|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110953531|NCT02098785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111498020|NCT02536248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111498021|NCT02536248|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111498022|NCT02536248|Protease Inhibitors|protease inhibitors|mesh-ancestor
111498023|NCT02536248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111498024|NCT02536248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111498026|NCT02538042|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111498027|NCT02538042|Autonomic Agents|autonomic agents|mesh-ancestor
111498028|NCT02538042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111498029|NCT02538042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111498030|NCT02538042|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111498031|NCT02538042|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111498032|NCT02538042|Cholinergic Agents|cholinergic agents|mesh-ancestor
111498033|NCT02538042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111498034|NCT02538042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111498035|NCT02538354|Riboflavin|riboflavin|mesh-list
111498036|NCT02538354|Vitamins|vitamins|mesh-ancestor
111498037|NCT02538354|Micronutrients|micronutrients|mesh-ancestor
111498038|NCT02538354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111498039|NCT02538354|Vitamin B Complex|vitamin b complex|mesh-ancestor
111498040|NCT02538354|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111498041|NCT02538354|Dermatologic Agents|dermatologic agents|mesh-ancestor
111498042|NCT02540226|Tranexamic Acid|tranexamic acid|mesh-list
111498043|NCT02540226|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111498044|NCT02540226|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111498045|NCT02540226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111498046|NCT02540226|Hemostatics|hemostatics|mesh-ancestor
111498047|NCT02540226|Coagulants|coagulants|mesh-ancestor
111498048|NCT02541864|Amoxicillin|amoxicillin|mesh-list
111498049|NCT02541864|Metronidazole|metronidazole|mesh-list
111498050|NCT02541864|Clarithromycin|clarithromycin|mesh-list
111498051|NCT02541864|Tetracycline|tetracycline|mesh-list
111498052|NCT02541864|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
111498053|NCT02541864|Pantoprazole|pantoprazole|mesh-list
111498054|NCT02541864|Bismuth|bismuth|mesh-list
111498055|NCT02541864|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111498056|NCT02541864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111498057|NCT02541864|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111498058|NCT02541864|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111498059|NCT02541864|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111498060|NCT02541864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111498061|NCT02541864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111498062|NCT02541864|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111498063|NCT02541864|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111498064|NCT02541864|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111498065|NCT02541864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111498066|NCT02541864|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111498067|NCT02541864|Antacids|antacids|mesh-ancestor
111498068|NCT02542410|Cabergoline|cabergoline|mesh-list
111498069|NCT02542410|Norethindrone|norethindrone|mesh-list
111498070|NCT02542410|Norethindrone Acetate|norethindrone acetate|mesh-list
111498071|NCT02542410|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111498072|NCT02542410|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111498073|NCT02542410|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111498074|NCT02542410|Contraceptive Agents|contraceptive agents|mesh-ancestor
111498075|NCT02542410|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111498076|NCT02542410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111498077|NCT02542410|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111498078|NCT02542410|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111498079|NCT02542410|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111498080|NCT02542410|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111498081|NCT02542410|Dopamine Agonists|dopamine agonists|mesh-ancestor
111498082|NCT02542410|Dopamine Agents|dopamine agents|mesh-ancestor
111498083|NCT02542410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111498084|NCT02542410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111498085|NCT02544984|Azithromycin|azithromycin|mesh-list
111498086|NCT02544984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111498087|NCT02544984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111498088|NCT02547012|Amoxicillin|amoxicillin|mesh-list
111498089|NCT02547012|Levofloxacin|levofloxacin|mesh-list
111498090|NCT02547012|Ofloxacin|ofloxacin|mesh-list
111498091|NCT02547012|Tetracycline|tetracycline|mesh-list
111498092|NCT02547012|Esomeprazole|esomeprazole|mesh-list
110450240|NCT03792256|Pegaspargase|pegaspargase|mesh-list
111498093|NCT02547012|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110773449|NCT04893252|Durvalumab|durvalumab|mesh-list
111498094|NCT02547012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111498095|NCT02547012|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110980415|NCT03219008|Dopamine Agents|dopamine agents|mesh-ancestor
111498096|NCT02547012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111498097|NCT02547012|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111498098|NCT02547012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111498099|NCT02547012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111498100|NCT02547012|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111498101|NCT02547012|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111498102|NCT02547012|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111498103|NCT02547012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111498104|NCT02547012|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111498105|NCT02547012|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111498106|NCT02547012|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111498107|NCT02548728|Oxytocin|oxytocin|mesh-list
111498108|NCT02548728|Oxytocics|oxytocics|mesh-ancestor
111498109|NCT02548728|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111498110|NCT02548728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111498111|NCT02553798|Glycopyrrolate|glycopyrrolate|mesh-list
111498112|NCT02553798|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111498113|NCT02553798|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111498114|NCT02553798|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111498115|NCT02553798|Cholinergic Agents|cholinergic agents|mesh-ancestor
111498116|NCT02553798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111498117|NCT02553798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111498118|NCT02553798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111498119|NCT02560038|Paclitaxel|paclitaxel|mesh-list
111498120|NCT02560038|Gemcitabine|gemcitabine|mesh-list
111498121|NCT02560038|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111498122|NCT02560038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111498123|NCT02560038|Tubulin Modulators|tubulin modulators|mesh-ancestor
111498124|NCT02560038|Antimitotic Agents|antimitotic agents|mesh-ancestor
111498125|NCT02560038|Mitosis Modulators|mitosis modulators|mesh-ancestor
111498126|NCT02560038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111498127|NCT02560038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111498128|NCT02560038|Antimetabolites|antimetabolites|mesh-ancestor
111498129|NCT02560584|Aminolevulinic Acid|aminolevulinic acid|mesh-list
111498130|NCT02560584|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111498131|NCT02560584|Dermatologic Agents|dermatologic agents|mesh-ancestor
111498132|NCT02561130|Metformin|metformin|mesh-list
111498133|NCT02561130|Insulin Glargine|insulin glargine|mesh-list
111498134|NCT02561130|Dapagliflozin|dapagliflozin|mesh-list
111498135|NCT02561130|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111498136|NCT02561130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111498137|NCT02561130|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111498138|NCT02561130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111498139|NCT02562066|Amifampridine|amifampridine|mesh-list
111498140|NCT02562066|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111498141|NCT02562066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111498142|NCT02562066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111498143|NCT02562066|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
111498144|NCT02562066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111498145|NCT02562066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111498146|NCT02562924|Prednisone|prednisone|mesh-list
111498147|NCT02562924|Budesonide|budesonide|mesh-list
111498148|NCT02562924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111498149|NCT02562924|Glucocorticoids|glucocorticoids|mesh-ancestor
111498150|NCT02562924|Hormones|hormones|mesh-ancestor
111498151|NCT02562924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111498152|NCT02562924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111498153|NCT02562924|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111498154|NCT02562924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111498155|NCT02562924|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111498156|NCT02562924|Autonomic Agents|autonomic agents|mesh-ancestor
111498157|NCT02562924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111498158|NCT02562924|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111498159|NCT02562924|Respiratory System Agents|respiratory system agents|mesh-ancestor
111498160|NCT02563860|Lovastatin|lovastatin|mesh-list
111498161|NCT02563860|L 647318|l 647318|mesh-list
111498162|NCT02563860|Dihydromevinolin|dihydromevinolin|mesh-list
111498163|NCT02563860|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111498164|NCT02563860|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111498165|NCT02563860|Antimetabolites|antimetabolites|mesh-ancestor
111498166|NCT02563860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111498167|NCT02563860|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111498168|NCT02563860|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111498169|NCT02563860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111498170|NCT02568852|Anesthetics|anesthetics|mesh-list
111498171|NCT02568852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111498172|NCT02568852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110980416|NCT03218930|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110980417|NCT03218930|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
111498173|NCT02570022|Bupivacaine|bupivacaine|mesh-list
111498174|NCT02570022|Ropivacaine|ropivacaine|mesh-list
111498175|NCT02570022|Anesthetics, Local|anesthetics, local|mesh-ancestor
111498176|NCT02570022|Anesthetics|anesthetics|mesh-ancestor
111498177|NCT02570022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111498178|NCT02570022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111498179|NCT02570022|Sensory System Agents|sensory system agents|mesh-ancestor
111498180|NCT02570022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111498181|NCT02572752|Nintedanib|nintedanib|mesh-list
111498182|NCT02572752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111498183|NCT02572752|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111498184|NCT02572752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111498185|NCT02572752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111498186|NCT02577042|Raltegravir Potassium|raltegravir potassium|mesh-list
111498187|NCT02577042|Atorvastatin|atorvastatin|mesh-list
111498188|NCT02577042|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111498189|NCT02577042|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111498190|NCT02577042|Antimetabolites|antimetabolites|mesh-ancestor
111498191|NCT02577042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111498192|NCT02577042|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111498193|NCT02577042|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111498194|NCT02577042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111498195|NCT02577042|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111498196|NCT02577042|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111498197|NCT02577042|Antiviral Agents|antiviral agents|mesh-ancestor
111498198|NCT02577042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111498199|NCT02577042|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111498200|NCT02577042|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111498201|NCT02582970|Bevacizumab|bevacizumab|mesh-list
111498202|NCT02582970|Fluorouracil|fluorouracil|mesh-list
111498203|NCT02582970|Oxaliplatin|oxaliplatin|mesh-list
111498204|NCT02582970|Irinotecan|irinotecan|mesh-list
111498205|NCT02582970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111498206|NCT02582970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111498207|NCT02582970|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111498208|NCT02582970|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111498209|NCT02582970|Growth Substances|growth substances|mesh-ancestor
111498210|NCT02582970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111498211|NCT02582970|Growth Inhibitors|growth inhibitors|mesh-ancestor
111498212|NCT02582970|Antimetabolites|antimetabolites|mesh-ancestor
111498213|NCT02582970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111498214|NCT02582970|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111498215|NCT02582970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111498216|NCT02582970|Immunologic Factors|immunologic factors|mesh-ancestor
110450271|NCT00613288|Testosterone|testosterone|mesh-list
111498217|NCT02582970|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111498218|NCT02582970|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111498219|NCT02582970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111498220|NCT02584608|Interferon-gamma|interferon-gamma|mesh-list
111498221|NCT02584608|Antiviral Agents|antiviral agents|mesh-ancestor
111498222|NCT02584608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111498223|NCT02584686|Botulinum Toxins|botulinum toxins|mesh-list
111498224|NCT02584686|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111498225|NCT02584686|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111498226|NCT02584686|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111498227|NCT02584686|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111498228|NCT02584686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111498229|NCT02584686|Cholinergic Agents|cholinergic agents|mesh-ancestor
111498230|NCT02584686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111498231|NCT02584686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111498232|NCT02584686|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111498233|NCT02584686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111498234|NCT05249556|Ganaxolone|ganaxolone|mesh-list
111498235|NCT05249556|Neurosteroids|neurosteroids|mesh-ancestor
111498236|NCT05249556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111498237|NCT05249556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111498238|NCT05249556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111498239|NCT05249556|GABA Modulators|gaba modulators|mesh-ancestor
111498240|NCT05249556|GABA Agents|gaba agents|mesh-ancestor
111498241|NCT05248152|Acetaminophen|acetaminophen|mesh-list
111498242|NCT05248152|Ibuprofen|ibuprofen|mesh-list
111498243|NCT05248152|Pregabalin|pregabalin|mesh-list
111498244|NCT05248152|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111498245|NCT05248152|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111498246|NCT05248152|Analgesics|analgesics|mesh-ancestor
111498247|NCT05248152|Sensory System Agents|sensory system agents|mesh-ancestor
111498248|NCT05248152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110980418|NCT03218930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111498249|NCT05248152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111498250|NCT05248152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111498251|NCT05248152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111498252|NCT05248152|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111498253|NCT05248152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111498254|NCT05248152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111498255|NCT05248152|Anticonvulsants|anticonvulsants|mesh-ancestor
111498256|NCT05248152|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111498257|NCT05248152|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111498258|NCT05248152|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111498259|NCT05248152|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111498260|NCT05248152|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111498261|NCT05248152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111498262|NCT05248152|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111498263|NCT05248152|Antipyretics|antipyretics|mesh-ancestor
111498264|NCT05247684|Paclitaxel|paclitaxel|mesh-list
111498265|NCT05247684|Carboplatin|carboplatin|mesh-list
111498266|NCT05247684|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111498267|NCT05247684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111498268|NCT05247684|Tubulin Modulators|tubulin modulators|mesh-ancestor
111498269|NCT05247684|Antimitotic Agents|antimitotic agents|mesh-ancestor
111498270|NCT05247684|Mitosis Modulators|mitosis modulators|mesh-ancestor
111498271|NCT05247684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111498272|NCT05132166|Sirolimus|sirolimus|mesh-list
111498273|NCT05132166|Everolimus|everolimus|mesh-list
111498274|NCT05132166|MTOR Inhibitors|mtor inhibitors|mesh-list
111498275|NCT05132166|Temsirolimus|temsirolimus|mesh-list
111498276|NCT05132166|Vedolizumab|vedolizumab|mesh-list
111498277|NCT05132166|Antilymphocyte Serum|antilymphocyte serum|mesh-list
111498278|NCT05132166|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111498279|NCT05132166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111498280|NCT05132166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111498281|NCT05132166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111498282|NCT05132166|Immunologic Factors|immunologic factors|mesh-ancestor
111498283|NCT05132166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111498284|NCT05132166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111498285|NCT05132166|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111498286|NCT05132166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111498287|NCT05132166|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111498288|NCT05132166|Antifungal Agents|antifungal agents|mesh-ancestor
111498289|NCT05132166|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111498290|NCT04808466|Paclitaxel|paclitaxel|mesh-list
111498291|NCT04808466|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111498292|NCT04808466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111498293|NCT04808466|Tubulin Modulators|tubulin modulators|mesh-ancestor
111498294|NCT04808466|Antimitotic Agents|antimitotic agents|mesh-ancestor
111498295|NCT04808466|Mitosis Modulators|mitosis modulators|mesh-ancestor
111498296|NCT04808466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111498297|NCT03939234|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
111498298|NCT03939234|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111498299|NCT03939234|Immunologic Factors|immunologic factors|mesh-ancestor
111498300|NCT03939234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111498301|NCT03907176|Acetaminophen|acetaminophen|mesh-list
111498302|NCT03907176|Ibuprofen|ibuprofen|mesh-list
111498303|NCT03907176|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111498304|NCT03907176|Analgesics|analgesics|mesh-ancestor
111498305|NCT03907176|Sensory System Agents|sensory system agents|mesh-ancestor
111498306|NCT03907176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111498307|NCT03907176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111498308|NCT03907176|Antipyretics|antipyretics|mesh-ancestor
111498309|NCT03907176|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111498310|NCT03907176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111498311|NCT03907176|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111498312|NCT03907176|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111498313|NCT03907176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111498314|NCT03907176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111498315|NCT03675672|Misoprostol|misoprostol|mesh-list
111498316|NCT03675672|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111498317|NCT03675672|Abortifacient Agents|abortifacient agents|mesh-ancestor
111498318|NCT03675672|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111498319|NCT03675672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111498320|NCT03675672|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111498321|NCT03675672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110980419|NCT03218930|Antitubercular Agents|antitubercular agents|mesh-ancestor
110980421|NCT00562497|Prednisone|prednisone|mesh-list
110980422|NCT00562497|Methylprednisolone|methylprednisolone|mesh-list
110980423|NCT00562497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110980424|NCT00562497|Glucocorticoids|glucocorticoids|mesh-ancestor
111498322|NCT03675672|Oxytocics|oxytocics|mesh-ancestor
111498323|NCT02108496|Hyaluronic Acid|hyaluronic acid|mesh-list
111498324|NCT02108496|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111498325|NCT02108496|Immunologic Factors|immunologic factors|mesh-ancestor
111498326|NCT02108496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111498327|NCT02108496|Viscosupplements|viscosupplements|mesh-ancestor
111498328|NCT02108496|Protective Agents|protective agents|mesh-ancestor
111498329|NCT02056236|Midazolam|midazolam|mesh-list
111498330|NCT02056236|Levetiracetam|levetiracetam|mesh-list
111498331|NCT02056236|Valproic Acid|valproic acid|mesh-list
111498332|NCT02056236|Lorazepam|lorazepam|mesh-list
111498333|NCT02056236|Thiopental|thiopental|mesh-list
111498334|NCT02056236|Anticonvulsants|anticonvulsants|mesh-list
111498335|NCT02056236|Propofol|propofol|mesh-list
111498336|NCT02056236|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111498337|NCT02056236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111498338|NCT02056236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111498339|NCT02056236|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111498340|NCT02056236|Anesthetics, General|anesthetics, general|mesh-ancestor
111498341|NCT02056236|Anesthetics|anesthetics|mesh-ancestor
111498342|NCT02056236|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111498343|NCT02056236|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111498344|NCT02056236|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111498345|NCT02056236|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111498346|NCT02056236|GABA Modulators|gaba modulators|mesh-ancestor
111498347|NCT02056236|GABA Agents|gaba agents|mesh-ancestor
111498348|NCT02056236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111498349|NCT02056236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111498350|NCT02056236|Nootropic Agents|nootropic agents|mesh-ancestor
111498351|NCT02056236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111498352|NCT02056236|Antimanic Agents|antimanic agents|mesh-ancestor
111498353|NCT02056236|Antiemetics|antiemetics|mesh-ancestor
111498354|NCT02056236|Autonomic Agents|autonomic agents|mesh-ancestor
111498355|NCT02056236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111498356|NCT02056236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111498357|NCT01962246|Capecitabine|capecitabine|mesh-list
111498358|NCT01962246|Oxaliplatin|oxaliplatin|mesh-list
111498359|NCT01962246|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111498360|NCT01962246|Antimetabolites|antimetabolites|mesh-ancestor
111498361|NCT01962246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111498362|NCT01962246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111498363|NCT02588586|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
111498364|NCT02588586|Antiviral Agents|antiviral agents|mesh-ancestor
111498365|NCT02588586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111498366|NCT02592486|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
111498367|NCT02592486|Immunologic Factors|immunologic factors|mesh-ancestor
111498368|NCT02592486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111498369|NCT05370846|Anti-Infective Agents|anti-infective agents|mesh-list
111498370|NCT05370846|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111498371|NCT04945122|Atorvastatin|atorvastatin|mesh-list
111498372|NCT04945122|Pitavastatin|pitavastatin|mesh-list
111498373|NCT04945122|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111498374|NCT04945122|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111498375|NCT04945122|Antimetabolites|antimetabolites|mesh-ancestor
111498376|NCT04945122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111498377|NCT04945122|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111498378|NCT04945122|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111498379|NCT04945122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111498380|NCT04227366|Methotrexate|methotrexate|mesh-list
111498381|NCT04227366|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111498382|NCT04227366|Abortifacient Agents|abortifacient agents|mesh-ancestor
111498383|NCT04227366|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111498384|NCT04227366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111498385|NCT04227366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111498386|NCT04227366|Antimetabolites|antimetabolites|mesh-ancestor
111498387|NCT04227366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111498388|NCT04227366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110980425|NCT00562497|Hormones|hormones|mesh-ancestor
110773822|NCT03787992|Gefitinib|gefitinib|mesh-list
111498389|NCT04227366|Dermatologic Agents|dermatologic agents|mesh-ancestor
111498390|NCT04227366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111498391|NCT04227366|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111498392|NCT04227366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111498393|NCT04227366|Immunologic Factors|immunologic factors|mesh-ancestor
111498394|NCT04227366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111498395|NCT04227366|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111498396|NCT03560466|Prednisone|prednisone|mesh-list
111498397|NCT03560466|Prednisolone|prednisolone|mesh-list
111498398|NCT03560466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111498399|NCT03560466|Glucocorticoids|glucocorticoids|mesh-ancestor
111498400|NCT03560466|Hormones|hormones|mesh-ancestor
111498401|NCT03560466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111498402|NCT03560466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111498403|NCT03560466|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111498404|NCT03560466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111498405|NCT03376698|Colchicine|colchicine|mesh-list
111498406|NCT03376698|Gout Suppressants|gout suppressants|mesh-ancestor
111498407|NCT03376698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111498408|NCT03376698|Tubulin Modulators|tubulin modulators|mesh-ancestor
111498409|NCT03376698|Antimitotic Agents|antimitotic agents|mesh-ancestor
111498410|NCT03376698|Mitosis Modulators|mitosis modulators|mesh-ancestor
111498411|NCT03376698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111498412|NCT03376698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111498413|NCT03295734|Losartan|losartan|mesh-list
111498414|NCT03295734|Perindopril|perindopril|mesh-list
111498415|NCT03295734|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111498416|NCT03295734|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111498417|NCT03295734|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111498418|NCT03295734|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111498419|NCT03295734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111498420|NCT03295734|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
111498421|NCT03295734|Protease Inhibitors|protease inhibitors|mesh-ancestor
111498422|NCT03295734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111498423|NCT02595684|Tadalafil|tadalafil|mesh-list
111498424|NCT02595684|Vasodilator Agents|vasodilator agents|mesh-ancestor
111498425|NCT02595684|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111498426|NCT02595684|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111498427|NCT02595684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111498428|NCT02595684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111498429|NCT02595684|Urological Agents|urological agents|mesh-ancestor
111498430|NCT02604810|Immunoglobulins|immunoglobulins|mesh-list
111498431|NCT02604810|Antibodies|antibodies|mesh-list
111498432|NCT02604810|gamma-Globulins|gamma-globulins|mesh-list
111498433|NCT02604810|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111498434|NCT02604810|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
111498435|NCT02604810|Immunoglobulin G|immunoglobulin g|mesh-list
111498436|NCT02604810|Immunologic Factors|immunologic factors|mesh-ancestor
111498437|NCT02604810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111498438|NCT02607618|Vancomycin|vancomycin|mesh-list
111498439|NCT02607618|Iclaprim|iclaprim|mesh-list
111498440|NCT02607618|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111498441|NCT02607618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111498442|NCT02607618|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111498443|NCT02607618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111498444|NCT02607618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111498445|NCT05732064|Dexmedetomidine|dexmedetomidine|mesh-list
111498446|NCT05732064|Esketamine|esketamine|mesh-list
111498447|NCT05732064|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111498448|NCT05732064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111498449|NCT05732064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111498450|NCT05732064|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111498451|NCT05732064|Analgesics|analgesics|mesh-ancestor
111498452|NCT05732064|Sensory System Agents|sensory system agents|mesh-ancestor
111498453|NCT05732064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111498454|NCT05732064|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111498455|NCT05732064|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111498456|NCT05732064|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111498457|NCT05732064|Adrenergic Agents|adrenergic agents|mesh-ancestor
111498458|NCT05732064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111498459|NCT05732064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111498460|NCT05732064|Antidepressive Agents|antidepressive agents|mesh-ancestor
111498461|NCT05732064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111498462|NCT05731752|Antibodies, Bispecific|antibodies, bispecific|mesh-list
111498463|NCT05731752|Immunologic Factors|immunologic factors|mesh-ancestor
111498464|NCT05731752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111498465|NCT05730738|4-Aminopyridine|4-aminopyridine|mesh-list
110773890|NCT01308684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111498466|NCT05730738|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
111498467|NCT05730738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110773966|NCT01307592|Gemcitabine|gemcitabine|mesh-list
111498468|NCT05730738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111498469|NCT05730660|Quercetin|quercetin|mesh-list
111498470|NCT05730660|Antioxidants|antioxidants|mesh-ancestor
111498471|NCT05730660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111498472|NCT05730660|Protective Agents|protective agents|mesh-ancestor
111498473|NCT05730660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111498474|NCT05419674|Amoxicillin|amoxicillin|mesh-list
111498475|NCT05419674|Clarithromycin|clarithromycin|mesh-list
111498476|NCT05419674|Rabeprazole|rabeprazole|mesh-list
111498477|NCT05419674|Bismuth|bismuth|mesh-list
111498478|NCT05419674|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111498479|NCT05419674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111498480|NCT05419674|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111498481|NCT05419674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111498482|NCT05419674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111498483|NCT05419674|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111498484|NCT05419674|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111498485|NCT05419674|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111498486|NCT05419674|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111498487|NCT05419674|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111498488|NCT05419674|Antacids|antacids|mesh-ancestor
111498489|NCT05386524|Bevacizumab|bevacizumab|mesh-list
111498490|NCT05386524|Doxorubicin|doxorubicin|mesh-list
111498491|NCT05386524|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111498492|NCT05386524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111498493|NCT05386524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111498494|NCT05386524|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111498495|NCT05386524|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111498496|NCT05386524|Growth Substances|growth substances|mesh-ancestor
111498497|NCT05386524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111498498|NCT05386524|Growth Inhibitors|growth inhibitors|mesh-ancestor
111498499|NCT05386524|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111498500|NCT05386524|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111498501|NCT05386524|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111498502|NCT05386524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111498503|NCT05386524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111498504|NCT04965714|Nivolumab|nivolumab|mesh-list
111498505|NCT04965714|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111498506|NCT04965714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111498507|NCT04965714|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111498508|NCT04965714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111498509|NCT04787562|Imipenem|imipenem|mesh-list
111498510|NCT04787562|Cilastatin|cilastatin|mesh-list
111498511|NCT04787562|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111498512|NCT04787562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111498513|NCT04787562|Protease Inhibitors|protease inhibitors|mesh-ancestor
111498514|NCT04787562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111498515|NCT04787562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111498516|NCT04780698|Immunoglobulin G|immunoglobulin g|mesh-list
111498517|NCT04780698|Immunologic Factors|immunologic factors|mesh-ancestor
111498518|NCT04780698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111498519|NCT04355130|Vitamin B 12|vitamin b 12|mesh-list
111498520|NCT04355130|Hydroxocobalamin|hydroxocobalamin|mesh-list
111498521|NCT04355130|Vitamins|vitamins|mesh-ancestor
111498522|NCT04355130|Micronutrients|micronutrients|mesh-ancestor
111498523|NCT04355130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111498524|NCT04355130|Vitamin B Complex|vitamin b complex|mesh-ancestor
111498525|NCT04355130|Hematinics|hematinics|mesh-ancestor
111498526|NCT04107168|Bevacizumab|bevacizumab|mesh-list
111498527|NCT04107168|Pembrolizumab|pembrolizumab|mesh-list
111498528|NCT04107168|Nivolumab|nivolumab|mesh-list
111498529|NCT04107168|Ipilimumab|ipilimumab|mesh-list
111498530|NCT04107168|Atezolizumab|atezolizumab|mesh-list
111498531|NCT04107168|Durvalumab|durvalumab|mesh-list
111498532|NCT04107168|Tremelimumab|tremelimumab|mesh-list
111498533|NCT04107168|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111498534|NCT04107168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111498535|NCT04107168|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111498536|NCT04107168|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111498537|NCT04107168|Growth Substances|growth substances|mesh-ancestor
111498538|NCT04107168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111498539|NCT04107168|Growth Inhibitors|growth inhibitors|mesh-ancestor
111498540|NCT04107168|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111498541|NCT04107168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111498542|NCT03958344|Prednisolone|prednisolone|mesh-list
111498543|NCT03958344|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111498544|NCT03958344|Methylprednisolone|methylprednisolone|mesh-list
111498545|NCT03958344|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111498546|NCT03958344|Prednisolone acetate|prednisolone acetate|mesh-list
111498547|NCT03958344|Triamcinolone|triamcinolone|mesh-list
111498548|NCT03958344|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111498549|NCT03958344|Prednisolone phosphate|prednisolone phosphate|mesh-list
111498550|NCT03958344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111498551|NCT03958344|Glucocorticoids|glucocorticoids|mesh-ancestor
111498552|NCT03958344|Hormones|hormones|mesh-ancestor
111498553|NCT03958344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111498554|NCT03958344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111498555|NCT03958344|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111498556|NCT03958344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111498557|NCT03958344|Antiemetics|antiemetics|mesh-ancestor
111498558|NCT03958344|Autonomic Agents|autonomic agents|mesh-ancestor
111498559|NCT03958344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111498560|NCT03958344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111498561|NCT03958344|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111498562|NCT03958344|Protective Agents|protective agents|mesh-ancestor
111498563|NCT02960646|Cyclophosphamide|cyclophosphamide|mesh-list
111498564|NCT02960646|Melphalan|melphalan|mesh-list
111498565|NCT02960646|Mechlorethamine|mechlorethamine|mesh-list
111498566|NCT02960646|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
111498567|NCT02960646|Rituximab|rituximab|mesh-list
111498568|NCT02960646|Fludarabine|fludarabine|mesh-list
111498569|NCT02960646|Fludarabine phosphate|fludarabine phosphate|mesh-list
111498570|NCT02960646|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111498571|NCT02960646|Tacrolimus|tacrolimus|mesh-list
111498572|NCT02960646|Antibodies|antibodies|mesh-list
111498573|NCT02960646|Immunoglobulins|immunoglobulins|mesh-list
111498574|NCT02960646|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111498575|NCT02960646|Lenograstim|lenograstim|mesh-list
111498576|NCT02960646|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111498577|NCT02960646|Immunologic Factors|immunologic factors|mesh-ancestor
111498578|NCT02960646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111498579|NCT02960646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111498580|NCT02960646|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111498581|NCT02960646|Alkylating Agents|alkylating agents|mesh-ancestor
111498582|NCT02960646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111498583|NCT02960646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111498584|NCT02960646|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111498585|NCT02960646|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111498586|NCT02960646|Antimetabolites|antimetabolites|mesh-ancestor
111498587|NCT02960646|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111498588|NCT02960646|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111498589|NCT02960646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111498590|NCT01448616|Tenofovir|tenofovir|mesh-list
111498591|NCT01448616|Antiviral Agents|antiviral agents|mesh-ancestor
111498592|NCT01448616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111498593|NCT01448616|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111498594|NCT01448616|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111498595|NCT01448616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111498596|NCT01448616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111498597|NCT01448616|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111498598|NCT01448616|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111498599|NCT00074412|Nevirapine|nevirapine|mesh-list
111498600|NCT00074412|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111498601|NCT00074412|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111498602|NCT00074412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111498603|NCT00074412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111498604|NCT00074412|Antiviral Agents|antiviral agents|mesh-ancestor
111498605|NCT00074412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111498606|NCT00074412|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111498607|NCT00074412|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111498608|NCT00074412|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111498609|NCT00074412|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111498610|NCT02618772|Midazolam|midazolam|mesh-list
111498611|NCT02618772|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111498612|NCT02618772|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111498613|NCT02618772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111498614|NCT02618772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111498615|NCT02618772|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111498616|NCT02618772|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111498617|NCT02618772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111498618|NCT02618772|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111498619|NCT02618772|Anesthetics, General|anesthetics, general|mesh-ancestor
111498620|NCT02618772|Anesthetics|anesthetics|mesh-ancestor
110774116|NCT01316874|Valrubicin|valrubicin|mesh-list
111498621|NCT02618772|GABA Modulators|gaba modulators|mesh-ancestor
111498622|NCT02618772|GABA Agents|gaba agents|mesh-ancestor
111498623|NCT02618772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111498624|NCT02618772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111498625|NCT02620878|Pancrelipase|pancrelipase|mesh-list
111498626|NCT02620878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111498627|NCT02624700|Pemetrexed|pemetrexed|mesh-list
111498628|NCT02624700|Sorafenib|sorafenib|mesh-list
111498629|NCT02624700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111498630|NCT02624700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111498631|NCT02624700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111498632|NCT02624700|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111498633|NCT02624700|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111498634|NCT02624700|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111498635|NCT02631954|Voriconazole|voriconazole|mesh-list
111498636|NCT02631954|Antifungal Agents|antifungal agents|mesh-ancestor
111498637|NCT02631954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111498638|NCT02631954|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111498639|NCT02631954|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111498640|NCT02631954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111498641|NCT02631954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111498642|NCT02631954|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111498643|NCT02631954|Hormone Antagonists|hormone antagonists|mesh-ancestor
111498644|NCT02631954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111498645|NCT02631954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111498646|NCT02631954|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111498647|NCT02632812|Naproxen|naproxen|mesh-list
111498648|NCT02632812|Rebamipide|rebamipide|mesh-list
111498649|NCT02632812|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111498650|NCT02632812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111498651|NCT02632812|Analgesics|analgesics|mesh-ancestor
111498652|NCT02632812|Sensory System Agents|sensory system agents|mesh-ancestor
111498653|NCT02632812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111498654|NCT02632812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111498655|NCT02632812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111498656|NCT02632812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111498657|NCT02632812|Gout Suppressants|gout suppressants|mesh-ancestor
111498658|NCT02632812|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111498659|NCT02632812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111498660|NCT02632812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111498661|NCT02632812|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111498662|NCT02632812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111498663|NCT02632812|Antioxidants|antioxidants|mesh-ancestor
111498664|NCT02632812|Protective Agents|protective agents|mesh-ancestor
111498665|NCT02634684|Amphetamine|amphetamine|mesh-list
111498666|NCT02634684|Dextroamphetamine|dextroamphetamine|mesh-list
111498667|NCT02634684|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111498668|NCT02634684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111498669|NCT02634684|Sympathomimetics|sympathomimetics|mesh-ancestor
111498670|NCT02634684|Autonomic Agents|autonomic agents|mesh-ancestor
111498671|NCT02634684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111498672|NCT02634684|Dopamine Agents|dopamine agents|mesh-ancestor
111498673|NCT02634684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111498674|NCT02634684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111498675|NCT02634684|Adrenergic Agents|adrenergic agents|mesh-ancestor
111498676|NCT02634684|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111498677|NCT02634684|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111498678|NCT02634684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111498679|NCT02634684|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111498680|NCT02635542|Cisatracurium|cisatracurium|mesh-list
111498681|NCT02635542|Succinylcholine|succinylcholine|mesh-list
111498682|NCT02635542|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
111498683|NCT02635542|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111498684|NCT02635542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111498685|NCT02635542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111498686|NCT02635542|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
111498687|NCT05585658|Epoetin Alfa|epoetin alfa|mesh-list
111498688|NCT05585658|Hematinics|hematinics|mesh-ancestor
111498689|NCT05510856|Lacosamide|lacosamide|mesh-list
111498690|NCT05510856|Gabapentin|gabapentin|mesh-list
111498691|NCT05510856|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
111498692|NCT05510856|Analgesics|analgesics|mesh-ancestor
111498693|NCT05510856|Sensory System Agents|sensory system agents|mesh-ancestor
111498694|NCT05510856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111498695|NCT05510856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111498697|NCT05510856|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111498698|NCT05510856|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111498699|NCT05510856|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111498700|NCT05510856|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111498701|NCT05510856|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111498702|NCT05510856|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111498703|NCT05510856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111498704|NCT05510856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111498705|NCT05510856|Antimanic Agents|antimanic agents|mesh-ancestor
111498706|NCT05510856|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111498707|NCT05510856|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111498708|NCT05510856|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111498709|NCT05510856|Antidepressive Agents|antidepressive agents|mesh-ancestor
111498710|NCT05510856|Dopamine Agents|dopamine agents|mesh-ancestor
111498711|NCT05510856|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111498712|NCT05510856|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111498713|NCT05281770|Erenumab|erenumab|mesh-list
111498714|NCT05281770|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
111498715|NCT05281770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111498716|NCT05281770|Analgesics|analgesics|mesh-ancestor
111498717|NCT05281770|Sensory System Agents|sensory system agents|mesh-ancestor
111498718|NCT05281770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111498719|NCT05281770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111498720|NCT05225610|Dexmedetomidine|dexmedetomidine|mesh-list
111498721|NCT05225610|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111498722|NCT05225610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111498723|NCT05225610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111498724|NCT05225610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111498725|NCT05225610|Analgesics|analgesics|mesh-ancestor
111498726|NCT05225610|Sensory System Agents|sensory system agents|mesh-ancestor
111498727|NCT05225610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111498728|NCT05225610|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111498729|NCT05225610|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111498730|NCT05225610|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111498731|NCT05225610|Adrenergic Agents|adrenergic agents|mesh-ancestor
111498732|NCT05225610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111498733|NCT05225610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111498734|NCT05150652|Tamoxifen|tamoxifen|mesh-list
111498735|NCT05150652|Letrozole|letrozole|mesh-list
111498736|NCT05150652|Anastrozole|anastrozole|mesh-list
111498737|NCT05150652|Exemestane|exemestane|mesh-list
111498738|NCT05150652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111498739|NCT05150652|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111498740|NCT05150652|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111498741|NCT05150652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111498742|NCT05150652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111498743|NCT05150652|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111498744|NCT05150652|Hormone Antagonists|hormone antagonists|mesh-ancestor
111498745|NCT05150652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111498746|NCT05150652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111498747|NCT05150652|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111498748|NCT05150652|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111498749|NCT05150652|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111498750|NCT05150652|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111498751|NCT04511052|Carotenoids|carotenoids|mesh-list
111498752|NCT04511052|Antioxidants|antioxidants|mesh-ancestor
111498753|NCT04511052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111498754|NCT04511052|Protective Agents|protective agents|mesh-ancestor
111498755|NCT04511052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111498756|NCT03693846|Nivolumab|nivolumab|mesh-list
111498757|NCT03693846|Ipilimumab|ipilimumab|mesh-list
111498758|NCT03693846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111498759|NCT03693846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111498760|NCT03693846|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111498761|NCT03693846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111498762|NCT03529890|Nivolumab|nivolumab|mesh-list
111498763|NCT03529890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111498764|NCT03529890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110774191|NCT02865850|Darbepoetin alfa|darbepoetin alfa|mesh-list
111498765|NCT03529890|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111498766|NCT03529890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111498767|NCT03441048|Cytarabine|cytarabine|mesh-list
111498768|NCT03441048|Mitoxantrone|mitoxantrone|mesh-list
111498769|NCT03441048|Cladribine|cladribine|mesh-list
111498770|NCT03441048|Lintuzumab|lintuzumab|mesh-list
111498771|NCT03441048|Lenograstim|lenograstim|mesh-list
111498772|NCT03441048|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111498773|NCT03441048|Antimetabolites|antimetabolites|mesh-ancestor
111498774|NCT03441048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111498775|NCT03441048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111498776|NCT03441048|Antiviral Agents|antiviral agents|mesh-ancestor
111498777|NCT03441048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111498778|NCT03441048|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111498779|NCT03441048|Immunologic Factors|immunologic factors|mesh-ancestor
111498780|NCT03441048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111498781|NCT03441048|Analgesics|analgesics|mesh-ancestor
111498782|NCT03441048|Sensory System Agents|sensory system agents|mesh-ancestor
111498783|NCT03441048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111498784|NCT03441048|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111498785|NCT03441048|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111498786|NCT03441048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111498787|NCT03441048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111498788|NCT03441048|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111498789|NCT02828592|Cyclophosphamide|cyclophosphamide|mesh-list
111498790|NCT02828592|Fludarabine|fludarabine|mesh-list
111498791|NCT02828592|Thymoglobulin|thymoglobulin|mesh-list
111498792|NCT02828592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111498793|NCT02828592|Immunologic Factors|immunologic factors|mesh-ancestor
111498794|NCT02828592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111498795|NCT02828592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111498796|NCT02828592|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111498797|NCT02828592|Alkylating Agents|alkylating agents|mesh-ancestor
111498798|NCT02828592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111498799|NCT02828592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111498800|NCT02828592|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111498801|NCT02369406|Lamivudine|lamivudine|mesh-list
111498802|NCT02369406|Zidovudine|zidovudine|mesh-list
111498803|NCT02369406|Nevirapine|nevirapine|mesh-list
111498804|NCT02369406|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111498805|NCT02369406|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111498806|NCT02369406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111498807|NCT02369406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111498808|NCT02369406|Antiviral Agents|antiviral agents|mesh-ancestor
111498809|NCT02369406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111498810|NCT02369406|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111498811|NCT02369406|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111498812|NCT02369406|Antimetabolites|antimetabolites|mesh-ancestor
111498813|NCT02369406|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111498814|NCT02369406|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111498815|NCT02649192|Vitamin D|vitamin d|mesh-list
111498816|NCT02649192|Vitamin A|vitamin a|mesh-list
111498817|NCT02649192|Vitamins|vitamins|mesh-ancestor
111498818|NCT02649192|Micronutrients|micronutrients|mesh-ancestor
111498819|NCT02649192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111498820|NCT02649192|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111498821|NCT02652390|Methylprednisolone|methylprednisolone|mesh-list
111498822|NCT02652390|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111498823|NCT02652390|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111498824|NCT02652390|Prednisolone|prednisolone|mesh-list
111498825|NCT02652390|Prednisolone acetate|prednisolone acetate|mesh-list
111498826|NCT02652390|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111498827|NCT02652390|Prednisolone phosphate|prednisolone phosphate|mesh-list
111498828|NCT02652390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111498829|NCT02652390|Antiemetics|antiemetics|mesh-ancestor
111498830|NCT02652390|Autonomic Agents|autonomic agents|mesh-ancestor
111498831|NCT02652390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111498832|NCT02652390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111498833|NCT02652390|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111498834|NCT02652390|Glucocorticoids|glucocorticoids|mesh-ancestor
111498835|NCT02652390|Hormones|hormones|mesh-ancestor
111498836|NCT02652390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110774267|NCT03072160|Pembrolizumab|pembrolizumab|mesh-list
111498837|NCT02652390|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111498838|NCT02652390|Protective Agents|protective agents|mesh-ancestor
111498839|NCT02652390|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111498840|NCT02652390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111498841|NCT02653560|Potassium Citrate|potassium citrate|mesh-list
111498842|NCT02653560|Magnesium citrate|magnesium citrate|mesh-list
111498843|NCT02653560|Citric Acid|citric acid|mesh-list
111498844|NCT02653560|Sodium Citrate|sodium citrate|mesh-list
111498845|NCT02653560|Anticoagulants|anticoagulants|mesh-ancestor
111498846|NCT02653560|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
111498847|NCT02653560|Chelating Agents|chelating agents|mesh-ancestor
111498848|NCT02653560|Sequestering Agents|sequestering agents|mesh-ancestor
111498849|NCT02653560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111498850|NCT02653560|Diuretics|diuretics|mesh-ancestor
111498851|NCT02653560|Natriuretic Agents|natriuretic agents|mesh-ancestor
111498852|NCT02653560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111498853|NCT02653560|Expectorants|expectorants|mesh-ancestor
111498854|NCT02653560|Respiratory System Agents|respiratory system agents|mesh-ancestor
111498855|NCT02653560|Cathartics|cathartics|mesh-ancestor
111498856|NCT02653560|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111498857|NCT02653872|Itraconazole|itraconazole|mesh-list
111498858|NCT02653872|Verapamil|verapamil|mesh-list
111498859|NCT02653872|Diltiazem|diltiazem|mesh-list
111498860|NCT02653872|Antifungal Agents|antifungal agents|mesh-ancestor
111498861|NCT02653872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111498862|NCT02653872|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111498863|NCT02653872|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111498864|NCT02653872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111498865|NCT02653872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111498866|NCT02653872|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111498867|NCT02653872|Hormone Antagonists|hormone antagonists|mesh-ancestor
111498868|NCT02653872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111498869|NCT02653872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111498870|NCT02653872|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111498871|NCT02653872|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111498872|NCT02653872|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111498873|NCT02653872|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111498874|NCT02653872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111498875|NCT02653872|Vasodilator Agents|vasodilator agents|mesh-ancestor
111498876|NCT02653872|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111498877|NCT02655354|Diphenhydramine|diphenhydramine|mesh-list
111498878|NCT02655354|Promethazine|promethazine|mesh-list
111498879|NCT02655354|Prazosin|prazosin|mesh-list
111498880|NCT02655354|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
111498881|NCT02655354|Mirtazapine|mirtazapine|mesh-list
111498882|NCT02655354|Fluvoxamine|fluvoxamine|mesh-list
111498883|NCT02655354|Trazodone|trazodone|mesh-list
111498884|NCT02655354|Sertraline|sertraline|mesh-list
111498885|NCT02655354|Fluoxetine|fluoxetine|mesh-list
111498886|NCT02655354|Paroxetine|paroxetine|mesh-list
111498887|NCT02655354|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
111498888|NCT02655354|Citalopram|citalopram|mesh-list
111498889|NCT02655354|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111498890|NCT02655354|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111498891|NCT02655354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111498892|NCT02655354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111498893|NCT02655354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111498894|NCT02655354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111498895|NCT02655354|Analgesics|analgesics|mesh-ancestor
111498896|NCT02655354|Sensory System Agents|sensory system agents|mesh-ancestor
111498897|NCT02655354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111498898|NCT02655354|Antidepressive Agents|antidepressive agents|mesh-ancestor
111498899|NCT02655354|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111498900|NCT02655354|Dopamine Agents|dopamine agents|mesh-ancestor
111498901|NCT02655354|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111498902|NCT02655354|Serotonin Agents|serotonin agents|mesh-ancestor
111498903|NCT02655354|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111498904|NCT02655354|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111498905|NCT02655354|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111498906|NCT02655354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111498907|NCT02655354|Autonomic Agents|autonomic agents|mesh-ancestor
111498908|NCT02655354|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111498909|NCT02655354|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111498910|NCT02655354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111498911|NCT02655354|Anesthetics, Local|anesthetics, local|mesh-ancestor
111498912|NCT02655354|Anesthetics|anesthetics|mesh-ancestor
110774339|NCT05201560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111498913|NCT02655354|Antiemetics|antiemetics|mesh-ancestor
111498914|NCT02655354|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111498915|NCT02655354|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111498916|NCT02655354|Histamine Antagonists|histamine antagonists|mesh-ancestor
111498917|NCT02655354|Histamine Agents|histamine agents|mesh-ancestor
111498918|NCT02655354|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111498919|NCT02655354|Antipruritics|antipruritics|mesh-ancestor
111498920|NCT02655354|Dermatologic Agents|dermatologic agents|mesh-ancestor
111498921|NCT02655354|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111498922|NCT02655354|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111498923|NCT02655354|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
111498924|NCT02655354|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111498925|NCT02655354|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111498926|NCT02655354|Adrenergic Agents|adrenergic agents|mesh-ancestor
111498927|NCT02655354|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111498928|NCT02655354|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111498929|NCT02655354|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111498930|NCT02655354|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111498931|NCT02655354|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111498932|NCT02655354|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111498933|NCT02655354|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111498934|NCT02657928|Letrozole|letrozole|mesh-list
111498935|NCT02657928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111498936|NCT02657928|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111498937|NCT02657928|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111498938|NCT02657928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111498939|NCT02657928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111498940|NCT02657928|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111498941|NCT02657928|Hormone Antagonists|hormone antagonists|mesh-ancestor
111498942|NCT02657928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111498943|NCT02657928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111498944|NCT02658240|Epinephrine|epinephrine|mesh-list
111498945|NCT02658240|Ropivacaine|ropivacaine|mesh-list
111498946|NCT02658240|Anesthetics, Local|anesthetics, local|mesh-ancestor
111498947|NCT02658240|Anesthetics|anesthetics|mesh-ancestor
111498948|NCT02658240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111498949|NCT02658240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111498950|NCT02658240|Sensory System Agents|sensory system agents|mesh-ancestor
111498951|NCT02658240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111498952|NCT02658240|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111498953|NCT02658240|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111498954|NCT02658240|Adrenergic Agents|adrenergic agents|mesh-ancestor
111498955|NCT02658240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111498956|NCT02658240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111498957|NCT02658240|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111498958|NCT02658240|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111498959|NCT02658240|Autonomic Agents|autonomic agents|mesh-ancestor
111498960|NCT02658240|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111498961|NCT02658240|Respiratory System Agents|respiratory system agents|mesh-ancestor
111498962|NCT02658240|Mydriatics|mydriatics|mesh-ancestor
111498963|NCT02658240|Sympathomimetics|sympathomimetics|mesh-ancestor
111498964|NCT02658240|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111498965|NCT02661126|Uprifosbuvir|uprifosbuvir|mesh-list
111498966|NCT02661126|Antiviral Agents|antiviral agents|mesh-ancestor
111498967|NCT02661126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111498968|NCT02661828|Antidepressive Agents|antidepressive agents|mesh-list
111498969|NCT02661828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111498970|NCT02665260|Cantharidin|cantharidin|mesh-list
111498971|NCT02665260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111498972|NCT02665260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111498973|NCT02665728|Laxatives|laxatives|mesh-list
111498974|NCT02665728|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111498975|NCT02666352|Ruzasvir|ruzasvir|mesh-list
111498976|NCT02666352|Uprifosbuvir|uprifosbuvir|mesh-list
111498977|NCT02666352|Antiviral Agents|antiviral agents|mesh-ancestor
111498978|NCT02666352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111498979|NCT02673138|Canagliflozin|canagliflozin|mesh-list
111498980|NCT02673138|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111498981|NCT02673138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111498982|NCT02673138|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111498983|NCT02673138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111498984|NCT02673372|Ketamine|ketamine|mesh-list
111498985|NCT02673372|Morphine|morphine|mesh-list
111498986|NCT02673372|Analgesics|analgesics|mesh-ancestor
111498987|NCT02673372|Sensory System Agents|sensory system agents|mesh-ancestor
111498988|NCT02673372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111498989|NCT02673372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111119109|NCT05362318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111498990|NCT02673372|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111498991|NCT02673372|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111498992|NCT02673372|Anesthetics, General|anesthetics, general|mesh-ancestor
111498993|NCT02673372|Anesthetics|anesthetics|mesh-ancestor
111498994|NCT02673372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111498995|NCT02673372|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111498996|NCT02673372|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111498997|NCT02673372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110450376|NCT04310579|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111498998|NCT02673372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111498999|NCT02673372|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111499000|NCT02673372|Narcotics|narcotics|mesh-ancestor
111499001|NCT02682498|Bupivacaine|bupivacaine|mesh-list
111499002|NCT02682498|Anesthetics, Local|anesthetics, local|mesh-ancestor
111499003|NCT02682498|Anesthetics|anesthetics|mesh-ancestor
111499004|NCT02682498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111499005|NCT02682498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111499006|NCT02682498|Sensory System Agents|sensory system agents|mesh-ancestor
111499007|NCT02682498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111499008|NCT02684136|Suvorexant|suvorexant|mesh-list
111499009|NCT02684136|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111499010|NCT02684136|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111499011|NCT02684136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111499012|NCT02684136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111499013|NCT02684136|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
111499014|NCT02684136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111499015|NCT02684136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111499016|NCT02695290|Afatinib|afatinib|mesh-list
111499017|NCT02695290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111499018|NCT02695290|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111499019|NCT02695290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111499020|NCT02695290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111499021|NCT02695446|Minocycline|minocycline|mesh-list
111499022|NCT02695446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111499023|NCT02695446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111499024|NCT02698566|Ranibizumab|ranibizumab|mesh-list
111499025|NCT02698566|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111499026|NCT02698566|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111499027|NCT02698566|Growth Substances|growth substances|mesh-ancestor
111499028|NCT02698566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111499029|NCT02698566|Growth Inhibitors|growth inhibitors|mesh-ancestor
111499030|NCT02698566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111499031|NCT02701062|Warfarin|warfarin|mesh-list
111499032|NCT02701062|Rivaroxaban|rivaroxaban|mesh-list
111499033|NCT02701062|Dabigatran|dabigatran|mesh-list
111499034|NCT02701062|Apixaban|apixaban|mesh-list
111499035|NCT02701062|Anticoagulants|anticoagulants|mesh-list
111499036|NCT02701062|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111499037|NCT02701062|Antithrombins|antithrombins|mesh-ancestor
111499038|NCT02701062|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111499039|NCT02701062|Protease Inhibitors|protease inhibitors|mesh-ancestor
111499040|NCT02701062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111499041|NCT02701062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111499042|NCT02704104|Hemostatics|hemostatics|mesh-list
111499043|NCT02704104|Coagulants|coagulants|mesh-ancestor
111499044|NCT02705352|Fluorouracil|fluorouracil|mesh-list
111499045|NCT02705352|Antimetabolites|antimetabolites|mesh-ancestor
111499046|NCT02705352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111499047|NCT02705352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111499048|NCT02705352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111499049|NCT02705352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111499050|NCT02705352|Immunologic Factors|immunologic factors|mesh-ancestor
111499051|NCT02705352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111499052|NCT02708238|Simethicone|simethicone|mesh-list
111499053|NCT02708238|Antifoaming Agents|antifoaming agents|mesh-ancestor
111499054|NCT02708238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111499055|NCT02708238|Emollients|emollients|mesh-ancestor
111499056|NCT02708238|Dermatologic Agents|dermatologic agents|mesh-ancestor
111499057|NCT02709018|Losartan|losartan|mesh-list
111499058|NCT02709018|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111499059|NCT02709018|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111499060|NCT02709018|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111499061|NCT02709018|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111499062|NCT02709018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111499063|NCT02713230|Bupivacaine|bupivacaine|mesh-list
111499064|NCT02713230|Anesthetics, Local|anesthetics, local|mesh-ancestor
111499065|NCT02713230|Anesthetics|anesthetics|mesh-ancestor
111499066|NCT02713230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111499067|NCT02713230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111499068|NCT02713230|Sensory System Agents|sensory system agents|mesh-ancestor
111499069|NCT02713230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111499070|NCT02713698|Propofol|propofol|mesh-list
111499071|NCT02713698|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111499072|NCT02713698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111499073|NCT02713698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111499074|NCT02713698|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111499075|NCT02713698|Anesthetics, General|anesthetics, general|mesh-ancestor
111499076|NCT02713698|Anesthetics|anesthetics|mesh-ancestor
111499077|NCT02714400|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
111499078|NCT02714400|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111499079|NCT02714400|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111499080|NCT02714400|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111499081|NCT02714400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111499082|NCT02714400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111499083|NCT02714400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111499084|NCT02714400|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111499085|NCT02714400|Antidepressive Agents|antidepressive agents|mesh-ancestor
111499086|NCT02714400|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111499087|NCT02716818|Dexamethasone|dexamethasone|mesh-list
111499088|NCT02716818|Prednisone|prednisone|mesh-list
111499089|NCT02716818|Prednisolone|prednisolone|mesh-list
111499090|NCT02716818|Hydrocortisone|hydrocortisone|mesh-list
111499091|NCT02716818|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
111499092|NCT02716818|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
111499093|NCT02716818|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
111499094|NCT02716818|Glucocorticoids|glucocorticoids|mesh-list
111499095|NCT02716818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111499096|NCT02716818|Antiemetics|antiemetics|mesh-ancestor
111499097|NCT02716818|Autonomic Agents|autonomic agents|mesh-ancestor
111499098|NCT02716818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111499099|NCT02716818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111499100|NCT02716818|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111499101|NCT02716818|Hormones|hormones|mesh-ancestor
111499102|NCT02716818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111499103|NCT02716818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111499104|NCT02716818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111499105|NCT02719158|Ciprofloxacin|ciprofloxacin|mesh-list
111499106|NCT02719158|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111499107|NCT02719158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111499108|NCT02719158|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111499109|NCT02719158|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111499110|NCT02719158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111499111|NCT02719158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111499112|NCT02719158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111499113|NCT02719158|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111499114|NCT02719158|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111499115|NCT02726178|Ibuprofen|ibuprofen|mesh-list
111499116|NCT02726178|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111499117|NCT02726178|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111499118|NCT02726178|Analgesics|analgesics|mesh-ancestor
111499119|NCT02726178|Sensory System Agents|sensory system agents|mesh-ancestor
111499120|NCT02726178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111499121|NCT02726178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111499122|NCT02726178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111499123|NCT02726178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111499124|NCT02726178|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111499125|NCT02726178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110450406|NCT05345236|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111499126|NCT02726178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111499127|NCT02733588|Glucagon|glucagon|mesh-list
111499128|NCT02733588|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
111499129|NCT02733588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111499130|NCT02733588|Hormones|hormones|mesh-ancestor
111499131|NCT02733588|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111499132|NCT02733588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111499133|NCT02733588|Incretins|incretins|mesh-ancestor
111499134|NCT02737332|Abiraterone Acetate|abiraterone acetate|mesh-list
111499135|NCT02737332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111499136|NCT02737332|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110980426|NCT00562497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111499137|NCT02737332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111499138|NCT02737332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111499139|NCT02737332|Hormone Antagonists|hormone antagonists|mesh-ancestor
111499140|NCT02737332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111499141|NCT02737332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111499142|NCT02737332|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111499144|NCT05444088|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111499145|NCT05444088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111499146|NCT05444088|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111499147|NCT05444088|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111499148|NCT05444088|Growth Substances|growth substances|mesh-ancestor
111499149|NCT05444088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111499150|NCT05444088|Growth Inhibitors|growth inhibitors|mesh-ancestor
111499151|NCT05443932|Dapagliflozin|dapagliflozin|mesh-list
111499152|NCT05443932|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
111499153|NCT05443932|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111499154|NCT05443932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111499155|NCT05443932|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111499156|NCT05443932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111499157|NCT05443932|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111499158|NCT05443932|Diuretics|diuretics|mesh-ancestor
111499159|NCT05443932|Natriuretic Agents|natriuretic agents|mesh-ancestor
111499160|NCT05443932|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
111499161|NCT05443932|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111499162|NCT05443308|Acetazolamide|acetazolamide|mesh-list
111499163|NCT05443308|Anticonvulsants|anticonvulsants|mesh-ancestor
111499164|NCT05443308|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
111499165|NCT05443308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111499166|NCT05443308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111499167|NCT05443308|Diuretics|diuretics|mesh-ancestor
111499168|NCT05443308|Natriuretic Agents|natriuretic agents|mesh-ancestor
111499169|NCT05443308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111499170|NCT05442996|Antibodies|antibodies|mesh-list
111499171|NCT05442996|Immunoglobulins|immunoglobulins|mesh-list
111499172|NCT05442996|Antibodies, Bispecific|antibodies, bispecific|mesh-list
111499173|NCT05442996|Immunologic Factors|immunologic factors|mesh-ancestor
111499174|NCT05442996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111499175|NCT05441046|Tislelizumab|tislelizumab|mesh-list
111499176|NCT05441046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111499177|NCT05441046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111499178|NCT05439564|Dexmedetomidine|dexmedetomidine|mesh-list
111499179|NCT05439564|Morphine|morphine|mesh-list
111499180|NCT05439564|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111499181|NCT05439564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111499182|NCT05439564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111499183|NCT05439564|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111499184|NCT05439564|Analgesics|analgesics|mesh-ancestor
111499185|NCT05439564|Sensory System Agents|sensory system agents|mesh-ancestor
111499186|NCT05439564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111499187|NCT05439564|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111499188|NCT05439564|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111499189|NCT05439564|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111499190|NCT05439564|Adrenergic Agents|adrenergic agents|mesh-ancestor
111499191|NCT05439564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111499192|NCT05439564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111499193|NCT05439564|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111499194|NCT05439564|Narcotics|narcotics|mesh-ancestor
111499195|NCT05340270|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
111499196|NCT05340270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111499197|NCT05340270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111499198|NCT05340270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111499199|NCT05266404|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111499200|NCT05266404|Dapagliflozin|dapagliflozin|mesh-list
111499201|NCT05266404|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111499202|NCT05266404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111499203|NCT05266404|Incretins|incretins|mesh-ancestor
111499204|NCT05266404|Hormones|hormones|mesh-ancestor
111499205|NCT05266404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111499206|NCT05266404|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111499207|NCT05266404|Protease Inhibitors|protease inhibitors|mesh-ancestor
110980427|NCT00562497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110980428|NCT00562497|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110774717|NCT01399918|Bevacizumab|bevacizumab|mesh-list
111499208|NCT05266404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111499209|NCT05266404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111499210|NCT05266404|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111499211|NCT05122494|Capecitabine|capecitabine|mesh-list
111499212|NCT05122494|Lapatinib|lapatinib|mesh-list
111499213|NCT05122494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111499214|NCT05122494|Antimetabolites|antimetabolites|mesh-ancestor
111499215|NCT05122494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111499216|NCT05122494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111499217|NCT05122494|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111499218|NCT05122494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111499219|NCT05063604|Citalopram|citalopram|mesh-list
111499220|NCT05063604|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111499221|NCT05063604|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111499222|NCT05063604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111499223|NCT05063604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111499224|NCT05063604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111499225|NCT05063604|Serotonin Agents|serotonin agents|mesh-ancestor
111499226|NCT05063604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111499227|NCT05063604|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111499228|NCT05063604|Antidepressive Agents|antidepressive agents|mesh-ancestor
111499229|NCT05063604|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111499230|NCT04978428|Cannabidiol|cannabidiol|mesh-list
111499231|NCT04978428|Anticonvulsants|anticonvulsants|mesh-ancestor
111499232|NCT04780464|Prednisone|prednisone|mesh-list
111499233|NCT04780464|Prednisolone|prednisolone|mesh-list
111499234|NCT04780464|Cyclophosphamide|cyclophosphamide|mesh-list
111499235|NCT04780464|Doxorubicin|doxorubicin|mesh-list
111499236|NCT04780464|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111499237|NCT04780464|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111499238|NCT04780464|Immunologic Factors|immunologic factors|mesh-ancestor
111499239|NCT04780464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111499240|NCT04780464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111499241|NCT04780464|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111499242|NCT04780464|Alkylating Agents|alkylating agents|mesh-ancestor
111499243|NCT04780464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111499244|NCT04780464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111499245|NCT04780464|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111499246|NCT04780464|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111499247|NCT04780464|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111499248|NCT04780464|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111499249|NCT04780464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111499250|NCT04780464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111499251|NCT04780464|Glucocorticoids|glucocorticoids|mesh-ancestor
111499252|NCT04780464|Hormones|hormones|mesh-ancestor
111499253|NCT04780464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111499254|NCT04780464|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111499255|NCT03770130|Dexmedetomidine|dexmedetomidine|mesh-list
111499256|NCT03770130|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111499257|NCT03770130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111499258|NCT03770130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111499259|NCT03770130|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111499260|NCT03770130|Analgesics|analgesics|mesh-ancestor
111499261|NCT03770130|Sensory System Agents|sensory system agents|mesh-ancestor
111499262|NCT03770130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111499263|NCT03770130|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111499264|NCT03770130|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111499265|NCT03770130|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111499266|NCT03770130|Adrenergic Agents|adrenergic agents|mesh-ancestor
111499267|NCT03770130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111499268|NCT03770130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111499269|NCT05452434|Mirabegron|mirabegron|mesh-list
111499270|NCT05452434|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
111499271|NCT05452434|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111499272|NCT05452434|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111499273|NCT05452434|Adrenergic Agents|adrenergic agents|mesh-ancestor
111499274|NCT05452434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111499275|NCT05452434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111499276|NCT05452434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111499277|NCT05452434|Urological Agents|urological agents|mesh-ancestor
111499278|NCT05450328|Epoprostenol|epoprostenol|mesh-list
110980429|NCT00562497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111499279|NCT05450328|Milrinone|milrinone|mesh-list
111499280|NCT05450328|Tezosentan|tezosentan|mesh-list
111499281|NCT05450328|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111499282|NCT05450328|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111499283|NCT05450328|Vasodilator Agents|vasodilator agents|mesh-ancestor
111499284|NCT05450328|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
111499285|NCT05450328|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111499286|NCT05450328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111499287|NCT05450328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111499288|NCT05450328|Protective Agents|protective agents|mesh-ancestor
111499289|NCT05450328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111499290|NCT05450328|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111499291|NCT05448924|Hormones|hormones|mesh-list
111499292|NCT05448924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111499293|NCT05448924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111499294|NCT05447364|Pregabalin|pregabalin|mesh-list
111499295|NCT05447364|Analgesics|analgesics|mesh-ancestor
111499296|NCT05447364|Sensory System Agents|sensory system agents|mesh-ancestor
111499297|NCT05447364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111499298|NCT05447364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111499299|NCT05447364|Anticonvulsants|anticonvulsants|mesh-ancestor
111499300|NCT05447364|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111499301|NCT05447364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111499302|NCT05447364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111499303|NCT05447364|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111499304|NCT05447364|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111499305|NCT05447364|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111499306|NCT05447364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111499307|NCT05447364|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111499308|NCT05418036|Sotalol|sotalol|mesh-list
111499309|NCT05418036|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111499310|NCT05418036|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111499311|NCT05418036|Adrenergic Agents|adrenergic agents|mesh-ancestor
111499312|NCT05418036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111499313|NCT05418036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111499314|NCT05418036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111499315|NCT05418036|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111499316|NCT05418036|Sympatholytics|sympatholytics|mesh-ancestor
111499317|NCT05418036|Autonomic Agents|autonomic agents|mesh-ancestor
111499318|NCT05418036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111499319|NCT05023278|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
111499320|NCT05023278|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111499321|NCT05023278|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111499322|NCT05023278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111499323|NCT05023278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111499324|NCT05023278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111499325|NCT05023278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111499326|NCT05023278|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111499327|NCT05023278|Antidepressive Agents|antidepressive agents|mesh-ancestor
111499328|NCT05023278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111499329|NCT04727424|Budesonide|budesonide|mesh-list
111499330|NCT04727424|Fluvoxamine|fluvoxamine|mesh-list
111499331|NCT04727424|Fluoxetine|fluoxetine|mesh-list
111499332|NCT04727424|Maleic acid|maleic acid|mesh-list
111499333|NCT04727424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111499334|NCT04727424|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111499335|NCT04727424|Autonomic Agents|autonomic agents|mesh-ancestor
111499336|NCT04727424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111499337|NCT04727424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111499338|NCT04727424|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111499339|NCT04727424|Respiratory System Agents|respiratory system agents|mesh-ancestor
111499340|NCT04727424|Glucocorticoids|glucocorticoids|mesh-ancestor
111499341|NCT04727424|Hormones|hormones|mesh-ancestor
111499342|NCT04727424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111499343|NCT04727424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111499344|NCT04727424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111499345|NCT04727424|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111499346|NCT04727424|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111499347|NCT04727424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111499348|NCT04727424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110980430|NCT00562497|Antiemetics|antiemetics|mesh-ancestor
110980431|NCT00562497|Autonomic Agents|autonomic agents|mesh-ancestor
111499349|NCT04727424|Serotonin Agents|serotonin agents|mesh-ancestor
111499350|NCT04727424|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111499351|NCT04727424|Antidepressive Agents|antidepressive agents|mesh-ancestor
111499352|NCT04727424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111499353|NCT04727424|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111499354|NCT04727424|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111499355|NCT04727424|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111499356|NCT04727424|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111499357|NCT04727424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111499358|NCT04727424|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111499359|NCT04727424|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111499360|NCT04569942|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
111499361|NCT04522206|Oxycodone|oxycodone|mesh-list
111499362|NCT04522206|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111499363|NCT04522206|Narcotics|narcotics|mesh-ancestor
111499364|NCT04522206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111499365|NCT04522206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111499366|NCT04522206|Analgesics|analgesics|mesh-ancestor
111499367|NCT04522206|Sensory System Agents|sensory system agents|mesh-ancestor
111499368|NCT04522206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111499369|NCT04505592|Tenecteplase|tenecteplase|mesh-list
111499370|NCT04505592|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111499371|NCT04505592|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111499372|NCT04505592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111499373|NCT04415892|Cinnamaldehyde|cinnamaldehyde|mesh-list
111499374|NCT04415892|Capsaicin|capsaicin|mesh-list
111499375|NCT04415892|Antipruritics|antipruritics|mesh-ancestor
111499376|NCT04415892|Dermatologic Agents|dermatologic agents|mesh-ancestor
111499377|NCT04415892|Sensory System Agents|sensory system agents|mesh-ancestor
111499378|NCT04415892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111499379|NCT04415892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111499380|NCT04415892|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111499381|NCT04415892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111499382|NCT04415892|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
111499383|NCT04415892|Protective Agents|protective agents|mesh-ancestor
111499384|NCT04176354|Letrozole|letrozole|mesh-list
111499385|NCT04176354|Palbociclib|palbociclib|mesh-list
111499386|NCT04176354|Aromatase Inhibitors|aromatase inhibitors|mesh-list
111499387|NCT04176354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111499388|NCT04176354|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111499389|NCT04176354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111499390|NCT04176354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111499391|NCT04176354|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111499392|NCT04176354|Hormone Antagonists|hormone antagonists|mesh-ancestor
111499393|NCT04176354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111499394|NCT04176354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111499395|NCT04176354|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111499396|NCT04128540|Fentanyl|fentanyl|mesh-list
111499397|NCT04128540|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111499398|NCT04128540|Narcotics|narcotics|mesh-ancestor
111499399|NCT04128540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111499400|NCT04128540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111499401|NCT04128540|Analgesics|analgesics|mesh-ancestor
111499402|NCT04128540|Sensory System Agents|sensory system agents|mesh-ancestor
111499403|NCT04128540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111499404|NCT04128540|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111499405|NCT04128540|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111499406|NCT04128540|Anesthetics, General|anesthetics, general|mesh-ancestor
111499407|NCT04128540|Anesthetics|anesthetics|mesh-ancestor
111499408|NCT04104438|Everolimus|everolimus|mesh-list
111499409|NCT04104438|Basiliximab|basiliximab|mesh-list
111499410|NCT04104438|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111499411|NCT04104438|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111499412|NCT04104438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111499413|NCT04104438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111499414|NCT04104438|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111499415|NCT04104438|Immunologic Factors|immunologic factors|mesh-ancestor
111499416|NCT04104438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111499417|NCT04104438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111499418|NCT03703206|Anesthetics|anesthetics|mesh-list
111499419|NCT03703206|Anesthetics, Local|anesthetics, local|mesh-list
111499420|NCT03703206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111499421|NCT03703206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111499422|NCT03703206|Sensory System Agents|sensory system agents|mesh-ancestor
111499423|NCT03703206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111499424|NCT03086616|Irinotecan|irinotecan|mesh-list
111499425|NCT03086616|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111499426|NCT03086616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111499427|NCT03086616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111499428|NCT03086616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111499429|NCT03086616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111499430|NCT02952924|Midazolam|midazolam|mesh-list
111499431|NCT02952924|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111499432|NCT02952924|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111499433|NCT02952924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111499434|NCT02952924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111499435|NCT02952924|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111499436|NCT02952924|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111499437|NCT02952924|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111499438|NCT02952924|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111499439|NCT02952924|Anesthetics, General|anesthetics, general|mesh-ancestor
111499440|NCT02952924|Anesthetics|anesthetics|mesh-ancestor
111499441|NCT02952924|GABA Modulators|gaba modulators|mesh-ancestor
111499442|NCT02952924|GABA Agents|gaba agents|mesh-ancestor
111499443|NCT02952924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111499444|NCT02952924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111499445|NCT02905578|Ascorbic Acid|ascorbic acid|mesh-list
111499446|NCT02905578|Paclitaxel|paclitaxel|mesh-list
111499447|NCT02905578|Gemcitabine|gemcitabine|mesh-list
111499448|NCT02905578|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111499449|NCT02905578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111499450|NCT02905578|Tubulin Modulators|tubulin modulators|mesh-ancestor
111499451|NCT02905578|Antimitotic Agents|antimitotic agents|mesh-ancestor
111499452|NCT02905578|Mitosis Modulators|mitosis modulators|mesh-ancestor
111499453|NCT02905578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111499454|NCT02905578|Vitamins|vitamins|mesh-ancestor
111499455|NCT02905578|Micronutrients|micronutrients|mesh-ancestor
111499456|NCT02905578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111499457|NCT02905578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111499458|NCT02905578|Antimetabolites|antimetabolites|mesh-ancestor
111499459|NCT02905578|Antioxidants|antioxidants|mesh-ancestor
111499460|NCT02905578|Protective Agents|protective agents|mesh-ancestor
111499461|NCT00677586|Liver Extracts|liver extracts|mesh-list
111499462|NCT00677586|Hematinics|hematinics|mesh-ancestor
111499463|NCT05453448|Tenofovir|tenofovir|mesh-list
111499464|NCT05453448|Entecavir|entecavir|mesh-list
111499465|NCT05453448|Antiviral Agents|antiviral agents|mesh-ancestor
111499466|NCT05453448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111499467|NCT05453448|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111499468|NCT05453448|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111499469|NCT05453448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111499470|NCT05453448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111499471|NCT05453448|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111499472|NCT05453448|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111499473|NCT05453214|Fludrocortisone|fludrocortisone|mesh-list
111499474|NCT05453214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111499475|NCT05444478|Lenvatinib|lenvatinib|mesh-list
111499476|NCT05444478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111499477|NCT05444478|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111499478|NCT05444478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111499479|NCT05444478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111499480|NCT05354466|Neostigmine|neostigmine|mesh-list
111499481|NCT05354466|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111499482|NCT05354466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111499483|NCT05354466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111499484|NCT05354466|Cholinergic Agents|cholinergic agents|mesh-ancestor
111499485|NCT05354466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111499486|NCT05354466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111499487|NCT05354466|Parasympathomimetics|parasympathomimetics|mesh-ancestor
111499488|NCT05354466|Autonomic Agents|autonomic agents|mesh-ancestor
111499489|NCT05354466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111499490|NCT04095624|Analgesics, Opioid|analgesics, opioid|mesh-list
111499491|NCT04095624|Narcotics|narcotics|mesh-ancestor
111499492|NCT04095624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111499493|NCT04095624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111499494|NCT04095624|Analgesics|analgesics|mesh-ancestor
111499495|NCT04095624|Sensory System Agents|sensory system agents|mesh-ancestor
111499496|NCT04095624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111499497|NCT03745716|Azacitidine|azacitidine|mesh-list
111499498|NCT03745716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111499499|NCT03745716|Antimetabolites|antimetabolites|mesh-ancestor
111499500|NCT03745716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111499501|NCT03745716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111499502|NCT03745716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111499504|NCT03341676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111499505|NCT03341676|Antiemetics|antiemetics|mesh-ancestor
111499506|NCT03341676|Autonomic Agents|autonomic agents|mesh-ancestor
111499507|NCT03341676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111499508|NCT03341676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111499509|NCT03341676|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111499510|NCT03341676|Glucocorticoids|glucocorticoids|mesh-ancestor
111499511|NCT03341676|Hormones|hormones|mesh-ancestor
111499512|NCT03341676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111499513|NCT03341676|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111499514|NCT03341676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111499515|NCT03121716|Gemcitabine|gemcitabine|mesh-list
111499516|NCT03121716|Cisplatin|cisplatin|mesh-list
111499517|NCT03121716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111499518|NCT03121716|Antimetabolites|antimetabolites|mesh-ancestor
111499519|NCT03121716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111499520|NCT03121716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111499521|NCT02714634|Hydroxychloroquine|hydroxychloroquine|mesh-list
111499522|NCT02714634|Sulfasalazine|sulfasalazine|mesh-list
111499523|NCT02714634|Methotrexate|methotrexate|mesh-list
111499524|NCT02714634|Leflunomide|leflunomide|mesh-list
111499525|NCT02714634|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111499526|NCT02714634|Abortifacient Agents|abortifacient agents|mesh-ancestor
111499527|NCT02714634|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111499528|NCT02714634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111499529|NCT02714634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111499530|NCT02714634|Antimetabolites|antimetabolites|mesh-ancestor
111499531|NCT02714634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111499532|NCT02714634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111499533|NCT02714634|Dermatologic Agents|dermatologic agents|mesh-ancestor
111499534|NCT02714634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110450441|NCT01059630|Obinutuzumab|obinutuzumab|mesh-list
111499535|NCT02714634|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111499536|NCT02714634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111499537|NCT02714634|Immunologic Factors|immunologic factors|mesh-ancestor
111499538|NCT02714634|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111499539|NCT02714634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111499540|NCT02714634|Antimalarials|antimalarials|mesh-ancestor
111499541|NCT02714634|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111499542|NCT02714634|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111499543|NCT02714634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111499544|NCT02714634|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111499545|NCT02714634|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111499546|NCT02714634|Analgesics|analgesics|mesh-ancestor
111499547|NCT02714634|Sensory System Agents|sensory system agents|mesh-ancestor
111499548|NCT02714634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111499549|NCT02714634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111499550|NCT02714634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111499551|NCT02708394|Olanzapine|olanzapine|mesh-list
111499552|NCT02708394|Antiemetics|antiemetics|mesh-ancestor
111499553|NCT02708394|Autonomic Agents|autonomic agents|mesh-ancestor
111499554|NCT02708394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111499555|NCT02708394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111499556|NCT02708394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111499557|NCT02708394|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111499558|NCT02708394|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111499559|NCT02708394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111499560|NCT02708394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111499561|NCT02708394|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111499562|NCT02708394|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111499563|NCT02708394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111499564|NCT02708394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111499565|NCT02708394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111499566|NCT02708394|Serotonin Agents|serotonin agents|mesh-ancestor
111499567|NCT00553800|Bevacizumab|bevacizumab|mesh-list
111499568|NCT00553800|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111499569|NCT00553800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111499570|NCT00553800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111499571|NCT00553800|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111499572|NCT00553800|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111499573|NCT00553800|Growth Substances|growth substances|mesh-ancestor
111499574|NCT00553800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111499575|NCT00553800|Growth Inhibitors|growth inhibitors|mesh-ancestor
111499576|NCT00553800|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111499577|NCT00553800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111499578|NCT00553800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111499579|NCT02747628|Melatonin|melatonin|mesh-list
111499580|NCT02747628|Nicotine|nicotine|mesh-list
111499581|NCT02747628|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111499582|NCT02747628|Autonomic Agents|autonomic agents|mesh-ancestor
111499583|NCT02747628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111499584|NCT02747628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111499585|NCT02747628|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111499586|NCT02747628|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111499587|NCT02747628|Cholinergic Agents|cholinergic agents|mesh-ancestor
111499588|NCT02747628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111499589|NCT02747628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111499590|NCT02747628|Antioxidants|antioxidants|mesh-ancestor
111499591|NCT02747628|Protective Agents|protective agents|mesh-ancestor
111499592|NCT02747628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111499593|NCT02754570|Pilocarpine|pilocarpine|mesh-list
111499594|NCT02754570|Miotics|miotics|mesh-ancestor
111499595|NCT02754570|Autonomic Agents|autonomic agents|mesh-ancestor
111499596|NCT02754570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111499597|NCT02754570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111499598|NCT02754570|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
111499599|NCT02754570|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111499600|NCT02754570|Cholinergic Agents|cholinergic agents|mesh-ancestor
111499601|NCT02754570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111499602|NCT02754570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111499603|NCT02765256|Promethazine|promethazine|mesh-list
111499604|NCT02765256|Diphenhydramine|diphenhydramine|mesh-list
111499605|NCT02765256|Vancomycin|vancomycin|mesh-list
111499606|NCT02765256|Ciprofloxacin|ciprofloxacin|mesh-list
111499607|NCT02765256|Neomycin|neomycin|mesh-list
111499608|NCT02765256|Fluconazole|fluconazole|mesh-list
111499609|NCT02765256|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
111499610|NCT02765256|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111499611|NCT02765256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111499612|NCT02765256|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111499613|NCT02765256|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111499614|NCT02765256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111499615|NCT02765256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111499616|NCT02765256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111499617|NCT02765256|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111499618|NCT02765256|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111499619|NCT02765256|Antifungal Agents|antifungal agents|mesh-ancestor
111499620|NCT02765256|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111499621|NCT02765256|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111499622|NCT02765256|Hormone Antagonists|hormone antagonists|mesh-ancestor
111499623|NCT02765256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111499624|NCT02765256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111499625|NCT02765256|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111499626|NCT02765256|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111499627|NCT02765256|Antipruritics|antipruritics|mesh-ancestor
111499628|NCT02765256|Dermatologic Agents|dermatologic agents|mesh-ancestor
111499629|NCT02765256|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111499630|NCT02765256|Histamine Antagonists|histamine antagonists|mesh-ancestor
111499631|NCT02765256|Histamine Agents|histamine agents|mesh-ancestor
111499632|NCT02765256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111499633|NCT02765256|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111499634|NCT02765256|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111499635|NCT02765256|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111499636|NCT02765256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111499637|NCT02765256|Anesthetics, Local|anesthetics, local|mesh-ancestor
111499638|NCT02765256|Anesthetics|anesthetics|mesh-ancestor
111499639|NCT02765256|Sensory System Agents|sensory system agents|mesh-ancestor
111499640|NCT02765256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111499641|NCT02765256|Antiemetics|antiemetics|mesh-ancestor
111499642|NCT02765256|Autonomic Agents|autonomic agents|mesh-ancestor
111499643|NCT02765256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111499644|NCT02765256|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111499645|NCT02765256|Laxatives|laxatives|mesh-ancestor
111499646|NCT02767128|Citric Acid|citric acid|mesh-list
111499647|NCT02767128|Sodium Citrate|sodium citrate|mesh-list
110775098|NCT04236258|Enalapril|enalapril|mesh-list
111499648|NCT02767128|Anticoagulants|anticoagulants|mesh-ancestor
111499649|NCT02767128|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
111499650|NCT02767128|Chelating Agents|chelating agents|mesh-ancestor
111499651|NCT02767128|Sequestering Agents|sequestering agents|mesh-ancestor
111499652|NCT02767128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111499653|NCT02769702|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
111499654|NCT02769702|Hormones|hormones|mesh-ancestor
111499655|NCT02769702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111499656|NCT02769702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111499657|NCT02770014|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111499658|NCT02770014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111499659|NCT02770014|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111499660|NCT02770014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111499661|NCT02770014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111499662|NCT02771340|Immunoconjugates|immunoconjugates|mesh-list
111499663|NCT02771340|Immunologic Factors|immunologic factors|mesh-ancestor
111499664|NCT02771340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111499665|NCT02773758|Fluorides|fluorides|mesh-list
111499666|NCT02773758|Tin Fluorides|tin fluorides|mesh-list
111499667|NCT02773758|Fluorophosphate|fluorophosphate|mesh-list
111499668|NCT02773758|Cariostatic Agents|cariostatic agents|mesh-ancestor
111499669|NCT02773758|Protective Agents|protective agents|mesh-ancestor
111499670|NCT02773758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111499671|NCT02774226|Vitamins|vitamins|mesh-list
111499672|NCT02774226|Vitamin E|vitamin e|mesh-list
111499673|NCT02774226|Thioctic Acid|thioctic acid|mesh-list
111499674|NCT02774226|Antioxidants|antioxidants|mesh-list
111499675|NCT02774226|Micronutrients|micronutrients|mesh-ancestor
111499676|NCT02774226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111499677|NCT02774226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111499678|NCT02774226|Protective Agents|protective agents|mesh-ancestor
111499679|NCT02774226|Vitamin B Complex|vitamin b complex|mesh-ancestor
111499680|NCT02775240|Maribavir|maribavir|mesh-list
111499681|NCT02775240|Digoxin|digoxin|mesh-list
111499682|NCT02775240|Dextromethorphan|dextromethorphan|mesh-list
111499683|NCT02775240|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111499684|NCT02775240|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111499685|NCT02775240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111499686|NCT02775240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111499687|NCT02775240|Protective Agents|protective agents|mesh-ancestor
111499688|NCT02775240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111499689|NCT02775240|Antitussive Agents|antitussive agents|mesh-ancestor
111499690|NCT02775240|Respiratory System Agents|respiratory system agents|mesh-ancestor
111499691|NCT02775240|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111499692|NCT02775240|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111499693|NCT02775240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111499694|NCT02775240|Antiviral Agents|antiviral agents|mesh-ancestor
111499695|NCT02775240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111499696|NCT02777268|Hydrocortisone|hydrocortisone|mesh-list
111499697|NCT02777268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111499698|NCT05350020|Hydrocortisone|hydrocortisone|mesh-list
111499699|NCT05350020|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
111499700|NCT05350020|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
111499701|NCT05350020|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
111499702|NCT05350020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111499703|NCT05349396|Eszopiclone|eszopiclone|mesh-list
111499704|NCT05349396|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111499705|NCT05349396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111499706|NCT05349396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111499707|NCT05348148|Mometasone Furoate|mometasone furoate|mesh-list
111499708|NCT05348148|Cetirizine|cetirizine|mesh-list
111499709|NCT05348148|Phenylephrine|phenylephrine|mesh-list
111499710|NCT05348148|Oxymetazoline|oxymetazoline|mesh-list
111499711|NCT05348148|Levocetirizine|levocetirizine|mesh-list
111499712|NCT05348148|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111499713|NCT05348148|Dermatologic Agents|dermatologic agents|mesh-ancestor
111499714|NCT05348148|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111499715|NCT05348148|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
111499716|NCT05348148|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111499717|NCT05348148|Histamine Antagonists|histamine antagonists|mesh-ancestor
111499718|NCT05348148|Histamine Agents|histamine agents|mesh-ancestor
111499719|NCT05348148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111499720|NCT05348148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111499721|NCT05348148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111499722|NCT05348148|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110980432|NCT00562497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111499723|NCT05348148|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111499724|NCT05348148|Adrenergic Agents|adrenergic agents|mesh-ancestor
111499725|NCT05348148|Sympathomimetics|sympathomimetics|mesh-ancestor
111499726|NCT05348148|Autonomic Agents|autonomic agents|mesh-ancestor
111499727|NCT05348148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111499728|NCT05348148|Nasal Decongestants|nasal decongestants|mesh-ancestor
111499729|NCT05348148|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111499730|NCT05348148|Respiratory System Agents|respiratory system agents|mesh-ancestor
111499731|NCT05348148|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111499732|NCT05348148|Mydriatics|mydriatics|mesh-ancestor
111499733|NCT05348148|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111499734|NCT05348148|Protective Agents|protective agents|mesh-ancestor
111499735|NCT05456022|Doxorubicin|doxorubicin|mesh-list
111499736|NCT05456022|Quercetin|quercetin|mesh-list
111499737|NCT05456022|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111499738|NCT05456022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111499739|NCT05456022|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111499740|NCT05456022|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111499741|NCT05456022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111499742|NCT05456022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111499743|NCT05456022|Antioxidants|antioxidants|mesh-ancestor
111499744|NCT05456022|Protective Agents|protective agents|mesh-ancestor
111499745|NCT05456022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111499746|NCT05453916|Rifaximin|rifaximin|mesh-list
111499747|NCT05453916|Nitazoxanide|nitazoxanide|mesh-list
111499748|NCT05453916|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111499749|NCT05453916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111499750|NCT05453916|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111499751|NCT05453916|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111499752|NCT05273814|Bevacizumab|bevacizumab|mesh-list
111499753|NCT05273814|Tislelizumab|tislelizumab|mesh-list
111499754|NCT05273814|Pemetrexed|pemetrexed|mesh-list
111499755|NCT05273814|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
111499756|NCT05273814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111499757|NCT05273814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111499758|NCT05273814|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111499759|NCT05273814|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111499760|NCT05273814|Growth Substances|growth substances|mesh-ancestor
111499761|NCT05273814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111499762|NCT05273814|Growth Inhibitors|growth inhibitors|mesh-ancestor
111499763|NCT05273814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111499764|NCT05273814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111499765|NCT05273814|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111499766|NCT05273814|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111499767|NCT04800510|Carbon Fiber|carbon fiber|mesh-list
111499768|NCT04800510|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111499769|NCT04800510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111499770|NCT04784208|Hormones|hormones|mesh-list
111499771|NCT04784208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111499772|NCT04784208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111499773|NCT04024878|Nivolumab|nivolumab|mesh-list
111499774|NCT04024878|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111499775|NCT04024878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111499776|NCT04024878|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111499777|NCT04024878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111499778|NCT03004248|Botulinum Toxins|botulinum toxins|mesh-list
111499779|NCT03004248|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111499780|NCT03004248|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111499781|NCT03004248|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111499782|NCT03004248|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111499783|NCT03004248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111499784|NCT03004248|Cholinergic Agents|cholinergic agents|mesh-ancestor
111499785|NCT03004248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111499786|NCT03004248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111499787|NCT03004248|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111499788|NCT03004248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111499789|NCT02529930|Vaccines|vaccines|mesh-list
111499790|NCT02529930|Immunologic Factors|immunologic factors|mesh-ancestor
111499791|NCT02529930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111499792|NCT00039780|2,2'-dithiodiethanesulfonic acid|2,2'-dithiodiethanesulfonic acid|mesh-list
111499793|NCT00039780|Protective Agents|protective agents|mesh-ancestor
111499794|NCT00039780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111499795|NCT04763226|Furosemide|furosemide|mesh-list
111499796|NCT04763226|Diuretics|diuretics|mesh-ancestor
111499797|NCT04763226|Natriuretic Agents|natriuretic agents|mesh-ancestor
111499798|NCT04763226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110980433|NCT00562497|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111499799|NCT04763226|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
111499800|NCT04763226|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111499801|NCT04763226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111499802|NCT04549428|Atezolizumab|atezolizumab|mesh-list
111499803|NCT04549428|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111499804|NCT04549428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111499805|NCT04549428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111499806|NCT04549428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111499807|NCT04340856|Bisacodyl|bisacodyl|mesh-list
111499808|NCT04340856|Laxatives|laxatives|mesh-list
111499809|NCT04340856|Cathartics|cathartics|mesh-ancestor
111499810|NCT04340856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111499811|NCT04040790|Phenylephrine|phenylephrine|mesh-list
111499812|NCT04040790|Oxymetazoline|oxymetazoline|mesh-list
111499813|NCT04040790|Tropicamide|tropicamide|mesh-list
111499814|NCT04040790|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111499815|NCT04040790|Mydriatics|mydriatics|mesh-ancestor
111499816|NCT04040790|Autonomic Agents|autonomic agents|mesh-ancestor
111499817|NCT04040790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111499818|NCT04040790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111499819|NCT04040790|Sympathomimetics|sympathomimetics|mesh-ancestor
111499820|NCT04040790|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111499821|NCT04040790|Nasal Decongestants|nasal decongestants|mesh-ancestor
111499822|NCT04040790|Respiratory System Agents|respiratory system agents|mesh-ancestor
111499823|NCT04040790|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111499824|NCT04040790|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111499825|NCT04040790|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111499826|NCT04040790|Adrenergic Agents|adrenergic agents|mesh-ancestor
111499827|NCT04040790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111499828|NCT04040790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111499829|NCT04040790|Protective Agents|protective agents|mesh-ancestor
111499830|NCT04040790|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111499831|NCT04040790|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111499832|NCT04040790|Cholinergic Agents|cholinergic agents|mesh-ancestor
111499833|NCT03556800|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
111499834|NCT03556800|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
111499835|NCT03556800|Estradiol|estradiol|mesh-list
111499836|NCT03556800|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
111499837|NCT03556800|Estrogens|estrogens|mesh-ancestor
111499838|NCT03556800|Hormones|hormones|mesh-ancestor
111499839|NCT03556800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111499840|NCT03556800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111499841|NCT03556800|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111499842|NCT03556800|Contraceptive Agents|contraceptive agents|mesh-ancestor
111499843|NCT03556800|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111499844|NCT03556800|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111499845|NCT04741620|Cinnamaldehyde|cinnamaldehyde|mesh-list
111499846|NCT04741620|Capsaicin|capsaicin|mesh-list
111499847|NCT04741620|Sodium Citrate|sodium citrate|mesh-list
111499848|NCT04741620|Citric Acid|citric acid|mesh-list
111499849|NCT04741620|Piperine|piperine|mesh-list
111499850|NCT04741620|Antipruritics|antipruritics|mesh-ancestor
111499851|NCT04741620|Dermatologic Agents|dermatologic agents|mesh-ancestor
111499852|NCT04741620|Sensory System Agents|sensory system agents|mesh-ancestor
111499853|NCT04741620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111499854|NCT04741620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111499855|NCT04741620|Anticoagulants|anticoagulants|mesh-ancestor
111499856|NCT04741620|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
111499857|NCT04741620|Chelating Agents|chelating agents|mesh-ancestor
111499858|NCT04741620|Sequestering Agents|sequestering agents|mesh-ancestor
111499859|NCT04741620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111499860|NCT04741620|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111499861|NCT04741620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111499862|NCT04741620|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111499863|NCT04741620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111499864|NCT04741620|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
111499865|NCT04741620|Protective Agents|protective agents|mesh-ancestor
111499866|NCT01785420|Trastuzumab|trastuzumab|mesh-list
111499867|NCT01785420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111499868|NCT01785420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111499869|NCT00800514|Amantadine|amantadine|mesh-list
111499870|NCT00800514|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111499871|NCT00800514|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111499872|NCT00800514|Antiviral Agents|antiviral agents|mesh-ancestor
111499873|NCT00800514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111499874|NCT00800514|Dopamine Agents|dopamine agents|mesh-ancestor
111499875|NCT00800514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111499876|NCT00800514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111499877|NCT00800514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111499878|NCT00800514|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111499879|NCT00800514|Analgesics|analgesics|mesh-ancestor
111499880|NCT00800514|Sensory System Agents|sensory system agents|mesh-ancestor
111499881|NCT00800514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111499882|NCT02780622|Oseltamivir|oseltamivir|mesh-list
111499883|NCT02780622|Warfarin|warfarin|mesh-list
111499884|NCT02780622|Anticoagulants|anticoagulants|mesh-ancestor
111499885|NCT02780622|Antiviral Agents|antiviral agents|mesh-ancestor
111499886|NCT02780622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110450465|NCT03903016|Insulin|insulin|mesh-list
111499887|NCT02780622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111499888|NCT02780622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111499889|NCT02791308|Pimecrolimus|pimecrolimus|mesh-list
111499890|NCT02791308|Tacrolimus|tacrolimus|mesh-list
111499891|NCT02791308|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111499892|NCT02791308|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111499893|NCT02791308|Analgesics|analgesics|mesh-ancestor
111499894|NCT02791308|Sensory System Agents|sensory system agents|mesh-ancestor
111499895|NCT02791308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111499896|NCT02791308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111499897|NCT02791308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111499898|NCT02791308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111499899|NCT02791308|Dermatologic Agents|dermatologic agents|mesh-ancestor
111499900|NCT02791308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111499901|NCT02791308|Immunologic Factors|immunologic factors|mesh-ancestor
111499902|NCT02791308|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111499903|NCT02791308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111499904|NCT02791308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111499905|NCT02796144|Metformin|metformin|mesh-list
111499906|NCT02796144|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111499907|NCT02796144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111499908|NCT02801370|Ciprofloxacin|ciprofloxacin|mesh-list
111499909|NCT02801370|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111499910|NCT02801370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111499911|NCT02801370|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111499912|NCT02801370|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111499913|NCT02801370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111499914|NCT02801370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111499915|NCT02801370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111499916|NCT02801370|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111499917|NCT02801370|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111499918|NCT02813070|Flutemetamol|flutemetamol|mesh-list
111499919|NCT02813070|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111499920|NCT02813070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111499921|NCT02815644|Empagliflozin|empagliflozin|mesh-list
111499922|NCT02815644|Linagliptin|linagliptin|mesh-list
111499923|NCT02815644|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111499924|NCT02815644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111499925|NCT02815644|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111499926|NCT02815644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111499927|NCT02815644|Incretins|incretins|mesh-ancestor
111499928|NCT02815644|Hormones|hormones|mesh-ancestor
111499929|NCT02815644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111499930|NCT02815644|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111499931|NCT02815644|Protease Inhibitors|protease inhibitors|mesh-ancestor
111499932|NCT02815644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111499933|NCT02820324|Morphine|morphine|mesh-list
111499934|NCT02820324|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111499935|NCT02820324|Narcotics|narcotics|mesh-ancestor
111499936|NCT02820324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111499937|NCT02820324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111499938|NCT02820324|Analgesics|analgesics|mesh-ancestor
111499939|NCT02820324|Sensory System Agents|sensory system agents|mesh-ancestor
111499940|NCT02820324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111499941|NCT02821338|Lamotrigine|lamotrigine|mesh-list
111499942|NCT02821338|Anticonvulsants|anticonvulsants|mesh-ancestor
111499943|NCT02821338|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111499944|NCT02821338|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111499945|NCT02821338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111499946|NCT02821338|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110775392|NCT03755778|Itraconazole|itraconazole|mesh-list
110980434|NCT00562497|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111499947|NCT02821338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111499949|NCT02821338|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111499950|NCT02821338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111499951|NCT02821338|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111499952|NCT02821338|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111499953|NCT02835846|Estrogens|estrogens|mesh-list
111499954|NCT02835846|Hormones|hormones|mesh-ancestor
111499955|NCT02835846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111499956|NCT02835846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111499957|NCT02844582|Prednisone|prednisone|mesh-list
111499958|NCT02844582|Cortisone|cortisone|mesh-list
111499959|NCT02844582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111499960|NCT02844582|Glucocorticoids|glucocorticoids|mesh-ancestor
111499961|NCT02844582|Hormones|hormones|mesh-ancestor
111499962|NCT02844582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111499963|NCT02844582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111499964|NCT02844582|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111499965|NCT02844582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111499966|NCT02845752|Bromides|bromides|mesh-list
111499967|NCT02845752|Tiotropium Bromide|tiotropium bromide|mesh-list
111499968|NCT02845752|Olodaterol|olodaterol|mesh-list
111499969|NCT02845752|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111499970|NCT02845752|Autonomic Agents|autonomic agents|mesh-ancestor
111499971|NCT02845752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111499972|NCT02845752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111499973|NCT02845752|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111499974|NCT02845752|Respiratory System Agents|respiratory system agents|mesh-ancestor
111499975|NCT02845752|Parasympatholytics|parasympatholytics|mesh-ancestor
111499976|NCT02845752|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111499977|NCT02845752|Cholinergic Agents|cholinergic agents|mesh-ancestor
111499978|NCT02845752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111499979|NCT02845752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111499980|NCT02845752|Anticonvulsants|anticonvulsants|mesh-ancestor
111499981|NCT02849184|Suvorexant|suvorexant|mesh-list
111499982|NCT02849184|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111499983|NCT02849184|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111499984|NCT02849184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111499985|NCT02849184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111499986|NCT02849184|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
111499987|NCT02849184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111499988|NCT02849184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111499989|NCT02862912|Fentanyl|fentanyl|mesh-list
111499990|NCT02862912|Bupivacaine|bupivacaine|mesh-list
111499991|NCT02862912|Chloroprocaine|chloroprocaine|mesh-list
111499992|NCT02862912|Anesthetics, Local|anesthetics, local|mesh-ancestor
111499993|NCT02862912|Anesthetics|anesthetics|mesh-ancestor
111499994|NCT02862912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111499995|NCT02862912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111499996|NCT02862912|Sensory System Agents|sensory system agents|mesh-ancestor
111499997|NCT02862912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111499998|NCT02862912|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111499999|NCT02862912|Narcotics|narcotics|mesh-ancestor
111500000|NCT02862912|Analgesics|analgesics|mesh-ancestor
111500001|NCT02862912|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111500002|NCT02862912|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111500003|NCT02862912|Anesthetics, General|anesthetics, general|mesh-ancestor
111500004|NCT02864706|Cyclosporine|cyclosporine|mesh-list
111500005|NCT02864706|Mycophenolic Acid|mycophenolic acid|mesh-list
111500006|NCT02864706|Everolimus|everolimus|mesh-list
111500007|NCT02864706|Cyclosporins|cyclosporins|mesh-list
111500008|NCT02864706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111500009|NCT02864706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111500010|NCT02864706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111500011|NCT02864706|Immunologic Factors|immunologic factors|mesh-ancestor
111500012|NCT02864706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111500013|NCT02864706|Antifungal Agents|antifungal agents|mesh-ancestor
111500014|NCT02864706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111500015|NCT02864706|Dermatologic Agents|dermatologic agents|mesh-ancestor
111500016|NCT02864706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111500017|NCT02864706|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111500018|NCT02864706|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111500019|NCT02864706|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111500020|NCT02864706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111500021|NCT02864706|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111500022|NCT02864706|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111500023|NCT02864706|Antitubercular Agents|antitubercular agents|mesh-ancestor
111500024|NCT02864706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111500025|NCT02865720|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
111500026|NCT02865720|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
111500027|NCT02865720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111500028|NCT02865720|Immunologic Factors|immunologic factors|mesh-ancestor
111500029|NCT02865720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111500030|NCT02867202|Contraceptive Agents|contraceptive agents|mesh-list
111500031|NCT02867202|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111500032|NCT02867202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111500033|NCT02873286|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
111500034|NCT02873286|Antiviral Agents|antiviral agents|mesh-ancestor
111500035|NCT02873286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111500036|NCT02874846|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111500037|NCT02874846|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111500038|NCT02880228|Dexamethasone|dexamethasone|mesh-list
111500039|NCT02880228|Dexamethasone acetate|dexamethasone acetate|mesh-list
111500040|NCT02880228|Pembrolizumab|pembrolizumab|mesh-list
111500041|NCT02880228|Lenalidomide|lenalidomide|mesh-list
111500042|NCT02880228|Ichthammol|ichthammol|mesh-list
111500043|NCT02880228|BB 1101|bb 1101|mesh-list
111500044|NCT02880228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111500045|NCT02880228|Antiemetics|antiemetics|mesh-ancestor
111500046|NCT02880228|Autonomic Agents|autonomic agents|mesh-ancestor
111500047|NCT02880228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111500048|NCT02880228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111500049|NCT02880228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111500050|NCT02880228|Glucocorticoids|glucocorticoids|mesh-ancestor
111500051|NCT02880228|Hormones|hormones|mesh-ancestor
111500052|NCT02880228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111500053|NCT02880228|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111500054|NCT02880228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111500055|NCT02880228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111500056|NCT02880228|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111500057|NCT02880228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111500058|NCT02880228|Immunologic Factors|immunologic factors|mesh-ancestor
111500059|NCT02880228|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111500060|NCT02880228|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111500061|NCT02880228|Growth Substances|growth substances|mesh-ancestor
111500062|NCT02880228|Growth Inhibitors|growth inhibitors|mesh-ancestor
111500063|NCT02880228|Protease Inhibitors|protease inhibitors|mesh-ancestor
111500064|NCT02880228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111500065|NCT02880228|Dermatologic Agents|dermatologic agents|mesh-ancestor
111500066|NCT02880852|Belimumab|belimumab|mesh-list
111500067|NCT02880852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111500068|NCT02880852|Immunologic Factors|immunologic factors|mesh-ancestor
111500069|NCT02880852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111500070|NCT02887404|Analgesics|analgesics|mesh-list
111500071|NCT02887404|Sensory System Agents|sensory system agents|mesh-ancestor
111500072|NCT02887404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111500073|NCT02887404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111500074|NCT02889510|Liraglutide|liraglutide|mesh-list
111500075|NCT02889510|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111500076|NCT02889510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111500077|NCT02889510|Incretins|incretins|mesh-ancestor
111500078|NCT02889510|Hormones|hormones|mesh-ancestor
111500079|NCT02889510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111500080|NCT02902770|Ketorolac|ketorolac|mesh-list
111500081|NCT02902770|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
111500082|NCT02902770|Lidocaine|lidocaine|mesh-list
111500083|NCT02902770|Anesthetics, Local|anesthetics, local|mesh-ancestor
111500084|NCT02902770|Anesthetics|anesthetics|mesh-ancestor
111500085|NCT02902770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111500086|NCT02902770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111500087|NCT02902770|Sensory System Agents|sensory system agents|mesh-ancestor
111500088|NCT02902770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111500089|NCT02902770|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111500090|NCT02902770|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111500091|NCT02902770|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111500092|NCT02902770|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111500093|NCT02902770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110980435|NCT00562497|Protective Agents|protective agents|mesh-ancestor
111500094|NCT02902770|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111500095|NCT02902770|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111500096|NCT02902770|Analgesics|analgesics|mesh-ancestor
111500097|NCT02902770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111500098|NCT02902770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111500099|NCT02902770|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111500100|NCT02902770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111500101|NCT02907918|Trastuzumab|trastuzumab|mesh-list
111500102|NCT02907918|Letrozole|letrozole|mesh-list
111500103|NCT02907918|Palbociclib|palbociclib|mesh-list
111500104|NCT02907918|Goserelin|goserelin|mesh-list
111500105|NCT02907918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111500106|NCT02907918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111500107|NCT02907918|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111500108|NCT02907918|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111500109|NCT02907918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111500110|NCT02907918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111500111|NCT02907918|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111500112|NCT02907918|Hormone Antagonists|hormone antagonists|mesh-ancestor
111500113|NCT02907918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111500114|NCT02907918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111500115|NCT02907918|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111500116|NCT02907918|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111500117|NCT02908620|Anesthetics|anesthetics|mesh-list
111500118|NCT02908620|Tetracaine|tetracaine|mesh-list
111500119|NCT02908620|Benzocaine|benzocaine|mesh-list
111500120|NCT02908620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111500121|NCT02908620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111500122|NCT02908620|Anesthetics, Local|anesthetics, local|mesh-ancestor
111500123|NCT02908620|Sensory System Agents|sensory system agents|mesh-ancestor
111500124|NCT02908620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111500125|NCT02911818|Liraglutide|liraglutide|mesh-list
111500126|NCT02911818|Phentermine|phentermine|mesh-list
111500127|NCT02911818|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111500128|NCT02911818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111500129|NCT02911818|Incretins|incretins|mesh-ancestor
111500130|NCT02911818|Hormones|hormones|mesh-ancestor
111500131|NCT02911818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111500132|NCT02911818|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111500133|NCT02911818|Appetite Depressants|appetite depressants|mesh-ancestor
111500134|NCT02911818|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111500135|NCT02911818|Sympathomimetics|sympathomimetics|mesh-ancestor
111500136|NCT02911818|Autonomic Agents|autonomic agents|mesh-ancestor
111500137|NCT02911818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111500138|NCT02911818|Adrenergic Agents|adrenergic agents|mesh-ancestor
111500139|NCT02911818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110450502|NCT04265001|Hyaluronic Acid|hyaluronic acid|mesh-list
111500140|NCT02911818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111500141|NCT02912364|Carbamazepine|carbamazepine|mesh-list
111500142|NCT02912364|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
111500143|NCT02912364|Anticonvulsants|anticonvulsants|mesh-ancestor
111500144|NCT02912364|Antimanic Agents|antimanic agents|mesh-ancestor
111500145|NCT02912364|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111500146|NCT02912364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111500147|NCT02912364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111500148|NCT02912364|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111500149|NCT02912364|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111500150|NCT02912364|Analgesics|analgesics|mesh-ancestor
111500151|NCT02912364|Sensory System Agents|sensory system agents|mesh-ancestor
111500152|NCT02912364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111500153|NCT02912364|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111500154|NCT02912364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111500155|NCT02912364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111500156|NCT02912364|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111500157|NCT02912364|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111500158|NCT02912364|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111500159|NCT02913924|Clonazepam|clonazepam|mesh-list
111500160|NCT02913924|Anticonvulsants|anticonvulsants|mesh-ancestor
111500161|NCT02913924|GABA Modulators|gaba modulators|mesh-ancestor
111500162|NCT02913924|GABA Agents|gaba agents|mesh-ancestor
111500163|NCT02913924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111500164|NCT02913924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111500165|NCT02913924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111500166|NCT02917122|Sertraline|sertraline|mesh-list
111500167|NCT02917122|Antidepressive Agents|antidepressive agents|mesh-ancestor
111500168|NCT02917122|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111500169|NCT02917122|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111500170|NCT02917122|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111500171|NCT02917122|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111500172|NCT02917122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111500173|NCT02917122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111500174|NCT02917122|Serotonin Agents|serotonin agents|mesh-ancestor
111500175|NCT02917122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111500176|NCT02922582|Tranexamic Acid|tranexamic acid|mesh-list
111500177|NCT02922582|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111500178|NCT02922582|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111500179|NCT02922582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111500180|NCT02922582|Hemostatics|hemostatics|mesh-ancestor
111500181|NCT02922582|Coagulants|coagulants|mesh-ancestor
111500182|NCT02925858|Ketamine|ketamine|mesh-list
111500183|NCT02925858|Analgesics|analgesics|mesh-ancestor
111500184|NCT02925858|Sensory System Agents|sensory system agents|mesh-ancestor
111500185|NCT02925858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111500186|NCT02925858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111500187|NCT02925858|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111500188|NCT02925858|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111500189|NCT02925858|Anesthetics, General|anesthetics, general|mesh-ancestor
111500190|NCT02925858|Anesthetics|anesthetics|mesh-ancestor
111500191|NCT02925858|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111500192|NCT02925858|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111500193|NCT02925858|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111500194|NCT02925858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111500195|NCT02925858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111500196|NCT02933034|Manganese|manganese|mesh-list
111500197|NCT02933034|Trace Elements|trace elements|mesh-ancestor
111500198|NCT02933034|Micronutrients|micronutrients|mesh-ancestor
111500199|NCT02933034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111500200|NCT02937168|Reslizumab|reslizumab|mesh-list
111500201|NCT02937168|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
111500202|NCT02937168|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111500203|NCT02937168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111500204|NCT02937168|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111500205|NCT02937168|Respiratory System Agents|respiratory system agents|mesh-ancestor
110980436|NCT00562497|Antiviral Agents|antiviral agents|mesh-ancestor
110775775|NCT03746444|Anesthetics|anesthetics|mesh-list
110775851|NCT04537806|Pregnanolone|pregnanolone|mesh-list
111119110|NCT05358886|BPN14770|bpn14770|mesh-list
110776143|NCT05761132|Pembrolizumab|pembrolizumab|mesh-list
110980437|NCT00562497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110980438|NCT00468975|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110776447|NCT03447262|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
110776602|NCT04322526|Naltrexone|naltrexone|mesh-list
110980440|NCT00468975|Autonomic Agents|autonomic agents|mesh-ancestor
110776747|NCT02054104|Sensory System Agents|sensory system agents|mesh-ancestor
110980441|NCT00468975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110980442|NCT00468975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110980443|NCT00468975|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110777435|NCT03626506|Amlodipine|amlodipine|mesh-list
110980444|NCT00468975|Respiratory System Agents|respiratory system agents|mesh-ancestor
110777663|NCT00972478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110980445|NCT00468975|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110980446|NCT00468975|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110980447|NCT00468975|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110980448|NCT00468975|Adrenergic Agents|adrenergic agents|mesh-ancestor
110777883|NCT02032810|Panobinostat|panobinostat|mesh-list
110980449|NCT00468975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110980450|NCT00468975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110980451|NCT01503515|Fluconazole|fluconazole|mesh-list
110980452|NCT01503515|Voriconazole|voriconazole|mesh-list
110980453|NCT01503515|Caspofungin|caspofungin|mesh-list
110980454|NCT01503515|Antifungal Agents|antifungal agents|mesh-ancestor
110980455|NCT01503515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110980456|NCT01503515|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110980457|NCT01503515|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110980458|NCT01503515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111119111|NCT05358886|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
110980459|NCT01503515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110980461|NCT01503515|Hormone Antagonists|hormone antagonists|mesh-ancestor
111119112|NCT05358886|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111119113|NCT05358886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110779676|NCT03435692|Autonomic Agents|autonomic agents|mesh-ancestor
110780198|NCT03641508|Triamcinolone|triamcinolone|mesh-list
110780422|NCT01098201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111119114|NCT05358886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110980462|NCT01503515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111119115|NCT05357794|Brentuximab Vedotin|brentuximab vedotin|mesh-list
110780942|NCT03444298|Antioxidants|antioxidants|mesh-ancestor
110980463|NCT01503515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110781169|NCT03679390|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110980464|NCT01503515|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110980465|NCT01503515|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110980466|NCT01503515|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110980467|NCT00468273|Immunoglobulins|immunoglobulins|mesh-list
110980468|NCT00468273|Antibodies|antibodies|mesh-list
110980469|NCT00468273|gamma-Globulins|gamma-globulins|mesh-list
110980470|NCT00468273|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110980471|NCT00468273|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110980472|NCT00468273|Immunologic Factors|immunologic factors|mesh-ancestor
110980473|NCT00468273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110980474|NCT03217916|polysaccharide-K|polysaccharide-k|mesh-list
110980475|NCT03217916|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110980476|NCT03217916|Immunologic Factors|immunologic factors|mesh-ancestor
110980477|NCT03217916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110980478|NCT03217916|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110980479|NCT03217916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110980480|NCT03217916|Antiviral Agents|antiviral agents|mesh-ancestor
110980481|NCT03217916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110781381|NCT03670888|Rituximab|rituximab|mesh-list
110980482|NCT03217916|Interferon Inducers|interferon inducers|mesh-ancestor
110781682|NCT01092975|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110781830|NCT00058539|Pertuzumab|pertuzumab|mesh-list
110781905|NCT03667300|Hormones|hormones|mesh-ancestor
110781980|NCT03006562|Anticoagulants|anticoagulants|mesh-ancestor
110980483|NCT03217916|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110782135|NCT03002038|Rituximab|rituximab|mesh-list
110980484|NCT03217916|Protective Agents|protective agents|mesh-ancestor
110980486|NCT00468117|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110980487|NCT00468117|Basiliximab|basiliximab|mesh-list
110782805|NCT05853458|Hydroxyurea|hydroxyurea|mesh-list
110782882|NCT05595044|Vitamin D|vitamin d|mesh-list
110782949|NCT05372133|Analgesics|analgesics|mesh-ancestor
111119116|NCT05357794|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111119117|NCT05357794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111119118|NCT05357794|Immunotoxins|immunotoxins|mesh-ancestor
111119119|NCT05357794|Immunoconjugates|immunoconjugates|mesh-ancestor
111119120|NCT05357794|Immunologic Factors|immunologic factors|mesh-ancestor
111119121|NCT05357794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111119122|NCT05347771|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110980489|NCT00468117|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111119123|NCT05347771|Immunologic Factors|immunologic factors|mesh-ancestor
110980490|NCT00468117|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110980491|NCT00468117|Analgesics|analgesics|mesh-ancestor
110980492|NCT00468117|Sensory System Agents|sensory system agents|mesh-ancestor
110980493|NCT00468117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110980494|NCT00468117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110784738|NCT01106235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110980495|NCT00468117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110980496|NCT00468117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110784978|NCT01209351|Teduglutide|teduglutide|mesh-list
110980497|NCT00468117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110785188|NCT01210677|Prednisone|prednisone|mesh-list
110980498|NCT00468117|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110980499|NCT00468117|Immunologic Factors|immunologic factors|mesh-ancestor
110980500|NCT00468039|Metformin|metformin|mesh-list
110980501|NCT00468039|Vildagliptin|vildagliptin|mesh-list
110980502|NCT00468039|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110980503|NCT00468039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110980504|NCT00468039|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110980505|NCT00468039|Protease Inhibitors|protease inhibitors|mesh-ancestor
110980506|NCT00468039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110786387|NCT01227603|Candesartan|candesartan|mesh-list
110786460|NCT01128075|Interferon beta-1a|interferon beta-1a|mesh-list
110786535|NCT02899156|Protective Agents|protective agents|mesh-ancestor
111119124|NCT05347771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111119125|NCT05342844|Dexmedetomidine|dexmedetomidine|mesh-list
111119126|NCT05342844|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110786912|NCT03930069|Vasopressins|vasopressins|mesh-list
110786988|NCT02961790|Urological Agents|urological agents|mesh-ancestor
111119127|NCT05342844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111119128|NCT05342844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110787283|NCT01137591|Antioxidants|antioxidants|mesh-ancestor
110980507|NCT00468039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110980508|NCT02742519|Ivacaftor|ivacaftor|mesh-list
110787660|NCT01235013|Maraviroc|maraviroc|mesh-list
110787881|NCT03615196|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110980509|NCT02742519|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
110788179|NCT01238055|Sunitinib|sunitinib|mesh-list
110788328|NCT03480932|Interferons|interferons|mesh-list
110788403|NCT03610282|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110980510|NCT02742519|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111119129|NCT05342844|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110980511|NCT02742519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110980512|NCT01375010|Vitamin D|vitamin d|mesh-list
110980513|NCT01375010|Cholecalciferol|cholecalciferol|mesh-list
110788927|NCT02238418|Cholecalciferol|cholecalciferol|mesh-list
110789084|NCT03590626|Dulaglutide|dulaglutide|mesh-list
110980515|NCT01375010|Micronutrients|micronutrients|mesh-ancestor
110980516|NCT01375010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110980517|NCT01375010|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110980518|NCT01375010|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110980519|NCT03231176|Capecitabine|capecitabine|mesh-list
110980520|NCT03231176|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110980521|NCT03231176|Antimetabolites|antimetabolites|mesh-ancestor
110980522|NCT03231176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110980523|NCT03231176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110980524|NCT00467025|Sorafenib|sorafenib|mesh-list
110980525|NCT00467025|Trebananib|trebananib|mesh-list
110980526|NCT00467025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110980527|NCT00467025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110980528|NCT00467025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111119130|NCT05342844|Analgesics|analgesics|mesh-ancestor
111119131|NCT05342844|Sensory System Agents|sensory system agents|mesh-ancestor
110980529|NCT00467025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110790038|NCT03915561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110980530|NCT00467025|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110980531|NCT00467025|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110980532|NCT00467025|Growth Substances|growth substances|mesh-ancestor
110697617|NCT00402324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110790938|NCT01261689|Sufentanil|sufentanil|mesh-list
110791014|NCT03886311|Alkylating Agents|alkylating agents|mesh-ancestor
110791160|NCT01155765|Purinergic Agents|purinergic agents|mesh-ancestor
110980533|NCT00467025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110980534|NCT00467025|Growth Inhibitors|growth inhibitors|mesh-ancestor
110980536|NCT03230786|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110791610|NCT03110432|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110980538|NCT02451098|Atorvastatin|atorvastatin|mesh-list
110980539|NCT02451098|Ezetimibe|ezetimibe|mesh-list
110980540|NCT02451098|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110980541|NCT02451098|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110980542|NCT02451098|Antimetabolites|antimetabolites|mesh-ancestor
110980543|NCT02451098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110792583|NCT02525991|Loxapine|loxapine|mesh-list
110792689|NCT03435003|Fentanyl|fentanyl|mesh-list
110792801|NCT01169025|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110980544|NCT02451098|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110980545|NCT02451098|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110980546|NCT02451098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110980547|NCT00546273|Vaccines|vaccines|mesh-list
110793180|NCT03864705|Metformin|metformin|mesh-list
110793306|NCT03562468|Niacin|niacin|mesh-list
110793392|NCT01177371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110793544|NCT06008106|Carboplatin|carboplatin|mesh-list
110793545|NCT06008106|Temozolomide|temozolomide|mesh-list
110793546|NCT06008106|Dacarbazine|dacarbazine|mesh-list
110793547|NCT06008106|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110793548|NCT06008106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110793549|NCT06008106|Tubulin Modulators|tubulin modulators|mesh-ancestor
110793550|NCT06008106|Antimitotic Agents|antimitotic agents|mesh-ancestor
110793551|NCT06008106|Mitosis Modulators|mitosis modulators|mesh-ancestor
110793552|NCT06008106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110793553|NCT06008106|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110793554|NCT06008106|Alkylating Agents|alkylating agents|mesh-ancestor
110793555|NCT06008093|Carboplatin|carboplatin|mesh-list
110793556|NCT06008093|Pembrolizumab|pembrolizumab|mesh-list
110793557|NCT06008093|Pemetrexed|pemetrexed|mesh-list
110793558|NCT06008093|Durvalumab|durvalumab|mesh-list
110793559|NCT06008093|Tremelimumab|tremelimumab|mesh-list
110793560|NCT06008093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110793561|NCT06008093|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110793562|NCT06008093|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110793563|NCT06008093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110793564|NCT06008093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110793565|NCT06008093|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110793566|NCT06008093|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110793619|NCT06007222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110980549|NCT00546273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110980550|NCT02452112|Lidocaine|lidocaine|mesh-list
110980551|NCT02452112|Anesthetics, Local|anesthetics, local|mesh-ancestor
110980552|NCT02452112|Anesthetics|anesthetics|mesh-ancestor
110980553|NCT02452112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110980554|NCT02452112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110980555|NCT02452112|Sensory System Agents|sensory system agents|mesh-ancestor
110980556|NCT02452112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110980557|NCT02452112|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110980558|NCT02452112|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110980559|NCT02452112|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110980560|NCT02452112|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110980561|NCT02452112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110980562|NCT00659061|Micronutrients|micronutrients|mesh-list
110980563|NCT00659061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110980564|NCT02451956|Paclitaxel|paclitaxel|mesh-list
110793843|NCT05981573|Methadone|methadone|mesh-list
110793917|NCT05902533|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110793992|NCT05777109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110793993|NCT05773365|Anesthetics|anesthetics|mesh-list
110793994|NCT05773365|Anesthetics, Local|anesthetics, local|mesh-list
110793995|NCT05773365|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110793996|NCT05773365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110793997|NCT05773365|Sensory System Agents|sensory system agents|mesh-ancestor
110980565|NCT02451956|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110794299|NCT04739813|Prednisone|prednisone|mesh-list
110794442|NCT04501861|Natriuretic Agents|natriuretic agents|mesh-ancestor
110980566|NCT02451956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110794588|NCT04196491|Growth Inhibitors|growth inhibitors|mesh-ancestor
110794589|NCT04165967|Nivolumab|nivolumab|mesh-list
110794590|NCT04165967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110794591|NCT04165967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110794592|NCT04165967|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110794594|NCT04064359|Antibodies|antibodies|mesh-list
110980567|NCT02451956|Tubulin Modulators|tubulin modulators|mesh-ancestor
110980568|NCT02451956|Antimitotic Agents|antimitotic agents|mesh-ancestor
110980569|NCT02451956|Mitosis Modulators|mitosis modulators|mesh-ancestor
110795182|NCT01289301|Antifungal Agents|antifungal agents|mesh-ancestor
110795329|NCT02524743|Anesthetics, Local|anesthetics, local|mesh-ancestor
111119132|NCT05342844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110795485|NCT01294059|Analgesics|analgesics|mesh-ancestor
110980570|NCT02451956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110980571|NCT02725372|Nitric Oxide|nitric oxide|mesh-list
110795939|NCT01199757|Xhance|xhance|mesh-list
110980572|NCT02725372|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110980573|NCT02725372|Autonomic Agents|autonomic agents|mesh-ancestor
110980574|NCT02725372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110796152|NCT01566669|Parecoxib|parecoxib|mesh-list
110796223|NCT01203735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110796224|NCT01203735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110796225|NCT01203735|GABA Agents|gaba agents|mesh-ancestor
110796226|NCT01203735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110796227|NCT01203735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110796228|NCT01203735|Antimanic Agents|antimanic agents|mesh-ancestor
110796229|NCT01203735|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110796230|NCT01203735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110796231|NCT01203735|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110796233|NCT03842631|Maleic acid|maleic acid|mesh-list
110796234|NCT03842631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110980575|NCT02725372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110980576|NCT02725372|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110980577|NCT02725372|Respiratory System Agents|respiratory system agents|mesh-ancestor
110980578|NCT02725372|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110980579|NCT02725372|Antioxidants|antioxidants|mesh-ancestor
110980580|NCT02725372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110980581|NCT02725372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110980582|NCT02725372|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
110980583|NCT02725372|Vasodilator Agents|vasodilator agents|mesh-ancestor
110980584|NCT02725372|Gasotransmitters|gasotransmitters|mesh-ancestor
110980585|NCT02725372|Protective Agents|protective agents|mesh-ancestor
110980586|NCT02450786|Donepezil|donepezil|mesh-list
110980587|NCT02450786|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110980588|NCT02450786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110980589|NCT02450786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110980590|NCT02450786|Cholinergic Agents|cholinergic agents|mesh-ancestor
110980591|NCT02450786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110980592|NCT02450786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110980593|NCT02450786|Nootropic Agents|nootropic agents|mesh-ancestor
110980594|NCT00539721|Ondansetron|ondansetron|mesh-list
110980595|NCT00539721|Rolapitant|rolapitant|mesh-list
110980596|NCT00539721|Antiemetics|antiemetics|mesh-ancestor
110980597|NCT00539721|Autonomic Agents|autonomic agents|mesh-ancestor
110980598|NCT00539721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110796338|NCT03559010|Norgestrel|norgestrel|mesh-list
110796373|NCT03930615|Letermovir|letermovir|mesh-list
110980599|NCT00539721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110796446|NCT01202487|Mydriatics|mydriatics|mesh-ancestor
110980600|NCT00539721|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110980601|NCT00539721|Antipruritics|antipruritics|mesh-ancestor
110980602|NCT00539721|Dermatologic Agents|dermatologic agents|mesh-ancestor
110796519|NCT03289676|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110796666|NCT01205139|Protease Inhibitors|protease inhibitors|mesh-ancestor
110980603|NCT00539721|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110980604|NCT00539721|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110980605|NCT00539721|Serotonin Agents|serotonin agents|mesh-ancestor
110796887|NCT03818295|Enzyme Activators|enzyme activators|mesh-ancestor
110796962|NCT03813771|Analgesics|analgesics|mesh-ancestor
110797048|NCT03280550|Omalizumab|omalizumab|mesh-list
110797117|NCT03637790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110980606|NCT00539721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110697697|NCT02532777|Glucocorticoids|glucocorticoids|mesh-ancestor
110797271|NCT03812523|Analgesics|analgesics|mesh-ancestor
110797354|NCT01303887|Hormones|hormones|mesh-ancestor
110797414|NCT02051530|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111119133|NCT05342844|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110797595|NCT02052388|Daptomycin|daptomycin|mesh-list
110797711|NCT03810261|Micronutrients|micronutrients|mesh-ancestor
110797939|NCT03789123|Contraceptive Agents|contraceptive agents|mesh-ancestor
110798014|NCT04753515|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110980607|NCT00539721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110980608|NCT00539721|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110980609|NCT00464061|Volinanserin|volinanserin|mesh-list
110798315|NCT02059018|Nitroglycerin|nitroglycerin|mesh-list
110980610|NCT00464061|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110980611|NCT00464061|Serotonin Agents|serotonin agents|mesh-ancestor
110980612|NCT00464061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110980613|NCT00464061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110980614|NCT00464061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110980615|NCT03230630|Melatonin|melatonin|mesh-list
110980616|NCT03230630|Antioxidants|antioxidants|mesh-ancestor
110798388|NCT03779451|Hormones|hormones|mesh-ancestor
111119134|NCT05342844|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111119136|NCT05342844|Adrenergic Agents|adrenergic agents|mesh-ancestor
110980617|NCT03230630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110980618|NCT03230630|Protective Agents|protective agents|mesh-ancestor
110980619|NCT03230630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110798991|NCT03773991|Protective Agents|protective agents|mesh-ancestor
110980620|NCT03230630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110980621|NCT00460941|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
110980622|NCT00460941|Incretins|incretins|mesh-ancestor
110980623|NCT00460941|Hormones|hormones|mesh-ancestor
111119137|NCT05342844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110799813|NCT02260336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111119138|NCT05342844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110980624|NCT00460941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110980625|NCT00460941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110980626|NCT00460317|Paclitaxel|paclitaxel|mesh-list
110980627|NCT00460317|Carboplatin|carboplatin|mesh-list
110980628|NCT00460317|Motesanib diphosphate|motesanib diphosphate|mesh-list
110980629|NCT00460317|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110980630|NCT00460317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110980631|NCT00460317|Tubulin Modulators|tubulin modulators|mesh-ancestor
110980632|NCT00460317|Antimitotic Agents|antimitotic agents|mesh-ancestor
110980633|NCT00460317|Mitosis Modulators|mitosis modulators|mesh-ancestor
110800114|NCT02079298|Sensory System Agents|sensory system agents|mesh-ancestor
110980634|NCT00460317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110980635|NCT00460317|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110980636|NCT00460317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110980637|NCT03213548|Daminozide|daminozide|mesh-list
110800562|NCT02082418|Caseins|caseins|mesh-list
110800632|NCT03749733|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110980638|NCT03213548|Plant Growth Regulators|plant growth regulators|mesh-ancestor
110800783|NCT02088424|Insulin|insulin|mesh-list
110980640|NCT03213548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110801155|NCT05471674|Nivolumab|nivolumab|mesh-list
110980642|NCT00534027|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110801898|NCT03745599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110980644|NCT02548078|Vaccines|vaccines|mesh-list
110802354|NCT05179070|Antioxidants|antioxidants|mesh-ancestor
110980645|NCT02548078|Immunologic Factors|immunologic factors|mesh-ancestor
110802571|NCT02118064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110802643|NCT02126956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110802644|NCT02126956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110802645|NCT02126956|Immunologic Factors|immunologic factors|mesh-ancestor
110802646|NCT02126956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110802647|NCT02124148|Leucovorin|leucovorin|mesh-list
110802648|NCT02124148|Fluorouracil|fluorouracil|mesh-list
110802649|NCT02124148|Pemetrexed|pemetrexed|mesh-list
110802650|NCT02124148|Cetuximab|cetuximab|mesh-list
110802651|NCT02124148|Prexasertib|prexasertib|mesh-list
110802652|NCT02124148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110802653|NCT02124148|Antimetabolites|antimetabolites|mesh-ancestor
110802654|NCT02124148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110802655|NCT02124148|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110802755|NCT02127190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110802757|NCT02932904|Paroxetine|paroxetine|mesh-list
110802758|NCT02932904|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110802759|NCT02932904|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110802760|NCT02932904|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110802761|NCT02932904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110802762|NCT02932904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110802763|NCT02932904|Serotonin Agents|serotonin agents|mesh-ancestor
110802764|NCT02932904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110802765|NCT02932904|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110802766|NCT02932904|Antidepressive Agents|antidepressive agents|mesh-ancestor
110802767|NCT02932904|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110802768|NCT02932904|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110802769|NCT02932904|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110802770|NCT02932904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110802771|NCT02932904|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110802772|NCT02932904|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110802773|NCT02932904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110802774|NCT02932904|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110802775|NCT02932904|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110802776|NCT02932904|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110802777|NCT02932904|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110802778|NCT02127736|Amitriptyline|amitriptyline|mesh-list
110802779|NCT02127736|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110802780|NCT02127736|Antidepressive Agents|antidepressive agents|mesh-ancestor
110802781|NCT02127736|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110802782|NCT02127736|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110802783|NCT02127736|Analgesics|analgesics|mesh-ancestor
110802784|NCT02127736|Sensory System Agents|sensory system agents|mesh-ancestor
110802785|NCT02127736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110802786|NCT02127736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110980646|NCT02548078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110980647|NCT00532311|Atorvastatin|atorvastatin|mesh-list
110980648|NCT00532311|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110980649|NCT00532311|Simvastatin|simvastatin|mesh-list
110980650|NCT00532311|Pravastatin|pravastatin|mesh-list
110980651|NCT00532311|Lovastatin|lovastatin|mesh-list
110980652|NCT00532311|L 647318|l 647318|mesh-list
110676986|NCT03233724|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111119140|NCT05339087|Enzyme Activators|enzyme activators|mesh-ancestor
110803463|NCT00129545|Warfarin|warfarin|mesh-list
110980654|NCT00532311|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
110803546|NCT00133991|Leucovorin|leucovorin|mesh-list
110980655|NCT00532311|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110980656|NCT00532311|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110980657|NCT00532311|Antimetabolites|antimetabolites|mesh-ancestor
110803987|NCT03704584|Lidocaine|lidocaine|mesh-list
110804062|NCT03396952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110804136|NCT00126191|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110980658|NCT00532311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110980659|NCT00532311|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110804432|NCT02142868|Letrozole|letrozole|mesh-list
110980660|NCT00532311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110980661|NCT03230474|Morphine|morphine|mesh-list
110980662|NCT03230474|Naloxone|naloxone|mesh-list
110980663|NCT03230474|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110980664|NCT03230474|Narcotics|narcotics|mesh-ancestor
110804725|NCT02154646|Gemcitabine|gemcitabine|mesh-list
110980665|NCT03230474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110804871|NCT03729375|Anesthetics, Local|anesthetics, local|mesh-ancestor
110980666|NCT03230474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110980667|NCT03230474|Analgesics|analgesics|mesh-ancestor
110980668|NCT03230474|Sensory System Agents|sensory system agents|mesh-ancestor
110805021|NCT00121199|Glucocorticoids|glucocorticoids|mesh-ancestor
110980669|NCT03230474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110980670|NCT03230474|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110980671|NCT02671435|Bevacizumab|bevacizumab|mesh-list
110980672|NCT02671435|Cetuximab|cetuximab|mesh-list
110980673|NCT02671435|Durvalumab|durvalumab|mesh-list
110805766|NCT03730857|Autonomic Agents|autonomic agents|mesh-ancestor
110806066|NCT03723135|Cc-486|cc-486|mesh-list
110806072|NCT02762578|Insulin|insulin|mesh-list
110980674|NCT02671435|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110806443|NCT02170792|Protease Inhibitors|protease inhibitors|mesh-ancestor
110806525|NCT02173756|Morphine|morphine|mesh-list
110806591|NCT02256280|Neostigmine|neostigmine|mesh-list
110980675|NCT02671435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110806898|NCT02177734|Vaccines|vaccines|mesh-list
110807417|NCT02187562|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110980676|NCT02671435|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110980677|NCT02671435|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110980678|NCT02671435|Growth Substances|growth substances|mesh-ancestor
110980679|NCT02671435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110980680|NCT02671435|Growth Inhibitors|growth inhibitors|mesh-ancestor
110980681|NCT00529503|Rituximab|rituximab|mesh-list
110980682|NCT00529503|Dacetuzumab|dacetuzumab|mesh-list
110980683|NCT00529503|Carboplatin|carboplatin|mesh-list
110980684|NCT00529503|Etoposide|etoposide|mesh-list
110980685|NCT00529503|Ifosfamide|ifosfamide|mesh-list
110980686|NCT00529503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110807937|NCT02199418|Paclitaxel|paclitaxel|mesh-list
110980687|NCT00529503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110808090|NCT02221102|Antipyretics|antipyretics|mesh-ancestor
110808235|NCT02220400|Ketamine|ketamine|mesh-list
110980688|NCT00529503|Immunologic Factors|immunologic factors|mesh-ancestor
110808306|NCT02222428|Olodaterol|olodaterol|mesh-list
110808530|NCT01087229|Anesthetics, General|anesthetics, general|mesh-ancestor
110980689|NCT00529503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110808607|NCT00099359|Antimetabolites|antimetabolites|mesh-ancestor
110980690|NCT00529503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110808751|NCT04174612|Cytarabine|cytarabine|mesh-list
110808981|NCT00069953|Paclitaxel|paclitaxel|mesh-list
110980691|NCT00529503|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110980692|NCT00529503|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110809211|NCT02580370|Botulinum Toxins|botulinum toxins|mesh-list
110809435|NCT01583777|Belinostat|belinostat|mesh-list
110980693|NCT00529503|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110809581|NCT01095575|Analgesics|analgesics|mesh-ancestor
110809655|NCT00064337|Thalidomide|thalidomide|mesh-list
110980694|NCT00529503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110980695|NCT00529503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110980696|NCT00529503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110980697|NCT00529503|Alkylating Agents|alkylating agents|mesh-ancestor
110810096|NCT01357642|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110810171|NCT01318252|Latanoprost|latanoprost|mesh-list
110810245|NCT02268370|Dasatinib|dasatinib|mesh-list
110980698|NCT05459194|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
110810396|NCT01198834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110810482|NCT01071850|Metformin|metformin|mesh-list
110980699|NCT05459194|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110810546|NCT02269540|Antioxidants|antioxidants|mesh-ancestor
110980700|NCT05459194|Autonomic Agents|autonomic agents|mesh-ancestor
110980701|NCT05459194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110980702|NCT05459194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110810845|NCT00978016|GABA Agents|gaba agents|mesh-ancestor
110810993|NCT01088555|Antioxidants|antioxidants|mesh-ancestor
110980704|NCT05459194|Respiratory System Agents|respiratory system agents|mesh-ancestor
110980705|NCT05459194|Glucocorticoids|glucocorticoids|mesh-ancestor
110980707|NCT05459194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110980708|NCT05459194|Sympathomimetics|sympathomimetics|mesh-ancestor
110980709|NCT05476198|Anesthetics|anesthetics|mesh-list
110811875|NCT01156220|Furosemide|furosemide|mesh-list
110980710|NCT05476198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110812029|NCT03191396|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110812253|NCT01104337|Antipyretics|antipyretics|mesh-ancestor
110812330|NCT01104571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110980711|NCT05476198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110980712|NCT02280057|Metformin|metformin|mesh-list
110980713|NCT02280057|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110980714|NCT02280057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110812477|NCT01333124|Gemcitabine|gemcitabine|mesh-list
110980715|NCT02279589|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110980717|NCT02279589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110980718|NCT02282709|Asunaprevir|asunaprevir|mesh-list
110980720|NCT02282709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110813307|NCT00384904|Ritonavir|ritonavir|mesh-list
110813445|NCT01315496|Antibodies|antibodies|mesh-list
110813449|NCT00544960|Docetaxel|docetaxel|mesh-list
110813519|NCT00540358|Carboplatin|carboplatin|mesh-list
110813668|NCT05208034|Methotrexate|methotrexate|mesh-list
110813820|NCT02284672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110813893|NCT05982301|Oxaliplatin|oxaliplatin|mesh-list
110813894|NCT05982301|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110813895|NCT05982301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110813896|NCT05982301|Tubulin Modulators|tubulin modulators|mesh-ancestor
110813977|NCT05981079|Tazobactam|tazobactam|mesh-list
110813978|NCT05981079|Piperacillin|piperacillin|mesh-list
110813979|NCT05981079|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
110813980|NCT05981079|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110813981|NCT05981079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110813982|NCT05981079|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110813983|NCT05981079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110813984|NCT05981079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110814044|NCT05980871|Doxycycline|doxycycline|mesh-list
110814269|NCT05816252|Carboplatin|carboplatin|mesh-list
110814491|NCT05371093|Growth Inhibitors|growth inhibitors|mesh-ancestor
110980721|NCT02282709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110980722|NCT02282787|Dexmedetomidine|dexmedetomidine|mesh-list
110815100|NCT04196413|Cyclophosphamide|cyclophosphamide|mesh-list
110980723|NCT02282787|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110980724|NCT02282787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110815477|NCT01342016|Immunologic Factors|immunologic factors|mesh-ancestor
110980725|NCT02282787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110815920|NCT01109485|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110815993|NCT00005608|Calcium|calcium|mesh-list
110980726|NCT02282787|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110980727|NCT02282787|Analgesics|analgesics|mesh-ancestor
110980728|NCT02282787|Sensory System Agents|sensory system agents|mesh-ancestor
110980729|NCT02282787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110980730|NCT02282787|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110980731|NCT02282787|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110980732|NCT02282787|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110980733|NCT02282787|Adrenergic Agents|adrenergic agents|mesh-ancestor
110980734|NCT02282787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110816283|NCT01211821|Adrenergic Agents|adrenergic agents|mesh-ancestor
110816427|NCT01344512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110816502|NCT03528616|Purinergic Agonists|purinergic agonists|mesh-ancestor
110980735|NCT02282787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110980736|NCT03223844|Dextroamphetamine|dextroamphetamine|mesh-list
110816730|NCT01115725|Hormones|hormones|mesh-ancestor
110816798|NCT04400188|Alkylating Agents|alkylating agents|mesh-ancestor
110816951|NCT04467346|Temozolomide|temozolomide|mesh-list
110817100|NCT01345370|Temozolomide|temozolomide|mesh-list
110817171|NCT01212913|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110817246|NCT04466176|Sympathomimetics|sympathomimetics|mesh-ancestor
110817320|NCT03143816|Insulin|insulin|mesh-list
110980737|NCT03223844|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110980738|NCT03223844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110980739|NCT03223844|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110980740|NCT03223844|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110980741|NCT03223844|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110817840|NCT05790070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110817841|NCT05790070|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110817843|NCT05789680|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110817845|NCT05789667|Lenvatinib|lenvatinib|mesh-list
110817985|NCT05767086|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110817986|NCT05767086|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110817987|NCT05767086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110817989|NCT05767086|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110817990|NCT05767086|Fertility Agents|fertility agents|mesh-ancestor
110817991|NCT05755282|Hand Sanitizers|hand sanitizers|mesh-list
110817992|NCT05755282|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110817993|NCT05755282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110817994|NCT05755282|Disinfectants|disinfectants|mesh-ancestor
110818007|NCT05722886|Pertuzumab|pertuzumab|mesh-list
110980742|NCT03223844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110980744|NCT03223844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110980745|NCT00458601|Temozolomide|temozolomide|mesh-list
110980746|NCT00458601|Molgramostim|molgramostim|mesh-list
110980747|NCT00458601|Rindopepimut|rindopepimut|mesh-list
110980748|NCT00458601|Sargramostim|sargramostim|mesh-list
110980749|NCT00458601|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110980750|NCT00458601|Alkylating Agents|alkylating agents|mesh-ancestor
110980751|NCT00458601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110980752|NCT00458601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110980753|NCT00458601|Immunologic Factors|immunologic factors|mesh-ancestor
110980754|NCT00458601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110980755|NCT00458601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110697909|NCT01067547|Iron|iron|mesh-list
110980757|NCT00658047|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110980758|NCT00658047|Abortifacient Agents|abortifacient agents|mesh-ancestor
110980759|NCT00658047|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110980760|NCT00658047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110818286|NCT04918810|Docetaxel|docetaxel|mesh-list
110818357|NCT04747847|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110980761|NCT00658047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110980762|NCT00658047|Antimetabolites|antimetabolites|mesh-ancestor
110980763|NCT00658047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110980764|NCT00658047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110980765|NCT00658047|Dermatologic Agents|dermatologic agents|mesh-ancestor
110980766|NCT00658047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110980767|NCT00658047|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110818582|NCT03875079|Pembrolizumab|pembrolizumab|mesh-list
110980768|NCT00658047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110980769|NCT00658047|Immunologic Factors|immunologic factors|mesh-ancestor
110980770|NCT00658047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110818952|NCT04481672|Anesthetics|anesthetics|mesh-ancestor
110980772|NCT03230162|Heparin|heparin|mesh-list
110980773|NCT03230162|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
110980774|NCT03230162|Tinzaparin|tinzaparin|mesh-list
110980775|NCT03230162|Dalteparin|dalteparin|mesh-list
110819324|NCT03874897|Antibodies|antibodies|mesh-list
110819405|NCT02298166|Analgesics|analgesics|mesh-ancestor
110980776|NCT03230162|Sildenafil Citrate|sildenafil citrate|mesh-list
110980777|NCT03230162|Anticoagulants|anticoagulants|mesh-ancestor
110980778|NCT03230162|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110819622|NCT01228357|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110980779|NCT03230162|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110820133|NCT01232023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110820377|NCT03515200|Antimetabolites|antimetabolites|mesh-ancestor
110980781|NCT03230162|Vasodilator Agents|vasodilator agents|mesh-ancestor
110980782|NCT03230162|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110820810|NCT04925180|Androgen Antagonists|androgen antagonists|mesh-ancestor
110820883|NCT02304094|Prednisolone|prednisolone|mesh-list
110980783|NCT03230162|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110821118|NCT01231165|Aspirin|aspirin|mesh-list
110821255|NCT02313064|CXA-10|cxa-10|mesh-list
110980784|NCT03230162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110980785|NCT03230162|Urological Agents|urological agents|mesh-ancestor
110980786|NCT00455559|Imatinib Mesylate|imatinib mesylate|mesh-list
110821563|NCT01238029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110821787|NCT01141465|Hormones|hormones|mesh-ancestor
110821869|NCT03498118|Bupivacaine|bupivacaine|mesh-list
110980787|NCT00455559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110980788|NCT00455559|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110822009|NCT01360190|Fluoxetine|fluoxetine|mesh-list
110980789|NCT00455559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110980790|NCT00455559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110980791|NCT02916433|Octreotide|octreotide|mesh-list
110980792|NCT02916433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110980793|NCT02916433|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110980794|NCT02916433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110822543|NCT01237249|Prednisone|prednisone|mesh-list
110822602|NCT01146145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110980795|NCT02284269|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
110822753|NCT00876031|Idarubicin|idarubicin|mesh-list
110822829|NCT03491098|Protective Agents|protective agents|mesh-ancestor
110822901|NCT00924326|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110980796|NCT02284269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110980797|NCT02284269|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110980798|NCT02284269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110980799|NCT04059523|Tretinoin|tretinoin|mesh-list
110980800|NCT04059523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110980801|NCT04059523|Keratolytic Agents|keratolytic agents|mesh-ancestor
110980802|NCT04059523|Dermatologic Agents|dermatologic agents|mesh-ancestor
110980803|NCT00657501|Testosterone|testosterone|mesh-list
110980804|NCT00657501|Androgens|androgens|mesh-ancestor
110980805|NCT00657501|Hormones|hormones|mesh-ancestor
110980806|NCT00657501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110980807|NCT00657501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110980808|NCT03675841|Carbamide Peroxide|carbamide peroxide|mesh-list
110980809|NCT03675841|Pazufloxacin|pazufloxacin|mesh-list
110980810|NCT03675841|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110980811|NCT03675841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110980812|NCT03675841|Antitubercular Agents|antitubercular agents|mesh-ancestor
110980813|NCT03675841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110980814|NCT03675841|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110980815|NCT03675841|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110980816|NCT03675841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110980817|NCT03675841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110980818|NCT03675841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110980819|NCT03229694|Bosentan|bosentan|mesh-list
110980820|NCT03229694|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-list
110980821|NCT03229694|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110980822|NCT03229694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110980823|NCT03223064|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
110980824|NCT03223064|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110980825|NCT03223064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110980826|NCT03209648|Itraconazole|itraconazole|mesh-list
110980827|NCT03209648|Antifungal Agents|antifungal agents|mesh-ancestor
110980828|NCT03209648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110980829|NCT03209648|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110980830|NCT03209648|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110980831|NCT03209648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110980832|NCT03209648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110980833|NCT03209648|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110980834|NCT03209648|Hormone Antagonists|hormone antagonists|mesh-ancestor
110980835|NCT03209648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110980836|NCT03209648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110980837|NCT03209648|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110980838|NCT04058899|Dexmedetomidine|dexmedetomidine|mesh-list
110980840|NCT04058899|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110980841|NCT04058899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110980842|NCT04058899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110980843|NCT04058899|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110980844|NCT04058899|Analgesics|analgesics|mesh-ancestor
110980845|NCT04058899|Sensory System Agents|sensory system agents|mesh-ancestor
110980846|NCT04058899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110980847|NCT04058899|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110980848|NCT04058899|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110450596|NCT01052844|Analgesics|analgesics|mesh-ancestor
110980849|NCT04058899|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110980850|NCT04058899|Adrenergic Agents|adrenergic agents|mesh-ancestor
110980851|NCT04058899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110980852|NCT04058899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110980853|NCT04058899|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110980854|NCT04058899|Narcotics|narcotics|mesh-ancestor
110980855|NCT00657189|Sifalimumab|sifalimumab|mesh-list
110980856|NCT00657189|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110980857|NCT00657189|Immunologic Factors|immunologic factors|mesh-ancestor
110980858|NCT00657189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110980859|NCT03209180|Carvedilol|carvedilol|mesh-list
110980860|NCT03209180|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110980861|NCT03209180|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110980862|NCT03209180|Adrenergic Agents|adrenergic agents|mesh-ancestor
110980863|NCT03209180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110980864|NCT03209180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110980865|NCT03209180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110980866|NCT03209180|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110980867|NCT03209180|Antioxidants|antioxidants|mesh-ancestor
110980868|NCT03209180|Protective Agents|protective agents|mesh-ancestor
110980869|NCT03209180|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110980870|NCT03209180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110980871|NCT03209180|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110980872|NCT03209180|Vasodilator Agents|vasodilator agents|mesh-ancestor
110980873|NCT03209180|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110980874|NCT03209180|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110980875|NCT03215017|Loperamide|loperamide|mesh-list
110980876|NCT03215017|Sorbitol|sorbitol|mesh-list
110980877|NCT03215017|Antidiarrheals|antidiarrheals|mesh-ancestor
110980878|NCT03215017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110980879|NCT03215017|Cathartics|cathartics|mesh-ancestor
110980880|NCT02500849|Busulfan|busulfan|mesh-list
110980881|NCT02500849|Alkylating Agents|alkylating agents|mesh-ancestor
110980882|NCT02500849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110980883|NCT02500849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110980884|NCT02500849|Immunologic Factors|immunologic factors|mesh-ancestor
110980885|NCT02500849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110980886|NCT02500849|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110980887|NCT02500849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110980888|NCT02500849|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110980889|NCT03209102|Hydrocortisone|hydrocortisone|mesh-list
110980890|NCT03209102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110980891|NCT02280447|Vaccines|vaccines|mesh-list
110980892|NCT02280447|Immunologic Factors|immunologic factors|mesh-ancestor
110980893|NCT02280447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110980894|NCT00528333|Cytarabine|cytarabine|mesh-list
110980895|NCT00528333|Lintuzumab|lintuzumab|mesh-list
110980896|NCT00528333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110980897|NCT00528333|Antimetabolites|antimetabolites|mesh-ancestor
110980898|NCT00528333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110980899|NCT00528333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110980900|NCT00528333|Antiviral Agents|antiviral agents|mesh-ancestor
110980901|NCT00528333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110980902|NCT00528333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110980903|NCT00528333|Immunologic Factors|immunologic factors|mesh-ancestor
110980904|NCT00528333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110980905|NCT00528333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110980906|NCT00526227|Clotrimazole|clotrimazole|mesh-list
110980907|NCT00526227|Miconazole|miconazole|mesh-list
110980908|NCT00526227|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110980909|NCT00526227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110980910|NCT00526227|Antifungal Agents|antifungal agents|mesh-ancestor
110980911|NCT00526227|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110980912|NCT00526227|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110980913|NCT00526227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110450600|NCT01052844|Anticonvulsants|anticonvulsants|mesh-ancestor
110980914|NCT00526227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110980915|NCT00526227|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110980916|NCT00526227|Hormone Antagonists|hormone antagonists|mesh-ancestor
110980917|NCT00526227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110980918|NCT00526227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110980919|NCT00526227|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110980920|NCT00526227|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110980921|NCT02280603|Minoxidil|minoxidil|mesh-list
110980922|NCT02280603|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110980923|NCT02280603|Vasodilator Agents|vasodilator agents|mesh-ancestor
110980924|NCT00524277|Molgramostim|molgramostim|mesh-list
110980925|NCT00524277|Vaccines|vaccines|mesh-list
110980926|NCT00524277|Sargramostim|sargramostim|mesh-list
110980927|NCT00524277|Immunologic Factors|immunologic factors|mesh-ancestor
110980928|NCT00524277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110980929|NCT00524277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110980930|NCT02284503|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110980931|NCT02284503|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110980932|NCT02284503|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110980933|NCT02284503|Antimetabolites|antimetabolites|mesh-ancestor
110980934|NCT02284503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110980935|NCT02284503|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110980936|NCT02284503|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110980937|NCT02284503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110980938|NCT00650949|Carboplatin|carboplatin|mesh-list
110980939|NCT00650949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110980940|NCT00520923|Olanzapine|olanzapine|mesh-list
110980941|NCT00520923|Antiemetics|antiemetics|mesh-ancestor
110980942|NCT00520923|Autonomic Agents|autonomic agents|mesh-ancestor
110024425|NCT00004734|Vitamin B 12|vitamin b 12|mesh-list
110980943|NCT00520923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110980944|NCT00520923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110980945|NCT00520923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110980946|NCT00520923|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110980947|NCT00520923|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110980948|NCT00520923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110980949|NCT00520923|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110980950|NCT00520923|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110980951|NCT00520923|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110980952|NCT00520923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110980953|NCT00520923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110980954|NCT00520923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110980955|NCT00520923|Serotonin Agents|serotonin agents|mesh-ancestor
110980956|NCT02283177|Cytarabine|cytarabine|mesh-list
110980957|NCT02283177|Daunorubicin|daunorubicin|mesh-list
110980958|NCT02283177|Idarubicin|idarubicin|mesh-list
110980959|NCT02283177|Crenolanib|crenolanib|mesh-list
110980960|NCT02283177|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110980961|NCT02283177|Antimetabolites|antimetabolites|mesh-ancestor
110980962|NCT02283177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110980963|NCT02283177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110980964|NCT02283177|Antiviral Agents|antiviral agents|mesh-ancestor
110980965|NCT02283177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110450609|NCT01052844|Antimanic Agents|antimanic agents|mesh-ancestor
110980966|NCT02283177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110980967|NCT02283177|Immunologic Factors|immunologic factors|mesh-ancestor
110980968|NCT02283177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110980969|NCT02283177|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110980970|NCT02283177|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110980971|NCT02283177|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110980972|NCT02283177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110980973|NCT00514371|Bortezomib|bortezomib|mesh-list
110980974|NCT00514371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110980975|NCT02547766|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
110980976|NCT02547766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110980977|NCT04470531|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
110980978|NCT04470531|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110980979|NCT04470531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110980980|NCT04470531|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110980981|NCT04470531|Antimalarials|antimalarials|mesh-ancestor
110980982|NCT04470531|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110980983|NCT04470531|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110980985|NCT02286453|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110980986|NCT02286453|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110980987|NCT02286453|Analgesics|analgesics|mesh-ancestor
110980988|NCT02286453|Sensory System Agents|sensory system agents|mesh-ancestor
110980989|NCT02286453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110980990|NCT02286453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110980991|NCT02286453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110980992|NCT02286453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110980993|NCT02286453|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110980994|NCT02286453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110980995|NCT02286453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110980996|NCT00385515|Meclocycline|meclocycline|mesh-list
110980997|NCT00385515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110980998|NCT00385515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110980999|NCT02286609|Deflazacort|deflazacort|mesh-list
110981000|NCT02286609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110981001|NCT02286609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110981002|NCT02286609|Immunologic Factors|immunologic factors|mesh-ancestor
110981003|NCT02286609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110981005|NCT00508989|Acetylcholine|acetylcholine|mesh-list
110981006|NCT00508989|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110981007|NCT00508989|Antimetabolites|antimetabolites|mesh-ancestor
110981008|NCT00508989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110981009|NCT00508989|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110981010|NCT00508989|Vasodilator Agents|vasodilator agents|mesh-ancestor
110981011|NCT00508989|Vitamin B Complex|vitamin b complex|mesh-ancestor
110981012|NCT00508989|Vitamins|vitamins|mesh-ancestor
110981013|NCT00508989|Micronutrients|micronutrients|mesh-ancestor
110981014|NCT00508989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110981015|NCT00508989|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110981016|NCT00508989|Cholinergic Agents|cholinergic agents|mesh-ancestor
110981017|NCT00508989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110446214|NCT02767102|Melatonin|melatonin|mesh-list
110981018|NCT03104842|Dexamethasone|dexamethasone|mesh-list
110981019|NCT03104842|Lenalidomide|lenalidomide|mesh-list
110981020|NCT03104842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110981021|NCT03104842|Antiemetics|antiemetics|mesh-ancestor
110981022|NCT03104842|Autonomic Agents|autonomic agents|mesh-ancestor
110981023|NCT03104842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110981024|NCT03104842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110981025|NCT03104842|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110981026|NCT03104842|Glucocorticoids|glucocorticoids|mesh-ancestor
110981027|NCT03104842|Hormones|hormones|mesh-ancestor
110981028|NCT03104842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110981029|NCT03104842|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110981030|NCT03104842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110981031|NCT03104842|Immunologic Factors|immunologic factors|mesh-ancestor
110981032|NCT03104842|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110450630|NCT02704546|Methylphenidate|methylphenidate|mesh-list
110981033|NCT03104842|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110981034|NCT03104842|Growth Substances|growth substances|mesh-ancestor
110981035|NCT03104842|Growth Inhibitors|growth inhibitors|mesh-ancestor
110981036|NCT00436683|Sevelamer|sevelamer|mesh-list
110981037|NCT00436683|Chelating Agents|chelating agents|mesh-ancestor
110981038|NCT00436683|Sequestering Agents|sequestering agents|mesh-ancestor
110981039|NCT00436683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110981040|NCT00434811|Sirolimus|sirolimus|mesh-list
110981041|NCT00434811|Etanercept|etanercept|mesh-list
110981042|NCT00434811|Tacrolimus|tacrolimus|mesh-list
110981043|NCT00434811|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110981044|NCT00434811|Basiliximab|basiliximab|mesh-list
110981045|NCT00434811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110981046|NCT00434811|Immunologic Factors|immunologic factors|mesh-ancestor
110981047|NCT00434811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110981048|NCT00434811|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110981049|NCT00434811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110981050|NCT00434811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110981051|NCT00434811|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110981052|NCT00434811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110981053|NCT00434811|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110981054|NCT00434811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110981055|NCT00434811|Antifungal Agents|antifungal agents|mesh-ancestor
110981056|NCT00434811|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110981057|NCT00434811|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110981058|NCT00434811|Analgesics|analgesics|mesh-ancestor
110981059|NCT00434811|Sensory System Agents|sensory system agents|mesh-ancestor
110981060|NCT00434811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110981061|NCT00434811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110981062|NCT00434811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110981063|NCT00434811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110981064|NCT03133845|Fentanyl|fentanyl|mesh-list
110981065|NCT03133845|Midazolam|midazolam|mesh-list
110981066|NCT03133845|Morphine|morphine|mesh-list
110981067|NCT03133845|Anesthetics|anesthetics|mesh-list
110981068|NCT03133845|Propofol|propofol|mesh-list
110981069|NCT03133845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110981070|NCT03133845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110981071|NCT03133845|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110981072|NCT03133845|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110981073|NCT03133845|Anesthetics, General|anesthetics, general|mesh-ancestor
110981074|NCT03133845|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110981075|NCT03133845|Narcotics|narcotics|mesh-ancestor
110981076|NCT03133845|Analgesics|analgesics|mesh-ancestor
110981077|NCT03133845|Sensory System Agents|sensory system agents|mesh-ancestor
110981078|NCT03133845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110981079|NCT03133845|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110981080|NCT03133845|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110981081|NCT03133845|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110981082|NCT03133845|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110981083|NCT03133845|GABA Modulators|gaba modulators|mesh-ancestor
110981084|NCT03133845|GABA Agents|gaba agents|mesh-ancestor
110981085|NCT03133845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110981086|NCT03133845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110981087|NCT00120393|Ritonavir|ritonavir|mesh-list
110981088|NCT00120393|Atazanavir Sulfate|atazanavir sulfate|mesh-list
110981089|NCT00120393|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110981090|NCT00120393|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110981091|NCT00120393|Protease Inhibitors|protease inhibitors|mesh-ancestor
110981092|NCT00120393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110981093|NCT00120393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110981094|NCT00120393|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110981095|NCT00120393|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110981096|NCT00120393|Antiviral Agents|antiviral agents|mesh-ancestor
110981097|NCT00120393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110981098|NCT00120393|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110981099|NCT00120393|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110981101|NCT05726019|Gout Suppressants|gout suppressants|mesh-ancestor
110981102|NCT05726019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110981103|NCT05726019|Tubulin Modulators|tubulin modulators|mesh-ancestor
110981104|NCT05726019|Antimitotic Agents|antimitotic agents|mesh-ancestor
110981105|NCT05726019|Mitosis Modulators|mitosis modulators|mesh-ancestor
110981106|NCT05726019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110981107|NCT05726019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110981108|NCT00116415|Lamivudine|lamivudine|mesh-list
110981109|NCT00116415|Efavirenz|efavirenz|mesh-list
110981110|NCT00116415|Didanosine|didanosine|mesh-list
110981111|NCT00116415|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110981112|NCT00116415|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110981113|NCT00116415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110981114|NCT00116415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110981115|NCT00116415|Antiviral Agents|antiviral agents|mesh-ancestor
110981116|NCT00116415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110981117|NCT00116415|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110981118|NCT00116415|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110981119|NCT00116415|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110981120|NCT00116415|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110981121|NCT00116415|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110981122|NCT00116415|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110981123|NCT00116415|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110981124|NCT00116415|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110981125|NCT00116415|Antimetabolites|antimetabolites|mesh-ancestor
110981126|NCT03207698|Metformin|metformin|mesh-list
110981127|NCT03207698|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110981128|NCT03207698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110981129|NCT03208712|Atezolizumab|atezolizumab|mesh-list
110698220|NCT01045980|Vitamin D|vitamin d|mesh-list
110981130|NCT03208712|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110981131|NCT03208712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110981132|NCT03208712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110981133|NCT03208712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110981134|NCT03201380|Choline|choline|mesh-list
110981135|NCT03201380|Lipotropic Agents|lipotropic agents|mesh-ancestor
110981136|NCT03201380|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110981137|NCT03201380|Antimetabolites|antimetabolites|mesh-ancestor
110981138|NCT03201380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110981139|NCT03201380|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110981140|NCT03201380|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110981141|NCT03201380|Nootropic Agents|nootropic agents|mesh-ancestor
110981142|NCT03208556|Cyclophosphamide|cyclophosphamide|mesh-list
110981143|NCT03208556|Fludarabine|fludarabine|mesh-list
110981144|NCT03208556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110981145|NCT03208556|Immunologic Factors|immunologic factors|mesh-ancestor
110981146|NCT03208556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110981147|NCT03208556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110981148|NCT03208556|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110981149|NCT03208556|Alkylating Agents|alkylating agents|mesh-ancestor
110981150|NCT03208556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110981151|NCT03208556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110981152|NCT03208556|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110981153|NCT00429429|Immunomodulating Agents|immunomodulating agents|mesh-list
110981154|NCT00429429|Immunologic Factors|immunologic factors|mesh-ancestor
110981155|NCT00429429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110981156|NCT03201146|Cisplatin|cisplatin|mesh-list
110981157|NCT03201146|Carboplatin|carboplatin|mesh-list
110981158|NCT03201146|Pemetrexed|pemetrexed|mesh-list
110981159|NCT03201146|Apatinib|apatinib|mesh-list
110981160|NCT03201146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110981161|NCT03201146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110981162|NCT03201146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110981163|NCT03201146|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110981164|NCT03201146|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110981165|NCT03201146|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110981166|NCT00370383|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110981167|NCT00370383|Satraplatin|satraplatin|mesh-list
110981168|NCT00370383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110981170|NCT00370383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110981171|NCT00370383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110981172|NCT00367887|Ribavirin|ribavirin|mesh-list
110981173|NCT00367887|Interferon alpha-2|interferon alpha-2|mesh-list
110981174|NCT00367887|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110981175|NCT00367887|Interferon-alpha|interferon-alpha|mesh-list
110981176|NCT00367887|Antimetabolites|antimetabolites|mesh-ancestor
110981177|NCT00367887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110981178|NCT00367887|Antiviral Agents|antiviral agents|mesh-ancestor
110981179|NCT00367887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110981180|NCT00367887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110981181|NCT00367887|Immunologic Factors|immunologic factors|mesh-ancestor
110981182|NCT00367887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110981183|NCT02547220|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
110981184|NCT02547220|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
110981185|NCT02547220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110981186|NCT02547220|Immunologic Factors|immunologic factors|mesh-ancestor
110981187|NCT02547220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110981188|NCT03207308|Vitamin A|vitamin a|mesh-list
110981189|NCT03207308|Vitamins|vitamins|mesh-ancestor
110981190|NCT03207308|Micronutrients|micronutrients|mesh-ancestor
110981191|NCT03207308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110981192|NCT00366795|Satavaptan|satavaptan|mesh-list
110981193|NCT00366795|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
110981194|NCT00366795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110981195|NCT00366795|Natriuretic Agents|natriuretic agents|mesh-ancestor
110981196|NCT00366795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110981197|NCT00422019|Rilotumumab|rilotumumab|mesh-list
110981198|NCT00422019|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110981199|NCT00422019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110981200|NCT00422019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110981201|NCT00422019|Immunologic Factors|immunologic factors|mesh-ancestor
110698293|NCT00387348|Serotonin Agents|serotonin agents|mesh-ancestor
110981202|NCT00422019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110981203|NCT03207542|Daratumumab|daratumumab|mesh-list
110981204|NCT03207542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110981205|NCT00360867|Motesanib diphosphate|motesanib diphosphate|mesh-list
110981206|NCT00360867|Imetelstat|imetelstat|mesh-list
110981207|NCT00360867|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110981208|NCT00360867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110981209|NCT00360867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110981210|NCT02287389|Mitomycins|mitomycins|mesh-list
110981211|NCT02287389|Mitomycin|mitomycin|mesh-list
110981212|NCT02287389|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110981213|NCT02287389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110981214|NCT02287389|Alkylating Agents|alkylating agents|mesh-ancestor
110981215|NCT02287389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110981216|NCT02287389|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110981217|NCT02287389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110981218|NCT00057993|Trastuzumab|trastuzumab|mesh-list
110981219|NCT00057993|Exemestane|exemestane|mesh-list
110981220|NCT00057993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110981221|NCT00057993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110981222|NCT00057993|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110981223|NCT00057993|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110981224|NCT00057993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110981225|NCT00057993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110981226|NCT00057993|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110981227|NCT00057993|Hormone Antagonists|hormone antagonists|mesh-ancestor
110981228|NCT00057993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110981229|NCT00057993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110981230|NCT02284737|Sildenafil Citrate|sildenafil citrate|mesh-list
110981231|NCT02284737|Vasodilator Agents|vasodilator agents|mesh-ancestor
110981232|NCT02284737|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110981233|NCT02284737|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110981234|NCT02284737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110981235|NCT02284737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110981236|NCT02284737|Urological Agents|urological agents|mesh-ancestor
110981237|NCT02448290|Docetaxel|docetaxel|mesh-list
110981238|NCT02448290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110981239|NCT02448290|Tubulin Modulators|tubulin modulators|mesh-ancestor
110981240|NCT02448290|Antimitotic Agents|antimitotic agents|mesh-ancestor
110981241|NCT02448290|Mitosis Modulators|mitosis modulators|mesh-ancestor
110981242|NCT02448290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110981243|NCT00357279|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110981244|NCT04484558|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
110981245|NCT04484558|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110981246|NCT04484558|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110981247|NCT04484558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110981248|NCT00055575|Scopolamine|scopolamine|mesh-list
110981249|NCT00055575|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
110981250|NCT00055575|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110981251|NCT00055575|Antiemetics|antiemetics|mesh-ancestor
110981252|NCT00055575|Autonomic Agents|autonomic agents|mesh-ancestor
110981253|NCT00055575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110981254|NCT00055575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110981255|NCT00055575|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110981256|NCT00055575|Mydriatics|mydriatics|mesh-ancestor
110981257|NCT00055575|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110981258|NCT00055575|Cholinergic Agents|cholinergic agents|mesh-ancestor
110981259|NCT00055575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110981260|NCT00055575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110981261|NCT00055575|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110981262|NCT00055575|Parasympatholytics|parasympatholytics|mesh-ancestor
110981263|NCT00051129|Hydrocortisone|hydrocortisone|mesh-list
110981264|NCT00051129|Anecortave|anecortave|mesh-list
110981265|NCT00051129|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110981266|NCT00051129|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110981267|NCT00051129|Growth Substances|growth substances|mesh-ancestor
110981268|NCT00051129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110981269|NCT00051129|Growth Inhibitors|growth inhibitors|mesh-ancestor
110981270|NCT00051129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110981271|NCT00051129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110981272|NCT03200600|Dexamethasone|dexamethasone|mesh-list
110981273|NCT03200600|Dexamethasone acetate|dexamethasone acetate|mesh-list
110981274|NCT03200600|Flurbiprofen|flurbiprofen|mesh-list
110981275|NCT03200600|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
110981276|NCT03200600|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
110981277|NCT03200600|BB 1101|bb 1101|mesh-list
110981278|NCT03200600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110981279|NCT03200600|Antiemetics|antiemetics|mesh-ancestor
110698387|NCT00429416|Mesna|mesna|mesh-list
110981280|NCT03200600|Autonomic Agents|autonomic agents|mesh-ancestor
110981281|NCT03200600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110981282|NCT03200600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110981283|NCT03200600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110981284|NCT03200600|Glucocorticoids|glucocorticoids|mesh-ancestor
110981285|NCT03200600|Hormones|hormones|mesh-ancestor
110981286|NCT03200600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110981287|NCT03200600|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110981288|NCT03200600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110981289|NCT03200600|Protease Inhibitors|protease inhibitors|mesh-ancestor
110981290|NCT03200600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110981291|NCT03200600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110981292|NCT03200600|Analgesics|analgesics|mesh-ancestor
110981293|NCT03200600|Sensory System Agents|sensory system agents|mesh-ancestor
110981294|NCT03200600|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110981295|NCT03200600|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110981296|NCT03200600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110981297|NCT03200600|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110981298|NCT02547454|Epoetin Alfa|epoetin alfa|mesh-list
110981299|NCT02547454|Hematinics|hematinics|mesh-ancestor
110981300|NCT00049959|Verteporfin|verteporfin|mesh-list
110981301|NCT00049959|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110981302|NCT00049959|Dermatologic Agents|dermatologic agents|mesh-ancestor
110981303|NCT03119324|Nimesulide|nimesulide|mesh-list
110981304|NCT03119324|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110981305|NCT03119324|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110450657|NCT00927069|Adalimumab|adalimumab|mesh-list
110981306|NCT03119324|Analgesics|analgesics|mesh-ancestor
110981307|NCT03119324|Sensory System Agents|sensory system agents|mesh-ancestor
110981308|NCT03119324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110981309|NCT03119324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110981310|NCT03119324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110981311|NCT03119324|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110981312|NCT03119324|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110981313|NCT03119324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110981314|NCT03119324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110981315|NCT00415623|Amlodipine|amlodipine|mesh-list
110981316|NCT00415623|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110981317|NCT00415623|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110981318|NCT00415623|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110981319|NCT00415623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110981320|NCT00415623|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110981321|NCT00415623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110981322|NCT00415623|Vasodilator Agents|vasodilator agents|mesh-ancestor
110981323|NCT03133923|Vaccines|vaccines|mesh-list
110981324|NCT03133923|Immunologic Factors|immunologic factors|mesh-ancestor
110981325|NCT03133923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110981326|NCT03134001|Analgesics|analgesics|mesh-list
110981327|NCT03134001|Sensory System Agents|sensory system agents|mesh-ancestor
110981328|NCT03134001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110981329|NCT03134001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110981330|NCT01969409|Rituximab|rituximab|mesh-list
110981331|NCT01969409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110981332|NCT01969409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110981333|NCT01969409|Immunologic Factors|immunologic factors|mesh-ancestor
110981334|NCT01969409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110981335|NCT01969409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110981336|NCT05218577|Selenium|selenium|mesh-list
110981337|NCT05218577|Antioxidants|antioxidants|mesh-ancestor
110981338|NCT05218577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110981339|NCT05218577|Protective Agents|protective agents|mesh-ancestor
110981340|NCT05218577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110981341|NCT05218577|Trace Elements|trace elements|mesh-ancestor
110981342|NCT05218577|Micronutrients|micronutrients|mesh-ancestor
110981343|NCT00150813|Levetiracetam|levetiracetam|mesh-list
110981344|NCT00150813|Anticonvulsants|anticonvulsants|mesh-ancestor
110981345|NCT00150813|Nootropic Agents|nootropic agents|mesh-ancestor
110981346|NCT02712788|Milrinone|milrinone|mesh-list
110981347|NCT02712788|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110981348|NCT02712788|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110981349|NCT02712788|Vasodilator Agents|vasodilator agents|mesh-ancestor
110981350|NCT02712788|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110981351|NCT02712788|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110698436|NCT00301821|Rituximab|rituximab|mesh-list
110981352|NCT02712788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110981353|NCT02712788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110981355|NCT02712788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110981356|NCT00035529|Abatacept|abatacept|mesh-list
110981357|NCT00035529|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110981358|NCT00035529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110981359|NCT00035529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110981360|NCT00035529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110981361|NCT00035529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110981362|NCT00035529|Immunologic Factors|immunologic factors|mesh-ancestor
110981363|NCT00035529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110981364|NCT00035529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110981365|NCT04470609|Vaccines|vaccines|mesh-list
110981366|NCT04470609|Immunologic Factors|immunologic factors|mesh-ancestor
110981367|NCT04470609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110981368|NCT00356109|Insulin|insulin|mesh-list
110981369|NCT00356109|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110981370|NCT00356109|Insulin Glargine|insulin glargine|mesh-list
110981371|NCT00356109|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110981372|NCT00356109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110981373|NCT03206138|Imiquimod|imiquimod|mesh-list
110981374|NCT03206138|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110981375|NCT03206138|Immunologic Factors|immunologic factors|mesh-ancestor
110981376|NCT03206138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110981377|NCT03206138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110981378|NCT03206138|Interferon Inducers|interferon inducers|mesh-ancestor
110981379|NCT00006225|Flt3 ligand protein|flt3 ligand protein|mesh-list
110981380|NCT00006225|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110981381|NCT00006225|Immunologic Factors|immunologic factors|mesh-ancestor
110981382|NCT00006225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110981383|NCT00006225|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110981384|NCT00006225|Protective Agents|protective agents|mesh-ancestor
110981385|NCT00005595|Arsenic Trioxide|arsenic trioxide|mesh-list
110981386|NCT00005595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110981387|NCT02447822|Thymoglobulin|thymoglobulin|mesh-list
110981388|NCT02447822|Immunologic Factors|immunologic factors|mesh-ancestor
110981389|NCT02447822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110981390|NCT02447822|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110981391|NCT04477265|Solifenacin Succinate|solifenacin succinate|mesh-list
110981392|NCT04477265|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110981393|NCT04477265|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110981394|NCT04477265|Cholinergic Agents|cholinergic agents|mesh-ancestor
110981395|NCT04477265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110981396|NCT04477265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110981397|NCT04477265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110981398|NCT04477265|Urological Agents|urological agents|mesh-ancestor
110981399|NCT00353457|Capecitabine|capecitabine|mesh-list
110981400|NCT00353457|Oxaliplatin|oxaliplatin|mesh-list
110981401|NCT00353457|Cetuximab|cetuximab|mesh-list
110981402|NCT00353457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110981403|NCT00353457|Antimetabolites|antimetabolites|mesh-ancestor
110981404|NCT00353457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110981405|NCT00353457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110981406|NCT00353457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110981407|NCT00411099|Agomelatine|agomelatine|mesh-list
110981408|NCT00411099|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110981409|NCT00411099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110981410|NCT00411099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110981411|NCT03195530|Propofol|propofol|mesh-list
110981412|NCT03195530|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110981413|NCT03195530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110981414|NCT03195530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110981415|NCT03195530|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110981416|NCT03195530|Anesthetics, General|anesthetics, general|mesh-ancestor
110981417|NCT03195530|Anesthetics|anesthetics|mesh-ancestor
110981418|NCT03195452|Raltegravir Potassium|raltegravir potassium|mesh-list
110981419|NCT03195452|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
110981420|NCT03195452|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110981421|NCT03195452|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110981422|NCT03195452|Antiviral Agents|antiviral agents|mesh-ancestor
110981423|NCT03195452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110981424|NCT03195452|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110981425|NCT03195452|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110981426|NCT03195452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110698507|NCT00428792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110981427|NCT03195452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110981428|NCT03195452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110981430|NCT00406809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110981431|NCT03200210|Febuxostat|febuxostat|mesh-list
110981432|NCT03200210|Gout Suppressants|gout suppressants|mesh-ancestor
110981433|NCT03200210|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110981434|NCT00004899|Etoposide|etoposide|mesh-list
110981435|NCT00004899|Busulfan|busulfan|mesh-list
110981436|NCT00004899|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110981437|NCT00004899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110981438|NCT00004899|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110981439|NCT00004899|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110981440|NCT00004899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110981441|NCT00004899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110981442|NCT00004899|Immunologic Factors|immunologic factors|mesh-ancestor
110981443|NCT00004899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110981444|NCT00004899|Alkylating Agents|alkylating agents|mesh-ancestor
110981445|NCT00004899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110981446|NCT00004899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110981447|NCT00004899|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110981448|NCT03199976|Fluticasone|fluticasone|mesh-list
110981449|NCT03199976|Xhance|xhance|mesh-list
110981450|NCT03199976|Bromides|bromides|mesh-list
110981451|NCT03199976|Albuterol|albuterol|mesh-list
110981452|NCT03199976|Tiotropium Bromide|tiotropium bromide|mesh-list
110981453|NCT03199976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110981454|NCT03199976|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110981455|NCT03199976|Autonomic Agents|autonomic agents|mesh-ancestor
110981456|NCT03199976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110981457|NCT03199976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110981458|NCT03199976|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110981459|NCT03199976|Respiratory System Agents|respiratory system agents|mesh-ancestor
110981460|NCT03199976|Dermatologic Agents|dermatologic agents|mesh-ancestor
110981461|NCT03199976|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110981462|NCT03199976|Parasympatholytics|parasympatholytics|mesh-ancestor
110981463|NCT03199976|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110981464|NCT03199976|Cholinergic Agents|cholinergic agents|mesh-ancestor
110981465|NCT03199976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110822979|NCT00943618|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110981466|NCT03199976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110981468|NCT03199976|Tocolytic Agents|tocolytic agents|mesh-ancestor
110981469|NCT03199976|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110981470|NCT03199976|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110981471|NCT03199976|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110981472|NCT03199976|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110981473|NCT03199976|Adrenergic Agents|adrenergic agents|mesh-ancestor
110981474|NCT00369317|Cytarabine|cytarabine|mesh-list
110981475|NCT00369317|Etoposide|etoposide|mesh-list
110981476|NCT00369317|Daunorubicin|daunorubicin|mesh-list
110981477|NCT00369317|Etoposide phosphate|etoposide phosphate|mesh-list
110981478|NCT00369317|Asparaginase|asparaginase|mesh-list
110981479|NCT00369317|Thioguanine|thioguanine|mesh-list
110981480|NCT00369317|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110981481|NCT00369317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110981482|NCT00369317|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110981483|NCT00369317|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110981484|NCT00369317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110981485|NCT00369317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110981486|NCT00369317|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110981487|NCT00369317|Antimetabolites|antimetabolites|mesh-ancestor
110981488|NCT00369317|Antiviral Agents|antiviral agents|mesh-ancestor
110981489|NCT00369317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110981490|NCT00369317|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110981491|NCT00369317|Immunologic Factors|immunologic factors|mesh-ancestor
110981492|NCT00369317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110981493|NCT00369317|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110981494|NCT02447666|Azacitidine|azacitidine|mesh-list
110981495|NCT02447666|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110981496|NCT02447666|Antimetabolites|antimetabolites|mesh-ancestor
110981497|NCT02447666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110981498|NCT02447666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110981499|NCT02447666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110981500|NCT04469829|Methotrexate|methotrexate|mesh-list
110698583|NCT00386022|Estrogens|estrogens|mesh-list
110981501|NCT04469829|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110981502|NCT04469829|Abortifacient Agents|abortifacient agents|mesh-ancestor
110981503|NCT04469829|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110981504|NCT04469829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110981505|NCT04469829|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110981506|NCT04469829|Antimetabolites|antimetabolites|mesh-ancestor
110981507|NCT04469829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110981508|NCT04469829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110981509|NCT04469829|Dermatologic Agents|dermatologic agents|mesh-ancestor
110981510|NCT04469829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110981511|NCT04469829|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110981512|NCT04469829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110981513|NCT04469829|Immunologic Factors|immunologic factors|mesh-ancestor
110981514|NCT04469829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110981515|NCT04469829|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110981517|NCT00405951|Obatoclax|obatoclax|mesh-list
110981518|NCT00405951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110981519|NCT00405951|Tubulin Modulators|tubulin modulators|mesh-ancestor
110981520|NCT00405951|Antimitotic Agents|antimitotic agents|mesh-ancestor
110981521|NCT00405951|Mitosis Modulators|mitosis modulators|mesh-ancestor
110981522|NCT00405951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110981523|NCT00405951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110981524|NCT03194984|Hydrogen Peroxide|hydrogen peroxide|mesh-list
110981525|NCT03194984|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110981526|NCT03194984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110981527|NCT03669757|Betamethasone|betamethasone|mesh-list
110981528|NCT03669757|Betamethasone Valerate|betamethasone valerate|mesh-list
110981529|NCT03669757|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
110981530|NCT03669757|Betamethasone benzoate|betamethasone benzoate|mesh-list
110981531|NCT03669757|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
110981532|NCT03669757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110981533|NCT03669757|Glucocorticoids|glucocorticoids|mesh-ancestor
110981534|NCT03669757|Hormones|hormones|mesh-ancestor
110981535|NCT03669757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110981536|NCT03669757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110981537|NCT03669757|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110981538|NCT03669757|Respiratory System Agents|respiratory system agents|mesh-ancestor
110981539|NCT02303821|Cytarabine|cytarabine|mesh-list
110981540|NCT02303821|Dexamethasone|dexamethasone|mesh-list
110981542|NCT02303821|Cyclophosphamide|cyclophosphamide|mesh-list
110981543|NCT02303821|Methotrexate|methotrexate|mesh-list
110981544|NCT02303821|Vincristine|vincristine|mesh-list
110981545|NCT02303821|Daunorubicin|daunorubicin|mesh-list
110981546|NCT02303821|Asparaginase|asparaginase|mesh-list
110981547|NCT02303821|Mitoxantrone|mitoxantrone|mesh-list
110981548|NCT02303821|Mercaptopurine|mercaptopurine|mesh-list
110981549|NCT02303821|Pegaspargase|pegaspargase|mesh-list
110981550|NCT02303821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110981551|NCT02303821|Immunologic Factors|immunologic factors|mesh-ancestor
110981552|NCT02303821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110981553|NCT02303821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110981554|NCT02303821|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110981555|NCT02303821|Alkylating Agents|alkylating agents|mesh-ancestor
110981556|NCT02303821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110981557|NCT02303821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110981558|NCT02303821|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110981559|NCT02303821|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110981560|NCT02303821|Antiemetics|antiemetics|mesh-ancestor
110981561|NCT02303821|Autonomic Agents|autonomic agents|mesh-ancestor
110981562|NCT02303821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110981563|NCT02303821|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110981564|NCT02303821|Glucocorticoids|glucocorticoids|mesh-ancestor
110981565|NCT02303821|Hormones|hormones|mesh-ancestor
110981566|NCT02303821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110981567|NCT02303821|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110981568|NCT02303821|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110981569|NCT02303821|Abortifacient Agents|abortifacient agents|mesh-ancestor
110981570|NCT02303821|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110981571|NCT02303821|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110981572|NCT02303821|Antimetabolites|antimetabolites|mesh-ancestor
110981573|NCT02303821|Dermatologic Agents|dermatologic agents|mesh-ancestor
110981574|NCT02303821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110981575|NCT02303821|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110981576|NCT02303821|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110981577|NCT02303821|Antiviral Agents|antiviral agents|mesh-ancestor
110450693|NCT04263519|Tacrolimus|tacrolimus|mesh-list
110981578|NCT02303821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110981579|NCT02303821|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110981580|NCT02303821|Tubulin Modulators|tubulin modulators|mesh-ancestor
110981581|NCT02303821|Antimitotic Agents|antimitotic agents|mesh-ancestor
110981582|NCT02303821|Mitosis Modulators|mitosis modulators|mesh-ancestor
110981583|NCT02303821|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110981584|NCT02303821|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110981585|NCT02303821|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110981586|NCT02303821|Analgesics|analgesics|mesh-ancestor
110981587|NCT02303821|Sensory System Agents|sensory system agents|mesh-ancestor
110981588|NCT03913091|Bupivacaine|bupivacaine|mesh-list
110981589|NCT03913091|Anesthetics, Local|anesthetics, local|mesh-ancestor
110981590|NCT03913091|Anesthetics|anesthetics|mesh-ancestor
110981591|NCT03913091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110981592|NCT03913091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110981593|NCT03913091|Sensory System Agents|sensory system agents|mesh-ancestor
110981594|NCT03913091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110981595|NCT00330369|Darusentan|darusentan|mesh-list
110981596|NCT00330369|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
110981597|NCT00330369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110981598|NCT03199664|Tacrolimus|tacrolimus|mesh-list
110981599|NCT03199664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110981600|NCT03199664|Immunologic Factors|immunologic factors|mesh-ancestor
110981601|NCT03199664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110981602|NCT03199664|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110981603|NCT03199664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110981604|NCT03199664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110981605|NCT02447510|Mitogens|mitogens|mesh-list
110981606|NCT02447510|Mitosis Modulators|mitosis modulators|mesh-ancestor
110981607|NCT02447510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110981608|NCT05674643|Acetaminophen|acetaminophen|mesh-list
110981609|NCT05674643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110981610|NCT05674643|Analgesics|analgesics|mesh-ancestor
110981611|NCT05674643|Sensory System Agents|sensory system agents|mesh-ancestor
110981612|NCT05674643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110981613|NCT05674643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110981614|NCT05674643|Antipyretics|antipyretics|mesh-ancestor
110981615|NCT02149537|Hydroxyurea|hydroxyurea|mesh-list
110981616|NCT02149537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110981617|NCT02149537|Antisickling Agents|antisickling agents|mesh-ancestor
110981618|NCT02149537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110981619|NCT02149537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110981620|NCT02149537|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110981621|NCT03179917|Pembrolizumab|pembrolizumab|mesh-list
110981622|NCT03179917|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110981623|NCT03179917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110981624|NCT03179917|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110981625|NCT03179917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110981626|NCT05216237|Oxaliplatin|oxaliplatin|mesh-list
110981627|NCT05216237|Apatinib|apatinib|mesh-list
110981628|NCT05216237|Tegafur|tegafur|mesh-list
110981629|NCT05216237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110981630|NCT05216237|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110981631|NCT05216237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110981632|NCT05216237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110981633|NCT05216237|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110981634|NCT05216237|Antimetabolites|antimetabolites|mesh-ancestor
110981635|NCT00322257|Insulin|insulin|mesh-list
110981636|NCT00322257|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110981637|NCT00322257|Insulin Aspart|insulin aspart|mesh-list
110981638|NCT00322257|Insulin Detemir|insulin detemir|mesh-list
110981639|NCT00322257|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110981640|NCT00322257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110981641|NCT00312975|Tremelimumab|tremelimumab|mesh-list
110981642|NCT00312975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110981643|NCT03199820|Dinoprostone|dinoprostone|mesh-list
110981644|NCT03199820|Oxytocics|oxytocics|mesh-ancestor
110981645|NCT03199820|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110981646|NCT03199820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110981647|NCT03199430|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
110981648|NCT03199430|Antioxidants|antioxidants|mesh-ancestor
110981649|NCT03199430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110981650|NCT03199430|Protective Agents|protective agents|mesh-ancestor
110981651|NCT03199430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110981652|NCT03199430|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
110981653|NCT03199430|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110698728|NCT03742466|Glucocorticoids|glucocorticoids|mesh-ancestor
110981654|NCT03199430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110981655|NCT03199430|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110981656|NCT02287857|Tenofovir|tenofovir|mesh-list
110981657|NCT02287857|Antiviral Agents|antiviral agents|mesh-ancestor
110981658|NCT02287857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110981659|NCT02287857|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110981660|NCT02287857|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110981661|NCT02287857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110981662|NCT02287857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110981663|NCT02287857|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110981664|NCT02287857|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110981665|NCT01318499|Nepafenac|nepafenac|mesh-list
110981666|NCT01318499|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110981667|NCT01318499|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110981668|NCT01318499|Analgesics|analgesics|mesh-ancestor
110981669|NCT01318499|Sensory System Agents|sensory system agents|mesh-ancestor
110981670|NCT01318499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110981671|NCT01318499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110981672|NCT01318499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110981673|NCT01318499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110981674|NCT00397293|Topotecan|topotecan|mesh-list
110981675|NCT00397293|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110981676|NCT00397293|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110981677|NCT00397293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110981678|NCT00397293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110981679|NCT00397293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110981680|NCT03628079|Mebendazole|mebendazole|mesh-list
110981681|NCT03628079|Antinematodal Agents|antinematodal agents|mesh-ancestor
110981682|NCT03628079|Anthelmintics|anthelmintics|mesh-ancestor
110981683|NCT03628079|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110981684|NCT03628079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110981685|NCT03628079|Tubulin Modulators|tubulin modulators|mesh-ancestor
110981686|NCT03628079|Antimitotic Agents|antimitotic agents|mesh-ancestor
110981687|NCT03628079|Mitosis Modulators|mitosis modulators|mesh-ancestor
110981688|NCT03628079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110981689|NCT03628079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110981690|NCT03204734|Capecitabine|capecitabine|mesh-list
110981691|NCT03204734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110981693|NCT03204734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110981694|NCT03204734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110981695|NCT00396357|Metformin|metformin|mesh-list
110981696|NCT00396357|Vildagliptin|vildagliptin|mesh-list
110981697|NCT00396357|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110981698|NCT00396357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110981699|NCT00396357|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110981700|NCT00396357|Protease Inhibitors|protease inhibitors|mesh-ancestor
110981701|NCT00396357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110981702|NCT00396357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110981703|NCT00394563|Tanezumab|tanezumab|mesh-list
110981704|NCT00394563|Analgesics|analgesics|mesh-ancestor
110981705|NCT00394563|Sensory System Agents|sensory system agents|mesh-ancestor
110981706|NCT00394563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110981707|NCT00394563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110981708|NCT02449538|Everolimus|everolimus|mesh-list
110981709|NCT02449538|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110981710|NCT02449538|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110981711|NCT02449538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110981712|NCT02449538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110981713|NCT02449538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110981714|NCT02449538|Immunologic Factors|immunologic factors|mesh-ancestor
110981715|NCT02449538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110981716|NCT02449538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110981717|NCT02446652|Paclitaxel|paclitaxel|mesh-list
110981718|NCT02446652|Carboplatin|carboplatin|mesh-list
110981719|NCT02446652|Hydralazine|hydralazine|mesh-list
110981720|NCT02446652|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110981721|NCT02446652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110981722|NCT02446652|Tubulin Modulators|tubulin modulators|mesh-ancestor
110981723|NCT02446652|Antimitotic Agents|antimitotic agents|mesh-ancestor
110981724|NCT02446652|Mitosis Modulators|mitosis modulators|mesh-ancestor
110981725|NCT02446652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110981726|NCT02446652|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110981727|NCT02446652|Vasodilator Agents|vasodilator agents|mesh-ancestor
110981728|NCT00299715|Paliperidone Palmitate|paliperidone palmitate|mesh-list
110981729|NCT00299715|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110981730|NCT00299715|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110981731|NCT00299715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110981732|NCT00299715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110981733|NCT00299715|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110981734|NCT00299715|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110981735|NCT00299715|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110981736|NCT00299715|Serotonin Agents|serotonin agents|mesh-ancestor
110981737|NCT00299715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110981738|NCT00299715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110981739|NCT00299715|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110981740|NCT00299715|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110981741|NCT00299715|Dopamine Agents|dopamine agents|mesh-ancestor
110981743|NCT00299325|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110981744|NCT00299325|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
110981745|NCT00299325|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110981746|NCT00299325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110981747|NCT00299325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110981748|NCT00299325|Hormones|hormones|mesh-ancestor
110981749|NCT00299325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110981750|NCT00299325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110981751|NCT00391209|Insulin|insulin|mesh-list
110981752|NCT00391209|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110981753|NCT00391209|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110981754|NCT00391209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110981755|NCT02446574|Paclitaxel|paclitaxel|mesh-list
110981756|NCT02446574|Cisplatin|cisplatin|mesh-list
110981757|NCT02446574|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110981758|NCT02446574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110981759|NCT02446574|Tubulin Modulators|tubulin modulators|mesh-ancestor
110981760|NCT02446574|Antimitotic Agents|antimitotic agents|mesh-ancestor
110981761|NCT02446574|Mitosis Modulators|mitosis modulators|mesh-ancestor
110981762|NCT02446574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110981763|NCT01775813|Metformin|metformin|mesh-list
110981764|NCT01775813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110981765|NCT01775813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110981766|NCT00287547|Abatacept|abatacept|mesh-list
110981767|NCT00287547|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110450717|NCT00627250|Amantadine|amantadine|mesh-list
110981768|NCT00287547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110981769|NCT00287547|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110981770|NCT00287547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110981771|NCT00287547|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110981772|NCT00287547|Immunologic Factors|immunologic factors|mesh-ancestor
110981773|NCT00287547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110981774|NCT00287547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110981775|NCT03204578|Midazolam|midazolam|mesh-list
110981776|NCT03204578|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110981777|NCT03204578|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110981778|NCT03204578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110981779|NCT03204578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110981780|NCT03204578|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110981781|NCT03204578|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110981782|NCT03204578|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110981783|NCT03204578|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110981784|NCT03204578|Anesthetics, General|anesthetics, general|mesh-ancestor
110981785|NCT03204578|Anesthetics|anesthetics|mesh-ancestor
110981786|NCT03204578|GABA Modulators|gaba modulators|mesh-ancestor
110981787|NCT03204578|GABA Agents|gaba agents|mesh-ancestor
110981788|NCT03204578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110981789|NCT03204578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110981790|NCT01694069|Tazobactam|tazobactam|mesh-list
110981791|NCT01694069|Piperacillin|piperacillin|mesh-list
110981792|NCT01694069|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
110981793|NCT01694069|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110981794|NCT01694069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110981795|NCT01694069|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110981796|NCT01694069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110981797|NCT01694069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110981798|NCT03204032|Thalidomide|thalidomide|mesh-list
110981799|NCT03204032|Temozolomide|temozolomide|mesh-list
110981800|NCT03204032|Tegafur|tegafur|mesh-list
110981801|NCT03204032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110981802|NCT03204032|Alkylating Agents|alkylating agents|mesh-ancestor
110981803|NCT03204032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110698875|NCT00282087|Docetaxel|docetaxel|mesh-list
110981805|NCT03204032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110981806|NCT03204032|Immunologic Factors|immunologic factors|mesh-ancestor
110981807|NCT03204032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110981808|NCT03204032|Leprostatic Agents|leprostatic agents|mesh-ancestor
110981809|NCT03204032|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110981810|NCT03204032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110981811|NCT03204032|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110981812|NCT03204032|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110981813|NCT03204032|Growth Substances|growth substances|mesh-ancestor
110981814|NCT03204032|Growth Inhibitors|growth inhibitors|mesh-ancestor
110981815|NCT03204032|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110981816|NCT03204032|Antimetabolites|antimetabolites|mesh-ancestor
110981817|NCT02285751|Aspirin|aspirin|mesh-list
110981818|NCT02285751|Clopidogrel|clopidogrel|mesh-list
110981819|NCT02285751|Ticagrelor|ticagrelor|mesh-list
110981820|NCT02285751|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
110981821|NCT02285751|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110981822|NCT02285751|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110981823|NCT02285751|Analgesics|analgesics|mesh-ancestor
110981824|NCT02285751|Sensory System Agents|sensory system agents|mesh-ancestor
110981825|NCT02285751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110981826|NCT02285751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110981827|NCT02285751|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110981828|NCT02285751|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110981829|NCT02285751|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110981830|NCT02285751|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110981831|NCT02285751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110981832|NCT02285751|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110981833|NCT02285751|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110981834|NCT02285751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110981835|NCT02285751|Antipyretics|antipyretics|mesh-ancestor
110981836|NCT02285751|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110981837|NCT02285751|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110981838|NCT02285751|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110981839|NCT02285751|Purinergic Agents|purinergic agents|mesh-ancestor
110981840|NCT02285751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110981841|NCT02446730|Clopidogrel|clopidogrel|mesh-list
110981842|NCT02446730|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110981843|NCT02446730|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110981844|NCT02446730|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110981845|NCT02446730|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110981846|NCT02446730|Purinergic Agents|purinergic agents|mesh-ancestor
110981847|NCT02446730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110981848|NCT02446730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110981849|NCT02446730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110981850|NCT05114915|Docetaxel|docetaxel|mesh-list
110981851|NCT05114915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110981852|NCT05114915|Tubulin Modulators|tubulin modulators|mesh-ancestor
110981853|NCT05114915|Antimitotic Agents|antimitotic agents|mesh-ancestor
110981854|NCT05114915|Mitosis Modulators|mitosis modulators|mesh-ancestor
110981855|NCT05114915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110981856|NCT03532035|Brincidofovir|brincidofovir|mesh-list
110981857|NCT03532035|Antiviral Agents|antiviral agents|mesh-ancestor
110981858|NCT03532035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110981859|NCT00282867|Insulin|insulin|mesh-list
110981860|NCT00282867|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110981861|NCT00282867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110981862|NCT03198338|Bupivacaine|bupivacaine|mesh-list
110981863|NCT03198338|Anesthetics, Local|anesthetics, local|mesh-ancestor
110981864|NCT03198338|Anesthetics|anesthetics|mesh-ancestor
110981865|NCT03198338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110981866|NCT03198338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110981867|NCT03198338|Sensory System Agents|sensory system agents|mesh-ancestor
110981868|NCT03198338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110981869|NCT05222633|Ranibizumab|ranibizumab|mesh-list
110981870|NCT05222633|Aflibercept|aflibercept|mesh-list
110981871|NCT05222633|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110981872|NCT05222633|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110981873|NCT05222633|Growth Substances|growth substances|mesh-ancestor
110981874|NCT05222633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110981875|NCT05222633|Growth Inhibitors|growth inhibitors|mesh-ancestor
110981876|NCT05222633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110981877|NCT05222243|Calcium|calcium|mesh-list
110698955|NCT00268983|Iodine|iodine|mesh-list
110981878|NCT05222243|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110981879|NCT05222243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110981880|NCT04469283|Caffeine|caffeine|mesh-list
110981881|NCT04469283|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110981882|NCT04469283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110981883|NCT04469283|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110981884|NCT04469283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110981885|NCT04469283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110981886|NCT04469283|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110981887|NCT04469283|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110981888|NCT04469283|Purinergic Agents|purinergic agents|mesh-ancestor
110981889|NCT04469283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110981890|NCT02285829|Bromides|bromides|mesh-list
110981891|NCT02285829|Rocuronium|rocuronium|mesh-list
110981892|NCT02285829|Cisatracurium|cisatracurium|mesh-list
110981893|NCT02285829|Anticonvulsants|anticonvulsants|mesh-ancestor
110981894|NCT02285829|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110981895|NCT02285829|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110981896|NCT02285829|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110981897|NCT02285829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110981898|NCT02285829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110981899|NCT03203408|Hylan|hylan|mesh-list
110981900|NCT03203408|Viscosupplements|viscosupplements|mesh-ancestor
110981901|NCT03203408|Protective Agents|protective agents|mesh-ancestor
110981902|NCT03203408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110981903|NCT02285985|Saxagliptin|saxagliptin|mesh-list
110981904|NCT02285985|Incretins|incretins|mesh-ancestor
110981905|NCT02285985|Hormones|hormones|mesh-ancestor
110981906|NCT02285985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110981907|NCT02285985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110981908|NCT02285985|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110981909|NCT02285985|Protease Inhibitors|protease inhibitors|mesh-ancestor
110981910|NCT02285985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110981911|NCT02285985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110981912|NCT02285985|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110981913|NCT02445872|Dexamethasone|dexamethasone|mesh-list
110981914|NCT02445872|Aprepitant|aprepitant|mesh-list
110981915|NCT02445872|Palonosetron|palonosetron|mesh-list
110981916|NCT02445872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110981917|NCT02445872|Antiemetics|antiemetics|mesh-ancestor
110981918|NCT02445872|Autonomic Agents|autonomic agents|mesh-ancestor
110981919|NCT02445872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110981920|NCT02445872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110981921|NCT02445872|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110981922|NCT02445872|Glucocorticoids|glucocorticoids|mesh-ancestor
110981923|NCT02445872|Hormones|hormones|mesh-ancestor
110981924|NCT02445872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110981925|NCT02445872|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110981926|NCT02445872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110981927|NCT02445872|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110981928|NCT02445872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110981929|NCT02445872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110981930|NCT02445872|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110981931|NCT02445872|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110981932|NCT02445872|Serotonin Agents|serotonin agents|mesh-ancestor
110981933|NCT05221775|Lenvatinib|lenvatinib|mesh-list
110981934|NCT05221775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110981935|NCT05221775|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110981936|NCT05221775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110981937|NCT05221775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110981938|NCT04700423|Ivermectin|ivermectin|mesh-list
110981939|NCT04700423|Albendazole|albendazole|mesh-list
110981940|NCT04700423|Moxidectin|moxidectin|mesh-list
110981941|NCT04700423|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110981942|NCT04700423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110981943|NCT04700423|Anthelmintics|anthelmintics|mesh-ancestor
110981944|NCT04700423|Anticestodal Agents|anticestodal agents|mesh-ancestor
110981945|NCT04700423|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110981946|NCT04700423|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110981947|NCT04700423|Tubulin Modulators|tubulin modulators|mesh-ancestor
110981948|NCT04700423|Antimitotic Agents|antimitotic agents|mesh-ancestor
110981949|NCT04700423|Mitosis Modulators|mitosis modulators|mesh-ancestor
110981950|NCT04700423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110981951|NCT04700423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110981952|NCT04700423|Antinematodal Agents|antinematodal agents|mesh-ancestor
110981953|NCT02286219|Immunoglobulins|immunoglobulins|mesh-list
110981954|NCT02286219|Immunoglobulin G|immunoglobulin g|mesh-list
110981955|NCT02286219|Immunologic Factors|immunologic factors|mesh-ancestor
110981956|NCT02286219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110981957|NCT02445716|Methyltestosterone|methyltestosterone|mesh-list
110981958|NCT02445716|Testosterone|testosterone|mesh-list
110981959|NCT02445716|Testosterone undecanoate|testosterone undecanoate|mesh-list
110981960|NCT02445716|Testosterone enanthate|testosterone enanthate|mesh-list
110981961|NCT02445716|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
110981962|NCT02445716|Androgens|androgens|mesh-ancestor
110981963|NCT02445716|Hormones|hormones|mesh-ancestor
110981964|NCT02445716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110981965|NCT02445716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110981966|NCT02445716|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110981967|NCT02445716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110981968|NCT02445716|Anabolic Agents|anabolic agents|mesh-ancestor
110981969|NCT03197636|Pembrolizumab|pembrolizumab|mesh-list
110981970|NCT03197636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110981971|NCT03197636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110981972|NCT03197636|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110981973|NCT03197636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110981974|NCT05724381|Phenol|phenol|mesh-list
110981975|NCT05724381|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110981976|NCT05724381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110981977|NCT05724381|Disinfectants|disinfectants|mesh-ancestor
110981978|NCT05724381|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
110981979|NCT05724381|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110981980|NCT03194594|Dexamethasone|dexamethasone|mesh-list
110981981|NCT03194594|Ketamine|ketamine|mesh-list
110981982|NCT03194594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110981983|NCT03194594|Antiemetics|antiemetics|mesh-ancestor
110981984|NCT03194594|Autonomic Agents|autonomic agents|mesh-ancestor
110981985|NCT03194594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110981986|NCT03194594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110981987|NCT03194594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110981988|NCT03194594|Glucocorticoids|glucocorticoids|mesh-ancestor
110981989|NCT03194594|Hormones|hormones|mesh-ancestor
110981990|NCT03194594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110981991|NCT03194594|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110981992|NCT03194594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110981993|NCT03194594|Analgesics|analgesics|mesh-ancestor
110981994|NCT03194594|Sensory System Agents|sensory system agents|mesh-ancestor
110981995|NCT03194594|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110981996|NCT03194594|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110981997|NCT03194594|Anesthetics, General|anesthetics, general|mesh-ancestor
110981998|NCT03194594|Anesthetics|anesthetics|mesh-ancestor
110981999|NCT03194594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110982000|NCT03194594|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110982001|NCT03194594|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110982002|NCT03194594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110982003|NCT03194594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110982004|NCT04407377|Cyclobenzaprine|cyclobenzaprine|mesh-list
110982005|NCT04407377|Tolperisone|tolperisone|mesh-list
110982006|NCT04407377|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110982007|NCT04407377|Antidepressive Agents|antidepressive agents|mesh-ancestor
110982008|NCT04407377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110982009|NCT04407377|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110982010|NCT04407377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110982011|NCT04407377|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110982012|NCT04407377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110982013|NCT04407377|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110982014|NCT04407377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110982015|NCT03203174|Botulinum Toxins|botulinum toxins|mesh-list
110982016|NCT03203174|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110982017|NCT03203174|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110982018|NCT03203174|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110982019|NCT03203174|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110982020|NCT03203174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110982021|NCT03203174|Cholinergic Agents|cholinergic agents|mesh-ancestor
110982022|NCT03203174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110982023|NCT03203174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110982024|NCT03203174|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110982025|NCT03203174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110982026|NCT00257205|Temozolomide|temozolomide|mesh-list
110982027|NCT00257205|Dacarbazine|dacarbazine|mesh-list
110982028|NCT00257205|Tremelimumab|tremelimumab|mesh-list
110982029|NCT00257205|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110982030|NCT00257205|Alkylating Agents|alkylating agents|mesh-ancestor
110982031|NCT00257205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110982032|NCT00257205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110982033|NCT03194204|Doxycycline|doxycycline|mesh-list
110982034|NCT03194204|Uric Acid|uric acid|mesh-list
110982035|NCT03194204|Rheumatoid Factor|rheumatoid factor|mesh-list
110982036|NCT03194204|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110982037|NCT03194204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110982038|NCT03194204|Antimalarials|antimalarials|mesh-ancestor
110982039|NCT03194204|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110982040|NCT03194204|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110982041|NCT03194204|Antioxidants|antioxidants|mesh-ancestor
110982042|NCT03194204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110982043|NCT03194204|Protective Agents|protective agents|mesh-ancestor
110982044|NCT03194204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110982045|NCT03194204|Immunologic Factors|immunologic factors|mesh-ancestor
110982046|NCT04045301|Omalizumab|omalizumab|mesh-list
110982047|NCT04045301|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110982048|NCT04045301|Immunologic Factors|immunologic factors|mesh-ancestor
110982049|NCT04045301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110982050|NCT04045301|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110982051|NCT04045301|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110982052|NCT04045301|Respiratory System Agents|respiratory system agents|mesh-ancestor
110982053|NCT03197480|Aflibercept|aflibercept|mesh-list
110982054|NCT03197480|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110982055|NCT03197480|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110982056|NCT03197480|Growth Substances|growth substances|mesh-ancestor
110982057|NCT03197480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110982058|NCT03197480|Growth Inhibitors|growth inhibitors|mesh-ancestor
110982059|NCT03197480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110982060|NCT00151281|Thalidomide|thalidomide|mesh-list
110982061|NCT00151281|Prednisone|prednisone|mesh-list
110982062|NCT00151281|Cyclophosphamide|cyclophosphamide|mesh-list
110982063|NCT00151281|Rituximab|rituximab|mesh-list
110982064|NCT00151281|Etoposide|etoposide|mesh-list
110982065|NCT00151281|Procarbazine|procarbazine|mesh-list
110982066|NCT00151281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110982067|NCT00151281|Immunologic Factors|immunologic factors|mesh-ancestor
110982068|NCT00151281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110982069|NCT00151281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110982070|NCT00151281|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110982071|NCT00151281|Alkylating Agents|alkylating agents|mesh-ancestor
110982072|NCT00151281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110982073|NCT00151281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110982074|NCT00151281|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110982075|NCT00151281|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110982076|NCT00151281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110982077|NCT00151281|Glucocorticoids|glucocorticoids|mesh-ancestor
110982078|NCT00151281|Hormones|hormones|mesh-ancestor
110982079|NCT00151281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110982080|NCT00151281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110982081|NCT00151281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110982082|NCT00151281|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110982083|NCT00151281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110982084|NCT00151281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110982085|NCT00151281|Leprostatic Agents|leprostatic agents|mesh-ancestor
110982086|NCT00151281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110982087|NCT00151281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110982088|NCT00151281|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110982089|NCT00151281|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110982090|NCT00151281|Growth Substances|growth substances|mesh-ancestor
110982091|NCT00151281|Growth Inhibitors|growth inhibitors|mesh-ancestor
110982092|NCT03202862|Fulvestrant|fulvestrant|mesh-list
110982093|NCT03202862|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110982094|NCT03202862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110982095|NCT03202862|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110982096|NCT03202862|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110982097|NCT03202862|Hormone Antagonists|hormone antagonists|mesh-ancestor
110982098|NCT03202862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110982099|NCT03202862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110982100|NCT00255099|Etravirine|etravirine|mesh-list
110676895|NCT03348969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110982101|NCT00255099|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110982102|NCT00255099|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110982103|NCT00255099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110982104|NCT00255099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110982105|NCT00255099|Antiviral Agents|antiviral agents|mesh-ancestor
110982106|NCT00255099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110982107|NCT00231153|Povidone-Iodine|povidone-iodine|mesh-list
110982109|NCT00231153|Plasma Substitutes|plasma substitutes|mesh-ancestor
110982110|NCT00231153|Blood Substitutes|blood substitutes|mesh-ancestor
110982111|NCT00231153|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110982112|NCT00231153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110982113|NCT03202784|Berotralstat|berotralstat|mesh-list
110982114|NCT03202784|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110982115|NCT03202784|Protease Inhibitors|protease inhibitors|mesh-ancestor
110982116|NCT03202784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110982117|NCT03202784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110982118|NCT05220527|Triamcinolone|triamcinolone|mesh-list
110982119|NCT05220527|Hyaluronic Acid|hyaluronic acid|mesh-list
110982120|NCT05220527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110982121|NCT05220527|Glucocorticoids|glucocorticoids|mesh-ancestor
110982122|NCT05220527|Hormones|hormones|mesh-ancestor
110982123|NCT05220527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110982124|NCT05220527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110982125|NCT05220527|Immunologic Factors|immunologic factors|mesh-ancestor
110982126|NCT05220527|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110982127|NCT05220527|Viscosupplements|viscosupplements|mesh-ancestor
110982128|NCT05220527|Protective Agents|protective agents|mesh-ancestor
110982129|NCT03197402|Caseins|caseins|mesh-list
110982130|NCT03197402|Chelating Agents|chelating agents|mesh-ancestor
110982131|NCT03197402|Sequestering Agents|sequestering agents|mesh-ancestor
110982132|NCT03197402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110982133|NCT05723991|Gemcitabine|gemcitabine|mesh-list
110982134|NCT05723991|Disitamab vedotin|disitamab vedotin|mesh-list
110982135|NCT05723991|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110982136|NCT05723991|Antimetabolites|antimetabolites|mesh-ancestor
110982137|NCT05723991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110982138|NCT05723991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110982139|NCT05723991|Immunoconjugates|immunoconjugates|mesh-ancestor
110982140|NCT05723991|Immunologic Factors|immunologic factors|mesh-ancestor
110982141|NCT05723991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110982142|NCT01318109|Metformin|metformin|mesh-list
110982143|NCT01318109|Alogliptin|alogliptin|mesh-list
110982144|NCT01318109|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110982145|NCT01318109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110982146|NCT01318109|Incretins|incretins|mesh-ancestor
110982147|NCT01318109|Hormones|hormones|mesh-ancestor
110982148|NCT01318109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110982149|NCT01318109|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110982150|NCT01318109|Protease Inhibitors|protease inhibitors|mesh-ancestor
110982151|NCT01318109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110982152|NCT01318109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110982153|NCT05720871|Capsaicin|capsaicin|mesh-list
110982154|NCT05720871|Antipruritics|antipruritics|mesh-ancestor
110982155|NCT05720871|Dermatologic Agents|dermatologic agents|mesh-ancestor
110982156|NCT05720871|Sensory System Agents|sensory system agents|mesh-ancestor
110982157|NCT05720871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110982158|NCT05720871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110982159|NCT05672927|Vaccines|vaccines|mesh-list
110982160|NCT05672927|Immunologic Factors|immunologic factors|mesh-ancestor
110982161|NCT05672927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110982162|NCT05636267|Carboplatin|carboplatin|mesh-list
110982163|NCT05636267|Pemetrexed|pemetrexed|mesh-list
110982164|NCT05636267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110982165|NCT05636267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110982166|NCT05636267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110982167|NCT05636267|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110982168|NCT05636267|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110982169|NCT03873311|Cytarabine|cytarabine|mesh-list
110982170|NCT03873311|Azacitidine|azacitidine|mesh-list
110982171|NCT03873311|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110982172|NCT03873311|Antimetabolites|antimetabolites|mesh-ancestor
110982173|NCT03873311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110699253|NCT01041170|Rimonabant|rimonabant|mesh-list
110982174|NCT03873311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110982175|NCT03873311|Antiviral Agents|antiviral agents|mesh-ancestor
110982176|NCT03873311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110982177|NCT03873311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110982178|NCT03873311|Immunologic Factors|immunologic factors|mesh-ancestor
110982179|NCT03873311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110982180|NCT03873311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110982182|NCT00162279|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110982183|NCT00162279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110982184|NCT00162279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110982185|NCT00162279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110982186|NCT00162279|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110982187|NCT00162279|Immunologic Factors|immunologic factors|mesh-ancestor
110982188|NCT00162279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110982189|NCT00162279|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110982190|NCT00145431|Atorvastatin|atorvastatin|mesh-list
110982191|NCT00145431|Torcetrapib|torcetrapib|mesh-list
110982192|NCT00145431|Fenofibrate|fenofibrate|mesh-list
110982193|NCT00145431|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110982194|NCT00145431|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110982195|NCT00145431|Antimetabolites|antimetabolites|mesh-ancestor
110982196|NCT00145431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110982197|NCT00145431|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110982198|NCT00145431|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110982199|NCT00145431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110982200|NCT00135369|Lamivudine|lamivudine|mesh-list
110982201|NCT00135369|Efavirenz|efavirenz|mesh-list
110982202|NCT00135369|Stavudine|stavudine|mesh-list
110982203|NCT00135369|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110982204|NCT00135369|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110982205|NCT00135369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110982206|NCT00135369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110982207|NCT00135369|Antiviral Agents|antiviral agents|mesh-ancestor
110982208|NCT00135369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110982209|NCT00135369|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110982210|NCT00135369|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110982211|NCT00135369|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110982212|NCT00135369|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110982213|NCT00135369|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110982214|NCT00135369|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110982215|NCT00135369|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110982216|NCT00135369|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110982217|NCT00135369|Antimetabolites|antimetabolites|mesh-ancestor
110982218|NCT03530319|Azithromycin|azithromycin|mesh-list
110982219|NCT03530319|Doxycycline|doxycycline|mesh-list
110982220|NCT03530319|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110982221|NCT03530319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110982222|NCT03530319|Antimalarials|antimalarials|mesh-ancestor
110982223|NCT03530319|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110982224|NCT03530319|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110982225|NCT05726253|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110982226|NCT05726253|Amoxicillin|amoxicillin|mesh-list
110982227|NCT05726253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110982228|NCT02445404|Dexamethasone|dexamethasone|mesh-list
110982229|NCT02445404|Prednisone|prednisone|mesh-list
110982230|NCT02445404|Cyclophosphamide|cyclophosphamide|mesh-list
110982231|NCT02445404|Ifosfamide|ifosfamide|mesh-list
110982232|NCT02445404|Carboplatin|carboplatin|mesh-list
110982233|NCT02445404|Etoposide|etoposide|mesh-list
110982234|NCT02445404|Vincristine|vincristine|mesh-list
110982235|NCT02445404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110982236|NCT02445404|Immunologic Factors|immunologic factors|mesh-ancestor
110982237|NCT02445404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110982238|NCT02445404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110982239|NCT02445404|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110982240|NCT02445404|Alkylating Agents|alkylating agents|mesh-ancestor
110982241|NCT02445404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110982242|NCT02445404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110982243|NCT02445404|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110982244|NCT02445404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110982245|NCT02445404|Antiemetics|antiemetics|mesh-ancestor
110982246|NCT02445404|Autonomic Agents|autonomic agents|mesh-ancestor
110982247|NCT02445404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110982248|NCT02445404|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110982249|NCT02445404|Glucocorticoids|glucocorticoids|mesh-ancestor
110982250|NCT02445404|Hormones|hormones|mesh-ancestor
110982251|NCT02445404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110982252|NCT02445404|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110982253|NCT02445404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110982254|NCT02445404|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110982255|NCT02445404|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110982256|NCT02445404|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110982257|NCT02445404|Tubulin Modulators|tubulin modulators|mesh-ancestor
110982258|NCT02445404|Antimitotic Agents|antimitotic agents|mesh-ancestor
110982259|NCT02445404|Mitosis Modulators|mitosis modulators|mesh-ancestor
110982260|NCT05726175|Disitamab vedotin|disitamab vedotin|mesh-list
110982261|NCT05726175|Immunoconjugates|immunoconjugates|mesh-ancestor
110982262|NCT05726175|Immunologic Factors|immunologic factors|mesh-ancestor
110982263|NCT05726175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110982264|NCT03530085|Fludarabine|fludarabine|mesh-list
110982266|NCT03530085|Decitabine|decitabine|mesh-list
110982267|NCT03530085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110982268|NCT03530085|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110982269|NCT03530085|Antimetabolites|antimetabolites|mesh-ancestor
110982270|NCT03530085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110982271|NCT03530085|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110982272|NCT03530085|Immunologic Factors|immunologic factors|mesh-ancestor
110982273|NCT03530085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110982274|NCT03530085|Alkylating Agents|alkylating agents|mesh-ancestor
110982275|NCT03530085|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110982276|NCT03530085|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110982277|NCT03530085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110982278|NCT03196934|Cannabidiol|cannabidiol|mesh-list
110982279|NCT03196934|Anticonvulsants|anticonvulsants|mesh-ancestor
110982280|NCT03197012|Octreotide|octreotide|mesh-list
110982281|NCT03197012|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
110982282|NCT03197012|Edotreotide|edotreotide|mesh-list
110982283|NCT03197012|Chelating Agents|chelating agents|mesh-ancestor
110982284|NCT03197012|Sequestering Agents|sequestering agents|mesh-ancestor
110982285|NCT03197012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110982286|NCT03197012|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110982287|NCT03197012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110982288|NCT03197012|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110982289|NCT03197012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110982290|NCT03530007|Ondansetron|ondansetron|mesh-list
110982291|NCT03530007|Antiemetics|antiemetics|mesh-ancestor
110982292|NCT03530007|Autonomic Agents|autonomic agents|mesh-ancestor
110982293|NCT03530007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110982294|NCT03530007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110982295|NCT03530007|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110982296|NCT03530007|Antipruritics|antipruritics|mesh-ancestor
110982297|NCT03530007|Dermatologic Agents|dermatologic agents|mesh-ancestor
110982298|NCT03530007|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110982299|NCT03530007|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110982300|NCT03530007|Serotonin Agents|serotonin agents|mesh-ancestor
110982301|NCT03530007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110982302|NCT03530007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110982303|NCT03529929|Methylprednisolone|methylprednisolone|mesh-list
110982304|NCT03529929|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110982305|NCT03529929|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110982306|NCT03529929|Prednisolone|prednisolone|mesh-list
110982307|NCT03529929|Prednisolone acetate|prednisolone acetate|mesh-list
110982308|NCT03529929|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110982309|NCT03529929|Prednisolone phosphate|prednisolone phosphate|mesh-list
110982310|NCT03529929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110982311|NCT03529929|Antiemetics|antiemetics|mesh-ancestor
110982312|NCT03529929|Autonomic Agents|autonomic agents|mesh-ancestor
110982313|NCT03529929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110982314|NCT03529929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110982315|NCT03529929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110982316|NCT03529929|Glucocorticoids|glucocorticoids|mesh-ancestor
110982317|NCT03529929|Hormones|hormones|mesh-ancestor
110982318|NCT03529929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110982319|NCT03529929|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110982320|NCT03529929|Protective Agents|protective agents|mesh-ancestor
110982321|NCT03529929|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110982322|NCT03529929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110982323|NCT03052751|Rozanolixizumab|rozanolixizumab|mesh-list
110982324|NCT03052751|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110982325|NCT03052751|Immunologic Factors|immunologic factors|mesh-ancestor
110982326|NCT03052751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110982327|NCT03525561|Acetazolamide|acetazolamide|mesh-list
110982328|NCT03525561|Anticonvulsants|anticonvulsants|mesh-ancestor
110982329|NCT03525561|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110982330|NCT03525561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110982331|NCT03525561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110982332|NCT03525561|Diuretics|diuretics|mesh-ancestor
110982333|NCT03525561|Natriuretic Agents|natriuretic agents|mesh-ancestor
110982334|NCT03525561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110982335|NCT05696691|Ketamine|ketamine|mesh-list
110982336|NCT05696691|Analgesics|analgesics|mesh-ancestor
110982337|NCT05696691|Sensory System Agents|sensory system agents|mesh-ancestor
110982338|NCT05696691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110982339|NCT05696691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110982340|NCT05696691|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110982341|NCT05696691|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110982342|NCT05696691|Anesthetics, General|anesthetics, general|mesh-ancestor
110982343|NCT05696691|Anesthetics|anesthetics|mesh-ancestor
110982344|NCT05696691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110982345|NCT05696691|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110982346|NCT05696691|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110982347|NCT05696691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110982348|NCT05696691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110982349|NCT03527355|Vaccines|vaccines|mesh-list
110982350|NCT03527355|Immunologic Factors|immunologic factors|mesh-ancestor
110982351|NCT03527355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110982352|NCT05707169|Lidocaine|lidocaine|mesh-list
110982353|NCT05707169|Epinephrine|epinephrine|mesh-list
110982354|NCT05707169|Racepinephrine|racepinephrine|mesh-list
110982355|NCT05707169|Levobupivacaine|levobupivacaine|mesh-list
110982356|NCT05707169|Epinephryl borate|epinephryl borate|mesh-list
110982357|NCT05707169|Anesthetics, Local|anesthetics, local|mesh-ancestor
110982358|NCT05707169|Anesthetics|anesthetics|mesh-ancestor
110982359|NCT05707169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110982360|NCT05707169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110982361|NCT05707169|Sensory System Agents|sensory system agents|mesh-ancestor
110982362|NCT05707169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110982363|NCT05707169|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110982364|NCT05707169|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110982365|NCT05707169|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110982366|NCT05707169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110982367|NCT05707169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110982368|NCT05707169|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110982369|NCT05707169|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110982370|NCT05707169|Adrenergic Agents|adrenergic agents|mesh-ancestor
110982371|NCT05707169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110982372|NCT05707169|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110982373|NCT05707169|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110982375|NCT05707169|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110982376|NCT05707169|Respiratory System Agents|respiratory system agents|mesh-ancestor
110982377|NCT05707169|Mydriatics|mydriatics|mesh-ancestor
110982378|NCT05707169|Sympathomimetics|sympathomimetics|mesh-ancestor
110982379|NCT05707169|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110982380|NCT05052827|Caseins|caseins|mesh-list
110982381|NCT05052827|Chelating Agents|chelating agents|mesh-ancestor
110982382|NCT05052827|Sequestering Agents|sequestering agents|mesh-ancestor
110982383|NCT05052827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110982384|NCT02712008|Aflibercept|aflibercept|mesh-list
110982385|NCT02712008|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110982386|NCT02712008|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110982387|NCT02712008|Growth Substances|growth substances|mesh-ancestor
110982388|NCT02712008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110982389|NCT02712008|Growth Inhibitors|growth inhibitors|mesh-ancestor
110982390|NCT02712008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110982391|NCT05130515|Niraparib|niraparib|mesh-list
110982392|NCT05130515|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110982393|NCT05130515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110982394|NCT05130515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110982395|NCT05130515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110982396|NCT03193814|Apatinib|apatinib|mesh-list
110982397|NCT03193814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110982398|NCT03193814|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110982399|NCT03193814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110982400|NCT03193814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110982401|NCT02450084|Fentanyl|fentanyl|mesh-list
110982402|NCT02450084|Ropivacaine|ropivacaine|mesh-list
110982403|NCT02450084|Anesthetics, Local|anesthetics, local|mesh-ancestor
110982404|NCT02450084|Anesthetics|anesthetics|mesh-ancestor
110982405|NCT02450084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110982406|NCT02450084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110982407|NCT02450084|Sensory System Agents|sensory system agents|mesh-ancestor
110982408|NCT02450084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110982409|NCT02450084|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110982410|NCT02450084|Narcotics|narcotics|mesh-ancestor
110982411|NCT02450084|Analgesics|analgesics|mesh-ancestor
110982412|NCT02450084|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110982413|NCT02450084|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110982414|NCT02450084|Anesthetics, General|anesthetics, general|mesh-ancestor
110982415|NCT03201770|Artesunate|artesunate|mesh-list
110982416|NCT03201770|Pyronaridine|pyronaridine|mesh-list
110982417|NCT03201770|Pyronaridine tetraphosphate, artesunate drug combination|pyronaridine tetraphosphate, artesunate drug combination|mesh-list
110982418|NCT03201770|Antimalarials|antimalarials|mesh-ancestor
110982419|NCT03201770|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110982420|NCT03201770|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110982421|NCT03201770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110982422|NCT03201770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110982423|NCT03201770|Antiviral Agents|antiviral agents|mesh-ancestor
110982424|NCT03201770|Schistosomicides|schistosomicides|mesh-ancestor
110982425|NCT03201770|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110982426|NCT03201770|Anthelmintics|anthelmintics|mesh-ancestor
110982427|NCT04213209|Brentuximab Vedotin|brentuximab vedotin|mesh-list
110982428|NCT04213209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110982429|NCT04213209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110982430|NCT04213209|Immunotoxins|immunotoxins|mesh-ancestor
110982431|NCT04213209|Immunoconjugates|immunoconjugates|mesh-ancestor
110982432|NCT04213209|Immunologic Factors|immunologic factors|mesh-ancestor
110982433|NCT04213209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110982434|NCT04188405|Decitabine|decitabine|mesh-list
110982435|NCT04188405|Venetoclax|venetoclax|mesh-list
110982436|NCT04188405|Ponatinib|ponatinib|mesh-list
110982437|NCT04188405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110982438|NCT04188405|Antimetabolites|antimetabolites|mesh-ancestor
110982439|NCT04188405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110982440|NCT04188405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110982441|NCT04188405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110982442|NCT04188405|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110982443|NCT04176393|Ivosidenib|ivosidenib|mesh-list
110982444|NCT04176393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110982445|NCT04176393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110982446|NCT04176393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110982447|NCT02449070|Nicorandil|nicorandil|mesh-list
110982448|NCT02449070|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110982449|NCT02449070|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110982450|NCT02449070|Vasodilator Agents|vasodilator agents|mesh-ancestor
110982451|NCT02449070|Vitamin B Complex|vitamin b complex|mesh-ancestor
110982452|NCT02449070|Vitamins|vitamins|mesh-ancestor
110982453|NCT02449070|Micronutrients|micronutrients|mesh-ancestor
110982454|NCT02449070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110982455|NCT03529149|Diltiazem|diltiazem|mesh-list
110982456|NCT03529149|Urapidil|urapidil|mesh-list
110982457|NCT03529149|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110982458|NCT03529149|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110982459|NCT03529149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110982460|NCT03529149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110982461|NCT03529149|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110982462|NCT03529149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110982463|NCT03529149|Vasodilator Agents|vasodilator agents|mesh-ancestor
110982464|NCT03529149|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110982465|NCT03529149|Serotonin Agents|serotonin agents|mesh-ancestor
110982466|NCT03529149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110982467|NCT03529149|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110982468|NCT03529149|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110982469|NCT03529149|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110982470|NCT03529149|Adrenergic Agents|adrenergic agents|mesh-ancestor
110982471|NCT03193502|Rivaroxaban|rivaroxaban|mesh-list
110982472|NCT03193502|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110982473|NCT03193502|Antithrombins|antithrombins|mesh-ancestor
110982474|NCT03193502|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110982475|NCT03193502|Protease Inhibitors|protease inhibitors|mesh-ancestor
110982476|NCT03193502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110982477|NCT03193502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110982478|NCT03193502|Anticoagulants|anticoagulants|mesh-ancestor
110982479|NCT02711306|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
110982480|NCT02711306|Cathartics|cathartics|mesh-ancestor
110982481|NCT02711306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110982482|NCT03193112|Agomelatine|agomelatine|mesh-list
110982483|NCT03193112|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110982484|NCT03193112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110982485|NCT03193112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110982486|NCT03196154|Insulin|insulin|mesh-list
110982487|NCT03196154|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110982488|NCT03196154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110982489|NCT03193424|Docetaxel|docetaxel|mesh-list
110982490|NCT03193424|Apatinib|apatinib|mesh-list
110982491|NCT03193424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110982492|NCT03193424|Tubulin Modulators|tubulin modulators|mesh-ancestor
110982493|NCT03193424|Antimitotic Agents|antimitotic agents|mesh-ancestor
110982494|NCT03193424|Mitosis Modulators|mitosis modulators|mesh-ancestor
110982495|NCT03193424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110982496|NCT03193424|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110982497|NCT03193424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110982498|NCT03193346|Botulinum Toxins|botulinum toxins|mesh-list
110982499|NCT03193346|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110982500|NCT03193346|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110982501|NCT03193346|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110982502|NCT03193346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110982503|NCT03193346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110982504|NCT03193346|Cholinergic Agents|cholinergic agents|mesh-ancestor
110982505|NCT03193346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110982506|NCT03193346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110982507|NCT03193346|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110982508|NCT03193346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110982509|NCT03118076|Dexmedetomidine|dexmedetomidine|mesh-list
110982510|NCT03118076|Ropivacaine|ropivacaine|mesh-list
110982511|NCT03118076|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110982512|NCT03118076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110982513|NCT03118076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110982514|NCT03118076|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110982515|NCT03118076|Analgesics|analgesics|mesh-ancestor
110982516|NCT03118076|Sensory System Agents|sensory system agents|mesh-ancestor
110982517|NCT03118076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110982518|NCT03118076|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110982519|NCT03118076|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110982520|NCT03118076|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110982521|NCT03118076|Adrenergic Agents|adrenergic agents|mesh-ancestor
110982522|NCT03118076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110982523|NCT03118076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110982525|NCT03118076|Anesthetics|anesthetics|mesh-ancestor
110982526|NCT03528915|Rifamycins|rifamycins|mesh-list
110982527|NCT03528915|Rifamycin SV|rifamycin sv|mesh-list
110982528|NCT03528915|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110982529|NCT03528915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110982530|NCT03528915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110982531|NCT03192878|Infliximab|infliximab|mesh-list
110982532|NCT03192878|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110982533|NCT03192878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110982534|NCT03192878|Dermatologic Agents|dermatologic agents|mesh-ancestor
110982535|NCT03192878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110982536|NCT03192878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110982537|NCT00294320|Imiquimod|imiquimod|mesh-list
110982538|NCT00294320|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110982539|NCT00294320|Immunologic Factors|immunologic factors|mesh-ancestor
110982540|NCT00294320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110982541|NCT00294320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110982542|NCT00294320|Interferon Inducers|interferon inducers|mesh-ancestor
110982543|NCT03526575|Zaleplon|zaleplon|mesh-list
110982544|NCT03526575|Zolpidem|zolpidem|mesh-list
110982545|NCT03526575|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110982546|NCT03526575|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110982547|NCT03526575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110982548|NCT03526575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110982549|NCT03526575|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
110982550|NCT03526575|GABA Agonists|gaba agonists|mesh-ancestor
110982551|NCT03526575|GABA Agents|gaba agents|mesh-ancestor
110982552|NCT03526575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110982553|NCT03526575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110982554|NCT03526575|Anticonvulsants|anticonvulsants|mesh-ancestor
110982555|NCT03526575|GABA Modulators|gaba modulators|mesh-ancestor
110982556|NCT00189254|Imiquimod|imiquimod|mesh-list
110982557|NCT00189254|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110982558|NCT00189254|Immunologic Factors|immunologic factors|mesh-ancestor
110982559|NCT00189254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110982560|NCT00189254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110982561|NCT00189254|Interferon Inducers|interferon inducers|mesh-ancestor
110982562|NCT03526419|Bupivacaine|bupivacaine|mesh-list
110982563|NCT03526419|Anesthetics, Local|anesthetics, local|mesh-ancestor
110982564|NCT03526419|Anesthetics|anesthetics|mesh-ancestor
110450842|NCT01114529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110982565|NCT03526419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110982566|NCT03526419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110982567|NCT03526419|Sensory System Agents|sensory system agents|mesh-ancestor
110982568|NCT03526419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110982569|NCT03192644|Leucovorin|leucovorin|mesh-list
110982570|NCT03192644|Oxaliplatin|oxaliplatin|mesh-list
110982571|NCT03192644|Ethiodized Oil|ethiodized oil|mesh-list
110982572|NCT03192644|Epirubicin|epirubicin|mesh-list
110982573|NCT03192644|Calcium|calcium|mesh-list
110982574|NCT03192644|Levoleucovorin|levoleucovorin|mesh-list
110982575|NCT03192644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110982576|NCT03192644|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110982577|NCT03192644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110982578|NCT03192644|Antidotes|antidotes|mesh-ancestor
110982579|NCT03192644|Protective Agents|protective agents|mesh-ancestor
110982580|NCT03192644|Vitamin B Complex|vitamin b complex|mesh-ancestor
110982581|NCT03192644|Vitamins|vitamins|mesh-ancestor
110982582|NCT03192644|Micronutrients|micronutrients|mesh-ancestor
110982583|NCT03192644|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110982584|NCT03192644|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110982585|NCT03192644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110982586|NCT03192644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110982587|NCT03192644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110982588|NCT03110055|Grazoprevir|grazoprevir|mesh-list
110982589|NCT03110055|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
110982590|NCT03110055|Antiviral Agents|antiviral agents|mesh-ancestor
110982591|NCT03110055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110982592|NCT01190852|Fluticasone|fluticasone|mesh-list
110982593|NCT01190852|Azelastine|azelastine|mesh-list
110982594|NCT01190852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110982595|NCT01190852|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110982596|NCT01190852|Autonomic Agents|autonomic agents|mesh-ancestor
110982597|NCT01190852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110982598|NCT01190852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110982599|NCT01190852|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110982600|NCT01190852|Respiratory System Agents|respiratory system agents|mesh-ancestor
110982601|NCT01190852|Dermatologic Agents|dermatologic agents|mesh-ancestor
110982602|NCT01190852|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110982603|NCT01190852|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
110982604|NCT01190852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110982605|NCT01190852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110982606|NCT01190852|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110982607|NCT01190852|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110982608|NCT01190852|Histamine Antagonists|histamine antagonists|mesh-ancestor
110982609|NCT01190852|Histamine Agents|histamine agents|mesh-ancestor
110982610|NCT01190852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110982611|NCT02710214|Estrogens|estrogens|mesh-list
110982612|NCT02710214|Hormones|hormones|mesh-ancestor
110982613|NCT02710214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110982614|NCT02710214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110982615|NCT05561205|Methylphenidate|methylphenidate|mesh-list
110982616|NCT05561205|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110982617|NCT05561205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110982618|NCT05561205|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110982619|NCT05561205|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110982620|NCT05561205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110982621|NCT05561205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110982622|NCT05561205|Dopamine Agents|dopamine agents|mesh-ancestor
110982623|NCT05561205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110982624|NCT03052517|Indoleacetic Acids|indoleacetic acids|mesh-list
110982625|NCT03052517|Plant Growth Regulators|plant growth regulators|mesh-ancestor
110982626|NCT03052517|Growth Substances|growth substances|mesh-ancestor
110450846|NCT00926289|Diuretics|diuretics|mesh-ancestor
110982627|NCT03052517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110982628|NCT02443844|Tamsulosin|tamsulosin|mesh-list
110982629|NCT02443844|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110982630|NCT02443844|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110982631|NCT02443844|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110982632|NCT02443844|Adrenergic Agents|adrenergic agents|mesh-ancestor
110982633|NCT02443844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110982634|NCT02443844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110982635|NCT02443844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110982636|NCT02443844|Urological Agents|urological agents|mesh-ancestor
110982637|NCT02440100|Midazolam|midazolam|mesh-list
110982638|NCT02440100|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110982639|NCT02440100|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110982640|NCT02440100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110982641|NCT02440100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110982642|NCT02440100|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110982643|NCT02440100|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110982644|NCT02440100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110982645|NCT02440100|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110982646|NCT02440100|Anesthetics, General|anesthetics, general|mesh-ancestor
110982647|NCT02440100|Anesthetics|anesthetics|mesh-ancestor
110982648|NCT02440100|GABA Modulators|gaba modulators|mesh-ancestor
110982649|NCT02440100|GABA Agents|gaba agents|mesh-ancestor
110982650|NCT02440100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110982651|NCT02440100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110982652|NCT03524313|Carbon Monoxide|carbon monoxide|mesh-list
110982653|NCT03524313|Antimetabolites|antimetabolites|mesh-ancestor
110982654|NCT03524313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110982655|NCT03524313|Gasotransmitters|gasotransmitters|mesh-ancestor
110982656|NCT03524313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110982657|NCT03524313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110982658|NCT02439944|Nicotine|nicotine|mesh-list
110982659|NCT02439944|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110982660|NCT02439944|Autonomic Agents|autonomic agents|mesh-ancestor
110982661|NCT02439944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110982662|NCT02439944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110982663|NCT02439944|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110982664|NCT02439944|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110982665|NCT02439944|Cholinergic Agents|cholinergic agents|mesh-ancestor
110982666|NCT02439944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110982667|NCT02439944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110982668|NCT03133065|Antiviral Agents|antiviral agents|mesh-list
110982669|NCT03133065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110982670|NCT03190616|Apatinib|apatinib|mesh-list
110982671|NCT03190616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110982672|NCT03190616|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110982673|NCT03190616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110982674|NCT03190616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110982675|NCT02443922|Metformin|metformin|mesh-list
110982676|NCT02443922|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110982677|NCT02443922|Glimepiride|glimepiride|mesh-list
110982678|NCT02443922|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110982679|NCT02443922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110982680|NCT02443922|Incretins|incretins|mesh-ancestor
110982681|NCT02443922|Hormones|hormones|mesh-ancestor
110982682|NCT02443922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110982683|NCT02443922|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110982684|NCT02443922|Protease Inhibitors|protease inhibitors|mesh-ancestor
110982685|NCT02443922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110982686|NCT02443922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110982687|NCT02443922|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110982688|NCT02443922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110982689|NCT02443922|Immunologic Factors|immunologic factors|mesh-ancestor
110982690|NCT04799847|Catumaxomab|catumaxomab|mesh-list
110982691|NCT04799847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110982692|NCT02439866|Methylprednisolone|methylprednisolone|mesh-list
110982693|NCT02439866|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110982694|NCT02439866|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110982695|NCT02439866|Prednisolone|prednisolone|mesh-list
110982696|NCT02439866|Prednisolone acetate|prednisolone acetate|mesh-list
110982697|NCT02439866|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110982698|NCT02439866|Prednisolone phosphate|prednisolone phosphate|mesh-list
110982699|NCT02439866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110982700|NCT02439866|Antiemetics|antiemetics|mesh-ancestor
110982701|NCT02439866|Autonomic Agents|autonomic agents|mesh-ancestor
110982702|NCT02439866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110982703|NCT02439866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110982704|NCT02439866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110982705|NCT02439866|Glucocorticoids|glucocorticoids|mesh-ancestor
110982706|NCT02439866|Hormones|hormones|mesh-ancestor
110982707|NCT02439866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110982708|NCT02439866|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110699779|NCT00377520|Pemetrexed|pemetrexed|mesh-list
110982709|NCT02439866|Protective Agents|protective agents|mesh-ancestor
110982710|NCT02439866|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110982711|NCT02439866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110982713|NCT02439788|Fludarabine|fludarabine|mesh-list
110982714|NCT02439788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110982715|NCT02439788|Immunologic Factors|immunologic factors|mesh-ancestor
110982716|NCT02439788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110982717|NCT02439788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110982718|NCT02439788|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110982719|NCT02439788|Alkylating Agents|alkylating agents|mesh-ancestor
110982720|NCT02439788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110982721|NCT02439788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110982722|NCT02439788|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110982723|NCT03188510|Mirikizumab|mirikizumab|mesh-list
110982724|NCT03188510|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110982725|NCT03188510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110982726|NCT03188510|Analgesics|analgesics|mesh-ancestor
110982727|NCT03188510|Sensory System Agents|sensory system agents|mesh-ancestor
110982728|NCT03188510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110982729|NCT03188510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110982730|NCT03188510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110982731|NCT03188510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110982732|NCT03188510|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110982733|NCT03188510|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110982734|NCT03188198|Prednisone|prednisone|mesh-list
110982735|NCT03188198|Cyclophosphamide|cyclophosphamide|mesh-list
110982736|NCT03188198|Rituximab|rituximab|mesh-list
110982737|NCT03188198|Doxorubicin|doxorubicin|mesh-list
110982738|NCT03188198|Etoposide|etoposide|mesh-list
110982739|NCT03188198|Etoposide phosphate|etoposide phosphate|mesh-list
110982740|NCT03188198|Vincristine|vincristine|mesh-list
110982741|NCT03188198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110982742|NCT03188198|Immunologic Factors|immunologic factors|mesh-ancestor
110982743|NCT03188198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110982744|NCT03188198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110982745|NCT03188198|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110982746|NCT03188198|Alkylating Agents|alkylating agents|mesh-ancestor
110982747|NCT03188198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110982748|NCT03188198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110982749|NCT03188198|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110982750|NCT03188198|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110982751|NCT03188198|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110982752|NCT03188198|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110982753|NCT03188198|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110982754|NCT03188198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110982755|NCT03188198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110982756|NCT03188198|Glucocorticoids|glucocorticoids|mesh-ancestor
110982757|NCT03188198|Hormones|hormones|mesh-ancestor
110982758|NCT03188198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110982759|NCT03188198|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110982760|NCT03188198|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110982761|NCT03188198|Tubulin Modulators|tubulin modulators|mesh-ancestor
110982762|NCT03188198|Antimitotic Agents|antimitotic agents|mesh-ancestor
110982763|NCT03188198|Mitosis Modulators|mitosis modulators|mesh-ancestor
110982764|NCT03188276|Sofosbuvir|sofosbuvir|mesh-list
110982765|NCT03188276|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
110982766|NCT03188276|Ledipasvir|ledipasvir|mesh-list
110982767|NCT03188276|Antiviral Agents|antiviral agents|mesh-ancestor
110982768|NCT03188276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110982769|NCT03190304|Enalapril|enalapril|mesh-list
110982770|NCT03190304|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
110982771|NCT03190304|Enzyme Inhibitors|enzyme inhibitors|mesh-list
110982772|NCT03190304|Protease Inhibitors|protease inhibitors|mesh-ancestor
110982773|NCT03190304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110982774|NCT03190304|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110982775|NCT02439632|Levofloxacin|levofloxacin|mesh-list
110982776|NCT02439632|Ofloxacin|ofloxacin|mesh-list
110982777|NCT02439632|Prulifloxacin|prulifloxacin|mesh-list
110982778|NCT02439632|Fluoroquinolones|fluoroquinolones|mesh-list
110982779|NCT02439632|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110982780|NCT02439632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110982781|NCT02439632|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110982782|NCT02439632|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110699857|NCT01041872|Lidocaine|lidocaine|mesh-list
110982783|NCT02439632|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110982784|NCT02439632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110982785|NCT02439632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110982786|NCT02439632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110982787|NCT02439632|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110982788|NCT02439632|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110982789|NCT02439632|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110982790|NCT02443064|Vancomycin|vancomycin|mesh-list
110982791|NCT02443064|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110982792|NCT02443064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110982793|NCT02741271|Mometasone Furoate|mometasone furoate|mesh-list
110982794|NCT02741271|Prednisone|prednisone|mesh-list
110982795|NCT02741271|Prednisolone|prednisolone|mesh-list
110982796|NCT02741271|Albuterol|albuterol|mesh-list
110982797|NCT02741271|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110982798|NCT02741271|Glucocorticoids|glucocorticoids|mesh-ancestor
110982799|NCT02741271|Hormones|hormones|mesh-ancestor
110982800|NCT02741271|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110982801|NCT02741271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110982802|NCT02741271|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110982803|NCT02741271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110982804|NCT02741271|Autonomic Agents|autonomic agents|mesh-ancestor
110982805|NCT02741271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110982806|NCT02741271|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110982807|NCT02741271|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110982808|NCT02741271|Respiratory System Agents|respiratory system agents|mesh-ancestor
110982809|NCT02741271|Tocolytic Agents|tocolytic agents|mesh-ancestor
110982810|NCT02741271|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110982811|NCT02741271|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110982812|NCT02741271|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110982813|NCT02741271|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110982814|NCT02741271|Adrenergic Agents|adrenergic agents|mesh-ancestor
110982815|NCT02741271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110982816|NCT02741271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110982817|NCT02741271|Dermatologic Agents|dermatologic agents|mesh-ancestor
110982818|NCT02741271|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110982819|NCT02443142|Acetaminophen|acetaminophen|mesh-list
110982820|NCT02443142|Ibuprofen|ibuprofen|mesh-list
110982821|NCT02443142|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110982822|NCT02443142|Analgesics|analgesics|mesh-ancestor
110982823|NCT02443142|Sensory System Agents|sensory system agents|mesh-ancestor
110982824|NCT02443142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110982825|NCT02443142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110982827|NCT02443142|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110982828|NCT02443142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110982829|NCT02443142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110982830|NCT02443142|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110982831|NCT02443142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110982832|NCT02443142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110982833|NCT03524079|Ajmaline|ajmaline|mesh-list
110982834|NCT03524079|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110982835|NCT03524079|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110450872|NCT04259073|Pregabalin|pregabalin|mesh-list
110982836|NCT03524079|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110982837|NCT03524079|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110982838|NCT03524079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110982839|NCT02438852|Ropivacaine|ropivacaine|mesh-list
110982840|NCT02438852|Anesthetics, Local|anesthetics, local|mesh-ancestor
110982841|NCT02438852|Anesthetics|anesthetics|mesh-ancestor
110982842|NCT02438852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110982843|NCT02438852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110982844|NCT02438852|Sensory System Agents|sensory system agents|mesh-ancestor
110982845|NCT02438852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110982846|NCT02442674|Tolvaptan|tolvaptan|mesh-list
110982847|NCT02442674|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
110982848|NCT02442674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110982849|NCT02442674|Natriuretic Agents|natriuretic agents|mesh-ancestor
110982850|NCT02442674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110982851|NCT02442752|Dexlansoprazole|dexlansoprazole|mesh-list
110982852|NCT02442752|Lansoprazole|lansoprazole|mesh-list
110982853|NCT02442752|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110982854|NCT02442752|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110982855|NCT02442752|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110982856|NCT02442752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110982857|NCT02442752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110982859|NCT02442362|Fluorouracil|fluorouracil|mesh-list
110982860|NCT02442362|Oxaliplatin|oxaliplatin|mesh-list
110982861|NCT02442362|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110982862|NCT02442362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110982863|NCT02442362|Tubulin Modulators|tubulin modulators|mesh-ancestor
110982864|NCT02442362|Antimitotic Agents|antimitotic agents|mesh-ancestor
110982865|NCT02442362|Mitosis Modulators|mitosis modulators|mesh-ancestor
110982866|NCT02442362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110982867|NCT02442362|Antimetabolites|antimetabolites|mesh-ancestor
110982868|NCT02442362|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110982869|NCT02442362|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110982870|NCT02442362|Immunologic Factors|immunologic factors|mesh-ancestor
110982871|NCT02442362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110982872|NCT04440488|Protease Inhibitors|protease inhibitors|mesh-list
110982873|NCT04440488|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
110982874|NCT04440488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110982875|NCT04440488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110982876|NCT04440488|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
110982877|NCT04440488|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110982878|NCT02433860|Nicotine|nicotine|mesh-list
110982879|NCT02433860|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110982880|NCT02433860|Autonomic Agents|autonomic agents|mesh-ancestor
110982881|NCT02433860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110982882|NCT02433860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110982883|NCT02433860|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110982884|NCT02433860|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110982885|NCT02433860|Cholinergic Agents|cholinergic agents|mesh-ancestor
110982886|NCT02433860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110982887|NCT02433860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110982888|NCT03189914|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110982889|NCT03189914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110982890|NCT03523455|Iron protein succinylate|iron protein succinylate|mesh-list
110982891|NCT03523455|Hematinics|hematinics|mesh-ancestor
110982892|NCT03189836|Rituximab|rituximab|mesh-list
110982893|NCT03189836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110982894|NCT03189836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110982895|NCT03189836|Immunologic Factors|immunologic factors|mesh-ancestor
110982896|NCT03189836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110982897|NCT03189836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110982898|NCT04466943|Rocuronium|rocuronium|mesh-list
110450874|NCT04259073|Sensory System Agents|sensory system agents|mesh-ancestor
110982899|NCT04466943|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110982900|NCT04466943|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110982901|NCT04466943|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110982902|NCT04466943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110982903|NCT04466943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110982904|NCT03212469|Durvalumab|durvalumab|mesh-list
110982905|NCT03212469|Tremelimumab|tremelimumab|mesh-list
110982906|NCT03212469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110982907|NCT03212469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110982908|NCT02442440|Anisodamine|anisodamine|mesh-list
110982909|NCT02442440|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110982910|NCT02442440|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110982911|NCT02442440|Adrenergic Agents|adrenergic agents|mesh-ancestor
110982912|NCT02442440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110982913|NCT02442440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110982914|NCT02442440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110982915|NCT02442440|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110982916|NCT02442440|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110982917|NCT02442440|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110982918|NCT02442440|Analgesics|analgesics|mesh-ancestor
110982919|NCT02442440|Sensory System Agents|sensory system agents|mesh-ancestor
110982920|NCT02442440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110982921|NCT02442440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110982922|NCT02442440|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110699989|NCT01042730|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110699990|NCT01042730|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110699991|NCT01042730|Antimetabolites|antimetabolites|mesh-ancestor
110699992|NCT01042730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110699993|NCT01042730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110699994|NCT01042730|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110699995|NCT00396812|Rituximab|rituximab|mesh-list
110982923|NCT02442440|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110982924|NCT02442440|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110982925|NCT02442440|Parasympatholytics|parasympatholytics|mesh-ancestor
110982926|NCT02442440|Autonomic Agents|autonomic agents|mesh-ancestor
110982927|NCT02442440|Vasodilator Agents|vasodilator agents|mesh-ancestor
110982928|NCT02442440|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110982929|NCT02442440|Antioxidants|antioxidants|mesh-ancestor
110982930|NCT02442440|Protective Agents|protective agents|mesh-ancestor
110982931|NCT03187496|Midazolam|midazolam|mesh-list
110982932|NCT03187496|Caffeine|caffeine|mesh-list
110982933|NCT03187496|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110982934|NCT03187496|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110982935|NCT03187496|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110982936|NCT03187496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110982937|NCT03187496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110982938|NCT03187496|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110982939|NCT03187496|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110982940|NCT03187496|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110982941|NCT03187496|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110982942|NCT03187496|Anesthetics, General|anesthetics, general|mesh-ancestor
110982943|NCT03187496|Anesthetics|anesthetics|mesh-ancestor
110982944|NCT03187496|GABA Modulators|gaba modulators|mesh-ancestor
110982945|NCT03187496|GABA Agents|gaba agents|mesh-ancestor
110982946|NCT03187496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110982947|NCT03187496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110982948|NCT03187496|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110982949|NCT03187496|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110982950|NCT03187496|Antimetabolites|antimetabolites|mesh-ancestor
110982951|NCT03187496|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110982952|NCT03187496|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110982953|NCT03187496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110982954|NCT03187496|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110982955|NCT03187496|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110982956|NCT03187496|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110982957|NCT03187496|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110982958|NCT03187496|Purinergic Agents|purinergic agents|mesh-ancestor
110982959|NCT02438072|Fexofenadine|fexofenadine|mesh-list
110982960|NCT02438072|Flurbiprofen|flurbiprofen|mesh-list
110982961|NCT02438072|Midazolam|midazolam|mesh-list
110982962|NCT02438072|Dextromethorphan|dextromethorphan|mesh-list
110982963|NCT02438072|Caffeine|caffeine|mesh-list
110982964|NCT02438072|Bupropion|bupropion|mesh-list
110982965|NCT02438072|Omeprazole|omeprazole|mesh-list
110982966|NCT02438072|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110982967|NCT02438072|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110982968|NCT02438072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110982969|NCT02438072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110982970|NCT02438072|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110982971|NCT02438072|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110982972|NCT02438072|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110982973|NCT02438072|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110982974|NCT02438072|Anesthetics, General|anesthetics, general|mesh-ancestor
110982975|NCT02438072|Anesthetics|anesthetics|mesh-ancestor
110982976|NCT02438072|GABA Modulators|gaba modulators|mesh-ancestor
110982977|NCT02438072|GABA Agents|gaba agents|mesh-ancestor
110982978|NCT02438072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110982979|NCT02438072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110982980|NCT02438072|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110982981|NCT02438072|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110982982|NCT02438072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110982983|NCT02438072|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110982984|NCT02438072|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110982985|NCT02438072|Purinergic Agents|purinergic agents|mesh-ancestor
110982986|NCT02438072|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110982987|NCT02438072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110982988|NCT02438072|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110982989|NCT02438072|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110982990|NCT02438072|Antidepressive Agents|antidepressive agents|mesh-ancestor
110982991|NCT02438072|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110982992|NCT02438072|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110982993|NCT02438072|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110982994|NCT02438072|Dopamine Agents|dopamine agents|mesh-ancestor
110982995|NCT02438072|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110982996|NCT02438072|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110982997|NCT02438072|Antitussive Agents|antitussive agents|mesh-ancestor
110982998|NCT02438072|Respiratory System Agents|respiratory system agents|mesh-ancestor
110982999|NCT02438072|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110983000|NCT02438072|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110983001|NCT02438072|Analgesics|analgesics|mesh-ancestor
110983002|NCT02438072|Sensory System Agents|sensory system agents|mesh-ancestor
110983003|NCT02438072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110983004|NCT02438072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110983005|NCT02438072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110983006|NCT02438072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110983007|NCT02438072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110983008|NCT02438072|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110983009|NCT02438072|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110983010|NCT02438072|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110983011|NCT02438072|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110983012|NCT02438072|Histamine Antagonists|histamine antagonists|mesh-ancestor
110983013|NCT02438072|Histamine Agents|histamine agents|mesh-ancestor
110983014|NCT03522987|Escitalopram|escitalopram|mesh-list
110983015|NCT03522987|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110983016|NCT03522987|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110983017|NCT03522987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110983018|NCT03522987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110983019|NCT03522987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110983020|NCT03522987|Serotonin Agents|serotonin agents|mesh-ancestor
110983021|NCT03522987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110983023|NCT02433626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110983024|NCT02442128|Fentanyl|fentanyl|mesh-list
110983025|NCT02442128|Propofol|propofol|mesh-list
110486693|NCT00740545|Enoxaparin|enoxaparin|mesh-list
110983026|NCT02442128|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110983027|NCT02442128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110983028|NCT02442128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110983029|NCT02442128|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110983030|NCT02442128|Anesthetics, General|anesthetics, general|mesh-ancestor
110983031|NCT02442128|Anesthetics|anesthetics|mesh-ancestor
110983032|NCT02442128|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110983033|NCT02442128|Narcotics|narcotics|mesh-ancestor
110983034|NCT02442128|Analgesics|analgesics|mesh-ancestor
110983035|NCT02442128|Sensory System Agents|sensory system agents|mesh-ancestor
110983036|NCT02442128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110983037|NCT02442128|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110983038|NCT04465773|Remifentanil|remifentanil|mesh-list
110983039|NCT04465773|Propofol|propofol|mesh-list
110983040|NCT04465773|Anesthetics|anesthetics|mesh-ancestor
110983041|NCT04465773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110983042|NCT04465773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110983043|NCT04465773|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110983044|NCT04465773|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110983045|NCT04465773|Anesthetics, General|anesthetics, general|mesh-ancestor
110983046|NCT04465773|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110983048|NCT04465773|Analgesics|analgesics|mesh-ancestor
110983049|NCT04465773|Sensory System Agents|sensory system agents|mesh-ancestor
110983050|NCT04465773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110983051|NCT02709746|Vortioxetine|vortioxetine|mesh-list
110983052|NCT02709746|Fluoxetine|fluoxetine|mesh-list
110983053|NCT02709746|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110983054|NCT02709746|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110983055|NCT02709746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110983056|NCT02709746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110983057|NCT02709746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110983058|NCT02709746|Serotonin Agents|serotonin agents|mesh-ancestor
110983059|NCT02709746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110983060|NCT02709746|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110983061|NCT02709746|Antidepressive Agents|antidepressive agents|mesh-ancestor
110983062|NCT02709746|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110983063|NCT02709746|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110983064|NCT02709746|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110983065|NCT02709746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110983066|NCT02709746|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110983067|NCT02709746|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110983068|NCT02709746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110983069|NCT02709746|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110983070|NCT02709746|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110983071|NCT02709746|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110983072|NCT02709746|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110983073|NCT02441894|Diphenhydramine|diphenhydramine|mesh-list
110983074|NCT02441894|Promethazine|promethazine|mesh-list
110983075|NCT02441894|Dexamethasone|dexamethasone|mesh-list
110983076|NCT02441894|Prednisolone|prednisolone|mesh-list
110983077|NCT02441894|Ondansetron|ondansetron|mesh-list
110983078|NCT02441894|Metoclopramide|metoclopramide|mesh-list
110983079|NCT02441894|Granisetron|granisetron|mesh-list
110983080|NCT02441894|Ranitidine|ranitidine|mesh-list
110983081|NCT02441894|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
110983082|NCT02441894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110983083|NCT02441894|Antiemetics|antiemetics|mesh-ancestor
110983084|NCT02441894|Autonomic Agents|autonomic agents|mesh-ancestor
110983085|NCT02441894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110983086|NCT02441894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110983087|NCT02441894|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110983088|NCT02441894|Glucocorticoids|glucocorticoids|mesh-ancestor
110983089|NCT02441894|Hormones|hormones|mesh-ancestor
110983090|NCT02441894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110983091|NCT02441894|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110983092|NCT02441894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110983093|NCT02441894|Antipruritics|antipruritics|mesh-ancestor
110983094|NCT02441894|Dermatologic Agents|dermatologic agents|mesh-ancestor
110983095|NCT02441894|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110983096|NCT02441894|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110983097|NCT02441894|Serotonin Agents|serotonin agents|mesh-ancestor
110983098|NCT02441894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110450900|NCT01114373|Protective Agents|protective agents|mesh-ancestor
110983099|NCT02441894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110983100|NCT02441894|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110983101|NCT02441894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110983102|NCT02441894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110983103|NCT02441894|Anesthetics, Local|anesthetics, local|mesh-ancestor
110983104|NCT02441894|Anesthetics|anesthetics|mesh-ancestor
110983105|NCT02441894|Sensory System Agents|sensory system agents|mesh-ancestor
110983106|NCT02441894|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110983107|NCT02441894|Histamine Antagonists|histamine antagonists|mesh-ancestor
110983108|NCT02441894|Histamine Agents|histamine agents|mesh-ancestor
110983109|NCT02441894|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110983110|NCT02441894|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110983111|NCT02441894|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110983112|NCT02441894|Dopamine Agents|dopamine agents|mesh-ancestor
110983113|NCT02441894|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110983114|NCT02441894|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110983115|NCT02433704|Cefazolin|cefazolin|mesh-list
110983116|NCT02433704|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110983117|NCT02433704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110983118|NCT05453825|Paclitaxel|paclitaxel|mesh-list
110983119|NCT05453825|Irinotecan|irinotecan|mesh-list
110983120|NCT05453825|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110983121|NCT05453825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110983122|NCT05453825|Tubulin Modulators|tubulin modulators|mesh-ancestor
110983123|NCT05453825|Antimitotic Agents|antimitotic agents|mesh-ancestor
110983124|NCT05453825|Mitosis Modulators|mitosis modulators|mesh-ancestor
110983125|NCT05453825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110983126|NCT05453825|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110983127|NCT05453825|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110983128|NCT05453825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110983129|NCT02441816|Aflibercept|aflibercept|mesh-list
110983130|NCT02441816|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110983131|NCT02441816|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110983132|NCT02441816|Growth Substances|growth substances|mesh-ancestor
110983133|NCT02441816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110983134|NCT02441816|Growth Inhibitors|growth inhibitors|mesh-ancestor
110983135|NCT02441816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110983136|NCT02433314|Brexanolone|brexanolone|mesh-list
110983137|NCT02433314|Neurosteroids|neurosteroids|mesh-ancestor
110983138|NCT02433314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110983139|NCT02433314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110983140|NCT02433314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110983141|NCT02433314|GABA Modulators|gaba modulators|mesh-ancestor
110983142|NCT02433314|GABA Agents|gaba agents|mesh-ancestor
110983143|NCT02290431|Dexamethasone|dexamethasone|mesh-list
110983144|NCT02290431|Bortezomib|bortezomib|mesh-list
110983145|NCT02290431|Panobinostat|panobinostat|mesh-list
110983146|NCT02290431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110983147|NCT02290431|Antiemetics|antiemetics|mesh-ancestor
110983148|NCT02290431|Autonomic Agents|autonomic agents|mesh-ancestor
110983149|NCT02290431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110983150|NCT02290431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110983151|NCT02290431|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110983153|NCT02290431|Hormones|hormones|mesh-ancestor
110983154|NCT02290431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110983155|NCT02290431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110983156|NCT02290431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110983157|NCT02290431|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110983158|NCT02290431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110983159|NCT02290431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110983160|NCT02441270|Cyclophosphamide|cyclophosphamide|mesh-list
110983161|NCT02441270|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110983162|NCT02441270|Immunologic Factors|immunologic factors|mesh-ancestor
110983163|NCT02441270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110983164|NCT02441270|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110983165|NCT02441270|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110983166|NCT02441270|Alkylating Agents|alkylating agents|mesh-ancestor
110983167|NCT02441270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110983168|NCT02441270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110983169|NCT02441270|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110983170|NCT02436980|Midazolam|midazolam|mesh-list
110983171|NCT02436980|Tramadol|tramadol|mesh-list
110983172|NCT02436980|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110983173|NCT02436980|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110983174|NCT02436980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110983175|NCT02436980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110983176|NCT02436980|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110983177|NCT02436980|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110983178|NCT02436980|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110983179|NCT02436980|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110983180|NCT02436980|Anesthetics, General|anesthetics, general|mesh-ancestor
110983181|NCT02436980|Anesthetics|anesthetics|mesh-ancestor
110983182|NCT02436980|GABA Modulators|gaba modulators|mesh-ancestor
110983183|NCT02436980|GABA Agents|gaba agents|mesh-ancestor
110983184|NCT02436980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110983185|NCT02436980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110983186|NCT02436980|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110983187|NCT02436980|Narcotics|narcotics|mesh-ancestor
110983188|NCT02436980|Analgesics|analgesics|mesh-ancestor
110983189|NCT02436980|Sensory System Agents|sensory system agents|mesh-ancestor
110983190|NCT02436980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110983191|NCT02436902|Sorafenib|sorafenib|mesh-list
110983192|NCT02436902|Chlorotrianisene|chlorotrianisene|mesh-list
110983193|NCT02436902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110983194|NCT02436902|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110983195|NCT02436902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110983196|NCT02436902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110983197|NCT02436902|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
110983198|NCT02436902|Estrogens|estrogens|mesh-ancestor
110983199|NCT02436902|Hormones|hormones|mesh-ancestor
110983200|NCT02436902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110983201|NCT02436902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110983202|NCT02436902|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110983203|NCT02436512|Nitric Oxide|nitric oxide|mesh-list
110983204|NCT02436512|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110983205|NCT02436512|Autonomic Agents|autonomic agents|mesh-ancestor
110983206|NCT02436512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110983207|NCT02436512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110983208|NCT02436512|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110983209|NCT02436512|Respiratory System Agents|respiratory system agents|mesh-ancestor
110983210|NCT02436512|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110983211|NCT02436512|Antioxidants|antioxidants|mesh-ancestor
110983212|NCT02436512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110983213|NCT02436512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110983214|NCT02436512|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
110983215|NCT02436512|Vasodilator Agents|vasodilator agents|mesh-ancestor
110983216|NCT02436512|Gasotransmitters|gasotransmitters|mesh-ancestor
110983217|NCT02436512|Protective Agents|protective agents|mesh-ancestor
110983218|NCT04466241|Ritonavir|ritonavir|mesh-list
110983219|NCT04466241|Lopinavir|lopinavir|mesh-list
110983220|NCT04466241|Telmisartan|telmisartan|mesh-list
110983221|NCT04466241|Atorvastatin|atorvastatin|mesh-list
110983222|NCT04466241|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110983223|NCT04466241|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110983224|NCT04466241|Antimetabolites|antimetabolites|mesh-ancestor
110983225|NCT04466241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110700295|NCT00278889|Antidotes|antidotes|mesh-ancestor
110983226|NCT04466241|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110983227|NCT04466241|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110983228|NCT04466241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110983229|NCT04466241|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110983230|NCT04466241|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110983231|NCT04466241|Protease Inhibitors|protease inhibitors|mesh-ancestor
110983232|NCT04466241|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110983233|NCT04466241|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110983234|NCT04466241|Antiviral Agents|antiviral agents|mesh-ancestor
110983235|NCT04466241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110983236|NCT04466241|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110983237|NCT04466241|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110983238|NCT04466241|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110983239|NCT04466241|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110983240|NCT04466241|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110983241|NCT02440880|Dexamethasone|dexamethasone|mesh-list
110983242|NCT02440880|Dexamethasone acetate|dexamethasone acetate|mesh-list
110983243|NCT02440880|BB 1101|bb 1101|mesh-list
110983244|NCT02440880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110983245|NCT02440880|Antiemetics|antiemetics|mesh-ancestor
110983246|NCT02440880|Autonomic Agents|autonomic agents|mesh-ancestor
110983247|NCT02440880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110983248|NCT02440880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110983249|NCT02440880|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110983250|NCT02440880|Glucocorticoids|glucocorticoids|mesh-ancestor
110983251|NCT02440880|Hormones|hormones|mesh-ancestor
110983252|NCT02440880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110983253|NCT02440880|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110983254|NCT02440880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110983255|NCT02440880|Protease Inhibitors|protease inhibitors|mesh-ancestor
110983256|NCT02440880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110983257|NCT02440880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110983258|NCT03186482|Rifampin|rifampin|mesh-list
110983259|NCT03186482|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
110983260|NCT03186482|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110983261|NCT03186482|Antitubercular Agents|antitubercular agents|mesh-ancestor
110983262|NCT03186482|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110983263|NCT03186482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110983264|NCT03186482|Leprostatic Agents|leprostatic agents|mesh-ancestor
110983265|NCT03186482|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110983266|NCT03186482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110983267|NCT03186482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110983268|NCT03186482|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110983269|NCT03186482|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110983270|NCT03186482|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110983271|NCT03186482|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110983272|NCT03186482|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110983273|NCT03186482|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110983274|NCT03186482|Antiviral Agents|antiviral agents|mesh-ancestor
110983275|NCT03186482|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110983276|NCT03186482|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110983277|NCT03186482|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110983278|NCT03522207|Trazodone|trazodone|mesh-list
110983279|NCT03522207|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110983280|NCT03522207|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110983281|NCT03522207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110983282|NCT03522207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110983283|NCT03522207|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110983284|NCT03522207|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110983285|NCT03522207|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110983286|NCT03522207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110983287|NCT03522207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110983288|NCT03522207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110983289|NCT03522207|Serotonin Agents|serotonin agents|mesh-ancestor
110983290|NCT03522207|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110983291|NCT03522207|Antidepressive Agents|antidepressive agents|mesh-ancestor
110983292|NCT03528057|Hemostatics|hemostatics|mesh-list
110983293|NCT03528057|Coagulants|coagulants|mesh-ancestor
110983294|NCT05018273|Atezolizumab|atezolizumab|mesh-list
110983295|NCT05018273|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110983296|NCT05018273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110983297|NCT05018273|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110983298|NCT05018273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110983300|NCT02707952|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110983301|NCT02707952|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110983302|NCT02707952|Protease Inhibitors|protease inhibitors|mesh-ancestor
110983303|NCT02707952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110983304|NCT02707952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110983305|NCT02707952|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110983306|NCT02707952|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110983307|NCT02707952|Antiviral Agents|antiviral agents|mesh-ancestor
110983308|NCT02707952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110983309|NCT02707952|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110983310|NCT02707952|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110983311|NCT02291211|Cisplatin|cisplatin|mesh-list
110983312|NCT02291211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110983313|NCT05392101|Deferasirox|deferasirox|mesh-list
110983314|NCT05392101|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110983315|NCT05392101|Chelating Agents|chelating agents|mesh-ancestor
110983316|NCT05392101|Sequestering Agents|sequestering agents|mesh-ancestor
110983317|NCT05392101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110983318|NCT02291367|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110983319|NCT02291367|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110983320|NCT02291367|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110983321|NCT02291367|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110983322|NCT02291367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110983323|NCT02291367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110983324|NCT02291367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110983325|NCT02291367|Analgesics|analgesics|mesh-ancestor
110983326|NCT02291367|Sensory System Agents|sensory system agents|mesh-ancestor
110983327|NCT02291367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110983328|NCT02291367|Antidepressive Agents|antidepressive agents|mesh-ancestor
110983329|NCT02291367|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110983330|NCT02291367|Dopamine Agents|dopamine agents|mesh-ancestor
110983331|NCT02440958|Folfirinox|folfirinox|mesh-list
110983332|NCT02440958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110983333|NCT02432534|Atorvastatin|atorvastatin|mesh-list
110983334|NCT02432534|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110983335|NCT02432534|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110983336|NCT02432534|Antimetabolites|antimetabolites|mesh-ancestor
110983337|NCT02432534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110983338|NCT02432534|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110983339|NCT02432534|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110983340|NCT02432534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110983341|NCT02432612|Nabiximols|nabiximols|mesh-list
110983342|NCT02432612|Analgesics|analgesics|mesh-ancestor
110983343|NCT02432612|Sensory System Agents|sensory system agents|mesh-ancestor
110983344|NCT02432612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110983345|NCT02432612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110983346|NCT05705843|Vancomycin|vancomycin|mesh-list
110983347|NCT05705843|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110983348|NCT05705843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110983349|NCT02436044|Leucovorin|leucovorin|mesh-list
110983350|NCT02436044|Fluorouracil|fluorouracil|mesh-list
110983351|NCT02436044|Oxaliplatin|oxaliplatin|mesh-list
110983352|NCT02436044|Levoleucovorin|levoleucovorin|mesh-list
110983353|NCT02436044|Antimetabolites|antimetabolites|mesh-ancestor
110983354|NCT02436044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110450939|NCT01030458|Amlodipine|amlodipine|mesh-list
110983355|NCT02436044|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110983356|NCT02436044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110983357|NCT02436044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110983358|NCT02436044|Immunologic Factors|immunologic factors|mesh-ancestor
110983359|NCT02436044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110983360|NCT02436044|Antidotes|antidotes|mesh-ancestor
110983361|NCT02436044|Protective Agents|protective agents|mesh-ancestor
110983362|NCT02436044|Vitamin B Complex|vitamin b complex|mesh-ancestor
110983363|NCT02436044|Vitamins|vitamins|mesh-ancestor
110983364|NCT02436044|Micronutrients|micronutrients|mesh-ancestor
110983365|NCT02435732|Heparin|heparin|mesh-list
110983366|NCT02435732|Anticoagulants|anticoagulants|mesh-ancestor
110983367|NCT02435732|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110983368|NCT02435732|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110983369|NCT02435732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110983370|NCT02435654|Olanzapine|olanzapine|mesh-list
110983371|NCT02435654|Antiemetics|antiemetics|mesh-ancestor
110983372|NCT02435654|Autonomic Agents|autonomic agents|mesh-ancestor
110983373|NCT02435654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110983374|NCT02435654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110983375|NCT02435654|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110983376|NCT02435654|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110983377|NCT02435654|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110983378|NCT02435654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110983379|NCT02435654|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110983380|NCT02435654|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110983381|NCT02435654|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110983382|NCT02435654|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110983383|NCT02435654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110983384|NCT02435654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110983385|NCT02435654|Serotonin Agents|serotonin agents|mesh-ancestor
110983386|NCT03191162|Benzonidazole|benzonidazole|mesh-list
110983387|NCT03191162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110983388|NCT03191162|Immunologic Factors|immunologic factors|mesh-ancestor
110983389|NCT03191162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110983390|NCT03191162|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
110983391|NCT03191162|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110983392|NCT03191162|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110983393|NCT03191162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110983394|NCT05571527|Hyaluronic Acid|hyaluronic acid|mesh-list
110983395|NCT05571527|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110983396|NCT05571527|Immunologic Factors|immunologic factors|mesh-ancestor
110983397|NCT05571527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110983398|NCT05571527|Viscosupplements|viscosupplements|mesh-ancestor
110983399|NCT05571527|Protective Agents|protective agents|mesh-ancestor
110983400|NCT02432066|3-(2,4-dimethoxybenzylidene)anabaseine|3-(2,4-dimethoxybenzylidene)anabaseine|mesh-list
110983401|NCT02432066|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110983402|NCT02432066|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110983403|NCT02432066|Cholinergic Agents|cholinergic agents|mesh-ancestor
110983404|NCT02432066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110983405|NCT02432066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110983406|NCT02432066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110983407|NCT05233514|Metformin|metformin|mesh-list
110983408|NCT05233514|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110983409|NCT05233514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110983410|NCT02431832|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
110983411|NCT02431832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110983412|NCT02431832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110983413|NCT02431832|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110983414|NCT02431832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110983415|NCT02431832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110983416|NCT02435186|Paclitaxel|paclitaxel|mesh-list
110983417|NCT02435186|Cisplatin|cisplatin|mesh-list
110983418|NCT02435186|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110983419|NCT02435186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110983420|NCT02435186|Tubulin Modulators|tubulin modulators|mesh-ancestor
110983421|NCT02435186|Antimitotic Agents|antimitotic agents|mesh-ancestor
110983422|NCT02435186|Mitosis Modulators|mitosis modulators|mesh-ancestor
110983423|NCT02435186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110983424|NCT02435108|Crizotinib|crizotinib|mesh-list
110983425|NCT02435108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110983426|NCT02435108|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110983427|NCT02435108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110983428|NCT02435108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110983429|NCT02434952|Primaquine|primaquine|mesh-list
110983430|NCT02434952|Piperaquine|piperaquine|mesh-list
110983431|NCT02434952|Artenimol|artenimol|mesh-list
110983432|NCT02434952|Antimalarials|antimalarials|mesh-ancestor
110983433|NCT02434952|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110983434|NCT02434952|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110983435|NCT02434952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110983436|NCT03117920|14-O-phosphonooxymethyltriptolide disodium salt|14-o-phosphonooxymethyltriptolide disodium salt|mesh-list
110983437|NCT03117920|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110983438|NCT03117920|Alkylating Agents|alkylating agents|mesh-ancestor
110983439|NCT03117920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110983440|NCT03117920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110983441|NCT03626753|Acetaminophen|acetaminophen|mesh-list
110983442|NCT03626753|Piroxicam|piroxicam|mesh-list
110983443|NCT03626753|Nefopam|nefopam|mesh-list
110983444|NCT03626753|Proroxan|proroxan|mesh-list
110983445|NCT03626753|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110983446|NCT03626753|Analgesics|analgesics|mesh-ancestor
110983447|NCT03626753|Sensory System Agents|sensory system agents|mesh-ancestor
110983448|NCT03626753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110983449|NCT03626753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110983451|NCT03626753|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110983452|NCT03626753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110983453|NCT03626753|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110983454|NCT03626753|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110983455|NCT03626753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110983456|NCT03626753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110983457|NCT03626753|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110983458|NCT03626753|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110983459|NCT03626753|Adrenergic Agents|adrenergic agents|mesh-ancestor
110983460|NCT03626753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110983461|NCT03626753|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110983462|NCT02440256|Analgesics, Opioid|analgesics, opioid|mesh-list
110983463|NCT02440256|Narcotics|narcotics|mesh-ancestor
110983464|NCT02440256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110983465|NCT02440256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110983466|NCT02440256|Analgesics|analgesics|mesh-ancestor
110983467|NCT02440256|Sensory System Agents|sensory system agents|mesh-ancestor
110983468|NCT02440256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110983469|NCT05157698|Naltrexone|naltrexone|mesh-list
110983470|NCT05157698|Bupropion|bupropion|mesh-list
110983471|NCT05157698|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110983472|NCT05157698|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110983473|NCT05157698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110983474|NCT05157698|Sensory System Agents|sensory system agents|mesh-ancestor
110983475|NCT05157698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110983476|NCT05157698|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110983477|NCT05157698|Antidepressive Agents|antidepressive agents|mesh-ancestor
110983478|NCT05157698|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110983479|NCT05157698|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110983480|NCT05157698|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110983481|NCT05157698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110983482|NCT05157698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110983483|NCT05157698|Dopamine Agents|dopamine agents|mesh-ancestor
110983484|NCT05157698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110983485|NCT05157698|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110983486|NCT05157698|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110983487|NCT05157698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110983488|NCT03185624|Rifaximin|rifaximin|mesh-list
110983489|NCT03185624|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110983490|NCT03185624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110983491|NCT03185624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110983492|NCT02707640|Acetylcysteine|acetylcysteine|mesh-list
110983493|NCT02707640|Pirfenidone|pirfenidone|mesh-list
110983494|NCT02707640|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110983495|NCT02707640|Antiviral Agents|antiviral agents|mesh-ancestor
110983496|NCT02707640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110983497|NCT02707640|Expectorants|expectorants|mesh-ancestor
110983498|NCT02707640|Respiratory System Agents|respiratory system agents|mesh-ancestor
110983499|NCT02707640|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110983500|NCT02707640|Antioxidants|antioxidants|mesh-ancestor
110983501|NCT02707640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110983502|NCT02707640|Protective Agents|protective agents|mesh-ancestor
110983503|NCT02707640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110983504|NCT02707640|Antidotes|antidotes|mesh-ancestor
110983505|NCT02707640|Analgesics|analgesics|mesh-ancestor
110983506|NCT02707640|Sensory System Agents|sensory system agents|mesh-ancestor
110983507|NCT02707640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110983508|NCT02707640|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110983509|NCT02707640|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110983510|NCT02707640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110983511|NCT02707640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110983512|NCT02707640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110983513|NCT03190694|Dapagliflozin|dapagliflozin|mesh-list
110983514|NCT03190694|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110983515|NCT03190694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110983516|NCT03190694|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110983517|NCT03190694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110983518|NCT02430272|Glycopyrrolate|glycopyrrolate|mesh-list
110983519|NCT02430272|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110983520|NCT02430272|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110983521|NCT02430272|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110983522|NCT02430272|Cholinergic Agents|cholinergic agents|mesh-ancestor
110983523|NCT02430272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110983524|NCT02430272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110983525|NCT02430272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110983526|NCT03188978|Atorvastatin|atorvastatin|mesh-list
110983527|NCT03188978|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110983528|NCT03188978|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110983529|NCT03188978|Antimetabolites|antimetabolites|mesh-ancestor
110983530|NCT03188978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110983531|NCT03188978|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110983532|NCT03188978|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110983533|NCT03188978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110983534|NCT02431286|Dexamethasone|dexamethasone|mesh-list
110983536|NCT02431286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110983537|NCT02431286|Antiemetics|antiemetics|mesh-ancestor
110983538|NCT02431286|Autonomic Agents|autonomic agents|mesh-ancestor
110983539|NCT02431286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110983540|NCT02431286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110983541|NCT02431286|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110983542|NCT02431286|Glucocorticoids|glucocorticoids|mesh-ancestor
110983543|NCT02431286|Hormones|hormones|mesh-ancestor
110983544|NCT02431286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110983545|NCT02431286|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110983546|NCT02431286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110983547|NCT02431286|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110983548|NCT02431286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110983549|NCT02431286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110983550|NCT02431208|Dexamethasone|dexamethasone|mesh-list
110983551|NCT02431208|Lenalidomide|lenalidomide|mesh-list
110983552|NCT02431208|Atezolizumab|atezolizumab|mesh-list
110983553|NCT02431208|Daratumumab|daratumumab|mesh-list
110983554|NCT02431208|Pomalidomide|pomalidomide|mesh-list
110983555|NCT02431208|Antibodies|antibodies|mesh-list
110983556|NCT02431208|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110983557|NCT02431208|Immunologic Factors|immunologic factors|mesh-ancestor
110983558|NCT02431208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110983559|NCT02431208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110983560|NCT02431208|Antiemetics|antiemetics|mesh-ancestor
110983561|NCT02431208|Autonomic Agents|autonomic agents|mesh-ancestor
110983562|NCT02431208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110983563|NCT02431208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110983564|NCT02431208|Glucocorticoids|glucocorticoids|mesh-ancestor
110983565|NCT02431208|Hormones|hormones|mesh-ancestor
110450958|NCT01030458|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110983566|NCT02431208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110983567|NCT02431208|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110983569|NCT02431208|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110983570|NCT02431208|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110983571|NCT02431208|Growth Substances|growth substances|mesh-ancestor
110983572|NCT02431208|Growth Inhibitors|growth inhibitors|mesh-ancestor
110983573|NCT02431208|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110983574|NCT02431208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110983575|NCT02431208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110983576|NCT03107078|Methylprednisolone|methylprednisolone|mesh-list
110983577|NCT03107078|Glucocorticoids|glucocorticoids|mesh-list
110983578|NCT03107078|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110983579|NCT03107078|Antiemetics|antiemetics|mesh-ancestor
110983580|NCT03107078|Autonomic Agents|autonomic agents|mesh-ancestor
110983581|NCT03107078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110983582|NCT03107078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110983583|NCT03107078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110983584|NCT03107078|Hormones|hormones|mesh-ancestor
110983585|NCT03107078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110983586|NCT03107078|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110983587|NCT03107078|Protective Agents|protective agents|mesh-ancestor
110983588|NCT02430350|Edaravone|edaravone|mesh-list
110983589|NCT02430350|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110983590|NCT02430350|Antioxidants|antioxidants|mesh-ancestor
110983591|NCT02430350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110983592|NCT02430350|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110983593|NCT02430350|Protective Agents|protective agents|mesh-ancestor
110983594|NCT02430350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110983595|NCT02429960|Remifentanil|remifentanil|mesh-list
110983596|NCT02429960|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110983597|NCT02429960|Narcotics|narcotics|mesh-ancestor
110983598|NCT02429960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110983599|NCT02429960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110983600|NCT02429960|Analgesics|analgesics|mesh-ancestor
110983601|NCT02429960|Sensory System Agents|sensory system agents|mesh-ancestor
110983602|NCT02429960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110983604|NCT02429804|Deoxyglucose|deoxyglucose|mesh-list
110983605|NCT02429804|Fluorides|fluorides|mesh-list
110983606|NCT02429804|Sodium Fluoride|sodium fluoride|mesh-list
110983607|NCT02429804|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110983608|NCT02429804|Cariostatic Agents|cariostatic agents|mesh-ancestor
110983609|NCT02429804|Protective Agents|protective agents|mesh-ancestor
110983610|NCT02429804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110983611|NCT02429804|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110983612|NCT02429804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110983613|NCT02429804|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110983614|NCT02429804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110983615|NCT02429804|Antimetabolites|antimetabolites|mesh-ancestor
110983616|NCT02429804|Antiviral Agents|antiviral agents|mesh-ancestor
110983617|NCT03185156|Propofol|propofol|mesh-list
110983618|NCT03185156|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110983619|NCT03185156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110983620|NCT03185156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110983621|NCT03185156|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110983622|NCT03185156|Anesthetics, General|anesthetics, general|mesh-ancestor
110983623|NCT03185156|Anesthetics|anesthetics|mesh-ancestor
110983624|NCT02429726|Cisplatin|cisplatin|mesh-list
110983625|NCT02429726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110983626|NCT02429882|Brodalumab|brodalumab|mesh-list
110983627|NCT02429882|Dermatologic Agents|dermatologic agents|mesh-ancestor
110983628|NCT02430896|Methylphenidate|methylphenidate|mesh-list
110983629|NCT02430896|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
110983630|NCT02430896|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110983631|NCT02430896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110983632|NCT02430896|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110983633|NCT02430896|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110983634|NCT02430896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110983635|NCT02430896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110983636|NCT02430896|Dopamine Agents|dopamine agents|mesh-ancestor
110983637|NCT02430896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110983638|NCT02430896|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110983639|NCT02430896|Adrenergic Agents|adrenergic agents|mesh-ancestor
110983640|NCT03184844|Thalidomide|thalidomide|mesh-list
110983641|NCT03184844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110983642|NCT03184844|Immunologic Factors|immunologic factors|mesh-ancestor
110983643|NCT03184844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110983644|NCT03184844|Leprostatic Agents|leprostatic agents|mesh-ancestor
110983645|NCT03184844|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110983646|NCT03184844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110983647|NCT03184844|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110983648|NCT03184844|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110983649|NCT03184844|Growth Substances|growth substances|mesh-ancestor
110983650|NCT03184844|Growth Inhibitors|growth inhibitors|mesh-ancestor
110983651|NCT03184844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110983652|NCT02425202|Ketamine|ketamine|mesh-list
110983653|NCT02425202|Analgesics|analgesics|mesh-ancestor
110983654|NCT02425202|Sensory System Agents|sensory system agents|mesh-ancestor
110983655|NCT02425202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110983656|NCT02425202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110983657|NCT02425202|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110983658|NCT02425202|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110983659|NCT02425202|Anesthetics, General|anesthetics, general|mesh-ancestor
110983660|NCT02425202|Anesthetics|anesthetics|mesh-ancestor
110983661|NCT02425202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110983662|NCT02425202|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110983663|NCT02425202|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110983664|NCT02425202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110983665|NCT02425202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110983666|NCT03182504|Meropenem|meropenem|mesh-list
110983667|NCT03182504|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110983668|NCT03182504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110983669|NCT02428946|Bromocriptine|bromocriptine|mesh-list
110983670|NCT02428946|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110983671|NCT02428946|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110983672|NCT02428946|Hormone Antagonists|hormone antagonists|mesh-ancestor
110700752|NCT00187096|Etoposide|etoposide|mesh-list
110983683|NCT02428868|Hemostatics|hemostatics|mesh-ancestor
110983684|NCT02428868|Coagulants|coagulants|mesh-ancestor
110983685|NCT03181880|Bromides|bromides|mesh-list
110983686|NCT03181880|Formoterol Fumarate|formoterol fumarate|mesh-list
110983687|NCT03181880|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110983688|NCT03181880|Autonomic Agents|autonomic agents|mesh-ancestor
110983689|NCT03181880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110983690|NCT03181880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110983691|NCT03181880|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110983692|NCT03181880|Respiratory System Agents|respiratory system agents|mesh-ancestor
110983693|NCT03181880|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110983694|NCT03181880|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110983695|NCT03181880|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110983696|NCT03181880|Adrenergic Agents|adrenergic agents|mesh-ancestor
110983697|NCT03181880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110983698|NCT03181880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110983699|NCT03181880|Anticonvulsants|anticonvulsants|mesh-ancestor
110983700|NCT03178994|Ketoconazole|ketoconazole|mesh-list
110983701|NCT03178994|Antifungal Agents|antifungal agents|mesh-ancestor
110983702|NCT03178994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110983703|NCT03178994|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110983704|NCT03178994|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110983705|NCT03178994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110983706|NCT03178994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110983707|NCT03178994|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110983708|NCT03178994|Hormone Antagonists|hormone antagonists|mesh-ancestor
110983709|NCT03178994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110983710|NCT03178994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110983711|NCT03178994|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110983712|NCT03182114|Bupivacaine|bupivacaine|mesh-list
110983713|NCT03182114|Anesthetics, Local|anesthetics, local|mesh-ancestor
110983714|NCT03182114|Anesthetics|anesthetics|mesh-ancestor
110983715|NCT03182114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110983716|NCT03182114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110983717|NCT03182114|Sensory System Agents|sensory system agents|mesh-ancestor
110983718|NCT03182114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110983719|NCT02428322|Vitamin D|vitamin d|mesh-list
110983720|NCT02428322|Cholecalciferol|cholecalciferol|mesh-list
110983721|NCT02428322|Vitamins|vitamins|mesh-ancestor
110983722|NCT02428322|Micronutrients|micronutrients|mesh-ancestor
110983723|NCT02428322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110983724|NCT02428322|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110983725|NCT02428322|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110983726|NCT03053063|Selonsertib|selonsertib|mesh-list
110983727|NCT03053063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110983728|NCT03053063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110983729|NCT03053063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110983730|NCT00702338|Hormones|hormones|mesh-list
110983731|NCT00702338|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
110983732|NCT00702338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110983733|NCT00702338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110983747|NCT02427932|Ampicillin|ampicillin|mesh-list
110983748|NCT02427932|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110983749|NCT02427932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110983750|NCT02427932|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110983751|NCT02427932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110983752|NCT02427932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110983753|NCT03626519|Menthol|menthol|mesh-list
110983754|NCT03626519|Antipruritics|antipruritics|mesh-ancestor
110983755|NCT03626519|Dermatologic Agents|dermatologic agents|mesh-ancestor
110983756|NCT03184766|Ibuprofen|ibuprofen|mesh-list
110983757|NCT03184766|Pseudoephedrine|pseudoephedrine|mesh-list
110983758|NCT03184766|Ephedrine|ephedrine|mesh-list
110983759|NCT03184766|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110983760|NCT03184766|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110983761|NCT03184766|Analgesics|analgesics|mesh-ancestor
110983762|NCT03184766|Sensory System Agents|sensory system agents|mesh-ancestor
110983763|NCT03184766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110983764|NCT03184766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110983765|NCT03184766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110983766|NCT03184766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110983767|NCT03184766|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110983768|NCT03184766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110983769|NCT03184766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110983770|NCT03184766|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110983771|NCT03184766|Autonomic Agents|autonomic agents|mesh-ancestor
110983772|NCT03184766|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110983773|NCT03184766|Respiratory System Agents|respiratory system agents|mesh-ancestor
110983774|NCT03184766|Nasal Decongestants|nasal decongestants|mesh-ancestor
110983775|NCT03184766|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110983776|NCT03184766|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110983777|NCT03184766|Sympathomimetics|sympathomimetics|mesh-ancestor
110983778|NCT03184766|Adrenergic Agents|adrenergic agents|mesh-ancestor
110983779|NCT03184766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110983780|NCT03181646|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
110983781|NCT03181646|Nootropic Agents|nootropic agents|mesh-ancestor
110983782|NCT02420834|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
110983783|NCT02420834|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110983784|NCT02420834|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110983785|NCT02420834|Laxatives|laxatives|mesh-ancestor
110983786|NCT02420834|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110983787|NCT02423954|Sirolimus|sirolimus|mesh-list
110983788|NCT02423954|Capecitabine|capecitabine|mesh-list
110983789|NCT02423954|Nivolumab|nivolumab|mesh-list
110983790|NCT02423954|Irinotecan|irinotecan|mesh-list
110983791|NCT02423954|Temsirolimus|temsirolimus|mesh-list
110983792|NCT02423954|MTOR Inhibitors|mtor inhibitors|mesh-list
110983793|NCT02423954|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110983794|NCT02423954|Antimetabolites|antimetabolites|mesh-ancestor
110983795|NCT02423954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110983796|NCT02423954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110983797|NCT02423954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110983798|NCT02423954|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110983799|NCT02423954|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110983800|NCT02423954|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110983801|NCT02423954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110983802|NCT02423954|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110983803|NCT02423954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110983804|NCT02423954|Immunologic Factors|immunologic factors|mesh-ancestor
110983805|NCT02423954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110983806|NCT02423954|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110983807|NCT02423954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110983808|NCT02423954|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110983809|NCT02423954|Antifungal Agents|antifungal agents|mesh-ancestor
110983810|NCT04221503|Niraparib|niraparib|mesh-list
110983811|NCT04221503|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110983812|NCT04221503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110983813|NCT04221503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110983814|NCT04221503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110983815|NCT02427308|Miltefosine|miltefosine|mesh-list
110983816|NCT02427308|Antifungal Agents|antifungal agents|mesh-ancestor
110983817|NCT02427308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110983818|NCT02427308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110983819|NCT02427308|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110983820|NCT02427308|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110983821|NCT03178292|Levofloxacin|levofloxacin|mesh-list
110983822|NCT03178292|Ofloxacin|ofloxacin|mesh-list
110983823|NCT03178292|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110983824|NCT03178292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110983825|NCT03178292|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110983826|NCT03178292|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110983827|NCT03178292|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110983828|NCT03178292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110983829|NCT03178292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110983830|NCT03178292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110983831|NCT03178292|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110983832|NCT03178292|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110983833|NCT02427386|Estradiol|estradiol|mesh-list
110983834|NCT02427386|Estrogens|estrogens|mesh-list
110983835|NCT02427386|Hormones|hormones|mesh-ancestor
110983836|NCT02427386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110983837|NCT02427386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110983838|NCT03181178|Micronutrients|micronutrients|mesh-list
110983839|NCT03181178|Trace Elements|trace elements|mesh-list
110983840|NCT03181178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110983841|NCT05478551|Botulinum Toxins|botulinum toxins|mesh-list
110983842|NCT05478551|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110983843|NCT05478551|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110983844|NCT05478551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110983845|NCT05478551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110983846|NCT05478551|Cholinergic Agents|cholinergic agents|mesh-ancestor
110983847|NCT05478551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110983848|NCT05478551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110983849|NCT02420444|BCG Vaccine|bcg vaccine|mesh-list
110983850|NCT02420444|Immunologic Factors|immunologic factors|mesh-ancestor
110983851|NCT02420444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110983852|NCT02420444|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110983853|NCT03180944|Lugol's solution|lugol's solution|mesh-list
110983854|NCT03180944|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110983855|NCT03180944|Hemostatics|hemostatics|mesh-ancestor
110983856|NCT03180944|Coagulants|coagulants|mesh-ancestor
110983857|NCT03180710|Insulin Lispro|insulin lispro|mesh-list
110983858|NCT03180710|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110983859|NCT03180710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110983860|NCT04322669|Pidotimod|pidotimod|mesh-list
110983861|NCT04322669|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110983862|NCT04322669|Immunologic Factors|immunologic factors|mesh-ancestor
110983863|NCT04322669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110983864|NCT03180476|Apatinib|apatinib|mesh-list
110983865|NCT03180476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110983866|NCT03180476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110983867|NCT03180476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110983868|NCT03180476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110983869|NCT03180632|Lorazepam|lorazepam|mesh-list
110983870|NCT03180632|Anticonvulsants|anticonvulsants|mesh-ancestor
110983871|NCT03180632|Antiemetics|antiemetics|mesh-ancestor
110983872|NCT03180632|Autonomic Agents|autonomic agents|mesh-ancestor
110983873|NCT03180632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110983874|NCT03180632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110983875|NCT03180632|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110983876|NCT03180632|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110450973|NCT02702674|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110983877|NCT03180632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110983878|NCT03180632|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110983879|NCT03180632|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110983880|NCT03180632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110983881|NCT03180632|GABA Modulators|gaba modulators|mesh-ancestor
110983882|NCT03180632|GABA Agents|gaba agents|mesh-ancestor
110983883|NCT03180632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110983884|NCT03180632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110983885|NCT02420132|Ranibizumab|ranibizumab|mesh-list
110983886|NCT02420132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110983887|NCT02420132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110983888|NCT02420132|Growth Substances|growth substances|mesh-ancestor
110983889|NCT02420132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110983890|NCT02420132|Growth Inhibitors|growth inhibitors|mesh-ancestor
110983891|NCT02420132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110983892|NCT03183752|Metformin|metformin|mesh-list
110983893|NCT03183752|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110983894|NCT03183752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110700969|NCT01324752|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110983895|NCT03183674|Oxytocin|oxytocin|mesh-list
110983896|NCT03183674|Oxytocics|oxytocics|mesh-ancestor
110983897|NCT03183674|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110983898|NCT03183674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110983899|NCT03117530|Minocycline|minocycline|mesh-list
110983900|NCT03117530|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110983901|NCT03117530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110983902|NCT03889925|Hyaluronic Acid|hyaluronic acid|mesh-list
110983903|NCT03889925|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110983904|NCT03889925|Immunologic Factors|immunologic factors|mesh-ancestor
110983905|NCT03889925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110983906|NCT03889925|Viscosupplements|viscosupplements|mesh-ancestor
110983907|NCT03889925|Protective Agents|protective agents|mesh-ancestor
110983908|NCT05103254|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
110983909|NCT05103254|Ezetimibe|ezetimibe|mesh-list
110983910|NCT05103254|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110983911|NCT05103254|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110983912|NCT05103254|Antimetabolites|antimetabolites|mesh-ancestor
110983913|NCT05103254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110983914|NCT05103254|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110983915|NCT05103254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110983916|NCT05103254|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110983917|NCT05103254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110983918|NCT02426840|Calcium, Dietary|calcium, dietary|mesh-list
110983919|NCT02426840|Vitamin D|vitamin d|mesh-list
110983920|NCT02426840|Ergocalciferols|ergocalciferols|mesh-list
110983921|NCT02426840|Cholecalciferol|cholecalciferol|mesh-list
110983922|NCT02426840|Vitamins|vitamins|mesh-list
110983923|NCT02426840|Calcium|calcium|mesh-list
110983924|NCT02426840|Micronutrients|micronutrients|mesh-ancestor
110983925|NCT02426840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110983926|NCT02426840|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110983927|NCT02426840|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110983928|NCT03178526|Lovastatin|lovastatin|mesh-list
110983929|NCT03178526|L 647318|l 647318|mesh-list
110983930|NCT03178526|Dihydromevinolin|dihydromevinolin|mesh-list
110983931|NCT03178526|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110983932|NCT03178526|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110983933|NCT03178526|Antimetabolites|antimetabolites|mesh-ancestor
110983934|NCT03178526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110983935|NCT03178526|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110983936|NCT03178526|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110983937|NCT03178526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110983938|NCT03857321|Insulin|insulin|mesh-list
110983939|NCT03857321|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110983940|NCT03857321|Insulin, Isophane|insulin, isophane|mesh-list
110983941|NCT03857321|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110983942|NCT03857321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110983943|NCT02423642|Heparin|heparin|mesh-list
110983944|NCT02423642|Anticoagulants|anticoagulants|mesh-ancestor
110983945|NCT02423642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110983946|NCT02423642|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110983947|NCT02423642|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110983948|NCT03180242|Trastuzumab|trastuzumab|mesh-list
110983949|NCT03180242|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110983950|NCT03180242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110983951|NCT00709904|Semuloparin|semuloparin|mesh-list
110983952|NCT00709904|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
110983953|NCT00709904|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110983954|NCT00709904|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110983955|NCT00709904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110983956|NCT00709904|Anticoagulants|anticoagulants|mesh-ancestor
110983957|NCT04356989|Rivaroxaban|rivaroxaban|mesh-list
110983958|NCT04356989|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110983959|NCT04356989|Antithrombins|antithrombins|mesh-ancestor
110983960|NCT04356989|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110983961|NCT04356989|Protease Inhibitors|protease inhibitors|mesh-ancestor
110983962|NCT04356989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110983963|NCT04356989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110983964|NCT04356989|Anticoagulants|anticoagulants|mesh-ancestor
110983965|NCT03183596|Dexamethasone|dexamethasone|mesh-list
110983966|NCT03183596|Bupivacaine|bupivacaine|mesh-list
110983967|NCT03183596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110983968|NCT03183596|Antiemetics|antiemetics|mesh-ancestor
110983969|NCT03183596|Autonomic Agents|autonomic agents|mesh-ancestor
110983970|NCT03183596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110983971|NCT03183596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110983972|NCT03183596|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110983973|NCT03183596|Glucocorticoids|glucocorticoids|mesh-ancestor
110983974|NCT03183596|Hormones|hormones|mesh-ancestor
110983975|NCT03183596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110983976|NCT03183596|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110983977|NCT03183596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110983978|NCT03183596|Anesthetics, Local|anesthetics, local|mesh-ancestor
110983979|NCT03183596|Anesthetics|anesthetics|mesh-ancestor
110983980|NCT03183596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110983981|NCT03183596|Sensory System Agents|sensory system agents|mesh-ancestor
110983982|NCT03117062|Salicylic Acid|salicylic acid|mesh-list
110983983|NCT03117062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110983984|NCT03117062|Antifungal Agents|antifungal agents|mesh-ancestor
110983985|NCT03117062|Keratolytic Agents|keratolytic agents|mesh-ancestor
110983986|NCT03117062|Dermatologic Agents|dermatologic agents|mesh-ancestor
110983987|NCT03620669|Durvalumab|durvalumab|mesh-list
110983988|NCT03620669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110983989|NCT03620669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110983990|NCT04325243|Sildenafil Citrate|sildenafil citrate|mesh-list
110983991|NCT04325243|Vasodilator Agents|vasodilator agents|mesh-ancestor
110983992|NCT04325243|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110983993|NCT04325243|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110983994|NCT04325243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110983995|NCT04325243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110983996|NCT04325243|Urological Agents|urological agents|mesh-ancestor
110983997|NCT02419820|Aspirin|aspirin|mesh-list
110983998|NCT02419820|Clopidogrel|clopidogrel|mesh-list
110984000|NCT02419820|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110984001|NCT02419820|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110984002|NCT02419820|Analgesics|analgesics|mesh-ancestor
110984003|NCT02419820|Sensory System Agents|sensory system agents|mesh-ancestor
110984004|NCT02419820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110984005|NCT02419820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110984006|NCT02419820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110984007|NCT02419820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110984008|NCT02419820|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110984009|NCT02419820|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110984010|NCT02419820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110984011|NCT02419820|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110984012|NCT02419820|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110984013|NCT02419820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110984014|NCT02419820|Antipyretics|antipyretics|mesh-ancestor
110984015|NCT02419820|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110984016|NCT02419820|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110450985|NCT02699008|Clopidogrel|clopidogrel|mesh-list
110984017|NCT02419820|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110984018|NCT02419820|Purinergic Agents|purinergic agents|mesh-ancestor
110984019|NCT02419820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110984020|NCT02419820|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110984021|NCT02419820|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110984022|NCT02419820|Serotonin Agents|serotonin agents|mesh-ancestor
110984023|NCT05692739|Cyclosporine|cyclosporine|mesh-list
110984024|NCT05692739|Lubricant Eye Drops|lubricant eye drops|mesh-list
110984025|NCT05692739|Cyclosporins|cyclosporins|mesh-list
110984026|NCT05692739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110984027|NCT05692739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110984028|NCT05692739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110984029|NCT05692739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110984030|NCT05692739|Immunologic Factors|immunologic factors|mesh-ancestor
110984031|NCT05692739|Antifungal Agents|antifungal agents|mesh-ancestor
110984032|NCT05692739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110984033|NCT05692739|Dermatologic Agents|dermatologic agents|mesh-ancestor
110984034|NCT05692739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110984035|NCT05692739|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110984036|NCT05692739|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110984037|NCT05692739|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110984038|NCT02419352|Atropine|atropine|mesh-list
110984039|NCT02419352|Neostigmine|neostigmine|mesh-list
110984040|NCT02419352|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110984041|NCT02419352|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110984042|NCT02419352|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110984043|NCT02419352|Autonomic Agents|autonomic agents|mesh-ancestor
110984044|NCT02419352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110984045|NCT02419352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110984046|NCT02419352|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110984047|NCT02419352|Respiratory System Agents|respiratory system agents|mesh-ancestor
110984048|NCT02419352|Mydriatics|mydriatics|mesh-ancestor
110984049|NCT02419352|Parasympatholytics|parasympatholytics|mesh-ancestor
110984050|NCT02419352|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110984051|NCT02419352|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110984052|NCT02419352|Cholinergic Agents|cholinergic agents|mesh-ancestor
110984053|NCT02419352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110984054|NCT02419352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110984055|NCT02419352|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110984056|NCT02419352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110984057|NCT02419352|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110984058|NCT03365687|Vitamin D|vitamin d|mesh-list
110984059|NCT03365687|Cholecalciferol|cholecalciferol|mesh-list
110984060|NCT03365687|Vitamins|vitamins|mesh-ancestor
110984061|NCT03365687|Micronutrients|micronutrients|mesh-ancestor
110984062|NCT03365687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110984063|NCT03365687|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110984064|NCT03365687|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110984065|NCT02419118|Dexamethasone|dexamethasone|mesh-list
110984066|NCT02419118|Lenalidomide|lenalidomide|mesh-list
110984067|NCT02419118|Daratumumab|daratumumab|mesh-list
110984068|NCT02419118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110984069|NCT02419118|Antiemetics|antiemetics|mesh-ancestor
110984070|NCT02419118|Autonomic Agents|autonomic agents|mesh-ancestor
110984071|NCT02419118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110984072|NCT02419118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110984073|NCT02419118|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110984074|NCT02419118|Glucocorticoids|glucocorticoids|mesh-ancestor
110984075|NCT02419118|Hormones|hormones|mesh-ancestor
110984076|NCT02419118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110984077|NCT02419118|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110984078|NCT02419118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110984079|NCT02419118|Immunologic Factors|immunologic factors|mesh-ancestor
110984080|NCT02419118|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110984081|NCT02419118|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110984082|NCT02419118|Growth Substances|growth substances|mesh-ancestor
110984083|NCT02419118|Growth Inhibitors|growth inhibitors|mesh-ancestor
110984084|NCT02426294|Pioglitazone|pioglitazone|mesh-list
110984085|NCT02426294|Glimepiride|glimepiride|mesh-list
110984086|NCT02426294|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110984087|NCT02426294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110984088|NCT02426294|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110984089|NCT02426294|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110984090|NCT02426294|Immunologic Factors|immunologic factors|mesh-ancestor
110984091|NCT02426450|Leucovorin|leucovorin|mesh-list
110984092|NCT02426450|Fluorouracil|fluorouracil|mesh-list
110984093|NCT02426450|Oxaliplatin|oxaliplatin|mesh-list
110984094|NCT02426450|Antimetabolites|antimetabolites|mesh-ancestor
110984095|NCT02426450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110984096|NCT02426450|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110984097|NCT02426450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110984098|NCT02426450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110984099|NCT02426450|Immunologic Factors|immunologic factors|mesh-ancestor
110984100|NCT02426450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110984101|NCT02426450|Antidotes|antidotes|mesh-ancestor
110984102|NCT02426450|Protective Agents|protective agents|mesh-ancestor
110984103|NCT02426450|Vitamin B Complex|vitamin b complex|mesh-ancestor
110984104|NCT02426450|Vitamins|vitamins|mesh-ancestor
110984105|NCT02426450|Micronutrients|micronutrients|mesh-ancestor
110984106|NCT02426060|Warfarin|warfarin|mesh-list
110984107|NCT02426060|Anticoagulants|anticoagulants|mesh-ancestor
110984108|NCT02422784|Vitamin D|vitamin d|mesh-list
110984109|NCT02422784|Ergocalciferols|ergocalciferols|mesh-list
110984110|NCT02422784|Cholecalciferol|cholecalciferol|mesh-list
110984111|NCT02422784|Vitamins|vitamins|mesh-list
110984112|NCT02422784|Micronutrients|micronutrients|mesh-ancestor
110984113|NCT02422784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110984114|NCT02422784|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110984115|NCT02422784|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110984116|NCT03740009|Bazedoxifene|bazedoxifene|mesh-list
110984117|NCT03740009|Estrogens|estrogens|mesh-list
110984118|NCT03740009|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
110984119|NCT03740009|Hormones|hormones|mesh-ancestor
110984120|NCT03740009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110984121|NCT03740009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110984122|NCT03740009|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110984123|NCT03740009|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110984124|NCT03740009|Hormone Antagonists|hormone antagonists|mesh-ancestor
110984125|NCT03740009|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110701196|NCT00373490|Vorinostat|vorinostat|mesh-list
110984126|NCT03179618|Vasodilator Agents|vasodilator agents|mesh-list
110984127|NCT03179618|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
110984128|NCT03179618|Lipid Regulating Agents|lipid regulating agents|mesh-list
110984129|NCT03182894|Pembrolizumab|pembrolizumab|mesh-list
110984130|NCT03182894|Azacitidine|azacitidine|mesh-list
110984131|NCT03182894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110984132|NCT03182894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110984133|NCT03182894|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110984134|NCT03182894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110984135|NCT03182894|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110984136|NCT03182894|Antimetabolites|antimetabolites|mesh-ancestor
110984137|NCT03182894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110984138|NCT02418884|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110984139|NCT02418884|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110984140|NCT02418884|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110984141|NCT02418884|Antimetabolites|antimetabolites|mesh-ancestor
110984142|NCT02418884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110984143|NCT02418884|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110984144|NCT02418884|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110984145|NCT02418884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110984146|NCT02423096|Haloperidol|haloperidol|mesh-list
110984147|NCT02423096|Olanzapine|olanzapine|mesh-list
110984148|NCT02423096|Risperidone|risperidone|mesh-list
110984149|NCT02423096|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110984150|NCT02423096|Sulpiride|sulpiride|mesh-list
110984151|NCT02423096|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110984152|NCT02423096|Serotonin Agents|serotonin agents|mesh-ancestor
110984153|NCT02423096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110450999|NCT00627666|Busulfan|busulfan|mesh-list
110984154|NCT02423096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110984155|NCT02423096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110984156|NCT02423096|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110984157|NCT02423096|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110984158|NCT02423096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110984159|NCT02423096|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110984160|NCT02423096|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110984161|NCT02423096|Dopamine Agents|dopamine agents|mesh-ancestor
110984162|NCT02423096|Antiemetics|antiemetics|mesh-ancestor
110984163|NCT02423096|Autonomic Agents|autonomic agents|mesh-ancestor
110984164|NCT02423096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110984165|NCT02423096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110984166|NCT02423096|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110984167|NCT02423096|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110984168|NCT02423096|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110984169|NCT02423096|Antidepressive Agents|antidepressive agents|mesh-ancestor
110984170|NCT02423096|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110984171|NCT02423096|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110984172|NCT03629951|Antipsychotic Agents|antipsychotic agents|mesh-list
110984173|NCT03629951|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110984174|NCT03629951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110984175|NCT03629951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110984176|NCT03629951|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110984177|NCT02423018|Pregabalin|pregabalin|mesh-list
110984178|NCT02423018|Analgesics|analgesics|mesh-ancestor
110984179|NCT02423018|Sensory System Agents|sensory system agents|mesh-ancestor
110984180|NCT02423018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110984181|NCT02423018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110984182|NCT02423018|Anticonvulsants|anticonvulsants|mesh-ancestor
110984183|NCT02423018|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110984184|NCT02423018|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110984185|NCT02423018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110984186|NCT02423018|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110984187|NCT02423018|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110984188|NCT02423018|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110984189|NCT02423018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110984190|NCT02423018|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110984191|NCT03179384|Ceftriaxone|ceftriaxone|mesh-list
110984192|NCT03179384|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110984193|NCT03179384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110984194|NCT05691959|Calcium|calcium|mesh-list
110984195|NCT05691959|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110984196|NCT05691959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110984197|NCT02422706|Metronidazole|metronidazole|mesh-list
110984198|NCT02422706|Clarithromycin|clarithromycin|mesh-list
110984199|NCT02422706|Levofloxacin|levofloxacin|mesh-list
110984200|NCT02422706|Ofloxacin|ofloxacin|mesh-list
110984201|NCT02422706|Nitazoxanide|nitazoxanide|mesh-list
110701268|NCT00183274|Sympathomimetics|sympathomimetics|mesh-ancestor
110984202|NCT02422706|Doxycycline|doxycycline|mesh-list
110984203|NCT02422706|Omeprazole|omeprazole|mesh-list
110984204|NCT02422706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110984205|NCT02422706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110984206|NCT02422706|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110984207|NCT02422706|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110984208|NCT02422706|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110984209|NCT02422706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110984210|NCT02422706|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110984211|NCT02422706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110984212|NCT02422706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110984213|NCT02422706|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110984214|NCT02422706|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110984215|NCT02422706|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110984216|NCT02422706|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110451006|NCT00627666|Abortifacient Agents|abortifacient agents|mesh-ancestor
110984217|NCT02422706|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110984218|NCT02422706|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110984219|NCT02422706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110984220|NCT02422706|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110984221|NCT02422706|Antimalarials|antimalarials|mesh-ancestor
110984222|NCT03058757|Mitomycins|mitomycins|mesh-list
110984223|NCT03058757|Mitomycin|mitomycin|mesh-list
110984224|NCT03058757|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110984225|NCT03058757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110984226|NCT03058757|Alkylating Agents|alkylating agents|mesh-ancestor
110984227|NCT03058757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110984228|NCT03058757|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110984229|NCT03058757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110984230|NCT03138889|Paclitaxel|paclitaxel|mesh-list
110984231|NCT03138889|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110984232|NCT03138889|Carboplatin|carboplatin|mesh-list
110984233|NCT03138889|Pembrolizumab|pembrolizumab|mesh-list
110984234|NCT03138889|Pemetrexed|pemetrexed|mesh-list
110984235|NCT03138889|Atezolizumab|atezolizumab|mesh-list
110984236|NCT03138889|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110984237|NCT03138889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110984238|NCT03138889|Tubulin Modulators|tubulin modulators|mesh-ancestor
110984239|NCT03138889|Antimitotic Agents|antimitotic agents|mesh-ancestor
110984240|NCT03138889|Mitosis Modulators|mitosis modulators|mesh-ancestor
110984241|NCT03138889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110984242|NCT03138889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110984243|NCT03138889|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110984244|NCT03138889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110984245|NCT03138889|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110984246|NCT03138889|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110984247|NCT01881763|Ketamine|ketamine|mesh-list
110984248|NCT01881763|Methohexital|methohexital|mesh-list
110984249|NCT01881763|Analgesics|analgesics|mesh-ancestor
110984250|NCT01881763|Sensory System Agents|sensory system agents|mesh-ancestor
110984251|NCT01881763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110984252|NCT01881763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110984253|NCT01881763|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110984254|NCT01881763|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110984255|NCT01881763|Anesthetics, General|anesthetics, general|mesh-ancestor
110984256|NCT01881763|Anesthetics|anesthetics|mesh-ancestor
110984257|NCT01881763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110984258|NCT01881763|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110984259|NCT01881763|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110984260|NCT01881763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110984261|NCT01881763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110984262|NCT03669601|Gemcitabine|gemcitabine|mesh-list
110984263|NCT03669601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110984264|NCT03669601|Antimetabolites|antimetabolites|mesh-ancestor
110984265|NCT03669601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110984266|NCT03669601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110984267|NCT02416388|Cytarabine|cytarabine|mesh-list
110984268|NCT02416388|Cyclosporine|cyclosporine|mesh-list
110984269|NCT02416388|Mycophenolic Acid|mycophenolic acid|mesh-list
110984270|NCT02416388|Dexamethasone|dexamethasone|mesh-list
110984271|NCT02416388|Methotrexate|methotrexate|mesh-list
110984272|NCT02416388|Daunorubicin|daunorubicin|mesh-list
110984273|NCT02416388|Venetoclax|venetoclax|mesh-list
110984274|NCT02416388|Idarubicin|idarubicin|mesh-list
110984275|NCT02416388|Cyclosporins|cyclosporins|mesh-list
110984276|NCT02416388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110984277|NCT02416388|Antiemetics|antiemetics|mesh-ancestor
110984278|NCT02416388|Autonomic Agents|autonomic agents|mesh-ancestor
110984279|NCT02416388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110984281|NCT02416388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110984282|NCT02416388|Glucocorticoids|glucocorticoids|mesh-ancestor
110984283|NCT02416388|Hormones|hormones|mesh-ancestor
110451019|NCT00627666|Antidotes|antidotes|mesh-ancestor
110984284|NCT02416388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110984285|NCT02416388|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110984286|NCT02416388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110984287|NCT02416388|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110984288|NCT02416388|Abortifacient Agents|abortifacient agents|mesh-ancestor
110984289|NCT02416388|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110984290|NCT02416388|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110984291|NCT02416388|Antimetabolites|antimetabolites|mesh-ancestor
110984292|NCT02416388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110984293|NCT02416388|Dermatologic Agents|dermatologic agents|mesh-ancestor
110984294|NCT02416388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110984295|NCT02416388|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110984296|NCT02416388|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110984297|NCT02416388|Immunologic Factors|immunologic factors|mesh-ancestor
110984298|NCT02416388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110984299|NCT02416388|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110984300|NCT02416388|Antiviral Agents|antiviral agents|mesh-ancestor
110984301|NCT02416388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110984302|NCT02416388|Antifungal Agents|antifungal agents|mesh-ancestor
110984303|NCT02416388|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110984304|NCT02416388|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110984305|NCT02416388|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110984306|NCT02416388|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110984307|NCT02416388|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110984308|NCT02416388|Antitubercular Agents|antitubercular agents|mesh-ancestor
110984309|NCT02416388|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110984310|NCT02886065|Lenalidomide|lenalidomide|mesh-list
110984311|NCT02886065|Poly ICLC|poly iclc|mesh-list
110984312|NCT02886065|Citarinostat|citarinostat|mesh-list
110984313|NCT02886065|Immunologic Factors|immunologic factors|mesh-ancestor
110984314|NCT02886065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110984315|NCT02886065|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110984316|NCT02886065|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110984317|NCT02886065|Growth Substances|growth substances|mesh-ancestor
110984318|NCT02886065|Growth Inhibitors|growth inhibitors|mesh-ancestor
110984319|NCT02886065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110984320|NCT02886065|Interferon Inducers|interferon inducers|mesh-ancestor
110984321|NCT02886065|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110984322|NCT02886065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110984323|NCT02886065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110984324|NCT03392441|Insulin|insulin|mesh-list
110984325|NCT03392441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110984326|NCT03392441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110984327|NCT03177824|Sildenafil Citrate|sildenafil citrate|mesh-list
110984328|NCT03177824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110984329|NCT03177824|Vasodilator Agents|vasodilator agents|mesh-ancestor
110984330|NCT03177824|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110984331|NCT03177824|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110984332|NCT03177824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110984333|NCT03177824|Urological Agents|urological agents|mesh-ancestor
110984334|NCT02416232|Trametinib|trametinib|mesh-list
110984335|NCT02416232|Dabrafenib|dabrafenib|mesh-list
110984336|NCT02416232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110984337|NCT02416232|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110984338|NCT02416232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110984339|NCT02416232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110984340|NCT04482842|Warfarin|warfarin|mesh-list
110984341|NCT04482842|Anticoagulants|anticoagulants|mesh-ancestor
110984342|NCT02767661|Capecitabine|capecitabine|mesh-list
110984343|NCT02767661|Letrozole|letrozole|mesh-list
110984344|NCT02767661|Anastrozole|anastrozole|mesh-list
110984345|NCT02767661|Exemestane|exemestane|mesh-list
110984346|NCT02767661|Aromatase Inhibitors|aromatase inhibitors|mesh-list
110984347|NCT02767661|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110984348|NCT02767661|Antimetabolites|antimetabolites|mesh-ancestor
110984349|NCT02767661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110984350|NCT02767661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110984351|NCT02767661|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110984352|NCT02767661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110984353|NCT02767661|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110451023|NCT00627666|Micronutrients|micronutrients|mesh-ancestor
110984354|NCT02767661|Hormone Antagonists|hormone antagonists|mesh-ancestor
110984355|NCT02767661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110984356|NCT02767661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110984357|NCT02767661|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110984358|NCT02415920|Oxytocin|oxytocin|mesh-list
110984359|NCT02415920|Oxytocics|oxytocics|mesh-ancestor
110984360|NCT02415920|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110984361|NCT02415920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110984362|NCT03389243|Acetaminophen|acetaminophen|mesh-list
110984363|NCT03389243|Dipyrone|dipyrone|mesh-list
110984364|NCT03389243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110984365|NCT03389243|Analgesics|analgesics|mesh-ancestor
110984366|NCT03389243|Sensory System Agents|sensory system agents|mesh-ancestor
110984367|NCT03389243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110984368|NCT03389243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110984369|NCT03389243|Antipyretics|antipyretics|mesh-ancestor
110984370|NCT03389243|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110984371|NCT03389243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110984372|NCT03389243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110984373|NCT02421926|Imatinib Mesylate|imatinib mesylate|mesh-list
110984374|NCT02421926|Dasatinib|dasatinib|mesh-list
110984375|NCT02421926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110984376|NCT02421926|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110984377|NCT02421926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110984378|NCT02421926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110984379|NCT02410460|Lidocaine|lidocaine|mesh-list
110984380|NCT02410460|Clonidine|clonidine|mesh-list
110984381|NCT02410460|Midazolam|midazolam|mesh-list
110984382|NCT02410460|Glycopyrrolate|glycopyrrolate|mesh-list
110984383|NCT02410460|Scopolamine|scopolamine|mesh-list
110984384|NCT02410460|Ketamine|ketamine|mesh-list
110984385|NCT02410460|Ondansetron|ondansetron|mesh-list
110984386|NCT02410460|Metoclopramide|metoclopramide|mesh-list
110984387|NCT02410460|Bupivacaine|bupivacaine|mesh-list
110984388|NCT02410460|Propofol|propofol|mesh-list
110984389|NCT02410460|Sevoflurane|sevoflurane|mesh-list
110984390|NCT02410460|Desflurane|desflurane|mesh-list
110984391|NCT02410460|Famotidine|famotidine|mesh-list
110984392|NCT02410460|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
110984393|NCT02410460|Anesthetics, Local|anesthetics, local|mesh-ancestor
110984394|NCT02410460|Anesthetics|anesthetics|mesh-ancestor
110984395|NCT02410460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110984396|NCT02410460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110984397|NCT02410460|Sensory System Agents|sensory system agents|mesh-ancestor
110984398|NCT02410460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110984399|NCT02410460|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110984400|NCT02410460|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110984401|NCT02410460|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110984402|NCT02410460|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110984403|NCT02410460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110984404|NCT02410460|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110984405|NCT02410460|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110984406|NCT02410460|Anesthetics, General|anesthetics, general|mesh-ancestor
110984407|NCT02410460|Analgesics|analgesics|mesh-ancestor
110984408|NCT02410460|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110984409|NCT02410460|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110984410|NCT02410460|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110984411|NCT02410460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110984412|NCT02410460|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110984413|NCT02410460|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110984414|NCT02410460|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110984415|NCT02410460|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110984416|NCT02410460|GABA Modulators|gaba modulators|mesh-ancestor
110984417|NCT02410460|GABA Agents|gaba agents|mesh-ancestor
110984418|NCT02410460|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110984419|NCT02410460|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110984420|NCT02410460|Antiemetics|antiemetics|mesh-ancestor
110984421|NCT02410460|Autonomic Agents|autonomic agents|mesh-ancestor
110984422|NCT02410460|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110984423|NCT02410460|Antipruritics|antipruritics|mesh-ancestor
110984424|NCT02410460|Dermatologic Agents|dermatologic agents|mesh-ancestor
110984425|NCT02410460|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110984426|NCT02410460|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110984427|NCT02410460|Serotonin Agents|serotonin agents|mesh-ancestor
110984428|NCT02410460|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110984429|NCT02410460|Sympatholytics|sympatholytics|mesh-ancestor
110984430|NCT02410460|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110984431|NCT02410460|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110984432|NCT02410460|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110984433|NCT02410460|Adrenergic Agents|adrenergic agents|mesh-ancestor
110984434|NCT02410460|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110984435|NCT02410460|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110984436|NCT02410460|Dopamine Agents|dopamine agents|mesh-ancestor
110984437|NCT02410460|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110984438|NCT02410460|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110984439|NCT02410460|Cholinergic Agents|cholinergic agents|mesh-ancestor
110984440|NCT02410460|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110984441|NCT02410460|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110984442|NCT02410460|Histamine Antagonists|histamine antagonists|mesh-ancestor
110984443|NCT02410460|Histamine Agents|histamine agents|mesh-ancestor
110984444|NCT02410460|Mydriatics|mydriatics|mesh-ancestor
110984445|NCT02410460|Parasympatholytics|parasympatholytics|mesh-ancestor
110984446|NCT02410226|Anesthetics|anesthetics|mesh-list
110984447|NCT02410226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110984448|NCT02410226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110984450|NCT03116672|Ketorolac|ketorolac|mesh-list
110984451|NCT03116672|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110984452|NCT03116672|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110984453|NCT03116672|Analgesics|analgesics|mesh-ancestor
110984454|NCT03116672|Sensory System Agents|sensory system agents|mesh-ancestor
110984455|NCT03116672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110984456|NCT03116672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110984457|NCT03116672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110984458|NCT03116672|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110984459|NCT03116672|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110984460|NCT03116672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110984461|NCT03116672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110984462|NCT03174860|Diclofenac|diclofenac|mesh-list
110984463|NCT03174860|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110984464|NCT03174860|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110984465|NCT03174860|Analgesics|analgesics|mesh-ancestor
110984466|NCT03174860|Sensory System Agents|sensory system agents|mesh-ancestor
110984467|NCT03174860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110984468|NCT03174860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110984469|NCT03174860|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110984470|NCT03174860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110984471|NCT03174860|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110984472|NCT03174860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110984473|NCT03174860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110984474|NCT03174548|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
110984475|NCT03174548|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110984476|NCT03174548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110984477|NCT03174548|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110984478|NCT03174548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110984479|NCT02417090|Metformin|metformin|mesh-list
110984480|NCT02417090|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110984481|NCT02417090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110984482|NCT00703820|Cytarabine|cytarabine|mesh-list
110984483|NCT00703820|Etoposide|etoposide|mesh-list
110984484|NCT00703820|Daunorubicin|daunorubicin|mesh-list
110984485|NCT00703820|Clofarabine|clofarabine|mesh-list
110984486|NCT00703820|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110984487|NCT00703820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110984488|NCT00703820|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110984489|NCT00703820|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110984490|NCT00703820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110984491|NCT00703820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110984492|NCT00703820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110984493|NCT00703820|Antimetabolites|antimetabolites|mesh-ancestor
110984494|NCT00703820|Antiviral Agents|antiviral agents|mesh-ancestor
110984495|NCT00703820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110984496|NCT00703820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110984497|NCT00703820|Immunologic Factors|immunologic factors|mesh-ancestor
110984498|NCT00703820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110984499|NCT00703820|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110984500|NCT03177980|Clonidine|clonidine|mesh-list
110984501|NCT03177980|Fentanyl|fentanyl|mesh-list
110984502|NCT03177980|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110984503|NCT03177980|Narcotics|narcotics|mesh-ancestor
110984504|NCT03177980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110984505|NCT03177980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110984506|NCT03177980|Analgesics|analgesics|mesh-ancestor
110984507|NCT03177980|Sensory System Agents|sensory system agents|mesh-ancestor
110984508|NCT03177980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110984509|NCT03177980|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110984510|NCT03177980|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110984511|NCT03177980|Anesthetics, General|anesthetics, general|mesh-ancestor
110984512|NCT03177980|Anesthetics|anesthetics|mesh-ancestor
110984513|NCT03177980|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110984514|NCT03177980|Sympatholytics|sympatholytics|mesh-ancestor
110984515|NCT03177980|Autonomic Agents|autonomic agents|mesh-ancestor
110984516|NCT03177980|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110984517|NCT03177980|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110984518|NCT03177980|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110984519|NCT03177980|Adrenergic Agents|adrenergic agents|mesh-ancestor
110984520|NCT03177980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110984521|NCT03177980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110984522|NCT03177434|Lactulose|lactulose|mesh-list
110984523|NCT03177434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110984524|NCT02587325|Sirolimus|sirolimus|mesh-list
110984525|NCT02587325|Temsirolimus|temsirolimus|mesh-list
110984526|NCT02587325|MTOR Inhibitors|mtor inhibitors|mesh-list
110984527|NCT02587325|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110984528|NCT02587325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110984529|NCT02587325|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110984530|NCT02587325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110984531|NCT02587325|Antifungal Agents|antifungal agents|mesh-ancestor
110984532|NCT02587325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110984533|NCT02587325|Immunologic Factors|immunologic factors|mesh-ancestor
110984534|NCT02587325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110984535|NCT02587325|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110984536|NCT02587325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110984537|NCT02587325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110984538|NCT02414984|Golimumab|golimumab|mesh-list
110984539|NCT02414984|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110984540|NCT02414984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110984541|NCT02414984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110984542|NCT02414984|Immunologic Factors|immunologic factors|mesh-ancestor
110984543|NCT02414984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110984544|NCT02415062|Donepezil|donepezil|mesh-list
110984545|NCT02415062|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110984546|NCT02415062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110984547|NCT02415062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110984548|NCT02415062|Cholinergic Agents|cholinergic agents|mesh-ancestor
110984549|NCT02415062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110984550|NCT02415062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110984551|NCT02415062|Nootropic Agents|nootropic agents|mesh-ancestor
110984552|NCT02408978|Naproxen|naproxen|mesh-list
110984553|NCT02408978|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110984554|NCT02408978|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110984555|NCT02408978|Analgesics|analgesics|mesh-ancestor
110984556|NCT02408978|Sensory System Agents|sensory system agents|mesh-ancestor
110984557|NCT02408978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110984558|NCT02408978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110984559|NCT02408978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110984560|NCT02408978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110984561|NCT02408978|Gout Suppressants|gout suppressants|mesh-ancestor
110984562|NCT02408978|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110984563|NCT02408978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110451039|NCT02698930|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110984564|NCT02408978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110984565|NCT02408744|Pirfenidone|pirfenidone|mesh-list
110984566|NCT02408744|Analgesics|analgesics|mesh-ancestor
110984567|NCT02408744|Sensory System Agents|sensory system agents|mesh-ancestor
110984568|NCT02408744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110984569|NCT02408744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110984570|NCT02408744|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110984571|NCT02408744|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110984572|NCT02408744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110984573|NCT02408744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110984574|NCT02408744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110984575|NCT03174080|Fluorides|fluorides|mesh-list
110984576|NCT03174080|Cariostatic Agents|cariostatic agents|mesh-ancestor
110984577|NCT03174080|Protective Agents|protective agents|mesh-ancestor
110984578|NCT03174080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110984579|NCT03116516|Amlodipine|amlodipine|mesh-list
110984580|NCT03116516|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110984581|NCT03116516|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110984582|NCT03116516|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110984583|NCT03116516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110984584|NCT03116516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110984585|NCT03116516|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110984586|NCT03116516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110984587|NCT03116516|Vasodilator Agents|vasodilator agents|mesh-ancestor
110984588|NCT03116516|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110984589|NCT03116516|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110984590|NCT03116516|Antimetabolites|antimetabolites|mesh-ancestor
110984591|NCT03116516|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110984592|NCT03116516|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110984593|NCT03116516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110984594|NCT01564537|Dexamethasone|dexamethasone|mesh-list
110984595|NCT01564537|Lenalidomide|lenalidomide|mesh-list
110984596|NCT01564537|Ixazomib|ixazomib|mesh-list
110984597|NCT01564537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110984598|NCT01564537|Antiemetics|antiemetics|mesh-ancestor
110984599|NCT01564537|Autonomic Agents|autonomic agents|mesh-ancestor
110984600|NCT01564537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110984601|NCT01564537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110984602|NCT01564537|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110984603|NCT01564537|Glucocorticoids|glucocorticoids|mesh-ancestor
110984604|NCT01564537|Hormones|hormones|mesh-ancestor
110984605|NCT01564537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110984606|NCT01564537|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110984607|NCT01564537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110984608|NCT01564537|Immunologic Factors|immunologic factors|mesh-ancestor
110984609|NCT01564537|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110984610|NCT01564537|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110984611|NCT01564537|Growth Substances|growth substances|mesh-ancestor
110984612|NCT01564537|Growth Inhibitors|growth inhibitors|mesh-ancestor
110984613|NCT01564537|Protease Inhibitors|protease inhibitors|mesh-ancestor
110984614|NCT01564537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110984615|NCT01564537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110984616|NCT03174236|Metronidazole|metronidazole|mesh-list
110984617|NCT03174236|Gentamicins|gentamicins|mesh-list
110984618|NCT03174236|Ceftriaxone|ceftriaxone|mesh-list
110984619|NCT03174236|Penicillins|penicillins|mesh-list
110984620|NCT03174236|Penicillin G|penicillin g|mesh-list
110984621|NCT03174236|Penicillin G Benzathine|penicillin g benzathine|mesh-list
110984622|NCT03174236|Penicillin G Procaine|penicillin g procaine|mesh-list
110984623|NCT03174236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110984624|NCT03174236|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110984625|NCT03174236|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110984626|NCT03174236|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110984627|NCT03174236|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110984628|NCT03174236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110984629|NCT03174236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110984630|NCT03172052|Streptokinase|streptokinase|mesh-list
110984631|NCT03172052|Mesna|mesna|mesh-list
110984632|NCT03172052|Protective Agents|protective agents|mesh-ancestor
110984633|NCT03172052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110984634|NCT03172052|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110984635|NCT03172052|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110984636|NCT03172052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110984637|NCT03171818|Darbepoetin alfa|darbepoetin alfa|mesh-list
110984638|NCT03171818|Hematinics|hematinics|mesh-ancestor
110984639|NCT02408354|Glycerol|glycerol|mesh-list
110984640|NCT02408354|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
110984641|NCT02408354|Protective Agents|protective agents|mesh-ancestor
110984642|NCT02408354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110984643|NCT03176264|Bevacizumab|bevacizumab|mesh-list
110984644|NCT03176264|Spartalizumab|spartalizumab|mesh-list
110984645|NCT03176264|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110984646|NCT03176264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110984647|NCT03176264|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110984648|NCT03176264|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110984649|NCT03176264|Growth Substances|growth substances|mesh-ancestor
110984650|NCT03176264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110984651|NCT03176264|Growth Inhibitors|growth inhibitors|mesh-ancestor
110984652|NCT03176264|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110984653|NCT03176264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110984654|NCT02406170|Paclitaxel|paclitaxel|mesh-list
110984655|NCT02406170|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110984656|NCT02406170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110984657|NCT02406170|Tubulin Modulators|tubulin modulators|mesh-ancestor
110701714|NCT01037348|Growth Substances|growth substances|mesh-ancestor
110984658|NCT02406170|Antimitotic Agents|antimitotic agents|mesh-ancestor
110984659|NCT02406170|Mitosis Modulators|mitosis modulators|mesh-ancestor
110984660|NCT02406170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110984661|NCT02413658|Phenytoin|phenytoin|mesh-list
110984662|NCT02413658|Anticonvulsants|anticonvulsants|mesh-ancestor
110984663|NCT02413658|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110984664|NCT02413658|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110984665|NCT02413658|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110984666|NCT02413658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110984667|NCT02413658|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110984668|NCT02413658|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110984669|NCT02406014|Diclofenac|diclofenac|mesh-list
110984670|NCT02406014|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110984671|NCT02406014|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110984672|NCT02406014|Analgesics|analgesics|mesh-ancestor
110984673|NCT02406014|Sensory System Agents|sensory system agents|mesh-ancestor
110984674|NCT02406014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110984675|NCT02406014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110984676|NCT02406014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110984677|NCT02406014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110984678|NCT02406014|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110984679|NCT02406014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110984680|NCT02406014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110984681|NCT02406092|Prednisone|prednisone|mesh-list
110984682|NCT02406092|Cyclophosphamide|cyclophosphamide|mesh-list
110984683|NCT02406092|Rituximab|rituximab|mesh-list
110984684|NCT02406092|Doxorubicin|doxorubicin|mesh-list
110984685|NCT02406092|Fludarabine|fludarabine|mesh-list
110984686|NCT02406092|Vincristine|vincristine|mesh-list
110984687|NCT02406092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110984688|NCT02406092|Immunologic Factors|immunologic factors|mesh-ancestor
110984689|NCT02406092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110984690|NCT02406092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110984691|NCT02406092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110984692|NCT02406092|Alkylating Agents|alkylating agents|mesh-ancestor
110984693|NCT02406092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110984694|NCT02406092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110984695|NCT02406092|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110984696|NCT02406092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110984697|NCT02406092|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110984698|NCT02406092|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110984699|NCT02406092|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110984700|NCT02406092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110984701|NCT02406092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110984702|NCT02406092|Glucocorticoids|glucocorticoids|mesh-ancestor
110984703|NCT02406092|Hormones|hormones|mesh-ancestor
110984704|NCT02406092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110984705|NCT02406092|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110984706|NCT02406092|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110984707|NCT02406092|Tubulin Modulators|tubulin modulators|mesh-ancestor
110984708|NCT02406092|Antimitotic Agents|antimitotic agents|mesh-ancestor
110984709|NCT02406092|Mitosis Modulators|mitosis modulators|mesh-ancestor
110984710|NCT02413268|Nitroglycerin|nitroglycerin|mesh-list
110984711|NCT02413268|Vasodilator Agents|vasodilator agents|mesh-ancestor
110984712|NCT02405858|Prednisolone|prednisolone|mesh-list
110984713|NCT02405858|Abiraterone Acetate|abiraterone acetate|mesh-list
110984714|NCT02405858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110984715|NCT02405858|Glucocorticoids|glucocorticoids|mesh-ancestor
110984716|NCT02405858|Hormones|hormones|mesh-ancestor
110984717|NCT02405858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110984718|NCT02405858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110984719|NCT02405858|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110984720|NCT02405858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110984722|NCT02405858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110984723|NCT02405858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110984724|NCT02405858|Hormone Antagonists|hormone antagonists|mesh-ancestor
110984725|NCT02405858|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110984726|NCT03171740|Midazolam|midazolam|mesh-list
110984727|NCT03171740|Dexmedetomidine|dexmedetomidine|mesh-list
110984728|NCT03171740|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110984729|NCT03171740|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110984730|NCT03171740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110701792|NCT00391898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110984731|NCT03171740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110984732|NCT03171740|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110984734|NCT03171740|Sensory System Agents|sensory system agents|mesh-ancestor
110984735|NCT03171740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110984736|NCT03171740|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110984737|NCT03171740|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110984738|NCT03171740|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110984739|NCT03171740|Adrenergic Agents|adrenergic agents|mesh-ancestor
110984740|NCT03171740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110984741|NCT03171740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110984742|NCT03171740|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110984743|NCT03171740|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110984744|NCT03171740|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110984745|NCT03171740|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110984746|NCT03171740|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110984747|NCT03171740|Anesthetics, General|anesthetics, general|mesh-ancestor
110984748|NCT03171740|Anesthetics|anesthetics|mesh-ancestor
110984749|NCT03171740|GABA Modulators|gaba modulators|mesh-ancestor
110984750|NCT03171740|GABA Agents|gaba agents|mesh-ancestor
110984751|NCT03176186|Xenon|xenon|mesh-list
110984752|NCT03176186|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110984753|NCT03176186|Anesthetics, General|anesthetics, general|mesh-ancestor
110984754|NCT03176186|Anesthetics|anesthetics|mesh-ancestor
110984755|NCT03176186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110984756|NCT03176186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110984757|NCT04482764|Valproic Acid|valproic acid|mesh-list
110984758|NCT04482764|Anticonvulsants|anticonvulsants|mesh-ancestor
110984759|NCT04482764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110984760|NCT04482764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110984761|NCT04482764|GABA Agents|gaba agents|mesh-ancestor
110984762|NCT04482764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110984763|NCT04482764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110984764|NCT04482764|Antimanic Agents|antimanic agents|mesh-ancestor
110984765|NCT04482764|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110984766|NCT04482764|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110984767|NCT04482764|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110984768|NCT02408042|Rituximab|rituximab|mesh-list
110984769|NCT02408042|Pembrolizumab|pembrolizumab|mesh-list
110984770|NCT02408042|Brentuximab Vedotin|brentuximab vedotin|mesh-list
110984771|NCT02408042|Carboplatin|carboplatin|mesh-list
110984772|NCT02408042|Etoposide|etoposide|mesh-list
110984773|NCT02408042|Ifosfamide|ifosfamide|mesh-list
110984774|NCT02408042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110984775|NCT02408042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110984776|NCT02408042|Immunologic Factors|immunologic factors|mesh-ancestor
110984777|NCT02408042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110984778|NCT02408042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110984779|NCT02408042|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110984780|NCT02408042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110984781|NCT02408042|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110984782|NCT02408042|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110984783|NCT02408042|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110984784|NCT02408042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110984785|NCT02408042|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110984786|NCT02408042|Alkylating Agents|alkylating agents|mesh-ancestor
110984787|NCT02408042|Immunotoxins|immunotoxins|mesh-ancestor
110984788|NCT02408042|Immunoconjugates|immunoconjugates|mesh-ancestor
110984789|NCT03172988|Dexamethasone|dexamethasone|mesh-list
110984790|NCT03172988|Dexamethasone acetate|dexamethasone acetate|mesh-list
110984791|NCT03172988|Flurbiprofen|flurbiprofen|mesh-list
110984792|NCT03172988|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
110984793|NCT03172988|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
110984794|NCT03172988|BB 1101|bb 1101|mesh-list
110984795|NCT03172988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110984797|NCT03172988|Autonomic Agents|autonomic agents|mesh-ancestor
110984798|NCT03172988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110984799|NCT03172988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110984800|NCT03172988|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110984801|NCT03172988|Glucocorticoids|glucocorticoids|mesh-ancestor
110984802|NCT03172988|Hormones|hormones|mesh-ancestor
110984803|NCT03172988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110984804|NCT03172988|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110984805|NCT03172988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110984806|NCT03172988|Protease Inhibitors|protease inhibitors|mesh-ancestor
110984807|NCT03172988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110984808|NCT03172988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110984809|NCT03172988|Analgesics|analgesics|mesh-ancestor
110984810|NCT03172988|Sensory System Agents|sensory system agents|mesh-ancestor
110984811|NCT03172988|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110984812|NCT03172988|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110984813|NCT03172988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110984814|NCT03172988|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110984815|NCT03042611|Apatinib|apatinib|mesh-list
110984816|NCT03042611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110984817|NCT03042611|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110984818|NCT03042611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110984819|NCT03042611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110984820|NCT03171584|Itraconazole|itraconazole|mesh-list
110984821|NCT03171584|Fluconazole|fluconazole|mesh-list
110984822|NCT03171584|Terbinafine|terbinafine|mesh-list
110984823|NCT03171584|Antifungal Agents|antifungal agents|mesh-ancestor
110984824|NCT03171584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110984825|NCT03171584|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110984826|NCT03171584|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110984827|NCT03171584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110984828|NCT03171584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110984829|NCT03171584|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110984830|NCT03171584|Hormone Antagonists|hormone antagonists|mesh-ancestor
110984831|NCT03171584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110984832|NCT03171584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110984833|NCT03171584|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110984834|NCT03171584|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110984835|NCT03171584|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110984836|NCT02950259|Indomethacin|indomethacin|mesh-list
110984837|NCT02950259|Cyclophosphamide|cyclophosphamide|mesh-list
110984838|NCT02950259|Omeprazole|omeprazole|mesh-list
110984839|NCT02950259|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110984840|NCT02950259|Immunologic Factors|immunologic factors|mesh-ancestor
110984841|NCT02950259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110984842|NCT02950259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110984843|NCT02950259|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110984844|NCT02950259|Alkylating Agents|alkylating agents|mesh-ancestor
110984845|NCT02950259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110984846|NCT02950259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110984847|NCT02950259|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110984848|NCT02950259|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110984849|NCT02950259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110984850|NCT02950259|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110984851|NCT02950259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110984852|NCT02950259|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110984853|NCT02950259|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110984854|NCT02950259|Analgesics|analgesics|mesh-ancestor
110984855|NCT02950259|Sensory System Agents|sensory system agents|mesh-ancestor
110984856|NCT02950259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110984857|NCT02950259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110984858|NCT02950259|Gout Suppressants|gout suppressants|mesh-ancestor
110984859|NCT02950259|Tocolytic Agents|tocolytic agents|mesh-ancestor
110984860|NCT02950259|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110984861|NCT02950259|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110984862|NCT02349815|Levonorgestrel|levonorgestrel|mesh-list
110984863|NCT02349815|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110984864|NCT02349815|Contraceptive Agents|contraceptive agents|mesh-ancestor
110984865|NCT02349815|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110984866|NCT02349815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110984867|NCT02349815|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110984868|NCT02349815|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110984869|NCT02349815|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110984870|NCT02818517|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
110984871|NCT02818517|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
110984872|NCT02818517|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110984873|NCT02818517|Adrenergic Agents|adrenergic agents|mesh-ancestor
110984874|NCT02818517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110984875|NCT02818517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110984876|NCT02818517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110984877|NCT02818517|Protease Inhibitors|protease inhibitors|mesh-ancestor
110984878|NCT02818517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110984879|NCT02407340|Benzalkonium Compounds|benzalkonium compounds|mesh-list
110984880|NCT02407340|Oxytocin|oxytocin|mesh-list
110984881|NCT02407340|Oxytocics|oxytocics|mesh-ancestor
110984882|NCT02407340|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110984883|NCT02407340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110984884|NCT02407340|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110984885|NCT02407340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110984886|NCT02405156|Letrozole|letrozole|mesh-list
110984887|NCT02405156|Misoprostol|misoprostol|mesh-list
110984888|NCT02405156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110984889|NCT02405156|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110984890|NCT02405156|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110984891|NCT02405156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110984892|NCT02405156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110984893|NCT02405156|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110984894|NCT02405156|Hormone Antagonists|hormone antagonists|mesh-ancestor
110984895|NCT02405156|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110984896|NCT02405156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110984897|NCT02405156|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110984898|NCT02405156|Abortifacient Agents|abortifacient agents|mesh-ancestor
110984899|NCT02405156|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110984900|NCT02405156|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110984901|NCT02405156|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110984902|NCT02405156|Oxytocics|oxytocics|mesh-ancestor
110984903|NCT02411942|Adapalene|adapalene|mesh-list
110984904|NCT02411942|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110984905|NCT02411942|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110984906|NCT02411942|Analgesics|analgesics|mesh-ancestor
110984907|NCT02411942|Sensory System Agents|sensory system agents|mesh-ancestor
110984908|NCT02411942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110984909|NCT02411942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110984910|NCT02411942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110984911|NCT02411942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110984912|NCT02411942|Dermatologic Agents|dermatologic agents|mesh-ancestor
110984913|NCT02406950|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110984914|NCT02406950|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110984915|NCT02406950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110984916|NCT02406950|Incretins|incretins|mesh-ancestor
110984917|NCT02406950|Hormones|hormones|mesh-ancestor
110984918|NCT02406950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110984919|NCT02406950|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110984920|NCT02406950|Protease Inhibitors|protease inhibitors|mesh-ancestor
110984921|NCT02406950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110984922|NCT02406950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110984923|NCT02406872|Propofol|propofol|mesh-list
110984924|NCT02406872|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110984925|NCT02406872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110984926|NCT02406872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110984927|NCT02406872|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110984928|NCT02406872|Anesthetics, General|anesthetics, general|mesh-ancestor
110984929|NCT02406872|Anesthetics|anesthetics|mesh-ancestor
110984930|NCT03172676|Amoxicillin|amoxicillin|mesh-list
110984931|NCT03172676|Clarithromycin|clarithromycin|mesh-list
110984932|NCT03172676|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
110984933|NCT03172676|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110984934|NCT03172676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110984935|NCT03172676|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110984936|NCT03172676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110984937|NCT03172676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110984938|NCT03172676|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110984939|NCT03172676|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110984940|NCT02404844|Tamoxifen|tamoxifen|mesh-list
110984941|NCT02404844|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110984943|NCT02404844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110984944|NCT02404844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110984945|NCT02404844|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110984946|NCT02404844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110984947|NCT02404844|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110984948|NCT02404844|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110984949|NCT02404844|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110984950|NCT04482296|Zinc Sulfate|zinc sulfate|mesh-list
110984951|NCT04482296|Astringents|astringents|mesh-ancestor
110984952|NCT04482296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110984953|NCT04482296|Dermatologic Agents|dermatologic agents|mesh-ancestor
110984954|NCT03116282|Ethanol|ethanol|mesh-list
110984955|NCT03116282|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110984956|NCT03116282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110984957|NCT03116282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110984958|NCT03116282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110984959|NCT02404454|Hyaluronic Acid|hyaluronic acid|mesh-list
110984960|NCT02404454|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110984961|NCT02404454|Immunologic Factors|immunologic factors|mesh-ancestor
110984962|NCT02404454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110984963|NCT02404454|Viscosupplements|viscosupplements|mesh-ancestor
110984964|NCT02404454|Protective Agents|protective agents|mesh-ancestor
110984965|NCT03115892|Chlorhexidine|chlorhexidine|mesh-list
110984966|NCT03115892|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110984967|NCT03115892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110984968|NCT03115892|Disinfectants|disinfectants|mesh-ancestor
110984969|NCT02411786|Molgramostim|molgramostim|mesh-list
110984970|NCT02411786|Sargramostim|sargramostim|mesh-list
110984971|NCT02411786|Immunologic Factors|immunologic factors|mesh-ancestor
110984972|NCT02411786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110984973|NCT02411786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110984974|NCT02404376|Exenatide|exenatide|mesh-list
110984975|NCT02404376|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110984976|NCT02404376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110984977|NCT02404376|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110984978|NCT02404376|Incretins|incretins|mesh-ancestor
110984979|NCT02404376|Hormones|hormones|mesh-ancestor
110984980|NCT02404376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110984981|NCT04466085|Vaccines|vaccines|mesh-list
110984982|NCT04466085|Immunologic Factors|immunologic factors|mesh-ancestor
110984983|NCT04466085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110984984|NCT03517995|Sulforaphane|sulforaphane|mesh-list
110984985|NCT03517995|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110984986|NCT03517995|Protective Agents|protective agents|mesh-ancestor
110984987|NCT03517995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110984988|NCT03517995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110984989|NCT02411630|Tenofovir|tenofovir|mesh-list
110984990|NCT02411630|Emtricitabine|emtricitabine|mesh-list
110984991|NCT02411630|Antiviral Agents|antiviral agents|mesh-ancestor
110984992|NCT02411630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110984993|NCT02411630|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110984994|NCT02411630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110984995|NCT02411630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110984996|NCT02411630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110984997|NCT02411630|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110984998|NCT02411630|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110984999|NCT02411318|Ethanol|ethanol|mesh-list
110985000|NCT02411318|Caffeine|caffeine|mesh-list
110985001|NCT02411318|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110985002|NCT02411318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110985003|NCT02411318|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110985004|NCT02411318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110985005|NCT02411318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110985006|NCT02411318|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110985007|NCT02411318|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110985008|NCT02411318|Purinergic Agents|purinergic agents|mesh-ancestor
110985009|NCT02411318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110985010|NCT02411318|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110985011|NCT02411318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110985012|NCT02411318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110985013|NCT03133299|Vitamin D|vitamin d|mesh-list
110985014|NCT03133299|Glucocorticoids|glucocorticoids|mesh-list
110985015|NCT03133299|Vitamins|vitamins|mesh-ancestor
110985016|NCT03133299|Micronutrients|micronutrients|mesh-ancestor
110985017|NCT03133299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110985018|NCT03133299|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110985019|NCT03133299|Hormones|hormones|mesh-ancestor
110985020|NCT03133299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110985021|NCT04465695|Interferons|interferons|mesh-list
110985022|NCT04465695|Interferon-beta|interferon-beta|mesh-list
110985023|NCT04465695|Clofazimine|clofazimine|mesh-list
110985024|NCT04465695|Interferon beta-1b|interferon beta-1b|mesh-list
110985025|NCT04465695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110985026|NCT04465695|Antiviral Agents|antiviral agents|mesh-ancestor
110985027|NCT04465695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110985028|NCT04465695|Immunologic Factors|immunologic factors|mesh-ancestor
110985029|NCT04465695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110985030|NCT04465695|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110985031|NCT04465695|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110985032|NCT04465695|Leprostatic Agents|leprostatic agents|mesh-ancestor
110985033|NCT04465695|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110985034|NCT03115736|Tenofovir|tenofovir|mesh-list
110985035|NCT03115736|Antiviral Agents|antiviral agents|mesh-ancestor
110985036|NCT03115736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110985037|NCT03115736|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110985038|NCT03115736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110985039|NCT03115736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110985040|NCT03115736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110985041|NCT03115736|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110985042|NCT03115736|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110985043|NCT04465851|Curcumin|curcumin|mesh-list
110985044|NCT04465851|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110985045|NCT04465851|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110985046|NCT04465851|Analgesics|analgesics|mesh-ancestor
110985047|NCT04465851|Sensory System Agents|sensory system agents|mesh-ancestor
110985048|NCT04465851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110985049|NCT04465851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110985050|NCT04465851|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110985051|NCT04465851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110985052|NCT04465851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110985053|NCT04465851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110985054|NCT04465851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110985055|NCT04465539|Hydrocortisone|hydrocortisone|mesh-list
110985056|NCT04465539|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
110985057|NCT04465539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110985058|NCT04465539|Plasma Substitutes|plasma substitutes|mesh-ancestor
110985059|NCT04465539|Blood Substitutes|blood substitutes|mesh-ancestor
110985060|NCT02404142|Atracurium|atracurium|mesh-list
110985061|NCT02404142|Curare|curare|mesh-list
110985062|NCT02404142|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110985063|NCT02404142|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110985064|NCT02404142|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110985065|NCT02404142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110985066|NCT02404142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110985067|NCT02404142|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
110985068|NCT02404142|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110985069|NCT02404142|Cholinergic Agents|cholinergic agents|mesh-ancestor
110985070|NCT02404142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110985071|NCT02404142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110985072|NCT03522051|Calcium|calcium|mesh-list
110985073|NCT03522051|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110985074|NCT03522051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110985075|NCT03171974|Dexamethasone|dexamethasone|mesh-list
110985076|NCT03171974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110985077|NCT03171974|Antiemetics|antiemetics|mesh-ancestor
110985078|NCT03171974|Autonomic Agents|autonomic agents|mesh-ancestor
110985079|NCT03171974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110985080|NCT03171974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110985081|NCT03171974|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110985082|NCT03171974|Glucocorticoids|glucocorticoids|mesh-ancestor
110985083|NCT03171974|Hormones|hormones|mesh-ancestor
110985084|NCT03171974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110985085|NCT03171974|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110985086|NCT03171974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110985087|NCT02292069|Amlodipine|amlodipine|mesh-list
110985088|NCT02292069|Atorvastatin|atorvastatin|mesh-list
110985089|NCT02292069|Calcium|calcium|mesh-list
110985090|NCT02292069|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110985091|NCT02292069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110985092|NCT02292069|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110985093|NCT02292069|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110985094|NCT02292069|Antimetabolites|antimetabolites|mesh-ancestor
110985095|NCT02292069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110985096|NCT02292069|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110985097|NCT02292069|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110985098|NCT02292069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110985099|NCT02292069|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110985100|NCT02292069|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110985101|NCT02292069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110985102|NCT02292069|Vasodilator Agents|vasodilator agents|mesh-ancestor
110985104|NCT02404064|Cefotaxime|cefotaxime|mesh-list
110985105|NCT02404064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110702166|NCT00390806|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110985106|NCT02404064|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110985108|NCT02404064|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110985109|NCT02294643|Aspirin|aspirin|mesh-list
110985110|NCT02294643|Sarpogrelate|sarpogrelate|mesh-list
110985111|NCT02294643|Clopidogrel|clopidogrel|mesh-list
110985112|NCT02294643|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110985113|NCT02294643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110985114|NCT02294643|Analgesics|analgesics|mesh-ancestor
110985115|NCT02294643|Sensory System Agents|sensory system agents|mesh-ancestor
110985116|NCT02294643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110985117|NCT02294643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110985118|NCT02294643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110985119|NCT02294643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110985120|NCT02294643|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110985121|NCT02294643|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110985122|NCT02294643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110985123|NCT02294643|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110985124|NCT02294643|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110985125|NCT02294643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110985126|NCT02294643|Antipyretics|antipyretics|mesh-ancestor
110985127|NCT02294643|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110985128|NCT02294643|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110985129|NCT02294643|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110985130|NCT02294643|Purinergic Agents|purinergic agents|mesh-ancestor
110985131|NCT02294643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110985132|NCT02294643|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110985133|NCT02294643|Serotonin Agents|serotonin agents|mesh-ancestor
110985134|NCT02410694|Thalidomide|thalidomide|mesh-list
110985135|NCT02410694|Dexamethasone|dexamethasone|mesh-list
110985136|NCT02410694|Ixazomib|ixazomib|mesh-list
110985137|NCT02410694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110985138|NCT02410694|Antiemetics|antiemetics|mesh-ancestor
110985139|NCT02410694|Autonomic Agents|autonomic agents|mesh-ancestor
110985140|NCT02410694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110985141|NCT02410694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110985142|NCT02410694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110985143|NCT02410694|Glucocorticoids|glucocorticoids|mesh-ancestor
110985144|NCT02410694|Hormones|hormones|mesh-ancestor
110985145|NCT02410694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110985146|NCT02410694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110985147|NCT02410694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110985148|NCT02410694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110985149|NCT02410694|Immunologic Factors|immunologic factors|mesh-ancestor
110985150|NCT02410694|Leprostatic Agents|leprostatic agents|mesh-ancestor
110985151|NCT02410694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110985152|NCT02410694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110985153|NCT02410694|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110985154|NCT02410694|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110985155|NCT02410694|Growth Substances|growth substances|mesh-ancestor
110985156|NCT02410694|Growth Inhibitors|growth inhibitors|mesh-ancestor
110985157|NCT02410694|Protease Inhibitors|protease inhibitors|mesh-ancestor
110985158|NCT02410694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110985159|NCT02410694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110985160|NCT03521895|Aflibercept|aflibercept|mesh-list
110985161|NCT03521895|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110985162|NCT03521895|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110985163|NCT03521895|Growth Substances|growth substances|mesh-ancestor
110985164|NCT03521895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110450308|NCT03615508|Mydriatics|mydriatics|mesh-ancestor
110985166|NCT03521895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110985167|NCT02401880|Empagliflozin|empagliflozin|mesh-list
110985168|NCT02401880|Linagliptin|linagliptin|mesh-list
110985169|NCT02401880|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110985170|NCT02401880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110985171|NCT02401880|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110985172|NCT02401880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110985173|NCT02401880|Incretins|incretins|mesh-ancestor
110985174|NCT02401880|Hormones|hormones|mesh-ancestor
110985175|NCT02401880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110985176|NCT02401880|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110985177|NCT02401880|Protease Inhibitors|protease inhibitors|mesh-ancestor
110985178|NCT02401880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110985179|NCT03170726|Ibuprofen|ibuprofen|mesh-list
110985180|NCT03170726|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
110985181|NCT03170726|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110985182|NCT03170726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110985184|NCT03170726|Sensory System Agents|sensory system agents|mesh-ancestor
110985185|NCT03170726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110985186|NCT03170726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110985187|NCT03170726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110985188|NCT03170726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110985189|NCT03170726|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110985190|NCT03170726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110985191|NCT03170726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110985192|NCT03175016|Irinotecan|irinotecan|mesh-list
110985193|NCT03175016|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110985194|NCT03175016|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110985195|NCT03175016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110985196|NCT03175016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110985197|NCT03175016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110985198|NCT03174938|Flutemetamol|flutemetamol|mesh-list
110985199|NCT03174938|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110985200|NCT03174938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110985201|NCT03520257|Apatinib|apatinib|mesh-list
110985202|NCT03520257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110985203|NCT03520257|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110985204|NCT03520257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110985205|NCT03520257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110985206|NCT02292303|Zinc|zinc|mesh-list
110985207|NCT02292303|Zinc Oxide|zinc oxide|mesh-list
110985208|NCT02292303|Trace Elements|trace elements|mesh-ancestor
110985209|NCT02292303|Micronutrients|micronutrients|mesh-ancestor
110985210|NCT02292303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110985211|NCT02292303|Dermatologic Agents|dermatologic agents|mesh-ancestor
110985212|NCT02292303|Sunscreening Agents|sunscreening agents|mesh-ancestor
110985213|NCT02292303|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110985214|NCT02292303|Protective Agents|protective agents|mesh-ancestor
110985215|NCT02294955|Amiodarone|amiodarone|mesh-list
110985216|NCT02294955|Sotalol|sotalol|mesh-list
110985217|NCT02294955|Flecainide|flecainide|mesh-list
110985218|NCT02294955|Dronedarone|dronedarone|mesh-list
110985219|NCT02294955|Propafenone|propafenone|mesh-list
110985220|NCT02294955|Disopyramide|disopyramide|mesh-list
110985221|NCT02294955|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110985222|NCT02294955|Vasodilator Agents|vasodilator agents|mesh-ancestor
110985223|NCT02294955|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
110985224|NCT02294955|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110985225|NCT02294955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110985226|NCT02294955|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110985227|NCT02294955|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110985228|NCT02294955|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110985229|NCT02294955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110985230|NCT02294955|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110985231|NCT02294955|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110985232|NCT02294955|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110985233|NCT02294955|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110985234|NCT02294955|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110985235|NCT02294955|Adrenergic Agents|adrenergic agents|mesh-ancestor
110985236|NCT02294955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110985237|NCT02294955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110985238|NCT02294955|Sympatholytics|sympatholytics|mesh-ancestor
110985239|NCT02294955|Autonomic Agents|autonomic agents|mesh-ancestor
110985240|NCT02294955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110985241|NCT02294955|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110985243|NCT02396888|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110985244|NCT02396888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110985245|NCT03517683|Methamphetamine|methamphetamine|mesh-list
110985246|NCT03517683|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110985247|NCT03517683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110985248|NCT03517683|Sympathomimetics|sympathomimetics|mesh-ancestor
110985249|NCT03517683|Autonomic Agents|autonomic agents|mesh-ancestor
110985250|NCT03517683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110985251|NCT03517683|Dopamine Agents|dopamine agents|mesh-ancestor
110985252|NCT03517683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110985253|NCT03517683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110985254|NCT03517683|Adrenergic Agents|adrenergic agents|mesh-ancestor
110985255|NCT03517683|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110985256|NCT03517683|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110985257|NCT03517683|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110985258|NCT03517683|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110985259|NCT02401334|Anti-Infective Agents|anti-infective agents|mesh-list
110985260|NCT02401334|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110985261|NCT02164643|Flutemetamol|flutemetamol|mesh-list
110985262|NCT02164643|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110985263|NCT02164643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110985264|NCT02292459|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
110985265|NCT02292459|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110985266|NCT02292459|Laxatives|laxatives|mesh-ancestor
110985267|NCT02292459|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110985268|NCT03170336|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110985269|NCT03170336|Amiloride|amiloride|mesh-list
110985270|NCT03170336|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110985271|NCT03170336|Diuretics|diuretics|mesh-ancestor
110985272|NCT03170336|Natriuretic Agents|natriuretic agents|mesh-ancestor
110985273|NCT03170336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110985274|NCT03170336|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110451149|NCT02698228|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110985275|NCT03170336|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110985276|NCT03170336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110985277|NCT03170336|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
110985278|NCT03170336|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110985279|NCT03170336|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
110985280|NCT03170336|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110985281|NCT02699684|Hydrogen Peroxide|hydrogen peroxide|mesh-list
110985282|NCT02699684|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110985283|NCT02699684|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110985284|NCT02699684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110985285|NCT02295189|Triamcinolone|triamcinolone|mesh-list
110985286|NCT02295189|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110985287|NCT02295189|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110985288|NCT02295189|Ketorolac|ketorolac|mesh-list
110985289|NCT02295189|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
110985290|NCT02295189|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110985291|NCT02295189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110985292|NCT02295189|Glucocorticoids|glucocorticoids|mesh-ancestor
110985293|NCT02295189|Hormones|hormones|mesh-ancestor
110985294|NCT02295189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110985295|NCT02295189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110985296|NCT02295189|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110985297|NCT02295189|Immunologic Factors|immunologic factors|mesh-ancestor
110985298|NCT02295189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110985299|NCT02295189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110985300|NCT02295189|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110985301|NCT02295189|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110985302|NCT02295189|Analgesics|analgesics|mesh-ancestor
110985303|NCT02295189|Sensory System Agents|sensory system agents|mesh-ancestor
110985304|NCT02295189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110985305|NCT02295189|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110985306|NCT02295189|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110985307|NCT03519633|Neostigmine|neostigmine|mesh-list
110985308|NCT03519633|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110985309|NCT03519633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110985310|NCT03519633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110985311|NCT03519633|Cholinergic Agents|cholinergic agents|mesh-ancestor
110985312|NCT03519633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110985313|NCT03519633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110985314|NCT03519633|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110985316|NCT03519633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110985317|NCT02289027|Vaccines|vaccines|mesh-list
110985318|NCT02289027|Immunologic Factors|immunologic factors|mesh-ancestor
110985319|NCT02289027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110985320|NCT02396030|Magnesium Sulfate|magnesium sulfate|mesh-list
110985321|NCT02396030|Analgesics|analgesics|mesh-ancestor
110985322|NCT02396030|Sensory System Agents|sensory system agents|mesh-ancestor
110985323|NCT02396030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110985324|NCT02396030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110985325|NCT02396030|Anesthetics|anesthetics|mesh-ancestor
110985326|NCT02396030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110985327|NCT02396030|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110702425|NCT03872843|Ibuprofen|ibuprofen|mesh-list
110985328|NCT02396030|Anticonvulsants|anticonvulsants|mesh-ancestor
110985329|NCT02396030|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110985330|NCT02396030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110985331|NCT02396030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110985332|NCT02396030|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110985333|NCT02396030|Tocolytic Agents|tocolytic agents|mesh-ancestor
110985334|NCT02396030|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110985335|NCT02289261|Dexmedetomidine|dexmedetomidine|mesh-list
110985337|NCT02289261|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110985338|NCT02289261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110985339|NCT02289261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110985340|NCT02289261|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110985341|NCT02289261|Analgesics|analgesics|mesh-ancestor
110985342|NCT02289261|Sensory System Agents|sensory system agents|mesh-ancestor
110985343|NCT02289261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110985344|NCT02289261|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110985345|NCT02289261|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110985346|NCT02289261|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110985347|NCT02289261|Adrenergic Agents|adrenergic agents|mesh-ancestor
110985348|NCT02289261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110985349|NCT02289261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110985350|NCT02289261|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110985351|NCT02289261|Narcotics|narcotics|mesh-ancestor
110985352|NCT03168074|Lenvatinib|lenvatinib|mesh-list
110985353|NCT03168074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110985354|NCT03168074|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110985355|NCT03168074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110985356|NCT03168074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110985357|NCT02396108|Paclitaxel|paclitaxel|mesh-list
110985358|NCT02396108|Carboplatin|carboplatin|mesh-list
110985359|NCT02396108|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110985360|NCT02396108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110985361|NCT02396108|Tubulin Modulators|tubulin modulators|mesh-ancestor
110985362|NCT02396108|Antimitotic Agents|antimitotic agents|mesh-ancestor
110985363|NCT02396108|Mitosis Modulators|mitosis modulators|mesh-ancestor
110985364|NCT02396108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110985365|NCT02403596|Tranexamic Acid|tranexamic acid|mesh-list
110985366|NCT02403596|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110985367|NCT02403596|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110985368|NCT02403596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110985369|NCT02403596|Hemostatics|hemostatics|mesh-ancestor
110985370|NCT02403596|Coagulants|coagulants|mesh-ancestor
110985371|NCT02289495|Ritonavir|ritonavir|mesh-list
110985372|NCT02289495|GSK-2838232|gsk-2838232|mesh-list
110985373|NCT02289495|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110985374|NCT02289495|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110985375|NCT02289495|Protease Inhibitors|protease inhibitors|mesh-ancestor
110985376|NCT02289495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110985377|NCT02289495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110985378|NCT02289495|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110985379|NCT02289495|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110985380|NCT02289495|Antiviral Agents|antiviral agents|mesh-ancestor
110985381|NCT02289495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110985382|NCT02289495|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110985383|NCT02289495|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110985384|NCT01774721|Gefitinib|gefitinib|mesh-list
110985385|NCT01774721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110985386|NCT01774721|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110985387|NCT01774721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110451159|NCT00610545|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110985388|NCT01774721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110985389|NCT02395952|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
110985390|NCT02395952|Laxatives|laxatives|mesh-ancestor
110985391|NCT02395952|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110985392|NCT03516903|Folic Acid|folic acid|mesh-list
110985393|NCT03516903|Methotrexate|methotrexate|mesh-list
110985394|NCT03516903|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110985395|NCT03516903|Abortifacient Agents|abortifacient agents|mesh-ancestor
110985396|NCT03516903|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110985397|NCT03516903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110985398|NCT03516903|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110985399|NCT03516903|Antimetabolites|antimetabolites|mesh-ancestor
110985400|NCT03516903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110702469|NCT00166114|Desipramine|desipramine|mesh-list
110985401|NCT03516903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110985402|NCT03516903|Dermatologic Agents|dermatologic agents|mesh-ancestor
110985403|NCT03516903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110985404|NCT03516903|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110985405|NCT03516903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110985406|NCT03516903|Immunologic Factors|immunologic factors|mesh-ancestor
110985407|NCT03516903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110985408|NCT03516903|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110985409|NCT03516903|Hematinics|hematinics|mesh-ancestor
110985410|NCT03516903|Vitamin B Complex|vitamin b complex|mesh-ancestor
110985411|NCT03516903|Vitamins|vitamins|mesh-ancestor
110985412|NCT03516903|Micronutrients|micronutrients|mesh-ancestor
110985413|NCT03516747|Hormones|hormones|mesh-list
110985414|NCT03516747|Parathyroid Hormone|parathyroid hormone|mesh-list
110985415|NCT03516747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110985416|NCT03516747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110985417|NCT03516747|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110985418|NCT03516669|Amoxicillin|amoxicillin|mesh-list
110985419|NCT03516669|Clarithromycin|clarithromycin|mesh-list
110985420|NCT03516669|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110985421|NCT03516669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110985422|NCT03516669|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110985423|NCT03516669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110985424|NCT03516669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110985425|NCT03516669|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110985426|NCT03516669|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110985427|NCT02289807|Cisplatin|cisplatin|mesh-list
110985428|NCT02289807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110985429|NCT02298153|Atezolizumab|atezolizumab|mesh-list
110985430|NCT02298153|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110985431|NCT02298153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110985432|NCT02298153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110985433|NCT02298153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110985434|NCT02298387|Antibodies, Bispecific|antibodies, bispecific|mesh-list
110985435|NCT02298387|Immunologic Factors|immunologic factors|mesh-ancestor
110985436|NCT02298387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110985437|NCT02293551|Insulin Lispro|insulin lispro|mesh-list
110985438|NCT02293551|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110985439|NCT02293551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110985440|NCT02296047|Bromides|bromides|mesh-list
110985441|NCT02296047|Albuterol|albuterol|mesh-list
110985442|NCT02296047|Ipratropium|ipratropium|mesh-list
110985443|NCT02296047|Anticonvulsants|anticonvulsants|mesh-ancestor
110985444|NCT02296047|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110985445|NCT02296047|Autonomic Agents|autonomic agents|mesh-ancestor
110985446|NCT02296047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110985447|NCT02296047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110985448|NCT02296047|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110985449|NCT02296047|Respiratory System Agents|respiratory system agents|mesh-ancestor
110985450|NCT02296047|Tocolytic Agents|tocolytic agents|mesh-ancestor
110985451|NCT02296047|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110985452|NCT02296047|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110985453|NCT02296047|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110985454|NCT02296047|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110985455|NCT02296047|Adrenergic Agents|adrenergic agents|mesh-ancestor
110985456|NCT02296047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110985457|NCT02296047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110451187|NCT04260711|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110985458|NCT02296047|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110985459|NCT02296047|Cholinergic Agents|cholinergic agents|mesh-ancestor
110985460|NCT02293785|Oxycodone|oxycodone|mesh-list
110985461|NCT02293785|Naloxone|naloxone|mesh-list
110985462|NCT02293785|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110985463|NCT02293785|Narcotics|narcotics|mesh-ancestor
110985464|NCT02293785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110985465|NCT02293785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110985466|NCT02293785|Analgesics|analgesics|mesh-ancestor
110985467|NCT02293785|Sensory System Agents|sensory system agents|mesh-ancestor
110985468|NCT02293785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110985469|NCT02293785|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110985470|NCT01162109|Zinc Sulfate|zinc sulfate|mesh-list
110985471|NCT01162109|Astringents|astringents|mesh-ancestor
110985472|NCT01162109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110985473|NCT01162109|Dermatologic Agents|dermatologic agents|mesh-ancestor
110985474|NCT02296203|Irinotecan|irinotecan|mesh-list
110985475|NCT02296203|Cetuximab|cetuximab|mesh-list
110985476|NCT02296203|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110985477|NCT02296203|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110985478|NCT02296203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110985479|NCT02296203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110985480|NCT02296203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110985481|NCT02296203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110985482|NCT03514251|Parathyroid Hormone|parathyroid hormone|mesh-list
110985483|NCT03514251|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110985484|NCT03514251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110985486|NCT02296281|Analgesics|analgesics|mesh-ancestor
110985487|NCT02296281|Sensory System Agents|sensory system agents|mesh-ancestor
110985488|NCT02296281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110985489|NCT02296281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110985490|NCT02296281|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110985491|NCT02296281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110985492|NCT02296281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110985493|NCT02296281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110985494|NCT02296281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110985495|NCT02299245|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110985496|NCT02299245|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110985497|NCT02299245|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110985498|NCT02299245|Antimetabolites|antimetabolites|mesh-ancestor
110985499|NCT02299245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110985500|NCT02299245|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110985501|NCT02299245|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110985502|NCT02299245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110985503|NCT03513549|Loxapine|loxapine|mesh-list
110985504|NCT03513549|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110985505|NCT03513549|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110985506|NCT03513549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110985507|NCT03513549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110985508|NCT03513549|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110985509|NCT03513549|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110985510|NCT03513549|Dopamine Agents|dopamine agents|mesh-ancestor
110985511|NCT03513549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110985512|NCT03513549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110985513|NCT03513471|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
110985514|NCT03513471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110985515|NCT03513393|Velpatasvir|velpatasvir|mesh-list
110985516|NCT03513393|Omeprazole|omeprazole|mesh-list
110985517|NCT03513393|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110985518|NCT03513393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110985519|NCT03513393|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110985520|NCT03513393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110985521|NCT03513393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110985522|NCT03513393|Antiviral Agents|antiviral agents|mesh-ancestor
110985523|NCT03513393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110985524|NCT02299401|Misoprostol|misoprostol|mesh-list
110985525|NCT02299401|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110985526|NCT02299401|Abortifacient Agents|abortifacient agents|mesh-ancestor
110985527|NCT02299401|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110985528|NCT02299401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110985529|NCT02299401|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110985530|NCT02299401|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110985531|NCT02299401|Oxytocics|oxytocics|mesh-ancestor
110985532|NCT02699450|Ranibizumab|ranibizumab|mesh-list
110985533|NCT02699450|Faricimab|faricimab|mesh-list
110985534|NCT02699450|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110985535|NCT02699450|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110985536|NCT02699450|Growth Substances|growth substances|mesh-ancestor
110985537|NCT02699450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110985538|NCT02699450|Growth Inhibitors|growth inhibitors|mesh-ancestor
110985539|NCT02699450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110985540|NCT02299557|Phenylephrine|phenylephrine|mesh-list
110985541|NCT02299557|Oxymetazoline|oxymetazoline|mesh-list
110985542|NCT02299557|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110985543|NCT02299557|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110985544|NCT02299557|Adrenergic Agents|adrenergic agents|mesh-ancestor
110985545|NCT02299557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110985546|NCT02299557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110985547|NCT02299557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110985548|NCT02299557|Sympathomimetics|sympathomimetics|mesh-ancestor
110985549|NCT02299557|Autonomic Agents|autonomic agents|mesh-ancestor
110985550|NCT02299557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110985551|NCT02299557|Nasal Decongestants|nasal decongestants|mesh-ancestor
110985552|NCT02299557|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110985553|NCT02299557|Respiratory System Agents|respiratory system agents|mesh-ancestor
110985554|NCT02299557|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110985555|NCT02299557|Mydriatics|mydriatics|mesh-ancestor
110985556|NCT02299557|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110985557|NCT02299557|Protective Agents|protective agents|mesh-ancestor
110985558|NCT02302989|Ranibizumab|ranibizumab|mesh-list
110985559|NCT02302989|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110985560|NCT02302989|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110985561|NCT02302989|Growth Substances|growth substances|mesh-ancestor
110985562|NCT02302989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110985563|NCT02302989|Growth Inhibitors|growth inhibitors|mesh-ancestor
110985564|NCT02302989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110985565|NCT02296671|Leucovorin|leucovorin|mesh-list
110985566|NCT02296671|Fluorouracil|fluorouracil|mesh-list
110985567|NCT02296671|Oxaliplatin|oxaliplatin|mesh-list
110985568|NCT02296671|Pemetrexed|pemetrexed|mesh-list
110985569|NCT02296671|Antimetabolites|antimetabolites|mesh-ancestor
110985570|NCT02296671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110985571|NCT02296671|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110985572|NCT02296671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110985573|NCT02296671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110985574|NCT02296671|Immunologic Factors|immunologic factors|mesh-ancestor
110985575|NCT02296671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110985576|NCT02296671|Antidotes|antidotes|mesh-ancestor
110985577|NCT02296671|Protective Agents|protective agents|mesh-ancestor
110985578|NCT02296671|Vitamin B Complex|vitamin b complex|mesh-ancestor
110985579|NCT02296671|Vitamins|vitamins|mesh-ancestor
110985580|NCT02296671|Micronutrients|micronutrients|mesh-ancestor
110985581|NCT02296671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110985582|NCT02296671|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110985583|NCT02296671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110985584|NCT02296749|Sirolimus|sirolimus|mesh-list
110985585|NCT02296749|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110985586|NCT02296749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110985587|NCT02296749|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110451208|NCT00928707|Hydroxyurea|hydroxyurea|mesh-list
110985588|NCT02296749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110985589|NCT02296749|Antifungal Agents|antifungal agents|mesh-ancestor
110985590|NCT02296749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110985591|NCT02296749|Immunologic Factors|immunologic factors|mesh-ancestor
110985592|NCT02296749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110985593|NCT04481750|Edaravone|edaravone|mesh-list
110985594|NCT04481750|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110985595|NCT04481750|Antioxidants|antioxidants|mesh-ancestor
110985596|NCT04481750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110985597|NCT04481750|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110985598|NCT04481750|Protective Agents|protective agents|mesh-ancestor
110985599|NCT04481750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110985600|NCT02303223|Propofol|propofol|mesh-list
110985601|NCT02303223|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110985602|NCT02303223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110024426|NCT00004734|Hydroxocobalamin|hydroxocobalamin|mesh-list
110985603|NCT02303223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110985604|NCT02303223|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110985605|NCT02303223|Anesthetics, General|anesthetics, general|mesh-ancestor
110985606|NCT02303223|Anesthetics|anesthetics|mesh-ancestor
110985607|NCT03168698|Oxytocin|oxytocin|mesh-list
110985608|NCT03168698|Carbetocin|carbetocin|mesh-list
110985609|NCT03168698|Oxytocics|oxytocics|mesh-ancestor
110985610|NCT03168698|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110985611|NCT03168698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110985612|NCT04464135|Acetic Acid|acetic acid|mesh-list
110985613|NCT04464135|Retinol acetate|retinol acetate|mesh-list
110985614|NCT04464135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110985615|NCT04464135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110985616|NCT04464135|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110985617|NCT04464135|Immunologic Factors|immunologic factors|mesh-ancestor
110985618|NCT04464135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110985619|NCT04464135|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110985620|NCT04464135|Protective Agents|protective agents|mesh-ancestor
110985621|NCT04464135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110985622|NCT03510351|Tazobactam|tazobactam|mesh-list
110985623|NCT03510351|Ceftolozane|ceftolozane|mesh-list
110985624|NCT03510351|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
110985625|NCT03510351|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110985626|NCT03510351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110985627|NCT03510351|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110985628|NCT03510351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110985629|NCT03510351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110985630|NCT03510351|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110985631|NCT02403284|Liraglutide|liraglutide|mesh-list
110985632|NCT02403284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110985633|NCT02403284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110985634|NCT02403284|Incretins|incretins|mesh-ancestor
110985635|NCT02403284|Hormones|hormones|mesh-ancestor
110985636|NCT02403284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110985637|NCT02400866|Olanzapine|olanzapine|mesh-list
110985638|NCT02400866|Antiemetics|antiemetics|mesh-ancestor
110985639|NCT02400866|Autonomic Agents|autonomic agents|mesh-ancestor
110985640|NCT02400866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110985641|NCT02400866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110985642|NCT02400866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110985643|NCT02400866|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110985644|NCT02400866|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110985645|NCT02400866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110985646|NCT02400866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110985647|NCT02400866|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110985648|NCT02400866|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110985649|NCT02400866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110985650|NCT02400866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110985651|NCT02400866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110985652|NCT02400866|Serotonin Agents|serotonin agents|mesh-ancestor
110985653|NCT02400788|Sorafenib|sorafenib|mesh-list
110985654|NCT02400788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110985655|NCT02400788|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110985656|NCT02400788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110985657|NCT02400788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110985658|NCT02403128|Aflibercept|aflibercept|mesh-list
110985659|NCT02403128|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110985660|NCT02403128|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110985661|NCT02403128|Growth Substances|growth substances|mesh-ancestor
110985662|NCT02403128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110985663|NCT02403128|Growth Inhibitors|growth inhibitors|mesh-ancestor
110985664|NCT02403128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110985665|NCT02297217|Paclitaxel|paclitaxel|mesh-list
110985666|NCT02297217|Carboplatin|carboplatin|mesh-list
110985667|NCT02297217|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110985668|NCT02297217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110985669|NCT02297217|Tubulin Modulators|tubulin modulators|mesh-ancestor
110985670|NCT02297217|Antimitotic Agents|antimitotic agents|mesh-ancestor
110985671|NCT02297217|Mitosis Modulators|mitosis modulators|mesh-ancestor
110985672|NCT02297217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110985673|NCT03515577|Edetic Acid|edetic acid|mesh-list
110985674|NCT03515577|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
110985675|NCT03515577|Chelating Agents|chelating agents|mesh-ancestor
110985676|NCT03515577|Sequestering Agents|sequestering agents|mesh-ancestor
110985677|NCT03515577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110985678|NCT03515577|Anticoagulants|anticoagulants|mesh-ancestor
110985679|NCT03515577|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110985680|NCT03515577|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110985681|NCT02300649|Dexmedetomidine|dexmedetomidine|mesh-list
110985682|NCT02300649|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110985683|NCT02300649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110985684|NCT02300649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110985685|NCT02300649|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110985687|NCT02300649|Sensory System Agents|sensory system agents|mesh-ancestor
110985688|NCT02300649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110985689|NCT02300649|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110985690|NCT02300649|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110985691|NCT02300649|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110985692|NCT02300649|Adrenergic Agents|adrenergic agents|mesh-ancestor
110985693|NCT02300649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110985694|NCT02300649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110985695|NCT02449161|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
110985696|NCT02449161|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110985697|NCT02449161|Contraceptive Agents|contraceptive agents|mesh-ancestor
110985698|NCT02449161|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110985699|NCT02449161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110985700|NCT02449161|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110985701|NCT02449161|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110985702|NCT02449161|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110702766|NCT00259857|Alendronate|alendronate|mesh-list
110985703|NCT02449161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110985704|NCT02297529|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
110985705|NCT02297529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110985706|NCT02297529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110985707|NCT02303769|Tamsulosin|tamsulosin|mesh-list
110985708|NCT02303769|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110985709|NCT02303769|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110985710|NCT02303769|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110985711|NCT02303769|Adrenergic Agents|adrenergic agents|mesh-ancestor
110985712|NCT02303769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110985713|NCT02303769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110985714|NCT02303769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110985715|NCT02303769|Urological Agents|urological agents|mesh-ancestor
110985716|NCT02303847|Ketamine|ketamine|mesh-list
110985717|NCT02303847|Analgesics|analgesics|mesh-ancestor
110985718|NCT02303847|Sensory System Agents|sensory system agents|mesh-ancestor
110985719|NCT02303847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110985720|NCT02303847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110985721|NCT02303847|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110985722|NCT02303847|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110985723|NCT02303847|Anesthetics, General|anesthetics, general|mesh-ancestor
110985724|NCT02303847|Anesthetics|anesthetics|mesh-ancestor
110985725|NCT02303847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110985726|NCT02303847|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110985727|NCT02303847|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110985728|NCT02303847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110985729|NCT02303847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110985730|NCT02297763|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110985731|NCT02297763|Antidepressive Agents|antidepressive agents|mesh-ancestor
110985732|NCT02297763|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110985733|NCT02297763|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110985734|NCT02297763|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110985735|NCT02297763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110985736|NCT02297763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110985737|NCT03511833|Ketamine|ketamine|mesh-list
110985738|NCT03511833|Morphine|morphine|mesh-list
110985739|NCT03511833|Analgesics|analgesics|mesh-ancestor
110985740|NCT03511833|Sensory System Agents|sensory system agents|mesh-ancestor
110985741|NCT03511833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110985742|NCT03511833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110985743|NCT03511833|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110985744|NCT03511833|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110985745|NCT03511833|Anesthetics, General|anesthetics, general|mesh-ancestor
110985746|NCT03511833|Anesthetics|anesthetics|mesh-ancestor
110985747|NCT03511833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110985748|NCT03511833|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110450903|NCT00925899|Melatonin|melatonin|mesh-list
110985749|NCT03511833|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110985750|NCT03511833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110985751|NCT03511833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110985752|NCT03511833|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110985754|NCT03511755|Neurotransmitter Agents|neurotransmitter agents|mesh-list
110985755|NCT03511755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110985756|NCT03511755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110985757|NCT02696798|Ixekizumab|ixekizumab|mesh-list
110985758|NCT02696798|Dermatologic Agents|dermatologic agents|mesh-ancestor
110985759|NCT02304081|Saxagliptin|saxagliptin|mesh-list
110985760|NCT02304081|Incretins|incretins|mesh-ancestor
110985761|NCT02304081|Hormones|hormones|mesh-ancestor
110985762|NCT02304081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110985763|NCT02304081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110985764|NCT02304081|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110985765|NCT02304081|Protease Inhibitors|protease inhibitors|mesh-ancestor
110985766|NCT02304081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110985767|NCT02304081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110985768|NCT02304081|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110985769|NCT02304237|Progesterone|progesterone|mesh-list
110985770|NCT02304237|Progestins|progestins|mesh-ancestor
110985771|NCT02304237|Hormones|hormones|mesh-ancestor
110985772|NCT02304237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110985773|NCT02304237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110985774|NCT03515187|Bromides|bromides|mesh-list
110985775|NCT03515187|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110985776|NCT03515187|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110985777|NCT03515187|Hyaluronic Acid|hyaluronic acid|mesh-list
110985778|NCT03515187|Anticonvulsants|anticonvulsants|mesh-ancestor
110985779|NCT03515187|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110985780|NCT03515187|Immunologic Factors|immunologic factors|mesh-ancestor
110451236|NCT02705872|Sufentanil|sufentanil|mesh-list
110985781|NCT03515187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110985782|NCT03515187|Viscosupplements|viscosupplements|mesh-ancestor
110985783|NCT03515187|Protective Agents|protective agents|mesh-ancestor
110985784|NCT02297997|Cetylpyridinium|cetylpyridinium|mesh-list
110985785|NCT02297997|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110985786|NCT02297997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110985787|NCT02395016|Gemcitabine|gemcitabine|mesh-list
110985788|NCT02395016|Nimotuzumab|nimotuzumab|mesh-list
110985789|NCT02395016|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110985790|NCT02395016|Antimetabolites|antimetabolites|mesh-ancestor
110985791|NCT02395016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110985792|NCT02395016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110985793|NCT02395016|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110985794|NCT04480268|Paclitaxel|paclitaxel|mesh-list
110985795|NCT04480268|Gemcitabine|gemcitabine|mesh-list
110985796|NCT04480268|Capecitabine|capecitabine|mesh-list
110985797|NCT04480268|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110985798|NCT04480268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110985799|NCT04480268|Tubulin Modulators|tubulin modulators|mesh-ancestor
110985800|NCT04480268|Antimitotic Agents|antimitotic agents|mesh-ancestor
110985801|NCT04480268|Mitosis Modulators|mitosis modulators|mesh-ancestor
110985802|NCT04480268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110985803|NCT04480268|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110985804|NCT04480268|Antimetabolites|antimetabolites|mesh-ancestor
110985805|NCT03510975|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
110985806|NCT03510975|Hemostatics|hemostatics|mesh-ancestor
110985807|NCT03510975|Coagulants|coagulants|mesh-ancestor
110985808|NCT03510975|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
110985809|NCT03510975|Natriuretic Agents|natriuretic agents|mesh-ancestor
110985810|NCT03510975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110985811|NCT03169790|Leucovorin|leucovorin|mesh-list
110985812|NCT03169790|Paclitaxel|paclitaxel|mesh-list
110985813|NCT03169790|Cyclophosphamide|cyclophosphamide|mesh-list
110985814|NCT03169790|Bevacizumab|bevacizumab|mesh-list
110985815|NCT03169790|Rituximab|rituximab|mesh-list
110985816|NCT03169790|Fluorouracil|fluorouracil|mesh-list
110985817|NCT03169790|Capecitabine|capecitabine|mesh-list
110985818|NCT03169790|Oxaliplatin|oxaliplatin|mesh-list
110985819|NCT03169790|Avelumab|avelumab|mesh-list
110985820|NCT03169790|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110985821|NCT03169790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110985822|NCT03169790|Tubulin Modulators|tubulin modulators|mesh-ancestor
110985823|NCT03169790|Antimitotic Agents|antimitotic agents|mesh-ancestor
110985824|NCT03169790|Mitosis Modulators|mitosis modulators|mesh-ancestor
110985825|NCT03169790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110985826|NCT03169790|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110985827|NCT03169790|Immunologic Factors|immunologic factors|mesh-ancestor
110985828|NCT03169790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110985829|NCT03169790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110985830|NCT03169790|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110985831|NCT03169790|Alkylating Agents|alkylating agents|mesh-ancestor
110985832|NCT03169790|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110985833|NCT03169790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110985834|NCT03169790|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110985835|NCT03169790|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110985836|NCT03169790|Growth Substances|growth substances|mesh-ancestor
110985837|NCT03169790|Growth Inhibitors|growth inhibitors|mesh-ancestor
110985838|NCT03169790|Antimetabolites|antimetabolites|mesh-ancestor
110985839|NCT03169790|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110985840|NCT03169790|Antidotes|antidotes|mesh-ancestor
110985841|NCT03169790|Protective Agents|protective agents|mesh-ancestor
110985842|NCT03169790|Vitamin B Complex|vitamin b complex|mesh-ancestor
110985843|NCT03169790|Vitamins|vitamins|mesh-ancestor
110985844|NCT03169790|Micronutrients|micronutrients|mesh-ancestor
110985845|NCT02304393|Atezolizumab|atezolizumab|mesh-list
110985846|NCT02304393|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110451248|NCT02705872|Anesthetics, General|anesthetics, general|mesh-ancestor
110985847|NCT02304393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110985848|NCT02304393|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110985849|NCT02304393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110985850|NCT02402972|Leucovorin|leucovorin|mesh-list
110985851|NCT02402972|Oxaliplatin|oxaliplatin|mesh-list
110985852|NCT02402972|Floxuridine|floxuridine|mesh-list
110985853|NCT02402972|Levoleucovorin|levoleucovorin|mesh-list
110985854|NCT02402972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110985855|NCT02402972|Antidotes|antidotes|mesh-ancestor
110985857|NCT02402972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110985858|NCT02402972|Vitamin B Complex|vitamin b complex|mesh-ancestor
110985859|NCT02402972|Vitamins|vitamins|mesh-ancestor
110985860|NCT02402972|Micronutrients|micronutrients|mesh-ancestor
110985861|NCT02402972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110985862|NCT02402972|Antimetabolites|antimetabolites|mesh-ancestor
110985863|NCT02402972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110985864|NCT02394470|Deuterium Oxide|deuterium oxide|mesh-list
110985865|NCT02394470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110985866|NCT02394470|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110985867|NCT02394470|Protective Agents|protective agents|mesh-ancestor
110985868|NCT02394470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110985869|NCT02304627|Insulin|insulin|mesh-list
110985870|NCT02304627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110985871|NCT02304627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110985872|NCT03508713|Antirheumatic Agents|antirheumatic agents|mesh-list
110985873|NCT02394158|Metformin|metformin|mesh-list
110985874|NCT02394158|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110985875|NCT02394158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110985876|NCT03508635|Prednisone|prednisone|mesh-list
110985877|NCT03508635|Cortisone|cortisone|mesh-list
110985878|NCT03508635|Mifepristone|mifepristone|mesh-list
110985879|NCT03508635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110985880|NCT03508635|Glucocorticoids|glucocorticoids|mesh-ancestor
110985881|NCT03508635|Hormones|hormones|mesh-ancestor
110985882|NCT03508635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110985883|NCT03508635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110985884|NCT03508635|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110985885|NCT03508635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110985886|NCT03508635|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
110985887|NCT03508635|Abortifacient Agents|abortifacient agents|mesh-ancestor
110985888|NCT03508635|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110985889|NCT03508635|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110985890|NCT03508635|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110985891|NCT03508635|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110985892|NCT03508635|Contraceptive Agents|contraceptive agents|mesh-ancestor
110985893|NCT03508635|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
110985894|NCT03508635|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
110985895|NCT03508635|Hormone Antagonists|hormone antagonists|mesh-ancestor
110985896|NCT03508635|Luteolytic Agents|luteolytic agents|mesh-ancestor
110985897|NCT03508635|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110985898|NCT03508635|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
110985899|NCT04481282|Terbutaline|terbutaline|mesh-list
110985900|NCT04481282|Danazol|danazol|mesh-list
110985901|NCT04481282|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110985902|NCT04481282|Autonomic Agents|autonomic agents|mesh-ancestor
110985903|NCT04481282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110985904|NCT04481282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110985905|NCT04481282|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110985906|NCT04481282|Respiratory System Agents|respiratory system agents|mesh-ancestor
110985907|NCT04481282|Sympathomimetics|sympathomimetics|mesh-ancestor
110985908|NCT04481282|Tocolytic Agents|tocolytic agents|mesh-ancestor
110985909|NCT04481282|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110985910|NCT04481282|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110985911|NCT04481282|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110985912|NCT04481282|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110985913|NCT04481282|Adrenergic Agents|adrenergic agents|mesh-ancestor
110985914|NCT04481282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110985915|NCT04481282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110451261|NCT05324800|Turmeric extract|turmeric extract|mesh-list
110985916|NCT04481282|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110985917|NCT04481282|Hormone Antagonists|hormone antagonists|mesh-ancestor
110985918|NCT04481282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110985919|NCT02541604|Atezolizumab|atezolizumab|mesh-list
110985920|NCT02541604|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110985921|NCT02541604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110985922|NCT02541604|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110985923|NCT02541604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110985924|NCT02393846|Ketoprofen|ketoprofen|mesh-list
110985925|NCT02393846|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110985926|NCT02393846|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110985927|NCT02393846|Analgesics|analgesics|mesh-ancestor
110985928|NCT02393846|Sensory System Agents|sensory system agents|mesh-ancestor
110985929|NCT02393846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110985930|NCT02393846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110985931|NCT02393846|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110985932|NCT02393846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110985933|NCT02393846|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110985934|NCT02393846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110985935|NCT02393846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110985936|NCT02302209|Oxytocin|oxytocin|mesh-list
110985937|NCT02302209|Oxytocics|oxytocics|mesh-ancestor
110985938|NCT02302209|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110985939|NCT02302209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110985940|NCT02394002|Propofol|propofol|mesh-list
110985941|NCT02394002|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110985942|NCT02394002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110985943|NCT02394002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110985944|NCT02394002|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110985945|NCT02394002|Anesthetics, General|anesthetics, general|mesh-ancestor
110985946|NCT02394002|Anesthetics|anesthetics|mesh-ancestor
110985947|NCT02306577|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110985948|NCT02306577|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110985949|NCT02306577|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110985950|NCT02306577|Antiviral Agents|antiviral agents|mesh-ancestor
110985951|NCT02306577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110985952|NCT02402348|Metformin|metformin|mesh-list
110985953|NCT02402348|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110985954|NCT02402348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110985955|NCT02399462|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
110985956|NCT02399462|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
110985957|NCT02399462|beta-Endorphin|beta-endorphin|mesh-list
110985958|NCT02399462|Hormones|hormones|mesh-ancestor
110985959|NCT02399462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110985960|NCT02399462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110985961|NCT02399462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110985962|NCT02399462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110985963|NCT02305173|Dexamethasone|dexamethasone|mesh-list
110985964|NCT02305173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110985965|NCT02305173|Antiemetics|antiemetics|mesh-ancestor
110985966|NCT02305173|Autonomic Agents|autonomic agents|mesh-ancestor
110985967|NCT02305173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110985968|NCT02305173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110985969|NCT02305173|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110985970|NCT02305173|Glucocorticoids|glucocorticoids|mesh-ancestor
110985971|NCT02305173|Hormones|hormones|mesh-ancestor
110985972|NCT02305173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110985973|NCT02305173|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110985974|NCT02305173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110985975|NCT03505047|Copper|copper|mesh-list
110985977|NCT03505047|Micronutrients|micronutrients|mesh-ancestor
110985978|NCT03505047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110985979|NCT02402114|Hydrocortisone|hydrocortisone|mesh-list
110985980|NCT02402114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110985981|NCT02305485|Everolimus|everolimus|mesh-list
110985982|NCT02305485|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110985983|NCT02305485|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110985984|NCT02305485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110985985|NCT02305485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110985986|NCT02305485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110985987|NCT02305485|Immunologic Factors|immunologic factors|mesh-ancestor
110985988|NCT02305485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110985989|NCT02305485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110985990|NCT02311569|Mirabegron|mirabegron|mesh-list
110985991|NCT02311569|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
110985992|NCT02311569|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110985993|NCT02311569|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110985994|NCT02311569|Adrenergic Agents|adrenergic agents|mesh-ancestor
110985995|NCT02311569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110985996|NCT02311569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110985997|NCT02311569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110985998|NCT02311569|Urological Agents|urological agents|mesh-ancestor
110985999|NCT02393456|Oxytocin|oxytocin|mesh-list
110986000|NCT02393456|Oxytocics|oxytocics|mesh-ancestor
110986001|NCT02393456|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110986002|NCT02393456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110986003|NCT02393612|Sarpogrelate|sarpogrelate|mesh-list
110986004|NCT02393612|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110986005|NCT02393612|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110986006|NCT02393612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110986007|NCT02393612|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110986008|NCT02393612|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110986009|NCT02393612|Serotonin Agents|serotonin agents|mesh-ancestor
110986010|NCT02393612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110986011|NCT02393612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110986012|NCT02306733|Oxytocin|oxytocin|mesh-list
110986013|NCT02306733|Ergonovine|ergonovine|mesh-list
110986014|NCT02306733|Oxytocics|oxytocics|mesh-ancestor
110986015|NCT02306733|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110986016|NCT02306733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110986017|NCT02698436|Benzoyl Peroxide|benzoyl peroxide|mesh-list
110986018|NCT02698436|Dermatologic Agents|dermatologic agents|mesh-ancestor
110986019|NCT03507465|Capecitabine|capecitabine|mesh-list
110986020|NCT03507465|Letrozole|letrozole|mesh-list
110986021|NCT03507465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110986022|NCT03507465|Antimetabolites|antimetabolites|mesh-ancestor
110986023|NCT03507465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110986024|NCT03507465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110986025|NCT03507465|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110986026|NCT03507465|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110986027|NCT03507465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110986028|NCT03507465|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110986029|NCT03507465|Hormone Antagonists|hormone antagonists|mesh-ancestor
110986030|NCT03507465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110986031|NCT03507465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110986032|NCT05476042|Epoetin Alfa|epoetin alfa|mesh-list
110986033|NCT05476042|Hematinics|hematinics|mesh-ancestor
110986034|NCT03507387|Phenylephrine|phenylephrine|mesh-list
110986035|NCT03507387|Oxymetazoline|oxymetazoline|mesh-list
110986036|NCT03507387|Bupivacaine|bupivacaine|mesh-list
110986037|NCT03507387|Anesthetics, Local|anesthetics, local|mesh-ancestor
110986038|NCT03507387|Anesthetics|anesthetics|mesh-ancestor
110986039|NCT03507387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110986040|NCT03507387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110986041|NCT03507387|Sensory System Agents|sensory system agents|mesh-ancestor
110986042|NCT03507387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110986043|NCT03507387|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110986044|NCT03507387|Mydriatics|mydriatics|mesh-ancestor
110986045|NCT03507387|Autonomic Agents|autonomic agents|mesh-ancestor
110986046|NCT03507387|Sympathomimetics|sympathomimetics|mesh-ancestor
110986047|NCT03507387|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110986048|NCT03507387|Nasal Decongestants|nasal decongestants|mesh-ancestor
110986049|NCT03507387|Respiratory System Agents|respiratory system agents|mesh-ancestor
110986050|NCT03507387|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110986051|NCT03507387|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110986053|NCT03507387|Adrenergic Agents|adrenergic agents|mesh-ancestor
110986054|NCT03507387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110986055|NCT03507387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110986056|NCT03507387|Protective Agents|protective agents|mesh-ancestor
110986057|NCT02694536|Gemcitabine|gemcitabine|mesh-list
110986058|NCT02694536|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110986059|NCT02694536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110986060|NCT02694536|Antimetabolites|antimetabolites|mesh-ancestor
110986061|NCT02694536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110986062|NCT02694536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110986063|NCT02694536|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110986064|NCT02694536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110986065|NCT02312037|Gemtuzumab|gemtuzumab|mesh-list
110986066|NCT02312037|Antibodies|antibodies|mesh-list
110986067|NCT02312037|Immunoconjugates|immunoconjugates|mesh-list
110986068|NCT02312037|Immunologic Factors|immunologic factors|mesh-ancestor
110986069|NCT02312037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110986070|NCT02312037|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110986071|NCT02312037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110986072|NCT02312037|Immunotoxins|immunotoxins|mesh-ancestor
110986073|NCT03167918|Calcium, Dietary|calcium, dietary|mesh-list
110986074|NCT03167918|Metformin|metformin|mesh-list
110986075|NCT03167918|Calcium Dobesilate|calcium dobesilate|mesh-list
110986076|NCT03167918|Calcium|calcium|mesh-list
110986077|NCT03167918|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110986078|NCT03167918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110986079|NCT03167918|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110986080|NCT03167918|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110986081|NCT03167918|Hemostatics|hemostatics|mesh-ancestor
110986082|NCT03167918|Coagulants|coagulants|mesh-ancestor
110986083|NCT05745818|Colchicine|colchicine|mesh-list
110986084|NCT05745818|Gout Suppressants|gout suppressants|mesh-ancestor
110986085|NCT05745818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110986086|NCT05745818|Tubulin Modulators|tubulin modulators|mesh-ancestor
110986087|NCT05745818|Antimitotic Agents|antimitotic agents|mesh-ancestor
110986088|NCT05745818|Mitosis Modulators|mitosis modulators|mesh-ancestor
110986089|NCT05745818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110986090|NCT05745818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110986091|NCT02393300|Tranexamic Acid|tranexamic acid|mesh-list
110986092|NCT02393300|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110986093|NCT02393300|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110986094|NCT02393300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110986095|NCT02393300|Hemostatics|hemostatics|mesh-ancestor
110986096|NCT02393300|Coagulants|coagulants|mesh-ancestor
110986097|NCT03106610|Nivolumab|nivolumab|mesh-list
110986098|NCT03106610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110986099|NCT03106610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110986100|NCT03106610|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110986101|NCT03106610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110986102|NCT02678884|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110986103|NCT02678884|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110986104|NCT02678884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110986105|NCT03504735|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
110986106|NCT03504735|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110986107|NCT03504735|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110986108|NCT03504735|Antimetabolites|antimetabolites|mesh-ancestor
110986109|NCT03504735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110986110|NCT03504735|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110986111|NCT03504735|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110986112|NCT03504735|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110986113|NCT03504735|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110986114|NCT03504735|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110986115|NCT03504735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110986116|NCT03504735|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110986117|NCT03504735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110986118|NCT05475886|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
110986119|NCT05475886|Plasma Substitutes|plasma substitutes|mesh-ancestor
110986120|NCT05475886|Blood Substitutes|blood substitutes|mesh-ancestor
110986121|NCT02312115|Furosemide|furosemide|mesh-list
110986122|NCT02312115|Diuretics|diuretics|mesh-ancestor
110986123|NCT02312115|Natriuretic Agents|natriuretic agents|mesh-ancestor
110986124|NCT02312115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110822989|NCT00943618|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110986125|NCT02312115|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110986126|NCT02312115|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110986127|NCT02312115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110986129|NCT03106532|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110986130|NCT03026140|Celecoxib|celecoxib|mesh-list
110986131|NCT03026140|Nivolumab|nivolumab|mesh-list
110986132|NCT03026140|Ipilimumab|ipilimumab|mesh-list
110986133|NCT03026140|Relatlimab|relatlimab|mesh-list
110986134|NCT03026140|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110986135|NCT03026140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110986136|NCT03026140|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110986137|NCT03026140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110986138|NCT03026140|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110986139|NCT03026140|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110986140|NCT03026140|Analgesics|analgesics|mesh-ancestor
110986141|NCT03026140|Sensory System Agents|sensory system agents|mesh-ancestor
110986142|NCT03026140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110986143|NCT03026140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110986144|NCT03026140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110986145|NCT03026140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110986146|NCT03026140|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110986147|NCT03026140|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110986148|NCT03026140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110986149|NCT02398994|Methylprednisolone|methylprednisolone|mesh-list
110986150|NCT02398994|Immunoglobulins|immunoglobulins|mesh-list
110986151|NCT02398994|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110986152|NCT02398994|gamma-Globulins|gamma-globulins|mesh-list
110986153|NCT02398994|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110986154|NCT02398994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110986155|NCT02398994|Antiemetics|antiemetics|mesh-ancestor
110986156|NCT02398994|Autonomic Agents|autonomic agents|mesh-ancestor
110986157|NCT02398994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110986158|NCT02398994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110986159|NCT02398994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110986160|NCT02398994|Glucocorticoids|glucocorticoids|mesh-ancestor
110986161|NCT02398994|Hormones|hormones|mesh-ancestor
110986162|NCT02398994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110986163|NCT02398994|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110986164|NCT02398994|Protective Agents|protective agents|mesh-ancestor
110986165|NCT02398994|Immunologic Factors|immunologic factors|mesh-ancestor
110986166|NCT02306889|Fenofibrate|fenofibrate|mesh-list
110986167|NCT02306889|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110986168|NCT02306889|Antimetabolites|antimetabolites|mesh-ancestor
110986169|NCT02306889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110986170|NCT02306889|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110986171|NCT02393144|Meperidine|meperidine|mesh-list
110986172|NCT02393144|Analgesics, Opioid|analgesics, opioid|mesh-list
110986173|NCT02393144|Analgesics|analgesics|mesh-list
110986174|NCT02393144|Oxytocin|oxytocin|mesh-list
110986175|NCT02393144|Dinoprostone|dinoprostone|mesh-list
110986176|NCT02393144|Oxytocics|oxytocics|mesh-ancestor
110986177|NCT02393144|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110986178|NCT02393144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110986179|NCT02393144|Narcotics|narcotics|mesh-ancestor
110986180|NCT02393144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110986181|NCT02393144|Sensory System Agents|sensory system agents|mesh-ancestor
110986182|NCT02393144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110986183|NCT02393144|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110986184|NCT02306031|Diclofenac|diclofenac|mesh-list
110986185|NCT02306031|Lubricant Eye Drops|lubricant eye drops|mesh-list
110986186|NCT02306031|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110986187|NCT02306031|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110986188|NCT02306031|Analgesics|analgesics|mesh-ancestor
110986189|NCT02306031|Sensory System Agents|sensory system agents|mesh-ancestor
110986190|NCT02306031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110986191|NCT02306031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110986192|NCT02306031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110986193|NCT02306031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110986194|NCT02306031|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110986195|NCT02306031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110986196|NCT02306031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110986197|NCT02306031|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110986198|NCT02306031|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110986199|NCT02392910|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
110986200|NCT02392910|Hematinics|hematinics|mesh-ancestor
110986202|NCT02307045|Varenicline|varenicline|mesh-list
110986203|NCT02307045|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110986204|NCT02307045|Autonomic Agents|autonomic agents|mesh-ancestor
110986205|NCT02307045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110986206|NCT02307045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110986207|NCT02307045|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110986208|NCT02307045|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110986209|NCT02307045|Cholinergic Agents|cholinergic agents|mesh-ancestor
110986210|NCT02307045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110986211|NCT02307045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110986212|NCT03167372|Imidacloprid|imidacloprid|mesh-list
110986213|NCT03167372|Cholinergic Agents|cholinergic agents|mesh-ancestor
110986214|NCT03167372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110986215|NCT03167372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110986216|NCT03167372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110986217|NCT03504345|Progesterone|progesterone|mesh-list
110986218|NCT03504345|Progestins|progestins|mesh-ancestor
110986219|NCT03504345|Hormones|hormones|mesh-ancestor
110986220|NCT03504345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110986221|NCT03504345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110986222|NCT02307201|Magnesium Sulfate|magnesium sulfate|mesh-list
110986223|NCT02307201|Analgesics|analgesics|mesh-ancestor
110986224|NCT02307201|Sensory System Agents|sensory system agents|mesh-ancestor
110986225|NCT02307201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110986226|NCT02307201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110986227|NCT02307201|Anesthetics|anesthetics|mesh-ancestor
110986228|NCT02307201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110986229|NCT02307201|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110986230|NCT02307201|Anticonvulsants|anticonvulsants|mesh-ancestor
110703294|NCT01048892|Alkylating Agents|alkylating agents|mesh-ancestor
110986231|NCT02307201|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110986232|NCT02307201|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110986233|NCT02307201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110986234|NCT02307201|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110986235|NCT02307201|Tocolytic Agents|tocolytic agents|mesh-ancestor
110986236|NCT02307201|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110986237|NCT02306187|Eldecalcitol|eldecalcitol|mesh-list
110986238|NCT02306187|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110986239|NCT02306187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110986240|NCT03167216|Cetirizine|cetirizine|mesh-list
110986241|NCT03167216|Cromolyn Sodium|cromolyn sodium|mesh-list
110986242|NCT03167216|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110986243|NCT03167216|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110986244|NCT03167216|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110986245|NCT03167216|Histamine Antagonists|histamine antagonists|mesh-ancestor
110986246|NCT03167216|Histamine Agents|histamine agents|mesh-ancestor
110986247|NCT03167216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110986248|NCT03167216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110986249|NCT03167216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110986250|NCT03167216|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
110986251|NCT03167216|Immunologic Factors|immunologic factors|mesh-ancestor
110986252|NCT03167216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110986253|NCT03167216|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110986254|NCT03167216|Respiratory System Agents|respiratory system agents|mesh-ancestor
110986255|NCT02393066|Dexmedetomidine|dexmedetomidine|mesh-list
110986256|NCT02393066|Propofol|propofol|mesh-list
110986257|NCT02393066|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110986258|NCT02393066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110986259|NCT02393066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110986260|NCT02393066|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110986261|NCT02393066|Analgesics|analgesics|mesh-ancestor
110986262|NCT02393066|Sensory System Agents|sensory system agents|mesh-ancestor
110986263|NCT02393066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110986264|NCT02393066|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110986265|NCT02393066|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110986266|NCT02393066|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110986267|NCT02393066|Adrenergic Agents|adrenergic agents|mesh-ancestor
110986268|NCT02393066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110986269|NCT02393066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110986270|NCT02393066|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110986271|NCT02393066|Anesthetics, General|anesthetics, general|mesh-ancestor
110986272|NCT02393066|Anesthetics|anesthetics|mesh-ancestor
110986273|NCT02398838|Misoprostol|misoprostol|mesh-list
110986274|NCT02398838|Mifepristone|mifepristone|mesh-list
110986275|NCT02398838|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110986276|NCT02398838|Abortifacient Agents|abortifacient agents|mesh-ancestor
110986277|NCT02398838|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110986278|NCT02398838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110986279|NCT02398838|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110986280|NCT02398838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110986281|NCT02398838|Oxytocics|oxytocics|mesh-ancestor
110986282|NCT02398838|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
110986283|NCT02398838|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110986284|NCT02398838|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110986285|NCT02398838|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110986286|NCT02398838|Contraceptive Agents|contraceptive agents|mesh-ancestor
110986287|NCT02398838|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
110986288|NCT02398838|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
110986289|NCT02398838|Hormone Antagonists|hormone antagonists|mesh-ancestor
110986290|NCT02398838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110986291|NCT02398838|Luteolytic Agents|luteolytic agents|mesh-ancestor
110986292|NCT02398838|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110986293|NCT02398838|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
110986294|NCT02398682|Tin Fluorides|tin fluorides|mesh-list
110986295|NCT02398682|Cariostatic Agents|cariostatic agents|mesh-ancestor
110986296|NCT02398682|Protective Agents|protective agents|mesh-ancestor
110986297|NCT02398682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110986298|NCT02312427|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
110986299|NCT02312427|Protease Inhibitors|protease inhibitors|mesh-ancestor
110986300|NCT02312427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110986301|NCT02312427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110986302|NCT02312427|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110451317|NCT02691910|Analgesics|analgesics|mesh-ancestor
110986303|NCT02312427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110986305|NCT03504033|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110986306|NCT03504033|Anesthetics, General|anesthetics, general|mesh-ancestor
110986307|NCT03504033|Anesthetics|anesthetics|mesh-ancestor
110986308|NCT03504033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110986309|NCT03504033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110986310|NCT03132519|Remifentanil|remifentanil|mesh-list
110986311|NCT03132519|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110986312|NCT03132519|Narcotics|narcotics|mesh-ancestor
110986313|NCT03132519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110986314|NCT03132519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110986315|NCT03132519|Analgesics|analgesics|mesh-ancestor
110986316|NCT03132519|Sensory System Agents|sensory system agents|mesh-ancestor
110986317|NCT03132519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110986318|NCT02398448|Allopurinol|allopurinol|mesh-list
110986319|NCT02398448|Antimetabolites|antimetabolites|mesh-ancestor
110986320|NCT02398448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110986321|NCT02398448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110986322|NCT02398448|Gout Suppressants|gout suppressants|mesh-ancestor
110986323|NCT02398448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110986324|NCT02398448|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110986325|NCT02398448|Antioxidants|antioxidants|mesh-ancestor
110986326|NCT02398448|Protective Agents|protective agents|mesh-ancestor
110986327|NCT02398448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110986329|NCT02392520|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110986330|NCT02392520|Fertility Agents|fertility agents|mesh-ancestor
110986331|NCT02392520|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110986332|NCT02392520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110986333|NCT02392520|Hormone Antagonists|hormone antagonists|mesh-ancestor
110986334|NCT02392520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110986335|NCT02316249|Estradiol|estradiol|mesh-list
110986336|NCT02316249|Hormones|hormones|mesh-ancestor
110986337|NCT02316249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110986338|NCT02316249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110986339|NCT02316249|Estrogens|estrogens|mesh-ancestor
110986340|NCT02696096|Buprenorphine|buprenorphine|mesh-list
110986341|NCT02696096|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
110986342|NCT02696096|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110986343|NCT02696096|Narcotics|narcotics|mesh-ancestor
110986344|NCT02696096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110986345|NCT02696096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110986346|NCT02696096|Analgesics|analgesics|mesh-ancestor
110986347|NCT02696096|Sensory System Agents|sensory system agents|mesh-ancestor
110986349|NCT02696096|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110986350|NCT02316327|Bevacizumab|bevacizumab|mesh-list
110986351|NCT02316327|Gemcitabine|gemcitabine|mesh-list
110986352|NCT02316327|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110986353|NCT02316327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110986354|NCT02316327|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110986355|NCT02316327|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110986356|NCT02316327|Growth Substances|growth substances|mesh-ancestor
110986357|NCT02316327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110986358|NCT02316327|Growth Inhibitors|growth inhibitors|mesh-ancestor
110986359|NCT02316327|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110986360|NCT02316327|Antimetabolites|antimetabolites|mesh-ancestor
110986361|NCT02316327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110986362|NCT02695628|Misonidazole|misonidazole|mesh-list
110986363|NCT02695628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110986364|NCT02695628|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110986365|NCT02695628|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110986366|NCT02695628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110986367|NCT02392364|Aflibercept|aflibercept|mesh-list
110986368|NCT02392364|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110986369|NCT02392364|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110986370|NCT02392364|Growth Substances|growth substances|mesh-ancestor
110986371|NCT02392364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110986372|NCT02392364|Growth Inhibitors|growth inhibitors|mesh-ancestor
110986373|NCT02392364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110986374|NCT02392676|Olaparib|olaparib|mesh-list
110986375|NCT02392676|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110986376|NCT02392676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110986377|NCT02392676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110986378|NCT02392676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110986379|NCT03106298|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
110986380|NCT03106298|Hematinics|hematinics|mesh-ancestor
110986381|NCT02307591|Amiodarone|amiodarone|mesh-list
110986382|NCT02307591|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110986383|NCT02307591|Vasodilator Agents|vasodilator agents|mesh-ancestor
110986384|NCT02307591|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
110986385|NCT02307591|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110986386|NCT02307591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110986387|NCT02307591|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110986388|NCT02307591|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110986389|NCT02307591|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110986390|NCT02307591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110986391|NCT02307591|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110986392|NCT02307591|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110986393|NCT02307591|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110986394|NCT03506997|Pembrolizumab|pembrolizumab|mesh-list
110986395|NCT03506997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110986396|NCT03506997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110986397|NCT03506997|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110986398|NCT03506997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110986399|NCT02398136|Midazolam|midazolam|mesh-list
110986400|NCT02398136|Ketamine|ketamine|mesh-list
110986401|NCT02398136|Analgesics|analgesics|mesh-ancestor
110986402|NCT02398136|Sensory System Agents|sensory system agents|mesh-ancestor
110986403|NCT02398136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110986404|NCT02398136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110986405|NCT02398136|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110986406|NCT02398136|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110986407|NCT02398136|Anesthetics, General|anesthetics, general|mesh-ancestor
110986408|NCT02398136|Anesthetics|anesthetics|mesh-ancestor
110986409|NCT02398136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110986410|NCT02398136|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110986411|NCT02398136|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110986412|NCT02398136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110986413|NCT02398136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110986414|NCT02398136|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110986415|NCT02398136|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110986416|NCT02398136|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110986417|NCT02398136|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110986418|NCT02398136|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110986419|NCT02398136|GABA Modulators|gaba modulators|mesh-ancestor
110986422|NCT05745584|Cholinergic Antagonists|cholinergic antagonists|mesh-list
110986423|NCT05745584|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
110986424|NCT05745584|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110986425|NCT05745584|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110986426|NCT05745584|Adrenergic Agents|adrenergic agents|mesh-ancestor
110986427|NCT05745584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110986428|NCT05745584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110986429|NCT05745584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110986430|NCT05745584|Urological Agents|urological agents|mesh-ancestor
110986431|NCT05745584|Cholinergic Agents|cholinergic agents|mesh-ancestor
110986432|NCT02312661|Metformin|metformin|mesh-list
110986433|NCT02312661|Paclitaxel|paclitaxel|mesh-list
110986434|NCT02312661|Carboplatin|carboplatin|mesh-list
110986435|NCT02312661|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110986436|NCT02312661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110986437|NCT02312661|Tubulin Modulators|tubulin modulators|mesh-ancestor
110986438|NCT02312661|Antimitotic Agents|antimitotic agents|mesh-ancestor
110986439|NCT02312661|Mitosis Modulators|mitosis modulators|mesh-ancestor
110986440|NCT02312661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110986441|NCT02312661|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110986442|NCT02312661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110986443|NCT02398058|Olaparib|olaparib|mesh-list
110986444|NCT02398058|Trabectedin|trabectedin|mesh-list
110986445|NCT02398058|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110986446|NCT02398058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110986447|NCT02398058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110986448|NCT02398058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110986449|NCT02398058|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110986450|NCT02398058|Alkylating Agents|alkylating agents|mesh-ancestor
110986451|NCT03501615|Immunotoxin HA22|immunotoxin ha22|mesh-list
110703524|NCT01326442|Vitamins|vitamins|mesh-ancestor
110986452|NCT03501615|Immunotoxins|immunotoxins|mesh-ancestor
110986453|NCT03501615|Immunoconjugates|immunoconjugates|mesh-ancestor
110986454|NCT03501615|Immunologic Factors|immunologic factors|mesh-ancestor
110986455|NCT03501615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110986456|NCT03501615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110986457|NCT05745350|Pembrolizumab|pembrolizumab|mesh-list
110986458|NCT05745350|Etoposide|etoposide|mesh-list
110986459|NCT05745350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110986460|NCT05745350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110986461|NCT05745350|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110986462|NCT05745350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110986463|NCT05745350|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110986464|NCT05745350|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110986465|NCT05745350|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110986466|NCT05745350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110986467|NCT03506919|Allopurinol|allopurinol|mesh-list
110986468|NCT03506919|Antimetabolites|antimetabolites|mesh-ancestor
110986469|NCT03506919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110986470|NCT03506919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110986471|NCT03506919|Gout Suppressants|gout suppressants|mesh-ancestor
110986472|NCT03506919|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110986473|NCT03506919|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110986474|NCT03506919|Antioxidants|antioxidants|mesh-ancestor
110986475|NCT03506919|Protective Agents|protective agents|mesh-ancestor
110986476|NCT03506919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110986477|NCT02545504|Leucovorin|leucovorin|mesh-list
110986478|NCT02545504|Fluorouracil|fluorouracil|mesh-list
110986479|NCT02545504|Oxaliplatin|oxaliplatin|mesh-list
110986480|NCT02545504|Antimetabolites|antimetabolites|mesh-ancestor
110986481|NCT02545504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110986482|NCT02545504|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110986483|NCT02545504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110986484|NCT02545504|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110986485|NCT02545504|Immunologic Factors|immunologic factors|mesh-ancestor
110986486|NCT02545504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110986487|NCT02545504|Antidotes|antidotes|mesh-ancestor
110986488|NCT02545504|Protective Agents|protective agents|mesh-ancestor
110986489|NCT02545504|Vitamin B Complex|vitamin b complex|mesh-ancestor
110986490|NCT02545504|Vitamins|vitamins|mesh-ancestor
110986491|NCT02545504|Micronutrients|micronutrients|mesh-ancestor
110986492|NCT03506841|Cerebrolysin|cerebrolysin|mesh-list
110986493|NCT03506841|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110986494|NCT03506841|Protective Agents|protective agents|mesh-ancestor
110986495|NCT03506841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110986496|NCT03506841|Nootropic Agents|nootropic agents|mesh-ancestor
110986497|NCT02397512|Lactulose|lactulose|mesh-list
110986498|NCT02397512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110986499|NCT02313051|Everolimus|everolimus|mesh-list
110986500|NCT02313051|Letrozole|letrozole|mesh-list
110986501|NCT02313051|Goserelin|goserelin|mesh-list
110986502|NCT02313051|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110986503|NCT02313051|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110986504|NCT02313051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110986505|NCT02313051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110986506|NCT02313051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110986507|NCT02313051|Immunologic Factors|immunologic factors|mesh-ancestor
110986508|NCT02313051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110986509|NCT02313051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110986510|NCT02313051|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110986511|NCT02313051|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110986512|NCT02313051|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110986513|NCT02313051|Hormone Antagonists|hormone antagonists|mesh-ancestor
110986514|NCT02313051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110986515|NCT02313051|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110986516|NCT02397590|Atorvastatin|atorvastatin|mesh-list
110986517|NCT02397590|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110986518|NCT02397590|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110986519|NCT02397590|Antimetabolites|antimetabolites|mesh-ancestor
110986520|NCT02397590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110986521|NCT02397590|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110986522|NCT02397590|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110986523|NCT02397590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110986524|NCT02397356|Ketamine|ketamine|mesh-list
110986525|NCT02397356|Analgesics|analgesics|mesh-ancestor
110986526|NCT02397356|Sensory System Agents|sensory system agents|mesh-ancestor
110986527|NCT02397356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110986528|NCT02397356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110986529|NCT02397356|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110986530|NCT02397356|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110986531|NCT02397356|Anesthetics, General|anesthetics, general|mesh-ancestor
110986532|NCT02397356|Anesthetics|anesthetics|mesh-ancestor
110986533|NCT02397356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110986534|NCT02397356|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110986535|NCT02397356|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110986536|NCT02397356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110986537|NCT02397356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110986538|NCT02307825|Azithromycin|azithromycin|mesh-list
110986539|NCT02307825|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110986540|NCT02307825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110986541|NCT02540668|Warfarin|warfarin|mesh-list
110986542|NCT02540668|Anticoagulants|anticoagulants|mesh-ancestor
110986543|NCT03506763|Diclofenac|diclofenac|mesh-list
110986544|NCT03506763|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110986545|NCT03506763|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110986546|NCT03506763|Analgesics|analgesics|mesh-ancestor
110986547|NCT03506763|Sensory System Agents|sensory system agents|mesh-ancestor
110986548|NCT03506763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110986549|NCT03506763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110986550|NCT03506763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110986551|NCT03506763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110986552|NCT03506763|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110986553|NCT03506763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110986554|NCT03506763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110986556|NCT02441439|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
110986557|NCT02441439|Trace Elements|trace elements|mesh-ancestor
110986558|NCT02441439|Micronutrients|micronutrients|mesh-ancestor
110986559|NCT02441439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110986560|NCT02441439|Hematinics|hematinics|mesh-ancestor
110986561|NCT02308137|Domperidone|domperidone|mesh-list
110986562|NCT02308137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110986563|NCT02308137|Antiemetics|antiemetics|mesh-ancestor
110986564|NCT02308137|Autonomic Agents|autonomic agents|mesh-ancestor
110986565|NCT02308137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110986566|NCT02308137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110986567|NCT02308137|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110986568|NCT02308137|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110986569|NCT02308137|Dopamine Agents|dopamine agents|mesh-ancestor
110986570|NCT02308137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110986571|NCT03501459|Rituximab|rituximab|mesh-list
110986572|NCT03501459|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110986573|NCT03501459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110986574|NCT03501459|Immunologic Factors|immunologic factors|mesh-ancestor
110986575|NCT03501459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110986576|NCT03501459|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110986577|NCT02317263|Testosterone|testosterone|mesh-list
110986578|NCT02317263|Androgens|androgens|mesh-ancestor
110986579|NCT02317263|Hormones|hormones|mesh-ancestor
110451350|NCT02700022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110986580|NCT02317263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110986581|NCT02317263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110986582|NCT02317341|Midazolam|midazolam|mesh-list
110986583|NCT02317341|Ketamine|ketamine|mesh-list
110986584|NCT02317341|Analgesics|analgesics|mesh-ancestor
110986585|NCT02317341|Sensory System Agents|sensory system agents|mesh-ancestor
110986586|NCT02317341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110986587|NCT02317341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110986588|NCT02317341|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110986589|NCT02317341|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110986590|NCT02317341|Anesthetics, General|anesthetics, general|mesh-ancestor
110986591|NCT02317341|Anesthetics|anesthetics|mesh-ancestor
110986592|NCT02317341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110986593|NCT02317341|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110986594|NCT02317341|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110986595|NCT02317341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110986596|NCT02317341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110986597|NCT02317341|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110986598|NCT02317341|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110986599|NCT02317341|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110986600|NCT02317341|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110986601|NCT02317341|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110986602|NCT02317341|GABA Modulators|gaba modulators|mesh-ancestor
110986603|NCT02317341|GABA Agents|gaba agents|mesh-ancestor
110986604|NCT02339740|Vitamins|vitamins|mesh-list
110986605|NCT02339740|Vitamin A|vitamin a|mesh-list
110986606|NCT02339740|Cytarabine|cytarabine|mesh-list
110986607|NCT02339740|Dexamethasone|dexamethasone|mesh-list
110986608|NCT02339740|Dexamethasone acetate|dexamethasone acetate|mesh-list
110986609|NCT02339740|Mitoxantrone|mitoxantrone|mesh-list
110986610|NCT02339740|Idarubicin|idarubicin|mesh-list
110986611|NCT02339740|Tretinoin|tretinoin|mesh-list
110986612|NCT02339740|Retinol palmitate|retinol palmitate|mesh-list
110986613|NCT02339740|Arsenic Trioxide|arsenic trioxide|mesh-list
110986614|NCT02339740|BB 1101|bb 1101|mesh-list
110986615|NCT02339740|Micronutrients|micronutrients|mesh-ancestor
110986616|NCT02339740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110986617|NCT02339740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110986618|NCT02339740|Antiemetics|antiemetics|mesh-ancestor
110986619|NCT02339740|Autonomic Agents|autonomic agents|mesh-ancestor
110986620|NCT02339740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110986621|NCT02339740|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110986622|NCT02339740|Glucocorticoids|glucocorticoids|mesh-ancestor
110986623|NCT02339740|Hormones|hormones|mesh-ancestor
110986624|NCT02339740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110986625|NCT02339740|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110986626|NCT02339740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110986627|NCT02339740|Protease Inhibitors|protease inhibitors|mesh-ancestor
110986628|NCT02339740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110986629|NCT02339740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110986630|NCT02339740|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110986631|NCT02339740|Antimetabolites|antimetabolites|mesh-ancestor
110986632|NCT02339740|Antiviral Agents|antiviral agents|mesh-ancestor
110986633|NCT02339740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110986634|NCT02339740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110986635|NCT02339740|Immunologic Factors|immunologic factors|mesh-ancestor
110986636|NCT02339740|Analgesics|analgesics|mesh-ancestor
110986637|NCT02339740|Sensory System Agents|sensory system agents|mesh-ancestor
110986638|NCT02339740|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110986639|NCT02339740|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110986640|NCT02339740|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110986641|NCT02339740|Keratolytic Agents|keratolytic agents|mesh-ancestor
110986642|NCT02339740|Dermatologic Agents|dermatologic agents|mesh-ancestor
110986643|NCT02339740|Antioxidants|antioxidants|mesh-ancestor
110986644|NCT02339740|Protective Agents|protective agents|mesh-ancestor
110986645|NCT02339740|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110986646|NCT02317419|Paclitaxel|paclitaxel|mesh-list
110986647|NCT02317419|Gemcitabine|gemcitabine|mesh-list
110986648|NCT02317419|LMB-100|lmb-100|mesh-list
110986649|NCT02317419|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110986650|NCT02317419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110986651|NCT02317419|Tubulin Modulators|tubulin modulators|mesh-ancestor
110986652|NCT02317419|Antimitotic Agents|antimitotic agents|mesh-ancestor
110986653|NCT02317419|Mitosis Modulators|mitosis modulators|mesh-ancestor
110986654|NCT02317419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110986655|NCT02317419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110986656|NCT02317419|Antimetabolites|antimetabolites|mesh-ancestor
110986657|NCT02317419|Immunoconjugates|immunoconjugates|mesh-ancestor
110986658|NCT02317419|Immunologic Factors|immunologic factors|mesh-ancestor
110986659|NCT02317419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110986660|NCT02317497|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
110986662|NCT02957968|Cyclophosphamide|cyclophosphamide|mesh-list
110986663|NCT02957968|Carboplatin|carboplatin|mesh-list
110986664|NCT02957968|Doxorubicin|doxorubicin|mesh-list
110986665|NCT02957968|Pembrolizumab|pembrolizumab|mesh-list
110986666|NCT02957968|Decitabine|decitabine|mesh-list
110986667|NCT02957968|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110986668|NCT02957968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110986669|NCT02957968|Tubulin Modulators|tubulin modulators|mesh-ancestor
110986670|NCT02957968|Antimitotic Agents|antimitotic agents|mesh-ancestor
110986671|NCT02957968|Mitosis Modulators|mitosis modulators|mesh-ancestor
110986672|NCT02957968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110986673|NCT02957968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110986674|NCT02957968|Immunologic Factors|immunologic factors|mesh-ancestor
110986675|NCT02957968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110986676|NCT02957968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110986677|NCT02957968|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110986678|NCT02957968|Alkylating Agents|alkylating agents|mesh-ancestor
110986679|NCT02957968|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110986680|NCT02957968|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110986681|NCT02957968|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110986682|NCT02957968|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110986683|NCT02957968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110986684|NCT02957968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110986685|NCT02957968|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110986686|NCT02957968|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110986687|NCT02957968|Antimetabolites|antimetabolites|mesh-ancestor
110986688|NCT03943888|Atropine|atropine|mesh-list
110986689|NCT03943888|Neostigmine|neostigmine|mesh-list
110986690|NCT03943888|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110986691|NCT03943888|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110986692|NCT03943888|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110986693|NCT03943888|Autonomic Agents|autonomic agents|mesh-ancestor
110986694|NCT03943888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110986695|NCT03943888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110986696|NCT03943888|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110986697|NCT03943888|Respiratory System Agents|respiratory system agents|mesh-ancestor
110986698|NCT03943888|Mydriatics|mydriatics|mesh-ancestor
110986699|NCT03943888|Parasympatholytics|parasympatholytics|mesh-ancestor
110986700|NCT03943888|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110986701|NCT03943888|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110986702|NCT03943888|Cholinergic Agents|cholinergic agents|mesh-ancestor
110986703|NCT03943888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110986704|NCT03943888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110986705|NCT03943888|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110986706|NCT03943888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110986707|NCT03943888|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110986708|NCT03502551|Ketamine|ketamine|mesh-list
110986709|NCT03502551|Analgesics|analgesics|mesh-ancestor
110986710|NCT03502551|Sensory System Agents|sensory system agents|mesh-ancestor
110986711|NCT03502551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110986712|NCT03502551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110986713|NCT03502551|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110986714|NCT03502551|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110986715|NCT03502551|Anesthetics, General|anesthetics, general|mesh-ancestor
110986716|NCT03502551|Anesthetics|anesthetics|mesh-ancestor
110986717|NCT03502551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110986718|NCT03502551|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110986719|NCT03502551|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110986720|NCT03502551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110986721|NCT03502551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110986722|NCT02314377|Bevacizumab|bevacizumab|mesh-list
110986723|NCT02314377|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110986724|NCT02314377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110986725|NCT02314377|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110986726|NCT02314377|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110986727|NCT02314377|Growth Substances|growth substances|mesh-ancestor
110986728|NCT02314377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110986729|NCT02314377|Growth Inhibitors|growth inhibitors|mesh-ancestor
110986731|NCT02942290|Venetoclax|venetoclax|mesh-list
110986732|NCT02942290|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110986733|NCT02942290|Antimetabolites|antimetabolites|mesh-ancestor
110986734|NCT02942290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110986735|NCT02942290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110986736|NCT02942290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110986737|NCT02540356|Antibodies|antibodies|mesh-list
110986738|NCT02540356|Immunoglobulins|immunoglobulins|mesh-list
110986739|NCT02540356|Immunologic Factors|immunologic factors|mesh-ancestor
110986740|NCT02540356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110986741|NCT05463094|Metformin|metformin|mesh-list
110986742|NCT05463094|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110986743|NCT05463094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110986744|NCT05431348|Hydrocortisone|hydrocortisone|mesh-list
110986745|NCT05431348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110986746|NCT05461378|Cilgavimab and tixagevimab drug combination|cilgavimab and tixagevimab drug combination|mesh-list
110986747|NCT05461378|Antiviral Agents|antiviral agents|mesh-ancestor
110986748|NCT05461378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110986749|NCT02392130|Clobetasol|clobetasol|mesh-list
110986750|NCT02392130|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110986751|NCT02392130|Glucocorticoids|glucocorticoids|mesh-ancestor
110986752|NCT02392130|Hormones|hormones|mesh-ancestor
110986753|NCT02392130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110986754|NCT02392130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110986755|NCT05356091|Sevoflurane|sevoflurane|mesh-list
110986756|NCT05356091|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110986757|NCT05356091|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110986758|NCT05356091|Anesthetics, General|anesthetics, general|mesh-ancestor
110986759|NCT05356091|Anesthetics|anesthetics|mesh-ancestor
110986760|NCT05356091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110986761|NCT05356091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110986762|NCT05351021|Metformin|metformin|mesh-list
110986763|NCT05351021|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110986764|NCT05351021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110986765|NCT02688764|Calcium|calcium|mesh-list
110986766|NCT02688764|Calcium acetate|calcium acetate|mesh-list
110986767|NCT02688764|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110986768|NCT02688764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110986769|NCT02688764|Chelating Agents|chelating agents|mesh-ancestor
110986770|NCT02688764|Sequestering Agents|sequestering agents|mesh-ancestor
110986771|NCT02688764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110986772|NCT02688608|Pembrolizumab|pembrolizumab|mesh-list
110986773|NCT02688608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110451385|NCT03140488|Oxytocin|oxytocin|mesh-list
110986774|NCT02688608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110986775|NCT02688608|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110986776|NCT02688608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110986777|NCT02688530|Dexamethasone|dexamethasone|mesh-list
110986778|NCT02688530|Dexamethasone acetate|dexamethasone acetate|mesh-list
110986779|NCT02688530|BB 1101|bb 1101|mesh-list
110986780|NCT02688530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110986781|NCT02688530|Antiemetics|antiemetics|mesh-ancestor
110986782|NCT02688530|Autonomic Agents|autonomic agents|mesh-ancestor
110986783|NCT02688530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110986784|NCT02688530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110986785|NCT02688530|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110986786|NCT02688530|Glucocorticoids|glucocorticoids|mesh-ancestor
110986787|NCT02688530|Hormones|hormones|mesh-ancestor
110986788|NCT02688530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110986789|NCT02688530|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110986790|NCT02688530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110986791|NCT02688530|Protease Inhibitors|protease inhibitors|mesh-ancestor
110986792|NCT02688530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110986793|NCT02688530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110986794|NCT05744804|Aspirin|aspirin|mesh-list
110986795|NCT05744804|Rivaroxaban|rivaroxaban|mesh-list
110986796|NCT05744804|Clopidogrel|clopidogrel|mesh-list
110986797|NCT05744804|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110986798|NCT05744804|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110986799|NCT05744804|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110986800|NCT05744804|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110986801|NCT05744804|Purinergic Agents|purinergic agents|mesh-ancestor
110986802|NCT05744804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110986803|NCT05744804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110986804|NCT05744804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110986805|NCT05744804|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110986806|NCT05744804|Antithrombins|antithrombins|mesh-ancestor
110986807|NCT05744804|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110986808|NCT05744804|Protease Inhibitors|protease inhibitors|mesh-ancestor
110986809|NCT05744804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110986810|NCT05744804|Anticoagulants|anticoagulants|mesh-ancestor
110986811|NCT05744804|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110986812|NCT05744804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110986813|NCT05744804|Analgesics|analgesics|mesh-ancestor
110986814|NCT05744804|Sensory System Agents|sensory system agents|mesh-ancestor
110986815|NCT05744804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110986816|NCT05744804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110986817|NCT05744804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110986818|NCT05744804|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110986819|NCT05744804|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110986820|NCT05744804|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110986821|NCT05744804|Antipyretics|antipyretics|mesh-ancestor
110986822|NCT05744726|Bone wax|bone wax|mesh-list
110986823|NCT05744726|Hemostatics|hemostatics|mesh-ancestor
110986824|NCT05744726|Coagulants|coagulants|mesh-ancestor
110986825|NCT02467270|Ponatinib|ponatinib|mesh-list
110986826|NCT02467270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110986827|NCT02467270|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110986828|NCT02467270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110986829|NCT02467270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110986830|NCT05150795|Pregabalin|pregabalin|mesh-list
110986831|NCT05150795|Fentanyl|fentanyl|mesh-list
110986832|NCT05150795|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110986833|NCT05150795|Narcotics|narcotics|mesh-ancestor
110986834|NCT05150795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110986835|NCT05150795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110986836|NCT05150795|Analgesics|analgesics|mesh-ancestor
110986837|NCT05150795|Sensory System Agents|sensory system agents|mesh-ancestor
110986838|NCT05150795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110986839|NCT05150795|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110986840|NCT05150795|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110986841|NCT05150795|Anesthetics, General|anesthetics, general|mesh-ancestor
110986842|NCT05150795|Anesthetics|anesthetics|mesh-ancestor
110986843|NCT05150795|Anticonvulsants|anticonvulsants|mesh-ancestor
110986844|NCT05150795|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110986845|NCT05150795|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110986846|NCT05150795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110451391|NCT00616408|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110986847|NCT05150795|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110986848|NCT05150795|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110986849|NCT05150795|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110986850|NCT05150795|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110986851|NCT03166280|Sofosbuvir|sofosbuvir|mesh-list
110986852|NCT03166280|Antiviral Agents|antiviral agents|mesh-ancestor
110986853|NCT03166280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110986854|NCT02533570|Brentuximab Vedotin|brentuximab vedotin|mesh-list
110986855|NCT02533570|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110986856|NCT02533570|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110986857|NCT02533570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110986858|NCT02533570|Immunotoxins|immunotoxins|mesh-ancestor
110986859|NCT02533570|Immunoconjugates|immunoconjugates|mesh-ancestor
110986860|NCT02533570|Immunologic Factors|immunologic factors|mesh-ancestor
110986861|NCT02533570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110986862|NCT02268448|Clonidine|clonidine|mesh-list
110986863|NCT02268448|Naltrexone|naltrexone|mesh-list
110986864|NCT02268448|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110986865|NCT02268448|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110986866|NCT02268448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110986867|NCT02268448|Sensory System Agents|sensory system agents|mesh-ancestor
110986868|NCT02268448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110986869|NCT02268448|Analgesics|analgesics|mesh-ancestor
110986870|NCT02268448|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110986871|NCT02268448|Sympatholytics|sympatholytics|mesh-ancestor
110986872|NCT02268448|Autonomic Agents|autonomic agents|mesh-ancestor
110986873|NCT02268448|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110986874|NCT02268448|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110986875|NCT02268448|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110986876|NCT02268448|Adrenergic Agents|adrenergic agents|mesh-ancestor
110986877|NCT02268448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110986878|NCT02268448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110986879|NCT05744570|Anesthetics|anesthetics|mesh-list
110986880|NCT05744570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110986881|NCT05744570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110986882|NCT03036839|Sofosbuvir|sofosbuvir|mesh-list
110986883|NCT03036839|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
110986884|NCT03036839|Ledipasvir|ledipasvir|mesh-list
110986885|NCT03036839|Antiviral Agents|antiviral agents|mesh-ancestor
110986886|NCT03036839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110986887|NCT04977791|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
110986888|NCT04977791|Antibodies|antibodies|mesh-list
110986889|NCT04977791|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110986890|NCT04977791|Immunologic Factors|immunologic factors|mesh-ancestor
110986891|NCT04977791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110986892|NCT04977791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110986893|NCT04977791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110986894|NCT04977791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110986895|NCT03625739|Amoxicillin|amoxicillin|mesh-list
110986896|NCT03625739|Moxifloxacin|moxifloxacin|mesh-list
110986897|NCT03625739|Levofloxacin|levofloxacin|mesh-list
110986898|NCT03625739|Isoniazid|isoniazid|mesh-list
110986899|NCT03625739|Cycloserine|cycloserine|mesh-list
110986900|NCT03625739|Clavulanic Acid|clavulanic acid|mesh-list
110986901|NCT03625739|Imipenem|imipenem|mesh-list
110986902|NCT03625739|Amikacin|amikacin|mesh-list
110986903|NCT03625739|Pyrazinamide|pyrazinamide|mesh-list
110986904|NCT03625739|Ethambutol|ethambutol|mesh-list
110986905|NCT03625739|Bedaquiline|bedaquiline|mesh-list
110986906|NCT03625739|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
110986907|NCT03625739|Clofazimine|clofazimine|mesh-list
110986908|NCT03625739|Gatifloxacin|gatifloxacin|mesh-list
110986909|NCT03625739|Aminosalicylic Acid|aminosalicylic acid|mesh-list
110986910|NCT03625739|Streptomycin|streptomycin|mesh-list
110986911|NCT03625739|Ethionamide|ethionamide|mesh-list
110703980|NCT00231777|Ondansetron|ondansetron|mesh-list
110986912|NCT03625739|Kanamycin|kanamycin|mesh-list
110986913|NCT03625739|Capreomycin|capreomycin|mesh-list
110986914|NCT03625739|Thioacetazone|thioacetazone|mesh-list
110986915|NCT03625739|Antitubercular Agents|antitubercular agents|mesh-list
110986916|NCT03625739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110986917|NCT03625739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110986918|NCT03625739|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110986919|NCT03625739|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110986920|NCT03625739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110986921|NCT03625739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110986922|NCT03625739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110986923|NCT03625739|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110986924|NCT03625739|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110986925|NCT03625739|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110986926|NCT03625739|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110986927|NCT03625739|Leprostatic Agents|leprostatic agents|mesh-ancestor
110986928|NCT03625739|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
110986929|NCT03625739|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110986931|NCT03625739|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110986932|NCT03625739|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110986933|NCT03625739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110986934|NCT03625739|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110986935|NCT03625739|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110986936|NCT03625739|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110986937|NCT03904199|Insulin|insulin|mesh-list
110986938|NCT03904199|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110986939|NCT03904199|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110986940|NCT03904199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110986941|NCT03902951|Leuprolide|leuprolide|mesh-list
110986942|NCT03902951|Abiraterone Acetate|abiraterone acetate|mesh-list
110986943|NCT03902951|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110986944|NCT03902951|Fertility Agents|fertility agents|mesh-ancestor
110986945|NCT03902951|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110986946|NCT03902951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110986947|NCT03902951|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110986948|NCT03902951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110986949|NCT03902951|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110986950|NCT03902951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110986951|NCT03902951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110986952|NCT03902951|Hormone Antagonists|hormone antagonists|mesh-ancestor
110986953|NCT03902951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110986954|NCT03902951|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110986955|NCT01286207|Rizatriptan|rizatriptan|mesh-list
110986956|NCT01286207|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110986957|NCT01286207|Serotonin Agents|serotonin agents|mesh-ancestor
110986958|NCT01286207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110986959|NCT01286207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110986960|NCT01286207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110986961|NCT05408026|Dexamethasone|dexamethasone|mesh-list
110986962|NCT05408026|Bortezomib|bortezomib|mesh-list
110986963|NCT05408026|Daratumumab|daratumumab|mesh-list
110986964|NCT05408026|Pomalidomide|pomalidomide|mesh-list
110986965|NCT05408026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110986966|NCT05408026|Antiemetics|antiemetics|mesh-ancestor
110986967|NCT05408026|Autonomic Agents|autonomic agents|mesh-ancestor
110986968|NCT05408026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110986969|NCT05408026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110986970|NCT05408026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110986971|NCT05408026|Glucocorticoids|glucocorticoids|mesh-ancestor
110986972|NCT05408026|Hormones|hormones|mesh-ancestor
110986973|NCT05408026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110986974|NCT05408026|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110986975|NCT05408026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110986976|NCT05408026|Immunologic Factors|immunologic factors|mesh-ancestor
110986977|NCT05408026|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110986978|NCT05408026|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110986979|NCT05408026|Growth Substances|growth substances|mesh-ancestor
110986980|NCT05408026|Growth Inhibitors|growth inhibitors|mesh-ancestor
110986981|NCT02170090|Gemcitabine|gemcitabine|mesh-list
110986982|NCT02170090|Capecitabine|capecitabine|mesh-list
110986983|NCT02170090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110986984|NCT02170090|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110986985|NCT02170090|Antimetabolites|antimetabolites|mesh-ancestor
110986986|NCT02170090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110986987|NCT04423510|Phenol|phenol|mesh-list
110704050|NCT00110890|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
110986988|NCT04423510|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110986989|NCT04423510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110986990|NCT04423510|Disinfectants|disinfectants|mesh-ancestor
110986991|NCT04423510|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
110986992|NCT04423510|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110986993|NCT00968201|Montelukast|montelukast|mesh-list
110986994|NCT00968201|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110986995|NCT00968201|Respiratory System Agents|respiratory system agents|mesh-ancestor
110986996|NCT00968201|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110986997|NCT00968201|Hormone Antagonists|hormone antagonists|mesh-ancestor
110986998|NCT00968201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110986999|NCT00968201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110987000|NCT00968201|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110987001|NCT00968201|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110987002|NCT00968201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110987003|NCT00943397|Montelukast|montelukast|mesh-list
110987004|NCT00943397|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110987005|NCT00943397|Respiratory System Agents|respiratory system agents|mesh-ancestor
110987006|NCT00943397|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110987007|NCT00943397|Hormone Antagonists|hormone antagonists|mesh-ancestor
110987008|NCT00943397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110987009|NCT00943397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110987010|NCT00943397|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110987011|NCT00943397|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110987012|NCT00943397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110987013|NCT00817817|Mometasone Furoate|mometasone furoate|mesh-list
110987014|NCT00817817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110987015|NCT00817817|Dermatologic Agents|dermatologic agents|mesh-ancestor
110987016|NCT00817817|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110987017|NCT00702845|Hormones|hormones|mesh-list
110987018|NCT00702845|Progesterone|progesterone|mesh-list
110987019|NCT00702845|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
110987020|NCT00702845|Ganirelix|ganirelix|mesh-list
110987021|NCT00702845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110987022|NCT00702845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110987023|NCT00702845|Progestins|progestins|mesh-ancestor
110987024|NCT00702845|Hormone Antagonists|hormone antagonists|mesh-ancestor
110987025|NCT00647933|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110987026|NCT00647933|Lynestrenol|lynestrenol|mesh-list
110987027|NCT00647933|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110987028|NCT00647933|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110987029|NCT00647933|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110987030|NCT00647933|Contraceptive Agents|contraceptive agents|mesh-ancestor
110987031|NCT00647933|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110987032|NCT00647933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110987033|NCT00647933|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110987035|NCT00647933|Hormones|hormones|mesh-ancestor
110987036|NCT00647933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110987037|NCT00647933|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110987038|NCT00641771|Cholecalciferol|cholecalciferol|mesh-list
110987039|NCT00641771|Vitamin D|vitamin d|mesh-list
110987040|NCT00641771|Alendronate|alendronate|mesh-list
110987041|NCT00641771|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110987042|NCT00641771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110987043|NCT00641771|Vitamins|vitamins|mesh-ancestor
110987044|NCT00641771|Micronutrients|micronutrients|mesh-ancestor
110987045|NCT00641771|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110987046|NCT00519857|Tibolone|tibolone|mesh-list
110987047|NCT00519857|Androgen Antagonists|androgen antagonists|mesh-ancestor
110987048|NCT00519857|Hormone Antagonists|hormone antagonists|mesh-ancestor
110987049|NCT00519857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110987050|NCT00519857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110987051|NCT00519857|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110987052|NCT00519857|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110987053|NCT00519857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110987054|NCT00519857|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110987055|NCT00519857|Anabolic Agents|anabolic agents|mesh-ancestor
110987056|NCT00519857|Hormones|hormones|mesh-ancestor
110987057|NCT00431093|Tibolone|tibolone|mesh-list
110987058|NCT00431093|Estradiol|estradiol|mesh-list
110987059|NCT00431093|Estrogens|estrogens|mesh-ancestor
110987060|NCT00431093|Hormones|hormones|mesh-ancestor
110987061|NCT00431093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110987062|NCT00431093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110987063|NCT00431093|Androgen Antagonists|androgen antagonists|mesh-ancestor
110987064|NCT00431093|Hormone Antagonists|hormone antagonists|mesh-ancestor
110987065|NCT00431093|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110987066|NCT00431093|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110987067|NCT00431093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110987068|NCT00431093|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110987069|NCT00431093|Anabolic Agents|anabolic agents|mesh-ancestor
110987070|NCT03665597|Pembrolizumab|pembrolizumab|mesh-list
110987071|NCT03665597|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110987072|NCT03665597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110987073|NCT03665597|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110987074|NCT03665597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110987075|NCT00092963|Rizatriptan|rizatriptan|mesh-list
110987076|NCT00092963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110987077|NCT00092963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110987078|NCT00092963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110987079|NCT00092963|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110987080|NCT00092963|Serotonin Agents|serotonin agents|mesh-ancestor
110987081|NCT00092885|Montelukast|montelukast|mesh-list
110987082|NCT00092885|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110987083|NCT00092885|Respiratory System Agents|respiratory system agents|mesh-ancestor
110987084|NCT00092885|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110987085|NCT00092885|Hormone Antagonists|hormone antagonists|mesh-ancestor
110987086|NCT00092885|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110987087|NCT00092885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110987088|NCT00092885|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110987089|NCT00092885|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110987090|NCT00092885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110987091|NCT03673735|Durvalumab|durvalumab|mesh-list
110987092|NCT03673735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110987093|NCT03673735|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110987094|NCT01272037|Tamoxifen|tamoxifen|mesh-list
110987095|NCT01272037|Letrozole|letrozole|mesh-list
110987096|NCT01272037|Anastrozole|anastrozole|mesh-list
110987097|NCT01272037|Exemestane|exemestane|mesh-list
110987098|NCT01272037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110987099|NCT01272037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110987100|NCT01272037|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110987101|NCT01272037|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110452257|NCT02879981|Expectorants|expectorants|mesh-ancestor
110987103|NCT01272037|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110987104|NCT01272037|Hormone Antagonists|hormone antagonists|mesh-ancestor
110987105|NCT01272037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110987106|NCT01272037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110987107|NCT01272037|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110987108|NCT01272037|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110987109|NCT01272037|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110987110|NCT01272037|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110987111|NCT00092105|Montelukast|montelukast|mesh-list
110987112|NCT00092105|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110987113|NCT00092105|Respiratory System Agents|respiratory system agents|mesh-ancestor
110987114|NCT00092105|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110987115|NCT00092105|Hormone Antagonists|hormone antagonists|mesh-ancestor
110987116|NCT00092105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110987117|NCT00092105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110987118|NCT00092105|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110987119|NCT00092105|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110987120|NCT00092105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110987121|NCT00092027|Alendronate|alendronate|mesh-list
110987122|NCT00092027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110987123|NCT00092027|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110987124|NCT00076973|Montelukast|montelukast|mesh-list
110987125|NCT00076973|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110987126|NCT00076973|Respiratory System Agents|respiratory system agents|mesh-ancestor
110987127|NCT00076973|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110987128|NCT00076973|Hormone Antagonists|hormone antagonists|mesh-ancestor
110987129|NCT00076973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110987130|NCT00076973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110987131|NCT00076973|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110704200|NCT00132028|Vorinostat|vorinostat|mesh-list
110987132|NCT00076973|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110987133|NCT00076973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110987134|NCT02314533|Fenofibrate|fenofibrate|mesh-list
110987135|NCT02314533|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110987136|NCT02314533|Antimetabolites|antimetabolites|mesh-ancestor
110987137|NCT02314533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110987138|NCT02314533|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110987139|NCT03502395|Lidocaine|lidocaine|mesh-list
110987140|NCT03502395|Anesthetics, Local|anesthetics, local|mesh-ancestor
110987141|NCT03502395|Anesthetics|anesthetics|mesh-ancestor
110987142|NCT03502395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110987143|NCT03502395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110987144|NCT03502395|Sensory System Agents|sensory system agents|mesh-ancestor
110987145|NCT03502395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110987146|NCT03502395|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110987147|NCT03502395|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110987148|NCT03502395|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110987149|NCT03502395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110987150|NCT03502395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110987151|NCT02318043|Fluticasone|fluticasone|mesh-list
110987152|NCT02318043|Budesonide|budesonide|mesh-list
110987153|NCT02318043|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110987154|NCT02318043|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
110987155|NCT02318043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110987156|NCT02318043|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110987157|NCT02318043|Autonomic Agents|autonomic agents|mesh-ancestor
110987158|NCT02318043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110987159|NCT02318043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110987160|NCT02318043|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110987161|NCT02318043|Respiratory System Agents|respiratory system agents|mesh-ancestor
110987162|NCT02318043|Dermatologic Agents|dermatologic agents|mesh-ancestor
110987163|NCT02318043|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110987164|NCT02318043|Glucocorticoids|glucocorticoids|mesh-ancestor
110987165|NCT02318043|Hormones|hormones|mesh-ancestor
110987166|NCT02318043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110987167|NCT02318043|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110987168|NCT02318043|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110987169|NCT02318043|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110987170|NCT02318043|Adrenergic Agents|adrenergic agents|mesh-ancestor
110987171|NCT02318043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110987172|NCT02318043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110987173|NCT02318043|Sympathomimetics|sympathomimetics|mesh-ancestor
110987174|NCT03433313|Trastuzumab|trastuzumab|mesh-list
110987175|NCT03433313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110987176|NCT03433313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110987177|NCT02318121|Oxytocin|oxytocin|mesh-list
110987178|NCT02318121|Oxytocics|oxytocics|mesh-ancestor
110987179|NCT02318121|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110987180|NCT02318121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110987181|NCT02318199|Anesthetics|anesthetics|mesh-list
110987182|NCT02318199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110987183|NCT02318199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110987184|NCT05225597|Carbachol|carbachol|mesh-list
110987185|NCT05225597|Epinephrine|epinephrine|mesh-list
110987186|NCT05225597|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110987187|NCT05225597|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110987188|NCT05225597|Adrenergic Agents|adrenergic agents|mesh-ancestor
110987189|NCT05225597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110987190|NCT05225597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110987191|NCT05225597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110987192|NCT05225597|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110987193|NCT05225597|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110987194|NCT05225597|Autonomic Agents|autonomic agents|mesh-ancestor
110987195|NCT05225597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110987196|NCT05225597|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110987197|NCT05225597|Respiratory System Agents|respiratory system agents|mesh-ancestor
110987198|NCT05225597|Mydriatics|mydriatics|mesh-ancestor
110987199|NCT05225597|Sympathomimetics|sympathomimetics|mesh-ancestor
110987200|NCT05225597|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110987201|NCT05225597|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110987202|NCT05225597|Miotics|miotics|mesh-ancestor
110987203|NCT05225597|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110987204|NCT05225597|Cholinergic Agents|cholinergic agents|mesh-ancestor
110987205|NCT05225597|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110987206|NCT05225597|Analgesics|analgesics|mesh-ancestor
110987207|NCT05225597|Sensory System Agents|sensory system agents|mesh-ancestor
110987208|NCT05225597|Protective Agents|protective agents|mesh-ancestor
110987209|NCT03070327|Cyclophosphamide|cyclophosphamide|mesh-list
110987210|NCT03070327|Lenalidomide|lenalidomide|mesh-list
110987211|NCT03070327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110987212|NCT03070327|Immunologic Factors|immunologic factors|mesh-ancestor
110987213|NCT03070327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110987214|NCT03070327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110987215|NCT03070327|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110987216|NCT03070327|Alkylating Agents|alkylating agents|mesh-ancestor
110987217|NCT03070327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110987218|NCT03070327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110987219|NCT03070327|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110987220|NCT03070327|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110987221|NCT03070327|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110987222|NCT03070327|Growth Substances|growth substances|mesh-ancestor
110987223|NCT03070327|Growth Inhibitors|growth inhibitors|mesh-ancestor
110987224|NCT00543127|Fulvestrant|fulvestrant|mesh-list
110987225|NCT00543127|Anastrozole|anastrozole|mesh-list
110987226|NCT00543127|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110987227|NCT00543127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110987228|NCT00543127|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110987229|NCT00543127|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110987230|NCT00543127|Hormone Antagonists|hormone antagonists|mesh-ancestor
110987231|NCT00543127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110987232|NCT00543127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110987233|NCT00543127|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110987234|NCT00543127|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110987235|NCT00543127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110987236|NCT00543127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110987237|NCT00409435|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
110987238|NCT00409435|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110987239|NCT00409435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110987240|NCT00409435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110987241|NCT00409435|Cholinergic Agents|cholinergic agents|mesh-ancestor
110987242|NCT00409435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110987243|NCT00409435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110987244|NCT03673501|Sunitinib|sunitinib|mesh-list
110987245|NCT03673501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110987247|NCT03673501|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110987248|NCT03673501|Growth Substances|growth substances|mesh-ancestor
110987249|NCT03673501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110987250|NCT03673501|Growth Inhibitors|growth inhibitors|mesh-ancestor
110987251|NCT03673501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110987252|NCT03673501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110987253|NCT03673501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110987254|NCT02309385|Dexamethasone|dexamethasone|mesh-list
110987255|NCT02309385|Dexamethasone acetate|dexamethasone acetate|mesh-list
110987256|NCT02309385|Prednisolone|prednisolone|mesh-list
110987257|NCT02309385|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110987258|NCT02309385|Methylprednisolone|methylprednisolone|mesh-list
110987259|NCT02309385|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110987260|NCT02309385|Prednisolone acetate|prednisolone acetate|mesh-list
110987261|NCT02309385|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110987262|NCT02309385|Prednisolone phosphate|prednisolone phosphate|mesh-list
110987263|NCT02309385|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
110987265|NCT02309385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110987266|NCT02309385|Antiemetics|antiemetics|mesh-ancestor
110987267|NCT02309385|Autonomic Agents|autonomic agents|mesh-ancestor
110987268|NCT02309385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110987269|NCT02309385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110987270|NCT02309385|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110987271|NCT02309385|Glucocorticoids|glucocorticoids|mesh-ancestor
110987272|NCT02309385|Hormones|hormones|mesh-ancestor
110987273|NCT02309385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110987274|NCT02309385|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110987275|NCT02309385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110987276|NCT02309385|Protease Inhibitors|protease inhibitors|mesh-ancestor
110987277|NCT02309385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110987278|NCT02309385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110987279|NCT02309385|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110987280|NCT02309385|Protective Agents|protective agents|mesh-ancestor
110987281|NCT02315001|Liraglutide|liraglutide|mesh-list
110987282|NCT02315001|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110987283|NCT02315001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110987284|NCT02315001|Incretins|incretins|mesh-ancestor
110987285|NCT02315001|Hormones|hormones|mesh-ancestor
110987286|NCT02315001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110987287|NCT02315157|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110987288|NCT02315157|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110987289|NCT02315157|Alkylating Agents|alkylating agents|mesh-ancestor
110987290|NCT02315157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110987291|NCT02315157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110987292|NCT02309463|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-list
110987293|NCT02309463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110987294|NCT03500367|Sirolimus|sirolimus|mesh-list
110987295|NCT03500367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110987296|NCT03500367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110987297|NCT03500367|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110987298|NCT03500367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110987299|NCT03500367|Antifungal Agents|antifungal agents|mesh-ancestor
110987300|NCT03500367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110987301|NCT03500367|Immunologic Factors|immunologic factors|mesh-ancestor
110987302|NCT03500367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110987303|NCT02318433|Dexamethasone|dexamethasone|mesh-list
110987304|NCT02318433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110987305|NCT02318433|Antiemetics|antiemetics|mesh-ancestor
110987306|NCT02318433|Autonomic Agents|autonomic agents|mesh-ancestor
110987307|NCT02318433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110987308|NCT02318433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110987309|NCT02318433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110987310|NCT02318433|Glucocorticoids|glucocorticoids|mesh-ancestor
110987311|NCT02318433|Hormones|hormones|mesh-ancestor
110987312|NCT02318433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110987313|NCT02318433|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110987314|NCT02318433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110987315|NCT02318511|Hyaluronic Acid|hyaluronic acid|mesh-list
110987316|NCT02318511|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110987317|NCT02318511|Immunologic Factors|immunologic factors|mesh-ancestor
110987318|NCT02318511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110987319|NCT02318511|Viscosupplements|viscosupplements|mesh-ancestor
110987320|NCT02318511|Protective Agents|protective agents|mesh-ancestor
110987321|NCT02315391|Glycine|glycine|mesh-list
110987322|NCT02315391|Glycine Agents|glycine agents|mesh-ancestor
110987323|NCT02315391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110987324|NCT02315391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110987325|NCT02315391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110987326|NCT03022981|Sofosbuvir|sofosbuvir|mesh-list
110987327|NCT03022981|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
110987328|NCT03022981|Velpatasvir|velpatasvir|mesh-list
110987329|NCT03022981|Antiviral Agents|antiviral agents|mesh-ancestor
110987330|NCT03022981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110987331|NCT03164967|Immunoglobulin G|immunoglobulin g|mesh-list
110987332|NCT03164967|Immunologic Factors|immunologic factors|mesh-ancestor
110987333|NCT03164967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110987334|NCT03502005|Tenofovir|tenofovir|mesh-list
110987335|NCT03502005|Emtricitabine|emtricitabine|mesh-list
110987336|NCT03502005|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
110987337|NCT03502005|Antiviral Agents|antiviral agents|mesh-ancestor
110987338|NCT03502005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110987339|NCT03502005|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110987340|NCT03502005|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110987341|NCT03502005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110987342|NCT03502005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110987343|NCT03502005|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110987344|NCT03502005|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110987345|NCT02315547|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110987346|NCT02315547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110987347|NCT03669445|Dexamethasone|dexamethasone|mesh-list
110987348|NCT03669445|Lenalidomide|lenalidomide|mesh-list
110987349|NCT03669445|Daratumumab|daratumumab|mesh-list
110987350|NCT03669445|Ixazomib|ixazomib|mesh-list
110987351|NCT03669445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110987352|NCT03669445|Antiemetics|antiemetics|mesh-ancestor
110987353|NCT03669445|Autonomic Agents|autonomic agents|mesh-ancestor
110987354|NCT03669445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110987355|NCT03669445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110987356|NCT03669445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110987357|NCT03669445|Glucocorticoids|glucocorticoids|mesh-ancestor
110987358|NCT03669445|Hormones|hormones|mesh-ancestor
110987359|NCT03669445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110987360|NCT03669445|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110987361|NCT03669445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110987362|NCT03669445|Immunologic Factors|immunologic factors|mesh-ancestor
110987363|NCT03669445|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110987364|NCT03669445|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110987365|NCT03669445|Growth Substances|growth substances|mesh-ancestor
110987366|NCT03669445|Growth Inhibitors|growth inhibitors|mesh-ancestor
110987367|NCT03669445|Protease Inhibitors|protease inhibitors|mesh-ancestor
110987368|NCT03669445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110987369|NCT03669445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110987370|NCT03500133|Cytarabine|cytarabine|mesh-list
110987371|NCT03500133|Methylprednisolone|methylprednisolone|mesh-list
110987372|NCT03500133|Cisplatin|cisplatin|mesh-list
110987373|NCT03500133|Etoposide|etoposide|mesh-list
110987374|NCT03500133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110987375|NCT03500133|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110987376|NCT03500133|Antimetabolites|antimetabolites|mesh-ancestor
110987377|NCT03500133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110987378|NCT03500133|Antiviral Agents|antiviral agents|mesh-ancestor
110987379|NCT03500133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110987380|NCT03500133|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110987381|NCT03500133|Immunologic Factors|immunologic factors|mesh-ancestor
110987382|NCT03500133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110987383|NCT03500133|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110987384|NCT03500133|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110987385|NCT03500133|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110987386|NCT03500133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110987387|NCT03500133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110987388|NCT03500133|Antiemetics|antiemetics|mesh-ancestor
110987389|NCT03500133|Autonomic Agents|autonomic agents|mesh-ancestor
110987390|NCT03500133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110987391|NCT03500133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110987392|NCT03500133|Glucocorticoids|glucocorticoids|mesh-ancestor
110987393|NCT03500133|Hormones|hormones|mesh-ancestor
110987394|NCT03500133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110987395|NCT03500133|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110987396|NCT03500133|Protective Agents|protective agents|mesh-ancestor
110987397|NCT04462809|Talazoparib|talazoparib|mesh-list
110987398|NCT04462809|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110987399|NCT04462809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110987400|NCT04462809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110987401|NCT04462809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110987402|NCT02320773|Mirabegron|mirabegron|mesh-list
110987403|NCT02320773|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
110987404|NCT02320773|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110987405|NCT02320773|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110987406|NCT02320773|Adrenergic Agents|adrenergic agents|mesh-ancestor
110987407|NCT02320773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110987408|NCT02320773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110987409|NCT02320773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110987410|NCT02320773|Urological Agents|urological agents|mesh-ancestor
110987411|NCT03377699|Insulin|insulin|mesh-list
110987412|NCT03377699|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110987413|NCT03377699|Insulin Aspart|insulin aspart|mesh-list
110987414|NCT03377699|Insulin Detemir|insulin detemir|mesh-list
110987415|NCT03377699|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110987416|NCT03377699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110987417|NCT04463901|Mitomycins|mitomycins|mesh-list
110987418|NCT04463901|Mitomycin|mitomycin|mesh-list
110987419|NCT04463901|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110987420|NCT04463901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110987421|NCT04463901|Alkylating Agents|alkylating agents|mesh-ancestor
110987422|NCT04463901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110987423|NCT04463901|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110987424|NCT04463901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110987425|NCT01314443|Vitamin E|vitamin e|mesh-list
110987426|NCT01314443|Tocopherols|tocopherols|mesh-list
110987427|NCT01314443|Tocotrienols|tocotrienols|mesh-list
110987428|NCT01314443|alpha-Tocopherol|alpha-tocopherol|mesh-list
110987429|NCT01314443|gamma-Tocopherol|gamma-tocopherol|mesh-list
110704493|NCT03235505|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110987430|NCT01314443|Nicotine|nicotine|mesh-list
110987431|NCT01314443|Vitamins|vitamins|mesh-ancestor
110987432|NCT01314443|Micronutrients|micronutrients|mesh-ancestor
110987433|NCT01314443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110987434|NCT01314443|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110987435|NCT01314443|Autonomic Agents|autonomic agents|mesh-ancestor
110987436|NCT01314443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110987437|NCT01314443|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110987438|NCT01314443|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110987439|NCT01314443|Cholinergic Agents|cholinergic agents|mesh-ancestor
110987440|NCT01314443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110987441|NCT01314443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110987442|NCT01314443|Antioxidants|antioxidants|mesh-ancestor
110987443|NCT01314443|Protective Agents|protective agents|mesh-ancestor
110987444|NCT02310009|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
110987445|NCT02310009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110987446|NCT03498417|Antibodies|antibodies|mesh-list
110987447|NCT03498417|Immunologic Factors|immunologic factors|mesh-ancestor
110987448|NCT03498417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110987449|NCT03212651|Pembrolizumab|pembrolizumab|mesh-list
110987450|NCT03212651|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110987451|NCT03212651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110987452|NCT03212651|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110451521|NCT00628056|Perhexiline|perhexiline|mesh-list
110987453|NCT03212651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110987454|NCT02319135|Cytarabine|cytarabine|mesh-list
110987455|NCT02319135|Fludarabine|fludarabine|mesh-list
110987456|NCT02319135|Lenograstim|lenograstim|mesh-list
110987457|NCT02319135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110987458|NCT02319135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110987459|NCT02319135|Antimetabolites|antimetabolites|mesh-ancestor
110987460|NCT02319135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110987461|NCT02319135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110987462|NCT02319135|Immunologic Factors|immunologic factors|mesh-ancestor
110987463|NCT02319135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110987464|NCT02319135|Antiviral Agents|antiviral agents|mesh-ancestor
110987465|NCT02319135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110987466|NCT02319135|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110987467|NCT04738097|Clopidogrel|clopidogrel|mesh-list
110987468|NCT04738097|Ticagrelor|ticagrelor|mesh-list
110987469|NCT04738097|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110987470|NCT04738097|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110987471|NCT04738097|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110987473|NCT04738097|Purinergic Agents|purinergic agents|mesh-ancestor
110987474|NCT04738097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110987475|NCT04738097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110987476|NCT04738097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110987477|NCT03499743|Celecoxib|celecoxib|mesh-list
110987478|NCT03499743|Scopolamine|scopolamine|mesh-list
110987479|NCT03499743|Bromides|bromides|mesh-list
110987480|NCT03499743|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
110987481|NCT03499743|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110987482|NCT03499743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110987483|NCT03499743|Analgesics|analgesics|mesh-ancestor
110987484|NCT03499743|Sensory System Agents|sensory system agents|mesh-ancestor
110987485|NCT03499743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110987486|NCT03499743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110987487|NCT03499743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110987488|NCT03499743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110987489|NCT03499743|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110987490|NCT03499743|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110987491|NCT03499743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110987492|NCT03499743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110987493|NCT03499743|Anticonvulsants|anticonvulsants|mesh-ancestor
110987494|NCT03499743|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110987495|NCT03499743|Antiemetics|antiemetics|mesh-ancestor
110987496|NCT03499743|Autonomic Agents|autonomic agents|mesh-ancestor
110987497|NCT03499743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110987498|NCT03499743|Mydriatics|mydriatics|mesh-ancestor
110987499|NCT03499743|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110987500|NCT03499743|Cholinergic Agents|cholinergic agents|mesh-ancestor
110987501|NCT03499743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110987502|NCT03499743|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110987503|NCT03499743|Parasympatholytics|parasympatholytics|mesh-ancestor
110987504|NCT02310087|Vitamin E|vitamin e|mesh-list
110987505|NCT02310087|Vitamins|vitamins|mesh-ancestor
110987506|NCT02310087|Micronutrients|micronutrients|mesh-ancestor
110987507|NCT02310087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110704575|NCT00099268|Levodopa|levodopa|mesh-list
110987508|NCT02310087|Antioxidants|antioxidants|mesh-ancestor
110987509|NCT02310087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110987510|NCT02310087|Protective Agents|protective agents|mesh-ancestor
110987511|NCT02923921|Leucovorin|leucovorin|mesh-list
110987512|NCT02923921|Oxaliplatin|oxaliplatin|mesh-list
110987513|NCT02923921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110987514|NCT02923921|Antidotes|antidotes|mesh-ancestor
110987515|NCT02923921|Protective Agents|protective agents|mesh-ancestor
110987516|NCT02923921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110987517|NCT02923921|Vitamin B Complex|vitamin b complex|mesh-ancestor
110987518|NCT02923921|Vitamins|vitamins|mesh-ancestor
110987519|NCT02923921|Micronutrients|micronutrients|mesh-ancestor
110987520|NCT02310243|Palbociclib|palbociclib|mesh-list
110987521|NCT02310243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110987522|NCT02310243|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110987523|NCT02310243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110987524|NCT02310243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110987525|NCT03497715|Ibuprofen|ibuprofen|mesh-list
110987526|NCT03497715|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110987527|NCT03497715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110987528|NCT03497715|Analgesics|analgesics|mesh-ancestor
110987529|NCT03497715|Sensory System Agents|sensory system agents|mesh-ancestor
110987530|NCT03497715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110987531|NCT03497715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110987532|NCT03497715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110987533|NCT03497715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110987534|NCT03497715|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110987535|NCT03497715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110987536|NCT03497715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110987537|NCT02321241|Aflibercept|aflibercept|mesh-list
110987538|NCT02321241|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110987539|NCT02321241|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110987540|NCT02321241|Growth Substances|growth substances|mesh-ancestor
110987541|NCT02321241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110987542|NCT02321241|Growth Inhibitors|growth inhibitors|mesh-ancestor
110987543|NCT02321241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110987544|NCT03583307|Sirolimus|sirolimus|mesh-list
110987545|NCT03583307|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110987546|NCT03583307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110987547|NCT03583307|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110987549|NCT03583307|Antifungal Agents|antifungal agents|mesh-ancestor
110987550|NCT03583307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110987551|NCT03583307|Immunologic Factors|immunologic factors|mesh-ancestor
110987552|NCT03583307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110987553|NCT03039023|Choline|choline|mesh-list
110987554|NCT03039023|Lipotropic Agents|lipotropic agents|mesh-ancestor
110987555|NCT03039023|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110987556|NCT03039023|Antimetabolites|antimetabolites|mesh-ancestor
110987557|NCT03039023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110987558|NCT03039023|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110987559|NCT03039023|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110987560|NCT03039023|Nootropic Agents|nootropic agents|mesh-ancestor
110987561|NCT02321397|Oxycodone|oxycodone|mesh-list
110987562|NCT02321397|Naloxone|naloxone|mesh-list
110987563|NCT02321397|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110987564|NCT02321397|Narcotics|narcotics|mesh-ancestor
110987565|NCT02321397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110987566|NCT02321397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110987567|NCT02321397|Analgesics|analgesics|mesh-ancestor
110987568|NCT02321397|Sensory System Agents|sensory system agents|mesh-ancestor
110987569|NCT02321397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110987570|NCT02321397|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110987571|NCT02319915|Tranexamic Acid|tranexamic acid|mesh-list
110987572|NCT02319915|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110987573|NCT02319915|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110987574|NCT02319915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110987575|NCT02319915|Hemostatics|hemostatics|mesh-ancestor
110987576|NCT02319915|Coagulants|coagulants|mesh-ancestor
110987577|NCT04898309|Complement C1s|complement c1s|mesh-list
110987578|NCT04898309|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
110987579|NCT04898309|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
110987580|NCT04898309|Immunologic Factors|immunologic factors|mesh-ancestor
110987581|NCT04898309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110987582|NCT04898309|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
110987583|NCT04898309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110987584|NCT03498963|Dimercaprol|dimercaprol|mesh-list
110987585|NCT03498963|Chelating Agents|chelating agents|mesh-ancestor
110987586|NCT03498963|Sequestering Agents|sequestering agents|mesh-ancestor
110987587|NCT03498963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110987589|NCT02311101|Mitomycin|mitomycin|mesh-list
110987590|NCT02311101|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110987591|NCT02311101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110987592|NCT02311101|Alkylating Agents|alkylating agents|mesh-ancestor
110987593|NCT02311101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110987594|NCT02311101|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110987595|NCT02311101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110987596|NCT04620187|Cisplatin|cisplatin|mesh-list
110987597|NCT04620187|Carboplatin|carboplatin|mesh-list
110987598|NCT04620187|Trastuzumab|trastuzumab|mesh-list
110987599|NCT04620187|Maytansine|maytansine|mesh-list
110987600|NCT04620187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110987601|NCT04620187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110987602|NCT04620187|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110987603|NCT04620187|Tubulin Modulators|tubulin modulators|mesh-ancestor
110987604|NCT04620187|Antimitotic Agents|antimitotic agents|mesh-ancestor
110987605|NCT04620187|Mitosis Modulators|mitosis modulators|mesh-ancestor
110987606|NCT04620187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110987607|NCT03668665|Hyaluronic Acid|hyaluronic acid|mesh-list
110987608|NCT03668665|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110987609|NCT03668665|Immunologic Factors|immunologic factors|mesh-ancestor
110987610|NCT03668665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110987611|NCT03668665|Viscosupplements|viscosupplements|mesh-ancestor
110987612|NCT03668665|Protective Agents|protective agents|mesh-ancestor
110987613|NCT02320383|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110987614|NCT02320383|Obinutuzumab|obinutuzumab|mesh-list
110987615|NCT02320383|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110987616|NCT02320383|Alkylating Agents|alkylating agents|mesh-ancestor
110987617|NCT02320383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110987618|NCT02320383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110987619|NCT02320383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110987620|NCT03704909|Epinephrine|epinephrine|mesh-list
110987621|NCT03704909|Racepinephrine|racepinephrine|mesh-list
110987622|NCT03704909|Ephedrine|ephedrine|mesh-list
110987623|NCT03704909|Epinephryl borate|epinephryl borate|mesh-list
110987624|NCT03704909|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110987625|NCT03704909|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110987626|NCT03704909|Adrenergic Agents|adrenergic agents|mesh-ancestor
110987627|NCT03704909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110987628|NCT03704909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110987629|NCT03704909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110987630|NCT03704909|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110987631|NCT03704909|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110987632|NCT03704909|Autonomic Agents|autonomic agents|mesh-ancestor
110987633|NCT03704909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110987634|NCT03704909|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110987635|NCT03704909|Respiratory System Agents|respiratory system agents|mesh-ancestor
110987636|NCT03704909|Mydriatics|mydriatics|mesh-ancestor
110987637|NCT03704909|Sympathomimetics|sympathomimetics|mesh-ancestor
110987638|NCT03704909|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110987639|NCT03704909|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110987640|NCT03704831|Anesthetics|anesthetics|mesh-list
110987641|NCT03704831|Anesthetics, Local|anesthetics, local|mesh-list
110987642|NCT03704831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110987643|NCT03704831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110987644|NCT03704831|Sensory System Agents|sensory system agents|mesh-ancestor
110987645|NCT03704831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110987646|NCT03704675|Vactosertib|vactosertib|mesh-list
110987647|NCT03704675|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110987648|NCT03704675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110987649|NCT03704675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110987650|NCT03494517|Magnesium Sulfate|magnesium sulfate|mesh-list
110987651|NCT03494517|Analgesics|analgesics|mesh-ancestor
110987652|NCT03494517|Sensory System Agents|sensory system agents|mesh-ancestor
110987653|NCT03494517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110987654|NCT03494517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110987655|NCT03494517|Anesthetics|anesthetics|mesh-ancestor
110987656|NCT03494517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110987657|NCT03494517|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110987658|NCT03494517|Anticonvulsants|anticonvulsants|mesh-ancestor
110987659|NCT03494517|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110987660|NCT03494517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110987661|NCT03494517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110987662|NCT03494517|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110987663|NCT03494517|Tocolytic Agents|tocolytic agents|mesh-ancestor
110987664|NCT03494517|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110987665|NCT04912427|Dexamethasone|dexamethasone|mesh-list
110987667|NCT04912427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110987668|NCT04912427|Antiemetics|antiemetics|mesh-ancestor
110987669|NCT04912427|Autonomic Agents|autonomic agents|mesh-ancestor
110987670|NCT04912427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110987671|NCT04912427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110987672|NCT04912427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110987673|NCT04912427|Glucocorticoids|glucocorticoids|mesh-ancestor
110987675|NCT04912427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110987676|NCT04912427|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110987677|NCT04912427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110987678|NCT02322645|Eszopiclone|eszopiclone|mesh-list
110987679|NCT02322645|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110987680|NCT02322645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110987681|NCT02322645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110987682|NCT04050761|Nivolumab|nivolumab|mesh-list
110987683|NCT04050761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110987684|NCT04050761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110987685|NCT04050761|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110987686|NCT04050761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110987687|NCT04785261|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110987688|NCT04785261|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110987689|NCT03496389|Acetaminophen|acetaminophen|mesh-list
110987690|NCT03496389|Gabapentin|gabapentin|mesh-list
110987691|NCT03496389|Tramadol|tramadol|mesh-list
110987692|NCT03496389|Analgesics|analgesics|mesh-ancestor
110987693|NCT03496389|Sensory System Agents|sensory system agents|mesh-ancestor
110987694|NCT03496389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110987695|NCT03496389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110987696|NCT03496389|Anticonvulsants|anticonvulsants|mesh-ancestor
110987697|NCT03496389|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110987698|NCT03496389|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110987700|NCT03496389|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110987701|NCT03496389|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110987702|NCT03496389|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110987703|NCT03496389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110987704|NCT03496389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110987705|NCT03496389|Antimanic Agents|antimanic agents|mesh-ancestor
110987706|NCT03496389|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110987707|NCT03496389|Narcotics|narcotics|mesh-ancestor
110987708|NCT03496389|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110987709|NCT03496389|Antipyretics|antipyretics|mesh-ancestor
110987710|NCT03491709|Cetuximab|cetuximab|mesh-list
110987711|NCT03491709|Antibodies|antibodies|mesh-list
110987712|NCT03491709|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110987713|NCT03491709|Immunologic Factors|immunologic factors|mesh-ancestor
110987714|NCT03491709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110987715|NCT03491709|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110987716|NCT03491709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110987717|NCT02325063|Botulinum Toxins|botulinum toxins|mesh-list
110987718|NCT02325063|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110987719|NCT02325063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110987720|NCT02325063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110987721|NCT02325063|Cholinergic Agents|cholinergic agents|mesh-ancestor
110987722|NCT02325063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110987723|NCT02325063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110987724|NCT02323191|Atezolizumab|atezolizumab|mesh-list
110987725|NCT02323191|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110987726|NCT02323191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110987727|NCT02323191|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110987728|NCT02323191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110987729|NCT02323269|Dimethyl Fumarate|dimethyl fumarate|mesh-list
110987730|NCT02323269|Dermatologic Agents|dermatologic agents|mesh-ancestor
110987731|NCT02323269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110987732|NCT02323269|Immunologic Factors|immunologic factors|mesh-ancestor
110987733|NCT02323269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110987735|NCT02323347|Progestins|progestins|mesh-ancestor
110987736|NCT02323347|Hormones|hormones|mesh-ancestor
110987737|NCT02323347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110987738|NCT02323347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110987739|NCT03495765|Ranibizumab|ranibizumab|mesh-list
110987740|NCT03495765|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110987741|NCT03495765|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110987742|NCT03495765|Growth Substances|growth substances|mesh-ancestor
110987743|NCT03495765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110987744|NCT03495765|Growth Inhibitors|growth inhibitors|mesh-ancestor
110987745|NCT03495765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110987746|NCT03491475|Ajmaline|ajmaline|mesh-list
110987747|NCT03491475|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110987748|NCT03491475|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110987749|NCT03491475|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110987750|NCT03491475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110987751|NCT03491475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110987752|NCT03499119|Erenumab|erenumab|mesh-list
110987753|NCT03499119|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
110987754|NCT03499119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110987755|NCT03499119|Analgesics|analgesics|mesh-ancestor
110987756|NCT03499119|Sensory System Agents|sensory system agents|mesh-ancestor
110987757|NCT03499119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110987758|NCT03499119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110987759|NCT03328845|Insulin|insulin|mesh-list
110987760|NCT03328845|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110987761|NCT03328845|Insulin Lispro|insulin lispro|mesh-list
110987762|NCT03328845|Insulin Aspart|insulin aspart|mesh-list
110987763|NCT03328845|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110987764|NCT03328845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110987765|NCT02323737|Cisplatin|cisplatin|mesh-list
110987766|NCT02323737|Irinotecan|irinotecan|mesh-list
110987767|NCT02323737|Etoposide|etoposide|mesh-list
110987768|NCT02323737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110987769|NCT02323737|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110987770|NCT02323737|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110987771|NCT02323737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110987772|NCT02323737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110987773|NCT02323737|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110987774|NCT02323737|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110987775|NCT03037359|Immunoglobulin G|immunoglobulin g|mesh-list
110987776|NCT03037359|Immunologic Factors|immunologic factors|mesh-ancestor
110987777|NCT03037359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110987778|NCT03491085|Amoxicillin|amoxicillin|mesh-list
110987779|NCT03491085|Clavulanic Acid|clavulanic acid|mesh-list
110987780|NCT03491085|Clavulanic Acids|clavulanic acids|mesh-list
110987781|NCT03491085|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
110987782|NCT03491085|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110987783|NCT03491085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110987784|NCT03491085|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110987785|NCT03491085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110987786|NCT03491085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110987787|NCT02323971|Ticagrelor|ticagrelor|mesh-list
110987788|NCT02323971|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110987789|NCT02323971|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110987790|NCT02323971|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110987791|NCT02323971|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110987792|NCT02323971|Purinergic Agents|purinergic agents|mesh-ancestor
110987793|NCT02323971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110987794|NCT02323971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110987795|NCT02323971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110987796|NCT03148899|Oxytocin|oxytocin|mesh-list
110987797|NCT03148899|Oxytocics|oxytocics|mesh-ancestor
110987798|NCT03148899|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110987799|NCT03148899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110987800|NCT03495063|Caffeine|caffeine|mesh-list
110987801|NCT03495063|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110987802|NCT03495063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110987803|NCT03495063|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110987804|NCT03495063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110987805|NCT03495063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110987806|NCT03495063|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110987807|NCT03495063|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110987808|NCT03495063|Purinergic Agents|purinergic agents|mesh-ancestor
110987809|NCT03495063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110987810|NCT03490617|Misoprostol|misoprostol|mesh-list
110987811|NCT03490617|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110987812|NCT03490617|Abortifacient Agents|abortifacient agents|mesh-ancestor
110987813|NCT03490617|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110987814|NCT03490617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110987815|NCT03490617|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110987816|NCT03490617|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110987817|NCT03490617|Oxytocics|oxytocics|mesh-ancestor
110987818|NCT03494907|Moxifloxacin|moxifloxacin|mesh-list
110987819|NCT03494907|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
110987820|NCT03494907|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110987821|NCT03494907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110987822|NCT03494907|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110987823|NCT03494907|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110987824|NCT03494907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110987825|NCT03494907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110987826|NCT03494907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110987827|NCT03494907|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110987828|NCT03494907|Contraceptive Agents|contraceptive agents|mesh-ancestor
110987829|NCT03494907|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110987830|NCT03494907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110987831|NCT03494907|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110987832|NCT03494907|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110987833|NCT03494907|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110987834|NCT03490539|Mycophenolic Acid|mycophenolic acid|mesh-list
110987835|NCT03490539|Azathioprine|azathioprine|mesh-list
110987836|NCT03490539|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110987837|NCT03490539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110987838|NCT03490539|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110987839|NCT03490539|Antitubercular Agents|antitubercular agents|mesh-ancestor
110987840|NCT03490539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110987841|NCT03490539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110987842|NCT03490539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110987843|NCT03490539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110987844|NCT03490539|Antimetabolites|antimetabolites|mesh-ancestor
110024427|NCT00004734|Hematinics|hematinics|mesh-ancestor
110987845|NCT03490539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110987846|NCT03490539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110987847|NCT03490539|Immunologic Factors|immunologic factors|mesh-ancestor
110987848|NCT03490539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110987849|NCT03490539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110987850|NCT03493503|Albuterol|albuterol|mesh-list
110987851|NCT03493503|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110987852|NCT03493503|Autonomic Agents|autonomic agents|mesh-ancestor
110987853|NCT03493503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110987854|NCT03493503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110987855|NCT03493503|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110987856|NCT03493503|Respiratory System Agents|respiratory system agents|mesh-ancestor
110987857|NCT03493503|Tocolytic Agents|tocolytic agents|mesh-ancestor
110987858|NCT03493503|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110987859|NCT03493503|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110987860|NCT03493503|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110987861|NCT03493503|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110987862|NCT03493503|Adrenergic Agents|adrenergic agents|mesh-ancestor
110987863|NCT03493503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110987864|NCT03493503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110987865|NCT04791761|Acetaminophen|acetaminophen|mesh-list
110987866|NCT04791761|Ibuprofen|ibuprofen|mesh-list
110987867|NCT04791761|Oxycodone|oxycodone|mesh-list
110987868|NCT04791761|Analgesics, Opioid|analgesics, opioid|mesh-list
110987869|NCT04791761|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110987870|NCT04791761|Analgesics|analgesics|mesh-ancestor
110987871|NCT04791761|Sensory System Agents|sensory system agents|mesh-ancestor
110987872|NCT04791761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110987873|NCT04791761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110987874|NCT04791761|Antipyretics|antipyretics|mesh-ancestor
110987875|NCT04791761|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110987876|NCT04791761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110987877|NCT04791761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110987878|NCT04791761|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110987879|NCT04791761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110987880|NCT04791761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110987881|NCT04791761|Narcotics|narcotics|mesh-ancestor
110987882|NCT04791761|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110987883|NCT03667963|Lactulose|lactulose|mesh-list
110987884|NCT03667963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110987885|NCT03489837|Dipropizine|dipropizine|mesh-list
110987886|NCT03489837|Antitussive Agents|antitussive agents|mesh-ancestor
110987887|NCT03489837|Respiratory System Agents|respiratory system agents|mesh-ancestor
110987888|NCT03014479|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
110987889|NCT03014479|Protease Inhibitors|protease inhibitors|mesh-ancestor
110987890|NCT03014479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110987891|NCT03014479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110987892|NCT03014479|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110987893|NCT03014479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110987894|NCT03625505|Venetoclax|venetoclax|mesh-list
110987895|NCT03625505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110987896|NCT03493269|Midazolam|midazolam|mesh-list
110987897|NCT03493269|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110987898|NCT03493269|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110987899|NCT03493269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110987900|NCT03493269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110987901|NCT03493269|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110987902|NCT03493269|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110987903|NCT03493269|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110987904|NCT03493269|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110987905|NCT03493269|Anesthetics, General|anesthetics, general|mesh-ancestor
110987906|NCT03493269|Anesthetics|anesthetics|mesh-ancestor
110987907|NCT03493269|GABA Modulators|gaba modulators|mesh-ancestor
110987908|NCT03493269|GABA Agents|gaba agents|mesh-ancestor
110987909|NCT03493269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110987910|NCT03493269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110987911|NCT04257682|Bupivacaine|bupivacaine|mesh-list
110987912|NCT04257682|Ropivacaine|ropivacaine|mesh-list
110987913|NCT04257682|Anesthetics, Local|anesthetics, local|mesh-list
110987914|NCT04257682|Mepivacaine|mepivacaine|mesh-list
110987915|NCT04257682|Anesthetics|anesthetics|mesh-list
110987916|NCT04257682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110987917|NCT04257682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110987918|NCT04257682|Sensory System Agents|sensory system agents|mesh-ancestor
110987919|NCT04257682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110987920|NCT05426434|Pyrimethamine|pyrimethamine|mesh-list
110987921|NCT05426434|Piperaquine|piperaquine|mesh-list
110987923|NCT05426434|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
110987924|NCT05426434|Artenimol|artenimol|mesh-list
110987925|NCT05426434|Antimalarials|antimalarials|mesh-ancestor
110987926|NCT05426434|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110987927|NCT05426434|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110987928|NCT05426434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110987929|NCT05426434|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110987930|NCT05426434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110987931|NCT05426434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110987932|NCT05426434|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110987933|NCT05404906|Azacitidine|azacitidine|mesh-list
110987934|NCT05404906|Venetoclax|venetoclax|mesh-list
110987935|NCT05404906|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110987936|NCT05404906|Antimetabolites|antimetabolites|mesh-ancestor
110987937|NCT05404906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110987938|NCT05404906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110987939|NCT05404906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110987940|NCT03020407|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110987941|NCT03020407|Dopamine|dopamine|mesh-list
110987942|NCT03020407|Epinephrine|epinephrine|mesh-list
110987943|NCT03020407|Norepinephrine|norepinephrine|mesh-list
110705015|NCT00357500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110705016|NCT00357500|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110705017|NCT00357500|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110705018|NCT00357500|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110705019|NCT00357500|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110705020|NCT00357500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110705021|NCT00357500|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110705022|NCT00357500|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110705023|NCT00357500|Analgesics|analgesics|mesh-ancestor
110705024|NCT00357500|Sensory System Agents|sensory system agents|mesh-ancestor
110987944|NCT03020407|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
110987945|NCT03020407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110987946|NCT03020407|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110987947|NCT03020407|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110987948|NCT03020407|Adrenergic Agents|adrenergic agents|mesh-ancestor
110987949|NCT03020407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110987950|NCT03020407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110987951|NCT03020407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110987952|NCT03020407|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110987953|NCT03020407|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110987954|NCT03020407|Autonomic Agents|autonomic agents|mesh-ancestor
110987955|NCT03020407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110987956|NCT03020407|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110987957|NCT03020407|Respiratory System Agents|respiratory system agents|mesh-ancestor
110987958|NCT03020407|Mydriatics|mydriatics|mesh-ancestor
110987959|NCT03020407|Sympathomimetics|sympathomimetics|mesh-ancestor
110987960|NCT03020407|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110987961|NCT03020407|Dopamine Agents|dopamine agents|mesh-ancestor
110987962|NCT03020407|Protective Agents|protective agents|mesh-ancestor
110987963|NCT03624959|Itraconazole|itraconazole|mesh-list
110987964|NCT03624959|Rifampin|rifampin|mesh-list
110987965|NCT03624959|Gemfibrozil|gemfibrozil|mesh-list
110987966|NCT03624959|Ozanimod|ozanimod|mesh-list
110987967|NCT03624959|Antifungal Agents|antifungal agents|mesh-ancestor
110987968|NCT03624959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110987969|NCT03624959|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110987970|NCT03624959|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110987971|NCT03624959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110987972|NCT03624959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110987973|NCT03624959|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110987974|NCT03624959|Hormone Antagonists|hormone antagonists|mesh-ancestor
110987975|NCT03624959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110987976|NCT03624959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110987977|NCT03624959|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110987978|NCT03624959|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110987979|NCT03624959|Antitubercular Agents|antitubercular agents|mesh-ancestor
110987980|NCT03624959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110987981|NCT03624959|Leprostatic Agents|leprostatic agents|mesh-ancestor
110987982|NCT03624959|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110987983|NCT03624959|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110987984|NCT03624959|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110987985|NCT03624959|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110987986|NCT03624959|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110987987|NCT03624959|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110987988|NCT03624959|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110987989|NCT03624959|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
110987990|NCT03624959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110987991|NCT03624959|Immunologic Factors|immunologic factors|mesh-ancestor
110987992|NCT03624959|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110987993|NCT03624959|Antimetabolites|antimetabolites|mesh-ancestor
110987994|NCT03624959|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110987995|NCT03624959|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
110987996|NCT02536846|Olanzapine|olanzapine|mesh-list
110987997|NCT02536846|Antiemetics|antiemetics|mesh-ancestor
110987998|NCT02536846|Autonomic Agents|autonomic agents|mesh-ancestor
110987999|NCT02536846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110988000|NCT02536846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110988001|NCT02536846|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110988002|NCT02536846|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110988003|NCT02536846|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110988004|NCT02536846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110988005|NCT02536846|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110988006|NCT02536846|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110988007|NCT02536846|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110988008|NCT02536846|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110988009|NCT02536846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110988010|NCT02536846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110988011|NCT02536846|Serotonin Agents|serotonin agents|mesh-ancestor
110988012|NCT03014011|Hypoglycemic Agents|hypoglycemic agents|mesh-list
110988013|NCT03014011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110988014|NCT02293655|Methylphenidate|methylphenidate|mesh-list
110988015|NCT02293655|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110988016|NCT02293655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110988017|NCT02293655|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110988018|NCT02293655|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110705088|NCT00095056|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110988019|NCT02293655|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110988020|NCT02293655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110988021|NCT02293655|Dopamine Agents|dopamine agents|mesh-ancestor
110988022|NCT02293655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110988023|NCT01764191|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110988024|NCT01764191|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110988025|NCT01764191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110988026|NCT05439460|Phenylephrine|phenylephrine|mesh-list
110988027|NCT05439460|Vasopressins|vasopressins|mesh-list
110988028|NCT05439460|Arginine Vasopressin|arginine vasopressin|mesh-list
110988029|NCT05439460|Epinephrine|epinephrine|mesh-list
110988030|NCT05439460|Racepinephrine|racepinephrine|mesh-list
110988031|NCT05439460|Oxymetazoline|oxymetazoline|mesh-list
110988032|NCT05439460|Epinephryl borate|epinephryl borate|mesh-list
110988033|NCT05439460|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110988034|NCT05439460|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110988035|NCT05439460|Adrenergic Agents|adrenergic agents|mesh-ancestor
110988036|NCT05439460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110988037|NCT05439460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110988038|NCT05439460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110988039|NCT05439460|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110988040|NCT05439460|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110988041|NCT05439460|Autonomic Agents|autonomic agents|mesh-ancestor
110988042|NCT05439460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110988043|NCT05439460|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110988044|NCT05439460|Respiratory System Agents|respiratory system agents|mesh-ancestor
110988045|NCT05439460|Mydriatics|mydriatics|mesh-ancestor
110988046|NCT05439460|Sympathomimetics|sympathomimetics|mesh-ancestor
110988047|NCT05439460|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110988048|NCT05439460|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110988049|NCT05439460|Nasal Decongestants|nasal decongestants|mesh-ancestor
110988050|NCT05439460|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110988051|NCT05439460|Protective Agents|protective agents|mesh-ancestor
110988052|NCT05439460|Hemostatics|hemostatics|mesh-ancestor
110988053|NCT05439460|Coagulants|coagulants|mesh-ancestor
110988054|NCT05439460|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
110988055|NCT05439460|Natriuretic Agents|natriuretic agents|mesh-ancestor
110988056|NCT01661140|Methotrexate|methotrexate|mesh-list
110822996|NCT01372670|Histamine Agents|histamine agents|mesh-ancestor
110988057|NCT01661140|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110988058|NCT01661140|Abortifacient Agents|abortifacient agents|mesh-ancestor
110988059|NCT01661140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110988060|NCT01661140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110988061|NCT01661140|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110988063|NCT01661140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110988064|NCT01661140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110988065|NCT01661140|Dermatologic Agents|dermatologic agents|mesh-ancestor
110988066|NCT01661140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110988067|NCT01661140|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110988068|NCT01661140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110988069|NCT01661140|Immunologic Factors|immunologic factors|mesh-ancestor
110988070|NCT01661140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110988071|NCT01661140|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110988072|NCT03019549|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110988073|NCT03019549|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110988074|NCT03019549|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110988075|NCT03019549|Antimetabolites|antimetabolites|mesh-ancestor
110988076|NCT03019549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110988077|NCT03019549|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110988078|NCT03019549|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110988079|NCT03019549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110988080|NCT05397886|Propofol|propofol|mesh-list
110988081|NCT05397886|Flumazenil|flumazenil|mesh-list
110988082|NCT05397886|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110988083|NCT05397886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110988084|NCT05397886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110988085|NCT05397886|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110988086|NCT05397886|Anesthetics, General|anesthetics, general|mesh-ancestor
110988087|NCT05397886|Anesthetics|anesthetics|mesh-ancestor
110988088|NCT05397886|Antidotes|antidotes|mesh-ancestor
110988089|NCT05397886|Protective Agents|protective agents|mesh-ancestor
110988090|NCT05397886|GABA Modulators|gaba modulators|mesh-ancestor
110988091|NCT05397886|GABA Agents|gaba agents|mesh-ancestor
110988092|NCT05397886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110988093|NCT05397886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110988094|NCT05436886|Gabapentin|gabapentin|mesh-list
110988095|NCT05436886|Analgesics|analgesics|mesh-ancestor
110988096|NCT05436886|Sensory System Agents|sensory system agents|mesh-ancestor
110988097|NCT05436886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110988098|NCT05436886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110988099|NCT05436886|Anticonvulsants|anticonvulsants|mesh-ancestor
110988100|NCT05436886|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110988101|NCT05436886|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110988102|NCT05436886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110988103|NCT05436886|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110988104|NCT05436886|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110988105|NCT05436886|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110988106|NCT05436886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110988107|NCT05436886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110988108|NCT05436886|Antimanic Agents|antimanic agents|mesh-ancestor
110988109|NCT01373151|Adalimumab|adalimumab|mesh-list
110988110|NCT01373151|Methotrexate|methotrexate|mesh-list
110988111|NCT01373151|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110988112|NCT01373151|Abortifacient Agents|abortifacient agents|mesh-ancestor
110988113|NCT01373151|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110988114|NCT01373151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110988115|NCT01373151|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110988116|NCT01373151|Antimetabolites|antimetabolites|mesh-ancestor
110988117|NCT01373151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110988118|NCT01373151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110988119|NCT01373151|Dermatologic Agents|dermatologic agents|mesh-ancestor
110988120|NCT01373151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110988121|NCT01373151|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110988122|NCT01373151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110988123|NCT01373151|Immunologic Factors|immunologic factors|mesh-ancestor
110988124|NCT01373151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110988125|NCT01373151|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110988126|NCT01373151|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110988127|NCT01373151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110988128|NCT05436652|Prednisolone|prednisolone|mesh-list
110988129|NCT05436652|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110988130|NCT05436652|Methylprednisolone|methylprednisolone|mesh-list
110988131|NCT05436652|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110988133|NCT05436652|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110988134|NCT05436652|Prednisolone phosphate|prednisolone phosphate|mesh-list
110988135|NCT05436652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110988136|NCT05436652|Glucocorticoids|glucocorticoids|mesh-ancestor
110988137|NCT05436652|Hormones|hormones|mesh-ancestor
110988138|NCT05436652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110988139|NCT05436652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110988140|NCT05436652|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110988141|NCT05436652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110988142|NCT05436652|Antiemetics|antiemetics|mesh-ancestor
110988143|NCT05436652|Autonomic Agents|autonomic agents|mesh-ancestor
110988144|NCT05436652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110988145|NCT05436652|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110988146|NCT05436652|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110988147|NCT05436652|Protective Agents|protective agents|mesh-ancestor
110988148|NCT01660906|Dasatinib|dasatinib|mesh-list
110988149|NCT01660906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110988150|NCT01660906|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110988151|NCT01660906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110988152|NCT01660906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110988153|NCT05435014|Ethiodized Oil|ethiodized oil|mesh-list
110988154|NCT05435014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110988155|NCT03666949|Anesthetics|anesthetics|mesh-list
110988156|NCT03666949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110988157|NCT03666949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110988158|NCT00886691|Bevacizumab|bevacizumab|mesh-list
110988159|NCT00886691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110988160|NCT00886691|Everolimus|everolimus|mesh-list
110988161|NCT00886691|Endothelial Growth Factors|endothelial growth factors|mesh-list
110988162|NCT00886691|Antibodies|antibodies|mesh-list
110988163|NCT00886691|Immunoglobulins|immunoglobulins|mesh-list
110988164|NCT00886691|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110988165|NCT00886691|Immunoglobulin G|immunoglobulin g|mesh-list
110988166|NCT00886691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110988167|NCT00886691|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110988168|NCT00886691|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110705245|NCT00227721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110988169|NCT00886691|Growth Substances|growth substances|mesh-ancestor
110988170|NCT00886691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110988171|NCT00886691|Growth Inhibitors|growth inhibitors|mesh-ancestor
110988172|NCT00886691|Immunologic Factors|immunologic factors|mesh-ancestor
110988173|NCT00886691|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110988174|NCT00886691|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110988175|NCT00886691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110988176|NCT00886691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110988177|NCT00886691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110988178|NCT00960297|Paclitaxel|paclitaxel|mesh-list
110988179|NCT00960297|Bevacizumab|bevacizumab|mesh-list
110988180|NCT00960297|Carboplatin|carboplatin|mesh-list
110988181|NCT00960297|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110988182|NCT00960297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110988183|NCT00960297|Tubulin Modulators|tubulin modulators|mesh-ancestor
110988184|NCT00960297|Antimitotic Agents|antimitotic agents|mesh-ancestor
110988185|NCT00960297|Mitosis Modulators|mitosis modulators|mesh-ancestor
110988186|NCT00960297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110988187|NCT00960297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110988188|NCT00960297|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110988189|NCT00960297|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110988190|NCT00960297|Growth Substances|growth substances|mesh-ancestor
110988191|NCT00960297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110988192|NCT00960297|Growth Inhibitors|growth inhibitors|mesh-ancestor
110988193|NCT05112861|Bevacizumab|bevacizumab|mesh-list
110988194|NCT05112861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110988195|NCT05112861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110988196|NCT05112861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110988197|NCT05112861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110988198|NCT05112861|Growth Substances|growth substances|mesh-ancestor
110988199|NCT05112861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110988200|NCT05112861|Growth Inhibitors|growth inhibitors|mesh-ancestor
110988201|NCT03012061|Fluticasone|fluticasone|mesh-list
110988202|NCT03012061|Xhance|xhance|mesh-list
110988203|NCT03012061|Albuterol|albuterol|mesh-list
110988204|NCT03012061|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110453381|NCT01955980|Hormones|hormones|mesh-ancestor
110988205|NCT03012061|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110988206|NCT03012061|Autonomic Agents|autonomic agents|mesh-ancestor
110988207|NCT03012061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110988208|NCT03012061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110988209|NCT03012061|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110988210|NCT03012061|Respiratory System Agents|respiratory system agents|mesh-ancestor
110988211|NCT03012061|Dermatologic Agents|dermatologic agents|mesh-ancestor
110988212|NCT03012061|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110988213|NCT03012061|Tocolytic Agents|tocolytic agents|mesh-ancestor
110988214|NCT03012061|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110988215|NCT03012061|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110988216|NCT03012061|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110988217|NCT03012061|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110988218|NCT03012061|Adrenergic Agents|adrenergic agents|mesh-ancestor
110988219|NCT03012061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110988220|NCT03012061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110988221|NCT00408863|Tibolone|tibolone|mesh-list
110988222|NCT00408863|Androgen Antagonists|androgen antagonists|mesh-ancestor
110988223|NCT00408863|Hormone Antagonists|hormone antagonists|mesh-ancestor
110988224|NCT00408863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110988225|NCT00408863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110988226|NCT00408863|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110988227|NCT00408863|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110988228|NCT00408863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110988229|NCT00408863|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110988230|NCT00408863|Anabolic Agents|anabolic agents|mesh-ancestor
110988231|NCT00408863|Hormones|hormones|mesh-ancestor
110988232|NCT05085327|Sunscreening Agents|sunscreening agents|mesh-list
110988233|NCT05085327|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110988234|NCT05085327|Protective Agents|protective agents|mesh-ancestor
110988235|NCT05085327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110988236|NCT05085327|Dermatologic Agents|dermatologic agents|mesh-ancestor
110988237|NCT03666715|Paliperidone Palmitate|paliperidone palmitate|mesh-list
110988238|NCT03666715|Antipsychotic Agents|antipsychotic agents|mesh-list
110988239|NCT03666715|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110988240|NCT03666715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110988241|NCT03666715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110988242|NCT03666715|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110988243|NCT03666715|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110988244|NCT03666715|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110988245|NCT03666715|Serotonin Agents|serotonin agents|mesh-ancestor
110988246|NCT03666715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110988247|NCT03666715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110988248|NCT03666715|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110988249|NCT03666715|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110988250|NCT03666715|Dopamine Agents|dopamine agents|mesh-ancestor
110988251|NCT04949399|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110988252|NCT04949399|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110988253|NCT04949399|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110988254|NCT04949399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110988255|NCT04949399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110988256|NCT04949399|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110988257|NCT04949399|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110988258|NCT04949399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110988259|NCT04949399|Cholinergic Agents|cholinergic agents|mesh-ancestor
110988260|NCT04949399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110988261|NCT03131973|Leucovorin|leucovorin|mesh-list
110988262|NCT03131973|Flurbiprofen|flurbiprofen|mesh-list
110988263|NCT03131973|Methotrexate|methotrexate|mesh-list
110988264|NCT03131973|Digoxin|digoxin|mesh-list
110988265|NCT03131973|Midazolam|midazolam|mesh-list
110988266|NCT03131973|Caffeine|caffeine|mesh-list
110988267|NCT03131973|Omeprazole|omeprazole|mesh-list
110988268|NCT03131973|Pravastatin|pravastatin|mesh-list
110988269|NCT03131973|Montelukast|montelukast|mesh-list
110988270|NCT03131973|Branebrutinib|branebrutinib|mesh-list
110988271|NCT03131973|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110988272|NCT03131973|Abortifacient Agents|abortifacient agents|mesh-ancestor
110988273|NCT03131973|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110988274|NCT03131973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110988275|NCT03131973|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110988276|NCT03131973|Antimetabolites|antimetabolites|mesh-ancestor
110988277|NCT03131973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110988278|NCT03131973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110988279|NCT03131973|Dermatologic Agents|dermatologic agents|mesh-ancestor
110988280|NCT03131973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110988281|NCT03131973|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110988282|NCT03131973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110988283|NCT03131973|Immunologic Factors|immunologic factors|mesh-ancestor
110988284|NCT03131973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110988285|NCT03131973|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110988286|NCT03131973|Antidotes|antidotes|mesh-ancestor
110988287|NCT03131973|Protective Agents|protective agents|mesh-ancestor
110988288|NCT03131973|Vitamin B Complex|vitamin b complex|mesh-ancestor
110988289|NCT03131973|Vitamins|vitamins|mesh-ancestor
110988290|NCT03131973|Micronutrients|micronutrients|mesh-ancestor
110988291|NCT03131973|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110988292|NCT03131973|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110988293|NCT03131973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110988294|NCT03131973|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110988295|NCT03131973|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110988296|NCT03131973|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110988297|NCT03131973|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110988298|NCT03131973|Anesthetics, General|anesthetics, general|mesh-ancestor
110988299|NCT03131973|Anesthetics|anesthetics|mesh-ancestor
110988300|NCT03131973|GABA Modulators|gaba modulators|mesh-ancestor
110988301|NCT03131973|GABA Agents|gaba agents|mesh-ancestor
110988302|NCT03131973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110988303|NCT03131973|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110988304|NCT03131973|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110988305|NCT03131973|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110988306|NCT03131973|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110988307|NCT03131973|Purinergic Agents|purinergic agents|mesh-ancestor
110988308|NCT03131973|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110988309|NCT03131973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110988310|NCT03131973|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110988311|NCT03131973|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110988312|NCT03131973|Respiratory System Agents|respiratory system agents|mesh-ancestor
110988313|NCT03131973|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110988314|NCT03131973|Hormone Antagonists|hormone antagonists|mesh-ancestor
110988315|NCT03131973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110988316|NCT03131973|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110988317|NCT03131973|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110988318|NCT03131973|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110705397|NCT01050452|Piperazine|piperazine|mesh-list
110988319|NCT03131973|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110988320|NCT03131973|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110988321|NCT03131973|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110988322|NCT03131973|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110988323|NCT03131973|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110988324|NCT03131973|Analgesics|analgesics|mesh-ancestor
110988325|NCT03131973|Sensory System Agents|sensory system agents|mesh-ancestor
110988326|NCT03131973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110988327|NCT03131973|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110988328|NCT03131973|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110988329|NCT03131973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110988330|NCT03131973|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110988331|NCT03131973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110988332|NCT05078931|Pembrolizumab|pembrolizumab|mesh-list
110988333|NCT05078931|Lenvatinib|lenvatinib|mesh-list
110988334|NCT05078931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110988335|NCT05078931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110988336|NCT05078931|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110988337|NCT05078931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110988338|NCT05078931|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110988339|NCT05078931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110988340|NCT04825197|Poractant alfa|poractant alfa|mesh-list
110988341|NCT04825197|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
110988342|NCT04825197|Respiratory System Agents|respiratory system agents|mesh-ancestor
110988343|NCT04703361|Niacin|niacin|mesh-list
110988344|NCT04703361|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110988345|NCT04703361|Antimetabolites|antimetabolites|mesh-ancestor
110988346|NCT04703361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110988347|NCT04703361|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110988348|NCT04703361|Vasodilator Agents|vasodilator agents|mesh-ancestor
110988349|NCT04703361|Vitamin B Complex|vitamin b complex|mesh-ancestor
110988350|NCT04703361|Vitamins|vitamins|mesh-ancestor
110988351|NCT04703361|Micronutrients|micronutrients|mesh-ancestor
110988352|NCT04703361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110988353|NCT03010423|Nicorandil|nicorandil|mesh-list
110988354|NCT03010423|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110988355|NCT03010423|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110988356|NCT03010423|Vasodilator Agents|vasodilator agents|mesh-ancestor
110988357|NCT03010423|Vitamin B Complex|vitamin b complex|mesh-ancestor
110988358|NCT03010423|Vitamins|vitamins|mesh-ancestor
110988359|NCT03010423|Micronutrients|micronutrients|mesh-ancestor
110988360|NCT03010423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110988361|NCT05576597|Butyric Acid|butyric acid|mesh-list
110988362|NCT05576597|Histamine Antagonists|histamine antagonists|mesh-ancestor
110988363|NCT05576597|Histamine Agents|histamine agents|mesh-ancestor
110988364|NCT05576597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110988365|NCT05576597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110988366|NCT05576597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110988367|NCT03665779|Pyridoxine|pyridoxine|mesh-list
110988368|NCT03665779|Isosorbide|isosorbide|mesh-list
110988369|NCT03665779|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
110988370|NCT03665779|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
110988371|NCT03665779|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110988372|NCT03665779|Diuretics|diuretics|mesh-ancestor
110988373|NCT03665779|Natriuretic Agents|natriuretic agents|mesh-ancestor
110988374|NCT03665779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110988375|NCT03665779|Vasodilator Agents|vasodilator agents|mesh-ancestor
110988376|NCT03665779|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
110988377|NCT03665779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110988378|NCT03665779|Vitamin B Complex|vitamin b complex|mesh-ancestor
110988379|NCT03665779|Vitamins|vitamins|mesh-ancestor
110988380|NCT03665779|Micronutrients|micronutrients|mesh-ancestor
110988381|NCT03703505|Mitapivat|mitapivat|mesh-list
110988382|NCT03703505|Enzyme Activators|enzyme activators|mesh-ancestor
110988383|NCT03703505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110988384|NCT04946435|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110988385|NCT04946435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110988386|NCT04944017|Ketamine|ketamine|mesh-list
110988387|NCT04944017|Analgesics|analgesics|mesh-ancestor
110988388|NCT04944017|Sensory System Agents|sensory system agents|mesh-ancestor
110988389|NCT04944017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110988390|NCT04944017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110988391|NCT04944017|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110988392|NCT04944017|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110988393|NCT04944017|Anesthetics, General|anesthetics, general|mesh-ancestor
110988394|NCT04944017|Anesthetics|anesthetics|mesh-ancestor
110988395|NCT04944017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110988396|NCT04944017|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110988397|NCT04944017|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110988398|NCT04944017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110988399|NCT04944017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110988401|NCT03703427|Vinorelbine|vinorelbine|mesh-list
110988402|NCT03703427|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110988403|NCT03703427|Antimetabolites|antimetabolites|mesh-ancestor
110988404|NCT03703427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110988405|NCT03703427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110988406|NCT03703427|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110988407|NCT03703427|Tubulin Modulators|tubulin modulators|mesh-ancestor
110988408|NCT03703427|Antimitotic Agents|antimitotic agents|mesh-ancestor
110988409|NCT03703427|Mitosis Modulators|mitosis modulators|mesh-ancestor
110988410|NCT03703349|Magnesium Sulfate|magnesium sulfate|mesh-list
110988411|NCT03703349|Analgesics|analgesics|mesh-ancestor
110988412|NCT03703349|Sensory System Agents|sensory system agents|mesh-ancestor
110988413|NCT03703349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110988414|NCT03703349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110988415|NCT03703349|Anesthetics|anesthetics|mesh-ancestor
110988416|NCT03703349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110988417|NCT03703349|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110988418|NCT03703349|Anticonvulsants|anticonvulsants|mesh-ancestor
110988419|NCT03703349|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110988420|NCT03703349|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110988421|NCT03703349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110988422|NCT03703349|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110988423|NCT03703349|Tocolytic Agents|tocolytic agents|mesh-ancestor
110988424|NCT03703349|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110988425|NCT03008005|Dronabinol|dronabinol|mesh-list
110988426|NCT03008005|Hallucinogens|hallucinogens|mesh-ancestor
110988427|NCT03008005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110988428|NCT03008005|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110988429|NCT03008005|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110988430|NCT03008005|Analgesics|analgesics|mesh-ancestor
110988431|NCT03008005|Sensory System Agents|sensory system agents|mesh-ancestor
110988432|NCT03008005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110988433|NCT03008005|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
110988434|NCT03008005|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110988435|NCT03008005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110988436|NCT03008005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110988437|NCT03008005|Hormones|hormones|mesh-ancestor
110988438|NCT03008005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110988439|NCT03666325|Pembrolizumab|pembrolizumab|mesh-list
110988440|NCT03666325|Cetuximab|cetuximab|mesh-list
110988441|NCT03666325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110988442|NCT03666325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110988443|NCT03666325|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110988444|NCT03666325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110988445|NCT02440425|Paclitaxel|paclitaxel|mesh-list
110988446|NCT02440425|Pembrolizumab|pembrolizumab|mesh-list
110988447|NCT02440425|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110988448|NCT02440425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110988449|NCT02440425|Tubulin Modulators|tubulin modulators|mesh-ancestor
110988450|NCT02440425|Antimitotic Agents|antimitotic agents|mesh-ancestor
110988451|NCT02440425|Mitosis Modulators|mitosis modulators|mesh-ancestor
110988452|NCT02440425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110988453|NCT02440425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110988454|NCT02440425|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110988455|NCT04931511|Betamethasone|betamethasone|mesh-list
110988456|NCT04931511|Betamethasone Valerate|betamethasone valerate|mesh-list
110988457|NCT04931511|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
110988458|NCT04931511|Betamethasone benzoate|betamethasone benzoate|mesh-list
110988459|NCT04931511|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
110988460|NCT04931511|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110988461|NCT04931511|Glucocorticoids|glucocorticoids|mesh-ancestor
110988462|NCT04931511|Hormones|hormones|mesh-ancestor
110988463|NCT04931511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110988464|NCT04931511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110988465|NCT04931511|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110988466|NCT04931511|Respiratory System Agents|respiratory system agents|mesh-ancestor
110988467|NCT04182321|Metformin|metformin|mesh-list
110988468|NCT04182321|Entecavir|entecavir|mesh-list
110988469|NCT04182321|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110988470|NCT04182321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110988471|NCT04182321|Antiviral Agents|antiviral agents|mesh-ancestor
110988472|NCT04182321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110988473|NCT03702959|Betamethasone|betamethasone|mesh-list
110988474|NCT03702959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110988475|NCT03702959|Glucocorticoids|glucocorticoids|mesh-ancestor
110988476|NCT03702959|Hormones|hormones|mesh-ancestor
110988477|NCT03702959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110988478|NCT03702959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110988479|NCT03702959|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110988480|NCT03702959|Respiratory System Agents|respiratory system agents|mesh-ancestor
110988481|NCT03001219|Methotrexate|methotrexate|mesh-list
110988482|NCT03001219|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110988483|NCT03001219|Abortifacient Agents|abortifacient agents|mesh-ancestor
110988484|NCT03001219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110988485|NCT03001219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110988486|NCT03001219|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110988487|NCT03001219|Antimetabolites|antimetabolites|mesh-ancestor
110988488|NCT03001219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110988489|NCT03001219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110988490|NCT03001219|Dermatologic Agents|dermatologic agents|mesh-ancestor
110988491|NCT03001219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110988492|NCT03001219|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110988493|NCT03001219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110988494|NCT03001219|Immunologic Factors|immunologic factors|mesh-ancestor
110988495|NCT03001219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110988496|NCT03001219|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110988497|NCT03702803|Alprazolam|alprazolam|mesh-list
110988498|NCT03702803|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110988499|NCT03702803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110988500|NCT03702803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110988501|NCT03702803|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110988502|NCT03702803|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110988503|NCT03702803|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110988504|NCT03702803|GABA Modulators|gaba modulators|mesh-ancestor
110988505|NCT03702803|GABA Agents|gaba agents|mesh-ancestor
110988506|NCT03702803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110988507|NCT03702803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110988508|NCT03702647|Ropivacaine|ropivacaine|mesh-list
110988509|NCT03702647|Anesthetics, Local|anesthetics, local|mesh-ancestor
110988510|NCT03702647|Anesthetics|anesthetics|mesh-ancestor
110988511|NCT03702647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110988512|NCT03702647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110988513|NCT03702647|Sensory System Agents|sensory system agents|mesh-ancestor
110988514|NCT03702647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110988515|NCT04583787|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
110988516|NCT04583787|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110988517|NCT04583787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110988518|NCT03000673|Heparin|heparin|mesh-list
110988519|NCT03000673|Enoxaparin|enoxaparin|mesh-list
110988520|NCT03000673|Calcium heparin|calcium heparin|mesh-list
110988521|NCT03000673|Anticoagulants|anticoagulants|mesh-ancestor
110988522|NCT03000673|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110988523|NCT03000673|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110988524|NCT03000673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110988525|NCT05423249|Ascorbic Acid|ascorbic acid|mesh-list
110988526|NCT05423249|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
110988527|NCT05423249|Antioxidants|antioxidants|mesh-ancestor
110988528|NCT05423249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110988529|NCT05423249|Protective Agents|protective agents|mesh-ancestor
110988530|NCT05423249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110988531|NCT05423249|Vitamins|vitamins|mesh-ancestor
110988532|NCT05423249|Micronutrients|micronutrients|mesh-ancestor
110988533|NCT05423249|Antidiarrheals|antidiarrheals|mesh-ancestor
110988534|NCT05423249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110988535|NCT02912455|Canagliflozin|canagliflozin|mesh-list
110988536|NCT02912455|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110988537|NCT02912455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110988538|NCT02912455|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110988539|NCT02912455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110988540|NCT03702491|Oxaliplatin|oxaliplatin|mesh-list
110988541|NCT03702491|Apatinib|apatinib|mesh-list
110988542|NCT03702491|Tegafur|tegafur|mesh-list
110988543|NCT03702491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110705629|NCT00491075|Pemetrexed|pemetrexed|mesh-list
110988544|NCT03702491|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110988545|NCT03702491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110988546|NCT03702491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110988547|NCT03702491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110988548|NCT03702491|Antimetabolites|antimetabolites|mesh-ancestor
110988549|NCT03663751|Decitabine|decitabine|mesh-list
110988550|NCT03663751|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110988551|NCT03663751|Antimetabolites|antimetabolites|mesh-ancestor
110988552|NCT03663751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110988553|NCT03663751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110988554|NCT03663751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110988555|NCT04054687|Tranexamic Acid|tranexamic acid|mesh-list
110988556|NCT04054687|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110988557|NCT04054687|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110988558|NCT04054687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110988559|NCT04054687|Hemostatics|hemostatics|mesh-ancestor
110988560|NCT04054687|Coagulants|coagulants|mesh-ancestor
110988561|NCT03492489|Cemiplimab|cemiplimab|mesh-list
110988562|NCT03492489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110988563|NCT03492489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110988564|NCT02531698|Vaccines|vaccines|mesh-list
110988565|NCT02531698|Immunologic Factors|immunologic factors|mesh-ancestor
110988566|NCT02531698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110988567|NCT04308837|Diphenhydramine|diphenhydramine|mesh-list
110988568|NCT04308837|Promethazine|promethazine|mesh-list
110988569|NCT04308837|Dexamethasone|dexamethasone|mesh-list
110988570|NCT04308837|Paclitaxel|paclitaxel|mesh-list
110988571|NCT04308837|Carboplatin|carboplatin|mesh-list
110988572|NCT04308837|Palonosetron|palonosetron|mesh-list
110988573|NCT04308837|Famotidine|famotidine|mesh-list
110988574|NCT04308837|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110988575|NCT04308837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110988576|NCT04308837|Tubulin Modulators|tubulin modulators|mesh-ancestor
110988577|NCT04308837|Antimitotic Agents|antimitotic agents|mesh-ancestor
110988578|NCT04308837|Mitosis Modulators|mitosis modulators|mesh-ancestor
110988579|NCT04308837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110988580|NCT04308837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110988581|NCT04308837|Antiemetics|antiemetics|mesh-ancestor
110988582|NCT04308837|Autonomic Agents|autonomic agents|mesh-ancestor
110988583|NCT04308837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110988584|NCT04308837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110988585|NCT04308837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110988586|NCT04308837|Glucocorticoids|glucocorticoids|mesh-ancestor
110988588|NCT04308837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110988589|NCT04308837|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110988590|NCT04308837|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110988591|NCT04308837|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110988592|NCT04308837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110988593|NCT04308837|Anesthetics, Local|anesthetics, local|mesh-ancestor
110988594|NCT04308837|Anesthetics|anesthetics|mesh-ancestor
110988595|NCT04308837|Sensory System Agents|sensory system agents|mesh-ancestor
110988596|NCT04308837|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110988597|NCT04308837|Histamine Antagonists|histamine antagonists|mesh-ancestor
110988598|NCT04308837|Histamine Agents|histamine agents|mesh-ancestor
110988599|NCT04308837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110988600|NCT04308837|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110988601|NCT04308837|Antipruritics|antipruritics|mesh-ancestor
110988602|NCT04308837|Dermatologic Agents|dermatologic agents|mesh-ancestor
110988603|NCT04308837|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110988604|NCT04308837|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110988605|NCT04308837|Serotonin Agents|serotonin agents|mesh-ancestor
110988606|NCT04308837|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110988607|NCT04308837|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110988608|NCT03664375|Botulinum Toxins|botulinum toxins|mesh-list
110988609|NCT03664375|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110988610|NCT03664375|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110988611|NCT03664375|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110988612|NCT03664375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110988613|NCT03664375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110988614|NCT03664375|Cholinergic Agents|cholinergic agents|mesh-ancestor
110988615|NCT03664375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110988616|NCT03664375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110988617|NCT03664375|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110988618|NCT03664375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110705692|NCT01012193|Purinergic Agents|purinergic agents|mesh-ancestor
110988619|NCT00403793|Methyltestosterone|methyltestosterone|mesh-list
110988620|NCT00403793|Etonogestrel|etonogestrel|mesh-list
110988621|NCT00403793|Testosterone|testosterone|mesh-list
110988622|NCT00403793|Testosterone undecanoate|testosterone undecanoate|mesh-list
110988623|NCT00403793|Testosterone enanthate|testosterone enanthate|mesh-list
110988624|NCT00403793|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
110988625|NCT00403793|Androgens|androgens|mesh-ancestor
110988626|NCT00403793|Hormones|hormones|mesh-ancestor
110988627|NCT00403793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110988628|NCT00403793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110988629|NCT00403793|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110988630|NCT00403793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110988631|NCT00403793|Anabolic Agents|anabolic agents|mesh-ancestor
110988632|NCT00403793|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110988633|NCT00403793|Contraceptive Agents|contraceptive agents|mesh-ancestor
110988634|NCT00403793|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110988635|NCT00403793|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110988636|NCT05597098|Cantharidin|cantharidin|mesh-list
110988637|NCT05597098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110988638|NCT05597098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110988639|NCT03034577|Neostigmine|neostigmine|mesh-list
110988640|NCT03034577|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110988641|NCT03034577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110988642|NCT03034577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110988643|NCT03034577|Cholinergic Agents|cholinergic agents|mesh-ancestor
110988644|NCT03034577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110988645|NCT03034577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110988646|NCT03034577|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110988647|NCT03034577|Autonomic Agents|autonomic agents|mesh-ancestor
110988648|NCT03034577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110988649|NCT04364997|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110988650|NCT04364997|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
110988651|NCT04364997|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110988652|NCT04364997|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110988653|NCT04364997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110988654|NCT04364997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110988655|NCT04364997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110988656|NCT04364997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110988657|NCT04364997|Analgesics|analgesics|mesh-ancestor
110988658|NCT04364997|Sensory System Agents|sensory system agents|mesh-ancestor
110988659|NCT04364997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110988660|NCT04364997|Antidepressive Agents|antidepressive agents|mesh-ancestor
110988661|NCT04364997|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110988662|NCT04364997|Dopamine Agents|dopamine agents|mesh-ancestor
110988663|NCT05417386|Leucovorin|leucovorin|mesh-list
110988664|NCT05417386|Fluorouracil|fluorouracil|mesh-list
110988665|NCT05417386|Capecitabine|capecitabine|mesh-list
110988666|NCT05417386|Oxaliplatin|oxaliplatin|mesh-list
110988667|NCT05417386|Irinotecan|irinotecan|mesh-list
110988668|NCT05417386|Folfirinox|folfirinox|mesh-list
110988669|NCT05417386|Camptothecin|camptothecin|mesh-list
110988670|NCT05417386|Levoleucovorin|levoleucovorin|mesh-list
110988671|NCT05417386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110988672|NCT05417386|Antimetabolites|antimetabolites|mesh-ancestor
110988673|NCT05417386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110988674|NCT05417386|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110988675|NCT05417386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110988676|NCT05417386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110988677|NCT05417386|Immunologic Factors|immunologic factors|mesh-ancestor
110988678|NCT05417386|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110988679|NCT05417386|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110988680|NCT05417386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110988681|NCT05417386|Antidotes|antidotes|mesh-ancestor
110988682|NCT05417386|Protective Agents|protective agents|mesh-ancestor
110988683|NCT05417386|Vitamin B Complex|vitamin b complex|mesh-ancestor
110988684|NCT05417386|Vitamins|vitamins|mesh-ancestor
110988685|NCT05417386|Micronutrients|micronutrients|mesh-ancestor
110988686|NCT05417386|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110988687|NCT04005729|Cangrelor|cangrelor|mesh-list
110988688|NCT04005729|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110988689|NCT04005729|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110988690|NCT04005729|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110988691|NCT04005729|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110988692|NCT04005729|Purinergic Agents|purinergic agents|mesh-ancestor
110988693|NCT04005729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110705811|NCT00502775|Xhance|xhance|mesh-list
110988694|NCT04005729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110988695|NCT04005729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110988697|NCT03487107|Yimitasvir|yimitasvir|mesh-list
110988698|NCT03487107|Antiviral Agents|antiviral agents|mesh-ancestor
110988699|NCT03487107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110988700|NCT02997163|Talazoparib|talazoparib|mesh-list
110988701|NCT02997163|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110988702|NCT02997163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110988703|NCT02997163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110988704|NCT02997163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110988705|NCT03705065|Bupivacaine|bupivacaine|mesh-list
110988706|NCT03705065|Anesthetics, Local|anesthetics, local|mesh-ancestor
110988707|NCT03705065|Anesthetics|anesthetics|mesh-ancestor
110988708|NCT03705065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110988709|NCT03705065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110988710|NCT03705065|Sensory System Agents|sensory system agents|mesh-ancestor
110988711|NCT03705065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110988712|NCT03702023|Acetaminophen|acetaminophen|mesh-list
110988713|NCT03702023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110988714|NCT03702023|Analgesics|analgesics|mesh-ancestor
110988715|NCT03702023|Sensory System Agents|sensory system agents|mesh-ancestor
110988716|NCT03702023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110988717|NCT03702023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110988718|NCT03702023|Antipyretics|antipyretics|mesh-ancestor
110988719|NCT03698513|Aspirin|aspirin|mesh-list
110988720|NCT03698513|Clopidogrel|clopidogrel|mesh-list
110988721|NCT03698513|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110988722|NCT03698513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110988723|NCT03698513|Analgesics|analgesics|mesh-ancestor
110988724|NCT03698513|Sensory System Agents|sensory system agents|mesh-ancestor
110988725|NCT03698513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110453927|NCT02688400|Celecoxib|celecoxib|mesh-list
110988726|NCT03698513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110988727|NCT03698513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110988728|NCT03698513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110988729|NCT03698513|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110988730|NCT03698513|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110988731|NCT03698513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110988732|NCT03698513|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110988733|NCT03698513|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110988734|NCT03698513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110988735|NCT03698513|Antipyretics|antipyretics|mesh-ancestor
110988736|NCT03698513|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110988737|NCT03698513|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110988738|NCT03698513|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110988739|NCT03698513|Purinergic Agents|purinergic agents|mesh-ancestor
110988740|NCT03698513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110988741|NCT03698435|Valganciclovir|valganciclovir|mesh-list
110988742|NCT03698435|Ganciclovir|ganciclovir|mesh-list
110988743|NCT03698435|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
110988744|NCT03698435|Antiviral Agents|antiviral agents|mesh-ancestor
110988745|NCT03698435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110988746|NCT03698435|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110988747|NCT03698435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110988748|NCT03698435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110988749|NCT01652092|Vidarabine|vidarabine|mesh-list
110988750|NCT01652092|Cyclophosphamide|cyclophosphamide|mesh-list
110988751|NCT01652092|Melphalan|melphalan|mesh-list
110988752|NCT01652092|Busulfan|busulfan|mesh-list
110988753|NCT01652092|Fludarabine|fludarabine|mesh-list
110988754|NCT01652092|Fludarabine phosphate|fludarabine phosphate|mesh-list
110988755|NCT01652092|Alemtuzumab|alemtuzumab|mesh-list
110988756|NCT01652092|Mesna|mesna|mesh-list
110988757|NCT01652092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110988758|NCT01652092|Immunologic Factors|immunologic factors|mesh-ancestor
110988759|NCT01652092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110988760|NCT01652092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110988761|NCT01652092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110988762|NCT01652092|Alkylating Agents|alkylating agents|mesh-ancestor
110988763|NCT01652092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110988764|NCT01652092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110988765|NCT01652092|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110988766|NCT01652092|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110988767|NCT01652092|Antimetabolites|antimetabolites|mesh-ancestor
110988768|NCT01652092|Antiviral Agents|antiviral agents|mesh-ancestor
110988769|NCT01652092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110988770|NCT01652092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110988771|NCT01652092|Protective Agents|protective agents|mesh-ancestor
110988772|NCT04572815|Interleukin-12|interleukin-12|mesh-list
110988773|NCT04572815|Ustekinumab|ustekinumab|mesh-list
110988774|NCT04572815|Immunoglobulins|immunoglobulins|mesh-list
110988775|NCT04572815|Immunoglobulin G|immunoglobulin g|mesh-list
110988776|NCT04572815|Immunologic Factors|immunologic factors|mesh-ancestor
110988777|NCT04572815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110988778|NCT04572815|Dermatologic Agents|dermatologic agents|mesh-ancestor
110988779|NCT04572815|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110988780|NCT04572815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110988781|NCT04572815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110988782|NCT04572815|Growth Substances|growth substances|mesh-ancestor
110988783|NCT04572815|Growth Inhibitors|growth inhibitors|mesh-ancestor
110988784|NCT04572815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110988785|NCT03698045|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110988786|NCT03698045|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110988787|NCT03697889|Naproxen|naproxen|mesh-list
110988788|NCT03697889|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110988789|NCT03697889|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110988790|NCT03697889|Analgesics|analgesics|mesh-ancestor
110988791|NCT03697889|Sensory System Agents|sensory system agents|mesh-ancestor
110988792|NCT03697889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110988793|NCT03697889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110988794|NCT03697889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110988795|NCT03697889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110988796|NCT03697889|Gout Suppressants|gout suppressants|mesh-ancestor
110988797|NCT03697889|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110988798|NCT03697889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110988799|NCT03697889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110988800|NCT03692819|Amoxicillin|amoxicillin|mesh-list
110988801|NCT03692819|Metronidazole|metronidazole|mesh-list
110988802|NCT03692819|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110988803|NCT03692819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110988804|NCT03692819|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110988805|NCT03692819|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110988806|NCT00458536|Molgramostim|molgramostim|mesh-list
110988807|NCT00458536|Sargramostim|sargramostim|mesh-list
110988808|NCT00458536|Immunologic Factors|immunologic factors|mesh-ancestor
110988809|NCT00458536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110988810|NCT00458536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110988811|NCT05577364|Prednisone|prednisone|mesh-list
110988812|NCT05577364|Cyclophosphamide|cyclophosphamide|mesh-list
110988813|NCT05577364|Doxorubicin|doxorubicin|mesh-list
110988814|NCT05577364|Vincristine|vincristine|mesh-list
110988815|NCT05577364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110988816|NCT05577364|Immunologic Factors|immunologic factors|mesh-ancestor
110988817|NCT05577364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110988818|NCT05577364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110988819|NCT05577364|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110988820|NCT05577364|Alkylating Agents|alkylating agents|mesh-ancestor
110988821|NCT05577364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110988822|NCT05577364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110988823|NCT05577364|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110988824|NCT05577364|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110988825|NCT05577364|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110988826|NCT05577364|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110988827|NCT05577364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110988828|NCT05577364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110988829|NCT05577364|Glucocorticoids|glucocorticoids|mesh-ancestor
110988830|NCT05577364|Hormones|hormones|mesh-ancestor
110988831|NCT05577364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110988832|NCT05577364|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110988833|NCT05577364|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110988834|NCT05577364|Tubulin Modulators|tubulin modulators|mesh-ancestor
110988835|NCT05577364|Antimitotic Agents|antimitotic agents|mesh-ancestor
110988836|NCT05577364|Mitosis Modulators|mitosis modulators|mesh-ancestor
110988837|NCT03697655|Daratumumab|daratumumab|mesh-list
110988838|NCT03697655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110988839|NCT02526550|Vaccines|vaccines|mesh-list
110988840|NCT02526550|Immunologic Factors|immunologic factors|mesh-ancestor
110988841|NCT02526550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110988842|NCT05565352|Ketamine|ketamine|mesh-list
110988843|NCT05565352|Analgesics|analgesics|mesh-ancestor
110988844|NCT05565352|Sensory System Agents|sensory system agents|mesh-ancestor
110988845|NCT05565352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110988846|NCT05565352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110988847|NCT05565352|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110988848|NCT05565352|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110988849|NCT05565352|Anesthetics, General|anesthetics, general|mesh-ancestor
110988851|NCT05565352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110988852|NCT05565352|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110988853|NCT05565352|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110988854|NCT05565352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110988855|NCT05565352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110988856|NCT04423276|Donepezil|donepezil|mesh-list
110988857|NCT04423276|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110988858|NCT04423276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110988859|NCT04423276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110988860|NCT04423276|Cholinergic Agents|cholinergic agents|mesh-ancestor
110988861|NCT04423276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110988862|NCT04423276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110988863|NCT04423276|Nootropic Agents|nootropic agents|mesh-ancestor
110988864|NCT05564416|Atezolizumab|atezolizumab|mesh-list
110988865|NCT05564416|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110988866|NCT05564416|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110988867|NCT05564416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110988868|NCT05564416|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110988869|NCT05564416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110988870|NCT05564416|Immunologic Factors|immunologic factors|mesh-ancestor
110988871|NCT05564416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110988872|NCT03701087|Vitamin D|vitamin d|mesh-list
110988873|NCT03701087|Vitamins|vitamins|mesh-ancestor
110988874|NCT03701087|Micronutrients|micronutrients|mesh-ancestor
110988875|NCT03701087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110988876|NCT03701087|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110988877|NCT03697265|Pregnanolone|pregnanolone|mesh-list
110988878|NCT03697265|Anesthetics|anesthetics|mesh-ancestor
110024428|NCT00004734|Vitamin B Complex|vitamin b complex|mesh-ancestor
110988879|NCT03697265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110988880|NCT03697265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110988881|NCT04523129|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110988882|NCT04523129|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110988883|NCT04513067|Pembrolizumab|pembrolizumab|mesh-list
110988884|NCT04513067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110988885|NCT04513067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110988886|NCT04513067|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110988887|NCT04513067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110988888|NCT04336943|Durvalumab|durvalumab|mesh-list
110988889|NCT04336943|Olaparib|olaparib|mesh-list
110988890|NCT04336943|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
110988891|NCT04336943|Immunoglobulins|immunoglobulins|mesh-list
110988892|NCT04336943|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110988893|NCT04336943|Immunoglobulin G|immunoglobulin g|mesh-list
110988894|NCT04336943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110988895|NCT04336943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110988896|NCT04336943|Immunologic Factors|immunologic factors|mesh-ancestor
110988897|NCT04336943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110988898|NCT04336943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110988899|NCT04336943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110988900|NCT03030989|Chlorhexidine|chlorhexidine|mesh-list
110988901|NCT03030989|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110988902|NCT03030989|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110988903|NCT03030989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110988904|NCT03030989|Disinfectants|disinfectants|mesh-ancestor
110988905|NCT03030989|Dermatologic Agents|dermatologic agents|mesh-ancestor
110988906|NCT03696641|Lithium Carbonate|lithium carbonate|mesh-list
110988907|NCT03696641|Antidepressive Agents|antidepressive agents|mesh-ancestor
110988908|NCT03696641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110988909|NCT03696641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110988910|NCT03696641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110988911|NCT03696641|Antimanic Agents|antimanic agents|mesh-ancestor
110988912|NCT03696641|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110988913|NCT03696641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110988914|NCT03696641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110988915|NCT03696329|Tetrabenazine|tetrabenazine|mesh-list
110988916|NCT03696329|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110988917|NCT03696329|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110988918|NCT03696329|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110988919|NCT03696329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110988920|NCT03696329|Adrenergic Agents|adrenergic agents|mesh-ancestor
110988921|NCT03696329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110988922|NCT03696329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110988923|NCT03696095|Ropivacaine|ropivacaine|mesh-list
110988924|NCT03696095|Anesthetics, Local|anesthetics, local|mesh-ancestor
110988925|NCT03696095|Anesthetics|anesthetics|mesh-ancestor
110988926|NCT03696095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110988927|NCT03696095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110988928|NCT03696095|Sensory System Agents|sensory system agents|mesh-ancestor
110988929|NCT03696095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110988930|NCT03700229|Rituximab|rituximab|mesh-list
110988931|NCT03700229|Bortezomib|bortezomib|mesh-list
110988932|NCT03700229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110988933|NCT03700229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110988934|NCT03700229|Immunologic Factors|immunologic factors|mesh-ancestor
110988935|NCT03700229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110988936|NCT03700229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110988937|NCT03695861|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110988938|NCT03695861|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110988939|NCT03695861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110988940|NCT03695705|Rifaximin|rifaximin|mesh-list
110988941|NCT03695705|Norfloxacin|norfloxacin|mesh-list
110988942|NCT03695705|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110988943|NCT03695705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110988944|NCT03695705|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110988945|NCT03695705|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110988946|NCT03695705|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110988947|NCT03695705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110988948|NCT03695705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110988949|NCT03695705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110988950|NCT03695705|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110988951|NCT03695705|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110988952|NCT03699839|Vaccines|vaccines|mesh-list
110988953|NCT03699839|Immunologic Factors|immunologic factors|mesh-ancestor
110988954|NCT03699839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110988955|NCT04050215|Edetic Acid|edetic acid|mesh-list
110988956|NCT04050215|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
110988957|NCT04050215|Chelating Agents|chelating agents|mesh-ancestor
110988958|NCT04050215|Sequestering Agents|sequestering agents|mesh-ancestor
110988959|NCT04050215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110988960|NCT04050215|Anticoagulants|anticoagulants|mesh-ancestor
110988961|NCT04050215|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110988962|NCT04050215|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110988963|NCT03699449|Paclitaxel|paclitaxel|mesh-list
110988964|NCT03699449|Durvalumab|durvalumab|mesh-list
110988965|NCT03699449|Olaparib|olaparib|mesh-list
110988966|NCT03699449|Tremelimumab|tremelimumab|mesh-list
110988967|NCT03699449|Cediranib|cediranib|mesh-list
110988968|NCT03699449|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110988969|NCT03699449|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110988970|NCT03699449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110988971|NCT03699449|Tubulin Modulators|tubulin modulators|mesh-ancestor
110988972|NCT03699449|Antimitotic Agents|antimitotic agents|mesh-ancestor
110988973|NCT03699449|Mitosis Modulators|mitosis modulators|mesh-ancestor
110988974|NCT03699449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110988975|NCT03699449|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110988976|NCT03699449|Immunologic Factors|immunologic factors|mesh-ancestor
110988977|NCT03699449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110988978|NCT03699449|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110988979|NCT03699449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110988980|NCT03699449|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110988981|NCT04475939|Pembrolizumab|pembrolizumab|mesh-list
110988982|NCT04475939|Niraparib|niraparib|mesh-list
110988983|NCT04475939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110988984|NCT04475939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110988985|NCT04475939|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110988986|NCT04475939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110988987|NCT04475939|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110988988|NCT04475939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110988989|NCT03699293|Aspirin|aspirin|mesh-list
110988990|NCT03699293|Celecoxib|celecoxib|mesh-list
110988991|NCT03699293|Naproxen|naproxen|mesh-list
110988992|NCT03699293|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110988993|NCT03699293|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110988994|NCT03699293|Analgesics|analgesics|mesh-ancestor
110988995|NCT03699293|Sensory System Agents|sensory system agents|mesh-ancestor
110706136|NCT00320424|PENTA|penta|mesh-list
110988996|NCT03699293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110988997|NCT03699293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110988998|NCT03699293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110988999|NCT03699293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110989000|NCT03699293|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110989001|NCT03699293|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110989002|NCT03699293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110989003|NCT03699293|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110989004|NCT03699293|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110989005|NCT03699293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110989006|NCT03699293|Antipyretics|antipyretics|mesh-ancestor
110989007|NCT03699293|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110989008|NCT03699293|Gout Suppressants|gout suppressants|mesh-ancestor
110989009|NCT03029819|Nicotine|nicotine|mesh-list
110989010|NCT03029819|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110989011|NCT03029819|Autonomic Agents|autonomic agents|mesh-ancestor
110989012|NCT03029819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110989013|NCT03029819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110989014|NCT03029819|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110989015|NCT03029819|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110989016|NCT03029819|Cholinergic Agents|cholinergic agents|mesh-ancestor
110989017|NCT03029819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110989018|NCT03029819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110989019|NCT03105830|Acetaminophen|acetaminophen|mesh-list
110989020|NCT03105830|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110989021|NCT03105830|Analgesics|analgesics|mesh-ancestor
110989022|NCT03105830|Sensory System Agents|sensory system agents|mesh-ancestor
110989023|NCT03105830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110989024|NCT03105830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110989025|NCT03105830|Antipyretics|antipyretics|mesh-ancestor
110989026|NCT03691415|Deoxycholic Acid|deoxycholic acid|mesh-list
110989027|NCT03691415|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
110024429|NCT00004734|Vitamins|vitamins|mesh-ancestor
110989028|NCT03691415|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110989030|NCT03699215|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110989031|NCT03699215|Vasodilator Agents|vasodilator agents|mesh-ancestor
110989032|NCT03699215|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110989033|NCT03699215|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110989034|NCT03699215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110989035|NCT03699215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110989036|NCT03699215|Protective Agents|protective agents|mesh-ancestor
110989037|NCT03699215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110989038|NCT03694535|Mitomycins|mitomycins|mesh-list
110989039|NCT03694535|Mitomycin|mitomycin|mesh-list
110989040|NCT03694535|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110989041|NCT03694535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110989042|NCT03694535|Alkylating Agents|alkylating agents|mesh-ancestor
110989043|NCT03694535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110989044|NCT03694535|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110989045|NCT03694535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110989046|NCT03115034|Melatonin|melatonin|mesh-list
110989047|NCT03115034|Antioxidants|antioxidants|mesh-ancestor
110989048|NCT03115034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110989049|NCT03115034|Protective Agents|protective agents|mesh-ancestor
110989050|NCT03115034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110989051|NCT03115034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110989052|NCT03027557|Denosumab|denosumab|mesh-list
110989053|NCT03027557|Cinacalcet|cinacalcet|mesh-list
110989054|NCT03027557|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110989055|NCT03027557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110989056|NCT03027557|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110989057|NCT03027557|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
110989058|NCT03027557|Hormone Antagonists|hormone antagonists|mesh-ancestor
110989059|NCT03027557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110989060|NCT03698825|Vactosertib|vactosertib|mesh-list
110989061|NCT03698825|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110989062|NCT03698825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110989063|NCT03698825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110989064|NCT02691572|Acetaminophen|acetaminophen|mesh-list
110989065|NCT02691572|Ketorolac|ketorolac|mesh-list
110989066|NCT02691572|Fentanyl|fentanyl|mesh-list
110989067|NCT02691572|Bupivacaine|bupivacaine|mesh-list
110989068|NCT02691572|Anesthetics, Local|anesthetics, local|mesh-ancestor
110989069|NCT02691572|Anesthetics|anesthetics|mesh-ancestor
110706207|NCT01054508|Niacin|niacin|mesh-list
110989070|NCT02691572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110989071|NCT02691572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110989072|NCT02691572|Sensory System Agents|sensory system agents|mesh-ancestor
110989073|NCT02691572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110989074|NCT02691572|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110989075|NCT02691572|Narcotics|narcotics|mesh-ancestor
110989076|NCT02691572|Analgesics|analgesics|mesh-ancestor
110989077|NCT02691572|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110989078|NCT02691572|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110989079|NCT02691572|Anesthetics, General|anesthetics, general|mesh-ancestor
110989080|NCT02691572|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110989081|NCT02691572|Antipyretics|antipyretics|mesh-ancestor
110989082|NCT02691572|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110989083|NCT02691572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110989084|NCT02691572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110989085|NCT02691572|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110989086|NCT02691572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110989087|NCT02691572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110989088|NCT05320172|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110989089|NCT05320172|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110989090|NCT03693833|Cannabidiol|cannabidiol|mesh-list
110989091|NCT03693833|Anticonvulsants|anticonvulsants|mesh-ancestor
110989092|NCT03693599|Carbetocin|carbetocin|mesh-list
110989093|NCT03693599|Syntometrine|syntometrine|mesh-list
110989094|NCT03693599|Oxytocics|oxytocics|mesh-ancestor
110989095|NCT03693599|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110989096|NCT03693599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110989097|NCT04277663|Interferons|interferons|mesh-list
110989098|NCT04277663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110989099|NCT04277663|Antiviral Agents|antiviral agents|mesh-ancestor
110989100|NCT04277663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110989101|NCT04270643|Vitamin D|vitamin d|mesh-list
110989102|NCT04270643|Cholecalciferol|cholecalciferol|mesh-list
110989103|NCT04270643|Vitamins|vitamins|mesh-ancestor
110989104|NCT04270643|Micronutrients|micronutrients|mesh-ancestor
110989105|NCT04270643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110989106|NCT04270643|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110989107|NCT04270643|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110989108|NCT03693131|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
110989109|NCT03693131|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110989110|NCT03693131|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110989111|NCT02677844|Loperamide|loperamide|mesh-list
110989112|NCT02677844|Antidiarrheals|antidiarrheals|mesh-list
110989113|NCT02677844|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110989114|NCT03687905|Hydroxychloroquine|hydroxychloroquine|mesh-list
110989115|NCT03687905|Chloroquine|chloroquine|mesh-list
110989116|NCT03687905|Antimalarials|antimalarials|mesh-ancestor
110989117|NCT03687905|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110989118|NCT03687905|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110989119|NCT03687905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110989120|NCT03687905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110989121|NCT03687905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110989122|NCT03687905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110989123|NCT03687905|Amebicides|amebicides|mesh-ancestor
110989124|NCT03687515|Prednisone|prednisone|mesh-list
110989125|NCT03687515|Budesonide|budesonide|mesh-list
110989126|NCT03687515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110989127|NCT03687515|Glucocorticoids|glucocorticoids|mesh-ancestor
110989128|NCT03687515|Hormones|hormones|mesh-ancestor
110989129|NCT03687515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110989130|NCT03687515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110989131|NCT03687515|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110989132|NCT03687515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110989133|NCT03687515|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110989134|NCT03687515|Autonomic Agents|autonomic agents|mesh-ancestor
110989135|NCT03687515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110989136|NCT03687515|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110989137|NCT03687515|Respiratory System Agents|respiratory system agents|mesh-ancestor
110989138|NCT02691494|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110989139|NCT02691494|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110989140|NCT02691494|Norethindrone|norethindrone|mesh-list
110989141|NCT02691494|Norethindrone Acetate|norethindrone acetate|mesh-list
110989142|NCT02691494|Estradiol|estradiol|mesh-list
110989143|NCT02691494|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110989144|NCT02691494|Estrogens|estrogens|mesh-ancestor
110989145|NCT02691494|Hormones|hormones|mesh-ancestor
110989146|NCT02691494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110989147|NCT02691494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110989148|NCT02691494|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110989149|NCT02691494|Contraceptive Agents|contraceptive agents|mesh-ancestor
110989150|NCT02691494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110989151|NCT02691494|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110989152|NCT02691494|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110989153|NCT02691494|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110989154|NCT02691494|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110989156|NCT02682602|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110989157|NCT02682602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110989158|NCT02682602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110989159|NCT02682602|Cholinergic Agents|cholinergic agents|mesh-ancestor
110989160|NCT02682602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110989161|NCT02682602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110989162|NCT02682602|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110989163|NCT02682602|Autonomic Agents|autonomic agents|mesh-ancestor
110989164|NCT02682602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110989165|NCT02682602|Nootropic Agents|nootropic agents|mesh-ancestor
110989166|NCT03691337|Bupivacaine|bupivacaine|mesh-list
110989167|NCT03691337|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110989168|NCT03691337|Anesthetics, Local|anesthetics, local|mesh-ancestor
110989169|NCT03691337|Anesthetics|anesthetics|mesh-ancestor
110989170|NCT03691337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110989171|NCT03691337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110989172|NCT03691337|Sensory System Agents|sensory system agents|mesh-ancestor
110989173|NCT03691337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110989174|NCT02681510|Nicotine|nicotine|mesh-list
110989175|NCT02681510|Varenicline|varenicline|mesh-list
110989176|NCT02681510|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110989177|NCT02681510|Autonomic Agents|autonomic agents|mesh-ancestor
110989178|NCT02681510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110989179|NCT02681510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110989180|NCT02681510|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110989181|NCT02681510|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110989182|NCT02681510|Cholinergic Agents|cholinergic agents|mesh-ancestor
110989183|NCT02681510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110989184|NCT02681510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110989185|NCT03690323|Paclitaxel|paclitaxel|mesh-list
110989186|NCT03690323|Gemcitabine|gemcitabine|mesh-list
110989187|NCT03690323|Folfirinox|folfirinox|mesh-list
110989188|NCT03690323|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110989189|NCT03690323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110989190|NCT03690323|Tubulin Modulators|tubulin modulators|mesh-ancestor
110989191|NCT03690323|Antimitotic Agents|antimitotic agents|mesh-ancestor
110989192|NCT03690323|Mitosis Modulators|mitosis modulators|mesh-ancestor
110989193|NCT03690323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110989194|NCT03690323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110989195|NCT03690323|Antimetabolites|antimetabolites|mesh-ancestor
110989196|NCT03682211|Fentanyl|fentanyl|mesh-list
110989197|NCT03682211|Morphine|morphine|mesh-list
110989198|NCT03682211|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110989199|NCT03682211|Narcotics|narcotics|mesh-ancestor
110989200|NCT03682211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110989201|NCT03682211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110989202|NCT03682211|Analgesics|analgesics|mesh-ancestor
110989203|NCT03682211|Sensory System Agents|sensory system agents|mesh-ancestor
110989204|NCT03682211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110989205|NCT03682211|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110989206|NCT03682211|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110989207|NCT03682211|Anesthetics, General|anesthetics, general|mesh-ancestor
110989208|NCT03682211|Anesthetics|anesthetics|mesh-ancestor
110989209|NCT04132505|Hydroxychloroquine|hydroxychloroquine|mesh-list
110989210|NCT04132505|Antimalarials|antimalarials|mesh-ancestor
110451717|NCT00833833|Antipyretics|antipyretics|mesh-ancestor
110989211|NCT04132505|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110989212|NCT04132505|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110989213|NCT04132505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110989214|NCT04132505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110989215|NCT04132505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110989216|NCT04132505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110989217|NCT02690714|Plasminogen|plasminogen|mesh-list
110989218|NCT02690714|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110989219|NCT02690714|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110989220|NCT02690714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110706287|NCT00490139|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110989221|NCT03690167|Mitogens|mitogens|mesh-list
110989222|NCT03690167|Mitosis Modulators|mitosis modulators|mesh-ancestor
110989223|NCT03690167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110989224|NCT03165890|Acetazolamide|acetazolamide|mesh-list
110989225|NCT03165890|Anticonvulsants|anticonvulsants|mesh-ancestor
110989226|NCT03165890|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110989227|NCT03165890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110989228|NCT03165890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110989229|NCT03165890|Diuretics|diuretics|mesh-ancestor
110989230|NCT03165890|Natriuretic Agents|natriuretic agents|mesh-ancestor
110989231|NCT03165890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110989232|NCT03681509|Pramipexole|pramipexole|mesh-list
110989233|NCT03681509|Antioxidants|antioxidants|mesh-ancestor
110989234|NCT03681509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110989235|NCT03681509|Protective Agents|protective agents|mesh-ancestor
110989236|NCT03681509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110989237|NCT03681509|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110989238|NCT03681509|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110989239|NCT03681509|Dopamine Agonists|dopamine agonists|mesh-ancestor
110989240|NCT03681509|Dopamine Agents|dopamine agents|mesh-ancestor
110989241|NCT03681509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110989242|NCT03686267|Lithium Carbonate|lithium carbonate|mesh-list
110989243|NCT03686267|Antidepressive Agents|antidepressive agents|mesh-ancestor
110989244|NCT03686267|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110989245|NCT03686267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110989246|NCT03686267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110989247|NCT03686267|Antimanic Agents|antimanic agents|mesh-ancestor
110989248|NCT03686267|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110989249|NCT03686267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110989250|NCT03686267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110989251|NCT03161210|Anesthetics|anesthetics|mesh-list
110989252|NCT03161210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110989253|NCT03161210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110989254|NCT01898793|Aldesleukin|aldesleukin|mesh-list
110989255|NCT01898793|Cyclophosphamide|cyclophosphamide|mesh-list
110989256|NCT01898793|Fludarabine|fludarabine|mesh-list
110989257|NCT01898793|Fludarabine phosphate|fludarabine phosphate|mesh-list
110989258|NCT01898793|Interleukin-2|interleukin-2|mesh-list
110989259|NCT01898793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110989260|NCT01898793|Immunologic Factors|immunologic factors|mesh-ancestor
110989261|NCT01898793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110989262|NCT01898793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110989263|NCT01898793|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110989264|NCT01898793|Alkylating Agents|alkylating agents|mesh-ancestor
110989265|NCT01898793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110989266|NCT01898793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110989267|NCT01898793|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110989268|NCT01898793|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110989269|NCT01898793|Antimetabolites|antimetabolites|mesh-ancestor
110989270|NCT01898793|Antiviral Agents|antiviral agents|mesh-ancestor
110989271|NCT01898793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110989272|NCT01898793|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110989273|NCT01898793|Analgesics|analgesics|mesh-ancestor
110989274|NCT01898793|Sensory System Agents|sensory system agents|mesh-ancestor
110989275|NCT01898793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110989276|NCT01898793|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110989277|NCT01898793|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110989278|NCT03164096|Bupivacaine|bupivacaine|mesh-list
110989279|NCT03164096|Anesthetics, Local|anesthetics, local|mesh-ancestor
110989280|NCT03164096|Anesthetics|anesthetics|mesh-ancestor
110989281|NCT03164096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110989282|NCT03164096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110989283|NCT03164096|Sensory System Agents|sensory system agents|mesh-ancestor
110989284|NCT03164096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110989285|NCT03164018|4-Aminopyridine|4-aminopyridine|mesh-list
110989286|NCT03164018|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
110989287|NCT03164018|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110989288|NCT03164018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110989289|NCT03163784|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110989290|NCT03163784|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
110989291|NCT03163784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110989292|NCT03163784|Antitubercular Agents|antitubercular agents|mesh-ancestor
110989293|NCT03681431|Ceftriaxone|ceftriaxone|mesh-list
110989294|NCT03681431|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110989295|NCT03681431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110706365|NCT03988010|Amantadine|amantadine|mesh-list
110989297|NCT03681197|Clomiphene|clomiphene|mesh-list
110989298|NCT03681197|Enclomiphene|enclomiphene|mesh-list
110989299|NCT03681197|Zuclomiphene|zuclomiphene|mesh-list
110989300|NCT03681197|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110989301|NCT03681197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110989302|NCT03681197|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110989303|NCT03681197|Hormone Antagonists|hormone antagonists|mesh-ancestor
110989304|NCT03681197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110989305|NCT03681197|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110989306|NCT03681197|Fertility Agents|fertility agents|mesh-ancestor
110989307|NCT03681197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110989308|NCT03681197|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110989309|NCT03681197|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110989310|NCT03485703|Azithromycin|azithromycin|mesh-list
110989311|NCT03485703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110989312|NCT03485703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110989313|NCT03165344|Prednisone|prednisone|mesh-list
110989314|NCT03165344|Triamcinolone|triamcinolone|mesh-list
110989315|NCT03165344|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110989316|NCT03165344|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110989317|NCT03165344|Hydrocortisone|hydrocortisone|mesh-list
110989318|NCT03165344|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
110989319|NCT03165344|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
110989320|NCT03165344|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
110989321|NCT03165344|Aluminum phosphate|aluminum phosphate|mesh-list
110989322|NCT03165344|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110989323|NCT03165344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110989324|NCT03165344|Glucocorticoids|glucocorticoids|mesh-ancestor
110989325|NCT03165344|Hormones|hormones|mesh-ancestor
110989326|NCT03165344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110989327|NCT03165344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110989328|NCT03165344|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110989329|NCT03165344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110989330|NCT03165344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110989331|NCT03165344|Immunologic Factors|immunologic factors|mesh-ancestor
110989332|NCT03165344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110989333|NCT03165344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110989334|NCT03165344|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110989335|NCT03165344|Antacids|antacids|mesh-ancestor
110989336|NCT03165344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110989337|NCT03487029|Oxymetazoline|oxymetazoline|mesh-list
110989338|NCT03487029|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110989339|NCT03487029|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110989340|NCT03487029|Adrenergic Agents|adrenergic agents|mesh-ancestor
110989341|NCT03487029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110989342|NCT03487029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110989343|NCT03487029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110989344|NCT03487029|Sympathomimetics|sympathomimetics|mesh-ancestor
110989345|NCT03487029|Autonomic Agents|autonomic agents|mesh-ancestor
110989346|NCT03487029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110989347|NCT03487029|Nasal Decongestants|nasal decongestants|mesh-ancestor
110989348|NCT03487029|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110989349|NCT03487029|Respiratory System Agents|respiratory system agents|mesh-ancestor
110989350|NCT03689465|Cyclosporine|cyclosporine|mesh-list
110989351|NCT03689465|Mycophenolic Acid|mycophenolic acid|mesh-list
110989352|NCT03689465|Methotrexate|methotrexate|mesh-list
110989353|NCT03689465|Cyclosporins|cyclosporins|mesh-list
110989354|NCT03689465|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110989355|NCT03689465|Abortifacient Agents|abortifacient agents|mesh-ancestor
110989356|NCT03689465|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110989357|NCT03689465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110989358|NCT03689465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110989359|NCT03689465|Antimetabolites|antimetabolites|mesh-ancestor
110989360|NCT03689465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110989361|NCT03689465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110989362|NCT03689465|Dermatologic Agents|dermatologic agents|mesh-ancestor
110989363|NCT03689465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110989364|NCT03689465|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110989365|NCT03689465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110989366|NCT03689465|Immunologic Factors|immunologic factors|mesh-ancestor
110989367|NCT03689465|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110989368|NCT03689465|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110451734|NCT00704743|Calpastatin|calpastatin|mesh-list
110989369|NCT03689465|Antifungal Agents|antifungal agents|mesh-ancestor
110989370|NCT03689465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110989371|NCT03689465|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110989372|NCT03689465|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110989373|NCT03689465|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110989374|NCT03689465|Antitubercular Agents|antitubercular agents|mesh-ancestor
110989375|NCT03689465|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110989376|NCT03485625|Acetaminophen|acetaminophen|mesh-list
110989377|NCT03485625|Ketorolac|ketorolac|mesh-list
110989378|NCT03485625|Lidocaine|lidocaine|mesh-list
110989379|NCT03485625|Anesthetics, Local|anesthetics, local|mesh-ancestor
110989380|NCT03485625|Anesthetics|anesthetics|mesh-ancestor
110989381|NCT03485625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110989382|NCT03485625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110989383|NCT03485625|Sensory System Agents|sensory system agents|mesh-ancestor
110989384|NCT03485625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110989385|NCT03485625|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110989386|NCT03485625|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110989387|NCT03485625|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110989388|NCT03485625|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110989389|NCT03485625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110989390|NCT03485625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110989391|NCT03485625|Analgesics|analgesics|mesh-ancestor
110989392|NCT03485625|Antipyretics|antipyretics|mesh-ancestor
110989393|NCT03485625|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110989394|NCT03485625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110989395|NCT03485625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110989396|NCT03485625|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110989397|NCT03485625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110989398|NCT03680885|Lidocaine|lidocaine|mesh-list
110989399|NCT03680885|Anesthetics, Local|anesthetics, local|mesh-ancestor
110989400|NCT03680885|Anesthetics|anesthetics|mesh-ancestor
110989401|NCT03680885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110989402|NCT03680885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110989403|NCT03680885|Sensory System Agents|sensory system agents|mesh-ancestor
110989404|NCT03680885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110989405|NCT03680885|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110989406|NCT03680885|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110989407|NCT03680885|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110989408|NCT03680885|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110989409|NCT03680885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110989410|NCT03033069|Sertraline|sertraline|mesh-list
110989411|NCT03033069|Brexpiprazole|brexpiprazole|mesh-list
110989412|NCT03033069|Antidepressive Agents|antidepressive agents|mesh-ancestor
110989413|NCT03033069|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110989414|NCT03033069|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110989415|NCT03033069|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110989416|NCT03033069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110989417|NCT03033069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110989418|NCT03033069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110989419|NCT03033069|Serotonin Agents|serotonin agents|mesh-ancestor
110989420|NCT03033069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110989421|NCT03033069|Dopamine Agonists|dopamine agonists|mesh-ancestor
110989422|NCT03033069|Dopamine Agents|dopamine agents|mesh-ancestor
110989423|NCT03685409|Metformin|metformin|mesh-list
110989424|NCT03685409|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110989425|NCT03685409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110989426|NCT03165500|Midazolam|midazolam|mesh-list
110989427|NCT03165500|Diazepam|diazepam|mesh-list
110989428|NCT03165500|Nitrous Oxide|nitrous oxide|mesh-list
110989429|NCT03165500|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110989430|NCT03165500|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110989431|NCT03165500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110989432|NCT03165500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110989433|NCT03165500|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110989434|NCT03165500|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110989435|NCT03165500|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110989436|NCT03165500|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110989437|NCT03165500|Anesthetics, General|anesthetics, general|mesh-ancestor
110989438|NCT03165500|Anesthetics|anesthetics|mesh-ancestor
110989439|NCT03165500|GABA Modulators|gaba modulators|mesh-ancestor
110989440|NCT03165500|GABA Agents|gaba agents|mesh-ancestor
110989441|NCT03165500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110989442|NCT03165500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110989443|NCT03165500|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110989444|NCT03165500|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110989445|NCT03165500|Analgesics|analgesics|mesh-ancestor
110989446|NCT03165500|Sensory System Agents|sensory system agents|mesh-ancestor
110989447|NCT03165500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110989448|NCT03165500|Anticonvulsants|anticonvulsants|mesh-ancestor
110989449|NCT03165500|Antiemetics|antiemetics|mesh-ancestor
110989450|NCT03165500|Autonomic Agents|autonomic agents|mesh-ancestor
110989451|NCT03165500|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110989452|NCT03165500|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110989453|NCT03165500|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110989454|NCT03163238|Dexmedetomidine|dexmedetomidine|mesh-list
110989455|NCT03163238|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110989456|NCT03163238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110989457|NCT03163238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110989458|NCT03163238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110989459|NCT03163238|Analgesics|analgesics|mesh-ancestor
110989460|NCT03163238|Sensory System Agents|sensory system agents|mesh-ancestor
110989461|NCT03163238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110989462|NCT03163238|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110989463|NCT03163238|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110989464|NCT03163238|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110989465|NCT03163238|Adrenergic Agents|adrenergic agents|mesh-ancestor
110989466|NCT03163238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110989467|NCT03163238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110989468|NCT03486561|Ranolazine|ranolazine|mesh-list
110989469|NCT03486561|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110989470|NCT03486561|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110989471|NCT03486561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110989472|NCT03680573|Allopurinol|allopurinol|mesh-list
110989473|NCT03680573|Nitroprusside|nitroprusside|mesh-list
110989474|NCT03680573|Nitroarginine|nitroarginine|mesh-list
110989475|NCT03680573|NG-Nitroarginine Methyl Ester|ng-nitroarginine methyl ester|mesh-list
110989476|NCT03680573|Antimetabolites|antimetabolites|mesh-ancestor
110823000|NCT02322658|Eszopiclone|eszopiclone|mesh-list
110989477|NCT03680573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110989478|NCT03680573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110989479|NCT03680573|Gout Suppressants|gout suppressants|mesh-ancestor
110989480|NCT03680573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110989481|NCT03680573|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110989482|NCT03680573|Antioxidants|antioxidants|mesh-ancestor
110989483|NCT03680573|Protective Agents|protective agents|mesh-ancestor
110989484|NCT03680573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110989485|NCT03680573|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110989486|NCT03680573|Vasodilator Agents|vasodilator agents|mesh-ancestor
110989487|NCT03680573|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
110989488|NCT03689075|Tacrolimus|tacrolimus|mesh-list
110989489|NCT03689075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110989490|NCT03689075|Immunologic Factors|immunologic factors|mesh-ancestor
110989491|NCT03689075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110989492|NCT03689075|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110989493|NCT03689075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110989494|NCT03689075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110989495|NCT03680495|Methylprednisolone|methylprednisolone|mesh-list
110989496|NCT03680495|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110989497|NCT03680495|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110989498|NCT03680495|Prednisolone|prednisolone|mesh-list
110989499|NCT03680495|Prednisolone acetate|prednisolone acetate|mesh-list
110989500|NCT03680495|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110989501|NCT03680495|Prednisolone phosphate|prednisolone phosphate|mesh-list
110989502|NCT03680495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110989503|NCT03680495|Antiemetics|antiemetics|mesh-ancestor
110989504|NCT03680495|Autonomic Agents|autonomic agents|mesh-ancestor
110989505|NCT03680495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110989506|NCT03680495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110989507|NCT03680495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110989508|NCT03680495|Glucocorticoids|glucocorticoids|mesh-ancestor
110989509|NCT03680495|Hormones|hormones|mesh-ancestor
110989510|NCT03680495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110989511|NCT03680495|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110989512|NCT03680495|Protective Agents|protective agents|mesh-ancestor
110989513|NCT03680495|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110989514|NCT03680495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110989515|NCT03492255|Mycophenolic Acid|mycophenolic acid|mesh-list
110989516|NCT03492255|Prednisone|prednisone|mesh-list
110989517|NCT03492255|Methylprednisolone|methylprednisolone|mesh-list
110989518|NCT03492255|Cyclophosphamide|cyclophosphamide|mesh-list
110989519|NCT03492255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110989520|NCT03492255|Immunologic Factors|immunologic factors|mesh-ancestor
110989521|NCT03492255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110989522|NCT03492255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110989523|NCT03492255|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110989524|NCT03492255|Alkylating Agents|alkylating agents|mesh-ancestor
110989525|NCT03492255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110989526|NCT03492255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110989527|NCT03492255|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110989528|NCT03492255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110989529|NCT03492255|Glucocorticoids|glucocorticoids|mesh-ancestor
110989530|NCT03492255|Hormones|hormones|mesh-ancestor
110989531|NCT03492255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110989532|NCT03492255|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110989533|NCT03492255|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110989534|NCT03492255|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110989535|NCT03492255|Antitubercular Agents|antitubercular agents|mesh-ancestor
110989536|NCT03492255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110989537|NCT03492255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110989538|NCT03492255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110989539|NCT03492255|Antiemetics|antiemetics|mesh-ancestor
110989540|NCT03492255|Autonomic Agents|autonomic agents|mesh-ancestor
110989541|NCT03492255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110989542|NCT03492255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110989543|NCT03492255|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110989544|NCT03492255|Protective Agents|protective agents|mesh-ancestor
110989545|NCT03684863|Capecitabine|capecitabine|mesh-list
110989546|NCT03684863|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110989547|NCT03684863|Antimetabolites|antimetabolites|mesh-ancestor
110989548|NCT03684863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110989549|NCT03684863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110989550|NCT03680339|Misoprostol|misoprostol|mesh-list
110989551|NCT03680339|Oxytocin|oxytocin|mesh-list
110989552|NCT03680339|Oxytocics|oxytocics|mesh-ancestor
110989553|NCT03680339|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110989554|NCT03680339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110989555|NCT03680339|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110989556|NCT03680339|Abortifacient Agents|abortifacient agents|mesh-ancestor
110989557|NCT03680339|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110989558|NCT03680339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110989559|NCT03680183|Entecavir|entecavir|mesh-list
110989560|NCT03680183|Antiviral Agents|antiviral agents|mesh-ancestor
110989561|NCT03680183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110989562|NCT02136069|Infliximab|infliximab|mesh-list
110989563|NCT02136069|Etrolizumab|etrolizumab|mesh-list
110989564|NCT02136069|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110989565|NCT02136069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110989566|NCT02136069|Dermatologic Agents|dermatologic agents|mesh-ancestor
110989567|NCT02136069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110989568|NCT02136069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110989569|NCT02136069|Immunologic Factors|immunologic factors|mesh-ancestor
110989570|NCT02136069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110989571|NCT02917031|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110989572|NCT02917031|Saxagliptin|saxagliptin|mesh-list
110989573|NCT02917031|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110989574|NCT02917031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110989575|NCT02917031|Incretins|incretins|mesh-ancestor
110989576|NCT02917031|Hormones|hormones|mesh-ancestor
110989577|NCT02917031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110989578|NCT02917031|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110989579|NCT02917031|Protease Inhibitors|protease inhibitors|mesh-ancestor
110989580|NCT02917031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110989581|NCT02917031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110989582|NCT04460547|Interferons|interferons|mesh-list
110989583|NCT04460547|Interferon-beta|interferon-beta|mesh-list
110989584|NCT04460547|Interferon beta-1a|interferon beta-1a|mesh-list
110989585|NCT04460547|Hydroxychloroquine|hydroxychloroquine|mesh-list
110989586|NCT04460547|Ivermectin|ivermectin|mesh-list
110989587|NCT04460547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110989588|NCT04460547|Antiviral Agents|antiviral agents|mesh-ancestor
110989589|NCT04460547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110989590|NCT04460547|Antimalarials|antimalarials|mesh-ancestor
110989591|NCT04460547|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110989592|NCT04460547|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110989593|NCT04460547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110989594|NCT04460547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110989595|NCT04460547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110989596|NCT04460547|Immunologic Factors|immunologic factors|mesh-ancestor
110989597|NCT04460547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110989598|NCT04460547|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110989599|NCT03132051|Triamcinolone|triamcinolone|mesh-list
110989600|NCT03132051|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110989601|NCT03132051|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110989602|NCT03132051|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110989603|NCT03132051|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110989604|NCT03132051|Glucocorticoids|glucocorticoids|mesh-ancestor
110989605|NCT03132051|Hormones|hormones|mesh-ancestor
110989606|NCT03132051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110989607|NCT03132051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110989608|NCT03132051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110989609|NCT03132051|Immunologic Factors|immunologic factors|mesh-ancestor
110989610|NCT03132051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110989611|NCT03132051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110989612|NCT03684707|Metformin|metformin|mesh-list
110989613|NCT03684707|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110989614|NCT03684707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110989615|NCT01018563|Farletuzumab|farletuzumab|mesh-list
110989616|NCT01018563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110989617|NCT02528188|Tanezumab|tanezumab|mesh-list
110989618|NCT02528188|Analgesics|analgesics|mesh-ancestor
110989619|NCT02528188|Sensory System Agents|sensory system agents|mesh-ancestor
110989620|NCT02528188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110989621|NCT02528188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110989622|NCT03684395|Warfarin|warfarin|mesh-list
110989623|NCT03684395|Rivaroxaban|rivaroxaban|mesh-list
110989624|NCT03684395|Dabigatran|dabigatran|mesh-list
110989625|NCT03684395|Apixaban|apixaban|mesh-list
110989626|NCT03684395|Anticoagulants|anticoagulants|mesh-ancestor
110989627|NCT03684395|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110989628|NCT03684395|Antithrombins|antithrombins|mesh-ancestor
110989629|NCT03684395|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110989630|NCT03684395|Protease Inhibitors|protease inhibitors|mesh-ancestor
110989631|NCT03684395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110989632|NCT03684395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110989634|NCT04460001|Ranibizumab|ranibizumab|mesh-list
110989635|NCT04460001|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110989636|NCT04460001|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110989637|NCT04460001|Growth Substances|growth substances|mesh-ancestor
110989638|NCT04460001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110989639|NCT04460001|Growth Inhibitors|growth inhibitors|mesh-ancestor
110989640|NCT04460001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110989641|NCT04460001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110989642|NCT04460001|Glucocorticoids|glucocorticoids|mesh-ancestor
110989643|NCT04460001|Hormones|hormones|mesh-ancestor
110989644|NCT04460001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110989645|NCT03484845|Ferrous fumarate|ferrous fumarate|mesh-list
110989646|NCT03484845|Lactoferrin|lactoferrin|mesh-list
110989647|NCT03484845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110989648|NCT03484845|Trace Elements|trace elements|mesh-ancestor
110989649|NCT03484845|Micronutrients|micronutrients|mesh-ancestor
110989650|NCT03484845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110989651|NCT03679481|Tranexamic Acid|tranexamic acid|mesh-list
110989652|NCT03679481|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110989653|NCT03679481|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110989654|NCT03679481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110989655|NCT03679481|Hemostatics|hemostatics|mesh-ancestor
110989656|NCT03679481|Coagulants|coagulants|mesh-ancestor
110989657|NCT04461249|Travoprost|travoprost|mesh-list
110989658|NCT04461249|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110989659|NCT04461249|Latanoprost|latanoprost|mesh-list
110989660|NCT04461249|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110989661|NCT04461249|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110989662|NCT05151549|Carboplatin|carboplatin|mesh-list
110989663|NCT05151549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110989664|NCT05151393|Vitamin D|vitamin d|mesh-list
110989665|NCT05151393|Cholecalciferol|cholecalciferol|mesh-list
110989666|NCT05151393|Vitamins|vitamins|mesh-ancestor
110989667|NCT05151393|Micronutrients|micronutrients|mesh-ancestor
110989668|NCT05151393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110989669|NCT05151393|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110989670|NCT05151393|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110989671|NCT03484611|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
110989672|NCT03484611|Cetrorelix|cetrorelix|mesh-list
110989673|NCT03484611|Menotropins|menotropins|mesh-list
110989674|NCT03484611|Progesterone|progesterone|mesh-list
110989675|NCT03484611|Progestins|progestins|mesh-ancestor
110706736|NCT01059110|Analgesics|analgesics|mesh-ancestor
110989676|NCT03484611|Hormones|hormones|mesh-ancestor
110989677|NCT03484611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110989678|NCT03484611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110989680|NCT03484611|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110989681|NCT03484611|Fertility Agents|fertility agents|mesh-ancestor
110989682|NCT03484611|Hormone Antagonists|hormone antagonists|mesh-ancestor
110989683|NCT03679325|Vitamin D|vitamin d|mesh-list
110989684|NCT03679325|Vitamins|vitamins|mesh-ancestor
110989685|NCT03679325|Micronutrients|micronutrients|mesh-ancestor
110989686|NCT03679325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110989687|NCT03679325|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110989688|NCT03878927|Gemtuzumab|gemtuzumab|mesh-list
110989689|NCT03878927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110989690|NCT03878927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110989691|NCT03878927|Immunotoxins|immunotoxins|mesh-ancestor
110989692|NCT03878927|Immunoconjugates|immunoconjugates|mesh-ancestor
110989693|NCT03878927|Immunologic Factors|immunologic factors|mesh-ancestor
110989694|NCT03878927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110989695|NCT03623555|Hydrocortisone|hydrocortisone|mesh-list
110989696|NCT03623555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110989697|NCT03623711|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110989698|NCT03623711|Bupropion|bupropion|mesh-list
110989699|NCT03623711|Escitalopram|escitalopram|mesh-list
110989700|NCT03623711|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110989701|NCT03623711|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110989702|NCT03623711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110989703|NCT03623711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110989704|NCT03623711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110989705|NCT03623711|Serotonin Agents|serotonin agents|mesh-ancestor
110989706|NCT03623711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110454883|NCT02670616|Doxorubicin|doxorubicin|mesh-list
110989707|NCT03623711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110989708|NCT03623711|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110989709|NCT03623711|Antidepressive Agents|antidepressive agents|mesh-ancestor
110989710|NCT03623711|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110989711|NCT03623711|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110989712|NCT03623711|Dopamine Agents|dopamine agents|mesh-ancestor
110989713|NCT03623711|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110989714|NCT03623711|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110989715|NCT03623711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110989716|NCT03623711|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110989717|NCT03623711|Analgesics|analgesics|mesh-ancestor
110989718|NCT03623711|Sensory System Agents|sensory system agents|mesh-ancestor
110989719|NCT05382442|Leucovorin|leucovorin|mesh-list
110989720|NCT05382442|Bevacizumab|bevacizumab|mesh-list
110989721|NCT05382442|Fluorouracil|fluorouracil|mesh-list
110989722|NCT05382442|Capecitabine|capecitabine|mesh-list
110989723|NCT05382442|Oxaliplatin|oxaliplatin|mesh-list
110989724|NCT05382442|Irinotecan|irinotecan|mesh-list
110989725|NCT05382442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110989726|NCT05382442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110989727|NCT05382442|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110989728|NCT05382442|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110989729|NCT05382442|Growth Substances|growth substances|mesh-ancestor
110989730|NCT05382442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110989731|NCT05382442|Growth Inhibitors|growth inhibitors|mesh-ancestor
110989732|NCT05382442|Antimetabolites|antimetabolites|mesh-ancestor
110989733|NCT05382442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110989734|NCT05382442|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110989735|NCT05382442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110989736|NCT05382442|Immunologic Factors|immunologic factors|mesh-ancestor
110989737|NCT05382442|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110989738|NCT05382442|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110989739|NCT05382442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110989740|NCT05382442|Antidotes|antidotes|mesh-ancestor
110989741|NCT05382442|Protective Agents|protective agents|mesh-ancestor
110989742|NCT05382442|Vitamin B Complex|vitamin b complex|mesh-ancestor
110989743|NCT05382442|Vitamins|vitamins|mesh-ancestor
110989744|NCT05382442|Micronutrients|micronutrients|mesh-ancestor
110989745|NCT05362474|Montelukast|montelukast|mesh-list
110989746|NCT05362474|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110989747|NCT05362474|Respiratory System Agents|respiratory system agents|mesh-ancestor
110989748|NCT05362474|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110989749|NCT05362474|Hormone Antagonists|hormone antagonists|mesh-ancestor
110989750|NCT05362474|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110989751|NCT05362474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110989752|NCT05362474|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110989753|NCT05362474|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110989754|NCT05362474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110989755|NCT05542342|Tislelizumab|tislelizumab|mesh-list
110989756|NCT05542342|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110989757|NCT05542342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110989758|NCT05599516|Vaccines|vaccines|mesh-list
110989759|NCT05599516|Immunologic Factors|immunologic factors|mesh-ancestor
110989760|NCT05599516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110989761|NCT05380024|Ensartinib|ensartinib|mesh-list
110989762|NCT05380024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110989763|NCT05380024|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110989764|NCT05380024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110989765|NCT05380024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110989766|NCT05342194|Gemcitabine|gemcitabine|mesh-list
110989767|NCT05342194|Oxaliplatin|oxaliplatin|mesh-list
110989768|NCT05342194|Lenvatinib|lenvatinib|mesh-list
110989769|NCT05342194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110989770|NCT05342194|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110989771|NCT05342194|Antimetabolites|antimetabolites|mesh-ancestor
110989772|NCT05342194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110989773|NCT05342194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110989774|NCT05342194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110989775|NCT03623789|Tranylcypromine|tranylcypromine|mesh-list
110989776|NCT03623789|Tranexamic Acid|tranexamic acid|mesh-list
110989777|NCT03623789|Hemostatics|hemostatics|mesh-list
110989778|NCT03623789|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110989779|NCT03623789|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110989780|NCT03623789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110989781|NCT03623789|Coagulants|coagulants|mesh-ancestor
110989782|NCT03623789|Antidepressive Agents|antidepressive agents|mesh-ancestor
110989783|NCT03623789|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110989784|NCT03623789|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
110989785|NCT03623789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110989786|NCT03623789|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110989787|NCT03623789|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110989788|NCT03623789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110989789|NCT03623789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110989790|NCT05306470|Lidocaine|lidocaine|mesh-list
110989791|NCT05306470|Ethyl Chloride|ethyl chloride|mesh-list
110989792|NCT05306470|Anesthetics, Local|anesthetics, local|mesh-ancestor
110989793|NCT05306470|Anesthetics|anesthetics|mesh-ancestor
110989794|NCT05306470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110989795|NCT05306470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110989796|NCT05306470|Sensory System Agents|sensory system agents|mesh-ancestor
110989797|NCT05306470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110989798|NCT05306470|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110989799|NCT05306470|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110989800|NCT05306470|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110989801|NCT05306470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110989802|NCT05306470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110989803|NCT05340010|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
110989804|NCT05340010|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110989805|NCT05340010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110989807|NCT05339386|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110989808|NCT05339386|Anesthetics, General|anesthetics, general|mesh-ancestor
110989809|NCT05339386|Anesthetics|anesthetics|mesh-ancestor
110989810|NCT05339386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110989811|NCT05339386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110989812|NCT05339074|Ketamine|ketamine|mesh-list
110989813|NCT05339074|Analgesics|analgesics|mesh-ancestor
110989814|NCT05339074|Sensory System Agents|sensory system agents|mesh-ancestor
110989815|NCT05339074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110989816|NCT05339074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110989817|NCT05339074|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110989818|NCT05339074|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110989819|NCT05339074|Anesthetics, General|anesthetics, general|mesh-ancestor
110989820|NCT05339074|Anesthetics|anesthetics|mesh-ancestor
110989821|NCT05339074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110989822|NCT05339074|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110989823|NCT05339074|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110989824|NCT05339074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110989825|NCT05339074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110989826|NCT05560282|Fenfluramine|fenfluramine|mesh-list
110989827|NCT05560282|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110989828|NCT05560282|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110989829|NCT05560282|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110989830|NCT05560282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110989831|NCT05560282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110989832|NCT05560282|Serotonin Agents|serotonin agents|mesh-ancestor
110989833|NCT05560282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110989834|NCT05338450|Clemastine|clemastine|mesh-list
110989835|NCT05338450|Antipruritics|antipruritics|mesh-ancestor
110989836|NCT05338450|Dermatologic Agents|dermatologic agents|mesh-ancestor
110989837|NCT05338450|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110989838|NCT05338450|Histamine Antagonists|histamine antagonists|mesh-ancestor
110989839|NCT05338450|Histamine Agents|histamine agents|mesh-ancestor
110989840|NCT05338450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110989841|NCT05338450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110989842|NCT05338450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110989843|NCT05338450|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110989844|NCT03677297|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110989845|NCT03677297|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110989846|NCT03677297|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110989847|NCT03677297|Antimetabolites|antimetabolites|mesh-ancestor
110451834|NCT00628290|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110989848|NCT03677297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110989849|NCT03677297|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110989850|NCT03677297|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110989851|NCT03677297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110989852|NCT03676985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110989853|NCT03676985|Antibodies|antibodies|mesh-list
110989854|NCT03676985|Immunoglobulins|immunoglobulins|mesh-list
110989855|NCT03676985|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110989856|NCT03676985|Immunologic Factors|immunologic factors|mesh-ancestor
110989857|NCT03676985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110989858|NCT03676985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110989859|NCT05348824|Sodium Hypochlorite|sodium hypochlorite|mesh-list
110989860|NCT05348824|Eusol|eusol|mesh-list
110989861|NCT05348824|Disinfectants|disinfectants|mesh-ancestor
110989862|NCT05348824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110989863|NCT02988401|Insulin|insulin|mesh-list
110989864|NCT02988401|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110989865|NCT02988401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110989866|NCT05266456|Vaccines|vaccines|mesh-list
110989867|NCT05266456|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110989868|NCT05266456|Immunologic Factors|immunologic factors|mesh-ancestor
110989869|NCT05266456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110989870|NCT02269917|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
110989871|NCT02269917|Protease Inhibitors|protease inhibitors|mesh-list
110989872|NCT02269917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110989873|NCT02269917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110989874|NCT02269917|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110989875|NCT02269917|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110989876|NCT02269917|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110989877|NCT02269917|Antiviral Agents|antiviral agents|mesh-ancestor
110989878|NCT02269917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110989879|NCT05293288|Anesthetics|anesthetics|mesh-list
110989880|NCT05293288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110989881|NCT05293288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110989882|NCT03484221|Fluorouracil|fluorouracil|mesh-list
110989883|NCT03484221|Capecitabine|capecitabine|mesh-list
110989884|NCT03484221|Oxaliplatin|oxaliplatin|mesh-list
110989885|NCT03484221|Irinotecan|irinotecan|mesh-list
110989886|NCT03484221|Antimetabolites|antimetabolites|mesh-ancestor
110989887|NCT03484221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110989888|NCT03484221|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110989889|NCT03484221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110989890|NCT03484221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110989891|NCT03484221|Immunologic Factors|immunologic factors|mesh-ancestor
110989892|NCT03484221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110989893|NCT03484221|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110989894|NCT03484221|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110989895|NCT03484221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110989896|NCT03857139|Nicotine|nicotine|mesh-list
110989897|NCT03857139|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110989898|NCT03857139|Autonomic Agents|autonomic agents|mesh-ancestor
110989899|NCT03857139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110989900|NCT03857139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110989901|NCT03857139|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110989902|NCT03857139|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110706960|NCT03991208|Antimalarials|antimalarials|mesh-ancestor
110989903|NCT03857139|Cholinergic Agents|cholinergic agents|mesh-ancestor
110989904|NCT03857139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110989905|NCT03857139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110989906|NCT01658020|Moxifloxacin|moxifloxacin|mesh-list
110989907|NCT01658020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110989908|NCT01658020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110451839|NCT00628290|Antidepressive Agents|antidepressive agents|mesh-ancestor
110989909|NCT01658020|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110989910|NCT01658020|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110989911|NCT01658020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110989912|NCT01658020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110989913|NCT01658020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110989914|NCT05255770|Benzocaine|benzocaine|mesh-list
110989915|NCT05255770|Anesthetics, Local|anesthetics, local|mesh-ancestor
110989916|NCT05255770|Anesthetics|anesthetics|mesh-ancestor
110989917|NCT05255770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110989918|NCT05255770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110989919|NCT05255770|Sensory System Agents|sensory system agents|mesh-ancestor
110989920|NCT05255770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110989921|NCT05322538|Vitamin D|vitamin d|mesh-list
110989922|NCT05322538|Ergocalciferols|ergocalciferols|mesh-list
110989923|NCT05322538|Cholecalciferol|cholecalciferol|mesh-list
110989924|NCT05322538|Vitamins|vitamins|mesh-list
110989925|NCT05322538|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
110989926|NCT05322538|Micronutrients|micronutrients|mesh-ancestor
110989927|NCT05322538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110989928|NCT05322538|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110989929|NCT05322538|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110989930|NCT04965220|Trametinib|trametinib|mesh-list
110989931|NCT04965220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110989932|NCT04965220|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110989934|NCT04965220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110989935|NCT05322070|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
110989936|NCT05322070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110989937|NCT05322070|Glucocorticoids|glucocorticoids|mesh-ancestor
110989938|NCT05322070|Hormones|hormones|mesh-ancestor
110989939|NCT05322070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110989940|NCT05322070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110989941|NCT03483753|Vasopressins|vasopressins|mesh-list
110989942|NCT03483753|Arginine Vasopressin|arginine vasopressin|mesh-list
110989943|NCT03483753|Norepinephrine|norepinephrine|mesh-list
110989944|NCT03483753|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110989945|NCT03483753|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110989946|NCT03483753|Adrenergic Agents|adrenergic agents|mesh-ancestor
110989947|NCT03483753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110989948|NCT03483753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110989949|NCT03483753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110989950|NCT03483753|Sympathomimetics|sympathomimetics|mesh-ancestor
110989951|NCT03483753|Autonomic Agents|autonomic agents|mesh-ancestor
110989952|NCT03483753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110989953|NCT03483753|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110989954|NCT03483753|Hemostatics|hemostatics|mesh-ancestor
110989955|NCT03483753|Coagulants|coagulants|mesh-ancestor
110989956|NCT03483753|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
110989957|NCT03483753|Natriuretic Agents|natriuretic agents|mesh-ancestor
110989958|NCT03389477|Cisplatin|cisplatin|mesh-list
110989959|NCT03389477|Cetuximab|cetuximab|mesh-list
110989960|NCT03389477|Palbociclib|palbociclib|mesh-list
110989961|NCT03389477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110989962|NCT03389477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110989963|NCT03389477|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110989964|NCT03389477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110989965|NCT03389477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110989966|NCT02680574|Darbepoetin alfa|darbepoetin alfa|mesh-list
110989967|NCT02680574|Hematinics|hematinics|mesh-ancestor
110989968|NCT03672149|Cefazolin|cefazolin|mesh-list
110989969|NCT03672149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110989970|NCT03672149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110989971|NCT03672071|Ephedrine|ephedrine|mesh-list
110989972|NCT03672071|Pseudoephedrine|pseudoephedrine|mesh-list
110989973|NCT03672071|Norepinephrine|norepinephrine|mesh-list
110989974|NCT03672071|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110989975|NCT03672071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110989976|NCT03672071|Sympathomimetics|sympathomimetics|mesh-ancestor
110989977|NCT03672071|Autonomic Agents|autonomic agents|mesh-ancestor
110989978|NCT03672071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110989979|NCT03672071|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110989980|NCT03672071|Adrenergic Agents|adrenergic agents|mesh-ancestor
110989981|NCT03672071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110989982|NCT03672071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110989983|NCT03672071|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110989984|NCT03672071|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110989985|NCT03672071|Respiratory System Agents|respiratory system agents|mesh-ancestor
110989986|NCT03672071|Nasal Decongestants|nasal decongestants|mesh-ancestor
110989987|NCT03672071|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110989988|NCT03672071|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110989989|NCT03480945|Nitroprusside|nitroprusside|mesh-list
110989990|NCT03480945|Serotonin|serotonin|mesh-list
110989991|NCT03480945|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110989992|NCT03480945|Serotonin Agents|serotonin agents|mesh-ancestor
110989993|NCT03480945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110989994|NCT03480945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110989995|NCT03480945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110989996|NCT03480945|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110989997|NCT03480945|Vasodilator Agents|vasodilator agents|mesh-ancestor
110989998|NCT03480945|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
110989999|NCT03483207|Heparin|heparin|mesh-list
110990000|NCT03483207|Warfarin|warfarin|mesh-list
110990001|NCT03483207|Anticoagulants|anticoagulants|mesh-ancestor
110990002|NCT03483207|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110990003|NCT03483207|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110990004|NCT03483207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110990005|NCT05132985|Carboplatin|carboplatin|mesh-list
110990006|NCT05132985|Pemetrexed|pemetrexed|mesh-list
110990008|NCT05132985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110990009|NCT05132985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110990010|NCT05132985|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110990011|NCT05132985|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110990012|NCT03739593|Dexamethasone|dexamethasone|mesh-list
110990013|NCT03739593|Dexamethasone acetate|dexamethasone acetate|mesh-list
110990014|NCT03739593|BB 1101|bb 1101|mesh-list
110990015|NCT03739593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110990016|NCT03739593|Antiemetics|antiemetics|mesh-ancestor
110990017|NCT03739593|Autonomic Agents|autonomic agents|mesh-ancestor
110990018|NCT03739593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110990019|NCT03739593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110990020|NCT03739593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110990021|NCT03739593|Glucocorticoids|glucocorticoids|mesh-ancestor
110990022|NCT03739593|Hormones|hormones|mesh-ancestor
110990023|NCT03739593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110990024|NCT03739593|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110990025|NCT03739593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110990026|NCT03739593|Protease Inhibitors|protease inhibitors|mesh-ancestor
110990027|NCT03739593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110990028|NCT03739593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110990029|NCT03480867|Temozolomide|temozolomide|mesh-list
110990030|NCT03480867|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110990031|NCT03480867|Alkylating Agents|alkylating agents|mesh-ancestor
110990032|NCT03480867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110990033|NCT03480867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110990034|NCT05254912|Sunscreening Agents|sunscreening agents|mesh-list
110990035|NCT05254912|Petrolatum|petrolatum|mesh-list
110990036|NCT05254912|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110990037|NCT05254912|Protective Agents|protective agents|mesh-ancestor
110990038|NCT05254912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110990039|NCT05254912|Dermatologic Agents|dermatologic agents|mesh-ancestor
110990040|NCT05254912|Emollients|emollients|mesh-ancestor
110990041|NCT03480789|Dexmedetomidine|dexmedetomidine|mesh-list
110990042|NCT03480789|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110990043|NCT03480789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110990044|NCT03480789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110990045|NCT03480789|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110990046|NCT03480789|Analgesics|analgesics|mesh-ancestor
110990047|NCT03480789|Sensory System Agents|sensory system agents|mesh-ancestor
110990048|NCT03480789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110990049|NCT03480789|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110990050|NCT03480789|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110990051|NCT03480789|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110990052|NCT03480789|Adrenergic Agents|adrenergic agents|mesh-ancestor
110990053|NCT03480789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110990054|NCT03480789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110990055|NCT03475407|Dexamethasone|dexamethasone|mesh-list
110990056|NCT03475407|Dexamethasone acetate|dexamethasone acetate|mesh-list
110990057|NCT03475407|BB 1101|bb 1101|mesh-list
110990058|NCT03475407|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110990059|NCT03475407|Antiemetics|antiemetics|mesh-ancestor
110990060|NCT03475407|Autonomic Agents|autonomic agents|mesh-ancestor
110990061|NCT03475407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110990062|NCT03475407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110990063|NCT03475407|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110990064|NCT03475407|Glucocorticoids|glucocorticoids|mesh-ancestor
110990065|NCT03475407|Hormones|hormones|mesh-ancestor
110990066|NCT03475407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110990067|NCT03475407|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110990068|NCT03475407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110990069|NCT03475407|Protease Inhibitors|protease inhibitors|mesh-ancestor
110990070|NCT03475407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110990071|NCT03475407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110990072|NCT03655197|Doxycycline|doxycycline|mesh-list
110990073|NCT03655197|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110990074|NCT03655197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110990075|NCT03655197|Antimalarials|antimalarials|mesh-ancestor
110990076|NCT03655197|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110990077|NCT03655197|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110990078|NCT05317624|Methylprednisolone|methylprednisolone|mesh-list
110990079|NCT05317624|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110990080|NCT05317624|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110990081|NCT05317624|Prednisolone|prednisolone|mesh-list
110990082|NCT05317624|Prednisolone acetate|prednisolone acetate|mesh-list
110990083|NCT05317624|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110990084|NCT05317624|Prednisolone phosphate|prednisolone phosphate|mesh-list
110990085|NCT05317624|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110990086|NCT05317624|Antiemetics|antiemetics|mesh-ancestor
110990087|NCT05317624|Autonomic Agents|autonomic agents|mesh-ancestor
110990088|NCT05317624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110990089|NCT05317624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110990090|NCT05317624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110990091|NCT05317624|Glucocorticoids|glucocorticoids|mesh-ancestor
110990092|NCT05317624|Hormones|hormones|mesh-ancestor
110990093|NCT05317624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110990094|NCT05317624|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110990095|NCT05317624|Protective Agents|protective agents|mesh-ancestor
110990096|NCT05317624|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110990097|NCT05317624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110990098|NCT03475017|Curcumin|curcumin|mesh-list
110990099|NCT03475017|Piperine|piperine|mesh-list
110990100|NCT03475017|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110990101|NCT03475017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110990102|NCT03475017|Analgesics|analgesics|mesh-ancestor
110990103|NCT03475017|Sensory System Agents|sensory system agents|mesh-ancestor
110990104|NCT03475017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110990105|NCT03475017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110990106|NCT03475017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110990107|NCT03475017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110990108|NCT03475017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110990109|NCT03475017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110990110|NCT03475017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110990111|NCT03475017|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110990112|NCT02674568|Rovalpituzumab tesirine|rovalpituzumab tesirine|mesh-list
110990113|NCT02674568|Immunoconjugates|immunoconjugates|mesh-ancestor
110990114|NCT02674568|Immunologic Factors|immunologic factors|mesh-ancestor
110990115|NCT02674568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110990116|NCT03474939|Midazolam|midazolam|mesh-list
110990117|NCT03474939|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110990118|NCT03474939|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110990119|NCT03474939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110990120|NCT03474939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110990121|NCT03474939|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110990122|NCT03474939|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110990123|NCT03474939|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110990124|NCT03474939|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110990125|NCT03474939|Anesthetics, General|anesthetics, general|mesh-ancestor
110990126|NCT03474939|Anesthetics|anesthetics|mesh-ancestor
110990127|NCT03474939|GABA Modulators|gaba modulators|mesh-ancestor
110990128|NCT03474939|GABA Agents|gaba agents|mesh-ancestor
110707192|NCT01057628|Ipragliflozin|ipragliflozin|mesh-list
110990129|NCT03474939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110990130|NCT03474939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110990131|NCT03131583|Colchicine|colchicine|mesh-list
110990132|NCT03131583|Febuxostat|febuxostat|mesh-list
110990133|NCT03131583|Gout Suppressants|gout suppressants|mesh-ancestor
110990134|NCT03131583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110990135|NCT03131583|Tubulin Modulators|tubulin modulators|mesh-ancestor
110990136|NCT03131583|Antimitotic Agents|antimitotic agents|mesh-ancestor
110990137|NCT03131583|Mitosis Modulators|mitosis modulators|mesh-ancestor
110990138|NCT03131583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110990139|NCT03131583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110990140|NCT04672928|Paclitaxel|paclitaxel|mesh-list
110990141|NCT04672928|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110990142|NCT04672928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110990143|NCT04672928|Tubulin Modulators|tubulin modulators|mesh-ancestor
110990144|NCT04672928|Antimitotic Agents|antimitotic agents|mesh-ancestor
110990145|NCT04672928|Mitosis Modulators|mitosis modulators|mesh-ancestor
110990146|NCT04672928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110990147|NCT03480321|Cilostazol|cilostazol|mesh-list
110990148|NCT03480321|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110990149|NCT03480321|Autonomic Agents|autonomic agents|mesh-ancestor
110990150|NCT03480321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110990151|NCT03480321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110990152|NCT03480321|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110990153|NCT03480321|Respiratory System Agents|respiratory system agents|mesh-ancestor
110990154|NCT03480321|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110990155|NCT03480321|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110990156|NCT03480321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110990157|NCT03480321|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110990159|NCT03480321|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110990160|NCT03480321|Protective Agents|protective agents|mesh-ancestor
110990161|NCT03480321|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110990162|NCT03480321|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110990163|NCT03480321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110990164|NCT04928950|Charcoal|charcoal|mesh-list
110990165|NCT04928950|Antidotes|antidotes|mesh-ancestor
110990166|NCT04928950|Protective Agents|protective agents|mesh-ancestor
110990167|NCT04928950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110990168|NCT02986269|Anesthetics|anesthetics|mesh-list
110990169|NCT02986269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110990170|NCT02986269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110990171|NCT05313256|Lidocaine|lidocaine|mesh-list
110990172|NCT05313256|Epinephrine|epinephrine|mesh-list
110990173|NCT05313256|Racepinephrine|racepinephrine|mesh-list
110990174|NCT05313256|Epinephryl borate|epinephryl borate|mesh-list
110990175|NCT05313256|Anesthetics, Local|anesthetics, local|mesh-ancestor
110990176|NCT05313256|Anesthetics|anesthetics|mesh-ancestor
110990177|NCT05313256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110990178|NCT05313256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110990179|NCT05313256|Sensory System Agents|sensory system agents|mesh-ancestor
110990180|NCT05313256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110990181|NCT05313256|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110990182|NCT05313256|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110990183|NCT05313256|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110990184|NCT05313256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110990185|NCT05313256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110990186|NCT05313256|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110990187|NCT05313256|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110990188|NCT05313256|Adrenergic Agents|adrenergic agents|mesh-ancestor
110990189|NCT05313256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110990190|NCT05313256|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110990191|NCT05313256|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110990192|NCT05313256|Autonomic Agents|autonomic agents|mesh-ancestor
110990193|NCT05313256|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110990194|NCT05313256|Respiratory System Agents|respiratory system agents|mesh-ancestor
110990195|NCT05313256|Mydriatics|mydriatics|mesh-ancestor
110990196|NCT05313256|Sympathomimetics|sympathomimetics|mesh-ancestor
110990197|NCT05313256|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110990198|NCT03474237|Hormones|hormones|mesh-list
110990199|NCT03474237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110990200|NCT03474237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110990201|NCT03480165|Parecoxib|parecoxib|mesh-list
110990202|NCT03480165|Ropivacaine|ropivacaine|mesh-list
110990203|NCT03480165|Anesthetics, Local|anesthetics, local|mesh-ancestor
110990204|NCT03480165|Anesthetics|anesthetics|mesh-ancestor
110990205|NCT03480165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110990206|NCT03480165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110990207|NCT03480165|Sensory System Agents|sensory system agents|mesh-ancestor
110990208|NCT03480165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110990209|NCT03480165|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110990210|NCT03480165|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110990211|NCT03480165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110990212|NCT03480165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110990213|NCT03480165|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110990214|NCT03480165|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110990215|NCT03480165|Analgesics|analgesics|mesh-ancestor
110990216|NCT03480165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110990217|NCT03480165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110990218|NCT05311852|Palmidrol|palmidrol|mesh-list
110990219|NCT05311852|Antioxidants|antioxidants|mesh-list
110990220|NCT05311852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110990221|NCT05311852|Protective Agents|protective agents|mesh-ancestor
110990222|NCT05311852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110990223|NCT05311852|Analgesics|analgesics|mesh-ancestor
110990224|NCT05311852|Sensory System Agents|sensory system agents|mesh-ancestor
110990225|NCT05311852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110990226|NCT05311852|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110990227|NCT05311852|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110455421|NCT00648622|Carvedilol|carvedilol|mesh-list
110990228|NCT05311852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110990229|NCT05311852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110990230|NCT05311852|Antiviral Agents|antiviral agents|mesh-ancestor
110990231|NCT05311852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110990232|NCT05311852|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
110990233|NCT05311852|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110990234|NCT05311852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110990236|NCT05311852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110990237|NCT01373918|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
110990238|NCT01373918|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
110990239|NCT01373918|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
110990240|NCT01373918|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110990241|NCT03671915|Insulin|insulin|mesh-list
110990242|NCT03671915|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110990243|NCT03671915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110990244|NCT03302195|Heparin|heparin|mesh-list
110990245|NCT03302195|Anticoagulants|anticoagulants|mesh-ancestor
110990246|NCT03302195|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110990247|NCT03302195|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110990248|NCT03302195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110990249|NCT03114020|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110990250|NCT03114020|Hyaluronic Acid|hyaluronic acid|mesh-list
110990251|NCT03114020|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110990252|NCT03114020|Immunologic Factors|immunologic factors|mesh-ancestor
110990253|NCT03114020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110990254|NCT03114020|Viscosupplements|viscosupplements|mesh-ancestor
110990255|NCT03114020|Protective Agents|protective agents|mesh-ancestor
110990256|NCT04460079|Lenograstim|lenograstim|mesh-list
110990257|NCT04460079|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110990258|NCT04460079|Immunologic Factors|immunologic factors|mesh-ancestor
110990259|NCT04460079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110990260|NCT03473691|Glembatumumab vedotin|glembatumumab vedotin|mesh-list
110990261|NCT03473691|Immunoconjugates|immunoconjugates|mesh-ancestor
110297012|NCT00236249|Anesthetics|anesthetics|mesh-ancestor
110990262|NCT03473691|Immunologic Factors|immunologic factors|mesh-ancestor
110990263|NCT03473691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110990264|NCT03473691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110990265|NCT03473691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110990266|NCT03676361|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
110990267|NCT03676361|Hemostatics|hemostatics|mesh-ancestor
110990268|NCT03676361|Coagulants|coagulants|mesh-ancestor
110990269|NCT03676361|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
110990270|NCT03676361|Natriuretic Agents|natriuretic agents|mesh-ancestor
110990271|NCT03676361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110990272|NCT01712763|Goserelin|goserelin|mesh-list
110990273|NCT01712763|Triptorelin Pamoate|triptorelin pamoate|mesh-list
110990274|NCT01712763|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110990275|NCT01712763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110990276|NCT01712763|Luteolytic Agents|luteolytic agents|mesh-ancestor
110990277|NCT01712763|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110990278|NCT01712763|Contraceptive Agents|contraceptive agents|mesh-ancestor
110990279|NCT01712763|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110990280|NCT01712763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110990281|NCT01712763|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110990282|NCT05218486|Isotretinoin|isotretinoin|mesh-list
110990283|NCT05218486|Dermatologic Agents|dermatologic agents|mesh-ancestor
110990284|NCT05216770|Bupivacaine|bupivacaine|mesh-list
110990285|NCT05216770|Anesthetics, Local|anesthetics, local|mesh-ancestor
110990286|NCT05216770|Anesthetics|anesthetics|mesh-ancestor
110990287|NCT05216770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110990288|NCT05216770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110990289|NCT05216770|Sensory System Agents|sensory system agents|mesh-ancestor
110990290|NCT05216770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110990291|NCT05236036|Mycophenolic Acid|mycophenolic acid|mesh-list
110990292|NCT05236036|Temozolomide|temozolomide|mesh-list
110990293|NCT05236036|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110990294|NCT05236036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110990295|NCT05236036|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110990296|NCT05236036|Antitubercular Agents|antitubercular agents|mesh-ancestor
110990297|NCT05236036|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110990298|NCT05236036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110990299|NCT05236036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110990300|NCT05236036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110990301|NCT05236036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110990302|NCT05236036|Alkylating Agents|alkylating agents|mesh-ancestor
110990303|NCT02781779|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
110990304|NCT02781779|Laxatives|laxatives|mesh-ancestor
110990305|NCT02781779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110990306|NCT05270200|Azacitidine|azacitidine|mesh-list
110990307|NCT05270200|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110990308|NCT05270200|Antimetabolites|antimetabolites|mesh-ancestor
110990309|NCT05270200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110990310|NCT05270200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110990311|NCT05270200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110990312|NCT04953104|Nivolumab|nivolumab|mesh-list
110990313|NCT04953104|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110990314|NCT04953104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110990315|NCT04953104|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110990316|NCT04953104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110990317|NCT03671057|Midazolam|midazolam|mesh-list
110990318|NCT03671057|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110990319|NCT03671057|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110990320|NCT03671057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110990321|NCT03671057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110990322|NCT03671057|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110990323|NCT03671057|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110990324|NCT03671057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110990325|NCT03671057|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110990326|NCT03671057|Anesthetics, General|anesthetics, general|mesh-ancestor
110990327|NCT03671057|Anesthetics|anesthetics|mesh-ancestor
110990328|NCT03671057|GABA Modulators|gaba modulators|mesh-ancestor
110990329|NCT03671057|GABA Agents|gaba agents|mesh-ancestor
110451875|NCT00704899|Analgesics|analgesics|mesh-ancestor
110990330|NCT03671057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110990331|NCT03671057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110990332|NCT03670901|Rituximab|rituximab|mesh-list
110990333|NCT03670901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110990334|NCT03670901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110990335|NCT03670901|Immunologic Factors|immunologic factors|mesh-ancestor
110990336|NCT03670901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110990337|NCT03670901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110990338|NCT05166616|Osimertinib|osimertinib|mesh-list
110990339|NCT05166616|Triptolide|triptolide|mesh-list
110990340|NCT05166616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110990341|NCT05166616|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110990342|NCT05166616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110990343|NCT05166616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110990344|NCT05166616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110990345|NCT05166616|Alkylating Agents|alkylating agents|mesh-ancestor
110990346|NCT05166616|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
110990347|NCT05166616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110990348|NCT05166616|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110990349|NCT05166616|Contraceptive Agents|contraceptive agents|mesh-ancestor
110990350|NCT05166616|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110990351|NCT05166616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110990352|NCT05166616|Immunologic Factors|immunologic factors|mesh-ancestor
110990353|NCT05213728|Vaccines|vaccines|mesh-list
110990354|NCT05213728|Immunologic Factors|immunologic factors|mesh-ancestor
110990355|NCT05213728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110990356|NCT05165836|Dexmedetomidine|dexmedetomidine|mesh-list
110990357|NCT05165836|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110990358|NCT05165836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110990359|NCT05165836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110990360|NCT05165836|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110990361|NCT05165836|Analgesics|analgesics|mesh-ancestor
110990362|NCT05165836|Sensory System Agents|sensory system agents|mesh-ancestor
110990363|NCT05165836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110990364|NCT05165836|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110990365|NCT05165836|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110990366|NCT05165836|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110990367|NCT05165836|Adrenergic Agents|adrenergic agents|mesh-ancestor
110990368|NCT05165836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110990369|NCT05165836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110990370|NCT04238416|Lactulose|lactulose|mesh-list
110990371|NCT04238416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110990372|NCT05162014|Empagliflozin|empagliflozin|mesh-list
110990373|NCT05162014|Hypoglycemic Agents|hypoglycemic agents|mesh-list
110990374|NCT05162014|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110990375|NCT05162014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110990376|NCT05162014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110990378|NCT05226754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110990379|NCT01657162|Alendronate|alendronate|mesh-list
110990380|NCT01657162|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110990381|NCT01657162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110990382|NCT05209906|Fentanyl|fentanyl|mesh-list
110990383|NCT05209906|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110990384|NCT05209906|Narcotics|narcotics|mesh-ancestor
110990385|NCT05209906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110990386|NCT05209906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110990387|NCT05209906|Analgesics|analgesics|mesh-ancestor
110990388|NCT05209906|Sensory System Agents|sensory system agents|mesh-ancestor
110990389|NCT05209906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110990390|NCT05209906|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110990391|NCT05209906|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110990392|NCT05209906|Anesthetics, General|anesthetics, general|mesh-ancestor
110990393|NCT05209906|Anesthetics|anesthetics|mesh-ancestor
110990394|NCT04422184|Potassium Citrate|potassium citrate|mesh-list
110990395|NCT04422184|Diuretics|diuretics|mesh-ancestor
110990396|NCT04422184|Natriuretic Agents|natriuretic agents|mesh-ancestor
110990397|NCT04422184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110990398|NCT04422184|Expectorants|expectorants|mesh-ancestor
110990399|NCT04422184|Respiratory System Agents|respiratory system agents|mesh-ancestor
110990400|NCT05633810|Aspirin|aspirin|mesh-list
110990401|NCT05633810|Colchicine|colchicine|mesh-list
110451881|NCT00704899|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110990402|NCT05633810|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110990403|NCT05633810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110990404|NCT05633810|Analgesics|analgesics|mesh-ancestor
110990405|NCT05633810|Sensory System Agents|sensory system agents|mesh-ancestor
110990406|NCT05633810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110990407|NCT05633810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110990408|NCT05633810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110990409|NCT05633810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110990410|NCT05633810|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110990411|NCT05633810|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110990412|NCT05633810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110990413|NCT05633810|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110990414|NCT05633810|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110990415|NCT05633810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110990416|NCT05633810|Antipyretics|antipyretics|mesh-ancestor
110990417|NCT05633810|Gout Suppressants|gout suppressants|mesh-ancestor
110990418|NCT05633810|Tubulin Modulators|tubulin modulators|mesh-ancestor
110990419|NCT05633810|Antimitotic Agents|antimitotic agents|mesh-ancestor
110990420|NCT05633810|Mitosis Modulators|mitosis modulators|mesh-ancestor
110990421|NCT05633810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110990422|NCT05203822|Itraconazole|itraconazole|mesh-list
110990423|NCT05203822|Tepotinib|tepotinib|mesh-list
110990424|NCT05203822|Antifungal Agents|antifungal agents|mesh-ancestor
110990425|NCT05203822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110990426|NCT05203822|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110990427|NCT05203822|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110990428|NCT05203822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110990429|NCT05203822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110990430|NCT05203822|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110990431|NCT05203822|Hormone Antagonists|hormone antagonists|mesh-ancestor
110990432|NCT05203822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110990433|NCT05203822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110990434|NCT05203822|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110990435|NCT05203822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110990436|NCT01373294|Lenalidomide|lenalidomide|mesh-list
110990437|NCT01373294|BCG Vaccine|bcg vaccine|mesh-list
110990438|NCT01373294|Immunologic Factors|immunologic factors|mesh-ancestor
110990439|NCT01373294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110990440|NCT01373294|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110990441|NCT01373294|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110990442|NCT01373294|Growth Substances|growth substances|mesh-ancestor
110990443|NCT01373294|Growth Inhibitors|growth inhibitors|mesh-ancestor
110990444|NCT01373294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110990445|NCT01373294|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110990446|NCT05220358|Fostemsavir|fostemsavir|mesh-list
110990447|NCT05220358|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110990448|NCT05220358|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110990449|NCT05220358|Antiviral Agents|antiviral agents|mesh-ancestor
110990450|NCT05220358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110990451|NCT05220358|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110990452|NCT05220358|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110990453|NCT05220358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110990454|NCT04422028|Desogestrel|desogestrel|mesh-list
110990455|NCT04422028|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110990456|NCT04422028|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110990457|NCT04422028|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110990458|NCT04422028|Contraceptive Agents|contraceptive agents|mesh-ancestor
110990459|NCT04422028|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110990460|NCT04422028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110990461|NCT04422028|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110990462|NCT04422028|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110990463|NCT04422028|Progestins|progestins|mesh-ancestor
110990464|NCT04422028|Hormones|hormones|mesh-ancestor
110990465|NCT04422028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110990466|NCT01656304|Bevacizumab|bevacizumab|mesh-list
110451890|NCT01104701|Hormones|hormones|mesh-ancestor
110990467|NCT01656304|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110990468|NCT01656304|Antibodies|antibodies|mesh-list
110990469|NCT01656304|Immunoglobulins|immunoglobulins|mesh-list
110990470|NCT01656304|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110990471|NCT01656304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110990472|NCT01656304|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110990473|NCT01656304|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110990474|NCT01656304|Growth Substances|growth substances|mesh-ancestor
110990475|NCT01656304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110990476|NCT01656304|Growth Inhibitors|growth inhibitors|mesh-ancestor
110990477|NCT01656304|Immunologic Factors|immunologic factors|mesh-ancestor
110990478|NCT04421872|Anesthetics|anesthetics|mesh-list
110990479|NCT04421872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110990480|NCT04421872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110990481|NCT04227028|Bevacizumab|bevacizumab|mesh-list
110990482|NCT04227028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110990483|NCT04227028|Endothelial Growth Factors|endothelial growth factors|mesh-list
110990484|NCT04227028|Antibodies|antibodies|mesh-list
110990485|NCT04227028|Immunoglobulins|immunoglobulins|mesh-list
110990486|NCT04227028|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110990487|NCT04227028|Immunoglobulin G|immunoglobulin g|mesh-list
110990488|NCT04227028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110990489|NCT04227028|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110990490|NCT04227028|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110990491|NCT04227028|Growth Substances|growth substances|mesh-ancestor
110990492|NCT04227028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110990493|NCT04227028|Growth Inhibitors|growth inhibitors|mesh-ancestor
110990494|NCT04227028|Immunologic Factors|immunologic factors|mesh-ancestor
110990495|NCT03023423|Atezolizumab|atezolizumab|mesh-list
110990496|NCT03023423|Daratumumab|daratumumab|mesh-list
110990497|NCT03023423|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110990498|NCT03023423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110990499|NCT03023423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110990500|NCT03023423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110990501|NCT03675191|Orlistat|orlistat|mesh-list
110990502|NCT03675191|Phentermine|phentermine|mesh-list
110990503|NCT03675191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110990504|NCT03675191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110990505|NCT03675191|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110990506|NCT03675191|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110990507|NCT03675191|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110990508|NCT03675191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110990509|NCT03675191|Appetite Depressants|appetite depressants|mesh-ancestor
110990510|NCT03675191|Sympathomimetics|sympathomimetics|mesh-ancestor
110990511|NCT03675191|Autonomic Agents|autonomic agents|mesh-ancestor
110990512|NCT03675191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110990513|NCT03675191|Adrenergic Agents|adrenergic agents|mesh-ancestor
110990514|NCT03675191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110990515|NCT03198689|Brentuximab Vedotin|brentuximab vedotin|mesh-list
110990516|NCT03198689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110990517|NCT03198689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110990518|NCT03198689|Immunotoxins|immunotoxins|mesh-ancestor
110990519|NCT03198689|Immunoconjugates|immunoconjugates|mesh-ancestor
110990520|NCT03198689|Immunologic Factors|immunologic factors|mesh-ancestor
110990521|NCT03198689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110990522|NCT02635061|Nivolumab|nivolumab|mesh-list
110990523|NCT02635061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110990524|NCT02635061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110990525|NCT02635061|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110990526|NCT02635061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110990527|NCT05096728|Nifedipine|nifedipine|mesh-list
110990528|NCT05096728|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110990529|NCT05096728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110990530|NCT05096728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110990531|NCT05096728|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110990532|NCT05096728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110990533|NCT05096728|Vasodilator Agents|vasodilator agents|mesh-ancestor
110990534|NCT05096728|Tocolytic Agents|tocolytic agents|mesh-ancestor
110990535|NCT05096728|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110990536|NCT04421716|Ursolic acid|ursolic acid|mesh-list
110990537|NCT04421716|Curcumin|curcumin|mesh-list
110990538|NCT04421716|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110990539|NCT04421716|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110990540|NCT04421716|Analgesics|analgesics|mesh-ancestor
110990541|NCT04421716|Sensory System Agents|sensory system agents|mesh-ancestor
110990542|NCT04421716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110990543|NCT04421716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110990544|NCT04421716|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110990545|NCT04421716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110990546|NCT04421716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110990547|NCT04421716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110990548|NCT04421716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110990549|NCT04421716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110990550|NCT04421716|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110990551|NCT04421716|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110990552|NCT05184868|Insulin Aspart|insulin aspart|mesh-list
110990553|NCT05184868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110990554|NCT05184868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110990555|NCT04226950|Interferons|interferons|mesh-list
110990556|NCT04226950|Interferon-alpha|interferon-alpha|mesh-list
110990557|NCT04226950|Interferon alpha-2|interferon alpha-2|mesh-list
110990558|NCT04226950|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110990559|NCT04226950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110990560|NCT04226950|Antiviral Agents|antiviral agents|mesh-ancestor
110990561|NCT04226950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110990562|NCT04226950|Immunologic Factors|immunologic factors|mesh-ancestor
110990563|NCT04226950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110990564|NCT05085574|Celecoxib|celecoxib|mesh-list
110990565|NCT05085574|Famotidine|famotidine|mesh-list
110990566|NCT05085574|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110990567|NCT05085574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110990568|NCT05085574|Analgesics|analgesics|mesh-ancestor
110990569|NCT05085574|Sensory System Agents|sensory system agents|mesh-ancestor
110990570|NCT05085574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110990571|NCT05085574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110990572|NCT05085574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110990573|NCT05085574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110990574|NCT05085574|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110990575|NCT05085574|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110990576|NCT05085574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110990577|NCT05085574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110990578|NCT05085574|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110990579|NCT05085574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110990580|NCT05085574|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110990581|NCT05085574|Histamine Antagonists|histamine antagonists|mesh-ancestor
110990582|NCT05085574|Histamine Agents|histamine agents|mesh-ancestor
110990583|NCT05085574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110990584|NCT05085340|Pyrimethamine|pyrimethamine|mesh-list
110990585|NCT05085340|Sulfadoxine|sulfadoxine|mesh-list
110990586|NCT05085340|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
110990587|NCT05085340|Antimalarials|antimalarials|mesh-ancestor
110990588|NCT05085340|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110990589|NCT05085340|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110990590|NCT05085340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110990591|NCT05085340|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110990592|NCT05085340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110990593|NCT05085340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110990594|NCT05085340|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110990595|NCT02667236|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110990596|NCT01126749|Gemcitabine|gemcitabine|mesh-list
110990597|NCT01126749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110990598|NCT01126749|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110990599|NCT01126749|Antimetabolites|antimetabolites|mesh-ancestor
110990600|NCT01126749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110990601|NCT03674411|Mycophenolic Acid|mycophenolic acid|mesh-list
110990602|NCT03674411|Cyclophosphamide|cyclophosphamide|mesh-list
110990604|NCT03674411|Busulfan|busulfan|mesh-list
110990605|NCT03674411|Fludarabine|fludarabine|mesh-list
110990606|NCT03674411|Tacrolimus|tacrolimus|mesh-list
110990607|NCT03674411|Lenograstim|lenograstim|mesh-list
110990608|NCT03674411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110990609|NCT03674411|Immunologic Factors|immunologic factors|mesh-ancestor
110990610|NCT03674411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110990611|NCT03674411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110990612|NCT03674411|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110990613|NCT03674411|Alkylating Agents|alkylating agents|mesh-ancestor
110990614|NCT03674411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110990615|NCT03674411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110990616|NCT03674411|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110990617|NCT03674411|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110990618|NCT03674411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110990619|NCT03674411|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110990620|NCT03674411|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110990621|NCT03674411|Antitubercular Agents|antitubercular agents|mesh-ancestor
110990622|NCT03674411|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110990623|NCT03674411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110990624|NCT03674411|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110990625|NCT03674333|Folic Acid|folic acid|mesh-list
110990626|NCT03674333|Hematinics|hematinics|mesh-ancestor
110990627|NCT03674333|Vitamin B Complex|vitamin b complex|mesh-ancestor
110990628|NCT03674333|Vitamins|vitamins|mesh-ancestor
110990629|NCT03674333|Micronutrients|micronutrients|mesh-ancestor
110990630|NCT03674333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110990631|NCT03674099|Methylprednisolone|methylprednisolone|mesh-list
110990632|NCT03674099|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110990633|NCT03674099|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110990634|NCT03674099|Prednisolone|prednisolone|mesh-list
110990635|NCT03674099|Prednisolone acetate|prednisolone acetate|mesh-list
110990636|NCT03674099|Imatinib Mesylate|imatinib mesylate|mesh-list
110990637|NCT03674099|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110990638|NCT03674099|Prednisolone phosphate|prednisolone phosphate|mesh-list
110990639|NCT03674099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110990640|NCT03674099|Antiemetics|antiemetics|mesh-ancestor
110990641|NCT03674099|Autonomic Agents|autonomic agents|mesh-ancestor
110990642|NCT03674099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110990643|NCT03674099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110990644|NCT03674099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110990645|NCT03674099|Glucocorticoids|glucocorticoids|mesh-ancestor
110990646|NCT03674099|Hormones|hormones|mesh-ancestor
110990647|NCT03674099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110990648|NCT03674099|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110990649|NCT03674099|Protective Agents|protective agents|mesh-ancestor
110990650|NCT03674099|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110990651|NCT03674099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110990652|NCT03674099|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110990653|NCT03674099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110990654|NCT03674099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110990656|NCT05124340|Immunologic Factors|immunologic factors|mesh-ancestor
110990657|NCT05124340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110990658|NCT05084404|Guanabenz|guanabenz|mesh-list
110990659|NCT05084404|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110990660|NCT05084404|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110990661|NCT05084404|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110990662|NCT05084404|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110990663|NCT05084404|Adrenergic Agents|adrenergic agents|mesh-ancestor
110990664|NCT05084404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110990665|NCT05084404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110990666|NCT05084404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110990667|NCT03473613|Calcium, Dietary|calcium, dietary|mesh-list
110990668|NCT03473613|Cabergoline|cabergoline|mesh-list
110990669|NCT03473613|Calcium|calcium|mesh-list
110990670|NCT03473613|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110990671|NCT03473613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110990672|NCT03473613|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110990673|NCT03473613|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110990674|NCT03473613|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110990675|NCT03473613|Dopamine Agonists|dopamine agonists|mesh-ancestor
110990676|NCT03473613|Dopamine Agents|dopamine agents|mesh-ancestor
110990677|NCT03473613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110990678|NCT03473613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110990679|NCT03670043|Metformin|metformin|mesh-list
110990681|NCT03670043|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110990682|NCT03670043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110990683|NCT03670043|Cathartics|cathartics|mesh-ancestor
110990684|NCT03670043|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110990685|NCT05561660|Aspirin|aspirin|mesh-list
110990686|NCT05561660|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110990687|NCT05561660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110990688|NCT05561660|Analgesics|analgesics|mesh-ancestor
110990689|NCT05561660|Sensory System Agents|sensory system agents|mesh-ancestor
110990690|NCT05561660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110990691|NCT05561660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110990692|NCT05561660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110990693|NCT05561660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110990694|NCT05561660|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110990695|NCT05561660|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110990696|NCT05561660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110990697|NCT05561660|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110990698|NCT05561660|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110990699|NCT05561660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110990700|NCT05561660|Antipyretics|antipyretics|mesh-ancestor
110990701|NCT03042819|Doxorubicin|doxorubicin|mesh-list
110990702|NCT03042819|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110990703|NCT03042819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110990704|NCT03042819|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110990705|NCT03042819|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110990706|NCT03042819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110990707|NCT03042819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110990708|NCT02832687|Acetaminophen|acetaminophen|mesh-list
110990709|NCT02832687|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110990710|NCT02832687|Analgesics|analgesics|mesh-ancestor
110990711|NCT02832687|Sensory System Agents|sensory system agents|mesh-ancestor
110990712|NCT02832687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110990713|NCT02832687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110990714|NCT02832687|Antipyretics|antipyretics|mesh-ancestor
110990715|NCT04372017|Vitamin D|vitamin d|mesh-list
110990716|NCT04372017|Hydroxychloroquine|hydroxychloroquine|mesh-list
110990717|NCT04372017|Vitamins|vitamins|mesh-ancestor
110990718|NCT04372017|Micronutrients|micronutrients|mesh-ancestor
110990719|NCT04372017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110990720|NCT04372017|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110990721|NCT04372017|Antimalarials|antimalarials|mesh-ancestor
110990722|NCT04372017|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110990723|NCT04372017|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110990724|NCT04372017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110990725|NCT04372017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110990726|NCT04372017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110990727|NCT04372017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110990728|NCT05233358|Pembrolizumab|pembrolizumab|mesh-list
110990729|NCT05233358|Nivolumab|nivolumab|mesh-list
110990730|NCT05233358|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
110990731|NCT05233358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110990732|NCT05233358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110990733|NCT05233358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110990734|NCT02387918|Dexamethasone|dexamethasone|mesh-list
110990735|NCT02387918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110990736|NCT02387918|Antiemetics|antiemetics|mesh-ancestor
110990737|NCT02387918|Autonomic Agents|autonomic agents|mesh-ancestor
110990738|NCT02387918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110990739|NCT02387918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110990740|NCT02387918|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110990741|NCT02387918|Glucocorticoids|glucocorticoids|mesh-ancestor
110990743|NCT02387918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110990744|NCT02387918|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110990745|NCT02387918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110990746|NCT04312971|Norepinephrine|norepinephrine|mesh-list
110990747|NCT04312971|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110990748|NCT04312971|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110990749|NCT04312971|Adrenergic Agents|adrenergic agents|mesh-ancestor
110990750|NCT04312971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110990751|NCT04312971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110990752|NCT04312971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110990753|NCT04312971|Sympathomimetics|sympathomimetics|mesh-ancestor
110990754|NCT04312971|Autonomic Agents|autonomic agents|mesh-ancestor
110990755|NCT04312971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110990756|NCT04312971|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110990757|NCT05231330|Fluorides|fluorides|mesh-list
110990758|NCT05231330|Cariostatic Agents|cariostatic agents|mesh-ancestor
110990759|NCT05231330|Protective Agents|protective agents|mesh-ancestor
110990760|NCT05231330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110990761|NCT03179475|Oxycodone|oxycodone|mesh-list
110990762|NCT03179475|Naloxone|naloxone|mesh-list
110990763|NCT03179475|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110990764|NCT03179475|Narcotics|narcotics|mesh-ancestor
110990765|NCT03179475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110990766|NCT03179475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110990767|NCT03179475|Analgesics|analgesics|mesh-ancestor
110990768|NCT03179475|Sensory System Agents|sensory system agents|mesh-ancestor
110990769|NCT03179475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110990770|NCT03179475|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110990771|NCT03105986|Probenecid|probenecid|mesh-list
110990772|NCT03105986|Uricosuric Agents|uricosuric agents|mesh-ancestor
110990773|NCT03105986|Gout Suppressants|gout suppressants|mesh-ancestor
110990774|NCT03105986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110990775|NCT03132129|Manganese|manganese|mesh-list
110990776|NCT03132129|Calcium|calcium|mesh-list
110990777|NCT03132129|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110990778|NCT03132129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110990779|NCT03132129|Trace Elements|trace elements|mesh-ancestor
110990780|NCT03132129|Micronutrients|micronutrients|mesh-ancestor
110990781|NCT02391662|Paclitaxel|paclitaxel|mesh-list
110990782|NCT02391662|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110990783|NCT02391662|Gemcitabine|gemcitabine|mesh-list
110990784|NCT02391662|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110990785|NCT02391662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110990786|NCT02391662|Tubulin Modulators|tubulin modulators|mesh-ancestor
110990787|NCT02391662|Antimitotic Agents|antimitotic agents|mesh-ancestor
110990788|NCT02391662|Mitosis Modulators|mitosis modulators|mesh-ancestor
110990789|NCT02391662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110990790|NCT02391662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110990791|NCT02391662|Antimetabolites|antimetabolites|mesh-ancestor
110990792|NCT05076604|Cardioplegic Solutions|cardioplegic solutions|mesh-list
110990793|NCT05076604|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110990794|NCT05258955|Chlorhexidine|chlorhexidine|mesh-list
110990795|NCT05258955|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110990796|NCT05258955|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110990797|NCT05258955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110990798|NCT05258955|Disinfectants|disinfectants|mesh-ancestor
110990799|NCT05258955|Dermatologic Agents|dermatologic agents|mesh-ancestor
110990800|NCT05173324|Vaccines|vaccines|mesh-list
110990801|NCT05173324|Immunologic Factors|immunologic factors|mesh-ancestor
110990802|NCT05173324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110990803|NCT04223518|Immunoglobulins|immunoglobulins|mesh-list
110990804|NCT04223518|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110990805|NCT04223518|Antibodies|antibodies|mesh-list
110990806|NCT04223518|Immunologic Factors|immunologic factors|mesh-ancestor
110676896|NCT03348969|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110990807|NCT04223518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110990808|NCT02387450|Sildenafil Citrate|sildenafil citrate|mesh-list
110990809|NCT02387450|Vasodilator Agents|vasodilator agents|mesh-ancestor
110990810|NCT02387450|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110990811|NCT02387450|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110990812|NCT02387450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110990813|NCT02387450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110990814|NCT02387450|Urological Agents|urological agents|mesh-ancestor
110990815|NCT02390882|Tamsulosin|tamsulosin|mesh-list
110990816|NCT02390882|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110990817|NCT02390882|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110990818|NCT02390882|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110990819|NCT02390882|Adrenergic Agents|adrenergic agents|mesh-ancestor
110990820|NCT02390882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110990821|NCT02390882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110990822|NCT02390882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110990823|NCT02390882|Urological Agents|urological agents|mesh-ancestor
110990824|NCT02387138|Oxaliplatin|oxaliplatin|mesh-list
110990825|NCT02387138|Irinotecan|irinotecan|mesh-list
110990826|NCT02387138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110990827|NCT02387138|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110990828|NCT02387138|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110990829|NCT02387138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110990830|NCT02387138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110990831|NCT02387060|Fentanyl|fentanyl|mesh-list
110990832|NCT02387060|Bupivacaine|bupivacaine|mesh-list
110990833|NCT02387060|Anesthetics, Local|anesthetics, local|mesh-ancestor
110990834|NCT02387060|Anesthetics|anesthetics|mesh-ancestor
110990835|NCT02387060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110990836|NCT02387060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110990837|NCT02387060|Sensory System Agents|sensory system agents|mesh-ancestor
110990838|NCT02387060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110990839|NCT02387060|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110990840|NCT02387060|Narcotics|narcotics|mesh-ancestor
110990841|NCT02387060|Analgesics|analgesics|mesh-ancestor
110990842|NCT02387060|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110990843|NCT02387060|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110990844|NCT02387060|Anesthetics, General|anesthetics, general|mesh-ancestor
110990845|NCT01365052|Naproxen|naproxen|mesh-list
110990846|NCT01365052|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110990847|NCT01365052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110990848|NCT01365052|Analgesics|analgesics|mesh-ancestor
110990849|NCT01365052|Sensory System Agents|sensory system agents|mesh-ancestor
110990850|NCT01365052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110990851|NCT01365052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110990852|NCT01365052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110990853|NCT01365052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110990854|NCT01365052|Gout Suppressants|gout suppressants|mesh-ancestor
110990855|NCT01365052|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110990856|NCT01365052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110990857|NCT01365052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110990858|NCT05155215|Cyclophosphamide|cyclophosphamide|mesh-list
110990859|NCT05155215|Fludarabine|fludarabine|mesh-list
110990860|NCT05155215|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110990861|NCT05155215|Immunologic Factors|immunologic factors|mesh-ancestor
110990862|NCT05155215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110990863|NCT05155215|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110990864|NCT05155215|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110990865|NCT05155215|Alkylating Agents|alkylating agents|mesh-ancestor
110098996|NCT01745614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110990866|NCT05155215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110990867|NCT05155215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110990868|NCT05155215|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110990869|NCT03471585|Dronabinol|dronabinol|mesh-list
110990870|NCT03471585|Hallucinogens|hallucinogens|mesh-ancestor
110990871|NCT03471585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110990872|NCT03471585|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110990873|NCT03471585|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110990874|NCT03471585|Analgesics|analgesics|mesh-ancestor
110990875|NCT03471585|Sensory System Agents|sensory system agents|mesh-ancestor
110990876|NCT03471585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110990877|NCT03471585|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
110990878|NCT03471585|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110990879|NCT03471585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110990880|NCT03471585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110990881|NCT03471585|Hormones|hormones|mesh-ancestor
110990882|NCT03471585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110990883|NCT05072782|Infliximab|infliximab|mesh-list
110990884|NCT05072782|Methotrexate|methotrexate|mesh-list
110990885|NCT05072782|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110990886|NCT05072782|Abortifacient Agents|abortifacient agents|mesh-ancestor
110990887|NCT05072782|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110990888|NCT05072782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110990889|NCT05072782|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110990890|NCT05072782|Antimetabolites|antimetabolites|mesh-ancestor
110990891|NCT05072782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110990892|NCT05072782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110990893|NCT05072782|Dermatologic Agents|dermatologic agents|mesh-ancestor
110990894|NCT05072782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110990895|NCT05072782|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110990896|NCT05072782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110990897|NCT05072782|Immunologic Factors|immunologic factors|mesh-ancestor
110990898|NCT05072782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110990899|NCT05072782|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110990900|NCT05072782|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110990901|NCT05072782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110990902|NCT05072782|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110990903|NCT03379389|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110990904|NCT03379389|Methenamine hippurate|methenamine hippurate|mesh-list
110990905|NCT03379389|Methenamine mandelate|methenamine mandelate|mesh-list
110990906|NCT03379389|Methenamine|methenamine|mesh-list
110990907|NCT03379389|Acriflavine|acriflavine|mesh-list
110990908|NCT03379389|Methylene Blue|methylene blue|mesh-list
110990909|NCT03379389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110990910|NCT03379389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110990911|NCT03379389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110990912|NCT03379389|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110990913|NCT03379389|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110990914|NCT05170438|Paclitaxel|paclitaxel|mesh-list
110990915|NCT05170438|Lenvatinib|lenvatinib|mesh-list
110990916|NCT05170438|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110990917|NCT05170438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110990918|NCT05170438|Tubulin Modulators|tubulin modulators|mesh-ancestor
110990919|NCT05170438|Antimitotic Agents|antimitotic agents|mesh-ancestor
110990920|NCT05170438|Mitosis Modulators|mitosis modulators|mesh-ancestor
110990921|NCT05170438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110990922|NCT05170438|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110990923|NCT05170438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110990924|NCT05109520|Insulin Glargine|insulin glargine|mesh-list
110990925|NCT05109520|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110990926|NCT05109520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110990927|NCT03478605|Dexamethasone|dexamethasone|mesh-list
110990928|NCT03478605|Ondansetron|ondansetron|mesh-list
110990929|NCT03478605|Olanzapine|olanzapine|mesh-list
110990930|NCT03478605|Aprepitant|aprepitant|mesh-list
110990931|NCT03478605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110990932|NCT03478605|Antiemetics|antiemetics|mesh-ancestor
110990933|NCT03478605|Autonomic Agents|autonomic agents|mesh-ancestor
110990934|NCT03478605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110990935|NCT03478605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110990936|NCT03478605|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110990937|NCT03478605|Glucocorticoids|glucocorticoids|mesh-ancestor
110990938|NCT03478605|Hormones|hormones|mesh-ancestor
110990939|NCT03478605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110990940|NCT03478605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110990941|NCT03478605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110990942|NCT03478605|Antipruritics|antipruritics|mesh-ancestor
110990943|NCT03478605|Dermatologic Agents|dermatologic agents|mesh-ancestor
110990944|NCT03478605|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110990945|NCT03478605|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110990946|NCT03478605|Serotonin Agents|serotonin agents|mesh-ancestor
110990947|NCT03478605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110990948|NCT03478605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110990949|NCT03478605|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110990950|NCT03478605|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110990951|NCT03478605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110990952|NCT03478605|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110990953|NCT03478605|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110990954|NCT03478605|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110990955|NCT03478605|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110708011|NCT03981068|Nimorazole|nimorazole|mesh-list
110990956|NCT03478605|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110990957|NCT05109364|Terazosin|terazosin|mesh-list
110990958|NCT05109364|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110990959|NCT05109364|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110990960|NCT05109364|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110990961|NCT05109364|Adrenergic Agents|adrenergic agents|mesh-ancestor
110990962|NCT05109364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110990963|NCT05109364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110990964|NCT05109364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110990965|NCT05109364|Urological Agents|urological agents|mesh-ancestor
110990966|NCT05258799|Cytarabine|cytarabine|mesh-list
110990967|NCT05258799|Decitabine|decitabine|mesh-list
110990968|NCT05258799|Aclarubicin|aclarubicin|mesh-list
110990969|NCT05258799|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110990970|NCT05258799|Antimetabolites|antimetabolites|mesh-ancestor
110990971|NCT05258799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110990972|NCT05258799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110990973|NCT05258799|Antiviral Agents|antiviral agents|mesh-ancestor
110990974|NCT05258799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110990975|NCT05258799|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110990976|NCT05258799|Immunologic Factors|immunologic factors|mesh-ancestor
110990977|NCT05258799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110990978|NCT05258799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110990979|NCT05258799|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110990980|NCT05258799|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110990981|NCT05258799|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110990982|NCT04233892|Estrogens|estrogens|mesh-list
110990983|NCT04233892|Hormones|hormones|mesh-ancestor
110990984|NCT04233892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110451953|NCT01021020|Uricosuric Agents|uricosuric agents|mesh-ancestor
110990985|NCT04233892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110990986|NCT02386358|Benzonidazole|benzonidazole|mesh-list
110990987|NCT02386358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110990988|NCT02386358|Immunologic Factors|immunologic factors|mesh-ancestor
110990989|NCT02386358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110990990|NCT02386358|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
110990991|NCT02386358|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110990992|NCT02386358|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110990993|NCT02386358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110990994|NCT03283371|Natalizumab|natalizumab|mesh-list
110990995|NCT03283371|Immunologic Factors|immunologic factors|mesh-ancestor
110990996|NCT03283371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110990997|NCT05069350|Bupivacaine|bupivacaine|mesh-list
110990998|NCT05069350|Anesthetics, Local|anesthetics, local|mesh-ancestor
110990999|NCT05069350|Anesthetics|anesthetics|mesh-ancestor
110991000|NCT05069350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110991001|NCT05069350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110991002|NCT05069350|Sensory System Agents|sensory system agents|mesh-ancestor
110991003|NCT05069350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110991004|NCT03471351|Pembrolizumab|pembrolizumab|mesh-list
110991005|NCT03471351|Tenalisib|tenalisib|mesh-list
110991006|NCT03471351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110991007|NCT03471351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110991008|NCT03471351|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110991009|NCT03471351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110991010|NCT03471351|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
110991011|NCT03471351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110991012|NCT02386592|Chlorhexidine|chlorhexidine|mesh-list
110991013|NCT02386592|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110991014|NCT02386592|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110991015|NCT02386592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110991016|NCT02386592|Disinfectants|disinfectants|mesh-ancestor
110991017|NCT02386592|Dermatologic Agents|dermatologic agents|mesh-ancestor
110991018|NCT02390258|S66913|s66913|mesh-list
110991019|NCT02390258|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
110991020|NCT02390258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110991021|NCT02390258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110991022|NCT03891446|Bimatoprost|bimatoprost|mesh-list
110991023|NCT03891446|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110991024|NCT03059511|Nalbuphine|nalbuphine|mesh-list
110991025|NCT03059511|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110991026|NCT03059511|Narcotics|narcotics|mesh-ancestor
110991027|NCT03059511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110708085|NCT00294684|Hormones|hormones|mesh-ancestor
110991028|NCT03059511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110991029|NCT03059511|Analgesics|analgesics|mesh-ancestor
110991030|NCT03059511|Sensory System Agents|sensory system agents|mesh-ancestor
110991031|NCT03059511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110991032|NCT04439786|Lidocaine|lidocaine|mesh-list
110991033|NCT04439786|Anesthetics, Local|anesthetics, local|mesh-ancestor
110991034|NCT04439786|Anesthetics|anesthetics|mesh-ancestor
110991035|NCT04439786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110991036|NCT04439786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110991037|NCT04439786|Sensory System Agents|sensory system agents|mesh-ancestor
110991038|NCT04439786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110991039|NCT04439786|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110991040|NCT04439786|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110991041|NCT04439786|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110991042|NCT04439786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110991043|NCT04439786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110991044|NCT02665286|Naproxen|naproxen|mesh-list
110991045|NCT02665286|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
110991046|NCT02665286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
110991047|NCT02665286|Orphenadrine|orphenadrine|mesh-list
110991048|NCT02665286|Methocarbamol|methocarbamol|mesh-list
110991049|NCT02665286|Cholinergic Antagonists|cholinergic antagonists|mesh-list
110991050|NCT02665286|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110991051|NCT02665286|Analgesics|analgesics|mesh-ancestor
110991052|NCT02665286|Sensory System Agents|sensory system agents|mesh-ancestor
110991053|NCT02665286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110991054|NCT02665286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110991055|NCT02665286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110451975|NCT01020786|Pemetrexed|pemetrexed|mesh-list
110991056|NCT02665286|Gout Suppressants|gout suppressants|mesh-ancestor
110991057|NCT02665286|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110991058|NCT02665286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110991059|NCT02665286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110991060|NCT02665286|Cholinergic Agents|cholinergic agents|mesh-ancestor
110991061|NCT02665286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110991062|NCT02665286|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110991063|NCT02665286|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110991064|NCT02665286|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110991065|NCT02665286|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110991066|NCT02665286|Parasympatholytics|parasympatholytics|mesh-ancestor
110991068|NCT02665286|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110991069|NCT02665286|Cytochrome P-450 CYP2B6 Inhibitors|cytochrome p-450 cyp2b6 inhibitors|mesh-ancestor
110991070|NCT02665286|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110991071|NCT02390102|Epoetin Alfa|epoetin alfa|mesh-list
110991072|NCT02390102|Hematinics|hematinics|mesh-ancestor
110991073|NCT02134925|Poly ICLC|poly iclc|mesh-list
110991074|NCT02134925|Interferon Inducers|interferon inducers|mesh-ancestor
110991075|NCT02134925|Immunologic Factors|immunologic factors|mesh-ancestor
110991076|NCT02134925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110991077|NCT03663673|Decanoic acid|decanoic acid|mesh-list
110991078|NCT03663673|Antifungal Agents|antifungal agents|mesh-ancestor
110991079|NCT03663673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110991081|NCT04058743|Chromium|chromium|mesh-list
110991082|NCT04058743|Nickel|nickel|mesh-list
110991083|NCT04058743|Trace Elements|trace elements|mesh-ancestor
110991084|NCT04058743|Micronutrients|micronutrients|mesh-ancestor
110991085|NCT04058743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110991086|NCT03664063|Azithromycin|azithromycin|mesh-list
110991087|NCT03664063|Ivermectin|ivermectin|mesh-list
110991088|NCT03664063|Albendazole|albendazole|mesh-list
110991089|NCT03664063|Diethylcarbamazine|diethylcarbamazine|mesh-list
110991090|NCT03664063|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110991091|NCT03664063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110991092|NCT03664063|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110991093|NCT03664063|Anthelmintics|anthelmintics|mesh-ancestor
110991094|NCT03664063|Anticestodal Agents|anticestodal agents|mesh-ancestor
110991095|NCT03664063|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110991096|NCT03664063|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110991097|NCT03664063|Tubulin Modulators|tubulin modulators|mesh-ancestor
110991098|NCT03664063|Antimitotic Agents|antimitotic agents|mesh-ancestor
110991099|NCT03664063|Mitosis Modulators|mitosis modulators|mesh-ancestor
110991100|NCT03664063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110991101|NCT03664063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110991102|NCT03664063|Filaricides|filaricides|mesh-ancestor
110991103|NCT03664063|Antinematodal Agents|antinematodal agents|mesh-ancestor
110991104|NCT03664063|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
110991105|NCT03664063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110991106|NCT02911285|Acetylcysteine|acetylcysteine|mesh-list
110991107|NCT02911285|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110991108|NCT02911285|Antiviral Agents|antiviral agents|mesh-ancestor
110991109|NCT02911285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110991110|NCT02911285|Expectorants|expectorants|mesh-ancestor
110991111|NCT02911285|Respiratory System Agents|respiratory system agents|mesh-ancestor
110991112|NCT02911285|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110991113|NCT02911285|Antioxidants|antioxidants|mesh-ancestor
110991114|NCT02911285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110991115|NCT02911285|Protective Agents|protective agents|mesh-ancestor
110991116|NCT02911285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110991117|NCT02911285|Antidotes|antidotes|mesh-ancestor
110991118|NCT04997902|Tipifarnib|tipifarnib|mesh-list
110991119|NCT04997902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110991120|NCT01061515|Bevacizumab|bevacizumab|mesh-list
110991121|NCT01061515|Capecitabine|capecitabine|mesh-list
110991122|NCT01061515|Oxaliplatin|oxaliplatin|mesh-list
110991123|NCT01061515|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110991124|NCT01061515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110991125|NCT01061515|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110991126|NCT01061515|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110991127|NCT01061515|Growth Substances|growth substances|mesh-ancestor
110991128|NCT01061515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110991129|NCT01061515|Growth Inhibitors|growth inhibitors|mesh-ancestor
110991130|NCT01061515|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110991131|NCT01061515|Antimetabolites|antimetabolites|mesh-ancestor
110991132|NCT01061515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110991133|NCT01069939|Esomeprazole|esomeprazole|mesh-list
110991134|NCT01069939|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110991135|NCT01069939|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110991136|NCT01069939|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110991137|NCT01069939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110991138|NCT01069939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110991139|NCT01069705|Tobramycin|tobramycin|mesh-list
110991140|NCT01069705|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110991141|NCT01069705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110991142|NCT01069627|Bevacizumab|bevacizumab|mesh-list
110991143|NCT01069627|Fotemustine|fotemustine|mesh-list
110991144|NCT01069627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110991145|NCT01069627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110991146|NCT01069627|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110991147|NCT01069627|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110991148|NCT01069627|Growth Substances|growth substances|mesh-ancestor
110991149|NCT01069627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110991150|NCT01069627|Growth Inhibitors|growth inhibitors|mesh-ancestor
110991151|NCT04057261|Liraglutide|liraglutide|mesh-list
110991152|NCT04057261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110991153|NCT04057261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110991154|NCT04057261|Incretins|incretins|mesh-ancestor
110991155|NCT04057261|Hormones|hormones|mesh-ancestor
110991156|NCT04057261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110991157|NCT01947023|Lapatinib|lapatinib|mesh-list
110991158|NCT01947023|Dabrafenib|dabrafenib|mesh-list
110991159|NCT01947023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110991160|NCT01947023|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110991161|NCT01947023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110991162|NCT01947023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110991163|NCT01064245|Mannitol|mannitol|mesh-list
110991164|NCT01064245|Methacholine Chloride|methacholine chloride|mesh-list
110991165|NCT01064245|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110991166|NCT01064245|Diuretics|diuretics|mesh-ancestor
110991167|NCT01064245|Natriuretic Agents|natriuretic agents|mesh-ancestor
110991168|NCT01064245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110991169|NCT01064245|Miotics|miotics|mesh-ancestor
110991170|NCT01064245|Autonomic Agents|autonomic agents|mesh-ancestor
110991171|NCT01064245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110991172|NCT01064245|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110991173|NCT01064245|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
110991174|NCT01064245|Respiratory System Agents|respiratory system agents|mesh-ancestor
110991175|NCT01064245|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
110991176|NCT01064245|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110991177|NCT01064245|Cholinergic Agents|cholinergic agents|mesh-ancestor
110991178|NCT01064245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110991179|NCT01064245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110991180|NCT04056949|Paclitaxel|paclitaxel|mesh-list
110991181|NCT04056949|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110991182|NCT04056949|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110991183|NCT04056949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110991184|NCT04056949|Tubulin Modulators|tubulin modulators|mesh-ancestor
110991185|NCT04056949|Antimitotic Agents|antimitotic agents|mesh-ancestor
110991186|NCT04056949|Mitosis Modulators|mitosis modulators|mesh-ancestor
110991187|NCT04056949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110991188|NCT03662425|Oxytocin|oxytocin|mesh-list
110991189|NCT03662425|Oxytocics|oxytocics|mesh-ancestor
110991190|NCT03662425|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110991191|NCT03662425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110991192|NCT03673163|Lidocaine|lidocaine|mesh-list
110991193|NCT03673163|Anesthetics, Local|anesthetics, local|mesh-ancestor
110991194|NCT03673163|Anesthetics|anesthetics|mesh-ancestor
110991195|NCT03673163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110991196|NCT03673163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110991197|NCT03673163|Sensory System Agents|sensory system agents|mesh-ancestor
110991198|NCT03673163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110991199|NCT03673163|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110991200|NCT03673163|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110991201|NCT03673163|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110991202|NCT03673163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110991203|NCT03673163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110991204|NCT03662269|Indomethacin|indomethacin|mesh-list
110991205|NCT03662269|Omeprazole|omeprazole|mesh-list
110991206|NCT03662269|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110991207|NCT03662269|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110991208|NCT03662269|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110991209|NCT03662269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110991210|NCT03662269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110991211|NCT03662269|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110991212|NCT03662269|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110991213|NCT03662269|Analgesics|analgesics|mesh-ancestor
110991214|NCT03662269|Sensory System Agents|sensory system agents|mesh-ancestor
110991215|NCT03662269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110991216|NCT03662269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110991217|NCT03662269|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110991218|NCT03662269|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110991219|NCT03662269|Gout Suppressants|gout suppressants|mesh-ancestor
110991220|NCT03662269|Tocolytic Agents|tocolytic agents|mesh-ancestor
110991221|NCT03662269|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110991222|NCT03662269|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110991223|NCT04056325|Ivermectin|ivermectin|mesh-list
110991224|NCT04056325|Moxidectin|moxidectin|mesh-list
110991225|NCT04056325|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110991226|NCT04056325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110991227|NCT04056325|Anthelmintics|anthelmintics|mesh-ancestor
110991228|NCT04056325|Antinematodal Agents|antinematodal agents|mesh-ancestor
110991229|NCT03662971|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110991230|NCT03662971|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110991231|NCT03662893|Muscarinic Antagonists|muscarinic antagonists|mesh-list
110991232|NCT03662893|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110991233|NCT03662893|Cholinergic Agents|cholinergic agents|mesh-ancestor
110991234|NCT03662893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110991235|NCT03662893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110991236|NCT03662893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110991237|NCT01624805|Cyclosporine|cyclosporine|mesh-list
110991238|NCT01624805|Methylprednisolone|methylprednisolone|mesh-list
110991239|NCT01624805|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110991240|NCT01624805|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110991241|NCT01624805|Prednisolone|prednisolone|mesh-list
110991242|NCT01624805|Prednisolone acetate|prednisolone acetate|mesh-list
110991243|NCT01624805|Lenograstim|lenograstim|mesh-list
110991244|NCT01624805|Cyclosporins|cyclosporins|mesh-list
110991245|NCT01624805|Thymoglobulin|thymoglobulin|mesh-list
110991246|NCT01624805|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110991247|NCT01624805|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110991248|NCT01624805|Prednisolone phosphate|prednisolone phosphate|mesh-list
110991249|NCT01624805|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110991250|NCT01624805|Immunologic Factors|immunologic factors|mesh-ancestor
110991251|NCT01624805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110991252|NCT01624805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110991253|NCT01624805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110991254|NCT01624805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110991255|NCT01624805|Antifungal Agents|antifungal agents|mesh-ancestor
110991256|NCT01624805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110991257|NCT01624805|Dermatologic Agents|dermatologic agents|mesh-ancestor
110991258|NCT01624805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110991259|NCT01624805|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110991260|NCT01624805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110676897|NCT03348969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110991261|NCT01624805|Antiemetics|antiemetics|mesh-ancestor
110991262|NCT01624805|Autonomic Agents|autonomic agents|mesh-ancestor
110991263|NCT01624805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110991264|NCT01624805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110991265|NCT01624805|Glucocorticoids|glucocorticoids|mesh-ancestor
110991266|NCT01624805|Hormones|hormones|mesh-ancestor
110991267|NCT01624805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110991268|NCT01624805|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110991269|NCT01624805|Protective Agents|protective agents|mesh-ancestor
110991270|NCT01624805|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110991271|NCT01624805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110991272|NCT01585025|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
110991273|NCT01585025|Cathartics|cathartics|mesh-ancestor
110991274|NCT01585025|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110991275|NCT00328653|Cyclosporine|cyclosporine|mesh-list
110991276|NCT00328653|Cyclosporins|cyclosporins|mesh-list
110991277|NCT00328653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110991278|NCT00328653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110991279|NCT00328653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110991280|NCT00328653|Immunologic Factors|immunologic factors|mesh-ancestor
110991281|NCT00328653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110991282|NCT00328653|Antifungal Agents|antifungal agents|mesh-ancestor
110991283|NCT00328653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110991284|NCT00328653|Dermatologic Agents|dermatologic agents|mesh-ancestor
110991285|NCT00328653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110991286|NCT00328653|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110991287|NCT03662113|Domperidone|domperidone|mesh-list
110991288|NCT03662113|Simethicone|simethicone|mesh-list
110991289|NCT03662113|Antiemetics|antiemetics|mesh-ancestor
110991290|NCT03662113|Autonomic Agents|autonomic agents|mesh-ancestor
110991291|NCT03662113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110991292|NCT03662113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110991293|NCT03662113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110991294|NCT03662113|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110991295|NCT03662113|Dopamine Agents|dopamine agents|mesh-ancestor
110991296|NCT03662113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110991297|NCT03662113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110991298|NCT03662113|Antifoaming Agents|antifoaming agents|mesh-ancestor
110991299|NCT03662113|Emollients|emollients|mesh-ancestor
110991300|NCT03662113|Dermatologic Agents|dermatologic agents|mesh-ancestor
110991301|NCT03662035|Apatinib|apatinib|mesh-list
110991302|NCT03662035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110991303|NCT03662035|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110991304|NCT03662035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110991305|NCT03662035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110991306|NCT05798546|Cyclophosphamide|cyclophosphamide|mesh-list
110991307|NCT05798546|Fludarabine|fludarabine|mesh-list
110991308|NCT05798546|Interleukin-2|interleukin-2|mesh-list
110991309|NCT05798546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110991310|NCT05798546|Immunologic Factors|immunologic factors|mesh-ancestor
110991311|NCT05798546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110991312|NCT05798546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110991313|NCT05798546|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110991314|NCT05798546|Alkylating Agents|alkylating agents|mesh-ancestor
110991315|NCT05798546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110991316|NCT05798546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110991317|NCT05798546|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110991318|NCT05798546|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110991319|NCT05798546|Analgesics|analgesics|mesh-ancestor
110991320|NCT05798546|Sensory System Agents|sensory system agents|mesh-ancestor
110991321|NCT05798546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110991322|NCT05798195|Dexamethasone|dexamethasone|mesh-list
110991323|NCT05798195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110991324|NCT05798195|Antiemetics|antiemetics|mesh-ancestor
110991325|NCT05798195|Autonomic Agents|autonomic agents|mesh-ancestor
110991326|NCT05798195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110991327|NCT05798195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110991328|NCT05798195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110991329|NCT05798195|Glucocorticoids|glucocorticoids|mesh-ancestor
110991330|NCT05798195|Hormones|hormones|mesh-ancestor
110991331|NCT05798195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110991332|NCT05798195|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110991333|NCT05798195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110991334|NCT05797948|Cyclophosphamide|cyclophosphamide|mesh-list
110991335|NCT05797948|Fludarabine|fludarabine|mesh-list
110991336|NCT05797948|Lenalidomide|lenalidomide|mesh-list
110991337|NCT05797948|Azacitidine|azacitidine|mesh-list
110991338|NCT05797948|Obinutuzumab|obinutuzumab|mesh-list
110991339|NCT05797948|Zanubrutinib|zanubrutinib|mesh-list
110991340|NCT05797948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110991341|NCT05797948|Immunologic Factors|immunologic factors|mesh-ancestor
110991342|NCT05797948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110991343|NCT05797948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110991344|NCT05797948|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110991345|NCT05797948|Alkylating Agents|alkylating agents|mesh-ancestor
110991346|NCT05797948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110991347|NCT05797948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110991348|NCT05797948|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110991349|NCT05797948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110991350|NCT05797948|Antimetabolites|antimetabolites|mesh-ancestor
110991351|NCT05797948|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110991352|NCT05797948|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110991353|NCT05797948|Growth Substances|growth substances|mesh-ancestor
110991354|NCT05797948|Growth Inhibitors|growth inhibitors|mesh-ancestor
110991355|NCT05797948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110991356|NCT05797948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110991357|NCT05797948|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110991358|NCT05797818|Chlorhexidine|chlorhexidine|mesh-list
110991359|NCT05797818|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110991360|NCT05797818|Methylene Blue|methylene blue|mesh-list
110991361|NCT05797818|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110991362|NCT05797818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110991363|NCT05797818|Disinfectants|disinfectants|mesh-ancestor
110991364|NCT05797818|Dermatologic Agents|dermatologic agents|mesh-ancestor
110991365|NCT05797818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110991366|NCT05797818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110991367|NCT05797792|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
110991368|NCT05797792|Plasminogen|plasminogen|mesh-list
110991369|NCT05797792|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110991370|NCT05797792|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110991371|NCT05797792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110991372|NCT05797753|Itraconazole|itraconazole|mesh-list
110991373|NCT05797753|Erythromycin|erythromycin|mesh-list
110991374|NCT05797753|Erythromycin Estolate|erythromycin estolate|mesh-list
110991375|NCT05797753|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
110991376|NCT05797753|Erythromycin stearate|erythromycin stearate|mesh-list
110991377|NCT05797753|Antifungal Agents|antifungal agents|mesh-ancestor
110991378|NCT05797753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110991379|NCT05797753|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110991380|NCT05797753|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110991381|NCT05797753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110991382|NCT05797753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110991383|NCT05797753|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110991384|NCT05797753|Hormone Antagonists|hormone antagonists|mesh-ancestor
110991385|NCT05797753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110991386|NCT05797753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110991387|NCT05797753|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110991388|NCT05797753|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110991389|NCT05797753|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110991390|NCT05797753|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110991391|NCT05797740|Cladribine|cladribine|mesh-list
110991392|NCT05797740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110991393|NCT05797740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110991394|NCT05797740|Immunologic Factors|immunologic factors|mesh-ancestor
110991395|NCT05797740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110991396|NCT05797714|Tenofovir|tenofovir|mesh-list
110991397|NCT05797714|Antiviral Agents|antiviral agents|mesh-ancestor
110991398|NCT05797714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110991399|NCT05797714|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110991400|NCT05797714|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110991401|NCT05797714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110991402|NCT05797714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110991403|NCT05797714|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110991404|NCT05797714|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110991405|NCT05797584|Dobutamine|dobutamine|mesh-list
110991406|NCT05797584|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110991407|NCT05797584|Sympathomimetics|sympathomimetics|mesh-ancestor
110991408|NCT05797584|Autonomic Agents|autonomic agents|mesh-ancestor
110991409|NCT05797584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110991410|NCT05797584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110991411|NCT05797584|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
110991412|NCT05797584|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110991413|NCT05797584|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110991414|NCT05797584|Adrenergic Agents|adrenergic agents|mesh-ancestor
110991415|NCT05797584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110991416|NCT05797584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110991417|NCT05797584|Protective Agents|protective agents|mesh-ancestor
110991418|NCT05797493|Atezolizumab|atezolizumab|mesh-list
110991419|NCT05797493|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110991420|NCT05797493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110991421|NCT05797493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110991422|NCT05797493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110991423|NCT05797220|Diltiazem|diltiazem|mesh-list
110991424|NCT05797220|Botulinum Toxins|botulinum toxins|mesh-list
110991425|NCT05797220|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110991426|NCT05797220|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110991427|NCT05797220|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110991428|NCT05797220|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110991429|NCT05797220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110991430|NCT05797220|Cholinergic Agents|cholinergic agents|mesh-ancestor
110991431|NCT05797220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110991432|NCT05797220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110991433|NCT05797220|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110991434|NCT05797220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110991435|NCT05797220|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110991436|NCT05797220|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110991437|NCT05797220|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110991438|NCT05797220|Vasodilator Agents|vasodilator agents|mesh-ancestor
110991440|NCT05797077|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110991441|NCT05797077|Antimetabolites|antimetabolites|mesh-ancestor
110991442|NCT05797077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110991443|NCT05797077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110991444|NCT05797038|Tacrolimus|tacrolimus|mesh-list
110991445|NCT05797038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110991446|NCT05797038|Immunologic Factors|immunologic factors|mesh-ancestor
110991447|NCT05797038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110991448|NCT05797038|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110991449|NCT05797038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110991450|NCT05797038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110991451|NCT05795933|Vitamin D|vitamin d|mesh-list
110991452|NCT05795933|Cholecalciferol|cholecalciferol|mesh-list
110991453|NCT05795933|Vitamins|vitamins|mesh-ancestor
110991454|NCT05795933|Micronutrients|micronutrients|mesh-ancestor
110991455|NCT05795933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110991456|NCT05795933|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110991457|NCT05795933|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110991458|NCT05792774|Bupivacaine|bupivacaine|mesh-list
110991459|NCT05792774|Anesthetics, Local|anesthetics, local|mesh-ancestor
110991460|NCT05792774|Anesthetics|anesthetics|mesh-ancestor
110991461|NCT05792774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110991462|NCT05792774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110991463|NCT05792774|Sensory System Agents|sensory system agents|mesh-ancestor
110991464|NCT05792774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110991465|NCT05703854|Cyclophosphamide|cyclophosphamide|mesh-list
110991466|NCT05703854|Fludarabine|fludarabine|mesh-list
110991467|NCT05703854|Fludarabine phosphate|fludarabine phosphate|mesh-list
110991468|NCT05703854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110991469|NCT05703854|Immunologic Factors|immunologic factors|mesh-ancestor
110991470|NCT05703854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110991471|NCT05703854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110991472|NCT05703854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110991473|NCT05703854|Alkylating Agents|alkylating agents|mesh-ancestor
110991474|NCT05703854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110991475|NCT05703854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110991476|NCT05703854|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110991477|NCT05703854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110991478|NCT05703854|Antimetabolites|antimetabolites|mesh-ancestor
110991479|NCT05692999|Pembrolizumab|pembrolizumab|mesh-list
110991480|NCT05692999|Pemetrexed|pemetrexed|mesh-list
110991481|NCT05692999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110991482|NCT05692999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110991483|NCT05692999|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110991484|NCT05692999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110676898|NCT03341936|Nivolumab|nivolumab|mesh-list
110991485|NCT05692999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110991486|NCT05692999|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110991487|NCT05692999|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110991488|NCT05665140|Dexamethasone|dexamethasone|mesh-list
110991489|NCT05665140|Lenalidomide|lenalidomide|mesh-list
110991490|NCT05665140|Bortezomib|bortezomib|mesh-list
110991491|NCT05665140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110991492|NCT05665140|Antiemetics|antiemetics|mesh-ancestor
110991493|NCT05665140|Autonomic Agents|autonomic agents|mesh-ancestor
110991494|NCT05665140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110991495|NCT05665140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110991496|NCT05665140|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110991497|NCT05665140|Glucocorticoids|glucocorticoids|mesh-ancestor
110991498|NCT05665140|Hormones|hormones|mesh-ancestor
110991499|NCT05665140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110991500|NCT05665140|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110991501|NCT05665140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110991502|NCT05665140|Immunologic Factors|immunologic factors|mesh-ancestor
110991503|NCT05665140|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110991504|NCT05665140|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110991505|NCT05665140|Growth Substances|growth substances|mesh-ancestor
110991506|NCT05665140|Growth Inhibitors|growth inhibitors|mesh-ancestor
110991507|NCT05661591|Fluconazole|fluconazole|mesh-list
110991509|NCT05661591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110991510|NCT05661591|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110991511|NCT05661591|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110991512|NCT05661591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110991513|NCT05661591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110991514|NCT05661591|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110991515|NCT05661591|Hormone Antagonists|hormone antagonists|mesh-ancestor
110991516|NCT05661591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110991517|NCT05661591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110991518|NCT05661591|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110991519|NCT05661591|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110991520|NCT05661201|Doxorubicin|doxorubicin|mesh-list
110991521|NCT05661201|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110991522|NCT05661201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110991523|NCT05661201|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110991524|NCT05661201|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110991525|NCT05661201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110991526|NCT05661201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110991527|NCT05634148|Dexmedetomidine|dexmedetomidine|mesh-list
110991528|NCT05634148|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110991529|NCT05634148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110991530|NCT05634148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110991531|NCT05634148|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110991532|NCT05634148|Analgesics|analgesics|mesh-ancestor
110991533|NCT05634148|Sensory System Agents|sensory system agents|mesh-ancestor
110991534|NCT05634148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110991535|NCT05634148|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110991536|NCT05634148|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110991537|NCT05634148|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110991538|NCT05634148|Adrenergic Agents|adrenergic agents|mesh-ancestor
110991539|NCT05634148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110991540|NCT05634148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110991541|NCT05622123|Exenatide|exenatide|mesh-list
110991542|NCT05622123|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110991543|NCT05622123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110991544|NCT05622123|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110991545|NCT05622123|Incretins|incretins|mesh-ancestor
110991546|NCT05622123|Hormones|hormones|mesh-ancestor
110991547|NCT05622123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110991548|NCT05594082|Trastuzumab|trastuzumab|mesh-list
110991549|NCT05594082|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
110991550|NCT05594082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110991551|NCT05594082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110991552|NCT05594082|Immunoconjugates|immunoconjugates|mesh-ancestor
110991553|NCT05594082|Immunologic Factors|immunologic factors|mesh-ancestor
110991554|NCT05594082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110991555|NCT05574374|Fexuprazan|fexuprazan|mesh-list
110991556|NCT05574374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110991557|NCT05566639|Vaccines|vaccines|mesh-list
110708608|NCT00298272|Adalimumab|adalimumab|mesh-list
110991558|NCT05566639|Immunologic Factors|immunologic factors|mesh-ancestor
110991559|NCT05566639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110991561|NCT05506787|Antidepressive Agents|antidepressive agents|mesh-ancestor
110991562|NCT05506787|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110991563|NCT05503511|Bumetanide|bumetanide|mesh-list
110991564|NCT05503511|Diuretics|diuretics|mesh-ancestor
110991565|NCT05503511|Natriuretic Agents|natriuretic agents|mesh-ancestor
110991566|NCT05503511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110991567|NCT05503511|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110991568|NCT05503511|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110991569|NCT05503511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110991570|NCT05503355|Venetoclax|venetoclax|mesh-list
110991571|NCT05503355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110991572|NCT05453851|Pancrelipase|pancrelipase|mesh-list
110991573|NCT05453851|Pancreatin|pancreatin|mesh-list
110991574|NCT05453851|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110991575|NCT05453500|Prednisone|prednisone|mesh-list
110991576|NCT05453500|Cortisone|cortisone|mesh-list
110991577|NCT05453500|Cyclophosphamide|cyclophosphamide|mesh-list
110991578|NCT05453500|Rituximab|rituximab|mesh-list
110991579|NCT05453500|Doxorubicin|doxorubicin|mesh-list
110991580|NCT05453500|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110991581|NCT05453500|Etoposide|etoposide|mesh-list
110991582|NCT05453500|Vincristine|vincristine|mesh-list
110991583|NCT05453500|Etoposide phosphate|etoposide phosphate|mesh-list
110991584|NCT05453500|Daunorubicin|daunorubicin|mesh-list
110991585|NCT05453500|Podophyllotoxin|podophyllotoxin|mesh-list
110991586|NCT05453500|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110991587|NCT05453500|Antibodies|antibodies|mesh-list
110991588|NCT05453500|Immunoglobulins|immunoglobulins|mesh-list
110991589|NCT05453500|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110991590|NCT05453500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110991591|NCT05453500|Immunologic Factors|immunologic factors|mesh-ancestor
110991592|NCT05453500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110991593|NCT05453500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110991594|NCT05453500|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110991595|NCT05453500|Alkylating Agents|alkylating agents|mesh-ancestor
110991596|NCT05453500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110991597|NCT05453500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110991598|NCT05453500|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110991599|NCT05453500|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110991600|NCT05453500|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110991601|NCT05453500|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110991602|NCT05453500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110991603|NCT05453500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110991604|NCT05453500|Glucocorticoids|glucocorticoids|mesh-ancestor
110991605|NCT05453500|Hormones|hormones|mesh-ancestor
110991606|NCT05453500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110991607|NCT05453500|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110991608|NCT05453500|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110991609|NCT05453500|Tubulin Modulators|tubulin modulators|mesh-ancestor
110991610|NCT05453500|Antimitotic Agents|antimitotic agents|mesh-ancestor
110991611|NCT05453500|Mitosis Modulators|mitosis modulators|mesh-ancestor
110991612|NCT05453500|Keratolytic Agents|keratolytic agents|mesh-ancestor
110991613|NCT05453500|Dermatologic Agents|dermatologic agents|mesh-ancestor
110991614|NCT05445024|Sufentanil|sufentanil|mesh-list
110991615|NCT05445024|Nalbuphine|nalbuphine|mesh-list
110991616|NCT05445024|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110991617|NCT05445024|Narcotics|narcotics|mesh-ancestor
110991618|NCT05445024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110991619|NCT05445024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110991620|NCT05445024|Analgesics|analgesics|mesh-ancestor
110991621|NCT05445024|Sensory System Agents|sensory system agents|mesh-ancestor
110991622|NCT05445024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110991623|NCT05445024|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110991624|NCT05445024|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110991625|NCT05445024|Anesthetics, General|anesthetics, general|mesh-ancestor
110991626|NCT05445024|Anesthetics|anesthetics|mesh-ancestor
110991627|NCT05429814|Menthol|menthol|mesh-list
110991628|NCT05429814|Antipruritics|antipruritics|mesh-ancestor
110991629|NCT05429814|Dermatologic Agents|dermatologic agents|mesh-ancestor
110991630|NCT05420337|Morphine|morphine|mesh-list
110991631|NCT05420337|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110991632|NCT05420337|Narcotics|narcotics|mesh-ancestor
110991633|NCT05420337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110991634|NCT05420337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110991635|NCT05420337|Analgesics|analgesics|mesh-ancestor
110991636|NCT05420337|Sensory System Agents|sensory system agents|mesh-ancestor
110991637|NCT05420337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110991638|NCT05409872|Vitamin D|vitamin d|mesh-list
110991639|NCT05409872|Vitamins|vitamins|mesh-list
110991640|NCT05409872|Inositol|inositol|mesh-list
110991641|NCT05409872|Vitamin B 6|vitamin b 6|mesh-list
110991642|NCT05409872|Pyridoxal|pyridoxal|mesh-list
110991643|NCT05409872|Pyridoxine|pyridoxine|mesh-list
110991644|NCT05409872|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
110991645|NCT05409872|Micronutrients|micronutrients|mesh-ancestor
110991646|NCT05409872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110991647|NCT05409872|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110991648|NCT05409872|Vitamin B Complex|vitamin b complex|mesh-ancestor
110991649|NCT05409872|Antioxidants|antioxidants|mesh-ancestor
110991650|NCT05409872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110991651|NCT05409872|Protective Agents|protective agents|mesh-ancestor
110991652|NCT05409872|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
110991653|NCT05409872|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110991654|NCT05409872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110991655|NCT05409872|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110991656|NCT05390905|Tramadol|tramadol|mesh-list
110991657|NCT05390905|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110991658|NCT05390905|Narcotics|narcotics|mesh-ancestor
110991659|NCT05390905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110991660|NCT05390905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110991661|NCT05390905|Analgesics|analgesics|mesh-ancestor
110991662|NCT05390905|Sensory System Agents|sensory system agents|mesh-ancestor
110991663|NCT05390905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110991665|NCT05366621|Diphosphonates|diphosphonates|mesh-list
110991666|NCT05366621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110991667|NCT05366621|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110991668|NCT05359146|Edotreotide lutetium LU-177|edotreotide lutetium lu-177|mesh-list
110991669|NCT05359146|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110991670|NCT05359146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110991671|NCT05335252|Dronabinol|dronabinol|mesh-list
110991672|NCT05335252|Hallucinogens|hallucinogens|mesh-ancestor
110991673|NCT05335252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110991674|NCT05335252|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110991675|NCT05335252|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110991676|NCT05335252|Analgesics|analgesics|mesh-ancestor
110991677|NCT05335252|Sensory System Agents|sensory system agents|mesh-ancestor
110991678|NCT05335252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110991679|NCT05335252|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
110991680|NCT05335252|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110991681|NCT05335252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110991682|NCT05335252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110991683|NCT05335252|Hormones|hormones|mesh-ancestor
110991684|NCT05335252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110991685|NCT05325775|SR 142801|sr 142801|mesh-list
110991686|NCT05325775|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110991687|NCT05325775|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110991688|NCT05325775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110991689|NCT05325775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110991690|NCT05325775|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110991691|NCT05289908|Folic Acid|folic acid|mesh-list
110991692|NCT05289908|Vitamin B 12|vitamin b 12|mesh-list
110991693|NCT05289908|Dexamethasone|dexamethasone|mesh-list
110991694|NCT05289908|Pemetrexed|pemetrexed|mesh-list
110991695|NCT05289908|Vitamins|vitamins|mesh-ancestor
110991696|NCT05289908|Micronutrients|micronutrients|mesh-ancestor
110991697|NCT05289908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110991698|NCT05289908|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110991699|NCT05289908|Antiemetics|antiemetics|mesh-ancestor
110991700|NCT05289908|Autonomic Agents|autonomic agents|mesh-ancestor
110991701|NCT05289908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110991702|NCT05289908|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110991703|NCT05289908|Glucocorticoids|glucocorticoids|mesh-ancestor
110991704|NCT05289908|Hormones|hormones|mesh-ancestor
110991705|NCT05289908|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110991706|NCT05289908|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110991707|NCT05289908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110991708|NCT05289908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110991709|NCT05289908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110991710|NCT05289908|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110991711|NCT05289908|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110676899|NCT03341936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110991712|NCT05289908|Hematinics|hematinics|mesh-ancestor
110991713|NCT05289908|Vitamin B Complex|vitamin b complex|mesh-ancestor
110991714|NCT05284084|Histamine H2 Antagonists|histamine h2 antagonists|mesh-list
110991715|NCT05284084|Histamine Antagonists|histamine antagonists|mesh-ancestor
110991716|NCT05284084|Histamine Agents|histamine agents|mesh-ancestor
110991717|NCT05284084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110991718|NCT05284084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110991719|NCT05284084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110991720|NCT05226351|Dronabinol|dronabinol|mesh-list
110991721|NCT05226351|Hallucinogens|hallucinogens|mesh-ancestor
110991722|NCT05226351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110991723|NCT05226351|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110991724|NCT05226351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110991725|NCT05226351|Analgesics|analgesics|mesh-ancestor
110991726|NCT05226351|Sensory System Agents|sensory system agents|mesh-ancestor
110991727|NCT05226351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110991728|NCT05226351|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
110991729|NCT05226351|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110991730|NCT05226351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110991731|NCT05226351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110991732|NCT05226351|Hormones|hormones|mesh-ancestor
110991733|NCT05226351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110991734|NCT05215548|Afatinib|afatinib|mesh-list
110991735|NCT05215548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110991736|NCT05215548|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110991737|NCT05215548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110991738|NCT05215548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110991739|NCT05209555|Pilocarpine|pilocarpine|mesh-list
110991740|NCT05209555|Miotics|miotics|mesh-ancestor
110991741|NCT05209555|Autonomic Agents|autonomic agents|mesh-ancestor
110991742|NCT05209555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110991743|NCT05209555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110991744|NCT05209555|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
110991745|NCT05209555|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110991746|NCT05209555|Cholinergic Agents|cholinergic agents|mesh-ancestor
110991747|NCT05209555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110991748|NCT05209555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110991749|NCT05202145|Cyclosporine|cyclosporine|mesh-list
110991750|NCT05202145|Tacrolimus|tacrolimus|mesh-list
110991751|NCT05202145|Cyclosporins|cyclosporins|mesh-list
110991752|NCT05202145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110991753|NCT05202145|Immunologic Factors|immunologic factors|mesh-ancestor
110991754|NCT05202145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110991755|NCT05202145|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110991756|NCT05202145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110991757|NCT05202145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110991758|NCT05202145|Antifungal Agents|antifungal agents|mesh-ancestor
110991759|NCT05202145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110991760|NCT05202145|Dermatologic Agents|dermatologic agents|mesh-ancestor
110991761|NCT05202145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110991762|NCT05150938|Vitamin K|vitamin k|mesh-list
110991763|NCT05150938|Heparin|heparin|mesh-list
110991764|NCT05150938|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
110991765|NCT05150938|Tinzaparin|tinzaparin|mesh-list
110991766|NCT05150938|Dalteparin|dalteparin|mesh-list
110991767|NCT05150938|Rivaroxaban|rivaroxaban|mesh-list
110991768|NCT05150938|Vitamins|vitamins|mesh-ancestor
110991769|NCT05150938|Micronutrients|micronutrients|mesh-ancestor
110991770|NCT05150938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110991771|NCT05150938|Anticoagulants|anticoagulants|mesh-ancestor
110991772|NCT05150938|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110991773|NCT05150938|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110991774|NCT05150938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110991775|NCT05150938|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110991776|NCT05150938|Antithrombins|antithrombins|mesh-ancestor
110991777|NCT05150938|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110991778|NCT05150938|Protease Inhibitors|protease inhibitors|mesh-ancestor
110991779|NCT05150938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110991780|NCT05150938|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110991781|NCT05150938|Hemostatics|hemostatics|mesh-ancestor
110991782|NCT05150938|Coagulants|coagulants|mesh-ancestor
110991784|NCT05142904|Cadexomer iodine|cadexomer iodine|mesh-list
110991785|NCT05142904|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110991786|NCT05142904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110991787|NCT05142904|Trace Elements|trace elements|mesh-ancestor
110991788|NCT05142904|Micronutrients|micronutrients|mesh-ancestor
110991789|NCT05142904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110991790|NCT05107856|Azacitidine|azacitidine|mesh-list
110991791|NCT05107856|Venetoclax|venetoclax|mesh-list
110991792|NCT05107856|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110991793|NCT05107856|Antimetabolites|antimetabolites|mesh-ancestor
110991794|NCT05107856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110991795|NCT05107856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110991796|NCT05107856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110991797|NCT05042648|Buprenorphine|buprenorphine|mesh-list
110991798|NCT05042648|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110991799|NCT05042648|Narcotics|narcotics|mesh-ancestor
110991800|NCT05042648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110991801|NCT05042648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110991802|NCT05042648|Analgesics|analgesics|mesh-ancestor
110991803|NCT05042648|Sensory System Agents|sensory system agents|mesh-ancestor
110991804|NCT05042648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110991805|NCT05042648|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110991806|NCT05036317|Empagliflozin|empagliflozin|mesh-list
110991807|NCT05036317|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110991808|NCT05036317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110991809|NCT05036317|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110991810|NCT05036317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110991811|NCT04990388|Acetaminophen|acetaminophen|mesh-list
110991812|NCT04990388|Antipyretics|antipyretics|mesh-list
110991813|NCT04990388|Cetirizine|cetirizine|mesh-list
110991814|NCT04990388|Ibuprofen|ibuprofen|mesh-list
110991815|NCT04990388|Famotidine|famotidine|mesh-list
110991816|NCT04990388|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110991817|NCT04990388|Analgesics|analgesics|mesh-ancestor
110991818|NCT04990388|Sensory System Agents|sensory system agents|mesh-ancestor
110991819|NCT04990388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110991820|NCT04990388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110991821|NCT04990388|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110991822|NCT04990388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110991823|NCT04990388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110991824|NCT04990388|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110991825|NCT04990388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110991826|NCT04990388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110991827|NCT04990388|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110991828|NCT04990388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110991829|NCT04990388|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110991830|NCT04990388|Histamine Antagonists|histamine antagonists|mesh-ancestor
110991831|NCT04990388|Histamine Agents|histamine agents|mesh-ancestor
110991832|NCT04990388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110991833|NCT04990388|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110991834|NCT04990388|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110991835|NCT04990388|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110991836|NCT04916002|Cemiplimab|cemiplimab|mesh-list
110991837|NCT04916002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110991838|NCT04916002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110991839|NCT04896866|Anti-Infective Agents|anti-infective agents|mesh-list
110991840|NCT04896866|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110991841|NCT04871269|Dronabinol|dronabinol|mesh-list
110991842|NCT04871269|Hallucinogens|hallucinogens|mesh-ancestor
110991843|NCT04871269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110991844|NCT04871269|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110991845|NCT04871269|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110991846|NCT04871269|Analgesics|analgesics|mesh-ancestor
110991847|NCT04871269|Sensory System Agents|sensory system agents|mesh-ancestor
110991848|NCT04871269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110991849|NCT04871269|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
110991850|NCT04871269|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110991851|NCT04871269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110991852|NCT04871269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110991853|NCT04871269|Hormones|hormones|mesh-ancestor
110991854|NCT04871269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110991855|NCT04837131|Ixazomib|ixazomib|mesh-list
110991856|NCT04837131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110991857|NCT04837131|Protease Inhibitors|protease inhibitors|mesh-ancestor
110991858|NCT04837131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110991859|NCT04837131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110991860|NCT04764214|Osimertinib|osimertinib|mesh-list
110991861|NCT04764214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110708911|NCT00494507|Dichlorphenamide|dichlorphenamide|mesh-list
110991862|NCT04764214|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110991863|NCT04764214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110991864|NCT04764214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110991869|NCT04675710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110991870|NCT04675710|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110991871|NCT04675710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110991872|NCT04675710|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110991873|NCT04675710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110991877|NCT04653818|Sofosbuvir|sofosbuvir|mesh-list
110991878|NCT04653818|Velpatasvir|velpatasvir|mesh-list
110991879|NCT04653818|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
110991880|NCT04653818|Antiviral Agents|antiviral agents|mesh-ancestor
110991881|NCT04653818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110991882|NCT04579848|Folic Acid|folic acid|mesh-list
110991883|NCT04579848|Methotrexate|methotrexate|mesh-list
110991884|NCT04579848|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110991885|NCT04579848|Abortifacient Agents|abortifacient agents|mesh-ancestor
110991886|NCT04579848|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110991887|NCT04579848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110991888|NCT04579848|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110991889|NCT04579848|Antimetabolites|antimetabolites|mesh-ancestor
110991890|NCT04579848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110991891|NCT04579848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110991892|NCT04579848|Dermatologic Agents|dermatologic agents|mesh-ancestor
110991893|NCT04579848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110991894|NCT04579848|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110991895|NCT04579848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110991896|NCT04579848|Immunologic Factors|immunologic factors|mesh-ancestor
110991897|NCT04579848|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110991898|NCT04579848|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110991899|NCT04579848|Hematinics|hematinics|mesh-ancestor
110991900|NCT04579848|Vitamin B Complex|vitamin b complex|mesh-ancestor
110991901|NCT04579848|Vitamins|vitamins|mesh-ancestor
110991902|NCT04579848|Micronutrients|micronutrients|mesh-ancestor
110991903|NCT04578652|Metformin|metformin|mesh-list
110991904|NCT04578652|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110991905|NCT04578652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110991906|NCT04570631|Dexamethasone|dexamethasone|mesh-list
110991907|NCT04570631|Bortezomib|bortezomib|mesh-list
110991908|NCT04570631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110991909|NCT04570631|Antiemetics|antiemetics|mesh-ancestor
110991910|NCT04570631|Autonomic Agents|autonomic agents|mesh-ancestor
110991911|NCT04570631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110991912|NCT04570631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110991913|NCT04570631|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110991914|NCT04570631|Glucocorticoids|glucocorticoids|mesh-ancestor
110991915|NCT04570631|Hormones|hormones|mesh-ancestor
110991916|NCT04570631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110991917|NCT04570631|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110991918|NCT04570631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110991919|NCT04550832|Moxifloxacin|moxifloxacin|mesh-list
110991920|NCT04550832|Bedaquiline|bedaquiline|mesh-list
110991921|NCT04550832|Delpazolid|delpazolid|mesh-list
110991922|NCT04550832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110991923|NCT04550832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110991924|NCT04550832|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110991925|NCT04550832|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110991926|NCT04550832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110991927|NCT04550832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110991928|NCT04550832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110991929|NCT04550832|Antitubercular Agents|antitubercular agents|mesh-ancestor
110991930|NCT04550832|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110991931|NCT04477629|Mycophenolic Acid|mycophenolic acid|mesh-list
110991932|NCT04477629|Abatacept|abatacept|mesh-list
110991933|NCT04477629|Tacrolimus|tacrolimus|mesh-list
110991934|NCT04477629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110991935|NCT04477629|Immunologic Factors|immunologic factors|mesh-ancestor
110991936|NCT04477629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110991937|NCT04477629|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110991938|NCT04477629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110708978|NCT00280566|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110991939|NCT04477629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110991940|NCT04477629|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110991941|NCT04477629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110991942|NCT04477629|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110991943|NCT04477629|Antitubercular Agents|antitubercular agents|mesh-ancestor
110991944|NCT04477629|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110991945|NCT04477629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110991946|NCT04477629|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110452071|NCT05321199|Hemostatics|hemostatics|mesh-ancestor
110991947|NCT04477629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110991948|NCT04477629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110991949|NCT04476277|Biotin|biotin|mesh-list
110991950|NCT04476277|Vitamin B Complex|vitamin b complex|mesh-ancestor
110991951|NCT04476277|Vitamins|vitamins|mesh-ancestor
110991952|NCT04476277|Micronutrients|micronutrients|mesh-ancestor
110991953|NCT04476277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110991954|NCT04430517|Niacinamide|niacinamide|mesh-list
110991955|NCT04430517|Niacin|niacin|mesh-list
110991956|NCT04430517|Nicotinic Acids|nicotinic acids|mesh-list
110991957|NCT04430517|Vitamin B Complex|vitamin b complex|mesh-ancestor
110991958|NCT04430517|Vitamins|vitamins|mesh-ancestor
110991959|NCT04430517|Micronutrients|micronutrients|mesh-ancestor
110991960|NCT04430517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110991961|NCT04430517|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110991962|NCT04430517|Antimetabolites|antimetabolites|mesh-ancestor
110991963|NCT04430517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110991964|NCT04430517|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110991965|NCT04430517|Vasodilator Agents|vasodilator agents|mesh-ancestor
110991966|NCT04414943|Ketamine|ketamine|mesh-list
110991967|NCT04414943|Esketamine|esketamine|mesh-list
110991968|NCT04414943|Analgesics|analgesics|mesh-ancestor
110991969|NCT04414943|Sensory System Agents|sensory system agents|mesh-ancestor
110991970|NCT04414943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110991971|NCT04414943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110991972|NCT04414943|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110991973|NCT04414943|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110991974|NCT04414943|Anesthetics, General|anesthetics, general|mesh-ancestor
110991975|NCT04414943|Anesthetics|anesthetics|mesh-ancestor
110991976|NCT04414943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110991977|NCT04414943|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110991978|NCT04414943|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110991979|NCT04414943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110991980|NCT04414943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110991981|NCT04414943|Antidepressive Agents|antidepressive agents|mesh-ancestor
110991982|NCT04414943|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110991983|NCT04354025|Cytarabine|cytarabine|mesh-list
110991984|NCT04354025|Fludarabine|fludarabine|mesh-list
110991985|NCT04354025|Interleukin-2|interleukin-2|mesh-list
110991986|NCT04354025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110991987|NCT04354025|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110991988|NCT04354025|Antimetabolites|antimetabolites|mesh-ancestor
110991989|NCT04354025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110991990|NCT04354025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110991991|NCT04354025|Immunologic Factors|immunologic factors|mesh-ancestor
110991992|NCT04354025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110991993|NCT04354025|Antiviral Agents|antiviral agents|mesh-ancestor
110991994|NCT04354025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110991995|NCT04354025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110991996|NCT04354025|Analgesics|analgesics|mesh-ancestor
110991997|NCT04354025|Sensory System Agents|sensory system agents|mesh-ancestor
110991998|NCT04354025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110991999|NCT04347720|Acetaminophen|acetaminophen|mesh-list
110992000|NCT04347720|Ibuprofen|ibuprofen|mesh-list
110992001|NCT04347720|Indomethacin|indomethacin|mesh-list
110992002|NCT04347720|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110992003|NCT04347720|Analgesics|analgesics|mesh-ancestor
110992004|NCT04347720|Sensory System Agents|sensory system agents|mesh-ancestor
110992005|NCT04347720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110992006|NCT04347720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110992007|NCT04347720|Antipyretics|antipyretics|mesh-ancestor
110992008|NCT04347720|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110992009|NCT04347720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110992010|NCT04347720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110992011|NCT04347720|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110992012|NCT04347720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110992013|NCT04347720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110992014|NCT04347720|Gout Suppressants|gout suppressants|mesh-ancestor
110992015|NCT04347720|Tocolytic Agents|tocolytic agents|mesh-ancestor
110992016|NCT04347720|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110992017|NCT04325802|Naltrexone|naltrexone|mesh-list
110452082|NCT01025154|Antimetabolites|antimetabolites|mesh-ancestor
110992018|NCT04325802|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110992019|NCT04325802|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110992020|NCT04325802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110992021|NCT04325802|Sensory System Agents|sensory system agents|mesh-ancestor
110992022|NCT04325802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110992023|NCT04285346|Ganaxolone|ganaxolone|mesh-list
110992024|NCT04285346|Neurosteroids|neurosteroids|mesh-ancestor
110992025|NCT04285346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110992026|NCT04285346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110992027|NCT04285346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110992028|NCT04285346|GABA Modulators|gaba modulators|mesh-ancestor
110992029|NCT04285346|GABA Agents|gaba agents|mesh-ancestor
110992030|NCT04241562|Mitogens|mitogens|mesh-list
110992031|NCT04241562|Mitosis Modulators|mitosis modulators|mesh-ancestor
110992032|NCT04241562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110992033|NCT04209192|Amikacin|amikacin|mesh-list
110992034|NCT04209192|Fosfomycin|fosfomycin|mesh-list
110992035|NCT04209192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110992036|NCT04209192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110992037|NCT04199468|Ketamine|ketamine|mesh-list
110992038|NCT04199468|Dronabinol|dronabinol|mesh-list
110992039|NCT04199468|Analgesics|analgesics|mesh-ancestor
110992040|NCT04199468|Sensory System Agents|sensory system agents|mesh-ancestor
110992041|NCT04199468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110992042|NCT04199468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110992043|NCT04199468|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110992044|NCT04199468|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110992045|NCT04199468|Anesthetics, General|anesthetics, general|mesh-ancestor
110992046|NCT04199468|Anesthetics|anesthetics|mesh-ancestor
110992047|NCT04199468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110992048|NCT04199468|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110992049|NCT04199468|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110992050|NCT04199468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110992051|NCT04199468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110992052|NCT04199468|Hallucinogens|hallucinogens|mesh-ancestor
110992053|NCT04199468|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110992054|NCT04199468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110992055|NCT04199468|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
110992056|NCT04199468|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110992057|NCT04199468|Hormones|hormones|mesh-ancestor
110992058|NCT04199468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110992059|NCT04178148|Amikacin|amikacin|mesh-list
110992060|NCT04178148|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110992061|NCT04178148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110992062|NCT04126681|Interferons|interferons|mesh-list
110992063|NCT04126681|Imatinib Mesylate|imatinib mesylate|mesh-list
110992064|NCT04126681|Dasatinib|dasatinib|mesh-list
110992065|NCT04126681|Hydroxyurea|hydroxyurea|mesh-list
110992066|NCT04126681|Homoharringtonine|homoharringtonine|mesh-list
110992067|NCT04126681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110992068|NCT04126681|Antiviral Agents|antiviral agents|mesh-ancestor
110992069|NCT04126681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110992070|NCT04126681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110992071|NCT04126681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110992072|NCT04126681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110992073|NCT04126681|Antisickling Agents|antisickling agents|mesh-ancestor
110992074|NCT04126681|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110992075|NCT04126681|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110992076|NCT04126681|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110992077|NCT04118855|Axitinib|axitinib|mesh-list
110992078|NCT04118855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110992079|NCT04118855|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110992080|NCT04118855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110992081|NCT04118855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110992082|NCT04084860|Ketamine|ketamine|mesh-list
110992083|NCT04084860|Analgesics|analgesics|mesh-ancestor
110992084|NCT04084860|Sensory System Agents|sensory system agents|mesh-ancestor
110992085|NCT04084860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110992086|NCT04084860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110452088|NCT01025154|Immunologic Factors|immunologic factors|mesh-ancestor
110992087|NCT04084860|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110992088|NCT04084860|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110992089|NCT04084860|Anesthetics, General|anesthetics, general|mesh-ancestor
110992090|NCT04084860|Anesthetics|anesthetics|mesh-ancestor
110992091|NCT04084860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110709127|NCT01070706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110992092|NCT04084860|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110992094|NCT04084860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110992095|NCT04084860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110992096|NCT04011150|Fentanyl|fentanyl|mesh-list
110992097|NCT04011150|Ropivacaine|ropivacaine|mesh-list
110992098|NCT04011150|Anesthetics, Local|anesthetics, local|mesh-list
110992099|NCT04011150|Anesthetics|anesthetics|mesh-list
110992100|NCT04011150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110992101|NCT04011150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110992102|NCT04011150|Sensory System Agents|sensory system agents|mesh-ancestor
110992103|NCT04011150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110992104|NCT04011150|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110992105|NCT04011150|Narcotics|narcotics|mesh-ancestor
110992106|NCT04011150|Analgesics|analgesics|mesh-ancestor
110992107|NCT04011150|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110992108|NCT04011150|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110992109|NCT04011150|Anesthetics, General|anesthetics, general|mesh-ancestor
110992110|NCT03927378|Ketamine|ketamine|mesh-list
110992111|NCT03927378|Esketamine|esketamine|mesh-list
110992112|NCT03927378|Analgesics|analgesics|mesh-ancestor
110992113|NCT03927378|Sensory System Agents|sensory system agents|mesh-ancestor
110992114|NCT03927378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110992115|NCT03927378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110992116|NCT03927378|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110992117|NCT03927378|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110992118|NCT03927378|Anesthetics, General|anesthetics, general|mesh-ancestor
110992119|NCT03927378|Anesthetics|anesthetics|mesh-ancestor
110992120|NCT03927378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110992121|NCT03927378|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110992122|NCT03927378|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110992123|NCT03927378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110992124|NCT03927378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110992125|NCT03927378|Antidepressive Agents|antidepressive agents|mesh-ancestor
110992126|NCT03927378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110992127|NCT03875391|Oxytocin|oxytocin|mesh-list
110992128|NCT03875391|Oxytocics|oxytocics|mesh-ancestor
110992129|NCT03875391|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110992130|NCT03875391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110992131|NCT03836066|Bevacizumab|bevacizumab|mesh-list
110992132|NCT03836066|Atezolizumab|atezolizumab|mesh-list
110992133|NCT03836066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110992134|NCT03836066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110992135|NCT03836066|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110992136|NCT03836066|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110992137|NCT03836066|Growth Substances|growth substances|mesh-ancestor
110992138|NCT03836066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110992139|NCT03836066|Growth Inhibitors|growth inhibitors|mesh-ancestor
110992140|NCT03836066|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110992141|NCT03836066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110992142|NCT03778242|Tranexamic Acid|tranexamic acid|mesh-list
110992143|NCT03778242|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110992144|NCT03778242|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110992145|NCT03778242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110992146|NCT03778242|Hemostatics|hemostatics|mesh-ancestor
110992147|NCT03778242|Coagulants|coagulants|mesh-ancestor
110992148|NCT03772613|Heparin|heparin|mesh-list
110992149|NCT03772613|Calcium heparin|calcium heparin|mesh-list
110992150|NCT03772613|Anticoagulants|anticoagulants|mesh-ancestor
110992151|NCT03772613|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110992152|NCT03772613|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110992153|NCT03772613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110992154|NCT03730194|Melatonin|melatonin|mesh-list
110992155|NCT03730194|Antioxidants|antioxidants|mesh-ancestor
110992156|NCT03730194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110992157|NCT03730194|Protective Agents|protective agents|mesh-ancestor
110992158|NCT03730194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110992159|NCT03730194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110992160|NCT03698461|Leucovorin|leucovorin|mesh-list
110992161|NCT03698461|Bevacizumab|bevacizumab|mesh-list
110992162|NCT03698461|Atezolizumab|atezolizumab|mesh-list
110992163|NCT03698461|Fluorouracil|fluorouracil|mesh-list
110992164|NCT03698461|Oxaliplatin|oxaliplatin|mesh-list
110992165|NCT03698461|Levoleucovorin|levoleucovorin|mesh-list
110992166|NCT03698461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110992167|NCT03698461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110992168|NCT03698461|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110992169|NCT03698461|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110992170|NCT03698461|Growth Substances|growth substances|mesh-ancestor
110992171|NCT03698461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110992172|NCT03698461|Growth Inhibitors|growth inhibitors|mesh-ancestor
110992173|NCT03698461|Antimetabolites|antimetabolites|mesh-ancestor
110992174|NCT03698461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110992175|NCT03698461|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110992176|NCT03698461|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110992177|NCT03698461|Immunologic Factors|immunologic factors|mesh-ancestor
110992178|NCT03698461|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110992179|NCT03698461|Antidotes|antidotes|mesh-ancestor
110992180|NCT03698461|Protective Agents|protective agents|mesh-ancestor
110992181|NCT03698461|Vitamin B Complex|vitamin b complex|mesh-ancestor
110992182|NCT03698461|Vitamins|vitamins|mesh-ancestor
110992183|NCT03698461|Micronutrients|micronutrients|mesh-ancestor
110992184|NCT03601923|Niraparib|niraparib|mesh-list
110992185|NCT03601923|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110992186|NCT03601923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110992187|NCT03601923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110992188|NCT03601923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110992189|NCT03590652|Dexamethasone|dexamethasone|mesh-list
110992190|NCT03590652|Daratumumab|daratumumab|mesh-list
110992191|NCT03590652|Pomalidomide|pomalidomide|mesh-list
110992192|NCT03590652|Ixazomib|ixazomib|mesh-list
110992193|NCT03590652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110992194|NCT03590652|Antiemetics|antiemetics|mesh-ancestor
110992195|NCT03590652|Autonomic Agents|autonomic agents|mesh-ancestor
110992196|NCT03590652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110992197|NCT03590652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110992198|NCT03590652|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110992199|NCT03590652|Glucocorticoids|glucocorticoids|mesh-ancestor
110992200|NCT03590652|Hormones|hormones|mesh-ancestor
110992201|NCT03590652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110992202|NCT03590652|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110992203|NCT03590652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110992204|NCT03590652|Immunologic Factors|immunologic factors|mesh-ancestor
110992205|NCT03590652|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110992206|NCT03590652|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110992207|NCT03590652|Growth Substances|growth substances|mesh-ancestor
110992208|NCT03590652|Growth Inhibitors|growth inhibitors|mesh-ancestor
110992209|NCT03590652|Protease Inhibitors|protease inhibitors|mesh-ancestor
110992210|NCT03590652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110992211|NCT03590652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110992212|NCT03535363|Osimertinib|osimertinib|mesh-list
110992213|NCT03535363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110992214|NCT03535363|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110992215|NCT03535363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110992216|NCT03535363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110992217|NCT03384836|Pembrolizumab|pembrolizumab|mesh-list
110992218|NCT03384836|Propranolol|propranolol|mesh-list
110992219|NCT03384836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110992220|NCT03384836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110992221|NCT03384836|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110992222|NCT03384836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110992223|NCT03384836|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110992224|NCT03384836|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110992225|NCT03384836|Adrenergic Agents|adrenergic agents|mesh-ancestor
110992226|NCT03384836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110992227|NCT03384836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110992228|NCT03384836|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110992229|NCT03384836|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110992230|NCT03384836|Vasodilator Agents|vasodilator agents|mesh-ancestor
110992231|NCT03377179|Hydroxychloroquine|hydroxychloroquine|mesh-list
110992232|NCT03377179|Antimalarials|antimalarials|mesh-ancestor
110992233|NCT03377179|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110992234|NCT03377179|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110992235|NCT03377179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110992236|NCT03377179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110992237|NCT03377179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110992238|NCT03377179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110992239|NCT03261102|Adalimumab|adalimumab|mesh-list
110992240|NCT03261102|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110992241|NCT03261102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110992242|NCT03261102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110992243|NCT03241732|Acetylcysteine|acetylcysteine|mesh-list
110992244|NCT03241732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
110992245|NCT03241732|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110992246|NCT03241732|Antiviral Agents|antiviral agents|mesh-ancestor
110992247|NCT03241732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110992248|NCT03241732|Expectorants|expectorants|mesh-ancestor
110992249|NCT03241732|Respiratory System Agents|respiratory system agents|mesh-ancestor
110992250|NCT03241732|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110992251|NCT03241732|Antioxidants|antioxidants|mesh-ancestor
110992252|NCT03241732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110992253|NCT03241732|Protective Agents|protective agents|mesh-ancestor
110992254|NCT03241732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110992255|NCT03241732|Antidotes|antidotes|mesh-ancestor
110992256|NCT02968212|Clofazimine|clofazimine|mesh-list
110992257|NCT02968212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110992258|NCT02968212|Leprostatic Agents|leprostatic agents|mesh-ancestor
110992259|NCT02968212|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110992260|NCT02968212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110992261|NCT02931253|Metformin|metformin|mesh-list
110992262|NCT02931253|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110992263|NCT02931253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110992264|NCT02848131|Dasatinib|dasatinib|mesh-list
110992265|NCT02848131|Quercetin|quercetin|mesh-list
110992266|NCT02848131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110992267|NCT02848131|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110992268|NCT02848131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110992269|NCT02848131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110992270|NCT02848131|Antioxidants|antioxidants|mesh-ancestor
110992271|NCT02848131|Protective Agents|protective agents|mesh-ancestor
110992272|NCT02848131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110992273|NCT02846376|Nivolumab|nivolumab|mesh-list
110992274|NCT02846376|Ipilimumab|ipilimumab|mesh-list
110992275|NCT02846376|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110992276|NCT02846376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110992277|NCT02846376|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110992278|NCT02846376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110992279|NCT02590601|Bromocriptine|bromocriptine|mesh-list
110992280|NCT02590601|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110992281|NCT02590601|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110992282|NCT02590601|Hormone Antagonists|hormone antagonists|mesh-ancestor
110992283|NCT02590601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110992284|NCT02590601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110992285|NCT02590601|Dopamine Agonists|dopamine agonists|mesh-ancestor
110992286|NCT02590601|Dopamine Agents|dopamine agents|mesh-ancestor
110992287|NCT02590601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110992288|NCT02590601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110992289|NCT02484443|Dinutuximab|dinutuximab|mesh-list
110992290|NCT02484443|Sargramostim|sargramostim|mesh-list
110992291|NCT02484443|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110992292|NCT02484443|Immunologic Factors|immunologic factors|mesh-ancestor
110992293|NCT02484443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110992294|NCT02484443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110992295|NCT02306161|Cyclophosphamide|cyclophosphamide|mesh-list
110992296|NCT02306161|Ifosfamide|ifosfamide|mesh-list
110992297|NCT02306161|Isophosphamide mustard|isophosphamide mustard|mesh-list
110992298|NCT02306161|Doxorubicin|doxorubicin|mesh-list
110992299|NCT02306161|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110992300|NCT02306161|Etoposide|etoposide|mesh-list
110992301|NCT02306161|Etoposide phosphate|etoposide phosphate|mesh-list
110992302|NCT02306161|Vincristine|vincristine|mesh-list
110992303|NCT02306161|Daunorubicin|daunorubicin|mesh-list
110992304|NCT02306161|Podophyllotoxin|podophyllotoxin|mesh-list
110992305|NCT02306161|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110992306|NCT02306161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110992307|NCT02306161|Immunologic Factors|immunologic factors|mesh-ancestor
110992308|NCT02306161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110992309|NCT02306161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110992310|NCT02306161|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110992311|NCT02306161|Alkylating Agents|alkylating agents|mesh-ancestor
110992312|NCT02306161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110992313|NCT02306161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110992314|NCT02306161|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110992315|NCT02306161|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110992316|NCT02306161|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110992317|NCT02306161|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110992318|NCT02306161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110992319|NCT02306161|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110992320|NCT02306161|Tubulin Modulators|tubulin modulators|mesh-ancestor
110992321|NCT02306161|Antimitotic Agents|antimitotic agents|mesh-ancestor
110992323|NCT02306161|Keratolytic Agents|keratolytic agents|mesh-ancestor
110992324|NCT02306161|Dermatologic Agents|dermatologic agents|mesh-ancestor
110992325|NCT02240498|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
110992326|NCT02240498|Methylene Blue|methylene blue|mesh-list
110992327|NCT02240498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110992328|NCT02240498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110992329|NCT02240498|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
110992330|NCT02240498|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
110992331|NCT02240498|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110992332|NCT02178098|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
110992333|NCT02178098|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110992334|NCT02178098|Antimetabolites|antimetabolites|mesh-ancestor
110992335|NCT02178098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110992336|NCT02178098|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110992337|NCT02178098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110992338|NCT02178098|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110992339|NCT02178098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110992340|NCT01885689|Sirolimus|sirolimus|mesh-list
110992341|NCT01885689|Melphalan|melphalan|mesh-list
110992342|NCT01885689|Clofarabine|clofarabine|mesh-list
110992343|NCT01885689|Tacrolimus|tacrolimus|mesh-list
110992344|NCT01885689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110992345|NCT01885689|Immunologic Factors|immunologic factors|mesh-ancestor
110992346|NCT01885689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110992347|NCT01885689|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110992348|NCT01885689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110992349|NCT01885689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110992350|NCT01885689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110992351|NCT01885689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110992352|NCT01885689|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110992353|NCT01885689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110992354|NCT01885689|Antifungal Agents|antifungal agents|mesh-ancestor
110992355|NCT01885689|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110992356|NCT01885689|Alkylating Agents|alkylating agents|mesh-ancestor
110992357|NCT01885689|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110992358|NCT01885689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110992359|NCT01885689|Antimetabolites|antimetabolites|mesh-ancestor
110992360|NCT01798004|Cyclophosphamide|cyclophosphamide|mesh-list
110992361|NCT01798004|Melphalan|melphalan|mesh-list
110992362|NCT01798004|Busulfan|busulfan|mesh-list
110992363|NCT01798004|Mechlorethamine|mechlorethamine|mesh-list
110992364|NCT01798004|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
110992365|NCT01798004|Cisplatin|cisplatin|mesh-list
110992366|NCT01798004|Doxorubicin|doxorubicin|mesh-list
110992367|NCT01798004|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110992368|NCT01798004|Etoposide|etoposide|mesh-list
110992369|NCT01798004|Vincristine|vincristine|mesh-list
110992370|NCT01798004|Etoposide phosphate|etoposide phosphate|mesh-list
110992371|NCT01798004|Topotecan|topotecan|mesh-list
110992372|NCT01798004|Podophyllotoxin|podophyllotoxin|mesh-list
110992373|NCT01798004|Lenograstim|lenograstim|mesh-list
110992374|NCT01798004|Mesna|mesna|mesh-list
110992375|NCT01798004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110992376|NCT01798004|Immunologic Factors|immunologic factors|mesh-ancestor
110992377|NCT01798004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110992378|NCT01798004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110992379|NCT01798004|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110992380|NCT01798004|Alkylating Agents|alkylating agents|mesh-ancestor
110992381|NCT01798004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110992382|NCT01798004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110992383|NCT01798004|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110992384|NCT01798004|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110992385|NCT01798004|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110992386|NCT01798004|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110992387|NCT01798004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110992388|NCT01798004|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110992389|NCT01798004|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110992390|NCT01798004|Tubulin Modulators|tubulin modulators|mesh-ancestor
110992391|NCT01798004|Antimitotic Agents|antimitotic agents|mesh-ancestor
110992392|NCT01798004|Mitosis Modulators|mitosis modulators|mesh-ancestor
110992393|NCT01798004|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110992394|NCT01798004|Protective Agents|protective agents|mesh-ancestor
110992395|NCT01798004|Keratolytic Agents|keratolytic agents|mesh-ancestor
110992396|NCT01798004|Dermatologic Agents|dermatologic agents|mesh-ancestor
110992397|NCT01693380|Vaccines|vaccines|mesh-list
110992398|NCT01693380|Immunologic Factors|immunologic factors|mesh-ancestor
110992399|NCT01693380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110992400|NCT01542879|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
110992401|NCT01542879|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110992402|NCT01542879|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110992403|NCT01542879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110992404|NCT01542879|Hematinics|hematinics|mesh-ancestor
110992405|NCT01542879|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
110992406|NCT01542879|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110992407|NCT01492972|Leuprolide|leuprolide|mesh-list
110992408|NCT01492972|Goserelin|goserelin|mesh-list
110992409|NCT01492972|Triptorelin Pamoate|triptorelin pamoate|mesh-list
110992410|NCT01492972|Buserelin|buserelin|mesh-list
110992411|NCT01492972|Androgens|androgens|mesh-list
110992412|NCT01492972|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110992413|NCT01492972|Fertility Agents|fertility agents|mesh-ancestor
110992414|NCT01492972|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110992415|NCT01492972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110992416|NCT01492972|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110992417|NCT01492972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110992418|NCT01492972|Hormones|hormones|mesh-ancestor
110992419|NCT01492972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110992420|NCT01492972|Luteolytic Agents|luteolytic agents|mesh-ancestor
110992421|NCT01492972|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110992422|NCT01492972|Contraceptive Agents|contraceptive agents|mesh-ancestor
110992423|NCT01492972|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110992424|NCT01256398|Calcium, Dietary|calcium, dietary|mesh-list
110992425|NCT01256398|Leucovorin|leucovorin|mesh-list
110992426|NCT01256398|Folic Acid|folic acid|mesh-list
110992427|NCT01256398|Cytarabine|cytarabine|mesh-list
110992428|NCT01256398|Dexamethasone|dexamethasone|mesh-list
110992429|NCT01256398|Dexamethasone acetate|dexamethasone acetate|mesh-list
110992430|NCT01256398|Cyclophosphamide|cyclophosphamide|mesh-list
110992431|NCT01256398|Melphalan|melphalan|mesh-list
110992432|NCT01256398|Mechlorethamine|mechlorethamine|mesh-list
110452129|NCT00918255|Adalimumab|adalimumab|mesh-list
110992433|NCT01256398|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
110992434|NCT01256398|Methotrexate|methotrexate|mesh-list
110992435|NCT01256398|Fludarabine|fludarabine|mesh-list
110992436|NCT01256398|Fludarabine phosphate|fludarabine phosphate|mesh-list
110992437|NCT01256398|Etoposide|etoposide|mesh-list
110992438|NCT01256398|Vincristine|vincristine|mesh-list
110992439|NCT01256398|Daunorubicin|daunorubicin|mesh-list
110992440|NCT01256398|Dasatinib|dasatinib|mesh-list
110992441|NCT01256398|Mercaptopurine|mercaptopurine|mesh-list
110992442|NCT01256398|Alemtuzumab|alemtuzumab|mesh-list
110992443|NCT01256398|Etoposide phosphate|etoposide phosphate|mesh-list
110992444|NCT01256398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110992445|NCT01256398|Tacrolimus|tacrolimus|mesh-list
110992446|NCT01256398|Antibodies|antibodies|mesh-list
110992447|NCT01256398|Immunoglobulins|immunoglobulins|mesh-list
110992448|NCT01256398|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110992449|NCT01256398|Lenograstim|lenograstim|mesh-list
110992450|NCT01256398|BB 1101|bb 1101|mesh-list
110992451|NCT01256398|Calcium|calcium|mesh-list
110992452|NCT01256398|Levoleucovorin|levoleucovorin|mesh-list
110992453|NCT01256398|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110992454|NCT01256398|Immunologic Factors|immunologic factors|mesh-ancestor
110992455|NCT01256398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110992456|NCT01256398|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110992457|NCT01256398|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110992458|NCT01256398|Alkylating Agents|alkylating agents|mesh-ancestor
110992459|NCT01256398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110992460|NCT01256398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110992461|NCT01256398|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110992462|NCT01256398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110992463|NCT01256398|Antiemetics|antiemetics|mesh-ancestor
110992464|NCT01256398|Autonomic Agents|autonomic agents|mesh-ancestor
110992465|NCT01256398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110992466|NCT01256398|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110992467|NCT01256398|Glucocorticoids|glucocorticoids|mesh-ancestor
110992468|NCT01256398|Hormones|hormones|mesh-ancestor
110992469|NCT01256398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110992470|NCT01256398|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110992471|NCT01256398|Protease Inhibitors|protease inhibitors|mesh-ancestor
110992472|NCT01256398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110992473|NCT01256398|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110992474|NCT01256398|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110992475|NCT01256398|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110992476|NCT01256398|Abortifacient Agents|abortifacient agents|mesh-ancestor
110992477|NCT01256398|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110992478|NCT01256398|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110992484|NCT01256398|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110992485|NCT01256398|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110992486|NCT01256398|Antiviral Agents|antiviral agents|mesh-ancestor
110992487|NCT01256398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110992488|NCT01256398|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110992489|NCT01256398|Antidotes|antidotes|mesh-ancestor
110992490|NCT01256398|Protective Agents|protective agents|mesh-ancestor
110992491|NCT01256398|Vitamin B Complex|vitamin b complex|mesh-ancestor
110992492|NCT01256398|Vitamins|vitamins|mesh-ancestor
110992493|NCT01256398|Micronutrients|micronutrients|mesh-ancestor
110992494|NCT01256398|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110992495|NCT01256398|Tubulin Modulators|tubulin modulators|mesh-ancestor
110992496|NCT01256398|Antimitotic Agents|antimitotic agents|mesh-ancestor
110992497|NCT01256398|Mitosis Modulators|mitosis modulators|mesh-ancestor
110992498|NCT01256398|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110992499|NCT01256398|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110992500|NCT01256398|Hematinics|hematinics|mesh-ancestor
110992501|NCT01175356|Vitamin A|vitamin a|mesh-list
110992502|NCT01175356|Cyclophosphamide|cyclophosphamide|mesh-list
110992503|NCT01175356|Melphalan|melphalan|mesh-list
110992504|NCT01175356|Busulfan|busulfan|mesh-list
110992505|NCT01175356|Mechlorethamine|mechlorethamine|mesh-list
110992506|NCT01175356|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
110992507|NCT01175356|Cisplatin|cisplatin|mesh-list
110992508|NCT01175356|Doxorubicin|doxorubicin|mesh-list
110992509|NCT01175356|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110992510|NCT01175356|Etoposide|etoposide|mesh-list
110992511|NCT01175356|Vincristine|vincristine|mesh-list
110992512|NCT01175356|Topotecan|topotecan|mesh-list
110992513|NCT01175356|Tretinoin|tretinoin|mesh-list
110992514|NCT01175356|Etoposide phosphate|etoposide phosphate|mesh-list
110992515|NCT01175356|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
110992516|NCT01175356|Isotretinoin|isotretinoin|mesh-list
110992517|NCT01175356|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110992518|NCT01175356|Immunologic Factors|immunologic factors|mesh-ancestor
110992519|NCT01175356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110992520|NCT01175356|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110992521|NCT01175356|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110992522|NCT01175356|Alkylating Agents|alkylating agents|mesh-ancestor
110992523|NCT01175356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110992524|NCT01175356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110992525|NCT01175356|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110992526|NCT01175356|Vitamins|vitamins|mesh-ancestor
110992527|NCT01175356|Micronutrients|micronutrients|mesh-ancestor
110992528|NCT01175356|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110992529|NCT01175356|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110992530|NCT01175356|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110992531|NCT01175356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110992532|NCT01175356|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110992533|NCT01175356|Tubulin Modulators|tubulin modulators|mesh-ancestor
110992534|NCT01175356|Antimitotic Agents|antimitotic agents|mesh-ancestor
110992535|NCT01175356|Mitosis Modulators|mitosis modulators|mesh-ancestor
110992536|NCT01175356|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110992537|NCT01175356|Keratolytic Agents|keratolytic agents|mesh-ancestor
110992538|NCT01175356|Dermatologic Agents|dermatologic agents|mesh-ancestor
110992539|NCT01175356|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110992540|NCT01020383|Abciximab|abciximab|mesh-list
110992541|NCT01020383|Anticoagulants|anticoagulants|mesh-ancestor
110992542|NCT01020383|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110992543|NCT00889876|Metformin|metformin|mesh-list
110992544|NCT00889876|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110992545|NCT00889876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110992552|NCT00587067|Floxuridine|floxuridine|mesh-list
110992553|NCT00587067|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110992554|NCT00587067|Antimetabolites|antimetabolites|mesh-ancestor
110992555|NCT00587067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110992556|NCT00587067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110992557|NCT00577278|Sirolimus|sirolimus|mesh-list
110992558|NCT00577278|Rituximab|rituximab|mesh-list
110992559|NCT00577278|Fludarabine|fludarabine|mesh-list
110992560|NCT00577278|Fludarabine phosphate|fludarabine phosphate|mesh-list
110992561|NCT00577278|Melphalan|melphalan|mesh-list
110992562|NCT00577278|Tacrolimus|tacrolimus|mesh-list
110992563|NCT00577278|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110992564|NCT00577278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110992565|NCT00577278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110992566|NCT00577278|Immunologic Factors|immunologic factors|mesh-ancestor
110992567|NCT00577278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110992568|NCT00577278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110992569|NCT00577278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110992570|NCT00577278|Antimetabolites|antimetabolites|mesh-ancestor
110992571|NCT00577278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110992572|NCT00577278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110992573|NCT00577278|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110992574|NCT00577278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110992575|NCT00577278|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110992576|NCT00577278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110992577|NCT00577278|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110992578|NCT00577278|Antifungal Agents|antifungal agents|mesh-ancestor
110992579|NCT00577278|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110992580|NCT00577278|Alkylating Agents|alkylating agents|mesh-ancestor
110992581|NCT00577278|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110992582|NCT00453154|Cisplatin|cisplatin|mesh-list
110992583|NCT00453154|Carboplatin|carboplatin|mesh-list
110992584|NCT00453154|Etoposide|etoposide|mesh-list
110992585|NCT00453154|Etoposide phosphate|etoposide phosphate|mesh-list
110992586|NCT00453154|Sunitinib|sunitinib|mesh-list
110992587|NCT00453154|Podophyllotoxin|podophyllotoxin|mesh-list
110992588|NCT00453154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110992589|NCT00453154|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110992590|NCT00453154|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110992591|NCT00453154|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110992592|NCT00453154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110992593|NCT00453154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110992594|NCT00453154|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110992595|NCT00453154|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110992596|NCT00453154|Growth Substances|growth substances|mesh-ancestor
110992597|NCT00453154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110992598|NCT00453154|Growth Inhibitors|growth inhibitors|mesh-ancestor
110992599|NCT00453154|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110992600|NCT00453154|Keratolytic Agents|keratolytic agents|mesh-ancestor
110992601|NCT00453154|Dermatologic Agents|dermatologic agents|mesh-ancestor
110992602|NCT00453154|Tubulin Modulators|tubulin modulators|mesh-ancestor
110992603|NCT00453154|Antimitotic Agents|antimitotic agents|mesh-ancestor
110992604|NCT00453154|Mitosis Modulators|mitosis modulators|mesh-ancestor
110992605|NCT00334815|Bevacizumab|bevacizumab|mesh-list
110992606|NCT00334815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110992607|NCT00334815|Cisplatin|cisplatin|mesh-list
110992608|NCT00334815|Docetaxel|docetaxel|mesh-list
110992609|NCT00334815|Etoposide|etoposide|mesh-list
110992610|NCT00334815|Etoposide phosphate|etoposide phosphate|mesh-list
110992611|NCT00334815|Podophyllotoxin|podophyllotoxin|mesh-list
110992612|NCT00334815|Endothelial Growth Factors|endothelial growth factors|mesh-list
110992613|NCT00334815|Antibodies|antibodies|mesh-list
110992614|NCT00334815|Immunoglobulins|immunoglobulins|mesh-list
110992615|NCT00334815|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110992616|NCT00334815|Lenograstim|lenograstim|mesh-list
110992617|NCT00334815|Immunoglobulin G|immunoglobulin g|mesh-list
110992618|NCT00334815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110992619|NCT00334815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110992620|NCT00334815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110992621|NCT00334815|Growth Substances|growth substances|mesh-ancestor
110992622|NCT00334815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110992623|NCT00334815|Growth Inhibitors|growth inhibitors|mesh-ancestor
110992624|NCT00334815|Immunologic Factors|immunologic factors|mesh-ancestor
110992625|NCT00334815|Tubulin Modulators|tubulin modulators|mesh-ancestor
110992626|NCT00334815|Antimitotic Agents|antimitotic agents|mesh-ancestor
110992627|NCT00334815|Mitosis Modulators|mitosis modulators|mesh-ancestor
110992628|NCT00334815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110992629|NCT00334815|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110992630|NCT00334815|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110992631|NCT00334815|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110992632|NCT00334815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110992633|NCT00334815|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110709653|NCT00275262|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110992634|NCT00334815|Keratolytic Agents|keratolytic agents|mesh-ancestor
110992635|NCT00334815|Dermatologic Agents|dermatologic agents|mesh-ancestor
110992636|NCT00309257|Valsartan|valsartan|mesh-list
110992637|NCT00309257|Benazepril|benazepril|mesh-list
110992638|NCT00309257|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110992639|NCT00309257|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110992640|NCT00309257|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110992641|NCT00309257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110992642|NCT00309257|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110992643|NCT00309257|Protease Inhibitors|protease inhibitors|mesh-ancestor
110992644|NCT00309257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110992645|NCT00258960|Cyclophosphamide|cyclophosphamide|mesh-list
110992646|NCT00258960|Doxorubicin|doxorubicin|mesh-list
110992647|NCT00258960|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110992648|NCT00258960|Trastuzumab|trastuzumab|mesh-list
110992649|NCT00258960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110992650|NCT00258960|Immunologic Factors|immunologic factors|mesh-ancestor
110992651|NCT00258960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110992652|NCT00258960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110992653|NCT00258960|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110992654|NCT00258960|Alkylating Agents|alkylating agents|mesh-ancestor
110992655|NCT00258960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110992656|NCT00258960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110992657|NCT00258960|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110992658|NCT00258960|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110992659|NCT00258960|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110992660|NCT00258960|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110992661|NCT00258960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110992662|NCT00258960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110992663|NCT00121992|Cyclophosphamide|cyclophosphamide|mesh-list
110992664|NCT00121992|Docetaxel|docetaxel|mesh-list
110992665|NCT00121992|Doxorubicin|doxorubicin|mesh-list
110992666|NCT00121992|Fluorouracil|fluorouracil|mesh-list
110992667|NCT00121992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110992668|NCT00121992|Immunologic Factors|immunologic factors|mesh-ancestor
110992669|NCT00121992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110992670|NCT00121992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110992671|NCT00121992|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110992672|NCT00121992|Alkylating Agents|alkylating agents|mesh-ancestor
110992673|NCT00121992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110992674|NCT00121992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110992675|NCT00121992|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110992676|NCT00121992|Tubulin Modulators|tubulin modulators|mesh-ancestor
110992677|NCT00121992|Antimitotic Agents|antimitotic agents|mesh-ancestor
110992678|NCT00121992|Mitosis Modulators|mitosis modulators|mesh-ancestor
110992679|NCT00121992|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110992680|NCT00121992|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110992681|NCT00121992|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110992682|NCT00121992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110992683|NCT00121992|Antimetabolites|antimetabolites|mesh-ancestor
110992684|NCT00121992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110992685|NCT00070564|Paclitaxel|paclitaxel|mesh-list
110992686|NCT00070564|Cyclophosphamide|cyclophosphamide|mesh-list
110992687|NCT00070564|Doxorubicin|doxorubicin|mesh-list
110992688|NCT00070564|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110992689|NCT00070564|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110992690|NCT00070564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110992691|NCT00070564|Tubulin Modulators|tubulin modulators|mesh-ancestor
110992692|NCT00070564|Antimitotic Agents|antimitotic agents|mesh-ancestor
110992693|NCT00070564|Mitosis Modulators|mitosis modulators|mesh-ancestor
110992694|NCT00070564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110992695|NCT00070564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110992696|NCT00070564|Immunologic Factors|immunologic factors|mesh-ancestor
110992697|NCT00070564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110992698|NCT00070564|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110992699|NCT00070564|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110992700|NCT00070564|Alkylating Agents|alkylating agents|mesh-ancestor
110992701|NCT00070564|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110992702|NCT00070564|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110992703|NCT00070564|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110992704|NCT00070564|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110992705|NCT00070564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110992706|NCT05158647|Magnesium Sulfate|magnesium sulfate|mesh-list
110992707|NCT05158647|Analgesics|analgesics|mesh-ancestor
110992708|NCT05158647|Sensory System Agents|sensory system agents|mesh-ancestor
110992709|NCT05158647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110992710|NCT05158647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110992711|NCT05158647|Anesthetics|anesthetics|mesh-ancestor
110992712|NCT05158647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110992713|NCT05158647|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110992714|NCT05158647|Anticonvulsants|anticonvulsants|mesh-ancestor
110992715|NCT05158647|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110992716|NCT05158647|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110452160|NCT04252521|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110992717|NCT05158647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110992718|NCT05158647|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110992719|NCT05158647|Tocolytic Agents|tocolytic agents|mesh-ancestor
110992720|NCT05158647|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110992721|NCT02738151|Insulin|insulin|mesh-list
110992722|NCT02738151|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110992723|NCT02738151|Insulin Glargine|insulin glargine|mesh-list
110992724|NCT02738151|Hypoglycemic Agents|hypoglycemic agents|mesh-list
110992725|NCT02738151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110992726|NCT05212389|Contraceptive Agents|contraceptive agents|mesh-list
110992727|NCT05212389|Contraceptives, Oral|contraceptives, oral|mesh-list
110992728|NCT05212389|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
110992729|NCT05212389|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110992730|NCT05212389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110992731|NCT05212389|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110992732|NCT03471039|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
110992733|NCT03471039|Growth Substances|growth substances|mesh-ancestor
110992734|NCT03471039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110992735|NCT03471039|Vasodilator Agents|vasodilator agents|mesh-ancestor
110992736|NCT03471039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110992737|NCT03471039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110992738|NCT03472677|Capsaicin|capsaicin|mesh-list
110992739|NCT03472677|Antipruritics|antipruritics|mesh-ancestor
110992740|NCT03472677|Dermatologic Agents|dermatologic agents|mesh-ancestor
110992741|NCT03472677|Sensory System Agents|sensory system agents|mesh-ancestor
110992742|NCT03472677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110992743|NCT03472677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110992744|NCT02673567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110992745|NCT02673567|Antibodies|antibodies|mesh-list
110992746|NCT02673567|Immunoglobulins|immunoglobulins|mesh-list
110992747|NCT02673567|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110992748|NCT02673567|Immunologic Factors|immunologic factors|mesh-ancestor
110992749|NCT02673567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110992750|NCT02673567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110992751|NCT00702195|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
110992752|NCT00702195|Hormones|hormones|mesh-ancestor
110992753|NCT00702195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110992754|NCT00702195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110992755|NCT02993731|Paclitaxel|paclitaxel|mesh-list
110992756|NCT02993731|Gemcitabine|gemcitabine|mesh-list
110992757|NCT02993731|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110992758|NCT02993731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110992759|NCT02993731|Tubulin Modulators|tubulin modulators|mesh-ancestor
110992760|NCT02993731|Antimitotic Agents|antimitotic agents|mesh-ancestor
110992761|NCT02993731|Mitosis Modulators|mitosis modulators|mesh-ancestor
110992762|NCT02993731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110992763|NCT02993731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110992764|NCT02993731|Antimetabolites|antimetabolites|mesh-ancestor
110992765|NCT02915159|Abatacept|abatacept|mesh-list
110992766|NCT02915159|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110992767|NCT02915159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110992768|NCT02915159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110992769|NCT02915159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110992770|NCT02915159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110992771|NCT02915159|Immunologic Factors|immunologic factors|mesh-ancestor
110992772|NCT02915159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110992773|NCT02915159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110992774|NCT03669263|Fentanyl|fentanyl|mesh-list
110992775|NCT03669263|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110992776|NCT03669263|Narcotics|narcotics|mesh-ancestor
110992777|NCT03669263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110992778|NCT03669263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110992779|NCT03669263|Analgesics|analgesics|mesh-ancestor
110992780|NCT03669263|Sensory System Agents|sensory system agents|mesh-ancestor
110992781|NCT03669263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110992782|NCT03669263|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110992783|NCT03669263|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110992784|NCT03669263|Anesthetics, General|anesthetics, general|mesh-ancestor
110452167|NCT00845065|Ribavirin|ribavirin|mesh-list
110992785|NCT03669263|Anesthetics|anesthetics|mesh-ancestor
110992787|NCT02669264|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110992788|NCT02669264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110992789|NCT02521870|Pembrolizumab|pembrolizumab|mesh-list
110992790|NCT02521870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110992791|NCT02521870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110992792|NCT02521870|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110992793|NCT02521870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110992794|NCT02385656|Modafinil|modafinil|mesh-list
110992795|NCT02385656|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110992796|NCT02385656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110992797|NCT02385656|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
110992798|NCT02385656|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110992799|NCT02385656|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110992800|NCT02385656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110992801|NCT02389868|Lovastatin|lovastatin|mesh-list
110992802|NCT02389868|L 647318|l 647318|mesh-list
110992803|NCT02389868|Dihydromevinolin|dihydromevinolin|mesh-list
110992804|NCT02389868|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110992805|NCT02389868|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110992806|NCT02389868|Antimetabolites|antimetabolites|mesh-ancestor
110992807|NCT02389868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110992808|NCT02389868|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110992809|NCT02389868|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110992810|NCT02389868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110992811|NCT03623087|Dexamethasone|dexamethasone|mesh-list
110992812|NCT03623087|Gemcitabine|gemcitabine|mesh-list
110992813|NCT03623087|Etoposide|etoposide|mesh-list
110992814|NCT03623087|Asparaginase|asparaginase|mesh-list
110992815|NCT03623087|Ifosfamide|ifosfamide|mesh-list
110992816|NCT03623087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110992817|NCT03623087|Antiemetics|antiemetics|mesh-ancestor
110992818|NCT03623087|Autonomic Agents|autonomic agents|mesh-ancestor
110992819|NCT03623087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110992820|NCT03623087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110992821|NCT03623087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110992822|NCT03623087|Glucocorticoids|glucocorticoids|mesh-ancestor
110992823|NCT03623087|Hormones|hormones|mesh-ancestor
110992824|NCT03623087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110024430|NCT00004734|Micronutrients|micronutrients|mesh-ancestor
110992825|NCT03623087|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110992826|NCT03623087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110992827|NCT03623087|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110992828|NCT03623087|Antimetabolites|antimetabolites|mesh-ancestor
110992829|NCT03623087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110992830|NCT03623087|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110992831|NCT03623087|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110992832|NCT03623087|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110992833|NCT03623087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110992834|NCT03623087|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110992835|NCT03623087|Alkylating Agents|alkylating agents|mesh-ancestor
110992836|NCT05420636|Paclitaxel|paclitaxel|mesh-list
110992837|NCT05420636|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110992838|NCT05420636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110992839|NCT05420636|Tubulin Modulators|tubulin modulators|mesh-ancestor
110992840|NCT05420636|Antimitotic Agents|antimitotic agents|mesh-ancestor
110992841|NCT05420636|Mitosis Modulators|mitosis modulators|mesh-ancestor
110992842|NCT05420636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110992843|NCT03113396|Baclofen|baclofen|mesh-list
110992844|NCT03113396|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110992845|NCT03113396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110992846|NCT03113396|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110992847|NCT03113396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110992848|NCT03113396|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
110992849|NCT03113396|GABA Agonists|gaba agonists|mesh-ancestor
110992850|NCT03113396|GABA Agents|gaba agents|mesh-ancestor
110992851|NCT03113396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110992852|NCT03113396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110992853|NCT03020615|Hydroxyurea|hydroxyurea|mesh-list
110992854|NCT03020615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110992855|NCT03020615|Antisickling Agents|antisickling agents|mesh-ancestor
110992856|NCT03020615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110992857|NCT03020615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110992858|NCT03020615|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110992859|NCT05063500|Polyene phosphatidylcholine|polyene phosphatidylcholine|mesh-list
110992860|NCT05063500|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110992861|NCT05063500|Antimetabolites|antimetabolites|mesh-ancestor
110992862|NCT05063500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110992863|NCT05063500|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110992864|NCT03693170|Cetuximab|cetuximab|mesh-list
110992865|NCT03693170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110992866|NCT03693170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110992867|NCT05062954|Proanthocyanidin|proanthocyanidin|mesh-list
110992868|NCT05062954|Procyanidin|procyanidin|mesh-list
110992869|NCT05062954|Antioxidants|antioxidants|mesh-ancestor
110992870|NCT05062954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110992871|NCT05062954|Protective Agents|protective agents|mesh-ancestor
110992872|NCT05062954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110992873|NCT05062954|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110992874|NCT05062954|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110992875|NCT05062954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110992876|NCT05048524|Leucovorin|leucovorin|mesh-list
110992877|NCT05048524|Gemcitabine|gemcitabine|mesh-list
110992878|NCT05048524|Oxaliplatin|oxaliplatin|mesh-list
110992879|NCT05048524|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110992880|NCT05048524|Antimetabolites|antimetabolites|mesh-ancestor
110992881|NCT05048524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110992882|NCT05048524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110992883|NCT05048524|Antidotes|antidotes|mesh-ancestor
110992884|NCT05048524|Protective Agents|protective agents|mesh-ancestor
110992885|NCT05048524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110992886|NCT05048524|Vitamin B Complex|vitamin b complex|mesh-ancestor
110992887|NCT05048524|Vitamins|vitamins|mesh-ancestor
110992888|NCT05048524|Micronutrients|micronutrients|mesh-ancestor
110992889|NCT02389400|Methotrexate|methotrexate|mesh-list
110992890|NCT02389400|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110992891|NCT02389400|Abortifacient Agents|abortifacient agents|mesh-ancestor
110992892|NCT02389400|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110992893|NCT02389400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110992894|NCT02389400|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110992895|NCT02389400|Antimetabolites|antimetabolites|mesh-ancestor
110992896|NCT02389400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110992897|NCT02389400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110992898|NCT02389400|Dermatologic Agents|dermatologic agents|mesh-ancestor
110992899|NCT02389400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110992900|NCT02389400|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110992901|NCT02389400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110992902|NCT02389400|Immunologic Factors|immunologic factors|mesh-ancestor
110992903|NCT02389400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110992904|NCT02389400|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110992905|NCT02389322|BCG Vaccine|bcg vaccine|mesh-list
110992906|NCT02389322|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110992907|NCT02389322|Immunologic Factors|immunologic factors|mesh-ancestor
110992908|NCT02389322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110992909|NCT03669029|Golimumab|golimumab|mesh-list
110992910|NCT03669029|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110992911|NCT03669029|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110992912|NCT03669029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110992913|NCT03669029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110992914|NCT03669029|Immunologic Factors|immunologic factors|mesh-ancestor
110992915|NCT03669029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110992916|NCT03668015|Sorbitol|sorbitol|mesh-list
110992917|NCT03668015|Cathartics|cathartics|mesh-ancestor
110992918|NCT03668015|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110992919|NCT02385734|Mitogens|mitogens|mesh-list
110992920|NCT02385734|Mitosis Modulators|mitosis modulators|mesh-ancestor
110992921|NCT02385734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110992922|NCT02385500|Fesoterodine|fesoterodine|mesh-list
110992923|NCT02385500|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110992924|NCT02385500|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110992925|NCT02385500|Cholinergic Agents|cholinergic agents|mesh-ancestor
110992926|NCT02385500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110992927|NCT02385500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110992928|NCT02385500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110992929|NCT02385500|Urological Agents|urological agents|mesh-ancestor
110992930|NCT02385422|Propranolol|propranolol|mesh-list
110992931|NCT02385422|Carvedilol|carvedilol|mesh-list
110992932|NCT02385422|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110992933|NCT02385422|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110992934|NCT02385422|Adrenergic Agents|adrenergic agents|mesh-ancestor
110992935|NCT02385422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110992936|NCT02385422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110992937|NCT02385422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110992938|NCT02385422|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110992939|NCT02385422|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110992940|NCT02385422|Vasodilator Agents|vasodilator agents|mesh-ancestor
110992941|NCT02385422|Antioxidants|antioxidants|mesh-ancestor
110992942|NCT02385422|Protective Agents|protective agents|mesh-ancestor
110992943|NCT02385422|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110992944|NCT02385422|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110992945|NCT02385422|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110992946|NCT02385422|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110992947|NCT02385422|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110992948|NCT02520388|Methylphenidate|methylphenidate|mesh-list
110992949|NCT02520388|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110992950|NCT02520388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110992951|NCT02520388|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110992952|NCT02520388|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110992953|NCT02520388|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110992954|NCT02520388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110992955|NCT02520388|Dopamine Agents|dopamine agents|mesh-ancestor
110992956|NCT02520388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110992957|NCT03667937|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
110992958|NCT03667937|Laxatives|laxatives|mesh-ancestor
110992959|NCT03667937|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110992960|NCT03667235|Glutaral|glutaral|mesh-list
110992961|NCT03667235|Disinfectants|disinfectants|mesh-ancestor
110992962|NCT03667235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110992963|NCT02668640|Adalimumab|adalimumab|mesh-list
110992964|NCT02668640|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110992965|NCT02668640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110992966|NCT02668640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110992967|NCT05043766|Naltrexone|naltrexone|mesh-list
110992968|NCT05043766|Oxycodone|oxycodone|mesh-list
110992969|NCT05043766|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110992970|NCT05043766|Narcotics|narcotics|mesh-ancestor
110992971|NCT05043766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110992972|NCT05043766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110992974|NCT05043766|Sensory System Agents|sensory system agents|mesh-ancestor
110992975|NCT05043766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110992976|NCT05043766|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110992977|NCT05043766|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110992978|NCT03462368|Anti-Infective Agents|anti-infective agents|mesh-list
110992979|NCT03462368|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110992980|NCT02383238|Dapagliflozin|dapagliflozin|mesh-list
110992981|NCT02383238|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110992982|NCT02383238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110992983|NCT02383238|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110992984|NCT02383238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110992985|NCT03011333|Epinephrine|epinephrine|mesh-list
110992986|NCT03011333|Bupivacaine|bupivacaine|mesh-list
110992987|NCT03011333|Anesthetics, Local|anesthetics, local|mesh-ancestor
110992988|NCT03011333|Anesthetics|anesthetics|mesh-ancestor
110992989|NCT03011333|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110992990|NCT03011333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110992991|NCT03011333|Sensory System Agents|sensory system agents|mesh-ancestor
110992992|NCT03011333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110992993|NCT03011333|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110992994|NCT03011333|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110992995|NCT03011333|Adrenergic Agents|adrenergic agents|mesh-ancestor
110992996|NCT03011333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110992997|NCT03011333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110992998|NCT03011333|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110992999|NCT03011333|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110993000|NCT03011333|Autonomic Agents|autonomic agents|mesh-ancestor
110993001|NCT03011333|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110993002|NCT03011333|Respiratory System Agents|respiratory system agents|mesh-ancestor
110993003|NCT03011333|Mydriatics|mydriatics|mesh-ancestor
110993004|NCT03011333|Sympathomimetics|sympathomimetics|mesh-ancestor
110993005|NCT03011333|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110993006|NCT04570397|Ravulizumab|ravulizumab|mesh-list
110993007|NCT04570397|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
110993008|NCT04570397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110993009|NCT04570397|Immunologic Factors|immunologic factors|mesh-ancestor
110676900|NCT03341936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110993010|NCT04570397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110993011|NCT02385188|Acetaminophen|acetaminophen|mesh-list
110993012|NCT02385188|Imiquimod|imiquimod|mesh-list
110993013|NCT02385188|Lidocaine|lidocaine|mesh-list
110993014|NCT02385188|Petrolatum|petrolatum|mesh-list
110993015|NCT02385188|Anesthetics, Local|anesthetics, local|mesh-ancestor
110993016|NCT02385188|Anesthetics|anesthetics|mesh-ancestor
110993017|NCT02385188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110993018|NCT02385188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110993019|NCT02385188|Sensory System Agents|sensory system agents|mesh-ancestor
110993020|NCT02385188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110993021|NCT02385188|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110993022|NCT02385188|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110993023|NCT02385188|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110993024|NCT02385188|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110993025|NCT02385188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110993026|NCT02385188|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110993027|NCT02385188|Analgesics|analgesics|mesh-ancestor
110993028|NCT02385188|Antipyretics|antipyretics|mesh-ancestor
110993029|NCT02385188|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110993030|NCT02385188|Immunologic Factors|immunologic factors|mesh-ancestor
110993031|NCT02385188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110993032|NCT02385188|Interferon Inducers|interferon inducers|mesh-ancestor
110993033|NCT02385188|Emollients|emollients|mesh-ancestor
110993034|NCT02385188|Dermatologic Agents|dermatologic agents|mesh-ancestor
110993035|NCT02385032|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
110993036|NCT02385032|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
110993037|NCT02385032|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110993038|NCT02384954|Rituximab|rituximab|mesh-list
110993039|NCT02384954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110993040|NCT02384954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110993041|NCT02384954|Immunologic Factors|immunologic factors|mesh-ancestor
110993042|NCT02384954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110993043|NCT02384954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110993044|NCT02384876|Ephedrine|ephedrine|mesh-list
110993045|NCT02384876|Pseudoephedrine|pseudoephedrine|mesh-list
110993046|NCT02384876|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110993047|NCT02384876|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110993048|NCT02384876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110993049|NCT02384876|Sympathomimetics|sympathomimetics|mesh-ancestor
110993050|NCT02384876|Autonomic Agents|autonomic agents|mesh-ancestor
110993051|NCT02384876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110993052|NCT02384876|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110993053|NCT02384876|Adrenergic Agents|adrenergic agents|mesh-ancestor
110993054|NCT02384876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110993055|NCT02384876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110993056|NCT02384876|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110993057|NCT02384876|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110993058|NCT02384876|Respiratory System Agents|respiratory system agents|mesh-ancestor
110993059|NCT02384876|Nasal Decongestants|nasal decongestants|mesh-ancestor
110993060|NCT03013985|Insulin Glargine|insulin glargine|mesh-list
110993061|NCT03013985|Insulin glulisine|insulin glulisine|mesh-list
110993062|NCT03013985|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110993063|NCT03013985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110993064|NCT02377388|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110993065|NCT02377388|Saxagliptin|saxagliptin|mesh-list
110993066|NCT02377388|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110993067|NCT02377388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110993068|NCT02377388|Incretins|incretins|mesh-ancestor
110993069|NCT02377388|Hormones|hormones|mesh-ancestor
110993070|NCT02377388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110993071|NCT02377388|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110993072|NCT02377388|Protease Inhibitors|protease inhibitors|mesh-ancestor
110993073|NCT02377388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110993074|NCT02377388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110993075|NCT02382380|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
110993076|NCT02382380|Chelating Agents|chelating agents|mesh-ancestor
110993077|NCT02382380|Sequestering Agents|sequestering agents|mesh-ancestor
110993078|NCT02382380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110993079|NCT02382146|Dexamethasone|dexamethasone|mesh-list
110993080|NCT02382146|Dexamethasone acetate|dexamethasone acetate|mesh-list
110993081|NCT02382146|Ondansetron|ondansetron|mesh-list
110993082|NCT02382146|BB 1101|bb 1101|mesh-list
110993083|NCT02382146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110710106|NCT01072812|Phenserine|phenserine|mesh-list
110993084|NCT02382146|Antiemetics|antiemetics|mesh-ancestor
110993085|NCT02382146|Autonomic Agents|autonomic agents|mesh-ancestor
110993086|NCT02382146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110993087|NCT02382146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110993088|NCT02382146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110993089|NCT02382146|Glucocorticoids|glucocorticoids|mesh-ancestor
110993090|NCT02382146|Hormones|hormones|mesh-ancestor
110993091|NCT02382146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110993092|NCT02382146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110993093|NCT02382146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110993094|NCT02382146|Protease Inhibitors|protease inhibitors|mesh-ancestor
110993095|NCT02382146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110993096|NCT02382146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110993097|NCT02382146|Antipruritics|antipruritics|mesh-ancestor
110993098|NCT02382146|Dermatologic Agents|dermatologic agents|mesh-ancestor
110993099|NCT02382146|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110993100|NCT02382146|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110993101|NCT02382146|Serotonin Agents|serotonin agents|mesh-ancestor
110993102|NCT02382146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110993103|NCT02382068|Dexamethasone|dexamethasone|mesh-list
110993104|NCT02382068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110993105|NCT02382068|Antiemetics|antiemetics|mesh-ancestor
110993106|NCT02382068|Autonomic Agents|autonomic agents|mesh-ancestor
110993107|NCT02382068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110993108|NCT02382068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110993109|NCT02382068|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110993110|NCT02382068|Glucocorticoids|glucocorticoids|mesh-ancestor
110993111|NCT02382068|Hormones|hormones|mesh-ancestor
110993112|NCT02382068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110993113|NCT02382068|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110993114|NCT02382068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110993115|NCT04731272|Dulaglutide|dulaglutide|mesh-list
110993116|NCT04731272|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110993117|NCT04731272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110993118|NCT02381600|Vitamin D|vitamin d|mesh-list
110993119|NCT02381600|Vitamins|vitamins|mesh-ancestor
110993120|NCT02381600|Micronutrients|micronutrients|mesh-ancestor
110993121|NCT02381600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110993123|NCT03113084|Heparin|heparin|mesh-list
110993124|NCT03113084|Calcium heparin|calcium heparin|mesh-list
110993125|NCT03113084|Anticoagulants|anticoagulants|mesh-ancestor
110993126|NCT03113084|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110993127|NCT03113084|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110993128|NCT03113084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110993129|NCT02377076|Calcium, Dietary|calcium, dietary|mesh-list
110993130|NCT02377076|Calcium|calcium|mesh-list
110993131|NCT02377076|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110993132|NCT02377076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110993133|NCT02377076|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110993134|NCT04439474|Vitamin D|vitamin d|mesh-list
110993135|NCT04439474|Cholecalciferol|cholecalciferol|mesh-list
110993136|NCT04439474|Vitamins|vitamins|mesh-ancestor
110993137|NCT04439474|Micronutrients|micronutrients|mesh-ancestor
110993138|NCT04439474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110993139|NCT04439474|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110993140|NCT04439474|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110993141|NCT02662556|Sufentanil|sufentanil|mesh-list
110993142|NCT02662556|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110993143|NCT02662556|Narcotics|narcotics|mesh-ancestor
110993144|NCT02662556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110993145|NCT02662556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110993146|NCT02662556|Analgesics|analgesics|mesh-ancestor
110993147|NCT02662556|Sensory System Agents|sensory system agents|mesh-ancestor
110993148|NCT02662556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110993149|NCT02662556|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110993150|NCT02662556|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110993151|NCT02662556|Anesthetics, General|anesthetics, general|mesh-ancestor
110993152|NCT02662556|Anesthetics|anesthetics|mesh-ancestor
110993153|NCT02376452|Leucovorin|leucovorin|mesh-list
110993154|NCT02376452|Fluorouracil|fluorouracil|mesh-list
110993155|NCT02376452|Raltitrexed|raltitrexed|mesh-list
110993156|NCT02376452|Irinotecan|irinotecan|mesh-list
110993157|NCT02376452|Antimetabolites|antimetabolites|mesh-ancestor
110993158|NCT02376452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110993159|NCT02376452|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110993160|NCT02376452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110710206|NCT00464087|PENTA|penta|mesh-list
110993161|NCT02376452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110993162|NCT02376452|Immunologic Factors|immunologic factors|mesh-ancestor
110993163|NCT02376452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110993164|NCT02376452|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110993165|NCT02376452|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110993166|NCT02376452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110993167|NCT02376452|Antidotes|antidotes|mesh-ancestor
110993168|NCT02376452|Protective Agents|protective agents|mesh-ancestor
110993169|NCT02376452|Vitamin B Complex|vitamin b complex|mesh-ancestor
110993170|NCT02376452|Vitamins|vitamins|mesh-ancestor
110993171|NCT02376452|Micronutrients|micronutrients|mesh-ancestor
110993172|NCT02376452|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110993173|NCT02516098|Scopolamine|scopolamine|mesh-list
110993174|NCT02516098|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
110993175|NCT02516098|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110993176|NCT02516098|Antiemetics|antiemetics|mesh-ancestor
110993177|NCT02516098|Autonomic Agents|autonomic agents|mesh-ancestor
110993178|NCT02516098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110993179|NCT02516098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110993180|NCT02516098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110993181|NCT02516098|Mydriatics|mydriatics|mesh-ancestor
110993182|NCT02516098|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110993183|NCT02516098|Cholinergic Agents|cholinergic agents|mesh-ancestor
110993184|NCT02516098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110993185|NCT02516098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110993186|NCT02516098|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110993187|NCT02516098|Parasympatholytics|parasympatholytics|mesh-ancestor
110993188|NCT02372318|Nalmefene|nalmefene|mesh-list
110993189|NCT02372318|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110993190|NCT02372318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110993191|NCT02372318|Sensory System Agents|sensory system agents|mesh-ancestor
110993192|NCT02372318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110993193|NCT03105674|Anesthetics|anesthetics|mesh-list
110993194|NCT03105674|Anesthetics, Local|anesthetics, local|mesh-list
110993195|NCT03105674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110993196|NCT03105674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110993197|NCT03105674|Sensory System Agents|sensory system agents|mesh-ancestor
110993199|NCT02380898|Ketorolac|ketorolac|mesh-list
110993200|NCT02380898|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110993201|NCT02380898|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110993202|NCT02380898|Analgesics|analgesics|mesh-ancestor
110993203|NCT02380898|Sensory System Agents|sensory system agents|mesh-ancestor
110993204|NCT02380898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110993205|NCT02380898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110993206|NCT02380898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110993207|NCT02380898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110993208|NCT02380898|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110993209|NCT02380898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110993210|NCT02380898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110993211|NCT02376296|Docetaxel|docetaxel|mesh-list
110993212|NCT02376296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110993213|NCT02376296|Tubulin Modulators|tubulin modulators|mesh-ancestor
110993214|NCT02376296|Antimitotic Agents|antimitotic agents|mesh-ancestor
110993215|NCT02376296|Mitosis Modulators|mitosis modulators|mesh-ancestor
110993216|NCT02376296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110993217|NCT01364428|Insulin|insulin|mesh-list
110993218|NCT01364428|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110993219|NCT01364428|Insulin, Long-Acting|insulin, long-acting|mesh-list
110993220|NCT01364428|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110993221|NCT01364428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110993222|NCT02380586|Anesthetics|anesthetics|mesh-list
110993223|NCT02380586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110993224|NCT02380586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110993225|NCT02375828|Glyburide|glyburide|mesh-list
110993226|NCT02375828|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110993227|NCT02375828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110993228|NCT02371226|Insulin|insulin|mesh-list
110993229|NCT02371226|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110993230|NCT02371226|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110993231|NCT02371226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110993232|NCT02371304|Capecitabine|capecitabine|mesh-list
110993233|NCT02371304|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110993234|NCT02371304|Antimetabolites|antimetabolites|mesh-ancestor
110993235|NCT02371304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110993236|NCT02371304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110993238|NCT02380352|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110993239|NCT02380352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110993240|NCT02380118|Midazolam|midazolam|mesh-list
110993241|NCT02380118|Haloperidol|haloperidol|mesh-list
110993242|NCT02380118|Olanzapine|olanzapine|mesh-list
110993243|NCT02380118|Haloperidol decanoate|haloperidol decanoate|mesh-list
110993244|NCT02380118|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110993245|NCT02380118|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110993246|NCT02380118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110993247|NCT02380118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110993248|NCT02380118|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110993249|NCT02380118|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110993250|NCT02380118|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110993251|NCT02380118|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110993252|NCT02380118|Anesthetics, General|anesthetics, general|mesh-ancestor
110993253|NCT02380118|Anesthetics|anesthetics|mesh-ancestor
110993254|NCT02380118|GABA Modulators|gaba modulators|mesh-ancestor
110993255|NCT02380118|GABA Agents|gaba agents|mesh-ancestor
110993256|NCT02380118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110993257|NCT02380118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110993258|NCT02380118|Antiemetics|antiemetics|mesh-ancestor
110993259|NCT02380118|Autonomic Agents|autonomic agents|mesh-ancestor
110993260|NCT02380118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110993261|NCT02380118|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110993262|NCT02380118|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110993263|NCT02380118|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110993264|NCT02380118|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110993265|NCT02380118|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110993266|NCT02380118|Serotonin Agents|serotonin agents|mesh-ancestor
110993267|NCT02380118|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110993268|NCT02380118|Dopamine Agents|dopamine agents|mesh-ancestor
110993269|NCT02380118|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110993270|NCT03113708|Heparin|heparin|mesh-list
110993271|NCT03113708|Calcium heparin|calcium heparin|mesh-list
110993272|NCT03113708|Anticoagulants|anticoagulants|mesh-ancestor
110993273|NCT03113708|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110993274|NCT03113708|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110993275|NCT03113708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110993276|NCT02371148|Rituximab|rituximab|mesh-list
110993277|NCT02371148|Bortezomib|bortezomib|mesh-list
110993278|NCT02371148|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110993279|NCT02371148|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110993280|NCT02371148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110993281|NCT02371148|Immunologic Factors|immunologic factors|mesh-ancestor
110993282|NCT02371148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110993283|NCT02371148|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110993284|NCT02371148|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110993285|NCT02371148|Alkylating Agents|alkylating agents|mesh-ancestor
110993286|NCT02371148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110993287|NCT02375360|Immunomodulating Agents|immunomodulating agents|mesh-list
110993288|NCT02375360|Immunologic Factors|immunologic factors|mesh-ancestor
110993289|NCT02375360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110993290|NCT02370680|Aspirin|aspirin|mesh-list
110993291|NCT02370680|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110452266|NCT02879981|Sympathomimetics|sympathomimetics|mesh-ancestor
110993292|NCT02370680|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110993293|NCT02370680|Analgesics|analgesics|mesh-ancestor
110993294|NCT02370680|Sensory System Agents|sensory system agents|mesh-ancestor
110993295|NCT02370680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110993296|NCT02370680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110993297|NCT02370680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110993298|NCT02370680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110993299|NCT02370680|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110993300|NCT02370680|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110993301|NCT02370680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110993302|NCT02370680|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110993303|NCT02370680|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110993304|NCT02370680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110993305|NCT02370680|Antipyretics|antipyretics|mesh-ancestor
110993306|NCT02370758|Valganciclovir|valganciclovir|mesh-list
110993307|NCT02370758|Ganciclovir|ganciclovir|mesh-list
110993308|NCT02370758|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
110993309|NCT02370758|Antiviral Agents|antiviral agents|mesh-ancestor
110993310|NCT02370758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110993311|NCT02370758|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110993312|NCT02370758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110993313|NCT02370758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110993314|NCT02379026|Vitamin D|vitamin d|mesh-list
110993315|NCT02379026|Cholecalciferol|cholecalciferol|mesh-list
110993316|NCT02379026|Vitamins|vitamins|mesh-ancestor
110993317|NCT02379026|Micronutrients|micronutrients|mesh-ancestor
110993318|NCT02379026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110993319|NCT02379026|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110993320|NCT02379026|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110993321|NCT02991859|Fluticasone|fluticasone|mesh-list
110993322|NCT02991859|Xhance|xhance|mesh-list
110993323|NCT02991859|Budesonide|budesonide|mesh-list
110993324|NCT02991859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110993325|NCT02991859|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110993326|NCT02991859|Autonomic Agents|autonomic agents|mesh-ancestor
110993327|NCT02991859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110993328|NCT02991859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110993329|NCT02991859|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110993330|NCT02991859|Respiratory System Agents|respiratory system agents|mesh-ancestor
110993331|NCT02991859|Dermatologic Agents|dermatologic agents|mesh-ancestor
110993332|NCT02991859|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110993333|NCT02991859|Glucocorticoids|glucocorticoids|mesh-ancestor
110993334|NCT02991859|Hormones|hormones|mesh-ancestor
110993335|NCT02991859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110993336|NCT02374736|Immunoglobulins|immunoglobulins|mesh-list
110993337|NCT02374736|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110993338|NCT02374736|Antibodies|antibodies|mesh-list
110993339|NCT02374736|Immunoglobulin G|immunoglobulin g|mesh-list
110993340|NCT02374736|Immunologic Factors|immunologic factors|mesh-ancestor
110993341|NCT02374736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110993342|NCT02369978|Benzonidazole|benzonidazole|mesh-list
110993343|NCT02369978|Nifurtimox|nifurtimox|mesh-list
110993344|NCT02369978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110993345|NCT02369978|Immunologic Factors|immunologic factors|mesh-ancestor
110993346|NCT02369978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110993347|NCT02369978|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
110993348|NCT02369978|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110993349|NCT02369978|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110993350|NCT02369978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110993352|NCT03661489|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110993353|NCT03661489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110993354|NCT03661489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110993355|NCT03661489|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110993356|NCT03661489|Anesthetics, General|anesthetics, general|mesh-ancestor
110993357|NCT03661489|Anesthetics|anesthetics|mesh-ancestor
110993358|NCT04056169|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110993359|NCT04056169|Ezetimibe|ezetimibe|mesh-list
110993360|NCT04056169|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110993361|NCT04056169|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110993362|NCT04056169|Antimetabolites|antimetabolites|mesh-ancestor
110993363|NCT04056169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110993364|NCT04056169|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110993365|NCT04056169|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110993366|NCT04056169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110993367|NCT02988115|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
110993368|NCT02988115|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110993369|NCT02988115|Antimetabolites|antimetabolites|mesh-ancestor
110993370|NCT02988115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110993371|NCT02988115|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110993372|NCT02988115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110993373|NCT02988115|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110993374|NCT02988115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110993375|NCT03008915|Aspirin|aspirin|mesh-list
110993376|NCT03008915|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
110993377|NCT03008915|Protein C Inhibitor|protein c inhibitor|mesh-list
110993378|NCT03008915|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110993379|NCT03008915|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110993380|NCT03008915|Analgesics|analgesics|mesh-ancestor
110993381|NCT03008915|Sensory System Agents|sensory system agents|mesh-ancestor
110993382|NCT03008915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110993383|NCT03008915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110993384|NCT03008915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110993385|NCT03008915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110993386|NCT03008915|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110993387|NCT03008915|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110993388|NCT03008915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110993389|NCT03008915|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110993390|NCT03008915|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110993391|NCT03008915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110993392|NCT03008915|Antipyretics|antipyretics|mesh-ancestor
110993393|NCT03008915|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
110993394|NCT03008915|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110993395|NCT03008915|Protease Inhibitors|protease inhibitors|mesh-ancestor
110993396|NCT03622489|Acetaminophen|acetaminophen|mesh-list
110993397|NCT03622489|Dipyrone|dipyrone|mesh-list
110993398|NCT03622489|Ibuprofen|ibuprofen|mesh-list
110993399|NCT03622489|Morphine|morphine|mesh-list
110993400|NCT03622489|Tramadol|tramadol|mesh-list
110993401|NCT03622489|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110993402|NCT03622489|Narcotics|narcotics|mesh-ancestor
110993403|NCT03622489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110993404|NCT03622489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110993405|NCT03622489|Analgesics|analgesics|mesh-ancestor
110993406|NCT03622489|Sensory System Agents|sensory system agents|mesh-ancestor
110993407|NCT03622489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110993408|NCT03622489|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110993409|NCT03622489|Antipyretics|antipyretics|mesh-ancestor
110993410|NCT03622489|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110993411|NCT03622489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110993412|NCT03622489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110993413|NCT03622489|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110993414|NCT03622489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110993415|NCT03622489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110993416|NCT03667001|Lidocaine|lidocaine|mesh-list
110993417|NCT03667001|Anesthetics, Local|anesthetics, local|mesh-ancestor
110993418|NCT03667001|Anesthetics|anesthetics|mesh-ancestor
110993419|NCT03667001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110993420|NCT03667001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110993421|NCT03667001|Sensory System Agents|sensory system agents|mesh-ancestor
110993422|NCT03667001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110993423|NCT03667001|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110458554|NCT00881530|Protease Inhibitors|protease inhibitors|mesh-ancestor
110993424|NCT03667001|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110993425|NCT03667001|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110993426|NCT03667001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110993427|NCT03667001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110993428|NCT02379650|Hydroxychloroquine|hydroxychloroquine|mesh-list
110993429|NCT02379650|Antimalarials|antimalarials|mesh-ancestor
110993430|NCT02379650|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110993431|NCT02379650|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110993432|NCT02379650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110993433|NCT02379650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110993434|NCT02379650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110993435|NCT02379650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110993437|NCT03666299|Anesthetics, Local|anesthetics, local|mesh-ancestor
110993438|NCT03666299|Anesthetics|anesthetics|mesh-ancestor
110993439|NCT03666299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110993440|NCT03666299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110993441|NCT03666299|Sensory System Agents|sensory system agents|mesh-ancestor
110993442|NCT03666299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110993443|NCT03666299|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110993444|NCT03666299|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110993445|NCT03666299|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110993446|NCT03666299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110993447|NCT03666299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110993448|NCT03660397|Antihypertensive Agents|antihypertensive agents|mesh-list
110993449|NCT03591380|Belimumab|belimumab|mesh-list
110993450|NCT03591380|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110993451|NCT03591380|Immunologic Factors|immunologic factors|mesh-ancestor
110993452|NCT03591380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110993453|NCT04057469|Tulobuterol|tulobuterol|mesh-list
110993454|NCT04057469|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110993455|NCT04057469|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110993456|NCT04057469|Adrenergic Agents|adrenergic agents|mesh-ancestor
110993457|NCT04057469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110993458|NCT04057469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110993459|NCT04057469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110993460|NCT04057469|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110993461|NCT04057469|Autonomic Agents|autonomic agents|mesh-ancestor
110993462|NCT04057469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110710486|NCT00312572|Buprenorphine|buprenorphine|mesh-list
110993463|NCT04057469|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110993464|NCT04057469|Respiratory System Agents|respiratory system agents|mesh-ancestor
110993465|NCT03666221|Nimotuzumab|nimotuzumab|mesh-list
110993466|NCT03666221|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110993467|NCT03666221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110993468|NCT03658291|Levofloxacin|levofloxacin|mesh-list
110993469|NCT03658291|Ofloxacin|ofloxacin|mesh-list
110993470|NCT03658291|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110993471|NCT03658291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110993472|NCT03658291|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110993473|NCT03658291|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110993474|NCT03658291|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110993475|NCT03658291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110993476|NCT03658291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110993477|NCT03658291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110993478|NCT03658291|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110993479|NCT03658291|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110993480|NCT03658213|Goserelin|goserelin|mesh-list
110993481|NCT03658213|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110993482|NCT03658213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110993483|NCT03006887|Pembrolizumab|pembrolizumab|mesh-list
110993484|NCT03006887|Lenvatinib|lenvatinib|mesh-list
110993485|NCT03006887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110993486|NCT03006887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110993487|NCT03006887|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110993488|NCT03006887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110993489|NCT03006887|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110993490|NCT03006887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110993491|NCT02377856|Interferons|interferons|mesh-list
110993492|NCT02377856|Ribavirin|ribavirin|mesh-list
110993493|NCT02377856|Interferon-alpha|interferon-alpha|mesh-list
110993494|NCT02377856|Interferon alpha-2|interferon alpha-2|mesh-list
110993495|NCT02377856|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110458642|NCT00626717|Riboflavin|riboflavin|mesh-list
110993496|NCT02377856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110993497|NCT02377856|Antiviral Agents|antiviral agents|mesh-ancestor
110993498|NCT02377856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110993499|NCT02377856|Antimetabolites|antimetabolites|mesh-ancestor
110993500|NCT02377856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110993501|NCT02377856|Immunologic Factors|immunologic factors|mesh-ancestor
110993502|NCT02377856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110993503|NCT02377778|Thiopental|thiopental|mesh-list
110993504|NCT02377778|Propofol|propofol|mesh-list
110993505|NCT02377778|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110993506|NCT02377778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110993507|NCT02377778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110993508|NCT02377778|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110993509|NCT02377778|Anesthetics, General|anesthetics, general|mesh-ancestor
110993510|NCT02377778|Anesthetics|anesthetics|mesh-ancestor
110993511|NCT02377778|Anticonvulsants|anticonvulsants|mesh-ancestor
110993512|NCT02377778|GABA Modulators|gaba modulators|mesh-ancestor
110993513|NCT02377778|GABA Agents|gaba agents|mesh-ancestor
110993514|NCT02377778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110993515|NCT02377778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110993516|NCT02514772|Rituximab|rituximab|mesh-list
110993517|NCT02514772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110993518|NCT02514772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110993519|NCT02514772|Immunologic Factors|immunologic factors|mesh-ancestor
110993520|NCT02514772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110993521|NCT02514772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110993522|NCT03658057|Rocuronium|rocuronium|mesh-list
110993523|NCT03658057|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110993524|NCT03658057|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110993525|NCT03658057|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110993526|NCT03658057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110993527|NCT03658057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110993528|NCT03657979|Ropivacaine|ropivacaine|mesh-list
110993529|NCT03657979|Anesthetics, Local|anesthetics, local|mesh-ancestor
110993530|NCT03657979|Anesthetics|anesthetics|mesh-ancestor
110993531|NCT03657979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110993532|NCT03657979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110993533|NCT03657979|Sensory System Agents|sensory system agents|mesh-ancestor
110993534|NCT03657979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110993535|NCT03659851|Simendan|simendan|mesh-list
110993536|NCT03659851|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110993537|NCT03659851|Vasodilator Agents|vasodilator agents|mesh-ancestor
110993538|NCT03659851|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110993539|NCT03659851|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110993540|NCT03659851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110993541|NCT03659851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110993542|NCT03659851|Protective Agents|protective agents|mesh-ancestor
110993543|NCT03659851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110993544|NCT03659383|Hypoglycemic Agents|hypoglycemic agents|mesh-list
110993545|NCT03659383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110993546|NCT02368730|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
110993548|NCT02368730|Coagulants|coagulants|mesh-ancestor
110993549|NCT02368730|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
110993550|NCT02368730|Natriuretic Agents|natriuretic agents|mesh-ancestor
110993551|NCT02368730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110993552|NCT03659305|Bevacizumab|bevacizumab|mesh-list
110993553|NCT03659305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110993554|NCT03659305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110993555|NCT03659305|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110993556|NCT03659305|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110993557|NCT03659305|Growth Substances|growth substances|mesh-ancestor
110993558|NCT03659305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110993559|NCT03659305|Growth Inhibitors|growth inhibitors|mesh-ancestor
110993560|NCT02788981|Paclitaxel|paclitaxel|mesh-list
110993561|NCT02788981|Mifepristone|mifepristone|mesh-list
110993562|NCT02788981|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110993563|NCT02788981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110993564|NCT02788981|Tubulin Modulators|tubulin modulators|mesh-ancestor
110993565|NCT02788981|Antimitotic Agents|antimitotic agents|mesh-ancestor
110993566|NCT02788981|Mitosis Modulators|mitosis modulators|mesh-ancestor
110993567|NCT02788981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110993568|NCT02788981|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
110993569|NCT02788981|Abortifacient Agents|abortifacient agents|mesh-ancestor
110993570|NCT02788981|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110993571|NCT02788981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110993572|NCT02788981|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110993573|NCT02788981|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110993574|NCT02788981|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110993575|NCT02788981|Contraceptive Agents|contraceptive agents|mesh-ancestor
110993576|NCT02788981|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
110993577|NCT02788981|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
110993578|NCT02788981|Hormone Antagonists|hormone antagonists|mesh-ancestor
110993579|NCT02788981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110993580|NCT02788981|Luteolytic Agents|luteolytic agents|mesh-ancestor
110993581|NCT02788981|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110993582|NCT02788981|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
110993583|NCT02368964|Triptorelin Pamoate|triptorelin pamoate|mesh-list
110993584|NCT02368964|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
110993585|NCT02368964|Luteolytic Agents|luteolytic agents|mesh-ancestor
110993586|NCT02368964|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110993587|NCT02368964|Contraceptive Agents|contraceptive agents|mesh-ancestor
110993588|NCT02368964|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110993589|NCT02368964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110993590|NCT02368964|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110993591|NCT02368964|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110993592|NCT02368964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110993593|NCT02373722|Petrolatum|petrolatum|mesh-list
110993594|NCT02373722|Mineral Oil|mineral oil|mesh-list
110993595|NCT02373722|Emollients|emollients|mesh-ancestor
110993596|NCT02373722|Dermatologic Agents|dermatologic agents|mesh-ancestor
110993597|NCT03000179|Avelumab|avelumab|mesh-list
110993598|NCT03000179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110993599|NCT03000179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110993600|NCT03658993|Rifaximin|rifaximin|mesh-list
110993601|NCT03658993|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110993602|NCT03658993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110993603|NCT03658993|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110993604|NCT02373410|Bupivacaine|bupivacaine|mesh-list
110993605|NCT02373410|Anesthetics, Local|anesthetics, local|mesh-ancestor
110993606|NCT02373410|Anesthetics|anesthetics|mesh-ancestor
110993607|NCT02373410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110993608|NCT02373410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110993609|NCT02373410|Sensory System Agents|sensory system agents|mesh-ancestor
110993610|NCT02373410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110993611|NCT02920177|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110993612|NCT02920177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110993614|NCT02920177|Hormones|hormones|mesh-ancestor
110993615|NCT02920177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110993616|NCT02920177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110993617|NCT02920177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110993618|NCT02920177|Immunologic Factors|immunologic factors|mesh-ancestor
110993619|NCT03006341|Telmisartan|telmisartan|mesh-list
110993620|NCT03006341|Warfarin|warfarin|mesh-list
110993621|NCT03006341|Dabigatran|dabigatran|mesh-list
110993622|NCT03006341|Anticoagulants|anticoagulants|mesh-ancestor
110993623|NCT03006341|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110993624|NCT03006341|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110993625|NCT03006341|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110993626|NCT03006341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110993627|NCT03006341|Antithrombins|antithrombins|mesh-ancestor
110993628|NCT03006341|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110993629|NCT03006341|Protease Inhibitors|protease inhibitors|mesh-ancestor
110993630|NCT03006341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110993631|NCT05022784|Nintedanib|nintedanib|mesh-list
110993632|NCT05022784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110993633|NCT05022784|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110993634|NCT05022784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110993635|NCT05022784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110993636|NCT04413799|Lidocaine|lidocaine|mesh-list
110993637|NCT04413799|Ketamine|ketamine|mesh-list
110993638|NCT04413799|Anesthetics, Local|anesthetics, local|mesh-ancestor
110993639|NCT04413799|Anesthetics|anesthetics|mesh-ancestor
110993640|NCT04413799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110993641|NCT04413799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110993642|NCT04413799|Sensory System Agents|sensory system agents|mesh-ancestor
110993643|NCT04413799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110993644|NCT04413799|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110993645|NCT04413799|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110993646|NCT04413799|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110993647|NCT04413799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110993648|NCT04413799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110993649|NCT04413799|Analgesics|analgesics|mesh-ancestor
110993650|NCT04413799|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110993651|NCT04413799|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110993652|NCT04413799|Anesthetics, General|anesthetics, general|mesh-ancestor
110993653|NCT04413799|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110993654|NCT04413799|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110993655|NCT04413799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110993656|NCT03665753|Ketorolac|ketorolac|mesh-list
110993657|NCT03665753|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110993658|NCT03665753|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110993659|NCT03665753|Analgesics|analgesics|mesh-ancestor
110993660|NCT03665753|Sensory System Agents|sensory system agents|mesh-ancestor
110993661|NCT03665753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110993662|NCT03665753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110993663|NCT03665753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110993664|NCT03665753|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110993665|NCT03665753|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110993666|NCT03665753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110993667|NCT03665753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110993668|NCT02512042|Brinzolamide|brinzolamide|mesh-list
110993669|NCT02512042|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110993670|NCT02512042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110993671|NCT02512042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110993672|NCT03665519|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
110993673|NCT03665519|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
110993674|NCT03665519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110993675|NCT01066897|Pramipexole|pramipexole|mesh-list
110993676|NCT01066897|Antioxidants|antioxidants|mesh-ancestor
110993677|NCT01066897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110993678|NCT01066897|Protective Agents|protective agents|mesh-ancestor
110993679|NCT01066897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110993680|NCT01066897|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110993681|NCT01066897|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110993682|NCT01066897|Dopamine Agonists|dopamine agonists|mesh-ancestor
110993683|NCT01066897|Dopamine Agents|dopamine agents|mesh-ancestor
110993684|NCT01066897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110993685|NCT02373254|Acetaminophen|acetaminophen|mesh-list
110993686|NCT02373254|Ibuprofen|ibuprofen|mesh-list
110993687|NCT02373254|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
110993688|NCT02373254|Hydrocodone|hydrocodone|mesh-list
110993689|NCT02373254|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110993690|NCT02373254|Analgesics|analgesics|mesh-ancestor
110993691|NCT02373254|Sensory System Agents|sensory system agents|mesh-ancestor
110993692|NCT02373254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110993693|NCT02373254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110993694|NCT02373254|Antipyretics|antipyretics|mesh-ancestor
110993695|NCT02373254|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110993696|NCT02373254|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110993697|NCT02373254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110993698|NCT02373254|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110993699|NCT02373254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110993700|NCT02373254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110993701|NCT02373254|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110993702|NCT02373254|Narcotics|narcotics|mesh-ancestor
110993703|NCT02373254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110993704|NCT02373254|Antitussive Agents|antitussive agents|mesh-ancestor
110993705|NCT02373254|Respiratory System Agents|respiratory system agents|mesh-ancestor
110993706|NCT03657355|Zolpidem|zolpidem|mesh-list
110993707|NCT03657355|Suvorexant|suvorexant|mesh-list
110993708|NCT03657355|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110993709|NCT03657355|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110993710|NCT03657355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110993711|NCT03657355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110993712|NCT03657355|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
110993713|NCT03657355|GABA Agonists|gaba agonists|mesh-ancestor
110993714|NCT03657355|GABA Agents|gaba agents|mesh-ancestor
110993715|NCT03657355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110993716|NCT03657355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110993717|NCT03657355|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
110993718|NCT02985541|Levonorgestrel|levonorgestrel|mesh-list
110993719|NCT02985541|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110993720|NCT02985541|Contraceptive Agents|contraceptive agents|mesh-ancestor
110993721|NCT02985541|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110993722|NCT02985541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110993723|NCT02985541|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110993724|NCT02985541|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110993725|NCT02985541|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110993726|NCT02365532|Dofetilide|dofetilide|mesh-list
110993727|NCT02365532|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110993728|NCT02365532|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
110993729|NCT02365532|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110993730|NCT02365532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110993731|NCT03113162|Cytarabine|cytarabine|mesh-list
110993732|NCT03113162|Etoposide|etoposide|mesh-list
110993733|NCT03113162|Melphalan|melphalan|mesh-list
110993734|NCT03113162|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110993735|NCT03113162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110993736|NCT03113162|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110993737|NCT03113162|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110993738|NCT03113162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110993739|NCT03113162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110993740|NCT03113162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110993741|NCT03113162|Antimetabolites|antimetabolites|mesh-ancestor
110993742|NCT03113162|Antiviral Agents|antiviral agents|mesh-ancestor
110993743|NCT03113162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110993744|NCT03113162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110993745|NCT03113162|Immunologic Factors|immunologic factors|mesh-ancestor
110993746|NCT03113162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110993747|NCT03113162|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110993748|NCT03113162|Alkylating Agents|alkylating agents|mesh-ancestor
110452327|NCT01095653|Dapagliflozin|dapagliflozin|mesh-list
110993749|NCT03113162|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110993750|NCT02356705|Lidocaine|lidocaine|mesh-list
110993751|NCT02356705|Midazolam|midazolam|mesh-list
110993752|NCT02356705|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110993753|NCT02356705|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110993754|NCT02356705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110993755|NCT02356705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110993756|NCT02356705|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110993757|NCT02356705|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110993758|NCT02356705|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110993759|NCT02356705|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110993760|NCT02356705|Anesthetics, General|anesthetics, general|mesh-ancestor
110993761|NCT02356705|Anesthetics|anesthetics|mesh-ancestor
110993762|NCT02356705|GABA Modulators|gaba modulators|mesh-ancestor
110993763|NCT02356705|GABA Agents|gaba agents|mesh-ancestor
110993764|NCT02356705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110993765|NCT02356705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110993766|NCT02356705|Anesthetics, Local|anesthetics, local|mesh-ancestor
110993767|NCT02356705|Sensory System Agents|sensory system agents|mesh-ancestor
110993768|NCT02356705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110993769|NCT02356705|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110993770|NCT02356705|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110993771|NCT02356705|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110993772|NCT02356705|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110993773|NCT03541850|Ascorbic Acid|ascorbic acid|mesh-list
110993774|NCT03541850|Methyltestosterone|methyltestosterone|mesh-list
110993775|NCT03541850|Hormones|hormones|mesh-list
110993776|NCT03541850|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
110993777|NCT03541850|Androgens|androgens|mesh-list
110993778|NCT03541850|Androgen Antagonists|androgen antagonists|mesh-list
110993779|NCT03541850|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110993780|NCT03541850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110993781|NCT03541850|Antioxidants|antioxidants|mesh-ancestor
110993782|NCT03541850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110993783|NCT03541850|Protective Agents|protective agents|mesh-ancestor
110993784|NCT03541850|Vitamins|vitamins|mesh-ancestor
110993785|NCT03541850|Micronutrients|micronutrients|mesh-ancestor
110993786|NCT03541850|Estrogens|estrogens|mesh-ancestor
110993787|NCT03541850|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110993788|NCT03541850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110993789|NCT03541850|Anabolic Agents|anabolic agents|mesh-ancestor
110993790|NCT03541850|Hormone Antagonists|hormone antagonists|mesh-ancestor
110993791|NCT02511184|Pembrolizumab|pembrolizumab|mesh-list
110993792|NCT02511184|Crizotinib|crizotinib|mesh-list
110993793|NCT02511184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110993794|NCT02511184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110993795|NCT02511184|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110993796|NCT02511184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110993797|NCT02511184|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110993798|NCT02511184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110993799|NCT02367560|Methylprednisolone|methylprednisolone|mesh-list
110993800|NCT02367560|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110993801|NCT02367560|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110993802|NCT02367560|Prednisolone|prednisolone|mesh-list
110993803|NCT02367560|Prednisolone acetate|prednisolone acetate|mesh-list
110993804|NCT02367560|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110993805|NCT02367560|Prednisolone phosphate|prednisolone phosphate|mesh-list
110993806|NCT02367560|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110993807|NCT02367560|Antiemetics|antiemetics|mesh-ancestor
110993808|NCT02367560|Autonomic Agents|autonomic agents|mesh-ancestor
110993809|NCT02367560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110993810|NCT02367560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110993811|NCT02367560|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110993812|NCT02367560|Glucocorticoids|glucocorticoids|mesh-ancestor
110993813|NCT02367560|Hormones|hormones|mesh-ancestor
110993814|NCT02367560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110993815|NCT02367560|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110993816|NCT02367560|Protective Agents|protective agents|mesh-ancestor
110993817|NCT02367560|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110993818|NCT02367560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110993819|NCT02372942|Progesterone|progesterone|mesh-list
110993820|NCT02372942|Progestins|progestins|mesh-ancestor
110993821|NCT02372942|Hormones|hormones|mesh-ancestor
110993822|NCT02372942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110993823|NCT02372942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110993824|NCT02364986|Interferons|interferons|mesh-list
110993825|NCT02364986|Interferon-beta|interferon-beta|mesh-list
110993826|NCT02364986|Interferon beta-1a|interferon beta-1a|mesh-list
110993827|NCT02364986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110993828|NCT02364986|Antiviral Agents|antiviral agents|mesh-ancestor
110993829|NCT02364986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110993830|NCT02364986|Immunologic Factors|immunologic factors|mesh-ancestor
110993831|NCT02364986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110993832|NCT02364986|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110993833|NCT02372786|Lidocaine|lidocaine|mesh-list
110993834|NCT02372786|Tetracaine|tetracaine|mesh-list
110993835|NCT02372786|Prilocaine|prilocaine|mesh-list
110993836|NCT02372786|Anesthetics, Local|anesthetics, local|mesh-ancestor
110676901|NCT03341936|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110993837|NCT02372786|Anesthetics|anesthetics|mesh-ancestor
110993838|NCT02372786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110993839|NCT02372786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110993840|NCT02372786|Sensory System Agents|sensory system agents|mesh-ancestor
110993841|NCT02372786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110993842|NCT02372786|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110993843|NCT02372786|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110993844|NCT02372786|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110993845|NCT02372786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110993846|NCT02372786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110993847|NCT02367404|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110993848|NCT02367404|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110993849|NCT02367404|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110993850|NCT02367404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110993851|NCT02367404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110993852|NCT02367404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110993853|NCT02367404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110993854|NCT02367404|Analgesics|analgesics|mesh-ancestor
110993855|NCT02367404|Sensory System Agents|sensory system agents|mesh-ancestor
110993856|NCT02367404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110993857|NCT02367404|Antidepressive Agents|antidepressive agents|mesh-ancestor
110993858|NCT02367404|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110993859|NCT02367404|Dopamine Agents|dopamine agents|mesh-ancestor
110993860|NCT02367248|Deferoxamine|deferoxamine|mesh-list
110993861|NCT02367248|Siderophores|siderophores|mesh-ancestor
110993862|NCT02367248|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110993863|NCT02367248|Chelating Agents|chelating agents|mesh-ancestor
110993864|NCT02367248|Sequestering Agents|sequestering agents|mesh-ancestor
110993865|NCT02367248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110993867|NCT03656965|Antiviral Agents|antiviral agents|mesh-ancestor
110993868|NCT03656965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110993869|NCT02384239|Tamoxifen|tamoxifen|mesh-list
110993870|NCT02384239|Fulvestrant|fulvestrant|mesh-list
110993871|NCT02384239|Palbociclib|palbociclib|mesh-list
110993872|NCT02384239|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110993873|NCT02384239|Hormone Antagonists|hormone antagonists|mesh-ancestor
110993874|NCT02384239|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110993875|NCT02384239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110993876|NCT02384239|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110993877|NCT02384239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110993878|NCT02384239|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110993879|NCT02384239|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110993880|NCT02384239|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110993881|NCT02384239|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110993882|NCT02384239|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110993883|NCT02384239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110452337|NCT00700297|Colchicine|colchicine|mesh-list
110993884|NCT02384239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110993885|NCT02364752|Diuretics|diuretics|mesh-list
110993886|NCT02364752|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
110993887|NCT02364752|Natriuretic Agents|natriuretic agents|mesh-ancestor
110993888|NCT02364752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110993889|NCT02364752|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110993890|NCT02364752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110993891|NCT02372240|Dexamethasone|dexamethasone|mesh-list
110993892|NCT02372240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110993893|NCT02372240|Antiemetics|antiemetics|mesh-ancestor
110993894|NCT02372240|Autonomic Agents|autonomic agents|mesh-ancestor
110993895|NCT02372240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110993896|NCT02372240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110993897|NCT02372240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110993898|NCT02372240|Glucocorticoids|glucocorticoids|mesh-ancestor
110993899|NCT02372240|Hormones|hormones|mesh-ancestor
110993900|NCT02372240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110993901|NCT02372240|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110993902|NCT02372240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110993903|NCT02364206|Temozolomide|temozolomide|mesh-list
110993904|NCT02364206|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110993905|NCT02364206|Alkylating Agents|alkylating agents|mesh-ancestor
110993906|NCT02364206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110993907|NCT02364206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110993908|NCT02366546|Cyclophosphamide|cyclophosphamide|mesh-list
110993909|NCT02366546|Fludarabine|fludarabine|mesh-list
110993910|NCT02366546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110993911|NCT02366546|Immunologic Factors|immunologic factors|mesh-ancestor
110993912|NCT02366546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110993913|NCT02366546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110993914|NCT02366546|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110993915|NCT02366546|Alkylating Agents|alkylating agents|mesh-ancestor
110993916|NCT02366546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110993917|NCT02366546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110993918|NCT02366546|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110993919|NCT03029702|Metformin|metformin|mesh-list
110993920|NCT03029702|Glyburide|glyburide|mesh-list
110993921|NCT03029702|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110993922|NCT03029702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110993923|NCT02364362|Docetaxel|docetaxel|mesh-list
110993924|NCT02364362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110993925|NCT02364362|Tubulin Modulators|tubulin modulators|mesh-ancestor
110993926|NCT02364362|Antimitotic Agents|antimitotic agents|mesh-ancestor
110993927|NCT02364362|Mitosis Modulators|mitosis modulators|mesh-ancestor
110993928|NCT02364362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110993929|NCT03004469|Finasteride|finasteride|mesh-list
110993930|NCT03004469|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
110993931|NCT03004469|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110993932|NCT03004469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110993933|NCT03004469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110993934|NCT03004469|Hormone Antagonists|hormone antagonists|mesh-ancestor
110993935|NCT03004469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110993936|NCT03004469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110993937|NCT03004469|Urological Agents|urological agents|mesh-ancestor
110993938|NCT02358824|Amlodipine|amlodipine|mesh-list
110993939|NCT02358824|Telmisartan|telmisartan|mesh-list
110993940|NCT02358824|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110993941|NCT02358824|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110993942|NCT02358824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110993943|NCT02358824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110993944|NCT02358824|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110993945|NCT02358824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110993946|NCT02358824|Vasodilator Agents|vasodilator agents|mesh-ancestor
110993947|NCT02358824|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110993948|NCT02358824|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110993950|NCT02359136|Analgesics|analgesics|mesh-list
110993951|NCT02359136|Anesthetics|anesthetics|mesh-list
110993952|NCT02359136|Ropivacaine|ropivacaine|mesh-list
110993953|NCT02359136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110993954|NCT02359136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110993955|NCT02359136|Anesthetics, Local|anesthetics, local|mesh-ancestor
110993956|NCT02359136|Sensory System Agents|sensory system agents|mesh-ancestor
110993957|NCT02359136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110993958|NCT02359136|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110993959|NCT02359136|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110993960|NCT02359136|Adrenergic Agents|adrenergic agents|mesh-ancestor
110993961|NCT02359136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110993962|NCT02359136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110993963|NCT02359136|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110993964|NCT02359136|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110993965|NCT02359136|Autonomic Agents|autonomic agents|mesh-ancestor
110993966|NCT02359136|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110993967|NCT02359136|Respiratory System Agents|respiratory system agents|mesh-ancestor
110993968|NCT02359136|Mydriatics|mydriatics|mesh-ancestor
110993969|NCT02359136|Sympathomimetics|sympathomimetics|mesh-ancestor
110993970|NCT02359136|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110993971|NCT02998151|Minocycline|minocycline|mesh-list
110993972|NCT02998151|Acamprosate|acamprosate|mesh-list
110993973|NCT02998151|Baclofen|baclofen|mesh-list
110993974|NCT02998151|Lovastatin|lovastatin|mesh-list
110993975|NCT02998151|L 647318|l 647318|mesh-list
110993976|NCT02998151|Dihydromevinolin|dihydromevinolin|mesh-list
110993977|NCT02998151|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110993978|NCT02998151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110993979|NCT02998151|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110993980|NCT02998151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110993981|NCT02998151|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110993982|NCT02998151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110993983|NCT02998151|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
110993984|NCT02998151|GABA Agonists|gaba agonists|mesh-ancestor
110993985|NCT02998151|GABA Agents|gaba agents|mesh-ancestor
110993986|NCT02998151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110993987|NCT02998151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110993988|NCT02998151|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110993989|NCT02998151|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110993990|NCT02998151|Antimetabolites|antimetabolites|mesh-ancestor
110993991|NCT02998151|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110993992|NCT02998151|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110993993|NCT02998151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110993994|NCT02998151|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110993995|NCT01066819|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110993996|NCT01066819|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110993997|NCT01066819|Antiviral Agents|antiviral agents|mesh-ancestor
110993998|NCT01066819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110993999|NCT04057937|Apremilast|apremilast|mesh-list
110994000|NCT04057937|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110994001|NCT04057937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110994002|NCT04057937|Analgesics|analgesics|mesh-ancestor
110994003|NCT04057937|Sensory System Agents|sensory system agents|mesh-ancestor
110994004|NCT04057937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110994005|NCT04057937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110994006|NCT04057937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110994007|NCT04057937|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110994008|NCT04057937|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
110994009|NCT04057937|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110994010|NCT04057937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110994011|NCT04057937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110994012|NCT01069523|Guanfacine|guanfacine|mesh-list
110994013|NCT01069523|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110994014|NCT01069523|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110994015|NCT01069523|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110994016|NCT01069523|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110994017|NCT01069523|Adrenergic Agents|adrenergic agents|mesh-ancestor
110994018|NCT01069523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110994019|NCT01069523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110994020|NCT01069523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110994021|NCT01069289|Budesonide|budesonide|mesh-list
110994022|NCT01069289|Formoterol Fumarate|formoterol fumarate|mesh-list
110994023|NCT01069289|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
110994024|NCT01069289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110994025|NCT01069289|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110994026|NCT01069289|Autonomic Agents|autonomic agents|mesh-ancestor
110994027|NCT01069289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110994028|NCT01069289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110994029|NCT01069289|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110994030|NCT01069289|Respiratory System Agents|respiratory system agents|mesh-ancestor
110994031|NCT01069289|Glucocorticoids|glucocorticoids|mesh-ancestor
110994032|NCT01069289|Hormones|hormones|mesh-ancestor
110994033|NCT01069289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110994034|NCT01069289|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110994035|NCT01069289|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110994036|NCT01069289|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110994037|NCT01069289|Adrenergic Agents|adrenergic agents|mesh-ancestor
110994038|NCT01069289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110994039|NCT01069289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110994040|NCT03303989|Mycophenolic Acid|mycophenolic acid|mesh-list
110994041|NCT03303989|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110994042|NCT03303989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110994043|NCT03303989|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110994044|NCT03303989|Antitubercular Agents|antitubercular agents|mesh-ancestor
110994045|NCT03303989|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110994046|NCT03303989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110994047|NCT03303989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110994048|NCT03303989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110994049|NCT02510794|Ranibizumab|ranibizumab|mesh-list
110994050|NCT02510794|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110994051|NCT02510794|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110994052|NCT02510794|Growth Substances|growth substances|mesh-ancestor
110994053|NCT02510794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110994054|NCT02510794|Growth Inhibitors|growth inhibitors|mesh-ancestor
110994055|NCT02510794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110994056|NCT04056923|Methylene Blue|methylene blue|mesh-list
110994057|NCT04056923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110994058|NCT04056923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110994060|NCT03664115|Antifungal Agents|antifungal agents|mesh-ancestor
110994061|NCT03664115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110994062|NCT03664115|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110994063|NCT03664115|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110994064|NCT03664115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110994065|NCT03664115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110994066|NCT03664115|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110994067|NCT03664115|Hormone Antagonists|hormone antagonists|mesh-ancestor
110994068|NCT03664115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110994069|NCT03664115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110994070|NCT03664115|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110994071|NCT04056845|Acetaminophen|acetaminophen|mesh-list
110994072|NCT04056845|Diclofenac|diclofenac|mesh-list
110994073|NCT04056845|Analgesics|analgesics|mesh-list
110994074|NCT04056845|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110994075|NCT04056845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110994076|NCT04056845|Sensory System Agents|sensory system agents|mesh-ancestor
110994077|NCT04056845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110994078|NCT04056845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110994079|NCT04056845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110994080|NCT04056845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110994081|NCT04056845|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110994082|NCT04056845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110994083|NCT04056845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110994084|NCT04056845|Antipyretics|antipyretics|mesh-ancestor
110994085|NCT02510014|Buprenorphine|buprenorphine|mesh-list
110994086|NCT02510014|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
110994087|NCT02510014|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110994088|NCT02510014|Narcotics|narcotics|mesh-ancestor
110994089|NCT02510014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110994090|NCT02510014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110994091|NCT02510014|Analgesics|analgesics|mesh-ancestor
110994092|NCT02510014|Sensory System Agents|sensory system agents|mesh-ancestor
110994093|NCT02510014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110994094|NCT02510014|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110994095|NCT02509312|Ketorolac|ketorolac|mesh-list
110994096|NCT02509312|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110994097|NCT02509312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110994098|NCT02509312|Analgesics|analgesics|mesh-ancestor
110994099|NCT02509312|Sensory System Agents|sensory system agents|mesh-ancestor
110994100|NCT02509312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110994101|NCT02509312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110994102|NCT02509312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110994103|NCT02509312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110994104|NCT02509312|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110994105|NCT02509312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110994106|NCT02509312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110994107|NCT02362958|Capecitabine|capecitabine|mesh-list
110994108|NCT02362958|Vinorelbine|vinorelbine|mesh-list
110994109|NCT02362958|Lapatinib|lapatinib|mesh-list
110994110|NCT02362958|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110994111|NCT02362958|Antimetabolites|antimetabolites|mesh-ancestor
110994112|NCT02362958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110994113|NCT02362958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110994114|NCT02362958|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110994115|NCT02362958|Tubulin Modulators|tubulin modulators|mesh-ancestor
110994116|NCT02362958|Antimitotic Agents|antimitotic agents|mesh-ancestor
110994117|NCT02362958|Mitosis Modulators|mitosis modulators|mesh-ancestor
110994118|NCT02362958|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110994119|NCT02362958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110994120|NCT04973800|Simvastatin|simvastatin|mesh-list
110994121|NCT04973800|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110994122|NCT04973800|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110994123|NCT04973800|Antimetabolites|antimetabolites|mesh-ancestor
110994124|NCT04973800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110994125|NCT04973800|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110994126|NCT04973800|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110994127|NCT04973800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110994128|NCT05020522|Phenobarbital|phenobarbital|mesh-list
110994129|NCT05020522|Anticonvulsants|anticonvulsants|mesh-ancestor
110711155|NCT01092130|Vitamins|vitamins|mesh-ancestor
110994130|NCT05020522|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110994131|NCT05020522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110994132|NCT05020522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110994133|NCT05020522|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110994134|NCT05020522|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110994135|NCT05020522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110994136|NCT05020522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110994137|NCT05020522|GABA Modulators|gaba modulators|mesh-ancestor
110994138|NCT05020522|GABA Agents|gaba agents|mesh-ancestor
110994139|NCT05020522|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110994140|NCT05020522|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110994141|NCT05020522|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110994142|NCT02519842|Dexamethasone|dexamethasone|mesh-list
110994143|NCT02519842|Ondansetron|ondansetron|mesh-list
110994144|NCT02519842|Fosaprepitant|fosaprepitant|mesh-list
110994145|NCT02519842|Aprepitant|aprepitant|mesh-list
110994146|NCT02519842|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-list
110994147|NCT02519842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110994148|NCT02519842|Antiemetics|antiemetics|mesh-ancestor
110994149|NCT02519842|Autonomic Agents|autonomic agents|mesh-ancestor
110994150|NCT02519842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110994151|NCT02519842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110994152|NCT02519842|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110994153|NCT02519842|Glucocorticoids|glucocorticoids|mesh-ancestor
110994154|NCT02519842|Hormones|hormones|mesh-ancestor
110994155|NCT02519842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110994156|NCT02519842|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110994157|NCT02519842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110994158|NCT02519842|Antipruritics|antipruritics|mesh-ancestor
110994159|NCT02519842|Dermatologic Agents|dermatologic agents|mesh-ancestor
110994160|NCT02519842|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110994162|NCT02519842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110994163|NCT02519842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110994164|NCT02519842|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110994165|NCT02509078|Cisatracurium|cisatracurium|mesh-list
110994166|NCT02509078|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110994167|NCT02509078|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110994168|NCT02509078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110994169|NCT02509078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110994170|NCT02993783|Vedolizumab|vedolizumab|mesh-list
110994171|NCT02993783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110994172|NCT03661775|Magnesium Sulfate|magnesium sulfate|mesh-list
110994173|NCT03661775|Analgesics|analgesics|mesh-ancestor
110994174|NCT03661775|Sensory System Agents|sensory system agents|mesh-ancestor
110994175|NCT03661775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110994176|NCT03661775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110994177|NCT03661775|Anesthetics|anesthetics|mesh-ancestor
110994178|NCT03661775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110994179|NCT03661775|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110994180|NCT03661775|Anticonvulsants|anticonvulsants|mesh-ancestor
110994181|NCT03661775|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110994182|NCT03661775|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110994183|NCT03661775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110994184|NCT03661775|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110994185|NCT03661775|Tocolytic Agents|tocolytic agents|mesh-ancestor
110994186|NCT03661775|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110994187|NCT03660761|Apatinib|apatinib|mesh-list
110994188|NCT03660761|Temozolomide|temozolomide|mesh-list
110994189|NCT03660761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110994190|NCT03660761|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110994191|NCT03660761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110994192|NCT03660761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110994193|NCT03660761|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110994194|NCT03660761|Alkylating Agents|alkylating agents|mesh-ancestor
110994195|NCT02993471|Vitamin K|vitamin k|mesh-list
110994196|NCT02993471|Midazolam|midazolam|mesh-list
110994197|NCT02993471|Dextromethorphan|dextromethorphan|mesh-list
110994198|NCT02993471|Caffeine|caffeine|mesh-list
110994199|NCT02993471|Ixekizumab|ixekizumab|mesh-list
110994200|NCT02993471|Omeprazole|omeprazole|mesh-list
110994201|NCT02993471|Warfarin|warfarin|mesh-list
110994202|NCT02993471|Vitamins|vitamins|mesh-ancestor
110994203|NCT02993471|Micronutrients|micronutrients|mesh-ancestor
110994204|NCT02993471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110711231|NCT00063934|Antimitotic Agents|antimitotic agents|mesh-ancestor
110994205|NCT02993471|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110994206|NCT02993471|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110994207|NCT02993471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110994208|NCT02993471|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110994209|NCT02993471|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110994210|NCT02993471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110994211|NCT02993471|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110994212|NCT02993471|Anesthetics, General|anesthetics, general|mesh-ancestor
110994213|NCT02993471|Anesthetics|anesthetics|mesh-ancestor
110994214|NCT02993471|GABA Modulators|gaba modulators|mesh-ancestor
110994215|NCT02993471|GABA Agents|gaba agents|mesh-ancestor
110994216|NCT02993471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110994217|NCT02993471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110994218|NCT02993471|Anticoagulants|anticoagulants|mesh-ancestor
110994219|NCT02993471|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110994220|NCT02993471|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110994221|NCT02993471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110994222|NCT02993471|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110994223|NCT02993471|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110994224|NCT02993471|Purinergic Agents|purinergic agents|mesh-ancestor
110994225|NCT02993471|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110994226|NCT02993471|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110994227|NCT02993471|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110994228|NCT02993471|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110994229|NCT02993471|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110994230|NCT02993471|Hemostatics|hemostatics|mesh-ancestor
110994231|NCT02993471|Coagulants|coagulants|mesh-ancestor
110994232|NCT02993471|Antitussive Agents|antitussive agents|mesh-ancestor
110994233|NCT02993471|Respiratory System Agents|respiratory system agents|mesh-ancestor
110994234|NCT02993471|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110994235|NCT02993471|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110994236|NCT02993471|Dermatologic Agents|dermatologic agents|mesh-ancestor
110994237|NCT01068743|Metformin|metformin|mesh-list
110994238|NCT01068743|Saxagliptin|saxagliptin|mesh-list
110994239|NCT01068743|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110994240|NCT01068743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110994241|NCT01068743|Incretins|incretins|mesh-ancestor
110994242|NCT01068743|Hormones|hormones|mesh-ancestor
110994243|NCT01068743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110994244|NCT01068743|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110994245|NCT01068743|Protease Inhibitors|protease inhibitors|mesh-ancestor
110994246|NCT01068743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110994247|NCT01068743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110994248|NCT03622541|Sorafenib|sorafenib|mesh-list
110994249|NCT03622541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110994250|NCT03622541|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110994251|NCT03622541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110994252|NCT03622541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110994253|NCT03658733|Amoxicillin|amoxicillin|mesh-list
110994254|NCT03658733|Tetracycline|tetracycline|mesh-list
110994255|NCT03658733|Furazolidone|furazolidone|mesh-list
110994256|NCT03658733|Esomeprazole|esomeprazole|mesh-list
110994257|NCT03658733|Rabeprazole|rabeprazole|mesh-list
110994258|NCT03658733|Bismuth|bismuth|mesh-list
110994259|NCT03658733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110994260|NCT03658733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110994261|NCT03658733|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110994262|NCT03658733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110994263|NCT03658733|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110994264|NCT03658733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110994265|NCT03658733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110994266|NCT03658733|Antacids|antacids|mesh-ancestor
110994267|NCT03658733|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110994268|NCT03658733|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110994269|NCT03658733|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110994270|NCT03658733|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
110994271|NCT03658733|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110994272|NCT03658733|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110994273|NCT03658733|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
110994274|NCT04056143|Rivaroxaban|rivaroxaban|mesh-list
110994275|NCT04056143|Apixaban|apixaban|mesh-list
110711307|NCT00285818|Abortifacient Agents|abortifacient agents|mesh-ancestor
110994276|NCT04056143|Edoxaban|edoxaban|mesh-list
110994277|NCT04056143|Dabigatran|dabigatran|mesh-list
110994278|NCT04056143|Thromboplastin|thromboplastin|mesh-list
110994279|NCT04056143|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110994280|NCT04056143|Antithrombins|antithrombins|mesh-ancestor
110994281|NCT04056143|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110994282|NCT04056143|Protease Inhibitors|protease inhibitors|mesh-ancestor
110994283|NCT04056143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110994284|NCT04056143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110994285|NCT04056143|Anticoagulants|anticoagulants|mesh-ancestor
110994286|NCT04056143|Hemostatics|hemostatics|mesh-ancestor
110994287|NCT04056143|Coagulants|coagulants|mesh-ancestor
110994288|NCT03661463|Aspirin|aspirin|mesh-list
110994289|NCT03661463|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110994290|NCT03661463|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110994291|NCT03661463|Analgesics|analgesics|mesh-ancestor
110994292|NCT03661463|Sensory System Agents|sensory system agents|mesh-ancestor
110994293|NCT03661463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110994294|NCT03661463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110994295|NCT03661463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110994296|NCT03661463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110994297|NCT03661463|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110994298|NCT03661463|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110994299|NCT03661463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110994300|NCT03661463|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110994301|NCT03661463|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110994302|NCT03661463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110994303|NCT03661463|Antipyretics|antipyretics|mesh-ancestor
110994304|NCT03658421|Dexmedetomidine|dexmedetomidine|mesh-list
110994305|NCT03658421|Morphine|morphine|mesh-list
110994306|NCT03658421|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110994307|NCT03658421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110994308|NCT03658421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110994309|NCT03658421|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110994310|NCT03658421|Analgesics|analgesics|mesh-ancestor
110994311|NCT03658421|Sensory System Agents|sensory system agents|mesh-ancestor
110459446|NCT05003713|Hormones|hormones|mesh-ancestor
110994312|NCT03658421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110994313|NCT03658421|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110994314|NCT03658421|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110994316|NCT03658421|Adrenergic Agents|adrenergic agents|mesh-ancestor
110994317|NCT03658421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110994318|NCT03658421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110994319|NCT03658421|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110994320|NCT03658421|Narcotics|narcotics|mesh-ancestor
110994321|NCT03660293|Captopril|captopril|mesh-list
110994322|NCT03660293|Atorvastatin|atorvastatin|mesh-list
110994323|NCT03660293|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110994324|NCT03660293|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110994325|NCT03660293|Antimetabolites|antimetabolites|mesh-ancestor
110994326|NCT03660293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110994327|NCT03660293|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110994328|NCT03660293|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110994329|NCT03660293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110994330|NCT03660293|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110994331|NCT03660293|Protease Inhibitors|protease inhibitors|mesh-ancestor
110994332|NCT03660293|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110994333|NCT02986139|Etanercept|etanercept|mesh-list
110994334|NCT02986139|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110994335|NCT02986139|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110994336|NCT02986139|Analgesics|analgesics|mesh-ancestor
110994337|NCT02986139|Sensory System Agents|sensory system agents|mesh-ancestor
110994338|NCT02986139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110994339|NCT02986139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110994340|NCT02986139|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110994341|NCT02986139|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110994342|NCT02986139|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110994343|NCT02986139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110994344|NCT02986139|Immunologic Factors|immunologic factors|mesh-ancestor
110994345|NCT02906917|Insulin|insulin|mesh-list
110994346|NCT02906917|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110994347|NCT02906917|Insulin Glargine|insulin glargine|mesh-list
110994348|NCT02906917|Insulin Aspart|insulin aspart|mesh-list
110994349|NCT02906917|Insulin, Long-Acting|insulin, long-acting|mesh-list
110994350|NCT02906917|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
110994351|NCT02906917|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110994352|NCT02906917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110994353|NCT01066585|Ivermectin|ivermectin|mesh-list
110994354|NCT01066585|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110994355|NCT01066585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110994356|NCT03654703|Cyclophosphamide|cyclophosphamide|mesh-list
110994357|NCT03654703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110994358|NCT03654703|Immunologic Factors|immunologic factors|mesh-ancestor
110994359|NCT03654703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110994360|NCT03654703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110994361|NCT03654703|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110994362|NCT03654703|Alkylating Agents|alkylating agents|mesh-ancestor
110994363|NCT03654703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110994364|NCT03654703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110994365|NCT03654703|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110994366|NCT02980783|Lidocaine|lidocaine|mesh-list
110994367|NCT02980783|Anesthetics, Local|anesthetics, local|mesh-ancestor
110994368|NCT02980783|Anesthetics|anesthetics|mesh-ancestor
110994369|NCT02980783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110994370|NCT02980783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110994371|NCT02980783|Sensory System Agents|sensory system agents|mesh-ancestor
110994372|NCT02980783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110994373|NCT02980783|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110994374|NCT02980783|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110994375|NCT02980783|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110994376|NCT02980783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110994377|NCT02980783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110994378|NCT02989649|Metformin|metformin|mesh-list
110994379|NCT02989649|Pioglitazone|pioglitazone|mesh-list
110994380|NCT02989649|Alogliptin|alogliptin|mesh-list
110994381|NCT02989649|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110994382|NCT02989649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110994383|NCT02989649|Incretins|incretins|mesh-ancestor
110994384|NCT02989649|Hormones|hormones|mesh-ancestor
110994385|NCT02989649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110994386|NCT02989649|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110994387|NCT02989649|Protease Inhibitors|protease inhibitors|mesh-ancestor
110994388|NCT02989649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110994389|NCT02989649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110994390|NCT03659435|Rivastigmine|rivastigmine|mesh-list
110994391|NCT03659435|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110994392|NCT03659435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110994393|NCT03659435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110994394|NCT03659435|Cholinergic Agents|cholinergic agents|mesh-ancestor
110994395|NCT03659435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110994396|NCT03659435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110994397|NCT03659435|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110994398|NCT03659435|Protective Agents|protective agents|mesh-ancestor
110994399|NCT01067339|Darapladib|darapladib|mesh-list
110994400|NCT01067339|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
110994401|NCT01067339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110994402|NCT01067339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110994403|NCT04484675|Milrinone|milrinone|mesh-list
110994404|NCT04484675|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110994405|NCT04484675|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110994406|NCT04484675|Vasodilator Agents|vasodilator agents|mesh-ancestor
110994407|NCT04484675|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110994408|NCT04484675|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110994409|NCT04484675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110994410|NCT04484675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110994411|NCT04484675|Protective Agents|protective agents|mesh-ancestor
110994412|NCT04484675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110994413|NCT03658109|Lidocaine|lidocaine|mesh-list
110994414|NCT03658109|Anesthetics, Local|anesthetics, local|mesh-ancestor
110994415|NCT03658109|Anesthetics|anesthetics|mesh-ancestor
110994416|NCT03658109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110994417|NCT03658109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110994418|NCT03658109|Sensory System Agents|sensory system agents|mesh-ancestor
110994419|NCT03658109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110994420|NCT03658109|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110994421|NCT03658109|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110994422|NCT03658109|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110994423|NCT03658109|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110994424|NCT03658109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110994425|NCT03658031|Dapagliflozin|dapagliflozin|mesh-list
110994426|NCT03658031|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110994427|NCT03658031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110994428|NCT03658031|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110994429|NCT03658031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110994432|NCT03660917|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110994434|NCT03660917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110994435|NCT03660917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110994436|NCT03660917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110994437|NCT03660917|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110994438|NCT03660917|Protective Agents|protective agents|mesh-ancestor
110994439|NCT02977507|Sunscreening Agents|sunscreening agents|mesh-list
110994440|NCT02977507|Hydroquinone|hydroquinone|mesh-list
110994441|NCT02977507|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110994442|NCT02977507|Protective Agents|protective agents|mesh-ancestor
110994443|NCT02977507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110994444|NCT02977507|Dermatologic Agents|dermatologic agents|mesh-ancestor
110994445|NCT02977507|Antioxidants|antioxidants|mesh-ancestor
110994446|NCT02977507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110994447|NCT04471415|Atezolizumab|atezolizumab|mesh-list
110994448|NCT04471415|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110994449|NCT04471415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110994450|NCT04471415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110994451|NCT04471415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110994452|NCT02976103|Analgesics|analgesics|mesh-list
110994453|NCT02976103|Sensory System Agents|sensory system agents|mesh-ancestor
110994454|NCT02976103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110994455|NCT02976103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110994459|NCT03653845|Epinephrine|epinephrine|mesh-list
110994460|NCT03653845|Racepinephrine|racepinephrine|mesh-list
110994461|NCT03653845|Epinephryl borate|epinephryl borate|mesh-list
110994462|NCT03653845|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110994463|NCT03653845|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110994464|NCT03653845|Adrenergic Agents|adrenergic agents|mesh-ancestor
110994465|NCT03653845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110994466|NCT03653845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110994467|NCT03653845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110994468|NCT03653845|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110994469|NCT03653845|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110994470|NCT03653845|Autonomic Agents|autonomic agents|mesh-ancestor
110994471|NCT03653845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110994472|NCT03653845|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110994473|NCT03653845|Respiratory System Agents|respiratory system agents|mesh-ancestor
110994474|NCT03653845|Mydriatics|mydriatics|mesh-ancestor
110994475|NCT03653845|Sympathomimetics|sympathomimetics|mesh-ancestor
110994476|NCT03653845|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110994477|NCT03470961|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110994478|NCT03470961|Immunologic Factors|immunologic factors|mesh-ancestor
110994479|NCT03470961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110994480|NCT03470961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110994481|NCT01066039|Bisoprolol|bisoprolol|mesh-list
110994482|NCT01066039|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110994483|NCT01066039|Sympatholytics|sympatholytics|mesh-ancestor
110994484|NCT01066039|Autonomic Agents|autonomic agents|mesh-ancestor
110994485|NCT01066039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110994486|NCT01066039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110994487|NCT01066039|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110994488|NCT01066039|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110994489|NCT01066039|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110994490|NCT01066039|Adrenergic Agents|adrenergic agents|mesh-ancestor
110994491|NCT01066039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110994492|NCT01066039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110994493|NCT04217967|Lenalidomide|lenalidomide|mesh-list
110994494|NCT04217967|Ixazomib|ixazomib|mesh-list
110994495|NCT04217967|Immunologic Factors|immunologic factors|mesh-ancestor
110994496|NCT04217967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110994497|NCT04217967|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110994498|NCT04217967|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110994499|NCT04217967|Growth Substances|growth substances|mesh-ancestor
110994500|NCT04217967|Growth Inhibitors|growth inhibitors|mesh-ancestor
110994501|NCT04217967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110994502|NCT04217967|Protease Inhibitors|protease inhibitors|mesh-ancestor
110994503|NCT04217967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110994504|NCT04217967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110994505|NCT02919761|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
110994506|NCT02919761|Hormones|hormones|mesh-ancestor
110994507|NCT02919761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110994508|NCT02919761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110994509|NCT02910167|Acetaminophen|acetaminophen|mesh-list
110994510|NCT02910167|Scopolamine|scopolamine|mesh-list
110994511|NCT02910167|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
110994512|NCT02910167|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110994513|NCT02910167|Analgesics|analgesics|mesh-ancestor
110994514|NCT02910167|Sensory System Agents|sensory system agents|mesh-ancestor
110994515|NCT02910167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110994516|NCT02910167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110994517|NCT02910167|Antipyretics|antipyretics|mesh-ancestor
110994518|NCT02910167|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110994519|NCT02910167|Antiemetics|antiemetics|mesh-ancestor
110994520|NCT02910167|Autonomic Agents|autonomic agents|mesh-ancestor
110994521|NCT02910167|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110994522|NCT02910167|Mydriatics|mydriatics|mesh-ancestor
110994523|NCT02910167|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110994524|NCT02910167|Cholinergic Agents|cholinergic agents|mesh-ancestor
110994525|NCT02910167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110994526|NCT02910167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110994527|NCT02910167|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110994528|NCT02910167|Parasympatholytics|parasympatholytics|mesh-ancestor
110994529|NCT04458285|Valsartan|valsartan|mesh-list
110994530|NCT04458285|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
110994531|NCT04458285|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110994532|NCT04458285|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110994533|NCT04458285|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110994534|NCT04458285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110994535|NCT05156541|Interferons|interferons|mesh-list
110994536|NCT05156541|Interferon-gamma|interferon-gamma|mesh-list
110994537|NCT05156541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110994538|NCT05156541|Antiviral Agents|antiviral agents|mesh-ancestor
110994539|NCT05156541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110994540|NCT01067105|Ciclesonide|ciclesonide|mesh-list
110994541|NCT01067105|Glucocorticoids|glucocorticoids|mesh-ancestor
110994542|NCT01067105|Hormones|hormones|mesh-ancestor
110994543|NCT01067105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110994544|NCT01067105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110994545|NCT01067105|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110994546|NCT03470727|Dialysis Solutions|dialysis solutions|mesh-list
110994547|NCT03470727|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110994548|NCT03470649|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
110994549|NCT03470649|Hematinics|hematinics|mesh-ancestor
110994550|NCT02910011|Doxycycline|doxycycline|mesh-list
110994551|NCT02910011|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110994552|NCT02910011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110994553|NCT02910011|Antimalarials|antimalarials|mesh-ancestor
110994554|NCT02910011|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110994555|NCT02910011|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110994556|NCT04456803|Sevelamer|sevelamer|mesh-list
110994557|NCT04456803|Chelating Agents|chelating agents|mesh-ancestor
110994558|NCT04456803|Sequestering Agents|sequestering agents|mesh-ancestor
110994559|NCT04456803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110994560|NCT02908529|Oxybutynin|oxybutynin|mesh-list
110994561|NCT02908529|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
110994562|NCT02908529|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110994563|NCT02908529|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110994564|NCT02908529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110994565|NCT02908529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110994566|NCT02908529|Adrenergic Agents|adrenergic agents|mesh-ancestor
110994567|NCT02908529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110994568|NCT02908529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110994569|NCT02908529|Parasympatholytics|parasympatholytics|mesh-ancestor
110994570|NCT02908529|Autonomic Agents|autonomic agents|mesh-ancestor
110994571|NCT02908529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110994572|NCT02908529|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110994573|NCT02908529|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110994574|NCT02908529|Cholinergic Agents|cholinergic agents|mesh-ancestor
110994575|NCT02908529|Urological Agents|urological agents|mesh-ancestor
110994576|NCT03469557|Capecitabine|capecitabine|mesh-list
110994577|NCT03469557|Oxaliplatin|oxaliplatin|mesh-list
110994578|NCT03469557|Tislelizumab|tislelizumab|mesh-list
110994579|NCT03469557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110994580|NCT03469557|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110994581|NCT03469557|Antimetabolites|antimetabolites|mesh-ancestor
110994582|NCT03469557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110994583|NCT03469557|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110994584|NCT02643381|Ketamine|ketamine|mesh-list
110994585|NCT02643381|Etomidate|etomidate|mesh-list
110994586|NCT02643381|Analgesics|analgesics|mesh-ancestor
110994587|NCT02643381|Sensory System Agents|sensory system agents|mesh-ancestor
110994588|NCT02643381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110994589|NCT02643381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110994590|NCT02643381|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110994591|NCT02643381|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110994592|NCT02643381|Anesthetics, General|anesthetics, general|mesh-ancestor
110994593|NCT02643381|Anesthetics|anesthetics|mesh-ancestor
110994594|NCT02643381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110994595|NCT02643381|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110994596|NCT02643381|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110994597|NCT02643381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110994598|NCT02643381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110994599|NCT02643381|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110994600|NCT04328961|Ascorbic Acid|ascorbic acid|mesh-list
110994601|NCT04328961|Hydroxychloroquine|hydroxychloroquine|mesh-list
110994602|NCT04328961|Antimalarials|antimalarials|mesh-ancestor
110994603|NCT04328961|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110994604|NCT04328961|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110994605|NCT04328961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110994606|NCT04328961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110994607|NCT04328961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110994608|NCT04328961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110994609|NCT04328961|Antioxidants|antioxidants|mesh-ancestor
110994610|NCT04328961|Protective Agents|protective agents|mesh-ancestor
110994611|NCT04328961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110994612|NCT04328961|Vitamins|vitamins|mesh-ancestor
110994613|NCT04328961|Micronutrients|micronutrients|mesh-ancestor
110994615|NCT00455403|Amebicides|amebicides|mesh-ancestor
110994616|NCT00455403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110994617|NCT00455403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110994618|NCT00455403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110994619|NCT00455403|Antimalarials|antimalarials|mesh-ancestor
110994620|NCT00455403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110994621|NCT03470337|Wobenzym|wobenzym|mesh-list
110994622|NCT03470337|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110994623|NCT03470337|Immunologic Factors|immunologic factors|mesh-ancestor
110994624|NCT03470337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110994625|NCT03576261|Polygeline|polygeline|mesh-list
110994626|NCT03576261|Plasma Substitutes|plasma substitutes|mesh-ancestor
110994627|NCT03576261|Blood Substitutes|blood substitutes|mesh-ancestor
110994628|NCT03469323|Succinylcholine|succinylcholine|mesh-list
110994629|NCT03469323|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
110994630|NCT03469323|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110994631|NCT03469323|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110994632|NCT03469323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110994633|NCT03469323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110994634|NCT05160285|Nivolumab|nivolumab|mesh-list
110994635|NCT05160285|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110994636|NCT05160285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110994637|NCT05160285|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110994638|NCT05160285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110994639|NCT05160051|FAPI-46|fapi-46|mesh-list
110994640|NCT05160051|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110994641|NCT05160051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110994642|NCT03471819|Serotonin|serotonin|mesh-list
110994643|NCT03471819|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110994644|NCT03471819|Serotonin Agents|serotonin agents|mesh-ancestor
110994645|NCT03471819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110994646|NCT03471819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110994647|NCT03471819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110994648|NCT03618693|Anesthetics|anesthetics|mesh-list
110994649|NCT03618693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110994650|NCT03618693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110994651|NCT01064167|Tranexamic Acid|tranexamic acid|mesh-list
110994652|NCT01064167|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110994653|NCT01064167|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110994654|NCT01064167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110994655|NCT01064167|Hemostatics|hemostatics|mesh-ancestor
110994656|NCT01064167|Coagulants|coagulants|mesh-ancestor
110994657|NCT04205305|Labetalol|labetalol|mesh-list
110994658|NCT04205305|Nicardipine|nicardipine|mesh-list
110994659|NCT04205305|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110994660|NCT04205305|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110994661|NCT04205305|Adrenergic Agents|adrenergic agents|mesh-ancestor
110994662|NCT04205305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110994663|NCT04205305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110994664|NCT04205305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110994665|NCT04205305|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110994666|NCT04205305|Sympathomimetics|sympathomimetics|mesh-ancestor
110994667|NCT04205305|Autonomic Agents|autonomic agents|mesh-ancestor
110994668|NCT04205305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110994669|NCT04205305|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110994670|NCT04205305|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110994671|NCT04205305|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110994672|NCT04205305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110994673|NCT04205305|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110994674|NCT04205305|Vasodilator Agents|vasodilator agents|mesh-ancestor
110994675|NCT03470103|Aflibercept|aflibercept|mesh-list
110994676|NCT03470103|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110994677|NCT03470103|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110994678|NCT03470103|Growth Substances|growth substances|mesh-ancestor
110994679|NCT03470103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110994680|NCT03470103|Growth Inhibitors|growth inhibitors|mesh-ancestor
110994681|NCT03470103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110994682|NCT01064947|Retapamulin|retapamulin|mesh-list
110994683|NCT01064947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110994684|NCT01064947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110994685|NCT03469947|Tranexamic Acid|tranexamic acid|mesh-list
110994686|NCT03469947|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110994687|NCT03469947|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110994688|NCT03469947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110994689|NCT03469947|Hemostatics|hemostatics|mesh-ancestor
110994690|NCT03469947|Coagulants|coagulants|mesh-ancestor
110994691|NCT05157087|Omalizumab|omalizumab|mesh-list
110994692|NCT05157087|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110994693|NCT05157087|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110994694|NCT05157087|Respiratory System Agents|respiratory system agents|mesh-ancestor
110994695|NCT04054063|Etomidate|etomidate|mesh-list
110994696|NCT04054063|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110994697|NCT04054063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110994698|NCT04054063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110994699|NCT04054063|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110994700|NCT04054063|Anesthetics, General|anesthetics, general|mesh-ancestor
110994701|NCT04054063|Anesthetics|anesthetics|mesh-ancestor
110994702|NCT03652441|Brentuximab Vedotin|brentuximab vedotin|mesh-list
110994703|NCT03652441|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110994704|NCT03652441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110994705|NCT03652441|Immunotoxins|immunotoxins|mesh-ancestor
110994706|NCT03652441|Immunoconjugates|immunoconjugates|mesh-ancestor
110994707|NCT03652441|Immunologic Factors|immunologic factors|mesh-ancestor
110994708|NCT03652441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110994709|NCT02918071|Benralizumab|benralizumab|mesh-list
110994710|NCT02918071|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110994711|NCT02918071|Respiratory System Agents|respiratory system agents|mesh-ancestor
110994712|NCT05162625|Moxifloxacin|moxifloxacin|mesh-list
110994713|NCT05162625|Ciprofloxacin|ciprofloxacin|mesh-list
110994714|NCT05162625|Cefazolin|cefazolin|mesh-list
110994715|NCT05162625|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110994716|NCT05162625|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110994717|NCT05162625|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110994718|NCT05162625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110994719|NCT05162625|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110994720|NCT05162625|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110994721|NCT05162625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110994722|NCT05162625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110994723|NCT05162625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110994724|NCT05162625|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110994725|NCT05162625|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110994726|NCT02506816|Olaparib|olaparib|mesh-list
110994727|NCT02506816|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110994728|NCT02506816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110994729|NCT02506816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110994730|NCT02506816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110711752|NCT00048568|Abatacept|abatacept|mesh-list
110994731|NCT05009901|Thioctic Acid|thioctic acid|mesh-list
110994732|NCT05009901|Antioxidants|antioxidants|mesh-ancestor
110994733|NCT05009901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110994734|NCT05009901|Protective Agents|protective agents|mesh-ancestor
110994735|NCT05009901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110994736|NCT05009901|Vitamin B Complex|vitamin b complex|mesh-ancestor
110994737|NCT05009901|Vitamins|vitamins|mesh-ancestor
110994738|NCT05009901|Micronutrients|micronutrients|mesh-ancestor
110994739|NCT01063855|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
110994740|NCT01063855|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110994741|NCT01063855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110994742|NCT01063855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110994743|NCT05162001|Disulfiram|disulfiram|mesh-list
110994744|NCT05162001|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110994745|NCT05162001|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
110994746|NCT05162001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110994747|NCT05162001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110994748|NCT03469167|Epinephrine|epinephrine|mesh-list
110994749|NCT03469167|CEGP-003|cegp-003|mesh-list
110994750|NCT03469167|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110994751|NCT03469167|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110994752|NCT03469167|Adrenergic Agents|adrenergic agents|mesh-ancestor
110994753|NCT03469167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110994754|NCT03469167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110994755|NCT03469167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110994756|NCT03469167|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110994757|NCT03469167|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110994758|NCT03469167|Autonomic Agents|autonomic agents|mesh-ancestor
110994759|NCT03469167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110994760|NCT03469167|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110994761|NCT03469167|Respiratory System Agents|respiratory system agents|mesh-ancestor
110994763|NCT03469167|Sympathomimetics|sympathomimetics|mesh-ancestor
110994764|NCT03469167|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110994765|NCT03469167|Hemostatics|hemostatics|mesh-ancestor
110994766|NCT03469167|Coagulants|coagulants|mesh-ancestor
110994767|NCT01063153|Methylphenidate|methylphenidate|mesh-list
110994768|NCT01063153|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110994769|NCT01063153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110994770|NCT01063153|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110994771|NCT01063153|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110994772|NCT01063153|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110994773|NCT01063153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110994774|NCT01063153|Dopamine Agents|dopamine agents|mesh-ancestor
110994775|NCT01063153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110994776|NCT05161221|Acetaminophen|acetaminophen|mesh-list
110994777|NCT05161221|Naproxen|naproxen|mesh-list
110994778|NCT05161221|Oxycodone|oxycodone|mesh-list
110994779|NCT05161221|Bupivacaine|bupivacaine|mesh-list
110994780|NCT05161221|Anesthetics, Local|anesthetics, local|mesh-ancestor
110994781|NCT05161221|Anesthetics|anesthetics|mesh-ancestor
110994782|NCT05161221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110994783|NCT05161221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110994784|NCT05161221|Sensory System Agents|sensory system agents|mesh-ancestor
110994785|NCT05161221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110994786|NCT05161221|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110994787|NCT05161221|Narcotics|narcotics|mesh-ancestor
110994788|NCT05161221|Analgesics|analgesics|mesh-ancestor
110994789|NCT05161221|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110994790|NCT05161221|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110994791|NCT05161221|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110994792|NCT05161221|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110994793|NCT05161221|Gout Suppressants|gout suppressants|mesh-ancestor
110994794|NCT05161221|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110994795|NCT05161221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110994796|NCT05161221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110994797|NCT05161221|Antipyretics|antipyretics|mesh-ancestor
110994798|NCT02505334|Liraglutide|liraglutide|mesh-list
110994799|NCT02505334|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110994800|NCT02505334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110994801|NCT02505334|Incretins|incretins|mesh-ancestor
110994802|NCT02505334|Hormones|hormones|mesh-ancestor
110994803|NCT02505334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110994804|NCT03469089|Ketamine|ketamine|mesh-list
110994805|NCT03469089|Modafinil|modafinil|mesh-list
110994806|NCT03469089|Analgesics|analgesics|mesh-ancestor
110994807|NCT03469089|Sensory System Agents|sensory system agents|mesh-ancestor
110994808|NCT03469089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110994809|NCT03469089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110994810|NCT03469089|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110994811|NCT03469089|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110994812|NCT03469089|Anesthetics, General|anesthetics, general|mesh-ancestor
110994813|NCT03469089|Anesthetics|anesthetics|mesh-ancestor
110994814|NCT03469089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110994815|NCT03469089|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110994816|NCT03469089|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110994817|NCT03469089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110994818|NCT03469089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110994819|NCT03469089|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110994820|NCT03469089|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
110994821|NCT03469089|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110994822|NCT03469089|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110994823|NCT04969510|Pramoxine|pramoxine|mesh-list
110994824|NCT04969510|Anesthetics, Local|anesthetics, local|mesh-ancestor
110994825|NCT04969510|Anesthetics|anesthetics|mesh-ancestor
110994826|NCT04969510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110994827|NCT04969510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110994828|NCT04969510|Sensory System Agents|sensory system agents|mesh-ancestor
110994829|NCT04969510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110994830|NCT02504320|Febuxostat|febuxostat|mesh-list
110994831|NCT02504320|Gout Suppressants|gout suppressants|mesh-ancestor
110994832|NCT02504320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110994833|NCT05014516|Xenon|xenon|mesh-list
110994834|NCT05014516|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110994835|NCT05014516|Anesthetics, General|anesthetics, general|mesh-ancestor
110994836|NCT05014516|Anesthetics|anesthetics|mesh-ancestor
110994837|NCT05014516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110994838|NCT05014516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110994839|NCT01061671|Simvastatin|simvastatin|mesh-list
110994840|NCT01061671|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110994841|NCT01061671|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110994842|NCT01061671|Antimetabolites|antimetabolites|mesh-ancestor
110994843|NCT01061671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110994844|NCT01061671|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110994845|NCT01061671|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110994846|NCT01061671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110994847|NCT04969120|Metoclopramide|metoclopramide|mesh-list
110994848|NCT04969120|Antiemetics|antiemetics|mesh-ancestor
110994849|NCT04969120|Autonomic Agents|autonomic agents|mesh-ancestor
110452483|NCT01018680|Analgesics|analgesics|mesh-ancestor
110994850|NCT04969120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110994851|NCT04969120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110994852|NCT04969120|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110994853|NCT04969120|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110994854|NCT04969120|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110994855|NCT04969120|Dopamine Agents|dopamine agents|mesh-ancestor
110994856|NCT04969120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110994857|NCT04969120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110994858|NCT00709995|Sunitinib|sunitinib|mesh-list
110994859|NCT00709995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110994860|NCT00709995|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110994861|NCT00709995|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110994862|NCT00709995|Growth Substances|growth substances|mesh-ancestor
110994863|NCT00709995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110994864|NCT00709995|Growth Inhibitors|growth inhibitors|mesh-ancestor
110994865|NCT00709995|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110994866|NCT00709995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110994867|NCT00709995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110994868|NCT02503540|Aflibercept|aflibercept|mesh-list
110994869|NCT02503540|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110994870|NCT02503540|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110994871|NCT02503540|Growth Substances|growth substances|mesh-ancestor
110994872|NCT02503540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110994873|NCT02503540|Growth Inhibitors|growth inhibitors|mesh-ancestor
110994874|NCT02503540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110994875|NCT04053985|Lenvatinib|lenvatinib|mesh-list
110994876|NCT04053985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110994877|NCT04053985|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110994878|NCT04053985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110994879|NCT04053985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110994880|NCT04455243|Acetylcysteine|acetylcysteine|mesh-list
110994881|NCT04455243|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110994882|NCT04455243|Antiviral Agents|antiviral agents|mesh-ancestor
110994883|NCT04455243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110994884|NCT04455243|Expectorants|expectorants|mesh-ancestor
110994885|NCT04455243|Respiratory System Agents|respiratory system agents|mesh-ancestor
110994886|NCT04455243|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110994887|NCT04455243|Antioxidants|antioxidants|mesh-ancestor
110994888|NCT04455243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110994889|NCT04455243|Protective Agents|protective agents|mesh-ancestor
110994890|NCT04455243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110994891|NCT04455243|Antidotes|antidotes|mesh-ancestor
110994892|NCT04454775|Protein C|protein c|mesh-list
110994893|NCT04454775|Antithrombins|antithrombins|mesh-list
110994894|NCT04454775|Antithrombin III|antithrombin iii|mesh-list
110994895|NCT04454775|Protein S|protein s|mesh-list
110994896|NCT04454775|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110994897|NCT04454775|Protease Inhibitors|protease inhibitors|mesh-ancestor
110994898|NCT04454775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110994899|NCT04454775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110994900|NCT04454775|Anticoagulants|anticoagulants|mesh-ancestor
110994901|NCT04454775|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110994903|NCT03651661|Insulin|insulin|mesh-list
110994904|NCT03651661|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110994905|NCT03651661|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110994906|NCT03651661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110994907|NCT01060111|Topiramate|topiramate|mesh-list
110994908|NCT01060111|Propranolol|propranolol|mesh-list
110994909|NCT01060111|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110994910|NCT01060111|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110994911|NCT01060111|Adrenergic Agents|adrenergic agents|mesh-ancestor
110994912|NCT01060111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110994913|NCT01060111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110994914|NCT01060111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110994915|NCT01060111|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110994916|NCT01060111|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110994917|NCT01060111|Vasodilator Agents|vasodilator agents|mesh-ancestor
110994918|NCT01060111|Anticonvulsants|anticonvulsants|mesh-ancestor
110994919|NCT01060111|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110994920|NCT02969863|Pancrelipase|pancrelipase|mesh-list
110994921|NCT02969863|Pancreatin|pancreatin|mesh-list
110994922|NCT02969863|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110994923|NCT03651427|Estradiol|estradiol|mesh-list
110994924|NCT03651427|Estrogens|estrogens|mesh-ancestor
110994925|NCT03651427|Hormones|hormones|mesh-ancestor
110994926|NCT03651427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110994927|NCT03651427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110994928|NCT05285293|Vitamin A|vitamin a|mesh-list
110994929|NCT05285293|Vitamins|vitamins|mesh-ancestor
110994930|NCT05285293|Micronutrients|micronutrients|mesh-ancestor
110994931|NCT05285293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110994932|NCT03650257|Temozolomide|temozolomide|mesh-list
110994933|NCT03650257|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110994934|NCT03650257|Alkylating Agents|alkylating agents|mesh-ancestor
110994935|NCT03650257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110994936|NCT03650257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110994937|NCT03649243|Propolis|propolis|mesh-list
110994938|NCT03649243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110994939|NCT03649165|Acetaminophen|acetaminophen|mesh-list
110994940|NCT03649165|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110994941|NCT03649165|Analgesics|analgesics|mesh-ancestor
110994942|NCT03649165|Sensory System Agents|sensory system agents|mesh-ancestor
110994943|NCT03649165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110994944|NCT03649165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110994945|NCT03649165|Antipyretics|antipyretics|mesh-ancestor
110994946|NCT03649009|Thiamine|thiamine|mesh-list
110994947|NCT03649009|Hydrocortisone|hydrocortisone|mesh-list
110994948|NCT03649009|Metoclopramide|metoclopramide|mesh-list
110994949|NCT03649009|Vitamins|vitamins|mesh-ancestor
110994950|NCT03649009|Micronutrients|micronutrients|mesh-ancestor
110994951|NCT03649009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110994952|NCT03649009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110994953|NCT03649009|Vitamin B Complex|vitamin b complex|mesh-ancestor
110994954|NCT03649009|Antiemetics|antiemetics|mesh-ancestor
110994955|NCT03649009|Autonomic Agents|autonomic agents|mesh-ancestor
110994956|NCT03649009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110994957|NCT03649009|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110994958|NCT03649009|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110994959|NCT03649009|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110994960|NCT03649009|Dopamine Agents|dopamine agents|mesh-ancestor
110994961|NCT03649009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110994962|NCT03649009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110994963|NCT03650023|Chitosan|chitosan|mesh-list
110994964|NCT03650023|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110994965|NCT03650023|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110994966|NCT03650023|Antimetabolites|antimetabolites|mesh-ancestor
110994967|NCT03650023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110994968|NCT03650023|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110994969|NCT03650023|Chelating Agents|chelating agents|mesh-ancestor
110994970|NCT03650023|Sequestering Agents|sequestering agents|mesh-ancestor
110994971|NCT03650023|Hemostatics|hemostatics|mesh-ancestor
110994972|NCT03650023|Coagulants|coagulants|mesh-ancestor
110994973|NCT04054999|Hydroxocobalamin|hydroxocobalamin|mesh-list
110994974|NCT04054999|Vitamin B 12|vitamin b 12|mesh-list
110994975|NCT04054999|Methylene Blue|methylene blue|mesh-list
110994976|NCT04054999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110994977|NCT04054999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110994978|NCT04054999|Hematinics|hematinics|mesh-ancestor
110994979|NCT04054999|Vitamin B Complex|vitamin b complex|mesh-ancestor
110994980|NCT04054999|Vitamins|vitamins|mesh-ancestor
110994982|NCT04054999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110994983|NCT03649945|Docetaxel|docetaxel|mesh-list
110994984|NCT03649945|Endostar protein|endostar protein|mesh-list
110994985|NCT03649945|Nedaplatin|nedaplatin|mesh-list
110994986|NCT03649945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110994987|NCT03649945|Tubulin Modulators|tubulin modulators|mesh-ancestor
110994988|NCT03649945|Antimitotic Agents|antimitotic agents|mesh-ancestor
110994989|NCT03649945|Mitosis Modulators|mitosis modulators|mesh-ancestor
110994990|NCT03649945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110994991|NCT03649945|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110994992|NCT03649945|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110994993|NCT03649945|Growth Substances|growth substances|mesh-ancestor
110994994|NCT03649945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110994995|NCT03649945|Growth Inhibitors|growth inhibitors|mesh-ancestor
110994996|NCT03650881|Adapalene|adapalene|mesh-list
110994997|NCT03650881|Benzoyl Peroxide|benzoyl peroxide|mesh-list
110994998|NCT03650881|Dermatologic Agents|dermatologic agents|mesh-ancestor
110994999|NCT03650881|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110995000|NCT03650881|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110995001|NCT03650881|Analgesics|analgesics|mesh-ancestor
110995002|NCT03650881|Sensory System Agents|sensory system agents|mesh-ancestor
110995003|NCT03650881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110995004|NCT03650881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110995005|NCT03650881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110995006|NCT03650881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110995007|NCT02904265|Acetazolamide|acetazolamide|mesh-list
110995008|NCT02904265|Diazepam|diazepam|mesh-list
110995009|NCT02904265|Anticonvulsants|anticonvulsants|mesh-ancestor
110995010|NCT02904265|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110995011|NCT02904265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110995012|NCT02904265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110995013|NCT02904265|Diuretics|diuretics|mesh-ancestor
110995014|NCT02904265|Natriuretic Agents|natriuretic agents|mesh-ancestor
110995015|NCT02904265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110995016|NCT02904265|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110995017|NCT02904265|Antiemetics|antiemetics|mesh-ancestor
110995018|NCT02904265|Autonomic Agents|autonomic agents|mesh-ancestor
110995019|NCT02904265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110995020|NCT02904265|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110995021|NCT02904265|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110995022|NCT02904265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110995023|NCT02904265|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110995024|NCT02904265|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110995025|NCT02904265|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110995026|NCT02904265|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110995027|NCT02904265|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110995028|NCT02904265|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110995029|NCT02904265|Anesthetics, General|anesthetics, general|mesh-ancestor
110995030|NCT02904265|Anesthetics|anesthetics|mesh-ancestor
110995031|NCT02904265|GABA Modulators|gaba modulators|mesh-ancestor
110995032|NCT02904265|GABA Agents|gaba agents|mesh-ancestor
110995033|NCT02904265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110995034|NCT03648229|Timolol|timolol|mesh-list
110995035|NCT03648229|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110995036|NCT03648229|Latanoprost|latanoprost|mesh-list
110995037|NCT03648229|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110995038|NCT03648229|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110995039|NCT03648229|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110995040|NCT03648229|Adrenergic Agents|adrenergic agents|mesh-ancestor
110995041|NCT03648229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110995042|NCT03648229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110995043|NCT03648229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110995044|NCT03648229|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110995045|NCT03648229|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110995047|NCT03648697|Fludarabine|fludarabine|mesh-list
110995048|NCT03648697|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110995049|NCT03648697|Immunologic Factors|immunologic factors|mesh-ancestor
110995050|NCT03648697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110995051|NCT03648697|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110995052|NCT03648697|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110995053|NCT03648697|Alkylating Agents|alkylating agents|mesh-ancestor
110995054|NCT03648697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110995055|NCT03648697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110995056|NCT03648697|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110460192|NCT01128842|Antimetabolites|antimetabolites|mesh-ancestor
110995057|NCT04535037|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110995058|NCT04535037|Immunologic Factors|immunologic factors|mesh-ancestor
110995059|NCT04535037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110995060|NCT02967679|Biotin|biotin|mesh-list
110995061|NCT02967679|Vitamin B Complex|vitamin b complex|mesh-ancestor
110995062|NCT02967679|Vitamins|vitamins|mesh-ancestor
110995063|NCT02967679|Micronutrients|micronutrients|mesh-ancestor
110995064|NCT02967679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110995065|NCT04447053|Belimumab|belimumab|mesh-list
110995066|NCT04447053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110995067|NCT04447053|Immunologic Factors|immunologic factors|mesh-ancestor
110995068|NCT04447053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110995069|NCT04361799|Insulin|insulin|mesh-list
110995070|NCT04361799|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110995071|NCT04361799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110995072|NCT05390073|Hormones|hormones|mesh-list
110995073|NCT05390073|Mitogens|mitogens|mesh-list
110995074|NCT05390073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110995075|NCT05390073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110995076|NCT05390073|Mitosis Modulators|mitosis modulators|mesh-ancestor
110995077|NCT05390073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110995078|NCT03647839|Nivolumab|nivolumab|mesh-list
110995079|NCT03647839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110995080|NCT03647839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110995081|NCT03647839|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110995082|NCT03647839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110995083|NCT04454619|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110995084|NCT04454307|Tramadol|tramadol|mesh-list
110995085|NCT04454307|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110995086|NCT04454307|Narcotics|narcotics|mesh-ancestor
110995087|NCT04454307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110995088|NCT04454307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110995089|NCT04454307|Analgesics|analgesics|mesh-ancestor
110995090|NCT04454307|Sensory System Agents|sensory system agents|mesh-ancestor
110995091|NCT04454307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110995092|NCT05388123|Rituximab|rituximab|mesh-list
110995093|NCT05388123|Vemurafenib|vemurafenib|mesh-list
110995094|NCT05388123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110995095|NCT05388123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110995096|NCT05388123|Immunologic Factors|immunologic factors|mesh-ancestor
110995097|NCT05388123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110995098|NCT05388123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110995099|NCT05388123|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110995100|NCT05388123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110995101|NCT05388123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110995102|NCT04455711|Lidocaine|lidocaine|mesh-list
110995103|NCT04455711|Remifentanil|remifentanil|mesh-list
110995104|NCT04455711|Anesthetics, Local|anesthetics, local|mesh-ancestor
110995105|NCT04455711|Anesthetics|anesthetics|mesh-ancestor
110995106|NCT04455711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110995107|NCT04455711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110995108|NCT04455711|Sensory System Agents|sensory system agents|mesh-ancestor
110995109|NCT04455711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110995110|NCT04455711|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110995111|NCT04455711|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110995112|NCT04455711|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110995113|NCT04455711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110712122|NCT00147537|Paclitaxel|paclitaxel|mesh-list
110995114|NCT04455711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110995115|NCT04455711|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110995116|NCT04455711|Narcotics|narcotics|mesh-ancestor
110995117|NCT04455711|Analgesics|analgesics|mesh-ancestor
110995118|NCT03717987|Botulinum Toxins|botulinum toxins|mesh-list
110995119|NCT03717987|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110995120|NCT03717987|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110995121|NCT03717987|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110995122|NCT03717987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110995123|NCT03717987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110995124|NCT03717987|Cholinergic Agents|cholinergic agents|mesh-ancestor
110995125|NCT03717987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110995126|NCT03717987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110995127|NCT03717987|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110995128|NCT03717987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110995129|NCT04062669|Vaccines|vaccines|mesh-list
110995130|NCT04062669|Immunologic Factors|immunologic factors|mesh-ancestor
110995131|NCT04062669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110995132|NCT05387967|Valsartan|valsartan|mesh-list
110995133|NCT05387967|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
110995134|NCT05387967|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
110995135|NCT05387967|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110995136|NCT05387967|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110995137|NCT05387967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110995138|NCT03856359|Rifaximin|rifaximin|mesh-list
110995139|NCT03856359|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110995140|NCT03856359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110995141|NCT03856359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110995142|NCT04052659|Azacitidine|azacitidine|mesh-list
110995143|NCT04052659|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110995144|NCT04052659|Antimetabolites|antimetabolites|mesh-ancestor
110995145|NCT04052659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110995146|NCT04052659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110995147|NCT04052659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110995148|NCT02964247|Liraglutide|liraglutide|mesh-list
110995149|NCT02964247|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110995150|NCT02964247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110995151|NCT02964247|Incretins|incretins|mesh-ancestor
110995152|NCT02964247|Hormones|hormones|mesh-ancestor
110995153|NCT02964247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110995154|NCT03654729|Pyridoxal Phosphate|pyridoxal phosphate|mesh-list
110995155|NCT03654729|Edetic Acid|edetic acid|mesh-list
110995156|NCT03654729|Anticoagulants|anticoagulants|mesh-ancestor
110995157|NCT03654729|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110995158|NCT03654729|Chelating Agents|chelating agents|mesh-ancestor
110995159|NCT03654729|Sequestering Agents|sequestering agents|mesh-ancestor
110995160|NCT03654729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110995161|NCT03654729|Vitamin B Complex|vitamin b complex|mesh-ancestor
110995162|NCT03654729|Vitamins|vitamins|mesh-ancestor
110995163|NCT03654729|Micronutrients|micronutrients|mesh-ancestor
110995164|NCT03654729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110995165|NCT04052269|Sildenafil Citrate|sildenafil citrate|mesh-list
110995166|NCT04052269|Tadalafil|tadalafil|mesh-list
110995167|NCT04052269|Vasodilator Agents|vasodilator agents|mesh-ancestor
110995168|NCT04052269|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110995169|NCT04052269|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110995170|NCT04052269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110995171|NCT04052269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110995172|NCT04052269|Urological Agents|urological agents|mesh-ancestor
110995173|NCT01377987|Acetazolamide|acetazolamide|mesh-list
110995174|NCT01377987|Anticonvulsants|anticonvulsants|mesh-ancestor
110995175|NCT01377987|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110995176|NCT01377987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110995177|NCT01377987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110995178|NCT01377987|Diuretics|diuretics|mesh-ancestor
110995179|NCT01377987|Natriuretic Agents|natriuretic agents|mesh-ancestor
110995180|NCT01377987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110995181|NCT03645187|Celecoxib|celecoxib|mesh-list
110995182|NCT03645187|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110995183|NCT03645187|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110995184|NCT03645187|Analgesics|analgesics|mesh-ancestor
110995185|NCT03645187|Sensory System Agents|sensory system agents|mesh-ancestor
110995186|NCT03645187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110995187|NCT03645187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110712206|NCT03975062|Dabigatran|dabigatran|mesh-list
110995188|NCT03645187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110995189|NCT03645187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110995190|NCT03645187|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110995191|NCT03645187|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110995192|NCT03645187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110995193|NCT03645187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110995195|NCT03645109|Cholecalciferol|cholecalciferol|mesh-list
110995196|NCT03645109|Vitamins|vitamins|mesh-ancestor
110995197|NCT03645109|Micronutrients|micronutrients|mesh-ancestor
110995198|NCT03645109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110995199|NCT03645109|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110995200|NCT03645109|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110995201|NCT04455555|Rotigotine|rotigotine|mesh-list
110995202|NCT04455555|Dopamine Agonists|dopamine agonists|mesh-ancestor
110995203|NCT04455555|Dopamine Agents|dopamine agents|mesh-ancestor
110995204|NCT04455555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110995205|NCT04455555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110995206|NCT04455555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110995207|NCT02898259|Rituximab|rituximab|mesh-list
110995208|NCT02898259|Lenalidomide|lenalidomide|mesh-list
110995209|NCT02898259|Ixazomib|ixazomib|mesh-list
110995210|NCT02898259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110995211|NCT02898259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110995212|NCT02898259|Immunologic Factors|immunologic factors|mesh-ancestor
110995213|NCT02898259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110995214|NCT02898259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110995215|NCT02898259|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110995216|NCT02898259|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110995217|NCT02898259|Growth Substances|growth substances|mesh-ancestor
110995218|NCT02898259|Growth Inhibitors|growth inhibitors|mesh-ancestor
110995219|NCT02898259|Protease Inhibitors|protease inhibitors|mesh-ancestor
110995220|NCT02898259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110995221|NCT02898259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110995222|NCT03646357|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
110995223|NCT03646357|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110995224|NCT03646357|Adrenergic Agents|adrenergic agents|mesh-ancestor
110995225|NCT03646357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110995226|NCT03646357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110995227|NCT03646357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110995228|NCT02963935|Liraglutide|liraglutide|mesh-list
110995229|NCT02963935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110995230|NCT02963935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110995231|NCT02963935|Incretins|incretins|mesh-ancestor
110995232|NCT02963935|Hormones|hormones|mesh-ancestor
110995233|NCT02963935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110995234|NCT03644641|Propofol|propofol|mesh-list
110995235|NCT03644641|Desflurane|desflurane|mesh-list
110995236|NCT03644641|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110995237|NCT03644641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110995238|NCT03644641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110995239|NCT03644641|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110995240|NCT03644641|Anesthetics, General|anesthetics, general|mesh-ancestor
110995241|NCT03644641|Anesthetics|anesthetics|mesh-ancestor
110995242|NCT03644641|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110995243|NCT05283421|Estrogens|estrogens|mesh-list
110995244|NCT05283421|Hormones|hormones|mesh-ancestor
110995245|NCT05283421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110995246|NCT05283421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110995247|NCT02963701|Ibuprofen|ibuprofen|mesh-list
110995248|NCT02963701|Pseudoephedrine|pseudoephedrine|mesh-list
110995249|NCT02963701|Ephedrine|ephedrine|mesh-list
110995250|NCT02963701|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110995251|NCT02963701|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110995252|NCT02963701|Analgesics|analgesics|mesh-ancestor
110995253|NCT02963701|Sensory System Agents|sensory system agents|mesh-ancestor
110995254|NCT02963701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110995255|NCT02963701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110995256|NCT02963701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110995257|NCT02963701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110995258|NCT02963701|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110995259|NCT02963701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110995260|NCT02963701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110995261|NCT02963701|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110375237|NCT04603664|Cystatins|cystatins|mesh-list
110995262|NCT02963701|Autonomic Agents|autonomic agents|mesh-ancestor
110995263|NCT02963701|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110995264|NCT02963701|Respiratory System Agents|respiratory system agents|mesh-ancestor
110995265|NCT02963701|Nasal Decongestants|nasal decongestants|mesh-ancestor
110995266|NCT02963701|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110995267|NCT02963701|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110995268|NCT02963701|Sympathomimetics|sympathomimetics|mesh-ancestor
110995269|NCT02963701|Adrenergic Agents|adrenergic agents|mesh-ancestor
110995270|NCT02963701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110995271|NCT02961751|Ciprofloxacin|ciprofloxacin|mesh-list
110995272|NCT02961751|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110995273|NCT02961751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110995274|NCT02961751|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110995275|NCT02961751|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110995276|NCT02961751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110995277|NCT02961751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110995278|NCT02961751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110024585|NCT00004926|Micronutrients|micronutrients|mesh-ancestor
110995279|NCT02961751|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110995280|NCT02961751|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110995281|NCT03643549|Temozolomide|temozolomide|mesh-list
110995282|NCT03643549|Bortezomib|bortezomib|mesh-list
110995283|NCT03643549|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110995284|NCT03643549|Alkylating Agents|alkylating agents|mesh-ancestor
110995285|NCT03643549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110995286|NCT03643549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110995287|NCT05262205|Anesthetics|anesthetics|mesh-list
110995288|NCT05262205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110995289|NCT05262205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110995291|NCT03641053|Povidone-Iodine|povidone-iodine|mesh-list
110995292|NCT03641053|Povidone|povidone|mesh-list
110995293|NCT03641053|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110995294|NCT03641053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110995295|NCT03641053|Trace Elements|trace elements|mesh-ancestor
110995296|NCT03641053|Micronutrients|micronutrients|mesh-ancestor
110995297|NCT03641053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110995298|NCT03641053|Plasma Substitutes|plasma substitutes|mesh-ancestor
110995299|NCT03641053|Blood Substitutes|blood substitutes|mesh-ancestor
110995300|NCT04455477|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
110995301|NCT04455477|Natriuretic Agents|natriuretic agents|mesh-ancestor
110995302|NCT04455477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110995303|NCT05165277|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110995304|NCT03468777|Lansoprazole|lansoprazole|mesh-list
110995305|NCT03468777|Dexlansoprazole|dexlansoprazole|mesh-list
110995306|NCT03468777|Ranitidine|ranitidine|mesh-list
110995307|NCT03468777|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
110995308|NCT03468777|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110995309|NCT03468777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110995310|NCT03468777|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110995311|NCT03468777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110995312|NCT03468777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110995313|NCT03468777|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110995314|NCT03468777|Histamine Antagonists|histamine antagonists|mesh-ancestor
110995315|NCT03468777|Histamine Agents|histamine agents|mesh-ancestor
110995316|NCT03468777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110995317|NCT03468777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110995318|NCT03640377|Praziquantel|praziquantel|mesh-list
110995319|NCT03640377|Anthelmintics|anthelmintics|mesh-ancestor
110995320|NCT03640377|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110995321|NCT03640377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110995322|NCT05323149|Tranexamic Acid|tranexamic acid|mesh-list
110995323|NCT05323149|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110995324|NCT05323149|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110995325|NCT05323149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110995326|NCT05323149|Hemostatics|hemostatics|mesh-ancestor
110995327|NCT05323149|Coagulants|coagulants|mesh-ancestor
110995328|NCT03642847|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110995329|NCT03642847|Immunologic Factors|immunologic factors|mesh-ancestor
110995330|NCT03642847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110995331|NCT03621163|Lithium Carbonate|lithium carbonate|mesh-list
110995332|NCT03621163|Antidepressive Agents|antidepressive agents|mesh-ancestor
110995333|NCT03621163|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110995334|NCT03621163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110995335|NCT03621163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110995336|NCT03621163|Antimanic Agents|antimanic agents|mesh-ancestor
110995337|NCT03621163|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110712357|NCT01071122|Valsartan|valsartan|mesh-list
110995338|NCT03621163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110995339|NCT03621163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110995340|NCT03632187|Abatacept|abatacept|mesh-list
110995341|NCT03632187|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110995342|NCT03632187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110995343|NCT03632187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110995344|NCT03632187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110995345|NCT03632187|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110995346|NCT03632187|Immunologic Factors|immunologic factors|mesh-ancestor
110995347|NCT03632187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110995348|NCT03632187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110995349|NCT05110209|Bevacizumab|bevacizumab|mesh-list
110995350|NCT05110209|Ranibizumab|ranibizumab|mesh-list
110995351|NCT05110209|Aflibercept|aflibercept|mesh-list
110995352|NCT05110209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110995353|NCT05110209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110995354|NCT05110209|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110995355|NCT05110209|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110995356|NCT05110209|Growth Substances|growth substances|mesh-ancestor
110995357|NCT05110209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110995358|NCT05110209|Growth Inhibitors|growth inhibitors|mesh-ancestor
110995359|NCT04454151|Azithromycin|azithromycin|mesh-list
110995360|NCT04454151|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110995361|NCT04454151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110995362|NCT05272683|Itraconazole|itraconazole|mesh-list
110995363|NCT05272683|Antifungal Agents|antifungal agents|mesh-ancestor
110995364|NCT05272683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110995365|NCT05272683|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110995366|NCT05272683|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110995367|NCT05272683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110995368|NCT05272683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110995369|NCT05272683|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110995370|NCT05272683|Hormone Antagonists|hormone antagonists|mesh-ancestor
110995371|NCT05272683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110995372|NCT05272683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110995373|NCT05272683|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110995374|NCT03934671|Antioxidants|antioxidants|mesh-list
110995375|NCT03934671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110995376|NCT03934671|Protective Agents|protective agents|mesh-ancestor
110995377|NCT03934671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110995378|NCT03130179|Nicotine|nicotine|mesh-list
110995379|NCT03130179|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110995380|NCT03130179|Autonomic Agents|autonomic agents|mesh-ancestor
110995381|NCT03130179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110995382|NCT03130179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110995383|NCT03130179|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110995384|NCT03130179|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110995385|NCT03130179|Cholinergic Agents|cholinergic agents|mesh-ancestor
110995386|NCT03130179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110995387|NCT03130179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110995388|NCT03466983|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
110995389|NCT03466983|Hematinics|hematinics|mesh-ancestor
110995390|NCT05439213|Epinephrine|epinephrine|mesh-list
110995391|NCT05439213|Racepinephrine|racepinephrine|mesh-list
110995392|NCT05439213|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110995393|NCT05439213|Epinephryl borate|epinephryl borate|mesh-list
110995394|NCT05439213|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110995395|NCT05439213|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110995396|NCT05439213|Adrenergic Agents|adrenergic agents|mesh-ancestor
110995397|NCT05439213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110995398|NCT05439213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110995399|NCT05439213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110995400|NCT05439213|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110995401|NCT05439213|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110995402|NCT05439213|Autonomic Agents|autonomic agents|mesh-ancestor
110995403|NCT05439213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110995404|NCT05439213|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110452557|NCT02987998|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110995405|NCT05439213|Respiratory System Agents|respiratory system agents|mesh-ancestor
110995406|NCT05439213|Mydriatics|mydriatics|mesh-ancestor
110995407|NCT05439213|Sympathomimetics|sympathomimetics|mesh-ancestor
110995408|NCT05439213|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110995409|NCT03466749|Paclitaxel|paclitaxel|mesh-list
110995410|NCT03466749|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110995411|NCT03466749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110995412|NCT03466749|Tubulin Modulators|tubulin modulators|mesh-ancestor
110995413|NCT03466749|Antimitotic Agents|antimitotic agents|mesh-ancestor
110995414|NCT03466749|Mitosis Modulators|mitosis modulators|mesh-ancestor
110995415|NCT03466749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110995416|NCT03466437|Methamphetamine|methamphetamine|mesh-list
110995417|NCT03466437|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110995418|NCT03466437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110995419|NCT03466437|Sympathomimetics|sympathomimetics|mesh-ancestor
110995420|NCT03466437|Autonomic Agents|autonomic agents|mesh-ancestor
110995421|NCT03466437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110995422|NCT03466437|Dopamine Agents|dopamine agents|mesh-ancestor
110995423|NCT03466437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110995424|NCT03466437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110995425|NCT03466437|Adrenergic Agents|adrenergic agents|mesh-ancestor
110995426|NCT03466437|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110024659|NCT00005028|Immunologic Factors|immunologic factors|mesh-ancestor
110995427|NCT03466437|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110995428|NCT03466437|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110995429|NCT03466437|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110995430|NCT03466359|Butyl phosphorotrithioate|butyl phosphorotrithioate|mesh-list
110995431|NCT03466359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110995432|NCT03466359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110995433|NCT01909245|Immunosuppressive Agents|immunosuppressive agents|mesh-list
110995435|NCT01909245|Immunologic Factors|immunologic factors|mesh-ancestor
110995436|NCT01909245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110995437|NCT01909245|Hormones|hormones|mesh-ancestor
110995438|NCT01909245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110995439|NCT04459065|Nimotuzumab|nimotuzumab|mesh-list
110995440|NCT04459065|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110995441|NCT04459065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110995442|NCT03465969|Tacrolimus|tacrolimus|mesh-list
110995443|NCT03465969|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110995444|NCT03465969|Immunologic Factors|immunologic factors|mesh-ancestor
110995445|NCT03465969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110995446|NCT03465969|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110995447|NCT03465969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110995448|NCT03465969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110995449|NCT05397795|Triptorelin Pamoate|triptorelin pamoate|mesh-list
110995450|NCT05397795|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
110995451|NCT05397795|Luteolytic Agents|luteolytic agents|mesh-ancestor
110995452|NCT05397795|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110995453|NCT05397795|Contraceptive Agents|contraceptive agents|mesh-ancestor
110995454|NCT05397795|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110995455|NCT05397795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110995456|NCT05397795|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110995457|NCT05397795|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110995458|NCT05397795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110995459|NCT03130101|Insulin|insulin|mesh-list
110995460|NCT03130101|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110995461|NCT03130101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110995462|NCT01067521|Glatiramer Acetate|glatiramer acetate|mesh-list
110995463|NCT01067521|(T,G)-A-L|(t,g)-a-l|mesh-list
110995464|NCT01067521|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110995465|NCT01067521|Immunologic Factors|immunologic factors|mesh-ancestor
110995466|NCT01067521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110995467|NCT01067521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110995468|NCT01067521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110995469|NCT02735577|Disulfiram|disulfiram|mesh-list
110995470|NCT02735577|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110995471|NCT02735577|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
110995472|NCT02735577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110995473|NCT02735577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110995474|NCT03642535|Aminolevulinic Acid|aminolevulinic acid|mesh-list
110995475|NCT03642535|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110995476|NCT03642535|Dermatologic Agents|dermatologic agents|mesh-ancestor
110995477|NCT05171257|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110995478|NCT05171257|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
110995479|NCT05171257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110995480|NCT05171257|Antitubercular Agents|antitubercular agents|mesh-ancestor
110995481|NCT01068613|Tiotropium Bromide|tiotropium bromide|mesh-list
110995482|NCT01068613|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110995483|NCT01068613|Autonomic Agents|autonomic agents|mesh-ancestor
110995484|NCT01068613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110712496|NCT03954262|Propofol|propofol|mesh-list
110995485|NCT01068613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110995486|NCT01068613|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110995487|NCT01068613|Respiratory System Agents|respiratory system agents|mesh-ancestor
110995488|NCT01068613|Parasympatholytics|parasympatholytics|mesh-ancestor
110995489|NCT01068613|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110995490|NCT01068613|Cholinergic Agents|cholinergic agents|mesh-ancestor
110995491|NCT01068613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110995492|NCT01068613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110995493|NCT05396937|Bevacizumab|bevacizumab|mesh-list
110995494|NCT05396937|Atezolizumab|atezolizumab|mesh-list
110995495|NCT05396937|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110995496|NCT05396937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110995497|NCT05396937|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110995498|NCT05396937|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110995499|NCT05396937|Growth Substances|growth substances|mesh-ancestor
110995500|NCT05396937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110995501|NCT05396937|Growth Inhibitors|growth inhibitors|mesh-ancestor
110995502|NCT05396937|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110995503|NCT05396937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110995505|NCT05424315|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110995506|NCT05424315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110995507|NCT05424315|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110995508|NCT05424315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110995509|NCT03642145|Deflazacort|deflazacort|mesh-list
110995510|NCT03642145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110995511|NCT03642145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110995512|NCT03642145|Immunologic Factors|immunologic factors|mesh-ancestor
110995513|NCT03642145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110995514|NCT01064791|Mycophenolic Acid|mycophenolic acid|mesh-list
110995515|NCT01064791|Tacrolimus|tacrolimus|mesh-list
110995516|NCT01064791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110995517|NCT01064791|Immunologic Factors|immunologic factors|mesh-ancestor
110995518|NCT01064791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110995519|NCT01064791|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110995520|NCT01064791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110995521|NCT01064791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110995522|NCT01064791|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110995523|NCT01064791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110995524|NCT01064791|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110995525|NCT01064791|Antitubercular Agents|antitubercular agents|mesh-ancestor
110995526|NCT01064791|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110995527|NCT01064791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110995528|NCT03465423|Propofol|propofol|mesh-list
110995529|NCT03465423|Anesthetics|anesthetics|mesh-ancestor
110995530|NCT03465423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110995531|NCT03465423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110995532|NCT03465423|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110995533|NCT03465423|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110995534|NCT03465423|Anesthetics, General|anesthetics, general|mesh-ancestor
110995535|NCT05161351|Vitamin D|vitamin d|mesh-list
110995536|NCT05161351|Cholecalciferol|cholecalciferol|mesh-list
110995537|NCT05161351|Baclofen|baclofen|mesh-list
110995538|NCT05161351|Vitamins|vitamins|mesh-ancestor
110995539|NCT05161351|Micronutrients|micronutrients|mesh-ancestor
110995540|NCT05161351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110995541|NCT05161351|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110995542|NCT05161351|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110995543|NCT05161351|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110995544|NCT05161351|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110995545|NCT05161351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110995546|NCT05161351|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
110995547|NCT05161351|GABA Agonists|gaba agonists|mesh-ancestor
110995548|NCT05161351|GABA Agents|gaba agents|mesh-ancestor
110995549|NCT05161351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110995550|NCT05161351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110995551|NCT03465345|Metformin|metformin|mesh-list
110995552|NCT03465345|Proanthocyanidin|proanthocyanidin|mesh-list
110995553|NCT03465345|Procyanidin|procyanidin|mesh-list
110995554|NCT03465345|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110995555|NCT03465345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110995556|NCT03465345|Antioxidants|antioxidants|mesh-ancestor
110995557|NCT03465345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110995558|NCT03465345|Protective Agents|protective agents|mesh-ancestor
110995559|NCT03465345|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110995561|NCT03465345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110995562|NCT02983799|Olaparib|olaparib|mesh-list
110995563|NCT02983799|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110995564|NCT02983799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110995565|NCT02983799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110995566|NCT02983799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110995567|NCT05385705|Cyclophosphamide|cyclophosphamide|mesh-list
110995568|NCT05385705|Trastuzumab|trastuzumab|mesh-list
110995569|NCT05385705|Interleukin-2|interleukin-2|mesh-list
110995570|NCT05385705|Pertuzumab|pertuzumab|mesh-list
110995571|NCT05385705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110995572|NCT05385705|Immunologic Factors|immunologic factors|mesh-ancestor
110995573|NCT05385705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110995574|NCT05385705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110995575|NCT05385705|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110995576|NCT05385705|Alkylating Agents|alkylating agents|mesh-ancestor
110995577|NCT05385705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110995578|NCT05385705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110995579|NCT05385705|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110995580|NCT05385705|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110995581|NCT05385705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110995582|NCT05385705|Analgesics|analgesics|mesh-ancestor
110995583|NCT05385705|Sensory System Agents|sensory system agents|mesh-ancestor
110995584|NCT05385705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110995585|NCT03912831|Cyclophosphamide|cyclophosphamide|mesh-list
110995586|NCT03912831|Fludarabine|fludarabine|mesh-list
110995587|NCT03912831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110995588|NCT03912831|Immunologic Factors|immunologic factors|mesh-ancestor
110995589|NCT03912831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110995590|NCT03912831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110995591|NCT03912831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110995592|NCT03912831|Alkylating Agents|alkylating agents|mesh-ancestor
110995593|NCT03912831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110995594|NCT03912831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110995595|NCT03912831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110995596|NCT02186847|Metformin|metformin|mesh-list
110995597|NCT02186847|Paclitaxel|paclitaxel|mesh-list
110995598|NCT02186847|Carboplatin|carboplatin|mesh-list
110995599|NCT02186847|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110995600|NCT02186847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110995601|NCT02186847|Tubulin Modulators|tubulin modulators|mesh-ancestor
110995602|NCT02186847|Antimitotic Agents|antimitotic agents|mesh-ancestor
110995603|NCT02186847|Mitosis Modulators|mitosis modulators|mesh-ancestor
110995604|NCT02186847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110995605|NCT02186847|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110995606|NCT02186847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110995607|NCT05274789|Dexmedetomidine|dexmedetomidine|mesh-list
110995608|NCT05274789|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110995609|NCT05274789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110995610|NCT05274789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110995611|NCT05274789|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110995612|NCT05274789|Analgesics|analgesics|mesh-ancestor
110995613|NCT05274789|Sensory System Agents|sensory system agents|mesh-ancestor
110995614|NCT05274789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110995615|NCT05274789|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110995616|NCT05274789|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110995617|NCT05274789|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110995618|NCT05274789|Adrenergic Agents|adrenergic agents|mesh-ancestor
110995619|NCT05274789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110995620|NCT05274789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110995621|NCT02353247|Norethindrone|norethindrone|mesh-list
110995622|NCT02353247|Norethindrone Acetate|norethindrone acetate|mesh-list
110995623|NCT02353247|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110995624|NCT02353247|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110995625|NCT02353247|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110995626|NCT02353247|Contraceptive Agents|contraceptive agents|mesh-ancestor
110995627|NCT02353247|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110995628|NCT02353247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110995629|NCT02353247|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110995630|NCT02353247|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110995631|NCT04343651|Leronlimab|leronlimab|mesh-list
110995632|NCT04343651|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110712644|NCT00035932|Ritonavir|ritonavir|mesh-list
110995633|NCT04343651|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110995634|NCT04343651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110995635|NCT04343651|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110995636|NCT04343651|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110995637|NCT04343651|Antiviral Agents|antiviral agents|mesh-ancestor
110995638|NCT04343651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110995639|NCT03343431|Tenofovir|tenofovir|mesh-list
110995640|NCT03343431|Antiviral Agents|antiviral agents|mesh-list
110995641|NCT03343431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110995642|NCT03343431|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110995643|NCT03343431|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110995644|NCT03343431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110995645|NCT03343431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110995646|NCT03343431|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110995647|NCT03343431|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110995649|NCT05226897|Dapagliflozin|dapagliflozin|mesh-list
110995650|NCT05226897|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110995651|NCT05226897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110995652|NCT05226897|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110995653|NCT05226897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110995654|NCT04453761|Vitamin B Complex|vitamin b complex|mesh-list
110995655|NCT04453761|Vitamins|vitamins|mesh-ancestor
110995656|NCT04453761|Micronutrients|micronutrients|mesh-ancestor
110995657|NCT04453761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110995658|NCT03463317|Aspirin|aspirin|mesh-list
110995659|NCT03463317|Warfarin|warfarin|mesh-list
110995660|NCT03463317|Rivaroxaban|rivaroxaban|mesh-list
110995661|NCT03463317|Dabigatran|dabigatran|mesh-list
110995662|NCT03463317|Apixaban|apixaban|mesh-list
110995663|NCT03463317|Edoxaban|edoxaban|mesh-list
110995664|NCT03463317|Phenprocoumon|phenprocoumon|mesh-list
110995665|NCT03463317|Clopidogrel|clopidogrel|mesh-list
110995666|NCT03463317|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110995667|NCT03463317|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110995668|NCT03463317|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110995669|NCT03463317|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110995670|NCT03463317|Purinergic Agents|purinergic agents|mesh-ancestor
110995671|NCT03463317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110995672|NCT03463317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110995673|NCT03463317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110995674|NCT03463317|Anticoagulants|anticoagulants|mesh-ancestor
110995675|NCT03463317|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110995676|NCT03463317|Antithrombins|antithrombins|mesh-ancestor
110995677|NCT03463317|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110995678|NCT03463317|Protease Inhibitors|protease inhibitors|mesh-ancestor
110995679|NCT03463317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110452578|NCT04213924|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110995680|NCT03463317|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110995681|NCT03463317|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110995682|NCT03463317|Analgesics|analgesics|mesh-ancestor
110995683|NCT03463317|Sensory System Agents|sensory system agents|mesh-ancestor
110995684|NCT03463317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110995685|NCT03463317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110995686|NCT03463317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110995687|NCT03463317|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110995688|NCT03463317|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110995689|NCT03463317|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110995690|NCT03463317|Antipyretics|antipyretics|mesh-ancestor
110995691|NCT02906579|Praliciguat|praliciguat|mesh-list
110995692|NCT02906579|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
110995693|NCT02906579|Enzyme Activators|enzyme activators|mesh-ancestor
110995694|NCT02906579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110995695|NCT02906579|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110995696|NCT04975347|Naloxone|naloxone|mesh-list
110995697|NCT04975347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110995698|NCT04975347|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110995699|NCT04975347|Sensory System Agents|sensory system agents|mesh-ancestor
110995700|NCT04975347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110995701|NCT03463083|Fentanyl|fentanyl|mesh-list
110995702|NCT03463083|Dexmedetomidine|dexmedetomidine|mesh-list
110995703|NCT03463083|Bupivacaine|bupivacaine|mesh-list
110995704|NCT03463083|Anesthetics, Local|anesthetics, local|mesh-ancestor
110995705|NCT03463083|Anesthetics|anesthetics|mesh-ancestor
110995706|NCT03463083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110995707|NCT03463083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110995708|NCT03463083|Sensory System Agents|sensory system agents|mesh-ancestor
110995709|NCT03463083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110995710|NCT03463083|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110995711|NCT03463083|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110995712|NCT03463083|Analgesics|analgesics|mesh-ancestor
110995713|NCT03463083|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110995714|NCT03463083|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110995715|NCT03463083|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110995716|NCT03463083|Adrenergic Agents|adrenergic agents|mesh-ancestor
110995717|NCT03463083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110995718|NCT03463083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110995719|NCT03463083|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110995720|NCT03463083|Narcotics|narcotics|mesh-ancestor
110995721|NCT03463083|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110995722|NCT03463083|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110995723|NCT03463083|Anesthetics, General|anesthetics, general|mesh-ancestor
110995724|NCT04971837|Cannabidiol|cannabidiol|mesh-list
110995725|NCT04971837|Sorbitol|sorbitol|mesh-list
110995726|NCT04971837|Anticonvulsants|anticonvulsants|mesh-ancestor
110995727|NCT04971837|Cathartics|cathartics|mesh-ancestor
110995728|NCT04971837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110995729|NCT01328535|Temozolomide|temozolomide|mesh-list
110995730|NCT01328535|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110995731|NCT01328535|Alkylating Agents|alkylating agents|mesh-ancestor
110995732|NCT01328535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110995733|NCT01328535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110995734|NCT03463005|Propolis|propolis|mesh-list
110995735|NCT03463005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110995736|NCT02522169|Infliximab|infliximab|mesh-list
110995737|NCT02522169|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110995738|NCT02522169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110995739|NCT02522169|Dermatologic Agents|dermatologic agents|mesh-ancestor
110995740|NCT02522169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110995741|NCT02522169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110995742|NCT03656393|Carboplatin|carboplatin|mesh-list
110995743|NCT03656393|Vinorelbine|vinorelbine|mesh-list
110995744|NCT03656393|Gefitinib|gefitinib|mesh-list
110995745|NCT03656393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110995746|NCT03656393|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110995747|NCT03656393|Tubulin Modulators|tubulin modulators|mesh-ancestor
110995748|NCT03656393|Antimitotic Agents|antimitotic agents|mesh-ancestor
110995749|NCT03656393|Mitosis Modulators|mitosis modulators|mesh-ancestor
110995750|NCT03656393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110995751|NCT03656393|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110995752|NCT03656393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110995753|NCT02979197|Celecoxib|celecoxib|mesh-list
110995754|NCT02979197|Amlodipine|amlodipine|mesh-list
110995755|NCT02979197|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110995756|NCT02979197|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110995757|NCT02979197|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110995758|NCT02979197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110995759|NCT02979197|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110995760|NCT02979197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110995761|NCT02979197|Vasodilator Agents|vasodilator agents|mesh-ancestor
110995762|NCT02979197|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110995763|NCT02979197|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110995764|NCT02979197|Analgesics|analgesics|mesh-ancestor
110995765|NCT02979197|Sensory System Agents|sensory system agents|mesh-ancestor
110995766|NCT02979197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110995767|NCT02979197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110995768|NCT02979197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110995769|NCT02979197|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110995770|NCT02979197|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110995771|NCT02979197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110995772|NCT01837277|Efavirenz|efavirenz|mesh-list
110995773|NCT01837277|Dolutegravir|dolutegravir|mesh-list
110995774|NCT01837277|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110995775|NCT01837277|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110995776|NCT01837277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110995777|NCT01837277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110995778|NCT01837277|Antiviral Agents|antiviral agents|mesh-ancestor
110995779|NCT01837277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110995780|NCT01837277|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110995781|NCT01837277|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110995782|NCT01837277|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110995783|NCT01837277|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110995784|NCT01837277|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110995785|NCT01837277|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110995786|NCT01837277|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110995787|NCT01837277|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110995788|NCT01837277|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110995789|NCT01837277|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110995790|NCT03655535|PAZ320|paz320|mesh-list
110995791|NCT03655535|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110995792|NCT03655535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110995793|NCT03654365|Caffeine|caffeine|mesh-list
110995794|NCT03654365|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110995795|NCT03654365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110995796|NCT03654365|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110995797|NCT03654365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110995798|NCT03654365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110995799|NCT03654365|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110995800|NCT03654365|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110995801|NCT03654365|Purinergic Agents|purinergic agents|mesh-ancestor
110995802|NCT03654365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110995803|NCT03655847|Dexmedetomidine|dexmedetomidine|mesh-list
110995804|NCT03655847|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110995805|NCT03655847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110995806|NCT03655847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110995807|NCT03655847|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110995808|NCT03655847|Analgesics|analgesics|mesh-ancestor
110995809|NCT03655847|Sensory System Agents|sensory system agents|mesh-ancestor
110995810|NCT03655847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110995811|NCT03655847|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110995812|NCT03655847|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110995813|NCT03655847|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110995814|NCT03655847|Adrenergic Agents|adrenergic agents|mesh-ancestor
110995815|NCT03655847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110995816|NCT03655847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110995817|NCT03655457|Poractant alfa|poractant alfa|mesh-list
110995818|NCT03655457|Beractant|beractant|mesh-list
110995819|NCT03655457|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
110995820|NCT03655457|Respiratory System Agents|respiratory system agents|mesh-ancestor
110995821|NCT01066793|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110995822|NCT01066793|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110995823|NCT01066793|Antiviral Agents|antiviral agents|mesh-ancestor
110995824|NCT01066793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110995825|NCT04453371|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
110995826|NCT04453371|Plasminogen|plasminogen|mesh-list
110995827|NCT04453371|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110995828|NCT04453371|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110995829|NCT04453371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110995830|NCT02980523|Moxifloxacin|moxifloxacin|mesh-list
110995831|NCT02980523|Gatifloxacin|gatifloxacin|mesh-list
110995832|NCT02980523|Pazufloxacin|pazufloxacin|mesh-list
110995833|NCT02980523|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110995834|NCT02980523|Hyaluronic Acid|hyaluronic acid|mesh-list
110995835|NCT02980523|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110995836|NCT02980523|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110995837|NCT02980523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110995838|NCT02980523|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110995839|NCT02980523|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110995840|NCT02980523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110995841|NCT02980523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110995842|NCT02980523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110995843|NCT02980523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110995844|NCT02980523|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110995845|NCT02980523|Immunologic Factors|immunologic factors|mesh-ancestor
110995846|NCT02980523|Viscosupplements|viscosupplements|mesh-ancestor
110995847|NCT02980523|Protective Agents|protective agents|mesh-ancestor
110995848|NCT02980523|Antitubercular Agents|antitubercular agents|mesh-ancestor
110995849|NCT03468465|Solifenacin Succinate|solifenacin succinate|mesh-list
110995850|NCT03468465|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110995851|NCT03468465|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110995852|NCT03468465|Cholinergic Agents|cholinergic agents|mesh-ancestor
110995853|NCT03468465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110995854|NCT03468465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110995855|NCT03468465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110995856|NCT03468465|Urological Agents|urological agents|mesh-ancestor
110995857|NCT03460743|Hemagglutinins|hemagglutinins|mesh-list
110995858|NCT03460743|Vaccines|vaccines|mesh-list
110995859|NCT03460743|Immunologic Factors|immunologic factors|mesh-ancestor
110712873|NCT01028339|Mannitol|mannitol|mesh-list
110995860|NCT03460743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110995861|NCT03460743|Agglutinins|agglutinins|mesh-ancestor
110995862|NCT03460743|Coagulants|coagulants|mesh-ancestor
110995863|NCT02980133|Fluticasone|fluticasone|mesh-list
110995864|NCT02980133|Xhance|xhance|mesh-list
110995865|NCT02980133|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110995866|NCT02980133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110995867|NCT02980133|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110995868|NCT02980133|Autonomic Agents|autonomic agents|mesh-ancestor
110995869|NCT02980133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110995870|NCT02980133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110995871|NCT02980133|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110995872|NCT02980133|Respiratory System Agents|respiratory system agents|mesh-ancestor
110995873|NCT02980133|Dermatologic Agents|dermatologic agents|mesh-ancestor
110995874|NCT02980133|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110995875|NCT02980133|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110995876|NCT02980133|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110995877|NCT02980133|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110995878|NCT02980133|Adrenergic Agents|adrenergic agents|mesh-ancestor
110995879|NCT02980133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110995880|NCT02980133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110995881|NCT03653663|Simvastatin|simvastatin|mesh-list
110995882|NCT03653663|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110995883|NCT03653663|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110995884|NCT03653663|Antimetabolites|antimetabolites|mesh-ancestor
110995885|NCT03653663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110995886|NCT03653663|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110995887|NCT03653663|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110995888|NCT03653663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110995889|NCT02979431|Gontivimab|gontivimab|mesh-list
110995890|NCT02979431|Antiviral Agents|antiviral agents|mesh-ancestor
110995891|NCT02979431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110995892|NCT03460275|Osimertinib|osimertinib|mesh-list
110995893|NCT03460275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110995894|NCT03460275|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110995895|NCT03460275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110995896|NCT03460275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110995897|NCT03468231|Leucovorin|leucovorin|mesh-list
110995898|NCT03468231|Fluorouracil|fluorouracil|mesh-list
110995899|NCT03468231|Oxaliplatin|oxaliplatin|mesh-list
110995900|NCT03468231|Sorafenib|sorafenib|mesh-list
110995901|NCT03468231|Antimetabolites|antimetabolites|mesh-ancestor
110995902|NCT03468231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110995903|NCT03468231|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110995904|NCT03468231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110995905|NCT03468231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110995906|NCT03468231|Immunologic Factors|immunologic factors|mesh-ancestor
110995907|NCT03468231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110995908|NCT03468231|Antidotes|antidotes|mesh-ancestor
110995909|NCT03468231|Protective Agents|protective agents|mesh-ancestor
110995910|NCT03468231|Vitamin B Complex|vitamin b complex|mesh-ancestor
110995911|NCT03468231|Vitamins|vitamins|mesh-ancestor
110995912|NCT03468231|Micronutrients|micronutrients|mesh-ancestor
110995913|NCT03468231|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110995914|NCT03468231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110995915|NCT03468153|Immunomodulating Agents|immunomodulating agents|mesh-list
110995916|NCT03468153|Immunologic Factors|immunologic factors|mesh-ancestor
110995917|NCT03468153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110995918|NCT03460041|Magnesium Sulfate|magnesium sulfate|mesh-list
110995919|NCT03460041|Bupivacaine|bupivacaine|mesh-list
110995920|NCT03460041|Anesthetics, Local|anesthetics, local|mesh-ancestor
110995921|NCT03460041|Anesthetics|anesthetics|mesh-ancestor
110995922|NCT03460041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110995923|NCT03460041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110995924|NCT03460041|Sensory System Agents|sensory system agents|mesh-ancestor
110995925|NCT03460041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110995926|NCT03460041|Analgesics|analgesics|mesh-ancestor
110995927|NCT03460041|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110995928|NCT03460041|Anticonvulsants|anticonvulsants|mesh-ancestor
110995929|NCT03460041|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110995930|NCT03460041|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110995931|NCT03460041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110995932|NCT03460041|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110995933|NCT03460041|Tocolytic Agents|tocolytic agents|mesh-ancestor
110712948|NCT01028573|Laxatives|laxatives|mesh-ancestor
110995934|NCT03460041|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110995935|NCT02522013|Aminophylline|aminophylline|mesh-list
110995936|NCT02522013|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110995937|NCT02522013|Autonomic Agents|autonomic agents|mesh-ancestor
110995938|NCT02522013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110995939|NCT02522013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110995940|NCT02522013|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110995941|NCT02522013|Respiratory System Agents|respiratory system agents|mesh-ancestor
110995942|NCT02522013|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110995943|NCT02522013|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110995944|NCT02522013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110995945|NCT02522013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110995946|NCT02522013|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110995947|NCT02522013|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110995948|NCT02522013|Purinergic Agents|purinergic agents|mesh-ancestor
110995949|NCT02522013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110995950|NCT02522013|Protective Agents|protective agents|mesh-ancestor
110995952|NCT02978417|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110995953|NCT02978417|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110995954|NCT02978417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110995955|NCT02978417|Sensory System Agents|sensory system agents|mesh-ancestor
110995956|NCT02978417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110995957|NCT03458559|Etidronic Acid|etidronic acid|mesh-list
110995958|NCT03458559|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
110995959|NCT03458559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110995960|NCT03458559|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110995961|NCT03458559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110995962|NCT03457467|Apatinib|apatinib|mesh-list
110995963|NCT03457467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110995964|NCT03457467|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110995965|NCT03457467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110995966|NCT03457467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110995967|NCT05191875|Doxycycline|doxycycline|mesh-list
110995968|NCT05191875|Furazolidone|furazolidone|mesh-list
110995969|NCT05191875|Bismuth|bismuth|mesh-list
110995970|NCT05191875|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110995971|NCT05191875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110995972|NCT05191875|Antimalarials|antimalarials|mesh-ancestor
110995973|NCT05191875|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110995974|NCT05191875|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110995975|NCT05191875|Antacids|antacids|mesh-ancestor
110995976|NCT05191875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110452642|NCT01091519|Fesoterodine|fesoterodine|mesh-list
110995977|NCT05191875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110995978|NCT05191875|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110995979|NCT05191875|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110995980|NCT05191875|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
110995981|NCT05191875|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
110995982|NCT05191875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110995983|NCT04370145|Meropenem|meropenem|mesh-list
110995984|NCT04370145|Tinidazole|tinidazole|mesh-list
110995985|NCT04370145|Teicoplanin|teicoplanin|mesh-list
110995986|NCT04370145|Sulperazone|sulperazone|mesh-list
110995987|NCT04370145|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110995988|NCT04370145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110995989|NCT04370145|Alkylating Agents|alkylating agents|mesh-ancestor
110995990|NCT04370145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110995991|NCT04370145|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
110995992|NCT04370145|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110995993|NCT04370145|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110995994|NCT04370145|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110995995|NCT03453723|Lidocaine|lidocaine|mesh-list
110995996|NCT03453723|Anesthetics, Local|anesthetics, local|mesh-ancestor
110995997|NCT03453723|Anesthetics|anesthetics|mesh-ancestor
110995998|NCT03453723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110995999|NCT03453723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110996000|NCT03453723|Sensory System Agents|sensory system agents|mesh-ancestor
110996001|NCT03453723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110996002|NCT03453723|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110996003|NCT03453723|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110996004|NCT03453723|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110996005|NCT03453723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110996006|NCT03453723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110996007|NCT04774965|Diphenhydramine|diphenhydramine|mesh-list
110996008|NCT04774965|Promethazine|promethazine|mesh-list
110996009|NCT04774965|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110996010|NCT04774965|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110996011|NCT04774965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110996012|NCT04774965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110996013|NCT04774965|Anesthetics, Local|anesthetics, local|mesh-ancestor
110996014|NCT04774965|Anesthetics|anesthetics|mesh-ancestor
110996015|NCT04774965|Sensory System Agents|sensory system agents|mesh-ancestor
110996016|NCT04774965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110996017|NCT04774965|Antiemetics|antiemetics|mesh-ancestor
110996018|NCT04774965|Autonomic Agents|autonomic agents|mesh-ancestor
110996019|NCT04774965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110996020|NCT04774965|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110996021|NCT04774965|Histamine Antagonists|histamine antagonists|mesh-ancestor
110996022|NCT04774965|Histamine Agents|histamine agents|mesh-ancestor
110996023|NCT04774965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110996024|NCT04774965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110996025|NCT04774965|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110996026|NCT04774965|Antipruritics|antipruritics|mesh-ancestor
110996027|NCT04774965|Dermatologic Agents|dermatologic agents|mesh-ancestor
110996028|NCT03452553|Doxorubicin|doxorubicin|mesh-list
110996029|NCT03452553|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110996030|NCT03452553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110996031|NCT03452553|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110996032|NCT03452553|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110996033|NCT03452553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110996034|NCT03452553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110996035|NCT03452475|Lumefantrine|lumefantrine|mesh-list
110996036|NCT03452475|Artemether|artemether|mesh-list
110996037|NCT03452475|Piperaquine|piperaquine|mesh-list
110996038|NCT03452475|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
110996039|NCT03452475|Mefloquine|mefloquine|mesh-list
110996040|NCT03452475|Antimalarials|antimalarials|mesh-ancestor
110996041|NCT03452475|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110996042|NCT03452475|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110996043|NCT03452475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110996044|NCT03451227|Dexmedetomidine|dexmedetomidine|mesh-list
110996045|NCT03451227|Remifentanil|remifentanil|mesh-list
110996046|NCT03451227|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110996047|NCT03451227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110996048|NCT03451227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110996049|NCT03451227|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110996050|NCT03451227|Analgesics|analgesics|mesh-ancestor
110996051|NCT03451227|Sensory System Agents|sensory system agents|mesh-ancestor
110996052|NCT03451227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110996053|NCT03451227|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110996054|NCT03451227|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110996055|NCT03451227|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110996056|NCT03451227|Adrenergic Agents|adrenergic agents|mesh-ancestor
110996057|NCT03451227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110996058|NCT03451227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110996059|NCT03451227|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110996060|NCT03451227|Narcotics|narcotics|mesh-ancestor
110996061|NCT02529813|Cyclophosphamide|cyclophosphamide|mesh-list
110996062|NCT02529813|Fludarabine|fludarabine|mesh-list
110996063|NCT02529813|Fludarabine phosphate|fludarabine phosphate|mesh-list
110996064|NCT02529813|Tisagenlecleucel|tisagenlecleucel|mesh-list
110996065|NCT02529813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110996066|NCT02529813|Immunologic Factors|immunologic factors|mesh-ancestor
110996067|NCT02529813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110996068|NCT02529813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110996069|NCT02529813|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110996070|NCT02529813|Alkylating Agents|alkylating agents|mesh-ancestor
110996071|NCT02529813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110996072|NCT02529813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110996073|NCT02529813|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110996074|NCT02529813|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110996075|NCT02529813|Antimetabolites|antimetabolites|mesh-ancestor
110996076|NCT02529813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110996077|NCT05321511|Triptorelin Pamoate|triptorelin pamoate|mesh-list
110996078|NCT05321511|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
110996079|NCT05321511|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
110996080|NCT05321511|Hormones|hormones|mesh-ancestor
110996081|NCT05321511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110996082|NCT05321511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110996083|NCT05321511|Luteolytic Agents|luteolytic agents|mesh-ancestor
110996084|NCT05321511|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110996085|NCT05321511|Contraceptive Agents|contraceptive agents|mesh-ancestor
110996086|NCT05321511|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110996087|NCT05321511|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110996088|NCT05321511|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110996089|NCT05321511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110996090|NCT02417103|Liraglutide|liraglutide|mesh-list
110996091|NCT02417103|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110996092|NCT02417103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110996093|NCT02417103|Incretins|incretins|mesh-ancestor
110996094|NCT02417103|Hormones|hormones|mesh-ancestor
110996095|NCT02417103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110996096|NCT02097225|Trametinib|trametinib|mesh-list
110996097|NCT02097225|Dabrafenib|dabrafenib|mesh-list
110996098|NCT02097225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110996099|NCT02097225|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110996100|NCT02097225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110024815|NCT00005616|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110996101|NCT02097225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110996102|NCT02958865|PF-06700841|pf-06700841|mesh-list
110996103|NCT02958865|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110996104|NCT02958865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110996105|NCT02958865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110996106|NCT02501902|Paclitaxel|paclitaxel|mesh-list
110996107|NCT02501902|Palbociclib|palbociclib|mesh-list
110996108|NCT02501902|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110996109|NCT02501902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110996110|NCT02501902|Tubulin Modulators|tubulin modulators|mesh-ancestor
110996111|NCT02501902|Antimitotic Agents|antimitotic agents|mesh-ancestor
110996112|NCT02501902|Mitosis Modulators|mitosis modulators|mesh-ancestor
110996113|NCT02501902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110996114|NCT02501902|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110996115|NCT02501902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110996116|NCT05320575|Zanubrutinib|zanubrutinib|mesh-list
110996117|NCT05320575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110996118|NCT05320575|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110996119|NCT05320575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110996120|NCT05320575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110996121|NCT03448731|Doxycycline|doxycycline|mesh-list
110996122|NCT03448731|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110996123|NCT03448731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110996124|NCT03448731|Antimalarials|antimalarials|mesh-ancestor
110996125|NCT03448731|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110996126|NCT03448731|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110996127|NCT04452669|Epoprostenol|epoprostenol|mesh-list
110996128|NCT04452669|Tezosentan|tezosentan|mesh-list
110996129|NCT04452669|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110996130|NCT04452669|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110996131|NCT04452669|Vasodilator Agents|vasodilator agents|mesh-ancestor
110996132|NCT03719001|Clevidipine|clevidipine|mesh-list
110996133|NCT03719001|Phenylephrine|phenylephrine|mesh-list
110996134|NCT03719001|Oxymetazoline|oxymetazoline|mesh-list
110996135|NCT03719001|Dexmedetomidine|dexmedetomidine|mesh-list
110996136|NCT03719001|Calcium|calcium|mesh-list
110996137|NCT03719001|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110996138|NCT03719001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110996139|NCT03719001|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110996140|NCT03719001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110996141|NCT03719001|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110996142|NCT03719001|Analgesics|analgesics|mesh-ancestor
110996143|NCT03719001|Sensory System Agents|sensory system agents|mesh-ancestor
110996144|NCT03719001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110996145|NCT03719001|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110996146|NCT03719001|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110996147|NCT03719001|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110996148|NCT03719001|Adrenergic Agents|adrenergic agents|mesh-ancestor
110996149|NCT03719001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110996150|NCT03719001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110996151|NCT03719001|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110996152|NCT03719001|Mydriatics|mydriatics|mesh-ancestor
110996153|NCT03719001|Autonomic Agents|autonomic agents|mesh-ancestor
110996154|NCT03719001|Sympathomimetics|sympathomimetics|mesh-ancestor
110996155|NCT03719001|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110996156|NCT03719001|Nasal Decongestants|nasal decongestants|mesh-ancestor
110996157|NCT03719001|Respiratory System Agents|respiratory system agents|mesh-ancestor
110996158|NCT03719001|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110996159|NCT03719001|Protective Agents|protective agents|mesh-ancestor
110996160|NCT03719001|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110996161|NCT03719001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110996162|NCT02500732|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
110996163|NCT02500732|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110996164|NCT02500732|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110996165|NCT02500732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110996166|NCT02500732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110996167|NCT02500732|Adrenergic Agents|adrenergic agents|mesh-ancestor
110996168|NCT02500732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110996169|NCT02500732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110996170|NCT02499952|Pembrolizumab|pembrolizumab|mesh-list
110996171|NCT02499952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110996172|NCT02499952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110996173|NCT02499952|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110996174|NCT02499952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110996175|NCT02498392|JNJ-42165279|jnj-42165279|mesh-list
110996176|NCT02498392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110996177|NCT02498392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110996178|NCT03205605|Mandelic Acids|mandelic acids|mesh-list
110996179|NCT03205605|Oxybutynin|oxybutynin|mesh-list
110996180|NCT03205605|Parasympatholytics|parasympatholytics|mesh-ancestor
110996181|NCT03205605|Autonomic Agents|autonomic agents|mesh-ancestor
110996182|NCT03205605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110996183|NCT03205605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110996184|NCT03205605|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110996185|NCT03205605|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110996186|NCT03205605|Cholinergic Agents|cholinergic agents|mesh-ancestor
110996187|NCT03205605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110996188|NCT03205605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110996189|NCT03205605|Urological Agents|urological agents|mesh-ancestor
110996190|NCT03205605|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110996191|NCT03205605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110996192|NCT05006638|Atropine|atropine|mesh-list
110996193|NCT05006638|Ondansetron|ondansetron|mesh-list
110996194|NCT05006638|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
110996195|NCT05006638|Obidoxime Chloride|obidoxime chloride|mesh-list
110996196|NCT05006638|Antiemetics|antiemetics|mesh-ancestor
110996197|NCT05006638|Autonomic Agents|autonomic agents|mesh-ancestor
110996198|NCT05006638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110996199|NCT05006638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110996200|NCT05006638|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110996201|NCT05006638|Antipruritics|antipruritics|mesh-ancestor
110996202|NCT05006638|Dermatologic Agents|dermatologic agents|mesh-ancestor
110996203|NCT05006638|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110996204|NCT05006638|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110996205|NCT05006638|Serotonin Agents|serotonin agents|mesh-ancestor
110996206|NCT05006638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110996207|NCT05006638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110996208|NCT05006638|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110996209|NCT05006638|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110996210|NCT05006638|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110996211|NCT05006638|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110996212|NCT05006638|Respiratory System Agents|respiratory system agents|mesh-ancestor
110996213|NCT05006638|Mydriatics|mydriatics|mesh-ancestor
110996214|NCT05006638|Parasympatholytics|parasympatholytics|mesh-ancestor
110996215|NCT05006638|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110996216|NCT05006638|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110996217|NCT05006638|Cholinergic Agents|cholinergic agents|mesh-ancestor
110996218|NCT05006638|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
110996219|NCT05006638|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110996220|NCT05006638|Cholinesterase Reactivators|cholinesterase reactivators|mesh-ancestor
110996221|NCT05006638|Enzyme Reactivators|enzyme reactivators|mesh-ancestor
110996222|NCT02498236|Oxytocin|oxytocin|mesh-list
110996223|NCT02498236|Oxytocics|oxytocics|mesh-ancestor
110996224|NCT02498236|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110996225|NCT02498236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110996226|NCT01283997|Minocycline|minocycline|mesh-list
110996227|NCT01283997|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110996228|NCT01283997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110996229|NCT02496676|Magnesium Sulfate|magnesium sulfate|mesh-list
110996230|NCT02496676|Analgesics|analgesics|mesh-ancestor
110996231|NCT02496676|Sensory System Agents|sensory system agents|mesh-ancestor
110996232|NCT02496676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110996233|NCT02496676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110996234|NCT02496676|Anesthetics|anesthetics|mesh-ancestor
110996235|NCT02496676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110996236|NCT02496676|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110996237|NCT02496676|Anticonvulsants|anticonvulsants|mesh-ancestor
110996238|NCT02496676|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110996239|NCT02496676|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110996240|NCT02496676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110996241|NCT02496676|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110996242|NCT02496676|Tocolytic Agents|tocolytic agents|mesh-ancestor
110996243|NCT02496676|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110996244|NCT01160211|Trastuzumab|trastuzumab|mesh-list
110996245|NCT01160211|Lapatinib|lapatinib|mesh-list
110996246|NCT01160211|Aromatase Inhibitors|aromatase inhibitors|mesh-list
110996247|NCT01160211|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110996248|NCT01160211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110996249|NCT01160211|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110996250|NCT01160211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110996251|NCT01160211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110996252|NCT01160211|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110996253|NCT01160211|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110996254|NCT01160211|Hormone Antagonists|hormone antagonists|mesh-ancestor
110996255|NCT01160211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110996256|NCT01160211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110996257|NCT03443271|Bupivacaine|bupivacaine|mesh-list
110996258|NCT03443271|Anesthetics, Local|anesthetics, local|mesh-ancestor
110996259|NCT03443271|Anesthetics|anesthetics|mesh-ancestor
110996260|NCT03443271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110996261|NCT03443271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110996262|NCT03443271|Sensory System Agents|sensory system agents|mesh-ancestor
110996263|NCT03443271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110996264|NCT01064687|Metformin|metformin|mesh-list
110996265|NCT01064687|Pioglitazone|pioglitazone|mesh-list
110996266|NCT01064687|Exenatide|exenatide|mesh-list
110996267|NCT01064687|Dulaglutide|dulaglutide|mesh-list
110996268|NCT01064687|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110996269|NCT01064687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110996270|NCT01064687|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110996271|NCT01064687|Incretins|incretins|mesh-ancestor
110996272|NCT01064687|Hormones|hormones|mesh-ancestor
110996273|NCT01064687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110996274|NCT03447873|Lamivudine|lamivudine|mesh-list
110996275|NCT03447873|Cobicistat|cobicistat|mesh-list
110996276|NCT03447873|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110996277|NCT03447873|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110996278|NCT03447873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110996279|NCT03447873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110996280|NCT03447873|Antiviral Agents|antiviral agents|mesh-ancestor
110996281|NCT03447873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110996282|NCT03447873|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110996283|NCT03447873|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110996284|NCT03447873|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110996285|NCT03447873|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110996286|NCT02493946|Botulinum Toxins|botulinum toxins|mesh-list
110996287|NCT02493946|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110996288|NCT02493946|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110996289|NCT02493946|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110996290|NCT02493946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110996291|NCT02493946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110996292|NCT02493946|Cholinergic Agents|cholinergic agents|mesh-ancestor
110996293|NCT02493946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110996294|NCT02493946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110996295|NCT02493946|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110996296|NCT02493946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110996297|NCT03621995|Catalase|catalase|mesh-list
110996298|NCT03621995|Antioxidants|antioxidants|mesh-ancestor
110996299|NCT03621995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110996300|NCT03621995|Protective Agents|protective agents|mesh-ancestor
110996301|NCT03621995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110996302|NCT03443037|Amantadine|amantadine|mesh-list
110996303|NCT03443037|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110996304|NCT03443037|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110996305|NCT03443037|Antiviral Agents|antiviral agents|mesh-ancestor
110996306|NCT03443037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110996307|NCT03443037|Dopamine Agents|dopamine agents|mesh-ancestor
110996308|NCT03443037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110996309|NCT03443037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110996310|NCT03443037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110996311|NCT03443037|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110996313|NCT03443037|Sensory System Agents|sensory system agents|mesh-ancestor
110996314|NCT03443037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110996315|NCT03442491|Hemostatics|hemostatics|mesh-list
110996316|NCT03442491|Coagulants|coagulants|mesh-ancestor
110996317|NCT02918279|Liraglutide|liraglutide|mesh-list
110996318|NCT02918279|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110996319|NCT02918279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110996320|NCT02918279|Incretins|incretins|mesh-ancestor
110996321|NCT02918279|Hormones|hormones|mesh-ancestor
110996322|NCT02918279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110996323|NCT02956837|Vaccines|vaccines|mesh-list
110996324|NCT02956837|Immunologic Factors|immunologic factors|mesh-ancestor
110996325|NCT02956837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110996326|NCT03447093|Methimazole|methimazole|mesh-list
110996328|NCT03447093|Antithyroid Agents|antithyroid agents|mesh-ancestor
110996329|NCT03447093|Hormone Antagonists|hormone antagonists|mesh-ancestor
110996330|NCT03447093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110996331|NCT03447093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110996332|NCT03447093|Antimetabolites|antimetabolites|mesh-ancestor
110996333|NCT03447093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110996334|NCT03640351|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110996335|NCT03640351|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110996336|NCT03640351|Hyaluronic Acid|hyaluronic acid|mesh-list
110996337|NCT03640351|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110996338|NCT03640351|Immunologic Factors|immunologic factors|mesh-ancestor
110996339|NCT03640351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110996340|NCT03640351|Viscosupplements|viscosupplements|mesh-ancestor
110996341|NCT03640351|Protective Agents|protective agents|mesh-ancestor
110996342|NCT03640273|Loratadine|loratadine|mesh-list
110996343|NCT03640273|Antipruritics|antipruritics|mesh-ancestor
110996344|NCT03640273|Dermatologic Agents|dermatologic agents|mesh-ancestor
110996345|NCT03640273|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110996346|NCT03640273|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110996347|NCT03640273|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110996348|NCT03640273|Histamine Antagonists|histamine antagonists|mesh-ancestor
110996349|NCT03640273|Histamine Agents|histamine agents|mesh-ancestor
110996350|NCT03640273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110996351|NCT03640273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110996352|NCT03640273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110996353|NCT03442023|Chlorhexidine|chlorhexidine|mesh-list
110996354|NCT03442023|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110996355|NCT03442023|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110996356|NCT03442023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110996357|NCT03442023|Disinfectants|disinfectants|mesh-ancestor
110996358|NCT03442023|Dermatologic Agents|dermatologic agents|mesh-ancestor
110996359|NCT01063283|Bevacizumab|bevacizumab|mesh-list
110996360|NCT01063283|Carboplatin|carboplatin|mesh-list
110996361|NCT01063283|Pemetrexed|pemetrexed|mesh-list
110996362|NCT01063283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110996363|NCT01063283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110996364|NCT01063283|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110996365|NCT01063283|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110996366|NCT01063283|Growth Substances|growth substances|mesh-ancestor
110996367|NCT01063283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110996368|NCT01063283|Growth Inhibitors|growth inhibitors|mesh-ancestor
110996369|NCT01063283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110996370|NCT01063283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110996371|NCT01063283|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110996372|NCT01063283|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110996373|NCT01062971|Timolol|timolol|mesh-list
110996374|NCT01062971|Brimonidine Tartrate|brimonidine tartrate|mesh-list
110996375|NCT01062971|Dorzolamide|dorzolamide|mesh-list
110996376|NCT01062971|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110996377|NCT01062971|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110996378|NCT01062971|Adrenergic Agents|adrenergic agents|mesh-ancestor
110996379|NCT01062971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110996380|NCT01062971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110996381|NCT01062971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110996382|NCT01062971|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110996383|NCT01062971|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110996384|NCT01062971|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110996385|NCT01062971|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110996386|NCT01062971|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110996387|NCT01062971|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110996388|NCT01062971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110996389|NCT03446937|Dexamethasone|dexamethasone|mesh-list
110996390|NCT03446937|Betamethasone|betamethasone|mesh-list
110996391|NCT03446937|Betamethasone Valerate|betamethasone valerate|mesh-list
110996392|NCT03446937|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
110996393|NCT03446937|Betamethasone benzoate|betamethasone benzoate|mesh-list
110996394|NCT03446937|Dexamethasone acetate|dexamethasone acetate|mesh-list
110996395|NCT03446937|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
110996396|NCT03446937|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
110996397|NCT03446937|BB 1101|bb 1101|mesh-list
110996398|NCT03446937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110996399|NCT03446937|Antiemetics|antiemetics|mesh-ancestor
110996400|NCT03446937|Autonomic Agents|autonomic agents|mesh-ancestor
110996401|NCT03446937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110996402|NCT03446937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110996403|NCT03446937|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110996404|NCT03446937|Glucocorticoids|glucocorticoids|mesh-ancestor
110996406|NCT03446937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110996407|NCT03446937|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110996408|NCT03446937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110996409|NCT03446937|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110996410|NCT03446937|Respiratory System Agents|respiratory system agents|mesh-ancestor
110996411|NCT03446937|Protease Inhibitors|protease inhibitors|mesh-ancestor
110996412|NCT03446937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110996413|NCT03446937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110996414|NCT03652493|Carboplatin|carboplatin|mesh-list
110996415|NCT03652493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110996416|NCT03652415|Lubricant Eye Drops|lubricant eye drops|mesh-list
110996417|NCT03652415|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110996418|NCT03652415|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110996419|NCT02493868|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110996420|NCT02493868|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
110996421|NCT02493868|Sertraline|sertraline|mesh-list
110996422|NCT02493868|Antidepressive Agents|antidepressive agents|mesh-list
110996423|NCT02493868|Esketamine|esketamine|mesh-list
110996424|NCT02493868|Escitalopram|escitalopram|mesh-list
110996425|NCT02493868|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110996426|NCT02493868|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110996427|NCT02493868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110996428|NCT02493868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110996429|NCT02493868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110996430|NCT02493868|Serotonin Agents|serotonin agents|mesh-ancestor
110996431|NCT02493868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110996432|NCT02493868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110996433|NCT02493868|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110996434|NCT02493868|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110996435|NCT02493868|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110996436|NCT02493868|Analgesics|analgesics|mesh-ancestor
110996437|NCT02493868|Sensory System Agents|sensory system agents|mesh-ancestor
110996438|NCT02493868|Dopamine Agents|dopamine agents|mesh-ancestor
110996439|NCT03619057|Anesthetics|anesthetics|mesh-list
110996440|NCT03619057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110996441|NCT03619057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110996442|NCT04451655|Insulin|insulin|mesh-list
110996443|NCT04451655|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110996444|NCT04451655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110996445|NCT03446625|Resveratrol|resveratrol|mesh-list
110996446|NCT03446625|Antioxidants|antioxidants|mesh-ancestor
110996447|NCT03446625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110996448|NCT03446625|Protective Agents|protective agents|mesh-ancestor
110996449|NCT03446625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110996450|NCT03446625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110996451|NCT03446625|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110996452|NCT04594005|Paclitaxel|paclitaxel|mesh-list
110996453|NCT04594005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110996454|NCT04594005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110996455|NCT04594005|Tubulin Modulators|tubulin modulators|mesh-ancestor
110996456|NCT04594005|Antimitotic Agents|antimitotic agents|mesh-ancestor
110996457|NCT04594005|Mitosis Modulators|mitosis modulators|mesh-ancestor
110713477|NCT01077999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110996458|NCT04594005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110996459|NCT02516410|Ivacaftor|ivacaftor|mesh-list
110996460|NCT02516410|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
110452689|NCT05295394|Lamivudine|lamivudine|mesh-list
110996461|NCT02516410|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110996462|NCT02516410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110996463|NCT02493712|Mesalamine|mesalamine|mesh-list
110996464|NCT02493712|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110996465|NCT02493712|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110996466|NCT02493712|Analgesics|analgesics|mesh-ancestor
110996467|NCT02493712|Sensory System Agents|sensory system agents|mesh-ancestor
110996468|NCT02493712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110996469|NCT02493712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110996470|NCT02493712|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110996471|NCT02493712|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110996472|NCT03446547|Durvalumab|durvalumab|mesh-list
110996473|NCT03446547|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110996474|NCT03446547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110996475|NCT02516332|Escitalopram|escitalopram|mesh-list
110996476|NCT02516332|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110996477|NCT02516332|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110996478|NCT02516332|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110996479|NCT02516332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110996480|NCT02516332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110996481|NCT02516332|Serotonin Agents|serotonin agents|mesh-ancestor
110996482|NCT02516332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110996483|NCT03437655|Eugenol|eugenol|mesh-list
110996484|NCT03437655|Zinc Oxide|zinc oxide|mesh-list
110996485|NCT03437655|Dermatologic Agents|dermatologic agents|mesh-ancestor
110996486|NCT03437655|Sunscreening Agents|sunscreening agents|mesh-ancestor
110996487|NCT03437655|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110996488|NCT03437655|Protective Agents|protective agents|mesh-ancestor
110996489|NCT03437655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110996490|NCT03437655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110996491|NCT01062425|Temozolomide|temozolomide|mesh-list
110996492|NCT01062425|Cediranib|cediranib|mesh-list
110996493|NCT01062425|Maleic acid|maleic acid|mesh-list
110996494|NCT01062425|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110996495|NCT01062425|Alkylating Agents|alkylating agents|mesh-ancestor
110996496|NCT01062425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110996497|NCT01062425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110996498|NCT01062425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110996499|NCT01062425|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110996500|NCT03437187|Analgesics|analgesics|mesh-list
110996501|NCT03437187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110996502|NCT03437187|Sensory System Agents|sensory system agents|mesh-ancestor
110996503|NCT03437187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110996504|NCT02491684|Interferons|interferons|mesh-list
110996505|NCT02491684|Interferon-beta|interferon-beta|mesh-list
110996506|NCT02491684|Interferon beta-1a|interferon beta-1a|mesh-list
110996507|NCT02491684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110996508|NCT02491684|Antiviral Agents|antiviral agents|mesh-ancestor
110996509|NCT02491684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110996510|NCT02491684|Immunologic Factors|immunologic factors|mesh-ancestor
110996511|NCT02491684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110996512|NCT02491684|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110996513|NCT03445611|Lidocaine|lidocaine|mesh-list
110996514|NCT03445611|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110996515|NCT03445611|Anesthetics, Local|anesthetics, local|mesh-ancestor
110996516|NCT03445611|Anesthetics|anesthetics|mesh-ancestor
110996517|NCT03445611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110996518|NCT03445611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110996519|NCT03445611|Sensory System Agents|sensory system agents|mesh-ancestor
110996520|NCT03445611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110996521|NCT03445611|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110996522|NCT03445611|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110996523|NCT03445611|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110996524|NCT03445611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110996525|NCT03445611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110996526|NCT04360629|Tranexamic Acid|tranexamic acid|mesh-list
110996527|NCT04360629|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110996528|NCT04360629|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110996529|NCT04360629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110996530|NCT04360629|Hemostatics|hemostatics|mesh-ancestor
110996531|NCT04360629|Coagulants|coagulants|mesh-ancestor
110996532|NCT04727229|Bupivacaine|bupivacaine|mesh-list
110996533|NCT04727229|Anesthetics, Local|anesthetics, local|mesh-ancestor
110996534|NCT04727229|Anesthetics|anesthetics|mesh-ancestor
110996535|NCT04727229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110996536|NCT04727229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110996537|NCT04727229|Sensory System Agents|sensory system agents|mesh-ancestor
110996538|NCT04727229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110996539|NCT03436719|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110996540|NCT03436719|Metronidazole|metronidazole|mesh-list
110996541|NCT03436719|Erythromycin|erythromycin|mesh-list
110996542|NCT03436719|Cefoperazone|cefoperazone|mesh-list
110996543|NCT03436719|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
110996544|NCT03436719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110996545|NCT03436719|Antitubercular Agents|antitubercular agents|mesh-ancestor
110996546|NCT03436719|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110996547|NCT03436719|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110996548|NCT03436719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110996549|NCT03436719|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110996550|NCT03436719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110996551|NCT03436719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110996552|NCT01061333|Mometasone Furoate|mometasone furoate|mesh-list
110996554|NCT01061333|Montelukast|montelukast|mesh-list
110996555|NCT01061333|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110996556|NCT01061333|Respiratory System Agents|respiratory system agents|mesh-ancestor
110996557|NCT01061333|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110996558|NCT01061333|Hormone Antagonists|hormone antagonists|mesh-ancestor
110996559|NCT01061333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110996560|NCT01061333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110996561|NCT01061333|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110996562|NCT01061333|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110996563|NCT01061333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110996564|NCT01061333|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110996565|NCT01061333|Dermatologic Agents|dermatologic agents|mesh-ancestor
110996566|NCT01061333|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110996567|NCT01061333|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
110996568|NCT01061333|Immunologic Factors|immunologic factors|mesh-ancestor
110996569|NCT02489968|Empagliflozin|empagliflozin|mesh-list
110996570|NCT02489968|Linagliptin|linagliptin|mesh-list
110996571|NCT02489968|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110996572|NCT02489968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110996573|NCT02489968|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110996574|NCT02489968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110996575|NCT02489968|Incretins|incretins|mesh-ancestor
110996576|NCT02489968|Hormones|hormones|mesh-ancestor
110996577|NCT02489968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110996578|NCT02489968|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110996579|NCT02489968|Protease Inhibitors|protease inhibitors|mesh-ancestor
110996580|NCT02489968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110996581|NCT03436173|Fluoxetine|fluoxetine|mesh-list
110996582|NCT03436173|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110996583|NCT03436173|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110996584|NCT03436173|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110996585|NCT03436173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110996586|NCT03436173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110996587|NCT03436173|Serotonin Agents|serotonin agents|mesh-ancestor
110996588|NCT03436173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110996589|NCT03436173|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110996590|NCT03436173|Antidepressive Agents|antidepressive agents|mesh-ancestor
110996591|NCT03436173|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110996592|NCT03436173|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110996593|NCT03436173|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110996594|NCT03436173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110996595|NCT03444831|Buspirone|buspirone|mesh-list
110996596|NCT03444831|Omeprazole|omeprazole|mesh-list
110996597|NCT03444831|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110996598|NCT03444831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110996599|NCT03444831|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110996600|NCT03444831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110452704|NCT02871648|Hormone Antagonists|hormone antagonists|mesh-ancestor
110996601|NCT03444831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110996602|NCT03444831|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110996603|NCT03444831|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110996604|NCT03444831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110996605|NCT03444831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110996606|NCT03444831|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110996607|NCT03444831|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110996608|NCT03444831|Serotonin Agents|serotonin agents|mesh-ancestor
110996609|NCT03444831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110996610|NCT02481934|Lenalidomide|lenalidomide|mesh-list
110996611|NCT02481934|Bortezomib|bortezomib|mesh-list
110996612|NCT02481934|Immunologic Factors|immunologic factors|mesh-ancestor
110996613|NCT02481934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110996614|NCT02481934|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110996615|NCT02481934|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110996616|NCT02481934|Growth Substances|growth substances|mesh-ancestor
110996617|NCT02481934|Growth Inhibitors|growth inhibitors|mesh-ancestor
110996618|NCT02481934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110996619|NCT03444519|Mannitol|mannitol|mesh-list
110996620|NCT03444519|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110996621|NCT03444519|Diuretics|diuretics|mesh-ancestor
110996622|NCT03444519|Natriuretic Agents|natriuretic agents|mesh-ancestor
110996623|NCT03444519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110996624|NCT03129009|Anesthetics|anesthetics|mesh-list
110996625|NCT03129009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110996626|NCT03129009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110996627|NCT02489500|Bortezomib|bortezomib|mesh-list
110996628|NCT02489500|Melphalan|melphalan|mesh-list
110996629|NCT02489500|Lenograstim|lenograstim|mesh-list
110996630|NCT02489500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110996631|NCT02489500|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110996632|NCT02489500|Alkylating Agents|alkylating agents|mesh-ancestor
110996633|NCT02489500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110996634|NCT02489500|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110996635|NCT02489500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110996636|NCT02489500|Immunologic Factors|immunologic factors|mesh-ancestor
110996637|NCT02489500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110996638|NCT02489500|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110996639|NCT04053959|Insulin|insulin|mesh-list
110996640|NCT04053959|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110996641|NCT04053959|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110996642|NCT04053959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110996643|NCT03652571|Nortriptyline|nortriptyline|mesh-list
110996644|NCT03652571|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110996645|NCT03652571|Antidepressive Agents|antidepressive agents|mesh-ancestor
110996646|NCT03652571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110996647|NCT03652571|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110996648|NCT03652571|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110996649|NCT03652571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110996650|NCT03652571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110996651|NCT03652571|Adrenergic Agents|adrenergic agents|mesh-ancestor
110996652|NCT03652571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110996653|NCT03652571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110996654|NCT03652103|Bupivacaine|bupivacaine|mesh-list
110996655|NCT03652103|Anesthetics, Local|anesthetics, local|mesh-ancestor
110996656|NCT03652103|Anesthetics|anesthetics|mesh-ancestor
110996657|NCT03652103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110996658|NCT03652103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110996659|NCT03652103|Sensory System Agents|sensory system agents|mesh-ancestor
110996660|NCT03652103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110996661|NCT03651947|Denosumab|denosumab|mesh-list
110996662|NCT03651947|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110996663|NCT03651947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110996664|NCT03651557|Salicylates|salicylates|mesh-list
110996665|NCT03651557|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110996666|NCT03651557|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110996667|NCT03651557|Analgesics|analgesics|mesh-ancestor
110996668|NCT03651557|Sensory System Agents|sensory system agents|mesh-ancestor
110996669|NCT03651557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110996670|NCT03651557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110996671|NCT03651557|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110996672|NCT03651557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110996673|NCT03651557|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110996674|NCT03651557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110996675|NCT03651557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110996676|NCT03432975|Povidone-Iodine|povidone-iodine|mesh-list
110996677|NCT03432975|Povidone|povidone|mesh-list
110996678|NCT03432975|Plasma Substitutes|plasma substitutes|mesh-ancestor
110996679|NCT03432975|Blood Substitutes|blood substitutes|mesh-ancestor
110996680|NCT03432975|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110996681|NCT03432975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110996682|NCT04953130|Vaccines|vaccines|mesh-list
110996683|NCT04953130|Immunologic Factors|immunologic factors|mesh-ancestor
110996684|NCT04953130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110996685|NCT02488330|Bevacizumab|bevacizumab|mesh-list
110996686|NCT02488330|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110996687|NCT02488330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110996688|NCT02488330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110996689|NCT02488330|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110996690|NCT02488330|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110996691|NCT02488330|Growth Substances|growth substances|mesh-ancestor
110996692|NCT02488330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110996693|NCT02488330|Growth Inhibitors|growth inhibitors|mesh-ancestor
110996694|NCT02488330|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110996695|NCT02488330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110996696|NCT02488330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110996697|NCT03432663|Amiodarone|amiodarone|mesh-list
110996698|NCT03432663|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110996699|NCT03432663|Vasodilator Agents|vasodilator agents|mesh-ancestor
110996700|NCT03432663|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
110996701|NCT03432663|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110996702|NCT03432663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110996703|NCT03432663|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110996704|NCT03432663|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110996705|NCT03432663|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110996706|NCT03432663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110996707|NCT03432663|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110996708|NCT03432663|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110996709|NCT03432663|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110996710|NCT03432273|Nicotine|nicotine|mesh-list
110996711|NCT03432273|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110996712|NCT03432273|Autonomic Agents|autonomic agents|mesh-ancestor
110996713|NCT03432273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110996714|NCT03432273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110996715|NCT03432273|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110996716|NCT03432273|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110996717|NCT03432273|Cholinergic Agents|cholinergic agents|mesh-ancestor
110996718|NCT03432273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110996719|NCT03432273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110996720|NCT02481310|Cytarabine|cytarabine|mesh-list
110996721|NCT02481310|Prednisone|prednisone|mesh-list
110996722|NCT02481310|Hydrocortisone|hydrocortisone|mesh-list
110996723|NCT02481310|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
110996724|NCT02481310|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
110996725|NCT02481310|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
110996726|NCT02481310|Cortisone|cortisone|mesh-list
110996727|NCT02481310|Cyclophosphamide|cyclophosphamide|mesh-list
110996728|NCT02481310|Rituximab|rituximab|mesh-list
110996729|NCT02481310|Doxorubicin|doxorubicin|mesh-list
110996730|NCT02481310|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110996731|NCT02481310|Methotrexate|methotrexate|mesh-list
110996732|NCT02481310|Etoposide|etoposide|mesh-list
110996733|NCT02481310|Vincristine|vincristine|mesh-list
110996734|NCT02481310|Etoposide phosphate|etoposide phosphate|mesh-list
110996735|NCT02481310|Ixazomib|ixazomib|mesh-list
110996736|NCT02481310|Podophyllotoxin|podophyllotoxin|mesh-list
110996737|NCT02481310|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110996738|NCT02481310|Antibodies|antibodies|mesh-list
110996739|NCT02481310|Immunoglobulins|immunoglobulins|mesh-list
110996740|NCT02481310|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110996741|NCT02481310|Glycine|glycine|mesh-list
110996742|NCT02481310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110996743|NCT02481310|Immunologic Factors|immunologic factors|mesh-ancestor
110996744|NCT02481310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110996745|NCT02481310|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110996746|NCT02481310|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110996747|NCT02481310|Alkylating Agents|alkylating agents|mesh-ancestor
110996748|NCT02481310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110996749|NCT02481310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110996750|NCT02481310|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110996751|NCT02481310|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110996752|NCT02481310|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110996753|NCT02481310|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110996754|NCT02481310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110996755|NCT02481310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110996756|NCT02481310|Glucocorticoids|glucocorticoids|mesh-ancestor
110996757|NCT02481310|Hormones|hormones|mesh-ancestor
110996758|NCT02481310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110996759|NCT02481310|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110996760|NCT02481310|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110996761|NCT02481310|Abortifacient Agents|abortifacient agents|mesh-ancestor
110996762|NCT02481310|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110996763|NCT02481310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110996765|NCT02481310|Dermatologic Agents|dermatologic agents|mesh-ancestor
110996766|NCT02481310|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110996767|NCT02481310|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110996768|NCT02481310|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110996769|NCT02481310|Antiviral Agents|antiviral agents|mesh-ancestor
110996770|NCT02481310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110996771|NCT02481310|Tubulin Modulators|tubulin modulators|mesh-ancestor
110996772|NCT02481310|Antimitotic Agents|antimitotic agents|mesh-ancestor
110996773|NCT02481310|Mitosis Modulators|mitosis modulators|mesh-ancestor
110996774|NCT02481310|Protease Inhibitors|protease inhibitors|mesh-ancestor
110996775|NCT02481310|Keratolytic Agents|keratolytic agents|mesh-ancestor
110996776|NCT02481310|Glycine Agents|glycine agents|mesh-ancestor
110996777|NCT02481310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110996778|NCT03432195|Donepezil|donepezil|mesh-list
110996779|NCT03432195|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110996780|NCT03432195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110996781|NCT03432195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110996782|NCT03432195|Cholinergic Agents|cholinergic agents|mesh-ancestor
110996783|NCT03432195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110996784|NCT03432195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110996785|NCT03432195|Nootropic Agents|nootropic agents|mesh-ancestor
110996786|NCT03431961|Triamcinolone|triamcinolone|mesh-list
110996787|NCT03431961|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110996788|NCT03431961|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110996789|NCT03431961|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110996790|NCT03431961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110996791|NCT03431961|Glucocorticoids|glucocorticoids|mesh-ancestor
110996792|NCT03431961|Hormones|hormones|mesh-ancestor
110996793|NCT03431961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110996794|NCT03431961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110996795|NCT03431961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110996796|NCT03431961|Immunologic Factors|immunologic factors|mesh-ancestor
110996797|NCT03431961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110996798|NCT03431961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110996799|NCT02480764|Valsartan|valsartan|mesh-list
110996800|NCT02480764|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
110996801|NCT02480764|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110996802|NCT02480764|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110996803|NCT02480764|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110996804|NCT02480764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110996805|NCT03434691|Remifentanil|remifentanil|mesh-list
110996806|NCT03434691|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110996807|NCT03434691|Narcotics|narcotics|mesh-ancestor
110996808|NCT03434691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110996809|NCT03434691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110996810|NCT03434691|Analgesics|analgesics|mesh-ancestor
110996811|NCT03434691|Sensory System Agents|sensory system agents|mesh-ancestor
110996812|NCT03434691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110996813|NCT03434613|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110996814|NCT03434613|Ezetimibe|ezetimibe|mesh-list
110996815|NCT03434613|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110996816|NCT03434613|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110996817|NCT03434613|Antimetabolites|antimetabolites|mesh-ancestor
110996818|NCT03434613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110996819|NCT03434613|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110996820|NCT03434613|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110996821|NCT03434613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110996822|NCT04953052|Imatinib Mesylate|imatinib mesylate|mesh-list
110996823|NCT04953052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110996824|NCT04953052|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110996825|NCT04953052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110996826|NCT04953052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110996827|NCT03428685|Dydrogesterone|dydrogesterone|mesh-list
110996828|NCT03428685|Progestins|progestins|mesh-ancestor
110996829|NCT03428685|Hormones|hormones|mesh-ancestor
110996830|NCT03428685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110996831|NCT03428685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110996832|NCT05665647|Ritonavir|ritonavir|mesh-list
110996833|NCT05665647|Itraconazole|itraconazole|mesh-list
110996834|NCT05665647|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
110996836|NCT05665647|Midazolam|midazolam|mesh-list
110996837|NCT05665647|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110996838|NCT05665647|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110996839|NCT05665647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110996840|NCT05665647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110996841|NCT05665647|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110996842|NCT05665647|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110996843|NCT05665647|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110996844|NCT05665647|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110996845|NCT05665647|Anesthetics, General|anesthetics, general|mesh-ancestor
110996846|NCT05665647|Anesthetics|anesthetics|mesh-ancestor
110996847|NCT05665647|GABA Modulators|gaba modulators|mesh-ancestor
110996848|NCT05665647|GABA Agents|gaba agents|mesh-ancestor
110996849|NCT05665647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110996850|NCT05665647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110996851|NCT05665647|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110996852|NCT05665647|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110996853|NCT05665647|Protease Inhibitors|protease inhibitors|mesh-ancestor
110996854|NCT05665647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110996855|NCT05665647|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110996856|NCT05665647|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110996857|NCT05665647|Antiviral Agents|antiviral agents|mesh-ancestor
110996858|NCT05665647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110996859|NCT05665647|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110996860|NCT05665647|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110996861|NCT05665647|Antifungal Agents|antifungal agents|mesh-ancestor
110996862|NCT05665647|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110996863|NCT05665647|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110996864|NCT05665647|Hormone Antagonists|hormone antagonists|mesh-ancestor
110996865|NCT05665647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110996866|NCT05665647|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110996867|NCT05665647|Antitubercular Agents|antitubercular agents|mesh-ancestor
110996868|NCT05665647|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110996869|NCT05665647|Leprostatic Agents|leprostatic agents|mesh-ancestor
110996870|NCT05665647|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110996871|NCT05665647|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110996872|NCT05665647|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110996873|NCT05665647|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110996874|NCT05665647|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110996875|NCT05665647|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110996876|NCT05665647|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110996877|NCT03943173|Olaparib|olaparib|mesh-list
110996878|NCT03943173|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
110996879|NCT03943173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110996880|NCT03943173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110996881|NCT03943173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110996882|NCT04941196|Ticagrelor|ticagrelor|mesh-list
110996883|NCT04941196|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110996884|NCT04941196|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110996885|NCT04941196|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110996886|NCT04941196|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110996887|NCT04941196|Purinergic Agents|purinergic agents|mesh-ancestor
110996888|NCT04941196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110996889|NCT04941196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110996890|NCT04941196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110996891|NCT03431805|Tranexamic Acid|tranexamic acid|mesh-list
110996892|NCT03431805|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110996893|NCT03431805|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110996894|NCT03431805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110996895|NCT03431805|Hemostatics|hemostatics|mesh-ancestor
110996896|NCT03431805|Coagulants|coagulants|mesh-ancestor
110996897|NCT03428607|Olaparib|olaparib|mesh-list
110996898|NCT03428607|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110996899|NCT03428607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110996900|NCT03428607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110996901|NCT03428607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110996902|NCT02521233|Losartan|losartan|mesh-list
110713934|NCT00023452|Isoniazid|isoniazid|mesh-list
110996903|NCT02521233|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110996904|NCT02521233|Candesartan|candesartan|mesh-list
110996905|NCT02521233|Candesartan cilexetil|candesartan cilexetil|mesh-list
110996906|NCT02521233|Chlorthalidone|chlorthalidone|mesh-list
110996907|NCT02521233|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110996908|NCT02521233|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110996909|NCT02521233|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110996910|NCT02521233|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110996911|NCT02521233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110996912|NCT02521233|Diuretics|diuretics|mesh-ancestor
110996913|NCT02521233|Natriuretic Agents|natriuretic agents|mesh-ancestor
110996914|NCT02521233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110996915|NCT02521233|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110996916|NCT02521233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110996917|NCT03428529|Fluorouracil|fluorouracil|mesh-list
110996918|NCT03428529|Capecitabine|capecitabine|mesh-list
110996919|NCT03428529|Antimetabolites|antimetabolites|mesh-ancestor
110996920|NCT03428529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110996921|NCT03428529|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110996922|NCT03428529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110996923|NCT03428529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110996924|NCT03428529|Immunologic Factors|immunologic factors|mesh-ancestor
110996925|NCT03428529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110996926|NCT03431649|Sildenafil Citrate|sildenafil citrate|mesh-list
110996927|NCT03431649|Beraprost|beraprost|mesh-list
110996928|NCT03431649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110996929|NCT03431649|Vasodilator Agents|vasodilator agents|mesh-ancestor
110996930|NCT03431649|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110996931|NCT03431649|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110996932|NCT03431649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110996933|NCT03431649|Urological Agents|urological agents|mesh-ancestor
110996934|NCT03431649|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110996935|NCT04450095|Ambrisentan|ambrisentan|mesh-list
110996936|NCT04450095|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110996937|NCT03101475|Durvalumab|durvalumab|mesh-list
110996938|NCT03101475|Tremelimumab|tremelimumab|mesh-list
110996939|NCT03101475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110996940|NCT03101475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110996941|NCT01060007|Leucovorin|leucovorin|mesh-list
110996942|NCT01060007|Fluorouracil|fluorouracil|mesh-list
110996943|NCT01060007|Capecitabine|capecitabine|mesh-list
110996944|NCT01060007|Oxaliplatin|oxaliplatin|mesh-list
110996945|NCT01060007|Antimetabolites|antimetabolites|mesh-ancestor
110996946|NCT01060007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110996947|NCT01060007|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110996948|NCT01060007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110996949|NCT01060007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110996950|NCT01060007|Immunologic Factors|immunologic factors|mesh-ancestor
110996951|NCT01060007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110996952|NCT01060007|Antidotes|antidotes|mesh-ancestor
110996953|NCT01060007|Protective Agents|protective agents|mesh-ancestor
110996954|NCT01060007|Vitamin B Complex|vitamin b complex|mesh-ancestor
110996955|NCT01060007|Vitamins|vitamins|mesh-ancestor
110996956|NCT01060007|Micronutrients|micronutrients|mesh-ancestor
110996957|NCT04175925|Famotidine|famotidine|mesh-list
110996958|NCT04175925|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110996959|NCT04175925|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110996960|NCT04175925|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110996961|NCT04175925|Histamine Antagonists|histamine antagonists|mesh-ancestor
110996962|NCT04175925|Histamine Agents|histamine agents|mesh-ancestor
110996963|NCT04175925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110996964|NCT04175925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110996965|NCT04175925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110996966|NCT02971007|Fluconazole|fluconazole|mesh-list
110996967|NCT02971007|Amphotericin B|amphotericin b|mesh-list
110996968|NCT02971007|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
110996969|NCT02971007|Antifungal Agents|antifungal agents|mesh-ancestor
110996970|NCT02971007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110996971|NCT02971007|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110996972|NCT02971007|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110996973|NCT02971007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110024816|NCT00005616|Immunologic Factors|immunologic factors|mesh-ancestor
110996974|NCT02971007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110996975|NCT02971007|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110996976|NCT02971007|Hormone Antagonists|hormone antagonists|mesh-ancestor
110996977|NCT02971007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110996978|NCT02971007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110996979|NCT02971007|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110996980|NCT02971007|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110996982|NCT02971007|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110996983|NCT02971007|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110996984|NCT02971007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110996985|NCT03428139|Thioctic Acid|thioctic acid|mesh-list
110996986|NCT03428139|Antioxidants|antioxidants|mesh-ancestor
110996987|NCT03428139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110996988|NCT03428139|Protective Agents|protective agents|mesh-ancestor
110996989|NCT03428139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110996990|NCT03428139|Vitamin B Complex|vitamin b complex|mesh-ancestor
110996991|NCT03428139|Vitamins|vitamins|mesh-ancestor
110996992|NCT03428139|Micronutrients|micronutrients|mesh-ancestor
110996993|NCT03650543|Amoxicillin|amoxicillin|mesh-list
110996994|NCT03650543|Clarithromycin|clarithromycin|mesh-list
110996995|NCT03650543|Omeprazole|omeprazole|mesh-list
110996996|NCT03650543|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110996997|NCT03650543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110996998|NCT03650543|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110996999|NCT03650543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110997000|NCT03650543|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110997001|NCT03650543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110997002|NCT03650543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110997003|NCT03650543|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110997004|NCT03650543|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110997005|NCT03650543|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110997006|NCT03650777|Warfarin|warfarin|mesh-list
110997007|NCT03650777|Anticoagulants|anticoagulants|mesh-ancestor
110997008|NCT02970305|Pimavanserin|pimavanserin|mesh-list
110997009|NCT02970305|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110997010|NCT02970305|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110997011|NCT02970305|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110997012|NCT02970305|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110997013|NCT02970305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110997014|NCT02970305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110997015|NCT02970305|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110997016|NCT02970305|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110997017|NCT02970305|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110997018|NCT02970305|Serotonin Agents|serotonin agents|mesh-ancestor
110997019|NCT02970305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110997020|NCT02970305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110997021|NCT03649763|Lidocaine|lidocaine|mesh-list
110997022|NCT03649763|Bupivacaine|bupivacaine|mesh-list
110997023|NCT03649763|Anesthetics, Local|anesthetics, local|mesh-ancestor
110997024|NCT03649763|Anesthetics|anesthetics|mesh-ancestor
110997025|NCT03649763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110997026|NCT03649763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110997027|NCT03649763|Sensory System Agents|sensory system agents|mesh-ancestor
110997028|NCT03649763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110997029|NCT03649763|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110997030|NCT03649763|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110997031|NCT03649763|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110997032|NCT03649763|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110997033|NCT03649763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110997034|NCT03427437|Epinephrine|epinephrine|mesh-list
110997035|NCT03427437|Racepinephrine|racepinephrine|mesh-list
110997036|NCT03427437|Bupivacaine|bupivacaine|mesh-list
110997037|NCT03427437|Epinephryl borate|epinephryl borate|mesh-list
110997038|NCT03427437|Anesthetics, Local|anesthetics, local|mesh-ancestor
110997039|NCT03427437|Anesthetics|anesthetics|mesh-ancestor
110997040|NCT03427437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110997041|NCT03427437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110997042|NCT03427437|Sensory System Agents|sensory system agents|mesh-ancestor
110997043|NCT03427437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110997044|NCT03427437|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110997045|NCT03427437|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110997046|NCT03427437|Adrenergic Agents|adrenergic agents|mesh-ancestor
110997047|NCT03427437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110997048|NCT03427437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110997050|NCT03427437|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110997051|NCT03427437|Autonomic Agents|autonomic agents|mesh-ancestor
110997052|NCT03427437|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110714080|NCT00183872|Docetaxel|docetaxel|mesh-list
110997053|NCT03427437|Respiratory System Agents|respiratory system agents|mesh-ancestor
110997054|NCT03427437|Mydriatics|mydriatics|mesh-ancestor
110997055|NCT03427437|Sympathomimetics|sympathomimetics|mesh-ancestor
110997056|NCT03427437|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110997057|NCT03427359|Capecitabine|capecitabine|mesh-list
110997058|NCT03427359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110997059|NCT03427359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110997060|NCT03427359|Antimetabolites|antimetabolites|mesh-ancestor
110997061|NCT03427359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110997062|NCT05053659|Venetoclax|venetoclax|mesh-list
110997063|NCT05053659|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
110997064|NCT05053659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110997065|NCT05053659|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110997066|NCT03423537|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
110997067|NCT03423537|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110997068|NCT03423537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110997069|NCT03649139|Immunomodulating Agents|immunomodulating agents|mesh-list
110997070|NCT03649139|Immunologic Factors|immunologic factors|mesh-ancestor
110997071|NCT03649139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110997072|NCT03648125|Salicylic Acid|salicylic acid|mesh-list
110997073|NCT03648125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110997074|NCT03648125|Antifungal Agents|antifungal agents|mesh-ancestor
110997075|NCT03648125|Keratolytic Agents|keratolytic agents|mesh-ancestor
110997076|NCT03648125|Dermatologic Agents|dermatologic agents|mesh-ancestor
110997077|NCT03423225|Tacrolimus|tacrolimus|mesh-list
110997078|NCT03423225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110997079|NCT03423225|Immunologic Factors|immunologic factors|mesh-ancestor
110997080|NCT03423225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110997081|NCT03423225|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110997082|NCT03423225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110997083|NCT03423225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110997084|NCT02521077|Ascorbic Acid|ascorbic acid|mesh-list
110997085|NCT02521077|Vitamins|vitamins|mesh-ancestor
110997086|NCT02521077|Micronutrients|micronutrients|mesh-ancestor
110997087|NCT02521077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110997088|NCT02521077|Antioxidants|antioxidants|mesh-ancestor
110997089|NCT02521077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110997090|NCT02521077|Protective Agents|protective agents|mesh-ancestor
110997091|NCT03564093|Dexmedetomidine|dexmedetomidine|mesh-list
110997092|NCT03564093|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110997093|NCT03564093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110997094|NCT03564093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110997095|NCT03564093|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110997096|NCT03564093|Analgesics|analgesics|mesh-ancestor
110997097|NCT03564093|Sensory System Agents|sensory system agents|mesh-ancestor
110997098|NCT03564093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110997099|NCT03564093|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110997100|NCT03564093|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110997101|NCT03564093|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110997102|NCT03564093|Adrenergic Agents|adrenergic agents|mesh-ancestor
110997103|NCT03564093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110997104|NCT03564093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110997105|NCT03429621|Simethicone|simethicone|mesh-list
110997106|NCT03429621|Antifoaming Agents|antifoaming agents|mesh-ancestor
110997107|NCT03429621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110997108|NCT03429621|Emollients|emollients|mesh-ancestor
110997109|NCT03429621|Dermatologic Agents|dermatologic agents|mesh-ancestor
110997110|NCT03426969|Mycophenolic Acid|mycophenolic acid|mesh-list
110997111|NCT03426969|Cyclophosphamide|cyclophosphamide|mesh-list
110997112|NCT03426969|Melphalan|melphalan|mesh-list
110997113|NCT03426969|Mechlorethamine|mechlorethamine|mesh-list
110997114|NCT03426969|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
110997115|NCT03426969|Fludarabine|fludarabine|mesh-list
110997116|NCT03426969|Fludarabine phosphate|fludarabine phosphate|mesh-list
110997117|NCT03426969|Tacrolimus|tacrolimus|mesh-list
110997118|NCT03426969|Lenograstim|lenograstim|mesh-list
110997119|NCT03426969|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110997120|NCT03426969|Immunologic Factors|immunologic factors|mesh-ancestor
110997121|NCT03426969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110997122|NCT03426969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110997123|NCT03426969|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110997124|NCT03426969|Alkylating Agents|alkylating agents|mesh-ancestor
110997125|NCT03426969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110997126|NCT03426969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110997127|NCT03426969|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110997128|NCT03426969|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110997129|NCT03426969|Antimetabolites|antimetabolites|mesh-ancestor
110997130|NCT03426969|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110997131|NCT03426969|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110997132|NCT03426969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110997133|NCT03426969|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110997134|NCT03426969|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110997135|NCT03426969|Antitubercular Agents|antitubercular agents|mesh-ancestor
110997136|NCT03426969|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110997137|NCT03426969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110997138|NCT03422445|Temozolomide|temozolomide|mesh-list
110997139|NCT03422445|Apatinib|apatinib|mesh-list
110997140|NCT03422445|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110997141|NCT03422445|Alkylating Agents|alkylating agents|mesh-ancestor
110997142|NCT03422445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110997143|NCT03422445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110997144|NCT03422445|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110997145|NCT03422445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110997146|NCT03429309|Propofol|propofol|mesh-list
110997147|NCT03429309|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110997148|NCT03429309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110997149|NCT03429309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110997150|NCT03429309|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110997151|NCT03429309|Anesthetics, General|anesthetics, general|mesh-ancestor
110997152|NCT03429309|Anesthetics|anesthetics|mesh-ancestor
110997153|NCT03429075|Psilocybin|psilocybin|mesh-list
110997154|NCT03429075|Escitalopram|escitalopram|mesh-list
110997155|NCT03429075|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110997156|NCT03429075|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110997157|NCT03429075|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110997158|NCT03429075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110997159|NCT03429075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110997160|NCT03429075|Serotonin Agents|serotonin agents|mesh-ancestor
110997161|NCT03429075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110997162|NCT03429075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110997163|NCT03429075|Hallucinogens|hallucinogens|mesh-ancestor
110997164|NCT03422289|Folic Acid|folic acid|mesh-list
110997165|NCT03422289|Vitamin B Complex|vitamin b complex|mesh-list
110997166|NCT03422289|Inositol|inositol|mesh-list
110997167|NCT03422289|Hematinics|hematinics|mesh-ancestor
110997168|NCT03422289|Vitamins|vitamins|mesh-ancestor
110997169|NCT03422289|Micronutrients|micronutrients|mesh-ancestor
110997170|NCT03422289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110997171|NCT03422055|Fucoidan|fucoidan|mesh-list
110997172|NCT03422055|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110997173|NCT03422055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110997174|NCT03422055|Anticoagulants|anticoagulants|mesh-ancestor
110997175|NCT03422055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110997176|NCT04449471|Naproxen|naproxen|mesh-list
110997177|NCT04449471|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110997178|NCT04449471|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110997179|NCT04449471|Analgesics|analgesics|mesh-ancestor
110997180|NCT04449471|Sensory System Agents|sensory system agents|mesh-ancestor
110997181|NCT04449471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110997182|NCT04449471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110997183|NCT04449471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110997184|NCT04449471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110997185|NCT04449471|Gout Suppressants|gout suppressants|mesh-ancestor
110997186|NCT04449471|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110997187|NCT04449471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110997188|NCT04449471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110997189|NCT03127371|Nitrous Oxide|nitrous oxide|mesh-list
110997190|NCT03127371|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110997191|NCT03127371|Anesthetics, General|anesthetics, general|mesh-ancestor
110997192|NCT03127371|Anesthetics|anesthetics|mesh-ancestor
110997193|NCT03127371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110997194|NCT03127371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110997195|NCT03127371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110997196|NCT03127371|Analgesics|analgesics|mesh-ancestor
110997197|NCT03127371|Sensory System Agents|sensory system agents|mesh-ancestor
110997198|NCT03127371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110997199|NCT03421821|Ropivacaine|ropivacaine|mesh-list
110997200|NCT03421821|Anesthetics, Local|anesthetics, local|mesh-ancestor
110997201|NCT03421821|Anesthetics|anesthetics|mesh-ancestor
110997202|NCT03421821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110997203|NCT03421821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110997204|NCT03421821|Sensory System Agents|sensory system agents|mesh-ancestor
110997205|NCT03421821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110997206|NCT03421743|Molgramostim|molgramostim|mesh-list
110997207|NCT03421743|Sargramostim|sargramostim|mesh-list
110997208|NCT03421743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110997209|NCT03421743|Immunologic Factors|immunologic factors|mesh-ancestor
110997210|NCT03421743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110997211|NCT01103349|Montelukast|montelukast|mesh-list
110997212|NCT01103349|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110997213|NCT01103349|Respiratory System Agents|respiratory system agents|mesh-ancestor
110997214|NCT01103349|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110997215|NCT01103349|Hormone Antagonists|hormone antagonists|mesh-ancestor
110997216|NCT01103349|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110997217|NCT01103349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110997218|NCT01103349|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110997219|NCT01103349|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110997220|NCT01103349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110997222|NCT03421275|Esketamine|esketamine|mesh-list
110997223|NCT03421275|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110997224|NCT03421275|Narcotics|narcotics|mesh-ancestor
110997225|NCT03421275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110997226|NCT03421275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110997227|NCT03421275|Analgesics|analgesics|mesh-ancestor
110997228|NCT03421275|Sensory System Agents|sensory system agents|mesh-ancestor
110997229|NCT03421275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110997230|NCT03421275|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110997231|NCT03421275|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110997232|NCT03421275|Anesthetics, General|anesthetics, general|mesh-ancestor
110997233|NCT03421275|Anesthetics|anesthetics|mesh-ancestor
110997234|NCT03421275|Antidepressive Agents|antidepressive agents|mesh-ancestor
110997235|NCT03421275|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110997236|NCT03416517|Irinotecan|irinotecan|mesh-list
110997237|NCT03416517|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110997238|NCT03416517|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110997239|NCT03416517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110997240|NCT03416517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110997241|NCT03416517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110997242|NCT03421119|Insulin|insulin|mesh-list
110997243|NCT03421119|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110997244|NCT03421119|Metformin|metformin|mesh-list
110997245|NCT03421119|Liraglutide|liraglutide|mesh-list
110997246|NCT03421119|Secretagogues|secretagogues|mesh-list
110997247|NCT03421119|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110997248|NCT03421119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110997249|NCT03421119|Incretins|incretins|mesh-ancestor
110997250|NCT03421119|Hormones|hormones|mesh-ancestor
110997251|NCT03421119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110997252|NCT03426033|Warfarin|warfarin|mesh-list
110997253|NCT03426033|Anticoagulants|anticoagulants|mesh-ancestor
110997254|NCT02432547|Aflibercept|aflibercept|mesh-list
110997255|NCT02432547|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110997256|NCT02432547|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110997257|NCT02432547|Growth Substances|growth substances|mesh-ancestor
110997258|NCT02432547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110997259|NCT02432547|Growth Inhibitors|growth inhibitors|mesh-ancestor
110997260|NCT02432547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110997261|NCT02345733|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110997262|NCT02345733|Amoxicillin|amoxicillin|mesh-list
110997263|NCT02345733|Metronidazole|metronidazole|mesh-list
110997264|NCT02345733|Doxycycline|doxycycline|mesh-list
110997265|NCT02345733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110997266|NCT02345733|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110997267|NCT02345733|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110997268|NCT02345733|Antimalarials|antimalarials|mesh-ancestor
110997269|NCT03415269|Ambroxol|ambroxol|mesh-list
110997270|NCT03415269|Expectorants|expectorants|mesh-ancestor
110997271|NCT03415269|Respiratory System Agents|respiratory system agents|mesh-ancestor
110997272|NCT03618589|Pregabalin|pregabalin|mesh-list
110997273|NCT03618589|Analgesics|analgesics|mesh-ancestor
110997274|NCT03618589|Sensory System Agents|sensory system agents|mesh-ancestor
110997275|NCT03618589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110997276|NCT03618589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110997277|NCT03618589|Anticonvulsants|anticonvulsants|mesh-ancestor
110997278|NCT03618589|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110997279|NCT03618589|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110997280|NCT03618589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110997281|NCT03618589|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110997282|NCT03618589|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110997283|NCT03618589|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110997284|NCT03618589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110997285|NCT03618589|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110997286|NCT03127449|Aflutinib|aflutinib|mesh-list
110997287|NCT03127449|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110997288|NCT03127449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110997289|NCT03127449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110997290|NCT02521155|Fenbendazole|fenbendazole|mesh-list
110997291|NCT02521155|Antinematodal Agents|antinematodal agents|mesh-ancestor
110997292|NCT02521155|Anthelmintics|anthelmintics|mesh-ancestor
110997293|NCT02521155|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110997294|NCT02521155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110997295|NCT03415191|Ketamine|ketamine|mesh-list
110997296|NCT03415191|Analgesics|analgesics|mesh-ancestor
110997297|NCT03415191|Sensory System Agents|sensory system agents|mesh-ancestor
110997298|NCT03415191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110997299|NCT03415191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110997300|NCT03415191|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110997301|NCT03415191|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110997302|NCT03415191|Anesthetics, General|anesthetics, general|mesh-ancestor
110997303|NCT03415191|Anesthetics|anesthetics|mesh-ancestor
110997304|NCT03415191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110997305|NCT03415191|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110997306|NCT03415191|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110997307|NCT03415191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110997308|NCT03415191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110997309|NCT03419949|Pregabalin|pregabalin|mesh-list
110997310|NCT03419949|Lamotrigine|lamotrigine|mesh-list
110997311|NCT03419949|Analgesics|analgesics|mesh-ancestor
110997312|NCT03419949|Sensory System Agents|sensory system agents|mesh-ancestor
110997313|NCT03419949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110997314|NCT03419949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110997315|NCT03419949|Anticonvulsants|anticonvulsants|mesh-ancestor
110997316|NCT03419949|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110997317|NCT03419949|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110997318|NCT03419949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110997319|NCT03419949|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110997320|NCT03419949|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110997321|NCT03419949|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110997322|NCT03419949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110997323|NCT03419949|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110997324|NCT03419949|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110997325|NCT03419949|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110997326|NCT03414879|Lidocaine|lidocaine|mesh-list
110997327|NCT03414879|Ketamine|ketamine|mesh-list
110997328|NCT03414879|Anesthetics, Local|anesthetics, local|mesh-ancestor
110997329|NCT03414879|Anesthetics|anesthetics|mesh-ancestor
110997330|NCT03414879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110997331|NCT03414879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110997332|NCT03414879|Sensory System Agents|sensory system agents|mesh-ancestor
110997333|NCT03414879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110997334|NCT03414879|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110997335|NCT03414879|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110997336|NCT03414879|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110997337|NCT03414879|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110997338|NCT03414879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110997339|NCT03414879|Analgesics|analgesics|mesh-ancestor
110997340|NCT03414879|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110997341|NCT03414879|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110997342|NCT03414879|Anesthetics, General|anesthetics, general|mesh-ancestor
110997343|NCT03414879|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110997344|NCT03414879|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110997345|NCT03414879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110997346|NCT03419715|Bimatoprost|bimatoprost|mesh-list
110997347|NCT03419715|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110997348|NCT03618355|Sirolimus|sirolimus|mesh-list
110997349|NCT03618355|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110997350|NCT03618355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110997351|NCT03618355|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110997352|NCT03618355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110997353|NCT03618355|Antifungal Agents|antifungal agents|mesh-ancestor
110997354|NCT03618355|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110997355|NCT03618355|Immunologic Factors|immunologic factors|mesh-ancestor
110997356|NCT03618355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110997358|NCT04448457|Oxycodone|oxycodone|mesh-list
110997359|NCT04448457|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110997360|NCT04448457|Narcotics|narcotics|mesh-ancestor
110997361|NCT04448457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110997362|NCT04448457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110997363|NCT04448457|Analgesics|analgesics|mesh-ancestor
110997364|NCT04448457|Sensory System Agents|sensory system agents|mesh-ancestor
110997365|NCT04448457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110997366|NCT04448457|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110997367|NCT04448457|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110997368|NCT04448457|Anesthetics, General|anesthetics, general|mesh-ancestor
110997369|NCT04448457|Anesthetics|anesthetics|mesh-ancestor
110997370|NCT05384743|Rituximab|rituximab|mesh-list
110997371|NCT05384743|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110997372|NCT05384743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110997373|NCT05384743|Immunologic Factors|immunologic factors|mesh-ancestor
110997374|NCT05384743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110997375|NCT05384743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110997376|NCT03414333|Hormones|hormones|mesh-list
110997377|NCT03414333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110997378|NCT03414333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110997379|NCT03617029|Ethiodized Oil|ethiodized oil|mesh-list
110997380|NCT03617029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110997381|NCT03616639|Morphine|morphine|mesh-list
110997382|NCT03616639|Oxycodone|oxycodone|mesh-list
110997383|NCT03616639|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110997384|NCT03616639|Narcotics|narcotics|mesh-ancestor
110997385|NCT03616639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110997386|NCT03616639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110997387|NCT03616639|Analgesics|analgesics|mesh-ancestor
110997388|NCT03616639|Sensory System Agents|sensory system agents|mesh-ancestor
110997389|NCT03616639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110997390|NCT03616561|Apremilast|apremilast|mesh-list
110997391|NCT03616561|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110997392|NCT03616561|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110997393|NCT03616561|Analgesics|analgesics|mesh-ancestor
110997394|NCT03616561|Sensory System Agents|sensory system agents|mesh-ancestor
110997395|NCT03616561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110997396|NCT03616561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110997397|NCT03616561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110997398|NCT03616561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110997399|NCT03616561|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
110997400|NCT03616561|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110997401|NCT03616561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110997402|NCT03616561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110997403|NCT03615313|Antibodies|antibodies|mesh-list
110997404|NCT03615313|Immunologic Factors|immunologic factors|mesh-ancestor
110997405|NCT03615313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110997406|NCT03617575|Lactoferrin|lactoferrin|mesh-list
110997407|NCT03617575|Fesoterodine|fesoterodine|mesh-list
110997408|NCT03617575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110997409|NCT03617575|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110997410|NCT03617575|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110997411|NCT03617575|Cholinergic Agents|cholinergic agents|mesh-ancestor
110997412|NCT03617575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110997413|NCT03617575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110997414|NCT03617575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110997415|NCT03617575|Urological Agents|urological agents|mesh-ancestor
110997416|NCT02983617|Obinutuzumab|obinutuzumab|mesh-list
110997417|NCT02983617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110997418|NCT02983617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110997419|NCT03616405|Amoxicillin|amoxicillin|mesh-list
110997420|NCT03616405|Tetracycline|tetracycline|mesh-list
110997421|NCT03616405|Furazolidone|furazolidone|mesh-list
110997422|NCT03616405|Rabeprazole|rabeprazole|mesh-list
110997423|NCT03616405|Bismuth|bismuth|mesh-list
110997424|NCT03616405|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110997425|NCT03616405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110997426|NCT03616405|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110997427|NCT03616405|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110997428|NCT03616405|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110997429|NCT03616405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110997430|NCT03616405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110997431|NCT03616405|Antacids|antacids|mesh-ancestor
110997432|NCT03616405|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110997433|NCT03616405|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110997434|NCT03616405|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110997435|NCT03616405|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
110997436|NCT03616405|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110997437|NCT03616405|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110997438|NCT03616405|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
110997439|NCT03419559|Durvalumab|durvalumab|mesh-list
110997440|NCT03419559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110997441|NCT03419559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110997442|NCT02873689|Dexlansoprazole|dexlansoprazole|mesh-list
110997443|NCT02873689|Lansoprazole|lansoprazole|mesh-list
110997444|NCT02873689|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110997445|NCT02873689|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110997446|NCT02873689|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110997447|NCT02873689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110997448|NCT02873689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110997449|NCT02873377|Nicotine|nicotine|mesh-list
110997450|NCT02873377|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110997451|NCT02873377|Autonomic Agents|autonomic agents|mesh-ancestor
110997452|NCT02873377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110997453|NCT02873377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110997454|NCT02873377|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110997455|NCT02873377|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110997456|NCT02873377|Cholinergic Agents|cholinergic agents|mesh-ancestor
110997457|NCT02873377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110997458|NCT02873377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110997459|NCT03647579|Midazolam|midazolam|mesh-list
110997460|NCT03647579|Dexmedetomidine|dexmedetomidine|mesh-list
110997461|NCT03647579|Ketamine|ketamine|mesh-list
110997462|NCT03647579|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110997463|NCT03647579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110997464|NCT03647579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110997465|NCT03647579|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110997466|NCT03647579|Analgesics|analgesics|mesh-ancestor
110997467|NCT03647579|Sensory System Agents|sensory system agents|mesh-ancestor
110997468|NCT03647579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110997469|NCT03647579|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110997470|NCT03647579|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110997471|NCT03647579|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110997472|NCT03647579|Adrenergic Agents|adrenergic agents|mesh-ancestor
110997473|NCT03647579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110997474|NCT03647579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110997475|NCT03647579|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110997476|NCT03647579|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110997477|NCT03647579|Anesthetics, General|anesthetics, general|mesh-ancestor
110997478|NCT03647579|Anesthetics|anesthetics|mesh-ancestor
110997479|NCT03647579|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110997480|NCT03647579|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110997481|NCT03647579|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110997482|NCT03647579|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110997483|NCT03647579|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110997484|NCT03647579|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110997485|NCT03647579|GABA Modulators|gaba modulators|mesh-ancestor
110997486|NCT03647579|GABA Agents|gaba agents|mesh-ancestor
110997487|NCT04046861|Ascorbic Acid|ascorbic acid|mesh-list
110997488|NCT04046861|Vitamins|vitamins|mesh-ancestor
110997489|NCT04046861|Micronutrients|micronutrients|mesh-ancestor
110997490|NCT04046861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110997491|NCT04046861|Antioxidants|antioxidants|mesh-ancestor
110997492|NCT04046861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110997493|NCT04046861|Protective Agents|protective agents|mesh-ancestor
110997494|NCT02236741|Pramipexole|pramipexole|mesh-list
110997495|NCT02236741|Antioxidants|antioxidants|mesh-ancestor
110997496|NCT02236741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110997497|NCT02236741|Protective Agents|protective agents|mesh-ancestor
110997498|NCT02236741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110997499|NCT02236741|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110997500|NCT02236741|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110997501|NCT02236741|Dopamine Agonists|dopamine agonists|mesh-ancestor
110997502|NCT02236741|Dopamine Agents|dopamine agents|mesh-ancestor
110997503|NCT02236741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110997504|NCT03648671|Rasagiline|rasagiline|mesh-list
110997505|NCT03648671|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
110997506|NCT03648671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110997507|NCT03648671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110997508|NCT03648671|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110997509|NCT03648671|Protective Agents|protective agents|mesh-ancestor
110997510|NCT03648671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110997511|NCT03647423|Cyclophosphamide|cyclophosphamide|mesh-list
110997512|NCT03647423|Cetuximab|cetuximab|mesh-list
110997513|NCT03647423|Avelumab|avelumab|mesh-list
110997514|NCT03647423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110997515|NCT03647423|Immunologic Factors|immunologic factors|mesh-ancestor
110997516|NCT03647423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110997517|NCT03647423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110997518|NCT03647423|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110997519|NCT03647423|Alkylating Agents|alkylating agents|mesh-ancestor
110997520|NCT03647423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110997521|NCT03647423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110997522|NCT03647423|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110997523|NCT03647423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110997524|NCT04052711|Minocycline|minocycline|mesh-list
110997525|NCT04052711|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110997526|NCT04052711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110997527|NCT03621683|Antioxidants|antioxidants|mesh-list
110997528|NCT03621683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110997529|NCT03621683|Protective Agents|protective agents|mesh-ancestor
110997530|NCT03621683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110997531|NCT03614065|Endostar protein|endostar protein|mesh-list
110997532|NCT03614065|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
110997533|NCT03614065|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110997534|NCT03614065|Growth Substances|growth substances|mesh-ancestor
110997535|NCT03614065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110997536|NCT03614065|Growth Inhibitors|growth inhibitors|mesh-ancestor
110997537|NCT03614065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110997538|NCT03621527|Remifentanil|remifentanil|mesh-list
110997539|NCT03621527|Anesthetics|anesthetics|mesh-list
110997540|NCT03621527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110997541|NCT03621527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110997542|NCT03621527|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110997543|NCT03621527|Narcotics|narcotics|mesh-ancestor
110997544|NCT03621527|Analgesics|analgesics|mesh-ancestor
110452817|NCT04209166|Sympathomimetics|sympathomimetics|mesh-ancestor
110997545|NCT03621527|Sensory System Agents|sensory system agents|mesh-ancestor
110997546|NCT03621527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110997547|NCT03646721|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110997548|NCT03646721|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110997549|NCT03646721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110997550|NCT03646721|Incretins|incretins|mesh-ancestor
110997551|NCT03646721|Hormones|hormones|mesh-ancestor
110997552|NCT03646721|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110997553|NCT03646721|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110997554|NCT03646721|Protease Inhibitors|protease inhibitors|mesh-ancestor
110997555|NCT03646721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110997556|NCT03646721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110997557|NCT03613753|Irinotecan|irinotecan|mesh-list
110997558|NCT03613753|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110997559|NCT03613753|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110997560|NCT03613753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110997561|NCT03613753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110997562|NCT03613753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110997563|NCT04051853|Sorafenib|sorafenib|mesh-list
110997564|NCT04051853|Midazolam|midazolam|mesh-list
110997565|NCT04051853|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110997566|NCT04051853|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110997567|NCT04051853|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110997568|NCT04051853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110997569|NCT04051853|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110997570|NCT04051853|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110997571|NCT04051853|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110997572|NCT04051853|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110997573|NCT04051853|Anesthetics, General|anesthetics, general|mesh-ancestor
110997574|NCT04051853|Anesthetics|anesthetics|mesh-ancestor
110997575|NCT04051853|GABA Modulators|gaba modulators|mesh-ancestor
110997576|NCT04051853|GABA Agents|gaba agents|mesh-ancestor
110997577|NCT04051853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110997578|NCT04051853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110997579|NCT04051853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110997580|NCT04051853|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110997581|NCT04051853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110997582|NCT03643757|Bupivacaine|bupivacaine|mesh-list
110997583|NCT03643757|Anesthetics, Local|anesthetics, local|mesh-ancestor
110997584|NCT03643757|Anesthetics|anesthetics|mesh-ancestor
110997585|NCT03643757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110997586|NCT03643757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110997587|NCT03643757|Sensory System Agents|sensory system agents|mesh-ancestor
110997588|NCT03643757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110997589|NCT03718793|Nitric Oxide|nitric oxide|mesh-list
110997590|NCT03718793|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110997591|NCT03718793|Autonomic Agents|autonomic agents|mesh-ancestor
110997592|NCT03718793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110997593|NCT03718793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110997594|NCT03718793|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110997595|NCT03718793|Respiratory System Agents|respiratory system agents|mesh-ancestor
110997596|NCT03718793|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110997597|NCT03718793|Antioxidants|antioxidants|mesh-ancestor
110997598|NCT03718793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110997599|NCT03718793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110997600|NCT03718793|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
110997601|NCT03718793|Vasodilator Agents|vasodilator agents|mesh-ancestor
110997602|NCT03718793|Gasotransmitters|gasotransmitters|mesh-ancestor
110997603|NCT03718793|Protective Agents|protective agents|mesh-ancestor
110997604|NCT02962739|Tenofovir|tenofovir|mesh-list
110997605|NCT02962739|Emtricitabine|emtricitabine|mesh-list
110997606|NCT02962739|Antiviral Agents|antiviral agents|mesh-ancestor
110997607|NCT02962739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110997608|NCT02962739|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110997609|NCT02962739|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110997610|NCT02962739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110997611|NCT02962739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110997612|NCT02962739|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110997613|NCT02962739|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110997614|NCT01344629|Telmisartan|telmisartan|mesh-list
110452823|NCT04209166|Serotonin Agents|serotonin agents|mesh-ancestor
110997615|NCT01344629|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110997616|NCT01344629|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110997617|NCT01344629|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110997618|NCT01344629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110997619|NCT03642665|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110997620|NCT03642665|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110997621|NCT03642665|Estradiol|estradiol|mesh-list
110997622|NCT03642665|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110997623|NCT03642665|Progesterone|progesterone|mesh-list
110997624|NCT03642665|Estrogens|estrogens|mesh-ancestor
110997625|NCT03642665|Hormones|hormones|mesh-ancestor
110997626|NCT03642665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110997627|NCT03642665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110997628|NCT03642665|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110997629|NCT03642665|Contraceptive Agents|contraceptive agents|mesh-ancestor
110997630|NCT03642665|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110997631|NCT03642665|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110997632|NCT03642665|Progestins|progestins|mesh-ancestor
110997633|NCT03642509|Rivaroxaban|rivaroxaban|mesh-list
110997634|NCT03642509|Apixaban|apixaban|mesh-list
110997635|NCT03642509|Edoxaban|edoxaban|mesh-list
110997636|NCT03642509|Dabigatran|dabigatran|mesh-list
110997637|NCT03642509|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110997638|NCT03642509|Antithrombins|antithrombins|mesh-ancestor
110997639|NCT03642509|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110997640|NCT03642509|Protease Inhibitors|protease inhibitors|mesh-ancestor
110997641|NCT03642509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110997642|NCT03642509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110997643|NCT03642509|Anticoagulants|anticoagulants|mesh-ancestor
110997644|NCT03642353|Listerine|listerine|mesh-list
110997645|NCT03642353|Triclosan|triclosan|mesh-list
110997646|NCT03642353|Sodium Fluoride|sodium fluoride|mesh-list
110997647|NCT03642353|Cariostatic Agents|cariostatic agents|mesh-ancestor
110997648|NCT03642353|Protective Agents|protective agents|mesh-ancestor
110997649|NCT03642353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110997650|NCT03642353|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110997651|NCT03642353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110997652|NCT03642353|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
110997653|NCT03642353|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110997654|NCT03642353|Antimetabolites|antimetabolites|mesh-ancestor
110997655|NCT03642353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110997656|NCT03642353|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110997657|NCT03424707|Eperisone|eperisone|mesh-list
110997658|NCT03424707|Anticonvulsants|anticonvulsants|mesh-ancestor
110997659|NCT03424707|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110997660|NCT03424707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110997661|NCT03424707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110997662|NCT03424707|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110997663|NCT03424707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110997664|NCT03424707|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110997665|NCT03424707|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110997666|NCT03424707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110997667|NCT03424707|Parasympatholytics|parasympatholytics|mesh-ancestor
110997668|NCT03424707|Autonomic Agents|autonomic agents|mesh-ancestor
110997669|NCT03424707|Vasodilator Agents|vasodilator agents|mesh-ancestor
110997670|NCT05174351|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
110997671|NCT05174351|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110997672|NCT05174351|Adrenergic Agents|adrenergic agents|mesh-ancestor
110997673|NCT05174351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110997674|NCT05174351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110997675|NCT05174351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110997676|NCT03418935|Niacinamide|niacinamide|mesh-list
110997677|NCT03418935|Niacin|niacin|mesh-list
110997678|NCT03418935|Nicotinic Acids|nicotinic acids|mesh-list
110997679|NCT03418935|Vitamin B Complex|vitamin b complex|mesh-ancestor
110997680|NCT03418935|Vitamins|vitamins|mesh-ancestor
110997681|NCT03418935|Micronutrients|micronutrients|mesh-ancestor
110997682|NCT03418935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110997683|NCT03418935|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110997684|NCT03418935|Antimetabolites|antimetabolites|mesh-ancestor
110997685|NCT03418935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110997686|NCT03418935|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110997687|NCT03418935|Vasodilator Agents|vasodilator agents|mesh-ancestor
110997688|NCT03413319|Tilavonemab|tilavonemab|mesh-list
110997689|NCT03413319|Nootropic Agents|nootropic agents|mesh-ancestor
110997690|NCT03424629|Methotrexate|methotrexate|mesh-list
110997691|NCT03424629|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110997692|NCT03424629|Abortifacient Agents|abortifacient agents|mesh-ancestor
110997693|NCT03424629|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110997694|NCT03424629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110997695|NCT03424629|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110997696|NCT03424629|Antimetabolites|antimetabolites|mesh-ancestor
110997697|NCT03424629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110997698|NCT03424629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110997699|NCT03424629|Dermatologic Agents|dermatologic agents|mesh-ancestor
110997700|NCT03424629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110997701|NCT03424629|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110997702|NCT03424629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110997703|NCT03424629|Immunologic Factors|immunologic factors|mesh-ancestor
110997704|NCT03424629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110997705|NCT03424629|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110997706|NCT03424473|Tucatinib|tucatinib|mesh-list
110997707|NCT03424473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110997708|NCT03424473|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110997709|NCT03424473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110997710|NCT03424473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110997711|NCT04448379|Osimertinib|osimertinib|mesh-list
110997712|NCT04448379|Afatinib|afatinib|mesh-list
110997713|NCT04448379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110997714|NCT04448379|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110997715|NCT04448379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110997716|NCT04448379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110997717|NCT04448223|Latanoprost|latanoprost|mesh-list
110997718|NCT04448223|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110997719|NCT04448223|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110997720|NCT03644147|Acetaminophen|acetaminophen|mesh-list
110997721|NCT03644147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110997722|NCT03644147|Analgesics|analgesics|mesh-ancestor
110997723|NCT03644147|Sensory System Agents|sensory system agents|mesh-ancestor
110997724|NCT03644147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110997725|NCT03644147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110997726|NCT03644147|Antipyretics|antipyretics|mesh-ancestor
110997727|NCT02743923|Paclitaxel|paclitaxel|mesh-list
110997728|NCT02743923|Bevacizumab|bevacizumab|mesh-list
110997729|NCT02743923|Carboplatin|carboplatin|mesh-list
110997730|NCT02743923|Pemetrexed|pemetrexed|mesh-list
110997731|NCT02743923|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110997732|NCT02743923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110997733|NCT02743923|Tubulin Modulators|tubulin modulators|mesh-ancestor
110997734|NCT02743923|Antimitotic Agents|antimitotic agents|mesh-ancestor
110997735|NCT02743923|Mitosis Modulators|mitosis modulators|mesh-ancestor
110997736|NCT02743923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110997737|NCT02743923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110997738|NCT02743923|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110997739|NCT02743923|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110997740|NCT02743923|Growth Substances|growth substances|mesh-ancestor
110997741|NCT02743923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110997742|NCT02743923|Growth Inhibitors|growth inhibitors|mesh-ancestor
110997743|NCT02743923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110997744|NCT02743923|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110997745|NCT02743923|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110997746|NCT01065779|Alendronate|alendronate|mesh-list
110997747|NCT01065779|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110997748|NCT01065779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110997749|NCT02357966|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110997750|NCT02357966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110997751|NCT03570359|Interferons|interferons|mesh-list
110997752|NCT03570359|Interferon-beta|interferon-beta|mesh-list
110997753|NCT03570359|Interferon beta-1a|interferon beta-1a|mesh-list
110997754|NCT03570359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110997755|NCT03570359|Antiviral Agents|antiviral agents|mesh-ancestor
110997756|NCT03570359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110997757|NCT03570359|Immunologic Factors|immunologic factors|mesh-ancestor
110997758|NCT03570359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110997759|NCT03570359|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110997760|NCT02358200|Paclitaxel|paclitaxel|mesh-list
110997761|NCT02358200|Carboplatin|carboplatin|mesh-list
110997762|NCT02358200|Talazoparib|talazoparib|mesh-list
110997763|NCT02358200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110997764|NCT02358200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110997765|NCT02358200|Tubulin Modulators|tubulin modulators|mesh-ancestor
110997766|NCT02358200|Antimitotic Agents|antimitotic agents|mesh-ancestor
110997767|NCT02358200|Mitosis Modulators|mitosis modulators|mesh-ancestor
110997768|NCT02358200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110997769|NCT02358200|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110997770|NCT02358200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110997771|NCT03413007|Antigen-Antibody Complex|antigen-antibody complex|mesh-list
110997772|NCT03413007|Immunologic Factors|immunologic factors|mesh-ancestor
110997773|NCT03413007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110997774|NCT03127605|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
110997775|NCT03127605|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110997776|NCT03127605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110997777|NCT03127605|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110997778|NCT03127605|Immunotoxins|immunotoxins|mesh-ancestor
110997779|NCT03127605|Immunoconjugates|immunoconjugates|mesh-ancestor
110997780|NCT03127605|Immunologic Factors|immunologic factors|mesh-ancestor
110997781|NCT03127605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110997782|NCT03112538|Insulin|insulin|mesh-list
110997783|NCT03112538|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110997784|NCT03112538|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110997785|NCT03112538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110997786|NCT05283551|Famciclovir|famciclovir|mesh-list
110997787|NCT05283551|Antiviral Agents|antiviral agents|mesh-ancestor
110997788|NCT05283551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110997789|NCT05283551|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110997790|NCT05283551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110997791|NCT05283551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110997792|NCT02357732|Nivolumab|nivolumab|mesh-list
110997793|NCT02357732|Trametinib|trametinib|mesh-list
110997794|NCT02357732|Dabrafenib|dabrafenib|mesh-list
110997795|NCT02357732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110997796|NCT02357732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110997797|NCT02357732|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110997798|NCT02357732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110997799|NCT02357732|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110997800|NCT02357732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110997801|NCT03112148|Tofacitinib|tofacitinib|mesh-list
110997802|NCT03112148|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
110997803|NCT03112148|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110997804|NCT03112148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110997805|NCT03112148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110997807|NCT03423849|Capecitabine|capecitabine|mesh-list
110997808|NCT03423849|Vinorelbine|vinorelbine|mesh-list
110997809|NCT03423849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110997810|NCT03423849|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110997811|NCT03423849|Antimetabolites|antimetabolites|mesh-ancestor
110997812|NCT03423849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110714832|NCT01108588|Aspirin|aspirin|mesh-list
110997813|NCT03423849|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110997814|NCT03423849|Tubulin Modulators|tubulin modulators|mesh-ancestor
110997815|NCT03423849|Antimitotic Agents|antimitotic agents|mesh-ancestor
110997816|NCT03423849|Mitosis Modulators|mitosis modulators|mesh-ancestor
110997817|NCT02362490|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110997818|NCT02362490|Antiviral Agents|antiviral agents|mesh-ancestor
110997819|NCT02362490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110997820|NCT02362256|Clonidine|clonidine|mesh-list
110997821|NCT02362256|Naltrexone|naltrexone|mesh-list
110997822|NCT02362256|Lorazepam|lorazepam|mesh-list
110997823|NCT02362256|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110997824|NCT02362256|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110997825|NCT02362256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110997826|NCT02362256|Sensory System Agents|sensory system agents|mesh-ancestor
110997827|NCT02362256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110997828|NCT02362256|Analgesics|analgesics|mesh-ancestor
110997829|NCT02362256|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110997830|NCT02362256|Sympatholytics|sympatholytics|mesh-ancestor
110997831|NCT02362256|Autonomic Agents|autonomic agents|mesh-ancestor
110997832|NCT02362256|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110997833|NCT02362256|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110997834|NCT02362256|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110997835|NCT02362256|Adrenergic Agents|adrenergic agents|mesh-ancestor
110997836|NCT02362256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110997837|NCT02362256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110997838|NCT02362256|Anticonvulsants|anticonvulsants|mesh-ancestor
110997839|NCT02362256|Antiemetics|antiemetics|mesh-ancestor
110997840|NCT02362256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110997841|NCT02362256|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110997842|NCT02362256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110997843|NCT02362256|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110997844|NCT02362256|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110997845|NCT02362256|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110997846|NCT02362256|GABA Modulators|gaba modulators|mesh-ancestor
110997847|NCT02362256|GABA Agents|gaba agents|mesh-ancestor
110997848|NCT03412305|Amoxicillin|amoxicillin|mesh-list
110997849|NCT03412305|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110997850|NCT03412305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110997851|NCT02109081|Dexamethasone|dexamethasone|mesh-list
110997852|NCT02109081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110997853|NCT02109081|Antiemetics|antiemetics|mesh-ancestor
110997854|NCT02109081|Autonomic Agents|autonomic agents|mesh-ancestor
110997855|NCT02109081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110997856|NCT02109081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110997857|NCT02109081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110997858|NCT02109081|Glucocorticoids|glucocorticoids|mesh-ancestor
110997859|NCT02109081|Hormones|hormones|mesh-ancestor
110997860|NCT02109081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110997861|NCT02109081|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110997862|NCT02109081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110997863|NCT04259996|Estradiol|estradiol|mesh-list
110997864|NCT04259996|Progesterone|progesterone|mesh-list
110997865|NCT04259996|Estrogens|estrogens|mesh-ancestor
110997866|NCT04259996|Hormones|hormones|mesh-ancestor
110997867|NCT04259996|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110997868|NCT04259996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110997869|NCT04259996|Progestins|progestins|mesh-ancestor
110997870|NCT03417453|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110997871|NCT03417453|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110997872|NCT04795557|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110997873|NCT03397875|Zinc Oxide|zinc oxide|mesh-list
110997874|NCT03397875|Dermatologic Agents|dermatologic agents|mesh-ancestor
110997875|NCT03397875|Sunscreening Agents|sunscreening agents|mesh-ancestor
110997876|NCT03397875|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110997877|NCT03397875|Protective Agents|protective agents|mesh-ancestor
110997878|NCT03397875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110997879|NCT02362022|Morphine|morphine|mesh-list
110997880|NCT02362022|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110997881|NCT02362022|Narcotics|narcotics|mesh-ancestor
110997882|NCT02362022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110997883|NCT02362022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110997884|NCT02362022|Analgesics|analgesics|mesh-ancestor
110997885|NCT02362022|Sensory System Agents|sensory system agents|mesh-ancestor
110997886|NCT02362022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110997887|NCT03412071|Metronidazole|metronidazole|mesh-list
110997888|NCT03412071|Clindamycin|clindamycin|mesh-list
110997889|NCT03412071|Clindamycin palmitate|clindamycin palmitate|mesh-list
110997890|NCT03412071|Clindamycin phosphate|clindamycin phosphate|mesh-list
110997891|NCT03412071|Hydrogen Peroxide|hydrogen peroxide|mesh-list
110997892|NCT03412071|Tinidazole|tinidazole|mesh-list
110997893|NCT03412071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110997894|NCT03412071|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110997895|NCT03412071|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110997896|NCT03412071|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110997897|NCT03412071|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110997898|NCT03412071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110997899|NCT03412071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110997900|NCT03412071|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110997901|NCT03412071|Alkylating Agents|alkylating agents|mesh-ancestor
110997902|NCT03412071|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
110997903|NCT03397797|Rocuronium|rocuronium|mesh-list
110997904|NCT03397797|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110452838|NCT00916149|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110997905|NCT03397797|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110997906|NCT03397797|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110997907|NCT03397797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110997908|NCT03397797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110997909|NCT05170581|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
110997910|NCT05170581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110997911|NCT05170581|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110997912|NCT05170581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110997913|NCT02351882|Nabilone|nabilone|mesh-list
110997914|NCT02351882|Antiemetics|antiemetics|mesh-ancestor
110997915|NCT02351882|Autonomic Agents|autonomic agents|mesh-ancestor
110997916|NCT02351882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110997917|NCT02351882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110997918|NCT02351882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110997919|NCT02351882|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110997920|NCT02351882|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110997921|NCT02351882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110997922|NCT02351882|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110997923|NCT02356640|Levobupivacaine|levobupivacaine|mesh-list
110997924|NCT02356640|Anesthetics, Local|anesthetics, local|mesh-ancestor
110997925|NCT02356640|Anesthetics|anesthetics|mesh-ancestor
110997926|NCT02356640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110997927|NCT02356640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110997928|NCT02356640|Sensory System Agents|sensory system agents|mesh-ancestor
110997929|NCT02356640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110997930|NCT05169801|Paclitaxel|paclitaxel|mesh-list
110997931|NCT05169801|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110997932|NCT05169801|Carboplatin|carboplatin|mesh-list
110997933|NCT05169801|Bevacizumab|bevacizumab|mesh-list
110997934|NCT05169801|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110997935|NCT05169801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110997936|NCT05169801|Tubulin Modulators|tubulin modulators|mesh-ancestor
110997937|NCT05169801|Antimitotic Agents|antimitotic agents|mesh-ancestor
110997938|NCT05169801|Mitosis Modulators|mitosis modulators|mesh-ancestor
110997939|NCT05169801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110997940|NCT05169801|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110997941|NCT05169801|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110997942|NCT05169801|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110997943|NCT05169801|Growth Substances|growth substances|mesh-ancestor
110997944|NCT05169801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110997945|NCT05169801|Growth Inhibitors|growth inhibitors|mesh-ancestor
110997946|NCT04447443|Loperamide|loperamide|mesh-list
110997947|NCT04447443|Antidiarrheals|antidiarrheals|mesh-list
110997948|NCT04447443|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110997949|NCT02356328|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110997950|NCT02356328|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110997951|NCT01345253|Belimumab|belimumab|mesh-list
110997952|NCT01345253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110997953|NCT01345253|Immunologic Factors|immunologic factors|mesh-ancestor
110997954|NCT01345253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110997955|NCT03397329|Mitapivat|mitapivat|mesh-list
110997956|NCT03397329|Enzyme Activators|enzyme activators|mesh-ancestor
110997957|NCT03397329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110997958|NCT03150134|Cyclosporine|cyclosporine|mesh-list
110997959|NCT03150134|Cyclosporins|cyclosporins|mesh-list
110997960|NCT03150134|Immunosuppressive Agents|immunosuppressive agents|mesh-list
110997961|NCT03150134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110997962|NCT03150134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110997963|NCT03150134|Immunologic Factors|immunologic factors|mesh-ancestor
110997964|NCT03150134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110997965|NCT03150134|Antifungal Agents|antifungal agents|mesh-ancestor
110997966|NCT03150134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110997967|NCT03150134|Dermatologic Agents|dermatologic agents|mesh-ancestor
110997968|NCT03150134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110997969|NCT03150134|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110997970|NCT03411369|Vitamins|vitamins|mesh-list
110997971|NCT03411369|Micronutrients|micronutrients|mesh-ancestor
110997972|NCT03411369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110997973|NCT04653207|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110997974|NCT02351804|Dexamethasone|dexamethasone|mesh-list
110997975|NCT02351804|Ropivacaine|ropivacaine|mesh-list
110997976|NCT02351804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110997977|NCT02351804|Antiemetics|antiemetics|mesh-ancestor
110997978|NCT02351804|Autonomic Agents|autonomic agents|mesh-ancestor
110997979|NCT02351804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110997980|NCT02351804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110997981|NCT02351804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110997982|NCT02351804|Glucocorticoids|glucocorticoids|mesh-ancestor
110997983|NCT02351804|Hormones|hormones|mesh-ancestor
110997984|NCT02351804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110997985|NCT02351804|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110997986|NCT02351804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110997987|NCT02351804|Anesthetics, Local|anesthetics, local|mesh-ancestor
110997988|NCT02351804|Anesthetics|anesthetics|mesh-ancestor
110997989|NCT02351804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110997990|NCT02351804|Sensory System Agents|sensory system agents|mesh-ancestor
110997991|NCT03640403|Artesunate|artesunate|mesh-list
110997992|NCT03640403|Piperaquine|piperaquine|mesh-list
110997993|NCT03640403|Amodiaquine|amodiaquine|mesh-list
110997994|NCT03640403|Artenimol|artenimol|mesh-list
110997995|NCT03640403|Antimalarials|antimalarials|mesh-ancestor
110997996|NCT03640403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110997997|NCT03640403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110997998|NCT03640403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110997999|NCT03640403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110998000|NCT03640403|Antiviral Agents|antiviral agents|mesh-ancestor
110998001|NCT03640403|Schistosomicides|schistosomicides|mesh-ancestor
110998002|NCT03640403|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110998003|NCT03640403|Anthelmintics|anthelmintics|mesh-ancestor
110998004|NCT02355938|Vancomycin|vancomycin|mesh-list
110998005|NCT02355938|Fidaxomicin|fidaxomicin|mesh-list
110998006|NCT02355938|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110998007|NCT02355938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110998008|NCT03397173|Ascorbic Acid|ascorbic acid|mesh-list
110998009|NCT03397173|Azacitidine|azacitidine|mesh-list
110998010|NCT03397173|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110998011|NCT03397173|Antimetabolites|antimetabolites|mesh-ancestor
110998012|NCT03397173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110998013|NCT03397173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110998014|NCT03397173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110998015|NCT03397173|Antioxidants|antioxidants|mesh-ancestor
110998016|NCT03397173|Protective Agents|protective agents|mesh-ancestor
110998017|NCT03397173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110998018|NCT03397173|Vitamins|vitamins|mesh-ancestor
110998019|NCT03397173|Micronutrients|micronutrients|mesh-ancestor
110998020|NCT03640247|Acetaminophen|acetaminophen|mesh-list
110998021|NCT03640247|Ibuprofen|ibuprofen|mesh-list
110998022|NCT03640247|Oxycodone|oxycodone|mesh-list
110998023|NCT03640247|Tramadol|tramadol|mesh-list
110998024|NCT03640247|Hydrocodone|hydrocodone|mesh-list
110998025|NCT03640247|Narcotics|narcotics|mesh-list
110998026|NCT03640247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110998027|NCT03640247|Analgesics|analgesics|mesh-ancestor
110998028|NCT03640247|Sensory System Agents|sensory system agents|mesh-ancestor
110998029|NCT03640247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110998030|NCT03640247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110998031|NCT03640247|Antipyretics|antipyretics|mesh-ancestor
110998032|NCT03640247|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110998033|NCT03640247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110998034|NCT03640247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110998035|NCT03640247|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110998036|NCT03640247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110998037|NCT03640247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110998038|NCT03640247|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110998039|NCT03640247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110998040|NCT03640247|Antitussive Agents|antitussive agents|mesh-ancestor
110998041|NCT03640247|Respiratory System Agents|respiratory system agents|mesh-ancestor
110998042|NCT03394131|Insulin|insulin|mesh-list
110715061|NCT01212250|Antioxidants|antioxidants|mesh-ancestor
110998043|NCT03394131|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110998044|NCT03394131|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110998045|NCT03394131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110998046|NCT02360618|Metformin|metformin|mesh-list
110998047|NCT02360618|Simvastatin|simvastatin|mesh-list
110998048|NCT02360618|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110998049|NCT02360618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110998050|NCT02360618|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110998051|NCT02360618|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110998052|NCT02360618|Antimetabolites|antimetabolites|mesh-ancestor
110998053|NCT02360618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110998054|NCT02360618|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110998055|NCT02360618|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110998056|NCT02360618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110998057|NCT05214183|Rituximab|rituximab|mesh-list
110998058|NCT05214183|Acalabrutinib|acalabrutinib|mesh-list
110998059|NCT05214183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110998060|NCT05214183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110998061|NCT05214183|Immunologic Factors|immunologic factors|mesh-ancestor
110998062|NCT05214183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110998063|NCT05214183|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110998064|NCT01344161|Vitamin D|vitamin d|mesh-list
110998065|NCT01344161|Cholecalciferol|cholecalciferol|mesh-list
110998066|NCT01344161|Vitamins|vitamins|mesh-ancestor
110998067|NCT01344161|Micronutrients|micronutrients|mesh-ancestor
110998068|NCT01344161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110998069|NCT01344161|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110998070|NCT01344161|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110998071|NCT02451358|Vaccines|vaccines|mesh-list
110998072|NCT02451358|Immunologic Factors|immunologic factors|mesh-ancestor
110998073|NCT02451358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110998074|NCT02360384|Linaclotide|linaclotide|mesh-list
110998075|NCT02360384|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
110998076|NCT02360384|Enzyme Activators|enzyme activators|mesh-ancestor
110998077|NCT02360384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110998078|NCT02360384|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110998079|NCT03396861|Aflibercept|aflibercept|mesh-list
110998080|NCT03396861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110998081|NCT03396861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110998082|NCT03396861|Growth Substances|growth substances|mesh-ancestor
110998083|NCT03396861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110998084|NCT03396861|Growth Inhibitors|growth inhibitors|mesh-ancestor
110998085|NCT03396861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110998086|NCT02749721|Vortioxetine|vortioxetine|mesh-list
110998087|NCT02749721|Antidepressive Agents|antidepressive agents|mesh-ancestor
110998088|NCT02749721|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110998089|NCT02749721|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110998090|NCT02749721|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110998091|NCT02749721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110998092|NCT02749721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110998093|NCT02749721|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110998094|NCT02749721|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110998095|NCT02749721|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110998096|NCT02749721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110998097|NCT02749721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110998098|NCT02749721|Serotonin Agents|serotonin agents|mesh-ancestor
110998099|NCT02749721|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110998100|NCT02749721|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110998101|NCT02749721|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110998102|NCT02749721|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110998103|NCT02351102|Valacyclovir|valacyclovir|mesh-list
110998104|NCT02351102|Antiviral Agents|antiviral agents|mesh-ancestor
110998105|NCT02351102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110998106|NCT02351024|Naproxen|naproxen|mesh-list
110998107|NCT02351024|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110998108|NCT02351024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110998109|NCT02351024|Analgesics|analgesics|mesh-ancestor
110998110|NCT02351024|Sensory System Agents|sensory system agents|mesh-ancestor
110998111|NCT02351024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110998112|NCT02351024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110998114|NCT02351024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110998115|NCT02351024|Gout Suppressants|gout suppressants|mesh-ancestor
110998116|NCT02351024|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110998117|NCT02351024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110998118|NCT02351024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110998119|NCT02355704|Atorvastatin|atorvastatin|mesh-list
110998120|NCT02355704|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110998121|NCT02355704|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110998122|NCT02355704|Antimetabolites|antimetabolites|mesh-ancestor
110998123|NCT02355704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110998124|NCT02355704|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110998125|NCT02355704|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110998126|NCT02355704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110998127|NCT03396393|Artenimol|artenimol|mesh-list
110998128|NCT03396393|Antimalarials|antimalarials|mesh-ancestor
110998129|NCT03396393|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110998130|NCT03396393|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110998131|NCT03396393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110998132|NCT03393819|Ethanol|ethanol|mesh-list
110998133|NCT03393819|Chlorhexidine|chlorhexidine|mesh-list
110998134|NCT03393819|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110998135|NCT03393819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110998136|NCT03393819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110998137|NCT03393819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110998138|NCT03393819|Disinfectants|disinfectants|mesh-ancestor
110998139|NCT03393507|Apatinib|apatinib|mesh-list
110998140|NCT03393507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110998141|NCT03393507|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110998142|NCT03393507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110998143|NCT03393507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110998144|NCT01348139|AZD-3199|azd-3199|mesh-list
110998145|NCT01348139|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110998146|NCT01348139|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110998147|NCT01348139|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110998148|NCT01348139|Adrenergic Agents|adrenergic agents|mesh-ancestor
110998149|NCT01348139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110998150|NCT01348139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110998151|NCT01348139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110998152|NCT02355236|Celecoxib|celecoxib|mesh-list
110998153|NCT02355236|Naproxen|naproxen|mesh-list
110998154|NCT02355236|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110998155|NCT02355236|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110998156|NCT02355236|Analgesics|analgesics|mesh-ancestor
110998157|NCT02355236|Sensory System Agents|sensory system agents|mesh-ancestor
110998158|NCT02355236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110998159|NCT02355236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110998160|NCT02355236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110998161|NCT02355236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110998162|NCT02355236|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110998163|NCT02355236|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110998164|NCT02355236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110998165|NCT02355236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110998166|NCT02355236|Gout Suppressants|gout suppressants|mesh-ancestor
110998167|NCT05169255|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110998168|NCT05169255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110998169|NCT02359604|Esomeprazole|esomeprazole|mesh-list
110998170|NCT02359604|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110998171|NCT02359604|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110998172|NCT02359604|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110998173|NCT02359604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110998174|NCT02359604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110998175|NCT03410511|Nicotine|nicotine|mesh-list
110998176|NCT03410511|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110998177|NCT03410511|Autonomic Agents|autonomic agents|mesh-ancestor
110998178|NCT03410511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110998179|NCT03410511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110998180|NCT03410511|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110998181|NCT03410511|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110998182|NCT03410511|Cholinergic Agents|cholinergic agents|mesh-ancestor
110998183|NCT03410511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110823014|NCT02710084|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110998184|NCT03410511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110998185|NCT05169021|Folic Acid|folic acid|mesh-list
110998186|NCT05169021|Vitamin B Complex|vitamin b complex|mesh-list
110998187|NCT05169021|Amlodipine|amlodipine|mesh-list
110452857|NCT04213222|Bevacizumab|bevacizumab|mesh-list
110998188|NCT05169021|Antihypertensive Agents|antihypertensive agents|mesh-list
110998189|NCT05169021|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110998190|NCT05169021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110998191|NCT05169021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110998192|NCT05169021|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110998193|NCT05169021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110998194|NCT05169021|Vasodilator Agents|vasodilator agents|mesh-ancestor
110998195|NCT05169021|Hematinics|hematinics|mesh-ancestor
110998196|NCT05169021|Vitamins|vitamins|mesh-ancestor
110998197|NCT05169021|Micronutrients|micronutrients|mesh-ancestor
110998198|NCT02359292|Charcoal|charcoal|mesh-list
110998199|NCT02359292|Antidotes|antidotes|mesh-ancestor
110998200|NCT02359292|Protective Agents|protective agents|mesh-ancestor
110998201|NCT02359292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110998202|NCT05168787|Valsartan|valsartan|mesh-list
110998203|NCT05168787|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
110998204|NCT05168787|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110998205|NCT05168787|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110998206|NCT05168787|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110998207|NCT05168787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110998208|NCT02359214|Vitamin D|vitamin d|mesh-list
110998209|NCT02359214|Cholecalciferol|cholecalciferol|mesh-list
110998210|NCT02359214|Vitamins|vitamins|mesh-ancestor
110998211|NCT02359214|Micronutrients|micronutrients|mesh-ancestor
110998212|NCT02359214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110998213|NCT02359214|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110998214|NCT02359214|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110998215|NCT02359370|Lidocaine|lidocaine|mesh-list
110998216|NCT02359370|Magnesium Sulfate|magnesium sulfate|mesh-list
110998217|NCT02359370|Anesthetics, Local|anesthetics, local|mesh-ancestor
110998218|NCT02359370|Anesthetics|anesthetics|mesh-ancestor
110998219|NCT02359370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110998220|NCT02359370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110998221|NCT02359370|Sensory System Agents|sensory system agents|mesh-ancestor
110998222|NCT02359370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110998223|NCT02359370|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110998224|NCT02359370|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110998225|NCT02359370|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110998226|NCT02359370|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110998227|NCT02359370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110998228|NCT02359370|Analgesics|analgesics|mesh-ancestor
110998229|NCT02359370|Anticonvulsants|anticonvulsants|mesh-ancestor
110998230|NCT02359370|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110998231|NCT02359370|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110998232|NCT02359370|Tocolytic Agents|tocolytic agents|mesh-ancestor
110998233|NCT02359370|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110998234|NCT02359448|Melatonin|melatonin|mesh-list
110998235|NCT02359448|Antioxidants|antioxidants|mesh-ancestor
110998236|NCT02359448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110998237|NCT02359448|Protective Agents|protective agents|mesh-ancestor
110998238|NCT02359448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110998239|NCT02359448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110998240|NCT02359526|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
110998241|NCT02359526|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110998242|NCT02359526|Glucocorticoids|glucocorticoids|mesh-ancestor
110998243|NCT02359526|Hormones|hormones|mesh-ancestor
110998244|NCT02359526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110998245|NCT02359526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110998246|NCT03618953|Atezolizumab|atezolizumab|mesh-list
110998247|NCT03618953|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110998248|NCT03618953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110998249|NCT03618953|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110998250|NCT03618953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110998251|NCT02354768|Lanreotide|lanreotide|mesh-list
110998252|NCT02354768|Loperamide|loperamide|mesh-list
110998253|NCT02354768|Antidiarrheals|antidiarrheals|mesh-list
110452864|NCT04213222|Growth Inhibitors|growth inhibitors|mesh-ancestor
110998254|NCT02354768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110998255|NCT02354768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110998256|NCT00000125|Antihypertensive Agents|antihypertensive agents|mesh-list
110998257|NCT00000125|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110998258|NCT00000125|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110998259|NCT02354612|Bevacizumab|bevacizumab|mesh-list
110998260|NCT02354612|Capecitabine|capecitabine|mesh-list
110998261|NCT02354612|Axitinib|axitinib|mesh-list
110998262|NCT02354612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110998263|NCT02354612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110998264|NCT02354612|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110998265|NCT02354612|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110998266|NCT02354612|Growth Substances|growth substances|mesh-ancestor
110998267|NCT02354612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110998268|NCT02354612|Growth Inhibitors|growth inhibitors|mesh-ancestor
110998269|NCT02354612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110998270|NCT02354612|Antimetabolites|antimetabolites|mesh-ancestor
110998271|NCT02354612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110998272|NCT02354612|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110998273|NCT02354612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110998274|NCT02348450|Irinotecan|irinotecan|mesh-list
110998275|NCT02348450|Etoposide|etoposide|mesh-list
110998276|NCT02348450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110998277|NCT02348450|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110998278|NCT02348450|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110998279|NCT02348450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110998280|NCT02348450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110998281|NCT02348450|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110998282|NCT02348450|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110998283|NCT03393273|Elotuzumab|elotuzumab|mesh-list
110998284|NCT03393273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110998285|NCT03613597|Etoposide|etoposide|mesh-list
110998286|NCT03613597|Etoposide phosphate|etoposide phosphate|mesh-list
110998287|NCT03613597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110998288|NCT03613597|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110998289|NCT03613597|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110998290|NCT03613597|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110998291|NCT03613597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110998292|NCT03613597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110998293|NCT02348372|Glycine|glycine|mesh-list
110998294|NCT02348372|Glycine Agents|glycine agents|mesh-ancestor
110998295|NCT02348372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110998296|NCT02348372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110998297|NCT02348372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110998298|NCT02031731|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110998299|NCT02031731|Immunologic Factors|immunologic factors|mesh-ancestor
110998300|NCT02031731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110998301|NCT03614533|Vaccines|vaccines|mesh-list
110998302|NCT03614533|Immunologic Factors|immunologic factors|mesh-ancestor
110998303|NCT03614533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110998304|NCT03147404|Avelumab|avelumab|mesh-list
110998305|NCT03147404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110998306|NCT03147404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110998307|NCT03614455|Itraconazole|itraconazole|mesh-list
110998308|NCT03614455|Posaconazole|posaconazole|mesh-list
110998309|NCT03614455|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-list
110998310|NCT03614455|Antifungal Agents|antifungal agents|mesh-ancestor
110998311|NCT03614455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110998312|NCT03614455|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110998313|NCT03614455|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110998314|NCT03614455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110998315|NCT03614455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110998316|NCT03614455|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110998317|NCT03614455|Hormone Antagonists|hormone antagonists|mesh-ancestor
110998318|NCT03614455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110998319|NCT03614455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110998320|NCT03614455|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
110998321|NCT03614455|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110998322|NCT03614455|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110998323|NCT03393117|Narcotics|narcotics|mesh-list
110998324|NCT03393117|Bupivacaine|bupivacaine|mesh-list
110998325|NCT03393117|Anesthetics, Local|anesthetics, local|mesh-ancestor
110998326|NCT03393117|Anesthetics|anesthetics|mesh-ancestor
110998327|NCT03393117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110998328|NCT03393117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110998329|NCT03393117|Sensory System Agents|sensory system agents|mesh-ancestor
110998330|NCT03393117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110998331|NCT03393117|Analgesics|analgesics|mesh-ancestor
110998333|NCT02032303|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
110998334|NCT02032303|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110998335|NCT02032303|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110998336|NCT02032303|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110998337|NCT02032303|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110998338|NCT02032303|Purinergic Agents|purinergic agents|mesh-ancestor
110998339|NCT02032303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110998340|NCT02032303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110998341|NCT02032303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110998342|NCT04297293|Ramosetron|ramosetron|mesh-list
110998343|NCT04297293|Antiemetics|antiemetics|mesh-ancestor
110998344|NCT04297293|Autonomic Agents|autonomic agents|mesh-ancestor
110998345|NCT04297293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110998346|NCT04297293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110998347|NCT04297293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110998348|NCT04297293|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110998349|NCT04297293|Serotonin Agents|serotonin agents|mesh-ancestor
110998350|NCT04297293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110998351|NCT04297293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110998352|NCT03392961|Insulin|insulin|mesh-list
110998353|NCT03392961|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110998354|NCT03392961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110998355|NCT02350946|Oxytocin|oxytocin|mesh-list
110998356|NCT02350946|Oxytocics|oxytocics|mesh-ancestor
110998357|NCT02350946|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110998358|NCT02350946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110998359|NCT00000371|Cycloserine|cycloserine|mesh-list
110998360|NCT00000371|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110998361|NCT00000371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110998362|NCT00000371|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110998363|NCT00000371|Antitubercular Agents|antitubercular agents|mesh-ancestor
110998364|NCT00000371|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110998365|NCT00000371|Antimetabolites|antimetabolites|mesh-ancestor
110998366|NCT00000371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110998367|NCT02350712|Carboplatin|carboplatin|mesh-list
110998368|NCT02350712|Cetuximab|cetuximab|mesh-list
110998369|NCT02350712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110998370|NCT02350712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110998371|NCT02867995|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110998372|NCT02867995|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110998373|NCT03618797|Fenofibrate|fenofibrate|mesh-list
110998374|NCT03618797|Pitavastatin|pitavastatin|mesh-list
110998375|NCT03618797|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110998376|NCT03618797|Antimetabolites|antimetabolites|mesh-ancestor
110998377|NCT03618797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110998378|NCT03618797|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110998379|NCT03618797|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110998380|NCT03618797|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110998381|NCT03618797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110998382|NCT03149432|Gabapentin|gabapentin|mesh-list
110998383|NCT03149432|Analgesics|analgesics|mesh-ancestor
110998384|NCT03149432|Sensory System Agents|sensory system agents|mesh-ancestor
110998385|NCT03149432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110998386|NCT03149432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110998387|NCT03149432|Anticonvulsants|anticonvulsants|mesh-ancestor
110998388|NCT03149432|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110998389|NCT03149432|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110998390|NCT03149432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110998391|NCT03149432|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110998392|NCT03149432|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110998393|NCT03149432|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110998394|NCT03149432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110998395|NCT03149432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110998396|NCT03149432|Antimanic Agents|antimanic agents|mesh-ancestor
110998397|NCT05384483|Cariprazine|cariprazine|mesh-list
110998398|NCT05384483|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110998399|NCT05384483|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110998400|NCT05384483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110998401|NCT05384483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110998402|NCT05384483|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110998403|NCT05061563|Esomeprazole|esomeprazole|mesh-list
110998404|NCT05061563|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110998405|NCT05061563|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110998406|NCT05061563|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110998407|NCT05061563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110998408|NCT05061563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110998409|NCT03147092|Losartan|losartan|mesh-list
110998410|NCT03147092|Atenolol|atenolol|mesh-list
110998411|NCT03147092|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110998412|NCT03147092|Clonidine|clonidine|mesh-list
110998413|NCT03147092|Captopril|captopril|mesh-list
110998414|NCT03147092|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110998415|NCT03147092|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110998416|NCT03147092|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110998417|NCT03147092|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110998418|NCT03147092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110715432|NCT01121848|Leucovorin|leucovorin|mesh-list
110998419|NCT03147092|Diuretics|diuretics|mesh-ancestor
110998420|NCT03147092|Natriuretic Agents|natriuretic agents|mesh-ancestor
110998421|NCT03147092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110998422|NCT03147092|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110998423|NCT03147092|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110998425|NCT03147092|Sensory System Agents|sensory system agents|mesh-ancestor
110998426|NCT03147092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110998427|NCT03147092|Sympatholytics|sympatholytics|mesh-ancestor
110998428|NCT03147092|Autonomic Agents|autonomic agents|mesh-ancestor
110998429|NCT03147092|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110998430|NCT03147092|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110998431|NCT03147092|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110998432|NCT03147092|Adrenergic Agents|adrenergic agents|mesh-ancestor
110998433|NCT03147092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110998434|NCT03147092|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110998435|NCT03147092|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110998436|NCT03147092|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110998437|NCT03147092|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110998438|NCT03147092|Protease Inhibitors|protease inhibitors|mesh-ancestor
110998439|NCT03147092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110998440|NCT03149588|Propofol|propofol|mesh-list
110998441|NCT03149588|Sevoflurane|sevoflurane|mesh-list
110998442|NCT03149588|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110998443|NCT03149588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110998444|NCT03149588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110998445|NCT03149588|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110998446|NCT03149588|Anesthetics, General|anesthetics, general|mesh-ancestor
110998447|NCT03149588|Anesthetics|anesthetics|mesh-ancestor
110998448|NCT03149588|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110998449|NCT03149588|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110998450|NCT03613207|Lidocaine|lidocaine|mesh-list
110998451|NCT03613207|Prilocaine|prilocaine|mesh-list
110998452|NCT03613207|Anesthetics, Local|anesthetics, local|mesh-ancestor
110998453|NCT03613207|Anesthetics|anesthetics|mesh-ancestor
110998454|NCT03613207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110998455|NCT03613207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110998456|NCT03613207|Sensory System Agents|sensory system agents|mesh-ancestor
110998457|NCT03613207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110998458|NCT03613207|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110452888|NCT00621400|Lenalidomide|lenalidomide|mesh-list
110998459|NCT03613207|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110998460|NCT03613207|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110998461|NCT03613207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110998462|NCT03613207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110998463|NCT03612739|Azacitidine|azacitidine|mesh-list
110998464|NCT03612739|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110998465|NCT03612739|Antimetabolites|antimetabolites|mesh-ancestor
110998466|NCT03612739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110998467|NCT03612739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110998468|NCT03612739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110998469|NCT02350400|Irinotecan|irinotecan|mesh-list
110998470|NCT02350400|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110998471|NCT02350400|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110998472|NCT02350400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110998473|NCT02350400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110998474|NCT02350400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110998475|NCT03612817|Timolol|timolol|mesh-list
110998476|NCT03612817|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110998477|NCT03612817|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110998478|NCT03612817|Adrenergic Agents|adrenergic agents|mesh-ancestor
110998479|NCT03612817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110025047|NCT00357084|Dermatologic Agents|dermatologic agents|mesh-ancestor
110998480|NCT03612817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110998481|NCT03612817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110998482|NCT03612817|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110998483|NCT03612817|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110998484|NCT02347904|Oxaliplatin|oxaliplatin|mesh-list
110998485|NCT02347904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110998486|NCT03612349|Menthol|menthol|mesh-list
110998487|NCT03612349|Antipruritics|antipruritics|mesh-ancestor
110998488|NCT03612349|Dermatologic Agents|dermatologic agents|mesh-ancestor
110998489|NCT03146858|Enoxaparin|enoxaparin|mesh-list
110998490|NCT03146858|Anticoagulants|anticoagulants|mesh-ancestor
110998491|NCT03146858|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110998492|NCT03146858|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110998493|NCT03146858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110998494|NCT03408405|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
110998495|NCT03408405|Hormones|hormones|mesh-ancestor
110998496|NCT03408405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110998497|NCT03408405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110998498|NCT03408093|Interferons|interferons|mesh-list
110998499|NCT03408093|Interferon-beta|interferon-beta|mesh-list
110998500|NCT03408093|Interferon beta-1b|interferon beta-1b|mesh-list
110998501|NCT03408093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110998502|NCT03408093|Antiviral Agents|antiviral agents|mesh-ancestor
110998503|NCT03408093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110998504|NCT03408093|Immunologic Factors|immunologic factors|mesh-ancestor
110998505|NCT03408093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110998506|NCT03408093|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110998507|NCT04679623|Midazolam|midazolam|mesh-list
110998508|NCT04679623|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110998509|NCT04679623|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110998510|NCT04679623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110998511|NCT04679623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110998512|NCT04679623|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110998513|NCT04679623|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110998514|NCT04679623|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110998515|NCT04679623|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110998516|NCT04679623|Anesthetics, General|anesthetics, general|mesh-ancestor
110998517|NCT04679623|Anesthetics|anesthetics|mesh-ancestor
110998518|NCT04679623|GABA Modulators|gaba modulators|mesh-ancestor
110998519|NCT04679623|GABA Agents|gaba agents|mesh-ancestor
110998520|NCT04679623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110998521|NCT04679623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110998522|NCT02353988|Bicalutamide|bicalutamide|mesh-list
110998523|NCT02353988|Androgen Antagonists|androgen antagonists|mesh-ancestor
110998524|NCT02353988|Hormone Antagonists|hormone antagonists|mesh-ancestor
110998525|NCT02353988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110998526|NCT02353988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110998527|NCT02353988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110998528|NCT03392571|Paclitaxel|paclitaxel|mesh-list
110998529|NCT03392571|Cisplatin|cisplatin|mesh-list
110998530|NCT03392571|Gemcitabine|gemcitabine|mesh-list
110998531|NCT03392571|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110998532|NCT03392571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110998533|NCT03392571|Tubulin Modulators|tubulin modulators|mesh-ancestor
110998534|NCT03392571|Antimitotic Agents|antimitotic agents|mesh-ancestor
110998535|NCT03392571|Mitosis Modulators|mitosis modulators|mesh-ancestor
110998536|NCT03392571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110998537|NCT03392571|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110998538|NCT03392571|Antimetabolites|antimetabolites|mesh-ancestor
110998539|NCT04656067|Tranexamic Acid|tranexamic acid|mesh-list
110998540|NCT04656067|Ethamsylate|ethamsylate|mesh-list
110998541|NCT04656067|Oxytocin|oxytocin|mesh-list
110998542|NCT04656067|Oxytocics|oxytocics|mesh-ancestor
110998543|NCT04656067|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110998544|NCT04656067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110998545|NCT04656067|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110998546|NCT04656067|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110998547|NCT04656067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110998548|NCT04656067|Hemostatics|hemostatics|mesh-ancestor
110998549|NCT04656067|Coagulants|coagulants|mesh-ancestor
110998550|NCT03612037|Thioctic Acid|thioctic acid|mesh-list
110998551|NCT03612037|Antioxidants|antioxidants|mesh-ancestor
110998552|NCT03612037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110998553|NCT03612037|Protective Agents|protective agents|mesh-ancestor
110998554|NCT03612037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110998555|NCT03612037|Vitamin B Complex|vitamin b complex|mesh-ancestor
110998556|NCT03612037|Vitamins|vitamins|mesh-ancestor
110998558|NCT04447209|Chrysarobin|chrysarobin|mesh-list
110998559|NCT04447209|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110998560|NCT04447209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110998561|NCT04447209|Analgesics|analgesics|mesh-ancestor
110998562|NCT04447209|Sensory System Agents|sensory system agents|mesh-ancestor
110998563|NCT04447209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110998564|NCT04447209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110998565|NCT04447209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110998566|NCT04447209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110998567|NCT04199624|Omeprazole|omeprazole|mesh-list
110998568|NCT04199624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110998569|NCT04199624|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110998570|NCT04199624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110998571|NCT04199624|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110998572|NCT04199624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110998573|NCT03611491|Lidocaine|lidocaine|mesh-list
110998574|NCT03611491|Anesthetics, Local|anesthetics, local|mesh-ancestor
110998575|NCT03611491|Anesthetics|anesthetics|mesh-ancestor
110998576|NCT03611491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110998577|NCT03611491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110998578|NCT03611491|Sensory System Agents|sensory system agents|mesh-ancestor
110998579|NCT03611491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110998580|NCT03611491|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110998581|NCT03611491|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110998582|NCT03611491|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110998583|NCT03611491|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110998584|NCT03611491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110998585|NCT02748863|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110998586|NCT02748863|Immunologic Factors|immunologic factors|mesh-ancestor
110998587|NCT02748863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110998588|NCT03611179|Bevacizumab|bevacizumab|mesh-list
110998589|NCT03611179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110998590|NCT03611179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110998591|NCT03611179|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110998592|NCT03611179|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110998593|NCT03611179|Growth Substances|growth substances|mesh-ancestor
110998594|NCT03611179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110998595|NCT03611179|Growth Inhibitors|growth inhibitors|mesh-ancestor
110998596|NCT03126123|Acetic Acid|acetic acid|mesh-list
110998597|NCT03126123|Retinol acetate|retinol acetate|mesh-list
110998598|NCT03126123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110998599|NCT03126123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110998600|NCT03126123|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110998601|NCT03126123|Immunologic Factors|immunologic factors|mesh-ancestor
110998602|NCT03126123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110998603|NCT03126123|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110998604|NCT03126123|Protective Agents|protective agents|mesh-ancestor
110998605|NCT03126123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110998606|NCT02353676|Bupivacaine|bupivacaine|mesh-list
110998607|NCT02353676|Anesthetics, Local|anesthetics, local|mesh-ancestor
110998608|NCT02353676|Anesthetics|anesthetics|mesh-ancestor
110998609|NCT02353676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110998610|NCT02353676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110998611|NCT02353676|Sensory System Agents|sensory system agents|mesh-ancestor
110998612|NCT02353676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110998613|NCT03617471|Acetaminophen|acetaminophen|mesh-list
110998614|NCT03617471|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110998615|NCT03617471|Analgesics|analgesics|mesh-ancestor
110998616|NCT03617471|Sensory System Agents|sensory system agents|mesh-ancestor
110998617|NCT03617471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110998618|NCT03617471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110998619|NCT03617471|Antipyretics|antipyretics|mesh-ancestor
110998620|NCT05168007|Cariprazine|cariprazine|mesh-list
110998621|NCT05168007|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110998622|NCT05168007|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110998623|NCT05168007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110998624|NCT05168007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110998625|NCT05168007|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110998626|NCT02032927|Acetaminophen|acetaminophen|mesh-list
110998627|NCT02032927|Oxycodone|oxycodone|mesh-list
110998628|NCT02032927|Codeine|codeine|mesh-list
110998629|NCT02032927|Naloxone|naloxone|mesh-list
110998630|NCT02032927|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110998631|NCT02032927|Analgesics|analgesics|mesh-ancestor
110998632|NCT02032927|Sensory System Agents|sensory system agents|mesh-ancestor
110998633|NCT02032927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110998634|NCT02032927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110998636|NCT02032927|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110998637|NCT02032927|Narcotics|narcotics|mesh-ancestor
110998638|NCT02032927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110998639|NCT02032927|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110998640|NCT02032927|Antitussive Agents|antitussive agents|mesh-ancestor
110998641|NCT02032927|Respiratory System Agents|respiratory system agents|mesh-ancestor
110998642|NCT02353598|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110998643|NCT02353598|Immunologic Factors|immunologic factors|mesh-ancestor
110998644|NCT02353598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110998645|NCT03392103|Raltitrexed|raltitrexed|mesh-list
110998646|NCT03392103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110998647|NCT03392103|Antimetabolites|antimetabolites|mesh-ancestor
110998648|NCT03392103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110998649|NCT03392103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110998650|NCT03392103|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110998651|NCT03392103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110998652|NCT03610945|Fluconazole|fluconazole|mesh-list
110998653|NCT03610945|Quinidine|quinidine|mesh-list
110998654|NCT03610945|Antifungal Agents|antifungal agents|mesh-ancestor
110998655|NCT03610945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110998656|NCT03610945|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110998657|NCT03610945|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110998658|NCT03610945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110998659|NCT03610945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110998660|NCT03610945|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110998661|NCT03610945|Hormone Antagonists|hormone antagonists|mesh-ancestor
110998662|NCT03610945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110998663|NCT03610945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110998664|NCT03610945|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110998665|NCT03610945|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110998666|NCT03610945|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110998667|NCT03610945|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110998668|NCT03610945|Adrenergic Agents|adrenergic agents|mesh-ancestor
110998669|NCT03610945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110998670|NCT03610945|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110998671|NCT03610945|Antimalarials|antimalarials|mesh-ancestor
110998672|NCT03610945|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110998673|NCT03610945|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110998674|NCT03610945|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110998675|NCT03610945|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110998676|NCT03610945|Cholinergic Agents|cholinergic agents|mesh-ancestor
110998677|NCT03610945|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110998678|NCT03610945|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110998679|NCT03610945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110998680|NCT03610945|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110998681|NCT03616769|Antihypertensive Agents|antihypertensive agents|mesh-list
110998682|NCT03616769|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
110998683|NCT05167851|Lazertinib|lazertinib|mesh-list
110998684|NCT05167851|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110998685|NCT05167851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110998686|NCT05167851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110998687|NCT02236715|Ipratropium|ipratropium|mesh-list
110998688|NCT02236715|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110998689|NCT02236715|Autonomic Agents|autonomic agents|mesh-ancestor
110998690|NCT02236715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110998691|NCT02236715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110998692|NCT02236715|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110998693|NCT02236715|Respiratory System Agents|respiratory system agents|mesh-ancestor
110998694|NCT02236715|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110998695|NCT02236715|Cholinergic Agents|cholinergic agents|mesh-ancestor
110998696|NCT02236715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110998697|NCT02236715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110998698|NCT03823365|Blinatumomab|blinatumomab|mesh-list
110998699|NCT03823365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110998700|NCT03616691|Bevacizumab|bevacizumab|mesh-list
110998701|NCT03616691|Atezolizumab|atezolizumab|mesh-list
110998702|NCT03616691|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110998703|NCT03616691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110998704|NCT03616691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110463846|NCT02852382|Morphine|morphine|mesh-list
110998705|NCT03616691|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110998706|NCT03616691|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110998707|NCT03616691|Growth Substances|growth substances|mesh-ancestor
110998708|NCT03616691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110998709|NCT03616691|Growth Inhibitors|growth inhibitors|mesh-ancestor
110998710|NCT03616691|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110998711|NCT03616691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110998712|NCT03616691|Immunologic Factors|immunologic factors|mesh-ancestor
110998713|NCT03158168|Zinc Sulfate|zinc sulfate|mesh-list
110998714|NCT03158168|Astringents|astringents|mesh-ancestor
110998715|NCT03158168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110998716|NCT03158168|Dermatologic Agents|dermatologic agents|mesh-ancestor
110998717|NCT02865499|Acarbose|acarbose|mesh-list
110998718|NCT02865499|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
110998719|NCT02865499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110998720|NCT02865499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110998721|NCT02865499|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110998722|NCT02865499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110998723|NCT03156062|Salicylic Acid|salicylic acid|mesh-list
110998724|NCT03156062|Salicylates|salicylates|mesh-list
110998725|NCT03156062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110998726|NCT03156062|Antifungal Agents|antifungal agents|mesh-ancestor
110998727|NCT03156062|Keratolytic Agents|keratolytic agents|mesh-ancestor
110998728|NCT03156062|Dermatologic Agents|dermatologic agents|mesh-ancestor
110998729|NCT03156062|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110998730|NCT03156062|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110998731|NCT03156062|Analgesics|analgesics|mesh-ancestor
110998732|NCT03156062|Sensory System Agents|sensory system agents|mesh-ancestor
110998733|NCT03156062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110998734|NCT03156062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110998735|NCT03156062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110998736|NCT03156062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110998737|NCT03156062|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110998738|NCT03156062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110998739|NCT03156062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110998740|NCT03404739|Ceftazidime|ceftazidime|mesh-list
110998741|NCT03404739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110998742|NCT03404739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110998743|NCT02031965|Dexamethasone|dexamethasone|mesh-list
110998744|NCT02031965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110998745|NCT02031965|Antiemetics|antiemetics|mesh-ancestor
110998746|NCT02031965|Autonomic Agents|autonomic agents|mesh-ancestor
110998747|NCT02031965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110998748|NCT02031965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110998749|NCT02031965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110998750|NCT02031965|Glucocorticoids|glucocorticoids|mesh-ancestor
110998751|NCT02031965|Hormones|hormones|mesh-ancestor
110998752|NCT02031965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110998753|NCT02031965|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110998754|NCT02031965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110998755|NCT03149120|Nivolumab|nivolumab|mesh-list
110998756|NCT03149120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110998757|NCT03149120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110998758|NCT03149120|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110998759|NCT03149120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110998760|NCT04849325|Sirolimus|sirolimus|mesh-list
110998761|NCT04849325|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110998762|NCT04849325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110998763|NCT04849325|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110998764|NCT04849325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110998765|NCT04849325|Antifungal Agents|antifungal agents|mesh-ancestor
110998766|NCT04849325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110998767|NCT04849325|Immunologic Factors|immunologic factors|mesh-ancestor
110998768|NCT04849325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110998769|NCT03403023|Cyclosporine|cyclosporine|mesh-list
110998770|NCT03403023|Cyclosporins|cyclosporins|mesh-list
110998771|NCT03403023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110998772|NCT03403023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110998773|NCT03403023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110998774|NCT03403023|Immunologic Factors|immunologic factors|mesh-ancestor
110998775|NCT03403023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110998776|NCT03403023|Antifungal Agents|antifungal agents|mesh-ancestor
110998777|NCT03403023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110998778|NCT03403023|Dermatologic Agents|dermatologic agents|mesh-ancestor
110998779|NCT03403023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110998780|NCT03403023|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110998781|NCT02864407|Tiotropium Bromide|tiotropium bromide|mesh-list
110998782|NCT02864407|Olodaterol|olodaterol|mesh-list
110998783|NCT02864407|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110998784|NCT02864407|Autonomic Agents|autonomic agents|mesh-ancestor
110998785|NCT02864407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110998786|NCT02864407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110998787|NCT02864407|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110998788|NCT02864407|Respiratory System Agents|respiratory system agents|mesh-ancestor
110998789|NCT02864407|Parasympatholytics|parasympatholytics|mesh-ancestor
110998790|NCT02864407|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110998791|NCT02864407|Cholinergic Agents|cholinergic agents|mesh-ancestor
110998792|NCT02864407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110998793|NCT02864407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110998794|NCT03616301|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
110452921|NCT04208776|Midodrine|midodrine|mesh-list
110998795|NCT03616301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110998796|NCT03616301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110998797|NCT03616301|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110998798|NCT03616301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110998799|NCT03616301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110998800|NCT03394989|Fluticasone|fluticasone|mesh-list
110998801|NCT03394989|Xhance|xhance|mesh-list
110998802|NCT03394989|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110998803|NCT03394989|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
110998804|NCT03394989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110998805|NCT03394989|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110998806|NCT03394989|Autonomic Agents|autonomic agents|mesh-ancestor
110998807|NCT03394989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110998808|NCT03394989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110998809|NCT03394989|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110998810|NCT03394989|Respiratory System Agents|respiratory system agents|mesh-ancestor
110998811|NCT03394989|Dermatologic Agents|dermatologic agents|mesh-ancestor
110998812|NCT03394989|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110998813|NCT03394989|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110998814|NCT03394989|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110998815|NCT03394989|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110998816|NCT03394989|Adrenergic Agents|adrenergic agents|mesh-ancestor
110998817|NCT03394989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110998818|NCT03394989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110998819|NCT03394989|Glucocorticoids|glucocorticoids|mesh-ancestor
110998820|NCT03394989|Hormones|hormones|mesh-ancestor
110998821|NCT03394989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110998822|NCT03394989|Sympathomimetics|sympathomimetics|mesh-ancestor
110998823|NCT02033239|Insulin|insulin|mesh-list
110998824|NCT02033239|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110998825|NCT02033239|Insulin Aspart|insulin aspart|mesh-list
110998826|NCT02033239|Insulin, Long-Acting|insulin, long-acting|mesh-list
110998827|NCT02033239|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
110998828|NCT02033239|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110998829|NCT02033239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110998830|NCT02486302|Etanercept|etanercept|mesh-list
110998831|NCT02486302|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110998832|NCT02486302|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110998833|NCT02486302|Analgesics|analgesics|mesh-ancestor
110998834|NCT02486302|Sensory System Agents|sensory system agents|mesh-ancestor
110998835|NCT02486302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110998836|NCT02486302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110998837|NCT02486302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110998838|NCT02486302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110998839|NCT02486302|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110998840|NCT02486302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110998841|NCT02486302|Immunologic Factors|immunologic factors|mesh-ancestor
110998842|NCT02034097|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110998843|NCT02034097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110998844|NCT02034097|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110998845|NCT02034097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110998846|NCT02034097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110998847|NCT03615833|Vitamin D|vitamin d|mesh-list
110998848|NCT03615833|Cholecalciferol|cholecalciferol|mesh-list
110998849|NCT03615833|Vitamins|vitamins|mesh-ancestor
110998850|NCT03615833|Micronutrients|micronutrients|mesh-ancestor
110998851|NCT03615833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110998852|NCT03615833|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110998853|NCT03615833|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110998854|NCT02747875|Fentanyl|fentanyl|mesh-list
110998855|NCT02747875|Methadone|methadone|mesh-list
110998856|NCT02747875|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110998857|NCT02747875|Narcotics|narcotics|mesh-ancestor
110998858|NCT02747875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110998859|NCT02747875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110998860|NCT02747875|Analgesics|analgesics|mesh-ancestor
110998861|NCT02747875|Sensory System Agents|sensory system agents|mesh-ancestor
110998862|NCT02747875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110998863|NCT02747875|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110998864|NCT02747875|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110998865|NCT02747875|Anesthetics, General|anesthetics, general|mesh-ancestor
110998866|NCT02747875|Anesthetics|anesthetics|mesh-ancestor
110998867|NCT02747875|Antitussive Agents|antitussive agents|mesh-ancestor
110998868|NCT02747875|Respiratory System Agents|respiratory system agents|mesh-ancestor
110998869|NCT03394833|Polygeline|polygeline|mesh-list
110998870|NCT03394833|Plasma Substitutes|plasma substitutes|mesh-ancestor
110998871|NCT03394833|Blood Substitutes|blood substitutes|mesh-ancestor
110998872|NCT02347358|Plasminogen|plasminogen|mesh-list
110998873|NCT02347358|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
110998874|NCT02347358|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110998875|NCT02347358|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110998876|NCT02347358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110998877|NCT03610321|Gefarnate|gefarnate|mesh-list
110998878|NCT03610321|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110998879|NCT03610321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110998880|NCT02236793|Becaplermin|becaplermin|mesh-list
110998881|NCT02236793|Anticoagulants|anticoagulants|mesh-ancestor
110998882|NCT02236793|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
110998883|NCT02236793|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110998884|NCT02236793|Growth Substances|growth substances|mesh-ancestor
110998885|NCT02236793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110998886|NCT02347046|Dotinurad|dotinurad|mesh-list
110998887|NCT02347046|Uricosuric Agents|uricosuric agents|mesh-ancestor
110998888|NCT02347046|Gout Suppressants|gout suppressants|mesh-ancestor
110998889|NCT02347046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110998890|NCT03391245|Vitamin D|vitamin d|mesh-list
110998891|NCT03391245|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
110998892|NCT03391245|Calcifediol|calcifediol|mesh-list
110998893|NCT03391245|Vitamins|vitamins|mesh-ancestor
110998894|NCT03391245|Micronutrients|micronutrients|mesh-ancestor
110998895|NCT03391245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110998896|NCT03391245|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110998897|NCT03401619|Vitamin D|vitamin d|mesh-list
110998898|NCT03401619|Calcitonin|calcitonin|mesh-list
110998899|NCT03401619|Salmon calcitonin|salmon calcitonin|mesh-list
110998900|NCT03401619|Diphosphonates|diphosphonates|mesh-list
110998901|NCT03401619|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
110998902|NCT03401619|Katacalcin|katacalcin|mesh-list
110998903|NCT03401619|Vitamins|vitamins|mesh-ancestor
110998904|NCT03401619|Micronutrients|micronutrients|mesh-ancestor
110998905|NCT03401619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110998906|NCT03401619|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110998907|NCT03401619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110998908|NCT03401619|Vasodilator Agents|vasodilator agents|mesh-ancestor
110998909|NCT03399903|Mesalamine|mesalamine|mesh-list
110998910|NCT03399903|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110998911|NCT03399903|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110998912|NCT03399903|Analgesics|analgesics|mesh-ancestor
110998913|NCT03399903|Sensory System Agents|sensory system agents|mesh-ancestor
110998914|NCT03399903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110998915|NCT03399903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110998916|NCT03399903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110998917|NCT03399903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110998918|NCT03146468|Nivolumab|nivolumab|mesh-list
110998919|NCT03146468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110998920|NCT03146468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110998921|NCT03146468|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110998922|NCT03146468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110998923|NCT02353130|Memantine|memantine|mesh-list
110998924|NCT02353130|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110998925|NCT02353130|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110998926|NCT02353130|Dopamine Agents|dopamine agents|mesh-ancestor
110998927|NCT02353130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110998928|NCT02353130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110998929|NCT02353130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110998930|NCT02353130|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110998931|NCT02353130|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110998932|NCT02033551|Paclitaxel|paclitaxel|mesh-list
110998933|NCT02033551|Carboplatin|carboplatin|mesh-list
110998934|NCT02033551|Veliparib|veliparib|mesh-list
110998935|NCT02033551|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110998936|NCT02033551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110998937|NCT02033551|Tubulin Modulators|tubulin modulators|mesh-ancestor
110998938|NCT02033551|Antimitotic Agents|antimitotic agents|mesh-ancestor
110998939|NCT02033551|Mitosis Modulators|mitosis modulators|mesh-ancestor
110998940|NCT02033551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110998941|NCT02033551|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110998942|NCT02033551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110998943|NCT02450578|Atovaquone|atovaquone|mesh-list
110998944|NCT02450578|Proguanil|proguanil|mesh-list
110998945|NCT02450578|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
110998946|NCT02450578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110998947|NCT02450578|Antimalarials|antimalarials|mesh-ancestor
110715954|NCT01218568|Lactulose|lactulose|mesh-list
110998948|NCT02450578|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110998949|NCT02450578|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110998950|NCT02450578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110998951|NCT02450578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110998952|NCT02450578|Antimetabolites|antimetabolites|mesh-ancestor
110998953|NCT02346890|Sevelamer|sevelamer|mesh-list
110998954|NCT02346890|Chelating Agents|chelating agents|mesh-ancestor
110998955|NCT02346890|Sequestering Agents|sequestering agents|mesh-ancestor
110998956|NCT02346890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110998957|NCT03146390|Listerine|listerine|mesh-list
110998958|NCT03146390|Sodium Fluoride|sodium fluoride|mesh-list
110998959|NCT03146390|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110998960|NCT03146390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110998961|NCT03146390|Cariostatic Agents|cariostatic agents|mesh-ancestor
110998962|NCT03146390|Protective Agents|protective agents|mesh-ancestor
110998963|NCT03146390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110998964|NCT02859415|Plicamycin|plicamycin|mesh-list
110998965|NCT02859415|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110998966|NCT02859415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110998967|NCT02859415|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110998968|NCT02859415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110998969|NCT02859415|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110998970|NCT02859415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110998971|NCT02859415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110998972|NCT02859415|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110998973|NCT02871791|Everolimus|everolimus|mesh-list
110998974|NCT02871791|Palbociclib|palbociclib|mesh-list
110998975|NCT02871791|Exemestane|exemestane|mesh-list
110998976|NCT02871791|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110998977|NCT02871791|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110998978|NCT02871791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110998979|NCT02871791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110998980|NCT02871791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110998981|NCT02871791|Immunologic Factors|immunologic factors|mesh-ancestor
110998982|NCT02871791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110998983|NCT02871791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110998984|NCT02871791|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110998985|NCT02871791|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110998986|NCT02871791|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110998987|NCT02871791|Hormone Antagonists|hormone antagonists|mesh-ancestor
110998988|NCT02871791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110998989|NCT02346578|Flutamide|flutamide|mesh-list
110998990|NCT02346578|Androgen Antagonists|androgen antagonists|mesh-ancestor
110998991|NCT02346578|Hormone Antagonists|hormone antagonists|mesh-ancestor
110998992|NCT02346578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110998993|NCT02346578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110998994|NCT02346578|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110998995|NCT02346578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110998996|NCT03112382|Vitamins|vitamins|mesh-list
110998997|NCT03112382|Vitamin A|vitamin a|mesh-list
110998998|NCT03112382|Retinol palmitate|retinol palmitate|mesh-list
110998999|NCT03112382|Micronutrients|micronutrients|mesh-ancestor
110999000|NCT03112382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110999001|NCT03112382|Antioxidants|antioxidants|mesh-ancestor
110999002|NCT03112382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110999003|NCT03112382|Protective Agents|protective agents|mesh-ancestor
110025048|NCT00357084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110999004|NCT03112382|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110999005|NCT03112382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110999006|NCT03399669|Gefitinib|gefitinib|mesh-list
110999007|NCT03399669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110999008|NCT03399669|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110999009|NCT03399669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110999010|NCT03399669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110999011|NCT03148574|Misoprostol|misoprostol|mesh-list
110999012|NCT03148574|Oxytocin|oxytocin|mesh-list
110999013|NCT03148574|Oxytocics|oxytocics|mesh-ancestor
110999014|NCT03148574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110999015|NCT03148574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110999016|NCT03148574|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110999017|NCT03148574|Abortifacient Agents|abortifacient agents|mesh-ancestor
110999018|NCT03148574|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110999019|NCT03148574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110999020|NCT02343536|Prednisone|prednisone|mesh-list
110999021|NCT02343536|Cyclophosphamide|cyclophosphamide|mesh-list
110999022|NCT02343536|Rituximab|rituximab|mesh-list
110999023|NCT02343536|Vincristine|vincristine|mesh-list
110999024|NCT02343536|Azacitidine|azacitidine|mesh-list
110999025|NCT02343536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110999026|NCT02343536|Immunologic Factors|immunologic factors|mesh-ancestor
110999027|NCT02343536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110999028|NCT02343536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110999029|NCT02343536|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110999030|NCT02343536|Alkylating Agents|alkylating agents|mesh-ancestor
110999031|NCT02343536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110999032|NCT02343536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110999033|NCT02343536|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110999034|NCT02343536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110999035|NCT02343536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110999037|NCT02343536|Hormones|hormones|mesh-ancestor
110999038|NCT02343536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110999039|NCT02343536|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110999040|NCT02343536|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110999041|NCT02343536|Tubulin Modulators|tubulin modulators|mesh-ancestor
110999042|NCT02343536|Antimitotic Agents|antimitotic agents|mesh-ancestor
110999043|NCT02343536|Mitosis Modulators|mitosis modulators|mesh-ancestor
110999044|NCT02343536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110999045|NCT02343536|Antimetabolites|antimetabolites|mesh-ancestor
110999046|NCT02343536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110999047|NCT02343614|Celecoxib|celecoxib|mesh-list
110999048|NCT02343614|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110999049|NCT02343614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110999050|NCT02343614|Analgesics|analgesics|mesh-ancestor
110999051|NCT02343614|Sensory System Agents|sensory system agents|mesh-ancestor
110999052|NCT02343614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110999053|NCT02343614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110999054|NCT02343614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110999055|NCT02343614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110999056|NCT02343614|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110999057|NCT02343614|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110999058|NCT02343614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110999059|NCT02343614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110999060|NCT02871635|Adalimumab|adalimumab|mesh-list
110999061|NCT02871635|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110999062|NCT02871635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110999063|NCT02871635|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110999064|NCT03390465|Amlodipine|amlodipine|mesh-list
110999065|NCT03390465|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110999066|NCT03390465|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110999067|NCT03390465|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110999068|NCT03390465|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110999069|NCT03390465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110999070|NCT03390465|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110999071|NCT03390465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110999072|NCT03390465|Vasodilator Agents|vasodilator agents|mesh-ancestor
110999073|NCT03390465|Diuretics|diuretics|mesh-ancestor
110999074|NCT03390465|Natriuretic Agents|natriuretic agents|mesh-ancestor
110999075|NCT03390465|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110999076|NCT03390387|Dexamethasone|dexamethasone|mesh-list
110999077|NCT03390387|Dexamethasone acetate|dexamethasone acetate|mesh-list
110999078|NCT03390387|Methylprednisolone|methylprednisolone|mesh-list
110999079|NCT03390387|Bortezomib|bortezomib|mesh-list
110999080|NCT03390387|Daunorubicin|daunorubicin|mesh-list
110999081|NCT03390387|Idarubicin|idarubicin|mesh-list
110999082|NCT03390387|BB 1101|bb 1101|mesh-list
110999083|NCT03390387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110999084|NCT03390387|Antiemetics|antiemetics|mesh-ancestor
110999085|NCT03390387|Autonomic Agents|autonomic agents|mesh-ancestor
110999086|NCT03390387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110999087|NCT03390387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110999088|NCT03390387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110999089|NCT03390387|Glucocorticoids|glucocorticoids|mesh-ancestor
110999090|NCT03390387|Hormones|hormones|mesh-ancestor
110999091|NCT03390387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110999092|NCT03390387|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110999093|NCT03390387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110999094|NCT03390387|Protease Inhibitors|protease inhibitors|mesh-ancestor
110999095|NCT03390387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110999096|NCT03390387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110999097|NCT03390387|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110999098|NCT03390387|Protective Agents|protective agents|mesh-ancestor
110999099|NCT03390387|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110999100|NCT03390387|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110999101|NCT03390387|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110999102|NCT03146000|Meloxicam|meloxicam|mesh-list
110999103|NCT03146000|Lidocaine|lidocaine|mesh-list
110999104|NCT03146000|Prilocaine|prilocaine|mesh-list
110999105|NCT03146000|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
110999106|NCT03146000|Anesthetics, Local|anesthetics, local|mesh-ancestor
110999107|NCT03146000|Anesthetics|anesthetics|mesh-ancestor
110999108|NCT03146000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110999109|NCT03146000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110999110|NCT03146000|Sensory System Agents|sensory system agents|mesh-ancestor
110999111|NCT03146000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110999112|NCT03146000|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110999113|NCT03146000|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110999114|NCT03146000|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110999115|NCT03146000|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110999116|NCT03146000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110999117|NCT03146000|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110999118|NCT03146000|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110999119|NCT03146000|Analgesics|analgesics|mesh-ancestor
110999120|NCT03146000|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110999121|NCT03146000|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110999122|NCT03146000|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110999123|NCT03146000|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110999124|NCT03146000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110999125|NCT03146000|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
110999126|NCT02346188|Ferrous fumarate|ferrous fumarate|mesh-list
110999127|NCT02346188|Zinc Oxide|zinc oxide|mesh-list
110999128|NCT02346188|Trace Elements|trace elements|mesh-ancestor
110999129|NCT02346188|Micronutrients|micronutrients|mesh-ancestor
110999130|NCT02346188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110999131|NCT02346188|Dermatologic Agents|dermatologic agents|mesh-ancestor
110999132|NCT02346188|Sunscreening Agents|sunscreening agents|mesh-ancestor
110999133|NCT02346188|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110999134|NCT02346188|Protective Agents|protective agents|mesh-ancestor
110999135|NCT02477332|Omalizumab|omalizumab|mesh-list
110999136|NCT02477332|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110999137|NCT02477332|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110999138|NCT02477332|Respiratory System Agents|respiratory system agents|mesh-ancestor
110999139|NCT02346110|Dexamethasone|dexamethasone|mesh-list
110999140|NCT02346110|Epinephrine|epinephrine|mesh-list
110999141|NCT02346110|Racepinephrine|racepinephrine|mesh-list
110999142|NCT02346110|Bupivacaine|bupivacaine|mesh-list
110999143|NCT02346110|Epinephryl borate|epinephryl borate|mesh-list
110999144|NCT02346110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110999145|NCT02346110|Antiemetics|antiemetics|mesh-ancestor
110999146|NCT02346110|Autonomic Agents|autonomic agents|mesh-ancestor
110999147|NCT02346110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110999148|NCT02346110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110999149|NCT02346110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110999150|NCT02346110|Glucocorticoids|glucocorticoids|mesh-ancestor
110999151|NCT02346110|Hormones|hormones|mesh-ancestor
110999152|NCT02346110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110999153|NCT02346110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110999154|NCT02346110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110999155|NCT02346110|Anesthetics, Local|anesthetics, local|mesh-ancestor
110999156|NCT02346110|Anesthetics|anesthetics|mesh-ancestor
110999157|NCT02346110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110999158|NCT02346110|Sensory System Agents|sensory system agents|mesh-ancestor
110999159|NCT02346110|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110999160|NCT02346110|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110999161|NCT02346110|Adrenergic Agents|adrenergic agents|mesh-ancestor
110999162|NCT02346110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110999163|NCT02346110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110999164|NCT02346110|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110999165|NCT02346110|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110999166|NCT02346110|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110999167|NCT02346110|Respiratory System Agents|respiratory system agents|mesh-ancestor
110999168|NCT02346110|Mydriatics|mydriatics|mesh-ancestor
110999169|NCT02346110|Sympathomimetics|sympathomimetics|mesh-ancestor
110999170|NCT02346110|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110999171|NCT02348528|Dexamethasone|dexamethasone|mesh-list
110999172|NCT02348528|Lenalidomide|lenalidomide|mesh-list
110999173|NCT02348528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110999174|NCT02348528|Antiemetics|antiemetics|mesh-ancestor
110999175|NCT02348528|Autonomic Agents|autonomic agents|mesh-ancestor
110999176|NCT02348528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110999177|NCT02348528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110999178|NCT02348528|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110999179|NCT02348528|Glucocorticoids|glucocorticoids|mesh-ancestor
110999180|NCT02348528|Hormones|hormones|mesh-ancestor
110999181|NCT02348528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110999182|NCT02348528|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110999183|NCT02348528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110999184|NCT02348528|Immunologic Factors|immunologic factors|mesh-ancestor
110999185|NCT02348528|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110999186|NCT02348528|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110999187|NCT02348528|Growth Substances|growth substances|mesh-ancestor
110999188|NCT02348528|Growth Inhibitors|growth inhibitors|mesh-ancestor
110999189|NCT02342600|Trametinib|trametinib|mesh-list
110999190|NCT02342600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110999191|NCT02342600|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110999192|NCT02342600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110999193|NCT02342600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110999194|NCT03147638|Warfarin|warfarin|mesh-list
110999195|NCT03147638|Anticoagulants|anticoagulants|mesh-ancestor
110999196|NCT02342366|Sodium Oxybate|sodium oxybate|mesh-list
110999197|NCT02342366|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110999198|NCT02342366|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110999199|NCT02342366|Anesthetics, General|anesthetics, general|mesh-ancestor
110999200|NCT02342366|Anesthetics|anesthetics|mesh-ancestor
110999201|NCT02342366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110999202|NCT02342366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110999203|NCT02862535|Oxaliplatin|oxaliplatin|mesh-list
110999204|NCT02862535|Nivolumab|nivolumab|mesh-list
110999205|NCT02862535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110999206|NCT02862535|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110999207|NCT02862535|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110999208|NCT02862535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110999209|NCT02033707|Scopolamine|scopolamine|mesh-list
110999210|NCT02033707|Hallucinogens|hallucinogens|mesh-list
110999211|NCT02033707|Nicotine|nicotine|mesh-list
110999212|NCT02033707|Histamine Antagonists|histamine antagonists|mesh-list
110999213|NCT02033707|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110999214|NCT02033707|Autonomic Agents|autonomic agents|mesh-ancestor
110999215|NCT02033707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110999216|NCT02033707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110999217|NCT02033707|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110999218|NCT02033707|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110999219|NCT02033707|Cholinergic Agents|cholinergic agents|mesh-ancestor
110999220|NCT02033707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110999221|NCT02033707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110999222|NCT02033707|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110999223|NCT02033707|Antiemetics|antiemetics|mesh-ancestor
110999224|NCT02033707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110999225|NCT02033707|Mydriatics|mydriatics|mesh-ancestor
110999226|NCT02033707|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110999227|NCT02033707|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110999228|NCT02033707|Histamine Agents|histamine agents|mesh-ancestor
110999229|NCT02033707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110999230|NCT02039336|Docetaxel|docetaxel|mesh-list
110999231|NCT02039336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110999232|NCT02039336|Tubulin Modulators|tubulin modulators|mesh-ancestor
110999233|NCT02039336|Antimitotic Agents|antimitotic agents|mesh-ancestor
110999234|NCT02039336|Mitosis Modulators|mitosis modulators|mesh-ancestor
110999235|NCT02039336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110999237|NCT04935476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110999238|NCT04935476|Antimalarials|antimalarials|mesh-ancestor
110999239|NCT04935476|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110999240|NCT04935476|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110999241|NCT04935476|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110999242|NCT04935476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110999243|NCT04935476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110999244|NCT04935476|Leprostatic Agents|leprostatic agents|mesh-ancestor
110999245|NCT04935476|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110999246|NCT02476006|Atorvastatin|atorvastatin|mesh-list
110999247|NCT02476006|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110716261|NCT01224652|Paclitaxel|paclitaxel|mesh-list
110999248|NCT02476006|Simvastatin|simvastatin|mesh-list
110999249|NCT02476006|Ezetimibe|ezetimibe|mesh-list
110999250|NCT02476006|Alirocumab|alirocumab|mesh-list
110999251|NCT02476006|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110999252|NCT02476006|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110999253|NCT02476006|Antimetabolites|antimetabolites|mesh-ancestor
110999254|NCT02476006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110999255|NCT02476006|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110999256|NCT02476006|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110999257|NCT02476006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110999258|NCT02476006|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
110999259|NCT02476006|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110999260|NCT02476006|Protease Inhibitors|protease inhibitors|mesh-ancestor
110999262|NCT02344940|Toremifene|toremifene|mesh-list
110999263|NCT02344940|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110999264|NCT02344940|Hormone Antagonists|hormone antagonists|mesh-ancestor
110999265|NCT02344940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110999266|NCT02344940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110999267|NCT02344940|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110999268|NCT02344940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110999269|NCT02344940|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110999270|NCT02344940|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110999271|NCT02344940|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110999272|NCT03615677|Esomeprazole|esomeprazole|mesh-list
110999273|NCT03615677|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110999274|NCT03615677|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110999275|NCT03615677|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110999276|NCT03615677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110999277|NCT03615677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110999278|NCT02344862|Dotinurad|dotinurad|mesh-list
110999279|NCT02344862|Uricosuric Agents|uricosuric agents|mesh-ancestor
110999280|NCT02344862|Gout Suppressants|gout suppressants|mesh-ancestor
110999281|NCT02344862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110999282|NCT03614429|Chlorhexidine|chlorhexidine|mesh-list
110999283|NCT03614429|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110999284|NCT03614429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110999285|NCT03614429|Disinfectants|disinfectants|mesh-ancestor
110999286|NCT03614273|Epinephrine|epinephrine|mesh-list
110999287|NCT03614273|Racepinephrine|racepinephrine|mesh-list
110999288|NCT03614273|Epinephryl borate|epinephryl borate|mesh-list
110999289|NCT03614273|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110999290|NCT03614273|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110999291|NCT03614273|Adrenergic Agents|adrenergic agents|mesh-ancestor
110999292|NCT03614273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110999293|NCT03614273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110999294|NCT03614273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110999295|NCT03614273|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110999296|NCT03614273|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110999297|NCT03614273|Autonomic Agents|autonomic agents|mesh-ancestor
110999298|NCT03614273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110999299|NCT03614273|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110999300|NCT03614273|Respiratory System Agents|respiratory system agents|mesh-ancestor
110999301|NCT03614273|Mydriatics|mydriatics|mesh-ancestor
110999302|NCT03614273|Sympathomimetics|sympathomimetics|mesh-ancestor
110999303|NCT03614273|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110999304|NCT02336984|Trastuzumab|trastuzumab|mesh-list
110999305|NCT02336984|Pertuzumab|pertuzumab|mesh-list
110999306|NCT02336984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110999307|NCT02336984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110999308|NCT03145610|Triclosan|triclosan|mesh-list
110999309|NCT03145610|Fluorides|fluorides|mesh-list
110464445|NCT01093586|Busulfan|busulfan|mesh-list
110999311|NCT03145610|Protective Agents|protective agents|mesh-ancestor
110999312|NCT03145610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110999313|NCT03145610|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110999314|NCT03145610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110999315|NCT03145610|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
110999316|NCT03145610|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110999317|NCT03145610|Antimetabolites|antimetabolites|mesh-ancestor
110999318|NCT03145610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110999319|NCT03145610|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110999320|NCT02341586|Iron|iron|mesh-list
110999321|NCT02341586|Trace Elements|trace elements|mesh-ancestor
110999322|NCT02341586|Micronutrients|micronutrients|mesh-ancestor
110999323|NCT02341586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110999324|NCT02336906|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
110999325|NCT02336906|Laxatives|laxatives|mesh-ancestor
110999326|NCT02336906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110999327|NCT03613961|Anesthetics|anesthetics|mesh-list
110999328|NCT03613961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110999329|NCT03613961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110999330|NCT02341352|Fluorides|fluorides|mesh-list
110999331|NCT02341352|Fluorides, Topical|fluorides, topical|mesh-list
110999332|NCT02341352|Immunoglobulins|immunoglobulins|mesh-list
110999333|NCT02341352|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110999334|NCT02341352|Antibodies|antibodies|mesh-list
110999335|NCT02341352|Cariostatic Agents|cariostatic agents|mesh-ancestor
110999336|NCT02341352|Protective Agents|protective agents|mesh-ancestor
110999337|NCT02341352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110999338|NCT02341352|Immunologic Factors|immunologic factors|mesh-ancestor
110999339|NCT02344550|Everolimus|everolimus|mesh-list
110999340|NCT02344550|Letrozole|letrozole|mesh-list
110999341|NCT02344550|Leuprolide|leuprolide|mesh-list
110999342|NCT02344550|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110999343|NCT02344550|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110999344|NCT02344550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110999345|NCT02344550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110999346|NCT02344550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110999347|NCT02344550|Immunologic Factors|immunologic factors|mesh-ancestor
110999348|NCT02344550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110999349|NCT02344550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110999350|NCT02344550|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110999351|NCT02344550|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110999352|NCT02344550|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110999353|NCT02344550|Hormone Antagonists|hormone antagonists|mesh-ancestor
110999354|NCT02344550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110999355|NCT02344550|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110999356|NCT02344550|Fertility Agents|fertility agents|mesh-ancestor
110999357|NCT02344550|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110999358|NCT02344550|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110999359|NCT02419612|Dapagliflozin|dapagliflozin|mesh-list
110999360|NCT02419612|Glimepiride|glimepiride|mesh-list
110999361|NCT02419612|Saxagliptin|saxagliptin|mesh-list
110999362|NCT02419612|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110999363|NCT02419612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110999364|NCT02419612|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110999365|NCT02419612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110999366|NCT02419612|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110999367|NCT02419612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110999368|NCT02419612|Immunologic Factors|immunologic factors|mesh-ancestor
110999369|NCT02419612|Incretins|incretins|mesh-ancestor
110999370|NCT02419612|Hormones|hormones|mesh-ancestor
110999371|NCT02419612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110999372|NCT02419612|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110999373|NCT02419612|Protease Inhibitors|protease inhibitors|mesh-ancestor
110999374|NCT02419612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110999375|NCT03612947|Magnesium Sulfate|magnesium sulfate|mesh-list
110999376|NCT03612947|Bupivacaine|bupivacaine|mesh-list
110999377|NCT03612947|Anesthetics, Local|anesthetics, local|mesh-ancestor
110999378|NCT03612947|Anesthetics|anesthetics|mesh-ancestor
110999379|NCT03612947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110999380|NCT03612947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110999381|NCT03612947|Sensory System Agents|sensory system agents|mesh-ancestor
110999382|NCT03612947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110999383|NCT03612947|Analgesics|analgesics|mesh-ancestor
110999384|NCT03612947|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110999386|NCT03612947|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110999387|NCT03612947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110999388|NCT03612947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110999389|NCT03612947|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110999390|NCT03612947|Tocolytic Agents|tocolytic agents|mesh-ancestor
110999391|NCT03612947|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110999392|NCT02344784|Methylphenidate|methylphenidate|mesh-list
110999393|NCT02344784|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110999394|NCT02344784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110999395|NCT02344784|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110999396|NCT02344784|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110999397|NCT02344784|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110999398|NCT02344784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110999399|NCT02344784|Dopamine Agents|dopamine agents|mesh-ancestor
110999400|NCT02344784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110999401|NCT02447848|Sufentanil|sufentanil|mesh-list
110999402|NCT02447848|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110999403|NCT02447848|Narcotics|narcotics|mesh-ancestor
110999404|NCT02447848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110999405|NCT02447848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110999406|NCT02447848|Analgesics|analgesics|mesh-ancestor
110999407|NCT02447848|Sensory System Agents|sensory system agents|mesh-ancestor
110999408|NCT02447848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110999409|NCT02447848|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110999410|NCT02447848|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110999411|NCT02447848|Anesthetics, General|anesthetics, general|mesh-ancestor
110999412|NCT02447848|Anesthetics|anesthetics|mesh-ancestor
110999413|NCT02336516|Azithromycin|azithromycin|mesh-list
110999414|NCT02336516|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110999415|NCT02336516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110999416|NCT05254652|Pregabalin|pregabalin|mesh-list
110999417|NCT05254652|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110999418|NCT05254652|Analgesics|analgesics|mesh-ancestor
110999419|NCT05254652|Sensory System Agents|sensory system agents|mesh-ancestor
110999420|NCT05254652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110999421|NCT05254652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110999422|NCT05254652|Anticonvulsants|anticonvulsants|mesh-ancestor
110999423|NCT05254652|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110999424|NCT05254652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110999425|NCT05254652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110999426|NCT05254652|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110999427|NCT05254652|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110999428|NCT05254652|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110999429|NCT05254652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110999430|NCT05254652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110999431|NCT05254652|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110999432|NCT05254652|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110999433|NCT05254652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110999434|NCT05254652|Antidepressive Agents|antidepressive agents|mesh-ancestor
110999435|NCT05254652|Dopamine Agents|dopamine agents|mesh-ancestor
110999436|NCT02343926|Metformin|metformin|mesh-list
110999437|NCT02343926|Vildagliptin|vildagliptin|mesh-list
110999438|NCT02343926|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110999439|NCT02343926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110999440|NCT02343926|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110999441|NCT02343926|Protease Inhibitors|protease inhibitors|mesh-ancestor
110999442|NCT02343926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110999443|NCT02343926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110999444|NCT03112226|Estradiol|estradiol|mesh-list
110999445|NCT03112226|LHRH, N-acetyl-(4-chlorophenylalanyl)(1)-(4-chlorophenylalanyl)(2)-tryptophyl(3)-arginyl(6)-alanine(10)-|lhrh, n-acetyl-(4-chlorophenylalanyl)(1)-(4-chlorophenylalanyl)(2)-tryptophyl(3)-arginyl(6)-alanine(10)-|mesh-list
110999446|NCT03112226|Estrogens|estrogens|mesh-ancestor
110999447|NCT03112226|Hormones|hormones|mesh-ancestor
110999448|NCT03112226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110999449|NCT03112226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110999450|NCT03112226|Hormone Antagonists|hormone antagonists|mesh-ancestor
110999451|NCT02343692|Pancrelipase|pancrelipase|mesh-list
110999452|NCT02343692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110999453|NCT02332616|Methylprednisolone|methylprednisolone|mesh-list
110999454|NCT02332616|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110464586|NCT04153084|Laxatives|laxatives|mesh-ancestor
110999455|NCT02332616|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110999456|NCT02332616|Prednisolone|prednisolone|mesh-list
110999457|NCT02332616|Prednisolone acetate|prednisolone acetate|mesh-list
110999458|NCT02332616|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110999459|NCT02332616|Prednisolone phosphate|prednisolone phosphate|mesh-list
110999460|NCT02332616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110999461|NCT02332616|Antiemetics|antiemetics|mesh-ancestor
110999462|NCT02332616|Autonomic Agents|autonomic agents|mesh-ancestor
110999463|NCT02332616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110999464|NCT02332616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110999465|NCT02332616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110999466|NCT02332616|Glucocorticoids|glucocorticoids|mesh-ancestor
110999467|NCT02332616|Hormones|hormones|mesh-ancestor
110999468|NCT02332616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110999469|NCT02332616|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110999470|NCT02332616|Protective Agents|protective agents|mesh-ancestor
110999471|NCT02332616|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110999472|NCT02332616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110999473|NCT03345173|Ketamine|ketamine|mesh-list
110999474|NCT03345173|Analgesics|analgesics|mesh-ancestor
110999475|NCT03345173|Sensory System Agents|sensory system agents|mesh-ancestor
110999476|NCT03345173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110999477|NCT03345173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110999478|NCT03345173|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110999479|NCT03345173|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110999480|NCT03345173|Anesthetics, General|anesthetics, general|mesh-ancestor
110999481|NCT03345173|Anesthetics|anesthetics|mesh-ancestor
110999482|NCT03345173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110999483|NCT03345173|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110999484|NCT03345173|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110999485|NCT03345173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110999486|NCT03345173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110999487|NCT03618173|Dexamethasone|dexamethasone|mesh-list
110999488|NCT03618173|Dexamethasone acetate|dexamethasone acetate|mesh-list
110999489|NCT03618173|BB 1101|bb 1101|mesh-list
110999490|NCT03618173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110999491|NCT03618173|Antiemetics|antiemetics|mesh-ancestor
110999492|NCT03618173|Autonomic Agents|autonomic agents|mesh-ancestor
110999493|NCT03618173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110999494|NCT03618173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110999495|NCT03618173|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110999496|NCT03618173|Glucocorticoids|glucocorticoids|mesh-ancestor
110999497|NCT03618173|Hormones|hormones|mesh-ancestor
110999498|NCT03618173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110999499|NCT03618173|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110999500|NCT03618173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110999501|NCT03618173|Protease Inhibitors|protease inhibitors|mesh-ancestor
110999502|NCT03618173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110999503|NCT03618173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110999504|NCT02336048|Obinutuzumab|obinutuzumab|mesh-list
110999505|NCT02336048|Chlorambucil|chlorambucil|mesh-list
110999506|NCT02336048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110999507|NCT02336048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110999508|NCT02336048|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110999509|NCT02336048|Alkylating Agents|alkylating agents|mesh-ancestor
110999510|NCT02336048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110999511|NCT03612401|Mirabegron|mirabegron|mesh-list
110999512|NCT03612401|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
110999513|NCT03612401|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110999514|NCT03612401|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110999515|NCT03612401|Adrenergic Agents|adrenergic agents|mesh-ancestor
110999516|NCT03612401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110999517|NCT03612401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110999518|NCT03612401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110999519|NCT03612401|Urological Agents|urological agents|mesh-ancestor
110999520|NCT03612323|Piroxicam|piroxicam|mesh-list
110999521|NCT03612323|Carticaine|carticaine|mesh-list
110999522|NCT03612323|Anesthetics, Local|anesthetics, local|mesh-ancestor
110999523|NCT03612323|Anesthetics|anesthetics|mesh-ancestor
110999524|NCT03612323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110999525|NCT03612323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110999526|NCT03612323|Sensory System Agents|sensory system agents|mesh-ancestor
110999527|NCT03612323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110999528|NCT03612323|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110999529|NCT03612323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110999530|NCT03612323|Analgesics|analgesics|mesh-ancestor
110999531|NCT03612323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110999532|NCT03612323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110999533|NCT03612323|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110999534|NCT03612323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110999535|NCT03612323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110999536|NCT02994719|Amantadine|amantadine|mesh-list
110999537|NCT02994719|Levodopa|levodopa|mesh-list
110999538|NCT02994719|Carbidopa|carbidopa|mesh-list
110999539|NCT02994719|Pramipexole|pramipexole|mesh-list
110999540|NCT02994719|Ropinirole|ropinirole|mesh-list
110999541|NCT02994719|Entacapone|entacapone|mesh-list
110999542|NCT02994719|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
110999543|NCT02994719|Tolcapone|tolcapone|mesh-list
110452997|NCT00618046|Anticonvulsants|anticonvulsants|mesh-ancestor
110999544|NCT02994719|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110999545|NCT02994719|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110999546|NCT02994719|Dopamine Agents|dopamine agents|mesh-ancestor
110999547|NCT02994719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110999548|NCT02994719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110999549|NCT02994719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110999550|NCT02994719|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
110999551|NCT02994719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110999552|NCT02994719|Antioxidants|antioxidants|mesh-ancestor
110999553|NCT02994719|Protective Agents|protective agents|mesh-ancestor
110999554|NCT02994719|Dopamine Agonists|dopamine agonists|mesh-ancestor
110999555|NCT02994719|Antiviral Agents|antiviral agents|mesh-ancestor
110999556|NCT02994719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110999557|NCT02994719|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110999559|NCT02994719|Sensory System Agents|sensory system agents|mesh-ancestor
110999560|NCT02994719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110999561|NCT02994719|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
110999562|NCT02994719|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110999563|NCT02994719|Immunologic Factors|immunologic factors|mesh-ancestor
110999564|NCT04356638|Midazolam|midazolam|mesh-list
110999565|NCT04356638|Dexmedetomidine|dexmedetomidine|mesh-list
110999566|NCT04356638|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110999567|NCT04356638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110999568|NCT04356638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110999569|NCT04356638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110999570|NCT04356638|Analgesics|analgesics|mesh-ancestor
110999571|NCT04356638|Sensory System Agents|sensory system agents|mesh-ancestor
110999572|NCT04356638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110999573|NCT04356638|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110999574|NCT04356638|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110999575|NCT04356638|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110999576|NCT04356638|Adrenergic Agents|adrenergic agents|mesh-ancestor
110999577|NCT04356638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110999578|NCT04356638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110999579|NCT04356638|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110999580|NCT04356638|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110999581|NCT04356638|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110999582|NCT04356638|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110999583|NCT04356638|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110999584|NCT04356638|Anesthetics, General|anesthetics, general|mesh-ancestor
110999585|NCT04356638|Anesthetics|anesthetics|mesh-ancestor
110999586|NCT04356638|GABA Modulators|gaba modulators|mesh-ancestor
110999587|NCT04356638|GABA Agents|gaba agents|mesh-ancestor
110999588|NCT04346108|Immunoglobulins|immunoglobulins|mesh-list
110999589|NCT04346108|Antibodies|antibodies|mesh-list
110999590|NCT04346108|gamma-Globulins|gamma-globulins|mesh-list
110999591|NCT04346108|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110999592|NCT04346108|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110999593|NCT04346108|Immunoglobulin G|immunoglobulin g|mesh-list
110999594|NCT04346108|Immunologic Factors|immunologic factors|mesh-ancestor
110999595|NCT04346108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110999596|NCT02335736|Cetrorelix|cetrorelix|mesh-list
110999597|NCT02335736|Hormones|hormones|mesh-list
110999598|NCT02335736|Hormone Antagonists|hormone antagonists|mesh-list
110999599|NCT02335736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110999600|NCT02335736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110999601|NCT02335736|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110999602|NCT02335736|Fertility Agents|fertility agents|mesh-ancestor
110999603|NCT02335736|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110999604|NCT03613259|Alovudine|alovudine|mesh-list
110999605|NCT03613259|Antiviral Agents|antiviral agents|mesh-ancestor
110999606|NCT03613259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110999607|NCT02032355|Anesthetics|anesthetics|mesh-list
110999608|NCT02032355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110999609|NCT02032355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110999610|NCT03095456|Tiotropium Bromide|tiotropium bromide|mesh-list
110999611|NCT03095456|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110999612|NCT03095456|Autonomic Agents|autonomic agents|mesh-ancestor
110999613|NCT03095456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110999614|NCT03095456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110999615|NCT03095456|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110999616|NCT03095456|Respiratory System Agents|respiratory system agents|mesh-ancestor
110999617|NCT03095456|Parasympatholytics|parasympatholytics|mesh-ancestor
110999618|NCT03095456|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110999619|NCT03095456|Cholinergic Agents|cholinergic agents|mesh-ancestor
110999620|NCT03095456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110999621|NCT03095456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110999622|NCT03612557|Penicillins|penicillins|mesh-list
110999623|NCT03612557|Penicillin G|penicillin g|mesh-list
110999624|NCT03612557|Penicillin G Benzathine|penicillin g benzathine|mesh-list
110999625|NCT03612557|Penicillin G Procaine|penicillin g procaine|mesh-list
110999626|NCT03612557|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110999627|NCT03612557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110999628|NCT03067844|Alirocumab|alirocumab|mesh-list
110999629|NCT03067844|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
110999630|NCT03067844|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110999631|NCT03067844|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110999632|NCT03067844|Antimetabolites|antimetabolites|mesh-ancestor
110999633|NCT03067844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110999634|NCT03067844|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110999635|NCT03067844|Protease Inhibitors|protease inhibitors|mesh-ancestor
110999636|NCT03067844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110999637|NCT03067844|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110999638|NCT02340182|Metronidazole|metronidazole|mesh-list
110999639|NCT02340182|Vancomycin|vancomycin|mesh-list
110999640|NCT02340182|Ciprofloxacin|ciprofloxacin|mesh-list
110999641|NCT02340182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110999642|NCT02340182|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110999643|NCT02340182|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110999644|NCT02340182|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110999645|NCT02340182|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110999646|NCT02340182|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110999647|NCT02340182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110999648|NCT02340182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110999649|NCT02340182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110999650|NCT02340182|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110999651|NCT02340182|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110999652|NCT02339714|Loratadine|loratadine|mesh-list
110999653|NCT02339714|Antipruritics|antipruritics|mesh-ancestor
110999654|NCT02339714|Dermatologic Agents|dermatologic agents|mesh-ancestor
110999655|NCT02339714|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110999656|NCT02339714|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110999657|NCT02339714|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110999658|NCT02339714|Histamine Antagonists|histamine antagonists|mesh-ancestor
110999659|NCT02339714|Histamine Agents|histamine agents|mesh-ancestor
110999660|NCT02339714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110999661|NCT02339714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110999662|NCT02339714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110999663|NCT02335190|Lidocaine|lidocaine|mesh-list
110999664|NCT02335190|Anesthetics, Local|anesthetics, local|mesh-ancestor
110999665|NCT02335190|Anesthetics|anesthetics|mesh-ancestor
110999666|NCT02335190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110999667|NCT02335190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110999668|NCT02335190|Sensory System Agents|sensory system agents|mesh-ancestor
110999669|NCT02335190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110999670|NCT02335190|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110999671|NCT02335190|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110999672|NCT02335190|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110999673|NCT02335190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110999674|NCT02335190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110999675|NCT02339324|Interferons|interferons|mesh-list
110999676|NCT02339324|Interferon-alpha|interferon-alpha|mesh-list
110999677|NCT02339324|Interferon alpha-2|interferon alpha-2|mesh-list
110999678|NCT02339324|Pembrolizumab|pembrolizumab|mesh-list
110999679|NCT02339324|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110999680|NCT02339324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110999681|NCT02339324|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110025127|NCT00357942|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110999682|NCT02339324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110999683|NCT02339324|Antiviral Agents|antiviral agents|mesh-ancestor
110999684|NCT02339324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110999685|NCT02339324|Immunologic Factors|immunologic factors|mesh-ancestor
110999686|NCT02339324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110999687|NCT02418754|Aflibercept|aflibercept|mesh-list
110999688|NCT02418754|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110999689|NCT02418754|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110999690|NCT02418754|Growth Substances|growth substances|mesh-ancestor
110999691|NCT02418754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110999692|NCT02418754|Growth Inhibitors|growth inhibitors|mesh-ancestor
110999693|NCT02418754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110999694|NCT02334488|Mycophenolic Acid|mycophenolic acid|mesh-list
110999695|NCT02334488|Everolimus|everolimus|mesh-list
110999696|NCT02334488|Tacrolimus|tacrolimus|mesh-list
110999697|NCT02334488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110999698|NCT02334488|Immunologic Factors|immunologic factors|mesh-ancestor
110999699|NCT02334488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110999700|NCT02334488|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110999701|NCT02334488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110999702|NCT02334488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110999703|NCT02334488|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110999704|NCT02334488|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110999705|NCT02334488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110999706|NCT02334488|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110999707|NCT02334488|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110999708|NCT02334488|Antitubercular Agents|antitubercular agents|mesh-ancestor
110999709|NCT02334488|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110999710|NCT02334488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110999711|NCT02862457|Paclitaxel|paclitaxel|mesh-list
110999712|NCT02862457|Cisplatin|cisplatin|mesh-list
110999713|NCT02862457|Carboplatin|carboplatin|mesh-list
110999714|NCT02862457|Pembrolizumab|pembrolizumab|mesh-list
110999715|NCT02862457|Pemetrexed|pemetrexed|mesh-list
110999716|NCT02862457|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110999717|NCT02862457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110999718|NCT02862457|Tubulin Modulators|tubulin modulators|mesh-ancestor
110999719|NCT02862457|Antimitotic Agents|antimitotic agents|mesh-ancestor
110999720|NCT02862457|Mitosis Modulators|mitosis modulators|mesh-ancestor
110999721|NCT02862457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110999722|NCT02862457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110999723|NCT02862457|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110999724|NCT02862457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110999725|NCT02862457|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110999726|NCT02862457|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110999727|NCT02334254|Warfarin|warfarin|mesh-list
110999728|NCT02334254|Rivaroxaban|rivaroxaban|mesh-list
110999729|NCT02334254|Clopidogrel|clopidogrel|mesh-list
110999730|NCT02334254|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110999731|NCT02334254|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110999732|NCT02334254|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110999733|NCT02334254|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110999734|NCT02334254|Purinergic Agents|purinergic agents|mesh-ancestor
110999735|NCT02334254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110999736|NCT02334254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110999737|NCT02334254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110999738|NCT02334254|Anticoagulants|anticoagulants|mesh-ancestor
110999739|NCT02334254|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110999740|NCT02334254|Antithrombins|antithrombins|mesh-ancestor
110999741|NCT02334254|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110999742|NCT02334254|Protease Inhibitors|protease inhibitors|mesh-ancestor
110999743|NCT02334254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110999744|NCT02331602|Rivaroxaban|rivaroxaban|mesh-list
110999745|NCT02331602|Dabigatran|dabigatran|mesh-list
110999746|NCT02331602|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110999747|NCT02331602|Antithrombins|antithrombins|mesh-ancestor
110999748|NCT02331602|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110999749|NCT02331602|Protease Inhibitors|protease inhibitors|mesh-ancestor
110999750|NCT02331602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110999751|NCT02331602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110999752|NCT02331602|Anticoagulants|anticoagulants|mesh-ancestor
110999753|NCT02338934|Vitamin D|vitamin d|mesh-list
110999754|NCT02338934|Cinacalcet|cinacalcet|mesh-list
110999755|NCT02338934|Vitamins|vitamins|mesh-ancestor
110999756|NCT02338934|Micronutrients|micronutrients|mesh-ancestor
110999757|NCT02338934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110999758|NCT02338934|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110999759|NCT02338934|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110999760|NCT02338934|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
110999761|NCT02338934|Hormone Antagonists|hormone antagonists|mesh-ancestor
110999762|NCT02338934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110999763|NCT03861039|Tirzepatide|tirzepatide|mesh-list
110999764|NCT03861039|Hypoglycemic Agents|hypoglycemic agents|mesh-list
110999765|NCT03861039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110999766|NCT03861039|Incretins|incretins|mesh-ancestor
110999767|NCT03861039|Hormones|hormones|mesh-ancestor
110999768|NCT03861039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110999769|NCT02334176|Lidocaine|lidocaine|mesh-list
110999770|NCT02334176|Epinephrine|epinephrine|mesh-list
110999771|NCT02334176|Anesthetics, Local|anesthetics, local|mesh-ancestor
110999772|NCT02334176|Anesthetics|anesthetics|mesh-ancestor
110999773|NCT02334176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110999774|NCT02334176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110999775|NCT02334176|Sensory System Agents|sensory system agents|mesh-ancestor
110999776|NCT02334176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110999777|NCT02334176|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110999778|NCT02334176|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110999779|NCT02334176|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110999780|NCT02334176|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110999781|NCT02334176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110999782|NCT02334176|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110999783|NCT02334176|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110999784|NCT02334176|Adrenergic Agents|adrenergic agents|mesh-ancestor
110999785|NCT02334176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110999786|NCT02334176|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110999787|NCT02334176|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110999788|NCT02334176|Autonomic Agents|autonomic agents|mesh-ancestor
110999789|NCT02334176|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110999790|NCT02334176|Respiratory System Agents|respiratory system agents|mesh-ancestor
110999791|NCT02334176|Mydriatics|mydriatics|mesh-ancestor
110999792|NCT02334176|Sympathomimetics|sympathomimetics|mesh-ancestor
110999793|NCT02334176|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110999794|NCT02338856|Beta-lapachone|beta-lapachone|mesh-list
110999795|NCT02338856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110999796|NCT02338856|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110999797|NCT02338856|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110999798|NCT02338856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110999799|NCT02338856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110999800|NCT02338856|Antiviral Agents|antiviral agents|mesh-ancestor
110999801|NCT03609307|Bevacizumab|bevacizumab|mesh-list
110999802|NCT03609307|Propranolol|propranolol|mesh-list
110999803|NCT03609307|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110999804|NCT03609307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110999805|NCT03609307|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110999806|NCT03609307|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110999807|NCT03609307|Growth Substances|growth substances|mesh-ancestor
110999808|NCT03609307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110999809|NCT03609307|Growth Inhibitors|growth inhibitors|mesh-ancestor
110999810|NCT03609307|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110999811|NCT03609307|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110999812|NCT03609307|Adrenergic Agents|adrenergic agents|mesh-ancestor
110999813|NCT03609307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110999814|NCT03609307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110453039|NCT02299414|Tocolytic Agents|tocolytic agents|mesh-ancestor
110999815|NCT03609307|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110999816|NCT03609307|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110999817|NCT03609307|Vasodilator Agents|vasodilator agents|mesh-ancestor
110999818|NCT03399435|Epinephrine|epinephrine|mesh-list
110999819|NCT03399435|Racepinephrine|racepinephrine|mesh-list
110999820|NCT03399435|Bupivacaine|bupivacaine|mesh-list
110999821|NCT03399435|Epinephryl borate|epinephryl borate|mesh-list
110999822|NCT03399435|Neosaxitoxin|neosaxitoxin|mesh-list
110999823|NCT03399435|Anesthetics, Local|anesthetics, local|mesh-ancestor
110999824|NCT03399435|Anesthetics|anesthetics|mesh-ancestor
110999825|NCT03399435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110999826|NCT03399435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110999827|NCT03399435|Sensory System Agents|sensory system agents|mesh-ancestor
110999828|NCT03399435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110999829|NCT03399435|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110999830|NCT03399435|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110999831|NCT03399435|Adrenergic Agents|adrenergic agents|mesh-ancestor
110999832|NCT03399435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110025128|NCT00357942|Narcotics|narcotics|mesh-ancestor
110999833|NCT03399435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110999834|NCT03399435|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110999835|NCT03399435|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110999836|NCT03399435|Autonomic Agents|autonomic agents|mesh-ancestor
110999837|NCT03399435|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110999838|NCT03399435|Respiratory System Agents|respiratory system agents|mesh-ancestor
110999839|NCT03399435|Mydriatics|mydriatics|mesh-ancestor
110999840|NCT03399435|Sympathomimetics|sympathomimetics|mesh-ancestor
110999841|NCT03399435|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110999842|NCT03399435|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110999843|NCT03399435|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110999844|NCT01936688|Etanercept|etanercept|mesh-list
110999845|NCT01936688|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110999846|NCT01936688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110999847|NCT01936688|Analgesics|analgesics|mesh-ancestor
110999848|NCT01936688|Sensory System Agents|sensory system agents|mesh-ancestor
110999849|NCT01936688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110999850|NCT01936688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110999851|NCT01936688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110999852|NCT01936688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110999853|NCT01936688|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110999854|NCT01936688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110999855|NCT01936688|Immunologic Factors|immunologic factors|mesh-ancestor
110999856|NCT02338544|Adapalene|adapalene|mesh-list
110999857|NCT02338544|Benzoyl Peroxide|benzoyl peroxide|mesh-list
110999858|NCT02338544|Dermatologic Agents|dermatologic agents|mesh-ancestor
110999859|NCT02338544|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110999860|NCT02338544|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110999861|NCT02338544|Analgesics|analgesics|mesh-ancestor
110999862|NCT02338544|Sensory System Agents|sensory system agents|mesh-ancestor
110999863|NCT02338544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110999864|NCT02338544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110999865|NCT02338544|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110999866|NCT02338544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110999867|NCT04446663|Paclitaxel|paclitaxel|mesh-list
110999868|NCT04446663|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110999869|NCT04446663|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110999870|NCT04446663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110999871|NCT04446663|Tubulin Modulators|tubulin modulators|mesh-ancestor
110999872|NCT04446663|Antimitotic Agents|antimitotic agents|mesh-ancestor
110999873|NCT04446663|Mitosis Modulators|mitosis modulators|mesh-ancestor
110999874|NCT04446663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110999875|NCT01861496|Cisplatin|cisplatin|mesh-list
110999876|NCT01861496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110999877|NCT02520219|Endostar protein|endostar protein|mesh-list
110999878|NCT02520219|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110999879|NCT02520219|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110999880|NCT02520219|Growth Substances|growth substances|mesh-ancestor
110999881|NCT02520219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110453044|NCT01016262|Analgesics|analgesics|mesh-ancestor
110999882|NCT02520219|Growth Inhibitors|growth inhibitors|mesh-ancestor
110999883|NCT02520219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110999884|NCT03394287|Apatinib|apatinib|mesh-list
110999885|NCT03394287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110999886|NCT03394287|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110999887|NCT03394287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110999888|NCT03394287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110999889|NCT02338622|Olaparib|olaparib|mesh-list
110999890|NCT02338622|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110999891|NCT02338622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110999892|NCT02338622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110999893|NCT02338622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110999894|NCT02338466|Tenecteplase|tenecteplase|mesh-list
110999895|NCT02338466|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110999896|NCT02338466|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110999897|NCT02338466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110999898|NCT03394209|Oseltamivir|oseltamivir|mesh-list
110999899|NCT03394209|Favipiravir|favipiravir|mesh-list
110999900|NCT03394209|Antiviral Agents|antiviral agents|mesh-ancestor
110999901|NCT03394209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110999902|NCT03394209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110999903|NCT03394209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110999904|NCT03399201|Anesthetics|anesthetics|mesh-list
110999905|NCT03399201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110999906|NCT03399201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110999907|NCT02520453|Durvalumab|durvalumab|mesh-list
110999908|NCT02520453|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110999909|NCT02520453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110999910|NCT03389763|Remifentanil|remifentanil|mesh-list
110999911|NCT03389763|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110999912|NCT03389763|Narcotics|narcotics|mesh-ancestor
110999913|NCT03389763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110999914|NCT03389763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110999915|NCT03389763|Analgesics|analgesics|mesh-ancestor
110999916|NCT03389763|Sensory System Agents|sensory system agents|mesh-ancestor
110999917|NCT03389763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110999918|NCT02866175|Vitamin K|vitamin k|mesh-list
110999919|NCT02866175|Edoxaban|edoxaban|mesh-list
110999920|NCT02866175|Clopidogrel|clopidogrel|mesh-list
110999921|NCT02866175|Ticagrelor|ticagrelor|mesh-list
110999922|NCT02866175|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
110999923|NCT02866175|Vitamins|vitamins|mesh-ancestor
110999924|NCT02866175|Micronutrients|micronutrients|mesh-ancestor
110999925|NCT02866175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110999926|NCT02866175|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110999927|NCT02866175|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110999928|NCT02866175|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110999929|NCT02866175|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110999930|NCT02866175|Purinergic Agents|purinergic agents|mesh-ancestor
110999931|NCT02866175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110716934|NCT01229332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110999932|NCT02866175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110999933|NCT02866175|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110999934|NCT02866175|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110999935|NCT02866175|Hemostatics|hemostatics|mesh-ancestor
110999936|NCT02866175|Coagulants|coagulants|mesh-ancestor
110999937|NCT02866175|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110999938|NCT02866175|Antithrombins|antithrombins|mesh-ancestor
110999939|NCT02866175|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110999940|NCT02866175|Protease Inhibitors|protease inhibitors|mesh-ancestor
110999941|NCT02866175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110999942|NCT02866175|Anticoagulants|anticoagulants|mesh-ancestor
110999943|NCT02330822|Hyaluronic Acid|hyaluronic acid|mesh-list
110999944|NCT02330822|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110999945|NCT02330822|Immunologic Factors|immunologic factors|mesh-ancestor
110999946|NCT02330822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110999947|NCT02330822|Viscosupplements|viscosupplements|mesh-ancestor
110999948|NCT02330822|Protective Agents|protective agents|mesh-ancestor
110999949|NCT02338310|Letrozole|letrozole|mesh-list
110999950|NCT02338310|Aromatase Inhibitors|aromatase inhibitors|mesh-list
110999951|NCT02338310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110999952|NCT02338310|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110999953|NCT02338310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110999954|NCT02338310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110999955|NCT02338310|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110999956|NCT02338310|Hormone Antagonists|hormone antagonists|mesh-ancestor
110999957|NCT02338310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110999958|NCT02338310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110999959|NCT03389607|Anesthetics|anesthetics|mesh-list
110999960|NCT03389607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110999961|NCT03389607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110999962|NCT02817789|Acetylsalicylic acid lysinate|acetylsalicylic acid lysinate|mesh-list
110999963|NCT02817789|Clopidogrel|clopidogrel|mesh-list
110999964|NCT02817789|Ticagrelor|ticagrelor|mesh-list
110999965|NCT02817789|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110999966|NCT02817789|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110999967|NCT02817789|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110999968|NCT02817789|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110999969|NCT02817789|Purinergic Agents|purinergic agents|mesh-ancestor
110999970|NCT02817789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110999971|NCT02817789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110999972|NCT02817789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110999973|NCT02817789|Analgesics|analgesics|mesh-ancestor
110999974|NCT02817789|Sensory System Agents|sensory system agents|mesh-ancestor
110999975|NCT02817789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110999976|NCT02817789|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110999977|NCT02817789|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110999978|NCT02817789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110999979|NCT02817789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110999980|NCT02817789|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110999981|NCT02817789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110999983|NCT05383625|Immunologic Factors|immunologic factors|mesh-ancestor
110999984|NCT05383625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110999985|NCT03389451|Edetic Acid|edetic acid|mesh-list
110999986|NCT03389451|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
110999987|NCT03389451|Chelating Agents|chelating agents|mesh-ancestor
110999988|NCT03389451|Sequestering Agents|sequestering agents|mesh-ancestor
110999989|NCT03389451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110999990|NCT03389451|Anticoagulants|anticoagulants|mesh-ancestor
110999991|NCT03389451|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110999992|NCT03389451|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110999993|NCT03385395|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
110999994|NCT03385395|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
110999995|NCT03385395|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110999996|NCT03385395|Protease Inhibitors|protease inhibitors|mesh-ancestor
110999997|NCT03385395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110999998|NCT03385395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110999999|NCT02330120|Dexmedetomidine|dexmedetomidine|mesh-list
111000000|NCT02330120|Propofol|propofol|mesh-list
111000001|NCT02330120|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111000002|NCT02330120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111000003|NCT02330120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111000004|NCT02330120|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111000005|NCT02330120|Analgesics|analgesics|mesh-ancestor
111000006|NCT02330120|Sensory System Agents|sensory system agents|mesh-ancestor
111000007|NCT02330120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111000008|NCT02330120|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111000009|NCT02330120|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111000010|NCT02330120|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111000011|NCT02330120|Adrenergic Agents|adrenergic agents|mesh-ancestor
111000012|NCT02330120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111000013|NCT02330120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111000014|NCT02330120|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111000015|NCT02330120|Anesthetics, General|anesthetics, general|mesh-ancestor
111000016|NCT02330120|Anesthetics|anesthetics|mesh-ancestor
111000017|NCT03389295|Cisplatin|cisplatin|mesh-list
111000018|NCT03389295|Docetaxel|docetaxel|mesh-list
111000019|NCT03389295|Fluorouracil|fluorouracil|mesh-list
111000020|NCT03389295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111000021|NCT03389295|Tubulin Modulators|tubulin modulators|mesh-ancestor
111000022|NCT03389295|Antimitotic Agents|antimitotic agents|mesh-ancestor
111000023|NCT03389295|Mitosis Modulators|mitosis modulators|mesh-ancestor
111000024|NCT03389295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111000025|NCT03389295|Antimetabolites|antimetabolites|mesh-ancestor
111000026|NCT03389295|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111000027|NCT03389295|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111000028|NCT03389295|Immunologic Factors|immunologic factors|mesh-ancestor
111000029|NCT03389295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111000030|NCT03398811|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
111000031|NCT03398811|Etonogestrel|etonogestrel|mesh-list
111000032|NCT03398811|Desogestrel|desogestrel|mesh-list
111000033|NCT03398811|Medroxyprogesterone|medroxyprogesterone|mesh-list
111000034|NCT03398811|Progesterone|progesterone|mesh-list
111000035|NCT03398811|Progestins|progestins|mesh-ancestor
111000036|NCT03398811|Hormones|hormones|mesh-ancestor
111000037|NCT03398811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111000038|NCT03398811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111000039|NCT03398811|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111000040|NCT03398811|Contraceptive Agents|contraceptive agents|mesh-ancestor
111000041|NCT03398811|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111000042|NCT03398811|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111000043|NCT03398811|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111000044|NCT03398811|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111000045|NCT03398811|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111000046|NCT03398811|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
111000047|NCT03398811|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111000048|NCT03398811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111000049|NCT01300143|Chlorotrianisene|chlorotrianisene|mesh-list
111000050|NCT01300143|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
111000051|NCT01300143|Estrogens|estrogens|mesh-ancestor
111000052|NCT01300143|Hormones|hormones|mesh-ancestor
111000053|NCT01300143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111000054|NCT01300143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111000055|NCT01300143|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111000056|NCT01300143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111000058|NCT01336205|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111000059|NCT01336205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111000060|NCT01336205|Sensory System Agents|sensory system agents|mesh-ancestor
111000061|NCT01336205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111000062|NCT02333240|Antihypertensive Agents|antihypertensive agents|mesh-list
111000063|NCT03610685|Prednisolone|prednisolone|mesh-list
111000064|NCT03610685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111000065|NCT03610685|Glucocorticoids|glucocorticoids|mesh-ancestor
111000066|NCT03610685|Hormones|hormones|mesh-ancestor
111000067|NCT03610685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111000068|NCT03610685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111000069|NCT03610685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111000070|NCT03610685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111000071|NCT02327234|Ibuprofen|ibuprofen|mesh-list
111000072|NCT02327234|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111000073|NCT02327234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111000074|NCT02327234|Analgesics|analgesics|mesh-ancestor
111000075|NCT02327234|Sensory System Agents|sensory system agents|mesh-ancestor
111000076|NCT02327234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111000077|NCT02327234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111000078|NCT02327234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111000079|NCT02327234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111000080|NCT02327234|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111000081|NCT02327234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111000082|NCT02327234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111000083|NCT01123707|Aripiprazole|aripiprazole|mesh-list
111000084|NCT01123707|Escitalopram|escitalopram|mesh-list
111000085|NCT01123707|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111000086|NCT01123707|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111000087|NCT01123707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111000088|NCT01123707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111000089|NCT01123707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111000090|NCT01123707|Serotonin Agents|serotonin agents|mesh-ancestor
111000091|NCT01123707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111000092|NCT01123707|Antidepressive Agents|antidepressive agents|mesh-ancestor
111000093|NCT01123707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111000094|NCT01123707|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111000095|NCT01123707|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111000096|NCT01123707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111000097|NCT01123707|Dopamine Agonists|dopamine agonists|mesh-ancestor
111000098|NCT01123707|Dopamine Agents|dopamine agents|mesh-ancestor
111000099|NCT01123707|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111000100|NCT01123707|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111000101|NCT01123707|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111000102|NCT01123707|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111000103|NCT01123707|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111000104|NCT01123707|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111000105|NCT01258803|Mometasone Furoate|mometasone furoate|mesh-list
111000106|NCT01258803|Formoterol Fumarate|formoterol fumarate|mesh-list
111000107|NCT01258803|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111000108|NCT01258803|Autonomic Agents|autonomic agents|mesh-ancestor
111000109|NCT01258803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111000110|NCT01258803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111000111|NCT01258803|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111000112|NCT01258803|Respiratory System Agents|respiratory system agents|mesh-ancestor
111000113|NCT01258803|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111000114|NCT01258803|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111000115|NCT01258803|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111000116|NCT01258803|Adrenergic Agents|adrenergic agents|mesh-ancestor
111000117|NCT01258803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111000118|NCT01258803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111000119|NCT01258803|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111000120|NCT01258803|Dermatologic Agents|dermatologic agents|mesh-ancestor
111000121|NCT01258803|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111000122|NCT02327156|Dexmedetomidine|dexmedetomidine|mesh-list
111000123|NCT02327156|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111000124|NCT02327156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111000125|NCT02327156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111000126|NCT02327156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111000127|NCT02327156|Analgesics|analgesics|mesh-ancestor
111000128|NCT02327156|Sensory System Agents|sensory system agents|mesh-ancestor
110823022|NCT02849990|Hormones|hormones|mesh-ancestor
111000129|NCT02327156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111000130|NCT02327156|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111000131|NCT02327156|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111000132|NCT02327156|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111000133|NCT02327156|Adrenergic Agents|adrenergic agents|mesh-ancestor
111000134|NCT02327156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111000135|NCT02327156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111000136|NCT02039804|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111000137|NCT02039804|Hyaluronic Acid|hyaluronic acid|mesh-list
111000138|NCT02039804|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111000139|NCT02039804|Immunologic Factors|immunologic factors|mesh-ancestor
111000140|NCT02039804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111000141|NCT02039804|Viscosupplements|viscosupplements|mesh-ancestor
111000142|NCT02039804|Protective Agents|protective agents|mesh-ancestor
111000143|NCT02039804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111000145|NCT03385161|Botulinum Toxins|botulinum toxins|mesh-list
111000146|NCT03385161|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111000147|NCT03385161|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111000148|NCT03385161|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111000149|NCT03385161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111000150|NCT03385161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111000151|NCT03385161|Cholinergic Agents|cholinergic agents|mesh-ancestor
111000152|NCT03385161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111000153|NCT03385161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110717157|NCT01140100|Anesthetics|anesthetics|mesh-ancestor
111000154|NCT03385161|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111000155|NCT03385161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111000156|NCT03385161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111000157|NCT03385161|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111000158|NCT03385161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111000159|NCT02327000|Pregabalin|pregabalin|mesh-list
111000160|NCT02327000|Analgesics|analgesics|mesh-ancestor
111000161|NCT02327000|Sensory System Agents|sensory system agents|mesh-ancestor
111000162|NCT02327000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111000163|NCT02327000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111000164|NCT02327000|Anticonvulsants|anticonvulsants|mesh-ancestor
111000165|NCT02327000|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111000166|NCT02327000|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111000167|NCT02327000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111000168|NCT02327000|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111000169|NCT02327000|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111000170|NCT02327000|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111000171|NCT02327000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111000172|NCT02327000|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111000173|NCT02033603|Ropivacaine|ropivacaine|mesh-list
111000174|NCT02033603|Anesthetics, Local|anesthetics, local|mesh-ancestor
111000175|NCT02033603|Anesthetics|anesthetics|mesh-ancestor
111000176|NCT02033603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111000177|NCT02033603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111000178|NCT02033603|Sensory System Agents|sensory system agents|mesh-ancestor
111000179|NCT02033603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111000180|NCT02326922|Levonorgestrel|levonorgestrel|mesh-list
111000181|NCT02326922|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111000182|NCT02326922|Contraceptive Agents|contraceptive agents|mesh-ancestor
111000183|NCT02326922|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111000184|NCT02326922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111000185|NCT02326922|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111000186|NCT02326922|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111000187|NCT02326922|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111000188|NCT00862251|Atorvastatin|atorvastatin|mesh-list
111000189|NCT00862251|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111000190|NCT00862251|Simvastatin|simvastatin|mesh-list
111000191|NCT00862251|Ezetimibe|ezetimibe|mesh-list
111000192|NCT00862251|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111000193|NCT00862251|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111000194|NCT00862251|Antimetabolites|antimetabolites|mesh-ancestor
111000195|NCT00862251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111000196|NCT00862251|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111000197|NCT00862251|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111000198|NCT00862251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111000199|NCT00885963|Sapacitabine|sapacitabine|mesh-list
111000200|NCT00885963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111000201|NCT00725127|Aspirin|aspirin|mesh-list
111000202|NCT00725127|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111000203|NCT00725127|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111000205|NCT00725127|Sensory System Agents|sensory system agents|mesh-ancestor
111000206|NCT00725127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111000207|NCT00725127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111000208|NCT00725127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111000209|NCT00725127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111000210|NCT00725127|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111000211|NCT00725127|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111000212|NCT00725127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111000213|NCT00725127|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111000214|NCT00725127|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111000215|NCT00725127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111000216|NCT00725127|Antipyretics|antipyretics|mesh-ancestor
111000217|NCT02328950|Cytarabine|cytarabine|mesh-list
111000218|NCT02328950|Cyclophosphamide|cyclophosphamide|mesh-list
111000219|NCT02328950|Busulfan|busulfan|mesh-list
111000220|NCT02328950|Fludarabine|fludarabine|mesh-list
111000221|NCT02328950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111000222|NCT02328950|Immunologic Factors|immunologic factors|mesh-ancestor
111000223|NCT02328950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111000224|NCT02328950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111000225|NCT02328950|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111000226|NCT02328950|Alkylating Agents|alkylating agents|mesh-ancestor
111000227|NCT02328950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111000228|NCT02328950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111000229|NCT02328950|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111000230|NCT02328950|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111000231|NCT02328950|Antimetabolites|antimetabolites|mesh-ancestor
111000232|NCT02328950|Antiviral Agents|antiviral agents|mesh-ancestor
111000233|NCT02328950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111000234|NCT03398577|Dapagliflozin|dapagliflozin|mesh-list
111000235|NCT03398577|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111000236|NCT03398577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111000237|NCT03398577|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111000238|NCT03398577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111000239|NCT03389061|Sofosbuvir|sofosbuvir|mesh-list
111000240|NCT03389061|Velpatasvir|velpatasvir|mesh-list
111000241|NCT03389061|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
111000242|NCT03389061|Antiviral Agents|antiviral agents|mesh-ancestor
111000243|NCT03389061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111000244|NCT02038868|Tamsulosin|tamsulosin|mesh-list
111000245|NCT02038868|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111000246|NCT02038868|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111000247|NCT02038868|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111000248|NCT02038868|Adrenergic Agents|adrenergic agents|mesh-ancestor
111000249|NCT02038868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111000250|NCT02038868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111000251|NCT02038868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111000252|NCT02038868|Urological Agents|urological agents|mesh-ancestor
111000253|NCT02328794|Varenicline|varenicline|mesh-list
111000254|NCT02328794|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111000255|NCT02328794|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111000256|NCT02328794|Cholinergic Agents|cholinergic agents|mesh-ancestor
111000257|NCT02328794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111000258|NCT02328794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111000259|NCT02328794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111000260|NCT03388827|Misoprostol|misoprostol|mesh-list
111000261|NCT03388827|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111000262|NCT03388827|Abortifacient Agents|abortifacient agents|mesh-ancestor
111000263|NCT03388827|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111000264|NCT03388827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111000265|NCT03388827|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111000266|NCT03388827|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111000267|NCT03388827|Oxytocics|oxytocics|mesh-ancestor
111000268|NCT02328716|Cisplatin|cisplatin|mesh-list
111000269|NCT02328716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111000270|NCT00445107|Montelukast|montelukast|mesh-list
111000271|NCT00445107|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111000272|NCT00445107|Respiratory System Agents|respiratory system agents|mesh-ancestor
111000273|NCT00445107|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
111000274|NCT00445107|Hormone Antagonists|hormone antagonists|mesh-ancestor
111119141|NCT05339087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111000275|NCT00445107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111000276|NCT00445107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111000277|NCT00445107|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
111000278|NCT00445107|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111000279|NCT00445107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111000280|NCT05077592|Povidone-Iodine|povidone-iodine|mesh-list
111000281|NCT05077592|Povidone|povidone|mesh-list
111000282|NCT05077592|Plasma Substitutes|plasma substitutes|mesh-ancestor
111000283|NCT05077592|Blood Substitutes|blood substitutes|mesh-ancestor
111000284|NCT05077592|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111000285|NCT05077592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111000286|NCT00038727|Metformin|metformin|mesh-list
111000287|NCT00038727|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111000288|NCT00038727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111000289|NCT02864381|Nivolumab|nivolumab|mesh-list
111000290|NCT02864381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111000291|NCT02864381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111000292|NCT02864381|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111000293|NCT02864381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111000294|NCT05230472|Simvastatin|simvastatin|mesh-list
111000295|NCT05230472|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111000296|NCT05230472|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111000297|NCT05230472|Antimetabolites|antimetabolites|mesh-ancestor
111000298|NCT05230472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111000299|NCT05230472|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111000300|NCT05230472|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111000301|NCT05230472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110717321|NCT01076439|Xhance|xhance|mesh-list
111000302|NCT03398031|Magnesium Oxide|magnesium oxide|mesh-list
111000303|NCT03398031|Antacids|antacids|mesh-ancestor
111000304|NCT03398031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111000305|NCT03398031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111000306|NCT02039960|Bupropion|bupropion|mesh-list
111000307|NCT02039960|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111000308|NCT02039960|Antidepressive Agents|antidepressive agents|mesh-ancestor
111000309|NCT02039960|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111000310|NCT02039960|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111000311|NCT02039960|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111000312|NCT02039960|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111000313|NCT02039960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111000314|NCT02039960|Dopamine Agents|dopamine agents|mesh-ancestor
111000315|NCT02039960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111000316|NCT02039960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111000317|NCT02039960|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111000318|NCT02039960|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111000319|NCT02039960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111000320|NCT05383313|Midazolam|midazolam|mesh-list
111000321|NCT05383313|Ketamine|ketamine|mesh-list
111000322|NCT05383313|Psilocybin|psilocybin|mesh-list
111000323|NCT05383313|Analgesics|analgesics|mesh-ancestor
111000324|NCT05383313|Sensory System Agents|sensory system agents|mesh-ancestor
111000325|NCT05383313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111000326|NCT05383313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111000327|NCT05383313|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111000328|NCT05383313|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111000329|NCT05383313|Anesthetics, General|anesthetics, general|mesh-ancestor
111000330|NCT05383313|Anesthetics|anesthetics|mesh-ancestor
111000331|NCT05383313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111000332|NCT05383313|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111000333|NCT05383313|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111000334|NCT05383313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111000335|NCT05383313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111000336|NCT05383313|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111000337|NCT05383313|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111000338|NCT05383313|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111000339|NCT05383313|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111000340|NCT05383313|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111000341|NCT05383313|GABA Modulators|gaba modulators|mesh-ancestor
111000342|NCT05383313|GABA Agents|gaba agents|mesh-ancestor
111000343|NCT05383313|Hallucinogens|hallucinogens|mesh-ancestor
111000344|NCT02033681|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111000345|NCT03144128|Vitamin D|vitamin d|mesh-list
111000346|NCT03144128|Vitamins|vitamins|mesh-ancestor
111000347|NCT03144128|Micronutrients|micronutrients|mesh-ancestor
111000348|NCT03144128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111000349|NCT03144128|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111000350|NCT02326610|Hormones|hormones|mesh-list
111000351|NCT02326610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111000352|NCT02326610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111000353|NCT00409773|Atorvastatin|atorvastatin|mesh-list
111000354|NCT00409773|Simvastatin|simvastatin|mesh-list
111000355|NCT00409773|Ezetimibe|ezetimibe|mesh-list
111000356|NCT00409773|Calcium|calcium|mesh-list
111000357|NCT00409773|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111000358|NCT00409773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111000359|NCT00409773|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111000360|NCT00409773|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111000361|NCT00409773|Antimetabolites|antimetabolites|mesh-ancestor
111000362|NCT00409773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111000363|NCT00409773|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111000364|NCT00409773|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111000365|NCT00409773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111000366|NCT02326376|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
111000367|NCT02326376|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111000368|NCT02034422|Antioxidants|antioxidants|mesh-list
111000369|NCT02034422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111000370|NCT02034422|Protective Agents|protective agents|mesh-ancestor
111000371|NCT02034422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111000372|NCT02325986|Fluorouracil|fluorouracil|mesh-list
111000373|NCT02325986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111000374|NCT02325986|Antimetabolites|antimetabolites|mesh-ancestor
111000375|NCT02325986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111000376|NCT02325986|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111000377|NCT02325986|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111000378|NCT02325986|Immunologic Factors|immunologic factors|mesh-ancestor
111000379|NCT02325986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111000380|NCT00398151|Montelukast|montelukast|mesh-list
111000381|NCT00398151|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111000382|NCT00398151|Respiratory System Agents|respiratory system agents|mesh-ancestor
111000383|NCT00398151|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
111000384|NCT00398151|Hormone Antagonists|hormone antagonists|mesh-ancestor
111000385|NCT00398151|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111000386|NCT00398151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111000387|NCT00398151|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
111000388|NCT00398151|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111000389|NCT00398151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111000390|NCT03610139|Vitamin D|vitamin d|mesh-list
111000391|NCT03610139|Cholecalciferol|cholecalciferol|mesh-list
111000392|NCT03610139|Vitamins|vitamins|mesh-ancestor
111000393|NCT03610139|Micronutrients|micronutrients|mesh-ancestor
111000394|NCT03610139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111000395|NCT03610139|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111000396|NCT03610139|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111000397|NCT02327624|Clopidogrel|clopidogrel|mesh-list
111000398|NCT02327624|Ticagrelor|ticagrelor|mesh-list
111000399|NCT02327624|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111000400|NCT02327624|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111000401|NCT02327624|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111000402|NCT02327624|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111000403|NCT02327624|Purinergic Agents|purinergic agents|mesh-ancestor
111000404|NCT02327624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111000405|NCT02327624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111000406|NCT02327624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111000407|NCT03388671|Bupivacaine|bupivacaine|mesh-list
111000408|NCT03388671|Anesthetics, Local|anesthetics, local|mesh-ancestor
111000409|NCT03388671|Anesthetics|anesthetics|mesh-ancestor
111000410|NCT03388671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111000411|NCT03388671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111000412|NCT03388671|Sensory System Agents|sensory system agents|mesh-ancestor
111000413|NCT03388671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111000414|NCT02327936|Fesoterodine|fesoterodine|mesh-list
111000415|NCT02327936|Oxybutynin|oxybutynin|mesh-list
111000416|NCT02327936|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111000417|NCT02327936|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111000418|NCT02327936|Cholinergic Agents|cholinergic agents|mesh-ancestor
111000419|NCT02327936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111000420|NCT02327936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111000421|NCT02327936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111000422|NCT02327936|Urological Agents|urological agents|mesh-ancestor
111000423|NCT02327936|Parasympatholytics|parasympatholytics|mesh-ancestor
111000424|NCT02327936|Autonomic Agents|autonomic agents|mesh-ancestor
111000425|NCT02327936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111000426|NCT03609827|Melphalan|melphalan|mesh-list
111000427|NCT03609827|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111000428|NCT03609827|Alkylating Agents|alkylating agents|mesh-ancestor
111000429|NCT03609827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111000430|NCT03609827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111000431|NCT03609827|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111000432|NCT03609827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111000433|NCT03609827|Immunologic Factors|immunologic factors|mesh-ancestor
111000434|NCT03609827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111000435|NCT02858401|Vesatolimod|vesatolimod|mesh-list
111000436|NCT02858401|Antiviral Agents|antiviral agents|mesh-ancestor
111000437|NCT02858401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111000438|NCT03144596|Tamsulosin|tamsulosin|mesh-list
111000439|NCT03144596|Alfuzosin|alfuzosin|mesh-list
111000440|NCT03144596|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111000441|NCT03144596|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111000442|NCT03144596|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111000443|NCT03144596|Adrenergic Agents|adrenergic agents|mesh-ancestor
111000444|NCT03144596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111000445|NCT03144596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111000446|NCT03144596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111000447|NCT03144596|Urological Agents|urological agents|mesh-ancestor
111000448|NCT00127647|Montelukast|montelukast|mesh-list
111000449|NCT00127647|Pranlukast|pranlukast|mesh-list
111000450|NCT00127647|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111000451|NCT00127647|Respiratory System Agents|respiratory system agents|mesh-ancestor
111000452|NCT00127647|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
111000453|NCT00127647|Hormone Antagonists|hormone antagonists|mesh-ancestor
111000454|NCT00127647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111000455|NCT00127647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111000456|NCT00127647|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
111000457|NCT00127647|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111000458|NCT00127647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111000460|NCT03111446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111000461|NCT03111446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111000462|NCT02034071|Diazoxide|diazoxide|mesh-list
111000463|NCT02034071|Choline|choline|mesh-list
111000464|NCT02034071|Lipotropic Agents|lipotropic agents|mesh-ancestor
111000465|NCT02034071|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111000466|NCT02034071|Antimetabolites|antimetabolites|mesh-ancestor
111000467|NCT02034071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111000468|NCT02034071|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111000469|NCT02034071|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111000470|NCT02034071|Nootropic Agents|nootropic agents|mesh-ancestor
111000471|NCT02034071|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111000472|NCT02034071|Vasodilator Agents|vasodilator agents|mesh-ancestor
111000473|NCT03609359|Pembrolizumab|pembrolizumab|mesh-list
111000474|NCT03609359|Lenvatinib|lenvatinib|mesh-list
111000475|NCT03609359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111000476|NCT03609359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111000477|NCT03609359|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111000478|NCT03609359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111000479|NCT03609359|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111000480|NCT03609359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111000481|NCT04833764|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111000482|NCT04833764|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111000483|NCT04833764|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111000484|NCT04833764|Antimetabolites|antimetabolites|mesh-ancestor
111000485|NCT04833764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111000486|NCT04833764|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111000487|NCT04833764|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111000488|NCT04833764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111000489|NCT03388125|Ethanolamine oleate|ethanolamine oleate|mesh-list
111000490|NCT03388125|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
111000491|NCT03388125|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111000492|NCT04822376|Ansuvimab|ansuvimab|mesh-list
111000493|NCT04822376|Antiviral Agents|antiviral agents|mesh-ancestor
111000495|NCT05173545|Mitoxantrone|mitoxantrone|mesh-list
111000496|NCT05173545|Analgesics|analgesics|mesh-ancestor
111000497|NCT05173545|Sensory System Agents|sensory system agents|mesh-ancestor
111000498|NCT05173545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111000499|NCT05173545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111000500|NCT05173545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111000501|NCT05173545|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111000502|NCT05173545|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111000503|NCT05173545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111000504|NCT05173545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111000505|NCT05383183|Choline|choline|mesh-list
111000506|NCT05383183|Lipotropic Agents|lipotropic agents|mesh-ancestor
111000507|NCT05383183|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111000508|NCT05383183|Antimetabolites|antimetabolites|mesh-ancestor
111000509|NCT05383183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111000510|NCT05383183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111000511|NCT05383183|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111000512|NCT05383183|Nootropic Agents|nootropic agents|mesh-ancestor
111000513|NCT02327702|Emtricitabine|emtricitabine|mesh-list
111000514|NCT02327702|Antiviral Agents|antiviral agents|mesh-ancestor
111000515|NCT02327702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111000516|NCT02327702|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111000517|NCT02327702|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111000518|NCT02327702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111000519|NCT02327702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111000520|NCT02327702|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111000521|NCT02327702|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111000522|NCT03609775|Ethanol|ethanol|mesh-list
110717530|NCT01763866|Ezetimibe|ezetimibe|mesh-list
111000523|NCT03609775|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111000524|NCT03609775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111000525|NCT03609775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111000526|NCT03609775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111000527|NCT03690765|Dydrogesterone|dydrogesterone|mesh-list
111000528|NCT03690765|Progestins|progestins|mesh-ancestor
111000529|NCT03690765|Hormones|hormones|mesh-ancestor
111000530|NCT03690765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111000531|NCT03690765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111000532|NCT02033941|Phenol|phenol|mesh-list
111000533|NCT02033941|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111000534|NCT02033941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111000535|NCT02033941|Disinfectants|disinfectants|mesh-ancestor
110453133|NCT00621790|Fenoldopam|fenoldopam|mesh-list
111000536|NCT02033941|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
111000537|NCT02033941|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111000538|NCT03143972|Dexmedetomidine|dexmedetomidine|mesh-list
111000539|NCT03143972|Remifentanil|remifentanil|mesh-list
111000540|NCT03143972|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111000541|NCT03143972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111000542|NCT03143972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111000543|NCT03143972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111000544|NCT03143972|Analgesics|analgesics|mesh-ancestor
111000545|NCT03143972|Sensory System Agents|sensory system agents|mesh-ancestor
111000546|NCT03143972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111000547|NCT03143972|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111000548|NCT03143972|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111000549|NCT03143972|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111000550|NCT03143972|Adrenergic Agents|adrenergic agents|mesh-ancestor
111000551|NCT03143972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111000552|NCT03143972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111000553|NCT03143972|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111000554|NCT03143972|Narcotics|narcotics|mesh-ancestor
111000555|NCT02237027|Tenofovir|tenofovir|mesh-list
111000556|NCT02237027|Emtricitabine|emtricitabine|mesh-list
111000557|NCT02237027|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
111000558|NCT02237027|Antiviral Agents|antiviral agents|mesh-ancestor
111000559|NCT02237027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111000560|NCT02237027|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111000561|NCT02237027|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111000562|NCT02237027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111000563|NCT02237027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111000564|NCT02237027|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111000565|NCT02237027|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111000566|NCT03609125|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111000567|NCT03609125|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111000569|NCT03143738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111000570|NCT03143738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111000571|NCT04393753|Avelumab|avelumab|mesh-list
111000572|NCT04393753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111000573|NCT04393753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111000574|NCT04647903|Amphetamine|amphetamine|mesh-list
111000575|NCT04647903|Dextroamphetamine|dextroamphetamine|mesh-list
111000576|NCT04647903|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111000577|NCT04647903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111000578|NCT04647903|Sympathomimetics|sympathomimetics|mesh-ancestor
111000579|NCT04647903|Autonomic Agents|autonomic agents|mesh-ancestor
111000580|NCT04647903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111000581|NCT04647903|Dopamine Agents|dopamine agents|mesh-ancestor
111000582|NCT04647903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111000583|NCT04647903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111000584|NCT04647903|Adrenergic Agents|adrenergic agents|mesh-ancestor
111000585|NCT04647903|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111000586|NCT04647903|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111000587|NCT04647903|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111000588|NCT04647903|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111000589|NCT03142256|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
111000590|NCT03142256|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111000591|NCT03142256|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111000592|NCT03142256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111000593|NCT03142256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111000594|NCT03142256|Antiviral Agents|antiviral agents|mesh-ancestor
111000595|NCT03142256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111000596|NCT03142256|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111000597|NCT03142256|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111000598|NCT03380403|Ciprofloxacin|ciprofloxacin|mesh-list
111000599|NCT03380403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111000600|NCT03380403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111000601|NCT03380403|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111000602|NCT03380403|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111000603|NCT03380403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111000604|NCT03380403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111000605|NCT03380403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111000606|NCT03380403|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111000607|NCT03380403|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111000608|NCT03380325|Iloprost|iloprost|mesh-list
111000609|NCT03380325|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111000610|NCT03380325|Vasodilator Agents|vasodilator agents|mesh-ancestor
111000611|NCT02237053|Hypoglycemic Agents|hypoglycemic agents|mesh-list
111000612|NCT02237053|Octreotide|octreotide|mesh-list
111000613|NCT02237053|Glucagon|glucagon|mesh-list
111000614|NCT02237053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111000615|NCT02237053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111000616|NCT02237053|Hormones|hormones|mesh-ancestor
111000617|NCT02237053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111000618|NCT02237053|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111000619|NCT02237053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111000620|NCT02237131|Contraceptive Agents|contraceptive agents|mesh-list
111000621|NCT02237131|Contraceptives, Oral|contraceptives, oral|mesh-list
111000622|NCT02237131|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
111000623|NCT02237131|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111000624|NCT02237131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111000625|NCT02237131|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111000626|NCT04997174|Celecoxib|celecoxib|mesh-list
111000627|NCT04997174|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111000628|NCT04997174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111000629|NCT04997174|Analgesics|analgesics|mesh-ancestor
111000630|NCT04997174|Sensory System Agents|sensory system agents|mesh-ancestor
111000631|NCT04997174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111000632|NCT04997174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111000633|NCT04997174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111000634|NCT04997174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111000635|NCT04997174|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111000636|NCT04997174|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111000637|NCT04997174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110465788|NCT04263402|Methylprednisolone|methylprednisolone|mesh-list
111000638|NCT04997174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111000640|NCT02237209|Immunologic Factors|immunologic factors|mesh-ancestor
111000641|NCT02237209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111000642|NCT03387111|Leucovorin|leucovorin|mesh-list
111000643|NCT03387111|Paclitaxel|paclitaxel|mesh-list
111000644|NCT03387111|Cyclophosphamide|cyclophosphamide|mesh-list
111000645|NCT03387111|Bevacizumab|bevacizumab|mesh-list
111000646|NCT03387111|Fluorouracil|fluorouracil|mesh-list
111000647|NCT03387111|Capecitabine|capecitabine|mesh-list
111000648|NCT03387111|Cetuximab|cetuximab|mesh-list
111000649|NCT03387111|Avelumab|avelumab|mesh-list
111000650|NCT03387111|Necitumumab|necitumumab|mesh-list
111000651|NCT03387111|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111000652|NCT03387111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111000653|NCT03387111|Tubulin Modulators|tubulin modulators|mesh-ancestor
111000654|NCT03387111|Antimitotic Agents|antimitotic agents|mesh-ancestor
111000655|NCT03387111|Mitosis Modulators|mitosis modulators|mesh-ancestor
111000656|NCT03387111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111000657|NCT03387111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111000658|NCT03387111|Immunologic Factors|immunologic factors|mesh-ancestor
111000659|NCT03387111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111000660|NCT03387111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111000661|NCT03387111|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111000662|NCT03387111|Alkylating Agents|alkylating agents|mesh-ancestor
111000663|NCT03387111|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111000664|NCT03387111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111000665|NCT03387111|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111000666|NCT03387111|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111000667|NCT03387111|Growth Substances|growth substances|mesh-ancestor
111000668|NCT03387111|Growth Inhibitors|growth inhibitors|mesh-ancestor
111000669|NCT03387111|Antimetabolites|antimetabolites|mesh-ancestor
111000670|NCT03387111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111000671|NCT03387111|Antidotes|antidotes|mesh-ancestor
111000672|NCT03387111|Protective Agents|protective agents|mesh-ancestor
111000673|NCT03387111|Vitamin B Complex|vitamin b complex|mesh-ancestor
111000674|NCT03387111|Vitamins|vitamins|mesh-ancestor
111000675|NCT03387111|Micronutrients|micronutrients|mesh-ancestor
111000676|NCT03608293|Dimercaprol|dimercaprol|mesh-list
111000677|NCT03608293|Chelating Agents|chelating agents|mesh-ancestor
111000678|NCT03608293|Sequestering Agents|sequestering agents|mesh-ancestor
111000679|NCT03608293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111000680|NCT03608501|Thalidomide|thalidomide|mesh-list
111000681|NCT03608501|Dexamethasone|dexamethasone|mesh-list
111000682|NCT03608501|Ixazomib|ixazomib|mesh-list
111000683|NCT03608501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111000684|NCT03608501|Antiemetics|antiemetics|mesh-ancestor
111000685|NCT03608501|Autonomic Agents|autonomic agents|mesh-ancestor
111000686|NCT03608501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111000687|NCT03608501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111000688|NCT03608501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111000689|NCT03608501|Glucocorticoids|glucocorticoids|mesh-ancestor
111000690|NCT03608501|Hormones|hormones|mesh-ancestor
111000691|NCT03608501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111000692|NCT03608501|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111000693|NCT03608501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111000694|NCT03608501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111000695|NCT03608501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111000696|NCT03608501|Immunologic Factors|immunologic factors|mesh-ancestor
111000697|NCT03608501|Leprostatic Agents|leprostatic agents|mesh-ancestor
111000698|NCT03608501|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111000699|NCT03608501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111000700|NCT03608501|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111000701|NCT03608501|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111000702|NCT03608501|Growth Substances|growth substances|mesh-ancestor
111000703|NCT03608501|Growth Inhibitors|growth inhibitors|mesh-ancestor
111000704|NCT03608501|Protease Inhibitors|protease inhibitors|mesh-ancestor
111000705|NCT03608501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111000706|NCT03608761|Rebamipide|rebamipide|mesh-list
111000707|NCT03608761|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111000708|NCT03608761|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111000709|NCT03608761|Antioxidants|antioxidants|mesh-ancestor
111000710|NCT03608761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111000711|NCT03608761|Protective Agents|protective agents|mesh-ancestor
111000712|NCT03608761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111000713|NCT03608761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111000714|NCT04554836|Cetuximab|cetuximab|mesh-list
110465862|NCT04258956|Avelumab|avelumab|mesh-list
111000715|NCT04554836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111000716|NCT04554836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111000717|NCT04536272|Heparin|heparin|mesh-list
111000718|NCT04536272|Calcium heparin|calcium heparin|mesh-list
111000719|NCT04536272|Enoxaparin|enoxaparin|mesh-list
111000720|NCT04536272|Nadroparin|nadroparin|mesh-list
111000721|NCT04536272|Anticoagulants|anticoagulants|mesh-ancestor
111000722|NCT04536272|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111000723|NCT04536272|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111000724|NCT04536272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111000725|NCT02731131|Ribavirin|ribavirin|mesh-list
111000726|NCT02731131|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
111000727|NCT02731131|Antimetabolites|antimetabolites|mesh-ancestor
111000728|NCT02731131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111000729|NCT02731131|Antiviral Agents|antiviral agents|mesh-ancestor
111000730|NCT02731131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111000731|NCT04585724|Palbociclib|palbociclib|mesh-list
111000732|NCT04585724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111000733|NCT04585724|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111000734|NCT04585724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111000735|NCT04585724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111000736|NCT02237261|Prednisone|prednisone|mesh-list
111000737|NCT02237261|Bortezomib|bortezomib|mesh-list
111000738|NCT02237261|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
111000739|NCT02237261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111000740|NCT02237261|Glucocorticoids|glucocorticoids|mesh-ancestor
111000741|NCT02237261|Hormones|hormones|mesh-ancestor
111000742|NCT02237261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111000743|NCT02237261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111000744|NCT02237261|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111000745|NCT02237261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111000746|NCT02237261|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111000747|NCT02237261|Alkylating Agents|alkylating agents|mesh-ancestor
111000748|NCT02237261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111000749|NCT03386643|Clobetasol|clobetasol|mesh-list
111000750|NCT03386643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111000751|NCT03386643|Glucocorticoids|glucocorticoids|mesh-ancestor
111000752|NCT03386643|Hormones|hormones|mesh-ancestor
111000753|NCT03386643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111000754|NCT03386643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111000755|NCT05171985|Dexmedetomidine|dexmedetomidine|mesh-list
111000756|NCT05171985|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111000757|NCT05171985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111000758|NCT05171985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111000759|NCT05171985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111000760|NCT05171985|Analgesics|analgesics|mesh-ancestor
111000761|NCT05171985|Sensory System Agents|sensory system agents|mesh-ancestor
111000762|NCT05171985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111000763|NCT05171985|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111000764|NCT05171985|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111000765|NCT05171985|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111000766|NCT05171985|Adrenergic Agents|adrenergic agents|mesh-ancestor
111000767|NCT05171985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111000768|NCT05171985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111000769|NCT02237365|Aspirin|aspirin|mesh-list
111000770|NCT02237365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111000771|NCT02237365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111000772|NCT02237365|Analgesics|analgesics|mesh-ancestor
111000773|NCT02237365|Sensory System Agents|sensory system agents|mesh-ancestor
111000774|NCT02237365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111000775|NCT02237365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111000776|NCT02237365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111000777|NCT02237365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111000778|NCT02237365|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111000779|NCT02237365|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111000780|NCT02237365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111000781|NCT02237365|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111000782|NCT02237365|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111000783|NCT02237365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111000784|NCT02237365|Antipyretics|antipyretics|mesh-ancestor
111000785|NCT03383367|TEMPO|tempo|mesh-list
111000786|NCT03383367|Antioxidants|antioxidants|mesh-ancestor
111000787|NCT03383367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111000788|NCT03383367|Protective Agents|protective agents|mesh-ancestor
111119142|NCT05323617|Cyclosporine|cyclosporine|mesh-list
111000789|NCT03383367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111000791|NCT02856113|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111000792|NCT02856113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111000793|NCT02856113|Incretins|incretins|mesh-ancestor
111000794|NCT02856113|Hormones|hormones|mesh-ancestor
111000795|NCT02856113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111000796|NCT02856113|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111000797|NCT02856113|Protease Inhibitors|protease inhibitors|mesh-ancestor
111000798|NCT02856113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111000799|NCT02856113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111000800|NCT03386565|Lidocaine|lidocaine|mesh-list
111000801|NCT03386565|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111000802|NCT03386565|Anesthetics, Local|anesthetics, local|mesh-ancestor
111000803|NCT03386565|Anesthetics|anesthetics|mesh-ancestor
111000804|NCT03386565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111000805|NCT03386565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111000806|NCT03386565|Sensory System Agents|sensory system agents|mesh-ancestor
111000807|NCT03386565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111000808|NCT03386565|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111000809|NCT03386565|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111000810|NCT03386565|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111000811|NCT03386565|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111000812|NCT03386565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111000813|NCT02237339|Allopurinol|allopurinol|mesh-list
111000814|NCT02237339|Antimetabolites|antimetabolites|mesh-ancestor
111000815|NCT02237339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111000816|NCT02237339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111000817|NCT02237339|Gout Suppressants|gout suppressants|mesh-ancestor
111000818|NCT02237339|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111000819|NCT02237339|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111000820|NCT02237339|Antioxidants|antioxidants|mesh-ancestor
111000821|NCT02237339|Protective Agents|protective agents|mesh-ancestor
111000822|NCT02237339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111000823|NCT05171751|Octreotide|octreotide|mesh-list
111000824|NCT05171751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111000825|NCT05171751|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111000826|NCT05171751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111000827|NCT03971084|6-chloro-2-(1-piperazinyl)pyrazine|6-chloro-2-(1-piperazinyl)pyrazine|mesh-list
111000828|NCT03971084|Caseins|caseins|mesh-list
111000829|NCT03971084|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111000830|NCT03971084|Serotonin Agents|serotonin agents|mesh-ancestor
111000831|NCT03971084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111000832|NCT03971084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111000833|NCT03971084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111000834|NCT03971084|Chelating Agents|chelating agents|mesh-ancestor
111000835|NCT03971084|Sequestering Agents|sequestering agents|mesh-ancestor
111000836|NCT03379779|Dimercaprol|dimercaprol|mesh-list
111000837|NCT03379779|Chelating Agents|chelating agents|mesh-ancestor
111000838|NCT03379779|Sequestering Agents|sequestering agents|mesh-ancestor
111000839|NCT03379779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111000840|NCT04083014|Bortezomib|bortezomib|mesh-list
111000841|NCT04083014|Antibodies|antibodies|mesh-list
111000842|NCT04083014|Immunologic Factors|immunologic factors|mesh-ancestor
111000843|NCT04083014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111000844|NCT04083014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111000845|NCT03563066|Benralizumab|benralizumab|mesh-list
111000846|NCT03563066|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111000847|NCT03563066|Respiratory System Agents|respiratory system agents|mesh-ancestor
111000848|NCT03140384|Misoprostol|misoprostol|mesh-list
111000849|NCT03140384|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111000850|NCT03140384|Abortifacient Agents|abortifacient agents|mesh-ancestor
111000851|NCT03140384|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111000852|NCT03140384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111000853|NCT03140384|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111000854|NCT03140384|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111000855|NCT03140384|Oxytocics|oxytocics|mesh-ancestor
111000856|NCT05117307|Bupivacaine|bupivacaine|mesh-list
111000857|NCT05117307|Anesthetics, Local|anesthetics, local|mesh-ancestor
111000858|NCT05117307|Anesthetics|anesthetics|mesh-ancestor
111000859|NCT05117307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111000860|NCT05117307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111000861|NCT05117307|Sensory System Agents|sensory system agents|mesh-ancestor
111000862|NCT05117307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111000863|NCT03739268|Sevelamer|sevelamer|mesh-list
111000864|NCT03739268|Chelating Agents|chelating agents|mesh-ancestor
111000865|NCT03739268|Sequestering Agents|sequestering agents|mesh-ancestor
111000866|NCT03739268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111000867|NCT02787590|Simvastatin|simvastatin|mesh-list
111000868|NCT02787590|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111000869|NCT02787590|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111000870|NCT02787590|Antimetabolites|antimetabolites|mesh-ancestor
111000871|NCT02787590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111000872|NCT02787590|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111000873|NCT02787590|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111000874|NCT02787590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111000875|NCT04445571|Pulmonary Surfactants|pulmonary surfactants|mesh-list
111000876|NCT04445571|Respiratory System Agents|respiratory system agents|mesh-ancestor
111000877|NCT03382743|Lidocaine|lidocaine|mesh-list
111000878|NCT03382743|Anesthetics, Local|anesthetics, local|mesh-ancestor
111000879|NCT03382743|Anesthetics|anesthetics|mesh-ancestor
111000880|NCT03382743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111000881|NCT03382743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111000882|NCT03382743|Sensory System Agents|sensory system agents|mesh-ancestor
111000883|NCT03382743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111000884|NCT03382743|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111000885|NCT03382743|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111000886|NCT03382743|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111000887|NCT03382743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111000888|NCT03382743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111000889|NCT02854631|Prednisolone|prednisolone|mesh-list
111000890|NCT02854631|Selonsertib|selonsertib|mesh-list
111000891|NCT02854631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111000892|NCT02854631|Glucocorticoids|glucocorticoids|mesh-ancestor
111000893|NCT02854631|Hormones|hormones|mesh-ancestor
111000894|NCT02854631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111000895|NCT02854631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110717908|NCT01236040|Vaccines|vaccines|mesh-list
111000896|NCT02854631|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111000897|NCT02854631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111000898|NCT02854631|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111000899|NCT02854631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111000900|NCT02854631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111000901|NCT03607643|Leucovorin|leucovorin|mesh-list
111000902|NCT03607643|Bevacizumab|bevacizumab|mesh-list
111000903|NCT03607643|Gemcitabine|gemcitabine|mesh-list
111000904|NCT03607643|Oxaliplatin|oxaliplatin|mesh-list
111000905|NCT03607643|Irinotecan|irinotecan|mesh-list
111000906|NCT03607643|Temozolomide|temozolomide|mesh-list
111000907|NCT03607643|Bortezomib|bortezomib|mesh-list
111000908|NCT03607643|Cannabidiol|cannabidiol|mesh-list
111000909|NCT03607643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111000910|NCT03607643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111000911|NCT03607643|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111000912|NCT03607643|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111000913|NCT03607643|Growth Substances|growth substances|mesh-ancestor
111000914|NCT03607643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111000915|NCT03607643|Growth Inhibitors|growth inhibitors|mesh-ancestor
111000916|NCT03607643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111000917|NCT03607643|Antimetabolites|antimetabolites|mesh-ancestor
111000918|NCT03607643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111000919|NCT03607643|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111000920|NCT03607643|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111000921|NCT03607643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111000922|NCT03607643|Antidotes|antidotes|mesh-ancestor
111000923|NCT03607643|Protective Agents|protective agents|mesh-ancestor
111000924|NCT03607643|Vitamin B Complex|vitamin b complex|mesh-ancestor
111000925|NCT03607643|Vitamins|vitamins|mesh-ancestor
111000926|NCT03607643|Micronutrients|micronutrients|mesh-ancestor
111000927|NCT03607643|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111000928|NCT03607643|Alkylating Agents|alkylating agents|mesh-ancestor
111000929|NCT03607643|Anticonvulsants|anticonvulsants|mesh-ancestor
111000930|NCT02855359|Prednisone|prednisone|mesh-list
111000931|NCT02855359|Cyclophosphamide|cyclophosphamide|mesh-list
111000932|NCT02855359|Rituximab|rituximab|mesh-list
111000933|NCT02855359|Doxorubicin|doxorubicin|mesh-list
111000934|NCT02855359|Vincristine|vincristine|mesh-list
111000935|NCT02855359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111000936|NCT02855359|Immunologic Factors|immunologic factors|mesh-ancestor
111000937|NCT02855359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111000952|NCT02855359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111000953|NCT02855359|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111000954|NCT02855359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111000955|NCT02855359|Tubulin Modulators|tubulin modulators|mesh-ancestor
111000956|NCT02855359|Antimitotic Agents|antimitotic agents|mesh-ancestor
111000957|NCT02855359|Mitosis Modulators|mitosis modulators|mesh-ancestor
111000958|NCT05084456|Docetaxel|docetaxel|mesh-list
111000959|NCT05084456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111000960|NCT05084456|Tubulin Modulators|tubulin modulators|mesh-ancestor
111000961|NCT05084456|Antimitotic Agents|antimitotic agents|mesh-ancestor
111000962|NCT05084456|Mitosis Modulators|mitosis modulators|mesh-ancestor
111000963|NCT05084456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111000964|NCT03607903|Adalimumab|adalimumab|mesh-list
111000965|NCT03607903|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111000966|NCT03607903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111000967|NCT03607903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111000968|NCT04438850|Ivermectin|ivermectin|mesh-list
111000969|NCT04438850|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111000970|NCT04438850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111000971|NCT03385863|Pulmonary Surfactants|pulmonary surfactants|mesh-list
111000972|NCT03385863|Poractant alfa|poractant alfa|mesh-list
111000973|NCT03385863|Respiratory System Agents|respiratory system agents|mesh-ancestor
111000974|NCT03939026|Cyclophosphamide|cyclophosphamide|mesh-list
111000975|NCT03939026|Fludarabine|fludarabine|mesh-list
111000976|NCT03939026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111000977|NCT03939026|Immunologic Factors|immunologic factors|mesh-ancestor
111000978|NCT03939026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111000979|NCT03939026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111000980|NCT03939026|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111000981|NCT03939026|Alkylating Agents|alkylating agents|mesh-ancestor
111000982|NCT03939026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111000983|NCT03939026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111000984|NCT03939026|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111000985|NCT03382431|PC-786|pc-786|mesh-list
111000986|NCT03382431|Antiviral Agents|antiviral agents|mesh-ancestor
111000987|NCT03382431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111000988|NCT03382431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111000989|NCT03382431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111000990|NCT03141632|Dulaglutide|dulaglutide|mesh-list
111000991|NCT03141632|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111000992|NCT03141632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111000993|NCT04282239|Lidocaine|lidocaine|mesh-list
111000994|NCT04282239|Epinephrine|epinephrine|mesh-list
111000995|NCT04282239|Dexmedetomidine|dexmedetomidine|mesh-list
111000996|NCT04282239|Ropivacaine|ropivacaine|mesh-list
111000997|NCT04282239|Anesthetics, Local|anesthetics, local|mesh-ancestor
111000998|NCT04282239|Anesthetics|anesthetics|mesh-ancestor
111000999|NCT04282239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111001000|NCT04282239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111001001|NCT04282239|Sensory System Agents|sensory system agents|mesh-ancestor
111001002|NCT04282239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111001003|NCT04282239|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111001004|NCT04282239|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111001005|NCT04282239|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111001006|NCT04282239|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111001007|NCT04282239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111001008|NCT04282239|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111001009|NCT04282239|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111001010|NCT04282239|Analgesics|analgesics|mesh-ancestor
111001011|NCT04282239|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111001012|NCT04282239|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111001013|NCT04282239|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111001014|NCT04282239|Adrenergic Agents|adrenergic agents|mesh-ancestor
111001016|NCT04282239|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111001017|NCT04282239|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111001018|NCT04282239|Autonomic Agents|autonomic agents|mesh-ancestor
111001019|NCT04282239|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111001020|NCT04282239|Respiratory System Agents|respiratory system agents|mesh-ancestor
111001021|NCT04282239|Mydriatics|mydriatics|mesh-ancestor
111001022|NCT04282239|Sympathomimetics|sympathomimetics|mesh-ancestor
111001023|NCT04282239|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111001024|NCT03605173|Vitamin D|vitamin d|mesh-list
111001025|NCT03605173|Ergocalciferols|ergocalciferols|mesh-list
111001026|NCT03605173|Cholecalciferol|cholecalciferol|mesh-list
111001027|NCT03605173|Vitamins|vitamins|mesh-list
111001028|NCT03605173|Micronutrients|micronutrients|mesh-ancestor
111001029|NCT03605173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111001030|NCT03605173|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111001031|NCT03605173|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111001032|NCT03605095|Nitroglycerin|nitroglycerin|mesh-list
111001033|NCT03605095|Vasodilator Agents|vasodilator agents|mesh-ancestor
111001034|NCT03382275|Iron|iron|mesh-list
111001035|NCT03382275|Ferric maltol|ferric maltol|mesh-list
111001036|NCT03382275|Trace Elements|trace elements|mesh-ancestor
111001037|NCT03382275|Micronutrients|micronutrients|mesh-ancestor
111001038|NCT03382275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111001039|NCT03382275|Hematinics|hematinics|mesh-ancestor
111001040|NCT05080478|Clopidogrel|clopidogrel|mesh-list
111001041|NCT05080478|Ticagrelor|ticagrelor|mesh-list
111001042|NCT05080478|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111001043|NCT05080478|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111001044|NCT05080478|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111001045|NCT05080478|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111001046|NCT05080478|Purinergic Agents|purinergic agents|mesh-ancestor
110718059|NCT01147432|Antipruritics|antipruritics|mesh-ancestor
111001047|NCT05080478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111001048|NCT05080478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111001049|NCT05080478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111001050|NCT05082974|Varenicline|varenicline|mesh-list
111001051|NCT05082974|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111001052|NCT05082974|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111001053|NCT05082974|Cholinergic Agents|cholinergic agents|mesh-ancestor
111001054|NCT05082974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111001055|NCT05082974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111001056|NCT05082974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111001057|NCT03604471|Atorvastatin|atorvastatin|mesh-list
111001058|NCT03604471|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111001059|NCT03604471|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111001060|NCT03604471|Antimetabolites|antimetabolites|mesh-ancestor
111001061|NCT03604471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111001062|NCT03604471|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111001063|NCT03604471|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111001064|NCT03604471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111001065|NCT02237443|Bromides|bromides|mesh-list
111001066|NCT02237443|Rocuronium|rocuronium|mesh-list
111001067|NCT02237443|Vecuronium Bromide|vecuronium bromide|mesh-list
111001068|NCT02237443|Succinylcholine|succinylcholine|mesh-list
111001069|NCT02237443|Anticonvulsants|anticonvulsants|mesh-ancestor
111001070|NCT02237443|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
111001071|NCT02237443|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
111001072|NCT02237443|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111001073|NCT02237443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111001074|NCT02237443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111001075|NCT02237443|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
111001076|NCT02237443|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
111001077|NCT02237443|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111001078|NCT02237443|Cholinergic Agents|cholinergic agents|mesh-ancestor
111001079|NCT02237443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111001080|NCT02237443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111001081|NCT03141398|Pancrelipase|pancrelipase|mesh-list
111001082|NCT03141398|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111001083|NCT03733418|Vitamin D|vitamin d|mesh-list
111001084|NCT03733418|Cholecalciferol|cholecalciferol|mesh-list
111001085|NCT03733418|Vitamins|vitamins|mesh-ancestor
111001086|NCT03733418|Micronutrients|micronutrients|mesh-ancestor
111001087|NCT03733418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111001088|NCT03733418|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111001089|NCT03733418|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111001091|NCT03607331|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111001092|NCT03607331|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111001093|NCT03607331|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111001094|NCT03607331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111001095|NCT03607331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111001096|NCT03607331|Serotonin Agents|serotonin agents|mesh-ancestor
111001097|NCT03607331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111001098|NCT03607331|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111001099|NCT03607331|Antidepressive Agents|antidepressive agents|mesh-ancestor
111001100|NCT03607331|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111001101|NCT05082896|Anesthetics|anesthetics|mesh-list
111001102|NCT05082896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111001103|NCT05082896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111001104|NCT03607955|Paclitaxel|paclitaxel|mesh-list
111001105|NCT03607955|Carboplatin|carboplatin|mesh-list
111001106|NCT03607955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111001107|NCT03607955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111001108|NCT03607955|Tubulin Modulators|tubulin modulators|mesh-ancestor
111001109|NCT03607955|Antimitotic Agents|antimitotic agents|mesh-ancestor
111001110|NCT03607955|Mitosis Modulators|mitosis modulators|mesh-ancestor
111001111|NCT03607955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111001112|NCT02067975|Tryptophan|tryptophan|mesh-list
111001113|NCT02067975|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111001114|NCT02067975|Antidepressive Agents|antidepressive agents|mesh-ancestor
111001115|NCT02067975|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111001116|NCT03143036|Thalidomide|thalidomide|mesh-list
111001117|NCT03143036|Dexamethasone|dexamethasone|mesh-list
111001118|NCT03143036|Daratumumab|daratumumab|mesh-list
110718135|NCT03908008|Botulinum Toxins|botulinum toxins|mesh-list
111001119|NCT03143036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111001120|NCT03143036|Antiemetics|antiemetics|mesh-ancestor
111001121|NCT03143036|Autonomic Agents|autonomic agents|mesh-ancestor
111001122|NCT03143036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111001123|NCT03143036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111001124|NCT03143036|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111001125|NCT03143036|Glucocorticoids|glucocorticoids|mesh-ancestor
111001127|NCT03143036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111001128|NCT03143036|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111001129|NCT03143036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111001130|NCT03143036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111001131|NCT03143036|Immunologic Factors|immunologic factors|mesh-ancestor
111001132|NCT03143036|Leprostatic Agents|leprostatic agents|mesh-ancestor
111001133|NCT03143036|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111001134|NCT03143036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111001135|NCT03143036|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111001136|NCT03143036|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111001137|NCT03143036|Growth Substances|growth substances|mesh-ancestor
111001138|NCT03143036|Growth Inhibitors|growth inhibitors|mesh-ancestor
111001139|NCT05080010|Carboplatin|carboplatin|mesh-list
111001140|NCT05080010|Etoposide|etoposide|mesh-list
111001141|NCT05080010|Vincristine|vincristine|mesh-list
111001142|NCT05080010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111001143|NCT05080010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111001144|NCT05080010|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111001145|NCT05080010|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111001146|NCT05080010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111001147|NCT05080010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111001148|NCT05080010|Tubulin Modulators|tubulin modulators|mesh-ancestor
111001149|NCT05080010|Antimitotic Agents|antimitotic agents|mesh-ancestor
111001150|NCT05080010|Mitosis Modulators|mitosis modulators|mesh-ancestor
111001151|NCT03385551|Estradiol|estradiol|mesh-list
111001152|NCT03385551|Estrogens|estrogens|mesh-ancestor
111001153|NCT03385551|Hormones|hormones|mesh-ancestor
111001154|NCT03385551|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111001155|NCT03385551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111001156|NCT03606473|Amphetamine|amphetamine|mesh-list
111001157|NCT03606473|Dextroamphetamine|dextroamphetamine|mesh-list
111001158|NCT03606473|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111001159|NCT03606473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111001160|NCT03606473|Sympathomimetics|sympathomimetics|mesh-ancestor
111001161|NCT03606473|Autonomic Agents|autonomic agents|mesh-ancestor
111001162|NCT03606473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111001163|NCT03606473|Dopamine Agents|dopamine agents|mesh-ancestor
111119143|NCT05323617|Cyclosporins|cyclosporins|mesh-list
111001164|NCT03606473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111001165|NCT03606473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111001166|NCT03606473|Adrenergic Agents|adrenergic agents|mesh-ancestor
111001167|NCT03606473|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111001168|NCT03606473|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111001169|NCT03606473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111001170|NCT03606473|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111001171|NCT03316274|Nivolumab|nivolumab|mesh-list
111001172|NCT03316274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111001173|NCT03316274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111001174|NCT03316274|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111001175|NCT03316274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111001176|NCT03252626|Alprostadil|alprostadil|mesh-list
111001177|NCT03252626|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111001178|NCT03252626|Vasodilator Agents|vasodilator agents|mesh-ancestor
111001179|NCT03252626|Urological Agents|urological agents|mesh-ancestor
111001180|NCT05072054|Atorvastatin|atorvastatin|mesh-list
111001181|NCT05072054|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111001182|NCT05072054|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111001183|NCT05072054|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111001184|NCT05072054|Antimetabolites|antimetabolites|mesh-ancestor
111001185|NCT05072054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111001186|NCT05072054|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111001187|NCT05072054|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111001188|NCT05072054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111001189|NCT03142880|Ropivacaine|ropivacaine|mesh-list
111001190|NCT03142880|Anesthetics, Local|anesthetics, local|mesh-ancestor
111001191|NCT03142880|Anesthetics|anesthetics|mesh-ancestor
111001192|NCT03142880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111001193|NCT03142880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111001194|NCT03142880|Sensory System Agents|sensory system agents|mesh-ancestor
111001195|NCT03142880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111001196|NCT03605537|Mometasone Furoate|mometasone furoate|mesh-list
111001197|NCT03605537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111001198|NCT03605537|Dermatologic Agents|dermatologic agents|mesh-ancestor
111001199|NCT03605537|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111001200|NCT03381495|Sufentanil|sufentanil|mesh-list
111001201|NCT03381495|Ropivacaine|ropivacaine|mesh-list
111001202|NCT03381495|Anesthetics, Local|anesthetics, local|mesh-ancestor
111001203|NCT03381495|Anesthetics|anesthetics|mesh-ancestor
111001204|NCT03381495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111001205|NCT03381495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111001206|NCT03381495|Sensory System Agents|sensory system agents|mesh-ancestor
111001207|NCT03381495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111001208|NCT03381495|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111001209|NCT03381495|Narcotics|narcotics|mesh-ancestor
111001210|NCT03381495|Analgesics|analgesics|mesh-ancestor
111001211|NCT03381495|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111001212|NCT03381495|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111001213|NCT03381495|Anesthetics, General|anesthetics, general|mesh-ancestor
111001214|NCT03059498|Bupivacaine|bupivacaine|mesh-list
111001215|NCT03059498|Anesthetics, Local|anesthetics, local|mesh-ancestor
111001216|NCT03059498|Anesthetics|anesthetics|mesh-ancestor
111001217|NCT03059498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111001218|NCT03059498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111001219|NCT03059498|Sensory System Agents|sensory system agents|mesh-ancestor
111001220|NCT03059498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111001221|NCT03142646|Cyclophosphamide|cyclophosphamide|mesh-list
111001222|NCT03142646|Fludarabine|fludarabine|mesh-list
111001223|NCT03142646|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111001224|NCT03142646|Immunologic Factors|immunologic factors|mesh-ancestor
111001225|NCT03142646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111001226|NCT03142646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111001227|NCT03142646|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111001228|NCT03142646|Alkylating Agents|alkylating agents|mesh-ancestor
111001229|NCT03142646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111001230|NCT03142646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111001231|NCT03142646|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111001232|NCT03541083|Blinatumomab|blinatumomab|mesh-list
111001233|NCT03541083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111001234|NCT04962230|Ritonavir|ritonavir|mesh-list
111001235|NCT04962230|Nirmatrelvir|nirmatrelvir|mesh-list
111001236|NCT04962230|Carbamazepine|carbamazepine|mesh-list
111001237|NCT04962230|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111001238|NCT04962230|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111001239|NCT04962230|Protease Inhibitors|protease inhibitors|mesh-ancestor
111001240|NCT04962230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111001241|NCT04962230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111001242|NCT04962230|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111001243|NCT04962230|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111001244|NCT04962230|Antiviral Agents|antiviral agents|mesh-ancestor
111001245|NCT04962230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111001246|NCT04962230|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111001247|NCT04962230|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111001248|NCT04962230|Anticonvulsants|anticonvulsants|mesh-ancestor
111001249|NCT04962230|Antimanic Agents|antimanic agents|mesh-ancestor
111001250|NCT04962230|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111001251|NCT04962230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111001252|NCT04962230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111001253|NCT04962230|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111001254|NCT04962230|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111001255|NCT04962230|Analgesics|analgesics|mesh-ancestor
111001256|NCT04962230|Sensory System Agents|sensory system agents|mesh-ancestor
111001257|NCT04962230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111001258|NCT04962230|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111001259|NCT04962230|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111001260|NCT04962230|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111001261|NCT04962230|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111001262|NCT03602027|Gefitinib|gefitinib|mesh-list
111001263|NCT03602027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111001264|NCT03602027|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111001265|NCT03602027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111001266|NCT03602027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111001267|NCT03141476|Cefuroxime|cefuroxime|mesh-list
111001268|NCT03141476|Cefuroxime axetil|cefuroxime axetil|mesh-list
111001269|NCT03141476|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111001270|NCT03141476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111001271|NCT03601871|Thalidomide|thalidomide|mesh-list
111001272|NCT03601871|Dexamethasone|dexamethasone|mesh-list
111001273|NCT03601871|Palonosetron|palonosetron|mesh-list
111001274|NCT03601871|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-list
111001275|NCT03601871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111001276|NCT03601871|Antiemetics|antiemetics|mesh-ancestor
111001277|NCT03601871|Autonomic Agents|autonomic agents|mesh-ancestor
111001278|NCT03601871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111001279|NCT03601871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111001280|NCT03601871|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111001281|NCT03601871|Glucocorticoids|glucocorticoids|mesh-ancestor
111001282|NCT03601871|Hormones|hormones|mesh-ancestor
111001283|NCT03601871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111001284|NCT03601871|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111001285|NCT03601871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111001286|NCT03601871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111001287|NCT03601871|Immunologic Factors|immunologic factors|mesh-ancestor
111001288|NCT03601871|Leprostatic Agents|leprostatic agents|mesh-ancestor
111001289|NCT03601871|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111001290|NCT03601871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111001291|NCT03601871|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111001292|NCT03601871|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111001293|NCT03601871|Growth Substances|growth substances|mesh-ancestor
111001294|NCT03601871|Growth Inhibitors|growth inhibitors|mesh-ancestor
111001295|NCT03601871|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111001296|NCT03601871|Serotonin Agents|serotonin agents|mesh-ancestor
111001297|NCT03601871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111001298|NCT03601871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111001299|NCT03380949|Remifentanil|remifentanil|mesh-list
111001300|NCT03380949|Analgesics, Opioid|analgesics, opioid|mesh-list
111001301|NCT03380949|Narcotics|narcotics|mesh-ancestor
111001302|NCT03380949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111001303|NCT03380949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111001304|NCT03380949|Analgesics|analgesics|mesh-ancestor
111001305|NCT03380949|Sensory System Agents|sensory system agents|mesh-ancestor
111001306|NCT03380949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111001307|NCT03604757|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
111001308|NCT03604757|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111001309|NCT03604757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111001310|NCT03604679|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
111001311|NCT03604679|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111001312|NCT03604679|Alkylating Agents|alkylating agents|mesh-ancestor
111001313|NCT03604679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111001314|NCT03604679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111001316|NCT05078372|Ropivacaine|ropivacaine|mesh-list
111001317|NCT05078372|Anesthetics, Local|anesthetics, local|mesh-ancestor
111001318|NCT05078372|Anesthetics|anesthetics|mesh-ancestor
111001319|NCT05078372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111001320|NCT05078372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111001321|NCT05078372|Sensory System Agents|sensory system agents|mesh-ancestor
111001322|NCT05078372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111001323|NCT05078372|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111001324|NCT05078372|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111001325|NCT05078372|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111001326|NCT05078372|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111001327|NCT05078372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111001328|NCT05078372|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111001329|NCT05078372|Anesthetics, General|anesthetics, general|mesh-ancestor
111001330|NCT05078372|GABA Modulators|gaba modulators|mesh-ancestor
111001331|NCT05078372|GABA Agents|gaba agents|mesh-ancestor
111001332|NCT05078372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111001333|NCT05078372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111001334|NCT03380871|Carboplatin|carboplatin|mesh-list
111001335|NCT03380871|Pembrolizumab|pembrolizumab|mesh-list
111001336|NCT03380871|Pemetrexed|pemetrexed|mesh-list
111001337|NCT03380871|Poly ICLC|poly iclc|mesh-list
111001338|NCT03380871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111001339|NCT03380871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111001340|NCT03380871|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111001341|NCT03380871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111001342|NCT03380871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111001343|NCT03380871|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111001344|NCT03380871|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111001345|NCT03380871|Interferon Inducers|interferon inducers|mesh-ancestor
111001346|NCT03380871|Immunologic Factors|immunologic factors|mesh-ancestor
111001347|NCT03380871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111001348|NCT02237495|Dexmedetomidine|dexmedetomidine|mesh-list
111001349|NCT02237495|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111001350|NCT02237495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111001351|NCT02237495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111001352|NCT02237495|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111001353|NCT02237495|Analgesics|analgesics|mesh-ancestor
111001354|NCT02237495|Sensory System Agents|sensory system agents|mesh-ancestor
111001355|NCT02237495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111001356|NCT02237495|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111001357|NCT02237495|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111001358|NCT02237495|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111001359|NCT02237495|Adrenergic Agents|adrenergic agents|mesh-ancestor
111001360|NCT02237495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111001361|NCT02237495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111001362|NCT02486666|Enoxaparin|enoxaparin|mesh-list
111001363|NCT02486666|Enoxaparin sodium|enoxaparin sodium|mesh-list
111001364|NCT02486666|Anticoagulants|anticoagulants|mesh-ancestor
111001365|NCT02486666|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111001366|NCT02486666|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111001367|NCT02486666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111001368|NCT02237807|Dirithromycin|dirithromycin|mesh-list
111001369|NCT02237807|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111001370|NCT02237807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111001371|NCT03125187|Heparin|heparin|mesh-list
111001372|NCT03125187|Calcium heparin|calcium heparin|mesh-list
111001373|NCT03125187|Anticoagulants|anticoagulants|mesh-ancestor
111001374|NCT03125187|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111001375|NCT03125187|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111001376|NCT03125187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111001377|NCT02038946|Nivolumab|nivolumab|mesh-list
111001378|NCT02038946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111001379|NCT02038946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111001380|NCT02038946|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111001381|NCT02038946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111001382|NCT03377907|Lidocaine|lidocaine|mesh-list
111001383|NCT03377907|Ketamine|ketamine|mesh-list
111001384|NCT03377907|Anesthetics, Local|anesthetics, local|mesh-ancestor
111001385|NCT03377907|Anesthetics|anesthetics|mesh-ancestor
111001386|NCT03377907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111001387|NCT03377907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111001388|NCT03377907|Sensory System Agents|sensory system agents|mesh-ancestor
111001389|NCT03377907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111001390|NCT03377907|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111001391|NCT03377907|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111001392|NCT03377907|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111001393|NCT03377907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111001394|NCT03377907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111001395|NCT03377907|Analgesics|analgesics|mesh-ancestor
111001396|NCT03377907|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111001397|NCT03377907|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111001398|NCT03377907|Anesthetics, General|anesthetics, general|mesh-ancestor
111001399|NCT03377907|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111001400|NCT03377907|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111001401|NCT03377907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111001402|NCT03141554|Chlorhexidine|chlorhexidine|mesh-list
111001403|NCT03141554|Povidone-Iodine|povidone-iodine|mesh-list
111001404|NCT03141554|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111001405|NCT03141554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111001406|NCT03141554|Disinfectants|disinfectants|mesh-ancestor
111001407|NCT03369795|Methotrexate|methotrexate|mesh-list
111001408|NCT03369795|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111001409|NCT03369795|Abortifacient Agents|abortifacient agents|mesh-ancestor
111001410|NCT03369795|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111001411|NCT03369795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111001412|NCT03369795|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111001413|NCT03369795|Antimetabolites|antimetabolites|mesh-ancestor
111001414|NCT03369795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111001415|NCT03369795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110618227|NCT00567567|Vitamins|vitamins|mesh-ancestor
111001416|NCT03369795|Dermatologic Agents|dermatologic agents|mesh-ancestor
111001417|NCT03369795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111001418|NCT03369795|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111001419|NCT03369795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111001420|NCT03369795|Immunologic Factors|immunologic factors|mesh-ancestor
111001421|NCT03369795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111001422|NCT03369795|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111001423|NCT03374709|Oxcarbazepine|oxcarbazepine|mesh-list
111001424|NCT03374709|Anticonvulsants|anticonvulsants|mesh-ancestor
111001425|NCT03374709|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111001426|NCT03374709|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111001427|NCT03374709|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111001428|NCT03374709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111001429|NCT03374709|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111001430|NCT03374709|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111001431|NCT05393414|Acetaminophen|acetaminophen|mesh-list
111001432|NCT05393414|Ketorolac|ketorolac|mesh-list
111001433|NCT05393414|Morphine|morphine|mesh-list
111001434|NCT05393414|Analgesics, Opioid|analgesics, opioid|mesh-list
111001435|NCT05393414|Narcotics|narcotics|mesh-ancestor
111001436|NCT05393414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111001437|NCT05393414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111001438|NCT05393414|Analgesics|analgesics|mesh-ancestor
111001439|NCT05393414|Sensory System Agents|sensory system agents|mesh-ancestor
111001440|NCT05393414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111001441|NCT05393414|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111001442|NCT05393414|Antipyretics|antipyretics|mesh-ancestor
111001443|NCT05393414|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111001444|NCT05393414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111001445|NCT05393414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111001446|NCT05393414|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111001447|NCT05393414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111001448|NCT05393414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111001449|NCT03369327|Sofosbuvir|sofosbuvir|mesh-list
111001450|NCT03369327|Antiviral Agents|antiviral agents|mesh-ancestor
111001451|NCT03369327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111001452|NCT02034500|Vaccines|vaccines|mesh-list
111001453|NCT02034500|Immunologic Factors|immunologic factors|mesh-ancestor
111001454|NCT02034500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111001455|NCT03377283|Antilymphocyte Serum|antilymphocyte serum|mesh-list
111001456|NCT03377283|Thymoglobulin|thymoglobulin|mesh-list
111001457|NCT03377283|Immunologic Factors|immunologic factors|mesh-ancestor
111001458|NCT03377283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111001459|NCT03377283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111001460|NCT03955640|Olaparib|olaparib|mesh-list
111001461|NCT03955640|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
111001462|NCT03955640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111001463|NCT03955640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111001464|NCT03955640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111001465|NCT03369093|Amoxicillin|amoxicillin|mesh-list
111001466|NCT03369093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111001467|NCT03369093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111001468|NCT03369015|Amphetamine|amphetamine|mesh-list
111001469|NCT03369015|Dextroamphetamine|dextroamphetamine|mesh-list
111001470|NCT03369015|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111001471|NCT03369015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111001472|NCT03369015|Sympathomimetics|sympathomimetics|mesh-ancestor
111001473|NCT03369015|Autonomic Agents|autonomic agents|mesh-ancestor
111001474|NCT03369015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111001475|NCT03369015|Dopamine Agents|dopamine agents|mesh-ancestor
111001476|NCT03369015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111001477|NCT03369015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111001478|NCT03369015|Adrenergic Agents|adrenergic agents|mesh-ancestor
111001479|NCT03369015|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111001480|NCT03369015|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111001481|NCT03369015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111001482|NCT03369015|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111001483|NCT03890744|Docetaxel|docetaxel|mesh-list
111001484|NCT03890744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111001485|NCT03890744|Tubulin Modulators|tubulin modulators|mesh-ancestor
111001486|NCT03890744|Antimitotic Agents|antimitotic agents|mesh-ancestor
111001487|NCT03890744|Mitosis Modulators|mitosis modulators|mesh-ancestor
111001488|NCT03890744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111001489|NCT03374163|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
111001490|NCT03374163|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
111001491|NCT03374163|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
111001492|NCT03374163|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111001493|NCT03374007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111001494|NCT03374007|Antibodies|antibodies|mesh-list
111001495|NCT03374007|Immunoglobulins|immunoglobulins|mesh-list
111001496|NCT03374007|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111001497|NCT03374007|Immunologic Factors|immunologic factors|mesh-ancestor
111001498|NCT03374007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111001499|NCT03374007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111001500|NCT04525521|Hand Sanitizers|hand sanitizers|mesh-list
111001501|NCT04525521|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111001502|NCT04525521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111001503|NCT04525521|Disinfectants|disinfectants|mesh-ancestor
111001505|NCT05392166|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111001506|NCT05392166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111001507|NCT02853331|Pembrolizumab|pembrolizumab|mesh-list
111001508|NCT02853331|Sunitinib|sunitinib|mesh-list
111001509|NCT02853331|Axitinib|axitinib|mesh-list
111001510|NCT02853331|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111001511|NCT02853331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111001512|NCT02853331|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111001513|NCT02853331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111001514|NCT02853331|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111001515|NCT02853331|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111001516|NCT02853331|Growth Substances|growth substances|mesh-ancestor
111001517|NCT02853331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111001518|NCT02853331|Growth Inhibitors|growth inhibitors|mesh-ancestor
111001519|NCT02853331|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111001520|NCT02853331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111001521|NCT03136640|Docetaxel|docetaxel|mesh-list
111001522|NCT03136640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111001523|NCT03136640|Tubulin Modulators|tubulin modulators|mesh-ancestor
111001524|NCT03136640|Antimitotic Agents|antimitotic agents|mesh-ancestor
111001525|NCT03136640|Mitosis Modulators|mitosis modulators|mesh-ancestor
111001526|NCT03136640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111001527|NCT02675439|Ipilimumab|ipilimumab|mesh-list
111001528|NCT02675439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111001529|NCT02675439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111001530|NCT02675439|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111001531|NCT02675439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111001532|NCT03604003|Losartan|losartan|mesh-list
111001533|NCT03604003|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111001534|NCT03604003|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111119144|NCT05323617|Antilymphocyte Serum|antilymphocyte serum|mesh-list
111001535|NCT03604003|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111001536|NCT03604003|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111001537|NCT03604003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111001538|NCT03368391|Lidocaine|lidocaine|mesh-list
111001539|NCT03368391|Phenylephrine|phenylephrine|mesh-list
111001540|NCT03368391|Epinephrine|epinephrine|mesh-list
111001541|NCT03368391|Racepinephrine|racepinephrine|mesh-list
111001542|NCT03368391|Oxymetazoline|oxymetazoline|mesh-list
111001543|NCT03368391|Tetracaine|tetracaine|mesh-list
111001544|NCT03368391|Mepivacaine|mepivacaine|mesh-list
111001545|NCT03368391|Epinephryl borate|epinephryl borate|mesh-list
111001546|NCT03368391|Anesthetics, Local|anesthetics, local|mesh-ancestor
111001547|NCT03368391|Anesthetics|anesthetics|mesh-ancestor
111001548|NCT03368391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111001549|NCT03368391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111001550|NCT03368391|Sensory System Agents|sensory system agents|mesh-ancestor
111001551|NCT03368391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111001552|NCT03368391|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111001553|NCT03368391|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111001554|NCT03368391|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111001555|NCT03368391|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111001556|NCT03368391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111001557|NCT03368391|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111001558|NCT03368391|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111001559|NCT03368391|Adrenergic Agents|adrenergic agents|mesh-ancestor
111001560|NCT03368391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111001561|NCT03368391|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111001562|NCT03368391|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111001563|NCT03368391|Autonomic Agents|autonomic agents|mesh-ancestor
111001564|NCT03368391|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111001565|NCT03368391|Respiratory System Agents|respiratory system agents|mesh-ancestor
111001566|NCT03368391|Mydriatics|mydriatics|mesh-ancestor
111001567|NCT03368391|Sympathomimetics|sympathomimetics|mesh-ancestor
111001568|NCT03368391|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111001569|NCT03368391|Nasal Decongestants|nasal decongestants|mesh-ancestor
111001570|NCT03368391|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111001571|NCT03368391|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111001572|NCT03368391|Protective Agents|protective agents|mesh-ancestor
111001573|NCT03373305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111001574|NCT03373305|Brentuximab Vedotin|brentuximab vedotin|mesh-list
111001575|NCT03373305|Lenalidomide|lenalidomide|mesh-list
111001576|NCT03373305|Piperidine|piperidine|mesh-list
111001577|NCT03373305|Antibodies|antibodies|mesh-list
111001578|NCT03373305|Immunoglobulins|immunoglobulins|mesh-list
111001579|NCT03373305|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111001580|NCT03373305|Immunoconjugates|immunoconjugates|mesh-list
111001581|NCT03373305|Immunologic Factors|immunologic factors|mesh-ancestor
111001582|NCT03373305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111001583|NCT03373305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111001584|NCT03373305|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111001585|NCT03373305|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111001586|NCT03373305|Growth Substances|growth substances|mesh-ancestor
111001587|NCT03373305|Growth Inhibitors|growth inhibitors|mesh-ancestor
111001588|NCT03373305|Immunotoxins|immunotoxins|mesh-ancestor
111001589|NCT03373305|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111001590|NCT03373305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111001591|NCT03373305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111001592|NCT03373305|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111001593|NCT03376737|Pemetrexed|pemetrexed|mesh-list
111001594|NCT03376737|Apatinib|apatinib|mesh-list
111001595|NCT03376737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111001596|NCT03376737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111001597|NCT03376737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111001598|NCT03376737|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111001599|NCT03376737|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111001600|NCT03376737|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111001601|NCT03373227|Tacrolimus|tacrolimus|mesh-list
111001602|NCT03373227|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111001603|NCT03373227|Immunologic Factors|immunologic factors|mesh-ancestor
111001604|NCT03373227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111001605|NCT03373227|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111001606|NCT03373227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111001607|NCT03373227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111001608|NCT02484716|Timolol|timolol|mesh-list
111001609|NCT02484716|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111001610|NCT02484716|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111001612|NCT02484716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111001613|NCT02484716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111001614|NCT02484716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111001615|NCT02484716|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111001616|NCT02484716|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111001617|NCT03373149|Hormones|hormones|mesh-list
111001618|NCT03373149|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
111001619|NCT03373149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111001620|NCT03373149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111001621|NCT05386784|Cholecalciferol|cholecalciferol|mesh-list
111001622|NCT05386784|Vitamin D|vitamin d|mesh-list
111001623|NCT05386784|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
111001624|NCT05386784|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111001625|NCT05386784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111001626|NCT05386784|Vitamins|vitamins|mesh-ancestor
111001627|NCT05386784|Micronutrients|micronutrients|mesh-ancestor
111001628|NCT05386784|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111001629|NCT05386784|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111001630|NCT05386784|Hormone Antagonists|hormone antagonists|mesh-ancestor
111001631|NCT05386784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111001632|NCT05386784|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111001633|NCT05386784|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111001634|NCT03602287|Lidocaine|lidocaine|mesh-list
111001635|NCT03602287|Anesthetics, Local|anesthetics, local|mesh-ancestor
111001636|NCT03602287|Anesthetics|anesthetics|mesh-ancestor
111001637|NCT03602287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111001638|NCT03602287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111001639|NCT03602287|Sensory System Agents|sensory system agents|mesh-ancestor
111001640|NCT03602287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111001641|NCT03602287|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111001642|NCT03602287|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111001643|NCT03602287|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111001644|NCT03602287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111001645|NCT03602287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111001647|NCT03137498|Lidocaine|lidocaine|mesh-list
111001648|NCT03137498|Prilocaine|prilocaine|mesh-list
111001649|NCT03137498|Anesthetics, Local|anesthetics, local|mesh-ancestor
111001650|NCT03137498|Anesthetics|anesthetics|mesh-ancestor
111001651|NCT03137498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111001652|NCT03137498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111001653|NCT03137498|Sensory System Agents|sensory system agents|mesh-ancestor
111001654|NCT03137498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111001655|NCT03137498|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111001656|NCT03137498|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111001657|NCT03137498|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111001658|NCT03137498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111001659|NCT03137498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111001660|NCT03137498|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111001661|NCT03137498|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111001662|NCT03137498|Analgesics|analgesics|mesh-ancestor
111001663|NCT03137498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111001664|NCT03137498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111001665|NCT03137498|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111001666|NCT03137498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111001667|NCT03602209|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111001668|NCT03602209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111001669|NCT03367377|Insulin Glargine|insulin glargine|mesh-list
111001670|NCT03367377|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111001671|NCT03367377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111001672|NCT03602131|Gemcitabine|gemcitabine|mesh-list
111001673|NCT03602131|Busulfan|busulfan|mesh-list
111001674|NCT03602131|Cladribine|cladribine|mesh-list
111001675|NCT03602131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111001676|NCT03602131|Antimetabolites|antimetabolites|mesh-ancestor
111001677|NCT03602131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111001678|NCT03602131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111001679|NCT03602131|Alkylating Agents|alkylating agents|mesh-ancestor
111001680|NCT03602131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111001681|NCT03602131|Immunologic Factors|immunologic factors|mesh-ancestor
111001682|NCT03602131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111119145|NCT05323617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111001683|NCT03602131|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111001684|NCT03602131|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111001685|NCT05851547|Triptorelin Pamoate|triptorelin pamoate|mesh-list
111001686|NCT05851547|Androgens|androgens|mesh-list
111001687|NCT05851547|Hormones|hormones|mesh-ancestor
111001688|NCT05851547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111001689|NCT05851547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111001690|NCT05851547|Luteolytic Agents|luteolytic agents|mesh-ancestor
111001691|NCT05851547|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111001692|NCT05851547|Contraceptive Agents|contraceptive agents|mesh-ancestor
111001693|NCT05851547|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111001694|NCT05851547|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111001695|NCT05851547|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111001696|NCT05851547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111001697|NCT05851508|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111001698|NCT05851508|Methylprednisolone|methylprednisolone|mesh-list
111001699|NCT05851508|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111001700|NCT05851508|Prednisolone|prednisolone|mesh-list
111001701|NCT05851508|Prednisolone acetate|prednisolone acetate|mesh-list
111001702|NCT05851508|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111001703|NCT05851508|Prednisolone phosphate|prednisolone phosphate|mesh-list
111001704|NCT05851508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111001705|NCT05851508|Antiemetics|antiemetics|mesh-ancestor
111001706|NCT05851508|Autonomic Agents|autonomic agents|mesh-ancestor
111001707|NCT05851508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111001708|NCT05851508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111001709|NCT05851508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111001710|NCT05851508|Glucocorticoids|glucocorticoids|mesh-ancestor
111001711|NCT05851508|Hormones|hormones|mesh-ancestor
111001712|NCT05851508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111001713|NCT05851508|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111001714|NCT05851508|Protective Agents|protective agents|mesh-ancestor
111001715|NCT05851508|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111001716|NCT05851508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111001717|NCT05851391|Anesthetics|anesthetics|mesh-list
111001718|NCT05851391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111001719|NCT05851391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111001720|NCT05851352|Antibodies|antibodies|mesh-list
111001721|NCT05851352|Immunologic Factors|immunologic factors|mesh-ancestor
111001722|NCT05851352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111001723|NCT05851014|Letrozole|letrozole|mesh-list
111001724|NCT05851014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111001725|NCT05851014|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111001726|NCT05851014|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111001727|NCT05851014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111001728|NCT05851014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111001729|NCT05851014|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111001730|NCT05851014|Hormone Antagonists|hormone antagonists|mesh-ancestor
111001731|NCT05851014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111001732|NCT05851014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111001733|NCT05850936|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111001734|NCT05850936|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111001735|NCT05850871|Aztreonam|aztreonam|mesh-list
111001736|NCT05850871|Avibactam|avibactam|mesh-list
111001737|NCT05850871|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111001738|NCT05850871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111001739|NCT05850871|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
111001740|NCT05850871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111001741|NCT05850871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111001742|NCT05850832|Magnesium Sulfate|magnesium sulfate|mesh-list
111001743|NCT05850832|Esmolol|esmolol|mesh-list
111001744|NCT05850832|Analgesics|analgesics|mesh-ancestor
111001745|NCT05850832|Sensory System Agents|sensory system agents|mesh-ancestor
111001746|NCT05850832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111001747|NCT05850832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111001748|NCT05850832|Anesthetics|anesthetics|mesh-ancestor
111001749|NCT05850832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111001750|NCT05850832|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111001751|NCT05850832|Anticonvulsants|anticonvulsants|mesh-ancestor
111001752|NCT05850832|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111001753|NCT05850832|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111001754|NCT05850832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111001755|NCT05850832|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111001756|NCT05850832|Tocolytic Agents|tocolytic agents|mesh-ancestor
111001757|NCT05850832|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111001758|NCT05850832|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
111001759|NCT05850832|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111001760|NCT05850832|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111001761|NCT05850832|Adrenergic Agents|adrenergic agents|mesh-ancestor
111001762|NCT05850832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111001763|NCT05850702|Lidocaine|lidocaine|mesh-list
111001764|NCT05850702|Anesthetics, Local|anesthetics, local|mesh-ancestor
111001765|NCT05850702|Anesthetics|anesthetics|mesh-ancestor
111001766|NCT05850702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111001767|NCT05850702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111001768|NCT05850702|Sensory System Agents|sensory system agents|mesh-ancestor
111001769|NCT05850702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111001770|NCT05850702|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111001771|NCT05850702|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111001772|NCT05850702|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111001773|NCT05850702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111001774|NCT05850702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111001775|NCT05850559|Mitogens|mitogens|mesh-list
111001776|NCT05850559|Mitosis Modulators|mitosis modulators|mesh-ancestor
111001777|NCT05850559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111001778|NCT05850507|Vaccines|vaccines|mesh-list
111001779|NCT05850507|Immunologic Factors|immunologic factors|mesh-ancestor
111001780|NCT05850507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111001781|NCT05850468|Lidocaine|lidocaine|mesh-list
111001782|NCT05850468|Fentanyl|fentanyl|mesh-list
111001783|NCT05850468|Anesthetics|anesthetics|mesh-list
111001784|NCT05850468|Anesthetics, Local|anesthetics, local|mesh-ancestor
111001785|NCT05850468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111001786|NCT05850468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111001787|NCT05850468|Sensory System Agents|sensory system agents|mesh-ancestor
111001788|NCT05850468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111001789|NCT05850468|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111001790|NCT05850468|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111001791|NCT05850468|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111001792|NCT05850468|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111001793|NCT05850468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111001794|NCT05850468|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111001795|NCT05850468|Narcotics|narcotics|mesh-ancestor
111001796|NCT05850468|Analgesics|analgesics|mesh-ancestor
111001797|NCT05850468|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111001798|NCT05850468|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111001799|NCT05850468|Anesthetics, General|anesthetics, general|mesh-ancestor
111001800|NCT05850455|Lidocaine|lidocaine|mesh-list
111001801|NCT05850455|Dexmedetomidine|dexmedetomidine|mesh-list
111001802|NCT05850455|Bupivacaine|bupivacaine|mesh-list
111001803|NCT05850455|Anesthetics, Local|anesthetics, local|mesh-ancestor
111001804|NCT05850455|Anesthetics|anesthetics|mesh-ancestor
111001805|NCT05850455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111001806|NCT05850455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111001807|NCT05850455|Sensory System Agents|sensory system agents|mesh-ancestor
111001808|NCT05850455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111001809|NCT05850455|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111001810|NCT05850455|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111001811|NCT05850455|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111001812|NCT05850455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111001813|NCT05850455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111001814|NCT05850455|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111001815|NCT05850455|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111001816|NCT05850455|Analgesics|analgesics|mesh-ancestor
111001817|NCT05850455|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111001818|NCT05850455|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111001819|NCT05850455|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111001820|NCT05850455|Adrenergic Agents|adrenergic agents|mesh-ancestor
111001821|NCT05850455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111001822|NCT05850377|Aminolevulinic Acid|aminolevulinic acid|mesh-list
111001823|NCT05850377|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111001824|NCT05850377|Dermatologic Agents|dermatologic agents|mesh-ancestor
111001825|NCT06042725|Dexamethasone|dexamethasone|mesh-list
111001826|NCT06042725|Dexamethasone acetate|dexamethasone acetate|mesh-list
111001827|NCT06042725|Lenalidomide|lenalidomide|mesh-list
111001828|NCT06042725|Venetoclax|venetoclax|mesh-list
111001829|NCT06042725|Daratumumab|daratumumab|mesh-list
111001830|NCT06042725|Ichthammol|ichthammol|mesh-list
111001831|NCT06042725|BB 1101|bb 1101|mesh-list
111001832|NCT06042725|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111001833|NCT06042725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111001834|NCT06042725|Antiemetics|antiemetics|mesh-ancestor
111001835|NCT06042725|Autonomic Agents|autonomic agents|mesh-ancestor
111001836|NCT06042725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111001837|NCT06042725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111001838|NCT06042725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111001839|NCT06042725|Glucocorticoids|glucocorticoids|mesh-ancestor
111001840|NCT06042725|Hormones|hormones|mesh-ancestor
111001841|NCT06042725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111001842|NCT06042725|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111001843|NCT06042725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111001844|NCT06042725|Protease Inhibitors|protease inhibitors|mesh-ancestor
111001845|NCT06042725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111001846|NCT06042725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111001847|NCT06042725|Immunologic Factors|immunologic factors|mesh-ancestor
111001848|NCT06042725|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111001849|NCT06042725|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111001850|NCT06042725|Growth Substances|growth substances|mesh-ancestor
111001851|NCT06042725|Growth Inhibitors|growth inhibitors|mesh-ancestor
111001852|NCT06042725|Dermatologic Agents|dermatologic agents|mesh-ancestor
111001853|NCT06042647|Clobetasol|clobetasol|mesh-list
111001854|NCT06042647|Halobetasol|halobetasol|mesh-list
111001855|NCT06042647|Tazarotene|tazarotene|mesh-list
111001856|NCT06042647|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111001857|NCT06042647|Glucocorticoids|glucocorticoids|mesh-ancestor
111001858|NCT06042647|Hormones|hormones|mesh-ancestor
111001859|NCT06042647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111001860|NCT06042647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111001861|NCT06042647|Dermatologic Agents|dermatologic agents|mesh-ancestor
111001862|NCT06042647|Keratolytic Agents|keratolytic agents|mesh-ancestor
111001863|NCT06042647|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111001864|NCT06042517|Liver Extracts|liver extracts|mesh-list
111001865|NCT06042517|Hematinics|hematinics|mesh-ancestor
111001866|NCT06042426|Acetaminophen|acetaminophen|mesh-list
110718880|NCT03893032|Modafinil|modafinil|mesh-list
111001867|NCT06042426|Dexamethasone|dexamethasone|mesh-list
111001868|NCT06042426|Morphine|morphine|mesh-list
111001869|NCT06042426|Oxycodone|oxycodone|mesh-list
111001870|NCT06042426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111001871|NCT06042426|Antiemetics|antiemetics|mesh-ancestor
111001872|NCT06042426|Autonomic Agents|autonomic agents|mesh-ancestor
111001873|NCT06042426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111001874|NCT06042426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111001875|NCT06042426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111001876|NCT06042426|Glucocorticoids|glucocorticoids|mesh-ancestor
111001877|NCT06042426|Hormones|hormones|mesh-ancestor
111001878|NCT06042426|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111001879|NCT06042426|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111001880|NCT06042426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111001881|NCT06042426|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111001882|NCT06042426|Narcotics|narcotics|mesh-ancestor
111001883|NCT06042426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111001884|NCT06042426|Analgesics|analgesics|mesh-ancestor
111001885|NCT06042426|Sensory System Agents|sensory system agents|mesh-ancestor
111001886|NCT06042426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111001887|NCT06042426|Antipyretics|antipyretics|mesh-ancestor
111001888|NCT06042309|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111001889|NCT06042270|Betaine|betaine|mesh-list
111001890|NCT06042270|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111001891|NCT06042270|Lipotropic Agents|lipotropic agents|mesh-ancestor
111001892|NCT06042270|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111001893|NCT06042270|Antimetabolites|antimetabolites|mesh-ancestor
111001894|NCT06042270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111001895|NCT06042270|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111001896|NCT06042010|Triamcinolone|triamcinolone|mesh-list
111001897|NCT06042010|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
111001898|NCT06042010|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
111001899|NCT06042010|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
111001900|NCT06042010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111001901|NCT06042010|Glucocorticoids|glucocorticoids|mesh-ancestor
111001902|NCT06042010|Hormones|hormones|mesh-ancestor
111001903|NCT06042010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111001904|NCT06042010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111001905|NCT06042010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111001906|NCT06042010|Immunologic Factors|immunologic factors|mesh-ancestor
111001908|NCT06042010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111001909|NCT06041984|Glycopyrrolate|glycopyrrolate|mesh-list
111001910|NCT06041984|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111001911|NCT06041984|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111001912|NCT06041984|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111001913|NCT06041984|Cholinergic Agents|cholinergic agents|mesh-ancestor
111001914|NCT06041984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111001915|NCT06041984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111001916|NCT06041984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111001917|NCT06041802|Pembrolizumab|pembrolizumab|mesh-list
111001918|NCT06041802|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111001919|NCT06041802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111001920|NCT06041802|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111001921|NCT06041802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111001922|NCT06041789|Donepezil|donepezil|mesh-list
111001923|NCT06041789|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111001924|NCT06041789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111001925|NCT06041789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111001926|NCT06041789|Cholinergic Agents|cholinergic agents|mesh-ancestor
111001927|NCT06041789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111001928|NCT06041789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111001929|NCT06041789|Nootropic Agents|nootropic agents|mesh-ancestor
111001930|NCT06041750|Anesthetics|anesthetics|mesh-list
111001931|NCT06041750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111001932|NCT06041750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111001933|NCT06041724|Endostatins|endostatins|mesh-list
111001934|NCT06041724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111001935|NCT06041724|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111001936|NCT06041724|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111001937|NCT06041724|Growth Substances|growth substances|mesh-ancestor
111001938|NCT06041724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111001939|NCT06041724|Growth Inhibitors|growth inhibitors|mesh-ancestor
111001940|NCT06041711|Anesthetics|anesthetics|mesh-list
111001941|NCT06041711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111001942|NCT06041711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111001943|NCT06041529|Amlodipine|amlodipine|mesh-list
111001944|NCT06041529|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
111001945|NCT06041529|Telmisartan|telmisartan|mesh-list
111001946|NCT06041529|Chlorthalidone|chlorthalidone|mesh-list
111001947|NCT06041529|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
111001948|NCT06041529|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111001949|NCT06041529|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111001950|NCT06041529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111001951|NCT06041529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111001952|NCT06041529|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111001953|NCT06041529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111001954|NCT06041529|Vasodilator Agents|vasodilator agents|mesh-ancestor
111001955|NCT06041529|Diuretics|diuretics|mesh-ancestor
111001956|NCT06041529|Natriuretic Agents|natriuretic agents|mesh-ancestor
111001957|NCT06041529|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
111001958|NCT06041529|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111001959|NCT06041529|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111001960|NCT06041490|Bevacizumab|bevacizumab|mesh-list
111001961|NCT06041490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111001962|NCT06041490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111001963|NCT06041490|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111001964|NCT06041490|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111001965|NCT06041490|Growth Substances|growth substances|mesh-ancestor
111001966|NCT06041490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111001967|NCT06041490|Growth Inhibitors|growth inhibitors|mesh-ancestor
111001968|NCT06041477|Leucovorin|leucovorin|mesh-list
111001969|NCT06041477|Folic Acid|folic acid|mesh-list
111001970|NCT06041477|Oxaliplatin|oxaliplatin|mesh-list
111001971|NCT06041477|Lenvatinib|lenvatinib|mesh-list
111001972|NCT06041477|Antibodies|antibodies|mesh-list
111001973|NCT06041477|Immunoglobulins|immunoglobulins|mesh-list
111001974|NCT06041477|Immunologic Factors|immunologic factors|mesh-list
111001975|NCT06041477|Immunomodulating Agents|immunomodulating agents|mesh-list
111001976|NCT06041477|Levoleucovorin|levoleucovorin|mesh-list
111001977|NCT06041477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111001978|NCT06041477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111001979|NCT06041477|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111001980|NCT06041477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111001981|NCT06041477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111001983|NCT06041477|Protective Agents|protective agents|mesh-ancestor
111001984|NCT06041477|Vitamin B Complex|vitamin b complex|mesh-ancestor
111001985|NCT06041477|Vitamins|vitamins|mesh-ancestor
111001986|NCT06041477|Micronutrients|micronutrients|mesh-ancestor
111001987|NCT06041477|Hematinics|hematinics|mesh-ancestor
111001988|NCT06041451|Methylprednisolone|methylprednisolone|mesh-list
111001989|NCT06041451|Immunoglobulins|immunoglobulins|mesh-list
111001990|NCT06041451|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111001991|NCT06041451|gamma-Globulins|gamma-globulins|mesh-list
111001992|NCT06041451|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
111001993|NCT06041451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111001994|NCT06041451|Antiemetics|antiemetics|mesh-ancestor
111001995|NCT06041451|Autonomic Agents|autonomic agents|mesh-ancestor
111001996|NCT06041451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111001997|NCT06041451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111001998|NCT06041451|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111001999|NCT06041451|Glucocorticoids|glucocorticoids|mesh-ancestor
111002000|NCT06041451|Hormones|hormones|mesh-ancestor
111002001|NCT06041451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111002002|NCT06041451|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111002003|NCT06041451|Protective Agents|protective agents|mesh-ancestor
111002004|NCT06041451|Immunologic Factors|immunologic factors|mesh-ancestor
111002005|NCT06041438|Itraconazole|itraconazole|mesh-list
111002006|NCT06041438|Antifungal Agents|antifungal agents|mesh-ancestor
111002007|NCT06041438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111002008|NCT06041438|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111002009|NCT06041438|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111002010|NCT06041438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111002011|NCT06041438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111002012|NCT06041438|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111002013|NCT06041438|Hormone Antagonists|hormone antagonists|mesh-ancestor
111002014|NCT06041438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111002015|NCT06041438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111002016|NCT06041438|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111002017|NCT06041425|Sufentanil|sufentanil|mesh-list
111002018|NCT06041425|Oxycodone|oxycodone|mesh-list
111002019|NCT06041425|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111002020|NCT06041425|Narcotics|narcotics|mesh-ancestor
111002021|NCT06041425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110719028|NCT03892330|Oxytetracycline|oxytetracycline|mesh-list
111002022|NCT06041425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111002023|NCT06041425|Analgesics|analgesics|mesh-ancestor
111002024|NCT06041425|Sensory System Agents|sensory system agents|mesh-ancestor
111002025|NCT06041425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111002026|NCT06041425|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111002027|NCT06041425|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111002028|NCT06041425|Anesthetics, General|anesthetics, general|mesh-ancestor
111002029|NCT06041425|Anesthetics|anesthetics|mesh-ancestor
111002030|NCT06041399|Metformin|metformin|mesh-list
111002031|NCT06041399|Hypoglycemic Agents|hypoglycemic agents|mesh-list
111002032|NCT06041399|Hypolipidemic Agents|hypolipidemic agents|mesh-list
111002033|NCT06041399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111002034|NCT06041399|Antimetabolites|antimetabolites|mesh-ancestor
111002035|NCT06041399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111002036|NCT06041399|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111002037|NCT06041282|Anesthetics|anesthetics|mesh-list
111002038|NCT06041282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111002039|NCT06041282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111002040|NCT06041204|Letrozole|letrozole|mesh-list
111002041|NCT06041204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111002042|NCT06041204|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111002043|NCT06041204|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111002044|NCT06041204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111002045|NCT06041204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111002046|NCT06041204|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111002047|NCT06041204|Hormone Antagonists|hormone antagonists|mesh-ancestor
111002048|NCT06041204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111002049|NCT06041204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111002050|NCT06041178|Flurbiprofen|flurbiprofen|mesh-list
111002051|NCT06041178|Analgesics|analgesics|mesh-ancestor
111002052|NCT06041178|Sensory System Agents|sensory system agents|mesh-ancestor
111002053|NCT06041178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110467223|NCT02839941|Hormones|hormones|mesh-ancestor
111002054|NCT06041178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111002055|NCT06041178|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111002056|NCT06041178|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111002057|NCT06041178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111002058|NCT06041178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111002059|NCT06041178|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111002060|NCT06041178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111002061|NCT06041178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111002062|NCT06041152|Psilocybin|psilocybin|mesh-list
111002063|NCT06041152|Hallucinogens|hallucinogens|mesh-ancestor
111002064|NCT06041152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111002065|NCT06041152|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111002066|NCT06041048|Modafinil|modafinil|mesh-list
111002067|NCT06041048|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111002068|NCT06041048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111002069|NCT06041048|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
111002070|NCT06041048|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111002071|NCT06041048|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111002072|NCT06041048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111002073|NCT06041035|Paclitaxel|paclitaxel|mesh-list
111002074|NCT06041035|Gemcitabine|gemcitabine|mesh-list
111002075|NCT06041035|Capecitabine|capecitabine|mesh-list
111002076|NCT06041035|Oxaliplatin|oxaliplatin|mesh-list
111002077|NCT06041035|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111002078|NCT06041035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111002079|NCT06041035|Tubulin Modulators|tubulin modulators|mesh-ancestor
111002080|NCT06041035|Antimitotic Agents|antimitotic agents|mesh-ancestor
111002081|NCT06041035|Mitosis Modulators|mitosis modulators|mesh-ancestor
111002082|NCT06041035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111002083|NCT06041035|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111002084|NCT06041035|Antimetabolites|antimetabolites|mesh-ancestor
111002085|NCT06040970|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
111002086|NCT06040970|Immunoconjugates|immunoconjugates|mesh-ancestor
111002087|NCT06040970|Immunologic Factors|immunologic factors|mesh-ancestor
111002088|NCT06040970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111002089|NCT06040944|Antipsychotic Agents|antipsychotic agents|mesh-list
111002090|NCT06040944|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111002091|NCT06040944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111002092|NCT06040944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111002093|NCT06040944|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111002094|NCT06040905|Ubiquinone|ubiquinone|mesh-list
111002095|NCT06040905|Coenzyme Q10|coenzyme q10|mesh-list
111002096|NCT06040905|Micronutrients|micronutrients|mesh-ancestor
111002097|NCT06040905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111002098|NCT06040905|Vitamins|vitamins|mesh-ancestor
111002099|NCT06040853|Tranexamic Acid|tranexamic acid|mesh-list
111002100|NCT06040853|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111002101|NCT06040853|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111002102|NCT06040853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111002103|NCT06040853|Hemostatics|hemostatics|mesh-ancestor
111002104|NCT06040853|Coagulants|coagulants|mesh-ancestor
111002105|NCT06040840|Lidocaine|lidocaine|mesh-list
111002106|NCT06040840|Epinephrine|epinephrine|mesh-list
111002107|NCT06040840|Anesthetics, Local|anesthetics, local|mesh-ancestor
111002108|NCT06040840|Anesthetics|anesthetics|mesh-ancestor
111002109|NCT06040840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111002110|NCT06040840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111002111|NCT06040840|Sensory System Agents|sensory system agents|mesh-ancestor
111002112|NCT06040840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111002113|NCT06040840|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111002114|NCT06040840|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111002115|NCT06040840|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111002116|NCT06040840|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111002117|NCT06040840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111002118|NCT06040840|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111002119|NCT06040840|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111002120|NCT06040840|Adrenergic Agents|adrenergic agents|mesh-ancestor
111002121|NCT06040840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111002122|NCT06040840|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111002123|NCT06040840|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111002124|NCT06040840|Autonomic Agents|autonomic agents|mesh-ancestor
111002125|NCT06040840|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111002126|NCT06040840|Respiratory System Agents|respiratory system agents|mesh-ancestor
111002127|NCT06040840|Mydriatics|mydriatics|mesh-ancestor
111002128|NCT06040840|Sympathomimetics|sympathomimetics|mesh-ancestor
111002129|NCT06040840|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111002138|NCT06032052|Immunomodulating Agents|immunomodulating agents|mesh-list
111002139|NCT06032052|Immunologic Factors|immunologic factors|mesh-list
110618960|NCT00540514|Carboplatin|carboplatin|mesh-list
111002140|NCT06032052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111002141|NCT06030804|Dexmedetomidine|dexmedetomidine|mesh-list
111002142|NCT06030804|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111002143|NCT06030804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111002144|NCT06030804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111002145|NCT06030804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111002146|NCT06030804|Analgesics|analgesics|mesh-ancestor
111002147|NCT06030804|Sensory System Agents|sensory system agents|mesh-ancestor
111002148|NCT06030804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111002149|NCT06030804|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111002150|NCT06030804|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111002151|NCT06030804|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111002152|NCT06030804|Adrenergic Agents|adrenergic agents|mesh-ancestor
111002153|NCT06030804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111002154|NCT06030804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111002155|NCT06024889|Furosemide|furosemide|mesh-list
111002156|NCT06024889|Diuretics|diuretics|mesh-ancestor
111002157|NCT06024889|Natriuretic Agents|natriuretic agents|mesh-ancestor
111002158|NCT06024889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111002159|NCT06024889|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
111002160|NCT06024889|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111002161|NCT06024889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111002162|NCT06017323|Paclitaxel|paclitaxel|mesh-list
111002163|NCT06017323|Gemcitabine|gemcitabine|mesh-list
111002164|NCT06017323|Proglumide|proglumide|mesh-list
111002165|NCT06017323|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111002166|NCT06017323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111002167|NCT06017323|Tubulin Modulators|tubulin modulators|mesh-ancestor
111002168|NCT06017323|Antimitotic Agents|antimitotic agents|mesh-ancestor
111002169|NCT06017323|Mitosis Modulators|mitosis modulators|mesh-ancestor
110719180|NCT01261078|Autonomic Agents|autonomic agents|mesh-ancestor
111002170|NCT06017323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111002171|NCT06017323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111002172|NCT06017323|Antimetabolites|antimetabolites|mesh-ancestor
111002173|NCT06017323|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111002174|NCT06017323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111002175|NCT06017297|Gemcitabine|gemcitabine|mesh-list
111002176|NCT06017297|Durvalumab|durvalumab|mesh-list
111002177|NCT06017297|Tremelimumab|tremelimumab|mesh-list
111002178|NCT06017297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111002179|NCT06017297|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111002180|NCT06017297|Antimetabolites|antimetabolites|mesh-ancestor
111002181|NCT06017297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111002182|NCT06017297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111002183|NCT06006884|Dimercaprol|dimercaprol|mesh-list
111002184|NCT06006884|Chelating Agents|chelating agents|mesh-ancestor
111002185|NCT06006884|Sequestering Agents|sequestering agents|mesh-ancestor
111002186|NCT06006884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111002187|NCT06006546|MEDI9197|medi9197|mesh-list
111002188|NCT06006546|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111002189|NCT06006546|Immunologic Factors|immunologic factors|mesh-ancestor
111002190|NCT06006546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111002191|NCT06005480|Prilocaine|prilocaine|mesh-list
111002192|NCT06005480|Mepivacaine|mepivacaine|mesh-list
111002193|NCT06005480|Anesthetics, Local|anesthetics, local|mesh-ancestor
111002194|NCT06005480|Anesthetics|anesthetics|mesh-ancestor
111002195|NCT06005480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111002196|NCT06005480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111002197|NCT06005480|Sensory System Agents|sensory system agents|mesh-ancestor
111002198|NCT06005480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111002199|NCT06003231|Disitamab vedotin|disitamab vedotin|mesh-list
111002200|NCT06003231|Immunoconjugates|immunoconjugates|mesh-ancestor
111002201|NCT06003231|Immunologic Factors|immunologic factors|mesh-ancestor
111002202|NCT06003231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111002203|NCT06000501|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
111002204|NCT06000501|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111002205|NCT06000501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110619013|NCT00795678|Tubulin Modulators|tubulin modulators|mesh-ancestor
111002206|NCT06000501|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111002207|NCT06000501|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111002208|NCT06000501|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111002209|NCT06000501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111002210|NCT06000501|Dopamine Agents|dopamine agents|mesh-ancestor
111002211|NCT06000501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111002212|NCT05987371|Albuterol|albuterol|mesh-list
111002213|NCT05987371|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111002214|NCT05987371|Autonomic Agents|autonomic agents|mesh-ancestor
111002215|NCT05987371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111002216|NCT05987371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111002217|NCT05987371|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111002218|NCT05987371|Respiratory System Agents|respiratory system agents|mesh-ancestor
111002219|NCT05987371|Tocolytic Agents|tocolytic agents|mesh-ancestor
111002220|NCT05987371|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111002221|NCT05987371|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111002222|NCT05987371|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111002223|NCT05987371|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111002224|NCT05987371|Adrenergic Agents|adrenergic agents|mesh-ancestor
111002225|NCT05987371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111002226|NCT05987371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111002227|NCT05980117|Midazolam|midazolam|mesh-list
111002228|NCT05980117|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111002229|NCT05980117|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111002230|NCT05980117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111002231|NCT05980117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111002232|NCT05980117|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111002233|NCT05980117|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111002234|NCT05980117|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111002235|NCT05980117|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111002236|NCT05980117|Anesthetics, General|anesthetics, general|mesh-ancestor
111002237|NCT05980117|Anesthetics|anesthetics|mesh-ancestor
111002238|NCT05980117|GABA Modulators|gaba modulators|mesh-ancestor
111002239|NCT05980117|GABA Agents|gaba agents|mesh-ancestor
111002240|NCT05980117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111002241|NCT05980117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111002242|NCT05960578|Golimumab|golimumab|mesh-list
110719255|NCT01586494|Tramadol|tramadol|mesh-list
111002243|NCT05960578|Immunoglobulins|immunoglobulins|mesh-list
111002244|NCT05960578|Immunoglobulin G|immunoglobulin g|mesh-list
111002245|NCT05960578|Immunologic Factors|immunologic factors|mesh-ancestor
111002246|NCT05960578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111002247|NCT05960578|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111002248|NCT05960578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111002249|NCT05960578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111002250|NCT05944887|Lidocaine|lidocaine|mesh-list
111002251|NCT05944887|Propofol|propofol|mesh-list
111002252|NCT05944887|Anesthetics, Local|anesthetics, local|mesh-ancestor
111002253|NCT05944887|Anesthetics|anesthetics|mesh-ancestor
111002254|NCT05944887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111002255|NCT05944887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111002256|NCT05944887|Sensory System Agents|sensory system agents|mesh-ancestor
111002257|NCT05944887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111002258|NCT05944887|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111002259|NCT05944887|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111002260|NCT05944887|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111002261|NCT05944887|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111002262|NCT05944887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111002263|NCT05944887|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111002264|NCT05944887|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111002265|NCT05944887|Anesthetics, General|anesthetics, general|mesh-ancestor
111002266|NCT05914077|Secretin|secretin|mesh-list
111002267|NCT05914077|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111002268|NCT05914077|Hormones|hormones|mesh-ancestor
111002269|NCT05914077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111002270|NCT05914077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111002271|NCT05904496|Tislelizumab|tislelizumab|mesh-list
111002272|NCT05904496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111002273|NCT05904496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111002274|NCT05896761|Rilpivirine|rilpivirine|mesh-list
111002275|NCT05896761|Cabotegravir|cabotegravir|mesh-list
111002276|NCT05896761|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111002277|NCT05896761|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111002278|NCT05896761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111002279|NCT05896761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111002280|NCT05896761|Antiviral Agents|antiviral agents|mesh-ancestor
111002281|NCT05896761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111002282|NCT05896761|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111002283|NCT05896761|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111002284|NCT05896761|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111002285|NCT05896761|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111002286|NCT05894239|Taxane|taxane|mesh-list
111002287|NCT05894239|Inavolisib|inavolisib|mesh-list
111002288|NCT05894239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111002289|NCT05894239|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
111002290|NCT05894239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111002291|NCT05894239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111002292|NCT05892770|Zinc|zinc|mesh-list
111002293|NCT05892770|Botulinum Toxins|botulinum toxins|mesh-list
111002294|NCT05892770|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111002295|NCT05892770|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111002296|NCT05892770|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111002297|NCT05892770|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111002298|NCT05892770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111002299|NCT05892770|Cholinergic Agents|cholinergic agents|mesh-ancestor
111002300|NCT05892770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111002301|NCT05892770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111002302|NCT05892770|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111002303|NCT05892770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111002304|NCT05892770|Trace Elements|trace elements|mesh-ancestor
111002305|NCT05892770|Micronutrients|micronutrients|mesh-ancestor
111002306|NCT05889182|Upadacitinib|upadacitinib|mesh-list
111002307|NCT05889182|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
111002308|NCT05889182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111002309|NCT05889182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111002310|NCT05889182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111002311|NCT05889182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111002312|NCT05878522|Moxifloxacin|moxifloxacin|mesh-list
111002313|NCT05878522|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111002314|NCT05878522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111002315|NCT05878522|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111002316|NCT05878522|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111002317|NCT05878522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111002318|NCT05878522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111002319|NCT05878522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111002320|NCT05845814|Pembrolizumab|pembrolizumab|mesh-list
111002321|NCT05845814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111002322|NCT05845814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111002323|NCT05845814|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111002324|NCT05845814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111002325|NCT05838664|Rivaroxaban|rivaroxaban|mesh-list
111002326|NCT05838664|Apixaban|apixaban|mesh-list
111002327|NCT05838664|Dabigatran|dabigatran|mesh-list
111002328|NCT05838664|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111002329|NCT05838664|Antithrombins|antithrombins|mesh-ancestor
111002330|NCT05838664|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111002331|NCT05838664|Protease Inhibitors|protease inhibitors|mesh-ancestor
111002332|NCT05838664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111002333|NCT05838664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111002334|NCT05838664|Anticoagulants|anticoagulants|mesh-ancestor
111002335|NCT05831124|Vaccines|vaccines|mesh-list
111002336|NCT05831124|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
111002337|NCT05831124|Immunologic Factors|immunologic factors|mesh-ancestor
111002338|NCT05831124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111002339|NCT05827159|Naltrexone|naltrexone|mesh-list
111002340|NCT05827159|Gabapentin|gabapentin|mesh-list
111002341|NCT05827159|Analgesics|analgesics|mesh-ancestor
111002342|NCT05827159|Sensory System Agents|sensory system agents|mesh-ancestor
111002343|NCT05827159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111002344|NCT05827159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111002345|NCT05827159|Anticonvulsants|anticonvulsants|mesh-ancestor
111002346|NCT05827159|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111002347|NCT05827159|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111002348|NCT05827159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111002349|NCT05827159|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111002350|NCT05827159|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111002351|NCT05827159|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111002352|NCT05827159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111002353|NCT05827159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111002354|NCT05827159|Antimanic Agents|antimanic agents|mesh-ancestor
111002355|NCT05827159|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111002356|NCT05827159|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111002357|NCT05827055|Paclitaxel|paclitaxel|mesh-list
111002358|NCT05827055|Gemcitabine|gemcitabine|mesh-list
111002359|NCT05827055|Proglumide|proglumide|mesh-list
111002360|NCT05827055|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111002361|NCT05827055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111002362|NCT05827055|Tubulin Modulators|tubulin modulators|mesh-ancestor
111002363|NCT05827055|Antimitotic Agents|antimitotic agents|mesh-ancestor
111002364|NCT05827055|Mitosis Modulators|mitosis modulators|mesh-ancestor
111002365|NCT05827055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111002366|NCT05827055|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111002367|NCT05827055|Antimetabolites|antimetabolites|mesh-ancestor
111002368|NCT05827055|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111002369|NCT05827055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111002370|NCT05807932|Mycophenolic Acid|mycophenolic acid|mesh-list
111002371|NCT05807932|Venetoclax|venetoclax|mesh-list
111002372|NCT05807932|Amsacrine|amsacrine|mesh-list
111002373|NCT05807932|Tacrolimus|tacrolimus|mesh-list
111002374|NCT05807932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111002375|NCT05807932|Immunologic Factors|immunologic factors|mesh-ancestor
111002376|NCT05807932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111002377|NCT05807932|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111002378|NCT05807932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111002379|NCT05807932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111002380|NCT05807932|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111002381|NCT05807932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111002382|NCT05807932|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111002383|NCT05807932|Antitubercular Agents|antitubercular agents|mesh-ancestor
111002384|NCT05807932|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111002385|NCT05807932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111002386|NCT05794230|Vaccines|vaccines|mesh-list
111002387|NCT05794230|Immunologic Factors|immunologic factors|mesh-ancestor
111002388|NCT05794230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111002389|NCT05781152|Adalimumab|adalimumab|mesh-list
111002390|NCT05781152|Infliximab|infliximab|mesh-list
111002391|NCT05781152|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111002392|NCT05781152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111002393|NCT05781152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111002394|NCT05781152|Dermatologic Agents|dermatologic agents|mesh-ancestor
111002395|NCT05781152|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111002396|NCT05769153|Aflibercept|aflibercept|mesh-list
111002397|NCT05769153|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111002398|NCT05769153|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111002399|NCT05769153|Growth Substances|growth substances|mesh-ancestor
111002400|NCT05769153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111002401|NCT05769153|Growth Inhibitors|growth inhibitors|mesh-ancestor
111002402|NCT05769153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111002403|NCT05735379|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
111002404|NCT05735379|Cholinergic Antagonists|cholinergic antagonists|mesh-list
111002405|NCT05735379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111002406|NCT05735379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111002407|NCT05735379|Cholinergic Agents|cholinergic agents|mesh-ancestor
111002408|NCT05735379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111002409|NCT05735379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111002410|NCT05708638|Anesthetics|anesthetics|mesh-list
111002411|NCT05708638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111002412|NCT05708638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111002413|NCT05695781|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111002414|NCT05695781|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111002415|NCT05671757|Daratumumab|daratumumab|mesh-list
111002416|NCT05671757|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111002417|NCT05671757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111002418|NCT05671757|Immunologic Factors|immunologic factors|mesh-ancestor
111002419|NCT05671757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111002420|NCT05656911|Zabedosertib|zabedosertib|mesh-list
111002421|NCT05656911|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111002422|NCT05656911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111002423|NCT05656911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111002424|NCT05653258|Dasatinib|dasatinib|mesh-list
111002425|NCT05653258|Quercetin|quercetin|mesh-list
111002426|NCT05653258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111002427|NCT05653258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111002428|NCT05653258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111002429|NCT05653258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111002430|NCT05653258|Antioxidants|antioxidants|mesh-ancestor
111002431|NCT05653258|Protective Agents|protective agents|mesh-ancestor
111002432|NCT05653258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111002433|NCT05647122|Osimertinib|osimertinib|mesh-list
111002434|NCT05647122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111002435|NCT05647122|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111002436|NCT05647122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111002437|NCT05647122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111002438|NCT05639712|Fentanyl|fentanyl|mesh-list
111002439|NCT05639712|Morphine|morphine|mesh-list
111002440|NCT05639712|Oxycodone|oxycodone|mesh-list
111002441|NCT05639712|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111002442|NCT05639712|Narcotics|narcotics|mesh-ancestor
111002443|NCT05639712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111002444|NCT05639712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111002445|NCT05639712|Analgesics|analgesics|mesh-ancestor
111002446|NCT05639712|Sensory System Agents|sensory system agents|mesh-ancestor
111002447|NCT05639712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111002448|NCT05639712|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111002449|NCT05639712|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111002450|NCT05639712|Anesthetics, General|anesthetics, general|mesh-ancestor
111002451|NCT05639712|Anesthetics|anesthetics|mesh-ancestor
111002452|NCT05626322|Lenalidomide|lenalidomide|mesh-list
111002453|NCT05626322|Immunologic Factors|immunologic factors|mesh-ancestor
111002454|NCT05626322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111002455|NCT05626322|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111002456|NCT05626322|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111002457|NCT05626322|Growth Substances|growth substances|mesh-ancestor
111002458|NCT05626322|Growth Inhibitors|growth inhibitors|mesh-ancestor
111002459|NCT05626322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111002460|NCT05624268|Psilocybin|psilocybin|mesh-list
111002461|NCT05624268|Hallucinogens|hallucinogens|mesh-ancestor
111002462|NCT05624268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111002463|NCT05624268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111002464|NCT05620407|Deucravacitinib|deucravacitinib|mesh-list
111002465|NCT05620407|Dermatologic Agents|dermatologic agents|mesh-ancestor
111002466|NCT05620407|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111002467|NCT05620407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111002468|NCT05620407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111002469|NCT05619172|Cetuximab|cetuximab|mesh-list
111002470|NCT05619172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111002471|NCT05619172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111002472|NCT05617677|Deucravacitinib|deucravacitinib|mesh-list
111002473|NCT05617677|Dermatologic Agents|dermatologic agents|mesh-ancestor
111002474|NCT05617677|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111002475|NCT05617677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111002476|NCT05617677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111002477|NCT05611242|Salicylic Acid|salicylic acid|mesh-list
111002478|NCT05611242|Salicylates|salicylates|mesh-list
111002479|NCT05611242|Tirofiban|tirofiban|mesh-list
111002480|NCT05611242|Abciximab|abciximab|mesh-list
111002481|NCT05611242|Clopidogrel|clopidogrel|mesh-list
111002482|NCT05611242|Cangrelor|cangrelor|mesh-list
111002483|NCT05611242|Eptifibatide|eptifibatide|mesh-list
111002484|NCT05611242|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
111002485|NCT05611242|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111002486|NCT05611242|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111002487|NCT05611242|Analgesics|analgesics|mesh-ancestor
111002488|NCT05611242|Sensory System Agents|sensory system agents|mesh-ancestor
111002489|NCT05611242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111002490|NCT05611242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111002491|NCT05611242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111002492|NCT05611242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111002493|NCT05611242|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111002494|NCT05611242|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111002495|NCT05611242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111002496|NCT05611242|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111002497|NCT05611242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111002498|NCT05611242|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111002499|NCT05611242|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111002500|NCT05611242|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111002501|NCT05611242|Purinergic Agents|purinergic agents|mesh-ancestor
111002502|NCT05611242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111002503|NCT05611242|Anticoagulants|anticoagulants|mesh-ancestor
111002504|NCT05611242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111002505|NCT05611242|Antifungal Agents|antifungal agents|mesh-ancestor
111002506|NCT05611242|Keratolytic Agents|keratolytic agents|mesh-ancestor
111002507|NCT05611242|Dermatologic Agents|dermatologic agents|mesh-ancestor
111002508|NCT05609370|Bevacizumab|bevacizumab|mesh-list
111002509|NCT05609370|Tislelizumab|tislelizumab|mesh-list
111002510|NCT05609370|Fluorouracil|fluorouracil|mesh-list
111002511|NCT05609370|Capecitabine|capecitabine|mesh-list
111002512|NCT05609370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111002513|NCT05609370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111002514|NCT05609370|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111002515|NCT05609370|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111002516|NCT05609370|Growth Substances|growth substances|mesh-ancestor
111002517|NCT05609370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111002518|NCT05609370|Growth Inhibitors|growth inhibitors|mesh-ancestor
111002519|NCT05609370|Antimetabolites|antimetabolites|mesh-ancestor
111002520|NCT05609370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111002521|NCT05609370|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111002522|NCT05609370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111002523|NCT05609370|Immunologic Factors|immunologic factors|mesh-ancestor
111002525|NCT05607017|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111002526|NCT05607017|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111002527|NCT05607017|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111002528|NCT05607017|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111002529|NCT05607017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111002531|NCT05582694|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111002532|NCT05582694|Antiviral Agents|antiviral agents|mesh-ancestor
111002533|NCT05582694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111002534|NCT05567094|Dexamethasone|dexamethasone|mesh-list
111002535|NCT05567094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111002536|NCT05567094|Antiemetics|antiemetics|mesh-ancestor
111002537|NCT05567094|Autonomic Agents|autonomic agents|mesh-ancestor
111002538|NCT05567094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111002539|NCT05567094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111002540|NCT05567094|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111002541|NCT05567094|Glucocorticoids|glucocorticoids|mesh-ancestor
111002542|NCT05567094|Hormones|hormones|mesh-ancestor
111002543|NCT05567094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111002544|NCT05567094|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111002545|NCT05567094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111002546|NCT05555888|Capecitabine|capecitabine|mesh-list
111002547|NCT05555888|Oxaliplatin|oxaliplatin|mesh-list
111002548|NCT05555888|Antibodies|antibodies|mesh-list
111002549|NCT05555888|Immunologic Factors|immunologic factors|mesh-ancestor
111002550|NCT05555888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111002551|NCT05555888|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111002552|NCT05555888|Antimetabolites|antimetabolites|mesh-ancestor
111002553|NCT05555888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111002554|NCT05555888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111002555|NCT05554211|Tranexamic Acid|tranexamic acid|mesh-list
111002556|NCT05554211|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111002557|NCT05554211|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111002558|NCT05554211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111002559|NCT05554211|Hemostatics|hemostatics|mesh-ancestor
111002560|NCT05554211|Coagulants|coagulants|mesh-ancestor
111002561|NCT05553366|Acetaminophen|acetaminophen|mesh-list
111002562|NCT05553366|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111002563|NCT05553366|Analgesics|analgesics|mesh-ancestor
111002564|NCT05553366|Sensory System Agents|sensory system agents|mesh-ancestor
111002565|NCT05553366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111002566|NCT05553366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111002567|NCT05553366|Antipyretics|antipyretics|mesh-ancestor
111002568|NCT05512819|Vaccines|vaccines|mesh-list
111002569|NCT05512819|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
111002570|NCT05512819|Immunologic Factors|immunologic factors|mesh-ancestor
111002571|NCT05512819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111002572|NCT05511038|Aflibercept|aflibercept|mesh-list
111002573|NCT05511038|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111002574|NCT05511038|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111002575|NCT05511038|Growth Substances|growth substances|mesh-ancestor
111002576|NCT05511038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111002577|NCT05511038|Growth Inhibitors|growth inhibitors|mesh-ancestor
111002578|NCT05511038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111002579|NCT05471830|Apixaban|apixaban|mesh-list
111002580|NCT05471830|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111002581|NCT05471830|Antithrombins|antithrombins|mesh-ancestor
111002582|NCT05471830|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111002583|NCT05471830|Protease Inhibitors|protease inhibitors|mesh-ancestor
111002584|NCT05471830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111002585|NCT05471830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111002586|NCT05471830|Anticoagulants|anticoagulants|mesh-ancestor
111002587|NCT05451173|Tislelizumab|tislelizumab|mesh-list
111002588|NCT05451173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111002589|NCT05451173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111002590|NCT05442554|Brentuximab Vedotin|brentuximab vedotin|mesh-list
111002591|NCT05442554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111002592|NCT05442554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111002593|NCT05442554|Immunotoxins|immunotoxins|mesh-ancestor
111002594|NCT05442554|Immunoconjugates|immunoconjugates|mesh-ancestor
111002595|NCT05442554|Immunologic Factors|immunologic factors|mesh-ancestor
111002596|NCT05442554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111002597|NCT05439876|Melatonin|melatonin|mesh-list
111002598|NCT05439876|Antioxidants|antioxidants|mesh-ancestor
111002599|NCT05439876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111002600|NCT05439876|Protective Agents|protective agents|mesh-ancestor
111002601|NCT05439876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111002602|NCT05439876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111002603|NCT05412394|Prednisolone|prednisolone|mesh-list
111002604|NCT05412394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111002605|NCT05412394|Glucocorticoids|glucocorticoids|mesh-ancestor
111002606|NCT05412394|Hormones|hormones|mesh-ancestor
111002607|NCT05412394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111002608|NCT05412394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111002609|NCT05412394|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111002610|NCT05412394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111002611|NCT05408559|Sulforaphane|sulforaphane|mesh-list
111002612|NCT05408559|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
111002613|NCT05408559|Protective Agents|protective agents|mesh-ancestor
111002614|NCT05408559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111002615|NCT05408559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111002616|NCT05408091|Antibodies|antibodies|mesh-list
111002617|NCT05408091|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111002618|NCT05408091|Immunologic Factors|immunologic factors|mesh-ancestor
111002619|NCT05408091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111002620|NCT05406401|Prednisone|prednisone|mesh-list
111002621|NCT05406401|Prednisolone|prednisolone|mesh-list
111002622|NCT05406401|Cyclophosphamide|cyclophosphamide|mesh-list
111002623|NCT05406401|Rituximab|rituximab|mesh-list
111002624|NCT05406401|Doxorubicin|doxorubicin|mesh-list
111002625|NCT05406401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111002626|NCT05406401|Immunologic Factors|immunologic factors|mesh-ancestor
111002627|NCT05406401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111002628|NCT05406401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111002629|NCT05406401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111002630|NCT05406401|Alkylating Agents|alkylating agents|mesh-ancestor
111002631|NCT05406401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111002632|NCT05406401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111002633|NCT05406401|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111002634|NCT05406401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111002635|NCT05406401|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111002636|NCT05406401|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111002637|NCT05406401|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111002638|NCT05406401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111002639|NCT05406401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111002640|NCT05406401|Glucocorticoids|glucocorticoids|mesh-ancestor
111002641|NCT05406401|Hormones|hormones|mesh-ancestor
111002642|NCT05406401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111002643|NCT05406401|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111002644|NCT05390307|Dapagliflozin|dapagliflozin|mesh-list
111002645|NCT05390307|Liraglutide|liraglutide|mesh-list
111002646|NCT05390307|Glucagon|glucagon|mesh-list
111002647|NCT05390307|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
111002648|NCT05390307|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111002649|NCT05390307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111002650|NCT05390307|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111002651|NCT05390307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111002652|NCT05390307|Incretins|incretins|mesh-ancestor
111002653|NCT05390307|Hormones|hormones|mesh-ancestor
111002654|NCT05390307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111002655|NCT05390307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111002656|NCT05382286|Paclitaxel|paclitaxel|mesh-list
111002657|NCT05382286|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111002658|NCT05382286|Carboplatin|carboplatin|mesh-list
111002659|NCT05382286|Gemcitabine|gemcitabine|mesh-list
111002660|NCT05382286|Pembrolizumab|pembrolizumab|mesh-list
111002661|NCT05382286|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
111002662|NCT05382286|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111002663|NCT05382286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111002665|NCT05382286|Antimitotic Agents|antimitotic agents|mesh-ancestor
111002666|NCT05382286|Mitosis Modulators|mitosis modulators|mesh-ancestor
111002667|NCT05382286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111002668|NCT05382286|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111002669|NCT05382286|Antimetabolites|antimetabolites|mesh-ancestor
111002670|NCT05382286|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111002671|NCT05382286|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111002672|NCT05382286|Immunoconjugates|immunoconjugates|mesh-ancestor
111002673|NCT05382286|Immunologic Factors|immunologic factors|mesh-ancestor
111002674|NCT05382286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111002675|NCT05372614|Trastuzumab|trastuzumab|mesh-list
111002676|NCT05372614|Camptothecin|camptothecin|mesh-list
111002677|NCT05372614|Maleic acid|maleic acid|mesh-list
111002678|NCT05372614|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
111002679|NCT05372614|Immunoconjugates|immunoconjugates|mesh-list
111002680|NCT05372614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111002681|NCT05372614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111002682|NCT05372614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111002683|NCT05372614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111002684|NCT05372614|Immunologic Factors|immunologic factors|mesh-ancestor
111002685|NCT05372614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111002686|NCT05372614|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111002687|NCT05372614|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111002688|NCT05372614|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111002689|NCT05369052|Linezolid|linezolid|mesh-list
111002690|NCT05369052|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111002691|NCT05369052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111002692|NCT05369052|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111002693|NCT05369052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111002694|NCT05369052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111002695|NCT05319639|Leucovorin|leucovorin|mesh-list
111002696|NCT05319639|Paclitaxel|paclitaxel|mesh-list
111002697|NCT05319639|Fluorouracil|fluorouracil|mesh-list
111002698|NCT05319639|Oxaliplatin|oxaliplatin|mesh-list
111002699|NCT05319639|Irinotecan|irinotecan|mesh-list
111002700|NCT05319639|Tislelizumab|tislelizumab|mesh-list
111002701|NCT05319639|Levoleucovorin|levoleucovorin|mesh-list
111002702|NCT05319639|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111002703|NCT05319639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111002704|NCT05319639|Tubulin Modulators|tubulin modulators|mesh-ancestor
111002705|NCT05319639|Antimitotic Agents|antimitotic agents|mesh-ancestor
111002706|NCT05319639|Mitosis Modulators|mitosis modulators|mesh-ancestor
111002707|NCT05319639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111002708|NCT05319639|Antimetabolites|antimetabolites|mesh-ancestor
111002709|NCT05319639|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111002710|NCT05319639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111002711|NCT05319639|Immunologic Factors|immunologic factors|mesh-ancestor
110619517|NCT00990886|Cholinergic Agents|cholinergic agents|mesh-ancestor
111002712|NCT05319639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111002713|NCT05319639|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111002714|NCT05319639|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111002715|NCT05319639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111002716|NCT05319639|Antidotes|antidotes|mesh-ancestor
111002717|NCT05319639|Protective Agents|protective agents|mesh-ancestor
111002718|NCT05319639|Vitamin B Complex|vitamin b complex|mesh-ancestor
111002719|NCT05319639|Vitamins|vitamins|mesh-ancestor
111002720|NCT05319639|Micronutrients|micronutrients|mesh-ancestor
111002721|NCT05319639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111002722|NCT05306340|Tamoxifen|tamoxifen|mesh-list
111002723|NCT05306340|Dexamethasone|dexamethasone|mesh-list
111002724|NCT05306340|Fulvestrant|fulvestrant|mesh-list
111002725|NCT05306340|Everolimus|everolimus|mesh-list
111002726|NCT05306340|Exemestane|exemestane|mesh-list
111002727|NCT05306340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111002728|NCT05306340|Antiemetics|antiemetics|mesh-ancestor
111002729|NCT05306340|Autonomic Agents|autonomic agents|mesh-ancestor
111002730|NCT05306340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111002731|NCT05306340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111002732|NCT05306340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111002733|NCT05306340|Glucocorticoids|glucocorticoids|mesh-ancestor
111002734|NCT05306340|Hormones|hormones|mesh-ancestor
111002735|NCT05306340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111002736|NCT05306340|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111002737|NCT05306340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111002738|NCT05306340|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111002739|NCT05306340|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111002740|NCT05306340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111002741|NCT05306340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111002742|NCT05306340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111002743|NCT05306340|Immunologic Factors|immunologic factors|mesh-ancestor
111002744|NCT05306340|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111002745|NCT05306340|Hormone Antagonists|hormone antagonists|mesh-ancestor
111002746|NCT05306340|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111002747|NCT05306340|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111002748|NCT05306340|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111002749|NCT05306340|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
111002750|NCT05306340|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111002751|NCT05306340|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111002752|NCT05286814|Leucovorin|leucovorin|mesh-list
111002753|NCT05286814|Dexamethasone|dexamethasone|mesh-list
111002754|NCT05286814|Gemcitabine|gemcitabine|mesh-list
111002755|NCT05286814|Fluorouracil|fluorouracil|mesh-list
111002756|NCT05286814|Oxaliplatin|oxaliplatin|mesh-list
111002757|NCT05286814|Irinotecan|irinotecan|mesh-list
111002758|NCT05286814|Floxuridine|floxuridine|mesh-list
111002759|NCT05286814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111002760|NCT05286814|Antiemetics|antiemetics|mesh-ancestor
111002761|NCT05286814|Autonomic Agents|autonomic agents|mesh-ancestor
111002762|NCT05286814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111002763|NCT05286814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111002764|NCT05286814|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111002765|NCT05286814|Glucocorticoids|glucocorticoids|mesh-ancestor
111002766|NCT05286814|Hormones|hormones|mesh-ancestor
111002767|NCT05286814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111002768|NCT05286814|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111002769|NCT05286814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111002770|NCT05286814|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111002771|NCT05286814|Antimetabolites|antimetabolites|mesh-ancestor
111002772|NCT05286814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111002773|NCT05286814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111002774|NCT05286814|Immunologic Factors|immunologic factors|mesh-ancestor
111002775|NCT05286814|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111002776|NCT05286814|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111002785|NCT05282121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111002787|NCT05282121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111002788|NCT05274048|Trastuzumab|trastuzumab|mesh-list
111002789|NCT05274048|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
111002790|NCT05274048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111002791|NCT05274048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111002792|NCT05274048|Immunoconjugates|immunoconjugates|mesh-ancestor
111002793|NCT05274048|Immunologic Factors|immunologic factors|mesh-ancestor
111002794|NCT05274048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111002795|NCT05261399|Carboplatin|carboplatin|mesh-list
111002796|NCT05261399|Pemetrexed|pemetrexed|mesh-list
111002797|NCT05261399|Osimertinib|osimertinib|mesh-list
111002798|NCT05261399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111002799|NCT05261399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111002800|NCT05261399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111002801|NCT05261399|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111002802|NCT05261399|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111002803|NCT05261399|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111002804|NCT05260684|Trametinib|trametinib|mesh-list
111002805|NCT05260684|Vemurafenib|vemurafenib|mesh-list
111002806|NCT05260684|Dabrafenib|dabrafenib|mesh-list
111002807|NCT05260684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111002808|NCT05260684|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111002809|NCT05260684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111002810|NCT05260684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111002811|NCT05239728|Pembrolizumab|pembrolizumab|mesh-list
111002812|NCT05239728|Belzutifan|belzutifan|mesh-list
111002813|NCT05239728|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111002814|NCT05239728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111002815|NCT05239728|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111002816|NCT05239728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111002817|NCT05228925|Vitamin D|vitamin d|mesh-list
111002818|NCT05228925|Vitamins|vitamins|mesh-ancestor
111002819|NCT05228925|Micronutrients|micronutrients|mesh-ancestor
111002820|NCT05228925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111002821|NCT05228925|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111002830|NCT05192200|Interferons|interferons|mesh-list
111002831|NCT05192200|Interferon-beta|interferon-beta|mesh-list
111002832|NCT05192200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111002833|NCT05192200|Antiviral Agents|antiviral agents|mesh-ancestor
111002834|NCT05192200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111002835|NCT05192200|Immunologic Factors|immunologic factors|mesh-ancestor
111002836|NCT05192200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111002838|NCT05160922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111002839|NCT05160922|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111002840|NCT05160922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111002841|NCT05160922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111002842|NCT05147662|Factor VIII|factor viii|mesh-list
111002843|NCT05147662|Coagulants|coagulants|mesh-ancestor
111002844|NCT05133531|Eculizumab|eculizumab|mesh-list
111002845|NCT05133531|Ravulizumab|ravulizumab|mesh-list
111002846|NCT05133531|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
111002847|NCT05133531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111002848|NCT05133531|Immunologic Factors|immunologic factors|mesh-ancestor
111002849|NCT05133531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111002850|NCT05103332|Amlodipine|amlodipine|mesh-list
111002851|NCT05103332|Olmesartan|olmesartan|mesh-list
111002852|NCT05103332|Indapamide|indapamide|mesh-list
111002853|NCT05103332|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111002854|NCT05103332|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111002869|NCT05083481|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111002870|NCT05083481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111002871|NCT05083481|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111002872|NCT05083481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111002874|NCT05048784|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111002875|NCT05048784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111002876|NCT05048784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111002877|NCT05048784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111002878|NCT05038228|Vitamin K|vitamin k|mesh-list
111002879|NCT05038228|Rivaroxaban|rivaroxaban|mesh-list
111002880|NCT05038228|Apixaban|apixaban|mesh-list
111002881|NCT05038228|Dabigatran|dabigatran|mesh-list
111002882|NCT05038228|Vitamins|vitamins|mesh-ancestor
111002883|NCT05038228|Micronutrients|micronutrients|mesh-ancestor
111002884|NCT05038228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111002885|NCT05038228|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111002886|NCT05038228|Antithrombins|antithrombins|mesh-ancestor
111002887|NCT05038228|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111002888|NCT05038228|Protease Inhibitors|protease inhibitors|mesh-ancestor
111002889|NCT05038228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111002890|NCT05038228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111002891|NCT05038228|Anticoagulants|anticoagulants|mesh-ancestor
111002892|NCT05038228|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111002893|NCT05038228|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111002894|NCT05038228|Hemostatics|hemostatics|mesh-ancestor
111002895|NCT05038228|Coagulants|coagulants|mesh-ancestor
111002896|NCT05002569|Nivolumab|nivolumab|mesh-list
111002897|NCT05002569|Relatlimab|relatlimab|mesh-list
111002898|NCT05002569|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111002899|NCT05002569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111002900|NCT05002569|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111002901|NCT05002569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111002902|NCT04985916|Botulinum Toxins|botulinum toxins|mesh-list
111002903|NCT04985916|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111002904|NCT04985916|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111002905|NCT04985916|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111002906|NCT04985916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111002907|NCT04985916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111002908|NCT04985916|Cholinergic Agents|cholinergic agents|mesh-ancestor
111002909|NCT04985916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111002910|NCT04985916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111002911|NCT04985916|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111002912|NCT04985916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111002947|NCT04895709|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111002949|NCT04894123|Oxaliplatin|oxaliplatin|mesh-list
111002950|NCT04894123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111002951|NCT04894123|Antimetabolites|antimetabolites|mesh-ancestor
111002952|NCT04894123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111002953|NCT04894123|Antiviral Agents|antiviral agents|mesh-ancestor
111002954|NCT04894123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111002955|NCT04893798|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
111002956|NCT04893798|Medroxyprogesterone|medroxyprogesterone|mesh-list
111002957|NCT04893798|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111002958|NCT04893798|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111002960|NCT04893798|Contraceptive Agents|contraceptive agents|mesh-ancestor
111002961|NCT04893798|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111002962|NCT04893798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111002963|NCT04893798|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111002964|NCT04893798|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111002965|NCT04893798|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
111002966|NCT04893798|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111002967|NCT04893798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111002968|NCT04892953|Paclitaxel|paclitaxel|mesh-list
111002969|NCT04892953|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111002970|NCT04892953|Carboplatin|carboplatin|mesh-list
111002971|NCT04892953|Gemcitabine|gemcitabine|mesh-list
111002972|NCT04892953|Pemetrexed|pemetrexed|mesh-list
111002973|NCT04892953|Durvalumab|durvalumab|mesh-list
111002974|NCT04892953|Immunoglobulins|immunoglobulins|mesh-list
111002975|NCT04892953|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111002976|NCT04892953|Immunoglobulin G|immunoglobulin g|mesh-list
111002977|NCT04892953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111002978|NCT04892953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111002979|NCT04892953|Tubulin Modulators|tubulin modulators|mesh-ancestor
111002980|NCT04892953|Antimitotic Agents|antimitotic agents|mesh-ancestor
111002981|NCT04892953|Mitosis Modulators|mitosis modulators|mesh-ancestor
111002982|NCT04892953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111002983|NCT04892953|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111002984|NCT04892953|Antimetabolites|antimetabolites|mesh-ancestor
111002985|NCT04892953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111002986|NCT04892953|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111002987|NCT04892953|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111002988|NCT04892953|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111002989|NCT04892953|Immunologic Factors|immunologic factors|mesh-ancestor
111002990|NCT04892953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111002991|NCT04884282|Docetaxel|docetaxel|mesh-list
111002992|NCT04884282|Nivolumab|nivolumab|mesh-list
111002993|NCT04884282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111002994|NCT04884282|Tubulin Modulators|tubulin modulators|mesh-ancestor
111002995|NCT04884282|Antimitotic Agents|antimitotic agents|mesh-ancestor
111002996|NCT04884282|Mitosis Modulators|mitosis modulators|mesh-ancestor
111002997|NCT04884282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111002998|NCT04884282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111002999|NCT04884282|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111003000|NCT04876781|Tofacitinib|tofacitinib|mesh-list
111003001|NCT04876781|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
111003002|NCT04876781|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111003003|NCT04876781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111003004|NCT04876781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111003005|NCT04873362|Trastuzumab|trastuzumab|mesh-list
111003059|NCT04827576|Mitosis Modulators|mitosis modulators|mesh-ancestor
111003060|NCT04827576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111003061|NCT04827576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111003062|NCT04803877|Nivolumab|nivolumab|mesh-list
111003063|NCT04803877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111003064|NCT04803877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111003065|NCT04803877|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111003066|NCT04803877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111003067|NCT04790370|Heparin|heparin|mesh-list
111003068|NCT04790370|Calcium heparin|calcium heparin|mesh-list
111003069|NCT04790370|Anticoagulants|anticoagulants|mesh-ancestor
111003070|NCT04790370|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111003071|NCT04790370|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111003072|NCT04790370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111003073|NCT04779242|Moxifloxacin|moxifloxacin|mesh-list
111003074|NCT04779242|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111003075|NCT04779242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111003076|NCT04779242|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111003077|NCT04779242|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111003078|NCT04779242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111003079|NCT04779242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111003080|NCT04779242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111003081|NCT04758871|Progesterone|progesterone|mesh-list
111003082|NCT04758871|Dydrogesterone|dydrogesterone|mesh-list
111003083|NCT04758871|Progestins|progestins|mesh-ancestor
111003092|NCT04737603|Buprenorphine|buprenorphine|mesh-list
111003093|NCT04737603|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
111003096|NCT04737603|Narcotics|narcotics|mesh-ancestor
111003097|NCT04737603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111003098|NCT04737603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111003099|NCT04737603|Analgesics|analgesics|mesh-ancestor
111003100|NCT04737603|Sensory System Agents|sensory system agents|mesh-ancestor
111003101|NCT04737603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111003102|NCT04737603|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111003112|NCT04713787|Albendazole|albendazole|mesh-list
111003113|NCT04713787|Oxfendazole|oxfendazole|mesh-list
111003114|NCT04713787|Anthelmintics|anthelmintics|mesh-ancestor
111003115|NCT04713787|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111003116|NCT04713787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111003117|NCT04713787|Anticestodal Agents|anticestodal agents|mesh-ancestor
111003118|NCT04713787|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
111003119|NCT04713787|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111003120|NCT04713787|Tubulin Modulators|tubulin modulators|mesh-ancestor
111003121|NCT04713787|Antimitotic Agents|antimitotic agents|mesh-ancestor
111003122|NCT04713787|Mitosis Modulators|mitosis modulators|mesh-ancestor
111003123|NCT04713787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111003124|NCT04713787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111003125|NCT04713787|Antinematodal Agents|antinematodal agents|mesh-ancestor
111003126|NCT04697628|Gemcitabine|gemcitabine|mesh-list
111003127|NCT04697628|Irinotecan|irinotecan|mesh-list
111003128|NCT04697628|Pemetrexed|pemetrexed|mesh-list
111003129|NCT04697628|Topotecan|topotecan|mesh-list
111003130|NCT04697628|Vinorelbine|vinorelbine|mesh-list
111003131|NCT04697628|Tisotumab vedotin|tisotumab vedotin|mesh-list
111003132|NCT04697628|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111003133|NCT04697628|Antimetabolites|antimetabolites|mesh-ancestor
111003134|NCT04697628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111003135|NCT04697628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111003136|NCT04697628|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111003137|NCT04697628|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111003138|NCT04697628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111003139|NCT04697628|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111003140|NCT04697628|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111003141|NCT04697628|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111003142|NCT04697628|Tubulin Modulators|tubulin modulators|mesh-ancestor
111003143|NCT04697628|Antimitotic Agents|antimitotic agents|mesh-ancestor
111003144|NCT04697628|Mitosis Modulators|mitosis modulators|mesh-ancestor
111003145|NCT04697628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111003146|NCT04659044|Rituximab|rituximab|mesh-list
111003147|NCT04659044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111003148|NCT04659044|Venetoclax|venetoclax|mesh-list
111003149|NCT04659044|Antibodies|antibodies|mesh-list
111003150|NCT04659044|Immunoglobulins|immunoglobulins|mesh-list
111003151|NCT04659044|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111003152|NCT04659044|Immunoconjugates|immunoconjugates|mesh-list
111003153|NCT04659044|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
111003154|NCT04659044|Immunologic Factors|immunologic factors|mesh-ancestor
111003155|NCT04659044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111003156|NCT04659044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111003157|NCT04659044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111003158|NCT04645160|Tivozanib|tivozanib|mesh-list
111003159|NCT04645160|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111003160|NCT04645160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111003161|NCT04645160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111003163|NCT04629248|Diphenhydramine|diphenhydramine|mesh-list
111003164|NCT04629248|Promethazine|promethazine|mesh-list
111003165|NCT04629248|Methylprednisolone|methylprednisolone|mesh-list
111003166|NCT04629248|Obinutuzumab|obinutuzumab|mesh-list
111003167|NCT04629248|Tacrolimus|tacrolimus|mesh-list
111003168|NCT04629248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111003169|NCT04629248|Immunologic Factors|immunologic factors|mesh-ancestor
111003170|NCT04629248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111003171|NCT04629248|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111003172|NCT04629248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111003173|NCT04629248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111003174|NCT04629248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111003175|NCT04629248|Analgesics|analgesics|mesh-ancestor
111003176|NCT04629248|Sensory System Agents|sensory system agents|mesh-ancestor
111003177|NCT04629248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111003178|NCT04629248|Antipyretics|antipyretics|mesh-ancestor
111003179|NCT04629248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111003180|NCT04629248|Antiemetics|antiemetics|mesh-ancestor
111003181|NCT04629248|Autonomic Agents|autonomic agents|mesh-ancestor
111003182|NCT04629248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111003183|NCT04629248|Glucocorticoids|glucocorticoids|mesh-ancestor
111003184|NCT04629248|Hormones|hormones|mesh-ancestor
111003185|NCT04629248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111003186|NCT04629248|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111003187|NCT04629248|Protective Agents|protective agents|mesh-ancestor
111003188|NCT04629248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111003189|NCT04629248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111003190|NCT04629248|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111003191|NCT04629248|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111003192|NCT04629248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111003193|NCT04629248|Anesthetics, Local|anesthetics, local|mesh-ancestor
111003194|NCT04629248|Anesthetics|anesthetics|mesh-ancestor
111003195|NCT04629248|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111003196|NCT04629248|Histamine Antagonists|histamine antagonists|mesh-ancestor
111003197|NCT04629248|Histamine Agents|histamine agents|mesh-ancestor
111003198|NCT04629248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111003199|NCT04629248|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111003200|NCT04629248|Antipruritics|antipruritics|mesh-ancestor
111003201|NCT04629248|Dermatologic Agents|dermatologic agents|mesh-ancestor
111003202|NCT04626518|Pembrolizumab|pembrolizumab|mesh-list
111003203|NCT04626518|Lenvatinib|lenvatinib|mesh-list
111003204|NCT04626518|Belzutifan|belzutifan|mesh-list
111003205|NCT04626518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111003206|NCT04626518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111003207|NCT04626518|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111003208|NCT04626518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111003209|NCT04626518|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111003210|NCT04626518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111003211|NCT04626479|Pembrolizumab|pembrolizumab|mesh-list
111003212|NCT04626479|Lenvatinib|lenvatinib|mesh-list
111003213|NCT04626479|Belzutifan|belzutifan|mesh-list
111003214|NCT04626479|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111003215|NCT04626479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111003216|NCT04626479|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111003217|NCT04626479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111003218|NCT04626479|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111003219|NCT04626479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111003220|NCT04626128|Aflibercept|aflibercept|mesh-list
111003221|NCT04626128|Axitinib|axitinib|mesh-list
111003222|NCT04626128|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111003223|NCT04626128|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111003224|NCT04626128|Growth Substances|growth substances|mesh-ancestor
111003225|NCT04626128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111003226|NCT04626128|Growth Inhibitors|growth inhibitors|mesh-ancestor
111003227|NCT04626128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111003228|NCT04626128|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111003229|NCT04626128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111003230|NCT04626128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111003231|NCT04624230|Tofacitinib|tofacitinib|mesh-list
111003232|NCT04624230|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
111003233|NCT04624230|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111003234|NCT04624230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111003235|NCT04624230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111003236|NCT04609566|Pembrolizumab|pembrolizumab|mesh-list
111003237|NCT04609566|Brentuximab Vedotin|brentuximab vedotin|mesh-list
111003238|NCT04609566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111003239|NCT04609566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111003240|NCT04609566|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111003241|NCT04609566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111003242|NCT04609566|Immunotoxins|immunotoxins|mesh-ancestor
111003243|NCT04609566|Immunoconjugates|immunoconjugates|mesh-ancestor
111003244|NCT04609566|Immunologic Factors|immunologic factors|mesh-ancestor
111003245|NCT04609566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111003246|NCT04582435|Insulin|insulin|mesh-list
111003247|NCT04582435|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111003248|NCT04582435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111003249|NCT04581824|Pembrolizumab|pembrolizumab|mesh-list
111003250|NCT04581824|Dostarlimab|dostarlimab|mesh-list
111003251|NCT04581824|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111003252|NCT04581824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111003253|NCT04581824|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111003254|NCT04581824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111003255|NCT04580121|Acetaminophen|acetaminophen|mesh-list
111003256|NCT04580121|Diphenhydramine|diphenhydramine|mesh-list
111003257|NCT04580121|Promethazine|promethazine|mesh-list
111003258|NCT04580121|Dexamethasone|dexamethasone|mesh-list
111003260|NCT04580121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111003261|NCT04580121|Antiemetics|antiemetics|mesh-ancestor
111003262|NCT04580121|Autonomic Agents|autonomic agents|mesh-ancestor
111003263|NCT04580121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111003264|NCT04580121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111003265|NCT04580121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111003266|NCT04580121|Glucocorticoids|glucocorticoids|mesh-ancestor
111003267|NCT04580121|Hormones|hormones|mesh-ancestor
111003268|NCT04580121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111003269|NCT04580121|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111003270|NCT04580121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111003271|NCT04580121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111003272|NCT04580121|Analgesics|analgesics|mesh-ancestor
111003273|NCT04580121|Sensory System Agents|sensory system agents|mesh-ancestor
111003274|NCT04580121|Antipyretics|antipyretics|mesh-ancestor
111003275|NCT04580121|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111003276|NCT04580121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111003277|NCT04580121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111003278|NCT04580121|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111003279|NCT04580121|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111003280|NCT04580121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111003281|NCT04580121|Anesthetics, Local|anesthetics, local|mesh-ancestor
111003282|NCT04580121|Anesthetics|anesthetics|mesh-ancestor
111003283|NCT04580121|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111003284|NCT04580121|Histamine Antagonists|histamine antagonists|mesh-ancestor
111003285|NCT04580121|Histamine Agents|histamine agents|mesh-ancestor
111003286|NCT04580121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111003287|NCT04580121|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111003288|NCT04580121|Antipruritics|antipruritics|mesh-ancestor
111003289|NCT04580121|Dermatologic Agents|dermatologic agents|mesh-ancestor
111003290|NCT04539964|Antirheumatic Agents|antirheumatic agents|mesh-list
111003291|NCT04536298|Vitamin D|vitamin d|mesh-list
111003292|NCT04536298|Ergocalciferols|ergocalciferols|mesh-list
111003293|NCT04536298|Cholecalciferol|cholecalciferol|mesh-list
111003294|NCT04536298|Vitamins|vitamins|mesh-list
111003295|NCT04536298|Micronutrients|micronutrients|mesh-ancestor
111003296|NCT04536298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111003297|NCT04536298|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111003298|NCT04536298|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111003299|NCT04503616|Cyclophosphamide|cyclophosphamide|mesh-list
111003300|NCT04503616|Abatacept|abatacept|mesh-list
111003301|NCT04503616|Tacrolimus|tacrolimus|mesh-list
111003302|NCT04503616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111003303|NCT04503616|Immunologic Factors|immunologic factors|mesh-ancestor
111003304|NCT04503616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111003305|NCT04503616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111003306|NCT04503616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111003307|NCT04503616|Alkylating Agents|alkylating agents|mesh-ancestor
111003308|NCT04503616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111003309|NCT04503616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111003310|NCT04503616|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111003311|NCT04503616|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110720345|NCT00163020|Hormones|hormones|mesh-ancestor
111003312|NCT04503616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110619979|NCT00801294|Nintedanib|nintedanib|mesh-list
111003313|NCT04503616|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111003314|NCT04503616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111003315|NCT04498117|Paclitaxel|paclitaxel|mesh-list
111003316|NCT04498117|Carboplatin|carboplatin|mesh-list
111003317|NCT04498117|Oregovomab|oregovomab|mesh-list
111003318|NCT04498117|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111003319|NCT04498117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111003320|NCT04498117|Tubulin Modulators|tubulin modulators|mesh-ancestor
111003321|NCT04498117|Antimitotic Agents|antimitotic agents|mesh-ancestor
111003322|NCT04498117|Mitosis Modulators|mitosis modulators|mesh-ancestor
111003323|NCT04498117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111003324|NCT04498117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111003325|NCT04424303|Tofacitinib|tofacitinib|mesh-list
111003326|NCT04424303|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
111003327|NCT04424303|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111003328|NCT04424303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111003329|NCT04424303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111003330|NCT04421820|Leucovorin|leucovorin|mesh-list
111003331|NCT04421820|Fluorouracil|fluorouracil|mesh-list
111003332|NCT04421820|Oxaliplatin|oxaliplatin|mesh-list
111003333|NCT04421820|Antimetabolites|antimetabolites|mesh-ancestor
110468323|NCT00914940|Fludarabine|fludarabine|mesh-list
111003334|NCT04421820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111003335|NCT04421820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111003336|NCT04421820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111003337|NCT04421820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111003338|NCT04421820|Immunologic Factors|immunologic factors|mesh-ancestor
111003339|NCT04421820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111003340|NCT04421820|Antidotes|antidotes|mesh-ancestor
111003341|NCT04421820|Protective Agents|protective agents|mesh-ancestor
111003342|NCT04421820|Vitamin B Complex|vitamin b complex|mesh-ancestor
111003343|NCT04421820|Vitamins|vitamins|mesh-ancestor
111003344|NCT04421820|Micronutrients|micronutrients|mesh-ancestor
111003345|NCT04411654|Sirolimus|sirolimus|mesh-list
111003346|NCT04411654|Prednisone|prednisone|mesh-list
111003347|NCT04411654|Methylprednisolone|methylprednisolone|mesh-list
111003348|NCT04411654|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111003349|NCT04411654|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111003350|NCT04411654|Prednisolone|prednisolone|mesh-list
111003351|NCT04411654|Prednisolone acetate|prednisolone acetate|mesh-list
111003352|NCT04411654|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111003353|NCT04411654|Prednisolone phosphate|prednisolone phosphate|mesh-list
111003354|NCT04411654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111003355|NCT04411654|Glucocorticoids|glucocorticoids|mesh-ancestor
111003356|NCT04411654|Hormones|hormones|mesh-ancestor
111003357|NCT04411654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111003358|NCT04411654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111003359|NCT04411654|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111003360|NCT04411654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111003361|NCT04411654|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111003362|NCT04411654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111003363|NCT04411654|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111003364|NCT04411654|Antifungal Agents|antifungal agents|mesh-ancestor
111003365|NCT04411654|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111003366|NCT04411654|Immunologic Factors|immunologic factors|mesh-ancestor
111003367|NCT04411654|Antiemetics|antiemetics|mesh-ancestor
111003368|NCT04411654|Autonomic Agents|autonomic agents|mesh-ancestor
111003369|NCT04411654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111003370|NCT04411654|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111003371|NCT04411654|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111003372|NCT04411654|Protective Agents|protective agents|mesh-ancestor
111003373|NCT04404283|Rituximab|rituximab|mesh-list
111003374|NCT04404283|Brentuximab Vedotin|brentuximab vedotin|mesh-list
111003375|NCT04404283|Lenalidomide|lenalidomide|mesh-list
111003376|NCT04404283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111003377|NCT04404283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111003378|NCT04404283|Immunologic Factors|immunologic factors|mesh-ancestor
111003379|NCT04404283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111003380|NCT04404283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111003381|NCT04404283|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111003382|NCT04404283|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111003383|NCT04404283|Growth Substances|growth substances|mesh-ancestor
111003384|NCT04404283|Growth Inhibitors|growth inhibitors|mesh-ancestor
111003385|NCT04404283|Immunotoxins|immunotoxins|mesh-ancestor
111003386|NCT04404283|Immunoconjugates|immunoconjugates|mesh-ancestor
111003387|NCT04367090|Docetaxel|docetaxel|mesh-list
111003388|NCT04367090|Trastuzumab|trastuzumab|mesh-list
111003389|NCT04367090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111003390|NCT04367090|Tubulin Modulators|tubulin modulators|mesh-ancestor
111003391|NCT04367090|Antimitotic Agents|antimitotic agents|mesh-ancestor
111003392|NCT04367090|Mitosis Modulators|mitosis modulators|mesh-ancestor
111003393|NCT04367090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111003394|NCT04367090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111003396|NCT04338204|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
111003397|NCT04338204|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111003398|NCT04338204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111003399|NCT04338204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111003400|NCT04337450|Lamivudine|lamivudine|mesh-list
111003401|NCT04337450|Dolutegravir|dolutegravir|mesh-list
111003402|NCT04337450|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111003403|NCT04337450|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111003404|NCT04337450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111003405|NCT04337450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111003406|NCT04337450|Antiviral Agents|antiviral agents|mesh-ancestor
111003407|NCT04337450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111003408|NCT04337450|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111003409|NCT04337450|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111003410|NCT04337450|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111003411|NCT04337450|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111003413|NCT04321993|Remdesivir|remdesivir|mesh-list
111003414|NCT04321993|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
111003415|NCT04321993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111003416|NCT04321993|Antimetabolites|antimetabolites|mesh-ancestor
111003417|NCT04321993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111003418|NCT04321993|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111003419|NCT04321993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111003420|NCT04305054|Pembrolizumab|pembrolizumab|mesh-list
111003421|NCT04305054|Lenvatinib|lenvatinib|mesh-list
111003422|NCT04305054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111003423|NCT04305054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111003424|NCT04305054|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111003425|NCT04305054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111003426|NCT04305054|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111003427|NCT04305054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111003428|NCT04296305|Hydromorphone|hydromorphone|mesh-list
111003429|NCT04296305|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111003430|NCT04296305|Narcotics|narcotics|mesh-ancestor
111003431|NCT04296305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111003432|NCT04296305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111003433|NCT04296305|Analgesics|analgesics|mesh-ancestor
111003434|NCT04296305|Sensory System Agents|sensory system agents|mesh-ancestor
111003435|NCT04296305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111003436|NCT04233567|Infigratinib|infigratinib|mesh-list
111003437|NCT04233567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111003438|NCT04230759|Fluorouracil|fluorouracil|mesh-list
111003439|NCT04230759|Durvalumab|durvalumab|mesh-list
111003440|NCT04230759|Mitomycins|mitomycins|mesh-list
111003441|NCT04230759|Mitomycin|mitomycin|mesh-list
111003442|NCT04230759|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
111003443|NCT04230759|Antimetabolites|antimetabolites|mesh-ancestor
111003444|NCT04230759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111003445|NCT04230759|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111003446|NCT04230759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111003447|NCT04230759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111003448|NCT04230759|Immunologic Factors|immunologic factors|mesh-ancestor
111003449|NCT04230759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111003450|NCT04230759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111003451|NCT04230759|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111003452|NCT04230759|Alkylating Agents|alkylating agents|mesh-ancestor
111003453|NCT04230759|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111003454|NCT04230759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111003455|NCT04218825|Mechlorethamine|mechlorethamine|mesh-list
111003456|NCT04218825|Alkylating Agents|alkylating agents|mesh-ancestor
111003457|NCT04218825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111003458|NCT04218825|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111003459|NCT04218825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111003460|NCT04127578|Sirolimus|sirolimus|mesh-list
111003461|NCT04127578|Methylprednisolone|methylprednisolone|mesh-list
111003462|NCT04127578|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110720460|NCT01284478|Dexamethasone|dexamethasone|mesh-list
111003463|NCT04127578|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111003464|NCT04127578|Prednisolone|prednisolone|mesh-list
111003465|NCT04127578|Prednisolone acetate|prednisolone acetate|mesh-list
111003466|NCT04127578|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111003467|NCT04127578|Prednisolone phosphate|prednisolone phosphate|mesh-list
111003468|NCT04127578|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111003469|NCT04127578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111003470|NCT04127578|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111003471|NCT04127578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111003472|NCT04127578|Antifungal Agents|antifungal agents|mesh-ancestor
111003473|NCT04127578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111003474|NCT04127578|Immunologic Factors|immunologic factors|mesh-ancestor
111003475|NCT04127578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111003476|NCT04127578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111003477|NCT04127578|Antiemetics|antiemetics|mesh-ancestor
111003478|NCT04127578|Autonomic Agents|autonomic agents|mesh-ancestor
111003479|NCT04127578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111003480|NCT04127578|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111003481|NCT04127578|Glucocorticoids|glucocorticoids|mesh-ancestor
111003482|NCT04127578|Hormones|hormones|mesh-ancestor
111003483|NCT04127578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111003484|NCT04127578|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111003485|NCT04127578|Protective Agents|protective agents|mesh-ancestor
110468475|NCT01077284|Febuxostat|febuxostat|mesh-list
111003486|NCT04127578|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111003487|NCT04095689|Docetaxel|docetaxel|mesh-list
111003488|NCT04095689|Pembrolizumab|pembrolizumab|mesh-list
111003489|NCT04095689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111003490|NCT04095689|Tubulin Modulators|tubulin modulators|mesh-ancestor
111003491|NCT04095689|Antimitotic Agents|antimitotic agents|mesh-ancestor
111003492|NCT04095689|Mitosis Modulators|mitosis modulators|mesh-ancestor
111003493|NCT04095689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111003494|NCT04095689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111003495|NCT04095689|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111003496|NCT04006457|Vaccines|vaccines|mesh-list
111003497|NCT04006457|Immunologic Factors|immunologic factors|mesh-ancestor
111003498|NCT04006457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111003499|NCT03978988|Aspirin|aspirin|mesh-list
110620147|NCT01060891|Colistin|colistin|mesh-list
111003500|NCT03978988|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111003501|NCT03978988|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111003502|NCT03978988|Analgesics|analgesics|mesh-ancestor
111003503|NCT03978988|Sensory System Agents|sensory system agents|mesh-ancestor
111003504|NCT03978988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111003505|NCT03978988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111003506|NCT03978988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111003507|NCT03978988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111003508|NCT03978988|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111003509|NCT03978988|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111003510|NCT03978988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111003511|NCT03978988|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111003512|NCT03978988|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111003513|NCT03978988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111003514|NCT03978988|Antipyretics|antipyretics|mesh-ancestor
111003515|NCT03975647|Tucatinib|tucatinib|mesh-list
111003516|NCT03975647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111003517|NCT03975647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111003518|NCT03975647|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111003519|NCT03975647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111003520|NCT03970746|Pembrolizumab|pembrolizumab|mesh-list
111003521|NCT03970746|Pemetrexed|pemetrexed|mesh-list
111003522|NCT03970746|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111003523|NCT03970746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111003524|NCT03970746|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111003525|NCT03970746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111003526|NCT03970746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111003527|NCT03970746|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111003528|NCT03970746|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111003529|NCT03954067|Pembrolizumab|pembrolizumab|mesh-list
111003530|NCT03954067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111003531|NCT03954067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111003532|NCT03954067|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111003533|NCT03954067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111003534|NCT03950427|Bupropion|bupropion|mesh-list
111003535|NCT03950427|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111003536|NCT03950427|Antidepressive Agents|antidepressive agents|mesh-ancestor
111003537|NCT03950427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111003538|NCT03950427|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111003539|NCT03950427|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111003540|NCT03950427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110620222|NCT00758030|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111003541|NCT03950427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111003542|NCT03950427|Dopamine Agents|dopamine agents|mesh-ancestor
111003543|NCT03950427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111003544|NCT03950427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111003545|NCT03950427|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111003546|NCT03950427|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111003547|NCT03950427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111003548|NCT03911505|Miglustat|miglustat|mesh-list
111003549|NCT03911505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111003550|NCT03911505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111003551|NCT03911505|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111003552|NCT03911505|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111003553|NCT03911505|Antiviral Agents|antiviral agents|mesh-ancestor
111003554|NCT03911505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111003555|NCT03911505|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
111003556|NCT03911505|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111003557|NCT03911505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111003558|NCT03885089|Infliximab|infliximab|mesh-list
111003559|NCT03885089|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111003560|NCT03885089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111003561|NCT03885089|Dermatologic Agents|dermatologic agents|mesh-ancestor
111003562|NCT03885089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111003563|NCT03885089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111003564|NCT03885037|Infliximab|infliximab|mesh-list
111003565|NCT03885037|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111003566|NCT03885037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111003567|NCT03885037|Dermatologic Agents|dermatologic agents|mesh-ancestor
111003568|NCT03885037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111003569|NCT03885037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111003570|NCT03884439|Infliximab|infliximab|mesh-list
111003571|NCT03884439|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111003572|NCT03884439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111003573|NCT03884439|Dermatologic Agents|dermatologic agents|mesh-ancestor
111003574|NCT03884439|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111003575|NCT03884439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111003576|NCT03871036|Paclitaxel|paclitaxel|mesh-list
111003577|NCT03871036|Durvalumab|durvalumab|mesh-list
111003578|NCT03871036|Tremelimumab|tremelimumab|mesh-list
111003579|NCT03871036|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111003580|NCT03871036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111003581|NCT03871036|Tubulin Modulators|tubulin modulators|mesh-ancestor
111003582|NCT03871036|Antimitotic Agents|antimitotic agents|mesh-ancestor
111003583|NCT03871036|Mitosis Modulators|mitosis modulators|mesh-ancestor
111003584|NCT03871036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111003585|NCT03871036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111003586|NCT03851588|Dolutegravir|dolutegravir|mesh-list
111003587|NCT03851588|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111003588|NCT03851588|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111003589|NCT03851588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111003590|NCT03851588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111003591|NCT03851588|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111003592|NCT03851588|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111003593|NCT03851588|Antiviral Agents|antiviral agents|mesh-ancestor
111003594|NCT03851588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111003595|NCT03850444|Paclitaxel|paclitaxel|mesh-list
111003596|NCT03850444|Carboplatin|carboplatin|mesh-list
111003597|NCT03850444|Pembrolizumab|pembrolizumab|mesh-list
111003598|NCT03850444|Pemetrexed|pemetrexed|mesh-list
111003599|NCT03850444|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111003600|NCT03850444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111003601|NCT03850444|Tubulin Modulators|tubulin modulators|mesh-ancestor
111003602|NCT03850444|Antimitotic Agents|antimitotic agents|mesh-ancestor
111003603|NCT03850444|Mitosis Modulators|mitosis modulators|mesh-ancestor
111003604|NCT03850444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111003605|NCT03850444|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111003606|NCT03850444|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111003607|NCT03850444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111003608|NCT03850444|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111003609|NCT03850444|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111003610|NCT03850379|Ciprofloxacin|ciprofloxacin|mesh-list
111003611|NCT03850379|Levofloxacin|levofloxacin|mesh-list
111003612|NCT03850379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111003613|NCT03850379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110620268|NCT00801606|Zinc|zinc|mesh-list
111003614|NCT03850379|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111003615|NCT03850379|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111003616|NCT03850379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111003617|NCT03850379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111003618|NCT03850379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111003619|NCT03850379|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111003620|NCT03850379|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111003621|NCT03850379|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111003622|NCT03824483|Venetoclax|venetoclax|mesh-list
111003623|NCT03824483|Obinutuzumab|obinutuzumab|mesh-list
111003624|NCT03824483|Zanubrutinib|zanubrutinib|mesh-list
111003625|NCT03824483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111003626|NCT03824483|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111003627|NCT03824483|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111003628|NCT03824483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111003629|NCT03824483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111003630|NCT03820141|Trastuzumab|trastuzumab|mesh-list
111003631|NCT03820141|Durvalumab|durvalumab|mesh-list
111003632|NCT03820141|Pertuzumab|pertuzumab|mesh-list
111003633|NCT03820141|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111003634|NCT03820141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111003636|NCT03816163|Gemcitabine|gemcitabine|mesh-list
111003637|NCT03816163|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111003638|NCT03816163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111003639|NCT03816163|Tubulin Modulators|tubulin modulators|mesh-ancestor
111003640|NCT03816163|Antimitotic Agents|antimitotic agents|mesh-ancestor
111003641|NCT03816163|Mitosis Modulators|mitosis modulators|mesh-ancestor
111003642|NCT03816163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111003643|NCT03816163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111003644|NCT03816163|Antimetabolites|antimetabolites|mesh-ancestor
111003645|NCT03793179|Carboplatin|carboplatin|mesh-list
111003646|NCT03793179|Pembrolizumab|pembrolizumab|mesh-list
111003647|NCT03793179|Pemetrexed|pemetrexed|mesh-list
111003648|NCT03793179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111003649|NCT03793179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111003650|NCT03793179|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111003651|NCT03793179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111003652|NCT03793179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111003653|NCT03793179|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111003654|NCT03793179|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111003655|NCT03747939|Thalidomide|thalidomide|mesh-list
111003656|NCT03747939|Apremilast|apremilast|mesh-list
111003657|NCT03747939|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111003658|NCT03747939|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111003659|NCT03747939|Analgesics|analgesics|mesh-ancestor
111003660|NCT03747939|Sensory System Agents|sensory system agents|mesh-ancestor
111003661|NCT03747939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111003662|NCT03747939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111003663|NCT03747939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111003664|NCT03747939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111003665|NCT03747939|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
111003666|NCT03747939|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111003667|NCT03747939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111003668|NCT03747939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111003669|NCT03747939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111003670|NCT03747939|Immunologic Factors|immunologic factors|mesh-ancestor
111003671|NCT03747939|Leprostatic Agents|leprostatic agents|mesh-ancestor
111003672|NCT03747939|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111003673|NCT03747939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111003674|NCT03747939|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111003675|NCT03747939|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111003676|NCT03747939|Growth Substances|growth substances|mesh-ancestor
111003677|NCT03747939|Growth Inhibitors|growth inhibitors|mesh-ancestor
111003678|NCT03747939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111003679|NCT03747120|Paclitaxel|paclitaxel|mesh-list
111003680|NCT03747120|Pembrolizumab|pembrolizumab|mesh-list
111003681|NCT03747120|Trastuzumab|trastuzumab|mesh-list
111003682|NCT03747120|Pertuzumab|pertuzumab|mesh-list
111003683|NCT03747120|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111003684|NCT03747120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111003685|NCT03747120|Tubulin Modulators|tubulin modulators|mesh-ancestor
111003686|NCT03747120|Antimitotic Agents|antimitotic agents|mesh-ancestor
111003687|NCT03747120|Mitosis Modulators|mitosis modulators|mesh-ancestor
111003688|NCT03747120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111003689|NCT03747120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111003690|NCT03747120|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111003692|NCT03742245|Vorinostat|vorinostat|mesh-list
111003693|NCT03742245|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111003694|NCT03742245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111003695|NCT03742245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111003696|NCT03742245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111003697|NCT03742245|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111003698|NCT03732677|Gemcitabine|gemcitabine|mesh-list
111003699|NCT03732677|Durvalumab|durvalumab|mesh-list
111003700|NCT03732677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111003701|NCT03732677|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111003702|NCT03732677|Antimetabolites|antimetabolites|mesh-ancestor
111003703|NCT03732677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111003704|NCT03732677|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111003705|NCT03728972|Pembrolizumab|pembrolizumab|mesh-list
111003706|NCT03728972|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111003707|NCT03728972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111003708|NCT03728972|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111003709|NCT03728972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111003711|NCT03666273|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111003712|NCT03666273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111003713|NCT03666273|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111003714|NCT03666273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111003715|NCT03662659|Nivolumab|nivolumab|mesh-list
111003716|NCT03662659|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111003717|NCT03662659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111003718|NCT03662659|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111003719|NCT03662659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111003720|NCT03619551|Busulfan|busulfan|mesh-list
111003721|NCT03619551|Alkylating Agents|alkylating agents|mesh-ancestor
111003722|NCT03619551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111003723|NCT03619551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111003724|NCT03619551|Immunologic Factors|immunologic factors|mesh-ancestor
111003725|NCT03619551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111003726|NCT03619551|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111003727|NCT03619551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111003728|NCT03619551|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111003729|NCT03522753|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
111003730|NCT03522753|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
111003731|NCT03522753|beta-Endorphin|beta-endorphin|mesh-list
111003732|NCT03522753|Hormones|hormones|mesh-ancestor
111003733|NCT03522753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111003734|NCT03522753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111003735|NCT03522753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111003736|NCT03522753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111003737|NCT03471507|Diclofenac|diclofenac|mesh-list
111003738|NCT03471507|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111003739|NCT03471507|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111003740|NCT03471507|Analgesics|analgesics|mesh-ancestor
111003741|NCT03471507|Sensory System Agents|sensory system agents|mesh-ancestor
111003742|NCT03471507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111003743|NCT03471507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111003744|NCT03471507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111003745|NCT03471507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111003746|NCT03471507|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111003747|NCT03471507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111003748|NCT03471507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111003749|NCT03467958|Ozanimod|ozanimod|mesh-list
111003750|NCT03467958|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
111003751|NCT03467958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111003752|NCT03467958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111003753|NCT03467958|Immunologic Factors|immunologic factors|mesh-ancestor
111003754|NCT03467958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111003755|NCT03464097|Ozanimod|ozanimod|mesh-list
111003756|NCT03464097|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
111003757|NCT03464097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111003758|NCT03464097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110720757|NCT03865888|Antifungal Agents|antifungal agents|mesh-ancestor
111003759|NCT03464097|Immunologic Factors|immunologic factors|mesh-ancestor
111003760|NCT03464097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111003761|NCT03459222|Nivolumab|nivolumab|mesh-list
111003762|NCT03459222|Ipilimumab|ipilimumab|mesh-list
111003763|NCT03459222|Relatlimab|relatlimab|mesh-list
111003764|NCT03459222|Linrodostat|linrodostat|mesh-list
111003765|NCT03459222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111003766|NCT03459222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111003767|NCT03459222|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111003768|NCT03459222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111003769|NCT03459222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111003770|NCT03452137|Atezolizumab|atezolizumab|mesh-list
111003771|NCT03452137|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111003772|NCT03452137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111003773|NCT03452137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111003774|NCT03452137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111003775|NCT03440385|Ozanimod|ozanimod|mesh-list
111003776|NCT03440385|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
110468771|NCT00784927|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111003777|NCT03440385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111003778|NCT03440385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111003779|NCT03440385|Immunologic Factors|immunologic factors|mesh-ancestor
111003780|NCT03440385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111003781|NCT03440372|Ozanimod|ozanimod|mesh-list
111003782|NCT03440372|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
111003783|NCT03440372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111003784|NCT03440372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111003785|NCT03440372|Immunologic Factors|immunologic factors|mesh-ancestor
111003786|NCT03440372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111003787|NCT03386929|Palbociclib|palbociclib|mesh-list
111003788|NCT03386929|Avelumab|avelumab|mesh-list
111003789|NCT03386929|Axitinib|axitinib|mesh-list
111003790|NCT03386929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111003791|NCT03386929|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111003792|NCT03386929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111003793|NCT03386929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111003794|NCT03386929|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111003795|NCT03366155|Oxaliplatin|oxaliplatin|mesh-list
111003796|NCT03366155|Irinotecan|irinotecan|mesh-list
111003797|NCT03366155|Cetuximab|cetuximab|mesh-list
111003798|NCT03366155|Panitumumab|panitumumab|mesh-list
111003799|NCT03366155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111003800|NCT03366155|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111003801|NCT03366155|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111003802|NCT03366155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111003803|NCT03366155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111003804|NCT03366155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111003805|NCT03321019|Capsaicin|capsaicin|mesh-list
111003806|NCT03321019|Antipruritics|antipruritics|mesh-ancestor
111003807|NCT03321019|Dermatologic Agents|dermatologic agents|mesh-ancestor
111003808|NCT03321019|Sensory System Agents|sensory system agents|mesh-ancestor
111003809|NCT03321019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111003810|NCT03321019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111003811|NCT03233139|Paclitaxel|paclitaxel|mesh-list
111003812|NCT03233139|Gemcitabine|gemcitabine|mesh-list
111003813|NCT03233139|Pemetrexed|pemetrexed|mesh-list
111003814|NCT03233139|Ipilimumab|ipilimumab|mesh-list
111003815|NCT03233139|Cemiplimab|cemiplimab|mesh-list
111003816|NCT03233139|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111003817|NCT03233139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111003818|NCT03233139|Tubulin Modulators|tubulin modulators|mesh-ancestor
111003819|NCT03233139|Antimitotic Agents|antimitotic agents|mesh-ancestor
111003820|NCT03233139|Mitosis Modulators|mitosis modulators|mesh-ancestor
111003821|NCT03233139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111003822|NCT03233139|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111003823|NCT03233139|Antimetabolites|antimetabolites|mesh-ancestor
111003824|NCT03233139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111003825|NCT03233139|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111003826|NCT03233139|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111003827|NCT03233139|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111003828|NCT03233139|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111003829|NCT03219268|Margetuximab|margetuximab|mesh-list
111003830|NCT03219268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111003831|NCT03215706|Paclitaxel|paclitaxel|mesh-list
111003832|NCT03215706|Carboplatin|carboplatin|mesh-list
110720834|NCT02525848|Analgesics|analgesics|mesh-ancestor
111003833|NCT03215706|Nivolumab|nivolumab|mesh-list
111003834|NCT03215706|Pemetrexed|pemetrexed|mesh-list
111003836|NCT03215706|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111003837|NCT03215706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111003838|NCT03215706|Tubulin Modulators|tubulin modulators|mesh-ancestor
111003839|NCT03215706|Antimitotic Agents|antimitotic agents|mesh-ancestor
111003840|NCT03215706|Mitosis Modulators|mitosis modulators|mesh-ancestor
111003841|NCT03215706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111003842|NCT03215706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111003843|NCT03215706|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111003844|NCT03215706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111003845|NCT03215706|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111003846|NCT03215706|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111003847|NCT03137407|Botulinum Toxins|botulinum toxins|mesh-list
111003848|NCT03137407|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111003849|NCT03137407|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111003850|NCT03137407|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111003851|NCT03137407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111003852|NCT03137407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111003853|NCT03137407|Cholinergic Agents|cholinergic agents|mesh-ancestor
111003854|NCT03137407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111003855|NCT03137407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111003856|NCT03137407|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111003857|NCT03137407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111003858|NCT03105336|Cyclophosphamide|cyclophosphamide|mesh-list
111003859|NCT03105336|Fludarabine|fludarabine|mesh-list
111003860|NCT03105336|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
111003861|NCT03105336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111003862|NCT03105336|Immunologic Factors|immunologic factors|mesh-ancestor
111003863|NCT03105336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111003864|NCT03105336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111003865|NCT03105336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111003866|NCT03105336|Alkylating Agents|alkylating agents|mesh-ancestor
111003867|NCT03105336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111003868|NCT03105336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111003869|NCT03105336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111003870|NCT03105336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111003871|NCT03076554|Avelumab|avelumab|mesh-list
111003872|NCT03076554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111003873|NCT03076554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111003874|NCT03007147|Calcium, Dietary|calcium, dietary|mesh-list
111003875|NCT03007147|Leucovorin|leucovorin|mesh-list
111003876|NCT03007147|Folic Acid|folic acid|mesh-list
111003877|NCT03007147|Cytarabine|cytarabine|mesh-list
111003878|NCT03007147|Dexamethasone|dexamethasone|mesh-list
111003879|NCT03007147|Dexamethasone acetate|dexamethasone acetate|mesh-list
111003880|NCT03007147|Methylprednisolone|methylprednisolone|mesh-list
111003881|NCT03007147|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111003882|NCT03007147|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111003883|NCT03007147|Prednisolone|prednisolone|mesh-list
111003884|NCT03007147|Prednisolone acetate|prednisolone acetate|mesh-list
111003885|NCT03007147|Hydrocortisone|hydrocortisone|mesh-list
111003886|NCT03007147|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
111003887|NCT03007147|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
111003888|NCT03007147|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
111003889|NCT03007147|Cyclophosphamide|cyclophosphamide|mesh-list
111003890|NCT03007147|Ifosfamide|ifosfamide|mesh-list
111003891|NCT03007147|Isophosphamide mustard|isophosphamide mustard|mesh-list
111003892|NCT03007147|Doxorubicin|doxorubicin|mesh-list
111003893|NCT03007147|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111003894|NCT03007147|Methotrexate|methotrexate|mesh-list
111003895|NCT03007147|Etoposide|etoposide|mesh-list
111003896|NCT03007147|Vincristine|vincristine|mesh-list
111003897|NCT03007147|Etoposide phosphate|etoposide phosphate|mesh-list
111003898|NCT03007147|Imatinib Mesylate|imatinib mesylate|mesh-list
111003899|NCT03007147|Daunorubicin|daunorubicin|mesh-list
111003900|NCT03007147|Asparaginase|asparaginase|mesh-list
111003901|NCT03007147|Mercaptopurine|mercaptopurine|mesh-list
111003902|NCT03007147|Podophyllotoxin|podophyllotoxin|mesh-list
111003903|NCT03007147|Pegaspargase|pegaspargase|mesh-list
111003904|NCT03007147|Thioguanine|thioguanine|mesh-list
111003905|NCT03007147|Dexrazoxane|dexrazoxane|mesh-list
111003906|NCT03007147|Razoxane|razoxane|mesh-list
111003907|NCT03007147|Azathioprine|azathioprine|mesh-list
111003908|NCT03007147|Lenograstim|lenograstim|mesh-list
111003909|NCT03007147|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111003910|NCT03007147|Prednisolone phosphate|prednisolone phosphate|mesh-list
111003911|NCT03007147|BB 1101|bb 1101|mesh-list
111003912|NCT03007147|Calcium|calcium|mesh-list
111003913|NCT03007147|2-Aminopurine|2-aminopurine|mesh-list
111003914|NCT03007147|Levoleucovorin|levoleucovorin|mesh-list
111003915|NCT03007147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111003916|NCT03007147|Immunologic Factors|immunologic factors|mesh-ancestor
111003917|NCT03007147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111003918|NCT03007147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111003919|NCT03007147|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111003920|NCT03007147|Alkylating Agents|alkylating agents|mesh-ancestor
111003921|NCT03007147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111003922|NCT03007147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111003923|NCT03007147|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111003924|NCT03007147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111003925|NCT03007147|Antiemetics|antiemetics|mesh-ancestor
111003926|NCT03007147|Autonomic Agents|autonomic agents|mesh-ancestor
111003927|NCT03007147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111003928|NCT03007147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111003929|NCT03007147|Glucocorticoids|glucocorticoids|mesh-ancestor
111003930|NCT03007147|Hormones|hormones|mesh-ancestor
111003931|NCT03007147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111003932|NCT03007147|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111003933|NCT03007147|Protease Inhibitors|protease inhibitors|mesh-ancestor
111003934|NCT03007147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111003935|NCT03007147|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111003936|NCT03007147|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111003937|NCT03007147|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111003938|NCT03007147|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111003939|NCT03007147|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111003940|NCT03007147|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111003941|NCT03007147|Abortifacient Agents|abortifacient agents|mesh-ancestor
111003942|NCT03007147|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111003943|NCT03007147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111003944|NCT03007147|Antimetabolites|antimetabolites|mesh-ancestor
111003945|NCT03007147|Dermatologic Agents|dermatologic agents|mesh-ancestor
111003946|NCT03007147|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111003947|NCT03007147|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111003948|NCT03007147|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111003949|NCT03007147|Antiviral Agents|antiviral agents|mesh-ancestor
111003950|NCT03007147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111003951|NCT03007147|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111003953|NCT03007147|Protective Agents|protective agents|mesh-ancestor
111003954|NCT03007147|Vitamin B Complex|vitamin b complex|mesh-ancestor
111003955|NCT03007147|Vitamins|vitamins|mesh-ancestor
111003956|NCT03007147|Micronutrients|micronutrients|mesh-ancestor
111003957|NCT03007147|Tubulin Modulators|tubulin modulators|mesh-ancestor
111003958|NCT03007147|Antimitotic Agents|antimitotic agents|mesh-ancestor
111003959|NCT03007147|Mitosis Modulators|mitosis modulators|mesh-ancestor
111003960|NCT03007147|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111003961|NCT03007147|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111003962|NCT03007147|Hematinics|hematinics|mesh-ancestor
111003963|NCT03007147|Keratolytic Agents|keratolytic agents|mesh-ancestor
111003964|NCT03007147|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111003965|NCT02900976|Rituximab|rituximab|mesh-list
111003966|NCT02900976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111003967|NCT02900976|Antibodies|antibodies|mesh-list
111003968|NCT02900976|Immunoglobulins|immunoglobulins|mesh-list
111003969|NCT02900976|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111003970|NCT02900976|Immunologic Factors|immunologic factors|mesh-ancestor
111003971|NCT02900976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111003972|NCT02900976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111003973|NCT02900976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111003974|NCT02759419|Riociguat|riociguat|mesh-list
111003975|NCT02759419|Enzyme Activators|enzyme activators|mesh-ancestor
111003976|NCT02759419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111003977|NCT02752035|Azacitidine|azacitidine|mesh-list
111003978|NCT02752035|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111003979|NCT02752035|Antimetabolites|antimetabolites|mesh-ancestor
111003980|NCT02752035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111003981|NCT02752035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111003982|NCT02752035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111003983|NCT02748018|Insulin|insulin|mesh-list
111003984|NCT02748018|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111003985|NCT02748018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111003986|NCT02743494|Nivolumab|nivolumab|mesh-list
111003987|NCT02743494|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111003988|NCT02743494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110720981|NCT01175200|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111003989|NCT02743494|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111003990|NCT02743494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111003991|NCT02722538|Gemcitabine|gemcitabine|mesh-list
111003992|NCT02722538|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111003993|NCT02722538|Antimetabolites|antimetabolites|mesh-ancestor
111003994|NCT02722538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111003995|NCT02722538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111003996|NCT02652052|Dasatinib|dasatinib|mesh-list
111003997|NCT02652052|Quercetin|quercetin|mesh-list
111003998|NCT02652052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111003999|NCT02652052|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111004000|NCT02652052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111004001|NCT02652052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111004002|NCT02652052|Antioxidants|antioxidants|mesh-ancestor
111004003|NCT02652052|Protective Agents|protective agents|mesh-ancestor
111004004|NCT02652052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111004005|NCT02531126|Ozanimod|ozanimod|mesh-list
111004006|NCT02531126|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
111004007|NCT02531126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111004008|NCT02531126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111004009|NCT02531126|Immunologic Factors|immunologic factors|mesh-ancestor
111004010|NCT02531126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111004012|NCT02465268|Sargramostim|sargramostim|mesh-list
111004013|NCT02465268|Immunologic Factors|immunologic factors|mesh-ancestor
111004014|NCT02465268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111004015|NCT02465268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111004016|NCT02401503|Venetoclax|venetoclax|mesh-list
111004017|NCT02401503|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
111004018|NCT02401503|Obinutuzumab|obinutuzumab|mesh-list
111004019|NCT02401503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111004020|NCT02401503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111004021|NCT02401503|Alkylating Agents|alkylating agents|mesh-ancestor
111004022|NCT02401503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111004023|NCT02401503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111004024|NCT02286726|Cytarabine|cytarabine|mesh-list
111004025|NCT02286726|Daunorubicin|daunorubicin|mesh-list
111004026|NCT02286726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111004027|NCT02286726|Antimetabolites|antimetabolites|mesh-ancestor
111004028|NCT02286726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111004029|NCT02286726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111004030|NCT02286726|Antiviral Agents|antiviral agents|mesh-ancestor
111004031|NCT02286726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111004032|NCT02286726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111004033|NCT02286726|Immunologic Factors|immunologic factors|mesh-ancestor
111004034|NCT02286726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111004035|NCT02286726|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111004036|NCT02286726|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111004037|NCT02286726|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111004038|NCT02286726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111004039|NCT02272998|Ponatinib|ponatinib|mesh-list
111004040|NCT02272998|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
111004041|NCT02272998|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111004042|NCT02272998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111004043|NCT02272998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111004044|NCT02272998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111004045|NCT02272842|Vitamin B 12|vitamin b 12|mesh-list
111004046|NCT02272842|Hydroxocobalamin|hydroxocobalamin|mesh-list
111004047|NCT02272842|Vitamins|vitamins|mesh-ancestor
111004048|NCT02272842|Micronutrients|micronutrients|mesh-ancestor
110620463|NCT00799890|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
111004049|NCT02272842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111004050|NCT02272842|Vitamin B Complex|vitamin b complex|mesh-ancestor
111004051|NCT02272842|Hematinics|hematinics|mesh-ancestor
111004052|NCT02258659|Paclitaxel|paclitaxel|mesh-list
111004053|NCT02258659|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111004054|NCT02258659|Carboplatin|carboplatin|mesh-list
111004055|NCT02258659|Fluorouracil|fluorouracil|mesh-list
111004056|NCT02258659|Hydroxyurea|hydroxyurea|mesh-list
111004057|NCT02258659|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111004058|NCT02258659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111004059|NCT02258659|Tubulin Modulators|tubulin modulators|mesh-ancestor
111004060|NCT02258659|Antimitotic Agents|antimitotic agents|mesh-ancestor
111004061|NCT02258659|Mitosis Modulators|mitosis modulators|mesh-ancestor
111004062|NCT02258659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111004063|NCT02258659|Antimetabolites|antimetabolites|mesh-ancestor
111004064|NCT02258659|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111004065|NCT02258659|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111004066|NCT02258659|Immunologic Factors|immunologic factors|mesh-ancestor
111004067|NCT02258659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111004068|NCT02258659|Antisickling Agents|antisickling agents|mesh-ancestor
111004069|NCT02258659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111004070|NCT02258659|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111004071|NCT02135419|Fluorouracil|fluorouracil|mesh-list
111004072|NCT02135419|Imiquimod|imiquimod|mesh-list
111004073|NCT02135419|Antimetabolites|antimetabolites|mesh-ancestor
111004074|NCT02135419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111004075|NCT02135419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111004076|NCT02135419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111004077|NCT02135419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111004078|NCT02135419|Immunologic Factors|immunologic factors|mesh-ancestor
111004079|NCT02135419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111004080|NCT02135419|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111004081|NCT02135419|Interferon Inducers|interferon inducers|mesh-ancestor
111004082|NCT02064673|Curcumin|curcumin|mesh-list
111004083|NCT02064673|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111004084|NCT02064673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111004085|NCT02064673|Analgesics|analgesics|mesh-ancestor
111004086|NCT02064673|Sensory System Agents|sensory system agents|mesh-ancestor
111004087|NCT02064673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111004088|NCT02064673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111004089|NCT02064673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111004090|NCT02064673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111004091|NCT02064673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111004092|NCT02064673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111004093|NCT02064673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111004094|NCT01990300|Pioglitazone|pioglitazone|mesh-list
111004095|NCT01990300|Alogliptin|alogliptin|mesh-list
111004096|NCT01990300|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111004097|NCT01990300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111004098|NCT01990300|Incretins|incretins|mesh-ancestor
111004099|NCT01990300|Hormones|hormones|mesh-ancestor
111004100|NCT01990300|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111004101|NCT01990300|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111004102|NCT01990300|Protease Inhibitors|protease inhibitors|mesh-ancestor
111004103|NCT01990300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111004104|NCT01990300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111004105|NCT01961375|Levonorgestrel|levonorgestrel|mesh-list
111004106|NCT01961375|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111004107|NCT01961375|Contraceptive Agents|contraceptive agents|mesh-ancestor
111004108|NCT01961375|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111004109|NCT01961375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111004110|NCT01961375|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111004111|NCT01961375|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111004112|NCT01961375|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111004113|NCT01909934|Brentuximab Vedotin|brentuximab vedotin|mesh-list
111004114|NCT01909934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111004115|NCT01909934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111004116|NCT01909934|Immunotoxins|immunotoxins|mesh-ancestor
111004117|NCT01909934|Immunoconjugates|immunoconjugates|mesh-ancestor
111004118|NCT01909934|Immunologic Factors|immunologic factors|mesh-ancestor
111004119|NCT01909934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111004120|NCT01864109|Cyclophosphamide|cyclophosphamide|mesh-list
111004121|NCT01864109|Temozolomide|temozolomide|mesh-list
111004122|NCT01864109|Ifosfamide|ifosfamide|mesh-list
111004123|NCT01864109|Doxorubicin|doxorubicin|mesh-list
111004124|NCT01864109|Irinotecan|irinotecan|mesh-list
111004125|NCT01864109|Etoposide|etoposide|mesh-list
111004126|NCT01864109|Vincristine|vincristine|mesh-list
111004127|NCT01864109|Dexrazoxane|dexrazoxane|mesh-list
111004128|NCT01864109|Razoxane|razoxane|mesh-list
111004129|NCT01864109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111004130|NCT01864109|Immunologic Factors|immunologic factors|mesh-ancestor
111004131|NCT01864109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111004132|NCT01864109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111004133|NCT01864109|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111004134|NCT01864109|Alkylating Agents|alkylating agents|mesh-ancestor
111004135|NCT01864109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111004136|NCT01864109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111004137|NCT01864109|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111004138|NCT01864109|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111004139|NCT01864109|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111004140|NCT01864109|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111004141|NCT01864109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111004142|NCT01864109|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111004143|NCT01864109|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111004144|NCT01864109|Tubulin Modulators|tubulin modulators|mesh-ancestor
111004145|NCT01864109|Antimitotic Agents|antimitotic agents|mesh-ancestor
111004146|NCT01864109|Mitosis Modulators|mitosis modulators|mesh-ancestor
111004147|NCT01864109|Protective Agents|protective agents|mesh-ancestor
111004148|NCT01864109|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111004149|NCT01740648|Fluorouracil|fluorouracil|mesh-list
111004150|NCT01740648|Trametinib|trametinib|mesh-list
111004151|NCT01740648|Antimetabolites|antimetabolites|mesh-ancestor
111004152|NCT01740648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111004153|NCT01740648|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111004154|NCT01740648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111004155|NCT01740648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111004156|NCT01740648|Immunologic Factors|immunologic factors|mesh-ancestor
111004157|NCT01740648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111004158|NCT01740648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111004159|NCT01740648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111004161|NCT01697566|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111004162|NCT01697566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111004163|NCT01638442|Tosedostat|tosedostat|mesh-list
111004164|NCT01638442|Glycine|glycine|mesh-list
111004165|NCT01638442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111004166|NCT01638442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111004167|NCT01638442|Glycine Agents|glycine agents|mesh-ancestor
111004168|NCT01638442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111004169|NCT01638442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111004170|NCT01318317|Plerixafor|plerixafor|mesh-list
111004171|NCT01318317|Rituximab|rituximab|mesh-list
111004172|NCT01318317|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111004173|NCT01318317|Antibodies|antibodies|mesh-list
111004174|NCT01318317|Immunoglobulins|immunoglobulins|mesh-list
111004175|NCT01318317|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111004176|NCT01318317|Lenograstim|lenograstim|mesh-list
111004177|NCT01318317|Immunologic Factors|immunologic factors|mesh-ancestor
111004178|NCT01318317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111004179|NCT01318317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111004180|NCT01318317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111004181|NCT01318317|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111004182|NCT01318317|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111004183|NCT01318317|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111004184|NCT01318317|Antiviral Agents|antiviral agents|mesh-ancestor
111004185|NCT01318317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111004186|NCT01076400|Topotecan|topotecan|mesh-list
111004187|NCT01076400|Adavosertib|adavosertib|mesh-list
111004188|NCT01076400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111004189|NCT01076400|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111004190|NCT01076400|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111004191|NCT01076400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111004192|NCT01076400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111004193|NCT00934895|Paclitaxel|paclitaxel|mesh-list
111004194|NCT00934895|Everolimus|everolimus|mesh-list
111004195|NCT00934895|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111004196|NCT00934895|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111004197|NCT00934895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111004198|NCT00934895|Tubulin Modulators|tubulin modulators|mesh-ancestor
111004199|NCT00934895|Antimitotic Agents|antimitotic agents|mesh-ancestor
111004200|NCT00934895|Mitosis Modulators|mitosis modulators|mesh-ancestor
111004201|NCT00934895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111004202|NCT00934895|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111004203|NCT00934895|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111004204|NCT00934895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111004205|NCT00934895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111004206|NCT00934895|Immunologic Factors|immunologic factors|mesh-ancestor
111004207|NCT00934895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111004208|NCT00913497|Insulin|insulin|mesh-list
111004209|NCT00913497|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111004210|NCT00913497|Insulin Aspart|insulin aspart|mesh-list
111004211|NCT00913497|Insulin glulisine|insulin glulisine|mesh-list
111004212|NCT00913497|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111004213|NCT00913497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111004214|NCT00736450|Prednisone|prednisone|mesh-list
111004215|NCT00736450|Cyclophosphamide|cyclophosphamide|mesh-list
111004216|NCT00736450|Rituximab|rituximab|mesh-list
111004217|NCT00736450|Doxorubicin|doxorubicin|mesh-list
111004218|NCT00736450|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111004219|NCT00736450|Vincristine|vincristine|mesh-list
111004220|NCT00736450|Oblimersen|oblimersen|mesh-list
111004221|NCT00736450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111004222|NCT00736450|Immunologic Factors|immunologic factors|mesh-ancestor
111004223|NCT00736450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111004224|NCT00736450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111004225|NCT00736450|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111004226|NCT00736450|Alkylating Agents|alkylating agents|mesh-ancestor
111004227|NCT00736450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111004228|NCT00736450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111004229|NCT00736450|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111004230|NCT00736450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111004231|NCT00736450|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111004232|NCT00736450|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111004233|NCT00736450|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111004234|NCT00736450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111004235|NCT00736450|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111004237|NCT00736450|Hormones|hormones|mesh-ancestor
110469212|NCT00845182|Exenatide|exenatide|mesh-list
111004238|NCT00736450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111004239|NCT00736450|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110620907|NCT03988075|Ibuprofen|ibuprofen|mesh-list
111004240|NCT00736450|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111004241|NCT00736450|Tubulin Modulators|tubulin modulators|mesh-ancestor
111004242|NCT00736450|Antimitotic Agents|antimitotic agents|mesh-ancestor
111004243|NCT00736450|Mitosis Modulators|mitosis modulators|mesh-ancestor
111004244|NCT00556933|Mycophenolic Acid|mycophenolic acid|mesh-list
111004245|NCT00556933|Sirolimus|sirolimus|mesh-list
111004246|NCT00556933|Tacrolimus|tacrolimus|mesh-list
111004247|NCT00556933|Thymoglobulin|thymoglobulin|mesh-list
111004248|NCT00556933|Antilymphocyte Serum|antilymphocyte serum|mesh-list
111004249|NCT00556933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111004250|NCT00556933|Immunologic Factors|immunologic factors|mesh-ancestor
111004251|NCT00556933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111004252|NCT00556933|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111004253|NCT00556933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111004254|NCT00556933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111004255|NCT00556933|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111004256|NCT00556933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111004257|NCT00556933|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111004258|NCT00556933|Antitubercular Agents|antitubercular agents|mesh-ancestor
111004259|NCT00556933|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111004260|NCT00556933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111004261|NCT00556933|Antifungal Agents|antifungal agents|mesh-ancestor
111004262|NCT00503880|Cytarabine|cytarabine|mesh-list
111004263|NCT00503880|Clofarabine|clofarabine|mesh-list
111004264|NCT00503880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111004265|NCT00503880|Antimetabolites|antimetabolites|mesh-ancestor
111004266|NCT00503880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111004267|NCT00503880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111004268|NCT00503880|Antiviral Agents|antiviral agents|mesh-ancestor
111004269|NCT00503880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111004270|NCT00503880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111004271|NCT00503880|Immunologic Factors|immunologic factors|mesh-ancestor
111004272|NCT00503880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111004273|NCT00378326|Tacrolimus|tacrolimus|mesh-list
111004274|NCT00378326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111004275|NCT00378326|Immunologic Factors|immunologic factors|mesh-ancestor
111004276|NCT00378326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111004277|NCT00378326|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111004278|NCT00378326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111004279|NCT00378326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111004280|NCT00106600|Pixantrone|pixantrone|mesh-list
111004281|NCT00106600|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111004282|NCT00106600|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111004283|NCT00106600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111004284|NCT00106600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111004285|NCT00106600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111004286|NCT00006478|Sargramostim|sargramostim|mesh-list
111004287|NCT00006478|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
111004288|NCT00006478|Immunologic Factors|immunologic factors|mesh-ancestor
111004289|NCT00006478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111004290|NCT00006478|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111004291|NCT05850143|Dexamethasone|dexamethasone|mesh-list
111004292|NCT05850143|Prednisolone|prednisolone|mesh-list
111004293|NCT05850143|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111004294|NCT05850143|Antiemetics|antiemetics|mesh-ancestor
111004295|NCT05850143|Autonomic Agents|autonomic agents|mesh-ancestor
110721283|NCT03859102|Serotonin Agents|serotonin agents|mesh-ancestor
111004296|NCT05850143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111004297|NCT05850143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111004298|NCT05850143|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111004299|NCT05850143|Glucocorticoids|glucocorticoids|mesh-ancestor
111004300|NCT05850143|Hormones|hormones|mesh-ancestor
111004301|NCT05850143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111004302|NCT05850143|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111004303|NCT05850143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111004304|NCT05850117|Amoxicillin|amoxicillin|mesh-list
111004305|NCT05850117|Metronidazole|metronidazole|mesh-list
111004306|NCT05850117|Levofloxacin|levofloxacin|mesh-list
111004307|NCT05850117|Ofloxacin|ofloxacin|mesh-list
111004308|NCT05850117|Tetracycline|tetracycline|mesh-list
111004309|NCT05850117|Esomeprazole|esomeprazole|mesh-list
111004310|NCT05850117|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111004311|NCT05850117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111004312|NCT05850117|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111004313|NCT05850117|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111004314|NCT05850117|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111004315|NCT05850117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111004316|NCT05850117|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111004317|NCT05850117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111004318|NCT05850117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111004319|NCT05850117|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111004320|NCT05850117|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111004321|NCT05850117|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111004322|NCT05850117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111004323|NCT05850117|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111004324|NCT05850117|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111004325|NCT05850117|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111004326|NCT05850091|Colchicine|colchicine|mesh-list
111004327|NCT05850091|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111004328|NCT05850091|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111004329|NCT05850091|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111004330|NCT05850091|Antimetabolites|antimetabolites|mesh-ancestor
111004331|NCT05850091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111004332|NCT05850091|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111004333|NCT05850091|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111004334|NCT05850091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111004335|NCT05850091|Gout Suppressants|gout suppressants|mesh-ancestor
111004336|NCT05850091|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111004337|NCT05850091|Tubulin Modulators|tubulin modulators|mesh-ancestor
111004338|NCT05850091|Antimitotic Agents|antimitotic agents|mesh-ancestor
111004339|NCT05850091|Mitosis Modulators|mitosis modulators|mesh-ancestor
111004340|NCT05850091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111004341|NCT05849883|Omeprazole|omeprazole|mesh-list
111004342|NCT05849883|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111004343|NCT05849883|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111004344|NCT05849883|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111004345|NCT05849883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111004346|NCT05849883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111004347|NCT05849857|Dexamethasone|dexamethasone|mesh-list
111004348|NCT05849857|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111004349|NCT05849857|Antiemetics|antiemetics|mesh-ancestor
111004350|NCT05849857|Autonomic Agents|autonomic agents|mesh-ancestor
111004351|NCT05849857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111004352|NCT05849857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111004353|NCT05849857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111004354|NCT05849857|Glucocorticoids|glucocorticoids|mesh-ancestor
111004355|NCT05849857|Hormones|hormones|mesh-ancestor
111004356|NCT05849857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111004357|NCT05849857|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111004358|NCT05849857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111004359|NCT05849766|Dapagliflozin|dapagliflozin|mesh-list
111004360|NCT05849766|Carvedilol|carvedilol|mesh-list
111004361|NCT05849766|Ramipril|ramipril|mesh-list
111004362|NCT05849766|Spironolactone|spironolactone|mesh-list
111004363|NCT05849766|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111004364|NCT05849766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111004365|NCT05849766|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111004366|NCT05849766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111004367|NCT05849766|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
111004368|NCT05849766|Hormone Antagonists|hormone antagonists|mesh-ancestor
111004369|NCT05849766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110721361|NCT01287052|Analgesics|analgesics|mesh-ancestor
111004370|NCT05849766|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
111004371|NCT05849766|Diuretics|diuretics|mesh-ancestor
111004372|NCT05849766|Natriuretic Agents|natriuretic agents|mesh-ancestor
111004373|NCT05849766|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111004374|NCT05849766|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111004375|NCT05849766|Adrenergic Agents|adrenergic agents|mesh-ancestor
111004376|NCT05849766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111004377|NCT05849766|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111004378|NCT05849766|Antioxidants|antioxidants|mesh-ancestor
111004379|NCT05849766|Protective Agents|protective agents|mesh-ancestor
111004380|NCT05849766|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111004381|NCT05849766|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111004382|NCT05849766|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111004383|NCT05849766|Vasodilator Agents|vasodilator agents|mesh-ancestor
111004384|NCT05849766|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111004385|NCT05849766|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111004386|NCT05849766|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
111004387|NCT05849766|Protease Inhibitors|protease inhibitors|mesh-ancestor
111004388|NCT05849766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111004390|NCT05849662|Fludarabine|fludarabine|mesh-list
111004391|NCT05849662|Azacitidine|azacitidine|mesh-list
111004392|NCT05849662|Trametinib|trametinib|mesh-list
111004393|NCT05849662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111004394|NCT05849662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111004395|NCT05849662|Antimetabolites|antimetabolites|mesh-ancestor
111004396|NCT05849662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111004397|NCT05849662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110620587|NCT01057849|Risperidone|risperidone|mesh-list
111004398|NCT05849662|Immunologic Factors|immunologic factors|mesh-ancestor
111004399|NCT05849662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111004400|NCT05849662|Antiviral Agents|antiviral agents|mesh-ancestor
111004401|NCT05849662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111004402|NCT05849662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111004403|NCT05849662|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111004404|NCT05849597|Dexmedetomidine|dexmedetomidine|mesh-list
111004405|NCT05849597|Propofol|propofol|mesh-list
111004406|NCT05849597|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111004407|NCT05849597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111004408|NCT05849597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111004409|NCT05849597|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111004410|NCT05849597|Analgesics|analgesics|mesh-ancestor
111004411|NCT05849597|Sensory System Agents|sensory system agents|mesh-ancestor
111004412|NCT05849597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111004413|NCT05849597|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111004414|NCT05849597|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111004415|NCT05849597|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111004416|NCT05849597|Adrenergic Agents|adrenergic agents|mesh-ancestor
111004417|NCT05849597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111004418|NCT05849597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111004419|NCT05849597|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111004420|NCT05849597|Anesthetics, General|anesthetics, general|mesh-ancestor
111004421|NCT05849597|Anesthetics|anesthetics|mesh-ancestor
111004422|NCT05847283|Dydrogesterone|dydrogesterone|mesh-list
111004423|NCT05847283|Progestins|progestins|mesh-ancestor
111004424|NCT05847283|Hormones|hormones|mesh-ancestor
111004425|NCT05847283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111004426|NCT05847283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111004427|NCT05846724|Pembrolizumab|pembrolizumab|mesh-list
111004428|NCT05846724|Lenvatinib|lenvatinib|mesh-list
111004429|NCT05846724|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111004430|NCT05846724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111004431|NCT05846724|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111004432|NCT05846724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111004433|NCT05846724|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111004434|NCT05846724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111004435|NCT05846620|Dimercaprol|dimercaprol|mesh-list
111004436|NCT05846620|Chelating Agents|chelating agents|mesh-ancestor
111004437|NCT05846620|Sequestering Agents|sequestering agents|mesh-ancestor
111004438|NCT05846620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111004439|NCT05845580|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
111004440|NCT05845580|Red yeast rice|red yeast rice|mesh-list
111004441|NCT05845580|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111004442|NCT05845580|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111004443|NCT05845580|Antimetabolites|antimetabolites|mesh-ancestor
111004444|NCT05845580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111004445|NCT05845580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111004446|NCT05845580|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111004447|NCT05845099|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
111004448|NCT05845099|Vasodilator Agents|vasodilator agents|mesh-ancestor
111004449|NCT05845099|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
111004450|NCT05845099|Protective Agents|protective agents|mesh-ancestor
111004451|NCT05845099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111004452|NCT05843968|Mycophenolic Acid|mycophenolic acid|mesh-list
111004453|NCT05843968|Rituximab|rituximab|mesh-list
111004454|NCT05843968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111004455|NCT05843968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111004456|NCT05843968|Immunologic Factors|immunologic factors|mesh-ancestor
111004457|NCT05843968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111004458|NCT05843968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111004459|NCT05843968|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110469431|NCT00768079|Benralizumab|benralizumab|mesh-list
111004460|NCT05843968|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111004461|NCT05843968|Antitubercular Agents|antitubercular agents|mesh-ancestor
111004462|NCT05843968|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111004463|NCT05843968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111004464|NCT05843968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111004465|NCT05843968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111004466|NCT05841134|Capecitabine|capecitabine|mesh-list
111004467|NCT05841134|Oxaliplatin|oxaliplatin|mesh-list
111004468|NCT05841134|Tislelizumab|tislelizumab|mesh-list
111004469|NCT05841134|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111004470|NCT05841134|Antimetabolites|antimetabolites|mesh-ancestor
111004471|NCT05841134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111004472|NCT05841134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111004473|NCT05841134|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111004474|NCT05831878|Disitamab vedotin|disitamab vedotin|mesh-list
111004475|NCT05831878|Immunoconjugates|immunoconjugates|mesh-ancestor
111004476|NCT05831878|Immunologic Factors|immunologic factors|mesh-ancestor
111004477|NCT05831878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111004479|NCT05827705|Pseudoephedrine|pseudoephedrine|mesh-list
111004480|NCT05827705|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111004481|NCT05827705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111004482|NCT05827705|Sympathomimetics|sympathomimetics|mesh-ancestor
111004483|NCT05827705|Autonomic Agents|autonomic agents|mesh-ancestor
111004484|NCT05827705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111004485|NCT05827705|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111004486|NCT05827705|Adrenergic Agents|adrenergic agents|mesh-ancestor
111004487|NCT05827705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111004488|NCT05827705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111004489|NCT05827705|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111004490|NCT05827705|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111004491|NCT05827705|Respiratory System Agents|respiratory system agents|mesh-ancestor
111004492|NCT05827705|Nasal Decongestants|nasal decongestants|mesh-ancestor
111004493|NCT05816746|Decitabine|decitabine|mesh-list
111004494|NCT05816746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111004495|NCT05816746|Antimetabolites|antimetabolites|mesh-ancestor
111004496|NCT05816746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111004497|NCT05816746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111004498|NCT05816746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111004499|NCT05949229|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
111004500|NCT05949229|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111004501|NCT05949229|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111004502|NCT05949229|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111004503|NCT05949229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111004504|NCT05949229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111004505|NCT05949229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111004506|NCT05949229|Analgesics|analgesics|mesh-ancestor
111004507|NCT05949229|Sensory System Agents|sensory system agents|mesh-ancestor
111004508|NCT05949229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111004509|NCT05949229|Antidepressive Agents|antidepressive agents|mesh-ancestor
111004510|NCT05949229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111004511|NCT05949229|Dopamine Agents|dopamine agents|mesh-ancestor
111004512|NCT05949203|Cabotegravir|cabotegravir|mesh-list
111004513|NCT05949203|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111004514|NCT05949203|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111004515|NCT05949203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111004516|NCT05949203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111004517|NCT05949203|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111004518|NCT05949203|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111004519|NCT05949203|Antiviral Agents|antiviral agents|mesh-ancestor
111004520|NCT05949203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111004521|NCT05949021|Doxorubicin|doxorubicin|mesh-list
111004522|NCT05949021|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111004523|NCT05949021|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111004524|NCT05949021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111004525|NCT05949021|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111004526|NCT05949021|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111004527|NCT05949021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111004528|NCT05949021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111004529|NCT05948891|Beclomethasone|beclomethasone|mesh-list
111004530|NCT05948891|Glycopyrrolate|glycopyrrolate|mesh-list
111004531|NCT05948891|Formoterol Fumarate|formoterol fumarate|mesh-list
111004532|NCT05948891|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111004533|NCT05948891|Autonomic Agents|autonomic agents|mesh-ancestor
111004534|NCT05948891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111004535|NCT05948891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111004536|NCT05948891|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111004537|NCT05948891|Respiratory System Agents|respiratory system agents|mesh-ancestor
111004538|NCT05948891|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111004539|NCT05948891|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111004540|NCT05948891|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111004541|NCT05948891|Adrenergic Agents|adrenergic agents|mesh-ancestor
111004542|NCT05948891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111004543|NCT05948891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111004544|NCT05948891|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111004545|NCT05948891|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111004546|NCT05948891|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111004547|NCT05948891|Cholinergic Agents|cholinergic agents|mesh-ancestor
111004548|NCT05948891|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111004549|NCT05948891|Glucocorticoids|glucocorticoids|mesh-ancestor
111004550|NCT05948891|Hormones|hormones|mesh-ancestor
111004551|NCT05948891|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111004552|NCT05948813|Osimertinib|osimertinib|mesh-list
111004553|NCT05948813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111004554|NCT05948813|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111004555|NCT05948813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111004556|NCT05948813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111004557|NCT05948449|Oxaliplatin|oxaliplatin|mesh-list
111004558|NCT05948449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111004559|NCT05948267|Lidocaine|lidocaine|mesh-list
111004560|NCT05948267|Fentanyl|fentanyl|mesh-list
111004561|NCT05948267|Ketamine|ketamine|mesh-list
111004562|NCT05948267|Propofol|propofol|mesh-list
111004563|NCT05948267|Anesthetics, Local|anesthetics, local|mesh-ancestor
111004564|NCT05948267|Anesthetics|anesthetics|mesh-ancestor
111004565|NCT05948267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111004566|NCT05948267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111004567|NCT05948267|Sensory System Agents|sensory system agents|mesh-ancestor
111004568|NCT05948267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111004569|NCT05948267|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111004570|NCT05948267|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111004571|NCT05948267|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111004572|NCT05948267|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111004573|NCT05948267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111004574|NCT05948267|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111004575|NCT05948267|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111004576|NCT05948267|Anesthetics, General|anesthetics, general|mesh-ancestor
111004577|NCT05948267|Analgesics|analgesics|mesh-ancestor
111004578|NCT05948267|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111004579|NCT05948267|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111004580|NCT05948267|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111004581|NCT05948267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111004582|NCT05948267|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111004583|NCT05948267|Narcotics|narcotics|mesh-ancestor
111004584|NCT05948267|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111004585|NCT05948228|Fluorides|fluorides|mesh-list
111004586|NCT05948228|Cariostatic Agents|cariostatic agents|mesh-ancestor
111004587|NCT05948228|Protective Agents|protective agents|mesh-ancestor
111004588|NCT05948228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111004589|NCT05948072|Cetuximab|cetuximab|mesh-list
111004590|NCT05948072|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111004591|NCT05948072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111004592|NCT05947825|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111004593|NCT05947825|Paclitaxel|paclitaxel|mesh-list
111004594|NCT05947825|Gemcitabine|gemcitabine|mesh-list
110392143|NCT01681667|Ibuprofen|ibuprofen|mesh-list
111004595|NCT05947825|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111004596|NCT05947825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111004598|NCT05947825|Antimitotic Agents|antimitotic agents|mesh-ancestor
111004599|NCT05947825|Mitosis Modulators|mitosis modulators|mesh-ancestor
111004600|NCT05947825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111004601|NCT05947825|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111004602|NCT05947825|Antimetabolites|antimetabolites|mesh-ancestor
111004603|NCT05947825|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111004604|NCT05947825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111004605|NCT05947825|Incretins|incretins|mesh-ancestor
111004606|NCT05947825|Hormones|hormones|mesh-ancestor
111004607|NCT05947825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111004608|NCT05947825|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111004609|NCT05947825|Protease Inhibitors|protease inhibitors|mesh-ancestor
111004610|NCT05947825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111004611|NCT05947812|Tafenoquine|tafenoquine|mesh-list
111004612|NCT05947812|Antimalarials|antimalarials|mesh-ancestor
111004613|NCT05947812|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111004614|NCT05947812|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111004615|NCT05947812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111004616|NCT05947760|Magnesium Sulfate|magnesium sulfate|mesh-list
111004617|NCT05947760|Analgesics|analgesics|mesh-ancestor
111004618|NCT05947760|Sensory System Agents|sensory system agents|mesh-ancestor
111004619|NCT05947760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111004620|NCT05947760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111004621|NCT05947760|Anesthetics|anesthetics|mesh-ancestor
111004622|NCT05947760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111004623|NCT05947760|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111004624|NCT05947760|Anticonvulsants|anticonvulsants|mesh-ancestor
111004625|NCT05947760|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111004626|NCT05947760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111004627|NCT05947760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111004628|NCT05947760|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111004629|NCT05947760|Tocolytic Agents|tocolytic agents|mesh-ancestor
111004630|NCT05947760|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111004631|NCT05947708|Dialysis Solutions|dialysis solutions|mesh-list
111004632|NCT05947708|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111004633|NCT05947669|Methylprednisolone|methylprednisolone|mesh-list
111004634|NCT05947669|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111004635|NCT05947669|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111004636|NCT05947669|Prednisolone|prednisolone|mesh-list
111004637|NCT05947669|Prednisolone acetate|prednisolone acetate|mesh-list
111004638|NCT05947669|Infliximab|infliximab|mesh-list
111004639|NCT05947669|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111004640|NCT05947669|Prednisolone phosphate|prednisolone phosphate|mesh-list
111004641|NCT05947669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111004642|NCT05947669|Antiemetics|antiemetics|mesh-ancestor
111004643|NCT05947669|Autonomic Agents|autonomic agents|mesh-ancestor
111004644|NCT05947669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111004645|NCT05947669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111004646|NCT05947669|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111004647|NCT05947669|Glucocorticoids|glucocorticoids|mesh-ancestor
111004648|NCT05947669|Hormones|hormones|mesh-ancestor
111004649|NCT05947669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111004650|NCT05947669|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111004651|NCT05947669|Protective Agents|protective agents|mesh-ancestor
111004652|NCT05947669|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111004653|NCT05947669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111004654|NCT05947669|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111004655|NCT05947669|Dermatologic Agents|dermatologic agents|mesh-ancestor
111004656|NCT05947669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111004657|NCT05947643|Theophylline|theophylline|mesh-list
111004658|NCT05947643|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111004659|NCT05947643|Autonomic Agents|autonomic agents|mesh-ancestor
111004660|NCT05947643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111004661|NCT05947643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111004662|NCT05947643|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111004663|NCT05947643|Respiratory System Agents|respiratory system agents|mesh-ancestor
111004664|NCT05947643|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111004665|NCT05947643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111004666|NCT05947643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111004667|NCT05947643|Vasodilator Agents|vasodilator agents|mesh-ancestor
111004668|NCT05947643|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
111004669|NCT05947643|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111004670|NCT05947643|Purinergic Agents|purinergic agents|mesh-ancestor
111004671|NCT05947643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111004672|NCT05947604|Midazolam|midazolam|mesh-list
111004673|NCT05947604|Dextromethorphan|dextromethorphan|mesh-list
111004674|NCT05947604|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111004675|NCT05947604|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111004676|NCT05947604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111004677|NCT05947604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111004678|NCT05947604|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111004679|NCT05947604|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111004680|NCT05947604|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111004681|NCT05947604|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111004682|NCT05947604|Anesthetics, General|anesthetics, general|mesh-ancestor
111004683|NCT05947604|Anesthetics|anesthetics|mesh-ancestor
111004684|NCT05947604|GABA Modulators|gaba modulators|mesh-ancestor
111004685|NCT05947604|GABA Agents|gaba agents|mesh-ancestor
111004686|NCT05947604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111004687|NCT05947604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111004688|NCT05947604|Antitussive Agents|antitussive agents|mesh-ancestor
111004689|NCT05947604|Respiratory System Agents|respiratory system agents|mesh-ancestor
111004690|NCT05947604|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111004691|NCT05947604|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111004692|NCT05947513|Curcumin|curcumin|mesh-list
111004693|NCT05947513|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111004694|NCT05947513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111004695|NCT05947513|Analgesics|analgesics|mesh-ancestor
111004696|NCT05947513|Sensory System Agents|sensory system agents|mesh-ancestor
111004697|NCT05947513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111004698|NCT05947513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111004699|NCT05947513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111004700|NCT05947513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111004701|NCT05947513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111004702|NCT05947513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111004703|NCT05947513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111004704|NCT05947500|Avelumab|avelumab|mesh-list
111004705|NCT05947500|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111004706|NCT05947500|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111004707|NCT05947500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111004708|NCT05947500|Immunologic Factors|immunologic factors|mesh-ancestor
111004709|NCT05947500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111004710|NCT05947461|Diclofenac|diclofenac|mesh-list
111004711|NCT05947461|Indomethacin|indomethacin|mesh-list
110799532|NCT05320107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111004712|NCT05947461|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111004713|NCT05947461|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111004714|NCT05947461|Analgesics|analgesics|mesh-ancestor
111004715|NCT05947461|Sensory System Agents|sensory system agents|mesh-ancestor
111004716|NCT05947461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111004717|NCT05947461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111004718|NCT05947461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111004719|NCT05947461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111004720|NCT05947461|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111004721|NCT05947461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111004722|NCT05947461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111004723|NCT05947461|Gout Suppressants|gout suppressants|mesh-ancestor
111004724|NCT05947461|Tocolytic Agents|tocolytic agents|mesh-ancestor
111004725|NCT05947461|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111004726|NCT05947383|Psilocybin|psilocybin|mesh-list
111004727|NCT05947383|Hallucinogens|hallucinogens|mesh-ancestor
111004728|NCT05947383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111004729|NCT05947383|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111004730|NCT05947162|Nicotine|nicotine|mesh-list
111004731|NCT05947162|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111004732|NCT05947162|Autonomic Agents|autonomic agents|mesh-ancestor
111004733|NCT05947162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111004734|NCT05947162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111004735|NCT05947162|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111004736|NCT05947162|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111004737|NCT05947162|Cholinergic Agents|cholinergic agents|mesh-ancestor
111004738|NCT05947162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111004739|NCT05947162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111004740|NCT05947071|Vaccines|vaccines|mesh-list
111004741|NCT05947071|Immunologic Factors|immunologic factors|mesh-ancestor
111004742|NCT05947071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111004743|NCT05944445|Linezolid|linezolid|mesh-list
111004744|NCT05944445|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111004745|NCT05944445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111004746|NCT05944445|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111004747|NCT05944445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111004748|NCT05944445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111004749|NCT05944055|Vitamin D|vitamin d|mesh-list
111004750|NCT05944055|Vitamins|vitamins|mesh-ancestor
111004751|NCT05944055|Micronutrients|micronutrients|mesh-ancestor
111004752|NCT05944055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111004753|NCT05944055|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111004754|NCT05941858|Nicotine|nicotine|mesh-list
111004755|NCT05941858|Carbon Monoxide|carbon monoxide|mesh-list
111004756|NCT05941858|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111004757|NCT05941858|Autonomic Agents|autonomic agents|mesh-ancestor
110469765|NCT05658861|Caseins|caseins|mesh-list
111004758|NCT05941858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111004759|NCT05941858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111004760|NCT05941858|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111004761|NCT05941858|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111004762|NCT05941858|Cholinergic Agents|cholinergic agents|mesh-ancestor
111004763|NCT05941858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111004764|NCT05941858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111004765|NCT05941858|Antimetabolites|antimetabolites|mesh-ancestor
111004766|NCT05941858|Gasotransmitters|gasotransmitters|mesh-ancestor
111004767|NCT05937854|Tadalafil|tadalafil|mesh-list
111004768|NCT05937854|Vasodilator Agents|vasodilator agents|mesh-ancestor
111004769|NCT05937854|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111004770|NCT05937854|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111004771|NCT05937854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111004772|NCT05937854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111004773|NCT05937854|Urological Agents|urological agents|mesh-ancestor
111004774|NCT05933057|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
111004775|NCT05933057|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111004776|NCT05933057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111004777|NCT05933057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111004778|NCT05925049|Natalizumab|natalizumab|mesh-list
111004779|NCT05925049|Immunologic Factors|immunologic factors|mesh-ancestor
111004780|NCT05925049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111004781|NCT05906459|Antibodies|antibodies|mesh-list
111004782|NCT05906459|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
111004783|NCT05906459|Immunologic Factors|immunologic factors|mesh-ancestor
111004784|NCT05906459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111004785|NCT05895747|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
111004786|NCT05895747|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111004787|NCT05895747|Antidepressive Agents|antidepressive agents|mesh-ancestor
111004788|NCT05895747|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111004789|NCT05862168|Paclitaxel|paclitaxel|mesh-list
111004790|NCT05862168|Fluorouracil|fluorouracil|mesh-list
111004791|NCT05862168|Tislelizumab|tislelizumab|mesh-list
111004792|NCT05862168|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111004793|NCT05862168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111004794|NCT05862168|Tubulin Modulators|tubulin modulators|mesh-ancestor
111004795|NCT05862168|Antimitotic Agents|antimitotic agents|mesh-ancestor
111004796|NCT05862168|Mitosis Modulators|mitosis modulators|mesh-ancestor
111004797|NCT05862168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111004798|NCT05862168|Antimetabolites|antimetabolites|mesh-ancestor
111004799|NCT05862168|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111004800|NCT05862168|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111004801|NCT05862168|Immunologic Factors|immunologic factors|mesh-ancestor
111004802|NCT05862168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111004803|NCT05862168|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111004804|NCT05855876|Ketamine|ketamine|mesh-list
111004805|NCT05855876|Analgesics|analgesics|mesh-ancestor
111004806|NCT05855876|Sensory System Agents|sensory system agents|mesh-ancestor
111004807|NCT05855876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111004808|NCT05855876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111004809|NCT05855876|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111004810|NCT05855876|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111004811|NCT05855876|Anesthetics, General|anesthetics, general|mesh-ancestor
111004812|NCT05855876|Anesthetics|anesthetics|mesh-ancestor
111004813|NCT05855876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111004814|NCT05855876|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111004815|NCT05855876|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111004816|NCT05855876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111004817|NCT05855876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111004818|NCT05838287|Pioglitazone|pioglitazone|mesh-list
111004819|NCT05838287|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111004826|NCT05825066|Gemcitabine|gemcitabine|mesh-list
110620758|NCT00935805|Natriuretic Agents|natriuretic agents|mesh-ancestor
111004827|NCT05825066|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111004828|NCT05825066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111004829|NCT05825066|Tubulin Modulators|tubulin modulators|mesh-ancestor
111004830|NCT05825066|Antimitotic Agents|antimitotic agents|mesh-ancestor
111004831|NCT05825066|Mitosis Modulators|mitosis modulators|mesh-ancestor
111004832|NCT05825066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111004833|NCT05825066|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111004834|NCT05825066|Antimetabolites|antimetabolites|mesh-ancestor
111004835|NCT05808010|Hydrotalcite|hydrotalcite|mesh-list
111004836|NCT05808010|Antacids|antacids|mesh-ancestor
111004837|NCT05808010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111004839|NCT05799378|Hydroxychloroquine|hydroxychloroquine|mesh-list
111004840|NCT05799378|Antimalarials|antimalarials|mesh-ancestor
111004841|NCT05799378|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111004842|NCT05799378|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111004843|NCT05799378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111004844|NCT05799378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111004845|NCT05799378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111004846|NCT05799378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111004847|NCT05794958|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
111004848|NCT05794958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111004849|NCT05794958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111004850|NCT05756777|Ivosidenib|ivosidenib|mesh-list
111004851|NCT05756777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111004852|NCT05756777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111004853|NCT05756777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111004854|NCT05754203|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
111004855|NCT05754203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111004856|NCT05754203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111004857|NCT05754203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111004858|NCT05748665|Etomidate|etomidate|mesh-list
111004859|NCT05748665|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111004860|NCT05748665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111004861|NCT05748665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111004862|NCT05748665|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111004863|NCT05748665|Anesthetics, General|anesthetics, general|mesh-ancestor
111004864|NCT05748665|Anesthetics|anesthetics|mesh-ancestor
111004865|NCT05724329|Dasatinib|dasatinib|mesh-list
111004866|NCT05724329|Tislelizumab|tislelizumab|mesh-list
111004867|NCT05724329|Quercetin|quercetin|mesh-list
111004868|NCT05724329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111004869|NCT05724329|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111004870|NCT05724329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111004871|NCT05724329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111004872|NCT05724329|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111004873|NCT05724329|Antioxidants|antioxidants|mesh-ancestor
111004874|NCT05724329|Protective Agents|protective agents|mesh-ancestor
111004875|NCT05724329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111004876|NCT05718466|Bevacizumab|bevacizumab|mesh-list
111004877|NCT05718466|Carboplatin|carboplatin|mesh-list
111004878|NCT05718466|Irinotecan|irinotecan|mesh-list
111004879|NCT05718466|Etoposide|etoposide|mesh-list
111004880|NCT05718466|Temozolomide|temozolomide|mesh-list
111004881|NCT05718466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111004882|NCT05718466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111004883|NCT05718466|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111004884|NCT05718466|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111004885|NCT05718466|Growth Substances|growth substances|mesh-ancestor
111004886|NCT05718466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111004887|NCT05718466|Growth Inhibitors|growth inhibitors|mesh-ancestor
111004888|NCT05718466|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111004889|NCT05718466|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111004890|NCT05718466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111004891|NCT05718466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111004892|NCT05718466|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111004893|NCT05718466|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111004894|NCT05718466|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111004895|NCT05718466|Alkylating Agents|alkylating agents|mesh-ancestor
111004897|NCT05680129|Dulaglutide|dulaglutide|mesh-list
111004898|NCT05680129|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111004899|NCT05680129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111004900|NCT05640934|Melatonin|melatonin|mesh-list
111004901|NCT05640934|Antioxidants|antioxidants|mesh-ancestor
111004902|NCT05640934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111004903|NCT05640934|Protective Agents|protective agents|mesh-ancestor
111004904|NCT05640934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111004905|NCT05640934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111004906|NCT05508009|Cyclophosphamide|cyclophosphamide|mesh-list
111004907|NCT05508009|Melphalan|melphalan|mesh-list
111004908|NCT05508009|Rituximab|rituximab|mesh-list
111004909|NCT05508009|Fludarabine|fludarabine|mesh-list
111004910|NCT05508009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111004911|NCT05508009|Immunologic Factors|immunologic factors|mesh-ancestor
111004912|NCT05508009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111004914|NCT05508009|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111004915|NCT05508009|Alkylating Agents|alkylating agents|mesh-ancestor
111004916|NCT05508009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111004917|NCT05508009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111004918|NCT05508009|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111004919|NCT05508009|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111004920|NCT05498272|Olaparib|olaparib|mesh-list
111004921|NCT05498272|Leuprolide|leuprolide|mesh-list
111004922|NCT05498272|Goserelin|goserelin|mesh-list
111004923|NCT05498272|Triptorelin Pamoate|triptorelin pamoate|mesh-list
111004924|NCT05498272|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111004925|NCT05498272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111004926|NCT05498272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111004927|NCT05498272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111004928|NCT05498272|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111004929|NCT05498272|Fertility Agents|fertility agents|mesh-ancestor
111004930|NCT05498272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111004931|NCT05498272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111004932|NCT05498272|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111004933|NCT05498272|Luteolytic Agents|luteolytic agents|mesh-ancestor
111004934|NCT05498272|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111004935|NCT05498272|Contraceptive Agents|contraceptive agents|mesh-ancestor
111004936|NCT05498272|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111004937|NCT05459298|Vitamin D|vitamin d|mesh-list
111004938|NCT05459298|Cholecalciferol|cholecalciferol|mesh-list
111004939|NCT05459298|Vitamins|vitamins|mesh-ancestor
111004940|NCT05459298|Micronutrients|micronutrients|mesh-ancestor
111004941|NCT05459298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111004942|NCT05459298|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111004943|NCT05459298|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111004944|NCT05400577|Sotorasib|sotorasib|mesh-list
111004945|NCT05400577|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111004946|NCT05400577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111004947|NCT05400577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111004948|NCT05400577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111004949|NCT05288777|Capecitabine|capecitabine|mesh-list
111004950|NCT05288777|Trastuzumab|trastuzumab|mesh-list
111004951|NCT05288777|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
111004952|NCT05288777|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111004953|NCT05288777|Antimetabolites|antimetabolites|mesh-ancestor
111004954|NCT05288777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111004955|NCT05288777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111004956|NCT05288777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110620781|NCT01055431|Iron|iron|mesh-list
111004957|NCT05288777|Tubulin Modulators|tubulin modulators|mesh-ancestor
111004958|NCT05288777|Antimitotic Agents|antimitotic agents|mesh-ancestor
111004959|NCT05288777|Mitosis Modulators|mitosis modulators|mesh-ancestor
111004960|NCT05288777|Immunotoxins|immunotoxins|mesh-ancestor
111004961|NCT05288777|Immunoconjugates|immunoconjugates|mesh-ancestor
111004962|NCT05288777|Immunologic Factors|immunologic factors|mesh-ancestor
111004963|NCT05288777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111004964|NCT05269381|Cyclophosphamide|cyclophosphamide|mesh-list
111004965|NCT05269381|Pembrolizumab|pembrolizumab|mesh-list
111004966|NCT05269381|Sargramostim|sargramostim|mesh-list
111004967|NCT05269381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111004968|NCT05269381|Immunologic Factors|immunologic factors|mesh-ancestor
111004969|NCT05269381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111004970|NCT05269381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111004971|NCT05269381|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111004972|NCT05269381|Alkylating Agents|alkylating agents|mesh-ancestor
111004973|NCT05269381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111004974|NCT05269381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111004975|NCT05269381|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111004976|NCT05269381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111004977|NCT05269381|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111004979|NCT05261269|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111004980|NCT05261269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111004981|NCT05261269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111004982|NCT05261269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111004983|NCT05194397|Niacinamide|niacinamide|mesh-list
111004984|NCT05194397|Niacin|niacin|mesh-list
111004985|NCT05194397|Nicotinic Acids|nicotinic acids|mesh-list
111004986|NCT05194397|Vitamin B Complex|vitamin b complex|mesh-ancestor
111004987|NCT05194397|Vitamins|vitamins|mesh-ancestor
111004988|NCT05194397|Micronutrients|micronutrients|mesh-ancestor
111004989|NCT05194397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111004990|NCT05194397|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111004991|NCT05194397|Antimetabolites|antimetabolites|mesh-ancestor
111004992|NCT05194397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111004993|NCT05194397|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111004994|NCT05194397|Vasodilator Agents|vasodilator agents|mesh-ancestor
111004995|NCT05156281|Teriflunomide|teriflunomide|mesh-list
111004996|NCT05156281|Remibrutinib|remibrutinib|mesh-list
111004997|NCT05156281|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111004998|NCT05156281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111004999|NCT05156281|Analgesics|analgesics|mesh-ancestor
111005000|NCT05156281|Sensory System Agents|sensory system agents|mesh-ancestor
111005001|NCT05156281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111005002|NCT05156281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111005003|NCT05156281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111005004|NCT05156281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111005005|NCT05156281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111005006|NCT05156281|Immunologic Factors|immunologic factors|mesh-ancestor
111005007|NCT05156281|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111005008|NCT05156281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111005009|NCT05156281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111005010|NCT05153174|Sulforaphane|sulforaphane|mesh-list
111005011|NCT05153174|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
111005012|NCT05153174|Protective Agents|protective agents|mesh-ancestor
111005013|NCT05153174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111005014|NCT05153174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111005015|NCT05101746|Nitric Oxide|nitric oxide|mesh-list
111005016|NCT05101746|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111005017|NCT05101746|Autonomic Agents|autonomic agents|mesh-ancestor
111005018|NCT05101746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111005019|NCT05101746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110153881|NCT00001083|Ritonavir|ritonavir|mesh-list
111005020|NCT05101746|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111005021|NCT05101746|Respiratory System Agents|respiratory system agents|mesh-ancestor
111005022|NCT05101746|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111005023|NCT05101746|Antioxidants|antioxidants|mesh-ancestor
111005024|NCT05101746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111005025|NCT05101746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111005026|NCT05101746|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
111005027|NCT05101746|Vasodilator Agents|vasodilator agents|mesh-ancestor
111005028|NCT05101746|Gasotransmitters|gasotransmitters|mesh-ancestor
111005029|NCT05101746|Protective Agents|protective agents|mesh-ancestor
111005030|NCT05098210|Poly I-C|poly i-c|mesh-list
111005031|NCT05098210|Nivolumab|nivolumab|mesh-list
111005032|NCT05098210|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
111005033|NCT05098210|Poly ICLC|poly iclc|mesh-list
111005034|NCT05098210|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111005035|NCT05098210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111005036|NCT05098210|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111005037|NCT05098210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111005038|NCT05098210|Interferon Inducers|interferon inducers|mesh-ancestor
111005039|NCT05098210|Immunologic Factors|immunologic factors|mesh-ancestor
111005040|NCT05098210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111005041|NCT05098210|Laxatives|laxatives|mesh-ancestor
111005042|NCT05098210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111005043|NCT05098210|Antiviral Agents|antiviral agents|mesh-ancestor
111005044|NCT05098210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111005045|NCT04951492|Olaparib|olaparib|mesh-list
111005046|NCT04951492|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
111005047|NCT04951492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111005048|NCT04951492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111005049|NCT04951492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111005051|NCT04938453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111005052|NCT04938453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111005053|NCT04938453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111005054|NCT04938453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111005055|NCT04926818|Ofatumumab|ofatumumab|mesh-list
111005056|NCT04926818|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111005057|NCT04926818|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
111005058|NCT04926818|Siponimod|siponimod|mesh-list
111005059|NCT04926818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111005060|NCT04926818|Immunologic Factors|immunologic factors|mesh-ancestor
111005061|NCT04926818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111005062|NCT04926818|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
110025286|NCT00361686|Tramadol|tramadol|mesh-list
111005063|NCT04926818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111005064|NCT04926818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111005065|NCT04887285|Anesthetics|anesthetics|mesh-list
111005066|NCT04887285|Anesthetics, Local|anesthetics, local|mesh-list
111005067|NCT04887285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111005068|NCT04887285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111005069|NCT04887285|Sensory System Agents|sensory system agents|mesh-ancestor
111005070|NCT04887285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111005071|NCT04778982|Fulvestrant|fulvestrant|mesh-list
111005072|NCT04778982|Palbociclib|palbociclib|mesh-list
111005073|NCT04778982|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111005074|NCT04778982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111005075|NCT04778982|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
111005076|NCT04778982|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111005077|NCT04778982|Hormone Antagonists|hormone antagonists|mesh-ancestor
111005078|NCT04778982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111005079|NCT04778982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111005080|NCT04778982|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111005081|NCT04778982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111005082|NCT04778982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111005083|NCT04772781|Ibuprofen|ibuprofen|mesh-list
111005084|NCT04772781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111005085|NCT04772781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111005086|NCT04772781|Analgesics|analgesics|mesh-ancestor
111005087|NCT04772781|Sensory System Agents|sensory system agents|mesh-ancestor
111005088|NCT04772781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111005089|NCT04772781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111005090|NCT04772781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111005091|NCT04772781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111005092|NCT04772781|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111005093|NCT04772781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111005094|NCT04772781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111005095|NCT04699591|Domperidone|domperidone|mesh-list
111005096|NCT04699591|Antiemetics|antiemetics|mesh-ancestor
111005097|NCT04699591|Autonomic Agents|autonomic agents|mesh-ancestor
111005098|NCT04699591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111005099|NCT04699591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111005100|NCT04699591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111005101|NCT04699591|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111005102|NCT04699591|Dopamine Agents|dopamine agents|mesh-ancestor
111005103|NCT04699591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111005104|NCT04699591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111005105|NCT04679948|Midazolam|midazolam|mesh-list
111005106|NCT04679948|Caffeine|caffeine|mesh-list
111005107|NCT04679948|Omeprazole|omeprazole|mesh-list
111005108|NCT04679948|Warfarin|warfarin|mesh-list
111005109|NCT04679948|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111005110|NCT04679948|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111005111|NCT04679948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111005112|NCT04679948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111005113|NCT04679948|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111005114|NCT04679948|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111005115|NCT04679948|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111005116|NCT04679948|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111005117|NCT04679948|Anesthetics, General|anesthetics, general|mesh-ancestor
111005118|NCT04679948|Anesthetics|anesthetics|mesh-ancestor
111005119|NCT04679948|GABA Modulators|gaba modulators|mesh-ancestor
111005121|NCT04679948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111005122|NCT04679948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111005123|NCT04679948|Anticoagulants|anticoagulants|mesh-ancestor
111005124|NCT04679948|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111005125|NCT04679948|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111005126|NCT04679948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111005127|NCT04679948|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
111005128|NCT04679948|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111005129|NCT04679948|Purinergic Agents|purinergic agents|mesh-ancestor
111005130|NCT04679948|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111005131|NCT04679948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111005132|NCT04679948|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111005133|NCT04647435|Tramadol|tramadol|mesh-list
111005134|NCT04647435|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111005135|NCT04647435|Narcotics|narcotics|mesh-ancestor
111005136|NCT04647435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111005137|NCT04647435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111005138|NCT04647435|Analgesics|analgesics|mesh-ancestor
111005139|NCT04647435|Sensory System Agents|sensory system agents|mesh-ancestor
111005140|NCT04647435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111005141|NCT04637529|Ibuprofen|ibuprofen|mesh-list
111005142|NCT04637529|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111005143|NCT04637529|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111005144|NCT04637529|Analgesics|analgesics|mesh-ancestor
111005145|NCT04637529|Sensory System Agents|sensory system agents|mesh-ancestor
111005146|NCT04637529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111005147|NCT04637529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111005148|NCT04637529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111005149|NCT04637529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111005150|NCT04637529|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111005151|NCT04637529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111005152|NCT04637529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111005153|NCT04625803|Apatinib|apatinib|mesh-list
111005154|NCT04625803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111005155|NCT04625803|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111005156|NCT04625803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110799533|NCT05320107|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111005157|NCT04625803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111005158|NCT04621526|Dexmedetomidine|dexmedetomidine|mesh-list
111005159|NCT04621526|Ketamine|ketamine|mesh-list
111005160|NCT04621526|Propofol|propofol|mesh-list
111005161|NCT04621526|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111005162|NCT04621526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111005163|NCT04621526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111005164|NCT04621526|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111005165|NCT04621526|Analgesics|analgesics|mesh-ancestor
111005166|NCT04621526|Sensory System Agents|sensory system agents|mesh-ancestor
111005167|NCT04621526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111005168|NCT04621526|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111005169|NCT04621526|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111005170|NCT04621526|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111005171|NCT04621526|Adrenergic Agents|adrenergic agents|mesh-ancestor
111005172|NCT04621526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111005173|NCT04621526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111005174|NCT04621526|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111005175|NCT04621526|Anesthetics, General|anesthetics, general|mesh-ancestor
111005176|NCT04621526|Anesthetics|anesthetics|mesh-ancestor
111005177|NCT04621526|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111005178|NCT04621526|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111005179|NCT04621526|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111005180|NCT04620759|Psilocybin|psilocybin|mesh-list
111005181|NCT04620759|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
111005182|NCT04620759|Hallucinogens|hallucinogens|mesh-ancestor
111005183|NCT04620759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111005184|NCT04620759|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111005185|NCT04620759|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111005186|NCT04620759|Serotonin Agents|serotonin agents|mesh-ancestor
111005187|NCT04620759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111005188|NCT04620759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111005189|NCT04620759|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111005190|NCT04544189|Fulvestrant|fulvestrant|mesh-list
111005191|NCT04544189|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111005192|NCT04544189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110722188|NCT03847792|Anesthetics|anesthetics|mesh-ancestor
111005193|NCT04544189|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
111005194|NCT04544189|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111005195|NCT04544189|Hormone Antagonists|hormone antagonists|mesh-ancestor
111005196|NCT04544189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111005197|NCT04544189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111005199|NCT04491084|Flt3 ligand protein|flt3 ligand protein|mesh-list
111005200|NCT04491084|Immunologic Factors|immunologic factors|mesh-ancestor
111005201|NCT04491084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111005202|NCT04491084|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111005203|NCT04491084|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111005204|NCT04491084|Protective Agents|protective agents|mesh-ancestor
111005205|NCT04446117|Prednisone|prednisone|mesh-list
111005206|NCT04446117|Atezolizumab|atezolizumab|mesh-list
111005207|NCT04446117|Abiraterone Acetate|abiraterone acetate|mesh-list
111005208|NCT04446117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111005209|NCT04446117|Glucocorticoids|glucocorticoids|mesh-ancestor
111005210|NCT04446117|Hormones|hormones|mesh-ancestor
111005211|NCT04446117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111005212|NCT04446117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111005213|NCT04446117|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111005214|NCT04446117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111005215|NCT04446117|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111005216|NCT04446117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111005217|NCT04446117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111005218|NCT04446117|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111005219|NCT04446117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111005220|NCT04446117|Hormone Antagonists|hormone antagonists|mesh-ancestor
111005221|NCT04446117|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111005222|NCT04397003|Durvalumab|durvalumab|mesh-list
111005223|NCT04397003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111005224|NCT04397003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111005225|NCT04329065|Paclitaxel|paclitaxel|mesh-list
111005226|NCT04329065|Trastuzumab|trastuzumab|mesh-list
111005227|NCT04329065|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111005228|NCT04329065|Pertuzumab|pertuzumab|mesh-list
111005229|NCT04329065|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
111005230|NCT04329065|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111005231|NCT04329065|Vaccines|vaccines|mesh-list
111005232|NCT04329065|Antibodies|antibodies|mesh-list
111005233|NCT04329065|Immunoglobulins|immunoglobulins|mesh-list
111005234|NCT04329065|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111005235|NCT04329065|Immunoglobulin G|immunoglobulin g|mesh-list
111005236|NCT04329065|Immunologic Factors|immunologic factors|mesh-ancestor
111005237|NCT04329065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111005238|NCT04329065|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111005239|NCT04329065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111005240|NCT04329065|Tubulin Modulators|tubulin modulators|mesh-ancestor
111005241|NCT04329065|Antimitotic Agents|antimitotic agents|mesh-ancestor
111005242|NCT04329065|Mitosis Modulators|mitosis modulators|mesh-ancestor
111005243|NCT04329065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111005244|NCT04326257|Nivolumab|nivolumab|mesh-list
111005245|NCT04326257|Ipilimumab|ipilimumab|mesh-list
111005246|NCT04326257|Relatlimab|relatlimab|mesh-list
111005247|NCT04326257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111005248|NCT04326257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111005249|NCT04326257|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111005250|NCT04326257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111005251|NCT04147260|Ciprofloxacin|ciprofloxacin|mesh-list
111005252|NCT04147260|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111005253|NCT04147260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111005254|NCT04147260|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111005255|NCT04147260|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111005256|NCT04147260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111005257|NCT04147260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111005258|NCT04147260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111005259|NCT04147260|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111005260|NCT04147260|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111005261|NCT04114136|Metformin|metformin|mesh-list
111005262|NCT04114136|Rosiglitazone|rosiglitazone|mesh-list
111005263|NCT04114136|Pembrolizumab|pembrolizumab|mesh-list
111005264|NCT04114136|Nivolumab|nivolumab|mesh-list
111005265|NCT04114136|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111005266|NCT04114136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111005267|NCT04114136|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111005268|NCT04114136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111005269|NCT04114136|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111005270|NCT04114136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111005271|NCT04112043|Niacinamide|niacinamide|mesh-list
111005273|NCT04112043|Nicotinic Acids|nicotinic acids|mesh-list
111005274|NCT04112043|Vitamin B Complex|vitamin b complex|mesh-ancestor
111005275|NCT04112043|Vitamins|vitamins|mesh-ancestor
111005276|NCT04112043|Micronutrients|micronutrients|mesh-ancestor
111005277|NCT04112043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111005278|NCT04112043|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111005279|NCT04112043|Antimetabolites|antimetabolites|mesh-ancestor
111005280|NCT04112043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111005281|NCT04112043|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111005282|NCT04112043|Vasodilator Agents|vasodilator agents|mesh-ancestor
111005283|NCT03997968|Rituximab|rituximab|mesh-list
111005284|NCT03997968|Gemcitabine|gemcitabine|mesh-list
111005285|NCT03997968|Capecitabine|capecitabine|mesh-list
111005286|NCT03997968|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
111005287|NCT03997968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111005288|NCT03997968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111005289|NCT03997968|Immunologic Factors|immunologic factors|mesh-ancestor
111005290|NCT03997968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111005291|NCT03997968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111005292|NCT03997968|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111005293|NCT03997968|Antimetabolites|antimetabolites|mesh-ancestor
111005294|NCT03997968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111005295|NCT03997968|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111005296|NCT03997968|Alkylating Agents|alkylating agents|mesh-ancestor
111005297|NCT03995706|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
111005298|NCT03995706|Immunoconjugates|immunoconjugates|mesh-ancestor
111005299|NCT03995706|Immunologic Factors|immunologic factors|mesh-ancestor
111005300|NCT03995706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111005301|NCT03984097|Dexamethasone|dexamethasone|mesh-list
111005302|NCT03984097|Lenalidomide|lenalidomide|mesh-list
111005303|NCT03984097|Bortezomib|bortezomib|mesh-list
111005304|NCT03984097|Pomalidomide|pomalidomide|mesh-list
111005305|NCT03984097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111005306|NCT03984097|Antiemetics|antiemetics|mesh-ancestor
111005307|NCT03984097|Autonomic Agents|autonomic agents|mesh-ancestor
111005308|NCT03984097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111005309|NCT03984097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111005310|NCT03984097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111005311|NCT03984097|Glucocorticoids|glucocorticoids|mesh-ancestor
111005312|NCT03984097|Hormones|hormones|mesh-ancestor
111005313|NCT03984097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111005314|NCT03984097|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111005315|NCT03984097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111005316|NCT03984097|Immunologic Factors|immunologic factors|mesh-ancestor
111005317|NCT03984097|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111005318|NCT03984097|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111005319|NCT03984097|Growth Substances|growth substances|mesh-ancestor
111005320|NCT03984097|Growth Inhibitors|growth inhibitors|mesh-ancestor
111005321|NCT03887377|Botulinum Toxins|botulinum toxins|mesh-list
111005322|NCT03887377|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111005323|NCT03887377|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111005324|NCT03887377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111005325|NCT03887377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111005326|NCT03887377|Cholinergic Agents|cholinergic agents|mesh-ancestor
111005327|NCT03887377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111005328|NCT03887377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111005329|NCT03833154|Durvalumab|durvalumab|mesh-list
111005330|NCT03833154|Osimertinib|osimertinib|mesh-list
111005331|NCT03833154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111005332|NCT03833154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111005333|NCT03833154|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111005334|NCT03833154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111005335|NCT03833154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111005336|NCT03780894|Tranexamic Acid|tranexamic acid|mesh-list
111005337|NCT03780894|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111005338|NCT03780894|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111005339|NCT03780894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111005340|NCT03780894|Hemostatics|hemostatics|mesh-ancestor
111005341|NCT03780894|Coagulants|coagulants|mesh-ancestor
110722340|NCT01189864|Analgesics|analgesics|mesh-ancestor
111005342|NCT03741478|Insulin|insulin|mesh-list
111005343|NCT03741478|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111005344|NCT03741478|Insulin Lispro|insulin lispro|mesh-list
111005345|NCT03741478|Olanzapine|olanzapine|mesh-list
111005346|NCT03741478|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111005347|NCT03741478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111005348|NCT03741478|Antiemetics|antiemetics|mesh-ancestor
111005349|NCT03741478|Autonomic Agents|autonomic agents|mesh-ancestor
111005350|NCT03741478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111005351|NCT03741478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111005352|NCT03741478|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111005353|NCT03741478|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111005354|NCT03741478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111005355|NCT03741478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111005356|NCT03741478|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111005357|NCT03741478|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111005358|NCT03741478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111005359|NCT03741478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111005360|NCT03741478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111005361|NCT03741478|Serotonin Agents|serotonin agents|mesh-ancestor
111005362|NCT03669367|Abatacept|abatacept|mesh-list
111005363|NCT03669367|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111005364|NCT03669367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111005365|NCT03669367|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111005366|NCT03669367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111005367|NCT03669367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111005368|NCT03669367|Immunologic Factors|immunologic factors|mesh-ancestor
111005369|NCT03669367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111005370|NCT03669367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111005371|NCT03650114|Ofatumumab|ofatumumab|mesh-list
111005372|NCT03650114|Vaccines|vaccines|mesh-list
111005373|NCT03650114|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
111005374|NCT03650114|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
111005375|NCT03650114|Immunologic Factors|immunologic factors|mesh-ancestor
111005376|NCT03650114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111005377|NCT03650114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111005378|NCT03650114|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111005379|NCT03630081|Ciprofloxacin|ciprofloxacin|mesh-list
111005380|NCT03630081|Meropenem|meropenem|mesh-list
111005381|NCT03630081|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111005382|NCT03630081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111005383|NCT03630081|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111005384|NCT03630081|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111005385|NCT03630081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111005386|NCT03630081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111005387|NCT03630081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111005388|NCT03630081|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111005389|NCT03630081|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111005390|NCT03522688|Dexmedetomidine|dexmedetomidine|mesh-list
111005391|NCT03522688|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111005392|NCT03522688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111005393|NCT03522688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111005394|NCT03522688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111005395|NCT03522688|Analgesics|analgesics|mesh-ancestor
111005396|NCT03522688|Sensory System Agents|sensory system agents|mesh-ancestor
111005397|NCT03522688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111005398|NCT03522688|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111005399|NCT03522688|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111005400|NCT03522688|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111005401|NCT03522688|Adrenergic Agents|adrenergic agents|mesh-ancestor
111005402|NCT03522688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111005403|NCT03522688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111005404|NCT03511118|Metformin|metformin|mesh-list
111005405|NCT03511118|Topiramate|topiramate|mesh-list
111005406|NCT03511118|Azithromycin|azithromycin|mesh-list
111005407|NCT03511118|Doxycycline|doxycycline|mesh-list
111005408|NCT03511118|Ciprofloxacin|ciprofloxacin|mesh-list
111005409|NCT03511118|Levofloxacin|levofloxacin|mesh-list
111005410|NCT03511118|Clindamycin|clindamycin|mesh-list
111005411|NCT03511118|Valganciclovir|valganciclovir|mesh-list
111005412|NCT03511118|Remdesivir|remdesivir|mesh-list
111005413|NCT03511118|Hydroxyurea|hydroxyurea|mesh-list
111005414|NCT03511118|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
111005415|NCT03511118|Verapamil|verapamil|mesh-list
111005416|NCT03511118|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
111005417|NCT03511118|Labetalol|labetalol|mesh-list
111005418|NCT03511118|Nifedipine|nifedipine|mesh-list
111005419|NCT03511118|Furosemide|furosemide|mesh-list
111005420|NCT03511118|Sumatriptan|sumatriptan|mesh-list
111005421|NCT03511118|Oxycodone|oxycodone|mesh-list
111005422|NCT03511118|Gabapentin|gabapentin|mesh-list
111005423|NCT03511118|Ondansetron|ondansetron|mesh-list
111005424|NCT03511118|Fluvoxamine|fluvoxamine|mesh-list
111005425|NCT03511118|Trazodone|trazodone|mesh-list
111005426|NCT03511118|Cyclobenzaprine|cyclobenzaprine|mesh-list
111005427|NCT03511118|Methylphenidate|methylphenidate|mesh-list
111005428|NCT03511118|Citalopram|citalopram|mesh-list
111005429|NCT03511118|Sertraline|sertraline|mesh-list
111005430|NCT03511118|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
111005431|NCT03511118|Tranexamic Acid|tranexamic acid|mesh-list
111005432|NCT03511118|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111005433|NCT03511118|Escitalopram|escitalopram|mesh-list
111005434|NCT03511118|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111005435|NCT03511118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111005436|NCT03511118|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110620908|NCT03988075|Hydrocodone|hydrocodone|mesh-list
111005437|NCT03511118|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111005438|NCT03511118|Antimetabolites|antimetabolites|mesh-ancestor
111005439|NCT03511118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111005440|NCT03511118|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111005441|NCT03511118|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111005442|NCT03511118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111005443|NCT03511118|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111005444|NCT03511118|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111005445|NCT03511118|Hemostatics|hemostatics|mesh-ancestor
111005446|NCT03511118|Coagulants|coagulants|mesh-ancestor
111005447|NCT03511118|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111005448|NCT03511118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111005449|NCT03511118|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111005450|NCT03511118|Narcotics|narcotics|mesh-ancestor
111005451|NCT03511118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111005452|NCT03511118|Analgesics|analgesics|mesh-ancestor
111005453|NCT03511118|Sensory System Agents|sensory system agents|mesh-ancestor
111005454|NCT03511118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111005455|NCT03511118|Anticonvulsants|anticonvulsants|mesh-ancestor
111005456|NCT03511118|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111005457|NCT03511118|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111005458|NCT03511118|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111005459|NCT03511118|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111005460|NCT03511118|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111005461|NCT03511118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111005462|NCT03511118|Antimanic Agents|antimanic agents|mesh-ancestor
111005463|NCT03511118|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111005464|NCT03511118|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111005465|NCT03511118|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111005466|NCT03511118|Serotonin Agents|serotonin agents|mesh-ancestor
111005467|NCT03511118|Autonomic Agents|autonomic agents|mesh-ancestor
111005468|NCT03511118|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111005469|NCT03511118|Antidepressive Agents|antidepressive agents|mesh-ancestor
111005470|NCT03511118|Antiemetics|antiemetics|mesh-ancestor
111005471|NCT03511118|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111005472|NCT03511118|Antipruritics|antipruritics|mesh-ancestor
111005473|NCT03511118|Dermatologic Agents|dermatologic agents|mesh-ancestor
111005474|NCT03511118|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111005475|NCT03511118|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111005476|NCT03511118|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111005477|NCT03511118|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111005478|NCT03511118|Dopamine Agents|dopamine agents|mesh-ancestor
111005479|NCT03511118|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111005480|NCT03511118|Diuretics|diuretics|mesh-ancestor
111005481|NCT03511118|Natriuretic Agents|natriuretic agents|mesh-ancestor
111005482|NCT03511118|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
111005483|NCT03511118|Antimalarials|antimalarials|mesh-ancestor
111005484|NCT03511118|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111005485|NCT03511118|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111005486|NCT03511118|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111005487|NCT03511118|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111005488|NCT03511118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111005489|NCT03511118|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111005490|NCT03511118|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111005491|NCT03511118|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111005492|NCT03511118|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
111005493|NCT03511118|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111005494|NCT03511118|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111005495|NCT03511118|Antisickling Agents|antisickling agents|mesh-ancestor
111005496|NCT03511118|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111005497|NCT03511118|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111005498|NCT03511118|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111005499|NCT03511118|Vasodilator Agents|vasodilator agents|mesh-ancestor
111005501|NCT03511118|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111005502|NCT03511118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111005503|NCT03511118|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111005504|NCT03511118|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111005505|NCT03511118|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111005506|NCT03511118|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111005507|NCT03511118|Antiviral Agents|antiviral agents|mesh-ancestor
111005508|NCT03511118|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111005509|NCT03511118|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111005510|NCT03511118|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111005511|NCT03511118|Adrenergic Agents|adrenergic agents|mesh-ancestor
111005512|NCT03511118|Sympathomimetics|sympathomimetics|mesh-ancestor
111005513|NCT03511118|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111005514|NCT03511118|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111005515|NCT03511118|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
111005516|NCT03511118|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
111005517|NCT03511118|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111005518|NCT03493919|Vaccines|vaccines|mesh-list
111005519|NCT03493919|Immunologic Factors|immunologic factors|mesh-ancestor
111005520|NCT03493919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111005521|NCT03396575|Cyclophosphamide|cyclophosphamide|mesh-list
111005522|NCT03396575|Fludarabine|fludarabine|mesh-list
111005523|NCT03396575|Vaccines|vaccines|mesh-list
111005524|NCT03396575|Immunologic Factors|immunologic factors|mesh-ancestor
111005525|NCT03396575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111005526|NCT03396575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111005527|NCT03396575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111005528|NCT03396575|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111005529|NCT03396575|Alkylating Agents|alkylating agents|mesh-ancestor
111005530|NCT03396575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111005531|NCT03396575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111005532|NCT03396575|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111005533|NCT03340506|Trametinib|trametinib|mesh-list
111005534|NCT03340506|Dabrafenib|dabrafenib|mesh-list
111005535|NCT03340506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111005536|NCT03340506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111005537|NCT03340506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111005538|NCT03340506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111005539|NCT03326128|Bupropion|bupropion|mesh-list
111005540|NCT03326128|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111005541|NCT03326128|Antidepressive Agents|antidepressive agents|mesh-ancestor
111005542|NCT03326128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111005543|NCT03326128|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111005544|NCT03326128|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111005545|NCT03326128|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111005546|NCT03326128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111005547|NCT03326128|Dopamine Agents|dopamine agents|mesh-ancestor
111005548|NCT03326128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111005549|NCT03326128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111005550|NCT03326128|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111005551|NCT03326128|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111005552|NCT03326128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111005553|NCT03277924|Doxorubicin|doxorubicin|mesh-list
111005554|NCT03277924|Nivolumab|nivolumab|mesh-list
111005555|NCT03277924|Methotrexate|methotrexate|mesh-list
111005556|NCT03277924|Sunitinib|sunitinib|mesh-list
111005557|NCT03277924|Epirubicin|epirubicin|mesh-list
111005558|NCT03277924|Ifosfamide|ifosfamide|mesh-list
111005559|NCT03277924|Dacarbazine|dacarbazine|mesh-list
111005560|NCT03277924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111005561|NCT03277924|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111005562|NCT03277924|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111005563|NCT03277924|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111005564|NCT03277924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111005565|NCT03277924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111005566|NCT03277924|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111005567|NCT03277924|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111005568|NCT03277924|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111005569|NCT03277924|Abortifacient Agents|abortifacient agents|mesh-ancestor
111005570|NCT03277924|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111005571|NCT03277924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111005572|NCT03277924|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111005574|NCT03277924|Dermatologic Agents|dermatologic agents|mesh-ancestor
111005575|NCT03277924|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111005576|NCT03277924|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111005577|NCT03277924|Immunologic Factors|immunologic factors|mesh-ancestor
111005578|NCT03277924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111005579|NCT03277924|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111005580|NCT03277924|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111005581|NCT03277924|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111005582|NCT03277924|Growth Substances|growth substances|mesh-ancestor
111005583|NCT03277924|Growth Inhibitors|growth inhibitors|mesh-ancestor
111005584|NCT03277924|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111005585|NCT03277924|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111005586|NCT03277924|Alkylating Agents|alkylating agents|mesh-ancestor
111005587|NCT03176134|Tedizolid|tedizolid|mesh-list
111005588|NCT03176134|Tedizolid phosphate|tedizolid phosphate|mesh-list
111005589|NCT03176134|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111005590|NCT03176134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111005591|NCT03152786|Propranolol|propranolol|mesh-list
111005592|NCT03152786|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111005593|NCT03152786|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111005594|NCT03152786|Adrenergic Agents|adrenergic agents|mesh-ancestor
111005595|NCT03152786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111005596|NCT03152786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111005597|NCT03152786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111005598|NCT03152786|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111005599|NCT03152786|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111005600|NCT03152786|Vasodilator Agents|vasodilator agents|mesh-ancestor
111005601|NCT03004443|Infliximab|infliximab|mesh-list
111005602|NCT03004443|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111005603|NCT03004443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111005604|NCT03004443|Dermatologic Agents|dermatologic agents|mesh-ancestor
111005605|NCT03004443|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111005606|NCT03004443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111005607|NCT02996773|Cyclophosphamide|cyclophosphamide|mesh-list
111005608|NCT02996773|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
111005609|NCT02996773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111005610|NCT02996773|Immunologic Factors|immunologic factors|mesh-ancestor
111005611|NCT02996773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111005612|NCT02996773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111005613|NCT02996773|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111005614|NCT02996773|Alkylating Agents|alkylating agents|mesh-ancestor
111005615|NCT02996773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111005616|NCT02996773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111005617|NCT02996773|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111005618|NCT02538484|Letrozole|letrozole|mesh-list
111005619|NCT02538484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111005620|NCT02538484|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111005621|NCT02538484|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111005622|NCT02538484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111005623|NCT02538484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111005624|NCT02538484|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111005625|NCT02538484|Hormone Antagonists|hormone antagonists|mesh-ancestor
111005626|NCT02538484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111005627|NCT02538484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111005628|NCT02484391|Thioctic Acid|thioctic acid|mesh-list
111005629|NCT02484391|Cytarabine|cytarabine|mesh-list
111005630|NCT02484391|Mitoxantrone|mitoxantrone|mesh-list
111005631|NCT02484391|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111005632|NCT02484391|Antimetabolites|antimetabolites|mesh-ancestor
111005633|NCT02484391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111005634|NCT02484391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111005635|NCT02484391|Antiviral Agents|antiviral agents|mesh-ancestor
111005636|NCT02484391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111005637|NCT02484391|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111005638|NCT02484391|Immunologic Factors|immunologic factors|mesh-ancestor
111005639|NCT02484391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111005640|NCT02484391|Analgesics|analgesics|mesh-ancestor
111005641|NCT02484391|Sensory System Agents|sensory system agents|mesh-ancestor
111005642|NCT02484391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111005643|NCT02484391|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111005644|NCT02484391|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111005645|NCT02484391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111005646|NCT02484391|Antioxidants|antioxidants|mesh-ancestor
111005647|NCT02484391|Protective Agents|protective agents|mesh-ancestor
111005648|NCT02484391|Vitamin B Complex|vitamin b complex|mesh-ancestor
111005649|NCT02484391|Vitamins|vitamins|mesh-ancestor
111005650|NCT02484391|Micronutrients|micronutrients|mesh-ancestor
111005651|NCT02478320|Ilorasertib|ilorasertib|mesh-list
111005652|NCT02478320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111005653|NCT02478320|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111005654|NCT02478320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111005655|NCT02478320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111005656|NCT02311998|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
111005657|NCT02311998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111005658|NCT02311998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111005659|NCT02311998|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111005660|NCT02311998|Immunotoxins|immunotoxins|mesh-ancestor
111005661|NCT02311998|Immunoconjugates|immunoconjugates|mesh-ancestor
111005662|NCT02311998|Immunologic Factors|immunologic factors|mesh-ancestor
111005663|NCT02311998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111005664|NCT02252042|Docetaxel|docetaxel|mesh-list
111005665|NCT02252042|Pembrolizumab|pembrolizumab|mesh-list
111005666|NCT02252042|Methotrexate|methotrexate|mesh-list
111005667|NCT02252042|Cetuximab|cetuximab|mesh-list
111005668|NCT02252042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111005669|NCT02252042|Tubulin Modulators|tubulin modulators|mesh-ancestor
111005670|NCT02252042|Antimitotic Agents|antimitotic agents|mesh-ancestor
111005671|NCT02252042|Mitosis Modulators|mitosis modulators|mesh-ancestor
111005672|NCT02252042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111005673|NCT02252042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111005674|NCT02252042|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111005675|NCT02252042|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111005676|NCT02252042|Abortifacient Agents|abortifacient agents|mesh-ancestor
111005677|NCT02252042|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111005678|NCT02252042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111005679|NCT02252042|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111005680|NCT02252042|Antimetabolites|antimetabolites|mesh-ancestor
111005681|NCT02252042|Dermatologic Agents|dermatologic agents|mesh-ancestor
111005682|NCT02252042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111005683|NCT02252042|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111005684|NCT02252042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111005685|NCT02252042|Immunologic Factors|immunologic factors|mesh-ancestor
111005686|NCT02252042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111005687|NCT02252042|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111005688|NCT02248597|Mycophenolic Acid|mycophenolic acid|mesh-list
111005689|NCT02248597|Cyclophosphamide|cyclophosphamide|mesh-list
111005690|NCT02248597|Busulfan|busulfan|mesh-list
111005691|NCT02248597|Fludarabine|fludarabine|mesh-list
111005692|NCT02248597|Fludarabine phosphate|fludarabine phosphate|mesh-list
111005693|NCT02248597|Tacrolimus|tacrolimus|mesh-list
111005694|NCT02248597|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111005695|NCT02248597|Immunologic Factors|immunologic factors|mesh-ancestor
111005696|NCT02248597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111005697|NCT02248597|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111005698|NCT02248597|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111005699|NCT02248597|Alkylating Agents|alkylating agents|mesh-ancestor
111005700|NCT02248597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111005701|NCT02248597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111005702|NCT02248597|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111005703|NCT02248597|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111005704|NCT02248597|Antimetabolites|antimetabolites|mesh-ancestor
111005705|NCT02248597|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111005706|NCT02248597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111005707|NCT02248597|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111005708|NCT02248597|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111005709|NCT02248597|Antitubercular Agents|antitubercular agents|mesh-ancestor
111005710|NCT02248597|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111005711|NCT02248597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111005712|NCT02157324|Acalabrutinib|acalabrutinib|mesh-list
111005713|NCT02157324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111005714|NCT02099058|Nivolumab|nivolumab|mesh-list
111005715|NCT02099058|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111005716|NCT02099058|Osimertinib|osimertinib|mesh-list
111005717|NCT02099058|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111005718|NCT02099058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111005719|NCT02099058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111005720|NCT02099058|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111005721|NCT02099058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111005722|NCT02099058|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111005723|NCT02099058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111005724|NCT02099058|Immunologic Factors|immunologic factors|mesh-ancestor
111005725|NCT02099058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111005726|NCT01900847|Ketamine|ketamine|mesh-list
111005727|NCT01900847|Morphine|morphine|mesh-list
111005728|NCT01900847|Analgesics|analgesics|mesh-ancestor
111005729|NCT01900847|Sensory System Agents|sensory system agents|mesh-ancestor
111005730|NCT01900847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111005731|NCT01900847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111005732|NCT01900847|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111005733|NCT01900847|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111005734|NCT01900847|Anesthetics, General|anesthetics, general|mesh-ancestor
111005735|NCT01900847|Anesthetics|anesthetics|mesh-ancestor
111005736|NCT01900847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111005737|NCT01900847|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111005738|NCT01900847|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111005739|NCT01900847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111005740|NCT01900847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111005741|NCT01900847|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111005742|NCT01900847|Narcotics|narcotics|mesh-ancestor
111005743|NCT01710007|Atorvastatin|atorvastatin|mesh-list
111005744|NCT01710007|Pitavastatin|pitavastatin|mesh-list
111005745|NCT01710007|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111005746|NCT01710007|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111005747|NCT01710007|Antimetabolites|antimetabolites|mesh-ancestor
111005748|NCT01710007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111005749|NCT01710007|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111005750|NCT01710007|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111005751|NCT01710007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111005752|NCT01357772|Tamoxifen|tamoxifen|mesh-list
111005753|NCT01357772|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111005754|NCT01357772|Hormone Antagonists|hormone antagonists|mesh-ancestor
111005755|NCT01357772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111005756|NCT01357772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111005757|NCT01357772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111005758|NCT01357772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111005759|NCT01357772|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111005760|NCT01357772|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111005761|NCT01357772|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111005762|NCT00378482|Tremelimumab|tremelimumab|mesh-list
111005763|NCT00378482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111005764|NCT05813860|Infliximab|infliximab|mesh-list
111005765|NCT05813860|Azathioprine|azathioprine|mesh-list
111005766|NCT05813860|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111005767|NCT05813860|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111005768|NCT05813860|Dermatologic Agents|dermatologic agents|mesh-ancestor
111005769|NCT05813860|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111005770|NCT05813860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111005771|NCT05813860|Antimetabolites|antimetabolites|mesh-ancestor
111005772|NCT05813860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111005773|NCT05813860|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111005774|NCT05813860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111005775|NCT05813860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111005776|NCT05813860|Immunologic Factors|immunologic factors|mesh-ancestor
111005777|NCT05813860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111005778|NCT05795517|Ezetimibe|ezetimibe|mesh-list
111005779|NCT05795517|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111005780|NCT05795517|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111005781|NCT05795517|Antimetabolites|antimetabolites|mesh-ancestor
111005782|NCT05795517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111005783|NCT05795517|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111005784|NCT05788276|Dapagliflozin|dapagliflozin|mesh-list
111005785|NCT05788276|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111005786|NCT05788276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111005787|NCT05788276|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111005788|NCT05788276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111005789|NCT05759572|Apatinib|apatinib|mesh-list
111005790|NCT05759572|Fulvestrant|fulvestrant|mesh-list
111005791|NCT05759572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111005792|NCT05759572|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111005793|NCT05759572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111005794|NCT05759572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111005795|NCT05759572|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111005796|NCT05759572|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
111005797|NCT05759572|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111005798|NCT05759572|Hormone Antagonists|hormone antagonists|mesh-ancestor
111005799|NCT05759572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111005800|NCT05759572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111005802|NCT05738694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111005803|NCT05738694|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111005804|NCT05738694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111005805|NCT05738694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111005806|NCT05737199|Pembrolizumab|pembrolizumab|mesh-list
111005807|NCT05737199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111005808|NCT05737199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111005809|NCT05737199|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111005810|NCT05737199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111005811|NCT05731986|Glycoprotein, Klebsiella pneumoniae|glycoprotein, klebsiella pneumoniae|mesh-list
111005812|NCT05731986|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111005813|NCT05731986|Immunologic Factors|immunologic factors|mesh-ancestor
111005814|NCT05731986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111005815|NCT05725499|Glycoprotein, Klebsiella pneumoniae|glycoprotein, klebsiella pneumoniae|mesh-list
111005816|NCT05725499|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111005817|NCT05725499|Immunologic Factors|immunologic factors|mesh-ancestor
111005818|NCT05725499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111005819|NCT05708521|Hydromorphone|hydromorphone|mesh-list
111005820|NCT05708521|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111005821|NCT05708521|Narcotics|narcotics|mesh-ancestor
111005822|NCT05708521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111005823|NCT05708521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111005824|NCT05708521|Analgesics|analgesics|mesh-ancestor
111005825|NCT05708521|Sensory System Agents|sensory system agents|mesh-ancestor
111005826|NCT05708521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111005827|NCT05707234|Midazolam|midazolam|mesh-list
111005828|NCT05707234|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111005829|NCT05707234|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111005830|NCT05707234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111005831|NCT05707234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111005832|NCT05707234|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111005833|NCT05707234|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111005834|NCT05707234|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111005835|NCT05707234|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111005836|NCT05707234|Anesthetics, General|anesthetics, general|mesh-ancestor
111005837|NCT05707234|Anesthetics|anesthetics|mesh-ancestor
111005838|NCT05707234|GABA Modulators|gaba modulators|mesh-ancestor
111005839|NCT05707234|GABA Agents|gaba agents|mesh-ancestor
111005840|NCT05707234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111005841|NCT05707234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111005842|NCT05702359|Vitamin D|vitamin d|mesh-list
111005843|NCT05702359|Ergocalciferols|ergocalciferols|mesh-list
111005844|NCT05702359|Cholecalciferol|cholecalciferol|mesh-list
111005845|NCT05702359|Vitamins|vitamins|mesh-list
111005846|NCT05702359|Micronutrients|micronutrients|mesh-ancestor
111005847|NCT05702359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111005848|NCT05702359|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111005849|NCT05702359|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111005850|NCT05702073|Insulin Glargine|insulin glargine|mesh-list
111005851|NCT05702073|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111005852|NCT05702073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111005853|NCT05690282|Acetaminophen|acetaminophen|mesh-list
111005854|NCT05690282|Ibuprofen|ibuprofen|mesh-list
111005855|NCT05690282|Gabapentin|gabapentin|mesh-list
111005856|NCT05690282|Bupivacaine|bupivacaine|mesh-list
111005857|NCT05690282|Anesthetics, Local|anesthetics, local|mesh-ancestor
111005858|NCT05690282|Anesthetics|anesthetics|mesh-ancestor
111005859|NCT05690282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111005860|NCT05690282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111005861|NCT05690282|Sensory System Agents|sensory system agents|mesh-ancestor
111005862|NCT05690282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111005863|NCT05690282|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111005864|NCT05690282|Analgesics|analgesics|mesh-ancestor
111005865|NCT05690282|Antipyretics|antipyretics|mesh-ancestor
111005866|NCT05690282|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111005867|NCT05690282|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111005868|NCT05690282|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111005869|NCT05690282|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111005870|NCT05690282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111005871|NCT05690282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111005872|NCT05690282|Anticonvulsants|anticonvulsants|mesh-ancestor
111005873|NCT05690282|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111005874|NCT05690282|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111005875|NCT05690282|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111005876|NCT05690282|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111005877|NCT05690282|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111005878|NCT05690282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111005879|NCT05690282|Antimanic Agents|antimanic agents|mesh-ancestor
111005880|NCT05677334|Insulin|insulin|mesh-list
111005881|NCT05677334|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111005882|NCT05677334|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111005883|NCT05677334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111005884|NCT05676645|Lumefantrine|lumefantrine|mesh-list
111005885|NCT05676645|Artemether|artemether|mesh-list
111005886|NCT05676645|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
111005887|NCT05676645|Antimalarials|antimalarials|mesh-ancestor
111005888|NCT05676645|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111005889|NCT05676645|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111005890|NCT05676645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111005891|NCT05591651|Hyaluronic Acid|hyaluronic acid|mesh-list
111005892|NCT05591651|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111005893|NCT05591651|Immunologic Factors|immunologic factors|mesh-ancestor
111005894|NCT05591651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111005895|NCT05591651|Viscosupplements|viscosupplements|mesh-ancestor
111005896|NCT05591651|Protective Agents|protective agents|mesh-ancestor
111005897|NCT05574504|Avelumab|avelumab|mesh-list
111005898|NCT05574504|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
111005899|NCT05574504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111005900|NCT05574504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111005901|NCT05574504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111005902|NCT05570409|Mycophenolic Acid|mycophenolic acid|mesh-list
111005903|NCT05570409|Prednisolone|prednisolone|mesh-list
111005904|NCT05570409|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111005905|NCT05570409|Methylprednisolone|methylprednisolone|mesh-list
111005906|NCT05570409|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111005907|NCT05570409|Prednisolone acetate|prednisolone acetate|mesh-list
111005908|NCT05570409|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111005909|NCT05570409|Prednisolone phosphate|prednisolone phosphate|mesh-list
111005910|NCT05570409|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111005911|NCT05570409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111005912|NCT05570409|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111005913|NCT05570409|Antitubercular Agents|antitubercular agents|mesh-ancestor
111005914|NCT05570409|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111005915|NCT05570409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111005916|NCT05570409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111005917|NCT05570409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111005918|NCT05570409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111005919|NCT05570409|Glucocorticoids|glucocorticoids|mesh-ancestor
111005920|NCT05570409|Hormones|hormones|mesh-ancestor
111005921|NCT05570409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111005922|NCT05570409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111005923|NCT05570409|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111005924|NCT05570409|Antiemetics|antiemetics|mesh-ancestor
111005925|NCT05570409|Autonomic Agents|autonomic agents|mesh-ancestor
111005926|NCT05570409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111005927|NCT05570409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111005928|NCT05570409|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111005929|NCT05570409|Protective Agents|protective agents|mesh-ancestor
111005930|NCT05545670|Allopurinol|allopurinol|mesh-list
111005931|NCT05545670|Antimetabolites|antimetabolites|mesh-ancestor
111005932|NCT05545670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111005933|NCT05545670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111005934|NCT05545670|Gout Suppressants|gout suppressants|mesh-ancestor
111005935|NCT05545670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111005936|NCT05545670|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111005937|NCT05545670|Antioxidants|antioxidants|mesh-ancestor
111005938|NCT05545670|Protective Agents|protective agents|mesh-ancestor
111005939|NCT05545670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111005940|NCT05514106|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
111005941|NCT05514106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111005942|NCT05514106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111005943|NCT05514106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111005944|NCT05514106|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111005945|NCT05487794|Methyltestosterone|methyltestosterone|mesh-list
111005946|NCT05487794|Testosterone|testosterone|mesh-list
111005947|NCT05487794|Testosterone undecanoate|testosterone undecanoate|mesh-list
111005948|NCT05487794|Testosterone enanthate|testosterone enanthate|mesh-list
111005949|NCT05487794|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
111005951|NCT05487794|Hormones|hormones|mesh-ancestor
111005952|NCT05487794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111005953|NCT05487794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111005954|NCT05487794|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111005955|NCT05487794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111005956|NCT05487794|Anabolic Agents|anabolic agents|mesh-ancestor
111005957|NCT05481528|Moxifloxacin|moxifloxacin|mesh-list
111005958|NCT05481528|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111005959|NCT05481528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111005960|NCT05481528|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111005961|NCT05481528|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111005962|NCT05481528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111005963|NCT05481528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111005964|NCT05481528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111005965|NCT05461131|Azithromycin|azithromycin|mesh-list
111005966|NCT05461131|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111005967|NCT05461131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111005968|NCT05458674|Trastuzumab|trastuzumab|mesh-list
111005969|NCT05458674|Tucatinib|tucatinib|mesh-list
111005970|NCT05458674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111005971|NCT05458674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111005972|NCT05458674|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111005973|NCT05458674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111005974|NCT05458674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111005975|NCT05429489|Morphine|morphine|mesh-list
111005976|NCT05429489|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111005977|NCT05429489|Narcotics|narcotics|mesh-ancestor
111005978|NCT05429489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111005979|NCT05429489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111005980|NCT05429489|Analgesics|analgesics|mesh-ancestor
111005981|NCT05429489|Sensory System Agents|sensory system agents|mesh-ancestor
111005982|NCT05429489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111005983|NCT05413863|Insulin|insulin|mesh-list
111005984|NCT05413863|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111005985|NCT05413863|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111005986|NCT05413863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111005987|NCT05412914|Propofol|propofol|mesh-list
111005988|NCT05412914|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111005989|NCT05412914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111005990|NCT05412914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111005991|NCT05412914|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111005992|NCT05412914|Anesthetics, General|anesthetics, general|mesh-ancestor
111005993|NCT05412914|Anesthetics|anesthetics|mesh-ancestor
111005994|NCT05374499|Epinephrine|epinephrine|mesh-list
111005995|NCT05374499|Bupivacaine|bupivacaine|mesh-list
111005996|NCT05374499|Anesthetics, Local|anesthetics, local|mesh-ancestor
111005997|NCT05374499|Anesthetics|anesthetics|mesh-ancestor
111005998|NCT05374499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111005999|NCT05374499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111006000|NCT05374499|Sensory System Agents|sensory system agents|mesh-ancestor
111006001|NCT05374499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111006002|NCT05374499|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111006003|NCT05374499|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111006004|NCT05374499|Adrenergic Agents|adrenergic agents|mesh-ancestor
111006005|NCT05374499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111006006|NCT05374499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111006007|NCT05374499|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111006008|NCT05374499|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111006009|NCT05374499|Autonomic Agents|autonomic agents|mesh-ancestor
111006010|NCT05374499|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111006011|NCT05374499|Respiratory System Agents|respiratory system agents|mesh-ancestor
111006012|NCT05374499|Mydriatics|mydriatics|mesh-ancestor
111006013|NCT05374499|Sympathomimetics|sympathomimetics|mesh-ancestor
111006014|NCT05374499|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111006025|NCT05367492|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111006026|NCT05367492|Cholinergic Agents|cholinergic agents|mesh-ancestor
111006027|NCT05367492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111006028|NCT05367492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111006029|NCT05367492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111006030|NCT05357690|Bupivacaine|bupivacaine|mesh-list
111006031|NCT05357690|Anesthetics, Local|anesthetics, local|mesh-ancestor
111006032|NCT05357690|Anesthetics|anesthetics|mesh-ancestor
111006033|NCT05357690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111006034|NCT05357690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111006035|NCT05357690|Sensory System Agents|sensory system agents|mesh-ancestor
111006036|NCT05357690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111006037|NCT05341154|Dexmedetomidine|dexmedetomidine|mesh-list
111006038|NCT05341154|Ketamine|ketamine|mesh-list
111006039|NCT05341154|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111006040|NCT05341154|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111006041|NCT05341154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111006042|NCT05341154|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111006043|NCT05341154|Analgesics|analgesics|mesh-ancestor
111006044|NCT05341154|Sensory System Agents|sensory system agents|mesh-ancestor
111006045|NCT05341154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111006046|NCT05341154|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111006047|NCT05341154|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111006048|NCT05341154|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111006049|NCT05341154|Adrenergic Agents|adrenergic agents|mesh-ancestor
111006050|NCT05341154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111006051|NCT05341154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111006052|NCT05341154|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111006053|NCT05341154|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111006054|NCT05341154|Anesthetics, General|anesthetics, general|mesh-ancestor
111006055|NCT05341154|Anesthetics|anesthetics|mesh-ancestor
111006056|NCT05341154|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111006057|NCT05341154|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111006058|NCT05330858|Rabeprazole|rabeprazole|mesh-list
111006059|NCT05330858|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111006060|NCT05330858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111006061|NCT05330858|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111006062|NCT05330858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111006063|NCT05330858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111006064|NCT05328102|Lenalidomide|lenalidomide|mesh-list
111006065|NCT05328102|Immunologic Factors|immunologic factors|mesh-ancestor
111006066|NCT05328102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111006067|NCT05328102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111006068|NCT05328102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111006069|NCT05328102|Growth Substances|growth substances|mesh-ancestor
111006070|NCT05328102|Growth Inhibitors|growth inhibitors|mesh-ancestor
111006071|NCT05328102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111006072|NCT05317676|Palmidrol|palmidrol|mesh-list
111006073|NCT05317676|Analgesics|analgesics|mesh-ancestor
111006074|NCT05317676|Sensory System Agents|sensory system agents|mesh-ancestor
111006075|NCT05317676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111006076|NCT05317676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111006077|NCT05317676|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111006078|NCT05317676|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111006079|NCT05317676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111006080|NCT05317676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111006081|NCT05317676|Antiviral Agents|antiviral agents|mesh-ancestor
111006082|NCT05317676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111006083|NCT05317676|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
111006084|NCT05317676|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
111006085|NCT05317676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111006086|NCT05317676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111006087|NCT05317676|Hormones|hormones|mesh-ancestor
111006088|NCT05317676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111006089|NCT05312268|Rasburicase|rasburicase|mesh-list
111006090|NCT05312268|Gout Suppressants|gout suppressants|mesh-ancestor
111006091|NCT05312268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111006092|NCT05295927|Prednisone|prednisone|mesh-list
111006093|NCT05295927|Prednisolone|prednisolone|mesh-list
111006094|NCT05295927|Abiraterone Acetate|abiraterone acetate|mesh-list
111006095|NCT05295927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111006103|NCT05295927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111006104|NCT05295927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111006105|NCT05295927|Hormone Antagonists|hormone antagonists|mesh-ancestor
111006106|NCT05295927|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111006107|NCT05288673|Ravulizumab|ravulizumab|mesh-list
111006108|NCT05288673|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
111006109|NCT05288673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111006110|NCT05288673|Immunologic Factors|immunologic factors|mesh-ancestor
111006111|NCT05288673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111006112|NCT05288660|Ravulizumab|ravulizumab|mesh-list
111006113|NCT05288660|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
111006114|NCT05288660|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111006115|NCT05288660|Immunologic Factors|immunologic factors|mesh-ancestor
111006116|NCT05288660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111006117|NCT05284812|Vaccines|vaccines|mesh-list
111006118|NCT05284812|Immunologic Factors|immunologic factors|mesh-ancestor
111006119|NCT05284812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111006120|NCT05283226|Paclitaxel|paclitaxel|mesh-list
111006121|NCT05283226|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111006122|NCT05283226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111006123|NCT05283226|Tubulin Modulators|tubulin modulators|mesh-ancestor
111006124|NCT05283226|Antimitotic Agents|antimitotic agents|mesh-ancestor
111006125|NCT05283226|Mitosis Modulators|mitosis modulators|mesh-ancestor
111006126|NCT05283226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111006127|NCT05257460|Insulin|insulin|mesh-list
111006128|NCT05257460|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111006129|NCT05257460|Insulin Lispro|insulin lispro|mesh-list
111006130|NCT05257460|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111006131|NCT05257460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111006132|NCT05254626|Pioglitazone|pioglitazone|mesh-list
111006133|NCT05254626|Dapagliflozin|dapagliflozin|mesh-list
111006134|NCT05254626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111006135|NCT05254626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111006136|NCT05254626|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111006137|NCT05254626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111006138|NCT05246085|Hydrocortisone|hydrocortisone|mesh-list
111006139|NCT05246085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111006148|NCT05223335|Clopidogrel|clopidogrel|mesh-list
111006149|NCT05223335|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
111006150|NCT05223335|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111006151|NCT05223335|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111006152|NCT05223335|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111006153|NCT05223335|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111006154|NCT05223335|Purinergic Agents|purinergic agents|mesh-ancestor
111006155|NCT05223335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111006156|NCT05223335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111006157|NCT05223335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111006158|NCT05216653|Capecitabine|capecitabine|mesh-list
111006159|NCT05216653|Oxaliplatin|oxaliplatin|mesh-list
111006160|NCT05216653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111006161|NCT05216653|Antimetabolites|antimetabolites|mesh-ancestor
111006162|NCT05216653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111006163|NCT05216653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111006164|NCT05211791|Anesthetics|anesthetics|mesh-list
111006165|NCT05211791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111006166|NCT05211791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111006167|NCT05166811|Magnesium Sulfate|magnesium sulfate|mesh-list
111006168|NCT05166811|Analgesics|analgesics|mesh-ancestor
111006169|NCT05166811|Sensory System Agents|sensory system agents|mesh-ancestor
111006170|NCT05166811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111006171|NCT05166811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111006172|NCT05166811|Anesthetics|anesthetics|mesh-ancestor
111006173|NCT05166811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111006174|NCT05166811|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110621005|NCT05427266|Bupivacaine|bupivacaine|mesh-list
111006175|NCT05166811|Anticonvulsants|anticonvulsants|mesh-ancestor
111006176|NCT05166811|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111006177|NCT05166811|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111006178|NCT05166811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111006179|NCT05166811|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111006180|NCT05166811|Tocolytic Agents|tocolytic agents|mesh-ancestor
111006181|NCT05166811|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111006182|NCT05165225|Cyclophosphamide|cyclophosphamide|mesh-list
111006183|NCT05165225|Docetaxel|docetaxel|mesh-list
111006184|NCT05165225|Epirubicin|epirubicin|mesh-list
111006185|NCT05165225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111006186|NCT05165225|Immunologic Factors|immunologic factors|mesh-ancestor
111006187|NCT05165225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111006188|NCT05165225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111006189|NCT05165225|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111006190|NCT05165225|Alkylating Agents|alkylating agents|mesh-ancestor
111006191|NCT05165225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111006192|NCT05165225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111006193|NCT05165225|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111006194|NCT05165225|Tubulin Modulators|tubulin modulators|mesh-ancestor
111006195|NCT05165225|Antimitotic Agents|antimitotic agents|mesh-ancestor
111006196|NCT05165225|Mitosis Modulators|mitosis modulators|mesh-ancestor
111006197|NCT05165225|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111006198|NCT05165225|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111006199|NCT05165225|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111006200|NCT05165225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111006201|NCT05150587|Rifaximin|rifaximin|mesh-list
111006202|NCT05150587|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111006203|NCT05150587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111006204|NCT05150587|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111006205|NCT05143229|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
111006206|NCT05143229|Immunoconjugates|immunoconjugates|mesh-ancestor
111006207|NCT05143229|Immunologic Factors|immunologic factors|mesh-ancestor
111006208|NCT05143229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111006209|NCT05120596|Pembrolizumab|pembrolizumab|mesh-list
111006210|NCT05120596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111006211|NCT05120596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111006212|NCT05120596|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111006213|NCT05120596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111006214|NCT05099055|Dexmedetomidine|dexmedetomidine|mesh-list
111006215|NCT05099055|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111006216|NCT05099055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111006217|NCT05099055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111006218|NCT05099055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111006219|NCT05099055|Analgesics|analgesics|mesh-ancestor
111006220|NCT05099055|Sensory System Agents|sensory system agents|mesh-ancestor
111006221|NCT05099055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111006222|NCT05099055|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111006223|NCT05099055|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111006224|NCT05099055|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111006225|NCT05099055|Adrenergic Agents|adrenergic agents|mesh-ancestor
111006226|NCT05099055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111006227|NCT05099055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111006228|NCT05024344|Dexamethasone|dexamethasone|mesh-list
111006229|NCT05024344|Ropivacaine|ropivacaine|mesh-list
111006230|NCT05024344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111006231|NCT05024344|Antiemetics|antiemetics|mesh-ancestor
111006232|NCT05024344|Autonomic Agents|autonomic agents|mesh-ancestor
111006233|NCT05024344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111006234|NCT05024344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111006235|NCT05024344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111006236|NCT05024344|Glucocorticoids|glucocorticoids|mesh-ancestor
111006237|NCT05024344|Hormones|hormones|mesh-ancestor
111006238|NCT05024344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111006239|NCT05024344|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111006240|NCT05024344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111006241|NCT05024344|Anesthetics, Local|anesthetics, local|mesh-ancestor
111006242|NCT05024344|Anesthetics|anesthetics|mesh-ancestor
111006243|NCT05024344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111006251|NCT04997304|Respiratory System Agents|respiratory system agents|mesh-ancestor
111006252|NCT04997304|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111006253|NCT04997304|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111006254|NCT04997304|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111006255|NCT04997304|Adrenergic Agents|adrenergic agents|mesh-ancestor
111006256|NCT04997304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111006257|NCT04997304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111006259|NCT04997304|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111006260|NCT04993027|Vancomycin|vancomycin|mesh-list
111006261|NCT04993027|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111006262|NCT04993027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111006263|NCT04991324|Vitamin D|vitamin d|mesh-list
111006264|NCT04991324|Cholecalciferol|cholecalciferol|mesh-list
111006265|NCT04991324|Vitamins|vitamins|mesh-ancestor
111006266|NCT04991324|Micronutrients|micronutrients|mesh-ancestor
111006267|NCT04991324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111006268|NCT04991324|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111006269|NCT04991324|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111006270|NCT04984616|Atorvastatin|atorvastatin|mesh-list
111006271|NCT04984616|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111006272|NCT04984616|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111006273|NCT04984616|Antimetabolites|antimetabolites|mesh-ancestor
111006274|NCT04984616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111006275|NCT04984616|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111006276|NCT04984616|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111006277|NCT04984616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111006278|NCT04966481|Cetuximab|cetuximab|mesh-list
111006279|NCT04966481|Palbociclib|palbociclib|mesh-list
111006280|NCT04966481|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111006281|NCT04966481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111006282|NCT04966481|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111006283|NCT04966481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111006284|NCT04966481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111006285|NCT04957329|Latanoprost|latanoprost|mesh-list
111006286|NCT04957329|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
111006287|NCT04957329|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111006288|NCT04937881|Tenofovir|tenofovir|mesh-list
111006289|NCT04937881|Antiviral Agents|antiviral agents|mesh-ancestor
111006290|NCT04937881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111006291|NCT04937881|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111006292|NCT04937881|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111006293|NCT04937881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111006294|NCT04937881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111006295|NCT04937881|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111006296|NCT04937881|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111006304|NCT04905810|Azacitidine|azacitidine|mesh-list
111006305|NCT04905810|Decitabine|decitabine|mesh-list
111006306|NCT04905810|Venetoclax|venetoclax|mesh-list
111006307|NCT04905810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111006308|NCT04905810|Antimetabolites|antimetabolites|mesh-ancestor
111006309|NCT04905810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111006310|NCT04905810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111006311|NCT04905810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111006312|NCT04871412|Vitamin D|vitamin d|mesh-list
111006313|NCT04871412|Ergocalciferols|ergocalciferols|mesh-list
111006314|NCT04871412|Cholecalciferol|cholecalciferol|mesh-list
111006315|NCT04871412|Vitamins|vitamins|mesh-list
111006316|NCT04871412|Curcumin|curcumin|mesh-list
111006317|NCT04871412|Micronutrients|micronutrients|mesh-ancestor
111006318|NCT04871412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111006319|NCT04871412|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111006320|NCT04871412|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111006321|NCT04871412|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111006322|NCT04871412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111006323|NCT04871412|Analgesics|analgesics|mesh-ancestor
111006324|NCT04871412|Sensory System Agents|sensory system agents|mesh-ancestor
111006325|NCT04871412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111006326|NCT04871412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111006327|NCT04871412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111006328|NCT04871412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111006329|NCT04871412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111006330|NCT04871412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111006331|NCT04868877|Osimertinib|osimertinib|mesh-list
111006332|NCT04868877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111006333|NCT04868877|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111006334|NCT04868877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111006335|NCT04868877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111006336|NCT04818086|Buprenorphine|buprenorphine|mesh-list
111006337|NCT04818086|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
111006338|NCT04818086|Lemborexant|lemborexant|mesh-list
111006339|NCT04818086|Naloxone|naloxone|mesh-list
111006340|NCT04818086|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111006341|NCT04818086|Narcotics|narcotics|mesh-ancestor
111006342|NCT04818086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111006343|NCT04818086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111006344|NCT04818086|Analgesics|analgesics|mesh-ancestor
111006345|NCT04818086|Sensory System Agents|sensory system agents|mesh-ancestor
111006346|NCT04818086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111006347|NCT04818086|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111006348|NCT04818086|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
111006349|NCT04818086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111006350|NCT04818086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111006351|NCT04818086|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111006352|NCT04818086|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111006353|NCT04799431|Poly I-C|poly i-c|mesh-list
111006354|NCT04799431|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
111006355|NCT04799431|Poly ICLC|poly iclc|mesh-list
111006356|NCT04799431|Interferon Inducers|interferon inducers|mesh-ancestor
111006357|NCT04799431|Immunologic Factors|immunologic factors|mesh-ancestor
111006358|NCT04799431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111006359|NCT04799431|Laxatives|laxatives|mesh-ancestor
111006360|NCT04799431|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111006361|NCT04799431|Antiviral Agents|antiviral agents|mesh-ancestor
111006362|NCT04799431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111006363|NCT04745832|Prednisone|prednisone|mesh-list
111006364|NCT04745832|Cyclophosphamide|cyclophosphamide|mesh-list
111006365|NCT04745832|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
111006366|NCT04745832|Rituximab|rituximab|mesh-list
111006367|NCT04745832|Vincristine|vincristine|mesh-list
111006368|NCT04745832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111006369|NCT04745832|Immunologic Factors|immunologic factors|mesh-ancestor
111006370|NCT04745832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111006371|NCT04745832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111006372|NCT04745832|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111006373|NCT04745832|Alkylating Agents|alkylating agents|mesh-ancestor
111006374|NCT04745832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111006375|NCT04745832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111006376|NCT04745832|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111006377|NCT04745832|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111006378|NCT04745832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111006379|NCT04745832|Glucocorticoids|glucocorticoids|mesh-ancestor
111006380|NCT04745832|Hormones|hormones|mesh-ancestor
110621044|NCT00803868|Cholinergic Agents|cholinergic agents|mesh-ancestor
111006381|NCT04745832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111006382|NCT04745832|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111006383|NCT04745832|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111006384|NCT04745832|Tubulin Modulators|tubulin modulators|mesh-ancestor
111006385|NCT04745832|Antimitotic Agents|antimitotic agents|mesh-ancestor
111006386|NCT04745832|Mitosis Modulators|mitosis modulators|mesh-ancestor
111006387|NCT04724668|Melatonin|melatonin|mesh-list
111006388|NCT04724668|Antioxidants|antioxidants|mesh-ancestor
111006389|NCT04724668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111006390|NCT04724668|Protective Agents|protective agents|mesh-ancestor
111006391|NCT04724668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111006392|NCT04724668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111006393|NCT04685772|Methylprednisolone|methylprednisolone|mesh-list
110723385|NCT03813784|Capecitabine|capecitabine|mesh-list
111006394|NCT04685772|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111006395|NCT04685772|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111006396|NCT04685772|Prednisolone|prednisolone|mesh-list
111006397|NCT04685772|Prednisolone acetate|prednisolone acetate|mesh-list
111006398|NCT04685772|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111006399|NCT04685772|Prednisolone phosphate|prednisolone phosphate|mesh-list
111006400|NCT04685772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111006401|NCT04685772|Antiemetics|antiemetics|mesh-ancestor
111006402|NCT04685772|Autonomic Agents|autonomic agents|mesh-ancestor
111006403|NCT04685772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111006404|NCT04685772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111006405|NCT04685772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111006406|NCT04685772|Glucocorticoids|glucocorticoids|mesh-ancestor
111006408|NCT04685772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111006409|NCT04685772|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111006410|NCT04685772|Protective Agents|protective agents|mesh-ancestor
111006411|NCT04685772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111006412|NCT04685772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111006413|NCT04609189|Vitamin D|vitamin d|mesh-list
111006414|NCT04609189|Cholecalciferol|cholecalciferol|mesh-list
111006415|NCT04609189|Calcium Carbonate|calcium carbonate|mesh-list
111006416|NCT04609189|Calcium|calcium|mesh-list
111006417|NCT04609189|Vitamins|vitamins|mesh-ancestor
111006418|NCT04609189|Micronutrients|micronutrients|mesh-ancestor
111006419|NCT04609189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111006420|NCT04609189|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111006421|NCT04609189|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111006422|NCT04609189|Antacids|antacids|mesh-ancestor
111006423|NCT04609189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111006424|NCT04609189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111006425|NCT04604795|Itraconazole|itraconazole|mesh-list
111006426|NCT04604795|Antifungal Agents|antifungal agents|mesh-ancestor
111006427|NCT04604795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111006428|NCT04604795|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111006429|NCT04604795|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111006430|NCT04604795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111006431|NCT04604795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111006432|NCT04604795|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111006433|NCT04604795|Hormone Antagonists|hormone antagonists|mesh-ancestor
111006434|NCT04604795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111006435|NCT04604795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111006436|NCT04604795|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111006437|NCT04587128|Irinotecan|irinotecan|mesh-list
111006438|NCT04587128|Cetuximab|cetuximab|mesh-list
111006439|NCT04587128|Panitumumab|panitumumab|mesh-list
111006440|NCT04587128|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111006441|NCT04587128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111006442|NCT04587128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111006443|NCT04587128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111006444|NCT04587128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111006445|NCT04587128|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111006446|NCT04570150|Neostigmine|neostigmine|mesh-list
111006447|NCT04570150|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111006448|NCT04570150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111006449|NCT04570150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111006450|NCT04570150|Cholinergic Agents|cholinergic agents|mesh-ancestor
111006451|NCT04570150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111006452|NCT04570150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111006453|NCT04570150|Parasympathomimetics|parasympathomimetics|mesh-ancestor
111006454|NCT04570150|Autonomic Agents|autonomic agents|mesh-ancestor
111006455|NCT04570150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111006456|NCT04563273|Vaccines|vaccines|mesh-list
111006457|NCT04563273|BCG Vaccine|bcg vaccine|mesh-list
111006458|NCT04563273|Immunologic Factors|immunologic factors|mesh-ancestor
111006459|NCT04563273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111006460|NCT04563273|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111006461|NCT04552782|Ethanol|ethanol|mesh-list
111006462|NCT04552782|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111006463|NCT04552782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111006464|NCT04552782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111006465|NCT04552782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111006466|NCT04539977|Carboplatin|carboplatin|mesh-list
111006467|NCT04539977|Etoposide|etoposide|mesh-list
111006468|NCT04539977|Etoposide phosphate|etoposide phosphate|mesh-list
111006469|NCT04539977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111006470|NCT04539977|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111006471|NCT04539977|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111006472|NCT04539977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111006473|NCT04539977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111006474|NCT04539977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111006476|NCT04535141|Antiemetics|antiemetics|mesh-ancestor
111006477|NCT04535141|Autonomic Agents|autonomic agents|mesh-ancestor
111006478|NCT04535141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111006479|NCT04535141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111006480|NCT04535141|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111006481|NCT04535141|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111006482|NCT04535141|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111006483|NCT04535141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111006484|NCT04535141|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111006485|NCT04535141|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111006486|NCT04535141|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111006487|NCT04535141|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111006488|NCT04535141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111006489|NCT04535141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111006490|NCT04535141|Serotonin Agents|serotonin agents|mesh-ancestor
111006491|NCT04534023|Idebenone|idebenone|mesh-list
111006492|NCT04534023|Antioxidants|antioxidants|mesh-ancestor
111006493|NCT04534023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111006494|NCT04534023|Protective Agents|protective agents|mesh-ancestor
111006495|NCT04534023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111006496|NCT04510506|Pancrelipase|pancrelipase|mesh-list
111006497|NCT04510506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111006498|NCT04480918|Ketamine|ketamine|mesh-list
111006499|NCT04480918|Esketamine|esketamine|mesh-list
111006500|NCT04480918|Analgesics|analgesics|mesh-ancestor
111006501|NCT04480918|Sensory System Agents|sensory system agents|mesh-ancestor
111006502|NCT04480918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111006503|NCT04480918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111006504|NCT04480918|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111006505|NCT04480918|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111006506|NCT04480918|Anesthetics, General|anesthetics, general|mesh-ancestor
110621066|NCT01063621|Emetics|emetics|mesh-ancestor
111006507|NCT04480918|Anesthetics|anesthetics|mesh-ancestor
111006508|NCT04480918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111006509|NCT04480918|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111006510|NCT04480918|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111006511|NCT04480918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111006512|NCT04480918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111006513|NCT04480918|Antidepressive Agents|antidepressive agents|mesh-ancestor
111006514|NCT04480918|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111006515|NCT04465487|Cemiplimab|cemiplimab|mesh-list
111006516|NCT04465487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111006517|NCT04465487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111006518|NCT04374500|Verapamil|verapamil|mesh-list
111006519|NCT04374500|Nitroprusside|nitroprusside|mesh-list
111006520|NCT04374500|Acetylcholine|acetylcholine|mesh-list
111006521|NCT04374500|Vasodilator Agents|vasodilator agents|mesh-list
111006522|NCT04374500|Bradykinin|bradykinin|mesh-list
111006523|NCT04374500|Substance P|substance p|mesh-list
111006524|NCT04374500|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111006525|NCT04374500|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111006526|NCT04374500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111006527|NCT04374500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111006528|NCT04374500|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111006529|NCT04374500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111006530|NCT04374500|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111006531|NCT04374500|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
111006532|NCT04374500|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111006533|NCT04374500|Cholinergic Agents|cholinergic agents|mesh-ancestor
111006534|NCT04374500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111006535|NCT04340947|Nicotine|nicotine|mesh-list
111006536|NCT04340947|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111006537|NCT04340947|Autonomic Agents|autonomic agents|mesh-ancestor
111006538|NCT04340947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111006539|NCT04340947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111006540|NCT04340947|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111006541|NCT04340947|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111006542|NCT04340947|Cholinergic Agents|cholinergic agents|mesh-ancestor
110723538|NCT01302340|Hormones|hormones|mesh-ancestor
111006543|NCT04340947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111006544|NCT04340947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111006546|NCT04326283|Riluzole|riluzole|mesh-list
111006547|NCT04326283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111006548|NCT04326283|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111006549|NCT04326283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111006550|NCT04326283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111006551|NCT04326283|Anticonvulsants|anticonvulsants|mesh-ancestor
111006552|NCT04326283|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111006553|NCT04326283|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111006554|NCT04326283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111006555|NCT04326283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111006556|NCT04326283|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111006557|NCT04326283|Protective Agents|protective agents|mesh-ancestor
111006558|NCT04280965|Quetiapine Fumarate|quetiapine fumarate|mesh-list
111006559|NCT04280965|Antidepressive Agents|antidepressive agents|mesh-ancestor
111006560|NCT04280965|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111006561|NCT04280965|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111006562|NCT04280965|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111006563|NCT04280965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111006564|NCT04280965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111006565|NCT04266353|Resveratrol|resveratrol|mesh-list
111006566|NCT04266353|Antioxidants|antioxidants|mesh-ancestor
111006567|NCT04266353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111006568|NCT04266353|Protective Agents|protective agents|mesh-ancestor
111006569|NCT04266353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111006570|NCT04266353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111006571|NCT04266353|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111006572|NCT04231643|Dronabinol|dronabinol|mesh-list
111006573|NCT04231643|Cannabidiol|cannabidiol|mesh-list
111006574|NCT04231643|Hallucinogens|hallucinogens|mesh-ancestor
111006575|NCT04231643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111006576|NCT04231643|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111006577|NCT04231643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111006578|NCT04231643|Analgesics|analgesics|mesh-ancestor
111006579|NCT04231643|Sensory System Agents|sensory system agents|mesh-ancestor
111006580|NCT04231643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111006581|NCT04231643|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
111006582|NCT04231643|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
111006583|NCT04231643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111006584|NCT04231643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111006585|NCT04231643|Hormones|hormones|mesh-ancestor
111006586|NCT04231643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111006587|NCT04231643|Anticonvulsants|anticonvulsants|mesh-ancestor
111006588|NCT04207190|Talazoparib|talazoparib|mesh-list
111006589|NCT04207190|Gemtuzumab|gemtuzumab|mesh-list
111006590|NCT04207190|Calicheamicins|calicheamicins|mesh-list
111006591|NCT04207190|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111006592|NCT04207190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111006593|NCT04207190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111006594|NCT04207190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111006595|NCT04207190|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111006596|NCT04207190|Immunotoxins|immunotoxins|mesh-ancestor
111006597|NCT04207190|Immunoconjugates|immunoconjugates|mesh-ancestor
111006598|NCT04207190|Immunologic Factors|immunologic factors|mesh-ancestor
111006599|NCT04207190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111006600|NCT04207190|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111006601|NCT04174196|Lenalidomide|lenalidomide|mesh-list
111006602|NCT04174196|Cc-486|cc-486|mesh-list
111006603|NCT04174196|Immunologic Factors|immunologic factors|mesh-ancestor
111006604|NCT04174196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111006605|NCT04174196|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111006606|NCT04174196|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111006607|NCT04174196|Growth Substances|growth substances|mesh-ancestor
111006608|NCT04174196|Growth Inhibitors|growth inhibitors|mesh-ancestor
111006609|NCT04174196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111006610|NCT04171167|Fluticasone|fluticasone|mesh-list
111006611|NCT04171167|Xhance|xhance|mesh-list
111006612|NCT04171167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111006613|NCT04171167|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111006614|NCT04171167|Autonomic Agents|autonomic agents|mesh-ancestor
111006615|NCT04171167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111006616|NCT04171167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111006617|NCT04171167|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111006618|NCT04171167|Respiratory System Agents|respiratory system agents|mesh-ancestor
111006619|NCT04171167|Dermatologic Agents|dermatologic agents|mesh-ancestor
111006620|NCT04171167|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111006621|NCT04129060|Cholinergic Agents|cholinergic agents|mesh-list
111006622|NCT04129060|Cholinergic Antagonists|cholinergic antagonists|mesh-list
111006623|NCT04129060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111006624|NCT04129060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111006625|NCT04129060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111006626|NCT04119284|Terephthalic acid|terephthalic acid|mesh-list
111006627|NCT04119284|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111006628|NCT04119284|Antioxidants|antioxidants|mesh-ancestor
111006629|NCT04119284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111006630|NCT04119284|Protective Agents|protective agents|mesh-ancestor
111006631|NCT04119284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111006632|NCT04117763|Empagliflozin|empagliflozin|mesh-list
111006633|NCT04117763|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111006634|NCT04117763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111006635|NCT04117763|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111006636|NCT04117763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111006637|NCT04078880|Ascorbic Acid|ascorbic acid|mesh-list
111006638|NCT04078880|Antioxidants|antioxidants|mesh-ancestor
111006639|NCT04078880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111006640|NCT04078880|Protective Agents|protective agents|mesh-ancestor
111006641|NCT04078880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111006642|NCT04078880|Vitamins|vitamins|mesh-ancestor
111006643|NCT04078880|Micronutrients|micronutrients|mesh-ancestor
111006644|NCT04077437|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
111006645|NCT04077437|Hallucinogens|hallucinogens|mesh-ancestor
111006646|NCT04077437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111006647|NCT04077437|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111006648|NCT04077437|Serotonin Agents|serotonin agents|mesh-ancestor
111006649|NCT04077437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111006650|NCT04077437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111006651|NCT04077437|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111006652|NCT04077437|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111006653|NCT04077437|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111006654|NCT04077437|Adrenergic Agents|adrenergic agents|mesh-ancestor
111006655|NCT04071574|Triptorelin Pamoate|triptorelin pamoate|mesh-list
111006656|NCT04071574|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
111006657|NCT04071574|Cetrorelix|cetrorelix|mesh-list
111006658|NCT04071574|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
111006659|NCT04071574|Hormones|hormones|mesh-ancestor
111006660|NCT04071574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111006661|NCT04071574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111006662|NCT04071574|Luteolytic Agents|luteolytic agents|mesh-ancestor
111006663|NCT04071574|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111006664|NCT04071574|Contraceptive Agents|contraceptive agents|mesh-ancestor
111006665|NCT04071574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111006666|NCT04071574|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111006667|NCT04071574|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111006668|NCT04071574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111006669|NCT04071574|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111006670|NCT04071574|Fertility Agents|fertility agents|mesh-ancestor
111006671|NCT04071574|Hormone Antagonists|hormone antagonists|mesh-ancestor
111006672|NCT04023669|Cyclophosphamide|cyclophosphamide|mesh-list
111006673|NCT04023669|Gemcitabine|gemcitabine|mesh-list
111006674|NCT04023669|Lenograstim|lenograstim|mesh-list
111006675|NCT04023669|Prexasertib|prexasertib|mesh-list
111006676|NCT04023669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111006677|NCT04023669|Immunologic Factors|immunologic factors|mesh-ancestor
111006678|NCT04023669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111006679|NCT04023669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111006680|NCT04023669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111006681|NCT04023669|Alkylating Agents|alkylating agents|mesh-ancestor
111006682|NCT04023669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111006683|NCT04023669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111006684|NCT04023669|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111006685|NCT04023669|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111006686|NCT04023669|Antimetabolites|antimetabolites|mesh-ancestor
111006687|NCT04023669|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111006688|NCT04023669|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111006689|NCT04023669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111006690|NCT04002362|Triamcinolone|triamcinolone|mesh-list
111006691|NCT04002362|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
111006692|NCT04002362|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
111006693|NCT04002362|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
111006694|NCT04002362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111006695|NCT04002362|Glucocorticoids|glucocorticoids|mesh-ancestor
111006696|NCT04002362|Hormones|hormones|mesh-ancestor
111006697|NCT04002362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111006698|NCT04002362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111006699|NCT04002362|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111006700|NCT04002362|Immunologic Factors|immunologic factors|mesh-ancestor
110621102|NCT00803946|Ibuprofen|ibuprofen|mesh-list
111006701|NCT04002362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111006702|NCT04002362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111006703|NCT03982381|Metformin|metformin|mesh-list
111006704|NCT03982381|Dapagliflozin|dapagliflozin|mesh-list
111006705|NCT03982381|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111006706|NCT03982381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111006707|NCT03982381|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111006708|NCT03982381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111006709|NCT03982186|JNJ-56136379|jnj-56136379|mesh-list
111006710|NCT03982186|Antiviral Agents|antiviral agents|mesh-ancestor
111006711|NCT03982186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111006712|NCT03970252|Calcium, Dietary|calcium, dietary|mesh-list
111006713|NCT03970252|Leucovorin|leucovorin|mesh-list
111006714|NCT03970252|Folic Acid|folic acid|mesh-list
111006715|NCT03970252|Fluorouracil|fluorouracil|mesh-list
111006716|NCT03970252|Oxaliplatin|oxaliplatin|mesh-list
111006717|NCT03970252|Nivolumab|nivolumab|mesh-list
111006718|NCT03970252|Irinotecan|irinotecan|mesh-list
111006719|NCT03970252|Camptothecin|camptothecin|mesh-list
111006720|NCT03970252|Calcium|calcium|mesh-list
111006721|NCT03970252|Levoleucovorin|levoleucovorin|mesh-list
111006722|NCT03970252|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111006723|NCT03970252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111006724|NCT03970252|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111006725|NCT03970252|Antimetabolites|antimetabolites|mesh-ancestor
111006726|NCT03970252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111006727|NCT03970252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111006728|NCT03970252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111006729|NCT03970252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111006730|NCT03970252|Immunologic Factors|immunologic factors|mesh-ancestor
111006731|NCT03970252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111006732|NCT03970252|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111006733|NCT03970252|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111006734|NCT03970252|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111006735|NCT03970252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111006736|NCT03970252|Antidotes|antidotes|mesh-ancestor
111006737|NCT03970252|Protective Agents|protective agents|mesh-ancestor
111006738|NCT03970252|Vitamin B Complex|vitamin b complex|mesh-ancestor
111006739|NCT03970252|Vitamins|vitamins|mesh-ancestor
110471690|NCT02737787|Nivolumab|nivolumab|mesh-list
111006740|NCT03970252|Micronutrients|micronutrients|mesh-ancestor
111006741|NCT03970252|Hematinics|hematinics|mesh-ancestor
111006742|NCT03970252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111006743|NCT03969004|Cemiplimab|cemiplimab|mesh-list
111006744|NCT03969004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111006745|NCT03969004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111006746|NCT03932409|Paclitaxel|paclitaxel|mesh-list
111006747|NCT03932409|Carboplatin|carboplatin|mesh-list
111006748|NCT03932409|Pembrolizumab|pembrolizumab|mesh-list
111006749|NCT03932409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111006750|NCT03932409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111006751|NCT03932409|Tubulin Modulators|tubulin modulators|mesh-ancestor
111006752|NCT03932409|Antimitotic Agents|antimitotic agents|mesh-ancestor
111006753|NCT03932409|Mitosis Modulators|mitosis modulators|mesh-ancestor
111006754|NCT03932409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111006755|NCT03932409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111006756|NCT03932409|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111006757|NCT03915613|Insulin|insulin|mesh-list
111006758|NCT03915613|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111006759|NCT03915613|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111006760|NCT03915613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110621117|NCT00676130|Cephalexin|cephalexin|mesh-list
111006761|NCT03907852|Cyclophosphamide|cyclophosphamide|mesh-list
111006762|NCT03907852|Nivolumab|nivolumab|mesh-list
111006763|NCT03907852|Fludarabine|fludarabine|mesh-list
111006764|NCT03907852|Ipilimumab|ipilimumab|mesh-list
111006765|NCT03907852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111006766|NCT03907852|Immunologic Factors|immunologic factors|mesh-ancestor
111006767|NCT03907852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111006768|NCT03907852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111006769|NCT03907852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111006770|NCT03907852|Alkylating Agents|alkylating agents|mesh-ancestor
111006771|NCT03907852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111006772|NCT03907852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111006773|NCT03907852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111006774|NCT03907852|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111006775|NCT03907852|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111006777|NCT03896633|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
111006778|NCT03896633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111006779|NCT03896633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111006780|NCT03890731|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
111006781|NCT03890731|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111006782|NCT03890731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111006783|NCT03890731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111006784|NCT03872180|Venetoclax|venetoclax|mesh-list
111006785|NCT03872180|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
111006786|NCT03872180|Obinutuzumab|obinutuzumab|mesh-list
111006787|NCT03872180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111006788|NCT03872180|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111006789|NCT03872180|Alkylating Agents|alkylating agents|mesh-ancestor
111006790|NCT03872180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111006791|NCT03872180|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111006792|NCT03847649|Prednisone|prednisone|mesh-list
111006793|NCT03847649|Durvalumab|durvalumab|mesh-list
111006794|NCT03847649|Tremelimumab|tremelimumab|mesh-list
111006795|NCT03847649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111006796|NCT03847649|Glucocorticoids|glucocorticoids|mesh-ancestor
111006797|NCT03847649|Hormones|hormones|mesh-ancestor
111006798|NCT03847649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111006799|NCT03847649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111006800|NCT03847649|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111006801|NCT03847649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111006802|NCT03847649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111006803|NCT03847311|Sulfasalazine|sulfasalazine|mesh-list
111006804|NCT03847311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111006805|NCT03847311|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111006806|NCT03847311|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111006807|NCT03847311|Analgesics|analgesics|mesh-ancestor
111006808|NCT03847311|Sensory System Agents|sensory system agents|mesh-ancestor
111006809|NCT03847311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111006810|NCT03847311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111006811|NCT03847311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111006812|NCT03847311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111006813|NCT03847311|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111006814|NCT03845543|Paclitaxel|paclitaxel|mesh-list
110025287|NCT00361686|Remifentanil|remifentanil|mesh-list
111006815|NCT03845543|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111006816|NCT03845543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111006817|NCT03845543|Tubulin Modulators|tubulin modulators|mesh-ancestor
111006818|NCT03845543|Antimitotic Agents|antimitotic agents|mesh-ancestor
111006819|NCT03845543|Mitosis Modulators|mitosis modulators|mesh-ancestor
111006820|NCT03845543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111006822|NCT03827889|Fluorides, Topical|fluorides, topical|mesh-list
111006823|NCT03827889|Cariostatic Agents|cariostatic agents|mesh-ancestor
111006824|NCT03827889|Protective Agents|protective agents|mesh-ancestor
111006825|NCT03827889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111006826|NCT03826563|Melatonin|melatonin|mesh-list
111006827|NCT03826563|Antioxidants|antioxidants|mesh-ancestor
111006828|NCT03826563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111006829|NCT03826563|Protective Agents|protective agents|mesh-ancestor
111006830|NCT03826563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111006831|NCT03826563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111006832|NCT03823131|Pembrolizumab|pembrolizumab|mesh-list
111006833|NCT03823131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111006834|NCT03823131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111006835|NCT03823131|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111006836|NCT03823131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111006837|NCT03822091|Terlipressin|terlipressin|mesh-list
111006838|NCT03822091|Norepinephrine|norepinephrine|mesh-list
111006839|NCT03822091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111006840|NCT03822091|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111006841|NCT03822091|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110723833|NCT00142584|Vasodilator Agents|vasodilator agents|mesh-ancestor
111006842|NCT03822091|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111006843|NCT03822091|Adrenergic Agents|adrenergic agents|mesh-ancestor
111006844|NCT03822091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111006845|NCT03822091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111006846|NCT03822091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111006847|NCT03822091|Sympathomimetics|sympathomimetics|mesh-ancestor
111006848|NCT03822091|Autonomic Agents|autonomic agents|mesh-ancestor
111006849|NCT03822091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111006851|NCT03739619|Nivolumab|nivolumab|mesh-list
111006852|NCT03739619|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
111006853|NCT03739619|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111006854|NCT03739619|Antimetabolites|antimetabolites|mesh-ancestor
111006855|NCT03739619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111006856|NCT03739619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111006857|NCT03739619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111006858|NCT03739619|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111006859|NCT03739619|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111006860|NCT03739619|Alkylating Agents|alkylating agents|mesh-ancestor
111006861|NCT03664544|Edaravone|edaravone|mesh-list
111006862|NCT03664544|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111006863|NCT03664544|Antioxidants|antioxidants|mesh-ancestor
111006864|NCT03664544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111006865|NCT03664544|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111006866|NCT03664544|Protective Agents|protective agents|mesh-ancestor
111006867|NCT03664544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111006868|NCT03535259|Sorafenib|sorafenib|mesh-list
111006869|NCT03535259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111006870|NCT03535259|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111006871|NCT03535259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111006872|NCT03535259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111006873|NCT03521570|Nivolumab|nivolumab|mesh-list
111006874|NCT03521570|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111006875|NCT03521570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111006876|NCT03521570|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111006877|NCT03521570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111006878|NCT03484299|Gemcitabine|gemcitabine|mesh-list
111006879|NCT03484299|Folfirinox|folfirinox|mesh-list
111006880|NCT03484299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111006881|NCT03484299|Antimetabolites|antimetabolites|mesh-ancestor
111006882|NCT03484299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111006883|NCT03484299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111006884|NCT03468218|Pembrolizumab|pembrolizumab|mesh-list
111006885|NCT03468218|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111006886|NCT03468218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111006887|NCT03468218|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110621132|NCT00809874|Sequestering Agents|sequestering agents|mesh-ancestor
111006888|NCT03468218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111006889|NCT03408574|Mecamylamine|mecamylamine|mesh-list
111006890|NCT03408574|Nicotine|nicotine|mesh-list
111006891|NCT03408574|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111006892|NCT03408574|Autonomic Agents|autonomic agents|mesh-ancestor
111006893|NCT03408574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111006894|NCT03408574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111006895|NCT03408574|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111006896|NCT03408574|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111006897|NCT03408574|Cholinergic Agents|cholinergic agents|mesh-ancestor
111006898|NCT03408574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111006899|NCT03408574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111006900|NCT03408574|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111006901|NCT03408574|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
111006902|NCT03408574|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
111006903|NCT03408574|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111006904|NCT03341520|Obinutuzumab|obinutuzumab|mesh-list
111006905|NCT03341520|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111006906|NCT03341520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111006907|NCT03222570|Serotonin|serotonin|mesh-list
111006908|NCT03222570|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
111006909|NCT03222570|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111006910|NCT03222570|Serotonin Agents|serotonin agents|mesh-ancestor
111006911|NCT03222570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111006912|NCT03222570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111006913|NCT03222570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110723909|NCT01300312|Diclofenac|diclofenac|mesh-list
111006914|NCT03222570|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111006915|NCT03222570|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111006916|NCT03136328|Edotreotide|edotreotide|mesh-list
111006917|NCT03136328|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111006918|NCT03136328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111006920|NCT03072771|Etoposide|etoposide|mesh-list
111006921|NCT03072771|Melphalan|melphalan|mesh-list
111006922|NCT03072771|Carmustine|carmustine|mesh-list
111006923|NCT03072771|Blinatumomab|blinatumomab|mesh-list
111006924|NCT03072771|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111006925|NCT03072771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111006926|NCT03072771|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111006927|NCT03072771|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111006928|NCT03072771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111006929|NCT03072771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111006930|NCT03072771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111006931|NCT03072771|Antimetabolites|antimetabolites|mesh-ancestor
111006932|NCT03072771|Antiviral Agents|antiviral agents|mesh-ancestor
111006933|NCT03072771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111006934|NCT03072771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111006935|NCT03072771|Immunologic Factors|immunologic factors|mesh-ancestor
111006936|NCT03072771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111006937|NCT03072771|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111006938|NCT03072771|Alkylating Agents|alkylating agents|mesh-ancestor
111006939|NCT03072771|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111006940|NCT03067272|Contraceptive Agents|contraceptive agents|mesh-list
111006941|NCT03067272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111006942|NCT03067272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111006943|NCT02966782|Azacitidine|azacitidine|mesh-list
111006944|NCT02966782|Venetoclax|venetoclax|mesh-list
111006945|NCT02966782|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111006946|NCT02966782|Antimetabolites|antimetabolites|mesh-ancestor
111006947|NCT02966782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111006948|NCT02966782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111006949|NCT02966782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111006950|NCT02925650|Phenserine|phenserine|mesh-list
110621143|NCT02560376|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111006951|NCT02925650|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111006952|NCT02925650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111006953|NCT02925650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111006954|NCT02925650|Cholinergic Agents|cholinergic agents|mesh-ancestor
111006955|NCT02925650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111006956|NCT02925650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111006957|NCT02914938|Rituximab|rituximab|mesh-list
111006958|NCT02914938|Zanubrutinib|zanubrutinib|mesh-list
111006959|NCT02914938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111006960|NCT02914938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111006961|NCT02914938|Immunologic Factors|immunologic factors|mesh-ancestor
111006962|NCT02914938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111006963|NCT02914938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111006964|NCT02914938|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111006965|NCT02914938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111006966|NCT02914938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111006967|NCT02849457|Vigabatrin|vigabatrin|mesh-list
111006968|NCT02849457|Anticonvulsants|anticonvulsants|mesh-ancestor
111006969|NCT02849457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111006970|NCT02849457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111006971|NCT02849457|GABA Agents|gaba agents|mesh-ancestor
111006972|NCT02849457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111006973|NCT02849457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111006974|NCT02802631|Minocycline|minocycline|mesh-list
111006975|NCT02802631|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111006976|NCT02802631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111006977|NCT02757898|Biotin|biotin|mesh-list
111006978|NCT02757898|Vitamin B Complex|vitamin b complex|mesh-ancestor
111006979|NCT02757898|Vitamins|vitamins|mesh-ancestor
111006980|NCT02757898|Micronutrients|micronutrients|mesh-ancestor
111006981|NCT02757898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111006982|NCT02730546|Calcium, Dietary|calcium, dietary|mesh-list
111006983|NCT02730546|Leucovorin|leucovorin|mesh-list
111006984|NCT02730546|Folic Acid|folic acid|mesh-list
111006985|NCT02730546|Paclitaxel|paclitaxel|mesh-list
111006986|NCT02730546|Carboplatin|carboplatin|mesh-list
111006987|NCT02730546|Pembrolizumab|pembrolizumab|mesh-list
111006988|NCT02730546|Fluorouracil|fluorouracil|mesh-list
111006989|NCT02730546|Oxaliplatin|oxaliplatin|mesh-list
111006990|NCT02730546|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111006991|NCT02730546|Calcium|calcium|mesh-list
111006992|NCT02730546|Levoleucovorin|levoleucovorin|mesh-list
111006993|NCT02730546|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111006994|NCT02730546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111006995|NCT02730546|Tubulin Modulators|tubulin modulators|mesh-ancestor
111006996|NCT02730546|Antimitotic Agents|antimitotic agents|mesh-ancestor
111006997|NCT02730546|Mitosis Modulators|mitosis modulators|mesh-ancestor
111006998|NCT02730546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111006999|NCT02730546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111007000|NCT02730546|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111007001|NCT02730546|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111007002|NCT02730546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111007003|NCT02730546|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111007004|NCT02730546|Antimetabolites|antimetabolites|mesh-ancestor
111007005|NCT02730546|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111007006|NCT02730546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111007007|NCT02730546|Immunologic Factors|immunologic factors|mesh-ancestor
111007008|NCT02730546|Antidotes|antidotes|mesh-ancestor
111007009|NCT02730546|Protective Agents|protective agents|mesh-ancestor
111007010|NCT02730546|Vitamin B Complex|vitamin b complex|mesh-ancestor
111007011|NCT02730546|Vitamins|vitamins|mesh-ancestor
111007012|NCT02730546|Micronutrients|micronutrients|mesh-ancestor
111007013|NCT02730546|Hematinics|hematinics|mesh-ancestor
111007014|NCT02672098|Carboplatin|carboplatin|mesh-list
111007015|NCT02672098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111007016|NCT02649335|Propranolol|propranolol|mesh-list
111007017|NCT02649335|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111007018|NCT02649335|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111007019|NCT02649335|Adrenergic Agents|adrenergic agents|mesh-ancestor
111007020|NCT02649335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111007021|NCT02649335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111007022|NCT02649335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111007023|NCT02649335|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111007024|NCT02649335|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111007025|NCT02649335|Vasodilator Agents|vasodilator agents|mesh-ancestor
111007026|NCT02609386|Zinc|zinc|mesh-list
111007027|NCT02609386|Indomethacin|indomethacin|mesh-list
111007028|NCT02609386|Cyclophosphamide|cyclophosphamide|mesh-list
111007029|NCT02609386|Omeprazole|omeprazole|mesh-list
111007030|NCT02609386|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
111007031|NCT02609386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111007032|NCT02609386|Immunologic Factors|immunologic factors|mesh-ancestor
111007033|NCT02609386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111007034|NCT02609386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111007035|NCT02609386|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111007036|NCT02609386|Alkylating Agents|alkylating agents|mesh-ancestor
111007037|NCT02609386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111007038|NCT02609386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111007039|NCT02609386|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111007040|NCT02609386|Micronutrients|micronutrients|mesh-ancestor
111007041|NCT02609386|Trace Elements|trace elements|mesh-ancestor
111007042|NCT02609386|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111007043|NCT02609386|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111007044|NCT02609386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111007045|NCT02609386|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111007046|NCT02609386|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111007047|NCT02609386|Analgesics|analgesics|mesh-ancestor
111007048|NCT02609386|Sensory System Agents|sensory system agents|mesh-ancestor
111007049|NCT02609386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111007050|NCT02609386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111007051|NCT02609386|Gout Suppressants|gout suppressants|mesh-ancestor
111007052|NCT02609386|Tocolytic Agents|tocolytic agents|mesh-ancestor
111007053|NCT02609386|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111007054|NCT02609386|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111007055|NCT02589496|Pembrolizumab|pembrolizumab|mesh-list
111007056|NCT02589496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111007057|NCT02589496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111007058|NCT02589496|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111007059|NCT02589496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111007060|NCT02213575|Minocycline|minocycline|mesh-list
111007061|NCT02213575|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111007062|NCT02213575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111007063|NCT02148796|Broncho-Vaxom|broncho-vaxom|mesh-list
111007064|NCT02148796|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111007065|NCT02148796|Immunologic Factors|immunologic factors|mesh-ancestor
111007066|NCT02148796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111007067|NCT02133872|Minocycline|minocycline|mesh-list
111007068|NCT02133872|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111007069|NCT02133872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111007070|NCT01958593|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
111007071|NCT01958593|Hallucinogens|hallucinogens|mesh-ancestor
111007072|NCT01958593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111007073|NCT01958593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111007074|NCT01958593|Serotonin Agents|serotonin agents|mesh-ancestor
111007075|NCT01958593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111007076|NCT01958593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111007077|NCT01958593|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111007078|NCT01958593|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111007079|NCT01958593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111007080|NCT01958593|Adrenergic Agents|adrenergic agents|mesh-ancestor
111007081|NCT01820858|Paclitaxel|paclitaxel|mesh-list
111007082|NCT01820858|Carboplatin|carboplatin|mesh-list
111007083|NCT01820858|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111007084|NCT01820858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111007085|NCT01820858|Tubulin Modulators|tubulin modulators|mesh-ancestor
111007086|NCT01820858|Antimitotic Agents|antimitotic agents|mesh-ancestor
111007087|NCT01820858|Mitosis Modulators|mitosis modulators|mesh-ancestor
111007088|NCT01820858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111007089|NCT01755897|Paclitaxel|paclitaxel|mesh-list
111007090|NCT01755897|Cisplatin|cisplatin|mesh-list
111007091|NCT01755897|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111007092|NCT01755897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111007093|NCT01755897|Tubulin Modulators|tubulin modulators|mesh-ancestor
111007094|NCT01755897|Antimitotic Agents|antimitotic agents|mesh-ancestor
111007095|NCT01755897|Mitosis Modulators|mitosis modulators|mesh-ancestor
111007096|NCT01755897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111007097|NCT01738607|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
111007098|NCT01738607|Psyllium|psyllium|mesh-list
111007099|NCT01738607|Laxatives|laxatives|mesh-ancestor
111007100|NCT01738607|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111007101|NCT01738607|Cathartics|cathartics|mesh-ancestor
111007102|NCT01728259|Dexamethasone|dexamethasone|mesh-list
111007103|NCT01728259|Bortezomib|bortezomib|mesh-list
111007104|NCT01728259|Pomalidomide|pomalidomide|mesh-list
111007105|NCT01728259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111007106|NCT01728259|Antiemetics|antiemetics|mesh-ancestor
111007107|NCT01728259|Autonomic Agents|autonomic agents|mesh-ancestor
111007108|NCT01728259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111007109|NCT01728259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111007110|NCT01728259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111007111|NCT01728259|Glucocorticoids|glucocorticoids|mesh-ancestor
111007112|NCT01728259|Hormones|hormones|mesh-ancestor
111007113|NCT01728259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111007114|NCT01728259|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111007115|NCT01728259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111007116|NCT01728259|Immunologic Factors|immunologic factors|mesh-ancestor
111007117|NCT01728259|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111007118|NCT01728259|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111007119|NCT01728259|Growth Substances|growth substances|mesh-ancestor
111007120|NCT01728259|Growth Inhibitors|growth inhibitors|mesh-ancestor
111007121|NCT01722604|Brinzolamide|brinzolamide|mesh-list
111007122|NCT01722604|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
111007123|NCT01722604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111007124|NCT01722604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111007125|NCT01689740|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
111007126|NCT01689740|Hallucinogens|hallucinogens|mesh-ancestor
111007127|NCT01689740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111007128|NCT01689740|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111007129|NCT01689740|Serotonin Agents|serotonin agents|mesh-ancestor
111007130|NCT01689740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111007131|NCT01689740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111007132|NCT01689740|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111007133|NCT01689740|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111007134|NCT01689740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111007135|NCT01689740|Adrenergic Agents|adrenergic agents|mesh-ancestor
111007136|NCT01567800|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
111007137|NCT01567800|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111007138|NCT01567800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111007139|NCT01305499|Azacitidine|azacitidine|mesh-list
111007140|NCT01305499|Entinostat|entinostat|mesh-list
111007141|NCT01305499|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111007142|NCT01305499|Antimetabolites|antimetabolites|mesh-ancestor
111007143|NCT01305499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111007145|NCT01305499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111007146|NCT01305499|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111007147|NCT01202994|Flutemetamol|flutemetamol|mesh-list
111007148|NCT01202994|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111007149|NCT01202994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111007150|NCT00930943|Oxymorphone|oxymorphone|mesh-list
111007151|NCT00930943|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111007152|NCT00930943|Narcotics|narcotics|mesh-ancestor
111007153|NCT00930943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111007154|NCT00930943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111007155|NCT00930943|Analgesics|analgesics|mesh-ancestor
111007156|NCT00930943|Sensory System Agents|sensory system agents|mesh-ancestor
111007157|NCT00930943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111007158|NCT00930943|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111007159|NCT00670670|6-chloro-2-(1-piperazinyl)pyrazine|6-chloro-2-(1-piperazinyl)pyrazine|mesh-list
111007160|NCT00670670|Caseins|caseins|mesh-list
111007161|NCT00670670|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111007162|NCT00670670|Serotonin Agents|serotonin agents|mesh-ancestor
111007163|NCT00670670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111007164|NCT00670670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111007165|NCT00670670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111007166|NCT00670670|Chelating Agents|chelating agents|mesh-ancestor
111007167|NCT00670670|Sequestering Agents|sequestering agents|mesh-ancestor
111007168|NCT00670618|Fluorides|fluorides|mesh-list
111007169|NCT00670618|Cariostatic Agents|cariostatic agents|mesh-ancestor
111007170|NCT00670618|Protective Agents|protective agents|mesh-ancestor
111007171|NCT00670618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111007172|NCT00620425|Sumatriptan|sumatriptan|mesh-list
111007173|NCT00620425|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111007174|NCT00620425|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111007175|NCT00620425|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111007176|NCT00620425|Serotonin Agents|serotonin agents|mesh-ancestor
111007177|NCT00620425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111007178|NCT00620425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111007179|NCT00620425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111007180|NCT00515281|Nitric Oxide|nitric oxide|mesh-list
111007181|NCT00515281|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111007182|NCT00515281|Autonomic Agents|autonomic agents|mesh-ancestor
111007183|NCT00515281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111007184|NCT00515281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111007185|NCT00515281|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111007186|NCT00515281|Respiratory System Agents|respiratory system agents|mesh-ancestor
111007187|NCT00515281|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111007188|NCT00515281|Antioxidants|antioxidants|mesh-ancestor
111007189|NCT00515281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111007190|NCT00515281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111007191|NCT00515281|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
111007192|NCT00515281|Vasodilator Agents|vasodilator agents|mesh-ancestor
111007193|NCT00515281|Gasotransmitters|gasotransmitters|mesh-ancestor
111007194|NCT00515281|Protective Agents|protective agents|mesh-ancestor
111007195|NCT00504582|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
111007196|NCT00504582|Hemostatics|hemostatics|mesh-ancestor
111007197|NCT00504582|Coagulants|coagulants|mesh-ancestor
111007198|NCT00436254|Molgramostim|molgramostim|mesh-list
111007199|NCT00436254|Sargramostim|sargramostim|mesh-list
111007200|NCT00436254|Immunologic Factors|immunologic factors|mesh-ancestor
111007201|NCT00436254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111007202|NCT00436254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111007203|NCT00353938|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
111007204|NCT00353938|Hallucinogens|hallucinogens|mesh-ancestor
111007205|NCT00353938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111007206|NCT00353938|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111007207|NCT00353938|Serotonin Agents|serotonin agents|mesh-ancestor
111007208|NCT00353938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111007209|NCT00353938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111007210|NCT00353938|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111007211|NCT00353938|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111007212|NCT00353938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111007213|NCT00353938|Adrenergic Agents|adrenergic agents|mesh-ancestor
111007214|NCT00335114|Cyclosporine|cyclosporine|mesh-list
111007215|NCT00335114|Cyclosporins|cyclosporins|mesh-list
111007216|NCT00335114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111007217|NCT00335114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111007218|NCT00335114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111007219|NCT00335114|Immunologic Factors|immunologic factors|mesh-ancestor
111007220|NCT00335114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111007221|NCT00335114|Antifungal Agents|antifungal agents|mesh-ancestor
111007222|NCT00335114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111007223|NCT00335114|Dermatologic Agents|dermatologic agents|mesh-ancestor
111007224|NCT00335114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111007225|NCT00335114|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111007226|NCT03606577|Dexamethasone|dexamethasone|mesh-list
111007227|NCT03606577|Lenalidomide|lenalidomide|mesh-list
111007228|NCT03606577|Daratumumab|daratumumab|mesh-list
111007229|NCT03606577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111007230|NCT03606577|Antiemetics|antiemetics|mesh-ancestor
111007231|NCT03606577|Autonomic Agents|autonomic agents|mesh-ancestor
111007232|NCT03606577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111007233|NCT03606577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111007234|NCT03606577|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111007235|NCT03606577|Glucocorticoids|glucocorticoids|mesh-ancestor
111007236|NCT03606577|Hormones|hormones|mesh-ancestor
111007237|NCT03606577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111007238|NCT03606577|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111007239|NCT03606577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111007240|NCT03606577|Immunologic Factors|immunologic factors|mesh-ancestor
111007241|NCT03606577|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111007242|NCT03606577|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111007243|NCT03606577|Growth Substances|growth substances|mesh-ancestor
111007244|NCT03606577|Growth Inhibitors|growth inhibitors|mesh-ancestor
111007245|NCT03601975|Gemcitabine|gemcitabine|mesh-list
111007246|NCT03601975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111007247|NCT03601975|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111007248|NCT03601975|Antimetabolites|antimetabolites|mesh-ancestor
111007249|NCT03601975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111007250|NCT03602911|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
111007251|NCT03602911|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111007252|NCT03602911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111007253|NCT03137186|Metformin|metformin|mesh-list
111007254|NCT03137186|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111007255|NCT03137186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111007256|NCT03137030|Acetaminophen|acetaminophen|mesh-list
111007257|NCT03137030|Hydrocodone|hydrocodone|mesh-list
111007258|NCT03137030|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111007259|NCT03137030|Analgesics|analgesics|mesh-ancestor
111007260|NCT03137030|Sensory System Agents|sensory system agents|mesh-ancestor
111007261|NCT03137030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111007262|NCT03137030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111007263|NCT03137030|Antipyretics|antipyretics|mesh-ancestor
111007264|NCT03137030|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111007265|NCT03137030|Narcotics|narcotics|mesh-ancestor
111007266|NCT03137030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111007267|NCT03137030|Antitussive Agents|antitussive agents|mesh-ancestor
111007268|NCT03137030|Respiratory System Agents|respiratory system agents|mesh-ancestor
111007269|NCT03596749|Sevelamer|sevelamer|mesh-list
111007270|NCT03596749|Chelating Agents|chelating agents|mesh-ancestor
111007271|NCT03596749|Sequestering Agents|sequestering agents|mesh-ancestor
111007272|NCT03596749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111007273|NCT01595061|Cisplatin|cisplatin|mesh-list
111007274|NCT01595061|Gemcitabine|gemcitabine|mesh-list
111007275|NCT01595061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111007276|NCT01595061|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111007277|NCT01595061|Antimetabolites|antimetabolites|mesh-ancestor
111007278|NCT01595061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111007279|NCT03367143|Carboplatin|carboplatin|mesh-list
111007280|NCT03367143|Etoposide|etoposide|mesh-list
111007281|NCT03367143|Lenalidomide|lenalidomide|mesh-list
111007282|NCT03367143|Ifosfamide|ifosfamide|mesh-list
111007283|NCT03367143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110621192|NCT04836832|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111007284|NCT03367143|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111007285|NCT03367143|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111007286|NCT03367143|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111007287|NCT03367143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111007288|NCT03367143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111007289|NCT03367143|Immunologic Factors|immunologic factors|mesh-ancestor
111007290|NCT03367143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111007291|NCT03367143|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111007292|NCT03367143|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111007293|NCT03367143|Growth Substances|growth substances|mesh-ancestor
111007294|NCT03367143|Growth Inhibitors|growth inhibitors|mesh-ancestor
111007295|NCT03367143|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111007296|NCT03367143|Alkylating Agents|alkylating agents|mesh-ancestor
111007297|NCT03372681|Antidiarrheals|antidiarrheals|mesh-list
111007298|NCT03372681|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111007299|NCT04762316|Pyridoxal|pyridoxal|mesh-list
111007300|NCT04762316|Pyridoxine|pyridoxine|mesh-list
111007301|NCT04762316|Vitamin B 6|vitamin b 6|mesh-list
111007302|NCT04762316|Pyridoxal Phosphate|pyridoxal phosphate|mesh-list
111007303|NCT04762316|Vitamin B Complex|vitamin b complex|mesh-ancestor
111007304|NCT04762316|Vitamins|vitamins|mesh-ancestor
111007305|NCT04762316|Micronutrients|micronutrients|mesh-ancestor
111007306|NCT04762316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111007307|NCT03372447|Thiamine|thiamine|mesh-list
111007308|NCT03372447|Pyridoxine|pyridoxine|mesh-list
111007309|NCT03372447|Hydroxocobalamin|hydroxocobalamin|mesh-list
111007310|NCT03372447|Vitamin B 12|vitamin b 12|mesh-list
111007311|NCT03372447|Vitamin B Complex|vitamin b complex|mesh-ancestor
111007312|NCT03372447|Vitamins|vitamins|mesh-ancestor
111007313|NCT03372447|Micronutrients|micronutrients|mesh-ancestor
111007314|NCT03372447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111007315|NCT03372447|Hematinics|hematinics|mesh-ancestor
111007316|NCT03376191|Apatinib|apatinib|mesh-list
111007317|NCT03376191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111007318|NCT03376191|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111007319|NCT03376191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111007320|NCT03376191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111007321|NCT03366597|Sevoflurane|sevoflurane|mesh-list
111007322|NCT03366597|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111007323|NCT03366597|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111007324|NCT03366597|Anesthetics, General|anesthetics, general|mesh-ancestor
111007325|NCT03366597|Anesthetics|anesthetics|mesh-ancestor
111007326|NCT03366597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111007327|NCT03366597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111007328|NCT03110120|Levobupivacaine|levobupivacaine|mesh-list
111007329|NCT03110120|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111007330|NCT03110120|Anesthetics, Local|anesthetics, local|mesh-ancestor
111007331|NCT03110120|Anesthetics|anesthetics|mesh-ancestor
111007332|NCT03110120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111007333|NCT03110120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111007334|NCT03110120|Sensory System Agents|sensory system agents|mesh-ancestor
111007335|NCT03110120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111007336|NCT03109886|Maleic acid|maleic acid|mesh-list
111007337|NCT03109886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111007338|NCT03109886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111007339|NCT03110198|Hydrocortisone|hydrocortisone|mesh-list
111007340|NCT03110198|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
111007341|NCT03110198|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
111007342|NCT03110198|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
111007343|NCT03110198|Mesalamine|mesalamine|mesh-list
111007344|NCT03110198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111007345|NCT03110198|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111007346|NCT03110198|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111007347|NCT03110198|Analgesics|analgesics|mesh-ancestor
111007348|NCT03110198|Sensory System Agents|sensory system agents|mesh-ancestor
111007349|NCT03110198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111007350|NCT03110198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111007351|NCT03110198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111007352|NCT04460781|Vaccines|vaccines|mesh-list
111007353|NCT04460781|Immunologic Factors|immunologic factors|mesh-ancestor
111007354|NCT04460781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110621202|NCT00675506|Hormones|hormones|mesh-list
111007355|NCT03371589|Dexamethasone|dexamethasone|mesh-list
111007356|NCT03371589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111007357|NCT03371589|Antiemetics|antiemetics|mesh-ancestor
111007358|NCT03371589|Autonomic Agents|autonomic agents|mesh-ancestor
111007359|NCT03371589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111007360|NCT03371589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111007361|NCT03371589|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111007362|NCT03371589|Glucocorticoids|glucocorticoids|mesh-ancestor
111007363|NCT03371589|Hormones|hormones|mesh-ancestor
111007364|NCT03371589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110724358|NCT03788902|Methylphenidate|methylphenidate|mesh-list
111007365|NCT03371589|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111007366|NCT03371589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111007367|NCT03365817|Fentanyl|fentanyl|mesh-list
111007368|NCT03365817|Morphine|morphine|mesh-list
111007369|NCT03365817|Oxycodone|oxycodone|mesh-list
111007370|NCT03365817|Analgesics, Opioid|analgesics, opioid|mesh-list
111007371|NCT03365817|Tramadol|tramadol|mesh-list
111007372|NCT03365817|Methadone|methadone|mesh-list
111007373|NCT03365817|Narcotics|narcotics|mesh-ancestor
111007374|NCT03365817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111007375|NCT03365817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111007376|NCT03365817|Analgesics|analgesics|mesh-ancestor
111007377|NCT03365817|Sensory System Agents|sensory system agents|mesh-ancestor
111007378|NCT03365817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111007379|NCT03365817|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111007380|NCT03365817|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111007381|NCT03365817|Anesthetics, General|anesthetics, general|mesh-ancestor
111007382|NCT03365817|Anesthetics|anesthetics|mesh-ancestor
111007383|NCT03365817|Antitussive Agents|antitussive agents|mesh-ancestor
111007384|NCT03365817|Respiratory System Agents|respiratory system agents|mesh-ancestor
111007385|NCT02852005|Vaccines|vaccines|mesh-list
111007386|NCT02852005|Immunologic Factors|immunologic factors|mesh-ancestor
111007387|NCT02852005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111007388|NCT03601741|Anti-Infective Agents|anti-infective agents|mesh-list
111007389|NCT03601741|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111007390|NCT03365115|Fentanyl|fentanyl|mesh-list
111007391|NCT03365115|Morphine|morphine|mesh-list
111007392|NCT03365115|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111007393|NCT03365115|Narcotics|narcotics|mesh-ancestor
111007394|NCT03365115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111007395|NCT03365115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111007396|NCT03365115|Analgesics|analgesics|mesh-ancestor
111007397|NCT03365115|Sensory System Agents|sensory system agents|mesh-ancestor
111007398|NCT03365115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111007399|NCT03365115|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111007400|NCT03365115|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111007401|NCT03365115|Anesthetics, General|anesthetics, general|mesh-ancestor
111007402|NCT03365115|Anesthetics|anesthetics|mesh-ancestor
111007403|NCT02237755|Citric Acid|citric acid|mesh-list
111007404|NCT02237755|Sodium Citrate|sodium citrate|mesh-list
111007405|NCT02237755|Clomiphene|clomiphene|mesh-list
111007406|NCT02237755|Enclomiphene|enclomiphene|mesh-list
111007407|NCT02237755|Zuclomiphene|zuclomiphene|mesh-list
111007408|NCT02237755|Anticoagulants|anticoagulants|mesh-ancestor
111007409|NCT02237755|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
111007410|NCT02237755|Chelating Agents|chelating agents|mesh-ancestor
111007411|NCT02237755|Sequestering Agents|sequestering agents|mesh-ancestor
111007412|NCT02237755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111007413|NCT02237755|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111007414|NCT02237755|Hormone Antagonists|hormone antagonists|mesh-ancestor
111007415|NCT02237755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111007416|NCT02237755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111007417|NCT02237755|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111007418|NCT02237755|Fertility Agents|fertility agents|mesh-ancestor
111007419|NCT02237755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111007420|NCT02237755|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111007421|NCT02237755|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111007422|NCT04524897|Triamcinolone|triamcinolone|mesh-list
111007423|NCT04524897|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
111007424|NCT04524897|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
111007425|NCT04524897|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
111007426|NCT04524897|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111007427|NCT04524897|Glucocorticoids|glucocorticoids|mesh-ancestor
111007429|NCT04524897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111007430|NCT04524897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111007431|NCT04524897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111007432|NCT04524897|Immunologic Factors|immunologic factors|mesh-ancestor
111007433|NCT04524897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111007434|NCT04524897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111007435|NCT03364569|Tranexamic Acid|tranexamic acid|mesh-list
111007436|NCT03364569|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111007437|NCT03364569|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111007438|NCT03364569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111007439|NCT03364569|Hemostatics|hemostatics|mesh-ancestor
111007440|NCT03364569|Coagulants|coagulants|mesh-ancestor
111007441|NCT03363477|Enoxaparin|enoxaparin|mesh-list
111007442|NCT03363477|Enoxaparin sodium|enoxaparin sodium|mesh-list
111007443|NCT03363477|Anticoagulants|anticoagulants|mesh-ancestor
110724443|NCT01306318|Diclofenac|diclofenac|mesh-list
111007444|NCT03363477|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111007445|NCT03363477|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111007446|NCT03363477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111007447|NCT03593707|Metformin|metformin|mesh-list
111007448|NCT03593707|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111007449|NCT03593707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111007450|NCT03592537|Fentanyl|fentanyl|mesh-list
111007451|NCT03592537|Midazolam|midazolam|mesh-list
111007452|NCT03592537|Bupivacaine|bupivacaine|mesh-list
111007453|NCT03592537|Anesthetics, Local|anesthetics, local|mesh-ancestor
111007454|NCT03592537|Anesthetics|anesthetics|mesh-ancestor
111007455|NCT03592537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111007456|NCT03592537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111007457|NCT03592537|Sensory System Agents|sensory system agents|mesh-ancestor
111007458|NCT03592537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111007459|NCT03592537|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111007460|NCT03592537|Narcotics|narcotics|mesh-ancestor
111007461|NCT03592537|Analgesics|analgesics|mesh-ancestor
111007462|NCT03592537|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111007463|NCT03592537|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111007464|NCT03592537|Anesthetics, General|anesthetics, general|mesh-ancestor
111007465|NCT03592537|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111007466|NCT03592537|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111007467|NCT03592537|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111007468|NCT03592537|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111007469|NCT03592537|GABA Modulators|gaba modulators|mesh-ancestor
111007470|NCT03592537|GABA Agents|gaba agents|mesh-ancestor
111007471|NCT03592537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111007472|NCT03592537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111007473|NCT03362853|Moxifloxacin|moxifloxacin|mesh-list
111007474|NCT03362853|Nemonoxacin|nemonoxacin|mesh-list
111007475|NCT03362853|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111007476|NCT03362853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111007477|NCT03362853|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111007478|NCT03362853|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111007479|NCT03362853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111007480|NCT03362853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111007481|NCT03362853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111007482|NCT02849743|Oxytocin|oxytocin|mesh-list
111007483|NCT02849743|Oxytocics|oxytocics|mesh-ancestor
111007484|NCT02849743|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111007485|NCT02849743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111007486|NCT05063006|Methamphetamine|methamphetamine|mesh-list
111007487|NCT05063006|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111007488|NCT05063006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111007489|NCT05063006|Sympathomimetics|sympathomimetics|mesh-ancestor
111007490|NCT05063006|Autonomic Agents|autonomic agents|mesh-ancestor
111007491|NCT05063006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111007492|NCT05063006|Dopamine Agents|dopamine agents|mesh-ancestor
111007493|NCT05063006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111007494|NCT05063006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111007495|NCT05063006|Adrenergic Agents|adrenergic agents|mesh-ancestor
111007496|NCT05063006|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111007497|NCT05063006|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111007498|NCT05063006|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111007499|NCT05063006|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111007500|NCT03587077|Isosorbide|isosorbide|mesh-list
111007501|NCT03587077|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
111007502|NCT03587077|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
111007503|NCT03587077|Misoprostol|misoprostol|mesh-list
111007504|NCT03587077|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111007505|NCT03587077|Abortifacient Agents|abortifacient agents|mesh-ancestor
111007506|NCT03587077|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111007507|NCT03587077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111007508|NCT03587077|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111007509|NCT03587077|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111007510|NCT03587077|Oxytocics|oxytocics|mesh-ancestor
111007511|NCT03587077|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
111007512|NCT03587077|Diuretics|diuretics|mesh-ancestor
111007513|NCT03587077|Natriuretic Agents|natriuretic agents|mesh-ancestor
111007514|NCT03587077|Vasodilator Agents|vasodilator agents|mesh-ancestor
111007515|NCT03587077|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
111007516|NCT03587077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111007517|NCT02238457|Losartan|losartan|mesh-list
111007518|NCT02238457|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111007519|NCT02238457|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111007520|NCT02238457|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111007521|NCT02238457|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111007522|NCT02238457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111007523|NCT02238535|Iloprost|iloprost|mesh-list
111007524|NCT02238535|Warfarin|warfarin|mesh-list
111007525|NCT02238535|Anticoagulants|anticoagulants|mesh-ancestor
111007526|NCT02238535|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111007527|NCT02238535|Vasodilator Agents|vasodilator agents|mesh-ancestor
111007528|NCT03362697|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111007529|NCT03362697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111007530|NCT03909074|Vaccines|vaccines|mesh-list
111007531|NCT03909074|Immunologic Factors|immunologic factors|mesh-ancestor
111007532|NCT03909074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111007533|NCT03138668|Ropivacaine|ropivacaine|mesh-list
111007534|NCT03138668|Anesthetics, Local|anesthetics, local|mesh-ancestor
111007535|NCT03138668|Anesthetics|anesthetics|mesh-ancestor
111007536|NCT03138668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111007537|NCT03138668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111007538|NCT03138668|Sensory System Agents|sensory system agents|mesh-ancestor
111007539|NCT03138668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111007540|NCT03371043|Analgesics|analgesics|mesh-list
111007541|NCT03371043|Sensory System Agents|sensory system agents|mesh-ancestor
111007542|NCT03371043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111007543|NCT03371043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111007544|NCT03600961|Sirolimus|sirolimus|mesh-list
111007545|NCT03600961|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111007546|NCT03600961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111007547|NCT03600961|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111007548|NCT03600961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111007549|NCT03600961|Antifungal Agents|antifungal agents|mesh-ancestor
111007550|NCT03600961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111007551|NCT03600961|Immunologic Factors|immunologic factors|mesh-ancestor
111007552|NCT03600961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111007553|NCT05013242|Goserelin|goserelin|mesh-list
111007554|NCT05013242|Dienogest|dienogest|mesh-list
111007555|NCT05013242|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111007556|NCT05013242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111007557|NCT05013242|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
111007558|NCT05013242|Contraceptive Agents|contraceptive agents|mesh-ancestor
111007559|NCT05013242|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111007560|NCT05013242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111007561|NCT05013242|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110621226|NCT00310375|Ezogabine|ezogabine|mesh-list
111007562|NCT05013242|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111007563|NCT05013242|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111007564|NCT05013242|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111007565|NCT05013242|Hormone Antagonists|hormone antagonists|mesh-ancestor
111007566|NCT05013242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111007567|NCT05089604|Tacrolimus|tacrolimus|mesh-list
111007568|NCT05089604|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111007569|NCT05089604|Immunologic Factors|immunologic factors|mesh-ancestor
111007570|NCT05089604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111007571|NCT05089604|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111007572|NCT05089604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111007573|NCT05089604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111007574|NCT03590275|Folfirinox|folfirinox|mesh-list
111007575|NCT03590275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111007576|NCT05089448|Amlodipine|amlodipine|mesh-list
111007577|NCT05089448|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111007578|NCT05089448|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111007579|NCT05089448|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111007580|NCT05089448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111007581|NCT05089448|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111007582|NCT05089448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111007583|NCT05089448|Vasodilator Agents|vasodilator agents|mesh-ancestor
111007584|NCT02849509|Vitamin K|vitamin k|mesh-list
111007585|NCT02849509|Dabigatran|dabigatran|mesh-list
111007586|NCT02849509|Vitamins|vitamins|mesh-ancestor
111007587|NCT02849509|Micronutrients|micronutrients|mesh-ancestor
111007588|NCT02849509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111007589|NCT02849509|Antithrombins|antithrombins|mesh-ancestor
111007590|NCT02849509|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111007591|NCT02849509|Protease Inhibitors|protease inhibitors|mesh-ancestor
111007592|NCT02849509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111007593|NCT02849509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111007594|NCT02849509|Anticoagulants|anticoagulants|mesh-ancestor
111007595|NCT02849509|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111007596|NCT02849509|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111007597|NCT02849509|Hemostatics|hemostatics|mesh-ancestor
111007598|NCT02849509|Coagulants|coagulants|mesh-ancestor
111007599|NCT00151424|Olanzapine|olanzapine|mesh-list
111007600|NCT00151424|Asenapine|asenapine|mesh-list
111007601|NCT00151424|Antiemetics|antiemetics|mesh-ancestor
111007602|NCT00151424|Autonomic Agents|autonomic agents|mesh-ancestor
111007603|NCT00151424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111007604|NCT00151424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111007605|NCT00151424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111007606|NCT00151424|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111007607|NCT00151424|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111007608|NCT00151424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111007609|NCT00151424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111007610|NCT00151424|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111007611|NCT00151424|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111007612|NCT00151424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111007613|NCT00151424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111007614|NCT00151424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111007615|NCT00151424|Serotonin Agents|serotonin agents|mesh-ancestor
111007616|NCT03600727|Dexmedetomidine|dexmedetomidine|mesh-list
111007617|NCT03600727|Propofol|propofol|mesh-list
111007618|NCT03600727|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110621230|NCT00309907|Methylprednisolone|methylprednisolone|mesh-list
111007619|NCT03600727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111007620|NCT03600727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111007621|NCT03600727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111007622|NCT03600727|Analgesics|analgesics|mesh-ancestor
111007623|NCT03600727|Sensory System Agents|sensory system agents|mesh-ancestor
111007624|NCT03600727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111007625|NCT03600727|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111007626|NCT03600727|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111007627|NCT03600727|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111007628|NCT03600727|Adrenergic Agents|adrenergic agents|mesh-ancestor
111007629|NCT03600727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111007630|NCT03600727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111007631|NCT03600727|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111007632|NCT03600727|Anesthetics, General|anesthetics, general|mesh-ancestor
111007633|NCT03600727|Anesthetics|anesthetics|mesh-ancestor
111007634|NCT02733133|Testosterone|testosterone|mesh-list
111007635|NCT02733133|Androgens|androgens|mesh-ancestor
111007636|NCT02733133|Hormones|hormones|mesh-ancestor
111007637|NCT02733133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111007638|NCT02733133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111007639|NCT03584893|Dehydrocholesterols|dehydrocholesterols|mesh-list
111007640|NCT03584893|Provitamins|provitamins|mesh-ancestor
111007641|NCT03584893|Vitamins|vitamins|mesh-ancestor
111007642|NCT03584893|Micronutrients|micronutrients|mesh-ancestor
111007643|NCT03584893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111007644|NCT03362073|Ketamine|ketamine|mesh-list
111007645|NCT03362073|Analgesics|analgesics|mesh-ancestor
111007646|NCT03362073|Sensory System Agents|sensory system agents|mesh-ancestor
111007647|NCT03362073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111007648|NCT03362073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111007649|NCT03362073|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111007650|NCT03362073|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111007651|NCT03362073|Anesthetics, General|anesthetics, general|mesh-ancestor
111007652|NCT03362073|Anesthetics|anesthetics|mesh-ancestor
111007653|NCT03362073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111007654|NCT03362073|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111007655|NCT03362073|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111007656|NCT03362073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111007657|NCT03362073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111007658|NCT03582865|Tamoxifen|tamoxifen|mesh-list
111007659|NCT03582865|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111007660|NCT03582865|Hormone Antagonists|hormone antagonists|mesh-ancestor
111007661|NCT03582865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111007662|NCT03582865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111007663|NCT03582865|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111007664|NCT03582865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111007665|NCT03582865|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111007666|NCT03582865|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111007667|NCT03582865|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111007668|NCT03136406|Leucovorin|leucovorin|mesh-list
111007669|NCT03136406|Paclitaxel|paclitaxel|mesh-list
111007670|NCT03136406|Cyclophosphamide|cyclophosphamide|mesh-list
111007671|NCT03136406|Bevacizumab|bevacizumab|mesh-list
111007672|NCT03136406|Fluorouracil|fluorouracil|mesh-list
111007673|NCT03136406|Capecitabine|capecitabine|mesh-list
111007674|NCT03136406|Oxaliplatin|oxaliplatin|mesh-list
111007675|NCT03136406|Avelumab|avelumab|mesh-list
111007677|NCT03136406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111007678|NCT03136406|Tubulin Modulators|tubulin modulators|mesh-ancestor
111007679|NCT03136406|Antimitotic Agents|antimitotic agents|mesh-ancestor
111007680|NCT03136406|Mitosis Modulators|mitosis modulators|mesh-ancestor
111007681|NCT03136406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111007682|NCT03136406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111007683|NCT03136406|Immunologic Factors|immunologic factors|mesh-ancestor
111007684|NCT03136406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111007685|NCT03136406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111007686|NCT03136406|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111007687|NCT03136406|Alkylating Agents|alkylating agents|mesh-ancestor
111007688|NCT03136406|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111007689|NCT03136406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111007690|NCT03136406|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111007691|NCT03136406|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111007692|NCT03136406|Growth Substances|growth substances|mesh-ancestor
111007693|NCT03136406|Growth Inhibitors|growth inhibitors|mesh-ancestor
111007694|NCT03136406|Antimetabolites|antimetabolites|mesh-ancestor
111007695|NCT03136406|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111007696|NCT03136406|Antidotes|antidotes|mesh-ancestor
111007697|NCT03136406|Protective Agents|protective agents|mesh-ancestor
111007698|NCT03136406|Vitamin B Complex|vitamin b complex|mesh-ancestor
111007699|NCT03136406|Vitamins|vitamins|mesh-ancestor
111007700|NCT03136406|Micronutrients|micronutrients|mesh-ancestor
111007701|NCT03590197|Melatonin|melatonin|mesh-list
111007702|NCT03590197|Antioxidants|antioxidants|mesh-ancestor
111007703|NCT03590197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111007704|NCT03590197|Protective Agents|protective agents|mesh-ancestor
111007705|NCT03590197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111007706|NCT03590197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111007707|NCT03357315|Immunomodulating Agents|immunomodulating agents|mesh-list
111007708|NCT03357315|Immunologic Factors|immunologic factors|mesh-ancestor
111007709|NCT03357315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111007710|NCT05057468|Cyclosporine|cyclosporine|mesh-list
111007711|NCT05057468|Rituximab|rituximab|mesh-list
111007712|NCT05057468|Cyclosporins|cyclosporins|mesh-list
111007713|NCT05057468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111007714|NCT05057468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111007715|NCT05057468|Immunologic Factors|immunologic factors|mesh-ancestor
111007716|NCT05057468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111007717|NCT05057468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111007718|NCT05057468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111007719|NCT05057468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111007720|NCT05057468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111007721|NCT05057468|Antifungal Agents|antifungal agents|mesh-ancestor
111007722|NCT05057468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111007723|NCT05057468|Dermatologic Agents|dermatologic agents|mesh-ancestor
111007724|NCT05057468|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111007725|NCT02518503|Atorvastatin|atorvastatin|mesh-list
111007726|NCT02518503|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111007727|NCT02518503|Simvastatin|simvastatin|mesh-list
111007728|NCT02518503|Pravastatin|pravastatin|mesh-list
111007730|NCT02518503|L 647318|l 647318|mesh-list
111007731|NCT02518503|Dihydromevinolin|dihydromevinolin|mesh-list
111007732|NCT02518503|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111007733|NCT02518503|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111007734|NCT02518503|Antimetabolites|antimetabolites|mesh-ancestor
111007735|NCT02518503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111007736|NCT02518503|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111007737|NCT02518503|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111007738|NCT02518503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111007739|NCT03600493|Lidocaine|lidocaine|mesh-list
111007740|NCT03600493|Dexmedetomidine|dexmedetomidine|mesh-list
111007741|NCT03600493|Anesthetics, Local|anesthetics, local|mesh-ancestor
111007742|NCT03600493|Anesthetics|anesthetics|mesh-ancestor
111007743|NCT03600493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111007744|NCT03600493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111007745|NCT03600493|Sensory System Agents|sensory system agents|mesh-ancestor
111007746|NCT03600493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111007747|NCT03600493|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111007748|NCT03600493|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111007749|NCT03600493|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111007750|NCT03600493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111007751|NCT03600493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111007753|NCT03600493|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111007754|NCT03600493|Analgesics|analgesics|mesh-ancestor
111007755|NCT03600493|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111007756|NCT03600493|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111007757|NCT03600493|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111007758|NCT03600493|Adrenergic Agents|adrenergic agents|mesh-ancestor
111007759|NCT03600493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111007760|NCT03138356|Metformin|metformin|mesh-list
111007761|NCT03138356|Dapagliflozin|dapagliflozin|mesh-list
111007762|NCT03138356|Saxagliptin|saxagliptin|mesh-list
111007763|NCT03138356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111007764|NCT03138356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111007765|NCT03138356|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111007766|NCT03138356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111007767|NCT03138356|Incretins|incretins|mesh-ancestor
111007768|NCT03138356|Hormones|hormones|mesh-ancestor
111007769|NCT03138356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111007770|NCT03138356|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111007771|NCT03138356|Protease Inhibitors|protease inhibitors|mesh-ancestor
111007772|NCT03138356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111007773|NCT03137966|Deferoxamine|deferoxamine|mesh-list
111007774|NCT03137966|Siderophores|siderophores|mesh-ancestor
111007775|NCT03137966|Iron Chelating Agents|iron chelating agents|mesh-ancestor
111007776|NCT03137966|Chelating Agents|chelating agents|mesh-ancestor
111007777|NCT03137966|Sequestering Agents|sequestering agents|mesh-ancestor
111007778|NCT03137966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111007779|NCT04521387|Hyaluronic Acid|hyaluronic acid|mesh-list
111007780|NCT04521387|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111007781|NCT04521387|Immunologic Factors|immunologic factors|mesh-ancestor
111007782|NCT04521387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111007783|NCT04521387|Viscosupplements|viscosupplements|mesh-ancestor
111007784|NCT04521387|Protective Agents|protective agents|mesh-ancestor
111007785|NCT03579979|Methylene Blue|methylene blue|mesh-list
111007786|NCT03579979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111007787|NCT03579979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111007788|NCT04509219|Methylprednisolone|methylprednisolone|mesh-list
111007789|NCT04509219|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111007790|NCT04509219|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111007791|NCT04509219|Prednisolone|prednisolone|mesh-list
111007792|NCT04509219|Prednisolone acetate|prednisolone acetate|mesh-list
111007793|NCT04509219|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111007794|NCT04509219|Prednisolone phosphate|prednisolone phosphate|mesh-list
111007795|NCT04509219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111007796|NCT04509219|Antiemetics|antiemetics|mesh-ancestor
111007797|NCT04509219|Autonomic Agents|autonomic agents|mesh-ancestor
111007798|NCT04509219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111007799|NCT04509219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111007800|NCT04509219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111007801|NCT04509219|Glucocorticoids|glucocorticoids|mesh-ancestor
111007802|NCT04509219|Hormones|hormones|mesh-ancestor
111007803|NCT04509219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111007805|NCT04509219|Protective Agents|protective agents|mesh-ancestor
111007806|NCT04509219|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111007807|NCT04509219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111007808|NCT04444635|Fentanyl|fentanyl|mesh-list
111007809|NCT04444635|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111007810|NCT04444635|Narcotics|narcotics|mesh-ancestor
111007811|NCT04444635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111007812|NCT04444635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111007813|NCT04444635|Analgesics|analgesics|mesh-ancestor
111007814|NCT04444635|Sensory System Agents|sensory system agents|mesh-ancestor
111007815|NCT04444635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111007816|NCT04444635|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111007817|NCT04444635|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111007818|NCT04444635|Anesthetics, General|anesthetics, general|mesh-ancestor
111007819|NCT04444635|Anesthetics|anesthetics|mesh-ancestor
111007820|NCT03033446|Nivolumab|nivolumab|mesh-list
111007821|NCT03033446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111007822|NCT03033446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111007823|NCT03033446|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111007824|NCT03033446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111007825|NCT03579823|Adalimumab|adalimumab|mesh-list
111007826|NCT03579823|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111007827|NCT03579823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111007828|NCT03579823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111007829|NCT04444011|Amoxicillin|amoxicillin|mesh-list
111007830|NCT04444011|Clarithromycin|clarithromycin|mesh-list
111007831|NCT04444011|Bismuth|bismuth|mesh-list
111007832|NCT04444011|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111007833|NCT04444011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111007834|NCT04444011|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111007835|NCT04444011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111007836|NCT04444011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111007837|NCT04444011|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111007838|NCT04444011|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111007839|NCT04444011|Antacids|antacids|mesh-ancestor
111007840|NCT04444011|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111007841|NCT04443387|Vitamin D|vitamin d|mesh-list
111007842|NCT04443387|Vitamins|vitamins|mesh-ancestor
111007843|NCT04443387|Micronutrients|micronutrients|mesh-ancestor
111007844|NCT04443387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111007845|NCT04443387|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111007846|NCT02316236|Dexmedetomidine|dexmedetomidine|mesh-list
111007847|NCT02316236|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111007848|NCT02316236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111007849|NCT02316236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111007850|NCT02316236|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111007851|NCT02316236|Analgesics|analgesics|mesh-ancestor
111007852|NCT02316236|Sensory System Agents|sensory system agents|mesh-ancestor
111007853|NCT02316236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111007854|NCT02316236|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111007855|NCT02316236|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111007856|NCT02316236|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111007857|NCT02316236|Adrenergic Agents|adrenergic agents|mesh-ancestor
111007858|NCT02316236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111007859|NCT02316236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111007860|NCT04521075|Nivolumab|nivolumab|mesh-list
111007861|NCT04521075|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111007862|NCT04521075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111007863|NCT04521075|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111007864|NCT04521075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111007865|NCT03577249|Dialysis Solutions|dialysis solutions|mesh-list
111007866|NCT03577249|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111007867|NCT03601091|Midazolam|midazolam|mesh-list
111007868|NCT03601091|Dexmedetomidine|dexmedetomidine|mesh-list
111007869|NCT03601091|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111007870|NCT03601091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111007871|NCT03601091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111007872|NCT03601091|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111007873|NCT03601091|Analgesics|analgesics|mesh-ancestor
111007874|NCT03601091|Sensory System Agents|sensory system agents|mesh-ancestor
111007875|NCT03601091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110472813|NCT04202406|Analgesics|analgesics|mesh-ancestor
111007876|NCT03601091|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111007877|NCT03601091|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111007878|NCT03601091|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111007879|NCT03601091|Adrenergic Agents|adrenergic agents|mesh-ancestor
111007880|NCT03601091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111007881|NCT03601091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111007882|NCT03601091|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111007883|NCT03601091|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111007884|NCT03601091|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111007885|NCT03601091|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111007886|NCT03601091|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111007887|NCT03601091|Anesthetics, General|anesthetics, general|mesh-ancestor
111007889|NCT03601091|GABA Modulators|gaba modulators|mesh-ancestor
111007890|NCT03601091|GABA Agents|gaba agents|mesh-ancestor
111007891|NCT04508829|Antibodies|antibodies|mesh-list
111007892|NCT04508829|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111007893|NCT04508829|Immunologic Factors|immunologic factors|mesh-ancestor
111007894|NCT04508829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111007895|NCT04521309|Antibodies|antibodies|mesh-list
111007896|NCT04521309|Immunologic Factors|immunologic factors|mesh-ancestor
111007897|NCT04521309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111007898|NCT02267252|Antibodies|antibodies|mesh-list
111007899|NCT02267252|Immunologic Factors|immunologic factors|mesh-ancestor
111007900|NCT02267252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111007901|NCT04521153|Apatinib|apatinib|mesh-list
111007902|NCT04521153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111007903|NCT04521153|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111007904|NCT04521153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111007905|NCT04521153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111007907|NCT04362566|Anesthetics, Local|anesthetics, local|mesh-ancestor
111007908|NCT04362566|Anesthetics|anesthetics|mesh-ancestor
110621258|NCT00655824|Ofatumumab|ofatumumab|mesh-list
111007909|NCT04362566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111007910|NCT04362566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111007911|NCT04362566|Sensory System Agents|sensory system agents|mesh-ancestor
111007912|NCT04362566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111007913|NCT03579589|Neostigmine|neostigmine|mesh-list
111007914|NCT03579589|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111007915|NCT03579589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111007916|NCT03579589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111007917|NCT03579589|Cholinergic Agents|cholinergic agents|mesh-ancestor
111007918|NCT03579589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111007919|NCT03579589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111007920|NCT03579589|Parasympathomimetics|parasympathomimetics|mesh-ancestor
111007921|NCT03579589|Autonomic Agents|autonomic agents|mesh-ancestor
111007922|NCT03579589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111007923|NCT03600857|Misoprostol|misoprostol|mesh-list
111007924|NCT03600857|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111007925|NCT03600857|Abortifacient Agents|abortifacient agents|mesh-ancestor
111007926|NCT03600857|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111007927|NCT03600857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111007928|NCT03600857|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111007929|NCT03600857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111007930|NCT03600857|Oxytocics|oxytocics|mesh-ancestor
111007931|NCT03600623|Paclitaxel|paclitaxel|mesh-list
111007932|NCT03600623|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111007933|NCT03600623|Gemcitabine|gemcitabine|mesh-list
111007934|NCT03600623|Fluorouracil|fluorouracil|mesh-list
111007935|NCT03600623|Oxaliplatin|oxaliplatin|mesh-list
111007936|NCT03600623|Irinotecan|irinotecan|mesh-list
111007937|NCT03600623|Folfirinox|folfirinox|mesh-list
111007938|NCT03600623|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111007939|NCT03600623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111007940|NCT03600623|Tubulin Modulators|tubulin modulators|mesh-ancestor
111007941|NCT03600623|Antimitotic Agents|antimitotic agents|mesh-ancestor
111007942|NCT03600623|Mitosis Modulators|mitosis modulators|mesh-ancestor
111007943|NCT03600623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111007944|NCT03600623|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111007945|NCT03600623|Antimetabolites|antimetabolites|mesh-ancestor
111007946|NCT03600623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111007947|NCT03600623|Immunologic Factors|immunologic factors|mesh-ancestor
111007948|NCT03600623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111007949|NCT03600623|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111007950|NCT03600623|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111007951|NCT03600623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111007952|NCT02848729|Acetaminophen|acetaminophen|mesh-list
111007953|NCT02848729|Morphine|morphine|mesh-list
111007954|NCT02848729|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111007955|NCT02848729|Narcotics|narcotics|mesh-ancestor
111007956|NCT02848729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111007957|NCT02848729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111007958|NCT02848729|Analgesics|analgesics|mesh-ancestor
111007959|NCT02848729|Sensory System Agents|sensory system agents|mesh-ancestor
111007960|NCT02848729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111007961|NCT02848729|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111007962|NCT02848729|Antipyretics|antipyretics|mesh-ancestor
111007963|NCT03600467|Seviteronel|seviteronel|mesh-list
111007964|NCT03600467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111007965|NCT03600467|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111007966|NCT03600467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111007967|NCT03600467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111007968|NCT05737784|Pramoxine|pramoxine|mesh-list
111007969|NCT05737784|Anesthetics, Local|anesthetics, local|mesh-ancestor
111007970|NCT05737784|Anesthetics|anesthetics|mesh-ancestor
111007971|NCT05737784|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111007972|NCT05737784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111007973|NCT05737784|Sensory System Agents|sensory system agents|mesh-ancestor
111007974|NCT05737784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111007975|NCT04520919|Anesthetics|anesthetics|mesh-list
111007976|NCT04520919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110724958|NCT03781258|Warfarin|warfarin|mesh-list
111007977|NCT04520919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111007978|NCT03600311|Vitamin D|vitamin d|mesh-list
111007979|NCT03600311|Calcium|calcium|mesh-list
111007980|NCT03600311|Vitamins|vitamins|mesh-ancestor
111007981|NCT03600311|Micronutrients|micronutrients|mesh-ancestor
111007982|NCT03600311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111007983|NCT03600311|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111007984|NCT03600311|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111007985|NCT04562324|Antipsychotic Agents|antipsychotic agents|mesh-list
111007986|NCT04562324|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
111007987|NCT04562324|Antidepressive Agents|antidepressive agents|mesh-list
111007988|NCT04562324|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-list
111007989|NCT04562324|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111007990|NCT04562324|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111007991|NCT04562324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111007992|NCT04562324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111007993|NCT03603119|Dexamethasone|dexamethasone|mesh-list
111007994|NCT03603119|Midazolam|midazolam|mesh-list
111007995|NCT03603119|Ondansetron|ondansetron|mesh-list
111007996|NCT03603119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111007997|NCT03603119|Antiemetics|antiemetics|mesh-ancestor
111007998|NCT03603119|Autonomic Agents|autonomic agents|mesh-ancestor
111007999|NCT03603119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111008000|NCT03603119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111008001|NCT03603119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111008002|NCT03603119|Glucocorticoids|glucocorticoids|mesh-ancestor
111008003|NCT03603119|Hormones|hormones|mesh-ancestor
111008004|NCT03603119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111008005|NCT03603119|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111008006|NCT03603119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111008007|NCT03603119|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111008008|NCT03603119|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111008009|NCT03603119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111008010|NCT03603119|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111008011|NCT03603119|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111008012|NCT03603119|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111008013|NCT03603119|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111008014|NCT03603119|Anesthetics, General|anesthetics, general|mesh-ancestor
111008015|NCT03603119|Anesthetics|anesthetics|mesh-ancestor
111008016|NCT03603119|GABA Modulators|gaba modulators|mesh-ancestor
111008017|NCT03603119|GABA Agents|gaba agents|mesh-ancestor
111008018|NCT03603119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111008019|NCT03603119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111008020|NCT03603119|Antipruritics|antipruritics|mesh-ancestor
111008021|NCT03603119|Dermatologic Agents|dermatologic agents|mesh-ancestor
111008022|NCT03603119|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111008023|NCT03603119|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111008024|NCT03603119|Serotonin Agents|serotonin agents|mesh-ancestor
111008025|NCT03356769|Aspirin|aspirin|mesh-list
111008026|NCT03356769|Anticonvulsants|anticonvulsants|mesh-list
111008027|NCT03356769|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111008028|NCT03356769|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111008029|NCT03356769|Analgesics|analgesics|mesh-ancestor
111008030|NCT03356769|Sensory System Agents|sensory system agents|mesh-ancestor
111008031|NCT03356769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111008032|NCT03356769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111008033|NCT03356769|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111008034|NCT03356769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111008035|NCT03356769|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111008036|NCT03356769|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111008037|NCT03356769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111008038|NCT03356769|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111008039|NCT03356769|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111008040|NCT03356769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111008041|NCT03356769|Antipyretics|antipyretics|mesh-ancestor
111008042|NCT04508439|Heparin|heparin|mesh-list
111008043|NCT04508439|Enoxaparin|enoxaparin|mesh-list
111008044|NCT04508439|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
111008045|NCT04508439|Tinzaparin|tinzaparin|mesh-list
111008046|NCT04508439|Dalteparin|dalteparin|mesh-list
111008047|NCT04508439|Anticoagulants|anticoagulants|mesh-ancestor
111008048|NCT04508439|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111008049|NCT04508439|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111008050|NCT04508439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111008051|NCT02237651|Anesthetics|anesthetics|mesh-list
111008052|NCT02237651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110725032|NCT03780634|Sorafenib|sorafenib|mesh-list
111008053|NCT02237651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111008055|NCT02237729|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111008056|NCT02237729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111008057|NCT02237729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111008058|NCT02238119|Formoterol Fumarate|formoterol fumarate|mesh-list
111008059|NCT02238119|Tiotropium Bromide|tiotropium bromide|mesh-list
111008060|NCT02238119|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111008061|NCT02238119|Autonomic Agents|autonomic agents|mesh-ancestor
111008062|NCT02238119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111008063|NCT02238119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111008064|NCT02238119|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111008065|NCT02238119|Respiratory System Agents|respiratory system agents|mesh-ancestor
111008066|NCT02238119|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111008067|NCT02238119|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111008068|NCT02238119|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111008069|NCT02238119|Adrenergic Agents|adrenergic agents|mesh-ancestor
111008070|NCT02238119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111008071|NCT02238119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111008072|NCT02238119|Parasympatholytics|parasympatholytics|mesh-ancestor
111008073|NCT02238119|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111008074|NCT02238119|Cholinergic Agents|cholinergic agents|mesh-ancestor
111008075|NCT03354117|Meloxicam|meloxicam|mesh-list
111008076|NCT03354117|Ulipristal acetate|ulipristal acetate|mesh-list
111008077|NCT03354117|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111008078|NCT03354117|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111008079|NCT03354117|Analgesics|analgesics|mesh-ancestor
111008080|NCT03354117|Sensory System Agents|sensory system agents|mesh-ancestor
111008081|NCT03354117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111008082|NCT03354117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111008083|NCT03354117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111008084|NCT03354117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111008085|NCT03354117|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111008086|NCT03354117|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111008087|NCT03354117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111008088|NCT03354117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111008089|NCT03354117|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111008090|NCT03354117|Contraceptive Agents|contraceptive agents|mesh-ancestor
111008091|NCT03354117|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111008092|NCT03354117|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111008093|NCT03360981|Incretins|incretins|mesh-list
111008094|NCT03360981|Hormones|hormones|mesh-ancestor
111008095|NCT03360981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111008096|NCT03360981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111008097|NCT03597815|Aflibercept|aflibercept|mesh-list
111008098|NCT03597815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111008099|NCT03597815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111008100|NCT03597815|Growth Substances|growth substances|mesh-ancestor
111008101|NCT03597815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111008102|NCT03597815|Growth Inhibitors|growth inhibitors|mesh-ancestor
111008103|NCT03597815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111008104|NCT03595085|Streptokinase|streptokinase|mesh-list
111008105|NCT03595085|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111008106|NCT03595085|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111008107|NCT03595085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111008108|NCT00158756|Vaccines|vaccines|mesh-list
111008109|NCT00158756|Immunologic Factors|immunologic factors|mesh-ancestor
111008110|NCT00158756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111008111|NCT03353883|Triptorelin Pamoate|triptorelin pamoate|mesh-list
111008112|NCT03353883|Luteolytic Agents|luteolytic agents|mesh-ancestor
111008113|NCT03353883|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111008114|NCT03353883|Contraceptive Agents|contraceptive agents|mesh-ancestor
111008115|NCT03353883|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111008116|NCT03353883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111008117|NCT03353883|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110621277|NCT01061437|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111008118|NCT03353883|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111008119|NCT03353883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111008120|NCT04519125|Tenofovir|tenofovir|mesh-list
111008121|NCT04519125|Emtricitabine|emtricitabine|mesh-list
111008122|NCT04519125|Antiviral Agents|antiviral agents|mesh-ancestor
111008123|NCT04519125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111008124|NCT04519125|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111008125|NCT04519125|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111008126|NCT04519125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111008127|NCT04519125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111008128|NCT04519125|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111008129|NCT04519125|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111008130|NCT02730195|Pioglitazone|pioglitazone|mesh-list
111008131|NCT02730195|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
111008132|NCT02730195|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111008133|NCT02730195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111008134|NCT02730195|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111008135|NCT02730195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111008136|NCT02730195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111008137|NCT03360279|Paclitaxel|paclitaxel|mesh-list
111008138|NCT03360279|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111008139|NCT03360279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111008140|NCT03360279|Tubulin Modulators|tubulin modulators|mesh-ancestor
111008141|NCT03360279|Antimitotic Agents|antimitotic agents|mesh-ancestor
111008142|NCT03360279|Mitosis Modulators|mitosis modulators|mesh-ancestor
111008143|NCT03360279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111008144|NCT03353103|Listerine|listerine|mesh-list
111008145|NCT03353103|Fluorides|fluorides|mesh-list
111008146|NCT03353103|Sodium Fluoride|sodium fluoride|mesh-list
111008147|NCT03353103|Cariostatic Agents|cariostatic agents|mesh-ancestor
111008148|NCT03353103|Protective Agents|protective agents|mesh-ancestor
111008149|NCT03353103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111008150|NCT03353103|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111008151|NCT03353103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111008152|NCT03360123|Midazolam|midazolam|mesh-list
111008153|NCT03360123|Triazolam|triazolam|mesh-list
111008154|NCT03360123|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111008155|NCT03360123|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111008156|NCT03360123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111008157|NCT03360123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111008158|NCT03360123|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111008159|NCT03360123|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111008160|NCT03360123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111008161|NCT03360123|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111008162|NCT03360123|Anesthetics, General|anesthetics, general|mesh-ancestor
111008163|NCT03360123|Anesthetics|anesthetics|mesh-ancestor
111008164|NCT03360123|GABA Modulators|gaba modulators|mesh-ancestor
111008165|NCT03360123|GABA Agents|gaba agents|mesh-ancestor
111008166|NCT03360123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111008167|NCT03360123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111008168|NCT03360045|Tranexamic Acid|tranexamic acid|mesh-list
111008169|NCT03360045|Polyvinyl alcohol formaldehyde foam|polyvinyl alcohol formaldehyde foam|mesh-list
111008170|NCT03360045|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111008171|NCT03360045|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111008172|NCT03360045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111008173|NCT03360045|Hemostatics|hemostatics|mesh-ancestor
111008174|NCT03360045|Coagulants|coagulants|mesh-ancestor
111008175|NCT03353025|Dopamine|dopamine|mesh-list
111008176|NCT03353025|Dopamine Agonists|dopamine agonists|mesh-list
111008177|NCT03353025|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111008178|NCT03353025|Sympathomimetics|sympathomimetics|mesh-ancestor
111008179|NCT03353025|Autonomic Agents|autonomic agents|mesh-ancestor
111008180|NCT03353025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111008181|NCT03353025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111008182|NCT03353025|Dopamine Agents|dopamine agents|mesh-ancestor
111008183|NCT03353025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111008184|NCT03353025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111008185|NCT03353025|Protective Agents|protective agents|mesh-ancestor
110621282|NCT00575588|Metformin|metformin|mesh-list
111008186|NCT03359967|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
111008187|NCT03359967|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111008188|NCT03359967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111008189|NCT04506957|Chrysarobin|chrysarobin|mesh-list
111008190|NCT04506957|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111008191|NCT04506957|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111008192|NCT04506957|Analgesics|analgesics|mesh-ancestor
111008193|NCT04506957|Sensory System Agents|sensory system agents|mesh-ancestor
111008194|NCT04506957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111008195|NCT04506957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111008196|NCT04506957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111008197|NCT04506957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111008198|NCT04516395|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111008199|NCT04516395|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
111008200|NCT04516395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111008201|NCT04516395|Antitubercular Agents|antitubercular agents|mesh-ancestor
111008202|NCT03352947|Trametinib|trametinib|mesh-list
111008203|NCT03352947|Dabrafenib|dabrafenib|mesh-list
111008204|NCT03352947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111008205|NCT03352947|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111008206|NCT03352947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111008207|NCT03352947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111008208|NCT02730351|Fluticasone|fluticasone|mesh-list
111008209|NCT02730351|Xhance|xhance|mesh-list
111008210|NCT02730351|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111008211|NCT02730351|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111008212|NCT02730351|Autonomic Agents|autonomic agents|mesh-ancestor
111008213|NCT02730351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111008214|NCT02730351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111008215|NCT02730351|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111008216|NCT02730351|Respiratory System Agents|respiratory system agents|mesh-ancestor
111008217|NCT02730351|Dermatologic Agents|dermatologic agents|mesh-ancestor
111008218|NCT02730351|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111008219|NCT03359655|Scopolamine|scopolamine|mesh-list
111008220|NCT03359655|Bromides|bromides|mesh-list
111008221|NCT03359655|Misoprostol|misoprostol|mesh-list
111008222|NCT03359655|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
111008223|NCT03359655|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111008224|NCT03359655|Abortifacient Agents|abortifacient agents|mesh-ancestor
111008225|NCT03359655|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111008226|NCT03359655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111008227|NCT03359655|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111008228|NCT03359655|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111008229|NCT03359655|Oxytocics|oxytocics|mesh-ancestor
111008230|NCT03359655|Anticonvulsants|anticonvulsants|mesh-ancestor
111008231|NCT03359655|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111008232|NCT03359655|Antiemetics|antiemetics|mesh-ancestor
111008233|NCT03359655|Autonomic Agents|autonomic agents|mesh-ancestor
111008234|NCT03359655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111008235|NCT03359655|Mydriatics|mydriatics|mesh-ancestor
111008236|NCT03359655|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111008237|NCT03359655|Cholinergic Agents|cholinergic agents|mesh-ancestor
111008238|NCT03359655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111008239|NCT03359655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111008240|NCT03359655|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111008241|NCT03359655|Parasympatholytics|parasympatholytics|mesh-ancestor
111008242|NCT03352869|Metformin|metformin|mesh-list
111008243|NCT03352869|Exenatide|exenatide|mesh-list
111008244|NCT03352869|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111008245|NCT03352869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111008246|NCT03352869|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111008247|NCT03352869|Incretins|incretins|mesh-ancestor
111008248|NCT03352869|Hormones|hormones|mesh-ancestor
111008249|NCT03352869|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111008250|NCT03359499|Trimebutine|trimebutine|mesh-list
111008251|NCT03359499|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111008252|NCT03359499|Parasympatholytics|parasympatholytics|mesh-ancestor
110621293|NCT01058317|Propranolol|propranolol|mesh-list
111008253|NCT03359499|Autonomic Agents|autonomic agents|mesh-ancestor
111008254|NCT03359499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111008255|NCT03359499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111008256|NCT03352479|Analgesics, Opioid|analgesics, opioid|mesh-list
111008257|NCT03352479|Narcotics|narcotics|mesh-ancestor
111008258|NCT03352479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111008259|NCT03352479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111008260|NCT03352479|Analgesics|analgesics|mesh-ancestor
111008261|NCT03352479|Sensory System Agents|sensory system agents|mesh-ancestor
111008262|NCT03352479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111008263|NCT03355053|Dexmedetomidine|dexmedetomidine|mesh-list
111008264|NCT03355053|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111008265|NCT03355053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111008266|NCT03355053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111008267|NCT03355053|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111008268|NCT03355053|Analgesics|analgesics|mesh-ancestor
111008269|NCT03355053|Sensory System Agents|sensory system agents|mesh-ancestor
111008270|NCT03355053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111008271|NCT03355053|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111008272|NCT03355053|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111008273|NCT03355053|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111008274|NCT03355053|Adrenergic Agents|adrenergic agents|mesh-ancestor
111008275|NCT03355053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111008276|NCT03355053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111008277|NCT03358953|Nicotine|nicotine|mesh-list
111008278|NCT03358953|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111008279|NCT03358953|Autonomic Agents|autonomic agents|mesh-ancestor
111008280|NCT03358953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111008281|NCT03358953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111008282|NCT03358953|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111008283|NCT03358953|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111008284|NCT03358953|Cholinergic Agents|cholinergic agents|mesh-ancestor
111008285|NCT03358953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111008286|NCT03358953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111008287|NCT04509999|Bicalutamide|bicalutamide|mesh-list
111008288|NCT04509999|Androgen Antagonists|androgen antagonists|mesh-ancestor
111008289|NCT04509999|Hormone Antagonists|hormone antagonists|mesh-ancestor
111008290|NCT04509999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111008291|NCT04509999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111008292|NCT04509999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111008293|NCT04505943|Isoniazid|isoniazid|mesh-list
111008294|NCT04505943|Misoprostol|misoprostol|mesh-list
111008295|NCT04505943|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111008296|NCT04505943|Abortifacient Agents|abortifacient agents|mesh-ancestor
111008297|NCT04505943|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111008298|NCT04505943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111008299|NCT04505943|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111008300|NCT04505943|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111008301|NCT04505943|Oxytocics|oxytocics|mesh-ancestor
111008302|NCT04505943|Antitubercular Agents|antitubercular agents|mesh-ancestor
111008303|NCT04505943|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111008304|NCT04505943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111008305|NCT04505943|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
111008306|NCT04505943|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111008307|NCT04505943|Antimetabolites|antimetabolites|mesh-ancestor
111008308|NCT04505943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111008309|NCT04505943|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111008310|NCT03358719|Poly I-C|poly i-c|mesh-list
111008311|NCT03358719|Nivolumab|nivolumab|mesh-list
111008312|NCT03358719|Decitabine|decitabine|mesh-list
111008313|NCT03358719|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
111008314|NCT03358719|Poly ICLC|poly iclc|mesh-list
111008315|NCT03358719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111008316|NCT03358719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111008317|NCT03358719|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111008318|NCT03358719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111008319|NCT03358719|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111008320|NCT03358719|Antimetabolites|antimetabolites|mesh-ancestor
111008321|NCT03358719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111008322|NCT03358719|Interferon Inducers|interferon inducers|mesh-ancestor
111008323|NCT03358719|Immunologic Factors|immunologic factors|mesh-ancestor
111008324|NCT03358719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111008325|NCT03358719|Laxatives|laxatives|mesh-ancestor
111008326|NCT03358719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111008327|NCT03358719|Antiviral Agents|antiviral agents|mesh-ancestor
111008328|NCT03358719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111008329|NCT04505475|Hemostatics|hemostatics|mesh-list
111008331|NCT01376349|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
111008332|NCT01376349|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111008333|NCT01376349|Immunologic Factors|immunologic factors|mesh-ancestor
111008334|NCT01376349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111008335|NCT03350373|Dotinurad|dotinurad|mesh-list
111008336|NCT03350373|Uricosuric Agents|uricosuric agents|mesh-ancestor
111008337|NCT03350373|Gout Suppressants|gout suppressants|mesh-ancestor
111008338|NCT03350373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111008339|NCT03350295|Nifurtimox|nifurtimox|mesh-list
111008340|NCT03350295|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
111008341|NCT03350295|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111008342|NCT03350295|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111008343|NCT03350295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111008344|NCT03349983|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
111008345|NCT03349983|Antiviral Agents|antiviral agents|mesh-ancestor
111008346|NCT03349983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111008347|NCT03349827|Apatinib|apatinib|mesh-list
111008348|NCT03349827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111008349|NCT03349827|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111008350|NCT03349827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111008351|NCT03349827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111008352|NCT04503915|Estrogens|estrogens|mesh-list
111008353|NCT04503915|Hormones|hormones|mesh-ancestor
111008354|NCT04503915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111008355|NCT04503915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111008357|NCT04504851|Isoniazid|isoniazid|mesh-list
111008358|NCT04504851|Pyrazinamide|pyrazinamide|mesh-list
111008359|NCT04504851|Ethambutol|ethambutol|mesh-list
111008360|NCT04504851|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111008361|NCT04504851|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111008362|NCT04504851|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111008363|NCT04504851|Antimetabolites|antimetabolites|mesh-ancestor
111008364|NCT04504851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111008365|NCT04504851|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111008366|NCT04504851|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111008367|NCT04504851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111008368|NCT04504851|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111008369|NCT04504851|Antitubercular Agents|antitubercular agents|mesh-ancestor
111008370|NCT04504851|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111008371|NCT04504851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111008372|NCT04504851|Leprostatic Agents|leprostatic agents|mesh-ancestor
111008373|NCT04504851|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111008374|NCT04504851|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111008375|NCT04504851|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111008376|NCT04504851|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
111008377|NCT04504851|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
111008378|NCT04504851|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
111008379|NCT04504851|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111008380|NCT04504851|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
111008381|NCT05509257|Naltrexone|naltrexone|mesh-list
111008382|NCT05509257|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111008383|NCT05509257|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111008384|NCT05509257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111008385|NCT05509257|Sensory System Agents|sensory system agents|mesh-ancestor
111008386|NCT05509257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111008387|NCT03349359|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
111008388|NCT03349359|Antiviral Agents|antiviral agents|mesh-ancestor
110621311|NCT00761228|Emetics|emetics|mesh-ancestor
111008389|NCT03349359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111008390|NCT03030261|Dexamethasone|dexamethasone|mesh-list
111008391|NCT03030261|Pomalidomide|pomalidomide|mesh-list
111008392|NCT03030261|Elotuzumab|elotuzumab|mesh-list
111008393|NCT03030261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111008394|NCT03030261|Antiemetics|antiemetics|mesh-ancestor
111008395|NCT03030261|Autonomic Agents|autonomic agents|mesh-ancestor
111008396|NCT03030261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111008397|NCT03030261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111008398|NCT03030261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111008399|NCT03030261|Glucocorticoids|glucocorticoids|mesh-ancestor
111008400|NCT03030261|Hormones|hormones|mesh-ancestor
111008401|NCT03030261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111008402|NCT03030261|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111008403|NCT03030261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111008404|NCT03030261|Immunologic Factors|immunologic factors|mesh-ancestor
111008406|NCT03030261|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111008407|NCT03030261|Growth Substances|growth substances|mesh-ancestor
111008408|NCT03030261|Growth Inhibitors|growth inhibitors|mesh-ancestor
111008409|NCT02176161|Metformin|metformin|mesh-list
111008410|NCT02176161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111008411|NCT02176161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111008412|NCT03348735|Lidocaine|lidocaine|mesh-list
111008413|NCT03348735|Pregabalin|pregabalin|mesh-list
111008414|NCT03348735|Capsaicin|capsaicin|mesh-list
111008415|NCT03348735|Anesthetics, Local|anesthetics, local|mesh-ancestor
111008416|NCT03348735|Anesthetics|anesthetics|mesh-ancestor
111008417|NCT03348735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111008418|NCT03348735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111008419|NCT03348735|Sensory System Agents|sensory system agents|mesh-ancestor
111008420|NCT03348735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111008421|NCT03348735|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111008422|NCT03348735|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111008423|NCT03348735|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111008424|NCT03348735|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111008425|NCT03348735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111008426|NCT03348735|Analgesics|analgesics|mesh-ancestor
111008427|NCT03348735|Anticonvulsants|anticonvulsants|mesh-ancestor
111008428|NCT03348735|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110725407|NCT05531890|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
111008429|NCT03348735|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111008430|NCT03348735|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111008431|NCT03348735|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111008432|NCT03348735|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111008433|NCT03348735|Antipruritics|antipruritics|mesh-ancestor
111008434|NCT03348735|Dermatologic Agents|dermatologic agents|mesh-ancestor
111008435|NCT01700673|Azacitidine|azacitidine|mesh-list
111008436|NCT01700673|Sargramostim|sargramostim|mesh-list
111008437|NCT01700673|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111008438|NCT01700673|Antimetabolites|antimetabolites|mesh-ancestor
111008439|NCT01700673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111008440|NCT01700673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111008441|NCT01700673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111008442|NCT01700673|Immunologic Factors|immunologic factors|mesh-ancestor
111008443|NCT01700673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111008444|NCT03898154|Dexamethasone|dexamethasone|mesh-list
111008445|NCT03898154|Methylprednisolone|methylprednisolone|mesh-list
111008446|NCT03898154|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111008447|NCT03898154|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111008448|NCT03898154|Prednisolone|prednisolone|mesh-list
111008449|NCT03898154|Prednisolone acetate|prednisolone acetate|mesh-list
111008450|NCT03898154|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111008451|NCT03898154|Prednisolone phosphate|prednisolone phosphate|mesh-list
111008452|NCT03898154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111008453|NCT03898154|Antiemetics|antiemetics|mesh-ancestor
111008454|NCT03898154|Autonomic Agents|autonomic agents|mesh-ancestor
111008455|NCT03898154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111008456|NCT03898154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111008457|NCT03898154|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111008458|NCT03898154|Glucocorticoids|glucocorticoids|mesh-ancestor
111008459|NCT03898154|Hormones|hormones|mesh-ancestor
111008460|NCT03898154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111008461|NCT03898154|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111008462|NCT03898154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111008463|NCT03898154|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111008464|NCT03898154|Protective Agents|protective agents|mesh-ancestor
111008465|NCT02517957|Loperamide|loperamide|mesh-list
111008466|NCT02517957|Antidiarrheals|antidiarrheals|mesh-list
111008467|NCT02517957|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111008468|NCT03348267|Caseins|caseins|mesh-list
111008469|NCT03348267|Chelating Agents|chelating agents|mesh-ancestor
111008470|NCT03348267|Sequestering Agents|sequestering agents|mesh-ancestor
111008471|NCT03348267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111008472|NCT03136796|Meropenem|meropenem|mesh-list
111008473|NCT03136796|Piperacillin|piperacillin|mesh-list
111008474|NCT03136796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111008475|NCT03136796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111008476|NCT05243745|Fluorides|fluorides|mesh-list
111008477|NCT05243745|Cariostatic Agents|cariostatic agents|mesh-ancestor
111008478|NCT05243745|Protective Agents|protective agents|mesh-ancestor
111008479|NCT05243745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111008480|NCT04500717|Carboplatin|carboplatin|mesh-list
111008481|NCT04500717|Pemetrexed|pemetrexed|mesh-list
111008482|NCT04500717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111008483|NCT04500717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111008484|NCT04500717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111008485|NCT04500717|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111008486|NCT04500717|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111008487|NCT01680458|Fluconazole|fluconazole|mesh-list
111008488|NCT01680458|Antifungal Agents|antifungal agents|mesh-ancestor
111008489|NCT01680458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111008490|NCT01680458|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111008491|NCT01680458|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111008492|NCT01680458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111008493|NCT01680458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111008494|NCT01680458|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111008495|NCT01680458|Hormone Antagonists|hormone antagonists|mesh-ancestor
111008496|NCT01680458|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111008497|NCT01680458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111008498|NCT01680458|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111008499|NCT01680458|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111008500|NCT03346317|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
111008501|NCT03346317|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
111008502|NCT03346317|Estradiol|estradiol|mesh-list
111008503|NCT03346317|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
111008504|NCT03346317|Dydrogesterone|dydrogesterone|mesh-list
111008505|NCT03346317|Estrogens|estrogens|mesh-ancestor
111008506|NCT03346317|Hormones|hormones|mesh-ancestor
111008507|NCT03346317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111008508|NCT03346317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111008509|NCT03346317|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111008510|NCT03346317|Contraceptive Agents|contraceptive agents|mesh-ancestor
111008511|NCT03346317|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111008512|NCT03346317|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111008513|NCT03346317|Progestins|progestins|mesh-ancestor
111008514|NCT01550432|Acetylcysteine|acetylcysteine|mesh-list
111008515|NCT01550432|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111008516|NCT01550432|Antiviral Agents|antiviral agents|mesh-ancestor
111008517|NCT01550432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111008518|NCT01550432|Expectorants|expectorants|mesh-ancestor
111008519|NCT01550432|Respiratory System Agents|respiratory system agents|mesh-ancestor
111008520|NCT01550432|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111008521|NCT01550432|Antioxidants|antioxidants|mesh-ancestor
111008522|NCT01550432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111008523|NCT01550432|Protective Agents|protective agents|mesh-ancestor
111008524|NCT01550432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111008525|NCT01550432|Antidotes|antidotes|mesh-ancestor
111008526|NCT04502277|Fluconazole|fluconazole|mesh-list
111008527|NCT04502277|Antifungal Agents|antifungal agents|mesh-ancestor
111008528|NCT04502277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111008529|NCT04502277|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111008530|NCT04502277|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111008531|NCT04502277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111008532|NCT04502277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111008533|NCT04502277|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111008534|NCT04502277|Hormone Antagonists|hormone antagonists|mesh-ancestor
111008535|NCT04502277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111008536|NCT04502277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111008537|NCT04502277|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111008538|NCT04502277|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111008539|NCT05730608|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
111008540|NCT05730608|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111008541|NCT05730608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111008542|NCT02517489|Hydrocortisone|hydrocortisone|mesh-list
111008543|NCT02517489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111008544|NCT04850144|Bromides|bromides|mesh-list
111008545|NCT04850144|Tiotropium Bromide|tiotropium bromide|mesh-list
111008546|NCT04850144|Charcoal|charcoal|mesh-list
111008547|NCT04850144|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111008548|NCT04850144|Autonomic Agents|autonomic agents|mesh-ancestor
111008549|NCT04850144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111008550|NCT04850144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111008551|NCT04850144|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111008552|NCT04850144|Respiratory System Agents|respiratory system agents|mesh-ancestor
111008553|NCT04850144|Parasympatholytics|parasympatholytics|mesh-ancestor
111008555|NCT04850144|Cholinergic Agents|cholinergic agents|mesh-ancestor
111008556|NCT04850144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111008557|NCT04850144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111008558|NCT04850144|Anticonvulsants|anticonvulsants|mesh-ancestor
111008559|NCT04850144|Antidotes|antidotes|mesh-ancestor
111008560|NCT04850144|Protective Agents|protective agents|mesh-ancestor
111008561|NCT04590794|Plasminogen|plasminogen|mesh-list
111008562|NCT04590794|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111008563|NCT04590794|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111008564|NCT04590794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111008565|NCT00709761|Paclitaxel|paclitaxel|mesh-list
111008566|NCT00709761|Lapatinib|lapatinib|mesh-list
111008567|NCT00709761|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111008568|NCT00709761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111008569|NCT00709761|Tubulin Modulators|tubulin modulators|mesh-ancestor
111008570|NCT00709761|Antimitotic Agents|antimitotic agents|mesh-ancestor
111008571|NCT00709761|Mitosis Modulators|mitosis modulators|mesh-ancestor
111008572|NCT00709761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111008573|NCT00709761|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111008574|NCT00709761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111008575|NCT03346083|Betrixaban|betrixaban|mesh-list
111008576|NCT03346083|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111008577|NCT03346083|Antithrombins|antithrombins|mesh-ancestor
111008578|NCT03346083|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111008579|NCT03346083|Protease Inhibitors|protease inhibitors|mesh-ancestor
111008580|NCT03346083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111008581|NCT03346083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111008582|NCT03346083|Anticoagulants|anticoagulants|mesh-ancestor
111008583|NCT05584683|Amoxicillin|amoxicillin|mesh-list
111008584|NCT05584683|Clavulanic Acid|clavulanic acid|mesh-list
111008585|NCT05584683|Clavulanic Acids|clavulanic acids|mesh-list
111008586|NCT05584683|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
111008587|NCT05584683|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111008588|NCT05584683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111008589|NCT05584683|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
111008590|NCT05584683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111008591|NCT05584683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111008592|NCT02516631|Misoprostol|misoprostol|mesh-list
111008593|NCT02516631|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111008594|NCT02516631|Abortifacient Agents|abortifacient agents|mesh-ancestor
111008595|NCT02516631|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111008596|NCT02516631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111008597|NCT02516631|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111008598|NCT02516631|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111008599|NCT02516631|Oxytocics|oxytocics|mesh-ancestor
111008600|NCT02516475|Zinc Sulfate|zinc sulfate|mesh-list
111008601|NCT02516475|Astringents|astringents|mesh-ancestor
111008602|NCT02516475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111008603|NCT02516475|Dermatologic Agents|dermatologic agents|mesh-ancestor
111008604|NCT05083286|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111008605|NCT05083286|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111008606|NCT05083286|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111008607|NCT05083286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111008608|NCT05083286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111008609|NCT05083286|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111008610|NCT05083286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111008611|NCT05083286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111008612|NCT05083286|Cholinergic Agents|cholinergic agents|mesh-ancestor
111008613|NCT05083286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111008614|NCT03423680|Aripiprazole|aripiprazole|mesh-list
111008615|NCT03423680|Antidepressive Agents|antidepressive agents|mesh-ancestor
111008616|NCT03423680|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111008617|NCT03423680|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111008618|NCT03423680|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111008619|NCT03423680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111008620|NCT03423680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111008621|NCT03423680|Dopamine Agonists|dopamine agonists|mesh-ancestor
111008622|NCT03423680|Dopamine Agents|dopamine agents|mesh-ancestor
111008623|NCT03423680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111008624|NCT03423680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111008625|NCT03423680|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111008626|NCT03423680|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111008627|NCT03423680|Serotonin Agents|serotonin agents|mesh-ancestor
111008628|NCT03423680|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111008629|NCT03423680|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111008630|NCT03423680|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111008631|NCT03423680|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111008632|NCT04443543|Fluorouracil|fluorouracil|mesh-list
111008633|NCT04443543|Capecitabine|capecitabine|mesh-list
111008634|NCT04443543|Oxaliplatin|oxaliplatin|mesh-list
111008635|NCT04443543|Irinotecan|irinotecan|mesh-list
111008636|NCT04443543|Tislelizumab|tislelizumab|mesh-list
111008637|NCT04443543|Antimetabolites|antimetabolites|mesh-ancestor
111008638|NCT04443543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111008639|NCT04443543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111008640|NCT04443543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111008641|NCT04443543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111008642|NCT04443543|Immunologic Factors|immunologic factors|mesh-ancestor
111008643|NCT04443543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111008644|NCT04443543|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111008645|NCT04443543|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111008646|NCT04443543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111008647|NCT04443543|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111008648|NCT02516085|Metformin|metformin|mesh-list
111008649|NCT02516085|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111008650|NCT02516085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111008651|NCT02515929|Proanthocyanidin|proanthocyanidin|mesh-list
111008652|NCT02515929|Procyanidin|procyanidin|mesh-list
110725633|NCT01567540|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111008653|NCT02515929|Antioxidants|antioxidants|mesh-ancestor
111008654|NCT02515929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111008655|NCT02515929|Protective Agents|protective agents|mesh-ancestor
111008656|NCT02515929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111008657|NCT02515929|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111008658|NCT02515929|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111008659|NCT02515929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111008661|NCT03347721|Anesthetics, Local|anesthetics, local|mesh-ancestor
111008662|NCT03347721|Anesthetics|anesthetics|mesh-ancestor
111008663|NCT03347721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111008664|NCT03347721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111008665|NCT03347721|Sensory System Agents|sensory system agents|mesh-ancestor
111008666|NCT03347721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111008667|NCT03347721|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111008668|NCT03347721|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111008669|NCT03347721|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111008670|NCT03347721|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111008671|NCT03347721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111008672|NCT02848651|Atezolizumab|atezolizumab|mesh-list
111008673|NCT02848651|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111008674|NCT02848651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111008675|NCT02848651|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111008676|NCT02848651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111008677|NCT00709059|Ribavirin|ribavirin|mesh-list
111008678|NCT00709059|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
111008679|NCT00709059|Interferon-alpha|interferon-alpha|mesh-list
111008680|NCT00709059|Antimetabolites|antimetabolites|mesh-ancestor
111008681|NCT00709059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111008682|NCT00709059|Antiviral Agents|antiviral agents|mesh-ancestor
111008683|NCT00709059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111008684|NCT00709059|Immunologic Factors|immunologic factors|mesh-ancestor
111008685|NCT00709059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111008686|NCT04500561|Gemcitabine|gemcitabine|mesh-list
111008687|NCT04500561|Oxaliplatin|oxaliplatin|mesh-list
111008688|NCT04500561|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111008689|NCT04500561|Antimetabolites|antimetabolites|mesh-ancestor
111008690|NCT04500561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111008691|NCT04500561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111008692|NCT04507256|Cilgavimab and tixagevimab drug combination|cilgavimab and tixagevimab drug combination|mesh-list
111008693|NCT04507256|Antiviral Agents|antiviral agents|mesh-ancestor
111008694|NCT04507256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111008695|NCT05094596|Montelukast|montelukast|mesh-list
111008696|NCT05094596|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111008697|NCT05094596|Respiratory System Agents|respiratory system agents|mesh-ancestor
111008698|NCT05094596|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
111008699|NCT05094596|Hormone Antagonists|hormone antagonists|mesh-ancestor
111008700|NCT05094596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111008701|NCT05094596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111008702|NCT05094596|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
111008703|NCT05094596|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111008704|NCT05094596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111008705|NCT01678820|Metformin|metformin|mesh-list
111008706|NCT01678820|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111008707|NCT01678820|Glimepiride|glimepiride|mesh-list
111008708|NCT01678820|Simvastatin|simvastatin|mesh-list
111008709|NCT01678820|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111008710|NCT01678820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111008711|NCT01678820|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111008712|NCT01678820|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111008713|NCT01678820|Antimetabolites|antimetabolites|mesh-ancestor
111008714|NCT01678820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111008715|NCT01678820|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111008716|NCT01678820|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111008717|NCT01678820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111008718|NCT01678820|Incretins|incretins|mesh-ancestor
111008719|NCT01678820|Hormones|hormones|mesh-ancestor
111008720|NCT01678820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111008721|NCT01678820|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111008722|NCT01678820|Protease Inhibitors|protease inhibitors|mesh-ancestor
111008723|NCT01678820|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111008724|NCT01678820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111008725|NCT01678820|Immunologic Factors|immunologic factors|mesh-ancestor
111008726|NCT02515695|Interferons|interferons|mesh-list
111008727|NCT02515695|Interferon-beta|interferon-beta|mesh-list
111008728|NCT02515695|Interferon beta-1a|interferon beta-1a|mesh-list
111008729|NCT02515695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111008730|NCT02515695|Antiviral Agents|antiviral agents|mesh-ancestor
111008731|NCT02515695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111008732|NCT02515695|Immunologic Factors|immunologic factors|mesh-ancestor
111008733|NCT02515695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111008734|NCT02515695|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111008735|NCT03346629|Misoprostol|misoprostol|mesh-list
111008736|NCT03346629|Mifepristone|mifepristone|mesh-list
111008737|NCT03346629|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111008738|NCT03346629|Abortifacient Agents|abortifacient agents|mesh-ancestor
111008739|NCT03346629|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111008740|NCT03346629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111008741|NCT03346629|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111008742|NCT03346629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111008743|NCT03346629|Oxytocics|oxytocics|mesh-ancestor
111008744|NCT03346629|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
111008745|NCT03346629|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111008746|NCT03346629|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111008747|NCT03346629|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111008748|NCT03346629|Contraceptive Agents|contraceptive agents|mesh-ancestor
111008749|NCT03346629|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
111008750|NCT03346629|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
111008751|NCT03346629|Hormone Antagonists|hormone antagonists|mesh-ancestor
111008752|NCT03346629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111008753|NCT03346629|Luteolytic Agents|luteolytic agents|mesh-ancestor
111008754|NCT03346629|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111008755|NCT03346629|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
111008756|NCT04501965|Azithromycin|azithromycin|mesh-list
111008757|NCT04501965|Hydroxychloroquine|hydroxychloroquine|mesh-list
111008758|NCT04501965|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111008759|NCT04501965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111008760|NCT04501965|Antimalarials|antimalarials|mesh-ancestor
111008761|NCT04501965|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111008762|NCT04501965|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111008763|NCT04501965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111008764|NCT04501965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111008765|NCT04501965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111008766|NCT04437836|Rifampin|rifampin|mesh-list
111008767|NCT04437836|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111008768|NCT04437836|Antitubercular Agents|antitubercular agents|mesh-ancestor
111008769|NCT04437836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111008770|NCT04437836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111008771|NCT04437836|Leprostatic Agents|leprostatic agents|mesh-ancestor
111008772|NCT04437836|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111008773|NCT04437836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111008774|NCT04437836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111008775|NCT04437836|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111008776|NCT04437836|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111008777|NCT04437836|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
111008778|NCT04437836|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
111008779|NCT04437836|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
111008780|NCT04437836|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111008781|NCT03122067|Oxytocin|oxytocin|mesh-list
111008782|NCT03122067|Oxytocics|oxytocics|mesh-ancestor
111008783|NCT03122067|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111008784|NCT03122067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111008785|NCT04536194|Dopamine|dopamine|mesh-list
111008786|NCT04536194|Norepinephrine|norepinephrine|mesh-list
111008787|NCT04536194|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111008788|NCT04536194|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111008789|NCT04536194|Adrenergic Agents|adrenergic agents|mesh-ancestor
111008790|NCT04536194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111008791|NCT04536194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111008792|NCT04536194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111008793|NCT04536194|Sympathomimetics|sympathomimetics|mesh-ancestor
111008794|NCT04536194|Autonomic Agents|autonomic agents|mesh-ancestor
111008795|NCT04536194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111008796|NCT04536194|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111008797|NCT04536194|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111008798|NCT04536194|Dopamine Agents|dopamine agents|mesh-ancestor
111008799|NCT04536194|Protective Agents|protective agents|mesh-ancestor
111008800|NCT03122769|Metformin|metformin|mesh-list
111008801|NCT03122769|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111008802|NCT03122769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111008803|NCT03121833|Endostar protein|endostar protein|mesh-list
111008804|NCT03121833|Endostatins|endostatins|mesh-list
111008805|NCT03121833|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111008806|NCT03121833|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111008807|NCT03121833|Growth Substances|growth substances|mesh-ancestor
111008808|NCT03121833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111008809|NCT03121833|Growth Inhibitors|growth inhibitors|mesh-ancestor
111008810|NCT03121833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111008811|NCT03121521|Melatonin|melatonin|mesh-list
111008812|NCT03121521|Antioxidants|antioxidants|mesh-ancestor
111008813|NCT03121521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111008814|NCT03121521|Protective Agents|protective agents|mesh-ancestor
111008815|NCT03121521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111008816|NCT03121521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111008817|NCT03046862|Gemcitabine|gemcitabine|mesh-list
111008818|NCT03046862|Durvalumab|durvalumab|mesh-list
111008819|NCT03046862|Tremelimumab|tremelimumab|mesh-list
111008820|NCT03046862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111008821|NCT03046862|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111008822|NCT03046862|Antimetabolites|antimetabolites|mesh-ancestor
111008823|NCT03046862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111008824|NCT03046862|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111008825|NCT05590923|Dexamethasone|dexamethasone|mesh-list
111008826|NCT05590923|Olanzapine|olanzapine|mesh-list
111008827|NCT05590923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111008828|NCT05590923|Antiemetics|antiemetics|mesh-ancestor
111008829|NCT05590923|Autonomic Agents|autonomic agents|mesh-ancestor
111008830|NCT05590923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111008831|NCT05590923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111008832|NCT05590923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111008833|NCT05590923|Glucocorticoids|glucocorticoids|mesh-ancestor
111008834|NCT05590923|Hormones|hormones|mesh-ancestor
111008835|NCT05590923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111008836|NCT05590923|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111008837|NCT05590923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111008838|NCT05590923|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111008839|NCT05590923|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111008840|NCT05590923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111008841|NCT05590923|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111008842|NCT05590923|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111008843|NCT05590923|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111008844|NCT05590923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111008845|NCT05590923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111008846|NCT05590923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111008847|NCT05590923|Serotonin Agents|serotonin agents|mesh-ancestor
111008848|NCT02643056|Panitumumab|panitumumab|mesh-list
111008849|NCT02643056|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111008850|NCT02643056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111008851|NCT02515617|Silver Sulfadiazine|silver sulfadiazine|mesh-list
111008852|NCT02515617|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111008853|NCT02515617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111008854|NCT04413422|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
111008855|NCT04413422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111008856|NCT04413422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111008858|NCT02238145|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111008859|NCT02238145|Autonomic Agents|autonomic agents|mesh-ancestor
111008860|NCT02238145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111008861|NCT02238145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111008862|NCT02238145|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111008863|NCT02238145|Respiratory System Agents|respiratory system agents|mesh-ancestor
111008864|NCT02238145|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111008865|NCT02238145|Cholinergic Agents|cholinergic agents|mesh-ancestor
111008866|NCT02238145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111008867|NCT02238145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111008868|NCT04550637|Apixaban|apixaban|mesh-list
111008869|NCT04550637|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111008870|NCT04550637|Antithrombins|antithrombins|mesh-ancestor
111008871|NCT04550637|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111008872|NCT04550637|Protease Inhibitors|protease inhibitors|mesh-ancestor
111008873|NCT04550637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111008874|NCT04550637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111008875|NCT04550637|Anticoagulants|anticoagulants|mesh-ancestor
111008876|NCT03345303|Bortezomib|bortezomib|mesh-list
111008877|NCT03345303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111008878|NCT03574909|Aspirin|aspirin|mesh-list
111008879|NCT03574909|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111008880|NCT03574909|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111008881|NCT03574909|Analgesics|analgesics|mesh-ancestor
111008882|NCT03574909|Sensory System Agents|sensory system agents|mesh-ancestor
111008883|NCT03574909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111008884|NCT03574909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111008885|NCT03574909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111008886|NCT03574909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111008887|NCT03574909|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111008888|NCT03574909|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111008889|NCT03574909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111008890|NCT03574909|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111008891|NCT03574909|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111008892|NCT03574909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111008893|NCT03574909|Antipyretics|antipyretics|mesh-ancestor
111008894|NCT03579043|Cocaine|cocaine|mesh-list
111008895|NCT03579043|Anesthetics, Local|anesthetics, local|mesh-ancestor
111008896|NCT03579043|Anesthetics|anesthetics|mesh-ancestor
111008897|NCT03579043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111008898|NCT03579043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111008899|NCT03579043|Sensory System Agents|sensory system agents|mesh-ancestor
111008900|NCT03579043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111008901|NCT03579043|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111008902|NCT03579043|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111008903|NCT03579043|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111008904|NCT03579043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111008905|NCT03579043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111008906|NCT03579043|Dopamine Agents|dopamine agents|mesh-ancestor
111008907|NCT03579043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111008908|NCT02660138|Hemagglutinins|hemagglutinins|mesh-list
111008909|NCT02660138|Botulinum Toxins|botulinum toxins|mesh-list
111008910|NCT02660138|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111008911|NCT02660138|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111008912|NCT02660138|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111008913|NCT02660138|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111008914|NCT02660138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111008915|NCT02660138|Cholinergic Agents|cholinergic agents|mesh-ancestor
111008916|NCT02660138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111008917|NCT02660138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111008918|NCT02660138|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111008919|NCT02660138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111008920|NCT02660138|Agglutinins|agglutinins|mesh-ancestor
111008921|NCT02660138|Immunologic Factors|immunologic factors|mesh-ancestor
111008922|NCT02660138|Coagulants|coagulants|mesh-ancestor
111008923|NCT03576469|Complement C1s|complement c1s|mesh-list
111008924|NCT03576469|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
110621364|NCT00759200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111008925|NCT03576469|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
111008926|NCT03576469|Immunologic Factors|immunologic factors|mesh-ancestor
111008927|NCT03576469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111008928|NCT03576469|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
111008929|NCT03576469|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111008930|NCT05036876|Insulin Glargine|insulin glargine|mesh-list
111008931|NCT05036876|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111008932|NCT05036876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111008933|NCT05097950|Acetaminophen|acetaminophen|mesh-list
111008934|NCT05097950|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111008935|NCT05097950|Analgesics|analgesics|mesh-ancestor
111008936|NCT05097950|Sensory System Agents|sensory system agents|mesh-ancestor
111008937|NCT05097950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111008938|NCT05097950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111008939|NCT05097950|Antipyretics|antipyretics|mesh-ancestor
111008940|NCT05097248|Doxorubicin|doxorubicin|mesh-list
111008941|NCT05097248|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111008942|NCT05097248|Losartan|losartan|mesh-list
111008943|NCT05097248|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111008944|NCT05097248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111008945|NCT05097248|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111008946|NCT05097248|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111008947|NCT05097248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111008948|NCT05097248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111008949|NCT05097248|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111008950|NCT05097248|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111008951|NCT05097248|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111008952|NCT05097248|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111008953|NCT01603394|Pregabalin|pregabalin|mesh-list
111008954|NCT01603394|Analgesics|analgesics|mesh-ancestor
111008955|NCT01603394|Sensory System Agents|sensory system agents|mesh-ancestor
111008956|NCT01603394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111008957|NCT01603394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111008958|NCT01603394|Anticonvulsants|anticonvulsants|mesh-ancestor
111008959|NCT01603394|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111008960|NCT01603394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111008961|NCT01603394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111008962|NCT01603394|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111008963|NCT01603394|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111008964|NCT01603394|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111008965|NCT01603394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111008966|NCT01603394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111008967|NCT04682522|Metronidazole|metronidazole|mesh-list
111008968|NCT04682522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111008969|NCT04682522|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111008970|NCT04682522|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111008971|NCT04682522|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111008972|NCT02837432|Hydrocortisone|hydrocortisone|mesh-list
111008973|NCT02837432|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
111008974|NCT02837432|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
111008975|NCT02837432|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
111008976|NCT02837432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111008977|NCT02729025|Evolocumab|evolocumab|mesh-list
111008978|NCT02729025|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
111008979|NCT02729025|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111008980|NCT02729025|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111008981|NCT02729025|Antimetabolites|antimetabolites|mesh-ancestor
111008982|NCT02729025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111008983|NCT02729025|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111008984|NCT02729025|Protease Inhibitors|protease inhibitors|mesh-ancestor
111008985|NCT02729025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111008986|NCT02729025|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111008987|NCT05599971|Fluorouracil|fluorouracil|mesh-list
111008988|NCT05599971|Digoxin|digoxin|mesh-list
111008989|NCT05599971|Furosemide|furosemide|mesh-list
111008990|NCT05599971|Antimetabolites|antimetabolites|mesh-ancestor
110621371|NCT01299753|Propranolol|propranolol|mesh-list
111008991|NCT05599971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111008992|NCT05599971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111008993|NCT05599971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111008994|NCT05599971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111008995|NCT05599971|Immunologic Factors|immunologic factors|mesh-ancestor
111008996|NCT05599971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111008997|NCT05599971|Diuretics|diuretics|mesh-ancestor
111008998|NCT05599971|Natriuretic Agents|natriuretic agents|mesh-ancestor
111008999|NCT05599971|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
111009000|NCT05599971|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111009001|NCT05599971|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111009002|NCT05599971|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111009003|NCT05599971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111009004|NCT05599971|Protective Agents|protective agents|mesh-ancestor
111009005|NCT02511873|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-list
111009006|NCT02511873|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111009007|NCT02511873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111009008|NCT02511873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111009009|NCT02511873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111009010|NCT02511795|Olaparib|olaparib|mesh-list
111009011|NCT02511795|Adavosertib|adavosertib|mesh-list
111009012|NCT02511795|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111009013|NCT02511795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111009014|NCT02511795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111009015|NCT02511795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111009016|NCT04796636|Ascorbic Acid|ascorbic acid|mesh-list
111009017|NCT04796636|Antioxidants|antioxidants|mesh-ancestor
111009018|NCT04796636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111009019|NCT04796636|Protective Agents|protective agents|mesh-ancestor
111009020|NCT04796636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111009021|NCT04796636|Vitamins|vitamins|mesh-ancestor
111009022|NCT04796636|Micronutrients|micronutrients|mesh-ancestor
111009023|NCT04501809|Misoprostol|misoprostol|mesh-list
111009024|NCT04501809|Oxytocin|oxytocin|mesh-list
111009026|NCT04501809|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111009027|NCT04501809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111009028|NCT04501809|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111009029|NCT04501809|Abortifacient Agents|abortifacient agents|mesh-ancestor
111009030|NCT04501809|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111009031|NCT04501809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111009032|NCT04718636|Moxifloxacin|moxifloxacin|mesh-list
111009033|NCT04718636|Contraceptive Agents|contraceptive agents|mesh-list
111009034|NCT04718636|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
111009035|NCT04718636|Contraceptives, Oral|contraceptives, oral|mesh-list
111009036|NCT04718636|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111009037|NCT04718636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111009038|NCT04718636|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111009039|NCT04718636|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111009040|NCT04718636|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
111009041|NCT04718636|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111009042|NCT04718636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111009043|NCT04718636|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111009044|NCT04718636|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111009045|NCT04718636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111009046|NCT04718636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111009047|NCT04718636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111009048|NCT02514681|Paclitaxel|paclitaxel|mesh-list
111009049|NCT02514681|Vinorelbine|vinorelbine|mesh-list
111009050|NCT02514681|Docetaxel|docetaxel|mesh-list
111009051|NCT02514681|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111009052|NCT02514681|Gemcitabine|gemcitabine|mesh-list
111009053|NCT02514681|Capecitabine|capecitabine|mesh-list
111009054|NCT02514681|Trastuzumab|trastuzumab|mesh-list
111009055|NCT02514681|Pertuzumab|pertuzumab|mesh-list
111009056|NCT02514681|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111009057|NCT02514681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111009058|NCT02514681|Tubulin Modulators|tubulin modulators|mesh-ancestor
111009059|NCT02514681|Antimitotic Agents|antimitotic agents|mesh-ancestor
111009060|NCT02514681|Mitosis Modulators|mitosis modulators|mesh-ancestor
111009061|NCT02514681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111009062|NCT02514681|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111009063|NCT02514681|Antimetabolites|antimetabolites|mesh-ancestor
111009064|NCT02514681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111009065|NCT02511639|Everolimus|everolimus|mesh-list
111009066|NCT02511639|Letrozole|letrozole|mesh-list
111009067|NCT02511639|Anastrozole|anastrozole|mesh-list
111009068|NCT02511639|Exemestane|exemestane|mesh-list
111009069|NCT02511639|Aromatase Inhibitors|aromatase inhibitors|mesh-list
111009070|NCT02511639|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111009071|NCT02511639|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111009072|NCT02511639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110474014|NCT02696733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111009073|NCT02511639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111009074|NCT02511639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111009075|NCT02511639|Immunologic Factors|immunologic factors|mesh-ancestor
111009076|NCT02511639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111009077|NCT02511639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111009078|NCT02511639|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111009079|NCT02511639|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111009080|NCT02511639|Hormone Antagonists|hormone antagonists|mesh-ancestor
111009081|NCT02511639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111009082|NCT02511639|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111009083|NCT02514603|Prexasertib|prexasertib|mesh-list
111009084|NCT02514603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111009085|NCT02514603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111009086|NCT02514603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111009087|NCT02511483|Propranolol|propranolol|mesh-list
111009089|NCT02511483|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111009090|NCT02511483|Narcotics|narcotics|mesh-ancestor
111009091|NCT02511483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111009092|NCT02511483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111009093|NCT02511483|Analgesics|analgesics|mesh-ancestor
111009094|NCT02511483|Sensory System Agents|sensory system agents|mesh-ancestor
111009095|NCT02511483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111009096|NCT02511483|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111009097|NCT02511483|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111009098|NCT02511483|Adrenergic Agents|adrenergic agents|mesh-ancestor
111009099|NCT02511483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111009100|NCT02511483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111009102|NCT02511483|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111009103|NCT02511483|Vasodilator Agents|vasodilator agents|mesh-ancestor
111009104|NCT04429802|Prucalopride|prucalopride|mesh-list
111009105|NCT04429802|Laxatives|laxatives|mesh-ancestor
111009106|NCT04429802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111009107|NCT04429802|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
111009108|NCT04429802|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111009109|NCT04429802|Serotonin Agents|serotonin agents|mesh-ancestor
111009110|NCT04429802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111009111|NCT04429802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111009112|NCT04429802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111009113|NCT02511405|Bevacizumab|bevacizumab|mesh-list
111009114|NCT02511405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111009115|NCT02511405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111009116|NCT02511405|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111009117|NCT02511405|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111009118|NCT02511405|Growth Substances|growth substances|mesh-ancestor
111009119|NCT02511405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111009120|NCT02511405|Growth Inhibitors|growth inhibitors|mesh-ancestor
111009121|NCT04387760|Hydroxychloroquine|hydroxychloroquine|mesh-list
111009122|NCT04387760|Favipiravir|favipiravir|mesh-list
111009123|NCT04387760|Antimalarials|antimalarials|mesh-ancestor
111009124|NCT04387760|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111009125|NCT04387760|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111009126|NCT04387760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110268668|NCT00551317|Darapladib|darapladib|mesh-list
111009127|NCT04387760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111009128|NCT04387760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111009129|NCT04387760|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111009130|NCT04387760|Antiviral Agents|antiviral agents|mesh-ancestor
111009131|NCT05091086|Zoledronic Acid|zoledronic acid|mesh-list
111009132|NCT05091086|Denosumab|denosumab|mesh-list
111009133|NCT05091086|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111009134|NCT05091086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111009135|NCT05091008|Sofosbuvir|sofosbuvir|mesh-list
111009136|NCT05091008|Ledipasvir|ledipasvir|mesh-list
111009137|NCT05091008|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
111009138|NCT05091008|Antiviral Agents|antiviral agents|mesh-ancestor
111009139|NCT05091008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111009140|NCT02918084|Letrozole|letrozole|mesh-list
111009141|NCT02918084|Anastrozole|anastrozole|mesh-list
111009142|NCT02918084|Exemestane|exemestane|mesh-list
111009143|NCT02918084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111009144|NCT02918084|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111009145|NCT02918084|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111009146|NCT02918084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111009147|NCT02918084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110474101|NCT02774187|Leucovorin|leucovorin|mesh-list
111009148|NCT02918084|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111009149|NCT02918084|Hormone Antagonists|hormone antagonists|mesh-ancestor
111009150|NCT02918084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111009151|NCT02918084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111009152|NCT02918084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111009153|NCT01603082|Clopidogrel|clopidogrel|mesh-list
111009154|NCT01603082|Ticagrelor|ticagrelor|mesh-list
111009155|NCT01603082|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111009156|NCT01603082|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111009157|NCT01603082|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111009158|NCT01603082|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111009159|NCT01603082|Purinergic Agents|purinergic agents|mesh-ancestor
111009160|NCT01603082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111009161|NCT01603082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111009162|NCT01603082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111009163|NCT04499313|Dexamethasone|dexamethasone|mesh-list
111009164|NCT04499313|Methylprednisolone|methylprednisolone|mesh-list
111009165|NCT04499313|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111009166|NCT04499313|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111009167|NCT04499313|Prednisolone|prednisolone|mesh-list
111009168|NCT04499313|Prednisolone acetate|prednisolone acetate|mesh-list
111009169|NCT04499313|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111009170|NCT04499313|Prednisolone phosphate|prednisolone phosphate|mesh-list
111009171|NCT04499313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111009172|NCT04499313|Antiemetics|antiemetics|mesh-ancestor
111009173|NCT04499313|Autonomic Agents|autonomic agents|mesh-ancestor
110726159|NCT01076556|Growth Inhibitors|growth inhibitors|mesh-ancestor
111009174|NCT04499313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111009175|NCT04499313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111009176|NCT04499313|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111009177|NCT04499313|Glucocorticoids|glucocorticoids|mesh-ancestor
111009178|NCT04499313|Hormones|hormones|mesh-ancestor
111009179|NCT04499313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111009180|NCT04499313|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111009181|NCT04499313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111009182|NCT04499313|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111009183|NCT04499313|Protective Agents|protective agents|mesh-ancestor
111009184|NCT04331756|Anesthetics|anesthetics|mesh-list
111009185|NCT04331756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111009186|NCT04331756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111009187|NCT02510781|Carboplatin|carboplatin|mesh-list
111009188|NCT02510781|Docetaxel|docetaxel|mesh-list
111009189|NCT02510781|Trastuzumab|trastuzumab|mesh-list
111009190|NCT02510781|Epirubicin|epirubicin|mesh-list
111009191|NCT02510781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111009192|NCT02510781|Tubulin Modulators|tubulin modulators|mesh-ancestor
111009193|NCT02510781|Antimitotic Agents|antimitotic agents|mesh-ancestor
111009194|NCT02510781|Mitosis Modulators|mitosis modulators|mesh-ancestor
111009195|NCT02510781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111009196|NCT02510781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111009197|NCT02510781|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111009198|NCT02510781|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111009199|NCT02510781|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111009200|NCT02510781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111009201|NCT03121599|Alovudine|alovudine|mesh-list
111009202|NCT03121599|Antiviral Agents|antiviral agents|mesh-ancestor
111009203|NCT03121599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111009204|NCT03576079|Salicylic Acid|salicylic acid|mesh-list
111009205|NCT03576079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111009206|NCT03576079|Antifungal Agents|antifungal agents|mesh-ancestor
111009207|NCT03576079|Keratolytic Agents|keratolytic agents|mesh-ancestor
111009208|NCT03576079|Dermatologic Agents|dermatologic agents|mesh-ancestor
111009209|NCT04181606|Esmolol|esmolol|mesh-list
111009210|NCT04181606|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
111009211|NCT04181606|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111009212|NCT04181606|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111009213|NCT04181606|Adrenergic Agents|adrenergic agents|mesh-ancestor
111009214|NCT04181606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111009215|NCT04181606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111009216|NCT04181606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111009217|NCT02510469|Apatinib|apatinib|mesh-list
111009218|NCT02510469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111009219|NCT02510469|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111009220|NCT02510469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111009221|NCT02510469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111009222|NCT02510235|Hyaluronic Acid|hyaluronic acid|mesh-list
111009223|NCT02510235|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111009224|NCT02510235|Immunologic Factors|immunologic factors|mesh-ancestor
111009225|NCT02510235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111009226|NCT02510235|Viscosupplements|viscosupplements|mesh-ancestor
111009227|NCT02510235|Protective Agents|protective agents|mesh-ancestor
111009228|NCT05081336|Alirocumab|alirocumab|mesh-list
111009229|NCT05081336|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
111009230|NCT05081336|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111009231|NCT05081336|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111009232|NCT05081336|Antimetabolites|antimetabolites|mesh-ancestor
111009233|NCT05081336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111009234|NCT05081336|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111009235|NCT05081336|Protease Inhibitors|protease inhibitors|mesh-ancestor
111009236|NCT05081336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111009237|NCT05081336|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111009238|NCT03578497|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
111009239|NCT03578497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111009240|NCT03710876|Celecoxib|celecoxib|mesh-list
111009241|NCT03710876|Gemcitabine|gemcitabine|mesh-list
111009242|NCT03710876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111009243|NCT03710876|Antimetabolites|antimetabolites|mesh-ancestor
111009244|NCT03710876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111009245|NCT03710876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111009246|NCT03710876|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111009247|NCT03710876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111009248|NCT03710876|Analgesics|analgesics|mesh-ancestor
111009249|NCT03710876|Sensory System Agents|sensory system agents|mesh-ancestor
111009250|NCT03710876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111009251|NCT03710876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111009252|NCT03710876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111009253|NCT03710876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111009254|NCT03710876|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111009255|NCT03710876|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111009256|NCT03710876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111009258|NCT02513433|Ropivacaine|ropivacaine|mesh-list
111009259|NCT02513433|Levobupivacaine|levobupivacaine|mesh-list
111009260|NCT02513433|Anesthetics, Local|anesthetics, local|mesh-ancestor
111009261|NCT02513433|Anesthetics|anesthetics|mesh-ancestor
111009262|NCT02513433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111009263|NCT02513433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111009264|NCT02513433|Sensory System Agents|sensory system agents|mesh-ancestor
111009265|NCT02513433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111009266|NCT02510157|Dexamethasone|dexamethasone|mesh-list
111009267|NCT02510157|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111009268|NCT02510157|Antiemetics|antiemetics|mesh-ancestor
111009269|NCT02510157|Autonomic Agents|autonomic agents|mesh-ancestor
111009270|NCT02510157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111009271|NCT02510157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111009272|NCT02510157|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111009273|NCT02510157|Glucocorticoids|glucocorticoids|mesh-ancestor
111009274|NCT02510157|Hormones|hormones|mesh-ancestor
111009275|NCT02510157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111009276|NCT02510157|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111009277|NCT02510157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111009278|NCT03345147|Vitamins|vitamins|mesh-list
111009279|NCT03345147|Vitamin A|vitamin a|mesh-list
111009280|NCT03345147|Retinol palmitate|retinol palmitate|mesh-list
111009281|NCT03345147|Micronutrients|micronutrients|mesh-ancestor
111009282|NCT03345147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111009283|NCT03345147|Antioxidants|antioxidants|mesh-ancestor
111009284|NCT03345147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111009285|NCT03345147|Protective Agents|protective agents|mesh-ancestor
111009286|NCT03345147|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
111009287|NCT03345147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111009288|NCT03662919|Adalimumab|adalimumab|mesh-list
111009289|NCT03662919|Infliximab|infliximab|mesh-list
111009290|NCT03662919|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111009291|NCT03662919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111009292|NCT03662919|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111009293|NCT03662919|Dermatologic Agents|dermatologic agents|mesh-ancestor
111009294|NCT03662919|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111009295|NCT05375240|Ceftriaxone|ceftriaxone|mesh-list
111009296|NCT05375240|Propranolol|propranolol|mesh-list
111009297|NCT05375240|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111009298|NCT05375240|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111009299|NCT05375240|Adrenergic Agents|adrenergic agents|mesh-ancestor
111009300|NCT05375240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111009301|NCT05375240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111009302|NCT05375240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111009303|NCT05375240|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111009304|NCT05375240|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111009305|NCT05375240|Vasodilator Agents|vasodilator agents|mesh-ancestor
111009306|NCT05375240|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111009307|NCT05375240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111009308|NCT00406393|Sirolimus|sirolimus|mesh-list
111009309|NCT00406393|Methotrexate|methotrexate|mesh-list
111009310|NCT00406393|Tacrolimus|tacrolimus|mesh-list
111009311|NCT00406393|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111009312|NCT00406393|Abortifacient Agents|abortifacient agents|mesh-ancestor
111009313|NCT00406393|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111009314|NCT00406393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111009315|NCT00406393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111009316|NCT00406393|Antimetabolites|antimetabolites|mesh-ancestor
111009317|NCT00406393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111009318|NCT00406393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111009319|NCT00406393|Dermatologic Agents|dermatologic agents|mesh-ancestor
111009320|NCT00406393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111009321|NCT00406393|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111009322|NCT00406393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111009323|NCT00406393|Immunologic Factors|immunologic factors|mesh-ancestor
111009324|NCT00406393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111009325|NCT00406393|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111009326|NCT00406393|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111009327|NCT00406393|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111009328|NCT00406393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111009329|NCT00406393|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111009330|NCT00406393|Antifungal Agents|antifungal agents|mesh-ancestor
111009332|NCT02513355|Endostar protein|endostar protein|mesh-list
111009333|NCT02513355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111009334|NCT02513355|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111009335|NCT02513355|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111009336|NCT02513355|Growth Substances|growth substances|mesh-ancestor
111009337|NCT02513355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111009338|NCT02513355|Growth Inhibitors|growth inhibitors|mesh-ancestor
111009339|NCT03574285|Sarpogrelate|sarpogrelate|mesh-list
111009340|NCT03574285|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111009341|NCT03574285|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111009342|NCT03574285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111009343|NCT03574285|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111009344|NCT03574285|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111009345|NCT03574285|Serotonin Agents|serotonin agents|mesh-ancestor
111009346|NCT03574285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111009347|NCT03574285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111009348|NCT02509923|Rabeprazole|rabeprazole|mesh-list
111009349|NCT02509923|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111009350|NCT02509923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111009351|NCT02509923|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111009352|NCT02509923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111009353|NCT02509923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111009354|NCT03578263|Oxytocin|oxytocin|mesh-list
111009355|NCT03578263|Carbetocin|carbetocin|mesh-list
111009356|NCT03578263|Ergonovine|ergonovine|mesh-list
111009357|NCT03578263|Oxytocics|oxytocics|mesh-ancestor
111009358|NCT03578263|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111009359|NCT03578263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111009360|NCT03572257|Quetiapine Fumarate|quetiapine fumarate|mesh-list
111009361|NCT03572257|Antidepressive Agents|antidepressive agents|mesh-ancestor
111009362|NCT03572257|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111009363|NCT03572257|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111009364|NCT03572257|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111009365|NCT03572257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111009366|NCT03572257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111009367|NCT02845375|Neostigmine|neostigmine|mesh-list
111009368|NCT02845375|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111009369|NCT02845375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111009370|NCT02845375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111009371|NCT02845375|Cholinergic Agents|cholinergic agents|mesh-ancestor
111009372|NCT02845375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111009373|NCT02845375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111009374|NCT02845375|Parasympathomimetics|parasympathomimetics|mesh-ancestor
111009375|NCT02845375|Autonomic Agents|autonomic agents|mesh-ancestor
111009376|NCT02845375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111009377|NCT02979860|Oxymetazoline|oxymetazoline|mesh-list
111009378|NCT02979860|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111009379|NCT02979860|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111009380|NCT02979860|Adrenergic Agents|adrenergic agents|mesh-ancestor
111009381|NCT02979860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111009382|NCT02979860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111009383|NCT02979860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111009384|NCT02979860|Sympathomimetics|sympathomimetics|mesh-ancestor
111009385|NCT02979860|Autonomic Agents|autonomic agents|mesh-ancestor
111009386|NCT02979860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111009387|NCT02979860|Nasal Decongestants|nasal decongestants|mesh-ancestor
111009388|NCT02979860|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111009389|NCT02979860|Respiratory System Agents|respiratory system agents|mesh-ancestor
111009390|NCT03344679|Magnesium Sulfate|magnesium sulfate|mesh-list
111009391|NCT03344679|Adenosine|adenosine|mesh-list
111009392|NCT03344679|Bupivacaine|bupivacaine|mesh-list
111009393|NCT03344679|Anesthetics, Local|anesthetics, local|mesh-ancestor
111009394|NCT03344679|Anesthetics|anesthetics|mesh-ancestor
111009395|NCT03344679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111009396|NCT03344679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111009397|NCT03344679|Sensory System Agents|sensory system agents|mesh-ancestor
111009398|NCT03344679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111009399|NCT03344679|Analgesics|analgesics|mesh-ancestor
111009400|NCT03344679|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111009401|NCT03344679|Anticonvulsants|anticonvulsants|mesh-ancestor
111009402|NCT03344679|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111009403|NCT03344679|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111009404|NCT03344679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111009405|NCT03344679|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111009406|NCT03344679|Tocolytic Agents|tocolytic agents|mesh-ancestor
111009407|NCT03344679|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111009408|NCT03344679|Vasodilator Agents|vasodilator agents|mesh-ancestor
111009409|NCT03344679|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
111009410|NCT03344679|Purinergic Agonists|purinergic agonists|mesh-ancestor
111009411|NCT03344679|Purinergic Agents|purinergic agents|mesh-ancestor
111009412|NCT03344679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111009413|NCT02259829|Amlodipine|amlodipine|mesh-list
111009414|NCT02259829|Telmisartan|telmisartan|mesh-list
111009415|NCT02259829|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
111009416|NCT02259829|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111009417|NCT02259829|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111009418|NCT02259829|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111009419|NCT02259829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111009420|NCT02259829|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111009421|NCT02259829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111009422|NCT02259829|Vasodilator Agents|vasodilator agents|mesh-ancestor
111009423|NCT02259829|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111009424|NCT02259829|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111009425|NCT03344523|Iron protein succinylate|iron protein succinylate|mesh-list
111009426|NCT03344523|Hematinics|hematinics|mesh-ancestor
111009427|NCT02658734|Trastuzumab|trastuzumab|mesh-list
111009428|NCT02658734|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
111009429|NCT02658734|Maytansine|maytansine|mesh-list
111009430|NCT02658734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111009431|NCT02658734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111009432|NCT02658734|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111009433|NCT02658734|Tubulin Modulators|tubulin modulators|mesh-ancestor
111009434|NCT02658734|Antimitotic Agents|antimitotic agents|mesh-ancestor
111009435|NCT02658734|Mitosis Modulators|mitosis modulators|mesh-ancestor
111009436|NCT02658734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111009437|NCT02658734|Immunotoxins|immunotoxins|mesh-ancestor
111009438|NCT02658734|Immunoconjugates|immunoconjugates|mesh-ancestor
111009439|NCT02658734|Immunologic Factors|immunologic factors|mesh-ancestor
111009440|NCT02658734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111009441|NCT03344445|Anesthetics|anesthetics|mesh-list
111009442|NCT03344445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111009443|NCT03344445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111009444|NCT04501107|Insulin|insulin|mesh-list
111009445|NCT04501107|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111009446|NCT04501107|Insulin Lispro|insulin lispro|mesh-list
111009447|NCT04501107|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111009448|NCT04501107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111009450|NCT03143985|Vactosertib|vactosertib|mesh-list
111009451|NCT03143985|Immunologic Factors|immunologic factors|mesh-ancestor
111009452|NCT03143985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111009453|NCT03143985|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111009454|NCT03143985|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111009455|NCT03143985|Growth Substances|growth substances|mesh-ancestor
111009456|NCT03143985|Growth Inhibitors|growth inhibitors|mesh-ancestor
111009457|NCT03143985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111009458|NCT03143985|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111009459|NCT03143985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111009460|NCT03143985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111009461|NCT02605148|Vitamin D|vitamin d|mesh-list
111009462|NCT02605148|Vitamins|vitamins|mesh-ancestor
111009463|NCT02605148|Micronutrients|micronutrients|mesh-ancestor
111009464|NCT02605148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111009465|NCT02605148|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111009466|NCT02395640|Capecitabine|capecitabine|mesh-list
111009467|NCT02395640|Oxaliplatin|oxaliplatin|mesh-list
111009468|NCT02395640|Epirubicin|epirubicin|mesh-list
111009469|NCT02395640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111009470|NCT02395640|Antimetabolites|antimetabolites|mesh-ancestor
111009471|NCT02395640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111009472|NCT02395640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111009473|NCT02395640|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111009474|NCT02395640|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111009475|NCT02395640|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111009476|NCT02395640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111009477|NCT02509143|Ramosetron|ramosetron|mesh-list
111009478|NCT02509143|Antiemetics|antiemetics|mesh-list
111009479|NCT02509143|Autonomic Agents|autonomic agents|mesh-ancestor
111009480|NCT02509143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111009481|NCT02509143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111009482|NCT02509143|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111009483|NCT02509143|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111009484|NCT02509143|Serotonin Agents|serotonin agents|mesh-ancestor
111009485|NCT02509143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111009486|NCT02509143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111009487|NCT05100446|Amoxicillin|amoxicillin|mesh-list
111009488|NCT05100446|Esomeprazole|esomeprazole|mesh-list
111009489|NCT05100446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111009490|NCT05100446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111009491|NCT05100446|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111009492|NCT05100446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111009493|NCT05100446|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111009494|NCT05100446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111009495|NCT05100446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111009496|NCT02506803|Paclitaxel|paclitaxel|mesh-list
111009497|NCT02506803|Gemcitabine|gemcitabine|mesh-list
111009498|NCT02506803|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111009499|NCT02506803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111009500|NCT02506803|Tubulin Modulators|tubulin modulators|mesh-ancestor
111009501|NCT02506803|Antimitotic Agents|antimitotic agents|mesh-ancestor
111009502|NCT02506803|Mitosis Modulators|mitosis modulators|mesh-ancestor
111009503|NCT02506803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111009504|NCT02506803|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111009505|NCT02506803|Antimetabolites|antimetabolites|mesh-ancestor
111009506|NCT02844439|XL647|xl647|mesh-list
111009507|NCT02844439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111009508|NCT02844439|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111009509|NCT02844439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111009510|NCT02844439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111009511|NCT04531592|Valproic Acid|valproic acid|mesh-list
111009512|NCT04531592|Anticonvulsants|anticonvulsants|mesh-ancestor
111009513|NCT04531592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111009514|NCT04531592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111009515|NCT04531592|GABA Agents|gaba agents|mesh-ancestor
111009516|NCT04531592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111009517|NCT04531592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111009518|NCT04531592|Antimanic Agents|antimanic agents|mesh-ancestor
111009519|NCT04531592|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111009520|NCT04531592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111009521|NCT04531592|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111009522|NCT03571711|Meropenem|meropenem|mesh-list
111009523|NCT03571711|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111009524|NCT03571711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111009525|NCT03570541|Acetaminophen|acetaminophen|mesh-list
111009526|NCT03570541|Morphine|morphine|mesh-list
111009527|NCT03570541|Ropivacaine|ropivacaine|mesh-list
111009528|NCT03570541|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111009529|NCT03570541|Narcotics|narcotics|mesh-ancestor
111009530|NCT03570541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111009531|NCT03570541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111009532|NCT03570541|Analgesics|analgesics|mesh-ancestor
111009533|NCT03570541|Sensory System Agents|sensory system agents|mesh-ancestor
111009534|NCT03570541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111009535|NCT03570541|Anesthetics, Local|anesthetics, local|mesh-ancestor
111009536|NCT03570541|Anesthetics|anesthetics|mesh-ancestor
111009537|NCT03570541|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111009538|NCT03570541|Antipyretics|antipyretics|mesh-ancestor
111009539|NCT00708435|Protein C|protein c|mesh-list
111009540|NCT00708435|Protein S|protein s|mesh-list
111009541|NCT00708435|Anticoagulants|anticoagulants|mesh-ancestor
111009542|NCT00708435|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111009543|NCT00708435|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111009544|NCT00708435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111009545|NCT02508753|Moxifloxacin|moxifloxacin|mesh-list
111009546|NCT02508753|Tazobactam|tazobactam|mesh-list
111009547|NCT02508753|Ceftolozane|ceftolozane|mesh-list
111009548|NCT02508753|Cephalosporins|cephalosporins|mesh-list
111009549|NCT02508753|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111009550|NCT02508753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111009551|NCT02508753|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111009552|NCT02508753|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111009553|NCT02508753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111009554|NCT02508753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111009555|NCT02508753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111009556|NCT02508753|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
111009557|NCT02506647|Insulin|insulin|mesh-list
111009558|NCT02506647|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111009559|NCT02506647|Insulin Glargine|insulin glargine|mesh-list
111009560|NCT02506647|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111009561|NCT02506647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111009562|NCT02571530|Trastuzumab|trastuzumab|mesh-list
111009563|NCT02571530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111009564|NCT02571530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111009565|NCT04379024|Bazedoxifene|bazedoxifene|mesh-list
111009566|NCT04379024|Estrogens|estrogens|mesh-list
111009567|NCT04379024|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
111009568|NCT04379024|Hormones|hormones|mesh-ancestor
111009569|NCT04379024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111009570|NCT04379024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111009571|NCT04379024|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111009572|NCT04379024|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111009573|NCT04379024|Hormone Antagonists|hormone antagonists|mesh-ancestor
111009574|NCT04379024|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111009575|NCT04497831|Morphine|morphine|mesh-list
111009576|NCT04497831|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111009577|NCT04497831|Narcotics|narcotics|mesh-ancestor
111009578|NCT04497831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111009579|NCT04497831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111009580|NCT04497831|Analgesics|analgesics|mesh-ancestor
111009581|NCT04497831|Sensory System Agents|sensory system agents|mesh-ancestor
111009582|NCT04497831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111009583|NCT04498689|Paclitaxel|paclitaxel|mesh-list
111009584|NCT04498689|Gemcitabine|gemcitabine|mesh-list
111009585|NCT04498689|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111009586|NCT04498689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111009587|NCT04498689|Tubulin Modulators|tubulin modulators|mesh-ancestor
111009588|NCT04498689|Antimitotic Agents|antimitotic agents|mesh-ancestor
111009589|NCT04498689|Mitosis Modulators|mitosis modulators|mesh-ancestor
111009590|NCT04498689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111009591|NCT04498689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111009592|NCT04498689|Antimetabolites|antimetabolites|mesh-ancestor
111009593|NCT05103098|Misoprostol|misoprostol|mesh-list
111009594|NCT05103098|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111009595|NCT05103098|Abortifacient Agents|abortifacient agents|mesh-ancestor
111009596|NCT05103098|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111009597|NCT05103098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110621498|NCT00762632|Everolimus|everolimus|mesh-list
111009598|NCT05103098|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111009599|NCT05103098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111009600|NCT05103098|Oxytocics|oxytocics|mesh-ancestor
111009601|NCT04272008|Ethinyl Estradiol|ethinyl estradiol|mesh-list
111009602|NCT04272008|Estradiol|estradiol|mesh-list
111009603|NCT04272008|Estrogens|estrogens|mesh-ancestor
111009604|NCT04272008|Hormones|hormones|mesh-ancestor
111009605|NCT04272008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111009606|NCT04272008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111009607|NCT04272008|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111009608|NCT04272008|Contraceptive Agents|contraceptive agents|mesh-ancestor
111009609|NCT04272008|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111009610|NCT04272008|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111009611|NCT04272008|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111009612|NCT04272008|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111009613|NCT05103020|Bevacizumab|bevacizumab|mesh-list
111009614|NCT05103020|Cetuximab|cetuximab|mesh-list
111009615|NCT05103020|Oxaliplatin|oxaliplatin|mesh-list
111009616|NCT05103020|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111009617|NCT05103020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111009618|NCT05103020|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111009619|NCT05103020|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111009620|NCT05103020|Growth Substances|growth substances|mesh-ancestor
111009621|NCT05103020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111009622|NCT05103020|Growth Inhibitors|growth inhibitors|mesh-ancestor
111009623|NCT02501109|Aripiprazole|aripiprazole|mesh-list
111009624|NCT02501109|Antidepressive Agents|antidepressive agents|mesh-ancestor
111009625|NCT02501109|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111009626|NCT02501109|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111009627|NCT02501109|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111009628|NCT02501109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111009629|NCT02501109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111009630|NCT02501109|Dopamine Agonists|dopamine agonists|mesh-ancestor
111009631|NCT02501109|Dopamine Agents|dopamine agents|mesh-ancestor
111009632|NCT02501109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111009633|NCT02501109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111009634|NCT02501109|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111009635|NCT02501109|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111009636|NCT02501109|Serotonin Agents|serotonin agents|mesh-ancestor
111009637|NCT02501109|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111009638|NCT02501109|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111009639|NCT02501109|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111009640|NCT02501109|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111009641|NCT05060666|Ivermectin|ivermectin|mesh-list
111009642|NCT05060666|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111009643|NCT05060666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111009644|NCT02506335|Cholic Acids|cholic acids|mesh-list
111009645|NCT02506335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111009646|NCT01353859|Methotrexate|methotrexate|mesh-list
111009647|NCT01353859|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111009648|NCT01353859|Abortifacient Agents|abortifacient agents|mesh-ancestor
111009649|NCT01353859|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111009650|NCT01353859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111009651|NCT01353859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111009652|NCT01353859|Antimetabolites|antimetabolites|mesh-ancestor
111009653|NCT01353859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111009654|NCT01353859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111009655|NCT01353859|Dermatologic Agents|dermatologic agents|mesh-ancestor
111009656|NCT01353859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111009657|NCT01353859|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111009658|NCT01353859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111009659|NCT01353859|Immunologic Factors|immunologic factors|mesh-ancestor
111009660|NCT01353859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111009661|NCT01353859|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111009662|NCT02238197|Ipratropium|ipratropium|mesh-list
111009663|NCT02238197|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111009664|NCT02238197|Autonomic Agents|autonomic agents|mesh-ancestor
111009665|NCT02238197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111009666|NCT02238197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111009667|NCT02238197|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111009668|NCT02238197|Respiratory System Agents|respiratory system agents|mesh-ancestor
111009669|NCT02238197|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111009670|NCT02238197|Cholinergic Agents|cholinergic agents|mesh-ancestor
111009671|NCT02238197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111009672|NCT02238197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111009674|NCT03592199|Axitinib|axitinib|mesh-list
111009675|NCT03592199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111009676|NCT03592199|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111009677|NCT03592199|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111009678|NCT03592199|Growth Substances|growth substances|mesh-ancestor
111009679|NCT03592199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111009680|NCT03592199|Growth Inhibitors|growth inhibitors|mesh-ancestor
111009681|NCT03592199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111009682|NCT03592199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111009683|NCT03592199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111009684|NCT02245867|Antibodies|antibodies|mesh-list
111009685|NCT02245867|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111009686|NCT02245867|Immunologic Factors|immunologic factors|mesh-ancestor
111009687|NCT02245867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111009688|NCT03139916|Temozolomide|temozolomide|mesh-list
111009689|NCT03139916|Bavituximab|bavituximab|mesh-list
111009690|NCT03139916|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111009691|NCT03139916|Alkylating Agents|alkylating agents|mesh-ancestor
111009692|NCT03139916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111009693|NCT03139916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111009694|NCT03139916|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111009695|NCT02507583|Insulin|insulin|mesh-list
111009696|NCT02507583|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111009697|NCT02507583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111009698|NCT02506023|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
111009699|NCT02506023|Hemostatics|hemostatics|mesh-ancestor
111009700|NCT02506023|Coagulants|coagulants|mesh-ancestor
111009701|NCT02506023|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
111009702|NCT02506023|Natriuretic Agents|natriuretic agents|mesh-ancestor
111009703|NCT02506023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111009704|NCT02246179|Lidocaine|lidocaine|mesh-list
111009705|NCT02246179|Epinephrine|epinephrine|mesh-list
111009707|NCT02246179|Carticaine|carticaine|mesh-list
111009708|NCT02246179|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
111009709|NCT02246179|Anesthetics, Local|anesthetics, local|mesh-ancestor
111009710|NCT02246179|Anesthetics|anesthetics|mesh-ancestor
111009711|NCT02246179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111009712|NCT02246179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111009713|NCT02246179|Sensory System Agents|sensory system agents|mesh-ancestor
111009714|NCT02246179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111009715|NCT02246179|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111009716|NCT02246179|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111009717|NCT02246179|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111009718|NCT02246179|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111009719|NCT02246179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111009720|NCT02246179|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111009721|NCT02246179|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111009722|NCT02246179|Adrenergic Agents|adrenergic agents|mesh-ancestor
111009723|NCT02246179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111009724|NCT02246179|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111009725|NCT02246179|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111009726|NCT02246179|Autonomic Agents|autonomic agents|mesh-ancestor
111009727|NCT02246179|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111009728|NCT02246179|Respiratory System Agents|respiratory system agents|mesh-ancestor
111009729|NCT02246179|Mydriatics|mydriatics|mesh-ancestor
110621512|NCT00561015|Ribavirin|ribavirin|mesh-list
111009730|NCT02246179|Sympathomimetics|sympathomimetics|mesh-ancestor
111009731|NCT02246179|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111009732|NCT02246179|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
111009733|NCT02238275|Telmisartan|telmisartan|mesh-list
111009734|NCT02238275|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111009735|NCT02238275|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111009736|NCT02238275|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111009737|NCT02238275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111009738|NCT04495101|Protease Inhibitors|protease inhibitors|mesh-list
111009739|NCT04495101|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
111009740|NCT04495101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111009741|NCT04495101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111009742|NCT04495101|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
111009743|NCT04495101|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111009744|NCT04394117|Losartan|losartan|mesh-list
111009745|NCT04394117|Valsartan|valsartan|mesh-list
111009746|NCT04394117|Telmisartan|telmisartan|mesh-list
111009747|NCT04394117|Candesartan|candesartan|mesh-list
111009748|NCT04394117|Olmesartan|olmesartan|mesh-list
111009749|NCT04394117|Irbesartan|irbesartan|mesh-list
111009750|NCT04394117|Eprosartan|eprosartan|mesh-list
111009751|NCT04394117|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
111009752|NCT04394117|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111009753|NCT04394117|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111009754|NCT04394117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111009755|NCT04394117|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111009756|NCT04394117|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
111009757|NCT02500563|Caseins|caseins|mesh-list
111009758|NCT02500563|Chelating Agents|chelating agents|mesh-ancestor
111009759|NCT02500563|Sequestering Agents|sequestering agents|mesh-ancestor
111009760|NCT02500563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111009761|NCT02500329|Acarbose|acarbose|mesh-list
111009762|NCT02500329|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
111009763|NCT02500329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111009764|NCT02500329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111009765|NCT02500329|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111009766|NCT02500329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111009767|NCT02243137|Aspirin|aspirin|mesh-list
111009768|NCT02243137|Acetylsalicylic acid lysinate|acetylsalicylic acid lysinate|mesh-list
111009769|NCT02243137|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
111009770|NCT02243137|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111009771|NCT02243137|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111009772|NCT02243137|Analgesics|analgesics|mesh-ancestor
111009773|NCT02243137|Sensory System Agents|sensory system agents|mesh-ancestor
111009774|NCT02243137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111009775|NCT02243137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111009776|NCT02243137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111009777|NCT02243137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111009778|NCT02243137|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111009779|NCT02243137|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111009780|NCT02243137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111009781|NCT02243137|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111009782|NCT02243137|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111009783|NCT02243137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111009784|NCT02243137|Antipyretics|antipyretics|mesh-ancestor
111009785|NCT03343977|Docetaxel|docetaxel|mesh-list
111009786|NCT03343977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111009787|NCT03343977|Tubulin Modulators|tubulin modulators|mesh-ancestor
111009788|NCT03343977|Antimitotic Agents|antimitotic agents|mesh-ancestor
111009789|NCT03343977|Mitosis Modulators|mitosis modulators|mesh-ancestor
111009790|NCT03343977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111009791|NCT02850965|Adalimumab|adalimumab|mesh-list
111009792|NCT02850965|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111009793|NCT02850965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111009794|NCT02850965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111009795|NCT03571087|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111009796|NCT03571087|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111009797|NCT03571087|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111009798|NCT03571087|Antimetabolites|antimetabolites|mesh-ancestor
111009799|NCT03571087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111009800|NCT03571087|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111009801|NCT03571087|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111009802|NCT03571087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111009803|NCT04557644|Dermatologic Agents|dermatologic agents|mesh-list
111009804|NCT01375959|Resveratrol|resveratrol|mesh-list
111009805|NCT01375959|Antioxidants|antioxidants|mesh-ancestor
111009806|NCT01375959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111009807|NCT01375959|Protective Agents|protective agents|mesh-ancestor
111009808|NCT01375959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111009809|NCT01375959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111009810|NCT01375959|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111009811|NCT02238353|Fluticasone|fluticasone|mesh-list
111009812|NCT02238353|Azelastine|azelastine|mesh-list
111009813|NCT02238353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111009814|NCT02238353|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111009815|NCT02238353|Autonomic Agents|autonomic agents|mesh-ancestor
111009816|NCT02238353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111009817|NCT02238353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111009818|NCT02238353|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111009819|NCT02238353|Respiratory System Agents|respiratory system agents|mesh-ancestor
111009820|NCT02238353|Dermatologic Agents|dermatologic agents|mesh-ancestor
111009821|NCT02238353|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111009822|NCT02238353|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
111009823|NCT02238353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111009824|NCT02238353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111009825|NCT02238353|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
111009826|NCT02238353|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111009827|NCT02238353|Histamine Antagonists|histamine antagonists|mesh-ancestor
111009828|NCT02238353|Histamine Agents|histamine agents|mesh-ancestor
111009829|NCT02238353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111009830|NCT04482686|Vitamin D|vitamin d|mesh-list
111009831|NCT04482686|Cholecalciferol|cholecalciferol|mesh-list
111009832|NCT04482686|Vitamins|vitamins|mesh-list
111009833|NCT04482686|Ascorbic Acid|ascorbic acid|mesh-list
111009835|NCT04482686|Doxycycline|doxycycline|mesh-list
111009836|NCT04482686|Ivermectin|ivermectin|mesh-list
111009837|NCT04482686|Zinc Sulfate|zinc sulfate|mesh-list
111009838|NCT04482686|Micronutrients|micronutrients|mesh-ancestor
111009839|NCT04482686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111009840|NCT04482686|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111009841|NCT04482686|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111009842|NCT04482686|Trace Elements|trace elements|mesh-ancestor
111009843|NCT04482686|Antioxidants|antioxidants|mesh-ancestor
111009844|NCT04482686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111009845|NCT04482686|Protective Agents|protective agents|mesh-ancestor
111009846|NCT04482686|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111009847|NCT04482686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111009848|NCT04482686|Antimalarials|antimalarials|mesh-ancestor
111009849|NCT04482686|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111009850|NCT04482686|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111009851|NCT04482686|Astringents|astringents|mesh-ancestor
111009852|NCT04482686|Dermatologic Agents|dermatologic agents|mesh-ancestor
111009853|NCT03580889|Atropine|atropine|mesh-list
111009854|NCT03580889|Glycopyrrolate|glycopyrrolate|mesh-list
111009855|NCT03580889|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111009856|NCT03580889|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111009857|NCT03580889|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111009858|NCT03580889|Autonomic Agents|autonomic agents|mesh-ancestor
111009859|NCT03580889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111009860|NCT03580889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111009861|NCT03580889|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111009862|NCT03580889|Respiratory System Agents|respiratory system agents|mesh-ancestor
111009864|NCT03580889|Parasympatholytics|parasympatholytics|mesh-ancestor
111009865|NCT03580889|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111009866|NCT03580889|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111009867|NCT03580889|Cholinergic Agents|cholinergic agents|mesh-ancestor
111009868|NCT03580889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111009869|NCT03580889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111009870|NCT02500017|Melatonin|melatonin|mesh-list
111009871|NCT02500017|Antioxidants|antioxidants|mesh-ancestor
111009872|NCT02500017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111009873|NCT02500017|Protective Agents|protective agents|mesh-ancestor
111009874|NCT02500017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111009875|NCT02500017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111009876|NCT02505633|Lidocaine|lidocaine|mesh-list
111009877|NCT02505633|Epinephrine|epinephrine|mesh-list
111009878|NCT02505633|Racepinephrine|racepinephrine|mesh-list
111009879|NCT02505633|Epinephryl borate|epinephryl borate|mesh-list
111009880|NCT02505633|Anesthetics, Local|anesthetics, local|mesh-ancestor
111009881|NCT02505633|Anesthetics|anesthetics|mesh-ancestor
111009882|NCT02505633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111009883|NCT02505633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111009884|NCT02505633|Sensory System Agents|sensory system agents|mesh-ancestor
111009885|NCT02505633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111009886|NCT02505633|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111009887|NCT02505633|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111009888|NCT02505633|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111009889|NCT02505633|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111009890|NCT02505633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111009891|NCT02505633|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111009892|NCT02505633|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111009893|NCT02505633|Adrenergic Agents|adrenergic agents|mesh-ancestor
111009894|NCT02505633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111009895|NCT02505633|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111009896|NCT02505633|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111009897|NCT02505633|Autonomic Agents|autonomic agents|mesh-ancestor
111009898|NCT02505633|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111009899|NCT02505633|Respiratory System Agents|respiratory system agents|mesh-ancestor
111009900|NCT02505633|Mydriatics|mydriatics|mesh-ancestor
111009901|NCT02505633|Sympathomimetics|sympathomimetics|mesh-ancestor
111009902|NCT02505633|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111009903|NCT03587441|Neostigmine|neostigmine|mesh-list
111009904|NCT03587441|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111009905|NCT03587441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111009906|NCT03587441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111009907|NCT03587441|Cholinergic Agents|cholinergic agents|mesh-ancestor
111009908|NCT03587441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111009909|NCT03587441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111009910|NCT03587441|Parasympathomimetics|parasympathomimetics|mesh-ancestor
111009911|NCT03587441|Autonomic Agents|autonomic agents|mesh-ancestor
111009912|NCT03587441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111009913|NCT05102396|Mandelic Acids|mandelic acids|mesh-list
111009914|NCT05102396|Oxybutynin|oxybutynin|mesh-list
111009915|NCT05102396|Parasympatholytics|parasympatholytics|mesh-ancestor
111009916|NCT05102396|Autonomic Agents|autonomic agents|mesh-ancestor
111009917|NCT05102396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111009918|NCT05102396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111009919|NCT05102396|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111009920|NCT05102396|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111009921|NCT05102396|Cholinergic Agents|cholinergic agents|mesh-ancestor
111009922|NCT05102396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111009923|NCT05102396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111009924|NCT05102396|Urological Agents|urological agents|mesh-ancestor
111009925|NCT05102396|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111009926|NCT05102396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111009927|NCT01165645|Ritonavir|ritonavir|mesh-list
111009928|NCT01165645|Lopinavir|lopinavir|mesh-list
111009929|NCT01165645|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111009930|NCT01165645|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111009931|NCT01165645|Protease Inhibitors|protease inhibitors|mesh-ancestor
111009932|NCT01165645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111009933|NCT01165645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111009934|NCT01165645|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111009935|NCT01165645|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111009936|NCT01165645|Antiviral Agents|antiviral agents|mesh-ancestor
110621539|NCT00941343|Alfuzosin|alfuzosin|mesh-list
111009937|NCT01165645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111009938|NCT01165645|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111009939|NCT01165645|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111009940|NCT03579875|Methylprednisolone|methylprednisolone|mesh-list
111009941|NCT03579875|Cyclophosphamide|cyclophosphamide|mesh-list
111009943|NCT03579875|Rituximab|rituximab|mesh-list
111009944|NCT03579875|Fludarabine|fludarabine|mesh-list
111009945|NCT03579875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111009946|NCT03579875|Immunologic Factors|immunologic factors|mesh-ancestor
111009947|NCT03579875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111009948|NCT03579875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111009949|NCT03579875|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111009950|NCT03579875|Alkylating Agents|alkylating agents|mesh-ancestor
111009951|NCT03579875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111009952|NCT03579875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111009953|NCT03579875|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111009954|NCT03579875|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111009955|NCT03579875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111009956|NCT03579875|Antiemetics|antiemetics|mesh-ancestor
111009957|NCT03579875|Autonomic Agents|autonomic agents|mesh-ancestor
111009958|NCT03579875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111009959|NCT03579875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111009960|NCT03579875|Glucocorticoids|glucocorticoids|mesh-ancestor
111009961|NCT03579875|Hormones|hormones|mesh-ancestor
111009962|NCT03579875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111009963|NCT03579875|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111009964|NCT03579875|Protective Agents|protective agents|mesh-ancestor
111009965|NCT03569995|Cytarabine|cytarabine|mesh-list
111009966|NCT03569995|Rituximab|rituximab|mesh-list
111009967|NCT03569995|Methotrexate|methotrexate|mesh-list
111009968|NCT03569995|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111009969|NCT03569995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111009970|NCT03569995|Immunologic Factors|immunologic factors|mesh-ancestor
111009971|NCT03569995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111009972|NCT03569995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111009973|NCT03569995|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111009974|NCT03569995|Abortifacient Agents|abortifacient agents|mesh-ancestor
111009975|NCT03569995|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111009976|NCT03569995|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111009978|NCT03569995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111009979|NCT03569995|Dermatologic Agents|dermatologic agents|mesh-ancestor
111009980|NCT03569995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111009981|NCT03569995|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111009982|NCT03569995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111009983|NCT03569995|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111009984|NCT03569995|Antiviral Agents|antiviral agents|mesh-ancestor
111009985|NCT03569995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111009986|NCT02238431|Leuprolide|leuprolide|mesh-list
111009987|NCT02238431|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111009988|NCT02238431|Fertility Agents|fertility agents|mesh-ancestor
111009989|NCT02238431|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111009990|NCT02238431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111009991|NCT02238431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111009992|NCT02238431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111009993|NCT05122598|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
111009994|NCT05122598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111009995|NCT02238509|Trastuzumab|trastuzumab|mesh-list
111009996|NCT02238509|Lapatinib|lapatinib|mesh-list
111009997|NCT02238509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111009998|NCT02238509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111009999|NCT02238509|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111010000|NCT02238509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111010001|NCT02238509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111010002|NCT03579914|Metoprolol|metoprolol|mesh-list
111010003|NCT03579914|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111010004|NCT03579914|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111010005|NCT03579914|Sympatholytics|sympatholytics|mesh-ancestor
111010006|NCT03579914|Autonomic Agents|autonomic agents|mesh-ancestor
111010007|NCT03579914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111010008|NCT03579914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111010009|NCT03579914|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
111010010|NCT03579914|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111010011|NCT03579914|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111010012|NCT03579914|Adrenergic Agents|adrenergic agents|mesh-ancestor
111010013|NCT03579914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111010014|NCT03579914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111010015|NCT03573037|Anticoagulants|anticoagulants|mesh-list
111010016|NCT05354635|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111010017|NCT05354635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111010018|NCT03585413|Micronutrients|micronutrients|mesh-list
111010019|NCT03585413|Trace Elements|trace elements|mesh-list
111010020|NCT03585413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111010021|NCT03569683|Hyaluronic Acid|hyaluronic acid|mesh-list
111010022|NCT03569683|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111010023|NCT03569683|Immunologic Factors|immunologic factors|mesh-ancestor
111010024|NCT03569683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111010025|NCT03569683|Viscosupplements|viscosupplements|mesh-ancestor
111010026|NCT03569683|Protective Agents|protective agents|mesh-ancestor
111010027|NCT00708201|Alvimopan|alvimopan|mesh-list
111010028|NCT00708201|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111010029|NCT03572959|Triamcinolone|triamcinolone|mesh-list
111010030|NCT03572959|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
111010031|NCT03572959|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
111010032|NCT03572959|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
111010033|NCT03572959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111010034|NCT03572959|Glucocorticoids|glucocorticoids|mesh-ancestor
111010035|NCT03572959|Hormones|hormones|mesh-ancestor
111010036|NCT03572959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111010037|NCT03572959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111010038|NCT03572959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111010039|NCT03572959|Immunologic Factors|immunologic factors|mesh-ancestor
111010040|NCT03572959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111010041|NCT03572959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111010042|NCT02500251|Rituximab|rituximab|mesh-list
111010043|NCT02500251|Bortezomib|bortezomib|mesh-list
111010044|NCT02500251|Belimumab|belimumab|mesh-list
111010045|NCT02500251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111010046|NCT02500251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111010047|NCT02500251|Immunologic Factors|immunologic factors|mesh-ancestor
111010048|NCT02500251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111010049|NCT02500251|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111010050|NCT02500251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111010051|NCT03568513|Curcumin|curcumin|mesh-list
111010052|NCT03568513|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111010053|NCT03568513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111010054|NCT03568513|Analgesics|analgesics|mesh-ancestor
111010055|NCT03568513|Sensory System Agents|sensory system agents|mesh-ancestor
111010056|NCT03568513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111010057|NCT03568513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111010058|NCT03568513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111010059|NCT03568513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111010060|NCT03568513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111010061|NCT03568513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111010062|NCT03568513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111010063|NCT02982668|Metoclopramide|metoclopramide|mesh-list
111010064|NCT02982668|Mosapride|mosapride|mesh-list
111010065|NCT02982668|Antiemetics|antiemetics|mesh-ancestor
111010066|NCT02982668|Autonomic Agents|autonomic agents|mesh-ancestor
111010067|NCT02982668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111010068|NCT02982668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111010069|NCT02982668|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111010070|NCT02982668|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111010071|NCT02982668|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111010072|NCT02982668|Dopamine Agents|dopamine agents|mesh-ancestor
111010073|NCT02982668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111010074|NCT02982668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111010075|NCT02982668|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111010076|NCT02982668|Serotonin Agents|serotonin agents|mesh-ancestor
111010077|NCT02398526|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
111010078|NCT02398526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111010079|NCT05354479|Acetaminophen|acetaminophen|mesh-list
111010080|NCT05354479|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111010081|NCT05354479|Analgesics|analgesics|mesh-ancestor
110727069|NCT04790812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111010082|NCT05354479|Sensory System Agents|sensory system agents|mesh-ancestor
111010083|NCT05354479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111010084|NCT05354479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111010085|NCT05354479|Antipyretics|antipyretics|mesh-ancestor
111010086|NCT02505399|Clopidogrel|clopidogrel|mesh-list
111010087|NCT02505399|Ticagrelor|ticagrelor|mesh-list
111010088|NCT02505399|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111010089|NCT02505399|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111010090|NCT02505399|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111010091|NCT02505399|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111010092|NCT02505399|Purinergic Agents|purinergic agents|mesh-ancestor
111010093|NCT02505399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111010094|NCT02505399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111010095|NCT02505399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111010096|NCT02728089|Tazobactam|tazobactam|mesh-list
111010097|NCT02728089|Ceftolozane|ceftolozane|mesh-list
111010098|NCT02728089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111010099|NCT02728089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111010100|NCT02728089|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
111010101|NCT02728089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111010102|NCT02728089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111010103|NCT05110118|Bevacizumab|bevacizumab|mesh-list
111010104|NCT05110118|Endothelial Growth Factors|endothelial growth factors|mesh-list
111010105|NCT05110118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111010106|NCT05110118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111010107|NCT05110118|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111010108|NCT05110118|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111010109|NCT05110118|Growth Substances|growth substances|mesh-ancestor
111010110|NCT05110118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111010111|NCT05110118|Growth Inhibitors|growth inhibitors|mesh-ancestor
111010112|NCT03572647|Epoetin Alfa|epoetin alfa|mesh-list
111010113|NCT03572647|Hematinics|hematinics|mesh-ancestor
111010114|NCT02495181|Aflibercept|aflibercept|mesh-list
111010115|NCT02495181|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111010116|NCT02495181|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111010117|NCT02495181|Growth Substances|growth substances|mesh-ancestor
111010118|NCT02495181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111010119|NCT02495181|Growth Inhibitors|growth inhibitors|mesh-ancestor
111010120|NCT02495181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111010121|NCT02499861|Decitabine|decitabine|mesh-list
111010122|NCT02499861|Genistein|genistein|mesh-list
111010123|NCT02499861|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111010124|NCT02499861|Antimetabolites|antimetabolites|mesh-ancestor
111010125|NCT02499861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111010126|NCT02499861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111010127|NCT02499861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111010128|NCT02499861|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
111010129|NCT02499861|Protective Agents|protective agents|mesh-ancestor
111010130|NCT02499861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111010131|NCT02499861|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111010132|NCT02499861|Phytoestrogens|phytoestrogens|mesh-ancestor
111010133|NCT02499861|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
111010134|NCT02499861|Estrogens|estrogens|mesh-ancestor
111010135|NCT02499861|Hormones|hormones|mesh-ancestor
110621565|NCT00560703|Antimalarials|antimalarials|mesh-ancestor
111010136|NCT02499861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111010137|NCT05505435|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
111010138|NCT05505435|Medroxyprogesterone|medroxyprogesterone|mesh-list
111010139|NCT05505435|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111010140|NCT05505435|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111010141|NCT05505435|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111010142|NCT05505435|Contraceptive Agents|contraceptive agents|mesh-ancestor
111010143|NCT05505435|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111010144|NCT05505435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111010145|NCT05505435|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111010146|NCT05505435|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111010147|NCT05505435|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
111010148|NCT05505435|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111010149|NCT05505435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111010150|NCT02840461|Ivermectin|ivermectin|mesh-list
111010151|NCT02840461|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111010152|NCT02840461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111010153|NCT05108714|Lidocaine|lidocaine|mesh-list
111010154|NCT05108714|Anesthetics, Local|anesthetics, local|mesh-ancestor
111010155|NCT05108714|Anesthetics|anesthetics|mesh-ancestor
111010156|NCT05108714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111010157|NCT05108714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111010158|NCT05108714|Sensory System Agents|sensory system agents|mesh-ancestor
111010159|NCT05108714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111010160|NCT05108714|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111010161|NCT05108714|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111010162|NCT05108714|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111010163|NCT05108714|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111010164|NCT05108714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111010166|NCT02495415|Retinamide|retinamide|mesh-list
111010167|NCT02495415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111010168|NCT02495415|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
111010169|NCT02495415|Protective Agents|protective agents|mesh-ancestor
111010170|NCT02495415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111010171|NCT02505009|Tenofovir|tenofovir|mesh-list
111010172|NCT02505009|Entecavir|entecavir|mesh-list
111010173|NCT02505009|Antiviral Agents|antiviral agents|mesh-ancestor
111010174|NCT02505009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111010175|NCT02505009|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111010176|NCT02505009|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111010177|NCT02505009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111010178|NCT02505009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111010179|NCT02505009|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111010180|NCT02505009|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111010181|NCT05353543|Antidepressive Agents|antidepressive agents|mesh-list
111010182|NCT05353543|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111010183|NCT02499627|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
111010184|NCT02499627|Brentuximab Vedotin|brentuximab vedotin|mesh-list
111010185|NCT02499627|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111010186|NCT02499627|Alkylating Agents|alkylating agents|mesh-ancestor
111010187|NCT02499627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111010188|NCT02499627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111010189|NCT02499627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111010190|NCT02499627|Immunotoxins|immunotoxins|mesh-ancestor
111010191|NCT02499627|Immunoconjugates|immunoconjugates|mesh-ancestor
111010192|NCT02499627|Immunologic Factors|immunologic factors|mesh-ancestor
111010193|NCT02499627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111010194|NCT03567655|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
111010195|NCT03567655|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111010196|NCT03567655|Contraceptive Agents|contraceptive agents|mesh-ancestor
111010197|NCT03567655|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111010198|NCT03567655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111010199|NCT03567655|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110025288|NCT00361686|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111010200|NCT03567655|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
111010201|NCT03567655|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111010203|NCT02505087|Acetylcysteine|acetylcysteine|mesh-list
111010204|NCT02505087|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111010205|NCT02505087|Antiviral Agents|antiviral agents|mesh-ancestor
111010206|NCT02505087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111010207|NCT02505087|Expectorants|expectorants|mesh-ancestor
111010208|NCT02505087|Respiratory System Agents|respiratory system agents|mesh-ancestor
111010209|NCT02505087|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111010210|NCT02505087|Antioxidants|antioxidants|mesh-ancestor
111010211|NCT02505087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111010212|NCT02505087|Protective Agents|protective agents|mesh-ancestor
111010213|NCT02505087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111010214|NCT02505087|Antidotes|antidotes|mesh-ancestor
111010215|NCT02839681|Maytansine|maytansine|mesh-list
111010216|NCT02839681|Anetumab ravtansine|anetumab ravtansine|mesh-list
111010217|NCT02839681|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111010218|NCT02839681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111010219|NCT02839681|Tubulin Modulators|tubulin modulators|mesh-ancestor
111010220|NCT02839681|Antimitotic Agents|antimitotic agents|mesh-ancestor
111010221|NCT02839681|Mitosis Modulators|mitosis modulators|mesh-ancestor
111010222|NCT02839681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111010223|NCT02839681|Immunoconjugates|immunoconjugates|mesh-ancestor
111010224|NCT02839681|Immunologic Factors|immunologic factors|mesh-ancestor
111010225|NCT02839681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111010226|NCT02504463|Naltrexone|naltrexone|mesh-list
111010227|NCT02504463|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111010228|NCT02504463|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111010229|NCT02504463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111010230|NCT02504463|Sensory System Agents|sensory system agents|mesh-ancestor
111010231|NCT02504463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111010233|NCT03566329|Magnesium Sulfate|magnesium sulfate|mesh-list
111010234|NCT03566329|Anesthetics, Local|anesthetics, local|mesh-ancestor
111010235|NCT03566329|Anesthetics|anesthetics|mesh-ancestor
111010236|NCT03566329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111010237|NCT03566329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111010238|NCT03566329|Sensory System Agents|sensory system agents|mesh-ancestor
111010239|NCT03566329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111010240|NCT03566329|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111010241|NCT03566329|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111010242|NCT03566329|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111010243|NCT03566329|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111010244|NCT03566329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111010245|NCT03566329|Analgesics|analgesics|mesh-ancestor
111010246|NCT03566329|Anticonvulsants|anticonvulsants|mesh-ancestor
111010247|NCT03566329|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111010248|NCT03566329|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111010249|NCT03566329|Tocolytic Agents|tocolytic agents|mesh-ancestor
111010250|NCT03566329|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111010251|NCT02499237|Zoledronic Acid|zoledronic acid|mesh-list
111010252|NCT02499237|Denosumab|denosumab|mesh-list
111010253|NCT02499237|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111010254|NCT02499237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111010255|NCT02499393|Magnesium Sulfate|magnesium sulfate|mesh-list
111010256|NCT02499393|Analgesics|analgesics|mesh-ancestor
111010257|NCT02499393|Sensory System Agents|sensory system agents|mesh-ancestor
111010258|NCT02499393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111010259|NCT02499393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111010260|NCT02499393|Anesthetics|anesthetics|mesh-ancestor
110621590|NCT00941499|Antimetabolites|antimetabolites|mesh-ancestor
111010261|NCT02499393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111010262|NCT02499393|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111010263|NCT02499393|Anticonvulsants|anticonvulsants|mesh-ancestor
111010264|NCT02499393|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111010265|NCT02499393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111010266|NCT02499393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111010267|NCT02499393|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111010268|NCT02499393|Tocolytic Agents|tocolytic agents|mesh-ancestor
111010269|NCT02499393|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111010270|NCT02504307|Sirolimus|sirolimus|mesh-list
111010271|NCT02504307|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111010272|NCT02504307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111010273|NCT02504307|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111010274|NCT02504307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111010275|NCT02504307|Antifungal Agents|antifungal agents|mesh-ancestor
111010276|NCT02504307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111010277|NCT02504307|Immunologic Factors|immunologic factors|mesh-ancestor
111010278|NCT02504307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111010279|NCT02504229|Oxaliplatin|oxaliplatin|mesh-list
111010280|NCT02504229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111010282|NCT03567343|Antioxidants|antioxidants|mesh-ancestor
111010283|NCT03567343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111010284|NCT03567343|Protective Agents|protective agents|mesh-ancestor
111010285|NCT03567343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111010286|NCT03567343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111010287|NCT04595864|Leucovorin|leucovorin|mesh-list
111010288|NCT04595864|Oxaliplatin|oxaliplatin|mesh-list
111010289|NCT04595864|Calcium|calcium|mesh-list
111010290|NCT04595864|Levoleucovorin|levoleucovorin|mesh-list
111010291|NCT04595864|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111010292|NCT04595864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111010293|NCT04595864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111010294|NCT04595864|Antidotes|antidotes|mesh-ancestor
111010295|NCT04595864|Protective Agents|protective agents|mesh-ancestor
111010296|NCT04595864|Vitamin B Complex|vitamin b complex|mesh-ancestor
111010297|NCT04595864|Vitamins|vitamins|mesh-ancestor
111010298|NCT04595864|Micronutrients|micronutrients|mesh-ancestor
111010299|NCT04583462|Metformin|metformin|mesh-list
111010300|NCT04583462|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111010301|NCT04583462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111010302|NCT04456322|Cisplatin|cisplatin|mesh-list
111010303|NCT04456322|Nimotuzumab|nimotuzumab|mesh-list
111010304|NCT04456322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111010305|NCT04456322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111010306|NCT02503761|Meropenem|meropenem|mesh-list
111010307|NCT02503761|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111010308|NCT02503761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111010309|NCT04097912|Aspirin|aspirin|mesh-list
111010310|NCT04097912|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111010311|NCT04097912|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111010312|NCT04097912|Analgesics|analgesics|mesh-ancestor
111010313|NCT04097912|Sensory System Agents|sensory system agents|mesh-ancestor
111010314|NCT04097912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111010315|NCT04097912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111010316|NCT04097912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111010317|NCT04097912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111010318|NCT04097912|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111010319|NCT04097912|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111010320|NCT04097912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111010321|NCT04097912|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111010322|NCT04097912|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111010323|NCT04097912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111010324|NCT04097912|Antipyretics|antipyretics|mesh-ancestor
111010325|NCT04966676|Nivolumab|nivolumab|mesh-list
111010326|NCT04966676|Ipilimumab|ipilimumab|mesh-list
111010327|NCT04966676|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111010328|NCT04966676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111010329|NCT04966676|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111010330|NCT04966676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111010331|NCT03340779|Dobutamine|dobutamine|mesh-list
111010332|NCT03340779|Norepinephrine|norepinephrine|mesh-list
111010333|NCT03340779|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111010334|NCT03340779|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111010335|NCT03340779|Adrenergic Agents|adrenergic agents|mesh-ancestor
111010336|NCT03340779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111010337|NCT03340779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111010338|NCT03340779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111010339|NCT03340779|Sympathomimetics|sympathomimetics|mesh-ancestor
111010340|NCT03340779|Autonomic Agents|autonomic agents|mesh-ancestor
111010341|NCT03340779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111010342|NCT03340779|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111010343|NCT03340779|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111010344|NCT03340779|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
111010345|NCT03340779|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111010346|NCT03340779|Protective Agents|protective agents|mesh-ancestor
111010347|NCT04040738|Anesthetics|anesthetics|mesh-list
111010348|NCT04040738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111010349|NCT04040738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111010350|NCT05104424|Insulin Aspart|insulin aspart|mesh-list
110475283|NCT02745717|Cyclosporine|cyclosporine|mesh-list
111010351|NCT05104424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111010352|NCT05104424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111010353|NCT05087732|Lidocaine|lidocaine|mesh-list
111010354|NCT05087732|Anesthetics, Local|anesthetics, local|mesh-ancestor
111010355|NCT05087732|Anesthetics|anesthetics|mesh-ancestor
111010356|NCT05087732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111010357|NCT05087732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111010358|NCT05087732|Sensory System Agents|sensory system agents|mesh-ancestor
111010359|NCT05087732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111010360|NCT05087732|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111010361|NCT05087732|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111010362|NCT05087732|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111010363|NCT05087732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111010364|NCT05087732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111010365|NCT03340701|Progesterone|progesterone|mesh-list
111010366|NCT03340701|Progestins|progestins|mesh-ancestor
111010367|NCT03340701|Hormones|hormones|mesh-ancestor
111010368|NCT03340701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111010369|NCT03340701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111010370|NCT02498535|Nitric Oxide|nitric oxide|mesh-list
111010371|NCT02498535|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111010372|NCT02498535|Autonomic Agents|autonomic agents|mesh-ancestor
111010373|NCT02498535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111010374|NCT02498535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111010375|NCT02498535|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111010376|NCT02498535|Respiratory System Agents|respiratory system agents|mesh-ancestor
111010377|NCT02498535|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111010378|NCT02498535|Antioxidants|antioxidants|mesh-ancestor
111010379|NCT02498535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111010380|NCT02498535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111010381|NCT02498535|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
111010382|NCT02498535|Vasodilator Agents|vasodilator agents|mesh-ancestor
111010383|NCT02498535|Gasotransmitters|gasotransmitters|mesh-ancestor
111010384|NCT02498535|Protective Agents|protective agents|mesh-ancestor
111010385|NCT04727138|Midazolam|midazolam|mesh-list
111010386|NCT04727138|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110621618|NCT00945789|Antioxidants|antioxidants|mesh-ancestor
111010387|NCT04727138|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111010388|NCT04727138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111010389|NCT04727138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111010390|NCT04727138|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111010391|NCT04727138|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111010392|NCT04727138|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111010393|NCT04727138|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111010394|NCT04727138|Anesthetics, General|anesthetics, general|mesh-ancestor
111010395|NCT04727138|Anesthetics|anesthetics|mesh-ancestor
111010396|NCT04727138|GABA Modulators|gaba modulators|mesh-ancestor
111010397|NCT04727138|GABA Agents|gaba agents|mesh-ancestor
111010398|NCT04727138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111010399|NCT04727138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111010400|NCT02498457|Calcium|calcium|mesh-list
111010401|NCT02498457|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111010402|NCT02498457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111010403|NCT02498301|Rifaximin|rifaximin|mesh-list
111010404|NCT02498301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111010405|NCT02498301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111010406|NCT02498301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111010407|NCT03343665|Nivolumab|nivolumab|mesh-list
111010408|NCT03343665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111010409|NCT03343665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111010410|NCT03343665|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111010411|NCT03343665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111010412|NCT02733614|SRX246|srx246|mesh-list
111010413|NCT02733614|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
111010414|NCT02733614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111010415|NCT02733614|Natriuretic Agents|natriuretic agents|mesh-ancestor
111010416|NCT02733614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111010417|NCT04674254|Bevacizumab|bevacizumab|mesh-list
111010418|NCT04674254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111010419|NCT04674254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111010420|NCT04674254|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111010421|NCT04674254|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111010422|NCT04674254|Growth Substances|growth substances|mesh-ancestor
110025289|NCT00361686|Narcotics|narcotics|mesh-ancestor
111010423|NCT04674254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111010424|NCT04674254|Growth Inhibitors|growth inhibitors|mesh-ancestor
111010425|NCT03342807|Insulin|insulin|mesh-list
111010426|NCT03342807|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111010427|NCT03342807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111010428|NCT02570672|Metformin|metformin|mesh-list
111010429|NCT02570672|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111010430|NCT02570672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111010431|NCT03339921|Botulinum Toxins|botulinum toxins|mesh-list
111010432|NCT03339921|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111010433|NCT03339921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111010434|NCT03339921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111010435|NCT03339921|Cholinergic Agents|cholinergic agents|mesh-ancestor
111010436|NCT03339921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111010437|NCT03339921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111010438|NCT04593914|Protective Agents|protective agents|mesh-list
111010439|NCT04593914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111010440|NCT04523090|Nitazoxanide|nitazoxanide|mesh-list
111010441|NCT04523090|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111010442|NCT04523090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111010443|NCT03342651|Vitamin D|vitamin d|mesh-list
111010444|NCT03342651|Vitamins|vitamins|mesh-ancestor
111010445|NCT03342651|Micronutrients|micronutrients|mesh-ancestor
111010446|NCT03342651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111010447|NCT03342651|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111010448|NCT04819568|Terlipressin|terlipressin|mesh-list
111010449|NCT04819568|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111010450|NCT04819568|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111010451|NCT02502981|Chlorthalidone|chlorthalidone|mesh-list
111010452|NCT02502981|Spironolactone|spironolactone|mesh-list
111010453|NCT02502981|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
111010454|NCT02502981|Diuretics|diuretics|mesh-list
110621626|NCT00941811|Imiquimod|imiquimod|mesh-list
111010455|NCT02502981|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
111010456|NCT02502981|Mineralocorticoids|mineralocorticoids|mesh-list
111010457|NCT02502981|Hormone Antagonists|hormone antagonists|mesh-ancestor
111010458|NCT02502981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111010459|NCT02502981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111010460|NCT02502981|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
111010461|NCT02502981|Natriuretic Agents|natriuretic agents|mesh-ancestor
111010462|NCT02502981|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111010463|NCT02502981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111010464|NCT02502981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111010466|NCT04230746|Trimethoprim|trimethoprim|mesh-list
111010467|NCT04230746|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
111010468|NCT04230746|Sulfamethoxazole|sulfamethoxazole|mesh-list
111010469|NCT04230746|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111010470|NCT04230746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111010471|NCT04230746|Antimalarials|antimalarials|mesh-ancestor
111010472|NCT04230746|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111010473|NCT04230746|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111010474|NCT04230746|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111010475|NCT04230746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111010476|NCT04230746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111010477|NCT04230746|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111010478|NCT04230746|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
111010479|NCT04230746|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111010480|NCT04230746|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111010481|NCT04633772|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
111010482|NCT04633772|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111010483|NCT04633772|Vasodilator Agents|vasodilator agents|mesh-ancestor
111010484|NCT05111444|Paclitaxel|paclitaxel|mesh-list
111010485|NCT05111444|Capecitabine|capecitabine|mesh-list
111010486|NCT05111444|Oxaliplatin|oxaliplatin|mesh-list
111010487|NCT05111444|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111010488|NCT05111444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111010489|NCT05111444|Tubulin Modulators|tubulin modulators|mesh-ancestor
111010490|NCT05111444|Antimitotic Agents|antimitotic agents|mesh-ancestor
111010491|NCT05111444|Mitosis Modulators|mitosis modulators|mesh-ancestor
111010492|NCT05111444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111010493|NCT05111444|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111010494|NCT05111444|Antimetabolites|antimetabolites|mesh-ancestor
111010495|NCT03769688|Metronidazole|metronidazole|mesh-list
111010496|NCT03769688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111010497|NCT03769688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111010498|NCT03769688|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111010499|NCT03769688|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111010500|NCT02502825|Methacholine Chloride|methacholine chloride|mesh-list
111010501|NCT02502825|Miotics|miotics|mesh-ancestor
111010502|NCT02502825|Autonomic Agents|autonomic agents|mesh-ancestor
111010503|NCT02502825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111010504|NCT02502825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111010505|NCT02502825|Parasympathomimetics|parasympathomimetics|mesh-ancestor
111010506|NCT02502825|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
111010507|NCT02502825|Respiratory System Agents|respiratory system agents|mesh-ancestor
111010508|NCT02502825|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
111010509|NCT02502825|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111010510|NCT02502825|Cholinergic Agents|cholinergic agents|mesh-ancestor
111010511|NCT02502825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111010512|NCT02502825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111010513|NCT02498145|Nicotine|nicotine|mesh-list
111010514|NCT02498145|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111010515|NCT02498145|Autonomic Agents|autonomic agents|mesh-ancestor
111010516|NCT02498145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111010517|NCT02498145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111010518|NCT02498145|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111010519|NCT02498145|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111010520|NCT02498145|Cholinergic Agents|cholinergic agents|mesh-ancestor
111010521|NCT02498145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111010522|NCT02498145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111010523|NCT02497911|Bupivacaine|bupivacaine|mesh-list
111010524|NCT02497911|Anesthetics, Local|anesthetics, local|mesh-ancestor
111010525|NCT02497911|Anesthetics|anesthetics|mesh-ancestor
111010526|NCT02497911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111010527|NCT02497911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111010528|NCT02497911|Sensory System Agents|sensory system agents|mesh-ancestor
111010529|NCT02497911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111010530|NCT02497833|Tretinoin|tretinoin|mesh-list
111010531|NCT02497833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111010532|NCT02497833|Keratolytic Agents|keratolytic agents|mesh-ancestor
111010533|NCT02497833|Dermatologic Agents|dermatologic agents|mesh-ancestor
111010535|NCT02493933|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111010536|NCT02493933|Phytoestrogens|phytoestrogens|mesh-list
111010537|NCT02493933|Antiviral Agents|antiviral agents|mesh-ancestor
111010538|NCT02493933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111010539|NCT02493933|Expectorants|expectorants|mesh-ancestor
111010540|NCT02493933|Respiratory System Agents|respiratory system agents|mesh-ancestor
111010541|NCT02493933|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111010542|NCT02493933|Antioxidants|antioxidants|mesh-ancestor
111010543|NCT02493933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111010544|NCT02493933|Protective Agents|protective agents|mesh-ancestor
111010545|NCT02493933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111010546|NCT02493933|Antidotes|antidotes|mesh-ancestor
111010547|NCT02493933|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
111010548|NCT02493933|Estrogens|estrogens|mesh-ancestor
111010549|NCT02493933|Hormones|hormones|mesh-ancestor
111010550|NCT02493933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111010551|NCT04153604|Doxycycline|doxycycline|mesh-list
111010552|NCT04153604|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111010553|NCT04153604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111010554|NCT04153604|Antimalarials|antimalarials|mesh-ancestor
111010555|NCT04153604|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111010556|NCT04153604|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111010557|NCT03338205|Ketamine|ketamine|mesh-list
111010558|NCT03338205|Analgesics|analgesics|mesh-ancestor
111010559|NCT03338205|Sensory System Agents|sensory system agents|mesh-ancestor
111010560|NCT03338205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111010561|NCT03338205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111010562|NCT03338205|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111010563|NCT03338205|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111010564|NCT03338205|Anesthetics, General|anesthetics, general|mesh-ancestor
111010565|NCT03338205|Anesthetics|anesthetics|mesh-ancestor
111010566|NCT03338205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111010567|NCT03338205|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111010568|NCT03338205|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111010569|NCT03338205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111010570|NCT03338205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111010571|NCT04314050|Dexmedetomidine|dexmedetomidine|mesh-list
111010572|NCT04314050|Tramadol|tramadol|mesh-list
111010573|NCT04314050|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111010574|NCT04314050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111010575|NCT04314050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111010576|NCT04314050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111010577|NCT04314050|Analgesics|analgesics|mesh-ancestor
111010578|NCT04314050|Sensory System Agents|sensory system agents|mesh-ancestor
111010579|NCT04314050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111010580|NCT04314050|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111010581|NCT04314050|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111010582|NCT04314050|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111010583|NCT04314050|Adrenergic Agents|adrenergic agents|mesh-ancestor
111010584|NCT04314050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111010585|NCT04314050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111010586|NCT04314050|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111010587|NCT04314050|Narcotics|narcotics|mesh-ancestor
111010588|NCT03343509|Metronidazole|metronidazole|mesh-list
111010589|NCT03343509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111010590|NCT03343509|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111010591|NCT03343509|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111010592|NCT03343509|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111010593|NCT04516148|Clindamycin|clindamycin|mesh-list
111010594|NCT04516148|Clindamycin palmitate|clindamycin palmitate|mesh-list
111010595|NCT04516148|Clindamycin phosphate|clindamycin phosphate|mesh-list
111010596|NCT04516148|Cefazolin|cefazolin|mesh-list
111010597|NCT04516148|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111010598|NCT04516148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111010599|NCT04516148|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111010600|NCT04516148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111010601|NCT04516148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111010602|NCT02497365|Cefazolin|cefazolin|mesh-list
111010603|NCT02497365|Tobramycin|tobramycin|mesh-list
111010604|NCT02497365|Besifloxacin|besifloxacin|mesh-list
111010605|NCT02497365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110727598|NCT03746158|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111010606|NCT02497365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111010607|NCT02497365|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111010608|NCT02497365|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111010609|NCT02497365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111010610|NCT02497365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111010611|NCT02497365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111010612|NCT02497053|Pemetrexed|pemetrexed|mesh-list
111010613|NCT02497053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111010614|NCT02497053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111010615|NCT02497053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111010616|NCT02497053|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111010617|NCT02497053|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111010618|NCT03120975|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111010619|NCT03120975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111010620|NCT03337581|Dexmedetomidine|dexmedetomidine|mesh-list
111010621|NCT03337581|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111010622|NCT03337581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111010623|NCT03337581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111010624|NCT03337581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111010625|NCT03337581|Analgesics|analgesics|mesh-ancestor
111010626|NCT03337581|Sensory System Agents|sensory system agents|mesh-ancestor
111010627|NCT03337581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111010628|NCT03337581|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111010629|NCT03337581|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111010630|NCT03337581|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111010631|NCT03337581|Adrenergic Agents|adrenergic agents|mesh-ancestor
111010632|NCT03337581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111010633|NCT03337581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111010634|NCT02496975|Cyclosporine|cyclosporine|mesh-list
111010635|NCT02496975|Cyclosporins|cyclosporins|mesh-list
111010636|NCT02496975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111010637|NCT02496975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111010638|NCT02496975|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111010639|NCT02496975|Immunologic Factors|immunologic factors|mesh-ancestor
111010640|NCT02496975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111010641|NCT02496975|Antifungal Agents|antifungal agents|mesh-ancestor
111010642|NCT02496975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111010643|NCT02496975|Dermatologic Agents|dermatologic agents|mesh-ancestor
111010644|NCT02496975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111010645|NCT02496975|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111010646|NCT03337503|Dronabinol|dronabinol|mesh-list
111010647|NCT03337503|Hallucinogens|hallucinogens|mesh-ancestor
111010648|NCT03337503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111010649|NCT03337503|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110621657|NCT00655746|Dasatinib|dasatinib|mesh-list
111010650|NCT03337503|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111010651|NCT03337503|Analgesics|analgesics|mesh-ancestor
111010652|NCT03337503|Sensory System Agents|sensory system agents|mesh-ancestor
111010653|NCT03337503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111010654|NCT03337503|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
111010655|NCT03337503|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
111010656|NCT03337503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111010657|NCT03337503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111010658|NCT03337503|Hormones|hormones|mesh-ancestor
111010659|NCT03337503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111010660|NCT01675622|Morphine|morphine|mesh-list
111010661|NCT01675622|Oxycodone|oxycodone|mesh-list
111010662|NCT01675622|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111010663|NCT01675622|Narcotics|narcotics|mesh-ancestor
111010664|NCT01675622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111010665|NCT01675622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111010666|NCT01675622|Analgesics|analgesics|mesh-ancestor
111010667|NCT01675622|Sensory System Agents|sensory system agents|mesh-ancestor
111010668|NCT01675622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111010669|NCT02496741|Metformin|metformin|mesh-list
111010670|NCT02496741|Chloroquine|chloroquine|mesh-list
111010671|NCT02496741|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111010672|NCT02496741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111010673|NCT02496741|Amebicides|amebicides|mesh-ancestor
111010674|NCT02496741|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111010675|NCT02496741|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111010676|NCT02496741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111010677|NCT02496741|Antimalarials|antimalarials|mesh-ancestor
111010678|NCT02496741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111010679|NCT04496037|Rituximab|rituximab|mesh-list
111010680|NCT04496037|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111010681|NCT04496037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111010683|NCT04496037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111010684|NCT04496037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111010685|NCT02493465|Everolimus|everolimus|mesh-list
111010686|NCT02493465|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111010687|NCT02493465|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111010688|NCT02493465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111010689|NCT02493465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111010690|NCT02493465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111010691|NCT02493465|Immunologic Factors|immunologic factors|mesh-ancestor
111010692|NCT02493465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111010693|NCT02493465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111010694|NCT03342261|Antiviral Agents|antiviral agents|mesh-list
111010695|NCT03342261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111010696|NCT04495569|Antibodies|antibodies|mesh-list
111010697|NCT04495569|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111010698|NCT04495569|Immunologic Factors|immunologic factors|mesh-ancestor
111010699|NCT04495569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111010700|NCT03337191|Morphine|morphine|mesh-list
111010701|NCT03337191|Levobupivacaine|levobupivacaine|mesh-list
111010702|NCT03337191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111010703|NCT03337191|Narcotics|narcotics|mesh-ancestor
111010704|NCT03337191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111010705|NCT03337191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111010706|NCT03337191|Analgesics|analgesics|mesh-ancestor
111010707|NCT03337191|Sensory System Agents|sensory system agents|mesh-ancestor
111010708|NCT03337191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111010709|NCT03337191|Anesthetics, Local|anesthetics, local|mesh-ancestor
111010710|NCT03337191|Anesthetics|anesthetics|mesh-ancestor
111010711|NCT04494243|Rabeprazole|rabeprazole|mesh-list
111010712|NCT04494243|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111010713|NCT04494243|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111010714|NCT04494243|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111010715|NCT04494243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111010716|NCT04494243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111010717|NCT03337035|Oxytocin|oxytocin|mesh-list
111010718|NCT03337035|Oxytocics|oxytocics|mesh-ancestor
111010719|NCT03337035|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111010720|NCT03337035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111010721|NCT03330717|Anesthetics|anesthetics|mesh-list
110621666|NCT00338455|Dobutamine|dobutamine|mesh-list
111010722|NCT03330717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111010723|NCT03330717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111010724|NCT02655224|Relugolix|relugolix|mesh-list
111010725|NCT02655224|Androgen Antagonists|androgen antagonists|mesh-ancestor
111010726|NCT02655224|Hormone Antagonists|hormone antagonists|mesh-ancestor
110025369|NCT00363948|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111010727|NCT02655224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111010728|NCT02655224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111010729|NCT04494321|Budesonide|budesonide|mesh-list
111010730|NCT04494321|Formoterol Fumarate|formoterol fumarate|mesh-list
111010731|NCT04494321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111010732|NCT04494321|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111010733|NCT04494321|Autonomic Agents|autonomic agents|mesh-ancestor
111010734|NCT04494321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111010735|NCT04494321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111010736|NCT04494321|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111010737|NCT04494321|Respiratory System Agents|respiratory system agents|mesh-ancestor
111010738|NCT04494321|Glucocorticoids|glucocorticoids|mesh-ancestor
111010739|NCT04494321|Hormones|hormones|mesh-ancestor
111010740|NCT04494321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111010741|NCT04494321|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111010742|NCT04494321|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111010743|NCT04494321|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111010744|NCT04494321|Adrenergic Agents|adrenergic agents|mesh-ancestor
111010745|NCT04494321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111010746|NCT04494321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111010747|NCT03330171|Vaccines|vaccines|mesh-list
111010748|NCT03330171|Immunologic Factors|immunologic factors|mesh-ancestor
111010749|NCT03330171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111010750|NCT05118542|Methimazole|methimazole|mesh-list
111010751|NCT05118542|Propylthiouracil|propylthiouracil|mesh-list
111010752|NCT05118542|Antithyroid Agents|antithyroid agents|mesh-ancestor
111010753|NCT05118542|Hormone Antagonists|hormone antagonists|mesh-ancestor
111010754|NCT05118542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111010755|NCT05118542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111010756|NCT05118542|Antimetabolites|antimetabolites|mesh-ancestor
111010757|NCT05118542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111010759|NCT03336801|Sevoflurane|sevoflurane|mesh-list
111010760|NCT03336801|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111010761|NCT03336801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111010762|NCT03336801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111010763|NCT03336801|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111010764|NCT03336801|Anesthetics, General|anesthetics, general|mesh-ancestor
111010765|NCT03336801|Anesthetics|anesthetics|mesh-ancestor
111010766|NCT03336801|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111010767|NCT03336801|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111010768|NCT05115578|Midazolam|midazolam|mesh-list
111010769|NCT05115578|Remifentanil|remifentanil|mesh-list
111010770|NCT05115578|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111010771|NCT05115578|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111010772|NCT05115578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111010773|NCT05115578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111010774|NCT05115578|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111010775|NCT05115578|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111010776|NCT05115578|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111010777|NCT05115578|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111010778|NCT05115578|Anesthetics, General|anesthetics, general|mesh-ancestor
111010779|NCT05115578|Anesthetics|anesthetics|mesh-ancestor
111010780|NCT05115578|GABA Modulators|gaba modulators|mesh-ancestor
111010781|NCT05115578|GABA Agents|gaba agents|mesh-ancestor
111010782|NCT05115578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111010783|NCT05115578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111010784|NCT05115578|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111010785|NCT05115578|Narcotics|narcotics|mesh-ancestor
111010786|NCT05115578|Analgesics|analgesics|mesh-ancestor
111010787|NCT05115578|Sensory System Agents|sensory system agents|mesh-ancestor
111010788|NCT05115578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111010789|NCT02636036|Nivolumab|nivolumab|mesh-list
111010790|NCT02636036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111010791|NCT02636036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111010792|NCT02636036|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111010793|NCT02636036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111010794|NCT03329781|Curcumin|curcumin|mesh-list
111010795|NCT03329781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111010796|NCT03329781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111010797|NCT03329781|Analgesics|analgesics|mesh-ancestor
111010798|NCT03329781|Sensory System Agents|sensory system agents|mesh-ancestor
111010799|NCT03329781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111010800|NCT03329781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111010801|NCT03329781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111010802|NCT03329781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111010803|NCT03329781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111010804|NCT03329781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111010805|NCT03329781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111010806|NCT02437604|Fluticasone|fluticasone|mesh-list
111010807|NCT02437604|Xhance|xhance|mesh-list
111010808|NCT02437604|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
111010809|NCT02437604|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
111010810|NCT02437604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111010811|NCT02437604|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111010812|NCT02437604|Autonomic Agents|autonomic agents|mesh-ancestor
111010813|NCT02437604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111010814|NCT02437604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111010815|NCT02437604|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111010816|NCT02437604|Respiratory System Agents|respiratory system agents|mesh-ancestor
111010817|NCT02437604|Dermatologic Agents|dermatologic agents|mesh-ancestor
111010818|NCT02437604|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111010819|NCT02437604|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111010820|NCT02437604|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111010821|NCT02437604|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111010822|NCT02437604|Adrenergic Agents|adrenergic agents|mesh-ancestor
111010823|NCT02437604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111010824|NCT02437604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111010825|NCT02437604|Glucocorticoids|glucocorticoids|mesh-ancestor
111010826|NCT02437604|Hormones|hormones|mesh-ancestor
111010827|NCT02437604|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111010828|NCT02437604|Sympathomimetics|sympathomimetics|mesh-ancestor
111010829|NCT03329547|Cefixime|cefixime|mesh-list
111010830|NCT03329547|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110727819|NCT00095498|Denosumab|denosumab|mesh-list
111010832|NCT05463627|Metformin|metformin|mesh-list
111010833|NCT05463627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111010834|NCT05463627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111010835|NCT01975298|Interferons|interferons|mesh-list
111010836|NCT01975298|Interferon beta-1a|interferon beta-1a|mesh-list
111010837|NCT01975298|Interferon-beta|interferon-beta|mesh-list
111010838|NCT01975298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111010839|NCT01975298|Antiviral Agents|antiviral agents|mesh-ancestor
111010840|NCT01975298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111010841|NCT01975298|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111010842|NCT01975298|Immunologic Factors|immunologic factors|mesh-ancestor
111010843|NCT01975298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111010844|NCT03324867|Insulin|insulin|mesh-list
111010845|NCT03324867|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111010846|NCT03324867|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111010847|NCT03324867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111010848|NCT05084534|Midodrine|midodrine|mesh-list
111010849|NCT05084534|Sympathomimetics|sympathomimetics|mesh-ancestor
111010850|NCT05084534|Autonomic Agents|autonomic agents|mesh-ancestor
111010851|NCT05084534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111010852|NCT05084534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111010853|NCT05084534|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111010854|NCT05084534|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111010855|NCT05084534|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111010856|NCT05084534|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111010857|NCT05084534|Adrenergic Agents|adrenergic agents|mesh-ancestor
111010858|NCT05084534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111010859|NCT05084534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111010860|NCT04645316|Propofol|propofol|mesh-list
111010861|NCT04645316|Sevoflurane|sevoflurane|mesh-list
111010862|NCT04645316|Desflurane|desflurane|mesh-list
111010863|NCT04645316|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111010864|NCT04645316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111010865|NCT04645316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111010866|NCT04645316|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111010867|NCT04645316|Anesthetics, General|anesthetics, general|mesh-ancestor
111010868|NCT04645316|Anesthetics|anesthetics|mesh-ancestor
111010869|NCT04645316|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111010870|NCT04645316|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111010871|NCT02491515|Denosumab|denosumab|mesh-list
111010872|NCT02491515|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111010873|NCT02491515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111010874|NCT05113628|Methylene Blue|methylene blue|mesh-list
111010875|NCT05113628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111010876|NCT05113628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111010877|NCT04247750|Sirolimus|sirolimus|mesh-list
111010878|NCT04247750|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111010879|NCT04247750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111010880|NCT04247750|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111010881|NCT04247750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111010882|NCT04247750|Antifungal Agents|antifungal agents|mesh-ancestor
111010883|NCT04247750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111010884|NCT04247750|Immunologic Factors|immunologic factors|mesh-ancestor
111010885|NCT04247750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111010886|NCT04513808|Anesthetics|anesthetics|mesh-list
111010887|NCT04513808|Propofol|propofol|mesh-list
111010888|NCT04513808|Sevoflurane|sevoflurane|mesh-list
111010889|NCT04513808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111010890|NCT04513808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111010891|NCT04513808|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111010892|NCT04513808|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111010893|NCT04513808|Anesthetics, General|anesthetics, general|mesh-ancestor
111010894|NCT04513808|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111010895|NCT04513808|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111010896|NCT02493231|Ketamine|ketamine|mesh-list
111010897|NCT02493231|Nefopam|nefopam|mesh-list
111010898|NCT02493231|Analgesics|analgesics|mesh-ancestor
111010899|NCT02493231|Sensory System Agents|sensory system agents|mesh-ancestor
111010900|NCT02493231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111010901|NCT02493231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111010902|NCT02493231|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111010903|NCT02493231|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111010904|NCT02493231|Anesthetics, General|anesthetics, general|mesh-ancestor
111010905|NCT02493231|Anesthetics|anesthetics|mesh-ancestor
110727896|NCT03744364|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111010906|NCT02493231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111010907|NCT02493231|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111010908|NCT02493231|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111010909|NCT02493231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111010910|NCT02493231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111010911|NCT02493231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111010913|NCT05112692|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
111010914|NCT05112692|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
111010915|NCT05112692|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
111010916|NCT05112692|Cetrorelix|cetrorelix|mesh-list
111010917|NCT05112692|Menotropins|menotropins|mesh-list
111010918|NCT05112692|Estradiol|estradiol|mesh-list
111010919|NCT05112692|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
111010920|NCT05112692|Progesterone|progesterone|mesh-list
111010921|NCT05112692|Dydrogesterone|dydrogesterone|mesh-list
111010922|NCT05112692|Estrogens|estrogens|mesh-ancestor
111010923|NCT05112692|Hormones|hormones|mesh-ancestor
111010924|NCT05112692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111010925|NCT05112692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111010926|NCT05112692|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111010927|NCT05112692|Contraceptive Agents|contraceptive agents|mesh-ancestor
111010928|NCT05112692|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111010929|NCT05112692|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111010930|NCT05112692|Progestins|progestins|mesh-ancestor
111010931|NCT05112692|Luteolytic Agents|luteolytic agents|mesh-ancestor
111010932|NCT05112692|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111010933|NCT05112692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111010934|NCT05112692|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111010935|NCT05112692|Fertility Agents|fertility agents|mesh-ancestor
111010936|NCT05112692|Hormone Antagonists|hormone antagonists|mesh-ancestor
111010937|NCT03328533|Phenylephrine|phenylephrine|mesh-list
111010938|NCT03328533|Oxymetazoline|oxymetazoline|mesh-list
111010939|NCT03328533|Norepinephrine|norepinephrine|mesh-list
111010940|NCT03328533|Bupivacaine|bupivacaine|mesh-list
111010941|NCT03328533|Anesthetics, Local|anesthetics, local|mesh-ancestor
111010942|NCT03328533|Anesthetics|anesthetics|mesh-ancestor
111010943|NCT03328533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111010944|NCT03328533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111010945|NCT03328533|Sensory System Agents|sensory system agents|mesh-ancestor
111010946|NCT03328533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111010947|NCT03328533|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111010948|NCT03328533|Mydriatics|mydriatics|mesh-ancestor
111010949|NCT03328533|Autonomic Agents|autonomic agents|mesh-ancestor
111010950|NCT03328533|Sympathomimetics|sympathomimetics|mesh-ancestor
111010951|NCT03328533|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111010952|NCT03328533|Nasal Decongestants|nasal decongestants|mesh-ancestor
111010953|NCT03328533|Respiratory System Agents|respiratory system agents|mesh-ancestor
111010954|NCT03328533|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110025370|NCT00363948|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111010955|NCT03328533|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111010956|NCT03328533|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111010957|NCT03328533|Adrenergic Agents|adrenergic agents|mesh-ancestor
111010958|NCT03328533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111010959|NCT03328533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111010960|NCT03328533|Protective Agents|protective agents|mesh-ancestor
111010961|NCT05117372|Immunomodulating Agents|immunomodulating agents|mesh-list
111010962|NCT05117372|Immunologic Factors|immunologic factors|mesh-ancestor
111010963|NCT05117372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111010964|NCT03324243|Cytarabine|cytarabine|mesh-list
111010965|NCT03324243|Fludarabine|fludarabine|mesh-list
111010966|NCT03324243|Crenolanib|crenolanib|mesh-list
111010967|NCT03324243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111010968|NCT03324243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111010969|NCT03324243|Antimetabolites|antimetabolites|mesh-ancestor
111010970|NCT03324243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111010971|NCT03324243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111010972|NCT03324243|Immunologic Factors|immunologic factors|mesh-ancestor
111010973|NCT03324243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111010974|NCT03324243|Antiviral Agents|antiviral agents|mesh-ancestor
111010975|NCT03324243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111010976|NCT03328299|Dexmedetomidine|dexmedetomidine|mesh-list
111010977|NCT03328299|Bupivacaine|bupivacaine|mesh-list
111010978|NCT03328299|Anesthetics, Local|anesthetics, local|mesh-ancestor
111010979|NCT03328299|Anesthetics|anesthetics|mesh-ancestor
110727978|NCT04428502|Etanercept|etanercept|mesh-list
111010980|NCT03328299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111010981|NCT03328299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111010982|NCT03328299|Sensory System Agents|sensory system agents|mesh-ancestor
111010983|NCT03328299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111010984|NCT03328299|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111010985|NCT03328299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111010986|NCT03328299|Analgesics|analgesics|mesh-ancestor
111010987|NCT03328299|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111010988|NCT03328299|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111010989|NCT03328299|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111010990|NCT03328299|Adrenergic Agents|adrenergic agents|mesh-ancestor
111010991|NCT03328299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111010992|NCT03328299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111010993|NCT03564301|Metronidazole|metronidazole|mesh-list
111010994|NCT03564301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111010995|NCT03564301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111010996|NCT03564301|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111010997|NCT03564301|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111010998|NCT05079854|Moxifloxacin|moxifloxacin|mesh-list
111010999|NCT05079854|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111011000|NCT05079854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111011001|NCT05079854|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111011002|NCT05079854|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111011003|NCT05079854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111011004|NCT05079854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111011005|NCT05079854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111011006|NCT03327987|Vaccines|vaccines|mesh-list
111011007|NCT03327987|Immunologic Factors|immunologic factors|mesh-ancestor
111011008|NCT03327987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111011009|NCT03335241|Doxorubicin|doxorubicin|mesh-list
111011010|NCT03335241|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111011011|NCT03335241|Fludarabine|fludarabine|mesh-list
111011012|NCT03335241|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111011013|NCT03335241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111011014|NCT03335241|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111011015|NCT03335241|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111011016|NCT03335241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111011017|NCT03335241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111011018|NCT03327831|Aminolevulinic Acid|aminolevulinic acid|mesh-list
111011019|NCT03327831|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111011020|NCT03327831|Dermatologic Agents|dermatologic agents|mesh-ancestor
111011021|NCT03120663|Amoxicillin|amoxicillin|mesh-list
111011022|NCT03120663|Clindamycin|clindamycin|mesh-list
111011023|NCT03120663|Meropenem|meropenem|mesh-list
111011024|NCT03120663|Tazobactam|tazobactam|mesh-list
111011025|NCT03120663|Piperacillin|piperacillin|mesh-list
111011026|NCT03120663|Clavulanic Acids|clavulanic acids|mesh-list
111011027|NCT03120663|Clavulanic Acid|clavulanic acid|mesh-list
111011028|NCT03120663|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
111011029|NCT03120663|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
111011030|NCT03120663|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111011031|NCT03120663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111011032|NCT03120663|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111011033|NCT03120663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111011034|NCT03120663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111011035|NCT03120663|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
111011036|NCT02578394|Methylprednisolone|methylprednisolone|mesh-list
111011037|NCT02578394|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111011038|NCT02578394|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111011039|NCT02578394|Prednisolone|prednisolone|mesh-list
111011040|NCT02578394|Prednisolone acetate|prednisolone acetate|mesh-list
111011041|NCT02578394|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
111011042|NCT02578394|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111011043|NCT02578394|Prednisolone phosphate|prednisolone phosphate|mesh-list
111011044|NCT02578394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111011045|NCT02578394|Antiemetics|antiemetics|mesh-ancestor
111011046|NCT02578394|Autonomic Agents|autonomic agents|mesh-ancestor
111011047|NCT02578394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111011048|NCT02578394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111011049|NCT02578394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111011050|NCT02578394|Glucocorticoids|glucocorticoids|mesh-ancestor
111011051|NCT02578394|Hormones|hormones|mesh-ancestor
111011052|NCT02578394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111011053|NCT02578394|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111011054|NCT02578394|Protective Agents|protective agents|mesh-ancestor
111011055|NCT02578394|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111011056|NCT02578394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111011057|NCT02578394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111011058|NCT04493229|Oxytocin|oxytocin|mesh-list
111011060|NCT04493229|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111011061|NCT04493229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111011062|NCT03120273|Lansoprazole|lansoprazole|mesh-list
111011063|NCT03120273|Dexlansoprazole|dexlansoprazole|mesh-list
111011064|NCT03120273|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111011065|NCT03120273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111011066|NCT03120273|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111011067|NCT03120273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111011068|NCT03120273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111011069|NCT02122718|Allopurinol|allopurinol|mesh-list
111011070|NCT02122718|Antimetabolites|antimetabolites|mesh-ancestor
111011071|NCT02122718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111011072|NCT02122718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111011073|NCT02122718|Gout Suppressants|gout suppressants|mesh-ancestor
111011074|NCT02122718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111011075|NCT02122718|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111011076|NCT02122718|Antioxidants|antioxidants|mesh-ancestor
111011077|NCT02122718|Protective Agents|protective agents|mesh-ancestor
111011078|NCT02122718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111011079|NCT04513652|Carticaine|carticaine|mesh-list
111011080|NCT04513652|Anesthetics, Local|anesthetics, local|mesh-ancestor
111011081|NCT04513652|Anesthetics|anesthetics|mesh-ancestor
111011082|NCT04513652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111011083|NCT04513652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111011084|NCT04513652|Sensory System Agents|sensory system agents|mesh-ancestor
111011085|NCT04513652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111011086|NCT00706797|Etanercept|etanercept|mesh-list
111011087|NCT00706797|Methotrexate|methotrexate|mesh-list
111011088|NCT00706797|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111011089|NCT00706797|Abortifacient Agents|abortifacient agents|mesh-ancestor
111011090|NCT00706797|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111011091|NCT00706797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111011092|NCT00706797|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111011093|NCT00706797|Antimetabolites|antimetabolites|mesh-ancestor
111011094|NCT00706797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111011095|NCT00706797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111011096|NCT00706797|Dermatologic Agents|dermatologic agents|mesh-ancestor
111011097|NCT00706797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111011098|NCT00706797|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111011099|NCT00706797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111011100|NCT00706797|Immunologic Factors|immunologic factors|mesh-ancestor
111011101|NCT00706797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111011102|NCT00706797|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111011103|NCT00706797|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111011104|NCT00706797|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111011105|NCT00706797|Analgesics|analgesics|mesh-ancestor
111011106|NCT00706797|Sensory System Agents|sensory system agents|mesh-ancestor
111011107|NCT00706797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111011108|NCT00706797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111011109|NCT00706797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111011111|NCT03323697|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111011112|NCT03323697|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111011113|NCT03323697|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110621716|NCT00942201|Antiemetics|antiemetics|mesh-ancestor
111011114|NCT03323697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111011115|NCT03323697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111011116|NCT03323697|Serotonin Agents|serotonin agents|mesh-ancestor
111011117|NCT03323697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111011118|NCT00706641|Dasatinib|dasatinib|mesh-list
111011119|NCT00706641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111011120|NCT00706641|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111011121|NCT00706641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111011122|NCT00706641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111011123|NCT03335085|Oxytocin|oxytocin|mesh-list
111011124|NCT03335085|Oxytocics|oxytocics|mesh-ancestor
111011125|NCT03335085|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111011126|NCT03335085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111011127|NCT03323619|Anesthetics|anesthetics|mesh-list
111011128|NCT03323619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111011129|NCT03323619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111011130|NCT03323541|Lenograstim|lenograstim|mesh-list
111011131|NCT03323541|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111011132|NCT03323541|Immunologic Factors|immunologic factors|mesh-ancestor
111011133|NCT03323541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111011134|NCT03335007|Aceclofenac|aceclofenac|mesh-list
111011135|NCT03335007|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111011136|NCT03335007|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111011137|NCT03335007|Analgesics|analgesics|mesh-ancestor
111011138|NCT03335007|Sensory System Agents|sensory system agents|mesh-ancestor
111011139|NCT03335007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111011140|NCT03335007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111011141|NCT03335007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111011142|NCT03335007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111011143|NCT01362530|Ondansetron|ondansetron|mesh-list
111011144|NCT01362530|Aprepitant|aprepitant|mesh-list
111011145|NCT01362530|Fosaprepitant|fosaprepitant|mesh-list
111011146|NCT01362530|Antiemetics|antiemetics|mesh-ancestor
111011147|NCT01362530|Autonomic Agents|autonomic agents|mesh-ancestor
111011148|NCT01362530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111011149|NCT01362530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111011150|NCT01362530|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111011151|NCT01362530|Antipruritics|antipruritics|mesh-ancestor
111011152|NCT01362530|Dermatologic Agents|dermatologic agents|mesh-ancestor
111011153|NCT01362530|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111011154|NCT01362530|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111011155|NCT01362530|Serotonin Agents|serotonin agents|mesh-ancestor
111011156|NCT01362530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111011157|NCT01362530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111011158|NCT01362530|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
111011159|NCT04494399|Interferons|interferons|mesh-list
111011160|NCT04494399|Ribavirin|ribavirin|mesh-list
111011161|NCT04494399|Interferon-beta|interferon-beta|mesh-list
111011162|NCT04494399|Interferon beta-1b|interferon beta-1b|mesh-list
111011163|NCT04494399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111011164|NCT04494399|Antiviral Agents|antiviral agents|mesh-ancestor
111011165|NCT04494399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111011166|NCT04494399|Antimetabolites|antimetabolites|mesh-ancestor
111011167|NCT04494399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111011168|NCT04494399|Immunologic Factors|immunologic factors|mesh-ancestor
111011169|NCT04494399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111011170|NCT04494399|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111011171|NCT01758614|Aspirin|aspirin|mesh-list
111011172|NCT01758614|Clopidogrel|clopidogrel|mesh-list
111011173|NCT01758614|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111011174|NCT01758614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111011175|NCT01758614|Analgesics|analgesics|mesh-ancestor
111011176|NCT01758614|Sensory System Agents|sensory system agents|mesh-ancestor
111011177|NCT01758614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111011178|NCT01758614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111011179|NCT01758614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111011180|NCT01758614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111011181|NCT01758614|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111011182|NCT01758614|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111011183|NCT01758614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111011184|NCT01758614|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111011185|NCT01758614|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111011186|NCT01758614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111011187|NCT01758614|Antipyretics|antipyretics|mesh-ancestor
111011188|NCT01758614|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111011189|NCT01758614|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111011190|NCT01758614|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111011191|NCT01758614|Purinergic Agents|purinergic agents|mesh-ancestor
111011192|NCT01758614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111011193|NCT02490657|Iloprost|iloprost|mesh-list
111011194|NCT02490657|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111011195|NCT02490657|Vasodilator Agents|vasodilator agents|mesh-ancestor
111011196|NCT04323566|Rituximab|rituximab|mesh-list
111011197|NCT04323566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111011198|NCT04323566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111011199|NCT04323566|Immunologic Factors|immunologic factors|mesh-ancestor
111011200|NCT04323566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111011201|NCT04323566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111011202|NCT03109119|Propofol|propofol|mesh-list
111011203|NCT03109119|Sevoflurane|sevoflurane|mesh-list
111011204|NCT03109119|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111011205|NCT03109119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111011206|NCT03109119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111011207|NCT03109119|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110728198|NCT01040195|Antimetabolites|antimetabolites|mesh-ancestor
111011208|NCT03109119|Anesthetics, General|anesthetics, general|mesh-ancestor
111011210|NCT03109119|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111011211|NCT03109119|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111011212|NCT03326661|Clindamycin|clindamycin|mesh-list
111011213|NCT03326661|Clindamycin palmitate|clindamycin palmitate|mesh-list
111011214|NCT03326661|Clindamycin phosphate|clindamycin phosphate|mesh-list
111011215|NCT03326661|Penicillins|penicillins|mesh-list
111011216|NCT03326661|Penicillin V|penicillin v|mesh-list
111011217|NCT03326661|Metronidazole|metronidazole|mesh-list
111011218|NCT03326661|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111011219|NCT03326661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111011220|NCT03326661|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111011221|NCT03326661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111011222|NCT03326661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111011223|NCT03326661|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111011224|NCT03326661|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111011225|NCT03333915|Pamiparib|pamiparib|mesh-list
111011226|NCT03333915|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111011227|NCT03333915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111011228|NCT03333915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111011229|NCT03333915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111011230|NCT04261478|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
111011231|NCT02654054|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
111011232|NCT02654054|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
111011233|NCT02654054|Norethindrone|norethindrone|mesh-list
111011234|NCT02654054|Norethindrone Acetate|norethindrone acetate|mesh-list
111011235|NCT02654054|Estradiol|estradiol|mesh-list
111011236|NCT02654054|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
111011237|NCT02654054|Estrogens|estrogens|mesh-ancestor
111011238|NCT02654054|Hormones|hormones|mesh-ancestor
111011239|NCT02654054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111011240|NCT02654054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111011241|NCT02654054|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111011242|NCT02654054|Contraceptive Agents|contraceptive agents|mesh-ancestor
111011243|NCT02654054|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111011244|NCT02654054|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111011245|NCT02654054|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111011246|NCT02654054|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111011247|NCT02654054|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111011248|NCT03186404|Atorvastatin|atorvastatin|mesh-list
111011249|NCT03186404|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111011250|NCT03186404|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111011251|NCT03186404|Antimetabolites|antimetabolites|mesh-ancestor
111011252|NCT03186404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111011253|NCT03186404|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111011254|NCT03186404|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111011255|NCT03186404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111011256|NCT02492373|Clobetasol|clobetasol|mesh-list
111011257|NCT02492373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111011258|NCT02492373|Glucocorticoids|glucocorticoids|mesh-ancestor
111011259|NCT02492373|Hormones|hormones|mesh-ancestor
111011260|NCT02492373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111011261|NCT02492373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111011262|NCT03073070|Biotin|biotin|mesh-list
111011263|NCT03073070|Vitamin B Complex|vitamin b complex|mesh-ancestor
111011264|NCT03073070|Vitamins|vitamins|mesh-ancestor
111011265|NCT03073070|Micronutrients|micronutrients|mesh-ancestor
111011266|NCT03073070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111011267|NCT02905214|Sirolimus|sirolimus|mesh-list
111011268|NCT02905214|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111011269|NCT02905214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111011270|NCT02905214|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111011271|NCT02905214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111011272|NCT02905214|Antifungal Agents|antifungal agents|mesh-ancestor
111011273|NCT02905214|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111011274|NCT02905214|Immunologic Factors|immunologic factors|mesh-ancestor
111011275|NCT02905214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111011276|NCT03333603|Esomeprazole|esomeprazole|mesh-list
111011277|NCT03333603|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111011278|NCT03333603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111011279|NCT03333603|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111011280|NCT03333603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111011281|NCT03333603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111011282|NCT03333525|Insulin|insulin|mesh-list
111011283|NCT03333525|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111011284|NCT03333525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111011286|NCT03333369|Benserazide|benserazide|mesh-list
111011287|NCT03333369|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111011288|NCT03333369|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111011289|NCT03333369|Dopamine Agents|dopamine agents|mesh-ancestor
111011290|NCT03333369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111011291|NCT03333369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111011292|NCT03333369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111011293|NCT03333369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111011294|NCT03325803|Lidocaine|lidocaine|mesh-list
111011295|NCT03325803|Prilocaine|prilocaine|mesh-list
111011296|NCT03325803|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
111011297|NCT03325803|Anesthetics, Local|anesthetics, local|mesh-ancestor
111011298|NCT03325803|Anesthetics|anesthetics|mesh-ancestor
111011299|NCT03325803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111011300|NCT03325803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111011301|NCT03325803|Sensory System Agents|sensory system agents|mesh-ancestor
111011302|NCT03325803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111011303|NCT03325803|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111011304|NCT03325803|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111011305|NCT03325803|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111011306|NCT03325803|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111011307|NCT03325803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111011308|NCT03325803|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
111011309|NCT05465343|Aflutinib|aflutinib|mesh-list
111011310|NCT05465343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111011311|NCT05465343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111011312|NCT05465343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111011313|NCT03325491|Acipimox|acipimox|mesh-list
111011314|NCT03325491|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111011315|NCT03325491|Antimetabolites|antimetabolites|mesh-ancestor
111011316|NCT03325491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111011317|NCT03325491|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111011318|NCT04150562|Avelumab|avelumab|mesh-list
111011319|NCT04150562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111011320|NCT04150562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111011321|NCT03325413|Anesthetics|anesthetics|mesh-list
111011322|NCT03325413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111011323|NCT03325413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111011324|NCT03325335|Midazolam|midazolam|mesh-list
111011325|NCT03325335|Remifentanil|remifentanil|mesh-list
111011326|NCT03325335|Propofol|propofol|mesh-list
111011327|NCT03325335|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111011328|NCT03325335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111011329|NCT03325335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111011330|NCT03325335|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111011331|NCT03325335|Anesthetics, General|anesthetics, general|mesh-ancestor
111011332|NCT03325335|Anesthetics|anesthetics|mesh-ancestor
111011333|NCT03325335|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111011334|NCT03325335|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111011335|NCT03325335|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111011336|NCT03325335|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111011337|NCT03325335|GABA Modulators|gaba modulators|mesh-ancestor
111011338|NCT03325335|GABA Agents|gaba agents|mesh-ancestor
111011339|NCT03325335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111011340|NCT03325335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111011341|NCT03325335|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111011342|NCT03325335|Narcotics|narcotics|mesh-ancestor
111011343|NCT03325335|Analgesics|analgesics|mesh-ancestor
111011344|NCT03325335|Sensory System Agents|sensory system agents|mesh-ancestor
111011345|NCT03325335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111011346|NCT05114720|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111011347|NCT05114720|Moxifloxacin|moxifloxacin|mesh-list
111011348|NCT05114720|Cyclophosphamide|cyclophosphamide|mesh-list
111011349|NCT05114720|Docetaxel|docetaxel|mesh-list
111011350|NCT05114720|Doxorubicin|doxorubicin|mesh-list
111011351|NCT05114720|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111011352|NCT05114720|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
111011353|NCT05114720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111011354|NCT05114720|Immunologic Factors|immunologic factors|mesh-ancestor
111011355|NCT05114720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111011356|NCT05114720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111011357|NCT05114720|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111011358|NCT05114720|Alkylating Agents|alkylating agents|mesh-ancestor
110728346|NCT01080638|Abciximab|abciximab|mesh-list
111011359|NCT05114720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111011360|NCT05114720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111011361|NCT05114720|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111011362|NCT05114720|Tubulin Modulators|tubulin modulators|mesh-ancestor
111011363|NCT05114720|Antimitotic Agents|antimitotic agents|mesh-ancestor
111011364|NCT05114720|Mitosis Modulators|mitosis modulators|mesh-ancestor
111011365|NCT05114720|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111011366|NCT05114720|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111011367|NCT05114720|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111011368|NCT05114720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111011369|NCT05114720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111011370|NCT05114720|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111011371|NCT05114720|Contraceptive Agents|contraceptive agents|mesh-ancestor
111011372|NCT05114720|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111011373|NCT05114720|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
111011374|NCT05114720|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111011375|NCT05114720|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111011376|NCT04493463|Methylprednisolone|methylprednisolone|mesh-list
111011377|NCT04493463|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110621752|NCT00942591|Interferons|interferons|mesh-list
111011378|NCT04493463|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111011379|NCT04493463|Prednisolone|prednisolone|mesh-list
111011380|NCT04493463|Prednisolone acetate|prednisolone acetate|mesh-list
111011381|NCT04493463|Ropivacaine|ropivacaine|mesh-list
111011382|NCT04493463|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111011383|NCT04493463|Prednisolone phosphate|prednisolone phosphate|mesh-list
111011384|NCT04493463|Anesthetics, Local|anesthetics, local|mesh-ancestor
111011385|NCT04493463|Anesthetics|anesthetics|mesh-ancestor
111011386|NCT04493463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111011387|NCT04493463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111011388|NCT04493463|Sensory System Agents|sensory system agents|mesh-ancestor
111011389|NCT04493463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111011390|NCT04493463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111011391|NCT04493463|Antiemetics|antiemetics|mesh-ancestor
111011392|NCT04493463|Autonomic Agents|autonomic agents|mesh-ancestor
111011393|NCT04493463|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111011394|NCT04493463|Glucocorticoids|glucocorticoids|mesh-ancestor
111011395|NCT04493463|Hormones|hormones|mesh-ancestor
111011396|NCT04493463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111011397|NCT04493463|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111011398|NCT04493463|Protective Agents|protective agents|mesh-ancestor
111011399|NCT04493463|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111011400|NCT04493463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111011401|NCT04493073|Mitomycins|mitomycins|mesh-list
111011402|NCT04493073|Mitomycin|mitomycin|mesh-list
111011403|NCT04493073|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111011404|NCT04493073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111011405|NCT04493073|Alkylating Agents|alkylating agents|mesh-ancestor
111011406|NCT04493073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110025447|NCT00365898|Hydromorphone|hydromorphone|mesh-list
111011407|NCT04493073|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111011408|NCT04493073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111011410|NCT00748904|Lactulose|lactulose|mesh-list
111011411|NCT00748904|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111011412|NCT00748904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111011413|NCT00748904|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111011414|NCT03321903|Charcoal|charcoal|mesh-list
111011415|NCT03321903|Antidotes|antidotes|mesh-ancestor
111011416|NCT03321903|Protective Agents|protective agents|mesh-ancestor
111011417|NCT03321903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111011418|NCT04411550|Pertuzumab|pertuzumab|mesh-list
111011419|NCT04411550|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111011420|NCT04411550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111011421|NCT03321825|Lidocaine|lidocaine|mesh-list
111011422|NCT03321825|Hyaluronic Acid|hyaluronic acid|mesh-list
111011423|NCT03321825|Anesthetics, Local|anesthetics, local|mesh-ancestor
111011424|NCT03321825|Anesthetics|anesthetics|mesh-ancestor
111011425|NCT03321825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111011426|NCT03321825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111011427|NCT03321825|Sensory System Agents|sensory system agents|mesh-ancestor
111011428|NCT03321825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111011429|NCT03321825|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111011430|NCT03321825|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111011431|NCT03321825|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111011432|NCT03321825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111011433|NCT03321825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111011434|NCT03321825|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111011436|NCT03321825|Viscosupplements|viscosupplements|mesh-ancestor
111011437|NCT03321825|Protective Agents|protective agents|mesh-ancestor
111011438|NCT02492217|Adalimumab|adalimumab|mesh-list
111011439|NCT02492217|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111011440|NCT02492217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111011441|NCT02492217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111011442|NCT05229536|Vaccines|vaccines|mesh-list
111011443|NCT05229536|Immunologic Factors|immunologic factors|mesh-ancestor
111011444|NCT05229536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111011445|NCT04810910|Molgramostim|molgramostim|mesh-list
111011446|NCT04810910|Sargramostim|sargramostim|mesh-list
111011447|NCT04810910|Immunologic Factors|immunologic factors|mesh-ancestor
111011448|NCT04810910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110621770|NCT00946335|Veliparib|veliparib|mesh-list
111011449|NCT04810910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111011450|NCT03320187|Nitroglycerin|nitroglycerin|mesh-list
111011451|NCT03320187|Dinoprostone|dinoprostone|mesh-list
111011452|NCT03320187|Vasodilator Agents|vasodilator agents|mesh-ancestor
111011453|NCT03320187|Oxytocics|oxytocics|mesh-ancestor
111011454|NCT03320187|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111011455|NCT03320187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111011456|NCT03320109|Vitamin D|vitamin d|mesh-list
111011457|NCT03320109|Ergocalciferols|ergocalciferols|mesh-list
111011458|NCT03320109|Cholecalciferol|cholecalciferol|mesh-list
111011459|NCT03320109|Vitamins|vitamins|mesh-list
111011460|NCT03320109|Micronutrients|micronutrients|mesh-ancestor
111011461|NCT03320109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111011462|NCT03320109|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111011463|NCT03320109|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111011464|NCT04529876|Abatacept|abatacept|mesh-list
111011465|NCT04529876|Tofacitinib|tofacitinib|mesh-list
111011466|NCT04529876|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111011467|NCT04529876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111011468|NCT04529876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111011469|NCT04529876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111011470|NCT04529876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111011471|NCT04529876|Immunologic Factors|immunologic factors|mesh-ancestor
111011472|NCT04529876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111011473|NCT04529876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111011474|NCT04529876|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
111011475|NCT04529876|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111011476|NCT04529876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111011477|NCT03320031|Insulin Lispro|insulin lispro|mesh-list
111011478|NCT03320031|Linagliptin|linagliptin|mesh-list
111011479|NCT03320031|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111011480|NCT03320031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111011481|NCT03320031|Incretins|incretins|mesh-ancestor
111011482|NCT03320031|Hormones|hormones|mesh-ancestor
111011483|NCT03320031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111011484|NCT03320031|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111011485|NCT03320031|Protease Inhibitors|protease inhibitors|mesh-ancestor
111011486|NCT03320031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111011487|NCT03320031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111011488|NCT04510922|Droxidopa|droxidopa|mesh-list
111011489|NCT04510922|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111011490|NCT04510922|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111011491|NCT05465031|Valsartan|valsartan|mesh-list
111011492|NCT05465031|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
111011493|NCT05465031|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111011494|NCT05465031|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111011495|NCT05465031|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111011496|NCT05465031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111011497|NCT04510844|Evolocumab|evolocumab|mesh-list
111011498|NCT04510844|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
111011499|NCT04510844|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111011500|NCT04510844|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111011501|NCT04510844|Antimetabolites|antimetabolites|mesh-ancestor
111011502|NCT04510844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111011503|NCT04510844|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111011504|NCT04510844|Protease Inhibitors|protease inhibitors|mesh-ancestor
111011505|NCT04510844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111011506|NCT04510844|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111011507|NCT05464953|Triamcinolone|triamcinolone|mesh-list
111011508|NCT05464953|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110728495|NCT00403481|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111011509|NCT05464953|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
111011510|NCT05464953|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
111011511|NCT05464953|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111011512|NCT05464953|Glucocorticoids|glucocorticoids|mesh-ancestor
111011513|NCT05464953|Hormones|hormones|mesh-ancestor
111011514|NCT05464953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111011515|NCT05464953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111011516|NCT05464953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111011517|NCT05464953|Immunologic Factors|immunologic factors|mesh-ancestor
111011518|NCT05464953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111011519|NCT05464953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111011520|NCT02491749|Anesthetics|anesthetics|mesh-list
111011521|NCT02491749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111011522|NCT02491749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111011523|NCT04408898|Pembrolizumab|pembrolizumab|mesh-list
111011524|NCT04408898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111011525|NCT04408898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111011526|NCT04408898|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111011527|NCT04408898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111011528|NCT02490345|Gabapentin|gabapentin|mesh-list
111011529|NCT02490345|Analgesics|analgesics|mesh-ancestor
111011530|NCT02490345|Sensory System Agents|sensory system agents|mesh-ancestor
111011531|NCT02490345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111011532|NCT02490345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111011533|NCT02490345|Anticonvulsants|anticonvulsants|mesh-ancestor
111011534|NCT02490345|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111011535|NCT02490345|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111011536|NCT02490345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111011537|NCT02490345|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111011538|NCT02490345|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111011539|NCT02490345|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111011540|NCT02490345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111011541|NCT02490345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111011542|NCT02490345|Antimanic Agents|antimanic agents|mesh-ancestor
111011543|NCT03331263|Chlorhexidine|chlorhexidine|mesh-list
111011544|NCT03331263|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
111011545|NCT03331263|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111011546|NCT03331263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111011547|NCT03331263|Disinfectants|disinfectants|mesh-ancestor
111011548|NCT03331263|Dermatologic Agents|dermatologic agents|mesh-ancestor
111011549|NCT03319563|Epinephrine|epinephrine|mesh-list
111011550|NCT03319563|Anesthetics|anesthetics|mesh-list
111011551|NCT03319563|Anesthetics, Local|anesthetics, local|mesh-list
111011552|NCT03319563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111011553|NCT03319563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111011554|NCT03319563|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111011555|NCT03319563|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111011556|NCT03319563|Adrenergic Agents|adrenergic agents|mesh-ancestor
111011557|NCT03319563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111011558|NCT03319563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111011559|NCT03319563|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111011560|NCT03319563|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111011561|NCT03319563|Autonomic Agents|autonomic agents|mesh-ancestor
111011562|NCT03319563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111011563|NCT03319563|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111011564|NCT03319563|Respiratory System Agents|respiratory system agents|mesh-ancestor
111011565|NCT03319563|Mydriatics|mydriatics|mesh-ancestor
111011566|NCT03319563|Sympathomimetics|sympathomimetics|mesh-ancestor
111011567|NCT03319563|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111011568|NCT03319563|Sensory System Agents|sensory system agents|mesh-ancestor
111011569|NCT02485119|Anetumab ravtansine|anetumab ravtansine|mesh-list
111011570|NCT02485119|Immunoconjugates|immunoconjugates|mesh-ancestor
111011571|NCT02485119|Immunologic Factors|immunologic factors|mesh-ancestor
111011572|NCT02485119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111011573|NCT02484573|Propranolol|propranolol|mesh-list
111011574|NCT02484573|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111011575|NCT02484573|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111011576|NCT02484573|Adrenergic Agents|adrenergic agents|mesh-ancestor
111011577|NCT02484573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111011578|NCT02484573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111011579|NCT02484573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111011580|NCT02484573|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111011581|NCT02484573|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111011582|NCT02484573|Vasodilator Agents|vasodilator agents|mesh-ancestor
111011583|NCT02489955|Tobramycin|tobramycin|mesh-list
110728611|NCT00401843|Bortezomib|bortezomib|mesh-list
111011585|NCT02489955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111011586|NCT02489955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111011587|NCT03734744|Vitamin D|vitamin d|mesh-list
111011588|NCT03734744|Cholecalciferol|cholecalciferol|mesh-list
111011589|NCT03734744|Vitamins|vitamins|mesh-ancestor
111011590|NCT03734744|Micronutrients|micronutrients|mesh-ancestor
111011591|NCT03734744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111011592|NCT03734744|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111011593|NCT03734744|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111011594|NCT03576716|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
111011595|NCT03576716|Calcifediol|calcifediol|mesh-list
111011596|NCT03576716|Vitamins|vitamins|mesh-ancestor
111011597|NCT03576716|Micronutrients|micronutrients|mesh-ancestor
111011598|NCT03576716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111011599|NCT03576716|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111011600|NCT02487381|Dronabinol|dronabinol|mesh-list
111011601|NCT02487381|Cannabidiol|cannabidiol|mesh-list
111011602|NCT02487381|Anticonvulsants|anticonvulsants|mesh-ancestor
111011603|NCT02487381|Hallucinogens|hallucinogens|mesh-ancestor
111011604|NCT02487381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111011605|NCT02487381|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111011606|NCT02487381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111011607|NCT02487381|Analgesics|analgesics|mesh-ancestor
111011608|NCT02487381|Sensory System Agents|sensory system agents|mesh-ancestor
111011609|NCT02487381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111011610|NCT02487381|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
111011611|NCT02487381|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
111011612|NCT02487381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111011613|NCT02487381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111011614|NCT02487381|Hormones|hormones|mesh-ancestor
111011615|NCT02487381|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111011616|NCT02487849|Carboplatin|carboplatin|mesh-list
111011617|NCT02487849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111011618|NCT02484339|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
111011619|NCT02484339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111011620|NCT04021550|Thioctic Acid|thioctic acid|mesh-list
111011621|NCT04021550|Telmisartan|telmisartan|mesh-list
111011622|NCT04021550|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111011623|NCT04021550|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111011624|NCT04021550|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111011625|NCT04021550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111011626|NCT04021550|Antioxidants|antioxidants|mesh-ancestor
111011627|NCT04021550|Protective Agents|protective agents|mesh-ancestor
111011628|NCT04021550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111011629|NCT04021550|Vitamin B Complex|vitamin b complex|mesh-ancestor
111011630|NCT04021550|Vitamins|vitamins|mesh-ancestor
111011631|NCT04021550|Micronutrients|micronutrients|mesh-ancestor
111011632|NCT02489487|Ritonavir|ritonavir|mesh-list
111011633|NCT02489487|Darunavir|darunavir|mesh-list
111011634|NCT02489487|Raltegravir Potassium|raltegravir potassium|mesh-list
111011635|NCT02489487|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111011636|NCT02489487|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111011637|NCT02489487|Protease Inhibitors|protease inhibitors|mesh-ancestor
111011638|NCT02489487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111011639|NCT02489487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111011640|NCT02489487|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111011641|NCT02489487|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111011642|NCT02489487|Antiviral Agents|antiviral agents|mesh-ancestor
111011643|NCT02489487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111011644|NCT02489487|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111011645|NCT02489487|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111011646|NCT02489487|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111011647|NCT02489487|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111011648|NCT02096354|Irinotecan|irinotecan|mesh-list
111011649|NCT02096354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111011650|NCT02096354|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111011651|NCT02096354|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111011652|NCT02096354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111011653|NCT02096354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111011654|NCT03177746|Tadalafil|tadalafil|mesh-list
111011655|NCT03177746|Vasodilator Agents|vasodilator agents|mesh-ancestor
111011656|NCT03177746|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111011657|NCT03177746|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110728645|NCT00400517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111011658|NCT03177746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111011659|NCT03177746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111011660|NCT03177746|Urological Agents|urological agents|mesh-ancestor
111011661|NCT02484027|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111011662|NCT02484027|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111011663|NCT02484027|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111011664|NCT02484027|Antimetabolites|antimetabolites|mesh-ancestor
111011665|NCT02484027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111011666|NCT02484027|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111011667|NCT02484027|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111011668|NCT02484027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111011669|NCT02483715|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111011670|NCT02483715|Amoxicillin|amoxicillin|mesh-list
111011671|NCT02483715|Metronidazole|metronidazole|mesh-list
111011672|NCT02483715|Tetracycline|tetracycline|mesh-list
111011673|NCT02483715|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
111011674|NCT02483715|Rabeprazole|rabeprazole|mesh-list
111011675|NCT02483715|Bismuth|bismuth|mesh-list
111011676|NCT02483715|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
111011677|NCT02483715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111011678|NCT02483715|Antitubercular Agents|antitubercular agents|mesh-ancestor
111011679|NCT02483715|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111011680|NCT02483715|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111011681|NCT02483715|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111011682|NCT02483715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111011683|NCT02483715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111011684|NCT02483715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111011685|NCT02483715|Antacids|antacids|mesh-ancestor
111011686|NCT02483715|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111011687|NCT02483793|Tamsulosin|tamsulosin|mesh-list
111011688|NCT02483793|Oxybutynin|oxybutynin|mesh-list
111011689|NCT02483793|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111011690|NCT02483793|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111011691|NCT02483793|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111011692|NCT02483793|Adrenergic Agents|adrenergic agents|mesh-ancestor
111011693|NCT02483793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111011694|NCT02483793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111011695|NCT02483793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111011696|NCT02483793|Urological Agents|urological agents|mesh-ancestor
111011697|NCT02483793|Parasympatholytics|parasympatholytics|mesh-ancestor
111011698|NCT02483793|Autonomic Agents|autonomic agents|mesh-ancestor
111011699|NCT02483793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111011700|NCT02483793|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111011701|NCT02483793|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111011702|NCT02483793|Cholinergic Agents|cholinergic agents|mesh-ancestor
111011703|NCT03200288|Hyaluronic Acid|hyaluronic acid|mesh-list
111011704|NCT03200288|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111011705|NCT03200288|Immunologic Factors|immunologic factors|mesh-ancestor
111011706|NCT03200288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111011707|NCT03200288|Viscosupplements|viscosupplements|mesh-ancestor
111011708|NCT03200288|Protective Agents|protective agents|mesh-ancestor
111011710|NCT03318471|Analgesics|analgesics|mesh-ancestor
111011711|NCT03318471|Sensory System Agents|sensory system agents|mesh-ancestor
111011712|NCT03318471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111011713|NCT03318471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111011714|NCT03318471|Anesthetics|anesthetics|mesh-ancestor
111011715|NCT03318471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111011716|NCT03318471|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111011717|NCT03318471|Anticonvulsants|anticonvulsants|mesh-ancestor
111011718|NCT03318471|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111011719|NCT03318471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111011720|NCT03318471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110621793|NCT00760448|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111011721|NCT03318471|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111011722|NCT03318471|Tocolytic Agents|tocolytic agents|mesh-ancestor
111011723|NCT03318471|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111011724|NCT04234022|Pomalidomide|pomalidomide|mesh-list
111011725|NCT04234022|Immunologic Factors|immunologic factors|mesh-ancestor
111011726|NCT04234022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111011727|NCT04234022|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111011728|NCT04234022|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111011729|NCT04234022|Growth Substances|growth substances|mesh-ancestor
111011730|NCT04234022|Growth Inhibitors|growth inhibitors|mesh-ancestor
111011731|NCT04234022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111011732|NCT02489409|Gemcitabine|gemcitabine|mesh-list
111011733|NCT02489409|Vinorelbine|vinorelbine|mesh-list
110728733|NCT01079312|Fentanyl|fentanyl|mesh-list
111011734|NCT02489409|Endostatins|endostatins|mesh-list
111011735|NCT02489409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111011736|NCT02489409|Antimetabolites|antimetabolites|mesh-ancestor
111011737|NCT02489409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111011738|NCT02489409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111011739|NCT02489409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111011740|NCT02489409|Tubulin Modulators|tubulin modulators|mesh-ancestor
111011741|NCT02489409|Antimitotic Agents|antimitotic agents|mesh-ancestor
111011742|NCT02489409|Mitosis Modulators|mitosis modulators|mesh-ancestor
111011743|NCT02489409|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111011744|NCT02489409|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111011745|NCT02489409|Growth Substances|growth substances|mesh-ancestor
111011746|NCT02489409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111011747|NCT02489409|Growth Inhibitors|growth inhibitors|mesh-ancestor
111011748|NCT03930602|Fluvoxamine|fluvoxamine|mesh-list
111011749|NCT03930602|Deucravacitinib|deucravacitinib|mesh-list
111011750|NCT03930602|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111011751|NCT03930602|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111011752|NCT03930602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111011753|NCT03930602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111011754|NCT03930602|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111011755|NCT03930602|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111011756|NCT03930602|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111011757|NCT03930602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111011758|NCT03930602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111011759|NCT03930602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111011760|NCT03930602|Serotonin Agents|serotonin agents|mesh-ancestor
111011761|NCT03930602|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111011762|NCT03930602|Antidepressive Agents|antidepressive agents|mesh-ancestor
111011763|NCT03930602|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111011764|NCT03930602|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111011765|NCT03930602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111011766|NCT03930602|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111011767|NCT03930602|Dermatologic Agents|dermatologic agents|mesh-ancestor
111011768|NCT03930602|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111011769|NCT02483871|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111011770|NCT02483871|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111011771|NCT02483871|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111011772|NCT02483871|Antimetabolites|antimetabolites|mesh-ancestor
111011773|NCT02483871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111011774|NCT02483871|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111011775|NCT02483871|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111011776|NCT02483871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111011777|NCT02489019|Fentanyl|fentanyl|mesh-list
111011778|NCT02489019|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111011779|NCT02489019|Narcotics|narcotics|mesh-ancestor
110476696|NCT00736645|Antioxidants|antioxidants|mesh-ancestor
111011780|NCT02489019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111011781|NCT02489019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111011782|NCT02489019|Analgesics|analgesics|mesh-ancestor
111011783|NCT02489019|Sensory System Agents|sensory system agents|mesh-ancestor
111011784|NCT02489019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111011785|NCT02489019|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111011786|NCT02489019|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111011787|NCT02489019|Anesthetics, General|anesthetics, general|mesh-ancestor
111011788|NCT02489019|Anesthetics|anesthetics|mesh-ancestor
111011790|NCT02604446|Tapentadol|tapentadol|mesh-list
111011791|NCT02604446|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111011792|NCT02604446|Narcotics|narcotics|mesh-ancestor
111011793|NCT02604446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111011794|NCT02604446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111011795|NCT02604446|Analgesics|analgesics|mesh-ancestor
111011796|NCT02604446|Sensory System Agents|sensory system agents|mesh-ancestor
111011797|NCT02604446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111011798|NCT02604446|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111011799|NCT02604446|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111011800|NCT02604446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111011801|NCT02604446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111011802|NCT02604446|Adrenergic Agents|adrenergic agents|mesh-ancestor
111011803|NCT02604446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111011804|NCT02847637|Factor VIII|factor viii|mesh-list
111011805|NCT02847637|Coagulants|coagulants|mesh-ancestor
111011806|NCT02652260|Tenofovir|tenofovir|mesh-list
111011807|NCT02652260|Lamivudine|lamivudine|mesh-list
111011808|NCT02652260|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
111011809|NCT02652260|Antiviral Agents|antiviral agents|mesh-ancestor
111011810|NCT02652260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111011811|NCT02652260|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111011812|NCT02652260|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111011813|NCT02652260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111011814|NCT02652260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111011815|NCT02652260|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111011816|NCT02652260|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111011818|NCT00584246|Analgesics|analgesics|mesh-ancestor
111011819|NCT00584246|Sensory System Agents|sensory system agents|mesh-ancestor
111011820|NCT00584246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111011821|NCT00584246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111011822|NCT00584246|Anticonvulsants|anticonvulsants|mesh-ancestor
111011823|NCT00584246|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111011824|NCT00584246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111011825|NCT00584246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111011826|NCT00584246|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111011827|NCT00584246|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111011828|NCT00584246|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111011829|NCT00584246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111011830|NCT00584246|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111011831|NCT05124314|Misoprostol|misoprostol|mesh-list
111011832|NCT05124314|Mifepristone|mifepristone|mesh-list
111011833|NCT05124314|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111011834|NCT05124314|Abortifacient Agents|abortifacient agents|mesh-ancestor
111011835|NCT05124314|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111011836|NCT05124314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111011837|NCT05124314|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111011838|NCT05124314|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111011839|NCT05124314|Oxytocics|oxytocics|mesh-ancestor
110621813|NCT04391348|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
111011840|NCT05124314|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
111011841|NCT05124314|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111011842|NCT05124314|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111011843|NCT05124314|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111011844|NCT05124314|Contraceptive Agents|contraceptive agents|mesh-ancestor
111011845|NCT05124314|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
111011846|NCT05124314|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
111011847|NCT05124314|Hormone Antagonists|hormone antagonists|mesh-ancestor
111011848|NCT05124314|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111011849|NCT05124314|Luteolytic Agents|luteolytic agents|mesh-ancestor
111011850|NCT05124314|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111011851|NCT05124314|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
111011852|NCT03320967|Arginine Vasopressin|arginine vasopressin|mesh-list
111011853|NCT03320967|Hemostatics|hemostatics|mesh-ancestor
111011854|NCT03320967|Coagulants|coagulants|mesh-ancestor
111011855|NCT03320967|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111011856|NCT03320967|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
111011857|NCT03320967|Natriuretic Agents|natriuretic agents|mesh-ancestor
111011858|NCT03320967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111011859|NCT02483325|Fludarabine|fludarabine|mesh-list
111011860|NCT02483325|Busulfan|busulfan|mesh-list
111011861|NCT02483325|Thymoglobulin|thymoglobulin|mesh-list
111011862|NCT02483325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111011863|NCT02483325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111011864|NCT02483325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111011865|NCT02483325|Immunologic Factors|immunologic factors|mesh-ancestor
111011866|NCT02483325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111011867|NCT02483325|Alkylating Agents|alkylating agents|mesh-ancestor
111011868|NCT02483325|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111011869|NCT02483325|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111011870|NCT04211090|Carboplatin|carboplatin|mesh-list
111011871|NCT04211090|Pemetrexed|pemetrexed|mesh-list
111011872|NCT04211090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111011873|NCT04211090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111011874|NCT04211090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111011875|NCT04211090|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111011876|NCT04211090|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111011877|NCT02486445|Rivaroxaban|rivaroxaban|mesh-list
111011878|NCT02486445|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111011879|NCT02486445|Antithrombins|antithrombins|mesh-ancestor
111011880|NCT02486445|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111011881|NCT02486445|Protease Inhibitors|protease inhibitors|mesh-ancestor
111011882|NCT02486445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111011883|NCT02486445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111011885|NCT02836873|Bexagliflozin|bexagliflozin|mesh-list
111011886|NCT02836873|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111011887|NCT02836873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111011888|NCT04538534|Nicardipine|nicardipine|mesh-list
111011889|NCT04538534|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111011890|NCT04538534|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111011891|NCT04538534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111011892|NCT04538534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111011893|NCT04538534|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111011894|NCT04538534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111011895|NCT04538534|Vasodilator Agents|vasodilator agents|mesh-ancestor
111011896|NCT03318159|Posaconazole|posaconazole|mesh-list
111011897|NCT03318159|Antifungal Agents|antifungal agents|mesh-ancestor
111011898|NCT03318159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111011899|NCT03318159|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
111011900|NCT03318159|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111011901|NCT03318159|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111011902|NCT03318159|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111011903|NCT03318159|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111011904|NCT03318159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111011905|NCT03318159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111011906|NCT03318159|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111011907|NCT03318159|Hormone Antagonists|hormone antagonists|mesh-ancestor
111011908|NCT03318159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111011909|NCT03318159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111011910|NCT03315507|VIP-ELP fusion molecule PB1046|vip-elp fusion molecule pb1046|mesh-list
111011911|NCT03315507|Vasodilator Agents|vasodilator agents|mesh-ancestor
111011912|NCT02724410|Amoxicillin|amoxicillin|mesh-list
111011913|NCT02724410|Clavulanic Acid|clavulanic acid|mesh-list
111011914|NCT02724410|Clavulanic Acids|clavulanic acids|mesh-list
111011915|NCT02724410|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
111011916|NCT02724410|Ertapenem|ertapenem|mesh-list
111011917|NCT02724410|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111011918|NCT02724410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111011919|NCT02724410|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
111011920|NCT02724410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111011921|NCT02724410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111011922|NCT02486601|Paclitaxel|paclitaxel|mesh-list
111011923|NCT02486601|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111011924|NCT02486601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111011925|NCT02486601|Tubulin Modulators|tubulin modulators|mesh-ancestor
111011926|NCT02486601|Antimitotic Agents|antimitotic agents|mesh-ancestor
111011927|NCT02486601|Mitosis Modulators|mitosis modulators|mesh-ancestor
111011928|NCT02486601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111011929|NCT02487069|Cyclosporine|cyclosporine|mesh-list
111011930|NCT02487069|Mycophenolic Acid|mycophenolic acid|mesh-list
111011931|NCT02487069|Methotrexate|methotrexate|mesh-list
111011932|NCT02487069|Cyclosporins|cyclosporins|mesh-list
111011933|NCT02487069|Antilymphocyte Serum|antilymphocyte serum|mesh-list
111011934|NCT02487069|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111011935|NCT02487069|Abortifacient Agents|abortifacient agents|mesh-ancestor
111011936|NCT02487069|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111011937|NCT02487069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111011938|NCT02487069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111011939|NCT02487069|Antimetabolites|antimetabolites|mesh-ancestor
111011940|NCT02487069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111011941|NCT02487069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111011942|NCT02487069|Dermatologic Agents|dermatologic agents|mesh-ancestor
111011943|NCT02487069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111011944|NCT02487069|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111011945|NCT02487069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111011946|NCT02487069|Immunologic Factors|immunologic factors|mesh-ancestor
111011947|NCT02487069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111011948|NCT02487069|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111011949|NCT02487069|Antifungal Agents|antifungal agents|mesh-ancestor
111011950|NCT02487069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111011951|NCT02487069|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111011952|NCT02487069|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111011953|NCT02487069|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111011954|NCT02487069|Antitubercular Agents|antitubercular agents|mesh-ancestor
111011955|NCT02487069|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111011956|NCT03564379|JNJ-42165279|jnj-42165279|mesh-list
111011957|NCT03564379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111011958|NCT03564379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111011959|NCT03317847|Dexamethasone|dexamethasone|mesh-list
111011960|NCT03317847|Bromfenac|bromfenac|mesh-list
111011961|NCT03317847|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111011962|NCT03317847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111011963|NCT03317847|Antiemetics|antiemetics|mesh-ancestor
111011964|NCT03317847|Autonomic Agents|autonomic agents|mesh-ancestor
111011965|NCT03317847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111011966|NCT03317847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111011967|NCT03317847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111011968|NCT03317847|Glucocorticoids|glucocorticoids|mesh-ancestor
111011969|NCT03317847|Hormones|hormones|mesh-ancestor
110621830|NCT00658320|Basiliximab|basiliximab|mesh-list
111011970|NCT03317847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111011971|NCT03317847|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111011972|NCT03317847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111011973|NCT03317847|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111011974|NCT03317847|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111011975|NCT03317847|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111011976|NCT03317847|Analgesics|analgesics|mesh-ancestor
111011977|NCT03317847|Sensory System Agents|sensory system agents|mesh-ancestor
111011978|NCT03317847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111011979|NCT01342081|Timolol|timolol|mesh-list
111011980|NCT01342081|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111011981|NCT01342081|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111011982|NCT01342081|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111011983|NCT01342081|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111011984|NCT01342081|Adrenergic Agents|adrenergic agents|mesh-ancestor
111011985|NCT01342081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111011986|NCT01342081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111011987|NCT01342081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111011988|NCT01342081|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111011989|NCT01342081|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111011990|NCT03563833|Anesthetics|anesthetics|mesh-list
111011991|NCT03563833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111011992|NCT03563833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111011993|NCT02483169|Aspirin|aspirin|mesh-list
111011994|NCT02483169|Cilostazol|cilostazol|mesh-list
111011995|NCT02483169|Probucol|probucol|mesh-list
111011996|NCT02483169|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111011997|NCT02483169|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111011998|NCT02483169|Analgesics|analgesics|mesh-ancestor
111011999|NCT02483169|Sensory System Agents|sensory system agents|mesh-ancestor
111012000|NCT02483169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111012001|NCT02483169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111012002|NCT02483169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111012003|NCT02483169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111012004|NCT02483169|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111012005|NCT02483169|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111012006|NCT02483169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111012007|NCT02483169|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111012008|NCT02483169|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111012009|NCT02483169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111012010|NCT02483169|Antipyretics|antipyretics|mesh-ancestor
111012011|NCT02483169|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111012012|NCT02483169|Autonomic Agents|autonomic agents|mesh-ancestor
111012013|NCT02483169|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111012014|NCT02483169|Respiratory System Agents|respiratory system agents|mesh-ancestor
111012015|NCT02483169|Vasodilator Agents|vasodilator agents|mesh-ancestor
111012016|NCT02483169|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111012017|NCT02483169|Protective Agents|protective agents|mesh-ancestor
111012018|NCT02483169|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
111012019|NCT02483169|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111012020|NCT02483169|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111012021|NCT02483169|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111012022|NCT02483169|Antimetabolites|antimetabolites|mesh-ancestor
111012023|NCT02483169|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111012024|NCT02483169|Antioxidants|antioxidants|mesh-ancestor
111012025|NCT02489097|Nitrous Oxide|nitrous oxide|mesh-list
111012026|NCT02489097|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111012027|NCT02489097|Anesthetics, General|anesthetics, general|mesh-ancestor
111012028|NCT02489097|Anesthetics|anesthetics|mesh-ancestor
111012029|NCT02489097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111012030|NCT02489097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111012031|NCT02489097|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111012032|NCT02489097|Analgesics|analgesics|mesh-ancestor
111012033|NCT02489097|Sensory System Agents|sensory system agents|mesh-ancestor
111012034|NCT02489097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111012035|NCT02203682|Doxycycline|doxycycline|mesh-list
111012036|NCT02203682|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111012037|NCT02203682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111012038|NCT02203682|Antimalarials|antimalarials|mesh-ancestor
111012039|NCT02203682|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111012040|NCT02203682|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111012041|NCT02256800|Leucovorin|leucovorin|mesh-list
111012042|NCT02256800|Bevacizumab|bevacizumab|mesh-list
111012043|NCT02256800|Irinotecan|irinotecan|mesh-list
111012044|NCT02256800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111012045|NCT02256800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111012046|NCT02256800|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111012047|NCT02256800|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111012048|NCT02256800|Growth Substances|growth substances|mesh-ancestor
111012049|NCT02256800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111012050|NCT02256800|Growth Inhibitors|growth inhibitors|mesh-ancestor
111012051|NCT02256800|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111012052|NCT02256800|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111012053|NCT02256800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111012054|NCT02256800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111012055|NCT02256800|Antidotes|antidotes|mesh-ancestor
111012056|NCT02256800|Protective Agents|protective agents|mesh-ancestor
111012057|NCT02256800|Vitamin B Complex|vitamin b complex|mesh-ancestor
111012058|NCT02256800|Vitamins|vitamins|mesh-ancestor
111012059|NCT02256800|Micronutrients|micronutrients|mesh-ancestor
111012060|NCT01341457|Gemcitabine|gemcitabine|mesh-list
111012061|NCT01341457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111012062|NCT01341457|Antimetabolites|antimetabolites|mesh-ancestor
111012063|NCT01341457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111012064|NCT01341457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111012065|NCT02488473|Dexmedetomidine|dexmedetomidine|mesh-list
111012066|NCT02488473|Ropivacaine|ropivacaine|mesh-list
111012067|NCT02488473|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111012068|NCT02488473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111012069|NCT02488473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111012070|NCT02488473|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111012071|NCT02488473|Analgesics|analgesics|mesh-ancestor
111012072|NCT02488473|Sensory System Agents|sensory system agents|mesh-ancestor
111012073|NCT02488473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111012074|NCT02488473|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111012075|NCT02488473|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111012076|NCT02488473|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111012077|NCT02488473|Adrenergic Agents|adrenergic agents|mesh-ancestor
111012078|NCT02488473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111012079|NCT02488473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111012080|NCT02488473|Anesthetics, Local|anesthetics, local|mesh-ancestor
111012081|NCT02488473|Anesthetics|anesthetics|mesh-ancestor
111012082|NCT05128292|Selenium|selenium|mesh-list
111012083|NCT05128292|Antioxidants|antioxidants|mesh-ancestor
111012084|NCT05128292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111012085|NCT05128292|Protective Agents|protective agents|mesh-ancestor
111012086|NCT05128292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111012087|NCT05128292|Trace Elements|trace elements|mesh-ancestor
111012088|NCT05128292|Micronutrients|micronutrients|mesh-ancestor
111012089|NCT05127980|Antibodies|antibodies|mesh-list
111012090|NCT05127980|Autoantibodies|autoantibodies|mesh-list
111012091|NCT05127980|Immunologic Factors|immunologic factors|mesh-ancestor
111012092|NCT05127980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111012093|NCT03971708|Lidocaine|lidocaine|mesh-list
111012094|NCT03971708|Ropivacaine|ropivacaine|mesh-list
111012095|NCT03971708|Anesthetics, Local|anesthetics, local|mesh-ancestor
111012096|NCT03971708|Anesthetics|anesthetics|mesh-ancestor
111012097|NCT03971708|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111012098|NCT03971708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111012099|NCT03971708|Sensory System Agents|sensory system agents|mesh-ancestor
111012100|NCT03971708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111012101|NCT03971708|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111012102|NCT03971708|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111012103|NCT03971708|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111012104|NCT03971708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111012105|NCT03971708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111012106|NCT02832037|BI 425809|bi 425809|mesh-list
111012107|NCT02832037|Nootropic Agents|nootropic agents|mesh-ancestor
111012108|NCT03966014|Amoxicillin|amoxicillin|mesh-list
111012109|NCT03966014|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111012110|NCT03966014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111012111|NCT02482857|Aspirin|aspirin|mesh-list
111012112|NCT02482857|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111012113|NCT02482857|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111012114|NCT02482857|Analgesics|analgesics|mesh-ancestor
111012115|NCT02482857|Sensory System Agents|sensory system agents|mesh-ancestor
111012116|NCT02482857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111012117|NCT02482857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111012118|NCT02482857|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111012119|NCT02482857|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111012120|NCT02482857|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111012121|NCT02482857|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111012122|NCT02482857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111012123|NCT02482857|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111012124|NCT02482857|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111012125|NCT02482857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111012126|NCT02482857|Antipyretics|antipyretics|mesh-ancestor
111012127|NCT02480049|Montelukast|montelukast|mesh-list
111012128|NCT02480049|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111012129|NCT02480049|Respiratory System Agents|respiratory system agents|mesh-ancestor
111012130|NCT02480049|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
111012131|NCT02480049|Hormone Antagonists|hormone antagonists|mesh-ancestor
111012132|NCT02480049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111012133|NCT02480049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111012134|NCT02480049|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
111012135|NCT02480049|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111012136|NCT02480049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111012137|NCT02479971|Clindamycin|clindamycin|mesh-list
111012138|NCT02479971|Clindamycin palmitate|clindamycin palmitate|mesh-list
111012139|NCT02479971|Clindamycin phosphate|clindamycin phosphate|mesh-list
111012140|NCT02479971|Gentamicins|gentamicins|mesh-list
111012141|NCT02479971|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111012142|NCT02479971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111012143|NCT02479971|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111012144|NCT02479971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111012145|NCT02479971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111012146|NCT02486133|Ritonavir|ritonavir|mesh-list
111012147|NCT02486133|Darunavir|darunavir|mesh-list
111012148|NCT02486133|Tenofovir|tenofovir|mesh-list
111012149|NCT02486133|Lamivudine|lamivudine|mesh-list
111012150|NCT02486133|Emtricitabine|emtricitabine|mesh-list
111012151|NCT02486133|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
111012152|NCT02486133|Dolutegravir|dolutegravir|mesh-list
111012153|NCT02486133|Abacavir|abacavir|mesh-list
111012154|NCT02486133|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111012155|NCT02486133|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111012156|NCT02486133|Protease Inhibitors|protease inhibitors|mesh-ancestor
111012157|NCT02486133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111012158|NCT02486133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111012159|NCT02486133|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111012160|NCT02486133|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111012161|NCT02486133|Antiviral Agents|antiviral agents|mesh-ancestor
111012162|NCT02486133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111012163|NCT02486133|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111012164|NCT02486133|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111012165|NCT02486133|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111012166|NCT02486133|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111012167|NCT02486133|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111012168|NCT02486133|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111012169|NCT02486055|Coenzyme Q10|coenzyme q10|mesh-list
111012170|NCT02486055|Micronutrients|micronutrients|mesh-ancestor
111012171|NCT02486055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111012172|NCT02486055|Vitamins|vitamins|mesh-ancestor
111012173|NCT02486289|N,N'-Bis(2-mercaptoethyl)isophthalamide|n,n'-bis(2-mercaptoethyl)isophthalamide|mesh-list
111012174|NCT02486289|Chelating Agents|chelating agents|mesh-ancestor
111012175|NCT02486289|Sequestering Agents|sequestering agents|mesh-ancestor
111012176|NCT02486289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111012177|NCT02485821|Misoprostol|misoprostol|mesh-list
111012178|NCT02485821|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
111012179|NCT02485821|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
111012180|NCT02485821|Ethinyl Estradiol|ethinyl estradiol|mesh-list
111012181|NCT02485821|Estradiol|estradiol|mesh-list
111012182|NCT02485821|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
111012183|NCT02485821|Estrogens|estrogens|mesh-ancestor
111012184|NCT02485821|Hormones|hormones|mesh-ancestor
111012185|NCT02485821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111012186|NCT02485821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111012187|NCT02485821|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111012188|NCT02485821|Contraceptive Agents|contraceptive agents|mesh-ancestor
111012189|NCT02485821|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111012190|NCT02485821|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111012191|NCT02485821|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111012192|NCT02485821|Abortifacient Agents|abortifacient agents|mesh-ancestor
111012193|NCT02485821|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111012194|NCT02485821|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111012195|NCT02485821|Oxytocics|oxytocics|mesh-ancestor
111012196|NCT02485821|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111012197|NCT02485821|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111012198|NCT02479815|Micronutrients|micronutrients|mesh-list
111012199|NCT02479815|Trace Elements|trace elements|mesh-list
111012200|NCT02479815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111012201|NCT04119830|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
111012202|NCT04119830|Pembrolizumab|pembrolizumab|mesh-list
111012203|NCT04119830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111012204|NCT04119830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111012205|NCT04119830|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111012206|NCT04119830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111012207|NCT04119830|Antiviral Agents|antiviral agents|mesh-ancestor
111012208|NCT04119830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111012209|NCT04049786|Metoprolol|metoprolol|mesh-list
111012210|NCT04049786|Carvedilol|carvedilol|mesh-list
111012211|NCT04049786|Midazolam|midazolam|mesh-list
111012212|NCT04049786|Simvastatin|simvastatin|mesh-list
111012213|NCT04049786|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111012214|NCT04049786|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111012215|NCT04049786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111012216|NCT04049786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111012217|NCT04049786|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111012218|NCT04049786|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111012219|NCT04049786|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111012220|NCT04049786|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111012221|NCT04049786|Anesthetics, General|anesthetics, general|mesh-ancestor
111012222|NCT04049786|Anesthetics|anesthetics|mesh-ancestor
111012223|NCT04049786|GABA Modulators|gaba modulators|mesh-ancestor
111012224|NCT04049786|GABA Agents|gaba agents|mesh-ancestor
111012225|NCT04049786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111012226|NCT04049786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111012227|NCT04049786|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111012228|NCT04049786|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111012229|NCT04049786|Antimetabolites|antimetabolites|mesh-ancestor
111012230|NCT04049786|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111012231|NCT04049786|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111012232|NCT04049786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111012233|NCT04049786|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111012234|NCT04049786|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111012235|NCT04049786|Sympatholytics|sympatholytics|mesh-ancestor
111012236|NCT04049786|Autonomic Agents|autonomic agents|mesh-ancestor
111012237|NCT04049786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111012238|NCT04049786|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
111012239|NCT04049786|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111012240|NCT04049786|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111012241|NCT04049786|Adrenergic Agents|adrenergic agents|mesh-ancestor
111012242|NCT04049786|Antioxidants|antioxidants|mesh-ancestor
111012243|NCT04049786|Protective Agents|protective agents|mesh-ancestor
111012244|NCT04049786|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111012245|NCT04049786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111012246|NCT04049786|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111012247|NCT04049786|Vasodilator Agents|vasodilator agents|mesh-ancestor
111012248|NCT04049786|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111012249|NCT04049786|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111012250|NCT02482077|Sofosbuvir|sofosbuvir|mesh-list
111012251|NCT02482077|Antiviral Agents|antiviral agents|mesh-ancestor
111012252|NCT02482077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111012253|NCT03316599|Paclitaxel|paclitaxel|mesh-list
111012254|NCT03316599|Gemcitabine|gemcitabine|mesh-list
111012255|NCT03316599|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111012256|NCT03316599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111012257|NCT03316599|Tubulin Modulators|tubulin modulators|mesh-ancestor
111012258|NCT03316599|Antimitotic Agents|antimitotic agents|mesh-ancestor
111012259|NCT03316599|Mitosis Modulators|mitosis modulators|mesh-ancestor
111012260|NCT03316599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111012261|NCT03316599|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111012262|NCT03316599|Antimetabolites|antimetabolites|mesh-ancestor
111012263|NCT02482155|Ibuprofen|ibuprofen|mesh-list
111012264|NCT02482155|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111012265|NCT02482155|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111012266|NCT02482155|Analgesics|analgesics|mesh-ancestor
111012267|NCT02482155|Sensory System Agents|sensory system agents|mesh-ancestor
111012268|NCT02482155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111012269|NCT02482155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111012270|NCT02482155|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111012271|NCT02482155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111012272|NCT02482155|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111012273|NCT02482155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111012274|NCT02482155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111012275|NCT01675154|Orlistat|orlistat|mesh-list
111012276|NCT01675154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111012277|NCT01675154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111012278|NCT01675154|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111012279|NCT01675154|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111012280|NCT02485431|Deflazacort|deflazacort|mesh-list
111012281|NCT02485431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111012282|NCT02485431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111012283|NCT02485431|Immunologic Factors|immunologic factors|mesh-ancestor
111012284|NCT02485431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111012285|NCT02744755|Adalimumab|adalimumab|mesh-list
111012286|NCT02744755|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111012287|NCT02744755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111012288|NCT02744755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111012289|NCT03314493|Spironolactone|spironolactone|mesh-list
111012290|NCT03314493|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
111012291|NCT03314493|Hormone Antagonists|hormone antagonists|mesh-ancestor
111012292|NCT03314493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111012293|NCT03314493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111012294|NCT03314493|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
111012295|NCT03314493|Diuretics|diuretics|mesh-ancestor
111012296|NCT03314493|Natriuretic Agents|natriuretic agents|mesh-ancestor
111012297|NCT03912350|Balovaptan|balovaptan|mesh-list
111012298|NCT03912350|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
111012299|NCT03912350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111012300|NCT03912350|Natriuretic Agents|natriuretic agents|mesh-ancestor
111012301|NCT03912350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111012302|NCT03829514|Fenofibrate|fenofibrate|mesh-list
111012303|NCT03829514|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111012304|NCT03829514|Antimetabolites|antimetabolites|mesh-ancestor
111012305|NCT03829514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111012306|NCT03829514|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111012307|NCT03801200|Apatinib|apatinib|mesh-list
111012308|NCT03801200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111012309|NCT03801200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111012310|NCT03801200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111012311|NCT03801200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111012312|NCT02485041|Mirodenafil|mirodenafil|mesh-list
111012313|NCT02485041|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111012314|NCT02485041|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111012315|NCT02485041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111012316|NCT02485041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111012317|NCT02484963|Zolpidem|zolpidem|mesh-list
111012318|NCT02484963|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111012319|NCT02484963|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111012320|NCT02484963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111012321|NCT02484963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111012322|NCT02484963|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
111012323|NCT02484963|GABA Agonists|gaba agonists|mesh-ancestor
111012324|NCT02484963|GABA Agents|gaba agents|mesh-ancestor
111012325|NCT02484963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111012326|NCT02484963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111012327|NCT05713773|Caffeine|caffeine|mesh-list
111012328|NCT05713773|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111012329|NCT05713773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111012330|NCT05713773|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111012331|NCT05713773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111012332|NCT05713773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111012333|NCT05713773|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
111012334|NCT05713773|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111012335|NCT05713773|Purinergic Agents|purinergic agents|mesh-ancestor
111012336|NCT05713773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111012337|NCT02829775|Interferons|interferons|mesh-list
111012338|NCT02829775|Interferon-alpha|interferon-alpha|mesh-list
111012339|NCT02829775|Interferon alpha-2|interferon alpha-2|mesh-list
111012340|NCT02829775|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
111012341|NCT02829775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111012342|NCT02829775|Antiviral Agents|antiviral agents|mesh-ancestor
111012343|NCT02829775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111012344|NCT02829775|Immunologic Factors|immunologic factors|mesh-ancestor
111012345|NCT02829775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111012346|NCT02476773|Aluminum Hydroxide|aluminum hydroxide|mesh-list
111012347|NCT02476773|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111012348|NCT02476773|Immunologic Factors|immunologic factors|mesh-ancestor
111012349|NCT02476773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111012350|NCT02476773|Antacids|antacids|mesh-ancestor
111012351|NCT02476773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111012352|NCT02476773|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111012353|NCT04500860|Tadalafil|tadalafil|mesh-list
111012354|NCT04500860|Tolterodine Tartrate|tolterodine tartrate|mesh-list
111012355|NCT04500860|Vasodilator Agents|vasodilator agents|mesh-ancestor
111012356|NCT04500860|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111012357|NCT04500860|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111012358|NCT04500860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111012359|NCT04500860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111012360|NCT04500860|Urological Agents|urological agents|mesh-ancestor
111012361|NCT04500860|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111012362|NCT04500860|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111012363|NCT04500860|Cholinergic Agents|cholinergic agents|mesh-ancestor
111012364|NCT04500860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111012365|NCT04500860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111012366|NCT02479503|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111012367|NCT02479503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111012368|NCT02479581|Floxacillin|floxacillin|mesh-list
111012369|NCT02479581|Dexamethasone|dexamethasone|mesh-list
111012370|NCT02479581|Methylprednisolone|methylprednisolone|mesh-list
111012371|NCT02479581|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111012372|NCT02479581|Scopolamine|scopolamine|mesh-list
111012373|NCT02479581|Morphine|morphine|mesh-list
111012374|NCT02479581|Anesthetics|anesthetics|mesh-list
111012375|NCT02479581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111012376|NCT02479581|Antiemetics|antiemetics|mesh-ancestor
111012377|NCT02479581|Autonomic Agents|autonomic agents|mesh-ancestor
111012378|NCT02479581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111012379|NCT02479581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111012380|NCT02479581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111012381|NCT02479581|Glucocorticoids|glucocorticoids|mesh-ancestor
111012382|NCT02479581|Hormones|hormones|mesh-ancestor
111012383|NCT02479581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111012384|NCT02479581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111012385|NCT02479581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111012386|NCT02479581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111012387|NCT02479581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111012388|NCT02479581|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111012389|NCT02479581|Narcotics|narcotics|mesh-ancestor
111012390|NCT02479581|Analgesics|analgesics|mesh-ancestor
111012391|NCT02479581|Sensory System Agents|sensory system agents|mesh-ancestor
111012392|NCT02479581|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111012393|NCT02479581|Protective Agents|protective agents|mesh-ancestor
111012394|NCT02479581|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111012395|NCT02479581|Mydriatics|mydriatics|mesh-ancestor
111012396|NCT02479581|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111012397|NCT02479581|Cholinergic Agents|cholinergic agents|mesh-ancestor
111012398|NCT02479581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111012399|NCT02479581|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111012400|NCT02479581|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111012401|NCT02479581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111012402|NCT02479347|Chlorhexidine|chlorhexidine|mesh-list
111012403|NCT02479347|Povidone-Iodine|povidone-iodine|mesh-list
111012404|NCT02479347|Povidone|povidone|mesh-list
111012405|NCT02479347|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111012406|NCT02479347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111012407|NCT02479347|Disinfectants|disinfectants|mesh-ancestor
111012408|NCT02479347|Plasma Substitutes|plasma substitutes|mesh-ancestor
111012409|NCT02479347|Blood Substitutes|blood substitutes|mesh-ancestor
111012410|NCT05125718|Anti-Infective Agents|anti-infective agents|mesh-list
111012411|NCT05125718|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111012412|NCT02481609|Acetylcysteine|acetylcysteine|mesh-list
111012413|NCT02481609|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111012414|NCT02481609|Antiviral Agents|antiviral agents|mesh-ancestor
111012415|NCT02481609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111012416|NCT02481609|Expectorants|expectorants|mesh-ancestor
111012417|NCT02481609|Respiratory System Agents|respiratory system agents|mesh-ancestor
111012418|NCT02481609|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111012419|NCT02481609|Antioxidants|antioxidants|mesh-ancestor
111012420|NCT02481609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111012421|NCT02481609|Protective Agents|protective agents|mesh-ancestor
111012422|NCT02481609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111012423|NCT02481609|Antidotes|antidotes|mesh-ancestor
111012424|NCT05373225|Acetic Acid|acetic acid|mesh-list
111012425|NCT05373225|Retinol acetate|retinol acetate|mesh-list
111012426|NCT05373225|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111012427|NCT05373225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111012428|NCT05373225|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111012429|NCT05373225|Immunologic Factors|immunologic factors|mesh-ancestor
111012430|NCT05373225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111012431|NCT05373225|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
111012432|NCT05373225|Protective Agents|protective agents|mesh-ancestor
111012433|NCT05373225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111012434|NCT01355575|Rifaximin|rifaximin|mesh-list
111012435|NCT01355575|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111012436|NCT01355575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111012437|NCT01355575|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111012438|NCT05125640|Progesterone|progesterone|mesh-list
111012439|NCT05125640|Progestins|progestins|mesh-ancestor
111012440|NCT05125640|Hormones|hormones|mesh-ancestor
111012441|NCT05125640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111012442|NCT05125640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111012443|NCT03314259|Tamsulosin|tamsulosin|mesh-list
111012444|NCT03314259|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111012445|NCT03314259|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111012446|NCT03314259|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111012447|NCT03314259|Adrenergic Agents|adrenergic agents|mesh-ancestor
111012448|NCT03314259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111012449|NCT03314259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111012450|NCT03314259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111012451|NCT03314259|Urological Agents|urological agents|mesh-ancestor
111012452|NCT05125328|Remifentanil|remifentanil|mesh-list
111012453|NCT05125328|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111012454|NCT05125328|Narcotics|narcotics|mesh-ancestor
111012455|NCT05125328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111012456|NCT05125328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111012457|NCT05125328|Analgesics|analgesics|mesh-ancestor
111012458|NCT05125328|Sensory System Agents|sensory system agents|mesh-ancestor
111012459|NCT05125328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111012460|NCT02481453|Sirolimus|sirolimus|mesh-list
111012461|NCT02481453|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111012462|NCT02481453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111012463|NCT02481453|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111012464|NCT02481453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111012465|NCT02481453|Antifungal Agents|antifungal agents|mesh-ancestor
111012466|NCT02481453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111012467|NCT02481453|Immunologic Factors|immunologic factors|mesh-ancestor
111012468|NCT02481453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111012469|NCT02825251|Insulin|insulin|mesh-list
111012470|NCT02825251|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111012471|NCT02825251|Insulin Aspart|insulin aspart|mesh-list
111012472|NCT02825251|Insulin, Long-Acting|insulin, long-acting|mesh-list
111012473|NCT02825251|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
111012474|NCT02825251|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111012475|NCT02825251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111012476|NCT03563365|Adapalene|adapalene|mesh-list
111012477|NCT03563365|Benzoyl Peroxide|benzoyl peroxide|mesh-list
111012478|NCT03563365|Resveratrol|resveratrol|mesh-list
111012479|NCT03563365|Antioxidants|antioxidants|mesh-ancestor
111012480|NCT03563365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111012481|NCT03563365|Protective Agents|protective agents|mesh-ancestor
111012482|NCT03563365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111012483|NCT03563365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111012484|NCT03563365|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111012485|NCT03563365|Dermatologic Agents|dermatologic agents|mesh-ancestor
111012486|NCT03563365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110629094|NCT00845754|Ketorolac|ketorolac|mesh-list
111012487|NCT03563365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111012488|NCT03563365|Analgesics|analgesics|mesh-ancestor
111012489|NCT03563365|Sensory System Agents|sensory system agents|mesh-ancestor
111012490|NCT03563365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111012491|NCT03563365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111012492|NCT03563365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111012493|NCT02475915|Tenofovir|tenofovir|mesh-list
111012494|NCT02475915|Emtricitabine|emtricitabine|mesh-list
111012495|NCT02475915|Efavirenz|efavirenz|mesh-list
111012496|NCT02475915|Maraviroc|maraviroc|mesh-list
111012497|NCT02475915|Darunavir|darunavir|mesh-list
111012498|NCT02475915|Hydroxychloroquine|hydroxychloroquine|mesh-list
111012499|NCT02475915|Vorinostat|vorinostat|mesh-list
111012500|NCT02475915|Antiviral Agents|antiviral agents|mesh-ancestor
111012501|NCT02475915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111012502|NCT02475915|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111012503|NCT02475915|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111012504|NCT02475915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111012505|NCT02475915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111012506|NCT02475915|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111012507|NCT02475915|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111012508|NCT02475915|Antimalarials|antimalarials|mesh-ancestor
111012509|NCT02475915|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111012510|NCT02475915|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111012511|NCT02475915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111012512|NCT02475915|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111012513|NCT02475915|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111012514|NCT02475915|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111012515|NCT02475915|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111012516|NCT02475915|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111012517|NCT02475915|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111012518|NCT02475915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111012519|NCT02475915|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111012520|NCT02475915|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
111012521|NCT02475915|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
111012522|NCT02475915|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
111012523|NCT02475915|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111012524|NCT02475915|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111012525|NCT02475915|Protease Inhibitors|protease inhibitors|mesh-ancestor
111012526|NCT03833323|Treprostinil|treprostinil|mesh-list
111012527|NCT03833323|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111012528|NCT03110575|Cyclobenzaprine|cyclobenzaprine|mesh-list
111012529|NCT03110575|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
111012530|NCT03110575|Antidepressive Agents|antidepressive agents|mesh-ancestor
111012531|NCT03110575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111012532|NCT03110575|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
111012533|NCT03110575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111012534|NCT03110575|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111012535|NCT03110575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111012536|NCT03110575|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111012537|NCT03110575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111012539|NCT02824627|Oxytocics|oxytocics|mesh-ancestor
111012540|NCT02824627|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111012541|NCT02824627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111012542|NCT05384847|Hormones|hormones|mesh-list
111012543|NCT05384847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111012544|NCT05384847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111012545|NCT02478879|Teriparatide|teriparatide|mesh-list
111012546|NCT02478879|Parathyroid Hormone|parathyroid hormone|mesh-list
111012547|NCT02478879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111012548|NCT02478879|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111012549|NCT02478879|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111012550|NCT02478645|Ramosetron|ramosetron|mesh-list
111012551|NCT02478645|Antiemetics|antiemetics|mesh-ancestor
111012552|NCT02478645|Autonomic Agents|autonomic agents|mesh-ancestor
111012553|NCT02478645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111012554|NCT02478645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111012555|NCT02478645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111012556|NCT02478645|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111012557|NCT02478645|Serotonin Agents|serotonin agents|mesh-ancestor
111012558|NCT02478645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111012559|NCT02478645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111012560|NCT05871957|Vitamin D|vitamin d|mesh-list
111012561|NCT05871957|Ergocalciferols|ergocalciferols|mesh-list
111012562|NCT05871957|Cholecalciferol|cholecalciferol|mesh-list
111012563|NCT05871957|Vitamins|vitamins|mesh-list
111012564|NCT05871957|Micronutrients|micronutrients|mesh-ancestor
111012565|NCT05871957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111012566|NCT05871957|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111012567|NCT05871957|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111012568|NCT05871073|Dexamethasone|dexamethasone|mesh-list
111012569|NCT05871073|Ropivacaine|ropivacaine|mesh-list
111012570|NCT05871073|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111012571|NCT05871073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111012572|NCT05871073|Antiemetics|antiemetics|mesh-ancestor
111012573|NCT05871073|Autonomic Agents|autonomic agents|mesh-ancestor
111012574|NCT05871073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111012575|NCT05871073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111012576|NCT05871073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111012577|NCT05871073|Glucocorticoids|glucocorticoids|mesh-ancestor
111012578|NCT05871073|Hormones|hormones|mesh-ancestor
111012579|NCT05871073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111012580|NCT05871073|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111012581|NCT05871073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111012582|NCT05871073|Anesthetics, Local|anesthetics, local|mesh-ancestor
111012583|NCT05871073|Anesthetics|anesthetics|mesh-ancestor
111012584|NCT05871073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111012585|NCT05871073|Sensory System Agents|sensory system agents|mesh-ancestor
111012586|NCT05871021|Bevacizumab|bevacizumab|mesh-list
111012587|NCT05871021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111012588|NCT05871021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111012589|NCT05871021|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111012590|NCT05871021|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111012591|NCT05871021|Growth Substances|growth substances|mesh-ancestor
111012592|NCT05871021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111012593|NCT05871021|Growth Inhibitors|growth inhibitors|mesh-ancestor
111012594|NCT05870969|Liver Extracts|liver extracts|mesh-list
111012595|NCT05870969|Hematinics|hematinics|mesh-ancestor
111012596|NCT05870917|Dexamethasone|dexamethasone|mesh-list
111012597|NCT05870917|Lenalidomide|lenalidomide|mesh-list
111012598|NCT05870917|Bortezomib|bortezomib|mesh-list
111012599|NCT05870917|Venetoclax|venetoclax|mesh-list
111012600|NCT05870917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111012601|NCT05870917|Antiemetics|antiemetics|mesh-ancestor
111012602|NCT05870917|Autonomic Agents|autonomic agents|mesh-ancestor
111012603|NCT05870917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111012604|NCT05870917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111012605|NCT05870917|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111012606|NCT05870917|Glucocorticoids|glucocorticoids|mesh-ancestor
111012607|NCT05870917|Hormones|hormones|mesh-ancestor
111012608|NCT05870917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111012609|NCT05870917|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111012610|NCT05870917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111012611|NCT05870917|Immunologic Factors|immunologic factors|mesh-ancestor
111012612|NCT05870917|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111012613|NCT05870917|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111012614|NCT05870917|Growth Substances|growth substances|mesh-ancestor
111012615|NCT05870917|Growth Inhibitors|growth inhibitors|mesh-ancestor
111012616|NCT05870553|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
111012618|NCT05870553|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111012619|NCT05870501|Midazolam|midazolam|mesh-list
111012620|NCT05870501|Ketamine|ketamine|mesh-list
111012621|NCT05870501|Analgesics|analgesics|mesh-ancestor
111012622|NCT05870501|Sensory System Agents|sensory system agents|mesh-ancestor
111012623|NCT05870501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111012624|NCT05870501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111012625|NCT05870501|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111012626|NCT05870501|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111012627|NCT05870501|Anesthetics, General|anesthetics, general|mesh-ancestor
111012628|NCT05870501|Anesthetics|anesthetics|mesh-ancestor
111012629|NCT05870501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111012630|NCT05870501|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111012631|NCT05870501|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111012632|NCT05870501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111012633|NCT05870501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111012634|NCT05870501|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111012635|NCT05870501|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111012636|NCT05870501|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111012637|NCT05870501|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111012638|NCT05870501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111012639|NCT05870501|GABA Modulators|gaba modulators|mesh-ancestor
111012640|NCT05870501|GABA Agents|gaba agents|mesh-ancestor
111012641|NCT05870475|Interferons|interferons|mesh-list
111012642|NCT05870475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111012643|NCT05870475|Antiviral Agents|antiviral agents|mesh-ancestor
111012644|NCT05870475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111012645|NCT05870436|Choline|choline|mesh-list
111012646|NCT05870436|Methacholine Chloride|methacholine chloride|mesh-list
111012647|NCT05870436|Lipotropic Agents|lipotropic agents|mesh-ancestor
111012648|NCT05870436|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111012649|NCT05870436|Antimetabolites|antimetabolites|mesh-ancestor
111012650|NCT05870436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111012651|NCT05870436|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111012652|NCT05870436|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111012653|NCT05870436|Nootropic Agents|nootropic agents|mesh-ancestor
111012654|NCT05870436|Miotics|miotics|mesh-ancestor
111012655|NCT05870436|Autonomic Agents|autonomic agents|mesh-ancestor
111012656|NCT05870436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111012657|NCT05870436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111012658|NCT05870436|Parasympathomimetics|parasympathomimetics|mesh-ancestor
111012659|NCT05870436|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
111012660|NCT05870436|Respiratory System Agents|respiratory system agents|mesh-ancestor
111012661|NCT05870436|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
111012662|NCT05870436|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111012663|NCT05870436|Cholinergic Agents|cholinergic agents|mesh-ancestor
111012664|NCT05870436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111012665|NCT05870423|Olaparib|olaparib|mesh-list
111012666|NCT05870423|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111012667|NCT05870423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111012668|NCT05870423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111012669|NCT05870423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111012670|NCT05870358|Melatonin|melatonin|mesh-list
111012671|NCT05870358|Antioxidants|antioxidants|mesh-ancestor
111012672|NCT05870358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111012673|NCT05870358|Protective Agents|protective agents|mesh-ancestor
111012674|NCT05870358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111012675|NCT05870358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111012676|NCT05870111|Choline|choline|mesh-list
111012677|NCT05870111|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
111012678|NCT05870111|Lipotropic Agents|lipotropic agents|mesh-ancestor
111012679|NCT05870111|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111012680|NCT05870111|Antimetabolites|antimetabolites|mesh-ancestor
111012681|NCT05870111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111012682|NCT05870111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111012683|NCT05870111|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111012684|NCT05870111|Nootropic Agents|nootropic agents|mesh-ancestor
111012685|NCT05870059|Chlorhexidine|chlorhexidine|mesh-list
111012686|NCT05870059|Propolis|propolis|mesh-list
111012687|NCT05870059|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110621942|NCT00672620|Analgesics|analgesics|mesh-ancestor
111012688|NCT05870059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111012689|NCT05870059|Disinfectants|disinfectants|mesh-ancestor
111012690|NCT05870007|Atorvastatin|atorvastatin|mesh-list
111012691|NCT05870007|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111012692|NCT05870007|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111012693|NCT05870007|Antimetabolites|antimetabolites|mesh-ancestor
111012694|NCT05870007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111012695|NCT05870007|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111012696|NCT05870007|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111012697|NCT05870007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111012698|NCT05868226|Trastuzumab|trastuzumab|mesh-list
111012699|NCT05868226|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
111012700|NCT05868226|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111012701|NCT05868226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111012702|NCT05868226|Immunoconjugates|immunoconjugates|mesh-ancestor
111012703|NCT05868226|Immunologic Factors|immunologic factors|mesh-ancestor
111012704|NCT05868226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111012705|NCT05866653|Lidocaine|lidocaine|mesh-list
111012706|NCT05866653|Anesthetics, Local|anesthetics, local|mesh-ancestor
111012707|NCT05866653|Anesthetics|anesthetics|mesh-ancestor
111012708|NCT05866653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111012709|NCT05866653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111012710|NCT05866653|Sensory System Agents|sensory system agents|mesh-ancestor
111012711|NCT05866653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110729698|NCT01079481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111012712|NCT05866653|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111012713|NCT05866653|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111012714|NCT05866653|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111012715|NCT05866653|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111012716|NCT05866653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111012717|NCT05790577|Niacinamide|niacinamide|mesh-list
111012719|NCT05790577|Nicotinic Acids|nicotinic acids|mesh-list
111012720|NCT05790577|Metformin|metformin|mesh-list
111012721|NCT05790577|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111012722|NCT05790577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111012723|NCT05790577|Vitamin B Complex|vitamin b complex|mesh-ancestor
111012724|NCT05790577|Vitamins|vitamins|mesh-ancestor
111012725|NCT05790577|Micronutrients|micronutrients|mesh-ancestor
111012726|NCT05790577|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111012727|NCT05790577|Antimetabolites|antimetabolites|mesh-ancestor
111012728|NCT05790577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111012729|NCT05790577|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111012730|NCT05790577|Vasodilator Agents|vasodilator agents|mesh-ancestor
111012731|NCT05778838|Midodrine|midodrine|mesh-list
111012732|NCT05778838|Sympathomimetics|sympathomimetics|mesh-ancestor
111012733|NCT05778838|Autonomic Agents|autonomic agents|mesh-ancestor
111012734|NCT05778838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111012735|NCT05778838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111012736|NCT05778838|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111012737|NCT05778838|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111012738|NCT05778838|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111012739|NCT05778838|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111012740|NCT05778838|Adrenergic Agents|adrenergic agents|mesh-ancestor
111012741|NCT05778838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111012742|NCT05778838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111012743|NCT05760248|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111012744|NCT05757544|Ganaxolone|ganaxolone|mesh-list
111012745|NCT05757544|Neurosteroids|neurosteroids|mesh-ancestor
111012746|NCT05757544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111012747|NCT05757544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111012748|NCT05757544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111012749|NCT05757544|GABA Modulators|gaba modulators|mesh-ancestor
111012750|NCT05757544|GABA Agents|gaba agents|mesh-ancestor
111012751|NCT05688943|Anesthetics|anesthetics|mesh-list
111012752|NCT05688943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111012753|NCT05688943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111012754|NCT05666310|Zoledronic Acid|zoledronic acid|mesh-list
111012755|NCT05666310|Denosumab|denosumab|mesh-list
111012756|NCT05666310|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111012757|NCT05666310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111012758|NCT05638919|Antiviral Agents|antiviral agents|mesh-list
111012759|NCT05638919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111012760|NCT05631405|Dexamethasone|dexamethasone|mesh-list
111012761|NCT05631405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111012762|NCT05631405|Antiemetics|antiemetics|mesh-ancestor
111012763|NCT05631405|Autonomic Agents|autonomic agents|mesh-ancestor
111012764|NCT05631405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111012765|NCT05631405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111012766|NCT05631405|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111012767|NCT05631405|Glucocorticoids|glucocorticoids|mesh-ancestor
111012768|NCT05631405|Hormones|hormones|mesh-ancestor
111012769|NCT05631405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111012770|NCT05631405|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111012771|NCT05631405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111012772|NCT05621655|Vaccines|vaccines|mesh-list
111012773|NCT05621655|Immunologic Factors|immunologic factors|mesh-ancestor
111012774|NCT05621655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111012775|NCT05586971|Allopurinol|allopurinol|mesh-list
111012776|NCT05586971|Antimetabolites|antimetabolites|mesh-ancestor
111012777|NCT05586971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111012778|NCT05586971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111012779|NCT05586971|Gout Suppressants|gout suppressants|mesh-ancestor
111012780|NCT05586971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111012781|NCT05586971|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111012782|NCT05586971|Antioxidants|antioxidants|mesh-ancestor
111012783|NCT05586971|Protective Agents|protective agents|mesh-ancestor
111012784|NCT05586971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111012785|NCT05586724|Norethindrone|norethindrone|mesh-list
111012786|NCT05586724|Norethindrone Acetate|norethindrone acetate|mesh-list
111012787|NCT05586724|Progesterone|progesterone|mesh-list
111012788|NCT05586724|Estrogens|estrogens|mesh-list
110729780|NCT00381797|Deoxyglucose|deoxyglucose|mesh-list
111012789|NCT05586724|Progestins|progestins|mesh-ancestor
111012790|NCT05586724|Hormones|hormones|mesh-ancestor
111012791|NCT05586724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111012792|NCT05586724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111012793|NCT05586724|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111012794|NCT05586724|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111012795|NCT05586724|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111012796|NCT05586724|Contraceptive Agents|contraceptive agents|mesh-ancestor
111012797|NCT05586724|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111012798|NCT05586724|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111012799|NCT05586724|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111012800|NCT05485558|Acetylcysteine|acetylcysteine|mesh-list
111012801|NCT05485558|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111012802|NCT05485558|Antiviral Agents|antiviral agents|mesh-ancestor
111012803|NCT05485558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111012804|NCT05485558|Expectorants|expectorants|mesh-ancestor
111012805|NCT05485558|Respiratory System Agents|respiratory system agents|mesh-ancestor
111012806|NCT05485558|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111012807|NCT05485558|Antioxidants|antioxidants|mesh-ancestor
111012808|NCT05485558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111012809|NCT05485558|Protective Agents|protective agents|mesh-ancestor
111012810|NCT05485558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111012811|NCT05485558|Antidotes|antidotes|mesh-ancestor
111012812|NCT05457556|Mycophenolic Acid|mycophenolic acid|mesh-list
111012813|NCT05457556|Cyclophosphamide|cyclophosphamide|mesh-list
111012814|NCT05457556|Melphalan|melphalan|mesh-list
111012815|NCT05457556|Busulfan|busulfan|mesh-list
111012816|NCT05457556|Mechlorethamine|mechlorethamine|mesh-list
111012817|NCT05457556|Thiotepa|thiotepa|mesh-list
111012818|NCT05457556|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
111012819|NCT05457556|Rituximab|rituximab|mesh-list
111012820|NCT05457556|Methotrexate|methotrexate|mesh-list
111012821|NCT05457556|Fludarabine|fludarabine|mesh-list
111012822|NCT05457556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111012823|NCT05457556|Tacrolimus|tacrolimus|mesh-list
111012824|NCT05457556|Thymoglobulin|thymoglobulin|mesh-list
111012825|NCT05457556|Antilymphocyte Serum|antilymphocyte serum|mesh-list
111012826|NCT05457556|Antibodies|antibodies|mesh-list
111012827|NCT05457556|Immunoglobulins|immunoglobulins|mesh-list
111012828|NCT05457556|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111012829|NCT05457556|gamma-Globulins|gamma-globulins|mesh-list
111012830|NCT05457556|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111012831|NCT05457556|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
111012832|NCT05457556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111012833|NCT05457556|Immunologic Factors|immunologic factors|mesh-ancestor
111012834|NCT05457556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111012835|NCT05457556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111012836|NCT05457556|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111012837|NCT05457556|Alkylating Agents|alkylating agents|mesh-ancestor
111012838|NCT05457556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111012839|NCT05457556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111012840|NCT05457556|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111012841|NCT05457556|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111012842|NCT05457556|Abortifacient Agents|abortifacient agents|mesh-ancestor
111012843|NCT05457556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111012844|NCT05457556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111012845|NCT05457556|Antimetabolites|antimetabolites|mesh-ancestor
111012846|NCT05457556|Dermatologic Agents|dermatologic agents|mesh-ancestor
111012847|NCT05457556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111012848|NCT05457556|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111012849|NCT05457556|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111012850|NCT05457556|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111012851|NCT05457556|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111012852|NCT05457556|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111012853|NCT05457556|Antitubercular Agents|antitubercular agents|mesh-ancestor
111012854|NCT05457556|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111012855|NCT05457556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111012856|NCT05447286|Oxycodone|oxycodone|mesh-list
111012857|NCT05447286|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111012858|NCT05447286|Narcotics|narcotics|mesh-ancestor
111012859|NCT05447286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111012860|NCT05447286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111012861|NCT05447286|Analgesics|analgesics|mesh-ancestor
111012862|NCT05447286|Sensory System Agents|sensory system agents|mesh-ancestor
110729859|NCT03737656|Hormones|hormones|mesh-ancestor
111012863|NCT05447286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111012864|NCT05411237|Paclitaxel|paclitaxel|mesh-list
111012865|NCT05411237|Doxorubicin|doxorubicin|mesh-list
111012866|NCT05411237|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111012867|NCT05411237|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111012868|NCT05411237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111012869|NCT05411237|Tubulin Modulators|tubulin modulators|mesh-ancestor
111012870|NCT05411237|Antimitotic Agents|antimitotic agents|mesh-ancestor
111012871|NCT05411237|Mitosis Modulators|mitosis modulators|mesh-ancestor
111012872|NCT05411237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111012873|NCT05411237|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111012874|NCT05411237|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111012875|NCT05411237|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111012876|NCT05411237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111012877|NCT05389462|Gemcitabine|gemcitabine|mesh-list
111012878|NCT05389462|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111012879|NCT05389462|Antimetabolites|antimetabolites|mesh-ancestor
111012880|NCT05389462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111012881|NCT05389462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111012882|NCT05383196|Paclitaxel|paclitaxel|mesh-list
111012883|NCT05383196|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111012884|NCT05383196|Onvansertib|onvansertib|mesh-list
111012885|NCT05383196|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111012886|NCT05383196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111012887|NCT05383196|Tubulin Modulators|tubulin modulators|mesh-ancestor
111012888|NCT05383196|Antimitotic Agents|antimitotic agents|mesh-ancestor
111012889|NCT05383196|Mitosis Modulators|mitosis modulators|mesh-ancestor
111012890|NCT05383196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111012891|NCT05383196|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111012892|NCT05383196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111012893|NCT05340582|Acetaminophen|acetaminophen|mesh-list
111012894|NCT05340582|Ibuprofen|ibuprofen|mesh-list
111012895|NCT05340582|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111012896|NCT05340582|Analgesics|analgesics|mesh-ancestor
111012897|NCT05340582|Sensory System Agents|sensory system agents|mesh-ancestor
111012898|NCT05340582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111012899|NCT05340582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111012900|NCT05340582|Antipyretics|antipyretics|mesh-ancestor
111012901|NCT05340582|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111012902|NCT05340582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111012903|NCT05340582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111012904|NCT05340582|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111012905|NCT05340582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111012906|NCT05340582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111012907|NCT05324501|Lomustine|lomustine|mesh-list
111012908|NCT05324501|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111012909|NCT05324501|Alkylating Agents|alkylating agents|mesh-ancestor
111012910|NCT05324501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111012911|NCT05324501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111012912|NCT05285605|Ulipristal acetate|ulipristal acetate|mesh-list
111012913|NCT05285605|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111012914|NCT05285605|Contraceptive Agents|contraceptive agents|mesh-ancestor
111012915|NCT05285605|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111012916|NCT05285605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111012917|NCT05285605|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111012919|NCT05245474|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
111012920|NCT05245474|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111012921|NCT05245474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111012922|NCT05245474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111012923|NCT05179733|Rituximab|rituximab|mesh-list
111012924|NCT05179733|Lenalidomide|lenalidomide|mesh-list
111012925|NCT05179733|Zanubrutinib|zanubrutinib|mesh-list
111012926|NCT05179733|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111012927|NCT05179733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111012928|NCT05179733|Immunologic Factors|immunologic factors|mesh-ancestor
111012929|NCT05179733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111012930|NCT05179733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111012931|NCT05179733|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111012932|NCT05179733|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111012933|NCT05179733|Growth Substances|growth substances|mesh-ancestor
111012934|NCT05179733|Growth Inhibitors|growth inhibitors|mesh-ancestor
111012935|NCT05179733|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111012936|NCT05179733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111012937|NCT05179733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111012938|NCT05170334|Belinostat|belinostat|mesh-list
111012939|NCT05170334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111012940|NCT05170334|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111012941|NCT05170334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111012942|NCT05170334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111012943|NCT05083247|Paclitaxel|paclitaxel|mesh-list
111012944|NCT05083247|Gemcitabine|gemcitabine|mesh-list
111012945|NCT05083247|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111012946|NCT05083247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111012947|NCT05083247|Tubulin Modulators|tubulin modulators|mesh-ancestor
111012948|NCT05083247|Antimitotic Agents|antimitotic agents|mesh-ancestor
111012949|NCT05083247|Mitosis Modulators|mitosis modulators|mesh-ancestor
111012950|NCT05083247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111012951|NCT05083247|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111012952|NCT05083247|Antimetabolites|antimetabolites|mesh-ancestor
111012953|NCT05076110|Acetaminophen|acetaminophen|mesh-list
111012954|NCT05076110|Ibuprofen|ibuprofen|mesh-list
111012955|NCT05076110|Oxycodone|oxycodone|mesh-list
111012956|NCT05076110|Gabapentin|gabapentin|mesh-list
111012957|NCT05076110|Methocarbamol|methocarbamol|mesh-list
111012958|NCT05076110|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111012959|NCT05076110|Analgesics|analgesics|mesh-ancestor
111012960|NCT05076110|Sensory System Agents|sensory system agents|mesh-ancestor
111012961|NCT05076110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111012962|NCT05076110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111012963|NCT05076110|Antipyretics|antipyretics|mesh-ancestor
111012964|NCT05076110|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111012965|NCT05076110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111012966|NCT05076110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111012967|NCT05076110|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111012968|NCT05076110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111012969|NCT05076110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111012970|NCT05076110|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111012971|NCT05076110|Narcotics|narcotics|mesh-ancestor
111012972|NCT05076110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111012973|NCT05076110|Anticonvulsants|anticonvulsants|mesh-ancestor
111012974|NCT05076110|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111012975|NCT05076110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111012976|NCT05076110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111012977|NCT05076110|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111012978|NCT05076110|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111012979|NCT05076110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111012980|NCT05076110|Antimanic Agents|antimanic agents|mesh-ancestor
111012981|NCT05076110|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
111012982|NCT05076110|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111012983|NCT05063838|Anesthetics|anesthetics|mesh-list
111012984|NCT05063838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111012985|NCT05063838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111012986|NCT05174650|Atezolizumab|atezolizumab|mesh-list
111012987|NCT05174650|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111012988|NCT05174650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111012989|NCT05174650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111012990|NCT05174650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111012991|NCT05014828|Lenvatinib|lenvatinib|mesh-list
111012992|NCT05014828|Tislelizumab|tislelizumab|mesh-list
111012993|NCT05014828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111012994|NCT05014828|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111012995|NCT05014828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111012996|NCT05014828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111012997|NCT05014828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111012998|NCT04986579|Trastuzumab|trastuzumab|mesh-list
111012999|NCT04986579|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
111013000|NCT04986579|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
111013001|NCT04986579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111013002|NCT04986579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111013003|NCT04986579|Immunoconjugates|immunoconjugates|mesh-ancestor
111013004|NCT04986579|Immunologic Factors|immunologic factors|mesh-ancestor
111013005|NCT04986579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111013006|NCT04940065|Ofatumumab|ofatumumab|mesh-list
111013007|NCT04940065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111013008|NCT04939441|Tenofovir|tenofovir|mesh-list
111013009|NCT04939441|Antiviral Agents|antiviral agents|mesh-ancestor
111013010|NCT04939441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111013011|NCT04939441|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111013012|NCT04939441|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111013013|NCT04939441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110730011|NCT03575806|Hormones|hormones|mesh-ancestor
111013014|NCT04939441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111013015|NCT04939441|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111013016|NCT04939441|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111013018|NCT04937738|Docetaxel|docetaxel|mesh-list
111013019|NCT04937738|Fluorouracil|fluorouracil|mesh-list
111013020|NCT04937738|Capecitabine|capecitabine|mesh-list
111013021|NCT04937738|Oxaliplatin|oxaliplatin|mesh-list
111013022|NCT04937738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111013023|NCT04937738|Tubulin Modulators|tubulin modulators|mesh-ancestor
111013024|NCT04937738|Antimitotic Agents|antimitotic agents|mesh-ancestor
111013025|NCT04937738|Mitosis Modulators|mitosis modulators|mesh-ancestor
111013026|NCT04937738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111013027|NCT04937738|Antimetabolites|antimetabolites|mesh-ancestor
111013028|NCT04937738|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111013029|NCT04937738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111013030|NCT04937738|Immunologic Factors|immunologic factors|mesh-ancestor
111013031|NCT04937738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111013032|NCT04937738|Antidotes|antidotes|mesh-ancestor
111013033|NCT04937738|Protective Agents|protective agents|mesh-ancestor
111013034|NCT04937738|Vitamin B Complex|vitamin b complex|mesh-ancestor
111013035|NCT04937738|Vitamins|vitamins|mesh-ancestor
111013036|NCT04937738|Micronutrients|micronutrients|mesh-ancestor
111013037|NCT04908189|Apremilast|apremilast|mesh-list
111013038|NCT04908189|Deucravacitinib|deucravacitinib|mesh-list
111013039|NCT04908189|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111013040|NCT04908189|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111013041|NCT04908189|Analgesics|analgesics|mesh-ancestor
111013042|NCT04908189|Sensory System Agents|sensory system agents|mesh-ancestor
111013043|NCT04908189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111013044|NCT04908189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111013045|NCT04908189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111013046|NCT04908189|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111013047|NCT04908189|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
111013048|NCT04908189|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111013049|NCT04908189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111013050|NCT04908189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111013051|NCT04908189|Dermatologic Agents|dermatologic agents|mesh-ancestor
111013052|NCT04908189|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111013053|NCT04860505|Doxycycline|doxycycline|mesh-list
111013054|NCT04860505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111013055|NCT04860505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111013056|NCT04860505|Antimalarials|antimalarials|mesh-ancestor
111013057|NCT04860505|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111013058|NCT04860505|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111013059|NCT04810559|Antibodies|antibodies|mesh-list
111013060|NCT04810559|Immunologic Factors|immunologic factors|mesh-ancestor
111013061|NCT04810559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111013062|NCT04799288|Teriflunomide|teriflunomide|mesh-list
111013063|NCT04799288|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111013064|NCT04799288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111013065|NCT04799288|Analgesics|analgesics|mesh-ancestor
111013066|NCT04799288|Sensory System Agents|sensory system agents|mesh-ancestor
111013067|NCT04799288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111013068|NCT04799288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111013069|NCT04799288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111013070|NCT04799288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111013071|NCT04799288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111013072|NCT04799288|Immunologic Factors|immunologic factors|mesh-ancestor
111013073|NCT04799054|Pembrolizumab|pembrolizumab|mesh-list
111013074|NCT04799054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111013075|NCT04799054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111013076|NCT04799054|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111013077|NCT04799054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111013078|NCT04724018|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
111013079|NCT04724018|Immunoconjugates|immunoconjugates|mesh-ancestor
111013080|NCT04724018|Immunologic Factors|immunologic factors|mesh-ancestor
111013081|NCT04724018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111013082|NCT04713592|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110622005|NCT00657150|Enoxaparin|enoxaparin|mesh-list
111013083|NCT04713592|Immunologic Factors|immunologic factors|mesh-ancestor
111013084|NCT04713592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111013085|NCT04687176|Arsenic Trioxide|arsenic trioxide|mesh-list
111013086|NCT04687176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111013087|NCT04653831|Pirfenidone|pirfenidone|mesh-list
111013088|NCT04653831|Analgesics|analgesics|mesh-ancestor
111013089|NCT04653831|Sensory System Agents|sensory system agents|mesh-ancestor
111013090|NCT04653831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111013091|NCT04653831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111013092|NCT04653831|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111013093|NCT04653831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111013094|NCT04653831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111013095|NCT04653831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111013096|NCT04653831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111013098|NCT04570956|Afimoxifene|afimoxifene|mesh-list
111013099|NCT04570956|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111013100|NCT04570956|Hormone Antagonists|hormone antagonists|mesh-ancestor
111013101|NCT04570956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111013102|NCT04570956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111013103|NCT04570956|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111013104|NCT04570956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111013105|NCT04570956|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111013106|NCT04570956|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111013107|NCT04570956|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111013108|NCT04512638|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111013109|NCT04512638|Amoxicillin|amoxicillin|mesh-list
111013110|NCT04512638|Chlorhexidine|chlorhexidine|mesh-list
111013111|NCT04512638|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
111013112|NCT04512638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111013113|NCT04512638|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111013114|NCT04512638|Disinfectants|disinfectants|mesh-ancestor
111013115|NCT04512638|Dermatologic Agents|dermatologic agents|mesh-ancestor
111013116|NCT04510428|Immunoglobulins|immunoglobulins|mesh-list
111013117|NCT04510428|Antibodies|antibodies|mesh-list
111013118|NCT04510428|gamma-Globulins|gamma-globulins|mesh-list
111013119|NCT04510428|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111013120|NCT04510428|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
111013121|NCT04510428|Immunologic Factors|immunologic factors|mesh-ancestor
111013122|NCT04510428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111013123|NCT04437303|Anticoagulants|anticoagulants|mesh-list
111013124|NCT04436107|Lenalidomide|lenalidomide|mesh-list
111013125|NCT04436107|Zanubrutinib|zanubrutinib|mesh-list
111013126|NCT04436107|Immunologic Factors|immunologic factors|mesh-ancestor
111013127|NCT04436107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111013128|NCT04436107|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111013129|NCT04436107|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111013130|NCT04436107|Growth Substances|growth substances|mesh-ancestor
111013131|NCT04436107|Growth Inhibitors|growth inhibitors|mesh-ancestor
111013132|NCT04436107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111013133|NCT04436107|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111013134|NCT04436107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111013135|NCT04436107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111013136|NCT04411693|Dexamethasone|dexamethasone|mesh-list
111013137|NCT04411693|Aflibercept|aflibercept|mesh-list
111013138|NCT04411693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111013139|NCT04411693|Antiemetics|antiemetics|mesh-ancestor
111013140|NCT04411693|Autonomic Agents|autonomic agents|mesh-ancestor
111013141|NCT04411693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111013142|NCT04411693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110622015|NCT00770354|Letrozole|letrozole|mesh-list
111013143|NCT04411693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111013144|NCT04411693|Glucocorticoids|glucocorticoids|mesh-ancestor
111013145|NCT04411693|Hormones|hormones|mesh-ancestor
111013146|NCT04411693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111013147|NCT04411693|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111013148|NCT04411693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111013149|NCT04411693|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111013150|NCT04411693|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111013151|NCT04411693|Growth Substances|growth substances|mesh-ancestor
111013152|NCT04411693|Growth Inhibitors|growth inhibitors|mesh-ancestor
111013153|NCT04380740|Abatacept|abatacept|mesh-list
111013154|NCT04380740|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111013155|NCT04380740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111013156|NCT04380740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111013157|NCT04380740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111013158|NCT04380740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111013159|NCT04380740|Immunologic Factors|immunologic factors|mesh-ancestor
111013160|NCT04380740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111013161|NCT04380740|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111013162|NCT04274335|Tranexamic Acid|tranexamic acid|mesh-list
111013163|NCT04274335|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111013164|NCT04274335|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111013165|NCT04274335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111013166|NCT04274335|Hemostatics|hemostatics|mesh-ancestor
111013167|NCT04274335|Coagulants|coagulants|mesh-ancestor
111013168|NCT04267887|Ascorbic Acid|ascorbic acid|mesh-list
111013169|NCT04267887|Prednisone|prednisone|mesh-list
111013170|NCT04267887|Cortisone|cortisone|mesh-list
111013171|NCT04267887|Methyltestosterone|methyltestosterone|mesh-list
111013172|NCT04267887|Abiraterone Acetate|abiraterone acetate|mesh-list
111013173|NCT04267887|Hormones|hormones|mesh-list
111013174|NCT04267887|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
111013175|NCT04267887|Androgens|androgens|mesh-list
111013176|NCT04267887|Androgen Antagonists|androgen antagonists|mesh-list
111013177|NCT04267887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111013178|NCT04267887|Glucocorticoids|glucocorticoids|mesh-ancestor
111013179|NCT04267887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111013180|NCT04267887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111013181|NCT04267887|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111013182|NCT04267887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111013183|NCT04267887|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111013184|NCT04267887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111013185|NCT04267887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111013186|NCT04267887|Hormone Antagonists|hormone antagonists|mesh-ancestor
111013187|NCT04267887|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111013188|NCT04267887|Antioxidants|antioxidants|mesh-ancestor
111013189|NCT04267887|Protective Agents|protective agents|mesh-ancestor
111013190|NCT04267887|Vitamins|vitamins|mesh-ancestor
111013191|NCT04267887|Micronutrients|micronutrients|mesh-ancestor
111013192|NCT04267887|Estrogens|estrogens|mesh-ancestor
111013193|NCT04267887|Anabolic Agents|anabolic agents|mesh-ancestor
111013194|NCT04238767|Dolutegravir|dolutegravir|mesh-list
111013195|NCT04238767|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111013196|NCT04238767|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111013197|NCT04238767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111013198|NCT04238767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111013199|NCT04238767|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111013200|NCT04238767|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111013201|NCT04238767|Antiviral Agents|antiviral agents|mesh-ancestor
111013202|NCT04238767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111013203|NCT04177355|Aluminum Hydroxide|aluminum hydroxide|mesh-list
111013204|NCT04177355|1018 oligonucleotide|1018 oligonucleotide|mesh-list
111013205|NCT04177355|MEDI9197|medi9197|mesh-list
111013206|NCT04177355|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111013207|NCT04177355|Immunologic Factors|immunologic factors|mesh-ancestor
111013208|NCT04177355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111013209|NCT04177355|Antacids|antacids|mesh-ancestor
111013210|NCT04177355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111013211|NCT04177355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111013212|NCT04166110|Oxymetazoline|oxymetazoline|mesh-list
111013213|NCT04166110|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111013214|NCT04166110|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111013215|NCT04166110|Adrenergic Agents|adrenergic agents|mesh-ancestor
111013216|NCT04166110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110025448|NCT00365898|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111013217|NCT04166110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111013219|NCT04166110|Sympathomimetics|sympathomimetics|mesh-ancestor
111013220|NCT04166110|Autonomic Agents|autonomic agents|mesh-ancestor
111013221|NCT04166110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111013222|NCT04166110|Nasal Decongestants|nasal decongestants|mesh-ancestor
111013223|NCT04166110|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111013224|NCT04166110|Respiratory System Agents|respiratory system agents|mesh-ancestor
111013225|NCT04126200|Dexamethasone|dexamethasone|mesh-list
111013226|NCT04126200|Lenalidomide|lenalidomide|mesh-list
111013227|NCT04126200|Pomalidomide|pomalidomide|mesh-list
111013228|NCT04126200|Dostarlimab|dostarlimab|mesh-list
111013229|NCT04126200|Nirogacestat|nirogacestat|mesh-list
111013230|NCT04126200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111013231|NCT04126200|Antiemetics|antiemetics|mesh-ancestor
111013232|NCT04126200|Autonomic Agents|autonomic agents|mesh-ancestor
111013233|NCT04126200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111013234|NCT04126200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111013235|NCT04126200|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111013236|NCT04126200|Glucocorticoids|glucocorticoids|mesh-ancestor
111013237|NCT04126200|Hormones|hormones|mesh-ancestor
111013238|NCT04126200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111013239|NCT04126200|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111013240|NCT04126200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111013241|NCT04126200|Immunologic Factors|immunologic factors|mesh-ancestor
111013242|NCT04126200|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111013243|NCT04126200|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111013244|NCT04126200|Growth Substances|growth substances|mesh-ancestor
111013246|NCT04126200|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
111013247|NCT04126200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111013248|NCT04126200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111013249|NCT04063865|Everolimus|everolimus|mesh-list
111013250|NCT04063865|Tacrolimus|tacrolimus|mesh-list
111013251|NCT04063865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111013252|NCT04063865|Immunologic Factors|immunologic factors|mesh-ancestor
111013253|NCT04063865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111013254|NCT04063865|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111013255|NCT04063865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111013256|NCT04063865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111013257|NCT04063865|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111013258|NCT04063865|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111013259|NCT04063865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111013260|NCT04045665|Anticoagulants|anticoagulants|mesh-list
111013261|NCT04015700|Coal Tar|coal tar|mesh-list
111013262|NCT04015700|Vaccines|vaccines|mesh-list
111013263|NCT04015700|Immunologic Factors|immunologic factors|mesh-ancestor
111013264|NCT04015700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111013265|NCT04015700|Keratolytic Agents|keratolytic agents|mesh-ancestor
111013266|NCT04015700|Dermatologic Agents|dermatologic agents|mesh-ancestor
111013267|NCT04004416|Lorazepam|lorazepam|mesh-list
111013268|NCT04004416|Anticonvulsants|anticonvulsants|mesh-ancestor
111013269|NCT04004416|Antiemetics|antiemetics|mesh-ancestor
111013270|NCT04004416|Autonomic Agents|autonomic agents|mesh-ancestor
111013271|NCT04004416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111013272|NCT04004416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111013273|NCT04004416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111013274|NCT04004416|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111013275|NCT04004416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111013276|NCT04004416|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111013277|NCT04004416|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111013278|NCT04004416|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111013279|NCT04004416|GABA Modulators|gaba modulators|mesh-ancestor
111013280|NCT04004416|GABA Agents|gaba agents|mesh-ancestor
111013281|NCT04004416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111013282|NCT04004416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111013283|NCT03996265|Bupropion|bupropion|mesh-list
111013284|NCT03996265|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111013285|NCT03996265|Antidepressive Agents|antidepressive agents|mesh-ancestor
111013286|NCT03996265|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111013287|NCT03996265|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111013288|NCT03996265|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111013289|NCT03996265|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111013290|NCT03996265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111013291|NCT03996265|Dopamine Agents|dopamine agents|mesh-ancestor
111013292|NCT03996265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111013293|NCT03996265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111013294|NCT03996265|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111013295|NCT03996265|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111013296|NCT03996265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111013297|NCT03994211|Itraconazole|itraconazole|mesh-list
111013299|NCT03994211|Pamiparib|pamiparib|mesh-list
111013300|NCT03994211|Antifungal Agents|antifungal agents|mesh-ancestor
111013301|NCT03994211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111013302|NCT03994211|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111013303|NCT03994211|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111013304|NCT03994211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111013305|NCT03994211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111013306|NCT03994211|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111013307|NCT03994211|Hormone Antagonists|hormone antagonists|mesh-ancestor
111013308|NCT03994211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111013309|NCT03994211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111013310|NCT03994211|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111013311|NCT03994211|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111013312|NCT03994211|Antitubercular Agents|antitubercular agents|mesh-ancestor
111013313|NCT03994211|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111013314|NCT03994211|Leprostatic Agents|leprostatic agents|mesh-ancestor
111013315|NCT03994211|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111013316|NCT03994211|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111013317|NCT03994211|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111013318|NCT03994211|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
111013319|NCT03994211|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
111013320|NCT03994211|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
111013321|NCT03994211|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111013322|NCT03994211|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111013323|NCT03994211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111013324|NCT03952637|Sirolimus|sirolimus|mesh-list
111013325|NCT03952637|Prednisone|prednisone|mesh-list
111013326|NCT03952637|Methylprednisolone|methylprednisolone|mesh-list
111013327|NCT03952637|Rituximab|rituximab|mesh-list
111013328|NCT03952637|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111013329|NCT03952637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111013330|NCT03952637|Immunologic Factors|immunologic factors|mesh-ancestor
111013331|NCT03952637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111013332|NCT03952637|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111013333|NCT03952637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111013334|NCT03952637|Glucocorticoids|glucocorticoids|mesh-ancestor
111013335|NCT03952637|Hormones|hormones|mesh-ancestor
111013336|NCT03952637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111013337|NCT03952637|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111013338|NCT03952637|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111013339|NCT03952637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111013340|NCT03952637|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111013341|NCT03952637|Antifungal Agents|antifungal agents|mesh-ancestor
111013342|NCT03952637|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111013343|NCT03952637|Antiemetics|antiemetics|mesh-ancestor
111013344|NCT03952637|Autonomic Agents|autonomic agents|mesh-ancestor
111013345|NCT03952637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111013346|NCT03952637|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111013347|NCT03952637|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111013348|NCT03952637|Protective Agents|protective agents|mesh-ancestor
111013349|NCT03950609|Everolimus|everolimus|mesh-list
111013350|NCT03950609|Lenvatinib|lenvatinib|mesh-list
111013351|NCT03950609|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111013352|NCT03950609|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111013353|NCT03950609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111013354|NCT03950609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111013355|NCT03950609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111013356|NCT03950609|Immunologic Factors|immunologic factors|mesh-ancestor
111013357|NCT03950609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111013358|NCT03950609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111013359|NCT03930732|Cholinergic Agents|cholinergic agents|mesh-list
111013360|NCT03930732|Muscarinic Antagonists|muscarinic antagonists|mesh-list
111013361|NCT03930732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111013362|NCT03930732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111013363|NCT03930732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111013364|NCT03930732|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111013365|NCT03910660|Pembrolizumab|pembrolizumab|mesh-list
111013366|NCT03910660|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111013367|NCT03910660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111013368|NCT03910660|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111013369|NCT03910660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111013370|NCT03875378|Estrogens|estrogens|mesh-list
111013371|NCT03875378|Hormones|hormones|mesh-ancestor
111013372|NCT03875378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111013373|NCT03875378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111013374|NCT03823768|Tacrolimus|tacrolimus|mesh-list
111013375|NCT03823768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111013376|NCT03823768|Immunologic Factors|immunologic factors|mesh-ancestor
111013377|NCT03823768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111013378|NCT03823768|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111013379|NCT03823768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111013380|NCT03823768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111013381|NCT03818607|Eculizumab|eculizumab|mesh-list
111013382|NCT03818607|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
111013383|NCT03818607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111013384|NCT03818607|Immunologic Factors|immunologic factors|mesh-ancestor
111013385|NCT03818607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111013386|NCT03796156|Aspirin|aspirin|mesh-list
111013387|NCT03796156|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111013388|NCT03796156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111013389|NCT03796156|Analgesics|analgesics|mesh-ancestor
111013390|NCT03796156|Sensory System Agents|sensory system agents|mesh-ancestor
111013391|NCT03796156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111013392|NCT03796156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111013393|NCT03796156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111013394|NCT03796156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111013395|NCT03796156|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111013396|NCT03796156|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111013397|NCT03796156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111013398|NCT03796156|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111013399|NCT03796156|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111013400|NCT03796156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111013401|NCT03796156|Antipyretics|antipyretics|mesh-ancestor
111013402|NCT03737292|Bupivacaine|bupivacaine|mesh-list
111013403|NCT03737292|Anesthetics, Local|anesthetics, local|mesh-ancestor
111013404|NCT03737292|Anesthetics|anesthetics|mesh-ancestor
111013405|NCT03737292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111013406|NCT03737292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111013407|NCT03737292|Sensory System Agents|sensory system agents|mesh-ancestor
111013408|NCT03737292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111013409|NCT03710460|Metformin|metformin|mesh-list
111013410|NCT03710460|Dapagliflozin|dapagliflozin|mesh-list
111013411|NCT03710460|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111013412|NCT03710460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111013413|NCT03710460|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111013414|NCT03710460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111013415|NCT03650894|Nivolumab|nivolumab|mesh-list
111013416|NCT03650894|Ipilimumab|ipilimumab|mesh-list
111013417|NCT03650894|Bicalutamide|bicalutamide|mesh-list
111013418|NCT03650894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111013419|NCT03650894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111013420|NCT03650894|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111013421|NCT03650894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111013422|NCT03650894|Androgen Antagonists|androgen antagonists|mesh-ancestor
111013423|NCT03650894|Hormone Antagonists|hormone antagonists|mesh-ancestor
111013424|NCT03650894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111013425|NCT03650894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111013426|NCT03606694|Metformin|metformin|mesh-list
111013427|NCT03606694|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111013428|NCT03606694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111013429|NCT03544281|Dexamethasone|dexamethasone|mesh-list
111013430|NCT03544281|Lenalidomide|lenalidomide|mesh-list
111013431|NCT03544281|Bortezomib|bortezomib|mesh-list
111013432|NCT03544281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111013433|NCT03544281|Antiemetics|antiemetics|mesh-ancestor
111013434|NCT03544281|Autonomic Agents|autonomic agents|mesh-ancestor
111013435|NCT03544281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111013436|NCT03544281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111013437|NCT03544281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111013438|NCT03544281|Glucocorticoids|glucocorticoids|mesh-ancestor
111013439|NCT03544281|Hormones|hormones|mesh-ancestor
111013440|NCT03544281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111013441|NCT03544281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111013442|NCT03544281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111013443|NCT03544281|Immunologic Factors|immunologic factors|mesh-ancestor
111013444|NCT03544281|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111013445|NCT03544281|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111013446|NCT03544281|Growth Substances|growth substances|mesh-ancestor
111013447|NCT03544281|Growth Inhibitors|growth inhibitors|mesh-ancestor
111013448|NCT03387579|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
111013449|NCT03387579|SMOFlipid|smoflipid|mesh-list
111013450|NCT03387579|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
111013451|NCT03387579|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
111013452|NCT03387579|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111013453|NCT03366272|Rituximab|rituximab|mesh-list
111013454|NCT03366272|Nivolumab|nivolumab|mesh-list
111013455|NCT03366272|Gemcitabine|gemcitabine|mesh-list
111013456|NCT03366272|Oxaliplatin|oxaliplatin|mesh-list
111013457|NCT03366272|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111013458|NCT03366272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111013459|NCT03366272|Immunologic Factors|immunologic factors|mesh-ancestor
111013460|NCT03366272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111013461|NCT03366272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111013462|NCT03366272|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111013463|NCT03366272|Antimetabolites|antimetabolites|mesh-ancestor
111013464|NCT03366272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111013465|NCT03366272|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111013466|NCT03339635|Methyltestosterone|methyltestosterone|mesh-list
111013467|NCT03339635|Testosterone|testosterone|mesh-list
111013468|NCT03339635|Testosterone undecanoate|testosterone undecanoate|mesh-list
111013469|NCT03339635|Testosterone enanthate|testosterone enanthate|mesh-list
111013470|NCT03339635|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
111013471|NCT03339635|Androgens|androgens|mesh-ancestor
111013473|NCT03339635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111013474|NCT03339635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111013475|NCT03339635|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111013476|NCT03339635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111013477|NCT03339635|Anabolic Agents|anabolic agents|mesh-ancestor
111013478|NCT03322215|Capecitabine|capecitabine|mesh-list
111013479|NCT03322215|Fulvestrant|fulvestrant|mesh-list
111013480|NCT03322215|Palbociclib|palbociclib|mesh-list
111013481|NCT03322215|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111013482|NCT03322215|Antimetabolites|antimetabolites|mesh-ancestor
111013483|NCT03322215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111013484|NCT03322215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111013485|NCT03322215|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111013486|NCT03322215|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
111013487|NCT03322215|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111013488|NCT03322215|Hormone Antagonists|hormone antagonists|mesh-ancestor
111013489|NCT03322215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111013490|NCT03322215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111013491|NCT03322215|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111013492|NCT03322215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111013493|NCT03300817|Poly ICLC|poly iclc|mesh-list
111013494|NCT03300817|Interferon Inducers|interferon inducers|mesh-ancestor
111013495|NCT03300817|Immunologic Factors|immunologic factors|mesh-ancestor
111013496|NCT03300817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111013497|NCT03246750|Cisplatin|cisplatin|mesh-list
111013498|NCT03246750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111013499|NCT03094884|Paclitaxel|paclitaxel|mesh-list
110622112|NCT00811200|Hormones|hormones|mesh-ancestor
111013500|NCT03094884|Carboplatin|carboplatin|mesh-list
111013501|NCT03094884|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111013502|NCT03094884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111013503|NCT03094884|Tubulin Modulators|tubulin modulators|mesh-ancestor
111013504|NCT03094884|Antimitotic Agents|antimitotic agents|mesh-ancestor
111013505|NCT03094884|Mitosis Modulators|mitosis modulators|mesh-ancestor
111013506|NCT03094884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111013507|NCT03029390|Metformin|metformin|mesh-list
111013508|NCT03029390|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111013509|NCT03029390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111013510|NCT02873962|Bevacizumab|bevacizumab|mesh-list
111013511|NCT02873962|Nivolumab|nivolumab|mesh-list
111013512|NCT02873962|Rucaparib|rucaparib|mesh-list
111013513|NCT02873962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111013514|NCT02873962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111013515|NCT02873962|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111013516|NCT02873962|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111013517|NCT02873962|Growth Substances|growth substances|mesh-ancestor
111013518|NCT02873962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111013519|NCT02873962|Growth Inhibitors|growth inhibitors|mesh-ancestor
111013520|NCT02873962|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111013521|NCT02873962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111013522|NCT02873962|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111013523|NCT02873962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111013524|NCT02822144|Lidocaine|lidocaine|mesh-list
111013525|NCT02822144|Remifentanil|remifentanil|mesh-list
111013526|NCT02822144|Propofol|propofol|mesh-list
111013527|NCT02822144|Etomidate|etomidate|mesh-list
111013528|NCT02822144|Succinylcholine|succinylcholine|mesh-list
111013529|NCT02822144|Anesthetics, Local|anesthetics, local|mesh-ancestor
111013530|NCT02822144|Anesthetics|anesthetics|mesh-ancestor
111013531|NCT02822144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111013532|NCT02822144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111013533|NCT02822144|Sensory System Agents|sensory system agents|mesh-ancestor
111013534|NCT02822144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111013535|NCT02822144|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111013536|NCT02822144|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111013537|NCT02822144|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111013538|NCT02822144|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111013539|NCT02822144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111013540|NCT02822144|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111013541|NCT02822144|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111013542|NCT02822144|Anesthetics, General|anesthetics, general|mesh-ancestor
111013543|NCT02822144|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111013544|NCT02822144|Narcotics|narcotics|mesh-ancestor
111013545|NCT02822144|Analgesics|analgesics|mesh-ancestor
111013546|NCT02822144|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
111013547|NCT02822144|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
111013548|NCT02822144|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111013549|NCT02725060|Phenylephrine|phenylephrine|mesh-list
111013550|NCT02725060|Isoproterenol|isoproterenol|mesh-list
111013551|NCT02725060|Oxymetazoline|oxymetazoline|mesh-list
111013552|NCT02725060|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111013553|NCT02725060|Mydriatics|mydriatics|mesh-ancestor
111013554|NCT02725060|Autonomic Agents|autonomic agents|mesh-ancestor
111013555|NCT02725060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111013556|NCT02725060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111013557|NCT02725060|Sympathomimetics|sympathomimetics|mesh-ancestor
111013558|NCT02725060|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111013559|NCT02725060|Nasal Decongestants|nasal decongestants|mesh-ancestor
111013560|NCT02725060|Respiratory System Agents|respiratory system agents|mesh-ancestor
111013561|NCT02725060|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111013562|NCT02725060|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111013563|NCT02725060|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111013564|NCT02725060|Adrenergic Agents|adrenergic agents|mesh-ancestor
111013565|NCT02725060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111013566|NCT02725060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111013567|NCT02725060|Protective Agents|protective agents|mesh-ancestor
111013568|NCT02725060|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111013569|NCT02725060|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111013570|NCT02725060|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111013571|NCT02565680|Prednisone|prednisone|mesh-list
111013572|NCT02565680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111013573|NCT02565680|Glucocorticoids|glucocorticoids|mesh-ancestor
111013574|NCT02565680|Hormones|hormones|mesh-ancestor
111013575|NCT02565680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111013576|NCT02565680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111013577|NCT02565680|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111013578|NCT02565680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111013579|NCT02422615|Fulvestrant|fulvestrant|mesh-list
111013580|NCT02422615|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111013581|NCT02422615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111013582|NCT02422615|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
111013583|NCT02422615|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111013584|NCT02422615|Hormone Antagonists|hormone antagonists|mesh-ancestor
111013585|NCT02422615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111013586|NCT02422615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111013587|NCT02382406|Paclitaxel|paclitaxel|mesh-list
111013588|NCT02382406|Carboplatin|carboplatin|mesh-list
111013589|NCT02382406|Pembrolizumab|pembrolizumab|mesh-list
111013590|NCT02382406|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111013591|NCT02382406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111013592|NCT02382406|Tubulin Modulators|tubulin modulators|mesh-ancestor
111013593|NCT02382406|Antimitotic Agents|antimitotic agents|mesh-ancestor
111013594|NCT02382406|Mitosis Modulators|mitosis modulators|mesh-ancestor
111013595|NCT02382406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111013596|NCT02382406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111013597|NCT02382406|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111013598|NCT02134327|Midazolam|midazolam|mesh-list
111013599|NCT02134327|Dexmedetomidine|dexmedetomidine|mesh-list
111013600|NCT02134327|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111013601|NCT02134327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111013602|NCT02134327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111013603|NCT02134327|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111013604|NCT02134327|Analgesics|analgesics|mesh-ancestor
111013605|NCT02134327|Sensory System Agents|sensory system agents|mesh-ancestor
111013606|NCT02134327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111013607|NCT02134327|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111013608|NCT02134327|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111013609|NCT02134327|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111013610|NCT02134327|Adrenergic Agents|adrenergic agents|mesh-ancestor
111013611|NCT02134327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111013612|NCT02134327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111013613|NCT02134327|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111013614|NCT02134327|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111013615|NCT02134327|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111013616|NCT02134327|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111013617|NCT02134327|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111013619|NCT02134327|Anesthetics|anesthetics|mesh-ancestor
111013620|NCT02134327|GABA Modulators|gaba modulators|mesh-ancestor
111013621|NCT02134327|GABA Agents|gaba agents|mesh-ancestor
111013622|NCT02101268|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
111013623|NCT02101268|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111013624|NCT02101268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111013625|NCT02101268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111013626|NCT01880515|Tetracycline|tetracycline|mesh-list
111013627|NCT01880515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111013628|NCT01880515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111013629|NCT01880515|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111013630|NCT01880515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111013631|NCT01880515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111013632|NCT01780883|Melatonin|melatonin|mesh-list
111013633|NCT01780883|Antioxidants|antioxidants|mesh-ancestor
111013634|NCT01780883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111013635|NCT01780883|Protective Agents|protective agents|mesh-ancestor
111013636|NCT01780883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111013637|NCT01780883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111013638|NCT01668719|Dexamethasone|dexamethasone|mesh-list
111013639|NCT01668719|Dexamethasone acetate|dexamethasone acetate|mesh-list
111013640|NCT01668719|Lenalidomide|lenalidomide|mesh-list
111013641|NCT01668719|Bortezomib|bortezomib|mesh-list
111013642|NCT01668719|Elotuzumab|elotuzumab|mesh-list
111013643|NCT01668719|Ichthammol|ichthammol|mesh-list
111013644|NCT01668719|BB 1101|bb 1101|mesh-list
111013645|NCT01668719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111013646|NCT01668719|Antiemetics|antiemetics|mesh-ancestor
111013647|NCT01668719|Autonomic Agents|autonomic agents|mesh-ancestor
111013648|NCT01668719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111013649|NCT01668719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111013650|NCT01668719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111013651|NCT01668719|Glucocorticoids|glucocorticoids|mesh-ancestor
111013652|NCT01668719|Hormones|hormones|mesh-ancestor
111013653|NCT01668719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111013654|NCT01668719|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111013655|NCT01668719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111013656|NCT01668719|Immunologic Factors|immunologic factors|mesh-ancestor
111013657|NCT01668719|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111013658|NCT01668719|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111013659|NCT01668719|Growth Substances|growth substances|mesh-ancestor
111013660|NCT01668719|Growth Inhibitors|growth inhibitors|mesh-ancestor
111013661|NCT01668719|Protease Inhibitors|protease inhibitors|mesh-ancestor
111013662|NCT01668719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111013663|NCT01668719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111013664|NCT01668719|Dermatologic Agents|dermatologic agents|mesh-ancestor
111013665|NCT01642901|Zoledronic Acid|zoledronic acid|mesh-list
111013666|NCT01642901|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111013667|NCT01642901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111013668|NCT01488045|Fentanyl|fentanyl|mesh-list
111013669|NCT01488045|Midazolam|midazolam|mesh-list
111013670|NCT01488045|Propofol|propofol|mesh-list
111013671|NCT01488045|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111013672|NCT01488045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111013673|NCT01488045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111013674|NCT01488045|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111013675|NCT01488045|Anesthetics, General|anesthetics, general|mesh-ancestor
111013676|NCT01488045|Anesthetics|anesthetics|mesh-ancestor
111013677|NCT01488045|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111013678|NCT01488045|Narcotics|narcotics|mesh-ancestor
111013679|NCT01488045|Analgesics|analgesics|mesh-ancestor
111013680|NCT01488045|Sensory System Agents|sensory system agents|mesh-ancestor
111013681|NCT01488045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111013682|NCT01488045|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111013683|NCT01488045|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111013684|NCT01488045|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111013685|NCT01488045|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111013686|NCT01488045|GABA Modulators|gaba modulators|mesh-ancestor
111013687|NCT01488045|GABA Agents|gaba agents|mesh-ancestor
111013688|NCT01488045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111013689|NCT01488045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111013690|NCT01404754|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
111013691|NCT01404754|Hallucinogens|hallucinogens|mesh-ancestor
110730674|NCT00075764|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111013692|NCT01404754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111013693|NCT01404754|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111013695|NCT01404754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111013696|NCT01404754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111013697|NCT01404754|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111013698|NCT01404754|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111013699|NCT01404754|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111013700|NCT01404754|Adrenergic Agents|adrenergic agents|mesh-ancestor
111013701|NCT01090479|Chlorhexidine|chlorhexidine|mesh-list
111013702|NCT01090479|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111013703|NCT01090479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111013704|NCT01090479|Disinfectants|disinfectants|mesh-ancestor
111013705|NCT00946712|Paclitaxel|paclitaxel|mesh-list
111013706|NCT00946712|Bevacizumab|bevacizumab|mesh-list
111013707|NCT00946712|Carboplatin|carboplatin|mesh-list
111013708|NCT00946712|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111013709|NCT00946712|Cetuximab|cetuximab|mesh-list
111013710|NCT00946712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111013711|NCT00946712|Endothelial Growth Factors|endothelial growth factors|mesh-list
111013712|NCT00946712|Antibodies|antibodies|mesh-list
111013713|NCT00946712|Immunoglobulins|immunoglobulins|mesh-list
111013714|NCT00946712|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111013715|NCT00946712|Immunoglobulin G|immunoglobulin g|mesh-list
111013716|NCT00946712|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111013717|NCT00946712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111013718|NCT00946712|Tubulin Modulators|tubulin modulators|mesh-ancestor
111013719|NCT00946712|Antimitotic Agents|antimitotic agents|mesh-ancestor
111013720|NCT00946712|Mitosis Modulators|mitosis modulators|mesh-ancestor
111013721|NCT00946712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111013722|NCT00946712|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111013723|NCT00946712|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111013724|NCT00946712|Growth Substances|growth substances|mesh-ancestor
111013725|NCT00946712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111013726|NCT00946712|Growth Inhibitors|growth inhibitors|mesh-ancestor
111013727|NCT00946712|Immunologic Factors|immunologic factors|mesh-ancestor
111013728|NCT00656669|Paclitaxel|paclitaxel|mesh-list
111013729|NCT00656669|Cyclophosphamide|cyclophosphamide|mesh-list
111013730|NCT00656669|Doxorubicin|doxorubicin|mesh-list
111013731|NCT00656669|Sunitinib|sunitinib|mesh-list
111013732|NCT00656669|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111013733|NCT00656669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111013734|NCT00656669|Tubulin Modulators|tubulin modulators|mesh-ancestor
111013735|NCT00656669|Antimitotic Agents|antimitotic agents|mesh-ancestor
111013736|NCT00656669|Mitosis Modulators|mitosis modulators|mesh-ancestor
111013737|NCT00656669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111013738|NCT00656669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111013739|NCT00656669|Immunologic Factors|immunologic factors|mesh-ancestor
111013740|NCT00656669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111013741|NCT00656669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111013742|NCT00656669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111013743|NCT00656669|Alkylating Agents|alkylating agents|mesh-ancestor
111013744|NCT00656669|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111013745|NCT00656669|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111013746|NCT00656669|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111013747|NCT00656669|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111013748|NCT00656669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111013749|NCT00656669|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111013750|NCT00656669|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111013751|NCT00656669|Growth Substances|growth substances|mesh-ancestor
111013752|NCT00656669|Growth Inhibitors|growth inhibitors|mesh-ancestor
111013753|NCT00656669|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111013754|NCT00494728|Nicotine|nicotine|mesh-list
111013755|NCT00494728|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111013756|NCT00494728|Autonomic Agents|autonomic agents|mesh-ancestor
111013757|NCT00494728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111013758|NCT00494728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111013759|NCT00494728|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111013760|NCT00494728|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111013761|NCT00494728|Cholinergic Agents|cholinergic agents|mesh-ancestor
111013762|NCT00494728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111013763|NCT00494728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111013764|NCT00470704|Trastuzumab|trastuzumab|mesh-list
111013765|NCT00470704|Lapatinib|lapatinib|mesh-list
111013766|NCT00470704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110730754|NCT01087983|Metformin|metformin|mesh-list
111013767|NCT00470704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111013768|NCT00470704|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111013769|NCT00470704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111013770|NCT00470704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111013771|NCT00412594|Rituximab|rituximab|mesh-list
111013772|NCT00412594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111013773|NCT00412594|Cladribine|cladribine|mesh-list
111013774|NCT00412594|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
111013775|NCT00412594|Antibodies|antibodies|mesh-list
111013776|NCT00412594|Immunoglobulins|immunoglobulins|mesh-list
111013777|NCT00412594|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111013778|NCT00412594|Immunologic Factors|immunologic factors|mesh-ancestor
111013779|NCT00412594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111013780|NCT00412594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111013781|NCT00412594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111013782|NCT00412594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111013783|NCT00412594|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111013784|NCT00412594|Antimetabolites|antimetabolites|mesh-ancestor
111013785|NCT00412594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111013786|NCT03829579|Esketamine|esketamine|mesh-list
111013787|NCT03829579|Antidepressive Agents|antidepressive agents|mesh-ancestor
111013788|NCT03829579|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111013789|NCT04759339|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111013790|NCT04759339|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111013791|NCT01362296|Docetaxel|docetaxel|mesh-list
111013792|NCT01362296|Trametinib|trametinib|mesh-list
111013793|NCT01362296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111013794|NCT01362296|Tubulin Modulators|tubulin modulators|mesh-ancestor
111013795|NCT01362296|Antimitotic Agents|antimitotic agents|mesh-ancestor
111013796|NCT01362296|Mitosis Modulators|mitosis modulators|mesh-ancestor
111013797|NCT01362296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111013798|NCT01362296|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111013799|NCT01362296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111013801|NCT01338415|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111013802|NCT01338415|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
111013803|NCT01338415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111013804|NCT04353128|Melatonin|melatonin|mesh-list
111013805|NCT04353128|Antioxidants|antioxidants|mesh-ancestor
111013806|NCT04353128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111013807|NCT04353128|Protective Agents|protective agents|mesh-ancestor
111013808|NCT04353128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111013809|NCT04353128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111013810|NCT04263350|Atazanavir Sulfate|atazanavir sulfate|mesh-list
111013811|NCT04263350|Cobicistat|cobicistat|mesh-list
111013812|NCT04263350|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111013813|NCT04263350|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111013814|NCT04263350|Protease Inhibitors|protease inhibitors|mesh-ancestor
111013815|NCT04263350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111013816|NCT04263350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111013817|NCT04263350|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111013818|NCT04263350|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111013819|NCT04263350|Antiviral Agents|antiviral agents|mesh-ancestor
111013820|NCT04263350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111013821|NCT04263350|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111013822|NCT04263350|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111013823|NCT03562585|Antibodies|antibodies|mesh-list
111013824|NCT03562585|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111013825|NCT03562585|Immunologic Factors|immunologic factors|mesh-ancestor
111013826|NCT03562585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111013827|NCT04578535|Immunoglobulins|immunoglobulins|mesh-list
111013828|NCT04578535|Immunologic Factors|immunologic factors|mesh-ancestor
111013829|NCT04578535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111013830|NCT05124938|Hormones|hormones|mesh-list
111013831|NCT05124938|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111013832|NCT05124938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111013833|NCT02259985|Itasetron|itasetron|mesh-list
111013834|NCT02259985|Antiemetics|antiemetics|mesh-ancestor
111013835|NCT02259985|Autonomic Agents|autonomic agents|mesh-ancestor
111013836|NCT02259985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111013837|NCT02259985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111013838|NCT02259985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111013839|NCT02259985|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110730821|NCT01081431|Growth Substances|growth substances|mesh-ancestor
111013840|NCT02259985|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111013841|NCT02259985|Serotonin Agents|serotonin agents|mesh-ancestor
111013843|NCT02259985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111013844|NCT01371643|Octreotide|octreotide|mesh-list
111013845|NCT01371643|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111013846|NCT01371643|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111013847|NCT01371643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111013848|NCT03023462|Droperidol|droperidol|mesh-list
111013849|NCT03023462|Oxycodone|oxycodone|mesh-list
111013850|NCT03023462|Ondansetron|ondansetron|mesh-list
111013851|NCT03023462|Ropivacaine|ropivacaine|mesh-list
111013852|NCT03023462|Anesthetics, Local|anesthetics, local|mesh-ancestor
111013853|NCT03023462|Anesthetics|anesthetics|mesh-ancestor
111013854|NCT03023462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111013855|NCT03023462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111013856|NCT03023462|Sensory System Agents|sensory system agents|mesh-ancestor
111013857|NCT03023462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111013858|NCT03023462|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111013859|NCT03023462|Narcotics|narcotics|mesh-ancestor
111013860|NCT03023462|Analgesics|analgesics|mesh-ancestor
111013861|NCT03023462|Antiemetics|antiemetics|mesh-ancestor
111013862|NCT03023462|Autonomic Agents|autonomic agents|mesh-ancestor
111013863|NCT03023462|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111013864|NCT03023462|Antipruritics|antipruritics|mesh-ancestor
111013865|NCT03023462|Dermatologic Agents|dermatologic agents|mesh-ancestor
111013866|NCT03023462|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111013867|NCT03023462|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111013868|NCT03023462|Serotonin Agents|serotonin agents|mesh-ancestor
110478802|NCT04115800|Sirolimus|sirolimus|mesh-list
111013869|NCT03023462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111013870|NCT03023462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111013871|NCT03023462|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111013872|NCT03023462|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111013873|NCT03023462|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111013874|NCT03023462|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111013875|NCT03023462|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111013876|NCT03023462|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111013877|NCT03023462|Dopamine Agents|dopamine agents|mesh-ancestor
111013878|NCT02824952|Osimertinib|osimertinib|mesh-list
111013879|NCT02824952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111013880|NCT02824952|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111013881|NCT02824952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111013882|NCT02824952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111013883|NCT01371565|Mifepristone|mifepristone|mesh-list
111013884|NCT01371565|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
111013885|NCT01371565|Abortifacient Agents|abortifacient agents|mesh-ancestor
111013886|NCT01371565|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111013887|NCT01371565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111013888|NCT01371565|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111013889|NCT01371565|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111013890|NCT01371565|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111013891|NCT01371565|Contraceptive Agents|contraceptive agents|mesh-ancestor
111013892|NCT01371565|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
111013893|NCT01371565|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
111013894|NCT01371565|Hormone Antagonists|hormone antagonists|mesh-ancestor
111013895|NCT01371565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111013896|NCT01371565|Luteolytic Agents|luteolytic agents|mesh-ancestor
111013897|NCT01371565|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111013898|NCT01371565|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
111013899|NCT02821819|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
111013900|NCT02821819|Hormones|hormones|mesh-ancestor
111013901|NCT02821819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111013902|NCT02821819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111013903|NCT04500548|Nivolumab|nivolumab|mesh-list
111013904|NCT04500548|Ipilimumab|ipilimumab|mesh-list
111013905|NCT04500548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111013906|NCT04500548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111013907|NCT04500548|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111013908|NCT04500548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111013909|NCT05707819|Antibodies|antibodies|mesh-list
111013910|NCT05707819|Immunologic Factors|immunologic factors|mesh-ancestor
111013911|NCT05707819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111013912|NCT03034538|Zonisamide|zonisamide|mesh-list
111013913|NCT03034538|Anticonvulsants|anticonvulsants|mesh-ancestor
111013914|NCT03034538|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111013915|NCT03034538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111013916|NCT03034538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111013917|NCT03034538|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111013918|NCT03034538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111013919|NCT02468180|Polidocanol|polidocanol|mesh-list
111013920|NCT02468180|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
111013921|NCT02468180|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111013922|NCT01836068|Enfuvirtide|enfuvirtide|mesh-list
111013923|NCT01836068|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
111013924|NCT01836068|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
111013925|NCT01836068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111013926|NCT01836068|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111013927|NCT01836068|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111013928|NCT01836068|Antiviral Agents|antiviral agents|mesh-ancestor
111013929|NCT01836068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111013930|NCT05053880|Pembrolizumab|pembrolizumab|mesh-list
111013931|NCT05053880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111013932|NCT05053880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111013933|NCT05053880|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111013934|NCT05053880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111013935|NCT00094016|Beclomethasone|beclomethasone|mesh-list
111013936|NCT00094016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111013937|NCT00094016|Glucocorticoids|glucocorticoids|mesh-ancestor
111013938|NCT00094016|Hormones|hormones|mesh-ancestor
111013939|NCT00094016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111013940|NCT00094016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111013941|NCT00094016|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111013942|NCT00094016|Respiratory System Agents|respiratory system agents|mesh-ancestor
111013944|NCT05134298|Tazobactam|tazobactam|mesh-list
111013945|NCT05134298|Piperacillin|piperacillin|mesh-list
111013946|NCT05134298|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
111013947|NCT05134298|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111013948|NCT05134298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111013949|NCT05134298|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
111013950|NCT05134298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111013951|NCT05134298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111013952|NCT05134220|Calcium|calcium|mesh-list
111013953|NCT05134220|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111013954|NCT05134220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111013955|NCT03954379|Dexamethasone|dexamethasone|mesh-list
111013956|NCT03954379|Dexamethasone acetate|dexamethasone acetate|mesh-list
111013957|NCT03954379|Analgesics|analgesics|mesh-list
111013958|NCT03954379|Anesthetics|anesthetics|mesh-list
111013959|NCT03954379|Anesthetics, Local|anesthetics, local|mesh-list
111013960|NCT03954379|BB 1101|bb 1101|mesh-list
111013961|NCT03954379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111013962|NCT03954379|Antiemetics|antiemetics|mesh-ancestor
111013963|NCT03954379|Autonomic Agents|autonomic agents|mesh-ancestor
111013964|NCT03954379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111013965|NCT03954379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111013966|NCT03954379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111013967|NCT03954379|Glucocorticoids|glucocorticoids|mesh-ancestor
111013968|NCT03954379|Hormones|hormones|mesh-ancestor
111013969|NCT03954379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111013970|NCT03954379|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111013971|NCT03954379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110630568|NCT00960921|Iron|iron|mesh-list
111013972|NCT03954379|Protease Inhibitors|protease inhibitors|mesh-ancestor
111013973|NCT03954379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111013974|NCT03954379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111013975|NCT03954379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111013976|NCT03954379|Sensory System Agents|sensory system agents|mesh-ancestor
111013977|NCT02036125|Methylprednisolone|methylprednisolone|mesh-list
111013978|NCT02036125|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111013979|NCT02036125|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111013980|NCT02036125|Prednisolone|prednisolone|mesh-list
111013981|NCT02036125|Prednisolone acetate|prednisolone acetate|mesh-list
111013982|NCT02036125|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111013983|NCT02036125|Prednisolone phosphate|prednisolone phosphate|mesh-list
111013984|NCT02036125|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111013985|NCT02036125|Antiemetics|antiemetics|mesh-ancestor
111013986|NCT02036125|Autonomic Agents|autonomic agents|mesh-ancestor
111013987|NCT02036125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110730980|NCT03586726|Rifampin|rifampin|mesh-list
111013988|NCT02036125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111013989|NCT02036125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111013990|NCT02036125|Glucocorticoids|glucocorticoids|mesh-ancestor
111013991|NCT02036125|Hormones|hormones|mesh-ancestor
111013992|NCT02036125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111013993|NCT02036125|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111013994|NCT02036125|Protective Agents|protective agents|mesh-ancestor
111013995|NCT02036125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111013996|NCT02036125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111013997|NCT05133752|Nemonoxacin|nemonoxacin|mesh-list
111013998|NCT05133752|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111013999|NCT05133752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111014000|NCT02818777|Cannabidiol|cannabidiol|mesh-list
111014001|NCT02818777|Anticonvulsants|anticonvulsants|mesh-ancestor
111014002|NCT05128916|Terbinafine|terbinafine|mesh-list
111014003|NCT05128916|Antifungal Agents|antifungal agents|mesh-ancestor
111014004|NCT05128916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111014005|NCT05128916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111014006|NCT05128916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111014007|NCT05133050|Ramipril|ramipril|mesh-list
111014008|NCT05133050|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
111014009|NCT05133050|Protease Inhibitors|protease inhibitors|mesh-ancestor
111014010|NCT05133050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111014011|NCT05133050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111014012|NCT05133050|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111014013|NCT02817841|Drospirenone|drospirenone|mesh-list
111014014|NCT02817841|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
111014015|NCT02817841|Hormone Antagonists|hormone antagonists|mesh-ancestor
111014016|NCT02817841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111014017|NCT02817841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111014018|NCT02817841|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
111014020|NCT02817841|Natriuretic Agents|natriuretic agents|mesh-ancestor
111014021|NCT05132270|Thalidomide|thalidomide|mesh-list
111014022|NCT05132270|Hydroxyurea|hydroxyurea|mesh-list
111014023|NCT05132270|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111014024|NCT05132270|Immunologic Factors|immunologic factors|mesh-ancestor
111014025|NCT05132270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111014026|NCT05132270|Leprostatic Agents|leprostatic agents|mesh-ancestor
111014027|NCT05132270|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111014028|NCT05132270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111014029|NCT05132270|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111014030|NCT05132270|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111014031|NCT05132270|Growth Substances|growth substances|mesh-ancestor
111014032|NCT05132270|Growth Inhibitors|growth inhibitors|mesh-ancestor
111014033|NCT05132270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111014034|NCT05132270|Antisickling Agents|antisickling agents|mesh-ancestor
111014035|NCT05132270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111014036|NCT05132270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111014037|NCT05132270|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111014038|NCT02814565|Cyclobenzaprine|cyclobenzaprine|mesh-list
111014039|NCT02814565|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
111014040|NCT02814565|Antidepressive Agents|antidepressive agents|mesh-ancestor
111014041|NCT02814565|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111014042|NCT02814565|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
111014043|NCT02814565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111014044|NCT02814565|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111014045|NCT02814565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111014046|NCT02814565|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111014047|NCT02814565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111014048|NCT05121038|Leucovorin|leucovorin|mesh-list
111014049|NCT05121038|Fluorouracil|fluorouracil|mesh-list
111014050|NCT05121038|Oxaliplatin|oxaliplatin|mesh-list
111014051|NCT05121038|Irinotecan|irinotecan|mesh-list
111014052|NCT05121038|Panitumumab|panitumumab|mesh-list
111014053|NCT05121038|Folfirinox|folfirinox|mesh-list
111014054|NCT05121038|Antimetabolites|antimetabolites|mesh-ancestor
111014055|NCT05121038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111014056|NCT05121038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111014057|NCT05121038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111014058|NCT05121038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111014059|NCT05121038|Immunologic Factors|immunologic factors|mesh-ancestor
111014060|NCT05121038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111014061|NCT05121038|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111014062|NCT05121038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111014063|NCT05121038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111014064|NCT05121038|Antidotes|antidotes|mesh-ancestor
111014065|NCT05121038|Protective Agents|protective agents|mesh-ancestor
111014066|NCT05121038|Vitamin B Complex|vitamin b complex|mesh-ancestor
111014067|NCT05121038|Vitamins|vitamins|mesh-ancestor
111014068|NCT05121038|Micronutrients|micronutrients|mesh-ancestor
111014069|NCT05121038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111014070|NCT05097794|Indapamide|indapamide|mesh-list
111014071|NCT05097794|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111014072|NCT05097794|Diuretics|diuretics|mesh-ancestor
111014073|NCT05097794|Natriuretic Agents|natriuretic agents|mesh-ancestor
111014074|NCT05097794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111014075|NCT05097794|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
111014076|NCT05097794|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111014077|NCT05097794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111014078|NCT02036281|Substance P|substance p|mesh-list
111014079|NCT02036281|Neurokinin A|neurokinin a|mesh-list
111014080|NCT02036281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111014081|NCT02036281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111014082|NCT02036281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111014083|NCT02036359|Docetaxel|docetaxel|mesh-list
111014084|NCT02036359|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111014085|NCT02036359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111014086|NCT02036359|Tubulin Modulators|tubulin modulators|mesh-ancestor
111014087|NCT02036359|Antimitotic Agents|antimitotic agents|mesh-ancestor
111014088|NCT02036359|Mitosis Modulators|mitosis modulators|mesh-ancestor
111014089|NCT02036359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111014090|NCT02036359|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111014091|NCT02036359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111014092|NCT02036437|Misoprostol|misoprostol|mesh-list
111014093|NCT02036437|Dinoprostone|dinoprostone|mesh-list
111014094|NCT02036437|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111014095|NCT02036437|Abortifacient Agents|abortifacient agents|mesh-ancestor
111014096|NCT02036437|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111014097|NCT02036437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111014098|NCT02036437|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111014099|NCT02036437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111014100|NCT02036437|Oxytocics|oxytocics|mesh-ancestor
111014101|NCT05027360|Nitroprusside|nitroprusside|mesh-list
111014102|NCT05027360|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111014103|NCT05027360|Vasodilator Agents|vasodilator agents|mesh-ancestor
111014104|NCT05027360|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
111014105|NCT05027360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111014106|NCT02036983|Anesthetics|anesthetics|mesh-list
111014107|NCT02036983|Anesthetics, Local|anesthetics, local|mesh-list
111014108|NCT02036983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111014109|NCT02036983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111014110|NCT02036983|Sensory System Agents|sensory system agents|mesh-ancestor
111014111|NCT02036983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111014112|NCT05020652|Hydroxyurea|hydroxyurea|mesh-list
111014113|NCT05020652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111014114|NCT05020652|Antisickling Agents|antisickling agents|mesh-ancestor
111014115|NCT05020652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111014116|NCT05020652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111014117|NCT05020652|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111014118|NCT05689177|Vaccines|vaccines|mesh-list
111014119|NCT05689177|Immunologic Factors|immunologic factors|mesh-ancestor
111014120|NCT05689177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111014121|NCT04818320|Favipiravir|favipiravir|mesh-list
111014122|NCT04818320|Antiviral Agents|antiviral agents|mesh-ancestor
111014123|NCT04818320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111014124|NCT02475135|Tenofovir|tenofovir|mesh-list
111014125|NCT02475135|Emtricitabine|emtricitabine|mesh-list
111014126|NCT02475135|Darunavir|darunavir|mesh-list
111014127|NCT02475135|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
111014128|NCT02475135|Cobicistat|cobicistat|mesh-list
111014129|NCT02475135|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
111014130|NCT02475135|Elvitegravir|elvitegravir|mesh-list
111014131|NCT02475135|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
111014132|NCT02475135|Antiviral Agents|antiviral agents|mesh-ancestor
111014133|NCT02475135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111014134|NCT02475135|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111014135|NCT02475135|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111014136|NCT02475135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111014137|NCT02475135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111014138|NCT02475135|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111014139|NCT02475135|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111014140|NCT02475135|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110731123|NCT05781620|Vitamin D|vitamin d|mesh-list
111014141|NCT02475135|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111014142|NCT02475135|Protease Inhibitors|protease inhibitors|mesh-ancestor
111014143|NCT02475135|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111014144|NCT02475135|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111014145|NCT02475135|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111014146|NCT05161754|Hemostatics|hemostatics|mesh-list
111014147|NCT05161754|Coagulants|coagulants|mesh-ancestor
111014148|NCT05118620|Bupivacaine|bupivacaine|mesh-list
111014149|NCT05118620|Anesthetics, Local|anesthetics, local|mesh-ancestor
111014150|NCT05118620|Anesthetics|anesthetics|mesh-ancestor
111014151|NCT05118620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111014152|NCT05118620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111014153|NCT05118620|Sensory System Agents|sensory system agents|mesh-ancestor
111014154|NCT05118620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111014155|NCT02814643|Benralizumab|benralizumab|mesh-list
111014156|NCT02814643|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111014157|NCT02814643|Respiratory System Agents|respiratory system agents|mesh-ancestor
111014158|NCT05080790|Zoledronic Acid|zoledronic acid|mesh-list
111014159|NCT05080790|Interleukin-2|interleukin-2|mesh-list
111014160|NCT05080790|Dinutuximab|dinutuximab|mesh-list
111014161|NCT05080790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111014162|NCT05080790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111014163|NCT05080790|Analgesics|analgesics|mesh-ancestor
111014164|NCT05080790|Sensory System Agents|sensory system agents|mesh-ancestor
111014165|NCT05080790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111014166|NCT05080790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111014167|NCT05080790|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111014168|NCT02036827|Bromides|bromides|mesh-list
111014169|NCT02036827|Rocuronium|rocuronium|mesh-list
111014170|NCT02036827|Anticonvulsants|anticonvulsants|mesh-ancestor
111014171|NCT02036827|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110154040|NCT00001119|Efavirenz|efavirenz|mesh-list
111014172|NCT02036827|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
111014173|NCT02036827|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111014174|NCT02036827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111014175|NCT02036827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111014176|NCT02475213|Pembrolizumab|pembrolizumab|mesh-list
111014177|NCT02475213|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111014178|NCT02475213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111014179|NCT02475213|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111014180|NCT02475213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111014181|NCT05256056|Bupivacaine|bupivacaine|mesh-list
111014182|NCT05256056|Anesthetics, Local|anesthetics, local|mesh-ancestor
111014183|NCT05256056|Anesthetics|anesthetics|mesh-ancestor
111014184|NCT05256056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111014185|NCT05256056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111014186|NCT05256056|Sensory System Agents|sensory system agents|mesh-ancestor
111014187|NCT05256056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111014188|NCT05360511|Epoetin Alfa|epoetin alfa|mesh-list
111014189|NCT05360511|Hematinics|hematinics|mesh-ancestor
111014190|NCT02724111|Rocuronium|rocuronium|mesh-list
111014191|NCT02724111|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
111014192|NCT02724111|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
111014193|NCT02724111|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111014194|NCT02724111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111014195|NCT02724111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111014196|NCT02480751|Beraprost|beraprost|mesh-list
111014197|NCT02480751|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111014198|NCT02480751|Vasodilator Agents|vasodilator agents|mesh-ancestor
111014199|NCT04227314|Apremilast|apremilast|mesh-list
111014200|NCT04227314|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111014201|NCT04227314|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111014202|NCT04227314|Analgesics|analgesics|mesh-ancestor
111014203|NCT04227314|Sensory System Agents|sensory system agents|mesh-ancestor
111014204|NCT04227314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111014205|NCT04227314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111014206|NCT04227314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111014207|NCT04227314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111014208|NCT04227314|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
111014209|NCT04227314|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111014210|NCT04227314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111014211|NCT04227314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111014212|NCT04223648|Nivolumab|nivolumab|mesh-list
111014213|NCT04223648|Ipilimumab|ipilimumab|mesh-list
111014214|NCT04223648|Durvalumab|durvalumab|mesh-list
111014215|NCT04223648|Tremelimumab|tremelimumab|mesh-list
111014216|NCT04223648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111014217|NCT04223648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111014218|NCT04223648|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111014219|NCT04223648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111014220|NCT02814175|Adalimumab|adalimumab|mesh-list
111014221|NCT02814175|Methotrexate|methotrexate|mesh-list
111014222|NCT02814175|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111014223|NCT02814175|Abortifacient Agents|abortifacient agents|mesh-ancestor
111014224|NCT02814175|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111014225|NCT02814175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111014226|NCT02814175|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111014227|NCT02814175|Antimetabolites|antimetabolites|mesh-ancestor
111014228|NCT02814175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111014229|NCT02814175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111014230|NCT02814175|Dermatologic Agents|dermatologic agents|mesh-ancestor
111014231|NCT02814175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111014232|NCT02814175|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111014233|NCT02814175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111014234|NCT02814175|Immunologic Factors|immunologic factors|mesh-ancestor
111014235|NCT02814175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111014236|NCT02814175|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111014237|NCT02814175|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111014238|NCT02814175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111014240|NCT02475057|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
111014241|NCT02475057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111014242|NCT02475057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111014243|NCT02474667|Mitogens|mitogens|mesh-list
111014244|NCT02474667|Mitosis Modulators|mitosis modulators|mesh-ancestor
111014245|NCT02474667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111014246|NCT03096080|XL647|xl647|mesh-list
111014247|NCT03096080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111014248|NCT03096080|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111014249|NCT03096080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111014250|NCT03096080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111014251|NCT01335997|Niacin|niacin|mesh-list
111014252|NCT01335997|Niacinamide|niacinamide|mesh-list
111014253|NCT01335997|Nicotinic Acids|nicotinic acids|mesh-list
111014254|NCT01335997|Simvastatin|simvastatin|mesh-list
111014255|NCT01335997|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111014256|NCT01335997|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111014257|NCT01335997|Antimetabolites|antimetabolites|mesh-ancestor
111014258|NCT01335997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111014259|NCT01335997|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111014260|NCT01335997|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111014261|NCT01335997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111014262|NCT01335997|Vasodilator Agents|vasodilator agents|mesh-ancestor
111014263|NCT01335997|Vitamin B Complex|vitamin b complex|mesh-ancestor
111014264|NCT01335997|Vitamins|vitamins|mesh-ancestor
111014265|NCT01335997|Micronutrients|micronutrients|mesh-ancestor
111014266|NCT01335997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111014267|NCT02048215|Ephedrine|ephedrine|mesh-list
111014268|NCT02048215|Caffeine|caffeine|mesh-list
111014269|NCT02048215|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111014270|NCT02048215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111014271|NCT02048215|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111014272|NCT02048215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111014273|NCT02048215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111014274|NCT02048215|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
111014275|NCT02048215|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111014276|NCT02048215|Purinergic Agents|purinergic agents|mesh-ancestor
111014277|NCT02048215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111014278|NCT02048215|Sympathomimetics|sympathomimetics|mesh-ancestor
111014279|NCT02048215|Autonomic Agents|autonomic agents|mesh-ancestor
111014280|NCT02048215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111014281|NCT02048215|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111014282|NCT02048215|Adrenergic Agents|adrenergic agents|mesh-ancestor
111014283|NCT04849832|Fesoterodine|fesoterodine|mesh-list
111014284|NCT04849832|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111014285|NCT04849832|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111014286|NCT04849832|Cholinergic Agents|cholinergic agents|mesh-ancestor
111014287|NCT04849832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111014288|NCT04849832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111014289|NCT04849832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110731276|NCT05851768|Bupivacaine|bupivacaine|mesh-list
111014290|NCT04849832|Urological Agents|urological agents|mesh-ancestor
111014291|NCT02048293|Remifentanil|remifentanil|mesh-list
111014292|NCT02048293|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111014293|NCT02048293|Narcotics|narcotics|mesh-ancestor
111014294|NCT02048293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111014295|NCT02048293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111014296|NCT02048293|Analgesics|analgesics|mesh-ancestor
111014297|NCT02048293|Sensory System Agents|sensory system agents|mesh-ancestor
111014298|NCT02048293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111014299|NCT02050009|Metformin|metformin|mesh-list
111014300|NCT02050009|Paclitaxel|paclitaxel|mesh-list
111014301|NCT02050009|Carboplatin|carboplatin|mesh-list
111014302|NCT02050009|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111014303|NCT02050009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111014304|NCT02050009|Tubulin Modulators|tubulin modulators|mesh-ancestor
111014305|NCT02050009|Antimitotic Agents|antimitotic agents|mesh-ancestor
111014306|NCT02050009|Mitosis Modulators|mitosis modulators|mesh-ancestor
111014307|NCT02050009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111014308|NCT02050009|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111014309|NCT02050009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111014310|NCT04495088|Leucovorin|leucovorin|mesh-list
111014311|NCT04495088|Folic Acid|folic acid|mesh-list
111014312|NCT04495088|Capecitabine|capecitabine|mesh-list
111014313|NCT04495088|Fluorouracil|fluorouracil|mesh-list
111014315|NCT04495088|Levoleucovorin|levoleucovorin|mesh-list
111014316|NCT04495088|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111014317|NCT04495088|Antimetabolites|antimetabolites|mesh-ancestor
111014318|NCT04495088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111014319|NCT04495088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111014320|NCT04495088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111014321|NCT04495088|Immunologic Factors|immunologic factors|mesh-ancestor
111014322|NCT04495088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111014323|NCT04495088|Antidotes|antidotes|mesh-ancestor
111014324|NCT04495088|Protective Agents|protective agents|mesh-ancestor
111014325|NCT04495088|Vitamin B Complex|vitamin b complex|mesh-ancestor
111014326|NCT04495088|Vitamins|vitamins|mesh-ancestor
111014327|NCT04495088|Micronutrients|micronutrients|mesh-ancestor
111014328|NCT04495088|Hematinics|hematinics|mesh-ancestor
111014329|NCT04717154|Nivolumab|nivolumab|mesh-list
111014330|NCT04717154|Ipilimumab|ipilimumab|mesh-list
111014331|NCT04717154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111014332|NCT04717154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111014333|NCT04717154|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111014334|NCT04717154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111014335|NCT02474511|Anesthetics|anesthetics|mesh-list
111014336|NCT02474511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111014337|NCT02474511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111014338|NCT03108963|Metformin|metformin|mesh-list
111014339|NCT03108963|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111014340|NCT03108963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111014341|NCT04697654|Hydroxychloroquine|hydroxychloroquine|mesh-list
111014342|NCT04697654|Antimalarials|antimalarials|mesh-ancestor
111014343|NCT04697654|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111014344|NCT04697654|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111014345|NCT04697654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111014346|NCT04697654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111014347|NCT04697654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111014348|NCT04697654|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111014349|NCT02474433|Misoprostol|misoprostol|mesh-list
111014350|NCT02474433|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111014351|NCT02474433|Abortifacient Agents|abortifacient agents|mesh-ancestor
111014352|NCT02474433|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111014353|NCT02474433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111014354|NCT02474433|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111014355|NCT02474433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111014356|NCT02474433|Oxytocics|oxytocics|mesh-ancestor
111014357|NCT04812002|Bevacizumab|bevacizumab|mesh-list
111014358|NCT04812002|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
111014359|NCT04812002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111014360|NCT04812002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111014361|NCT04812002|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111014362|NCT04812002|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111014363|NCT04812002|Growth Substances|growth substances|mesh-ancestor
111014364|NCT04812002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111014365|NCT04812002|Growth Inhibitors|growth inhibitors|mesh-ancestor
111014366|NCT04812002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111014367|NCT03424460|Hemostatics|hemostatics|mesh-list
111014369|NCT05712837|Salicylic Acid|salicylic acid|mesh-list
111014370|NCT05712837|Salicylates|salicylates|mesh-list
111014371|NCT05712837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111014372|NCT05712837|Antifungal Agents|antifungal agents|mesh-ancestor
111014373|NCT05712837|Keratolytic Agents|keratolytic agents|mesh-ancestor
110622217|NCT04048226|Ketamine|ketamine|mesh-list
111014374|NCT05712837|Dermatologic Agents|dermatologic agents|mesh-ancestor
111014375|NCT05712837|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111014376|NCT05712837|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111014377|NCT05712837|Analgesics|analgesics|mesh-ancestor
111014378|NCT05712837|Sensory System Agents|sensory system agents|mesh-ancestor
111014379|NCT05712837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111014380|NCT05712837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111014381|NCT05712837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111014382|NCT05712837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111014383|NCT05712837|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111014384|NCT05712837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111014385|NCT05712837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111014386|NCT02472249|Norepinephrine|norepinephrine|mesh-list
111014387|NCT02472249|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111014388|NCT02472249|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111014389|NCT02472249|Adrenergic Agents|adrenergic agents|mesh-ancestor
110479331|NCT03373383|Padsevonil|padsevonil|mesh-list
111014390|NCT02472249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111014391|NCT02472249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111014392|NCT02472249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111014394|NCT02472249|Autonomic Agents|autonomic agents|mesh-ancestor
111014395|NCT02472249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111014396|NCT02472249|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111014397|NCT02313194|Buspirone|buspirone|mesh-list
111014398|NCT02313194|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111014399|NCT02313194|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111014400|NCT02313194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111014401|NCT02313194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111014402|NCT02313194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111014403|NCT02313194|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111014404|NCT02313194|Serotonin Agents|serotonin agents|mesh-ancestor
111014405|NCT02313194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111014406|NCT02313194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111014407|NCT04435652|Paclitaxel|paclitaxel|mesh-list
111014408|NCT04435652|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111014409|NCT04435652|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111014410|NCT04435652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111014411|NCT04435652|Tubulin Modulators|tubulin modulators|mesh-ancestor
111014412|NCT04435652|Antimitotic Agents|antimitotic agents|mesh-ancestor
111014413|NCT04435652|Mitosis Modulators|mitosis modulators|mesh-ancestor
111014414|NCT04435652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111014415|NCT02473887|Ondansetron|ondansetron|mesh-list
111014416|NCT02473887|Antiemetics|antiemetics|mesh-ancestor
111014417|NCT02473887|Autonomic Agents|autonomic agents|mesh-ancestor
111014418|NCT02473887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111014419|NCT02473887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111014420|NCT02473887|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111014421|NCT02473887|Antipruritics|antipruritics|mesh-ancestor
111014422|NCT02473887|Dermatologic Agents|dermatologic agents|mesh-ancestor
111014423|NCT02473887|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111014424|NCT02473887|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111014425|NCT02473887|Serotonin Agents|serotonin agents|mesh-ancestor
111014426|NCT02473887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111014427|NCT02473887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111014428|NCT02478021|Hydrocortisone|hydrocortisone|mesh-list
111014429|NCT02478021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111014430|NCT00071552|Fluticasone|fluticasone|mesh-list
111014431|NCT00071552|Xhance|xhance|mesh-list
111014432|NCT00071552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111014433|NCT00071552|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111014434|NCT00071552|Autonomic Agents|autonomic agents|mesh-ancestor
111014435|NCT00071552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111014436|NCT00071552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111014437|NCT00071552|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111014438|NCT00071552|Respiratory System Agents|respiratory system agents|mesh-ancestor
111014439|NCT00071552|Dermatologic Agents|dermatologic agents|mesh-ancestor
111014440|NCT00071552|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111014441|NCT05164263|Empagliflozin|empagliflozin|mesh-list
111014442|NCT05164263|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111014443|NCT05164263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111014444|NCT05164263|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111014445|NCT05164263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111014446|NCT04767711|Prednisolone|prednisolone|mesh-list
111014447|NCT04767711|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111014448|NCT04767711|Glucocorticoids|glucocorticoids|mesh-ancestor
111014449|NCT04767711|Hormones|hormones|mesh-ancestor
111014450|NCT04767711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111014451|NCT04767711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111014452|NCT04767711|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111014453|NCT04767711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111014454|NCT02473809|Liraglutide|liraglutide|mesh-list
111014455|NCT02473809|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111014456|NCT02473809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111014457|NCT02473809|Incretins|incretins|mesh-ancestor
111014458|NCT02473809|Hormones|hormones|mesh-ancestor
111014459|NCT02473809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111014460|NCT03976934|Tamsulosin|tamsulosin|mesh-list
111014461|NCT03976934|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111014462|NCT03976934|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110479399|NCT00784654|Dopamine Agents|dopamine agents|mesh-ancestor
111014463|NCT03976934|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111014464|NCT03976934|Adrenergic Agents|adrenergic agents|mesh-ancestor
111014465|NCT03976934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111014466|NCT03976934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111014467|NCT03976934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111014468|NCT03976934|Urological Agents|urological agents|mesh-ancestor
111014469|NCT02416180|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
111014470|NCT02416180|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111014471|NCT02416180|Autonomic Agents|autonomic agents|mesh-ancestor
111014472|NCT02416180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111014473|NCT02416180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111014474|NCT02416180|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111014475|NCT02416180|Respiratory System Agents|respiratory system agents|mesh-ancestor
111014476|NCT02416180|Glucocorticoids|glucocorticoids|mesh-ancestor
111014477|NCT02416180|Hormones|hormones|mesh-ancestor
111014478|NCT02416180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111014479|NCT02416180|Sympathomimetics|sympathomimetics|mesh-ancestor
111014480|NCT02473575|Caffeine|caffeine|mesh-list
111014481|NCT02473575|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111014482|NCT02473575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111014483|NCT02473575|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111014484|NCT02473575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111014485|NCT02473575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111014486|NCT02473575|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
111014487|NCT02473575|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111014488|NCT02473575|Purinergic Agents|purinergic agents|mesh-ancestor
111014489|NCT02473575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111014490|NCT03770546|Betamethasone|betamethasone|mesh-list
111014491|NCT03770546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111014492|NCT03770546|Glucocorticoids|glucocorticoids|mesh-ancestor
111014493|NCT03770546|Hormones|hormones|mesh-ancestor
111014494|NCT03770546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111014495|NCT03770546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111014496|NCT03770546|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111014497|NCT03770546|Respiratory System Agents|respiratory system agents|mesh-ancestor
111014498|NCT05341323|Ketamine|ketamine|mesh-list
111014499|NCT05341323|Bupivacaine|bupivacaine|mesh-list
111014500|NCT05341323|Anesthetics, Local|anesthetics, local|mesh-ancestor
111014501|NCT05341323|Anesthetics|anesthetics|mesh-ancestor
111014502|NCT05341323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111014503|NCT05341323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111014504|NCT05341323|Sensory System Agents|sensory system agents|mesh-ancestor
111014505|NCT05341323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111014506|NCT05341323|Analgesics|analgesics|mesh-ancestor
111014507|NCT05341323|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111014508|NCT05341323|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111014509|NCT05341323|Anesthetics, General|anesthetics, general|mesh-ancestor
111014510|NCT05341323|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111014511|NCT05341323|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111014512|NCT05341323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111014513|NCT05341323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111014514|NCT04622865|Quercetin|quercetin|mesh-list
111014515|NCT04622865|Antioxidants|antioxidants|mesh-ancestor
111014516|NCT04622865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111014517|NCT04622865|Protective Agents|protective agents|mesh-ancestor
111014518|NCT04622865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111014519|NCT02473185|Methylphenidate|methylphenidate|mesh-list
111014520|NCT02473185|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111014521|NCT02473185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111014522|NCT02473185|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111014523|NCT02473185|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111014524|NCT02473185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111014525|NCT02473185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111014526|NCT02473185|Dopamine Agents|dopamine agents|mesh-ancestor
111014527|NCT02473185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111014529|NCT02445586|Trastuzumab|trastuzumab|mesh-list
111014530|NCT02445586|Pertuzumab|pertuzumab|mesh-list
111014531|NCT02445586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111014532|NCT02445586|Tubulin Modulators|tubulin modulators|mesh-ancestor
111014533|NCT02445586|Antimitotic Agents|antimitotic agents|mesh-ancestor
111014534|NCT02445586|Mitosis Modulators|mitosis modulators|mesh-ancestor
110823040|NCT02849990|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111014535|NCT02445586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111014536|NCT02445586|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111014537|NCT02471547|Mitomycins|mitomycins|mesh-list
111014538|NCT02471547|Mitomycin|mitomycin|mesh-list
111014539|NCT02471547|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111014540|NCT02471547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111014541|NCT02471547|Alkylating Agents|alkylating agents|mesh-ancestor
111014542|NCT02471547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111014543|NCT02471547|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111014544|NCT02471547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111014545|NCT02477631|Deferiprone|deferiprone|mesh-list
111014546|NCT02477631|Iron Chelating Agents|iron chelating agents|mesh-ancestor
111014547|NCT02477631|Chelating Agents|chelating agents|mesh-ancestor
111014548|NCT02477631|Sequestering Agents|sequestering agents|mesh-ancestor
111014549|NCT02477631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111014550|NCT01674062|Trastuzumab|trastuzumab|mesh-list
111014551|NCT01674062|Pertuzumab|pertuzumab|mesh-list
111014552|NCT01674062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111014553|NCT01674062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111014554|NCT02472873|Ethanol|ethanol|mesh-list
111014555|NCT02472873|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111014556|NCT02472873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111014557|NCT02472873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111014558|NCT02472873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111014559|NCT02472886|Sofosbuvir|sofosbuvir|mesh-list
111014560|NCT02472886|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
111014561|NCT02472886|Ledipasvir|ledipasvir|mesh-list
111014562|NCT02472886|Antiviral Agents|antiviral agents|mesh-ancestor
111014563|NCT02472886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111014564|NCT04570839|Nivolumab|nivolumab|mesh-list
111014565|NCT04570839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111014566|NCT04570839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111014567|NCT04570839|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111014568|NCT04570839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111014569|NCT05283356|Ticagrelor|ticagrelor|mesh-list
111014570|NCT05283356|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110731567|NCT04493320|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110731568|NCT04493320|Dopamine Agents|dopamine agents|mesh-ancestor
110731569|NCT04493320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110731570|NCT04493320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110731571|NCT04493320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110731572|NCT04493320|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
110731573|NCT04493320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110731574|NCT04493320|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110731575|NCT04493320|Immunologic Factors|immunologic factors|mesh-ancestor
110731576|NCT04493320|Dopamine Agonists|dopamine agonists|mesh-ancestor
110731577|NCT04417166|Pembrolizumab|pembrolizumab|mesh-list
110731578|NCT04417166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110731579|NCT04417166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110731580|NCT04417166|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110731581|NCT04417166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110731599|NCT04189744|Metronidazole|metronidazole|mesh-list
110731600|NCT04189744|Pyrimethamine|pyrimethamine|mesh-list
110731601|NCT04189744|Piperaquine|piperaquine|mesh-list
111014571|NCT05283356|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111014572|NCT05283356|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111014573|NCT05283356|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111014575|NCT05283356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111014576|NCT05283356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111014577|NCT05283356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111014578|NCT02472652|Aripiprazole|aripiprazole|mesh-list
111014579|NCT02472652|Antidepressive Agents|antidepressive agents|mesh-ancestor
111014580|NCT02472652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111014581|NCT02472652|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111014582|NCT02472652|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111014583|NCT02472652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111014584|NCT02472652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111014585|NCT02472652|Dopamine Agonists|dopamine agonists|mesh-ancestor
111014586|NCT02472652|Dopamine Agents|dopamine agents|mesh-ancestor
111014587|NCT02472652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111014588|NCT02472652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111014589|NCT02472652|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111014590|NCT02472652|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111014591|NCT02472652|Serotonin Agents|serotonin agents|mesh-ancestor
111014592|NCT02472652|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111014593|NCT02472652|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111014594|NCT02472652|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111014595|NCT02472652|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111014596|NCT05243186|Methylphenidate|methylphenidate|mesh-list
111014597|NCT05243186|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111014598|NCT05243186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111014599|NCT05243186|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111014600|NCT05243186|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111014601|NCT05243186|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111014602|NCT05243186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111014603|NCT05243186|Dopamine Agents|dopamine agents|mesh-ancestor
111014604|NCT05243186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111014605|NCT02808182|Niacin|niacin|mesh-list
111014606|NCT02808182|Nicotinic Acids|nicotinic acids|mesh-list
111014607|NCT02808182|Niacinamide|niacinamide|mesh-list
111014608|NCT02808182|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111014609|NCT02808182|Antimetabolites|antimetabolites|mesh-ancestor
111014610|NCT02808182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111014611|NCT02808182|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111014612|NCT02808182|Vasodilator Agents|vasodilator agents|mesh-ancestor
111014613|NCT02808182|Vitamin B Complex|vitamin b complex|mesh-ancestor
111014614|NCT02808182|Vitamins|vitamins|mesh-ancestor
111014615|NCT02808182|Micronutrients|micronutrients|mesh-ancestor
111014616|NCT02808182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111014617|NCT04695704|Montelukast|montelukast|mesh-list
111014618|NCT04695704|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
111014619|NCT04695704|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111014620|NCT04695704|Respiratory System Agents|respiratory system agents|mesh-ancestor
111014621|NCT04695704|Hormone Antagonists|hormone antagonists|mesh-ancestor
111014622|NCT04695704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111014623|NCT04695704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111014624|NCT04695704|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
111014625|NCT04695704|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111014626|NCT04695704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111014627|NCT02051569|Tryptophan|tryptophan|mesh-list
111014628|NCT02051569|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111014629|NCT02051569|Antidepressive Agents|antidepressive agents|mesh-ancestor
111014630|NCT02051569|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111014631|NCT02591420|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
111014632|NCT02591420|Antiviral Agents|antiviral agents|mesh-ancestor
111014633|NCT02591420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111014634|NCT05217758|Mifepristone|mifepristone|mesh-list
111014635|NCT05217758|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
111014636|NCT05217758|Abortifacient Agents|abortifacient agents|mesh-ancestor
111014637|NCT05217758|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111014638|NCT05217758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111014639|NCT05217758|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111014640|NCT05217758|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111014641|NCT05217758|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111014642|NCT05217758|Contraceptive Agents|contraceptive agents|mesh-ancestor
111014643|NCT05217758|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
111014644|NCT05217758|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
111014646|NCT05217758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111014647|NCT05217758|Luteolytic Agents|luteolytic agents|mesh-ancestor
111014648|NCT05217758|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111014649|NCT05217758|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
111014650|NCT02051023|Fluorometholone|fluorometholone|mesh-list
111014651|NCT02051023|Lubricant Eye Drops|lubricant eye drops|mesh-list
111014652|NCT02051023|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111014653|NCT02051023|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111014654|NCT02051023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111014655|NCT02051023|Glucocorticoids|glucocorticoids|mesh-ancestor
111014656|NCT02051023|Hormones|hormones|mesh-ancestor
111014657|NCT02051023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111014658|NCT02051023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111014659|NCT02051023|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111014660|NCT02415556|Insulin|insulin|mesh-list
111014661|NCT02415556|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111014662|NCT02415556|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111014663|NCT02415556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111014664|NCT05192798|Paclitaxel|paclitaxel|mesh-list
111014665|NCT05192798|Bevacizumab|bevacizumab|mesh-list
111014666|NCT05192798|Apatinib|apatinib|mesh-list
111014667|NCT05192798|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111014668|NCT05192798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111014669|NCT05192798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111014670|NCT05192798|Tubulin Modulators|tubulin modulators|mesh-ancestor
111014671|NCT05192798|Antimitotic Agents|antimitotic agents|mesh-ancestor
110622262|NCT00571064|Donepezil|donepezil|mesh-list
111014672|NCT05192798|Mitosis Modulators|mitosis modulators|mesh-ancestor
111014673|NCT05192798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111014674|NCT05192798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111014675|NCT05192798|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111014676|NCT05192798|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111014677|NCT05192798|Growth Substances|growth substances|mesh-ancestor
111014678|NCT05192798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111014679|NCT05192798|Growth Inhibitors|growth inhibitors|mesh-ancestor
111014680|NCT05192798|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111014681|NCT05192798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111014682|NCT02048683|Sevoflurane|sevoflurane|mesh-list
111014683|NCT02048683|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111014684|NCT02048683|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111014685|NCT02048683|Anesthetics, General|anesthetics, general|mesh-ancestor
111014686|NCT02048683|Anesthetics|anesthetics|mesh-ancestor
111014687|NCT02048683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111014688|NCT02048683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111014689|NCT03108807|Fibrin fragment D|fibrin fragment d|mesh-list
111014690|NCT03108807|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111014691|NCT03108807|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111014692|NCT03108807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111014693|NCT03108807|Hemostatics|hemostatics|mesh-ancestor
111014694|NCT03108807|Coagulants|coagulants|mesh-ancestor
111014695|NCT02048761|Metformin|metformin|mesh-list
111014696|NCT02048761|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111014697|NCT02048761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111014698|NCT03108729|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
111014699|NCT03108729|Anticonvulsants|anticonvulsants|mesh-ancestor
111014700|NCT03108729|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111014701|NCT03108729|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111014702|NCT03108729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111014703|NCT03108729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111014704|NCT02048917|Bupropion|bupropion|mesh-list
111014705|NCT02048917|Varenicline|varenicline|mesh-list
111014706|NCT02048917|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111014707|NCT02048917|Antidepressive Agents|antidepressive agents|mesh-ancestor
111014708|NCT02048917|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111014709|NCT02048917|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111014710|NCT02048917|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111014711|NCT02048917|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111014712|NCT02048917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111014713|NCT02048917|Dopamine Agents|dopamine agents|mesh-ancestor
111014714|NCT02048917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111014715|NCT02048917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111014716|NCT02048917|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111014717|NCT02048917|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111014718|NCT02048917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111014719|NCT02048917|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111014720|NCT02048917|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111014721|NCT02048917|Cholinergic Agents|cholinergic agents|mesh-ancestor
111014722|NCT02472717|Liraglutide|liraglutide|mesh-list
111014723|NCT02472717|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111014724|NCT02472717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111014725|NCT02472717|Incretins|incretins|mesh-ancestor
111014726|NCT02472717|Hormones|hormones|mesh-ancestor
111014727|NCT02472717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111014728|NCT02049073|Methylprednisolone|methylprednisolone|mesh-list
111014729|NCT02049073|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111014730|NCT02049073|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111014731|NCT02049073|Prednisolone|prednisolone|mesh-list
110622278|NCT00775034|Hemostatics|hemostatics|mesh-ancestor
111014732|NCT02049073|Prednisolone acetate|prednisolone acetate|mesh-list
111014733|NCT02049073|Zonisamide|zonisamide|mesh-list
111014734|NCT02049073|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111014735|NCT02049073|Prednisolone phosphate|prednisolone phosphate|mesh-list
111014736|NCT02049073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111014737|NCT02049073|Antiemetics|antiemetics|mesh-ancestor
111014738|NCT02049073|Autonomic Agents|autonomic agents|mesh-ancestor
111014739|NCT02049073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110025449|NCT00365898|Narcotics|narcotics|mesh-ancestor
111014740|NCT02049073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111014742|NCT02049073|Glucocorticoids|glucocorticoids|mesh-ancestor
111014743|NCT02049073|Hormones|hormones|mesh-ancestor
111014744|NCT02049073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111014745|NCT02049073|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111014746|NCT02049073|Protective Agents|protective agents|mesh-ancestor
111014747|NCT02049073|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111014748|NCT02049073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111014749|NCT02049073|Anticonvulsants|anticonvulsants|mesh-ancestor
111014750|NCT02049073|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111014751|NCT02049073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111014752|NCT02049073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111014753|NCT02049073|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111014754|NCT04518345|Azacitidine|azacitidine|mesh-list
111014755|NCT04518345|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111014756|NCT04518345|Antimetabolites|antimetabolites|mesh-ancestor
111014757|NCT04518345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111014758|NCT04518345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111014759|NCT04518345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111014760|NCT02260063|Epinastine|epinastine|mesh-list
111014761|NCT02260063|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111014762|NCT02260063|Histamine Antagonists|histamine antagonists|mesh-ancestor
111014763|NCT02260063|Histamine Agents|histamine agents|mesh-ancestor
111014764|NCT02260063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111014765|NCT02260063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111014766|NCT02260063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111014767|NCT04398914|Paclitaxel|paclitaxel|mesh-list
111014768|NCT04398914|Trastuzumab|trastuzumab|mesh-list
111014769|NCT04398914|Pertuzumab|pertuzumab|mesh-list
111014770|NCT04398914|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111014771|NCT04398914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111014772|NCT04398914|Tubulin Modulators|tubulin modulators|mesh-ancestor
111014773|NCT04398914|Antimitotic Agents|antimitotic agents|mesh-ancestor
111014774|NCT04398914|Mitosis Modulators|mitosis modulators|mesh-ancestor
111014775|NCT04398914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111014776|NCT04398914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111014777|NCT03561649|Adalimumab|adalimumab|mesh-list
111014778|NCT03561649|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111014779|NCT03561649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111014780|NCT03561649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111014781|NCT02807623|Ibuprofen|ibuprofen|mesh-list
111014782|NCT02807623|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111014783|NCT02807623|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111014784|NCT02807623|Analgesics|analgesics|mesh-ancestor
111014785|NCT02807623|Sensory System Agents|sensory system agents|mesh-ancestor
111014786|NCT02807623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111014787|NCT02807623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110731801|NCT03663205|Tislelizumab|tislelizumab|mesh-list
111014788|NCT02807623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111014789|NCT02807623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111014790|NCT02807623|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111014791|NCT02807623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111014792|NCT02807623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111014793|NCT05137964|Vitamin D|vitamin d|mesh-list
111014794|NCT05137964|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
111014795|NCT05137964|Vitamins|vitamins|mesh-ancestor
111014796|NCT05137964|Micronutrients|micronutrients|mesh-ancestor
111014797|NCT05137964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111014798|NCT05137964|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111014799|NCT04374578|Dulaglutide|dulaglutide|mesh-list
111014800|NCT04374578|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111014801|NCT04374578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111014802|NCT02470923|Nicotine|nicotine|mesh-list
111014803|NCT02470923|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111014804|NCT02470923|Autonomic Agents|autonomic agents|mesh-ancestor
111014805|NCT02470923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111014806|NCT02470923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111014807|NCT02470923|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111014808|NCT02470923|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111014809|NCT02470923|Cholinergic Agents|cholinergic agents|mesh-ancestor
111014810|NCT02470923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110479775|NCT03272217|Atezolizumab|atezolizumab|mesh-list
111014811|NCT02470923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111014813|NCT02049229|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111014814|NCT02049229|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111014815|NCT02049229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111014816|NCT02049229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111014817|NCT02049229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111014818|NCT02049229|Immunologic Factors|immunologic factors|mesh-ancestor
111014819|NCT02049229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111014820|NCT02049229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111014821|NCT02805907|Calcifediol|calcifediol|mesh-list
111014822|NCT02805907|Vitamins|vitamins|mesh-ancestor
111014823|NCT02805907|Micronutrients|micronutrients|mesh-ancestor
111014824|NCT02805907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111014825|NCT02805907|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111014826|NCT02477397|Fluticasone|fluticasone|mesh-list
111014827|NCT02477397|Xhance|xhance|mesh-list
111014828|NCT02477397|Budesonide|budesonide|mesh-list
111014829|NCT02477397|Formoterol Fumarate|formoterol fumarate|mesh-list
111014830|NCT02477397|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
111014831|NCT02477397|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
111014832|NCT02477397|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
111014833|NCT02477397|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111014834|NCT02477397|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111014835|NCT02477397|Autonomic Agents|autonomic agents|mesh-ancestor
111014836|NCT02477397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111014837|NCT02477397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111014838|NCT02477397|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111014839|NCT02477397|Respiratory System Agents|respiratory system agents|mesh-ancestor
111014840|NCT02477397|Dermatologic Agents|dermatologic agents|mesh-ancestor
111014841|NCT02477397|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111014842|NCT02477397|Glucocorticoids|glucocorticoids|mesh-ancestor
111014843|NCT02477397|Hormones|hormones|mesh-ancestor
111014844|NCT02477397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111014845|NCT02477397|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111014846|NCT02477397|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111014847|NCT02477397|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111014848|NCT02477397|Adrenergic Agents|adrenergic agents|mesh-ancestor
111014849|NCT02477397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111014850|NCT02477397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111014851|NCT02477397|Sympathomimetics|sympathomimetics|mesh-ancestor
110622292|NCT02557490|Oxaliplatin|oxaliplatin|mesh-list
111014852|NCT02051413|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
111014853|NCT02051413|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111014854|NCT02051413|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111014855|NCT02051413|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111014856|NCT02051413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111014857|NCT02051413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111014858|NCT02051413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111014859|NCT02051413|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111014860|NCT02051413|Antidepressive Agents|antidepressive agents|mesh-ancestor
111014861|NCT02051413|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111014862|NCT02470767|Anticoagulants|anticoagulants|mesh-list
111014863|NCT02049541|Rituximab|rituximab|mesh-list
111014864|NCT02049541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111014865|NCT02049541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111014866|NCT02049541|Immunologic Factors|immunologic factors|mesh-ancestor
111014867|NCT02049541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111014868|NCT02049541|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111014870|NCT02470611|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111014871|NCT02470611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111014872|NCT05305898|Metformin|metformin|mesh-list
111014873|NCT05305898|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111014874|NCT05305898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111014875|NCT05580861|Sulfasalazine|sulfasalazine|mesh-list
111014876|NCT05580861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111014877|NCT05580861|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111014878|NCT05580861|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111014879|NCT05580861|Analgesics|analgesics|mesh-ancestor
111014880|NCT05580861|Sensory System Agents|sensory system agents|mesh-ancestor
111014881|NCT05580861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111014882|NCT05580861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111014883|NCT05580861|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111014884|NCT05580861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111014885|NCT05580861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111014886|NCT02469831|Rocuronium|rocuronium|mesh-list
111014887|NCT02469831|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
111014888|NCT02469831|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
111014889|NCT02469831|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111014890|NCT02469831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111014891|NCT02469831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111014892|NCT02995005|Tenofovir|tenofovir|mesh-list
111014893|NCT02995005|Antiviral Agents|antiviral agents|mesh-ancestor
111014894|NCT02995005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111014895|NCT02995005|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111014896|NCT02995005|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111014897|NCT02995005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111014898|NCT02995005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111014899|NCT02995005|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111014900|NCT02995005|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111014901|NCT03561415|Posaconazole|posaconazole|mesh-list
111014902|NCT03561415|Antifungal Agents|antifungal agents|mesh-ancestor
111014903|NCT03561415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111014904|NCT03561415|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
111014905|NCT03561415|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111014906|NCT03561415|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111014907|NCT03561415|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111014908|NCT03561415|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111014909|NCT03561415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111014910|NCT03561415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111014911|NCT03561415|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111014912|NCT03561415|Hormone Antagonists|hormone antagonists|mesh-ancestor
111014913|NCT03561415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111014914|NCT03561415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111014915|NCT02477007|Acetaminophen|acetaminophen|mesh-list
111014916|NCT02477007|Ibuprofen|ibuprofen|mesh-list
111014917|NCT02477007|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111014918|NCT02477007|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111014919|NCT02477007|Analgesics|analgesics|mesh-ancestor
111014920|NCT02477007|Sensory System Agents|sensory system agents|mesh-ancestor
111014921|NCT02477007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111014922|NCT02477007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111014923|NCT02477007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111014924|NCT02477007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111014925|NCT02477007|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111014926|NCT02477007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111014927|NCT02477007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111014928|NCT02477007|Antipyretics|antipyretics|mesh-ancestor
111014929|NCT02052973|Propolis|propolis|mesh-list
111014930|NCT02052973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111014931|NCT04347434|Atorvastatin|atorvastatin|mesh-list
111014932|NCT04347434|Ezetimibe|ezetimibe|mesh-list
111014933|NCT04347434|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111014934|NCT04347434|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111014935|NCT04347434|Antimetabolites|antimetabolites|mesh-ancestor
111014936|NCT04347434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110731949|NCT03056755|Leuprolide|leuprolide|mesh-list
111014937|NCT04347434|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111014938|NCT04347434|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111014939|NCT04347434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111014940|NCT02053519|Vitamin D|vitamin d|mesh-list
111014941|NCT02053519|Cholecalciferol|cholecalciferol|mesh-list
111014942|NCT02053519|Vitamins|vitamins|mesh-ancestor
111014943|NCT02053519|Micronutrients|micronutrients|mesh-ancestor
111014944|NCT02053519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111014945|NCT02053519|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111014946|NCT02053519|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111014947|NCT02053597|Paclitaxel|paclitaxel|mesh-list
111014948|NCT02053597|Doxorubicin|doxorubicin|mesh-list
111014949|NCT02053597|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111014950|NCT02053597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111014951|NCT02053597|Tubulin Modulators|tubulin modulators|mesh-ancestor
111014952|NCT02053597|Antimitotic Agents|antimitotic agents|mesh-ancestor
111014953|NCT02053597|Mitosis Modulators|mitosis modulators|mesh-ancestor
111014954|NCT02053597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111014955|NCT02053597|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111014956|NCT02053597|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111014957|NCT02053597|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111014958|NCT02053597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111014959|NCT02801617|Latanoprost|latanoprost|mesh-list
111014960|NCT02801617|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
111014961|NCT02801617|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111014962|NCT02056249|Norepinephrine|norepinephrine|mesh-list
111014963|NCT02056249|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111014964|NCT02056249|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111014965|NCT02056249|Adrenergic Agents|adrenergic agents|mesh-ancestor
111014966|NCT02056249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111014967|NCT02056249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111014968|NCT02056249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111014969|NCT02056249|Sympathomimetics|sympathomimetics|mesh-ancestor
111014970|NCT02056249|Autonomic Agents|autonomic agents|mesh-ancestor
111014971|NCT02056249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111014972|NCT02056249|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111014973|NCT04140968|Progesterone|progesterone|mesh-list
111014974|NCT04140968|Progestins|progestins|mesh-ancestor
111014975|NCT04140968|Hormones|hormones|mesh-ancestor
111014976|NCT04140968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111014977|NCT04140968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111014978|NCT04383938|Pembrolizumab|pembrolizumab|mesh-list
111014979|NCT04383938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111014980|NCT04383938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111014981|NCT04383938|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111014982|NCT04383938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111014983|NCT01334515|Isotretinoin|isotretinoin|mesh-list
111014984|NCT01334515|Sargramostim|sargramostim|mesh-list
111014985|NCT01334515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111014986|NCT01334515|Immunologic Factors|immunologic factors|mesh-ancestor
111014987|NCT01334515|Dermatologic Agents|dermatologic agents|mesh-ancestor
111014988|NCT02415400|Aspirin|aspirin|mesh-list
111014989|NCT02415400|Vitamin K|vitamin k|mesh-list
111014990|NCT02415400|Apixaban|apixaban|mesh-list
111014991|NCT02415400|Vitamins|vitamins|mesh-ancestor
111014992|NCT02415400|Micronutrients|micronutrients|mesh-ancestor
111014993|NCT02415400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111014994|NCT02415400|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111014995|NCT02415400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111014996|NCT02415400|Analgesics|analgesics|mesh-ancestor
111014997|NCT02415400|Sensory System Agents|sensory system agents|mesh-ancestor
111014998|NCT02415400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111014999|NCT02415400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111015000|NCT02415400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111015001|NCT02415400|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111015002|NCT02415400|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111015003|NCT02415400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111015004|NCT02415400|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111015005|NCT02415400|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111015006|NCT02415400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111015007|NCT02415400|Antipyretics|antipyretics|mesh-ancestor
111015008|NCT02415400|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111015009|NCT02415400|Antithrombins|antithrombins|mesh-ancestor
110732025|NCT02989597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111015010|NCT02415400|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111015011|NCT02415400|Protease Inhibitors|protease inhibitors|mesh-ancestor
111015012|NCT02415400|Anticoagulants|anticoagulants|mesh-ancestor
111015013|NCT02415400|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111015014|NCT02415400|Hemostatics|hemostatics|mesh-ancestor
111015015|NCT02415400|Coagulants|coagulants|mesh-ancestor
111015016|NCT02053675|Vasopressins|vasopressins|mesh-list
111015017|NCT02053675|Arginine Vasopressin|arginine vasopressin|mesh-list
111015018|NCT02053675|Hemostatics|hemostatics|mesh-ancestor
111015019|NCT02053675|Coagulants|coagulants|mesh-ancestor
111015020|NCT02053675|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111015021|NCT02053675|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
111015022|NCT02053675|Natriuretic Agents|natriuretic agents|mesh-ancestor
111015023|NCT02053675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111015024|NCT02037997|Docetaxel|docetaxel|mesh-list
111015025|NCT02037997|Pemetrexed|pemetrexed|mesh-list
111015026|NCT02037997|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111015027|NCT02037997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111015028|NCT02037997|Tubulin Modulators|tubulin modulators|mesh-ancestor
111015029|NCT02037997|Antimitotic Agents|antimitotic agents|mesh-ancestor
111015030|NCT02037997|Mitosis Modulators|mitosis modulators|mesh-ancestor
111015031|NCT02037997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111015032|NCT02037997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111015033|NCT02037997|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111015034|NCT02037997|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111015035|NCT02037997|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111015037|NCT02056405|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111015038|NCT02056405|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111015039|NCT02056405|Serotonin Agents|serotonin agents|mesh-ancestor
111015040|NCT02056405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111015041|NCT02056405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111015042|NCT02056405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111015043|NCT02056717|Dexamethasone|dexamethasone|mesh-list
111015044|NCT02056717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111015045|NCT02056717|Antiemetics|antiemetics|mesh-ancestor
111015046|NCT02056717|Autonomic Agents|autonomic agents|mesh-ancestor
111015047|NCT02056717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111015048|NCT02056717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111015049|NCT02056717|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111015050|NCT02056717|Glucocorticoids|glucocorticoids|mesh-ancestor
111015051|NCT02056717|Hormones|hormones|mesh-ancestor
111015052|NCT02056717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111015053|NCT02056717|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111015054|NCT02056717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111015055|NCT04194801|Fisogatinib|fisogatinib|mesh-list
111015056|NCT04194801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111015057|NCT02802865|Letrozole|letrozole|mesh-list
111015058|NCT02802865|Clomiphene|clomiphene|mesh-list
111015059|NCT02802865|Enclomiphene|enclomiphene|mesh-list
111015060|NCT02802865|Zuclomiphene|zuclomiphene|mesh-list
111015061|NCT02802865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111015062|NCT02802865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111015063|NCT02802865|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111015064|NCT02802865|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111015065|NCT02802865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111015066|NCT02802865|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111015067|NCT02802865|Hormone Antagonists|hormone antagonists|mesh-ancestor
111015068|NCT02802865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111015069|NCT02802865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111015070|NCT02802865|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111015071|NCT02802865|Fertility Agents|fertility agents|mesh-ancestor
111015072|NCT02802865|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111015073|NCT02802865|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111015074|NCT02802865|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111015075|NCT02414932|Midazolam|midazolam|mesh-list
111015076|NCT02414932|Ketamine|ketamine|mesh-list
111015077|NCT02414932|Analgesics|analgesics|mesh-ancestor
111015078|NCT02414932|Sensory System Agents|sensory system agents|mesh-ancestor
111015079|NCT02414932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111015080|NCT02414932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111015081|NCT02414932|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111015082|NCT02414932|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111015083|NCT02414932|Anesthetics, General|anesthetics, general|mesh-ancestor
111015084|NCT02414932|Anesthetics|anesthetics|mesh-ancestor
111015085|NCT02414932|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111015086|NCT02414932|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110732098|NCT02446600|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111015087|NCT02414932|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111015088|NCT02414932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111015089|NCT02414932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111015090|NCT02414932|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111015091|NCT02414932|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111015092|NCT02414932|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111015093|NCT02414932|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111015094|NCT02414932|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111015095|NCT02414932|GABA Modulators|gaba modulators|mesh-ancestor
111015096|NCT02414932|GABA Agents|gaba agents|mesh-ancestor
111015097|NCT02476929|Nitrous Oxide|nitrous oxide|mesh-list
111015098|NCT02476929|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111015099|NCT02476929|Anesthetics, General|anesthetics, general|mesh-ancestor
111015100|NCT02476929|Anesthetics|anesthetics|mesh-ancestor
111015101|NCT02476929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111015102|NCT02476929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111015103|NCT02476929|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111015104|NCT02476929|Analgesics|analgesics|mesh-ancestor
111015105|NCT02476929|Sensory System Agents|sensory system agents|mesh-ancestor
111015106|NCT02476929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111015107|NCT02054143|Sevoflurane|sevoflurane|mesh-list
111015108|NCT02054143|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111015109|NCT02054143|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111015110|NCT02054143|Anesthetics, General|anesthetics, general|mesh-ancestor
111015111|NCT02054143|Anesthetics|anesthetics|mesh-ancestor
111015112|NCT02054143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111015113|NCT02054143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111015115|NCT02058667|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111015116|NCT02058667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111015117|NCT02058667|Tubulin Modulators|tubulin modulators|mesh-ancestor
111015118|NCT02058667|Antimitotic Agents|antimitotic agents|mesh-ancestor
111015119|NCT02058667|Mitosis Modulators|mitosis modulators|mesh-ancestor
111015120|NCT02058667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111015121|NCT02470455|Atorvastatin|atorvastatin|mesh-list
111015122|NCT02470455|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111015123|NCT02470455|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111015124|NCT02470455|Antimetabolites|antimetabolites|mesh-ancestor
111015125|NCT02470455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111015126|NCT02470455|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111015127|NCT02470455|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111015128|NCT02470455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111015129|NCT02057263|Alendronate|alendronate|mesh-list
111015130|NCT02057263|Diphosphonates|diphosphonates|mesh-list
111015131|NCT02057263|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111015132|NCT02057263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111015133|NCT05550909|Artesunate|artesunate|mesh-list
111015134|NCT05550909|Lumefantrine|lumefantrine|mesh-list
111015135|NCT05550909|Artemether|artemether|mesh-list
111015136|NCT05550909|Primaquine|primaquine|mesh-list
111015137|NCT05550909|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
111015138|NCT05550909|Amodiaquine|amodiaquine|mesh-list
111015139|NCT05550909|Amodiaquine, artesunate drug combination|amodiaquine, artesunate drug combination|mesh-list
111015140|NCT05550909|Antimalarials|antimalarials|mesh-ancestor
111015141|NCT05550909|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111015142|NCT05550909|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111015143|NCT05550909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111015144|NCT05550909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111015145|NCT05550909|Antiviral Agents|antiviral agents|mesh-ancestor
111015146|NCT05550909|Schistosomicides|schistosomicides|mesh-ancestor
111015147|NCT05550909|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
111015148|NCT05550909|Anthelmintics|anthelmintics|mesh-ancestor
111015149|NCT02054299|Thiamine|thiamine|mesh-list
111015150|NCT02054299|Proguanil|proguanil|mesh-list
111015151|NCT02054299|Sumatriptan|sumatriptan|mesh-list
111015152|NCT02054299|Amitriptyline|amitriptyline|mesh-list
111015153|NCT02054299|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
111015154|NCT02054299|Fenoterol|fenoterol|mesh-list
111015155|NCT02054299|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111015156|NCT02054299|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111015157|NCT02054299|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111015158|NCT02054299|Serotonin Agents|serotonin agents|mesh-ancestor
111015159|NCT02054299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111015160|NCT02054299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111015161|NCT02054299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111015162|NCT02054299|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
111015163|NCT02054299|Antidepressive Agents|antidepressive agents|mesh-ancestor
110732178|NCT05639686|Hemostatics|hemostatics|mesh-ancestor
111015164|NCT02054299|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111015165|NCT02054299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111015166|NCT02054299|Analgesics|analgesics|mesh-ancestor
111015167|NCT02054299|Sensory System Agents|sensory system agents|mesh-ancestor
111015168|NCT02054299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111015169|NCT02054299|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111015170|NCT02054299|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111015171|NCT02054299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111015172|NCT02054299|Adrenergic Agents|adrenergic agents|mesh-ancestor
111015173|NCT02054299|Vitamin B Complex|vitamin b complex|mesh-ancestor
111015174|NCT02054299|Vitamins|vitamins|mesh-ancestor
111015175|NCT02054299|Micronutrients|micronutrients|mesh-ancestor
111015176|NCT02054299|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111015177|NCT02054299|Antimalarials|antimalarials|mesh-ancestor
111015178|NCT02054299|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111015179|NCT02054299|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111015180|NCT02054299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111015181|NCT02054299|Antimetabolites|antimetabolites|mesh-ancestor
111015182|NCT02054299|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111015183|NCT02054299|Autonomic Agents|autonomic agents|mesh-ancestor
111015184|NCT02054299|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111015185|NCT02054299|Respiratory System Agents|respiratory system agents|mesh-ancestor
111015186|NCT02054299|Sympathomimetics|sympathomimetics|mesh-ancestor
111015187|NCT02054299|Tocolytic Agents|tocolytic agents|mesh-ancestor
111015188|NCT02054299|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111015189|NCT02054299|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111015190|NCT02054299|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111015191|NCT02054299|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111015193|NCT02058823|Valsartan|valsartan|mesh-list
111015194|NCT02058823|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111015195|NCT02058823|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111015196|NCT02058823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111015197|NCT02058823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111015198|NCT02058823|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111015199|NCT02058823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111015200|NCT02058823|Vasodilator Agents|vasodilator agents|mesh-ancestor
111015201|NCT02058823|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111015202|NCT02058823|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111015203|NCT00704535|Ezetimibe|ezetimibe|mesh-list
111015204|NCT00704535|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111015205|NCT00704535|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111015206|NCT00704535|Antimetabolites|antimetabolites|mesh-ancestor
111015207|NCT00704535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111015208|NCT00704535|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111015209|NCT02058901|Sunitinib|sunitinib|mesh-list
111015210|NCT02058901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111015211|NCT02058901|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110622399|NCT00771368|Vasodilator Agents|vasodilator agents|mesh-ancestor
111015212|NCT02058901|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111015213|NCT02058901|Growth Substances|growth substances|mesh-ancestor
111015214|NCT02058901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111015215|NCT02058901|Growth Inhibitors|growth inhibitors|mesh-ancestor
111015216|NCT02058901|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111015217|NCT02058901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111015218|NCT02058901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111015219|NCT01955499|Lenalidomide|lenalidomide|mesh-list
111015220|NCT01955499|Immunologic Factors|immunologic factors|mesh-ancestor
111015221|NCT01955499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111015222|NCT01955499|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111015223|NCT01955499|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111015224|NCT01955499|Growth Substances|growth substances|mesh-ancestor
111015225|NCT01955499|Growth Inhibitors|growth inhibitors|mesh-ancestor
111015226|NCT01955499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111015227|NCT02058979|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111015228|NCT02058979|Cefazolin|cefazolin|mesh-list
111015229|NCT02058979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111015230|NCT02057887|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
111015231|NCT02057887|Antiviral Agents|antiviral agents|mesh-ancestor
111015232|NCT02057887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111015233|NCT03893955|Paclitaxel|paclitaxel|mesh-list
111015234|NCT03893955|Carboplatin|carboplatin|mesh-list
111015235|NCT03893955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111015236|NCT03893955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111015237|NCT03893955|Tubulin Modulators|tubulin modulators|mesh-ancestor
111015238|NCT03893955|Antimitotic Agents|antimitotic agents|mesh-ancestor
110732254|NCT05525416|Propranolol|propranolol|mesh-list
111015239|NCT03893955|Mitosis Modulators|mitosis modulators|mesh-ancestor
111015240|NCT03893955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111015241|NCT02648204|Dulaglutide|dulaglutide|mesh-list
111015242|NCT02648204|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111015243|NCT02648204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111015244|NCT03310749|Metformin|metformin|mesh-list
111015245|NCT03310749|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111015246|NCT03310749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111015247|NCT01217931|Bevacizumab|bevacizumab|mesh-list
111015248|NCT01217931|Everolimus|everolimus|mesh-list
111015249|NCT01217931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111015250|NCT01217931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111015251|NCT01217931|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111015252|NCT01217931|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111015253|NCT01217931|Growth Substances|growth substances|mesh-ancestor
111015254|NCT01217931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111015255|NCT01217931|Growth Inhibitors|growth inhibitors|mesh-ancestor
111015256|NCT01217931|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111015257|NCT01217931|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111015258|NCT01217931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111015259|NCT01217931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111015260|NCT01217931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111015261|NCT01217931|Immunologic Factors|immunologic factors|mesh-ancestor
111015263|NCT05291325|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
111015264|NCT05291325|Enzyme Activators|enzyme activators|mesh-ancestor
111015265|NCT05291325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111015266|NCT05291325|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111015267|NCT03310593|Cannabidiol|cannabidiol|mesh-list
111015268|NCT03310593|Anticonvulsants|anticonvulsants|mesh-ancestor
111015269|NCT05304338|Chlorhexidine|chlorhexidine|mesh-list
111015270|NCT05304338|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111015271|NCT05304338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111015272|NCT05304338|Disinfectants|disinfectants|mesh-ancestor
111015273|NCT02058199|Rivaroxaban|rivaroxaban|mesh-list
111015274|NCT02058199|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111015275|NCT02058199|Antithrombins|antithrombins|mesh-ancestor
111015276|NCT02058199|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111015277|NCT02058199|Protease Inhibitors|protease inhibitors|mesh-ancestor
111015278|NCT02058199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111015279|NCT02058199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111015280|NCT02058199|Anticoagulants|anticoagulants|mesh-ancestor
111015281|NCT02058277|Aprepitant|aprepitant|mesh-list
111015282|NCT02058277|Antiemetics|antiemetics|mesh-ancestor
111015283|NCT02058277|Autonomic Agents|autonomic agents|mesh-ancestor
111015284|NCT02058277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111015285|NCT02058277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111015286|NCT02058277|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111015287|NCT02058277|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
111015288|NCT02058277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111015289|NCT02058277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111015290|NCT04813562|Vaccines|vaccines|mesh-list
111015291|NCT04813562|Immunologic Factors|immunologic factors|mesh-ancestor
111015292|NCT04813562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111015293|NCT03314025|Tamsulosin|tamsulosin|mesh-list
111015294|NCT03314025|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111015295|NCT03314025|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111015296|NCT03314025|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111015297|NCT03314025|Adrenergic Agents|adrenergic agents|mesh-ancestor
111015298|NCT03314025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111015299|NCT03314025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111015300|NCT03314025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111015301|NCT03314025|Urological Agents|urological agents|mesh-ancestor
111015302|NCT02055079|Sirolimus|sirolimus|mesh-list
111015303|NCT02055079|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111015304|NCT02055079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111015305|NCT02055079|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111015306|NCT02055079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111015307|NCT02055079|Antifungal Agents|antifungal agents|mesh-ancestor
111015308|NCT02055079|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111015309|NCT02055079|Immunologic Factors|immunologic factors|mesh-ancestor
111015310|NCT02055079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111015311|NCT02470065|Afatinib|afatinib|mesh-list
111015312|NCT02470065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110732335|NCT05273996|Dopamine Agents|dopamine agents|mesh-ancestor
111015313|NCT02470065|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111015314|NCT02470065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111015315|NCT02470065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111015316|NCT03313869|Vitamin E|vitamin e|mesh-list
111015317|NCT03313869|Selenium|selenium|mesh-list
111015318|NCT03313869|Vitamins|vitamins|mesh-ancestor
111015319|NCT03313869|Micronutrients|micronutrients|mesh-ancestor
111015320|NCT03313869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111015321|NCT03313869|Antioxidants|antioxidants|mesh-ancestor
111015322|NCT03313869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111015323|NCT03313869|Protective Agents|protective agents|mesh-ancestor
111015324|NCT03313869|Trace Elements|trace elements|mesh-ancestor
111015325|NCT00705159|Loteprednol Etabonate|loteprednol etabonate|mesh-list
111015326|NCT00705159|Tobramycin|tobramycin|mesh-list
111015327|NCT00705159|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111015328|NCT00705159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111015329|NCT00705159|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111015330|NCT01673984|Triptorelin Pamoate|triptorelin pamoate|mesh-list
111015331|NCT01673984|Goserelin|goserelin|mesh-list
111015332|NCT01673984|Luteolytic Agents|luteolytic agents|mesh-ancestor
111015333|NCT01673984|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111015334|NCT01673984|Contraceptive Agents|contraceptive agents|mesh-ancestor
111015335|NCT01673984|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111015336|NCT01673984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111015337|NCT01673984|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111015338|NCT01673984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111015339|NCT01673984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111015340|NCT03313791|Caseins|caseins|mesh-list
111015341|NCT03313791|Chelating Agents|chelating agents|mesh-ancestor
111015342|NCT03313791|Sequestering Agents|sequestering agents|mesh-ancestor
111015343|NCT03313791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111015344|NCT03310047|Lidocaine|lidocaine|mesh-list
111015345|NCT03310047|Anesthetics, Local|anesthetics, local|mesh-ancestor
111015346|NCT03310047|Anesthetics|anesthetics|mesh-ancestor
111015347|NCT03310047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110622416|NCT00767468|Sorafenib|sorafenib|mesh-list
111015348|NCT03310047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111015349|NCT03310047|Sensory System Agents|sensory system agents|mesh-ancestor
111015350|NCT03310047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111015351|NCT03310047|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111015352|NCT03310047|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111015353|NCT03310047|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111015354|NCT03310047|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111015355|NCT03310047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111015356|NCT03313557|Adavosertib|adavosertib|mesh-list
111015357|NCT03313557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111015358|NCT03313557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111015359|NCT04103216|Nitazoxanide|nitazoxanide|mesh-list
111015360|NCT04103216|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111015361|NCT04103216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111015362|NCT03313479|Dexmedetomidine|dexmedetomidine|mesh-list
111015363|NCT03313479|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111015364|NCT03313479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111015365|NCT03313479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111015366|NCT03313479|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111015367|NCT03313479|Analgesics|analgesics|mesh-ancestor
111015368|NCT03313479|Sensory System Agents|sensory system agents|mesh-ancestor
111015369|NCT03313479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111015370|NCT03313479|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111015371|NCT03313479|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111015372|NCT03313479|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111015373|NCT03313479|Adrenergic Agents|adrenergic agents|mesh-ancestor
111015374|NCT03313479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111015375|NCT03313479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111015376|NCT03313401|Aflibercept|aflibercept|mesh-list
111015377|NCT03313401|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111015378|NCT03313401|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111015379|NCT03313401|Growth Substances|growth substances|mesh-ancestor
111015380|NCT03313401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111015381|NCT03313401|Growth Inhibitors|growth inhibitors|mesh-ancestor
111015382|NCT03313401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111015383|NCT05278065|Nicotine|nicotine|mesh-list
111015384|NCT05278065|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111015385|NCT05278065|Autonomic Agents|autonomic agents|mesh-ancestor
111015386|NCT05278065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111015387|NCT05278065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111015388|NCT05278065|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111015389|NCT05278065|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111015390|NCT05278065|Cholinergic Agents|cholinergic agents|mesh-ancestor
111015391|NCT05278065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111015392|NCT05278065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111015393|NCT03313323|Ipilimumab|ipilimumab|mesh-list
111015394|NCT03313323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111015395|NCT03313323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111015396|NCT03313323|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111015397|NCT03313323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111015398|NCT05302232|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111015399|NCT05302232|Methylprednisolone|methylprednisolone|mesh-list
111015400|NCT05302232|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111015401|NCT05302232|Prednisolone|prednisolone|mesh-list
111015402|NCT05302232|Prednisolone acetate|prednisolone acetate|mesh-list
111015403|NCT05302232|Lidocaine|lidocaine|mesh-list
111015404|NCT05302232|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111015405|NCT05302232|Prednisolone phosphate|prednisolone phosphate|mesh-list
111015406|NCT05302232|Anesthetics, Local|anesthetics, local|mesh-ancestor
110622427|NCT00775580|Atenolol|atenolol|mesh-list
111015408|NCT05302232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111015409|NCT05302232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111015410|NCT05302232|Sensory System Agents|sensory system agents|mesh-ancestor
111015411|NCT05302232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111015412|NCT05302232|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111015413|NCT05302232|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111015414|NCT05302232|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111015415|NCT05302232|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111015416|NCT05302232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111015417|NCT05302232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111015418|NCT05302232|Antiemetics|antiemetics|mesh-ancestor
111015419|NCT05302232|Autonomic Agents|autonomic agents|mesh-ancestor
111015420|NCT05302232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111015421|NCT05302232|Glucocorticoids|glucocorticoids|mesh-ancestor
111015422|NCT05302232|Hormones|hormones|mesh-ancestor
111015423|NCT05302232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111015424|NCT05302232|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111015425|NCT05302232|Protective Agents|protective agents|mesh-ancestor
111015426|NCT05302232|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111015427|NCT05302232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111015428|NCT02468661|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111015429|NCT02468661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111015430|NCT02468661|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111015431|NCT02468661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111015432|NCT02468661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111015433|NCT03304431|Lidocaine|lidocaine|mesh-list
111015434|NCT03304431|Anesthetics, Local|anesthetics, local|mesh-ancestor
111015435|NCT03304431|Anesthetics|anesthetics|mesh-ancestor
111015436|NCT03304431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111015437|NCT03304431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111015438|NCT03304431|Sensory System Agents|sensory system agents|mesh-ancestor
111015439|NCT03304431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111015440|NCT03304431|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111015441|NCT03304431|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111015442|NCT03304431|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111015443|NCT03304431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111015444|NCT03304431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111015445|NCT04741334|Anticoagulants|anticoagulants|mesh-list
111015446|NCT04741334|Dicumarol|dicumarol|mesh-list
111015447|NCT04741334|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
111015448|NCT04741334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111015449|NCT04741334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111015450|NCT04741334|Uncoupling Agents|uncoupling agents|mesh-ancestor
111015451|NCT03309735|Progesterone|progesterone|mesh-list
111015452|NCT03309735|Dydrogesterone|dydrogesterone|mesh-list
111015453|NCT03309735|Progestins|progestins|mesh-ancestor
111015454|NCT03309735|Hormones|hormones|mesh-ancestor
111015455|NCT03309735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111015456|NCT03309735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111015457|NCT02926586|Cytarabine|cytarabine|mesh-list
111015458|NCT02926586|Fludarabine|fludarabine|mesh-list
111015459|NCT02926586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111015460|NCT02926586|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111015461|NCT02926586|Antimetabolites|antimetabolites|mesh-ancestor
110732477|NCT04881747|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111015462|NCT02926586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111015463|NCT02926586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111015464|NCT02926586|Immunologic Factors|immunologic factors|mesh-ancestor
111015465|NCT02926586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111015466|NCT02926586|Antiviral Agents|antiviral agents|mesh-ancestor
111015467|NCT02926586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111015468|NCT04490967|Salicylic Acid|salicylic acid|mesh-list
111015469|NCT04490967|Salicylates|salicylates|mesh-list
111015470|NCT04490967|Silybin|silybin|mesh-list
111015471|NCT04490967|Silymarin|silymarin|mesh-list
111015472|NCT04490967|Antioxidants|antioxidants|mesh-ancestor
111015473|NCT04490967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111015474|NCT04490967|Protective Agents|protective agents|mesh-ancestor
111015475|NCT04490967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110480462|NCT02584543|Vaccines|vaccines|mesh-list
111015476|NCT04490967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111015477|NCT04490967|Antifungal Agents|antifungal agents|mesh-ancestor
111015478|NCT04490967|Keratolytic Agents|keratolytic agents|mesh-ancestor
111015479|NCT04490967|Dermatologic Agents|dermatologic agents|mesh-ancestor
111015480|NCT04490967|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111015481|NCT04490967|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111015483|NCT04490967|Sensory System Agents|sensory system agents|mesh-ancestor
111015484|NCT04490967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111015485|NCT04490967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111015486|NCT04490967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111015487|NCT04490967|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111015488|NCT04490967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111015489|NCT04490967|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111015490|NCT04490967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111015491|NCT03312855|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
111015492|NCT03312855|Immunologic Factors|immunologic factors|mesh-ancestor
111015493|NCT03312855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111015494|NCT03312777|Tramadol|tramadol|mesh-list
111015495|NCT03312777|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111015496|NCT03312777|Narcotics|narcotics|mesh-ancestor
111015497|NCT03312777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111015498|NCT03312777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111015499|NCT03312777|Analgesics|analgesics|mesh-ancestor
111015500|NCT03312777|Sensory System Agents|sensory system agents|mesh-ancestor
111015501|NCT03312777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111015502|NCT02332928|Melatonin|melatonin|mesh-list
111015503|NCT02332928|Antioxidants|antioxidants|mesh-ancestor
111015504|NCT02332928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111015505|NCT02332928|Protective Agents|protective agents|mesh-ancestor
111015506|NCT02332928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111015507|NCT02332928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111015508|NCT03738878|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111015509|NCT03738878|Valsartan|valsartan|mesh-list
111015510|NCT03738878|Bradykinin|bradykinin|mesh-list
111015511|NCT03738878|Kininogens|kininogens|mesh-list
111015512|NCT03738878|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
111015513|NCT03738878|Substance P|substance p|mesh-list
111015514|NCT03738878|Neurokinin A|neurokinin a|mesh-list
111015515|NCT03738878|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111015516|NCT03738878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111015517|NCT03738878|Incretins|incretins|mesh-ancestor
111015518|NCT03738878|Hormones|hormones|mesh-ancestor
111015519|NCT03738878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111015520|NCT03738878|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111015521|NCT03738878|Protease Inhibitors|protease inhibitors|mesh-ancestor
111015522|NCT03738878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111015523|NCT03738878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111015524|NCT03738878|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111015525|NCT03738878|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111015526|NCT03738878|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111015527|NCT03738878|Vasodilator Agents|vasodilator agents|mesh-ancestor
111015528|NCT03738878|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
111015529|NCT03738878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111015530|NCT04682834|Probenecid|probenecid|mesh-list
111015531|NCT04682834|Uricosuric Agents|uricosuric agents|mesh-ancestor
110732550|NCT04635735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110732551|NCT04595513|Sirolimus|sirolimus|mesh-list
110732552|NCT04595513|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110732553|NCT04595513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110732554|NCT04595513|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111015532|NCT04682834|Gout Suppressants|gout suppressants|mesh-ancestor
111015533|NCT04682834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111015534|NCT00703677|Lithium Carbonate|lithium carbonate|mesh-list
111015535|NCT00703677|Antidepressive Agents|antidepressive agents|mesh-ancestor
111015536|NCT00703677|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111015537|NCT00703677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111015538|NCT00703677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111015539|NCT00703677|Antimanic Agents|antimanic agents|mesh-ancestor
111015540|NCT00703677|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111015541|NCT00703677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111015542|NCT00703677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111015543|NCT05426252|Sirolimus|sirolimus|mesh-list
111015544|NCT05426252|Abatacept|abatacept|mesh-list
110480543|NCT02874989|Dasatinib|dasatinib|mesh-list
111015545|NCT05426252|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111015546|NCT05426252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111015547|NCT05426252|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111015548|NCT05426252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111015549|NCT05426252|Antifungal Agents|antifungal agents|mesh-ancestor
111015550|NCT05426252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111015551|NCT05426252|Immunologic Factors|immunologic factors|mesh-ancestor
111015552|NCT05426252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111015553|NCT05426252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111015554|NCT05426252|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111015555|NCT05426252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111015556|NCT05426252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111015557|NCT01506986|Metronidazole|metronidazole|mesh-list
111015558|NCT01506986|Clarithromycin|clarithromycin|mesh-list
111015559|NCT01506986|Lansoprazole|lansoprazole|mesh-list
111015560|NCT01506986|Dexlansoprazole|dexlansoprazole|mesh-list
111015561|NCT01506986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111015562|NCT01506986|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111015563|NCT01506986|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111015564|NCT01506986|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111015565|NCT01506986|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111015566|NCT01506986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111015567|NCT01506986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111015568|NCT01506986|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111015569|NCT01506986|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111015570|NCT01506986|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111015571|NCT01506986|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111015572|NCT01506986|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111015574|NCT02714894|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111015575|NCT02714894|Serotonin Agents|serotonin agents|mesh-ancestor
111015576|NCT02714894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111015577|NCT02714894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111015578|NCT02714894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111015579|NCT02714894|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111015580|NCT02714894|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111015581|NCT02714894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111015582|NCT02714894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111015583|NCT02714894|GABA Antagonists|gaba antagonists|mesh-ancestor
111015584|NCT02714894|GABA Agents|gaba agents|mesh-ancestor
111015585|NCT03303651|Analgesics, Opioid|analgesics, opioid|mesh-list
111015586|NCT03303651|Narcotics|narcotics|mesh-ancestor
111015587|NCT03303651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111015588|NCT03303651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111015589|NCT03303651|Analgesics|analgesics|mesh-ancestor
111015590|NCT03303651|Sensory System Agents|sensory system agents|mesh-ancestor
111015591|NCT03303651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111015592|NCT03312153|Sodium Hypochlorite|sodium hypochlorite|mesh-list
111015593|NCT03312153|Eusol|eusol|mesh-list
111015594|NCT03312153|Disinfectants|disinfectants|mesh-ancestor
111015595|NCT03312153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111015596|NCT03303573|Epoetin Alfa|epoetin alfa|mesh-list
111015597|NCT03303573|Hematinics|hematinics|mesh-ancestor
111015598|NCT03303495|Leucovorin|leucovorin|mesh-list
111015599|NCT03303495|Bevacizumab|bevacizumab|mesh-list
111015600|NCT03303495|Fluorouracil|fluorouracil|mesh-list
111015601|NCT03303495|Irinotecan|irinotecan|mesh-list
111015602|NCT03303495|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110732625|NCT04346589|Antibodies|antibodies|mesh-list
110732626|NCT04346589|Immunoglobulins|immunoglobulins|mesh-list
110732630|NCT05934110|Orlistat|orlistat|mesh-list
111015603|NCT03303495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111015604|NCT03303495|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111015605|NCT03303495|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111015606|NCT03303495|Growth Substances|growth substances|mesh-ancestor
111015607|NCT03303495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111015608|NCT03303495|Growth Inhibitors|growth inhibitors|mesh-ancestor
111015609|NCT03303495|Antimetabolites|antimetabolites|mesh-ancestor
111015610|NCT03303495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111015611|NCT03303495|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111015612|NCT03303495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111015613|NCT03303495|Immunologic Factors|immunologic factors|mesh-ancestor
111015614|NCT03303495|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111015615|NCT03303495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111015616|NCT03303495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111015617|NCT03303495|Antidotes|antidotes|mesh-ancestor
111015618|NCT03303495|Protective Agents|protective agents|mesh-ancestor
111015619|NCT03303495|Vitamin B Complex|vitamin b complex|mesh-ancestor
111015620|NCT03303495|Vitamins|vitamins|mesh-ancestor
111015621|NCT03303495|Micronutrients|micronutrients|mesh-ancestor
111015622|NCT03308955|Tramadol|tramadol|mesh-list
111015623|NCT03308955|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111015624|NCT03308955|Narcotics|narcotics|mesh-ancestor
111015625|NCT03308955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111015626|NCT03308955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111015627|NCT03308955|Analgesics|analgesics|mesh-ancestor
111015628|NCT03308955|Sensory System Agents|sensory system agents|mesh-ancestor
111015629|NCT03308955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111015630|NCT03311607|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
111015631|NCT03311607|Antifungal Agents|antifungal agents|mesh-ancestor
111015632|NCT03311607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111015633|NCT03311607|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111015634|NCT03311607|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111015635|NCT03308643|Oxytocin|oxytocin|mesh-list
111015636|NCT03308643|Oxytocics|oxytocics|mesh-ancestor
111015637|NCT03308643|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111015638|NCT03308643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111015639|NCT03302871|Botulinum Toxins|botulinum toxins|mesh-list
111015640|NCT03302871|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111015641|NCT03302871|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111015642|NCT03302871|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111015643|NCT03302871|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111015644|NCT03302871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111015645|NCT03302871|Cholinergic Agents|cholinergic agents|mesh-ancestor
111015646|NCT03302871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111015647|NCT03302871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111015648|NCT03302871|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111015649|NCT03302871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111015650|NCT03311139|Fibrinolytic Agents|fibrinolytic agents|mesh-list
111015651|NCT03311139|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111015652|NCT03311139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111015653|NCT03308487|Vitamin D|vitamin d|mesh-list
111015654|NCT03308487|Ergocalciferols|ergocalciferols|mesh-list
111015655|NCT03308487|Cholecalciferol|cholecalciferol|mesh-list
111015656|NCT03308487|Vitamins|vitamins|mesh-list
111015657|NCT03308487|Micronutrients|micronutrients|mesh-ancestor
111015658|NCT03308487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111015659|NCT03308487|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111015660|NCT03308487|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111015661|NCT03308331|Nicotine|nicotine|mesh-list
111015662|NCT03308331|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111015663|NCT03308331|Autonomic Agents|autonomic agents|mesh-ancestor
111015664|NCT03308331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111015665|NCT03308331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111015666|NCT03308331|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111015667|NCT03308331|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111015668|NCT03308331|Cholinergic Agents|cholinergic agents|mesh-ancestor
111015669|NCT03308331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111015670|NCT03308331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111015671|NCT02414854|Albuterol|albuterol|mesh-list
111015672|NCT02414854|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111015673|NCT02414854|Autonomic Agents|autonomic agents|mesh-ancestor
111015674|NCT02414854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111015675|NCT02414854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111015676|NCT02414854|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111015677|NCT02414854|Respiratory System Agents|respiratory system agents|mesh-ancestor
111015678|NCT02414854|Tocolytic Agents|tocolytic agents|mesh-ancestor
111015679|NCT02414854|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111015680|NCT02414854|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110732704|NCT05933213|Mescaline|mescaline|mesh-list
111015681|NCT02414854|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111015682|NCT02414854|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111015683|NCT02414854|Adrenergic Agents|adrenergic agents|mesh-ancestor
111015684|NCT02414854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111015685|NCT02414854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111015687|NCT03308253|Tobramycin|tobramycin|mesh-list
111015688|NCT03308253|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111015689|NCT03308253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111015690|NCT02467023|Lidocaine|lidocaine|mesh-list
111015691|NCT02467023|Fentanyl|fentanyl|mesh-list
111015692|NCT02467023|Midazolam|midazolam|mesh-list
111015693|NCT02467023|Anesthetics, Local|anesthetics, local|mesh-ancestor
111015694|NCT02467023|Anesthetics|anesthetics|mesh-ancestor
111015695|NCT02467023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111015696|NCT02467023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111015697|NCT02467023|Sensory System Agents|sensory system agents|mesh-ancestor
111015698|NCT02467023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111015699|NCT02467023|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111015700|NCT02467023|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111015701|NCT02467023|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111015702|NCT02467023|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111015703|NCT02467023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111015704|NCT02467023|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111015705|NCT02467023|Narcotics|narcotics|mesh-ancestor
111015706|NCT02467023|Analgesics|analgesics|mesh-ancestor
111015707|NCT02467023|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111015708|NCT02467023|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111015709|NCT02467023|Anesthetics, General|anesthetics, general|mesh-ancestor
111015710|NCT02467023|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111015711|NCT02467023|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111015712|NCT02467023|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111015713|NCT02467023|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111015714|NCT02467023|GABA Modulators|gaba modulators|mesh-ancestor
111015715|NCT02467023|GABA Agents|gaba agents|mesh-ancestor
111015716|NCT02467023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111015717|NCT02055703|Itraconazole|itraconazole|mesh-list
111015718|NCT02055703|Rifampin|rifampin|mesh-list
111015719|NCT02055703|Digoxin|digoxin|mesh-list
111015720|NCT02055703|Donepezil|donepezil|mesh-list
111015721|NCT02055703|Antifungal Agents|antifungal agents|mesh-ancestor
111015722|NCT02055703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111015723|NCT02055703|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111015724|NCT02055703|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111015725|NCT02055703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111015726|NCT02055703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111015727|NCT02055703|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111015728|NCT02055703|Hormone Antagonists|hormone antagonists|mesh-ancestor
111015729|NCT02055703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111015730|NCT02055703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111015731|NCT02055703|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111015732|NCT02055703|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111015733|NCT02055703|Cholinergic Agents|cholinergic agents|mesh-ancestor
111015734|NCT02055703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111015735|NCT02055703|Nootropic Agents|nootropic agents|mesh-ancestor
111015736|NCT02055703|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111015737|NCT02055703|Antitubercular Agents|antitubercular agents|mesh-ancestor
111015738|NCT02055703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111015739|NCT02055703|Leprostatic Agents|leprostatic agents|mesh-ancestor
111015740|NCT02055703|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111015741|NCT02055703|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111015742|NCT02055703|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111015743|NCT02055703|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
111015744|NCT02055703|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
111015745|NCT02055703|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
111015746|NCT02055703|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111015747|NCT02055703|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111015748|NCT02055703|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111015749|NCT02055703|Protective Agents|protective agents|mesh-ancestor
111015750|NCT02058433|Paclitaxel|paclitaxel|mesh-list
111015751|NCT02058433|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111015752|NCT02058433|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111015753|NCT02058433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111015754|NCT02058433|Tubulin Modulators|tubulin modulators|mesh-ancestor
111015755|NCT02058433|Antimitotic Agents|antimitotic agents|mesh-ancestor
111015756|NCT02058433|Mitosis Modulators|mitosis modulators|mesh-ancestor
111015757|NCT02058433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111015758|NCT03561181|Vaccines|vaccines|mesh-list
111015759|NCT03561181|Immunologic Factors|immunologic factors|mesh-ancestor
111015760|NCT03561181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111015761|NCT02060149|Minocycline|minocycline|mesh-list
111015762|NCT02060149|Sulbactam|sulbactam|mesh-list
111015763|NCT02060149|Cefoperazone|cefoperazone|mesh-list
111015764|NCT02060149|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111015765|NCT02060149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111015766|NCT02060149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111015767|NCT02060149|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
111015768|NCT02060149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110480775|NCT01010126|Sirolimus|sirolimus|mesh-list
111015769|NCT02060149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111015770|NCT03302403|Cyclophosphamide|cyclophosphamide|mesh-list
111015771|NCT03302403|Fludarabine|fludarabine|mesh-list
111015772|NCT03302403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111015773|NCT03302403|Immunologic Factors|immunologic factors|mesh-ancestor
111015774|NCT03302403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111015775|NCT03302403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111015776|NCT03302403|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111015777|NCT03302403|Alkylating Agents|alkylating agents|mesh-ancestor
111015778|NCT03302403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111015779|NCT03302403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111015780|NCT03302403|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111015781|NCT02038621|Paclitaxel|paclitaxel|mesh-list
111015782|NCT02038621|Capecitabine|capecitabine|mesh-list
111015783|NCT02038621|Oxaliplatin|oxaliplatin|mesh-list
111015784|NCT02038621|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111015785|NCT02038621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111015786|NCT02038621|Tubulin Modulators|tubulin modulators|mesh-ancestor
111015787|NCT02038621|Antimitotic Agents|antimitotic agents|mesh-ancestor
111015788|NCT02038621|Mitosis Modulators|mitosis modulators|mesh-ancestor
111015789|NCT02038621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111015790|NCT02038621|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111015791|NCT02038621|Antimetabolites|antimetabolites|mesh-ancestor
111015792|NCT03332498|Pembrolizumab|pembrolizumab|mesh-list
111015793|NCT03332498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111015794|NCT03332498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111015795|NCT03332498|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111015796|NCT03332498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111015797|NCT05727969|Dexmedetomidine|dexmedetomidine|mesh-list
111015798|NCT05727969|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111015799|NCT05727969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111015800|NCT05727969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111015801|NCT05727969|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111015802|NCT05727969|Analgesics|analgesics|mesh-ancestor
111015803|NCT05727969|Sensory System Agents|sensory system agents|mesh-ancestor
111015804|NCT05727969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111015805|NCT05727969|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111015806|NCT05727969|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111015807|NCT05727969|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111015808|NCT05727969|Adrenergic Agents|adrenergic agents|mesh-ancestor
111015809|NCT05727969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111015810|NCT05727969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111015811|NCT01334125|Metformin|metformin|mesh-list
111015812|NCT01334125|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111015813|NCT01334125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111015814|NCT02414152|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
111015815|NCT02414152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111015816|NCT01333501|Interferons|interferons|mesh-list
111015817|NCT01333501|Interferon-beta|interferon-beta|mesh-list
111015818|NCT01333501|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
111015819|NCT01333501|Interferon beta-1b|interferon beta-1b|mesh-list
111015820|NCT01333501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111015821|NCT01333501|Antiviral Agents|antiviral agents|mesh-ancestor
111015822|NCT01333501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111015823|NCT01333501|Immunologic Factors|immunologic factors|mesh-ancestor
111015824|NCT01333501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111015825|NCT01333501|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
111015826|NCT01333501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111015827|NCT01333501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111015828|NCT01333501|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111015829|NCT01362140|Darbepoetin alfa|darbepoetin alfa|mesh-list
111015830|NCT01362140|Hematinics|hematinics|mesh-ancestor
111015832|NCT03307941|Oxaliplatin|oxaliplatin|mesh-list
111015833|NCT03307941|Antimetabolites|antimetabolites|mesh-ancestor
111015834|NCT03307941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111015835|NCT03307941|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111015836|NCT03307941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111015837|NCT03307941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111015838|NCT03307941|Immunologic Factors|immunologic factors|mesh-ancestor
111015839|NCT03307941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111015840|NCT03307863|Topiramate|topiramate|mesh-list
111015841|NCT03307863|Carbamazepine|carbamazepine|mesh-list
111015842|NCT03307863|Anticonvulsants|anticonvulsants|mesh-ancestor
111015843|NCT03307863|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111015844|NCT03307863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111015845|NCT03307863|Antimanic Agents|antimanic agents|mesh-ancestor
111015846|NCT03307863|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111015847|NCT03307863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111015848|NCT03307863|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111015849|NCT03307863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111015850|NCT03307863|Analgesics|analgesics|mesh-ancestor
111015851|NCT03307863|Sensory System Agents|sensory system agents|mesh-ancestor
111015852|NCT03307863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111015853|NCT03307863|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110622580|NCT05355610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111015854|NCT03307863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111015855|NCT03307863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111015856|NCT03307863|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111015857|NCT03307863|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111015858|NCT04656470|Dexmedetomidine|dexmedetomidine|mesh-list
111015859|NCT04656470|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111015860|NCT04656470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111015861|NCT04656470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111015862|NCT04656470|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111015863|NCT04656470|Analgesics|analgesics|mesh-ancestor
111015864|NCT04656470|Sensory System Agents|sensory system agents|mesh-ancestor
111015865|NCT04656470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111015866|NCT04656470|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111015867|NCT04656470|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111015868|NCT04656470|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111015869|NCT04656470|Adrenergic Agents|adrenergic agents|mesh-ancestor
111015870|NCT04656470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111015871|NCT04656470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111015873|NCT05391074|Micronutrients|micronutrients|mesh-ancestor
111015874|NCT05391074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111015875|NCT02467647|Thalidomide|thalidomide|mesh-list
111015876|NCT02467647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111015877|NCT02467647|Immunologic Factors|immunologic factors|mesh-ancestor
111015878|NCT02467647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111015879|NCT02467647|Leprostatic Agents|leprostatic agents|mesh-ancestor
111015880|NCT02467647|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111015881|NCT02467647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111015882|NCT02467647|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111015883|NCT02467647|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111015884|NCT02467647|Growth Substances|growth substances|mesh-ancestor
111015885|NCT02467647|Growth Inhibitors|growth inhibitors|mesh-ancestor
111015886|NCT02467647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111015887|NCT03263936|Cytarabine|cytarabine|mesh-list
111015888|NCT03263936|Fludarabine|fludarabine|mesh-list
111015889|NCT03263936|Decitabine|decitabine|mesh-list
111015890|NCT03263936|Vorinostat|vorinostat|mesh-list
111015891|NCT03263936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111015892|NCT03263936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111015893|NCT03263936|Antimetabolites|antimetabolites|mesh-ancestor
111015894|NCT03263936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111015895|NCT03263936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111015896|NCT03263936|Immunologic Factors|immunologic factors|mesh-ancestor
111015897|NCT03263936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111015898|NCT03263936|Antiviral Agents|antiviral agents|mesh-ancestor
111015899|NCT03263936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111015900|NCT03263936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111015901|NCT03263936|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111015902|NCT03307551|Propofol|propofol|mesh-list
111015903|NCT03307551|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111015904|NCT03307551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110732919|NCT05931328|Pomalidomide|pomalidomide|mesh-list
111015905|NCT03307551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111015906|NCT03307551|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111015907|NCT03307551|Anesthetics, General|anesthetics, general|mesh-ancestor
111015908|NCT03307551|Anesthetics|anesthetics|mesh-ancestor
111015909|NCT02060305|Bevacizumab|bevacizumab|mesh-list
111015910|NCT02060305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111015911|NCT02060305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111015912|NCT02060305|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111015913|NCT02060305|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111015914|NCT02060305|Growth Substances|growth substances|mesh-ancestor
111015915|NCT02060305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111015916|NCT02060305|Growth Inhibitors|growth inhibitors|mesh-ancestor
110480900|NCT01009814|Ritonavir|ritonavir|mesh-list
111015917|NCT03561025|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
111015918|NCT03561025|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111015919|NCT03561025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111015920|NCT02059759|Aldesleukin|aldesleukin|mesh-list
111015921|NCT02059759|Interleukin-2|interleukin-2|mesh-list
111015922|NCT02059759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111015923|NCT02059759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111015924|NCT02059759|Analgesics|analgesics|mesh-ancestor
111015925|NCT02059759|Sensory System Agents|sensory system agents|mesh-ancestor
111015926|NCT02059759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111015927|NCT02059759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111015928|NCT02059759|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111015929|NCT02059759|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111015930|NCT02059759|Antiviral Agents|antiviral agents|mesh-ancestor
111015931|NCT02059759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111015932|NCT03103022|Acetaminophen|acetaminophen|mesh-list
111015933|NCT03103022|Ibuprofen|ibuprofen|mesh-list
111015934|NCT03103022|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111015935|NCT03103022|Analgesics|analgesics|mesh-ancestor
111015936|NCT03103022|Sensory System Agents|sensory system agents|mesh-ancestor
111015937|NCT03103022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111015938|NCT03103022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111015939|NCT03103022|Antipyretics|antipyretics|mesh-ancestor
111015940|NCT03103022|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111015941|NCT03103022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111015942|NCT03103022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111015943|NCT03103022|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111015944|NCT03103022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111015945|NCT03103022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111015946|NCT00702507|Miconazole|miconazole|mesh-list
111015947|NCT00702507|Clotrimazole|clotrimazole|mesh-list
111015948|NCT00702507|Antifungal Agents|antifungal agents|mesh-ancestor
111015949|NCT00702507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111015950|NCT00702507|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111015951|NCT00702507|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111015952|NCT00702507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111015953|NCT00702507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111015954|NCT00702507|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111015955|NCT00702507|Hormone Antagonists|hormone antagonists|mesh-ancestor
111015956|NCT00702507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111015957|NCT00702507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111015958|NCT00702507|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111015959|NCT00702507|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111015960|NCT00702507|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111015961|NCT03324932|Denosumab|denosumab|mesh-list
111015962|NCT03324932|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111015963|NCT03324932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111015964|NCT03301233|Sildenafil Citrate|sildenafil citrate|mesh-list
111015965|NCT03301233|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
111015966|NCT03301233|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
111015967|NCT03301233|Estradiol|estradiol|mesh-list
111015968|NCT03301233|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
111015969|NCT03301233|Estrogens|estrogens|mesh-ancestor
111015970|NCT03301233|Hormones|hormones|mesh-ancestor
111015971|NCT03301233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111015972|NCT03301233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111015973|NCT03301233|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111015974|NCT03301233|Contraceptive Agents|contraceptive agents|mesh-ancestor
111015975|NCT03301233|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111015976|NCT03301233|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111015977|NCT03301233|Vasodilator Agents|vasodilator agents|mesh-ancestor
111015978|NCT03301233|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111015979|NCT03301233|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111015981|NCT03301233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111015982|NCT03301233|Urological Agents|urological agents|mesh-ancestor
111015983|NCT02581748|Trastuzumab|trastuzumab|mesh-list
111015984|NCT02581748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111015985|NCT02581748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111015986|NCT01003028|Remifentanil|remifentanil|mesh-list
111015987|NCT01003028|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111015988|NCT01003028|Narcotics|narcotics|mesh-ancestor
111015989|NCT01003028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111015990|NCT01003028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111015991|NCT01003028|Analgesics|analgesics|mesh-ancestor
111015992|NCT01003028|Sensory System Agents|sensory system agents|mesh-ancestor
111015993|NCT01003028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111015994|NCT03113942|Thalidomide|thalidomide|mesh-list
111015995|NCT03113942|Pomalidomide|pomalidomide|mesh-list
111015996|NCT03113942|Immunologic Factors|immunologic factors|mesh-ancestor
111015997|NCT03113942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111015998|NCT03113942|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111015999|NCT03113942|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111016000|NCT03113942|Growth Substances|growth substances|mesh-ancestor
111016001|NCT03113942|Growth Inhibitors|growth inhibitors|mesh-ancestor
111016002|NCT03113942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111016003|NCT03113942|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111016004|NCT03113942|Leprostatic Agents|leprostatic agents|mesh-ancestor
111016005|NCT03113942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111016006|NCT03113942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111016007|NCT03104270|Dexamethasone|dexamethasone|mesh-list
111016008|NCT03104270|Pomalidomide|pomalidomide|mesh-list
111016009|NCT03104270|Elotuzumab|elotuzumab|mesh-list
111016010|NCT03104270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111016011|NCT03104270|Antiemetics|antiemetics|mesh-ancestor
111016012|NCT03104270|Autonomic Agents|autonomic agents|mesh-ancestor
111016013|NCT03104270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111016014|NCT03104270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111016015|NCT03104270|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111016016|NCT03104270|Glucocorticoids|glucocorticoids|mesh-ancestor
111016017|NCT03104270|Hormones|hormones|mesh-ancestor
111016018|NCT03104270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111016019|NCT03104270|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111016020|NCT03104270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111016021|NCT03104270|Immunologic Factors|immunologic factors|mesh-ancestor
111016022|NCT03104270|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111016023|NCT03104270|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111016024|NCT03104270|Growth Substances|growth substances|mesh-ancestor
111016025|NCT03104270|Growth Inhibitors|growth inhibitors|mesh-ancestor
111016026|NCT03300765|Apatinib|apatinib|mesh-list
111016027|NCT03300765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111016028|NCT03300765|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111016029|NCT03300765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111016030|NCT03300765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111016031|NCT04064918|Timolol|timolol|mesh-list
111016032|NCT04064918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111016033|NCT04064918|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111016034|NCT04064918|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111016035|NCT04064918|Adrenergic Agents|adrenergic agents|mesh-ancestor
111016036|NCT04064918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111016037|NCT04064918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111016038|NCT04064918|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111016039|NCT04064918|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111016040|NCT02467946|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
111016041|NCT02467946|Brentuximab Vedotin|brentuximab vedotin|mesh-list
111016042|NCT02467946|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111016043|NCT02467946|Alkylating Agents|alkylating agents|mesh-ancestor
110733070|NCT05930080|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110733071|NCT05930080|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110733072|NCT05930080|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110733073|NCT05930080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110733074|NCT05930080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110733075|NCT05930002|Ivermectin|ivermectin|mesh-list
110733076|NCT05930002|Colchicine|colchicine|mesh-list
110733077|NCT05930002|Gout Suppressants|gout suppressants|mesh-ancestor
110733078|NCT05930002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110733079|NCT05930002|Tubulin Modulators|tubulin modulators|mesh-ancestor
111016044|NCT02467946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111016045|NCT02467946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111016046|NCT02467946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111016048|NCT02467946|Immunoconjugates|immunoconjugates|mesh-ancestor
111016049|NCT02467946|Immunologic Factors|immunologic factors|mesh-ancestor
111016050|NCT02467946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111016051|NCT04688294|Valsartan|valsartan|mesh-list
111016052|NCT04688294|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
111016053|NCT04688294|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111016054|NCT04688294|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111016055|NCT04688294|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111016056|NCT04688294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111016057|NCT03300609|Calcium, Dietary|calcium, dietary|mesh-list
111016058|NCT03300609|Leucovorin|leucovorin|mesh-list
111016059|NCT03300609|Folic Acid|folic acid|mesh-list
111016060|NCT03300609|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
111016061|NCT03300609|Tetrahydrofolates|tetrahydrofolates|mesh-list
111016062|NCT03300609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111016063|NCT03300609|Panitumumab|panitumumab|mesh-list
111016064|NCT03300609|Fluorouracil|fluorouracil|mesh-list
111016065|NCT03300609|Capecitabine|capecitabine|mesh-list
111016066|NCT03300609|Oxaliplatin|oxaliplatin|mesh-list
111016067|NCT03300609|Antibodies|antibodies|mesh-list
111016068|NCT03300609|Immunoglobulins|immunoglobulins|mesh-list
111016069|NCT03300609|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111016070|NCT03300609|Calcium|calcium|mesh-list
111016071|NCT03300609|Levoleucovorin|levoleucovorin|mesh-list
111016072|NCT03300609|Immunologic Factors|immunologic factors|mesh-ancestor
111016073|NCT03300609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111016074|NCT03300609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111016075|NCT03300609|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111016076|NCT03300609|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111016077|NCT03300609|Antimetabolites|antimetabolites|mesh-ancestor
111016078|NCT03300609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111016079|NCT03300609|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111016080|NCT03300609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111016081|NCT03300609|Antidotes|antidotes|mesh-ancestor
111016082|NCT03300609|Protective Agents|protective agents|mesh-ancestor
111016083|NCT03300609|Vitamin B Complex|vitamin b complex|mesh-ancestor
111016084|NCT03300609|Vitamins|vitamins|mesh-ancestor
111016085|NCT03300609|Micronutrients|micronutrients|mesh-ancestor
111016086|NCT03300609|Hematinics|hematinics|mesh-ancestor
111016087|NCT00583778|Ipratropium|ipratropium|mesh-list
111016088|NCT00583778|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111016089|NCT00583778|Autonomic Agents|autonomic agents|mesh-ancestor
111016090|NCT00583778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111016091|NCT00583778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111016092|NCT00583778|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111016093|NCT00583778|Respiratory System Agents|respiratory system agents|mesh-ancestor
111016094|NCT00583778|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111016095|NCT00583778|Cholinergic Agents|cholinergic agents|mesh-ancestor
111016096|NCT00583778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111016097|NCT00583778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111016098|NCT03300531|Betamethasone|betamethasone|mesh-list
111016099|NCT03300531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111016100|NCT03300531|Glucocorticoids|glucocorticoids|mesh-ancestor
111016101|NCT03300531|Hormones|hormones|mesh-ancestor
111016102|NCT03300531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111016103|NCT03300531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111016104|NCT03300531|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111016105|NCT03300531|Respiratory System Agents|respiratory system agents|mesh-ancestor
111016106|NCT02467335|Fostemsavir|fostemsavir|mesh-list
111016107|NCT02467335|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111016108|NCT02467335|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111016109|NCT02467335|Antiviral Agents|antiviral agents|mesh-ancestor
111016110|NCT02467335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111016111|NCT02467335|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
111016112|NCT02467335|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110733146|NCT05899010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110733147|NCT05899010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111016113|NCT02467335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111016114|NCT02809820|Metoprolol|metoprolol|mesh-list
111016115|NCT02809820|Carvedilol|carvedilol|mesh-list
111016116|NCT02809820|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
111016117|NCT02809820|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111016118|NCT02809820|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111016119|NCT02809820|Sympatholytics|sympatholytics|mesh-ancestor
111016120|NCT02809820|Autonomic Agents|autonomic agents|mesh-ancestor
111016121|NCT02809820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111016122|NCT02809820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111016123|NCT02809820|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
111016124|NCT02809820|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111016125|NCT02809820|Adrenergic Agents|adrenergic agents|mesh-ancestor
111016126|NCT02809820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111016127|NCT02809820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111016128|NCT02809820|Antioxidants|antioxidants|mesh-ancestor
111016129|NCT02809820|Protective Agents|protective agents|mesh-ancestor
111016130|NCT02809820|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111016131|NCT02809820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111016132|NCT02809820|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111016133|NCT02809820|Vasodilator Agents|vasodilator agents|mesh-ancestor
111016134|NCT02809820|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111016135|NCT02809820|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111016136|NCT04491357|Calcium, Dietary|calcium, dietary|mesh-list
111016138|NCT04491357|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111016139|NCT04491357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111016140|NCT04491357|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111016142|NCT01673594|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111016143|NCT01673594|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111016144|NCT01673594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111016145|NCT01673594|Sensory System Agents|sensory system agents|mesh-ancestor
111016146|NCT01673594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111016147|NCT03249207|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
111016148|NCT03249207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111016149|NCT02786498|Vitamin D|vitamin d|mesh-list
111016150|NCT02786498|Cholecalciferol|cholecalciferol|mesh-list
111016151|NCT02786498|Vitamins|vitamins|mesh-ancestor
111016152|NCT02786498|Micronutrients|micronutrients|mesh-ancestor
111016153|NCT02786498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111016154|NCT02786498|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111016155|NCT02786498|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111016156|NCT03891914|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
111016157|NCT03891914|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111016158|NCT03891914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111016159|NCT02597660|Hormones|hormones|mesh-list
111016160|NCT02597660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111016161|NCT02597660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111016162|NCT02419664|Edotreotide|edotreotide|mesh-list
111016163|NCT02419664|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111016164|NCT02419664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111016165|NCT03102476|Insulin Lispro|insulin lispro|mesh-list
111016166|NCT03102476|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111016167|NCT03102476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111016168|NCT04435574|Lactoferrin|lactoferrin|mesh-list
111016169|NCT04435574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111016170|NCT03104426|Darbepoetin alfa|darbepoetin alfa|mesh-list
111016171|NCT03104426|Hematinics|hematinics|mesh-ancestor
111016172|NCT02163356|Ketoconazole|ketoconazole|mesh-list
111016173|NCT02163356|Vincristine|vincristine|mesh-list
111016174|NCT02163356|Fenretinide|fenretinide|mesh-list
111016175|NCT02163356|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111016176|NCT02163356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111016177|NCT02163356|Tubulin Modulators|tubulin modulators|mesh-ancestor
111016178|NCT02163356|Antimitotic Agents|antimitotic agents|mesh-ancestor
111016179|NCT02163356|Mitosis Modulators|mitosis modulators|mesh-ancestor
111016180|NCT02163356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111016181|NCT02163356|Antifungal Agents|antifungal agents|mesh-ancestor
111016182|NCT02163356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111016183|NCT02163356|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111016184|NCT02163356|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111016185|NCT02163356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111016186|NCT02163356|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111016187|NCT02163356|Hormone Antagonists|hormone antagonists|mesh-ancestor
111016188|NCT02163356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111016189|NCT02163356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111016190|NCT02163356|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111016191|NCT02163356|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
111016192|NCT02163356|Protective Agents|protective agents|mesh-ancestor
111016193|NCT04412642|Methoxyflurane|methoxyflurane|mesh-list
111016194|NCT04412642|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111016195|NCT04412642|Anesthetics, General|anesthetics, general|mesh-ancestor
111016196|NCT04412642|Anesthetics|anesthetics|mesh-ancestor
111016197|NCT04412642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111016198|NCT04412642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111016199|NCT03867110|Atorvastatin|atorvastatin|mesh-list
111016200|NCT03867110|Ezetimibe|ezetimibe|mesh-list
111016201|NCT03867110|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111016202|NCT03867110|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111016203|NCT03867110|Antimetabolites|antimetabolites|mesh-ancestor
110481192|NCT00618579|Warfarin|warfarin|mesh-list
111016204|NCT03867110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111016205|NCT03867110|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111016206|NCT03867110|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111016207|NCT03867110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111016208|NCT03865082|Nivolumab|nivolumab|mesh-list
111016209|NCT03865082|Ipilimumab|ipilimumab|mesh-list
111016210|NCT03865082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111016211|NCT03865082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110622664|NCT00776282|Histamine Agents|histamine agents|mesh-ancestor
111016212|NCT03865082|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111016213|NCT03865082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111016214|NCT03102398|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
111016215|NCT03102398|Vasodilator Agents|vasodilator agents|mesh-ancestor
111016216|NCT03102398|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111016217|NCT03102398|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111016218|NCT03102398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111016219|NCT03102398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111016220|NCT03102398|Urological Agents|urological agents|mesh-ancestor
111016221|NCT01187810|Cytarabine|cytarabine|mesh-list
111016222|NCT01187810|Methotrexate|methotrexate|mesh-list
111016223|NCT01187810|Fenretinide|fenretinide|mesh-list
111016224|NCT01187810|Retinamide|retinamide|mesh-list
111016225|NCT01187810|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111016226|NCT01187810|Abortifacient Agents|abortifacient agents|mesh-ancestor
111016227|NCT01187810|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111016228|NCT01187810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111016229|NCT01187810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111016230|NCT01187810|Antimetabolites|antimetabolites|mesh-ancestor
111016231|NCT01187810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111016232|NCT01187810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111016233|NCT01187810|Dermatologic Agents|dermatologic agents|mesh-ancestor
111016234|NCT01187810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111016235|NCT01187810|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111016236|NCT01187810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111016237|NCT01187810|Immunologic Factors|immunologic factors|mesh-ancestor
111016238|NCT01187810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111016239|NCT01187810|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111016240|NCT01187810|Antiviral Agents|antiviral agents|mesh-ancestor
111016241|NCT01187810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111016242|NCT01187810|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
111016243|NCT01187810|Protective Agents|protective agents|mesh-ancestor
111016244|NCT03104036|Mesalamine|mesalamine|mesh-list
111016245|NCT03104036|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111016246|NCT03104036|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111016247|NCT03104036|Analgesics|analgesics|mesh-ancestor
111016248|NCT03104036|Sensory System Agents|sensory system agents|mesh-ancestor
111016249|NCT03104036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111016250|NCT03104036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111016251|NCT03104036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111016252|NCT03104036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110733293|NCT05785832|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110733294|NCT05785832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111016253|NCT03449888|Calcium, Dietary|calcium, dietary|mesh-list
110733295|NCT05773664|Dexamethasone|dexamethasone|mesh-list
110733296|NCT05773664|Dexamethasone acetate|dexamethasone acetate|mesh-list
110733297|NCT05773664|Ichthammol|ichthammol|mesh-list
110733298|NCT05773664|BB 1101|bb 1101|mesh-list
110733299|NCT05773664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110733300|NCT05773664|Antiemetics|antiemetics|mesh-ancestor
110733301|NCT05773664|Autonomic Agents|autonomic agents|mesh-ancestor
110733302|NCT05773664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110733303|NCT05773664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110733304|NCT05773664|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111016255|NCT03449888|Regadenoson|regadenoson|mesh-list
111016256|NCT03449888|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111016257|NCT03449888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111016258|NCT03449888|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111016259|NCT03449888|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
111016260|NCT03449888|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
111016261|NCT03449888|Purinergic Agonists|purinergic agonists|mesh-ancestor
111016262|NCT03449888|Purinergic Agents|purinergic agents|mesh-ancestor
111016263|NCT03449888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111016264|NCT03449888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111016265|NCT03308396|Durvalumab|durvalumab|mesh-list
111016266|NCT03308396|Guadecitabine|guadecitabine|mesh-list
110622668|NCT00943293|Fludarabine|fludarabine|mesh-list
111016267|NCT03308396|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111016268|NCT03308396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111016269|NCT02720523|Upadacitinib|upadacitinib|mesh-list
111016270|NCT02720523|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
111016271|NCT02720523|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111016272|NCT02720523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111016273|NCT02720523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111016274|NCT02720523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111016275|NCT02646332|Amoxicillin|amoxicillin|mesh-list
111016276|NCT02646332|Metronidazole|metronidazole|mesh-list
111016277|NCT02646332|Clarithromycin|clarithromycin|mesh-list
111016278|NCT02646332|Dexlansoprazole|dexlansoprazole|mesh-list
111016279|NCT02646332|Lansoprazole|lansoprazole|mesh-list
111016280|NCT02646332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111016281|NCT02646332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111016282|NCT02646332|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111016283|NCT02646332|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111016284|NCT02646332|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111016285|NCT02646332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111016286|NCT02646332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111016287|NCT02646332|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111016288|NCT02646332|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111016289|NCT02646332|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111016290|NCT02646332|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111016291|NCT02646332|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111016292|NCT00015002|Betamethasone|betamethasone|mesh-list
111016293|NCT00015002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111016294|NCT00015002|Glucocorticoids|glucocorticoids|mesh-ancestor
111016295|NCT00015002|Hormones|hormones|mesh-ancestor
111016296|NCT00015002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111016297|NCT00015002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111016298|NCT00015002|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111016299|NCT00015002|Respiratory System Agents|respiratory system agents|mesh-ancestor
111016300|NCT03103412|Tofacitinib|tofacitinib|mesh-list
111016301|NCT03103412|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
111016302|NCT03103412|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111016303|NCT03103412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111016304|NCT03103412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111016305|NCT02061007|Misonidazole|misonidazole|mesh-list
111016306|NCT02061007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111016307|NCT02061007|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111016308|NCT02061007|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111016309|NCT02061007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111016310|NCT02086604|Lenalidomide|lenalidomide|mesh-list
111016311|NCT02086604|Brentuximab Vedotin|brentuximab vedotin|mesh-list
111016312|NCT02086604|Immunologic Factors|immunologic factors|mesh-ancestor
111016313|NCT02086604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111016314|NCT02086604|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111016315|NCT02086604|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111016316|NCT02086604|Growth Substances|growth substances|mesh-ancestor
111016317|NCT02086604|Growth Inhibitors|growth inhibitors|mesh-ancestor
111016318|NCT02086604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111016319|NCT02086604|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111016320|NCT02086604|Immunotoxins|immunotoxins|mesh-ancestor
111016321|NCT02086604|Immunoconjugates|immunoconjugates|mesh-ancestor
111016322|NCT03103568|Tolbutamide|tolbutamide|mesh-list
111016323|NCT03103568|Metoprolol|metoprolol|mesh-list
111016324|NCT03103568|Furosemide|furosemide|mesh-list
111016325|NCT03103568|Chlorzoxazone|chlorzoxazone|mesh-list
111016326|NCT03103568|Nitisinone|nitisinone|mesh-list
111016327|NCT03103568|Diuretics|diuretics|mesh-ancestor
111016328|NCT03103568|Natriuretic Agents|natriuretic agents|mesh-ancestor
111016329|NCT03103568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110799534|NCT05320107|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111016330|NCT03103568|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
111016331|NCT03103568|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111016332|NCT03103568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111016333|NCT03103568|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111016334|NCT03103568|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111016335|NCT03103568|Sympatholytics|sympatholytics|mesh-ancestor
111016336|NCT03103568|Autonomic Agents|autonomic agents|mesh-ancestor
111016337|NCT03103568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111016338|NCT03103568|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
111016339|NCT03103568|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111016340|NCT03103568|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111016341|NCT03103568|Adrenergic Agents|adrenergic agents|mesh-ancestor
111016342|NCT03103568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111016343|NCT03103568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111016344|NCT03103568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111016345|NCT03103568|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
111016346|NCT03103568|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111016347|NCT03101072|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111016348|NCT03101072|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
111016349|NCT03101072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111016350|NCT03101072|Antitubercular Agents|antitubercular agents|mesh-ancestor
111016351|NCT02925195|Vitamin D|vitamin d|mesh-list
111016352|NCT02925195|Cholecalciferol|cholecalciferol|mesh-list
111016353|NCT02925195|Vitamins|vitamins|mesh-ancestor
111016354|NCT02925195|Micronutrients|micronutrients|mesh-ancestor
111016355|NCT02925195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111016356|NCT02925195|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111016357|NCT02925195|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111016358|NCT03103646|Itraconazole|itraconazole|mesh-list
111016359|NCT03103646|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
111016360|NCT03103646|Antifungal Agents|antifungal agents|mesh-ancestor
111016361|NCT03103646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111016362|NCT03103646|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111016363|NCT03103646|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111016364|NCT03103646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111016365|NCT03103646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111016366|NCT03103646|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111016367|NCT03103646|Hormone Antagonists|hormone antagonists|mesh-ancestor
111016368|NCT03103646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111016369|NCT03103646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111016370|NCT03103646|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111016371|NCT01554410|Gemcitabine|gemcitabine|mesh-list
111016372|NCT01554410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111016373|NCT01554410|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111016374|NCT01554410|Antimetabolites|antimetabolites|mesh-ancestor
111016375|NCT01554410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111016376|NCT03299829|Trientine|trientine|mesh-list
111016377|NCT03299829|Chelating Agents|chelating agents|mesh-ancestor
111016378|NCT03299829|Sequestering Agents|sequestering agents|mesh-ancestor
111016379|NCT03299829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111016380|NCT04968158|Acetaminophen|acetaminophen|mesh-list
111016381|NCT04968158|Etoricoxib|etoricoxib|mesh-list
111016382|NCT04968158|Tramadol|tramadol|mesh-list
111016383|NCT04968158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111016384|NCT04968158|Analgesics|analgesics|mesh-ancestor
111016385|NCT04968158|Sensory System Agents|sensory system agents|mesh-ancestor
111016386|NCT04968158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111016387|NCT04968158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111016388|NCT04968158|Antipyretics|antipyretics|mesh-ancestor
111016389|NCT04968158|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111016390|NCT04968158|Narcotics|narcotics|mesh-ancestor
111016391|NCT04968158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111016392|NCT04968158|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111016393|NCT04968158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111016394|NCT04968158|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111016395|NCT04968158|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111016396|NCT04968158|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111016397|NCT04968158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111016398|NCT04968158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111016399|NCT02059915|Oxycodone|oxycodone|mesh-list
111016400|NCT02059915|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111016401|NCT02059915|Narcotics|narcotics|mesh-ancestor
110733444|NCT05627557|Autonomic Agents|autonomic agents|mesh-ancestor
111016402|NCT02059915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111016403|NCT02059915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111016404|NCT02059915|Analgesics|analgesics|mesh-ancestor
111016405|NCT02059915|Sensory System Agents|sensory system agents|mesh-ancestor
111016406|NCT02059915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111016407|NCT02471404|Dapagliflozin|dapagliflozin|mesh-list
111016408|NCT02471404|Glimepiride|glimepiride|mesh-list
111016409|NCT02471404|Saxagliptin|saxagliptin|mesh-list
111016410|NCT02471404|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111016411|NCT02471404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111016412|NCT02471404|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111016413|NCT02471404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111016414|NCT02471404|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111016415|NCT02471404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111016416|NCT02471404|Immunologic Factors|immunologic factors|mesh-ancestor
111016418|NCT02471404|Hormones|hormones|mesh-ancestor
111016419|NCT02471404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111016420|NCT02471404|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111016421|NCT02471404|Protease Inhibitors|protease inhibitors|mesh-ancestor
111016422|NCT02471404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111016423|NCT00835094|Mometasone Furoate|mometasone furoate|mesh-list
111016424|NCT00835094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111016425|NCT00835094|Dermatologic Agents|dermatologic agents|mesh-ancestor
111016426|NCT00835094|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111016427|NCT02061475|Lidocaine|lidocaine|mesh-list
111016428|NCT02061475|Anesthetics, Local|anesthetics, local|mesh-ancestor
111016429|NCT02061475|Anesthetics|anesthetics|mesh-ancestor
111016430|NCT02061475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111016431|NCT02061475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111016432|NCT02061475|Sensory System Agents|sensory system agents|mesh-ancestor
111016433|NCT02061475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111016434|NCT02061475|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111016435|NCT02061475|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111016436|NCT02061475|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111016437|NCT02061475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111016438|NCT02061475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111016439|NCT03100994|Bupivacaine|bupivacaine|mesh-list
111016440|NCT03100994|Anesthetics, Local|anesthetics, local|mesh-ancestor
111016441|NCT03100994|Anesthetics|anesthetics|mesh-ancestor
111016442|NCT03100994|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111016443|NCT03100994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111016444|NCT03100994|Sensory System Agents|sensory system agents|mesh-ancestor
111016445|NCT03100994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111016446|NCT04160936|Bupivacaine|bupivacaine|mesh-list
111016447|NCT04160936|Anesthetics, Local|anesthetics, local|mesh-ancestor
111016448|NCT04160936|Anesthetics|anesthetics|mesh-ancestor
111016449|NCT04160936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111016450|NCT04160936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111016451|NCT04160936|Sensory System Agents|sensory system agents|mesh-ancestor
111016452|NCT04160936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111016453|NCT03103334|Methotrexate|methotrexate|mesh-list
111016454|NCT03103334|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111016455|NCT03103334|Abortifacient Agents|abortifacient agents|mesh-ancestor
111016456|NCT03103334|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111016457|NCT03103334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111016458|NCT03103334|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111016459|NCT03103334|Antimetabolites|antimetabolites|mesh-ancestor
111016460|NCT03103334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111016461|NCT03103334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111016462|NCT03103334|Dermatologic Agents|dermatologic agents|mesh-ancestor
111016463|NCT03103334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111016464|NCT03103334|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111016465|NCT03103334|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111016466|NCT03103334|Immunologic Factors|immunologic factors|mesh-ancestor
111016467|NCT03103334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111016468|NCT03103334|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111016469|NCT02471014|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
111016470|NCT02471014|Immunologic Factors|immunologic factors|mesh-ancestor
110733517|NCT05542615|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110733518|NCT05542615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110733519|NCT05542615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110733520|NCT05542615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110733521|NCT05532163|Natalizumab|natalizumab|mesh-list
111016471|NCT02471014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111016472|NCT00795158|Desloratadine|desloratadine|mesh-list
111016473|NCT00795158|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111016474|NCT00795158|Cholinergic Agents|cholinergic agents|mesh-ancestor
111016475|NCT00795158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111016476|NCT00795158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111016477|NCT00795158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111016478|NCT00795158|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
111016479|NCT00795158|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111016480|NCT00795158|Histamine Antagonists|histamine antagonists|mesh-ancestor
111016481|NCT00795158|Histamine Agents|histamine agents|mesh-ancestor
111016482|NCT02063269|Rivastigmine|rivastigmine|mesh-list
111016483|NCT02063269|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111016485|NCT02063269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111016486|NCT02063269|Cholinergic Agents|cholinergic agents|mesh-ancestor
111016487|NCT02063269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111016488|NCT02063269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111016489|NCT02063269|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111016490|NCT02063269|Protective Agents|protective agents|mesh-ancestor
111016491|NCT00794846|Cetirizine|cetirizine|mesh-list
111016492|NCT00794846|Desloratadine|desloratadine|mesh-list
111016493|NCT00794846|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111016494|NCT00794846|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
111016495|NCT00794846|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111016496|NCT00794846|Histamine Antagonists|histamine antagonists|mesh-ancestor
111016497|NCT00794846|Histamine Agents|histamine agents|mesh-ancestor
111016498|NCT00794846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111016499|NCT00794846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111016500|NCT00794846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111016501|NCT00794846|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111016502|NCT00794846|Cholinergic Agents|cholinergic agents|mesh-ancestor
111016503|NCT00794768|Fexofenadine|fexofenadine|mesh-list
111016504|NCT00794768|Desloratadine|desloratadine|mesh-list
111016505|NCT00794768|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111016506|NCT00794768|Cholinergic Agents|cholinergic agents|mesh-ancestor
111016507|NCT00794768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111016508|NCT00794768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111016509|NCT00794768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111016510|NCT00794768|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
111016511|NCT00794768|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111016512|NCT00794768|Histamine Antagonists|histamine antagonists|mesh-ancestor
111016513|NCT00794768|Histamine Agents|histamine agents|mesh-ancestor
111016514|NCT00794768|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111016515|NCT02060851|Iron|iron|mesh-list
111016516|NCT02060851|Trace Elements|trace elements|mesh-ancestor
111016517|NCT02060851|Micronutrients|micronutrients|mesh-ancestor
111016518|NCT02060851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111016519|NCT00779636|Desloratadine|desloratadine|mesh-list
111016520|NCT00779636|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111016521|NCT00779636|Cholinergic Agents|cholinergic agents|mesh-ancestor
111016522|NCT00779636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111016523|NCT00779636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111016524|NCT00779636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111016525|NCT00779636|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
111016526|NCT00779636|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111016527|NCT00779636|Histamine Antagonists|histamine antagonists|mesh-ancestor
111016528|NCT00779636|Histamine Agents|histamine agents|mesh-ancestor
111016529|NCT02060929|Esketamine|esketamine|mesh-list
111016530|NCT02060929|Antidepressive Agents|antidepressive agents|mesh-ancestor
111016531|NCT02060929|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111016532|NCT00757562|Desloratadine|desloratadine|mesh-list
111016533|NCT00757562|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111016534|NCT00757562|Cholinergic Agents|cholinergic agents|mesh-ancestor
111016535|NCT00757562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111016536|NCT00757562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111016537|NCT00757562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111016538|NCT00757562|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
111016539|NCT00757562|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111016540|NCT00757562|Histamine Antagonists|histamine antagonists|mesh-ancestor
111016541|NCT00757562|Histamine Agents|histamine agents|mesh-ancestor
111016542|NCT03299517|Lidocaine|lidocaine|mesh-list
111016543|NCT03299517|Amiodarone|amiodarone|mesh-list
111016544|NCT03299517|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
111016545|NCT03299517|Anesthetics, Local|anesthetics, local|mesh-ancestor
111016547|NCT03299517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111016548|NCT03299517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111016549|NCT03299517|Sensory System Agents|sensory system agents|mesh-ancestor
111016550|NCT03299517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111016551|NCT03299517|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111016552|NCT03299517|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111016553|NCT03299517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111016554|NCT03299517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111016555|NCT03299517|Vasodilator Agents|vasodilator agents|mesh-ancestor
111016556|NCT03299517|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
111016557|NCT03299517|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111016558|NCT03299517|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111016559|NCT03299517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111016560|NCT03299517|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111016561|NCT03299517|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111016562|NCT03299517|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111016564|NCT00651404|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111016565|NCT00651404|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111016566|NCT00651404|Antimetabolites|antimetabolites|mesh-ancestor
111016567|NCT00651404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111016568|NCT00651404|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111016569|NCT00651014|Ezetimibe|ezetimibe|mesh-list
111016570|NCT00651014|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111016571|NCT00651014|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111016572|NCT00651014|Antimetabolites|antimetabolites|mesh-ancestor
111016573|NCT00651014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111016574|NCT00651014|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111016575|NCT04435418|Apixaban|apixaban|mesh-list
111016576|NCT04435418|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111016577|NCT04435418|Antithrombins|antithrombins|mesh-ancestor
111016578|NCT04435418|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111016579|NCT04435418|Protease Inhibitors|protease inhibitors|mesh-ancestor
111016580|NCT04435418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111016581|NCT04435418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111016582|NCT04435418|Anticoagulants|anticoagulants|mesh-ancestor
111016583|NCT02062255|Aspirin|aspirin|mesh-list
111016584|NCT02062255|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111016585|NCT02062255|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111016586|NCT02062255|Analgesics|analgesics|mesh-ancestor
111016587|NCT02062255|Sensory System Agents|sensory system agents|mesh-ancestor
111016588|NCT02062255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111016589|NCT02062255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111016590|NCT02062255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111016591|NCT02062255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111016592|NCT02062255|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111016593|NCT02062255|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111016594|NCT02062255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111016595|NCT02062255|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111016596|NCT02062255|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111016597|NCT02062255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111016598|NCT02062255|Antipyretics|antipyretics|mesh-ancestor
111016599|NCT02739542|Dimethyl Fumarate|dimethyl fumarate|mesh-list
111016600|NCT02739542|Dermatologic Agents|dermatologic agents|mesh-ancestor
111016601|NCT02739542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111016602|NCT02739542|Immunologic Factors|immunologic factors|mesh-ancestor
111016603|NCT02739542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111016604|NCT02466477|Psychotropic Drugs|psychotropic drugs|mesh-list
111016605|NCT05547243|Vaccines|vaccines|mesh-list
111016606|NCT05547243|Immunologic Factors|immunologic factors|mesh-ancestor
111016607|NCT05547243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111016608|NCT03100604|Sevoflurane|sevoflurane|mesh-list
111016609|NCT03100604|Desflurane|desflurane|mesh-list
111016610|NCT03100604|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111016611|NCT03100604|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111016612|NCT03100604|Anesthetics, General|anesthetics, general|mesh-ancestor
111016613|NCT03100604|Anesthetics|anesthetics|mesh-ancestor
111016614|NCT03100604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111016615|NCT03100604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111016616|NCT00398294|Simvastatin|simvastatin|mesh-list
111016617|NCT00398294|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111016618|NCT00398294|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110733693|NCT05296837|Doxycycline|doxycycline|mesh-list
111016620|NCT00398294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111016621|NCT00398294|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111016622|NCT00398294|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111016623|NCT00398294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111016624|NCT04823403|Nivolumab|nivolumab|mesh-list
111016625|NCT04823403|Ipilimumab|ipilimumab|mesh-list
111016626|NCT04823403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111016627|NCT04823403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111016628|NCT04823403|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111016629|NCT04823403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111016630|NCT03493646|Azacitidine|azacitidine|mesh-list
111016631|NCT03493646|Cc-486|cc-486|mesh-list
111016632|NCT03493646|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111016634|NCT03493646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111016635|NCT03493646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111016636|NCT03493646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111016637|NCT05519865|Tislelizumab|tislelizumab|mesh-list
111016638|NCT05519865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111016639|NCT05519865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111016640|NCT05500443|Vitamin K|vitamin k|mesh-list
111016641|NCT05500443|Vitamin K 2|vitamin k 2|mesh-list
111016642|NCT05500443|Menaquinone 7|menaquinone 7|mesh-list
111016643|NCT05500443|Vitamins|vitamins|mesh-ancestor
111016644|NCT05500443|Micronutrients|micronutrients|mesh-ancestor
111016645|NCT05500443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111016646|NCT05500443|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111016647|NCT05500443|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111016648|NCT05500443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111016649|NCT05500443|Hemostatics|hemostatics|mesh-ancestor
111016650|NCT05500443|Coagulants|coagulants|mesh-ancestor
111016651|NCT05244200|Insulin|insulin|mesh-list
111016652|NCT05244200|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111016653|NCT05244200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111016654|NCT03451370|Bevacizumab|bevacizumab|mesh-list
111016655|NCT03451370|Capecitabine|capecitabine|mesh-list
111016656|NCT03451370|Oxaliplatin|oxaliplatin|mesh-list
111016657|NCT03451370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111016658|NCT03451370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111016659|NCT03451370|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111016660|NCT03451370|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111016661|NCT03451370|Growth Substances|growth substances|mesh-ancestor
111016662|NCT03451370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111016663|NCT03451370|Growth Inhibitors|growth inhibitors|mesh-ancestor
111016664|NCT03451370|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111016665|NCT03451370|Antimetabolites|antimetabolites|mesh-ancestor
111016666|NCT03451370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111016667|NCT03991832|Durvalumab|durvalumab|mesh-list
111016668|NCT03991832|Olaparib|olaparib|mesh-list
111016669|NCT03991832|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111016670|NCT03991832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111016671|NCT03991832|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111016672|NCT03991832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111016673|NCT03991832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111016674|NCT01361594|Insulin|insulin|mesh-list
111016675|NCT01361594|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111016676|NCT01361594|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111016677|NCT01361594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111016678|NCT04435028|Ketotifen|ketotifen|mesh-list
111016679|NCT04435028|Antipruritics|antipruritics|mesh-ancestor
111016680|NCT04435028|Dermatologic Agents|dermatologic agents|mesh-ancestor
111016681|NCT04435028|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111016682|NCT04435028|Histamine Antagonists|histamine antagonists|mesh-ancestor
111016683|NCT04435028|Histamine Agents|histamine agents|mesh-ancestor
111016684|NCT04435028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111016685|NCT04435028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111016686|NCT04435028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111016687|NCT04435028|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111016688|NCT03945812|Lenograstim|lenograstim|mesh-list
111016689|NCT03945812|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111016690|NCT03945812|Immunologic Factors|immunologic factors|mesh-ancestor
111016691|NCT03945812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111016692|NCT05060198|Lumefantrine|lumefantrine|mesh-list
111016693|NCT05060198|Artemether|artemether|mesh-list
111016694|NCT05060198|Piperaquine|piperaquine|mesh-list
111016695|NCT05060198|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
111016696|NCT05060198|Artenimol|artenimol|mesh-list
111016697|NCT05060198|Antimalarials|antimalarials|mesh-ancestor
111016698|NCT05060198|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111016699|NCT05060198|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111016700|NCT05060198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111016701|NCT04478084|Vaccines|vaccines|mesh-list
111016702|NCT04478084|Immunoglobulins|immunoglobulins|mesh-list
111016703|NCT04478084|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111016704|NCT04478084|Antibodies|antibodies|mesh-list
111016705|NCT04478084|Immunologic Factors|immunologic factors|mesh-ancestor
111016706|NCT04478084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111016707|NCT03098888|Dimercaprol|dimercaprol|mesh-list
111016708|NCT03098888|Chelating Agents|chelating agents|mesh-ancestor
111016709|NCT03098888|Sequestering Agents|sequestering agents|mesh-ancestor
110823043|NCT01366352|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111016710|NCT03098888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111016712|NCT03098810|Astringents|astringents|mesh-ancestor
111016713|NCT03098810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111016714|NCT03098810|Dermatologic Agents|dermatologic agents|mesh-ancestor
111016715|NCT02464761|Verteporfin|verteporfin|mesh-list
111016716|NCT02464761|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111016717|NCT02464761|Dermatologic Agents|dermatologic agents|mesh-ancestor
111016718|NCT02462889|Aflibercept|aflibercept|mesh-list
111016719|NCT02462889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111016720|NCT02462889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111016721|NCT02462889|Growth Substances|growth substances|mesh-ancestor
111016722|NCT02462889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111016723|NCT02462889|Growth Inhibitors|growth inhibitors|mesh-ancestor
111016724|NCT02462889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111016725|NCT02462577|Morphine|morphine|mesh-list
111016726|NCT02462577|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111016727|NCT02462577|Narcotics|narcotics|mesh-ancestor
111016728|NCT02462577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111016729|NCT02462577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111016730|NCT02462577|Analgesics|analgesics|mesh-ancestor
111016731|NCT02462577|Sensory System Agents|sensory system agents|mesh-ancestor
111016732|NCT02462577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111016733|NCT02462499|Eplerenone|eplerenone|mesh-list
111016734|NCT02462499|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
111016735|NCT02462499|Hormone Antagonists|hormone antagonists|mesh-ancestor
111016736|NCT02462499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111016737|NCT02462499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111016738|NCT02462499|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
111016739|NCT02462499|Diuretics|diuretics|mesh-ancestor
111016740|NCT02462499|Natriuretic Agents|natriuretic agents|mesh-ancestor
111016741|NCT02462499|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111016742|NCT02464683|Vitamin D|vitamin d|mesh-list
111016743|NCT02464683|Vitamins|vitamins|mesh-ancestor
111016744|NCT02464683|Micronutrients|micronutrients|mesh-ancestor
111016745|NCT02464683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111016746|NCT02464683|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111016747|NCT02061631|Dexamethasone|dexamethasone|mesh-list
111016748|NCT02061631|Dexamethasone acetate|dexamethasone acetate|mesh-list
111016749|NCT02061631|Docetaxel|docetaxel|mesh-list
111016750|NCT02061631|BB 1101|bb 1101|mesh-list
111016751|NCT02061631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111016752|NCT02061631|Antiemetics|antiemetics|mesh-ancestor
111016753|NCT02061631|Autonomic Agents|autonomic agents|mesh-ancestor
111016754|NCT02061631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111016755|NCT02061631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111016756|NCT02061631|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111016757|NCT02061631|Glucocorticoids|glucocorticoids|mesh-ancestor
111016758|NCT02061631|Hormones|hormones|mesh-ancestor
111016759|NCT02061631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111016760|NCT02061631|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111016761|NCT02061631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111016762|NCT02061631|Protease Inhibitors|protease inhibitors|mesh-ancestor
111016763|NCT02061631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111016764|NCT02061631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110733819|NCT05117710|Sensory System Agents|sensory system agents|mesh-ancestor
110733820|NCT05117710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110733821|NCT05117710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110733822|NCT05117710|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110733823|NCT05117710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111016765|NCT02061631|Tubulin Modulators|tubulin modulators|mesh-ancestor
111016766|NCT02061631|Antimitotic Agents|antimitotic agents|mesh-ancestor
111016767|NCT02061631|Mitosis Modulators|mitosis modulators|mesh-ancestor
111016768|NCT03098342|Amorolfine|amorolfine|mesh-list
111016769|NCT03098342|Methylene Blue|methylene blue|mesh-list
111016770|NCT03098342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111016771|NCT03098342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111016772|NCT03098342|Antifungal Agents|antifungal agents|mesh-ancestor
111016773|NCT03098342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111016774|NCT05059418|Clonazepam|clonazepam|mesh-list
111016775|NCT05059418|Capsaicin|capsaicin|mesh-list
111016776|NCT05059418|Antipruritics|antipruritics|mesh-ancestor
111016777|NCT05059418|Dermatologic Agents|dermatologic agents|mesh-ancestor
111016778|NCT05059418|Sensory System Agents|sensory system agents|mesh-ancestor
111016779|NCT05059418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111016780|NCT05059418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111016782|NCT05059418|GABA Modulators|gaba modulators|mesh-ancestor
111016783|NCT05059418|GABA Agents|gaba agents|mesh-ancestor
111016784|NCT05059418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111016785|NCT05059418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111016786|NCT02062333|Dexmedetomidine|dexmedetomidine|mesh-list
111016787|NCT02062333|Esmolol|esmolol|mesh-list
111016788|NCT02062333|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111016789|NCT02062333|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111016790|NCT02062333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111016791|NCT02062333|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111016792|NCT02062333|Analgesics|analgesics|mesh-ancestor
111016793|NCT02062333|Sensory System Agents|sensory system agents|mesh-ancestor
111016794|NCT02062333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111016795|NCT02062333|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111016796|NCT02062333|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111016797|NCT02062333|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111016798|NCT02062333|Adrenergic Agents|adrenergic agents|mesh-ancestor
111016799|NCT02062333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111016800|NCT02062333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111016801|NCT02062333|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
111016802|NCT02062333|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111016803|NCT02062333|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111016804|NCT05014724|Rozanolixizumab|rozanolixizumab|mesh-list
111016805|NCT05014724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111016806|NCT05014724|Immunologic Factors|immunologic factors|mesh-ancestor
111016807|NCT05014724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111016808|NCT02063425|Fluoxetine|fluoxetine|mesh-list
111016809|NCT02063425|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111016810|NCT02063425|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111016811|NCT02063425|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111016812|NCT02063425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111016813|NCT02063425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111016814|NCT02063425|Serotonin Agents|serotonin agents|mesh-ancestor
111016815|NCT02063425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111016816|NCT02063425|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111016817|NCT02063425|Antidepressive Agents|antidepressive agents|mesh-ancestor
111016818|NCT02063425|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111016819|NCT02063425|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111016820|NCT02063425|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111016821|NCT02063425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111016822|NCT05071118|Pregabalin|pregabalin|mesh-list
111016823|NCT05071118|Analgesics|analgesics|mesh-ancestor
111016824|NCT05071118|Sensory System Agents|sensory system agents|mesh-ancestor
111016825|NCT05071118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111016826|NCT05071118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111016827|NCT05071118|Anticonvulsants|anticonvulsants|mesh-ancestor
111016828|NCT05071118|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111016829|NCT05071118|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111016830|NCT05071118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111016831|NCT05071118|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111016832|NCT05071118|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111016833|NCT05071118|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111016834|NCT05071118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111016835|NCT05071118|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111016836|NCT03559400|Gentamicins|gentamicins|mesh-list
111016837|NCT03559400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111016838|NCT03559400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111016839|NCT03559400|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111016840|NCT03559400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111016841|NCT03559400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111016843|NCT03464019|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111016844|NCT03464019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111016845|NCT03464019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111016846|NCT03464019|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111016847|NCT03464019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111016848|NCT05070416|Lithium Carbonate|lithium carbonate|mesh-list
111016849|NCT05070416|Antidepressive Agents|antidepressive agents|mesh-ancestor
111016850|NCT05070416|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111016851|NCT05070416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110481870|NCT02389465|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111016852|NCT05070416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111016853|NCT05070416|Antimanic Agents|antimanic agents|mesh-ancestor
111016854|NCT05070416|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111016855|NCT05070416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111016856|NCT05070416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111016857|NCT05069870|Itraconazole|itraconazole|mesh-list
111016858|NCT05069870|Rifampin|rifampin|mesh-list
111016859|NCT05069870|Gemfibrozil|gemfibrozil|mesh-list
111016860|NCT05069870|Antifungal Agents|antifungal agents|mesh-ancestor
111016861|NCT05069870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111016862|NCT05069870|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111016863|NCT05069870|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111016864|NCT05069870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111016865|NCT05069870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111016866|NCT05069870|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111016867|NCT05069870|Hormone Antagonists|hormone antagonists|mesh-ancestor
111016868|NCT05069870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111016869|NCT05069870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111016870|NCT05069870|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111016871|NCT05069870|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111016872|NCT05069870|Antitubercular Agents|antitubercular agents|mesh-ancestor
111016873|NCT05069870|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111016874|NCT05069870|Leprostatic Agents|leprostatic agents|mesh-ancestor
111016875|NCT05069870|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111016876|NCT05069870|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111016877|NCT05069870|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111016878|NCT05069870|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
111016879|NCT05069870|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
111016880|NCT05069870|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
111016881|NCT05069870|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111016882|NCT05069870|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111016883|NCT05069870|Antimetabolites|antimetabolites|mesh-ancestor
111016884|NCT05069870|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111016885|NCT05069870|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
111016886|NCT05275491|Calcium|calcium|mesh-list
111016887|NCT05275491|Parathyroid Hormone|parathyroid hormone|mesh-list
111016888|NCT05275491|Hormones|hormones|mesh-list
111016889|NCT05275491|Mitogens|mitogens|mesh-list
111016890|NCT05275491|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111016891|NCT05275491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111016892|NCT05275491|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111016893|NCT05275491|Mitosis Modulators|mitosis modulators|mesh-ancestor
111016894|NCT05275491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111016895|NCT02976753|Factor VIII|factor viii|mesh-list
111016896|NCT02976753|Coagulants|coagulants|mesh-ancestor
111016897|NCT04559529|Levetiracetam|levetiracetam|mesh-list
111016898|NCT04559529|Anticonvulsants|anticonvulsants|mesh-ancestor
111016899|NCT04559529|Nootropic Agents|nootropic agents|mesh-ancestor
111016900|NCT04490421|Etoposide|etoposide|mesh-list
111016901|NCT04490421|Apatinib|apatinib|mesh-list
111016902|NCT04490421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111016903|NCT04490421|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111016904|NCT04490421|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111016905|NCT04490421|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111016906|NCT04490421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111016907|NCT04490421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111016908|NCT04490421|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111016909|NCT04542291|Dapagliflozin|dapagliflozin|mesh-list
111016910|NCT04542291|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110733969|NCT05021913|Viscosupplements|viscosupplements|mesh-ancestor
111016911|NCT04542291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111016912|NCT04542291|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111016913|NCT04542291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111016914|NCT02462109|Lorazepam|lorazepam|mesh-list
111016915|NCT02462109|Anticonvulsants|anticonvulsants|mesh-ancestor
111016916|NCT02462109|Antiemetics|antiemetics|mesh-ancestor
111016917|NCT02462109|Autonomic Agents|autonomic agents|mesh-ancestor
111016918|NCT02462109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111016919|NCT02462109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111016920|NCT02462109|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111016921|NCT02462109|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111016922|NCT02462109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111016923|NCT02462109|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111016924|NCT02462109|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111016925|NCT02462109|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111016926|NCT02462109|GABA Modulators|gaba modulators|mesh-ancestor
111016927|NCT02462109|GABA Agents|gaba agents|mesh-ancestor
111016928|NCT02462109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111016929|NCT02462109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111016930|NCT02063581|Ipatasertib|ipatasertib|mesh-list
111016931|NCT02063581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111016932|NCT02063581|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111016933|NCT02063581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111016934|NCT02063581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111016935|NCT02056899|Gabapentin|gabapentin|mesh-list
111016936|NCT02056899|Analgesics|analgesics|mesh-ancestor
111016937|NCT02056899|Sensory System Agents|sensory system agents|mesh-ancestor
110622804|NCT00570908|Capecitabine|capecitabine|mesh-list
111016938|NCT02056899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111016939|NCT02056899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111016940|NCT02056899|Anticonvulsants|anticonvulsants|mesh-ancestor
111016941|NCT02056899|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111016942|NCT02056899|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111016943|NCT02056899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111016944|NCT02056899|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111016945|NCT02056899|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111016946|NCT02056899|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111016947|NCT02056899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111016948|NCT02056899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111016949|NCT02056899|Antimanic Agents|antimanic agents|mesh-ancestor
111016950|NCT02462265|Mitoxantrone|mitoxantrone|mesh-list
111016951|NCT02462265|Antineoplastic Agents|antineoplastic agents|mesh-list
111016952|NCT02462265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111016953|NCT02462265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111016954|NCT02462265|Analgesics|analgesics|mesh-ancestor
111016955|NCT02462265|Sensory System Agents|sensory system agents|mesh-ancestor
111016956|NCT02462265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111016957|NCT02462265|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111016958|NCT02462265|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111016959|NCT02462265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111016960|NCT02461875|Cabergoline|cabergoline|mesh-list
111016961|NCT02461875|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111016962|NCT02461875|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111016963|NCT02461875|Dopamine Agonists|dopamine agonists|mesh-ancestor
111016964|NCT02461875|Dopamine Agents|dopamine agents|mesh-ancestor
111016965|NCT02461875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111016966|NCT02461875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111016967|NCT02461875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111016968|NCT02461719|Cyclosporine|cyclosporine|mesh-list
111016969|NCT02461719|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111016970|NCT02461719|Cyclosporins|cyclosporins|mesh-list
111016971|NCT02461719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111016972|NCT02461719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111016973|NCT02461719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111016974|NCT02461719|Immunologic Factors|immunologic factors|mesh-ancestor
111016975|NCT02461719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111016976|NCT02461719|Antifungal Agents|antifungal agents|mesh-ancestor
111016977|NCT02461719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111016978|NCT02461719|Dermatologic Agents|dermatologic agents|mesh-ancestor
111016979|NCT02461719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111016980|NCT02461719|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111016981|NCT02461719|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111016982|NCT04322643|Pembrolizumab|pembrolizumab|mesh-list
111016983|NCT04322643|Nivolumab|nivolumab|mesh-list
111016984|NCT04322643|Atezolizumab|atezolizumab|mesh-list
111016985|NCT04322643|Durvalumab|durvalumab|mesh-list
111016986|NCT04322643|Avelumab|avelumab|mesh-list
111016987|NCT04322643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111016988|NCT04322643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111016989|NCT04322643|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111016990|NCT04322643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111016991|NCT02796391|Nicotine|nicotine|mesh-list
111016992|NCT02796391|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111016993|NCT02796391|Autonomic Agents|autonomic agents|mesh-ancestor
111016994|NCT02796391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111016995|NCT02796391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111016996|NCT02796391|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111016997|NCT02796391|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111016998|NCT02796391|Cholinergic Agents|cholinergic agents|mesh-ancestor
111016999|NCT02796391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111017000|NCT02796391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111017002|NCT02064049|Velpatasvir|velpatasvir|mesh-list
111017003|NCT02064049|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
111017004|NCT02064049|Antiviral Agents|antiviral agents|mesh-ancestor
111017005|NCT02064049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111017006|NCT02064829|Paclitaxel|paclitaxel|mesh-list
111017007|NCT02064829|genexol-PM|genexol-pm|mesh-list
111017008|NCT02064829|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111017009|NCT02064829|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111017010|NCT02064829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111017011|NCT02064829|Tubulin Modulators|tubulin modulators|mesh-ancestor
111017012|NCT02064829|Antimitotic Agents|antimitotic agents|mesh-ancestor
111017013|NCT02064829|Mitosis Modulators|mitosis modulators|mesh-ancestor
111017014|NCT02064829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111017015|NCT02064517|Calcium|calcium|mesh-list
111017016|NCT02064517|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111017017|NCT02064517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111017018|NCT02067949|Simvastatin|simvastatin|mesh-list
111017019|NCT02067949|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111017020|NCT02067949|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111017021|NCT02067949|Antimetabolites|antimetabolites|mesh-ancestor
111017022|NCT02067949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111017023|NCT02067949|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111017024|NCT02067949|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111017025|NCT02067949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111017026|NCT02068339|Oltipraz|oltipraz|mesh-list
111017027|NCT02068339|Antiviral Agents|antiviral agents|mesh-ancestor
111017028|NCT02068339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111017029|NCT02068339|Schistosomicides|schistosomicides|mesh-ancestor
111017030|NCT02068339|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
111017031|NCT02068339|Anthelmintics|anthelmintics|mesh-ancestor
111017032|NCT02068339|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111017033|NCT02068339|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
111017034|NCT02068339|Protective Agents|protective agents|mesh-ancestor
111017035|NCT02068339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111017036|NCT02068339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111017037|NCT02068339|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111017038|NCT02068339|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111017039|NCT02068339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111017040|NCT02068339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111017041|NCT02065843|Midazolam|midazolam|mesh-list
111017042|NCT02065843|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111017043|NCT02065843|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111017044|NCT02065843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111017045|NCT02065843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111017046|NCT02065843|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111017047|NCT02065843|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111017048|NCT02065843|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111017049|NCT02065843|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111017050|NCT02065843|Anesthetics, General|anesthetics, general|mesh-ancestor
111017051|NCT02065843|Anesthetics|anesthetics|mesh-ancestor
111017052|NCT02065843|GABA Modulators|gaba modulators|mesh-ancestor
111017053|NCT02065843|GABA Agents|gaba agents|mesh-ancestor
111017054|NCT02065843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111017055|NCT02065843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111017056|NCT02066077|Propofol|propofol|mesh-list
111017057|NCT02066077|Etomidate|etomidate|mesh-list
111017058|NCT02066077|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111017059|NCT02066077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111017060|NCT02066077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111017061|NCT02066077|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111017063|NCT02066077|Anesthetics|anesthetics|mesh-ancestor
111017064|NCT03350815|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111017065|NCT03350815|Immunologic Factors|immunologic factors|mesh-ancestor
111017066|NCT03350815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111017067|NCT02065063|Palbociclib|palbociclib|mesh-list
111017068|NCT02065063|Trametinib|trametinib|mesh-list
111017069|NCT02065063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111017070|NCT02065063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111017071|NCT02065063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111017072|NCT02065063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111017073|NCT02069197|Orlistat|orlistat|mesh-list
111017074|NCT02069197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110823044|NCT01366352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111017075|NCT02069197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111017077|NCT02069197|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111017078|NCT02069431|Oxytocin|oxytocin|mesh-list
111017079|NCT02069431|Oxytocics|oxytocics|mesh-ancestor
111017080|NCT02069431|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111017081|NCT02069431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111017082|NCT01652872|Darbepoetin alfa|darbepoetin alfa|mesh-list
111017083|NCT01652872|Hematinics|hematinics|mesh-ancestor
111017084|NCT02065219|Bupivacaine|bupivacaine|mesh-list
111017085|NCT02065219|Anesthetics, Local|anesthetics, local|mesh-ancestor
111017086|NCT02065219|Anesthetics|anesthetics|mesh-ancestor
111017087|NCT02065219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111017088|NCT02065219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111017089|NCT02065219|Sensory System Agents|sensory system agents|mesh-ancestor
111017090|NCT02065219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111017091|NCT03560011|Immunoglobulins|immunoglobulins|mesh-list
111017092|NCT03560011|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111017093|NCT03560011|Antibodies|antibodies|mesh-list
111017094|NCT03560011|Immunologic Factors|immunologic factors|mesh-ancestor
111017095|NCT03560011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111017096|NCT02069665|Ribavirin|ribavirin|mesh-list
111017097|NCT02069665|Ibuprofen|ibuprofen|mesh-list
111017098|NCT02069665|Phenylpropanolamine|phenylpropanolamine|mesh-list
111017099|NCT02069665|Albuterol|albuterol|mesh-list
111017100|NCT02069665|Guaifenesin|guaifenesin|mesh-list
111017101|NCT02069665|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
111017102|NCT02069665|Antimetabolites|antimetabolites|mesh-ancestor
111017103|NCT02069665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111017104|NCT02069665|Antiviral Agents|antiviral agents|mesh-ancestor
111017105|NCT02069665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111017106|NCT02069665|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111017107|NCT02069665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111017108|NCT02069665|Analgesics|analgesics|mesh-ancestor
111017109|NCT02069665|Sensory System Agents|sensory system agents|mesh-ancestor
111017110|NCT02069665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111017111|NCT02069665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111017112|NCT02069665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111017113|NCT02069665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111017114|NCT02069665|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111017115|NCT02069665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111017116|NCT02069665|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111017117|NCT02069665|Autonomic Agents|autonomic agents|mesh-ancestor
111017118|NCT02069665|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111017119|NCT02069665|Respiratory System Agents|respiratory system agents|mesh-ancestor
111017120|NCT02069665|Tocolytic Agents|tocolytic agents|mesh-ancestor
111017121|NCT02069665|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111017122|NCT02069665|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111017123|NCT02069665|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111017124|NCT02069665|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111017125|NCT02069665|Adrenergic Agents|adrenergic agents|mesh-ancestor
111017126|NCT02069665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111017127|NCT02069665|Expectorants|expectorants|mesh-ancestor
111017128|NCT02069665|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111017129|NCT02069665|Appetite Depressants|appetite depressants|mesh-ancestor
111017130|NCT02069665|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111017131|NCT02069665|Sympathomimetics|sympathomimetics|mesh-ancestor
111017132|NCT02069665|Nasal Decongestants|nasal decongestants|mesh-ancestor
111017133|NCT02069665|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111017134|NCT04938856|Lamotrigine|lamotrigine|mesh-list
111017135|NCT04938856|Anticonvulsants|anticonvulsants|mesh-ancestor
111017136|NCT04938856|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110734189|NCT04557527|Immunologic Factors|immunologic factors|mesh-ancestor
111017137|NCT04938856|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111017138|NCT04938856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111017139|NCT04938856|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111017140|NCT04938856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111017141|NCT04938856|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111017142|NCT04938856|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111017143|NCT04938856|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111017144|NCT04938856|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111017145|NCT04938856|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111017146|NCT02461329|Polygeline|polygeline|mesh-list
111017147|NCT02461329|Plasma Substitutes|plasma substitutes|mesh-ancestor
111017148|NCT02461329|Blood Substitutes|blood substitutes|mesh-ancestor
111017149|NCT02463825|Pimozide|pimozide|mesh-list
111017151|NCT02463825|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111017152|NCT02463825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111017153|NCT02463825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111017154|NCT02463825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111017155|NCT02463825|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111017156|NCT02463825|Dopamine Agents|dopamine agents|mesh-ancestor
111017157|NCT02463825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111017158|NCT02463825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111017159|NCT02463825|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111017160|NCT02069977|Aripiprazole|aripiprazole|mesh-list
111017161|NCT02069977|Antidepressive Agents|antidepressive agents|mesh-ancestor
111017162|NCT02069977|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111017163|NCT02069977|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111017164|NCT02069977|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111017165|NCT02069977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111017166|NCT02069977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111017167|NCT02069977|Dopamine Agonists|dopamine agonists|mesh-ancestor
111017168|NCT02069977|Dopamine Agents|dopamine agents|mesh-ancestor
111017169|NCT02069977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111017170|NCT02069977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111017171|NCT02069977|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111017172|NCT02069977|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111017173|NCT02069977|Serotonin Agents|serotonin agents|mesh-ancestor
111017174|NCT02069977|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111017175|NCT02069977|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111017176|NCT02069977|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111017177|NCT02069977|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111017178|NCT04490031|Ketamine|ketamine|mesh-list
111017179|NCT04490031|Analgesics|analgesics|mesh-ancestor
111017180|NCT04490031|Sensory System Agents|sensory system agents|mesh-ancestor
111017181|NCT04490031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111017182|NCT04490031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111017183|NCT04490031|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111017184|NCT04490031|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111017185|NCT04490031|Anesthetics, General|anesthetics, general|mesh-ancestor
111017186|NCT04490031|Anesthetics|anesthetics|mesh-ancestor
111017187|NCT04490031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111017188|NCT04490031|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111017189|NCT04490031|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111017190|NCT04490031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111017191|NCT04490031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111017192|NCT02443402|Insulin|insulin|mesh-list
111017193|NCT02443402|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111017194|NCT02443402|Insulin Glargine|insulin glargine|mesh-list
111017195|NCT02443402|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111017196|NCT02443402|Insulin Aspart|insulin aspart|mesh-list
111017197|NCT02443402|Insulin Lispro|insulin lispro|mesh-list
111017198|NCT02443402|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111017199|NCT02443402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111017200|NCT02443402|Incretins|incretins|mesh-ancestor
111017201|NCT02443402|Hormones|hormones|mesh-ancestor
111017202|NCT02443402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111017203|NCT02443402|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111017204|NCT02443402|Protease Inhibitors|protease inhibitors|mesh-ancestor
111017205|NCT02443402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111017206|NCT02443402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111017207|NCT02067013|Ranibizumab|ranibizumab|mesh-list
111017208|NCT02067013|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111017209|NCT02067013|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111017210|NCT02067013|Growth Substances|growth substances|mesh-ancestor
111017211|NCT02067013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111017212|NCT02067013|Growth Inhibitors|growth inhibitors|mesh-ancestor
111017213|NCT02067013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111017214|NCT03298581|Clobetasol|clobetasol|mesh-list
111017215|NCT03298581|Halobetasol|halobetasol|mesh-list
111017216|NCT03298581|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111017217|NCT03298581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111017218|NCT03298581|Glucocorticoids|glucocorticoids|mesh-ancestor
111017219|NCT03298581|Hormones|hormones|mesh-ancestor
111017220|NCT03298581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111017221|NCT03298581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111017222|NCT01370005|Empagliflozin|empagliflozin|mesh-list
110823045|NCT01366352|Sensory System Agents|sensory system agents|mesh-ancestor
111017223|NCT01370005|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111017224|NCT01370005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111017225|NCT01370005|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111017226|NCT01370005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111017227|NCT02070133|Simvastatin|simvastatin|mesh-list
111017228|NCT02070133|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111017229|NCT02070133|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111017230|NCT02070133|Antimetabolites|antimetabolites|mesh-ancestor
111017231|NCT02070133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111017232|NCT02070133|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111017233|NCT02070133|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111017234|NCT02070133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111017235|NCT02070289|PF-06372865|pf-06372865|mesh-list
111017236|NCT02070289|GABA Modulators|gaba modulators|mesh-ancestor
111017237|NCT02070289|GABA Agents|gaba agents|mesh-ancestor
111017238|NCT02070289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111017239|NCT02070289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111017240|NCT02070289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111017241|NCT02071927|Azacitidine|azacitidine|mesh-list
111017242|NCT02071927|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111017243|NCT02071927|Antimetabolites|antimetabolites|mesh-ancestor
111017244|NCT02071927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111017245|NCT02071927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111017246|NCT02071927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111017247|NCT02072083|Dexmedetomidine|dexmedetomidine|mesh-list
111017248|NCT02072083|Ketamine|ketamine|mesh-list
111017249|NCT02072083|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111017250|NCT02072083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111017251|NCT02072083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111017252|NCT02072083|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111017253|NCT02072083|Analgesics|analgesics|mesh-ancestor
111017254|NCT02072083|Sensory System Agents|sensory system agents|mesh-ancestor
111017255|NCT02072083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111017256|NCT02072083|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111017257|NCT02072083|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111017258|NCT02072083|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111017259|NCT02072083|Adrenergic Agents|adrenergic agents|mesh-ancestor
111017260|NCT02072083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111017261|NCT02072083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111017262|NCT02072083|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111017263|NCT02072083|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111017264|NCT02072083|Anesthetics, General|anesthetics, general|mesh-ancestor
111017265|NCT02072083|Anesthetics|anesthetics|mesh-ancestor
111017266|NCT02072083|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111017267|NCT02072083|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111017268|NCT02070679|Vitamin E|vitamin e|mesh-list
111017269|NCT02070679|Tocopherols|tocopherols|mesh-list
111017270|NCT02070679|alpha-Tocopherol|alpha-tocopherol|mesh-list
111017271|NCT02070679|Vitamins|vitamins|mesh-ancestor
111017272|NCT02070679|Micronutrients|micronutrients|mesh-ancestor
111017273|NCT02070679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111017274|NCT02070679|Antioxidants|antioxidants|mesh-ancestor
111017275|NCT02070679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111017276|NCT02070679|Protective Agents|protective agents|mesh-ancestor
111017277|NCT02412436|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
111017278|NCT02412436|Medroxyprogesterone|medroxyprogesterone|mesh-list
111017279|NCT02412436|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111017280|NCT02412436|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111017281|NCT02412436|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111017282|NCT02412436|Contraceptive Agents|contraceptive agents|mesh-ancestor
111017283|NCT02412436|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111017284|NCT02412436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111017285|NCT02412436|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111017286|NCT02412436|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111017287|NCT02412436|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
111017288|NCT02412436|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111017289|NCT02412436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111017290|NCT02067715|Hydrogen Peroxide|hydrogen peroxide|mesh-list
111017291|NCT02067715|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111017292|NCT02067715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111017293|NCT02072317|Raltitrexed|raltitrexed|mesh-list
111017294|NCT02072317|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111017295|NCT02072317|Antimetabolites|antimetabolites|mesh-ancestor
111017296|NCT02072317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111017297|NCT02072317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111017298|NCT02072317|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111017299|NCT02072317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111017300|NCT01651000|Calcifediol|calcifediol|mesh-list
111017301|NCT01651000|Vitamins|vitamins|mesh-ancestor
111017302|NCT01651000|Micronutrients|micronutrients|mesh-ancestor
111017303|NCT01651000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111017304|NCT01651000|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111017305|NCT02469610|Bupivacaine|bupivacaine|mesh-list
111017306|NCT02469610|Anesthetics, Local|anesthetics, local|mesh-ancestor
111017307|NCT02469610|Anesthetics|anesthetics|mesh-ancestor
111017308|NCT02469610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111017309|NCT02469610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111017310|NCT02469610|Sensory System Agents|sensory system agents|mesh-ancestor
111017311|NCT02469610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111017312|NCT02071069|Fluorouracil|fluorouracil|mesh-list
111017313|NCT02071069|Irinotecan|irinotecan|mesh-list
111017314|NCT02071069|Cetuximab|cetuximab|mesh-list
111017315|NCT02071069|Antimetabolites|antimetabolites|mesh-ancestor
111017316|NCT02071069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111017317|NCT02071069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111017318|NCT02071069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111017319|NCT02071069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111017320|NCT02071069|Immunologic Factors|immunologic factors|mesh-ancestor
111017321|NCT02071069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111017322|NCT02071069|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111017323|NCT02071069|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111017324|NCT02071069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111017325|NCT02071069|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111017326|NCT02076373|Epoetin Alfa|epoetin alfa|mesh-list
111017327|NCT02076373|Hematinics|hematinics|mesh-ancestor
111017328|NCT02072785|Vincristine|vincristine|mesh-list
111017329|NCT02072785|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111017330|NCT02072785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111017331|NCT02072785|Tubulin Modulators|tubulin modulators|mesh-ancestor
111017332|NCT02072785|Antimitotic Agents|antimitotic agents|mesh-ancestor
111017333|NCT02072785|Mitosis Modulators|mitosis modulators|mesh-ancestor
111017334|NCT02072785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111017335|NCT02469298|Oseltamivir|oseltamivir|mesh-list
111017336|NCT02469298|Antiviral Agents|antiviral agents|mesh-ancestor
111017337|NCT02469298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111017338|NCT02469298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111017339|NCT02469298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111017340|NCT02076451|DS-8273a|ds-8273a|mesh-list
111017341|NCT02076451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111017342|NCT02076451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111017343|NCT02071303|Celecoxib|celecoxib|mesh-list
111017344|NCT02071303|Tramadol|tramadol|mesh-list
111017345|NCT02071303|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111017346|NCT02071303|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111017347|NCT02071303|Analgesics|analgesics|mesh-ancestor
111017348|NCT02071303|Sensory System Agents|sensory system agents|mesh-ancestor
111017349|NCT02071303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111017350|NCT02071303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111017351|NCT02071303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111017352|NCT02071303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111017353|NCT02071303|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111017354|NCT02071303|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111017355|NCT02071303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111017356|NCT02071303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111017357|NCT02071303|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111017358|NCT02071303|Narcotics|narcotics|mesh-ancestor
111017359|NCT02071303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111017360|NCT02076529|Ramosetron|ramosetron|mesh-list
111017361|NCT02076529|Antiemetics|antiemetics|mesh-ancestor
111017363|NCT02076529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111017364|NCT02076529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111017365|NCT02076529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111017366|NCT02076529|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111017367|NCT02076529|Serotonin Agents|serotonin agents|mesh-ancestor
111017368|NCT02076529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111017369|NCT02076529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111017370|NCT02411578|Glucagon|glucagon|mesh-list
111017371|NCT02411578|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
111017372|NCT02411578|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111017373|NCT02411578|Hormones|hormones|mesh-ancestor
111017374|NCT02411578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111017375|NCT02411578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111017376|NCT02411578|Incretins|incretins|mesh-ancestor
111017377|NCT02076685|Isoniazid|isoniazid|mesh-list
111017378|NCT02076685|Antitubercular Agents|antitubercular agents|mesh-ancestor
111017379|NCT02076685|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111017380|NCT02076685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111017381|NCT02076685|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
111017382|NCT02076685|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111017383|NCT02076685|Antimetabolites|antimetabolites|mesh-ancestor
111017384|NCT02076685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111017385|NCT02076685|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111017386|NCT05077917|Cromolyn Sodium|cromolyn sodium|mesh-list
111017387|NCT05077917|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
111017388|NCT05077917|Immunologic Factors|immunologic factors|mesh-ancestor
111017389|NCT05077917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111017390|NCT05077917|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111017391|NCT05077917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111017392|NCT05077917|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111017393|NCT05077917|Respiratory System Agents|respiratory system agents|mesh-ancestor
111017394|NCT02071459|Droxidopa|droxidopa|mesh-list
111017395|NCT02071459|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111017396|NCT02071459|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111017397|NCT02463747|Vancomycin|vancomycin|mesh-list
111017398|NCT02463747|Meropenem|meropenem|mesh-list
111017399|NCT02463747|Tazobactam|tazobactam|mesh-list
111017400|NCT02463747|Piperacillin|piperacillin|mesh-list
111017401|NCT02463747|Ceftazidime|ceftazidime|mesh-list
111017402|NCT02463747|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
111017403|NCT02463747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111017404|NCT02463747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111017405|NCT02463747|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
111017406|NCT02463747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111017407|NCT02463747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111017408|NCT02071537|Chloroquine|chloroquine|mesh-list
111017409|NCT02071537|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
111017410|NCT02071537|Carboplatin|carboplatin|mesh-list
111017411|NCT02071537|Gemcitabine|gemcitabine|mesh-list
111017412|NCT02071537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111017413|NCT02071537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111017414|NCT02071537|Antimetabolites|antimetabolites|mesh-ancestor
111017415|NCT02071537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111017416|NCT02071537|Amebicides|amebicides|mesh-ancestor
111017417|NCT02071537|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111017418|NCT02071537|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111017419|NCT02071537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111017420|NCT02071537|Antimalarials|antimalarials|mesh-ancestor
111017421|NCT02071537|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111017422|NCT02071537|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111017423|NCT02071537|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111017424|NCT02071537|Analgesics|analgesics|mesh-ancestor
111017425|NCT02071537|Sensory System Agents|sensory system agents|mesh-ancestor
111017426|NCT02071537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111017427|NCT02071537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111017428|NCT02071537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111017429|NCT02071537|Filaricides|filaricides|mesh-ancestor
111017430|NCT02071537|Antinematodal Agents|antinematodal agents|mesh-ancestor
111017431|NCT02071537|Anthelmintics|anthelmintics|mesh-ancestor
111017432|NCT02076841|Interferons|interferons|mesh-list
111017433|NCT02076841|Interferon-beta|interferon-beta|mesh-list
111017434|NCT02076841|Interferon beta-1a|interferon beta-1a|mesh-list
111017435|NCT02076841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111017436|NCT02076841|Antiviral Agents|antiviral agents|mesh-ancestor
111017437|NCT02076841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111017438|NCT02076841|Immunologic Factors|immunologic factors|mesh-ancestor
111017439|NCT02076841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111017440|NCT02076841|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111017441|NCT02442310|Deferiprone|deferiprone|mesh-list
111017442|NCT02442310|Iron Chelating Agents|iron chelating agents|mesh-ancestor
111017443|NCT02442310|Chelating Agents|chelating agents|mesh-ancestor
111017444|NCT02442310|Sequestering Agents|sequestering agents|mesh-ancestor
111017445|NCT02442310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111017446|NCT02071615|Caffeine|caffeine|mesh-list
111017447|NCT02071615|Methylphenidate|methylphenidate|mesh-list
111017448|NCT02071615|Modafinil|modafinil|mesh-list
111017449|NCT02071615|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111017450|NCT02071615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111017451|NCT02071615|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111017452|NCT02071615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111017453|NCT02071615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111017454|NCT02071615|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
111017455|NCT02071615|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111017456|NCT02071615|Purinergic Agents|purinergic agents|mesh-ancestor
111017457|NCT02071615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111017458|NCT02071615|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111017459|NCT02071615|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111017460|NCT02071615|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111017461|NCT02071615|Dopamine Agents|dopamine agents|mesh-ancestor
111017462|NCT02071615|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
111017463|NCT02071615|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111017464|NCT02071615|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111017466|NCT02077231|Vitamin A|vitamin a|mesh-list
111017467|NCT02077231|Retinol palmitate|retinol palmitate|mesh-list
111017468|NCT02077231|Micronutrients|micronutrients|mesh-ancestor
111017469|NCT02077231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111017470|NCT02077231|Antioxidants|antioxidants|mesh-ancestor
111017471|NCT02077231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111017472|NCT02077231|Protective Agents|protective agents|mesh-ancestor
111017473|NCT02077231|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
111017474|NCT02077231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111017475|NCT02077309|Linagliptin|linagliptin|mesh-list
111017476|NCT02077309|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111017477|NCT02077309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111017478|NCT02077309|Incretins|incretins|mesh-ancestor
111017479|NCT02077309|Hormones|hormones|mesh-ancestor
111017480|NCT02077309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111017481|NCT02077309|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111017482|NCT02077309|Protease Inhibitors|protease inhibitors|mesh-ancestor
111017483|NCT02077309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111017484|NCT02077309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111017485|NCT01369849|Rituximab|rituximab|mesh-list
111017486|NCT01369849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111017487|NCT01369849|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
111017488|NCT01369849|Antibodies|antibodies|mesh-list
111017489|NCT01369849|Immunoglobulins|immunoglobulins|mesh-list
111017490|NCT01369849|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111017491|NCT01369849|Immunologic Factors|immunologic factors|mesh-ancestor
111017492|NCT01369849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111017493|NCT01369849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111017494|NCT01369849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111017495|NCT01369849|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111017496|NCT01369849|Alkylating Agents|alkylating agents|mesh-ancestor
111017497|NCT01369849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111017498|NCT02716779|Interferons|interferons|mesh-list
111017499|NCT02716779|Ribavirin|ribavirin|mesh-list
111017500|NCT02716779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111017501|NCT02716779|Antiviral Agents|antiviral agents|mesh-ancestor
111017502|NCT02716779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111017503|NCT02716779|Antimetabolites|antimetabolites|mesh-ancestor
111017504|NCT02716779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111017505|NCT02074189|Gemcitabine|gemcitabine|mesh-list
110622923|NCT00777218|Topiramate|topiramate|mesh-list
111017506|NCT02074189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111017507|NCT02074189|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111017508|NCT02074189|Antimetabolites|antimetabolites|mesh-ancestor
111017509|NCT02074189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111017510|NCT02463591|Thrombin|thrombin|mesh-list
111017511|NCT02463591|Hemostatics|hemostatics|mesh-ancestor
110734571|NCT03980509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110734573|NCT03980509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111017512|NCT02463591|Coagulants|coagulants|mesh-ancestor
111017513|NCT02079961|Micronutrients|micronutrients|mesh-list
111017514|NCT02079961|Trace Elements|trace elements|mesh-list
111017515|NCT02079961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111017516|NCT03298347|Caffeine|caffeine|mesh-list
111017517|NCT03298347|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111017518|NCT03298347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111017519|NCT03298347|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111017520|NCT03298347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110823047|NCT03490396|Povidone|povidone|mesh-list
111017521|NCT03298347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111017522|NCT03298347|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
111017523|NCT03298347|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111017524|NCT03298347|Purinergic Agents|purinergic agents|mesh-ancestor
111017525|NCT03298347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111017527|NCT02074267|Analgesics|analgesics|mesh-ancestor
111017528|NCT02074267|Sensory System Agents|sensory system agents|mesh-ancestor
111017529|NCT02074267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111017530|NCT02074267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111017531|NCT02074267|Anticonvulsants|anticonvulsants|mesh-ancestor
111017532|NCT02074267|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111017533|NCT02074267|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111017534|NCT02074267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111017535|NCT02074267|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111017536|NCT02074267|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111017537|NCT02074267|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111017538|NCT02074267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111017539|NCT02074267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111017540|NCT02074267|Antimanic Agents|antimanic agents|mesh-ancestor
111017541|NCT02077777|Aminosalicylic Acid|aminosalicylic acid|mesh-list
111017542|NCT02077777|Mesalamine|mesalamine|mesh-list
111017543|NCT02077777|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111017544|NCT02077777|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111017545|NCT02077777|Analgesics|analgesics|mesh-ancestor
111017546|NCT02077777|Sensory System Agents|sensory system agents|mesh-ancestor
111017547|NCT02077777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111017548|NCT02077777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111017549|NCT02077777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111017550|NCT02077777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111017551|NCT02077777|Antitubercular Agents|antitubercular agents|mesh-ancestor
111017552|NCT02077777|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111017553|NCT02077777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111017554|NCT05036421|Empagliflozin|empagliflozin|mesh-list
111017555|NCT05036421|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111017556|NCT05036421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111017557|NCT05036421|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111017558|NCT05036421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111017559|NCT03298191|Magnesium Sulfate|magnesium sulfate|mesh-list
111017560|NCT03298191|Calcium Channel Blockers|calcium channel blockers|mesh-list
111017561|NCT03298191|Ritodrine|ritodrine|mesh-list
111017562|NCT03298191|Calcium|calcium|mesh-list
111017563|NCT03298191|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111017564|NCT03298191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111017565|NCT03298191|Analgesics|analgesics|mesh-ancestor
111017566|NCT03298191|Sensory System Agents|sensory system agents|mesh-ancestor
111017567|NCT03298191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111017568|NCT03298191|Anesthetics|anesthetics|mesh-ancestor
111017569|NCT03298191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111017570|NCT03298191|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111017571|NCT03298191|Anticonvulsants|anticonvulsants|mesh-ancestor
111017572|NCT03298191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111017573|NCT03298191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111017574|NCT03298191|Tocolytic Agents|tocolytic agents|mesh-ancestor
111017575|NCT03298191|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111017576|NCT03298191|Sympathomimetics|sympathomimetics|mesh-ancestor
111017577|NCT03298191|Autonomic Agents|autonomic agents|mesh-ancestor
111017578|NCT03298191|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111017579|NCT03298191|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111017580|NCT03298191|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111017581|NCT03298191|Adrenergic Agents|adrenergic agents|mesh-ancestor
111017582|NCT03298191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111017583|NCT01369615|Oxycodone|oxycodone|mesh-list
111017584|NCT01369615|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111017585|NCT01369615|Narcotics|narcotics|mesh-ancestor
111017586|NCT01369615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111017587|NCT01369615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111017588|NCT01369615|Analgesics|analgesics|mesh-ancestor
111017589|NCT01369615|Sensory System Agents|sensory system agents|mesh-ancestor
111017590|NCT01369615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111017591|NCT02077933|Everolimus|everolimus|mesh-list
111017592|NCT02077933|Exemestane|exemestane|mesh-list
111017593|NCT02077933|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111017594|NCT02077933|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110482617|NCT02873351|Levodopa|levodopa|mesh-list
111017595|NCT02077933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111017596|NCT02077933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111017597|NCT02077933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111017598|NCT02077933|Immunologic Factors|immunologic factors|mesh-ancestor
111017599|NCT02077933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111017600|NCT02077933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111017601|NCT02077933|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111017602|NCT02077933|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111017603|NCT02077933|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111017604|NCT02077933|Hormone Antagonists|hormone antagonists|mesh-ancestor
111017605|NCT02077933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111017606|NCT02078089|Oxcarbazepine|oxcarbazepine|mesh-list
111017608|NCT02078089|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111017609|NCT02078089|Narcotics|narcotics|mesh-ancestor
111017610|NCT02078089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111017611|NCT02078089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111017612|NCT02078089|Analgesics|analgesics|mesh-ancestor
111017613|NCT02078089|Sensory System Agents|sensory system agents|mesh-ancestor
111017614|NCT02078089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111017615|NCT02078089|Anticonvulsants|anticonvulsants|mesh-ancestor
111017616|NCT02078089|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111017617|NCT02078089|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111017618|NCT02078089|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111017619|NCT02078089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111017620|NCT02078089|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111017621|NCT02078089|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111017622|NCT02074891|Tenofovir|tenofovir|mesh-list
111017623|NCT02074891|Antiviral Agents|antiviral agents|mesh-ancestor
111017624|NCT02074891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111017625|NCT02074891|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111017626|NCT02074891|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111017627|NCT02074891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111017628|NCT02074891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111017629|NCT02074891|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111017630|NCT02074891|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111017631|NCT02078167|Policosanol|policosanol|mesh-list
111017632|NCT02078167|Red yeast rice|red yeast rice|mesh-list
111017633|NCT02078167|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111017634|NCT02078167|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111017635|NCT02078167|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111017636|NCT02078167|Antimetabolites|antimetabolites|mesh-ancestor
111017637|NCT02078167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111017638|NCT02078167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111017639|NCT02078167|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111017640|NCT02078167|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111017641|NCT02078323|Linaclotide|linaclotide|mesh-list
111017642|NCT02078323|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
111017643|NCT02078323|Enzyme Activators|enzyme activators|mesh-ancestor
111017644|NCT02078323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110622935|NCT00777218|Anticonvulsants|anticonvulsants|mesh-ancestor
111017645|NCT02078323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111017646|NCT02075749|Triamcinolone|triamcinolone|mesh-list
111017647|NCT02075749|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
111017648|NCT02075749|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
111017649|NCT02075749|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
111017650|NCT02075749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111017651|NCT02075749|Glucocorticoids|glucocorticoids|mesh-ancestor
111017652|NCT02075749|Hormones|hormones|mesh-ancestor
111017653|NCT02075749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111017654|NCT02075749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111017655|NCT02075749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111017656|NCT02075749|Immunologic Factors|immunologic factors|mesh-ancestor
111017657|NCT02075749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111017658|NCT02075749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111017659|NCT02081287|Inositol|inositol|mesh-list
111017660|NCT02081287|Lamotrigine|lamotrigine|mesh-list
111017661|NCT02081287|Anticonvulsants|anticonvulsants|mesh-ancestor
111017662|NCT02081287|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111017663|NCT02081287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111017664|NCT02081287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111017665|NCT02081287|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111017666|NCT02081287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111017667|NCT02081287|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111017668|NCT02081287|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111017669|NCT02081287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111017670|NCT02081287|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111017671|NCT02081287|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111017672|NCT02081287|Vitamin B Complex|vitamin b complex|mesh-ancestor
111017674|NCT02081287|Micronutrients|micronutrients|mesh-ancestor
111017675|NCT02078791|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111017676|NCT02078791|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111017677|NCT02078791|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111017678|NCT02078791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111017679|NCT02078791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111017680|NCT02078791|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111017681|NCT02078791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111017682|NCT02078791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111017683|NCT02078791|Cholinergic Agents|cholinergic agents|mesh-ancestor
111017684|NCT02078791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111017685|NCT04918069|Capsaicin|capsaicin|mesh-list
111017686|NCT04918069|Antipruritics|antipruritics|mesh-ancestor
111017687|NCT04918069|Dermatologic Agents|dermatologic agents|mesh-ancestor
111017688|NCT04918069|Sensory System Agents|sensory system agents|mesh-ancestor
111017689|NCT04918069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111017690|NCT04918069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111017691|NCT02083315|Morphine|morphine|mesh-list
111017692|NCT02083315|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111017693|NCT02083315|Narcotics|narcotics|mesh-ancestor
111017694|NCT02083315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111017695|NCT02083315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111017696|NCT02083315|Analgesics|analgesics|mesh-ancestor
111017697|NCT02083315|Sensory System Agents|sensory system agents|mesh-ancestor
111017698|NCT02083315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111017699|NCT03559387|Lenograstim|lenograstim|mesh-list
111017700|NCT03559387|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111017701|NCT03559387|Immunologic Factors|immunologic factors|mesh-ancestor
111017702|NCT03559387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111017703|NCT05519059|Paclitaxel|paclitaxel|mesh-list
111017704|NCT05519059|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111017705|NCT05519059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111017706|NCT05519059|Tubulin Modulators|tubulin modulators|mesh-ancestor
111017707|NCT05519059|Antimitotic Agents|antimitotic agents|mesh-ancestor
111017708|NCT05519059|Mitosis Modulators|mitosis modulators|mesh-ancestor
111017709|NCT05519059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111017710|NCT02079337|Rocuronium|rocuronium|mesh-list
111017711|NCT02079337|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
111017712|NCT02079337|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
111017713|NCT02079337|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111017714|NCT02079337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111017715|NCT02079337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111017716|NCT02083627|Fidaxomicin|fidaxomicin|mesh-list
111017717|NCT02083627|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111017718|NCT02083627|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111017719|NCT02083627|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111017720|NCT02083627|Antimetabolites|antimetabolites|mesh-ancestor
111017721|NCT02083627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111017722|NCT02083627|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111017723|NCT02083627|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111017724|NCT02083627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110823050|NCT03490396|Immunologic Factors|immunologic factors|mesh-ancestor
110823065|NCT03496246|Alfacalcidol|alfacalcidol|mesh-list
110823218|NCT01372904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110823290|NCT04742140|Anesthetics|anesthetics|mesh-ancestor
111017725|NCT02083627|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110823434|NCT03494686|Anesthetics|anesthetics|mesh-list
110823435|NCT03494686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110823436|NCT03494686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110823437|NCT03487198|Brexpiprazole|brexpiprazole|mesh-list
110823438|NCT03487198|Serotonin Agents|serotonin agents|mesh-ancestor
110823655|NCT01373684|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110823656|NCT01373684|Entecavir|entecavir|mesh-list
110823657|NCT01373684|Adefovir|adefovir|mesh-list
110823748|NCT05197088|Tamsulosin|tamsulosin|mesh-list
110823807|NCT03135262|Immunologic Factors|immunologic factors|mesh-ancestor
110823960|NCT05193734|Hemagglutinins|hemagglutinins|mesh-list
111017726|NCT02083627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111017727|NCT02079727|Celecoxib|celecoxib|mesh-list
111017728|NCT02079727|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110824625|NCT03482440|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111017729|NCT02079727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111017730|NCT02079727|Analgesics|analgesics|mesh-ancestor
110824848|NCT03912727|Vitamins|vitamins|mesh-ancestor
110824930|NCT03525834|Everolimus|everolimus|mesh-list
111017731|NCT02079727|Sensory System Agents|sensory system agents|mesh-ancestor
111017732|NCT02079727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110825368|NCT01149577|Olanzapine|olanzapine|mesh-list
110825445|NCT01256905|Modafinil|modafinil|mesh-list
110825661|NCT01257529|Pregabalin|pregabalin|mesh-list
110734792|NCT03412773|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110799535|NCT05320107|Anesthetics, General|anesthetics, general|mesh-ancestor
111017733|NCT02079727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110825888|NCT03891277|Hematinics|hematinics|mesh-ancestor
111017734|NCT02079727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111017736|NCT02079727|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111017737|NCT02079727|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110826783|NCT01327235|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110826860|NCT03877705|Sodium Fluoride|sodium fluoride|mesh-list
111017739|NCT02079727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111017740|NCT02082067|Ketorolac|ketorolac|mesh-list
111017741|NCT02082067|Morphine|morphine|mesh-list
111017742|NCT02082067|Anesthetics|anesthetics|mesh-list
111017743|NCT02082067|Ropivacaine|ropivacaine|mesh-list
111017744|NCT02082067|Levobupivacaine|levobupivacaine|mesh-list
111017745|NCT02082067|Anesthetics, Local|anesthetics, local|mesh-list
111017746|NCT02082067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111017747|NCT02082067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111017748|NCT02082067|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111017749|NCT02082067|Narcotics|narcotics|mesh-ancestor
111017750|NCT02082067|Analgesics|analgesics|mesh-ancestor
111017751|NCT02082067|Sensory System Agents|sensory system agents|mesh-ancestor
111017752|NCT02082067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111017753|NCT02082067|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111017754|NCT02082067|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111017755|NCT02082067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111017756|NCT02082067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111017757|NCT02082067|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111017758|NCT02082067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111017759|NCT02082067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111017760|NCT02084563|Cytarabine|cytarabine|mesh-list
111017761|NCT02084563|Decitabine|decitabine|mesh-list
111017762|NCT02084563|Daunorubicin|daunorubicin|mesh-list
111017763|NCT02084563|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111017764|NCT02084563|Antimetabolites|antimetabolites|mesh-ancestor
111017765|NCT02084563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111017766|NCT02084563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111017767|NCT02084563|Antiviral Agents|antiviral agents|mesh-ancestor
111017768|NCT02084563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111017769|NCT02084563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111017770|NCT02084563|Immunologic Factors|immunologic factors|mesh-ancestor
111017771|NCT02084563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111017772|NCT02084563|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111017773|NCT02084563|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111017774|NCT02084563|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111017775|NCT02084563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111017776|NCT02084719|Antibodies|antibodies|mesh-list
111017777|NCT02084719|Immunologic Factors|immunologic factors|mesh-ancestor
111017778|NCT02084719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111017779|NCT02084875|Tofacitinib|tofacitinib|mesh-list
111017780|NCT02084875|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
111017781|NCT02084875|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111017782|NCT02084875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111017783|NCT02084875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111017784|NCT02689453|Alemtuzumab|alemtuzumab|mesh-list
111017785|NCT02689453|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111017786|NCT02689453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111017787|NCT02084953|Moxifloxacin|moxifloxacin|mesh-list
111017788|NCT02084953|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111017789|NCT02084953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111017790|NCT02084953|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111017791|NCT02084953|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111017792|NCT02084953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111017793|NCT02084953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111017794|NCT02084953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111017795|NCT02082613|Polidocanol|polidocanol|mesh-list
111017796|NCT02082613|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
111017797|NCT02082613|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111017798|NCT02085109|Theobromine|theobromine|mesh-list
111017799|NCT02085109|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111017800|NCT02085109|Autonomic Agents|autonomic agents|mesh-ancestor
111017801|NCT02085109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111017802|NCT02085109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111017803|NCT02085109|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111017804|NCT02085109|Respiratory System Agents|respiratory system agents|mesh-ancestor
111017805|NCT02085109|Vasodilator Agents|vasodilator agents|mesh-ancestor
111017806|NCT03557983|Fenofibrate|fenofibrate|mesh-list
111017807|NCT03557983|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111017808|NCT03557983|Antimetabolites|antimetabolites|mesh-ancestor
110734876|NCT03264404|Pembrolizumab|pembrolizumab|mesh-list
111017809|NCT03557983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111017810|NCT03557983|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111017811|NCT03558919|Solifenacin Succinate|solifenacin succinate|mesh-list
111017812|NCT03558919|Mirabegron|mirabegron|mesh-list
111017813|NCT03558919|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111017814|NCT03558919|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111017815|NCT03558919|Cholinergic Agents|cholinergic agents|mesh-ancestor
111017816|NCT03558919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111017817|NCT03558919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111017818|NCT03558919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111017819|NCT03558919|Urological Agents|urological agents|mesh-ancestor
111017820|NCT03558919|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
111017821|NCT03558919|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111017822|NCT03558919|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111017823|NCT03558919|Adrenergic Agents|adrenergic agents|mesh-ancestor
111017824|NCT02085577|Acetaminophen|acetaminophen|mesh-list
111017825|NCT02085577|Sufentanil|sufentanil|mesh-list
111017827|NCT02085577|Morphine|morphine|mesh-list
111017828|NCT02085577|Dsuvia|dsuvia|mesh-list
111017829|NCT02085577|Ondansetron|ondansetron|mesh-list
111017830|NCT02085577|Analgesics|analgesics|mesh-ancestor
111017831|NCT02085577|Sensory System Agents|sensory system agents|mesh-ancestor
111017832|NCT02085577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111017833|NCT02085577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111017834|NCT02085577|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111017835|NCT02085577|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111017836|NCT02085577|Anesthetics, General|anesthetics, general|mesh-ancestor
111017837|NCT02085577|Anesthetics|anesthetics|mesh-ancestor
111017838|NCT02085577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111017839|NCT02085577|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111017840|NCT02085577|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111017841|NCT02085577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111017842|NCT02085577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111017843|NCT02085577|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111017844|NCT02085577|Narcotics|narcotics|mesh-ancestor
111017845|NCT02085577|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111017846|NCT02085577|Antipyretics|antipyretics|mesh-ancestor
111017847|NCT02085577|Antiemetics|antiemetics|mesh-ancestor
111017848|NCT02085577|Autonomic Agents|autonomic agents|mesh-ancestor
111017849|NCT02085577|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111017850|NCT02085577|Antipruritics|antipruritics|mesh-ancestor
111017851|NCT02085577|Dermatologic Agents|dermatologic agents|mesh-ancestor
111017852|NCT02085577|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111017853|NCT02085577|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111017854|NCT02085577|Serotonin Agents|serotonin agents|mesh-ancestor
111017855|NCT02085577|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111017856|NCT02085655|Thalidomide|thalidomide|mesh-list
111017857|NCT02085655|Dexamethasone|dexamethasone|mesh-list
111017858|NCT02085655|Gemcitabine|gemcitabine|mesh-list
111017859|NCT02085655|Oxaliplatin|oxaliplatin|mesh-list
111017860|NCT02085655|Methotrexate|methotrexate|mesh-list
111017861|NCT02085655|Pegaspargase|pegaspargase|mesh-list
111017862|NCT02085655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111017863|NCT02085655|Antiemetics|antiemetics|mesh-ancestor
111017864|NCT02085655|Autonomic Agents|autonomic agents|mesh-ancestor
111017865|NCT02085655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111017866|NCT02085655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111017867|NCT02085655|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111017868|NCT02085655|Glucocorticoids|glucocorticoids|mesh-ancestor
111017869|NCT02085655|Hormones|hormones|mesh-ancestor
111017870|NCT02085655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111017871|NCT02085655|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111017872|NCT02085655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111017873|NCT02085655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111017874|NCT02085655|Antimetabolites|antimetabolites|mesh-ancestor
111017875|NCT02085655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111017876|NCT02085655|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111017877|NCT02085655|Abortifacient Agents|abortifacient agents|mesh-ancestor
111017878|NCT02085655|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111017879|NCT02085655|Dermatologic Agents|dermatologic agents|mesh-ancestor
111017880|NCT02085655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111017881|NCT02085655|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111017882|NCT02085655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111017883|NCT02085655|Immunologic Factors|immunologic factors|mesh-ancestor
111017884|NCT02085655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111017885|NCT02085655|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111017887|NCT02085655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111017888|NCT02085655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111017889|NCT02085655|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111017890|NCT02085655|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111017891|NCT02085655|Growth Substances|growth substances|mesh-ancestor
111017892|NCT02085655|Growth Inhibitors|growth inhibitors|mesh-ancestor
111017893|NCT02085967|Itraconazole|itraconazole|mesh-list
111017894|NCT02085967|Rifampin|rifampin|mesh-list
111017895|NCT02085967|Midazolam|midazolam|mesh-list
111017896|NCT02085967|Bupropion|bupropion|mesh-list
111017897|NCT02085967|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111017898|NCT02085967|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111017899|NCT02085967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111017900|NCT02085967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111017901|NCT02085967|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111017902|NCT02085967|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111017903|NCT02085967|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111017904|NCT02085967|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111017905|NCT02085967|Anesthetics, General|anesthetics, general|mesh-ancestor
111017906|NCT02085967|Anesthetics|anesthetics|mesh-ancestor
111017907|NCT02085967|GABA Modulators|gaba modulators|mesh-ancestor
111017908|NCT02085967|GABA Agents|gaba agents|mesh-ancestor
111017909|NCT02085967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111017910|NCT02085967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111017911|NCT02085967|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111017912|NCT02085967|Antidepressive Agents|antidepressive agents|mesh-ancestor
111017913|NCT02085967|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110799536|NCT05320107|Anesthetics|anesthetics|mesh-ancestor
111017914|NCT02085967|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111017915|NCT02085967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111017916|NCT02085967|Dopamine Agents|dopamine agents|mesh-ancestor
111017917|NCT02085967|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111017918|NCT02085967|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111017919|NCT02085967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111017920|NCT02085967|Antifungal Agents|antifungal agents|mesh-ancestor
111017921|NCT02085967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111017922|NCT02085967|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111017923|NCT02085967|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111017924|NCT02085967|Hormone Antagonists|hormone antagonists|mesh-ancestor
111017925|NCT02085967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111017926|NCT02085967|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111017927|NCT02085967|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111017928|NCT02085967|Antitubercular Agents|antitubercular agents|mesh-ancestor
111017929|NCT02085967|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111017930|NCT02085967|Leprostatic Agents|leprostatic agents|mesh-ancestor
111017931|NCT02085967|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111017932|NCT02085967|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111017933|NCT02085967|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111017934|NCT02085967|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
111017935|NCT02085967|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
111017936|NCT02085967|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
111017937|NCT02085967|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111017938|NCT02091505|Ranibizumab|ranibizumab|mesh-list
111017939|NCT02091505|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111017940|NCT02091505|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111017941|NCT02091505|Growth Substances|growth substances|mesh-ancestor
111017942|NCT02091505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111017943|NCT02091505|Growth Inhibitors|growth inhibitors|mesh-ancestor
111017944|NCT02091505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111017946|NCT02091817|Oxytocics|oxytocics|mesh-ancestor
111017947|NCT02091817|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111017948|NCT02091817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111017949|NCT02086279|Hormones|hormones|mesh-list
111017950|NCT02086279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111017951|NCT02086279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111017952|NCT02091973|Everolimus|everolimus|mesh-list
111017953|NCT02091973|Tacrolimus|tacrolimus|mesh-list
111017954|NCT02091973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111017955|NCT02091973|Immunologic Factors|immunologic factors|mesh-ancestor
111017956|NCT02091973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111017957|NCT02091973|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111017958|NCT02091973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111017959|NCT02091973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111017960|NCT02091973|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111017961|NCT02091973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111017962|NCT02091973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111017963|NCT03558295|Anticoagulants|anticoagulants|mesh-list
111017964|NCT02089399|Olmesartan|olmesartan|mesh-list
111017965|NCT02089399|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111017966|NCT02089399|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111017967|NCT02089399|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111017968|NCT02089399|Antimetabolites|antimetabolites|mesh-ancestor
111017969|NCT02089399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111017970|NCT02089399|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111017971|NCT02089399|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111017972|NCT02089399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111017973|NCT02089399|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111017974|NCT02089399|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111017975|NCT02089399|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111017977|NCT03557437|Metronidazole|metronidazole|mesh-list
111017978|NCT03557437|Potassium Citrate|potassium citrate|mesh-list
111017979|NCT03557437|Esomeprazole|esomeprazole|mesh-list
111017980|NCT03557437|Bismuth|bismuth|mesh-list
111017981|NCT03557437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111017982|NCT03557437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111017983|NCT03557437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111017984|NCT03557437|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111017985|NCT03557437|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111017986|NCT03557437|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111017987|NCT03557437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111017988|NCT03557437|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111017989|NCT03557437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111017990|NCT03557437|Antacids|antacids|mesh-ancestor
111017991|NCT03557437|Diuretics|diuretics|mesh-ancestor
111017992|NCT03557437|Natriuretic Agents|natriuretic agents|mesh-ancestor
111017993|NCT03557437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111017994|NCT03557437|Expectorants|expectorants|mesh-ancestor
111017995|NCT03557437|Respiratory System Agents|respiratory system agents|mesh-ancestor
111017996|NCT02089633|BCT-100|bct-100|mesh-list
111017997|NCT02089633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111017998|NCT02086747|Acetaminophen|acetaminophen|mesh-list
111017999|NCT02086747|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111018000|NCT02086747|Analgesics|analgesics|mesh-ancestor
111018001|NCT02086747|Sensory System Agents|sensory system agents|mesh-ancestor
111018002|NCT02086747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111018003|NCT02086747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111018004|NCT02086747|Antipyretics|antipyretics|mesh-ancestor
111018005|NCT02086825|Rifaximin|rifaximin|mesh-list
111018006|NCT02086825|Lactulose|lactulose|mesh-list
111018007|NCT02086825|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111018008|NCT02086825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111018009|NCT02086825|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111018010|NCT02086903|Clopidogrel|clopidogrel|mesh-list
111018011|NCT02086903|Ticagrelor|ticagrelor|mesh-list
111018012|NCT02086903|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111018013|NCT02086903|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111018014|NCT02086903|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111018015|NCT02086903|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111018016|NCT02086903|Purinergic Agents|purinergic agents|mesh-ancestor
111018017|NCT02086903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111018018|NCT02086903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111018019|NCT02086903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111018020|NCT02087215|Boron|boron|mesh-list
111018021|NCT02087215|Trace Elements|trace elements|mesh-ancestor
111018022|NCT02087215|Micronutrients|micronutrients|mesh-ancestor
110735092|NCT02899299|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110735093|NCT02899195|Durvalumab|durvalumab|mesh-list
110735094|NCT02899195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110735095|NCT02899195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110735096|NCT02833233|Nivolumab|nivolumab|mesh-list
110735097|NCT02833233|Ipilimumab|ipilimumab|mesh-list
110735098|NCT02833233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110735099|NCT02833233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110735100|NCT02833233|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110735101|NCT02833233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110735102|NCT02814916|Dalbavancin|dalbavancin|mesh-list
110735103|NCT02814916|Teicoplanin|teicoplanin|mesh-list
110735104|NCT02814916|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111018023|NCT02087215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111018024|NCT02087527|Dexamethasone|dexamethasone|mesh-list
111018025|NCT02087527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111018026|NCT02087527|Antiemetics|antiemetics|mesh-ancestor
111018027|NCT02087527|Autonomic Agents|autonomic agents|mesh-ancestor
111018028|NCT02087527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111018029|NCT02087527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111018030|NCT02087527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111018031|NCT02087527|Glucocorticoids|glucocorticoids|mesh-ancestor
111018032|NCT02087527|Hormones|hormones|mesh-ancestor
111018033|NCT02087527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111018034|NCT02087527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111018035|NCT02087527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111018036|NCT02087683|Vitamin D|vitamin d|mesh-list
111018037|NCT02087683|Vitamins|vitamins|mesh-ancestor
111018038|NCT02087683|Micronutrients|micronutrients|mesh-ancestor
111018039|NCT02087683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111018040|NCT02087683|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111018041|NCT02092363|Paclitaxel|paclitaxel|mesh-list
111018042|NCT02092363|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111018043|NCT02092363|Carboplatin|carboplatin|mesh-list
111018044|NCT02092363|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
111018045|NCT02092363|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111018046|NCT02092363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111018047|NCT02092363|Tubulin Modulators|tubulin modulators|mesh-ancestor
111018048|NCT02092363|Antimitotic Agents|antimitotic agents|mesh-ancestor
111018049|NCT02092363|Mitosis Modulators|mitosis modulators|mesh-ancestor
111018050|NCT02092363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111018051|NCT02092363|Immunologic Factors|immunologic factors|mesh-ancestor
111018052|NCT02092363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111018053|NCT03558139|Avelumab|avelumab|mesh-list
111018054|NCT03558139|Magrolimab|magrolimab|mesh-list
111018055|NCT03558139|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111018056|NCT03558139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111018057|NCT02089867|Ezetimibe|ezetimibe|mesh-list
111018058|NCT02089867|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111018059|NCT02089867|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111018060|NCT02089867|Antimetabolites|antimetabolites|mesh-ancestor
111018061|NCT02089867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111018062|NCT02089867|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111018063|NCT02092597|Exenatide|exenatide|mesh-list
111018064|NCT02092597|Linagliptin|linagliptin|mesh-list
111018065|NCT02092597|Gliclazide|gliclazide|mesh-list
111018066|NCT02092597|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111018067|NCT02092597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111018068|NCT02092597|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111018069|NCT02092597|Incretins|incretins|mesh-ancestor
111018070|NCT02092597|Hormones|hormones|mesh-ancestor
111018071|NCT02092597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111018072|NCT02092597|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111018073|NCT02092597|Protease Inhibitors|protease inhibitors|mesh-ancestor
111018074|NCT02092597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111018075|NCT02092597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111018076|NCT02090101|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
111018077|NCT02090101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111018078|NCT02093143|Remifentanil|remifentanil|mesh-list
111018079|NCT02093143|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111018080|NCT02093143|Narcotics|narcotics|mesh-ancestor
111018081|NCT02093143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111018082|NCT02093143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111018083|NCT02093143|Analgesics|analgesics|mesh-ancestor
111018084|NCT02093143|Sensory System Agents|sensory system agents|mesh-ancestor
111018085|NCT02093143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111018086|NCT02093299|Clopidogrel|clopidogrel|mesh-list
111018087|NCT02093299|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111018088|NCT02093299|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110735178|NCT02598349|Capecitabine|capecitabine|mesh-list
110735179|NCT02598349|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110735180|NCT02598349|Antimetabolites|antimetabolites|mesh-ancestor
110735181|NCT02598349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110735182|NCT02598349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110735183|NCT02581943|Paclitaxel|paclitaxel|mesh-list
110735184|NCT02581943|Carboplatin|carboplatin|mesh-list
110735185|NCT02581943|Pembrolizumab|pembrolizumab|mesh-list
110735189|NCT02581943|Tubulin Modulators|tubulin modulators|mesh-ancestor
111018089|NCT02093299|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111018090|NCT02093299|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111018091|NCT02093299|Purinergic Agents|purinergic agents|mesh-ancestor
111018092|NCT02093299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111018093|NCT02093299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111018094|NCT02093299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111018095|NCT00454753|Dasatinib|dasatinib|mesh-list
111018096|NCT00454753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111018097|NCT00454753|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111018098|NCT00454753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111018099|NCT00454753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111018100|NCT02093533|Eculizumab|eculizumab|mesh-list
111018101|NCT02093533|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
111018102|NCT02093533|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111018103|NCT02093533|Immunologic Factors|immunologic factors|mesh-ancestor
111018104|NCT02093533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111018105|NCT03297879|Metformin|metformin|mesh-list
111018106|NCT03297879|Exenatide|exenatide|mesh-list
111018107|NCT03297879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111018108|NCT03297879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111018109|NCT03297879|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111018110|NCT03297879|Incretins|incretins|mesh-ancestor
111018111|NCT03297879|Hormones|hormones|mesh-ancestor
111018112|NCT03297879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111018113|NCT02093845|Everolimus|everolimus|mesh-list
111018114|NCT02093845|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111018115|NCT02093845|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111018116|NCT02093845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111018117|NCT02093845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111018118|NCT02093845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111018119|NCT02093845|Immunologic Factors|immunologic factors|mesh-ancestor
111018120|NCT02093845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111018121|NCT02093845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111018122|NCT04489797|Acalabrutinib|acalabrutinib|mesh-list
111018123|NCT04489797|Rabeprazole|rabeprazole|mesh-list
111018124|NCT04489797|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111018125|NCT04489797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111018126|NCT04489797|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111018127|NCT04489797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111018128|NCT04489797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111018129|NCT04489797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111018130|NCT02094001|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
111018131|NCT02094001|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111018132|NCT02094001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111018133|NCT02096419|Clopidogrel|clopidogrel|mesh-list
111018134|NCT02096419|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111018135|NCT02096419|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111018136|NCT02096419|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111018137|NCT02096419|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111018138|NCT02096419|Purinergic Agents|purinergic agents|mesh-ancestor
111018139|NCT02096419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111018140|NCT02096419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111018141|NCT02096419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111018142|NCT02094157|Heparin|heparin|mesh-list
111018143|NCT02094157|Calcium heparin|calcium heparin|mesh-list
111018144|NCT02094157|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
111018145|NCT02094157|Tinzaparin|tinzaparin|mesh-list
111018146|NCT02094157|Dalteparin|dalteparin|mesh-list
111018147|NCT02094157|Warfarin|warfarin|mesh-list
111018148|NCT02094157|Anticoagulants|anticoagulants|mesh-ancestor
111018149|NCT02094157|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111018150|NCT02094157|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111018151|NCT02094157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111018152|NCT02094313|Atorvastatin|atorvastatin|mesh-list
111018153|NCT02094313|Anticholesteremic Agents|anticholesteremic agents|mesh-list
111018154|NCT02094313|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111018155|NCT02094313|Antimetabolites|antimetabolites|mesh-ancestor
111018156|NCT02094313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111018157|NCT02094313|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111018158|NCT02094313|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111018159|NCT02094313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111018160|NCT02094391|Ipilimumab|ipilimumab|mesh-list
111018161|NCT02094391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111018162|NCT02094391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111018163|NCT02094391|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110735250|NCT02267603|Pembrolizumab|pembrolizumab|mesh-list
111018164|NCT02094391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111018166|NCT02094469|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111018167|NCT02094469|Autonomic Agents|autonomic agents|mesh-ancestor
111018168|NCT02094469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111018169|NCT02094469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111018170|NCT02094469|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111018171|NCT02094469|Respiratory System Agents|respiratory system agents|mesh-ancestor
111018172|NCT02094469|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111018173|NCT02094469|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111018174|NCT02094469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111018175|NCT02094469|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111018176|NCT02094469|Vasodilator Agents|vasodilator agents|mesh-ancestor
111018177|NCT02094469|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111018179|NCT02094469|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
111018180|NCT02094469|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111018181|NCT02094469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111018182|NCT02094703|Levofloxacin|levofloxacin|mesh-list
111018183|NCT02094703|Solifenacin Succinate|solifenacin succinate|mesh-list
111018184|NCT02094703|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111018185|NCT02094703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111018186|NCT02094703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111018187|NCT02094703|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111018188|NCT02094703|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111018189|NCT02094703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111018190|NCT02094703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111018191|NCT02094703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111018192|NCT02094703|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111018193|NCT02094703|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111018194|NCT02094703|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111018195|NCT02094703|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111018196|NCT02094703|Cholinergic Agents|cholinergic agents|mesh-ancestor
111018197|NCT02094703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111018198|NCT02094703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111018199|NCT02094703|Urological Agents|urological agents|mesh-ancestor
111018200|NCT02098837|Dolutegravir|dolutegravir|mesh-list
111018201|NCT02098837|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111018202|NCT02098837|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111018203|NCT02098837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111018204|NCT02098837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111018205|NCT02098837|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111018206|NCT02098837|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111018207|NCT02098837|Antiviral Agents|antiviral agents|mesh-ancestor
111018208|NCT02098837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111018209|NCT02098915|Metoclopramide|metoclopramide|mesh-list
111018210|NCT02098915|Antiemetics|antiemetics|mesh-ancestor
111018211|NCT02098915|Autonomic Agents|autonomic agents|mesh-ancestor
111018212|NCT02098915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111018213|NCT02098915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111018214|NCT02098915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111018215|NCT02098915|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111018216|NCT02098915|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111018217|NCT02098915|Dopamine Agents|dopamine agents|mesh-ancestor
111018218|NCT02098915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111018219|NCT02098915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111018220|NCT03556033|Dapagliflozin|dapagliflozin|mesh-list
111018221|NCT03556033|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111018222|NCT03556033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111018223|NCT03556033|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111018224|NCT03556033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111018225|NCT05046860|Dalbavancin|dalbavancin|mesh-list
111018226|NCT05046860|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111018227|NCT05046860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111018228|NCT02095405|Caffeine|caffeine|mesh-list
111018229|NCT02095405|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111018230|NCT02095405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111018231|NCT02095405|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111018232|NCT02095405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111018233|NCT02095405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111018234|NCT02095405|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110735318|NCT02037048|Protective Agents|protective agents|mesh-ancestor
111018245|NCT02096965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111018246|NCT02096965|Natriuretic Agents|natriuretic agents|mesh-ancestor
111018247|NCT02096965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111018248|NCT02097043|Tedizolid phosphate|tedizolid phosphate|mesh-list
111018249|NCT02097043|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111018250|NCT02097043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111018251|NCT05069246|Chlorhexidine|chlorhexidine|mesh-list
111018252|NCT05069246|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111018253|NCT05069246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111018254|NCT05069246|Disinfectants|disinfectants|mesh-ancestor
111018256|NCT02095717|Docetaxel|docetaxel|mesh-list
111018257|NCT02095717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111018258|NCT02095717|Tubulin Modulators|tubulin modulators|mesh-ancestor
111018259|NCT02095717|Antimitotic Agents|antimitotic agents|mesh-ancestor
111018260|NCT02095717|Mitosis Modulators|mitosis modulators|mesh-ancestor
111018262|NCT02095717|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111018263|NCT02095717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111018264|NCT02095717|Analgesics|analgesics|mesh-ancestor
111018265|NCT02095717|Sensory System Agents|sensory system agents|mesh-ancestor
111018266|NCT02095717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111018267|NCT02095717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111018268|NCT02095717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111018269|NCT02095717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111018270|NCT02095717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111018271|NCT03099824|Avasopasem manganese|avasopasem manganese|mesh-list
111018272|NCT03099824|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111018273|NCT03099824|Antioxidants|antioxidants|mesh-ancestor
111018274|NCT03099824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111018275|NCT03099824|Protective Agents|protective agents|mesh-ancestor
111018276|NCT03099824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111018277|NCT02718417|Paclitaxel|paclitaxel|mesh-list
111018278|NCT02718417|Carboplatin|carboplatin|mesh-list
111018279|NCT02718417|Avelumab|avelumab|mesh-list
111018280|NCT02718417|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111018281|NCT02718417|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111018282|NCT02718417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111018283|NCT02718417|Tubulin Modulators|tubulin modulators|mesh-ancestor
111018284|NCT02718417|Antimitotic Agents|antimitotic agents|mesh-ancestor
111018285|NCT02718417|Mitosis Modulators|mitosis modulators|mesh-ancestor
111018286|NCT02718417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111018287|NCT02718417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111018288|NCT02718417|Immunologic Factors|immunologic factors|mesh-ancestor
111018289|NCT02718417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111018290|NCT05067530|Paclitaxel|paclitaxel|mesh-list
111018291|NCT05067530|Carboplatin|carboplatin|mesh-list
111018292|NCT05067530|Palbociclib|palbociclib|mesh-list
111018293|NCT05067530|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111018294|NCT05067530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111018295|NCT05067530|Tubulin Modulators|tubulin modulators|mesh-ancestor
111018296|NCT05067530|Antimitotic Agents|antimitotic agents|mesh-ancestor
111018297|NCT05067530|Mitosis Modulators|mitosis modulators|mesh-ancestor
111018298|NCT05067530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111018299|NCT05067530|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111018300|NCT05067530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111018301|NCT02640404|Vaccines|vaccines|mesh-list
111018302|NCT02640404|Immunologic Factors|immunologic factors|mesh-ancestor
111018303|NCT02640404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111018304|NCT03097406|Imidacloprid|imidacloprid|mesh-list
111018305|NCT03097406|Cholinergic Agents|cholinergic agents|mesh-ancestor
111018306|NCT03097406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111018307|NCT03097406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111018308|NCT03097406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110735406|NCT01413100|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111018309|NCT03099590|Puerarin|puerarin|mesh-list
111018310|NCT03099590|Vasodilator Agents|vasodilator agents|mesh-ancestor
111018311|NCT05054426|Methotrexate|methotrexate|mesh-list
111018312|NCT05054426|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111018313|NCT05054426|Abortifacient Agents|abortifacient agents|mesh-ancestor
111018314|NCT05054426|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111018315|NCT05054426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111018316|NCT05054426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111018317|NCT05054426|Antimetabolites|antimetabolites|mesh-ancestor
111018318|NCT05054426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111018319|NCT05054426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111018320|NCT05054426|Dermatologic Agents|dermatologic agents|mesh-ancestor
111018321|NCT05054426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111018322|NCT05054426|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111018323|NCT05054426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111018324|NCT05054426|Immunologic Factors|immunologic factors|mesh-ancestor
111018325|NCT05054426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111018326|NCT05054426|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111018327|NCT00701727|Ezetimibe|ezetimibe|mesh-list
111018328|NCT00701727|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111018329|NCT00701727|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111018330|NCT00701727|Antimetabolites|antimetabolites|mesh-ancestor
111018331|NCT00701727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111018332|NCT00701727|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111018333|NCT02463513|Vitamins|vitamins|mesh-list
111018334|NCT02463513|Riboflavin|riboflavin|mesh-list
111018335|NCT02463513|Vitamin B Complex|vitamin b complex|mesh-list
111018336|NCT02463513|Micronutrients|micronutrients|mesh-ancestor
111018337|NCT02463513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111018338|NCT02463513|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111018339|NCT02463513|Dermatologic Agents|dermatologic agents|mesh-ancestor
111018340|NCT04155008|Dexamethasone|dexamethasone|mesh-list
111018341|NCT04155008|Dronabinol|dronabinol|mesh-list
111018342|NCT04155008|Mirtazapine|mirtazapine|mesh-list
111018343|NCT04155008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111018344|NCT04155008|Antiemetics|antiemetics|mesh-ancestor
111018345|NCT04155008|Autonomic Agents|autonomic agents|mesh-ancestor
111018346|NCT04155008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111018347|NCT04155008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111018348|NCT04155008|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111018349|NCT04155008|Glucocorticoids|glucocorticoids|mesh-ancestor
111018350|NCT04155008|Hormones|hormones|mesh-ancestor
111018351|NCT04155008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111018352|NCT04155008|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111018353|NCT04155008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111018354|NCT04155008|Antidepressive Agents|antidepressive agents|mesh-ancestor
111018355|NCT04155008|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111018356|NCT04155008|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111018357|NCT04155008|Histamine Antagonists|histamine antagonists|mesh-ancestor
111018358|NCT04155008|Histamine Agents|histamine agents|mesh-ancestor
111018359|NCT04155008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111018360|NCT04155008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111018361|NCT04155008|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111018362|NCT04155008|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111018363|NCT04155008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111018364|NCT04155008|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
111018365|NCT04155008|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111018366|NCT04155008|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111018367|NCT04155008|Adrenergic Agents|adrenergic agents|mesh-ancestor
111018368|NCT04155008|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111018369|NCT04155008|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111018370|NCT04155008|Serotonin Agents|serotonin agents|mesh-ancestor
111018371|NCT04155008|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111018372|NCT04155008|Hallucinogens|hallucinogens|mesh-ancestor
111018373|NCT04155008|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111018374|NCT04155008|Analgesics|analgesics|mesh-ancestor
111018375|NCT04155008|Sensory System Agents|sensory system agents|mesh-ancestor
111018376|NCT04155008|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
111018377|NCT04155008|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
111018378|NCT05044364|Clevidipine|clevidipine|mesh-list
111018379|NCT05044364|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111018380|NCT05044364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111018381|NCT05044364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111018382|NCT05044364|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111018383|NCT05044364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111018385|NCT03993717|Immunologic Factors|immunologic factors|mesh-ancestor
111018386|NCT03993717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111018387|NCT04150640|Pembrolizumab|pembrolizumab|mesh-list
111018388|NCT04150640|Nivolumab|nivolumab|mesh-list
111018389|NCT04150640|Trastuzumab|trastuzumab|mesh-list
111018390|NCT04150640|Fluorouracil|fluorouracil|mesh-list
111018391|NCT04150640|Oxaliplatin|oxaliplatin|mesh-list
111018392|NCT04150640|Irinotecan|irinotecan|mesh-list
111018393|NCT04150640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111018394|NCT04150640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111018395|NCT04150640|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111018396|NCT04150640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111018397|NCT04150640|Antimetabolites|antimetabolites|mesh-ancestor
111018398|NCT04150640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111018399|NCT04150640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111018400|NCT04150640|Immunologic Factors|immunologic factors|mesh-ancestor
111018401|NCT04150640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111018402|NCT04150640|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111018403|NCT04150640|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111018404|NCT04150640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111018405|NCT05054114|Interferons|interferons|mesh-list
111018406|NCT05054114|Interferon-gamma|interferon-gamma|mesh-list
111018407|NCT05054114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110270390|NCT00193011|Docetaxel|docetaxel|mesh-list
111018409|NCT05054114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111018410|NCT04665531|Ropivacaine|ropivacaine|mesh-list
111018411|NCT04665531|Anesthetics, Local|anesthetics, local|mesh-ancestor
111018412|NCT04665531|Anesthetics|anesthetics|mesh-ancestor
111018413|NCT04665531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111018414|NCT04665531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111018415|NCT04665531|Sensory System Agents|sensory system agents|mesh-ancestor
111018416|NCT04665531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111018417|NCT01369069|Insulin|insulin|mesh-list
111018418|NCT01369069|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111018419|NCT01369069|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111018420|NCT01369069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111018421|NCT02097511|Metoprolol|metoprolol|mesh-list
111018422|NCT02097511|Sarpogrelate|sarpogrelate|mesh-list
111018423|NCT02097511|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111018424|NCT02097511|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111018425|NCT02097511|Sympatholytics|sympatholytics|mesh-ancestor
111018426|NCT02097511|Autonomic Agents|autonomic agents|mesh-ancestor
111018427|NCT02097511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111018428|NCT02097511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111018429|NCT02097511|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
111018430|NCT02097511|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111018431|NCT02097511|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111018432|NCT02097511|Adrenergic Agents|adrenergic agents|mesh-ancestor
111018433|NCT02097511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111018434|NCT02097511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111018435|NCT02097511|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111018436|NCT02097511|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111018437|NCT02097511|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111018438|NCT02097511|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111018439|NCT02097511|Serotonin Agents|serotonin agents|mesh-ancestor
111018440|NCT03957681|Brodalumab|brodalumab|mesh-list
111018441|NCT03957681|Dermatologic Agents|dermatologic agents|mesh-ancestor
111018442|NCT05043740|Evolocumab|evolocumab|mesh-list
111018443|NCT05043740|Alirocumab|alirocumab|mesh-list
111018444|NCT05043740|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
111018445|NCT05043740|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111018446|NCT05043740|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111018447|NCT05043740|Antimetabolites|antimetabolites|mesh-ancestor
111018448|NCT05043740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111018449|NCT05043740|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111018450|NCT05043740|Protease Inhibitors|protease inhibitors|mesh-ancestor
111018451|NCT05043740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111018452|NCT05043740|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111018453|NCT03928275|Aldesleukin|aldesleukin|mesh-list
111018454|NCT03928275|Interleukin-2|interleukin-2|mesh-list
111018455|NCT03928275|BCG Vaccine|bcg vaccine|mesh-list
111018456|NCT03928275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111018457|NCT03928275|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111018458|NCT03928275|Analgesics|analgesics|mesh-ancestor
111018459|NCT03928275|Sensory System Agents|sensory system agents|mesh-ancestor
111018460|NCT03928275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111018461|NCT03928275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111018462|NCT03928275|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111018463|NCT03928275|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111018464|NCT03928275|Antiviral Agents|antiviral agents|mesh-ancestor
111018465|NCT03928275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111018466|NCT03928275|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111018467|NCT03928275|Immunologic Factors|immunologic factors|mesh-ancestor
111018468|NCT05043896|Tadalafil|tadalafil|mesh-list
111018469|NCT05043896|Vasodilator Agents|vasodilator agents|mesh-ancestor
111018470|NCT05043896|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111018471|NCT05043896|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111018472|NCT05043896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111018473|NCT05043896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111018474|NCT05043896|Urological Agents|urological agents|mesh-ancestor
111018475|NCT02099617|Oxymetazoline|oxymetazoline|mesh-list
111018476|NCT02099617|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111018477|NCT02099617|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111018478|NCT02099617|Adrenergic Agents|adrenergic agents|mesh-ancestor
111018479|NCT02099617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111018480|NCT02099617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111018481|NCT02099617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111018482|NCT02099617|Sympathomimetics|sympathomimetics|mesh-ancestor
110623123|NCT00770042|Ritonavir|ritonavir|mesh-list
111018483|NCT02099617|Autonomic Agents|autonomic agents|mesh-ancestor
110483522|NCT02686983|Betamethasone|betamethasone|mesh-list
111018484|NCT02099617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111018485|NCT02099617|Nasal Decongestants|nasal decongestants|mesh-ancestor
111018486|NCT02099617|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111018487|NCT02099617|Respiratory System Agents|respiratory system agents|mesh-ancestor
111018488|NCT03096704|Vitamin D|vitamin d|mesh-list
111018489|NCT03096704|Vitamins|vitamins|mesh-ancestor
111018490|NCT03096704|Micronutrients|micronutrients|mesh-ancestor
111018491|NCT03096704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111018492|NCT03096704|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111018493|NCT02099695|Oxybutynin|oxybutynin|mesh-list
111018494|NCT02099695|Parasympatholytics|parasympatholytics|mesh-ancestor
111018495|NCT02099695|Autonomic Agents|autonomic agents|mesh-ancestor
111018496|NCT02099695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111018497|NCT02099695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111018498|NCT02099695|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111018499|NCT02099695|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111018500|NCT02099695|Cholinergic Agents|cholinergic agents|mesh-ancestor
111018501|NCT02099695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111018502|NCT02099695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111018503|NCT02099695|Urological Agents|urological agents|mesh-ancestor
111018504|NCT05066516|Dapagliflozin|dapagliflozin|mesh-list
111018505|NCT05066516|Linagliptin|linagliptin|mesh-list
111018506|NCT05066516|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111018507|NCT05066516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111018508|NCT05066516|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111018509|NCT05066516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111018510|NCT05066516|Incretins|incretins|mesh-ancestor
111018511|NCT05066516|Hormones|hormones|mesh-ancestor
111018512|NCT05066516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111018513|NCT05066516|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111018514|NCT05066516|Protease Inhibitors|protease inhibitors|mesh-ancestor
111018515|NCT05066516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111018516|NCT02097589|Atorvastatin|atorvastatin|mesh-list
111018517|NCT02097589|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
111018518|NCT02097589|Immunologic Factors|immunologic factors|mesh-ancestor
111018519|NCT02097589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111018520|NCT02097589|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111018521|NCT02097589|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111018522|NCT02097589|Antimetabolites|antimetabolites|mesh-ancestor
111018523|NCT02097589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111018524|NCT02097589|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111018525|NCT02097589|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111018526|NCT02097589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111018527|NCT03836001|Serlopitant|serlopitant|mesh-list
111018528|NCT03836001|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
111018529|NCT03836001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111018530|NCT03836001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111018531|NCT03836001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111018532|NCT02465866|Promethazine|promethazine|mesh-list
111018533|NCT02465866|Antipruritics|antipruritics|mesh-ancestor
111018534|NCT02465866|Dermatologic Agents|dermatologic agents|mesh-ancestor
110735622|NCT00074165|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111018535|NCT02465866|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111018536|NCT02465866|Histamine Antagonists|histamine antagonists|mesh-ancestor
111018537|NCT02465866|Histamine Agents|histamine agents|mesh-ancestor
111018538|NCT02465866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111018539|NCT02465866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111018540|NCT02465866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111018541|NCT02465866|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111018543|NCT05052008|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
111018544|NCT05052008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111018545|NCT05052008|Analgesics|analgesics|mesh-ancestor
111018546|NCT05052008|Sensory System Agents|sensory system agents|mesh-ancestor
111018547|NCT05052008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111018548|NCT05052008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111018549|NCT05066360|Hormones|hormones|mesh-list
110799537|NCT05320107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111018550|NCT05066360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111018551|NCT05066360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111018552|NCT02439970|Valganciclovir|valganciclovir|mesh-list
111018553|NCT02439970|Brincidofovir|brincidofovir|mesh-list
111018554|NCT02439970|Antiviral Agents|antiviral agents|mesh-ancestor
111018555|NCT02439970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111018556|NCT03290859|Propofol|propofol|mesh-list
111018557|NCT03290859|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111018558|NCT03290859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111018559|NCT03290859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111018560|NCT03290859|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111018561|NCT03290859|Anesthetics, General|anesthetics, general|mesh-ancestor
111018562|NCT03290859|Anesthetics|anesthetics|mesh-ancestor
111018563|NCT05065658|Posaconazole|posaconazole|mesh-list
111018564|NCT05065658|Antifungal Agents|antifungal agents|mesh-ancestor
111018565|NCT05065658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111018566|NCT05065658|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
111018567|NCT05065658|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111018568|NCT05065658|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111018569|NCT05065658|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111018570|NCT05065658|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111018571|NCT05065658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111018572|NCT05065658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111018573|NCT05065658|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111018574|NCT05065658|Hormone Antagonists|hormone antagonists|mesh-ancestor
111018575|NCT05065658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111018576|NCT05065658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111018577|NCT02102815|Dexamethasone|dexamethasone|mesh-list
111018578|NCT02102815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111018579|NCT02102815|Antiemetics|antiemetics|mesh-ancestor
111018580|NCT02102815|Autonomic Agents|autonomic agents|mesh-ancestor
111018581|NCT02102815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111018582|NCT02102815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111018583|NCT02102815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111018584|NCT02102815|Glucocorticoids|glucocorticoids|mesh-ancestor
111018585|NCT02102815|Hormones|hormones|mesh-ancestor
111018586|NCT02102815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111018587|NCT02102815|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111018588|NCT02102815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111018589|NCT04935112|Pantoprazole|pantoprazole|mesh-list
111018590|NCT04935112|Famotidine|famotidine|mesh-list
111018591|NCT04935112|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111018592|NCT04935112|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111018593|NCT04935112|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111018594|NCT04935112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111018595|NCT04935112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111018596|NCT04935112|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
111018597|NCT04935112|Histamine Antagonists|histamine antagonists|mesh-ancestor
111018598|NCT04935112|Histamine Agents|histamine agents|mesh-ancestor
111018599|NCT04935112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111018600|NCT04935112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111018601|NCT02102971|Liver Extracts|liver extracts|mesh-list
111018602|NCT02102971|Hematinics|hematinics|mesh-ancestor
111018603|NCT03555487|Choline|choline|mesh-list
111018604|NCT03555487|Lipotropic Agents|lipotropic agents|mesh-ancestor
111018605|NCT03555487|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111018606|NCT03555487|Antimetabolites|antimetabolites|mesh-ancestor
111018607|NCT03555487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110735703|NCT00046930|Antiviral Agents|antiviral agents|mesh-ancestor
111018608|NCT03555487|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111018609|NCT03555487|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111018610|NCT03555487|Nootropic Agents|nootropic agents|mesh-ancestor
111018611|NCT05043194|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
111018612|NCT05043194|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
111018613|NCT05043194|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111018615|NCT02103049|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111018616|NCT02103049|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111018617|NCT02103049|Antimetabolites|antimetabolites|mesh-ancestor
111018618|NCT02103049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111018619|NCT02103049|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111018620|NCT03099278|Ezetimibe|ezetimibe|mesh-list
111018621|NCT03099278|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111018622|NCT03099278|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111018623|NCT03099278|Antimetabolites|antimetabolites|mesh-ancestor
111018624|NCT03099278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111018625|NCT03099278|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111018626|NCT02103205|Iron|iron|mesh-list
111018627|NCT02103205|Lactoferrin|lactoferrin|mesh-list
111018628|NCT02103205|Trace Elements|trace elements|mesh-ancestor
111018629|NCT02103205|Micronutrients|micronutrients|mesh-ancestor
111018630|NCT02103205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111018631|NCT02103205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111018632|NCT03290703|Rabeprazole|rabeprazole|mesh-list
111018633|NCT03290703|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111018634|NCT03290703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111018635|NCT03290703|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111018636|NCT03290703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111018637|NCT03290703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111018638|NCT02408068|Dexamethasone|dexamethasone|mesh-list
111018639|NCT02408068|Hydrocortisone|hydrocortisone|mesh-list
111018640|NCT02408068|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
111018641|NCT02408068|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
111018642|NCT02408068|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
111018643|NCT02408068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111018644|NCT02408068|Antiemetics|antiemetics|mesh-ancestor
111018645|NCT02408068|Autonomic Agents|autonomic agents|mesh-ancestor
111018646|NCT02408068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111018647|NCT02408068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111018648|NCT02408068|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111018649|NCT02408068|Glucocorticoids|glucocorticoids|mesh-ancestor
111018650|NCT02408068|Hormones|hormones|mesh-ancestor
111018651|NCT02408068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111018652|NCT02408068|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111018653|NCT02408068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111018654|NCT02465853|Hyaluronic Acid|hyaluronic acid|mesh-list
111018655|NCT02465853|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111018656|NCT02465853|Immunologic Factors|immunologic factors|mesh-ancestor
111018657|NCT02465853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111018658|NCT02465853|Viscosupplements|viscosupplements|mesh-ancestor
111018659|NCT02465853|Protective Agents|protective agents|mesh-ancestor
111018660|NCT02465385|Linaclotide|linaclotide|mesh-list
111018661|NCT02465385|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
111018662|NCT02465385|Enzyme Activators|enzyme activators|mesh-ancestor
111018663|NCT02465385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111018664|NCT02465385|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111018665|NCT05050604|Choline|choline|mesh-list
111018666|NCT05050604|Lipotropic Agents|lipotropic agents|mesh-ancestor
111018667|NCT05050604|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111018668|NCT05050604|Antimetabolites|antimetabolites|mesh-ancestor
111018669|NCT05050604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111018670|NCT05050604|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111018671|NCT05050604|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111018672|NCT05050604|Nootropic Agents|nootropic agents|mesh-ancestor
111018673|NCT03290625|Dexmedetomidine|dexmedetomidine|mesh-list
111018674|NCT03290625|Ketamine|ketamine|mesh-list
111018675|NCT03290625|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111018676|NCT03290625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111018677|NCT03290625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111018678|NCT03290625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111018679|NCT03290625|Analgesics|analgesics|mesh-ancestor
111018680|NCT03290625|Sensory System Agents|sensory system agents|mesh-ancestor
111018681|NCT03290625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111018682|NCT03290625|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111018683|NCT03290625|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111018684|NCT03290625|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111018685|NCT03290625|Adrenergic Agents|adrenergic agents|mesh-ancestor
111018686|NCT03290625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111018687|NCT03290625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111018688|NCT03290625|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111018689|NCT03290625|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111018690|NCT03290625|Anesthetics, General|anesthetics, general|mesh-ancestor
111018691|NCT03290625|Anesthetics|anesthetics|mesh-ancestor
111018692|NCT03290625|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111018693|NCT03290625|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111018694|NCT02250781|TIC10 compound|tic10 compound|mesh-list
111018695|NCT02250781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111018696|NCT03099122|Mycophenolic Acid|mycophenolic acid|mesh-list
111018697|NCT03099122|Prednisone|prednisone|mesh-list
111018698|NCT03099122|Methylprednisolone|methylprednisolone|mesh-list
111018699|NCT03099122|Tacrolimus|tacrolimus|mesh-list
111018700|NCT03099122|Thymoglobulin|thymoglobulin|mesh-list
111018701|NCT03099122|Antilymphocyte Serum|antilymphocyte serum|mesh-list
111018702|NCT03099122|Immunoglobulins|immunoglobulins|mesh-list
111018703|NCT03099122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111018704|NCT03099122|Glucocorticoids|glucocorticoids|mesh-ancestor
111018705|NCT03099122|Hormones|hormones|mesh-ancestor
111018706|NCT03099122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111018707|NCT03099122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111018708|NCT03099122|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111018709|NCT03099122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111018710|NCT03099122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111018711|NCT03099122|Immunologic Factors|immunologic factors|mesh-ancestor
111018712|NCT03099122|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111018713|NCT03099122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111018714|NCT03099122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111018715|NCT03099122|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111018716|NCT03099122|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111018717|NCT03099122|Antitubercular Agents|antitubercular agents|mesh-ancestor
111018718|NCT03099122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111018719|NCT03099122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111018720|NCT03099122|Antiemetics|antiemetics|mesh-ancestor
111018721|NCT03099122|Autonomic Agents|autonomic agents|mesh-ancestor
111018722|NCT03099122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111018723|NCT03099122|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111018724|NCT03099122|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111018725|NCT03099122|Protective Agents|protective agents|mesh-ancestor
111018726|NCT04335201|Defibrotide|defibrotide|mesh-list
111018727|NCT04335201|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111018728|NCT04335201|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111018729|NCT04335201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111018730|NCT04335201|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111018731|NCT03295851|Iron|iron|mesh-list
111018732|NCT03295851|Ferrous fumarate|ferrous fumarate|mesh-list
111018733|NCT03295851|Trace Elements|trace elements|mesh-ancestor
111018734|NCT03295851|Micronutrients|micronutrients|mesh-ancestor
111018735|NCT03295851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111018736|NCT03096470|Anesthetics|anesthetics|mesh-list
111018737|NCT03096470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111018738|NCT03096470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111018739|NCT02100553|Itraconazole|itraconazole|mesh-list
111018740|NCT02100553|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
111018741|NCT02100553|Antifungal Agents|antifungal agents|mesh-ancestor
111018742|NCT02100553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111018743|NCT02100553|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111018744|NCT02100553|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111018745|NCT02100553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111018746|NCT02100553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111018747|NCT02100553|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110623150|NCT03275818|Paclitaxel|paclitaxel|mesh-list
111018748|NCT02100553|Hormone Antagonists|hormone antagonists|mesh-ancestor
111018749|NCT02100553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111018750|NCT02100553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111018751|NCT02100553|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111018752|NCT02100787|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
111018753|NCT02100787|Laxatives|laxatives|mesh-ancestor
111018754|NCT02100787|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111018755|NCT03295695|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
111018756|NCT03295695|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111018757|NCT03295695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110735867|NCT04264897|Metformin|metformin|mesh-list
111018759|NCT04718805|Cobicistat|cobicistat|mesh-list
111018760|NCT04718805|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
111018761|NCT04718805|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111018762|NCT04718805|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111018763|NCT04718805|Protease Inhibitors|protease inhibitors|mesh-ancestor
111018764|NCT04718805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111018765|NCT04718805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111018766|NCT04718805|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111018767|NCT04718805|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111018768|NCT04718805|Antiviral Agents|antiviral agents|mesh-ancestor
111018769|NCT04718805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111018770|NCT04718805|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111018771|NCT04718805|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111018772|NCT05042336|Lenvatinib|lenvatinib|mesh-list
111018773|NCT05042336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111018774|NCT05042336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111018775|NCT05042336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111018776|NCT05042336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111018777|NCT03096392|Insulin|insulin|mesh-list
111018778|NCT03096392|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111018779|NCT03096392|Insulin Lispro|insulin lispro|mesh-list
111018780|NCT03096392|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111018781|NCT03096392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111018782|NCT05042024|N-Methylaspartate|n-methylaspartate|mesh-list
111018783|NCT05042024|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
111018784|NCT05042024|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111018785|NCT05042024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111018786|NCT05042024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111018787|NCT05042024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111018788|NCT02460393|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111018789|NCT02460393|Antibodies|antibodies|mesh-list
111018790|NCT02460393|Immunoglobulins|immunoglobulins|mesh-list
111018791|NCT02460393|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111018792|NCT02460393|Immunologic Factors|immunologic factors|mesh-ancestor
111018793|NCT02460393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111018794|NCT02460393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111018795|NCT02250859|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111018796|NCT02250859|Minocycline|minocycline|mesh-list
111018797|NCT02250859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111018798|NCT03295461|Chlorhexidine|chlorhexidine|mesh-list
111018799|NCT03295461|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111018800|NCT03295461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111018801|NCT03295461|Disinfectants|disinfectants|mesh-ancestor
111018802|NCT03295383|Cyclophosphamide|cyclophosphamide|mesh-list
111018803|NCT03295383|Rituximab|rituximab|mesh-list
111018804|NCT03295383|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111018805|NCT03295383|Immunologic Factors|immunologic factors|mesh-ancestor
111018806|NCT03295383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111018807|NCT03295383|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110623155|NCT03275818|Mitosis Modulators|mitosis modulators|mesh-ancestor
111018808|NCT03295383|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111018809|NCT03295383|Alkylating Agents|alkylating agents|mesh-ancestor
111018810|NCT03295383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111018811|NCT03295383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111018812|NCT03295383|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111018813|NCT03295383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111018814|NCT02101255|Fluorides|fluorides|mesh-list
111018815|NCT02101255|Cariostatic Agents|cariostatic agents|mesh-ancestor
111018816|NCT02101255|Protective Agents|protective agents|mesh-ancestor
111018817|NCT02101255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111018818|NCT05063318|Itraconazole|itraconazole|mesh-list
111018819|NCT05063318|Antifungal Agents|antifungal agents|mesh-ancestor
111018820|NCT05063318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111018821|NCT05063318|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111018822|NCT05063318|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111018823|NCT05063318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111018824|NCT05063318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111018825|NCT05063318|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111018826|NCT05063318|Hormone Antagonists|hormone antagonists|mesh-ancestor
111018827|NCT05063318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111018828|NCT05063318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111018829|NCT05063318|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110735926|NCT03983954|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111018830|NCT02104297|Remifentanil|remifentanil|mesh-list
111018831|NCT02104297|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111018832|NCT02104297|Narcotics|narcotics|mesh-ancestor
111018833|NCT02104297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111018834|NCT02104297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111018835|NCT02104297|Analgesics|analgesics|mesh-ancestor
111018836|NCT02104297|Sensory System Agents|sensory system agents|mesh-ancestor
111018837|NCT02104297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111018838|NCT02106481|Ropivacaine|ropivacaine|mesh-list
111018839|NCT02106481|Anesthetics, Local|anesthetics, local|mesh-ancestor
111018840|NCT02106481|Anesthetics|anesthetics|mesh-ancestor
111018841|NCT02106481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111018842|NCT02106481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111018843|NCT02106481|Sensory System Agents|sensory system agents|mesh-ancestor
111018844|NCT02106481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111018845|NCT02106559|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
111018846|NCT02106559|Trioxsalen|trioxsalen|mesh-list
111018847|NCT02106559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111018848|NCT02106559|Dermatologic Agents|dermatologic agents|mesh-ancestor
111018849|NCT02106559|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111018850|NCT05047874|Methylprednisolone|methylprednisolone|mesh-list
111018851|NCT05047874|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111018852|NCT05047874|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111018853|NCT05047874|Prednisolone|prednisolone|mesh-list
111018854|NCT05047874|Prednisolone acetate|prednisolone acetate|mesh-list
111018855|NCT05047874|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111018856|NCT05047874|Prednisolone phosphate|prednisolone phosphate|mesh-list
111018857|NCT05047874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111018858|NCT05047874|Antiemetics|antiemetics|mesh-ancestor
111018859|NCT05047874|Autonomic Agents|autonomic agents|mesh-ancestor
111018860|NCT05047874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111018861|NCT05047874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111018862|NCT05047874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111018863|NCT05047874|Glucocorticoids|glucocorticoids|mesh-ancestor
111018864|NCT05047874|Hormones|hormones|mesh-ancestor
111018865|NCT05047874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111018866|NCT05047874|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111018867|NCT05047874|Protective Agents|protective agents|mesh-ancestor
111018868|NCT05047874|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111018869|NCT05047874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111018870|NCT04488705|Albuterol|albuterol|mesh-list
111018871|NCT04488705|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111018872|NCT04488705|Autonomic Agents|autonomic agents|mesh-ancestor
111018873|NCT04488705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111018874|NCT04488705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111018875|NCT04488705|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111018876|NCT04488705|Respiratory System Agents|respiratory system agents|mesh-ancestor
111018877|NCT04488705|Tocolytic Agents|tocolytic agents|mesh-ancestor
111018878|NCT04488705|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111018879|NCT04488705|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111018880|NCT04488705|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111018881|NCT04488705|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111018882|NCT04488705|Adrenergic Agents|adrenergic agents|mesh-ancestor
111018883|NCT04488705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111018884|NCT04488705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111018885|NCT02106637|Varenicline|varenicline|mesh-list
111018886|NCT02106637|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111018887|NCT02106637|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111018888|NCT02106637|Cholinergic Agents|cholinergic agents|mesh-ancestor
111018889|NCT02106637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111018890|NCT02106637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111018891|NCT02106637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111018892|NCT05047328|Inolimomab|inolimomab|mesh-list
111018893|NCT05047328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111018894|NCT05047328|Immunologic Factors|immunologic factors|mesh-ancestor
111018895|NCT05047328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111018896|NCT02104609|Levonorgestrel|levonorgestrel|mesh-list
111018897|NCT02104609|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111018898|NCT02104609|Contraceptive Agents|contraceptive agents|mesh-ancestor
111018899|NCT02104609|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111018900|NCT02104609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111018901|NCT02104609|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111018902|NCT02104609|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111018903|NCT02104609|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111018904|NCT02106793|Mitomycins|mitomycins|mesh-list
111018905|NCT02106793|Mitomycin|mitomycin|mesh-list
110736001|NCT03482024|Tirzepatide|tirzepatide|mesh-list
111018906|NCT02106793|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111018907|NCT02106793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111018908|NCT02106793|Alkylating Agents|alkylating agents|mesh-ancestor
111018909|NCT02106793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111018910|NCT02106793|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111018911|NCT02106793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111018912|NCT02104843|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111018913|NCT02104843|Asunaprevir|asunaprevir|mesh-list
111018914|NCT02104843|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111018915|NCT02104843|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111018916|NCT02104843|Antimetabolites|antimetabolites|mesh-ancestor
111018917|NCT02104843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111018918|NCT02104843|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111018919|NCT02104843|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111018920|NCT02104843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111018921|NCT02104843|Protease Inhibitors|protease inhibitors|mesh-ancestor
111018922|NCT05041790|Choline|choline|mesh-list
111018923|NCT05041790|Lipotropic Agents|lipotropic agents|mesh-ancestor
111018925|NCT05041790|Antimetabolites|antimetabolites|mesh-ancestor
110623184|NCT03274804|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111018926|NCT05041790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111018927|NCT05041790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111018928|NCT05041790|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111018929|NCT05041790|Nootropic Agents|nootropic agents|mesh-ancestor
111018930|NCT02105077|Anesthetics|anesthetics|mesh-list
111018931|NCT02105077|Xenon|xenon|mesh-list
111018932|NCT02105077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111018933|NCT02105077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111018934|NCT02105077|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111018935|NCT02105077|Anesthetics, General|anesthetics, general|mesh-ancestor
111018936|NCT02101567|Oxytocin|oxytocin|mesh-list
111018937|NCT02101567|Carbetocin|carbetocin|mesh-list
111018938|NCT02101567|Oxytocics|oxytocics|mesh-ancestor
111018939|NCT02101567|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111018940|NCT02101567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111018941|NCT02106871|Sildenafil Citrate|sildenafil citrate|mesh-list
111018942|NCT02106871|Vasodilator Agents|vasodilator agents|mesh-ancestor
111018943|NCT02106871|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111018944|NCT02106871|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111018945|NCT02106871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111018946|NCT02106871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111018947|NCT02106871|Urological Agents|urological agents|mesh-ancestor
111018948|NCT02251015|Salicylic Acid|salicylic acid|mesh-list
111018949|NCT02251015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111018950|NCT02251015|Antifungal Agents|antifungal agents|mesh-ancestor
111018951|NCT02251015|Keratolytic Agents|keratolytic agents|mesh-ancestor
111018952|NCT02251015|Dermatologic Agents|dermatologic agents|mesh-ancestor
111018953|NCT03288597|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
111018954|NCT03288597|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111018955|NCT03288597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111018956|NCT02407990|Tislelizumab|tislelizumab|mesh-list
111018957|NCT02407990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111018958|NCT02407990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111018959|NCT02105155|Tacrolimus|tacrolimus|mesh-list
111018960|NCT02105155|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111018961|NCT02105155|Immunologic Factors|immunologic factors|mesh-ancestor
111018962|NCT02105155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111018963|NCT02105155|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111018964|NCT02105155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111018965|NCT02105155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111018966|NCT03294525|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
111018967|NCT03294525|Mirtazapine|mirtazapine|mesh-list
111018968|NCT03294525|Antidepressive Agents|antidepressive agents|mesh-list
111018969|NCT03294525|Escitalopram|escitalopram|mesh-list
111018970|NCT03294525|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111018971|NCT03294525|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111018972|NCT03294525|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111018973|NCT03294525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111018974|NCT03294525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111018975|NCT03294525|Serotonin Agents|serotonin agents|mesh-ancestor
111018976|NCT03294525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111018977|NCT03294525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111018978|NCT03294525|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111018979|NCT03294525|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111018980|NCT03294525|Analgesics|analgesics|mesh-ancestor
111018981|NCT03294525|Sensory System Agents|sensory system agents|mesh-ancestor
111018982|NCT03294525|Dopamine Agents|dopamine agents|mesh-ancestor
111018983|NCT03294525|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111018984|NCT03294525|Histamine Antagonists|histamine antagonists|mesh-ancestor
111018985|NCT03294525|Histamine Agents|histamine agents|mesh-ancestor
111018986|NCT03294525|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111018987|NCT03294525|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111018988|NCT03294525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111018989|NCT03294525|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
111018990|NCT03294525|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111018991|NCT03294525|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111018992|NCT03294525|Adrenergic Agents|adrenergic agents|mesh-ancestor
111018993|NCT03294525|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111018994|NCT03294525|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111018995|NCT03294525|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111018996|NCT05036174|Diphenhydramine|diphenhydramine|mesh-list
111018997|NCT05036174|Promethazine|promethazine|mesh-list
111018998|NCT05036174|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111018999|NCT05036174|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111019000|NCT05036174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111019001|NCT05036174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111019002|NCT05036174|Anesthetics, Local|anesthetics, local|mesh-ancestor
111019003|NCT05036174|Anesthetics|anesthetics|mesh-ancestor
111019004|NCT05036174|Sensory System Agents|sensory system agents|mesh-ancestor
111019005|NCT05036174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111019006|NCT05036174|Antiemetics|antiemetics|mesh-ancestor
111019007|NCT05036174|Autonomic Agents|autonomic agents|mesh-ancestor
111019008|NCT05036174|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111019009|NCT05036174|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111019010|NCT05036174|Histamine Antagonists|histamine antagonists|mesh-ancestor
111019011|NCT05036174|Histamine Agents|histamine agents|mesh-ancestor
111019012|NCT05036174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111019013|NCT05036174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111019014|NCT05036174|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111019015|NCT05036174|Antipruritics|antipruritics|mesh-ancestor
111019016|NCT05036174|Dermatologic Agents|dermatologic agents|mesh-ancestor
111019017|NCT03283059|Donepezil|donepezil|mesh-list
111019018|NCT03283059|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111019019|NCT03283059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111019020|NCT03283059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111019021|NCT03283059|Cholinergic Agents|cholinergic agents|mesh-ancestor
111019022|NCT03283059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111019023|NCT03283059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111019024|NCT03283059|Nootropic Agents|nootropic agents|mesh-ancestor
111019025|NCT05060588|Valsartan|valsartan|mesh-list
111019026|NCT05060588|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
111019027|NCT05060588|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111019028|NCT05060588|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111019029|NCT05060588|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111019030|NCT05060588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111019031|NCT02105311|Benzalkonium Compounds|benzalkonium compounds|mesh-list
111019032|NCT02105311|Travoprost|travoprost|mesh-list
111019033|NCT02105311|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111019034|NCT02105311|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111019035|NCT02105311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111019036|NCT03554395|Antibodies|antibodies|mesh-list
111019037|NCT03554395|Antibodies, Bispecific|antibodies, bispecific|mesh-list
111019038|NCT03554395|Immunologic Factors|immunologic factors|mesh-ancestor
111019039|NCT03554395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111019040|NCT03282825|Paclitaxel|paclitaxel|mesh-list
111019041|NCT03282825|Decitabine|decitabine|mesh-list
111019042|NCT03282825|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111019043|NCT03282825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111019044|NCT03282825|Tubulin Modulators|tubulin modulators|mesh-ancestor
111019045|NCT03282825|Antimitotic Agents|antimitotic agents|mesh-ancestor
111019046|NCT03282825|Mitosis Modulators|mitosis modulators|mesh-ancestor
111019047|NCT03282825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111019048|NCT03282825|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111019049|NCT03282825|Antimetabolites|antimetabolites|mesh-ancestor
111019050|NCT03282825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111019051|NCT02105623|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111019052|NCT02105623|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111019053|NCT02105623|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111019054|NCT02105623|Antimetabolites|antimetabolites|mesh-ancestor
111019055|NCT02105623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111019056|NCT02105623|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111019057|NCT02105623|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111019058|NCT02105623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111019059|NCT05039606|Nedaplatin|nedaplatin|mesh-list
111019060|NCT05039606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111019061|NCT03288051|Dobutamine|dobutamine|mesh-list
111019062|NCT03288051|Norepinephrine|norepinephrine|mesh-list
111019063|NCT03288051|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111019064|NCT03288051|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111019065|NCT03288051|Adrenergic Agents|adrenergic agents|mesh-ancestor
111019066|NCT03288051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111019067|NCT03288051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111019068|NCT03288051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111019069|NCT03288051|Sympathomimetics|sympathomimetics|mesh-ancestor
111019070|NCT03288051|Autonomic Agents|autonomic agents|mesh-ancestor
111019071|NCT03288051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111019072|NCT03288051|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111019073|NCT03288051|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111019074|NCT03288051|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
111019075|NCT03288051|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111019076|NCT03288051|Protective Agents|protective agents|mesh-ancestor
111019077|NCT05035472|Phenylephrine|phenylephrine|mesh-list
111019078|NCT05035472|Oxymetazoline|oxymetazoline|mesh-list
111019079|NCT05035472|Norepinephrine|norepinephrine|mesh-list
111019080|NCT05035472|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
111019081|NCT05035472|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111019082|NCT05035472|Mydriatics|mydriatics|mesh-ancestor
111019083|NCT05035472|Autonomic Agents|autonomic agents|mesh-ancestor
111019084|NCT05035472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111019085|NCT05035472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111019086|NCT05035472|Sympathomimetics|sympathomimetics|mesh-ancestor
111019087|NCT05035472|Nasal Decongestants|nasal decongestants|mesh-ancestor
111019088|NCT05035472|Respiratory System Agents|respiratory system agents|mesh-ancestor
111019089|NCT05035472|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111019090|NCT05035472|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111019091|NCT05035472|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111019092|NCT05035472|Adrenergic Agents|adrenergic agents|mesh-ancestor
111019093|NCT05035472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111019094|NCT05035472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111019095|NCT05035472|Protective Agents|protective agents|mesh-ancestor
111019096|NCT02460627|Lidocaine|lidocaine|mesh-list
111019097|NCT02460627|Anesthetics, Local|anesthetics, local|mesh-ancestor
111019098|NCT02460627|Anesthetics|anesthetics|mesh-ancestor
111019099|NCT02460627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111019100|NCT02460627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111019101|NCT02460627|Sensory System Agents|sensory system agents|mesh-ancestor
110623237|NCT00321685|Antidotes|antidotes|mesh-ancestor
111019102|NCT02460627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111019103|NCT02460627|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111019104|NCT02460627|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111019105|NCT02460627|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111019106|NCT02460627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111019107|NCT02460627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111019108|NCT02107729|Lidocaine|lidocaine|mesh-list
111019109|NCT02107729|Anesthetics, Local|anesthetics, local|mesh-ancestor
111019110|NCT02107729|Anesthetics|anesthetics|mesh-ancestor
111019111|NCT02107729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111019112|NCT02107729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111019113|NCT02107729|Sensory System Agents|sensory system agents|mesh-ancestor
111019114|NCT02107729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111019115|NCT02107729|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111019116|NCT02107729|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111019117|NCT02107729|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111019118|NCT02107729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111019119|NCT02107729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111019120|NCT03282513|Ivosidenib|ivosidenib|mesh-list
111019121|NCT03282513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111019122|NCT03282513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111019123|NCT03282513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111019124|NCT02107807|Lactitol|lactitol|mesh-list
111019125|NCT02107807|Vaccines|vaccines|mesh-list
111019126|NCT02107807|Immunologic Factors|immunologic factors|mesh-ancestor
111019127|NCT02107807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111019128|NCT02107807|Cathartics|cathartics|mesh-ancestor
110736249|NCT01233635|Losartan|losartan|mesh-list
111019129|NCT02107807|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111019130|NCT01673282|Lacosamide|lacosamide|mesh-list
111019131|NCT01673282|Anticonvulsants|anticonvulsants|mesh-ancestor
111019132|NCT01673282|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111019133|NCT01673282|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111019134|NCT01673282|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111019135|NCT01673282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111019136|NCT02113735|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
111019137|NCT02113735|Hormones|hormones|mesh-ancestor
111019138|NCT02113735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111019139|NCT02113735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111019140|NCT02113813|Naquotinib|naquotinib|mesh-list
111019141|NCT02113813|Midazolam|midazolam|mesh-list
111019142|NCT02113813|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111019143|NCT02113813|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111019144|NCT02113813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111019145|NCT02113813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111019146|NCT02113813|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111019147|NCT02113813|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111019148|NCT02113813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111019149|NCT02113813|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111019150|NCT02113813|Anesthetics, General|anesthetics, general|mesh-ancestor
111019151|NCT02113813|Anesthetics|anesthetics|mesh-ancestor
111019152|NCT02113813|GABA Modulators|gaba modulators|mesh-ancestor
111019153|NCT02113813|GABA Agents|gaba agents|mesh-ancestor
111019154|NCT02113813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111019155|NCT02113813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111019156|NCT02113813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111019157|NCT02113813|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111019158|NCT02113813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111019159|NCT03095144|Anesthetics|anesthetics|mesh-list
111019160|NCT03095144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111019161|NCT03095144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111019162|NCT03095222|Ketamine|ketamine|mesh-list
111019163|NCT03095222|Analgesics|analgesics|mesh-ancestor
111019164|NCT03095222|Sensory System Agents|sensory system agents|mesh-ancestor
111019165|NCT03095222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111019166|NCT03095222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111019167|NCT03095222|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111019168|NCT03095222|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111019169|NCT03095222|Anesthetics, General|anesthetics, general|mesh-ancestor
111019170|NCT03095222|Anesthetics|anesthetics|mesh-ancestor
111019171|NCT03095222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111019172|NCT03095222|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111019173|NCT03095222|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111019174|NCT03095222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111019175|NCT03095222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111019176|NCT02113891|Eculizumab|eculizumab|mesh-list
111019177|NCT02113891|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
111019178|NCT02113891|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111019179|NCT02113891|Immunologic Factors|immunologic factors|mesh-ancestor
111019180|NCT02113891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111019181|NCT03095378|Anti-Infective Agents|anti-infective agents|mesh-list
111019182|NCT03095378|Tetracycline|tetracycline|mesh-list
111019183|NCT03095378|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111019184|NCT03095378|Citric Acid|citric acid|mesh-list
111019185|NCT03095378|Sodium Citrate|sodium citrate|mesh-list
111019186|NCT03095378|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111019187|NCT03095378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111019188|NCT03095378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111019189|NCT03095378|Anticoagulants|anticoagulants|mesh-ancestor
111019190|NCT03095378|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
111019191|NCT03095378|Chelating Agents|chelating agents|mesh-ancestor
111019192|NCT03095378|Sequestering Agents|sequestering agents|mesh-ancestor
111019193|NCT05025098|Azacitidine|azacitidine|mesh-list
111019194|NCT05025098|Venetoclax|venetoclax|mesh-list
111019195|NCT05025098|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111019196|NCT05025098|Antimetabolites|antimetabolites|mesh-ancestor
111019197|NCT05025098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111019198|NCT05025098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111019199|NCT05025098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111019200|NCT05038202|Mometasone Furoate|mometasone furoate|mesh-list
111019201|NCT05038202|Bromides|bromides|mesh-list
111019202|NCT05038202|Anticonvulsants|anticonvulsants|mesh-ancestor
111019203|NCT05038202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111019204|NCT05038202|Dermatologic Agents|dermatologic agents|mesh-ancestor
111019205|NCT05038202|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111019206|NCT02114359|Cisplatin|cisplatin|mesh-list
111019207|NCT02114359|Fluorouracil|fluorouracil|mesh-list
111019208|NCT02114359|Capecitabine|capecitabine|mesh-list
111019209|NCT02114359|Oxaliplatin|oxaliplatin|mesh-list
111019210|NCT02114359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111019211|NCT02114359|Antimetabolites|antimetabolites|mesh-ancestor
111019212|NCT02114359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111019213|NCT02114359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111019214|NCT02114359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111019215|NCT02114359|Immunologic Factors|immunologic factors|mesh-ancestor
111019216|NCT02114359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111019217|NCT02110303|Ticagrelor|ticagrelor|mesh-list
111019218|NCT02110303|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111019219|NCT02110303|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111019220|NCT02110303|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111019221|NCT02110303|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111019222|NCT02110303|Purinergic Agents|purinergic agents|mesh-ancestor
111019223|NCT02110303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111019224|NCT02110303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111019225|NCT02110303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111019227|NCT03093740|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
111019228|NCT03093740|Antiviral Agents|antiviral agents|mesh-ancestor
111019229|NCT03093740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111019230|NCT02108353|Melatonin|melatonin|mesh-list
111019231|NCT02108353|Antioxidants|antioxidants|mesh-ancestor
111019232|NCT02108353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111019233|NCT02108353|Protective Agents|protective agents|mesh-ancestor
111019234|NCT02108353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111019235|NCT02108353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111019236|NCT04157751|Empagliflozin|empagliflozin|mesh-list
111019237|NCT04157751|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111019238|NCT04157751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111019239|NCT04157751|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111019240|NCT04157751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111019241|NCT02114671|Ciprofloxacin|ciprofloxacin|mesh-list
111019242|NCT02114671|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111019243|NCT02114671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111019244|NCT02114671|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111019245|NCT02114671|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111019246|NCT02114671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111019247|NCT02114671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111019248|NCT02114671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111019249|NCT02114671|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111019250|NCT02114671|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111019251|NCT02110459|Murepavadin|murepavadin|mesh-list
111019252|NCT02110459|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111019253|NCT02110459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111019254|NCT03287505|Aripiprazole|aripiprazole|mesh-list
111019255|NCT03287505|Antidepressive Agents|antidepressive agents|mesh-ancestor
111019256|NCT03287505|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111019257|NCT03287505|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111019258|NCT03287505|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111019259|NCT03287505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111019260|NCT03287505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111019261|NCT03287505|Dopamine Agonists|dopamine agonists|mesh-ancestor
111019262|NCT03287505|Dopamine Agents|dopamine agents|mesh-ancestor
111019263|NCT03287505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111019264|NCT03287505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111019265|NCT03287505|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111019266|NCT03287505|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111019267|NCT03287505|Serotonin Agents|serotonin agents|mesh-ancestor
111019268|NCT03287505|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111019269|NCT03287505|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111019270|NCT03287505|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111019271|NCT03287505|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111019272|NCT03090698|Triamcinolone|triamcinolone|mesh-list
111019273|NCT03090698|Hylan|hylan|mesh-list
111019274|NCT03090698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111019275|NCT03090698|Glucocorticoids|glucocorticoids|mesh-ancestor
111019276|NCT03090698|Hormones|hormones|mesh-ancestor
111019277|NCT03090698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111019278|NCT03090698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111019280|NCT03090698|Protective Agents|protective agents|mesh-ancestor
111019281|NCT03293511|Oxytocin|oxytocin|mesh-list
111019282|NCT03293511|Oxytocics|oxytocics|mesh-ancestor
110623285|NCT00778232|Antimanic Agents|antimanic agents|mesh-ancestor
111019283|NCT03293511|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111019284|NCT03293511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111019285|NCT02251171|Ritonavir|ritonavir|mesh-list
111019286|NCT02251171|Tipranavir|tipranavir|mesh-list
111019287|NCT02251171|Rifabutin|rifabutin|mesh-list
111019288|NCT02251171|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111019289|NCT02251171|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111019290|NCT02251171|Protease Inhibitors|protease inhibitors|mesh-ancestor
111019291|NCT02251171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110827018|NCT01161277|Antiemetics|antiemetics|mesh-ancestor
111019292|NCT02251171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111019293|NCT02251171|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111019294|NCT02251171|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111019295|NCT02251171|Antiviral Agents|antiviral agents|mesh-ancestor
111019296|NCT02251171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111019297|NCT02251171|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111019298|NCT02251171|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111019299|NCT02251171|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111019300|NCT02251171|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111019301|NCT02251171|Antitubercular Agents|antitubercular agents|mesh-ancestor
111019302|NCT02110537|Flecainide|flecainide|mesh-list
111019303|NCT02110537|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111019304|NCT02110537|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111019305|NCT02110537|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111019306|NCT02110537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111019307|NCT02110537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111019308|NCT03293277|Dexmedetomidine|dexmedetomidine|mesh-list
111019309|NCT03293277|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111019310|NCT03293277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111019311|NCT03293277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111019312|NCT03293277|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111019313|NCT03293277|Analgesics|analgesics|mesh-ancestor
111019314|NCT03293277|Sensory System Agents|sensory system agents|mesh-ancestor
111019315|NCT03293277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111019316|NCT03293277|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111019317|NCT03293277|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111019318|NCT03293277|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111019319|NCT03293277|Adrenergic Agents|adrenergic agents|mesh-ancestor
111019320|NCT03293277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111019321|NCT03293277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111019322|NCT02108743|Albuterol|albuterol|mesh-list
111019323|NCT02108743|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111019324|NCT02108743|Autonomic Agents|autonomic agents|mesh-ancestor
111019325|NCT02108743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111019326|NCT02108743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111019327|NCT02108743|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111019328|NCT02108743|Respiratory System Agents|respiratory system agents|mesh-ancestor
111019329|NCT02108743|Tocolytic Agents|tocolytic agents|mesh-ancestor
111019330|NCT02108743|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111019331|NCT02108743|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111019332|NCT02108743|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111019333|NCT02108743|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111019334|NCT02108743|Adrenergic Agents|adrenergic agents|mesh-ancestor
111019335|NCT02108743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111019336|NCT02108743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111019337|NCT03292965|Neostigmine|neostigmine|mesh-list
111019338|NCT03292965|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111019339|NCT03292965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111019340|NCT03292965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111019341|NCT03292965|Cholinergic Agents|cholinergic agents|mesh-ancestor
111019342|NCT03292965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111019343|NCT03292965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111019344|NCT03292965|Parasympathomimetics|parasympathomimetics|mesh-ancestor
111019345|NCT03292965|Autonomic Agents|autonomic agents|mesh-ancestor
111019346|NCT03292965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111019347|NCT05024084|Anesthetics|anesthetics|mesh-list
111019348|NCT05024084|Sevoflurane|sevoflurane|mesh-list
111019349|NCT05024084|Desflurane|desflurane|mesh-list
111019350|NCT05024084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111019351|NCT05024084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110736455|NCT00071396|Rituximab|rituximab|mesh-list
111019352|NCT05024084|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111019353|NCT05024084|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111019354|NCT05024084|Anesthetics, General|anesthetics, general|mesh-ancestor
111019355|NCT02109289|Etanercept|etanercept|mesh-list
111019356|NCT02109289|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111019357|NCT02109289|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111019358|NCT02109289|Analgesics|analgesics|mesh-ancestor
111019359|NCT02109289|Sensory System Agents|sensory system agents|mesh-ancestor
111019360|NCT02109289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111019361|NCT02109289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111019362|NCT02109289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111019363|NCT02109289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111019364|NCT02109289|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111019365|NCT02109289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111019366|NCT02109289|Immunologic Factors|immunologic factors|mesh-ancestor
111019367|NCT03292731|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
111019368|NCT03292731|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
111019369|NCT03292731|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111019370|NCT03292731|Hormone Antagonists|hormone antagonists|mesh-ancestor
111019371|NCT03292731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111019372|NCT03292731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111019373|NCT03292731|Progestins|progestins|mesh-ancestor
111019374|NCT03292731|Hormones|hormones|mesh-ancestor
111019375|NCT03553303|Valsartan|valsartan|mesh-list
111019376|NCT03553303|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
111019377|NCT03553303|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111019378|NCT03553303|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111019379|NCT03553303|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111019380|NCT03553303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111019381|NCT03286959|Calcium|calcium|mesh-list
111019382|NCT03286959|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111019383|NCT03286959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111019384|NCT03292575|Anticoagulants|anticoagulants|mesh-list
111019385|NCT02115529|Nabilone|nabilone|mesh-list
111019386|NCT02115529|Antiemetics|antiemetics|mesh-ancestor
111019387|NCT02115529|Autonomic Agents|autonomic agents|mesh-ancestor
111019388|NCT02115529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111019389|NCT02115529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111019390|NCT02115529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111019391|NCT02115529|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111019392|NCT02115529|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111019393|NCT02115529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111019394|NCT02115529|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111019395|NCT01652716|Exenatide|exenatide|mesh-list
111019396|NCT01652716|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111019397|NCT01652716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111019398|NCT01652716|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111019399|NCT01652716|Incretins|incretins|mesh-ancestor
111019400|NCT01652716|Hormones|hormones|mesh-ancestor
111019401|NCT01652716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111019402|NCT02459613|Annexin A5|annexin a5|mesh-list
111019403|NCT02459613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111019404|NCT02459613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111019405|NCT02251249|Acetaminophen|acetaminophen|mesh-list
111019406|NCT02251249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111019407|NCT02251249|Analgesics|analgesics|mesh-ancestor
111019408|NCT02251249|Sensory System Agents|sensory system agents|mesh-ancestor
111019409|NCT02251249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111019410|NCT02251249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111019411|NCT02251249|Antipyretics|antipyretics|mesh-ancestor
111019412|NCT05017766|Anti-Infective Agents|anti-infective agents|mesh-list
111019413|NCT05017766|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111019414|NCT03292263|Nivolumab|nivolumab|mesh-list
111019415|NCT03292263|Melphalan|melphalan|mesh-list
111019416|NCT03292263|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111019417|NCT03292263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111019418|NCT03292263|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111019419|NCT03292263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111019420|NCT03292263|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111019421|NCT03292263|Alkylating Agents|alkylating agents|mesh-ancestor
111019422|NCT03292263|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111019423|NCT03292263|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111019424|NCT03292263|Immunologic Factors|immunologic factors|mesh-ancestor
111019425|NCT03292263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110736530|NCT00065468|Sirolimus|sirolimus|mesh-list
111019426|NCT02115763|Caffeine|caffeine|mesh-list
111019427|NCT02115763|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111019428|NCT02115763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111019429|NCT02115763|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111019430|NCT02115763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111019431|NCT02115763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111019432|NCT02115763|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
111019433|NCT02115763|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111019434|NCT02115763|Purinergic Agents|purinergic agents|mesh-ancestor
111019435|NCT02115763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111019436|NCT03286803|Vaccines|vaccines|mesh-list
111019437|NCT03286803|Immunologic Factors|immunologic factors|mesh-ancestor
111019438|NCT03286803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111019439|NCT03292185|Insulin|insulin|mesh-list
111019440|NCT03292185|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111019441|NCT03292185|Liraglutide|liraglutide|mesh-list
111019442|NCT03292185|Insulin, Long-Acting|insulin, long-acting|mesh-list
111019443|NCT03292185|Xultophy|xultophy|mesh-list
111019444|NCT03292185|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111019445|NCT03292185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111019446|NCT03292185|Incretins|incretins|mesh-ancestor
111019447|NCT03292185|Hormones|hormones|mesh-ancestor
111019448|NCT03292185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111019449|NCT04239339|Escitalopram|escitalopram|mesh-list
111019450|NCT04239339|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111019451|NCT04239339|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111019452|NCT04239339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111019453|NCT04239339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111019454|NCT04239339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111019455|NCT04239339|Serotonin Agents|serotonin agents|mesh-ancestor
111019456|NCT04239339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111019457|NCT02109679|Metformin|metformin|mesh-list
111019458|NCT02109679|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111019459|NCT02109679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111019460|NCT05023304|Prednisolone|prednisolone|mesh-list
111019461|NCT05023304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111019462|NCT05023304|Glucocorticoids|glucocorticoids|mesh-ancestor
111019463|NCT05023304|Hormones|hormones|mesh-ancestor
111019464|NCT05023304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111019465|NCT05023304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111019466|NCT05023304|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111019467|NCT05023304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111019468|NCT02109913|Everolimus|everolimus|mesh-list
111019469|NCT02109913|Exemestane|exemestane|mesh-list
111019470|NCT02109913|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111019471|NCT02109913|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111019472|NCT02109913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111019473|NCT02109913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111019474|NCT02109913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111019475|NCT02109913|Immunologic Factors|immunologic factors|mesh-ancestor
111019476|NCT02109913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111019477|NCT02109913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111019478|NCT02109913|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111019479|NCT02109913|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111019480|NCT02109913|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111019481|NCT02109913|Hormone Antagonists|hormone antagonists|mesh-ancestor
111019482|NCT02109913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111019483|NCT02116231|Cisplatin|cisplatin|mesh-list
111019484|NCT02116231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111019485|NCT02111161|Immunoglobulins|immunoglobulins|mesh-list
111019486|NCT02111161|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111019487|NCT02111161|Immunoglobulin G|immunoglobulin g|mesh-list
111019488|NCT02111161|gamma-Globulins|gamma-globulins|mesh-list
111019489|NCT02111161|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
111019490|NCT02111161|Immunologic Factors|immunologic factors|mesh-ancestor
111019491|NCT02111161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111019492|NCT02116465|Levodopa|levodopa|mesh-list
111019493|NCT02116465|Carbidopa|carbidopa|mesh-list
111019494|NCT02116465|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
111019495|NCT02116465|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111019496|NCT02116465|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111019497|NCT02116465|Dopamine Agents|dopamine agents|mesh-ancestor
111019498|NCT02116465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111019499|NCT02116465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111019500|NCT02116465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111019501|NCT02116465|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
111019502|NCT02116465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111019503|NCT02116465|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111019504|NCT02116465|Immunologic Factors|immunologic factors|mesh-ancestor
111019505|NCT02116465|Dopamine Agonists|dopamine agonists|mesh-ancestor
111019506|NCT02119039|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111019507|NCT02119039|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111019509|NCT02119117|Vitamins|vitamins|mesh-ancestor
111019510|NCT02119117|Micronutrients|micronutrients|mesh-ancestor
111019511|NCT02119117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111019512|NCT05016128|Ketamine|ketamine|mesh-list
111019513|NCT05016128|Esketamine|esketamine|mesh-list
111019514|NCT05016128|Analgesics|analgesics|mesh-ancestor
111019515|NCT05016128|Sensory System Agents|sensory system agents|mesh-ancestor
111019516|NCT05016128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111019517|NCT05016128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111019518|NCT05016128|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111019519|NCT05016128|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111019520|NCT05016128|Anesthetics, General|anesthetics, general|mesh-ancestor
111019521|NCT05016128|Anesthetics|anesthetics|mesh-ancestor
111019522|NCT05016128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111019523|NCT05016128|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111019524|NCT05016128|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111019525|NCT05016128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111019526|NCT05016128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111019527|NCT05016128|Antidepressive Agents|antidepressive agents|mesh-ancestor
111019528|NCT05016128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111019529|NCT02111317|Verapamil|verapamil|mesh-list
111019530|NCT02111317|Peficitinib|peficitinib|mesh-list
111019531|NCT02111317|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111019532|NCT02111317|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111019533|NCT02111317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111019534|NCT02111317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111019535|NCT02111317|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111019536|NCT02111317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111019537|NCT02111317|Vasodilator Agents|vasodilator agents|mesh-ancestor
111019538|NCT02111317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111019539|NCT02111317|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111019540|NCT02111317|Immunologic Factors|immunologic factors|mesh-ancestor
111019541|NCT03553615|Ivermectin|ivermectin|mesh-list
111019542|NCT03553615|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111019543|NCT03553615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111019544|NCT05016206|Moxifloxacin|moxifloxacin|mesh-list
111019545|NCT05016206|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
111019546|NCT05016206|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111019547|NCT05016206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111019548|NCT05016206|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111019549|NCT05016206|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111019550|NCT05016206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111019551|NCT05016206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111019552|NCT05016206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111019553|NCT05016206|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111019554|NCT05016206|Contraceptive Agents|contraceptive agents|mesh-ancestor
111019555|NCT05016206|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111019556|NCT05016206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111019557|NCT05016206|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
111019558|NCT05016206|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111019559|NCT05016206|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111019560|NCT02111473|Testosterone|testosterone|mesh-list
111019561|NCT02111473|Androgens|androgens|mesh-ancestor
111019562|NCT02111473|Hormones|hormones|mesh-ancestor
111019563|NCT02111473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111019564|NCT02111473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111019565|NCT02111551|3-(2,4-dimethoxybenzylidene)anabaseine|3-(2,4-dimethoxybenzylidene)anabaseine|mesh-list
111019566|NCT02111551|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111019567|NCT02111551|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111019568|NCT02111551|Cholinergic Agents|cholinergic agents|mesh-ancestor
111019569|NCT02111551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111019570|NCT02111551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110736674|NCT00038948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111019571|NCT02111551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111019572|NCT02119273|Prednisone|prednisone|mesh-list
111019573|NCT02119273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111019574|NCT02119273|Glucocorticoids|glucocorticoids|mesh-ancestor
111019576|NCT02119273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111019577|NCT02119273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111019578|NCT02119273|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111019579|NCT02119273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111019580|NCT05029076|Liraglutide|liraglutide|mesh-list
111019582|NCT05029076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111019583|NCT05029076|Incretins|incretins|mesh-ancestor
111019584|NCT05029076|Hormones|hormones|mesh-ancestor
111019585|NCT05029076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111019586|NCT05016440|Lisinopril|lisinopril|mesh-list
111019587|NCT05016440|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
111019588|NCT05016440|Protease Inhibitors|protease inhibitors|mesh-ancestor
111019589|NCT05016440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111019590|NCT05016440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111019591|NCT05016440|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111019592|NCT05016440|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111019593|NCT05016440|Protective Agents|protective agents|mesh-ancestor
111019594|NCT05016440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111019595|NCT02111629|Fluconazole|fluconazole|mesh-list
111019596|NCT02111629|Secnidazole|secnidazole|mesh-list
111019597|NCT02111629|Antifungal Agents|antifungal agents|mesh-ancestor
111019598|NCT02111629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111019599|NCT02111629|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111019600|NCT02111629|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111019601|NCT02111629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111019602|NCT02111629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111019603|NCT02111629|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111019604|NCT02111629|Hormone Antagonists|hormone antagonists|mesh-ancestor
111019605|NCT02111629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111019606|NCT02111629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111019607|NCT02111629|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111019608|NCT02111629|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111019609|NCT02111629|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111019610|NCT02111629|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111019611|NCT02111707|Indomethacin|indomethacin|mesh-list
111019612|NCT02111707|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111019613|NCT02111707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111019614|NCT02111707|Analgesics|analgesics|mesh-ancestor
111019615|NCT02111707|Sensory System Agents|sensory system agents|mesh-ancestor
111019616|NCT02111707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111019617|NCT02111707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111019618|NCT02111707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111019619|NCT02111707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111019620|NCT02111707|Gout Suppressants|gout suppressants|mesh-ancestor
111019621|NCT02111707|Tocolytic Agents|tocolytic agents|mesh-ancestor
111019622|NCT02111707|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111019623|NCT02111707|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111019624|NCT02111707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111019625|NCT02111707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111019626|NCT03552601|Methamphetamine|methamphetamine|mesh-list
111019627|NCT03552601|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111019628|NCT03552601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111019629|NCT03552601|Sympathomimetics|sympathomimetics|mesh-ancestor
111019630|NCT03552601|Autonomic Agents|autonomic agents|mesh-ancestor
111019631|NCT03552601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111019632|NCT03552601|Dopamine Agents|dopamine agents|mesh-ancestor
111019633|NCT03552601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111019634|NCT03552601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111019635|NCT03552601|Adrenergic Agents|adrenergic agents|mesh-ancestor
111019636|NCT03552601|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111019637|NCT03552601|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111019638|NCT03552601|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111019639|NCT03552601|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111019640|NCT05021588|Anticoagulants|anticoagulants|mesh-list
111019641|NCT03087890|Trimethoprim|trimethoprim|mesh-list
111019642|NCT03087890|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
111019643|NCT03087890|Sulfamethoxazole|sulfamethoxazole|mesh-list
111019644|NCT03087890|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110736749|NCT00031694|Paclitaxel|paclitaxel|mesh-list
111019645|NCT03087890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111019646|NCT03087890|Antimalarials|antimalarials|mesh-ancestor
111019647|NCT03087890|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111019648|NCT03087890|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110827023|NCT01268215|Budesonide|budesonide|mesh-list
111019650|NCT03087890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111019651|NCT03087890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111019652|NCT03087890|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111019653|NCT03087890|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
111019654|NCT03087890|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111019655|NCT03087890|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111019656|NCT02112019|Hydrocortisone|hydrocortisone|mesh-list
110623351|NCT00778466|Metformin|metformin|mesh-list
111019657|NCT02112019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111019658|NCT02117401|Midazolam|midazolam|mesh-list
111019659|NCT02117401|Ketamine|ketamine|mesh-list
111019660|NCT02117401|Remifentanil|remifentanil|mesh-list
111019661|NCT02117401|Propofol|propofol|mesh-list
111019662|NCT02117401|Mivacurium|mivacurium|mesh-list
111019663|NCT02117401|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111019664|NCT02117401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111019665|NCT02117401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111019666|NCT02117401|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111019667|NCT02117401|Anesthetics, General|anesthetics, general|mesh-ancestor
111019668|NCT02117401|Anesthetics|anesthetics|mesh-ancestor
111019669|NCT02117401|Analgesics|analgesics|mesh-ancestor
111019670|NCT02117401|Sensory System Agents|sensory system agents|mesh-ancestor
111019671|NCT02117401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111019672|NCT02117401|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111019673|NCT02117401|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111019674|NCT02117401|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111019675|NCT02117401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111019676|NCT02117401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111019677|NCT02117401|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111019678|NCT02117401|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111019679|NCT02117401|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111019680|NCT02117401|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111019681|NCT02117401|GABA Modulators|gaba modulators|mesh-ancestor
111019682|NCT02117401|GABA Agents|gaba agents|mesh-ancestor
111019683|NCT02117401|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111019684|NCT02117401|Narcotics|narcotics|mesh-ancestor
111019685|NCT02117401|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
111019686|NCT02117401|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
111019687|NCT02117401|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111019688|NCT04434404|Silymarin|silymarin|mesh-list
111019689|NCT04434404|Antioxidants|antioxidants|mesh-ancestor
111019690|NCT04434404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111019691|NCT04434404|Protective Agents|protective agents|mesh-ancestor
111019692|NCT04434404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111019693|NCT02251483|Immunoglobulins|immunoglobulins|mesh-list
111019694|NCT02251483|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111019695|NCT02251483|Antibodies|antibodies|mesh-list
111019696|NCT02251483|Immunologic Factors|immunologic factors|mesh-ancestor
111019697|NCT02251483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111019698|NCT02117869|Furocoumarins|furocoumarins|mesh-list
111019699|NCT02117869|Dermatologic Agents|dermatologic agents|mesh-ancestor
111019700|NCT02117869|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111019701|NCT02120599|Folic Acid|folic acid|mesh-list
111019702|NCT02120599|Hematinics|hematinics|mesh-ancestor
111019703|NCT02120599|Vitamin B Complex|vitamin b complex|mesh-ancestor
111019704|NCT02120599|Vitamins|vitamins|mesh-ancestor
111019705|NCT02120599|Micronutrients|micronutrients|mesh-ancestor
111019706|NCT02120599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111019707|NCT02112097|Etanercept|etanercept|mesh-list
111019708|NCT02112097|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111019709|NCT02112097|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111019710|NCT02112097|Analgesics|analgesics|mesh-ancestor
111019711|NCT02112097|Sensory System Agents|sensory system agents|mesh-ancestor
111019712|NCT02112097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111019713|NCT02112097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111019714|NCT02112097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111019715|NCT02112097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111019716|NCT02112097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111019717|NCT02112097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111019718|NCT02112097|Immunologic Factors|immunologic factors|mesh-ancestor
111019719|NCT02112175|Lenalidomide|lenalidomide|mesh-list
110736821|NCT03802994|Vaccines|vaccines|mesh-list
111019720|NCT02112175|Immunologic Factors|immunologic factors|mesh-ancestor
111019721|NCT02112175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111019722|NCT02112175|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111019723|NCT02112175|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111019724|NCT02112175|Growth Substances|growth substances|mesh-ancestor
111019725|NCT02112175|Growth Inhibitors|growth inhibitors|mesh-ancestor
111019726|NCT02112175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111019728|NCT03553537|Cyclophosphamide|cyclophosphamide|mesh-list
111019729|NCT03553537|Doxorubicin|doxorubicin|mesh-list
111019730|NCT03553537|Vincristine|vincristine|mesh-list
111019731|NCT03553537|Decitabine|decitabine|mesh-list
111019732|NCT03553537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111019733|NCT03553537|Immunologic Factors|immunologic factors|mesh-ancestor
111019734|NCT03553537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111019735|NCT03553537|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111019736|NCT03553537|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111019737|NCT03553537|Alkylating Agents|alkylating agents|mesh-ancestor
111019738|NCT03553537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111019739|NCT03553537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111019740|NCT03553537|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111019741|NCT03553537|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111019742|NCT03553537|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111019743|NCT03553537|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111019744|NCT03553537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111019745|NCT03553537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111019746|NCT03553537|Glucocorticoids|glucocorticoids|mesh-ancestor
111019747|NCT03553537|Hormones|hormones|mesh-ancestor
111019748|NCT03553537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111019749|NCT03553537|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111019750|NCT03553537|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111019751|NCT03553537|Tubulin Modulators|tubulin modulators|mesh-ancestor
111019752|NCT03553537|Antimitotic Agents|antimitotic agents|mesh-ancestor
111019753|NCT03553537|Mitosis Modulators|mitosis modulators|mesh-ancestor
111019754|NCT03553537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111019755|NCT03553537|Antimetabolites|antimetabolites|mesh-ancestor
111019756|NCT04434170|Valsartan|valsartan|mesh-list
111019757|NCT04434170|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
111019758|NCT04434170|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111019759|NCT04434170|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111019760|NCT04434170|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111019761|NCT04434170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111019762|NCT03086174|Antibodies|antibodies|mesh-list
111019763|NCT03086174|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111019764|NCT03086174|Immunologic Factors|immunologic factors|mesh-ancestor
111019765|NCT03086174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111019766|NCT03085784|Aflibercept|aflibercept|mesh-list
111019767|NCT03085784|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111019768|NCT03085784|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111019769|NCT03085784|Growth Substances|growth substances|mesh-ancestor
111019770|NCT03085784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111019771|NCT03085784|Growth Inhibitors|growth inhibitors|mesh-ancestor
111019772|NCT03085784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111019773|NCT05021276|Basiliximab|basiliximab|mesh-list
111019774|NCT05021276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111019775|NCT05021276|Immunologic Factors|immunologic factors|mesh-ancestor
111019776|NCT05021276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111019777|NCT05014490|Etoricoxib|etoricoxib|mesh-list
111019778|NCT05014490|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111019779|NCT05014490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111019780|NCT05014490|Analgesics|analgesics|mesh-ancestor
111019781|NCT05014490|Sensory System Agents|sensory system agents|mesh-ancestor
111019782|NCT05014490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111019783|NCT05014490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111019784|NCT05014490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111019785|NCT05014490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111019786|NCT05014490|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111019787|NCT05014490|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111019788|NCT05014490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111019789|NCT05014490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111019790|NCT05020964|Trastuzumab|trastuzumab|mesh-list
111019791|NCT05020964|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111019792|NCT05020964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111019793|NCT05014100|Lenalidomide|lenalidomide|mesh-list
111019794|NCT05014100|Immunologic Factors|immunologic factors|mesh-ancestor
111019795|NCT05014100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111019796|NCT05014100|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111019797|NCT05014100|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111019798|NCT05014100|Growth Substances|growth substances|mesh-ancestor
111019799|NCT05014100|Growth Inhibitors|growth inhibitors|mesh-ancestor
111019800|NCT05014100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111019801|NCT05027126|Folic Acid|folic acid|mesh-list
111019802|NCT05027126|Vitamin B Complex|vitamin b complex|mesh-list
111019803|NCT05027126|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
111019804|NCT05027126|Vitamins|vitamins|mesh-ancestor
111019805|NCT05027126|Micronutrients|micronutrients|mesh-ancestor
111019806|NCT05027126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111019807|NCT05027126|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111019808|NCT05027126|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111019809|NCT05027126|Analgesics|analgesics|mesh-ancestor
111019810|NCT05027126|Sensory System Agents|sensory system agents|mesh-ancestor
111019811|NCT05027126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111019812|NCT05027126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111019813|NCT05027126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111019814|NCT05027126|Hematinics|hematinics|mesh-ancestor
111019815|NCT02120677|Itraconazole|itraconazole|mesh-list
111019816|NCT02120677|Antifungal Agents|antifungal agents|mesh-ancestor
111019817|NCT02120677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111019818|NCT02120677|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111019819|NCT02120677|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111019820|NCT02120677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111019821|NCT02120677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111019822|NCT02120677|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111019823|NCT02120677|Hormone Antagonists|hormone antagonists|mesh-ancestor
111019824|NCT02120677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111019825|NCT02120677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111019826|NCT02120677|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111019827|NCT02120911|Trastuzumab|trastuzumab|mesh-list
111019828|NCT02120911|Pertuzumab|pertuzumab|mesh-list
111019829|NCT02120911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111019830|NCT02120911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111019831|NCT02112487|Macitentan|macitentan|mesh-list
111019832|NCT02112487|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
111019833|NCT02112487|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
111019834|NCT02112487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111019835|NCT02112487|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
111019836|NCT03094442|Dexamethasone|dexamethasone|mesh-list
111019837|NCT03094442|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111019838|NCT03094442|Antiemetics|antiemetics|mesh-ancestor
111019839|NCT03094442|Autonomic Agents|autonomic agents|mesh-ancestor
111019840|NCT03094442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111019841|NCT03094442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111019842|NCT03094442|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111019843|NCT03094442|Glucocorticoids|glucocorticoids|mesh-ancestor
111019844|NCT03094442|Hormones|hormones|mesh-ancestor
111019845|NCT03094442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111019846|NCT03094442|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111019847|NCT03094442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111019848|NCT02406742|Obinutuzumab|obinutuzumab|mesh-list
111019849|NCT02406742|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111019850|NCT02406742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111019851|NCT02112643|Selenium|selenium|mesh-list
111019852|NCT02112643|Selenic Acid|selenic acid|mesh-list
111019853|NCT02112643|Antioxidants|antioxidants|mesh-ancestor
111019854|NCT02112643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111019855|NCT02112643|Protective Agents|protective agents|mesh-ancestor
111019856|NCT02112643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111019857|NCT02112643|Trace Elements|trace elements|mesh-ancestor
111019858|NCT02112643|Micronutrients|micronutrients|mesh-ancestor
111019859|NCT02112721|Vitamin D|vitamin d|mesh-list
111019860|NCT02112721|Vitamins|vitamins|mesh-ancestor
111019861|NCT02112721|Micronutrients|micronutrients|mesh-ancestor
111019862|NCT02112721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111019863|NCT02112721|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111019864|NCT02112799|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
111019865|NCT02112799|Antiviral Agents|antiviral agents|mesh-ancestor
111019866|NCT02112799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111019867|NCT02122939|Escitalopram|escitalopram|mesh-list
111019868|NCT02122939|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111019869|NCT02122939|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111019870|NCT02122939|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111019871|NCT02122939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111019872|NCT02122939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111019873|NCT02122939|Serotonin Agents|serotonin agents|mesh-ancestor
111019874|NCT02122939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111019875|NCT04434248|Ritonavir|ritonavir|mesh-list
111019876|NCT04434248|Lopinavir|lopinavir|mesh-list
111019877|NCT04434248|Hydroxychloroquine|hydroxychloroquine|mesh-list
111019878|NCT04434248|Chloroquine|chloroquine|mesh-list
111019879|NCT04434248|Favipiravir|favipiravir|mesh-list
111019880|NCT04434248|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111019881|NCT04434248|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111019882|NCT04434248|Protease Inhibitors|protease inhibitors|mesh-ancestor
111019883|NCT04434248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111019884|NCT04434248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111019885|NCT04434248|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111019886|NCT04434248|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111019887|NCT04434248|Antiviral Agents|antiviral agents|mesh-ancestor
111019888|NCT04434248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111019889|NCT04434248|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111019890|NCT04434248|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111019891|NCT04434248|Antimalarials|antimalarials|mesh-ancestor
111019892|NCT04434248|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111019893|NCT04434248|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111019894|NCT04434248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111019895|NCT04434248|Amebicides|amebicides|mesh-ancestor
111019896|NCT02121457|Selenium|selenium|mesh-list
111019897|NCT02121457|Antioxidants|antioxidants|mesh-ancestor
111019898|NCT02121457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111019899|NCT02121457|Protective Agents|protective agents|mesh-ancestor
111019900|NCT02121457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111019901|NCT02121457|Trace Elements|trace elements|mesh-ancestor
111019902|NCT02121457|Micronutrients|micronutrients|mesh-ancestor
111019903|NCT02251795|Aspirin|aspirin|mesh-list
111019904|NCT02251795|Ritonavir|ritonavir|mesh-list
111019905|NCT02251795|Darunavir|darunavir|mesh-list
111019906|NCT02251795|Tipranavir|tipranavir|mesh-list
111019907|NCT02251795|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111019908|NCT02251795|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111019909|NCT02251795|Analgesics|analgesics|mesh-ancestor
111019910|NCT02251795|Sensory System Agents|sensory system agents|mesh-ancestor
111019911|NCT02251795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111019912|NCT02251795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111019913|NCT02251795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111019914|NCT02251795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111019915|NCT02251795|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111019916|NCT02251795|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111019917|NCT02251795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111019918|NCT02251795|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111019919|NCT02251795|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111019920|NCT02251795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111019921|NCT02251795|Antipyretics|antipyretics|mesh-ancestor
111019922|NCT02251795|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111019923|NCT02251795|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111019924|NCT02251795|Protease Inhibitors|protease inhibitors|mesh-ancestor
111019925|NCT02251795|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111019926|NCT02251795|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111019927|NCT02251795|Antiviral Agents|antiviral agents|mesh-ancestor
111019928|NCT02251795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111019929|NCT02251795|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111019930|NCT02251795|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111019931|NCT05013164|Leucovorin|leucovorin|mesh-list
111019932|NCT05013164|Folic Acid|folic acid|mesh-list
111019933|NCT05013164|Levoleucovorin|levoleucovorin|mesh-list
111019934|NCT05013164|Antidotes|antidotes|mesh-ancestor
111019935|NCT05013164|Protective Agents|protective agents|mesh-ancestor
111019936|NCT05013164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111019937|NCT05013164|Vitamin B Complex|vitamin b complex|mesh-ancestor
111019938|NCT05013164|Vitamins|vitamins|mesh-ancestor
111019939|NCT05013164|Micronutrients|micronutrients|mesh-ancestor
111019940|NCT05013164|Hematinics|hematinics|mesh-ancestor
111019941|NCT02251951|Paclitaxel|paclitaxel|mesh-list
111019942|NCT02251951|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111019943|NCT02251951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111019944|NCT02251951|Tubulin Modulators|tubulin modulators|mesh-ancestor
111019945|NCT02251951|Antimitotic Agents|antimitotic agents|mesh-ancestor
111019946|NCT02251951|Mitosis Modulators|mitosis modulators|mesh-ancestor
111019947|NCT02251951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111019948|NCT03091868|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
111019949|NCT03091868|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111019950|NCT03091868|Immunologic Factors|immunologic factors|mesh-ancestor
111019951|NCT03091868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111019952|NCT03091868|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111019953|NCT03091868|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111019954|NCT03091868|Dopamine Agonists|dopamine agonists|mesh-ancestor
111019955|NCT03091868|Dopamine Agents|dopamine agents|mesh-ancestor
111019956|NCT03091868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111019957|NCT03091868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111019958|NCT02121613|Tamsulosin|tamsulosin|mesh-list
111019959|NCT02121613|Saw palmetto extract|saw palmetto extract|mesh-list
111019960|NCT02121613|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111019961|NCT02121613|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111019962|NCT02121613|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111019963|NCT02121613|Adrenergic Agents|adrenergic agents|mesh-ancestor
111019964|NCT02121613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111019965|NCT02121613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111019966|NCT02121613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111019967|NCT02121613|Urological Agents|urological agents|mesh-ancestor
111019968|NCT03091712|Insulin|insulin|mesh-list
111019969|NCT03091712|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111019970|NCT03091712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111019971|NCT03552211|Biotin|biotin|mesh-list
111019972|NCT03552211|Vitamin B Complex|vitamin b complex|mesh-ancestor
111019973|NCT03552211|Vitamins|vitamins|mesh-ancestor
111019974|NCT03552211|Micronutrients|micronutrients|mesh-ancestor
111019975|NCT03552211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111019976|NCT02113267|Mometasone Furoate|mometasone furoate|mesh-list
111019977|NCT02113267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111019978|NCT02113267|Dermatologic Agents|dermatologic agents|mesh-ancestor
111019979|NCT02113267|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111019980|NCT03281187|Methyltestosterone|methyltestosterone|mesh-list
111019981|NCT03281187|Testosterone|testosterone|mesh-list
111019982|NCT03281187|Testosterone undecanoate|testosterone undecanoate|mesh-list
111019983|NCT03281187|Testosterone enanthate|testosterone enanthate|mesh-list
111019984|NCT03281187|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
111019985|NCT03281187|Androgens|androgens|mesh-ancestor
111019986|NCT03281187|Hormones|hormones|mesh-ancestor
111019987|NCT03281187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111019988|NCT03281187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111019989|NCT03281187|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111019990|NCT03281187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111019991|NCT03281187|Anabolic Agents|anabolic agents|mesh-ancestor
111019992|NCT03291249|Omeprazole|omeprazole|mesh-list
111019993|NCT03291249|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111019994|NCT03291249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111019995|NCT03291249|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111019996|NCT03291249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111019997|NCT03291249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111019998|NCT05013320|Glycopyrrolate|glycopyrrolate|mesh-list
111019999|NCT05013320|Dexmedetomidine|dexmedetomidine|mesh-list
111020000|NCT05013320|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111020001|NCT05013320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111020002|NCT05013320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111020003|NCT05013320|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111020004|NCT05013320|Analgesics|analgesics|mesh-ancestor
111020005|NCT05013320|Sensory System Agents|sensory system agents|mesh-ancestor
111020006|NCT05013320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110827041|NCT01269307|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111020007|NCT05013320|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111020008|NCT05013320|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111020009|NCT05013320|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111020010|NCT05013320|Adrenergic Agents|adrenergic agents|mesh-ancestor
111020011|NCT05013320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111020012|NCT05013320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111020013|NCT05013320|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111020014|NCT05013320|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111020015|NCT05013320|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111020016|NCT05013320|Cholinergic Agents|cholinergic agents|mesh-ancestor
111020018|NCT02437162|Ustekinumab|ustekinumab|mesh-list
111020019|NCT02437162|Dermatologic Agents|dermatologic agents|mesh-ancestor
111020020|NCT02437162|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111020021|NCT02437162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111020022|NCT02437162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111020023|NCT02437162|Immunologic Factors|immunologic factors|mesh-ancestor
111020024|NCT02437162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111020025|NCT03291093|Flutemetamol|flutemetamol|mesh-list
111020026|NCT03291093|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111020027|NCT03291093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111020029|NCT02123563|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111020030|NCT02123563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111020031|NCT02122003|Sorafenib|sorafenib|mesh-list
111020032|NCT02122003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111020033|NCT02122003|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111020034|NCT02122003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111020035|NCT02122003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111020036|NCT03079388|Azithromycin|azithromycin|mesh-list
111020037|NCT03079388|Pyrimethamine|pyrimethamine|mesh-list
111020038|NCT03079388|Sulfadoxine|sulfadoxine|mesh-list
111020039|NCT03079388|Albendazole|albendazole|mesh-list
111020040|NCT03079388|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
111020041|NCT03079388|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111020042|NCT03079388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111020043|NCT03079388|Antimalarials|antimalarials|mesh-ancestor
111020044|NCT03079388|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111020045|NCT03079388|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111020046|NCT03079388|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111020047|NCT03079388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111020048|NCT03079388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111020049|NCT03079388|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111020050|NCT03079388|Anthelmintics|anthelmintics|mesh-ancestor
111020051|NCT03079388|Anticestodal Agents|anticestodal agents|mesh-ancestor
111020052|NCT03079388|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
111020053|NCT03079388|Tubulin Modulators|tubulin modulators|mesh-ancestor
111020054|NCT03079388|Antimitotic Agents|antimitotic agents|mesh-ancestor
111020055|NCT03079388|Mitosis Modulators|mitosis modulators|mesh-ancestor
111020056|NCT03079388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111020057|NCT03079544|Asparaginase|asparaginase|mesh-list
111020058|NCT03079544|Pegaspargase|pegaspargase|mesh-list
111020059|NCT03079544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111020060|NCT03286101|Ivermectin|ivermectin|mesh-list
111020061|NCT03286101|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111020062|NCT03286101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111020063|NCT02437084|Atorvastatin|atorvastatin|mesh-list
111020064|NCT02437084|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111020065|NCT02437084|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111020066|NCT02437084|Antimetabolites|antimetabolites|mesh-ancestor
111020067|NCT02437084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111020068|NCT02437084|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111020069|NCT02437084|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111020070|NCT02437084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111020071|NCT05009498|Vitamin D|vitamin d|mesh-list
111020072|NCT05009498|Cholecalciferol|cholecalciferol|mesh-list
111020073|NCT05009498|Vitamins|vitamins|mesh-ancestor
111020074|NCT05009498|Micronutrients|micronutrients|mesh-ancestor
111020075|NCT05009498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111020076|NCT05009498|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111020077|NCT05009498|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111020078|NCT02406586|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
111020079|NCT02406586|Carvedilol|carvedilol|mesh-list
111020080|NCT02406586|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
111020081|NCT02406586|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111020082|NCT02406586|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111020083|NCT02406586|Adrenergic Agents|adrenergic agents|mesh-ancestor
111020084|NCT02406586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111020085|NCT02406586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111020086|NCT02406586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111020087|NCT02406586|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111020088|NCT02406586|Antioxidants|antioxidants|mesh-ancestor
111020089|NCT02406586|Protective Agents|protective agents|mesh-ancestor
111020090|NCT02406586|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111020091|NCT02406586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111020092|NCT02406586|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111020093|NCT02406586|Vasodilator Agents|vasodilator agents|mesh-ancestor
110623437|NCT00295633|Pioglitazone|pioglitazone|mesh-list
111020094|NCT02406586|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111020095|NCT02406586|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111020096|NCT02406586|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
111020097|NCT02406586|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
111020098|NCT02406586|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111020099|NCT02406586|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111020100|NCT02406586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111020102|NCT02406586|Sensory System Agents|sensory system agents|mesh-ancestor
111020103|NCT02406586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111020104|NCT02406586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111020105|NCT02406586|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111020106|NCT03091166|Dexmedetomidine|dexmedetomidine|mesh-list
111020107|NCT03091166|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111020108|NCT03091166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111020109|NCT03091166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111020110|NCT03091166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111020111|NCT03091166|Analgesics|analgesics|mesh-ancestor
111020112|NCT03091166|Sensory System Agents|sensory system agents|mesh-ancestor
111020113|NCT03091166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111020114|NCT03091166|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111020115|NCT03091166|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111020116|NCT03091166|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111020117|NCT03091166|Adrenergic Agents|adrenergic agents|mesh-ancestor
111020118|NCT03091166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111020119|NCT03091166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111020120|NCT02122393|Sertraline|sertraline|mesh-list
111020121|NCT02122393|Antidepressive Agents|antidepressive agents|mesh-ancestor
111020122|NCT02122393|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111020123|NCT02122393|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111020124|NCT02122393|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111020125|NCT02122393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111020126|NCT02122393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111020127|NCT02122393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111020128|NCT02122393|Serotonin Agents|serotonin agents|mesh-ancestor
111020129|NCT02122393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111020130|NCT03821883|Aspirin|aspirin|mesh-list
111020131|NCT03821883|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111020132|NCT03821883|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111020133|NCT03821883|Analgesics|analgesics|mesh-ancestor
111020134|NCT03821883|Sensory System Agents|sensory system agents|mesh-ancestor
111020135|NCT03821883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111020136|NCT03821883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111020137|NCT03821883|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111020138|NCT03821883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111020139|NCT03821883|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111020140|NCT03821883|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111020141|NCT03821883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111020142|NCT03821883|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111020143|NCT03821883|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111020144|NCT03821883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111020145|NCT03821883|Antipyretics|antipyretics|mesh-ancestor
111020146|NCT03080480|Pioglitazone|pioglitazone|mesh-list
111020147|NCT03080480|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111020148|NCT03080480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111020149|NCT02126761|Vaccines|vaccines|mesh-list
111020150|NCT02126761|Immunologic Factors|immunologic factors|mesh-ancestor
111020151|NCT02126761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111020152|NCT02788357|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
111020153|NCT02788357|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111020154|NCT02788357|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111020155|NCT02788357|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111020156|NCT02788357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111020157|NCT02788357|Adrenergic Agents|adrenergic agents|mesh-ancestor
111020158|NCT02788357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111020159|NCT02788357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111020160|NCT03280641|Warfarin|warfarin|mesh-list
111020161|NCT03280641|Dabigatran|dabigatran|mesh-list
111020162|NCT03280641|Anticoagulants|anticoagulants|mesh-ancestor
111020163|NCT03280641|Antithrombins|antithrombins|mesh-ancestor
111020164|NCT03280641|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111020165|NCT03280641|Protease Inhibitors|protease inhibitors|mesh-ancestor
111020166|NCT03280641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111020167|NCT03280641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111020168|NCT03285165|Propofol|propofol|mesh-list
111020169|NCT03285165|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111020170|NCT03285165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111020171|NCT03285165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111020172|NCT03285165|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111020173|NCT03285165|Anesthetics, General|anesthetics, general|mesh-ancestor
111020174|NCT03285165|Anesthetics|anesthetics|mesh-ancestor
111020175|NCT03285087|Dexmedetomidine|dexmedetomidine|mesh-list
111020176|NCT03285087|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111020177|NCT03285087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111020178|NCT03285087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111020179|NCT03285087|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111020180|NCT03285087|Analgesics|analgesics|mesh-ancestor
111020181|NCT03285087|Sensory System Agents|sensory system agents|mesh-ancestor
111020182|NCT03285087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111020183|NCT03285087|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111020184|NCT03285087|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111020185|NCT03285087|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111020186|NCT03285087|Adrenergic Agents|adrenergic agents|mesh-ancestor
111020187|NCT03285087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111020188|NCT03285087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111020189|NCT02122627|Vitamin D|vitamin d|mesh-list
111020190|NCT02122627|Ergocalciferols|ergocalciferols|mesh-list
111020191|NCT02122627|Cholecalciferol|cholecalciferol|mesh-list
111020192|NCT02122627|Vitamins|vitamins|mesh-list
111020193|NCT02122627|Micronutrients|micronutrients|mesh-ancestor
111020194|NCT02122627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111020195|NCT02122627|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111020196|NCT02122627|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111020197|NCT02122705|Remifentanil|remifentanil|mesh-list
111020198|NCT02122705|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111020199|NCT02122705|Narcotics|narcotics|mesh-ancestor
111020200|NCT02122705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111020201|NCT02122705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111020202|NCT02122705|Analgesics|analgesics|mesh-ancestor
111020203|NCT02122705|Sensory System Agents|sensory system agents|mesh-ancestor
111020204|NCT02122705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111020205|NCT05011916|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111020206|NCT05011916|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111020207|NCT03384225|Cytarabine|cytarabine|mesh-list
111020208|NCT03384225|Fludarabine|fludarabine|mesh-list
111020209|NCT03384225|Busulfan|busulfan|mesh-list
111020210|NCT03384225|Cladribine|cladribine|mesh-list
111020211|NCT03384225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111020212|NCT03384225|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111020213|NCT03384225|Antimetabolites|antimetabolites|mesh-ancestor
111020214|NCT03384225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111020215|NCT03384225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111020216|NCT03384225|Immunologic Factors|immunologic factors|mesh-ancestor
111020217|NCT03384225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111020218|NCT03384225|Antiviral Agents|antiviral agents|mesh-ancestor
111020219|NCT03384225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111020220|NCT03384225|Alkylating Agents|alkylating agents|mesh-ancestor
111020221|NCT03384225|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111020222|NCT03384225|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111020223|NCT05019326|Andrographolide|andrographolide|mesh-list
111020224|NCT05019326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111020225|NCT05019326|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111020226|NCT05019326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111020227|NCT05019326|Analgesics|analgesics|mesh-ancestor
111020228|NCT05019326|Sensory System Agents|sensory system agents|mesh-ancestor
111020229|NCT05019326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111020230|NCT05019326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111020231|NCT05019326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111020232|NCT05019326|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111020233|NCT05019326|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111020234|NCT05019326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111020235|NCT05019326|Antiviral Agents|antiviral agents|mesh-ancestor
111020236|NCT05019326|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111020238|NCT05008250|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111020239|NCT05008250|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111020240|NCT05008250|Sympatholytics|sympatholytics|mesh-ancestor
111020241|NCT05008250|Autonomic Agents|autonomic agents|mesh-ancestor
111020242|NCT05008250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111020243|NCT05008250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111020244|NCT05008250|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
111020245|NCT05008250|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111020246|NCT05008250|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111020247|NCT05008250|Adrenergic Agents|adrenergic agents|mesh-ancestor
111020248|NCT05008250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111020249|NCT05008250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111020250|NCT03079076|Bupivacaine|bupivacaine|mesh-list
111020251|NCT03079076|Anesthetics, Local|anesthetics, local|mesh-ancestor
111020252|NCT03079076|Anesthetics|anesthetics|mesh-ancestor
111020253|NCT03079076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111020254|NCT03079076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111020255|NCT03079076|Sensory System Agents|sensory system agents|mesh-ancestor
111020256|NCT03079076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111020257|NCT03271749|Anesthetics|anesthetics|mesh-list
111020258|NCT03271749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111020259|NCT03271749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111020260|NCT03280407|Leucovorin|leucovorin|mesh-list
111020261|NCT03280407|Capecitabine|capecitabine|mesh-list
111020262|NCT03280407|Oxaliplatin|oxaliplatin|mesh-list
111020263|NCT03280407|Levoleucovorin|levoleucovorin|mesh-list
111020264|NCT03280407|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111020265|NCT03280407|Antimetabolites|antimetabolites|mesh-ancestor
111020266|NCT03280407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111020267|NCT03280407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111020268|NCT03280407|Antidotes|antidotes|mesh-ancestor
111020269|NCT03280407|Protective Agents|protective agents|mesh-ancestor
111020270|NCT03280407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111020271|NCT03280407|Vitamin B Complex|vitamin b complex|mesh-ancestor
111020272|NCT03280407|Vitamins|vitamins|mesh-ancestor
111020273|NCT03280407|Micronutrients|micronutrients|mesh-ancestor
111020274|NCT03078842|Zinc|zinc|mesh-list
111020275|NCT03078842|Trace Elements|trace elements|mesh-ancestor
111020276|NCT03078842|Micronutrients|micronutrients|mesh-ancestor
111020277|NCT03078842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111020278|NCT05007860|Vaccines|vaccines|mesh-list
111020279|NCT05007860|Immunologic Factors|immunologic factors|mesh-ancestor
111020280|NCT05007860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111020281|NCT03270033|Dexamethasone|dexamethasone|mesh-list
111020282|NCT03270033|Dexamethasone acetate|dexamethasone acetate|mesh-list
111020283|NCT03270033|Dexmedetomidine|dexmedetomidine|mesh-list
111020284|NCT03270033|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
111020285|NCT03270033|BB 1101|bb 1101|mesh-list
111020286|NCT03270033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111020287|NCT03270033|Antiemetics|antiemetics|mesh-ancestor
111020288|NCT03270033|Autonomic Agents|autonomic agents|mesh-ancestor
111020289|NCT03270033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111020290|NCT03270033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111020291|NCT03270033|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111020292|NCT03270033|Glucocorticoids|glucocorticoids|mesh-ancestor
111020293|NCT03270033|Hormones|hormones|mesh-ancestor
111020294|NCT03270033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111020295|NCT03270033|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111020296|NCT03270033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111020297|NCT03270033|Protease Inhibitors|protease inhibitors|mesh-ancestor
111020298|NCT03270033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111020299|NCT03270033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111020300|NCT03270033|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111020301|NCT03270033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111020302|NCT03270033|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111020303|NCT03270033|Analgesics|analgesics|mesh-ancestor
111020304|NCT03270033|Sensory System Agents|sensory system agents|mesh-ancestor
111020305|NCT03270033|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111020306|NCT03270033|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111020307|NCT03270033|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111020308|NCT03270033|Adrenergic Agents|adrenergic agents|mesh-ancestor
111020309|NCT03270033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111020310|NCT03280095|Acetaminophen|acetaminophen|mesh-list
111020311|NCT03280095|Codeine|codeine|mesh-list
111020312|NCT03280095|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111020313|NCT03280095|Analgesics|analgesics|mesh-ancestor
111020314|NCT03280095|Sensory System Agents|sensory system agents|mesh-ancestor
111020315|NCT03280095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111020316|NCT03280095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111020317|NCT03280095|Antipyretics|antipyretics|mesh-ancestor
111020318|NCT03280095|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111020319|NCT03280095|Narcotics|narcotics|mesh-ancestor
111020320|NCT03280095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111020321|NCT03280095|Antitussive Agents|antitussive agents|mesh-ancestor
111020322|NCT03280095|Respiratory System Agents|respiratory system agents|mesh-ancestor
111020323|NCT04463030|Vitamins|vitamins|mesh-list
111020324|NCT04463030|Ascorbic Acid|ascorbic acid|mesh-list
111020325|NCT04463030|Micronutrients|micronutrients|mesh-ancestor
111020326|NCT04463030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111020327|NCT04463030|Antioxidants|antioxidants|mesh-ancestor
111020328|NCT04463030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111020329|NCT04463030|Protective Agents|protective agents|mesh-ancestor
111020330|NCT03269721|Carbon Monoxide|carbon monoxide|mesh-list
111020331|NCT03269721|Antimetabolites|antimetabolites|mesh-ancestor
111020332|NCT03269721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111020333|NCT03269721|Gasotransmitters|gasotransmitters|mesh-ancestor
111020334|NCT03269721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111020335|NCT03269721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111020336|NCT05010356|Insulin|insulin|mesh-list
111020337|NCT05010356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111020338|NCT05010356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111020339|NCT03269955|Thrombin|thrombin|mesh-list
111020340|NCT03269955|Hemostatics|hemostatics|mesh-ancestor
111020341|NCT03269955|Coagulants|coagulants|mesh-ancestor
111020342|NCT05006846|Analgesics, Opioid|analgesics, opioid|mesh-list
111020343|NCT05006846|Narcotics|narcotics|mesh-ancestor
111020344|NCT05006846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111020345|NCT05006846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111020346|NCT05006846|Analgesics|analgesics|mesh-ancestor
111020347|NCT05006846|Sensory System Agents|sensory system agents|mesh-ancestor
111020348|NCT05006846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111020349|NCT02457520|Isotretinoin|isotretinoin|mesh-list
111020350|NCT02457520|Dermatologic Agents|dermatologic agents|mesh-ancestor
111020351|NCT02457585|Infliximab|infliximab|mesh-list
111020352|NCT02457585|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
111020353|NCT02457585|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111020354|NCT02457585|Dermatologic Agents|dermatologic agents|mesh-ancestor
111020355|NCT02457585|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111020356|NCT02457585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111020357|NCT02457507|Vitamin B 12|vitamin b 12|mesh-list
111020358|NCT02457507|Hydroxocobalamin|hydroxocobalamin|mesh-list
111020359|NCT02457507|Vitamins|vitamins|mesh-ancestor
111020360|NCT02457507|Micronutrients|micronutrients|mesh-ancestor
111020361|NCT02457507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111020362|NCT02457507|Vitamin B Complex|vitamin b complex|mesh-ancestor
111020363|NCT02457507|Hematinics|hematinics|mesh-ancestor
111020364|NCT03265197|Lidocaine|lidocaine|mesh-list
111020365|NCT03265197|Anesthetics, Local|anesthetics, local|mesh-ancestor
111020366|NCT03265197|Anesthetics|anesthetics|mesh-ancestor
111020367|NCT03265197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111020368|NCT03265197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111020369|NCT03265197|Sensory System Agents|sensory system agents|mesh-ancestor
111020370|NCT03265197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111020371|NCT03265197|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111020372|NCT03265197|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111020373|NCT03265197|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111020374|NCT03265197|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111020375|NCT03265197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111020376|NCT03078374|Warfarin|warfarin|mesh-list
111020377|NCT03078374|Anticoagulants|anticoagulants|mesh-ancestor
111020378|NCT04944836|Clomiphene|clomiphene|mesh-list
111020379|NCT04944836|Enclomiphene|enclomiphene|mesh-list
111020380|NCT04944836|Zuclomiphene|zuclomiphene|mesh-list
111020381|NCT04944836|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111020382|NCT04944836|Hormone Antagonists|hormone antagonists|mesh-ancestor
111119146|NCT05323617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111020383|NCT04944836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111020384|NCT04944836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111020385|NCT04944836|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111020386|NCT04944836|Fertility Agents|fertility agents|mesh-ancestor
111020387|NCT04944836|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111020388|NCT04944836|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111020389|NCT04944836|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111020390|NCT02788279|Atezolizumab|atezolizumab|mesh-list
111020391|NCT02788279|Antibodies|antibodies|mesh-list
111020392|NCT02788279|Immunologic Factors|immunologic factors|mesh-ancestor
111020393|NCT02788279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111020394|NCT02788279|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111020395|NCT02788279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111020396|NCT02788279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111020397|NCT02788279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111020398|NCT03268863|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
111020399|NCT03264651|Anastrozole|anastrozole|mesh-list
111020400|NCT03264651|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111020401|NCT03264651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110737494|NCT01089621|Dopamine Agents|dopamine agents|mesh-ancestor
111020402|NCT03264651|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111020403|NCT03264651|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111020404|NCT03264651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111020405|NCT03264651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111020406|NCT03264651|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111020407|NCT03264651|Hormone Antagonists|hormone antagonists|mesh-ancestor
111020408|NCT03264651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111020409|NCT03264651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111020410|NCT03078062|Dexamethasone|dexamethasone|mesh-list
111020411|NCT03078062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111020412|NCT03078062|Antiemetics|antiemetics|mesh-ancestor
111020413|NCT03078062|Autonomic Agents|autonomic agents|mesh-ancestor
111020414|NCT03078062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111020415|NCT03078062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111020416|NCT03078062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111020417|NCT03078062|Glucocorticoids|glucocorticoids|mesh-ancestor
111020418|NCT03078062|Hormones|hormones|mesh-ancestor
111020419|NCT03078062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111020420|NCT03078062|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111020421|NCT03078062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111020422|NCT02435992|Ozanimod|ozanimod|mesh-list
111020423|NCT02435992|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
111020424|NCT02435992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111020425|NCT02435992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111020426|NCT02435992|Immunologic Factors|immunologic factors|mesh-ancestor
111020427|NCT02435992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111020428|NCT02457351|Itraconazole|itraconazole|mesh-list
111020429|NCT02457351|Antifungal Agents|antifungal agents|mesh-ancestor
111020430|NCT02457351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111020431|NCT02457351|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111020432|NCT02457351|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111020433|NCT02457351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111020434|NCT02457351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111020435|NCT02457351|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111020436|NCT02457351|Hormone Antagonists|hormone antagonists|mesh-ancestor
111020437|NCT02457351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111020438|NCT02457351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111020439|NCT02457351|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111020440|NCT02788513|BI 425809|bi 425809|mesh-list
111020441|NCT02788513|Nootropic Agents|nootropic agents|mesh-ancestor
111020442|NCT03077828|Carboplatin|carboplatin|mesh-list
111020443|NCT03077828|Pembrolizumab|pembrolizumab|mesh-list
111020444|NCT03077828|Etoposide|etoposide|mesh-list
111020445|NCT03077828|Etoposide phosphate|etoposide phosphate|mesh-list
111020446|NCT03077828|Ifosfamide|ifosfamide|mesh-list
111020447|NCT03077828|Isophosphamide mustard|isophosphamide mustard|mesh-list
111020448|NCT03077828|Podophyllotoxin|podophyllotoxin|mesh-list
111020449|NCT03077828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111020450|NCT03077828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111020451|NCT03077828|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111020452|NCT03077828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111020453|NCT03077828|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111020454|NCT03077828|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111020455|NCT03077828|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111020456|NCT03077828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111020457|NCT03077828|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111020458|NCT03077828|Alkylating Agents|alkylating agents|mesh-ancestor
111020459|NCT03077828|Keratolytic Agents|keratolytic agents|mesh-ancestor
111020460|NCT03077828|Dermatologic Agents|dermatologic agents|mesh-ancestor
111020461|NCT03077828|Tubulin Modulators|tubulin modulators|mesh-ancestor
111020462|NCT03077828|Antimitotic Agents|antimitotic agents|mesh-ancestor
111020463|NCT03077828|Mitosis Modulators|mitosis modulators|mesh-ancestor
111020465|NCT02126995|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111020466|NCT04459052|Acetylcysteine|acetylcysteine|mesh-list
111020467|NCT04459052|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111020468|NCT04459052|Antiviral Agents|antiviral agents|mesh-ancestor
111020469|NCT04459052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111020470|NCT04459052|Expectorants|expectorants|mesh-ancestor
111020471|NCT04459052|Respiratory System Agents|respiratory system agents|mesh-ancestor
111020472|NCT04459052|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111020473|NCT04459052|Antioxidants|antioxidants|mesh-ancestor
111020474|NCT04459052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111020475|NCT04459052|Protective Agents|protective agents|mesh-ancestor
111020476|NCT04459052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111020477|NCT04459052|Antidotes|antidotes|mesh-ancestor
111020478|NCT05257291|Melatonin|melatonin|mesh-list
111020479|NCT05257291|Antioxidants|antioxidants|mesh-ancestor
111020480|NCT05257291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111020481|NCT05257291|Protective Agents|protective agents|mesh-ancestor
111020482|NCT05257291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111020483|NCT05257291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111020484|NCT04930900|Epinephrine|epinephrine|mesh-list
111020485|NCT04930900|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111020486|NCT04930900|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111020487|NCT04930900|Adrenergic Agents|adrenergic agents|mesh-ancestor
111020488|NCT04930900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111020489|NCT04930900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111020490|NCT04930900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111020491|NCT04930900|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111020492|NCT04930900|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111020493|NCT04930900|Autonomic Agents|autonomic agents|mesh-ancestor
110623559|NCT00779792|Protective Agents|protective agents|mesh-ancestor
111020494|NCT04930900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111020495|NCT04930900|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111020496|NCT04930900|Respiratory System Agents|respiratory system agents|mesh-ancestor
111020497|NCT04930900|Mydriatics|mydriatics|mesh-ancestor
111020498|NCT04930900|Sympathomimetics|sympathomimetics|mesh-ancestor
111020499|NCT04930900|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111020500|NCT02458209|Bococizumab|bococizumab|mesh-list
111020501|NCT02458209|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111020502|NCT02458209|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111020503|NCT02458209|Antimetabolites|antimetabolites|mesh-ancestor
111020504|NCT02458209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111020505|NCT02458209|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111020506|NCT02127151|Talazoparib|talazoparib|mesh-list
111020507|NCT02127151|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111020508|NCT02127151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111020509|NCT02127151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111020510|NCT02127151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111020511|NCT03077516|Meloxicam|meloxicam|mesh-list
111020512|NCT03077516|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111020513|NCT03077516|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111020514|NCT03077516|Analgesics|analgesics|mesh-ancestor
111020515|NCT03077516|Sensory System Agents|sensory system agents|mesh-ancestor
111020516|NCT03077516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111020517|NCT03077516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111020518|NCT03077516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111020519|NCT03077516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111020520|NCT03077516|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111020521|NCT03077516|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111020522|NCT03077516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111020523|NCT03077516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111020524|NCT02435914|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111020525|NCT02435914|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111020526|NCT04993040|Paclitaxel|paclitaxel|mesh-list
110485585|NCT00642291|Emtricitabine|emtricitabine|mesh-list
111020527|NCT04993040|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111020528|NCT04993040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111020530|NCT04993040|Antimitotic Agents|antimitotic agents|mesh-ancestor
111020531|NCT04993040|Mitosis Modulators|mitosis modulators|mesh-ancestor
111020532|NCT04993040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111020533|NCT03072992|Curcumin|curcumin|mesh-list
111020534|NCT03072992|Paclitaxel|paclitaxel|mesh-list
111020535|NCT03072992|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111020536|NCT03072992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111020537|NCT03072992|Tubulin Modulators|tubulin modulators|mesh-ancestor
111020538|NCT03072992|Antimitotic Agents|antimitotic agents|mesh-ancestor
111020539|NCT03072992|Mitosis Modulators|mitosis modulators|mesh-ancestor
111020540|NCT03072992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111020541|NCT03072992|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111020542|NCT03072992|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111020543|NCT03072992|Analgesics|analgesics|mesh-ancestor
111020544|NCT03072992|Sensory System Agents|sensory system agents|mesh-ancestor
111020545|NCT03072992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111020546|NCT03072992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111020547|NCT03072992|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111020548|NCT03072992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111020549|NCT03072992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110737645|NCT00365105|Calcium|calcium|mesh-list
111020550|NCT03267771|Progesterone|progesterone|mesh-list
111020551|NCT03267771|Dydrogesterone|dydrogesterone|mesh-list
111020552|NCT03267771|Progestins|progestins|mesh-ancestor
111020553|NCT03267771|Hormones|hormones|mesh-ancestor
111020554|NCT03267771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111020555|NCT03267771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111020556|NCT03073304|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111020557|NCT03550651|Chlorhexidine|chlorhexidine|mesh-list
111020558|NCT03550651|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
111020559|NCT03550651|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111020560|NCT03550651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111020561|NCT03550651|Disinfectants|disinfectants|mesh-ancestor
111020562|NCT03550651|Dermatologic Agents|dermatologic agents|mesh-ancestor
111020563|NCT02456961|Riboflavin|riboflavin|mesh-list
111020564|NCT02456961|Vitamin B Complex|vitamin b complex|mesh-ancestor
111020565|NCT02456961|Vitamins|vitamins|mesh-ancestor
111020566|NCT02456961|Micronutrients|micronutrients|mesh-ancestor
111020567|NCT02456961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111020568|NCT02456961|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111020569|NCT02456961|Dermatologic Agents|dermatologic agents|mesh-ancestor
111020570|NCT03551197|Budesonide|budesonide|mesh-list
111020571|NCT03551197|Formoterol Fumarate|formoterol fumarate|mesh-list
111020572|NCT03551197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111020573|NCT03551197|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111020574|NCT03551197|Autonomic Agents|autonomic agents|mesh-ancestor
111020575|NCT03551197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111020576|NCT03551197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111020577|NCT03551197|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111020578|NCT03551197|Respiratory System Agents|respiratory system agents|mesh-ancestor
111020579|NCT03551197|Glucocorticoids|glucocorticoids|mesh-ancestor
111020580|NCT03551197|Hormones|hormones|mesh-ancestor
111020581|NCT03551197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111020582|NCT03551197|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111020583|NCT03551197|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111020584|NCT03551197|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111020585|NCT03551197|Adrenergic Agents|adrenergic agents|mesh-ancestor
111020586|NCT03551197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111020587|NCT03551197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111020588|NCT02435836|Aripiprazole|aripiprazole|mesh-list
111020589|NCT02435836|Antidepressive Agents|antidepressive agents|mesh-ancestor
111020590|NCT02435836|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111020591|NCT02435836|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111020592|NCT02435836|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111020593|NCT02435836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111020594|NCT02435836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111020595|NCT02435836|Dopamine Agonists|dopamine agonists|mesh-ancestor
111020596|NCT02435836|Dopamine Agents|dopamine agents|mesh-ancestor
111020597|NCT02435836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111020598|NCT02435836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111020599|NCT02435836|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111020600|NCT02435836|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111020601|NCT02435836|Serotonin Agents|serotonin agents|mesh-ancestor
111020602|NCT02435836|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111020603|NCT02435836|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111020604|NCT02435836|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111020605|NCT02435836|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111020606|NCT02127463|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111020607|NCT02127463|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111020608|NCT05075265|Methadone|methadone|mesh-list
111020609|NCT05075265|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111020610|NCT05075265|Narcotics|narcotics|mesh-ancestor
111020611|NCT05075265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111020612|NCT05075265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111020613|NCT05075265|Analgesics|analgesics|mesh-ancestor
111020614|NCT05075265|Sensory System Agents|sensory system agents|mesh-ancestor
111020615|NCT05075265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111020616|NCT05075265|Antitussive Agents|antitussive agents|mesh-ancestor
111020617|NCT05075265|Respiratory System Agents|respiratory system agents|mesh-ancestor
111020618|NCT02127541|Exenatide|exenatide|mesh-list
111020619|NCT02127541|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111020620|NCT02127541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111020621|NCT02127541|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110737734|NCT00048074|Ibandronic Acid|ibandronic acid|mesh-list
111020622|NCT02127541|Incretins|incretins|mesh-ancestor
111020623|NCT02127541|Hormones|hormones|mesh-ancestor
110799538|NCT05320107|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111020624|NCT02127541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111020625|NCT03263871|Micronutrients|micronutrients|mesh-list
111020626|NCT03263871|Trace Elements|trace elements|mesh-list
111020627|NCT03263871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111020628|NCT04992182|Vaccines|vaccines|mesh-list
111020629|NCT04992182|Immunologic Factors|immunologic factors|mesh-ancestor
111020630|NCT04992182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111020631|NCT02124655|Chlorhexidine|chlorhexidine|mesh-list
111020632|NCT02124655|Listerine|listerine|mesh-list
111020633|NCT02124655|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111020634|NCT02124655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111020635|NCT02124655|Disinfectants|disinfectants|mesh-ancestor
111020636|NCT03263715|Glucocorticoids|glucocorticoids|mesh-list
111020637|NCT03263715|Hormones|hormones|mesh-ancestor
111020638|NCT03263715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111020639|NCT03263715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111020640|NCT02457039|Cyclophosphamide|cyclophosphamide|mesh-list
111020641|NCT02457039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111020642|NCT02457039|Immunologic Factors|immunologic factors|mesh-ancestor
111020643|NCT02457039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111020644|NCT02457039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111020645|NCT02457039|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111020646|NCT02457039|Alkylating Agents|alkylating agents|mesh-ancestor
111020647|NCT02457039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111020648|NCT02457039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111020649|NCT02457039|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111020650|NCT03266991|Isoniazid|isoniazid|mesh-list
111020651|NCT03266991|Rifapentine|rifapentine|mesh-list
111020652|NCT03266991|Antitubercular Agents|antitubercular agents|mesh-ancestor
111020653|NCT03266991|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111020654|NCT03266991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111020655|NCT03266991|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
111020656|NCT03266991|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111020657|NCT03266991|Antimetabolites|antimetabolites|mesh-ancestor
111020658|NCT03266991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111020659|NCT03266991|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111020660|NCT03266991|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111020661|NCT03266991|Leprostatic Agents|leprostatic agents|mesh-ancestor
111020662|NCT02456740|Erenumab|erenumab|mesh-list
111020663|NCT02456740|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
111020664|NCT02456740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111020665|NCT02456740|Analgesics|analgesics|mesh-ancestor
111020666|NCT02456740|Sensory System Agents|sensory system agents|mesh-ancestor
111020667|NCT02456740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111020668|NCT02456740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111020669|NCT03768115|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111020670|NCT03768115|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111020671|NCT03266601|Interferons|interferons|mesh-list
111020672|NCT03266601|Ribavirin|ribavirin|mesh-list
111020673|NCT03266601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111020674|NCT03266601|Antiviral Agents|antiviral agents|mesh-ancestor
111020675|NCT03266601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111020676|NCT03266601|Antimetabolites|antimetabolites|mesh-ancestor
111020677|NCT03266601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111020678|NCT02124733|Aminolevulinic Acid|aminolevulinic acid|mesh-list
111020679|NCT02124733|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111020680|NCT02124733|Dermatologic Agents|dermatologic agents|mesh-ancestor
111020682|NCT02458755|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111020683|NCT02458755|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111020684|NCT02458755|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111020685|NCT02458755|Antimetabolites|antimetabolites|mesh-ancestor
111020686|NCT02458755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110623594|NCT02551536|Histamine Agents|histamine agents|mesh-ancestor
111020687|NCT02458755|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111020688|NCT02458755|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111020689|NCT02458755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111020690|NCT04462406|Pembrolizumab|pembrolizumab|mesh-list
111020691|NCT04462406|Nivolumab|nivolumab|mesh-list
111020692|NCT04462406|Ipilimumab|ipilimumab|mesh-list
111020693|NCT04462406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111020694|NCT04462406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111020695|NCT04462406|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111020696|NCT04462406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111020697|NCT02400580|Acetaminophen|acetaminophen|mesh-list
111020698|NCT02400580|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111020699|NCT02400580|Analgesics|analgesics|mesh-ancestor
111020700|NCT02400580|Sensory System Agents|sensory system agents|mesh-ancestor
111020701|NCT02400580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111020702|NCT02400580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111020703|NCT02400580|Antipyretics|antipyretics|mesh-ancestor
111020704|NCT03262857|Lidocaine|lidocaine|mesh-list
111020705|NCT03262857|Magnesium Sulfate|magnesium sulfate|mesh-list
111020706|NCT03262857|Anesthetics, Local|anesthetics, local|mesh-ancestor
111020707|NCT03262857|Anesthetics|anesthetics|mesh-ancestor
111020708|NCT03262857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111020709|NCT03262857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111020710|NCT03262857|Sensory System Agents|sensory system agents|mesh-ancestor
111020711|NCT03262857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111020712|NCT03262857|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111020713|NCT03262857|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111020714|NCT03262857|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111020715|NCT03262857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111020716|NCT03262857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111020717|NCT03262857|Analgesics|analgesics|mesh-ancestor
111020718|NCT03262857|Anticonvulsants|anticonvulsants|mesh-ancestor
111020719|NCT03262857|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111020720|NCT03262857|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111020721|NCT03262857|Tocolytic Agents|tocolytic agents|mesh-ancestor
111020722|NCT03262857|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111020723|NCT02127697|Glycopyrrolate|glycopyrrolate|mesh-list
111020724|NCT02127697|Albuterol|albuterol|mesh-list
111020725|NCT02127697|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111020726|NCT02127697|Autonomic Agents|autonomic agents|mesh-ancestor
111020727|NCT02127697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111020728|NCT02127697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111020729|NCT02127697|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111020730|NCT02127697|Respiratory System Agents|respiratory system agents|mesh-ancestor
111020731|NCT02127697|Tocolytic Agents|tocolytic agents|mesh-ancestor
111020732|NCT02127697|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111020733|NCT02127697|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111020734|NCT02127697|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111020735|NCT02127697|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111020736|NCT02127697|Adrenergic Agents|adrenergic agents|mesh-ancestor
111020737|NCT02127697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111020738|NCT02127697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111020739|NCT02127697|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111020740|NCT02127697|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111020741|NCT02127697|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111020742|NCT02127697|Cholinergic Agents|cholinergic agents|mesh-ancestor
111020743|NCT02127775|Lesinurad|lesinurad|mesh-list
111020744|NCT02127775|Gout Suppressants|gout suppressants|mesh-ancestor
111020745|NCT02127775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111020746|NCT02127775|Uricosuric Agents|uricosuric agents|mesh-ancestor
111020747|NCT02252341|Acetylcysteine|acetylcysteine|mesh-list
111020748|NCT02252341|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111020750|NCT02252341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111020751|NCT02252341|Expectorants|expectorants|mesh-ancestor
111020752|NCT02252341|Respiratory System Agents|respiratory system agents|mesh-ancestor
111020753|NCT02252341|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111020754|NCT02252341|Antioxidants|antioxidants|mesh-ancestor
111020755|NCT02252341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111020756|NCT02252341|Protective Agents|protective agents|mesh-ancestor
111020757|NCT02252341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111020758|NCT02252341|Antidotes|antidotes|mesh-ancestor
111020759|NCT02127853|Gabapentin|gabapentin|mesh-list
111020760|NCT02127853|Analgesics|analgesics|mesh-ancestor
111020761|NCT02127853|Sensory System Agents|sensory system agents|mesh-ancestor
111020762|NCT02127853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111020763|NCT02127853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111020764|NCT02127853|Anticonvulsants|anticonvulsants|mesh-ancestor
111020765|NCT02127853|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111020766|NCT02127853|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111020767|NCT02127853|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111020768|NCT02127853|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111020769|NCT02127853|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111020770|NCT02127853|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111020771|NCT02127853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111020772|NCT02127853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111020773|NCT02127853|Antimanic Agents|antimanic agents|mesh-ancestor
111020774|NCT03266445|Buprenorphine|buprenorphine|mesh-list
111020775|NCT03266445|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
111020776|NCT03266445|Naloxone|naloxone|mesh-list
111020777|NCT03266445|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111020778|NCT03266445|Narcotics|narcotics|mesh-ancestor
111020779|NCT03266445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111020780|NCT03266445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111020781|NCT03266445|Analgesics|analgesics|mesh-ancestor
111020782|NCT03266445|Sensory System Agents|sensory system agents|mesh-ancestor
111020783|NCT03266445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111020784|NCT03266445|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111020785|NCT01367119|Ketamine|ketamine|mesh-list
111020786|NCT01367119|Methohexital|methohexital|mesh-list
111020787|NCT01367119|Analgesics|analgesics|mesh-ancestor
111020788|NCT01367119|Sensory System Agents|sensory system agents|mesh-ancestor
111020789|NCT01367119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111020790|NCT01367119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111020791|NCT01367119|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111020792|NCT01367119|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111020793|NCT01367119|Anesthetics, General|anesthetics, general|mesh-ancestor
111020794|NCT01367119|Anesthetics|anesthetics|mesh-ancestor
111020795|NCT01367119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111020796|NCT01367119|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111020797|NCT01367119|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111020798|NCT01367119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111020799|NCT01367119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111020800|NCT02252107|Decitabine|decitabine|mesh-list
111020801|NCT02252107|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111020802|NCT02252107|Antimetabolites|antimetabolites|mesh-ancestor
111020803|NCT02252107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111020804|NCT02252107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111020805|NCT02252107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111020806|NCT03262545|Apatinib|apatinib|mesh-list
111020807|NCT03262545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111020808|NCT03262545|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110827062|NCT01268371|Everolimus|everolimus|mesh-list
111020810|NCT03262545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111020811|NCT03262077|Methylene Blue|methylene blue|mesh-list
111020812|NCT03262077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111020813|NCT03262077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111020814|NCT03265899|Lactitol|lactitol|mesh-list
111020815|NCT03265899|Oxytocin|oxytocin|mesh-list
111020816|NCT03265899|Oxytocics|oxytocics|mesh-ancestor
111020817|NCT03265899|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111020818|NCT03265899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111020819|NCT03265899|Cathartics|cathartics|mesh-ancestor
111020820|NCT03265899|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111020821|NCT04459988|Ocrelizumab|ocrelizumab|mesh-list
111020822|NCT04459988|Immunologic Factors|immunologic factors|mesh-ancestor
111020823|NCT04459988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111020824|NCT02125201|Fentanyl|fentanyl|mesh-list
111020825|NCT02125201|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111020826|NCT02125201|Narcotics|narcotics|mesh-ancestor
111020827|NCT02125201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111020828|NCT02125201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111020829|NCT02125201|Analgesics|analgesics|mesh-ancestor
111020830|NCT02125201|Sensory System Agents|sensory system agents|mesh-ancestor
111020831|NCT02125201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111020832|NCT02125201|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111020833|NCT02125201|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111020834|NCT02125201|Anesthetics, General|anesthetics, general|mesh-ancestor
111020835|NCT02125201|Anesthetics|anesthetics|mesh-ancestor
111020836|NCT02125357|Abiraterone Acetate|abiraterone acetate|mesh-list
111020837|NCT02125357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111020838|NCT02125357|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111020839|NCT02125357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111020840|NCT02125357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111020841|NCT02125357|Hormone Antagonists|hormone antagonists|mesh-ancestor
111020842|NCT02125357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111020843|NCT02125357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111020844|NCT02125357|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111020845|NCT03074942|Reslizumab|reslizumab|mesh-list
111020846|NCT03074942|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111020847|NCT03074942|Respiratory System Agents|respiratory system agents|mesh-ancestor
111020848|NCT02125435|ASP2408|asp2408|mesh-list
111020849|NCT02125435|Immunoconjugates|immunoconjugates|mesh-ancestor
111020850|NCT02125435|Immunologic Factors|immunologic factors|mesh-ancestor
111020851|NCT02125435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110737941|NCT01103648|Simvastatin|simvastatin|mesh-list
111020852|NCT02458911|Paclitaxel|paclitaxel|mesh-list
111020853|NCT02458911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111020854|NCT02458911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111020855|NCT02458911|Tubulin Modulators|tubulin modulators|mesh-ancestor
111020856|NCT02458911|Antimitotic Agents|antimitotic agents|mesh-ancestor
111020857|NCT02458911|Mitosis Modulators|mitosis modulators|mesh-ancestor
111020858|NCT02458911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111020859|NCT03075020|Carbon Monoxide|carbon monoxide|mesh-list
111020860|NCT03075020|Antimetabolites|antimetabolites|mesh-ancestor
111020861|NCT03075020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111020862|NCT03075020|Gasotransmitters|gasotransmitters|mesh-ancestor
111020863|NCT03075020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111020864|NCT03075020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111020865|NCT04998344|Vaccines|vaccines|mesh-list
111020866|NCT04998344|Immunologic Factors|immunologic factors|mesh-ancestor
111020867|NCT04998344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111020868|NCT02128243|Leucovorin|leucovorin|mesh-list
111020869|NCT02128243|Cisplatin|cisplatin|mesh-list
111020870|NCT02128243|Docetaxel|docetaxel|mesh-list
111020871|NCT02128243|Fluorouracil|fluorouracil|mesh-list
111020872|NCT02128243|Capecitabine|capecitabine|mesh-list
111020873|NCT02128243|Oxaliplatin|oxaliplatin|mesh-list
111020874|NCT02128243|Epirubicin|epirubicin|mesh-list
111020875|NCT02128243|Levoleucovorin|levoleucovorin|mesh-list
111020876|NCT02128243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111020877|NCT02128243|Tubulin Modulators|tubulin modulators|mesh-ancestor
111020878|NCT02128243|Antimitotic Agents|antimitotic agents|mesh-ancestor
111020879|NCT02128243|Mitosis Modulators|mitosis modulators|mesh-ancestor
111020880|NCT02128243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111020881|NCT02128243|Antimetabolites|antimetabolites|mesh-ancestor
111020882|NCT02128243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111020883|NCT02128243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111020884|NCT02128243|Immunologic Factors|immunologic factors|mesh-ancestor
111020885|NCT02128243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111020886|NCT02128243|Antidotes|antidotes|mesh-ancestor
111020887|NCT02128243|Protective Agents|protective agents|mesh-ancestor
111020888|NCT02128243|Vitamin B Complex|vitamin b complex|mesh-ancestor
111020889|NCT02128243|Vitamins|vitamins|mesh-ancestor
111020890|NCT02128243|Micronutrients|micronutrients|mesh-ancestor
111020891|NCT02128243|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111020892|NCT02128243|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111020893|NCT02128243|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111020894|NCT02128243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111020895|NCT03072290|Triamcinolone|triamcinolone|mesh-list
111020896|NCT03072290|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
111020897|NCT03072290|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
111020898|NCT03072290|Lidocaine|lidocaine|mesh-list
111020899|NCT03072290|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
111020900|NCT03072290|Anesthetics, Local|anesthetics, local|mesh-ancestor
111020901|NCT03072290|Anesthetics|anesthetics|mesh-ancestor
111020902|NCT03072290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111020903|NCT03072290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111020904|NCT03072290|Sensory System Agents|sensory system agents|mesh-ancestor
111020905|NCT03072290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111020906|NCT03072290|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111020907|NCT03072290|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111020908|NCT03072290|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111020909|NCT03072290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111020910|NCT03072290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111020911|NCT03072290|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111020912|NCT03072290|Glucocorticoids|glucocorticoids|mesh-ancestor
111020913|NCT03072290|Hormones|hormones|mesh-ancestor
111020914|NCT03072290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111020915|NCT03072290|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111020916|NCT03072290|Immunologic Factors|immunologic factors|mesh-ancestor
111020917|NCT03072290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111020918|NCT02132689|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
111020919|NCT02132689|Fibrinolytic Agents|fibrinolytic agents|mesh-list
111020920|NCT02132689|Heparin|heparin|mesh-list
111020921|NCT02132689|Calcium heparin|calcium heparin|mesh-list
111020922|NCT02132689|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111020923|NCT02132689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111020924|NCT02132689|Anticoagulants|anticoagulants|mesh-ancestor
111020925|NCT02128321|Repaglinide|repaglinide|mesh-list
111020926|NCT02128321|Isavuconazole|isavuconazole|mesh-list
110738018|NCT01096082|Antimanic Agents|antimanic agents|mesh-ancestor
111020927|NCT02128321|Caffeine|caffeine|mesh-list
111020928|NCT02128321|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111020929|NCT02128321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111020930|NCT02128321|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111020931|NCT02128321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111020932|NCT02128321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111020933|NCT02128321|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
111020934|NCT02128321|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111020935|NCT02128321|Purinergic Agents|purinergic agents|mesh-ancestor
111020936|NCT02128321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111020937|NCT02128321|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111020938|NCT02128321|Antifungal Agents|antifungal agents|mesh-ancestor
111020939|NCT02128321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111020940|NCT02457975|Ranibizumab|ranibizumab|mesh-list
111020941|NCT02457975|Aflibercept|aflibercept|mesh-list
111020942|NCT02457975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111020943|NCT02457975|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111020944|NCT02457975|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111020945|NCT02457975|Growth Substances|growth substances|mesh-ancestor
111020946|NCT02457975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111020947|NCT02457975|Growth Inhibitors|growth inhibitors|mesh-ancestor
111020948|NCT03074864|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111020949|NCT03074864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111020950|NCT03074864|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111020951|NCT03074864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111020952|NCT03074864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111020953|NCT02125903|Ropivacaine|ropivacaine|mesh-list
111020954|NCT02125903|Anesthetics, Local|anesthetics, local|mesh-ancestor
111020955|NCT02125903|Anesthetics|anesthetics|mesh-ancestor
111020956|NCT02125903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111020957|NCT02125903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111020958|NCT02125903|Sensory System Agents|sensory system agents|mesh-ancestor
111020959|NCT02125903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111020961|NCT04997564|Sofosbuvir|sofosbuvir|mesh-list
111020962|NCT04997564|Velpatasvir|velpatasvir|mesh-list
111020963|NCT04997564|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
111020964|NCT04997564|Antiviral Agents|antiviral agents|mesh-ancestor
111020965|NCT04997564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111020966|NCT04997564|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111020967|NCT04997564|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111020968|NCT04997564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111020969|NCT04997564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111020970|NCT04997564|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111020971|NCT04997564|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111020972|NCT03842943|Pembrolizumab|pembrolizumab|mesh-list
111020973|NCT03842943|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
111020974|NCT03842943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111020975|NCT03842943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111020976|NCT03842943|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111020977|NCT03842943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111020978|NCT02126137|Ezetimibe|ezetimibe|mesh-list
111020979|NCT02126137|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110623676|NCT00815256|Riboflavin|riboflavin|mesh-list
111020980|NCT02126137|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111020981|NCT02126137|Antimetabolites|antimetabolites|mesh-ancestor
111020982|NCT02126137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111020983|NCT02126137|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111020985|NCT02126293|Trace Elements|trace elements|mesh-ancestor
111020986|NCT02126293|Micronutrients|micronutrients|mesh-ancestor
111020987|NCT02126293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111020988|NCT03261921|Dexamethasone|dexamethasone|mesh-list
111020989|NCT03261921|Dexmedetomidine|dexmedetomidine|mesh-list
111020990|NCT03261921|Bupivacaine|bupivacaine|mesh-list
111020991|NCT03261921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111020992|NCT03261921|Antiemetics|antiemetics|mesh-ancestor
111020993|NCT03261921|Autonomic Agents|autonomic agents|mesh-ancestor
111020994|NCT03261921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111020995|NCT03261921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111020996|NCT03261921|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111020997|NCT03261921|Glucocorticoids|glucocorticoids|mesh-ancestor
111020998|NCT03261921|Hormones|hormones|mesh-ancestor
111020999|NCT03261921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111021000|NCT03261921|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111021001|NCT03261921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110827072|NCT01267669|Hormones|hormones|mesh-ancestor
111021002|NCT03261921|Anesthetics, Local|anesthetics, local|mesh-ancestor
111021003|NCT03261921|Anesthetics|anesthetics|mesh-ancestor
111021004|NCT03261921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111021005|NCT03261921|Sensory System Agents|sensory system agents|mesh-ancestor
111021006|NCT03261921|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111021007|NCT03261921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111021008|NCT03261921|Analgesics|analgesics|mesh-ancestor
111021009|NCT03261921|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111021010|NCT03261921|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111021011|NCT03261921|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111021012|NCT03261921|Adrenergic Agents|adrenergic agents|mesh-ancestor
111021013|NCT03261921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111021014|NCT03261921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111021015|NCT02635724|Peramivir|peramivir|mesh-list
111021016|NCT02635724|Antiviral Agents|antiviral agents|mesh-ancestor
111021017|NCT02635724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111021018|NCT02635724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111021019|NCT02635724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111021020|NCT02133469|Vaccines|vaccines|mesh-list
111021021|NCT02133469|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
111021022|NCT02133469|Immunologic Factors|immunologic factors|mesh-ancestor
111021023|NCT02133469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111021024|NCT05001854|Fludrocortisone|fludrocortisone|mesh-list
111021025|NCT05001854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111021026|NCT02126527|Sirolimus|sirolimus|mesh-list
111021027|NCT02126527|Auranofin|auranofin|mesh-list
111021028|NCT02126527|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111021029|NCT02126527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111021030|NCT02126527|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111021031|NCT02126527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111021032|NCT02126527|Antifungal Agents|antifungal agents|mesh-ancestor
111021033|NCT02126527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111021034|NCT02126527|Immunologic Factors|immunologic factors|mesh-ancestor
111021035|NCT02126527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111021036|NCT02126527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111021037|NCT02133625|Pioglitazone|pioglitazone|mesh-list
111021038|NCT02133625|Carboplatin|carboplatin|mesh-list
111021039|NCT02133625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111021040|NCT02133625|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111021041|NCT02133625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111021042|NCT02260687|Aflibercept|aflibercept|mesh-list
111021043|NCT02260687|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111021044|NCT02260687|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111021045|NCT02260687|Growth Substances|growth substances|mesh-ancestor
111021046|NCT02260687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111021047|NCT02260687|Growth Inhibitors|growth inhibitors|mesh-ancestor
111021048|NCT02260687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111021049|NCT03071822|Dexamethasone|dexamethasone|mesh-list
111021050|NCT03071822|Gemcitabine|gemcitabine|mesh-list
111021051|NCT03071822|Etoposide|etoposide|mesh-list
111021052|NCT03071822|Asparaginase|asparaginase|mesh-list
111021053|NCT03071822|Ifosfamide|ifosfamide|mesh-list
111021054|NCT03071822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111021055|NCT03071822|Antiemetics|antiemetics|mesh-ancestor
111021056|NCT03071822|Autonomic Agents|autonomic agents|mesh-ancestor
111021057|NCT03071822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111021058|NCT03071822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111021059|NCT03071822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111021060|NCT03071822|Glucocorticoids|glucocorticoids|mesh-ancestor
111021061|NCT03071822|Hormones|hormones|mesh-ancestor
111021062|NCT03071822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111021063|NCT03071822|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111021064|NCT03071822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111021065|NCT03071822|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111021066|NCT03071822|Antimetabolites|antimetabolites|mesh-ancestor
111021067|NCT03071822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111021068|NCT03071822|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111021069|NCT03071822|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111021070|NCT03071822|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111021071|NCT03071822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111021072|NCT03071822|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111021073|NCT03071822|Alkylating Agents|alkylating agents|mesh-ancestor
111021074|NCT04991012|Triamcinolone|triamcinolone|mesh-list
111021075|NCT04991012|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
111021076|NCT04991012|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
111021077|NCT04991012|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
111021078|NCT04991012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111021079|NCT04991012|Glucocorticoids|glucocorticoids|mesh-ancestor
111021080|NCT04991012|Hormones|hormones|mesh-ancestor
111021081|NCT04991012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111021082|NCT04991012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111021083|NCT04991012|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111021085|NCT04991012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111021086|NCT04991012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111021087|NCT02252731|Warfarin|warfarin|mesh-list
111021088|NCT02252731|Anticoagulants|anticoagulants|mesh-ancestor
111021089|NCT02128633|Listerine|listerine|mesh-list
111021090|NCT02128633|Fluorides|fluorides|mesh-list
111021091|NCT02128633|Sodium Fluoride|sodium fluoride|mesh-list
111021092|NCT02128633|Cariostatic Agents|cariostatic agents|mesh-ancestor
111021093|NCT02128633|Protective Agents|protective agents|mesh-ancestor
111021094|NCT02128633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111021095|NCT02128633|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111021096|NCT02128633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111021097|NCT02126683|Hydroxychloroquine|hydroxychloroquine|mesh-list
111021098|NCT02126683|Antimalarials|antimalarials|mesh-ancestor
111021099|NCT02126683|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111021100|NCT02126683|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111021101|NCT02126683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110623708|NCT00305695|Imidazole|imidazole|mesh-list
111021102|NCT02126683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111021103|NCT02126683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111021104|NCT02126683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111021105|NCT03252561|Anesthetics|anesthetics|mesh-list
111021106|NCT03252561|Anesthetics, Local|anesthetics, local|mesh-list
111021107|NCT03252561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111021108|NCT03252561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111021109|NCT03252561|Sensory System Agents|sensory system agents|mesh-ancestor
111021110|NCT03252561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111021111|NCT02252263|Elotuzumab|elotuzumab|mesh-list
111021112|NCT02252263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111021113|NCT04996550|Metoprolol|metoprolol|mesh-list
111021114|NCT04996550|Carvedilol|carvedilol|mesh-list
111021115|NCT04996550|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111021116|NCT04996550|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111021117|NCT04996550|Sympatholytics|sympatholytics|mesh-ancestor
111021118|NCT04996550|Autonomic Agents|autonomic agents|mesh-ancestor
111021119|NCT04996550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111021120|NCT04996550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111021121|NCT04996550|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
111021122|NCT04996550|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111021123|NCT04996550|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111021124|NCT04996550|Adrenergic Agents|adrenergic agents|mesh-ancestor
111021125|NCT04996550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111021126|NCT04996550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111021127|NCT04996550|Antioxidants|antioxidants|mesh-ancestor
111021128|NCT04996550|Protective Agents|protective agents|mesh-ancestor
111021129|NCT04996550|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111021130|NCT04996550|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111021131|NCT04996550|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111021132|NCT04996550|Vasodilator Agents|vasodilator agents|mesh-ancestor
111021133|NCT04996550|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111021134|NCT04996550|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111021135|NCT03252171|Immunomodulating Agents|immunomodulating agents|mesh-list
111021136|NCT03252171|Immunologic Factors|immunologic factors|mesh-ancestor
111021137|NCT03252171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111021138|NCT02133937|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111021139|NCT02133937|Immunologic Factors|immunologic factors|mesh-ancestor
111021140|NCT02133937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111021141|NCT02135965|Caffeine|caffeine|mesh-list
111021142|NCT02135965|Albuterol|albuterol|mesh-list
111021143|NCT02135965|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111021144|NCT02135965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111021145|NCT02135965|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111021146|NCT02135965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111021147|NCT02135965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111021148|NCT02135965|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
111021149|NCT02135965|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111021150|NCT02135965|Purinergic Agents|purinergic agents|mesh-ancestor
111021151|NCT02135965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111021152|NCT02135965|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111021153|NCT02135965|Autonomic Agents|autonomic agents|mesh-ancestor
111021154|NCT02135965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111021155|NCT02135965|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111021156|NCT02135965|Respiratory System Agents|respiratory system agents|mesh-ancestor
111021157|NCT02135965|Tocolytic Agents|tocolytic agents|mesh-ancestor
111021158|NCT02135965|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111021159|NCT02135965|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111021160|NCT02135965|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111021161|NCT02135965|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111021162|NCT02135965|Adrenergic Agents|adrenergic agents|mesh-ancestor
111021163|NCT02455401|Remifentanil|remifentanil|mesh-list
111021164|NCT02455401|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111021165|NCT02455401|Narcotics|narcotics|mesh-ancestor
111021166|NCT02455401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111021167|NCT02455401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111021168|NCT02455401|Analgesics|analgesics|mesh-ancestor
111021169|NCT02455401|Sensory System Agents|sensory system agents|mesh-ancestor
111021170|NCT02455401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111021171|NCT03260829|Ascorbic Acid|ascorbic acid|mesh-list
111021172|NCT03260829|Vitamins|vitamins|mesh-ancestor
111021173|NCT03260829|Micronutrients|micronutrients|mesh-ancestor
111021174|NCT03260829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111021175|NCT03260829|Antioxidants|antioxidants|mesh-ancestor
111021176|NCT03260829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111021177|NCT03260829|Protective Agents|protective agents|mesh-ancestor
111021178|NCT02134093|Midazolam|midazolam|mesh-list
111021179|NCT02134093|Sufentanil|sufentanil|mesh-list
111021180|NCT02134093|Dexmedetomidine|dexmedetomidine|mesh-list
111021181|NCT02134093|Remifentanil|remifentanil|mesh-list
111021182|NCT02134093|Anesthetics|anesthetics|mesh-list
111021183|NCT02134093|Propofol|propofol|mesh-list
111021184|NCT02134093|Etomidate|etomidate|mesh-list
111021185|NCT02134093|Vecuronium Bromide|vecuronium bromide|mesh-list
111021186|NCT02134093|Rocuronium|rocuronium|mesh-list
111021187|NCT02134093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111021188|NCT02134093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111021189|NCT02134093|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111021190|NCT02134093|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111021191|NCT02134093|Analgesics|analgesics|mesh-ancestor
111021192|NCT02134093|Sensory System Agents|sensory system agents|mesh-ancestor
111021193|NCT02134093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111021194|NCT02134093|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111021195|NCT02134093|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111021196|NCT02134093|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111021197|NCT02134093|Adrenergic Agents|adrenergic agents|mesh-ancestor
111021198|NCT02134093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111021199|NCT02134093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111021200|NCT02134093|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111021201|NCT02134093|Anesthetics, General|anesthetics, general|mesh-ancestor
111021202|NCT02134093|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111021203|NCT02134093|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111021204|NCT02134093|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111021205|NCT02134093|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111021206|NCT02134093|GABA Modulators|gaba modulators|mesh-ancestor
111021207|NCT02134093|GABA Agents|gaba agents|mesh-ancestor
111021208|NCT02134093|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111021209|NCT02134093|Narcotics|narcotics|mesh-ancestor
111021210|NCT02134093|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
111021211|NCT02134093|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
111021212|NCT02134093|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111021213|NCT02134093|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
111021214|NCT02134093|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111021215|NCT02134093|Cholinergic Agents|cholinergic agents|mesh-ancestor
111021216|NCT03074786|Tenofovir|tenofovir|mesh-list
111021217|NCT03074786|Emtricitabine|emtricitabine|mesh-list
111021218|NCT03074786|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
111021219|NCT03074786|Dapivirine|dapivirine|mesh-list
111021220|NCT03074786|Antiviral Agents|antiviral agents|mesh-ancestor
111021221|NCT03074786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111021222|NCT03074786|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111021223|NCT03074786|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111021224|NCT03074786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111021225|NCT03074786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111021226|NCT03074786|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111021227|NCT03074786|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111021228|NCT03070028|Phenol|phenol|mesh-list
111021229|NCT03070028|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111021230|NCT03070028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111021231|NCT03070028|Disinfectants|disinfectants|mesh-ancestor
111021232|NCT03070028|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
111021234|NCT03260439|Tramadol|tramadol|mesh-list
111021235|NCT03260439|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111021236|NCT03260439|Narcotics|narcotics|mesh-ancestor
111021237|NCT03260439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111021238|NCT03260439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111021239|NCT03260439|Analgesics|analgesics|mesh-ancestor
111021240|NCT03260439|Sensory System Agents|sensory system agents|mesh-ancestor
111021241|NCT03260439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111021242|NCT02634788|Buprenorphine|buprenorphine|mesh-list
111021243|NCT02634788|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111021244|NCT02634788|Narcotics|narcotics|mesh-ancestor
111021245|NCT02634788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111021246|NCT02634788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111021247|NCT02634788|Analgesics|analgesics|mesh-ancestor
111021248|NCT02634788|Sensory System Agents|sensory system agents|mesh-ancestor
111021249|NCT02634788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111021250|NCT02634788|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111021251|NCT03260283|Fentanyl|fentanyl|mesh-list
111021252|NCT03260283|Meperidine|meperidine|mesh-list
111021253|NCT03260283|Ropivacaine|ropivacaine|mesh-list
111021254|NCT03260283|Anesthetics, Local|anesthetics, local|mesh-ancestor
111021255|NCT03260283|Anesthetics|anesthetics|mesh-ancestor
111021256|NCT03260283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111021257|NCT03260283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111021258|NCT03260283|Sensory System Agents|sensory system agents|mesh-ancestor
111021259|NCT03260283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111021260|NCT03260283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111021261|NCT03260283|Narcotics|narcotics|mesh-ancestor
111021262|NCT03260283|Analgesics|analgesics|mesh-ancestor
111021263|NCT03260283|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111021264|NCT03260283|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111021265|NCT03260283|Anesthetics, General|anesthetics, general|mesh-ancestor
111021266|NCT03251469|Tranexamic Acid|tranexamic acid|mesh-list
111021267|NCT03251469|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111021268|NCT03251469|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111021269|NCT03251469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111021270|NCT03251469|Hemostatics|hemostatics|mesh-ancestor
111021271|NCT03251469|Coagulants|coagulants|mesh-ancestor
111021272|NCT04986644|Hyaluronic Acid|hyaluronic acid|mesh-list
111021273|NCT04986644|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111021274|NCT04986644|Immunologic Factors|immunologic factors|mesh-ancestor
111021275|NCT04986644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111021276|NCT04986644|Viscosupplements|viscosupplements|mesh-ancestor
111021277|NCT04986644|Protective Agents|protective agents|mesh-ancestor
111021278|NCT02785939|Docetaxel|docetaxel|mesh-list
111021279|NCT02785939|Palbociclib|palbociclib|mesh-list
111021280|NCT02785939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111021281|NCT02785939|Tubulin Modulators|tubulin modulators|mesh-ancestor
111021282|NCT02785939|Antimitotic Agents|antimitotic agents|mesh-ancestor
111021283|NCT02785939|Mitosis Modulators|mitosis modulators|mesh-ancestor
111021284|NCT02785939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111021285|NCT02785939|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111021286|NCT02785939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111021287|NCT03583229|Aspirin|aspirin|mesh-list
111021288|NCT03583229|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111021289|NCT03583229|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111021290|NCT03583229|Analgesics|analgesics|mesh-ancestor
111021291|NCT03583229|Sensory System Agents|sensory system agents|mesh-ancestor
111021292|NCT03583229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111021293|NCT03583229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111021294|NCT03583229|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111021295|NCT03583229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111021296|NCT03583229|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111021297|NCT03583229|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111021298|NCT03583229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111021299|NCT03583229|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111021300|NCT03583229|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111021301|NCT03583229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111021302|NCT03583229|Antipyretics|antipyretics|mesh-ancestor
111021303|NCT02259803|Amlodipine|amlodipine|mesh-list
111021304|NCT02259803|Telmisartan|telmisartan|mesh-list
111021305|NCT02259803|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
111021306|NCT02259803|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111021307|NCT02259803|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111021308|NCT02259803|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111021309|NCT02259803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111021310|NCT02259803|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111021311|NCT02259803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111021312|NCT02259803|Vasodilator Agents|vasodilator agents|mesh-ancestor
111021313|NCT02259803|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111021314|NCT02259803|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111021315|NCT03260049|Antiviral Agents|antiviral agents|mesh-list
111021316|NCT03260049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111021317|NCT03069950|Leucovorin|leucovorin|mesh-list
111021318|NCT03069950|Dexamethasone|dexamethasone|mesh-list
111021319|NCT03069950|Fluorouracil|fluorouracil|mesh-list
111021320|NCT03069950|Irinotecan|irinotecan|mesh-list
111021321|NCT03069950|Panitumumab|panitumumab|mesh-list
111021322|NCT03069950|Floxuridine|floxuridine|mesh-list
111021323|NCT03069950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111021324|NCT03069950|Antiemetics|antiemetics|mesh-ancestor
111021325|NCT03069950|Autonomic Agents|autonomic agents|mesh-ancestor
111021326|NCT03069950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111021327|NCT03069950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111021328|NCT03069950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111021329|NCT03069950|Glucocorticoids|glucocorticoids|mesh-ancestor
111021330|NCT03069950|Hormones|hormones|mesh-ancestor
111021331|NCT03069950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111021332|NCT03069950|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111021333|NCT03069950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111021334|NCT03069950|Antimetabolites|antimetabolites|mesh-ancestor
111021335|NCT03069950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111021336|NCT03069950|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111021337|NCT03069950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111021338|NCT03069950|Immunologic Factors|immunologic factors|mesh-ancestor
111021339|NCT03069950|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111021340|NCT03069950|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111021341|NCT03069950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111021342|NCT03069950|Antidotes|antidotes|mesh-ancestor
111021343|NCT03069950|Protective Agents|protective agents|mesh-ancestor
111021344|NCT03069950|Vitamin B Complex|vitamin b complex|mesh-ancestor
111021345|NCT03069950|Vitamins|vitamins|mesh-ancestor
111021346|NCT03069950|Micronutrients|micronutrients|mesh-ancestor
111021347|NCT03069950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111021348|NCT04913870|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
111021349|NCT04913870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111021350|NCT03577457|Oxytocin|oxytocin|mesh-list
111021351|NCT03577457|Oxytocics|oxytocics|mesh-ancestor
111021352|NCT03577457|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111021353|NCT03577457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111021354|NCT02455245|Carboplatin|carboplatin|mesh-list
111021355|NCT02455245|Vincristine|vincristine|mesh-list
111021356|NCT02455245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111021357|NCT02455245|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111021358|NCT02455245|Tubulin Modulators|tubulin modulators|mesh-ancestor
111021359|NCT02455245|Antimitotic Agents|antimitotic agents|mesh-ancestor
111021360|NCT02455245|Mitosis Modulators|mitosis modulators|mesh-ancestor
111021361|NCT02455245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111021362|NCT03537599|Daratumumab|daratumumab|mesh-list
111021363|NCT03537599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111021364|NCT04986254|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111021365|NCT04986254|Meropenem|meropenem|mesh-list
111021366|NCT04986254|Ceftriaxone|ceftriaxone|mesh-list
111021367|NCT04986254|Tazobactam|tazobactam|mesh-list
111021368|NCT04986254|Piperacillin|piperacillin|mesh-list
111021369|NCT04986254|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
111021370|NCT04986254|Penicillin G|penicillin g|mesh-list
111021371|NCT04986254|Penicillin G Benzathine|penicillin g benzathine|mesh-list
111021372|NCT04986254|Penicillin G Procaine|penicillin g procaine|mesh-list
111021373|NCT04986254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111021374|NCT04986254|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
111021375|NCT04986254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111021376|NCT04986254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111021377|NCT03257943|Ivermectin|ivermectin|mesh-list
111021378|NCT03257943|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111021379|NCT03257943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111021380|NCT04996160|Dexamethasone|dexamethasone|mesh-list
111021381|NCT04996160|Dexamethasone acetate|dexamethasone acetate|mesh-list
111021382|NCT04996160|Doxorubicin|doxorubicin|mesh-list
110486431|NCT00648843|Oxybutynin|oxybutynin|mesh-list
111021383|NCT04996160|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111021385|NCT04996160|Palbociclib|palbociclib|mesh-list
111021386|NCT04996160|BB 1101|bb 1101|mesh-list
111021387|NCT04996160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111021388|NCT04996160|Antiemetics|antiemetics|mesh-ancestor
111021389|NCT04996160|Autonomic Agents|autonomic agents|mesh-ancestor
111021390|NCT04996160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111021391|NCT04996160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111021392|NCT04996160|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111021393|NCT04996160|Glucocorticoids|glucocorticoids|mesh-ancestor
111021394|NCT04996160|Hormones|hormones|mesh-ancestor
111021395|NCT04996160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111021396|NCT04996160|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111021397|NCT04996160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111021398|NCT04996160|Protease Inhibitors|protease inhibitors|mesh-ancestor
111021399|NCT04996160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111021400|NCT04996160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111021401|NCT04996160|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111021402|NCT04996160|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111021403|NCT04996160|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111021404|NCT04996160|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111021405|NCT04986098|Paclitaxel|paclitaxel|mesh-list
111021406|NCT04986098|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111021407|NCT04986098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111021408|NCT04986098|Tubulin Modulators|tubulin modulators|mesh-ancestor
111021409|NCT04986098|Antimitotic Agents|antimitotic agents|mesh-ancestor
111021410|NCT04986098|Mitosis Modulators|mitosis modulators|mesh-ancestor
111021411|NCT04986098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111021412|NCT02239445|Dexmedetomidine|dexmedetomidine|mesh-list
111021413|NCT02239445|Chloral Hydrate|chloral hydrate|mesh-list
111021414|NCT02239445|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111021415|NCT02239445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111021416|NCT02239445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111021417|NCT02239445|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111021418|NCT02239445|Analgesics|analgesics|mesh-ancestor
111021419|NCT02239445|Sensory System Agents|sensory system agents|mesh-ancestor
111021420|NCT02239445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111021421|NCT02239445|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111021422|NCT02239445|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111021423|NCT02239445|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111021424|NCT02239445|Adrenergic Agents|adrenergic agents|mesh-ancestor
111021425|NCT02239445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111021426|NCT02239445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111021427|NCT03071042|Docetaxel|docetaxel|mesh-list
111021428|NCT03071042|Apatinib|apatinib|mesh-list
111021429|NCT03071042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111021430|NCT03071042|Tubulin Modulators|tubulin modulators|mesh-ancestor
111021431|NCT03071042|Antimitotic Agents|antimitotic agents|mesh-ancestor
111021432|NCT03071042|Mitosis Modulators|mitosis modulators|mesh-ancestor
111021433|NCT03071042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111021434|NCT03071042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111021435|NCT03071042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111021436|NCT03582605|Amoxicillin|amoxicillin|mesh-list
111021437|NCT03582605|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111021438|NCT03582605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111021439|NCT04433546|VIP-ELP fusion molecule PB1046|vip-elp fusion molecule pb1046|mesh-list
111021440|NCT04433546|Vasodilator Agents|vasodilator agents|mesh-ancestor
111021441|NCT04989140|Dexamethasone|dexamethasone|mesh-list
111021442|NCT04989140|Pomalidomide|pomalidomide|mesh-list
111021443|NCT04989140|Ixazomib|ixazomib|mesh-list
111021444|NCT04989140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111021445|NCT04989140|Antiemetics|antiemetics|mesh-ancestor
111021446|NCT04989140|Autonomic Agents|autonomic agents|mesh-ancestor
111021447|NCT04989140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111021448|NCT04989140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111021449|NCT04989140|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111021450|NCT04989140|Glucocorticoids|glucocorticoids|mesh-ancestor
111021451|NCT04989140|Hormones|hormones|mesh-ancestor
111021452|NCT04989140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111021453|NCT04989140|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111021454|NCT04989140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111021455|NCT04989140|Immunologic Factors|immunologic factors|mesh-ancestor
111021456|NCT04989140|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111021457|NCT04989140|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111021458|NCT04989140|Growth Substances|growth substances|mesh-ancestor
111021459|NCT04989140|Growth Inhibitors|growth inhibitors|mesh-ancestor
111021460|NCT04989140|Protease Inhibitors|protease inhibitors|mesh-ancestor
111021461|NCT04989140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111021462|NCT04989140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111021463|NCT03246009|Lenograstim|lenograstim|mesh-list
111021464|NCT03246009|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111021465|NCT03246009|Immunologic Factors|immunologic factors|mesh-ancestor
111021466|NCT03246009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111021467|NCT03246399|Lorecivivint|lorecivivint|mesh-list
111021468|NCT03246399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111021469|NCT02134249|Cabergoline|cabergoline|mesh-list
111021470|NCT02134249|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111021471|NCT02134249|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111021472|NCT02134249|Dopamine Agonists|dopamine agonists|mesh-ancestor
111021473|NCT02134249|Dopamine Agents|dopamine agents|mesh-ancestor
111021474|NCT02134249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111021475|NCT02134249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111021476|NCT02134249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111021477|NCT03245853|Riboflavin|riboflavin|mesh-list
111021478|NCT03245853|Flavin Mononucleotide|flavin mononucleotide|mesh-list
111021479|NCT03245853|Vitamin B Complex|vitamin b complex|mesh-ancestor
111021480|NCT03245853|Vitamins|vitamins|mesh-ancestor
111021481|NCT03245853|Micronutrients|micronutrients|mesh-ancestor
111021482|NCT03245853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111021483|NCT03245853|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111021484|NCT03245853|Dermatologic Agents|dermatologic agents|mesh-ancestor
111021485|NCT03574649|Paclitaxel|paclitaxel|mesh-list
111021486|NCT03574649|Docetaxel|docetaxel|mesh-list
111021487|NCT03574649|Cyclophosphamide|cyclophosphamide|mesh-list
111021488|NCT03574649|Carboplatin|carboplatin|mesh-list
111021489|NCT03574649|Fluorouracil|fluorouracil|mesh-list
111021490|NCT03574649|Avelumab|avelumab|mesh-list
111021491|NCT03574649|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111021492|NCT03574649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111021493|NCT03574649|Tubulin Modulators|tubulin modulators|mesh-ancestor
111021494|NCT03574649|Antimitotic Agents|antimitotic agents|mesh-ancestor
111021495|NCT03574649|Mitosis Modulators|mitosis modulators|mesh-ancestor
111021496|NCT03574649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111021497|NCT03574649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111021498|NCT03574649|Immunologic Factors|immunologic factors|mesh-ancestor
111021499|NCT03574649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111021500|NCT03574649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111021501|NCT03574649|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111021502|NCT03574649|Alkylating Agents|alkylating agents|mesh-ancestor
111021503|NCT03574649|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111021504|NCT03574649|Antimetabolites|antimetabolites|mesh-ancestor
111021505|NCT03574649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111021506|NCT03574649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111021507|NCT02128945|Fludarabine|fludarabine|mesh-list
111021508|NCT02128945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111021509|NCT02136277|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111021510|NCT03073928|Ropivacaine|ropivacaine|mesh-list
111021511|NCT03073928|Anesthetics, Local|anesthetics, local|mesh-ancestor
111021512|NCT03073928|Anesthetics|anesthetics|mesh-ancestor
111021513|NCT03073928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111021514|NCT03073928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111021515|NCT03073928|Sensory System Agents|sensory system agents|mesh-ancestor
111021516|NCT03073928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111021517|NCT02134405|Esomeprazole|esomeprazole|mesh-list
111021518|NCT02134405|Rebamipide|rebamipide|mesh-list
111021519|NCT02134405|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111021520|NCT02134405|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111021521|NCT02134405|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111021522|NCT02134405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111021523|NCT02134405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111021524|NCT02134405|Antioxidants|antioxidants|mesh-ancestor
111021525|NCT02134405|Protective Agents|protective agents|mesh-ancestor
111021526|NCT02134405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111021527|NCT03574415|Fexuprazan|fexuprazan|mesh-list
111021528|NCT03574415|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111021529|NCT02456025|Tacrolimus|tacrolimus|mesh-list
111021530|NCT02456025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111021531|NCT02456025|Immunologic Factors|immunologic factors|mesh-ancestor
111021532|NCT02456025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111021533|NCT02456025|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111021534|NCT02456025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111021535|NCT02456025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111021536|NCT02134483|Parathyroid Hormone|parathyroid hormone|mesh-list
111021537|NCT02134483|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111021538|NCT02134483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111021540|NCT02136511|Idelalisib|idelalisib|mesh-list
111021541|NCT02136511|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111021542|NCT02136511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111021543|NCT02136511|Immunologic Factors|immunologic factors|mesh-ancestor
111021544|NCT02136511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111021545|NCT02136511|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111021546|NCT02136511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111021547|NCT02136511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111021548|NCT02136589|Diclofenac|diclofenac|mesh-list
111021549|NCT02136589|Travoprost|travoprost|mesh-list
111021550|NCT02136589|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111021551|NCT02136589|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111021552|NCT02136589|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111021553|NCT02136589|Analgesics|analgesics|mesh-ancestor
111021554|NCT02136589|Sensory System Agents|sensory system agents|mesh-ancestor
111021555|NCT02136589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111021556|NCT02136589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111021557|NCT02136589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111021558|NCT02136589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111021559|NCT02136589|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111021560|NCT02136589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111021561|NCT02136589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111021562|NCT02134639|Edotreotide|edotreotide|mesh-list
111021563|NCT02134639|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111021564|NCT02134639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111021565|NCT02129101|Azacitidine|azacitidine|mesh-list
111021566|NCT02129101|Decitabine|decitabine|mesh-list
111021567|NCT02129101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111021568|NCT02129101|Antimetabolites|antimetabolites|mesh-ancestor
111021569|NCT02129101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111021570|NCT02129101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111021571|NCT02129101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111021572|NCT02134717|Maraviroc|maraviroc|mesh-list
111021573|NCT02134717|Dimercaprol|dimercaprol|mesh-list
111021574|NCT02134717|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
111021575|NCT02134717|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
111021576|NCT02134717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111021577|NCT02134717|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111021578|NCT02134717|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111021579|NCT02134717|Antiviral Agents|antiviral agents|mesh-ancestor
111021580|NCT02134717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111021581|NCT02134717|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
111021582|NCT02134717|Chelating Agents|chelating agents|mesh-ancestor
111021583|NCT02134717|Sequestering Agents|sequestering agents|mesh-ancestor
111021584|NCT03245385|Halobetasol|halobetasol|mesh-list
111021585|NCT03245385|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111021586|NCT02136823|Isradipine|isradipine|mesh-list
111021587|NCT02136823|Riluzole|riluzole|mesh-list
111021588|NCT02136823|Memantine|memantine|mesh-list
111021589|NCT02136823|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111021590|NCT02136823|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111021591|NCT02136823|Dopamine Agents|dopamine agents|mesh-ancestor
111021592|NCT02136823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111021593|NCT02136823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111021594|NCT02136823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111021595|NCT02136823|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111021596|NCT02136823|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111021597|NCT02136823|Anticonvulsants|anticonvulsants|mesh-ancestor
111021598|NCT02136823|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111021599|NCT02136823|Protective Agents|protective agents|mesh-ancestor
111021600|NCT02136823|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111021601|NCT02136823|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111021602|NCT02136823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111021603|NCT02136823|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111021604|NCT02136823|Vasodilator Agents|vasodilator agents|mesh-ancestor
111021605|NCT03250143|Cyclosporine|cyclosporine|mesh-list
111021606|NCT03250143|Azathioprine|azathioprine|mesh-list
111021607|NCT03250143|Cyclosporins|cyclosporins|mesh-list
111021608|NCT03250143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111021609|NCT03250143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111021610|NCT03250143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111021611|NCT03250143|Immunologic Factors|immunologic factors|mesh-ancestor
111021612|NCT03250143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111021613|NCT03250143|Antifungal Agents|antifungal agents|mesh-ancestor
110623814|NCT00815568|Alkylating Agents|alkylating agents|mesh-ancestor
111021614|NCT03250143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111021615|NCT03250143|Dermatologic Agents|dermatologic agents|mesh-ancestor
111021616|NCT03250143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111021617|NCT03250143|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111021618|NCT03250143|Antimetabolites|antimetabolites|mesh-ancestor
111021619|NCT03250143|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111021620|NCT03250143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111021621|NCT03073850|Anticoagulants|anticoagulants|mesh-list
111021623|NCT03073850|Clopidogrel|clopidogrel|mesh-list
111021624|NCT03073850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111021625|NCT03073850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111021626|NCT03073850|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111021627|NCT03073850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111021628|NCT03073850|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111021629|NCT03073850|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111021630|NCT03073850|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111021631|NCT03073850|Purinergic Agents|purinergic agents|mesh-ancestor
111021632|NCT03073850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111021633|NCT03073850|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111021634|NCT03073850|Antithrombins|antithrombins|mesh-ancestor
111021635|NCT03073850|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111021636|NCT03073850|Protease Inhibitors|protease inhibitors|mesh-ancestor
111021637|NCT03257319|Morphine|morphine|mesh-list
111021638|NCT03257319|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111021639|NCT03257319|Narcotics|narcotics|mesh-ancestor
111021640|NCT03257319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111021641|NCT03257319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111021642|NCT03257319|Analgesics|analgesics|mesh-ancestor
111021643|NCT03257319|Sensory System Agents|sensory system agents|mesh-ancestor
111021644|NCT03257319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111021645|NCT03070574|Aminosalicylic Acid|aminosalicylic acid|mesh-list
111021646|NCT03070574|Mesalamine|mesalamine|mesh-list
111021647|NCT03070574|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111021648|NCT03070574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111021649|NCT03070574|Analgesics|analgesics|mesh-ancestor
111021650|NCT03070574|Sensory System Agents|sensory system agents|mesh-ancestor
111021651|NCT03070574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111021652|NCT03070574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111021653|NCT03070574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111021654|NCT03070574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111021655|NCT03070574|Antitubercular Agents|antitubercular agents|mesh-ancestor
111021656|NCT03070574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111021657|NCT03070574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111021658|NCT03257241|Cytarabine|cytarabine|mesh-list
111021659|NCT03257241|Fludarabine|fludarabine|mesh-list
111021660|NCT03257241|Daunorubicin|daunorubicin|mesh-list
111021661|NCT03257241|Mitoxantrone|mitoxantrone|mesh-list
111021662|NCT03257241|Idarubicin|idarubicin|mesh-list
111021663|NCT03257241|Cladribine|cladribine|mesh-list
111021664|NCT03257241|Lenograstim|lenograstim|mesh-list
111021665|NCT03257241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110623824|NCT01066351|Epoetin Alfa|epoetin alfa|mesh-list
111021666|NCT03257241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111021667|NCT03257241|Antimetabolites|antimetabolites|mesh-ancestor
111021668|NCT03257241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111021669|NCT03257241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111021670|NCT03257241|Immunologic Factors|immunologic factors|mesh-ancestor
111021671|NCT03257241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111021672|NCT03257241|Antiviral Agents|antiviral agents|mesh-ancestor
111021673|NCT03257241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111021674|NCT03257241|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111021675|NCT03257241|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111021676|NCT03257241|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111021677|NCT03257241|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111021678|NCT03257241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111021680|NCT03257241|Sensory System Agents|sensory system agents|mesh-ancestor
111021681|NCT03257241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111021682|NCT02129179|Glucagon|glucagon|mesh-list
111021683|NCT02129179|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
111021684|NCT02129179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111021685|NCT02129179|Hormones|hormones|mesh-ancestor
111021686|NCT02129179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111021687|NCT02129179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111021688|NCT02129179|Incretins|incretins|mesh-ancestor
111021689|NCT02129257|Leucovorin|leucovorin|mesh-list
111021690|NCT02129257|Folic Acid|folic acid|mesh-list
111021691|NCT02129257|Fluorouracil|fluorouracil|mesh-list
111021692|NCT02129257|Irinotecan|irinotecan|mesh-list
111021693|NCT02129257|Aflibercept|aflibercept|mesh-list
111021694|NCT02129257|Levoleucovorin|levoleucovorin|mesh-list
111021695|NCT02129257|Antimetabolites|antimetabolites|mesh-ancestor
111021696|NCT02129257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111021697|NCT02129257|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111021698|NCT02129257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111021699|NCT02129257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111021700|NCT02129257|Immunologic Factors|immunologic factors|mesh-ancestor
111021701|NCT02129257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111021702|NCT02129257|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111021703|NCT02129257|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111021704|NCT02129257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111021705|NCT02129257|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111021706|NCT02129257|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111021707|NCT02129257|Growth Substances|growth substances|mesh-ancestor
111021708|NCT02129257|Growth Inhibitors|growth inhibitors|mesh-ancestor
111021709|NCT02129257|Antidotes|antidotes|mesh-ancestor
111021710|NCT02129257|Protective Agents|protective agents|mesh-ancestor
111021711|NCT02129257|Vitamin B Complex|vitamin b complex|mesh-ancestor
111021712|NCT02129257|Vitamins|vitamins|mesh-ancestor
111021713|NCT02129257|Micronutrients|micronutrients|mesh-ancestor
111021714|NCT02129257|Hematinics|hematinics|mesh-ancestor
111021715|NCT03245307|Apatinib|apatinib|mesh-list
111021716|NCT03245307|Nifedipine|nifedipine|mesh-list
111021717|NCT03245307|Warfarin|warfarin|mesh-list
111021718|NCT03245307|Anticoagulants|anticoagulants|mesh-ancestor
111021719|NCT03245307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111021720|NCT03245307|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111021721|NCT03245307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111021722|NCT03245307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111021723|NCT03245307|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111021724|NCT03245307|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111021725|NCT03245307|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111021726|NCT03245307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111021727|NCT03245307|Vasodilator Agents|vasodilator agents|mesh-ancestor
111021728|NCT03245307|Tocolytic Agents|tocolytic agents|mesh-ancestor
111021729|NCT03245307|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111021730|NCT02136979|Propofol|propofol|mesh-list
111021731|NCT02136979|Sevoflurane|sevoflurane|mesh-list
111021732|NCT02136979|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111021733|NCT02136979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111021734|NCT02136979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111021735|NCT02136979|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111021736|NCT02136979|Anesthetics, General|anesthetics, general|mesh-ancestor
111021737|NCT02136979|Anesthetics|anesthetics|mesh-ancestor
111021738|NCT02136979|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111021739|NCT02136979|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111021740|NCT02455011|Volagidemab|volagidemab|mesh-list
111021741|NCT02455011|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111021742|NCT02455011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111021743|NCT03249285|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
111021744|NCT03249285|Perindopril|perindopril|mesh-list
111021745|NCT03249285|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111021746|NCT03249285|Diuretics|diuretics|mesh-ancestor
111021747|NCT03249285|Natriuretic Agents|natriuretic agents|mesh-ancestor
111021748|NCT03249285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111021749|NCT03249285|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
111021750|NCT03249285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111021751|NCT03249285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111021752|NCT03249285|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
111021753|NCT03249285|Protease Inhibitors|protease inhibitors|mesh-ancestor
111021754|NCT03249285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111021756|NCT03249519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111021757|NCT04983524|Propolis|propolis|mesh-list
111021758|NCT04983524|Calcium|calcium|mesh-list
111021759|NCT04983524|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111021760|NCT04983524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111021761|NCT04983524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111021762|NCT03576911|Ubiquinone|ubiquinone|mesh-list
111021763|NCT03576911|Coenzyme Q10|coenzyme q10|mesh-list
111021764|NCT03576911|Micronutrients|micronutrients|mesh-ancestor
111021765|NCT03576911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111021766|NCT03576911|Vitamins|vitamins|mesh-ancestor
110738847|NCT03768414|Tubulin Modulators|tubulin modulators|mesh-ancestor
111021767|NCT02634320|Aripiprazole|aripiprazole|mesh-list
111021768|NCT02634320|Aripiprazole lauroxil|aripiprazole lauroxil|mesh-list
111021769|NCT02634320|Antidepressive Agents|antidepressive agents|mesh-ancestor
111021770|NCT02634320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111021771|NCT02634320|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111021772|NCT02634320|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111021773|NCT02634320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111021774|NCT02634320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111021775|NCT02634320|Dopamine Agonists|dopamine agonists|mesh-ancestor
111021776|NCT02634320|Dopamine Agents|dopamine agents|mesh-ancestor
111021777|NCT02634320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111021778|NCT02634320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111021779|NCT02634320|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111021780|NCT02634320|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111021781|NCT02634320|Serotonin Agents|serotonin agents|mesh-ancestor
111021782|NCT02634320|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111021783|NCT02634320|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111021784|NCT02634320|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111021785|NCT02634320|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111021786|NCT02435680|Carboplatin|carboplatin|mesh-list
111021787|NCT02435680|Gemcitabine|gemcitabine|mesh-list
111021788|NCT02435680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111021789|NCT02435680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111021790|NCT02435680|Antimetabolites|antimetabolites|mesh-ancestor
111021791|NCT02435680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111021792|NCT04988048|Vaccines|vaccines|mesh-list
111021793|NCT04988048|Immunologic Factors|immunologic factors|mesh-ancestor
111021794|NCT04988048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111021795|NCT04982900|Aflutinib|aflutinib|mesh-list
111021796|NCT04982900|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111021797|NCT04982900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111021798|NCT04982900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111021799|NCT03256071|Decitabine|decitabine|mesh-list
111021800|NCT03256071|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111021801|NCT03256071|Antimetabolites|antimetabolites|mesh-ancestor
111021802|NCT03256071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111021803|NCT03256071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111021804|NCT03256071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111021805|NCT04912856|Ezogabine|ezogabine|mesh-list
111021806|NCT04912856|Anticonvulsants|anticonvulsants|mesh-ancestor
111021807|NCT04912856|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111021808|NCT04912856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111021809|NCT03248817|Phenylephrine|phenylephrine|mesh-list
111021810|NCT03248817|Oxymetazoline|oxymetazoline|mesh-list
111021811|NCT03248817|Bupivacaine|bupivacaine|mesh-list
111021812|NCT03248817|Anesthetics, Local|anesthetics, local|mesh-ancestor
111021813|NCT03248817|Anesthetics|anesthetics|mesh-ancestor
111021814|NCT03248817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111021815|NCT03248817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111021816|NCT03248817|Sensory System Agents|sensory system agents|mesh-ancestor
111021817|NCT03248817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111021818|NCT03248817|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111021819|NCT03248817|Mydriatics|mydriatics|mesh-ancestor
111021820|NCT03248817|Autonomic Agents|autonomic agents|mesh-ancestor
111021821|NCT03248817|Sympathomimetics|sympathomimetics|mesh-ancestor
111021822|NCT03248817|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111021823|NCT03248817|Nasal Decongestants|nasal decongestants|mesh-ancestor
111021824|NCT03248817|Respiratory System Agents|respiratory system agents|mesh-ancestor
111021825|NCT03248817|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111021826|NCT03248817|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111021827|NCT03248817|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111021828|NCT03248817|Adrenergic Agents|adrenergic agents|mesh-ancestor
111021829|NCT03248817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111021830|NCT03248817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111021831|NCT03248817|Protective Agents|protective agents|mesh-ancestor
111021832|NCT03647774|Naltrexone|naltrexone|mesh-list
111021833|NCT03647774|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111021834|NCT03647774|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111021835|NCT03647774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111021836|NCT03647774|Sensory System Agents|sensory system agents|mesh-ancestor
111021837|NCT03647774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111021838|NCT03248973|Ampicillin|ampicillin|mesh-list
111021839|NCT03248973|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111021840|NCT03248973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111021841|NCT02832531|Aspirin|aspirin|mesh-list
111021842|NCT02832531|Rivaroxaban|rivaroxaban|mesh-list
111021843|NCT02832531|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110738922|NCT03365882|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111021844|NCT02832531|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111021845|NCT02832531|Analgesics|analgesics|mesh-ancestor
111021846|NCT02832531|Sensory System Agents|sensory system agents|mesh-ancestor
111021847|NCT02832531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111021848|NCT02832531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111021849|NCT02832531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111021850|NCT02832531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111021851|NCT02832531|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111021852|NCT02832531|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111021853|NCT02832531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111021854|NCT02832531|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111021855|NCT02832531|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111021856|NCT02832531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111021857|NCT02832531|Antipyretics|antipyretics|mesh-ancestor
111021858|NCT02832531|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111021859|NCT02832531|Antithrombins|antithrombins|mesh-ancestor
111021860|NCT02832531|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111021861|NCT02832531|Protease Inhibitors|protease inhibitors|mesh-ancestor
111021862|NCT02832531|Anticoagulants|anticoagulants|mesh-ancestor
111021863|NCT03248427|Paclitaxel|paclitaxel|mesh-list
111021864|NCT03248427|Cyclophosphamide|cyclophosphamide|mesh-list
111021865|NCT03248427|Doxorubicin|doxorubicin|mesh-list
111021866|NCT03248427|Letrozole|letrozole|mesh-list
111021867|NCT03248427|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111021868|NCT03248427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111021869|NCT03248427|Tubulin Modulators|tubulin modulators|mesh-ancestor
111021870|NCT03248427|Antimitotic Agents|antimitotic agents|mesh-ancestor
111021871|NCT03248427|Mitosis Modulators|mitosis modulators|mesh-ancestor
111021872|NCT03248427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111021873|NCT03248427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111021874|NCT03248427|Immunologic Factors|immunologic factors|mesh-ancestor
111021875|NCT03248427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111021876|NCT03248427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111021877|NCT03248427|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111021878|NCT03248427|Alkylating Agents|alkylating agents|mesh-ancestor
111021879|NCT03248427|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111021880|NCT03248427|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111021881|NCT03248427|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111021882|NCT03248427|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111021883|NCT03248427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111021884|NCT03248427|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111021885|NCT03248427|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111021886|NCT03248427|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111021887|NCT03248427|Hormone Antagonists|hormone antagonists|mesh-ancestor
111021888|NCT03248427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111021889|NCT03248349|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111021890|NCT03248349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111021891|NCT03243903|Insulin|insulin|mesh-list
111021892|NCT03243903|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111021893|NCT03243903|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111021894|NCT03243903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111021895|NCT03576677|Simendan|simendan|mesh-list
111021896|NCT03576677|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111021897|NCT03576677|Vasodilator Agents|vasodilator agents|mesh-ancestor
111021898|NCT03576677|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
111021899|NCT03576677|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111021900|NCT03576677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111021901|NCT03576677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111021902|NCT03576677|Protective Agents|protective agents|mesh-ancestor
111021903|NCT03576677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111021905|NCT03247257|Anesthetics|anesthetics|mesh-list
111021906|NCT03247257|Propofol|propofol|mesh-list
111021907|NCT03247257|Anesthetics, Local|anesthetics, local|mesh-ancestor
111021908|NCT03247257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111021909|NCT03247257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111021910|NCT03247257|Sensory System Agents|sensory system agents|mesh-ancestor
111021911|NCT03247257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111021912|NCT03247257|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111021913|NCT03247257|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111021914|NCT03247257|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111021915|NCT03247257|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111021916|NCT03247257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111021917|NCT03247257|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111021918|NCT03247257|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111021919|NCT03247257|Anesthetics, General|anesthetics, general|mesh-ancestor
111021920|NCT03576599|Zoledronic Acid|zoledronic acid|mesh-list
111021921|NCT03576599|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111021922|NCT03576599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111021923|NCT02239835|Ritonavir|ritonavir|mesh-list
111021924|NCT02239835|Saquinavir|saquinavir|mesh-list
111021925|NCT02239835|Tipranavir|tipranavir|mesh-list
111021926|NCT02239835|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111021927|NCT02239835|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111021928|NCT02239835|Protease Inhibitors|protease inhibitors|mesh-ancestor
111021929|NCT02239835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111021930|NCT02239835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111021931|NCT02239835|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111021932|NCT02239835|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111021933|NCT02239835|Antiviral Agents|antiviral agents|mesh-ancestor
111021934|NCT02239835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111021935|NCT02239835|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111021936|NCT02239835|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111021937|NCT02239913|Topiramate|topiramate|mesh-list
111021938|NCT02239913|Phentermine|phentermine|mesh-list
111021939|NCT02239913|Cocaine|cocaine|mesh-list
111021940|NCT02239913|Anticonvulsants|anticonvulsants|mesh-ancestor
111021941|NCT02239913|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111021942|NCT02239913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111021943|NCT02239913|Anesthetics, Local|anesthetics, local|mesh-ancestor
111021944|NCT02239913|Anesthetics|anesthetics|mesh-ancestor
111021945|NCT02239913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111021946|NCT02239913|Sensory System Agents|sensory system agents|mesh-ancestor
111021947|NCT02239913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111021948|NCT02239913|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111021949|NCT02239913|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111021950|NCT02239913|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111021951|NCT02239913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111021952|NCT02239913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111021953|NCT02239913|Dopamine Agents|dopamine agents|mesh-ancestor
111021954|NCT02239913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111021955|NCT02239913|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111021956|NCT02239913|Appetite Depressants|appetite depressants|mesh-ancestor
111021957|NCT02239913|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111021958|NCT02239913|Sympathomimetics|sympathomimetics|mesh-ancestor
111021959|NCT02239913|Autonomic Agents|autonomic agents|mesh-ancestor
111021960|NCT02239913|Adrenergic Agents|adrenergic agents|mesh-ancestor
111021961|NCT03576287|Apremilast|apremilast|mesh-list
111021962|NCT03576287|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111021963|NCT03576287|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111021964|NCT03576287|Analgesics|analgesics|mesh-ancestor
111021965|NCT03576287|Sensory System Agents|sensory system agents|mesh-ancestor
111021966|NCT03576287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111021967|NCT03576287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111021968|NCT03576287|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111021969|NCT03576287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111021970|NCT03576287|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
111021971|NCT03576287|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111021972|NCT03576287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111021973|NCT03576287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111021974|NCT02455869|Alendronate|alendronate|mesh-list
111021975|NCT02455869|Atorvastatin|atorvastatin|mesh-list
111021976|NCT02455869|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111021977|NCT02455869|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111021978|NCT02455869|Antimetabolites|antimetabolites|mesh-ancestor
111021979|NCT02455869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111021980|NCT02455869|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111021981|NCT02455869|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111021982|NCT02455869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111021983|NCT02455869|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111021984|NCT02455869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111021985|NCT03246555|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
111021986|NCT03246555|Perindopril|perindopril|mesh-list
111021987|NCT03246555|Indapamide|indapamide|mesh-list
111021988|NCT03246555|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111021989|NCT03246555|Diuretics|diuretics|mesh-ancestor
111021990|NCT03246555|Natriuretic Agents|natriuretic agents|mesh-ancestor
111021991|NCT03246555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111021992|NCT03246555|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110739073|NCT01698918|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111021993|NCT03246555|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111021994|NCT03246555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111021995|NCT03246555|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
111021996|NCT03246555|Protease Inhibitors|protease inhibitors|mesh-ancestor
111021997|NCT03246555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111021999|NCT03576053|Serotonin|serotonin|mesh-list
111022000|NCT03576053|Histamine|histamine|mesh-list
111022001|NCT03576053|Anesthetics, Local|anesthetics, local|mesh-ancestor
111022002|NCT03576053|Anesthetics|anesthetics|mesh-ancestor
111022003|NCT03576053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111022004|NCT03576053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111022005|NCT03576053|Sensory System Agents|sensory system agents|mesh-ancestor
111022006|NCT03576053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111022007|NCT03576053|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111022008|NCT03576053|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111022009|NCT03576053|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111022010|NCT03576053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111022011|NCT03576053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111022012|NCT03576053|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111022013|NCT03576053|Serotonin Agents|serotonin agents|mesh-ancestor
111022014|NCT03576053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111022015|NCT03576053|Histamine Agonists|histamine agonists|mesh-ancestor
111022016|NCT03576053|Histamine Agents|histamine agents|mesh-ancestor
111022017|NCT03242967|Darbepoetin alfa|darbepoetin alfa|mesh-list
111022018|NCT03242967|Hematinics|hematinics|mesh-ancestor
111022019|NCT03239457|Mitogens|mitogens|mesh-list
111022020|NCT03239457|Mitosis Modulators|mitosis modulators|mesh-ancestor
111022021|NCT03239457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111022022|NCT00075803|Fluconazole|fluconazole|mesh-list
111022023|NCT00075803|Voriconazole|voriconazole|mesh-list
111022024|NCT00075803|Antifungal Agents|antifungal agents|mesh-ancestor
111022025|NCT00075803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111022026|NCT00075803|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111022027|NCT00075803|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111022028|NCT00075803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110623916|NCT00809172|Antifungal Agents|antifungal agents|mesh-ancestor
111022029|NCT00075803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111022030|NCT00075803|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111022031|NCT00075803|Hormone Antagonists|hormone antagonists|mesh-ancestor
111022032|NCT00075803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111022033|NCT00075803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111022034|NCT00075803|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111022035|NCT00075803|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111022036|NCT00075803|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111022037|NCT03242499|Lovastatin|lovastatin|mesh-list
111022038|NCT03242499|L 647318|l 647318|mesh-list
111022039|NCT03242499|Dihydromevinolin|dihydromevinolin|mesh-list
111022040|NCT03242499|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111022041|NCT03242499|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111022042|NCT03242499|Antimetabolites|antimetabolites|mesh-ancestor
111022043|NCT03242499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111022044|NCT03242499|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111022045|NCT03242499|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111022046|NCT03242499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111022047|NCT02523911|Magnesium Sulfate|magnesium sulfate|mesh-list
111022048|NCT02523911|Simethicone|simethicone|mesh-list
111022049|NCT02523911|Sodium sulfate|sodium sulfate|mesh-list
111022050|NCT02523911|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111022051|NCT02523911|Analgesics|analgesics|mesh-ancestor
111022052|NCT02523911|Sensory System Agents|sensory system agents|mesh-ancestor
111022053|NCT02523911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111022054|NCT02523911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111022055|NCT02523911|Anesthetics|anesthetics|mesh-ancestor
111022056|NCT02523911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111022057|NCT02523911|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111022058|NCT02523911|Anticonvulsants|anticonvulsants|mesh-ancestor
111022059|NCT02523911|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111022060|NCT02523911|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111022061|NCT02523911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111022062|NCT02523911|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111022063|NCT02523911|Tocolytic Agents|tocolytic agents|mesh-ancestor
111022064|NCT02523911|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111022065|NCT02523911|Antifoaming Agents|antifoaming agents|mesh-ancestor
111022066|NCT02523911|Emollients|emollients|mesh-ancestor
111022067|NCT02523911|Dermatologic Agents|dermatologic agents|mesh-ancestor
111022068|NCT02523911|Cathartics|cathartics|mesh-ancestor
111022069|NCT02523911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111022070|NCT03572231|Solifenacin Succinate|solifenacin succinate|mesh-list
111022071|NCT03572231|Mirabegron|mirabegron|mesh-list
111022072|NCT03572231|Tolterodine Tartrate|tolterodine tartrate|mesh-list
111022073|NCT03572231|Fesoterodine|fesoterodine|mesh-list
111022074|NCT03572231|Oxybutynin|oxybutynin|mesh-list
111022075|NCT03572231|Darifenacin|darifenacin|mesh-list
111022076|NCT03572231|Propiverine|propiverine|mesh-list
111022077|NCT03572231|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111022078|NCT03572231|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111022079|NCT03572231|Cholinergic Agents|cholinergic agents|mesh-ancestor
111022080|NCT03572231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111022081|NCT03572231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111022082|NCT03572231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111022083|NCT03572231|Urological Agents|urological agents|mesh-ancestor
111022084|NCT03572231|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
111022085|NCT03572231|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111022086|NCT03572231|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110623934|NCT00784940|Tamoxifen|tamoxifen|mesh-list
111022087|NCT03572231|Adrenergic Agents|adrenergic agents|mesh-ancestor
111022088|NCT03572231|Parasympatholytics|parasympatholytics|mesh-ancestor
111022089|NCT03572231|Autonomic Agents|autonomic agents|mesh-ancestor
111022090|NCT03572231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111022091|NCT02135029|Atorvastatin|atorvastatin|mesh-list
111022092|NCT02135029|Bococizumab|bococizumab|mesh-list
111022093|NCT02135029|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111022094|NCT02135029|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111022095|NCT02135029|Antimetabolites|antimetabolites|mesh-ancestor
111022096|NCT02135029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111022097|NCT02135029|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111022098|NCT02135029|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111022099|NCT02135029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111022100|NCT03573245|Tranexamic Acid|tranexamic acid|mesh-list
111022101|NCT03573245|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111022102|NCT03573245|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111022103|NCT03573245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111022104|NCT03573245|Hemostatics|hemostatics|mesh-ancestor
111022105|NCT03573245|Coagulants|coagulants|mesh-ancestor
111022106|NCT02241161|Bacteriocins|bacteriocins|mesh-list
111022107|NCT02241161|Antioxidants|antioxidants|mesh-list
111022108|NCT02241161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111022109|NCT02241161|Protective Agents|protective agents|mesh-ancestor
111022110|NCT02241161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111022111|NCT02241161|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111022112|NCT02241161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111022113|NCT02135263|Enalapril|enalapril|mesh-list
111022114|NCT02135263|Methylphenidate|methylphenidate|mesh-list
111022115|NCT02135263|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111022116|NCT02135263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111022117|NCT02135263|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111022118|NCT02135263|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111022119|NCT02135263|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111022120|NCT02135263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111022121|NCT02135263|Dopamine Agents|dopamine agents|mesh-ancestor
111022122|NCT02135263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111022123|NCT02135263|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
111022124|NCT02135263|Protease Inhibitors|protease inhibitors|mesh-ancestor
111022125|NCT02135263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111022126|NCT02135263|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111022127|NCT02135341|Botulinum Toxins|botulinum toxins|mesh-list
111022128|NCT02135341|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111022129|NCT02135341|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111022130|NCT02135341|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
111022131|NCT02135341|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111022132|NCT02135341|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111022133|NCT02135341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111022134|NCT02135341|Cholinergic Agents|cholinergic agents|mesh-ancestor
111022135|NCT02135341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111022136|NCT02135341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111022137|NCT02135341|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111022138|NCT02135341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111022139|NCT02239523|Denosumab|denosumab|mesh-list
111022140|NCT02239523|Teriparatide|teriparatide|mesh-list
111022141|NCT02239523|Diphosphonates|diphosphonates|mesh-list
111022142|NCT02239523|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111022143|NCT02239523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111022144|NCT02239523|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111022145|NCT02137213|Naloxone|naloxone|mesh-list
111022146|NCT02137213|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111022147|NCT02137213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111022148|NCT02137213|Sensory System Agents|sensory system agents|mesh-ancestor
111022149|NCT02137213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111022150|NCT03571919|Lidocaine|lidocaine|mesh-list
111022151|NCT03571919|Anesthetics, Local|anesthetics, local|mesh-ancestor
111022152|NCT03571919|Anesthetics|anesthetics|mesh-ancestor
111022153|NCT03571919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111022154|NCT03571919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111022155|NCT03571919|Sensory System Agents|sensory system agents|mesh-ancestor
111022156|NCT03571919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111022157|NCT03571919|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111022158|NCT03571919|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111022159|NCT03571919|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111022160|NCT03571919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111022161|NCT03571919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111022162|NCT02252809|Methylprednisolone|methylprednisolone|mesh-list
111022163|NCT02252809|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111022164|NCT02252809|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111022165|NCT02252809|Prednisolone|prednisolone|mesh-list
111022166|NCT02252809|Prednisolone acetate|prednisolone acetate|mesh-list
111022167|NCT02252809|Adalimumab|adalimumab|mesh-list
111022168|NCT02252809|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111022169|NCT02252809|Prednisolone phosphate|prednisolone phosphate|mesh-list
111022170|NCT02252809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111022171|NCT02252809|Antiemetics|antiemetics|mesh-ancestor
111022172|NCT02252809|Autonomic Agents|autonomic agents|mesh-ancestor
111022173|NCT02252809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111022174|NCT02252809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111022175|NCT02252809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111022176|NCT02252809|Glucocorticoids|glucocorticoids|mesh-ancestor
111022177|NCT02252809|Hormones|hormones|mesh-ancestor
111022178|NCT02252809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111022179|NCT02252809|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111022180|NCT02252809|Protective Agents|protective agents|mesh-ancestor
111022181|NCT02252809|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111022182|NCT02252809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111022183|NCT02252809|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111022184|NCT02252809|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111022185|NCT02137525|Fentanyl|fentanyl|mesh-list
111022186|NCT02137525|Morphine|morphine|mesh-list
111022187|NCT02137525|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111022188|NCT02137525|Narcotics|narcotics|mesh-ancestor
111022189|NCT02137525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111022190|NCT02137525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111022191|NCT02137525|Analgesics|analgesics|mesh-ancestor
111022192|NCT02137525|Sensory System Agents|sensory system agents|mesh-ancestor
111022193|NCT02137525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111022194|NCT02137525|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110487237|NCT04288700|Timolol|timolol|mesh-list
111022195|NCT02137525|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111022196|NCT02137525|Anesthetics, General|anesthetics, general|mesh-ancestor
111022197|NCT02137525|Anesthetics|anesthetics|mesh-ancestor
111022198|NCT02137681|Rituximab|rituximab|mesh-list
111022199|NCT02137681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111022200|NCT02137681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111022201|NCT02137681|Immunologic Factors|immunologic factors|mesh-ancestor
111022202|NCT02137681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111022203|NCT02137681|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111022204|NCT02842073|Naltrexone|naltrexone|mesh-list
111022205|NCT02842073|Bupropion|bupropion|mesh-list
111022206|NCT02842073|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111022207|NCT02842073|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111022208|NCT02842073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111022209|NCT02842073|Sensory System Agents|sensory system agents|mesh-ancestor
111022210|NCT02842073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110623964|NCT00785018|Immunologic Factors|immunologic factors|mesh-ancestor
111022211|NCT02842073|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111022212|NCT02842073|Antidepressive Agents|antidepressive agents|mesh-ancestor
111022213|NCT02842073|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111022214|NCT02842073|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111022215|NCT02842073|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111022216|NCT02842073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111022217|NCT02842073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111022218|NCT02842073|Dopamine Agents|dopamine agents|mesh-ancestor
111022219|NCT02842073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111022220|NCT02842073|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111022221|NCT02842073|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111022222|NCT02842073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111022224|NCT02135887|Folic Acid|folic acid|mesh-list
111022225|NCT02135887|Fluorouracil|fluorouracil|mesh-list
111022226|NCT02135887|Oxaliplatin|oxaliplatin|mesh-list
111022227|NCT02135887|Levoleucovorin|levoleucovorin|mesh-list
111022228|NCT02135887|Antimetabolites|antimetabolites|mesh-ancestor
111022229|NCT02135887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111022230|NCT02135887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111022231|NCT02135887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111022232|NCT02135887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111022233|NCT02135887|Immunologic Factors|immunologic factors|mesh-ancestor
111022234|NCT02135887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111022235|NCT02135887|Antidotes|antidotes|mesh-ancestor
111022236|NCT02135887|Protective Agents|protective agents|mesh-ancestor
111022237|NCT02135887|Vitamin B Complex|vitamin b complex|mesh-ancestor
111022238|NCT02135887|Vitamins|vitamins|mesh-ancestor
111022239|NCT02135887|Micronutrients|micronutrients|mesh-ancestor
111022240|NCT02135887|Hematinics|hematinics|mesh-ancestor
111022241|NCT02137993|Olanzapine|olanzapine|mesh-list
111022242|NCT02137993|Antiemetics|antiemetics|mesh-ancestor
111022243|NCT02137993|Autonomic Agents|autonomic agents|mesh-ancestor
111022244|NCT02137993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111022245|NCT02137993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111022246|NCT02137993|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111022247|NCT02137993|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111022248|NCT02137993|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111022249|NCT02137993|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111022250|NCT02137993|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111022251|NCT02137993|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111022252|NCT02137993|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111022253|NCT02137993|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111022254|NCT02137993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111022255|NCT02137993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111022256|NCT02137993|Serotonin Agents|serotonin agents|mesh-ancestor
111022257|NCT02245841|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
111022258|NCT02245841|Hormones|hormones|mesh-ancestor
111022259|NCT02245841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111022260|NCT02245841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111022261|NCT05709041|Anesthetics|anesthetics|mesh-list
111022262|NCT05709041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111022263|NCT05709041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111022265|NCT03570281|Edoxaban|edoxaban|mesh-list
111022266|NCT03570281|Anticoagulants|anticoagulants|mesh-ancestor
111022267|NCT03570281|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111022268|NCT03570281|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110623976|NCT00534352|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111022269|NCT03570281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111022270|NCT03570281|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111022271|NCT03570281|Antithrombins|antithrombins|mesh-ancestor
111022272|NCT03570281|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111022273|NCT03570281|Protease Inhibitors|protease inhibitors|mesh-ancestor
111022274|NCT03570281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111022275|NCT02242799|Artesunate|artesunate|mesh-list
111022276|NCT02242799|Lumefantrine|lumefantrine|mesh-list
111022277|NCT02242799|Artemether|artemether|mesh-list
111022278|NCT02242799|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
111022279|NCT02242799|Amodiaquine|amodiaquine|mesh-list
111022280|NCT02242799|Dolutegravir|dolutegravir|mesh-list
111022281|NCT02242799|Antimalarials|antimalarials|mesh-ancestor
111022282|NCT02242799|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111022283|NCT02242799|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111022284|NCT02242799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111022285|NCT02242799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111022286|NCT02242799|Antiviral Agents|antiviral agents|mesh-ancestor
111022287|NCT02242799|Schistosomicides|schistosomicides|mesh-ancestor
111022288|NCT02242799|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
111022289|NCT02242799|Anthelmintics|anthelmintics|mesh-ancestor
111022290|NCT02242799|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111022291|NCT02242799|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111022292|NCT02242799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111022293|NCT02242799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111022294|NCT02242799|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111022295|NCT02242799|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111022296|NCT02138383|Paclitaxel|paclitaxel|mesh-list
111022297|NCT02138383|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111022298|NCT02138383|Gemcitabine|gemcitabine|mesh-list
111022299|NCT02138383|Androgens|androgens|mesh-list
111022300|NCT02138383|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111022301|NCT02138383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111022302|NCT02138383|Tubulin Modulators|tubulin modulators|mesh-ancestor
111022303|NCT02138383|Antimitotic Agents|antimitotic agents|mesh-ancestor
111022304|NCT02138383|Mitosis Modulators|mitosis modulators|mesh-ancestor
111022305|NCT02138383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111022306|NCT02138383|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111022307|NCT02138383|Antimetabolites|antimetabolites|mesh-ancestor
111022308|NCT02138383|Hormones|hormones|mesh-ancestor
111022309|NCT02138383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111022310|NCT02138383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111022311|NCT02243735|Ferrous fumarate|ferrous fumarate|mesh-list
111022312|NCT02243735|Trace Elements|trace elements|mesh-ancestor
111022313|NCT02243735|Micronutrients|micronutrients|mesh-ancestor
111022314|NCT02243735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111022315|NCT02138539|Hydroquinone|hydroquinone|mesh-list
111022316|NCT02138539|Antioxidants|antioxidants|mesh-ancestor
111022317|NCT02138539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111022318|NCT02138539|Protective Agents|protective agents|mesh-ancestor
111022319|NCT02138539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111022320|NCT02138539|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111022321|NCT02252419|Acetaminophen|acetaminophen|mesh-list
111022322|NCT02252419|Dexamethasone|dexamethasone|mesh-list
111022323|NCT02252419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111022324|NCT02252419|Antiemetics|antiemetics|mesh-ancestor
111022325|NCT02252419|Autonomic Agents|autonomic agents|mesh-ancestor
111022326|NCT02252419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111022327|NCT02252419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111022328|NCT02252419|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111022329|NCT02252419|Glucocorticoids|glucocorticoids|mesh-ancestor
111022330|NCT02252419|Hormones|hormones|mesh-ancestor
111022331|NCT02252419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111022332|NCT02252419|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111022333|NCT02252419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111022334|NCT02252419|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111022335|NCT02252419|Analgesics|analgesics|mesh-ancestor
111022336|NCT02252419|Sensory System Agents|sensory system agents|mesh-ancestor
111022337|NCT02252419|Antipyretics|antipyretics|mesh-ancestor
111022338|NCT02252497|Tranexamic Acid|tranexamic acid|mesh-list
110739444|NCT01052597|Curcumin|curcumin|mesh-list
111022339|NCT02252497|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111022340|NCT02252497|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111022341|NCT02252497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111022342|NCT02252497|Hemostatics|hemostatics|mesh-ancestor
111022343|NCT02252497|Coagulants|coagulants|mesh-ancestor
111022345|NCT02138773|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111022346|NCT02138773|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111022347|NCT02138773|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111022348|NCT02138773|Adrenergic Agents|adrenergic agents|mesh-ancestor
111022349|NCT02138773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111022350|NCT02138773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111022351|NCT02138773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111022352|NCT02138773|Urological Agents|urological agents|mesh-ancestor
111022353|NCT01367275|Irinotecan|irinotecan|mesh-list
111022354|NCT01367275|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111022355|NCT01367275|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111022356|NCT01367275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111022357|NCT01367275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111022358|NCT01367275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111022359|NCT02138929|Everolimus|everolimus|mesh-list
111022360|NCT02138929|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111022361|NCT02138929|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111022362|NCT02138929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111022363|NCT02138929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111022364|NCT02138929|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111022365|NCT02138929|Immunologic Factors|immunologic factors|mesh-ancestor
111022366|NCT02138929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111022367|NCT02138929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111022368|NCT02253199|Dexmedetomidine|dexmedetomidine|mesh-list
111022369|NCT02253199|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111022370|NCT02253199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111022371|NCT02253199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111022372|NCT02253199|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111022373|NCT02253199|Analgesics|analgesics|mesh-ancestor
111022374|NCT02253199|Sensory System Agents|sensory system agents|mesh-ancestor
111022375|NCT02253199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111022376|NCT02253199|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111022377|NCT02253199|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111022378|NCT02253199|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111022379|NCT02253199|Adrenergic Agents|adrenergic agents|mesh-ancestor
111022380|NCT02253199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111022381|NCT02253199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111022382|NCT02842853|Vaccines|vaccines|mesh-list
111022383|NCT02842853|Immunologic Factors|immunologic factors|mesh-ancestor
111022384|NCT02842853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111022385|NCT02139241|Ramosetron|ramosetron|mesh-list
111022386|NCT02139241|Antiemetics|antiemetics|mesh-ancestor
111022387|NCT02139241|Autonomic Agents|autonomic agents|mesh-ancestor
111022388|NCT02139241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111022389|NCT02139241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111022390|NCT02139241|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111022391|NCT02139241|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111022392|NCT02139241|Serotonin Agents|serotonin agents|mesh-ancestor
111022393|NCT02139241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111022394|NCT02139241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111022395|NCT03569579|Memantine|memantine|mesh-list
111022396|NCT03569579|Donepezil|donepezil|mesh-list
111022397|NCT03569579|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111022398|NCT03569579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111022399|NCT03569579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111022400|NCT03569579|Cholinergic Agents|cholinergic agents|mesh-ancestor
111022401|NCT03569579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111022402|NCT03569579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111022403|NCT03569579|Nootropic Agents|nootropic agents|mesh-ancestor
111022404|NCT03569579|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111022405|NCT03569579|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111022406|NCT03569579|Dopamine Agents|dopamine agents|mesh-ancestor
111022407|NCT03569579|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111022408|NCT03569579|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111022409|NCT02130661|Itraconazole|itraconazole|mesh-list
111022410|NCT02130661|Antifungal Agents|antifungal agents|mesh-ancestor
111022411|NCT02130661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111022412|NCT02130661|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111022413|NCT02130661|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110739533|NCT00063258|Paclitaxel|paclitaxel|mesh-list
111022415|NCT02130661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111022416|NCT02130661|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111022417|NCT02130661|Hormone Antagonists|hormone antagonists|mesh-ancestor
111022418|NCT02130661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110487462|NCT02567773|Anabolic Agents|anabolic agents|mesh-ancestor
111022419|NCT02130661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111022420|NCT02130661|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111022421|NCT02130739|Fentanyl|fentanyl|mesh-list
111022422|NCT02130739|Propofol|propofol|mesh-list
111022423|NCT02130739|Ropivacaine|ropivacaine|mesh-list
111022424|NCT02130739|Anesthetics|anesthetics|mesh-ancestor
111022425|NCT02130739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111022426|NCT02130739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111022427|NCT02130739|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111022428|NCT02130739|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111022429|NCT02130739|Anesthetics, General|anesthetics, general|mesh-ancestor
111022430|NCT02130739|Anesthetics, Local|anesthetics, local|mesh-ancestor
111022431|NCT02130739|Sensory System Agents|sensory system agents|mesh-ancestor
111022432|NCT02130739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111022433|NCT02130739|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111022434|NCT02130739|Narcotics|narcotics|mesh-ancestor
111022435|NCT02130739|Analgesics|analgesics|mesh-ancestor
111022436|NCT02130739|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111022437|NCT02248493|Acetaminophen|acetaminophen|mesh-list
111022438|NCT02248493|Ketoprofen|ketoprofen|mesh-list
111022439|NCT02248493|Morphine|morphine|mesh-list
111022440|NCT02248493|Tramadol|tramadol|mesh-list
111022441|NCT02248493|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111022442|NCT02248493|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111022443|NCT02248493|Narcotics|narcotics|mesh-ancestor
111022444|NCT02248493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111022445|NCT02248493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111022446|NCT02248493|Analgesics|analgesics|mesh-ancestor
111022447|NCT02248493|Sensory System Agents|sensory system agents|mesh-ancestor
111022448|NCT02248493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111022449|NCT02248493|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111022450|NCT02248493|Antipyretics|antipyretics|mesh-ancestor
111022451|NCT02248493|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111022452|NCT02248493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111022453|NCT02248493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111022454|NCT02248493|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111022455|NCT02248493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111022456|NCT02248493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111022457|NCT05577871|Dexmedetomidine|dexmedetomidine|mesh-list
111022458|NCT05577871|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111022459|NCT05577871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111022460|NCT05577871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111022461|NCT05577871|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111022462|NCT05577871|Analgesics|analgesics|mesh-ancestor
111022463|NCT05577871|Sensory System Agents|sensory system agents|mesh-ancestor
111022464|NCT05577871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111022465|NCT05577871|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111022466|NCT05577871|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111022467|NCT05577871|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111022468|NCT05577871|Adrenergic Agents|adrenergic agents|mesh-ancestor
111022469|NCT05577871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111022470|NCT05577871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111022471|NCT02130817|Mycophenolic Acid|mycophenolic acid|mesh-list
111022472|NCT02130817|Dexamethasone|dexamethasone|mesh-list
111022473|NCT02130817|Prednisone|prednisone|mesh-list
111022474|NCT02130817|Abatacept|abatacept|mesh-list
111022475|NCT02130817|Tacrolimus|tacrolimus|mesh-list
111022476|NCT02130817|Thymoglobulin|thymoglobulin|mesh-list
111022477|NCT02130817|Antilymphocyte Serum|antilymphocyte serum|mesh-list
111022478|NCT02130817|Immunoglobulins|immunoglobulins|mesh-list
111022479|NCT02130817|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111022480|NCT02130817|Immunoglobulin G|immunoglobulin g|mesh-list
111022481|NCT02130817|gamma-Globulins|gamma-globulins|mesh-list
111022482|NCT02130817|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
111022483|NCT02130817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111022484|NCT02130817|Antiemetics|antiemetics|mesh-ancestor
111022485|NCT02130817|Autonomic Agents|autonomic agents|mesh-ancestor
111022486|NCT02130817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111022487|NCT02130817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111022488|NCT02130817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111022489|NCT02130817|Glucocorticoids|glucocorticoids|mesh-ancestor
111022490|NCT02130817|Hormones|hormones|mesh-ancestor
111022491|NCT02130817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111022492|NCT02130817|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111022493|NCT02130817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111022494|NCT02130817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111022495|NCT02130817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111022496|NCT02130817|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111022497|NCT02130817|Immunologic Factors|immunologic factors|mesh-ancestor
111022498|NCT02130817|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111022499|NCT02130817|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111022500|NCT02130817|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111022501|NCT02130817|Antitubercular Agents|antitubercular agents|mesh-ancestor
111022502|NCT02130817|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111022503|NCT02130817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111022504|NCT02130817|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111022505|NCT02130817|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111022506|NCT02130817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111022507|NCT02400346|Brexpiprazole|brexpiprazole|mesh-list
111022508|NCT02400346|Serotonin Agents|serotonin agents|mesh-ancestor
111022509|NCT02400346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111022510|NCT02400346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111022511|NCT02400346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111022512|NCT02400346|Dopamine Agonists|dopamine agonists|mesh-ancestor
111022513|NCT02400346|Dopamine Agents|dopamine agents|mesh-ancestor
111022514|NCT02130973|Denosumab|denosumab|mesh-list
111022515|NCT02130973|Teriparatide|teriparatide|mesh-list
111022516|NCT02130973|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111022517|NCT02130973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111022518|NCT02130973|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111022519|NCT02456662|Ondansetron|ondansetron|mesh-list
111022520|NCT02456662|Antiemetics|antiemetics|mesh-ancestor
111022521|NCT02456662|Autonomic Agents|autonomic agents|mesh-ancestor
111022522|NCT02456662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111022523|NCT02456662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111022524|NCT02456662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111022525|NCT02456662|Antipruritics|antipruritics|mesh-ancestor
111022526|NCT02456662|Dermatologic Agents|dermatologic agents|mesh-ancestor
111022527|NCT02456662|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111022528|NCT02456662|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111022529|NCT02456662|Serotonin Agents|serotonin agents|mesh-ancestor
111022530|NCT02456662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111022531|NCT02456662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111022532|NCT03548311|Vitamin B 12|vitamin b 12|mesh-list
111022533|NCT03548311|Vitamin B Complex|vitamin b complex|mesh-ancestor
111022534|NCT03548311|Vitamins|vitamins|mesh-ancestor
111022535|NCT03548311|Micronutrients|micronutrients|mesh-ancestor
111022536|NCT03548311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111022537|NCT01653262|Brivaracetam|brivaracetam|mesh-list
111022538|NCT01653262|Anticonvulsants|anticonvulsants|mesh-ancestor
111022539|NCT02455336|Fenofibrate|fenofibrate|mesh-list
111022540|NCT02455336|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111022541|NCT02455336|Antimetabolites|antimetabolites|mesh-ancestor
111022542|NCT02455336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111022543|NCT02455336|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111022544|NCT02253121|Insulin|insulin|mesh-list
111022545|NCT02253121|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111022546|NCT02253121|Dapagliflozin|dapagliflozin|mesh-list
111022547|NCT02253121|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111022548|NCT02253121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111022549|NCT02253121|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111022550|NCT02253121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111022551|NCT03548233|BCG Vaccine|bcg vaccine|mesh-list
111022552|NCT03548233|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111022553|NCT03548233|Immunologic Factors|immunologic factors|mesh-ancestor
111022554|NCT03548233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111022555|NCT03568721|Acetaminophen|acetaminophen|mesh-list
111022556|NCT03568721|Ibuprofen|ibuprofen|mesh-list
111022557|NCT03568721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111022558|NCT03568721|Analgesics|analgesics|mesh-ancestor
111022559|NCT03568721|Sensory System Agents|sensory system agents|mesh-ancestor
111022560|NCT03568721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111022561|NCT03568721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111022562|NCT03568721|Antipyretics|antipyretics|mesh-ancestor
111022563|NCT03568721|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111022564|NCT03568721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111022565|NCT03568721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111022566|NCT03568721|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111022568|NCT03568721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111022569|NCT05354375|Immunomodulating Agents|immunomodulating agents|mesh-list
111022570|NCT05354375|Immunologic Factors|immunologic factors|mesh-ancestor
111022571|NCT05354375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111022572|NCT03566303|Vitamin K|vitamin k|mesh-list
111022573|NCT03566303|Warfarin|warfarin|mesh-list
111022574|NCT03566303|Rivaroxaban|rivaroxaban|mesh-list
111022575|NCT03566303|Vitamins|vitamins|mesh-ancestor
111022576|NCT03566303|Micronutrients|micronutrients|mesh-ancestor
111022577|NCT03566303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111022578|NCT03566303|Anticoagulants|anticoagulants|mesh-ancestor
111022579|NCT03566303|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111022580|NCT03566303|Antithrombins|antithrombins|mesh-ancestor
111022581|NCT03566303|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111022582|NCT03566303|Protease Inhibitors|protease inhibitors|mesh-ancestor
111022583|NCT03566303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111022584|NCT03566303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111022585|NCT03566303|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111022586|NCT03566303|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111022587|NCT03566303|Hemostatics|hemostatics|mesh-ancestor
111022588|NCT03566303|Coagulants|coagulants|mesh-ancestor
111022589|NCT02140333|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111022590|NCT02140333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111022591|NCT02140333|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111022592|NCT02140333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111022593|NCT02140333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111022594|NCT05936528|Lactoferrin|lactoferrin|mesh-list
111022595|NCT05936528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111022596|NCT05936216|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
111022597|NCT05936216|Immunologic Factors|immunologic factors|mesh-ancestor
111022598|NCT05936216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111022599|NCT05936190|Lidocaine|lidocaine|mesh-list
111022600|NCT05936190|Anesthetics, Local|anesthetics, local|mesh-ancestor
111022601|NCT05936190|Anesthetics|anesthetics|mesh-ancestor
111022602|NCT05936190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111022603|NCT05936190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111022604|NCT05936190|Sensory System Agents|sensory system agents|mesh-ancestor
111022605|NCT05936190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111022606|NCT05936190|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111022607|NCT05936190|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111022608|NCT05936190|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111022609|NCT05936190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111022610|NCT05936190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111022611|NCT05936060|Plasma-lyte 148|plasma-lyte 148|mesh-list
111022612|NCT05936060|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
111022613|NCT05936060|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111022614|NCT05936021|Darbepoetin alfa|darbepoetin alfa|mesh-list
111022615|NCT05936021|Hematinics|hematinics|mesh-ancestor
111022616|NCT05935917|Brincidofovir|brincidofovir|mesh-list
111022617|NCT05935917|Antiviral Agents|antiviral agents|mesh-ancestor
111022618|NCT05935917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111022619|NCT05935579|Durvalumab|durvalumab|mesh-list
111022620|NCT05935579|Lenvatinib|lenvatinib|mesh-list
111022621|NCT05935579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111022622|NCT05935579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111022623|NCT05935579|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111022624|NCT05935579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111022625|NCT05935579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111022626|NCT05935553|Baclofen|baclofen|mesh-list
111022627|NCT05935553|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
111022628|NCT05935553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111022629|NCT05935553|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111022630|NCT05935553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111022631|NCT05935553|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
111022632|NCT05935553|GABA Agonists|gaba agonists|mesh-ancestor
111022633|NCT05935553|GABA Agents|gaba agents|mesh-ancestor
111022634|NCT05935553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111022635|NCT05935553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111022636|NCT05935449|Lidocaine|lidocaine|mesh-list
111022637|NCT05935449|Anesthetics, Local|anesthetics, local|mesh-ancestor
111022638|NCT05935449|Anesthetics|anesthetics|mesh-ancestor
111022639|NCT05935449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111022640|NCT05935449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110739747|NCT05627648|Mitogens|mitogens|mesh-list
111022641|NCT05935449|Sensory System Agents|sensory system agents|mesh-ancestor
111022642|NCT05935449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111022643|NCT05935449|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111119147|NCT05323617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111022644|NCT05935449|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111022645|NCT05935449|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111022646|NCT05935449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111022647|NCT05935449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111022648|NCT05935293|Dexmedetomidine|dexmedetomidine|mesh-list
111022649|NCT05935293|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111022650|NCT05935293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111022651|NCT05935293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111022652|NCT05935293|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111022653|NCT05935293|Analgesics|analgesics|mesh-ancestor
111022654|NCT05935293|Sensory System Agents|sensory system agents|mesh-ancestor
111022655|NCT05935293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111022656|NCT05935293|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111022657|NCT05935293|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111022658|NCT05935293|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111022659|NCT05935293|Adrenergic Agents|adrenergic agents|mesh-ancestor
111022660|NCT05935293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111022661|NCT05935293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111022662|NCT05935280|Lidocaine|lidocaine|mesh-list
111022663|NCT05935280|Sodium Channel Blockers|sodium channel blockers|mesh-list
111022664|NCT05935280|Anesthetics, Local|anesthetics, local|mesh-ancestor
111022665|NCT05935280|Anesthetics|anesthetics|mesh-ancestor
111022666|NCT05935280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111022667|NCT05935280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111022668|NCT05935280|Sensory System Agents|sensory system agents|mesh-ancestor
111022669|NCT05935280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111022670|NCT05935280|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111022671|NCT05935280|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111022672|NCT05935280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111022673|NCT05935280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111022674|NCT05934812|Oxytocin|oxytocin|mesh-list
111022675|NCT05934812|Oxytocics|oxytocics|mesh-ancestor
111022676|NCT05934812|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111022677|NCT05934812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111022678|NCT05934799|Clopidogrel|clopidogrel|mesh-list
111022679|NCT05934799|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111022680|NCT05934799|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111022681|NCT05934799|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111022682|NCT05934799|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111022683|NCT05934799|Purinergic Agents|purinergic agents|mesh-ancestor
111022684|NCT05934799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111022685|NCT05934799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111022686|NCT05934799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111022687|NCT05934669|Midazolam|midazolam|mesh-list
111022688|NCT05934669|Dexmedetomidine|dexmedetomidine|mesh-list
111022689|NCT05934669|Ketamine|ketamine|mesh-list
111022690|NCT05934669|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111022691|NCT05934669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111022692|NCT05934669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111022693|NCT05934669|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111022694|NCT05934669|Analgesics|analgesics|mesh-ancestor
111022695|NCT05934669|Sensory System Agents|sensory system agents|mesh-ancestor
111022696|NCT05934669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111022697|NCT05934669|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111022698|NCT05934669|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111022699|NCT05934669|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111022700|NCT05934669|Adrenergic Agents|adrenergic agents|mesh-ancestor
111022701|NCT05934669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111022702|NCT05934669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111022703|NCT05934669|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111022704|NCT05934669|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111022705|NCT05934669|Anesthetics, General|anesthetics, general|mesh-ancestor
111022706|NCT05934669|Anesthetics|anesthetics|mesh-ancestor
111022707|NCT05934669|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111022708|NCT05934669|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111022709|NCT05934669|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111022710|NCT05934669|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111022711|NCT05934669|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111022712|NCT05934669|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111022714|NCT05934669|GABA Agents|gaba agents|mesh-ancestor
111022715|NCT05934552|Lactulose|lactulose|mesh-list
111022716|NCT05934552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111022717|NCT05934448|Cyclophosphamide|cyclophosphamide|mesh-list
111022718|NCT05934448|Pembrolizumab|pembrolizumab|mesh-list
111022719|NCT05934448|Fludarabine|fludarabine|mesh-list
111022720|NCT05934448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111022721|NCT05934448|Immunologic Factors|immunologic factors|mesh-ancestor
111022722|NCT05934448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111022723|NCT05934448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111022724|NCT05934448|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111022725|NCT05934448|Alkylating Agents|alkylating agents|mesh-ancestor
111022726|NCT05934448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111022727|NCT05934448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111022728|NCT05934448|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111022729|NCT05934448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111022730|NCT05934448|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111022731|NCT05934409|Niacin|niacin|mesh-list
111022732|NCT05934409|Nicotinic Acids|nicotinic acids|mesh-list
111022733|NCT05934409|Niacinamide|niacinamide|mesh-list
111022734|NCT05934409|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111022735|NCT05934409|Antimetabolites|antimetabolites|mesh-ancestor
111022736|NCT05934409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111022737|NCT05934409|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111022738|NCT05934409|Vasodilator Agents|vasodilator agents|mesh-ancestor
111022739|NCT05934409|Vitamin B Complex|vitamin b complex|mesh-ancestor
111022740|NCT05934409|Vitamins|vitamins|mesh-ancestor
111022741|NCT05934409|Micronutrients|micronutrients|mesh-ancestor
111022742|NCT05934409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111022743|NCT05933538|Cariprazine|cariprazine|mesh-list
111022744|NCT05933538|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111022745|NCT05933538|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111022746|NCT05933538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111022747|NCT05933538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111022748|NCT05933538|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111022749|NCT05932238|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111022750|NCT05932199|Carboplatin|carboplatin|mesh-list
111022751|NCT05932199|Pemetrexed|pemetrexed|mesh-list
111022752|NCT05932199|Durvalumab|durvalumab|mesh-list
111022753|NCT05932199|Tremelimumab|tremelimumab|mesh-list
111022754|NCT05932199|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111022755|NCT05932199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111022756|NCT05932199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111022757|NCT05932199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111022758|NCT05932199|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111022759|NCT05932199|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111022760|NCT05932199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111022761|NCT05932199|Immunologic Factors|immunologic factors|mesh-ancestor
111022762|NCT05932199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111022763|NCT05924776|Immunomodulating Agents|immunomodulating agents|mesh-list
111022764|NCT05924776|Immunologic Factors|immunologic factors|mesh-ancestor
111022765|NCT05924776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111022766|NCT05922124|Meropenem|meropenem|mesh-list
111022767|NCT05922124|Colistin|colistin|mesh-list
111022768|NCT05922124|Ampicillin|ampicillin|mesh-list
111022769|NCT05922124|Sulbactam|sulbactam|mesh-list
111022770|NCT05922124|Sultamicillin|sultamicillin|mesh-list
111022771|NCT05922124|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111022772|NCT05922124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111022773|NCT05922124|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
111022774|NCT05922124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111022775|NCT05922124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111022776|NCT05919888|Povidone-Iodine|povidone-iodine|mesh-list
111022777|NCT05919888|Povidone|povidone|mesh-list
111022778|NCT05919888|Plasma Substitutes|plasma substitutes|mesh-ancestor
111022779|NCT05919888|Blood Substitutes|blood substitutes|mesh-ancestor
111022780|NCT05919888|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111022781|NCT05919888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111022782|NCT05916053|Vitamin D|vitamin d|mesh-list
111022783|NCT05916053|Vitamins|vitamins|mesh-ancestor
111022784|NCT05916053|Micronutrients|micronutrients|mesh-ancestor
111022785|NCT05916053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110739898|NCT01102478|Losartan|losartan|mesh-list
111022786|NCT05916053|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111022787|NCT05901519|Prednisone|prednisone|mesh-list
111022788|NCT05901519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111022789|NCT05901519|Glucocorticoids|glucocorticoids|mesh-ancestor
111022790|NCT05901519|Hormones|hormones|mesh-ancestor
110827128|NCT01167049|Antimetabolites|antimetabolites|mesh-ancestor
111022792|NCT05901519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111022793|NCT05901519|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111022794|NCT05901519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111022795|NCT05892393|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
111022796|NCT05892393|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111022797|NCT05892393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111022798|NCT05880849|Choline|choline|mesh-list
111022799|NCT05880849|Lipotropic Agents|lipotropic agents|mesh-ancestor
111022800|NCT05880849|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111022801|NCT05880849|Antimetabolites|antimetabolites|mesh-ancestor
111022802|NCT05880849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111022803|NCT05880849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111022804|NCT05880849|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111022805|NCT05880849|Nootropic Agents|nootropic agents|mesh-ancestor
111022806|NCT05879419|Benzocaine|benzocaine|mesh-list
111022807|NCT05879419|Anesthetics, Local|anesthetics, local|mesh-ancestor
111022808|NCT05879419|Anesthetics|anesthetics|mesh-ancestor
111022809|NCT05879419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111022810|NCT05879419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111022811|NCT05879419|Sensory System Agents|sensory system agents|mesh-ancestor
111022812|NCT05879419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111022813|NCT05878691|Pembrolizumab|pembrolizumab|mesh-list
111022814|NCT05878691|Atezolizumab|atezolizumab|mesh-list
111022815|NCT05878691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111022816|NCT05878691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111022817|NCT05878691|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111022818|NCT05878691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111022819|NCT05825391|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
111022820|NCT05820594|BCG Vaccine|bcg vaccine|mesh-list
111022821|NCT05820594|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111022822|NCT05820594|Immunologic Factors|immunologic factors|mesh-ancestor
111022823|NCT05820594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111022824|NCT05790499|Atorvastatin|atorvastatin|mesh-list
111022825|NCT05790499|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111022826|NCT05790499|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111022827|NCT05790499|Antimetabolites|antimetabolites|mesh-ancestor
111022828|NCT05790499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111022829|NCT05790499|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110799539|NCT05320107|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111022830|NCT05790499|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111022831|NCT05790499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111022832|NCT05785065|Mycophenolic Acid|mycophenolic acid|mesh-list
111022833|NCT05785065|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111022834|NCT05785065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111022835|NCT05785065|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111022836|NCT05785065|Antitubercular Agents|antitubercular agents|mesh-ancestor
111022837|NCT05785065|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111022838|NCT05785065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111022839|NCT05785065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111022840|NCT05785065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111022841|NCT05775380|Pioglitazone|pioglitazone|mesh-list
111022842|NCT05775380|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111022843|NCT05775380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111022844|NCT05772169|Mifepristone|mifepristone|mesh-list
111022845|NCT05772169|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
111022846|NCT05772169|Abortifacient Agents|abortifacient agents|mesh-ancestor
111022847|NCT05772169|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111022848|NCT05772169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111022849|NCT05772169|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111022850|NCT05772169|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111022851|NCT05772169|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111022852|NCT05772169|Contraceptive Agents|contraceptive agents|mesh-ancestor
111022853|NCT05772169|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
111022854|NCT05772169|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
111022855|NCT05772169|Hormone Antagonists|hormone antagonists|mesh-ancestor
111022856|NCT05772169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111022857|NCT05772169|Luteolytic Agents|luteolytic agents|mesh-ancestor
111022858|NCT05772169|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111022859|NCT05772169|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
111022860|NCT05714007|Ferrous succinate|ferrous succinate|mesh-list
111022861|NCT05714007|Hematinics|hematinics|mesh-ancestor
111022866|NCT05643170|Trospium chloride|trospium chloride|mesh-list
111022867|NCT05643170|Parasympatholytics|parasympatholytics|mesh-ancestor
111022868|NCT05643170|Autonomic Agents|autonomic agents|mesh-ancestor
111022869|NCT05643170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111022870|NCT05643170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111022871|NCT05643170|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111022872|NCT05643170|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111022873|NCT05643170|Cholinergic Agents|cholinergic agents|mesh-ancestor
111022874|NCT05643170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111022875|NCT05643170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111022876|NCT05643170|Urological Agents|urological agents|mesh-ancestor
111022877|NCT05643170|Parasympathomimetics|parasympathomimetics|mesh-ancestor
111022878|NCT05643170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111022879|NCT05643170|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
111022880|NCT05643170|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111022881|NCT05635916|Bupivacaine|bupivacaine|mesh-list
111022882|NCT05635916|Anesthetics, Local|anesthetics, local|mesh-ancestor
111022883|NCT05635916|Anesthetics|anesthetics|mesh-ancestor
111022884|NCT05635916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111022885|NCT05635916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111022886|NCT05635916|Sensory System Agents|sensory system agents|mesh-ancestor
111022887|NCT05635916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111022888|NCT05633771|Adalimumab|adalimumab|mesh-list
111022889|NCT05633771|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111022890|NCT05633771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111022891|NCT05633771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111022892|NCT05633381|Temozolomide|temozolomide|mesh-list
111022893|NCT05633381|Trabectedin|trabectedin|mesh-list
111022894|NCT05633381|Olaparib|olaparib|mesh-list
111022895|NCT05633381|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111022896|NCT05633381|Alkylating Agents|alkylating agents|mesh-ancestor
111022897|NCT05633381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111022898|NCT05633381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111022899|NCT05633381|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111022900|NCT05633381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111022901|NCT05613062|Oren gedoku to|oren gedoku to|mesh-list
111022902|NCT05613062|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111022903|NCT05613062|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111022904|NCT05613062|Analgesics|analgesics|mesh-ancestor
111022905|NCT05613062|Sensory System Agents|sensory system agents|mesh-ancestor
111022906|NCT05613062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111022907|NCT05613062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111022908|NCT05613062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111022909|NCT05613062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111022910|NCT05600322|Aminolevulinic Acid|aminolevulinic acid|mesh-list
111022911|NCT05600322|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111022912|NCT05600322|Dermatologic Agents|dermatologic agents|mesh-ancestor
111022913|NCT05576350|Ethanol|ethanol|mesh-list
111022914|NCT05576350|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111022915|NCT05576350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111022916|NCT05576350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111022917|NCT05576350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111022918|NCT05511415|Dexmedetomidine|dexmedetomidine|mesh-list
111022919|NCT05511415|Oxytocin|oxytocin|mesh-list
111022920|NCT05511415|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111022921|NCT05511415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111022922|NCT05511415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111022923|NCT05511415|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111022924|NCT05511415|Analgesics|analgesics|mesh-ancestor
111022925|NCT05511415|Sensory System Agents|sensory system agents|mesh-ancestor
111022926|NCT05511415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111022927|NCT05511415|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111022928|NCT05511415|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111022929|NCT05511415|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111022930|NCT05511415|Adrenergic Agents|adrenergic agents|mesh-ancestor
111022931|NCT05511415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111022932|NCT05511415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111022933|NCT05511415|Oxytocics|oxytocics|mesh-ancestor
111022934|NCT05511415|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111022935|NCT05485012|Analgesics, Opioid|analgesics, opioid|mesh-list
111022936|NCT05485012|Narcotics|narcotics|mesh-ancestor
111022937|NCT05485012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111022938|NCT05485012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111022939|NCT05485012|Analgesics|analgesics|mesh-ancestor
111022940|NCT05485012|Sensory System Agents|sensory system agents|mesh-ancestor
111022941|NCT05485012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111022942|NCT05457959|Poly I-C|poly i-c|mesh-list
111022943|NCT05457959|Nivolumab|nivolumab|mesh-list
111022944|NCT05457959|Ipilimumab|ipilimumab|mesh-list
111022945|NCT05457959|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
111022946|NCT05457959|Vaccines|vaccines|mesh-list
111022947|NCT05457959|Poly ICLC|poly iclc|mesh-list
111022948|NCT05457959|Immunologic Factors|immunologic factors|mesh-ancestor
111022949|NCT05457959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111022950|NCT05457959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111022951|NCT05457959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111022952|NCT05457959|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111022953|NCT05457959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111022954|NCT05457959|Interferon Inducers|interferon inducers|mesh-ancestor
111022955|NCT05457959|Laxatives|laxatives|mesh-ancestor
111022956|NCT05457959|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111022957|NCT05457959|Antiviral Agents|antiviral agents|mesh-ancestor
111022958|NCT05457959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111022959|NCT05422612|Fluoxetine|fluoxetine|mesh-list
111022960|NCT05422612|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
111022961|NCT05422612|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111022962|NCT05422612|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111022963|NCT05422612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111022964|NCT05422612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111022965|NCT05422612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111022966|NCT05422612|Serotonin Agents|serotonin agents|mesh-ancestor
111022967|NCT05422612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111022968|NCT05422612|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111022969|NCT05422612|Antidepressive Agents|antidepressive agents|mesh-ancestor
111022970|NCT05422612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111022971|NCT05422612|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111022972|NCT05422612|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111022973|NCT05422612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111022974|NCT05422612|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111022975|NCT05422612|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111022976|NCT05350215|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
111022977|NCT05350215|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111022978|NCT05350215|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111022979|NCT05350215|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111022980|NCT05350215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111022981|NCT05350215|Adrenergic Agents|adrenergic agents|mesh-ancestor
111022982|NCT05350215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111022983|NCT05350215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111022984|NCT05258747|Olaparib|olaparib|mesh-list
111022985|NCT05258747|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111022986|NCT05258747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111022987|NCT05258747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111022988|NCT05258747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111022989|NCT05127395|Acyclovir|acyclovir|mesh-list
111022990|NCT05127395|Antiviral Agents|antiviral agents|mesh-ancestor
111022991|NCT05127395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111022992|NCT05071053|Ramucirumab|ramucirumab|mesh-list
111022993|NCT05071053|Maytansine|maytansine|mesh-list
111022994|NCT05071053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111022995|NCT05071053|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111022996|NCT05071053|Tubulin Modulators|tubulin modulators|mesh-ancestor
111022997|NCT05071053|Antimitotic Agents|antimitotic agents|mesh-ancestor
111022998|NCT05071053|Mitosis Modulators|mitosis modulators|mesh-ancestor
111022999|NCT05071053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111023000|NCT05041062|Nivolumab|nivolumab|mesh-list
111023001|NCT05041062|Ipilimumab|ipilimumab|mesh-list
111023002|NCT05041062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111023003|NCT05041062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111023004|NCT05041062|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111023005|NCT05041062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111023006|NCT05022342|Fulvestrant|fulvestrant|mesh-list
111023007|NCT05022342|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111023008|NCT05022342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111023009|NCT05022342|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
111023010|NCT05022342|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111023011|NCT05022342|Hormone Antagonists|hormone antagonists|mesh-ancestor
110740145|NCT01209026|Xhance|xhance|mesh-list
111023012|NCT05022342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111023013|NCT05022342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111023014|NCT05019716|Cisplatin|cisplatin|mesh-list
111023015|NCT05019716|Etoposide|etoposide|mesh-list
111023016|NCT05019716|Etoposide phosphate|etoposide phosphate|mesh-list
111023018|NCT05019716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111023019|NCT05019716|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111023020|NCT05019716|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111023021|NCT05019716|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111023022|NCT05019716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111023023|NCT05019716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111023024|NCT05019716|Keratolytic Agents|keratolytic agents|mesh-ancestor
111023025|NCT05019716|Dermatologic Agents|dermatologic agents|mesh-ancestor
110624127|NCT00999232|Erythromycin|erythromycin|mesh-list
111023026|NCT05019716|Tubulin Modulators|tubulin modulators|mesh-ancestor
111023027|NCT05019716|Antimitotic Agents|antimitotic agents|mesh-ancestor
111023028|NCT05019716|Mitosis Modulators|mitosis modulators|mesh-ancestor
111023029|NCT05008224|Prednisone|prednisone|mesh-list
111023030|NCT05008224|Cyclophosphamide|cyclophosphamide|mesh-list
111023031|NCT05008224|Dacarbazine|dacarbazine|mesh-list
111023032|NCT05008224|Doxorubicin|doxorubicin|mesh-list
111023033|NCT05008224|Pembrolizumab|pembrolizumab|mesh-list
111023034|NCT05008224|Etoposide|etoposide|mesh-list
111023035|NCT05008224|Etoposide phosphate|etoposide phosphate|mesh-list
111023036|NCT05008224|Vincristine|vincristine|mesh-list
111023037|NCT05008224|Bleomycin|bleomycin|mesh-list
111023038|NCT05008224|Vinblastine|vinblastine|mesh-list
111023039|NCT05008224|Procarbazine|procarbazine|mesh-list
111023040|NCT05008224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111023041|NCT05008224|Immunologic Factors|immunologic factors|mesh-ancestor
111023042|NCT05008224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111023043|NCT05008224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111023044|NCT05008224|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111023045|NCT05008224|Alkylating Agents|alkylating agents|mesh-ancestor
111023046|NCT05008224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111023047|NCT05008224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111023048|NCT05008224|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111023049|NCT05008224|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111023050|NCT05008224|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111023051|NCT05008224|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111023052|NCT05008224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111023053|NCT05008224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111023054|NCT05008224|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111023055|NCT05008224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111023056|NCT05008224|Glucocorticoids|glucocorticoids|mesh-ancestor
111023057|NCT05008224|Hormones|hormones|mesh-ancestor
111023058|NCT05008224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111023059|NCT05008224|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111023060|NCT05008224|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111023061|NCT05008224|Tubulin Modulators|tubulin modulators|mesh-ancestor
111023062|NCT05008224|Antimitotic Agents|antimitotic agents|mesh-ancestor
111023063|NCT05008224|Mitosis Modulators|mitosis modulators|mesh-ancestor
111023064|NCT04980495|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111023065|NCT04971226|Imatinib Mesylate|imatinib mesylate|mesh-list
111023066|NCT04971226|Dasatinib|dasatinib|mesh-list
111023067|NCT04971226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111023068|NCT04971226|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111023069|NCT04971226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111023070|NCT04971226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111023071|NCT04967196|Nivolumab|nivolumab|mesh-list
111023072|NCT04967196|Ipilimumab|ipilimumab|mesh-list
111023073|NCT04967196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111023074|NCT04967196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111023075|NCT04967196|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111023076|NCT04967196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111023077|NCT04964466|Becaplermin|becaplermin|mesh-list
111023078|NCT04964466|Anticoagulants|anticoagulants|mesh-ancestor
111023079|NCT04964466|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
111023080|NCT04964466|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111023081|NCT04964466|Growth Substances|growth substances|mesh-ancestor
111023082|NCT04964466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111023083|NCT04950270|Arginine Vasopressin|arginine vasopressin|mesh-list
111023084|NCT04950270|Hemostatics|hemostatics|mesh-ancestor
111023085|NCT04950270|Coagulants|coagulants|mesh-ancestor
111023086|NCT04950270|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110740194|NCT01107782|Vasodilator Agents|vasodilator agents|mesh-ancestor
110624137|NCT00993070|Capsaicin|capsaicin|mesh-list
111023087|NCT04950270|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
111023088|NCT04950270|Natriuretic Agents|natriuretic agents|mesh-ancestor
111023089|NCT04950270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111023090|NCT04820179|Atezolizumab|atezolizumab|mesh-list
111023091|NCT04820179|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111023092|NCT04820179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111023093|NCT04820179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111023094|NCT04820179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111023095|NCT04804553|Apremilast|apremilast|mesh-list
111023096|NCT04804553|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111023097|NCT04804553|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111023098|NCT04804553|Analgesics|analgesics|mesh-ancestor
111023099|NCT04804553|Sensory System Agents|sensory system agents|mesh-ancestor
111023100|NCT04804553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111023101|NCT04804553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111023102|NCT04804553|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111023103|NCT04804553|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111023104|NCT04804553|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
111023105|NCT04804553|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111023106|NCT04804553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111023107|NCT04804553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111023108|NCT04802876|Tislelizumab|tislelizumab|mesh-list
111023109|NCT04802876|Spartalizumab|spartalizumab|mesh-list
111023110|NCT04802876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111023111|NCT04802876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111023112|NCT04802876|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111023113|NCT04802876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111023114|NCT04789928|Gentamicins|gentamicins|mesh-list
111023115|NCT04789928|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111023116|NCT04789928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111023117|NCT04789928|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111023118|NCT04789928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111023119|NCT04789928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111023120|NCT04762992|Enoxaparin|enoxaparin|mesh-list
111023121|NCT04762992|Anticoagulants|anticoagulants|mesh-ancestor
111023122|NCT04762992|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111023123|NCT04762992|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111023124|NCT04762992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111023125|NCT04738123|Xanomeline|xanomeline|mesh-list
111023126|NCT04738123|Trospium chloride|trospium chloride|mesh-list
111023127|NCT04738123|Parasympatholytics|parasympatholytics|mesh-ancestor
111023128|NCT04738123|Autonomic Agents|autonomic agents|mesh-ancestor
111023129|NCT04738123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111023130|NCT04738123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111023131|NCT04738123|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111023132|NCT04738123|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111023133|NCT04738123|Cholinergic Agents|cholinergic agents|mesh-ancestor
111023134|NCT04738123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111023135|NCT04738123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111023136|NCT04738123|Urological Agents|urological agents|mesh-ancestor
111023137|NCT04738123|Parasympathomimetics|parasympathomimetics|mesh-ancestor
111023138|NCT04738123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111023139|NCT04738123|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
111023140|NCT04738123|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111023141|NCT04715191|Cyclophosphamide|cyclophosphamide|mesh-list
111023142|NCT04715191|Fludarabine|fludarabine|mesh-list
111023143|NCT04715191|Fludarabine phosphate|fludarabine phosphate|mesh-list
111023144|NCT04715191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111023145|NCT04715191|Immunologic Factors|immunologic factors|mesh-ancestor
111023146|NCT04715191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111023147|NCT04715191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111023148|NCT04715191|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111023149|NCT04715191|Alkylating Agents|alkylating agents|mesh-ancestor
110799540|NCT05320107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111023150|NCT04715191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111023151|NCT04715191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111023152|NCT04715191|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111023153|NCT04715191|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111023154|NCT04715191|Antimetabolites|antimetabolites|mesh-ancestor
111023155|NCT04704453|Amitriptyline|amitriptyline|mesh-list
111023156|NCT04704453|Capsaicin|capsaicin|mesh-list
111023157|NCT04704453|Antipruritics|antipruritics|mesh-ancestor
111023158|NCT04704453|Dermatologic Agents|dermatologic agents|mesh-ancestor
111023159|NCT04704453|Sensory System Agents|sensory system agents|mesh-ancestor
111023160|NCT04704453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111023161|NCT04704453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111023162|NCT04704453|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
111023163|NCT04704453|Antidepressive Agents|antidepressive agents|mesh-ancestor
111023164|NCT04704453|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111023165|NCT04704453|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111023167|NCT04704453|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111023168|NCT04704453|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111023169|NCT04704453|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111023170|NCT04704453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111023171|NCT04704453|Adrenergic Agents|adrenergic agents|mesh-ancestor
111023172|NCT04704453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111023173|NCT04695847|Antibodies|antibodies|mesh-list
111023174|NCT04695847|Immunoglobulins|immunoglobulins|mesh-list
111023175|NCT04695847|Antibodies, Bispecific|antibodies, bispecific|mesh-list
111023176|NCT04695847|Immunoconjugates|immunoconjugates|mesh-list
111023177|NCT04695847|Immunologic Factors|immunologic factors|mesh-ancestor
111023178|NCT04695847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111023179|NCT04682353|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
111023180|NCT04682353|Medroxyprogesterone|medroxyprogesterone|mesh-list
111023181|NCT04682353|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111023182|NCT04682353|Contraceptive Agents|contraceptive agents|mesh-ancestor
111023183|NCT04682353|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111023184|NCT04682353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111023185|NCT04682353|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111023186|NCT04682353|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
111023187|NCT04682353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111023188|NCT04682353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111023189|NCT04682353|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111023190|NCT04682353|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111023191|NCT04682353|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111023192|NCT04675333|Carboplatin|carboplatin|mesh-list
111023193|NCT04675333|Pembrolizumab|pembrolizumab|mesh-list
111023194|NCT04675333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111023195|NCT04675333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111023196|NCT04675333|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111023197|NCT04675333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111023198|NCT04665050|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
111023199|NCT04665050|Immunologic Factors|immunologic factors|mesh-ancestor
111023200|NCT04665050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111023201|NCT04581395|Rocuronium|rocuronium|mesh-list
111023202|NCT04581395|Succinylcholine|succinylcholine|mesh-list
111023203|NCT04581395|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
111023204|NCT04581395|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
111023205|NCT04581395|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111023206|NCT04581395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111023207|NCT04581395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111023208|NCT04581395|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
111023209|NCT04572100|Paclitaxel|paclitaxel|mesh-list
111023210|NCT04572100|Carboplatin|carboplatin|mesh-list
111023211|NCT04572100|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111023212|NCT04572100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111023213|NCT04572100|Tubulin Modulators|tubulin modulators|mesh-ancestor
111023214|NCT04572100|Antimitotic Agents|antimitotic agents|mesh-ancestor
111023215|NCT04572100|Mitosis Modulators|mitosis modulators|mesh-ancestor
111023216|NCT04572100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111023217|NCT04564625|Vitamin D|vitamin d|mesh-list
111023218|NCT04564625|Vitamins|vitamins|mesh-ancestor
111023219|NCT04564625|Micronutrients|micronutrients|mesh-ancestor
111023220|NCT04564625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111023221|NCT04564625|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111023222|NCT04560322|Venetoclax|venetoclax|mesh-list
111023223|NCT04560322|Obinutuzumab|obinutuzumab|mesh-list
111023224|NCT04560322|Acalabrutinib|acalabrutinib|mesh-list
111023225|NCT04560322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111023226|NCT04560322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111023227|NCT04538352|Insulin|insulin|mesh-list
111023228|NCT04538352|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111023229|NCT04538352|Insulin Aspart|insulin aspart|mesh-list
111023230|NCT04538352|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111023231|NCT04538352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111023232|NCT04504734|Bucillamine|bucillamine|mesh-list
111023233|NCT04504734|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111023234|NCT04504734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111023236|NCT04504734|Sensory System Agents|sensory system agents|mesh-ancestor
111023237|NCT04504734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111023238|NCT04504734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111023239|NCT04504734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111023240|NCT04504734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111023241|NCT04504734|Antioxidants|antioxidants|mesh-ancestor
111023242|NCT04504734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111023243|NCT04504734|Protective Agents|protective agents|mesh-ancestor
111023244|NCT04469842|Mycophenolic Acid|mycophenolic acid|mesh-list
111023245|NCT04469842|Prednisone|prednisone|mesh-list
111023246|NCT04469842|Azathioprine|azathioprine|mesh-list
111023247|NCT04469842|Tacrolimus|tacrolimus|mesh-list
111023248|NCT04469842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111023249|NCT04469842|Glucocorticoids|glucocorticoids|mesh-ancestor
111023250|NCT04469842|Hormones|hormones|mesh-ancestor
111023251|NCT04469842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111023252|NCT04469842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111023253|NCT04469842|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111023254|NCT04469842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111023255|NCT04469842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111023256|NCT04469842|Immunologic Factors|immunologic factors|mesh-ancestor
111023257|NCT04469842|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111023258|NCT04469842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111023259|NCT04469842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111023260|NCT04469842|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111023261|NCT04469842|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111023262|NCT04469842|Antitubercular Agents|antitubercular agents|mesh-ancestor
111023263|NCT04469842|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111023264|NCT04469842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111023265|NCT04469842|Antimetabolites|antimetabolites|mesh-ancestor
111023266|NCT04469842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111023267|NCT04469842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111023268|NCT04439227|Adavosertib|adavosertib|mesh-list
111023269|NCT04439227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111023270|NCT04439227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111023271|NCT04416633|Durvalumab|durvalumab|mesh-list
111023272|NCT04416633|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111023273|NCT04416633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111023274|NCT04388774|Ketamine|ketamine|mesh-list
111023275|NCT04388774|Analgesics|analgesics|mesh-ancestor
111023276|NCT04388774|Sensory System Agents|sensory system agents|mesh-ancestor
111023277|NCT04388774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111023278|NCT04388774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111023279|NCT04388774|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111023280|NCT04388774|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111023281|NCT04388774|Anesthetics, General|anesthetics, general|mesh-ancestor
111023282|NCT04388774|Anesthetics|anesthetics|mesh-ancestor
111023283|NCT04388774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111023284|NCT04388774|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111023285|NCT04388774|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111023286|NCT04388774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111023287|NCT04388774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111023288|NCT04303169|Pembrolizumab|pembrolizumab|mesh-list
111023289|NCT04303169|Tretinoin|tretinoin|mesh-list
111023290|NCT04303169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111023291|NCT04303169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111023292|NCT04303169|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111023293|NCT04303169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111023294|NCT04303169|Keratolytic Agents|keratolytic agents|mesh-ancestor
111023295|NCT04303169|Dermatologic Agents|dermatologic agents|mesh-ancestor
111023296|NCT04267614|Etanercept|etanercept|mesh-list
111023297|NCT04267614|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111023298|NCT04267614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111023299|NCT04267614|Analgesics|analgesics|mesh-ancestor
111023300|NCT04267614|Sensory System Agents|sensory system agents|mesh-ancestor
111023301|NCT04267614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111023302|NCT04267614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111023303|NCT04267614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111023304|NCT04267614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111023305|NCT04267614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111023306|NCT04267614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111023307|NCT04267614|Immunologic Factors|immunologic factors|mesh-ancestor
111023309|NCT04175431|Abiraterone Acetate|abiraterone acetate|mesh-list
111023310|NCT04175431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111023311|NCT04175431|Glucocorticoids|glucocorticoids|mesh-ancestor
111023318|NCT04175431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111023319|NCT04175431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111023320|NCT04175431|Hormone Antagonists|hormone antagonists|mesh-ancestor
111023321|NCT04175431|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111023322|NCT04170309|Ceftobiprole|ceftobiprole|mesh-list
111023323|NCT04170309|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
111023324|NCT04170309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111023325|NCT04170309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111023326|NCT04164212|Vaccines|vaccines|mesh-list
111023327|NCT04164212|Immunologic Factors|immunologic factors|mesh-ancestor
111023328|NCT04164212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111023329|NCT04112199|Terlipressin|terlipressin|mesh-list
111023330|NCT04112199|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111023331|NCT04112199|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111023332|NCT04089904|Pembrolizumab|pembrolizumab|mesh-list
111023333|NCT04089904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111023334|NCT04089904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110624193|NCT00821496|Contraceptive Agents|contraceptive agents|mesh-ancestor
111023335|NCT04089904|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111023336|NCT04089904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111023337|NCT04068831|Avelumab|avelumab|mesh-list
111023338|NCT04068831|Talazoparib|talazoparib|mesh-list
111023339|NCT04068831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111023340|NCT04068831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111023341|NCT04068831|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111023342|NCT04068831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111023343|NCT04068831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111023344|NCT04055428|Valsartan|valsartan|mesh-list
111023345|NCT04055428|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
111023346|NCT04055428|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111023347|NCT04055428|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111023348|NCT04055428|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111023349|NCT04055428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111023350|NCT03998488|Psyllium|psyllium|mesh-list
111023351|NCT03998488|Calcium polycarbophil|calcium polycarbophil|mesh-list
111023352|NCT03998488|Cathartics|cathartics|mesh-ancestor
111023353|NCT03998488|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111023354|NCT03998488|Antidiarrheals|antidiarrheals|mesh-ancestor
111023355|NCT03963960|Dialysis Solutions|dialysis solutions|mesh-list
111023356|NCT03963960|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111023357|NCT03923374|Buprenorphine|buprenorphine|mesh-list
111023358|NCT03923374|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111023359|NCT03923374|Narcotics|narcotics|mesh-ancestor
111023360|NCT03923374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111023361|NCT03923374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111023362|NCT03923374|Analgesics|analgesics|mesh-ancestor
111023363|NCT03923374|Sensory System Agents|sensory system agents|mesh-ancestor
111023364|NCT03923374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111023365|NCT03923374|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111023373|NCT03910972|Aluminum Hydroxide|aluminum hydroxide|mesh-list
111023374|NCT03910972|Vaccines|vaccines|mesh-list
111023375|NCT03910972|Immunologic Factors|immunologic factors|mesh-ancestor
111023376|NCT03910972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111023377|NCT03910972|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111023378|NCT03910972|Antacids|antacids|mesh-ancestor
111023379|NCT03910972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111023380|NCT03910972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111023381|NCT03861702|Irinotecan|irinotecan|mesh-list
111023382|NCT03861702|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111023383|NCT03861702|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111023384|NCT03861702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111023385|NCT03861702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111023386|NCT03861702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111023387|NCT03781128|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
111023388|NCT03781128|Hallucinogens|hallucinogens|mesh-ancestor
111023389|NCT03781128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111023390|NCT03781128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111023391|NCT03781128|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111023392|NCT03781128|Serotonin Agents|serotonin agents|mesh-ancestor
111023393|NCT03781128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111119148|NCT05323617|Immunologic Factors|immunologic factors|mesh-ancestor
111023394|NCT03781128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111023395|NCT03781128|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111023396|NCT03774641|Lamotrigine|lamotrigine|mesh-list
111023397|NCT03774641|Anticonvulsants|anticonvulsants|mesh-ancestor
111023398|NCT03774641|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110624208|NCT00999700|Cisplatin|cisplatin|mesh-list
111023399|NCT03774641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111023400|NCT03774641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111023401|NCT03774641|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111023402|NCT03774641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111023403|NCT03774641|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111023404|NCT03774641|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111023405|NCT03774641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111023406|NCT03774641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111023407|NCT03774641|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111023408|NCT03716349|Anesthetics|anesthetics|mesh-list
111023409|NCT03716349|Anesthetics, Local|anesthetics, local|mesh-list
111023410|NCT03716349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111023411|NCT03716349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111023412|NCT03716349|Sensory System Agents|sensory system agents|mesh-ancestor
111023413|NCT03716349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111023414|NCT03682536|Epoetin Alfa|epoetin alfa|mesh-list
111023415|NCT03682536|Luspatercept|luspatercept|mesh-list
111023416|NCT03682536|Hematinics|hematinics|mesh-ancestor
111023417|NCT03653338|Rituximab|rituximab|mesh-list
111023418|NCT03653338|Alemtuzumab|alemtuzumab|mesh-list
111023419|NCT03653338|Fludarabine|fludarabine|mesh-list
111023420|NCT03653338|Thiotepa|thiotepa|mesh-list
111023421|NCT03653338|Hydroxyurea|hydroxyurea|mesh-list
111023422|NCT03653338|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111023423|NCT03653338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111023424|NCT03653338|Immunologic Factors|immunologic factors|mesh-ancestor
111023425|NCT03653338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111023426|NCT03653338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111023427|NCT03653338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111023428|NCT03653338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111023429|NCT03653338|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111023430|NCT03653338|Alkylating Agents|alkylating agents|mesh-ancestor
111023431|NCT03653338|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111023432|NCT03653338|Antisickling Agents|antisickling agents|mesh-ancestor
111023433|NCT03653338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111023434|NCT03653338|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111023435|NCT03610724|Tisagenlecleucel|tisagenlecleucel|mesh-list
111023436|NCT03610724|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111023437|NCT03610724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111023438|NCT03576755|Spironolactone|spironolactone|mesh-list
111023439|NCT03576755|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
111023440|NCT03576755|Hormone Antagonists|hormone antagonists|mesh-ancestor
111023441|NCT03576755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111023442|NCT03576755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111023443|NCT03576755|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
111023444|NCT03576755|Diuretics|diuretics|mesh-ancestor
111023445|NCT03576755|Natriuretic Agents|natriuretic agents|mesh-ancestor
111023446|NCT03572049|Itraconazole|itraconazole|mesh-list
111023447|NCT03572049|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
111023448|NCT03572049|Antifungal Agents|antifungal agents|mesh-ancestor
111023449|NCT03572049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111023450|NCT03572049|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111023451|NCT03572049|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111023452|NCT03572049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110624223|NCT00818298|Ziprasidone|ziprasidone|mesh-list
111023453|NCT03572049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111023454|NCT03572049|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111023455|NCT03572049|Hormone Antagonists|hormone antagonists|mesh-ancestor
111023456|NCT03572049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111023457|NCT03572049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111023458|NCT03572049|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111023459|NCT03556332|Dexamethasone|dexamethasone|mesh-list
111023460|NCT03556332|Lenalidomide|lenalidomide|mesh-list
111023461|NCT03556332|Daratumumab|daratumumab|mesh-list
111023462|NCT03556332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111023463|NCT03556332|Antiemetics|antiemetics|mesh-ancestor
111023464|NCT03556332|Autonomic Agents|autonomic agents|mesh-ancestor
111023465|NCT03556332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111023466|NCT03556332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111023467|NCT03556332|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111023468|NCT03556332|Glucocorticoids|glucocorticoids|mesh-ancestor
111023469|NCT03556332|Hormones|hormones|mesh-ancestor
111023470|NCT03556332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111023471|NCT03556332|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111023472|NCT03556332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111023473|NCT03556332|Immunologic Factors|immunologic factors|mesh-ancestor
111023474|NCT03556332|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111023475|NCT03556332|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111023476|NCT03556332|Growth Substances|growth substances|mesh-ancestor
111023477|NCT03556332|Growth Inhibitors|growth inhibitors|mesh-ancestor
111023478|NCT03555877|Letrozole|letrozole|mesh-list
111023479|NCT03555877|Fulvestrant|fulvestrant|mesh-list
111023480|NCT03555877|Anastrozole|anastrozole|mesh-list
111023481|NCT03555877|Exemestane|exemestane|mesh-list
111023482|NCT03555877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111023483|NCT03555877|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111023484|NCT03555877|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111023485|NCT03555877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111023486|NCT03555877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111023487|NCT03555877|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111023488|NCT03555877|Hormone Antagonists|hormone antagonists|mesh-ancestor
111023489|NCT03555877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111023490|NCT03555877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111023491|NCT03555877|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111023492|NCT03555877|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
111023493|NCT03481972|Doxycycline|doxycycline|mesh-list
111023494|NCT03481972|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
111023495|NCT03481972|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111023496|NCT03481972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111023497|NCT03481972|Antimalarials|antimalarials|mesh-ancestor
111023498|NCT03481972|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111023499|NCT03481972|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111023500|NCT03481972|Antiviral Agents|antiviral agents|mesh-ancestor
111023501|NCT03481972|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
111023502|NCT03481972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111023503|NCT03472560|Avelumab|avelumab|mesh-list
111023504|NCT03472560|Axitinib|axitinib|mesh-list
111023505|NCT03472560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111023506|NCT03472560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111023507|NCT03472560|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111023508|NCT03472560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111023509|NCT03472560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111023510|NCT03397004|Doxycycline|doxycycline|mesh-list
111023511|NCT03397004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111023512|NCT03397004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111023513|NCT03397004|Antimalarials|antimalarials|mesh-ancestor
111023514|NCT03397004|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111023515|NCT03397004|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111023516|NCT03336216|Leucovorin|leucovorin|mesh-list
111023517|NCT03336216|Paclitaxel|paclitaxel|mesh-list
111023518|NCT03336216|Gemcitabine|gemcitabine|mesh-list
111023519|NCT03336216|Fluorouracil|fluorouracil|mesh-list
111023520|NCT03336216|Oxaliplatin|oxaliplatin|mesh-list
111023521|NCT03336216|Nivolumab|nivolumab|mesh-list
111023522|NCT03336216|Irinotecan|irinotecan|mesh-list
111023523|NCT03336216|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111023524|NCT03336216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111023525|NCT03336216|Tubulin Modulators|tubulin modulators|mesh-ancestor
111023526|NCT03336216|Antimitotic Agents|antimitotic agents|mesh-ancestor
111023527|NCT03336216|Mitosis Modulators|mitosis modulators|mesh-ancestor
111023528|NCT03336216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111023529|NCT03336216|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111023530|NCT03336216|Antimetabolites|antimetabolites|mesh-ancestor
111023531|NCT03336216|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111023532|NCT03336216|Immunologic Factors|immunologic factors|mesh-ancestor
111023533|NCT03336216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111023534|NCT03336216|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111023535|NCT03336216|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111023536|NCT03336216|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111023537|NCT03336216|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111023538|NCT03336216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111023539|NCT03336216|Antidotes|antidotes|mesh-ancestor
111023540|NCT03336216|Protective Agents|protective agents|mesh-ancestor
111023541|NCT03336216|Vitamin B Complex|vitamin b complex|mesh-ancestor
111023542|NCT03336216|Vitamins|vitamins|mesh-ancestor
111023543|NCT03336216|Micronutrients|micronutrients|mesh-ancestor
111023544|NCT03319940|Pembrolizumab|pembrolizumab|mesh-list
111023545|NCT03319940|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111023546|NCT03319940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111023547|NCT03319940|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111023548|NCT03319940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111023549|NCT03298815|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111023550|NCT03298815|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111023552|NCT03269994|Piperacillin|piperacillin|mesh-list
111023553|NCT03269994|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
111023554|NCT03269994|Cefoxitin|cefoxitin|mesh-list
111023555|NCT03269994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111023556|NCT03269994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111023557|NCT03269994|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
111023558|NCT03269994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111023559|NCT03269994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111023560|NCT03148327|Durvalumab|durvalumab|mesh-list
111023561|NCT03148327|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111023562|NCT03148327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111023563|NCT03065387|Everolimus|everolimus|mesh-list
111023564|NCT03065387|Palbociclib|palbociclib|mesh-list
111023565|NCT03065387|Trametinib|trametinib|mesh-list
111023566|NCT03065387|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111023567|NCT03065387|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111023568|NCT03065387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111023569|NCT03065387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111023570|NCT03065387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111023571|NCT03065387|Immunologic Factors|immunologic factors|mesh-ancestor
111023572|NCT03065387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111023573|NCT03065387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111023574|NCT03063606|Bupropion hydrochloride, naltrexone hydrochoride drug combination|bupropion hydrochloride, naltrexone hydrochoride drug combination|mesh-list
111023575|NCT03063606|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111023576|NCT03062358|Pembrolizumab|pembrolizumab|mesh-list
111023577|NCT03062358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111023578|NCT03062358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111023579|NCT03062358|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111023580|NCT03062358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111023581|NCT02903537|Vitamin D|vitamin d|mesh-list
111023582|NCT02903537|Cholecalciferol|cholecalciferol|mesh-list
111023583|NCT02903537|Interferons|interferons|mesh-list
111023584|NCT02903537|Interferon-beta|interferon-beta|mesh-list
111023585|NCT02903537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111023586|NCT02903537|Antiviral Agents|antiviral agents|mesh-ancestor
111023587|NCT02903537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111023588|NCT02903537|Immunologic Factors|immunologic factors|mesh-ancestor
111023589|NCT02903537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111023590|NCT02903537|Vitamins|vitamins|mesh-ancestor
111023591|NCT02903537|Micronutrients|micronutrients|mesh-ancestor
111023592|NCT02903537|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111023593|NCT02903537|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111023594|NCT02706873|Methotrexate|methotrexate|mesh-list
111023595|NCT02706873|Upadacitinib|upadacitinib|mesh-list
111023596|NCT02706873|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111023597|NCT02706873|Abortifacient Agents|abortifacient agents|mesh-ancestor
111023598|NCT02706873|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111023599|NCT02706873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111023600|NCT02706873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111023601|NCT02706873|Antimetabolites|antimetabolites|mesh-ancestor
111023602|NCT02706873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111023603|NCT02706873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111023604|NCT02706873|Dermatologic Agents|dermatologic agents|mesh-ancestor
111023605|NCT02706873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111023606|NCT02706873|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111023607|NCT02706873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111023608|NCT02706873|Immunologic Factors|immunologic factors|mesh-ancestor
111023609|NCT02706873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111023610|NCT02706873|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111023611|NCT02706873|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
111023612|NCT02706873|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111023614|NCT02677038|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
111023615|NCT02677038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111023616|NCT02677038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111023617|NCT02677038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111023618|NCT02584634|Avelumab|avelumab|mesh-list
111023619|NCT02584634|Crizotinib|crizotinib|mesh-list
111023620|NCT02584634|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111023621|NCT02584634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111023622|NCT02584634|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111023623|NCT02584634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111023624|NCT02584634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111023625|NCT02570542|Cytarabine|cytarabine|mesh-list
111023626|NCT02570542|Plerixafor|plerixafor|mesh-list
111023627|NCT02570542|Etoposide|etoposide|mesh-list
111023628|NCT02570542|Melphalan|melphalan|mesh-list
111023629|NCT02570542|Carmustine|carmustine|mesh-list
111023630|NCT02570542|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111023631|NCT02570542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111023632|NCT02570542|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111023633|NCT02570542|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111023634|NCT02570542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111023635|NCT02570542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111023636|NCT02570542|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111023637|NCT02570542|Antimetabolites|antimetabolites|mesh-ancestor
111023638|NCT02570542|Antiviral Agents|antiviral agents|mesh-ancestor
111023639|NCT02570542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111023640|NCT02570542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111023641|NCT02570542|Immunologic Factors|immunologic factors|mesh-ancestor
111023642|NCT02570542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111023643|NCT02570542|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111023644|NCT02570542|Alkylating Agents|alkylating agents|mesh-ancestor
111023645|NCT02570542|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111023646|NCT02570542|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111023647|NCT02570542|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111023648|NCT02513563|Paclitaxel|paclitaxel|mesh-list
111023649|NCT02513563|Carboplatin|carboplatin|mesh-list
111023650|NCT02513563|Adavosertib|adavosertib|mesh-list
111023651|NCT02513563|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111023652|NCT02513563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111023653|NCT02513563|Tubulin Modulators|tubulin modulators|mesh-ancestor
111023654|NCT02513563|Antimitotic Agents|antimitotic agents|mesh-ancestor
111023655|NCT02513563|Mitosis Modulators|mitosis modulators|mesh-ancestor
111023656|NCT02513563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111023657|NCT02513563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111023658|NCT02365441|Imatinib Mesylate|imatinib mesylate|mesh-list
111023659|NCT02365441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111023660|NCT02365441|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111023661|NCT02365441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111023662|NCT02365441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111023663|NCT02124941|Acetylcysteine|acetylcysteine|mesh-list
111023664|NCT02124941|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111023665|NCT02124941|Antiviral Agents|antiviral agents|mesh-ancestor
111023666|NCT02124941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111023667|NCT02124941|Expectorants|expectorants|mesh-ancestor
111023668|NCT02124941|Respiratory System Agents|respiratory system agents|mesh-ancestor
111023669|NCT02124941|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111023670|NCT02124941|Antioxidants|antioxidants|mesh-ancestor
111023671|NCT02124941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111023672|NCT02124941|Protective Agents|protective agents|mesh-ancestor
111023673|NCT02124941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111023674|NCT02124941|Antidotes|antidotes|mesh-ancestor
111023675|NCT02114229|Cyclophosphamide|cyclophosphamide|mesh-list
111023676|NCT02114229|Carboplatin|carboplatin|mesh-list
111023677|NCT02114229|Methotrexate|methotrexate|mesh-list
111023678|NCT02114229|Etoposide|etoposide|mesh-list
111023679|NCT02114229|Etoposide phosphate|etoposide phosphate|mesh-list
111023680|NCT02114229|Vincristine|vincristine|mesh-list
111023681|NCT02114229|Topotecan|topotecan|mesh-list
111023682|NCT02114229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111023683|NCT02114229|Immunologic Factors|immunologic factors|mesh-ancestor
111023684|NCT02114229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111023685|NCT02114229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111023686|NCT02114229|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110740800|NCT00354107|Immunotoxins|immunotoxins|mesh-ancestor
111023687|NCT02114229|Alkylating Agents|alkylating agents|mesh-ancestor
111023688|NCT02114229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111023689|NCT02114229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111023690|NCT02114229|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111023691|NCT02114229|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111023692|NCT02114229|Abortifacient Agents|abortifacient agents|mesh-ancestor
111023693|NCT02114229|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111023694|NCT02114229|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111023695|NCT02114229|Antimetabolites|antimetabolites|mesh-ancestor
111023696|NCT02114229|Dermatologic Agents|dermatologic agents|mesh-ancestor
111023697|NCT02114229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111023698|NCT02114229|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111023699|NCT02114229|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111023700|NCT02114229|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111023701|NCT02114229|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111023702|NCT02114229|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111023703|NCT02114229|Tubulin Modulators|tubulin modulators|mesh-ancestor
111023704|NCT02114229|Antimitotic Agents|antimitotic agents|mesh-ancestor
111023705|NCT02114229|Mitosis Modulators|mitosis modulators|mesh-ancestor
111023706|NCT02114229|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111023707|NCT02000622|Olaparib|olaparib|mesh-list
111023708|NCT02000622|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111023709|NCT02000622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111023710|NCT02000622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111023711|NCT02000622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111023712|NCT01868451|Doxorubicin|doxorubicin|mesh-list
111023713|NCT01868451|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111023714|NCT01868451|Brentuximab Vedotin|brentuximab vedotin|mesh-list
111023715|NCT01868451|Dacarbazine|dacarbazine|mesh-list
111023716|NCT01868451|Vinblastine|vinblastine|mesh-list
111023717|NCT01868451|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111023718|NCT01868451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111023719|NCT01868451|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111023720|NCT01868451|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111023721|NCT01868451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111023722|NCT01868451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111023723|NCT01868451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111023724|NCT01868451|Immunotoxins|immunotoxins|mesh-ancestor
111023725|NCT01868451|Immunoconjugates|immunoconjugates|mesh-ancestor
111023726|NCT01868451|Immunologic Factors|immunologic factors|mesh-ancestor
111023727|NCT01868451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111023728|NCT01868451|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111023729|NCT01868451|Alkylating Agents|alkylating agents|mesh-ancestor
111023730|NCT01868451|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111023731|NCT01868451|Tubulin Modulators|tubulin modulators|mesh-ancestor
111023732|NCT01868451|Antimitotic Agents|antimitotic agents|mesh-ancestor
111023733|NCT01868451|Mitosis Modulators|mitosis modulators|mesh-ancestor
111023734|NCT01767675|Carboplatin|carboplatin|mesh-list
111023735|NCT01767675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111023736|NCT01275729|Furosemide|furosemide|mesh-list
111023737|NCT01275729|Diuretics|diuretics|mesh-ancestor
111023738|NCT01275729|Natriuretic Agents|natriuretic agents|mesh-ancestor
111023739|NCT01275729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111023740|NCT01275729|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
111023741|NCT01275729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111023742|NCT01275729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111023743|NCT01107626|Paclitaxel|paclitaxel|mesh-list
111023744|NCT01107626|Bevacizumab|bevacizumab|mesh-list
111023745|NCT01107626|Carboplatin|carboplatin|mesh-list
111023746|NCT01107626|Pemetrexed|pemetrexed|mesh-list
111023747|NCT01107626|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111023748|NCT01107626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111023749|NCT01107626|Tubulin Modulators|tubulin modulators|mesh-ancestor
111023750|NCT01107626|Antimitotic Agents|antimitotic agents|mesh-ancestor
111023751|NCT01107626|Mitosis Modulators|mitosis modulators|mesh-ancestor
111023752|NCT01107626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111023753|NCT01107626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111023754|NCT01107626|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111023755|NCT01107626|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111023756|NCT01107626|Growth Substances|growth substances|mesh-ancestor
111023757|NCT01107626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111023758|NCT01107626|Growth Inhibitors|growth inhibitors|mesh-ancestor
111023759|NCT01107626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111023760|NCT01107626|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111023761|NCT01107626|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111023762|NCT01082224|Motexafin gadolinium|motexafin gadolinium|mesh-list
110740872|NCT01055249|Analgesics|analgesics|mesh-ancestor
111023763|NCT01082224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111023764|NCT01082224|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111023765|NCT01082224|Dermatologic Agents|dermatologic agents|mesh-ancestor
111023766|NCT00828009|Paclitaxel|paclitaxel|mesh-list
111023767|NCT00828009|Cyclophosphamide|cyclophosphamide|mesh-list
111023768|NCT00828009|Bevacizumab|bevacizumab|mesh-list
111023769|NCT00828009|Carboplatin|carboplatin|mesh-list
111023770|NCT00828009|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111023771|NCT00828009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111023772|NCT00828009|Tubulin Modulators|tubulin modulators|mesh-ancestor
111023773|NCT00828009|Antimitotic Agents|antimitotic agents|mesh-ancestor
111023774|NCT00828009|Mitosis Modulators|mitosis modulators|mesh-ancestor
111023775|NCT00828009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111023776|NCT00828009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111023777|NCT00828009|Immunologic Factors|immunologic factors|mesh-ancestor
111023778|NCT00828009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111023779|NCT00828009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111023780|NCT00828009|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111023781|NCT00828009|Alkylating Agents|alkylating agents|mesh-ancestor
111023782|NCT00828009|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111023783|NCT00828009|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111023784|NCT00828009|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111023785|NCT00828009|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111023786|NCT00828009|Growth Substances|growth substances|mesh-ancestor
111023787|NCT00828009|Growth Inhibitors|growth inhibitors|mesh-ancestor
111023788|NCT00578721|Aspirin|aspirin|mesh-list
111023789|NCT00578721|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111023790|NCT00578721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111023791|NCT00578721|Analgesics|analgesics|mesh-ancestor
111023792|NCT00578721|Sensory System Agents|sensory system agents|mesh-ancestor
111023793|NCT00578721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111023794|NCT00578721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111023795|NCT00578721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111023796|NCT00578721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111023797|NCT00578721|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111023798|NCT00578721|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111023799|NCT00578721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111023800|NCT00578721|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111023801|NCT00578721|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111023802|NCT00578721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111023803|NCT00578721|Antipyretics|antipyretics|mesh-ancestor
111023804|NCT00357890|Insulin|insulin|mesh-list
111023805|NCT00357890|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111023806|NCT00357890|Insulin Glargine|insulin glargine|mesh-list
111023807|NCT00357890|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111023808|NCT00357890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111023809|NCT00068393|Gemcitabine|gemcitabine|mesh-list
111023810|NCT00068393|Doxorubicin|doxorubicin|mesh-list
111023811|NCT00068393|Lenograstim|lenograstim|mesh-list
111023812|NCT00068393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111023813|NCT00068393|Antimetabolites|antimetabolites|mesh-ancestor
111023814|NCT00068393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111023815|NCT00068393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111023816|NCT00068393|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111023817|NCT00068393|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111023818|NCT00068393|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111023819|NCT00068393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111023820|NCT00068393|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111023821|NCT00068393|Immunologic Factors|immunologic factors|mesh-ancestor
111023822|NCT00068393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111023823|NCT00062010|Interferons|interferons|mesh-list
111023824|NCT00062010|Interferon-alpha|interferon-alpha|mesh-list
111023825|NCT00062010|Interferon alpha-2|interferon alpha-2|mesh-list
111023826|NCT00062010|Paclitaxel|paclitaxel|mesh-list
111023827|NCT00062010|Tretinoin|tretinoin|mesh-list
111023828|NCT00062010|Isotretinoin|isotretinoin|mesh-list
111023829|NCT00062010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111023830|NCT00062010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111023831|NCT00062010|Tubulin Modulators|tubulin modulators|mesh-ancestor
111023832|NCT00062010|Antimitotic Agents|antimitotic agents|mesh-ancestor
111023833|NCT00062010|Mitosis Modulators|mitosis modulators|mesh-ancestor
111023834|NCT00062010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111023835|NCT00062010|Antiviral Agents|antiviral agents|mesh-ancestor
110740952|NCT03390166|Vaccines|vaccines|mesh-list
111023836|NCT00062010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111023837|NCT00062010|Immunologic Factors|immunologic factors|mesh-ancestor
111023838|NCT00062010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111023840|NCT00062010|Dermatologic Agents|dermatologic agents|mesh-ancestor
111023841|NCT00061568|Sirolimus|sirolimus|mesh-list
111023842|NCT00061568|Alemtuzumab|alemtuzumab|mesh-list
111023843|NCT00061568|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111023844|NCT00061568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111023845|NCT00061568|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111023846|NCT00061568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111023847|NCT00061568|Antifungal Agents|antifungal agents|mesh-ancestor
111023848|NCT00061568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111023849|NCT00061568|Immunologic Factors|immunologic factors|mesh-ancestor
111023850|NCT00061568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111023851|NCT00061568|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111023852|NCT00047008|Cisplatin|cisplatin|mesh-list
111023853|NCT00047008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111023854|NCT03567941|Acetaminophen|acetaminophen|mesh-list
111023855|NCT03567941|Hydrocodone|hydrocodone|mesh-list
111023856|NCT03567941|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111023857|NCT03567941|Analgesics|analgesics|mesh-ancestor
111023858|NCT03567941|Sensory System Agents|sensory system agents|mesh-ancestor
111023859|NCT03567941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111023860|NCT03567941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111023861|NCT03567941|Antipyretics|antipyretics|mesh-ancestor
111023862|NCT03567941|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111023863|NCT03567941|Narcotics|narcotics|mesh-ancestor
111023864|NCT03567941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111023865|NCT03567941|Antitussive Agents|antitussive agents|mesh-ancestor
111023866|NCT03567941|Respiratory System Agents|respiratory system agents|mesh-ancestor
111023867|NCT02140489|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111023868|NCT02140489|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111023869|NCT02140489|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111023870|NCT02140489|Antimetabolites|antimetabolites|mesh-ancestor
111023871|NCT02140489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111023872|NCT02140489|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111023873|NCT02140489|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111023874|NCT02140489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111023875|NCT03566225|Metformin|metformin|mesh-list
111023876|NCT03566225|Pioglitazone|pioglitazone|mesh-list
111023877|NCT03566225|Clomiphene|clomiphene|mesh-list
111023878|NCT03566225|Enclomiphene|enclomiphene|mesh-list
111023879|NCT03566225|Zuclomiphene|zuclomiphene|mesh-list
111023880|NCT03566225|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111023881|NCT03566225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111023882|NCT03566225|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111023883|NCT03566225|Hormone Antagonists|hormone antagonists|mesh-ancestor
111023884|NCT03566225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111023885|NCT03566225|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111023886|NCT03566225|Fertility Agents|fertility agents|mesh-ancestor
111023887|NCT03566225|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111023888|NCT03566225|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111023889|NCT03566225|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111023890|NCT02397694|Dolutegravir|dolutegravir|mesh-list
111023891|NCT02397694|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111023892|NCT02397694|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111023893|NCT02397694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111023894|NCT02397694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111023895|NCT02397694|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111023896|NCT02397694|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111023897|NCT02397694|Antiviral Agents|antiviral agents|mesh-ancestor
111023898|NCT02397694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111023899|NCT03566069|Oxytocin|oxytocin|mesh-list
111023900|NCT03566069|Oxytocics|oxytocics|mesh-ancestor
111023901|NCT03566069|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111023902|NCT03566069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111023903|NCT03567629|Calcium, Dietary|calcium, dietary|mesh-list
111023904|NCT03567629|Leucovorin|leucovorin|mesh-list
111023905|NCT03567629|Bevacizumab|bevacizumab|mesh-list
111023906|NCT03567629|Cetuximab|cetuximab|mesh-list
111023907|NCT03567629|Fluorouracil|fluorouracil|mesh-list
111023908|NCT03567629|Capecitabine|capecitabine|mesh-list
111023909|NCT03567629|Oxaliplatin|oxaliplatin|mesh-list
111023910|NCT03567629|Irinotecan|irinotecan|mesh-list
111023911|NCT03567629|Calcium|calcium|mesh-list
111023912|NCT03567629|Levoleucovorin|levoleucovorin|mesh-list
111023913|NCT03567629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111023914|NCT03567629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111023915|NCT03567629|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111023916|NCT03567629|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111023917|NCT03567629|Growth Substances|growth substances|mesh-ancestor
111023918|NCT03567629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111023920|NCT03567629|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111023921|NCT03567629|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111023923|NCT03567629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111023924|NCT03567629|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111023925|NCT03567629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111023926|NCT03567629|Immunologic Factors|immunologic factors|mesh-ancestor
111023927|NCT03567629|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111023928|NCT03567629|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111023929|NCT03567629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111023930|NCT03567629|Antidotes|antidotes|mesh-ancestor
111023931|NCT03567629|Protective Agents|protective agents|mesh-ancestor
111023932|NCT03567629|Vitamin B Complex|vitamin b complex|mesh-ancestor
111023933|NCT03567629|Vitamins|vitamins|mesh-ancestor
111023934|NCT03567629|Micronutrients|micronutrients|mesh-ancestor
111023935|NCT02783599|Doxorubicin|doxorubicin|mesh-list
111023936|NCT02783599|Olaratumab|olaratumab|mesh-list
111023937|NCT02783599|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111023938|NCT02783599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111023939|NCT02783599|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111023940|NCT02783599|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111023941|NCT02783599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111023942|NCT02783599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111023943|NCT03567395|Melatonin|melatonin|mesh-list
111023944|NCT03567395|Antioxidants|antioxidants|mesh-ancestor
111023945|NCT03567395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111023946|NCT03567395|Protective Agents|protective agents|mesh-ancestor
111023947|NCT03567395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111023948|NCT03567395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111023949|NCT03565133|Quinine|quinine|mesh-list
111023950|NCT03565133|Antimalarials|antimalarials|mesh-ancestor
111023951|NCT03565133|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111023952|NCT03565133|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111023953|NCT03565133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111023954|NCT03565133|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
111023955|NCT03565133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111023956|NCT03565133|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111023957|NCT03565133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111023958|NCT03565133|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111023959|NCT03565133|Analgesics|analgesics|mesh-ancestor
111023960|NCT03565133|Sensory System Agents|sensory system agents|mesh-ancestor
111023961|NCT05353673|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111023962|NCT05353673|Danazol|danazol|mesh-list
111023963|NCT05353673|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111023964|NCT05353673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111023965|NCT05353673|Incretins|incretins|mesh-ancestor
111023966|NCT05353673|Hormones|hormones|mesh-ancestor
111023967|NCT05353673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111023968|NCT05353673|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111023969|NCT05353673|Protease Inhibitors|protease inhibitors|mesh-ancestor
111023970|NCT05353673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111023971|NCT05353673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111023972|NCT05353673|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111023973|NCT05353673|Hormone Antagonists|hormone antagonists|mesh-ancestor
111023974|NCT05353205|Flumatinib|flumatinib|mesh-list
111023975|NCT05353205|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111023976|NCT05353205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111023977|NCT05353205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111023978|NCT03068234|Pirfenidone|pirfenidone|mesh-list
111023979|NCT03068234|Analgesics|analgesics|mesh-ancestor
111023980|NCT03068234|Sensory System Agents|sensory system agents|mesh-ancestor
111023981|NCT03068234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111023982|NCT03068234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111023983|NCT03068234|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111023984|NCT03068234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111023985|NCT03068234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111023986|NCT03068234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111023987|NCT03068234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111023988|NCT05339399|Oxytocin|oxytocin|mesh-list
111023989|NCT05339399|Oxytocics|oxytocics|mesh-ancestor
111023990|NCT05339399|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111023991|NCT05339399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111023992|NCT05634824|Immunoglobulins|immunoglobulins|mesh-list
111023994|NCT05634824|Antibodies|antibodies|mesh-list
111023995|NCT05634824|gamma-Globulins|gamma-globulins|mesh-list
111023996|NCT05634824|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
111023997|NCT05634824|Immunologic Factors|immunologic factors|mesh-ancestor
111023998|NCT05634824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111023999|NCT02454478|Everolimus|everolimus|mesh-list
111024000|NCT02454478|Lenvatinib|lenvatinib|mesh-list
111024001|NCT02454478|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111024002|NCT02454478|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111024003|NCT02454478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110624358|NCT00816426|Leprostatic Agents|leprostatic agents|mesh-ancestor
111024004|NCT02454478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111024005|NCT02454478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111024006|NCT02454478|Immunologic Factors|immunologic factors|mesh-ancestor
111024007|NCT02454478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111024008|NCT02454478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111024009|NCT02359097|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
111024010|NCT02359097|Hematinics|hematinics|mesh-ancestor
111024011|NCT02359097|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
111024012|NCT02359097|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111024013|NCT03563963|Lidocaine|lidocaine|mesh-list
111024014|NCT03563963|Ropivacaine|ropivacaine|mesh-list
111024015|NCT03563963|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111024016|NCT03563963|Anesthetics, Local|anesthetics, local|mesh-ancestor
111024017|NCT03563963|Anesthetics|anesthetics|mesh-ancestor
111024018|NCT03563963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111024019|NCT03563963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111024020|NCT03563963|Sensory System Agents|sensory system agents|mesh-ancestor
111024021|NCT03563963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111024022|NCT03563963|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111024023|NCT03563963|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111024024|NCT03563963|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111024025|NCT03563963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111024026|NCT03563963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111024027|NCT03066518|Melatonin|melatonin|mesh-list
111024028|NCT03066518|Antioxidants|antioxidants|mesh-ancestor
111024029|NCT03066518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111024030|NCT03066518|Protective Agents|protective agents|mesh-ancestor
111024031|NCT03066518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111024032|NCT03066518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111024033|NCT03069248|Interferons|interferons|mesh-list
111024034|NCT03069248|Interferon-alpha|interferon-alpha|mesh-list
111024035|NCT03069248|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
111024036|NCT03069248|Rituximab|rituximab|mesh-list
111024037|NCT03069248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111024038|NCT03069248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111024039|NCT03069248|Immunologic Factors|immunologic factors|mesh-ancestor
111024040|NCT03069248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111024041|NCT03069248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111024042|NCT03069248|Antiviral Agents|antiviral agents|mesh-ancestor
111024043|NCT03069248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111024044|NCT05730062|Oxycodone|oxycodone|mesh-list
111024045|NCT05730062|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111024046|NCT05730062|Narcotics|narcotics|mesh-ancestor
111024047|NCT05730062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111024048|NCT05730062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111024049|NCT05730062|Analgesics|analgesics|mesh-ancestor
111024050|NCT05730062|Sensory System Agents|sensory system agents|mesh-ancestor
111024051|NCT05730062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111024052|NCT03068936|Cisplatin|cisplatin|mesh-list
111024053|NCT03068936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111024054|NCT05017610|Lomustine|lomustine|mesh-list
111024055|NCT05017610|Methimazole|methimazole|mesh-list
111024056|NCT05017610|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111024057|NCT05017610|Alkylating Agents|alkylating agents|mesh-ancestor
111024058|NCT05017610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111024059|NCT05017610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111024060|NCT05017610|Antithyroid Agents|antithyroid agents|mesh-ancestor
111024061|NCT05017610|Hormone Antagonists|hormone antagonists|mesh-ancestor
111024062|NCT05017610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111024063|NCT05017610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111024064|NCT02431468|Bryostatin 1|bryostatin 1|mesh-list
111024065|NCT02431468|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111024066|NCT02431468|Immunologic Factors|immunologic factors|mesh-ancestor
111024067|NCT02431468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111024068|NCT02431468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111024069|NCT04454528|Pembrolizumab|pembrolizumab|mesh-list
111024070|NCT04454528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111024071|NCT04454528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111024072|NCT04454528|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111024073|NCT04454528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111024075|NCT02452762|Cholecalciferol|cholecalciferol|mesh-list
111024076|NCT02452762|Vitamins|vitamins|mesh-ancestor
111024077|NCT02452762|Micronutrients|micronutrients|mesh-ancestor
111024078|NCT02452762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111024079|NCT02452762|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111024080|NCT02452762|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111024081|NCT04886414|Hand Sanitizers|hand sanitizers|mesh-list
111024082|NCT04886414|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111024083|NCT04886414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111024084|NCT04886414|Disinfectants|disinfectants|mesh-ancestor
111024085|NCT05633420|Artesunate|artesunate|mesh-list
111024086|NCT05633420|Pyronaridine|pyronaridine|mesh-list
111024087|NCT05633420|Pyronaridine tetraphosphate, artesunate drug combination|pyronaridine tetraphosphate, artesunate drug combination|mesh-list
111024088|NCT05633420|Antimalarials|antimalarials|mesh-ancestor
111024089|NCT05633420|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111024090|NCT05633420|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111024091|NCT05633420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111024092|NCT05633420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111024093|NCT05633420|Antiviral Agents|antiviral agents|mesh-ancestor
111024094|NCT05633420|Schistosomicides|schistosomicides|mesh-ancestor
111024095|NCT05633420|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
111024096|NCT05633420|Anthelmintics|anthelmintics|mesh-ancestor
111024097|NCT05729594|Bimatoprost|bimatoprost|mesh-list
111024098|NCT05729594|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111024099|NCT02631746|Nivolumab|nivolumab|mesh-list
111024100|NCT02631746|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111024101|NCT02631746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111024102|NCT02631746|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111024103|NCT02631746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111024104|NCT04699058|Antibodies|antibodies|mesh-list
111024105|NCT04699058|Immunologic Factors|immunologic factors|mesh-ancestor
111024106|NCT04699058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111024107|NCT05487092|Letrozole|letrozole|mesh-list
111024108|NCT05487092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111024109|NCT05487092|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111024110|NCT05487092|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111024111|NCT05487092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111024112|NCT05487092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111024113|NCT05487092|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111024114|NCT05487092|Hormone Antagonists|hormone antagonists|mesh-ancestor
111024115|NCT05487092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111024116|NCT05487092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111024117|NCT05728892|Melatonin|melatonin|mesh-list
111024118|NCT05728892|Antioxidants|antioxidants|mesh-ancestor
111024119|NCT05728892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111024120|NCT05728892|Protective Agents|protective agents|mesh-ancestor
111024121|NCT05728892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111024122|NCT05728892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111024123|NCT03067688|Amlodipine|amlodipine|mesh-list
111024124|NCT03067688|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
111024125|NCT03067688|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111024126|NCT03067688|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111024127|NCT03067688|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111024128|NCT03067688|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111024129|NCT03067688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111024130|NCT03067688|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111024131|NCT03067688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111024132|NCT03067688|Vasodilator Agents|vasodilator agents|mesh-ancestor
111024133|NCT03067688|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111024134|NCT03067688|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111024135|NCT03067688|Antimetabolites|antimetabolites|mesh-ancestor
111024136|NCT03067688|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111024137|NCT03067688|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111024138|NCT03067688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111024139|NCT03067688|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111024140|NCT03067688|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111024141|NCT02396758|Plasminogen|plasminogen|mesh-list
111024142|NCT02396758|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
111024144|NCT02396758|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111024145|NCT02396758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111024146|NCT05728424|Amoxicillin|amoxicillin|mesh-list
111024147|NCT05728424|Levofloxacin|levofloxacin|mesh-list
111024148|NCT05728424|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111024149|NCT05728424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111024150|NCT05728424|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111024151|NCT05728424|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111024152|NCT05728424|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111024153|NCT05728424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111024154|NCT05728424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111024155|NCT05728424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111024156|NCT05728424|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111024157|NCT05728424|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111024158|NCT05728268|Paclitaxel|paclitaxel|mesh-list
111024159|NCT05728268|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111024160|NCT05728268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111024161|NCT05728268|Tubulin Modulators|tubulin modulators|mesh-ancestor
111024162|NCT05728268|Antimitotic Agents|antimitotic agents|mesh-ancestor
111024163|NCT05728268|Mitosis Modulators|mitosis modulators|mesh-ancestor
111024164|NCT05728268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111024165|NCT04882358|Dapagliflozin|dapagliflozin|mesh-list
111024166|NCT04882358|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
111024167|NCT04882358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111024168|NCT04882358|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111024169|NCT04882358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111024170|NCT04926844|Midazolam|midazolam|mesh-list
111024171|NCT04926844|Levetiracetam|levetiracetam|mesh-list
111024172|NCT04926844|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111024173|NCT04926844|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111024174|NCT04926844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111024175|NCT04926844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111024176|NCT04926844|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111024177|NCT04926844|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111024178|NCT04926844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111024179|NCT04926844|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111024180|NCT04926844|Anesthetics, General|anesthetics, general|mesh-ancestor
111024181|NCT04926844|Anesthetics|anesthetics|mesh-ancestor
111024182|NCT04926844|GABA Modulators|gaba modulators|mesh-ancestor
111024183|NCT04926844|GABA Agents|gaba agents|mesh-ancestor
111024184|NCT04926844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111024185|NCT04926844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111024186|NCT04926844|Anticonvulsants|anticonvulsants|mesh-ancestor
111024187|NCT04926844|Nootropic Agents|nootropic agents|mesh-ancestor
111024188|NCT05482256|Listerine|listerine|mesh-list
111024189|NCT05482256|Sodium Fluoride|sodium fluoride|mesh-list
111024190|NCT05482256|Cariostatic Agents|cariostatic agents|mesh-ancestor
111024191|NCT05482256|Protective Agents|protective agents|mesh-ancestor
111024192|NCT05482256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111024193|NCT05482256|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111024194|NCT05482256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111024195|NCT01651936|Methotrexate|methotrexate|mesh-list
111024196|NCT01651936|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111024197|NCT01651936|Abortifacient Agents|abortifacient agents|mesh-ancestor
111024198|NCT01651936|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111024199|NCT01651936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111024200|NCT01651936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111024201|NCT01651936|Antimetabolites|antimetabolites|mesh-ancestor
111024202|NCT01651936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111024203|NCT01651936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111024204|NCT01651936|Dermatologic Agents|dermatologic agents|mesh-ancestor
111024205|NCT01651936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111024206|NCT01651936|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111024207|NCT01651936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111024208|NCT01651936|Immunologic Factors|immunologic factors|mesh-ancestor
111024209|NCT01651936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111024210|NCT01651936|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111024211|NCT04075916|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
111024212|NCT04075916|Antiviral Agents|antiviral agents|mesh-ancestor
111024213|NCT04075916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111024215|NCT03065504|Antioxidants|antioxidants|mesh-ancestor
110741342|NCT01219088|Morphine|morphine|mesh-list
111024216|NCT03065504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111024217|NCT03065504|Protective Agents|protective agents|mesh-ancestor
111024218|NCT03065504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111024219|NCT02630966|Vedolizumab|vedolizumab|mesh-list
111024220|NCT02630966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111024221|NCT05724212|Interferons|interferons|mesh-list
111024222|NCT05724212|Interferon-gamma|interferon-gamma|mesh-list
111024223|NCT05724212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111024224|NCT05724212|Antiviral Agents|antiviral agents|mesh-ancestor
111024225|NCT05724212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111024226|NCT01651780|Heparin|heparin|mesh-list
111024227|NCT01651780|Calcium heparin|calcium heparin|mesh-list
111024228|NCT01651780|Bivalirudin|bivalirudin|mesh-list
111024229|NCT01651780|Anticoagulants|anticoagulants|mesh-ancestor
111024230|NCT01651780|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111024231|NCT01651780|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111024232|NCT01651780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111024233|NCT01651780|Antithrombins|antithrombins|mesh-ancestor
111024234|NCT01651780|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111024235|NCT01651780|Protease Inhibitors|protease inhibitors|mesh-ancestor
111024236|NCT01651780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111024237|NCT02394730|Vorapaxar|vorapaxar|mesh-list
111024238|NCT02394730|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111024239|NCT05376878|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111024240|NCT05376878|Trastuzumab|trastuzumab|mesh-list
111024241|NCT05376878|Camptothecin|camptothecin|mesh-list
111024242|NCT05376878|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
111024243|NCT05376878|Antibodies|antibodies|mesh-list
111024244|NCT05376878|Immunoglobulins|immunoglobulins|mesh-list
111024245|NCT05376878|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111024246|NCT05376878|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
111024247|NCT05376878|Immunoconjugates|immunoconjugates|mesh-list
111024248|NCT05376878|Immunologic Factors|immunologic factors|mesh-ancestor
111024249|NCT05376878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111024250|NCT05376878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111024251|NCT05376878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111024252|NCT05376878|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111024253|NCT05376878|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111024254|NCT05376878|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111024255|NCT05376878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111024256|NCT02430532|Dimethyl Fumarate|dimethyl fumarate|mesh-list
111024257|NCT02430532|Dermatologic Agents|dermatologic agents|mesh-ancestor
111024258|NCT02430532|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111024259|NCT02430532|Immunologic Factors|immunologic factors|mesh-ancestor
111024260|NCT02430532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111024261|NCT05357612|Pimavanserin|pimavanserin|mesh-list
111024262|NCT05357612|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111024263|NCT05357612|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111024264|NCT05357612|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111024265|NCT05357612|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111024266|NCT05357612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111024267|NCT05357612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111024268|NCT05357612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111024269|NCT05357612|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111024270|NCT05357612|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111024271|NCT05357612|Serotonin Agents|serotonin agents|mesh-ancestor
111024272|NCT05357612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111024273|NCT05357612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111024274|NCT02394340|Luliconazole|luliconazole|mesh-list
111024275|NCT02394340|Omeprazole|omeprazole|mesh-list
111024276|NCT02394340|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111024277|NCT02394340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111024278|NCT02394340|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111024279|NCT02394340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111024280|NCT02394340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111024281|NCT02394340|Antifungal Agents|antifungal agents|mesh-ancestor
111024282|NCT02394340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111024283|NCT01672736|Dexamethasone|dexamethasone|mesh-list
111024284|NCT01672736|Dexamethasone acetate|dexamethasone acetate|mesh-list
111024285|NCT01672736|Bortezomib|bortezomib|mesh-list
111024286|NCT01672736|BB 1101|bb 1101|mesh-list
111024287|NCT01672736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111024288|NCT01672736|Antiemetics|antiemetics|mesh-ancestor
111024289|NCT01672736|Autonomic Agents|autonomic agents|mesh-ancestor
111024290|NCT01672736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110741402|NCT01119482|Vaccines|vaccines|mesh-list
111024291|NCT01672736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111024292|NCT01672736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111024293|NCT01672736|Glucocorticoids|glucocorticoids|mesh-ancestor
111024294|NCT01672736|Hormones|hormones|mesh-ancestor
111024295|NCT01672736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111024296|NCT01672736|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111024297|NCT01672736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111024298|NCT01672736|Protease Inhibitors|protease inhibitors|mesh-ancestor
111024299|NCT01672736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111024300|NCT01672736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111024301|NCT03065660|Mifepristone|mifepristone|mesh-list
111024302|NCT03065660|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
111024303|NCT03065660|Abortifacient Agents|abortifacient agents|mesh-ancestor
111024304|NCT03065660|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111024305|NCT03065660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111024306|NCT03065660|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111024307|NCT03065660|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111024308|NCT03065660|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111024309|NCT03065660|Contraceptive Agents|contraceptive agents|mesh-ancestor
111024310|NCT03065660|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
111024311|NCT03065660|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
111024312|NCT03065660|Hormone Antagonists|hormone antagonists|mesh-ancestor
111024313|NCT03065660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111024314|NCT03065660|Luteolytic Agents|luteolytic agents|mesh-ancestor
111024315|NCT03065660|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111024316|NCT03065660|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
111024317|NCT03893630|Aspirin|aspirin|mesh-list
111024318|NCT03893630|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111024319|NCT03893630|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111024320|NCT03893630|Analgesics|analgesics|mesh-ancestor
111024321|NCT03893630|Sensory System Agents|sensory system agents|mesh-ancestor
111024322|NCT03893630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111024323|NCT03893630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111024324|NCT03893630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111024325|NCT03893630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111024326|NCT03893630|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111024327|NCT03893630|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111024328|NCT03893630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111024329|NCT03893630|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111024330|NCT03893630|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111024331|NCT03893630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111024332|NCT03893630|Antipyretics|antipyretics|mesh-ancestor
111024333|NCT03065816|Alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|mesh-list
111024334|NCT03065816|Antacids|antacids|mesh-ancestor
111024335|NCT03065816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111024336|NCT03065816|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111024337|NCT05619848|Midazolam|midazolam|mesh-list
111024338|NCT05619848|Remifentanil|remifentanil|mesh-list
111024339|NCT05619848|Bromides|bromides|mesh-list
111024340|NCT05619848|Propofol|propofol|mesh-list
111024341|NCT05619848|Etomidate|etomidate|mesh-list
111024342|NCT05619848|Rocuronium|rocuronium|mesh-list
111024343|NCT05619848|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111024344|NCT05619848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111024345|NCT05619848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111024346|NCT05619848|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111024347|NCT05619848|Anesthetics, General|anesthetics, general|mesh-ancestor
111024348|NCT05619848|Anesthetics|anesthetics|mesh-ancestor
111024349|NCT05619848|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111024350|NCT05619848|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111024351|NCT05619848|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111024352|NCT05619848|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111024353|NCT05619848|GABA Modulators|gaba modulators|mesh-ancestor
111024354|NCT05619848|GABA Agents|gaba agents|mesh-ancestor
111024355|NCT05619848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111024356|NCT05619848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111024357|NCT05619848|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111024358|NCT05619848|Narcotics|narcotics|mesh-ancestor
111024359|NCT05619848|Analgesics|analgesics|mesh-ancestor
111024360|NCT05619848|Sensory System Agents|sensory system agents|mesh-ancestor
111024361|NCT05619848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111024362|NCT05619848|Anticonvulsants|anticonvulsants|mesh-ancestor
111024363|NCT05619848|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
111024364|NCT05619848|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
111024365|NCT05619848|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111024366|NCT01560637|Treprostinil|treprostinil|mesh-list
111024367|NCT01560637|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111024369|NCT04447352|Docetaxel|docetaxel|mesh-list
111024370|NCT04447352|Fluorouracil|fluorouracil|mesh-list
111024371|NCT04447352|Oxaliplatin|oxaliplatin|mesh-list
111024372|NCT04447352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111024373|NCT04447352|Tubulin Modulators|tubulin modulators|mesh-ancestor
111024374|NCT04447352|Antimitotic Agents|antimitotic agents|mesh-ancestor
111024375|NCT04447352|Mitosis Modulators|mitosis modulators|mesh-ancestor
111024376|NCT04447352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111024377|NCT04447352|Antimetabolites|antimetabolites|mesh-ancestor
111024378|NCT04447352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111024379|NCT04447352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111024380|NCT04447352|Immunologic Factors|immunologic factors|mesh-ancestor
111024381|NCT04447352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111024382|NCT04447352|Antidotes|antidotes|mesh-ancestor
111024383|NCT04447352|Protective Agents|protective agents|mesh-ancestor
111024384|NCT04447352|Vitamin B Complex|vitamin b complex|mesh-ancestor
111024385|NCT04447352|Vitamins|vitamins|mesh-ancestor
111024386|NCT04447352|Micronutrients|micronutrients|mesh-ancestor
111024387|NCT04157036|Ibuprofen|ibuprofen|mesh-list
111024388|NCT04157036|Methylprednisolone|methylprednisolone|mesh-list
111024389|NCT04157036|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111024390|NCT04157036|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111024391|NCT04157036|Prednisolone|prednisolone|mesh-list
111024392|NCT04157036|Prednisolone acetate|prednisolone acetate|mesh-list
111024393|NCT04157036|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111024394|NCT04157036|Prednisolone phosphate|prednisolone phosphate|mesh-list
111024395|NCT04157036|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111024396|NCT04157036|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111024397|NCT04157036|Analgesics|analgesics|mesh-ancestor
111024398|NCT04157036|Sensory System Agents|sensory system agents|mesh-ancestor
111024399|NCT04157036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111024400|NCT04157036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111024401|NCT04157036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111024402|NCT04157036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111024403|NCT04157036|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111024404|NCT04157036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111024405|NCT04157036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111024406|NCT04157036|Antiemetics|antiemetics|mesh-ancestor
111024407|NCT04157036|Autonomic Agents|autonomic agents|mesh-ancestor
111024408|NCT04157036|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111024409|NCT04157036|Glucocorticoids|glucocorticoids|mesh-ancestor
111024410|NCT04157036|Hormones|hormones|mesh-ancestor
111024411|NCT04157036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111024412|NCT04157036|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111024413|NCT04157036|Protective Agents|protective agents|mesh-ancestor
111024414|NCT04157036|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111024415|NCT04157036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111024416|NCT03547375|Apatinib|apatinib|mesh-list
111024417|NCT03547375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111024418|NCT03547375|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111024419|NCT03547375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111024420|NCT03547375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111024421|NCT01353911|Interferons|interferons|mesh-list
111024422|NCT01353911|Ribavirin|ribavirin|mesh-list
111024423|NCT01353911|Interferon-alpha|interferon-alpha|mesh-list
111024424|NCT01353911|Interferon alpha-2|interferon alpha-2|mesh-list
111024425|NCT01353911|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
111024426|NCT01353911|Grazoprevir|grazoprevir|mesh-list
111024427|NCT01353911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111024428|NCT01353911|Antiviral Agents|antiviral agents|mesh-ancestor
111024429|NCT01353911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111024430|NCT01353911|Antimetabolites|antimetabolites|mesh-ancestor
111024431|NCT01353911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111024432|NCT01353911|Immunologic Factors|immunologic factors|mesh-ancestor
111024433|NCT01353911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111024434|NCT05575297|Rifampin|rifampin|mesh-list
111024435|NCT05575297|Methotrexate|methotrexate|mesh-list
111024436|NCT05575297|Febuxostat|febuxostat|mesh-list
110827148|NCT03715296|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111024437|NCT05575297|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111024438|NCT05575297|Abortifacient Agents|abortifacient agents|mesh-ancestor
111024439|NCT05575297|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111024440|NCT05575297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111024441|NCT05575297|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111024442|NCT05575297|Antimetabolites|antimetabolites|mesh-ancestor
111024443|NCT05575297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111024444|NCT05575297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111024445|NCT05575297|Dermatologic Agents|dermatologic agents|mesh-ancestor
111024446|NCT05575297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111024447|NCT05575297|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111024448|NCT05575297|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111024449|NCT05575297|Immunologic Factors|immunologic factors|mesh-ancestor
111024450|NCT05575297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111024451|NCT05575297|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111024452|NCT05575297|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111024453|NCT05575297|Antitubercular Agents|antitubercular agents|mesh-ancestor
111024454|NCT05575297|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111024455|NCT05575297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111024456|NCT05575297|Leprostatic Agents|leprostatic agents|mesh-ancestor
111024457|NCT05575297|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111024458|NCT05575297|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111024459|NCT05575297|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
111024460|NCT05575297|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
111024461|NCT05575297|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
111024462|NCT05575297|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111024463|NCT05575297|Gout Suppressants|gout suppressants|mesh-ancestor
111024464|NCT01671488|Mitomycins|mitomycins|mesh-list
111024465|NCT01671488|Mitomycin|mitomycin|mesh-list
111024466|NCT01671488|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111024467|NCT01671488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111024468|NCT01671488|Alkylating Agents|alkylating agents|mesh-ancestor
111024469|NCT01671488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111024470|NCT01671488|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111024471|NCT01671488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111024472|NCT05400889|Tofacitinib|tofacitinib|mesh-list
111024473|NCT05400889|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
111024474|NCT05400889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111024475|NCT05400889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111024476|NCT05400889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111024477|NCT05395117|Digoxin|digoxin|mesh-list
111024478|NCT05395117|Midazolam|midazolam|mesh-list
111024479|NCT05395117|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111024480|NCT05395117|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111024481|NCT05395117|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111024482|NCT05395117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111024483|NCT05395117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111024484|NCT05395117|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111024485|NCT05395117|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111024486|NCT05395117|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111024487|NCT05395117|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111024488|NCT05395117|Anesthetics, General|anesthetics, general|mesh-ancestor
111024489|NCT05395117|Anesthetics|anesthetics|mesh-ancestor
111024490|NCT05395117|GABA Modulators|gaba modulators|mesh-ancestor
111024491|NCT05395117|GABA Agents|gaba agents|mesh-ancestor
111024492|NCT05395117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111024493|NCT05395117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111024494|NCT05395117|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111024495|NCT05395117|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111024496|NCT05395117|Antimetabolites|antimetabolites|mesh-ancestor
111024497|NCT05395117|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111024498|NCT05395117|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111024499|NCT05395117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111024500|NCT05395117|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111024501|NCT05395117|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111024502|NCT05395117|Protective Agents|protective agents|mesh-ancestor
111024503|NCT05325229|Bevacizumab|bevacizumab|mesh-list
111024504|NCT05325229|Docetaxel|docetaxel|mesh-list
111024505|NCT05325229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111024506|NCT05325229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111024507|NCT05325229|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111024508|NCT05325229|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111024509|NCT05325229|Growth Substances|growth substances|mesh-ancestor
111024510|NCT05325229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111024511|NCT05325229|Growth Inhibitors|growth inhibitors|mesh-ancestor
111024512|NCT05325229|Tubulin Modulators|tubulin modulators|mesh-ancestor
111024513|NCT05325229|Antimitotic Agents|antimitotic agents|mesh-ancestor
111024514|NCT05325229|Mitosis Modulators|mitosis modulators|mesh-ancestor
111024515|NCT05325229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111024516|NCT05573581|Botulinum Toxins|botulinum toxins|mesh-list
111024517|NCT05573581|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110741614|NCT01121120|Vasodilator Agents|vasodilator agents|mesh-ancestor
111024518|NCT05573581|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111024519|NCT05573581|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111024520|NCT05573581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111024521|NCT05573581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111024522|NCT05573581|Cholinergic Agents|cholinergic agents|mesh-ancestor
111024523|NCT05573581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111024524|NCT05573581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111024525|NCT05573581|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111024526|NCT05573581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111024527|NCT01358357|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
111024528|NCT01358357|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111024529|NCT01358357|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111024530|NCT01358357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111024531|NCT01358357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111024532|NCT01358357|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111024533|NCT01358357|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
111024534|NCT01358357|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111024535|NCT01358357|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111024536|NCT01358357|Adrenergic Agents|adrenergic agents|mesh-ancestor
111024537|NCT01358357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111024538|NCT01358357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111024539|NCT01358357|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111024540|NCT01358357|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111024541|NCT01358357|Serotonin Agents|serotonin agents|mesh-ancestor
111024542|NCT01358357|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111024543|NCT01358357|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111024544|NCT01358357|Dopamine Agents|dopamine agents|mesh-ancestor
111024545|NCT05573425|Tazarotene|tazarotene|mesh-list
111024546|NCT05573425|Dermatologic Agents|dermatologic agents|mesh-ancestor
111024547|NCT05573425|Keratolytic Agents|keratolytic agents|mesh-ancestor
111024548|NCT02253901|Ritonavir|ritonavir|mesh-list
111024549|NCT02253901|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
111024550|NCT02253901|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111024551|NCT02253901|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111024552|NCT02253901|Protease Inhibitors|protease inhibitors|mesh-ancestor
111024553|NCT02253901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111024554|NCT02253901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111024555|NCT02253901|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111024556|NCT02253901|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111024557|NCT02253901|Antiviral Agents|antiviral agents|mesh-ancestor
111024558|NCT02253901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111024559|NCT02253901|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111024560|NCT02253901|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111024561|NCT02253901|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111024562|NCT02253901|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111024563|NCT03546283|Cardiac Glycosides|cardiac glycosides|mesh-list
111024564|NCT03546283|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111024565|NCT03546283|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111024566|NCT03546283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111024567|NCT03546283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111024568|NCT03546283|Protective Agents|protective agents|mesh-ancestor
111024569|NCT03546283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111024570|NCT02831387|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111024571|NCT02831387|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111024572|NCT03547219|Escitalopram|escitalopram|mesh-list
111024573|NCT03547219|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111024574|NCT03547219|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111024575|NCT03547219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111024576|NCT03547219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111024577|NCT03547219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111024578|NCT03547219|Serotonin Agents|serotonin agents|mesh-ancestor
111024579|NCT03547219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111024580|NCT04069819|Cilostazol|cilostazol|mesh-list
111024581|NCT04069819|Escitalopram|escitalopram|mesh-list
111024582|NCT04069819|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111024583|NCT04069819|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111024584|NCT04069819|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111024585|NCT04069819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111024586|NCT04069819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111024587|NCT04069819|Serotonin Agents|serotonin agents|mesh-ancestor
111024588|NCT04069819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111024589|NCT04069819|Autonomic Agents|autonomic agents|mesh-ancestor
111024590|NCT04069819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111024591|NCT04069819|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111024592|NCT04069819|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111024593|NCT04069819|Respiratory System Agents|respiratory system agents|mesh-ancestor
111024594|NCT04069819|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111024595|NCT04069819|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111024596|NCT04069819|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111024597|NCT04069819|Vasodilator Agents|vasodilator agents|mesh-ancestor
111024598|NCT04069819|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111024599|NCT04069819|Protective Agents|protective agents|mesh-ancestor
111024600|NCT04069819|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
111024601|NCT04069819|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111024602|NCT04069819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111024603|NCT04084496|Folfirinox|folfirinox|mesh-list
111024604|NCT04084496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111024605|NCT02831855|Methotrexate|methotrexate|mesh-list
111024606|NCT02831855|Tofacitinib|tofacitinib|mesh-list
111024607|NCT02831855|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111024608|NCT02831855|Abortifacient Agents|abortifacient agents|mesh-ancestor
111024609|NCT02831855|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111024610|NCT02831855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111024611|NCT02831855|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111024612|NCT02831855|Antimetabolites|antimetabolites|mesh-ancestor
111024613|NCT02831855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111024614|NCT02831855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111024615|NCT02831855|Dermatologic Agents|dermatologic agents|mesh-ancestor
111024616|NCT02831855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111024617|NCT02831855|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111024618|NCT02831855|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111024619|NCT02831855|Immunologic Factors|immunologic factors|mesh-ancestor
111024620|NCT02831855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111024621|NCT02831855|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111024622|NCT02831855|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
111024623|NCT02831855|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111024624|NCT04071626|Ertugliflozin|ertugliflozin|mesh-list
111024625|NCT04071626|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110624489|NCT01066429|Dexamethasone|dexamethasone|mesh-list
111024626|NCT04071626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111024627|NCT04071626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111024628|NCT04071626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111024629|NCT01356407|Picosulfate sodium|picosulfate sodium|mesh-list
111024630|NCT01356407|Cathartics|cathartics|mesh-ancestor
111024631|NCT01356407|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111024632|NCT00109837|Leucovorin|leucovorin|mesh-list
111024633|NCT00109837|Cytarabine|cytarabine|mesh-list
111024634|NCT00109837|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
111024635|NCT00109837|Dexamethasone|dexamethasone|mesh-list
111024636|NCT00109837|Prednisone|prednisone|mesh-list
111024637|NCT00109837|Cyclophosphamide|cyclophosphamide|mesh-list
111024638|NCT00109837|Doxorubicin|doxorubicin|mesh-list
111024639|NCT00109837|Methotrexate|methotrexate|mesh-list
111024640|NCT00109837|Vincristine|vincristine|mesh-list
111024641|NCT00109837|Daunorubicin|daunorubicin|mesh-list
111024642|NCT00109837|Asparaginase|asparaginase|mesh-list
111024643|NCT00109837|Mitoxantrone|mitoxantrone|mesh-list
111024644|NCT00109837|Mercaptopurine|mercaptopurine|mesh-list
111024645|NCT00109837|Thioguanine|thioguanine|mesh-list
111024646|NCT00109837|Allopurinol|allopurinol|mesh-list
111024647|NCT00109837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111024648|NCT00109837|Immunologic Factors|immunologic factors|mesh-ancestor
111024649|NCT00109837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111024650|NCT00109837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111024651|NCT00109837|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111024652|NCT00109837|Alkylating Agents|alkylating agents|mesh-ancestor
111024653|NCT00109837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111024654|NCT00109837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111024655|NCT00109837|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111024657|NCT00109837|Antiemetics|antiemetics|mesh-ancestor
111024658|NCT00109837|Autonomic Agents|autonomic agents|mesh-ancestor
111024659|NCT00109837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111024660|NCT00109837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111024661|NCT00109837|Glucocorticoids|glucocorticoids|mesh-ancestor
111024662|NCT00109837|Hormones|hormones|mesh-ancestor
111024663|NCT00109837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111024664|NCT00109837|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111024665|NCT00109837|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111024666|NCT00109837|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111024667|NCT00109837|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111024668|NCT00109837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111024669|NCT00109837|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111024670|NCT00109837|Abortifacient Agents|abortifacient agents|mesh-ancestor
111024671|NCT00109837|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111024672|NCT00109837|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111024673|NCT00109837|Antimetabolites|antimetabolites|mesh-ancestor
111024674|NCT00109837|Dermatologic Agents|dermatologic agents|mesh-ancestor
111024675|NCT00109837|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111024676|NCT00109837|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111024677|NCT00109837|Antiviral Agents|antiviral agents|mesh-ancestor
111024678|NCT00109837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111024679|NCT00109837|Antidotes|antidotes|mesh-ancestor
111024680|NCT00109837|Protective Agents|protective agents|mesh-ancestor
111024681|NCT00109837|Vitamin B Complex|vitamin b complex|mesh-ancestor
111024682|NCT00109837|Vitamins|vitamins|mesh-ancestor
111024683|NCT00109837|Micronutrients|micronutrients|mesh-ancestor
111024684|NCT00109837|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111024685|NCT00109837|Tubulin Modulators|tubulin modulators|mesh-ancestor
111024686|NCT00109837|Antimitotic Agents|antimitotic agents|mesh-ancestor
111024687|NCT00109837|Mitosis Modulators|mitosis modulators|mesh-ancestor
111024688|NCT00109837|Analgesics|analgesics|mesh-ancestor
111024689|NCT00109837|Sensory System Agents|sensory system agents|mesh-ancestor
111024690|NCT00109837|Gout Suppressants|gout suppressants|mesh-ancestor
111024691|NCT00109837|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111024692|NCT00109837|Antioxidants|antioxidants|mesh-ancestor
111024693|NCT00109837|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111024694|NCT00109837|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111024695|NCT00109837|Antimalarials|antimalarials|mesh-ancestor
111024696|NCT00109837|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111024697|NCT00109837|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111024698|NCT05229445|Insulin|insulin|mesh-list
111024699|NCT05229445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111024700|NCT05229445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111024701|NCT01671332|Suramin|suramin|mesh-list
111024702|NCT01671332|Docetaxel|docetaxel|mesh-list
111024703|NCT01671332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111024704|NCT01671332|Tubulin Modulators|tubulin modulators|mesh-ancestor
111024705|NCT01671332|Antimitotic Agents|antimitotic agents|mesh-ancestor
111024706|NCT01671332|Mitosis Modulators|mitosis modulators|mesh-ancestor
111024707|NCT01671332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111024708|NCT01671332|Antinematodal Agents|antinematodal agents|mesh-ancestor
111024709|NCT01671332|Anthelmintics|anthelmintics|mesh-ancestor
111024710|NCT01671332|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111024711|NCT01671332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111024712|NCT01671332|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
111024713|NCT01671332|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111024714|NCT03063242|Sargramostim|sargramostim|mesh-list
111024715|NCT03063242|Immunologic Factors|immunologic factors|mesh-ancestor
111024716|NCT03063242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111024717|NCT03897062|Suvorexant|suvorexant|mesh-list
111024718|NCT03897062|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111024719|NCT03897062|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111024720|NCT03897062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111024721|NCT03897062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111024722|NCT03897062|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
111024723|NCT03897062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111024724|NCT03897062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111024725|NCT00100802|Temozolomide|temozolomide|mesh-list
111024726|NCT00100802|Lomustine|lomustine|mesh-list
111024727|NCT00100802|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111024728|NCT00100802|Alkylating Agents|alkylating agents|mesh-ancestor
111024729|NCT00100802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111024730|NCT00100802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111024731|NCT01355159|Folic Acid|folic acid|mesh-list
111024732|NCT01355159|Hematinics|hematinics|mesh-ancestor
111024733|NCT01355159|Vitamin B Complex|vitamin b complex|mesh-ancestor
111024734|NCT01355159|Vitamins|vitamins|mesh-ancestor
111024735|NCT01355159|Micronutrients|micronutrients|mesh-ancestor
111024736|NCT01355159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111024737|NCT04661852|Cyclophosphamide|cyclophosphamide|mesh-list
111024738|NCT04661852|Topotecan|topotecan|mesh-list
111024739|NCT04661852|Mitogens|mitogens|mesh-list
111024740|NCT04661852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110741841|NCT01222442|Moxifloxacin|moxifloxacin|mesh-list
111024741|NCT04661852|Immunologic Factors|immunologic factors|mesh-ancestor
111024742|NCT04661852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111024743|NCT04661852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111024744|NCT04661852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111024751|NCT04661852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111024752|NCT04661852|Mitosis Modulators|mitosis modulators|mesh-ancestor
111024753|NCT02630186|Atezolizumab|atezolizumab|mesh-list
111024754|NCT02630186|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111024755|NCT02630186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111024756|NCT02630186|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111024757|NCT02630186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111024759|NCT00002462|Prednisone|prednisone|mesh-list
111024760|NCT00002462|Doxorubicin|doxorubicin|mesh-list
111024761|NCT00002462|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111024762|NCT00002462|Bleomycin|bleomycin|mesh-list
111024763|NCT00002462|Vincristine|vincristine|mesh-list
111024764|NCT00002462|Vinblastine|vinblastine|mesh-list
111024765|NCT00002462|Procarbazine|procarbazine|mesh-list
111024766|NCT00002462|Mechlorethamine|mechlorethamine|mesh-list
111024767|NCT00002462|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111024768|NCT00002462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111024769|NCT00002462|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111024770|NCT00002462|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111024771|NCT00002462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111024772|NCT00002462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111024773|NCT00002462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111024774|NCT00002462|Glucocorticoids|glucocorticoids|mesh-ancestor
111024775|NCT00002462|Hormones|hormones|mesh-ancestor
111024776|NCT00002462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111024777|NCT00002462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111024778|NCT00002462|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111024779|NCT00002462|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111024780|NCT00002462|Tubulin Modulators|tubulin modulators|mesh-ancestor
111024781|NCT00002462|Antimitotic Agents|antimitotic agents|mesh-ancestor
111024782|NCT00002462|Mitosis Modulators|mitosis modulators|mesh-ancestor
111024783|NCT00002462|Trace Elements|trace elements|mesh-ancestor
111024784|NCT00002462|Micronutrients|micronutrients|mesh-ancestor
111024785|NCT00002462|Alkylating Agents|alkylating agents|mesh-ancestor
111024786|NCT00002462|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111024787|NCT01669928|Antihypertensive Agents|antihypertensive agents|mesh-list
111024788|NCT01669928|Calcium Channel Blockers|calcium channel blockers|mesh-list
111024789|NCT01669928|Angiotensin II|angiotensin ii|mesh-list
111024790|NCT01669928|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
111024791|NCT01669928|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
111024792|NCT01669928|Renin Inhibitors|renin inhibitors|mesh-list
111024793|NCT01669928|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111024794|NCT01669928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111024795|NCT01669928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111024796|NCT01669928|Protease Inhibitors|protease inhibitors|mesh-ancestor
111024797|NCT01669928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111024798|NCT01669928|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111024799|NCT01669928|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111024806|NCT04440176|Vaccines|vaccines|mesh-list
111024807|NCT04440176|Immunologic Factors|immunologic factors|mesh-ancestor
111024808|NCT04440176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111024809|NCT03595592|Paclitaxel|paclitaxel|mesh-list
111024810|NCT03595592|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111024811|NCT03595592|Cyclophosphamide|cyclophosphamide|mesh-list
111024812|NCT03595592|Carboplatin|carboplatin|mesh-list
111024813|NCT03595592|Doxorubicin|doxorubicin|mesh-list
111024814|NCT03595592|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111024815|NCT03595592|Trastuzumab|trastuzumab|mesh-list
111024816|NCT03595592|Atezolizumab|atezolizumab|mesh-list
111024817|NCT03595592|Pertuzumab|pertuzumab|mesh-list
110827151|NCT03715296|Growth Inhibitors|growth inhibitors|mesh-ancestor
111024818|NCT03595592|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111024819|NCT03595592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111024820|NCT03595592|Tubulin Modulators|tubulin modulators|mesh-ancestor
111024821|NCT03595592|Antimitotic Agents|antimitotic agents|mesh-ancestor
111024822|NCT03595592|Mitosis Modulators|mitosis modulators|mesh-ancestor
111024823|NCT03595592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111024824|NCT03595592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111024825|NCT03595592|Immunologic Factors|immunologic factors|mesh-ancestor
111024826|NCT03595592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111024827|NCT03595592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111024828|NCT03595592|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111024829|NCT03595592|Alkylating Agents|alkylating agents|mesh-ancestor
111024830|NCT03595592|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111024831|NCT03595592|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111024832|NCT03595592|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111024833|NCT03595592|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111024834|NCT03595592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111024835|NCT03595592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111024836|NCT03595592|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111024837|NCT01355081|Vortioxetine|vortioxetine|mesh-list
111024838|NCT01355081|Antidepressive Agents|antidepressive agents|mesh-ancestor
111024839|NCT01355081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111024840|NCT01355081|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111024841|NCT01355081|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111024842|NCT01355081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111024843|NCT01355081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111024844|NCT01355081|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111024845|NCT01355081|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111024846|NCT01355081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111024847|NCT01355081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111024848|NCT01355081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111024849|NCT01355081|Serotonin Agents|serotonin agents|mesh-ancestor
111024850|NCT01355081|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111024851|NCT01355081|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111024852|NCT01355081|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111024853|NCT01355081|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111024854|NCT02259959|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111024855|NCT02259959|Tiotropium Bromide|tiotropium bromide|mesh-list
111024856|NCT02259959|Olodaterol|olodaterol|mesh-list
111024857|NCT02259959|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111024858|NCT02259959|Autonomic Agents|autonomic agents|mesh-ancestor
111024859|NCT02259959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111024860|NCT02259959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111024861|NCT02259959|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111024862|NCT02259959|Respiratory System Agents|respiratory system agents|mesh-ancestor
111024863|NCT02259959|Parasympatholytics|parasympatholytics|mesh-ancestor
111024864|NCT02259959|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111024865|NCT02259959|Cholinergic Agents|cholinergic agents|mesh-ancestor
111024866|NCT02259959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111024867|NCT02259959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111024868|NCT03062462|Clopidogrel|clopidogrel|mesh-list
111024869|NCT03062462|Ticagrelor|ticagrelor|mesh-list
111024870|NCT03062462|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111024871|NCT03062462|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111024872|NCT03062462|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111024873|NCT03062462|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111024874|NCT03062462|Purinergic Agents|purinergic agents|mesh-ancestor
111024875|NCT03062462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111024876|NCT03062462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111024877|NCT03062462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111024878|NCT04433078|Doxycycline|doxycycline|mesh-list
111024879|NCT04433078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111024880|NCT04433078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111024881|NCT04433078|Antimalarials|antimalarials|mesh-ancestor
111024882|NCT04433078|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111024883|NCT04433078|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111024884|NCT04458311|Abiraterone Acetate|abiraterone acetate|mesh-list
111024885|NCT04458311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111024886|NCT04458311|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111024887|NCT04458311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111024888|NCT04458311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111024889|NCT04458311|Hormone Antagonists|hormone antagonists|mesh-ancestor
111024890|NCT04458311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110741985|NCT01127594|Alkylating Agents|alkylating agents|mesh-ancestor
111024891|NCT04458311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111024892|NCT04458311|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111024894|NCT04368533|Cariostatic Agents|cariostatic agents|mesh-ancestor
111024895|NCT04368533|Protective Agents|protective agents|mesh-ancestor
111024896|NCT04368533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111024897|NCT02627144|Interferons|interferons|mesh-list
111024898|NCT02627144|Interferon-alpha|interferon-alpha|mesh-list
111024899|NCT02627144|Interferon alpha-2|interferon alpha-2|mesh-list
111024900|NCT02627144|Bevacizumab|bevacizumab|mesh-list
111024901|NCT02627144|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111024902|NCT02627144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111024903|NCT02627144|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111024904|NCT02627144|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111024905|NCT02627144|Growth Substances|growth substances|mesh-ancestor
111024906|NCT02627144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111024907|NCT02627144|Growth Inhibitors|growth inhibitors|mesh-ancestor
111024908|NCT02627144|Antiviral Agents|antiviral agents|mesh-ancestor
111024909|NCT02627144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111024910|NCT02627144|Immunologic Factors|immunologic factors|mesh-ancestor
111024911|NCT04586335|Olaparib|olaparib|mesh-list
111024912|NCT04586335|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111024913|NCT04586335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111024914|NCT04586335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111024915|NCT04586335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111024916|NCT04981886|Bimatoprost|bimatoprost|mesh-list
111024917|NCT04981886|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111024918|NCT03873727|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
111024919|NCT03873727|Immunologic Factors|immunologic factors|mesh-ancestor
111024920|NCT03873727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111024921|NCT04548440|Paclitaxel|paclitaxel|mesh-list
111024922|NCT04548440|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111024923|NCT04548440|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111024924|NCT04548440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111024925|NCT04548440|Tubulin Modulators|tubulin modulators|mesh-ancestor
111024926|NCT04548440|Antimitotic Agents|antimitotic agents|mesh-ancestor
111024927|NCT04548440|Mitosis Modulators|mitosis modulators|mesh-ancestor
111024928|NCT04548440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111024929|NCT03742921|Romidepsin|romidepsin|mesh-list
111024930|NCT03742921|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111024931|NCT03742921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111024932|NCT03742921|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111024933|NCT03742921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111024934|NCT03742921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111024935|NCT02626520|Paclitaxel|paclitaxel|mesh-list
111024936|NCT02626520|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111024937|NCT02626520|Gemcitabine|gemcitabine|mesh-list
111024938|NCT02626520|Fluorouracil|fluorouracil|mesh-list
111024939|NCT02626520|Irinotecan|irinotecan|mesh-list
111024940|NCT02626520|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111024941|NCT02626520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111024942|NCT02626520|Tubulin Modulators|tubulin modulators|mesh-ancestor
111024943|NCT02626520|Antimitotic Agents|antimitotic agents|mesh-ancestor
111024944|NCT02626520|Mitosis Modulators|mitosis modulators|mesh-ancestor
111024945|NCT02626520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111024946|NCT02626520|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111024947|NCT02626520|Antimetabolites|antimetabolites|mesh-ancestor
111024948|NCT02626520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111024949|NCT02626520|Immunologic Factors|immunologic factors|mesh-ancestor
111024950|NCT02626520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111024951|NCT02626520|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111024952|NCT02626520|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111024953|NCT02626520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111024954|NCT03063710|Olaparib|olaparib|mesh-list
111024955|NCT03063710|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111024956|NCT03063710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111024957|NCT03063710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111024958|NCT03063710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111024959|NCT05084521|Famotidine|famotidine|mesh-list
111024960|NCT05084521|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111024961|NCT05084521|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111024962|NCT05084521|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
111024963|NCT05084521|Histamine Antagonists|histamine antagonists|mesh-ancestor
111024964|NCT05084521|Histamine Agents|histamine agents|mesh-ancestor
110742058|NCT01126112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111024965|NCT05084521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111024966|NCT05084521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111024967|NCT05084521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111024968|NCT05069857|Apatinib|apatinib|mesh-list
111024969|NCT05069857|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
111024970|NCT05069857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111024971|NCT05069857|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111024972|NCT05069857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111024973|NCT05069857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111024974|NCT05069857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111024975|NCT05063851|Memantine|memantine|mesh-list
111024976|NCT05063851|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111024977|NCT05063851|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111024978|NCT05063851|Dopamine Agents|dopamine agents|mesh-ancestor
111024979|NCT05063851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111024980|NCT05063851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111024981|NCT05063851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111024982|NCT05063851|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111024983|NCT05063851|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111024984|NCT03359161|Furosemide|furosemide|mesh-list
111024985|NCT03359161|Diuretics|diuretics|mesh-ancestor
111024986|NCT03359161|Natriuretic Agents|natriuretic agents|mesh-ancestor
111024987|NCT03359161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111024988|NCT03359161|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110624582|NCT01004380|Carboplatin|carboplatin|mesh-list
111024989|NCT03359161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111024990|NCT03359161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111024991|NCT05030623|Tadalafil|tadalafil|mesh-list
111024992|NCT05030623|Vasodilator Agents|vasodilator agents|mesh-ancestor
111024993|NCT05030623|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111024994|NCT05030623|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111024995|NCT05030623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111024996|NCT05030623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111024997|NCT05030623|Urological Agents|urological agents|mesh-ancestor
111024998|NCT04986631|Topiramate|topiramate|mesh-list
111024999|NCT04986631|Anticonvulsants|anticonvulsants|mesh-ancestor
111025000|NCT04986631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111025001|NCT04986631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111025002|NCT03277339|Paroxetine|paroxetine|mesh-list
111025003|NCT03277339|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111025004|NCT03277339|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111025005|NCT03277339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111025006|NCT03277339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111025007|NCT03277339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111025008|NCT03277339|Serotonin Agents|serotonin agents|mesh-ancestor
111025009|NCT03277339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111025010|NCT03277339|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111025011|NCT03277339|Antidepressive Agents|antidepressive agents|mesh-ancestor
111025012|NCT03277339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111025013|NCT03277339|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111025014|NCT03277339|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111025015|NCT03277339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111025016|NCT03145675|Enoxaparin|enoxaparin|mesh-list
111025017|NCT03145675|Enoxaparin sodium|enoxaparin sodium|mesh-list
111025018|NCT03145675|Anticoagulants|anticoagulants|mesh-ancestor
111025019|NCT03145675|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111025020|NCT03145675|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111025021|NCT03145675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111025022|NCT04251715|Leucovorin|leucovorin|mesh-list
111025023|NCT04251715|Dexamethasone|dexamethasone|mesh-list
111025024|NCT04251715|Dexamethasone acetate|dexamethasone acetate|mesh-list
111025025|NCT04251715|Fluorouracil|fluorouracil|mesh-list
111025026|NCT04251715|Oxaliplatin|oxaliplatin|mesh-list
111025027|NCT04251715|Irinotecan|irinotecan|mesh-list
111025028|NCT04251715|Floxuridine|floxuridine|mesh-list
111025029|NCT04251715|BB 1101|bb 1101|mesh-list
111025030|NCT04251715|Deoxyuridine|deoxyuridine|mesh-list
111025031|NCT04251715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111025032|NCT04251715|Antiemetics|antiemetics|mesh-ancestor
111025033|NCT04251715|Autonomic Agents|autonomic agents|mesh-ancestor
111025034|NCT04251715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111025035|NCT04251715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111025036|NCT04251715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111025037|NCT04251715|Glucocorticoids|glucocorticoids|mesh-ancestor
111025038|NCT04251715|Hormones|hormones|mesh-ancestor
111025039|NCT04251715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111025040|NCT04251715|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111025041|NCT04251715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111025042|NCT04251715|Protease Inhibitors|protease inhibitors|mesh-ancestor
111025043|NCT04251715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110624601|NCT04000126|Anesthetics|anesthetics|mesh-ancestor
111025044|NCT04251715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111025045|NCT04251715|Antimetabolites|antimetabolites|mesh-ancestor
111025046|NCT04251715|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111025047|NCT04251715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111025048|NCT04251715|Immunologic Factors|immunologic factors|mesh-ancestor
111025049|NCT04251715|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111025050|NCT04251715|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111025051|NCT04251715|Antidotes|antidotes|mesh-ancestor
111025052|NCT04251715|Protective Agents|protective agents|mesh-ancestor
111025053|NCT04251715|Vitamin B Complex|vitamin b complex|mesh-ancestor
111025054|NCT04251715|Vitamins|vitamins|mesh-ancestor
111025055|NCT04251715|Micronutrients|micronutrients|mesh-ancestor
111025056|NCT04042727|Dexmedetomidine|dexmedetomidine|mesh-list
111025057|NCT04042727|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111025058|NCT04042727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111025059|NCT04042727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111025060|NCT04042727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111025061|NCT04042727|Analgesics|analgesics|mesh-ancestor
111025062|NCT04042727|Sensory System Agents|sensory system agents|mesh-ancestor
111025063|NCT04042727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111025064|NCT04042727|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111025065|NCT04042727|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111025066|NCT04042727|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111025067|NCT04042727|Adrenergic Agents|adrenergic agents|mesh-ancestor
111025068|NCT04042727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111025069|NCT04042727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111025070|NCT02035943|Insulin|insulin|mesh-list
111025071|NCT02035943|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111025072|NCT02035943|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111025073|NCT02035943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111025074|NCT03819413|Antibodies|antibodies|mesh-list
111025075|NCT03819413|Immunoglobulins|immunoglobulins|mesh-list
111025076|NCT03819413|Immunologic Factors|immunologic factors|mesh-ancestor
111025077|NCT03819413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111025078|NCT04099901|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
111025079|NCT04099901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111025080|NCT02394028|Etrolizumab|etrolizumab|mesh-list
111025081|NCT02394028|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111025082|NCT02394028|Immunologic Factors|immunologic factors|mesh-ancestor
111025083|NCT02394028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111025084|NCT04079621|Primaquine|primaquine|mesh-list
111025085|NCT04079621|Antimalarials|antimalarials|mesh-ancestor
111025086|NCT04079621|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111025087|NCT04079621|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111025088|NCT04079621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111025089|NCT02819297|Laxatives|laxatives|mesh-list
111025090|NCT02819297|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111025091|NCT05134441|Calcium, Dietary|calcium, dietary|mesh-list
111025092|NCT05134441|Calcium|calcium|mesh-list
111025093|NCT05134441|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111025094|NCT05134441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111025095|NCT05134441|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111025096|NCT03063788|Copper|copper|mesh-list
111025097|NCT03063788|Trace Elements|trace elements|mesh-ancestor
111025098|NCT03063788|Micronutrients|micronutrients|mesh-ancestor
111025099|NCT03063788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111025100|NCT02821715|Flecainide|flecainide|mesh-list
111025101|NCT02821715|Modafinil|modafinil|mesh-list
111025102|NCT02821715|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111025103|NCT02821715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111025104|NCT02821715|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
110624619|NCT01005238|Telbivudine|telbivudine|mesh-list
111025105|NCT02821715|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111025106|NCT02821715|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110490136|NCT00957944|Rotigotine|rotigotine|mesh-list
111025107|NCT02821715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111025108|NCT02821715|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111025109|NCT02821715|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111025110|NCT02821715|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110742208|NCT01218620|Anesthetics|anesthetics|mesh-ancestor
111025111|NCT02821715|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111025112|NCT03545347|Nandrolone Decanoate|nandrolone decanoate|mesh-list
111025113|NCT03545347|Nandrolone|nandrolone|mesh-list
111025114|NCT03545347|Nandrolone phenpropionate|nandrolone phenpropionate|mesh-list
111025115|NCT03545347|Androgens|androgens|mesh-ancestor
111025117|NCT03545347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111025118|NCT03545347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111025119|NCT03545347|Anabolic Agents|anabolic agents|mesh-ancestor
111025120|NCT03545347|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111025121|NCT02815397|Metformin|metformin|mesh-list
111025122|NCT02815397|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111025123|NCT02815397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111025124|NCT04980404|Decitabine|decitabine|mesh-list
111025125|NCT04980404|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111025126|NCT04980404|Antimetabolites|antimetabolites|mesh-ancestor
111025127|NCT04980404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111025128|NCT04980404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111025129|NCT04980404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111025130|NCT02427958|Leuprolide|leuprolide|mesh-list
111025131|NCT02427958|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111025132|NCT02427958|Fertility Agents|fertility agents|mesh-ancestor
111025133|NCT02427958|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111025134|NCT02427958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111025135|NCT02427958|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111025136|NCT02427958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111025137|NCT03715127|Psilocybin|psilocybin|mesh-list
111025138|NCT03715127|Hallucinogens|hallucinogens|mesh-ancestor
111025139|NCT03715127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111025140|NCT03715127|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111025141|NCT02260037|Epinastine|epinastine|mesh-list
111025142|NCT02260037|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111025143|NCT02260037|Histamine Antagonists|histamine antagonists|mesh-ancestor
111025144|NCT02260037|Histamine Agents|histamine agents|mesh-ancestor
111025145|NCT02260037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111025146|NCT02260037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111025147|NCT02260037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111025148|NCT02036489|Prednisone|prednisone|mesh-list
111025149|NCT02036489|Vincristine|vincristine|mesh-list
111025150|NCT02036489|Daunorubicin|daunorubicin|mesh-list
111025151|NCT02036489|Asparaginase|asparaginase|mesh-list
111025152|NCT02036489|Mercaptopurine|mercaptopurine|mesh-list
111025153|NCT02036489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111025154|NCT02036489|Glucocorticoids|glucocorticoids|mesh-ancestor
111025155|NCT02036489|Hormones|hormones|mesh-ancestor
111025156|NCT02036489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111025157|NCT02036489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111025158|NCT02036489|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111025159|NCT02036489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111025160|NCT02036489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111025161|NCT02036489|Tubulin Modulators|tubulin modulators|mesh-ancestor
111025162|NCT02036489|Antimitotic Agents|antimitotic agents|mesh-ancestor
111025163|NCT02036489|Mitosis Modulators|mitosis modulators|mesh-ancestor
111025164|NCT02036489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111025165|NCT02036489|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111025166|NCT02036489|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111025167|NCT02036489|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111025168|NCT02036489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111025169|NCT02036489|Antimetabolites|antimetabolites|mesh-ancestor
111025170|NCT02036489|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111025171|NCT02036489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111025172|NCT02036489|Immunologic Factors|immunologic factors|mesh-ancestor
111025173|NCT02036489|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111025174|NCT02392624|Omalizumab|omalizumab|mesh-list
111025175|NCT02392624|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111025176|NCT02392624|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111025177|NCT02392624|Respiratory System Agents|respiratory system agents|mesh-ancestor
111025178|NCT02047565|Edoxaban|edoxaban|mesh-list
111025179|NCT02047565|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111025180|NCT02047565|Antithrombins|antithrombins|mesh-ancestor
111025181|NCT02047565|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111025182|NCT02047565|Protease Inhibitors|protease inhibitors|mesh-ancestor
111025183|NCT02047565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111025184|NCT02047565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111025185|NCT02047565|Anticoagulants|anticoagulants|mesh-ancestor
111025186|NCT03063866|Fentanyl|fentanyl|mesh-list
111025187|NCT03063866|Midazolam|midazolam|mesh-list
111025188|NCT03063866|Propofol|propofol|mesh-list
111025189|NCT03063866|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110742284|NCT01225094|Curcumin|curcumin|mesh-list
111025190|NCT03063866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111025191|NCT03063866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111025192|NCT03063866|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111025193|NCT03063866|Anesthetics, General|anesthetics, general|mesh-ancestor
111025194|NCT03063866|Anesthetics|anesthetics|mesh-ancestor
111025195|NCT03063866|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111025196|NCT03063866|Narcotics|narcotics|mesh-ancestor
111025197|NCT03063866|Analgesics|analgesics|mesh-ancestor
111025198|NCT03063866|Sensory System Agents|sensory system agents|mesh-ancestor
111025199|NCT03063866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111025200|NCT03063866|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111025201|NCT03063866|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111025202|NCT03063866|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111025203|NCT03063866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111025204|NCT03063866|GABA Modulators|gaba modulators|mesh-ancestor
111025205|NCT03063866|GABA Agents|gaba agents|mesh-ancestor
111025206|NCT03063866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111025207|NCT03063866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111025208|NCT02037191|Methotrexate|methotrexate|mesh-list
111025209|NCT02037191|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111025210|NCT02037191|Abortifacient Agents|abortifacient agents|mesh-ancestor
111025211|NCT02037191|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111025212|NCT02037191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111025213|NCT02037191|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111025214|NCT02037191|Antimetabolites|antimetabolites|mesh-ancestor
111025215|NCT02037191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111025216|NCT02037191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111025217|NCT02037191|Dermatologic Agents|dermatologic agents|mesh-ancestor
111025218|NCT02037191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111025219|NCT02037191|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111025220|NCT02037191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111025221|NCT02037191|Immunologic Factors|immunologic factors|mesh-ancestor
111025222|NCT02037191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111025223|NCT02037191|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111025224|NCT04980170|Amoxicillin|amoxicillin|mesh-list
111025225|NCT04980170|Clindamycin|clindamycin|mesh-list
111025226|NCT04980170|Clindamycin palmitate|clindamycin palmitate|mesh-list
111025227|NCT04980170|Clindamycin phosphate|clindamycin phosphate|mesh-list
111025228|NCT04980170|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
111025229|NCT04980170|Clavulanic Acids|clavulanic acids|mesh-list
111025230|NCT04980170|Clavulanic Acid|clavulanic acid|mesh-list
111025231|NCT04980170|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111025232|NCT04980170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111025233|NCT04980170|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111025234|NCT04980170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111025235|NCT04980170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111025236|NCT04980170|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
111025237|NCT02387164|Vitamin D|vitamin d|mesh-list
111025238|NCT02387164|Cholecalciferol|cholecalciferol|mesh-list
111025239|NCT02387164|Vitamins|vitamins|mesh-ancestor
111025240|NCT02387164|Micronutrients|micronutrients|mesh-ancestor
111025241|NCT02387164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111025242|NCT02387164|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111025243|NCT02387164|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111025244|NCT02047799|Calcitriol|calcitriol|mesh-list
111025245|NCT02047799|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111025246|NCT02047799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111025247|NCT02047799|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
111025248|NCT02047799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111025249|NCT02047799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111025250|NCT02047799|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111025251|NCT02047799|Vitamins|vitamins|mesh-ancestor
111025252|NCT02047799|Micronutrients|micronutrients|mesh-ancestor
111025253|NCT02047799|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111025254|NCT02048189|Insulin Detemir|insulin detemir|mesh-list
111025255|NCT02048189|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111025256|NCT02048189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111025257|NCT02392234|Ivacaftor|ivacaftor|mesh-list
111025258|NCT02392234|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
111025259|NCT02392234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111025260|NCT02392234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111025261|NCT02036723|Bevacizumab|bevacizumab|mesh-list
111025262|NCT02036723|Ranibizumab|ranibizumab|mesh-list
111025263|NCT02036723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111025264|NCT02036723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111025265|NCT02036723|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111025266|NCT02036723|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111025267|NCT02036723|Growth Substances|growth substances|mesh-ancestor
111025268|NCT02036723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111025269|NCT02036723|Growth Inhibitors|growth inhibitors|mesh-ancestor
111025270|NCT02036879|Ethinyl Estradiol|ethinyl estradiol|mesh-list
111025271|NCT02036879|Norethindrone|norethindrone|mesh-list
111025272|NCT02036879|Norethindrone Acetate|norethindrone acetate|mesh-list
111025273|NCT02036879|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
111025274|NCT02036879|Estradiol|estradiol|mesh-list
111025275|NCT02036879|Estrogens|estrogens|mesh-ancestor
111025276|NCT02036879|Hormones|hormones|mesh-ancestor
111025277|NCT02036879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111025278|NCT02036879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111025279|NCT02036879|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111025280|NCT02036879|Contraceptive Agents|contraceptive agents|mesh-ancestor
111025281|NCT02036879|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111025282|NCT02036879|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111025283|NCT02036879|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111025284|NCT02036879|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111025285|NCT02036879|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111025286|NCT02036879|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
111025287|NCT02036879|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
111025288|NCT02048345|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111025289|NCT02963090|Pembrolizumab|pembrolizumab|mesh-list
111025290|NCT02963090|Topotecan|topotecan|mesh-list
111025291|NCT02963090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111025292|NCT02963090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111025293|NCT02963090|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111025294|NCT02963090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111025295|NCT02963090|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111025296|NCT02963090|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111025297|NCT02963090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111025298|NCT02048423|Ketamine|ketamine|mesh-list
111025299|NCT02048423|Analgesics|analgesics|mesh-ancestor
111025300|NCT02048423|Sensory System Agents|sensory system agents|mesh-ancestor
111025301|NCT02048423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111025302|NCT02048423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111025303|NCT02048423|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111025304|NCT02048423|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111025305|NCT02048423|Anesthetics, General|anesthetics, general|mesh-ancestor
111025306|NCT02048423|Anesthetics|anesthetics|mesh-ancestor
111025307|NCT02048423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111025308|NCT02048423|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111025309|NCT02048423|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111025310|NCT02048423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111025311|NCT02048423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111025312|NCT02037035|Ketamine|ketamine|mesh-list
111025313|NCT02037035|Analgesics|analgesics|mesh-ancestor
111025314|NCT02037035|Sensory System Agents|sensory system agents|mesh-ancestor
111025315|NCT02037035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111025316|NCT02037035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111025317|NCT02037035|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111025318|NCT02037035|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111025319|NCT02037035|Anesthetics, General|anesthetics, general|mesh-ancestor
111025320|NCT02037035|Anesthetics|anesthetics|mesh-ancestor
111025321|NCT02037035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111025322|NCT02037035|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111025323|NCT02037035|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111025324|NCT02037035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111119149|NCT05323617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111025325|NCT02037035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111025326|NCT04979468|Lamivudine|lamivudine|mesh-list
111025327|NCT04979468|Dolutegravir|dolutegravir|mesh-list
111025328|NCT04979468|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111025329|NCT04979468|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111025330|NCT04979468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111025331|NCT04979468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111025332|NCT04979468|Antiviral Agents|antiviral agents|mesh-ancestor
111025333|NCT04979468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111025334|NCT04979468|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111025335|NCT04979468|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111025336|NCT04979468|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111025337|NCT04979468|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111025338|NCT03562169|Thalidomide|thalidomide|mesh-list
111025339|NCT03562169|Dexamethasone|dexamethasone|mesh-list
111025340|NCT03562169|Ixazomib|ixazomib|mesh-list
111025341|NCT03562169|Glycine|glycine|mesh-list
111025342|NCT03562169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111025343|NCT03562169|Antiemetics|antiemetics|mesh-ancestor
111025344|NCT03562169|Autonomic Agents|autonomic agents|mesh-ancestor
111025345|NCT03562169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111025346|NCT03562169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111025347|NCT03562169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111025348|NCT03562169|Glucocorticoids|glucocorticoids|mesh-ancestor
111025349|NCT03562169|Hormones|hormones|mesh-ancestor
111025350|NCT03562169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111025351|NCT03562169|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111025352|NCT03562169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111025353|NCT03562169|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111025354|NCT03562169|Immunologic Factors|immunologic factors|mesh-ancestor
111025355|NCT03562169|Leprostatic Agents|leprostatic agents|mesh-ancestor
111025356|NCT03562169|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111025357|NCT03562169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111025358|NCT03562169|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111025359|NCT03562169|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111025360|NCT03562169|Growth Substances|growth substances|mesh-ancestor
111025361|NCT03562169|Growth Inhibitors|growth inhibitors|mesh-ancestor
111025362|NCT03562169|Protease Inhibitors|protease inhibitors|mesh-ancestor
111025363|NCT03562169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110624717|NCT01006798|Vaccines|vaccines|mesh-list
111025364|NCT03562169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111025365|NCT03562169|Glycine Agents|glycine agents|mesh-ancestor
111025366|NCT03562169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111025367|NCT02427802|Gentamicins|gentamicins|mesh-list
111025368|NCT02427802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111025369|NCT02427802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111025370|NCT02427802|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111025371|NCT02427802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111025372|NCT02427802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111025373|NCT02050529|Labetalol|labetalol|mesh-list
111025374|NCT02050529|Hydralazine|hydralazine|mesh-list
111025375|NCT02050529|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111025376|NCT02050529|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111025377|NCT02050529|Adrenergic Agents|adrenergic agents|mesh-ancestor
111025378|NCT02050529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111025379|NCT02050529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111025380|NCT02050529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111025381|NCT02050529|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111025382|NCT02050529|Sympathomimetics|sympathomimetics|mesh-ancestor
111025383|NCT02050529|Autonomic Agents|autonomic agents|mesh-ancestor
111025384|NCT02050529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111025385|NCT02050529|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111025386|NCT02050529|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111025387|NCT02050529|Vasodilator Agents|vasodilator agents|mesh-ancestor
111025388|NCT02427646|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
111025389|NCT02427646|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111025390|NCT02427646|Botulinum Toxins|botulinum toxins|mesh-list
111025391|NCT02427646|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111025392|NCT02427646|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111025393|NCT02427646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111025394|NCT02427646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111025395|NCT02427646|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111025396|NCT02427646|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111025397|NCT02427646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111025398|NCT02427646|Cholinergic Agents|cholinergic agents|mesh-ancestor
111025399|NCT02427646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111025400|NCT02048969|Flumazenil|flumazenil|mesh-list
111025401|NCT02048969|Antidotes|antidotes|mesh-ancestor
111025402|NCT02048969|Protective Agents|protective agents|mesh-ancestor
111025403|NCT02048969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111025404|NCT02048969|GABA Modulators|gaba modulators|mesh-ancestor
111025405|NCT02048969|GABA Agents|gaba agents|mesh-ancestor
111025406|NCT02048969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111025407|NCT02048969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111025408|NCT03561935|Propafenone|propafenone|mesh-list
111025409|NCT03561935|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111025410|NCT03561935|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111025411|NCT03561935|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111025412|NCT03561935|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111025413|NCT03561935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111025414|NCT02808143|Pembrolizumab|pembrolizumab|mesh-list
111025415|NCT02808143|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111025416|NCT02808143|BCG Vaccine|bcg vaccine|mesh-list
111025417|NCT02808143|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111025418|NCT02808143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111025419|NCT02808143|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111025420|NCT02808143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111025421|NCT02808143|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111025422|NCT02808143|Immunologic Factors|immunologic factors|mesh-ancestor
111025423|NCT02808143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111025424|NCT02620280|Paclitaxel|paclitaxel|mesh-list
111025425|NCT02620280|Carboplatin|carboplatin|mesh-list
111025426|NCT02620280|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111025427|NCT02620280|Atezolizumab|atezolizumab|mesh-list
111025428|NCT02620280|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111025429|NCT02620280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111025430|NCT02620280|Tubulin Modulators|tubulin modulators|mesh-ancestor
111025431|NCT02620280|Antimitotic Agents|antimitotic agents|mesh-ancestor
111025432|NCT02620280|Mitosis Modulators|mitosis modulators|mesh-ancestor
111025433|NCT02620280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111025434|NCT02620280|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111025435|NCT02620280|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111025436|NCT02806973|Glucagon|glucagon|mesh-list
111025437|NCT02806973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111025438|NCT02806973|Hormones|hormones|mesh-ancestor
111025439|NCT02806973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111025440|NCT02806973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111025441|NCT02049203|5-chloro-2-(5-chlorothiophene-2-sulfonylamino)-N-(4-(morpholine-4-sulfonyl)phenyl)benzamide|5-chloro-2-(5-chlorothiophene-2-sulfonylamino)-n-(4-(morpholine-4-sulfonyl)phenyl)benzamide|mesh-list
111025442|NCT02049203|Enzyme Activators|enzyme activators|mesh-ancestor
111025443|NCT02049203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111025444|NCT02037737|Abatacept|abatacept|mesh-list
111025445|NCT02037737|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111025446|NCT02037737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111025447|NCT02037737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111025448|NCT02037737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111025449|NCT02037737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111025450|NCT02037737|Immunologic Factors|immunologic factors|mesh-ancestor
111025451|NCT02037737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111025452|NCT02037737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111025453|NCT02037503|Ketamine|ketamine|mesh-list
111025454|NCT02037503|Analgesics|analgesics|mesh-ancestor
111025455|NCT02037503|Sensory System Agents|sensory system agents|mesh-ancestor
111025456|NCT02037503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111025457|NCT02037503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111025458|NCT02037503|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111025459|NCT02037503|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111025460|NCT02037503|Anesthetics, General|anesthetics, general|mesh-ancestor
111025461|NCT02037503|Anesthetics|anesthetics|mesh-ancestor
111025462|NCT02037503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111025463|NCT02037503|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111025464|NCT02037503|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111025465|NCT02037503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111025466|NCT02037503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111025467|NCT02049671|Hormones|hormones|mesh-list
111025468|NCT02049671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111119150|NCT05323617|Antifungal Agents|antifungal agents|mesh-ancestor
111025469|NCT02049671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111025470|NCT02037815|Mannitol|mannitol|mesh-list
111025471|NCT02037815|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111025472|NCT02037815|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
111025473|NCT02037815|Diuretics|diuretics|mesh-ancestor
111025474|NCT02037815|Natriuretic Agents|natriuretic agents|mesh-ancestor
111025475|NCT02037815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111025476|NCT02051621|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
111025477|NCT02806505|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
111025478|NCT02806505|Antiviral Agents|antiviral agents|mesh-ancestor
111025479|NCT02806505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111025480|NCT02053727|Abatacept|abatacept|mesh-list
111025481|NCT02053727|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111025482|NCT02053727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111025483|NCT02053727|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111025484|NCT02053727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111025485|NCT02053727|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111025486|NCT02053727|Immunologic Factors|immunologic factors|mesh-ancestor
111025487|NCT02053727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111025488|NCT02053727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111025490|NCT02051153|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111025491|NCT02051153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111025492|NCT02051153|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
111025493|NCT02051153|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111025494|NCT02051153|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111025495|NCT02051153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111025496|NCT02807363|Leuprolide|leuprolide|mesh-list
111025497|NCT02807363|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111025498|NCT02807363|Fertility Agents|fertility agents|mesh-ancestor
111025499|NCT02807363|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111025500|NCT02807363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111025501|NCT02807363|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111025502|NCT02807363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111025503|NCT02051231|Oxytocin|oxytocin|mesh-list
111025504|NCT02051231|Oxytocics|oxytocics|mesh-ancestor
111025505|NCT02051231|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111025506|NCT02051231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111025507|NCT02051387|Cannabidiol|cannabidiol|mesh-list
111025508|NCT02051387|Olanzapine|olanzapine|mesh-list
111025509|NCT02051387|Risperidone|risperidone|mesh-list
111025510|NCT02051387|Quetiapine Fumarate|quetiapine fumarate|mesh-list
111025511|NCT02051387|Amisulpride|amisulpride|mesh-list
111025512|NCT02051387|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111025513|NCT02051387|Serotonin Agents|serotonin agents|mesh-ancestor
111025514|NCT02051387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111025515|NCT02051387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111025516|NCT02051387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111025517|NCT02051387|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111025518|NCT02051387|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111025519|NCT02051387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111025520|NCT02051387|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111025521|NCT02051387|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111025522|NCT02051387|Dopamine Agents|dopamine agents|mesh-ancestor
111025523|NCT02051387|Antiemetics|antiemetics|mesh-ancestor
111025524|NCT02051387|Autonomic Agents|autonomic agents|mesh-ancestor
111025525|NCT02051387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111025526|NCT02051387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111025527|NCT02051387|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111025528|NCT02051387|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111025529|NCT02051387|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111025530|NCT02051387|Antidepressive Agents|antidepressive agents|mesh-ancestor
111025531|NCT02051387|Anticonvulsants|anticonvulsants|mesh-ancestor
111025532|NCT02051387|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111025533|NCT02052167|Methotrexate|methotrexate|mesh-list
111025534|NCT02052167|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111025535|NCT02052167|Abortifacient Agents|abortifacient agents|mesh-ancestor
111025536|NCT02052167|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111025537|NCT02052167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111025538|NCT02052167|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111025539|NCT02052167|Antimetabolites|antimetabolites|mesh-ancestor
111025540|NCT02052167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111025541|NCT02052167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111025542|NCT02052167|Dermatologic Agents|dermatologic agents|mesh-ancestor
111025543|NCT02052167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111025544|NCT02052167|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111025545|NCT02052167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111025546|NCT02052167|Immunologic Factors|immunologic factors|mesh-ancestor
111025547|NCT02052167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111025548|NCT02052167|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111025549|NCT03524417|Immunoglobulins|immunoglobulins|mesh-list
111025550|NCT03524417|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111025551|NCT03524417|Antibodies|antibodies|mesh-list
111025552|NCT03524417|Immunologic Factors|immunologic factors|mesh-ancestor
111025553|NCT03524417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111025554|NCT02054429|Insulin|insulin|mesh-list
111025555|NCT02054429|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111025556|NCT02054429|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111025557|NCT02054429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111025558|NCT03806543|Vancomycin|vancomycin|mesh-list
111025559|NCT03806543|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111025560|NCT03806543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111025562|NCT02052323|Mefloquine|mefloquine|mesh-list
111025563|NCT02052323|Antimalarials|antimalarials|mesh-ancestor
111025564|NCT02052323|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111025565|NCT02052323|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110624825|NCT01008046|Metformin|metformin|mesh-list
111025566|NCT02052323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111025567|NCT02052323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111025568|NCT02052323|Antiviral Agents|antiviral agents|mesh-ancestor
111025569|NCT02052323|Schistosomicides|schistosomicides|mesh-ancestor
111025570|NCT02052323|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
111025571|NCT02052323|Anthelmintics|anthelmintics|mesh-ancestor
111025572|NCT02056223|Acetaminophen|acetaminophen|mesh-list
111025573|NCT02056223|Ibuprofen|ibuprofen|mesh-list
111025574|NCT02056223|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111025575|NCT02056223|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111025576|NCT02056223|Analgesics|analgesics|mesh-ancestor
111025577|NCT02056223|Sensory System Agents|sensory system agents|mesh-ancestor
111025578|NCT02056223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111025579|NCT02056223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111025580|NCT02056223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111025581|NCT02056223|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111025582|NCT02056223|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111025583|NCT02056223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111025584|NCT02056223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111025585|NCT02056223|Antipyretics|antipyretics|mesh-ancestor
111025586|NCT02056379|Dexamethasone|dexamethasone|mesh-list
111025587|NCT02056379|Budesonide|budesonide|mesh-list
111025588|NCT02056379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111025589|NCT02056379|Antiemetics|antiemetics|mesh-ancestor
111025590|NCT02056379|Autonomic Agents|autonomic agents|mesh-ancestor
111025591|NCT02056379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111025592|NCT02056379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111025593|NCT02056379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111025594|NCT02056379|Glucocorticoids|glucocorticoids|mesh-ancestor
111025595|NCT02056379|Hormones|hormones|mesh-ancestor
111025596|NCT02056379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111025597|NCT02056379|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111025598|NCT02056379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111025599|NCT02056379|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111025600|NCT02056379|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111025601|NCT02056379|Respiratory System Agents|respiratory system agents|mesh-ancestor
111025602|NCT02383966|Carboplatin|carboplatin|mesh-list
111025603|NCT02383966|Fluorouracil|fluorouracil|mesh-list
111025604|NCT02383966|Cetuximab|cetuximab|mesh-list
111025605|NCT02383966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111025606|NCT02383966|Antimetabolites|antimetabolites|mesh-ancestor
111025607|NCT02383966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111025608|NCT02383966|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111025609|NCT02383966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111025610|NCT02383966|Immunologic Factors|immunologic factors|mesh-ancestor
111025611|NCT02383966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111025612|NCT02383966|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111025613|NCT02054663|Clopidogrel|clopidogrel|mesh-list
111025614|NCT02054663|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111025615|NCT02054663|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111025616|NCT02054663|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111025617|NCT02054663|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111025618|NCT02054663|Purinergic Agents|purinergic agents|mesh-ancestor
111025619|NCT02054663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111025620|NCT02054663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111025621|NCT02054663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111025622|NCT02054975|Vitamin D|vitamin d|mesh-list
111025623|NCT02054975|Ergocalciferols|ergocalciferols|mesh-list
110154334|NCT00010231|Hormones|hormones|mesh-ancestor
111025624|NCT02054975|Cholecalciferol|cholecalciferol|mesh-list
111025625|NCT02054975|Vitamins|vitamins|mesh-list
111025626|NCT02054975|Micronutrients|micronutrients|mesh-ancestor
111025627|NCT02054975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111025628|NCT02054975|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111025629|NCT02054975|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111025630|NCT02055131|Aspirin|aspirin|mesh-list
111025631|NCT02055131|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111025632|NCT02055131|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111025633|NCT02055131|Analgesics|analgesics|mesh-ancestor
111025634|NCT02055131|Sensory System Agents|sensory system agents|mesh-ancestor
111025635|NCT02055131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111025636|NCT02055131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111025637|NCT02055131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111025638|NCT02055131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111025639|NCT02055131|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111025640|NCT02055131|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111025641|NCT02055131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111025642|NCT02055131|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111025643|NCT02055131|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111025644|NCT02055131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111025645|NCT02055131|Antipyretics|antipyretics|mesh-ancestor
111025646|NCT02056847|Calcium, Dietary|calcium, dietary|mesh-list
111025647|NCT02056847|Pitavastatin|pitavastatin|mesh-list
111025648|NCT02056847|Calcium|calcium|mesh-list
111025649|NCT02056847|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111025650|NCT02056847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111025651|NCT02056847|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111025652|NCT02056847|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111025653|NCT02056847|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111025654|NCT02056847|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111025655|NCT02056847|Antimetabolites|antimetabolites|mesh-ancestor
111025656|NCT02056847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111025657|NCT02056847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111025658|NCT02056847|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111025659|NCT02052713|Tamsulosin|tamsulosin|mesh-list
111025660|NCT02052713|Dutasteride|dutasteride|mesh-list
111025661|NCT02052713|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111025662|NCT02052713|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111025663|NCT02052713|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111025664|NCT02052713|Adrenergic Agents|adrenergic agents|mesh-ancestor
111025665|NCT02052713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111025666|NCT02052713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111025667|NCT02052713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111025668|NCT02052713|Urological Agents|urological agents|mesh-ancestor
111025669|NCT02052713|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
111025670|NCT02052713|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111025671|NCT02052713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111025672|NCT02052713|Hormone Antagonists|hormone antagonists|mesh-ancestor
111025673|NCT02052713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111025674|NCT02057003|Sofosbuvir|sofosbuvir|mesh-list
111025675|NCT02057003|Grazoprevir|grazoprevir|mesh-list
111025676|NCT02057003|Ledipasvir|ledipasvir|mesh-list
111025677|NCT02057003|Velpatasvir|velpatasvir|mesh-list
111025678|NCT02057003|Simeprevir|simeprevir|mesh-list
111025679|NCT02057003|Antiviral Agents|antiviral agents|mesh-ancestor
111025680|NCT02057003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111025681|NCT02057003|Protease Inhibitors|protease inhibitors|mesh-ancestor
111025682|NCT02057003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111025683|NCT02057003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111025684|NCT02426086|Niacinamide|niacinamide|mesh-list
111025685|NCT02426086|Imetelstat|imetelstat|mesh-list
111025686|NCT02426086|Motesanib diphosphate|motesanib diphosphate|mesh-list
111025687|NCT02426086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111025688|NCT02426086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111025689|NCT02426086|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111025690|NCT02426086|Vitamin B Complex|vitamin b complex|mesh-ancestor
111025691|NCT02426086|Vitamins|vitamins|mesh-ancestor
111025692|NCT02426086|Micronutrients|micronutrients|mesh-ancestor
111025693|NCT02426086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111025695|NCT02055911|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111025696|NCT02055911|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111025697|NCT02055911|Growth Substances|growth substances|mesh-ancestor
111025698|NCT02055911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111025699|NCT02055911|Growth Inhibitors|growth inhibitors|mesh-ancestor
111025700|NCT02055911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111025701|NCT02422264|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
111025702|NCT02422264|Immunologic Factors|immunologic factors|mesh-ancestor
111025703|NCT02422264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111025704|NCT02390362|Rituximab|rituximab|mesh-list
111025705|NCT02390362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111025706|NCT02390362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111025707|NCT02390362|Immunologic Factors|immunologic factors|mesh-ancestor
111025708|NCT02390362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111025709|NCT02390362|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111025710|NCT02389816|Vortioxetine|vortioxetine|mesh-list
111025711|NCT02389816|Antidepressive Agents|antidepressive agents|mesh-ancestor
111025712|NCT02389816|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111025713|NCT02389816|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111025714|NCT02389816|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111025715|NCT02389816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111025716|NCT02389816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111025717|NCT02389816|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111025718|NCT02389816|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111025719|NCT02389816|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111025720|NCT02389816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111025721|NCT02389816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111025722|NCT02389816|Serotonin Agents|serotonin agents|mesh-ancestor
111025723|NCT02389816|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111025724|NCT02389816|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111025725|NCT02389816|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111025726|NCT02389816|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111025727|NCT02388724|Lansoprazole|lansoprazole|mesh-list
111025728|NCT02388724|Dexlansoprazole|dexlansoprazole|mesh-list
111025729|NCT02388724|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111025730|NCT02388724|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111025731|NCT02388724|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111025732|NCT02388724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111025733|NCT02388724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111025734|NCT02382640|Febuxostat|febuxostat|mesh-list
111025735|NCT02382640|Gout Suppressants|gout suppressants|mesh-ancestor
111025736|NCT02382640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111025737|NCT02801669|Edoxaban|edoxaban|mesh-list
111025738|NCT02801669|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111025739|NCT02801669|Antithrombins|antithrombins|mesh-ancestor
111025740|NCT02801669|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111025741|NCT02801669|Protease Inhibitors|protease inhibitors|mesh-ancestor
111025742|NCT02801669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111025743|NCT02801669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111025744|NCT02801669|Anticoagulants|anticoagulants|mesh-ancestor
111025745|NCT02804399|Rifampin|rifampin|mesh-list
111025746|NCT02804399|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111025747|NCT02804399|Antitubercular Agents|antitubercular agents|mesh-ancestor
111025748|NCT02804399|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111025749|NCT02804399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111025750|NCT02804399|Leprostatic Agents|leprostatic agents|mesh-ancestor
111025751|NCT02804399|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111025752|NCT02804399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111025753|NCT02804399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111025754|NCT02804399|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111025755|NCT02804399|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111025756|NCT02804399|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
111025757|NCT02804399|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
111025758|NCT02804399|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
111025759|NCT02804399|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111025760|NCT05614037|Felodipine|felodipine|mesh-list
111025761|NCT05614037|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111025762|NCT05614037|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111025763|NCT05614037|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111025764|NCT05614037|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111025765|NCT05614037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111025766|NCT05614037|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111025767|NCT05614037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111025768|NCT05614037|Vasodilator Agents|vasodilator agents|mesh-ancestor
111025769|NCT02058875|Cyclosporine|cyclosporine|mesh-list
111025770|NCT02058875|Mycophenolic Acid|mycophenolic acid|mesh-list
111025771|NCT02058875|Prednisone|prednisone|mesh-list
111025772|NCT02058875|Cyclosporins|cyclosporins|mesh-list
111025773|NCT02058875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111025774|NCT02058875|Glucocorticoids|glucocorticoids|mesh-ancestor
111025775|NCT02058875|Hormones|hormones|mesh-ancestor
111025776|NCT02058875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111025777|NCT02058875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111025778|NCT02058875|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111025779|NCT02058875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111025780|NCT02058875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111025781|NCT02058875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111025782|NCT02058875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111025783|NCT02058875|Immunologic Factors|immunologic factors|mesh-ancestor
111025784|NCT02058875|Antifungal Agents|antifungal agents|mesh-ancestor
111025785|NCT02058875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111025786|NCT02058875|Dermatologic Agents|dermatologic agents|mesh-ancestor
111025787|NCT02058875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111025788|NCT02058875|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111025789|NCT02058875|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111025790|NCT02058875|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111025791|NCT02058875|Antitubercular Agents|antitubercular agents|mesh-ancestor
111025792|NCT02058875|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111025793|NCT02059031|Cabotegravir|cabotegravir|mesh-list
111025794|NCT02059031|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111025795|NCT02059031|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111025796|NCT02059031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111025797|NCT02059031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111025798|NCT02059031|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111025799|NCT02059031|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111025800|NCT02059031|Antiviral Agents|antiviral agents|mesh-ancestor
111025801|NCT02059031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111025802|NCT01333865|Memantine|memantine|mesh-list
111025803|NCT01333865|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111025804|NCT01333865|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111025805|NCT01333865|Dopamine Agents|dopamine agents|mesh-ancestor
111025806|NCT01333865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111025807|NCT01333865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111025808|NCT01333865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111025809|NCT01333865|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111025810|NCT01333865|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111025811|NCT04978688|Relugolix|relugolix|mesh-list
111025812|NCT04978688|Androgen Antagonists|androgen antagonists|mesh-ancestor
111025813|NCT04978688|Hormone Antagonists|hormone antagonists|mesh-ancestor
111025814|NCT04978688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111025815|NCT04978688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111025816|NCT03062072|Antineoplastic Agents|antineoplastic agents|mesh-list
111025817|NCT04434326|Vorolanib|vorolanib|mesh-list
111025818|NCT04434326|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111025819|NCT04434326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111025820|NCT04434326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111025821|NCT01333397|Botulinum Toxins|botulinum toxins|mesh-list
111025822|NCT01333397|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111025823|NCT01333397|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111025824|NCT01333397|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111025825|NCT01333397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111025826|NCT01333397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111025827|NCT01333397|Cholinergic Agents|cholinergic agents|mesh-ancestor
111025828|NCT01333397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111025829|NCT01333397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111025830|NCT01333397|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111025831|NCT01333397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111025832|NCT02172872|Decitabine|decitabine|mesh-list
111025833|NCT02172872|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111025834|NCT02172872|Antimetabolites|antimetabolites|mesh-ancestor
111025835|NCT02172872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111025836|NCT02172872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111025837|NCT02172872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111025838|NCT02059655|Benzalkonium Compounds|benzalkonium compounds|mesh-list
111025839|NCT02059655|Bimatoprost|bimatoprost|mesh-list
111025840|NCT02059655|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111025841|NCT02059655|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111025842|NCT02059655|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111025843|NCT02059655|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111025844|NCT02059655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111025845|NCT05636501|Prednisolone|prednisolone|mesh-list
111025846|NCT05636501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111025847|NCT05636501|Glucocorticoids|glucocorticoids|mesh-ancestor
111025848|NCT05636501|Hormones|hormones|mesh-ancestor
111025849|NCT05636501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111025850|NCT05636501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111025851|NCT05636501|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111025852|NCT05636501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111025853|NCT02058173|Chloroquine|chloroquine|mesh-list
111025854|NCT02058173|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
111025855|NCT02058173|Amebicides|amebicides|mesh-ancestor
111025856|NCT02058173|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111025857|NCT02058173|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110742958|NCT03918590|Nepafenac|nepafenac|mesh-list
111025858|NCT02058173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111025859|NCT02058173|Antimalarials|antimalarials|mesh-ancestor
111025860|NCT02058173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111025861|NCT02058173|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111025862|NCT02058173|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111025863|NCT02058173|Analgesics|analgesics|mesh-ancestor
111025864|NCT02058173|Sensory System Agents|sensory system agents|mesh-ancestor
111025865|NCT02058173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111025866|NCT02058173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111025867|NCT02058173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111025868|NCT02058173|Filaricides|filaricides|mesh-ancestor
111025869|NCT02058173|Antinematodal Agents|antinematodal agents|mesh-ancestor
111025870|NCT02058173|Anthelmintics|anthelmintics|mesh-ancestor
111025871|NCT02060201|Dapagliflozin|dapagliflozin|mesh-list
111025872|NCT02060201|Saxagliptin|saxagliptin|mesh-list
111025873|NCT02060201|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111025874|NCT02060201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111025875|NCT02060201|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111025876|NCT02060201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111025877|NCT02060201|Incretins|incretins|mesh-ancestor
111025878|NCT02060201|Hormones|hormones|mesh-ancestor
111025879|NCT02060201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111025880|NCT02060201|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111025881|NCT02060201|Protease Inhibitors|protease inhibitors|mesh-ancestor
111025882|NCT02060201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111025883|NCT03561233|Omeprazole|omeprazole|mesh-list
111025884|NCT03561233|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111025885|NCT03561233|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111025886|NCT03561233|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111025887|NCT03561233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111025888|NCT03561233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111025889|NCT02058407|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111025890|NCT02058485|Midazolam|midazolam|mesh-list
111025891|NCT02058485|Dexmedetomidine|dexmedetomidine|mesh-list
111025892|NCT02058485|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111025893|NCT02058485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111025894|NCT02058485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111025895|NCT02058485|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111025896|NCT02058485|Analgesics|analgesics|mesh-ancestor
111025897|NCT02058485|Sensory System Agents|sensory system agents|mesh-ancestor
111025898|NCT02058485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111025899|NCT02058485|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111025900|NCT02058485|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111025901|NCT02058485|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111025902|NCT02058485|Adrenergic Agents|adrenergic agents|mesh-ancestor
111025903|NCT02058485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111025904|NCT02058485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111025905|NCT02058485|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111025906|NCT02058485|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111025907|NCT02058485|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111025908|NCT02058485|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111025909|NCT02058485|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111025910|NCT02058485|Anesthetics, General|anesthetics, general|mesh-ancestor
111025911|NCT02058485|Anesthetics|anesthetics|mesh-ancestor
111025912|NCT02058485|GABA Modulators|gaba modulators|mesh-ancestor
111025913|NCT02058485|GABA Agents|gaba agents|mesh-ancestor
111025914|NCT02060279|Carotenoids|carotenoids|mesh-list
111025915|NCT02060279|Antioxidants|antioxidants|mesh-ancestor
111025916|NCT02060279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111025917|NCT02060279|Protective Agents|protective agents|mesh-ancestor
111025918|NCT02060279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111025919|NCT02058641|Darapladib|darapladib|mesh-list
111025920|NCT02058641|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
111025921|NCT02058641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111025922|NCT02058641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111025923|NCT02059889|Deoxyglucose|deoxyglucose|mesh-list
111025924|NCT02059889|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
111025925|NCT02059889|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111025926|NCT02059889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111025927|NCT02059889|Antimetabolites|antimetabolites|mesh-ancestor
111025928|NCT02059889|Antiviral Agents|antiviral agents|mesh-ancestor
111025929|NCT02059889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111025930|NCT02059967|Paclitaxel|paclitaxel|mesh-list
111025931|NCT02059967|Carboplatin|carboplatin|mesh-list
111025932|NCT02059967|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110624920|NCT01062529|Hormones|hormones|mesh-ancestor
111025933|NCT02059967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111025934|NCT02059967|Tubulin Modulators|tubulin modulators|mesh-ancestor
111025935|NCT02059967|Antimitotic Agents|antimitotic agents|mesh-ancestor
111025936|NCT02059967|Mitosis Modulators|mitosis modulators|mesh-ancestor
111025937|NCT02059967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111025938|NCT02061137|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
111025939|NCT02061137|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
111025940|NCT02061137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111025941|NCT02061137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111025942|NCT02061137|Immunologic Factors|immunologic factors|mesh-ancestor
111025943|NCT02061137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111025944|NCT02061449|Romidepsin|romidepsin|mesh-list
111025945|NCT02061449|Poly ICLC|poly iclc|mesh-list
111025946|NCT02061449|Interferon Inducers|interferon inducers|mesh-ancestor
111025947|NCT02061449|Immunologic Factors|immunologic factors|mesh-ancestor
111025948|NCT02061449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111025949|NCT02061449|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111025950|NCT02061449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111025951|NCT02061449|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111025952|NCT02061449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111025953|NCT02061449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111025954|NCT02060591|Bupivacaine|bupivacaine|mesh-list
111025955|NCT02060591|Anesthetics, Local|anesthetics, local|mesh-ancestor
111025956|NCT02060591|Anesthetics|anesthetics|mesh-ancestor
111025957|NCT02060591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111025958|NCT02060591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111025959|NCT02060591|Sensory System Agents|sensory system agents|mesh-ancestor
111025960|NCT02060591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111025961|NCT02060669|Capecitabine|capecitabine|mesh-list
111025962|NCT02060669|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111025963|NCT02060669|Antimetabolites|antimetabolites|mesh-ancestor
111025964|NCT02060669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111025965|NCT02060669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111025966|NCT04428008|Thymalfasin|thymalfasin|mesh-list
111025967|NCT04428008|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111025968|NCT04428008|Immunologic Factors|immunologic factors|mesh-ancestor
111025969|NCT04428008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111025970|NCT02046590|Propofol|propofol|mesh-list
111025971|NCT02046590|Anesthetics|anesthetics|mesh-ancestor
111025972|NCT02046590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111025973|NCT02046590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111025974|NCT02046590|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111025975|NCT02046590|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111025976|NCT02046590|Anesthetics, General|anesthetics, general|mesh-ancestor
111025977|NCT02796755|Riluzole|riluzole|mesh-list
111025978|NCT02796755|Anticonvulsants|anticonvulsants|mesh-ancestor
111025979|NCT02796755|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111025980|NCT02796755|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111025981|NCT02796755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111025982|NCT02796755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111025983|NCT02796755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111025984|NCT02796755|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111025986|NCT02061917|Lobeline|lobeline|mesh-list
111025987|NCT02061917|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111025988|NCT02061917|Autonomic Agents|autonomic agents|mesh-ancestor
111025989|NCT02061917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111025990|NCT02061917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111025991|NCT02061917|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111025992|NCT02061917|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111025993|NCT02061917|Cholinergic Agents|cholinergic agents|mesh-ancestor
111025994|NCT02061917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111025995|NCT02061917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111025996|NCT02061917|Respiratory System Agents|respiratory system agents|mesh-ancestor
111025997|NCT03560375|Empagliflozin|empagliflozin|mesh-list
111025998|NCT03560375|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111025999|NCT03560375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111026000|NCT03560375|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111026001|NCT03560375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111026002|NCT02382016|Macitentan|macitentan|mesh-list
111026003|NCT02382016|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
111026004|NCT02382016|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
111026005|NCT02382016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110743107|NCT01228136|Hemostatics|hemostatics|mesh-ancestor
111026006|NCT02382016|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
111026007|NCT02422186|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
111026008|NCT02422186|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
111026009|NCT02422186|Sertraline|sertraline|mesh-list
111026010|NCT02422186|Antidepressive Agents|antidepressive agents|mesh-list
111026011|NCT02422186|Esketamine|esketamine|mesh-list
111026012|NCT02422186|Escitalopram|escitalopram|mesh-list
111026013|NCT02422186|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111026014|NCT02422186|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111026015|NCT02422186|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111026016|NCT02422186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111026017|NCT02422186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111026018|NCT02422186|Serotonin Agents|serotonin agents|mesh-ancestor
111026019|NCT02422186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111026020|NCT02422186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111026021|NCT02422186|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111026022|NCT02422186|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111026023|NCT02422186|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111026024|NCT02422186|Analgesics|analgesics|mesh-ancestor
111026025|NCT02422186|Sensory System Agents|sensory system agents|mesh-ancestor
111026026|NCT02422186|Dopamine Agents|dopamine agents|mesh-ancestor
111026027|NCT02796677|Bromides|bromides|mesh-list
111026028|NCT02796677|Formoterol Fumarate|formoterol fumarate|mesh-list
111026029|NCT02796677|Tiotropium Bromide|tiotropium bromide|mesh-list
111026030|NCT02796677|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111026031|NCT02796677|Autonomic Agents|autonomic agents|mesh-ancestor
111026032|NCT02796677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111026033|NCT02796677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111026034|NCT02796677|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110624964|NCT05559112|Vitamin D|vitamin d|mesh-list
111026035|NCT02796677|Respiratory System Agents|respiratory system agents|mesh-ancestor
111026036|NCT02796677|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111026037|NCT02796677|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111026038|NCT02796677|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111026039|NCT02796677|Adrenergic Agents|adrenergic agents|mesh-ancestor
111026040|NCT02796677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111026041|NCT02796677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111026042|NCT02796677|Parasympatholytics|parasympatholytics|mesh-ancestor
111026043|NCT02796677|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111026044|NCT02796677|Cholinergic Agents|cholinergic agents|mesh-ancestor
111026045|NCT02796677|Anticonvulsants|anticonvulsants|mesh-ancestor
111026046|NCT04973462|Oseltamivir|oseltamivir|mesh-list
111026047|NCT04973462|Antiviral Agents|antiviral agents|mesh-ancestor
111026048|NCT04973462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111026049|NCT04973462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111026050|NCT04973462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111026051|NCT02378506|Etanercept|etanercept|mesh-list
111026052|NCT02378506|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111026053|NCT02378506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111026054|NCT02378506|Analgesics|analgesics|mesh-ancestor
111026056|NCT02378506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111026057|NCT02378506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111026058|NCT02378506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111026059|NCT02378506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111026060|NCT02378506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111026061|NCT02378506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111026062|NCT02378506|Immunologic Factors|immunologic factors|mesh-ancestor
111026063|NCT02794883|Durvalumab|durvalumab|mesh-list
111026064|NCT02794883|Ipilimumab|ipilimumab|mesh-list
111026065|NCT02794883|Tremelimumab|tremelimumab|mesh-list
111026066|NCT02794883|Immunoglobulins|immunoglobulins|mesh-list
111026067|NCT02794883|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111026068|NCT02794883|Immunoglobulin G|immunoglobulin g|mesh-list
111026069|NCT02794883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111026070|NCT02794883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111026071|NCT02794883|Immunologic Factors|immunologic factors|mesh-ancestor
111026072|NCT02794883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111026073|NCT02794883|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111026074|NCT02794883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111026075|NCT02063789|Immunoglobulins|immunoglobulins|mesh-list
111026076|NCT02063789|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111026077|NCT02063789|Antibodies|antibodies|mesh-list
110743181|NCT01131026|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111026078|NCT02063789|Immunologic Factors|immunologic factors|mesh-ancestor
111026079|NCT02063789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111026080|NCT02063945|Risperidone|risperidone|mesh-list
111026081|NCT02063945|Methylphenidate|methylphenidate|mesh-list
111026082|NCT02063945|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111026083|NCT02063945|Serotonin Agents|serotonin agents|mesh-ancestor
111026084|NCT02063945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111026085|NCT02063945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111026086|NCT02063945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111026087|NCT02063945|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111026088|NCT02063945|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111026089|NCT02063945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111026090|NCT02063945|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111026091|NCT02063945|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111026092|NCT02063945|Dopamine Agents|dopamine agents|mesh-ancestor
111026093|NCT02063945|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111026094|NCT02063945|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111026095|NCT02063945|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111026096|NCT02063945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111026097|NCT02064023|Insulin|insulin|mesh-list
111026098|NCT02064023|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111026099|NCT02064023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111026100|NCT02064023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111026101|NCT02064725|10-carboxymethyl-9-acridanone|10-carboxymethyl-9-acridanone|mesh-list
111026102|NCT02064725|Interferon Inducers|interferon inducers|mesh-ancestor
111026103|NCT02064725|Immunologic Factors|immunologic factors|mesh-ancestor
111026104|NCT02064725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111026105|NCT01370603|Atorvastatin|atorvastatin|mesh-list
111026106|NCT01370603|Ezetimibe|ezetimibe|mesh-list
111026107|NCT01370603|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111026108|NCT01370603|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111026109|NCT01370603|Antimetabolites|antimetabolites|mesh-ancestor
111026110|NCT01370603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111026111|NCT01370603|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111026112|NCT01370603|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111026113|NCT01370603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111026114|NCT02659397|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
111026115|NCT02659397|Atorvastatin|atorvastatin|mesh-list
111026116|NCT02659397|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111026117|NCT02659397|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111026118|NCT02659397|Antimetabolites|antimetabolites|mesh-ancestor
111026119|NCT02659397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111026120|NCT02659397|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111026121|NCT02659397|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111026122|NCT02659397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111026123|NCT02659397|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111026124|NCT02659397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111026125|NCT02347072|Glycopyrrolate|glycopyrrolate|mesh-list
111026126|NCT02347072|Bromides|bromides|mesh-list
111026127|NCT02347072|Formoterol Fumarate|formoterol fumarate|mesh-list
111026129|NCT02347072|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111026130|NCT02347072|Autonomic Agents|autonomic agents|mesh-ancestor
111026131|NCT02347072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111026132|NCT02347072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111026133|NCT02347072|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111026134|NCT02347072|Respiratory System Agents|respiratory system agents|mesh-ancestor
111026135|NCT02347072|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111026136|NCT02347072|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111026137|NCT02347072|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111026138|NCT02347072|Adrenergic Agents|adrenergic agents|mesh-ancestor
111026139|NCT02347072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111026140|NCT02347072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111026141|NCT02347072|Parasympatholytics|parasympatholytics|mesh-ancestor
111026142|NCT02347072|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111026143|NCT02347072|Cholinergic Agents|cholinergic agents|mesh-ancestor
111026144|NCT02347072|Anticonvulsants|anticonvulsants|mesh-ancestor
111026145|NCT02347072|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111026146|NCT02347072|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111026147|NCT02064491|Paclitaxel|paclitaxel|mesh-list
111026148|NCT02064491|Docetaxel|docetaxel|mesh-list
111026149|NCT02064491|Cisplatin|cisplatin|mesh-list
111026150|NCT02064491|Carboplatin|carboplatin|mesh-list
111026151|NCT02064491|Pemetrexed|pemetrexed|mesh-list
111026152|NCT02064491|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111026153|NCT02064491|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110743263|NCT01136252|Adalimumab|adalimumab|mesh-list
111026154|NCT02064491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111026155|NCT02064491|Tubulin Modulators|tubulin modulators|mesh-ancestor
111026156|NCT02064491|Antimitotic Agents|antimitotic agents|mesh-ancestor
111026157|NCT02064491|Mitosis Modulators|mitosis modulators|mesh-ancestor
111026158|NCT02064491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111026159|NCT02064491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111026160|NCT02064491|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111026161|NCT02064491|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111026162|NCT02064491|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111026164|NCT02064881|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111026165|NCT02064881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111026166|NCT02346370|Docetaxel|docetaxel|mesh-list
111026167|NCT02346370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111026168|NCT02346370|Tubulin Modulators|tubulin modulators|mesh-ancestor
111026169|NCT02346370|Antimitotic Agents|antimitotic agents|mesh-ancestor
111026170|NCT02346370|Mitosis Modulators|mitosis modulators|mesh-ancestor
111026171|NCT02346370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111026172|NCT02065739|Itraconazole|itraconazole|mesh-list
111026173|NCT02065739|JNJ-42165279|jnj-42165279|mesh-list
111026174|NCT02065739|Antifungal Agents|antifungal agents|mesh-ancestor
111026175|NCT02065739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111026176|NCT02065739|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111026177|NCT02065739|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111026178|NCT02065739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111026179|NCT02065739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111026180|NCT02065739|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111026181|NCT02065739|Hormone Antagonists|hormone antagonists|mesh-ancestor
111026182|NCT02065739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111026183|NCT02065739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111026184|NCT02065739|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111026185|NCT02068079|Vemurafenib|vemurafenib|mesh-list
111026186|NCT02068079|Trientine|trientine|mesh-list
111026187|NCT02068079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111026188|NCT02068079|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111026189|NCT02068079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111026190|NCT02068079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111026191|NCT02068079|Chelating Agents|chelating agents|mesh-ancestor
111026192|NCT02068079|Sequestering Agents|sequestering agents|mesh-ancestor
111026193|NCT02793947|Epinephrine|epinephrine|mesh-list
111026194|NCT02793947|Morphine|morphine|mesh-list
111026195|NCT02793947|Ropivacaine|ropivacaine|mesh-list
111026196|NCT02793947|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111026197|NCT02793947|Narcotics|narcotics|mesh-ancestor
111026198|NCT02793947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111026199|NCT02793947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111026200|NCT02793947|Analgesics|analgesics|mesh-ancestor
111026201|NCT02793947|Sensory System Agents|sensory system agents|mesh-ancestor
111026202|NCT02793947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111026204|NCT02793947|Anesthetics|anesthetics|mesh-ancestor
111026205|NCT02793947|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111026206|NCT02793947|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111026207|NCT02793947|Adrenergic Agents|adrenergic agents|mesh-ancestor
111026208|NCT02793947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111026209|NCT02793947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111026210|NCT02793947|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111026211|NCT02793947|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111026212|NCT02793947|Autonomic Agents|autonomic agents|mesh-ancestor
111026213|NCT02793947|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111026214|NCT02793947|Respiratory System Agents|respiratory system agents|mesh-ancestor
111026215|NCT02793947|Mydriatics|mydriatics|mesh-ancestor
111026216|NCT02793947|Sympathomimetics|sympathomimetics|mesh-ancestor
111026217|NCT02793947|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111026218|NCT02068235|Ponesimod|ponesimod|mesh-list
111026219|NCT02068235|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
111026220|NCT02068235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111026221|NCT02068235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111026222|NCT02068235|Immunologic Factors|immunologic factors|mesh-ancestor
111026223|NCT02068235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111026224|NCT01370213|Interleukin-2|interleukin-2|mesh-list
111026225|NCT01370213|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110743331|NCT01233752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110743332|NCT01233752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111026226|NCT01370213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111026227|NCT01370213|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111026228|NCT01370213|Analgesics|analgesics|mesh-ancestor
111026229|NCT01370213|Sensory System Agents|sensory system agents|mesh-ancestor
111026230|NCT01370213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111026231|NCT01370213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111026232|NCT01370213|Immunologic Factors|immunologic factors|mesh-ancestor
111026233|NCT01370213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111026234|NCT02066207|Atorvastatin|atorvastatin|mesh-list
111026235|NCT02066207|Fenofibrate|fenofibrate|mesh-list
111026236|NCT02066207|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111026237|NCT02066207|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111026238|NCT02066207|Antimetabolites|antimetabolites|mesh-ancestor
111026239|NCT02066207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111026240|NCT02066207|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111026241|NCT02066207|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111026242|NCT02066207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111026243|NCT01370525|Esomeprazole|esomeprazole|mesh-list
111026244|NCT01370525|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111026245|NCT01370525|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111026246|NCT01370525|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111026247|NCT01370525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111026248|NCT01370525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111026249|NCT02065349|ASP8477|asp8477|mesh-list
111026250|NCT02065349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111026251|NCT02065349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111026252|NCT02068625|Rasagiline|rasagiline|mesh-list
111026253|NCT02068625|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
111026254|NCT02068625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111026255|NCT02068625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111026256|NCT02068625|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111026257|NCT02068625|Protective Agents|protective agents|mesh-ancestor
111026258|NCT02068625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111026259|NCT02068859|Diclofenac|diclofenac|mesh-list
111026260|NCT02068859|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111026261|NCT02068859|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111026262|NCT02068859|Analgesics|analgesics|mesh-ancestor
111026263|NCT02068859|Sensory System Agents|sensory system agents|mesh-ancestor
111026264|NCT02068859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111026265|NCT02068859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111026266|NCT02068859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111026267|NCT02068859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111026268|NCT02068859|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111026269|NCT02068859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111026270|NCT02068859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111026271|NCT02068937|Furosemide|furosemide|mesh-list
111026272|NCT02068937|Diuretics|diuretics|mesh-ancestor
111026273|NCT02068937|Natriuretic Agents|natriuretic agents|mesh-ancestor
111026274|NCT02068937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111026275|NCT02068937|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
111026276|NCT02068937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111026277|NCT02068937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111026278|NCT02066675|Trabectedin|trabectedin|mesh-list
111026279|NCT02066675|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111026280|NCT02066675|Alkylating Agents|alkylating agents|mesh-ancestor
111026281|NCT02066675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111026282|NCT02066675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111026283|NCT02072135|Bupivacaine|bupivacaine|mesh-list
111026284|NCT02072135|Anesthetics, Local|anesthetics, local|mesh-ancestor
111026285|NCT02072135|Anesthetics|anesthetics|mesh-ancestor
111026286|NCT02072135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110625002|NCT00586625|Bepotastine besilate|bepotastine besilate|mesh-list
111026287|NCT02072135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111026288|NCT02072135|Sensory System Agents|sensory system agents|mesh-ancestor
111026289|NCT02072135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111026290|NCT02067065|Propofol|propofol|mesh-list
111026291|NCT02067065|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111026292|NCT02067065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111026293|NCT02067065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111026294|NCT02067065|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111026295|NCT02067065|Anesthetics, General|anesthetics, general|mesh-ancestor
111026296|NCT02067065|Anesthetics|anesthetics|mesh-ancestor
111026297|NCT02067143|Cytarabine|cytarabine|mesh-list
111026298|NCT02067143|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111026299|NCT02067143|Antimetabolites|antimetabolites|mesh-ancestor
111026300|NCT02067143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111026301|NCT02067143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111026302|NCT02067143|Antiviral Agents|antiviral agents|mesh-ancestor
111026303|NCT02067143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111026304|NCT02067143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111026305|NCT02067143|Immunologic Factors|immunologic factors|mesh-ancestor
111026306|NCT02067143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111026307|NCT02072213|Tamsulosin|tamsulosin|mesh-list
111026308|NCT02072213|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111026309|NCT02072213|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111026310|NCT02072213|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111026311|NCT02072213|Adrenergic Agents|adrenergic agents|mesh-ancestor
111026312|NCT02072213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111026313|NCT02072213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111026314|NCT02072213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111026315|NCT02072213|Urological Agents|urological agents|mesh-ancestor
111026316|NCT02072291|Nifedipine|nifedipine|mesh-list
111026317|NCT02072291|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111026318|NCT02072291|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111026319|NCT02072291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111026320|NCT02072291|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111026321|NCT02072291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111026322|NCT02072291|Vasodilator Agents|vasodilator agents|mesh-ancestor
111026323|NCT02072291|Tocolytic Agents|tocolytic agents|mesh-ancestor
111026324|NCT02072291|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111026325|NCT02072525|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
111026326|NCT02072525|Immunologic Factors|immunologic factors|mesh-ancestor
111026327|NCT02072525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111026328|NCT03059888|Abatacept|abatacept|mesh-list
111026329|NCT03059888|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111026330|NCT03059888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111026331|NCT03059888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111026332|NCT03059888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111026333|NCT03059888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111026334|NCT03059888|Immunologic Factors|immunologic factors|mesh-ancestor
111026335|NCT03059888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111026336|NCT03059888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111026337|NCT04976816|Triamcinolone|triamcinolone|mesh-list
111026338|NCT04976816|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
111026339|NCT04976816|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
111026340|NCT04976816|Betamethasone|betamethasone|mesh-list
111026341|NCT04976816|Betamethasone Valerate|betamethasone valerate|mesh-list
111026342|NCT04976816|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
111026343|NCT04976816|Betamethasone benzoate|betamethasone benzoate|mesh-list
111026344|NCT04976816|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
111026345|NCT04976816|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
111026346|NCT04976816|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111026347|NCT04976816|Glucocorticoids|glucocorticoids|mesh-ancestor
111026348|NCT04976816|Hormones|hormones|mesh-ancestor
111026349|NCT04976816|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111026350|NCT04976816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111026351|NCT04976816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111026352|NCT04976816|Immunologic Factors|immunologic factors|mesh-ancestor
111026353|NCT04976816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111026354|NCT04976816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111026355|NCT04976816|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111026356|NCT04976816|Respiratory System Agents|respiratory system agents|mesh-ancestor
111026357|NCT03061838|Rituximab|rituximab|mesh-list
111026358|NCT03061838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111026359|NCT03061838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111026360|NCT03061838|Immunologic Factors|immunologic factors|mesh-ancestor
111026361|NCT03061838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111026362|NCT03061838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111026363|NCT04964180|Indomethacin|indomethacin|mesh-list
111026364|NCT04964180|Lidocaine|lidocaine|mesh-list
111026365|NCT04964180|Anesthetics, Local|anesthetics, local|mesh-ancestor
111026366|NCT04964180|Anesthetics|anesthetics|mesh-ancestor
111026367|NCT04964180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111026368|NCT04964180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111026369|NCT04964180|Sensory System Agents|sensory system agents|mesh-ancestor
111026370|NCT04964180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111026371|NCT04964180|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111026372|NCT04964180|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111026373|NCT04964180|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111026374|NCT04964180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111026375|NCT04964180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111026376|NCT04964180|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111026377|NCT04964180|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111026378|NCT04964180|Analgesics|analgesics|mesh-ancestor
111026379|NCT04964180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111026380|NCT04964180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111026381|NCT04964180|Gout Suppressants|gout suppressants|mesh-ancestor
111026382|NCT04964180|Tocolytic Agents|tocolytic agents|mesh-ancestor
111026383|NCT04964180|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111026384|NCT04964180|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111026385|NCT04964180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111026386|NCT02067377|Immunoglobulins|immunoglobulins|mesh-list
111026387|NCT02067377|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111026388|NCT02067377|Antibodies|antibodies|mesh-list
111026389|NCT02067377|Immunologic Factors|immunologic factors|mesh-ancestor
111026390|NCT02067377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111026391|NCT02073149|Iron|iron|mesh-list
111026392|NCT02073149|Fe(III)-EDTA|fe(iii)-edta|mesh-list
111026393|NCT02073149|Trace Elements|trace elements|mesh-ancestor
111026394|NCT02073149|Micronutrients|micronutrients|mesh-ancestor
111026395|NCT02073149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111026396|NCT02073149|Iron Chelating Agents|iron chelating agents|mesh-ancestor
111026397|NCT02073149|Chelating Agents|chelating agents|mesh-ancestor
111026398|NCT02073149|Sequestering Agents|sequestering agents|mesh-ancestor
111026399|NCT02073149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111026400|NCT02625974|Nifurtimox|nifurtimox|mesh-list
111026401|NCT02625974|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
111026402|NCT02625974|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111026403|NCT02625974|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111026404|NCT02625974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111026405|NCT02067767|Lamivudine|lamivudine|mesh-list
111026406|NCT02067767|Abacavir|abacavir|mesh-list
111026407|NCT02067767|Dolutegravir|dolutegravir|mesh-list
111026408|NCT02067767|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111026409|NCT02067767|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111026410|NCT02067767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111026411|NCT02067767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111026412|NCT02067767|Antiviral Agents|antiviral agents|mesh-ancestor
111026413|NCT02067767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111026414|NCT02067767|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111026415|NCT02067767|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111026416|NCT02067767|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111026417|NCT02067767|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111026418|NCT02073227|Metformin|metformin|mesh-list
111026419|NCT02073227|Canagliflozin|canagliflozin|mesh-list
111026420|NCT02073227|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111026421|NCT02073227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111026422|NCT02073227|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111026423|NCT02073227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111026424|NCT03060044|Fluticasone|fluticasone|mesh-list
111026425|NCT03060044|Xhance|xhance|mesh-list
111026426|NCT03060044|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
111026427|NCT03060044|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
111026428|NCT03060044|Charcoal|charcoal|mesh-list
111026429|NCT03060044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111026430|NCT03060044|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111026431|NCT03060044|Autonomic Agents|autonomic agents|mesh-ancestor
111026432|NCT03060044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111026433|NCT03060044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111026434|NCT03060044|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111026435|NCT03060044|Respiratory System Agents|respiratory system agents|mesh-ancestor
111026436|NCT03060044|Dermatologic Agents|dermatologic agents|mesh-ancestor
111026437|NCT03060044|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111026438|NCT03060044|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111026439|NCT03060044|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111026440|NCT03060044|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111026441|NCT03060044|Adrenergic Agents|adrenergic agents|mesh-ancestor
110743557|NCT03727724|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110743558|NCT03727724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110743559|NCT03727724|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110743560|NCT03727724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110743561|NCT03727724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110743562|NCT05032508|Lidocaine|lidocaine|mesh-list
110743563|NCT05032508|Anesthetics, Local|anesthetics, local|mesh-ancestor
111026442|NCT03060044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111026443|NCT03060044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111026445|NCT03060044|Hormones|hormones|mesh-ancestor
111026446|NCT03060044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111026447|NCT03060044|Sympathomimetics|sympathomimetics|mesh-ancestor
111026448|NCT03060044|Antidotes|antidotes|mesh-ancestor
111026449|NCT03060044|Protective Agents|protective agents|mesh-ancestor
111026450|NCT02070653|Ticagrelor|ticagrelor|mesh-list
111026451|NCT02070653|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111026452|NCT02070653|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111026453|NCT02070653|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111026454|NCT02070653|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111026455|NCT02070653|Purinergic Agents|purinergic agents|mesh-ancestor
111026456|NCT02070653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111026457|NCT02070653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111026458|NCT02070653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111026459|NCT04831892|Isosorbide|isosorbide|mesh-list
111026460|NCT04831892|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
111026461|NCT04831892|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
111026462|NCT04831892|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
111026463|NCT04831892|Diuretics|diuretics|mesh-ancestor
111026464|NCT04831892|Natriuretic Agents|natriuretic agents|mesh-ancestor
111026465|NCT04831892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111026466|NCT04831892|Vasodilator Agents|vasodilator agents|mesh-ancestor
111026467|NCT04831892|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
111026468|NCT04831892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111026469|NCT02073773|Levodopa|levodopa|mesh-list
111026470|NCT02073773|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111026471|NCT02073773|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111026472|NCT02073773|Dopamine Agents|dopamine agents|mesh-ancestor
111026473|NCT02073773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111026474|NCT02073773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111026475|NCT02073773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111026476|NCT03062150|Cycloserine|cycloserine|mesh-list
111026477|NCT03062150|Fludrocortisone|fludrocortisone|mesh-list
111026478|NCT03062150|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111026479|NCT03062150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111026480|NCT03062150|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111026481|NCT03062150|Antitubercular Agents|antitubercular agents|mesh-ancestor
111026482|NCT03062150|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111026483|NCT03062150|Antimetabolites|antimetabolites|mesh-ancestor
110827177|NCT05657652|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111026484|NCT03062150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111026485|NCT03062150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111026486|NCT03061916|Chlorhexidine|chlorhexidine|mesh-list
111026487|NCT03061916|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
111026488|NCT03061916|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111026489|NCT03061916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111026490|NCT03061916|Disinfectants|disinfectants|mesh-ancestor
111026491|NCT03061916|Dermatologic Agents|dermatologic agents|mesh-ancestor
111026492|NCT02076659|Methotrexate|methotrexate|mesh-list
111026493|NCT02076659|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111026494|NCT02076659|Abortifacient Agents|abortifacient agents|mesh-ancestor
111026495|NCT02076659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111026496|NCT02076659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111026497|NCT02076659|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111026498|NCT02076659|Antimetabolites|antimetabolites|mesh-ancestor
111026499|NCT02076659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111026500|NCT02076659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111026501|NCT02076659|Dermatologic Agents|dermatologic agents|mesh-ancestor
111026502|NCT02076659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111026503|NCT02076659|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111026504|NCT02076659|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111026505|NCT02076659|Immunologic Factors|immunologic factors|mesh-ancestor
111026506|NCT02076659|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111026507|NCT02076659|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111026508|NCT04975724|Citalopram|citalopram|mesh-list
111026509|NCT04975724|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111026510|NCT04975724|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111026511|NCT04975724|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111026512|NCT04975724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111026513|NCT04975724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111026514|NCT04975724|Serotonin Agents|serotonin agents|mesh-ancestor
111026515|NCT04975724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111026516|NCT04975724|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111026517|NCT04975724|Antidepressive Agents|antidepressive agents|mesh-ancestor
111026518|NCT04975724|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111026519|NCT02076815|Anagrelide|anagrelide|mesh-list
111026520|NCT02076815|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111026521|NCT02076815|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111026522|NCT02076815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111026523|NCT02076815|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111026524|NCT02071043|Capecitabine|capecitabine|mesh-list
111026525|NCT02071043|Oxaliplatin|oxaliplatin|mesh-list
111026526|NCT02071043|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111026527|NCT02071043|Antimetabolites|antimetabolites|mesh-ancestor
111026528|NCT02071043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111026529|NCT02071043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111026530|NCT02076893|Ibuprofen|ibuprofen|mesh-list
111026531|NCT02076893|Gabapentin|gabapentin|mesh-list
111026532|NCT02076893|Tramadol|tramadol|mesh-list
111026533|NCT02076893|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111026534|NCT02076893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111026535|NCT02076893|Analgesics|analgesics|mesh-ancestor
111026536|NCT02076893|Sensory System Agents|sensory system agents|mesh-ancestor
111026537|NCT02076893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111026538|NCT02076893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111026539|NCT02076893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111026540|NCT02076893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111026541|NCT02076893|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111026542|NCT02076893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111026543|NCT02076893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111026544|NCT02076893|Anticonvulsants|anticonvulsants|mesh-ancestor
111026545|NCT02076893|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111026546|NCT02076893|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111026547|NCT02076893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111026548|NCT02076893|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111026549|NCT02076893|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111026550|NCT02076893|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111026551|NCT02076893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111026552|NCT02076893|Antimanic Agents|antimanic agents|mesh-ancestor
111026553|NCT02076893|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111026554|NCT02076893|Narcotics|narcotics|mesh-ancestor
111026555|NCT02074163|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111026556|NCT02074163|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111026557|NCT02074163|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111026558|NCT02074163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111026559|NCT02074163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111026560|NCT02074163|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111026561|NCT02074163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111026562|NCT02074163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111026563|NCT02074163|Cholinergic Agents|cholinergic agents|mesh-ancestor
111026564|NCT02074163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111026565|NCT04963088|Capecitabine|capecitabine|mesh-list
111026566|NCT04963088|Oxaliplatin|oxaliplatin|mesh-list
111026567|NCT04963088|Tislelizumab|tislelizumab|mesh-list
111026568|NCT04963088|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111026569|NCT04963088|Antimetabolites|antimetabolites|mesh-ancestor
111026570|NCT04963088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111026571|NCT04963088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111026572|NCT04963088|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111026573|NCT02074319|Methotrexate|methotrexate|mesh-list
111026574|NCT02074319|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111026575|NCT02074319|Abortifacient Agents|abortifacient agents|mesh-ancestor
111026576|NCT02074319|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111026577|NCT02074319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111026578|NCT02074319|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111026579|NCT02074319|Antimetabolites|antimetabolites|mesh-ancestor
111026580|NCT02074319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111026581|NCT02074319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111026582|NCT02074319|Dermatologic Agents|dermatologic agents|mesh-ancestor
111026583|NCT02074319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111026584|NCT02074319|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111026585|NCT02074319|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111026586|NCT02074319|Immunologic Factors|immunologic factors|mesh-ancestor
111026587|NCT02074319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111026588|NCT02074319|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111026589|NCT04975022|Insulin|insulin|mesh-list
111026590|NCT04975022|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111026591|NCT04975022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111026592|NCT03061604|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111026593|NCT03061604|Ceftriaxone|ceftriaxone|mesh-list
111026594|NCT03061604|Octreotide|octreotide|mesh-list
111026595|NCT03061604|Hemostatics|hemostatics|mesh-list
111026596|NCT03061604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111026597|NCT03061604|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111026598|NCT03061604|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111026599|NCT03061604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111026600|NCT03061604|Coagulants|coagulants|mesh-ancestor
111026601|NCT04974944|Paclitaxel|paclitaxel|mesh-list
111026602|NCT04974944|Bevacizumab|bevacizumab|mesh-list
111026603|NCT04974944|Carboplatin|carboplatin|mesh-list
111026604|NCT04974944|Apatinib|apatinib|mesh-list
111026605|NCT04974944|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111026606|NCT04974944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111026607|NCT04974944|Tubulin Modulators|tubulin modulators|mesh-ancestor
111026608|NCT04974944|Antimitotic Agents|antimitotic agents|mesh-ancestor
111026609|NCT04974944|Mitosis Modulators|mitosis modulators|mesh-ancestor
111026610|NCT04974944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111026611|NCT04974944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111026612|NCT04974944|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111026613|NCT04974944|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111026614|NCT04974944|Growth Substances|growth substances|mesh-ancestor
111026615|NCT04974944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111026616|NCT04974944|Growth Inhibitors|growth inhibitors|mesh-ancestor
110625117|NCT05773911|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111026617|NCT04974944|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111026618|NCT04974944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111026619|NCT04962386|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
111026620|NCT04962386|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
111026621|NCT04962386|Hormones|hormones|mesh-list
111026622|NCT04962386|Estradiol|estradiol|mesh-list
111026623|NCT04962386|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
111026624|NCT04962386|Progesterone|progesterone|mesh-list
111026625|NCT04962386|Estrogens|estrogens|mesh-list
111026626|NCT04962386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111026627|NCT04962386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111026628|NCT04962386|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111026629|NCT04962386|Contraceptive Agents|contraceptive agents|mesh-ancestor
111026630|NCT04962386|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111026631|NCT04962386|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111026632|NCT04962386|Progestins|progestins|mesh-ancestor
111026633|NCT02071355|Simeprevir|simeprevir|mesh-list
111026634|NCT02071355|Antiviral Agents|antiviral agents|mesh-ancestor
111026635|NCT02071355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111026636|NCT02071355|Protease Inhibitors|protease inhibitors|mesh-ancestor
111026637|NCT02071355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111026638|NCT02071355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111026639|NCT02071433|Iodine|iodine|mesh-list
111026640|NCT02071433|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111026641|NCT02071433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111026642|NCT02071433|Trace Elements|trace elements|mesh-ancestor
111026643|NCT02071433|Micronutrients|micronutrients|mesh-ancestor
111026644|NCT02071433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111026645|NCT04962308|Vaccines|vaccines|mesh-list
111026646|NCT04962308|Immunologic Factors|immunologic factors|mesh-ancestor
111026647|NCT04962308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111026648|NCT02071589|Nifedipine|nifedipine|mesh-list
111026649|NCT02071589|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111026650|NCT02071589|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111026651|NCT02071589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111026652|NCT02071589|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111026653|NCT02071589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111026654|NCT02071589|Vasodilator Agents|vasodilator agents|mesh-ancestor
111026655|NCT02071589|Tocolytic Agents|tocolytic agents|mesh-ancestor
111026656|NCT02071589|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111026657|NCT02077751|Biotin|biotin|mesh-list
111026658|NCT02077751|Vitamin B Complex|vitamin b complex|mesh-ancestor
111026659|NCT02077751|Vitamins|vitamins|mesh-ancestor
111026660|NCT02077751|Micronutrients|micronutrients|mesh-ancestor
111026661|NCT02077751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111026662|NCT04961684|Amorolfine|amorolfine|mesh-list
111026663|NCT04961684|Antifungal Agents|antifungal agents|mesh-ancestor
111026664|NCT04961684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111026665|NCT03061058|Docetaxel|docetaxel|mesh-list
111026666|NCT03061058|Oxaliplatin|oxaliplatin|mesh-list
111026667|NCT03061058|Irinotecan|irinotecan|mesh-list
111026668|NCT03061058|Pemetrexed|pemetrexed|mesh-list
111026669|NCT03061058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111026670|NCT03061058|Tubulin Modulators|tubulin modulators|mesh-ancestor
111026671|NCT03061058|Antimitotic Agents|antimitotic agents|mesh-ancestor
111026672|NCT03061058|Mitosis Modulators|mitosis modulators|mesh-ancestor
111026673|NCT03061058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111026674|NCT03061058|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111026675|NCT03061058|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111026676|NCT03061058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111026677|NCT03061058|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111026678|NCT03061058|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111026679|NCT04961918|Durvalumab|durvalumab|mesh-list
111026680|NCT04961918|Lenvatinib|lenvatinib|mesh-list
111026681|NCT04961918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111026682|NCT04961918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111026683|NCT04961918|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111026684|NCT04961918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111026685|NCT04961918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111026686|NCT04954040|Azithromycin|azithromycin|mesh-list
111026687|NCT04954040|Hydroxychloroquine|hydroxychloroquine|mesh-list
111026688|NCT04954040|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111026689|NCT04954040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111026690|NCT04954040|Antimalarials|antimalarials|mesh-ancestor
111026691|NCT04954040|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111026692|NCT04954040|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111026693|NCT04954040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111026694|NCT04954040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111026695|NCT04954040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111026696|NCT04424654|Methyltestosterone|methyltestosterone|mesh-list
111026697|NCT04424654|Testosterone|testosterone|mesh-list
111026698|NCT04424654|Testosterone undecanoate|testosterone undecanoate|mesh-list
111026699|NCT04424654|Testosterone enanthate|testosterone enanthate|mesh-list
111026700|NCT04424654|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
111026701|NCT04424654|Androgens|androgens|mesh-ancestor
111026702|NCT04424654|Hormones|hormones|mesh-ancestor
111026703|NCT04424654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111026704|NCT04424654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111026705|NCT04424654|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111026706|NCT04424654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111026707|NCT04424654|Anabolic Agents|anabolic agents|mesh-ancestor
111026708|NCT04968392|Dexmedetomidine|dexmedetomidine|mesh-list
111026709|NCT04968392|Levobupivacaine|levobupivacaine|mesh-list
111026710|NCT04968392|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111026711|NCT04968392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111026712|NCT04968392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111026713|NCT04968392|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111026714|NCT04968392|Analgesics|analgesics|mesh-ancestor
111026715|NCT04968392|Sensory System Agents|sensory system agents|mesh-ancestor
111026716|NCT04968392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111026717|NCT04968392|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111026718|NCT04968392|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111026719|NCT04968392|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111026720|NCT04968392|Adrenergic Agents|adrenergic agents|mesh-ancestor
111026721|NCT04968392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111026722|NCT04968392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111026723|NCT04968392|Anesthetics, Local|anesthetics, local|mesh-ancestor
111026724|NCT04968392|Anesthetics|anesthetics|mesh-ancestor
111026725|NCT02792699|Rituximab|rituximab|mesh-list
111026726|NCT02792699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111026727|NCT02792699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111026728|NCT02792699|Immunologic Factors|immunologic factors|mesh-ancestor
111026729|NCT02792699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111026730|NCT02792699|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111026731|NCT04968002|Apatinib|apatinib|mesh-list
111026732|NCT04968002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111026733|NCT04968002|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111026734|NCT04968002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111026735|NCT04968002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111026736|NCT04961138|Lenvatinib|lenvatinib|mesh-list
111026737|NCT04961138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111026738|NCT04961138|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111026739|NCT04961138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111026740|NCT04961138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111026741|NCT03061136|Clonazepam|clonazepam|mesh-list
111026742|NCT03061136|Anticonvulsants|anticonvulsants|mesh-ancestor
111026743|NCT03061136|GABA Modulators|gaba modulators|mesh-ancestor
111026744|NCT03061136|GABA Agents|gaba agents|mesh-ancestor
111026745|NCT03061136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111026746|NCT03061136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111026747|NCT03061136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111026748|NCT02075333|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111026749|NCT02080169|Fentanyl|fentanyl|mesh-list
111026750|NCT02080169|Midazolam|midazolam|mesh-list
111026751|NCT02080169|Dexmedetomidine|dexmedetomidine|mesh-list
111026752|NCT02080169|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111026753|NCT02080169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111026754|NCT02080169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111026755|NCT02080169|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111026756|NCT02080169|Analgesics|analgesics|mesh-ancestor
111026757|NCT02080169|Sensory System Agents|sensory system agents|mesh-ancestor
111026758|NCT02080169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111026759|NCT02080169|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111026760|NCT02080169|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111026761|NCT02080169|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111026762|NCT02080169|Adrenergic Agents|adrenergic agents|mesh-ancestor
111026763|NCT02080169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111026764|NCT02080169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111026765|NCT02080169|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111026766|NCT02080169|Narcotics|narcotics|mesh-ancestor
111026767|NCT02080169|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111026768|NCT02080169|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111026769|NCT02080169|Anesthetics, General|anesthetics, general|mesh-ancestor
111026770|NCT02080169|Anesthetics|anesthetics|mesh-ancestor
111026771|NCT02080169|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111026772|NCT02080169|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111026773|NCT02080169|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111026774|NCT02080169|GABA Modulators|gaba modulators|mesh-ancestor
111026775|NCT02080169|GABA Agents|gaba agents|mesh-ancestor
111026776|NCT02078063|Mepivacaine|mepivacaine|mesh-list
111026777|NCT02078063|Anesthetics, Local|anesthetics, local|mesh-ancestor
111026778|NCT02078063|Anesthetics|anesthetics|mesh-ancestor
111026779|NCT02078063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111026780|NCT02078063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111026781|NCT02078063|Sensory System Agents|sensory system agents|mesh-ancestor
111026782|NCT02078063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111026783|NCT04951856|Evolocumab|evolocumab|mesh-list
111026784|NCT04951856|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
111026785|NCT04951856|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111026786|NCT04951856|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111026787|NCT04951856|Antimetabolites|antimetabolites|mesh-ancestor
111026788|NCT04951856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111026789|NCT04951856|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111026790|NCT04951856|Protease Inhibitors|protease inhibitors|mesh-ancestor
111026791|NCT04951856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111026792|NCT04951856|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111026793|NCT04951232|Cinepazide|cinepazide|mesh-list
111026794|NCT04951232|Vasodilator Agents|vasodilator agents|mesh-ancestor
111026795|NCT04959578|Epoetin Alfa|epoetin alfa|mesh-list
111026796|NCT04959578|Darbepoetin alfa|darbepoetin alfa|mesh-list
111026797|NCT04959578|Hematinics|hematinics|mesh-ancestor
111026798|NCT04959500|Temozolomide|temozolomide|mesh-list
111026799|NCT04959500|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111026800|NCT04959500|Alkylating Agents|alkylating agents|mesh-ancestor
111026801|NCT04959500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111026802|NCT04959500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111026803|NCT02076191|Decitabine|decitabine|mesh-list
111026804|NCT02076191|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111026805|NCT02076191|Antimetabolites|antimetabolites|mesh-ancestor
111026806|NCT02076191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111026807|NCT02076191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111026808|NCT02076191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111026809|NCT02080715|Tolcapone|tolcapone|mesh-list
111026810|NCT02080715|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111026811|NCT02080715|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111026812|NCT02080715|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
111026813|NCT02080715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111026814|NCT02080715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111026815|NCT04965662|Tenofovir|tenofovir|mesh-list
111026816|NCT04965662|Emtricitabine|emtricitabine|mesh-list
111026817|NCT04965662|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110743929|NCT01238978|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111026818|NCT04965662|Maraviroc|maraviroc|mesh-list
111026819|NCT04965662|Antiviral Agents|antiviral agents|mesh-ancestor
111026820|NCT04965662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111026821|NCT04965662|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111026822|NCT04965662|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111026823|NCT04965662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111026824|NCT04965662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111026825|NCT04965662|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111026826|NCT04965662|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111026827|NCT04965662|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
111026828|NCT04965662|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
111026829|NCT04965662|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
111026830|NCT02078609|Midostaurin|midostaurin|mesh-list
111026831|NCT02078609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111026832|NCT02078609|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111026833|NCT02078609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111026834|NCT02078609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111026835|NCT04957940|SMOFlipid|smoflipid|mesh-list
111026836|NCT04957940|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
111026837|NCT04957940|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
111026838|NCT04957940|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111026839|NCT03060278|Nicotine|nicotine|mesh-list
111026840|NCT03060278|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111026841|NCT03060278|Autonomic Agents|autonomic agents|mesh-ancestor
111026842|NCT03060278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111026843|NCT03060278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111026844|NCT03060278|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111026845|NCT03060278|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111026846|NCT03060278|Cholinergic Agents|cholinergic agents|mesh-ancestor
111026847|NCT03060278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111026848|NCT03060278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111026849|NCT02083991|Prednisolone|prednisolone|mesh-list
111026850|NCT02083991|Thymoglobulin|thymoglobulin|mesh-list
111026851|NCT02083991|Basiliximab|basiliximab|mesh-list
111026852|NCT02083991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111026854|NCT02083991|Hormones|hormones|mesh-ancestor
110625180|NCT05667896|Hormones|hormones|mesh-ancestor
111026855|NCT02083991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111026856|NCT02083991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111026857|NCT02083991|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111026858|NCT02083991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111026859|NCT02083991|Immunologic Factors|immunologic factors|mesh-ancestor
111026860|NCT02083991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111026861|NCT02081027|Riluzole|riluzole|mesh-list
111026862|NCT02081027|Anticonvulsants|anticonvulsants|mesh-ancestor
111026863|NCT02081027|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111026864|NCT02081027|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111026865|NCT02081027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111026866|NCT02081027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111026867|NCT02081027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111026868|NCT02081027|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111026869|NCT02081027|Protective Agents|protective agents|mesh-ancestor
111026870|NCT04948034|Tislelizumab|tislelizumab|mesh-list
111026871|NCT04948034|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111026872|NCT04948034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111026873|NCT04947956|Apatinib|apatinib|mesh-list
111026874|NCT04947956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111026875|NCT04947956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111026876|NCT04947956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111026877|NCT04947956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111026878|NCT03254511|Enoxaparin|enoxaparin|mesh-list
111026879|NCT03254511|Enoxaparin sodium|enoxaparin sodium|mesh-list
111026880|NCT03254511|Anticoagulants|anticoagulants|mesh-ancestor
111026881|NCT03254511|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111026882|NCT03254511|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111026883|NCT03254511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111026884|NCT04947566|Ibuprofen|ibuprofen|mesh-list
111026885|NCT04947566|Naproxen|naproxen|mesh-list
111026886|NCT04947566|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111026887|NCT04947566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111026888|NCT04947566|Analgesics|analgesics|mesh-ancestor
111026889|NCT04947566|Sensory System Agents|sensory system agents|mesh-ancestor
111026890|NCT04947566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111026891|NCT04947566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111026892|NCT04947566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111026893|NCT04947566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110744009|NCT02049905|Docetaxel|docetaxel|mesh-list
111026895|NCT04947566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111026896|NCT04947566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111026897|NCT04947566|Gout Suppressants|gout suppressants|mesh-ancestor
111026898|NCT03241875|Pregabalin|pregabalin|mesh-list
111026899|NCT03241875|Gabapentin|gabapentin|mesh-list
111026900|NCT03241875|Analgesics|analgesics|mesh-ancestor
111026901|NCT03241875|Sensory System Agents|sensory system agents|mesh-ancestor
111026902|NCT03241875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111026903|NCT03241875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111026904|NCT03241875|Anticonvulsants|anticonvulsants|mesh-ancestor
111026905|NCT03241875|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111026906|NCT03241875|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110625191|NCT05667883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111026907|NCT03241875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111026908|NCT03241875|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111026909|NCT03241875|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111026910|NCT03241875|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111026911|NCT03241875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111026912|NCT03241875|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111026913|NCT03241875|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111026914|NCT03241875|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111026915|NCT03241875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111026916|NCT03241875|Antimanic Agents|antimanic agents|mesh-ancestor
111026917|NCT03058094|Pemetrexed|pemetrexed|mesh-list
111026918|NCT03058094|Abivertinib|abivertinib|mesh-list
111026919|NCT03058094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111026920|NCT03058094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111026921|NCT03058094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111026922|NCT03058094|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111026923|NCT03058094|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111026924|NCT03058094|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111026925|NCT04413266|Curcumin|curcumin|mesh-list
110491949|NCT00752635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111026926|NCT04413266|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111026927|NCT04413266|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111026928|NCT04413266|Analgesics|analgesics|mesh-ancestor
111026929|NCT04413266|Sensory System Agents|sensory system agents|mesh-ancestor
111026930|NCT04413266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111026931|NCT04413266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111026932|NCT04413266|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111026933|NCT04413266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111026934|NCT04413266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111026935|NCT04413266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111026936|NCT04413266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111026937|NCT04944524|Methotrexate|methotrexate|mesh-list
111026938|NCT04944524|Tofacitinib|tofacitinib|mesh-list
111026939|NCT04944524|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111026940|NCT04944524|Abortifacient Agents|abortifacient agents|mesh-ancestor
111026941|NCT04944524|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111026942|NCT04944524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111026943|NCT04944524|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111026944|NCT04944524|Antimetabolites|antimetabolites|mesh-ancestor
111026945|NCT04944524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111026946|NCT04944524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111026947|NCT04944524|Dermatologic Agents|dermatologic agents|mesh-ancestor
111026948|NCT04944524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110625213|NCT05644496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111026949|NCT04944524|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111026950|NCT04944524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111026951|NCT04944524|Immunologic Factors|immunologic factors|mesh-ancestor
111026952|NCT04944524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111026953|NCT04944524|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111026954|NCT04944524|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
111026955|NCT04944524|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111026956|NCT04412876|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
111026957|NCT04412876|Imipramine|imipramine|mesh-list
111026958|NCT04412876|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111026959|NCT04412876|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111026960|NCT04412876|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111026961|NCT04412876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111026962|NCT04412876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111026963|NCT04412876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111026964|NCT04412876|Analgesics|analgesics|mesh-ancestor
111026965|NCT04412876|Sensory System Agents|sensory system agents|mesh-ancestor
111026966|NCT04412876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111026967|NCT04412876|Antidepressive Agents|antidepressive agents|mesh-ancestor
111026968|NCT04412876|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111026969|NCT04412876|Dopamine Agents|dopamine agents|mesh-ancestor
111026970|NCT04412876|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
111026971|NCT04412876|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111026972|NCT04412876|Adrenergic Agents|adrenergic agents|mesh-ancestor
111026974|NCT03241563|Deoxycholic Acid|deoxycholic acid|mesh-list
111026975|NCT03241563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111026976|NCT03241563|Glucocorticoids|glucocorticoids|mesh-ancestor
111026977|NCT03241563|Hormones|hormones|mesh-ancestor
111026978|NCT03241563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111026979|NCT03241563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111026980|NCT03241563|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
111026981|NCT03241563|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111026982|NCT03241641|Tenofovir|tenofovir|mesh-list
111026983|NCT03241641|Antiviral Agents|antiviral agents|mesh-ancestor
111026984|NCT03241641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111026985|NCT03241641|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111026986|NCT03241641|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111026987|NCT03241641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111026988|NCT03241641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111026989|NCT03241641|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111026990|NCT03241641|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111026991|NCT04486521|Siltuximab|siltuximab|mesh-list
111026992|NCT04486521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111026993|NCT04955834|Insulin|insulin|mesh-list
111026994|NCT04955834|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111026995|NCT04955834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111026996|NCT03241407|Triclosan|triclosan|mesh-list
111026997|NCT03241407|Fluorides|fluorides|mesh-list
111026998|NCT03241407|Cariostatic Agents|cariostatic agents|mesh-ancestor
111026999|NCT03241407|Protective Agents|protective agents|mesh-ancestor
111027000|NCT03241407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111027001|NCT03241407|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111027002|NCT03241407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111027003|NCT03241407|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
111027004|NCT03241407|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111027006|NCT03241407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111027007|NCT03241407|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111027008|NCT03238131|Ivermectin|ivermectin|mesh-list
111027009|NCT03238131|Albendazole|albendazole|mesh-list
111027010|NCT03238131|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111027011|NCT03238131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111027012|NCT03238131|Anthelmintics|anthelmintics|mesh-ancestor
111027013|NCT03238131|Anticestodal Agents|anticestodal agents|mesh-ancestor
111027014|NCT03238131|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
111027015|NCT03238131|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111027016|NCT03238131|Tubulin Modulators|tubulin modulators|mesh-ancestor
111027017|NCT03238131|Antimitotic Agents|antimitotic agents|mesh-ancestor
111027018|NCT03238131|Mitosis Modulators|mitosis modulators|mesh-ancestor
111027019|NCT03238131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111027020|NCT03238131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111027021|NCT01369433|Sirolimus|sirolimus|mesh-list
111027022|NCT01369433|Paclitaxel|paclitaxel|mesh-list
111027023|NCT01369433|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111027024|NCT01369433|Capecitabine|capecitabine|mesh-list
111027025|NCT01369433|Temsirolimus|temsirolimus|mesh-list
111027026|NCT01369433|MTOR Inhibitors|mtor inhibitors|mesh-list
111027027|NCT01369433|Tivozanib|tivozanib|mesh-list
111027028|NCT01369433|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111027029|NCT01369433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111027030|NCT01369433|Tubulin Modulators|tubulin modulators|mesh-ancestor
111027031|NCT01369433|Antimitotic Agents|antimitotic agents|mesh-ancestor
111027032|NCT01369433|Mitosis Modulators|mitosis modulators|mesh-ancestor
111027033|NCT01369433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111027034|NCT01369433|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111027035|NCT01369433|Antimetabolites|antimetabolites|mesh-ancestor
111027036|NCT01369433|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111027037|NCT01369433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110744153|NCT02528396|Insulin Lispro|insulin lispro|mesh-list
111027038|NCT01369433|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111027039|NCT01369433|Immunologic Factors|immunologic factors|mesh-ancestor
111027040|NCT01369433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111027041|NCT01369433|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111027042|NCT01369433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111027043|NCT01369433|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111027044|NCT01369433|Antifungal Agents|antifungal agents|mesh-ancestor
111027045|NCT04946162|Tadalafil|tadalafil|mesh-list
111027046|NCT04946162|Vasodilator Agents|vasodilator agents|mesh-ancestor
111027047|NCT04946162|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111027048|NCT04946162|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111027049|NCT04946162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111027050|NCT04946162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111027051|NCT04946162|Urological Agents|urological agents|mesh-ancestor
111027052|NCT02084225|Lidocaine|lidocaine|mesh-list
111027053|NCT02084225|Anesthetics, Local|anesthetics, local|mesh-ancestor
111027054|NCT02084225|Anesthetics|anesthetics|mesh-ancestor
111027055|NCT02084225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111027056|NCT02084225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111027057|NCT02084225|Sensory System Agents|sensory system agents|mesh-ancestor
111027058|NCT02084225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111027059|NCT02084225|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111027060|NCT02084225|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111027061|NCT02084225|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111027062|NCT02084225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111027063|NCT02084225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111027064|NCT04945694|Fentanyl|fentanyl|mesh-list
111027065|NCT04945694|Propofol|propofol|mesh-list
111027066|NCT04945694|Sevoflurane|sevoflurane|mesh-list
111027067|NCT04945694|Atracurium|atracurium|mesh-list
111027068|NCT04945694|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111027069|NCT04945694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111027070|NCT04945694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111027071|NCT04945694|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111027072|NCT04945694|Anesthetics, General|anesthetics, general|mesh-ancestor
111027073|NCT04945694|Anesthetics|anesthetics|mesh-ancestor
111027074|NCT04945694|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111027075|NCT04945694|Narcotics|narcotics|mesh-ancestor
111027076|NCT04945694|Analgesics|analgesics|mesh-ancestor
111027077|NCT04945694|Sensory System Agents|sensory system agents|mesh-ancestor
111027078|NCT04945694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111027079|NCT04945694|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111027080|NCT04945694|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111027081|NCT04945694|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111027082|NCT04945694|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
111027083|NCT04945694|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
111027084|NCT04945694|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111027085|NCT04945694|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
111027086|NCT04945694|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111027087|NCT04945694|Cholinergic Agents|cholinergic agents|mesh-ancestor
111027088|NCT04945694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111027089|NCT04945694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111027090|NCT02084303|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
111027091|NCT02084303|Hematinics|hematinics|mesh-ancestor
111027092|NCT02084303|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
111027093|NCT02084303|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111027094|NCT02420847|Gemcitabine|gemcitabine|mesh-list
111027095|NCT02420847|Doxorubicin|doxorubicin|mesh-list
111027096|NCT02420847|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111027097|NCT02420847|Ixazomib|ixazomib|mesh-list
111027098|NCT02420847|Glycine|glycine|mesh-list
111027099|NCT02420847|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111027100|NCT02420847|Antimetabolites|antimetabolites|mesh-ancestor
111027101|NCT02420847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111027102|NCT02420847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111027103|NCT02420847|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111027104|NCT02420847|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111027105|NCT02420847|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111027106|NCT02420847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111027107|NCT02420847|Protease Inhibitors|protease inhibitors|mesh-ancestor
111027108|NCT02420847|Glycine Agents|glycine agents|mesh-ancestor
111027109|NCT02420847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111027110|NCT02420847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111027111|NCT03253887|Ethanol|ethanol|mesh-list
111027112|NCT03253887|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111027113|NCT03253887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111027114|NCT03253887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111027115|NCT03253887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111027116|NCT02453607|Infliximab|infliximab|mesh-list
110744226|NCT01242410|Micronutrients|micronutrients|mesh-ancestor
111027117|NCT02453607|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111027119|NCT02453607|Dermatologic Agents|dermatologic agents|mesh-ancestor
111027120|NCT02453607|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111027121|NCT02453607|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111027122|NCT02453529|Nafithromycin|nafithromycin|mesh-list
111027123|NCT02453529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111027124|NCT02453529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111027125|NCT02453529|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111027126|NCT02453529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111027127|NCT02453529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111027128|NCT03241017|Durvalumab|durvalumab|mesh-list
111027129|NCT03241017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111027130|NCT03241017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111027131|NCT03237741|Rabeprazole|rabeprazole|mesh-list
111027132|NCT03237741|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111027133|NCT03237741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111027134|NCT03237741|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111027135|NCT03237741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111027136|NCT03237741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111027137|NCT03240939|Tadalafil|tadalafil|mesh-list
111027138|NCT03240939|Dutasteride|dutasteride|mesh-list
111027139|NCT03240939|Vasodilator Agents|vasodilator agents|mesh-ancestor
111027140|NCT03240939|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111027141|NCT03240939|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111027142|NCT03240939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111027143|NCT03240939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111027144|NCT03240939|Urological Agents|urological agents|mesh-ancestor
111027145|NCT03240939|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
111027146|NCT03240939|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111027147|NCT03240939|Hormone Antagonists|hormone antagonists|mesh-ancestor
111027148|NCT03240939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111027149|NCT03240939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111027150|NCT02624492|Rituximab|rituximab|mesh-list
111027151|NCT02624492|BI 836826|bi 836826|mesh-list
111027152|NCT02624492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111027153|NCT02624492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111027154|NCT02624492|Immunologic Factors|immunologic factors|mesh-ancestor
111027155|NCT02624492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111027156|NCT02624492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111027157|NCT03240783|Dexamethasone|dexamethasone|mesh-list
111027158|NCT03240783|Dexamethasone acetate|dexamethasone acetate|mesh-list
111027159|NCT03240783|Betamethasone|betamethasone|mesh-list
111027160|NCT03240783|BB 1101|bb 1101|mesh-list
111027161|NCT03240783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111027162|NCT03240783|Antiemetics|antiemetics|mesh-ancestor
111027163|NCT03240783|Autonomic Agents|autonomic agents|mesh-ancestor
111027164|NCT03240783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111027165|NCT03240783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111027166|NCT03240783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111027167|NCT03240783|Glucocorticoids|glucocorticoids|mesh-ancestor
111027168|NCT03240783|Hormones|hormones|mesh-ancestor
111027169|NCT03240783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111027170|NCT03240783|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111027171|NCT03240783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111027172|NCT03240783|Protease Inhibitors|protease inhibitors|mesh-ancestor
111027173|NCT03240783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111027174|NCT03240783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111027175|NCT03240783|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111027176|NCT03240783|Respiratory System Agents|respiratory system agents|mesh-ancestor
111027177|NCT03237507|Paclitaxel|paclitaxel|mesh-list
111027178|NCT03237507|Oxaliplatin|oxaliplatin|mesh-list
111027179|NCT03237507|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111027180|NCT03237507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111027181|NCT03237507|Tubulin Modulators|tubulin modulators|mesh-ancestor
111027182|NCT03237507|Antimitotic Agents|antimitotic agents|mesh-ancestor
111027183|NCT03237507|Mitosis Modulators|mitosis modulators|mesh-ancestor
111027184|NCT03237507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111027185|NCT04945226|Finasteride|finasteride|mesh-list
111027186|NCT04945226|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
111027187|NCT04945226|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111027188|NCT04945226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111027189|NCT04945226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111027190|NCT04945226|Hormone Antagonists|hormone antagonists|mesh-ancestor
111027191|NCT04945226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111027192|NCT04945226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111027193|NCT04945226|Urological Agents|urological agents|mesh-ancestor
111027194|NCT01975831|Durvalumab|durvalumab|mesh-list
111027195|NCT01975831|Tremelimumab|tremelimumab|mesh-list
111027196|NCT01975831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111027197|NCT01975831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111027198|NCT04945070|Insulin|insulin|mesh-list
111027199|NCT04945070|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111027200|NCT04945070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111027201|NCT03240471|Calpastatin|calpastatin|mesh-list
111027202|NCT03240471|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
111027203|NCT03240471|Protease Inhibitors|protease inhibitors|mesh-ancestor
111027204|NCT03240471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111027205|NCT03240471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111027206|NCT04942652|Itraconazole|itraconazole|mesh-list
111027207|NCT04942652|Esomeprazole|esomeprazole|mesh-list
111027208|NCT04942652|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111027209|NCT04942652|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111027210|NCT04942652|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111027211|NCT04942652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111027212|NCT04942652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111027213|NCT04942652|Antifungal Agents|antifungal agents|mesh-ancestor
111027214|NCT04942652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111027215|NCT04942652|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111027216|NCT04942652|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111027217|NCT04942652|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111027218|NCT04942652|Hormone Antagonists|hormone antagonists|mesh-ancestor
111027219|NCT04942652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111027220|NCT04942652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111027221|NCT04942652|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111027222|NCT03240549|Bevacizumab|bevacizumab|mesh-list
111027223|NCT03240549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111027224|NCT03240549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111027225|NCT03240549|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111027226|NCT03240549|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111027227|NCT03240549|Growth Substances|growth substances|mesh-ancestor
111027228|NCT03240549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111027229|NCT03240549|Growth Inhibitors|growth inhibitors|mesh-ancestor
111027230|NCT04933292|Mycophenolic Acid|mycophenolic acid|mesh-list
111027231|NCT04933292|Methylprednisolone|methylprednisolone|mesh-list
111027232|NCT04933292|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111027233|NCT04933292|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111027234|NCT04933292|Prednisolone|prednisolone|mesh-list
111027235|NCT04933292|Prednisolone acetate|prednisolone acetate|mesh-list
111027236|NCT04933292|Azathioprine|azathioprine|mesh-list
111027237|NCT04933292|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111027238|NCT04933292|Prednisolone phosphate|prednisolone phosphate|mesh-list
111027239|NCT04933292|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111027240|NCT04933292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111027241|NCT04933292|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111027242|NCT04933292|Antitubercular Agents|antitubercular agents|mesh-ancestor
111027243|NCT04933292|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111027244|NCT04933292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111027245|NCT04933292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111027246|NCT04933292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111027247|NCT04933292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111027248|NCT04933292|Antiemetics|antiemetics|mesh-ancestor
111027249|NCT04933292|Autonomic Agents|autonomic agents|mesh-ancestor
111027250|NCT04933292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111027251|NCT04933292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111027252|NCT04933292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111027253|NCT04933292|Glucocorticoids|glucocorticoids|mesh-ancestor
111027254|NCT04933292|Hormones|hormones|mesh-ancestor
111027255|NCT04933292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111027256|NCT04933292|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111027257|NCT04933292|Protective Agents|protective agents|mesh-ancestor
111027258|NCT04933292|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111027259|NCT04933292|Antimetabolites|antimetabolites|mesh-ancestor
111027260|NCT04933292|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111027261|NCT04933292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111027262|NCT04933292|Immunologic Factors|immunologic factors|mesh-ancestor
111027263|NCT04933292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110744384|NCT01251458|Temsirolimus|temsirolimus|mesh-list
111027264|NCT04942496|Chlorhexidine|chlorhexidine|mesh-list
111027265|NCT04942496|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
111027266|NCT04942496|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111027267|NCT04942496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111027268|NCT04942496|Disinfectants|disinfectants|mesh-ancestor
111027269|NCT04942496|Dermatologic Agents|dermatologic agents|mesh-ancestor
111027270|NCT03237117|Hormones|hormones|mesh-list
111027271|NCT03237117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111027272|NCT03237117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111027273|NCT03239691|ACT-709478|act-709478|mesh-list
111027274|NCT03239691|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111027275|NCT03239691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111027276|NCT03239691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111027277|NCT03239691|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111027278|NCT03239691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111027279|NCT04944602|Omalizumab|omalizumab|mesh-list
111027280|NCT04944602|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111027281|NCT04944602|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111027282|NCT04944602|Respiratory System Agents|respiratory system agents|mesh-ancestor
111027283|NCT03253107|Trastuzumab|trastuzumab|mesh-list
111027284|NCT03253107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111027285|NCT03253107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111027286|NCT03236883|Gemcitabine|gemcitabine|mesh-list
111027287|NCT03236883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111027288|NCT03236883|Antimetabolites|antimetabolites|mesh-ancestor
111027289|NCT03236883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111027290|NCT03236883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111027291|NCT03236961|Moxifloxacin|moxifloxacin|mesh-list
111027292|NCT03236961|Metronidazole|metronidazole|mesh-list
111027293|NCT03236961|Levofloxacin|levofloxacin|mesh-list
111027294|NCT03236961|Ertapenem|ertapenem|mesh-list
111027295|NCT03236961|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111027296|NCT03236961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111027297|NCT03236961|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111027298|NCT03236961|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111027299|NCT03236961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111027300|NCT03236961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111027301|NCT03236961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111027302|NCT03236961|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111027303|NCT03236961|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111027304|NCT03236961|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111027305|NCT03236961|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111027306|NCT03236961|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111027307|NCT05234619|Ketorolac|ketorolac|mesh-list
111027308|NCT05234619|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
111027309|NCT05234619|Lidocaine|lidocaine|mesh-list
111027310|NCT05234619|Anesthetics, Local|anesthetics, local|mesh-ancestor
111027311|NCT05234619|Anesthetics|anesthetics|mesh-ancestor
111027312|NCT05234619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111027313|NCT05234619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111027314|NCT05234619|Sensory System Agents|sensory system agents|mesh-ancestor
111027315|NCT05234619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111027316|NCT05234619|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111027317|NCT05234619|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111027318|NCT05234619|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111027319|NCT05234619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111027320|NCT05234619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111027321|NCT05234619|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111027322|NCT05234619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111027323|NCT05234619|Analgesics|analgesics|mesh-ancestor
111027324|NCT05234619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111027325|NCT05234619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111027326|NCT05234619|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111027327|NCT05234619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111027328|NCT04921904|Ramucirumab|ramucirumab|mesh-list
111027329|NCT04921904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111027330|NCT02622386|Riboflavin|riboflavin|mesh-list
111027331|NCT02622386|Vitamins|vitamins|mesh-ancestor
111027332|NCT02622386|Micronutrients|micronutrients|mesh-ancestor
111027333|NCT02622386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111027334|NCT02622386|Vitamin B Complex|vitamin b complex|mesh-ancestor
111027335|NCT02622386|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111027336|NCT02622386|Dermatologic Agents|dermatologic agents|mesh-ancestor
111027337|NCT04427618|Tranexamic Acid|tranexamic acid|mesh-list
111027338|NCT04427618|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111027339|NCT04427618|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111027340|NCT04427618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111027342|NCT04427618|Coagulants|coagulants|mesh-ancestor
111027343|NCT03236727|Dexmedetomidine|dexmedetomidine|mesh-list
111027344|NCT03236727|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111027345|NCT03236727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111027346|NCT03236727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111027347|NCT03236727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111027348|NCT03236727|Analgesics|analgesics|mesh-ancestor
111027349|NCT03236727|Sensory System Agents|sensory system agents|mesh-ancestor
111027350|NCT03236727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111027351|NCT03236727|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111027352|NCT03236727|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111027353|NCT03236727|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111027354|NCT03236727|Adrenergic Agents|adrenergic agents|mesh-ancestor
111027355|NCT03236727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111027356|NCT03236727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111027357|NCT03236493|PF-06700841|pf-06700841|mesh-list
111027358|NCT03236493|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111027359|NCT03236493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111027360|NCT03236493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111027361|NCT04921124|Teriparatide|teriparatide|mesh-list
111027362|NCT04921124|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111027363|NCT04921124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111027364|NCT04921124|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111027365|NCT04921046|Lidocaine|lidocaine|mesh-list
111027366|NCT04921046|Midazolam|midazolam|mesh-list
111027367|NCT04921046|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111027368|NCT04921046|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111027369|NCT04921046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111027370|NCT04921046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111027371|NCT04921046|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111027372|NCT04921046|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111027373|NCT04921046|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111027374|NCT04921046|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111027375|NCT04921046|Anesthetics, General|anesthetics, general|mesh-ancestor
111027376|NCT04921046|Anesthetics|anesthetics|mesh-ancestor
111027377|NCT04921046|GABA Modulators|gaba modulators|mesh-ancestor
111027378|NCT04921046|GABA Agents|gaba agents|mesh-ancestor
111027379|NCT04921046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111027380|NCT04921046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111027381|NCT04921046|Anesthetics, Local|anesthetics, local|mesh-ancestor
111027382|NCT04921046|Sensory System Agents|sensory system agents|mesh-ancestor
111027383|NCT04921046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111027384|NCT04921046|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111027385|NCT04921046|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111027386|NCT04921046|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111027387|NCT04921046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111027388|NCT02792231|Teriflunomide|teriflunomide|mesh-list
111027389|NCT02792231|Ofatumumab|ofatumumab|mesh-list
111027390|NCT02792231|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111027391|NCT02792231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111027392|NCT02792231|Immunologic Factors|immunologic factors|mesh-ancestor
111027393|NCT02792231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111027394|NCT02792231|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111027395|NCT02792231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111027396|NCT02792231|Analgesics|analgesics|mesh-ancestor
111027397|NCT02792231|Sensory System Agents|sensory system agents|mesh-ancestor
111027398|NCT02792231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111027399|NCT02792231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111027400|NCT02792231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111027401|NCT02792231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111027402|NCT04930952|Ethanol|ethanol|mesh-list
111027403|NCT04930952|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111027404|NCT04930952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111027405|NCT04930952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111027406|NCT04930952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111027407|NCT04920968|Rituximab|rituximab|mesh-list
111027408|NCT04920968|Obinutuzumab|obinutuzumab|mesh-list
111027409|NCT04920968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111027410|NCT04920968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111027411|NCT04920968|Immunologic Factors|immunologic factors|mesh-ancestor
111027412|NCT04920968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111027413|NCT04920968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111027414|NCT00700401|Ribavirin|ribavirin|mesh-list
111027415|NCT00700401|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
111027416|NCT00700401|Antimetabolites|antimetabolites|mesh-ancestor
111027417|NCT00700401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111027418|NCT00700401|Antiviral Agents|antiviral agents|mesh-ancestor
111027419|NCT00700401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111027420|NCT04931108|Atenolol|atenolol|mesh-list
111027421|NCT04931108|Nitrendipine|nitrendipine|mesh-list
111027422|NCT04931108|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111027423|NCT04931108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111027424|NCT04931108|Sympatholytics|sympatholytics|mesh-ancestor
111027425|NCT04931108|Autonomic Agents|autonomic agents|mesh-ancestor
111027426|NCT04931108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111027427|NCT04931108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111027428|NCT04931108|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
111027429|NCT04931108|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111027430|NCT04931108|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111027431|NCT04931108|Adrenergic Agents|adrenergic agents|mesh-ancestor
111027432|NCT04931108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111027433|NCT04931108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111027434|NCT04931108|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111027435|NCT04931108|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111027436|NCT04931108|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111027437|NCT04931108|Vasodilator Agents|vasodilator agents|mesh-ancestor
111027438|NCT04920500|Cytarabine|cytarabine|mesh-list
111027439|NCT04920500|Daunorubicin|daunorubicin|mesh-list
111027440|NCT04920500|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111027441|NCT04920500|Antimetabolites|antimetabolites|mesh-ancestor
111027442|NCT04920500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111027444|NCT04920500|Antiviral Agents|antiviral agents|mesh-ancestor
111027445|NCT04920500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111027446|NCT04920500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111027447|NCT04920500|Immunologic Factors|immunologic factors|mesh-ancestor
111027448|NCT04920500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111027449|NCT04920500|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111027450|NCT04920500|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111027451|NCT04920500|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111027452|NCT04920500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111027453|NCT02084615|Aspirin|aspirin|mesh-list
111027454|NCT02084615|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111027455|NCT02084615|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111027456|NCT02084615|Analgesics|analgesics|mesh-ancestor
111027457|NCT02084615|Sensory System Agents|sensory system agents|mesh-ancestor
111027458|NCT02084615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111027459|NCT02084615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111027460|NCT02084615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111027461|NCT02084615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111027462|NCT02084615|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111027463|NCT02084615|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111027464|NCT02084615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111027465|NCT02084615|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111027466|NCT02084615|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111027467|NCT02084615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111027468|NCT02084615|Antipyretics|antipyretics|mesh-ancestor
111027469|NCT03559751|Nicotine|nicotine|mesh-list
111027470|NCT03559751|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111027471|NCT03559751|Autonomic Agents|autonomic agents|mesh-ancestor
111027472|NCT03559751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111027473|NCT03559751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111027474|NCT03559751|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111027475|NCT03559751|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111027476|NCT03559751|Cholinergic Agents|cholinergic agents|mesh-ancestor
111027477|NCT03559751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111027478|NCT03559751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111027479|NCT03234699|Midazolam|midazolam|mesh-list
111027480|NCT03234699|Cenobamate|cenobamate|mesh-list
111027481|NCT03234699|Bupropion|bupropion|mesh-list
111027482|NCT03234699|Omeprazole|omeprazole|mesh-list
111027483|NCT03234699|Warfarin|warfarin|mesh-list
111027484|NCT03234699|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111027485|NCT03234699|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111027486|NCT03234699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111027487|NCT03234699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110744601|NCT03914534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111027488|NCT03234699|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111027489|NCT03234699|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111027490|NCT03234699|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111027491|NCT03234699|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111027492|NCT03234699|Anesthetics, General|anesthetics, general|mesh-ancestor
111027493|NCT03234699|Anesthetics|anesthetics|mesh-ancestor
111027494|NCT03234699|GABA Modulators|gaba modulators|mesh-ancestor
111027495|NCT03234699|GABA Agents|gaba agents|mesh-ancestor
111027496|NCT03234699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111027497|NCT03234699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111027498|NCT03234699|Anticoagulants|anticoagulants|mesh-ancestor
111027499|NCT03234699|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111027500|NCT03234699|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111027501|NCT03234699|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111027502|NCT03234699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111027503|NCT03234699|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111027504|NCT03234699|Antidepressive Agents|antidepressive agents|mesh-ancestor
111027505|NCT03234699|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111027506|NCT03234699|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111027507|NCT03234699|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111027508|NCT03234699|Dopamine Agents|dopamine agents|mesh-ancestor
111027509|NCT03234699|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111027510|NCT03234699|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111027511|NCT03234699|Anticonvulsants|anticonvulsants|mesh-ancestor
111027512|NCT03228771|Atorvastatin|atorvastatin|mesh-list
111027513|NCT03228771|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111027514|NCT03228771|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111027515|NCT03228771|Antimetabolites|antimetabolites|mesh-ancestor
111027516|NCT03228771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111027517|NCT03228771|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111027518|NCT03228771|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111027519|NCT03228771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111027521|NCT02081339|Aflibercept|aflibercept|mesh-list
111027522|NCT02081339|Verteporfin|verteporfin|mesh-list
111027523|NCT02081339|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111027524|NCT02081339|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111027525|NCT02081339|Growth Substances|growth substances|mesh-ancestor
111027526|NCT02081339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111027527|NCT02081339|Growth Inhibitors|growth inhibitors|mesh-ancestor
111027528|NCT02081339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111027529|NCT02081339|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111027530|NCT02081339|Dermatologic Agents|dermatologic agents|mesh-ancestor
111027531|NCT04939766|Insulin|insulin|mesh-list
111027532|NCT04939766|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111027533|NCT04939766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111027534|NCT02079545|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111027535|NCT02079545|Immunologic Factors|immunologic factors|mesh-ancestor
111027536|NCT02079545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111027537|NCT03559673|Lacosamide|lacosamide|mesh-list
111027538|NCT03559673|Anticonvulsants|anticonvulsants|mesh-ancestor
111027539|NCT03559673|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111027540|NCT03559673|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111027541|NCT03559673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111027542|NCT03559673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111027543|NCT03234387|Acetylcholine|acetylcholine|mesh-list
111027544|NCT03234387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111027545|NCT03234387|Vasodilator Agents|vasodilator agents|mesh-ancestor
111027546|NCT03234387|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111027547|NCT03234387|Cholinergic Agents|cholinergic agents|mesh-ancestor
111027548|NCT03234387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111027549|NCT03234387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111027550|NCT03235947|Trimethoprim|trimethoprim|mesh-list
111027551|NCT03235947|Sulfamethoxazole|sulfamethoxazole|mesh-list
111027552|NCT03235947|Fosfomycin|fosfomycin|mesh-list
111027553|NCT03235947|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111027554|NCT03235947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111027555|NCT03235947|Antimalarials|antimalarials|mesh-ancestor
111027556|NCT03235947|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111027557|NCT03235947|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111027558|NCT03235947|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111027559|NCT03235947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111027560|NCT03235947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111027561|NCT03235947|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111027562|NCT03235947|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
111027563|NCT03235947|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111027564|NCT03235947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111027565|NCT03057470|Insulin|insulin|mesh-list
111027566|NCT03057470|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111027567|NCT03057470|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111027568|NCT03057470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111027569|NCT02871401|Valganciclovir|valganciclovir|mesh-list
111027570|NCT02871401|Antiviral Agents|antiviral agents|mesh-ancestor
111027571|NCT02871401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111027572|NCT03228303|Imatinib Mesylate|imatinib mesylate|mesh-list
111027573|NCT03228303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111027574|NCT03228303|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111027575|NCT03228303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111027576|NCT03228303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111027577|NCT02085005|Capecitabine|capecitabine|mesh-list
111027578|NCT02085005|Oxaliplatin|oxaliplatin|mesh-list
111027579|NCT02085005|Aflibercept|aflibercept|mesh-list
111027580|NCT02085005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111027581|NCT02085005|Antimetabolites|antimetabolites|mesh-ancestor
111027582|NCT02085005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111027583|NCT02085005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111027584|NCT02085005|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111027585|NCT02085005|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111027586|NCT02085005|Growth Substances|growth substances|mesh-ancestor
111027587|NCT02085005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111027588|NCT02085005|Growth Inhibitors|growth inhibitors|mesh-ancestor
111027589|NCT03235869|Durvalumab|durvalumab|mesh-list
111027590|NCT03235869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111027591|NCT03235869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111027592|NCT02079701|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
111027593|NCT02079701|Immunologic Factors|immunologic factors|mesh-ancestor
111027594|NCT02079701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111027595|NCT03057314|Calcium Carbonate|calcium carbonate|mesh-list
111027596|NCT03057314|Calcium|calcium|mesh-list
111027597|NCT03057314|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111027598|NCT03057314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111027599|NCT03057314|Antacids|antacids|mesh-ancestor
111027600|NCT03057314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111027601|NCT03057314|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111027602|NCT02081495|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111027603|NCT02081495|Doxorubicin|doxorubicin|mesh-list
111027604|NCT02081495|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111027605|NCT02081495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111027606|NCT02081495|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111027607|NCT02081495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111027608|NCT02081495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111027609|NCT02081495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111027610|NCT03056846|Sulfalene|sulfalene|mesh-list
111027611|NCT03056846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111027612|NCT03056846|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111027613|NCT03056846|Antimalarials|antimalarials|mesh-ancestor
111027614|NCT03056846|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111027615|NCT03056846|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111027616|NCT03227679|Bupropion|bupropion|mesh-list
111027617|NCT03227679|Nicotine|nicotine|mesh-list
111027618|NCT03227679|Varenicline|varenicline|mesh-list
111027619|NCT03227679|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111027620|NCT03227679|Autonomic Agents|autonomic agents|mesh-ancestor
111027621|NCT03227679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111027622|NCT03227679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111027623|NCT03227679|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111027624|NCT03227679|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111027625|NCT03227679|Cholinergic Agents|cholinergic agents|mesh-ancestor
111027626|NCT03227679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111027627|NCT03227679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111027628|NCT03227679|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111027629|NCT03227679|Antidepressive Agents|antidepressive agents|mesh-ancestor
111027630|NCT03227679|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111027631|NCT03227679|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111027632|NCT03227679|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111027633|NCT03227679|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111027634|NCT03227679|Dopamine Agents|dopamine agents|mesh-ancestor
111027635|NCT03227679|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111027636|NCT03227679|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111027637|NCT03227679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111027638|NCT04886167|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111027639|NCT04886167|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110625426|NCT05025865|Viscosupplements|viscosupplements|mesh-ancestor
111027640|NCT04886167|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111027641|NCT04886167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111027642|NCT04886167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111027643|NCT04886167|Cholinergic Agents|cholinergic agents|mesh-ancestor
111027644|NCT04886167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111027645|NCT04886167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111027646|NCT04886167|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111027647|NCT04886167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111027648|NCT04937894|Tigecycline|tigecycline|mesh-list
111027649|NCT04937894|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111027650|NCT04937894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111027651|NCT04937894|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111027652|NCT04937894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111027653|NCT04937894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111027654|NCT04919252|Vedolizumab|vedolizumab|mesh-list
111027655|NCT04919252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111027656|NCT04919174|Dexmedetomidine|dexmedetomidine|mesh-list
111027657|NCT04919174|Remifentanil|remifentanil|mesh-list
111027658|NCT04919174|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111027659|NCT04919174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111027660|NCT04919174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111027661|NCT04919174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111027662|NCT04919174|Analgesics|analgesics|mesh-ancestor
111027663|NCT04919174|Sensory System Agents|sensory system agents|mesh-ancestor
111027664|NCT04919174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111027665|NCT04919174|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111027666|NCT04919174|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111027667|NCT04919174|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111027668|NCT04919174|Adrenergic Agents|adrenergic agents|mesh-ancestor
111027669|NCT04919174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111027670|NCT04919174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111027671|NCT04919174|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111027672|NCT04919174|Narcotics|narcotics|mesh-ancestor
111027673|NCT02085239|Lidocaine|lidocaine|mesh-list
111027674|NCT02085239|Ropivacaine|ropivacaine|mesh-list
111027675|NCT02085239|Anesthetics, Local|anesthetics, local|mesh-ancestor
111027676|NCT02085239|Anesthetics|anesthetics|mesh-ancestor
111027677|NCT02085239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111027678|NCT02085239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111027679|NCT02085239|Sensory System Agents|sensory system agents|mesh-ancestor
111027680|NCT02085239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111027681|NCT02085239|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111027682|NCT02085239|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111027683|NCT02085239|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111027684|NCT02085239|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111027685|NCT02085239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111027686|NCT05143489|Lidocaine|lidocaine|mesh-list
111027687|NCT05143489|Anesthetics, Local|anesthetics, local|mesh-ancestor
111027688|NCT05143489|Anesthetics|anesthetics|mesh-ancestor
111027689|NCT05143489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111027690|NCT05143489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111027691|NCT05143489|Sensory System Agents|sensory system agents|mesh-ancestor
111027692|NCT05143489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111027693|NCT05143489|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111027694|NCT05143489|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111027695|NCT05143489|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111027696|NCT05143489|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111027697|NCT05143489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111027698|NCT02085317|Nitroprusside|nitroprusside|mesh-list
111027699|NCT02085317|Acetylcholine|acetylcholine|mesh-list
111027700|NCT02085317|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111027701|NCT02085317|Vasodilator Agents|vasodilator agents|mesh-ancestor
111027702|NCT02085317|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
111027703|NCT02085317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111027704|NCT02085317|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111027705|NCT02085317|Cholinergic Agents|cholinergic agents|mesh-ancestor
111027706|NCT02085317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111027707|NCT02085317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111027708|NCT03234153|Durvalumab|durvalumab|mesh-list
111027709|NCT03234153|Tremelimumab|tremelimumab|mesh-list
111027710|NCT03234153|Immunomodulating Agents|immunomodulating agents|mesh-list
111027711|NCT03234153|Immunologic Factors|immunologic factors|mesh-list
111027712|NCT03234153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111027713|NCT03234153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111027714|NCT03234153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111027716|NCT03056924|Immunologic Factors|immunologic factors|mesh-ancestor
111027717|NCT03056924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111027718|NCT05523401|Psilocybin|psilocybin|mesh-list
111027719|NCT05523401|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
111027720|NCT05523401|2-(4-bromo-2,5-dimethoxyphenyl)ethylamine|2-(4-bromo-2,5-dimethoxyphenyl)ethylamine|mesh-list
111027721|NCT05523401|Hallucinogens|hallucinogens|mesh-ancestor
111027722|NCT05523401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111027723|NCT05523401|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111027724|NCT05523401|Serotonin Agents|serotonin agents|mesh-ancestor
111027725|NCT05523401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111027726|NCT05523401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111027727|NCT05523401|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111027728|NCT05523401|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111027729|NCT05523401|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111027730|NCT05523401|Adrenergic Agents|adrenergic agents|mesh-ancestor
111027731|NCT05523401|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111027732|NCT05523401|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111027733|NCT05523401|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111027734|NCT05523401|Serotonin 5-HT2 Receptor Agonists|serotonin 5-ht2 receptor agonists|mesh-ancestor
111027735|NCT05523401|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111027736|NCT04918862|Granisetron|granisetron|mesh-list
111027737|NCT04918862|Antiemetics|antiemetics|mesh-ancestor
111027738|NCT04918862|Autonomic Agents|autonomic agents|mesh-ancestor
111027739|NCT04918862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111027740|NCT04918862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111027741|NCT04918862|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111027742|NCT04918862|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111027743|NCT04918862|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111027744|NCT04918862|Serotonin Agents|serotonin agents|mesh-ancestor
111027745|NCT04918862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111027746|NCT04918862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111027747|NCT02452905|Nitazoxanide|nitazoxanide|mesh-list
111027748|NCT02452905|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111027749|NCT02452905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111027750|NCT02081885|Chitosan|chitosan|mesh-list
111027751|NCT02081885|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111027752|NCT02081885|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111027753|NCT02081885|Antimetabolites|antimetabolites|mesh-ancestor
111027754|NCT02081885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111027755|NCT02081885|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111027756|NCT02081885|Chelating Agents|chelating agents|mesh-ancestor
111027757|NCT02081885|Sequestering Agents|sequestering agents|mesh-ancestor
111027758|NCT02081885|Hemostatics|hemostatics|mesh-ancestor
111027759|NCT02081885|Coagulants|coagulants|mesh-ancestor
111027760|NCT03235245|Nivolumab|nivolumab|mesh-list
111027761|NCT03235245|Ipilimumab|ipilimumab|mesh-list
111027762|NCT03235245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111027763|NCT03235245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111027764|NCT03235245|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111027765|NCT03235245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111027766|NCT02452281|Ipilimumab|ipilimumab|mesh-list
111027767|NCT02452281|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111027768|NCT02452281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111027769|NCT02452281|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111027770|NCT02452281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111027771|NCT02452125|Nicotine|nicotine|mesh-list
111027772|NCT02452125|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111027773|NCT02452125|Autonomic Agents|autonomic agents|mesh-ancestor
111027774|NCT02452125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111027775|NCT02452125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111027776|NCT02452125|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111027777|NCT02452125|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111027778|NCT02452125|Cholinergic Agents|cholinergic agents|mesh-ancestor
111027779|NCT02452125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111027780|NCT02452125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111027781|NCT02619812|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
111027782|NCT02619812|Immunoglobulins|immunoglobulins|mesh-list
111027783|NCT02619812|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111027784|NCT02619812|Antibodies|antibodies|mesh-list
111027785|NCT02619812|Immunologic Factors|immunologic factors|mesh-ancestor
111027786|NCT02619812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111027787|NCT02619812|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111027788|NCT02619812|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111027789|NCT02619812|Antimetabolites|antimetabolites|mesh-ancestor
111027790|NCT02619812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111027791|NCT02619812|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111027792|NCT04928066|Prednisone|prednisone|mesh-list
111027793|NCT04928066|Tofacitinib|tofacitinib|mesh-list
111027794|NCT04928066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111027795|NCT04928066|Glucocorticoids|glucocorticoids|mesh-ancestor
111027796|NCT04928066|Hormones|hormones|mesh-ancestor
111027797|NCT04928066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111027798|NCT04928066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111027799|NCT04928066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111027800|NCT04928066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111027801|NCT04928066|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
111027802|NCT04928066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111027803|NCT04928066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111027804|NCT04928066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111027805|NCT03222765|Metformin|metformin|mesh-list
111027806|NCT03222765|Linagliptin|linagliptin|mesh-list
111027807|NCT03222765|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111027808|NCT03222765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111027809|NCT03222765|Incretins|incretins|mesh-ancestor
111027810|NCT03222765|Hormones|hormones|mesh-ancestor
111027811|NCT03222765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111027812|NCT03222765|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111027813|NCT03222765|Protease Inhibitors|protease inhibitors|mesh-ancestor
111027814|NCT03222765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111027815|NCT03222765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111027817|NCT04485585|Mirabegron|mirabegron|mesh-list
111027818|NCT04485585|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111027819|NCT04485585|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111027820|NCT04485585|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111027821|NCT04485585|Adrenergic Agents|adrenergic agents|mesh-ancestor
111027822|NCT04485585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111027823|NCT04485585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111027824|NCT04485585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111027825|NCT04485585|Urological Agents|urological agents|mesh-ancestor
111027826|NCT04485585|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
111027827|NCT04485585|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111027828|NCT04485585|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111027829|NCT03222687|Prednisone|prednisone|mesh-list
111027830|NCT03222687|Tacrolimus|tacrolimus|mesh-list
111027831|NCT03222687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111027832|NCT03222687|Glucocorticoids|glucocorticoids|mesh-ancestor
111027833|NCT03222687|Hormones|hormones|mesh-ancestor
111027834|NCT03222687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111027835|NCT03222687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111027836|NCT03222687|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111027837|NCT03222687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111027838|NCT03222687|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111027839|NCT03222687|Immunologic Factors|immunologic factors|mesh-ancestor
111027840|NCT03222687|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111027841|NCT03222687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111027842|NCT03222687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111027843|NCT03055442|Inositol|inositol|mesh-list
111027844|NCT03055442|Vitamin B Complex|vitamin b complex|mesh-ancestor
111027845|NCT03055442|Vitamins|vitamins|mesh-ancestor
111027846|NCT03055442|Micronutrients|micronutrients|mesh-ancestor
111027847|NCT03055442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111027848|NCT03226431|Ascorbic Acid|ascorbic acid|mesh-list
111027849|NCT03226431|Antioxidants|antioxidants|mesh-ancestor
111027850|NCT03226431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110625452|NCT04974216|Lenalidomide|lenalidomide|mesh-list
111027851|NCT03226431|Protective Agents|protective agents|mesh-ancestor
111027852|NCT03226431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111027853|NCT03226431|Vitamins|vitamins|mesh-ancestor
111027854|NCT03226431|Micronutrients|micronutrients|mesh-ancestor
111027855|NCT02451579|Cetirizine|cetirizine|mesh-list
111027856|NCT02451579|Histamine Antagonists|histamine antagonists|mesh-list
111027857|NCT02451579|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
111027858|NCT02451579|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111027859|NCT02451579|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
111027860|NCT02451579|Histamine Agents|histamine agents|mesh-ancestor
111027861|NCT02451579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111027862|NCT02451579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111027863|NCT02451579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111027864|NCT04935788|Caseins|caseins|mesh-list
111027865|NCT04935788|Chelating Agents|chelating agents|mesh-ancestor
111027866|NCT04935788|Sequestering Agents|sequestering agents|mesh-ancestor
111027867|NCT04935788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111027868|NCT03233295|Vitamin D|vitamin d|mesh-list
111027869|NCT03233295|Cholecalciferol|cholecalciferol|mesh-list
111027870|NCT03233295|Vitamins|vitamins|mesh-ancestor
111027871|NCT03233295|Micronutrients|micronutrients|mesh-ancestor
111027872|NCT03233295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111027873|NCT03233295|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111027874|NCT03233295|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111027875|NCT04917458|Vitamin D|vitamin d|mesh-list
111027876|NCT04917458|Cholecalciferol|cholecalciferol|mesh-list
111027877|NCT04917458|Vitamins|vitamins|mesh-ancestor
111027878|NCT04917458|Micronutrients|micronutrients|mesh-ancestor
111027879|NCT04917458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111027880|NCT04917458|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111027881|NCT04917458|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111027883|NCT03225963|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111027884|NCT03225963|Alkylating Agents|alkylating agents|mesh-ancestor
111027885|NCT03225963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111027886|NCT03225963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111027887|NCT03221907|Pregabalin|pregabalin|mesh-list
111027888|NCT03221907|Analgesics|analgesics|mesh-ancestor
111027889|NCT03221907|Sensory System Agents|sensory system agents|mesh-ancestor
111027890|NCT03221907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111027891|NCT03221907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111027892|NCT03221907|Anticonvulsants|anticonvulsants|mesh-ancestor
111027893|NCT03221907|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111027894|NCT03221907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111027895|NCT03221907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111027896|NCT03221907|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111027897|NCT03221907|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111027898|NCT03221907|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111027899|NCT03221907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111027900|NCT03221907|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111027901|NCT04934930|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
111027902|NCT04934930|Obinutuzumab|obinutuzumab|mesh-list
111027903|NCT04934930|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111027904|NCT04934930|Alkylating Agents|alkylating agents|mesh-ancestor
111027905|NCT04934930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111027906|NCT04934930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111027907|NCT04934930|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111027908|NCT03107481|Acetaminophen|acetaminophen|mesh-list
111027909|NCT03107481|Hydromorphone|hydromorphone|mesh-list
111027910|NCT03107481|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111027911|NCT03107481|Analgesics|analgesics|mesh-ancestor
111027912|NCT03107481|Sensory System Agents|sensory system agents|mesh-ancestor
111027913|NCT03107481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111027914|NCT03107481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111027915|NCT03107481|Antipyretics|antipyretics|mesh-ancestor
111027916|NCT03107481|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111027917|NCT03107481|Narcotics|narcotics|mesh-ancestor
111027918|NCT03107481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111027919|NCT04934852|Ephedrine|ephedrine|mesh-list
111027920|NCT04934852|Pseudoephedrine|pseudoephedrine|mesh-list
111027921|NCT04934852|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111027922|NCT04934852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111027923|NCT04934852|Sympathomimetics|sympathomimetics|mesh-ancestor
111027924|NCT04934852|Autonomic Agents|autonomic agents|mesh-ancestor
111027925|NCT04934852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111027926|NCT04934852|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111027927|NCT04934852|Adrenergic Agents|adrenergic agents|mesh-ancestor
111027928|NCT04934852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111027929|NCT04934852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111027930|NCT04934852|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111027931|NCT04934852|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111027932|NCT04934852|Respiratory System Agents|respiratory system agents|mesh-ancestor
111027933|NCT04934852|Nasal Decongestants|nasal decongestants|mesh-ancestor
110745053|NCT03901118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111027934|NCT04934618|Irinotecan|irinotecan|mesh-list
111027935|NCT04934618|Apatinib|apatinib|mesh-list
111027936|NCT04934618|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111027937|NCT04934618|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111027938|NCT04934618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111027939|NCT04934618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111027940|NCT04934618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111027941|NCT04934618|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111027942|NCT03107325|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
111027943|NCT03107325|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111027944|NCT03107325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111027945|NCT04916522|Colchicine|colchicine|mesh-list
111027946|NCT04916522|Gout Suppressants|gout suppressants|mesh-ancestor
111027947|NCT04916522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111027948|NCT04916522|Tubulin Modulators|tubulin modulators|mesh-ancestor
111027949|NCT04916522|Antimitotic Agents|antimitotic agents|mesh-ancestor
111027950|NCT04916522|Mitosis Modulators|mitosis modulators|mesh-ancestor
111027951|NCT04916522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111027952|NCT04916522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111027953|NCT04407650|Metformin|metformin|mesh-list
111027954|NCT04407650|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
111027955|NCT04407650|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111027956|NCT04407650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111027957|NCT04407650|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
111027958|NCT04407650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111027959|NCT00105157|Raltegravir Potassium|raltegravir potassium|mesh-list
111027960|NCT00105157|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111027961|NCT00105157|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111027962|NCT00105157|Antiviral Agents|antiviral agents|mesh-ancestor
111027963|NCT00105157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111027964|NCT00105157|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111027965|NCT00105157|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111027966|NCT00105157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111027967|NCT00105157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111027968|NCT03220815|Methamphetamine|methamphetamine|mesh-list
111027969|NCT03220815|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111027970|NCT03220815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111027971|NCT03220815|Sympathomimetics|sympathomimetics|mesh-ancestor
111027972|NCT03220815|Autonomic Agents|autonomic agents|mesh-ancestor
111027973|NCT03220815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111027974|NCT03220815|Dopamine Agents|dopamine agents|mesh-ancestor
111027975|NCT03220815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111027976|NCT03220815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111027977|NCT03220815|Adrenergic Agents|adrenergic agents|mesh-ancestor
111027978|NCT03220815|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111027979|NCT03220815|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111027980|NCT03220815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111027981|NCT03220815|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111027982|NCT04913402|Sufentanil|sufentanil|mesh-list
111027983|NCT04913402|Dsuvia|dsuvia|mesh-list
111027984|NCT04913402|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111027985|NCT04913402|Narcotics|narcotics|mesh-ancestor
111027986|NCT04913402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111027987|NCT04913402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111027988|NCT04913402|Analgesics|analgesics|mesh-ancestor
111027989|NCT04913402|Sensory System Agents|sensory system agents|mesh-ancestor
111027990|NCT04913402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111027991|NCT04913402|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111027992|NCT04913402|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111027993|NCT04913402|Anesthetics, General|anesthetics, general|mesh-ancestor
111027994|NCT04913402|Anesthetics|anesthetics|mesh-ancestor
111027995|NCT04912934|Insulin|insulin|mesh-list
111027996|NCT04912934|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111027997|NCT04912934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111027998|NCT04915586|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
111027999|NCT04915586|Plasminogen|plasminogen|mesh-list
111028000|NCT04915586|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111028001|NCT04915586|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111028002|NCT04915586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111028003|NCT03232125|Ramosetron|ramosetron|mesh-list
111028004|NCT03232125|Antiemetics|antiemetics|mesh-ancestor
111028005|NCT03232125|Autonomic Agents|autonomic agents|mesh-ancestor
111028006|NCT03232125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111028007|NCT03232125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111028008|NCT03232125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111028009|NCT03232125|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110745148|NCT03905018|Tadalafil|tadalafil|mesh-list
111028010|NCT03232125|Serotonin Agents|serotonin agents|mesh-ancestor
111028011|NCT03232125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111028012|NCT03232125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111028013|NCT03224637|Acetaminophen|acetaminophen|mesh-list
111028014|NCT03224637|Ketorolac|ketorolac|mesh-list
111028015|NCT03224637|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
111028016|NCT03224637|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111028017|NCT03224637|Analgesics|analgesics|mesh-ancestor
111028018|NCT03224637|Sensory System Agents|sensory system agents|mesh-ancestor
111028019|NCT03224637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111028020|NCT03224637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111028022|NCT03224637|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111028023|NCT03224637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111028024|NCT03224637|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111028025|NCT03224637|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111028026|NCT03224637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111028027|NCT03224637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111028028|NCT04912700|Vaccines|vaccines|mesh-list
111028029|NCT04912700|Immunologic Factors|immunologic factors|mesh-ancestor
111028030|NCT04912700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111028031|NCT03224871|Aldesleukin|aldesleukin|mesh-list
111028032|NCT03224871|Pembrolizumab|pembrolizumab|mesh-list
111028033|NCT03224871|Nivolumab|nivolumab|mesh-list
111028034|NCT03224871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111028035|NCT03224871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111028036|NCT03224871|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111028037|NCT03224871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111028038|NCT03224871|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111028039|NCT03224871|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111028040|NCT03224871|Antiviral Agents|antiviral agents|mesh-ancestor
111028041|NCT03224871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111028042|NCT03220425|Insulin|insulin|mesh-list
111028043|NCT03220425|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111028044|NCT03220425|Insulin Detemir|insulin detemir|mesh-list
111028045|NCT03220425|Insulin, Isophane|insulin, isophane|mesh-list
111028046|NCT03220425|Isophane Insulin, Human|isophane insulin, human|mesh-list
111028047|NCT03220425|Isophane insulin, beef|isophane insulin, beef|mesh-list
111028048|NCT03220425|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111028049|NCT03220425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111028050|NCT04924868|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
111028051|NCT04924868|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
111028052|NCT04924868|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111028053|NCT03220191|Palbociclib|palbociclib|mesh-list
111028054|NCT03220191|Rabeprazole|rabeprazole|mesh-list
111028055|NCT03220191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111028056|NCT03220191|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111028057|NCT03220191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111028058|NCT03220191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111028059|NCT03220191|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111028060|NCT03220191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111028061|NCT03220191|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111028062|NCT03220113|Thiamine|thiamine|mesh-list
111028063|NCT03220113|Dexamethasone|dexamethasone|mesh-list
111028064|NCT03220113|Lidocaine|lidocaine|mesh-list
111028065|NCT03220113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111028066|NCT03220113|Antiemetics|antiemetics|mesh-ancestor
111028067|NCT03220113|Autonomic Agents|autonomic agents|mesh-ancestor
111028068|NCT03220113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111028069|NCT03220113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111028070|NCT03220113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111028071|NCT03220113|Glucocorticoids|glucocorticoids|mesh-ancestor
111028072|NCT03220113|Hormones|hormones|mesh-ancestor
111028073|NCT03220113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111028074|NCT03220113|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111028075|NCT03220113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111028076|NCT03220113|Anesthetics, Local|anesthetics, local|mesh-ancestor
111028077|NCT03220113|Anesthetics|anesthetics|mesh-ancestor
111028078|NCT03220113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111028079|NCT03220113|Sensory System Agents|sensory system agents|mesh-ancestor
111028080|NCT03220113|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111028081|NCT03220113|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111028082|NCT03220113|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111028083|NCT03220113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111028084|NCT03220113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111028085|NCT03220113|Vitamin B Complex|vitamin b complex|mesh-ancestor
111028086|NCT03220113|Vitamins|vitamins|mesh-ancestor
111028087|NCT03220113|Micronutrients|micronutrients|mesh-ancestor
111028088|NCT02254525|Ibuprofen|ibuprofen|mesh-list
111028089|NCT02254525|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111028090|NCT02254525|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111028091|NCT02254525|Analgesics|analgesics|mesh-ancestor
111028092|NCT02254525|Sensory System Agents|sensory system agents|mesh-ancestor
111028093|NCT02254525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111028094|NCT02254525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110827202|NCT03872011|Micronutrients|micronutrients|mesh-ancestor
111028096|NCT02254525|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111028097|NCT02254525|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111028098|NCT02254525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111028099|NCT02254525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111028100|NCT03231813|Emollients|emollients|mesh-list
111028101|NCT03231813|Dermatologic Agents|dermatologic agents|mesh-ancestor
111028102|NCT04914962|Lithium Carbonate|lithium carbonate|mesh-list
111028103|NCT04914962|Antidepressive Agents|antidepressive agents|mesh-ancestor
111028104|NCT04914962|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111028105|NCT04914962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111028106|NCT04914962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111028107|NCT04914962|Antimanic Agents|antimanic agents|mesh-ancestor
111028108|NCT04914962|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111028109|NCT04914962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111028110|NCT04914962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111028111|NCT02143531|Haloperidol|haloperidol|mesh-list
111028112|NCT02143531|Ondansetron|ondansetron|mesh-list
111028113|NCT02143531|Haloperidol decanoate|haloperidol decanoate|mesh-list
111028114|NCT02143531|Antiemetics|antiemetics|mesh-ancestor
111028115|NCT02143531|Autonomic Agents|autonomic agents|mesh-ancestor
111028116|NCT02143531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111028117|NCT02143531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111028118|NCT02143531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111028119|NCT02143531|Antipruritics|antipruritics|mesh-ancestor
111028120|NCT02143531|Dermatologic Agents|dermatologic agents|mesh-ancestor
111028121|NCT02143531|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111028122|NCT02143531|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111028123|NCT02143531|Serotonin Agents|serotonin agents|mesh-ancestor
111028124|NCT02143531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111028125|NCT02143531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111028126|NCT02143531|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111028127|NCT02143531|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111028128|NCT02143531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111028129|NCT02143531|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111028130|NCT02143531|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111028131|NCT02143531|Dopamine Agents|dopamine agents|mesh-ancestor
111028132|NCT02143531|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111028133|NCT04485117|Anesthetics|anesthetics|mesh-list
111028134|NCT04485117|Propofol|propofol|mesh-list
111028135|NCT04485117|Sevoflurane|sevoflurane|mesh-list
111028136|NCT04485117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111028137|NCT04485117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111028138|NCT04485117|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111028139|NCT04485117|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111028140|NCT04485117|Anesthetics, General|anesthetics, general|mesh-ancestor
111028141|NCT04485117|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111028142|NCT04485117|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111028143|NCT00803569|Sargramostim|sargramostim|mesh-list
111028144|NCT00803569|Immunologic Factors|immunologic factors|mesh-ancestor
111028145|NCT00803569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111028146|NCT02143687|Sevoflurane|sevoflurane|mesh-list
111028147|NCT02143687|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111028148|NCT02143687|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111028149|NCT02143687|Anesthetics, General|anesthetics, general|mesh-ancestor
111028150|NCT02143687|Anesthetics|anesthetics|mesh-ancestor
111028151|NCT02143687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111028152|NCT02143687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111028153|NCT02143765|Acarbose|acarbose|mesh-list
111028154|NCT02143765|Mitiglinide|mitiglinide|mesh-list
111028155|NCT02143765|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
111028156|NCT02143765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111028157|NCT02143765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111028158|NCT02143765|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111028159|NCT02143765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111028160|NCT02148367|Epoetin Alfa|epoetin alfa|mesh-list
111028161|NCT02148367|Hematinics|hematinics|mesh-ancestor
110745277|NCT03893864|Vitamins|vitamins|mesh-ancestor
111028162|NCT00482833|Methotrexate|methotrexate|mesh-list
111028163|NCT00482833|Mercaptopurine|mercaptopurine|mesh-list
111028164|NCT00482833|Idarubicin|idarubicin|mesh-list
111028165|NCT00482833|Tretinoin|tretinoin|mesh-list
111028166|NCT00482833|Arsenic Trioxide|arsenic trioxide|mesh-list
111028167|NCT00482833|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111028168|NCT00482833|Abortifacient Agents|abortifacient agents|mesh-ancestor
111028169|NCT00482833|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111028170|NCT00482833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111028171|NCT00482833|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111028172|NCT00482833|Antimetabolites|antimetabolites|mesh-ancestor
111028173|NCT00482833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111028174|NCT00482833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111028175|NCT00482833|Dermatologic Agents|dermatologic agents|mesh-ancestor
111028176|NCT00482833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111028177|NCT00482833|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111028178|NCT00482833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111028179|NCT00482833|Immunologic Factors|immunologic factors|mesh-ancestor
111028180|NCT00482833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111028181|NCT00482833|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111028182|NCT00482833|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111028183|NCT00482833|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111028184|NCT00482833|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111028185|NCT00482833|Keratolytic Agents|keratolytic agents|mesh-ancestor
111028186|NCT02451033|Hormones|hormones|mesh-list
111028187|NCT02451033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111028188|NCT02451033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111028189|NCT04485429|Methylprednisolone|methylprednisolone|mesh-list
111028190|NCT04485429|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111028191|NCT04485429|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111028192|NCT04485429|Prednisolone|prednisolone|mesh-list
111028193|NCT04485429|Prednisolone acetate|prednisolone acetate|mesh-list
111028194|NCT04485429|Heparin|heparin|mesh-list
111028195|NCT04485429|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111028196|NCT04485429|Prednisolone phosphate|prednisolone phosphate|mesh-list
111028197|NCT04485429|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111028198|NCT04485429|Antiemetics|antiemetics|mesh-ancestor
111028199|NCT04485429|Autonomic Agents|autonomic agents|mesh-ancestor
111028200|NCT04485429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111028201|NCT04485429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111028202|NCT04485429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111028203|NCT04485429|Glucocorticoids|glucocorticoids|mesh-ancestor
111028204|NCT04485429|Hormones|hormones|mesh-ancestor
111028205|NCT04485429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111028206|NCT04485429|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111028207|NCT04485429|Protective Agents|protective agents|mesh-ancestor
111028208|NCT04485429|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111028209|NCT04485429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111028210|NCT04485429|Anticoagulants|anticoagulants|mesh-ancestor
111028211|NCT04485429|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111028212|NCT04485429|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111028213|NCT04485429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111028214|NCT00112957|Vaccines|vaccines|mesh-list
111028215|NCT00112957|Immunologic Factors|immunologic factors|mesh-ancestor
111028216|NCT00112957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111028217|NCT02140801|Clopidogrel|clopidogrel|mesh-list
111028218|NCT02140801|Ticagrelor|ticagrelor|mesh-list
111028219|NCT02140801|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111028220|NCT02140801|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111028221|NCT02140801|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111028222|NCT02140801|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111028223|NCT02140801|Purinergic Agents|purinergic agents|mesh-ancestor
111028224|NCT02140801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111028225|NCT02140801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111028226|NCT02140801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111028227|NCT02148601|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111028228|NCT02148601|Vancomycin|vancomycin|mesh-list
111028229|NCT02148601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111028230|NCT02141035|Acetylcarnitine|acetylcarnitine|mesh-list
111028231|NCT02141035|Vitamin B Complex|vitamin b complex|mesh-ancestor
111028232|NCT02141035|Vitamins|vitamins|mesh-ancestor
111028233|NCT02141035|Micronutrients|micronutrients|mesh-ancestor
111028234|NCT02141035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111028235|NCT02141035|Nootropic Agents|nootropic agents|mesh-ancestor
111028236|NCT03214653|Propofol|propofol|mesh-list
111028237|NCT03214653|Sevoflurane|sevoflurane|mesh-list
111028238|NCT03214653|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111028239|NCT03214653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111028240|NCT03214653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111028241|NCT03214653|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111028243|NCT03214653|Anesthetics|anesthetics|mesh-ancestor
111028244|NCT03214653|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111028245|NCT03214653|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111028246|NCT02450877|Azacitidine|azacitidine|mesh-list
111028247|NCT02450877|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111028248|NCT02450877|Antimetabolites|antimetabolites|mesh-ancestor
111028249|NCT02450877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111028250|NCT02450877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111028251|NCT02450877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111028252|NCT02141113|Guanfacine|guanfacine|mesh-list
111028253|NCT02141113|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111028254|NCT02141113|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111028255|NCT02141113|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111028256|NCT02141113|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111028257|NCT02141113|Adrenergic Agents|adrenergic agents|mesh-ancestor
111028258|NCT02141113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111028259|NCT02141113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111028260|NCT02141113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111028261|NCT03213639|Esomeprazole|esomeprazole|mesh-list
111028262|NCT03213639|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111028263|NCT03213639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111028264|NCT03213639|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111028265|NCT03213639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111028266|NCT03213639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111028267|NCT03231033|Pioglitazone|pioglitazone|mesh-list
111028268|NCT03231033|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111028269|NCT03231033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111028270|NCT02141347|Durvalumab|durvalumab|mesh-list
111028271|NCT02141347|Tremelimumab|tremelimumab|mesh-list
111028272|NCT02141347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111028273|NCT02141347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111028274|NCT02254759|Midazolam|midazolam|mesh-list
111028275|NCT02254759|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111028276|NCT02254759|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111028277|NCT02254759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111028278|NCT02254759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111028279|NCT02254759|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111028280|NCT02254759|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111028281|NCT02254759|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111028282|NCT02254759|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111028283|NCT02254759|Anesthetics, General|anesthetics, general|mesh-ancestor
111028284|NCT02254759|Anesthetics|anesthetics|mesh-ancestor
111028285|NCT02254759|GABA Modulators|gaba modulators|mesh-ancestor
111028286|NCT02254759|GABA Agents|gaba agents|mesh-ancestor
111028287|NCT02254759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110625520|NCT04815876|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111028288|NCT02254759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111028289|NCT03208257|Esmolol|esmolol|mesh-list
111028290|NCT03208257|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
111028291|NCT03208257|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111028292|NCT03208257|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111028293|NCT03208257|Adrenergic Agents|adrenergic agents|mesh-ancestor
111028294|NCT03208257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111028295|NCT03208257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111028296|NCT03208257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111028297|NCT02141425|Peficitinib|peficitinib|mesh-list
111028298|NCT02141425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111028299|NCT02141425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111028300|NCT02141425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111028301|NCT02141425|Immunologic Factors|immunologic factors|mesh-ancestor
111028302|NCT02141425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111028303|NCT02148913|Melphalan|melphalan|mesh-list
111028304|NCT02148913|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
111028305|NCT02148913|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111028306|NCT02148913|Alkylating Agents|alkylating agents|mesh-ancestor
111028307|NCT02148913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111028308|NCT02148913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111028309|NCT02148913|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111028310|NCT02148913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111028311|NCT02148913|Immunologic Factors|immunologic factors|mesh-ancestor
111028312|NCT02148913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111028314|NCT03208101|Immunologic Factors|immunologic factors|mesh-ancestor
111028315|NCT03208101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111028316|NCT02149225|Poly I-C|poly i-c|mesh-list
111028317|NCT02149225|Molgramostim|molgramostim|mesh-list
111028318|NCT02149225|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
111028319|NCT02149225|Vaccines|vaccines|mesh-list
111028320|NCT02149225|Sargramostim|sargramostim|mesh-list
111028321|NCT02149225|Poly ICLC|poly iclc|mesh-list
111028322|NCT02149225|Immunologic Factors|immunologic factors|mesh-ancestor
111028323|NCT02149225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111028324|NCT02149225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111028325|NCT02149225|Interferon Inducers|interferon inducers|mesh-ancestor
111028326|NCT02149225|Laxatives|laxatives|mesh-ancestor
111028327|NCT02149225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111028328|NCT02149225|Antiviral Agents|antiviral agents|mesh-ancestor
111028329|NCT02149225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111028330|NCT03208335|Endostatins|endostatins|mesh-list
111028331|NCT03208335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111028332|NCT03208335|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111028333|NCT03208335|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111028334|NCT03208335|Growth Substances|growth substances|mesh-ancestor
111028335|NCT03208335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111028336|NCT03208335|Growth Inhibitors|growth inhibitors|mesh-ancestor
111028337|NCT03211065|Immunoglobulins|immunoglobulins|mesh-list
111028338|NCT03211065|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111028339|NCT03211065|Antibodies|antibodies|mesh-list
111028340|NCT03211065|Immunologic Factors|immunologic factors|mesh-ancestor
111028341|NCT03211065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111028342|NCT02149459|Metformin|metformin|mesh-list
111028343|NCT02149459|Biguanides|biguanides|mesh-list
111028344|NCT02149459|Hypoglycemic Agents|hypoglycemic agents|mesh-list
111028345|NCT02149459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111028346|NCT02376790|Etanercept|etanercept|mesh-list
111028347|NCT02376790|Methotrexate|methotrexate|mesh-list
111028348|NCT02376790|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111028349|NCT02376790|Abortifacient Agents|abortifacient agents|mesh-ancestor
111028350|NCT02376790|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111028351|NCT02376790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111028352|NCT02376790|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111028353|NCT02376790|Antimetabolites|antimetabolites|mesh-ancestor
111028354|NCT02376790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111028355|NCT02376790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111028356|NCT02376790|Dermatologic Agents|dermatologic agents|mesh-ancestor
111028357|NCT02376790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111028358|NCT02376790|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111028359|NCT02376790|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111028360|NCT02376790|Immunologic Factors|immunologic factors|mesh-ancestor
111028361|NCT02376790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111028362|NCT02376790|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111028363|NCT02376790|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111028364|NCT02376790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111028365|NCT02376790|Analgesics|analgesics|mesh-ancestor
111028366|NCT02376790|Sensory System Agents|sensory system agents|mesh-ancestor
111028367|NCT02376790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111028368|NCT02376790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111028369|NCT02376790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111028370|NCT02141737|Lidocaine|lidocaine|mesh-list
111028371|NCT02141737|Fentanyl|fentanyl|mesh-list
111028372|NCT02141737|Midazolam|midazolam|mesh-list
111028373|NCT02141737|Etomidate|etomidate|mesh-list
111028374|NCT02141737|Rocuronium|rocuronium|mesh-list
111028375|NCT02141737|Anesthetics, Local|anesthetics, local|mesh-ancestor
111028376|NCT02141737|Anesthetics|anesthetics|mesh-ancestor
111028377|NCT02141737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111028378|NCT02141737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111028379|NCT02141737|Sensory System Agents|sensory system agents|mesh-ancestor
111028380|NCT02141737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111028381|NCT02141737|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111028382|NCT02141737|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111028383|NCT02141737|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111028384|NCT02141737|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111028385|NCT02141737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111028386|NCT02141737|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111028387|NCT02141737|Narcotics|narcotics|mesh-ancestor
111028388|NCT02141737|Analgesics|analgesics|mesh-ancestor
111028389|NCT02141737|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111028390|NCT02141737|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111028391|NCT02141737|Anesthetics, General|anesthetics, general|mesh-ancestor
110493435|NCT02586610|Pembrolizumab|pembrolizumab|mesh-list
111028392|NCT02141737|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111028394|NCT02141737|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111028395|NCT02141737|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111028396|NCT02141737|GABA Modulators|gaba modulators|mesh-ancestor
111028397|NCT02141737|GABA Agents|gaba agents|mesh-ancestor
111028398|NCT02141737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111028399|NCT02141737|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
111028400|NCT02141737|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
111028401|NCT02141737|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111028402|NCT02254447|Candesartan|candesartan|mesh-list
111028403|NCT02254447|Candesartan cilexetil|candesartan cilexetil|mesh-list
111028404|NCT02254447|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111028405|NCT02254447|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111028406|NCT02254447|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111028407|NCT02254447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111028408|NCT02376166|Metformin|metformin|mesh-list
111028409|NCT02376166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111028410|NCT02376166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111028411|NCT03207165|Dobutamine|dobutamine|mesh-list
111028412|NCT03207165|Milrinone|milrinone|mesh-list
111028413|NCT03207165|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-list
111028414|NCT03207165|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111028415|NCT03207165|Sympathomimetics|sympathomimetics|mesh-ancestor
111028416|NCT03207165|Autonomic Agents|autonomic agents|mesh-ancestor
111028417|NCT03207165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111028418|NCT03207165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111028419|NCT03207165|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
111028420|NCT03207165|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111028421|NCT03207165|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111028422|NCT03207165|Adrenergic Agents|adrenergic agents|mesh-ancestor
111028423|NCT03207165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111028424|NCT03207165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111028425|NCT03207165|Protective Agents|protective agents|mesh-ancestor
111028426|NCT03207165|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111028427|NCT03207165|Vasodilator Agents|vasodilator agents|mesh-ancestor
111028428|NCT03207165|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111028429|NCT03207165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111028430|NCT02142205|Natalizumab|natalizumab|mesh-list
111028431|NCT02142205|Immunologic Factors|immunologic factors|mesh-ancestor
111028432|NCT02142205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111028433|NCT03209427|Morphine|morphine|mesh-list
111028434|NCT03209427|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111028435|NCT03209427|Narcotics|narcotics|mesh-ancestor
111028436|NCT03209427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111028437|NCT03209427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111028438|NCT03209427|Analgesics|analgesics|mesh-ancestor
111028439|NCT03209427|Sensory System Agents|sensory system agents|mesh-ancestor
111028440|NCT03209427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111028441|NCT03544723|Pembrolizumab|pembrolizumab|mesh-list
111028442|NCT03544723|Nivolumab|nivolumab|mesh-list
111028443|NCT03544723|Atezolizumab|atezolizumab|mesh-list
111028444|NCT03544723|Durvalumab|durvalumab|mesh-list
111028445|NCT03544723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111028446|NCT03544723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111028447|NCT03544723|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111028448|NCT03544723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111028449|NCT03209661|Menthol|menthol|mesh-list
111028450|NCT03209661|Nicotine|nicotine|mesh-list
111028451|NCT03209661|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111028452|NCT03209661|Autonomic Agents|autonomic agents|mesh-ancestor
111028453|NCT03209661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111028454|NCT03209661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111028455|NCT03209661|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111028456|NCT03209661|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111028457|NCT03209661|Cholinergic Agents|cholinergic agents|mesh-ancestor
111028458|NCT03209661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111028459|NCT03209661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111028460|NCT03209661|Antipruritics|antipruritics|mesh-ancestor
111028461|NCT03209661|Dermatologic Agents|dermatologic agents|mesh-ancestor
111028462|NCT03209037|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
111028463|NCT03209037|Antiviral Agents|antiviral agents|mesh-ancestor
111028464|NCT03209037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111028465|NCT03209115|Calcium, Dietary|calcium, dietary|mesh-list
110745576|NCT01157312|Clomiphene|clomiphene|mesh-list
111028466|NCT03209115|Chlorhexidine|chlorhexidine|mesh-list
111028467|NCT03209115|Calcium|calcium|mesh-list
111028468|NCT03209115|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111028469|NCT03209115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111028470|NCT03209115|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111028471|NCT03209115|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111028472|NCT03209115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111028474|NCT03209193|Sevoflurane|sevoflurane|mesh-list
111028475|NCT03209193|Desflurane|desflurane|mesh-list
110625563|NCT04632069|Acetylcysteine|acetylcysteine|mesh-list
111028476|NCT03209193|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111028477|NCT03209193|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111028478|NCT03209193|Anesthetics, General|anesthetics, general|mesh-ancestor
111028479|NCT03209193|Anesthetics|anesthetics|mesh-ancestor
111028480|NCT03209193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111028481|NCT03209193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111028482|NCT02142595|Midazolam|midazolam|mesh-list
111028483|NCT02142595|Dexmedetomidine|dexmedetomidine|mesh-list
111028484|NCT02142595|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111028485|NCT02142595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111028486|NCT02142595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111028487|NCT02142595|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111028488|NCT02142595|Analgesics|analgesics|mesh-ancestor
111028489|NCT02142595|Sensory System Agents|sensory system agents|mesh-ancestor
111028490|NCT02142595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111028491|NCT02142595|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111028492|NCT02142595|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111028493|NCT02142595|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111028494|NCT02142595|Adrenergic Agents|adrenergic agents|mesh-ancestor
111028495|NCT02142595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111028496|NCT02142595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111028497|NCT02142595|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111028498|NCT02142595|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111028499|NCT02142595|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111028500|NCT02142595|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111028501|NCT02142595|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111028502|NCT02142595|Anesthetics, General|anesthetics, general|mesh-ancestor
111028503|NCT02142595|Anesthetics|anesthetics|mesh-ancestor
111028504|NCT02142595|GABA Modulators|gaba modulators|mesh-ancestor
111028505|NCT02142595|GABA Agents|gaba agents|mesh-ancestor
111028506|NCT04898374|Cisplatin|cisplatin|mesh-list
111028507|NCT04898374|Gemcitabine|gemcitabine|mesh-list
111028508|NCT04898374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111028509|NCT04898374|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111028510|NCT04898374|Antimetabolites|antimetabolites|mesh-ancestor
111028511|NCT04898374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111028512|NCT03207477|Mydriatics|mydriatics|mesh-list
111028513|NCT03207477|Autonomic Agents|autonomic agents|mesh-ancestor
111028514|NCT03207477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111028515|NCT03207477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111028516|NCT02452515|Fulacimstat|fulacimstat|mesh-list
111028517|NCT02452515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111028518|NCT02452515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111028519|NCT03206931|Selitrectinib|selitrectinib|mesh-list
111028520|NCT03206931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111028521|NCT03206931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111028522|NCT02344342|Diuretics|diuretics|mesh-list
111028523|NCT02344342|Natriuretic Agents|natriuretic agents|mesh-ancestor
111028524|NCT02344342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111028525|NCT02452437|Oxycodone|oxycodone|mesh-list
111028526|NCT02452437|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111028527|NCT02452437|Narcotics|narcotics|mesh-ancestor
111028528|NCT02452437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111028529|NCT02452437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111028530|NCT02452437|Analgesics|analgesics|mesh-ancestor
111028531|NCT02452437|Sensory System Agents|sensory system agents|mesh-ancestor
111028532|NCT02452437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111028533|NCT03208413|Thalidomide|thalidomide|mesh-list
111028534|NCT03208413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111028535|NCT03208413|Immunologic Factors|immunologic factors|mesh-ancestor
111028536|NCT03208413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111028537|NCT03208413|Leprostatic Agents|leprostatic agents|mesh-ancestor
111028538|NCT03208413|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111028539|NCT03208413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111028540|NCT03208413|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111028541|NCT03208413|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111028542|NCT03208413|Growth Substances|growth substances|mesh-ancestor
111028543|NCT03208413|Growth Inhibitors|growth inhibitors|mesh-ancestor
111028544|NCT03208413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111028545|NCT03201159|Pentamidine|pentamidine|mesh-list
111028546|NCT03201159|Antifungal Agents|antifungal agents|mesh-ancestor
111028547|NCT03201159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111028548|NCT03201159|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111028549|NCT03201159|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111028550|NCT03201159|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
111028551|NCT02149927|Sevoflurane|sevoflurane|mesh-list
111028552|NCT02149927|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111028553|NCT02149927|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111028554|NCT02149927|Anesthetics, General|anesthetics, general|mesh-ancestor
111028555|NCT02149927|Anesthetics|anesthetics|mesh-ancestor
111028556|NCT02149927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111028557|NCT02149927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111028558|NCT02142751|Meropenem|meropenem|mesh-list
111028559|NCT02142751|Ceftriaxone|ceftriaxone|mesh-list
111028560|NCT02142751|Fosfomycin|fosfomycin|mesh-list
111028561|NCT02142751|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111028562|NCT02142751|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111028563|NCT02142751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111028564|NCT02142829|Bupivacaine|bupivacaine|mesh-list
111028565|NCT02142829|Anesthetics, Local|anesthetics, local|mesh-ancestor
111028566|NCT02142829|Anesthetics|anesthetics|mesh-ancestor
111028567|NCT02142829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111028568|NCT02142829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111028569|NCT02142829|Sensory System Agents|sensory system agents|mesh-ancestor
111028570|NCT02142829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111028571|NCT03200691|Antibodies|antibodies|mesh-list
111028572|NCT03200691|Immunologic Factors|immunologic factors|mesh-ancestor
111028573|NCT03200691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111028574|NCT02150161|Lidocaine|lidocaine|mesh-list
111028575|NCT02150161|Fentanyl|fentanyl|mesh-list
111028576|NCT02150161|Ketamine|ketamine|mesh-list
111028577|NCT02150161|Anesthetics, Local|anesthetics, local|mesh-ancestor
111028578|NCT02150161|Anesthetics|anesthetics|mesh-ancestor
111028579|NCT02150161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111028580|NCT02150161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111028581|NCT02150161|Sensory System Agents|sensory system agents|mesh-ancestor
111028582|NCT02150161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111028583|NCT02150161|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111028584|NCT02150161|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111028585|NCT02150161|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111028586|NCT02150161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111028587|NCT02150161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111028588|NCT02150161|Analgesics|analgesics|mesh-ancestor
111028589|NCT02150161|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111028590|NCT02150161|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111028591|NCT02150161|Anesthetics, General|anesthetics, general|mesh-ancestor
111028592|NCT02150161|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111028593|NCT02150161|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111028594|NCT02150161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111028595|NCT02150161|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111028596|NCT02150161|Narcotics|narcotics|mesh-ancestor
111028597|NCT02150161|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111028598|NCT03200613|Heparin|heparin|mesh-list
111028599|NCT03200613|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
111028600|NCT03200613|Tinzaparin|tinzaparin|mesh-list
111028601|NCT03200613|Dalteparin|dalteparin|mesh-list
111028602|NCT03200613|Apixaban|apixaban|mesh-list
111028603|NCT03200613|Anticoagulants|anticoagulants|mesh-ancestor
111028604|NCT03200613|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111028605|NCT03200613|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111028606|NCT03200613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111028607|NCT03200613|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111028608|NCT03200613|Antithrombins|antithrombins|mesh-ancestor
111028609|NCT03200613|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111028610|NCT03200613|Protease Inhibitors|protease inhibitors|mesh-ancestor
111028611|NCT03200613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111028612|NCT02150317|Sorafenib|sorafenib|mesh-list
111028613|NCT02150317|Chlorotrianisene|chlorotrianisene|mesh-list
111028614|NCT02150317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111028615|NCT02150317|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111028616|NCT02150317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111028617|NCT02150317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111028618|NCT02150317|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
111028620|NCT02150317|Hormones|hormones|mesh-ancestor
111028621|NCT02150317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111028622|NCT02150317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111028623|NCT02150317|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111028624|NCT02310568|PF-06372865|pf-06372865|mesh-list
111028625|NCT02310568|GABA Modulators|gaba modulators|mesh-ancestor
111028626|NCT02310568|GABA Agents|gaba agents|mesh-ancestor
111028627|NCT02310568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111028628|NCT02310568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111028629|NCT02310568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111028630|NCT02448069|Argatroban|argatroban|mesh-list
111028631|NCT02448069|Antithrombins|antithrombins|mesh-ancestor
111028632|NCT02448069|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111028633|NCT02448069|Protease Inhibitors|protease inhibitors|mesh-ancestor
111028634|NCT02448069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111028635|NCT02448069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111028636|NCT02448069|Anticoagulants|anticoagulants|mesh-ancestor
111028637|NCT02448069|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111028638|NCT02449941|Rabeprazole|rabeprazole|mesh-list
111028639|NCT02449941|Pantoprazole|pantoprazole|mesh-list
111028640|NCT02449941|Lansoprazole|lansoprazole|mesh-list
111028641|NCT02449941|Dexlansoprazole|dexlansoprazole|mesh-list
111028642|NCT02449941|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
111028643|NCT02449941|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111028644|NCT02449941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111028645|NCT02449941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111028646|NCT02449941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111028647|NCT04484493|Mometasone Furoate|mometasone furoate|mesh-list
111028648|NCT04484493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111028649|NCT04484493|Dermatologic Agents|dermatologic agents|mesh-ancestor
111028650|NCT04484493|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111028651|NCT03199989|Capecitabine|capecitabine|mesh-list
111028652|NCT03199989|Oxaliplatin|oxaliplatin|mesh-list
111028653|NCT03199989|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111028654|NCT03199989|Antimetabolites|antimetabolites|mesh-ancestor
111028655|NCT03199989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111028656|NCT03199989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111028657|NCT03195933|Hydrocortisone|hydrocortisone|mesh-list
111028658|NCT03195933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111028659|NCT03195543|Thrombin|thrombin|mesh-list
111028660|NCT03195543|Hemostatics|hemostatics|mesh-ancestor
111028661|NCT03195543|Coagulants|coagulants|mesh-ancestor
111028662|NCT03204669|Trace Elements|trace elements|mesh-list
111028663|NCT03204669|Micronutrients|micronutrients|mesh-list
111028664|NCT03204669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111028665|NCT03199677|Apatinib|apatinib|mesh-list
111028666|NCT03199677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111028667|NCT03199677|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111028668|NCT03199677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111028669|NCT03199677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111028670|NCT02780167|Abrocitinib|abrocitinib|mesh-list
111028671|NCT02780167|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111028672|NCT02780167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111028673|NCT02780167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111028674|NCT02447757|Remifentanil|remifentanil|mesh-list
111028675|NCT02447757|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111028676|NCT02447757|Narcotics|narcotics|mesh-ancestor
111028677|NCT02447757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111028678|NCT02447757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111028679|NCT02447757|Analgesics|analgesics|mesh-ancestor
111028680|NCT02447757|Sensory System Agents|sensory system agents|mesh-ancestor
111028681|NCT02447757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111028682|NCT02447835|Olanzapine|olanzapine|mesh-list
111028683|NCT02447835|Antiemetics|antiemetics|mesh-ancestor
111028684|NCT02447835|Autonomic Agents|autonomic agents|mesh-ancestor
111028685|NCT02447835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111028686|NCT02447835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111028687|NCT02447835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111028688|NCT02447835|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111028689|NCT02447835|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111028690|NCT02447835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111028691|NCT02447835|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111028692|NCT02447835|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111028693|NCT02447835|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111028694|NCT02447835|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111028695|NCT02447835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111028696|NCT02447835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111028697|NCT02447835|Serotonin Agents|serotonin agents|mesh-ancestor
111028698|NCT02447679|Tegafur|tegafur|mesh-list
111028699|NCT02447679|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111028700|NCT02447679|Antimetabolites|antimetabolites|mesh-ancestor
111028701|NCT02447679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111028702|NCT02447679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111028704|NCT03203967|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111028705|NCT03203967|Narcotics|narcotics|mesh-ancestor
111028706|NCT03203967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111028707|NCT03203967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111028708|NCT03203967|Analgesics|analgesics|mesh-ancestor
111028709|NCT03203967|Sensory System Agents|sensory system agents|mesh-ancestor
111028710|NCT03203967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111028711|NCT03204045|Fentanyl|fentanyl|mesh-list
111028712|NCT03204045|Oxycodone|oxycodone|mesh-list
111028713|NCT03204045|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111028714|NCT03204045|Narcotics|narcotics|mesh-ancestor
111028715|NCT03204045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111028716|NCT03204045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111028717|NCT03204045|Analgesics|analgesics|mesh-ancestor
111028718|NCT03204045|Sensory System Agents|sensory system agents|mesh-ancestor
111028719|NCT03204045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111028720|NCT03204045|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111028721|NCT03204045|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111028722|NCT03204045|Anesthetics, General|anesthetics, general|mesh-ancestor
111028723|NCT03204045|Anesthetics|anesthetics|mesh-ancestor
111028724|NCT03199521|Thrombin|thrombin|mesh-list
111028725|NCT03199521|Hemostatics|hemostatics|mesh-ancestor
111028726|NCT03199521|Coagulants|coagulants|mesh-ancestor
111028727|NCT03195153|Allopurinol|allopurinol|mesh-list
111028728|NCT03195153|Atorvastatin|atorvastatin|mesh-list
111028729|NCT03195153|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111028730|NCT03195153|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111028731|NCT03195153|Antimetabolites|antimetabolites|mesh-ancestor
111028732|NCT03195153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111028733|NCT03195153|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111028734|NCT03195153|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111028735|NCT03195153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111028736|NCT03195153|Gout Suppressants|gout suppressants|mesh-ancestor
111028737|NCT03195153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111028738|NCT03195153|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111028739|NCT03195153|Antioxidants|antioxidants|mesh-ancestor
111028740|NCT03195153|Protective Agents|protective agents|mesh-ancestor
111028741|NCT03195153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111028742|NCT03195309|Fentanyl|fentanyl|mesh-list
111028743|NCT03195309|Ropivacaine|ropivacaine|mesh-list
111028744|NCT03195309|Anesthetics, Local|anesthetics, local|mesh-ancestor
111028745|NCT03195309|Anesthetics|anesthetics|mesh-ancestor
111028746|NCT03195309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111028747|NCT03195309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111028748|NCT03195309|Sensory System Agents|sensory system agents|mesh-ancestor
111028749|NCT03195309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111028750|NCT03195309|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111028751|NCT03195309|Narcotics|narcotics|mesh-ancestor
111028752|NCT03195309|Analgesics|analgesics|mesh-ancestor
111028753|NCT03195309|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111028754|NCT03195309|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111028755|NCT03195309|Anesthetics, General|anesthetics, general|mesh-ancestor
111028756|NCT03198819|Cefotaxime|cefotaxime|mesh-list
111028757|NCT03198819|Cefoxitin|cefoxitin|mesh-list
111028758|NCT03198819|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111028759|NCT03198819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111028760|NCT02447601|Simvastatin|simvastatin|mesh-list
111028761|NCT02447601|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111028762|NCT02447601|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111028763|NCT02447601|Antimetabolites|antimetabolites|mesh-ancestor
111028764|NCT02447601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111028765|NCT02447601|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111028766|NCT02447601|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111028767|NCT02447601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111028768|NCT03118713|Metformin|metformin|mesh-list
111028769|NCT03118713|Glimepiride|glimepiride|mesh-list
111028770|NCT03118713|Ipragliflozin|ipragliflozin|mesh-list
111028771|NCT03118713|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110827212|NCT03876067|Cardioplegic Solutions|cardioplegic solutions|mesh-list
111028772|NCT03118713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111028773|NCT03118713|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111028774|NCT03118713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111028775|NCT03118713|Immunologic Factors|immunologic factors|mesh-ancestor
111028776|NCT03118713|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111028777|NCT03118713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111028778|NCT03198585|Empagliflozin|empagliflozin|mesh-list
111028779|NCT03198585|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111028780|NCT03198585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111028781|NCT03198585|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111028782|NCT03198585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111028783|NCT02447289|Midazolam|midazolam|mesh-list
111028784|NCT02447289|Ketamine|ketamine|mesh-list
110625648|NCT04207086|Pembrolizumab|pembrolizumab|mesh-list
111028785|NCT02447289|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111028786|NCT02447289|Analgesics|analgesics|mesh-ancestor
111028787|NCT02447289|Sensory System Agents|sensory system agents|mesh-ancestor
111028788|NCT02447289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111028789|NCT02447289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111028790|NCT02447289|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111028791|NCT02447289|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111028792|NCT02447289|Anesthetics, General|anesthetics, general|mesh-ancestor
111028793|NCT02447289|Anesthetics|anesthetics|mesh-ancestor
111028794|NCT02447289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111028795|NCT02447289|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111028796|NCT02447289|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111028797|NCT02447289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111028798|NCT02447289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111028799|NCT02447289|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111028800|NCT02447289|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111028801|NCT02447289|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111028802|NCT02447289|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111028803|NCT02447289|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111028804|NCT02447289|GABA Modulators|gaba modulators|mesh-ancestor
111028805|NCT02447289|GABA Agents|gaba agents|mesh-ancestor
111028806|NCT02447211|Doxepin|doxepin|mesh-list
111028807|NCT02447211|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111028808|NCT02447211|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111028809|NCT02447211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111028810|NCT02447211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111028811|NCT02447211|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
111028812|NCT02447211|Antidepressive Agents|antidepressive agents|mesh-ancestor
111028813|NCT02447211|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111028814|NCT02447211|Histamine Antagonists|histamine antagonists|mesh-ancestor
111028815|NCT02447211|Histamine Agents|histamine agents|mesh-ancestor
111028816|NCT02447211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111028817|NCT02447211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111028818|NCT03198195|Cyclophosphamide|cyclophosphamide|mesh-list
111028819|NCT03198195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111028820|NCT03198195|Immunologic Factors|immunologic factors|mesh-ancestor
111028821|NCT03198195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111028822|NCT03198195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111028823|NCT03198195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111028824|NCT03198195|Alkylating Agents|alkylating agents|mesh-ancestor
111028825|NCT03198195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111028826|NCT03198195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111028827|NCT03198195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111028828|NCT03203421|Heparin Cofactor II|heparin cofactor ii|mesh-list
111028829|NCT03203421|Antithrombins|antithrombins|mesh-ancestor
111028830|NCT03203421|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111028831|NCT03203421|Protease Inhibitors|protease inhibitors|mesh-ancestor
111028832|NCT03203421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111028833|NCT03203421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111028834|NCT03203421|Anticoagulants|anticoagulants|mesh-ancestor
111028835|NCT03203031|Anesthetics|anesthetics|mesh-list
111028836|NCT03203031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111028837|NCT03203031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111028838|NCT03118479|Anastrozole|anastrozole|mesh-list
111028839|NCT03118479|Testosterone|testosterone|mesh-list
111028840|NCT03118479|Androgens|androgens|mesh-ancestor
111028841|NCT03118479|Hormones|hormones|mesh-ancestor
111028842|NCT03118479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111028843|NCT03118479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111028844|NCT03118479|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111028845|NCT03118479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111028846|NCT03118479|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111028847|NCT03118479|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111028848|NCT03118479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110625651|NCT04207086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111028849|NCT03118479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111028850|NCT03118479|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111028851|NCT03118479|Hormone Antagonists|hormone antagonists|mesh-ancestor
111028852|NCT03197961|Tenofovir|tenofovir|mesh-list
111028853|NCT03197961|Emtricitabine|emtricitabine|mesh-list
111028854|NCT03197961|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
111028855|NCT03197961|Medroxyprogesterone|medroxyprogesterone|mesh-list
111028856|NCT03197961|Antiviral Agents|antiviral agents|mesh-ancestor
111028857|NCT03197961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111028858|NCT03197961|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111028859|NCT03197961|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111028860|NCT03197961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111028861|NCT03197961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111028862|NCT03197961|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111028863|NCT03197961|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111028864|NCT03197961|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111028865|NCT03197961|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111028866|NCT03197961|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111028867|NCT03197961|Contraceptive Agents|contraceptive agents|mesh-ancestor
111028868|NCT03197961|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111028869|NCT03197961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111028870|NCT03197961|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111028871|NCT03197961|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111028872|NCT03197961|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
111028873|NCT03197961|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111028874|NCT03197961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111028875|NCT03202875|Insulin|insulin|mesh-list
111028876|NCT03202875|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111028877|NCT03202875|Insulin Aspart|insulin aspart|mesh-list
111028878|NCT03202875|Insulin, Long-Acting|insulin, long-acting|mesh-list
111028879|NCT03202875|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
111028880|NCT03202875|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111028881|NCT03202875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111028882|NCT03197571|Leucovorin|leucovorin|mesh-list
111028883|NCT03197571|Paclitaxel|paclitaxel|mesh-list
111028884|NCT03197571|Cyclophosphamide|cyclophosphamide|mesh-list
111028885|NCT03197571|Bevacizumab|bevacizumab|mesh-list
111028886|NCT03197571|Fluorouracil|fluorouracil|mesh-list
111028887|NCT03197571|Capecitabine|capecitabine|mesh-list
111028888|NCT03197571|Fulvestrant|fulvestrant|mesh-list
111028889|NCT03197571|Avelumab|avelumab|mesh-list
111028890|NCT03197571|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111028891|NCT03197571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111028892|NCT03197571|Tubulin Modulators|tubulin modulators|mesh-ancestor
111028893|NCT03197571|Antimitotic Agents|antimitotic agents|mesh-ancestor
111028894|NCT03197571|Mitosis Modulators|mitosis modulators|mesh-ancestor
111028895|NCT03197571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111028896|NCT03197571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111028897|NCT03197571|Immunologic Factors|immunologic factors|mesh-ancestor
111028898|NCT03197571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111028899|NCT03197571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111028900|NCT03197571|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111028901|NCT03197571|Alkylating Agents|alkylating agents|mesh-ancestor
111028902|NCT03197571|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111028903|NCT03197571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111028904|NCT03197571|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111028905|NCT03197571|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111028906|NCT03197571|Growth Substances|growth substances|mesh-ancestor
111028907|NCT03197571|Growth Inhibitors|growth inhibitors|mesh-ancestor
111028908|NCT03197571|Antimetabolites|antimetabolites|mesh-ancestor
111028909|NCT03197571|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111028910|NCT03197571|Antidotes|antidotes|mesh-ancestor
111028911|NCT03197571|Protective Agents|protective agents|mesh-ancestor
111028912|NCT03197571|Vitamin B Complex|vitamin b complex|mesh-ancestor
111028913|NCT03197571|Vitamins|vitamins|mesh-ancestor
111028914|NCT03197571|Micronutrients|micronutrients|mesh-ancestor
111028915|NCT03197571|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111028916|NCT03197571|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
111028917|NCT03197571|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111028918|NCT03197571|Hormone Antagonists|hormone antagonists|mesh-ancestor
111028919|NCT03197571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111028921|NCT02446977|Vitamins|vitamins|mesh-ancestor
111028922|NCT02446977|Micronutrients|micronutrients|mesh-ancestor
111028923|NCT02446977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111028924|NCT02446977|Vitamin B Complex|vitamin b complex|mesh-ancestor
111028925|NCT02446977|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111028926|NCT02446977|Dermatologic Agents|dermatologic agents|mesh-ancestor
111028927|NCT02447055|Mycophenolic Acid|mycophenolic acid|mesh-list
111028928|NCT02447055|Cyclophosphamide|cyclophosphamide|mesh-list
111028929|NCT02447055|Melphalan|melphalan|mesh-list
111028930|NCT02447055|Fludarabine|fludarabine|mesh-list
111028931|NCT02447055|Fludarabine phosphate|fludarabine phosphate|mesh-list
111028932|NCT02447055|Tacrolimus|tacrolimus|mesh-list
111028933|NCT02447055|Lenograstim|lenograstim|mesh-list
111028934|NCT02447055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111028935|NCT02447055|Immunologic Factors|immunologic factors|mesh-ancestor
111028936|NCT02447055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111028937|NCT02447055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111028938|NCT02447055|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111028939|NCT02447055|Alkylating Agents|alkylating agents|mesh-ancestor
111028940|NCT02447055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111028941|NCT02447055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111028942|NCT02447055|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111028943|NCT02447055|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111028944|NCT02447055|Antimetabolites|antimetabolites|mesh-ancestor
111028945|NCT02447055|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111028946|NCT02447055|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111028947|NCT02447055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111028948|NCT02447055|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111028949|NCT02447055|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111028950|NCT02447055|Antitubercular Agents|antitubercular agents|mesh-ancestor
111028951|NCT02447055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111028952|NCT02447055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111028953|NCT03202563|Metformin|metformin|mesh-list
111028954|NCT03202563|Dapagliflozin|dapagliflozin|mesh-list
111028955|NCT03202563|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111028956|NCT03202563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111028957|NCT03202563|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111028958|NCT03202563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111028959|NCT03197493|Levodopa|levodopa|mesh-list
111028960|NCT03197493|Carbidopa|carbidopa|mesh-list
111028961|NCT03197493|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
111028962|NCT03197493|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111028963|NCT03197493|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111028964|NCT03197493|Dopamine Agents|dopamine agents|mesh-ancestor
111028965|NCT03197493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111028966|NCT03197493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111028967|NCT03197493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111028968|NCT03197493|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
111028969|NCT03197493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111028970|NCT03197493|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111028971|NCT03197493|Immunologic Factors|immunologic factors|mesh-ancestor
111028972|NCT03197493|Dopamine Agonists|dopamine agonists|mesh-ancestor
111028973|NCT02450175|Everolimus|everolimus|mesh-list
111028974|NCT02450175|Letrozole|letrozole|mesh-list
111028975|NCT02450175|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111028976|NCT02450175|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111028977|NCT02450175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111028978|NCT02450175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111028979|NCT02450175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111028980|NCT02450175|Immunologic Factors|immunologic factors|mesh-ancestor
111028981|NCT02450175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111028982|NCT02450175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111028983|NCT02450175|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111028984|NCT02450175|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111028985|NCT02450175|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111028986|NCT02450175|Hormone Antagonists|hormone antagonists|mesh-ancestor
111028987|NCT02450175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111028988|NCT03202719|Vaccines|vaccines|mesh-list
111028989|NCT03202719|Immunologic Factors|immunologic factors|mesh-ancestor
111028990|NCT03202719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111028991|NCT03202407|Calcium|calcium|mesh-list
111028992|NCT03202407|Sevelamer|sevelamer|mesh-list
111028993|NCT03202407|Calcium acetate|calcium acetate|mesh-list
111028994|NCT03202407|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111028995|NCT03202407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111028996|NCT03202407|Chelating Agents|chelating agents|mesh-ancestor
111028997|NCT03202407|Sequestering Agents|sequestering agents|mesh-ancestor
111028998|NCT03202407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111028999|NCT02261077|Scopolamine|scopolamine|mesh-list
111029000|NCT02261077|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
111029001|NCT02261077|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111029002|NCT02261077|Antiemetics|antiemetics|mesh-ancestor
111029003|NCT02261077|Autonomic Agents|autonomic agents|mesh-ancestor
111029004|NCT02261077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111029005|NCT02261077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111029006|NCT02261077|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111029007|NCT02261077|Mydriatics|mydriatics|mesh-ancestor
111029008|NCT02261077|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111029009|NCT02261077|Cholinergic Agents|cholinergic agents|mesh-ancestor
111029010|NCT02261077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111029011|NCT02261077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111029012|NCT02261077|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111029013|NCT02261077|Parasympatholytics|parasympatholytics|mesh-ancestor
111029014|NCT03196869|Cisplatin|cisplatin|mesh-list
111029015|NCT03196869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111029016|NCT02150473|Adalimumab|adalimumab|mesh-list
111029017|NCT02150473|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111029018|NCT02150473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111029019|NCT02150473|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111029020|NCT02446431|Sirolimus|sirolimus|mesh-list
111029021|NCT02446431|Cyclophosphamide|cyclophosphamide|mesh-list
111029022|NCT02446431|Bevacizumab|bevacizumab|mesh-list
111029023|NCT02446431|Temsirolimus|temsirolimus|mesh-list
111029024|NCT02446431|MTOR Inhibitors|mtor inhibitors|mesh-list
111029025|NCT02446431|Valproic Acid|valproic acid|mesh-list
111029026|NCT02446431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111029027|NCT02446431|Immunologic Factors|immunologic factors|mesh-ancestor
111029028|NCT02446431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111029029|NCT02446431|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111029030|NCT02446431|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111029031|NCT02446431|Alkylating Agents|alkylating agents|mesh-ancestor
111029032|NCT02446431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111029033|NCT02446431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111029034|NCT02446431|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111029035|NCT02446431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111029036|NCT02446431|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111029037|NCT02446431|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111029038|NCT02446431|Growth Substances|growth substances|mesh-ancestor
111029039|NCT02446431|Growth Inhibitors|growth inhibitors|mesh-ancestor
111029040|NCT02446431|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111029041|NCT02446431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111029042|NCT02446431|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111029043|NCT02446431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111029044|NCT02446431|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111029045|NCT02446431|Antifungal Agents|antifungal agents|mesh-ancestor
111029046|NCT02446431|Anticonvulsants|anticonvulsants|mesh-ancestor
111029047|NCT02446431|GABA Agents|gaba agents|mesh-ancestor
111029048|NCT02446431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111029049|NCT02446431|Antimanic Agents|antimanic agents|mesh-ancestor
111029050|NCT02446431|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111029051|NCT02446431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111029052|NCT02446431|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111029053|NCT02446353|Megestrol Acetate|megestrol acetate|mesh-list
111029054|NCT02446353|Megestrol|megestrol|mesh-list
111029055|NCT02446353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111029056|NCT02446353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111029057|NCT02446353|Appetite Stimulants|appetite stimulants|mesh-ancestor
111029058|NCT02446353|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111029059|NCT02446353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111029060|NCT02446353|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111029061|NCT02446353|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111029062|NCT02446353|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111029063|NCT02446353|Contraceptive Agents|contraceptive agents|mesh-ancestor
111029064|NCT02446353|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111029065|NCT02446353|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111029066|NCT02446353|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111029067|NCT02144389|Praziquantel|praziquantel|mesh-list
111029068|NCT02144389|Anthelmintics|anthelmintics|mesh-ancestor
111029069|NCT02144389|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111029070|NCT02144389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111029071|NCT03197103|Acetylcysteine|acetylcysteine|mesh-list
111029072|NCT03197103|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111029073|NCT03197103|Antiviral Agents|antiviral agents|mesh-ancestor
111029074|NCT03197103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111029075|NCT03197103|Expectorants|expectorants|mesh-ancestor
111029076|NCT03197103|Respiratory System Agents|respiratory system agents|mesh-ancestor
111029077|NCT03197103|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111029078|NCT03197103|Antioxidants|antioxidants|mesh-ancestor
111029079|NCT03197103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111029080|NCT03197103|Protective Agents|protective agents|mesh-ancestor
111029081|NCT03197103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111029082|NCT03197103|Antidotes|antidotes|mesh-ancestor
111029083|NCT02144623|Valproic Acid|valproic acid|mesh-list
111029084|NCT02144623|Anticonvulsants|anticonvulsants|mesh-ancestor
111029085|NCT02144623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111029086|NCT02144623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111029087|NCT02144623|GABA Agents|gaba agents|mesh-ancestor
111029088|NCT02144623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111029089|NCT02144623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111029090|NCT02144623|Antimanic Agents|antimanic agents|mesh-ancestor
111029091|NCT02144623|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111029092|NCT02144623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111029093|NCT02144623|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111029094|NCT03201861|Paclitaxel|paclitaxel|mesh-list
111029095|NCT03201861|Docetaxel|docetaxel|mesh-list
111029096|NCT03201861|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111029097|NCT03201861|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111029098|NCT03201861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111029099|NCT03201861|Tubulin Modulators|tubulin modulators|mesh-ancestor
111029100|NCT03201861|Antimitotic Agents|antimitotic agents|mesh-ancestor
111029101|NCT03201861|Mitosis Modulators|mitosis modulators|mesh-ancestor
111029102|NCT03201861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111029103|NCT03194685|FF-10101|ff-10101|mesh-list
111029104|NCT03194685|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111029105|NCT03194685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111029106|NCT03194685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111029107|NCT00105079|Ritonavir|ritonavir|mesh-list
111029108|NCT00105079|Lopinavir|lopinavir|mesh-list
111029109|NCT00105079|Saquinavir|saquinavir|mesh-list
111029110|NCT00105079|Tenofovir|tenofovir|mesh-list
111029111|NCT00105079|Emtricitabine|emtricitabine|mesh-list
111029112|NCT00105079|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
111029113|NCT00105079|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111029114|NCT00105079|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111029115|NCT00105079|Protease Inhibitors|protease inhibitors|mesh-ancestor
111029116|NCT00105079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111029117|NCT00105079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111029118|NCT00105079|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111029119|NCT00105079|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111029120|NCT00105079|Antiviral Agents|antiviral agents|mesh-ancestor
111029121|NCT00105079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111029122|NCT00105079|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111029123|NCT00105079|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111029124|NCT00105079|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111029125|NCT00105079|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111029126|NCT03196401|Durvalumab|durvalumab|mesh-list
111029127|NCT03196401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111029128|NCT03196401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111029129|NCT02150707|Liraglutide|liraglutide|mesh-list
111029130|NCT02150707|Exenatide|exenatide|mesh-list
111029131|NCT02150707|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
111029132|NCT02150707|Glucagon|glucagon|mesh-list
111029133|NCT02150707|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
111029134|NCT02150707|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111029135|NCT02150707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111029136|NCT02150707|Incretins|incretins|mesh-ancestor
111029137|NCT02150707|Hormones|hormones|mesh-ancestor
111029138|NCT02150707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111029139|NCT02150707|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111029140|NCT02150707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111029141|NCT02150707|Protease Inhibitors|protease inhibitors|mesh-ancestor
111029142|NCT02150707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111029143|NCT02150707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111029144|NCT03196479|Ketamine|ketamine|mesh-list
111029145|NCT03196479|Propofol|propofol|mesh-list
110494164|NCT03962855|Ifetroban|ifetroban|mesh-list
111029146|NCT03196479|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111029147|NCT03196479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111029148|NCT03196479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111029149|NCT03196479|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111029150|NCT03196479|Anesthetics, General|anesthetics, general|mesh-ancestor
111029152|NCT03196479|Analgesics|analgesics|mesh-ancestor
111029153|NCT03196479|Sensory System Agents|sensory system agents|mesh-ancestor
111029154|NCT03196479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111029155|NCT03196479|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111029156|NCT03196479|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111029157|NCT03196479|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111029158|NCT03196479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111029159|NCT03196479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111029160|NCT03201627|Lithium Carbonate|lithium carbonate|mesh-list
111029161|NCT03201627|Antidepressive Agents|antidepressive agents|mesh-ancestor
111029162|NCT03201627|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111029163|NCT03201627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111029164|NCT03201627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111029165|NCT03201627|Antimanic Agents|antimanic agents|mesh-ancestor
111029166|NCT03201627|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110625719|NCT03957590|Tubulin Modulators|tubulin modulators|mesh-ancestor
111029167|NCT03201627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111029168|NCT03201627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111029169|NCT02151721|Gefitinib|gefitinib|mesh-list
111029170|NCT02151721|Vorinostat|vorinostat|mesh-list
111029171|NCT02151721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111029172|NCT02151721|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111029173|NCT02151721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111029174|NCT02151721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111029175|NCT02151721|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111029176|NCT03201393|Acetaminophen|acetaminophen|mesh-list
111029177|NCT03201393|Naltrexone|naltrexone|mesh-list
111029178|NCT03201393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111029179|NCT03201393|Analgesics|analgesics|mesh-ancestor
111029180|NCT03201393|Sensory System Agents|sensory system agents|mesh-ancestor
111029181|NCT03201393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111029182|NCT03201393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111029183|NCT03201393|Antipyretics|antipyretics|mesh-ancestor
111029184|NCT03201393|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111029185|NCT03201393|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111029186|NCT03192969|Abatacept|abatacept|mesh-list
111029187|NCT03192969|Glucocorticoids|glucocorticoids|mesh-list
111029188|NCT03192969|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111029189|NCT03192969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111029190|NCT03192969|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111029191|NCT03192969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111029192|NCT03192969|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111029193|NCT03192969|Immunologic Factors|immunologic factors|mesh-ancestor
111029194|NCT03192969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111029195|NCT03192969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111029196|NCT03192969|Hormones|hormones|mesh-ancestor
111029197|NCT03192969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111029198|NCT03194139|Avasopasem manganese|avasopasem manganese|mesh-list
111029199|NCT03194139|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111029200|NCT03194139|Antioxidants|antioxidants|mesh-ancestor
111029201|NCT03194139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111029202|NCT03194139|Protective Agents|protective agents|mesh-ancestor
111029203|NCT03194139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111029204|NCT03118167|Antioxidants|antioxidants|mesh-list
111029205|NCT03118167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111029206|NCT03118167|Protective Agents|protective agents|mesh-ancestor
111029207|NCT03118167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111029208|NCT00189267|Imiquimod|imiquimod|mesh-list
111029209|NCT00189267|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111029210|NCT00189267|Immunologic Factors|immunologic factors|mesh-ancestor
111029211|NCT00189267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111029212|NCT00189267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111029213|NCT00189267|Interferon Inducers|interferon inducers|mesh-ancestor
111029214|NCT02444949|Cisplatin|cisplatin|mesh-list
111029215|NCT02444949|Endostar protein|endostar protein|mesh-list
111029216|NCT02444949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111029217|NCT02444949|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111029218|NCT02444949|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111029220|NCT02444949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111029221|NCT02444949|Growth Inhibitors|growth inhibitors|mesh-ancestor
111029222|NCT03192579|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111029223|NCT03192579|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111029224|NCT03192579|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110625724|NCT03921866|Palbociclib|palbociclib|mesh-list
111029225|NCT03192579|Antimetabolites|antimetabolites|mesh-ancestor
111029226|NCT03192579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111029227|NCT03192579|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111029228|NCT03192579|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111029229|NCT03192579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111029230|NCT03192657|Basiliximab|basiliximab|mesh-list
111029231|NCT03192657|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
111029232|NCT03192657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111029233|NCT03192657|Immunologic Factors|immunologic factors|mesh-ancestor
111029234|NCT03192657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111029235|NCT03192657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111029236|NCT03192657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111029237|NCT02444169|Hyaluronic Acid|hyaluronic acid|mesh-list
111029238|NCT02444169|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111029239|NCT02444169|Immunologic Factors|immunologic factors|mesh-ancestor
111029240|NCT02444169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111029241|NCT02444169|Viscosupplements|viscosupplements|mesh-ancestor
111029242|NCT02444169|Protective Agents|protective agents|mesh-ancestor
111029243|NCT03194061|Cisplatin|cisplatin|mesh-list
111029244|NCT03194061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111029245|NCT02343406|Temozolomide|temozolomide|mesh-list
111029246|NCT02343406|Lomustine|lomustine|mesh-list
111029247|NCT02343406|ABT-414|abt-414|mesh-list
111029248|NCT02343406|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111029249|NCT02343406|Alkylating Agents|alkylating agents|mesh-ancestor
111029250|NCT02343406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111029251|NCT02343406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111029252|NCT02343406|Immunoconjugates|immunoconjugates|mesh-ancestor
111029253|NCT02343406|Immunologic Factors|immunologic factors|mesh-ancestor
111029254|NCT02343406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111029255|NCT02444091|Cyclophosphamide|cyclophosphamide|mesh-list
111029256|NCT02444091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111029257|NCT02444091|Immunologic Factors|immunologic factors|mesh-ancestor
111029258|NCT02444091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111029259|NCT02444091|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111029260|NCT02444091|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111029261|NCT02444091|Alkylating Agents|alkylating agents|mesh-ancestor
111029262|NCT02444091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111029263|NCT02444091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111029264|NCT02444091|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111029265|NCT02443935|CPG-oligonucleotide|cpg-oligonucleotide|mesh-list
111029266|NCT02443935|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111029267|NCT02443935|Immunologic Factors|immunologic factors|mesh-ancestor
111029268|NCT02443935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111029269|NCT03193749|Amiodarone|amiodarone|mesh-list
111029270|NCT03193749|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111029271|NCT03193749|Vasodilator Agents|vasodilator agents|mesh-ancestor
111029272|NCT03193749|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
111029273|NCT03193749|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111029274|NCT03193749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111029275|NCT03193749|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111029276|NCT03193749|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111029277|NCT03193749|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111029278|NCT03193749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111029279|NCT03193749|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111029280|NCT03193749|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111029281|NCT03193749|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111029282|NCT02444013|Folic Acid|folic acid|mesh-list
111029283|NCT02444013|Uric Acid|uric acid|mesh-list
111029284|NCT02444013|Hematinics|hematinics|mesh-ancestor
111029285|NCT02444013|Vitamin B Complex|vitamin b complex|mesh-ancestor
111029286|NCT02444013|Vitamins|vitamins|mesh-ancestor
111029287|NCT02444013|Micronutrients|micronutrients|mesh-ancestor
111029288|NCT02444013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111029289|NCT02444013|Antioxidants|antioxidants|mesh-ancestor
110625739|NCT03919955|Autonomic Agents|autonomic agents|mesh-ancestor
111029290|NCT02444013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111029291|NCT02444013|Protective Agents|protective agents|mesh-ancestor
111029292|NCT02444637|Rivastigmine|rivastigmine|mesh-list
111029293|NCT02444637|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111029294|NCT02444637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111029295|NCT02444637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111029296|NCT02444637|Cholinergic Agents|cholinergic agents|mesh-ancestor
111029297|NCT02444637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111029298|NCT02444637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111029299|NCT02444637|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111029300|NCT02444637|Protective Agents|protective agents|mesh-ancestor
111029301|NCT05172999|Levonorgestrel|levonorgestrel|mesh-list
111029302|NCT05172999|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111029303|NCT05172999|Contraceptive Agents|contraceptive agents|mesh-ancestor
111029304|NCT05172999|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111029305|NCT05172999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111029306|NCT05172999|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111029307|NCT05172999|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111029308|NCT05172999|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111029309|NCT02710071|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
111029310|NCT02710071|Nebivolol|nebivolol|mesh-list
111029311|NCT02710071|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111029312|NCT02710071|Diuretics|diuretics|mesh-ancestor
111029313|NCT02710071|Natriuretic Agents|natriuretic agents|mesh-ancestor
111029314|NCT02710071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111029315|NCT02710071|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
111029316|NCT02710071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111029317|NCT02710071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111029318|NCT02710071|Vasodilator Agents|vasodilator agents|mesh-ancestor
111029319|NCT02710071|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
111029320|NCT02710071|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111029321|NCT02710071|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111029322|NCT02710071|Adrenergic Agents|adrenergic agents|mesh-ancestor
111029323|NCT02710071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111029324|NCT02443545|Deferiprone|deferiprone|mesh-list
111029325|NCT02443545|Iron Chelating Agents|iron chelating agents|mesh-ancestor
111029326|NCT02443545|Chelating Agents|chelating agents|mesh-ancestor
111029327|NCT02443545|Sequestering Agents|sequestering agents|mesh-ancestor
111029328|NCT02443545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111029329|NCT02439489|Carboplatin|carboplatin|mesh-list
111029330|NCT02439489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111029331|NCT02444481|Polymyxins|polymyxins|mesh-list
111029332|NCT02444481|Neomycin|neomycin|mesh-list
111029333|NCT02444481|Nystatin|nystatin|mesh-list
111029334|NCT02444481|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111029335|NCT02444481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111029336|NCT02444481|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111029337|NCT02444481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111029338|NCT02444481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111029339|NCT02444481|Antifungal Agents|antifungal agents|mesh-ancestor
111029340|NCT02444481|Ionophores|ionophores|mesh-ancestor
111029341|NCT02444481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111029342|NCT02444559|Clonidine|clonidine|mesh-list
111029343|NCT02444559|Ropivacaine|ropivacaine|mesh-list
111029344|NCT02444559|Anesthetics, Local|anesthetics, local|mesh-ancestor
111029345|NCT02444559|Anesthetics|anesthetics|mesh-ancestor
111029346|NCT02444559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111029347|NCT02444559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111029348|NCT02444559|Sensory System Agents|sensory system agents|mesh-ancestor
111029349|NCT02444559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111029350|NCT02444559|Analgesics|analgesics|mesh-ancestor
111029351|NCT02444559|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111029352|NCT02444559|Sympatholytics|sympatholytics|mesh-ancestor
111029353|NCT02444559|Autonomic Agents|autonomic agents|mesh-ancestor
111029354|NCT02444559|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111029355|NCT02444559|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111029356|NCT02444559|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111029357|NCT02444559|Adrenergic Agents|adrenergic agents|mesh-ancestor
111029358|NCT02444559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111029359|NCT02444559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111029360|NCT03190239|Pemetrexed|pemetrexed|mesh-list
111029361|NCT03190239|Apatinib|apatinib|mesh-list
111029362|NCT03190239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111029363|NCT03190239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111029364|NCT03190239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111029365|NCT03190239|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111029366|NCT03190239|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111029368|NCT02439411|Trametinib|trametinib|mesh-list
111029369|NCT02439411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111029370|NCT02439411|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111029371|NCT02439411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111029372|NCT02439411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111029373|NCT03192735|Oxaliplatin|oxaliplatin|mesh-list
111029374|NCT03192735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111029375|NCT02443311|Betamethasone|betamethasone|mesh-list
111029376|NCT02443311|Betamethasone Valerate|betamethasone valerate|mesh-list
111029377|NCT02443311|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
111029378|NCT02443311|Betamethasone benzoate|betamethasone benzoate|mesh-list
111029379|NCT02443311|Pimecrolimus|pimecrolimus|mesh-list
111029380|NCT02443311|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
111029381|NCT02443311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111029382|NCT02443311|Glucocorticoids|glucocorticoids|mesh-ancestor
111029383|NCT02443311|Hormones|hormones|mesh-ancestor
111029384|NCT02443311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111029385|NCT02443311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111029386|NCT02443311|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111029387|NCT02443311|Respiratory System Agents|respiratory system agents|mesh-ancestor
111029388|NCT02443311|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111029389|NCT02443311|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111029390|NCT02443311|Analgesics|analgesics|mesh-ancestor
111029391|NCT02443311|Sensory System Agents|sensory system agents|mesh-ancestor
111029392|NCT02443311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111029393|NCT02443311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111029394|NCT02443311|Dermatologic Agents|dermatologic agents|mesh-ancestor
111029395|NCT02443311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111029396|NCT02443311|Immunologic Factors|immunologic factors|mesh-ancestor
111029397|NCT02443311|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111029398|NCT02443311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111029399|NCT02443311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111029400|NCT02373202|Sulfasalazine|sulfasalazine|mesh-list
111029401|NCT02373202|Mizoribine|mizoribine|mesh-list
111029402|NCT02373202|Bucillamine|bucillamine|mesh-list
111029403|NCT02373202|Tacrolimus|tacrolimus|mesh-list
111029404|NCT02373202|Leflunomide|leflunomide|mesh-list
111029405|NCT02373202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111029406|NCT02373202|Immunologic Factors|immunologic factors|mesh-ancestor
111029407|NCT02373202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111029408|NCT02373202|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111029409|NCT02373202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111029410|NCT02373202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111029411|NCT02373202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111029412|NCT02373202|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111029413|NCT02373202|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111029414|NCT02373202|Analgesics|analgesics|mesh-ancestor
111029415|NCT02373202|Sensory System Agents|sensory system agents|mesh-ancestor
111029416|NCT02373202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111029417|NCT02373202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111029418|NCT02373202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111029419|NCT02373202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111029420|NCT02373202|Antioxidants|antioxidants|mesh-ancestor
111029421|NCT02373202|Protective Agents|protective agents|mesh-ancestor
110625754|NCT03681561|Nivolumab|nivolumab|mesh-list
111029422|NCT02373202|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111029423|NCT02373202|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111029424|NCT02373202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111029425|NCT02373202|Antimalarials|antimalarials|mesh-ancestor
111029426|NCT02373202|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111029427|NCT02373202|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111029428|NCT03192111|Entinostat|entinostat|mesh-list
111029429|NCT03192111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111029430|NCT03192111|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111029431|NCT03192111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111029432|NCT03192111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111029433|NCT02622074|Paclitaxel|paclitaxel|mesh-list
111029434|NCT02622074|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111029435|NCT02622074|Cyclophosphamide|cyclophosphamide|mesh-list
111029436|NCT02622074|Carboplatin|carboplatin|mesh-list
111029437|NCT02622074|Doxorubicin|doxorubicin|mesh-list
111029438|NCT02622074|Pembrolizumab|pembrolizumab|mesh-list
111029439|NCT02622074|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111029440|NCT02622074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111029441|NCT02622074|Tubulin Modulators|tubulin modulators|mesh-ancestor
111029443|NCT02622074|Mitosis Modulators|mitosis modulators|mesh-ancestor
111029444|NCT02622074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111029445|NCT02622074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111029446|NCT02622074|Immunologic Factors|immunologic factors|mesh-ancestor
111029447|NCT02622074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111029448|NCT02622074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111029449|NCT02622074|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111029450|NCT02622074|Alkylating Agents|alkylating agents|mesh-ancestor
111029451|NCT02622074|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111029452|NCT02622074|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111029453|NCT02622074|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111029454|NCT02622074|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111029455|NCT02622074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111029456|NCT02622074|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111029457|NCT02622074|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111029458|NCT02438709|Etoricoxib|etoricoxib|mesh-list
111029459|NCT02438709|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
111029460|NCT02438709|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111029461|NCT02438709|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111029462|NCT02438709|Analgesics|analgesics|mesh-ancestor
111029463|NCT02438709|Sensory System Agents|sensory system agents|mesh-ancestor
111029464|NCT02438709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111029465|NCT02438709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111029466|NCT02438709|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111029467|NCT02438709|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111029468|NCT02438709|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111029469|NCT02438709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111029470|NCT02438709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111029471|NCT05438758|Ketamine|ketamine|mesh-list
111029472|NCT05438758|Esketamine|esketamine|mesh-list
111029473|NCT05438758|Analgesics|analgesics|mesh-ancestor
111029474|NCT05438758|Sensory System Agents|sensory system agents|mesh-ancestor
111029475|NCT05438758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111029476|NCT05438758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111029477|NCT05438758|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111029478|NCT05438758|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111029479|NCT05438758|Anesthetics, General|anesthetics, general|mesh-ancestor
111029480|NCT05438758|Anesthetics|anesthetics|mesh-ancestor
111029481|NCT05438758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111029482|NCT05438758|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111029483|NCT05438758|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111029484|NCT05438758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110625765|NCT03656081|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111029485|NCT05438758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111029486|NCT05438758|Antidepressive Agents|antidepressive agents|mesh-ancestor
111029487|NCT05438758|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111029488|NCT02442921|Colchicine|colchicine|mesh-list
111029489|NCT02442921|Gout Suppressants|gout suppressants|mesh-ancestor
111029490|NCT02442921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111029491|NCT02442921|Tubulin Modulators|tubulin modulators|mesh-ancestor
111029492|NCT02442921|Antimitotic Agents|antimitotic agents|mesh-ancestor
111029493|NCT02442921|Mitosis Modulators|mitosis modulators|mesh-ancestor
111029494|NCT02442921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111029495|NCT02442921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111029496|NCT02438865|Epirubicin|epirubicin|mesh-list
111029497|NCT02438865|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111029498|NCT02438865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111029499|NCT02438865|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111029500|NCT02438865|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111029501|NCT02438865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111029502|NCT02438865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111029503|NCT04924946|Antihypertensive Agents|antihypertensive agents|mesh-list
111029504|NCT03189771|Salicylic Acid|salicylic acid|mesh-list
111029505|NCT03189771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111029506|NCT03189771|Antifungal Agents|antifungal agents|mesh-ancestor
111029507|NCT03189771|Keratolytic Agents|keratolytic agents|mesh-ancestor
111029508|NCT03189771|Dermatologic Agents|dermatologic agents|mesh-ancestor
111029509|NCT02342704|Natalizumab|natalizumab|mesh-list
111029510|NCT02342704|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
111029511|NCT02342704|Immunologic Factors|immunologic factors|mesh-ancestor
111029512|NCT02342704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111029513|NCT02342704|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
111029514|NCT02342704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111029515|NCT02342704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111029516|NCT02442453|Turmeric extract|turmeric extract|mesh-list
111029517|NCT02442453|Antioxidants|antioxidants|mesh-ancestor
111029518|NCT02442453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111029519|NCT02442453|Protective Agents|protective agents|mesh-ancestor
111029520|NCT02442453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111029521|NCT02438397|Insulin|insulin|mesh-list
111029522|NCT02438397|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111029523|NCT02438397|Metformin|metformin|mesh-list
111029524|NCT02438397|Acarbose|acarbose|mesh-list
111029525|NCT02438397|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111029526|NCT02438397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111029527|NCT02438397|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
111029528|NCT02438397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111029529|NCT02438397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111029530|NCT03193359|Botulinum Toxins|botulinum toxins|mesh-list
111029531|NCT03193359|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111029532|NCT03193359|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111029533|NCT03193359|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111029534|NCT03193359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111029535|NCT03193359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111029536|NCT03193359|Cholinergic Agents|cholinergic agents|mesh-ancestor
111029537|NCT03193359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111029538|NCT03193359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111029539|NCT03193359|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111029540|NCT03193359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111029541|NCT02442531|Docetaxel|docetaxel|mesh-list
111029542|NCT02442531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111029543|NCT02442531|Tubulin Modulators|tubulin modulators|mesh-ancestor
111029544|NCT02442531|Antimitotic Agents|antimitotic agents|mesh-ancestor
111029545|NCT02442531|Mitosis Modulators|mitosis modulators|mesh-ancestor
111029546|NCT02442531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111029547|NCT03193203|Etanercept|etanercept|mesh-list
111029548|NCT03193203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111029549|NCT03193203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111029550|NCT03193203|Analgesics|analgesics|mesh-ancestor
111029551|NCT03193203|Sensory System Agents|sensory system agents|mesh-ancestor
111029552|NCT03193203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111029553|NCT03193203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111029554|NCT03193203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111029555|NCT03193203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111029556|NCT03193203|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111029557|NCT03193203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111029558|NCT03193203|Immunologic Factors|immunologic factors|mesh-ancestor
111029559|NCT02442063|Paclitaxel|paclitaxel|mesh-list
111029560|NCT02442063|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
111029561|NCT02442063|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111029562|NCT02442063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111029563|NCT02442063|Tubulin Modulators|tubulin modulators|mesh-ancestor
111029564|NCT02442063|Antimitotic Agents|antimitotic agents|mesh-ancestor
111029565|NCT02442063|Mitosis Modulators|mitosis modulators|mesh-ancestor
111029566|NCT02442063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111029567|NCT04923152|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
111029568|NCT04923152|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111029569|NCT04923152|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111029570|NCT04923152|Antimetabolites|antimetabolites|mesh-ancestor
111029571|NCT04923152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111029572|NCT04923152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111029573|NCT04923152|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111029574|NCT03369717|Clavulanic Acid|clavulanic acid|mesh-list
111029575|NCT03369717|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
111029576|NCT03369717|Clavulanic Acids|clavulanic acids|mesh-list
111029577|NCT03369717|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
111029578|NCT03369717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111029579|NCT03369717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111029580|NCT03369717|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111029581|NCT03369717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111029582|NCT03054662|Hemostatics|hemostatics|mesh-list
111029583|NCT03054662|Coagulants|coagulants|mesh-ancestor
111029584|NCT04922996|Calcium Dobesilate|calcium dobesilate|mesh-list
111029585|NCT04922996|Calcium|calcium|mesh-list
111029586|NCT04922996|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111029587|NCT04922996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111029588|NCT04922996|Hemostatics|hemostatics|mesh-ancestor
111029589|NCT04922996|Coagulants|coagulants|mesh-ancestor
111029590|NCT04913480|Durvalumab|durvalumab|mesh-list
111029591|NCT04913480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111029592|NCT04913480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111029593|NCT02441907|Aflibercept|aflibercept|mesh-list
111029594|NCT02441907|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111029595|NCT02441907|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111029596|NCT02441907|Growth Substances|growth substances|mesh-ancestor
110625800|NCT03621982|Pembrolizumab|pembrolizumab|mesh-list
111029597|NCT02441907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111029598|NCT02441907|Growth Inhibitors|growth inhibitors|mesh-ancestor
111029599|NCT02441907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111029600|NCT02437461|Triamcinolone|triamcinolone|mesh-list
111029601|NCT02437461|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
111029602|NCT02437461|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
111029603|NCT02437461|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
111029604|NCT02437461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111029605|NCT02437461|Glucocorticoids|glucocorticoids|mesh-ancestor
111029606|NCT02437461|Hormones|hormones|mesh-ancestor
111029607|NCT02437461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111029608|NCT02437461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111029609|NCT02437461|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111029610|NCT02437461|Immunologic Factors|immunologic factors|mesh-ancestor
111029611|NCT02437461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111029612|NCT02437461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111029613|NCT04910594|Epoetin Alfa|epoetin alfa|mesh-list
111029614|NCT04910594|Hematinics|hematinics|mesh-ancestor
111029615|NCT02441673|Ephedrine|ephedrine|mesh-list
111029616|NCT02441673|Meperidine|meperidine|mesh-list
111029617|NCT02441673|Tramadol|tramadol|mesh-list
111029618|NCT02441673|Nefopam|nefopam|mesh-list
111029619|NCT02441673|Metoclopramide|metoclopramide|mesh-list
111029620|NCT02441673|Ranitidine|ranitidine|mesh-list
111029621|NCT02441673|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
111029622|NCT02441673|Oxytocin|oxytocin|mesh-list
111029623|NCT02441673|Oxytocics|oxytocics|mesh-ancestor
111029624|NCT02441673|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111029625|NCT02441673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111029626|NCT02441673|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111029627|NCT02441673|Narcotics|narcotics|mesh-ancestor
111029628|NCT02441673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111029629|NCT02441673|Analgesics|analgesics|mesh-ancestor
111029630|NCT02441673|Sensory System Agents|sensory system agents|mesh-ancestor
111029631|NCT02441673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111029632|NCT02441673|Antiemetics|antiemetics|mesh-ancestor
111029633|NCT02441673|Autonomic Agents|autonomic agents|mesh-ancestor
111029634|NCT02441673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111029635|NCT02441673|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111029636|NCT02441673|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111029637|NCT02441673|Dopamine Agents|dopamine agents|mesh-ancestor
111029638|NCT02441673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111029639|NCT02441673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111029640|NCT02441673|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111029641|NCT02441673|Sympathomimetics|sympathomimetics|mesh-ancestor
111029642|NCT02441673|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111029643|NCT02441673|Adrenergic Agents|adrenergic agents|mesh-ancestor
111029644|NCT02441673|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111029645|NCT02441673|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
111029646|NCT02441673|Histamine Antagonists|histamine antagonists|mesh-ancestor
111029647|NCT02441673|Histamine Agents|histamine agents|mesh-ancestor
111029648|NCT02441673|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111029649|NCT02441673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111029650|NCT04910126|Doxorubicin|doxorubicin|mesh-list
111029651|NCT04910126|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111029652|NCT04910126|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111029653|NCT04910126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111029654|NCT04910126|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111029655|NCT04910126|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111029656|NCT04910126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111029657|NCT04910126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111029658|NCT04922450|Paclitaxel|paclitaxel|mesh-list
111029659|NCT04922450|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
111029660|NCT04922450|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111029661|NCT04922450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111029662|NCT04922450|Tubulin Modulators|tubulin modulators|mesh-ancestor
111029663|NCT04922450|Antimitotic Agents|antimitotic agents|mesh-ancestor
111029664|NCT04922450|Mitosis Modulators|mitosis modulators|mesh-ancestor
111029665|NCT04922450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111029666|NCT04922450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111029667|NCT04903808|Allyl sulfide|allyl sulfide|mesh-list
111029668|NCT04903808|Antioxidants|antioxidants|mesh-ancestor
111029669|NCT04903808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111029670|NCT04903808|Protective Agents|protective agents|mesh-ancestor
111029671|NCT04903808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111029672|NCT04903808|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
111029673|NCT04903808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111029674|NCT04903808|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111029675|NCT04903808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111029676|NCT03189537|Pentanedioic acid imidazolyl ethanamide|pentanedioic acid imidazolyl ethanamide|mesh-list
111029677|NCT03189537|Antiviral Agents|antiviral agents|mesh-ancestor
111029678|NCT03189537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111029679|NCT04893980|Aldesleukin|aldesleukin|mesh-list
111029680|NCT04893980|Interleukin-2|interleukin-2|mesh-list
111029681|NCT04893980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111029682|NCT04893980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111029683|NCT04893980|Analgesics|analgesics|mesh-ancestor
111029684|NCT04893980|Sensory System Agents|sensory system agents|mesh-ancestor
111029685|NCT04893980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111029686|NCT04893980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111029687|NCT04893980|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111029688|NCT04893980|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111029689|NCT04893980|Antiviral Agents|antiviral agents|mesh-ancestor
111029690|NCT04893980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111029691|NCT04149470|Omeprazole|omeprazole|mesh-list
111029692|NCT04149470|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111029693|NCT04149470|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111029694|NCT04149470|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111029695|NCT04149470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111029696|NCT04149470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111029697|NCT04902638|Dexamethasone|dexamethasone|mesh-list
111029698|NCT04902638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111029699|NCT04902638|Antiemetics|antiemetics|mesh-ancestor
111029700|NCT04902638|Autonomic Agents|autonomic agents|mesh-ancestor
111029701|NCT04902638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111029702|NCT04902638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111029703|NCT04902638|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111029704|NCT04902638|Glucocorticoids|glucocorticoids|mesh-ancestor
111029705|NCT04902638|Hormones|hormones|mesh-ancestor
111029706|NCT04902638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111029707|NCT04902638|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111029708|NCT04902638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111029709|NCT02617628|Naltrexone|naltrexone|mesh-list
111029710|NCT02617628|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111029711|NCT02617628|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111029712|NCT02617628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111029713|NCT02617628|Sensory System Agents|sensory system agents|mesh-ancestor
111029714|NCT02617628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111029715|NCT03053414|Vitamin D|vitamin d|mesh-list
111029716|NCT03053414|Cholecalciferol|cholecalciferol|mesh-list
111029717|NCT03053414|Ergocalciferols|ergocalciferols|mesh-list
111029718|NCT03053414|Vitamins|vitamins|mesh-ancestor
111029719|NCT03053414|Micronutrients|micronutrients|mesh-ancestor
111029720|NCT03053414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111029721|NCT03053414|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111029722|NCT03053414|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111029723|NCT02308540|Vaccines|vaccines|mesh-list
110625815|NCT03604406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111029724|NCT02308540|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
111029725|NCT02308540|Immunologic Factors|immunologic factors|mesh-ancestor
111029726|NCT02308540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111029727|NCT02308228|Metformin|metformin|mesh-list
111029728|NCT02308228|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111029729|NCT02308228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111029730|NCT03051932|Acetaminophen|acetaminophen|mesh-list
111029731|NCT03051932|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111029732|NCT03051932|Analgesics|analgesics|mesh-ancestor
111029733|NCT03051932|Sensory System Agents|sensory system agents|mesh-ancestor
111029734|NCT03051932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111029735|NCT03051932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111029736|NCT03051932|Antipyretics|antipyretics|mesh-ancestor
111029737|NCT04900766|Mitoxantrone|mitoxantrone|mesh-list
111029738|NCT04900766|Analgesics|analgesics|mesh-ancestor
111029740|NCT04900766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111029741|NCT04900766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111029742|NCT04900766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111029743|NCT04900766|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111029744|NCT04900766|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111029745|NCT04900766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111029746|NCT04900766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111029747|NCT04908566|Folfirinox|folfirinox|mesh-list
111029748|NCT04908566|Antibodies|antibodies|mesh-list
111029749|NCT04908566|Immunoglobulins|immunoglobulins|mesh-list
111029750|NCT04908566|Immunologic Factors|immunologic factors|mesh-ancestor
111029751|NCT04908566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111029752|NCT04908566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111029753|NCT04892654|Dolutegravir|dolutegravir|mesh-list
111029754|NCT04892654|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111029755|NCT04892654|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111029756|NCT04892654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111029757|NCT04892654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111029758|NCT04892654|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111029759|NCT04892654|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111029760|NCT04892654|Antiviral Agents|antiviral agents|mesh-ancestor
111029761|NCT04892654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111029762|NCT04899674|Bupropion|bupropion|mesh-list
111029763|NCT04899674|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111029764|NCT04899674|Antidepressive Agents|antidepressive agents|mesh-ancestor
111029765|NCT04899674|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111029766|NCT04899674|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111029767|NCT04899674|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111029768|NCT04899674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111029769|NCT04899674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111029770|NCT04899674|Dopamine Agents|dopamine agents|mesh-ancestor
111029771|NCT04899674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111029772|NCT04899674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111029773|NCT04899674|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111029774|NCT04899674|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111029775|NCT04899674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111029776|NCT04907708|Metformin|metformin|mesh-list
111029777|NCT04907708|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111029778|NCT04907708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111029779|NCT04890626|Tenofovir|tenofovir|mesh-list
111029780|NCT04890626|Emtricitabine|emtricitabine|mesh-list
111029781|NCT04890626|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
111029782|NCT04890626|Dexamethasone|dexamethasone|mesh-list
111029783|NCT04890626|Dexamethasone acetate|dexamethasone acetate|mesh-list
111029784|NCT04890626|BB 1101|bb 1101|mesh-list
111029785|NCT04890626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111029786|NCT04890626|Antiemetics|antiemetics|mesh-ancestor
111029787|NCT04890626|Autonomic Agents|autonomic agents|mesh-ancestor
110625833|NCT03530371|Dexmedetomidine|dexmedetomidine|mesh-list
111029788|NCT04890626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111029789|NCT04890626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111029790|NCT04890626|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111029791|NCT04890626|Glucocorticoids|glucocorticoids|mesh-ancestor
111029792|NCT04890626|Hormones|hormones|mesh-ancestor
111029793|NCT04890626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111029794|NCT04890626|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111029795|NCT04890626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111029796|NCT04890626|Protease Inhibitors|protease inhibitors|mesh-ancestor
111029797|NCT04890626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111029798|NCT04890626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111029799|NCT04890626|Antiviral Agents|antiviral agents|mesh-ancestor
111029800|NCT04890626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111029801|NCT04890626|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111029802|NCT04890626|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111029803|NCT04890626|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111029804|NCT04890626|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111029805|NCT04907864|Ibuprofen|ibuprofen|mesh-list
111029806|NCT04907864|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111029807|NCT04907864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111029808|NCT04907864|Analgesics|analgesics|mesh-ancestor
111029809|NCT04907864|Sensory System Agents|sensory system agents|mesh-ancestor
111029811|NCT04907864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111029812|NCT04907864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111029813|NCT04907864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111029814|NCT04907864|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111029815|NCT04907864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111029816|NCT04907864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111029817|NCT03051542|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
111029818|NCT03051542|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111029819|NCT03051542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111029820|NCT04907474|Phenylephrine|phenylephrine|mesh-list
111029821|NCT04907474|Oxymetazoline|oxymetazoline|mesh-list
111029822|NCT04907474|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111029823|NCT04907474|Tropicamide|tropicamide|mesh-list
111029824|NCT04907474|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111029825|NCT04907474|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111029826|NCT04907474|Mydriatics|mydriatics|mesh-ancestor
111029827|NCT04907474|Autonomic Agents|autonomic agents|mesh-ancestor
111029828|NCT04907474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111029829|NCT04907474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111029830|NCT04907474|Sympathomimetics|sympathomimetics|mesh-ancestor
111029831|NCT04907474|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111029832|NCT04907474|Nasal Decongestants|nasal decongestants|mesh-ancestor
111029833|NCT04907474|Respiratory System Agents|respiratory system agents|mesh-ancestor
111029834|NCT04907474|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111029835|NCT04907474|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111029836|NCT04907474|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111029837|NCT04907474|Adrenergic Agents|adrenergic agents|mesh-ancestor
111029838|NCT04907474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111029839|NCT04907474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111029840|NCT04907474|Protective Agents|protective agents|mesh-ancestor
111029841|NCT04907474|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111029842|NCT04907474|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111029843|NCT04907474|Cholinergic Agents|cholinergic agents|mesh-ancestor
111029844|NCT04898738|Hand Sanitizers|hand sanitizers|mesh-list
111029845|NCT04898738|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111029846|NCT04898738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111029847|NCT04898738|Disinfectants|disinfectants|mesh-ancestor
111029848|NCT04890392|Oxaliplatin|oxaliplatin|mesh-list
111029849|NCT04890392|Tislelizumab|tislelizumab|mesh-list
111029850|NCT04890392|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
111029851|NCT04890392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111029852|NCT04890392|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111029853|NCT04890392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111029854|NCT04900532|Tocotrienols|tocotrienols|mesh-list
111029855|NCT04900532|Vitamin E|vitamin e|mesh-list
111029856|NCT04900532|Tocopherols|tocopherols|mesh-list
111029857|NCT04900532|Antioxidants|antioxidants|mesh-ancestor
111029858|NCT04900532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111029859|NCT04900532|Protective Agents|protective agents|mesh-ancestor
111029860|NCT04900532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111029861|NCT04900532|Vitamins|vitamins|mesh-ancestor
111029862|NCT04900532|Micronutrients|micronutrients|mesh-ancestor
111029863|NCT02616614|Clindamycin|clindamycin|mesh-list
111029864|NCT02616614|Clindamycin palmitate|clindamycin palmitate|mesh-list
111029865|NCT02616614|Clindamycin phosphate|clindamycin phosphate|mesh-list
111029866|NCT02616614|Benzoyl Peroxide|benzoyl peroxide|mesh-list
111029867|NCT02616614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111029868|NCT02616614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111029869|NCT02616614|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111029870|NCT02616614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111029871|NCT02616614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111029872|NCT02616614|Dermatologic Agents|dermatologic agents|mesh-ancestor
111029873|NCT04906772|Dexmedetomidine|dexmedetomidine|mesh-list
111029874|NCT04906772|Ketamine|ketamine|mesh-list
111029875|NCT04906772|Propofol|propofol|mesh-list
111029876|NCT04906772|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111029877|NCT04906772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111029878|NCT04906772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111029879|NCT04906772|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111029880|NCT04906772|Analgesics|analgesics|mesh-ancestor
111029881|NCT04906772|Sensory System Agents|sensory system agents|mesh-ancestor
111029882|NCT04906772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111029883|NCT04906772|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111029884|NCT04906772|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111029885|NCT04906772|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111029886|NCT04906772|Adrenergic Agents|adrenergic agents|mesh-ancestor
111029887|NCT04906772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111029888|NCT04906772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111029889|NCT04906772|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111029890|NCT04906772|Anesthetics, General|anesthetics, general|mesh-ancestor
111029891|NCT04906772|Anesthetics|anesthetics|mesh-ancestor
111029892|NCT04906772|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111029893|NCT04906772|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111029894|NCT04906772|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111029895|NCT04404140|Docetaxel|docetaxel|mesh-list
111029896|NCT04404140|Atezolizumab|atezolizumab|mesh-list
111029897|NCT04404140|Ipatasertib|ipatasertib|mesh-list
111029898|NCT04404140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111029899|NCT04404140|Tubulin Modulators|tubulin modulators|mesh-ancestor
111029900|NCT04404140|Antimitotic Agents|antimitotic agents|mesh-ancestor
111029901|NCT04404140|Mitosis Modulators|mitosis modulators|mesh-ancestor
111029902|NCT04404140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111029903|NCT04404140|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111029904|NCT04404140|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111029905|NCT04404140|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111029906|NCT04404140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111029907|NCT04889768|Antibodies|antibodies|mesh-list
111029908|NCT04889768|Immunologic Factors|immunologic factors|mesh-ancestor
111029909|NCT04889768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111029910|NCT04898270|Antipsychotic Agents|antipsychotic agents|mesh-list
111029912|NCT04898270|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
111029913|NCT04898270|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111029914|NCT04898270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111029915|NCT04898270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111029916|NCT04898270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111029917|NCT04898270|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111029918|NCT04898270|Dopamine Agents|dopamine agents|mesh-ancestor
111029919|NCT04898270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111029920|NCT04898270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111029921|NCT04906304|Mycophenolic Acid|mycophenolic acid|mesh-list
111029922|NCT04906304|Cyclosporine|cyclosporine|mesh-list
111029923|NCT04906304|Everolimus|everolimus|mesh-list
111029924|NCT04906304|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111029925|NCT04906304|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111029926|NCT04906304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111029927|NCT04906304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111029928|NCT04906304|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111029929|NCT04906304|Immunologic Factors|immunologic factors|mesh-ancestor
110625847|NCT03521830|Nivolumab|nivolumab|mesh-list
111029930|NCT04906304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111029931|NCT04906304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111029932|NCT04906304|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111029933|NCT04906304|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111029934|NCT04906304|Antitubercular Agents|antitubercular agents|mesh-ancestor
111029935|NCT04906304|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111029936|NCT04906304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111029937|NCT04906304|Antifungal Agents|antifungal agents|mesh-ancestor
111029938|NCT04906304|Dermatologic Agents|dermatologic agents|mesh-ancestor
111029939|NCT04906304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111029940|NCT04906304|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111029941|NCT03051698|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111029942|NCT03051698|Metronidazole|metronidazole|mesh-list
111029943|NCT03051698|Vancomycin|vancomycin|mesh-list
111029944|NCT03051698|Ciprofloxacin|ciprofloxacin|mesh-list
111029945|NCT03051698|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
111029946|NCT03051698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111029947|NCT03051698|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111029948|NCT03051698|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111029949|NCT03051698|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111029950|NCT03051698|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111029951|NCT03051698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111029952|NCT03051698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111029953|NCT03051698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111029954|NCT03051698|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111029955|NCT03051698|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111029956|NCT03051698|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
111029957|NCT03051698|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111029958|NCT03051698|Immunologic Factors|immunologic factors|mesh-ancestor
111029959|NCT03051698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111029960|NCT04896164|Curcumin|curcumin|mesh-list
111029961|NCT04896164|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111029962|NCT04896164|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111029963|NCT04896164|Analgesics|analgesics|mesh-ancestor
111029964|NCT04896164|Sensory System Agents|sensory system agents|mesh-ancestor
111029965|NCT04896164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111029966|NCT04896164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111029967|NCT04896164|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111029968|NCT04896164|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111029969|NCT04896164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111029970|NCT04896164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111029971|NCT04896164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111029972|NCT04887818|Lidocaine|lidocaine|mesh-list
111029973|NCT04887818|Diltiazem|diltiazem|mesh-list
111029974|NCT04887818|Nifedipine|nifedipine|mesh-list
111029975|NCT04887818|Anesthetics, Local|anesthetics, local|mesh-ancestor
111029976|NCT04887818|Anesthetics|anesthetics|mesh-ancestor
111029977|NCT04887818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111029978|NCT04887818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111029979|NCT04887818|Sensory System Agents|sensory system agents|mesh-ancestor
111029980|NCT04887818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111029981|NCT04887818|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111029982|NCT04887818|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111029983|NCT04887818|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111029984|NCT04887818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111029985|NCT04887818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111029986|NCT04887818|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111029987|NCT04887818|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111029988|NCT04887818|Vasodilator Agents|vasodilator agents|mesh-ancestor
111029989|NCT04887818|Tocolytic Agents|tocolytic agents|mesh-ancestor
110625854|NCT03496610|Bupivacaine|bupivacaine|mesh-list
111029990|NCT04887818|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111029991|NCT04887818|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111029992|NCT04883996|Pilocarpine|pilocarpine|mesh-list
111029994|NCT04883996|Autonomic Agents|autonomic agents|mesh-ancestor
111029995|NCT04883996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111029996|NCT04883996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111029997|NCT04883996|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
111029998|NCT04883996|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111029999|NCT04883996|Cholinergic Agents|cholinergic agents|mesh-ancestor
111030000|NCT04883996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111030001|NCT04883996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111030002|NCT04884464|Chlorhexidine|chlorhexidine|mesh-list
111030003|NCT04884464|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
111030004|NCT04884464|Hyaluronic Acid|hyaluronic acid|mesh-list
111030005|NCT04884464|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111030006|NCT04884464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111030007|NCT04884464|Disinfectants|disinfectants|mesh-ancestor
111030008|NCT04884464|Dermatologic Agents|dermatologic agents|mesh-ancestor
111030009|NCT04884464|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111030010|NCT04884464|Immunologic Factors|immunologic factors|mesh-ancestor
111030011|NCT04884464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111030012|NCT04884464|Viscosupplements|viscosupplements|mesh-ancestor
111030013|NCT04884464|Protective Agents|protective agents|mesh-ancestor
111030014|NCT05028608|Carbamazepine|carbamazepine|mesh-list
111030015|NCT05028608|Midazolam|midazolam|mesh-list
111030016|NCT05028608|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111030017|NCT05028608|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111030018|NCT05028608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111030019|NCT05028608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111030020|NCT05028608|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111030021|NCT05028608|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111030022|NCT05028608|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111030023|NCT05028608|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111030024|NCT05028608|Anesthetics, General|anesthetics, general|mesh-ancestor
111030025|NCT05028608|Anesthetics|anesthetics|mesh-ancestor
111030026|NCT05028608|GABA Modulators|gaba modulators|mesh-ancestor
111030027|NCT05028608|GABA Agents|gaba agents|mesh-ancestor
111030028|NCT05028608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111030029|NCT05028608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111030030|NCT05028608|Anticonvulsants|anticonvulsants|mesh-ancestor
111030031|NCT05028608|Antimanic Agents|antimanic agents|mesh-ancestor
111030032|NCT05028608|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111030033|NCT05028608|Analgesics|analgesics|mesh-ancestor
111030034|NCT05028608|Sensory System Agents|sensory system agents|mesh-ancestor
111030035|NCT05028608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111030036|NCT05028608|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111030037|NCT05028608|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111030038|NCT05028608|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111030039|NCT05028608|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111030040|NCT04882826|Sildenafil Citrate|sildenafil citrate|mesh-list
111030041|NCT04882826|Vasodilator Agents|vasodilator agents|mesh-ancestor
111030042|NCT04882826|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111030043|NCT04882826|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111030044|NCT04882826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111030045|NCT04882826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111030046|NCT04882826|Urological Agents|urological agents|mesh-ancestor
111030047|NCT04309916|Esomeprazole|esomeprazole|mesh-list
111030048|NCT04309916|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111030049|NCT04309916|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111030050|NCT04309916|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111030051|NCT04309916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111030052|NCT04309916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111030053|NCT01596062|Cyclosporine|cyclosporine|mesh-list
111030054|NCT01596062|Mycophenolic Acid|mycophenolic acid|mesh-list
111030056|NCT01596062|Cyclosporins|cyclosporins|mesh-list
111030057|NCT01596062|Basiliximab|basiliximab|mesh-list
111030058|NCT01596062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111030059|NCT01596062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110625871|NCT03448783|Apixaban|apixaban|mesh-list
111030060|NCT01596062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111030061|NCT01596062|Immunologic Factors|immunologic factors|mesh-ancestor
111030062|NCT01596062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111030063|NCT01596062|Antifungal Agents|antifungal agents|mesh-ancestor
111030064|NCT01596062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111030065|NCT01596062|Dermatologic Agents|dermatologic agents|mesh-ancestor
111030066|NCT01596062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111030067|NCT01596062|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111030068|NCT01596062|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111030069|NCT01596062|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111030070|NCT01596062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111030071|NCT01596062|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111030072|NCT01596062|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111030073|NCT01596062|Antitubercular Agents|antitubercular agents|mesh-ancestor
111030074|NCT01596062|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111030075|NCT02614898|Eculizumab|eculizumab|mesh-list
111030076|NCT02614898|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
111030077|NCT02614898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111030078|NCT02614898|Immunologic Factors|immunologic factors|mesh-ancestor
111030079|NCT02614898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111030080|NCT02145091|Psilocybin|psilocybin|mesh-list
111030081|NCT02145091|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
111030082|NCT02145091|Hallucinogens|hallucinogens|mesh-ancestor
111030083|NCT02145091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111030084|NCT02145091|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111030085|NCT02145091|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111030086|NCT02145091|Serotonin Agents|serotonin agents|mesh-ancestor
111030087|NCT02145091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111030088|NCT02145091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111030089|NCT02145091|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111030090|NCT03352934|Avelumab|avelumab|mesh-list
111030091|NCT03352934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111030092|NCT03352934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111030093|NCT04871828|Leukotriene Antagonists|leukotriene antagonists|mesh-list
111030094|NCT04871828|Hormone Antagonists|hormone antagonists|mesh-ancestor
111030095|NCT04871828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111030096|NCT04871828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111030097|NCT04871828|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111030098|NCT04871828|Respiratory System Agents|respiratory system agents|mesh-ancestor
111030099|NCT04881110|Liraglutide|liraglutide|mesh-list
111030100|NCT04881110|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111030101|NCT04881110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111030102|NCT04881110|Incretins|incretins|mesh-ancestor
111030103|NCT04881110|Hormones|hormones|mesh-ancestor
111030104|NCT04881110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111030105|NCT02152423|Enoxaparin|enoxaparin|mesh-list
111030106|NCT02152423|Anticoagulants|anticoagulants|mesh-ancestor
111030107|NCT02152423|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111030108|NCT02152423|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110827233|NCT01270789|Incretins|incretins|mesh-ancestor
111030109|NCT02152423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111030111|NCT02145559|Sirolimus|sirolimus|mesh-list
111030112|NCT02145559|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111030113|NCT02145559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111030114|NCT02145559|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111030115|NCT02145559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111030116|NCT02145559|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111030117|NCT02145559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111030118|NCT02145559|Antifungal Agents|antifungal agents|mesh-ancestor
111030119|NCT02145559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111030120|NCT02145559|Immunologic Factors|immunologic factors|mesh-ancestor
111030121|NCT02145637|Afatinib|afatinib|mesh-list
111030122|NCT02145637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111030123|NCT02145637|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111030124|NCT02145637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111030125|NCT02145637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111030126|NCT03154580|Acetylcysteine|acetylcysteine|mesh-list
111030127|NCT03154580|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111030128|NCT03154580|Antiviral Agents|antiviral agents|mesh-ancestor
111030129|NCT03154580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111030130|NCT03154580|Expectorants|expectorants|mesh-ancestor
111030131|NCT03154580|Respiratory System Agents|respiratory system agents|mesh-ancestor
111030132|NCT03154580|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111030133|NCT03154580|Antioxidants|antioxidants|mesh-ancestor
111030134|NCT03154580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111030135|NCT03154580|Protective Agents|protective agents|mesh-ancestor
111030136|NCT03154580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111030138|NCT02145715|Thalidomide|thalidomide|mesh-list
111030139|NCT02145715|Dexamethasone|dexamethasone|mesh-list
111030140|NCT02145715|Bortezomib|bortezomib|mesh-list
111030141|NCT02145715|Panobinostat|panobinostat|mesh-list
111030142|NCT02145715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111030143|NCT02145715|Antiemetics|antiemetics|mesh-ancestor
111030144|NCT02145715|Autonomic Agents|autonomic agents|mesh-ancestor
111030145|NCT02145715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111030146|NCT02145715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111030147|NCT02145715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111030148|NCT02145715|Glucocorticoids|glucocorticoids|mesh-ancestor
111030149|NCT02145715|Hormones|hormones|mesh-ancestor
111030150|NCT02145715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111030151|NCT02145715|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111030152|NCT02145715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111030153|NCT02145715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111030154|NCT02145715|Immunologic Factors|immunologic factors|mesh-ancestor
111030155|NCT02145715|Leprostatic Agents|leprostatic agents|mesh-ancestor
111030156|NCT02145715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111030157|NCT02145715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111030158|NCT02145715|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111030159|NCT02145715|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111030160|NCT02145715|Growth Substances|growth substances|mesh-ancestor
111030161|NCT02145715|Growth Inhibitors|growth inhibitors|mesh-ancestor
111030162|NCT02145715|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111030163|NCT02145715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111030164|NCT02145715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111030165|NCT04871750|Caseins|caseins|mesh-list
111030166|NCT04871750|Chelating Agents|chelating agents|mesh-ancestor
111030167|NCT04871750|Sequestering Agents|sequestering agents|mesh-ancestor
111030168|NCT04871750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111030169|NCT02152579|Isosorbide|isosorbide|mesh-list
111030170|NCT02152579|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
111030171|NCT02152579|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
111030172|NCT02152579|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
111030173|NCT02152579|Diuretics|diuretics|mesh-ancestor
111030174|NCT02152579|Natriuretic Agents|natriuretic agents|mesh-ancestor
111030175|NCT02152579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111030176|NCT02152579|Vasodilator Agents|vasodilator agents|mesh-ancestor
111030177|NCT02152579|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
111030178|NCT02152579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111030179|NCT02155777|Norinyl|norinyl|mesh-list
111030180|NCT02155777|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
111030181|NCT02155777|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111030182|NCT02155777|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111030183|NCT02155777|Contraceptive Agents|contraceptive agents|mesh-ancestor
111030184|NCT02155777|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111030185|NCT02155777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111030186|NCT02155777|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111030187|NCT02155777|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111030188|NCT02145949|Tryptophan|tryptophan|mesh-list
111030189|NCT02145949|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111030190|NCT02145949|Antidepressive Agents|antidepressive agents|mesh-ancestor
111030191|NCT02145949|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111030192|NCT00806390|Metoprolol|metoprolol|mesh-list
111030193|NCT00806390|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111030194|NCT00806390|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111030195|NCT00806390|Sympatholytics|sympatholytics|mesh-ancestor
111030196|NCT00806390|Autonomic Agents|autonomic agents|mesh-ancestor
111030197|NCT00806390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111030198|NCT00806390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111030199|NCT00806390|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
111030200|NCT00806390|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111030201|NCT00806390|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111030202|NCT00806390|Adrenergic Agents|adrenergic agents|mesh-ancestor
111030203|NCT00806390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111030204|NCT00806390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111030205|NCT00566618|Zoledronic Acid|zoledronic acid|mesh-list
111030206|NCT00566618|Dasatinib|dasatinib|mesh-list
111030207|NCT00566618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111030208|NCT00566618|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111030209|NCT00566618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111030210|NCT00566618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111030211|NCT00566618|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111030212|NCT00566618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111030213|NCT02769481|Glimepiride|glimepiride|mesh-list
111030214|NCT02769481|Bexagliflozin|bexagliflozin|mesh-list
111030215|NCT02769481|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111030216|NCT02769481|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111030217|NCT02769481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111030218|NCT02769481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111030219|NCT02769481|Immunologic Factors|immunologic factors|mesh-ancestor
111030220|NCT04877210|Insulin|insulin|mesh-list
111030221|NCT04877210|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111030222|NCT04877210|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111030223|NCT04877210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111030224|NCT02152969|Amlodipine|amlodipine|mesh-list
111030225|NCT02152969|Telmisartan|telmisartan|mesh-list
111030226|NCT02152969|Chlorthalidone|chlorthalidone|mesh-list
111030227|NCT02152969|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111030228|NCT02152969|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111030229|NCT02152969|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111030230|NCT02152969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111030231|NCT02152969|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111030232|NCT02152969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111030233|NCT02152969|Vasodilator Agents|vasodilator agents|mesh-ancestor
111030234|NCT02152969|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111030235|NCT02152969|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111030236|NCT02152969|Diuretics|diuretics|mesh-ancestor
111030237|NCT02152969|Natriuretic Agents|natriuretic agents|mesh-ancestor
111030238|NCT02152969|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
111030239|NCT04879004|Ropivacaine|ropivacaine|mesh-list
111030240|NCT04879004|Anesthetics, Local|anesthetics, local|mesh-ancestor
111030241|NCT04879004|Anesthetics|anesthetics|mesh-ancestor
111030242|NCT04879004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111030243|NCT04879004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111030244|NCT04879004|Sensory System Agents|sensory system agents|mesh-ancestor
111030245|NCT04879004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111030246|NCT02153125|Eplerenone|eplerenone|mesh-list
111030247|NCT02153125|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
111030248|NCT02153125|Hormone Antagonists|hormone antagonists|mesh-ancestor
111030249|NCT02153125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111030250|NCT02153125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111030251|NCT02153125|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
111030252|NCT02153125|Diuretics|diuretics|mesh-ancestor
111030253|NCT02153125|Natriuretic Agents|natriuretic agents|mesh-ancestor
111030254|NCT02153125|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111030255|NCT04878926|Midazolam|midazolam|mesh-list
111030256|NCT04878926|Propofol|propofol|mesh-list
111030257|NCT04878926|Anesthetics|anesthetics|mesh-list
111030258|NCT04878926|Anesthetics, Local|anesthetics, local|mesh-list
111030259|NCT04878926|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111030260|NCT04878926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111030261|NCT04878926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111030262|NCT04878926|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111030263|NCT04878926|Anesthetics, General|anesthetics, general|mesh-ancestor
111030264|NCT04878926|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111030265|NCT04878926|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111030266|NCT04878926|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111030267|NCT04878926|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111030268|NCT04878926|GABA Modulators|gaba modulators|mesh-ancestor
111030269|NCT04878926|GABA Agents|gaba agents|mesh-ancestor
111030270|NCT04878926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111030271|NCT04878926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111030272|NCT04878926|Sensory System Agents|sensory system agents|mesh-ancestor
111030273|NCT04878926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111030274|NCT04862767|Aldesleukin|aldesleukin|mesh-list
111030275|NCT04862767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111030276|NCT04862767|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111030277|NCT04862767|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111030278|NCT04862767|Antiviral Agents|antiviral agents|mesh-ancestor
111030279|NCT04862767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111030280|NCT02146261|Quetmolimab|quetmolimab|mesh-list
111030281|NCT02146261|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111030282|NCT02153281|Phenelzine|phenelzine|mesh-list
111030283|NCT02153281|Antidepressive Agents|antidepressive agents|mesh-ancestor
111030284|NCT02153281|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111030285|NCT02153281|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
111030286|NCT02153281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111030287|NCT02153281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111030288|NCT03542851|Pentylenetetrazole|pentylenetetrazole|mesh-list
111030289|NCT03542851|Convulsants|convulsants|mesh-ancestor
111030290|NCT03542851|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111030291|NCT03542851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111030292|NCT03542851|GABA Antagonists|gaba antagonists|mesh-ancestor
111030293|NCT03542851|GABA Agents|gaba agents|mesh-ancestor
111030294|NCT03542851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111030295|NCT03542851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111030296|NCT02769247|Naproxen|naproxen|mesh-list
111030297|NCT02769247|Lidocaine|lidocaine|mesh-list
111030298|NCT02769247|Anesthetics, Local|anesthetics, local|mesh-ancestor
111030299|NCT02769247|Anesthetics|anesthetics|mesh-ancestor
111030300|NCT02769247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111030301|NCT02769247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111030302|NCT02769247|Sensory System Agents|sensory system agents|mesh-ancestor
111030303|NCT02769247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111030304|NCT02769247|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111030305|NCT02769247|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111030306|NCT02769247|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111030307|NCT02769247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111030308|NCT02769247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111030309|NCT02769247|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111030310|NCT02769247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111030311|NCT02769247|Analgesics|analgesics|mesh-ancestor
111030312|NCT02769247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111030313|NCT02769247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111030314|NCT02769247|Gout Suppressants|gout suppressants|mesh-ancestor
111030315|NCT02769247|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111030316|NCT02769247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111030317|NCT02153437|Sotalol|sotalol|mesh-list
111030318|NCT02153437|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111030319|NCT02153437|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111030320|NCT02153437|Adrenergic Agents|adrenergic agents|mesh-ancestor
111030321|NCT02153437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111030322|NCT02153437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111030323|NCT02153437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111030324|NCT02153437|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111030325|NCT02153437|Sympatholytics|sympatholytics|mesh-ancestor
111030326|NCT02153437|Autonomic Agents|autonomic agents|mesh-ancestor
111030327|NCT02153437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111030328|NCT02146651|Insulin|insulin|mesh-list
111030329|NCT02146651|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111030330|NCT02146651|Insulin Lispro|insulin lispro|mesh-list
111030331|NCT02146651|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111030332|NCT02146651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111030333|NCT03542149|Tocopherols|tocopherols|mesh-list
111030334|NCT03542149|Vitamin E|vitamin e|mesh-list
111030335|NCT03542149|Tocotrienols|tocotrienols|mesh-list
111030336|NCT03542149|alpha-Tocopherol|alpha-tocopherol|mesh-list
111030337|NCT03542149|Piperaquine|piperaquine|mesh-list
111030338|NCT03542149|Antimalarials|antimalarials|mesh-ancestor
111030339|NCT03542149|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111030340|NCT03542149|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111030341|NCT03542149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111030342|NCT03542149|Antioxidants|antioxidants|mesh-ancestor
111030343|NCT03542149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111030344|NCT03542149|Protective Agents|protective agents|mesh-ancestor
111030345|NCT03542149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111030346|NCT03542149|Vitamins|vitamins|mesh-ancestor
111030347|NCT03542149|Micronutrients|micronutrients|mesh-ancestor
111030348|NCT02153593|Tranexamic Acid|tranexamic acid|mesh-list
111030349|NCT02153593|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
111030350|NCT02153593|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111030351|NCT02153593|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111030352|NCT02153593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111030353|NCT02153593|Hemostatics|hemostatics|mesh-ancestor
111030354|NCT02153593|Coagulants|coagulants|mesh-ancestor
111030355|NCT02154217|Timolol|timolol|mesh-list
111030356|NCT02154217|Bimatoprost|bimatoprost|mesh-list
111030357|NCT02154217|Latanoprost|latanoprost|mesh-list
111030358|NCT02154217|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111030359|NCT02154217|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111030360|NCT02154217|Adrenergic Agents|adrenergic agents|mesh-ancestor
111030361|NCT02154217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111030362|NCT02154217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110747440|NCT05216614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111030363|NCT02154217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111030364|NCT02154217|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111030365|NCT02154217|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111030366|NCT02154217|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
111030367|NCT02154217|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111030368|NCT02147041|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
111030369|NCT02147041|Antioxidants|antioxidants|mesh-ancestor
111030370|NCT02147041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111030371|NCT02147041|Protective Agents|protective agents|mesh-ancestor
111030372|NCT02147041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111030373|NCT02147041|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
111030374|NCT02147041|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
111030375|NCT02147041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111030376|NCT02147041|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111030377|NCT02767765|Epoetin Alfa|epoetin alfa|mesh-list
111030378|NCT02767765|Hematinics|hematinics|mesh-ancestor
111030379|NCT00103207|Cetuximab|cetuximab|mesh-list
111030380|NCT00103207|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111030381|NCT00103207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111030382|NCT02254915|BCG Vaccine|bcg vaccine|mesh-list
111030383|NCT02254915|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111030384|NCT02254915|Immunologic Factors|immunologic factors|mesh-ancestor
111030385|NCT02254915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111030386|NCT02157181|Rituximab|rituximab|mesh-list
111030387|NCT02157181|Cladribine|cladribine|mesh-list
111030388|NCT02157181|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111030389|NCT02157181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111030390|NCT02157181|Immunologic Factors|immunologic factors|mesh-ancestor
111030391|NCT02157181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111030392|NCT02157181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111030393|NCT02157181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111030394|NCT02159287|Heparin|heparin|mesh-list
111030395|NCT02159287|Calcium heparin|calcium heparin|mesh-list
111030396|NCT02159287|Enoxaparin|enoxaparin|mesh-list
111030397|NCT02159287|Enoxaparin sodium|enoxaparin sodium|mesh-list
111030398|NCT02159287|Anticoagulants|anticoagulants|mesh-ancestor
111030399|NCT02159287|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111030400|NCT02159287|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111030401|NCT02159287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111030402|NCT05005273|Nivolumab|nivolumab|mesh-list
111030403|NCT05005273|Ipilimumab|ipilimumab|mesh-list
111030404|NCT05005273|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111030405|NCT05005273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111030406|NCT05005273|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111030407|NCT05005273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111030408|NCT02157337|Atorvastatin|atorvastatin|mesh-list
111030409|NCT02157337|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111030411|NCT02157337|Antimetabolites|antimetabolites|mesh-ancestor
111030412|NCT02157337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111030413|NCT02157337|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111030414|NCT02157337|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111030415|NCT02157337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111030416|NCT02159599|Ritonavir|ritonavir|mesh-list
111030417|NCT02159599|Darunavir|darunavir|mesh-list
111030418|NCT02159599|Tenofovir|tenofovir|mesh-list
111030419|NCT02159599|Lamivudine|lamivudine|mesh-list
111030420|NCT02159599|Emtricitabine|emtricitabine|mesh-list
111030421|NCT02159599|Abacavir|abacavir|mesh-list
111030422|NCT02159599|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111030423|NCT02159599|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111030424|NCT02159599|Protease Inhibitors|protease inhibitors|mesh-ancestor
111030425|NCT02159599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111030426|NCT02159599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111030427|NCT02159599|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111030428|NCT02159599|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111030429|NCT02159599|Antiviral Agents|antiviral agents|mesh-ancestor
111030430|NCT02159599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111030431|NCT02159599|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111030432|NCT02159599|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111030433|NCT02159599|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111030434|NCT02159599|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111030435|NCT03541681|Anesthetics|anesthetics|mesh-list
111030436|NCT03541681|Glucocorticoids|glucocorticoids|mesh-list
111030437|NCT03541681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111030438|NCT03541681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111030439|NCT03541681|Hormones|hormones|mesh-ancestor
111030440|NCT03541681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111030441|NCT02157415|Polihexanide|polihexanide|mesh-list
111030442|NCT02157415|Disinfectants|disinfectants|mesh-ancestor
111030443|NCT02157415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111030444|NCT02157571|Levofloxacin|levofloxacin|mesh-list
111030445|NCT02157571|Ofloxacin|ofloxacin|mesh-list
111030446|NCT02157571|Prulifloxacin|prulifloxacin|mesh-list
111030447|NCT02157571|Fluoroquinolones|fluoroquinolones|mesh-list
111030448|NCT02157571|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111030449|NCT02157571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111030450|NCT02157571|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111030451|NCT02157571|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111030452|NCT02157571|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111030453|NCT02157571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111030454|NCT02157571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111030455|NCT02157571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111030456|NCT02157571|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111030457|NCT02157571|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111030458|NCT02157571|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111030459|NCT01369355|Ustekinumab|ustekinumab|mesh-list
111030460|NCT01369355|Dermatologic Agents|dermatologic agents|mesh-ancestor
111030461|NCT03541993|Resveratrol|resveratrol|mesh-list
111030462|NCT03541993|Antioxidants|antioxidants|mesh-ancestor
111030463|NCT03541993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111030464|NCT03541993|Protective Agents|protective agents|mesh-ancestor
111030465|NCT03541993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111030466|NCT03541993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111030467|NCT03541993|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111030468|NCT02157649|Phenylpropanolamine|phenylpropanolamine|mesh-list
111030469|NCT02157649|Codeine|codeine|mesh-list
111030470|NCT02157649|Guaifenesin|guaifenesin|mesh-list
111030471|NCT02157649|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
111030472|NCT02157649|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111030473|NCT02157649|Narcotics|narcotics|mesh-ancestor
111030474|NCT02157649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111030475|NCT02157649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111030476|NCT02157649|Analgesics|analgesics|mesh-ancestor
111030477|NCT02157649|Sensory System Agents|sensory system agents|mesh-ancestor
111030478|NCT02157649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111030479|NCT02157649|Antitussive Agents|antitussive agents|mesh-ancestor
111030480|NCT02157649|Respiratory System Agents|respiratory system agents|mesh-ancestor
111030481|NCT02157649|Expectorants|expectorants|mesh-ancestor
111030482|NCT02157649|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111030483|NCT02157649|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111030484|NCT02157649|Adrenergic Agents|adrenergic agents|mesh-ancestor
111030485|NCT02157649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111030486|NCT02157649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111030487|NCT02157649|Appetite Depressants|appetite depressants|mesh-ancestor
111030488|NCT02157649|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111030489|NCT02157649|Sympathomimetics|sympathomimetics|mesh-ancestor
111030490|NCT02157649|Autonomic Agents|autonomic agents|mesh-ancestor
111030491|NCT02157649|Nasal Decongestants|nasal decongestants|mesh-ancestor
111030492|NCT02157649|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111030493|NCT02159911|Misoprostol|misoprostol|mesh-list
111030494|NCT02159911|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111030495|NCT02159911|Abortifacient Agents|abortifacient agents|mesh-ancestor
111030496|NCT02159911|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111030497|NCT02159911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111030498|NCT02159911|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111030499|NCT02159911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111030500|NCT02159911|Oxytocics|oxytocics|mesh-ancestor
111030501|NCT03542617|Dexamethasone|dexamethasone|mesh-list
111030502|NCT03542617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111030503|NCT03542617|Antiemetics|antiemetics|mesh-ancestor
111030504|NCT03542617|Autonomic Agents|autonomic agents|mesh-ancestor
111030505|NCT03542617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111030506|NCT03542617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111030507|NCT03542617|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111030508|NCT03542617|Glucocorticoids|glucocorticoids|mesh-ancestor
111030509|NCT03542617|Hormones|hormones|mesh-ancestor
111030510|NCT03542617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111030511|NCT03542617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111030512|NCT03542617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111030513|NCT04878770|Cyclosporine|cyclosporine|mesh-list
111030514|NCT04878770|Cyclosporins|cyclosporins|mesh-list
111030515|NCT04878770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111030516|NCT04878770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111030517|NCT04878770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111030518|NCT04878770|Immunologic Factors|immunologic factors|mesh-ancestor
111030519|NCT04878770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111030520|NCT04878770|Antifungal Agents|antifungal agents|mesh-ancestor
111030521|NCT04878770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111030522|NCT04878770|Dermatologic Agents|dermatologic agents|mesh-ancestor
111030523|NCT04878770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111030524|NCT04878770|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111030526|NCT02086019|Bisoprolol|bisoprolol|mesh-list
111030527|NCT02086019|Heparin|heparin|mesh-list
111030528|NCT02086019|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
111030529|NCT02086019|Tinzaparin|tinzaparin|mesh-list
111030530|NCT02086019|Dalteparin|dalteparin|mesh-list
111030531|NCT02086019|Clopidogrel|clopidogrel|mesh-list
111030532|NCT02086019|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
111030533|NCT02086019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111030534|NCT02086019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111030535|NCT02086019|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111030536|NCT02086019|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111030537|NCT02086019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111030538|NCT02086019|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111030539|NCT02086019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111030540|NCT02086019|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111030541|NCT02086019|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111030542|NCT02086019|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111030543|NCT02086019|Purinergic Agents|purinergic agents|mesh-ancestor
111030544|NCT02086019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111030545|NCT02086019|Anticoagulants|anticoagulants|mesh-ancestor
111030546|NCT02086019|Protease Inhibitors|protease inhibitors|mesh-ancestor
111030547|NCT02086019|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111030548|NCT02086019|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111030549|NCT02086019|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111030550|NCT02086019|Adrenergic Agents|adrenergic agents|mesh-ancestor
111030551|NCT02086019|Sympatholytics|sympatholytics|mesh-ancestor
111030552|NCT02086019|Autonomic Agents|autonomic agents|mesh-ancestor
111030553|NCT02086019|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
111030554|NCT02086097|Ibuprofen|ibuprofen|mesh-list
111030555|NCT02086097|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
111030556|NCT02086097|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111030557|NCT02086097|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111030558|NCT02086097|Analgesics|analgesics|mesh-ancestor
111030559|NCT02086097|Sensory System Agents|sensory system agents|mesh-ancestor
111030560|NCT02086097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111030561|NCT02086097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111030562|NCT02086097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111030563|NCT02086097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111030564|NCT02086097|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111030565|NCT02086097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111030566|NCT02086097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111030567|NCT02307682|Aflibercept|aflibercept|mesh-list
111030568|NCT02307682|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111030569|NCT02307682|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111030570|NCT02307682|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111030571|NCT02307682|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111030572|NCT02307682|Growth Substances|growth substances|mesh-ancestor
111030573|NCT02307682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111030574|NCT02307682|Growth Inhibitors|growth inhibitors|mesh-ancestor
111030575|NCT02307682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111030576|NCT02088515|Docetaxel|docetaxel|mesh-list
111030577|NCT02088515|Nedaplatin|nedaplatin|mesh-list
111030578|NCT02088515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111030579|NCT02088515|Tubulin Modulators|tubulin modulators|mesh-ancestor
111030580|NCT02088515|Antimitotic Agents|antimitotic agents|mesh-ancestor
111030581|NCT02088515|Mitosis Modulators|mitosis modulators|mesh-ancestor
111030582|NCT02088515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111030583|NCT02086253|BQ 788|bq 788|mesh-list
111030584|NCT02086253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111030585|NCT02086253|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
111030586|NCT02086253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111030587|NCT02086253|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
111030588|NCT04870502|Clomiphene|clomiphene|mesh-list
111030589|NCT04870502|Enclomiphene|enclomiphene|mesh-list
111030590|NCT04870502|Zuclomiphene|zuclomiphene|mesh-list
111030591|NCT04870502|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111030592|NCT04870502|Hormone Antagonists|hormone antagonists|mesh-ancestor
111030593|NCT04870502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111030594|NCT04870502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111030595|NCT04870502|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111030596|NCT04870502|Fertility Agents|fertility agents|mesh-ancestor
111030597|NCT04870502|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111030598|NCT04870502|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111030599|NCT04870502|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111030600|NCT02088671|Propofol|propofol|mesh-list
111030601|NCT02088671|Desflurane|desflurane|mesh-list
111030602|NCT02088671|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111030603|NCT02088671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111030604|NCT02088671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111030605|NCT02088671|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111030606|NCT02088671|Anesthetics, General|anesthetics, general|mesh-ancestor
111030607|NCT02088671|Anesthetics|anesthetics|mesh-ancestor
111030608|NCT02088671|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111030609|NCT04870190|Osimertinib|osimertinib|mesh-list
111030610|NCT04870190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111030611|NCT04870190|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111030612|NCT04870190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111030613|NCT04870190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111030614|NCT03049046|Caffeic acid|caffeic acid|mesh-list
111030615|NCT03049046|Antioxidants|antioxidants|mesh-ancestor
111030616|NCT03049046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111030617|NCT03049046|Protective Agents|protective agents|mesh-ancestor
111030618|NCT03049046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111030619|NCT04385966|Levobupivacaine|levobupivacaine|mesh-list
111030620|NCT04385966|Anesthetics, Local|anesthetics, local|mesh-ancestor
111030621|NCT04385966|Anesthetics|anesthetics|mesh-ancestor
111030622|NCT04385966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111030623|NCT04385966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111030624|NCT04385966|Sensory System Agents|sensory system agents|mesh-ancestor
111030625|NCT04385966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111030626|NCT03046082|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111030627|NCT03046082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111030628|NCT03048110|Itraconazole|itraconazole|mesh-list
111030629|NCT03048110|Rifampin|rifampin|mesh-list
111030630|NCT03048110|Antifungal Agents|antifungal agents|mesh-ancestor
111030631|NCT03048110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111030632|NCT03048110|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111030633|NCT03048110|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111030634|NCT03048110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111030635|NCT03048110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111030636|NCT03048110|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111030637|NCT03048110|Hormone Antagonists|hormone antagonists|mesh-ancestor
111030638|NCT03048110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111030639|NCT03048110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111030640|NCT03048110|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111030641|NCT03048110|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111030642|NCT03048110|Antitubercular Agents|antitubercular agents|mesh-ancestor
111030643|NCT03048110|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111030644|NCT03048110|Leprostatic Agents|leprostatic agents|mesh-ancestor
111030645|NCT03048110|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111030646|NCT03048110|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111030647|NCT03048110|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111030648|NCT03048110|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
111030649|NCT03048110|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
111030650|NCT03048110|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
111030651|NCT03048110|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111030652|NCT05256758|Fenofibrate|fenofibrate|mesh-list
111030653|NCT05256758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111030654|NCT05256758|Antimetabolites|antimetabolites|mesh-ancestor
111030655|NCT05256758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111030656|NCT05256758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111030658|NCT02791763|Glycine Agents|glycine agents|mesh-ancestor
111030659|NCT02791763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111030660|NCT02791763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111030661|NCT02791763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111030662|NCT02086409|Calcium, Dietary|calcium, dietary|mesh-list
111030663|NCT02086409|Vitamin D|vitamin d|mesh-list
111030664|NCT02086409|Ergocalciferols|ergocalciferols|mesh-list
111030665|NCT02086409|Cholecalciferol|cholecalciferol|mesh-list
111030666|NCT02086409|Vitamins|vitamins|mesh-list
111030667|NCT02086409|Calcium|calcium|mesh-list
111030668|NCT02086409|Micronutrients|micronutrients|mesh-ancestor
111030669|NCT02086409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111030670|NCT02086409|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111030671|NCT02086409|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111030672|NCT02613572|Thioctic Acid|thioctic acid|mesh-list
111030673|NCT02613572|Antioxidants|antioxidants|mesh-ancestor
111030674|NCT02613572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111030675|NCT02613572|Protective Agents|protective agents|mesh-ancestor
111030676|NCT02613572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111030677|NCT02613572|Vitamin B Complex|vitamin b complex|mesh-ancestor
111030678|NCT02613572|Vitamins|vitamins|mesh-ancestor
111030679|NCT02613572|Micronutrients|micronutrients|mesh-ancestor
111030680|NCT02088983|Choline|choline|mesh-list
111030681|NCT02088983|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
111030682|NCT02088983|Lipotropic Agents|lipotropic agents|mesh-ancestor
111030683|NCT02088983|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111030684|NCT02088983|Antimetabolites|antimetabolites|mesh-ancestor
111030685|NCT02088983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111030686|NCT02088983|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111030687|NCT02088983|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111030688|NCT02088983|Nootropic Agents|nootropic agents|mesh-ancestor
111030689|NCT02089061|Atorvastatin|atorvastatin|mesh-list
111030690|NCT02089061|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111030691|NCT02089061|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111030692|NCT02089061|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111030693|NCT02089061|Antimetabolites|antimetabolites|mesh-ancestor
111030694|NCT02089061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111030695|NCT02089061|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111030696|NCT02089061|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111030697|NCT02089061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111030698|NCT02082665|Dabrafenib|dabrafenib|mesh-list
111030699|NCT02082665|Midazolam|midazolam|mesh-list
111030700|NCT02082665|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111030701|NCT02082665|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111030702|NCT02082665|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111030703|NCT02082665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111030704|NCT02082665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111030705|NCT02082665|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111030706|NCT02082665|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111030707|NCT02082665|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111030709|NCT02082665|Anesthetics, General|anesthetics, general|mesh-ancestor
111030710|NCT02082665|Anesthetics|anesthetics|mesh-ancestor
111030711|NCT02082665|GABA Modulators|gaba modulators|mesh-ancestor
111030712|NCT02082665|GABA Agents|gaba agents|mesh-ancestor
111030713|NCT02082665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111030714|NCT02082665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111030715|NCT02082665|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111030716|NCT02082665|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111030717|NCT02082665|Antimetabolites|antimetabolites|mesh-ancestor
111030718|NCT02082665|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111030719|NCT02082665|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111030720|NCT02082665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111030721|NCT02082665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111030722|NCT02082665|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111030723|NCT03047954|Broncho-Vaxom|broncho-vaxom|mesh-list
111030724|NCT03047954|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111030725|NCT03047954|Immunologic Factors|immunologic factors|mesh-ancestor
111030726|NCT03047954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111030727|NCT03558971|Hydrocortisone|hydrocortisone|mesh-list
111030728|NCT03558971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111030729|NCT02341456|Paclitaxel|paclitaxel|mesh-list
111030730|NCT02341456|Carboplatin|carboplatin|mesh-list
111030731|NCT02341456|Adavosertib|adavosertib|mesh-list
111030732|NCT02341456|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111030733|NCT02341456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111030734|NCT02341456|Tubulin Modulators|tubulin modulators|mesh-ancestor
111030735|NCT02341456|Antimitotic Agents|antimitotic agents|mesh-ancestor
111030736|NCT02341456|Mitosis Modulators|mitosis modulators|mesh-ancestor
111030737|NCT02341456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111030738|NCT02341456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111030739|NCT02083055|Nitroglycerin|nitroglycerin|mesh-list
111030740|NCT02083055|Dexmedetomidine|dexmedetomidine|mesh-list
111030741|NCT02083055|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111030742|NCT02083055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111030743|NCT02083055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111030744|NCT02083055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111030745|NCT02083055|Analgesics|analgesics|mesh-ancestor
111030746|NCT02083055|Sensory System Agents|sensory system agents|mesh-ancestor
111030747|NCT02083055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111030748|NCT02083055|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111030749|NCT02083055|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111030750|NCT02083055|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111030751|NCT02083055|Adrenergic Agents|adrenergic agents|mesh-ancestor
111030752|NCT02083055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111030753|NCT02083055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111030754|NCT02083055|Vasodilator Agents|vasodilator agents|mesh-ancestor
111030755|NCT02089295|Oxycodone|oxycodone|mesh-list
111030756|NCT02089295|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111030757|NCT02089295|Narcotics|narcotics|mesh-ancestor
111030758|NCT02089295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111030759|NCT02089295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111030760|NCT02089295|Analgesics|analgesics|mesh-ancestor
111030761|NCT02089295|Sensory System Agents|sensory system agents|mesh-ancestor
111030762|NCT02089295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111030763|NCT02370784|Atorvastatin|atorvastatin|mesh-list
111030764|NCT02370784|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111030765|NCT02370784|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111030766|NCT02370784|Antimetabolites|antimetabolites|mesh-ancestor
111030767|NCT02370784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111030768|NCT02370784|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111030769|NCT02370784|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111030770|NCT02370784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111030771|NCT02083211|Nimotuzumab|nimotuzumab|mesh-list
111030772|NCT02083211|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111030773|NCT02083211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111030774|NCT01595438|Ciprofloxacin|ciprofloxacin|mesh-list
111030775|NCT01595438|Ceftazidime|ceftazidime|mesh-list
111030776|NCT01595438|Avibactam|avibactam|mesh-list
111030777|NCT01595438|Doripenem|doripenem|mesh-list
111030778|NCT01595438|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
111030779|NCT01595438|Trimethoprim|trimethoprim|mesh-list
111030780|NCT01595438|Sulfamethoxazole|sulfamethoxazole|mesh-list
111030781|NCT01595438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110495792|NCT02557087|Antiemetics|antiemetics|mesh-ancestor
111030783|NCT01595438|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111030784|NCT01595438|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111030785|NCT01595438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111030786|NCT01595438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111030787|NCT01595438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111030788|NCT01595438|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111030789|NCT01595438|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111030790|NCT01595438|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111030791|NCT01595438|Antimalarials|antimalarials|mesh-ancestor
111030792|NCT01595438|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111030793|NCT01595438|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111030794|NCT01595438|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111030795|NCT01595438|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111030796|NCT01595438|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
111030797|NCT01595438|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
111030798|NCT02089451|Insulin Aspart|insulin aspart|mesh-list
111030799|NCT02089451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111030800|NCT02089451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111030801|NCT02340520|Theophylline|theophylline|mesh-list
111030802|NCT02340520|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111030803|NCT02340520|Autonomic Agents|autonomic agents|mesh-ancestor
111030804|NCT02340520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111030805|NCT02340520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111030806|NCT02340520|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111030807|NCT02340520|Respiratory System Agents|respiratory system agents|mesh-ancestor
111030808|NCT02340520|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111030809|NCT02340520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111030810|NCT02340520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111030811|NCT02340520|Vasodilator Agents|vasodilator agents|mesh-ancestor
111030812|NCT02340520|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
111030813|NCT02340520|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111030814|NCT02340520|Purinergic Agents|purinergic agents|mesh-ancestor
111030815|NCT02340520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110747927|NCT01180322|Cytarabine|cytarabine|mesh-list
111030816|NCT02087579|Olanzapine|olanzapine|mesh-list
111030817|NCT02087579|Risperidone|risperidone|mesh-list
111030818|NCT02087579|Aripiprazole|aripiprazole|mesh-list
111030819|NCT02087579|Quetiapine Fumarate|quetiapine fumarate|mesh-list
111030820|NCT02087579|Paliperidone Palmitate|paliperidone palmitate|mesh-list
111030821|NCT02087579|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111030822|NCT02087579|Serotonin Agents|serotonin agents|mesh-ancestor
111030823|NCT02087579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111030824|NCT02087579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111030825|NCT02087579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111030826|NCT02087579|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111030827|NCT02087579|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111030828|NCT02087579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111030829|NCT02087579|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111030830|NCT02087579|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111030831|NCT02087579|Dopamine Agents|dopamine agents|mesh-ancestor
111030832|NCT02087579|Antiemetics|antiemetics|mesh-ancestor
111030833|NCT02087579|Autonomic Agents|autonomic agents|mesh-ancestor
111030834|NCT02087579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111030835|NCT02087579|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111030836|NCT02087579|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111030837|NCT02087579|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111030838|NCT02087579|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111030839|NCT02087579|Antidepressive Agents|antidepressive agents|mesh-ancestor
111030840|NCT02087579|Dopamine Agonists|dopamine agonists|mesh-ancestor
111030841|NCT02087579|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111030842|NCT02087579|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111030843|NCT02087579|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111030844|NCT02087579|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111030845|NCT02339584|Brimonidine Tartrate|brimonidine tartrate|mesh-list
111030846|NCT02339584|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110625968|NCT02889523|Rituximab|rituximab|mesh-list
111030847|NCT02339584|Brinzolamide|brinzolamide|mesh-list
111030848|NCT02339584|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111030849|NCT02339584|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111030850|NCT02339584|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111030851|NCT02339584|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111030852|NCT02339584|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111030853|NCT02339584|Adrenergic Agents|adrenergic agents|mesh-ancestor
111030854|NCT02339584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111030855|NCT02339584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111030856|NCT02339584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111030857|NCT02339584|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
111030858|NCT02339584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111030859|NCT02339506|Cosyntropin|cosyntropin|mesh-list
111030860|NCT02339506|Hormones|hormones|mesh-ancestor
111030861|NCT02339506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111030862|NCT02339506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111030863|NCT02087813|Methylprednisolone|methylprednisolone|mesh-list
111030864|NCT02087813|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111030865|NCT02087813|Protease Inhibitors|protease inhibitors|mesh-list
111030866|NCT02087813|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
111030867|NCT02087813|Protein C Inhibitor|protein c inhibitor|mesh-list
111030868|NCT02087813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111030869|NCT02087813|Antiemetics|antiemetics|mesh-ancestor
111030870|NCT02087813|Autonomic Agents|autonomic agents|mesh-ancestor
111030871|NCT02087813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111030872|NCT02087813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111030873|NCT02087813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111030874|NCT02087813|Glucocorticoids|glucocorticoids|mesh-ancestor
111030875|NCT02087813|Hormones|hormones|mesh-ancestor
111030876|NCT02087813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111030877|NCT02087813|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111030878|NCT02087813|Protective Agents|protective agents|mesh-ancestor
111030879|NCT02087813|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111030880|NCT02087813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111030881|NCT02087813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111030882|NCT02087813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111030883|NCT02087813|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
111030884|NCT02087813|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111030885|NCT02089529|Ibuprofen|ibuprofen|mesh-list
111030886|NCT02089529|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111030887|NCT02089529|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111030888|NCT02089529|Analgesics|analgesics|mesh-ancestor
111030889|NCT02089529|Sensory System Agents|sensory system agents|mesh-ancestor
111030890|NCT02089529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111030891|NCT02089529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111030892|NCT02089529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111030893|NCT02089529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111030894|NCT02089529|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111030895|NCT02089529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111030896|NCT02089529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111030897|NCT02090933|Celecoxib|celecoxib|mesh-list
111030898|NCT02090933|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111030899|NCT02090933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111030900|NCT02090933|Analgesics|analgesics|mesh-ancestor
111030901|NCT02090933|Sensory System Agents|sensory system agents|mesh-ancestor
111030902|NCT02090933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111030903|NCT02090933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111030904|NCT02090933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111030905|NCT02090933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111030906|NCT02090933|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111030907|NCT02090933|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111030908|NCT02090933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111030909|NCT02090933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111030910|NCT03046238|Dexmedetomidine|dexmedetomidine|mesh-list
111030911|NCT03046238|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111030912|NCT03046238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111030913|NCT03046238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111030914|NCT03046238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111030915|NCT03046238|Analgesics|analgesics|mesh-ancestor
111030916|NCT03046238|Sensory System Agents|sensory system agents|mesh-ancestor
111030917|NCT03046238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111030918|NCT03046238|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111030919|NCT03046238|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111030920|NCT03046238|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111030921|NCT03046238|Adrenergic Agents|adrenergic agents|mesh-ancestor
111030922|NCT03046238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111030923|NCT03046238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111030924|NCT02089763|BCT-100|bct-100|mesh-list
111030925|NCT02089763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111030926|NCT02089841|Lumefantrine|lumefantrine|mesh-list
111030928|NCT02089841|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
111030929|NCT02089841|Antimalarials|antimalarials|mesh-ancestor
111030930|NCT02089841|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111030931|NCT02089841|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111030932|NCT02089841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111030933|NCT03045770|Leucovorin|leucovorin|mesh-list
111030934|NCT03045770|Paclitaxel|paclitaxel|mesh-list
111030935|NCT03045770|Fluorouracil|fluorouracil|mesh-list
111030936|NCT03045770|Oxaliplatin|oxaliplatin|mesh-list
111030937|NCT03045770|Irinotecan|irinotecan|mesh-list
111030938|NCT03045770|Calcium|calcium|mesh-list
111030939|NCT03045770|Levoleucovorin|levoleucovorin|mesh-list
111030940|NCT03045770|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111030941|NCT03045770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111030942|NCT03045770|Tubulin Modulators|tubulin modulators|mesh-ancestor
111030943|NCT03045770|Antimitotic Agents|antimitotic agents|mesh-ancestor
111030944|NCT03045770|Mitosis Modulators|mitosis modulators|mesh-ancestor
111030945|NCT03045770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111030946|NCT03045770|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111030947|NCT03045770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111030948|NCT03045770|Antimetabolites|antimetabolites|mesh-ancestor
111030949|NCT03045770|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111030950|NCT03045770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111030951|NCT03045770|Immunologic Factors|immunologic factors|mesh-ancestor
111030952|NCT03045770|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111030953|NCT03045770|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111030954|NCT03045770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111030955|NCT03045770|Antidotes|antidotes|mesh-ancestor
111030956|NCT03045770|Protective Agents|protective agents|mesh-ancestor
111030957|NCT03045770|Vitamin B Complex|vitamin b complex|mesh-ancestor
111030958|NCT03045770|Vitamins|vitamins|mesh-ancestor
111030959|NCT03045770|Micronutrients|micronutrients|mesh-ancestor
111030960|NCT02260505|Imatinib Mesylate|imatinib mesylate|mesh-list
111030961|NCT02260505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111030962|NCT02260505|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111030963|NCT02260505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111030964|NCT02260505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111030965|NCT02095847|Proflavine|proflavine|mesh-list
111030966|NCT02095847|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111030967|NCT02095847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111030968|NCT02091401|Magnesium Sulfate|magnesium sulfate|mesh-list
111030969|NCT02091401|Analgesics|analgesics|mesh-ancestor
111030970|NCT02091401|Sensory System Agents|sensory system agents|mesh-ancestor
111030971|NCT02091401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111030972|NCT02091401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111030973|NCT02091401|Anesthetics|anesthetics|mesh-ancestor
111030974|NCT02091401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111030975|NCT02091401|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111030976|NCT02091401|Anticonvulsants|anticonvulsants|mesh-ancestor
111030977|NCT02091401|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111030978|NCT02091401|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111030979|NCT02091401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111030980|NCT02091401|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111030981|NCT02091401|Tocolytic Agents|tocolytic agents|mesh-ancestor
111030982|NCT02091401|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111030983|NCT01594970|Bimatoprost|bimatoprost|mesh-list
111030984|NCT01594970|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111030985|NCT04869176|Caffeine|caffeine|mesh-list
111030986|NCT04869176|Caffeine citrate|caffeine citrate|mesh-list
111030987|NCT04869176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111030988|NCT04869176|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111030989|NCT04869176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111030990|NCT04869176|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111030991|NCT04869176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111030992|NCT04869176|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
111030993|NCT04869176|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111030994|NCT04869176|Purinergic Agents|purinergic agents|mesh-ancestor
111030995|NCT04869176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111030996|NCT03557255|Simendan|simendan|mesh-list
111030997|NCT03557255|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111030998|NCT03557255|Vasodilator Agents|vasodilator agents|mesh-ancestor
111030999|NCT03557255|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
111031000|NCT03557255|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111031001|NCT03557255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111031002|NCT03557255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111031003|NCT03557255|Protective Agents|protective agents|mesh-ancestor
111031004|NCT03557255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111031005|NCT04868552|Naloxone|naloxone|mesh-list
111031006|NCT04868552|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111031007|NCT04868552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111031008|NCT04868552|Sensory System Agents|sensory system agents|mesh-ancestor
111031009|NCT04868552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111031010|NCT02090153|Leucovorin|leucovorin|mesh-list
111031011|NCT02090153|Tegafur|tegafur|mesh-list
111031012|NCT02090153|Antidotes|antidotes|mesh-ancestor
111031013|NCT02090153|Protective Agents|protective agents|mesh-ancestor
111031014|NCT02090153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111031015|NCT02090153|Vitamin B Complex|vitamin b complex|mesh-ancestor
111031016|NCT02090153|Vitamins|vitamins|mesh-ancestor
111031017|NCT02090153|Micronutrients|micronutrients|mesh-ancestor
111031018|NCT02090153|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111031019|NCT02090153|Antimetabolites|antimetabolites|mesh-ancestor
111031020|NCT02090153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111031021|NCT02090153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111031022|NCT00358163|Paclitaxel|paclitaxel|mesh-list
111031023|NCT00358163|Vatalanib|vatalanib|mesh-list
111031024|NCT00358163|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111031025|NCT00358163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111031026|NCT00358163|Tubulin Modulators|tubulin modulators|mesh-ancestor
111031027|NCT00358163|Antimitotic Agents|antimitotic agents|mesh-ancestor
111031028|NCT00358163|Mitosis Modulators|mitosis modulators|mesh-ancestor
111031029|NCT00358163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111031030|NCT00358163|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111031031|NCT00358163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111031032|NCT02096315|Murepavadin|murepavadin|mesh-list
111031033|NCT02096315|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111031034|NCT02096315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111031035|NCT02337946|Calcium, Dietary|calcium, dietary|mesh-list
111031036|NCT02337946|Leucovorin|leucovorin|mesh-list
111031037|NCT02337946|Oxaliplatin|oxaliplatin|mesh-list
111031038|NCT02337946|Fluorouracil|fluorouracil|mesh-list
111031039|NCT02337946|Panitumumab|panitumumab|mesh-list
111031040|NCT02337946|Calcium|calcium|mesh-list
111031041|NCT02337946|Levoleucovorin|levoleucovorin|mesh-list
110748114|NCT01290926|Sorafenib|sorafenib|mesh-list
111031042|NCT02337946|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111031043|NCT02337946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111031044|NCT02337946|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111031045|NCT02337946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111031047|NCT02337946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111031048|NCT02337946|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111031049|NCT02337946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111031050|NCT02337946|Immunologic Factors|immunologic factors|mesh-ancestor
111031051|NCT02337946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111031052|NCT02337946|Antidotes|antidotes|mesh-ancestor
111031053|NCT02337946|Protective Agents|protective agents|mesh-ancestor
111031054|NCT02337946|Vitamin B Complex|vitamin b complex|mesh-ancestor
111031055|NCT02337946|Vitamins|vitamins|mesh-ancestor
111031056|NCT02337946|Micronutrients|micronutrients|mesh-ancestor
111031057|NCT04865510|Heparin|heparin|mesh-list
111031058|NCT04865510|Anticoagulants|anticoagulants|mesh-ancestor
111031059|NCT04865510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111031060|NCT04865510|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111031061|NCT04865510|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111031062|NCT02090309|Hydrocortisone|hydrocortisone|mesh-list
111031063|NCT02090309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111031064|NCT03047096|Hyaluronic Acid|hyaluronic acid|mesh-list
111031065|NCT03047096|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111031066|NCT03047096|Immunologic Factors|immunologic factors|mesh-ancestor
111031067|NCT03047096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111031068|NCT03047096|Viscosupplements|viscosupplements|mesh-ancestor
111031069|NCT03047096|Protective Agents|protective agents|mesh-ancestor
111031070|NCT02090543|Rivaroxaban|rivaroxaban|mesh-list
111031071|NCT02090543|Phenprocoumon|phenprocoumon|mesh-list
111031072|NCT02090543|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111031073|NCT02090543|Antithrombins|antithrombins|mesh-ancestor
111031074|NCT02090543|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111031075|NCT02090543|Protease Inhibitors|protease inhibitors|mesh-ancestor
111031076|NCT02090543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110827246|NCT01164085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111031077|NCT02090543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111031078|NCT02090543|Anticoagulants|anticoagulants|mesh-ancestor
111031079|NCT02093195|Bosentan|bosentan|mesh-list
111031080|NCT02093195|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
111031081|NCT02093195|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111031082|NCT02093195|Respiratory System Agents|respiratory system agents|mesh-ancestor
111031083|NCT02093195|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111031084|NCT02093195|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
111031085|NCT02093195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111031086|NCT02096939|Antihypertensive Agents|antihypertensive agents|mesh-list
111031087|NCT03555617|Itraconazole|itraconazole|mesh-list
111031088|NCT03555617|Antifungal Agents|antifungal agents|mesh-ancestor
111031089|NCT03555617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111031090|NCT03555617|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111031091|NCT03555617|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111031092|NCT03555617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111031093|NCT03555617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111031094|NCT03555617|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111031095|NCT03555617|Hormone Antagonists|hormone antagonists|mesh-ancestor
111031096|NCT03555617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111031097|NCT03555617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111031098|NCT03555617|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111031099|NCT02098889|Scopolamine|scopolamine|mesh-list
111031100|NCT02098889|Bromides|bromides|mesh-list
111031101|NCT02098889|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
111031102|NCT02098889|Anticonvulsants|anticonvulsants|mesh-ancestor
111031103|NCT02098889|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111031104|NCT02098889|Antiemetics|antiemetics|mesh-ancestor
111031105|NCT02098889|Autonomic Agents|autonomic agents|mesh-ancestor
111031106|NCT02098889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111031107|NCT02098889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111031108|NCT02098889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111031109|NCT02098889|Mydriatics|mydriatics|mesh-ancestor
111031110|NCT02098889|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111031111|NCT02098889|Cholinergic Agents|cholinergic agents|mesh-ancestor
111031112|NCT02098889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111031113|NCT02098889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111031114|NCT02098889|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111031115|NCT02098889|Parasympatholytics|parasympatholytics|mesh-ancestor
110748190|NCT00061932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111031116|NCT01369199|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
111031117|NCT01369199|Entecavir|entecavir|mesh-list
111031118|NCT01369199|Antiviral Agents|antiviral agents|mesh-ancestor
111031119|NCT01369199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111031120|NCT02097173|Methotrexate|methotrexate|mesh-list
111031121|NCT02097173|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111031122|NCT02097173|Abortifacient Agents|abortifacient agents|mesh-ancestor
111031123|NCT02097173|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111031124|NCT02097173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111031125|NCT02097173|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111031126|NCT02097173|Antimetabolites|antimetabolites|mesh-ancestor
111031127|NCT02097173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111031128|NCT02097173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111031129|NCT02097173|Dermatologic Agents|dermatologic agents|mesh-ancestor
111031130|NCT02097173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111031131|NCT02097173|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111031132|NCT02097173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111031133|NCT02097173|Immunologic Factors|immunologic factors|mesh-ancestor
111031134|NCT02097173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111031135|NCT02097173|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111031136|NCT02097329|Palbociclib|palbociclib|mesh-list
111031137|NCT02097329|Rabeprazole|rabeprazole|mesh-list
111031138|NCT02097329|Famotidine|famotidine|mesh-list
111031139|NCT02097329|Anti-Ulcer Agents|anti-ulcer agents|mesh-list
111031140|NCT02097329|Aluminum hydroxide, magnesium hydroxide, simethicone drug combination|aluminum hydroxide, magnesium hydroxide, simethicone drug combination|mesh-list
111031141|NCT02097329|Aluminum Hydroxide|aluminum hydroxide|mesh-list
111031142|NCT02097329|Magnesium Hydroxide|magnesium hydroxide|mesh-list
111031143|NCT02097329|Antacids|antacids|mesh-list
111031144|NCT02097329|TEMPO|tempo|mesh-list
111031145|NCT02097329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111031146|NCT02097329|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111031147|NCT02097329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111031148|NCT02097329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111031149|NCT02097329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111031150|NCT02097329|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111031151|NCT02097329|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
111031152|NCT02097329|Histamine Antagonists|histamine antagonists|mesh-ancestor
111031153|NCT02097329|Histamine Agents|histamine agents|mesh-ancestor
111031154|NCT02097329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111031155|NCT02097329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111031156|NCT02097329|Antioxidants|antioxidants|mesh-ancestor
111031157|NCT02097329|Protective Agents|protective agents|mesh-ancestor
111031158|NCT02097329|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111031159|NCT02097329|Immunologic Factors|immunologic factors|mesh-ancestor
111031160|NCT02093585|Tenofovir|tenofovir|mesh-list
111031161|NCT02093585|Abacavir|abacavir|mesh-list
111031162|NCT02093585|Antiviral Agents|antiviral agents|mesh-ancestor
111031163|NCT02093585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111031164|NCT02093585|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111031165|NCT02093585|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111031166|NCT02093585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111031167|NCT02093585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111031168|NCT02093585|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111031169|NCT02093585|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111031170|NCT02099357|Vitamin D|vitamin d|mesh-list
111031171|NCT02099357|Vitamins|vitamins|mesh-ancestor
111031172|NCT02099357|Micronutrients|micronutrients|mesh-ancestor
111031173|NCT02099357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111031174|NCT02099357|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111031175|NCT02093741|Factor VIII|factor viii|mesh-list
111031176|NCT02093741|Coagulants|coagulants|mesh-ancestor
111031177|NCT02097407|Dexmedetomidine|dexmedetomidine|mesh-list
111031178|NCT02097407|Propofol|propofol|mesh-list
111031179|NCT02097407|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111031180|NCT02097407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111031181|NCT02097407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111031182|NCT02097407|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111031183|NCT02097407|Analgesics|analgesics|mesh-ancestor
111031184|NCT02097407|Sensory System Agents|sensory system agents|mesh-ancestor
111031185|NCT02097407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111031186|NCT02097407|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111031187|NCT02097407|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111031188|NCT02097407|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111031189|NCT02097407|Adrenergic Agents|adrenergic agents|mesh-ancestor
111031190|NCT02097407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111031191|NCT02097407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111031192|NCT02097407|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111031193|NCT02097407|Anesthetics, General|anesthetics, general|mesh-ancestor
111031195|NCT02250599|Paclitaxel|paclitaxel|mesh-list
111031196|NCT02250599|Bevacizumab|bevacizumab|mesh-list
111031197|NCT02250599|Carboplatin|carboplatin|mesh-list
111031198|NCT02250599|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111031199|NCT02250599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111031200|NCT02250599|Tubulin Modulators|tubulin modulators|mesh-ancestor
111031201|NCT02250599|Antimitotic Agents|antimitotic agents|mesh-ancestor
111031202|NCT02250599|Mitosis Modulators|mitosis modulators|mesh-ancestor
111031203|NCT02250599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111031204|NCT02250599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111031205|NCT02250599|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111031206|NCT02250599|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111031207|NCT02250599|Growth Substances|growth substances|mesh-ancestor
111031208|NCT02250599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111031209|NCT02250599|Growth Inhibitors|growth inhibitors|mesh-ancestor
111031210|NCT02094053|Donepezil|donepezil|mesh-list
111031211|NCT02094053|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111031212|NCT02094053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111031213|NCT02094053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111031214|NCT02094053|Cholinergic Agents|cholinergic agents|mesh-ancestor
111031215|NCT02094053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111031216|NCT02094053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111031217|NCT02094053|Nootropic Agents|nootropic agents|mesh-ancestor
111031218|NCT03555929|Dexamethasone|dexamethasone|mesh-list
111031219|NCT03555929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111031220|NCT03555929|Antiemetics|antiemetics|mesh-ancestor
111031221|NCT03555929|Autonomic Agents|autonomic agents|mesh-ancestor
111031222|NCT03555929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110827248|NCT01271179|Insulin|insulin|mesh-list
111031223|NCT03555929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111031224|NCT03555929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111031225|NCT03555929|Glucocorticoids|glucocorticoids|mesh-ancestor
111031226|NCT03555929|Hormones|hormones|mesh-ancestor
111031227|NCT03555929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111031228|NCT03555929|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111031229|NCT03555929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111031230|NCT02099981|Pimagedine|pimagedine|mesh-list
111031231|NCT02099981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111031232|NCT02099981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111031233|NCT02250209|Capecitabine|capecitabine|mesh-list
111031234|NCT02250209|Oxaliplatin|oxaliplatin|mesh-list
111031235|NCT02250209|Trastuzumab|trastuzumab|mesh-list
111031236|NCT02250209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111031237|NCT02250209|Antimetabolites|antimetabolites|mesh-ancestor
111031238|NCT02250209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111031239|NCT02250209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111031240|NCT02250209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111031241|NCT02097953|Rifampin|rifampin|mesh-list
111031242|NCT02097953|Daptomycin|daptomycin|mesh-list
111031243|NCT02097953|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111031244|NCT02097953|Antitubercular Agents|antitubercular agents|mesh-ancestor
111031245|NCT02097953|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111031246|NCT02097953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111031247|NCT02097953|Leprostatic Agents|leprostatic agents|mesh-ancestor
111031248|NCT02097953|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111031249|NCT02097953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111031250|NCT02097953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111031251|NCT02097953|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111031252|NCT02097953|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111031253|NCT02097953|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
111031254|NCT02097953|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
111031255|NCT02097953|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
111031256|NCT02097953|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111031257|NCT02094287|Dimethindene|dimethindene|mesh-list
111031258|NCT02094287|Antipruritics|antipruritics|mesh-ancestor
111031259|NCT02094287|Dermatologic Agents|dermatologic agents|mesh-ancestor
111031260|NCT02094287|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111031261|NCT02094287|Histamine Antagonists|histamine antagonists|mesh-ancestor
111031262|NCT02094287|Histamine Agents|histamine agents|mesh-ancestor
111031263|NCT02094287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111031264|NCT02094287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111031265|NCT02094287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111031266|NCT02094287|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111031267|NCT02100293|Magnesium Sulfate|magnesium sulfate|mesh-list
111031268|NCT02100293|Analgesics|analgesics|mesh-ancestor
111031269|NCT02100293|Sensory System Agents|sensory system agents|mesh-ancestor
111031270|NCT02100293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111031271|NCT02100293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111031272|NCT02100293|Anesthetics|anesthetics|mesh-ancestor
111031273|NCT02100293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111031274|NCT02100293|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111031275|NCT02100293|Anticonvulsants|anticonvulsants|mesh-ancestor
111031276|NCT02100293|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111031277|NCT02100293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111031278|NCT02100293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111031279|NCT02100293|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111031280|NCT02100293|Tocolytic Agents|tocolytic agents|mesh-ancestor
111031281|NCT02100293|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111031282|NCT02094599|Dronabinol|dronabinol|mesh-list
111031283|NCT02094599|Hallucinogens|hallucinogens|mesh-ancestor
111031284|NCT02094599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111031285|NCT02094599|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111031286|NCT02094599|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111031287|NCT02094599|Analgesics|analgesics|mesh-ancestor
111031288|NCT02094599|Sensory System Agents|sensory system agents|mesh-ancestor
111031289|NCT02094599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111031290|NCT02094599|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
111031291|NCT02094599|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
111031292|NCT02094599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111031293|NCT02094599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111031294|NCT02094599|Hormones|hormones|mesh-ancestor
111031295|NCT02094599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111031297|NCT02094833|Immunologic Factors|immunologic factors|mesh-ancestor
111031298|NCT02094833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111031299|NCT02100605|Nasal Decongestants|nasal decongestants|mesh-list
111031300|NCT02100605|Pseudoephedrine|pseudoephedrine|mesh-list
111031301|NCT02100605|Ephedrine|ephedrine|mesh-list
111031302|NCT02100605|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111031303|NCT02100605|Respiratory System Agents|respiratory system agents|mesh-ancestor
111031304|NCT02100605|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111031305|NCT02100605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111031306|NCT02100605|Sympathomimetics|sympathomimetics|mesh-ancestor
111031307|NCT02100605|Autonomic Agents|autonomic agents|mesh-ancestor
111031308|NCT02100605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111031309|NCT02100605|Adrenergic Agents|adrenergic agents|mesh-ancestor
111031310|NCT02100605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111031311|NCT02100605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111031312|NCT02100605|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111031313|NCT02100605|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111031314|NCT02100761|Voriconazole|voriconazole|mesh-list
111031315|NCT02100761|Antifungal Agents|antifungal agents|mesh-ancestor
111031316|NCT02100761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111031317|NCT02100761|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111031318|NCT02100761|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111031319|NCT02100761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111031320|NCT02100761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111031321|NCT02100761|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111031322|NCT02100761|Hormone Antagonists|hormone antagonists|mesh-ancestor
111031323|NCT02100761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111031324|NCT02100761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111031325|NCT02100761|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111031326|NCT02100917|Trastuzumab|trastuzumab|mesh-list
111031327|NCT02100917|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111031328|NCT02100917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111031329|NCT02098421|Oxytocin|oxytocin|mesh-list
111031330|NCT02098421|Oxytocics|oxytocics|mesh-ancestor
111031331|NCT02098421|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111031332|NCT02098421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111031333|NCT02098499|Diphenhydramine|diphenhydramine|mesh-list
111031334|NCT02098499|Promethazine|promethazine|mesh-list
111031335|NCT02098499|Haloperidol|haloperidol|mesh-list
111031336|NCT02098499|Metoclopramide|metoclopramide|mesh-list
111031337|NCT02098499|Haloperidol decanoate|haloperidol decanoate|mesh-list
111031338|NCT02098499|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111031339|NCT02098499|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111031340|NCT02098499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111031341|NCT02098499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111031342|NCT02098499|Anesthetics, Local|anesthetics, local|mesh-ancestor
111031343|NCT02098499|Anesthetics|anesthetics|mesh-ancestor
111031344|NCT02098499|Sensory System Agents|sensory system agents|mesh-ancestor
111031345|NCT02098499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111031346|NCT02098499|Antiemetics|antiemetics|mesh-ancestor
111031347|NCT02098499|Autonomic Agents|autonomic agents|mesh-ancestor
111031348|NCT02098499|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111031349|NCT02098499|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111031350|NCT02098499|Histamine Antagonists|histamine antagonists|mesh-ancestor
111031351|NCT02098499|Histamine Agents|histamine agents|mesh-ancestor
111031352|NCT02098499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111031353|NCT02098499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111031354|NCT02098499|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111031355|NCT02098499|Antipruritics|antipruritics|mesh-ancestor
111031356|NCT02098499|Dermatologic Agents|dermatologic agents|mesh-ancestor
111031357|NCT02098499|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111031358|NCT02098499|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111031359|NCT02098499|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111031360|NCT02098499|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111031361|NCT02098499|Dopamine Agents|dopamine agents|mesh-ancestor
111031362|NCT02098499|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111031363|NCT02098499|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111031364|NCT02097017|Lidocaine|lidocaine|mesh-list
111031365|NCT02097017|Anesthetics, Local|anesthetics, local|mesh-ancestor
111031366|NCT02097017|Anesthetics|anesthetics|mesh-ancestor
111031367|NCT02097017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110827252|NCT01271179|Analgesics|analgesics|mesh-ancestor
111031368|NCT02097017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111031369|NCT02097017|Sensory System Agents|sensory system agents|mesh-ancestor
111031370|NCT02097017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111031371|NCT02097017|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111031372|NCT02097017|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111031373|NCT02097017|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111031374|NCT02097017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111031375|NCT02097017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111031376|NCT03555383|Hemostatics|hemostatics|mesh-list
111031377|NCT03555383|Coagulants|coagulants|mesh-ancestor
111031378|NCT02101151|Vitamin D|vitamin d|mesh-list
111031379|NCT02101151|Cholecalciferol|cholecalciferol|mesh-list
111031380|NCT02101151|Vitamins|vitamins|mesh-ancestor
111031381|NCT02101151|Micronutrients|micronutrients|mesh-ancestor
111031382|NCT02101151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111031383|NCT02101151|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111031384|NCT02101151|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111031385|NCT02101229|Insulin|insulin|mesh-list
111031386|NCT02101229|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111031387|NCT02101229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111031388|NCT02101229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111031389|NCT02102555|Acetaminophen|acetaminophen|mesh-list
111031390|NCT02102555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111031391|NCT02102555|Analgesics|analgesics|mesh-ancestor
111031392|NCT02102555|Sensory System Agents|sensory system agents|mesh-ancestor
111031393|NCT02102555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111031394|NCT02102555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111031395|NCT02102555|Antipyretics|antipyretics|mesh-ancestor
111031396|NCT02102633|Dabigatran|dabigatran|mesh-list
111031397|NCT02102633|Antithrombins|antithrombins|mesh-ancestor
111031398|NCT02102633|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111031399|NCT02102633|Protease Inhibitors|protease inhibitors|mesh-ancestor
111031400|NCT02102633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111031401|NCT02102633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111031402|NCT02102633|Anticoagulants|anticoagulants|mesh-ancestor
111031403|NCT02102711|Vitamin A|vitamin a|mesh-list
111031404|NCT02102711|Vitamins|vitamins|mesh-ancestor
111031405|NCT02102711|Micronutrients|micronutrients|mesh-ancestor
111031406|NCT02102711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111031407|NCT02106767|Rifampin|rifampin|mesh-list
111031408|NCT02106767|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111031409|NCT02106767|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111031410|NCT02106767|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111031411|NCT02106767|Antimetabolites|antimetabolites|mesh-ancestor
111031412|NCT02106767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111031413|NCT02106767|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111031414|NCT02106767|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111031415|NCT02106767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111031416|NCT02106767|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111031417|NCT02106767|Antitubercular Agents|antitubercular agents|mesh-ancestor
111031418|NCT02106767|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111031419|NCT02106767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111031420|NCT02106767|Leprostatic Agents|leprostatic agents|mesh-ancestor
111031421|NCT02106767|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111031422|NCT02106767|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111031423|NCT02106767|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110648318|NCT00718757|Irinotecan|irinotecan|mesh-list
111031424|NCT02106767|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
111031425|NCT02106767|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
111031426|NCT02106767|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
111031427|NCT02106767|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111031428|NCT02103023|Imiquimod|imiquimod|mesh-list
111031429|NCT02103023|Vaccines|vaccines|mesh-list
111031430|NCT02103023|Immunologic Factors|immunologic factors|mesh-ancestor
111031431|NCT02103023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111031432|NCT02103023|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111031433|NCT02103023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111031434|NCT02103023|Interferon Inducers|interferon inducers|mesh-ancestor
111031435|NCT02101931|Aminolevulinic Acid|aminolevulinic acid|mesh-list
111031436|NCT02101931|Levulinic acid|levulinic acid|mesh-list
111031437|NCT02101931|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111031438|NCT02101931|Dermatologic Agents|dermatologic agents|mesh-ancestor
111031439|NCT02101931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111031440|NCT02101931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111031441|NCT02106845|Digoxin|digoxin|mesh-list
111031442|NCT02106845|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111031443|NCT02106845|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111031444|NCT02106845|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111031445|NCT02106845|Antimetabolites|antimetabolites|mesh-ancestor
111031446|NCT02106845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111031447|NCT02106845|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111031448|NCT02106845|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111031449|NCT02106845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111031450|NCT02106845|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111031451|NCT02106845|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111031452|NCT02106845|Protective Agents|protective agents|mesh-ancestor
111031453|NCT02106845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111031454|NCT03554447|Pentoxifylline|pentoxifylline|mesh-list
111031455|NCT03554447|Dexetimide|dexetimide|mesh-list
111031456|NCT03554447|Citalopram|citalopram|mesh-list
111031457|NCT03554447|Escitalopram|escitalopram|mesh-list
111031458|NCT03554447|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111031459|NCT03554447|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111031460|NCT03554447|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111031461|NCT03554447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111031462|NCT03554447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111031463|NCT03554447|Serotonin Agents|serotonin agents|mesh-ancestor
111031464|NCT03554447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111031465|NCT03554447|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111031466|NCT03554447|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111031467|NCT03554447|Parasympatholytics|parasympatholytics|mesh-ancestor
111031468|NCT03554447|Autonomic Agents|autonomic agents|mesh-ancestor
111031469|NCT03554447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111031470|NCT03554447|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111031471|NCT03554447|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111031472|NCT03554447|Cholinergic Agents|cholinergic agents|mesh-ancestor
111031473|NCT03554447|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111031474|NCT03554447|Antidepressive Agents|antidepressive agents|mesh-ancestor
111031475|NCT03554447|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111031476|NCT03554447|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111031477|NCT03554447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111031478|NCT03554447|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111031479|NCT03554447|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111031480|NCT03554447|Protective Agents|protective agents|mesh-ancestor
111031481|NCT03554447|Vasodilator Agents|vasodilator agents|mesh-ancestor
111031482|NCT03554447|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111031483|NCT03554447|Antioxidants|antioxidants|mesh-ancestor
111031484|NCT02103335|Dexamethasone|dexamethasone|mesh-list
111031485|NCT02103335|Pomalidomide|pomalidomide|mesh-list
111031486|NCT02103335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111031487|NCT02103335|Antiemetics|antiemetics|mesh-ancestor
111031488|NCT02103335|Autonomic Agents|autonomic agents|mesh-ancestor
111031489|NCT02103335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111031490|NCT02103335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111031491|NCT02103335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110748568|NCT00054132|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111031492|NCT02103335|Glucocorticoids|glucocorticoids|mesh-ancestor
111031493|NCT02103335|Hormones|hormones|mesh-ancestor
111031494|NCT02103335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111031495|NCT02103335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111031496|NCT02103335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111031497|NCT02103335|Immunologic Factors|immunologic factors|mesh-ancestor
111031498|NCT02103335|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111031499|NCT02103335|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111031500|NCT02103335|Growth Substances|growth substances|mesh-ancestor
111031501|NCT02103335|Growth Inhibitors|growth inhibitors|mesh-ancestor
111031502|NCT02610140|Vinorelbine|vinorelbine|mesh-list
111031503|NCT02610140|Maytansine|maytansine|mesh-list
111031504|NCT02610140|Anetumab ravtansine|anetumab ravtansine|mesh-list
111031505|NCT02610140|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111031506|NCT02610140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111031507|NCT02610140|Tubulin Modulators|tubulin modulators|mesh-ancestor
111031508|NCT02610140|Antimitotic Agents|antimitotic agents|mesh-ancestor
111031509|NCT02610140|Mitosis Modulators|mitosis modulators|mesh-ancestor
111031510|NCT02610140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111031511|NCT02610140|Immunoconjugates|immunoconjugates|mesh-ancestor
111031512|NCT02610140|Immunologic Factors|immunologic factors|mesh-ancestor
111031513|NCT02610140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111031514|NCT02102321|Albendazole|albendazole|mesh-list
111031515|NCT02102321|Anthelmintics|anthelmintics|mesh-ancestor
111031516|NCT02102321|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111031517|NCT02102321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111031518|NCT02102321|Anticestodal Agents|anticestodal agents|mesh-ancestor
111031519|NCT02102321|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
111031520|NCT02102321|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111031521|NCT02102321|Tubulin Modulators|tubulin modulators|mesh-ancestor
111031522|NCT02102321|Antimitotic Agents|antimitotic agents|mesh-ancestor
111031523|NCT02102321|Mitosis Modulators|mitosis modulators|mesh-ancestor
111031524|NCT02102321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111031525|NCT02102321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111031526|NCT02103569|Ethinyl Estradiol|ethinyl estradiol|mesh-list
111031528|NCT02103569|Norethindrone Acetate|norethindrone acetate|mesh-list
111031529|NCT02103569|Estradiol|estradiol|mesh-list
111031530|NCT02103569|Asunaprevir|asunaprevir|mesh-list
111031531|NCT02103569|Estrogens|estrogens|mesh-ancestor
111031532|NCT02103569|Hormones|hormones|mesh-ancestor
111031533|NCT02103569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111031534|NCT02103569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111031535|NCT02103569|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111031536|NCT02103569|Contraceptive Agents|contraceptive agents|mesh-ancestor
111031537|NCT02103569|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111031538|NCT02103569|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111031539|NCT02103569|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111031540|NCT02103569|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111031541|NCT02103569|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111031542|NCT02103569|Protease Inhibitors|protease inhibitors|mesh-ancestor
111031543|NCT02103569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111031544|NCT02103569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111031545|NCT02103647|Pregabalin|pregabalin|mesh-list
111031546|NCT02103647|Analgesics|analgesics|mesh-ancestor
111031547|NCT02103647|Sensory System Agents|sensory system agents|mesh-ancestor
111031548|NCT02103647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111031549|NCT02103647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111031550|NCT02103647|Anticonvulsants|anticonvulsants|mesh-ancestor
111031551|NCT02103647|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111031552|NCT02103647|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111031553|NCT02103647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111031554|NCT02103647|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111031555|NCT02103647|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111031556|NCT02103647|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111031557|NCT02103647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111031558|NCT02103647|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111031559|NCT02109965|Midazolam|midazolam|mesh-list
111031560|NCT02109965|Dexmedetomidine|dexmedetomidine|mesh-list
111031561|NCT02109965|Propofol|propofol|mesh-list
111031562|NCT02109965|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111031563|NCT02109965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111031564|NCT02109965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111031565|NCT02109965|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111031566|NCT02109965|Analgesics|analgesics|mesh-ancestor
110748647|NCT01183910|Calcium|calcium|mesh-list
111031567|NCT02109965|Sensory System Agents|sensory system agents|mesh-ancestor
111031568|NCT02109965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111031569|NCT02109965|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111031570|NCT02109965|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111031571|NCT02109965|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111031572|NCT02109965|Adrenergic Agents|adrenergic agents|mesh-ancestor
111031573|NCT02109965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111031574|NCT02109965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111031575|NCT02109965|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111031576|NCT02109965|Anesthetics, General|anesthetics, general|mesh-ancestor
111031578|NCT02109965|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111031579|NCT02109965|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111031580|NCT02109965|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111031581|NCT02109965|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111031582|NCT02109965|GABA Modulators|gaba modulators|mesh-ancestor
111031583|NCT02109965|GABA Agents|gaba agents|mesh-ancestor
111031584|NCT02789657|Paclitaxel|paclitaxel|mesh-list
111031585|NCT02789657|Carboplatin|carboplatin|mesh-list
111031586|NCT02789657|Trastuzumab|trastuzumab|mesh-list
111031587|NCT02789657|Pertuzumab|pertuzumab|mesh-list
111031588|NCT02789657|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111031589|NCT02789657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111031590|NCT02789657|Tubulin Modulators|tubulin modulators|mesh-ancestor
111031591|NCT02789657|Antimitotic Agents|antimitotic agents|mesh-ancestor
111031592|NCT02789657|Mitosis Modulators|mitosis modulators|mesh-ancestor
111031593|NCT02789657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111031594|NCT02789657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111031595|NCT03555071|Vaccines|vaccines|mesh-list
111031596|NCT03555071|Immunologic Factors|immunologic factors|mesh-ancestor
111031597|NCT03555071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111031598|NCT02609984|Atezolizumab|atezolizumab|mesh-list
111031599|NCT02609984|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111031600|NCT02609984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111031601|NCT02609984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111031602|NCT02609984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111031603|NCT02107079|Melatonin|melatonin|mesh-list
111031604|NCT02107079|Antioxidants|antioxidants|mesh-ancestor
111031605|NCT02107079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111031606|NCT02107079|Protective Agents|protective agents|mesh-ancestor
111031607|NCT02107079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111031608|NCT02107079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111031609|NCT02107235|ON 01910|on 01910|mesh-list
111031610|NCT02107235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111031611|NCT02107235|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111031612|NCT02107235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111031613|NCT02107235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111031614|NCT02103725|Pimecrolimus|pimecrolimus|mesh-list
111031615|NCT02103725|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111031616|NCT02103725|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111031617|NCT02103725|Analgesics|analgesics|mesh-ancestor
111031618|NCT02103725|Sensory System Agents|sensory system agents|mesh-ancestor
111031619|NCT02103725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111031620|NCT02103725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111031621|NCT02103725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111031622|NCT02103725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111031623|NCT02103725|Dermatologic Agents|dermatologic agents|mesh-ancestor
111031624|NCT02103725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111031625|NCT02103725|Immunologic Factors|immunologic factors|mesh-ancestor
111031626|NCT02103725|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111031627|NCT02103725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111031628|NCT02103725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111031629|NCT03042260|Trimethoprim|trimethoprim|mesh-list
111031630|NCT03042260|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
111031631|NCT03042260|Sulfamethoxazole|sulfamethoxazole|mesh-list
111031632|NCT03042260|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111031633|NCT03042260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111031634|NCT03042260|Antimalarials|antimalarials|mesh-ancestor
111031635|NCT03042260|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111031636|NCT03042260|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111031637|NCT03042260|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111031638|NCT03042260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111031639|NCT03042260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111031640|NCT03042260|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111031641|NCT03042260|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
111031642|NCT03042260|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111031643|NCT03042260|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111031644|NCT02110355|Trametinib|trametinib|mesh-list
111031645|NCT02110355|Dabrafenib|dabrafenib|mesh-list
111031646|NCT02110355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111031647|NCT02110355|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111031648|NCT02110355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111031649|NCT02110355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111031650|NCT02107391|Leuprolide|leuprolide|mesh-list
111031651|NCT02107391|Goserelin|goserelin|mesh-list
111031652|NCT02107391|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111031653|NCT02107391|Fertility Agents|fertility agents|mesh-ancestor
111031654|NCT02107391|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111031655|NCT02107391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111031656|NCT02107391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111031657|NCT02107391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111031658|NCT02103881|Ketamine|ketamine|mesh-list
111031659|NCT02103881|Haloperidol|haloperidol|mesh-list
111031660|NCT02103881|Haloperidol decanoate|haloperidol decanoate|mesh-list
111031661|NCT02103881|Analgesics|analgesics|mesh-ancestor
111031662|NCT02103881|Sensory System Agents|sensory system agents|mesh-ancestor
111031663|NCT02103881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111031664|NCT02103881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111031665|NCT02103881|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111031666|NCT02103881|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111031667|NCT02103881|Anesthetics, General|anesthetics, general|mesh-ancestor
111031668|NCT02103881|Anesthetics|anesthetics|mesh-ancestor
111031669|NCT02103881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111031670|NCT02103881|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111031671|NCT02103881|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111031672|NCT02103881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111031673|NCT02103881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111031674|NCT02103881|Antiemetics|antiemetics|mesh-ancestor
111031675|NCT02103881|Autonomic Agents|autonomic agents|mesh-ancestor
111031676|NCT02103881|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111031677|NCT02103881|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111031678|NCT02103881|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111031679|NCT02103881|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111031680|NCT02103881|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111031681|NCT02103881|Dopamine Agents|dopamine agents|mesh-ancestor
111031682|NCT02103881|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111031683|NCT03554915|Midazolam|midazolam|mesh-list
111031684|NCT03554915|Ketamine|ketamine|mesh-list
111031685|NCT03554915|Analgesics|analgesics|mesh-ancestor
111031686|NCT03554915|Sensory System Agents|sensory system agents|mesh-ancestor
111031687|NCT03554915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111031688|NCT03554915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111031689|NCT03554915|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111031690|NCT03554915|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111031691|NCT03554915|Anesthetics, General|anesthetics, general|mesh-ancestor
111031692|NCT03554915|Anesthetics|anesthetics|mesh-ancestor
111031693|NCT03554915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111031694|NCT03554915|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111031695|NCT03554915|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111031696|NCT03554915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111031697|NCT03554915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111031698|NCT03554915|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111031699|NCT03554915|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111031700|NCT03554915|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111031701|NCT03554915|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111031702|NCT03554915|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111031703|NCT03554915|GABA Modulators|gaba modulators|mesh-ancestor
111031704|NCT03554915|GABA Agents|gaba agents|mesh-ancestor
111031705|NCT03044522|Analgesics, Opioid|analgesics, opioid|mesh-list
111031706|NCT03044522|Narcotics|narcotics|mesh-ancestor
111031707|NCT03044522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111031708|NCT03044522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111031709|NCT03044522|Analgesics|analgesics|mesh-ancestor
111031710|NCT03044522|Sensory System Agents|sensory system agents|mesh-ancestor
111031711|NCT03044522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111031712|NCT03044366|Anesthetics|anesthetics|mesh-list
111031713|NCT03044366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111031714|NCT03044366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111031715|NCT02250833|Amlodipine|amlodipine|mesh-list
111031716|NCT02250833|Telmisartan|telmisartan|mesh-list
111031717|NCT02250833|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111031718|NCT02250833|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111031719|NCT02250833|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111031720|NCT02250833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111031721|NCT02250833|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111031722|NCT02250833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111031723|NCT02250833|Vasodilator Agents|vasodilator agents|mesh-ancestor
111031724|NCT02250833|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111031725|NCT02250833|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111031726|NCT02110745|Propofol|propofol|mesh-list
111031727|NCT02110745|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111031728|NCT02110745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111031729|NCT02110745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111031730|NCT02110745|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111031731|NCT02110745|Anesthetics, General|anesthetics, general|mesh-ancestor
111031732|NCT02110745|Anesthetics|anesthetics|mesh-ancestor
111031733|NCT04857320|Insulin|insulin|mesh-list
111031734|NCT04857320|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111031735|NCT04857320|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111031736|NCT04857320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111031737|NCT03041948|Acetaminophen|acetaminophen|mesh-list
111031738|NCT03041948|Dexamethasone|dexamethasone|mesh-list
111031739|NCT03041948|Ketorolac|ketorolac|mesh-list
111031740|NCT03041948|Morphine|morphine|mesh-list
111031741|NCT03041948|Remifentanil|remifentanil|mesh-list
111031742|NCT03041948|Ondansetron|ondansetron|mesh-list
111031743|NCT03041948|Propofol|propofol|mesh-list
111031744|NCT03041948|Sevoflurane|sevoflurane|mesh-list
111031745|NCT03041948|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111031746|NCT03041948|Antiemetics|antiemetics|mesh-ancestor
111031747|NCT03041948|Autonomic Agents|autonomic agents|mesh-ancestor
111031748|NCT03041948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111031749|NCT03041948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111031750|NCT03041948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111031751|NCT03041948|Glucocorticoids|glucocorticoids|mesh-ancestor
111031752|NCT03041948|Hormones|hormones|mesh-ancestor
111031753|NCT03041948|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111031754|NCT03041948|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111031755|NCT03041948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111031756|NCT03041948|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111031757|NCT03041948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111031758|NCT03041948|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111031759|NCT03041948|Anesthetics, General|anesthetics, general|mesh-ancestor
111031760|NCT03041948|Anesthetics|anesthetics|mesh-ancestor
111031761|NCT03041948|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111031762|NCT03041948|Narcotics|narcotics|mesh-ancestor
111031763|NCT03041948|Analgesics|analgesics|mesh-ancestor
111031764|NCT03041948|Sensory System Agents|sensory system agents|mesh-ancestor
111031765|NCT03041948|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111031766|NCT03041948|Antipyretics|antipyretics|mesh-ancestor
111031767|NCT03041948|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111031768|NCT03041948|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111031769|NCT03041948|Antipruritics|antipruritics|mesh-ancestor
111031770|NCT03041948|Dermatologic Agents|dermatologic agents|mesh-ancestor
111031771|NCT03041948|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111031772|NCT03041948|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111031773|NCT03041948|Serotonin Agents|serotonin agents|mesh-ancestor
111031774|NCT03041948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111031775|NCT03041948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111031776|NCT03041948|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111031777|NCT03041948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111031778|NCT03041948|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111031779|NCT03041948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111031780|NCT02104193|Simvastatin|simvastatin|mesh-list
111031781|NCT02104193|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111031782|NCT02104193|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111031783|NCT02104193|Antimetabolites|antimetabolites|mesh-ancestor
111031784|NCT02104193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111031785|NCT02104193|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111031786|NCT02104193|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111031787|NCT02104193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111031788|NCT03042182|Vaccines|vaccines|mesh-list
111031789|NCT03042182|Immunologic Factors|immunologic factors|mesh-ancestor
111031790|NCT03042182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111031791|NCT02104661|Oxcarbazepine|oxcarbazepine|mesh-list
111031792|NCT02104661|Anticonvulsants|anticonvulsants|mesh-ancestor
111031793|NCT02104661|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111031794|NCT02104661|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111031795|NCT02104661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111031796|NCT02104661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111031797|NCT02104661|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111031798|NCT02104661|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111031799|NCT02611778|Ranibizumab|ranibizumab|mesh-list
111031800|NCT02611778|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111031801|NCT02611778|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111031802|NCT02611778|Growth Substances|growth substances|mesh-ancestor
111031803|NCT02611778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111031804|NCT02611778|Growth Inhibitors|growth inhibitors|mesh-ancestor
111031805|NCT02611778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111031806|NCT04867226|Colchicine|colchicine|mesh-list
111031807|NCT04867226|Gout Suppressants|gout suppressants|mesh-ancestor
111031808|NCT04867226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111031809|NCT04867226|Tubulin Modulators|tubulin modulators|mesh-ancestor
111031810|NCT04867226|Antimitotic Agents|antimitotic agents|mesh-ancestor
111031811|NCT04867226|Mitosis Modulators|mitosis modulators|mesh-ancestor
111031812|NCT04867226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111031813|NCT04867226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111031814|NCT04856852|Iodine|iodine|mesh-list
111031815|NCT04856852|Temozolomide|temozolomide|mesh-list
110626196|NCT01067053|Oxaliplatin|oxaliplatin|mesh-list
111031816|NCT04856852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111031817|NCT04856852|Alkylating Agents|alkylating agents|mesh-ancestor
111031818|NCT04856852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111031819|NCT04856852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111031820|NCT04856852|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111031821|NCT04856852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111031822|NCT04856852|Trace Elements|trace elements|mesh-ancestor
111031823|NCT04856852|Micronutrients|micronutrients|mesh-ancestor
111031824|NCT04856852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111031825|NCT02711553|Gemcitabine|gemcitabine|mesh-list
111031826|NCT02711553|Ramucirumab|ramucirumab|mesh-list
111031827|NCT02711553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111031828|NCT02711553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111031829|NCT02711553|Antimetabolites|antimetabolites|mesh-ancestor
111031830|NCT02711553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111031831|NCT01453179|Diclofenac|diclofenac|mesh-list
111031832|NCT01453179|Imiquimod|imiquimod|mesh-list
111031833|NCT01453179|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111031834|NCT01453179|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111031835|NCT01453179|Analgesics|analgesics|mesh-ancestor
111031836|NCT01453179|Sensory System Agents|sensory system agents|mesh-ancestor
111031837|NCT01453179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111031838|NCT01453179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111031839|NCT01453179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111031840|NCT01453179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111031841|NCT01453179|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111031842|NCT01453179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111031843|NCT01453179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111031844|NCT01453179|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111031845|NCT01453179|Immunologic Factors|immunologic factors|mesh-ancestor
111031846|NCT01453179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111031847|NCT01453179|Interferon Inducers|interferon inducers|mesh-ancestor
111031848|NCT03192033|Hemostatics|hemostatics|mesh-list
111031849|NCT03192033|Coagulants|coagulants|mesh-ancestor
111031850|NCT03188445|Ascorbic Acid|ascorbic acid|mesh-list
111031851|NCT03188445|Ferrous fumarate|ferrous fumarate|mesh-list
111031852|NCT03188445|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
111031853|NCT03188445|Antioxidants|antioxidants|mesh-ancestor
111031854|NCT03188445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111031855|NCT03188445|Protective Agents|protective agents|mesh-ancestor
111031856|NCT03188445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111031857|NCT03188445|Vitamins|vitamins|mesh-ancestor
111031858|NCT03188445|Micronutrients|micronutrients|mesh-ancestor
111031859|NCT03188445|Trace Elements|trace elements|mesh-ancestor
111031860|NCT03188445|Hematinics|hematinics|mesh-ancestor
111031861|NCT04483635|Vitamin D|vitamin d|mesh-list
111031862|NCT04483635|Cholecalciferol|cholecalciferol|mesh-list
111031863|NCT04483635|Vitamins|vitamins|mesh-ancestor
111031864|NCT04483635|Micronutrients|micronutrients|mesh-ancestor
111031865|NCT04483635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111031866|NCT04483635|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111031867|NCT04483635|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111031868|NCT04865900|Antibodies|antibodies|mesh-list
111031869|NCT04865900|Immunologic Factors|immunologic factors|mesh-ancestor
111031870|NCT04865900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111031871|NCT03191721|Triclosan|triclosan|mesh-list
111031872|NCT03191721|Anti-Infective Agents|anti-infective agents|mesh-list
111031873|NCT03191721|Fluorides|fluorides|mesh-list
111031874|NCT03191721|Cariostatic Agents|cariostatic agents|mesh-ancestor
111031875|NCT03191721|Protective Agents|protective agents|mesh-ancestor
111031876|NCT03191721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111031877|NCT03191721|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111031878|NCT03191721|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
111031879|NCT03191721|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111031880|NCT03191721|Antimetabolites|antimetabolites|mesh-ancestor
111031881|NCT03191721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110626219|NCT01067365|Sodium Citrate|sodium citrate|mesh-list
111031882|NCT03191721|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111031884|NCT04864496|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111031885|NCT04864496|Antiviral Agents|antiviral agents|mesh-ancestor
111031886|NCT04864496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111031887|NCT04864496|Expectorants|expectorants|mesh-ancestor
111031888|NCT04864496|Respiratory System Agents|respiratory system agents|mesh-ancestor
111031889|NCT04864496|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111031890|NCT04864496|Antioxidants|antioxidants|mesh-ancestor
111031891|NCT04864496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111031892|NCT04864496|Protective Agents|protective agents|mesh-ancestor
111031893|NCT04864496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111031894|NCT04864496|Antidotes|antidotes|mesh-ancestor
111031895|NCT03188289|Chitosan|chitosan|mesh-list
111031896|NCT03188289|Hyaluronic Acid|hyaluronic acid|mesh-list
111031897|NCT03188289|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111031898|NCT03188289|Immunologic Factors|immunologic factors|mesh-ancestor
111031899|NCT03188289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111031900|NCT03188289|Viscosupplements|viscosupplements|mesh-ancestor
111031901|NCT03188289|Protective Agents|protective agents|mesh-ancestor
111031902|NCT03188289|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111031903|NCT03188289|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111031904|NCT03188289|Antimetabolites|antimetabolites|mesh-ancestor
111031905|NCT03188289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111031906|NCT03188289|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111031907|NCT03188289|Chelating Agents|chelating agents|mesh-ancestor
111031908|NCT03188289|Sequestering Agents|sequestering agents|mesh-ancestor
111031909|NCT03188289|Hemostatics|hemostatics|mesh-ancestor
111031910|NCT03188289|Coagulants|coagulants|mesh-ancestor
111031911|NCT03044912|Mirabegron|mirabegron|mesh-list
111031912|NCT03044912|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
111031913|NCT03044912|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111031914|NCT03044912|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111031915|NCT03044912|Adrenergic Agents|adrenergic agents|mesh-ancestor
111031916|NCT03044912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111031917|NCT03044912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111031918|NCT03044912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111031919|NCT03044912|Urological Agents|urological agents|mesh-ancestor
111031920|NCT03041012|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
111031921|NCT03041012|Romidepsin|romidepsin|mesh-list
111031922|NCT03041012|Antibodies, Blocking|antibodies, blocking|mesh-list
111031923|NCT03041012|Antiviral Agents|antiviral agents|mesh-ancestor
111031924|NCT03041012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111031925|NCT03041012|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111031926|NCT03041012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111031927|NCT03041012|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111031928|NCT03041012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111031929|NCT03041012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111031930|NCT03041012|Immunologic Factors|immunologic factors|mesh-ancestor
111031931|NCT03041012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111031932|NCT03187899|Ropivacaine|ropivacaine|mesh-list
111031933|NCT03187899|Anesthetics, Local|anesthetics, local|mesh-ancestor
111031934|NCT03187899|Anesthetics|anesthetics|mesh-ancestor
111031935|NCT03187899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111031936|NCT03187899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111031937|NCT03187899|Sensory System Agents|sensory system agents|mesh-ancestor
111031938|NCT03187899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111031939|NCT01648582|Metformin|metformin|mesh-list
111031940|NCT01648582|Insulin Glargine|insulin glargine|mesh-list
111031941|NCT01648582|Dulaglutide|dulaglutide|mesh-list
111031942|NCT01648582|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111031943|NCT01648582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111031944|NCT02440347|Anesthetics|anesthetics|mesh-list
111031945|NCT02440347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111031946|NCT02440347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111031947|NCT03043820|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
111031948|NCT03043820|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111031949|NCT03043820|Hormone Antagonists|hormone antagonists|mesh-ancestor
111031950|NCT03043820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111031951|NCT03043820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111031952|NCT03043820|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111031953|NCT03043820|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111031954|NCT03043820|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111031955|NCT03191097|Pentanedioic acid imidazolyl ethanamide|pentanedioic acid imidazolyl ethanamide|mesh-list
111031956|NCT03191097|Antiviral Agents|antiviral agents|mesh-ancestor
111031957|NCT03191097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111031959|NCT04854668|Capecitabine|capecitabine|mesh-list
111031960|NCT04854668|Oxaliplatin|oxaliplatin|mesh-list
111031961|NCT04854668|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111031962|NCT04854668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111031963|NCT04854668|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111031964|NCT04854668|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111031965|NCT04854668|Growth Substances|growth substances|mesh-ancestor
111031966|NCT04854668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111031967|NCT04854668|Growth Inhibitors|growth inhibitors|mesh-ancestor
111031968|NCT04854668|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111031969|NCT04854668|Antimetabolites|antimetabolites|mesh-ancestor
111031970|NCT04854668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111031971|NCT03189069|Warfarin|warfarin|mesh-list
111031972|NCT03189069|Rivaroxaban|rivaroxaban|mesh-list
111031973|NCT03189069|Dabigatran|dabigatran|mesh-list
111031974|NCT03189069|Apixaban|apixaban|mesh-list
111031975|NCT03189069|Anticoagulants|anticoagulants|mesh-ancestor
111031976|NCT03189069|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111031977|NCT03189069|Antithrombins|antithrombins|mesh-ancestor
111031978|NCT03189069|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111031979|NCT03189069|Protease Inhibitors|protease inhibitors|mesh-ancestor
111031980|NCT03189069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111031981|NCT03189069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111031982|NCT03040934|Sirolimus|sirolimus|mesh-list
111031983|NCT03040934|Everolimus|everolimus|mesh-list
111031984|NCT03040934|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111031985|NCT03040934|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111031986|NCT03040934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111031987|NCT03040934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111031988|NCT03040934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111031989|NCT03040934|Immunologic Factors|immunologic factors|mesh-ancestor
111031990|NCT03040934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111031991|NCT03040934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111031992|NCT03040934|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111031993|NCT03040934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111031994|NCT03040934|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111031995|NCT03040934|Antifungal Agents|antifungal agents|mesh-ancestor
111031996|NCT04861142|Denosumab|denosumab|mesh-list
111031997|NCT04861142|Alendronate|alendronate|mesh-list
111031998|NCT04861142|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111031999|NCT04861142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111032000|NCT03117855|Capecitabine|capecitabine|mesh-list
111032001|NCT03117855|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111032002|NCT03117855|Antimetabolites|antimetabolites|mesh-ancestor
111032003|NCT03117855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111032004|NCT03117855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111032005|NCT02607800|Sofosbuvir|sofosbuvir|mesh-list
111032006|NCT02607800|Velpatasvir|velpatasvir|mesh-list
111032007|NCT02607800|Antiviral Agents|antiviral agents|mesh-ancestor
111032008|NCT02607800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111032009|NCT02304484|Evolocumab|evolocumab|mesh-list
111032010|NCT02304484|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
111032011|NCT02304484|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111032012|NCT02304484|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111032013|NCT02304484|Antimetabolites|antimetabolites|mesh-ancestor
111032014|NCT02304484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111032015|NCT02304484|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111032016|NCT02304484|Protease Inhibitors|protease inhibitors|mesh-ancestor
111032017|NCT02304484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111032018|NCT02304484|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111032019|NCT02434029|Budesonide|budesonide|mesh-list
111032020|NCT02434029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111032021|NCT02434029|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111032022|NCT02434029|Autonomic Agents|autonomic agents|mesh-ancestor
111032023|NCT02434029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111032024|NCT02434029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110648922|NCT00461500|Xhance|xhance|mesh-list
111032026|NCT02434029|Respiratory System Agents|respiratory system agents|mesh-ancestor
111032027|NCT02434029|Glucocorticoids|glucocorticoids|mesh-ancestor
111032028|NCT02434029|Hormones|hormones|mesh-ancestor
111032029|NCT02434029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111032030|NCT02708355|Esomeprazole|esomeprazole|mesh-list
111032031|NCT02708355|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111032032|NCT02708355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111032033|NCT02708355|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111032034|NCT02708355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111032035|NCT02708355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111032036|NCT04854044|TIC10 compound|tic10 compound|mesh-list
111032037|NCT04854044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111032038|NCT02708277|Contraceptive Agents|contraceptive agents|mesh-list
111032039|NCT02708277|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111032040|NCT02708277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111032041|NCT02337478|Vincristine|vincristine|mesh-list
111032042|NCT02337478|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111032043|NCT02337478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111032044|NCT02337478|Tubulin Modulators|tubulin modulators|mesh-ancestor
111032045|NCT02337478|Antimitotic Agents|antimitotic agents|mesh-ancestor
111032046|NCT02337478|Mitosis Modulators|mitosis modulators|mesh-ancestor
111032047|NCT02337478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111032048|NCT02434653|Chrysarobin|chrysarobin|mesh-list
111032049|NCT02434653|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111032050|NCT02434653|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111032051|NCT02434653|Analgesics|analgesics|mesh-ancestor
111032052|NCT02434653|Sensory System Agents|sensory system agents|mesh-ancestor
111032053|NCT02434653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111032054|NCT02434653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111032055|NCT02434653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111032056|NCT02434653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111032057|NCT03043196|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111032058|NCT03043196|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111032059|NCT03043196|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111032060|NCT03043196|Antimetabolites|antimetabolites|mesh-ancestor
111032061|NCT03043196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111032062|NCT03043196|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111032063|NCT03043196|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111032064|NCT03043196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111032065|NCT03188835|Glycerol|glycerol|mesh-list
111032066|NCT03188835|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
111032067|NCT03188835|Protective Agents|protective agents|mesh-ancestor
111032068|NCT03188835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111032069|NCT04847024|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
111032070|NCT04847024|Parecoxib|parecoxib|mesh-list
111032071|NCT04847024|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111032072|NCT04847024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111032073|NCT04847024|Analgesics|analgesics|mesh-ancestor
111032074|NCT04847024|Sensory System Agents|sensory system agents|mesh-ancestor
111032075|NCT04847024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111032076|NCT04847024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111032077|NCT04847024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111032078|NCT04847024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111032079|NCT04847024|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111032080|NCT04847024|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111032081|NCT04847024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111032082|NCT04847024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111032083|NCT04860674|Carboplatin|carboplatin|mesh-list
111032084|NCT04860674|Etoposide|etoposide|mesh-list
111032085|NCT04860674|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
111032086|NCT04860674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111032087|NCT04860674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111032088|NCT04860674|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111032089|NCT04860674|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111032090|NCT04860674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111032091|NCT04860674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111032092|NCT04860674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111032093|NCT04853342|Aflutinib|aflutinib|mesh-list
111032094|NCT04853342|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111032095|NCT04853342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110749175|NCT01192724|Analgesics|analgesics|mesh-ancestor
111032096|NCT04853342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111032097|NCT04853030|Insulin Aspart|insulin aspart|mesh-list
111032098|NCT04853030|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111032099|NCT04853030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111032100|NCT02430363|Pembrolizumab|pembrolizumab|mesh-list
111032101|NCT02430363|Ipatasertib|ipatasertib|mesh-list
111032102|NCT02430363|Dactolisib|dactolisib|mesh-list
111032103|NCT02430363|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111032104|NCT02430363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111032105|NCT02430363|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111032106|NCT02430363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111032107|NCT02430363|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111032108|NCT02430363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111032109|NCT02429973|Sirolimus|sirolimus|mesh-list
111032110|NCT02429973|Gemcitabine|gemcitabine|mesh-list
111032111|NCT02429973|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111032112|NCT02429973|Antimetabolites|antimetabolites|mesh-ancestor
111032113|NCT02429973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111032114|NCT02429973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111032115|NCT02429973|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111032116|NCT02429973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111032117|NCT02429973|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111032118|NCT02429973|Antifungal Agents|antifungal agents|mesh-ancestor
111032119|NCT02429973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111032120|NCT02429973|Immunologic Factors|immunologic factors|mesh-ancestor
111032121|NCT02429973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111032122|NCT04860284|Hydroxychloroquine|hydroxychloroquine|mesh-list
111032123|NCT04860284|Antimalarials|antimalarials|mesh-ancestor
111032124|NCT04860284|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111032125|NCT04860284|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111032126|NCT04860284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111032127|NCT04860284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111032128|NCT04860284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111032129|NCT04860284|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111032130|NCT04846634|Paclitaxel|paclitaxel|mesh-list
111032131|NCT04846634|Docetaxel|docetaxel|mesh-list
111032132|NCT04846634|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111032133|NCT04846634|Cisplatin|cisplatin|mesh-list
111032134|NCT04846634|Carboplatin|carboplatin|mesh-list
111032135|NCT04846634|Gemcitabine|gemcitabine|mesh-list
111032136|NCT04846634|Pemetrexed|pemetrexed|mesh-list
111032137|NCT04846634|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111032138|NCT04846634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111032139|NCT04846634|Tubulin Modulators|tubulin modulators|mesh-ancestor
111032140|NCT04846634|Antimitotic Agents|antimitotic agents|mesh-ancestor
111032141|NCT04846634|Mitosis Modulators|mitosis modulators|mesh-ancestor
111032142|NCT04846634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111032143|NCT04846634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111032144|NCT04846634|Antimetabolites|antimetabolites|mesh-ancestor
111032145|NCT04846634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111032146|NCT04846634|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111032147|NCT04846634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111032148|NCT02433717|Paliperidone Palmitate|paliperidone palmitate|mesh-list
111032149|NCT02433717|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111032150|NCT02433717|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111032151|NCT02433717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111032152|NCT02433717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111032153|NCT02433717|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111032154|NCT02433717|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111032155|NCT02433717|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111032156|NCT02433717|Serotonin Agents|serotonin agents|mesh-ancestor
111032157|NCT02433717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111032158|NCT02433717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111032159|NCT02433717|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111032160|NCT02433717|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111032161|NCT02433717|Dopamine Agents|dopamine agents|mesh-ancestor
111032162|NCT02429817|Edetic Acid|edetic acid|mesh-list
111032163|NCT02429817|Pentetic Acid|pentetic acid|mesh-list
111032164|NCT02429817|Antidotes|antidotes|mesh-ancestor
111032165|NCT02429817|Protective Agents|protective agents|mesh-ancestor
111032166|NCT02429817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111032167|NCT02429817|Chelating Agents|chelating agents|mesh-ancestor
111032168|NCT02429817|Sequestering Agents|sequestering agents|mesh-ancestor
111032169|NCT02429817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110749271|NCT01193504|Hormones|hormones|mesh-ancestor
111032170|NCT02429817|Iron Chelating Agents|iron chelating agents|mesh-ancestor
111032171|NCT02429817|Anticoagulants|anticoagulants|mesh-ancestor
111032172|NCT02429817|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
111032173|NCT04851860|Immunomodulating Agents|immunomodulating agents|mesh-list
111032174|NCT04851860|Immunologic Factors|immunologic factors|mesh-ancestor
111032175|NCT04851860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111032176|NCT04851548|Hyaluronic Acid|hyaluronic acid|mesh-list
111032177|NCT04851548|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111032178|NCT04851548|Immunologic Factors|immunologic factors|mesh-ancestor
111032179|NCT04851548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111032180|NCT04851548|Viscosupplements|viscosupplements|mesh-ancestor
111032181|NCT04851548|Protective Agents|protective agents|mesh-ancestor
111032182|NCT02706951|Methotrexate|methotrexate|mesh-list
111032183|NCT02706951|Upadacitinib|upadacitinib|mesh-list
111032184|NCT02706951|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111032185|NCT02706951|Abortifacient Agents|abortifacient agents|mesh-ancestor
111032186|NCT02706951|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111032187|NCT02706951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111032188|NCT02706951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111032189|NCT02706951|Antimetabolites|antimetabolites|mesh-ancestor
111032190|NCT02706951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111032191|NCT02706951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111032192|NCT02706951|Dermatologic Agents|dermatologic agents|mesh-ancestor
111032193|NCT02706951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111032194|NCT02706951|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111032195|NCT02706951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111032196|NCT02706951|Immunologic Factors|immunologic factors|mesh-ancestor
111032197|NCT02706951|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111032198|NCT02706951|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111032199|NCT02706951|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
111032200|NCT02706951|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111032201|NCT04851626|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
111032202|NCT04851626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111032203|NCT04851626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111032204|NCT04851392|Dronabinol|dronabinol|mesh-list
111032205|NCT04851392|Cannabidiol|cannabidiol|mesh-list
111032206|NCT04851392|Anticonvulsants|anticonvulsants|mesh-ancestor
111032207|NCT04851392|Hallucinogens|hallucinogens|mesh-ancestor
111032208|NCT04851392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111032209|NCT04851392|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111032210|NCT04851392|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111032211|NCT04851392|Analgesics|analgesics|mesh-ancestor
111032212|NCT04851392|Sensory System Agents|sensory system agents|mesh-ancestor
111032213|NCT04851392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111032214|NCT04851392|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
111032215|NCT04851392|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
111032216|NCT04851392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111032217|NCT04851392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111032218|NCT04851392|Hormones|hormones|mesh-ancestor
111032219|NCT04851392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111032220|NCT02429193|Prednisone|prednisone|mesh-list
111032221|NCT02429193|Abiraterone Acetate|abiraterone acetate|mesh-list
111032222|NCT02429193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111032223|NCT02429193|Glucocorticoids|glucocorticoids|mesh-ancestor
111032224|NCT02429193|Hormones|hormones|mesh-ancestor
111032225|NCT02429193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111032226|NCT02429193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111032227|NCT02429193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111032228|NCT02429193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111032229|NCT02429193|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111032230|NCT02429193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111032231|NCT02429193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111032232|NCT02429193|Hormone Antagonists|hormone antagonists|mesh-ancestor
111032233|NCT02429193|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111032234|NCT04859738|Lidocaine|lidocaine|mesh-list
111032235|NCT04859738|Anesthetics, Local|anesthetics, local|mesh-ancestor
111032236|NCT04859738|Anesthetics|anesthetics|mesh-ancestor
111032237|NCT04859738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111032238|NCT04859738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111032239|NCT04859738|Sensory System Agents|sensory system agents|mesh-ancestor
111032240|NCT04859738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111032241|NCT04859738|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111032242|NCT04859738|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111032243|NCT04859738|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111032244|NCT04859738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111032245|NCT04859738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111032246|NCT02429271|Clopidogrel|clopidogrel|mesh-list
111032247|NCT02429271|Ticagrelor|ticagrelor|mesh-list
111032248|NCT02429271|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111032249|NCT02429271|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111032250|NCT02429271|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111032251|NCT02429271|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111032253|NCT02429271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111032254|NCT02429271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111032255|NCT02429271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111032256|NCT02429505|Miltefosine|miltefosine|mesh-list
111032257|NCT02429505|Antifungal Agents|antifungal agents|mesh-ancestor
111032258|NCT02429505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111032259|NCT02429505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111032260|NCT02429505|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111032261|NCT02429505|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111032262|NCT04851002|Mitogens|mitogens|mesh-list
111032263|NCT04851002|Mitosis Modulators|mitosis modulators|mesh-ancestor
111032264|NCT04851002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111032265|NCT04844996|Ezetimibe|ezetimibe|mesh-list
111032266|NCT04844996|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111032267|NCT04844996|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111032268|NCT04844996|Antimetabolites|antimetabolites|mesh-ancestor
111032269|NCT04844996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111032270|NCT04844996|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111032271|NCT02425137|Gemcitabine|gemcitabine|mesh-list
111032272|NCT02425137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111032273|NCT02425137|Antimetabolites|antimetabolites|mesh-ancestor
111032274|NCT02425137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111032275|NCT02425137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111032276|NCT03182595|Acetaminophen|acetaminophen|mesh-list
111032277|NCT03182595|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111032278|NCT03182595|Analgesics|analgesics|mesh-ancestor
111032279|NCT03182595|Sensory System Agents|sensory system agents|mesh-ancestor
111032280|NCT03182595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111032281|NCT03182595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111032282|NCT03182595|Antipyretics|antipyretics|mesh-ancestor
111032283|NCT02428959|Amyl Nitrite|amyl nitrite|mesh-list
111032284|NCT02428959|Vasodilator Agents|vasodilator agents|mesh-ancestor
111032285|NCT02429037|Cisplatin|cisplatin|mesh-list
111032286|NCT02429037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111032287|NCT04833608|Carbon Fiber|carbon fiber|mesh-list
111032288|NCT04833608|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111032289|NCT04833608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111032290|NCT02428881|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111032291|NCT02428881|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111032292|NCT02428881|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111032293|NCT02428881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111032294|NCT02428881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111032295|NCT02428881|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111032296|NCT02428881|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111032297|NCT02428881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111032298|NCT02428881|Cholinergic Agents|cholinergic agents|mesh-ancestor
111032299|NCT02428881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111032300|NCT04833218|Propranolol|propranolol|mesh-list
111032301|NCT04833218|Clonidine|clonidine|mesh-list
111032302|NCT04833218|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111032303|NCT04833218|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111032304|NCT04833218|Adrenergic Agents|adrenergic agents|mesh-ancestor
111032305|NCT04833218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111032306|NCT04833218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111032307|NCT04833218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111032308|NCT04833218|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111032309|NCT04833218|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111032310|NCT04833218|Vasodilator Agents|vasodilator agents|mesh-ancestor
111032311|NCT04833218|Analgesics|analgesics|mesh-ancestor
111032312|NCT04833218|Sensory System Agents|sensory system agents|mesh-ancestor
111032313|NCT04833218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111032314|NCT04833218|Sympatholytics|sympatholytics|mesh-ancestor
111032315|NCT04833218|Autonomic Agents|autonomic agents|mesh-ancestor
111032316|NCT04833218|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111032317|NCT04833218|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111032318|NCT04833218|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111032319|NCT04833374|Prednisone|prednisone|mesh-list
111032320|NCT04833374|Methylprednisolone|methylprednisolone|mesh-list
111032321|NCT04833374|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111032322|NCT04833374|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111032323|NCT04833374|Prednisolone|prednisolone|mesh-list
111032324|NCT04833374|Prednisolone acetate|prednisolone acetate|mesh-list
111032325|NCT04833374|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111032326|NCT04833374|Prednisolone phosphate|prednisolone phosphate|mesh-list
111032327|NCT04833374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111032328|NCT04833374|Glucocorticoids|glucocorticoids|mesh-ancestor
111032329|NCT04833374|Hormones|hormones|mesh-ancestor
111032330|NCT04833374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111032331|NCT04833374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111032332|NCT04833374|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111032333|NCT04833374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111032334|NCT04833374|Antiemetics|antiemetics|mesh-ancestor
111032335|NCT04833374|Autonomic Agents|autonomic agents|mesh-ancestor
111032336|NCT04833374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111032337|NCT04833374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111032338|NCT04833374|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111032339|NCT04833374|Protective Agents|protective agents|mesh-ancestor
111032340|NCT02707965|Topiramate|topiramate|mesh-list
111032341|NCT02707965|Lamotrigine|lamotrigine|mesh-list
111032342|NCT02707965|Zonisamide|zonisamide|mesh-list
111032343|NCT02707965|Carbamazepine|carbamazepine|mesh-list
111032344|NCT02707965|Phenytoin|phenytoin|mesh-list
111032345|NCT02707965|Oxcarbazepine|oxcarbazepine|mesh-list
111032346|NCT02707965|Levetiracetam|levetiracetam|mesh-list
111032347|NCT02707965|Valproic Acid|valproic acid|mesh-list
111032348|NCT02707965|Anticonvulsants|anticonvulsants|mesh-ancestor
111032349|NCT02707965|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111032350|NCT02707965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111032351|NCT02707965|Nootropic Agents|nootropic agents|mesh-ancestor
111032352|NCT02707965|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111032353|NCT02707965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111032354|NCT02707965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111032355|NCT02707965|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111032356|NCT02707965|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111032357|NCT02707965|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111032358|NCT02707965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111032359|NCT02707965|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111032360|NCT02707965|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111032361|NCT02707965|Antimanic Agents|antimanic agents|mesh-ancestor
111032362|NCT02707965|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111032363|NCT02707965|Analgesics|analgesics|mesh-ancestor
111032364|NCT02707965|Sensory System Agents|sensory system agents|mesh-ancestor
111032365|NCT02707965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111032366|NCT02707965|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111032367|NCT02707965|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110626264|NCT00822666|Clopidogrel|clopidogrel|mesh-list
111032368|NCT02707965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111032369|NCT02707965|GABA Agents|gaba agents|mesh-ancestor
111032370|NCT02707965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111032371|NCT02707965|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111032372|NCT02707965|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
111032373|NCT04839536|Sevoflurane|sevoflurane|mesh-list
111032374|NCT04839536|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111032375|NCT04839536|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111032376|NCT04839536|Anesthetics, General|anesthetics, general|mesh-ancestor
111032377|NCT04839536|Anesthetics|anesthetics|mesh-ancestor
111032378|NCT04839536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111032379|NCT04839536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111032380|NCT02428257|Ephedrine|ephedrine|mesh-list
111032381|NCT02428257|Bupivacaine|bupivacaine|mesh-list
111032382|NCT02428257|Anesthetics, Local|anesthetics, local|mesh-ancestor
111032383|NCT02428257|Anesthetics|anesthetics|mesh-ancestor
111032384|NCT02428257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111032385|NCT02428257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111032386|NCT02428257|Sensory System Agents|sensory system agents|mesh-ancestor
111032387|NCT02428257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111032388|NCT02428257|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111032389|NCT02428257|Sympathomimetics|sympathomimetics|mesh-ancestor
111032390|NCT02428257|Autonomic Agents|autonomic agents|mesh-ancestor
111032391|NCT02428257|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110749478|NCT01190462|Simvastatin|simvastatin|mesh-list
111032392|NCT02428257|Adrenergic Agents|adrenergic agents|mesh-ancestor
111032393|NCT02428257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111032394|NCT02428257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111032395|NCT04839224|Phenylephrine|phenylephrine|mesh-list
111032396|NCT04839224|Oxymetazoline|oxymetazoline|mesh-list
111032397|NCT04839224|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111032398|NCT04839224|Mydriatics|mydriatics|mesh-ancestor
111032399|NCT04839224|Autonomic Agents|autonomic agents|mesh-ancestor
111032400|NCT04839224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111032401|NCT04839224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111032402|NCT04839224|Sympathomimetics|sympathomimetics|mesh-ancestor
111032403|NCT04839224|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111032404|NCT04839224|Nasal Decongestants|nasal decongestants|mesh-ancestor
111032405|NCT04839224|Respiratory System Agents|respiratory system agents|mesh-ancestor
111032406|NCT04839224|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111032407|NCT04839224|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111032408|NCT04839224|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111032409|NCT04839224|Adrenergic Agents|adrenergic agents|mesh-ancestor
111032410|NCT04839224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111032411|NCT04839224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111032412|NCT04839224|Protective Agents|protective agents|mesh-ancestor
111032413|NCT03036644|Nicotine|nicotine|mesh-list
111032414|NCT03036644|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111032415|NCT03036644|Autonomic Agents|autonomic agents|mesh-ancestor
111032416|NCT03036644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111032417|NCT03036644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111032418|NCT03036644|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111032419|NCT03036644|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111032420|NCT03036644|Cholinergic Agents|cholinergic agents|mesh-ancestor
111032421|NCT03036644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111032422|NCT03036644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111032423|NCT02424201|Ascorbic Acid|ascorbic acid|mesh-list
111032424|NCT02424201|Misoprostol|misoprostol|mesh-list
111032425|NCT02424201|Vitamins|vitamins|mesh-ancestor
111032426|NCT02424201|Micronutrients|micronutrients|mesh-ancestor
111032427|NCT02424201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111032428|NCT02424201|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111032429|NCT02424201|Abortifacient Agents|abortifacient agents|mesh-ancestor
111032430|NCT02424201|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111032431|NCT02424201|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111032432|NCT02424201|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111032433|NCT02424201|Oxytocics|oxytocics|mesh-ancestor
111032434|NCT02424201|Antioxidants|antioxidants|mesh-ancestor
111032435|NCT02424201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111032436|NCT02424201|Protective Agents|protective agents|mesh-ancestor
111032437|NCT02432781|Insulin|insulin|mesh-list
111032438|NCT02432781|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111032439|NCT02432781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111032440|NCT01667900|Dulaglutide|dulaglutide|mesh-list
111032441|NCT01667900|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111032442|NCT01667900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111032443|NCT04843280|Coal Tar|coal tar|mesh-list
111032444|NCT04843280|Keratolytic Agents|keratolytic agents|mesh-ancestor
111032445|NCT04843280|Dermatologic Agents|dermatologic agents|mesh-ancestor
111032446|NCT04833296|Ropivacaine|ropivacaine|mesh-list
111032447|NCT04833296|Anesthetics, Local|anesthetics, local|mesh-ancestor
111032448|NCT04833296|Anesthetics|anesthetics|mesh-ancestor
111032449|NCT04833296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111032450|NCT04833296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111032451|NCT04833296|Sensory System Agents|sensory system agents|mesh-ancestor
111032452|NCT04833296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111032453|NCT04832906|Ulipristal acetate|ulipristal acetate|mesh-list
111032454|NCT04832906|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111032455|NCT04832906|Contraceptive Agents|contraceptive agents|mesh-ancestor
111032456|NCT04832906|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111032457|NCT04832906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111032458|NCT04832906|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111032459|NCT00702273|Progesterone|progesterone|mesh-list
111032460|NCT00702273|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
111032461|NCT00702273|Ganirelix|ganirelix|mesh-list
111032462|NCT00702273|Progestins|progestins|mesh-ancestor
111032463|NCT00702273|Hormones|hormones|mesh-ancestor
111032464|NCT00702273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111032465|NCT00702273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111032466|NCT00702273|Hormone Antagonists|hormone antagonists|mesh-ancestor
111032467|NCT02433795|Rituximab|rituximab|mesh-list
111032468|NCT02433795|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
111032469|NCT02433795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111032470|NCT02433795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111032471|NCT02433795|Immunologic Factors|immunologic factors|mesh-ancestor
110749554|NCT00333359|Antimanic Agents|antimanic agents|mesh-ancestor
110025760|NCT00373464|Analgesics|analgesics|mesh-ancestor
111032472|NCT02433795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111032473|NCT02433795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111032474|NCT02433795|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111032475|NCT02433795|Alkylating Agents|alkylating agents|mesh-ancestor
111032476|NCT02433795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111032477|NCT03038516|Cholecalciferol|cholecalciferol|mesh-list
111032479|NCT03038516|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111032480|NCT03038516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111032481|NCT03038516|Vitamins|vitamins|mesh-ancestor
111032482|NCT03038516|Micronutrients|micronutrients|mesh-ancestor
111032483|NCT03038516|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111032484|NCT02424435|Methylprednisolone|methylprednisolone|mesh-list
111032485|NCT02424435|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111032486|NCT02424435|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111032487|NCT02424435|Prednisolone|prednisolone|mesh-list
111032488|NCT02424435|Prednisolone acetate|prednisolone acetate|mesh-list
111032489|NCT02424435|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111032490|NCT02424435|Prednisolone phosphate|prednisolone phosphate|mesh-list
111032491|NCT02424435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111032492|NCT02424435|Antiemetics|antiemetics|mesh-ancestor
111032493|NCT02424435|Autonomic Agents|autonomic agents|mesh-ancestor
111032494|NCT02424435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111032495|NCT02424435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111032496|NCT02424435|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111032497|NCT02424435|Glucocorticoids|glucocorticoids|mesh-ancestor
111032498|NCT02424435|Hormones|hormones|mesh-ancestor
111032499|NCT02424435|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111032500|NCT02424435|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111032501|NCT02424435|Protective Agents|protective agents|mesh-ancestor
111032502|NCT02424435|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111032503|NCT02424435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111032504|NCT04842968|Methylene Blue|methylene blue|mesh-list
111032505|NCT04842968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111032506|NCT04842968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111032507|NCT04832204|Apatinib|apatinib|mesh-list
111032508|NCT04832204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111032509|NCT04832204|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111032510|NCT04832204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111032511|NCT04832204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111032512|NCT03038282|Chromium|chromium|mesh-list
111032513|NCT03038282|Chromous chloride|chromous chloride|mesh-list
111032514|NCT03038282|Trace Elements|trace elements|mesh-ancestor
111032515|NCT03038282|Micronutrients|micronutrients|mesh-ancestor
111032516|NCT03038282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111032517|NCT03038282|Antioxidants|antioxidants|mesh-ancestor
111032518|NCT03038282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111032519|NCT03038282|Protective Agents|protective agents|mesh-ancestor
111032520|NCT02424045|Dexamethasone|dexamethasone|mesh-list
111032521|NCT02424045|Carboplatin|carboplatin|mesh-list
111032522|NCT02424045|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
111032523|NCT02424045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111032524|NCT02424045|Antiemetics|antiemetics|mesh-ancestor
111032525|NCT02424045|Autonomic Agents|autonomic agents|mesh-ancestor
111032526|NCT02424045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111032527|NCT02424045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111032528|NCT02424045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111032529|NCT02424045|Glucocorticoids|glucocorticoids|mesh-ancestor
111032530|NCT02424045|Hormones|hormones|mesh-ancestor
111032531|NCT02424045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111032532|NCT02424045|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111032533|NCT02424045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111032534|NCT02424045|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111032535|NCT02424045|Alkylating Agents|alkylating agents|mesh-ancestor
111032536|NCT02424045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111032537|NCT03037970|Becaplermin|becaplermin|mesh-list
111032538|NCT03037970|Anticoagulants|anticoagulants|mesh-ancestor
111032539|NCT03037970|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
111032540|NCT03037970|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111032541|NCT03037970|Growth Substances|growth substances|mesh-ancestor
111032542|NCT03037970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111032543|NCT04841720|Metformin|metformin|mesh-list
111032544|NCT04841720|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111032545|NCT04841720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111032546|NCT05117931|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
111032547|NCT05117931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111032548|NCT05117931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111032549|NCT03039842|Valproic Acid|valproic acid|mesh-list
111032550|NCT03039842|Memantine|memantine|mesh-list
111032551|NCT03039842|Dextromethorphan|dextromethorphan|mesh-list
111032552|NCT03039842|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111032553|NCT03039842|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111032554|NCT03039842|Dopamine Agents|dopamine agents|mesh-ancestor
111032555|NCT03039842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111032556|NCT03039842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111032557|NCT03039842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111032558|NCT03039842|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111032559|NCT03039842|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111032560|NCT03039842|Antitussive Agents|antitussive agents|mesh-ancestor
111032561|NCT03039842|Respiratory System Agents|respiratory system agents|mesh-ancestor
111032562|NCT03039842|Anticonvulsants|anticonvulsants|mesh-ancestor
111032563|NCT03039842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111032564|NCT03039842|GABA Agents|gaba agents|mesh-ancestor
111032565|NCT03039842|Antimanic Agents|antimanic agents|mesh-ancestor
111032566|NCT03039842|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111032567|NCT03039842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110626285|NCT00816894|Olanzapine|olanzapine|mesh-list
111032568|NCT03039842|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111032569|NCT03181815|Cytarabine|cytarabine|mesh-list
111032570|NCT03181815|Cladribine|cladribine|mesh-list
111032571|NCT03181815|Aclarubicin|aclarubicin|mesh-list
111032572|NCT03181815|Aclacinomycins|aclacinomycins|mesh-list
111032573|NCT03181815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111032574|NCT03181815|Antimetabolites|antimetabolites|mesh-ancestor
111032575|NCT03181815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111032576|NCT03181815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111032577|NCT03181815|Antiviral Agents|antiviral agents|mesh-ancestor
111032578|NCT03181815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111032579|NCT03181815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111032580|NCT03181815|Immunologic Factors|immunologic factors|mesh-ancestor
111032581|NCT03181815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111032582|NCT03181815|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111032583|NCT03181815|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111032584|NCT03181815|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111032585|NCT03181815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111032586|NCT03181815|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111032587|NCT03038048|Ranibizumab|ranibizumab|mesh-list
111032588|NCT03038048|Aflibercept|aflibercept|mesh-list
111032589|NCT03038048|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111032590|NCT03038048|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111032591|NCT03038048|Growth Substances|growth substances|mesh-ancestor
111032592|NCT03038048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111032593|NCT03038048|Growth Inhibitors|growth inhibitors|mesh-ancestor
111032594|NCT03038048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111032595|NCT03185871|Celecoxib|celecoxib|mesh-list
111032596|NCT03185871|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111032597|NCT03185871|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111032598|NCT03185871|Analgesics|analgesics|mesh-ancestor
111032599|NCT03185871|Sensory System Agents|sensory system agents|mesh-ancestor
111032600|NCT03185871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111032601|NCT03185871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111032602|NCT03185871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111032603|NCT03185871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111032604|NCT03185871|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111032605|NCT03185871|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111032606|NCT03185871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111032607|NCT03185871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111032608|NCT03181113|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
111032609|NCT03181113|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
111032610|NCT03181113|Antiviral Agents|antiviral agents|mesh-ancestor
111032611|NCT03181113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111032612|NCT03180957|Adalimumab|adalimumab|mesh-list
111032613|NCT03180957|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111032614|NCT03180957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111032615|NCT03180957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111032616|NCT02427165|Albuterol|albuterol|mesh-list
111032617|NCT02427165|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111032618|NCT02427165|Autonomic Agents|autonomic agents|mesh-ancestor
111032619|NCT02427165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111032620|NCT02427165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111032621|NCT02427165|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111032623|NCT02427165|Tocolytic Agents|tocolytic agents|mesh-ancestor
111032624|NCT02427165|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111032625|NCT02427165|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111032626|NCT02427165|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111032627|NCT02427165|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111032628|NCT02427165|Adrenergic Agents|adrenergic agents|mesh-ancestor
111032629|NCT02427165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111032630|NCT02427165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111032632|NCT03037736|Fluorouracil|fluorouracil|mesh-list
111032633|NCT03037736|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111032634|NCT03037736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111032635|NCT03037736|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111032636|NCT03037736|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111032637|NCT03037736|Growth Substances|growth substances|mesh-ancestor
111032638|NCT03037736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111032639|NCT03037736|Growth Inhibitors|growth inhibitors|mesh-ancestor
111032640|NCT03037736|Antimetabolites|antimetabolites|mesh-ancestor
111032641|NCT03037736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111032642|NCT03037736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111032643|NCT03037736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111032644|NCT03037736|Immunologic Factors|immunologic factors|mesh-ancestor
111032645|NCT04838132|Ropivacaine|ropivacaine|mesh-list
111032646|NCT04838132|Anesthetics, Local|anesthetics, local|mesh-ancestor
111032647|NCT04838132|Anesthetics|anesthetics|mesh-ancestor
111032648|NCT04838132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111032649|NCT04838132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111032650|NCT04838132|Sensory System Agents|sensory system agents|mesh-ancestor
111032651|NCT04838132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111032652|NCT03037892|Fentanyl|fentanyl|mesh-list
111032653|NCT03037892|Midazolam|midazolam|mesh-list
111032654|NCT03037892|Remifentanil|remifentanil|mesh-list
111032655|NCT03037892|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111032656|NCT03037892|Narcotics|narcotics|mesh-ancestor
111032657|NCT03037892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111032658|NCT03037892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111032659|NCT03037892|Analgesics|analgesics|mesh-ancestor
111032660|NCT03037892|Sensory System Agents|sensory system agents|mesh-ancestor
111032661|NCT03037892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111032662|NCT03037892|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111032663|NCT03037892|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111032664|NCT03037892|Anesthetics, General|anesthetics, general|mesh-ancestor
111032665|NCT03037892|Anesthetics|anesthetics|mesh-ancestor
111032666|NCT03037892|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111032667|NCT03037892|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111032668|NCT03037892|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111032669|NCT03037892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111032670|NCT03037892|GABA Modulators|gaba modulators|mesh-ancestor
111032671|NCT03037892|GABA Agents|gaba agents|mesh-ancestor
111032672|NCT03037892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111032673|NCT03037892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111032674|NCT03183843|Warfarin|warfarin|mesh-list
111032675|NCT03183843|Dabigatran|dabigatran|mesh-list
111032676|NCT03183843|Anticoagulants|anticoagulants|mesh-ancestor
111032677|NCT03183843|Antithrombins|antithrombins|mesh-ancestor
111032678|NCT03183843|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111032679|NCT03183843|Protease Inhibitors|protease inhibitors|mesh-ancestor
111032680|NCT03183843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111032681|NCT03183843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111032682|NCT03180879|Ibuprofen|ibuprofen|mesh-list
111032683|NCT03180879|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111032684|NCT03180879|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111032685|NCT03180879|Analgesics|analgesics|mesh-ancestor
111032686|NCT03180879|Sensory System Agents|sensory system agents|mesh-ancestor
111032687|NCT03180879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111032688|NCT03180879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111032689|NCT03180879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111032690|NCT03180879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111032691|NCT03180879|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111032692|NCT03180879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111032693|NCT03180879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111032694|NCT03180723|Cyclosporine|cyclosporine|mesh-list
111032695|NCT03180723|Rituximab|rituximab|mesh-list
111032696|NCT03180723|Cyclosporins|cyclosporins|mesh-list
110749785|NCT01097148|Atracurium|atracurium|mesh-list
110827284|NCT03388164|Autonomic Agents|autonomic agents|mesh-ancestor
111032697|NCT03180723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111032698|NCT03180723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111032699|NCT03180723|Immunologic Factors|immunologic factors|mesh-ancestor
111032700|NCT03180723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111032701|NCT03180723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111032702|NCT03180723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111032703|NCT03180723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111032704|NCT03180723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111032705|NCT03180723|Antifungal Agents|antifungal agents|mesh-ancestor
111032706|NCT03180723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111032707|NCT03180723|Dermatologic Agents|dermatologic agents|mesh-ancestor
111032708|NCT03180723|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111032710|NCT04841096|Glimepiride|glimepiride|mesh-list
111032711|NCT04841096|Vildagliptin|vildagliptin|mesh-list
111032712|NCT04841096|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111032713|NCT04841096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111032714|NCT04841096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111032715|NCT04841096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111032716|NCT04841096|Immunologic Factors|immunologic factors|mesh-ancestor
111032717|NCT04841096|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111032718|NCT04841096|Protease Inhibitors|protease inhibitors|mesh-ancestor
111032719|NCT04841096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111032720|NCT04841096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111032721|NCT02427243|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111032722|NCT02427243|Immunologic Factors|immunologic factors|mesh-ancestor
111032723|NCT02427243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111032724|NCT02426697|Fentanyl|fentanyl|mesh-list
111032725|NCT02426697|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111032726|NCT02426697|Narcotics|narcotics|mesh-ancestor
111032727|NCT02426697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111032728|NCT02426697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111032729|NCT02426697|Analgesics|analgesics|mesh-ancestor
111032730|NCT02426697|Sensory System Agents|sensory system agents|mesh-ancestor
111032731|NCT02426697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111032732|NCT02426697|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111032733|NCT02426697|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111032734|NCT02426697|Anesthetics, General|anesthetics, general|mesh-ancestor
111032735|NCT02426697|Anesthetics|anesthetics|mesh-ancestor
111032736|NCT03039608|Prednisone|prednisone|mesh-list
111032737|NCT03039608|Triamcinolone|triamcinolone|mesh-list
111032738|NCT03039608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111032739|NCT03039608|Glucocorticoids|glucocorticoids|mesh-ancestor
111032740|NCT03039608|Hormones|hormones|mesh-ancestor
111032741|NCT03039608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111032742|NCT03039608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111032743|NCT03039608|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111032744|NCT03039608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111032745|NCT02423811|Fursultiamin|fursultiamin|mesh-list
111032746|NCT02423811|Vitamin B Complex|vitamin b complex|mesh-ancestor
111032747|NCT02423811|Vitamins|vitamins|mesh-ancestor
111032748|NCT02423811|Micronutrients|micronutrients|mesh-ancestor
111032749|NCT02423811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111032750|NCT04837664|Nystatin|nystatin|mesh-list
111032751|NCT04837664|Curcumin|curcumin|mesh-list
111032752|NCT04837664|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111032753|NCT04837664|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111032754|NCT04837664|Analgesics|analgesics|mesh-ancestor
111032755|NCT04837664|Sensory System Agents|sensory system agents|mesh-ancestor
111032756|NCT04837664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111032757|NCT04837664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111032758|NCT04837664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111032759|NCT04837664|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111032760|NCT04837664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111032761|NCT04837664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111032762|NCT04837664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111032763|NCT04837664|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111032764|NCT04837664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111032765|NCT04837664|Antifungal Agents|antifungal agents|mesh-ancestor
111032766|NCT04837664|Ionophores|ionophores|mesh-ancestor
111032767|NCT04837664|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111032768|NCT01331837|Etanercept|etanercept|mesh-list
111032769|NCT01331837|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111032770|NCT01331837|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111032771|NCT01331837|Analgesics|analgesics|mesh-ancestor
111032772|NCT01331837|Sensory System Agents|sensory system agents|mesh-ancestor
111032773|NCT01331837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111032774|NCT01331837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111032775|NCT01331837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111032776|NCT01331837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111032777|NCT01331837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111032778|NCT01331837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111032779|NCT01331837|Immunologic Factors|immunologic factors|mesh-ancestor
111032780|NCT02706483|Plecanatide|plecanatide|mesh-list
111032781|NCT02706483|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
111032782|NCT02706483|Enzyme Activators|enzyme activators|mesh-ancestor
111032783|NCT02706483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111032784|NCT02706483|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111032785|NCT03183375|Hydroxyurea|hydroxyurea|mesh-list
111032786|NCT03183375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111032787|NCT03183375|Antisickling Agents|antisickling agents|mesh-ancestor
111032788|NCT03183375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111032789|NCT03183375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111032790|NCT03183375|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111032791|NCT03183297|Fexofenadine|fexofenadine|mesh-list
111032792|NCT03183297|Naproxen|naproxen|mesh-list
111032793|NCT03183297|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111032794|NCT03183297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111032795|NCT03183297|Analgesics|analgesics|mesh-ancestor
111032796|NCT03183297|Sensory System Agents|sensory system agents|mesh-ancestor
111032797|NCT03183297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111032798|NCT03183297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111032799|NCT03183297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111032800|NCT03183297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111032801|NCT03183297|Gout Suppressants|gout suppressants|mesh-ancestor
111032802|NCT03183297|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111032803|NCT03183297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111032804|NCT03183297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111032805|NCT03183297|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111032806|NCT03183297|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
111032807|NCT03183297|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111032808|NCT03183297|Histamine Antagonists|histamine antagonists|mesh-ancestor
111032809|NCT03183297|Histamine Agents|histamine agents|mesh-ancestor
111032810|NCT03183297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111032811|NCT02426619|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111032812|NCT02426619|Fluorides|fluorides|mesh-list
111032813|NCT02426619|Sodium Fluoride|sodium fluoride|mesh-list
111032814|NCT02426619|Fluorides, Topical|fluorides, topical|mesh-list
111032815|NCT02426619|Cariostatic Agents|cariostatic agents|mesh-ancestor
111032816|NCT02426619|Protective Agents|protective agents|mesh-ancestor
111032817|NCT02426619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111032818|NCT02108483|Dapsone|dapsone|mesh-list
111032819|NCT02108483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111032820|NCT02108483|Antimalarials|antimalarials|mesh-ancestor
111032821|NCT02108483|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111032822|NCT02108483|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111032823|NCT02108483|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111032824|NCT02108483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111032825|NCT02108483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111032826|NCT02108483|Leprostatic Agents|leprostatic agents|mesh-ancestor
111032827|NCT02108483|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111032828|NCT01648348|Bevacizumab|bevacizumab|mesh-list
111032829|NCT01648348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111032830|NCT01648348|Endothelial Growth Factors|endothelial growth factors|mesh-list
111032831|NCT01648348|Antibodies|antibodies|mesh-list
111032832|NCT01648348|Immunoglobulins|immunoglobulins|mesh-list
111032833|NCT01648348|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111032834|NCT01648348|Immunoglobulin G|immunoglobulin g|mesh-list
111032835|NCT01648348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111032836|NCT01648348|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111032837|NCT01648348|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111032838|NCT01648348|Growth Substances|growth substances|mesh-ancestor
111032839|NCT01648348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111032840|NCT01648348|Growth Inhibitors|growth inhibitors|mesh-ancestor
111032841|NCT01648348|Immunologic Factors|immunologic factors|mesh-ancestor
111032842|NCT03180255|Dexamethasone|dexamethasone|mesh-list
111032843|NCT03180255|Sodium Citrate|sodium citrate|mesh-list
111032844|NCT03180255|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
111032845|NCT03180255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111032846|NCT03180255|Antiemetics|antiemetics|mesh-ancestor
111032847|NCT03180255|Autonomic Agents|autonomic agents|mesh-ancestor
111032848|NCT03180255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111032849|NCT03180255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111032850|NCT03180255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111032851|NCT03180255|Glucocorticoids|glucocorticoids|mesh-ancestor
111032853|NCT03180255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111032854|NCT03180255|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111032855|NCT03180255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111032856|NCT03180255|Anticoagulants|anticoagulants|mesh-ancestor
111032857|NCT02431221|Perhexiline|perhexiline|mesh-list
111032858|NCT02431221|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111032859|NCT02431221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111032860|NCT02431221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111032861|NCT02431221|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111032862|NCT02431221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111032863|NCT02431221|Vasodilator Agents|vasodilator agents|mesh-ancestor
111032864|NCT02108639|Asunaprevir|asunaprevir|mesh-list
111032865|NCT02108639|Protease Inhibitors|protease inhibitors|mesh-ancestor
111032866|NCT02108639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111032867|NCT02108639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111032868|NCT03180099|Bupivacaine|bupivacaine|mesh-list
111032869|NCT03180099|Anesthetics, Local|anesthetics, local|mesh-ancestor
111032870|NCT03180099|Anesthetics|anesthetics|mesh-ancestor
111032871|NCT03180099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111032872|NCT03180099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111032873|NCT03180099|Sensory System Agents|sensory system agents|mesh-ancestor
111032874|NCT03180099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111032876|NCT04770272|Cyclophosphamide|cyclophosphamide|mesh-list
111032877|NCT04770272|Carboplatin|carboplatin|mesh-list
111032878|NCT04770272|Atezolizumab|atezolizumab|mesh-list
111032879|NCT04770272|Epirubicin|epirubicin|mesh-list
111032880|NCT04770272|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111032881|NCT04770272|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111032882|NCT04770272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111032883|NCT04770272|Tubulin Modulators|tubulin modulators|mesh-ancestor
111032884|NCT04770272|Antimitotic Agents|antimitotic agents|mesh-ancestor
111032885|NCT04770272|Mitosis Modulators|mitosis modulators|mesh-ancestor
111032886|NCT04770272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111032887|NCT04770272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111032888|NCT04770272|Immunologic Factors|immunologic factors|mesh-ancestor
111032889|NCT04770272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111032890|NCT04770272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111032891|NCT04770272|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111032892|NCT04770272|Alkylating Agents|alkylating agents|mesh-ancestor
111032893|NCT04770272|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111032894|NCT04770272|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111032895|NCT04770272|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111032896|NCT04770272|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111032897|NCT04770272|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111032898|NCT04770272|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111032899|NCT04770272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111032900|NCT02251145|Ritonavir|ritonavir|mesh-list
111032901|NCT02251145|Tenofovir|tenofovir|mesh-list
111032902|NCT02251145|Tipranavir|tipranavir|mesh-list
111032903|NCT02251145|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111032904|NCT02251145|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111032905|NCT02251145|Protease Inhibitors|protease inhibitors|mesh-ancestor
111032906|NCT02251145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111032907|NCT02251145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111032908|NCT02251145|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111032909|NCT02251145|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111032910|NCT02251145|Antiviral Agents|antiviral agents|mesh-ancestor
111032911|NCT02251145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111032912|NCT02251145|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111032913|NCT02251145|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111032914|NCT02251145|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111032915|NCT02251145|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111032916|NCT04792424|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111032917|NCT04792424|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
111032918|NCT04792424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111032919|NCT00709371|Zonisamide|zonisamide|mesh-list
111032921|NCT00709371|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111032922|NCT00709371|Antidepressive Agents|antidepressive agents|mesh-ancestor
111032923|NCT00709371|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111032924|NCT00709371|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111032925|NCT00709371|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111032926|NCT00709371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111032927|NCT00709371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111032928|NCT00709371|Dopamine Agents|dopamine agents|mesh-ancestor
111032929|NCT00709371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111032930|NCT00709371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111032931|NCT00709371|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111032932|NCT00709371|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111032933|NCT00709371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111032934|NCT00709371|Anticonvulsants|anticonvulsants|mesh-ancestor
111032935|NCT00709371|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111032936|NCT00709371|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111032938|NCT02426463|Propofol|propofol|mesh-list
111032939|NCT02426463|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111032940|NCT02426463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111032941|NCT02426463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111032942|NCT02426463|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111032943|NCT02426463|Anesthetics, General|anesthetics, general|mesh-ancestor
111032944|NCT02426463|Anesthetics|anesthetics|mesh-ancestor
111032945|NCT02426463|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111032946|NCT02426463|Narcotics|narcotics|mesh-ancestor
111032947|NCT02426463|Analgesics|analgesics|mesh-ancestor
111032948|NCT02426463|Sensory System Agents|sensory system agents|mesh-ancestor
111032949|NCT02426463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111032950|NCT02426229|Dabigatran|dabigatran|mesh-list
111032951|NCT02426229|Antithrombins|antithrombins|mesh-ancestor
111032952|NCT02426229|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111032953|NCT02426229|Protease Inhibitors|protease inhibitors|mesh-ancestor
111032954|NCT02426229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111032955|NCT02426229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111032956|NCT02426229|Anticoagulants|anticoagulants|mesh-ancestor
111032957|NCT01648270|Buprenorphine|buprenorphine|mesh-list
111032958|NCT01648270|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111032959|NCT01648270|Narcotics|narcotics|mesh-ancestor
111032960|NCT01648270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111032961|NCT01648270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111032962|NCT01648270|Analgesics|analgesics|mesh-ancestor
111032963|NCT01648270|Sensory System Agents|sensory system agents|mesh-ancestor
111032964|NCT01648270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111032965|NCT01648270|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111032966|NCT02108795|Remifentanil|remifentanil|mesh-list
111032967|NCT02108795|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111032968|NCT02108795|Narcotics|narcotics|mesh-ancestor
111032969|NCT02108795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111032970|NCT02108795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111032971|NCT02108795|Analgesics|analgesics|mesh-ancestor
111032972|NCT02108795|Sensory System Agents|sensory system agents|mesh-ancestor
111032973|NCT02108795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111032974|NCT02431143|Miltefosine|miltefosine|mesh-list
111032975|NCT02431143|Antifungal Agents|antifungal agents|mesh-ancestor
111032976|NCT02431143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111032977|NCT02431143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111032978|NCT02431143|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111032979|NCT02431143|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111032980|NCT02302846|Ixazomib|ixazomib|mesh-list
111032981|NCT02302846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111032982|NCT02302846|Protease Inhibitors|protease inhibitors|mesh-ancestor
111032983|NCT02302846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110626320|NCT00822744|Escitalopram|escitalopram|mesh-list
111032984|NCT02302846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111032985|NCT02431065|Ropivacaine|ropivacaine|mesh-list
111032986|NCT02431065|Anesthetics, Local|anesthetics, local|mesh-ancestor
111032987|NCT02431065|Anesthetics|anesthetics|mesh-ancestor
111032988|NCT02431065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111032989|NCT02431065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111032990|NCT02431065|Sensory System Agents|sensory system agents|mesh-ancestor
111032991|NCT02431065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111032992|NCT04836806|Cetirizine|cetirizine|mesh-list
111032993|NCT04836806|Famotidine|famotidine|mesh-list
111032994|NCT04836806|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111032995|NCT04836806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111032996|NCT04836806|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
111032997|NCT04836806|Histamine Antagonists|histamine antagonists|mesh-ancestor
111032998|NCT04836806|Histamine Agents|histamine agents|mesh-ancestor
111032999|NCT04836806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111033000|NCT04836806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111033001|NCT04836806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111033002|NCT04836806|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111033003|NCT04836806|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
111033004|NCT04836806|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111033005|NCT04836728|Paclitaxel|paclitaxel|mesh-list
111033006|NCT04836728|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111033007|NCT04836728|Carboplatin|carboplatin|mesh-list
111033008|NCT04836728|Pemetrexed|pemetrexed|mesh-list
111033009|NCT04836728|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
111033010|NCT04836728|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111033011|NCT04836728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111033012|NCT04836728|Tubulin Modulators|tubulin modulators|mesh-ancestor
111033013|NCT04836728|Antimitotic Agents|antimitotic agents|mesh-ancestor
111033014|NCT04836728|Mitosis Modulators|mitosis modulators|mesh-ancestor
111033015|NCT04836728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111033016|NCT04836728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111033017|NCT04836728|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111033018|NCT04836728|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111033019|NCT04836728|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111033020|NCT02109185|Mometasone Furoate|mometasone furoate|mesh-list
111033021|NCT02109185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111033022|NCT02109185|Dermatologic Agents|dermatologic agents|mesh-ancestor
111033023|NCT02109185|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111033024|NCT02430909|Certolizumab Pegol|certolizumab pegol|mesh-list
111033025|NCT02430909|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111033026|NCT02430909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111033027|NCT02430909|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111033028|NCT02430909|Immunologic Factors|immunologic factors|mesh-ancestor
111033029|NCT02430909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111033030|NCT02430909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111033031|NCT02105675|Docetaxel|docetaxel|mesh-list
111033032|NCT02105675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111033033|NCT02105675|Tubulin Modulators|tubulin modulators|mesh-ancestor
111033034|NCT02105675|Antimitotic Agents|antimitotic agents|mesh-ancestor
111033035|NCT02105675|Mitosis Modulators|mitosis modulators|mesh-ancestor
111033036|NCT02105675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111033037|NCT02336230|Remestemcel-l|remestemcel-l|mesh-list
111033038|NCT02336230|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111033039|NCT02336230|Antiviral Agents|antiviral agents|mesh-ancestor
111033040|NCT02336230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111033041|NCT04835948|Antilymphocyte Serum|antilymphocyte serum|mesh-list
111033042|NCT04835948|Immunologic Factors|immunologic factors|mesh-ancestor
111033043|NCT04835948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111033044|NCT04835948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111033045|NCT04824404|Buprenorphine|buprenorphine|mesh-list
111033046|NCT04824404|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111033047|NCT04824404|Narcotics|narcotics|mesh-ancestor
111033048|NCT04824404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111033049|NCT04824404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111033050|NCT04824404|Analgesics|analgesics|mesh-ancestor
111033051|NCT04824404|Sensory System Agents|sensory system agents|mesh-ancestor
111033052|NCT04824404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111033053|NCT04824404|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111033054|NCT02109341|Paclitaxel|paclitaxel|mesh-list
111033055|NCT02109341|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111033056|NCT02109341|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111033057|NCT02109341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111033058|NCT02109341|Tubulin Modulators|tubulin modulators|mesh-ancestor
111033059|NCT02109341|Antimitotic Agents|antimitotic agents|mesh-ancestor
111033060|NCT02109341|Mitosis Modulators|mitosis modulators|mesh-ancestor
111033061|NCT02109341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111033062|NCT02336074|Raltegravir Potassium|raltegravir potassium|mesh-list
111033063|NCT02336074|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
111033064|NCT02336074|Vorinostat|vorinostat|mesh-list
111033065|NCT02336074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111033066|NCT02336074|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111033067|NCT02336074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111033068|NCT02336074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111033069|NCT02336074|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111033071|NCT02336074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111033072|NCT02336074|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111033073|NCT02336074|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111033074|NCT04367168|Colchicine|colchicine|mesh-list
111033075|NCT04367168|Gout Suppressants|gout suppressants|mesh-ancestor
111033076|NCT04367168|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111033077|NCT04367168|Tubulin Modulators|tubulin modulators|mesh-ancestor
111033078|NCT04367168|Antimitotic Agents|antimitotic agents|mesh-ancestor
111033079|NCT04367168|Mitosis Modulators|mitosis modulators|mesh-ancestor
111033080|NCT04367168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111033081|NCT04367168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111033082|NCT02113943|Citalopram|citalopram|mesh-list
111033083|NCT02113943|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111033084|NCT02113943|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111033085|NCT02113943|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111033086|NCT02113943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111033087|NCT02113943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111033088|NCT02113943|Serotonin Agents|serotonin agents|mesh-ancestor
111033089|NCT02113943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111033090|NCT02113943|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111033091|NCT02113943|Antidepressive Agents|antidepressive agents|mesh-ancestor
111033092|NCT02113943|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111033093|NCT02114021|Betamethasone|betamethasone|mesh-list
111033094|NCT02114021|Lidocaine|lidocaine|mesh-list
111033095|NCT02114021|Anesthetics, Local|anesthetics, local|mesh-ancestor
111033096|NCT02114021|Anesthetics|anesthetics|mesh-ancestor
111033097|NCT02114021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111033098|NCT02114021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111033099|NCT02114021|Sensory System Agents|sensory system agents|mesh-ancestor
111033100|NCT02114021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111033101|NCT02114021|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111033102|NCT02114021|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111033103|NCT02114021|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111033104|NCT02114021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111033105|NCT02114021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111033106|NCT02114021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111033107|NCT02114021|Glucocorticoids|glucocorticoids|mesh-ancestor
111033108|NCT02114021|Hormones|hormones|mesh-ancestor
111033109|NCT02114021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111033110|NCT02114021|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111033111|NCT02114021|Respiratory System Agents|respiratory system agents|mesh-ancestor
111033112|NCT04826822|Dexamethasone|dexamethasone|mesh-list
111033113|NCT04826822|Spironolactone|spironolactone|mesh-list
111033114|NCT04826822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111033115|NCT04826822|Antiemetics|antiemetics|mesh-ancestor
111033116|NCT04826822|Autonomic Agents|autonomic agents|mesh-ancestor
111033117|NCT04826822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111033118|NCT04826822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111033119|NCT04826822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111033120|NCT04826822|Glucocorticoids|glucocorticoids|mesh-ancestor
111033121|NCT04826822|Hormones|hormones|mesh-ancestor
111033122|NCT04826822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111033123|NCT04826822|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111033124|NCT04826822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111033125|NCT04826822|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
111033126|NCT04826822|Hormone Antagonists|hormone antagonists|mesh-ancestor
111033127|NCT04826822|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
111033128|NCT04826822|Diuretics|diuretics|mesh-ancestor
111033129|NCT04826822|Natriuretic Agents|natriuretic agents|mesh-ancestor
111033130|NCT02251457|Ranolazine|ranolazine|mesh-list
111033131|NCT02251457|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111033132|NCT02251457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111033133|NCT02251457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111033134|NCT02112305|Magnesium Sulfate|magnesium sulfate|mesh-list
111033135|NCT02112305|Analgesics|analgesics|mesh-ancestor
111033136|NCT02112305|Sensory System Agents|sensory system agents|mesh-ancestor
111033137|NCT02112305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111033138|NCT02112305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111033139|NCT02112305|Anesthetics|anesthetics|mesh-ancestor
111033140|NCT02112305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111033141|NCT02112305|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111033142|NCT02112305|Anticonvulsants|anticonvulsants|mesh-ancestor
111033143|NCT02112305|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111033144|NCT02112305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111033145|NCT02112305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111033146|NCT02112305|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111033147|NCT02112305|Tocolytic Agents|tocolytic agents|mesh-ancestor
111033148|NCT02112305|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111033149|NCT02114099|Atorvastatin|atorvastatin|mesh-list
111033150|NCT02114099|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111033151|NCT02114099|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111033152|NCT02114099|Antimetabolites|antimetabolites|mesh-ancestor
111033153|NCT02114099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111033154|NCT02114099|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111033155|NCT02114099|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111033156|NCT02114099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111033157|NCT02251223|Ritonavir|ritonavir|mesh-list
111033158|NCT02251223|Tipranavir|tipranavir|mesh-list
111033159|NCT02251223|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111033160|NCT02251223|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111033161|NCT02251223|Protease Inhibitors|protease inhibitors|mesh-ancestor
111033162|NCT02251223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111033163|NCT02251223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111033164|NCT02251223|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111033165|NCT02251223|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111033166|NCT02251223|Antiviral Agents|antiviral agents|mesh-ancestor
111033167|NCT02251223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111033168|NCT02251223|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111033169|NCT02251223|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111033170|NCT02114333|Vaccines|vaccines|mesh-list
111033171|NCT02114333|Immunologic Factors|immunologic factors|mesh-ancestor
111033172|NCT02114333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111033173|NCT02114489|Ibandronic Acid|ibandronic acid|mesh-list
111033174|NCT02114489|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111033175|NCT02114489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111033176|NCT02114645|Leuprolide|leuprolide|mesh-list
111033177|NCT02114645|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
111033178|NCT02114645|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
111033179|NCT02114645|Estradiol|estradiol|mesh-list
111033180|NCT02114645|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
111033181|NCT02114645|Progesterone|progesterone|mesh-list
111033182|NCT02114645|Estrogens|estrogens|mesh-ancestor
111033183|NCT02114645|Hormones|hormones|mesh-ancestor
111033184|NCT02114645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111033185|NCT02114645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111033186|NCT02114645|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110626343|NCT00778817|Mitotane|mitotane|mesh-list
111033187|NCT02114645|Contraceptive Agents|contraceptive agents|mesh-ancestor
111033188|NCT02114645|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111033189|NCT02114645|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111033190|NCT02114645|Progestins|progestins|mesh-ancestor
111033191|NCT02114645|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111033192|NCT02114645|Fertility Agents|fertility agents|mesh-ancestor
111033193|NCT02114645|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111033194|NCT02114645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111033195|NCT02112695|Diprenorphine|diprenorphine|mesh-list
111033196|NCT02112695|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111033197|NCT02112695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111033198|NCT02112695|Sensory System Agents|sensory system agents|mesh-ancestor
111033199|NCT02112695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111033200|NCT04361162|Nivolumab|nivolumab|mesh-list
111033201|NCT04361162|Ipilimumab|ipilimumab|mesh-list
111033202|NCT04361162|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111033203|NCT04361162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111033204|NCT04361162|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111033205|NCT04361162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111033206|NCT04823390|Fentanyl|fentanyl|mesh-list
111033207|NCT04823390|Midazolam|midazolam|mesh-list
111033208|NCT04823390|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111033209|NCT04823390|Narcotics|narcotics|mesh-ancestor
111033210|NCT04823390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111033211|NCT04823390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111033212|NCT04823390|Analgesics|analgesics|mesh-ancestor
111033213|NCT04823390|Sensory System Agents|sensory system agents|mesh-ancestor
111033214|NCT04823390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111033215|NCT04823390|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111033216|NCT04823390|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111033217|NCT04823390|Anesthetics, General|anesthetics, general|mesh-ancestor
111033218|NCT04823390|Anesthetics|anesthetics|mesh-ancestor
111033219|NCT04823390|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111033220|NCT04823390|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111033221|NCT04823390|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111033222|NCT04823390|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111033223|NCT04823390|GABA Modulators|gaba modulators|mesh-ancestor
111033224|NCT04823390|GABA Agents|gaba agents|mesh-ancestor
111033225|NCT04823390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111033226|NCT04823390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111033227|NCT05618912|Petrolatum|petrolatum|mesh-list
111033228|NCT05618912|Emollients|emollients|mesh-ancestor
111033230|NCT04826510|Lithium Carbonate|lithium carbonate|mesh-list
111033231|NCT04826510|Perospirone|perospirone|mesh-list
111033232|NCT04826510|Antidepressive Agents|antidepressive agents|mesh-ancestor
111033233|NCT04826510|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111033234|NCT04826510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111033235|NCT04826510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111033236|NCT04826510|Antimanic Agents|antimanic agents|mesh-ancestor
111033237|NCT04826510|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111033238|NCT04826510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111033239|NCT04826510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111033240|NCT04826510|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111033241|NCT03036800|Liraglutide|liraglutide|mesh-list
111033242|NCT03036800|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111033243|NCT03036800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111033244|NCT03036800|Incretins|incretins|mesh-ancestor
111033245|NCT03036800|Hormones|hormones|mesh-ancestor
111033246|NCT03036800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111033247|NCT02301988|Paclitaxel|paclitaxel|mesh-list
111033248|NCT02301988|Ipatasertib|ipatasertib|mesh-list
111033249|NCT02301988|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111033250|NCT02301988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111033251|NCT02301988|Tubulin Modulators|tubulin modulators|mesh-ancestor
111033252|NCT02301988|Antimitotic Agents|antimitotic agents|mesh-ancestor
111033253|NCT02301988|Mitosis Modulators|mitosis modulators|mesh-ancestor
111033254|NCT02301988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111033255|NCT02301988|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111033256|NCT02301988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111033257|NCT04326920|Sargramostim|sargramostim|mesh-list
111033258|NCT04326920|Immunologic Factors|immunologic factors|mesh-ancestor
111033259|NCT04326920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111033260|NCT02112929|Xenon|xenon|mesh-list
111033261|NCT02112929|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111033262|NCT02112929|Anesthetics, General|anesthetics, general|mesh-ancestor
111033263|NCT02112929|Anesthetics|anesthetics|mesh-ancestor
111033264|NCT02112929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111033265|NCT02112929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111033266|NCT02119091|Moxifloxacin|moxifloxacin|mesh-list
111033267|NCT02119091|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111033268|NCT02119091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111033269|NCT02119091|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111033270|NCT02119091|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111033271|NCT02119091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111033272|NCT02119091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111033273|NCT02119091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111033274|NCT02115035|Vemurafenib|vemurafenib|mesh-list
111033275|NCT02115035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111033276|NCT02115035|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111033277|NCT02115035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111033278|NCT02115035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111033279|NCT02113319|Dasatinib|dasatinib|mesh-list
111033280|NCT02113319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111033281|NCT02113319|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111033282|NCT02113319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111033283|NCT02113319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111033284|NCT02113397|Tobramycin|tobramycin|mesh-list
111033285|NCT02113397|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111033286|NCT02113397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111033287|NCT04822064|Dexmedetomidine|dexmedetomidine|mesh-list
111033288|NCT04822064|Ketamine|ketamine|mesh-list
111033289|NCT04822064|Chloral Hydrate|chloral hydrate|mesh-list
111033290|NCT04822064|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111033291|NCT04822064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111033292|NCT04822064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111033294|NCT04822064|Analgesics|analgesics|mesh-ancestor
111033295|NCT04822064|Sensory System Agents|sensory system agents|mesh-ancestor
111033296|NCT04822064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111033297|NCT04822064|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111033298|NCT04822064|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111033299|NCT04822064|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111033300|NCT04822064|Adrenergic Agents|adrenergic agents|mesh-ancestor
111033301|NCT04822064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110750375|NCT01205984|Antiemetics|antiemetics|mesh-ancestor
111033302|NCT04822064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111033303|NCT04822064|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111033304|NCT04822064|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111033305|NCT04822064|Anesthetics, General|anesthetics, general|mesh-ancestor
111033306|NCT04822064|Anesthetics|anesthetics|mesh-ancestor
111033307|NCT04822064|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111033308|NCT04822064|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111033309|NCT03553433|Apremilast|apremilast|mesh-list
111033310|NCT03553433|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111033311|NCT03553433|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111033312|NCT03553433|Analgesics|analgesics|mesh-ancestor
111033313|NCT03553433|Sensory System Agents|sensory system agents|mesh-ancestor
111033314|NCT03553433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111033315|NCT03553433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111033316|NCT03553433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111033317|NCT03553433|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111033318|NCT03553433|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
111033319|NCT03553433|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111033320|NCT03553433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111033321|NCT03553433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111033322|NCT02604212|Tenofovir|tenofovir|mesh-list
111033323|NCT02604212|Entecavir|entecavir|mesh-list
111033324|NCT02604212|Histamine Antagonists|histamine antagonists|mesh-list
111033325|NCT02604212|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
111033326|NCT02604212|Antiviral Agents|antiviral agents|mesh-ancestor
111033327|NCT02604212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111033328|NCT02604212|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111033329|NCT02604212|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111033330|NCT02604212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111033331|NCT02604212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111033332|NCT02604212|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111033333|NCT02604212|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111033334|NCT02604212|Histamine Agents|histamine agents|mesh-ancestor
111033335|NCT02604212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111033336|NCT02604212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111033337|NCT02115659|Triptolide|triptolide|mesh-list
111033338|NCT02115659|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
111033339|NCT02115659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111033340|NCT02115659|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
111033341|NCT02115659|Contraceptive Agents|contraceptive agents|mesh-ancestor
111033342|NCT02115659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111033343|NCT02115659|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111033344|NCT02115659|Immunologic Factors|immunologic factors|mesh-ancestor
111033345|NCT02115659|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111033346|NCT02115659|Alkylating Agents|alkylating agents|mesh-ancestor
111033347|NCT02115659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111033348|NCT02115659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111033349|NCT02113631|Interferons|interferons|mesh-list
111033350|NCT02113631|Ribavirin|ribavirin|mesh-list
111033351|NCT02113631|Interferon-alpha|interferon-alpha|mesh-list
111033352|NCT02113631|Interferon alpha-2|interferon alpha-2|mesh-list
111033353|NCT02113631|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
111033354|NCT02113631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111033355|NCT02113631|Antiviral Agents|antiviral agents|mesh-ancestor
111033356|NCT02113631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111033357|NCT02113631|Antimetabolites|antimetabolites|mesh-ancestor
111033358|NCT02113631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111033359|NCT02113631|Immunologic Factors|immunologic factors|mesh-ancestor
111033360|NCT02113631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111033361|NCT02123069|Nitroprusside|nitroprusside|mesh-list
111033362|NCT02123069|Phenylephrine|phenylephrine|mesh-list
111033363|NCT02123069|Oxymetazoline|oxymetazoline|mesh-list
111033364|NCT02123069|Norepinephrine|norepinephrine|mesh-list
111033365|NCT02123069|Acetylcholine|acetylcholine|mesh-list
111033366|NCT02123069|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111033367|NCT02123069|Mydriatics|mydriatics|mesh-ancestor
111033368|NCT02123069|Autonomic Agents|autonomic agents|mesh-ancestor
111033369|NCT02123069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111033370|NCT02123069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111033371|NCT02123069|Sympathomimetics|sympathomimetics|mesh-ancestor
111033372|NCT02123069|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111033373|NCT02123069|Nasal Decongestants|nasal decongestants|mesh-ancestor
111033374|NCT02123069|Respiratory System Agents|respiratory system agents|mesh-ancestor
111033375|NCT02123069|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111033376|NCT02123069|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111033377|NCT02123069|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111033378|NCT02123069|Adrenergic Agents|adrenergic agents|mesh-ancestor
111033379|NCT02123069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111033380|NCT02123069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111033381|NCT02123069|Protective Agents|protective agents|mesh-ancestor
111033382|NCT02123069|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111033383|NCT02123069|Vasodilator Agents|vasodilator agents|mesh-ancestor
111033384|NCT02123069|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
111033385|NCT02123069|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111033386|NCT02123069|Cholinergic Agents|cholinergic agents|mesh-ancestor
111033387|NCT04428632|Berotralstat|berotralstat|mesh-list
111033388|NCT04428632|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111033389|NCT04428632|Protease Inhibitors|protease inhibitors|mesh-ancestor
111033390|NCT04428632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111033391|NCT04428632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111033392|NCT05618210|Anesthetics|anesthetics|mesh-list
111033393|NCT05618210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110626365|NCT00756275|Nicotine|nicotine|mesh-list
111033394|NCT05618210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111033395|NCT04807634|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
111033396|NCT04807634|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
111033397|NCT04807634|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
111033398|NCT04807634|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111033399|NCT02789111|Alvimopan|alvimopan|mesh-list
111033400|NCT02789111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111033401|NCT04807166|Paclitaxel|paclitaxel|mesh-list
111033402|NCT04807166|Carboplatin|carboplatin|mesh-list
111033403|NCT04807166|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111033404|NCT04807166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111033405|NCT04807166|Tubulin Modulators|tubulin modulators|mesh-ancestor
111033406|NCT04807166|Antimitotic Agents|antimitotic agents|mesh-ancestor
111033407|NCT04807166|Mitosis Modulators|mitosis modulators|mesh-ancestor
111033408|NCT04807166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111033409|NCT02251925|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
111033410|NCT02251925|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
111033411|NCT02251925|Estradiol|estradiol|mesh-list
111033412|NCT02251925|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
111033413|NCT02251925|Estrogens|estrogens|mesh-ancestor
111033414|NCT02251925|Hormones|hormones|mesh-ancestor
111033415|NCT02251925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111033416|NCT02251925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111033417|NCT02251925|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111033418|NCT02251925|Contraceptive Agents|contraceptive agents|mesh-ancestor
111033419|NCT02251925|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111033420|NCT02251925|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111033421|NCT03552653|Vitamin D|vitamin d|mesh-list
111033422|NCT03552653|Ergocalciferols|ergocalciferols|mesh-list
111033423|NCT03552653|Cholecalciferol|cholecalciferol|mesh-list
111033424|NCT03552653|Vitamins|vitamins|mesh-list
111033425|NCT03552653|Micronutrients|micronutrients|mesh-ancestor
111033426|NCT03552653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111033427|NCT03552653|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111033428|NCT03552653|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111033429|NCT01359644|Ribavirin|ribavirin|mesh-list
111033430|NCT01359644|Sofosbuvir|sofosbuvir|mesh-list
111033431|NCT01359644|Antimetabolites|antimetabolites|mesh-ancestor
111033432|NCT01359644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111033433|NCT01359644|Antiviral Agents|antiviral agents|mesh-ancestor
111033434|NCT01359644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111033435|NCT04821206|Antirheumatic Agents|antirheumatic agents|mesh-list
111033436|NCT04821206|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
111033437|NCT04821206|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111033438|NCT04821206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110827299|NCT01268839|Efavirenz|efavirenz|mesh-list
111033439|NCT04821206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111033441|NCT04806230|Citalopram|citalopram|mesh-list
111033442|NCT04806230|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
111033443|NCT04806230|Sertraline|sertraline|mesh-list
111033444|NCT04806230|Escitalopram|escitalopram|mesh-list
111033445|NCT04806230|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111033446|NCT04806230|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111033447|NCT04806230|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111033448|NCT04806230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111033449|NCT04806230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111033450|NCT04806230|Serotonin Agents|serotonin agents|mesh-ancestor
111033451|NCT04806230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111033452|NCT04806230|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111033453|NCT04806230|Antidepressive Agents|antidepressive agents|mesh-ancestor
111033454|NCT04806230|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111033455|NCT04806230|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111033456|NCT04806230|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111033457|NCT04806230|Histamine Antagonists|histamine antagonists|mesh-ancestor
111033458|NCT04806230|Histamine Agents|histamine agents|mesh-ancestor
111033459|NCT04806230|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111033460|NCT04806230|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111033461|NCT04806230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111033462|NCT04806230|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
111033463|NCT04806230|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111033464|NCT04806230|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111033465|NCT04806230|Adrenergic Agents|adrenergic agents|mesh-ancestor
111033466|NCT04806230|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111033467|NCT04806230|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111033468|NCT04806230|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111033469|NCT02603120|Tenofovir|tenofovir|mesh-list
111033470|NCT02603120|Emtricitabine|emtricitabine|mesh-list
111033471|NCT02603120|Lamivudine|lamivudine|mesh-list
111033472|NCT02603120|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
111033473|NCT02603120|Antiviral Agents|antiviral agents|mesh-ancestor
111033474|NCT02603120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111033475|NCT02603120|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111033476|NCT02603120|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111033477|NCT02603120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111033478|NCT02603120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111033479|NCT02603120|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111033480|NCT02603120|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111033481|NCT04815200|Copper|copper|mesh-list
111033482|NCT04815200|Nickel|nickel|mesh-list
111033483|NCT04815200|Trace Elements|trace elements|mesh-ancestor
111033484|NCT04815200|Micronutrients|micronutrients|mesh-ancestor
111033485|NCT04815200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111033486|NCT04426994|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
111033487|NCT04426994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111033488|NCT04426994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111033489|NCT04814030|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
111033490|NCT04814030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111033491|NCT04814030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111033492|NCT04814030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111033493|NCT04412252|Tofacitinib|tofacitinib|mesh-list
111033494|NCT04412252|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
111033495|NCT04412252|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111033496|NCT04412252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111033497|NCT04412252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111033498|NCT04813952|Sevoflurane|sevoflurane|mesh-list
111033499|NCT04813952|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111033500|NCT04813952|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111033501|NCT04813952|Anesthetics, General|anesthetics, general|mesh-ancestor
111033502|NCT04813952|Anesthetics|anesthetics|mesh-ancestor
111033503|NCT04813952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111033504|NCT04813952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111033505|NCT04813874|Nitrous Oxide|nitrous oxide|mesh-list
111033506|NCT04813874|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111033507|NCT04813874|Anesthetics, General|anesthetics, general|mesh-ancestor
111033508|NCT04813874|Anesthetics|anesthetics|mesh-ancestor
111033509|NCT04813874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111033510|NCT04813874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110827300|NCT01268839|Rilpivirine|rilpivirine|mesh-list
111033511|NCT04813874|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111033512|NCT04813874|Analgesics|analgesics|mesh-ancestor
111033513|NCT04813874|Sensory System Agents|sensory system agents|mesh-ancestor
111033514|NCT04813874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111033515|NCT04803500|Simvastatin|simvastatin|mesh-list
111033516|NCT04803500|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111033517|NCT04803500|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111033518|NCT04803500|Antimetabolites|antimetabolites|mesh-ancestor
111033519|NCT04803500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111033520|NCT04803500|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111033521|NCT04803500|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111033522|NCT04803500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111033523|NCT01331681|Aflibercept|aflibercept|mesh-list
111033524|NCT01331681|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110626381|NCT04096547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111033525|NCT01331681|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111033526|NCT01331681|Growth Substances|growth substances|mesh-ancestor
110750616|NCT01207310|Nicotine|nicotine|mesh-list
111033527|NCT01331681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111033528|NCT01331681|Growth Inhibitors|growth inhibitors|mesh-ancestor
111033529|NCT01331681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111033530|NCT02120339|Carvedilol|carvedilol|mesh-list
111033531|NCT02120339|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111033532|NCT02120339|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111033533|NCT02120339|Adrenergic Agents|adrenergic agents|mesh-ancestor
111033534|NCT02120339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111033535|NCT02120339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111033536|NCT02120339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111033537|NCT02120339|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111033538|NCT02120339|Antioxidants|antioxidants|mesh-ancestor
111033539|NCT02120339|Protective Agents|protective agents|mesh-ancestor
111033540|NCT02120339|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111033541|NCT02120339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111033542|NCT02120339|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111033543|NCT02120339|Vasodilator Agents|vasodilator agents|mesh-ancestor
111033544|NCT02120339|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111033545|NCT02120339|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111033546|NCT02123381|Cetuximab|cetuximab|mesh-list
111033547|NCT02123381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111033548|NCT02123381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111033549|NCT02123615|Immunoglobulins|immunoglobulins|mesh-list
111033550|NCT02123615|Antibodies|antibodies|mesh-list
111033551|NCT02123615|gamma-Globulins|gamma-globulins|mesh-list
111033552|NCT02123615|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111033553|NCT02123615|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
111033554|NCT02123615|Immunoglobulin G|immunoglobulin g|mesh-list
111033555|NCT02123615|Immunologic Factors|immunologic factors|mesh-ancestor
111033556|NCT02123615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111033557|NCT02120651|Hemostatics|hemostatics|mesh-list
111033558|NCT02120651|Coagulants|coagulants|mesh-ancestor
111033559|NCT02117219|Azacitidine|azacitidine|mesh-list
111033560|NCT02117219|Durvalumab|durvalumab|mesh-list
111033561|NCT02117219|Tremelimumab|tremelimumab|mesh-list
111033562|NCT02117219|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111033563|NCT02117219|Antimetabolites|antimetabolites|mesh-ancestor
111033564|NCT02117219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111033565|NCT02117219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111033566|NCT02117219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111033567|NCT02117219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111033568|NCT02117453|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111033569|NCT02117453|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111033570|NCT02117453|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111033571|NCT02117453|Antimetabolites|antimetabolites|mesh-ancestor
111033572|NCT02117453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111033573|NCT02117453|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111033574|NCT02117453|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111033575|NCT02117453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111033576|NCT02124005|Bupivacaine|bupivacaine|mesh-list
111033577|NCT02124005|Anesthetics, Local|anesthetics, local|mesh-ancestor
111033578|NCT02124005|Anesthetics|anesthetics|mesh-ancestor
111033579|NCT02124005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111033580|NCT02124005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111033581|NCT02124005|Sensory System Agents|sensory system agents|mesh-ancestor
111033582|NCT02124005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111033583|NCT03551873|Plecanatide|plecanatide|mesh-list
111033584|NCT03551873|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
111033585|NCT03551873|Enzyme Activators|enzyme activators|mesh-ancestor
111033586|NCT03551873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111033587|NCT03551873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111033588|NCT02117765|Ustekinumab|ustekinumab|mesh-list
111033589|NCT02117765|Dermatologic Agents|dermatologic agents|mesh-ancestor
111033590|NCT02121119|Lidocaine|lidocaine|mesh-list
111033591|NCT02121119|Bupivacaine|bupivacaine|mesh-list
111033592|NCT02121119|Anesthetics, Local|anesthetics, local|mesh-ancestor
111033593|NCT02121119|Anesthetics|anesthetics|mesh-ancestor
111033594|NCT02121119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111033595|NCT02121119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111033596|NCT02121119|Sensory System Agents|sensory system agents|mesh-ancestor
111033597|NCT02121119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111033598|NCT02121119|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111033599|NCT02121119|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111033600|NCT02121119|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111033601|NCT02121119|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111033602|NCT02121119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111033603|NCT02121197|Dexamethasone|dexamethasone|mesh-list
111033604|NCT02121197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111033605|NCT02121197|Antiemetics|antiemetics|mesh-ancestor
111033606|NCT02121197|Autonomic Agents|autonomic agents|mesh-ancestor
111033607|NCT02121197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111033608|NCT02121197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111033609|NCT02121197|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111033610|NCT02121197|Glucocorticoids|glucocorticoids|mesh-ancestor
111033611|NCT02121197|Hormones|hormones|mesh-ancestor
111033612|NCT02121197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111033613|NCT02121197|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111033614|NCT02121197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111033615|NCT02124317|Paclitaxel|paclitaxel|mesh-list
111033616|NCT02124317|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111033617|NCT02124317|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111033618|NCT02124317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111033619|NCT02124317|Tubulin Modulators|tubulin modulators|mesh-ancestor
111033620|NCT02124317|Antimitotic Agents|antimitotic agents|mesh-ancestor
111033621|NCT02124317|Mitosis Modulators|mitosis modulators|mesh-ancestor
111033622|NCT02124317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111033623|NCT02117843|Arsenic Trioxide|arsenic trioxide|mesh-list
111033624|NCT02117843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111033625|NCT02121353|Ranibizumab|ranibizumab|mesh-list
111033626|NCT02121353|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111033627|NCT02121353|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111033628|NCT02121353|Growth Substances|growth substances|mesh-ancestor
111033629|NCT02121353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111033630|NCT02121353|Growth Inhibitors|growth inhibitors|mesh-ancestor
111033631|NCT02121353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111033632|NCT05617430|Leucovorin|leucovorin|mesh-list
111033633|NCT05617430|Bevacizumab|bevacizumab|mesh-list
111033634|NCT05617430|Fluorouracil|fluorouracil|mesh-list
111033635|NCT05617430|Oxaliplatin|oxaliplatin|mesh-list
111033636|NCT05617430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111033637|NCT05617430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111033638|NCT05617430|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111033639|NCT05617430|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111033640|NCT05617430|Growth Substances|growth substances|mesh-ancestor
111033641|NCT05617430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111033642|NCT05617430|Growth Inhibitors|growth inhibitors|mesh-ancestor
111033643|NCT05617430|Antimetabolites|antimetabolites|mesh-ancestor
111033644|NCT05617430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111033645|NCT05617430|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111033646|NCT05617430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111033647|NCT05617430|Immunologic Factors|immunologic factors|mesh-ancestor
111033648|NCT05617430|Antidotes|antidotes|mesh-ancestor
111033649|NCT05617430|Protective Agents|protective agents|mesh-ancestor
111033650|NCT05617430|Vitamin B Complex|vitamin b complex|mesh-ancestor
111033651|NCT05617430|Vitamins|vitamins|mesh-ancestor
111033652|NCT05617430|Micronutrients|micronutrients|mesh-ancestor
111033653|NCT02251691|Tacrolimus|tacrolimus|mesh-list
111033654|NCT02251691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111033655|NCT02251691|Immunologic Factors|immunologic factors|mesh-ancestor
111033656|NCT02251691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111033657|NCT02251691|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111033658|NCT02251691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111033659|NCT02251691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111033660|NCT02595398|Triamcinolone|triamcinolone|mesh-list
111033661|NCT02595398|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
111033662|NCT02595398|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
111033663|NCT02595398|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
111033664|NCT02595398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111033665|NCT02595398|Glucocorticoids|glucocorticoids|mesh-ancestor
111033666|NCT02595398|Hormones|hormones|mesh-ancestor
111033667|NCT02595398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111033668|NCT02595398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111033669|NCT02595398|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111033670|NCT02595398|Immunologic Factors|immunologic factors|mesh-ancestor
111033671|NCT02595398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111033672|NCT02595398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111033673|NCT02251769|Ritonavir|ritonavir|mesh-list
111033674|NCT02251769|Tipranavir|tipranavir|mesh-list
111033675|NCT02251769|Clarithromycin|clarithromycin|mesh-list
111033676|NCT02251769|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111033677|NCT02251769|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111033678|NCT02251769|Protease Inhibitors|protease inhibitors|mesh-ancestor
111033679|NCT02251769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111033680|NCT02251769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111033681|NCT02251769|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111033682|NCT02251769|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111033683|NCT02251769|Antiviral Agents|antiviral agents|mesh-ancestor
111033684|NCT02251769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111033685|NCT02251769|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111033686|NCT02251769|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111033687|NCT02251769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111033688|NCT02251769|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111033689|NCT02118311|Cyclophosphamide|cyclophosphamide|mesh-list
111033690|NCT02118311|Fludarabine|fludarabine|mesh-list
111033691|NCT02118311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111033692|NCT02118311|Immunologic Factors|immunologic factors|mesh-ancestor
111033693|NCT02118311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111033694|NCT02118311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111033695|NCT02118311|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111033696|NCT02118311|Alkylating Agents|alkylating agents|mesh-ancestor
111033697|NCT02118311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111033698|NCT02118311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111033699|NCT02118311|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111033700|NCT01368497|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
111033701|NCT01368497|Entecavir|entecavir|mesh-list
111033702|NCT01368497|Antiviral Agents|antiviral agents|mesh-ancestor
111033703|NCT01368497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111033704|NCT04812860|Tramadol|tramadol|mesh-list
111033705|NCT04812860|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111033706|NCT04812860|Narcotics|narcotics|mesh-ancestor
111033707|NCT04812860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111033708|NCT04812860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111033709|NCT04812860|Analgesics|analgesics|mesh-ancestor
111033710|NCT04812860|Sensory System Agents|sensory system agents|mesh-ancestor
111033711|NCT04812860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111033712|NCT03551561|Chlorhexidine|chlorhexidine|mesh-list
111033713|NCT03551561|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
111033714|NCT03551561|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111033715|NCT03551561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111033716|NCT03551561|Disinfectants|disinfectants|mesh-ancestor
111033717|NCT03551561|Dermatologic Agents|dermatologic agents|mesh-ancestor
111033718|NCT04427540|Oxytocin|oxytocin|mesh-list
111033719|NCT04427540|Oxytocics|oxytocics|mesh-ancestor
111033720|NCT04427540|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111033721|NCT04427540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111033722|NCT04801940|Apixaban|apixaban|mesh-list
111033723|NCT04801940|Atorvastatin|atorvastatin|mesh-list
111033724|NCT04801940|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111033725|NCT04801940|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111033726|NCT04801940|Antimetabolites|antimetabolites|mesh-ancestor
111033727|NCT04801940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111033728|NCT04801940|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111033729|NCT04801940|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111033730|NCT04801940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111033731|NCT04801940|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111033732|NCT04801940|Antithrombins|antithrombins|mesh-ancestor
111033733|NCT04801940|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111033734|NCT04801940|Protease Inhibitors|protease inhibitors|mesh-ancestor
111033735|NCT04801940|Anticoagulants|anticoagulants|mesh-ancestor
111033736|NCT02251847|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111033738|NCT02251847|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111033739|NCT02251847|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111033740|NCT02251847|Antimetabolites|antimetabolites|mesh-ancestor
111033741|NCT02251847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111033742|NCT02251847|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111033743|NCT02251847|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111033744|NCT02251847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111033745|NCT02127047|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111033746|NCT02127047|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111033747|NCT02127047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111033748|NCT02127047|Incretins|incretins|mesh-ancestor
111033749|NCT02127047|Hormones|hormones|mesh-ancestor
111033750|NCT02127047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111033751|NCT02127047|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111033752|NCT02127047|Protease Inhibitors|protease inhibitors|mesh-ancestor
111033753|NCT02127047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111033754|NCT02127047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111033755|NCT02122055|Fentanyl|fentanyl|mesh-list
111033756|NCT02122055|Midazolam|midazolam|mesh-list
111033757|NCT02122055|Dexmedetomidine|dexmedetomidine|mesh-list
111033758|NCT02122055|Propofol|propofol|mesh-list
111033759|NCT02122055|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111033760|NCT02122055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111033761|NCT02122055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111033762|NCT02122055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111033763|NCT02122055|Analgesics|analgesics|mesh-ancestor
111033764|NCT02122055|Sensory System Agents|sensory system agents|mesh-ancestor
111033765|NCT02122055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111033766|NCT02122055|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111033767|NCT02122055|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111033768|NCT02122055|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111033769|NCT02122055|Adrenergic Agents|adrenergic agents|mesh-ancestor
111033770|NCT02122055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111033771|NCT02122055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111033772|NCT02122055|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111033773|NCT02122055|Anesthetics, General|anesthetics, general|mesh-ancestor
111033774|NCT02122055|Anesthetics|anesthetics|mesh-ancestor
111033775|NCT02122055|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111033776|NCT02122055|Narcotics|narcotics|mesh-ancestor
111033777|NCT02122055|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111033778|NCT02122055|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111033779|NCT02122055|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111033780|NCT02122055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111033781|NCT02122055|GABA Modulators|gaba modulators|mesh-ancestor
111033782|NCT02122055|GABA Agents|gaba agents|mesh-ancestor
111033783|NCT02125409|Aspirin|aspirin|mesh-list
111033784|NCT02125409|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111033785|NCT02125409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111033786|NCT02125409|Analgesics|analgesics|mesh-ancestor
111033787|NCT02125409|Sensory System Agents|sensory system agents|mesh-ancestor
111033788|NCT02125409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111033789|NCT02125409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111033790|NCT02125409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111033791|NCT02125409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111033792|NCT02125409|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111033793|NCT02125409|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111033794|NCT02125409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111033795|NCT02125409|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111033796|NCT02125409|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111033797|NCT02125409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111033798|NCT02125409|Antipyretics|antipyretics|mesh-ancestor
111033799|NCT04816838|Osimertinib|osimertinib|mesh-list
111033800|NCT04816838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111033801|NCT04816838|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111033802|NCT04816838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111033803|NCT04816838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111033804|NCT02788175|Vedolizumab|vedolizumab|mesh-list
111033805|NCT02788175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111033806|NCT03551171|Niraparib|niraparib|mesh-list
111033807|NCT03551171|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111033809|NCT03551171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111033810|NCT03551171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111033811|NCT02787083|Mirabegron|mirabegron|mesh-list
111033812|NCT02787083|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
111033813|NCT02787083|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111033814|NCT02787083|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111033815|NCT02787083|Adrenergic Agents|adrenergic agents|mesh-ancestor
111033816|NCT02787083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111033817|NCT02787083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111033818|NCT02787083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111033819|NCT02787083|Urological Agents|urological agents|mesh-ancestor
111033820|NCT02122211|Betaine|betaine|mesh-list
111033821|NCT02122211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111033822|NCT02122211|Lipotropic Agents|lipotropic agents|mesh-ancestor
111033823|NCT02122211|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111033824|NCT02122211|Antimetabolites|antimetabolites|mesh-ancestor
111033825|NCT02122211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111033826|NCT02122211|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111033827|NCT02125565|Lidocaine|lidocaine|mesh-list
111033828|NCT02125565|Anesthetics, Local|anesthetics, local|mesh-ancestor
111033829|NCT02125565|Anesthetics|anesthetics|mesh-ancestor
111033830|NCT02125565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111033831|NCT02125565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111033833|NCT02125565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111033834|NCT02125565|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111033835|NCT02125565|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111033836|NCT02125565|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111033837|NCT02125565|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111033838|NCT02125565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111033839|NCT02125643|Caffeine|caffeine|mesh-list
111033840|NCT02125643|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111033841|NCT02125643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111033842|NCT02125643|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111033843|NCT02125643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111033844|NCT02125643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111033845|NCT02125643|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
111033846|NCT02125643|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111033847|NCT02125643|Purinergic Agents|purinergic agents|mesh-ancestor
111033848|NCT02125643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111033849|NCT02127437|Lanreotide|lanreotide|mesh-list
111033850|NCT02127437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111033851|NCT02122601|Hyaluronic Acid|hyaluronic acid|mesh-list
111033852|NCT02122601|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111033853|NCT02122601|Immunologic Factors|immunologic factors|mesh-ancestor
111033854|NCT02122601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111033855|NCT02122601|Viscosupplements|viscosupplements|mesh-ancestor
111033856|NCT02122601|Protective Agents|protective agents|mesh-ancestor
111033857|NCT02127593|Moxifloxacin|moxifloxacin|mesh-list
111033858|NCT02127593|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
111033859|NCT02127593|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
111033860|NCT02127593|Ethinyl Estradiol|ethinyl estradiol|mesh-list
111033861|NCT02127593|Norgestimate|norgestimate|mesh-list
111033862|NCT02127593|Norgestrel|norgestrel|mesh-list
111033863|NCT02127593|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
111033864|NCT02127593|Estradiol|estradiol|mesh-list
111033865|NCT02127593|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
111033866|NCT02127593|Estrogens|estrogens|mesh-ancestor
111033867|NCT02127593|Hormones|hormones|mesh-ancestor
111033868|NCT02127593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111033869|NCT02127593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111033870|NCT02127593|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111033871|NCT02127593|Contraceptive Agents|contraceptive agents|mesh-ancestor
111033872|NCT02127593|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111033873|NCT02127593|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111033874|NCT02127593|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111033875|NCT02127593|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111033876|NCT02127593|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111033877|NCT02127593|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111033878|NCT02127593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111033879|NCT02127593|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110498889|NCT05832697|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
111033880|NCT02127593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111033881|NCT02127593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111033882|NCT02127593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111033883|NCT02127593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111033884|NCT02127593|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
111033885|NCT02122679|Tranexamic Acid|tranexamic acid|mesh-list
111033886|NCT02122679|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111033887|NCT02122679|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111033888|NCT02122679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111033889|NCT02122679|Hemostatics|hemostatics|mesh-ancestor
111033890|NCT02122679|Coagulants|coagulants|mesh-ancestor
111033891|NCT04810754|Daratumumab|daratumumab|mesh-list
111033892|NCT04810754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111033893|NCT02127749|Metronidazole|metronidazole|mesh-list
111033894|NCT02127749|Vancomycin|vancomycin|mesh-list
111033895|NCT02127749|Ciprofloxacin|ciprofloxacin|mesh-list
111033896|NCT02127749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111033897|NCT02127749|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111033898|NCT02127749|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111033899|NCT02127749|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111033900|NCT02127749|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111033901|NCT02127749|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111033902|NCT02127749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110750973|NCT00302003|Antimetabolites|antimetabolites|mesh-ancestor
111033903|NCT02127749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111033904|NCT02127749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111033905|NCT02127749|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111033906|NCT02127749|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111033907|NCT04797338|Nafarelin|nafarelin|mesh-list
111033908|NCT04797338|Progesterone|progesterone|mesh-list
111033909|NCT04797338|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
111033910|NCT04797338|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
111033911|NCT04797338|Estradiol|estradiol|mesh-list
111033912|NCT04797338|Progestins|progestins|mesh-ancestor
111033913|NCT04797338|Hormones|hormones|mesh-ancestor
111033914|NCT04797338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111033915|NCT04797338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111033916|NCT04797338|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111033917|NCT04797338|Hormone Antagonists|hormone antagonists|mesh-ancestor
111033918|NCT04797338|Estrogens|estrogens|mesh-ancestor
111033919|NCT04797338|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111033920|NCT04797338|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111033921|NCT04797338|Fertility Agents|fertility agents|mesh-ancestor
111033922|NCT05272865|Dronabinol|dronabinol|mesh-list
111033923|NCT05272865|Hallucinogens|hallucinogens|mesh-ancestor
111033924|NCT05272865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111033925|NCT05272865|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111033926|NCT05272865|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111033927|NCT05272865|Analgesics|analgesics|mesh-ancestor
111033928|NCT05272865|Sensory System Agents|sensory system agents|mesh-ancestor
111033929|NCT05272865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111033930|NCT05272865|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
111033931|NCT05272865|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
111033932|NCT05272865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111033933|NCT05272865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111033934|NCT05272865|Hormones|hormones|mesh-ancestor
111033935|NCT05272865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111033936|NCT02787863|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
111033937|NCT02787863|Immunologic Factors|immunologic factors|mesh-ancestor
111033938|NCT02787863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111033939|NCT04809818|Aspirin|aspirin|mesh-list
111033940|NCT04809818|Dabigatran|dabigatran|mesh-list
111033941|NCT04809818|Apixaban|apixaban|mesh-list
111033942|NCT04809818|Clopidogrel|clopidogrel|mesh-list
111033943|NCT04809818|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111033944|NCT04809818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111033945|NCT04809818|Analgesics|analgesics|mesh-ancestor
111033946|NCT04809818|Sensory System Agents|sensory system agents|mesh-ancestor
111033947|NCT04809818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111033948|NCT04809818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111033949|NCT04809818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111033950|NCT04809818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111033951|NCT04809818|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111033952|NCT04809818|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111033953|NCT04809818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110025911|NCT00378144|Adrenergic Agents|adrenergic agents|mesh-ancestor
111033954|NCT04809818|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111033955|NCT04809818|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111033956|NCT04809818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111033957|NCT04809818|Antipyretics|antipyretics|mesh-ancestor
111033958|NCT04809818|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111033959|NCT04809818|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111033960|NCT04809818|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111033961|NCT04809818|Purinergic Agents|purinergic agents|mesh-ancestor
111033962|NCT04809818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111033963|NCT04809818|Antithrombins|antithrombins|mesh-ancestor
111033964|NCT04809818|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111033965|NCT04809818|Protease Inhibitors|protease inhibitors|mesh-ancestor
111033966|NCT04809818|Anticoagulants|anticoagulants|mesh-ancestor
111033967|NCT04809818|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111033968|NCT04796402|Bamlanivimab|bamlanivimab|mesh-list
111033969|NCT04796402|Antiviral Agents|antiviral agents|mesh-ancestor
111033970|NCT04796402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111033971|NCT04809584|Motexafin gadolinium|motexafin gadolinium|mesh-list
111033972|NCT04809584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111033973|NCT04809584|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111033974|NCT04809584|Dermatologic Agents|dermatologic agents|mesh-ancestor
111033975|NCT02126267|Chlorhexidine|chlorhexidine|mesh-list
111033976|NCT02126267|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
111033977|NCT02126267|Azithromycin|azithromycin|mesh-list
110751045|NCT00033540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111033978|NCT02126267|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111033979|NCT02126267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111033981|NCT02126267|Dermatologic Agents|dermatologic agents|mesh-ancestor
111033982|NCT02126267|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111033983|NCT02128061|Rituximab|rituximab|mesh-list
111033984|NCT02128061|Lenalidomide|lenalidomide|mesh-list
111033985|NCT02128061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111033986|NCT02128061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111033987|NCT02128061|Immunologic Factors|immunologic factors|mesh-ancestor
111033988|NCT02128061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111033989|NCT02128061|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111033990|NCT02128061|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111033991|NCT02128061|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111033992|NCT02128061|Growth Substances|growth substances|mesh-ancestor
111033993|NCT02128061|Growth Inhibitors|growth inhibitors|mesh-ancestor
111033994|NCT02596958|Bevacizumab|bevacizumab|mesh-list
111033995|NCT02596958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111033996|NCT02596958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111033997|NCT02596958|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111033998|NCT02596958|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111033999|NCT02596958|Growth Substances|growth substances|mesh-ancestor
111034000|NCT02596958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111034001|NCT02596958|Growth Inhibitors|growth inhibitors|mesh-ancestor
111034002|NCT02126579|Poly ICLC|poly iclc|mesh-list
111034003|NCT02126579|Interferon Inducers|interferon inducers|mesh-ancestor
111034004|NCT02126579|Immunologic Factors|immunologic factors|mesh-ancestor
111034005|NCT02126579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111034006|NCT04808648|Itraconazole|itraconazole|mesh-list
111034007|NCT04808648|Rifampin|rifampin|mesh-list
111034008|NCT04808648|Antifungal Agents|antifungal agents|mesh-ancestor
111034009|NCT04808648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111034010|NCT04808648|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111034011|NCT04808648|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111034012|NCT04808648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111034013|NCT04808648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111034014|NCT04808648|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111034015|NCT04808648|Hormone Antagonists|hormone antagonists|mesh-ancestor
111034016|NCT04808648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111034017|NCT04808648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111034018|NCT04808648|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111034019|NCT04808648|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111034020|NCT04808648|Antitubercular Agents|antitubercular agents|mesh-ancestor
111034021|NCT04808648|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111034022|NCT04808648|Leprostatic Agents|leprostatic agents|mesh-ancestor
111034023|NCT04808648|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111034024|NCT04808648|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111034025|NCT04808648|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111034026|NCT04808648|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
111034027|NCT04808648|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
111034028|NCT04808648|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
111034029|NCT04808648|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111034030|NCT02126657|Glycolic acid|glycolic acid|mesh-list
111034031|NCT02126657|Keratolytic Agents|keratolytic agents|mesh-ancestor
111034032|NCT02126657|Dermatologic Agents|dermatologic agents|mesh-ancestor
111034033|NCT02128451|Fentanyl|fentanyl|mesh-list
111034034|NCT02128451|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111034035|NCT02128451|Narcotics|narcotics|mesh-ancestor
111034036|NCT02128451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111034037|NCT02128451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111034038|NCT02128451|Analgesics|analgesics|mesh-ancestor
111034039|NCT02128451|Sensory System Agents|sensory system agents|mesh-ancestor
111034040|NCT02128451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111034041|NCT02128451|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111034042|NCT02128451|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111034043|NCT02128451|Anesthetics, General|anesthetics, general|mesh-ancestor
111034044|NCT02128451|Anesthetics|anesthetics|mesh-ancestor
111034045|NCT04785716|Niraparib|niraparib|mesh-list
111034046|NCT04785716|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111034047|NCT04785716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111034048|NCT04785716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111034049|NCT04785716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111034050|NCT01367249|Bromfenac|bromfenac|mesh-list
111034051|NCT01367249|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111034052|NCT01367249|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111034053|NCT01367249|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111034054|NCT01367249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111034055|NCT01367249|Analgesics|analgesics|mesh-ancestor
111034056|NCT01367249|Sensory System Agents|sensory system agents|mesh-ancestor
111034057|NCT01367249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111034058|NCT01367249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111034059|NCT01367249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111034060|NCT01367249|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111034061|NCT02128685|Dydrogesterone|dydrogesterone|mesh-list
111034062|NCT02128685|Progestins|progestins|mesh-ancestor
111034063|NCT02128685|Hormones|hormones|mesh-ancestor
111034064|NCT02128685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111034065|NCT02128685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111034066|NCT02252627|Phenylephrine|phenylephrine|mesh-list
111034067|NCT02252627|Oxymetazoline|oxymetazoline|mesh-list
111034068|NCT02252627|Ephedrine|ephedrine|mesh-list
111034069|NCT02252627|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111034070|NCT02252627|Mydriatics|mydriatics|mesh-ancestor
111034071|NCT02252627|Autonomic Agents|autonomic agents|mesh-ancestor
111034072|NCT02252627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111034073|NCT02252627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111034074|NCT02252627|Sympathomimetics|sympathomimetics|mesh-ancestor
111034075|NCT02252627|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111034076|NCT02252627|Nasal Decongestants|nasal decongestants|mesh-ancestor
111034077|NCT02252627|Respiratory System Agents|respiratory system agents|mesh-ancestor
111034078|NCT02252627|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111034079|NCT02252627|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111034080|NCT02252627|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111034081|NCT02252627|Adrenergic Agents|adrenergic agents|mesh-ancestor
111034082|NCT02252627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111034083|NCT02252627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111034084|NCT02252627|Protective Agents|protective agents|mesh-ancestor
111034085|NCT02252627|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111034086|NCT02128841|Rivaroxaban|rivaroxaban|mesh-list
111034087|NCT02128841|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111034088|NCT02128841|Antithrombins|antithrombins|mesh-ancestor
111034089|NCT02128841|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111034090|NCT02128841|Protease Inhibitors|protease inhibitors|mesh-ancestor
111034091|NCT02128841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111034092|NCT02128841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111034093|NCT02128841|Anticoagulants|anticoagulants|mesh-ancestor
111034094|NCT03550859|Telmisartan|telmisartan|mesh-list
111034095|NCT03550859|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111034096|NCT03550859|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111034097|NCT03550859|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111034098|NCT03550859|Antimetabolites|antimetabolites|mesh-ancestor
111034099|NCT03550859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111034100|NCT03550859|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110025990|NCT00380640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111034101|NCT03550859|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111034102|NCT03550859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111034103|NCT03550859|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111034104|NCT03550859|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111034105|NCT03550859|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111034106|NCT03550781|Prednisone|prednisone|mesh-list
111034107|NCT03550781|Cyclophosphamide|cyclophosphamide|mesh-list
111034108|NCT03550781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111034109|NCT03550781|Immunologic Factors|immunologic factors|mesh-ancestor
111034110|NCT03550781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111034111|NCT03550781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111034112|NCT03550781|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111034113|NCT03550781|Alkylating Agents|alkylating agents|mesh-ancestor
111034114|NCT03550781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111034115|NCT03550781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111034116|NCT03550781|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111034117|NCT03550781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111034118|NCT03550781|Glucocorticoids|glucocorticoids|mesh-ancestor
111034119|NCT03550781|Hormones|hormones|mesh-ancestor
111034120|NCT03550781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111034121|NCT03550781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111034122|NCT02260661|Fulvestrant|fulvestrant|mesh-list
111034123|NCT02260661|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111034124|NCT02260661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110751196|NCT03979469|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111034125|NCT02260661|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
111034126|NCT02260661|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111034127|NCT02260661|Hormone Antagonists|hormone antagonists|mesh-ancestor
111034128|NCT02260661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111034129|NCT02260661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111034130|NCT02136329|Sildenafil Citrate|sildenafil citrate|mesh-list
111034131|NCT02136329|Vasodilator Agents|vasodilator agents|mesh-ancestor
111034132|NCT02136329|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111034133|NCT02136329|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111034134|NCT02136329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111034135|NCT02136329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111034136|NCT02136329|Urological Agents|urological agents|mesh-ancestor
111034137|NCT02129231|Magnesium Oxide|magnesium oxide|mesh-list
111034138|NCT02129231|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111034139|NCT02129231|Simvastatin|simvastatin|mesh-list
111034140|NCT02129231|Ezetimibe|ezetimibe|mesh-list
111034141|NCT02129231|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
111034142|NCT02129231|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111034143|NCT02129231|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111034144|NCT02129231|Antimetabolites|antimetabolites|mesh-ancestor
111034145|NCT02129231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111034146|NCT02129231|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111034147|NCT02129231|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111034148|NCT02129231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111034149|NCT02129231|Antacids|antacids|mesh-ancestor
111034150|NCT02129231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111034151|NCT02136641|Fentanyl|fentanyl|mesh-list
111034152|NCT02136641|Midazolam|midazolam|mesh-list
111034153|NCT02136641|Ketamine|ketamine|mesh-list
111034154|NCT02136641|Analgesics|analgesics|mesh-ancestor
111034155|NCT02136641|Sensory System Agents|sensory system agents|mesh-ancestor
111034156|NCT02136641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111034157|NCT02136641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111034158|NCT02136641|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111034159|NCT02136641|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111034160|NCT02136641|Anesthetics, General|anesthetics, general|mesh-ancestor
111034161|NCT02136641|Anesthetics|anesthetics|mesh-ancestor
111034162|NCT02136641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111034163|NCT02136641|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111034164|NCT02136641|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111034165|NCT02136641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111034166|NCT02136641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111034167|NCT02136641|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111034168|NCT02136641|Narcotics|narcotics|mesh-ancestor
111034169|NCT02136641|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111034170|NCT02136641|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111034171|NCT02136641|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111034172|NCT02136641|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111034173|NCT02136641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111034174|NCT02136641|GABA Modulators|gaba modulators|mesh-ancestor
111034175|NCT02136641|GABA Agents|gaba agents|mesh-ancestor
111034176|NCT03549689|Tenofovir|tenofovir|mesh-list
111034177|NCT03549689|Lamivudine|lamivudine|mesh-list
111034178|NCT03549689|Dolutegravir|dolutegravir|mesh-list
111034179|NCT03549689|Antiviral Agents|antiviral agents|mesh-ancestor
111034180|NCT03549689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111034181|NCT03549689|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110626470|NCT02600741|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111034182|NCT03549689|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111034183|NCT03549689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111034184|NCT03549689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111034185|NCT03549689|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111034186|NCT03549689|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111034187|NCT03549689|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111034188|NCT03549689|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111034189|NCT02129621|Spironolactone|spironolactone|mesh-list
111034190|NCT02129621|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
111034191|NCT02129621|Hormone Antagonists|hormone antagonists|mesh-ancestor
111034192|NCT02129621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111034193|NCT02129621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111034194|NCT02129621|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
111034195|NCT02129621|Diuretics|diuretics|mesh-ancestor
111034196|NCT02129621|Natriuretic Agents|natriuretic agents|mesh-ancestor
111034197|NCT02129699|Denosumab|denosumab|mesh-list
111034198|NCT02129699|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111034199|NCT02129699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111034201|NCT03549923|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
111034202|NCT03549923|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111034203|NCT03549923|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111034204|NCT03549923|Adrenergic Agents|adrenergic agents|mesh-ancestor
111034205|NCT03549923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111034206|NCT03549923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111034207|NCT03549923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111034208|NCT02136875|Fluticasone|fluticasone|mesh-list
111034209|NCT02136875|Xhance|xhance|mesh-list
111034210|NCT02136875|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
111034211|NCT02136875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111034212|NCT02136875|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111034213|NCT02136875|Autonomic Agents|autonomic agents|mesh-ancestor
111034214|NCT02136875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111034215|NCT02136875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111034216|NCT02136875|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111034217|NCT02136875|Respiratory System Agents|respiratory system agents|mesh-ancestor
111034218|NCT02136875|Dermatologic Agents|dermatologic agents|mesh-ancestor
111034219|NCT02136875|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111034220|NCT02136875|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111034221|NCT02136875|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111034222|NCT02136875|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111034223|NCT02136875|Adrenergic Agents|adrenergic agents|mesh-ancestor
111034224|NCT02136875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111034225|NCT02136875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111034226|NCT02129933|Bevacizumab|bevacizumab|mesh-list
111034227|NCT02129933|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111034228|NCT02129933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111034229|NCT02129933|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111034230|NCT02129933|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111034231|NCT02129933|Growth Substances|growth substances|mesh-ancestor
111034232|NCT02129933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111034233|NCT02129933|Growth Inhibitors|growth inhibitors|mesh-ancestor
111034235|NCT02132897|Anticonvulsants|anticonvulsants|mesh-ancestor
111034236|NCT02132897|Antimanic Agents|antimanic agents|mesh-ancestor
111034237|NCT02132897|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111034238|NCT02132897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111034239|NCT02132897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111034240|NCT02132897|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111034241|NCT02132897|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111034242|NCT02132897|Analgesics|analgesics|mesh-ancestor
111034243|NCT02132897|Sensory System Agents|sensory system agents|mesh-ancestor
111034244|NCT02132897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111034245|NCT02132897|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111034246|NCT02132897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111034247|NCT02132897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111034248|NCT02132897|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111034249|NCT02132897|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111034250|NCT02133053|Beclomethasone|beclomethasone|mesh-list
111034251|NCT02133053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111034252|NCT02133053|Glucocorticoids|glucocorticoids|mesh-ancestor
111034253|NCT02133053|Hormones|hormones|mesh-ancestor
111034254|NCT02133053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111034255|NCT02133053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111034256|NCT02133053|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111034257|NCT02133053|Respiratory System Agents|respiratory system agents|mesh-ancestor
111034258|NCT02137109|Natalizumab|natalizumab|mesh-list
111034259|NCT02137109|Immunologic Factors|immunologic factors|mesh-ancestor
111034260|NCT02137109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111034261|NCT02130167|Atropine|atropine|mesh-list
111034262|NCT02130167|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111034263|NCT02130167|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111034264|NCT02130167|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111034265|NCT02130167|Autonomic Agents|autonomic agents|mesh-ancestor
111034266|NCT02130167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111034267|NCT02130167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111034268|NCT02130167|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111034269|NCT02130167|Respiratory System Agents|respiratory system agents|mesh-ancestor
111034270|NCT02130167|Mydriatics|mydriatics|mesh-ancestor
111034271|NCT02130167|Parasympatholytics|parasympatholytics|mesh-ancestor
111034272|NCT02130167|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111034273|NCT02130167|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111034274|NCT02130167|Cholinergic Agents|cholinergic agents|mesh-ancestor
111034275|NCT02130167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111034276|NCT02130167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111034277|NCT02130323|Imiquimod|imiquimod|mesh-list
111034278|NCT02130323|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111034279|NCT02130323|Immunologic Factors|immunologic factors|mesh-ancestor
111034280|NCT02130323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111034281|NCT02130323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111034282|NCT02130323|Interferon Inducers|interferon inducers|mesh-ancestor
111034283|NCT03549611|Acetaminophen|acetaminophen|mesh-list
111034284|NCT03549611|Celecoxib|celecoxib|mesh-list
111034285|NCT03549611|Oxycodone|oxycodone|mesh-list
111034286|NCT03549611|Gabapentin|gabapentin|mesh-list
111034287|NCT03549611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111034288|NCT03549611|Analgesics|analgesics|mesh-ancestor
111034289|NCT03549611|Sensory System Agents|sensory system agents|mesh-ancestor
111034290|NCT03549611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111034291|NCT03549611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111034292|NCT03549611|Antipyretics|antipyretics|mesh-ancestor
111034293|NCT03549611|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111034294|NCT03549611|Narcotics|narcotics|mesh-ancestor
111034295|NCT03549611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111034296|NCT03549611|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111034297|NCT03549611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111034298|NCT03549611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111034299|NCT03549611|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111034300|NCT03549611|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111034301|NCT03549611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111034302|NCT03549611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111034303|NCT03549611|Anticonvulsants|anticonvulsants|mesh-ancestor
111034304|NCT03549611|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111034305|NCT03549611|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111034306|NCT03549611|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111034307|NCT03549611|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111034309|NCT03549611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111034310|NCT03549611|Antimanic Agents|antimanic agents|mesh-ancestor
111034311|NCT02133287|Sirolimus|sirolimus|mesh-list
111034312|NCT02133287|Arsenic Trioxide|arsenic trioxide|mesh-list
111034313|NCT02133287|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111034314|NCT02133287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111034315|NCT02133287|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111034316|NCT02133287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111034317|NCT02133287|Antifungal Agents|antifungal agents|mesh-ancestor
111034318|NCT02133287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111034319|NCT02133287|Immunologic Factors|immunologic factors|mesh-ancestor
111034320|NCT02133287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111034321|NCT02137265|Clomiphene|clomiphene|mesh-list
111034322|NCT02137265|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111034323|NCT02137265|Hormone Antagonists|hormone antagonists|mesh-ancestor
111034324|NCT02137265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111034325|NCT02137265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111034326|NCT02137265|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111034327|NCT02137265|Fertility Agents|fertility agents|mesh-ancestor
111034328|NCT02137265|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111034329|NCT02137265|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111034330|NCT02137265|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111034331|NCT02592434|Tofacitinib|tofacitinib|mesh-list
111034332|NCT02592434|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
111034333|NCT02592434|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111034334|NCT02592434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111034335|NCT02592434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111034336|NCT02130713|Fluoroquinolones|fluoroquinolones|mesh-list
111034337|NCT02130713|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111034338|NCT02130713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111034339|NCT02130713|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111034340|NCT02130713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111034341|NCT02130713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111034342|NCT02137421|Resveratrol|resveratrol|mesh-list
111034343|NCT02137421|Antioxidants|antioxidants|mesh-ancestor
111034344|NCT02137421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111034345|NCT02137421|Protective Agents|protective agents|mesh-ancestor
111034346|NCT02137421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111034347|NCT02137421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111034348|NCT02137421|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111034350|NCT02133677|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111034351|NCT02133677|Alkylating Agents|alkylating agents|mesh-ancestor
111034352|NCT02133677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111034353|NCT02133677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111034354|NCT02137733|Carvedilol|carvedilol|mesh-list
111034355|NCT02137733|Bisoprolol|bisoprolol|mesh-list
111034356|NCT02137733|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111034357|NCT02137733|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111034358|NCT02137733|Adrenergic Agents|adrenergic agents|mesh-ancestor
111034359|NCT02137733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111034360|NCT02137733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111034361|NCT02137733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111034362|NCT02137733|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111034363|NCT02137733|Antioxidants|antioxidants|mesh-ancestor
111034364|NCT02137733|Protective Agents|protective agents|mesh-ancestor
111034365|NCT02137733|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111034366|NCT02137733|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111034367|NCT02137733|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111034368|NCT02137733|Vasodilator Agents|vasodilator agents|mesh-ancestor
111034369|NCT02137733|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111034370|NCT02137733|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111034371|NCT02137733|Sympatholytics|sympatholytics|mesh-ancestor
111034372|NCT02137733|Autonomic Agents|autonomic agents|mesh-ancestor
111034373|NCT02137733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111034374|NCT02137733|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
111034375|NCT02133755|Bromocriptine|bromocriptine|mesh-list
111034376|NCT02133755|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111034377|NCT02133755|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111034378|NCT02133755|Hormone Antagonists|hormone antagonists|mesh-ancestor
111034379|NCT02133755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111034380|NCT02133755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111034381|NCT02133755|Dopamine Agonists|dopamine agonists|mesh-ancestor
111034383|NCT02133755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111034384|NCT02133755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111034385|NCT02130869|Cytarabine|cytarabine|mesh-list
111034386|NCT02130869|Aldesleukin|aldesleukin|mesh-list
111034387|NCT02130869|Carboplatin|carboplatin|mesh-list
111034388|NCT02130869|Etoposide|etoposide|mesh-list
111034389|NCT02130869|Etoposide phosphate|etoposide phosphate|mesh-list
111034390|NCT02130869|Melphalan|melphalan|mesh-list
111034391|NCT02130869|Busulfan|busulfan|mesh-list
111034392|NCT02130869|Interleukin-2|interleukin-2|mesh-list
111034393|NCT02130869|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
111034394|NCT02130869|Mechlorethamine|mechlorethamine|mesh-list
111034395|NCT02130869|Sargramostim|sargramostim|mesh-list
111034396|NCT02130869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111034397|NCT02130869|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111034398|NCT02130869|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111034399|NCT02130869|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111034400|NCT02130869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111034401|NCT02130869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111034402|NCT02130869|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111034403|NCT02130869|Antimetabolites|antimetabolites|mesh-ancestor
111034404|NCT02130869|Antiviral Agents|antiviral agents|mesh-ancestor
111034405|NCT02130869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111034406|NCT02130869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111034407|NCT02130869|Immunologic Factors|immunologic factors|mesh-ancestor
111034408|NCT02130869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111034409|NCT02130869|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111034410|NCT02130869|Alkylating Agents|alkylating agents|mesh-ancestor
111034411|NCT02130869|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111034412|NCT02130869|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111034413|NCT02130869|Analgesics|analgesics|mesh-ancestor
111034414|NCT02130869|Sensory System Agents|sensory system agents|mesh-ancestor
111034415|NCT02130869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111034416|NCT02130869|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111034417|NCT02130869|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111034418|NCT02133911|Ranolazine|ranolazine|mesh-list
111034419|NCT02133911|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111034420|NCT02133911|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111034421|NCT02133911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111034422|NCT02133989|Ticlopidine|ticlopidine|mesh-list
111034423|NCT02133989|Clopidogrel|clopidogrel|mesh-list
111034424|NCT02133989|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111034425|NCT02133989|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111034426|NCT02133989|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111034427|NCT02133989|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111034428|NCT02133989|Purinergic Agents|purinergic agents|mesh-ancestor
111034429|NCT02133989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111034430|NCT02133989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111034431|NCT02133989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111034432|NCT02133989|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111034433|NCT02133989|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111034434|NCT02133989|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111034435|NCT02133989|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111034436|NCT02133989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111034437|NCT02138045|Liraglutide|liraglutide|mesh-list
111034438|NCT02138045|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111034439|NCT02138045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111034440|NCT02138045|Incretins|incretins|mesh-ancestor
111034441|NCT02138045|Hormones|hormones|mesh-ancestor
111034442|NCT02138045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111034443|NCT02134067|Paclitaxel|paclitaxel|mesh-list
111034444|NCT02134067|TAS-119|tas-119|mesh-list
111034445|NCT02134067|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111034446|NCT02134067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111034447|NCT02134067|Tubulin Modulators|tubulin modulators|mesh-ancestor
111034448|NCT02134067|Antimitotic Agents|antimitotic agents|mesh-ancestor
111034449|NCT02134067|Mitosis Modulators|mitosis modulators|mesh-ancestor
111034450|NCT02134067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111034451|NCT02134067|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111034452|NCT02134067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111034453|NCT04091126|Dexamethasone|dexamethasone|mesh-list
111034454|NCT04091126|Lenalidomide|lenalidomide|mesh-list
111034455|NCT04091126|Bortezomib|bortezomib|mesh-list
111034456|NCT04091126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111034457|NCT04091126|Antiemetics|antiemetics|mesh-ancestor
111034458|NCT04091126|Autonomic Agents|autonomic agents|mesh-ancestor
111034459|NCT04091126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111034460|NCT04091126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111034461|NCT04091126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111034462|NCT04091126|Glucocorticoids|glucocorticoids|mesh-ancestor
111034463|NCT04091126|Hormones|hormones|mesh-ancestor
111034464|NCT04091126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111034465|NCT04091126|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111034466|NCT04091126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111034467|NCT04091126|Immunologic Factors|immunologic factors|mesh-ancestor
111034468|NCT04091126|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111034469|NCT04091126|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111034470|NCT04091126|Growth Substances|growth substances|mesh-ancestor
111034471|NCT04091126|Growth Inhibitors|growth inhibitors|mesh-ancestor
111034472|NCT03962114|Niacinamide|niacinamide|mesh-list
111034473|NCT03962114|Niacin|niacin|mesh-list
111034474|NCT03962114|Nicotinic Acids|nicotinic acids|mesh-list
111034475|NCT03962114|Vitamins|vitamins|mesh-ancestor
111034476|NCT03962114|Micronutrients|micronutrients|mesh-ancestor
111034477|NCT03962114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111034478|NCT03962114|Vitamin B Complex|vitamin b complex|mesh-ancestor
111034479|NCT03962114|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111034480|NCT03962114|Antimetabolites|antimetabolites|mesh-ancestor
111034481|NCT03962114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111034482|NCT03962114|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111034483|NCT03962114|Vasodilator Agents|vasodilator agents|mesh-ancestor
111034484|NCT04346186|Immunoglobulin G|immunoglobulin g|mesh-list
111034485|NCT04346186|Immunoglobulin M|immunoglobulin m|mesh-list
111034486|NCT04346186|Immunologic Factors|immunologic factors|mesh-ancestor
111034487|NCT04346186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111034488|NCT05472896|Epirubicin|epirubicin|mesh-list
111034489|NCT05472896|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111034490|NCT05472896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111034491|NCT05472896|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111034492|NCT05472896|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111034493|NCT05472896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111034494|NCT05472896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111034495|NCT02138357|Buprenorphine|buprenorphine|mesh-list
111034496|NCT02138357|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111034497|NCT02138357|Narcotics|narcotics|mesh-ancestor
111034498|NCT02138357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111034499|NCT02138357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111034500|NCT02138357|Analgesics|analgesics|mesh-ancestor
111034501|NCT02138357|Sensory System Agents|sensory system agents|mesh-ancestor
111034502|NCT02138357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111034503|NCT02138357|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111034504|NCT03596918|Vincristine|vincristine|mesh-list
111034505|NCT03596918|Bleomycin|bleomycin|mesh-list
111034506|NCT03596918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111034507|NCT03596918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111034508|NCT03596918|Tubulin Modulators|tubulin modulators|mesh-ancestor
111034509|NCT03596918|Antimitotic Agents|antimitotic agents|mesh-ancestor
111034510|NCT03596918|Mitosis Modulators|mitosis modulators|mesh-ancestor
111034511|NCT03596918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111034512|NCT03596918|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111034513|NCT02134379|Clotrimazole|clotrimazole|mesh-list
111034514|NCT02134379|Miconazole|miconazole|mesh-list
111034515|NCT02134379|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111034516|NCT02134379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111034517|NCT02134379|Antifungal Agents|antifungal agents|mesh-ancestor
111034518|NCT02134379|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111034519|NCT02134379|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111034520|NCT02134379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111034521|NCT02134379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111034522|NCT02134379|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111034523|NCT02134379|Hormone Antagonists|hormone antagonists|mesh-ancestor
111034524|NCT02134379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111034525|NCT02134379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111034526|NCT02134379|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111034527|NCT02134379|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111034528|NCT02134457|Ranibizumab|ranibizumab|mesh-list
111034529|NCT02134457|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110827325|NCT01165567|Sarpogrelate|sarpogrelate|mesh-list
111034530|NCT02134457|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111034531|NCT02134457|Growth Substances|growth substances|mesh-ancestor
111034532|NCT02134457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111034533|NCT02134457|Growth Inhibitors|growth inhibitors|mesh-ancestor
111034534|NCT02134457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111034535|NCT04090190|Solifenacin Succinate|solifenacin succinate|mesh-list
111034536|NCT04090190|Tolterodine Tartrate|tolterodine tartrate|mesh-list
111034538|NCT04090190|Oxybutynin|oxybutynin|mesh-list
111034539|NCT04090190|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111034540|NCT04090190|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111034541|NCT04090190|Cholinergic Agents|cholinergic agents|mesh-ancestor
111034542|NCT04090190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111034543|NCT04090190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111034544|NCT04090190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111034545|NCT04090190|Urological Agents|urological agents|mesh-ancestor
111034546|NCT04090190|Parasympatholytics|parasympatholytics|mesh-ancestor
111034547|NCT04090190|Autonomic Agents|autonomic agents|mesh-ancestor
111034548|NCT04090190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111034549|NCT04792034|Cocaine|cocaine|mesh-list
111034550|NCT04792034|Anesthetics, Local|anesthetics, local|mesh-ancestor
111034551|NCT04792034|Anesthetics|anesthetics|mesh-ancestor
111034552|NCT04792034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111034553|NCT04792034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111034554|NCT04792034|Sensory System Agents|sensory system agents|mesh-ancestor
111034555|NCT04792034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111034556|NCT04792034|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111034557|NCT04792034|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111034558|NCT04792034|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111034559|NCT04792034|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111034560|NCT04792034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111034561|NCT04792034|Dopamine Agents|dopamine agents|mesh-ancestor
111034562|NCT04792034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111034563|NCT02253095|Micronutrients|micronutrients|mesh-list
111034564|NCT02253095|Trace Elements|trace elements|mesh-list
111034565|NCT02253095|Albendazole|albendazole|mesh-list
111034566|NCT02253095|Anthelmintics|anthelmintics|mesh-ancestor
111034567|NCT02253095|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111034568|NCT02253095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111034569|NCT02253095|Anticestodal Agents|anticestodal agents|mesh-ancestor
111034570|NCT02253095|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
111034571|NCT02253095|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111034572|NCT02253095|Tubulin Modulators|tubulin modulators|mesh-ancestor
111034573|NCT02253095|Antimitotic Agents|antimitotic agents|mesh-ancestor
111034574|NCT02253095|Mitosis Modulators|mitosis modulators|mesh-ancestor
111034575|NCT02253095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111034576|NCT02253095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111034577|NCT02253095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111034579|NCT04791332|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111034580|NCT04791332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111034581|NCT04791332|Sensory System Agents|sensory system agents|mesh-ancestor
111034582|NCT04791332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111034583|NCT05461820|Methimazole|methimazole|mesh-list
111034584|NCT05461820|Antithyroid Agents|antithyroid agents|mesh-ancestor
111034585|NCT05461820|Hormone Antagonists|hormone antagonists|mesh-ancestor
111034586|NCT05461820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111034587|NCT05461820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111034588|NCT04791020|Lidocaine|lidocaine|mesh-list
111034589|NCT04791020|Anesthetics, Local|anesthetics, local|mesh-ancestor
111034590|NCT04791020|Anesthetics|anesthetics|mesh-ancestor
111034591|NCT04791020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111034592|NCT04791020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111034593|NCT04791020|Sensory System Agents|sensory system agents|mesh-ancestor
110626515|NCT01065805|Alovudine|alovudine|mesh-list
111034594|NCT04791020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111034595|NCT04791020|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111034596|NCT04791020|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111034597|NCT04791020|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111034598|NCT04791020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111034599|NCT04791020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111034600|NCT02531906|Oxycodone|oxycodone|mesh-list
111034601|NCT02531906|Methadone|methadone|mesh-list
111034602|NCT02531906|Gabapentin|gabapentin|mesh-list
111034603|NCT02531906|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111034604|NCT02531906|Narcotics|narcotics|mesh-ancestor
111034605|NCT02531906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111034606|NCT02531906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111034607|NCT02531906|Analgesics|analgesics|mesh-ancestor
111034608|NCT02531906|Sensory System Agents|sensory system agents|mesh-ancestor
111034609|NCT02531906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111034610|NCT02531906|Anticonvulsants|anticonvulsants|mesh-ancestor
111034611|NCT02531906|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111034612|NCT02531906|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111034613|NCT02531906|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111034614|NCT02531906|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111034615|NCT02531906|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111034616|NCT02531906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111034617|NCT02531906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111034618|NCT02531906|Antimanic Agents|antimanic agents|mesh-ancestor
111034619|NCT02531906|Antitussive Agents|antitussive agents|mesh-ancestor
111034620|NCT02531906|Respiratory System Agents|respiratory system agents|mesh-ancestor
111034621|NCT02783729|Zolpidem|zolpidem|mesh-list
111034622|NCT02783729|Lemborexant|lemborexant|mesh-list
111034623|NCT02783729|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111034624|NCT02783729|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111034625|NCT02783729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111034626|NCT02783729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111034627|NCT02783729|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
111034628|NCT02783729|GABA Agonists|gaba agonists|mesh-ancestor
111034629|NCT02783729|GABA Agents|gaba agents|mesh-ancestor
111034630|NCT02783729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111034631|NCT02783729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111034632|NCT02783729|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
111034633|NCT02227940|Paclitaxel|paclitaxel|mesh-list
111034634|NCT02227940|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111034635|NCT02227940|Cisplatin|cisplatin|mesh-list
111034636|NCT02227940|Gemcitabine|gemcitabine|mesh-list
111034637|NCT02227940|Ceritinib|ceritinib|mesh-list
111034638|NCT02227940|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111034639|NCT02227940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111034640|NCT02227940|Tubulin Modulators|tubulin modulators|mesh-ancestor
111034641|NCT02227940|Antimitotic Agents|antimitotic agents|mesh-ancestor
111034642|NCT02227940|Mitosis Modulators|mitosis modulators|mesh-ancestor
111034643|NCT02227940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111034644|NCT02227940|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111034645|NCT02227940|Antimetabolites|antimetabolites|mesh-ancestor
111034646|NCT02227940|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111034647|NCT02227940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110751713|NCT03175120|Insulin|insulin|mesh-list
111034648|NCT02072486|Sorafenib|sorafenib|mesh-list
111034649|NCT02072486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111034650|NCT02072486|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111034652|NCT02072486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111034653|NCT00988364|Simvastatin|simvastatin|mesh-list
111034654|NCT00988364|Ezetimibe|ezetimibe|mesh-list
111034655|NCT00988364|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
110626527|NCT00311623|Immunologic Factors|immunologic factors|mesh-ancestor
111034656|NCT00988364|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111034657|NCT00988364|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111034658|NCT00988364|Antimetabolites|antimetabolites|mesh-ancestor
111034659|NCT00988364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111034660|NCT00988364|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111034661|NCT00988364|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111034662|NCT00988364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111034663|NCT05578001|Pilocarpine|pilocarpine|mesh-list
111034664|NCT05578001|Miotics|miotics|mesh-ancestor
111034665|NCT05578001|Autonomic Agents|autonomic agents|mesh-ancestor
111034666|NCT05578001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111034667|NCT05578001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111034668|NCT05578001|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
111034669|NCT05578001|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111034670|NCT05578001|Cholinergic Agents|cholinergic agents|mesh-ancestor
111034671|NCT05578001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111034672|NCT05578001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111034673|NCT05577923|Trastuzumab|trastuzumab|mesh-list
111034674|NCT05577923|Fulvestrant|fulvestrant|mesh-list
111034675|NCT05577923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111034676|NCT05577923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111034677|NCT05577923|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111034678|NCT05577923|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
111034679|NCT05577923|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111034680|NCT05577923|Hormone Antagonists|hormone antagonists|mesh-ancestor
111034681|NCT05577923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111034682|NCT05577923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111034683|NCT04790708|Octreotide|octreotide|mesh-list
111034684|NCT04790708|Edotreotide|edotreotide|mesh-list
111034685|NCT04790708|Edotreotide lutetium LU-177|edotreotide lutetium lu-177|mesh-list
111034686|NCT04790708|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111034687|NCT04790708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111034688|NCT04790708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111034689|NCT04790708|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111034690|NCT04790708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111034691|NCT05614934|Clarithromycin|clarithromycin|mesh-list
111034692|NCT05614934|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111034693|NCT05614934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111034694|NCT05614934|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111034695|NCT05614934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111034696|NCT05614934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111034697|NCT05614934|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111034698|NCT05614934|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111034699|NCT02135393|Folic Acid|folic acid|mesh-list
111034700|NCT02135393|Hematinics|hematinics|mesh-ancestor
111034701|NCT02135393|Vitamin B Complex|vitamin b complex|mesh-ancestor
111034702|NCT02135393|Vitamins|vitamins|mesh-ancestor
111034703|NCT02135393|Micronutrients|micronutrients|mesh-ancestor
111034704|NCT02135393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111034705|NCT02139761|Tetrahydropalmatine|tetrahydropalmatine|mesh-list
111034706|NCT02139761|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111034707|NCT02139761|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111034708|NCT02139761|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111034709|NCT02139761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111034710|NCT02139761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111034711|NCT02139761|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111034712|NCT02139761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111034713|NCT02139761|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111034714|NCT02139761|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111034715|NCT02139761|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111034716|NCT02139761|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111034717|NCT02139761|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111034718|NCT02139761|Dopamine Agents|dopamine agents|mesh-ancestor
111034719|NCT02139761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111034720|NCT02139761|Adrenergic Agents|adrenergic agents|mesh-ancestor
110751787|NCT01331122|Droxidopa|droxidopa|mesh-list
111034722|NCT02139761|Analgesics|analgesics|mesh-ancestor
111034723|NCT02139761|Sensory System Agents|sensory system agents|mesh-ancestor
111034724|NCT02139761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111034725|NCT05614778|Zoledronic Acid|zoledronic acid|mesh-list
111034726|NCT05614778|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111034727|NCT05614778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111034728|NCT05474924|Prednisolone|prednisolone|mesh-list
111034729|NCT05474924|Budesonide|budesonide|mesh-list
111034730|NCT05474924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111034731|NCT05474924|Glucocorticoids|glucocorticoids|mesh-ancestor
111034732|NCT05474924|Hormones|hormones|mesh-ancestor
111034733|NCT05474924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111034734|NCT05474924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111034735|NCT05474924|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111034736|NCT05474924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111034737|NCT05474924|Autonomic Agents|autonomic agents|mesh-ancestor
111034738|NCT05474924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111034739|NCT05474924|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111034740|NCT05474924|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111034741|NCT05474924|Respiratory System Agents|respiratory system agents|mesh-ancestor
111034742|NCT02135627|Epinephrine|epinephrine|mesh-list
111034743|NCT02135627|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111034744|NCT02135627|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111034745|NCT02135627|Adrenergic Agents|adrenergic agents|mesh-ancestor
111034746|NCT02135627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111034747|NCT02135627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111034748|NCT02135627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111034749|NCT02135627|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111034750|NCT02135627|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111034751|NCT02135627|Autonomic Agents|autonomic agents|mesh-ancestor
111034752|NCT02135627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111034753|NCT02135627|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111034754|NCT02135627|Respiratory System Agents|respiratory system agents|mesh-ancestor
111034755|NCT02135627|Mydriatics|mydriatics|mesh-ancestor
111034756|NCT02135627|Sympathomimetics|sympathomimetics|mesh-ancestor
111034757|NCT02135627|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111034758|NCT05614622|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111034759|NCT05614622|Cyclopentolate|cyclopentolate|mesh-list
111034760|NCT05614622|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111034761|NCT05614622|Mydriatics|mydriatics|mesh-ancestor
111034762|NCT05614622|Autonomic Agents|autonomic agents|mesh-ancestor
111034763|NCT05614622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111034764|NCT05614622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111034765|NCT05614622|Parasympatholytics|parasympatholytics|mesh-ancestor
111034766|NCT05614622|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111034767|NCT05614622|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111034768|NCT05614622|Cholinergic Agents|cholinergic agents|mesh-ancestor
111034769|NCT05614622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111034770|NCT05614622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111034771|NCT03548129|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111034772|NCT03548129|Fosfomycin|fosfomycin|mesh-list
111034773|NCT03548129|Anti-Infective Agents|anti-infective agents|mesh-list
111034774|NCT02140073|Domperidone|domperidone|mesh-list
111034775|NCT02140073|Omeprazole|omeprazole|mesh-list
111034776|NCT02140073|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111034777|NCT02140073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111034778|NCT02140073|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111034779|NCT02140073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111034780|NCT02140073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111034781|NCT02140073|Antiemetics|antiemetics|mesh-ancestor
111034782|NCT02140073|Autonomic Agents|autonomic agents|mesh-ancestor
111034783|NCT02140073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111034784|NCT02140073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111034785|NCT02140073|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111034786|NCT02140073|Dopamine Agents|dopamine agents|mesh-ancestor
111034787|NCT02140073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111034788|NCT05474690|Cyclophosphamide|cyclophosphamide|mesh-list
111034789|NCT05474690|Carboplatin|carboplatin|mesh-list
111034790|NCT05474690|Docetaxel|docetaxel|mesh-list
111034791|NCT05474690|Trastuzumab|trastuzumab|mesh-list
111034792|NCT05474690|Epirubicin|epirubicin|mesh-list
111034793|NCT05474690|Pertuzumab|pertuzumab|mesh-list
111034794|NCT05474690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111034795|NCT05474690|Immunologic Factors|immunologic factors|mesh-ancestor
111034796|NCT05474690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111034797|NCT05474690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111034798|NCT05474690|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111034799|NCT05474690|Alkylating Agents|alkylating agents|mesh-ancestor
111034800|NCT05474690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111034801|NCT05474690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111034802|NCT05474690|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111034803|NCT05474690|Tubulin Modulators|tubulin modulators|mesh-ancestor
111034804|NCT05474690|Antimitotic Agents|antimitotic agents|mesh-ancestor
111034805|NCT05474690|Mitosis Modulators|mitosis modulators|mesh-ancestor
111034806|NCT05474690|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111034807|NCT05474690|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111034808|NCT05474690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111034809|NCT05474690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111034810|NCT05474690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111034811|NCT05575973|Rituximab|rituximab|mesh-list
111034812|NCT05575973|Lenalidomide|lenalidomide|mesh-list
111034813|NCT05575973|Mitoxantrone|mitoxantrone|mesh-list
111034814|NCT05575973|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111034815|NCT05575973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111034816|NCT05575973|Immunologic Factors|immunologic factors|mesh-ancestor
111034817|NCT05575973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111034818|NCT05575973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111034819|NCT05575973|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111034820|NCT05575973|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111034821|NCT05575973|Growth Substances|growth substances|mesh-ancestor
111034822|NCT05575973|Growth Inhibitors|growth inhibitors|mesh-ancestor
111034823|NCT05575973|Analgesics|analgesics|mesh-ancestor
111034824|NCT05575973|Sensory System Agents|sensory system agents|mesh-ancestor
111034825|NCT05575973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111034826|NCT05575973|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111034827|NCT05575973|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111034828|NCT05575973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111034829|NCT05575973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111034830|NCT03547895|Vitamin K|vitamin k|mesh-list
111034831|NCT03547895|Vitamin K 1|vitamin k 1|mesh-list
111034832|NCT03547895|Ribavirin|ribavirin|mesh-list
111034833|NCT03547895|Sofosbuvir|sofosbuvir|mesh-list
111034834|NCT03547895|Furosemide|furosemide|mesh-list
111034835|NCT03547895|Spironolactone|spironolactone|mesh-list
111034836|NCT03547895|Silymarin|silymarin|mesh-list
111034837|NCT03547895|Vitamins|vitamins|mesh-ancestor
111034838|NCT03547895|Micronutrients|micronutrients|mesh-ancestor
111034839|NCT03547895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111034840|NCT03547895|Antimetabolites|antimetabolites|mesh-ancestor
111034841|NCT03547895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111034842|NCT03547895|Antiviral Agents|antiviral agents|mesh-ancestor
111034843|NCT03547895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111034844|NCT03547895|Diuretics|diuretics|mesh-ancestor
111034845|NCT03547895|Natriuretic Agents|natriuretic agents|mesh-ancestor
111034846|NCT03547895|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
111034847|NCT03547895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111034848|NCT03547895|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
111034849|NCT03547895|Hormone Antagonists|hormone antagonists|mesh-ancestor
111034850|NCT03547895|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111034851|NCT03547895|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
111034852|NCT03547895|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111034853|NCT03547895|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111034854|NCT03547895|Hemostatics|hemostatics|mesh-ancestor
111034855|NCT03547895|Coagulants|coagulants|mesh-ancestor
111034856|NCT03547895|Antioxidants|antioxidants|mesh-ancestor
111034857|NCT03547895|Protective Agents|protective agents|mesh-ancestor
111034858|NCT01359254|Fludarabine|fludarabine|mesh-list
110626558|NCT01067989|Analgesics|analgesics|mesh-ancestor
111034859|NCT01359254|Fludarabine phosphate|fludarabine phosphate|mesh-list
111034860|NCT01359254|Melphalan|melphalan|mesh-list
111034861|NCT01359254|Busulfan|busulfan|mesh-list
111034862|NCT01359254|Antilymphocyte Serum|antilymphocyte serum|mesh-list
111034863|NCT01359254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111034864|NCT01359254|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111034865|NCT01359254|Antimetabolites|antimetabolites|mesh-ancestor
111034866|NCT01359254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111034867|NCT01359254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111034868|NCT01359254|Immunologic Factors|immunologic factors|mesh-ancestor
111034869|NCT01359254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111034870|NCT01359254|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111034871|NCT01359254|Alkylating Agents|alkylating agents|mesh-ancestor
111034872|NCT01359254|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111034873|NCT05575739|Antioxidants|antioxidants|mesh-list
111034874|NCT05575739|Superoxide Dismutase|superoxide dismutase|mesh-list
111034875|NCT05575739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111034876|NCT05575739|Protective Agents|protective agents|mesh-ancestor
111034877|NCT05575739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111034878|NCT05575739|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111034879|NCT05035862|Interferons|interferons|mesh-list
111034880|NCT05035862|Interferon-gamma|interferon-gamma|mesh-list
111034881|NCT05035862|Prednisone|prednisone|mesh-list
111034882|NCT05035862|Albuterol|albuterol|mesh-list
111034883|NCT05035862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111034884|NCT05035862|Glucocorticoids|glucocorticoids|mesh-ancestor
111034885|NCT05035862|Hormones|hormones|mesh-ancestor
111034886|NCT05035862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111034887|NCT05035862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111034888|NCT05035862|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111034889|NCT05035862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111034890|NCT05035862|Antiviral Agents|antiviral agents|mesh-ancestor
111034891|NCT05035862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111034892|NCT05035862|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111034893|NCT05035862|Autonomic Agents|autonomic agents|mesh-ancestor
111034894|NCT05035862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111034895|NCT05035862|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111034896|NCT05035862|Respiratory System Agents|respiratory system agents|mesh-ancestor
111034897|NCT05035862|Tocolytic Agents|tocolytic agents|mesh-ancestor
111034898|NCT05035862|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111034899|NCT05035862|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111034900|NCT05035862|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111034901|NCT05035862|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111034902|NCT05035862|Adrenergic Agents|adrenergic agents|mesh-ancestor
111034903|NCT05035862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111034904|NCT05035862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111034905|NCT03549221|Ketorolac|ketorolac|mesh-list
111034906|NCT03549221|Epinephrine|epinephrine|mesh-list
111034907|NCT03549221|Levobupivacaine|levobupivacaine|mesh-list
111034908|NCT03549221|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111034909|NCT03549221|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111034910|NCT03549221|Adrenergic Agents|adrenergic agents|mesh-ancestor
111034911|NCT03549221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111034912|NCT03549221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111034913|NCT03549221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111034914|NCT03549221|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111034915|NCT03549221|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111034916|NCT03549221|Autonomic Agents|autonomic agents|mesh-ancestor
111034917|NCT03549221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111034918|NCT03549221|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111034919|NCT03549221|Respiratory System Agents|respiratory system agents|mesh-ancestor
111034920|NCT03549221|Mydriatics|mydriatics|mesh-ancestor
111034921|NCT03549221|Sympathomimetics|sympathomimetics|mesh-ancestor
111034922|NCT03549221|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111034923|NCT03549221|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111034924|NCT03549221|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111034925|NCT03549221|Analgesics|analgesics|mesh-ancestor
111034926|NCT03549221|Sensory System Agents|sensory system agents|mesh-ancestor
111034927|NCT03549221|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111034928|NCT03549221|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111034929|NCT03549221|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111034930|NCT03549221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111034931|NCT03549221|Anesthetics, Local|anesthetics, local|mesh-ancestor
111034932|NCT03549221|Anesthetics|anesthetics|mesh-ancestor
111034933|NCT03549221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111034934|NCT05013632|Antiviral Agents|antiviral agents|mesh-list
111034935|NCT05013632|Remdesivir|remdesivir|mesh-list
111034936|NCT05013632|Sotrovimab|sotrovimab|mesh-list
111034937|NCT05013632|Molnupiravir|molnupiravir|mesh-list
111034938|NCT05013632|Casirivimab and imdevimab drug combination|casirivimab and imdevimab drug combination|mesh-list
111034939|NCT05013632|Antibodies|antibodies|mesh-list
111034940|NCT05013632|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111034941|NCT05013632|Immunologic Factors|immunologic factors|mesh-ancestor
111034942|NCT05013632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111034943|NCT05013632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111034944|NCT05013632|Antimetabolites|antimetabolites|mesh-ancestor
111034945|NCT05013632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111034946|NCT05614544|Propofol|propofol|mesh-list
111034947|NCT05614544|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111034948|NCT05614544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111034949|NCT05614544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111034950|NCT05614544|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111034951|NCT05614544|Anesthetics, General|anesthetics, general|mesh-ancestor
111034952|NCT05614544|Anesthetics|anesthetics|mesh-ancestor
111034953|NCT05185505|Bevacizumab|bevacizumab|mesh-list
111034954|NCT05185505|Atezolizumab|atezolizumab|mesh-list
111034955|NCT05185505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111034956|NCT05185505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111034957|NCT05185505|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111034958|NCT05185505|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111034959|NCT05185505|Growth Substances|growth substances|mesh-ancestor
111034960|NCT05185505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111034961|NCT05185505|Growth Inhibitors|growth inhibitors|mesh-ancestor
111034962|NCT05185505|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111034963|NCT05185505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111034964|NCT01667432|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
111034965|NCT01667432|Antiviral Agents|antiviral agents|mesh-ancestor
111034966|NCT01667432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111034967|NCT05575271|Norepinephrine|norepinephrine|mesh-list
111034968|NCT05575271|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111034969|NCT05575271|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111034970|NCT05575271|Adrenergic Agents|adrenergic agents|mesh-ancestor
111034971|NCT05575271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111034972|NCT05575271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111034973|NCT05575271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110827335|NCT03387462|Emtricitabine|emtricitabine|mesh-list
110626579|NCT04840888|Omeprazole|omeprazole|mesh-list
111034974|NCT05575271|Sympathomimetics|sympathomimetics|mesh-ancestor
111034975|NCT05575271|Autonomic Agents|autonomic agents|mesh-ancestor
111034976|NCT05575271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111034977|NCT05575271|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111034978|NCT04750460|Teriparatide|teriparatide|mesh-list
111034979|NCT04750460|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111034980|NCT04750460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111034981|NCT04750460|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111034982|NCT05575037|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111034983|NCT05575037|Immunologic Factors|immunologic factors|mesh-ancestor
111034984|NCT05575037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111034985|NCT05574881|Trastuzumab|trastuzumab|mesh-list
111034986|NCT05574881|Pertuzumab|pertuzumab|mesh-list
111034987|NCT05574881|Fulvestrant|fulvestrant|mesh-list
111034988|NCT05574881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111034989|NCT05574881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111034990|NCT05574881|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111034991|NCT05574881|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
111034992|NCT05574881|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111034993|NCT05574881|Hormone Antagonists|hormone antagonists|mesh-ancestor
111034994|NCT05574881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111034995|NCT05574881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111034996|NCT05612984|Aspirin|aspirin|mesh-list
111034997|NCT05612984|Folic Acid|folic acid|mesh-list
111034998|NCT05612984|Micronutrients|micronutrients|mesh-list
111034999|NCT05612984|Trace Elements|trace elements|mesh-list
111035000|NCT05612984|Calcium|calcium|mesh-list
111035001|NCT05612984|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111035002|NCT05612984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111035003|NCT05612984|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111035004|NCT05612984|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111035005|NCT05612984|Analgesics|analgesics|mesh-ancestor
111035006|NCT05612984|Sensory System Agents|sensory system agents|mesh-ancestor
111035007|NCT05612984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111035008|NCT05612984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111035009|NCT05612984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111035010|NCT05612984|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111035011|NCT05612984|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111035012|NCT05612984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111035013|NCT05612984|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111035014|NCT05612984|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111035015|NCT05612984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111035016|NCT05612984|Antipyretics|antipyretics|mesh-ancestor
111035017|NCT05612984|Hematinics|hematinics|mesh-ancestor
111035018|NCT05612984|Vitamin B Complex|vitamin b complex|mesh-ancestor
111035019|NCT05612984|Vitamins|vitamins|mesh-ancestor
111035020|NCT04787510|Heparin|heparin|mesh-list
111035021|NCT04787510|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
111035022|NCT04787510|Tinzaparin|tinzaparin|mesh-list
111035023|NCT04787510|Dalteparin|dalteparin|mesh-list
111035024|NCT04787510|Anticoagulants|anticoagulants|mesh-ancestor
111035025|NCT04787510|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110752147|NCT05182138|Zinc|zinc|mesh-list
111035026|NCT04787510|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111035027|NCT04787510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111035028|NCT05424263|Calcium, Dietary|calcium, dietary|mesh-list
111035029|NCT05424263|Calcium Carbonate|calcium carbonate|mesh-list
111035030|NCT05424263|Calcium|calcium|mesh-list
111035031|NCT05424263|Calcium acetate|calcium acetate|mesh-list
111035032|NCT05424263|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111035033|NCT05424263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111035034|NCT05424263|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111035035|NCT05424263|Antacids|antacids|mesh-ancestor
111035036|NCT05424263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111035037|NCT05424263|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111035038|NCT05424263|Chelating Agents|chelating agents|mesh-ancestor
111035039|NCT05424263|Sequestering Agents|sequestering agents|mesh-ancestor
111035040|NCT04787276|Rifaximin|rifaximin|mesh-list
111035041|NCT04787276|Lactulose|lactulose|mesh-list
111035042|NCT04787276|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111035043|NCT04787276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111035044|NCT04787276|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111035045|NCT01564979|Botulinum Toxins|botulinum toxins|mesh-list
111035046|NCT01564979|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111035047|NCT01564979|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111035048|NCT01564979|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111035049|NCT01564979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111035050|NCT01564979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111035051|NCT01564979|Cholinergic Agents|cholinergic agents|mesh-ancestor
111035052|NCT01564979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111035053|NCT01564979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111035054|NCT01564979|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111035055|NCT01564979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111035056|NCT05613140|Valsartan|valsartan|mesh-list
111035057|NCT05613140|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
111035058|NCT05613140|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111035059|NCT05613140|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111035060|NCT05613140|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111035061|NCT05613140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111035062|NCT03547505|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
111035063|NCT03547505|Vasodilator Agents|vasodilator agents|mesh-ancestor
111035064|NCT03547505|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
111035065|NCT03547505|Protective Agents|protective agents|mesh-ancestor
111035066|NCT03547505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111035067|NCT05279183|Erythritol|erythritol|mesh-list
111035068|NCT05279183|Vasodilator Agents|vasodilator agents|mesh-ancestor
111035069|NCT04462952|Adavosertib|adavosertib|mesh-list
111035070|NCT04462952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111035071|NCT04462952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111035072|NCT02253485|Telbivudine|telbivudine|mesh-list
111035073|NCT02253485|Antiviral Agents|antiviral agents|mesh-ancestor
111035074|NCT02253485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111035075|NCT02253485|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111035076|NCT02253485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111035077|NCT02253485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111035078|NCT05612516|Hydrogen Peroxide|hydrogen peroxide|mesh-list
111035079|NCT05612516|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111035080|NCT05612516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111035081|NCT02589626|Empagliflozin|empagliflozin|mesh-list
111035082|NCT02589626|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111035083|NCT02589626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111035084|NCT02589626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111035085|NCT02589626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111035086|NCT04976036|Nintedanib|nintedanib|mesh-list
111035087|NCT04976036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111035088|NCT04976036|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111035089|NCT04976036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111035090|NCT04976036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111035091|NCT05557604|Triptorelin Pamoate|triptorelin pamoate|mesh-list
111035092|NCT05557604|Luteolytic Agents|luteolytic agents|mesh-ancestor
111035093|NCT05557604|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111035094|NCT05557604|Contraceptive Agents|contraceptive agents|mesh-ancestor
111035095|NCT05557604|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111035096|NCT05557604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111035097|NCT05557604|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111035098|NCT05557604|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110752160|NCT00265343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111035099|NCT05557604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111035101|NCT05556122|Ropivacaine|ropivacaine|mesh-list
111035102|NCT05556122|Anesthetics, Local|anesthetics, local|mesh-ancestor
111035103|NCT05556122|Anesthetics|anesthetics|mesh-ancestor
111035104|NCT05556122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111035105|NCT05556122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111035106|NCT05556122|Sensory System Agents|sensory system agents|mesh-ancestor
111035107|NCT05556122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111035108|NCT05556122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111035109|NCT05556122|Glucocorticoids|glucocorticoids|mesh-ancestor
111035110|NCT05556122|Hormones|hormones|mesh-ancestor
111035111|NCT05556122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111035112|NCT05556122|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111035113|NCT05556122|Respiratory System Agents|respiratory system agents|mesh-ancestor
111035114|NCT05611268|Pentoxifylline|pentoxifylline|mesh-list
111035115|NCT05611268|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111035116|NCT05611268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111035117|NCT05611268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111035118|NCT05611268|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111035119|NCT05611268|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111035120|NCT05611268|Protective Agents|protective agents|mesh-ancestor
111035121|NCT05611268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111035122|NCT05611268|Vasodilator Agents|vasodilator agents|mesh-ancestor
111035123|NCT05611268|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111035124|NCT05611268|Antioxidants|antioxidants|mesh-ancestor
111035125|NCT05549570|Metformin|metformin|mesh-list
111035126|NCT05549570|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111035127|NCT05549570|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111035128|NCT05549570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111035129|NCT05549570|Incretins|incretins|mesh-ancestor
111035130|NCT05549570|Hormones|hormones|mesh-ancestor
111035131|NCT05549570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111035132|NCT05549570|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111035133|NCT05549570|Protease Inhibitors|protease inhibitors|mesh-ancestor
111035134|NCT05549570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111035135|NCT05549570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111035136|NCT05549492|Buprenorphine|buprenorphine|mesh-list
111035137|NCT05549492|Ropivacaine|ropivacaine|mesh-list
111035138|NCT05549492|Anesthetics, Local|anesthetics, local|mesh-ancestor
111035139|NCT05549492|Anesthetics|anesthetics|mesh-ancestor
111035140|NCT05549492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111035141|NCT05549492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111035142|NCT05549492|Sensory System Agents|sensory system agents|mesh-ancestor
111035143|NCT05549492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111035144|NCT05549492|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111035145|NCT05549492|Narcotics|narcotics|mesh-ancestor
111035146|NCT05549492|Analgesics|analgesics|mesh-ancestor
111035147|NCT05549492|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111035148|NCT04331132|Tolvaptan|tolvaptan|mesh-list
111035149|NCT04331132|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
111035150|NCT04331132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111035151|NCT04331132|Natriuretic Agents|natriuretic agents|mesh-ancestor
111035152|NCT04331132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111035153|NCT05549336|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
111035154|NCT05549336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111035155|NCT05549336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111035156|NCT05549336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111035157|NCT04759274|Diuretics|diuretics|mesh-list
111035158|NCT04759274|Natriuretic Agents|natriuretic agents|mesh-ancestor
111035159|NCT04759274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111035160|NCT05549024|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
111035161|NCT05549024|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111035162|NCT05549024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111035163|NCT01666730|Leucovorin|leucovorin|mesh-list
111035164|NCT01666730|Metformin|metformin|mesh-list
111035165|NCT01666730|Fluorouracil|fluorouracil|mesh-list
111035166|NCT01666730|Oxaliplatin|oxaliplatin|mesh-list
111035167|NCT01666730|Calcium|calcium|mesh-list
111035168|NCT01666730|Levoleucovorin|levoleucovorin|mesh-list
111035169|NCT01666730|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111035170|NCT01666730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111035171|NCT01666730|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111035172|NCT01666730|Antimetabolites|antimetabolites|mesh-ancestor
110752233|NCT03233308|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111035173|NCT01666730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111035174|NCT01666730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111035175|NCT01666730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111035176|NCT01666730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111035177|NCT01666730|Immunologic Factors|immunologic factors|mesh-ancestor
111035178|NCT01666730|Antidotes|antidotes|mesh-ancestor
111035179|NCT01666730|Protective Agents|protective agents|mesh-ancestor
111035180|NCT01666730|Vitamin B Complex|vitamin b complex|mesh-ancestor
111035181|NCT01666730|Vitamins|vitamins|mesh-ancestor
111035182|NCT01666730|Micronutrients|micronutrients|mesh-ancestor
111035183|NCT05554094|Psilocybin|psilocybin|mesh-list
111035184|NCT05554094|Hallucinogens|hallucinogens|mesh-ancestor
111035185|NCT05554094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111035186|NCT05554094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111035187|NCT04434560|Nivolumab|nivolumab|mesh-list
111035188|NCT04434560|Ipilimumab|ipilimumab|mesh-list
111035189|NCT04434560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111035190|NCT04434560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111035191|NCT04434560|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111035192|NCT04434560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111035193|NCT05700656|Capecitabine|capecitabine|mesh-list
111035194|NCT05700656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111035195|NCT05700656|Antimetabolites|antimetabolites|mesh-ancestor
111035196|NCT05700656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111035197|NCT05700656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111035198|NCT00103285|Calcium, Dietary|calcium, dietary|mesh-list
111035199|NCT00103285|Leucovorin|leucovorin|mesh-list
111035200|NCT00103285|Folic Acid|folic acid|mesh-list
111035201|NCT00103285|Cytarabine|cytarabine|mesh-list
111035202|NCT00103285|Dexamethasone|dexamethasone|mesh-list
111035203|NCT00103285|Dexamethasone acetate|dexamethasone acetate|mesh-list
111035204|NCT00103285|Cyclophosphamide|cyclophosphamide|mesh-list
111035205|NCT00103285|Doxorubicin|doxorubicin|mesh-list
111035206|NCT00103285|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111035207|NCT00103285|Methotrexate|methotrexate|mesh-list
111035208|NCT00103285|Vincristine|vincristine|mesh-list
111035209|NCT00103285|Asparaginase|asparaginase|mesh-list
111035210|NCT00103285|Mercaptopurine|mercaptopurine|mesh-list
111035211|NCT00103285|Pegaspargase|pegaspargase|mesh-list
111035212|NCT00103285|Thioguanine|thioguanine|mesh-list
111035213|NCT00103285|BB 1101|bb 1101|mesh-list
111035214|NCT00103285|Calcium|calcium|mesh-list
111035215|NCT00103285|2-Aminopurine|2-aminopurine|mesh-list
111035216|NCT00103285|Levoleucovorin|levoleucovorin|mesh-list
111035217|NCT00103285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111035218|NCT00103285|Immunologic Factors|immunologic factors|mesh-ancestor
111035219|NCT00103285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111035220|NCT00103285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111035221|NCT00103285|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111035222|NCT00103285|Alkylating Agents|alkylating agents|mesh-ancestor
111035223|NCT00103285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111035224|NCT00103285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111035225|NCT00103285|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111035226|NCT00103285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111035227|NCT00103285|Antiemetics|antiemetics|mesh-ancestor
111035228|NCT00103285|Autonomic Agents|autonomic agents|mesh-ancestor
111035229|NCT00103285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111035230|NCT00103285|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111035231|NCT00103285|Glucocorticoids|glucocorticoids|mesh-ancestor
111035232|NCT00103285|Hormones|hormones|mesh-ancestor
111035233|NCT00103285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111035234|NCT00103285|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111035235|NCT00103285|Protease Inhibitors|protease inhibitors|mesh-ancestor
111035236|NCT00103285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111035237|NCT00103285|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111035238|NCT00103285|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111035239|NCT00103285|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111035240|NCT00103285|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111035241|NCT00103285|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111035242|NCT00103285|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111035243|NCT00103285|Abortifacient Agents|abortifacient agents|mesh-ancestor
111035244|NCT00103285|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111035245|NCT00103285|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111035246|NCT00103285|Antimetabolites|antimetabolites|mesh-ancestor
110752314|NCT05000710|Durvalumab|durvalumab|mesh-list
111035247|NCT00103285|Dermatologic Agents|dermatologic agents|mesh-ancestor
111035248|NCT00103285|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111035249|NCT00103285|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111035250|NCT00103285|Antiviral Agents|antiviral agents|mesh-ancestor
111035251|NCT00103285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111035252|NCT00103285|Antidotes|antidotes|mesh-ancestor
111035253|NCT00103285|Protective Agents|protective agents|mesh-ancestor
111035254|NCT00103285|Vitamin B Complex|vitamin b complex|mesh-ancestor
111035255|NCT00103285|Vitamins|vitamins|mesh-ancestor
111035256|NCT00103285|Micronutrients|micronutrients|mesh-ancestor
111035257|NCT00103285|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111035258|NCT00103285|Tubulin Modulators|tubulin modulators|mesh-ancestor
111035259|NCT00103285|Antimitotic Agents|antimitotic agents|mesh-ancestor
111035260|NCT00103285|Mitosis Modulators|mitosis modulators|mesh-ancestor
111035261|NCT00103285|Hematinics|hematinics|mesh-ancestor
111035262|NCT03541915|Magnesium Sulfate|magnesium sulfate|mesh-list
111035263|NCT03541915|Analgesics|analgesics|mesh-ancestor
111035264|NCT03541915|Sensory System Agents|sensory system agents|mesh-ancestor
111035265|NCT03541915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111035266|NCT03541915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111035267|NCT03541915|Anesthetics|anesthetics|mesh-ancestor
111035268|NCT03541915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111035269|NCT03541915|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111035270|NCT03541915|Anticonvulsants|anticonvulsants|mesh-ancestor
111035271|NCT03541915|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111035272|NCT03541915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111035273|NCT03541915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111035274|NCT03541915|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111035275|NCT03541915|Tocolytic Agents|tocolytic agents|mesh-ancestor
111035276|NCT03541915|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111035277|NCT03541837|Ropivacaine|ropivacaine|mesh-list
111035278|NCT03541837|Anesthetics, Local|anesthetics, local|mesh-ancestor
111035279|NCT03541837|Anesthetics|anesthetics|mesh-ancestor
111035280|NCT03541837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111035281|NCT03541837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111035282|NCT03541837|Sensory System Agents|sensory system agents|mesh-ancestor
111035283|NCT03541837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111035284|NCT02158117|Naloxone|naloxone|mesh-list
111035285|NCT02158117|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111035286|NCT02158117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111035287|NCT02158117|Sensory System Agents|sensory system agents|mesh-ancestor
111035288|NCT02158117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111035289|NCT03541603|Simendan|simendan|mesh-list
111035290|NCT03541603|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111035291|NCT03541603|Vasodilator Agents|vasodilator agents|mesh-ancestor
111035292|NCT03541603|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
111035293|NCT03541603|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111035294|NCT03541603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111035295|NCT03541603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111035296|NCT03541603|Protective Agents|protective agents|mesh-ancestor
111035297|NCT03541603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111035298|NCT02160223|Neostigmine|neostigmine|mesh-list
111035299|NCT02160223|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111035300|NCT02160223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111035301|NCT02160223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111035302|NCT02160223|Cholinergic Agents|cholinergic agents|mesh-ancestor
111035303|NCT02160223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111035304|NCT02160223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111035305|NCT02160223|Parasympathomimetics|parasympathomimetics|mesh-ancestor
111035306|NCT02160223|Autonomic Agents|autonomic agents|mesh-ancestor
111035307|NCT02160223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111035308|NCT02160301|Acetaminophen|acetaminophen|mesh-list
111035309|NCT02160301|Dexamethasone|dexamethasone|mesh-list
111035310|NCT02160301|Celecoxib|celecoxib|mesh-list
111035311|NCT02160301|Oxycodone|oxycodone|mesh-list
111035312|NCT02160301|Gabapentin|gabapentin|mesh-list
111035313|NCT02160301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111035314|NCT02160301|Antiemetics|antiemetics|mesh-ancestor
111035315|NCT02160301|Autonomic Agents|autonomic agents|mesh-ancestor
111035316|NCT02160301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111035317|NCT02160301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111035318|NCT02160301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111035319|NCT02160301|Glucocorticoids|glucocorticoids|mesh-ancestor
111035320|NCT02160301|Hormones|hormones|mesh-ancestor
111035321|NCT02160301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111035322|NCT02160301|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111035323|NCT02160301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111035324|NCT02160301|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111035325|NCT02160301|Analgesics|analgesics|mesh-ancestor
111035326|NCT02160301|Sensory System Agents|sensory system agents|mesh-ancestor
111035327|NCT02160301|Antipyretics|antipyretics|mesh-ancestor
111035329|NCT02160301|Narcotics|narcotics|mesh-ancestor
111035330|NCT02160301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111035331|NCT02160301|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111035332|NCT02160301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111035333|NCT02160301|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111035334|NCT02160301|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111035335|NCT02160301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111035336|NCT02160301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111035337|NCT02160301|Anticonvulsants|anticonvulsants|mesh-ancestor
111035338|NCT02160301|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111035339|NCT02160301|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111035340|NCT02160301|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111035341|NCT02160301|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111035342|NCT02160301|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111035343|NCT02160301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111035344|NCT02160301|Antimanic Agents|antimanic agents|mesh-ancestor
111035345|NCT03541759|Hydromorphone|hydromorphone|mesh-list
111035346|NCT03541759|Pirinitramide|pirinitramide|mesh-list
111035347|NCT03541759|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111035348|NCT03541759|Narcotics|narcotics|mesh-ancestor
111035349|NCT03541759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111035350|NCT03541759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111035351|NCT03541759|Analgesics|analgesics|mesh-ancestor
111035352|NCT03541759|Sensory System Agents|sensory system agents|mesh-ancestor
111035353|NCT03541759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111035354|NCT05206955|Tadalafil|tadalafil|mesh-list
111035355|NCT05206955|Vasodilator Agents|vasodilator agents|mesh-ancestor
111035356|NCT05206955|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111035357|NCT05206955|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111035358|NCT05206955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111035359|NCT05206955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111035360|NCT05206955|Urological Agents|urological agents|mesh-ancestor
111035361|NCT01666652|Aluminum Hydroxide|aluminum hydroxide|mesh-list
111035362|NCT01666652|Aluminum sulfate|aluminum sulfate|mesh-list
111035363|NCT01666652|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111035364|NCT01666652|Immunologic Factors|immunologic factors|mesh-ancestor
111035365|NCT01666652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111035366|NCT01666652|Antacids|antacids|mesh-ancestor
111035367|NCT01666652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111035368|NCT01666652|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111035369|NCT05174585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111035370|NCT05174585|Pembrolizumab|pembrolizumab|mesh-list
111035371|NCT05174585|Antibodies|antibodies|mesh-list
111035372|NCT05174585|Immunoglobulins|immunoglobulins|mesh-list
111035373|NCT05174585|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111035374|NCT05174585|Immunologic Factors|immunologic factors|mesh-ancestor
111035375|NCT05174585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111035376|NCT05174585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111035377|NCT05174585|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111035378|NCT05174585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111035379|NCT04428086|Metformin|metformin|mesh-list
111035380|NCT04428086|Apatinib|apatinib|mesh-list
111035381|NCT04428086|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111035382|NCT04428086|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110626637|NCT00817284|Bevacizumab|bevacizumab|mesh-list
111035383|NCT04428086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111035384|NCT04428086|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111035385|NCT04428086|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111035386|NCT04428086|Antimetabolites|antimetabolites|mesh-ancestor
111035387|NCT04428086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111035388|NCT04428086|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111035389|NCT04428086|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111035390|NCT04428086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111035391|NCT04428086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111035392|NCT04428086|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111035393|NCT05125055|Paclitaxel|paclitaxel|mesh-list
111035394|NCT05125055|Docetaxel|docetaxel|mesh-list
111035395|NCT05125055|Fluorouracil|fluorouracil|mesh-list
111035396|NCT05125055|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111035397|NCT05125055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111035398|NCT05125055|Tubulin Modulators|tubulin modulators|mesh-ancestor
111035399|NCT05125055|Antimitotic Agents|antimitotic agents|mesh-ancestor
111035400|NCT05125055|Mitosis Modulators|mitosis modulators|mesh-ancestor
111035401|NCT05125055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111035402|NCT05125055|Antimetabolites|antimetabolites|mesh-ancestor
111035403|NCT05125055|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111035404|NCT05125055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111035405|NCT05125055|Immunologic Factors|immunologic factors|mesh-ancestor
111035406|NCT05125055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111035407|NCT04355858|Paclitaxel|paclitaxel|mesh-list
111035408|NCT04355858|Capecitabine|capecitabine|mesh-list
111035409|NCT04355858|Everolimus|everolimus|mesh-list
111035410|NCT04355858|Fluzoparib|fluzoparib|mesh-list
111035411|NCT04355858|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111035412|NCT04355858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111035413|NCT04355858|Tubulin Modulators|tubulin modulators|mesh-ancestor
111035414|NCT04355858|Antimitotic Agents|antimitotic agents|mesh-ancestor
111035415|NCT04355858|Mitosis Modulators|mitosis modulators|mesh-ancestor
111035416|NCT04355858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111035417|NCT04355858|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111035418|NCT04355858|Antimetabolites|antimetabolites|mesh-ancestor
111035419|NCT04355858|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110500432|NCT02617485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111035420|NCT04355858|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111035421|NCT04355858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111035422|NCT04355858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111035423|NCT04355858|Immunologic Factors|immunologic factors|mesh-ancestor
111035424|NCT04355858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111035425|NCT04355858|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111035426|NCT05610956|Empagliflozin|empagliflozin|mesh-list
111035427|NCT05610956|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111035428|NCT05610956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111035429|NCT05610956|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111035430|NCT05610956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111035432|NCT00109733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111035433|NCT00109733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111035434|NCT05699876|Gabapentin|gabapentin|mesh-list
111035435|NCT05699876|Melatonin|melatonin|mesh-list
111035436|NCT05699876|Analgesics|analgesics|mesh-ancestor
111035437|NCT05699876|Sensory System Agents|sensory system agents|mesh-ancestor
111035438|NCT05699876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111035439|NCT05699876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111035440|NCT05699876|Anticonvulsants|anticonvulsants|mesh-ancestor
111035441|NCT05699876|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111035442|NCT05699876|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111035443|NCT05699876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111035444|NCT05699876|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111035445|NCT05699876|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111035446|NCT05699876|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111035447|NCT05699876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111035448|NCT05699876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111035449|NCT05699876|Antimanic Agents|antimanic agents|mesh-ancestor
111035450|NCT05699876|Antioxidants|antioxidants|mesh-ancestor
111035451|NCT05699876|Protective Agents|protective agents|mesh-ancestor
111035452|NCT05610878|Curcumin|curcumin|mesh-list
111035453|NCT05610878|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111035454|NCT05610878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111035455|NCT05610878|Analgesics|analgesics|mesh-ancestor
111035456|NCT05610878|Sensory System Agents|sensory system agents|mesh-ancestor
111035457|NCT05610878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111035458|NCT05610878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111035459|NCT05610878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111035460|NCT05610878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111035461|NCT05610878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111035462|NCT05610878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111035463|NCT05610878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111035464|NCT02706405|Cyclophosphamide|cyclophosphamide|mesh-list
111035465|NCT02706405|Fludarabine|fludarabine|mesh-list
111035466|NCT02706405|Durvalumab|durvalumab|mesh-list
111035467|NCT02706405|Immunoglobulins|immunoglobulins|mesh-list
111035468|NCT02706405|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111035469|NCT02706405|Immunoglobulin G|immunoglobulin g|mesh-list
111035470|NCT02706405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111035471|NCT02706405|Immunologic Factors|immunologic factors|mesh-ancestor
111035472|NCT02706405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111035473|NCT02706405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111035474|NCT02706405|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111035475|NCT02706405|Alkylating Agents|alkylating agents|mesh-ancestor
111035476|NCT02706405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111035477|NCT02706405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111035478|NCT02706405|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111035479|NCT02706405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111035480|NCT02254031|Maytansine|maytansine|mesh-list
111035481|NCT02254031|Bivatuzumab mertansine|bivatuzumab mertansine|mesh-list
111035482|NCT02254031|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111035483|NCT02254031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111035484|NCT02254031|Tubulin Modulators|tubulin modulators|mesh-ancestor
111035485|NCT02254031|Antimitotic Agents|antimitotic agents|mesh-ancestor
111035486|NCT02254031|Mitosis Modulators|mitosis modulators|mesh-ancestor
111035487|NCT02254031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111035488|NCT02254031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111035489|NCT02254031|Immunotoxins|immunotoxins|mesh-ancestor
111035490|NCT02254031|Immunoconjugates|immunoconjugates|mesh-ancestor
111035491|NCT02254031|Immunologic Factors|immunologic factors|mesh-ancestor
111035492|NCT02254031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111035493|NCT03545711|Irinotecan|irinotecan|mesh-list
111035494|NCT03545711|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111035495|NCT03545711|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111035496|NCT03545711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111035497|NCT03545711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111035498|NCT03545711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111035499|NCT03546959|Botulinum Toxins|botulinum toxins|mesh-list
111035500|NCT03546959|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111035501|NCT03546959|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111035502|NCT03546959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111035503|NCT03546959|Cholinergic Agents|cholinergic agents|mesh-ancestor
111035504|NCT03546959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111035505|NCT03546959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111035506|NCT01569659|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
111035507|NCT01569659|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111035508|NCT01569659|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111035509|NCT01569659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111035510|NCT01569659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111035511|NCT01569659|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110626647|NCT00817284|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111035512|NCT01569659|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
111035513|NCT01569659|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111035514|NCT01569659|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111035515|NCT01569659|Adrenergic Agents|adrenergic agents|mesh-ancestor
111035516|NCT01569659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111035517|NCT01569659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111035518|NCT01569659|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111035519|NCT01569659|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111035520|NCT01569659|Serotonin Agents|serotonin agents|mesh-ancestor
111035521|NCT01569659|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111035522|NCT01569659|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111035523|NCT01569659|Dopamine Agents|dopamine agents|mesh-ancestor
111035524|NCT02253953|Ritonavir|ritonavir|mesh-list
111035525|NCT02253953|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111035526|NCT02253953|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111035527|NCT02253953|Protease Inhibitors|protease inhibitors|mesh-ancestor
111035528|NCT02253953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111035529|NCT02253953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111035530|NCT02253953|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111035531|NCT02253953|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111035532|NCT02253953|Antiviral Agents|antiviral agents|mesh-ancestor
111035533|NCT02253953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111035534|NCT02253953|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111035535|NCT02253953|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111035536|NCT03546803|Protective Agents|protective agents|mesh-list
111035537|NCT03546803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111035538|NCT02422953|Micronutrients|micronutrients|mesh-list
111035539|NCT02422953|Trace Elements|trace elements|mesh-list
111035540|NCT02422953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111035541|NCT04053140|Penicillins|penicillins|mesh-list
111035542|NCT04053140|Penicillin G|penicillin g|mesh-list
111035543|NCT04053140|Penicillin G Benzathine|penicillin g benzathine|mesh-list
111035544|NCT04053140|Penicillin G Procaine|penicillin g procaine|mesh-list
111035545|NCT04053140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111035546|NCT04053140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111035547|NCT03713879|Indomethacin|indomethacin|mesh-list
111035548|NCT03713879|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111035549|NCT03713879|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111035550|NCT03713879|Analgesics|analgesics|mesh-ancestor
111035551|NCT03713879|Sensory System Agents|sensory system agents|mesh-ancestor
111035552|NCT03713879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111035553|NCT03713879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111035554|NCT03713879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111035555|NCT03713879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111035556|NCT03713879|Gout Suppressants|gout suppressants|mesh-ancestor
111035557|NCT03713879|Tocolytic Agents|tocolytic agents|mesh-ancestor
111035558|NCT03713879|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111035559|NCT03713879|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111035560|NCT03713879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111035561|NCT03713879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111035562|NCT03107169|Vancomycin|vancomycin|mesh-list
111035563|NCT03107169|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111035564|NCT03107169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110827340|NCT03387462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111035565|NCT05552300|Antihypertensive Agents|antihypertensive agents|mesh-list
111035566|NCT05064059|Pembrolizumab|pembrolizumab|mesh-list
111035567|NCT05064059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111035568|NCT05064059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111035569|NCT05064059|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111035570|NCT05064059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111035571|NCT02425605|Sorafenib|sorafenib|mesh-list
111035572|NCT02425605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111035573|NCT02425605|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111035574|NCT02425605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111035575|NCT02425605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111035576|NCT02422563|Paclitaxel|paclitaxel|mesh-list
111035577|NCT02422563|Carboplatin|carboplatin|mesh-list
111035578|NCT02422563|Ifosfamide|ifosfamide|mesh-list
111035579|NCT02422563|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111035580|NCT02422563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111035581|NCT02422563|Tubulin Modulators|tubulin modulators|mesh-ancestor
111035582|NCT02422563|Antimitotic Agents|antimitotic agents|mesh-ancestor
111035583|NCT02422563|Mitosis Modulators|mitosis modulators|mesh-ancestor
111035584|NCT02422563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111035585|NCT02422563|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111035586|NCT02422563|Alkylating Agents|alkylating agents|mesh-ancestor
111035587|NCT03185403|Sufentanil|sufentanil|mesh-list
111035588|NCT03185403|Ropivacaine|ropivacaine|mesh-list
111035589|NCT03185403|Anesthetics, Local|anesthetics, local|mesh-ancestor
111035590|NCT03185403|Anesthetics|anesthetics|mesh-ancestor
111035591|NCT03185403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111035592|NCT03185403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111035593|NCT03185403|Sensory System Agents|sensory system agents|mesh-ancestor
111035594|NCT03185403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111035595|NCT03185403|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111035596|NCT03185403|Narcotics|narcotics|mesh-ancestor
111035597|NCT03185403|Analgesics|analgesics|mesh-ancestor
111035598|NCT03185403|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111035599|NCT03185403|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111035600|NCT03185403|Anesthetics, General|anesthetics, general|mesh-ancestor
111035601|NCT02422485|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
111035602|NCT02422485|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111035603|NCT02422485|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111035604|NCT02422485|Analgesics|analgesics|mesh-ancestor
111035605|NCT02422485|Sensory System Agents|sensory system agents|mesh-ancestor
111035606|NCT02422485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111035607|NCT02422485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111035608|NCT02422485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111035609|NCT02422485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111035610|NCT05551910|Remifentanil|remifentanil|mesh-list
111035611|NCT05551910|Propofol|propofol|mesh-list
111035612|NCT05551910|Esketamine|esketamine|mesh-list
111035613|NCT05551910|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111035614|NCT05551910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111035615|NCT05551910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111035616|NCT05551910|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111035617|NCT05551910|Anesthetics, General|anesthetics, general|mesh-ancestor
111035618|NCT05551910|Anesthetics|anesthetics|mesh-ancestor
111035619|NCT05551910|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111035620|NCT05551910|Narcotics|narcotics|mesh-ancestor
111035621|NCT05551910|Analgesics|analgesics|mesh-ancestor
111035622|NCT05551910|Sensory System Agents|sensory system agents|mesh-ancestor
111035623|NCT05551910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111035624|NCT05551910|Antidepressive Agents|antidepressive agents|mesh-ancestor
111035625|NCT05551910|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111035626|NCT05699720|Magnesium Sulfate|magnesium sulfate|mesh-list
110752686|NCT05575700|Ibuprofen|ibuprofen|mesh-list
111035627|NCT05699720|Analgesics|analgesics|mesh-ancestor
111035629|NCT05699720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111035630|NCT05699720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111035631|NCT05699720|Anesthetics|anesthetics|mesh-ancestor
111035632|NCT05699720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111035633|NCT05699720|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111035634|NCT05699720|Anticonvulsants|anticonvulsants|mesh-ancestor
111035635|NCT05699720|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111035636|NCT05699720|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111035637|NCT05699720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111035638|NCT05699720|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111035639|NCT05699720|Tocolytic Agents|tocolytic agents|mesh-ancestor
111035640|NCT05699720|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111035641|NCT05546762|Povidone-Iodine|povidone-iodine|mesh-list
111035642|NCT05546762|Povidone|povidone|mesh-list
111035643|NCT05546762|Plasma Substitutes|plasma substitutes|mesh-ancestor
111035644|NCT05546762|Blood Substitutes|blood substitutes|mesh-ancestor
111035645|NCT05546762|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111035646|NCT05546762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111035647|NCT03535883|Anticoagulants|anticoagulants|mesh-list
111035648|NCT03535883|Coagulants|coagulants|mesh-list
111035649|NCT05551598|Mitoxantrone|mitoxantrone|mesh-list
111035650|NCT05551598|Analgesics|analgesics|mesh-ancestor
111035651|NCT05551598|Sensory System Agents|sensory system agents|mesh-ancestor
111035652|NCT05551598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111035653|NCT05551598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111035654|NCT05551598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111035655|NCT05551598|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111035656|NCT05551598|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111035657|NCT05551598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111035658|NCT05551598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111035659|NCT03810794|Donepezil|donepezil|mesh-list
111035660|NCT03810794|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111035661|NCT03810794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111035662|NCT03810794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111035663|NCT03810794|Cholinergic Agents|cholinergic agents|mesh-ancestor
111035664|NCT03810794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111035665|NCT03810794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111035666|NCT03810794|Nootropic Agents|nootropic agents|mesh-ancestor
111035667|NCT03185793|Benzbromarone|benzbromarone|mesh-list
111035668|NCT03185793|Uricosuric Agents|uricosuric agents|mesh-ancestor
111035669|NCT03185793|Gout Suppressants|gout suppressants|mesh-ancestor
111035670|NCT03185793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111035671|NCT03660488|Penicillins|penicillins|mesh-list
111035672|NCT03660488|Cefixime|cefixime|mesh-list
111035673|NCT03660488|Penicillin G|penicillin g|mesh-list
111035674|NCT03660488|Penicillin G Benzathine|penicillin g benzathine|mesh-list
111035675|NCT03660488|Penicillin G Procaine|penicillin g procaine|mesh-list
111035676|NCT03660488|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111035677|NCT03660488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111035678|NCT02422017|Timolol|timolol|mesh-list
111035679|NCT02422017|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111035680|NCT02422017|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111035681|NCT02422017|Adrenergic Agents|adrenergic agents|mesh-ancestor
111035682|NCT02422017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111035683|NCT02422017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111035684|NCT02422017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111035685|NCT02422017|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111035686|NCT02422017|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111035687|NCT02761915|Cyclophosphamide|cyclophosphamide|mesh-list
111035688|NCT02761915|Fludarabine|fludarabine|mesh-list
111035689|NCT02761915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111035690|NCT02761915|Immunologic Factors|immunologic factors|mesh-ancestor
111035691|NCT02761915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111035692|NCT02761915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111035693|NCT02761915|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111035694|NCT02761915|Alkylating Agents|alkylating agents|mesh-ancestor
111035695|NCT02761915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111035696|NCT02761915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111035697|NCT02761915|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111035698|NCT03464084|Melatonin|melatonin|mesh-list
111035699|NCT03464084|Antioxidants|antioxidants|mesh-ancestor
110626673|NCT00755417|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111035700|NCT03464084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111035701|NCT03464084|Protective Agents|protective agents|mesh-ancestor
111035702|NCT03464084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111035703|NCT03464084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111035704|NCT05551208|Bevacizumab|bevacizumab|mesh-list
111035705|NCT05551208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111035706|NCT05551208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111035707|NCT05551208|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111035708|NCT05551208|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111035709|NCT05551208|Growth Substances|growth substances|mesh-ancestor
111035710|NCT05551208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111035711|NCT05551208|Growth Inhibitors|growth inhibitors|mesh-ancestor
111035712|NCT02764333|Durvalumab|durvalumab|mesh-list
111035713|NCT02764333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111035714|NCT02764333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111035715|NCT02161159|Botulinum Toxins|botulinum toxins|mesh-list
111035716|NCT02161159|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111035717|NCT02161159|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111035718|NCT02161159|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111035719|NCT02161159|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111035720|NCT02161159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111035721|NCT02161159|Cholinergic Agents|cholinergic agents|mesh-ancestor
111035722|NCT02161159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111035723|NCT02161159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111035724|NCT02161159|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111035725|NCT02161159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111035726|NCT02160925|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
111035727|NCT02160925|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111035728|NCT02160925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111035729|NCT02161237|Tacrolimus|tacrolimus|mesh-list
111035730|NCT02161237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111035731|NCT02161237|Immunologic Factors|immunologic factors|mesh-ancestor
111035732|NCT02161237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111035733|NCT02161237|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111035734|NCT02161237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111035735|NCT02161237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111035736|NCT03173066|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
111035737|NCT03173066|Hematinics|hematinics|mesh-ancestor
111035738|NCT03173066|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
111035739|NCT03173066|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111035740|NCT05546060|Dexamethasone|dexamethasone|mesh-list
111035741|NCT05546060|Etoposide|etoposide|mesh-list
111035742|NCT05546060|Venetoclax|venetoclax|mesh-list
111035743|NCT05546060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111035744|NCT05546060|Antiemetics|antiemetics|mesh-ancestor
111035745|NCT05546060|Autonomic Agents|autonomic agents|mesh-ancestor
111035746|NCT05546060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111035747|NCT05546060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111035748|NCT05546060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111035749|NCT05546060|Glucocorticoids|glucocorticoids|mesh-ancestor
111035750|NCT05546060|Hormones|hormones|mesh-ancestor
111035751|NCT05546060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111035752|NCT05546060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111035753|NCT05546060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111035754|NCT05546060|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111035755|NCT05546060|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111035756|NCT05546060|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111035757|NCT05546060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111035758|NCT05546060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111035759|NCT02416869|Dexamethasone|dexamethasone|mesh-list
111035760|NCT02416869|Dexamethasone acetate|dexamethasone acetate|mesh-list
111035761|NCT02416869|BB 1101|bb 1101|mesh-list
111035762|NCT02416869|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111035763|NCT02416869|Antiemetics|antiemetics|mesh-ancestor
111035764|NCT02416869|Autonomic Agents|autonomic agents|mesh-ancestor
111035765|NCT02416869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111035766|NCT02416869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111035767|NCT02416869|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111035768|NCT02416869|Glucocorticoids|glucocorticoids|mesh-ancestor
111035769|NCT02416869|Hormones|hormones|mesh-ancestor
111035770|NCT02416869|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111035771|NCT02416869|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111035772|NCT02416869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111035773|NCT02416869|Protease Inhibitors|protease inhibitors|mesh-ancestor
111035774|NCT02416869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111035775|NCT02416869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111035776|NCT02588612|Cyclophosphamide|cyclophosphamide|mesh-list
111035777|NCT02588612|Fludarabine|fludarabine|mesh-list
111035778|NCT02588612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111035779|NCT02588612|Immunologic Factors|immunologic factors|mesh-ancestor
111035780|NCT02588612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111035781|NCT02588612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111035782|NCT02588612|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111035783|NCT02588612|Alkylating Agents|alkylating agents|mesh-ancestor
111035784|NCT02588612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111035785|NCT02588612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111035786|NCT02588612|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111035787|NCT02161939|Sofosbuvir|sofosbuvir|mesh-list
111035788|NCT02161939|Antiviral Agents|antiviral agents|mesh-ancestor
111035789|NCT02161939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111035790|NCT03540979|Letrozole|letrozole|mesh-list
111035791|NCT03540979|Progesterone|progesterone|mesh-list
111035792|NCT03540979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111035793|NCT03540979|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111035794|NCT03540979|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111035795|NCT03540979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111035796|NCT03540979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111035797|NCT03540979|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111035798|NCT03540979|Hormone Antagonists|hormone antagonists|mesh-ancestor
111035799|NCT03540979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111035800|NCT03540979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111035801|NCT03540979|Progestins|progestins|mesh-ancestor
111035802|NCT03540979|Hormones|hormones|mesh-ancestor
111035803|NCT02946788|Minocycline|minocycline|mesh-list
111035804|NCT02946788|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111035805|NCT02946788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111035806|NCT02159131|Cabotegravir|cabotegravir|mesh-list
111035807|NCT02159131|Levonorgestrel|levonorgestrel|mesh-list
111035808|NCT02159131|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111035809|NCT02159131|Contraceptive Agents|contraceptive agents|mesh-ancestor
111035810|NCT02159131|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111035811|NCT02159131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111035812|NCT02159131|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111035813|NCT02159131|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111035814|NCT02159131|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111035815|NCT02159131|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111035816|NCT02159131|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111035817|NCT02159131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111035818|NCT02159131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111035819|NCT02159131|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111035820|NCT02159131|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111035821|NCT02159131|Antiviral Agents|antiviral agents|mesh-ancestor
111035822|NCT02159131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111035823|NCT05550506|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
111035824|NCT05550506|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111035825|NCT05550506|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111035826|NCT05550506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111035827|NCT05550506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111035828|NCT05550506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111035829|NCT05550506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111035830|NCT05550506|Analgesics|analgesics|mesh-ancestor
111035831|NCT05550506|Sensory System Agents|sensory system agents|mesh-ancestor
111035832|NCT05550506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111035833|NCT05550506|Antidepressive Agents|antidepressive agents|mesh-ancestor
111035834|NCT05550506|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111035835|NCT05550506|Dopamine Agents|dopamine agents|mesh-ancestor
111035836|NCT03174795|Meropenem|meropenem|mesh-list
111035837|NCT03174795|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111035838|NCT03174795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111035840|NCT02163655|Diuretics|diuretics|mesh-ancestor
111035841|NCT02163655|Natriuretic Agents|natriuretic agents|mesh-ancestor
111035842|NCT02163655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111035843|NCT02163655|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
111035844|NCT02163655|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111035845|NCT02163655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111035846|NCT02410083|Aspirin|aspirin|mesh-list
111035847|NCT02410083|Clopidogrel|clopidogrel|mesh-list
111035848|NCT02410083|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111035849|NCT02410083|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111035850|NCT02410083|Analgesics|analgesics|mesh-ancestor
110752917|NCT03794492|Antiemetics|antiemetics|mesh-ancestor
111035851|NCT02410083|Sensory System Agents|sensory system agents|mesh-ancestor
111035852|NCT02410083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111035853|NCT02410083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111035854|NCT02410083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111035855|NCT02410083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111035856|NCT02410083|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111035857|NCT02410083|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111035858|NCT02410083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111035859|NCT02410083|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111035860|NCT02410083|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111035861|NCT02410083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111035862|NCT02410083|Antipyretics|antipyretics|mesh-ancestor
111035863|NCT02410083|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111035864|NCT02410083|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111035865|NCT02410083|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111035866|NCT02410083|Purinergic Agents|purinergic agents|mesh-ancestor
111035867|NCT02410083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111035868|NCT02416245|Micronutrients|micronutrients|mesh-list
111035869|NCT02416245|Trace Elements|trace elements|mesh-list
111035870|NCT02416245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111035871|NCT02416167|Dotinurad|dotinurad|mesh-list
111035872|NCT02416167|Uricosuric Agents|uricosuric agents|mesh-ancestor
111035873|NCT02416167|Gout Suppressants|gout suppressants|mesh-ancestor
111035874|NCT02416167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111035875|NCT02166853|Midazolam|midazolam|mesh-list
111035876|NCT02166853|Sevoflurane|sevoflurane|mesh-list
111035877|NCT02166853|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111035878|NCT02166853|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111035879|NCT02166853|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111035880|NCT02166853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111035881|NCT02166853|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111035882|NCT02166853|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111035883|NCT02166853|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111035884|NCT02166853|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111035885|NCT02166853|Anesthetics, General|anesthetics, general|mesh-ancestor
111035886|NCT02166853|Anesthetics|anesthetics|mesh-ancestor
111035887|NCT02166853|GABA Modulators|gaba modulators|mesh-ancestor
111035888|NCT02166853|GABA Agents|gaba agents|mesh-ancestor
111035889|NCT02166853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111035890|NCT02166853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111035891|NCT02166853|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111035892|NCT02166853|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111035893|NCT02162251|Donepezil|donepezil|mesh-list
111035894|NCT02162251|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111035895|NCT02162251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111035896|NCT02162251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111035897|NCT02162251|Cholinergic Agents|cholinergic agents|mesh-ancestor
111035898|NCT02162251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111035899|NCT02162251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111035900|NCT02162251|Nootropic Agents|nootropic agents|mesh-ancestor
111035901|NCT02164045|Fostemsavir|fostemsavir|mesh-list
111035902|NCT02164045|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111035903|NCT02164045|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111035904|NCT02164045|Antiviral Agents|antiviral agents|mesh-ancestor
111035905|NCT02164045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111035906|NCT02164045|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
111035907|NCT02164045|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
111035908|NCT02164045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111035909|NCT02410005|Calcitriol|calcitriol|mesh-list
111035910|NCT02410005|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
111035911|NCT02410005|Losartan|losartan|mesh-list
111035912|NCT02410005|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111035913|NCT02410005|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111035914|NCT02410005|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111035915|NCT02410005|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111035916|NCT02410005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111035917|NCT02410005|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111035918|NCT02410005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111035919|NCT02410005|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
111035920|NCT02410005|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111035921|NCT02410005|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111035922|NCT02410005|Vitamins|vitamins|mesh-ancestor
111035923|NCT02410005|Micronutrients|micronutrients|mesh-ancestor
111035924|NCT02410005|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111035925|NCT05543330|Cisplatin|cisplatin|mesh-list
111035926|NCT05543330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111035928|NCT03174561|Silymarin|silymarin|mesh-list
111035929|NCT03174561|Lipotropic Agents|lipotropic agents|mesh-ancestor
111035930|NCT03174561|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111035931|NCT03174561|Antimetabolites|antimetabolites|mesh-ancestor
111035932|NCT03174561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111035933|NCT03174561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111035934|NCT03174561|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111035935|NCT03174561|Nootropic Agents|nootropic agents|mesh-ancestor
111035936|NCT03174561|Antioxidants|antioxidants|mesh-ancestor
111035937|NCT03174561|Protective Agents|protective agents|mesh-ancestor
111035938|NCT03174561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111035939|NCT05545592|Estrogens|estrogens|mesh-list
111035940|NCT05545592|Hormones|hormones|mesh-ancestor
111035941|NCT05545592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111035942|NCT05545592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111035943|NCT05545436|Capecitabine|capecitabine|mesh-list
111035944|NCT05545436|Oxaliplatin|oxaliplatin|mesh-list
111035945|NCT05545436|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111035946|NCT05545436|Antimetabolites|antimetabolites|mesh-ancestor
111035947|NCT05545436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111035948|NCT05545436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111035949|NCT02167165|Digoxin|digoxin|mesh-list
111035950|NCT02167165|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111035951|NCT02167165|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111035952|NCT02167165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111035953|NCT02167165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111035954|NCT02167165|Protective Agents|protective agents|mesh-ancestor
111035955|NCT02167165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111035956|NCT05545124|Tislelizumab|tislelizumab|mesh-list
111035957|NCT05545124|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111035958|NCT05545124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111035959|NCT02409849|Octreotide|octreotide|mesh-list
111035960|NCT02409849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111035961|NCT02409849|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111035962|NCT02409849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111035963|NCT00664040|Aspirin|aspirin|mesh-list
111035964|NCT00664040|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111035965|NCT00664040|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111035966|NCT00664040|Analgesics|analgesics|mesh-ancestor
111035967|NCT00664040|Sensory System Agents|sensory system agents|mesh-ancestor
111035968|NCT00664040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111035969|NCT00664040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111035970|NCT00664040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111035971|NCT00664040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111035972|NCT00664040|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111035973|NCT00664040|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111035974|NCT00664040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111035975|NCT00664040|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111035976|NCT00664040|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111035977|NCT00664040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111035978|NCT00664040|Antipyretics|antipyretics|mesh-ancestor
111035979|NCT02162407|Insulin|insulin|mesh-list
111035980|NCT02162407|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111035981|NCT02162407|Insulin Detemir|insulin detemir|mesh-list
111035982|NCT02162407|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111035983|NCT02162407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111035984|NCT02162485|Fluticasone|fluticasone|mesh-list
111035985|NCT02162485|Xhance|xhance|mesh-list
110827371|NCT01586611|Antimetabolites|antimetabolites|mesh-ancestor
111035986|NCT02162485|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
111035987|NCT02162485|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
111035988|NCT02162485|Charcoal|charcoal|mesh-list
111035989|NCT02162485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111035990|NCT02162485|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111035991|NCT02162485|Autonomic Agents|autonomic agents|mesh-ancestor
111035992|NCT02162485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111035993|NCT02162485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111035994|NCT02162485|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111035995|NCT02162485|Respiratory System Agents|respiratory system agents|mesh-ancestor
111035996|NCT02162485|Dermatologic Agents|dermatologic agents|mesh-ancestor
111035997|NCT02162485|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111035998|NCT02162485|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111035999|NCT02162485|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111036000|NCT02162485|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111036001|NCT02162485|Adrenergic Agents|adrenergic agents|mesh-ancestor
111036002|NCT02162485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111036003|NCT02162485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111036004|NCT02162485|Glucocorticoids|glucocorticoids|mesh-ancestor
111036005|NCT02162485|Hormones|hormones|mesh-ancestor
111036006|NCT02162485|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111036007|NCT02162485|Sympathomimetics|sympathomimetics|mesh-ancestor
111036008|NCT02162485|Antidotes|antidotes|mesh-ancestor
111036009|NCT02162485|Protective Agents|protective agents|mesh-ancestor
111036010|NCT02415777|Riboflavin|riboflavin|mesh-list
111036011|NCT02415777|Thiamine|thiamine|mesh-list
111036012|NCT02415777|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
111036013|NCT02415777|Vitamin B Complex|vitamin b complex|mesh-ancestor
111036014|NCT02415777|Vitamins|vitamins|mesh-ancestor
111036015|NCT02415777|Micronutrients|micronutrients|mesh-ancestor
111036016|NCT02415777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111036017|NCT02415777|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111036018|NCT02415777|Dermatologic Agents|dermatologic agents|mesh-ancestor
111036019|NCT02415777|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
111036020|NCT02415777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111036021|NCT05544968|Antibodies|antibodies|mesh-list
111036022|NCT05544968|Antibodies, Bispecific|antibodies, bispecific|mesh-list
111036023|NCT05544968|Immunologic Factors|immunologic factors|mesh-ancestor
111036024|NCT05544968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111036025|NCT03178539|Diclofenac|diclofenac|mesh-list
111036026|NCT03178539|Ketorolac|ketorolac|mesh-list
111036027|NCT03178539|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111036028|NCT03178539|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111036029|NCT03178539|Analgesics|analgesics|mesh-ancestor
110626737|NCT00820092|Hormones|hormones|mesh-ancestor
111036030|NCT03178539|Sensory System Agents|sensory system agents|mesh-ancestor
111036031|NCT03178539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111036032|NCT03178539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111036033|NCT03178539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111036034|NCT03178539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111036035|NCT03178539|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111036036|NCT03178539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111036037|NCT03178539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111036038|NCT03174483|Fluticasone|fluticasone|mesh-list
111036039|NCT03174483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111036040|NCT03174483|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111036041|NCT03174483|Autonomic Agents|autonomic agents|mesh-ancestor
111036042|NCT03174483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111036043|NCT03174483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111036044|NCT03174483|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111036045|NCT03174483|Respiratory System Agents|respiratory system agents|mesh-ancestor
111036046|NCT03174483|Dermatologic Agents|dermatologic agents|mesh-ancestor
111036047|NCT03174483|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111036048|NCT05699174|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111036049|NCT05699174|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
111036050|NCT05699174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111036051|NCT05699174|Antitubercular Agents|antitubercular agents|mesh-ancestor
111036052|NCT04320914|Ibuprofen|ibuprofen|mesh-list
111036053|NCT04320914|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111036054|NCT04320914|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111036055|NCT04320914|Analgesics|analgesics|mesh-ancestor
111036056|NCT04320914|Sensory System Agents|sensory system agents|mesh-ancestor
111036057|NCT04320914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111036058|NCT04320914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111036059|NCT04320914|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111036060|NCT04320914|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111036061|NCT04320914|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111036062|NCT04320914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111036063|NCT04320914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111036064|NCT05544812|Cetuximab|cetuximab|mesh-list
111036065|NCT05544812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111036066|NCT05544812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111036067|NCT02415699|Leucovorin|leucovorin|mesh-list
111036068|NCT02415699|Fluorouracil|fluorouracil|mesh-list
111036069|NCT02415699|Oxaliplatin|oxaliplatin|mesh-list
111036070|NCT02415699|Antimetabolites|antimetabolites|mesh-ancestor
111036071|NCT02415699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111036072|NCT02415699|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111036073|NCT02415699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111036074|NCT02415699|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110753140|NCT01306760|Anesthetics|anesthetics|mesh-ancestor
111036075|NCT02415699|Immunologic Factors|immunologic factors|mesh-ancestor
111036076|NCT02415699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111036077|NCT02415699|Antidotes|antidotes|mesh-ancestor
111036078|NCT02415699|Protective Agents|protective agents|mesh-ancestor
110626748|NCT00820326|Dolasetron|dolasetron|mesh-list
111036079|NCT02415699|Vitamin B Complex|vitamin b complex|mesh-ancestor
111036080|NCT02415699|Vitamins|vitamins|mesh-ancestor
111036081|NCT02415699|Micronutrients|micronutrients|mesh-ancestor
111036082|NCT05544656|Tolperisone|tolperisone|mesh-list
111036083|NCT05544656|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
111036084|NCT05544656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111036085|NCT05544656|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111036086|NCT05544656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111036087|NCT02409537|Resveratrol|resveratrol|mesh-list
111036088|NCT02409537|Antioxidants|antioxidants|mesh-ancestor
111036089|NCT02409537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111036090|NCT02409537|Protective Agents|protective agents|mesh-ancestor
111036091|NCT02409537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111036092|NCT02409537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111036093|NCT02409537|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111036094|NCT03177993|Ivermectin|ivermectin|mesh-list
111036095|NCT03177993|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111036096|NCT03177993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111036097|NCT04425590|Aspirin|aspirin|mesh-list
111036098|NCT04425590|Atorvastatin|atorvastatin|mesh-list
111036099|NCT04425590|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111036100|NCT04425590|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111036101|NCT04425590|Analgesics|analgesics|mesh-ancestor
111036102|NCT04425590|Sensory System Agents|sensory system agents|mesh-ancestor
111036103|NCT04425590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111036104|NCT04425590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111036105|NCT04425590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111036106|NCT04425590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111036107|NCT04425590|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111036108|NCT04425590|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111036109|NCT04425590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111036110|NCT04425590|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111036111|NCT04425590|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111036112|NCT04425590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111036113|NCT04425590|Antipyretics|antipyretics|mesh-ancestor
111036114|NCT04425590|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111036115|NCT04425590|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111036116|NCT04425590|Antimetabolites|antimetabolites|mesh-ancestor
111036117|NCT04425590|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111036118|NCT04425590|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111036119|NCT00707889|Leucovorin|leucovorin|mesh-list
111036120|NCT00707889|Folic Acid|folic acid|mesh-list
111036121|NCT00707889|Bevacizumab|bevacizumab|mesh-list
111036122|NCT00707889|Fluorouracil|fluorouracil|mesh-list
111036123|NCT00707889|Oxaliplatin|oxaliplatin|mesh-list
111036124|NCT00707889|Levoleucovorin|levoleucovorin|mesh-list
111036125|NCT00707889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111036126|NCT00707889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111036127|NCT00707889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111036128|NCT00707889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111036129|NCT00707889|Growth Substances|growth substances|mesh-ancestor
111036130|NCT00707889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111036131|NCT00707889|Growth Inhibitors|growth inhibitors|mesh-ancestor
111036132|NCT00707889|Antimetabolites|antimetabolites|mesh-ancestor
111036133|NCT00707889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111036134|NCT00707889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111036135|NCT00707889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111036136|NCT00707889|Immunologic Factors|immunologic factors|mesh-ancestor
111036137|NCT00707889|Antidotes|antidotes|mesh-ancestor
111036138|NCT00707889|Protective Agents|protective agents|mesh-ancestor
111036139|NCT00707889|Vitamin B Complex|vitamin b complex|mesh-ancestor
111036140|NCT00707889|Vitamins|vitamins|mesh-ancestor
111036141|NCT00707889|Micronutrients|micronutrients|mesh-ancestor
111036142|NCT00707889|Hematinics|hematinics|mesh-ancestor
111036143|NCT00109031|Cyclophosphamide|cyclophosphamide|mesh-list
111036144|NCT00109031|Etoposide|etoposide|mesh-list
111036145|NCT00109031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111036146|NCT00109031|Immunologic Factors|immunologic factors|mesh-ancestor
111036147|NCT00109031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111036148|NCT00109031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111036149|NCT00109031|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111036150|NCT00109031|Alkylating Agents|alkylating agents|mesh-ancestor
111036151|NCT00109031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111036152|NCT00109031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111036153|NCT00109031|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111036154|NCT00109031|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111036155|NCT00109031|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111036156|NCT00109031|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111036157|NCT00109031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111036158|NCT02419443|Gabapentin|gabapentin|mesh-list
111036159|NCT02419443|Analgesics|analgesics|mesh-ancestor
111036160|NCT02419443|Sensory System Agents|sensory system agents|mesh-ancestor
111036161|NCT02419443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111036162|NCT02419443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111036163|NCT02419443|Anticonvulsants|anticonvulsants|mesh-ancestor
111036164|NCT02419443|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111036165|NCT02419443|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111036166|NCT02419443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111036167|NCT02419443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111036168|NCT02419443|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111036169|NCT02419443|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111036170|NCT02419443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111036171|NCT02419443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111036172|NCT02419443|Antimanic Agents|antimanic agents|mesh-ancestor
111036173|NCT05017103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111036174|NCT05017103|Antibodies|antibodies|mesh-list
111036175|NCT05017103|Immunoglobulins|immunoglobulins|mesh-list
111036176|NCT05017103|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111036177|NCT05017103|Immunologic Factors|immunologic factors|mesh-ancestor
111036178|NCT05017103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111036179|NCT05017103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111036180|NCT02414919|Levonorgestrel|levonorgestrel|mesh-list
111036181|NCT02414919|Etonogestrel|etonogestrel|mesh-list
111036182|NCT02414919|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111036183|NCT02414919|Contraceptive Agents|contraceptive agents|mesh-ancestor
111036184|NCT02414919|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111036185|NCT02414919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111036186|NCT02414919|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111036187|NCT02414919|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111036188|NCT02414919|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111036189|NCT05005559|Myeloma Proteins|myeloma proteins|mesh-list
111036190|NCT05005559|Paraproteins|paraproteins|mesh-list
111036191|NCT05005559|Immunologic Factors|immunologic factors|mesh-ancestor
111036192|NCT05005559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111036193|NCT05543954|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
111036194|NCT05543954|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111036195|NCT05543954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111036196|NCT02408679|Vitamin D|vitamin d|mesh-list
111036197|NCT02408679|Vitamins|vitamins|mesh-ancestor
111036198|NCT02408679|Micronutrients|micronutrients|mesh-ancestor
111036199|NCT02408679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111036200|NCT02408679|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111036201|NCT04486781|Pembrolizumab|pembrolizumab|mesh-list
111036202|NCT04486781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111036203|NCT04486781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111036204|NCT04486781|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111036205|NCT04486781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111036206|NCT05089565|Interferons|interferons|mesh-list
111036207|NCT05089565|Interferon-gamma|interferon-gamma|mesh-list
111036208|NCT05089565|Antibodies|antibodies|mesh-list
111036209|NCT05089565|Immunoglobulin G|immunoglobulin g|mesh-list
111036210|NCT05089565|Immunologic Factors|immunologic factors|mesh-ancestor
111036211|NCT05089565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111036212|NCT05089565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111036213|NCT05089565|Antiviral Agents|antiviral agents|mesh-ancestor
111036214|NCT05089565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111036215|NCT03174171|Everolimus|everolimus|mesh-list
111036216|NCT03174171|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111036217|NCT03174171|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111036218|NCT03174171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111036219|NCT03174171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111036220|NCT03174171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111036221|NCT03174171|Immunologic Factors|immunologic factors|mesh-ancestor
111036222|NCT03174171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111036223|NCT03174171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111036224|NCT02414529|Vitamin D|vitamin d|mesh-list
111036225|NCT02414529|Ergocalciferols|ergocalciferols|mesh-list
111036226|NCT02414529|Cholecalciferol|cholecalciferol|mesh-list
111036227|NCT02414529|Vitamins|vitamins|mesh-list
111036228|NCT02414529|Micronutrients|micronutrients|mesh-ancestor
111036229|NCT02414529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111036230|NCT02414529|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110753287|NCT05690048|Vancomycin|vancomycin|mesh-list
111036231|NCT02414529|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111036232|NCT02418273|Denosumab|denosumab|mesh-list
111036233|NCT02418273|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111036234|NCT02418273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111036235|NCT02414685|Paclitaxel|paclitaxel|mesh-list
111036236|NCT02414685|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111036237|NCT02414685|Cisplatin|cisplatin|mesh-list
111036238|NCT02414685|Ifosfamide|ifosfamide|mesh-list
111036239|NCT02414685|Isophosphamide mustard|isophosphamide mustard|mesh-list
111036240|NCT02414685|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111036241|NCT02414685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111036242|NCT02414685|Tubulin Modulators|tubulin modulators|mesh-ancestor
111036243|NCT02414685|Antimitotic Agents|antimitotic agents|mesh-ancestor
111036244|NCT02414685|Mitosis Modulators|mitosis modulators|mesh-ancestor
111036245|NCT02414685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111036246|NCT02414685|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111036247|NCT02414685|Alkylating Agents|alkylating agents|mesh-ancestor
111036248|NCT04425824|Rituximab|rituximab|mesh-list
111036249|NCT04425824|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111036250|NCT04425824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111036251|NCT04425824|Immunologic Factors|immunologic factors|mesh-ancestor
111036252|NCT04425824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111036253|NCT04425824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111036254|NCT02414451|Propranolol|propranolol|mesh-list
111036255|NCT02414451|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111036256|NCT02414451|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111036257|NCT02414451|Adrenergic Agents|adrenergic agents|mesh-ancestor
111036258|NCT02414451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111036259|NCT02414451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111036260|NCT02414451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111036261|NCT02414451|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111036262|NCT02414451|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111036263|NCT02414451|Vasodilator Agents|vasodilator agents|mesh-ancestor
111036264|NCT02408289|Proanthocyanidin|proanthocyanidin|mesh-list
111036265|NCT02408289|Procyanidin|procyanidin|mesh-list
111036266|NCT02408289|Antioxidants|antioxidants|mesh-ancestor
111036267|NCT02408289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111036268|NCT02408289|Protective Agents|protective agents|mesh-ancestor
111036269|NCT02408289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111036270|NCT02408289|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111036271|NCT02408289|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111036272|NCT02408289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111036273|NCT02417883|Furosemide|furosemide|mesh-list
111036274|NCT02417883|Diuretics|diuretics|mesh-ancestor
111036275|NCT02417883|Natriuretic Agents|natriuretic agents|mesh-ancestor
111036276|NCT02417883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111036277|NCT02417883|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
111036278|NCT02417883|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111036279|NCT02417883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111036280|NCT01664624|Exenatide|exenatide|mesh-list
111036281|NCT01664624|Alogliptin|alogliptin|mesh-list
111036282|NCT01664624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111036283|NCT01664624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111036284|NCT01664624|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111036285|NCT01664624|Incretins|incretins|mesh-ancestor
111036286|NCT01664624|Hormones|hormones|mesh-ancestor
111036287|NCT01664624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111036288|NCT01664624|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111036289|NCT01664624|Protease Inhibitors|protease inhibitors|mesh-ancestor
111036290|NCT01664624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111036291|NCT01664624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111036292|NCT03173781|Droxidopa|droxidopa|mesh-list
111036293|NCT03173781|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111036294|NCT03173781|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111036295|NCT05540834|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
111036296|NCT05540834|Plasminogen|plasminogen|mesh-list
111036297|NCT05540834|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111036298|NCT05540834|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111036299|NCT05540834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111036300|NCT05696132|Povidone-Iodine|povidone-iodine|mesh-list
111036301|NCT05696132|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111036302|NCT05696132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111036303|NCT02407899|Vitamin D|vitamin d|mesh-list
111036304|NCT02407899|Cholecalciferol|cholecalciferol|mesh-list
111036305|NCT02407899|Insulin|insulin|mesh-list
111036306|NCT02407899|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111036307|NCT02407899|Metformin|metformin|mesh-list
111036308|NCT02407899|Saxagliptin|saxagliptin|mesh-list
111036309|NCT02407899|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
111036310|NCT02407899|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111036311|NCT02407899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111036312|NCT02407899|Vitamins|vitamins|mesh-ancestor
111036313|NCT02407899|Micronutrients|micronutrients|mesh-ancestor
111036314|NCT02407899|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111036315|NCT02407899|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111036316|NCT02407899|Incretins|incretins|mesh-ancestor
111036317|NCT02407899|Hormones|hormones|mesh-ancestor
111036318|NCT02407899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111036319|NCT02407899|Protease Inhibitors|protease inhibitors|mesh-ancestor
111036320|NCT02407899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111036321|NCT02407899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111036322|NCT02417493|Epinephrine|epinephrine|mesh-list
111036323|NCT02417493|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111036324|NCT02417493|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111036325|NCT02417493|Adrenergic Agents|adrenergic agents|mesh-ancestor
111036326|NCT02417493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111036327|NCT02417493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111036328|NCT02417493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111036329|NCT02417493|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111036330|NCT02417493|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111036331|NCT02417493|Autonomic Agents|autonomic agents|mesh-ancestor
111036332|NCT02417493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111036333|NCT02417493|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111036334|NCT02417493|Respiratory System Agents|respiratory system agents|mesh-ancestor
111036335|NCT02417493|Mydriatics|mydriatics|mesh-ancestor
111036336|NCT02417493|Sympathomimetics|sympathomimetics|mesh-ancestor
111036337|NCT02417493|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111036338|NCT05540600|Digoxin|digoxin|mesh-list
111036339|NCT05540600|Bisoprolol|bisoprolol|mesh-list
111036340|NCT05540600|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111036341|NCT05540600|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111036342|NCT05540600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111036343|NCT05540600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111036344|NCT05540600|Protective Agents|protective agents|mesh-ancestor
111036345|NCT05540600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111036346|NCT05540600|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111036347|NCT05540600|Sympatholytics|sympatholytics|mesh-ancestor
111036348|NCT05540600|Autonomic Agents|autonomic agents|mesh-ancestor
111036349|NCT05540600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111036350|NCT05540600|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
111036351|NCT05540600|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111036352|NCT05540600|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111036353|NCT05540600|Adrenergic Agents|adrenergic agents|mesh-ancestor
111036354|NCT05540600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111036355|NCT02417649|Broncho-Vaxom|broncho-vaxom|mesh-list
111036356|NCT02417649|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111036357|NCT02417649|Immunologic Factors|immunologic factors|mesh-ancestor
111036359|NCT03265574|Enalapril|enalapril|mesh-list
111036360|NCT03265574|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
111036361|NCT03265574|Protease Inhibitors|protease inhibitors|mesh-ancestor
111036362|NCT03265574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111036363|NCT03265574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111036364|NCT03265574|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111036365|NCT03177837|Acetazolamide|acetazolamide|mesh-list
111036366|NCT03177837|Anticonvulsants|anticonvulsants|mesh-ancestor
111036367|NCT03177837|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
111036368|NCT03177837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111036369|NCT03177837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111036370|NCT03177837|Diuretics|diuretics|mesh-ancestor
111036371|NCT03177837|Natriuretic Agents|natriuretic agents|mesh-ancestor
111036372|NCT03177837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111036373|NCT02414373|Bupivacaine|bupivacaine|mesh-list
111036374|NCT02414373|Ropivacaine|ropivacaine|mesh-list
111036375|NCT02414373|Anesthetics, Local|anesthetics, local|mesh-ancestor
111036376|NCT02414373|Anesthetics|anesthetics|mesh-ancestor
111036377|NCT02414373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111036378|NCT02414373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111036379|NCT02414373|Sensory System Agents|sensory system agents|mesh-ancestor
111036380|NCT02414373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111036381|NCT04320290|Antiviral Agents|antiviral agents|mesh-list
110753477|NCT00379288|Xhance|xhance|mesh-list
111036382|NCT04320290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111036384|NCT03173235|Vitamins|vitamins|mesh-ancestor
111036385|NCT03173235|Micronutrients|micronutrients|mesh-ancestor
111036386|NCT03173235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111036387|NCT03173235|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111036388|NCT05697692|Heparin|heparin|mesh-list
111036389|NCT05697692|Calcium heparin|calcium heparin|mesh-list
111036390|NCT05697692|Anticoagulants|anticoagulants|mesh-ancestor
111036391|NCT05697692|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111036392|NCT05697692|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111036393|NCT05697692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111036394|NCT02761057|Sunitinib|sunitinib|mesh-list
111036395|NCT02761057|Crizotinib|crizotinib|mesh-list
111036396|NCT02761057|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
111036397|NCT02761057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111036398|NCT02761057|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111036399|NCT02761057|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111036400|NCT02761057|Growth Substances|growth substances|mesh-ancestor
111036401|NCT02761057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111036402|NCT02761057|Growth Inhibitors|growth inhibitors|mesh-ancestor
111036403|NCT02761057|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111036404|NCT02761057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111036405|NCT02761057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111036406|NCT02407821|Escitalopram|escitalopram|mesh-list
111036407|NCT02407821|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111036408|NCT02407821|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111036409|NCT02407821|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111036410|NCT02407821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111036411|NCT02407821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111036412|NCT02407821|Serotonin Agents|serotonin agents|mesh-ancestor
111036413|NCT02407821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111036414|NCT02164357|Fibrinolytic Agents|fibrinolytic agents|mesh-list
111036415|NCT02164357|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111036416|NCT02164357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111036417|NCT02417337|Acetaminophen|acetaminophen|mesh-list
111036418|NCT02417337|Ibuprofen|ibuprofen|mesh-list
111036419|NCT02417337|Diclofenac|diclofenac|mesh-list
111036420|NCT02417337|Mefenamic Acid|mefenamic acid|mesh-list
111036421|NCT02417337|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111036422|NCT02417337|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111036423|NCT02417337|Analgesics|analgesics|mesh-ancestor
111036424|NCT02417337|Sensory System Agents|sensory system agents|mesh-ancestor
111036425|NCT02417337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111036426|NCT02417337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111036427|NCT02417337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111036428|NCT02417337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111036429|NCT02417337|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111036430|NCT02417337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111036431|NCT02417337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111036433|NCT02167321|Leucovorin|leucovorin|mesh-list
111036434|NCT02167321|Fluorouracil|fluorouracil|mesh-list
111036435|NCT02167321|Oxaliplatin|oxaliplatin|mesh-list
111036436|NCT02167321|Antimetabolites|antimetabolites|mesh-ancestor
111036437|NCT02167321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111036438|NCT02167321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111036439|NCT02167321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111036440|NCT02167321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111036441|NCT02167321|Immunologic Factors|immunologic factors|mesh-ancestor
111036442|NCT02167321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111036443|NCT02167321|Antidotes|antidotes|mesh-ancestor
111036444|NCT02167321|Protective Agents|protective agents|mesh-ancestor
111036445|NCT02167321|Vitamin B Complex|vitamin b complex|mesh-ancestor
111036446|NCT02167321|Vitamins|vitamins|mesh-ancestor
111036447|NCT02167321|Micronutrients|micronutrients|mesh-ancestor
111036448|NCT02162797|Zinc|zinc|mesh-list
111036449|NCT02162797|Trace Elements|trace elements|mesh-ancestor
111036450|NCT02162797|Micronutrients|micronutrients|mesh-ancestor
111036451|NCT02162797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111036452|NCT02162875|Praziquantel|praziquantel|mesh-list
111036453|NCT02162875|Anthelmintics|anthelmintics|mesh-ancestor
111036454|NCT02162875|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111036455|NCT02162875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111036456|NCT02167633|Pantoprazole|pantoprazole|mesh-list
111036457|NCT02167633|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
111036458|NCT02167633|Glucocorticoids|glucocorticoids|mesh-list
111036459|NCT02167633|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111036460|NCT02167633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111036461|NCT02167633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111036462|NCT02167633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111036464|NCT02167633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111036465|NCT02167633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111036466|NCT02413281|Buprenorphine|buprenorphine|mesh-list
111036467|NCT02413281|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111036468|NCT02413281|Narcotics|narcotics|mesh-ancestor
111036469|NCT02413281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111036470|NCT02413281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111036471|NCT02413281|Analgesics|analgesics|mesh-ancestor
111036472|NCT02413281|Sensory System Agents|sensory system agents|mesh-ancestor
111036473|NCT02413281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111036474|NCT02413281|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111036475|NCT02170909|Dabigatran|dabigatran|mesh-list
111036476|NCT02170909|Antithrombins|antithrombins|mesh-ancestor
111036477|NCT02170909|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111036478|NCT02170909|Protease Inhibitors|protease inhibitors|mesh-ancestor
111036479|NCT02170909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111036480|NCT02170909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111036481|NCT02170909|Anticoagulants|anticoagulants|mesh-ancestor
111036482|NCT02164825|Morphine|morphine|mesh-list
111036483|NCT02164825|Ropivacaine|ropivacaine|mesh-list
111036484|NCT02164825|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111036485|NCT02164825|Narcotics|narcotics|mesh-ancestor
111036486|NCT02164825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111036487|NCT02164825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111036488|NCT02164825|Analgesics|analgesics|mesh-ancestor
111036489|NCT02164825|Sensory System Agents|sensory system agents|mesh-ancestor
111036490|NCT02164825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111036491|NCT02164825|Anesthetics, Local|anesthetics, local|mesh-ancestor
111036492|NCT02164825|Anesthetics|anesthetics|mesh-ancestor
111036493|NCT02170987|Moxifloxacin|moxifloxacin|mesh-list
111036494|NCT02170987|Dabigatran|dabigatran|mesh-list
111036495|NCT02170987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111036496|NCT02170987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111036497|NCT02170987|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111036498|NCT02170987|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111036499|NCT02170987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111036500|NCT02170987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111036501|NCT02170987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111036502|NCT02170987|Antithrombins|antithrombins|mesh-ancestor
111036503|NCT02170987|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111036504|NCT02170987|Protease Inhibitors|protease inhibitors|mesh-ancestor
111036505|NCT02170987|Anticoagulants|anticoagulants|mesh-ancestor
111036506|NCT03176121|Oxycodone|oxycodone|mesh-list
111036507|NCT03176121|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111036508|NCT03176121|Narcotics|narcotics|mesh-ancestor
111036509|NCT03176121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111036510|NCT03176121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111036511|NCT03176121|Analgesics|analgesics|mesh-ancestor
111036512|NCT03176121|Sensory System Agents|sensory system agents|mesh-ancestor
110274127|NCT03097939|Nivolumab|nivolumab|mesh-list
111036513|NCT03176121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111036514|NCT02261155|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
111036515|NCT02261155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111036516|NCT02261155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111036517|NCT02171143|ASP2409|asp2409|mesh-list
111036518|NCT02171143|Immunoconjugates|immunoconjugates|mesh-ancestor
111036519|NCT02171143|Immunologic Factors|immunologic factors|mesh-ancestor
111036520|NCT02171143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111036521|NCT03176199|Oxycodone|oxycodone|mesh-list
111036522|NCT03176199|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111036523|NCT03176199|Narcotics|narcotics|mesh-ancestor
111036524|NCT03176199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111036525|NCT03176199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111036526|NCT03176199|Analgesics|analgesics|mesh-ancestor
111036527|NCT03176199|Sensory System Agents|sensory system agents|mesh-ancestor
111036528|NCT03176199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111036529|NCT05697614|Lamotrigine|lamotrigine|mesh-list
111036530|NCT05697614|Carbamazepine|carbamazepine|mesh-list
111036531|NCT05697614|Phenytoin|phenytoin|mesh-list
111036532|NCT05697614|Oxcarbazepine|oxcarbazepine|mesh-list
111036533|NCT05697614|Valproic Acid|valproic acid|mesh-list
111036534|NCT05697614|Clobazam|clobazam|mesh-list
111036535|NCT05697614|Anticonvulsants|anticonvulsants|mesh-ancestor
111036536|NCT05697614|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111036537|NCT05697614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111036538|NCT05697614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111036539|NCT05697614|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111036540|NCT05697614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111036541|NCT05697614|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111036542|NCT05697614|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111036543|NCT05697614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111036544|NCT05697614|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111036545|NCT05697614|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111036546|NCT05697614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111036547|NCT05697614|GABA Agents|gaba agents|mesh-ancestor
111036548|NCT05697614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111036549|NCT05697614|Antimanic Agents|antimanic agents|mesh-ancestor
111036550|NCT05697614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111036551|NCT05697614|Analgesics|analgesics|mesh-ancestor
111036552|NCT05697614|Sensory System Agents|sensory system agents|mesh-ancestor
111036553|NCT05697614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111036554|NCT05697614|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111036555|NCT05697614|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111036556|NCT05697614|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111036557|NCT05697614|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
111036558|NCT05697614|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111036559|NCT05697614|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
111036560|NCT05697614|GABA Agonists|gaba agonists|mesh-ancestor
111036561|NCT02171221|DFP-11207|dfp-11207|mesh-list
111036562|NCT02171221|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111036563|NCT02171221|Antimetabolites|antimetabolites|mesh-ancestor
111036564|NCT02171221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111036565|NCT02171221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111036566|NCT02413515|Nifedipine|nifedipine|mesh-list
111036567|NCT02413515|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111036568|NCT02413515|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111036569|NCT02413515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111036570|NCT02413515|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111036571|NCT02413515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111036572|NCT02413515|Vasodilator Agents|vasodilator agents|mesh-ancestor
111036573|NCT02413515|Tocolytic Agents|tocolytic agents|mesh-ancestor
111036574|NCT02413515|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111036575|NCT03194906|Memantine|memantine|mesh-list
111036576|NCT03194906|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111036577|NCT03194906|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111036578|NCT03194906|Dopamine Agents|dopamine agents|mesh-ancestor
111036579|NCT03194906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111036580|NCT03194906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111036581|NCT03194906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110626869|NCT00626028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111036582|NCT03194906|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111036583|NCT03194906|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111036584|NCT03171987|Flurbiprofen|flurbiprofen|mesh-list
111036586|NCT03171987|Anesthetics, Local|anesthetics, local|mesh-ancestor
111036587|NCT03171987|Anesthetics|anesthetics|mesh-ancestor
111036588|NCT03171987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111036589|NCT03171987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111036590|NCT03171987|Sensory System Agents|sensory system agents|mesh-ancestor
111036591|NCT03171987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111036592|NCT03171987|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111036593|NCT03171987|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111036594|NCT03171987|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111036595|NCT03171987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111036596|NCT03171987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111036597|NCT03171987|Analgesics|analgesics|mesh-ancestor
111036598|NCT03171987|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111036599|NCT03171987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111036600|NCT03171987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111036601|NCT03171987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111036602|NCT03171987|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111036603|NCT03171987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111036604|NCT05540288|Nalmefene|nalmefene|mesh-list
111036605|NCT05540288|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111036606|NCT05540288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111036607|NCT05540288|Sensory System Agents|sensory system agents|mesh-ancestor
111036608|NCT05540288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111036609|NCT03172065|Dexmedetomidine|dexmedetomidine|mesh-list
111036610|NCT03172065|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111036611|NCT03172065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111036612|NCT03172065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111036613|NCT03172065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111036615|NCT03172065|Sensory System Agents|sensory system agents|mesh-ancestor
111036616|NCT03172065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111036617|NCT03172065|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111036618|NCT03172065|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111036619|NCT03172065|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111036620|NCT03172065|Adrenergic Agents|adrenergic agents|mesh-ancestor
111036621|NCT03172065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111036622|NCT03172065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111036623|NCT02171299|Ropivacaine|ropivacaine|mesh-list
111036624|NCT02171299|Anesthetics, Local|anesthetics, local|mesh-list
111036625|NCT02171299|Anesthetics|anesthetics|mesh-list
111036626|NCT02171299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111036627|NCT02171299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111036628|NCT02171299|Sensory System Agents|sensory system agents|mesh-ancestor
111036629|NCT02171299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111036630|NCT03171831|Mycophenolic Acid|mycophenolic acid|mesh-list
111036631|NCT03171831|Cyclophosphamide|cyclophosphamide|mesh-list
111036632|NCT03171831|Busulfan|busulfan|mesh-list
111036633|NCT03171831|Methotrexate|methotrexate|mesh-list
111036634|NCT03171831|Fludarabine|fludarabine|mesh-list
111036635|NCT03171831|Tacrolimus|tacrolimus|mesh-list
111036636|NCT03171831|Thymoglobulin|thymoglobulin|mesh-list
111036637|NCT03171831|Basiliximab|basiliximab|mesh-list
111036638|NCT03171831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111036639|NCT03171831|Immunologic Factors|immunologic factors|mesh-ancestor
111036640|NCT03171831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111036641|NCT03171831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111036642|NCT03171831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111036643|NCT03171831|Alkylating Agents|alkylating agents|mesh-ancestor
111036644|NCT03171831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111036645|NCT03171831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111036646|NCT03171831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111036647|NCT03171831|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111036648|NCT03171831|Abortifacient Agents|abortifacient agents|mesh-ancestor
111036649|NCT03171831|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111036650|NCT03171831|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111036651|NCT03171831|Antimetabolites|antimetabolites|mesh-ancestor
111036652|NCT03171831|Dermatologic Agents|dermatologic agents|mesh-ancestor
111036653|NCT03171831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111036654|NCT03171831|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111036655|NCT03171831|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111036656|NCT03171831|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111036657|NCT03171831|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111036658|NCT03171831|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111036659|NCT03171831|Antitubercular Agents|antitubercular agents|mesh-ancestor
111036660|NCT03171831|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111036661|NCT03171831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111036663|NCT02171455|Antithrombins|antithrombins|mesh-ancestor
111036664|NCT02171455|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111036665|NCT02171455|Protease Inhibitors|protease inhibitors|mesh-ancestor
111036666|NCT02171455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111036667|NCT02171455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111036668|NCT02171455|Anticoagulants|anticoagulants|mesh-ancestor
111036669|NCT02171533|Verapamil|verapamil|mesh-list
111036670|NCT02171533|Dabigatran|dabigatran|mesh-list
111036671|NCT02171533|Antithrombins|antithrombins|mesh-ancestor
111036672|NCT02171533|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111036673|NCT02171533|Protease Inhibitors|protease inhibitors|mesh-ancestor
111036674|NCT02171533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111036675|NCT02171533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111036676|NCT02171533|Anticoagulants|anticoagulants|mesh-ancestor
111036677|NCT02171533|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111036678|NCT02171533|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111036679|NCT02171533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111036680|NCT02171533|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111036681|NCT02171533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111036682|NCT02171533|Vasodilator Agents|vasodilator agents|mesh-ancestor
111036683|NCT04482543|Methotrexate|methotrexate|mesh-list
111036684|NCT04482543|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111036685|NCT04482543|Abortifacient Agents|abortifacient agents|mesh-ancestor
111036686|NCT04482543|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111036687|NCT04482543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111036688|NCT04482543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111036689|NCT04482543|Antimetabolites|antimetabolites|mesh-ancestor
111036690|NCT04482543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111036691|NCT04482543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111036692|NCT04482543|Dermatologic Agents|dermatologic agents|mesh-ancestor
111036693|NCT04482543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111036694|NCT04482543|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111036695|NCT04482543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111036696|NCT04482543|Immunologic Factors|immunologic factors|mesh-ancestor
111036697|NCT04482543|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111036698|NCT04482543|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111036699|NCT02406183|Ipilimumab|ipilimumab|mesh-list
111036700|NCT02406183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111036701|NCT02406183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111036702|NCT02406183|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111036703|NCT02406183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111036704|NCT04723472|Cefuroxime|cefuroxime|mesh-list
111036705|NCT04723472|Cefuroxime axetil|cefuroxime axetil|mesh-list
111036706|NCT04723472|Bismuth|bismuth|mesh-list
111036707|NCT04723472|Antacids|antacids|mesh-ancestor
111036708|NCT04723472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111036709|NCT04723472|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111036710|NCT04723472|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111036711|NCT04723472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111036712|NCT02412813|Cobalt|cobalt|mesh-list
111036713|NCT02412813|Trace Elements|trace elements|mesh-ancestor
111036714|NCT02412813|Micronutrients|micronutrients|mesh-ancestor
111036715|NCT02412813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111036716|NCT03116295|Opicapone|opicapone|mesh-list
111036717|NCT03116295|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
111036718|NCT03116295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111036719|NCT03116295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111036720|NCT03116295|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111036721|NCT03116295|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111036722|NCT02405715|Oxytocin|oxytocin|mesh-list
111036723|NCT02405715|Oxytocics|oxytocics|mesh-ancestor
111036724|NCT02405715|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111036725|NCT02405715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111036726|NCT02412423|Cyclophosphamide|cyclophosphamide|mesh-list
111036727|NCT02412423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111036728|NCT02412423|Immunologic Factors|immunologic factors|mesh-ancestor
111036729|NCT02412423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111036730|NCT02412423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111036731|NCT02412423|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111036732|NCT02412423|Alkylating Agents|alkylating agents|mesh-ancestor
111119151|NCT05323617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111036733|NCT02412423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111036734|NCT02412423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111036735|NCT02412423|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111036736|NCT02412345|Alprostadil|alprostadil|mesh-list
111036737|NCT02412345|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111036738|NCT02412345|Vasodilator Agents|vasodilator agents|mesh-ancestor
111036739|NCT02412345|Urological Agents|urological agents|mesh-ancestor
111036741|NCT05679050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111036742|NCT02412267|Carboplatin|carboplatin|mesh-list
111036743|NCT02412267|Etoposide|etoposide|mesh-list
111036744|NCT02412267|Ifosfamide|ifosfamide|mesh-list
111036745|NCT02412267|Ofatumumab|ofatumumab|mesh-list
111036746|NCT02412267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111036747|NCT02412267|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111036748|NCT02412267|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111036749|NCT02412267|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111036750|NCT02412267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111036751|NCT02412267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111036752|NCT02412267|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111036753|NCT02412267|Alkylating Agents|alkylating agents|mesh-ancestor
111036754|NCT03172455|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
111036755|NCT03172455|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
111036756|NCT03172455|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111036757|NCT03172455|Protease Inhibitors|protease inhibitors|mesh-ancestor
111036758|NCT03172455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111036759|NCT03172455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111036760|NCT03171597|Vasodilator Agents|vasodilator agents|mesh-list
111036761|NCT03171597|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
111036762|NCT03171597|Lipid Regulating Agents|lipid regulating agents|mesh-list
111036763|NCT05698394|Esketamine|esketamine|mesh-list
111036764|NCT05698394|Antidepressive Agents|antidepressive agents|mesh-ancestor
111036765|NCT05698394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111036766|NCT05539118|Interferons|interferons|mesh-list
111036767|NCT05539118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111036768|NCT05539118|Antiviral Agents|antiviral agents|mesh-ancestor
111036769|NCT05539118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111036770|NCT02405793|Meloxicam|meloxicam|mesh-list
111036771|NCT02405793|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111036772|NCT02405793|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111036773|NCT02405793|Analgesics|analgesics|mesh-ancestor
111036774|NCT02405793|Sensory System Agents|sensory system agents|mesh-ancestor
111036775|NCT02405793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111036776|NCT02405793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111036777|NCT02405793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111036778|NCT02405793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111036779|NCT02405793|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111036780|NCT02405793|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111036781|NCT02405793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111036782|NCT02405793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111036783|NCT05695664|Ibuprofen|ibuprofen|mesh-list
111036784|NCT05695664|Ketorolac|ketorolac|mesh-list
111036785|NCT05695664|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111036786|NCT05695664|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111036787|NCT05695664|Analgesics|analgesics|mesh-ancestor
111036788|NCT05695664|Sensory System Agents|sensory system agents|mesh-ancestor
111036789|NCT05695664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111036790|NCT05695664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111036791|NCT05695664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111036792|NCT05695664|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111036793|NCT05695664|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111036794|NCT05695664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111036795|NCT05695664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111036796|NCT02412189|Norepinephrine|norepinephrine|mesh-list
111036797|NCT02412189|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111036798|NCT02412189|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111036799|NCT02412189|Adrenergic Agents|adrenergic agents|mesh-ancestor
111036800|NCT02412189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111036801|NCT02412189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111036802|NCT02412189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111036803|NCT02412189|Sympathomimetics|sympathomimetics|mesh-ancestor
111036804|NCT02412189|Autonomic Agents|autonomic agents|mesh-ancestor
111036805|NCT02412189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111036806|NCT02412189|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111036807|NCT02411955|Nicotinic Acids|nicotinic acids|mesh-list
111036808|NCT02411955|Tazarotene|tazarotene|mesh-list
111036809|NCT02411955|Dermatologic Agents|dermatologic agents|mesh-ancestor
111036810|NCT02411955|Keratolytic Agents|keratolytic agents|mesh-ancestor
111036811|NCT02411955|Vitamin B Complex|vitamin b complex|mesh-ancestor
111036812|NCT02411955|Vitamins|vitamins|mesh-ancestor
111036813|NCT02411955|Micronutrients|micronutrients|mesh-ancestor
111036814|NCT02411955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111036815|NCT03172533|Dienogest|dienogest|mesh-list
111036816|NCT03172533|Ethinyl Estradiol|ethinyl estradiol|mesh-list
111036817|NCT03172533|Estradiol|estradiol|mesh-list
111036818|NCT03172533|Estrogens|estrogens|mesh-ancestor
111036819|NCT03172533|Hormones|hormones|mesh-ancestor
111036820|NCT03172533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111036821|NCT03172533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111036822|NCT03172533|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111036823|NCT03172533|Contraceptive Agents|contraceptive agents|mesh-ancestor
111036824|NCT03172533|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111036825|NCT03172533|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111036826|NCT03172533|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111036827|NCT03172533|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111036828|NCT03172533|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
111036829|NCT03172533|Hormone Antagonists|hormone antagonists|mesh-ancestor
111036830|NCT03172533|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111036831|NCT03172533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111036832|NCT02412033|Misoprostol|misoprostol|mesh-list
111036833|NCT02412033|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111036834|NCT02412033|Abortifacient Agents|abortifacient agents|mesh-ancestor
111036835|NCT02412033|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111036836|NCT02412033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111036837|NCT02412033|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111036838|NCT02412033|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111036839|NCT02412033|Oxytocics|oxytocics|mesh-ancestor
111036840|NCT02401971|Thalidomide|thalidomide|mesh-list
111036841|NCT02401971|Irinotecan|irinotecan|mesh-list
111036842|NCT02401971|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111036843|NCT02401971|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111036844|NCT02401971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111036845|NCT02401971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111036846|NCT02401971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111036847|NCT02401971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111036848|NCT02401971|Immunologic Factors|immunologic factors|mesh-ancestor
111036849|NCT02401971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111036850|NCT02401971|Leprostatic Agents|leprostatic agents|mesh-ancestor
111036851|NCT02401971|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111036852|NCT02401971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111036853|NCT02401971|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111036854|NCT02401971|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111036855|NCT02401971|Growth Substances|growth substances|mesh-ancestor
111036856|NCT02401971|Growth Inhibitors|growth inhibitors|mesh-ancestor
111036857|NCT00701883|Atorvastatin|atorvastatin|mesh-list
111036858|NCT00701883|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111036859|NCT00701883|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111036860|NCT00701883|Antimetabolites|antimetabolites|mesh-ancestor
111036861|NCT00701883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111036862|NCT00701883|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111036863|NCT00701883|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111036864|NCT00701883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111036865|NCT05678738|Antioxidants|antioxidants|mesh-list
111036866|NCT05678738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111036867|NCT05678738|Protective Agents|protective agents|mesh-ancestor
111036868|NCT05678738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111036869|NCT03175653|Oxycodone|oxycodone|mesh-list
111036870|NCT03175653|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111036871|NCT03175653|Narcotics|narcotics|mesh-ancestor
111036872|NCT03175653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111036873|NCT03175653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111036874|NCT03175653|Analgesics|analgesics|mesh-ancestor
111036875|NCT03175653|Sensory System Agents|sensory system agents|mesh-ancestor
111036876|NCT03175653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111036877|NCT02401737|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
111036878|NCT02401737|Antiviral Agents|antiviral agents|mesh-ancestor
111036879|NCT02401737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111036880|NCT03175341|Ascorbic Acid|ascorbic acid|mesh-list
111036881|NCT03175341|Vitamins|vitamins|mesh-ancestor
111036882|NCT03175341|Micronutrients|micronutrients|mesh-ancestor
111036883|NCT03175341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111036884|NCT03175341|Antioxidants|antioxidants|mesh-ancestor
111036885|NCT03175341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111036886|NCT03175341|Protective Agents|protective agents|mesh-ancestor
111036887|NCT05538026|Mesalamine|mesalamine|mesh-list
111036888|NCT05538026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111036889|NCT05538026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111036890|NCT05538026|Analgesics|analgesics|mesh-ancestor
111036891|NCT05538026|Sensory System Agents|sensory system agents|mesh-ancestor
111036892|NCT05538026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111036893|NCT05538026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111036894|NCT05538026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111036895|NCT05538026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111036896|NCT02401425|Letrozole|letrozole|mesh-list
111036897|NCT02401425|Misoprostol|misoprostol|mesh-list
111036898|NCT02401425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111036899|NCT02401425|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111036900|NCT02401425|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111036901|NCT02401425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111036902|NCT02401425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111036903|NCT02401425|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111036904|NCT02401425|Hormone Antagonists|hormone antagonists|mesh-ancestor
111036905|NCT02401425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111036906|NCT02401425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111036907|NCT02401425|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111036908|NCT02401425|Abortifacient Agents|abortifacient agents|mesh-ancestor
111036909|NCT02401425|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111036910|NCT02401425|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111036911|NCT02401425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111036912|NCT02401425|Oxytocics|oxytocics|mesh-ancestor
111036913|NCT05537948|Pitavastatin|pitavastatin|mesh-list
111036914|NCT05537948|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-list
111036915|NCT05537948|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111036916|NCT05537948|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111036917|NCT05537948|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111036918|NCT05537948|Antimetabolites|antimetabolites|mesh-ancestor
111036919|NCT05537948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111036920|NCT05537948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111036921|NCT05537948|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111036922|NCT05537948|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111036923|NCT05537948|Protease Inhibitors|protease inhibitors|mesh-ancestor
111036924|NCT02401269|Aspirin|aspirin|mesh-list
111036925|NCT02401269|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111036926|NCT02401269|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111036927|NCT02401269|Analgesics|analgesics|mesh-ancestor
111036928|NCT02401269|Sensory System Agents|sensory system agents|mesh-ancestor
111036929|NCT02401269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111036930|NCT02401269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111036931|NCT02401269|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111036932|NCT02401269|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111036933|NCT02401269|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111036934|NCT02401269|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111036935|NCT02401269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111036936|NCT02401269|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111036937|NCT02401269|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111036938|NCT02401269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111036939|NCT02401269|Antipyretics|antipyretics|mesh-ancestor
111036940|NCT04480827|Cholic Acids|cholic acids|mesh-list
111036941|NCT04480827|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111036942|NCT02582684|Lamivudine|lamivudine|mesh-list
111036943|NCT02582684|Dolutegravir|dolutegravir|mesh-list
111036944|NCT02582684|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111036945|NCT02582684|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111036946|NCT02582684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111036947|NCT02582684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111036948|NCT02582684|Antiviral Agents|antiviral agents|mesh-ancestor
110827389|NCT03386448|Antiemetics|antiemetics|mesh-ancestor
111036949|NCT02582684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111036951|NCT02582684|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111036952|NCT02582684|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111036953|NCT02582684|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111036954|NCT02411877|Clotrimazole|clotrimazole|mesh-list
111036955|NCT02411877|Miconazole|miconazole|mesh-list
111036956|NCT02411877|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111036957|NCT02411877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111036958|NCT02411877|Antifungal Agents|antifungal agents|mesh-ancestor
111036959|NCT02411877|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111036960|NCT02411877|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111036961|NCT02411877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111036962|NCT02411877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111036963|NCT02411877|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111036964|NCT02411877|Hormone Antagonists|hormone antagonists|mesh-ancestor
111036965|NCT02411877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111036966|NCT02411877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111036967|NCT02411877|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111036968|NCT02411877|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111036969|NCT03169569|Hemostatics|hemostatics|mesh-list
111036970|NCT03169569|Coagulants|coagulants|mesh-ancestor
111036971|NCT02585960|Factor VIII|factor viii|mesh-list
111036972|NCT02585960|BAX 855|bax 855|mesh-list
111036973|NCT02585960|Coagulants|coagulants|mesh-ancestor
111036974|NCT03169413|Adenosine|adenosine|mesh-list
111036975|NCT03169413|Analgesics|analgesics|mesh-ancestor
111036976|NCT03169413|Sensory System Agents|sensory system agents|mesh-ancestor
111036977|NCT03169413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111036978|NCT03169413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111036979|NCT03169413|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111036980|NCT03169413|Vasodilator Agents|vasodilator agents|mesh-ancestor
111036981|NCT03169413|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
111036982|NCT03169413|Purinergic Agonists|purinergic agonists|mesh-ancestor
111036983|NCT03169413|Purinergic Agents|purinergic agents|mesh-ancestor
111036984|NCT03169413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111036985|NCT03169413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111036986|NCT03169335|Paclitaxel|paclitaxel|mesh-list
111036987|NCT03169335|Bevacizumab|bevacizumab|mesh-list
111036988|NCT03169335|Carboplatin|carboplatin|mesh-list
111036989|NCT03169335|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111036990|NCT03169335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111036991|NCT03169335|Tubulin Modulators|tubulin modulators|mesh-ancestor
111036992|NCT03169335|Antimitotic Agents|antimitotic agents|mesh-ancestor
111036993|NCT03169335|Mitosis Modulators|mitosis modulators|mesh-ancestor
111036994|NCT03169335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111036995|NCT03169335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111036996|NCT03169335|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111036997|NCT03169335|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111036998|NCT03169335|Growth Substances|growth substances|mesh-ancestor
111036999|NCT03169335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111037000|NCT03169335|Growth Inhibitors|growth inhibitors|mesh-ancestor
111037001|NCT03106623|Solifenacin Succinate|solifenacin succinate|mesh-list
111037002|NCT03106623|Mirabegron|mirabegron|mesh-list
111037003|NCT03106623|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111037004|NCT03106623|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111037005|NCT03106623|Cholinergic Agents|cholinergic agents|mesh-ancestor
111037006|NCT03106623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111037007|NCT03106623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111037008|NCT03106623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111037009|NCT03106623|Urological Agents|urological agents|mesh-ancestor
111037010|NCT03106623|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
111037011|NCT03106623|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111037012|NCT03106623|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111037013|NCT03106623|Adrenergic Agents|adrenergic agents|mesh-ancestor
111037014|NCT02411175|Ethanol|ethanol|mesh-list
111037015|NCT02411175|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111037016|NCT02411175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111037017|NCT02411175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111037018|NCT02411175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111037019|NCT05537558|Antidepressive Agents|antidepressive agents|mesh-list
111037020|NCT05537558|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111037021|NCT02411331|Ethanol|ethanol|mesh-list
111037022|NCT02411331|Enoxaparin|enoxaparin|mesh-list
111037023|NCT02411331|Anticoagulants|anticoagulants|mesh-ancestor
111037025|NCT02411331|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111037026|NCT02411331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111037027|NCT02411331|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111037028|NCT02411331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111037029|NCT02411331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111037030|NCT02411331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111037031|NCT00100789|Paclitaxel|paclitaxel|mesh-list
111037032|NCT00100789|Gemcitabine|gemcitabine|mesh-list
111037033|NCT00100789|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111037034|NCT00100789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111037035|NCT00100789|Tubulin Modulators|tubulin modulators|mesh-ancestor
111037036|NCT00100789|Antimitotic Agents|antimitotic agents|mesh-ancestor
111037037|NCT00100789|Mitosis Modulators|mitosis modulators|mesh-ancestor
111037038|NCT00100789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111037039|NCT00100789|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111037040|NCT00100789|Antimetabolites|antimetabolites|mesh-ancestor
111037041|NCT02410863|Trametinib|trametinib|mesh-list
111037042|NCT02410863|Dabrafenib|dabrafenib|mesh-list
111037043|NCT02410863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111037044|NCT02410863|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111037045|NCT02410863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111037046|NCT02410863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111037047|NCT05678192|Hormones|hormones|mesh-list
111037048|NCT05678192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111037049|NCT05678192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111037050|NCT00708123|Listerine|listerine|mesh-list
111037051|NCT00708123|Fluorides|fluorides|mesh-list
111037052|NCT00708123|Sodium Fluoride|sodium fluoride|mesh-list
111037053|NCT00708123|Cariostatic Agents|cariostatic agents|mesh-ancestor
111037054|NCT00708123|Protective Agents|protective agents|mesh-ancestor
111037055|NCT00708123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111037056|NCT00708123|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111037057|NCT00708123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111037058|NCT05678036|Analgesics, Opioid|analgesics, opioid|mesh-list
111037059|NCT05678036|Narcotics|narcotics|mesh-ancestor
111037060|NCT05678036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111037061|NCT05678036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111037063|NCT05678036|Sensory System Agents|sensory system agents|mesh-ancestor
111037064|NCT05678036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111037065|NCT05537090|Midazolam|midazolam|mesh-list
111037066|NCT05537090|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111037067|NCT05537090|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111037068|NCT05537090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111037069|NCT05537090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111037070|NCT05537090|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111037071|NCT05537090|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111037072|NCT05537090|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111037073|NCT05537090|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111037074|NCT05537090|Anesthetics, General|anesthetics, general|mesh-ancestor
111037075|NCT05537090|Anesthetics|anesthetics|mesh-ancestor
111037076|NCT05537090|GABA Modulators|gaba modulators|mesh-ancestor
111037077|NCT05537090|GABA Agents|gaba agents|mesh-ancestor
111037078|NCT05537090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111037079|NCT05537090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111037080|NCT02400879|Sufentanil|sufentanil|mesh-list
111037081|NCT02400879|Remifentanil|remifentanil|mesh-list
111037082|NCT02400879|Sevoflurane|sevoflurane|mesh-list
111037083|NCT02400879|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111037084|NCT02400879|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111037085|NCT02400879|Anesthetics, General|anesthetics, general|mesh-ancestor
111037086|NCT02400879|Anesthetics|anesthetics|mesh-ancestor
111037087|NCT02400879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111037088|NCT02400879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111037089|NCT02400879|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111037090|NCT02400879|Narcotics|narcotics|mesh-ancestor
111037091|NCT02400879|Analgesics|analgesics|mesh-ancestor
111037092|NCT02400879|Sensory System Agents|sensory system agents|mesh-ancestor
111037093|NCT02400879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111037094|NCT02400879|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111037095|NCT02400879|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111037096|NCT04133480|Cannabidiol|cannabidiol|mesh-list
111037097|NCT04133480|Anticonvulsants|anticonvulsants|mesh-ancestor
111037098|NCT02400645|Ketorolac|ketorolac|mesh-list
111037099|NCT02400645|Bupivacaine|bupivacaine|mesh-list
111037100|NCT02400645|Anesthetics, Local|anesthetics, local|mesh-ancestor
111037101|NCT02400645|Anesthetics|anesthetics|mesh-ancestor
111037102|NCT02400645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111037103|NCT02400645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111037104|NCT02400645|Sensory System Agents|sensory system agents|mesh-ancestor
111037105|NCT02400645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111037106|NCT02400645|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111037107|NCT02400645|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111037108|NCT02400645|Analgesics|analgesics|mesh-ancestor
111037109|NCT02400645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111037110|NCT02400645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111037111|NCT02400645|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111037112|NCT02400645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111037113|NCT02400645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111037114|NCT02165215|Etrolizumab|etrolizumab|mesh-list
111037115|NCT02165215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111037116|NCT02165215|Immunologic Factors|immunologic factors|mesh-ancestor
111037117|NCT02165215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111037118|NCT02400801|Triptorelin Pamoate|triptorelin pamoate|mesh-list
111037119|NCT02400801|Dienogest|dienogest|mesh-list
111037120|NCT02400801|Ethinyl Estradiol|ethinyl estradiol|mesh-list
111037121|NCT02400801|Luteolytic Agents|luteolytic agents|mesh-ancestor
111037122|NCT02400801|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111037123|NCT02400801|Contraceptive Agents|contraceptive agents|mesh-ancestor
111037124|NCT02400801|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111037125|NCT02400801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111037126|NCT02400801|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111037127|NCT02400801|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111037128|NCT02400801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111037129|NCT02400801|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111037130|NCT02400801|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111037131|NCT02400801|Estrogens|estrogens|mesh-ancestor
111037132|NCT02400801|Hormones|hormones|mesh-ancestor
111037133|NCT02400801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111037134|NCT02400801|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
111037135|NCT02400801|Hormone Antagonists|hormone antagonists|mesh-ancestor
111037136|NCT02168569|Artesunate|artesunate|mesh-list
111037137|NCT02168569|Lumefantrine|lumefantrine|mesh-list
111037138|NCT02168569|Artemether|artemether|mesh-list
111037139|NCT02168569|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
111037140|NCT02168569|Amodiaquine|amodiaquine|mesh-list
111037141|NCT02168569|Antimalarials|antimalarials|mesh-ancestor
111037142|NCT02168569|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111037143|NCT02168569|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111037144|NCT02168569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111037145|NCT02168569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111037146|NCT02168569|Antiviral Agents|antiviral agents|mesh-ancestor
111037147|NCT02168569|Schistosomicides|schistosomicides|mesh-ancestor
111037148|NCT02168569|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
111037149|NCT02168569|Anthelmintics|anthelmintics|mesh-ancestor
111037150|NCT02400255|Crenolanib|crenolanib|mesh-list
111037151|NCT02400255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111037152|NCT02171689|Afatinib|afatinib|mesh-list
111037153|NCT02171689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111037154|NCT02171689|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111037155|NCT02171689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111037156|NCT02171689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111037157|NCT02171767|Afatinib|afatinib|mesh-list
111037158|NCT02171767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111037159|NCT02171767|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111037160|NCT02171767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111037161|NCT02171767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111037162|NCT02400021|Progesterone|progesterone|mesh-list
111037163|NCT02400021|Progestins|progestins|mesh-ancestor
111037164|NCT02400021|Hormones|hormones|mesh-ancestor
111037165|NCT02400021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111037166|NCT02400021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111037167|NCT02165449|Ketamine|ketamine|mesh-list
111037168|NCT02165449|Analgesics|analgesics|mesh-ancestor
111037169|NCT02165449|Sensory System Agents|sensory system agents|mesh-ancestor
111037170|NCT02165449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111037171|NCT02165449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111037172|NCT02165449|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111037173|NCT02165449|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111037174|NCT02165449|Anesthetics, General|anesthetics, general|mesh-ancestor
111037175|NCT02165449|Anesthetics|anesthetics|mesh-ancestor
111037176|NCT02165449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111037177|NCT02165449|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111037178|NCT02165449|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111037179|NCT02165449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111037180|NCT02165449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111037181|NCT02172001|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
111037182|NCT02172001|Hematinics|hematinics|mesh-ancestor
111037183|NCT05535998|Chlorotrianisene|chlorotrianisene|mesh-list
111037184|NCT05535998|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
111037185|NCT05535998|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
111037186|NCT05535998|Estrogens|estrogens|mesh-ancestor
111037187|NCT05535998|Hormones|hormones|mesh-ancestor
111037188|NCT05535998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111037189|NCT05535998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111037190|NCT05535998|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111037191|NCT05535998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111037192|NCT05535998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111037193|NCT05535998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111037194|NCT03540199|Antibodies|antibodies|mesh-list
111037195|NCT03540199|Antibodies, Bispecific|antibodies, bispecific|mesh-list
111037196|NCT03540199|Immunologic Factors|immunologic factors|mesh-ancestor
111037197|NCT03540199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111037198|NCT02165917|Hyaluronic Acid|hyaluronic acid|mesh-list
111037199|NCT02165917|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111037200|NCT02165917|Immunologic Factors|immunologic factors|mesh-ancestor
111037201|NCT02165917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111037202|NCT02165917|Viscosupplements|viscosupplements|mesh-ancestor
111037203|NCT02165917|Protective Agents|protective agents|mesh-ancestor
111037204|NCT02168881|Misoprostol|misoprostol|mesh-list
111037205|NCT02168881|Dinoprostone|dinoprostone|mesh-list
111037206|NCT02168881|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111037207|NCT02168881|Abortifacient Agents|abortifacient agents|mesh-ancestor
111037208|NCT02168881|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111037209|NCT02168881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111037210|NCT02168881|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111037211|NCT02168881|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111037212|NCT02168881|Oxytocics|oxytocics|mesh-ancestor
111037213|NCT02168959|Bupivacaine|bupivacaine|mesh-list
111037214|NCT02168959|Anesthetics, Local|anesthetics, local|mesh-ancestor
111037216|NCT02168959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111037217|NCT02168959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111037218|NCT02168959|Sensory System Agents|sensory system agents|mesh-ancestor
111037219|NCT02168959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111037220|NCT05696678|Morphine|morphine|mesh-list
111037221|NCT05696678|Ropivacaine|ropivacaine|mesh-list
111037222|NCT05696678|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111037223|NCT05696678|Narcotics|narcotics|mesh-ancestor
111037224|NCT05696678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111037225|NCT05696678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111037226|NCT05696678|Analgesics|analgesics|mesh-ancestor
111037227|NCT05696678|Sensory System Agents|sensory system agents|mesh-ancestor
111037228|NCT05696678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111037229|NCT05696678|Anesthetics, Local|anesthetics, local|mesh-ancestor
111037230|NCT05696678|Anesthetics|anesthetics|mesh-ancestor
111037231|NCT05450822|Lamotrigine|lamotrigine|mesh-list
111037232|NCT05450822|Levetiracetam|levetiracetam|mesh-list
111037233|NCT05450822|Anticonvulsants|anticonvulsants|mesh-list
111037234|NCT05450822|Nootropic Agents|nootropic agents|mesh-ancestor
111037235|NCT05450822|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111037236|NCT05450822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111037237|NCT05450822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111037238|NCT05450822|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111037239|NCT05450822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111037240|NCT05450822|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111037241|NCT05450822|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111037242|NCT05450822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111037243|NCT05450822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111037244|NCT05450822|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111037245|NCT02172157|Olodaterol|olodaterol|mesh-list
111037246|NCT02172157|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111037247|NCT02172157|Autonomic Agents|autonomic agents|mesh-ancestor
111037248|NCT02172157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111037249|NCT02172157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111037250|NCT02172157|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111037251|NCT02172157|Respiratory System Agents|respiratory system agents|mesh-ancestor
111037252|NCT02172235|Pioglitazone|pioglitazone|mesh-list
111037253|NCT02172235|Empagliflozin|empagliflozin|mesh-list
111037254|NCT02172235|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111037255|NCT02172235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111037256|NCT02172235|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111037257|NCT02172235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111037258|NCT02166229|Valproic Acid|valproic acid|mesh-list
111037259|NCT02166229|Anticonvulsants|anticonvulsants|mesh-ancestor
111037260|NCT02166229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111037261|NCT02166229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111037262|NCT02166229|GABA Agents|gaba agents|mesh-ancestor
111037263|NCT02166229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111037264|NCT02166229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111037265|NCT02166229|Antimanic Agents|antimanic agents|mesh-ancestor
111037266|NCT02166229|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111037267|NCT02166229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111037268|NCT02166229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111037269|NCT05297864|Niraparib|niraparib|mesh-list
111037270|NCT05297864|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111037271|NCT05297864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111037272|NCT05297864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111037273|NCT05297864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111037274|NCT02757625|Dexmedetomidine|dexmedetomidine|mesh-list
111037275|NCT02757625|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111037276|NCT02757625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111037277|NCT02757625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111037278|NCT02757625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111037279|NCT02757625|Analgesics|analgesics|mesh-ancestor
111037280|NCT02757625|Sensory System Agents|sensory system agents|mesh-ancestor
111037281|NCT02757625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111037282|NCT02757625|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111037283|NCT02757625|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111037284|NCT02757625|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111037285|NCT02757625|Adrenergic Agents|adrenergic agents|mesh-ancestor
111037286|NCT02757625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111037287|NCT02757625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111037288|NCT05691920|Fentanyl|fentanyl|mesh-list
111037289|NCT05691920|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111037290|NCT05691920|Narcotics|narcotics|mesh-ancestor
111037291|NCT05691920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111037292|NCT05691920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111037293|NCT05691920|Analgesics|analgesics|mesh-ancestor
111037294|NCT05691920|Sensory System Agents|sensory system agents|mesh-ancestor
111037295|NCT05691920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111037296|NCT05691920|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111037297|NCT05691920|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111037298|NCT05691920|Anesthetics, General|anesthetics, general|mesh-ancestor
111037299|NCT05691920|Anesthetics|anesthetics|mesh-ancestor
111037300|NCT05696366|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
111037301|NCT05696366|Volagidemab|volagidemab|mesh-list
111037302|NCT05696366|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111037303|NCT05696366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111037304|NCT05696366|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111037305|NCT05696366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111037306|NCT02169583|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111037307|NCT02172391|Tiotropium Bromide|tiotropium bromide|mesh-list
111037308|NCT02172391|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111037309|NCT02172391|Autonomic Agents|autonomic agents|mesh-ancestor
111037310|NCT02172391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111037311|NCT02172391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111037312|NCT02172391|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111037313|NCT02172391|Respiratory System Agents|respiratory system agents|mesh-ancestor
111037314|NCT02172391|Parasympatholytics|parasympatholytics|mesh-ancestor
111037315|NCT02172391|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111037316|NCT02172391|Cholinergic Agents|cholinergic agents|mesh-ancestor
111037317|NCT02172391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111037318|NCT02172391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111037320|NCT00109681|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111037321|NCT00109681|Vasodilator Agents|vasodilator agents|mesh-ancestor
111037322|NCT02172469|Bromides|bromides|mesh-list
111037323|NCT02172469|Tiotropium Bromide|tiotropium bromide|mesh-list
111037324|NCT02172469|Ipratropium|ipratropium|mesh-list
111037325|NCT02172469|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111037326|NCT02172469|Autonomic Agents|autonomic agents|mesh-ancestor
111037327|NCT02172469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111037328|NCT02172469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111037329|NCT02172469|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111037330|NCT02172469|Respiratory System Agents|respiratory system agents|mesh-ancestor
111037331|NCT02172469|Parasympatholytics|parasympatholytics|mesh-ancestor
111037332|NCT02172469|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111037333|NCT02172469|Cholinergic Agents|cholinergic agents|mesh-ancestor
111037334|NCT02172469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111037335|NCT02172469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111037336|NCT02172469|Anticonvulsants|anticonvulsants|mesh-ancestor
111037337|NCT02172547|Tiotropium Bromide|tiotropium bromide|mesh-list
111037338|NCT02172547|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111037339|NCT02172547|Autonomic Agents|autonomic agents|mesh-ancestor
111037340|NCT02172547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111037341|NCT02172547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111037342|NCT02172547|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111037343|NCT02172547|Respiratory System Agents|respiratory system agents|mesh-ancestor
111037344|NCT02172547|Parasympatholytics|parasympatholytics|mesh-ancestor
111037345|NCT02172547|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111037346|NCT02172547|Cholinergic Agents|cholinergic agents|mesh-ancestor
111037347|NCT02172547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111037348|NCT02172547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111037349|NCT02174887|Paclitaxel|paclitaxel|mesh-list
111037350|NCT02174887|Gemcitabine|gemcitabine|mesh-list
111037351|NCT02174887|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111037352|NCT02174887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111037353|NCT02174887|Tubulin Modulators|tubulin modulators|mesh-ancestor
111037354|NCT02174887|Antimitotic Agents|antimitotic agents|mesh-ancestor
111037355|NCT02174887|Mitosis Modulators|mitosis modulators|mesh-ancestor
111037356|NCT02174887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111037357|NCT02174887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111037358|NCT02174887|Antimetabolites|antimetabolites|mesh-ancestor
110754413|NCT01352572|Nortriptyline|nortriptyline|mesh-list
111037359|NCT04373564|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
111037360|NCT04373564|Chelating Agents|chelating agents|mesh-ancestor
111037361|NCT04373564|Sequestering Agents|sequestering agents|mesh-ancestor
111037362|NCT04373564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111037364|NCT05142319|Immunologic Factors|immunologic factors|mesh-ancestor
111037365|NCT05142319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111037366|NCT02169973|JNJ-42165279|jnj-42165279|mesh-list
111037367|NCT02169973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111037368|NCT02169973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111037369|NCT04298528|Dronabinol|dronabinol|mesh-list
111037370|NCT04298528|Hallucinogens|hallucinogens|mesh-ancestor
111037371|NCT04298528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111037372|NCT04298528|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111037373|NCT04298528|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111037374|NCT04298528|Analgesics|analgesics|mesh-ancestor
111037375|NCT04298528|Sensory System Agents|sensory system agents|mesh-ancestor
111037376|NCT04298528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111037377|NCT04298528|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
111037378|NCT04298528|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
111037379|NCT04298528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111037380|NCT04298528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111037381|NCT04298528|Hormones|hormones|mesh-ancestor
111037382|NCT04298528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111037383|NCT00100711|Motexafin gadolinium|motexafin gadolinium|mesh-list
111037384|NCT00100711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111037385|NCT00100711|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111037386|NCT00100711|Dermatologic Agents|dermatologic agents|mesh-ancestor
111037387|NCT02581202|Ritonavir|ritonavir|mesh-list
111037388|NCT02581202|Lopinavir|lopinavir|mesh-list
111037389|NCT02581202|Lamivudine|lamivudine|mesh-list
111037390|NCT02581202|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111037391|NCT02581202|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111037392|NCT02581202|Protease Inhibitors|protease inhibitors|mesh-ancestor
111037393|NCT02581202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111037394|NCT02581202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111037395|NCT02581202|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111037396|NCT02581202|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111037397|NCT02581202|Antiviral Agents|antiviral agents|mesh-ancestor
111037398|NCT02581202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111037399|NCT02581202|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111037400|NCT02581202|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111037401|NCT02581202|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111037402|NCT02581202|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111037403|NCT02758171|Empagliflozin|empagliflozin|mesh-list
111037404|NCT02758171|Linagliptin|linagliptin|mesh-list
111037405|NCT02758171|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111037406|NCT02758171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111037407|NCT02758171|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111037408|NCT02758171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111037409|NCT02758171|Incretins|incretins|mesh-ancestor
111037410|NCT02758171|Hormones|hormones|mesh-ancestor
111037411|NCT02758171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111037412|NCT02758171|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111037413|NCT02758171|Protease Inhibitors|protease inhibitors|mesh-ancestor
111037414|NCT02758171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111037415|NCT02172781|Tiotropium Bromide|tiotropium bromide|mesh-list
111037416|NCT02172781|Ipratropium|ipratropium|mesh-list
111037417|NCT02172781|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111037418|NCT02172781|Autonomic Agents|autonomic agents|mesh-ancestor
111037419|NCT02172781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111037420|NCT02172781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111037421|NCT02172781|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111037422|NCT02172781|Respiratory System Agents|respiratory system agents|mesh-ancestor
111037423|NCT02172781|Parasympatholytics|parasympatholytics|mesh-ancestor
111037424|NCT02172781|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111037425|NCT02172781|Cholinergic Agents|cholinergic agents|mesh-ancestor
111037426|NCT02172781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111037427|NCT02172781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111037428|NCT02173093|Aldesleukin|aldesleukin|mesh-list
111037429|NCT02173093|Interleukin-2|interleukin-2|mesh-list
111037430|NCT02173093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111037431|NCT02173093|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111037432|NCT02173093|Analgesics|analgesics|mesh-ancestor
111037433|NCT02173093|Sensory System Agents|sensory system agents|mesh-ancestor
111037434|NCT02173093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111037435|NCT02173093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111037436|NCT02173093|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111037437|NCT02173093|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111037438|NCT02173093|Antiviral Agents|antiviral agents|mesh-ancestor
111037439|NCT02173093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111037440|NCT05142085|Mineral Oil|mineral oil|mesh-list
111037441|NCT05142085|Emollients|emollients|mesh-ancestor
111037442|NCT05142085|Dermatologic Agents|dermatologic agents|mesh-ancestor
111037443|NCT00103831|Taxane|taxane|mesh-list
111037444|NCT00103831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111037445|NCT03538483|Bupivacaine|bupivacaine|mesh-list
111037446|NCT03538483|Anesthetics, Local|anesthetics, local|mesh-ancestor
111037447|NCT03538483|Anesthetics|anesthetics|mesh-ancestor
111037448|NCT03538483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111037449|NCT03538483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111037450|NCT03538483|Sensory System Agents|sensory system agents|mesh-ancestor
111037451|NCT03538483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111037452|NCT02175355|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
111037453|NCT02175355|Telmisartan|telmisartan|mesh-list
111119152|NCT05323617|Dermatologic Agents|dermatologic agents|mesh-ancestor
111037454|NCT02175355|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111037455|NCT02175355|Diuretics|diuretics|mesh-ancestor
111037456|NCT02175355|Natriuretic Agents|natriuretic agents|mesh-ancestor
111037457|NCT02175355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111037458|NCT02175355|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
111037459|NCT02175355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111037460|NCT02175355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111037461|NCT02175355|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111037462|NCT02175355|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111037463|NCT03538327|Silybin|silybin|mesh-list
111037464|NCT03538327|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111037465|NCT03538327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111037466|NCT03538327|Protective Agents|protective agents|mesh-ancestor
111037467|NCT03538327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111037468|NCT02170597|Dabigatran|dabigatran|mesh-list
111037469|NCT02170597|Antithrombins|antithrombins|mesh-ancestor
111037470|NCT02170597|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111037471|NCT02170597|Protease Inhibitors|protease inhibitors|mesh-ancestor
111037472|NCT02170597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111037473|NCT02170597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111037474|NCT02170597|Anticoagulants|anticoagulants|mesh-ancestor
111037475|NCT02170675|Ketoconazole|ketoconazole|mesh-list
111037476|NCT02170675|Dabigatran|dabigatran|mesh-list
111037477|NCT02170675|Antithrombins|antithrombins|mesh-ancestor
111037478|NCT02170675|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111037479|NCT02170675|Protease Inhibitors|protease inhibitors|mesh-ancestor
111037480|NCT02170675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111037481|NCT02170675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111037482|NCT02170675|Anticoagulants|anticoagulants|mesh-ancestor
111037483|NCT02170675|Antifungal Agents|antifungal agents|mesh-ancestor
111037484|NCT02170675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111037485|NCT02170675|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111037486|NCT02170675|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111037487|NCT02170675|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111037488|NCT02170675|Hormone Antagonists|hormone antagonists|mesh-ancestor
111037489|NCT02170675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111037490|NCT02170675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111037491|NCT02170675|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111037492|NCT02175433|AGS67E|ags67e|mesh-list
111037493|NCT02175433|Immunoconjugates|immunoconjugates|mesh-ancestor
111037494|NCT02175433|Immunologic Factors|immunologic factors|mesh-ancestor
111037495|NCT02175433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111037496|NCT04154150|Ketamine|ketamine|mesh-list
111037497|NCT04154150|Analgesics|analgesics|mesh-ancestor
111037498|NCT04154150|Sensory System Agents|sensory system agents|mesh-ancestor
111037499|NCT04154150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111037500|NCT04154150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111037501|NCT04154150|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111037502|NCT04154150|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111037503|NCT04154150|Anesthetics, General|anesthetics, general|mesh-ancestor
111037504|NCT04154150|Anesthetics|anesthetics|mesh-ancestor
111037505|NCT04154150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111037506|NCT04154150|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111037507|NCT04154150|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111037508|NCT04154150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111037509|NCT04154150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111037510|NCT00521846|Cimetidine|cimetidine|mesh-list
111037511|NCT00521846|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111037512|NCT00521846|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111037513|NCT00521846|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
111037514|NCT00521846|Histamine Antagonists|histamine antagonists|mesh-ancestor
111037515|NCT00521846|Histamine Agents|histamine agents|mesh-ancestor
111037516|NCT00521846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111037517|NCT00521846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111037518|NCT00521846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111037519|NCT00521846|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111037520|NCT00521846|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111037521|NCT00521846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111037522|NCT02170831|Dabigatran|dabigatran|mesh-list
111037523|NCT02170831|Antithrombins|antithrombins|mesh-ancestor
111119153|NCT05323617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111037524|NCT02170831|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111037525|NCT02170831|Protease Inhibitors|protease inhibitors|mesh-ancestor
111037526|NCT02170831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111037527|NCT02170831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111037528|NCT02170831|Anticoagulants|anticoagulants|mesh-ancestor
110627040|NCT00524134|Carvedilol|carvedilol|mesh-list
111037530|NCT02175589|Gout Suppressants|gout suppressants|mesh-ancestor
111037531|NCT02175589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111037532|NCT02175589|Tubulin Modulators|tubulin modulators|mesh-ancestor
111037533|NCT02175589|Antimitotic Agents|antimitotic agents|mesh-ancestor
111037534|NCT02175589|Mitosis Modulators|mitosis modulators|mesh-ancestor
111037535|NCT02175589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111037536|NCT02175589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111037537|NCT05438186|Liraglutide|liraglutide|mesh-list
111037538|NCT05438186|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111037539|NCT05438186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111037540|NCT05438186|Incretins|incretins|mesh-ancestor
111037541|NCT05438186|Hormones|hormones|mesh-ancestor
111037542|NCT05438186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111037543|NCT02178397|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111037544|NCT02178397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111037545|NCT02178397|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111037546|NCT02178397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111037547|NCT02178397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111037548|NCT02173639|Metformin|metformin|mesh-list
111037549|NCT02173639|Linagliptin|linagliptin|mesh-list
111037550|NCT02173639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111037551|NCT02173639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111037552|NCT02173639|Incretins|incretins|mesh-ancestor
111037553|NCT02173639|Hormones|hormones|mesh-ancestor
111037554|NCT02173639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111037555|NCT02173639|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111037556|NCT02173639|Protease Inhibitors|protease inhibitors|mesh-ancestor
111037557|NCT02173639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111037558|NCT02173639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111037559|NCT02173717|Rifampin|rifampin|mesh-list
111037560|NCT02173717|Dabigatran|dabigatran|mesh-list
111037561|NCT02173717|Antithrombins|antithrombins|mesh-ancestor
111037562|NCT02173717|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111037563|NCT02173717|Protease Inhibitors|protease inhibitors|mesh-ancestor
111037564|NCT02173717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111037565|NCT02173717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111037566|NCT02173717|Anticoagulants|anticoagulants|mesh-ancestor
111037567|NCT02173717|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111037568|NCT02173717|Antitubercular Agents|antitubercular agents|mesh-ancestor
111037569|NCT02173717|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111037570|NCT02173717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111037571|NCT02173717|Leprostatic Agents|leprostatic agents|mesh-ancestor
111037572|NCT02173717|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111037573|NCT02173717|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111037574|NCT02173717|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111037575|NCT02173717|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
111037576|NCT02173717|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
111037577|NCT02173717|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
111037578|NCT02173717|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111037579|NCT04067648|Sufentanil|sufentanil|mesh-list
111037580|NCT04067648|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111037581|NCT04067648|Narcotics|narcotics|mesh-ancestor
111037582|NCT04067648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110827421|NCT01268917|Antipyretics|antipyretics|mesh-ancestor
111037583|NCT04067648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111037584|NCT04067648|Analgesics|analgesics|mesh-ancestor
111037585|NCT04067648|Sensory System Agents|sensory system agents|mesh-ancestor
111037586|NCT04067648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111037587|NCT04067648|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111037588|NCT04067648|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111037589|NCT04067648|Anesthetics, General|anesthetics, general|mesh-ancestor
111037590|NCT04067648|Anesthetics|anesthetics|mesh-ancestor
111037591|NCT02173795|Fenoterol|fenoterol|mesh-list
111037592|NCT02173795|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
111037593|NCT02173795|Ipratropium|ipratropium|mesh-list
111037594|NCT02173795|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111037595|NCT02173795|Autonomic Agents|autonomic agents|mesh-ancestor
111037596|NCT02173795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111037597|NCT02173795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111037598|NCT02173795|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111037599|NCT02173795|Respiratory System Agents|respiratory system agents|mesh-ancestor
111037600|NCT02173795|Sympathomimetics|sympathomimetics|mesh-ancestor
111037601|NCT02173795|Tocolytic Agents|tocolytic agents|mesh-ancestor
111037602|NCT02173795|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111037603|NCT02173795|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111037604|NCT02173795|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111037605|NCT02173795|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111037606|NCT02173795|Adrenergic Agents|adrenergic agents|mesh-ancestor
111037607|NCT02173795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111037608|NCT02173795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111037609|NCT02173795|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111037610|NCT02173795|Cholinergic Agents|cholinergic agents|mesh-ancestor
111037611|NCT02175901|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111037612|NCT02175901|Amoxicillin|amoxicillin|mesh-list
111037613|NCT02175901|Metronidazole|metronidazole|mesh-list
111037614|NCT02175901|Clarithromycin|clarithromycin|mesh-list
111037615|NCT02175901|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
111037616|NCT02175901|Potassium Citrate|potassium citrate|mesh-list
111037617|NCT02175901|Lansoprazole|lansoprazole|mesh-list
111037618|NCT02175901|Bismuth|bismuth|mesh-list
111037619|NCT02175901|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
111037620|NCT02175901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111037621|NCT02175901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111037622|NCT02175901|Antitubercular Agents|antitubercular agents|mesh-ancestor
111037623|NCT02175901|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111037624|NCT02175901|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111037625|NCT02175901|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111037626|NCT02175901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111037627|NCT02175901|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111037628|NCT02175901|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111037629|NCT02175901|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111037630|NCT02175901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111037631|NCT02175901|Antacids|antacids|mesh-ancestor
111037632|NCT02175901|Diuretics|diuretics|mesh-ancestor
111037633|NCT02175901|Natriuretic Agents|natriuretic agents|mesh-ancestor
111037634|NCT02175901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111037635|NCT02175901|Expectorants|expectorants|mesh-ancestor
111037636|NCT02175901|Respiratory System Agents|respiratory system agents|mesh-ancestor
111037637|NCT05534750|Linezolid|linezolid|mesh-list
111037638|NCT05534750|Tedizolid|tedizolid|mesh-list
111037639|NCT05534750|Tedizolid phosphate|tedizolid phosphate|mesh-list
111037640|NCT05534750|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111037641|NCT05534750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111037642|NCT05534750|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111037643|NCT05534750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111037644|NCT05534750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111037645|NCT02173873|Aflibercept|aflibercept|mesh-list
111037646|NCT02173873|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111037647|NCT02173873|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111037648|NCT02173873|Growth Substances|growth substances|mesh-ancestor
111037649|NCT02173873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111037650|NCT02173873|Growth Inhibitors|growth inhibitors|mesh-ancestor
111037651|NCT02173873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111037652|NCT02176057|Azithromycin|azithromycin|mesh-list
111037653|NCT02176057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111037654|NCT02176057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111037655|NCT02173951|Deferiprone|deferiprone|mesh-list
111037656|NCT02173951|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110754716|NCT03078478|Insulin|insulin|mesh-list
111037657|NCT02173951|Chelating Agents|chelating agents|mesh-ancestor
111037658|NCT02173951|Sequestering Agents|sequestering agents|mesh-ancestor
111037659|NCT02173951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111037661|NCT02176135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111037662|NCT02176213|Dexamethasone|dexamethasone|mesh-list
111037663|NCT02176213|Cyclophosphamide|cyclophosphamide|mesh-list
111037664|NCT02176213|Pomalidomide|pomalidomide|mesh-list
111037665|NCT02176213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111037666|NCT02176213|Immunologic Factors|immunologic factors|mesh-ancestor
111037667|NCT02176213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111037668|NCT02176213|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111037669|NCT02176213|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111037670|NCT02176213|Alkylating Agents|alkylating agents|mesh-ancestor
111037671|NCT02176213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111037672|NCT02176213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111037673|NCT02176213|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111037674|NCT02176213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111037675|NCT02176213|Antiemetics|antiemetics|mesh-ancestor
111037676|NCT02176213|Autonomic Agents|autonomic agents|mesh-ancestor
111037677|NCT02176213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111037678|NCT02176213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111037679|NCT02176213|Glucocorticoids|glucocorticoids|mesh-ancestor
111037680|NCT02176213|Hormones|hormones|mesh-ancestor
111037681|NCT02176213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111037682|NCT02176213|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111037683|NCT02176213|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111037684|NCT02176213|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111037685|NCT02176213|Growth Substances|growth substances|mesh-ancestor
111037686|NCT02176213|Growth Inhibitors|growth inhibitors|mesh-ancestor
111037687|NCT03537547|Antipsychotic Agents|antipsychotic agents|mesh-list
111037688|NCT03537547|Antidepressive Agents|antidepressive agents|mesh-list
111037689|NCT03537547|Psychotropic Drugs|psychotropic drugs|mesh-list
111037690|NCT03537547|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111037691|NCT03537547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111037692|NCT03537547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111037693|NCT04305002|Exenatide|exenatide|mesh-list
111037694|NCT04305002|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111037695|NCT04305002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111037696|NCT04305002|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111037697|NCT04305002|Incretins|incretins|mesh-ancestor
111037698|NCT04305002|Hormones|hormones|mesh-ancestor
111037699|NCT04305002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111037700|NCT02253797|Ritonavir|ritonavir|mesh-list
111037701|NCT02253797|Tipranavir|tipranavir|mesh-list
111037702|NCT02253797|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111037703|NCT02253797|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111037704|NCT02253797|Protease Inhibitors|protease inhibitors|mesh-ancestor
111037705|NCT02253797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111037706|NCT02253797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111037707|NCT02253797|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111037708|NCT02253797|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111037709|NCT02253797|Antiviral Agents|antiviral agents|mesh-ancestor
111037710|NCT02253797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111037711|NCT02253797|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111037712|NCT02253797|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111037713|NCT02253875|Ritonavir|ritonavir|mesh-list
111037714|NCT02253875|Tipranavir|tipranavir|mesh-list
111037715|NCT02253875|Omeprazole|omeprazole|mesh-list
111037716|NCT02253875|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111037717|NCT02253875|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111037718|NCT02253875|Protease Inhibitors|protease inhibitors|mesh-ancestor
111037719|NCT02253875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111037720|NCT02253875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111037721|NCT02253875|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111037722|NCT02253875|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111037723|NCT02253875|Antiviral Agents|antiviral agents|mesh-ancestor
111037724|NCT02253875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111037725|NCT02253875|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111037726|NCT02253875|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111037727|NCT02253875|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111037728|NCT02253875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111037729|NCT02253875|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111037730|NCT03819140|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
111037731|NCT03819140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110827431|NCT01268995|Immunologic Factors|immunologic factors|mesh-ancestor
111037732|NCT03819140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111037733|NCT04597268|Midazolam|midazolam|mesh-list
111037734|NCT04597268|Dexmedetomidine|dexmedetomidine|mesh-list
111037735|NCT04597268|Ketamine|ketamine|mesh-list
110754788|NCT01357252|Vildagliptin|vildagliptin|mesh-list
111037736|NCT04597268|Propofol|propofol|mesh-list
111037737|NCT04597268|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111037738|NCT04597268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111037739|NCT04597268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111037740|NCT04597268|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111037741|NCT04597268|Analgesics|analgesics|mesh-ancestor
111037742|NCT04597268|Sensory System Agents|sensory system agents|mesh-ancestor
111037743|NCT04597268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111037744|NCT04597268|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111037745|NCT04597268|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111037746|NCT04597268|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111037747|NCT04597268|Adrenergic Agents|adrenergic agents|mesh-ancestor
111037748|NCT04597268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111037749|NCT04597268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111037750|NCT04597268|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111037751|NCT04597268|Anesthetics, General|anesthetics, general|mesh-ancestor
111037752|NCT04597268|Anesthetics|anesthetics|mesh-ancestor
111037753|NCT04597268|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111037754|NCT04597268|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111037755|NCT04597268|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111037756|NCT04597268|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111037757|NCT04597268|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111037758|NCT04597268|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111037759|NCT04597268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111037760|NCT04597268|GABA Modulators|gaba modulators|mesh-ancestor
111037761|NCT04597268|GABA Agents|gaba agents|mesh-ancestor
111037762|NCT04976543|Nadroparin|nadroparin|mesh-list
111037763|NCT04976543|Warfarin|warfarin|mesh-list
111037764|NCT04976543|Calcium|calcium|mesh-list
111037765|NCT04976543|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111037766|NCT04976543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111037767|NCT04976543|Anticoagulants|anticoagulants|mesh-ancestor
111037768|NCT04976543|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111037769|NCT04976543|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111037770|NCT04976543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111037771|NCT05533892|Lenvatinib|lenvatinib|mesh-list
111037772|NCT05533892|Tislelizumab|tislelizumab|mesh-list
111037773|NCT05533892|Cell Wall Skeleton|cell wall skeleton|mesh-list
111037774|NCT05533892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111037775|NCT05533892|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111037776|NCT05533892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111037777|NCT05533892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111037778|NCT05533892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111037779|NCT05533892|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111037780|NCT05533892|Immunologic Factors|immunologic factors|mesh-ancestor
111037781|NCT05533892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111037782|NCT02924441|Lidocaine|lidocaine|mesh-list
111037783|NCT02924441|Anesthetics, Local|anesthetics, local|mesh-ancestor
111037784|NCT02924441|Anesthetics|anesthetics|mesh-ancestor
111037785|NCT02924441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111037786|NCT02924441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111037787|NCT02924441|Sensory System Agents|sensory system agents|mesh-ancestor
111037788|NCT02924441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111037789|NCT02924441|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111037790|NCT02924441|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111037791|NCT02924441|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111037792|NCT02924441|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111037793|NCT02924441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111037794|NCT00109967|Sirolimus|sirolimus|mesh-list
111037795|NCT00109967|Rituximab|rituximab|mesh-list
111037796|NCT00109967|Temsirolimus|temsirolimus|mesh-list
111037797|NCT00109967|MTOR Inhibitors|mtor inhibitors|mesh-list
111037798|NCT00109967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111037799|NCT00109967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111037800|NCT00109967|Immunologic Factors|immunologic factors|mesh-ancestor
111037801|NCT00109967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111037802|NCT00109967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111037803|NCT00109967|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111037804|NCT00109967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111037805|NCT00109967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111037806|NCT00109967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111037807|NCT00109967|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111037808|NCT00109967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110754858|NCT01353742|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
111037809|NCT00109967|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111037811|NCT02579096|Allopurinol|allopurinol|mesh-list
111037812|NCT02579096|Febuxostat|febuxostat|mesh-list
111037813|NCT02579096|Antimetabolites|antimetabolites|mesh-ancestor
111037814|NCT02579096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111037815|NCT02579096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111037816|NCT02579096|Gout Suppressants|gout suppressants|mesh-ancestor
111037817|NCT02579096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111037818|NCT02579096|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111037819|NCT02579096|Antioxidants|antioxidants|mesh-ancestor
111037820|NCT02579096|Protective Agents|protective agents|mesh-ancestor
111037821|NCT02579096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111037822|NCT02578862|Propofol|propofol|mesh-list
111037823|NCT02578862|Sevoflurane|sevoflurane|mesh-list
111037824|NCT02578862|Isoflurane|isoflurane|mesh-list
111037825|NCT02578862|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111037826|NCT02578862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111037827|NCT02578862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111037828|NCT02578862|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111037829|NCT02578862|Anesthetics, General|anesthetics, general|mesh-ancestor
111037830|NCT02578862|Anesthetics|anesthetics|mesh-ancestor
111037831|NCT02578862|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111037832|NCT02578862|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111037833|NCT02578706|Aspirin|aspirin|mesh-list
111037834|NCT02578706|Clopidogrel|clopidogrel|mesh-list
111037835|NCT02578706|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111037836|NCT02578706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111037837|NCT02578706|Analgesics|analgesics|mesh-ancestor
111037838|NCT02578706|Sensory System Agents|sensory system agents|mesh-ancestor
111037839|NCT02578706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111037840|NCT02578706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111037841|NCT02578706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111037842|NCT02578706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111037843|NCT02578706|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111037844|NCT02578706|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111037845|NCT02578706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111037846|NCT02578706|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111037847|NCT02578706|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111037848|NCT02578706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111037849|NCT02578706|Antipyretics|antipyretics|mesh-ancestor
111037850|NCT02578706|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111037851|NCT02578706|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111037852|NCT02578706|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111037853|NCT02578706|Purinergic Agents|purinergic agents|mesh-ancestor
111037854|NCT02578706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111037855|NCT03455504|Venetoclax|venetoclax|mesh-list
111037856|NCT03455504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111037857|NCT00108953|Doxorubicin|doxorubicin|mesh-list
111037858|NCT00108953|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111037859|NCT00108953|Sorafenib|sorafenib|mesh-list
111037860|NCT00108953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111037861|NCT00108953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111037862|NCT00108953|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111037863|NCT00108953|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111037864|NCT00108953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111037865|NCT00108953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111037866|NCT00108953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111037867|NCT02741531|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111037868|NCT02578316|Lenvatinib|lenvatinib|mesh-list
111037869|NCT02578316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111037870|NCT02578316|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111037871|NCT02578316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111037872|NCT02578316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111037873|NCT05532878|Apixaban|apixaban|mesh-list
111037874|NCT05532878|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111037875|NCT05532878|Antithrombins|antithrombins|mesh-ancestor
111037876|NCT05532878|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111037877|NCT05532878|Protease Inhibitors|protease inhibitors|mesh-ancestor
111037878|NCT05532878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111037879|NCT05532878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111037881|NCT02576678|Apremilast|apremilast|mesh-list
111037882|NCT02576678|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111037883|NCT02576678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111037884|NCT02576678|Analgesics|analgesics|mesh-ancestor
111037885|NCT02576678|Sensory System Agents|sensory system agents|mesh-ancestor
111037886|NCT02576678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111037887|NCT02576678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111037888|NCT02576678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111037889|NCT02576678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111037890|NCT02576678|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
111037891|NCT02576678|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111037892|NCT02576678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111037893|NCT02576678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111037895|NCT05532332|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111037896|NCT05532332|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111037897|NCT05532332|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111037898|NCT05532332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111037899|NCT05532332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111037900|NCT05532332|Serotonin Agents|serotonin agents|mesh-ancestor
111037901|NCT05532332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111037902|NCT05532332|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111037903|NCT05532332|Antidepressive Agents|antidepressive agents|mesh-ancestor
111037904|NCT05532332|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111037905|NCT05532332|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111037906|NCT05532332|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111037907|NCT05532332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111037908|NCT05532254|Aripiprazole|aripiprazole|mesh-list
111037909|NCT05532254|Antidepressive Agents|antidepressive agents|mesh-ancestor
111037910|NCT05532254|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111037911|NCT05532254|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111037912|NCT05532254|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111037913|NCT05532254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111037914|NCT05532254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111037915|NCT05532254|Dopamine Agonists|dopamine agonists|mesh-ancestor
111037916|NCT05532254|Dopamine Agents|dopamine agents|mesh-ancestor
111037917|NCT05532254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111037918|NCT05532254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111037919|NCT05532254|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111037920|NCT05532254|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111037921|NCT05532254|Serotonin Agents|serotonin agents|mesh-ancestor
111037922|NCT05532254|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111037923|NCT05532254|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111037924|NCT05532254|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111037925|NCT05532254|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111037926|NCT05471648|Pertuzumab|pertuzumab|mesh-list
111037927|NCT05471648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111037928|NCT05471648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111037929|NCT00108745|Paclitaxel|paclitaxel|mesh-list
111037930|NCT00108745|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111037931|NCT00108745|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
111037932|NCT00108745|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111037933|NCT00108745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111037934|NCT00108745|Tubulin Modulators|tubulin modulators|mesh-ancestor
111037935|NCT00108745|Antimitotic Agents|antimitotic agents|mesh-ancestor
111037936|NCT00108745|Mitosis Modulators|mitosis modulators|mesh-ancestor
111037937|NCT00108745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111037938|NCT05532020|Diazoxide|diazoxide|mesh-list
111037939|NCT05532020|Choline|choline|mesh-list
111037940|NCT05532020|Lipotropic Agents|lipotropic agents|mesh-ancestor
111037941|NCT05532020|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111037942|NCT05532020|Antimetabolites|antimetabolites|mesh-ancestor
111037943|NCT05532020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111037944|NCT05532020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111037945|NCT05532020|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111037946|NCT05532020|Nootropic Agents|nootropic agents|mesh-ancestor
111037947|NCT05532020|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111037948|NCT05532020|Vasodilator Agents|vasodilator agents|mesh-ancestor
111037949|NCT02098343|Carboplatin|carboplatin|mesh-list
111037950|NCT02098343|Doxorubicin|doxorubicin|mesh-list
111037951|NCT02098343|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111037952|NCT02098343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111037953|NCT02098343|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111037954|NCT02098343|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111037955|NCT02098343|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111037956|NCT02098343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111037957|NCT02098343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111037958|NCT02176369|Vinorelbine|vinorelbine|mesh-list
111037959|NCT02176369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111037960|NCT02176369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111037961|NCT02176369|Tubulin Modulators|tubulin modulators|mesh-ancestor
111037962|NCT02176369|Antimitotic Agents|antimitotic agents|mesh-ancestor
111037963|NCT02176369|Mitosis Modulators|mitosis modulators|mesh-ancestor
111037964|NCT02176369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111037965|NCT02716805|Melphalan|melphalan|mesh-list
111037966|NCT02716805|Durvalumab|durvalumab|mesh-list
111037967|NCT02716805|Tremelimumab|tremelimumab|mesh-list
111037968|NCT02716805|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111037969|NCT02716805|Alkylating Agents|alkylating agents|mesh-ancestor
111037970|NCT02716805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111037971|NCT02716805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111037972|NCT02716805|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111037973|NCT02716805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111037974|NCT02716805|Immunologic Factors|immunologic factors|mesh-ancestor
111037975|NCT02716805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111037976|NCT02716805|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111037977|NCT02174263|Immunoglobulins|immunoglobulins|mesh-list
111037978|NCT02174263|Immunoglobulin G|immunoglobulin g|mesh-list
111037979|NCT02174263|Immunologic Factors|immunologic factors|mesh-ancestor
111037980|NCT02174263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111037981|NCT04152473|Proglumide|proglumide|mesh-list
111037982|NCT04152473|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111037983|NCT04152473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111037984|NCT04099355|Dronabinol|dronabinol|mesh-list
111037985|NCT04099355|Hallucinogens|hallucinogens|mesh-ancestor
111037986|NCT04099355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111037987|NCT04099355|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111037988|NCT04099355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111037989|NCT04099355|Analgesics|analgesics|mesh-ancestor
111037990|NCT04099355|Sensory System Agents|sensory system agents|mesh-ancestor
111037991|NCT04099355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111037992|NCT04099355|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
111037993|NCT04099355|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
111037994|NCT04099355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111037995|NCT04099355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111037996|NCT04099355|Hormones|hormones|mesh-ancestor
111037997|NCT04099355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111037998|NCT02581982|Paclitaxel|paclitaxel|mesh-list
111037999|NCT02581982|Pembrolizumab|pembrolizumab|mesh-list
111038000|NCT02581982|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111038001|NCT02581982|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111038002|NCT02581982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111038003|NCT02581982|Tubulin Modulators|tubulin modulators|mesh-ancestor
111038004|NCT02581982|Antimitotic Agents|antimitotic agents|mesh-ancestor
111038005|NCT02581982|Mitosis Modulators|mitosis modulators|mesh-ancestor
111038006|NCT02581982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111038007|NCT02581982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111038008|NCT02581982|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111038009|NCT03751397|Cystatins|cystatins|mesh-list
111038010|NCT03751397|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
111038011|NCT03751397|Protease Inhibitors|protease inhibitors|mesh-ancestor
111038012|NCT03751397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111038013|NCT03751397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111038014|NCT02176681|Vildagliptin|vildagliptin|mesh-list
111038015|NCT02176681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111038016|NCT02176681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111038017|NCT02176681|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111038018|NCT02176681|Protease Inhibitors|protease inhibitors|mesh-ancestor
111038019|NCT02176681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111038020|NCT02176681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111038021|NCT02179099|Botulinum Toxins|botulinum toxins|mesh-list
111038022|NCT02179099|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111038023|NCT02179099|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110627145|NCT00523978|Sotalol|sotalol|mesh-list
111038024|NCT02179099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110827434|NCT01268995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111038025|NCT02179099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111038026|NCT02179099|Cholinergic Agents|cholinergic agents|mesh-ancestor
111038027|NCT02179099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111038028|NCT02179099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111038029|NCT02179099|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111038030|NCT02179099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111038031|NCT02254577|Progesterone|progesterone|mesh-list
111038032|NCT02254577|Progestins|progestins|mesh-ancestor
111038034|NCT02254577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111038035|NCT02254577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111038036|NCT02176759|Citric Acid|citric acid|mesh-list
111038037|NCT02176759|Sodium Citrate|sodium citrate|mesh-list
111038038|NCT02176759|Anticoagulants|anticoagulants|mesh-ancestor
111038039|NCT02176759|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
111038040|NCT02176759|Chelating Agents|chelating agents|mesh-ancestor
111038041|NCT02176759|Sequestering Agents|sequestering agents|mesh-ancestor
111038042|NCT02176759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111038043|NCT06010602|Analgesics|analgesics|mesh-list
111038044|NCT06010602|Sensory System Agents|sensory system agents|mesh-ancestor
111038045|NCT06010602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111038046|NCT06010602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111038047|NCT06010329|Maleic acid|maleic acid|mesh-list
111038048|NCT06010329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111038049|NCT06010329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111038050|NCT06010303|Tislelizumab|tislelizumab|mesh-list
111038051|NCT06010303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111038052|NCT06010303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111038053|NCT06010290|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
111038054|NCT06010290|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111038055|NCT06010290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111038056|NCT06010277|Leucovorin|leucovorin|mesh-list
111038057|NCT06010277|Folic Acid|folic acid|mesh-list
111038058|NCT06010277|Levoleucovorin|levoleucovorin|mesh-list
111038059|NCT06010277|Antidotes|antidotes|mesh-ancestor
111038060|NCT06010277|Protective Agents|protective agents|mesh-ancestor
111038061|NCT06010277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111038062|NCT06010277|Vitamin B Complex|vitamin b complex|mesh-ancestor
111038063|NCT06010277|Vitamins|vitamins|mesh-ancestor
111038064|NCT06010277|Micronutrients|micronutrients|mesh-ancestor
111038065|NCT06010277|Hematinics|hematinics|mesh-ancestor
111038066|NCT06010212|Paclitaxel|paclitaxel|mesh-list
111038067|NCT06010212|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111038068|NCT06010212|Nedaplatin|nedaplatin|mesh-list
111038069|NCT06010212|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111038070|NCT06010212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111038071|NCT06010212|Tubulin Modulators|tubulin modulators|mesh-ancestor
111038072|NCT06010212|Antimitotic Agents|antimitotic agents|mesh-ancestor
111038073|NCT06010212|Mitosis Modulators|mitosis modulators|mesh-ancestor
111038074|NCT06010212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111038075|NCT06010095|Nivolumab|nivolumab|mesh-list
111038076|NCT06010095|Ipilimumab|ipilimumab|mesh-list
111038077|NCT06010095|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111038078|NCT06010095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111038079|NCT06010095|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111038080|NCT06010095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111038081|NCT06010056|Ketamine|ketamine|mesh-list
111038082|NCT06010056|Morphine|morphine|mesh-list
111038083|NCT06010056|Analgesics|analgesics|mesh-ancestor
111038084|NCT06010056|Sensory System Agents|sensory system agents|mesh-ancestor
111038085|NCT06010056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111038086|NCT06010056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111038087|NCT06010056|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111038088|NCT06010056|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111038089|NCT06010056|Anesthetics, General|anesthetics, general|mesh-ancestor
111038090|NCT06010056|Anesthetics|anesthetics|mesh-ancestor
111038091|NCT06010056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111038092|NCT06010056|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111038093|NCT06010056|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111038094|NCT06010056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111038095|NCT06010056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111038096|NCT06010056|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111038097|NCT06010056|Narcotics|narcotics|mesh-ancestor
111038098|NCT06009900|Celecoxib|celecoxib|mesh-list
111038099|NCT06009900|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111038100|NCT06009900|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111038101|NCT06009900|Analgesics|analgesics|mesh-ancestor
111038102|NCT06009900|Sensory System Agents|sensory system agents|mesh-ancestor
111038103|NCT06009900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111038104|NCT06009900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111038105|NCT06009900|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111038106|NCT06009900|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111038107|NCT06009900|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111038108|NCT06009900|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111038110|NCT06009900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111038111|NCT06009874|Dapagliflozin|dapagliflozin|mesh-list
111038112|NCT06009874|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111038113|NCT06009874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111038114|NCT06009874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111038115|NCT06009874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111038116|NCT06009861|Paclitaxel|paclitaxel|mesh-list
111038117|NCT06009861|Tislelizumab|tislelizumab|mesh-list
111038118|NCT06009861|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111038119|NCT06009861|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111038120|NCT06009861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111038121|NCT06009861|Tubulin Modulators|tubulin modulators|mesh-ancestor
111038122|NCT06009861|Antimitotic Agents|antimitotic agents|mesh-ancestor
111038123|NCT06009861|Mitosis Modulators|mitosis modulators|mesh-ancestor
111038124|NCT06009861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111038125|NCT06009861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111038126|NCT06009744|Vitamins|vitamins|mesh-list
111038127|NCT06009744|Ascorbic Acid|ascorbic acid|mesh-list
111038128|NCT06009744|Zinc|zinc|mesh-list
111038129|NCT06009744|Micronutrients|micronutrients|mesh-ancestor
111038130|NCT06009744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111038131|NCT06009744|Trace Elements|trace elements|mesh-ancestor
111038132|NCT06009744|Antioxidants|antioxidants|mesh-ancestor
111038133|NCT06009744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111038134|NCT06009744|Protective Agents|protective agents|mesh-ancestor
111038135|NCT06009679|Misoprostol|misoprostol|mesh-list
111038136|NCT06009679|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111038137|NCT06009679|Abortifacient Agents|abortifacient agents|mesh-ancestor
111038138|NCT06009679|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111038139|NCT06009679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111038140|NCT06009679|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111038141|NCT06009679|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111038142|NCT06009679|Oxytocics|oxytocics|mesh-ancestor
111038143|NCT06009627|Cyclophosphamide|cyclophosphamide|mesh-list
111038144|NCT06009627|Docetaxel|docetaxel|mesh-list
111038145|NCT06009627|Epirubicin|epirubicin|mesh-list
111038146|NCT06009627|Exemestane|exemestane|mesh-list
111038147|NCT06009627|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111038148|NCT06009627|Immunologic Factors|immunologic factors|mesh-ancestor
111038149|NCT06009627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111038150|NCT06009627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111038151|NCT06009627|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111038152|NCT06009627|Alkylating Agents|alkylating agents|mesh-ancestor
110627172|NCT00296647|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111038153|NCT06009627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111038154|NCT06009627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111038155|NCT06009627|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111038156|NCT06009627|Tubulin Modulators|tubulin modulators|mesh-ancestor
111038157|NCT06009627|Antimitotic Agents|antimitotic agents|mesh-ancestor
111038158|NCT06009627|Mitosis Modulators|mitosis modulators|mesh-ancestor
111038159|NCT06009627|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111038160|NCT06009627|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111038161|NCT06009627|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111038162|NCT06009627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111038163|NCT06009627|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111038164|NCT06009627|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111038165|NCT06009627|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111038166|NCT06009627|Hormone Antagonists|hormone antagonists|mesh-ancestor
111038167|NCT06009627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111038168|NCT06009497|Cyclosporine|cyclosporine|mesh-list
111038169|NCT06009497|Cyclosporins|cyclosporins|mesh-list
111038170|NCT06009497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111038171|NCT06009497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111038172|NCT06009497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111038173|NCT06009497|Immunologic Factors|immunologic factors|mesh-ancestor
111038174|NCT06009497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111038175|NCT06009497|Antifungal Agents|antifungal agents|mesh-ancestor
111038176|NCT06009497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111038177|NCT06009497|Dermatologic Agents|dermatologic agents|mesh-ancestor
111038179|NCT06009497|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111038180|NCT06009055|Propofol|propofol|mesh-list
111038181|NCT06009055|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110755234|NCT03951558|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
111038182|NCT06009055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111038183|NCT06009055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111038184|NCT06009055|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111038185|NCT06009055|Anesthetics, General|anesthetics, general|mesh-ancestor
111038186|NCT06009055|Anesthetics|anesthetics|mesh-ancestor
111038187|NCT06009042|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111038188|NCT06009042|gamma-Globulins|gamma-globulins|mesh-list
111038189|NCT06009042|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
111038190|NCT06009042|Immunologic Factors|immunologic factors|mesh-ancestor
111038191|NCT06009042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111038192|NCT06009029|Immunomodulating Agents|immunomodulating agents|mesh-list
111038193|NCT06009029|Immunologic Factors|immunologic factors|mesh-ancestor
111038194|NCT06009029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111038195|NCT06008925|Nivolumab|nivolumab|mesh-list
111038196|NCT06008925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111038197|NCT06008925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111038198|NCT06008925|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111038199|NCT06008925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111038200|NCT06008821|Epinephrine|epinephrine|mesh-list
111038201|NCT06008821|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111038202|NCT06008821|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111038203|NCT06008821|Adrenergic Agents|adrenergic agents|mesh-ancestor
111038204|NCT06008821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111038205|NCT06008821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111038206|NCT06008821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111038207|NCT06008821|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111038208|NCT06008821|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111038209|NCT06008821|Autonomic Agents|autonomic agents|mesh-ancestor
111038210|NCT06008821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111038211|NCT06008821|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111038212|NCT06008821|Respiratory System Agents|respiratory system agents|mesh-ancestor
111038213|NCT06008821|Mydriatics|mydriatics|mesh-ancestor
111038214|NCT06008821|Sympathomimetics|sympathomimetics|mesh-ancestor
111038215|NCT06008821|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111038216|NCT06008795|Dexamethasone|dexamethasone|mesh-list
111038217|NCT06008795|Ropivacaine|ropivacaine|mesh-list
111038218|NCT06008795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111038219|NCT06008795|Antiemetics|antiemetics|mesh-ancestor
111038220|NCT06008795|Autonomic Agents|autonomic agents|mesh-ancestor
111038221|NCT06008795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111038222|NCT06008795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111038223|NCT06008795|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111038224|NCT06008795|Glucocorticoids|glucocorticoids|mesh-ancestor
111038225|NCT06008795|Hormones|hormones|mesh-ancestor
111038226|NCT06008795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111038227|NCT06008795|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111038228|NCT06008795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111038229|NCT06008795|Anesthetics, Local|anesthetics, local|mesh-ancestor
111038230|NCT06008795|Anesthetics|anesthetics|mesh-ancestor
111038231|NCT06008795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111038232|NCT06008795|Sensory System Agents|sensory system agents|mesh-ancestor
111038233|NCT06007378|Fentanyl|fentanyl|mesh-list
111038234|NCT06007378|Ketamine|ketamine|mesh-list
111038235|NCT06007378|Bupivacaine|bupivacaine|mesh-list
111038236|NCT06007378|Anesthetics, Local|anesthetics, local|mesh-ancestor
111038237|NCT06007378|Anesthetics|anesthetics|mesh-ancestor
111038238|NCT06007378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111038239|NCT06007378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111038240|NCT06007378|Sensory System Agents|sensory system agents|mesh-ancestor
111038241|NCT06007378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111038242|NCT06007378|Analgesics|analgesics|mesh-ancestor
111038243|NCT06007378|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111038244|NCT06007378|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111038245|NCT06007378|Anesthetics, General|anesthetics, general|mesh-ancestor
111038246|NCT06007378|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111038247|NCT06007378|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111038248|NCT06007378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111038249|NCT06007378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111038250|NCT06007378|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111038251|NCT06007378|Narcotics|narcotics|mesh-ancestor
111038252|NCT06007378|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111038253|NCT06006273|Irinotecan|irinotecan|mesh-list
111038254|NCT06006273|Temozolomide|temozolomide|mesh-list
111038255|NCT06006273|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111038256|NCT06006273|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111038257|NCT06006273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111038258|NCT06006273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111038259|NCT06006273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111038260|NCT06006273|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111038261|NCT06006273|Alkylating Agents|alkylating agents|mesh-ancestor
111038262|NCT06005597|Ezetimibe|ezetimibe|mesh-list
111038263|NCT06005597|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111038264|NCT06005597|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111038265|NCT06005597|Antimetabolites|antimetabolites|mesh-ancestor
111038266|NCT06005597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111038267|NCT06005597|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111038268|NCT06003621|Atezolizumab|atezolizumab|mesh-list
111038269|NCT06003621|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111038270|NCT06003621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111038271|NCT06003621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111038272|NCT06003621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111038273|NCT05999604|Ocrelizumab|ocrelizumab|mesh-list
111038274|NCT05999604|Immunologic Factors|immunologic factors|mesh-ancestor
111038275|NCT05999604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111038276|NCT05992428|Paroxetine|paroxetine|mesh-list
111038277|NCT05992428|Mirabegron|mirabegron|mesh-list
111038278|NCT05992428|DA-8010|da-8010|mesh-list
111038279|NCT05992428|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111038280|NCT05992428|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111038281|NCT05992428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111038282|NCT05992428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111038283|NCT05992428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111038284|NCT05992428|Serotonin Agents|serotonin agents|mesh-ancestor
111038285|NCT05992428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111038286|NCT05992428|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111038287|NCT05992428|Antidepressive Agents|antidepressive agents|mesh-ancestor
111038288|NCT05992428|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111038289|NCT05992428|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111038290|NCT05992428|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111038291|NCT05992428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111038292|NCT05992428|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
111038293|NCT05992428|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111038294|NCT05992428|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111038295|NCT05992428|Adrenergic Agents|adrenergic agents|mesh-ancestor
111038296|NCT05992428|Urological Agents|urological agents|mesh-ancestor
111038297|NCT05992428|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111038298|NCT05992428|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111038299|NCT05992428|Cholinergic Agents|cholinergic agents|mesh-ancestor
111038300|NCT05981352|Hyaluronic Acid|hyaluronic acid|mesh-list
111038301|NCT05981352|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111038302|NCT05981352|Immunologic Factors|immunologic factors|mesh-ancestor
111038303|NCT05981352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111038304|NCT05981352|Viscosupplements|viscosupplements|mesh-ancestor
111038305|NCT05981352|Protective Agents|protective agents|mesh-ancestor
111038306|NCT05969327|Vitamin D|vitamin d|mesh-list
111038307|NCT05969327|Vitamins|vitamins|mesh-ancestor
111038308|NCT05969327|Micronutrients|micronutrients|mesh-ancestor
111038309|NCT05969327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111038310|NCT05969327|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111038311|NCT05963022|Tirzepatide|tirzepatide|mesh-list
111038312|NCT05963022|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111038313|NCT05963022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111038314|NCT05963022|Incretins|incretins|mesh-ancestor
111038315|NCT05963022|Hormones|hormones|mesh-ancestor
111038316|NCT05963022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111038317|NCT05955261|Cytarabine|cytarabine|mesh-list
111038318|NCT05955261|Fludarabine|fludarabine|mesh-list
111038319|NCT05955261|Fludarabine phosphate|fludarabine phosphate|mesh-list
111038320|NCT05955261|Etoposide|etoposide|mesh-list
111038322|NCT05955261|Daunorubicin|daunorubicin|mesh-list
111038323|NCT05955261|Venetoclax|venetoclax|mesh-list
111038324|NCT05955261|Mitoxantrone|mitoxantrone|mesh-list
111038325|NCT05955261|Idarubicin|idarubicin|mesh-list
111038326|NCT05955261|Gemtuzumab|gemtuzumab|mesh-list
111038327|NCT05955261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111038328|NCT05955261|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111038329|NCT05955261|Antimetabolites|antimetabolites|mesh-ancestor
111038330|NCT05955261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111038331|NCT05955261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111038332|NCT05955261|Immunologic Factors|immunologic factors|mesh-ancestor
111038333|NCT05955261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110755391|NCT01584492|Glucocorticoids|glucocorticoids|mesh-ancestor
111038334|NCT05955261|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111038335|NCT05955261|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111038336|NCT05955261|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111038337|NCT05955261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111038338|NCT05955261|Antiviral Agents|antiviral agents|mesh-ancestor
111038339|NCT05955261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111038340|NCT05955261|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111038341|NCT05955261|Analgesics|analgesics|mesh-ancestor
111038342|NCT05955261|Sensory System Agents|sensory system agents|mesh-ancestor
111038343|NCT05955261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111038344|NCT05955261|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111038345|NCT05955261|Immunotoxins|immunotoxins|mesh-ancestor
111038346|NCT05955261|Immunoconjugates|immunoconjugates|mesh-ancestor
111038347|NCT05945901|Bevacizumab|bevacizumab|mesh-list
111038348|NCT05945901|Oxaliplatin|oxaliplatin|mesh-list
111038349|NCT05945901|Fluorouracil|fluorouracil|mesh-list
111038350|NCT05945901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111038351|NCT05945901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110627192|NCT00523744|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
111038352|NCT05945901|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111038353|NCT05945901|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111038354|NCT05945901|Growth Substances|growth substances|mesh-ancestor
111038355|NCT05945901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111038356|NCT05945901|Growth Inhibitors|growth inhibitors|mesh-ancestor
111038357|NCT05945901|Antimetabolites|antimetabolites|mesh-ancestor
111038358|NCT05945901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111038359|NCT05945901|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111038360|NCT05945901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111038361|NCT05945901|Immunologic Factors|immunologic factors|mesh-ancestor
111038362|NCT05943106|Durvalumab|durvalumab|mesh-list
111038363|NCT05943106|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111038364|NCT05943106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111038365|NCT05938075|Vaccines|vaccines|mesh-list
111038366|NCT05938075|Immunologic Factors|immunologic factors|mesh-ancestor
111038367|NCT05938075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111038368|NCT05920642|Morphine|morphine|mesh-list
111038369|NCT05920642|Analgesics|analgesics|mesh-list
111038370|NCT05920642|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111038371|NCT05920642|Narcotics|narcotics|mesh-ancestor
111038372|NCT05920642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111038373|NCT05920642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111038374|NCT05920642|Sensory System Agents|sensory system agents|mesh-ancestor
111038375|NCT05920642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111038376|NCT05920005|Amlodipine|amlodipine|mesh-list
111038377|NCT05920005|Valsartan|valsartan|mesh-list
111038378|NCT05920005|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
111038379|NCT05920005|Candesartan|candesartan|mesh-list
111038380|NCT05920005|Candesartan cilexetil|candesartan cilexetil|mesh-list
111038381|NCT05920005|Chlorthalidone|chlorthalidone|mesh-list
111038382|NCT05920005|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
111038383|NCT05920005|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111038384|NCT05920005|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111038385|NCT05920005|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111038386|NCT05920005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111038387|NCT05920005|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111038388|NCT05920005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111038389|NCT05920005|Vasodilator Agents|vasodilator agents|mesh-ancestor
111038390|NCT05920005|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111038391|NCT05920005|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111038392|NCT05920005|Diuretics|diuretics|mesh-ancestor
111038393|NCT05920005|Natriuretic Agents|natriuretic agents|mesh-ancestor
111038394|NCT05920005|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
111038396|NCT05918796|Bupivacaine|bupivacaine|mesh-list
111038397|NCT05918796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111038398|NCT05918796|Antiemetics|antiemetics|mesh-ancestor
111038399|NCT05918796|Autonomic Agents|autonomic agents|mesh-ancestor
111038400|NCT05918796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111038401|NCT05918796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111038402|NCT05918796|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111038403|NCT05918796|Glucocorticoids|glucocorticoids|mesh-ancestor
111038404|NCT05918796|Hormones|hormones|mesh-ancestor
111038405|NCT05918796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111038406|NCT05918796|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111038407|NCT05918796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111038408|NCT05918796|Anesthetics, Local|anesthetics, local|mesh-ancestor
111038409|NCT05918796|Anesthetics|anesthetics|mesh-ancestor
111038410|NCT05918796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111038411|NCT05918796|Sensory System Agents|sensory system agents|mesh-ancestor
111038413|NCT05846698|Androgen Antagonists|androgen antagonists|mesh-ancestor
111038414|NCT05846698|Hormone Antagonists|hormone antagonists|mesh-ancestor
111038415|NCT05846698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110627201|NCT00523744|Vasodilator Agents|vasodilator agents|mesh-ancestor
111038416|NCT05846698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111038417|NCT05846698|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111038418|NCT05846698|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111038419|NCT05846698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111038420|NCT05846698|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111038421|NCT05846698|Anabolic Agents|anabolic agents|mesh-ancestor
111038422|NCT05846698|Hormones|hormones|mesh-ancestor
111038423|NCT05815199|Nicotine|nicotine|mesh-list
111038424|NCT05815199|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111038425|NCT05815199|Autonomic Agents|autonomic agents|mesh-ancestor
111038426|NCT05815199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111038427|NCT05815199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111038428|NCT05815199|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111038429|NCT05815199|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111038430|NCT05815199|Cholinergic Agents|cholinergic agents|mesh-ancestor
111038431|NCT05815199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111038432|NCT05815199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111038433|NCT05800600|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
111038434|NCT05800600|Hematinics|hematinics|mesh-ancestor
111038435|NCT05774704|Curcumin|curcumin|mesh-list
111038436|NCT05774704|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111038437|NCT05774704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111038438|NCT05774704|Analgesics|analgesics|mesh-ancestor
111038439|NCT05774704|Sensory System Agents|sensory system agents|mesh-ancestor
111038440|NCT05774704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111038441|NCT05774704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111038442|NCT05774704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111038443|NCT05774704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111038444|NCT05774704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111038445|NCT05774704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111038446|NCT05774704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111038447|NCT05745233|Pembrolizumab|pembrolizumab|mesh-list
111038448|NCT05745233|Nivolumab|nivolumab|mesh-list
111038449|NCT05745233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111038450|NCT05745233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111038451|NCT05745233|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111038452|NCT05745233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111038453|NCT05736224|Sunscreening Agents|sunscreening agents|mesh-list
111038454|NCT05736224|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111038455|NCT05736224|Protective Agents|protective agents|mesh-ancestor
111038456|NCT05736224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111038457|NCT05736224|Dermatologic Agents|dermatologic agents|mesh-ancestor
111038458|NCT05727904|Pembrolizumab|pembrolizumab|mesh-list
111038459|NCT05727904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111038460|NCT05727904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111038461|NCT05727904|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111038462|NCT05727904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111038463|NCT05725382|Remifentanil|remifentanil|mesh-list
111038464|NCT05725382|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111038465|NCT05725382|Narcotics|narcotics|mesh-ancestor
111038466|NCT05725382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111038467|NCT05725382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111038468|NCT05725382|Analgesics|analgesics|mesh-ancestor
111038469|NCT05725382|Sensory System Agents|sensory system agents|mesh-ancestor
111038470|NCT05725382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111038471|NCT05721404|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111038472|NCT05721404|Icodextrin|icodextrin|mesh-list
111038473|NCT05721404|Dialysis Solutions|dialysis solutions|mesh-list
111038474|NCT05710874|Fluorides|fluorides|mesh-list
111038475|NCT05710874|Cariostatic Agents|cariostatic agents|mesh-ancestor
111038476|NCT05710874|Protective Agents|protective agents|mesh-ancestor
111038477|NCT05710874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111038478|NCT05710237|Risperidone|risperidone|mesh-list
111038479|NCT05710237|Psilocybin|psilocybin|mesh-list
111038480|NCT05710237|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111038481|NCT05710237|Serotonin Agents|serotonin agents|mesh-ancestor
111038482|NCT05710237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111038483|NCT05710237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111038484|NCT05710237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111038485|NCT05710237|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111038486|NCT05710237|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111038487|NCT05710237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111038488|NCT05710237|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111038489|NCT05710237|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111038490|NCT05710237|Dopamine Agents|dopamine agents|mesh-ancestor
111038491|NCT05710237|Hallucinogens|hallucinogens|mesh-ancestor
111038492|NCT05696080|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
111038493|NCT05696080|Immunologic Factors|immunologic factors|mesh-ancestor
111038494|NCT05696080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111038495|NCT05691699|Itraconazole|itraconazole|mesh-list
111038496|NCT05691699|Antifungal Agents|antifungal agents|mesh-ancestor
111038497|NCT05691699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111038498|NCT05691699|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111038499|NCT05691699|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111038500|NCT05691699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111038501|NCT05691699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111038502|NCT05691699|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111038503|NCT05691699|Hormone Antagonists|hormone antagonists|mesh-ancestor
111038504|NCT05691699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111038505|NCT05691699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111038506|NCT05691699|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111038507|NCT05684289|Sildenafil Citrate|sildenafil citrate|mesh-list
111038508|NCT05684289|Vasodilator Agents|vasodilator agents|mesh-ancestor
111038509|NCT05684289|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111038510|NCT05684289|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111038511|NCT05684289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111038512|NCT05684289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111038513|NCT05684289|Urological Agents|urological agents|mesh-ancestor
111038514|NCT05677126|Copper|copper|mesh-list
111038515|NCT05677126|Trace Elements|trace elements|mesh-list
111038516|NCT05677126|Selenious Acid|selenious acid|mesh-list
111038517|NCT05677126|Micronutrients|micronutrients|mesh-list
111038518|NCT05677126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111038519|NCT05673187|Adagrasib|adagrasib|mesh-list
111038520|NCT05673187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111038521|NCT05661682|Zinc|zinc|mesh-list
111038522|NCT05661682|Copper|copper|mesh-list
111038523|NCT05661682|Manganese|manganese|mesh-list
111038524|NCT05661682|Trace Elements|trace elements|mesh-list
111038525|NCT05661682|Selenious Acid|selenious acid|mesh-list
111038526|NCT05661682|Micronutrients|micronutrients|mesh-list
111038527|NCT05661682|Copper Sulfate|copper sulfate|mesh-list
111038528|NCT05661682|Zinc Sulfate|zinc sulfate|mesh-list
111038529|NCT05661682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111038530|NCT05661682|Astringents|astringents|mesh-ancestor
111038531|NCT05661682|Dermatologic Agents|dermatologic agents|mesh-ancestor
111038532|NCT05661682|Antidotes|antidotes|mesh-ancestor
111038533|NCT05661682|Protective Agents|protective agents|mesh-ancestor
111038534|NCT05661682|Emetics|emetics|mesh-ancestor
111038535|NCT05661682|Autonomic Agents|autonomic agents|mesh-ancestor
111038536|NCT05661682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111038537|NCT05661682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111038538|NCT05617820|Estradiol|estradiol|mesh-list
111038539|NCT05617820|Estrogens|estrogens|mesh-ancestor
111038540|NCT05617820|Hormones|hormones|mesh-ancestor
111038541|NCT05617820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111038542|NCT05617820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111038543|NCT05609578|Carboplatin|carboplatin|mesh-list
111038544|NCT05609578|Pembrolizumab|pembrolizumab|mesh-list
111038545|NCT05609578|Pemetrexed|pemetrexed|mesh-list
111038546|NCT05609578|Adagrasib|adagrasib|mesh-list
111038547|NCT05609578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111038548|NCT05609578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111038549|NCT05609578|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111038550|NCT05609578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110627222|NCT00752219|Avibactam|avibactam|mesh-list
111038551|NCT05609578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111038552|NCT05609578|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111038553|NCT05609578|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111038554|NCT05607147|Antibodies|antibodies|mesh-list
111038555|NCT05607147|Immunologic Factors|immunologic factors|mesh-ancestor
111038556|NCT05607147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111038557|NCT05579964|Dexmedetomidine|dexmedetomidine|mesh-list
111038558|NCT05579964|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111038559|NCT05579964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111038560|NCT05579964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111038561|NCT05579964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111038562|NCT05579964|Analgesics|analgesics|mesh-ancestor
111038563|NCT05579964|Sensory System Agents|sensory system agents|mesh-ancestor
111038564|NCT05579964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111038565|NCT05579964|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111038566|NCT05579964|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111038568|NCT05579964|Adrenergic Agents|adrenergic agents|mesh-ancestor
111038569|NCT05579964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111038570|NCT05579964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111038571|NCT05567770|Androgens|androgens|mesh-list
111038572|NCT05567770|Hormones|hormones|mesh-ancestor
111038573|NCT05567770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111038574|NCT05567770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111038575|NCT05550337|Trifarotene|trifarotene|mesh-list
111038576|NCT05550337|Dermatologic Agents|dermatologic agents|mesh-ancestor
111038577|NCT05549180|Emtricitabine|emtricitabine|mesh-list
111038578|NCT05549180|Antiviral Agents|antiviral agents|mesh-ancestor
111038579|NCT05549180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111038580|NCT05549180|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111038581|NCT05549180|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111038582|NCT05549180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111038583|NCT05549180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111038584|NCT05549180|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111038585|NCT05549180|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111038586|NCT05514912|Paclitaxel|paclitaxel|mesh-list
111038587|NCT05514912|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111038588|NCT05514912|Cisplatin|cisplatin|mesh-list
111038589|NCT05514912|Gemcitabine|gemcitabine|mesh-list
111038590|NCT05514912|Infigratinib|infigratinib|mesh-list
111038591|NCT05514912|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111038592|NCT05514912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111038593|NCT05514912|Tubulin Modulators|tubulin modulators|mesh-ancestor
111038594|NCT05514912|Antimitotic Agents|antimitotic agents|mesh-ancestor
111038595|NCT05514912|Mitosis Modulators|mitosis modulators|mesh-ancestor
111038596|NCT05514912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111038597|NCT05514912|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111038598|NCT05514912|Antimetabolites|antimetabolites|mesh-ancestor
111038599|NCT05514119|Fenofibrate|fenofibrate|mesh-list
111038600|NCT05514119|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111038601|NCT05514119|Antimetabolites|antimetabolites|mesh-ancestor
111038602|NCT05514119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111038603|NCT05514119|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111038604|NCT05425862|Talazoparib|talazoparib|mesh-list
111038605|NCT05425862|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111038606|NCT05425862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111038607|NCT05425862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111038608|NCT05425862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111038609|NCT05416229|Psilocybin|psilocybin|mesh-list
111038610|NCT05416229|Hallucinogens|hallucinogens|mesh-ancestor
111038611|NCT05416229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111038612|NCT05416229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111038613|NCT05414877|Phenylephrine|phenylephrine|mesh-list
111038614|NCT05414877|Oxymetazoline|oxymetazoline|mesh-list
111038615|NCT05414877|Norepinephrine|norepinephrine|mesh-list
111038616|NCT05414877|Ephedrine|ephedrine|mesh-list
111038617|NCT05414877|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111038618|NCT05414877|Mydriatics|mydriatics|mesh-ancestor
111038619|NCT05414877|Autonomic Agents|autonomic agents|mesh-ancestor
111038620|NCT05414877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111038621|NCT05414877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111038622|NCT05414877|Sympathomimetics|sympathomimetics|mesh-ancestor
111038623|NCT05414877|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111038624|NCT05414877|Nasal Decongestants|nasal decongestants|mesh-ancestor
111038625|NCT05414877|Respiratory System Agents|respiratory system agents|mesh-ancestor
111038626|NCT05414877|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111038627|NCT05414877|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111038628|NCT05414877|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111038629|NCT05414877|Adrenergic Agents|adrenergic agents|mesh-ancestor
111038630|NCT05414877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111038631|NCT05414877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111038632|NCT05414877|Protective Agents|protective agents|mesh-ancestor
111038633|NCT05414877|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111038634|NCT05345327|Metformin|metformin|mesh-list
111038635|NCT05345327|Dapagliflozin|dapagliflozin|mesh-list
111038636|NCT05345327|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111038637|NCT05345327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111038638|NCT05345327|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111038639|NCT05345327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111038640|NCT05305287|Pioglitazone|pioglitazone|mesh-list
111038641|NCT05305287|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111038642|NCT05305287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111038643|NCT05211895|Durvalumab|durvalumab|mesh-list
111038644|NCT05211895|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111038645|NCT05211895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111038646|NCT05188677|Vaccines|vaccines|mesh-list
111038647|NCT05188677|Immunologic Factors|immunologic factors|mesh-ancestor
111038648|NCT05188677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111038649|NCT05177055|Methamphetamine|methamphetamine|mesh-list
111038650|NCT05177055|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111038651|NCT05177055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111038652|NCT05177055|Sympathomimetics|sympathomimetics|mesh-ancestor
111038653|NCT05177055|Autonomic Agents|autonomic agents|mesh-ancestor
111038654|NCT05177055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111038655|NCT05177055|Dopamine Agents|dopamine agents|mesh-ancestor
111038656|NCT05177055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111038657|NCT05177055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111038658|NCT05177055|Adrenergic Agents|adrenergic agents|mesh-ancestor
111038659|NCT05177055|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111038660|NCT05177055|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111038661|NCT05177055|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111038662|NCT05177055|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111038663|NCT05174065|Apremilast|apremilast|mesh-list
111038664|NCT05174065|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111038665|NCT05174065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111038666|NCT05174065|Analgesics|analgesics|mesh-ancestor
111038667|NCT05174065|Sensory System Agents|sensory system agents|mesh-ancestor
111038668|NCT05174065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111038669|NCT05174065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111038670|NCT05174065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111038671|NCT05174065|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111038672|NCT05174065|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
111038673|NCT05174065|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111038674|NCT05174065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111038675|NCT05174065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111038676|NCT05170009|Oseltamivir|oseltamivir|mesh-list
111038677|NCT05170009|Baloxavir|baloxavir|mesh-list
111038678|NCT05170009|Antiviral Agents|antiviral agents|mesh-ancestor
111038679|NCT05170009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111038680|NCT05170009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111038681|NCT05170009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111038682|NCT05159427|Glipizide|glipizide|mesh-list
111038683|NCT05159427|Rifaximin|rifaximin|mesh-list
111038684|NCT05159427|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111038685|NCT05159427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111038686|NCT05159427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111038687|NCT05159427|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111038688|NCT05159427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111038689|NCT05132699|Cannabidiol|cannabidiol|mesh-list
111038690|NCT05132699|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111038691|NCT05132699|Anticonvulsants|anticonvulsants|mesh-ancestor
111038692|NCT05126784|Denosumab|denosumab|mesh-list
111038693|NCT05126784|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111038694|NCT05126784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111038695|NCT05117476|Pembrolizumab|pembrolizumab|mesh-list
111038696|NCT05117476|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111038697|NCT05117476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111038698|NCT05117476|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111038699|NCT05117476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111038700|NCT05033665|Benzocaine|benzocaine|mesh-list
111038701|NCT05033665|Anesthetics, Local|anesthetics, local|mesh-ancestor
111038702|NCT05033665|Anesthetics|anesthetics|mesh-ancestor
111038703|NCT05033665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111038704|NCT05033665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111038705|NCT05033665|Sensory System Agents|sensory system agents|mesh-ancestor
111038706|NCT05033665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111038707|NCT05020236|Dexamethasone|dexamethasone|mesh-list
111038708|NCT05020236|Daratumumab|daratumumab|mesh-list
111038709|NCT05020236|Pomalidomide|pomalidomide|mesh-list
111038710|NCT05020236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111038711|NCT05020236|Antiemetics|antiemetics|mesh-ancestor
110755769|NCT05626140|Diclofenac|diclofenac|mesh-list
111038712|NCT05020236|Autonomic Agents|autonomic agents|mesh-ancestor
111038713|NCT05020236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111038718|NCT05020236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111038719|NCT05020236|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111038720|NCT05020236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111038721|NCT05020236|Immunologic Factors|immunologic factors|mesh-ancestor
111038722|NCT05020236|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111038723|NCT05020236|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111038724|NCT05020236|Growth Substances|growth substances|mesh-ancestor
111038725|NCT05020236|Growth Inhibitors|growth inhibitors|mesh-ancestor
111038729|NCT04934683|Propofol|propofol|mesh-list
111038730|NCT04934683|Etomidate|etomidate|mesh-list
111038731|NCT04934683|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111038732|NCT04934683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111038733|NCT04934683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111038734|NCT04934683|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111038735|NCT04934683|Anesthetics, General|anesthetics, general|mesh-ancestor
111038736|NCT04934683|Anesthetics|anesthetics|mesh-ancestor
111038737|NCT04919629|Bevacizumab|bevacizumab|mesh-list
111038738|NCT04919629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111038739|NCT04919629|Pembrolizumab|pembrolizumab|mesh-list
111038740|NCT04919629|Endothelial Growth Factors|endothelial growth factors|mesh-list
111038741|NCT04919629|Antibodies|antibodies|mesh-list
111038742|NCT04919629|Immunoglobulins|immunoglobulins|mesh-list
111038743|NCT04919629|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111038744|NCT04919629|Immunoglobulin G|immunoglobulin g|mesh-list
111038745|NCT04919629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111038746|NCT04919629|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111038747|NCT04919629|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111038748|NCT04919629|Growth Substances|growth substances|mesh-ancestor
111038749|NCT04919629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111038750|NCT04919629|Growth Inhibitors|growth inhibitors|mesh-ancestor
111038751|NCT04919629|Immunologic Factors|immunologic factors|mesh-ancestor
111038752|NCT04919629|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111038753|NCT04919629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111038754|NCT04902040|Pembrolizumab|pembrolizumab|mesh-list
111038755|NCT04902040|Nivolumab|nivolumab|mesh-list
111038756|NCT04902040|Atezolizumab|atezolizumab|mesh-list
111038757|NCT04902040|Durvalumab|durvalumab|mesh-list
111038758|NCT04902040|Avelumab|avelumab|mesh-list
111038759|NCT04902040|Immunoglobulins|immunoglobulins|mesh-list
111038760|NCT04902040|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111038761|NCT04902040|Immunoglobulin G|immunoglobulin g|mesh-list
111038762|NCT04902040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111038763|NCT04902040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111038764|NCT04902040|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111038765|NCT04902040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111038766|NCT04902040|Immunologic Factors|immunologic factors|mesh-ancestor
111038767|NCT04902040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111038768|NCT04901208|Nicotine|nicotine|mesh-list
111038769|NCT04901208|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111038770|NCT04901208|Autonomic Agents|autonomic agents|mesh-ancestor
111038771|NCT04901208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111038772|NCT04901208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111038773|NCT04901208|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111038774|NCT04901208|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111038775|NCT04901208|Cholinergic Agents|cholinergic agents|mesh-ancestor
111038776|NCT04901208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111038777|NCT04901208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111038778|NCT04821141|Bazedoxifene|bazedoxifene|mesh-list
111038779|NCT04821141|Estrogens|estrogens|mesh-list
111038780|NCT04821141|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
111038781|NCT04821141|Hormones|hormones|mesh-ancestor
111038782|NCT04821141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111038783|NCT04821141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111038784|NCT04821141|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111038785|NCT04821141|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111038786|NCT04821141|Hormone Antagonists|hormone antagonists|mesh-ancestor
111038787|NCT04821141|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111038788|NCT04781855|Nivolumab|nivolumab|mesh-list
111038789|NCT04781855|Ipilimumab|ipilimumab|mesh-list
111038790|NCT04781855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111038791|NCT04781855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111038792|NCT04781855|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111038793|NCT04781855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111038795|NCT04701307|Dostarlimab|dostarlimab|mesh-list
111038796|NCT04701307|Immunoglobulins|immunoglobulins|mesh-list
111038797|NCT04701307|Immunoglobulin G|immunoglobulin g|mesh-list
111038798|NCT04701307|Immunologic Factors|immunologic factors|mesh-ancestor
111038799|NCT04701307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111038800|NCT04701307|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111038801|NCT04701307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111038802|NCT04701307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111038803|NCT04701307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111038804|NCT04673461|Xylometazoline|xylometazoline|mesh-list
111038805|NCT04673461|Nasal Decongestants|nasal decongestants|mesh-ancestor
111038806|NCT04673461|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111038807|NCT04673461|Respiratory System Agents|respiratory system agents|mesh-ancestor
111038808|NCT04673175|Tazobactam|tazobactam|mesh-list
111038809|NCT04673175|Ceftolozane|ceftolozane|mesh-list
111038810|NCT04673175|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
111038811|NCT04673175|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111038812|NCT04673175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111038813|NCT04673175|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
111038814|NCT04673175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111038815|NCT04673175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111038816|NCT04673175|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111038817|NCT04666649|Venetoclax|venetoclax|mesh-list
111038818|NCT04666649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111038819|NCT04634604|Bevacizumab|bevacizumab|mesh-list
111038820|NCT04634604|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111038821|NCT04634604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111038822|NCT04634604|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111038823|NCT04634604|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111038824|NCT04634604|Growth Substances|growth substances|mesh-ancestor
111038825|NCT04634604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111038826|NCT04634604|Growth Inhibitors|growth inhibitors|mesh-ancestor
111038827|NCT04606901|Glycopyrrolate|glycopyrrolate|mesh-list
111038828|NCT04606901|Neostigmine|neostigmine|mesh-list
111038829|NCT04606901|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111038830|NCT04606901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111038831|NCT04606901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111038832|NCT04606901|Cholinergic Agents|cholinergic agents|mesh-ancestor
111038833|NCT04606901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111038834|NCT04606901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111038835|NCT04606901|Parasympathomimetics|parasympathomimetics|mesh-ancestor
111038836|NCT04606901|Autonomic Agents|autonomic agents|mesh-ancestor
111038837|NCT04606901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111038838|NCT04606901|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111038839|NCT04606901|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111038840|NCT04606901|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111038841|NCT04553536|Sufentanil|sufentanil|mesh-list
111038842|NCT04553536|Remifentanil|remifentanil|mesh-list
111038843|NCT04553536|Dsuvia|dsuvia|mesh-list
111038844|NCT04553536|Bromides|bromides|mesh-list
111038845|NCT04553536|Propofol|propofol|mesh-list
111038846|NCT04553536|Esketamine|esketamine|mesh-list
111038847|NCT04553536|Rocuronium|rocuronium|mesh-list
111038848|NCT04553536|Cisatracurium|cisatracurium|mesh-list
111038849|NCT04553536|Atracurium|atracurium|mesh-list
111038850|NCT04553536|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111038851|NCT04553536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111038852|NCT04553536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111038853|NCT04553536|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111038854|NCT04553536|Anesthetics, General|anesthetics, general|mesh-ancestor
111038855|NCT04553536|Anesthetics|anesthetics|mesh-ancestor
111038856|NCT04553536|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111038857|NCT04553536|Narcotics|narcotics|mesh-ancestor
111038858|NCT04553536|Analgesics|analgesics|mesh-ancestor
111038859|NCT04553536|Sensory System Agents|sensory system agents|mesh-ancestor
111038860|NCT04553536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111038861|NCT04553536|Anticonvulsants|anticonvulsants|mesh-ancestor
111038862|NCT04553536|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
111038863|NCT04553536|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
111038864|NCT04553536|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111038865|NCT04553536|Antidepressive Agents|antidepressive agents|mesh-ancestor
111038866|NCT04553536|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111038867|NCT04553536|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
111038868|NCT04553536|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111038869|NCT04553536|Cholinergic Agents|cholinergic agents|mesh-ancestor
111038870|NCT04553536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111038871|NCT04553536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111038872|NCT04553536|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111038873|NCT04545736|Metformin|metformin|mesh-list
111038874|NCT04545736|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111038875|NCT04545736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111038876|NCT04534725|Interferons|interferons|mesh-list
111038877|NCT04534725|Interferon-alpha|interferon-alpha|mesh-list
111038878|NCT04534725|Lenzilumab|lenzilumab|mesh-list
111038879|NCT04534725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111038880|NCT04534725|Antiviral Agents|antiviral agents|mesh-ancestor
111038881|NCT04534725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111038882|NCT04534725|Immunologic Factors|immunologic factors|mesh-ancestor
111038883|NCT04534725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111038884|NCT04534725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111038885|NCT04517851|Elotuzumab|elotuzumab|mesh-list
111038886|NCT04517851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111038887|NCT04489719|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
111038888|NCT04489719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111038889|NCT04463498|Methamphetamine|methamphetamine|mesh-list
111038890|NCT04463498|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111038891|NCT04463498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111038892|NCT04463498|Sympathomimetics|sympathomimetics|mesh-ancestor
111038893|NCT04463498|Autonomic Agents|autonomic agents|mesh-ancestor
111038894|NCT04463498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111038895|NCT04463498|Dopamine Agents|dopamine agents|mesh-ancestor
111038896|NCT04463498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111038897|NCT04463498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111038898|NCT04463498|Adrenergic Agents|adrenergic agents|mesh-ancestor
111038899|NCT04463498|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111038900|NCT04463498|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111038901|NCT04463498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111038902|NCT04463498|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111038903|NCT04439201|Palbociclib|palbociclib|mesh-list
111038904|NCT04439201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111038905|NCT04439201|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111038906|NCT04439201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111038907|NCT04439201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111038908|NCT04385433|Pravastatin|pravastatin|mesh-list
111038909|NCT04385433|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111038910|NCT04385433|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111038911|NCT04385433|Antimetabolites|antimetabolites|mesh-ancestor
111038912|NCT04385433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111038913|NCT04385433|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111038914|NCT04385433|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111038915|NCT04385433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111038916|NCT04362839|Nivolumab|nivolumab|mesh-list
111038917|NCT04362839|Ipilimumab|ipilimumab|mesh-list
111038918|NCT04362839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111038919|NCT04362839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111038920|NCT04362839|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111038921|NCT04362839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111038922|NCT04362111|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
111038923|NCT04362111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111038924|NCT04331288|Ethanol|ethanol|mesh-list
111038925|NCT04331288|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111038926|NCT04331288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111038927|NCT04331288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111038928|NCT04331288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111038929|NCT04284761|Bicalutamide|bicalutamide|mesh-list
111038930|NCT04284761|Androgen Antagonists|androgen antagonists|mesh-ancestor
111038931|NCT04284761|Hormone Antagonists|hormone antagonists|mesh-ancestor
111038932|NCT04284761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111038933|NCT04284761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111038934|NCT04284761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111038935|NCT04275024|Calcipotriene|calcipotriene|mesh-list
111038936|NCT04275024|Dermatologic Agents|dermatologic agents|mesh-ancestor
111038938|NCT04259255|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111038939|NCT04259255|Antioxidants|antioxidants|mesh-ancestor
111038940|NCT04259255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111038941|NCT04259255|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111038942|NCT04259255|Protective Agents|protective agents|mesh-ancestor
111038943|NCT04259255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111038945|NCT04169763|Cisplatin|cisplatin|mesh-list
111038946|NCT04169763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111038947|NCT04169763|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111038948|NCT04169763|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111038949|NCT04169763|Protease Inhibitors|protease inhibitors|mesh-ancestor
111038950|NCT04169763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111038951|NCT04169763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111038952|NCT04169763|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111038953|NCT04169763|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111038954|NCT04169763|Antiviral Agents|antiviral agents|mesh-ancestor
111038955|NCT04169763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111038956|NCT04151082|Prednisone|prednisone|mesh-list
111038957|NCT04151082|Methylprednisolone|methylprednisolone|mesh-list
111038958|NCT04151082|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111038959|NCT04151082|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111038960|NCT04151082|Prednisolone|prednisolone|mesh-list
111038961|NCT04151082|Prednisolone acetate|prednisolone acetate|mesh-list
111038962|NCT04151082|Cortisone|cortisone|mesh-list
111038963|NCT04151082|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111038964|NCT04151082|Prednisolone phosphate|prednisolone phosphate|mesh-list
111038965|NCT04151082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111038966|NCT04151082|Glucocorticoids|glucocorticoids|mesh-ancestor
111038967|NCT04151082|Hormones|hormones|mesh-ancestor
111038968|NCT04151082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111038969|NCT04151082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111038970|NCT04151082|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111038971|NCT04151082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111038972|NCT04151082|Antiemetics|antiemetics|mesh-ancestor
111038973|NCT04151082|Autonomic Agents|autonomic agents|mesh-ancestor
111038974|NCT04151082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111038975|NCT04151082|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111038976|NCT04151082|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111038977|NCT04151082|Protective Agents|protective agents|mesh-ancestor
111038978|NCT04146935|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111038979|NCT04146935|Immunologic Factors|immunologic factors|mesh-ancestor
111038980|NCT04146935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111038981|NCT04128748|Cytarabine|cytarabine|mesh-list
111038982|NCT04128748|Daunorubicin|daunorubicin|mesh-list
111038983|NCT04128748|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111038984|NCT04128748|Antimetabolites|antimetabolites|mesh-ancestor
111038985|NCT04128748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111038986|NCT04128748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111038987|NCT04128748|Antiviral Agents|antiviral agents|mesh-ancestor
111038988|NCT04128748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111038989|NCT04128748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111038990|NCT04128748|Immunologic Factors|immunologic factors|mesh-ancestor
111038991|NCT04128748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111038992|NCT04128748|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111038993|NCT04128748|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111038994|NCT04128748|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111038995|NCT04128748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111038996|NCT04069156|Aspirin|aspirin|mesh-list
111038997|NCT04069156|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111038998|NCT04069156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111038999|NCT04069156|Analgesics|analgesics|mesh-ancestor
111039000|NCT04069156|Sensory System Agents|sensory system agents|mesh-ancestor
111039001|NCT04069156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111039002|NCT04069156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111039003|NCT04069156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111039004|NCT04069156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111039005|NCT04069156|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111039006|NCT04069156|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111039007|NCT04069156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111039008|NCT04069156|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111039009|NCT04069156|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111039010|NCT04069156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111039011|NCT04069156|Antipyretics|antipyretics|mesh-ancestor
111039012|NCT04030455|Cisplatin|cisplatin|mesh-list
111039013|NCT04030455|Carboplatin|carboplatin|mesh-list
111039014|NCT04030455|Docetaxel|docetaxel|mesh-list
111039015|NCT04030455|Pembrolizumab|pembrolizumab|mesh-list
111039016|NCT04030455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111039017|NCT04030455|Tubulin Modulators|tubulin modulators|mesh-ancestor
111039018|NCT04030455|Antimitotic Agents|antimitotic agents|mesh-ancestor
111039019|NCT04030455|Mitosis Modulators|mitosis modulators|mesh-ancestor
111039020|NCT04030455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111039021|NCT04030455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111039022|NCT04030455|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111039023|NCT04011345|Folic Acid|folic acid|mesh-list
111039024|NCT04011345|Hematinics|hematinics|mesh-ancestor
111039025|NCT04011345|Vitamin B Complex|vitamin b complex|mesh-ancestor
111039026|NCT04011345|Vitamins|vitamins|mesh-ancestor
111039027|NCT04011345|Micronutrients|micronutrients|mesh-ancestor
111039028|NCT04011345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111039029|NCT04002297|Rituximab|rituximab|mesh-list
111039030|NCT04002297|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
111039031|NCT04002297|Zanubrutinib|zanubrutinib|mesh-list
111039032|NCT04002297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111039033|NCT04002297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111039034|NCT04002297|Immunologic Factors|immunologic factors|mesh-ancestor
111039035|NCT04002297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111039036|NCT04002297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111039037|NCT04002297|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111039038|NCT04002297|Alkylating Agents|alkylating agents|mesh-ancestor
111039039|NCT04002297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111039040|NCT04002297|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111039041|NCT04002297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111039042|NCT03993353|Pembrolizumab|pembrolizumab|mesh-list
111039043|NCT03993353|Tadalafil|tadalafil|mesh-list
111039044|NCT03993353|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111039045|NCT03993353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111039046|NCT03993353|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111039047|NCT03993353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111039048|NCT03993353|Vasodilator Agents|vasodilator agents|mesh-ancestor
111039049|NCT03993353|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111039050|NCT03993353|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111039051|NCT03993353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111039052|NCT03993353|Urological Agents|urological agents|mesh-ancestor
111039053|NCT03970837|Tofacitinib|tofacitinib|mesh-list
111039054|NCT03970837|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
111039055|NCT03970837|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111039056|NCT03970837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111039057|NCT03970837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111039058|NCT03945357|Clindamycin|clindamycin|mesh-list
111039059|NCT03945357|Clindamycin palmitate|clindamycin palmitate|mesh-list
111039060|NCT03945357|Clindamycin phosphate|clindamycin phosphate|mesh-list
111039061|NCT03945357|Gemcitabine|gemcitabine|mesh-list
111039062|NCT03945357|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111039063|NCT03945357|Antimetabolites|antimetabolites|mesh-ancestor
111039064|NCT03945357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111039065|NCT03945357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111039066|NCT03945357|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111039067|NCT03945357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111039068|NCT03945357|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111039069|NCT03945357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111039070|NCT03896009|Meloxicam|meloxicam|mesh-list
111039071|NCT03896009|Rizatriptan|rizatriptan|mesh-list
111039072|NCT03896009|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111039073|NCT03896009|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111039074|NCT03896009|Analgesics|analgesics|mesh-ancestor
111039075|NCT03896009|Sensory System Agents|sensory system agents|mesh-ancestor
111039076|NCT03896009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111039077|NCT03896009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111039078|NCT03896009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111039079|NCT03896009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111039080|NCT03896009|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111039081|NCT03896009|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111039082|NCT03896009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111039083|NCT03896009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111039084|NCT03896009|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111039085|NCT03896009|Serotonin Agents|serotonin agents|mesh-ancestor
111039086|NCT03896009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111039087|NCT03744975|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
111039088|NCT03744975|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111039089|NCT03744975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111039090|NCT03606174|Pembrolizumab|pembrolizumab|mesh-list
111039091|NCT03606174|Nivolumab|nivolumab|mesh-list
111039092|NCT03606174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111039093|NCT03606174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111039094|NCT03606174|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111039095|NCT03606174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111039096|NCT03450707|Thiamine|thiamine|mesh-list
111039097|NCT03450707|Vitamins|vitamins|mesh-ancestor
111039098|NCT03450707|Micronutrients|micronutrients|mesh-ancestor
111039099|NCT03450707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111039100|NCT03450707|Vitamin B Complex|vitamin b complex|mesh-ancestor
111039101|NCT03392311|Calcipotriene|calcipotriene|mesh-list
111039102|NCT03392311|Dermatologic Agents|dermatologic agents|mesh-ancestor
111039103|NCT03337009|Naloxone|naloxone|mesh-list
111039104|NCT03337009|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111039105|NCT03337009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111039106|NCT03337009|Sensory System Agents|sensory system agents|mesh-ancestor
111039107|NCT03337009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111039108|NCT03324373|Everolimus|everolimus|mesh-list
111039109|NCT03324373|Lenvatinib|lenvatinib|mesh-list
111039110|NCT03324373|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111039111|NCT03324373|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111039112|NCT03324373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111039113|NCT03324373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111039114|NCT03324373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111039115|NCT03324373|Immunologic Factors|immunologic factors|mesh-ancestor
111039116|NCT03324373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111039117|NCT03324373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111039118|NCT03322865|Obinutuzumab|obinutuzumab|mesh-list
111039119|NCT03322865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111039120|NCT03322865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111039121|NCT03296527|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
111039122|NCT03296527|Hormones|hormones|mesh-ancestor
111039123|NCT03296527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111039124|NCT03296527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111039125|NCT03267498|Nivolumab|nivolumab|mesh-list
111039126|NCT03267498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111039127|NCT03267498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111039128|NCT03267498|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111039129|NCT03267498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111039130|NCT03258567|Nivolumab|nivolumab|mesh-list
111039131|NCT03258567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111039132|NCT03258567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111039133|NCT03258567|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111039134|NCT03258567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111039135|NCT03241771|Naloxone|naloxone|mesh-list
111039136|NCT03241771|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111039137|NCT03241771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111039138|NCT03241771|Sensory System Agents|sensory system agents|mesh-ancestor
111039139|NCT03241771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111039140|NCT03228680|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
111039141|NCT03228680|Hormones|hormones|mesh-ancestor
111039142|NCT03228680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111039143|NCT03228680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111039144|NCT03194542|Luspatercept|luspatercept|mesh-list
111039145|NCT03194542|Hematinics|hematinics|mesh-ancestor
111039146|NCT03160079|Pembrolizumab|pembrolizumab|mesh-list
111039147|NCT03160079|Blinatumomab|blinatumomab|mesh-list
111039148|NCT03160079|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111039149|NCT03160079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111039150|NCT03160079|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111039151|NCT03160079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111039152|NCT03083808|Pembrolizumab|pembrolizumab|mesh-list
111039153|NCT03083808|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111039154|NCT03083808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111039155|NCT03083808|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111039156|NCT03083808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111039157|NCT03047330|Leuprolide|leuprolide|mesh-list
111039158|NCT03047330|Estradiol|estradiol|mesh-list
111039159|NCT03047330|Estrogens|estrogens|mesh-ancestor
111039160|NCT03047330|Hormones|hormones|mesh-ancestor
111039161|NCT03047330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111039162|NCT03047330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111039163|NCT03047330|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111039164|NCT03047330|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111039165|NCT03047330|Fertility Agents|fertility agents|mesh-ancestor
111039166|NCT03047330|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111039167|NCT03047330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111039169|NCT02762266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111039170|NCT02717611|Acalabrutinib|acalabrutinib|mesh-list
111039171|NCT02717611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111039172|NCT02707926|Anti-HIV Agents|anti-hiv agents|mesh-list
111039173|NCT02707926|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111039174|NCT02707926|Antiviral Agents|antiviral agents|mesh-ancestor
111039175|NCT02707926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111039176|NCT02608216|Paclitaxel|paclitaxel|mesh-list
111039177|NCT02608216|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111039178|NCT02608216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111039179|NCT02608216|Tubulin Modulators|tubulin modulators|mesh-ancestor
111039180|NCT02608216|Antimitotic Agents|antimitotic agents|mesh-ancestor
111039181|NCT02608216|Mitosis Modulators|mitosis modulators|mesh-ancestor
111039182|NCT02608216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111039183|NCT02511028|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
111039184|NCT02511028|Hematinics|hematinics|mesh-ancestor
111039185|NCT02511028|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
111039186|NCT02511028|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111039187|NCT02362035|Pembrolizumab|pembrolizumab|mesh-list
111039188|NCT02362035|Acalabrutinib|acalabrutinib|mesh-list
111039189|NCT02362035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111039190|NCT02362035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111039191|NCT02362035|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111039192|NCT02362035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111039193|NCT02328014|Acalabrutinib|acalabrutinib|mesh-list
111039194|NCT02328014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111039195|NCT02213926|Acalabrutinib|acalabrutinib|mesh-list
111039196|NCT02213926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111039197|NCT02180724|Acalabrutinib|acalabrutinib|mesh-list
111039198|NCT02180724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111039199|NCT02125786|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
111039200|NCT02125786|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111039201|NCT02125786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111039202|NCT02107963|Cyclophosphamide|cyclophosphamide|mesh-list
111039203|NCT02107963|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110827450|NCT00009737|Antidotes|antidotes|mesh-ancestor
111039204|NCT02107963|Immunologic Factors|immunologic factors|mesh-ancestor
111039205|NCT02107963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111039206|NCT02107963|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111039207|NCT02107963|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111039208|NCT02107963|Alkylating Agents|alkylating agents|mesh-ancestor
111039209|NCT02107963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111039210|NCT02107963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111039211|NCT02107963|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111039212|NCT01419561|Zidovudine|zidovudine|mesh-list
111039213|NCT01419561|Rituximab|rituximab|mesh-list
111039214|NCT01419561|Doxorubicin|doxorubicin|mesh-list
111039215|NCT01419561|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111039216|NCT01419561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111039217|NCT01419561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111039218|NCT01419561|Immunologic Factors|immunologic factors|mesh-ancestor
111039219|NCT01419561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111039220|NCT01419561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111039221|NCT01419561|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111039222|NCT01419561|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111039223|NCT01419561|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111039224|NCT01419561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111039225|NCT01419561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111039226|NCT01419561|Antimetabolites|antimetabolites|mesh-ancestor
111039227|NCT01419561|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111039228|NCT01419561|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111039229|NCT01419561|Antiviral Agents|antiviral agents|mesh-ancestor
111039230|NCT01419561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111039231|NCT01419561|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111039232|NCT01419561|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111039233|NCT01311713|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
111039234|NCT01311713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111039235|NCT01311713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111039236|NCT01311713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111039237|NCT00390325|Sorafenib|sorafenib|mesh-list
111039238|NCT00390325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111039239|NCT00390325|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110756283|NCT00229931|Glucocorticoids|glucocorticoids|mesh-ancestor
111039240|NCT00390325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111039241|NCT00390325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111039243|NCT00381641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111039244|NCT00381641|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111039245|NCT00381641|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111039246|NCT00381641|Growth Substances|growth substances|mesh-ancestor
111039247|NCT00381641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111039248|NCT00381641|Growth Inhibitors|growth inhibitors|mesh-ancestor
111039249|NCT00381641|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111039250|NCT00381641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111039251|NCT00381641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111039252|NCT00265798|Sorafenib|sorafenib|mesh-list
111039253|NCT00265798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111039254|NCT00265798|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111039255|NCT00265798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111039256|NCT00265798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111039257|NCT00114101|Lenalidomide|lenalidomide|mesh-list
111039258|NCT00114101|Melphalan|melphalan|mesh-list
111039259|NCT00114101|Mechlorethamine|mechlorethamine|mesh-list
111039260|NCT00114101|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
111039261|NCT00114101|Immunologic Factors|immunologic factors|mesh-ancestor
111039262|NCT00114101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111039263|NCT00114101|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111039264|NCT00114101|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111039265|NCT00114101|Growth Substances|growth substances|mesh-ancestor
111039266|NCT00114101|Growth Inhibitors|growth inhibitors|mesh-ancestor
111039267|NCT00114101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111039268|NCT00114101|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111039269|NCT00114101|Alkylating Agents|alkylating agents|mesh-ancestor
111039270|NCT00114101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111039271|NCT00114101|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111039272|NCT00114101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111039273|NCT03538171|Exemestane|exemestane|mesh-list
111039274|NCT03538171|Entinostat|entinostat|mesh-list
111039275|NCT03538171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111039276|NCT03538171|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111039277|NCT03538171|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111039278|NCT03538171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111039279|NCT03538171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111039280|NCT03538171|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111039281|NCT03538171|Hormone Antagonists|hormone antagonists|mesh-ancestor
111039282|NCT03538171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111039283|NCT03538171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111039284|NCT03538171|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111039285|NCT05312216|Durvalumab|durvalumab|mesh-list
111039286|NCT05312216|Lenvatinib|lenvatinib|mesh-list
111039287|NCT05312216|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111039288|NCT05312216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111039289|NCT05312216|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111039290|NCT05312216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111039291|NCT05312216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111039292|NCT02256319|Dexmedetomidine|dexmedetomidine|mesh-list
111039293|NCT02256319|Propofol|propofol|mesh-list
111039294|NCT02256319|Imidazole|imidazole|mesh-list
111039295|NCT02256319|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111039296|NCT02256319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111039297|NCT02256319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111039298|NCT02256319|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111039299|NCT02256319|Analgesics|analgesics|mesh-ancestor
111039300|NCT02256319|Sensory System Agents|sensory system agents|mesh-ancestor
111039301|NCT02256319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111039302|NCT02256319|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111039303|NCT02256319|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111039304|NCT02256319|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111039305|NCT02256319|Adrenergic Agents|adrenergic agents|mesh-ancestor
111039306|NCT02256319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111039307|NCT02256319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111039308|NCT02256319|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111039309|NCT02256319|Anesthetics, General|anesthetics, general|mesh-ancestor
111039310|NCT02256319|Anesthetics|anesthetics|mesh-ancestor
111039311|NCT02256319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111039312|NCT04510285|Pembrolizumab|pembrolizumab|mesh-list
111039313|NCT04510285|Trastuzumab|trastuzumab|mesh-list
111039314|NCT04510285|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111039315|NCT04510285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111039316|NCT04510285|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111039317|NCT04510285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111039319|NCT05450432|Esketamine|esketamine|mesh-list
111039320|NCT05450432|Analgesics|analgesics|mesh-ancestor
111039321|NCT05450432|Sensory System Agents|sensory system agents|mesh-ancestor
111039322|NCT05450432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111039323|NCT05450432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111039324|NCT05450432|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111039325|NCT05450432|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111039326|NCT05450432|Anesthetics, General|anesthetics, general|mesh-ancestor
111039327|NCT05450432|Anesthetics|anesthetics|mesh-ancestor
111039328|NCT05450432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111039329|NCT05450432|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111039330|NCT05450432|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111039331|NCT05450432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111039332|NCT05450432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111039333|NCT05450432|Antidepressive Agents|antidepressive agents|mesh-ancestor
111039334|NCT05450432|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111039335|NCT02179255|Hormones|hormones|mesh-list
111039336|NCT02179255|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
111039337|NCT02179255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111039338|NCT02179255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111039339|NCT02182063|Nintedanib|nintedanib|mesh-list
111039340|NCT02182063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111039341|NCT02182063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111039342|NCT02182063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111039343|NCT02182063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111039344|NCT02182141|Nintedanib|nintedanib|mesh-list
111039345|NCT02182141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111039346|NCT02182141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111039347|NCT02182141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111039348|NCT02182141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111039350|NCT02182219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111039351|NCT02182219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111039352|NCT02182219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111039353|NCT02182219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111039354|NCT05303480|Mechlorethamine|mechlorethamine|mesh-list
111039355|NCT05303480|Alkylating Agents|alkylating agents|mesh-ancestor
111039356|NCT05303480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111039357|NCT05303480|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111039358|NCT05303480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111039359|NCT02182375|Raltegravir Potassium|raltegravir potassium|mesh-list
111039360|NCT02182375|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111039361|NCT02182375|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111039362|NCT02182375|Antiviral Agents|antiviral agents|mesh-ancestor
111039363|NCT02182375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111039364|NCT02182375|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111039365|NCT02182375|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111039366|NCT02182375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111039367|NCT02182375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111039368|NCT02179567|Bevacizumab|bevacizumab|mesh-list
111039369|NCT02179567|Docetaxel|docetaxel|mesh-list
111039370|NCT02179567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111039371|NCT02179567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111039372|NCT02179567|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111039373|NCT02179567|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111039374|NCT02179567|Growth Substances|growth substances|mesh-ancestor
111039375|NCT02179567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111039376|NCT02179567|Growth Inhibitors|growth inhibitors|mesh-ancestor
111039377|NCT02179567|Tubulin Modulators|tubulin modulators|mesh-ancestor
111039378|NCT02179567|Antimitotic Agents|antimitotic agents|mesh-ancestor
111039379|NCT02179567|Mitosis Modulators|mitosis modulators|mesh-ancestor
111039380|NCT02179567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111039381|NCT02182453|Empagliflozin|empagliflozin|mesh-list
111039382|NCT02182453|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111039383|NCT02182453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111039384|NCT02182453|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111039385|NCT02182453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111039386|NCT02182531|Pseudoephedrine|pseudoephedrine|mesh-list
111039387|NCT02182531|Ephedrine|ephedrine|mesh-list
111039388|NCT02182531|Epinastine|epinastine|mesh-list
111039389|NCT02182531|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111039390|NCT02182531|Autonomic Agents|autonomic agents|mesh-ancestor
111039391|NCT02182531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111039392|NCT02182531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111039393|NCT02182531|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111039394|NCT02182531|Respiratory System Agents|respiratory system agents|mesh-ancestor
111039395|NCT02182531|Nasal Decongestants|nasal decongestants|mesh-ancestor
111039396|NCT02182531|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111039397|NCT02182531|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111039398|NCT02182531|Sympathomimetics|sympathomimetics|mesh-ancestor
111039399|NCT02182531|Adrenergic Agents|adrenergic agents|mesh-ancestor
111039400|NCT02182531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111039401|NCT02182531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111039402|NCT02182531|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111039403|NCT02182531|Histamine Antagonists|histamine antagonists|mesh-ancestor
111039404|NCT02182531|Histamine Agents|histamine agents|mesh-ancestor
111039405|NCT02177305|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111039406|NCT02177305|Tiotropium Bromide|tiotropium bromide|mesh-list
111039407|NCT02177305|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111039408|NCT02177305|Autonomic Agents|autonomic agents|mesh-ancestor
111039409|NCT02177305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111039410|NCT02177305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111039411|NCT02177305|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111039412|NCT02177305|Respiratory System Agents|respiratory system agents|mesh-ancestor
111039413|NCT02177305|Parasympatholytics|parasympatholytics|mesh-ancestor
111039414|NCT02177305|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111039415|NCT02177305|Cholinergic Agents|cholinergic agents|mesh-ancestor
111039416|NCT02177305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111039417|NCT02177305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111039418|NCT02182765|Nevirapine|nevirapine|mesh-list
111039419|NCT02182765|Abacavir|abacavir|mesh-list
111039420|NCT02182765|Amprenavir|amprenavir|mesh-list
110504429|NCT05041127|Immunoglobulins|immunoglobulins|mesh-list
111039421|NCT02182765|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111039422|NCT02182765|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111039423|NCT02182765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111039424|NCT02182765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111039425|NCT02182765|Antiviral Agents|antiviral agents|mesh-ancestor
111039426|NCT02182765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111039427|NCT02182765|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111039428|NCT02182765|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111039429|NCT02182765|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111039430|NCT02182765|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111039431|NCT02182765|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111039432|NCT02182765|Antitubercular Agents|antitubercular agents|mesh-ancestor
111039433|NCT02182765|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111039434|NCT02182765|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111039435|NCT02182765|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111039436|NCT02182765|Protease Inhibitors|protease inhibitors|mesh-ancestor
111039437|NCT02179645|Celecoxib|celecoxib|mesh-list
111039438|NCT02179645|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111039439|NCT02179645|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111039440|NCT02179645|Analgesics|analgesics|mesh-ancestor
111039441|NCT02179645|Sensory System Agents|sensory system agents|mesh-ancestor
111039442|NCT02179645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111039443|NCT02179645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111039444|NCT02179645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111039445|NCT02179645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111039446|NCT02179645|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111039447|NCT02179645|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111039448|NCT02179645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111039449|NCT02179645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111039450|NCT03537157|Rifaximin|rifaximin|mesh-list
111039451|NCT03537157|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111039452|NCT03537157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111039453|NCT03537157|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111039454|NCT01606202|Nabiximols|nabiximols|mesh-list
111039455|NCT01606202|Analgesics|analgesics|mesh-ancestor
111039456|NCT01606202|Sensory System Agents|sensory system agents|mesh-ancestor
111039457|NCT01606202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111039458|NCT01606202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111039459|NCT03536611|Warfarin|warfarin|mesh-list
111039460|NCT03536611|Dabigatran|dabigatran|mesh-list
111039461|NCT03536611|Anticoagulants|anticoagulants|mesh-ancestor
111039462|NCT03536611|Antithrombins|antithrombins|mesh-ancestor
111039463|NCT03536611|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111039464|NCT03536611|Protease Inhibitors|protease inhibitors|mesh-ancestor
111039465|NCT03536611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111039466|NCT03536611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111039467|NCT02630459|Erenumab|erenumab|mesh-list
111039468|NCT02630459|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111039469|NCT02630459|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
111039470|NCT02630459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111039471|NCT02630459|Analgesics|analgesics|mesh-ancestor
111039472|NCT02630459|Sensory System Agents|sensory system agents|mesh-ancestor
111039473|NCT02630459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111039474|NCT02630459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111039475|NCT02630459|Immunologic Factors|immunologic factors|mesh-ancestor
111039476|NCT02183077|Meloxicam|meloxicam|mesh-list
111039477|NCT02183077|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111039478|NCT02183077|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111039479|NCT02183077|Analgesics|analgesics|mesh-ancestor
111039480|NCT02183077|Sensory System Agents|sensory system agents|mesh-ancestor
111039481|NCT02183077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111039482|NCT02183077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111039483|NCT02183077|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111039484|NCT02183077|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111039485|NCT02183077|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111039486|NCT02183077|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111039487|NCT02183077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111039488|NCT02183077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111039489|NCT02183155|Indomethacin|indomethacin|mesh-list
111039490|NCT02183155|Meloxicam|meloxicam|mesh-list
111039491|NCT02183155|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111039492|NCT02183155|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111039493|NCT02183155|Analgesics|analgesics|mesh-ancestor
111039494|NCT02183155|Sensory System Agents|sensory system agents|mesh-ancestor
111039495|NCT02183155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111039496|NCT02183155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111039497|NCT02183155|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111039498|NCT02183155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111039499|NCT02183155|Gout Suppressants|gout suppressants|mesh-ancestor
111039500|NCT02183155|Tocolytic Agents|tocolytic agents|mesh-ancestor
111039501|NCT02183155|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111039502|NCT02183155|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111039503|NCT02183155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111039504|NCT02183155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111039505|NCT02183155|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111039506|NCT02177461|Telmisartan|telmisartan|mesh-list
111039507|NCT02177461|Clonidine|clonidine|mesh-list
111039508|NCT02177461|Enalapril|enalapril|mesh-list
111039509|NCT02177461|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111039510|NCT02177461|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111039511|NCT02177461|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111039512|NCT02177461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111039513|NCT02177461|Analgesics|analgesics|mesh-ancestor
111039514|NCT02177461|Sensory System Agents|sensory system agents|mesh-ancestor
111039515|NCT02177461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111039516|NCT02177461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111039517|NCT02177461|Sympatholytics|sympatholytics|mesh-ancestor
111039518|NCT02177461|Autonomic Agents|autonomic agents|mesh-ancestor
111039519|NCT02177461|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111039520|NCT02177461|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111039521|NCT02177461|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111039522|NCT02177461|Adrenergic Agents|adrenergic agents|mesh-ancestor
111039523|NCT02177461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111039524|NCT02177461|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
111039525|NCT02177461|Protease Inhibitors|protease inhibitors|mesh-ancestor
111039526|NCT02177461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111039527|NCT03545243|Pantoprazole|pantoprazole|mesh-list
111039528|NCT03545243|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111039529|NCT03545243|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111039530|NCT03545243|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111039531|NCT03545243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111039532|NCT03545243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111039533|NCT02183311|Linagliptin|linagliptin|mesh-list
111039534|NCT02183311|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110756588|NCT03615664|Hormones|hormones|mesh-ancestor
111039535|NCT02183311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111039536|NCT02183311|Incretins|incretins|mesh-ancestor
111039537|NCT02183311|Hormones|hormones|mesh-ancestor
111039538|NCT02183311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111039539|NCT02183311|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111039540|NCT02183311|Protease Inhibitors|protease inhibitors|mesh-ancestor
111039541|NCT02183311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111039542|NCT02183311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111039543|NCT05518526|Annamycin|annamycin|mesh-list
111039544|NCT05518526|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111039545|NCT05518526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111039546|NCT01464593|Doxorubicin|doxorubicin|mesh-list
111039547|NCT01464593|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111039548|NCT01464593|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111039549|NCT01464593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111039550|NCT01464593|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111039551|NCT01464593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111039552|NCT01464593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111039553|NCT01464593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111039554|NCT02183389|Linagliptin|linagliptin|mesh-list
111039555|NCT02183389|Warfarin|warfarin|mesh-list
111039556|NCT02183389|Anticoagulants|anticoagulants|mesh-ancestor
111039557|NCT02183389|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111039558|NCT02183389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111039559|NCT02183389|Incretins|incretins|mesh-ancestor
111039560|NCT02183389|Hormones|hormones|mesh-ancestor
111039561|NCT02183389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111039562|NCT02183389|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111039563|NCT02183389|Protease Inhibitors|protease inhibitors|mesh-ancestor
111039564|NCT02183389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111119154|NCT05323617|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111039565|NCT02183389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111039566|NCT02177539|Phenylephrine|phenylephrine|mesh-list
111039567|NCT02177539|Oxymetazoline|oxymetazoline|mesh-list
111039568|NCT02177539|Tropicamide|tropicamide|mesh-list
111039569|NCT02177539|Cyclopentolate|cyclopentolate|mesh-list
111039570|NCT02177539|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111039571|NCT02177539|Mydriatics|mydriatics|mesh-ancestor
111039572|NCT02177539|Autonomic Agents|autonomic agents|mesh-ancestor
111039573|NCT02177539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111039574|NCT02177539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111039575|NCT02177539|Sympathomimetics|sympathomimetics|mesh-ancestor
111039576|NCT02177539|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111039577|NCT02177539|Nasal Decongestants|nasal decongestants|mesh-ancestor
111039578|NCT02177539|Respiratory System Agents|respiratory system agents|mesh-ancestor
111039579|NCT02177539|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111039580|NCT02177539|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111039581|NCT02177539|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111039582|NCT02177539|Adrenergic Agents|adrenergic agents|mesh-ancestor
111039583|NCT02177539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111039584|NCT02177539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111039585|NCT02177539|Protective Agents|protective agents|mesh-ancestor
111039586|NCT02177539|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111039587|NCT02177539|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111039588|NCT02177539|Cholinergic Agents|cholinergic agents|mesh-ancestor
111039589|NCT02177539|Parasympatholytics|parasympatholytics|mesh-ancestor
111039590|NCT04141904|Tofacitinib|tofacitinib|mesh-list
111039591|NCT04141904|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
111039592|NCT04141904|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111039593|NCT04141904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111039594|NCT04141904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111039595|NCT01361711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111039596|NCT01361711|Alemtuzumab|alemtuzumab|mesh-list
111039597|NCT01361711|Ofatumumab|ofatumumab|mesh-list
111039598|NCT01361711|Antibodies|antibodies|mesh-list
111039599|NCT01361711|Immunoglobulins|immunoglobulins|mesh-list
111039600|NCT01361711|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111039601|NCT01361711|Immunologic Factors|immunologic factors|mesh-ancestor
111039602|NCT01361711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111039603|NCT01361711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111039604|NCT05517746|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111039605|NCT05527340|Dexamethasone|dexamethasone|mesh-list
111039606|NCT05527340|Daratumumab|daratumumab|mesh-list
111039607|NCT05527340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111039608|NCT05527340|Antiemetics|antiemetics|mesh-ancestor
110756657|NCT03127384|Lidocaine|lidocaine|mesh-list
111039609|NCT05527340|Autonomic Agents|autonomic agents|mesh-ancestor
111039610|NCT05527340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111039611|NCT05527340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111039612|NCT05527340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111039613|NCT05527340|Glucocorticoids|glucocorticoids|mesh-ancestor
111039614|NCT05527340|Hormones|hormones|mesh-ancestor
111039615|NCT05527340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111039616|NCT05527340|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111039617|NCT05527340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111039618|NCT05527106|Ascorbic Acid|ascorbic acid|mesh-list
111039619|NCT05527106|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
111039620|NCT05527106|Vitamins|vitamins|mesh-ancestor
111039621|NCT05527106|Micronutrients|micronutrients|mesh-ancestor
111039622|NCT05527106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111039623|NCT05527106|Antioxidants|antioxidants|mesh-ancestor
111039624|NCT05527106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111039625|NCT05527106|Protective Agents|protective agents|mesh-ancestor
111039626|NCT05527106|Nootropic Agents|nootropic agents|mesh-ancestor
111039627|NCT05526794|Analgesics|analgesics|mesh-list
111039628|NCT05526794|Sensory System Agents|sensory system agents|mesh-ancestor
111039629|NCT05526794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111039630|NCT05526794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111039631|NCT05522894|Paclitaxel|paclitaxel|mesh-list
111039632|NCT05522894|Cisplatin|cisplatin|mesh-list
111039633|NCT05522894|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111039634|NCT05522894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111039635|NCT05522894|Tubulin Modulators|tubulin modulators|mesh-ancestor
111039636|NCT05522894|Antimitotic Agents|antimitotic agents|mesh-ancestor
111039637|NCT05522894|Mitosis Modulators|mitosis modulators|mesh-ancestor
111039638|NCT05522894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111039639|NCT05522816|Tirbanibulin|tirbanibulin|mesh-list
111039640|NCT05522816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111039641|NCT05522816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111039642|NCT02573870|Fluticasone|fluticasone|mesh-list
111039643|NCT02573870|Xhance|xhance|mesh-list
111039644|NCT02573870|Albuterol|albuterol|mesh-list
111039645|NCT02573870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111039646|NCT02573870|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111039647|NCT02573870|Autonomic Agents|autonomic agents|mesh-ancestor
111039648|NCT02573870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111039649|NCT02573870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111039650|NCT02573870|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111039651|NCT02573870|Respiratory System Agents|respiratory system agents|mesh-ancestor
111039652|NCT02573870|Dermatologic Agents|dermatologic agents|mesh-ancestor
111039653|NCT02573870|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111039654|NCT02573870|Tocolytic Agents|tocolytic agents|mesh-ancestor
111039655|NCT02573870|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111039656|NCT02573870|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111039657|NCT02573870|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111039658|NCT02573870|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111039659|NCT02573870|Adrenergic Agents|adrenergic agents|mesh-ancestor
111039660|NCT02573870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111039661|NCT02573870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111039662|NCT05149898|Cannabidiol|cannabidiol|mesh-list
111039663|NCT05149898|Anticonvulsants|anticonvulsants|mesh-ancestor
111039664|NCT05148026|Heparin|heparin|mesh-list
111039665|NCT05148026|Calcium heparin|calcium heparin|mesh-list
111039666|NCT05148026|Dialysis Solutions|dialysis solutions|mesh-list
111039667|NCT05148026|Anticoagulants|anticoagulants|mesh-ancestor
111039668|NCT05148026|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111039669|NCT05148026|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111039670|NCT05148026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111039671|NCT05148026|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110756728|NCT01111734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110756729|NCT01111734|Protective Agents|protective agents|mesh-ancestor
110756730|NCT01111734|Antidotes|antidotes|mesh-ancestor
110756731|NCT01698138|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110756732|NCT01698138|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110756733|NCT01698138|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110756734|NCT01698138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110756735|NCT01698138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110756736|NCT01698138|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110756737|NCT01698138|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110756738|NCT01698138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110756739|NCT01698138|Cholinergic Agents|cholinergic agents|mesh-ancestor
110756740|NCT01698138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110756741|NCT01111890|Timolol|timolol|mesh-list
111039673|NCT05522270|Mitosis Modulators|mitosis modulators|mesh-ancestor
111039674|NCT05522270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111039675|NCT05522192|Venetoclax|venetoclax|mesh-list
111039676|NCT05522192|Mitoxantrone|mitoxantrone|mesh-list
111039677|NCT05522192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111039678|NCT05522192|Analgesics|analgesics|mesh-ancestor
111039679|NCT05522192|Sensory System Agents|sensory system agents|mesh-ancestor
111039680|NCT05522192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111039681|NCT05522192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111039682|NCT05522192|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111039683|NCT05522192|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111039684|NCT05522192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111039685|NCT05522192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111039686|NCT05522036|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
111039687|NCT05522036|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111039688|NCT05522036|Dermatologic Agents|dermatologic agents|mesh-ancestor
111039689|NCT05515874|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
111039690|NCT05515874|Hematinics|hematinics|mesh-ancestor
111039691|NCT05515874|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
111039692|NCT05515874|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111039693|NCT05525234|Thalidomide|thalidomide|mesh-list
111039694|NCT05525234|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111039695|NCT05525234|Immunologic Factors|immunologic factors|mesh-ancestor
111039696|NCT05525234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111039697|NCT05525234|Leprostatic Agents|leprostatic agents|mesh-ancestor
111039698|NCT05525234|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111039699|NCT05525234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111039700|NCT05525234|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111039701|NCT05525234|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111039702|NCT05525234|Growth Substances|growth substances|mesh-ancestor
111039703|NCT05525234|Growth Inhibitors|growth inhibitors|mesh-ancestor
111039704|NCT05525234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111039705|NCT02574260|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
111039706|NCT02574260|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111039707|NCT02574260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111039708|NCT04300790|Metformin|metformin|mesh-list
111039709|NCT04300790|Letrozole|letrozole|mesh-list
111039710|NCT04300790|Fulvestrant|fulvestrant|mesh-list
111039711|NCT04300790|Exemestane|exemestane|mesh-list
111039712|NCT04300790|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111039713|NCT04300790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111039714|NCT04300790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111039715|NCT04300790|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111039716|NCT04300790|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111039717|NCT04300790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111039718|NCT04300790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111039719|NCT04300790|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111039720|NCT04300790|Hormone Antagonists|hormone antagonists|mesh-ancestor
111039721|NCT04300790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111039722|NCT04300790|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111039723|NCT04300790|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
111039724|NCT04295330|Lidocaine|lidocaine|mesh-list
111039725|NCT04295330|Anesthetics, Local|anesthetics, local|mesh-ancestor
111039726|NCT04295330|Anesthetics|anesthetics|mesh-ancestor
111039727|NCT04295330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111039728|NCT04295330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111039729|NCT04295330|Sensory System Agents|sensory system agents|mesh-ancestor
111039730|NCT04295330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111039731|NCT04295330|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111039732|NCT04295330|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111039733|NCT04295330|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111039734|NCT04295330|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111039735|NCT04295330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111039736|NCT05525156|Aspirin|aspirin|mesh-list
111039737|NCT05525156|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111039738|NCT05525156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111039739|NCT05525156|Analgesics|analgesics|mesh-ancestor
111039740|NCT05525156|Sensory System Agents|sensory system agents|mesh-ancestor
111039741|NCT05525156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111039742|NCT05525156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111039743|NCT05525156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111039744|NCT05525156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111039745|NCT05525156|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111039746|NCT05525156|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111039747|NCT05525156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111039748|NCT05525156|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111039749|NCT05525156|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111039750|NCT05525156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111039751|NCT05525156|Antipyretics|antipyretics|mesh-ancestor
111039752|NCT05512364|Tamoxifen|tamoxifen|mesh-list
111039753|NCT05512364|Letrozole|letrozole|mesh-list
111039754|NCT05512364|Anastrozole|anastrozole|mesh-list
111039755|NCT05512364|Exemestane|exemestane|mesh-list
111039756|NCT05512364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111039757|NCT05512364|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111039758|NCT05512364|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111039759|NCT05512364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111039760|NCT05512364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111039761|NCT05512364|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111039762|NCT05512364|Hormone Antagonists|hormone antagonists|mesh-ancestor
111039763|NCT05512364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111039764|NCT05512364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111039765|NCT05512364|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111039766|NCT05512364|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111039767|NCT05512364|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111039768|NCT05512364|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111039769|NCT05512130|Empagliflozin|empagliflozin|mesh-list
111039770|NCT05512130|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111039771|NCT05512130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111039772|NCT05512130|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111039773|NCT05512130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111039774|NCT02180425|Adapalene|adapalene|mesh-list
111039775|NCT02180425|Tretinoin|tretinoin|mesh-list
111039776|NCT02180425|Isotretinoin|isotretinoin|mesh-list
111039777|NCT02180425|Dermatologic Agents|dermatologic agents|mesh-ancestor
111039778|NCT02180425|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111039779|NCT02180425|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111039780|NCT02180425|Analgesics|analgesics|mesh-ancestor
111039781|NCT02180425|Sensory System Agents|sensory system agents|mesh-ancestor
111039782|NCT02180425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111039783|NCT02180425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111039784|NCT02180425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111039785|NCT02180425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111039786|NCT02180425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111039787|NCT02180425|Keratolytic Agents|keratolytic agents|mesh-ancestor
111039788|NCT02183467|Linagliptin|linagliptin|mesh-list
111039789|NCT02183467|Moxifloxacin|moxifloxacin|mesh-list
111039790|NCT02183467|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111039791|NCT02183467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111039792|NCT02183467|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111039793|NCT02183467|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111039794|NCT02183467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111039795|NCT02183467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111039796|NCT02183467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111039797|NCT02183467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111039798|NCT02183467|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111039799|NCT02183467|Incretins|incretins|mesh-ancestor
111039800|NCT02183467|Hormones|hormones|mesh-ancestor
111039801|NCT02183467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111039802|NCT02183467|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111039803|NCT02183467|Protease Inhibitors|protease inhibitors|mesh-ancestor
111039804|NCT02180503|Linagliptin|linagliptin|mesh-list
111039805|NCT02180503|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111039806|NCT02180503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111039807|NCT02180503|Incretins|incretins|mesh-ancestor
111039808|NCT02180503|Hormones|hormones|mesh-ancestor
111039809|NCT02180503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111039810|NCT02180503|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111039811|NCT02180503|Protease Inhibitors|protease inhibitors|mesh-ancestor
111039812|NCT02180503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111039813|NCT02180503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111039814|NCT02177851|Iron|iron|mesh-list
111039815|NCT02177851|Trace Elements|trace elements|mesh-ancestor
111039816|NCT02177851|Micronutrients|micronutrients|mesh-ancestor
111039817|NCT02177851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111039818|NCT05075876|Granisetron|granisetron|mesh-list
111039819|NCT05075876|Antiemetics|antiemetics|mesh-ancestor
111039820|NCT05075876|Autonomic Agents|autonomic agents|mesh-ancestor
111039821|NCT05075876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111039822|NCT05075876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111039824|NCT05075876|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111039825|NCT05075876|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111039826|NCT05075876|Serotonin Agents|serotonin agents|mesh-ancestor
111039827|NCT05075876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111039828|NCT05075876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111039829|NCT02180737|Dexmedetomidine|dexmedetomidine|mesh-list
111039830|NCT02180737|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111039831|NCT02180737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111039832|NCT02180737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111039833|NCT02180737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111039834|NCT02180737|Analgesics|analgesics|mesh-ancestor
111039835|NCT02180737|Sensory System Agents|sensory system agents|mesh-ancestor
111039836|NCT02180737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111039837|NCT02180737|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111039838|NCT02180737|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111039839|NCT02180737|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111039840|NCT02180737|Adrenergic Agents|adrenergic agents|mesh-ancestor
111039841|NCT02180737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110627411|NCT01065961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111039842|NCT02180737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111039843|NCT05520944|Chlorpheniramine|chlorpheniramine|mesh-list
111039844|NCT05520944|Antipruritics|antipruritics|mesh-ancestor
111039845|NCT05520944|Dermatologic Agents|dermatologic agents|mesh-ancestor
111039846|NCT05520944|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111039847|NCT05520944|Histamine Antagonists|histamine antagonists|mesh-ancestor
111039848|NCT05520944|Histamine Agents|histamine agents|mesh-ancestor
111039849|NCT05520944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111039850|NCT05520944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111039851|NCT05520944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111039852|NCT05520944|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111039853|NCT02183623|Linagliptin|linagliptin|mesh-list
111039854|NCT02183623|Simvastatin|simvastatin|mesh-list
111039855|NCT02183623|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111039856|NCT02183623|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111039857|NCT02183623|Antimetabolites|antimetabolites|mesh-ancestor
111039858|NCT02183623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111039859|NCT02183623|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111039860|NCT02183623|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111039861|NCT02183623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111039862|NCT02183623|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111039863|NCT02183623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111039864|NCT02183623|Incretins|incretins|mesh-ancestor
111039865|NCT02183623|Hormones|hormones|mesh-ancestor
111039866|NCT02183623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111039867|NCT02183623|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111039868|NCT02183623|Protease Inhibitors|protease inhibitors|mesh-ancestor
111039869|NCT02183701|Losartan|losartan|mesh-list
111039870|NCT02183701|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
111039871|NCT02183701|Telmisartan|telmisartan|mesh-list
111039872|NCT02183701|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111039873|NCT02183701|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111039874|NCT02183701|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111039875|NCT02183701|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111039876|NCT02183701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111039877|NCT02183701|Diuretics|diuretics|mesh-ancestor
111039878|NCT02183701|Natriuretic Agents|natriuretic agents|mesh-ancestor
111039879|NCT02183701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111039880|NCT02183701|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
111039881|NCT02183701|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111039882|NCT02183779|Fluconazole|fluconazole|mesh-list
111039883|NCT02183779|Antifungal Agents|antifungal agents|mesh-ancestor
111039884|NCT02183779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111039885|NCT02183779|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111039886|NCT02183779|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111039887|NCT02183779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111039888|NCT02183779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111039889|NCT02183779|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111039890|NCT02183779|Hormone Antagonists|hormone antagonists|mesh-ancestor
111039891|NCT02183779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111039892|NCT02183779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111039893|NCT02183779|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111039894|NCT02183779|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111039895|NCT02184091|Nevirapine|nevirapine|mesh-list
111039896|NCT02184091|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111039897|NCT02184091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111039898|NCT02184091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111039899|NCT02184091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111039900|NCT02184091|Antiviral Agents|antiviral agents|mesh-ancestor
111039901|NCT02184091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111039902|NCT02184091|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111039903|NCT02184091|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111039904|NCT02184091|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111039905|NCT02184091|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111039906|NCT02184247|Theophylline|theophylline|mesh-list
111039907|NCT02184247|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111039908|NCT02184247|Autonomic Agents|autonomic agents|mesh-ancestor
111039909|NCT02184247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111039910|NCT02184247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111039911|NCT02184247|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111039912|NCT02184247|Respiratory System Agents|respiratory system agents|mesh-ancestor
111039913|NCT02184247|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111039914|NCT02184247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111039915|NCT02184247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111039916|NCT02184247|Vasodilator Agents|vasodilator agents|mesh-ancestor
111039917|NCT02184247|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
111039918|NCT02184247|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111039919|NCT02184247|Purinergic Agents|purinergic agents|mesh-ancestor
111039920|NCT02184247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111039921|NCT04292756|Triamcinolone|triamcinolone|mesh-list
111039922|NCT04292756|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
111039923|NCT04292756|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
111039924|NCT04292756|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
111039925|NCT04292756|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111039926|NCT04292756|Glucocorticoids|glucocorticoids|mesh-ancestor
111039927|NCT04292756|Hormones|hormones|mesh-ancestor
111039928|NCT04292756|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111039929|NCT04292756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111039930|NCT04292756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111039931|NCT04292756|Immunologic Factors|immunologic factors|mesh-ancestor
111039932|NCT04292756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111039933|NCT04292756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111039934|NCT05074706|Antibodies|antibodies|mesh-list
111039935|NCT05074706|Immunoglobulin G|immunoglobulin g|mesh-list
111039936|NCT05074706|Immunologic Factors|immunologic factors|mesh-ancestor
111039937|NCT05074706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111039938|NCT02181205|Bupivacaine|bupivacaine|mesh-list
111039939|NCT02181205|Anesthetics, Local|anesthetics, local|mesh-ancestor
111039940|NCT02181205|Anesthetics|anesthetics|mesh-ancestor
111039941|NCT02181205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111039942|NCT02181205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111039943|NCT02181205|Sensory System Agents|sensory system agents|mesh-ancestor
111039944|NCT02181205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111039945|NCT02184559|Ropivacaine|ropivacaine|mesh-list
111039946|NCT02184559|Anesthetics, Local|anesthetics, local|mesh-ancestor
111039947|NCT02184559|Anesthetics|anesthetics|mesh-ancestor
111039948|NCT02184559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111039949|NCT02184559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111039950|NCT02184559|Sensory System Agents|sensory system agents|mesh-ancestor
111039951|NCT02184559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111039952|NCT02185651|Miglustat|miglustat|mesh-list
111039953|NCT02185651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111039954|NCT02185651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111039955|NCT02185651|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111039956|NCT02185651|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111039957|NCT02185651|Antiviral Agents|antiviral agents|mesh-ancestor
111039958|NCT02185651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111039959|NCT02185651|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
111039960|NCT02185651|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111039961|NCT02185651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111039962|NCT02181361|Aspirin|aspirin|mesh-list
111039963|NCT02181361|Hirudins|hirudins|mesh-list
111039964|NCT02181361|Warfarin|warfarin|mesh-list
111039965|NCT02181361|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111039966|NCT02181361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111039967|NCT02181361|Analgesics|analgesics|mesh-ancestor
111039968|NCT02181361|Sensory System Agents|sensory system agents|mesh-ancestor
111039969|NCT02181361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111039970|NCT02181361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111039971|NCT02181361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111039972|NCT02181361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111039973|NCT02181361|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111039974|NCT02181361|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111039975|NCT02181361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111039976|NCT02181361|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111039977|NCT02181361|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111039978|NCT02181361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111039979|NCT02181361|Antipyretics|antipyretics|mesh-ancestor
111039980|NCT02181361|Anticoagulants|anticoagulants|mesh-ancestor
111039981|NCT02181361|Antithrombins|antithrombins|mesh-ancestor
111039982|NCT02181361|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111039983|NCT02181361|Protease Inhibitors|protease inhibitors|mesh-ancestor
111039984|NCT05060276|Immunoconjugates|immunoconjugates|mesh-list
111039985|NCT05060276|Immunologic Factors|immunologic factors|mesh-ancestor
111039986|NCT05060276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111039987|NCT02184637|Lumefantrine|lumefantrine|mesh-list
111039988|NCT02184637|Artemether|artemether|mesh-list
111039990|NCT02184637|Artenimol|artenimol|mesh-list
111039991|NCT02184637|Tafenoquine|tafenoquine|mesh-list
111039992|NCT02184637|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
111039993|NCT02184637|Antimalarials|antimalarials|mesh-ancestor
111039994|NCT02184637|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111039995|NCT02184637|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111039996|NCT02184637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111039997|NCT04870424|Colchicine|colchicine|mesh-list
111039998|NCT04870424|Gout Suppressants|gout suppressants|mesh-ancestor
111039999|NCT04870424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111040000|NCT04870424|Tubulin Modulators|tubulin modulators|mesh-ancestor
111040001|NCT04870424|Antimitotic Agents|antimitotic agents|mesh-ancestor
111040002|NCT04870424|Mitosis Modulators|mitosis modulators|mesh-ancestor
111040003|NCT04870424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111040004|NCT04870424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111040005|NCT03536845|Vitamin D|vitamin d|mesh-list
111040006|NCT03536845|Cholecalciferol|cholecalciferol|mesh-list
111040007|NCT03536845|Vitamins|vitamins|mesh-ancestor
111040008|NCT03536845|Micronutrients|micronutrients|mesh-ancestor
111040009|NCT03536845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111040010|NCT03536845|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111040011|NCT03536845|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111040012|NCT02256709|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111040013|NCT02181985|Heparin|heparin|mesh-list
111040014|NCT02181985|Enoxaparin|enoxaparin|mesh-list
111040015|NCT02181985|Tenecteplase|tenecteplase|mesh-list
111040016|NCT02181985|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
111040017|NCT02181985|Abciximab|abciximab|mesh-list
111040018|NCT02181985|Anticoagulants|anticoagulants|mesh-ancestor
111040019|NCT02181985|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110627444|NCT01068301|Plerixafor|plerixafor|mesh-list
111040020|NCT02181985|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111040021|NCT02181985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111040022|NCT02181985|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111040023|NCT05514080|Insulin|insulin|mesh-list
111040024|NCT05514080|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111040025|NCT05514080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111040026|NCT02185963|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111040027|NCT02185963|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111040028|NCT02185963|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111040029|NCT02185963|Antimetabolites|antimetabolites|mesh-ancestor
111040030|NCT02185963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111040031|NCT02185963|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111040032|NCT02185963|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111040033|NCT02185963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111040034|NCT02186119|Ranibizumab|ranibizumab|mesh-list
111040035|NCT02186119|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111040036|NCT02186119|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111040037|NCT02186119|Growth Substances|growth substances|mesh-ancestor
111040038|NCT02186119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111040039|NCT02186119|Growth Inhibitors|growth inhibitors|mesh-ancestor
111040040|NCT02186119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111040041|NCT02185261|Interferons|interferons|mesh-list
111040042|NCT02185261|Interferon-alpha|interferon-alpha|mesh-list
111040043|NCT02185261|Interferon alpha-2|interferon alpha-2|mesh-list
111040044|NCT02185261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111040045|NCT02185261|Antiviral Agents|antiviral agents|mesh-ancestor
111040046|NCT02185261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111040047|NCT02185261|Immunologic Factors|immunologic factors|mesh-ancestor
111040048|NCT02185261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111040049|NCT02573012|Prednisone|prednisone|mesh-list
111040050|NCT02573012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111040051|NCT02573012|Glucocorticoids|glucocorticoids|mesh-ancestor
111040052|NCT02573012|Hormones|hormones|mesh-ancestor
111040053|NCT02573012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111040054|NCT02573012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111040055|NCT02573012|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111040056|NCT02573012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111040057|NCT04128176|Omalizumab|omalizumab|mesh-list
111040058|NCT04128176|Rituximab|rituximab|mesh-list
111040059|NCT04128176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111040060|NCT04128176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111040061|NCT04128176|Immunologic Factors|immunologic factors|mesh-ancestor
111040062|NCT04128176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111040063|NCT04128176|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111040064|NCT04128176|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111040065|NCT04128176|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111040066|NCT04128176|Respiratory System Agents|respiratory system agents|mesh-ancestor
111040067|NCT02186275|Vitamin D|vitamin d|mesh-list
111040068|NCT02186275|Ergocalciferols|ergocalciferols|mesh-list
111040069|NCT02186275|Cholecalciferol|cholecalciferol|mesh-list
111040070|NCT02186275|Vitamins|vitamins|mesh-list
111040071|NCT02186275|Micronutrients|micronutrients|mesh-ancestor
111040072|NCT02186275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111040073|NCT02186275|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111040074|NCT02186275|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111040075|NCT05117281|Levobupivacaine|levobupivacaine|mesh-list
111040076|NCT05117281|Anesthetics, Local|anesthetics, local|mesh-ancestor
111040077|NCT05117281|Anesthetics|anesthetics|mesh-ancestor
111040078|NCT05117281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111040079|NCT05117281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111040080|NCT05117281|Sensory System Agents|sensory system agents|mesh-ancestor
111040081|NCT05117281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111040082|NCT05519072|Ciprofloxacin|ciprofloxacin|mesh-list
111040083|NCT05519072|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
111040084|NCT05519072|Cephalexin|cephalexin|mesh-list
111040085|NCT05519072|Fosfomycin|fosfomycin|mesh-list
111040086|NCT05519072|Nitrofurantoin|nitrofurantoin|mesh-list
111040087|NCT05519072|Trimethoprim|trimethoprim|mesh-list
111040088|NCT05519072|Sulfamethoxazole|sulfamethoxazole|mesh-list
111040089|NCT05519072|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111040090|NCT05519072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111040091|NCT05519072|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111040092|NCT05519072|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111040093|NCT05519072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111040094|NCT05519072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111040095|NCT05519072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111040096|NCT05519072|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111040097|NCT05519072|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111040098|NCT05519072|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111040099|NCT05519072|Antimalarials|antimalarials|mesh-ancestor
111040100|NCT05519072|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111040101|NCT05519072|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111040102|NCT05519072|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111040103|NCT05519072|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111040104|NCT05519072|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
111040105|NCT05519072|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
111040106|NCT04411706|Capecitabine|capecitabine|mesh-list
111040107|NCT04411706|Apatinib|apatinib|mesh-list
111040108|NCT04411706|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111040109|NCT04411706|Antimetabolites|antimetabolites|mesh-ancestor
111040110|NCT04411706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111040111|NCT04411706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111040112|NCT04411706|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111040113|NCT04411706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111040114|NCT05518994|Bevacizumab|bevacizumab|mesh-list
111040115|NCT05518994|Tislelizumab|tislelizumab|mesh-list
111040116|NCT05518994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111040117|NCT05518994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111040118|NCT05518994|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111040119|NCT05518994|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111040120|NCT05518994|Growth Substances|growth substances|mesh-ancestor
111040121|NCT05518994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111040122|NCT05518994|Growth Inhibitors|growth inhibitors|mesh-ancestor
111040123|NCT02256943|Amitriptyline|amitriptyline|mesh-list
111040124|NCT02256943|Tolterodine Tartrate|tolterodine tartrate|mesh-list
111040125|NCT02256943|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111040126|NCT02256943|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111040127|NCT02256943|Cholinergic Agents|cholinergic agents|mesh-ancestor
111040128|NCT02256943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111040129|NCT02256943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111040130|NCT02256943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111040131|NCT02256943|Urological Agents|urological agents|mesh-ancestor
111040132|NCT02256943|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
111040133|NCT02256943|Antidepressive Agents|antidepressive agents|mesh-ancestor
111040134|NCT02256943|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111040135|NCT02256943|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111040136|NCT02256943|Analgesics|analgesics|mesh-ancestor
111040137|NCT02256943|Sensory System Agents|sensory system agents|mesh-ancestor
110827480|NCT05459844|Octreotide|octreotide|mesh-list
111040138|NCT02256943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111040139|NCT02256943|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111040140|NCT02256943|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111040141|NCT02256943|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111040142|NCT02256943|Adrenergic Agents|adrenergic agents|mesh-ancestor
111040143|NCT05059951|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
111040144|NCT05059951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111040145|NCT05059951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111040146|NCT05059951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111040147|NCT02186899|Anesthetics|anesthetics|mesh-list
111040148|NCT02186899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111040149|NCT02186899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111040150|NCT05510024|Immunomodulating Agents|immunomodulating agents|mesh-list
111040151|NCT05510024|Immunologic Factors|immunologic factors|mesh-ancestor
111040152|NCT05510024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111040153|NCT02752633|Allopurinol|allopurinol|mesh-list
111040155|NCT02752633|Antimetabolites|antimetabolites|mesh-ancestor
111040156|NCT02752633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111040157|NCT02752633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111040158|NCT02752633|Gout Suppressants|gout suppressants|mesh-ancestor
111040159|NCT02752633|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111040160|NCT02752633|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111040161|NCT02752633|Antioxidants|antioxidants|mesh-ancestor
111040162|NCT02752633|Protective Agents|protective agents|mesh-ancestor
111040163|NCT02752633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111040164|NCT02191189|Nevirapine|nevirapine|mesh-list
111040165|NCT02191189|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111040166|NCT02191189|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111040167|NCT02191189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111040168|NCT02191189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111040169|NCT02191189|Antiviral Agents|antiviral agents|mesh-ancestor
111040170|NCT02191189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111040171|NCT02191189|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111040172|NCT02191189|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111040173|NCT02191189|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111040174|NCT02191189|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111040175|NCT05512520|Capecitabine|capecitabine|mesh-list
111040176|NCT05512520|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111040177|NCT05512520|Antimetabolites|antimetabolites|mesh-ancestor
111040178|NCT05512520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111040179|NCT05512520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111040180|NCT02187133|Rituximab|rituximab|mesh-list
111040181|NCT02187133|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
111040182|NCT02187133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111040183|NCT02187133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111040184|NCT02187133|Immunologic Factors|immunologic factors|mesh-ancestor
111040185|NCT02187133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111040186|NCT02187133|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111040187|NCT02187133|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111040188|NCT02187133|Alkylating Agents|alkylating agents|mesh-ancestor
111040189|NCT02187133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111040190|NCT04411862|Choline|choline|mesh-list
111040191|NCT04411862|Lipotropic Agents|lipotropic agents|mesh-ancestor
111040192|NCT04411862|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111040193|NCT04411862|Antimetabolites|antimetabolites|mesh-ancestor
111040194|NCT04411862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111040196|NCT04411862|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111040197|NCT04411862|Nootropic Agents|nootropic agents|mesh-ancestor
111040198|NCT02187211|Minocycline|minocycline|mesh-list
111040199|NCT02187211|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111040200|NCT02187211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111040201|NCT04766996|Aspirin|aspirin|mesh-list
111040202|NCT04766996|Acetaminophen|acetaminophen|mesh-list
111040203|NCT04766996|Prednisone|prednisone|mesh-list
111040204|NCT04766996|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
111040205|NCT04766996|Meloxicam|meloxicam|mesh-list
111040206|NCT04766996|Diclofenac|diclofenac|mesh-list
111040207|NCT04766996|Lidocaine|lidocaine|mesh-list
111040208|NCT04766996|Pregabalin|pregabalin|mesh-list
111040209|NCT04766996|Tramadol|tramadol|mesh-list
111040210|NCT04766996|Bupivacaine|bupivacaine|mesh-list
111040211|NCT04766996|Propofol|propofol|mesh-list
111040212|NCT04766996|Omeprazole|omeprazole|mesh-list
111040213|NCT04766996|Tranexamic Acid|tranexamic acid|mesh-list
111040214|NCT04766996|Anesthetics, Local|anesthetics, local|mesh-ancestor
111040215|NCT04766996|Anesthetics|anesthetics|mesh-ancestor
111040217|NCT04766996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111040218|NCT04766996|Sensory System Agents|sensory system agents|mesh-ancestor
111040219|NCT04766996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111040220|NCT04766996|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111040221|NCT04766996|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111040222|NCT04766996|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111040223|NCT04766996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111040224|NCT04766996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111040225|NCT04766996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111040226|NCT04766996|Glucocorticoids|glucocorticoids|mesh-ancestor
111040227|NCT04766996|Hormones|hormones|mesh-ancestor
110627498|NCT00831636|Antimetabolites|antimetabolites|mesh-ancestor
111040228|NCT04766996|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111040229|NCT04766996|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111040230|NCT04766996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111040231|NCT04766996|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111040232|NCT04766996|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111040233|NCT04766996|Anesthetics, General|anesthetics, general|mesh-ancestor
111040234|NCT04766996|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111040235|NCT04766996|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111040236|NCT04766996|Analgesics|analgesics|mesh-ancestor
111040237|NCT04766996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111040238|NCT04766996|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111040239|NCT04766996|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111040240|NCT04766996|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111040241|NCT04766996|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111040242|NCT04766996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111040243|NCT04766996|Antipyretics|antipyretics|mesh-ancestor
111040244|NCT04766996|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111040245|NCT04766996|Anticonvulsants|anticonvulsants|mesh-ancestor
111040246|NCT04766996|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111040247|NCT04766996|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111040248|NCT04766996|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111040249|NCT04766996|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111040250|NCT04766996|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111040251|NCT04766996|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111040252|NCT04766996|Hemostatics|hemostatics|mesh-ancestor
111040253|NCT04766996|Coagulants|coagulants|mesh-ancestor
111040254|NCT04766996|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111040255|NCT04766996|Narcotics|narcotics|mesh-ancestor
111040256|NCT04766996|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111040257|NCT04766996|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111040258|NCT04766996|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111040259|NCT02191423|Oxytocin|oxytocin|mesh-list
111040260|NCT02191423|Oxytocics|oxytocics|mesh-ancestor
111040261|NCT02191423|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111040262|NCT02191423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111040263|NCT05509946|Celecoxib|celecoxib|mesh-list
111040264|NCT05509946|Pregabalin|pregabalin|mesh-list
111040265|NCT05509946|Analgesics|analgesics|mesh-ancestor
111040266|NCT05509946|Sensory System Agents|sensory system agents|mesh-ancestor
111040267|NCT05509946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111040268|NCT05509946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111040269|NCT05509946|Anticonvulsants|anticonvulsants|mesh-ancestor
111040270|NCT05509946|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111040271|NCT05509946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111040272|NCT05509946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111040273|NCT05509946|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111040274|NCT05509946|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111040275|NCT05509946|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111040276|NCT05509946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111040277|NCT05509946|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111040278|NCT05509946|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111040279|NCT05509946|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111040280|NCT05509946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111040281|NCT05509946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111040282|NCT05509946|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111040283|NCT05509946|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111040284|NCT05509946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111040285|NCT04304209|Capecitabine|capecitabine|mesh-list
111040286|NCT04304209|Oxaliplatin|oxaliplatin|mesh-list
111040287|NCT04304209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111040288|NCT04304209|Antimetabolites|antimetabolites|mesh-ancestor
111119155|NCT05306873|Mycophenolic Acid|mycophenolic acid|mesh-list
111040289|NCT04304209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111040290|NCT04304209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111040291|NCT02187367|Cyclophosphamide|cyclophosphamide|mesh-list
111040292|NCT02187367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111040293|NCT02187367|Immunologic Factors|immunologic factors|mesh-ancestor
111040294|NCT02187367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111040295|NCT02187367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110627500|NCT00831636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111040296|NCT02187367|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111040297|NCT02187367|Alkylating Agents|alkylating agents|mesh-ancestor
111040298|NCT02187367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111040299|NCT02187367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111040300|NCT02187367|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111040301|NCT02187445|Budesonide|budesonide|mesh-list
111040302|NCT02187445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111040303|NCT02187445|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111040304|NCT02187445|Autonomic Agents|autonomic agents|mesh-ancestor
111040305|NCT02187445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111040306|NCT02187445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111040307|NCT02187445|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111040308|NCT02187445|Respiratory System Agents|respiratory system agents|mesh-ancestor
111040309|NCT02187445|Glucocorticoids|glucocorticoids|mesh-ancestor
111040310|NCT02187445|Hormones|hormones|mesh-ancestor
111040311|NCT02187445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111040312|NCT02187523|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
111040313|NCT02187523|Telmisartan|telmisartan|mesh-list
111040314|NCT02187523|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111040315|NCT02187523|Diuretics|diuretics|mesh-ancestor
111040316|NCT02187523|Natriuretic Agents|natriuretic agents|mesh-ancestor
111040317|NCT02187523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111040318|NCT02187523|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
111040319|NCT02187523|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111040320|NCT02187523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111040321|NCT02187523|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111040322|NCT02187523|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111040323|NCT02187679|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111040324|NCT02187679|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111040325|NCT02187679|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111040326|NCT02187679|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111040327|NCT02187679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111040328|NCT02187679|Cholinergic Agents|cholinergic agents|mesh-ancestor
111040329|NCT02187679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111040330|NCT02187679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111040331|NCT02187679|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111040332|NCT02187679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111040333|NCT05507606|Bevacizumab|bevacizumab|mesh-list
111040334|NCT05507606|Carboplatin|carboplatin|mesh-list
111040335|NCT05507606|Pemetrexed|pemetrexed|mesh-list
111040336|NCT05507606|Osimertinib|osimertinib|mesh-list
111040337|NCT05507606|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111040338|NCT05507606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111040339|NCT05507606|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111040340|NCT05507606|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111040341|NCT05507606|Growth Substances|growth substances|mesh-ancestor
111040342|NCT05507606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111040343|NCT05507606|Growth Inhibitors|growth inhibitors|mesh-ancestor
110757404|NCT03120520|Plecanatide|plecanatide|mesh-list
111040344|NCT05507606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111040345|NCT05507606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111040346|NCT05507606|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111040347|NCT05507606|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111040348|NCT05507606|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111040349|NCT02191657|Deferiprone|deferiprone|mesh-list
111040350|NCT02191657|Iron Chelating Agents|iron chelating agents|mesh-ancestor
111040351|NCT02191657|Chelating Agents|chelating agents|mesh-ancestor
111040352|NCT02191657|Sequestering Agents|sequestering agents|mesh-ancestor
111040353|NCT02191657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111040354|NCT02191891|Afatinib|afatinib|mesh-list
111040355|NCT02191891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111040356|NCT02191891|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111040357|NCT02191891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111040358|NCT02191891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111040360|NCT05507372|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111040361|NCT05507372|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111040362|NCT05507372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111040363|NCT05507372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111040364|NCT05507372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111040365|NCT05507372|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111040366|NCT05507372|Dopamine Agents|dopamine agents|mesh-ancestor
111040367|NCT05507372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111040368|NCT05507372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111040369|NCT05507372|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111040371|NCT02192203|Menthol|menthol|mesh-list
111040372|NCT02192203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111040373|NCT02192203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111040374|NCT02192203|Analgesics|analgesics|mesh-ancestor
111040375|NCT02192203|Sensory System Agents|sensory system agents|mesh-ancestor
111040376|NCT02192203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111040377|NCT02192203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111040378|NCT02192203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111040379|NCT02192203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111040380|NCT02192203|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111040381|NCT02192203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111040382|NCT02192203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111040383|NCT02192203|Antipruritics|antipruritics|mesh-ancestor
111040384|NCT02192203|Dermatologic Agents|dermatologic agents|mesh-ancestor
111040385|NCT02257021|Ritonavir|ritonavir|mesh-list
111040386|NCT02257021|Tipranavir|tipranavir|mesh-list
111040387|NCT02257021|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111040388|NCT02257021|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111040389|NCT02257021|Protease Inhibitors|protease inhibitors|mesh-ancestor
111040390|NCT02257021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111040391|NCT02257021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111040392|NCT02257021|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111040393|NCT02257021|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111040394|NCT02257021|Antiviral Agents|antiviral agents|mesh-ancestor
111040395|NCT02257021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111040396|NCT02257021|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111040397|NCT02257021|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111040398|NCT03536065|Analgesics, Opioid|analgesics, opioid|mesh-list
111040399|NCT03536065|Narcotics|narcotics|mesh-ancestor
111040400|NCT03536065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111040401|NCT03536065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111040402|NCT03536065|Analgesics|analgesics|mesh-ancestor
111040403|NCT03536065|Sensory System Agents|sensory system agents|mesh-ancestor
111040404|NCT03536065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111040405|NCT02192827|Dexamethasone|dexamethasone|mesh-list
111040406|NCT02192827|Dexamethasone acetate|dexamethasone acetate|mesh-list
111040407|NCT02192827|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
111040408|NCT02192827|BB 1101|bb 1101|mesh-list
111040409|NCT02192827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111040410|NCT02192827|Antiemetics|antiemetics|mesh-ancestor
111040411|NCT02192827|Autonomic Agents|autonomic agents|mesh-ancestor
111040412|NCT02192827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111040413|NCT02192827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111040414|NCT02192827|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111040415|NCT02192827|Glucocorticoids|glucocorticoids|mesh-ancestor
111040416|NCT02192827|Hormones|hormones|mesh-ancestor
111040417|NCT02192827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111040418|NCT02192827|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111040419|NCT02192827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111040420|NCT02192827|Protease Inhibitors|protease inhibitors|mesh-ancestor
111040421|NCT02192827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111040422|NCT02192827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111040424|NCT02188225|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111040425|NCT02188225|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111040426|NCT02188225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111040427|NCT02188225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111040428|NCT02188225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111040429|NCT02188225|Serotonin Agents|serotonin agents|mesh-ancestor
111040430|NCT02188225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111040431|NCT02188225|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111040432|NCT02188225|Antidepressive Agents|antidepressive agents|mesh-ancestor
111040433|NCT02188225|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111040434|NCT02188225|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111040435|NCT02188225|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111040436|NCT02188225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111040437|NCT04535089|Lidocaine|lidocaine|mesh-list
111040438|NCT04535089|Dexmedetomidine|dexmedetomidine|mesh-list
111040439|NCT04535089|Anesthetics, Local|anesthetics, local|mesh-ancestor
111040440|NCT04535089|Anesthetics|anesthetics|mesh-ancestor
111040441|NCT04535089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111040442|NCT04535089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111040443|NCT04535089|Sensory System Agents|sensory system agents|mesh-ancestor
111040444|NCT04535089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111040445|NCT04535089|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111040446|NCT04535089|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111040447|NCT04535089|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111040448|NCT04535089|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111040449|NCT04535089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111040450|NCT04535089|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111040451|NCT04535089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111040452|NCT04535089|Analgesics|analgesics|mesh-ancestor
111040453|NCT04535089|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111040454|NCT04535089|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111040455|NCT04535089|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111040456|NCT04535089|Adrenergic Agents|adrenergic agents|mesh-ancestor
111040457|NCT04535089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111040458|NCT02188537|Nelfinavir|nelfinavir|mesh-list
111040459|NCT02188537|Dexamethasone|dexamethasone|mesh-list
111040460|NCT02188537|Bortezomib|bortezomib|mesh-list
111040461|NCT02188537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111040462|NCT02188537|Antiemetics|antiemetics|mesh-ancestor
111040463|NCT02188537|Autonomic Agents|autonomic agents|mesh-ancestor
111040464|NCT02188537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111040465|NCT02188537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111040466|NCT02188537|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111040467|NCT02188537|Glucocorticoids|glucocorticoids|mesh-ancestor
111040468|NCT02188537|Hormones|hormones|mesh-ancestor
111040469|NCT02188537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111040470|NCT02188537|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111040471|NCT02188537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111040472|NCT02188537|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111040473|NCT02188537|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111040474|NCT02188537|Protease Inhibitors|protease inhibitors|mesh-ancestor
111040475|NCT02188537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111040476|NCT02188537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111040477|NCT02188537|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111040478|NCT02188537|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111040479|NCT02188537|Antiviral Agents|antiviral agents|mesh-ancestor
111040480|NCT02188537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111040481|NCT03535051|Tacrolimus|tacrolimus|mesh-list
111040482|NCT03535051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111040483|NCT03535051|Immunologic Factors|immunologic factors|mesh-ancestor
111040484|NCT03535051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111040485|NCT03535051|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111040486|NCT03535051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111040487|NCT03535051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111040488|NCT02188615|Vinorelbine|vinorelbine|mesh-list
110627532|NCT00831714|Antithrombins|antithrombins|mesh-ancestor
111040489|NCT02188615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111040490|NCT02188615|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110757552|NCT01121796|Vitamin D|vitamin d|mesh-list
111040491|NCT02188615|Tubulin Modulators|tubulin modulators|mesh-ancestor
111040492|NCT02188615|Antimitotic Agents|antimitotic agents|mesh-ancestor
111040493|NCT02188615|Mitosis Modulators|mitosis modulators|mesh-ancestor
111040494|NCT02188615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111040495|NCT02188771|Hyaluronic Acid|hyaluronic acid|mesh-list
111040496|NCT02188771|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111040497|NCT02188771|Immunologic Factors|immunologic factors|mesh-ancestor
111040498|NCT02188771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111040499|NCT02188771|Viscosupplements|viscosupplements|mesh-ancestor
111040500|NCT02188771|Protective Agents|protective agents|mesh-ancestor
111040501|NCT02194075|Fluvoxamine|fluvoxamine|mesh-list
111040502|NCT02194075|Methylphenidate|methylphenidate|mesh-list
111040503|NCT02194075|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111040504|NCT02194075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111040505|NCT02194075|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111040506|NCT02194075|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111040507|NCT02194075|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111040508|NCT02194075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111040509|NCT02194075|Dopamine Agents|dopamine agents|mesh-ancestor
111040510|NCT02194075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111040511|NCT02194075|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111040512|NCT02194075|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111040513|NCT02194075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111040514|NCT02194075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111040515|NCT02194075|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111040516|NCT02194075|Serotonin Agents|serotonin agents|mesh-ancestor
111040517|NCT02194075|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111040518|NCT02194075|Antidepressive Agents|antidepressive agents|mesh-ancestor
111040519|NCT02194075|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111040520|NCT02194075|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111040521|NCT02194075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111040522|NCT02194075|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111040523|NCT02193217|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
111040524|NCT02193217|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
111040525|NCT02193217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111040526|NCT02193217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111040527|NCT02193217|Immunologic Factors|immunologic factors|mesh-ancestor
111040528|NCT02193217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111040529|NCT03534973|Caffeine|caffeine|mesh-list
111040530|NCT03534973|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111040531|NCT03534973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111040532|NCT03534973|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111040533|NCT03534973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111040534|NCT03534973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111040535|NCT03534973|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
111040536|NCT03534973|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111040537|NCT03534973|Purinergic Agents|purinergic agents|mesh-ancestor
111040538|NCT03534973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111040539|NCT03534895|Midazolam|midazolam|mesh-list
111040540|NCT03534895|Anesthetics|anesthetics|mesh-ancestor
111040541|NCT03534895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111040542|NCT03534895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111040543|NCT03534895|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111040544|NCT03534895|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111040545|NCT03534895|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111040546|NCT03534895|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111040547|NCT03534895|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111040548|NCT03534895|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111040549|NCT03534895|Anesthetics, General|anesthetics, general|mesh-ancestor
111040550|NCT03534895|GABA Modulators|gaba modulators|mesh-ancestor
111040551|NCT03534895|GABA Agents|gaba agents|mesh-ancestor
111040552|NCT03534895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111040553|NCT03534895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111040554|NCT03535753|Decitabine|decitabine|mesh-list
111040555|NCT03535753|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111040556|NCT03535753|Antimetabolites|antimetabolites|mesh-ancestor
111040557|NCT03535753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111040558|NCT03535753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111040559|NCT03535753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111040560|NCT02189395|Insulin|insulin|mesh-list
111040561|NCT02189395|Insulin Lispro|insulin lispro|mesh-list
111040562|NCT02189395|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110757634|NCT01216488|Lidocaine|lidocaine|mesh-list
111040563|NCT02189395|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111040564|NCT02189395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111040565|NCT03535519|Methotrexate|methotrexate|mesh-list
111040566|NCT03535519|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111040567|NCT03535519|Abortifacient Agents|abortifacient agents|mesh-ancestor
111040568|NCT03535519|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111040569|NCT03535519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111040570|NCT03535519|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111040571|NCT03535519|Antimetabolites|antimetabolites|mesh-ancestor
111040572|NCT03535519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111040573|NCT03535519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111040574|NCT03535519|Dermatologic Agents|dermatologic agents|mesh-ancestor
111040575|NCT03535519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111040576|NCT03535519|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111040577|NCT03535519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111040578|NCT03535519|Immunologic Factors|immunologic factors|mesh-ancestor
111040579|NCT03535519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111040580|NCT03535519|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111040581|NCT02194153|Tenecteplase|tenecteplase|mesh-list
111040582|NCT02194153|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111040583|NCT02194153|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111040584|NCT02194153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111040585|NCT02194231|Trabectedin|trabectedin|mesh-list
111040586|NCT02194231|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111040587|NCT02194231|Alkylating Agents|alkylating agents|mesh-ancestor
111040588|NCT02194231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111040589|NCT02194231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111040590|NCT04292054|Cefazolin|cefazolin|mesh-list
111040591|NCT04292054|Tazobactam|tazobactam|mesh-list
111040592|NCT04292054|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111040593|NCT04292054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111040594|NCT04292054|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
111040595|NCT04292054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111040596|NCT04292054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111040597|NCT04291508|Acetaminophen|acetaminophen|mesh-list
111040598|NCT04291508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111040599|NCT04291508|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111040600|NCT04291508|Analgesics|analgesics|mesh-ancestor
111040601|NCT04291508|Sensory System Agents|sensory system agents|mesh-ancestor
111040602|NCT04291508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111040603|NCT04291508|Antipyretics|antipyretics|mesh-ancestor
111040604|NCT02933671|Ropivacaine|ropivacaine|mesh-list
111040605|NCT02933671|Anesthetics, Local|anesthetics, local|mesh-ancestor
111040606|NCT02933671|Anesthetics|anesthetics|mesh-ancestor
111040607|NCT02933671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111040608|NCT02933671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111040609|NCT02933671|Sensory System Agents|sensory system agents|mesh-ancestor
111040610|NCT02933671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111040611|NCT05509478|Lenvatinib|lenvatinib|mesh-list
111040612|NCT05509478|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
111040613|NCT05509478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111040614|NCT05509478|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111040615|NCT05509478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111040616|NCT05509478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111040617|NCT05509478|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111040618|NCT02194309|Amlodipine|amlodipine|mesh-list
111040619|NCT02194309|Telmisartan|telmisartan|mesh-list
111040620|NCT02194309|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111040621|NCT02194309|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111040622|NCT02194309|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111040623|NCT02194309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111040624|NCT02194309|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111040625|NCT02194309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111040626|NCT02194309|Vasodilator Agents|vasodilator agents|mesh-ancestor
111040627|NCT02194309|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111040628|NCT02194309|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111040629|NCT04392505|Durvalumab|durvalumab|mesh-list
111040630|NCT04392505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111040631|NCT04392505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111040632|NCT05502458|Propofol|propofol|mesh-list
111040633|NCT05502458|Desflurane|desflurane|mesh-list
111040634|NCT05502458|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111040635|NCT05502458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111040636|NCT05502458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111040637|NCT05502458|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111040638|NCT05502458|Anesthetics, General|anesthetics, general|mesh-ancestor
111040639|NCT05502458|Anesthetics|anesthetics|mesh-ancestor
111040640|NCT05502458|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111040641|NCT03534037|Febuxostat|febuxostat|mesh-list
111040642|NCT03534037|Benzbromarone|benzbromarone|mesh-list
111040643|NCT03534037|Gout Suppressants|gout suppressants|mesh-ancestor
111040644|NCT03534037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111040645|NCT03534037|Uricosuric Agents|uricosuric agents|mesh-ancestor
111040646|NCT03533959|Alirocumab|alirocumab|mesh-list
111040647|NCT03533959|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
110827487|NCT03874975|Vitamin D|vitamin d|mesh-list
111040648|NCT03533959|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111040649|NCT03533959|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111040650|NCT03533959|Antimetabolites|antimetabolites|mesh-ancestor
111040651|NCT03533959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111040652|NCT03533959|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111040653|NCT03533959|Protease Inhibitors|protease inhibitors|mesh-ancestor
111040654|NCT03533959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111040655|NCT03533959|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111040656|NCT05502380|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111040657|NCT05502380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111040658|NCT02567708|Nemiralisib|nemiralisib|mesh-list
111040659|NCT02567708|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111040660|NCT02567708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111040661|NCT02567708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111040662|NCT05509244|Acetaminophen|acetaminophen|mesh-list
111040663|NCT05509244|Ibuprofen|ibuprofen|mesh-list
111040664|NCT05509244|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111040665|NCT05509244|Analgesics|analgesics|mesh-ancestor
111040666|NCT05509244|Sensory System Agents|sensory system agents|mesh-ancestor
111040667|NCT05509244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111040668|NCT05509244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111040669|NCT05509244|Antipyretics|antipyretics|mesh-ancestor
111040670|NCT05509244|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111040671|NCT05509244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111040672|NCT05509244|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111040673|NCT05509244|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111040674|NCT05509244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111040675|NCT05509244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111040676|NCT05502068|Vitamin D|vitamin d|mesh-list
111040677|NCT05502068|Vitamins|vitamins|mesh-ancestor
111040678|NCT05502068|Micronutrients|micronutrients|mesh-ancestor
111040679|NCT05502068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111040680|NCT05502068|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111040681|NCT02194777|Olcegepant|olcegepant|mesh-list
111040682|NCT02194777|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
111040683|NCT02194777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111040684|NCT02194777|Analgesics|analgesics|mesh-ancestor
111040685|NCT02194777|Sensory System Agents|sensory system agents|mesh-ancestor
111040686|NCT02194777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111040687|NCT02194777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111040688|NCT02030977|Resveratrol|resveratrol|mesh-list
111040689|NCT02030977|Antioxidants|antioxidants|mesh-ancestor
111040690|NCT02030977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111040691|NCT02030977|Protective Agents|protective agents|mesh-ancestor
111040692|NCT02030977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111040693|NCT02030977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111040694|NCT02030977|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111040695|NCT02194855|Rocuronium|rocuronium|mesh-list
111040696|NCT02194855|Cisatracurium|cisatracurium|mesh-list
111040697|NCT02194855|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
111040698|NCT02194855|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
111040699|NCT02194855|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111040700|NCT02194855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111040701|NCT02194855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111040702|NCT03534661|Teduglutide|teduglutide|mesh-list
111040703|NCT03534661|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
111040704|NCT03534661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111040705|NCT03534661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111040706|NCT03534661|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111040707|NCT03534661|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111040708|NCT03534661|Protective Agents|protective agents|mesh-ancestor
111040709|NCT03534661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111040710|NCT02562716|Paclitaxel|paclitaxel|mesh-list
111040711|NCT02562716|Camptothecin|camptothecin|mesh-list
111040712|NCT02562716|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111040713|NCT02562716|Gemcitabine|gemcitabine|mesh-list
111040714|NCT02562716|Fluorouracil|fluorouracil|mesh-list
111040715|NCT02562716|Oxaliplatin|oxaliplatin|mesh-list
111040716|NCT02562716|Irinotecan|irinotecan|mesh-list
111040717|NCT02562716|Pancrelipase|pancrelipase|mesh-list
111040718|NCT02562716|Pancreatin|pancreatin|mesh-list
111040719|NCT02562716|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111040720|NCT02562716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111040721|NCT02562716|Tubulin Modulators|tubulin modulators|mesh-ancestor
111040722|NCT02562716|Antimitotic Agents|antimitotic agents|mesh-ancestor
111040723|NCT02562716|Mitosis Modulators|mitosis modulators|mesh-ancestor
111040724|NCT02562716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111040725|NCT02562716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111040726|NCT02562716|Antimetabolites|antimetabolites|mesh-ancestor
111040727|NCT02562716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111040728|NCT02562716|Immunologic Factors|immunologic factors|mesh-ancestor
111040729|NCT02562716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111040730|NCT02562716|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111040731|NCT02562716|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111040732|NCT02562716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111040733|NCT02562716|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111040734|NCT02031211|Etanercept|etanercept|mesh-list
111040735|NCT02031211|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111040736|NCT02031211|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111040737|NCT02031211|Analgesics|analgesics|mesh-ancestor
111040738|NCT02031211|Sensory System Agents|sensory system agents|mesh-ancestor
111040739|NCT02031211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111040740|NCT02031211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111040741|NCT02031211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111040742|NCT02031211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111040743|NCT02031211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111040744|NCT02031211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111040745|NCT02031211|Immunologic Factors|immunologic factors|mesh-ancestor
111040746|NCT02195089|Vaccines|vaccines|mesh-list
111040747|NCT02195089|Immunologic Factors|immunologic factors|mesh-ancestor
111040748|NCT02195089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111040749|NCT02031289|Folic Acid|folic acid|mesh-list
111040750|NCT02031289|Vitamin B 12|vitamin b 12|mesh-list
111040751|NCT02031289|Hydroxocobalamin|hydroxocobalamin|mesh-list
111040752|NCT02031289|Epoetin Alfa|epoetin alfa|mesh-list
111040753|NCT02031289|Vitamins|vitamins|mesh-ancestor
111040754|NCT02031289|Micronutrients|micronutrients|mesh-ancestor
111040755|NCT02031289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111040756|NCT02031289|Hematinics|hematinics|mesh-ancestor
111040757|NCT02031289|Vitamin B Complex|vitamin b complex|mesh-ancestor
111040758|NCT02197741|Opiate Alkaloids|opiate alkaloids|mesh-list
111040759|NCT02197741|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111040760|NCT02197741|Narcotics|narcotics|mesh-ancestor
111040761|NCT02197741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111040762|NCT02197741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111040763|NCT02197741|Analgesics|analgesics|mesh-ancestor
111040764|NCT02197741|Sensory System Agents|sensory system agents|mesh-ancestor
111040765|NCT02197741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111040766|NCT02196493|Azithromycin|azithromycin|mesh-list
111040767|NCT02196493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111040768|NCT02196493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111040769|NCT05506592|Dermatologic Agents|dermatologic agents|mesh-list
111040770|NCT03533803|Indomethacin|indomethacin|mesh-list
111040771|NCT03533803|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111040772|NCT03533803|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111040773|NCT03533803|Analgesics|analgesics|mesh-ancestor
111040774|NCT03533803|Sensory System Agents|sensory system agents|mesh-ancestor
111040775|NCT03533803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111040776|NCT03533803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111040777|NCT03533803|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111040778|NCT03533803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111040779|NCT03533803|Gout Suppressants|gout suppressants|mesh-ancestor
111040780|NCT03533803|Tocolytic Agents|tocolytic agents|mesh-ancestor
111040781|NCT03533803|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111040782|NCT03533803|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111040783|NCT03533803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111040784|NCT03533803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111040785|NCT02198209|Liraglutide|liraglutide|mesh-list
111040786|NCT02198209|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111040787|NCT02198209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111040788|NCT02198209|Incretins|incretins|mesh-ancestor
111040789|NCT02198209|Hormones|hormones|mesh-ancestor
111040790|NCT02198209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111040791|NCT02031055|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111040793|NCT02195557|Viscosupplements|viscosupplements|mesh-ancestor
111040794|NCT02195557|Protective Agents|protective agents|mesh-ancestor
111040795|NCT02195557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111040796|NCT02195635|Octreotide|octreotide|mesh-list
111040797|NCT02195635|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111040798|NCT02195635|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111040799|NCT02195635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111040800|NCT03534505|Ketorolac|ketorolac|mesh-list
111040801|NCT03534505|Bupivacaine|bupivacaine|mesh-list
111040802|NCT03534505|Anesthetics, Local|anesthetics, local|mesh-ancestor
111040803|NCT03534505|Anesthetics|anesthetics|mesh-ancestor
111040804|NCT03534505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111040805|NCT03534505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111040806|NCT03534505|Sensory System Agents|sensory system agents|mesh-ancestor
111040807|NCT03534505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111040808|NCT03534505|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111040809|NCT03534505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111040810|NCT03534505|Analgesics|analgesics|mesh-ancestor
111040811|NCT03534505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111040812|NCT03534505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111040813|NCT03534505|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111040814|NCT03534505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111040815|NCT03534505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111040816|NCT02195791|Pioglitazone|pioglitazone|mesh-list
111040817|NCT02195791|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110627577|NCT00311311|Mycophenolic Acid|mycophenolic acid|mesh-list
111040818|NCT02195791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111040819|NCT02196805|Probucol|probucol|mesh-list
111040820|NCT02196805|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111040821|NCT02196805|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111040822|NCT02196805|Antimetabolites|antimetabolites|mesh-ancestor
111040823|NCT02196805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111040824|NCT02196805|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111040825|NCT02196805|Antioxidants|antioxidants|mesh-ancestor
111040826|NCT02196805|Protective Agents|protective agents|mesh-ancestor
111040827|NCT02196805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111040828|NCT02198443|Ritonavir|ritonavir|mesh-list
111040829|NCT02198443|Lopinavir|lopinavir|mesh-list
111040830|NCT02198443|Tenofovir|tenofovir|mesh-list
111040831|NCT02198443|Emtricitabine|emtricitabine|mesh-list
111040832|NCT02198443|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
111040833|NCT02198443|Cobicistat|cobicistat|mesh-list
111040834|NCT02198443|Elvitegravir|elvitegravir|mesh-list
111040835|NCT02198443|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111040836|NCT02198443|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111040837|NCT02198443|Protease Inhibitors|protease inhibitors|mesh-ancestor
111040838|NCT02198443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111040839|NCT02198443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111040840|NCT02198443|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111040841|NCT02198443|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111040842|NCT02198443|Antiviral Agents|antiviral agents|mesh-ancestor
111040843|NCT02198443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111040844|NCT02198443|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111040845|NCT02198443|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111040846|NCT02198443|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111040847|NCT02198443|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111040848|NCT02198443|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111040849|NCT03533179|Glucagon|glucagon|mesh-list
111040850|NCT03533179|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
111040851|NCT03533179|Esmolol|esmolol|mesh-list
111040852|NCT03533179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111040853|NCT03533179|Hormones|hormones|mesh-ancestor
111040854|NCT03533179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111040855|NCT03533179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111040856|NCT03533179|Incretins|incretins|mesh-ancestor
111040857|NCT03533179|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
111040858|NCT03533179|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111040859|NCT03533179|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111040860|NCT03533179|Adrenergic Agents|adrenergic agents|mesh-ancestor
111040861|NCT03533179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111040862|NCT03533179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111040863|NCT02201407|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
111040864|NCT02201407|Antiviral Agents|antiviral agents|mesh-ancestor
111040865|NCT02201407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111040866|NCT05261971|Etodolac|etodolac|mesh-list
111040867|NCT05261971|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111040868|NCT05261971|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111040869|NCT05261971|Analgesics|analgesics|mesh-ancestor
111040870|NCT05261971|Sensory System Agents|sensory system agents|mesh-ancestor
111040871|NCT05261971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111040872|NCT05261971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111040873|NCT05261971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111040874|NCT05261971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111040875|NCT05261971|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111040876|NCT05261971|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111040877|NCT05261971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111040878|NCT05261971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111040880|NCT02201563|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111040881|NCT02201563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111040882|NCT02206477|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
111040883|NCT02206477|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
111040884|NCT02206477|Protective Agents|protective agents|mesh-ancestor
110627582|NCT00311311|Glucocorticoids|glucocorticoids|mesh-ancestor
111040885|NCT02206477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111040886|NCT02206477|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111040887|NCT02206477|Antioxidants|antioxidants|mesh-ancestor
111040888|NCT02206477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111040889|NCT02201641|Calcium|calcium|mesh-list
111040890|NCT02201641|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111040891|NCT02201641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111040892|NCT02206555|Tenofovir|tenofovir|mesh-list
111040893|NCT02206555|Emtricitabine|emtricitabine|mesh-list
111040894|NCT02206555|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
111040895|NCT02206555|Antiviral Agents|antiviral agents|mesh-ancestor
111040896|NCT02206555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111040897|NCT02206555|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111040898|NCT02206555|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111040899|NCT02206555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111040900|NCT02206555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111040901|NCT02206555|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111040902|NCT02206555|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111040903|NCT02206711|BMS-955176|bms-955176|mesh-list
111040904|NCT02206711|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111040905|NCT02206711|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111040906|NCT02206711|Antiviral Agents|antiviral agents|mesh-ancestor
111040907|NCT02206711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111040908|NCT02202187|Gepotidacin|gepotidacin|mesh-list
111040909|NCT02202187|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111040910|NCT02202187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111040911|NCT02202187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111040912|NCT02202187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111040913|NCT02206789|Cyclosporine|cyclosporine|mesh-list
111040914|NCT02206789|Prednisolone|prednisolone|mesh-list
111040915|NCT02206789|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111040916|NCT02206789|Methylprednisolone|methylprednisolone|mesh-list
111040917|NCT02206789|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111040918|NCT02206789|Prednisolone acetate|prednisolone acetate|mesh-list
111040919|NCT02206789|Cyclosporins|cyclosporins|mesh-list
111040920|NCT02206789|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111040921|NCT02206789|Prednisolone phosphate|prednisolone phosphate|mesh-list
111040922|NCT02206789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111040923|NCT02206789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111040924|NCT02206789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111040925|NCT02206789|Immunologic Factors|immunologic factors|mesh-ancestor
111040926|NCT02206789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111040927|NCT02206789|Antifungal Agents|antifungal agents|mesh-ancestor
111040928|NCT02206789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111040929|NCT02206789|Dermatologic Agents|dermatologic agents|mesh-ancestor
111040930|NCT02206789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111040931|NCT02206789|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111040932|NCT02206789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111040933|NCT02206789|Glucocorticoids|glucocorticoids|mesh-ancestor
111040934|NCT02206789|Hormones|hormones|mesh-ancestor
111040935|NCT02206789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111040936|NCT02206789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111040937|NCT02206789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111040938|NCT02206789|Antiemetics|antiemetics|mesh-ancestor
111040939|NCT02206789|Autonomic Agents|autonomic agents|mesh-ancestor
111040940|NCT02206789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110758005|NCT01215084|4-Aminopyridine|4-aminopyridine|mesh-list
111040941|NCT02206789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111040942|NCT02206789|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111040943|NCT02206789|Protective Agents|protective agents|mesh-ancestor
111040944|NCT03892369|Ethanol|ethanol|mesh-list
111040945|NCT03892369|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111040946|NCT03892369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111040947|NCT03892369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111040948|NCT03892369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111040949|NCT02206867|Adalimumab|adalimumab|mesh-list
111040950|NCT02206867|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111040951|NCT02206867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111040952|NCT02206867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111040953|NCT02751931|Mirabegron|mirabegron|mesh-list
111040954|NCT02751931|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
111040955|NCT02751931|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111040956|NCT02751931|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111040957|NCT02751931|Adrenergic Agents|adrenergic agents|mesh-ancestor
111040958|NCT02751931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111040959|NCT02751931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111040960|NCT02751931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111040961|NCT02751931|Urological Agents|urological agents|mesh-ancestor
111040962|NCT05261581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
111040963|NCT05261581|Analgesics|analgesics|mesh-list
111040964|NCT05261581|Sensory System Agents|sensory system agents|mesh-ancestor
111040965|NCT05261581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111040966|NCT05261581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111040967|NCT02199223|Panitumumab|panitumumab|mesh-list
111040968|NCT02199223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111040969|NCT02199223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111040970|NCT02207335|Carboplatin|carboplatin|mesh-list
111040971|NCT02207335|Gemcitabine|gemcitabine|mesh-list
111040972|NCT02207335|Capecitabine|capecitabine|mesh-list
111040973|NCT02207335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111040974|NCT02207335|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111040975|NCT02207335|Antimetabolites|antimetabolites|mesh-ancestor
111040976|NCT02207335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111040977|NCT02561078|Insulin|insulin|mesh-list
111040978|NCT02561078|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111040979|NCT02561078|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111040980|NCT02561078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111040981|NCT02202889|Calcium|calcium|mesh-list
111040982|NCT02202889|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111040983|NCT02202889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111040984|NCT04058197|Deferoxamine|deferoxamine|mesh-list
111040985|NCT04058197|Siderophores|siderophores|mesh-ancestor
111040986|NCT04058197|Iron Chelating Agents|iron chelating agents|mesh-ancestor
111040987|NCT04058197|Chelating Agents|chelating agents|mesh-ancestor
111040988|NCT04058197|Sequestering Agents|sequestering agents|mesh-ancestor
111040989|NCT04058197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111040990|NCT02202967|Misoprostol|misoprostol|mesh-list
111040991|NCT02202967|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110627602|NCT04089605|BB 1101|bb 1101|mesh-list
111040992|NCT02202967|Abortifacient Agents|abortifacient agents|mesh-ancestor
111040993|NCT02202967|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111040994|NCT02202967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111040995|NCT02202967|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111040996|NCT02202967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111040997|NCT02202967|Oxytocics|oxytocics|mesh-ancestor
111040998|NCT05977738|Pitavastatin|pitavastatin|mesh-list
111040999|NCT05977738|Calcium|calcium|mesh-list
111041000|NCT05977738|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111041001|NCT05977738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111041002|NCT05977738|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111041003|NCT05977738|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111041004|NCT05977738|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111041005|NCT05977738|Antimetabolites|antimetabolites|mesh-ancestor
111041006|NCT05977738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111041007|NCT05977738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111041008|NCT05977738|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111041009|NCT05977699|Albuterol|albuterol|mesh-list
111041010|NCT05977699|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111041011|NCT05977699|Autonomic Agents|autonomic agents|mesh-ancestor
111041012|NCT05977699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111041013|NCT05977699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111041014|NCT05977699|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111041015|NCT05977699|Respiratory System Agents|respiratory system agents|mesh-ancestor
110758080|NCT01220154|Paclitaxel|paclitaxel|mesh-list
111041016|NCT05977699|Tocolytic Agents|tocolytic agents|mesh-ancestor
111041017|NCT05977699|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111041018|NCT05977699|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111041019|NCT05977699|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111041020|NCT05977699|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111041021|NCT05977699|Adrenergic Agents|adrenergic agents|mesh-ancestor
111041022|NCT05977699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111041023|NCT05977699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111041024|NCT05977647|Tamsulosin|tamsulosin|mesh-list
111041025|NCT05977647|Silodosin|silodosin|mesh-list
111041026|NCT05977647|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111041027|NCT05977647|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111041028|NCT05977647|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111041029|NCT05977647|Adrenergic Agents|adrenergic agents|mesh-ancestor
111041030|NCT05977647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111041031|NCT05977647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111041032|NCT05977647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111041033|NCT05977647|Urological Agents|urological agents|mesh-ancestor
111041034|NCT05977465|Empagliflozin|empagliflozin|mesh-list
111041035|NCT05977465|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111041036|NCT05977465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111041037|NCT05977465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111041038|NCT05977465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111041039|NCT05977400|Gentamicins|gentamicins|mesh-list
111041040|NCT05977400|Ampicillin|ampicillin|mesh-list
111041041|NCT05977400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111041042|NCT05977400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111041043|NCT05977400|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111041044|NCT05977400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111041045|NCT05977400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111041046|NCT05977101|Antibodies|antibodies|mesh-list
111041047|NCT05977101|Immunoglobulins|immunoglobulins|mesh-list
111041048|NCT05977101|Antibodies, Blocking|antibodies, blocking|mesh-list
111041049|NCT05977101|Immunologic Factors|immunologic factors|mesh-ancestor
111041050|NCT05977101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111041051|NCT05976932|Doxorubicin|doxorubicin|mesh-list
111041052|NCT05976932|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111041053|NCT05976932|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111041054|NCT05976932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111041055|NCT05976932|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111041056|NCT05976932|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111041057|NCT05976932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110627633|NCT00311155|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111041058|NCT05976932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111041059|NCT05976893|Evolocumab|evolocumab|mesh-list
111041060|NCT05976893|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
111041061|NCT05976893|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111041062|NCT05976893|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111041063|NCT05976893|Antimetabolites|antimetabolites|mesh-ancestor
111041064|NCT05976893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111041065|NCT05976893|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111041066|NCT05976893|Protease Inhibitors|protease inhibitors|mesh-ancestor
111041067|NCT05976893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111041068|NCT05976893|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111041069|NCT05976802|Budesonide|budesonide|mesh-list
111041070|NCT05976802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111041071|NCT05976802|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111041072|NCT05976802|Autonomic Agents|autonomic agents|mesh-ancestor
111041073|NCT05976802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111041074|NCT05976802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111041075|NCT05976802|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111041076|NCT05976802|Respiratory System Agents|respiratory system agents|mesh-ancestor
111041077|NCT05976802|Glucocorticoids|glucocorticoids|mesh-ancestor
111041078|NCT05976802|Hormones|hormones|mesh-ancestor
111041079|NCT05976802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111041080|NCT05976737|Levodopa|levodopa|mesh-list
111041081|NCT05976737|Carbidopa|carbidopa|mesh-list
111041082|NCT05976737|Entacapone|entacapone|mesh-list
111041083|NCT05976737|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111041084|NCT05976737|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111041085|NCT05976737|Dopamine Agents|dopamine agents|mesh-ancestor
111041086|NCT05976737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111041087|NCT05976737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110758159|NCT01123824|Clopidogrel|clopidogrel|mesh-list
111041088|NCT05976737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111041089|NCT05976737|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
111041091|NCT05976737|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
111041092|NCT05976698|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
111041093|NCT05976698|Hallucinogens|hallucinogens|mesh-ancestor
111041094|NCT05976698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111041095|NCT05976698|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111041096|NCT05976698|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111041097|NCT05976698|Serotonin Agents|serotonin agents|mesh-ancestor
111041098|NCT05976698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111041099|NCT05976698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111041100|NCT05976698|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111041102|NCT05976568|Capecitabine|capecitabine|mesh-list
111041103|NCT05976568|Oxaliplatin|oxaliplatin|mesh-list
111041104|NCT05976568|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111041105|NCT05976568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111041106|NCT05976568|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111041107|NCT05976568|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111041108|NCT05976568|Growth Substances|growth substances|mesh-ancestor
111041109|NCT05976568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111041110|NCT05976568|Growth Inhibitors|growth inhibitors|mesh-ancestor
111041111|NCT05976568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111041112|NCT05976568|Antimetabolites|antimetabolites|mesh-ancestor
111041113|NCT05976568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111041114|NCT05976451|Melatonin|melatonin|mesh-list
111041115|NCT05976451|Antioxidants|antioxidants|mesh-ancestor
111041116|NCT05976451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111041117|NCT05976451|Protective Agents|protective agents|mesh-ancestor
111041118|NCT05976451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111041119|NCT05976451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111041120|NCT05976438|Amlodipine|amlodipine|mesh-list
111041121|NCT05976438|Chlorthalidone|chlorthalidone|mesh-list
111041122|NCT05976438|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111041123|NCT05976438|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111041124|NCT05976438|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111041125|NCT05976438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110627638|NCT00311155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111041126|NCT05976438|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111041127|NCT05976438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111041128|NCT05976438|Vasodilator Agents|vasodilator agents|mesh-ancestor
111041129|NCT05976438|Diuretics|diuretics|mesh-ancestor
111041130|NCT05976438|Natriuretic Agents|natriuretic agents|mesh-ancestor
111041131|NCT05976438|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
111041132|NCT05976360|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111041133|NCT05976360|Immunologic Factors|immunologic factors|mesh-ancestor
111041134|NCT05976360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111041135|NCT05976152|3-n-butylphthalide|3-n-butylphthalide|mesh-list
111041136|NCT05976152|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111041137|NCT05976152|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111041138|NCT05976152|Protective Agents|protective agents|mesh-ancestor
111041139|NCT05976152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111041140|NCT05976126|Trace Elements|trace elements|mesh-list
111041141|NCT05976126|Micronutrients|micronutrients|mesh-list
111041142|NCT05976126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111041143|NCT05975996|Cyclophosphamide|cyclophosphamide|mesh-list
111041144|NCT05975996|Immunosuppressive Agents|immunosuppressive agents|mesh-list
111041145|NCT05975996|Immunologic Factors|immunologic factors|mesh-ancestor
111041146|NCT05975996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111041147|NCT05975996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111041148|NCT05975996|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111041149|NCT05975996|Alkylating Agents|alkylating agents|mesh-ancestor
111041150|NCT05975996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111041151|NCT05975996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111041152|NCT05975996|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111041153|NCT05975944|Olaparib|olaparib|mesh-list
111041154|NCT05975944|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111041155|NCT05975944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111041156|NCT05975944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111041157|NCT05975944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111041158|NCT05975879|Vitamin D|vitamin d|mesh-list
111041159|NCT05975879|Cholecalciferol|cholecalciferol|mesh-list
111041160|NCT05975879|Vitamins|vitamins|mesh-list
111041161|NCT05975879|Dimethyl sulfone|dimethyl sulfone|mesh-list
110758228|NCT05123170|Analgesics|analgesics|mesh-ancestor
111041162|NCT05975879|Micronutrients|micronutrients|mesh-ancestor
111041163|NCT05975879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111041164|NCT05975879|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111041165|NCT05975879|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111041166|NCT05975879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111041167|NCT05975866|Curcumin|curcumin|mesh-list
111041168|NCT05975866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
111041169|NCT05975866|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111041170|NCT05975866|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111041171|NCT05975866|Analgesics|analgesics|mesh-ancestor
111041172|NCT05975866|Sensory System Agents|sensory system agents|mesh-ancestor
111041173|NCT05975866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111041174|NCT05975866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111041175|NCT05975866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111041176|NCT05975866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111041177|NCT05975866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111041178|NCT05975866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111041179|NCT05975554|Interleukin-2|interleukin-2|mesh-list
111041180|NCT05975554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111041181|NCT05975554|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111041182|NCT05975554|Analgesics|analgesics|mesh-ancestor
111041183|NCT05975554|Sensory System Agents|sensory system agents|mesh-ancestor
111041184|NCT05975554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111041185|NCT05975554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111041186|NCT05975528|Glimepiride|glimepiride|mesh-list
111041187|NCT05975528|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
111041188|NCT05975528|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111041189|NCT05975528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111041190|NCT05975528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111041191|NCT05975528|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111041192|NCT05975528|Immunologic Factors|immunologic factors|mesh-ancestor
111041193|NCT05975528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111041194|NCT05974124|Chlorhexidine|chlorhexidine|mesh-list
111041195|NCT05974124|Povidone-Iodine|povidone-iodine|mesh-list
111041196|NCT05974124|Povidone|povidone|mesh-list
111041197|NCT05974124|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111041198|NCT05974124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111041199|NCT05974124|Disinfectants|disinfectants|mesh-ancestor
111041200|NCT05974124|Plasma Substitutes|plasma substitutes|mesh-ancestor
111041201|NCT05974124|Blood Substitutes|blood substitutes|mesh-ancestor
111041202|NCT05969054|Lacosamide|lacosamide|mesh-list
111041203|NCT05969054|Levetiracetam|levetiracetam|mesh-list
111041204|NCT05969054|Anticonvulsants|anticonvulsants|mesh-ancestor
111041205|NCT05969054|Nootropic Agents|nootropic agents|mesh-ancestor
111041206|NCT05969054|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111041207|NCT05969054|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111041208|NCT05969054|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111041209|NCT05969054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111041210|NCT05957107|Antibodies|antibodies|mesh-list
111041211|NCT05957107|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111041212|NCT05957107|Immunologic Factors|immunologic factors|mesh-ancestor
111041213|NCT05957107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111041214|NCT05892341|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
111041215|NCT05892341|Laxatives|laxatives|mesh-ancestor
111041216|NCT05892341|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111041217|NCT05866536|BCG Vaccine|bcg vaccine|mesh-list
111041218|NCT05866536|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111041219|NCT05866536|Immunologic Factors|immunologic factors|mesh-ancestor
111041220|NCT05866536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111041221|NCT05849298|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
111041222|NCT05849298|177Lu-PSMA-617|177lu-psma-617|mesh-list
111041223|NCT05849298|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111041224|NCT05849298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111041225|NCT05796661|Citric Acid|citric acid|mesh-list
111041226|NCT05796661|Sodium Citrate|sodium citrate|mesh-list
111041227|NCT05796661|Anticoagulants|anticoagulants|mesh-ancestor
111041228|NCT05796661|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
111041229|NCT05796661|Chelating Agents|chelating agents|mesh-ancestor
111041230|NCT05796661|Sequestering Agents|sequestering agents|mesh-ancestor
111041231|NCT05796661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111041232|NCT05790525|Bismuth|bismuth|mesh-list
111041233|NCT05790525|Antacids|antacids|mesh-ancestor
111041234|NCT05790525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111041235|NCT05790525|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111041236|NCT05757310|Vidarabine|vidarabine|mesh-list
111041237|NCT05757310|Cyclophosphamide|cyclophosphamide|mesh-list
111041238|NCT05757310|Pentostatin|pentostatin|mesh-list
110758328|NCT01376440|Eusol|eusol|mesh-list
111041239|NCT05757310|Antilymphocyte Serum|antilymphocyte serum|mesh-list
111041240|NCT05757310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111041241|NCT05757310|Immunologic Factors|immunologic factors|mesh-ancestor
111041242|NCT05757310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111041243|NCT05757310|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111041244|NCT05757310|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111041245|NCT05757310|Alkylating Agents|alkylating agents|mesh-ancestor
111041246|NCT05757310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111041247|NCT05757310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111041248|NCT05757310|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111041249|NCT05757310|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
111041250|NCT05757310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111041251|NCT05757310|Antimetabolites|antimetabolites|mesh-ancestor
111041252|NCT05757310|Antiviral Agents|antiviral agents|mesh-ancestor
111041253|NCT05757310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111041254|NCT05751668|Paclitaxel|paclitaxel|mesh-list
111041255|NCT05751668|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111041256|NCT05751668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111041257|NCT05751668|Tubulin Modulators|tubulin modulators|mesh-ancestor
111041258|NCT05751668|Antimitotic Agents|antimitotic agents|mesh-ancestor
111041259|NCT05751668|Mitosis Modulators|mitosis modulators|mesh-ancestor
111041260|NCT05751668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111041261|NCT05710406|Cetuximab|cetuximab|mesh-list
111041262|NCT05710406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111041263|NCT05710406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111041264|NCT05685277|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
111041265|NCT05685277|Ramipril|ramipril|mesh-list
111041266|NCT05685277|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111041267|NCT05685277|Diuretics|diuretics|mesh-ancestor
111041268|NCT05685277|Natriuretic Agents|natriuretic agents|mesh-ancestor
111041269|NCT05685277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111041270|NCT05685277|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
111041271|NCT05685277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111041272|NCT05685277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111041273|NCT05685277|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
111041274|NCT05685277|Protease Inhibitors|protease inhibitors|mesh-ancestor
111041275|NCT05685277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111041276|NCT05678348|Pyrimethamine|pyrimethamine|mesh-list
111041277|NCT05678348|Antimalarials|antimalarials|mesh-ancestor
111041278|NCT05678348|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111041279|NCT05678348|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111041280|NCT05678348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111041281|NCT05678348|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111041282|NCT05678348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111041283|NCT05678348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111041284|NCT05668585|Trametinib|trametinib|mesh-list
111041285|NCT05668585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111041286|NCT05668585|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111041287|NCT05668585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111041288|NCT05668585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111041289|NCT05667285|Sirolimus|sirolimus|mesh-list
111041290|NCT05667285|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111041291|NCT05667285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111041292|NCT05667285|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111041293|NCT05667285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111041294|NCT05667285|Antifungal Agents|antifungal agents|mesh-ancestor
111041295|NCT05667285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111041296|NCT05667285|Immunologic Factors|immunologic factors|mesh-ancestor
111041297|NCT05667285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111041298|NCT05642780|Pembrolizumab|pembrolizumab|mesh-list
111041299|NCT05642780|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111041300|NCT05642780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111041301|NCT05642780|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111041302|NCT05642780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111041303|NCT05627635|Calcium, Dietary|calcium, dietary|mesh-list
111041304|NCT05627635|Leucovorin|leucovorin|mesh-list
111041305|NCT05627635|Folic Acid|folic acid|mesh-list
111041306|NCT05627635|Bevacizumab|bevacizumab|mesh-list
111041307|NCT05627635|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111041308|NCT05627635|Fluorouracil|fluorouracil|mesh-list
111041309|NCT05627635|Oxaliplatin|oxaliplatin|mesh-list
111041310|NCT05627635|Endothelial Growth Factors|endothelial growth factors|mesh-list
111041311|NCT05627635|Antibodies|antibodies|mesh-list
111041312|NCT05627635|Immunoglobulins|immunoglobulins|mesh-list
111041313|NCT05627635|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111041314|NCT05627635|Immunoglobulin G|immunoglobulin g|mesh-list
110627677|NCT01068847|Verapamil|verapamil|mesh-list
111041316|NCT05627635|Levoleucovorin|levoleucovorin|mesh-list
111041317|NCT05627635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111041318|NCT05627635|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111041319|NCT05627635|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111041320|NCT05627635|Growth Substances|growth substances|mesh-ancestor
111041321|NCT05627635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111041322|NCT05627635|Growth Inhibitors|growth inhibitors|mesh-ancestor
111041323|NCT05627635|Immunologic Factors|immunologic factors|mesh-ancestor
111041324|NCT05627635|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111041325|NCT05627635|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111041326|NCT05627635|Antimetabolites|antimetabolites|mesh-ancestor
111041327|NCT05627635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111041328|NCT05627635|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111041329|NCT05627635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111041330|NCT05627635|Antidotes|antidotes|mesh-ancestor
111041331|NCT05627635|Protective Agents|protective agents|mesh-ancestor
111041332|NCT05627635|Vitamin B Complex|vitamin b complex|mesh-ancestor
111041333|NCT05627635|Vitamins|vitamins|mesh-ancestor
111041334|NCT05627635|Micronutrients|micronutrients|mesh-ancestor
111041335|NCT05627635|Hematinics|hematinics|mesh-ancestor
111041336|NCT05590598|Azelastine|azelastine|mesh-list
111041337|NCT05590598|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111041338|NCT05590598|Autonomic Agents|autonomic agents|mesh-ancestor
111041339|NCT05590598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111041340|NCT05590598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111041341|NCT05590598|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111041342|NCT05590598|Respiratory System Agents|respiratory system agents|mesh-ancestor
111041343|NCT05590598|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
111041344|NCT05590598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111041345|NCT05590598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111041346|NCT05590598|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111041347|NCT05590598|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
111041348|NCT05590598|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111041349|NCT05590598|Histamine Antagonists|histamine antagonists|mesh-ancestor
111041350|NCT05590598|Histamine Agents|histamine agents|mesh-ancestor
111041351|NCT05590598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111041352|NCT05524935|Pembrolizumab|pembrolizumab|mesh-list
111041353|NCT05524935|Olaparib|olaparib|mesh-list
111041354|NCT05524935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111041355|NCT05524935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111041356|NCT05524935|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111041357|NCT05524935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111041358|NCT05524935|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111041359|NCT05524935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111041360|NCT05507775|Digoxin|digoxin|mesh-list
111041361|NCT05507775|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111041362|NCT05507775|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111041363|NCT05507775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111041364|NCT05507775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111041365|NCT05507775|Protective Agents|protective agents|mesh-ancestor
111041366|NCT05507775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111041367|NCT05503797|Cobicistat|cobicistat|mesh-list
111041368|NCT05503797|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111041369|NCT05503797|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111041370|NCT05503797|Antiviral Agents|antiviral agents|mesh-ancestor
111041371|NCT05503797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111041372|NCT05503797|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111041373|NCT05503797|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111041374|NCT05503797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111041375|NCT05503797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111041376|NCT05495945|Propofol|propofol|mesh-list
111041377|NCT05495945|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111041378|NCT05495945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111041379|NCT05495945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111041380|NCT05495945|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111041381|NCT05495945|Anesthetics, General|anesthetics, general|mesh-ancestor
111041382|NCT05495945|Anesthetics|anesthetics|mesh-ancestor
111041383|NCT05441592|Tranexamic Acid|tranexamic acid|mesh-list
111041384|NCT05441592|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111041385|NCT05441592|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111041386|NCT05441592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111041387|NCT05441592|Hemostatics|hemostatics|mesh-ancestor
111041388|NCT05441592|Coagulants|coagulants|mesh-ancestor
111041390|NCT05430152|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111041391|NCT05430152|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111041392|NCT05430152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111041393|NCT05430152|Sensory System Agents|sensory system agents|mesh-ancestor
111041394|NCT05430152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111041395|NCT05406505|Dapagliflozin|dapagliflozin|mesh-list
111041396|NCT05406505|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111041397|NCT05406505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111041398|NCT05406505|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111041399|NCT05406505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111041400|NCT05398094|Sotorasib|sotorasib|mesh-list
111041401|NCT05398094|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111041402|NCT05398094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111041403|NCT05398094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111041404|NCT05398094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111041405|NCT05354778|Hydrocortisone|hydrocortisone|mesh-list
111041406|NCT05354778|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
111041407|NCT05354778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111041408|NCT05331183|Ivacaftor|ivacaftor|mesh-list
111041409|NCT05331183|Elexacaftor|elexacaftor|mesh-list
111041410|NCT05331183|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
111041411|NCT05331183|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111041412|NCT05331183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111041413|NCT05325632|Paclitaxel|paclitaxel|mesh-list
111041414|NCT05325632|Trastuzumab|trastuzumab|mesh-list
111041415|NCT05325632|Pertuzumab|pertuzumab|mesh-list
111041416|NCT05325632|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111041417|NCT05325632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111041418|NCT05325632|Tubulin Modulators|tubulin modulators|mesh-ancestor
111041419|NCT05325632|Antimitotic Agents|antimitotic agents|mesh-ancestor
111041420|NCT05325632|Mitosis Modulators|mitosis modulators|mesh-ancestor
111041421|NCT05325632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111041422|NCT05325632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111041423|NCT05298592|Paclitaxel|paclitaxel|mesh-list
111041424|NCT05298592|Carboplatin|carboplatin|mesh-list
111041425|NCT05298592|Nivolumab|nivolumab|mesh-list
111041426|NCT05298592|Pemetrexed|pemetrexed|mesh-list
111041427|NCT05298592|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111041428|NCT05298592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111041429|NCT05298592|Tubulin Modulators|tubulin modulators|mesh-ancestor
111041430|NCT05298592|Antimitotic Agents|antimitotic agents|mesh-ancestor
111041431|NCT05298592|Mitosis Modulators|mitosis modulators|mesh-ancestor
111041432|NCT05298592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111041433|NCT05298592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111041434|NCT05298592|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111041435|NCT05298592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110627697|NCT01068847|Antimetabolites|antimetabolites|mesh-ancestor
111041436|NCT05298592|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111041437|NCT05298592|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111041438|NCT05259800|Peppermint oil|peppermint oil|mesh-list
111041439|NCT05259800|Mineral Oil|mineral oil|mesh-list
111041440|NCT05259800|Antiemetics|antiemetics|mesh-ancestor
111041441|NCT05259800|Autonomic Agents|autonomic agents|mesh-ancestor
111041442|NCT05259800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111041443|NCT05259800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111041444|NCT05259800|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111041445|NCT05259800|Parasympatholytics|parasympatholytics|mesh-ancestor
111041446|NCT05259800|Emollients|emollients|mesh-ancestor
111041447|NCT05259800|Dermatologic Agents|dermatologic agents|mesh-ancestor
111041448|NCT05215236|Opiate Alkaloids|opiate alkaloids|mesh-list
111041449|NCT05215236|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111041450|NCT05215236|Narcotics|narcotics|mesh-ancestor
111041451|NCT05215236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111041452|NCT05215236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111041453|NCT05215236|Analgesics|analgesics|mesh-ancestor
111041454|NCT05215236|Sensory System Agents|sensory system agents|mesh-ancestor
111041455|NCT05215236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111041456|NCT05209295|Azacitidine|azacitidine|mesh-list
111041457|NCT05209295|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111041458|NCT05209295|Antimetabolites|antimetabolites|mesh-ancestor
111041459|NCT05209295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111041460|NCT05209295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111041461|NCT05209295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111041462|NCT05180591|BCG Vaccine|bcg vaccine|mesh-list
110758548|NCT01221792|Carvedilol|carvedilol|mesh-list
111041463|NCT05180591|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111041464|NCT05180591|Immunologic Factors|immunologic factors|mesh-ancestor
111041465|NCT05180591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111041467|NCT05169567|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111041468|NCT05169567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111041469|NCT05169567|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
111041470|NCT05169567|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111041471|NCT05169567|Hormone Antagonists|hormone antagonists|mesh-ancestor
111041472|NCT05169567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111041473|NCT05169567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111041475|NCT05157971|Prednisone|prednisone|mesh-list
111041476|NCT05157971|Cortisone|cortisone|mesh-list
111041477|NCT05157971|Cyclophosphamide|cyclophosphamide|mesh-list
111041478|NCT05157971|Methotrexate|methotrexate|mesh-list
111041479|NCT05157971|Vincristine|vincristine|mesh-list
111041480|NCT05157971|Daunorubicin|daunorubicin|mesh-list
111041481|NCT05157971|Venetoclax|venetoclax|mesh-list
111041482|NCT05157971|Asparaginase|asparaginase|mesh-list
111041483|NCT05157971|Mercaptopurine|mercaptopurine|mesh-list
111041484|NCT05157971|Pegaspargase|pegaspargase|mesh-list
111041485|NCT05157971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111041486|NCT05157971|Immunologic Factors|immunologic factors|mesh-ancestor
111041487|NCT05157971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111041488|NCT05157971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111041489|NCT05157971|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111041490|NCT05157971|Alkylating Agents|alkylating agents|mesh-ancestor
111041491|NCT05157971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111041492|NCT05157971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111041493|NCT05157971|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111041494|NCT05157971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111041495|NCT05157971|Glucocorticoids|glucocorticoids|mesh-ancestor
111041496|NCT05157971|Hormones|hormones|mesh-ancestor
111041497|NCT05157971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111041498|NCT05157971|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111041499|NCT05157971|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111041500|NCT05157971|Abortifacient Agents|abortifacient agents|mesh-ancestor
111041501|NCT05157971|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111041502|NCT05157971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111041503|NCT05157971|Antimetabolites|antimetabolites|mesh-ancestor
111041504|NCT05157971|Dermatologic Agents|dermatologic agents|mesh-ancestor
111041505|NCT05157971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111041506|NCT05157971|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110627713|NCT01070875|Heparin|heparin|mesh-list
111041507|NCT05157971|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111041508|NCT05157971|Antiviral Agents|antiviral agents|mesh-ancestor
111041509|NCT05157971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111041510|NCT05157971|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111041511|NCT05157971|Tubulin Modulators|tubulin modulators|mesh-ancestor
111041512|NCT05157971|Antimitotic Agents|antimitotic agents|mesh-ancestor
111041513|NCT05157971|Mitosis Modulators|mitosis modulators|mesh-ancestor
111041514|NCT05157971|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111041515|NCT05157971|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111041516|NCT05157971|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111041517|NCT05070260|Glenzocimab|glenzocimab|mesh-list
111041518|NCT05070260|Anticoagulants|anticoagulants|mesh-ancestor
111041519|NCT04995653|Vancomycin|vancomycin|mesh-list
111041520|NCT04995653|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111041521|NCT04995653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111041522|NCT04972968|Glucocorticoids|glucocorticoids|mesh-list
111041523|NCT04972968|Hormones|hormones|mesh-ancestor
111041524|NCT04972968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111041525|NCT04972968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111041526|NCT04928651|Clonidine|clonidine|mesh-list
111041527|NCT04928651|Analgesics|analgesics|mesh-ancestor
111041528|NCT04928651|Sensory System Agents|sensory system agents|mesh-ancestor
111041529|NCT04928651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111041530|NCT04928651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111041531|NCT04928651|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111041532|NCT04928651|Sympatholytics|sympatholytics|mesh-ancestor
111041533|NCT04928651|Autonomic Agents|autonomic agents|mesh-ancestor
111041534|NCT04928651|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111041535|NCT04928651|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111041536|NCT04928651|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111041537|NCT04928651|Adrenergic Agents|adrenergic agents|mesh-ancestor
111041538|NCT04928651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111041539|NCT04928651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111041541|NCT04916327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111041542|NCT04916327|Protective Agents|protective agents|mesh-ancestor
111041543|NCT04916327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111041544|NCT04907227|Dexamethasone|dexamethasone|mesh-list
111041545|NCT04907227|Prednisone|prednisone|mesh-list
111041546|NCT04907227|Docetaxel|docetaxel|mesh-list
111041547|NCT04907227|Pembrolizumab|pembrolizumab|mesh-list
111041548|NCT04907227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111041549|NCT04907227|Antiemetics|antiemetics|mesh-ancestor
111041550|NCT04907227|Autonomic Agents|autonomic agents|mesh-ancestor
111041551|NCT04907227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111041552|NCT04907227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111041553|NCT04907227|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111041554|NCT04907227|Glucocorticoids|glucocorticoids|mesh-ancestor
111041555|NCT04907227|Hormones|hormones|mesh-ancestor
111041556|NCT04907227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111041557|NCT04907227|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111041558|NCT04907227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111041559|NCT04907227|Tubulin Modulators|tubulin modulators|mesh-ancestor
111041560|NCT04907227|Antimitotic Agents|antimitotic agents|mesh-ancestor
111041561|NCT04907227|Mitosis Modulators|mitosis modulators|mesh-ancestor
111041562|NCT04907227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111041563|NCT04907227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111041564|NCT04907227|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111041565|NCT04875364|Eszopiclone|eszopiclone|mesh-list
111041566|NCT04875364|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111041567|NCT04875364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111041568|NCT04875364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111041569|NCT04848116|Nivolumab|nivolumab|mesh-list
111041570|NCT04848116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111041571|NCT04848116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111041572|NCT04848116|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111041573|NCT04848116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111041574|NCT04846829|Citalopram|citalopram|mesh-list
111041575|NCT04846829|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111041576|NCT04846829|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111041577|NCT04846829|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111041578|NCT04846829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111041579|NCT04846829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111041580|NCT04846829|Serotonin Agents|serotonin agents|mesh-ancestor
111041581|NCT04846829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111041582|NCT04846829|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111041583|NCT04846829|Antidepressive Agents|antidepressive agents|mesh-ancestor
111041584|NCT04846829|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111041585|NCT04825704|Bupivacaine|bupivacaine|mesh-list
111041586|NCT04825704|Anesthetics, Local|anesthetics, local|mesh-ancestor
111041587|NCT04825704|Anesthetics|anesthetics|mesh-ancestor
111041588|NCT04825704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111041589|NCT04825704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111041590|NCT04825704|Sensory System Agents|sensory system agents|mesh-ancestor
111041591|NCT04825704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111041592|NCT04815083|Aminolevulinic Acid|aminolevulinic acid|mesh-list
111041593|NCT04815083|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111041594|NCT04815083|Dermatologic Agents|dermatologic agents|mesh-ancestor
111041595|NCT04798469|Methyltestosterone|methyltestosterone|mesh-list
111041596|NCT04798469|Testosterone|testosterone|mesh-list
111041597|NCT04798469|Testosterone undecanoate|testosterone undecanoate|mesh-list
111041598|NCT04798469|Testosterone enanthate|testosterone enanthate|mesh-list
111041599|NCT04798469|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
111041600|NCT04798469|Androgens|androgens|mesh-ancestor
111041601|NCT04798469|Hormones|hormones|mesh-ancestor
111041602|NCT04798469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111041603|NCT04798469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111041604|NCT04798469|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111041605|NCT04798469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111041606|NCT04798469|Anabolic Agents|anabolic agents|mesh-ancestor
111041607|NCT04787991|Hydroxychloroquine|hydroxychloroquine|mesh-list
111041608|NCT04787991|Paclitaxel|paclitaxel|mesh-list
111041609|NCT04787991|Gemcitabine|gemcitabine|mesh-list
111041610|NCT04787991|Nivolumab|nivolumab|mesh-list
111041611|NCT04787991|Ipilimumab|ipilimumab|mesh-list
111041612|NCT04787991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111041613|NCT04787991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111041614|NCT04787991|Tubulin Modulators|tubulin modulators|mesh-ancestor
110758672|NCT01227174|Propofol|propofol|mesh-list
111041615|NCT04787991|Antimitotic Agents|antimitotic agents|mesh-ancestor
111041616|NCT04787991|Mitosis Modulators|mitosis modulators|mesh-ancestor
111041617|NCT04787991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111041618|NCT04787991|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111041619|NCT04787991|Antimetabolites|antimetabolites|mesh-ancestor
111041620|NCT04787991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111041621|NCT04787991|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111041622|NCT04787991|Antimalarials|antimalarials|mesh-ancestor
111041623|NCT04787991|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111041624|NCT04787991|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111041625|NCT04787991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111041626|NCT04787991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111041627|NCT04787991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111041628|NCT04758000|Metformin|metformin|mesh-list
111041629|NCT04758000|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111041630|NCT04758000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111041631|NCT04728087|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
111041632|NCT04728087|Hemostatics|hemostatics|mesh-ancestor
111041633|NCT04728087|Coagulants|coagulants|mesh-ancestor
111041634|NCT04688320|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
111041635|NCT04688320|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111041636|NCT04688320|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111041637|NCT04688320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111041638|NCT04659616|Cytarabine|cytarabine|mesh-list
111041639|NCT04659616|Daunorubicin|daunorubicin|mesh-list
111041640|NCT04659616|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111041641|NCT04659616|Antimetabolites|antimetabolites|mesh-ancestor
111041642|NCT04659616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111041643|NCT04659616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111041644|NCT04659616|Antiviral Agents|antiviral agents|mesh-ancestor
111041645|NCT04659616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111041646|NCT04659616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111041647|NCT04659616|Immunologic Factors|immunologic factors|mesh-ancestor
111041648|NCT04659616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111041649|NCT04659616|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111041650|NCT04659616|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111041651|NCT04659616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111041652|NCT04659616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111041653|NCT04627870|Paclitaxel|paclitaxel|mesh-list
111041654|NCT04627870|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111041655|NCT04627870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111041656|NCT04627870|Tubulin Modulators|tubulin modulators|mesh-ancestor
111041657|NCT04627870|Antimitotic Agents|antimitotic agents|mesh-ancestor
111041658|NCT04627870|Mitosis Modulators|mitosis modulators|mesh-ancestor
111041659|NCT04627870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111041660|NCT04610671|Nivolumab|nivolumab|mesh-list
111041661|NCT04610671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111041662|NCT04610671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111041663|NCT04610671|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111041664|NCT04610671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111041665|NCT04595617|Antibodies|antibodies|mesh-list
111041666|NCT04595617|Immunologic Factors|immunologic factors|mesh-ancestor
111041667|NCT04595617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111041668|NCT04564742|Dapagliflozin|dapagliflozin|mesh-list
111041669|NCT04564742|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111041670|NCT04564742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111041671|NCT04564742|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111041672|NCT04564742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111041673|NCT04508790|Dexamethasone|dexamethasone|mesh-list
111041674|NCT04508790|Dexamethasone acetate|dexamethasone acetate|mesh-list
111041675|NCT04508790|Pomalidomide|pomalidomide|mesh-list
111041676|NCT04508790|Ichthammol|ichthammol|mesh-list
111041677|NCT04508790|BB 1101|bb 1101|mesh-list
111041678|NCT04508790|Leflunomide|leflunomide|mesh-list
110627733|NCT02549742|Bleomycin|bleomycin|mesh-list
111041679|NCT04508790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111041680|NCT04508790|Antiemetics|antiemetics|mesh-ancestor
111041681|NCT04508790|Autonomic Agents|autonomic agents|mesh-ancestor
111041682|NCT04508790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111041683|NCT04508790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111041684|NCT04508790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111041685|NCT04508790|Glucocorticoids|glucocorticoids|mesh-ancestor
111041686|NCT04508790|Hormones|hormones|mesh-ancestor
111119156|NCT05306873|Cyclosporine|cyclosporine|mesh-list
111041687|NCT04508790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111041688|NCT04508790|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111041689|NCT04508790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111041690|NCT04508790|Protease Inhibitors|protease inhibitors|mesh-ancestor
111041691|NCT04508790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111041692|NCT04508790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111041693|NCT04508790|Immunologic Factors|immunologic factors|mesh-ancestor
111041694|NCT04508790|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111041695|NCT04508790|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111041696|NCT04508790|Growth Substances|growth substances|mesh-ancestor
111041697|NCT04508790|Growth Inhibitors|growth inhibitors|mesh-ancestor
111041698|NCT04508790|Dermatologic Agents|dermatologic agents|mesh-ancestor
111041699|NCT04508790|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111041700|NCT04492566|Pancrelipase|pancrelipase|mesh-list
111041701|NCT04492566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111041702|NCT04393389|Paclitaxel|paclitaxel|mesh-list
111041703|NCT04393389|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111041704|NCT04393389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111041705|NCT04393389|Tubulin Modulators|tubulin modulators|mesh-ancestor
111041706|NCT04393389|Antimitotic Agents|antimitotic agents|mesh-ancestor
111041707|NCT04393389|Mitosis Modulators|mitosis modulators|mesh-ancestor
111041708|NCT04393389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111041709|NCT04273061|Atezolizumab|atezolizumab|mesh-list
111041710|NCT04273061|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111041711|NCT04273061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111041712|NCT04273061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111041713|NCT04273061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111041714|NCT04256317|Azacitidine|azacitidine|mesh-list
111041715|NCT04256317|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111041716|NCT04256317|Antimetabolites|antimetabolites|mesh-ancestor
111041717|NCT04256317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111041718|NCT04256317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111041719|NCT04256317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111041720|NCT04161248|Dexamethasone|dexamethasone|mesh-list
111041721|NCT04161248|Rituximab|rituximab|mesh-list
111041722|NCT04161248|Gemcitabine|gemcitabine|mesh-list
111041723|NCT04161248|Venetoclax|venetoclax|mesh-list
111041724|NCT04161248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111041725|NCT04161248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111041726|NCT04161248|Immunologic Factors|immunologic factors|mesh-ancestor
111041727|NCT04161248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111041728|NCT04161248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111041729|NCT04161248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111041730|NCT04161248|Antiemetics|antiemetics|mesh-ancestor
111041731|NCT04161248|Autonomic Agents|autonomic agents|mesh-ancestor
111041732|NCT04161248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111041733|NCT04161248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111041734|NCT04161248|Glucocorticoids|glucocorticoids|mesh-ancestor
111041735|NCT04161248|Hormones|hormones|mesh-ancestor
111041736|NCT04161248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111041737|NCT04161248|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111041738|NCT04161248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111041739|NCT04161248|Antimetabolites|antimetabolites|mesh-ancestor
111041740|NCT04161248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111041741|NCT04151667|Dexamethasone|dexamethasone|mesh-list
111041742|NCT04151667|Lenalidomide|lenalidomide|mesh-list
111041743|NCT04151667|Bortezomib|bortezomib|mesh-list
111041744|NCT04151667|Daratumumab|daratumumab|mesh-list
111041745|NCT04151667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111041746|NCT04151667|Antiemetics|antiemetics|mesh-ancestor
111041747|NCT04151667|Autonomic Agents|autonomic agents|mesh-ancestor
111041748|NCT04151667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111041749|NCT04151667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111041750|NCT04151667|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111041751|NCT04151667|Glucocorticoids|glucocorticoids|mesh-ancestor
111041752|NCT04151667|Hormones|hormones|mesh-ancestor
111041753|NCT04151667|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111041754|NCT04151667|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111041755|NCT04151667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111041756|NCT04151667|Immunologic Factors|immunologic factors|mesh-ancestor
111041757|NCT04151667|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111041758|NCT04151667|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111041759|NCT04151667|Growth Substances|growth substances|mesh-ancestor
111041760|NCT04151667|Growth Inhibitors|growth inhibitors|mesh-ancestor
111041762|NCT04140266|Emtricitabine|emtricitabine|mesh-list
111041763|NCT04140266|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110758823|NCT01130298|Testosterone|testosterone|mesh-list
111041764|NCT04140266|Dapivirine|dapivirine|mesh-list
111041765|NCT04140266|Antiviral Agents|antiviral agents|mesh-ancestor
111041766|NCT04140266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111041767|NCT04140266|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111041768|NCT04140266|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111041769|NCT04140266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111041770|NCT04140266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111041771|NCT04140266|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111041772|NCT04140266|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111041773|NCT04120415|Vedolizumab|vedolizumab|mesh-list
111041774|NCT04120415|Vaccines|vaccines|mesh-list
111041775|NCT04120415|Immunologic Factors|immunologic factors|mesh-ancestor
111041776|NCT04120415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111041777|NCT04120415|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111041778|NCT04102098|Bevacizumab|bevacizumab|mesh-list
111041779|NCT04102098|Atezolizumab|atezolizumab|mesh-list
111041780|NCT04102098|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111041781|NCT04102098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111041782|NCT04102098|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111041783|NCT04102098|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111041784|NCT04102098|Growth Substances|growth substances|mesh-ancestor
111041785|NCT04102098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111041786|NCT04102098|Growth Inhibitors|growth inhibitors|mesh-ancestor
111041787|NCT04102098|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111041788|NCT04102098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111041789|NCT04093570|Decitabine|decitabine|mesh-list
111041790|NCT04093570|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
111041791|NCT04093570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111041792|NCT04093570|Antimetabolites|antimetabolites|mesh-ancestor
111041793|NCT04093570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111041794|NCT04093570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111041795|NCT04093570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111041796|NCT04093167|Pembrolizumab|pembrolizumab|mesh-list
110627753|NCT00521014|Antimetabolites|antimetabolites|mesh-ancestor
111041797|NCT04093167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111041798|NCT04093167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111041799|NCT04093167|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111041800|NCT04093167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111041801|NCT04034004|Naloxone|naloxone|mesh-list
111041802|NCT04034004|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111041803|NCT04034004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111041804|NCT04034004|Sensory System Agents|sensory system agents|mesh-ancestor
111041805|NCT04034004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111041806|NCT03971461|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
111041807|NCT03971461|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111041808|NCT03971461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111041809|NCT03960008|Doxorubicin|doxorubicin|mesh-list
111041810|NCT03960008|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111041811|NCT03960008|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111041812|NCT03960008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111041813|NCT03960008|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111041814|NCT03960008|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111041815|NCT03960008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111041816|NCT03960008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111041817|NCT03939520|Pirfenidone|pirfenidone|mesh-list
111041818|NCT03939520|Nintedanib|nintedanib|mesh-list
111041819|NCT03939520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111041820|NCT03939520|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111041821|NCT03939520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111041822|NCT03939520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111041823|NCT03939520|Analgesics|analgesics|mesh-ancestor
111041824|NCT03939520|Sensory System Agents|sensory system agents|mesh-ancestor
111041825|NCT03939520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111041826|NCT03939520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111041827|NCT03939520|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111041828|NCT03939520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111041829|NCT03939520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111041830|NCT03939520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111041832|NCT03926143|Tubulin Modulators|tubulin modulators|mesh-list
111041833|NCT03926143|Anetumab ravtansine|anetumab ravtansine|mesh-list
111041834|NCT03926143|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111041835|NCT03926143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111041836|NCT03926143|Antimitotic Agents|antimitotic agents|mesh-ancestor
111041837|NCT03926143|Mitosis Modulators|mitosis modulators|mesh-ancestor
111041838|NCT03926143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111041839|NCT03926143|Immunoconjugates|immunoconjugates|mesh-ancestor
111041840|NCT03926143|Immunologic Factors|immunologic factors|mesh-ancestor
111041841|NCT03926143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111041842|NCT03878459|Pioglitazone|pioglitazone|mesh-list
111041843|NCT03878459|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111041844|NCT03878459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111041845|NCT03876262|Ivermectin|ivermectin|mesh-list
111041846|NCT03876262|Moxidectin|moxidectin|mesh-list
111041847|NCT03876262|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111041848|NCT03876262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111041849|NCT03876262|Anthelmintics|anthelmintics|mesh-ancestor
111041850|NCT03876262|Antinematodal Agents|antinematodal agents|mesh-ancestor
111041851|NCT03867682|Venetoclax|venetoclax|mesh-list
111041852|NCT03867682|Lintuzumab|lintuzumab|mesh-list
111041853|NCT03867682|Spironolactone|spironolactone|mesh-list
111041854|NCT03867682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111041855|NCT03867682|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
111041856|NCT03867682|Hormone Antagonists|hormone antagonists|mesh-ancestor
111041857|NCT03867682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111041858|NCT03867682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111041859|NCT03867682|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
111041860|NCT03867682|Diuretics|diuretics|mesh-ancestor
111041861|NCT03867682|Natriuretic Agents|natriuretic agents|mesh-ancestor
111041862|NCT03867682|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111041863|NCT03846505|Oxytocin|oxytocin|mesh-list
111041864|NCT03846505|Oxytocics|oxytocics|mesh-ancestor
111041865|NCT03846505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111041866|NCT03846505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111041867|NCT03822897|Cisplatin|cisplatin|mesh-list
111041868|NCT03822897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111041869|NCT03815643|Avelumab|avelumab|mesh-list
111041870|NCT03815643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111041871|NCT03815643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111041872|NCT03799003|Pembrolizumab|pembrolizumab|mesh-list
111041873|NCT03799003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111041874|NCT03799003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111041875|NCT03799003|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111041876|NCT03799003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111041877|NCT03768570|Durvalumab|durvalumab|mesh-list
111041878|NCT03768570|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111041879|NCT03768570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111041880|NCT03617445|Vancomycin|vancomycin|mesh-list
111041881|NCT03617445|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111041882|NCT03617445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111041883|NCT03593317|Spironolactone|spironolactone|mesh-list
111041884|NCT03593317|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
111041885|NCT03593317|Hormone Antagonists|hormone antagonists|mesh-ancestor
111041886|NCT03593317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111041887|NCT03593317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111041888|NCT03593317|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
111041889|NCT03593317|Diuretics|diuretics|mesh-ancestor
111041890|NCT03593317|Natriuretic Agents|natriuretic agents|mesh-ancestor
111041891|NCT03574571|Docetaxel|docetaxel|mesh-list
111041892|NCT03574571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111041893|NCT03574571|Tubulin Modulators|tubulin modulators|mesh-ancestor
111041894|NCT03574571|Antimitotic Agents|antimitotic agents|mesh-ancestor
111041895|NCT03574571|Mitosis Modulators|mitosis modulators|mesh-ancestor
111041896|NCT03574571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111041897|NCT03550391|Memantine|memantine|mesh-list
111041898|NCT03550391|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111041899|NCT03550391|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111041900|NCT03550391|Dopamine Agents|dopamine agents|mesh-ancestor
111041901|NCT03550391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111041902|NCT03550391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111041903|NCT03550391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111041904|NCT03550391|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111041905|NCT03550391|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111041907|NCT03480776|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111041908|NCT03480776|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111041909|NCT03480776|Analgesics|analgesics|mesh-ancestor
111041910|NCT03480776|Sensory System Agents|sensory system agents|mesh-ancestor
111041911|NCT03480776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111041912|NCT03480776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111041913|NCT03480776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111041914|NCT03480776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111041915|NCT03480776|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111041916|NCT03480776|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111041917|NCT03480776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111041918|NCT03480776|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111041919|NCT03480776|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111041920|NCT03480776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111041921|NCT03480776|Antipyretics|antipyretics|mesh-ancestor
111041922|NCT03456063|Paclitaxel|paclitaxel|mesh-list
111041923|NCT03456063|Carboplatin|carboplatin|mesh-list
111041924|NCT03456063|Gemcitabine|gemcitabine|mesh-list
111041925|NCT03456063|Pemetrexed|pemetrexed|mesh-list
111041926|NCT03456063|Atezolizumab|atezolizumab|mesh-list
111041927|NCT03456063|Antibodies|antibodies|mesh-list
111041928|NCT03456063|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111041929|NCT03456063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111041930|NCT03456063|Tubulin Modulators|tubulin modulators|mesh-ancestor
111041931|NCT03456063|Antimitotic Agents|antimitotic agents|mesh-ancestor
111041932|NCT03456063|Mitosis Modulators|mitosis modulators|mesh-ancestor
111041933|NCT03456063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111041934|NCT03456063|Immunologic Factors|immunologic factors|mesh-ancestor
111041935|NCT03456063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111041936|NCT03456063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111041937|NCT03456063|Antimetabolites|antimetabolites|mesh-ancestor
111041938|NCT03456063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111041939|NCT03456063|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111041940|NCT03456063|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111041941|NCT03456063|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111041942|NCT03456063|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111041943|NCT03450018|Gemcitabine|gemcitabine|mesh-list
111041944|NCT03450018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111041945|NCT03450018|Antimetabolites|antimetabolites|mesh-ancestor
111041946|NCT03450018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111041947|NCT03450018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111041948|NCT03421652|Nivolumab|nivolumab|mesh-list
111041949|NCT03421652|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111041950|NCT03421652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111041951|NCT03421652|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111041952|NCT03421652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111041953|NCT03410615|Durvalumab|durvalumab|mesh-list
111041954|NCT03410615|Tremelimumab|tremelimumab|mesh-list
111041955|NCT03410615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111041956|NCT03410615|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111041957|NCT03297606|Nivolumab|nivolumab|mesh-list
111041958|NCT03297606|Trastuzumab|trastuzumab|mesh-list
111041959|NCT03297606|Ipilimumab|ipilimumab|mesh-list
111041960|NCT03297606|Pertuzumab|pertuzumab|mesh-list
111041961|NCT03297606|Sunitinib|sunitinib|mesh-list
111041962|NCT03297606|Dasatinib|dasatinib|mesh-list
111041963|NCT03297606|Olaparib|olaparib|mesh-list
111041964|NCT03297606|Palbociclib|palbociclib|mesh-list
111041965|NCT03297606|Temsirolimus|temsirolimus|mesh-list
111041966|NCT03297606|Axitinib|axitinib|mesh-list
111041967|NCT03297606|Vemurafenib|vemurafenib|mesh-list
111041968|NCT03297606|Crizotinib|crizotinib|mesh-list
111041969|NCT03297606|Tucatinib|tucatinib|mesh-list
111041970|NCT03297606|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111041971|NCT03297606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111041972|NCT03297606|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111041973|NCT03297606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111041974|NCT03297606|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111041975|NCT03297606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111041976|NCT03297606|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111041977|NCT03297606|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111041978|NCT03297606|Growth Substances|growth substances|mesh-ancestor
111041979|NCT03297606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111041980|NCT03297606|Growth Inhibitors|growth inhibitors|mesh-ancestor
111041981|NCT03297606|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111041982|NCT03297606|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111041983|NCT03297606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111041985|NCT03215524|Thalidomide|thalidomide|mesh-list
111041986|NCT03215524|Dexamethasone|dexamethasone|mesh-list
111041987|NCT03215524|Dexamethasone acetate|dexamethasone acetate|mesh-list
111041988|NCT03215524|Cyclophosphamide|cyclophosphamide|mesh-list
111041989|NCT03215524|Daratumumab|daratumumab|mesh-list
111041990|NCT03215524|Pomalidomide|pomalidomide|mesh-list
111041991|NCT03215524|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111041992|NCT03215524|BB 1101|bb 1101|mesh-list
111041993|NCT03215524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111041994|NCT03215524|Immunologic Factors|immunologic factors|mesh-ancestor
111041995|NCT03215524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111041996|NCT03215524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111041997|NCT03215524|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111041998|NCT03215524|Alkylating Agents|alkylating agents|mesh-ancestor
111041999|NCT03215524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111042000|NCT03215524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111042001|NCT03215524|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111042002|NCT03215524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111042003|NCT03215524|Antiemetics|antiemetics|mesh-ancestor
111042004|NCT03215524|Autonomic Agents|autonomic agents|mesh-ancestor
111042005|NCT03215524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111042006|NCT03215524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111042007|NCT03215524|Glucocorticoids|glucocorticoids|mesh-ancestor
111042008|NCT03215524|Hormones|hormones|mesh-ancestor
111042009|NCT03215524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111042010|NCT03215524|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111042011|NCT03215524|Protease Inhibitors|protease inhibitors|mesh-ancestor
111042012|NCT03215524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111042013|NCT03215524|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111042014|NCT03215524|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111042015|NCT03215524|Growth Substances|growth substances|mesh-ancestor
111042016|NCT03215524|Growth Inhibitors|growth inhibitors|mesh-ancestor
111042017|NCT03215524|Leprostatic Agents|leprostatic agents|mesh-ancestor
111042018|NCT03215524|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111042019|NCT03215524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111042020|NCT03045029|Treprostinil|treprostinil|mesh-list
111042021|NCT03045029|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111042022|NCT03018080|Paclitaxel|paclitaxel|mesh-list
111042023|NCT03018080|Pembrolizumab|pembrolizumab|mesh-list
111042024|NCT03018080|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111042025|NCT03018080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111042026|NCT03018080|Tubulin Modulators|tubulin modulators|mesh-ancestor
111042027|NCT03018080|Antimitotic Agents|antimitotic agents|mesh-ancestor
111042028|NCT03018080|Mitosis Modulators|mitosis modulators|mesh-ancestor
111042029|NCT03018080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111042030|NCT03018080|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111042031|NCT03018080|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111042032|NCT02907983|Bupivacaine|bupivacaine|mesh-list
111042033|NCT02907983|Anesthetics, Local|anesthetics, local|mesh-ancestor
111042034|NCT02907983|Anesthetics|anesthetics|mesh-ancestor
111042035|NCT02907983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111042036|NCT02907983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111042037|NCT02907983|Sensory System Agents|sensory system agents|mesh-ancestor
111042038|NCT02907983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111042039|NCT02905318|Palbociclib|palbociclib|mesh-list
111042040|NCT02905318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111042041|NCT02905318|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111042042|NCT02905318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111042043|NCT02905318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111042044|NCT02821013|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
111042045|NCT02821013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111042046|NCT02821013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111042047|NCT02821013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111042048|NCT02811133|Inositol|inositol|mesh-list
111042049|NCT02811133|Vitamin B Complex|vitamin b complex|mesh-ancestor
111042050|NCT02811133|Vitamins|vitamins|mesh-ancestor
111042051|NCT02811133|Micronutrients|micronutrients|mesh-ancestor
111042052|NCT02811133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111042053|NCT02799641|Lidocaine|lidocaine|mesh-list
111042054|NCT02799641|Diazepam|diazepam|mesh-list
111042055|NCT02799641|Anesthetics, Local|anesthetics, local|mesh-ancestor
111042056|NCT02799641|Anesthetics|anesthetics|mesh-ancestor
111042057|NCT02799641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111042058|NCT02799641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111042060|NCT02799641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111042061|NCT02799641|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111042062|NCT02799641|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111042063|NCT02799641|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111042064|NCT02799641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111042065|NCT02799641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111042066|NCT02799641|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110759117|NCT03919812|Vitamin D|vitamin d|mesh-list
111042067|NCT02799641|Anticonvulsants|anticonvulsants|mesh-ancestor
111042068|NCT02799641|Antiemetics|antiemetics|mesh-ancestor
111042069|NCT02799641|Autonomic Agents|autonomic agents|mesh-ancestor
111042070|NCT02799641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111042071|NCT02799641|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111042072|NCT02799641|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
111042073|NCT02799641|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111042074|NCT02799641|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111042075|NCT02799641|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111042076|NCT02799641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111042077|NCT02799641|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111042078|NCT02799641|Anesthetics, General|anesthetics, general|mesh-ancestor
111042079|NCT02799641|GABA Modulators|gaba modulators|mesh-ancestor
111042080|NCT02799641|GABA Agents|gaba agents|mesh-ancestor
111042081|NCT02799641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111042082|NCT02784171|Pembrolizumab|pembrolizumab|mesh-list
111042083|NCT02784171|Pemetrexed|pemetrexed|mesh-list
111042084|NCT02784171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111042085|NCT02784171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111042086|NCT02784171|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111042087|NCT02784171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111042088|NCT02784171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111042089|NCT02784171|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111042090|NCT02784171|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111042091|NCT02782546|Mycophenolic Acid|mycophenolic acid|mesh-list
111042092|NCT02782546|Tacrolimus|tacrolimus|mesh-list
111042093|NCT02782546|Lenograstim|lenograstim|mesh-list
111042094|NCT02782546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111042095|NCT02782546|Immunologic Factors|immunologic factors|mesh-ancestor
111042096|NCT02782546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111042097|NCT02782546|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111042098|NCT02782546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111042099|NCT02782546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111042100|NCT02782546|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111042101|NCT02782546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111042102|NCT02782546|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111042103|NCT02782546|Antitubercular Agents|antitubercular agents|mesh-ancestor
111042104|NCT02782546|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111042105|NCT02782546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111042106|NCT02782546|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111042107|NCT02781090|Nicotine|nicotine|mesh-list
111042108|NCT02781090|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111042109|NCT02781090|Autonomic Agents|autonomic agents|mesh-ancestor
111042110|NCT02781090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111042111|NCT02781090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111042112|NCT02781090|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111042113|NCT02781090|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111042114|NCT02781090|Cholinergic Agents|cholinergic agents|mesh-ancestor
111042115|NCT02781090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111042116|NCT02781090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111042117|NCT02774291|Aldesleukin|aldesleukin|mesh-list
111042118|NCT02774291|Cyclophosphamide|cyclophosphamide|mesh-list
111042119|NCT02774291|Fludarabine|fludarabine|mesh-list
111042120|NCT02774291|Fludarabine phosphate|fludarabine phosphate|mesh-list
111042121|NCT02774291|Interleukin-2|interleukin-2|mesh-list
111042122|NCT02774291|Lenograstim|lenograstim|mesh-list
111042123|NCT02774291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111042124|NCT02774291|Immunologic Factors|immunologic factors|mesh-ancestor
111042125|NCT02774291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111042126|NCT02774291|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111042127|NCT02774291|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111042128|NCT02774291|Alkylating Agents|alkylating agents|mesh-ancestor
111042129|NCT02774291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111042130|NCT02774291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111042131|NCT02774291|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111042132|NCT02774291|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111042133|NCT02774291|Antimetabolites|antimetabolites|mesh-ancestor
111042134|NCT02774291|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111042135|NCT02774291|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111042136|NCT02774291|Analgesics|analgesics|mesh-ancestor
111042137|NCT02774291|Sensory System Agents|sensory system agents|mesh-ancestor
111042138|NCT02774291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111042139|NCT02774291|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111042140|NCT02774291|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111042141|NCT02774291|Antiviral Agents|antiviral agents|mesh-ancestor
111042142|NCT02774291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111042143|NCT02734771|Prednisone|prednisone|mesh-list
111042145|NCT02734771|Rituximab|rituximab|mesh-list
111042146|NCT02734771|Doxorubicin|doxorubicin|mesh-list
111042147|NCT02734771|Brentuximab Vedotin|brentuximab vedotin|mesh-list
111042148|NCT02734771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111042149|NCT02734771|Immunologic Factors|immunologic factors|mesh-ancestor
111042150|NCT02734771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111042151|NCT02734771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111042152|NCT02734771|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111042153|NCT02734771|Alkylating Agents|alkylating agents|mesh-ancestor
111042154|NCT02734771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111042155|NCT02734771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111042156|NCT02734771|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111042157|NCT02734771|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111042158|NCT02734771|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111042159|NCT02734771|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111042160|NCT02734771|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111042161|NCT02734771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111042162|NCT02734771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111042163|NCT02734771|Glucocorticoids|glucocorticoids|mesh-ancestor
111042164|NCT02734771|Hormones|hormones|mesh-ancestor
111042165|NCT02734771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111042166|NCT02734771|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111042167|NCT02734771|Immunotoxins|immunotoxins|mesh-ancestor
111042168|NCT02734771|Immunoconjugates|immunoconjugates|mesh-ancestor
111042169|NCT02704858|Perillyl alcohol|perillyl alcohol|mesh-list
111042170|NCT02704858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111042171|NCT02704858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111042172|NCT02704858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111042173|NCT02689024|Acetaminophen|acetaminophen|mesh-list
111042174|NCT02689024|Dipyrone|dipyrone|mesh-list
111042175|NCT02689024|Ibuprofen|ibuprofen|mesh-list
111042176|NCT02689024|Diclofenac|diclofenac|mesh-list
111042177|NCT02689024|Naproxen|naproxen|mesh-list
111042178|NCT02689024|Fentanyl|fentanyl|mesh-list
111042179|NCT02689024|Morphine|morphine|mesh-list
111042180|NCT02689024|Bupivacaine|bupivacaine|mesh-list
111042181|NCT02689024|Ropivacaine|ropivacaine|mesh-list
111042182|NCT02689024|Levobupivacaine|levobupivacaine|mesh-list
111042183|NCT02689024|Anesthetics, Local|anesthetics, local|mesh-ancestor
111042184|NCT02689024|Anesthetics|anesthetics|mesh-ancestor
111042185|NCT02689024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111042186|NCT02689024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111042187|NCT02689024|Sensory System Agents|sensory system agents|mesh-ancestor
111042188|NCT02689024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111042189|NCT02689024|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111042190|NCT02689024|Narcotics|narcotics|mesh-ancestor
111042191|NCT02689024|Analgesics|analgesics|mesh-ancestor
111042192|NCT02689024|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111042193|NCT02689024|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111042194|NCT02689024|Anesthetics, General|anesthetics, general|mesh-ancestor
111042195|NCT02689024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111042196|NCT02689024|Antipyretics|antipyretics|mesh-ancestor
111042197|NCT02689024|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111042198|NCT02689024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111042199|NCT02689024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111042200|NCT02689024|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111042201|NCT02689024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111042202|NCT02689024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111042203|NCT02689024|Gout Suppressants|gout suppressants|mesh-ancestor
111042204|NCT02658279|Pembrolizumab|pembrolizumab|mesh-list
111042205|NCT02658279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111042206|NCT02658279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111042207|NCT02658279|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111042208|NCT02658279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111042209|NCT02649686|Trastuzumab|trastuzumab|mesh-list
111042210|NCT02649686|Durvalumab|durvalumab|mesh-list
111042211|NCT02649686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111042212|NCT02649686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111042213|NCT02486718|Gemcitabine|gemcitabine|mesh-list
111042214|NCT02486718|Docetaxel|docetaxel|mesh-list
111042215|NCT02486718|Pemetrexed|pemetrexed|mesh-list
111042216|NCT02486718|Atezolizumab|atezolizumab|mesh-list
111042217|NCT02486718|Vinorelbine|vinorelbine|mesh-list
110759274|NCT01233492|Mannitol|mannitol|mesh-list
111042218|NCT02486718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111042219|NCT02486718|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111042220|NCT02486718|Antimetabolites|antimetabolites|mesh-ancestor
111042221|NCT02486718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111042222|NCT02486718|Tubulin Modulators|tubulin modulators|mesh-ancestor
111042223|NCT02486718|Antimitotic Agents|antimitotic agents|mesh-ancestor
111042224|NCT02486718|Mitosis Modulators|mitosis modulators|mesh-ancestor
111042225|NCT02486718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111042226|NCT02486718|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111042227|NCT02486718|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111042228|NCT02486718|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111042229|NCT02486718|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111042230|NCT02486718|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111042231|NCT02436707|Dexamethasone|dexamethasone|mesh-list
111042232|NCT02436707|Cyclophosphamide|cyclophosphamide|mesh-list
111042233|NCT02436707|Rituximab|rituximab|mesh-list
111042234|NCT02436707|Gemcitabine|gemcitabine|mesh-list
111042235|NCT02436707|Etoposide|etoposide|mesh-list
111042236|NCT02436707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111042237|NCT02436707|Immunologic Factors|immunologic factors|mesh-ancestor
111042238|NCT02436707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111042239|NCT02436707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111042240|NCT02436707|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111042241|NCT02436707|Alkylating Agents|alkylating agents|mesh-ancestor
111042242|NCT02436707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111042243|NCT02436707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111042244|NCT02436707|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111042245|NCT02436707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111042246|NCT02436707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111042247|NCT02436707|Antiemetics|antiemetics|mesh-ancestor
111042248|NCT02436707|Autonomic Agents|autonomic agents|mesh-ancestor
111042249|NCT02436707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111042250|NCT02436707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111042251|NCT02436707|Glucocorticoids|glucocorticoids|mesh-ancestor
111042252|NCT02436707|Hormones|hormones|mesh-ancestor
111042253|NCT02436707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111042254|NCT02436707|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111042255|NCT02436707|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111042256|NCT02436707|Antimetabolites|antimetabolites|mesh-ancestor
111042257|NCT02436707|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111042258|NCT02436707|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111042259|NCT02436707|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111042260|NCT02436707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111042261|NCT02337985|Prednisone|prednisone|mesh-list
111042262|NCT02337985|Cyclophosphamide|cyclophosphamide|mesh-list
111042263|NCT02337985|Rituximab|rituximab|mesh-list
111042264|NCT02337985|Doxorubicin|doxorubicin|mesh-list
111042265|NCT02337985|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111042266|NCT02337985|Etoposide|etoposide|mesh-list
111042267|NCT02337985|Vincristine|vincristine|mesh-list
111042268|NCT02337985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111042269|NCT02337985|Immunologic Factors|immunologic factors|mesh-ancestor
111042270|NCT02337985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111042271|NCT02337985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111042272|NCT02337985|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111042273|NCT02337985|Alkylating Agents|alkylating agents|mesh-ancestor
111042274|NCT02337985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111042275|NCT02337985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111042276|NCT02337985|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111042277|NCT02337985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111042278|NCT02337985|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111042279|NCT02337985|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111042280|NCT02337985|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111042281|NCT02337985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111042282|NCT02337985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111042283|NCT02337985|Glucocorticoids|glucocorticoids|mesh-ancestor
111042284|NCT02337985|Hormones|hormones|mesh-ancestor
111042285|NCT02337985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111042286|NCT02337985|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111042287|NCT02337985|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111042288|NCT02337985|Tubulin Modulators|tubulin modulators|mesh-ancestor
111042289|NCT02337985|Antimitotic Agents|antimitotic agents|mesh-ancestor
111042290|NCT02337985|Mitosis Modulators|mitosis modulators|mesh-ancestor
111042291|NCT02273375|Durvalumab|durvalumab|mesh-list
111042292|NCT02273375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111042293|NCT02273375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111042294|NCT02153580|Cyclophosphamide|cyclophosphamide|mesh-list
111042295|NCT02153580|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
111042296|NCT02153580|Fludarabine|fludarabine|mesh-list
111042297|NCT02153580|Fludarabine phosphate|fludarabine phosphate|mesh-list
111042298|NCT02153580|Etoposide|etoposide|mesh-list
111042299|NCT02153580|Etoposide phosphate|etoposide phosphate|mesh-list
111042300|NCT02153580|Podophyllotoxin|podophyllotoxin|mesh-list
111042301|NCT02153580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111042302|NCT02153580|Immunologic Factors|immunologic factors|mesh-ancestor
111042303|NCT02153580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111042304|NCT02153580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111042305|NCT02153580|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111042306|NCT02153580|Alkylating Agents|alkylating agents|mesh-ancestor
111042307|NCT02153580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111042308|NCT02153580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111042309|NCT02153580|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111042310|NCT02153580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111042311|NCT02153580|Antimetabolites|antimetabolites|mesh-ancestor
111042312|NCT02153580|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111042313|NCT02153580|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111042314|NCT02153580|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111042315|NCT02153580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111042316|NCT02153580|Keratolytic Agents|keratolytic agents|mesh-ancestor
111042317|NCT02153580|Dermatologic Agents|dermatologic agents|mesh-ancestor
111042318|NCT02153580|Tubulin Modulators|tubulin modulators|mesh-ancestor
111042319|NCT02153580|Antimitotic Agents|antimitotic agents|mesh-ancestor
111042320|NCT02153580|Mitosis Modulators|mitosis modulators|mesh-ancestor
111042321|NCT02144584|Memantine|memantine|mesh-list
111042322|NCT02144584|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111042323|NCT02144584|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111042324|NCT02144584|Dopamine Agents|dopamine agents|mesh-ancestor
111042325|NCT02144584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111042326|NCT02144584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111042327|NCT02144584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111042328|NCT02144584|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111042329|NCT02144584|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111042330|NCT02124421|Paclitaxel|paclitaxel|mesh-list
111042331|NCT02124421|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111042332|NCT02124421|Carboplatin|carboplatin|mesh-list
111042333|NCT02124421|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111042334|NCT02124421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111042335|NCT02124421|Tubulin Modulators|tubulin modulators|mesh-ancestor
111042336|NCT02124421|Antimitotic Agents|antimitotic agents|mesh-ancestor
111042337|NCT02124421|Mitosis Modulators|mitosis modulators|mesh-ancestor
111042338|NCT02124421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111042339|NCT01897571|Prednisolone|prednisolone|mesh-list
111042340|NCT01897571|Prednisolone acetate|prednisolone acetate|mesh-list
111042341|NCT01897571|Prednisolone phosphate|prednisolone phosphate|mesh-list
111042342|NCT01897571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111042343|NCT01897571|Glucocorticoids|glucocorticoids|mesh-ancestor
111042344|NCT01897571|Hormones|hormones|mesh-ancestor
111042345|NCT01897571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111042346|NCT01897571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111042347|NCT01897571|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111042348|NCT01897571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111042349|NCT01846390|Dexamethasone|dexamethasone|mesh-list
111042350|NCT01846390|Gemcitabine|gemcitabine|mesh-list
111042351|NCT01846390|Romidepsin|romidepsin|mesh-list
111042352|NCT01846390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111042353|NCT01846390|Antiemetics|antiemetics|mesh-ancestor
111042354|NCT01846390|Autonomic Agents|autonomic agents|mesh-ancestor
111042355|NCT01846390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111042356|NCT01846390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111042357|NCT01846390|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111042358|NCT01846390|Glucocorticoids|glucocorticoids|mesh-ancestor
111042359|NCT01846390|Hormones|hormones|mesh-ancestor
111042360|NCT01846390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111042361|NCT01846390|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111042362|NCT01846390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111042363|NCT01846390|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111042364|NCT01846390|Antimetabolites|antimetabolites|mesh-ancestor
111042365|NCT01846390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111042366|NCT01846390|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111042367|NCT01846390|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111042368|NCT01846390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111042369|NCT01783197|Paclitaxel|paclitaxel|mesh-list
111042370|NCT01783197|Carboplatin|carboplatin|mesh-list
111042371|NCT01783197|Pemetrexed|pemetrexed|mesh-list
111042372|NCT01783197|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111042373|NCT01783197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111042374|NCT01783197|Tubulin Modulators|tubulin modulators|mesh-ancestor
111042375|NCT01783197|Antimitotic Agents|antimitotic agents|mesh-ancestor
111042376|NCT01783197|Mitosis Modulators|mitosis modulators|mesh-ancestor
111042377|NCT01783197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111042378|NCT01783197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111042379|NCT01783197|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111042380|NCT01783197|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111042381|NCT01765855|Betrixaban|betrixaban|mesh-list
111042382|NCT01765855|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111042383|NCT01765855|Antithrombins|antithrombins|mesh-ancestor
111042384|NCT01765855|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111042385|NCT01765855|Protease Inhibitors|protease inhibitors|mesh-ancestor
111042386|NCT01765855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111042387|NCT01765855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111042388|NCT01765855|Anticoagulants|anticoagulants|mesh-ancestor
111042389|NCT01708993|Docetaxel|docetaxel|mesh-list
111042390|NCT01708993|Pemetrexed|pemetrexed|mesh-list
111042391|NCT01708993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111042392|NCT01708993|Tubulin Modulators|tubulin modulators|mesh-ancestor
111042393|NCT01708993|Antimitotic Agents|antimitotic agents|mesh-ancestor
111042394|NCT01708993|Mitosis Modulators|mitosis modulators|mesh-ancestor
111042395|NCT01708993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111042396|NCT01708993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111042397|NCT01708993|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111042398|NCT01708993|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111042399|NCT01656538|Paclitaxel|paclitaxel|mesh-list
111042400|NCT01656538|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111042401|NCT01656538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111042402|NCT01656538|Tubulin Modulators|tubulin modulators|mesh-ancestor
111042403|NCT01656538|Antimitotic Agents|antimitotic agents|mesh-ancestor
111042404|NCT01656538|Mitosis Modulators|mitosis modulators|mesh-ancestor
111042405|NCT01656538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111042406|NCT01651403|Tenofovir|tenofovir|mesh-list
111042407|NCT01651403|Antiviral Agents|antiviral agents|mesh-ancestor
111042408|NCT01651403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111042409|NCT01651403|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111042410|NCT01651403|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111042411|NCT01651403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111042412|NCT01651403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111042413|NCT01651403|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111042414|NCT01651403|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111042415|NCT01619813|Prednisone|prednisone|mesh-list
111042416|NCT01619813|Docetaxel|docetaxel|mesh-list
111042417|NCT01619813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111042418|NCT01619813|Tubulin Modulators|tubulin modulators|mesh-ancestor
111042419|NCT01619813|Antimitotic Agents|antimitotic agents|mesh-ancestor
111042420|NCT01619813|Mitosis Modulators|mitosis modulators|mesh-ancestor
111042421|NCT01619813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111042422|NCT01619813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111042423|NCT01619813|Glucocorticoids|glucocorticoids|mesh-ancestor
111042424|NCT01619813|Hormones|hormones|mesh-ancestor
111042425|NCT01619813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111042426|NCT01619813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111042427|NCT01619813|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111042428|NCT01591421|Panitumumab|panitumumab|mesh-list
111042429|NCT01591421|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111042430|NCT01591421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111042431|NCT01419834|Antibodies|antibodies|mesh-list
111042432|NCT01419834|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111042433|NCT01419834|Immunologic Factors|immunologic factors|mesh-ancestor
111042434|NCT01419834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111042435|NCT01138384|Lapatinib|lapatinib|mesh-list
111042436|NCT01138384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111042437|NCT01138384|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111042438|NCT01138384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111042439|NCT01138384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111042440|NCT01075308|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
111042441|NCT01075308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111042442|NCT01075308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111042443|NCT01068587|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111042444|NCT01068587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111042445|NCT01068587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110759519|NCT01140126|UB-421|ub-421|mesh-list
111042446|NCT01068587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111042447|NCT01068587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111042448|NCT00953771|Danazol|danazol|mesh-list
111042449|NCT00953771|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111042450|NCT00953771|Hormone Antagonists|hormone antagonists|mesh-ancestor
111042451|NCT00953771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111042452|NCT00953771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111042453|NCT00930332|Methadone|methadone|mesh-list
111042454|NCT00930332|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111042455|NCT00930332|Narcotics|narcotics|mesh-ancestor
111042456|NCT00930332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111042457|NCT00930332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111042458|NCT00930332|Analgesics|analgesics|mesh-ancestor
111042459|NCT00930332|Sensory System Agents|sensory system agents|mesh-ancestor
111042460|NCT00930332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111042461|NCT00930332|Antitussive Agents|antitussive agents|mesh-ancestor
111042462|NCT00930332|Respiratory System Agents|respiratory system agents|mesh-ancestor
111042463|NCT00869752|Etoposide|etoposide|mesh-list
111042464|NCT00869752|Antibodies|antibodies|mesh-list
111042465|NCT00869752|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111042466|NCT00869752|Immunologic Factors|immunologic factors|mesh-ancestor
111042467|NCT00869752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111042468|NCT00869752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111042469|NCT00869752|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111042470|NCT00869752|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111042471|NCT00869752|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111042472|NCT00869752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111042473|NCT00869752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111042474|NCT00836485|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
111042475|NCT00836485|Ketotifen|ketotifen|mesh-list
111042476|NCT00836485|Lubricant Eye Drops|lubricant eye drops|mesh-list
111042477|NCT00836485|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
111042478|NCT00836485|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111042479|NCT00836485|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111042480|NCT00836485|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111042481|NCT00836485|Analgesics|analgesics|mesh-ancestor
111042482|NCT00836485|Sensory System Agents|sensory system agents|mesh-ancestor
111042483|NCT00836485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111042484|NCT00836485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111042485|NCT00836485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111042486|NCT00836485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111042487|NCT00836485|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111042488|NCT00836485|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
111042489|NCT00836485|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111042490|NCT00836485|Histamine Antagonists|histamine antagonists|mesh-ancestor
111042491|NCT00836485|Histamine Agents|histamine agents|mesh-ancestor
111042492|NCT00836485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111042493|NCT00836485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111042494|NCT00836485|Antipruritics|antipruritics|mesh-ancestor
111042495|NCT00836485|Dermatologic Agents|dermatologic agents|mesh-ancestor
111042496|NCT00658593|Gemcitabine|gemcitabine|mesh-list
111042497|NCT00658593|Capecitabine|capecitabine|mesh-list
111042498|NCT00658593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111042499|NCT00658593|Antimetabolites|antimetabolites|mesh-ancestor
111042500|NCT00658593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111042501|NCT00658593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111042502|NCT00651326|Docetaxel|docetaxel|mesh-list
111042503|NCT00651326|Leuprolide|leuprolide|mesh-list
111042504|NCT00651326|Goserelin|goserelin|mesh-list
111042505|NCT00651326|Bicalutamide|bicalutamide|mesh-list
111042506|NCT00651326|Flutamide|flutamide|mesh-list
111042507|NCT00651326|Buserelin|buserelin|mesh-list
111042508|NCT00651326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111042509|NCT00651326|Tubulin Modulators|tubulin modulators|mesh-ancestor
111042510|NCT00651326|Antimitotic Agents|antimitotic agents|mesh-ancestor
111042511|NCT00651326|Mitosis Modulators|mitosis modulators|mesh-ancestor
111042512|NCT00651326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111042513|NCT00651326|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111042514|NCT00651326|Fertility Agents|fertility agents|mesh-ancestor
111042515|NCT00651326|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111042516|NCT00651326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111042517|NCT00651326|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111042518|NCT00651326|Androgen Antagonists|androgen antagonists|mesh-ancestor
111042519|NCT00651326|Hormone Antagonists|hormone antagonists|mesh-ancestor
111042520|NCT00651326|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110759609|NCT04751604|Niacin|niacin|mesh-list
111042521|NCT00640471|Cetuximab|cetuximab|mesh-list
111042522|NCT00640471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111042523|NCT00640471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111042524|NCT00535353|Irinotecan|irinotecan|mesh-list
111042525|NCT00535353|Olaparib|olaparib|mesh-list
111042526|NCT00535353|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111042527|NCT00535353|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111042528|NCT00535353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111042529|NCT00535353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111042530|NCT00535353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111042531|NCT00535353|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111042532|NCT00516828|Cytarabine|cytarabine|mesh-list
111042533|NCT00516828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111042534|NCT00516828|Antimetabolites|antimetabolites|mesh-ancestor
111042535|NCT00516828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111042536|NCT00516828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111042537|NCT00516828|Antiviral Agents|antiviral agents|mesh-ancestor
111042538|NCT00516828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111042539|NCT00516828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111042540|NCT00516828|Immunologic Factors|immunologic factors|mesh-ancestor
111042541|NCT00516828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111042542|NCT00504296|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
111042543|NCT00504296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111042544|NCT00504296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111042545|NCT00482755|Sunitinib|sunitinib|mesh-list
111042546|NCT00482755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111042547|NCT00482755|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111042548|NCT00482755|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111042549|NCT00482755|Growth Substances|growth substances|mesh-ancestor
111042550|NCT00482755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111042551|NCT00482755|Growth Inhibitors|growth inhibitors|mesh-ancestor
111042552|NCT00482755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111042553|NCT00482755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111042554|NCT00482755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111042555|NCT00471432|Docetaxel|docetaxel|mesh-list
111042556|NCT00471432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111042557|NCT00471432|Tubulin Modulators|tubulin modulators|mesh-ancestor
111042558|NCT00471432|Antimitotic Agents|antimitotic agents|mesh-ancestor
111042559|NCT00471432|Mitosis Modulators|mitosis modulators|mesh-ancestor
111042560|NCT00471432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111042561|NCT00470353|Cholecalciferol|cholecalciferol|mesh-list
111042562|NCT00470353|Vitamin D|vitamin d|mesh-list
111042563|NCT00470353|Calcium Carbonate|calcium carbonate|mesh-list
111042564|NCT00470353|Calcium|calcium|mesh-list
111042565|NCT00470353|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111042566|NCT00470353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111042567|NCT00470353|Vitamins|vitamins|mesh-ancestor
111042568|NCT00470353|Micronutrients|micronutrients|mesh-ancestor
111042569|NCT00470353|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111042570|NCT00470353|Antacids|antacids|mesh-ancestor
111042571|NCT00470353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111042572|NCT00470353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111042573|NCT00428142|Prednisone|prednisone|mesh-list
111042574|NCT00428142|Cyclophosphamide|cyclophosphamide|mesh-list
111042575|NCT00428142|Rituximab|rituximab|mesh-list
111042576|NCT00428142|Vincristine|vincristine|mesh-list
111042577|NCT00428142|Bortezomib|bortezomib|mesh-list
111042578|NCT00428142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111042579|NCT00428142|Immunologic Factors|immunologic factors|mesh-ancestor
111042580|NCT00428142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111042581|NCT00428142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111042582|NCT00428142|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111042583|NCT00428142|Alkylating Agents|alkylating agents|mesh-ancestor
111042584|NCT00428142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111042585|NCT00428142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111042586|NCT00428142|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111042587|NCT00428142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111042588|NCT00428142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111042589|NCT00428142|Glucocorticoids|glucocorticoids|mesh-ancestor
111042590|NCT00428142|Hormones|hormones|mesh-ancestor
111042591|NCT00428142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111042592|NCT00428142|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111042593|NCT00428142|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111042594|NCT00428142|Tubulin Modulators|tubulin modulators|mesh-ancestor
111042595|NCT00428142|Antimitotic Agents|antimitotic agents|mesh-ancestor
111042596|NCT00428142|Mitosis Modulators|mitosis modulators|mesh-ancestor
111042597|NCT00387400|Everolimus|everolimus|mesh-list
111042598|NCT00387400|Temozolomide|temozolomide|mesh-list
111042599|NCT00387400|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111042600|NCT00387400|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111042601|NCT00387400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111042602|NCT00387400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111042603|NCT00387400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111042604|NCT00387400|Immunologic Factors|immunologic factors|mesh-ancestor
111042605|NCT00387400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111042606|NCT00387400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111042607|NCT00387400|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111042608|NCT00387400|Alkylating Agents|alkylating agents|mesh-ancestor
111042609|NCT00377052|Gemcitabine|gemcitabine|mesh-list
111042610|NCT00377052|Bortezomib|bortezomib|mesh-list
111042611|NCT00377052|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111042612|NCT00377052|Antimetabolites|antimetabolites|mesh-ancestor
111042613|NCT00377052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111042614|NCT00377052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111042615|NCT00372736|Docetaxel|docetaxel|mesh-list
111042616|NCT00372736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111042617|NCT00372736|Tubulin Modulators|tubulin modulators|mesh-ancestor
111042618|NCT00372736|Antimitotic Agents|antimitotic agents|mesh-ancestor
111042619|NCT00372736|Mitosis Modulators|mitosis modulators|mesh-ancestor
111042620|NCT00372736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111042621|NCT00357747|Docetaxel|docetaxel|mesh-list
111042622|NCT00357747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111042623|NCT00357747|Tubulin Modulators|tubulin modulators|mesh-ancestor
111042624|NCT00357747|Antimitotic Agents|antimitotic agents|mesh-ancestor
111042625|NCT00357747|Mitosis Modulators|mitosis modulators|mesh-ancestor
111042626|NCT00357747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111042627|NCT00352079|Gefitinib|gefitinib|mesh-list
111042628|NCT00352079|BCG Vaccine|bcg vaccine|mesh-list
111042629|NCT00352079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111042630|NCT00352079|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111042631|NCT00352079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111042632|NCT00352079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111042633|NCT00352079|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111042634|NCT00352079|Immunologic Factors|immunologic factors|mesh-ancestor
111042635|NCT00352079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111042636|NCT00343408|Leucovorin|leucovorin|mesh-list
111042637|NCT00343408|Gemcitabine|gemcitabine|mesh-list
111042638|NCT00343408|Fluorouracil|fluorouracil|mesh-list
111042639|NCT00343408|Oxaliplatin|oxaliplatin|mesh-list
111042640|NCT00343408|Cediranib|cediranib|mesh-list
111042641|NCT00343408|Calcium|calcium|mesh-list
111042642|NCT00343408|Levoleucovorin|levoleucovorin|mesh-list
111042643|NCT00343408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111042644|NCT00343408|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111042645|NCT00343408|Antimetabolites|antimetabolites|mesh-ancestor
111042646|NCT00343408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111042647|NCT00343408|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111042648|NCT00343408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111042649|NCT00343408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111042650|NCT00343408|Immunologic Factors|immunologic factors|mesh-ancestor
111042651|NCT00343408|Antidotes|antidotes|mesh-ancestor
111042652|NCT00343408|Protective Agents|protective agents|mesh-ancestor
111042653|NCT00343408|Vitamin B Complex|vitamin b complex|mesh-ancestor
111042655|NCT00343408|Micronutrients|micronutrients|mesh-ancestor
111042656|NCT00343408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111042657|NCT00343408|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111042658|NCT00305812|Dexamethasone|dexamethasone|mesh-list
111042659|NCT00305812|Lenalidomide|lenalidomide|mesh-list
111042660|NCT00305812|Melphalan|melphalan|mesh-list
111042661|NCT00305812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111042662|NCT00305812|Antiemetics|antiemetics|mesh-ancestor
111042663|NCT00305812|Autonomic Agents|autonomic agents|mesh-ancestor
111042664|NCT00305812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111042665|NCT00305812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111042666|NCT00305812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111042667|NCT00305812|Glucocorticoids|glucocorticoids|mesh-ancestor
111042668|NCT00305812|Hormones|hormones|mesh-ancestor
111042669|NCT00305812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111042670|NCT00305812|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111042671|NCT00305812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111042672|NCT00305812|Immunologic Factors|immunologic factors|mesh-ancestor
111042673|NCT00305812|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111042674|NCT00305812|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111042675|NCT00305812|Growth Substances|growth substances|mesh-ancestor
111042676|NCT00305812|Growth Inhibitors|growth inhibitors|mesh-ancestor
111042677|NCT00305812|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111042678|NCT00305812|Alkylating Agents|alkylating agents|mesh-ancestor
111042679|NCT00305812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111042680|NCT00305812|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111042681|NCT00305812|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111042682|NCT00265876|Gemcitabine|gemcitabine|mesh-list
111042683|NCT00265876|Saracatinib|saracatinib|mesh-list
111042684|NCT00265876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111042685|NCT00265876|Antimetabolites|antimetabolites|mesh-ancestor
111042686|NCT00265876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111042687|NCT00265876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111042688|NCT00265876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111042689|NCT00258388|Prednisone|prednisone|mesh-list
111042690|NCT00258388|Docetaxel|docetaxel|mesh-list
111042691|NCT00258388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111042692|NCT00258388|Tubulin Modulators|tubulin modulators|mesh-ancestor
111042693|NCT00258388|Antimitotic Agents|antimitotic agents|mesh-ancestor
111042694|NCT00258388|Mitosis Modulators|mitosis modulators|mesh-ancestor
111042695|NCT00258388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111042696|NCT00258388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111042697|NCT00258388|Glucocorticoids|glucocorticoids|mesh-ancestor
111042698|NCT00258388|Hormones|hormones|mesh-ancestor
111042699|NCT00258388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111042700|NCT00258388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111042701|NCT00258388|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111042702|NCT00258375|Docetaxel|docetaxel|mesh-list
111042703|NCT00258375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111042704|NCT00258375|Tubulin Modulators|tubulin modulators|mesh-ancestor
111042705|NCT00258375|Antimitotic Agents|antimitotic agents|mesh-ancestor
111042706|NCT00258375|Mitosis Modulators|mitosis modulators|mesh-ancestor
111042707|NCT00258375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111042708|NCT00255788|Everolimus|everolimus|mesh-list
111042709|NCT00255788|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111042710|NCT00255788|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111042711|NCT00255788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111042712|NCT00255788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111042713|NCT00255788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111042714|NCT00255788|Immunologic Factors|immunologic factors|mesh-ancestor
111042715|NCT00255788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111042716|NCT00255788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111042717|NCT00245154|Paclitaxel|paclitaxel|mesh-list
111042718|NCT00245154|Carboplatin|carboplatin|mesh-list
111042719|NCT00245154|Cediranib|cediranib|mesh-list
111042720|NCT00245154|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111042721|NCT00245154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111042722|NCT00245154|Tubulin Modulators|tubulin modulators|mesh-ancestor
111042723|NCT00245154|Antimitotic Agents|antimitotic agents|mesh-ancestor
111042724|NCT00245154|Mitosis Modulators|mitosis modulators|mesh-ancestor
111042725|NCT00245154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111042726|NCT00245154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111042727|NCT00245154|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111042729|NCT00093457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111042730|NCT00093457|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111042731|NCT00093457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111042732|NCT00093457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111042733|NCT00084734|Docetaxel|docetaxel|mesh-list
111042734|NCT00084734|Capecitabine|capecitabine|mesh-list
111042735|NCT00084734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111042736|NCT00084734|Tubulin Modulators|tubulin modulators|mesh-ancestor
111042737|NCT00084734|Antimitotic Agents|antimitotic agents|mesh-ancestor
111042738|NCT00084734|Mitosis Modulators|mitosis modulators|mesh-ancestor
111042739|NCT00084734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111042740|NCT00084734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111042741|NCT00084734|Antimetabolites|antimetabolites|mesh-ancestor
111042742|NCT00080756|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
111042743|NCT00080756|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
111042744|NCT00080756|Estradiol|estradiol|mesh-list
111042745|NCT00080756|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
111042746|NCT00080756|Testosterone|testosterone|mesh-list
111042747|NCT00080756|Deslorelin|deslorelin|mesh-list
111042748|NCT00080756|Estrogens|estrogens|mesh-ancestor
111042749|NCT00080756|Hormones|hormones|mesh-ancestor
110759790|NCT01140984|Prednisolone|prednisolone|mesh-list
111042750|NCT00080756|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111042751|NCT00080756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111042752|NCT00080756|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111042753|NCT00080756|Contraceptive Agents|contraceptive agents|mesh-ancestor
111042754|NCT00080756|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111042755|NCT00080756|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111042756|NCT00080756|Androgens|androgens|mesh-ancestor
110627946|NCT00623766|Dexamethasone|dexamethasone|mesh-list
111042757|NCT00080756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111042758|NCT00080756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111042759|NCT00079079|Carboplatin|carboplatin|mesh-list
111042760|NCT00079079|Gemcitabine|gemcitabine|mesh-list
111042761|NCT00079079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111042762|NCT00079079|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111042763|NCT00079079|Antimetabolites|antimetabolites|mesh-ancestor
111042764|NCT00079079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111042765|NCT00079066|Cetuximab|cetuximab|mesh-list
111042766|NCT00079066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111042767|NCT00079066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111042768|NCT00079053|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111042769|NCT00079053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111042770|NCT00079053|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111042771|NCT00079053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111042772|NCT00079053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111042773|NCT00066443|Docetaxel|docetaxel|mesh-list
111042774|NCT00066443|Epirubicin|epirubicin|mesh-list
111042775|NCT00066443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111042776|NCT00066443|Tubulin Modulators|tubulin modulators|mesh-ancestor
111042777|NCT00066443|Antimitotic Agents|antimitotic agents|mesh-ancestor
111042778|NCT00066443|Mitosis Modulators|mitosis modulators|mesh-ancestor
111042779|NCT00066443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111042780|NCT00066443|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111042781|NCT00066443|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111042782|NCT00066443|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111042783|NCT00066443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111042784|NCT00054106|Flutamide|flutamide|mesh-list
111042785|NCT00054106|Buserelin|buserelin|mesh-list
111042786|NCT00054106|Androgen Antagonists|androgen antagonists|mesh-ancestor
111042787|NCT00054106|Hormone Antagonists|hormone antagonists|mesh-ancestor
111042788|NCT00054106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111042789|NCT00054106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111042790|NCT00054106|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111042791|NCT00054106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111042792|NCT00054106|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111042793|NCT00054106|Fertility Agents|fertility agents|mesh-ancestor
111042794|NCT00054106|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111042795|NCT00030875|Bortezomib|bortezomib|mesh-list
111042796|NCT00030875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111042797|NCT03532867|Tin Fluorides|tin fluorides|mesh-list
111042798|NCT03532867|Cariostatic Agents|cariostatic agents|mesh-ancestor
111042799|NCT03532867|Protective Agents|protective agents|mesh-ancestor
111042800|NCT03532867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111042801|NCT02207959|Proflavine|proflavine|mesh-list
111042802|NCT02207959|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111042803|NCT02207959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111042804|NCT02567552|Progesterone|progesterone|mesh-list
111042805|NCT02567552|Progestins|progestins|mesh-ancestor
111042806|NCT02567552|Hormones|hormones|mesh-ancestor
111042807|NCT02567552|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111042808|NCT02567552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111042809|NCT02208427|Isoniazid|isoniazid|mesh-list
111042810|NCT02208427|Rifapentine|rifapentine|mesh-list
111042811|NCT02208427|Antitubercular Agents|antitubercular agents|mesh-ancestor
111042812|NCT02208427|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111042813|NCT02208427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110627953|NCT00623766|Fludrocortisone|fludrocortisone|mesh-list
111042814|NCT02208427|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
111042815|NCT02208427|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111042816|NCT02208427|Antimetabolites|antimetabolites|mesh-ancestor
111042817|NCT02208427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111042818|NCT02208427|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111042819|NCT02208427|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111042820|NCT02208427|Leprostatic Agents|leprostatic agents|mesh-ancestor
111042821|NCT05508620|Sirolimus|sirolimus|mesh-list
111042822|NCT05508620|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111042823|NCT05508620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110759869|NCT05849220|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111042824|NCT05508620|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111042825|NCT05508620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111042826|NCT05508620|Antifungal Agents|antifungal agents|mesh-ancestor
111042827|NCT05508620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111042828|NCT05508620|Immunologic Factors|immunologic factors|mesh-ancestor
111042829|NCT05508620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111042830|NCT03803605|Vorinostat|vorinostat|mesh-list
111042831|NCT03803605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111042832|NCT03803605|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111042833|NCT03803605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111042834|NCT03803605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111042835|NCT02208505|Dexmedetomidine|dexmedetomidine|mesh-list
111042836|NCT02208505|Remifentanil|remifentanil|mesh-list
111042837|NCT02208505|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111042838|NCT02208505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111042839|NCT02208505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111042840|NCT02208505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111042841|NCT02208505|Analgesics|analgesics|mesh-ancestor
111042842|NCT02208505|Sensory System Agents|sensory system agents|mesh-ancestor
111042843|NCT02208505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111042844|NCT02208505|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111042845|NCT02208505|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111042846|NCT02208505|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111042847|NCT02208505|Adrenergic Agents|adrenergic agents|mesh-ancestor
111042848|NCT02208505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111042849|NCT02208505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111042850|NCT02208505|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111042851|NCT02208505|Narcotics|narcotics|mesh-ancestor
111042852|NCT02208583|Prednisone|prednisone|mesh-list
111042853|NCT02208583|Cisplatin|cisplatin|mesh-list
111042854|NCT02208583|Docetaxel|docetaxel|mesh-list
111042855|NCT02208583|Etoposide|etoposide|mesh-list
111042856|NCT02208583|Etoposide phosphate|etoposide phosphate|mesh-list
111042857|NCT02208583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111042858|NCT02208583|Tubulin Modulators|tubulin modulators|mesh-ancestor
111042859|NCT02208583|Antimitotic Agents|antimitotic agents|mesh-ancestor
111042860|NCT02208583|Mitosis Modulators|mitosis modulators|mesh-ancestor
111042861|NCT02208583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111042862|NCT02208583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111042863|NCT02208583|Glucocorticoids|glucocorticoids|mesh-ancestor
111042864|NCT02208583|Hormones|hormones|mesh-ancestor
111042865|NCT02208583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111042866|NCT02208583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111042867|NCT02208583|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111042868|NCT02208583|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111042869|NCT02208583|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111042870|NCT02208583|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111042871|NCT02208583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111042872|NCT05501288|Pholcodine|pholcodine|mesh-list
111042873|NCT05501288|Analgesics|analgesics|mesh-ancestor
111042874|NCT05501288|Sensory System Agents|sensory system agents|mesh-ancestor
111042875|NCT05501288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111042876|NCT05501288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111042878|NCT05501288|Respiratory System Agents|respiratory system agents|mesh-ancestor
111042879|NCT04738292|Fulvestrant|fulvestrant|mesh-list
111042880|NCT04738292|Onapristone|onapristone|mesh-list
111042881|NCT04738292|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111042882|NCT04738292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111042883|NCT04738292|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
111042884|NCT04738292|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111042885|NCT04738292|Hormone Antagonists|hormone antagonists|mesh-ancestor
111042886|NCT04738292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111042887|NCT04738292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111042888|NCT04738292|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111042889|NCT04738292|Fertility Agents|fertility agents|mesh-ancestor
111042890|NCT04738292|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111042891|NCT02199379|Lenvatinib|lenvatinib|mesh-list
111042892|NCT02199379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111042893|NCT02199379|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110759942|NCT05848492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110759943|NCT05848492|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110759944|NCT05848492|Hormone Antagonists|hormone antagonists|mesh-ancestor
111042894|NCT02199379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110759949|NCT05848336|Caseins|caseins|mesh-list
111042895|NCT02199379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111042896|NCT03532711|Leucovorin|leucovorin|mesh-list
111042897|NCT03532711|Fluorouracil|fluorouracil|mesh-list
111042898|NCT03532711|Capecitabine|capecitabine|mesh-list
111042899|NCT03532711|Oxaliplatin|oxaliplatin|mesh-list
111042900|NCT03532711|Irinotecan|irinotecan|mesh-list
111042901|NCT03532711|Levoleucovorin|levoleucovorin|mesh-list
111042902|NCT03532711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111042903|NCT03532711|Antimetabolites|antimetabolites|mesh-ancestor
111042904|NCT03532711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111042905|NCT03532711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111042906|NCT03532711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111042907|NCT03532711|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111042908|NCT03532711|Immunologic Factors|immunologic factors|mesh-ancestor
111042909|NCT03532711|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111042910|NCT03532711|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111042911|NCT03532711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111042912|NCT03532711|Antidotes|antidotes|mesh-ancestor
111042913|NCT03532711|Protective Agents|protective agents|mesh-ancestor
111042914|NCT03532711|Vitamin B Complex|vitamin b complex|mesh-ancestor
111042915|NCT03532711|Vitamins|vitamins|mesh-ancestor
111042916|NCT03532711|Micronutrients|micronutrients|mesh-ancestor
111042917|NCT04714112|Dexamethasone|dexamethasone|mesh-list
111042918|NCT04714112|Dexamethasone acetate|dexamethasone acetate|mesh-list
111042919|NCT04714112|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
111042920|NCT04714112|BB 1101|bb 1101|mesh-list
111042921|NCT04714112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111042922|NCT04714112|Antiemetics|antiemetics|mesh-ancestor
111042923|NCT04714112|Autonomic Agents|autonomic agents|mesh-ancestor
111042924|NCT04714112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111042925|NCT04714112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111042926|NCT04714112|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111042927|NCT04714112|Glucocorticoids|glucocorticoids|mesh-ancestor
111042928|NCT04714112|Hormones|hormones|mesh-ancestor
111042929|NCT04714112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111042930|NCT04714112|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111042931|NCT04714112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111042932|NCT04714112|Protease Inhibitors|protease inhibitors|mesh-ancestor
111042933|NCT04714112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111042934|NCT04714112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111042935|NCT02199613|Darunavir|darunavir|mesh-list
111042936|NCT02199613|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111042937|NCT02199613|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111042938|NCT02199613|Protease Inhibitors|protease inhibitors|mesh-ancestor
111042939|NCT02199613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111042940|NCT02199613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111042941|NCT02199613|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111042942|NCT02199613|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111042943|NCT02199613|Antiviral Agents|antiviral agents|mesh-ancestor
111042944|NCT02199613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111042945|NCT02209441|Sorafenib|sorafenib|mesh-list
111042946|NCT02209441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111042947|NCT02209441|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111042948|NCT02209441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111042949|NCT02209441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111042950|NCT02199925|gamma-Globulins|gamma-globulins|mesh-list
111042951|NCT02199925|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111042952|NCT02199925|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
111042953|NCT02199925|Immunologic Factors|immunologic factors|mesh-ancestor
111042954|NCT02199925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111042955|NCT03338647|Doxorubicin|doxorubicin|mesh-list
111042956|NCT03338647|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110760015|NCT05845567|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110760016|NCT05845567|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110760017|NCT05845424|Ezetimibe|ezetimibe|mesh-list
110760018|NCT05845424|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
110760019|NCT05845424|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110760020|NCT05845424|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110760021|NCT05845424|Antimetabolites|antimetabolites|mesh-ancestor
110760022|NCT05845424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110760023|NCT05845424|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110760024|NCT05845424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110760025|NCT05845385|Analgesics|analgesics|mesh-list
110760026|NCT05845385|Sensory System Agents|sensory system agents|mesh-ancestor
111042957|NCT03338647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111042958|NCT03338647|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111042959|NCT03338647|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111042960|NCT03338647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111042961|NCT03338647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111042962|NCT05500742|Selenium|selenium|mesh-list
111042963|NCT05500742|Ubiquinone|ubiquinone|mesh-list
111042964|NCT05500742|Coenzyme Q10|coenzyme q10|mesh-list
111042965|NCT05500742|Resveratrol|resveratrol|mesh-list
111042966|NCT05500742|Antioxidants|antioxidants|mesh-ancestor
111042967|NCT05500742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111042968|NCT05500742|Protective Agents|protective agents|mesh-ancestor
111042969|NCT05500742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111042970|NCT05500742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111042971|NCT05500742|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111042972|NCT05500742|Trace Elements|trace elements|mesh-ancestor
111042973|NCT05500742|Micronutrients|micronutrients|mesh-ancestor
111042974|NCT05500742|Vitamins|vitamins|mesh-ancestor
111042975|NCT03533335|Chlorhexidine|chlorhexidine|mesh-list
111042976|NCT03533335|Chlorine dioxide|chlorine dioxide|mesh-list
111042977|NCT03533335|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111042978|NCT03533335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111042979|NCT03533335|Disinfectants|disinfectants|mesh-ancestor
111042980|NCT03533335|Dental Disinfectants|dental disinfectants|mesh-ancestor
111042981|NCT02200159|Dexmedetomidine|dexmedetomidine|mesh-list
111042982|NCT02200159|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111042983|NCT02200159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111042984|NCT02200159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111042985|NCT02200159|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111042986|NCT02200159|Analgesics|analgesics|mesh-ancestor
111042987|NCT02200159|Sensory System Agents|sensory system agents|mesh-ancestor
111042988|NCT02200159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111042989|NCT02200159|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111042990|NCT02200159|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111042991|NCT02200159|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111042992|NCT02200159|Adrenergic Agents|adrenergic agents|mesh-ancestor
111042993|NCT02200159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111042994|NCT02200159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111042995|NCT02204527|Vitamin D|vitamin d|mesh-list
111042996|NCT02204527|Ergocalciferols|ergocalciferols|mesh-list
111042997|NCT02204527|Cholecalciferol|cholecalciferol|mesh-list
111042998|NCT02204527|Vitamins|vitamins|mesh-list
111042999|NCT02204527|Micronutrients|micronutrients|mesh-ancestor
111043000|NCT02204527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111043001|NCT02204527|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111043002|NCT02204527|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111043003|NCT02200237|Aluminum phosphate|aluminum phosphate|mesh-list
111043004|NCT02200237|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111043005|NCT02200237|Immunologic Factors|immunologic factors|mesh-ancestor
111043006|NCT02200237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111043007|NCT02200237|Antacids|antacids|mesh-ancestor
111043008|NCT02200237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111043009|NCT02200237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111043010|NCT02209831|Pantoprazole|pantoprazole|mesh-list
111043011|NCT02209831|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111043012|NCT02209831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111043013|NCT02209831|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111043014|NCT02209831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111043015|NCT02209831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111043016|NCT01663532|Aripiprazole|aripiprazole|mesh-list
111043017|NCT01663532|Antidepressive Agents|antidepressive agents|mesh-ancestor
111043018|NCT01663532|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111043019|NCT01663532|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111043020|NCT01663532|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111043021|NCT01663532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111043022|NCT01663532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111043023|NCT01663532|Dopamine Agonists|dopamine agonists|mesh-ancestor
111043024|NCT01663532|Dopamine Agents|dopamine agents|mesh-ancestor
111043025|NCT01663532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111043026|NCT01663532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111043027|NCT01663532|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111043028|NCT01663532|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111043029|NCT01663532|Serotonin Agents|serotonin agents|mesh-ancestor
111043030|NCT01663532|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111043031|NCT01663532|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111043032|NCT01663532|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110760087|NCT05844683|Dermatologic Agents|dermatologic agents|mesh-ancestor
111043033|NCT01663532|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111043034|NCT02200315|Anti-Infective Agents|anti-infective agents|mesh-list
111043035|NCT02200315|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111043036|NCT02204839|Insulin|insulin|mesh-list
111043037|NCT02204839|Insulin Glargine|insulin glargine|mesh-list
111043038|NCT02204839|Insulin Detemir|insulin detemir|mesh-list
111043039|NCT02204839|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111043040|NCT02204839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111043041|NCT02209909|Aspirin|aspirin|mesh-list
111043042|NCT02209909|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111043043|NCT02209909|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111043044|NCT02209909|Analgesics|analgesics|mesh-ancestor
111043045|NCT02209909|Sensory System Agents|sensory system agents|mesh-ancestor
111043046|NCT02209909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111043047|NCT02209909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111043048|NCT02209909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111043049|NCT02209909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111043050|NCT02209909|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111043051|NCT02209909|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111043052|NCT02209909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111043053|NCT02209909|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111043054|NCT02209909|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111043055|NCT02209909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111043056|NCT02209909|Antipyretics|antipyretics|mesh-ancestor
111043057|NCT02209987|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111043058|NCT02209987|Immunologic Factors|immunologic factors|mesh-ancestor
111043059|NCT02209987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111043060|NCT02205151|Amlodipine|amlodipine|mesh-list
111043061|NCT02205151|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111043062|NCT02205151|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111043063|NCT02205151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111043064|NCT02205151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111043065|NCT02205151|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111043066|NCT02205151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111043068|NCT05262985|Durvalumab|durvalumab|mesh-list
111043069|NCT05262985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111043070|NCT05262985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111043071|NCT05504720|Pembrolizumab|pembrolizumab|mesh-list
111043072|NCT05504720|Trastuzumab|trastuzumab|mesh-list
111043073|NCT05504720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111043074|NCT05504720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111043075|NCT05504720|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111043076|NCT05504720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111043077|NCT04476992|Nitric Oxide|nitric oxide|mesh-list
111043078|NCT04476992|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111043079|NCT04476992|Autonomic Agents|autonomic agents|mesh-ancestor
111043080|NCT04476992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111043081|NCT04476992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111043082|NCT04476992|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111043083|NCT04476992|Respiratory System Agents|respiratory system agents|mesh-ancestor
111043084|NCT04476992|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111043085|NCT04476992|Antioxidants|antioxidants|mesh-ancestor
111043086|NCT04476992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111043087|NCT04476992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111043088|NCT04476992|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
111043089|NCT04476992|Vasodilator Agents|vasodilator agents|mesh-ancestor
111043090|NCT04476992|Gasotransmitters|gasotransmitters|mesh-ancestor
111043091|NCT04476992|Protective Agents|protective agents|mesh-ancestor
111043092|NCT02220673|Butylated Hydroxytoluene|butylated hydroxytoluene|mesh-list
111043093|NCT02220673|Antioxidants|antioxidants|mesh-ancestor
111043094|NCT02220673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111043095|NCT02220673|Protective Agents|protective agents|mesh-ancestor
111043096|NCT02220673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111043097|NCT05499572|Minocycline|minocycline|mesh-list
111043098|NCT05499572|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110760162|NCT05843344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110760163|NCT05843344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110760164|NCT05843344|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110760165|NCT05843344|Analgesics|analgesics|mesh-ancestor
110760166|NCT05843344|Sensory System Agents|sensory system agents|mesh-ancestor
110760167|NCT05843344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110760168|NCT05843344|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110760169|NCT05843344|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110760175|NCT05843344|Narcotics|narcotics|mesh-ancestor
111043099|NCT05499572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111043100|NCT02220751|Doxycycline|doxycycline|mesh-list
111043101|NCT02220751|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111043102|NCT02220751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111043103|NCT02220751|Antimalarials|antimalarials|mesh-ancestor
111043104|NCT02220751|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111043105|NCT02220751|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111043106|NCT02205541|Eculizumab|eculizumab|mesh-list
111043107|NCT02205541|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
111043108|NCT02205541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111043109|NCT02205541|Immunologic Factors|immunologic factors|mesh-ancestor
111043110|NCT02205541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111043111|NCT02205619|Glycine|glycine|mesh-list
111043112|NCT02205619|Glycine Agents|glycine agents|mesh-ancestor
111043113|NCT02205619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111043114|NCT02205619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111043115|NCT02205619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111043116|NCT05504330|Aspirin|aspirin|mesh-list
111043117|NCT05504330|Clopidogrel|clopidogrel|mesh-list
111043118|NCT05504330|Atorvastatin|atorvastatin|mesh-list
111043119|NCT05504330|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111043120|NCT05504330|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111043121|NCT05504330|Analgesics|analgesics|mesh-ancestor
111043122|NCT05504330|Sensory System Agents|sensory system agents|mesh-ancestor
111043123|NCT05504330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111043124|NCT05504330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111043125|NCT05504330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111043126|NCT05504330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111043127|NCT05504330|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111043128|NCT05504330|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111043129|NCT05504330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111043130|NCT05504330|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111043131|NCT05504330|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111043132|NCT05504330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111043133|NCT05504330|Antipyretics|antipyretics|mesh-ancestor
111043134|NCT05504330|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111043135|NCT05504330|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111043136|NCT05504330|Antimetabolites|antimetabolites|mesh-ancestor
111043137|NCT05504330|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111043138|NCT05504330|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111043139|NCT05504330|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111043140|NCT05504330|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111043141|NCT05504330|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111043142|NCT05504330|Purinergic Agents|purinergic agents|mesh-ancestor
111043143|NCT05504330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111043144|NCT02220829|Silodosin|silodosin|mesh-list
111043145|NCT02220829|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111043146|NCT02220829|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111043147|NCT02220829|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111043148|NCT02220829|Adrenergic Agents|adrenergic agents|mesh-ancestor
111043149|NCT02220829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111043150|NCT02220829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111043151|NCT02220829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111043152|NCT02220829|Urological Agents|urological agents|mesh-ancestor
111043153|NCT02525939|Dalcetrapib|dalcetrapib|mesh-list
111043154|NCT02525939|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111043155|NCT02525939|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111043156|NCT02525939|Antimetabolites|antimetabolites|mesh-ancestor
111043157|NCT02525939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111043158|NCT02525939|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111043159|NCT02215213|Vitamin D|vitamin d|mesh-list
111043160|NCT02215213|Ergocalciferols|ergocalciferols|mesh-list
111043161|NCT02215213|Cholecalciferol|cholecalciferol|mesh-list
111043162|NCT02215213|Vitamins|vitamins|mesh-list
111043163|NCT02215213|Micronutrients|micronutrients|mesh-ancestor
111043164|NCT02215213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111043165|NCT02215213|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111043166|NCT02215213|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111043167|NCT02205775|Atorvastatin|atorvastatin|mesh-list
111043168|NCT02205775|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111043169|NCT02205775|Ezetimibe|ezetimibe|mesh-list
111043170|NCT02205775|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111043171|NCT02205775|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111043172|NCT02205775|Antimetabolites|antimetabolites|mesh-ancestor
111043173|NCT02205775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110760239|NCT05840848|Beta Carotene|beta carotene|mesh-list
111043174|NCT02205775|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111043175|NCT02205775|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111043176|NCT02205775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111043177|NCT02217787|PF-06372865|pf-06372865|mesh-list
111043178|NCT02217787|GABA Modulators|gaba modulators|mesh-ancestor
111043179|NCT02217787|GABA Agents|gaba agents|mesh-ancestor
111043180|NCT02217787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110628017|NCT02549118|Meperidine|meperidine|mesh-list
111043181|NCT02217787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111043182|NCT02217787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111043184|NCT02205931|Lamotrigine|lamotrigine|mesh-list
111043185|NCT02205931|Zonisamide|zonisamide|mesh-list
111043186|NCT02205931|Carbamazepine|carbamazepine|mesh-list
111043187|NCT02205931|Phenytoin|phenytoin|mesh-list
111043188|NCT02205931|Rufinamide|rufinamide|mesh-list
111043189|NCT02205931|Levetiracetam|levetiracetam|mesh-list
111043190|NCT02205931|Valproic Acid|valproic acid|mesh-list
111043191|NCT02205931|Clonazepam|clonazepam|mesh-list
111043192|NCT02205931|Vigabatrin|vigabatrin|mesh-list
111043193|NCT02205931|Anticonvulsants|anticonvulsants|mesh-list
111043194|NCT02205931|Clobazam|clobazam|mesh-list
111043195|NCT02205931|Ethosuximide|ethosuximide|mesh-list
111043196|NCT02205931|Stiripentol|stiripentol|mesh-list
111043197|NCT02205931|Nitrazepam|nitrazepam|mesh-list
111043198|NCT02205931|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111043199|NCT02205931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111043200|NCT02205931|Nootropic Agents|nootropic agents|mesh-ancestor
111043201|NCT02205931|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110827521|NCT03960671|Anticonvulsants|anticonvulsants|mesh-ancestor
111043202|NCT02205931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111043203|NCT02205931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111043204|NCT02205931|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111043205|NCT02205931|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111043206|NCT02205931|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111043207|NCT02205931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111043208|NCT02205931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111043209|NCT02205931|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111043210|NCT02205931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111043211|NCT02205931|GABA Agents|gaba agents|mesh-ancestor
111043212|NCT02205931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111043213|NCT02205931|Antimanic Agents|antimanic agents|mesh-ancestor
111043214|NCT02205931|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111043215|NCT02205931|Analgesics|analgesics|mesh-ancestor
111043216|NCT02205931|Sensory System Agents|sensory system agents|mesh-ancestor
111043217|NCT02205931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111043218|NCT02205931|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111043219|NCT02205931|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111043220|NCT02205931|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111043221|NCT02205931|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
111043222|NCT02205931|GABA Modulators|gaba modulators|mesh-ancestor
111043223|NCT02205931|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111043224|NCT02205931|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
111043225|NCT02205931|GABA Agonists|gaba agonists|mesh-ancestor
111043226|NCT02205931|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111043227|NCT02221063|Thiamine|thiamine|mesh-list
111043228|NCT02221063|Vitamin B Complex|vitamin b complex|mesh-ancestor
111043229|NCT02221063|Vitamins|vitamins|mesh-ancestor
111043230|NCT02221063|Micronutrients|micronutrients|mesh-ancestor
111043231|NCT02221063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111043232|NCT02220049|Bortezomib|bortezomib|mesh-list
111043233|NCT02220049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111043234|NCT01351805|Vitamin D|vitamin d|mesh-list
111043235|NCT01351805|Ergocalciferols|ergocalciferols|mesh-list
111043236|NCT01351805|Cholecalciferol|cholecalciferol|mesh-list
111043237|NCT01351805|Vitamins|vitamins|mesh-list
111043238|NCT01351805|Micronutrients|micronutrients|mesh-ancestor
111043239|NCT01351805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111043240|NCT01351805|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111043241|NCT01351805|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111043242|NCT02206165|Amlodipine|amlodipine|mesh-list
111043243|NCT02206165|Candesartan|candesartan|mesh-list
111043244|NCT02206165|Candesartan cilexetil|candesartan cilexetil|mesh-list
111043245|NCT02206165|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111043246|NCT02206165|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111043247|NCT02206165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111043248|NCT02206165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110760317|NCT05825573|Hemostatics|hemostatics|mesh-ancestor
111043249|NCT02206165|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111043250|NCT02206165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111043251|NCT02206165|Vasodilator Agents|vasodilator agents|mesh-ancestor
111043252|NCT02206165|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111043254|NCT04356950|Thrombin|thrombin|mesh-list
111043255|NCT04356950|Hemostatics|hemostatics|mesh-ancestor
111043256|NCT04356950|Coagulants|coagulants|mesh-ancestor
111043257|NCT02254187|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
111043258|NCT02254187|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111043259|NCT02254187|Autonomic Agents|autonomic agents|mesh-ancestor
111043260|NCT02254187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111043261|NCT02254187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111043262|NCT02254187|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111043263|NCT02254187|Respiratory System Agents|respiratory system agents|mesh-ancestor
111043264|NCT02254187|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111043265|NCT02254187|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111043266|NCT02254187|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111043267|NCT02254187|Adrenergic Agents|adrenergic agents|mesh-ancestor
111043268|NCT02254187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111043269|NCT02254187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111043270|NCT05563610|Amoxicillin|amoxicillin|mesh-list
111043271|NCT05563610|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111043272|NCT05563610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111043273|NCT05503706|Selenium|selenium|mesh-list
111043274|NCT05503706|Salicylic Acid|salicylic acid|mesh-list
111043275|NCT05503706|Salicylates|salicylates|mesh-list
111043276|NCT05503706|Selenium disulfide|selenium disulfide|mesh-list
111043277|NCT05503706|Antioxidants|antioxidants|mesh-ancestor
111043278|NCT05503706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111043279|NCT05503706|Protective Agents|protective agents|mesh-ancestor
111043280|NCT05503706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111043281|NCT05503706|Trace Elements|trace elements|mesh-ancestor
111043282|NCT05503706|Micronutrients|micronutrients|mesh-ancestor
111043283|NCT05503706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111043284|NCT05503706|Antifungal Agents|antifungal agents|mesh-ancestor
111043285|NCT05503706|Keratolytic Agents|keratolytic agents|mesh-ancestor
111043286|NCT05503706|Dermatologic Agents|dermatologic agents|mesh-ancestor
111043287|NCT05503706|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111043288|NCT05503706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111043289|NCT05503706|Analgesics|analgesics|mesh-ancestor
111043290|NCT05503706|Sensory System Agents|sensory system agents|mesh-ancestor
111043291|NCT05503706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111043292|NCT05503706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111043293|NCT05503706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111043294|NCT05503706|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111043295|NCT05503706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111043296|NCT02174861|Erenumab|erenumab|mesh-list
111043297|NCT02174861|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
111043298|NCT02174861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111043299|NCT02174861|Analgesics|analgesics|mesh-ancestor
111043300|NCT02174861|Sensory System Agents|sensory system agents|mesh-ancestor
111043301|NCT02174861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111043302|NCT02174861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111043303|NCT02221375|Ciclesonide|ciclesonide|mesh-list
111043304|NCT02221375|Glucocorticoids|glucocorticoids|mesh-ancestor
111043305|NCT02221375|Hormones|hormones|mesh-ancestor
111043306|NCT02221375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111043307|NCT02221375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111043308|NCT02221375|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111043309|NCT02399709|Simvastatin|simvastatin|mesh-list
111043310|NCT02399709|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111043311|NCT02399709|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111043312|NCT02399709|Antimetabolites|antimetabolites|mesh-ancestor
111043313|NCT02399709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111043314|NCT02399709|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111043315|NCT02399709|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111043316|NCT02399709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111043317|NCT02220361|Dexmedetomidine|dexmedetomidine|mesh-list
111043318|NCT02220361|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111043319|NCT02220361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111043320|NCT02220361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111043321|NCT02220361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111043322|NCT02220361|Analgesics|analgesics|mesh-ancestor
111043323|NCT02220361|Sensory System Agents|sensory system agents|mesh-ancestor
111043324|NCT02220361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110760388|NCT05805605|Mycophenolic Acid|mycophenolic acid|mesh-list
111043325|NCT02220361|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111043326|NCT02220361|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111043327|NCT02220361|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111043328|NCT02220361|Adrenergic Agents|adrenergic agents|mesh-ancestor
111043329|NCT02220361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111043330|NCT02220361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111043331|NCT05175001|Betamethasone|betamethasone|mesh-list
111043332|NCT05175001|Betamethasone dipropionate, betamethasone sodium phosphate drug combination|betamethasone dipropionate, betamethasone sodium phosphate drug combination|mesh-list
111043333|NCT05175001|Ropivacaine|ropivacaine|mesh-list
111043334|NCT05175001|Anesthetics, Local|anesthetics, local|mesh-ancestor
111043335|NCT05175001|Anesthetics|anesthetics|mesh-ancestor
111043336|NCT05175001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111043337|NCT05175001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111043338|NCT05175001|Sensory System Agents|sensory system agents|mesh-ancestor
111043339|NCT05175001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111043340|NCT05175001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111043341|NCT05175001|Glucocorticoids|glucocorticoids|mesh-ancestor
111043342|NCT05175001|Hormones|hormones|mesh-ancestor
111043343|NCT05175001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111043344|NCT05175001|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111043345|NCT05175001|Respiratory System Agents|respiratory system agents|mesh-ancestor
111043346|NCT00140855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111043347|NCT00140855|Ipilimumab|ipilimumab|mesh-list
111043348|NCT00140855|Antibodies|antibodies|mesh-list
111043349|NCT00140855|Immunoglobulins|immunoglobulins|mesh-list
111043350|NCT00140855|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111043351|NCT00140855|Immunologic Factors|immunologic factors|mesh-ancestor
111043352|NCT00140855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111043353|NCT00140855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111043354|NCT00140855|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111043355|NCT00140855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111043356|NCT02399397|Fentanyl|fentanyl|mesh-list
111043357|NCT02399397|Midazolam|midazolam|mesh-list
111043358|NCT02399397|Anesthetics|anesthetics|mesh-list
111043359|NCT02399397|Propofol|propofol|mesh-list
111043360|NCT02399397|Rocuronium|rocuronium|mesh-list
111043361|NCT02399397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111043362|NCT02399397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111043363|NCT02399397|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111043364|NCT02399397|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111043365|NCT02399397|Anesthetics, General|anesthetics, general|mesh-ancestor
111043366|NCT02399397|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111043367|NCT02399397|Narcotics|narcotics|mesh-ancestor
111043368|NCT02399397|Analgesics|analgesics|mesh-ancestor
111043369|NCT02399397|Sensory System Agents|sensory system agents|mesh-ancestor
111043370|NCT02399397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111043371|NCT02399397|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111043372|NCT02399397|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111043373|NCT02399397|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111043374|NCT02399397|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111043375|NCT02399397|GABA Modulators|gaba modulators|mesh-ancestor
111043376|NCT02399397|GABA Agents|gaba agents|mesh-ancestor
111043377|NCT02399397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111043378|NCT02399397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111043379|NCT02399397|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
111043380|NCT02399397|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
111043381|NCT02399397|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111043382|NCT02221453|Triamcinolone|triamcinolone|mesh-list
111043383|NCT02221453|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
111043384|NCT02221453|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
111043385|NCT02221453|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
111043386|NCT02221453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111043387|NCT02221453|Glucocorticoids|glucocorticoids|mesh-ancestor
111043388|NCT02221453|Hormones|hormones|mesh-ancestor
111043389|NCT02221453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111043390|NCT02221453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111043391|NCT02221453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111043392|NCT02221453|Immunologic Factors|immunologic factors|mesh-ancestor
111043393|NCT02221453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111043394|NCT02221453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111043395|NCT03106545|Bupivacaine|bupivacaine|mesh-list
111043396|NCT03106545|Anesthetics, Local|anesthetics, local|mesh-ancestor
111043397|NCT03106545|Anesthetics|anesthetics|mesh-ancestor
111043398|NCT03106545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111043399|NCT03106545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111043400|NCT03106545|Sensory System Agents|sensory system agents|mesh-ancestor
111043401|NCT03106545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111043402|NCT02221531|Carbetocin|carbetocin|mesh-list
111043403|NCT02221531|Oxytocin|oxytocin|mesh-list
111043404|NCT02221531|Oxytocics|oxytocics|mesh-ancestor
111043405|NCT02221531|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111043406|NCT02221531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111043407|NCT02231125|Losartan|losartan|mesh-list
111043408|NCT02231125|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111043409|NCT02231125|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111043410|NCT02231125|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111043411|NCT02231125|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111043412|NCT02231125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111043413|NCT02396433|Carboplatin|carboplatin|mesh-list
111043414|NCT02396433|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
111043415|NCT02396433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111043416|NCT02396433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111043417|NCT02396433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111043418|NCT02231203|Tocopherols|tocopherols|mesh-list
111043419|NCT02231203|Antioxidants|antioxidants|mesh-list
111043420|NCT02231203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111043421|NCT02231203|Protective Agents|protective agents|mesh-ancestor
111043422|NCT02231203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111043423|NCT02231203|Vitamins|vitamins|mesh-ancestor
111043424|NCT02231203|Micronutrients|micronutrients|mesh-ancestor
111043425|NCT02231281|Ritonavir|ritonavir|mesh-list
111043426|NCT02231281|Lopinavir|lopinavir|mesh-list
111043427|NCT02231281|Tenofovir|tenofovir|mesh-list
111043428|NCT02231281|Lamivudine|lamivudine|mesh-list
111043429|NCT02231281|Zidovudine|zidovudine|mesh-list
111043430|NCT02231281|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111043431|NCT02231281|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111043432|NCT02231281|Protease Inhibitors|protease inhibitors|mesh-ancestor
111043433|NCT02231281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111043434|NCT02231281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111043435|NCT02231281|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111043436|NCT02231281|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111043437|NCT02231281|Antiviral Agents|antiviral agents|mesh-ancestor
111043438|NCT02231281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111043439|NCT02231281|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111043440|NCT02231281|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111043441|NCT02231281|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111043442|NCT02231281|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111043443|NCT02231281|Antimetabolites|antimetabolites|mesh-ancestor
111043444|NCT02231359|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
111043445|NCT02231359|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111043446|NCT02231359|Autonomic Agents|autonomic agents|mesh-ancestor
111043447|NCT02231359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111043448|NCT02231359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111043449|NCT02231359|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111043450|NCT02231359|Respiratory System Agents|respiratory system agents|mesh-ancestor
111043451|NCT02780687|Afatinib|afatinib|mesh-list
111043452|NCT02780687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111043453|NCT02780687|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111043454|NCT02780687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111043455|NCT02780687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111043456|NCT02231437|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
111043457|NCT02231437|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111043458|NCT02231437|Autonomic Agents|autonomic agents|mesh-ancestor
111043459|NCT02231437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111043460|NCT02231437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111043461|NCT02231437|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111043462|NCT02231437|Respiratory System Agents|respiratory system agents|mesh-ancestor
111043463|NCT02147873|Azacitidine|azacitidine|mesh-list
111043464|NCT02147873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111043465|NCT02147873|Antimetabolites|antimetabolites|mesh-ancestor
111043466|NCT02147873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111043467|NCT02147873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111043468|NCT02147873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111043469|NCT02398929|Bisoprolol|bisoprolol|mesh-list
111043470|NCT02398929|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111043471|NCT02398929|Sympatholytics|sympatholytics|mesh-ancestor
111043472|NCT02398929|Autonomic Agents|autonomic agents|mesh-ancestor
111043473|NCT02398929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111043474|NCT02398929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111043475|NCT02398929|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
111043476|NCT02398929|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111043477|NCT02398929|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111043478|NCT02398929|Adrenergic Agents|adrenergic agents|mesh-ancestor
111043479|NCT02398929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111043480|NCT02398929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111043481|NCT02221765|Pancreatic Polypeptide|pancreatic polypeptide|mesh-list
111043482|NCT02221765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111043484|NCT02221765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111043485|NCT02221765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111043486|NCT05069129|Vaccines|vaccines|mesh-list
111043487|NCT05069129|Immunologic Factors|immunologic factors|mesh-ancestor
111043488|NCT05069129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111043489|NCT02147951|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
111043490|NCT02147951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111043491|NCT02147951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111043492|NCT03544073|Leuprolide|leuprolide|mesh-list
111043493|NCT03544073|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111043494|NCT03544073|Fertility Agents|fertility agents|mesh-ancestor
111043495|NCT03544073|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111043496|NCT03544073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111043497|NCT03544073|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111043498|NCT03544073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111043500|NCT02398383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111043501|NCT03168087|Plasma-lyte 148|plasma-lyte 148|mesh-list
111043502|NCT03168087|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
111043503|NCT03168087|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111043504|NCT02781311|Finasteride|finasteride|mesh-list
111043505|NCT02781311|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
111043506|NCT02781311|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111043507|NCT02781311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111043508|NCT02781311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111043509|NCT02781311|Hormone Antagonists|hormone antagonists|mesh-ancestor
111043510|NCT02781311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111043511|NCT02781311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111043512|NCT02781311|Urological Agents|urological agents|mesh-ancestor
111043513|NCT02144441|Insulin Glargine|insulin glargine|mesh-list
111043514|NCT02144441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111043515|NCT02144441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111043516|NCT02225977|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
111043517|NCT02225977|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
111043518|NCT02225977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111043519|NCT02225977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111043520|NCT02225977|Immunologic Factors|immunologic factors|mesh-ancestor
111043521|NCT02225977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111043522|NCT02141009|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
111043523|NCT02141009|Immunologic Factors|immunologic factors|mesh-ancestor
111043524|NCT02141009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111043525|NCT02564198|Ramucirumab|ramucirumab|mesh-list
111043526|NCT02564198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111043527|NCT02398539|Silver Nitrate|silver nitrate|mesh-list
111043528|NCT02398539|Triamcinolone|triamcinolone|mesh-list
111043529|NCT02398539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111043530|NCT02398539|Glucocorticoids|glucocorticoids|mesh-ancestor
111043531|NCT02398539|Hormones|hormones|mesh-ancestor
111043532|NCT02398539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111043533|NCT02398539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111043534|NCT02398539|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111043535|NCT02398539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111043536|NCT02144753|Psyllium|psyllium|mesh-list
111043537|NCT02144753|Calcium polycarbophil|calcium polycarbophil|mesh-list
111043538|NCT02144753|Cathartics|cathartics|mesh-ancestor
111043539|NCT02144753|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111043540|NCT02144753|Antidiarrheals|antidiarrheals|mesh-ancestor
111043541|NCT02231905|Pramipexole|pramipexole|mesh-list
111043542|NCT02231905|Antioxidants|antioxidants|mesh-ancestor
111043543|NCT02231905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111043544|NCT02231905|Protective Agents|protective agents|mesh-ancestor
111043545|NCT02231905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111043546|NCT02231905|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111043547|NCT02231905|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111043549|NCT02231905|Dopamine Agents|dopamine agents|mesh-ancestor
111043550|NCT02231905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111043551|NCT02141087|Pirfenidone|pirfenidone|mesh-list
111043552|NCT02141087|Analgesics|analgesics|mesh-ancestor
111043553|NCT02141087|Sensory System Agents|sensory system agents|mesh-ancestor
111043554|NCT02141087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111043555|NCT02141087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111043556|NCT02141087|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111043557|NCT02141087|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111043558|NCT02141087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111043559|NCT02141087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111043560|NCT02141087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111043561|NCT02698293|Vitamin D|vitamin d|mesh-list
111043562|NCT02698293|Ergocalciferols|ergocalciferols|mesh-list
111043563|NCT02698293|Cholecalciferol|cholecalciferol|mesh-list
111043564|NCT02698293|Vitamins|vitamins|mesh-list
111043565|NCT02698293|Micronutrients|micronutrients|mesh-ancestor
111043566|NCT02698293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111043567|NCT02698293|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111043568|NCT02698293|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111043569|NCT02226289|Bevacizumab|bevacizumab|mesh-list
111043570|NCT02226289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111043571|NCT02226289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111043572|NCT02226289|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111043573|NCT02226289|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111043574|NCT02226289|Growth Substances|growth substances|mesh-ancestor
111043575|NCT02226289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111043576|NCT02226289|Growth Inhibitors|growth inhibitors|mesh-ancestor
111043577|NCT04480593|Propolis|propolis|mesh-list
111043578|NCT04480593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111043579|NCT05079217|Vaccines|vaccines|mesh-list
111043580|NCT05079217|Immunologic Factors|immunologic factors|mesh-ancestor
110628068|NCT00550407|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111043581|NCT05079217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111043582|NCT02141321|Alprostadil|alprostadil|mesh-list
111043583|NCT02141321|Misoprostol|misoprostol|mesh-list
111043584|NCT02141321|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111043585|NCT02141321|Abortifacient Agents|abortifacient agents|mesh-ancestor
111043586|NCT02141321|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111043587|NCT02141321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111043588|NCT02141321|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111043589|NCT02141321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111043590|NCT02141321|Oxytocics|oxytocics|mesh-ancestor
111043591|NCT02141321|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111043592|NCT02141321|Vasodilator Agents|vasodilator agents|mesh-ancestor
111043593|NCT02141321|Urological Agents|urological agents|mesh-ancestor
111043594|NCT03965078|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
111043595|NCT03965078|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111043596|NCT03965078|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111043597|NCT02141477|Decitabine|decitabine|mesh-list
111043598|NCT02141477|Homoharringtonine|homoharringtonine|mesh-list
111043599|NCT02141477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111043600|NCT02141477|Antimetabolites|antimetabolites|mesh-ancestor
111043601|NCT02141477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111043602|NCT02141477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111043603|NCT02141477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111043604|NCT02141477|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111043605|NCT02141477|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111043606|NCT02232139|Midazolam|midazolam|mesh-list
111043607|NCT02232139|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111043608|NCT02232139|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111043609|NCT02232139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111043610|NCT02232139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111043611|NCT02232139|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111043612|NCT02232139|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111043613|NCT02232139|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111043614|NCT02232139|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111043615|NCT02232139|Anesthetics, General|anesthetics, general|mesh-ancestor
111043616|NCT02232139|Anesthetics|anesthetics|mesh-ancestor
111043617|NCT02232139|GABA Modulators|gaba modulators|mesh-ancestor
111043618|NCT02232139|GABA Agents|gaba agents|mesh-ancestor
111043619|NCT02232139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110760695|NCT05542264|Risperidone|risperidone|mesh-list
111043620|NCT02232139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111043621|NCT02226601|Aprepitant|aprepitant|mesh-list
111043622|NCT02226601|Antiemetics|antiemetics|mesh-ancestor
111043623|NCT02226601|Autonomic Agents|autonomic agents|mesh-ancestor
111043624|NCT02226601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111043625|NCT02226601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111043626|NCT02226601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111043627|NCT02226601|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
111043628|NCT02226601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111043629|NCT02226601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111043630|NCT02397603|Dexmedetomidine|dexmedetomidine|mesh-list
111043631|NCT02397603|Bupivacaine|bupivacaine|mesh-list
111043632|NCT02397603|Anesthetics, Local|anesthetics, local|mesh-ancestor
111043633|NCT02397603|Anesthetics|anesthetics|mesh-ancestor
111043634|NCT02397603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111043635|NCT02397603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111043636|NCT02397603|Sensory System Agents|sensory system agents|mesh-ancestor
111043637|NCT02397603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111043638|NCT02397603|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111043639|NCT02397603|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111043640|NCT02397603|Analgesics|analgesics|mesh-ancestor
111043641|NCT02397603|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111043642|NCT02397603|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111043643|NCT02397603|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111043644|NCT02397603|Adrenergic Agents|adrenergic agents|mesh-ancestor
111043645|NCT02397603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111043646|NCT02397603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111043647|NCT02145065|Paclitaxel|paclitaxel|mesh-list
111043648|NCT02145065|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111043649|NCT02145065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111043650|NCT02145065|Tubulin Modulators|tubulin modulators|mesh-ancestor
111043651|NCT02145065|Antimitotic Agents|antimitotic agents|mesh-ancestor
111043652|NCT02145065|Mitosis Modulators|mitosis modulators|mesh-ancestor
111043653|NCT02145065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111043654|NCT02226757|Paclitaxel|paclitaxel|mesh-list
111043655|NCT02226757|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111043656|NCT02226757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111043657|NCT02226757|Tubulin Modulators|tubulin modulators|mesh-ancestor
111043658|NCT02226757|Antimitotic Agents|antimitotic agents|mesh-ancestor
111043659|NCT02226757|Mitosis Modulators|mitosis modulators|mesh-ancestor
111043660|NCT02226757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111043661|NCT04616924|Clarithromycin|clarithromycin|mesh-list
111043662|NCT04616924|Rifabutin|rifabutin|mesh-list
111043663|NCT04616924|Clofazimine|clofazimine|mesh-list
111043664|NCT04616924|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111043665|NCT04616924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111043666|NCT04616924|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111043667|NCT04616924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111043668|NCT04616924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111043669|NCT04616924|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111043670|NCT04616924|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111043671|NCT04616924|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111043672|NCT04616924|Antitubercular Agents|antitubercular agents|mesh-ancestor
111043673|NCT04616924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111043674|NCT04616924|Leprostatic Agents|leprostatic agents|mesh-ancestor
111043675|NCT02226913|Lidocaine|lidocaine|mesh-list
111043676|NCT02226913|Epinephrine|epinephrine|mesh-list
111043677|NCT02226913|Anesthetics, Local|anesthetics, local|mesh-ancestor
111043678|NCT02226913|Anesthetics|anesthetics|mesh-ancestor
111043679|NCT02226913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111043680|NCT02226913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111043681|NCT02226913|Sensory System Agents|sensory system agents|mesh-ancestor
111043682|NCT02226913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111043683|NCT02226913|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111043684|NCT02226913|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111043685|NCT02226913|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111043686|NCT02226913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111043687|NCT02226913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111043688|NCT02226913|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111043689|NCT02226913|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111043690|NCT02226913|Adrenergic Agents|adrenergic agents|mesh-ancestor
111043691|NCT02226913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111043692|NCT02226913|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111043693|NCT02226913|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111043694|NCT02226913|Autonomic Agents|autonomic agents|mesh-ancestor
111043695|NCT02226913|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111043696|NCT02226913|Respiratory System Agents|respiratory system agents|mesh-ancestor
111043697|NCT02226913|Mydriatics|mydriatics|mesh-ancestor
111043698|NCT02226913|Sympathomimetics|sympathomimetics|mesh-ancestor
111043699|NCT02226913|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111043700|NCT05491616|Nivolumab|nivolumab|mesh-list
111043701|NCT05491616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111043702|NCT05491616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111043703|NCT05491616|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111043704|NCT05491616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111043705|NCT02254655|Antirheumatic Agents|antirheumatic agents|mesh-list
111043706|NCT02254655|Puerarin|puerarin|mesh-list
111043707|NCT02254655|Vasodilator Agents|vasodilator agents|mesh-ancestor
111043708|NCT02226991|Ritonavir|ritonavir|mesh-list
111043709|NCT02226991|Tipranavir|tipranavir|mesh-list
111043710|NCT02226991|Efavirenz|efavirenz|mesh-list
111043711|NCT02226991|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111043712|NCT02226991|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111043713|NCT02226991|Protease Inhibitors|protease inhibitors|mesh-ancestor
111043715|NCT02226991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111043716|NCT02226991|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111043717|NCT02226991|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111043718|NCT02226991|Antiviral Agents|antiviral agents|mesh-ancestor
111043719|NCT02226991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111043720|NCT02226991|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111043721|NCT02226991|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111043722|NCT02226991|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111043723|NCT02226991|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111043724|NCT02226991|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111043725|NCT02226991|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111043726|NCT02226991|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111043727|NCT02226991|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111043728|NCT02226991|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111043729|NCT05042791|Capecitabine|capecitabine|mesh-list
111043730|NCT05042791|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111043731|NCT05042791|Antimetabolites|antimetabolites|mesh-ancestor
111043732|NCT05042791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111043733|NCT05042791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111043734|NCT00705783|Aripiprazole|aripiprazole|mesh-list
111043735|NCT00705783|Antidepressive Agents|antidepressive agents|mesh-ancestor
111043736|NCT00705783|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111043737|NCT00705783|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111043738|NCT00705783|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111043739|NCT00705783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111043740|NCT00705783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111043741|NCT00705783|Dopamine Agonists|dopamine agonists|mesh-ancestor
111043742|NCT00705783|Dopamine Agents|dopamine agents|mesh-ancestor
111043743|NCT00705783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111043744|NCT00705783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111043745|NCT00705783|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111043746|NCT00705783|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111043747|NCT00705783|Serotonin Agents|serotonin agents|mesh-ancestor
111043748|NCT00705783|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111043749|NCT00705783|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111043750|NCT00705783|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111043751|NCT00705783|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111043752|NCT02145611|Vildagliptin|vildagliptin|mesh-list
111043753|NCT02145611|Glyburide|glyburide|mesh-list
111043754|NCT02145611|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111043755|NCT02145611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111043756|NCT02145611|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111043757|NCT02145611|Protease Inhibitors|protease inhibitors|mesh-ancestor
111043758|NCT02145611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111043759|NCT02145611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111043760|NCT02222623|Isophane Insulin, Human|isophane insulin, human|mesh-list
111043761|NCT02222623|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111043762|NCT02222623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111043763|NCT03543683|Aspirin|aspirin|mesh-list
111043764|NCT03543683|Osimertinib|osimertinib|mesh-list
111043765|NCT03543683|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111043766|NCT03543683|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111043767|NCT03543683|Analgesics|analgesics|mesh-ancestor
111043768|NCT03543683|Sensory System Agents|sensory system agents|mesh-ancestor
111043769|NCT03543683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111043770|NCT03543683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111043772|NCT03543683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111043773|NCT03543683|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111043774|NCT03543683|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111043775|NCT03543683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111043776|NCT03543683|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110508850|NCT04954664|Dimenhydrinate|dimenhydrinate|mesh-list
111043777|NCT03543683|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111043778|NCT03543683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111043779|NCT03543683|Antipyretics|antipyretics|mesh-ancestor
111043780|NCT03543683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111043781|NCT03543683|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111043782|NCT02145689|Botulinum Toxins|botulinum toxins|mesh-list
111043783|NCT02145689|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111043784|NCT02145689|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111043785|NCT02145689|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111043786|NCT02145689|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111043787|NCT02145689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111043788|NCT02145689|Cholinergic Agents|cholinergic agents|mesh-ancestor
111043789|NCT02145689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111043790|NCT02145689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111043791|NCT02145689|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111043792|NCT02145689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111043793|NCT02396979|Methadone|methadone|mesh-list
111043794|NCT02396979|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111043795|NCT02396979|Narcotics|narcotics|mesh-ancestor
111043796|NCT02396979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111043797|NCT02396979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111043798|NCT02396979|Analgesics|analgesics|mesh-ancestor
111043799|NCT02396979|Sensory System Agents|sensory system agents|mesh-ancestor
111043800|NCT02396979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111043801|NCT02396979|Antitussive Agents|antitussive agents|mesh-ancestor
111043802|NCT02396979|Respiratory System Agents|respiratory system agents|mesh-ancestor
111043803|NCT02145767|Progesterone|progesterone|mesh-list
111043804|NCT02145767|Progestins|progestins|mesh-ancestor
111043805|NCT02145767|Hormones|hormones|mesh-ancestor
111043806|NCT02145767|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111043807|NCT02145767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111043808|NCT02031523|Analgesics|analgesics|mesh-list
111043809|NCT02031523|Sensory System Agents|sensory system agents|mesh-ancestor
111043810|NCT02031523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111043811|NCT02031523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111043812|NCT02397213|Cyclosporine|cyclosporine|mesh-list
111043813|NCT02397213|Cyclosporins|cyclosporins|mesh-list
111043814|NCT02397213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111043815|NCT02397213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111043816|NCT02397213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111043817|NCT02397213|Immunologic Factors|immunologic factors|mesh-ancestor
111043818|NCT02397213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111043819|NCT02397213|Antifungal Agents|antifungal agents|mesh-ancestor
111043820|NCT02397213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111043821|NCT02397213|Dermatologic Agents|dermatologic agents|mesh-ancestor
111043822|NCT02397213|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111043823|NCT02397213|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111043824|NCT04480281|Lidocaine|lidocaine|mesh-list
111043825|NCT04480281|Anesthetics, Local|anesthetics, local|mesh-ancestor
111043826|NCT04480281|Anesthetics|anesthetics|mesh-ancestor
111043827|NCT04480281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111043828|NCT04480281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111043829|NCT04480281|Sensory System Agents|sensory system agents|mesh-ancestor
111043830|NCT04480281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111043831|NCT04480281|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111043832|NCT04480281|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111043833|NCT04480281|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111043834|NCT04480281|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110827536|NCT01164787|Trandolapril|trandolapril|mesh-list
111043835|NCT04480281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111043836|NCT03544775|Anesthetics|anesthetics|mesh-list
111043837|NCT03544775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111043838|NCT03544775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111043839|NCT02258815|Dinutuximab|dinutuximab|mesh-list
111043840|NCT02258815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111043842|NCT02149433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111043843|NCT02149433|Glucocorticoids|glucocorticoids|mesh-ancestor
111043844|NCT02149433|Hormones|hormones|mesh-ancestor
111043845|NCT02149433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111043846|NCT02149433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111043847|NCT02149433|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111043848|NCT02149433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111043849|NCT02228005|Sertraline|sertraline|mesh-list
111043850|NCT02228005|Antidepressive Agents|antidepressive agents|mesh-ancestor
111043851|NCT02228005|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111043852|NCT02228005|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111043853|NCT02228005|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111043854|NCT02228005|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111043855|NCT02228005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111043856|NCT02228005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111043857|NCT02228005|Serotonin Agents|serotonin agents|mesh-ancestor
111043858|NCT02228005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111043859|NCT02228083|Lidocaine|lidocaine|mesh-list
111043860|NCT02228083|Epinephrine|epinephrine|mesh-list
111043861|NCT02228083|Anesthetics, Local|anesthetics, local|mesh-ancestor
111043862|NCT02228083|Anesthetics|anesthetics|mesh-ancestor
111043863|NCT02228083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111043864|NCT02228083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111043865|NCT02228083|Sensory System Agents|sensory system agents|mesh-ancestor
111043866|NCT02228083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111043867|NCT02228083|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111043868|NCT02228083|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111043869|NCT02228083|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111043870|NCT02228083|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111043871|NCT02228083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111043872|NCT02228083|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111043873|NCT02228083|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111043874|NCT02228083|Adrenergic Agents|adrenergic agents|mesh-ancestor
111043875|NCT02228083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111043876|NCT02228083|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111043877|NCT02228083|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111043878|NCT02228083|Autonomic Agents|autonomic agents|mesh-ancestor
111043879|NCT02228083|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111043880|NCT02228083|Respiratory System Agents|respiratory system agents|mesh-ancestor
111043881|NCT02228083|Mydriatics|mydriatics|mesh-ancestor
111043882|NCT02228083|Sympathomimetics|sympathomimetics|mesh-ancestor
111043883|NCT02228083|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111043884|NCT02394483|Olorofim|olorofim|mesh-list
111043885|NCT02394483|Antifungal Agents|antifungal agents|mesh-ancestor
111043886|NCT02394483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111043887|NCT02142335|Rituximab|rituximab|mesh-list
111043888|NCT02142335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111043889|NCT02142335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111043890|NCT02142335|Immunologic Factors|immunologic factors|mesh-ancestor
111043891|NCT02142335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111043892|NCT02142335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111043893|NCT02228239|Mirtazapine|mirtazapine|mesh-list
111043894|NCT02228239|Esketamine|esketamine|mesh-list
111043895|NCT02228239|Antidepressive Agents|antidepressive agents|mesh-ancestor
111043896|NCT02228239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111043897|NCT02228239|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111043898|NCT02228239|Histamine Antagonists|histamine antagonists|mesh-ancestor
111043899|NCT02228239|Histamine Agents|histamine agents|mesh-ancestor
111043900|NCT02228239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111043901|NCT02228239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111043902|NCT02228239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111043903|NCT02228239|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111043904|NCT02228239|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111043905|NCT02228239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111043906|NCT02228239|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
111043907|NCT02228239|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110827551|NCT00028769|Leuprolide|leuprolide|mesh-list
111043908|NCT02228239|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111043909|NCT02228239|Adrenergic Agents|adrenergic agents|mesh-ancestor
111043910|NCT02228239|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111043911|NCT02228239|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111043912|NCT02228239|Serotonin Agents|serotonin agents|mesh-ancestor
111043913|NCT02228239|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111043915|NCT03167385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111043916|NCT03167385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111043917|NCT03167385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110760996|NCT05199311|Hormones|hormones|mesh-ancestor
111043918|NCT03167385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111043920|NCT02142569|Vitamin E|vitamin e|mesh-list
111043921|NCT02142569|Tocopherols|tocopherols|mesh-list
111043922|NCT02142569|Red yeast rice|red yeast rice|mesh-list
111043923|NCT02142569|Antioxidants|antioxidants|mesh-ancestor
111043924|NCT02142569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111043925|NCT02142569|Protective Agents|protective agents|mesh-ancestor
111043926|NCT02142569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111043927|NCT02142569|Vitamins|vitamins|mesh-ancestor
111043928|NCT02142569|Micronutrients|micronutrients|mesh-ancestor
111043929|NCT02142569|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111043930|NCT02142569|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111043931|NCT02142569|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111043932|NCT02142569|Antimetabolites|antimetabolites|mesh-ancestor
111043933|NCT02142569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111043934|NCT02142569|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111043935|NCT02228473|Atropine|atropine|mesh-list
111043936|NCT02228473|Glycopyrrolate|glycopyrrolate|mesh-list
111043937|NCT02228473|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111043938|NCT02228473|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111043939|NCT02228473|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111043940|NCT02228473|Autonomic Agents|autonomic agents|mesh-ancestor
111043941|NCT02228473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111043942|NCT02228473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111043943|NCT02228473|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111043944|NCT02228473|Respiratory System Agents|respiratory system agents|mesh-ancestor
111043945|NCT02228473|Mydriatics|mydriatics|mesh-ancestor
111043946|NCT02228473|Parasympatholytics|parasympatholytics|mesh-ancestor
111043947|NCT02228473|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111043948|NCT02228473|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111043949|NCT02228473|Cholinergic Agents|cholinergic agents|mesh-ancestor
111043950|NCT02228473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111043951|NCT02228473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111043952|NCT02394093|Aspirin|aspirin|mesh-list
111043953|NCT02394093|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111043954|NCT02394093|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111043955|NCT02394093|Analgesics|analgesics|mesh-ancestor
111043956|NCT02394093|Sensory System Agents|sensory system agents|mesh-ancestor
111043957|NCT02394093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111043958|NCT02394093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111043959|NCT02394093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111043960|NCT02394093|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111043961|NCT02394093|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111043962|NCT02394093|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111043963|NCT02394093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111043964|NCT02394093|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111043965|NCT02394093|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111043966|NCT02394093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111043967|NCT02394093|Antipyretics|antipyretics|mesh-ancestor
111043968|NCT02146391|Enclomiphene|enclomiphene|mesh-list
111043969|NCT02146391|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111043970|NCT02146391|Hormone Antagonists|hormone antagonists|mesh-ancestor
111043971|NCT02146391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111043972|NCT02146391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111043973|NCT02146391|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111043974|NCT02146391|Fertility Agents|fertility agents|mesh-ancestor
111043975|NCT02146391|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111043976|NCT02146391|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111043977|NCT02146391|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111043978|NCT04225273|Lidocaine|lidocaine|mesh-list
111043979|NCT04225273|Anesthetics, Local|anesthetics, local|mesh-ancestor
111043980|NCT04225273|Anesthetics|anesthetics|mesh-ancestor
111043981|NCT04225273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111043982|NCT04225273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111043983|NCT04225273|Sensory System Agents|sensory system agents|mesh-ancestor
111043984|NCT04225273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111043985|NCT04225273|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111043986|NCT04225273|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111043987|NCT04225273|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111043988|NCT04225273|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111043989|NCT04225273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111043990|NCT02146547|Aripiprazole|aripiprazole|mesh-list
111043991|NCT02146547|Paliperidone Palmitate|paliperidone palmitate|mesh-list
111043992|NCT02146547|Antidepressive Agents|antidepressive agents|mesh-ancestor
111043993|NCT02146547|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111043994|NCT02146547|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111043995|NCT02146547|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111043996|NCT02146547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111043997|NCT02146547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111043998|NCT02146547|Dopamine Agonists|dopamine agonists|mesh-ancestor
111044000|NCT02146547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111044001|NCT02146547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111044002|NCT02146547|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111044003|NCT02146547|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111044004|NCT02146547|Serotonin Agents|serotonin agents|mesh-ancestor
111044005|NCT02146547|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111044006|NCT02146547|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111044007|NCT02146547|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111044008|NCT02146547|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111044009|NCT02394015|Doxorubicin|doxorubicin|mesh-list
111044010|NCT02394015|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111044011|NCT02394015|Trabectedin|trabectedin|mesh-list
111044012|NCT02394015|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111044013|NCT02394015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111044014|NCT02394015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111044015|NCT02394015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111044016|NCT02394015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111044017|NCT02394015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111044018|NCT02394015|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111044019|NCT02394015|Alkylating Agents|alkylating agents|mesh-ancestor
111044020|NCT02142881|Antihypertensive Agents|antihypertensive agents|mesh-list
111044021|NCT02146703|Gemcitabine|gemcitabine|mesh-list
111044022|NCT02146703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111044023|NCT02146703|Antimetabolites|antimetabolites|mesh-ancestor
111044024|NCT02146703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111044025|NCT02146703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111044026|NCT02228863|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111044027|NCT02228863|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111044028|NCT02228863|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111044029|NCT02228863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111044030|NCT02228863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111044031|NCT02228863|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111044032|NCT02228863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111044033|NCT02228863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111044034|NCT02228863|Cholinergic Agents|cholinergic agents|mesh-ancestor
111044035|NCT02228863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111044036|NCT02782169|Pregabalin|pregabalin|mesh-list
111044037|NCT02782169|Analgesics|analgesics|mesh-ancestor
111044038|NCT02782169|Sensory System Agents|sensory system agents|mesh-ancestor
111044039|NCT02782169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111044040|NCT02782169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111044041|NCT02782169|Anticonvulsants|anticonvulsants|mesh-ancestor
111044042|NCT02782169|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111044043|NCT02782169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111044044|NCT02782169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111044045|NCT02782169|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111044046|NCT02782169|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111044047|NCT02782169|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111044048|NCT02782169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111044049|NCT02782169|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111044050|NCT04163185|Meloxicam|meloxicam|mesh-list
111044051|NCT04163185|Rizatriptan|rizatriptan|mesh-list
111044052|NCT04163185|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111044053|NCT04163185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111044054|NCT04163185|Analgesics|analgesics|mesh-ancestor
111044055|NCT04163185|Sensory System Agents|sensory system agents|mesh-ancestor
111044056|NCT04163185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111044057|NCT04163185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111044058|NCT04163185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111044059|NCT04163185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111044060|NCT04163185|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111044061|NCT04163185|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111044062|NCT04163185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111044063|NCT04163185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111044064|NCT04163185|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111044065|NCT04163185|Serotonin Agents|serotonin agents|mesh-ancestor
111044066|NCT04163185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111044067|NCT02149901|Pseudoephedrine|pseudoephedrine|mesh-list
111044069|NCT02149901|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111044070|NCT02149901|Autonomic Agents|autonomic agents|mesh-ancestor
111044071|NCT02149901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111044072|NCT02149901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111044073|NCT02149901|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111044074|NCT02149901|Respiratory System Agents|respiratory system agents|mesh-ancestor
111044075|NCT02149901|Nasal Decongestants|nasal decongestants|mesh-ancestor
111044076|NCT02149901|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111044077|NCT02149901|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111044078|NCT02149901|Sympathomimetics|sympathomimetics|mesh-ancestor
111044079|NCT02149901|Adrenergic Agents|adrenergic agents|mesh-ancestor
111044080|NCT02149901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111044081|NCT02149901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111044082|NCT04440267|Dexamethasone|dexamethasone|mesh-list
111044083|NCT04440267|Prednisone|prednisone|mesh-list
111044084|NCT04440267|Cyclophosphamide|cyclophosphamide|mesh-list
111044085|NCT04440267|Methotrexate|methotrexate|mesh-list
111044086|NCT04440267|Vincristine|vincristine|mesh-list
111044087|NCT04440267|Daunorubicin|daunorubicin|mesh-list
111044088|NCT04440267|Asparaginase|asparaginase|mesh-list
111044089|NCT04440267|Mercaptopurine|mercaptopurine|mesh-list
111044090|NCT04440267|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
111044091|NCT04440267|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111044092|NCT04440267|Immunologic Factors|immunologic factors|mesh-ancestor
111044093|NCT04440267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111044094|NCT04440267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111044095|NCT04440267|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111044096|NCT04440267|Alkylating Agents|alkylating agents|mesh-ancestor
111044097|NCT04440267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111044098|NCT04440267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111044099|NCT04440267|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111044100|NCT04440267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111044101|NCT04440267|Antiemetics|antiemetics|mesh-ancestor
111044102|NCT04440267|Autonomic Agents|autonomic agents|mesh-ancestor
111044103|NCT04440267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111044104|NCT04440267|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111044105|NCT04440267|Glucocorticoids|glucocorticoids|mesh-ancestor
111044106|NCT04440267|Hormones|hormones|mesh-ancestor
111044107|NCT04440267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111044108|NCT04440267|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111044109|NCT04440267|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111044110|NCT04440267|Abortifacient Agents|abortifacient agents|mesh-ancestor
111044111|NCT04440267|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111044112|NCT04440267|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111044113|NCT04440267|Antimetabolites|antimetabolites|mesh-ancestor
111044114|NCT04440267|Dermatologic Agents|dermatologic agents|mesh-ancestor
111044115|NCT04440267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111044116|NCT04440267|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111044117|NCT04440267|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111044118|NCT04440267|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111044119|NCT04440267|Tubulin Modulators|tubulin modulators|mesh-ancestor
111044120|NCT04440267|Antimitotic Agents|antimitotic agents|mesh-ancestor
111044121|NCT04440267|Mitosis Modulators|mitosis modulators|mesh-ancestor
111044122|NCT04440267|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111044123|NCT04440267|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111044124|NCT04440267|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111044125|NCT04440267|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111044126|NCT02043847|Melphalan|melphalan|mesh-list
111044127|NCT02043847|Lenograstim|lenograstim|mesh-list
111044128|NCT02043847|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111044129|NCT02043847|Immunologic Factors|immunologic factors|mesh-ancestor
111044130|NCT02043847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111044131|NCT02043847|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111044132|NCT02043847|Alkylating Agents|alkylating agents|mesh-ancestor
111044133|NCT02043847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110676902|NCT03341936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110676903|NCT03318900|Aldesleukin|aldesleukin|mesh-list
110676904|NCT03318900|Cyclophosphamide|cyclophosphamide|mesh-list
110676905|NCT03318900|Interleukin-2|interleukin-2|mesh-list
111044134|NCT02043847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111044135|NCT02043847|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111044136|NCT02043847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111044138|NCT02146937|Finasteride|finasteride|mesh-list
111044139|NCT02146937|Androgen Antagonists|androgen antagonists|mesh-ancestor
111044140|NCT02146937|Hormone Antagonists|hormone antagonists|mesh-ancestor
111044141|NCT02146937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111044142|NCT02146937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111044143|NCT02146937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111044144|NCT02146937|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
111044145|NCT02146937|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111044146|NCT02146937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111044147|NCT02146937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111044148|NCT02146937|Urological Agents|urological agents|mesh-ancestor
111044149|NCT02147015|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111044150|NCT02147015|Methylprednisolone|methylprednisolone|mesh-list
111044151|NCT02147015|Glucocorticoids|glucocorticoids|mesh-list
111044152|NCT02147015|Cholinergic Agents|cholinergic agents|mesh-list
111044153|NCT02147015|Muscarinic Antagonists|muscarinic antagonists|mesh-list
111044154|NCT02147015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111044155|NCT02147015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111044156|NCT02147015|Antiemetics|antiemetics|mesh-ancestor
111044157|NCT02147015|Autonomic Agents|autonomic agents|mesh-ancestor
111044158|NCT02147015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111044159|NCT02147015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111044160|NCT02147015|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111044161|NCT02147015|Hormones|hormones|mesh-ancestor
111044162|NCT02147015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111044163|NCT02147015|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111044164|NCT02147015|Protective Agents|protective agents|mesh-ancestor
111044165|NCT02147015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111044166|NCT02147015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111044167|NCT02147015|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111044168|NCT02229175|Bevacizumab|bevacizumab|mesh-list
111044169|NCT02229175|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111044170|NCT02229175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111044171|NCT02229175|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111044172|NCT02229175|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111044173|NCT02229175|Growth Substances|growth substances|mesh-ancestor
111044174|NCT02229175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111044175|NCT02229175|Growth Inhibitors|growth inhibitors|mesh-ancestor
111044176|NCT04947007|Bupivacaine|bupivacaine|mesh-list
111044177|NCT04947007|Anesthetics, Local|anesthetics, local|mesh-ancestor
111044178|NCT04947007|Anesthetics|anesthetics|mesh-ancestor
111044179|NCT04947007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111044180|NCT04947007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111044181|NCT04947007|Sensory System Agents|sensory system agents|mesh-ancestor
111044182|NCT04947007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111044183|NCT04104685|Minocycline|minocycline|mesh-list
111044184|NCT04104685|Adapalene|adapalene|mesh-list
111044185|NCT04104685|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111044186|NCT04104685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111044187|NCT04104685|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111044188|NCT04104685|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111044189|NCT04104685|Analgesics|analgesics|mesh-ancestor
111044190|NCT04104685|Sensory System Agents|sensory system agents|mesh-ancestor
111044191|NCT04104685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111044192|NCT04104685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111044193|NCT04104685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110827556|NCT00028769|Nilutamide|nilutamide|mesh-list
111044195|NCT04104685|Dermatologic Agents|dermatologic agents|mesh-ancestor
111044196|NCT02147249|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111044197|NCT02147249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111044198|NCT02392845|Docetaxel|docetaxel|mesh-list
111044199|NCT02392845|Epirubicin|epirubicin|mesh-list
111044200|NCT02392845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111044201|NCT02392845|Tubulin Modulators|tubulin modulators|mesh-ancestor
111044202|NCT02392845|Antimitotic Agents|antimitotic agents|mesh-ancestor
111044203|NCT02392845|Mitosis Modulators|mitosis modulators|mesh-ancestor
111044204|NCT02392845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111044205|NCT02392845|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111044206|NCT02392845|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111044207|NCT02392845|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111044208|NCT02392845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111044209|NCT04093765|Antimalarials|antimalarials|mesh-list
111044210|NCT04093765|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111044211|NCT04093765|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111044212|NCT04093765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111044214|NCT03166605|Antifoaming Agents|antifoaming agents|mesh-ancestor
111044215|NCT03166605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111044216|NCT03166605|Emollients|emollients|mesh-ancestor
111044217|NCT03166605|Dermatologic Agents|dermatologic agents|mesh-ancestor
111044218|NCT03699956|Carboplatin|carboplatin|mesh-list
111044219|NCT03699956|Etoposide|etoposide|mesh-list
111044220|NCT03699956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111044221|NCT03699956|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111044222|NCT03699956|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111044223|NCT03699956|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111044224|NCT03699956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111044225|NCT03699956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111044226|NCT03166527|Immunoglobulins|immunoglobulins|mesh-list
111044227|NCT03166527|Antibodies|antibodies|mesh-list
111044228|NCT03166527|gamma-Globulins|gamma-globulins|mesh-list
111044229|NCT03166527|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111044230|NCT03166527|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
111044231|NCT03166527|Immunologic Factors|immunologic factors|mesh-ancestor
111044232|NCT03166527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111044233|NCT02695719|Lubiprostone|lubiprostone|mesh-list
111044234|NCT02695719|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
111044235|NCT02695719|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111044236|NCT02695719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111044237|NCT05498012|Cannabidiol|cannabidiol|mesh-list
111044238|NCT05498012|Anticonvulsants|anticonvulsants|mesh-ancestor
111044239|NCT02150291|Folic Acid|folic acid|mesh-list
111044240|NCT02150291|Vitamin B Complex|vitamin b complex|mesh-list
111044241|NCT02150291|Hematinics|hematinics|mesh-ancestor
111044242|NCT02150291|Vitamins|vitamins|mesh-ancestor
111044243|NCT02150291|Micronutrients|micronutrients|mesh-ancestor
111044244|NCT02150291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111044245|NCT04907071|Coal Tar|coal tar|mesh-list
111044246|NCT04907071|Keratolytic Agents|keratolytic agents|mesh-ancestor
111044247|NCT04907071|Dermatologic Agents|dermatologic agents|mesh-ancestor
111044248|NCT02155517|Propofol|propofol|mesh-list
110628225|NCT00958269|Hormones|hormones|mesh-ancestor
111044249|NCT02155517|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111044250|NCT02155517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111044251|NCT02155517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111044252|NCT02155517|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111044253|NCT02155517|Anesthetics, General|anesthetics, general|mesh-ancestor
111044254|NCT02155517|Anesthetics|anesthetics|mesh-ancestor
111044255|NCT05497934|Glycerol|glycerol|mesh-list
111044256|NCT05497934|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
111044257|NCT05497934|Protective Agents|protective agents|mesh-ancestor
111044258|NCT05497934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111044259|NCT02229721|Oxytocin|oxytocin|mesh-list
111044260|NCT02229721|Oxytocics|oxytocics|mesh-ancestor
111044261|NCT02229721|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111044262|NCT02229721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111044263|NCT05497700|Norepinephrine|norepinephrine|mesh-list
111044264|NCT05497700|Ephedrine|ephedrine|mesh-list
111044265|NCT05497700|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111044266|NCT05497700|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111044267|NCT05497700|Adrenergic Agents|adrenergic agents|mesh-ancestor
111044268|NCT05497700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111044269|NCT05497700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111044270|NCT05497700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111044271|NCT05497700|Sympathomimetics|sympathomimetics|mesh-ancestor
111044272|NCT05497700|Autonomic Agents|autonomic agents|mesh-ancestor
111044273|NCT05497700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111044274|NCT05497700|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111044275|NCT05497700|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111044276|NCT03106389|Misoprostol|misoprostol|mesh-list
111044277|NCT03106389|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111044278|NCT03106389|Abortifacient Agents|abortifacient agents|mesh-ancestor
111044279|NCT03106389|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111044280|NCT03106389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111044281|NCT03106389|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111044282|NCT03106389|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111044283|NCT03106389|Oxytocics|oxytocics|mesh-ancestor
111044284|NCT03106311|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
111044285|NCT03106311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111044286|NCT03106311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111044287|NCT02255045|Diclofenac|diclofenac|mesh-list
111044288|NCT02255045|Meloxicam|meloxicam|mesh-list
111044289|NCT02255045|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111044290|NCT02255045|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111044292|NCT02255045|Sensory System Agents|sensory system agents|mesh-ancestor
111044293|NCT02255045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111044294|NCT02255045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111044295|NCT02255045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111044296|NCT02255045|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111044297|NCT02255045|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111044298|NCT02255045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111044299|NCT02255045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111044300|NCT02255045|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111044301|NCT02229799|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
111044302|NCT02229799|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111044303|NCT02229799|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111044304|NCT02229799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111044305|NCT02150447|Lansoprazole|lansoprazole|mesh-list
111044306|NCT02150447|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
111044307|NCT02150447|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111044308|NCT02150447|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111044309|NCT02150447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111044310|NCT02150447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111044311|NCT02254889|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
111044312|NCT02254889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111044313|NCT02254889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111044314|NCT02229955|Cyclosporine|cyclosporine|mesh-list
111044315|NCT02229955|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111044316|NCT02229955|Cyclosporins|cyclosporins|mesh-list
111044317|NCT02229955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111044318|NCT02229955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111044319|NCT02229955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111044320|NCT02229955|Immunologic Factors|immunologic factors|mesh-ancestor
111044321|NCT02229955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111044322|NCT02229955|Antifungal Agents|antifungal agents|mesh-ancestor
111044323|NCT02229955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111044324|NCT02229955|Dermatologic Agents|dermatologic agents|mesh-ancestor
111044325|NCT02229955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111044326|NCT02229955|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111044327|NCT02229955|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111044328|NCT02230033|Itraconazole|itraconazole|mesh-list
111044329|NCT02230033|Gemfibrozil|gemfibrozil|mesh-list
111044330|NCT02230033|Antifungal Agents|antifungal agents|mesh-ancestor
111044331|NCT02230033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111044332|NCT02230033|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111044333|NCT02230033|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111044334|NCT02230033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111044335|NCT02230033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111044336|NCT02230033|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111044337|NCT02230033|Hormone Antagonists|hormone antagonists|mesh-ancestor
111044338|NCT02230033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111044339|NCT02230033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111044340|NCT02230033|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111044341|NCT02230033|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111044342|NCT02230033|Antimetabolites|antimetabolites|mesh-ancestor
111044343|NCT02230033|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111044344|NCT02230033|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
111044345|NCT05740371|Argatroban|argatroban|mesh-list
111044346|NCT05740371|Antithrombins|antithrombins|mesh-ancestor
111044347|NCT05740371|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111044348|NCT05740371|Protease Inhibitors|protease inhibitors|mesh-ancestor
111044349|NCT05740371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111044350|NCT05740371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111044351|NCT05740371|Anticoagulants|anticoagulants|mesh-ancestor
111044352|NCT05740371|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111044353|NCT02223949|Alprostadil|alprostadil|mesh-list
111044354|NCT02223949|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111044355|NCT02223949|Vasodilator Agents|vasodilator agents|mesh-ancestor
111044356|NCT02223949|Urological Agents|urological agents|mesh-ancestor
111044357|NCT02691507|Decanoic acid|decanoic acid|mesh-list
111044358|NCT02691507|Antifungal Agents|antifungal agents|mesh-ancestor
111044359|NCT02691507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111044360|NCT02259361|4-Aminopyridine|4-aminopyridine|mesh-list
111044361|NCT02259361|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
111044362|NCT02259361|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111044363|NCT02259361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111044364|NCT02151695|Aflibercept|aflibercept|mesh-list
111044365|NCT02151695|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111044366|NCT02151695|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111044367|NCT02151695|Growth Substances|growth substances|mesh-ancestor
111044368|NCT02151695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111044369|NCT02151695|Growth Inhibitors|growth inhibitors|mesh-ancestor
111044370|NCT02151695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111044372|NCT02151929|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111044373|NCT02151929|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111044374|NCT02151929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111044375|NCT02151929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111044376|NCT02151929|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111044377|NCT02151929|Immunologic Factors|immunologic factors|mesh-ancestor
111044378|NCT02151929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111044379|NCT02151929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111044380|NCT03542357|Calcitonin|calcitonin|mesh-list
110628292|NCT00829608|Vaccines|vaccines|mesh-list
111044381|NCT03542357|Salmon calcitonin|salmon calcitonin|mesh-list
111044382|NCT03542357|Sumatriptan|sumatriptan|mesh-list
111044383|NCT03542357|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
111044384|NCT03542357|Katacalcin|katacalcin|mesh-list
111044385|NCT03542357|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111044386|NCT03542357|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111044387|NCT03542357|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111044388|NCT03542357|Serotonin Agents|serotonin agents|mesh-ancestor
111044389|NCT03542357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111044390|NCT03542357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111044391|NCT03542357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111044392|NCT03542357|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111044393|NCT03542357|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111044394|NCT03542357|Vasodilator Agents|vasodilator agents|mesh-ancestor
111044395|NCT04811001|Osimertinib|osimertinib|mesh-list
111044396|NCT04811001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111044397|NCT04811001|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111044398|NCT04811001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111044399|NCT04811001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111044400|NCT02150993|Ritonavir|ritonavir|mesh-list
111044401|NCT02150993|Lopinavir|lopinavir|mesh-list
111044402|NCT02150993|Tenofovir|tenofovir|mesh-list
111044403|NCT02150993|Lamivudine|lamivudine|mesh-list
111044404|NCT02150993|Emtricitabine|emtricitabine|mesh-list
111044405|NCT02150993|Zidovudine|zidovudine|mesh-list
111044406|NCT02150993|Raltegravir Potassium|raltegravir potassium|mesh-list
111044407|NCT02150993|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
111044408|NCT02150993|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111044409|NCT02150993|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111044410|NCT02150993|Protease Inhibitors|protease inhibitors|mesh-ancestor
111044411|NCT02150993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111044412|NCT02150993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111044413|NCT02150993|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111044414|NCT02150993|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111044415|NCT02150993|Antiviral Agents|antiviral agents|mesh-ancestor
111044416|NCT02150993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111044417|NCT02150993|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111044418|NCT02150993|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111044420|NCT02150993|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111044421|NCT02150993|Antimetabolites|antimetabolites|mesh-ancestor
111044422|NCT02150993|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111044423|NCT02150993|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111044424|NCT02690727|Tenalisib|tenalisib|mesh-list
111044425|NCT02690727|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
111044426|NCT02690727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111044427|NCT02690727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111044428|NCT02224105|Prednisolone|prednisolone|mesh-list
111044429|NCT02224105|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111044430|NCT02224105|Methylprednisolone|methylprednisolone|mesh-list
111044431|NCT02224105|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111044432|NCT02224105|Prednisolone acetate|prednisolone acetate|mesh-list
111044433|NCT02224105|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111044434|NCT02224105|Prednisolone phosphate|prednisolone phosphate|mesh-list
111044435|NCT02224105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111044436|NCT02224105|Glucocorticoids|glucocorticoids|mesh-ancestor
111044437|NCT02224105|Hormones|hormones|mesh-ancestor
111044438|NCT02224105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111044439|NCT02224105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111044440|NCT02224105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111044441|NCT02224105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111044442|NCT02224105|Antiemetics|antiemetics|mesh-ancestor
111044443|NCT02224105|Autonomic Agents|autonomic agents|mesh-ancestor
111044444|NCT02224105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111044445|NCT02224105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111044446|NCT02224105|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111044447|NCT02224105|Protective Agents|protective agents|mesh-ancestor
111044448|NCT02156375|Ustekinumab|ustekinumab|mesh-list
111044449|NCT02156375|Dermatologic Agents|dermatologic agents|mesh-ancestor
111044450|NCT03542279|Glucocorticoids|glucocorticoids|mesh-list
111044451|NCT03542279|Hormones|hormones|mesh-ancestor
111044452|NCT03542279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111044453|NCT03542279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111044454|NCT02230735|Epinephrine|epinephrine|mesh-list
111044455|NCT02230735|Racepinephrine|racepinephrine|mesh-list
111044456|NCT02230735|Epinephryl borate|epinephryl borate|mesh-list
111044457|NCT02230735|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111044458|NCT02230735|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111044459|NCT02230735|Adrenergic Agents|adrenergic agents|mesh-ancestor
111044460|NCT02230735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111044461|NCT02230735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111044462|NCT02230735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111044463|NCT02230735|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111044464|NCT02230735|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111044465|NCT02230735|Autonomic Agents|autonomic agents|mesh-ancestor
111044466|NCT02230735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111044467|NCT02230735|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111044468|NCT02230735|Respiratory System Agents|respiratory system agents|mesh-ancestor
111044469|NCT02230735|Mydriatics|mydriatics|mesh-ancestor
111044470|NCT02230735|Sympathomimetics|sympathomimetics|mesh-ancestor
111044471|NCT02230735|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111044472|NCT02258581|Tenofovir|tenofovir|mesh-list
111044473|NCT02258581|Vesatolimod|vesatolimod|mesh-list
111044474|NCT02258581|Antiviral Agents|antiviral agents|mesh-ancestor
111044475|NCT02258581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111044476|NCT02258581|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111044477|NCT02258581|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111044478|NCT02258581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111044479|NCT02258581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111044480|NCT02258581|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111044481|NCT02258581|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111044482|NCT03165825|Dexamethasone|dexamethasone|mesh-list
111044483|NCT03165825|Betamethasone|betamethasone|mesh-list
111044484|NCT03165825|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111044485|NCT03165825|Antiemetics|antiemetics|mesh-ancestor
111044486|NCT03165825|Autonomic Agents|autonomic agents|mesh-ancestor
111044487|NCT03165825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111044488|NCT03165825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111044489|NCT03165825|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111044490|NCT03165825|Glucocorticoids|glucocorticoids|mesh-ancestor
111044491|NCT03165825|Hormones|hormones|mesh-ancestor
111044492|NCT03165825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111044493|NCT03165825|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111044494|NCT03165825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111044495|NCT03165825|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111044496|NCT03165825|Respiratory System Agents|respiratory system agents|mesh-ancestor
111044497|NCT03167853|Antibodies|antibodies|mesh-list
111044498|NCT03167853|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111044499|NCT03167853|Immunologic Factors|immunologic factors|mesh-ancestor
111044500|NCT03167853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111044501|NCT05746143|Zolpidem|zolpidem|mesh-list
111044502|NCT05746143|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111044503|NCT05746143|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111044504|NCT05746143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111044505|NCT05746143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111044506|NCT05746143|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
111044507|NCT05746143|GABA Agonists|gaba agonists|mesh-ancestor
111044508|NCT05746143|GABA Agents|gaba agents|mesh-ancestor
111044509|NCT05746143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111044510|NCT05746143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111044511|NCT03165591|Vaccines|vaccines|mesh-list
110676906|NCT03318900|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111044512|NCT03165591|Immunologic Factors|immunologic factors|mesh-ancestor
111044513|NCT03165591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111044514|NCT03114813|Carvedilol|carvedilol|mesh-list
111044515|NCT03114813|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111044516|NCT03114813|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111044517|NCT03114813|Adrenergic Agents|adrenergic agents|mesh-ancestor
111044518|NCT03114813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111044519|NCT03114813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111044520|NCT03114813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111044521|NCT03114813|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111044522|NCT03114813|Antioxidants|antioxidants|mesh-ancestor
111044523|NCT03114813|Protective Agents|protective agents|mesh-ancestor
111044524|NCT03114813|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111044525|NCT03114813|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111044526|NCT03114813|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111044527|NCT03114813|Vasodilator Agents|vasodilator agents|mesh-ancestor
111044528|NCT03114813|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111044529|NCT03114813|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111044530|NCT01358864|Interferons|interferons|mesh-list
111044531|NCT01358864|Ribavirin|ribavirin|mesh-list
111044532|NCT01358864|Interferon-alpha|interferon-alpha|mesh-list
111044533|NCT01358864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111044534|NCT01358864|Antiviral Agents|antiviral agents|mesh-ancestor
111044535|NCT01358864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111044536|NCT01358864|Antimetabolites|antimetabolites|mesh-ancestor
111044537|NCT01358864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111044538|NCT01358864|Immunologic Factors|immunologic factors|mesh-ancestor
111044539|NCT01358864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111044540|NCT02750761|Tedizolid phosphate|tedizolid phosphate|mesh-list
111044541|NCT02750761|Tedizolid|tedizolid|mesh-list
111044542|NCT02750761|Oxazolidinones|oxazolidinones|mesh-list
111044543|NCT02750761|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111044544|NCT02750761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111044545|NCT02750761|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111044546|NCT02750761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111044547|NCT02750761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111044548|NCT02814019|Idebenone|idebenone|mesh-list
111044549|NCT02814019|Antioxidants|antioxidants|mesh-ancestor
111044550|NCT02814019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111044551|NCT02814019|Protective Agents|protective agents|mesh-ancestor
111044552|NCT02814019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111044553|NCT03364244|Sildenafil Citrate|sildenafil citrate|mesh-list
111044554|NCT03364244|Vasodilator Agents|vasodilator agents|mesh-ancestor
111044555|NCT03364244|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111044556|NCT03364244|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111044557|NCT03364244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111044558|NCT03364244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111044559|NCT03364244|Urological Agents|urological agents|mesh-ancestor
111044560|NCT03165123|Azithromycin|azithromycin|mesh-list
111044561|NCT03165123|Dexamethasone|dexamethasone|mesh-list
111044562|NCT03165123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111044563|NCT03165123|Antiemetics|antiemetics|mesh-ancestor
111044564|NCT03165123|Autonomic Agents|autonomic agents|mesh-ancestor
111044565|NCT03165123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111044566|NCT03165123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111044567|NCT03165123|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111044568|NCT03165123|Glucocorticoids|glucocorticoids|mesh-ancestor
111044569|NCT03165123|Hormones|hormones|mesh-ancestor
111044570|NCT03165123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111044571|NCT03165123|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111044572|NCT03165123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111044573|NCT03165123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111044574|NCT03165123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111044575|NCT01131169|Vidarabine|vidarabine|mesh-list
111044576|NCT01131169|Fludarabine|fludarabine|mesh-list
111044577|NCT01131169|Fludarabine phosphate|fludarabine phosphate|mesh-list
111044578|NCT01131169|Melphalan|melphalan|mesh-list
111044579|NCT01131169|Busulfan|busulfan|mesh-list
111044580|NCT01131169|Lenograstim|lenograstim|mesh-list
111044581|NCT01131169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111044582|NCT01131169|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111044583|NCT01131169|Antimetabolites|antimetabolites|mesh-ancestor
111044584|NCT01131169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111044585|NCT01131169|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111044586|NCT01131169|Immunologic Factors|immunologic factors|mesh-ancestor
111044587|NCT01131169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111044588|NCT01131169|Antiviral Agents|antiviral agents|mesh-ancestor
111044589|NCT01131169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111044590|NCT01131169|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111044591|NCT01131169|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111044592|NCT01131169|Alkylating Agents|alkylating agents|mesh-ancestor
111044593|NCT01131169|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111044595|NCT02688933|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111044596|NCT02688933|Insulin Glargine|insulin glargine|mesh-list
111044597|NCT02688933|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111044598|NCT02688933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111044599|NCT04372628|Ritonavir|ritonavir|mesh-list
111044600|NCT04372628|Lopinavir|lopinavir|mesh-list
111044601|NCT04372628|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111044602|NCT04372628|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111044603|NCT04372628|Protease Inhibitors|protease inhibitors|mesh-ancestor
111044604|NCT04372628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111044605|NCT04372628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111044606|NCT04372628|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111044607|NCT04372628|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111044608|NCT04372628|Antiviral Agents|antiviral agents|mesh-ancestor
111044609|NCT04372628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111044610|NCT04372628|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111044611|NCT04372628|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111044612|NCT04230980|Gabapentin|gabapentin|mesh-list
111044613|NCT04230980|Analgesics|analgesics|mesh-ancestor
111044614|NCT04230980|Sensory System Agents|sensory system agents|mesh-ancestor
111044615|NCT04230980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111044616|NCT04230980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111044617|NCT04230980|Anticonvulsants|anticonvulsants|mesh-ancestor
111044618|NCT04230980|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111044619|NCT04230980|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111044620|NCT04230980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111044621|NCT04230980|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111044622|NCT04230980|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111044623|NCT04230980|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111044624|NCT04230980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111044625|NCT04230980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111044626|NCT04230980|Antimanic Agents|antimanic agents|mesh-ancestor
111044627|NCT00882505|Vitamin D|vitamin d|mesh-list
111044628|NCT00882505|Vitamins|vitamins|mesh-ancestor
111044629|NCT00882505|Micronutrients|micronutrients|mesh-ancestor
111044630|NCT00882505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111044631|NCT00882505|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111044632|NCT04480359|Meloxicam|meloxicam|mesh-list
111044633|NCT04480359|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111044634|NCT04480359|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111044635|NCT04480359|Analgesics|analgesics|mesh-ancestor
111044636|NCT04480359|Sensory System Agents|sensory system agents|mesh-ancestor
111044637|NCT04480359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111044638|NCT04480359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111044639|NCT04480359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111044640|NCT04480359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111044641|NCT04480359|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111044642|NCT04480359|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111044643|NCT04480359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111044644|NCT04480359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111044645|NCT03724825|Testosterone|testosterone|mesh-list
111044646|NCT03724825|Androgens|androgens|mesh-ancestor
111044647|NCT03724825|Hormones|hormones|mesh-ancestor
111044648|NCT03724825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111044649|NCT03724825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111044650|NCT04227704|Ketamine|ketamine|mesh-list
111044651|NCT04227704|Analgesics|analgesics|mesh-ancestor
111044652|NCT04227704|Sensory System Agents|sensory system agents|mesh-ancestor
111044653|NCT04227704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111044654|NCT04227704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111044655|NCT04227704|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111044656|NCT04227704|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111044657|NCT04227704|Anesthetics, General|anesthetics, general|mesh-ancestor
111044658|NCT04227704|Anesthetics|anesthetics|mesh-ancestor
111044659|NCT04227704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111044660|NCT04227704|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111044661|NCT04227704|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111044662|NCT04227704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111044663|NCT04227704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111044664|NCT03720613|Naloxegol|naloxegol|mesh-list
111044665|NCT03720613|Lubiprostone|lubiprostone|mesh-list
111044666|NCT03720613|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
111044667|NCT03720613|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111044668|NCT03720613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111044669|NCT03720613|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111044670|NCT03720613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111044671|NCT03720613|Sensory System Agents|sensory system agents|mesh-ancestor
111044672|NCT03720613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111044673|NCT02709512|Cisplatin|cisplatin|mesh-list
111044674|NCT02709512|Pemetrexed|pemetrexed|mesh-list
111044675|NCT02709512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111044676|NCT02709512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111044677|NCT02709512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111044678|NCT02709512|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111044679|NCT02709512|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111044680|NCT03659929|Amphetamine|amphetamine|mesh-list
111044681|NCT03659929|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111044682|NCT03659929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111044683|NCT03659929|Sympathomimetics|sympathomimetics|mesh-ancestor
111044684|NCT03659929|Autonomic Agents|autonomic agents|mesh-ancestor
111044685|NCT03659929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111044686|NCT03659929|Dopamine Agents|dopamine agents|mesh-ancestor
111044687|NCT03659929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111044688|NCT03659929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111044689|NCT03659929|Adrenergic Agents|adrenergic agents|mesh-ancestor
111044690|NCT03659929|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111044691|NCT03659929|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111044692|NCT03659929|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111044693|NCT03659929|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111044694|NCT02811679|Blinatumomab|blinatumomab|mesh-list
111044695|NCT02811679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111044696|NCT03448081|Calcipotriene|calcipotriene|mesh-list
111044697|NCT03448081|Dermatologic Agents|dermatologic agents|mesh-ancestor
111044698|NCT02232607|Lacidipine|lacidipine|mesh-list
111044699|NCT02232607|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111044700|NCT02232607|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111044701|NCT02232607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111044702|NCT02232607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111044703|NCT02232607|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111044704|NCT02232607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111044705|NCT02232685|Choline|choline|mesh-list
111044706|NCT02232685|Lipotropic Agents|lipotropic agents|mesh-ancestor
111044707|NCT02232685|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111044708|NCT02232685|Antimetabolites|antimetabolites|mesh-ancestor
111044709|NCT02232685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111044710|NCT02232685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111044711|NCT02232685|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111044712|NCT02232685|Nootropic Agents|nootropic agents|mesh-ancestor
111044713|NCT02232763|Losartan|losartan|mesh-list
111044714|NCT02232763|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110026144|NCT00384618|Antioxidants|antioxidants|mesh-ancestor
111044715|NCT02232763|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111044716|NCT02232763|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111044717|NCT02232763|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111044718|NCT02232763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111044719|NCT04294784|Paclitaxel|paclitaxel|mesh-list
111044720|NCT04294784|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111044721|NCT04294784|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
111044722|NCT04294784|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111044723|NCT04294784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111044724|NCT04294784|Tubulin Modulators|tubulin modulators|mesh-ancestor
111044725|NCT04294784|Antimitotic Agents|antimitotic agents|mesh-ancestor
111044726|NCT04294784|Mitosis Modulators|mitosis modulators|mesh-ancestor
111044727|NCT04294784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111044728|NCT04294784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111044729|NCT02262559|Telmisartan|telmisartan|mesh-list
111044730|NCT02262559|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111044731|NCT02262559|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111044732|NCT02262559|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111044733|NCT02262559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111044734|NCT05491460|Rivaroxaban|rivaroxaban|mesh-list
111044736|NCT05491460|Edoxaban|edoxaban|mesh-list
111044737|NCT05491460|Dabigatran|dabigatran|mesh-list
111044738|NCT05491460|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111044739|NCT05491460|Antithrombins|antithrombins|mesh-ancestor
111044740|NCT05491460|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111044741|NCT05491460|Protease Inhibitors|protease inhibitors|mesh-ancestor
111044742|NCT05491460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111044743|NCT05491460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111044744|NCT05491460|Anticoagulants|anticoagulants|mesh-ancestor
111044745|NCT03311269|Sodium Tetradecyl Sulfate|sodium tetradecyl sulfate|mesh-list
111044746|NCT03311269|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
111044747|NCT03311269|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111044748|NCT02762929|Bupivacaine|bupivacaine|mesh-list
111044749|NCT02762929|Anesthetics, Local|anesthetics, local|mesh-ancestor
111044750|NCT02762929|Anesthetics|anesthetics|mesh-ancestor
111044751|NCT02762929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111044752|NCT02762929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111044753|NCT02762929|Sensory System Agents|sensory system agents|mesh-ancestor
111044754|NCT02762929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111044755|NCT02262637|Telmisartan|telmisartan|mesh-list
111044756|NCT02262637|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
111044757|NCT02262637|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111044758|NCT02262637|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111044759|NCT02262637|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111044760|NCT02262637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111044761|NCT02262637|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
111044762|NCT02262637|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111044763|NCT02262637|Diuretics|diuretics|mesh-ancestor
111044764|NCT02262637|Natriuretic Agents|natriuretic agents|mesh-ancestor
111044765|NCT02262637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111044766|NCT02606305|Bevacizumab|bevacizumab|mesh-list
111044767|NCT02606305|Pembrolizumab|pembrolizumab|mesh-list
111044768|NCT02606305|Carboplatin|carboplatin|mesh-list
111044769|NCT02606305|Doxorubicin|doxorubicin|mesh-list
111044770|NCT02606305|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111044771|NCT02606305|Maytansine|maytansine|mesh-list
111044772|NCT02606305|Mirvetuximab soravtansine|mirvetuximab soravtansine|mesh-list
111044773|NCT02606305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111044774|NCT02606305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111044775|NCT02606305|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111044776|NCT02606305|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111044777|NCT02606305|Growth Substances|growth substances|mesh-ancestor
111044778|NCT02606305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111044779|NCT02606305|Growth Inhibitors|growth inhibitors|mesh-ancestor
111044780|NCT02606305|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111044781|NCT02606305|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111044782|NCT02606305|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111044783|NCT02606305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111044784|NCT02606305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111044785|NCT02606305|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111044786|NCT02606305|Immunoconjugates|immunoconjugates|mesh-ancestor
111044787|NCT02606305|Immunologic Factors|immunologic factors|mesh-ancestor
111044788|NCT02606305|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111044789|NCT02606305|Tubulin Modulators|tubulin modulators|mesh-ancestor
111044790|NCT02606305|Antimitotic Agents|antimitotic agents|mesh-ancestor
111044791|NCT02606305|Mitosis Modulators|mitosis modulators|mesh-ancestor
111044792|NCT01662986|Bromides|bromides|mesh-list
111044793|NCT01662986|Tiotropium Bromide|tiotropium bromide|mesh-list
111044794|NCT01662986|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111044795|NCT01662986|Autonomic Agents|autonomic agents|mesh-ancestor
111044796|NCT01662986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111044797|NCT01662986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111044798|NCT01662986|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111044799|NCT01662986|Respiratory System Agents|respiratory system agents|mesh-ancestor
111044800|NCT01662986|Parasympatholytics|parasympatholytics|mesh-ancestor
111044801|NCT01662986|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111044802|NCT01662986|Cholinergic Agents|cholinergic agents|mesh-ancestor
111044803|NCT01662986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111044804|NCT01662986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111044805|NCT01662986|Anticonvulsants|anticonvulsants|mesh-ancestor
111044806|NCT05497232|Pancrelipase|pancrelipase|mesh-list
111044807|NCT05497232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111044808|NCT00054158|Thalidomide|thalidomide|mesh-list
111044809|NCT00054158|Dexamethasone|dexamethasone|mesh-list
111044810|NCT00054158|Doxorubicin|doxorubicin|mesh-list
111044811|NCT00054158|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111044812|NCT00054158|Vincristine|vincristine|mesh-list
111044813|NCT00054158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111044814|NCT00054158|Antiemetics|antiemetics|mesh-ancestor
111044815|NCT00054158|Autonomic Agents|autonomic agents|mesh-ancestor
110628400|NCT00271609|Growth Substances|growth substances|mesh-ancestor
111044816|NCT00054158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111044817|NCT00054158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111044818|NCT00054158|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111044819|NCT00054158|Glucocorticoids|glucocorticoids|mesh-ancestor
111044820|NCT00054158|Hormones|hormones|mesh-ancestor
111044821|NCT00054158|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111044822|NCT00054158|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111044823|NCT00054158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111044824|NCT00054158|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111044825|NCT00054158|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111044826|NCT00054158|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111044827|NCT00054158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111044828|NCT00054158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111044829|NCT00054158|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111044830|NCT00054158|Tubulin Modulators|tubulin modulators|mesh-ancestor
111044831|NCT00054158|Antimitotic Agents|antimitotic agents|mesh-ancestor
111044832|NCT00054158|Mitosis Modulators|mitosis modulators|mesh-ancestor
111044833|NCT00054158|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111044834|NCT00054158|Immunologic Factors|immunologic factors|mesh-ancestor
111044835|NCT00054158|Leprostatic Agents|leprostatic agents|mesh-ancestor
111044836|NCT00054158|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111044837|NCT00054158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111044838|NCT00054158|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111044839|NCT00054158|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111044840|NCT00054158|Growth Substances|growth substances|mesh-ancestor
111044841|NCT00054158|Growth Inhibitors|growth inhibitors|mesh-ancestor
111044842|NCT01337167|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
111044843|NCT01337167|Immunologic Factors|immunologic factors|mesh-ancestor
111044844|NCT01337167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111044845|NCT05496764|Dexamethasone|dexamethasone|mesh-list
111044846|NCT05496764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111044847|NCT05496764|Antiemetics|antiemetics|mesh-ancestor
111044848|NCT05496764|Autonomic Agents|autonomic agents|mesh-ancestor
111044849|NCT05496764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111044850|NCT05496764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111044851|NCT05496764|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111044852|NCT05496764|Glucocorticoids|glucocorticoids|mesh-ancestor
111044853|NCT05496764|Hormones|hormones|mesh-ancestor
111044854|NCT05496764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111044855|NCT05496764|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111044856|NCT05496764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111044857|NCT05496530|Triamcinolone|triamcinolone|mesh-list
111044858|NCT05496530|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
111044859|NCT05496530|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
111044860|NCT05496530|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
111044861|NCT05496530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111044862|NCT05496530|Glucocorticoids|glucocorticoids|mesh-ancestor
111044863|NCT05496530|Hormones|hormones|mesh-ancestor
111044864|NCT05496530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111044865|NCT05496530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111044866|NCT05496530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111044867|NCT05496530|Immunologic Factors|immunologic factors|mesh-ancestor
111044868|NCT05496530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111044869|NCT05496530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111044870|NCT02744833|Enoxaparin|enoxaparin|mesh-list
111044871|NCT02744833|Enoxaparin sodium|enoxaparin sodium|mesh-list
111044872|NCT02744833|Anticoagulants|anticoagulants|mesh-ancestor
111044873|NCT02744833|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111044874|NCT02744833|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111044875|NCT02744833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111044876|NCT02234869|Interferons|interferons|mesh-list
110761903|NCT04378933|Autonomic Agents|autonomic agents|mesh-ancestor
110761904|NCT04378933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110761905|NCT04378933|Dopamine Agents|dopamine agents|mesh-ancestor
110761906|NCT04378933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110761907|NCT04378933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110761908|NCT04378933|Adrenergic Agents|adrenergic agents|mesh-ancestor
110761909|NCT04378933|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110761910|NCT04378933|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111044887|NCT05499026|Cathartics|cathartics|mesh-ancestor
111044888|NCT05499026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111044889|NCT05498714|Lactulose|lactulose|mesh-list
111044890|NCT05498714|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111044891|NCT05490836|Interferon-alpha|interferon-alpha|mesh-list
111044892|NCT05490836|Interferon alpha-2|interferon alpha-2|mesh-list
111044893|NCT05490836|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
111044894|NCT05490836|Antiviral Agents|antiviral agents|mesh-ancestor
111044895|NCT05490836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111044896|NCT05490836|Immunologic Factors|immunologic factors|mesh-ancestor
111044897|NCT05490836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111044898|NCT05490836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111044899|NCT01338025|Lamivudine|lamivudine|mesh-list
111044900|NCT01338025|Emtricitabine|emtricitabine|mesh-list
111044901|NCT01338025|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111044902|NCT01338025|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111044903|NCT01338025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111044904|NCT01338025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111044905|NCT01338025|Antiviral Agents|antiviral agents|mesh-ancestor
111044906|NCT01338025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111044907|NCT01338025|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111044908|NCT01338025|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111044909|NCT05498636|Prednisone|prednisone|mesh-list
111044910|NCT05498636|Etoposide|etoposide|mesh-list
111044911|NCT05498636|Lenalidomide|lenalidomide|mesh-list
111044912|NCT05498636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111044913|NCT05498636|Glucocorticoids|glucocorticoids|mesh-ancestor
111044914|NCT05498636|Hormones|hormones|mesh-ancestor
111044915|NCT05498636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111044916|NCT05498636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111044917|NCT05498636|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111044918|NCT05498636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111044919|NCT05498636|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111044920|NCT05498636|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111044921|NCT05498636|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111044922|NCT05498636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111044923|NCT05498636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111044924|NCT05498636|Immunologic Factors|immunologic factors|mesh-ancestor
111044925|NCT05498636|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111044926|NCT05498636|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111044927|NCT05498636|Growth Substances|growth substances|mesh-ancestor
111044928|NCT05498636|Growth Inhibitors|growth inhibitors|mesh-ancestor
111044929|NCT02262715|Oseltamivir|oseltamivir|mesh-list
111044930|NCT02262715|Antiviral Agents|antiviral agents|mesh-ancestor
111044931|NCT02262715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111044932|NCT02262715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111044933|NCT02262715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111044943|NCT04424420|Acetaminophen|acetaminophen|mesh-list
111044944|NCT04424420|Ibuprofen|ibuprofen|mesh-list
111044945|NCT04424420|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111044946|NCT04424420|Analgesics|analgesics|mesh-ancestor
111044947|NCT04424420|Sensory System Agents|sensory system agents|mesh-ancestor
111044948|NCT04424420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111044949|NCT04424420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111044950|NCT04424420|Antipyretics|antipyretics|mesh-ancestor
111044951|NCT04424420|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110762023|NCT04071769|Xenon|xenon|mesh-list
111044952|NCT04424420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111044954|NCT04424420|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111044955|NCT04424420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111044956|NCT04424420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111044957|NCT05495750|Bupivacaine|bupivacaine|mesh-list
111044958|NCT05495750|Anesthetics, Local|anesthetics, local|mesh-ancestor
111044959|NCT05495750|Anesthetics|anesthetics|mesh-ancestor
111044960|NCT05495750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111044961|NCT05495750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111044962|NCT05495750|Sensory System Agents|sensory system agents|mesh-ancestor
111044963|NCT05495750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111044964|NCT02233075|Interferons|interferons|mesh-list
111044965|NCT02233075|Interferon-alpha|interferon-alpha|mesh-list
111044966|NCT02233075|Interferon alpha-2|interferon alpha-2|mesh-list
111044967|NCT02233075|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
111044968|NCT02233075|REP 2139|rep 2139|mesh-list
111044969|NCT02233075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111044970|NCT02233075|Antiviral Agents|antiviral agents|mesh-ancestor
111044971|NCT02233075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111044972|NCT02233075|Immunologic Factors|immunologic factors|mesh-ancestor
111044973|NCT02233075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111044974|NCT04300244|Nivolumab|nivolumab|mesh-list
111044975|NCT04300244|Ipilimumab|ipilimumab|mesh-list
111044976|NCT04300244|Sargramostim|sargramostim|mesh-list
111044977|NCT04300244|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111044978|NCT04300244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111044979|NCT04300244|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111044980|NCT04300244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111044981|NCT04300244|Immunologic Factors|immunologic factors|mesh-ancestor
111044982|NCT04300244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111044983|NCT02578771|Methylene Blue|methylene blue|mesh-list
111044984|NCT02578771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111044985|NCT02578771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111044986|NCT02259595|Acetylcysteine|acetylcysteine|mesh-list
111044987|NCT02259595|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111044988|NCT02259595|Disufenton sodium|disufenton sodium|mesh-list
111044989|NCT02259595|Antiviral Agents|antiviral agents|mesh-ancestor
111044990|NCT02259595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111044991|NCT02259595|Expectorants|expectorants|mesh-ancestor
111044992|NCT02259595|Respiratory System Agents|respiratory system agents|mesh-ancestor
111044993|NCT02259595|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111044994|NCT02259595|Antioxidants|antioxidants|mesh-ancestor
111044995|NCT02259595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111044996|NCT02259595|Protective Agents|protective agents|mesh-ancestor
111044997|NCT02259595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111044998|NCT02259595|Antidotes|antidotes|mesh-ancestor
111044999|NCT02804035|Furosemide|furosemide|mesh-list
111045000|NCT02804035|Diuretics|diuretics|mesh-ancestor
111045001|NCT02804035|Natriuretic Agents|natriuretic agents|mesh-ancestor
111045002|NCT02804035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111045003|NCT02804035|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
111045004|NCT02804035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111045005|NCT02804035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111045006|NCT02262793|Telmisartan|telmisartan|mesh-list
110762052|NCT04016714|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110762053|NCT04016714|Immunologic Factors|immunologic factors|mesh-ancestor
110762054|NCT04016714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110762055|NCT03988530|Scopolamine|scopolamine|mesh-list
110762056|NCT03988530|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
110762057|NCT03988530|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110762058|NCT03988530|Antiemetics|antiemetics|mesh-ancestor
110762059|NCT03988530|Autonomic Agents|autonomic agents|mesh-ancestor
110762060|NCT03988530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110762061|NCT03988530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110762062|NCT03988530|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110762063|NCT03988530|Mydriatics|mydriatics|mesh-ancestor
110762064|NCT03988530|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110762065|NCT03988530|Cholinergic Agents|cholinergic agents|mesh-ancestor
110762066|NCT03988530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110762067|NCT03988530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110762068|NCT03988530|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110762069|NCT03988530|Parasympatholytics|parasympatholytics|mesh-ancestor
110762092|NCT03980769|Fludarabine|fludarabine|mesh-list
110762093|NCT03980769|Fludarabine phosphate|fludarabine phosphate|mesh-list
111045007|NCT02262793|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111045008|NCT02262793|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111045009|NCT02262793|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111045010|NCT02262793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111045012|NCT02559206|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
111045013|NCT02559206|Enzyme Activators|enzyme activators|mesh-ancestor
111045014|NCT02559206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111045015|NCT02559206|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111045016|NCT05485766|Paclitaxel|paclitaxel|mesh-list
111045017|NCT05485766|Carboplatin|carboplatin|mesh-list
111045018|NCT05485766|Pembrolizumab|pembrolizumab|mesh-list
111045019|NCT05485766|Olaparib|olaparib|mesh-list
111045020|NCT05485766|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111045021|NCT05485766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111045022|NCT05485766|Tubulin Modulators|tubulin modulators|mesh-ancestor
111045023|NCT05485766|Antimitotic Agents|antimitotic agents|mesh-ancestor
111045024|NCT05485766|Mitosis Modulators|mitosis modulators|mesh-ancestor
111045025|NCT05485766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111045026|NCT05485766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111045027|NCT05485766|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111045028|NCT05485766|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111045029|NCT05485766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111045030|NCT04402723|Cytarabine|cytarabine|mesh-list
111045031|NCT04402723|Daunorubicin|daunorubicin|mesh-list
111045032|NCT04402723|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111045033|NCT04402723|Antimetabolites|antimetabolites|mesh-ancestor
111045034|NCT04402723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111045035|NCT04402723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111045036|NCT04402723|Antiviral Agents|antiviral agents|mesh-ancestor
111045037|NCT04402723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111045038|NCT04402723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111045039|NCT04402723|Immunologic Factors|immunologic factors|mesh-ancestor
111045040|NCT04402723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111045041|NCT04402723|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111045042|NCT04402723|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111045043|NCT04402723|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111045044|NCT04402723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111045045|NCT02235337|Riboflavin|riboflavin|mesh-list
111045046|NCT02235337|Vitamins|vitamins|mesh-ancestor
111045047|NCT02235337|Micronutrients|micronutrients|mesh-ancestor
111045048|NCT02235337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111045049|NCT02235337|Vitamin B Complex|vitamin b complex|mesh-ancestor
111045050|NCT02235337|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111045051|NCT02235337|Dermatologic Agents|dermatologic agents|mesh-ancestor
111045052|NCT02233231|Varenicline|varenicline|mesh-list
111045053|NCT02233231|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111045054|NCT02233231|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111045055|NCT02233231|Cholinergic Agents|cholinergic agents|mesh-ancestor
111045056|NCT02233231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111045057|NCT02233231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111045058|NCT02233231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111045059|NCT02263027|Vaccines|vaccines|mesh-list
111045060|NCT02263027|Immunologic Factors|immunologic factors|mesh-ancestor
111045061|NCT02263027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111045062|NCT02263105|Temozolomide|temozolomide|mesh-list
111045063|NCT02263105|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111045064|NCT02263105|Alkylating Agents|alkylating agents|mesh-ancestor
111045065|NCT02263105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111045066|NCT02263105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111045067|NCT05485064|Fentanyl|fentanyl|mesh-list
111045068|NCT05485064|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111045069|NCT05485064|Narcotics|narcotics|mesh-ancestor
111045070|NCT05485064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111045071|NCT05485064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111045072|NCT05485064|Analgesics|analgesics|mesh-ancestor
111045073|NCT05485064|Sensory System Agents|sensory system agents|mesh-ancestor
111045074|NCT05485064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111045075|NCT05485064|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111045076|NCT05485064|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111045077|NCT05485064|Anesthetics, General|anesthetics, general|mesh-ancestor
111045078|NCT05485064|Anesthetics|anesthetics|mesh-ancestor
111045079|NCT05626153|Anesthetics|anesthetics|mesh-list
111045080|NCT05626153|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110762140|NCT03948035|Elotuzumab|elotuzumab|mesh-list
111045081|NCT05626153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111045082|NCT02553343|Vaccines|vaccines|mesh-list
111045083|NCT02553343|Immunologic Factors|immunologic factors|mesh-ancestor
111045084|NCT02553343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111045085|NCT02235415|Lacidipine|lacidipine|mesh-list
111045086|NCT02235415|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111045087|NCT02235415|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110628495|NCT00622284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111045088|NCT02235415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111045089|NCT02235415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111045090|NCT02235415|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111045091|NCT02235415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111045092|NCT03995017|Nivolumab|nivolumab|mesh-list
111045093|NCT03995017|Ramucirumab|ramucirumab|mesh-list
111045094|NCT03995017|Rucaparib|rucaparib|mesh-list
111045095|NCT03995017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111045096|NCT03995017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111045097|NCT03995017|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111045098|NCT03995017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111045099|NCT03995017|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111045100|NCT03995017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111045101|NCT02558894|Durvalumab|durvalumab|mesh-list
111045102|NCT02558894|Tremelimumab|tremelimumab|mesh-list
111045103|NCT02558894|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111045104|NCT02558894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111045105|NCT02558894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111045106|NCT02558894|Immunologic Factors|immunologic factors|mesh-ancestor
111045107|NCT02558894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111045108|NCT02233387|Imidazole|imidazole|mesh-list
111045109|NCT02233387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111045110|NCT02233387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111045111|NCT02510599|Solithromycin|solithromycin|mesh-list
111045112|NCT02510599|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111045113|NCT02510599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111045114|NCT02235805|Magnesium citrate|magnesium citrate|mesh-list
111045115|NCT02235805|Cathartics|cathartics|mesh-ancestor
111045116|NCT02235805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111045117|NCT04227769|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
111045118|NCT04227769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111045119|NCT02688387|Ambrisentan|ambrisentan|mesh-list
111045120|NCT02688387|Tadalafil|tadalafil|mesh-list
111045121|NCT02688387|Vasodilator Agents|vasodilator agents|mesh-ancestor
111045122|NCT02688387|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111045123|NCT02688387|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111045124|NCT02688387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111045125|NCT02688387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111045126|NCT02688387|Urological Agents|urological agents|mesh-ancestor
111045127|NCT02688387|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111045128|NCT05489900|Dexmedetomidine|dexmedetomidine|mesh-list
111045129|NCT05489900|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111045130|NCT05489900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111045131|NCT05489900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111045132|NCT05489900|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111045133|NCT05489900|Analgesics|analgesics|mesh-ancestor
111045134|NCT05489900|Sensory System Agents|sensory system agents|mesh-ancestor
111045135|NCT05489900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111045136|NCT05489900|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111045137|NCT05489900|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111045138|NCT05489900|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111045139|NCT05489900|Adrenergic Agents|adrenergic agents|mesh-ancestor
111045140|NCT05489900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111045141|NCT05489900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111045142|NCT05489666|Vitamin D|vitamin d|mesh-list
111045143|NCT05489666|Cholecalciferol|cholecalciferol|mesh-list
111045144|NCT05489666|Vitamins|vitamins|mesh-ancestor
111045145|NCT05489666|Micronutrients|micronutrients|mesh-ancestor
111045146|NCT05489666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111045147|NCT05489666|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111045148|NCT05489666|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111045149|NCT05484284|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111045150|NCT05484284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111045151|NCT05483894|Atorvastatin|atorvastatin|mesh-list
111045152|NCT05483894|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111045153|NCT05483894|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111045154|NCT05483894|Antimetabolites|antimetabolites|mesh-ancestor
111045155|NCT05483894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111045156|NCT05483894|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111045157|NCT05483894|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111045158|NCT05483894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111045159|NCT01621243|Paclitaxel|paclitaxel|mesh-list
111045160|NCT01621243|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111045161|NCT01621243|Gemcitabine|gemcitabine|mesh-list
111045162|NCT01621243|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111045163|NCT01621243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111045164|NCT01621243|Tubulin Modulators|tubulin modulators|mesh-ancestor
111045165|NCT01621243|Antimitotic Agents|antimitotic agents|mesh-ancestor
111045166|NCT01621243|Mitosis Modulators|mitosis modulators|mesh-ancestor
111045167|NCT01621243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111045168|NCT01621243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111045169|NCT01621243|Antimetabolites|antimetabolites|mesh-ancestor
111045170|NCT04076761|Trifluridine|trifluridine|mesh-list
111045171|NCT04076761|Antimetabolites|antimetabolites|mesh-ancestor
111045172|NCT04076761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111045173|NCT04076761|Antiviral Agents|antiviral agents|mesh-ancestor
111045174|NCT04076761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111045175|NCT04046887|Paclitaxel|paclitaxel|mesh-list
111045176|NCT04046887|Gemcitabine|gemcitabine|mesh-list
111045177|NCT04046887|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111045178|NCT04046887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111045179|NCT04046887|Tubulin Modulators|tubulin modulators|mesh-ancestor
111045180|NCT04046887|Antimitotic Agents|antimitotic agents|mesh-ancestor
111045181|NCT04046887|Mitosis Modulators|mitosis modulators|mesh-ancestor
111045182|NCT04046887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111045183|NCT04046887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111045184|NCT04046887|Antimetabolites|antimetabolites|mesh-ancestor
111045185|NCT02235961|Liraglutide|liraglutide|mesh-list
111045186|NCT02235961|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111045187|NCT02235961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111045188|NCT02235961|Incretins|incretins|mesh-ancestor
111045189|NCT02235961|Hormones|hormones|mesh-ancestor
111045190|NCT02235961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111045191|NCT01610245|Oseltamivir|oseltamivir|mesh-list
111045192|NCT01610245|Nitazoxanide|nitazoxanide|mesh-list
111045193|NCT01610245|Antiviral Agents|antiviral agents|mesh-ancestor
111045194|NCT01610245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111045195|NCT01610245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111045196|NCT01610245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111045197|NCT01610245|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111045198|NCT04138628|Atezolizumab|atezolizumab|mesh-list
111045199|NCT04138628|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111045200|NCT04138628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111045201|NCT04138628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111045202|NCT04138628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111045203|NCT02741791|Bupropion|bupropion|mesh-list
111045204|NCT02741791|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111045205|NCT02741791|Antidepressive Agents|antidepressive agents|mesh-ancestor
111045206|NCT02741791|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111045207|NCT02741791|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111045208|NCT02741791|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111045209|NCT02741791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111045210|NCT02741791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111045211|NCT02741791|Dopamine Agents|dopamine agents|mesh-ancestor
111045212|NCT02741791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111045213|NCT02741791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111045214|NCT02741791|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111045215|NCT02741791|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111045216|NCT02741791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111045217|NCT04275518|Cytarabine|cytarabine|mesh-list
111045218|NCT04275518|Azacitidine|azacitidine|mesh-list
110628590|NCT00961857|Incretins|incretins|mesh-ancestor
111045219|NCT04275518|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111045220|NCT04275518|Antimetabolites|antimetabolites|mesh-ancestor
111045221|NCT04275518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111045222|NCT04275518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111045223|NCT04275518|Antiviral Agents|antiviral agents|mesh-ancestor
111045224|NCT04275518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111045225|NCT04275518|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111045226|NCT04275518|Immunologic Factors|immunologic factors|mesh-ancestor
111045227|NCT04275518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111045228|NCT04275518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111045230|NCT02263495|Gemcitabine|gemcitabine|mesh-list
111045231|NCT02263495|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111045232|NCT02263495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111045233|NCT02263495|Tubulin Modulators|tubulin modulators|mesh-ancestor
111045234|NCT02263495|Antimitotic Agents|antimitotic agents|mesh-ancestor
111045235|NCT02263495|Mitosis Modulators|mitosis modulators|mesh-ancestor
111045236|NCT02263495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111045237|NCT02263495|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111045238|NCT02263495|Antimetabolites|antimetabolites|mesh-ancestor
111045239|NCT02687451|Oxymorphone|oxymorphone|mesh-list
111045240|NCT02687451|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111045241|NCT02687451|Narcotics|narcotics|mesh-ancestor
111045242|NCT02687451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111045243|NCT02687451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111045244|NCT02687451|Analgesics|analgesics|mesh-ancestor
111045245|NCT02687451|Sensory System Agents|sensory system agents|mesh-ancestor
111045246|NCT02687451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111045247|NCT02687451|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111045248|NCT02557646|Ribavirin|ribavirin|mesh-list
111045249|NCT02557646|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
111045250|NCT02557646|Antimetabolites|antimetabolites|mesh-ancestor
111045251|NCT02557646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111045252|NCT02557646|Antiviral Agents|antiviral agents|mesh-ancestor
111045253|NCT02557646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111045254|NCT03859687|Vitamins|vitamins|mesh-list
111045255|NCT03859687|Vitamin A|vitamin a|mesh-list
111045256|NCT03859687|Retinol palmitate|retinol palmitate|mesh-list
111045257|NCT03859687|Micronutrients|micronutrients|mesh-ancestor
111045258|NCT03859687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111045259|NCT03859687|Antioxidants|antioxidants|mesh-ancestor
111045260|NCT03859687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111045261|NCT03859687|Protective Agents|protective agents|mesh-ancestor
111045262|NCT03859687|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
111045263|NCT03859687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111045264|NCT02679573|Moxifloxacin|moxifloxacin|mesh-list
111045265|NCT02679573|Linezolid|linezolid|mesh-list
111045266|NCT02679573|Delafloxacin|delafloxacin|mesh-list
111045267|NCT02679573|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111045268|NCT02679573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111045269|NCT02679573|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111045270|NCT02679573|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111045271|NCT02679573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111045272|NCT02679573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111045273|NCT02679573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111045274|NCT02679573|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111045275|NCT05493332|Leucovorin|leucovorin|mesh-list
111045276|NCT05493332|Fluorouracil|fluorouracil|mesh-list
111045277|NCT05493332|Oxaliplatin|oxaliplatin|mesh-list
111045278|NCT05493332|Antimetabolites|antimetabolites|mesh-ancestor
111045279|NCT05493332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111045280|NCT05493332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111045281|NCT05493332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111045282|NCT05493332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111045283|NCT05493332|Immunologic Factors|immunologic factors|mesh-ancestor
111045284|NCT05493332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111045285|NCT05493332|Antidotes|antidotes|mesh-ancestor
111045286|NCT05493332|Protective Agents|protective agents|mesh-ancestor
111045287|NCT05493332|Vitamin B Complex|vitamin b complex|mesh-ancestor
111045288|NCT05493332|Vitamins|vitamins|mesh-ancestor
111045289|NCT05493332|Micronutrients|micronutrients|mesh-ancestor
111045290|NCT01591447|Solithromycin|solithromycin|mesh-list
111045291|NCT01591447|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111045292|NCT01591447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111045293|NCT01578655|Prednisone|prednisone|mesh-list
111045294|NCT01578655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111045295|NCT01578655|Glucocorticoids|glucocorticoids|mesh-ancestor
111045296|NCT01578655|Hormones|hormones|mesh-ancestor
111045297|NCT01578655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111045298|NCT01578655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111045299|NCT01578655|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111045300|NCT01578655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111045301|NCT05361447|Diazepam|diazepam|mesh-list
111045302|NCT05361447|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111045303|NCT05361447|Anticonvulsants|anticonvulsants|mesh-ancestor
111045304|NCT05361447|Antiemetics|antiemetics|mesh-ancestor
111045305|NCT05361447|Autonomic Agents|autonomic agents|mesh-ancestor
111045306|NCT05361447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111045307|NCT05361447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111045308|NCT05361447|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111045309|NCT05361447|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111045310|NCT05361447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111045311|NCT05361447|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
111045312|NCT05361447|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111045313|NCT05361447|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111045314|NCT05361447|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111045315|NCT05361447|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111045316|NCT05361447|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111045317|NCT05361447|Anesthetics, General|anesthetics, general|mesh-ancestor
111045318|NCT05361447|Anesthetics|anesthetics|mesh-ancestor
111045319|NCT05361447|GABA Modulators|gaba modulators|mesh-ancestor
111045320|NCT05361447|GABA Agents|gaba agents|mesh-ancestor
111045321|NCT05361447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111045322|NCT05361447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111045323|NCT01577173|Cetuximab|cetuximab|mesh-list
111045324|NCT01577173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111045325|NCT01577173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111045326|NCT01573351|Interferons|interferons|mesh-list
111045327|NCT01573351|Ribavirin|ribavirin|mesh-list
111045328|NCT01573351|Interferon-alpha|interferon-alpha|mesh-list
111045329|NCT01573351|Interferon alpha-2|interferon alpha-2|mesh-list
111045330|NCT01573351|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
111045331|NCT01573351|Asunaprevir|asunaprevir|mesh-list
111045332|NCT01573351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111045333|NCT01573351|Antiviral Agents|antiviral agents|mesh-ancestor
111045334|NCT01573351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111045335|NCT01573351|Antimetabolites|antimetabolites|mesh-ancestor
111045336|NCT01573351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111045337|NCT01573351|Immunologic Factors|immunologic factors|mesh-ancestor
111045338|NCT01573351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111045339|NCT01573351|Protease Inhibitors|protease inhibitors|mesh-ancestor
111045340|NCT01573351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111045341|NCT02685033|Dalbavancin|dalbavancin|mesh-list
111045342|NCT02685033|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111045343|NCT02685033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111045344|NCT05579223|Hydromorphone|hydromorphone|mesh-list
111045345|NCT05579223|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111045346|NCT05579223|Narcotics|narcotics|mesh-ancestor
111045347|NCT05579223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111045348|NCT05579223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111045349|NCT05579223|Analgesics|analgesics|mesh-ancestor
111045350|NCT05579223|Sensory System Agents|sensory system agents|mesh-ancestor
111045351|NCT05579223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111045352|NCT00258427|Methylprednisolone|methylprednisolone|mesh-list
111045353|NCT00258427|Cyclophosphamide|cyclophosphamide|mesh-list
111045354|NCT00258427|Busulfan|busulfan|mesh-list
111045355|NCT00258427|Fludarabine|fludarabine|mesh-list
111045356|NCT00258427|Fludarabine phosphate|fludarabine phosphate|mesh-list
111045357|NCT00258427|Antilymphocyte Serum|antilymphocyte serum|mesh-list
111045358|NCT00258427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111045359|NCT00258427|Immunologic Factors|immunologic factors|mesh-ancestor
111045360|NCT00258427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111045361|NCT00258427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111045362|NCT00258427|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111045363|NCT00258427|Alkylating Agents|alkylating agents|mesh-ancestor
111045364|NCT00258427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111045365|NCT00258427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111045366|NCT00258427|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111045367|NCT00258427|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111045368|NCT00258427|Antimetabolites|antimetabolites|mesh-ancestor
111045369|NCT00258427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111045370|NCT00258427|Antiemetics|antiemetics|mesh-ancestor
111045371|NCT00258427|Autonomic Agents|autonomic agents|mesh-ancestor
111045372|NCT00258427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111045373|NCT00258427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111045374|NCT00258427|Glucocorticoids|glucocorticoids|mesh-ancestor
111045375|NCT00258427|Hormones|hormones|mesh-ancestor
111045376|NCT00258427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111045377|NCT00258427|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111045378|NCT00258427|Protective Agents|protective agents|mesh-ancestor
111045379|NCT01531699|Povidone-Iodine|povidone-iodine|mesh-list
111045380|NCT01531699|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111045381|NCT01531699|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111045382|NCT01531699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111045383|NCT02233621|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
111045384|NCT02233621|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
111045385|NCT02233621|Estradiol|estradiol|mesh-list
111045386|NCT02233621|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
111045387|NCT02233621|Estrogens|estrogens|mesh-ancestor
111045389|NCT02233621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111045390|NCT02233621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111045391|NCT02233621|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111045392|NCT02233621|Contraceptive Agents|contraceptive agents|mesh-ancestor
111045393|NCT02233621|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111045394|NCT02233621|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111045395|NCT02557100|Adalimumab|adalimumab|mesh-list
111045396|NCT02557100|Methotrexate|methotrexate|mesh-list
111045397|NCT02557100|Abatacept|abatacept|mesh-list
111045398|NCT02557100|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111045399|NCT02557100|Abortifacient Agents|abortifacient agents|mesh-ancestor
111045400|NCT02557100|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111045401|NCT02557100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111045402|NCT02557100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111045403|NCT02557100|Antimetabolites|antimetabolites|mesh-ancestor
111045404|NCT02557100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111045405|NCT02557100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111045406|NCT02557100|Dermatologic Agents|dermatologic agents|mesh-ancestor
111045407|NCT02557100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111045408|NCT02557100|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111045409|NCT02557100|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111045410|NCT02557100|Immunologic Factors|immunologic factors|mesh-ancestor
111045411|NCT02557100|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111045412|NCT02557100|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111045413|NCT02557100|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111045414|NCT02557100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111045415|NCT02557100|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111045416|NCT02557100|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111045417|NCT02233777|Pregabalin|pregabalin|mesh-list
111045418|NCT02233777|Analgesics|analgesics|mesh-ancestor
111045419|NCT02233777|Sensory System Agents|sensory system agents|mesh-ancestor
111045420|NCT02233777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111045421|NCT02233777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111045422|NCT02233777|Anticonvulsants|anticonvulsants|mesh-ancestor
111045423|NCT02233777|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111045424|NCT02233777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111045425|NCT02233777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111045426|NCT02233777|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111045427|NCT02233777|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111045428|NCT02233777|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111045429|NCT02233777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111045430|NCT02233777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111045431|NCT02634853|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111045432|NCT02634853|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111045433|NCT01520545|Baclofen|baclofen|mesh-list
111045434|NCT01520545|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
111045435|NCT01520545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111045436|NCT01520545|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111045437|NCT01520545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111045438|NCT01520545|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
111045439|NCT01520545|GABA Agonists|gaba agonists|mesh-ancestor
111045440|NCT01520545|GABA Agents|gaba agents|mesh-ancestor
111045441|NCT01520545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111045442|NCT01520545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111045443|NCT05488106|Riboflavin|riboflavin|mesh-list
111045444|NCT05488106|Vitamin B Complex|vitamin b complex|mesh-ancestor
111045445|NCT05488106|Vitamins|vitamins|mesh-ancestor
111045446|NCT05488106|Micronutrients|micronutrients|mesh-ancestor
111045447|NCT05488106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111045448|NCT05488106|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111045449|NCT05488106|Dermatologic Agents|dermatologic agents|mesh-ancestor
111045450|NCT05492318|Clarithromycin|clarithromycin|mesh-list
111045451|NCT05492318|Midazolam|midazolam|mesh-list
111045452|NCT05492318|Dabigatran|dabigatran|mesh-list
111045453|NCT05492318|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
111045454|NCT05492318|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111045455|NCT05492318|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111045456|NCT05492318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111045457|NCT05492318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111045458|NCT05492318|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111045459|NCT05492318|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111045460|NCT05492318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111045461|NCT05492318|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111045462|NCT05492318|Anesthetics, General|anesthetics, general|mesh-ancestor
111045463|NCT05492318|Anesthetics|anesthetics|mesh-ancestor
111045464|NCT05492318|GABA Modulators|gaba modulators|mesh-ancestor
111045465|NCT05492318|GABA Agents|gaba agents|mesh-ancestor
111045466|NCT05492318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111045467|NCT05492318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111045468|NCT05492318|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111045469|NCT05492318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111045470|NCT05492318|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111045471|NCT05492318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111045472|NCT05492318|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111045473|NCT05492318|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111045474|NCT05492318|Antithrombins|antithrombins|mesh-ancestor
111045475|NCT05492318|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111045476|NCT05492318|Protease Inhibitors|protease inhibitors|mesh-ancestor
111045477|NCT05492318|Anticoagulants|anticoagulants|mesh-ancestor
111045478|NCT05492318|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111045479|NCT01337635|Vitamin D|vitamin d|mesh-list
111045480|NCT01337635|Vitamins|vitamins|mesh-ancestor
111045481|NCT01337635|Micronutrients|micronutrients|mesh-ancestor
111045482|NCT01337635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111045483|NCT01337635|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111045484|NCT02264041|Itraconazole|itraconazole|mesh-list
111045485|NCT02264041|Antifungal Agents|antifungal agents|mesh-ancestor
111045486|NCT02264041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111045487|NCT02264041|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111045488|NCT02264041|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111045489|NCT02264041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111045490|NCT02264041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111045491|NCT02264041|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111045492|NCT02264041|Hormone Antagonists|hormone antagonists|mesh-ancestor
111045493|NCT02264041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111045494|NCT02264041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111045495|NCT02264041|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111045496|NCT02261779|Tretinoin|tretinoin|mesh-list
111045497|NCT02261779|Tranylcypromine|tranylcypromine|mesh-list
111045498|NCT02261779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111045499|NCT02261779|Keratolytic Agents|keratolytic agents|mesh-ancestor
111045500|NCT02261779|Dermatologic Agents|dermatologic agents|mesh-ancestor
111045501|NCT02261779|Antidepressive Agents|antidepressive agents|mesh-ancestor
111045502|NCT02261779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111045503|NCT02261779|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
111045504|NCT02261779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111045505|NCT02261779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111045506|NCT02261779|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111045507|NCT02261779|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111045508|NCT02261779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111045509|NCT02261779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111045510|NCT05157685|Azithromycin|azithromycin|mesh-list
111045511|NCT05157685|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111045512|NCT05157685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111045513|NCT02556632|Curcumin|curcumin|mesh-list
111045514|NCT02556632|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111045515|NCT02556632|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111045516|NCT02556632|Analgesics|analgesics|mesh-ancestor
111045517|NCT02556632|Sensory System Agents|sensory system agents|mesh-ancestor
111045518|NCT02556632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111045519|NCT02556632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111045520|NCT02556632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111045521|NCT02556632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111045522|NCT02556632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111045523|NCT02556632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111045524|NCT02556632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111045526|NCT05491928|Antioxidants|antioxidants|mesh-ancestor
111045527|NCT05491928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111045528|NCT05491928|Protective Agents|protective agents|mesh-ancestor
111045529|NCT05491928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111045530|NCT05491928|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111045531|NCT05491928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111045532|NCT05491928|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111045533|NCT05491928|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111045534|NCT01515007|Ciprofloxacin|ciprofloxacin|mesh-list
111045535|NCT01515007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111045536|NCT01515007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111045537|NCT01515007|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111045538|NCT01515007|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111045539|NCT01515007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111045540|NCT01515007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111045541|NCT01515007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111045542|NCT01515007|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111045543|NCT01515007|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111045544|NCT02262169|Omeprazole|omeprazole|mesh-list
111045545|NCT02262169|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111045546|NCT02262169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111045547|NCT02262169|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111045548|NCT02262169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111045549|NCT02262169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111045550|NCT05491694|Paclitaxel|paclitaxel|mesh-list
111045551|NCT05491694|Cyclophosphamide|cyclophosphamide|mesh-list
111045552|NCT05491694|Carboplatin|carboplatin|mesh-list
111045553|NCT05491694|Epirubicin|epirubicin|mesh-list
111045554|NCT05491694|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111045555|NCT05491694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111045556|NCT05491694|Tubulin Modulators|tubulin modulators|mesh-ancestor
111045557|NCT05491694|Antimitotic Agents|antimitotic agents|mesh-ancestor
111045558|NCT05491694|Mitosis Modulators|mitosis modulators|mesh-ancestor
111045559|NCT05491694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111045560|NCT05491694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111045561|NCT05491694|Immunologic Factors|immunologic factors|mesh-ancestor
111045562|NCT05491694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111045563|NCT05491694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111045564|NCT05491694|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111045565|NCT05491694|Alkylating Agents|alkylating agents|mesh-ancestor
111045566|NCT05491694|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111045567|NCT05491694|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111045568|NCT05491694|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111045569|NCT05491694|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111045570|NCT05491694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111045571|NCT01501513|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
111045572|NCT01501513|Laxatives|laxatives|mesh-ancestor
111045573|NCT01501513|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111045574|NCT05480072|Palmidrol|palmidrol|mesh-list
111045575|NCT05480072|Analgesics|analgesics|mesh-ancestor
111045576|NCT05480072|Sensory System Agents|sensory system agents|mesh-ancestor
111045577|NCT05480072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111045578|NCT05480072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111045579|NCT05480072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111045580|NCT05480072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111045581|NCT05480072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111045582|NCT05480072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111045583|NCT05480072|Antiviral Agents|antiviral agents|mesh-ancestor
111045584|NCT05480072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111045585|NCT05480072|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
111045586|NCT05480072|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
111045587|NCT05480072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111045588|NCT05480072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111045589|NCT05480072|Hormones|hormones|mesh-ancestor
111045590|NCT05480072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111045591|NCT01499563|Risperidone|risperidone|mesh-list
111045592|NCT01499563|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111045593|NCT01499563|Serotonin Agents|serotonin agents|mesh-ancestor
111045594|NCT01499563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111045595|NCT01499563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111045596|NCT01499563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111045598|NCT01499563|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111045599|NCT01499563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111045600|NCT01499563|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111045601|NCT01499563|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111045602|NCT01499563|Dopamine Agents|dopamine agents|mesh-ancestor
111045603|NCT03922880|Nivolumab|nivolumab|mesh-list
111045604|NCT03922880|Ipilimumab|ipilimumab|mesh-list
111045605|NCT03922880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111045606|NCT03922880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111045607|NCT03922880|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111045608|NCT03922880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111045610|NCT02264119|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111045611|NCT02264119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111045612|NCT02264119|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111045613|NCT02264119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111045614|NCT02264119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111045615|NCT02262481|Dydrogesterone|dydrogesterone|mesh-list
111045616|NCT02262481|Progestins|progestins|mesh-ancestor
111045617|NCT02262481|Hormones|hormones|mesh-ancestor
111045618|NCT02262481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111045619|NCT02262481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111045620|NCT01435369|Pidilizumab|pidilizumab|mesh-list
111045621|NCT01435369|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111045622|NCT01435369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111045623|NCT01257607|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111045624|NCT01257607|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111045625|NCT01252693|Goserelin|goserelin|mesh-list
111045626|NCT01252693|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111045627|NCT01252693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111045628|NCT01486849|Riluzole|riluzole|mesh-list
111045629|NCT01486849|Anticonvulsants|anticonvulsants|mesh-ancestor
111045630|NCT01486849|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111045631|NCT01486849|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111045632|NCT01486849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111045633|NCT01486849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111045634|NCT01486849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111045635|NCT01486849|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111045636|NCT01486849|Protective Agents|protective agents|mesh-ancestor
111045637|NCT01484119|Cetirizine|cetirizine|mesh-list
111045638|NCT01484119|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111045639|NCT01484119|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
111045640|NCT01484119|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111045641|NCT01484119|Histamine Antagonists|histamine antagonists|mesh-ancestor
111045642|NCT01484119|Histamine Agents|histamine agents|mesh-ancestor
111045643|NCT01484119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111045644|NCT01484119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111045645|NCT01484119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111045646|NCT01482403|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
111045647|NCT01482403|Interferon-alpha|interferon-alpha|mesh-list
111045648|NCT01482403|Ribavirin|ribavirin|mesh-list
111045649|NCT01482403|Antiviral Agents|antiviral agents|mesh-ancestor
111045650|NCT01482403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111045651|NCT01482403|Immunologic Factors|immunologic factors|mesh-ancestor
111045652|NCT01482403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111045653|NCT01482403|Antimetabolites|antimetabolites|mesh-ancestor
111045654|NCT01482403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111045655|NCT01481077|Latanoprost|latanoprost|mesh-list
111045656|NCT01481077|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
111045657|NCT01481077|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111045658|NCT02268409|Luspatercept|luspatercept|mesh-list
111045659|NCT02268409|Hematinics|hematinics|mesh-ancestor
111045660|NCT02268487|Sertraline|sertraline|mesh-list
111045661|NCT02268487|Antidepressive Agents|antidepressive agents|mesh-ancestor
111045662|NCT02268487|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111045663|NCT02268487|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111045664|NCT02268487|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111045665|NCT02268487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111045666|NCT02268487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111045667|NCT02268487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111045668|NCT02268487|Serotonin Agents|serotonin agents|mesh-ancestor
110827577|NCT01281787|Metoprolol|metoprolol|mesh-list
111045669|NCT02268487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111045670|NCT02265289|Clopidogrel|clopidogrel|mesh-list
111045671|NCT02265289|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111045672|NCT02265289|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111045673|NCT02265289|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111045674|NCT02265289|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111045675|NCT02265289|Purinergic Agents|purinergic agents|mesh-ancestor
111045676|NCT02265289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111045677|NCT02265289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111045678|NCT02265289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111045679|NCT02265445|beta-Lactams|beta-lactams|mesh-list
111045680|NCT02265445|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111045681|NCT02265445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111045682|NCT04476121|Aspirin|aspirin|mesh-list
111045683|NCT04476121|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111045684|NCT04476121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111045685|NCT04476121|Analgesics|analgesics|mesh-ancestor
111045686|NCT04476121|Sensory System Agents|sensory system agents|mesh-ancestor
111045687|NCT04476121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111045688|NCT04476121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111045689|NCT04476121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111045690|NCT04476121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111045691|NCT04476121|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111045692|NCT04476121|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111045693|NCT04476121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111045694|NCT04476121|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111045695|NCT04476121|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111045696|NCT04476121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111045697|NCT04476121|Antipyretics|antipyretics|mesh-ancestor
111045698|NCT01234519|Doxorubicin|doxorubicin|mesh-list
111045699|NCT01234519|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111045700|NCT01234519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111045701|NCT01234519|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111045702|NCT01234519|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111045703|NCT01234519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111045704|NCT01234519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111045705|NCT01474135|Travoprost|travoprost|mesh-list
111045706|NCT01474135|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111045707|NCT02268565|Aspirin|aspirin|mesh-list
111045708|NCT02268565|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
111045709|NCT02268565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
111045710|NCT02268565|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111045711|NCT02268565|Analgesics|analgesics|mesh-ancestor
111045712|NCT02268565|Sensory System Agents|sensory system agents|mesh-ancestor
111045713|NCT02268565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111045714|NCT02268565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111045715|NCT02268565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111045716|NCT02268565|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111045717|NCT02268565|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111045718|NCT02268565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111045719|NCT02268565|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111045720|NCT02268565|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111045721|NCT02268565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111045722|NCT02268565|Antipyretics|antipyretics|mesh-ancestor
111045723|NCT05479448|Prednisone|prednisone|mesh-list
111045724|NCT05479448|Hormones|hormones|mesh-list
111045725|NCT05479448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111045726|NCT05479448|Glucocorticoids|glucocorticoids|mesh-ancestor
111045727|NCT05479448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111045728|NCT05479448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111045729|NCT05479448|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111045730|NCT05479448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111045731|NCT02264587|Domperidone|domperidone|mesh-list
111045732|NCT02264587|Mosapride|mosapride|mesh-list
111045733|NCT02264587|Antiemetics|antiemetics|mesh-ancestor
111045734|NCT02264587|Autonomic Agents|autonomic agents|mesh-ancestor
111045735|NCT02264587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111045736|NCT02264587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111045737|NCT02264587|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111045738|NCT02264587|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111045739|NCT02264587|Dopamine Agents|dopamine agents|mesh-ancestor
111045740|NCT02264587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111045741|NCT02264587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111045742|NCT02264587|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111045744|NCT05475080|Anticoagulants|anticoagulants|mesh-list
111045745|NCT05475080|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
111045746|NCT02264665|Everolimus|everolimus|mesh-list
111045747|NCT02264665|Sunitinib|sunitinib|mesh-list
111045748|NCT02264665|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111045749|NCT02264665|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111045750|NCT02264665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111045751|NCT02264665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111045752|NCT02264665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111045753|NCT02264665|Immunologic Factors|immunologic factors|mesh-ancestor
111045754|NCT02264665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111045755|NCT02264665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111045756|NCT02264665|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111045757|NCT02264665|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111045758|NCT02264665|Growth Substances|growth substances|mesh-ancestor
111045759|NCT02264665|Growth Inhibitors|growth inhibitors|mesh-ancestor
111045760|NCT02683941|Lanreotide|lanreotide|mesh-list
111045761|NCT02683941|Somatostatin|somatostatin|mesh-list
111045762|NCT02683941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111045763|NCT02683941|Hormones|hormones|mesh-ancestor
111045764|NCT02683941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111045765|NCT02683941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111045766|NCT01225393|Adalimumab|adalimumab|mesh-list
111045767|NCT01225393|Methotrexate|methotrexate|mesh-list
111045768|NCT01225393|Leflunomide|leflunomide|mesh-list
111045769|NCT01225393|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111045770|NCT01225393|Abortifacient Agents|abortifacient agents|mesh-ancestor
111045771|NCT01225393|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111045772|NCT01225393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111045773|NCT01225393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111045774|NCT01225393|Antimetabolites|antimetabolites|mesh-ancestor
111045775|NCT01225393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111045776|NCT01225393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111045777|NCT01225393|Dermatologic Agents|dermatologic agents|mesh-ancestor
111045778|NCT01225393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111045779|NCT01225393|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111045780|NCT01225393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111045781|NCT01225393|Immunologic Factors|immunologic factors|mesh-ancestor
111045782|NCT01225393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111045783|NCT01225393|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111045784|NCT01225393|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111045785|NCT01225393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111045786|NCT02264743|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
111045787|NCT02264743|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
111045788|NCT02264743|Estradiol|estradiol|mesh-list
111045789|NCT02264743|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
111045790|NCT02264743|Estrogens|estrogens|mesh-ancestor
111045791|NCT02264743|Hormones|hormones|mesh-ancestor
111045792|NCT02264743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111045793|NCT02264743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111045794|NCT02264743|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111045795|NCT02264743|Contraceptive Agents|contraceptive agents|mesh-ancestor
111045796|NCT02264743|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111045797|NCT02264743|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111045798|NCT01220947|Ritonavir|ritonavir|mesh-list
111045799|NCT01220947|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
111045800|NCT01220947|Lactams|lactams|mesh-list
111045801|NCT01220947|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111045802|NCT01220947|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111045803|NCT01220947|Protease Inhibitors|protease inhibitors|mesh-ancestor
111045804|NCT01220947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111045805|NCT01220947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111045806|NCT01220947|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111045807|NCT01220947|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111045808|NCT01220947|Antiviral Agents|antiviral agents|mesh-ancestor
111045809|NCT01220947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111045810|NCT01220947|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111045811|NCT01220947|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111045812|NCT01220947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111045813|NCT01393639|Prednisone|prednisone|mesh-list
111045814|NCT01393639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111045815|NCT01393639|Glucocorticoids|glucocorticoids|mesh-ancestor
111045817|NCT01393639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111045818|NCT01393639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111045819|NCT01393639|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111045820|NCT01393639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111045821|NCT01379209|Mycophenolic Acid|mycophenolic acid|mesh-list
111045822|NCT01379209|Sirolimus|sirolimus|mesh-list
111045823|NCT01379209|Methotrexate|methotrexate|mesh-list
111045824|NCT01379209|KRN 7000|krn 7000|mesh-list
111045825|NCT01379209|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
111045826|NCT01379209|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111045827|NCT01379209|Abortifacient Agents|abortifacient agents|mesh-ancestor
111045828|NCT01379209|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111045829|NCT01379209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111045830|NCT01379209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111045831|NCT01379209|Antimetabolites|antimetabolites|mesh-ancestor
110762887|NCT02800785|Cefuroxime|cefuroxime|mesh-list
111045832|NCT01379209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111045833|NCT01379209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111045834|NCT01379209|Dermatologic Agents|dermatologic agents|mesh-ancestor
111045835|NCT01379209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111045836|NCT01379209|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111045837|NCT01379209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111045838|NCT01379209|Immunologic Factors|immunologic factors|mesh-ancestor
111045839|NCT01379209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111045840|NCT01379209|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111045841|NCT01379209|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111045842|NCT01379209|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111045843|NCT01379209|Antitubercular Agents|antitubercular agents|mesh-ancestor
111045844|NCT01379209|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111045845|NCT01379209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111045846|NCT01379209|Antifungal Agents|antifungal agents|mesh-ancestor
111045847|NCT01379209|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111045848|NCT01204099|Docetaxel|docetaxel|mesh-list
111045849|NCT01204099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111045850|NCT01204099|Tubulin Modulators|tubulin modulators|mesh-ancestor
111045851|NCT01204099|Antimitotic Agents|antimitotic agents|mesh-ancestor
111045852|NCT01204099|Mitosis Modulators|mitosis modulators|mesh-ancestor
111045853|NCT01204099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111045854|NCT02853500|Doxorubicin|doxorubicin|mesh-list
111045855|NCT02853500|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111045856|NCT02853500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111045857|NCT02853500|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111045858|NCT02853500|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111045859|NCT02853500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111045860|NCT02853500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111045861|NCT01188187|Dexamethasone|dexamethasone|mesh-list
111045862|NCT01188187|Prednisone|prednisone|mesh-list
111045863|NCT01188187|Docetaxel|docetaxel|mesh-list
111045864|NCT01188187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111045865|NCT01188187|Antiemetics|antiemetics|mesh-ancestor
111045866|NCT01188187|Autonomic Agents|autonomic agents|mesh-ancestor
111045867|NCT01188187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111045868|NCT01188187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111045869|NCT01188187|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111045870|NCT01188187|Glucocorticoids|glucocorticoids|mesh-ancestor
111045871|NCT01188187|Hormones|hormones|mesh-ancestor
111045872|NCT01188187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111045873|NCT01188187|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111045874|NCT01188187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111045875|NCT01188187|Tubulin Modulators|tubulin modulators|mesh-ancestor
111045876|NCT01188187|Antimitotic Agents|antimitotic agents|mesh-ancestor
111045877|NCT01188187|Mitosis Modulators|mitosis modulators|mesh-ancestor
111045878|NCT01188187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111045879|NCT05478356|Atropine|atropine|mesh-list
111045880|NCT05478356|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111045881|NCT05478356|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111045882|NCT05478356|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111045883|NCT05478356|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111045884|NCT05478356|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111045885|NCT05478356|Autonomic Agents|autonomic agents|mesh-ancestor
111045886|NCT05478356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111045887|NCT05478356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111045888|NCT05478356|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111045889|NCT05478356|Respiratory System Agents|respiratory system agents|mesh-ancestor
111045890|NCT05478356|Mydriatics|mydriatics|mesh-ancestor
111045891|NCT05478356|Parasympatholytics|parasympatholytics|mesh-ancestor
111045892|NCT05478356|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111045893|NCT05478356|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111045894|NCT05478356|Cholinergic Agents|cholinergic agents|mesh-ancestor
111045895|NCT05478356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111045896|NCT05478356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111045897|NCT01186861|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111045898|NCT01186861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111045899|NCT01186861|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111045900|NCT01186861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111045901|NCT01186861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111045902|NCT01175785|Cyclosporine|cyclosporine|mesh-list
111045903|NCT01175785|Mycophenolic Acid|mycophenolic acid|mesh-list
110628738|NCT00837174|Bortezomib|bortezomib|mesh-list
111045904|NCT01175785|Cyclophosphamide|cyclophosphamide|mesh-list
111045905|NCT01175785|Fludarabine|fludarabine|mesh-list
110676907|NCT03318900|Immunoglobulin G|immunoglobulin g|mesh-list
111045906|NCT01175785|Fludarabine phosphate|fludarabine phosphate|mesh-list
111045907|NCT01175785|Cyclosporins|cyclosporins|mesh-list
111045908|NCT01175785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111045909|NCT01175785|Immunologic Factors|immunologic factors|mesh-ancestor
111045910|NCT01175785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111045911|NCT01175785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111045912|NCT01175785|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111045913|NCT01175785|Alkylating Agents|alkylating agents|mesh-ancestor
111045914|NCT01175785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111045915|NCT01175785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111045916|NCT01175785|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111045917|NCT01175785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111045918|NCT01175785|Antimetabolites|antimetabolites|mesh-ancestor
111045919|NCT01175785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111045920|NCT01175785|Antifungal Agents|antifungal agents|mesh-ancestor
111045921|NCT01175785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111045922|NCT01175785|Dermatologic Agents|dermatologic agents|mesh-ancestor
111045923|NCT01175785|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111045924|NCT01175785|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111045925|NCT01175785|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111045926|NCT01175785|Antitubercular Agents|antitubercular agents|mesh-ancestor
111045927|NCT01175785|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111045928|NCT05478044|Ascorbic Acid|ascorbic acid|mesh-list
111045930|NCT05478044|Micronutrients|micronutrients|mesh-ancestor
111045931|NCT05478044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111045932|NCT05478044|Antioxidants|antioxidants|mesh-ancestor
111045933|NCT05478044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111045934|NCT05478044|Protective Agents|protective agents|mesh-ancestor
111045935|NCT05472506|Nivolumab|nivolumab|mesh-list
111045936|NCT05472506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111045937|NCT05472506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111045938|NCT05472506|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111045939|NCT05472506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111045940|NCT01445899|Ranibizumab|ranibizumab|mesh-list
111045941|NCT01445899|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111045942|NCT01445899|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111045943|NCT01445899|Growth Substances|growth substances|mesh-ancestor
111045944|NCT01445899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111045945|NCT01445899|Growth Inhibitors|growth inhibitors|mesh-ancestor
111045946|NCT01445899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111045947|NCT03649724|Leuprolide|leuprolide|mesh-list
111045948|NCT03649724|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111045949|NCT03649724|Fertility Agents|fertility agents|mesh-ancestor
111045950|NCT03649724|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111045951|NCT03649724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111045952|NCT03649724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111045953|NCT03649724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111045954|NCT01358695|Botulinum Toxins|botulinum toxins|mesh-list
111045955|NCT01358695|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111045956|NCT01358695|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111045957|NCT01358695|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111045958|NCT01358695|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111045959|NCT01358695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111045960|NCT01358695|Cholinergic Agents|cholinergic agents|mesh-ancestor
110511076|NCT02785146|Leucovorin|leucovorin|mesh-list
111045961|NCT01358695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111045962|NCT01358695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111045963|NCT01358695|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111045964|NCT01358695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111045965|NCT02266303|Insulin|insulin|mesh-list
111045966|NCT02266303|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111045967|NCT02266303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111045968|NCT02551874|Metformin|metformin|mesh-list
111045969|NCT02551874|Insulin Glargine|insulin glargine|mesh-list
111045970|NCT02551874|Dapagliflozin|dapagliflozin|mesh-list
111045971|NCT02551874|Saxagliptin|saxagliptin|mesh-list
111045972|NCT02551874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111045973|NCT02551874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111045974|NCT02551874|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111045975|NCT02551874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111045976|NCT02551874|Incretins|incretins|mesh-ancestor
111045977|NCT02551874|Hormones|hormones|mesh-ancestor
111045978|NCT02551874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111045979|NCT02551874|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111045980|NCT02551874|Protease Inhibitors|protease inhibitors|mesh-ancestor
111045981|NCT02551874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111045983|NCT03646604|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
111045984|NCT03646604|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111045985|NCT03646604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111045986|NCT03646604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111045987|NCT03646604|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111045988|NCT01354717|Fluorouracil|fluorouracil|mesh-list
111045989|NCT01354717|Antimetabolites|antimetabolites|mesh-ancestor
111045990|NCT01354717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111045991|NCT01354717|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111045992|NCT01354717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111045993|NCT01354717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111045994|NCT01354717|Immunologic Factors|immunologic factors|mesh-ancestor
111045995|NCT01354717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111045996|NCT01072981|Gemcitabine|gemcitabine|mesh-list
111045997|NCT01072981|Fluorouracil|fluorouracil|mesh-list
111045998|NCT01072981|Pancrelipase|pancrelipase|mesh-list
111045999|NCT01072981|Immunologic Factors|immunologic factors|mesh-list
111046000|NCT01072981|Immunomodulating Agents|immunomodulating agents|mesh-list
111046001|NCT01072981|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111046002|NCT01072981|Antimetabolites|antimetabolites|mesh-ancestor
111046003|NCT01072981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111046004|NCT01072981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111046005|NCT01072981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111046006|NCT01072981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111046007|NCT01072981|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111046008|NCT03347708|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111046009|NCT03347708|Hyaluronic Acid|hyaluronic acid|mesh-list
111046010|NCT03347708|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111046011|NCT03347708|Immunologic Factors|immunologic factors|mesh-ancestor
111046012|NCT03347708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111046013|NCT03347708|Viscosupplements|viscosupplements|mesh-ancestor
111046014|NCT03347708|Protective Agents|protective agents|mesh-ancestor
111046015|NCT01159249|Vildagliptin|vildagliptin|mesh-list
111046016|NCT01159249|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111046017|NCT01159249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111046018|NCT01159249|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111046019|NCT01159249|Protease Inhibitors|protease inhibitors|mesh-ancestor
111046020|NCT01159249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111046021|NCT01159249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111046022|NCT01156753|Glembatumumab vedotin|glembatumumab vedotin|mesh-list
111046023|NCT01156753|Immunoconjugates|immunoconjugates|mesh-ancestor
111046024|NCT01156753|Immunologic Factors|immunologic factors|mesh-ancestor
111046025|NCT01156753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111046026|NCT01156753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111046027|NCT01156753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111046028|NCT01345045|Pregabalin|pregabalin|mesh-list
111046029|NCT01345045|Analgesics|analgesics|mesh-ancestor
111046030|NCT01345045|Sensory System Agents|sensory system agents|mesh-ancestor
111046031|NCT01345045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111046032|NCT01345045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111046033|NCT01345045|Anticonvulsants|anticonvulsants|mesh-ancestor
111046034|NCT01345045|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110026223|NCT00422214|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111046035|NCT01345045|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111046036|NCT01345045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111046037|NCT01345045|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111046038|NCT01345045|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111046039|NCT01345045|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111046040|NCT01345045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111046041|NCT01345045|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111046042|NCT01344187|Riboflavin|riboflavin|mesh-list
111046043|NCT01344187|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111046044|NCT01344187|Vitamin B Complex|vitamin b complex|mesh-ancestor
111046045|NCT01344187|Vitamins|vitamins|mesh-ancestor
111046046|NCT01344187|Micronutrients|micronutrients|mesh-ancestor
111046047|NCT01344187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111046048|NCT01344187|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111046049|NCT01344187|Dermatologic Agents|dermatologic agents|mesh-ancestor
111046050|NCT01338883|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
111046051|NCT01338883|Efavirenz|efavirenz|mesh-list
111046052|NCT01338883|Cenicriviroc|cenicriviroc|mesh-list
111046053|NCT01338883|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111046054|NCT01338883|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111046055|NCT01338883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111046056|NCT01338883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111046057|NCT01338883|Antiviral Agents|antiviral agents|mesh-ancestor
111046058|NCT01338883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111046059|NCT01338883|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111046060|NCT01338883|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111046061|NCT01338883|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111046062|NCT01338883|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111046063|NCT01338883|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111046064|NCT01338883|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111046065|NCT01338883|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111046066|NCT01338883|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111046067|NCT01338883|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
111046068|NCT05625919|Sirolimus|sirolimus|mesh-list
111046069|NCT05625919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111046070|NCT05625919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111046071|NCT05625919|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111046072|NCT05625919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111046073|NCT05625919|Antifungal Agents|antifungal agents|mesh-ancestor
111046074|NCT05625919|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111046075|NCT05625919|Immunologic Factors|immunologic factors|mesh-ancestor
111046076|NCT05625919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111046077|NCT02266537|Doxazosin|doxazosin|mesh-list
111046078|NCT02266537|Tamsulosin|tamsulosin|mesh-list
111046079|NCT02266537|Alfuzosin|alfuzosin|mesh-list
111046080|NCT02266537|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111046081|NCT02266537|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111046082|NCT02266537|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111046083|NCT02266537|Adrenergic Agents|adrenergic agents|mesh-ancestor
111046084|NCT02266537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111046085|NCT02266537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111046086|NCT02266537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111046087|NCT02266537|Urological Agents|urological agents|mesh-ancestor
111046088|NCT02266537|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111046089|NCT02269735|Insulin|insulin|mesh-list
111046090|NCT02269735|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111046091|NCT02269735|Insulin Aspart|insulin aspart|mesh-list
111046092|NCT02269735|MK-2640|mk-2640|mesh-list
111046093|NCT02269735|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111046094|NCT02269735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111046095|NCT05625373|Vancomycin|vancomycin|mesh-list
111046096|NCT05625373|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111046097|NCT05625373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111046098|NCT01038739|Mesalamine|mesalamine|mesh-list
111046099|NCT01038739|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111046100|NCT01038739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111046101|NCT01038739|Analgesics|analgesics|mesh-ancestor
111046102|NCT01038739|Sensory System Agents|sensory system agents|mesh-ancestor
111046103|NCT01038739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111046104|NCT01038739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111046105|NCT01038739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111046106|NCT01038739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111046107|NCT01336465|Etrolizumab|etrolizumab|mesh-list
111046108|NCT01336465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111046109|NCT01336465|Immunologic Factors|immunologic factors|mesh-ancestor
111046110|NCT01336465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111046111|NCT03315026|Siltuximab|siltuximab|mesh-list
111046112|NCT03315026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111046113|NCT02769065|Donepezil|donepezil|mesh-list
111046114|NCT02769065|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111046115|NCT02769065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111046116|NCT02769065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111046117|NCT02769065|Cholinergic Agents|cholinergic agents|mesh-ancestor
111046118|NCT02769065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111046119|NCT02769065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111046120|NCT02769065|Nootropic Agents|nootropic agents|mesh-ancestor
111046121|NCT02540954|Aflibercept|aflibercept|mesh-list
111046122|NCT02540954|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111046123|NCT02540954|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111046124|NCT02540954|Growth Substances|growth substances|mesh-ancestor
111046125|NCT02540954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111046126|NCT02540954|Growth Inhibitors|growth inhibitors|mesh-ancestor
111046127|NCT02540954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111046128|NCT05265975|Rituximab|rituximab|mesh-list
111046129|NCT05265975|Lenalidomide|lenalidomide|mesh-list
111046130|NCT05265975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111046131|NCT05265975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111046132|NCT05265975|Immunologic Factors|immunologic factors|mesh-ancestor
111046133|NCT05265975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111046134|NCT05265975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111046135|NCT05265975|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111046136|NCT05265975|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111046137|NCT05265975|Growth Substances|growth substances|mesh-ancestor
111046138|NCT05265975|Growth Inhibitors|growth inhibitors|mesh-ancestor
111046139|NCT02151305|Remifentanil|remifentanil|mesh-list
111046140|NCT02151305|Propofol|propofol|mesh-list
111046141|NCT02151305|Sevoflurane|sevoflurane|mesh-list
111046142|NCT02151305|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111046143|NCT02151305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111046144|NCT02151305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111046145|NCT02151305|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111046146|NCT02151305|Anesthetics, General|anesthetics, general|mesh-ancestor
111046147|NCT02151305|Anesthetics|anesthetics|mesh-ancestor
111046148|NCT02151305|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111046149|NCT02151305|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111046150|NCT02151305|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111046151|NCT02151305|Narcotics|narcotics|mesh-ancestor
111046152|NCT02151305|Analgesics|analgesics|mesh-ancestor
111046153|NCT02151305|Sensory System Agents|sensory system agents|mesh-ancestor
111046154|NCT02151305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111046155|NCT03164421|Acetylcysteine|acetylcysteine|mesh-list
111046156|NCT03164421|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111046157|NCT03164421|Antiviral Agents|antiviral agents|mesh-ancestor
111046158|NCT03164421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111046159|NCT03164421|Expectorants|expectorants|mesh-ancestor
111046160|NCT03164421|Respiratory System Agents|respiratory system agents|mesh-ancestor
111046161|NCT03164421|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111046162|NCT03164421|Antioxidants|antioxidants|mesh-ancestor
111046163|NCT03164421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111046164|NCT03164421|Protective Agents|protective agents|mesh-ancestor
111046165|NCT03164421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111046166|NCT03164421|Antidotes|antidotes|mesh-ancestor
111046167|NCT05228613|Vaccines|vaccines|mesh-list
111046168|NCT05228613|Immunologic Factors|immunologic factors|mesh-ancestor
111046169|NCT05228613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111046170|NCT02658812|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
111046171|NCT02658812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111046172|NCT02658812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111046173|NCT02628704|Dexamethasone|dexamethasone|mesh-list
111046174|NCT02628704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111046175|NCT02628704|Antiemetics|antiemetics|mesh-ancestor
111046176|NCT02628704|Autonomic Agents|autonomic agents|mesh-ancestor
111046177|NCT02628704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111046178|NCT02628704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111046179|NCT02628704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111046180|NCT02628704|Glucocorticoids|glucocorticoids|mesh-ancestor
111046181|NCT02628704|Hormones|hormones|mesh-ancestor
111046182|NCT02628704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110827583|NCT01281787|Sympatholytics|sympatholytics|mesh-ancestor
111046183|NCT02628704|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111046184|NCT02628704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111046185|NCT02152475|Curcumin|curcumin|mesh-list
111046186|NCT02152475|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111046187|NCT02152475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111046188|NCT02152475|Analgesics|analgesics|mesh-ancestor
111046189|NCT02152475|Sensory System Agents|sensory system agents|mesh-ancestor
111046190|NCT02152475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111046191|NCT02152475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111046192|NCT02152475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111046193|NCT02152475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111046194|NCT02152475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111046195|NCT02152475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111046196|NCT02152475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111046197|NCT02152553|Hydrocortisone|hydrocortisone|mesh-list
111046198|NCT02152553|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
111046199|NCT02152553|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111046200|NCT03161457|Rituximab|rituximab|mesh-list
111046201|NCT03161457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111046202|NCT03161457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111046203|NCT03161457|Immunologic Factors|immunologic factors|mesh-ancestor
111046204|NCT03161457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111046205|NCT03161457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111046206|NCT02159573|Dimethyl Fumarate|dimethyl fumarate|mesh-list
111046207|NCT02159573|Natalizumab|natalizumab|mesh-list
111046208|NCT02159573|Immunologic Factors|immunologic factors|mesh-ancestor
111046209|NCT02159573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111046211|NCT02159573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111046212|NCT02152709|Vaccines|vaccines|mesh-list
111046213|NCT02152709|Immunologic Factors|immunologic factors|mesh-ancestor
111046214|NCT02152709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111046215|NCT03164109|Moxifloxacin|moxifloxacin|mesh-list
111046216|NCT03164109|Avasopasem manganese|avasopasem manganese|mesh-list
111046217|NCT03164109|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111046218|NCT03164109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111046219|NCT03164109|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111046220|NCT03164109|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111046221|NCT03164109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111046222|NCT03164109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111046223|NCT03164109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111046224|NCT03164109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111046225|NCT03164109|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111046226|NCT03164109|Antioxidants|antioxidants|mesh-ancestor
111046227|NCT03164109|Protective Agents|protective agents|mesh-ancestor
111046228|NCT02152787|Propofol|propofol|mesh-list
111046229|NCT02152787|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111046230|NCT02152787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111046231|NCT02152787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111046232|NCT02152787|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111046233|NCT02152787|Anesthetics, General|anesthetics, general|mesh-ancestor
111046234|NCT02152787|Anesthetics|anesthetics|mesh-ancestor
111046235|NCT00154375|Imatinib Mesylate|imatinib mesylate|mesh-list
111046236|NCT00154375|Hydroxyurea|hydroxyurea|mesh-list
111046237|NCT00154375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111046238|NCT00154375|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111046239|NCT00154375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111046240|NCT00154375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111046241|NCT00154375|Antisickling Agents|antisickling agents|mesh-ancestor
111046242|NCT00154375|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111046243|NCT02765399|Liraglutide|liraglutide|mesh-list
111046244|NCT02765399|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111046245|NCT02765399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111046246|NCT02765399|Incretins|incretins|mesh-ancestor
111046247|NCT02765399|Hormones|hormones|mesh-ancestor
111046248|NCT02765399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111046249|NCT03970304|Vaccines|vaccines|mesh-list
111046250|NCT03970304|Immunologic Factors|immunologic factors|mesh-ancestor
111046251|NCT03970304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111046252|NCT01037179|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
111046253|NCT01037179|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111046254|NCT01037179|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111046255|NCT01037179|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111046256|NCT01037179|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111046257|NCT01037179|Analgesics|analgesics|mesh-ancestor
111046258|NCT01037179|Sensory System Agents|sensory system agents|mesh-ancestor
111046259|NCT01037179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111046260|NCT01037179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111046261|NCT01037179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111046262|NCT01037179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111046263|NCT01037179|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111046264|NCT01037179|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
111046265|NCT01037179|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111046266|NCT01037179|Histamine Antagonists|histamine antagonists|mesh-ancestor
111046267|NCT01037179|Histamine Agents|histamine agents|mesh-ancestor
111046268|NCT01037179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111046269|NCT01037179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111046270|NCT02269969|Tobramycin|tobramycin|mesh-list
111046271|NCT02269969|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111046272|NCT02269969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111046273|NCT03555578|Leuprolide|leuprolide|mesh-list
111046274|NCT03555578|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111046275|NCT03555578|Fertility Agents|fertility agents|mesh-ancestor
111046276|NCT03555578|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111046277|NCT03555578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111046278|NCT03555578|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111046279|NCT03555578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111046280|NCT03232424|Temozolomide|temozolomide|mesh-list
111046281|NCT03232424|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110763337|NCT01027000|Fludarabine|fludarabine|mesh-list
111046282|NCT03232424|Alkylating Agents|alkylating agents|mesh-ancestor
111046283|NCT03232424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111046284|NCT03232424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111046285|NCT03163407|Norepinephrine|norepinephrine|mesh-list
111046286|NCT03163407|Ephedrine|ephedrine|mesh-list
111046287|NCT03163407|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111046288|NCT03163407|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111046289|NCT03163407|Adrenergic Agents|adrenergic agents|mesh-ancestor
111046290|NCT03163407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111046291|NCT03163407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111046292|NCT03163407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111046293|NCT03163407|Sympathomimetics|sympathomimetics|mesh-ancestor
111046294|NCT03163407|Autonomic Agents|autonomic agents|mesh-ancestor
111046295|NCT03163407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111046296|NCT03163407|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111046297|NCT03163407|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111046298|NCT02547974|Vaccines|vaccines|mesh-list
111046299|NCT02547974|Immunologic Factors|immunologic factors|mesh-ancestor
111046300|NCT02547974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111046301|NCT00154297|Everolimus|everolimus|mesh-list
111046302|NCT00154297|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111046303|NCT00154297|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111046304|NCT00154297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111046305|NCT00154297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111046306|NCT00154297|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111046307|NCT00154297|Immunologic Factors|immunologic factors|mesh-ancestor
111046308|NCT00154297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111046309|NCT00154297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111046310|NCT02270281|Dexmedetomidine|dexmedetomidine|mesh-list
111046311|NCT02270281|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111046312|NCT02270281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111046313|NCT02270281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111046314|NCT02270281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111046315|NCT02270281|Analgesics|analgesics|mesh-ancestor
111046316|NCT02270281|Sensory System Agents|sensory system agents|mesh-ancestor
111046317|NCT02270281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111046318|NCT02270281|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111046319|NCT02270281|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111046320|NCT02270281|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111046321|NCT02270281|Adrenergic Agents|adrenergic agents|mesh-ancestor
111046322|NCT02270281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111046323|NCT02270281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111046324|NCT01033123|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
111046325|NCT01033123|Iniparib|iniparib|mesh-list
111046326|NCT01033123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111046327|NCT01033123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111046328|NCT01033123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111046329|NCT03163173|Avasopasem manganese|avasopasem manganese|mesh-list
111046330|NCT03163173|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111046331|NCT03163173|Antioxidants|antioxidants|mesh-ancestor
111046332|NCT03163173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111046333|NCT03163173|Protective Agents|protective agents|mesh-ancestor
111046334|NCT03163173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111046335|NCT01323205|Antipsychotic Agents|antipsychotic agents|mesh-list
111046336|NCT01323205|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111046337|NCT01323205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111046338|NCT01323205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111046339|NCT01323205|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111046340|NCT03162861|Anesthetics|anesthetics|mesh-list
111046341|NCT03162861|Propofol|propofol|mesh-list
111046342|NCT03162861|Sevoflurane|sevoflurane|mesh-list
111046343|NCT03162861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111046344|NCT03162861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111046345|NCT03162861|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111046346|NCT03162861|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111046347|NCT03162861|Anesthetics, General|anesthetics, general|mesh-ancestor
111046348|NCT03162861|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111046349|NCT03162861|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111046350|NCT04506554|Nivolumab|nivolumab|mesh-list
111046351|NCT04506554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111046352|NCT04506554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111046353|NCT04506554|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111046354|NCT04506554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111046355|NCT02765165|Lomustine|lomustine|mesh-list
110763416|NCT00497029|Fluorides|fluorides|mesh-list
111046356|NCT02765165|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111046357|NCT02765165|Alkylating Agents|alkylating agents|mesh-ancestor
111046358|NCT02765165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111046359|NCT02765165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111046361|NCT02156843|Vitamin B Complex|vitamin b complex|mesh-ancestor
111046362|NCT02156843|Vitamins|vitamins|mesh-ancestor
111046363|NCT02156843|Micronutrients|micronutrients|mesh-ancestor
111046364|NCT02156843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111046365|NCT02675907|Meloxicam|meloxicam|mesh-list
111046366|NCT02675907|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111046367|NCT02675907|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111046368|NCT02675907|Analgesics|analgesics|mesh-ancestor
111046369|NCT02675907|Sensory System Agents|sensory system agents|mesh-ancestor
111046370|NCT02675907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111046371|NCT02675907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111046372|NCT02675907|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111046373|NCT02675907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111046374|NCT02675907|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111046375|NCT02675907|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111046376|NCT02675907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111046377|NCT02675907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111046378|NCT02152865|Lupeol|lupeol|mesh-list
111046379|NCT02152865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111046380|NCT02152943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111046381|NCT02152943|Trastuzumab|trastuzumab|mesh-list
111046382|NCT02152943|Everolimus|everolimus|mesh-list
111046383|NCT02152943|Letrozole|letrozole|mesh-list
111046384|NCT02152943|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
111046385|NCT02152943|Antibodies|antibodies|mesh-list
111046386|NCT02152943|Immunoglobulins|immunoglobulins|mesh-list
111046387|NCT02152943|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111046388|NCT02152943|Immunologic Factors|immunologic factors|mesh-ancestor
111046389|NCT02152943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111046390|NCT02152943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111046391|NCT02152943|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111046392|NCT02152943|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111046393|NCT02152943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111046394|NCT02152943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111046395|NCT02152943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111046396|NCT02152943|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111046397|NCT02152943|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111046398|NCT02152943|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111046399|NCT02152943|Hormone Antagonists|hormone antagonists|mesh-ancestor
111046400|NCT02152943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111046401|NCT02156999|Vitamin D|vitamin d|mesh-list
111046402|NCT02156999|Ibandronic Acid|ibandronic acid|mesh-list
111046403|NCT02156999|Vitamins|vitamins|mesh-ancestor
111046404|NCT02156999|Micronutrients|micronutrients|mesh-ancestor
111046405|NCT02156999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111046406|NCT02156999|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111046408|NCT05014581|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111046409|NCT05014581|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111046410|NCT05014581|Adrenergic Agents|adrenergic agents|mesh-ancestor
111046411|NCT05014581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111046412|NCT05014581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111046413|NCT05014581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111046414|NCT05014581|Sympathomimetics|sympathomimetics|mesh-ancestor
111046415|NCT05014581|Autonomic Agents|autonomic agents|mesh-ancestor
111046416|NCT05014581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111046417|NCT05014581|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111046418|NCT02159651|Tacrolimus|tacrolimus|mesh-list
111046419|NCT02159651|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111046420|NCT02159651|Immunologic Factors|immunologic factors|mesh-ancestor
111046421|NCT02159651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111046422|NCT02159651|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111046423|NCT02159651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111046424|NCT02159651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111046425|NCT02774681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111046426|NCT02774681|Trastuzumab|trastuzumab|mesh-list
111046427|NCT02774681|Palbociclib|palbociclib|mesh-list
111046428|NCT02774681|Antibodies|antibodies|mesh-list
111046429|NCT02774681|Immunoglobulins|immunoglobulins|mesh-list
111046430|NCT02774681|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111046431|NCT02774681|Immunologic Factors|immunologic factors|mesh-ancestor
111046432|NCT02774681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111046433|NCT02774681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111046434|NCT02774681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111046435|NCT02774681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111046436|NCT02774681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111046438|NCT02157311|Lamivudine|lamivudine|mesh-list
111046439|NCT02157311|Emtricitabine|emtricitabine|mesh-list
111046440|NCT02157311|Efavirenz|efavirenz|mesh-list
111046441|NCT02157311|Lopinavir|lopinavir|mesh-list
111046442|NCT02157311|Atazanavir Sulfate|atazanavir sulfate|mesh-list
111046443|NCT02157311|Darunavir|darunavir|mesh-list
111046444|NCT02157311|Abacavir|abacavir|mesh-list
111046445|NCT02157311|Rilpivirine|rilpivirine|mesh-list
111046446|NCT02157311|Etravirine|etravirine|mesh-list
111046447|NCT02157311|Antiviral Agents|antiviral agents|mesh-ancestor
111046448|NCT02157311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111046449|NCT02157311|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111046450|NCT02157311|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111046451|NCT02157311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111046452|NCT02157311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111046453|NCT02157311|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111046454|NCT02157311|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111046455|NCT02157311|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111046456|NCT02157311|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111046457|NCT02157311|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111046458|NCT02157311|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111046459|NCT02157311|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111046460|NCT02157311|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111046461|NCT02157311|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111046462|NCT02157311|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111046463|NCT02157311|Protease Inhibitors|protease inhibitors|mesh-ancestor
111046464|NCT02157311|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111046465|NCT04784039|Fibrin fragment D|fibrin fragment d|mesh-list
111046466|NCT04784039|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111046467|NCT04784039|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111046468|NCT04784039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111046469|NCT04784039|Hemostatics|hemostatics|mesh-ancestor
111046470|NCT04784039|Coagulants|coagulants|mesh-ancestor
111046471|NCT02157467|Moxifloxacin|moxifloxacin|mesh-list
111046472|NCT02157467|BMS-955176|bms-955176|mesh-list
111046473|NCT02157467|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
111046474|NCT02157467|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111046475|NCT02157467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111046476|NCT02157467|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111046477|NCT02157467|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111046478|NCT02157467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111046479|NCT02157467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111046480|NCT02157467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111046481|NCT02157467|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111046482|NCT02157467|Contraceptive Agents|contraceptive agents|mesh-ancestor
111046483|NCT02157467|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111046484|NCT02157467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111046485|NCT02157467|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
111046486|NCT02157467|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111046487|NCT02157467|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111046488|NCT02157467|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111046489|NCT02157467|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111046490|NCT02157467|Antiviral Agents|antiviral agents|mesh-ancestor
111046491|NCT01374087|Triptorelin Pamoate|triptorelin pamoate|mesh-list
111046492|NCT01374087|Luteolytic Agents|luteolytic agents|mesh-ancestor
111046493|NCT01374087|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111046494|NCT01374087|Contraceptive Agents|contraceptive agents|mesh-ancestor
111046495|NCT01374087|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111046496|NCT01374087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111046497|NCT01374087|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111046498|NCT01374087|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111046499|NCT01374087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111046500|NCT00152971|Enoxaparin|enoxaparin|mesh-list
111046501|NCT00152971|Dabigatran|dabigatran|mesh-list
111046502|NCT00152971|Anticoagulants|anticoagulants|mesh-ancestor
111046503|NCT00152971|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111046504|NCT00152971|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111046505|NCT00152971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111046506|NCT00152971|Antithrombins|antithrombins|mesh-ancestor
111046507|NCT00152971|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111046508|NCT00152971|Protease Inhibitors|protease inhibitors|mesh-ancestor
111046509|NCT00152971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111046511|NCT02538614|BI 836826|bi 836826|mesh-list
111046512|NCT02538614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111046513|NCT02538614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111046514|NCT02538614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111046515|NCT02538614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111046516|NCT03504644|Vincristine|vincristine|mesh-list
111046517|NCT03504644|Venetoclax|venetoclax|mesh-list
111046518|NCT03504644|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111046519|NCT03504644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111046520|NCT03504644|Tubulin Modulators|tubulin modulators|mesh-ancestor
111046521|NCT03504644|Antimitotic Agents|antimitotic agents|mesh-ancestor
111046522|NCT03504644|Mitosis Modulators|mitosis modulators|mesh-ancestor
111046523|NCT03504644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111046524|NCT04620135|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111046525|NCT04620135|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111046526|NCT02160275|Insulin|insulin|mesh-list
111046527|NCT02160275|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111046528|NCT02160275|Pancrelipase|pancrelipase|mesh-list
111046529|NCT02160275|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111046530|NCT02160275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111046531|NCT02160275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111046532|NCT03126968|Epinephrine|epinephrine|mesh-list
111046533|NCT03126968|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111046534|NCT03126968|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111046535|NCT03126968|Adrenergic Agents|adrenergic agents|mesh-ancestor
111046536|NCT03126968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111046537|NCT03126968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111046538|NCT03126968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111046539|NCT03126968|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111046540|NCT03126968|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111046541|NCT03126968|Autonomic Agents|autonomic agents|mesh-ancestor
111046542|NCT03126968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111046543|NCT03126968|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111046544|NCT03126968|Respiratory System Agents|respiratory system agents|mesh-ancestor
111046545|NCT03126968|Mydriatics|mydriatics|mesh-ancestor
111046546|NCT03126968|Sympathomimetics|sympathomimetics|mesh-ancestor
111046547|NCT03126968|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111046548|NCT02266849|Loperamide|loperamide|mesh-list
111046549|NCT02266849|Antidiarrheals|antidiarrheals|mesh-list
111046550|NCT02266849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111046551|NCT01309945|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
111046552|NCT01309945|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111046553|NCT01309945|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111046554|NCT01309945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110511661|NCT00880867|Poly ICLC|poly iclc|mesh-list
111046555|NCT01309945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111046556|NCT01309945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111046557|NCT01309945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111046558|NCT01309945|Analgesics|analgesics|mesh-ancestor
111046559|NCT01309945|Sensory System Agents|sensory system agents|mesh-ancestor
111046560|NCT01309945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111046561|NCT01309945|Antidepressive Agents|antidepressive agents|mesh-ancestor
111046562|NCT01309945|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111046563|NCT01309945|Dopamine Agents|dopamine agents|mesh-ancestor
111046564|NCT02153567|Escitalopram|escitalopram|mesh-list
111046565|NCT02153567|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111046566|NCT02153567|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111046567|NCT02153567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111046568|NCT02153567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111046569|NCT02153567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111046570|NCT02153567|Serotonin Agents|serotonin agents|mesh-ancestor
111046571|NCT02153567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111046572|NCT02441660|Capsaicin|capsaicin|mesh-list
111046573|NCT02441660|Antipruritics|antipruritics|mesh-ancestor
111046574|NCT02441660|Dermatologic Agents|dermatologic agents|mesh-ancestor
111046575|NCT02441660|Sensory System Agents|sensory system agents|mesh-ancestor
111046576|NCT02441660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111046577|NCT02441660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111046578|NCT01303783|Candesartan|candesartan|mesh-list
111046579|NCT01303783|Candesartan cilexetil|candesartan cilexetil|mesh-list
111046580|NCT01303783|Nifedipine|nifedipine|mesh-list
111046581|NCT01303783|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111046582|NCT01303783|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111046583|NCT01303783|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111046584|NCT01303783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111046585|NCT01303783|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111046586|NCT01303783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111046587|NCT01303783|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111046588|NCT01303783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111046589|NCT01303783|Vasodilator Agents|vasodilator agents|mesh-ancestor
111046590|NCT01303783|Tocolytic Agents|tocolytic agents|mesh-ancestor
111046591|NCT01303783|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111046592|NCT02160587|Chlorhexidine|chlorhexidine|mesh-list
110628869|NCT03641547|Capecitabine|capecitabine|mesh-list
111046593|NCT02160587|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
111046594|NCT02160587|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111046595|NCT02160587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111046596|NCT02160587|Disinfectants|disinfectants|mesh-ancestor
111046597|NCT02160587|Dermatologic Agents|dermatologic agents|mesh-ancestor
111046598|NCT02153879|Niacin|niacin|mesh-list
111046599|NCT02153879|Fenofibrate|fenofibrate|mesh-list
111046600|NCT02153879|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111046601|NCT02153879|Antimetabolites|antimetabolites|mesh-ancestor
111046602|NCT02153879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111046603|NCT02153879|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111046604|NCT02153879|Vasodilator Agents|vasodilator agents|mesh-ancestor
111046605|NCT02153879|Vitamin B Complex|vitamin b complex|mesh-ancestor
111046606|NCT02153879|Vitamins|vitamins|mesh-ancestor
111046607|NCT02153879|Micronutrients|micronutrients|mesh-ancestor
111046608|NCT02153879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111046609|NCT01373931|Moxifloxacin|moxifloxacin|mesh-list
111046610|NCT01373931|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
111046611|NCT01373931|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111046612|NCT01373931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111046613|NCT01373931|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111046614|NCT01373931|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111046615|NCT01373931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111046616|NCT01373931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111046617|NCT01373931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111046618|NCT01373931|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111046619|NCT01373931|Contraceptive Agents|contraceptive agents|mesh-ancestor
111046620|NCT01373931|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111046621|NCT01373931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111046622|NCT01373931|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
111046623|NCT01373931|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111046624|NCT01373931|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111046625|NCT02160743|Metformin|metformin|mesh-list
111046626|NCT02160743|Atorvastatin|atorvastatin|mesh-list
111046627|NCT02160743|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111046628|NCT02160743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111046629|NCT02160743|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111046630|NCT02160743|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111046631|NCT02160743|Antimetabolites|antimetabolites|mesh-ancestor
111046632|NCT02160743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111046633|NCT02160743|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111046634|NCT02160743|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111046635|NCT02160743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111046636|NCT02158013|Diltiazem|diltiazem|mesh-list
111046637|NCT02158013|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111046638|NCT02158013|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111046639|NCT02158013|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111046640|NCT02158013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111046641|NCT02158013|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111046642|NCT02158013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111046643|NCT02158013|Vasodilator Agents|vasodilator agents|mesh-ancestor
111046644|NCT01023295|Fosbretabulin|fosbretabulin|mesh-list
111046645|NCT01023295|Combretastatin|combretastatin|mesh-list
111046646|NCT01023295|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111046647|NCT01023295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111046648|NCT01023295|Tubulin Modulators|tubulin modulators|mesh-ancestor
111046649|NCT01023295|Antimitotic Agents|antimitotic agents|mesh-ancestor
111046650|NCT01023295|Mitosis Modulators|mitosis modulators|mesh-ancestor
110628877|NCT00851370|Respiratory System Agents|respiratory system agents|mesh-ancestor
111046651|NCT01023295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111046652|NCT05468138|Antibodies|antibodies|mesh-list
111046653|NCT05468138|Immunologic Factors|immunologic factors|mesh-ancestor
111046654|NCT05468138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111046655|NCT01140217|Norethindrone|norethindrone|mesh-list
111046656|NCT01140217|Norethindrone Acetate|norethindrone acetate|mesh-list
111046657|NCT01140217|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111046658|NCT01140217|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111046659|NCT01140217|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111046660|NCT01140217|Contraceptive Agents|contraceptive agents|mesh-ancestor
111046661|NCT01140217|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111046662|NCT01140217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111046663|NCT01140217|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111046664|NCT01140217|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111046665|NCT01297543|Lenograstim|lenograstim|mesh-list
111046666|NCT01297543|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111046667|NCT01297543|Immunologic Factors|immunologic factors|mesh-ancestor
111046668|NCT01297543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111046669|NCT03541265|Bupivacaine|bupivacaine|mesh-list
111046670|NCT03541265|Anesthetics, Local|anesthetics, local|mesh-ancestor
111046671|NCT03541265|Anesthetics|anesthetics|mesh-ancestor
111046672|NCT03541265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111046673|NCT03541265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111046674|NCT03541265|Sensory System Agents|sensory system agents|mesh-ancestor
111046675|NCT03541265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111046676|NCT02547038|Amoxicillin|amoxicillin|mesh-list
111046677|NCT02547038|Metronidazole|metronidazole|mesh-list
111046678|NCT02547038|Clarithromycin|clarithromycin|mesh-list
111046679|NCT02547038|Tetracycline|tetracycline|mesh-list
111046680|NCT02547038|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
111046681|NCT02547038|Pantoprazole|pantoprazole|mesh-list
111046682|NCT02547038|Bismuth|bismuth|mesh-list
111046683|NCT02547038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111046684|NCT02547038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111046685|NCT02547038|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111046686|NCT02547038|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111046687|NCT02547038|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111046688|NCT02547038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111046689|NCT02547038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111046690|NCT02547038|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111046691|NCT02547038|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111046692|NCT02547038|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111046693|NCT02547038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111046694|NCT02547038|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111046695|NCT02547038|Antacids|antacids|mesh-ancestor
111046696|NCT02161055|Insulin|insulin|mesh-list
111046697|NCT02161055|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111046698|NCT02161055|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111046699|NCT02161055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111046701|NCT02764697|Hormones|hormones|mesh-ancestor
111046702|NCT02764697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111046703|NCT02764697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111046704|NCT02266927|Fluticasone|fluticasone|mesh-list
111046705|NCT02266927|Xhance|xhance|mesh-list
111046706|NCT02266927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111046707|NCT02266927|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111046708|NCT02266927|Autonomic Agents|autonomic agents|mesh-ancestor
111046709|NCT02266927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111046710|NCT02266927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111046711|NCT02266927|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111046712|NCT02266927|Respiratory System Agents|respiratory system agents|mesh-ancestor
111046713|NCT02266927|Dermatologic Agents|dermatologic agents|mesh-ancestor
111046714|NCT02266927|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111046715|NCT02158481|Carotenoids|carotenoids|mesh-list
111046716|NCT02158481|Antioxidants|antioxidants|mesh-ancestor
110628893|NCT00840606|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111046717|NCT02158481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111046718|NCT02158481|Protective Agents|protective agents|mesh-ancestor
111046719|NCT02158481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111046720|NCT05445362|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111046721|NCT05445362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111046722|NCT01020565|Entecavir|entecavir|mesh-list
111046723|NCT01020565|Antiviral Agents|antiviral agents|mesh-ancestor
111046724|NCT01020565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111046725|NCT01020097|Fluorides|fluorides|mesh-list
111046726|NCT01020097|Cariostatic Agents|cariostatic agents|mesh-ancestor
111046727|NCT01020097|Protective Agents|protective agents|mesh-ancestor
111046728|NCT01020097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111046729|NCT02154269|Lenograstim|lenograstim|mesh-list
111046730|NCT02154269|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111046731|NCT02154269|Immunologic Factors|immunologic factors|mesh-ancestor
111046732|NCT02154269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111046734|NCT03738683|Piperacillin|piperacillin|mesh-list
111046735|NCT03738683|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
111046736|NCT03738683|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111046737|NCT03738683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111046738|NCT03738683|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
111046739|NCT03738683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111046740|NCT03738683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111046741|NCT04475887|Iron|iron|mesh-list
111046742|NCT04475887|Trace Elements|trace elements|mesh-ancestor
111046743|NCT04475887|Micronutrients|micronutrients|mesh-ancestor
111046744|NCT04475887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111046745|NCT02267239|Chlorhexidine|chlorhexidine|mesh-list
111046746|NCT02267239|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
111046747|NCT02267239|Listerine|listerine|mesh-list
111046748|NCT02267239|Hexetidine|hexetidine|mesh-list
111046749|NCT02267239|Menthol|menthol|mesh-list
111046750|NCT02267239|Sodium Fluoride|sodium fluoride|mesh-list
111046751|NCT02267239|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111046752|NCT02267239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111046753|NCT02267239|Disinfectants|disinfectants|mesh-ancestor
111046754|NCT02267239|Dermatologic Agents|dermatologic agents|mesh-ancestor
111046755|NCT02267239|Cariostatic Agents|cariostatic agents|mesh-ancestor
111046756|NCT02267239|Protective Agents|protective agents|mesh-ancestor
111046757|NCT02267239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111046758|NCT02267239|Antipruritics|antipruritics|mesh-ancestor
111046759|NCT02267239|Antifungal Agents|antifungal agents|mesh-ancestor
111046760|NCT02766023|Metronidazole|metronidazole|mesh-list
111046761|NCT02766023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111046762|NCT02766023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111046763|NCT02766023|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111046764|NCT02766023|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111046765|NCT05466500|Dexamethasone|dexamethasone|mesh-list
111046766|NCT05466500|Dexamethasone acetate|dexamethasone acetate|mesh-list
111046767|NCT05466500|Bupivacaine|bupivacaine|mesh-list
111046768|NCT05466500|BB 1101|bb 1101|mesh-list
111046769|NCT05466500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111046770|NCT05466500|Antiemetics|antiemetics|mesh-ancestor
111046771|NCT05466500|Autonomic Agents|autonomic agents|mesh-ancestor
111046772|NCT05466500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111046773|NCT05466500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111046774|NCT05466500|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111046775|NCT05466500|Glucocorticoids|glucocorticoids|mesh-ancestor
111046776|NCT05466500|Hormones|hormones|mesh-ancestor
111046777|NCT05466500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111046778|NCT05466500|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111046780|NCT05466500|Protease Inhibitors|protease inhibitors|mesh-ancestor
111046781|NCT05466500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111046782|NCT05466500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111046783|NCT05466500|Anesthetics, Local|anesthetics, local|mesh-ancestor
111046784|NCT05466500|Anesthetics|anesthetics|mesh-ancestor
111046785|NCT05466500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111046786|NCT05466500|Sensory System Agents|sensory system agents|mesh-ancestor
111046787|NCT04475107|Artesunate|artesunate|mesh-list
111046788|NCT04475107|Pyronaridine|pyronaridine|mesh-list
111046789|NCT04475107|Pyronaridine tetraphosphate, artesunate drug combination|pyronaridine tetraphosphate, artesunate drug combination|mesh-list
111046790|NCT04475107|Antimalarials|antimalarials|mesh-ancestor
111046791|NCT04475107|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111046792|NCT04475107|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111046793|NCT04475107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111046794|NCT04475107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111046795|NCT04475107|Antiviral Agents|antiviral agents|mesh-ancestor
111046796|NCT04475107|Schistosomicides|schistosomicides|mesh-ancestor
111046797|NCT04475107|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
111046798|NCT04475107|Anthelmintics|anthelmintics|mesh-ancestor
111046799|NCT02254967|Vancomycin|vancomycin|mesh-list
111046800|NCT02254967|Fidaxomicin|fidaxomicin|mesh-list
111046801|NCT02254967|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111046802|NCT02254967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111046803|NCT05444036|Ketamine|ketamine|mesh-list
111046804|NCT05444036|Analgesics|analgesics|mesh-ancestor
111046805|NCT05444036|Sensory System Agents|sensory system agents|mesh-ancestor
111046806|NCT05444036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111046807|NCT05444036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111046808|NCT05444036|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111046809|NCT05444036|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111046810|NCT05444036|Anesthetics, General|anesthetics, general|mesh-ancestor
111046811|NCT05444036|Anesthetics|anesthetics|mesh-ancestor
111046812|NCT05444036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111046813|NCT05444036|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111046814|NCT05444036|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111046815|NCT05444036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111046816|NCT05444036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111046818|NCT03923959|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111046819|NCT03923959|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111046820|NCT03923959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111046821|NCT03923959|Hemostatics|hemostatics|mesh-ancestor
111046822|NCT03923959|Coagulants|coagulants|mesh-ancestor
111046823|NCT02161367|Simethicone|simethicone|mesh-list
111046824|NCT02161367|Antifoaming Agents|antifoaming agents|mesh-ancestor
111046825|NCT02161367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111046826|NCT02161367|Emollients|emollients|mesh-ancestor
111046827|NCT02161367|Dermatologic Agents|dermatologic agents|mesh-ancestor
111046828|NCT03542825|Iron|iron|mesh-list
111046829|NCT03542825|Lactoferrin|lactoferrin|mesh-list
111046830|NCT03542825|Iron Chelating Agents|iron chelating agents|mesh-list
111046831|NCT03542825|Trace Elements|trace elements|mesh-ancestor
111046832|NCT03542825|Micronutrients|micronutrients|mesh-ancestor
111046833|NCT03542825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111046834|NCT03542825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111046835|NCT03542825|Chelating Agents|chelating agents|mesh-ancestor
111046836|NCT03542825|Sequestering Agents|sequestering agents|mesh-ancestor
111046837|NCT03542825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111046838|NCT01001923|Fasinumab|fasinumab|mesh-list
111046839|NCT01001923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111046840|NCT01001923|Analgesics|analgesics|mesh-ancestor
111046841|NCT01001923|Sensory System Agents|sensory system agents|mesh-ancestor
111046842|NCT01001923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111046843|NCT01001923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111046844|NCT02154503|Minoxidil|minoxidil|mesh-list
111046845|NCT02154503|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111046846|NCT02154503|Vasodilator Agents|vasodilator agents|mesh-ancestor
111046847|NCT02536976|Mirabegron|mirabegron|mesh-list
111046848|NCT02536976|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
111046849|NCT02536976|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110628923|NCT00840684|Analgesics|analgesics|mesh-ancestor
111046850|NCT02536976|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111046851|NCT02536976|Adrenergic Agents|adrenergic agents|mesh-ancestor
111046852|NCT02536976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111046853|NCT02536976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111046854|NCT02536976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111046855|NCT02536976|Urological Agents|urological agents|mesh-ancestor
111046857|NCT00992563|Ranibizumab|ranibizumab|mesh-list
111046858|NCT00992563|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111046859|NCT00992563|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111046860|NCT00992563|Growth Substances|growth substances|mesh-ancestor
111046861|NCT00992563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111046862|NCT00992563|Growth Inhibitors|growth inhibitors|mesh-ancestor
111046863|NCT00992563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111046864|NCT02267707|Paclitaxel|paclitaxel|mesh-list
111046865|NCT02267707|Gemcitabine|gemcitabine|mesh-list
111046866|NCT02267707|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111046867|NCT02267707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111046868|NCT02267707|Tubulin Modulators|tubulin modulators|mesh-ancestor
111046869|NCT02267707|Antimitotic Agents|antimitotic agents|mesh-ancestor
111046870|NCT02267707|Mitosis Modulators|mitosis modulators|mesh-ancestor
111046871|NCT02267707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111046872|NCT02267707|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111046873|NCT02267707|Antimetabolites|antimetabolites|mesh-ancestor
111046874|NCT01373229|Plerixafor|plerixafor|mesh-list
111046875|NCT01373229|Rituximab|rituximab|mesh-list
111046876|NCT01373229|Lenalidomide|lenalidomide|mesh-list
111046877|NCT01373229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111046878|NCT01373229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111046879|NCT01373229|Immunologic Factors|immunologic factors|mesh-ancestor
111046880|NCT01373229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111046881|NCT01373229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111046882|NCT01373229|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111046883|NCT01373229|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111046884|NCT01373229|Growth Substances|growth substances|mesh-ancestor
111046885|NCT01373229|Growth Inhibitors|growth inhibitors|mesh-ancestor
111046886|NCT01373229|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110763937|NCT04147494|Anticoagulants|anticoagulants|mesh-ancestor
111046887|NCT01373229|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111046888|NCT01373229|Antiviral Agents|antiviral agents|mesh-ancestor
111046889|NCT01373229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111046890|NCT02671461|Aspirin|aspirin|mesh-list
111046891|NCT02671461|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111046892|NCT02671461|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111046893|NCT02671461|Analgesics|analgesics|mesh-ancestor
111046894|NCT02671461|Sensory System Agents|sensory system agents|mesh-ancestor
111046895|NCT02671461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111046896|NCT02671461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111046897|NCT02671461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111046898|NCT02671461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111046899|NCT02671461|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111046900|NCT02671461|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111046901|NCT02671461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111046902|NCT02671461|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111046903|NCT02671461|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111046904|NCT02671461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111046905|NCT02671461|Antipyretics|antipyretics|mesh-ancestor
111046906|NCT05467033|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
111046907|NCT05467033|Hemostatics|hemostatics|mesh-ancestor
111046908|NCT05467033|Coagulants|coagulants|mesh-ancestor
111046909|NCT05467033|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
111046910|NCT05467033|Natriuretic Agents|natriuretic agents|mesh-ancestor
111046911|NCT05467033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111046912|NCT04196283|Paclitaxel|paclitaxel|mesh-list
111046913|NCT04196283|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111046914|NCT04196283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111046915|NCT04196283|Tubulin Modulators|tubulin modulators|mesh-ancestor
111046916|NCT04196283|Antimitotic Agents|antimitotic agents|mesh-ancestor
111046917|NCT04196283|Mitosis Modulators|mitosis modulators|mesh-ancestor
111046918|NCT04196283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111046919|NCT02268019|Epinephrine|epinephrine|mesh-list
111046920|NCT02268019|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111046921|NCT02268019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111046922|NCT02268019|Adrenergic Agents|adrenergic agents|mesh-ancestor
111046923|NCT02268019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111046924|NCT02268019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111046925|NCT02268019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111046926|NCT02268019|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111046927|NCT02268019|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111046928|NCT02268019|Autonomic Agents|autonomic agents|mesh-ancestor
111046929|NCT02268019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111046930|NCT02268019|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111046931|NCT02268019|Respiratory System Agents|respiratory system agents|mesh-ancestor
111046933|NCT02268019|Sympathomimetics|sympathomimetics|mesh-ancestor
111046934|NCT02268019|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111046935|NCT03114111|Aminolevulinic Acid|aminolevulinic acid|mesh-list
111046936|NCT03114111|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111046937|NCT03114111|Dermatologic Agents|dermatologic agents|mesh-ancestor
111046938|NCT01110889|Agomelatine|agomelatine|mesh-list
111046939|NCT01110889|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111046940|NCT01110889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111046941|NCT01110889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111046942|NCT01106989|Lidocaine|lidocaine|mesh-list
111046943|NCT01106989|Tetracaine|tetracaine|mesh-list
111046944|NCT01106989|Anesthetics, Local|anesthetics, local|mesh-ancestor
111046945|NCT01106989|Anesthetics|anesthetics|mesh-ancestor
111046946|NCT01106989|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111046947|NCT01106989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111046948|NCT01106989|Sensory System Agents|sensory system agents|mesh-ancestor
111046949|NCT01106989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111046950|NCT01106989|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111046951|NCT01106989|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111046952|NCT01106989|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111046953|NCT01106989|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111046954|NCT01106989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111046955|NCT00975091|Entecavir|entecavir|mesh-list
111046956|NCT00975091|Antiviral Agents|antiviral agents|mesh-ancestor
111046957|NCT00975091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111046958|NCT02535416|Diphenhydramine|diphenhydramine|mesh-list
111046959|NCT02535416|Promethazine|promethazine|mesh-list
111046960|NCT02535416|Cetirizine|cetirizine|mesh-list
111046961|NCT02535416|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111046962|NCT02535416|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111046963|NCT02535416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111046964|NCT02535416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111046965|NCT02535416|Anesthetics, Local|anesthetics, local|mesh-ancestor
111046966|NCT02535416|Anesthetics|anesthetics|mesh-ancestor
111046967|NCT02535416|Sensory System Agents|sensory system agents|mesh-ancestor
111046968|NCT02535416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111046969|NCT02535416|Antiemetics|antiemetics|mesh-ancestor
111046970|NCT02535416|Autonomic Agents|autonomic agents|mesh-ancestor
111046971|NCT02535416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111046972|NCT02535416|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111046973|NCT02535416|Histamine Antagonists|histamine antagonists|mesh-ancestor
111046974|NCT02535416|Histamine Agents|histamine agents|mesh-ancestor
111046975|NCT02535416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111046976|NCT02535416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111046977|NCT02535416|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111046978|NCT02535416|Antipruritics|antipruritics|mesh-ancestor
111046979|NCT02535416|Dermatologic Agents|dermatologic agents|mesh-ancestor
111046980|NCT02535416|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
111046981|NCT00911443|Interferons|interferons|mesh-list
111046982|NCT00911443|Interferon-alpha|interferon-alpha|mesh-list
111046983|NCT00911443|Interferon alpha-2|interferon alpha-2|mesh-list
111046984|NCT00911443|Dacarbazine|dacarbazine|mesh-list
111046985|NCT00911443|Thymalfasin|thymalfasin|mesh-list
111046986|NCT00911443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111046987|NCT00911443|Antiviral Agents|antiviral agents|mesh-ancestor
111046988|NCT00911443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111046989|NCT00911443|Immunologic Factors|immunologic factors|mesh-ancestor
111046990|NCT00911443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111046991|NCT00911443|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111046992|NCT00911443|Alkylating Agents|alkylating agents|mesh-ancestor
111046993|NCT00911443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111046994|NCT00911443|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111046995|NCT03949478|Ibuprofen|ibuprofen|mesh-list
111046996|NCT03949478|Nifedipine|nifedipine|mesh-list
111046997|NCT03949478|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111046998|NCT03949478|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111046999|NCT03949478|Analgesics|analgesics|mesh-ancestor
111047000|NCT03949478|Sensory System Agents|sensory system agents|mesh-ancestor
111047001|NCT03949478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111047002|NCT03949478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111047003|NCT03949478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111047004|NCT03949478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111047005|NCT03949478|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111047007|NCT03949478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111047008|NCT03949478|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111047009|NCT03949478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111047010|NCT03949478|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111047011|NCT03949478|Vasodilator Agents|vasodilator agents|mesh-ancestor
111047012|NCT03949478|Tocolytic Agents|tocolytic agents|mesh-ancestor
111047013|NCT03949478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111047014|NCT00909649|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
111047015|NCT00909649|Hemostatics|hemostatics|mesh-ancestor
111047016|NCT00909649|Coagulants|coagulants|mesh-ancestor
111047017|NCT00971035|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111047018|NCT00971035|Immunologic Factors|immunologic factors|mesh-ancestor
111047019|NCT00971035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111047020|NCT04787965|Opicapone|opicapone|mesh-list
111047021|NCT04787965|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
111047022|NCT04787965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111047023|NCT04787965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111047024|NCT04787965|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111047025|NCT04787965|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111047026|NCT02670915|Insulin|insulin|mesh-list
111047027|NCT02670915|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111047028|NCT02670915|Insulin Aspart|insulin aspart|mesh-list
111047029|NCT02670915|Insulin, Long-Acting|insulin, long-acting|mesh-list
111047030|NCT02670915|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
111047031|NCT02670915|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111047032|NCT02670915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111047033|NCT02545868|Vaccines|vaccines|mesh-list
111047034|NCT02545868|Immunologic Factors|immunologic factors|mesh-ancestor
111047035|NCT02545868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111047036|NCT00821977|Vildagliptin|vildagliptin|mesh-list
111047037|NCT00821977|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111047038|NCT00821977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111047039|NCT00821977|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111047040|NCT00821977|Protease Inhibitors|protease inhibitors|mesh-ancestor
111047041|NCT00821977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111047042|NCT00821977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111047043|NCT04474327|Montelukast|montelukast|mesh-list
111047044|NCT04474327|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111047045|NCT04474327|Respiratory System Agents|respiratory system agents|mesh-ancestor
111047046|NCT04474327|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
111047047|NCT04474327|Hormone Antagonists|hormone antagonists|mesh-ancestor
111047048|NCT04474327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111047049|NCT04474327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111047050|NCT04474327|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
111047051|NCT04474327|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111047052|NCT04474327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111047053|NCT00961675|Ciprofloxacin|ciprofloxacin|mesh-list
111047054|NCT00961675|Povidone-Iodine|povidone-iodine|mesh-list
111047055|NCT00961675|Dexamethasone|dexamethasone|mesh-list
111047056|NCT00961675|Dexamethasone acetate|dexamethasone acetate|mesh-list
111047057|NCT00961675|Povidone|povidone|mesh-list
111047058|NCT00961675|BB 1101|bb 1101|mesh-list
111047059|NCT00961675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111047060|NCT00961675|Antiemetics|antiemetics|mesh-ancestor
111047061|NCT00961675|Autonomic Agents|autonomic agents|mesh-ancestor
111047062|NCT00961675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111047063|NCT00961675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111047064|NCT00961675|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111047065|NCT00961675|Glucocorticoids|glucocorticoids|mesh-ancestor
111047066|NCT00961675|Hormones|hormones|mesh-ancestor
111047067|NCT00961675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111047068|NCT00961675|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111047069|NCT00961675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111047070|NCT00961675|Protease Inhibitors|protease inhibitors|mesh-ancestor
111047071|NCT00961675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111047072|NCT00961675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111047073|NCT00961675|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111047074|NCT00961675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111047075|NCT00961675|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111047076|NCT00961675|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111047077|NCT00961675|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111047078|NCT00961675|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111047079|NCT00961675|Plasma Substitutes|plasma substitutes|mesh-ancestor
111047080|NCT00961675|Blood Substitutes|blood substitutes|mesh-ancestor
111047081|NCT00961675|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111047082|NCT00819169|Conatumumab|conatumumab|mesh-list
111047083|NCT00819169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111047084|NCT00819169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111047085|NCT02161679|Carboplatin|carboplatin|mesh-list
111047086|NCT02161679|Camptothecin|camptothecin|mesh-list
111047087|NCT02161679|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
111047088|NCT02161679|Immunoconjugates|immunoconjugates|mesh-list
111047089|NCT02161679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111047090|NCT02161679|Immunologic Factors|immunologic factors|mesh-ancestor
111047091|NCT02161679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111047092|NCT02161679|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111047093|NCT02161679|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111047094|NCT02161679|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111047095|NCT02161679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111047096|NCT02161679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111047097|NCT04262492|Rivaroxaban|rivaroxaban|mesh-list
111047098|NCT04262492|Apixaban|apixaban|mesh-list
111047099|NCT04262492|Edoxaban|edoxaban|mesh-list
111047100|NCT04262492|Dabigatran|dabigatran|mesh-list
111047101|NCT04262492|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111047102|NCT04262492|Antithrombins|antithrombins|mesh-ancestor
111047103|NCT04262492|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111047104|NCT04262492|Protease Inhibitors|protease inhibitors|mesh-ancestor
111047105|NCT04262492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111047106|NCT04262492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111047107|NCT04262492|Anticoagulants|anticoagulants|mesh-ancestor
111047108|NCT00955981|Lesinurad|lesinurad|mesh-list
111047109|NCT00955981|Gout Suppressants|gout suppressants|mesh-ancestor
111047110|NCT00955981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111047111|NCT00955981|Uricosuric Agents|uricosuric agents|mesh-ancestor
111047112|NCT03541031|Micronutrients|micronutrients|mesh-list
111047113|NCT03541031|Trace Elements|trace elements|mesh-list
111047114|NCT03541031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111047116|NCT05454709|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111047117|NCT05454709|Hormones|hormones|mesh-ancestor
111047118|NCT05454709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111047119|NCT05454709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111047120|NCT02154737|Gemcitabine|gemcitabine|mesh-list
111047121|NCT02154737|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111047122|NCT02154737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111047123|NCT02154737|Antimetabolites|antimetabolites|mesh-ancestor
111047124|NCT02154737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111047125|NCT02154737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111047126|NCT02154737|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111047127|NCT02154737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111047128|NCT00813163|Irinotecan|irinotecan|mesh-list
111047129|NCT00813163|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111047130|NCT00813163|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111047131|NCT00813163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111047132|NCT00813163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111047133|NCT00813163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111047134|NCT05440916|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
111047135|NCT05440916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111047136|NCT05440916|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111047137|NCT05440916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111047138|NCT00901693|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111047139|NCT00901693|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111047140|NCT04474093|Lithium Carbonate|lithium carbonate|mesh-list
111047141|NCT04474093|Antidepressive Agents|antidepressive agents|mesh-ancestor
111047142|NCT04474093|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111047143|NCT04474093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111047144|NCT04474093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111047145|NCT04474093|Antimanic Agents|antimanic agents|mesh-ancestor
111047146|NCT04474093|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111047147|NCT04474093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111047148|NCT04474093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111047149|NCT02159027|Maraviroc|maraviroc|mesh-list
111047150|NCT02159027|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
111047151|NCT02159027|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
111047152|NCT02159027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111047153|NCT02159027|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111047154|NCT02159027|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111047155|NCT02159027|Antiviral Agents|antiviral agents|mesh-ancestor
111047156|NCT02159027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111047157|NCT02159027|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
111047158|NCT02161991|Aprepitant|aprepitant|mesh-list
111047159|NCT02161991|Antiemetics|antiemetics|mesh-ancestor
111047160|NCT02161991|Autonomic Agents|autonomic agents|mesh-ancestor
111047161|NCT02161991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111047162|NCT02161991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111047163|NCT02161991|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111047164|NCT02161991|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
111047165|NCT02161991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111047166|NCT02161991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111047167|NCT00948961|Poly I-C|poly i-c|mesh-list
111047168|NCT00948961|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
111047169|NCT00948961|Poly ICLC|poly iclc|mesh-list
111047170|NCT00948961|Interferon Inducers|interferon inducers|mesh-ancestor
111047171|NCT00948961|Immunologic Factors|immunologic factors|mesh-ancestor
111047172|NCT00948961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111047173|NCT00948961|Laxatives|laxatives|mesh-ancestor
111047174|NCT00948961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111047175|NCT00948961|Antiviral Agents|antiviral agents|mesh-ancestor
111047176|NCT00948961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111047177|NCT02159105|Chrysarobin|chrysarobin|mesh-list
111047178|NCT02159105|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111047179|NCT02159105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111047180|NCT02159105|Analgesics|analgesics|mesh-ancestor
111047181|NCT02159105|Sensory System Agents|sensory system agents|mesh-ancestor
111047182|NCT02159105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111047183|NCT02159105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111047184|NCT02159105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111047185|NCT02159105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111047186|NCT00890305|Pidilizumab|pidilizumab|mesh-list
111047187|NCT00890305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110764248|NCT01141452|Hormones|hormones|mesh-ancestor
111047188|NCT00890305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111047189|NCT01661972|Capecitabine|capecitabine|mesh-list
111047190|NCT01661972|Aflibercept|aflibercept|mesh-list
111047191|NCT01661972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111047192|NCT01661972|Antimetabolites|antimetabolites|mesh-ancestor
111047193|NCT01661972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111047194|NCT01661972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111047195|NCT01661972|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111047196|NCT01661972|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111047197|NCT01661972|Growth Substances|growth substances|mesh-ancestor
111047198|NCT01661972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111047199|NCT01661972|Growth Inhibitors|growth inhibitors|mesh-ancestor
111047200|NCT02155049|Bimatoprost|bimatoprost|mesh-list
111047201|NCT02155049|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111047202|NCT03540953|Mitomycins|mitomycins|mesh-list
111047203|NCT03540953|Mitomycin|mitomycin|mesh-list
111047204|NCT03540953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111047205|NCT03540953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111047206|NCT03540953|Alkylating Agents|alkylating agents|mesh-ancestor
111047207|NCT03540953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111047208|NCT03540953|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111047209|NCT03540953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111047210|NCT00888355|Losartan|losartan|mesh-list
111047211|NCT00888355|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111047212|NCT00888355|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111047213|NCT00888355|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111047214|NCT00888355|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111047215|NCT00888355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111047216|NCT00794677|Ezetimibe|ezetimibe|mesh-list
111047217|NCT00794677|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111047218|NCT00794677|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111047219|NCT00794677|Antimetabolites|antimetabolites|mesh-ancestor
111047220|NCT00794677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111047221|NCT00794677|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111047222|NCT00792727|Ketoprofen|ketoprofen|mesh-list
111047223|NCT00792727|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111047224|NCT00792727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111047225|NCT00792727|Analgesics|analgesics|mesh-ancestor
111047226|NCT00792727|Sensory System Agents|sensory system agents|mesh-ancestor
111047227|NCT00792727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111047228|NCT00792727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111047229|NCT00792727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111047230|NCT00792727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111047231|NCT00792727|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111047232|NCT00792727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111047233|NCT00792727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111047234|NCT00945763|Ibuprofen|ibuprofen|mesh-list
111047235|NCT00945763|Meloxicam|meloxicam|mesh-list
111047236|NCT00945763|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111047237|NCT00945763|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111047238|NCT00945763|Analgesics|analgesics|mesh-ancestor
111047239|NCT00945763|Sensory System Agents|sensory system agents|mesh-ancestor
111047240|NCT00945763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111047241|NCT00945763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111047242|NCT00945763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111047243|NCT00945763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111047244|NCT00945763|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111047245|NCT00945763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110628980|NCT00845364|Vasodilator Agents|vasodilator agents|mesh-ancestor
111047246|NCT00945763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111047247|NCT00945763|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111047248|NCT02770391|Leuprolide|leuprolide|mesh-list
111047249|NCT02770391|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111047250|NCT02770391|Fertility Agents|fertility agents|mesh-ancestor
111047251|NCT02770391|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111047252|NCT02770391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111047253|NCT02770391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111047254|NCT02770391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111047255|NCT02155205|Moxifloxacin|moxifloxacin|mesh-list
111047256|NCT02155205|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111047257|NCT02155205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111047258|NCT02155205|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111047259|NCT02155205|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111047260|NCT02155205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111047261|NCT02155205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111047263|NCT00938587|Prednisone|prednisone|mesh-list
111047264|NCT00938587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111047265|NCT00938587|Glucocorticoids|glucocorticoids|mesh-ancestor
111047266|NCT00938587|Hormones|hormones|mesh-ancestor
111047267|NCT00938587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111047268|NCT00938587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111047269|NCT00938587|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111047270|NCT00938587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111047271|NCT02162303|Colchicine|colchicine|mesh-list
111047272|NCT02162303|Gout Suppressants|gout suppressants|mesh-ancestor
111047273|NCT02162303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111047274|NCT02162303|Tubulin Modulators|tubulin modulators|mesh-ancestor
111047275|NCT02162303|Antimitotic Agents|antimitotic agents|mesh-ancestor
111047276|NCT02162303|Mitosis Modulators|mitosis modulators|mesh-ancestor
111047277|NCT02162303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111047278|NCT02162303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111047279|NCT05430308|Chlorhexidine|chlorhexidine|mesh-list
111047280|NCT05430308|Povidone-Iodine|povidone-iodine|mesh-list
111047281|NCT05430308|Povidone|povidone|mesh-list
111047282|NCT05430308|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111047283|NCT05430308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111047284|NCT05430308|Disinfectants|disinfectants|mesh-ancestor
111047285|NCT05430308|Plasma Substitutes|plasma substitutes|mesh-ancestor
111047286|NCT05430308|Blood Substitutes|blood substitutes|mesh-ancestor
111047287|NCT00877903|Remestemcel-l|remestemcel-l|mesh-list
111047288|NCT00877903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111047289|NCT00877903|Antiviral Agents|antiviral agents|mesh-ancestor
111047290|NCT00877903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111047291|NCT04707703|Isavuconazole|isavuconazole|mesh-list
111047292|NCT04707703|Antifungal Agents|antifungal agents|mesh-ancestor
111047293|NCT04707703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111047294|NCT00936871|Moxifloxacin|moxifloxacin|mesh-list
111047295|NCT00936871|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111047296|NCT00936871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111047297|NCT00936871|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111047298|NCT00936871|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111047299|NCT00936871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111047300|NCT00936871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111047301|NCT00936871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111047302|NCT00934921|Ondansetron|ondansetron|mesh-list
111047303|NCT00934921|Antiemetics|antiemetics|mesh-ancestor
111047305|NCT00934921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111047306|NCT00934921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111047307|NCT00934921|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111047308|NCT00934921|Antipruritics|antipruritics|mesh-ancestor
111047309|NCT00934921|Dermatologic Agents|dermatologic agents|mesh-ancestor
111047310|NCT00934921|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111047311|NCT00934921|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111047312|NCT00934921|Serotonin Agents|serotonin agents|mesh-ancestor
111047313|NCT00934921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111047314|NCT00934921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111047315|NCT05429450|Triamcinolone|triamcinolone|mesh-list
111047316|NCT05429450|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
111047317|NCT05429450|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
111047318|NCT05429450|Methotrexate|methotrexate|mesh-list
111047319|NCT05429450|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
111047320|NCT05429450|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111047321|NCT05429450|Abortifacient Agents|abortifacient agents|mesh-ancestor
111047322|NCT05429450|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111047323|NCT05429450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111047324|NCT05429450|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111047325|NCT05429450|Antimetabolites|antimetabolites|mesh-ancestor
111047326|NCT05429450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111047327|NCT05429450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111047328|NCT05429450|Dermatologic Agents|dermatologic agents|mesh-ancestor
111047329|NCT05429450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111047330|NCT05429450|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111047331|NCT05429450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111047332|NCT05429450|Immunologic Factors|immunologic factors|mesh-ancestor
111047333|NCT05429450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111047334|NCT05429450|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111047335|NCT05429450|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111047336|NCT05429450|Glucocorticoids|glucocorticoids|mesh-ancestor
111047337|NCT05429450|Hormones|hormones|mesh-ancestor
111047338|NCT05429450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111047339|NCT00103259|Irinotecan|irinotecan|mesh-list
111047340|NCT00103259|Bortezomib|bortezomib|mesh-list
111047341|NCT00103259|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111047342|NCT00103259|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111047343|NCT00103259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111047344|NCT00103259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111047345|NCT00103259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111047346|NCT02162381|Methylphenidate|methylphenidate|mesh-list
111047347|NCT02162381|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111047348|NCT02162381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111047349|NCT02162381|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111047350|NCT02162381|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111047351|NCT02162381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111047352|NCT02162381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111047353|NCT02162381|Dopamine Agents|dopamine agents|mesh-ancestor
111047354|NCT02162381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111047355|NCT00782431|Vaccines|vaccines|mesh-list
111047356|NCT00782431|Immunologic Factors|immunologic factors|mesh-ancestor
111047357|NCT00782431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111047358|NCT02155439|Triamcinolone|triamcinolone|mesh-list
111047359|NCT02155439|Fluorouracil|fluorouracil|mesh-list
111047360|NCT02155439|Antimetabolites|antimetabolites|mesh-ancestor
111047361|NCT02155439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111047362|NCT02155439|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111047363|NCT02155439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111047364|NCT02155439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111047365|NCT02155439|Immunologic Factors|immunologic factors|mesh-ancestor
111047366|NCT02155439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111047367|NCT02155439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111047368|NCT02155439|Glucocorticoids|glucocorticoids|mesh-ancestor
111047369|NCT02155439|Hormones|hormones|mesh-ancestor
111047370|NCT02155439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111047371|NCT04627285|Lacosamide|lacosamide|mesh-list
111047372|NCT04627285|Anticonvulsants|anticonvulsants|mesh-ancestor
111047373|NCT04627285|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111047374|NCT04627285|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111047375|NCT04627285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111047376|NCT04627285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111047377|NCT02544152|Lubiprostone|lubiprostone|mesh-list
111047378|NCT02544152|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
111047379|NCT02544152|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111047380|NCT02544152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111047381|NCT02162537|Bevacizumab|bevacizumab|mesh-list
111047382|NCT02162537|Pemetrexed|pemetrexed|mesh-list
111047383|NCT02162537|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111047384|NCT02162537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111047385|NCT02162537|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111047386|NCT02162537|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111047387|NCT02162537|Growth Substances|growth substances|mesh-ancestor
111047388|NCT02162537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111047389|NCT02162537|Growth Inhibitors|growth inhibitors|mesh-ancestor
111047390|NCT02162537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111047391|NCT02162537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111047392|NCT02162537|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111047393|NCT02162537|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111047394|NCT02534324|Antihypertensive Agents|antihypertensive agents|mesh-list
111047395|NCT00864175|Docetaxel|docetaxel|mesh-list
111047396|NCT00864175|Trastuzumab|trastuzumab|mesh-list
111047397|NCT00864175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111047398|NCT00864175|Tubulin Modulators|tubulin modulators|mesh-ancestor
111047399|NCT00864175|Antimitotic Agents|antimitotic agents|mesh-ancestor
111047400|NCT00864175|Mitosis Modulators|mitosis modulators|mesh-ancestor
111047401|NCT00864175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111047402|NCT00864175|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111047403|NCT02166593|Atorvastatin|atorvastatin|mesh-list
111047404|NCT02166593|Pravastatin|pravastatin|mesh-list
111047405|NCT02166593|Fenofibrate|fenofibrate|mesh-list
111047406|NCT02166593|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111047407|NCT02166593|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111047408|NCT02166593|Antimetabolites|antimetabolites|mesh-ancestor
111047409|NCT02166593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111047410|NCT02166593|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111047411|NCT02166593|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111047413|NCT00858871|Sorafenib|sorafenib|mesh-list
111047414|NCT00858871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111047415|NCT00858871|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111047416|NCT00858871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111047417|NCT00858871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111047418|NCT02162693|Hyaluronic Acid|hyaluronic acid|mesh-list
111047419|NCT02162693|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111047420|NCT02162693|Immunologic Factors|immunologic factors|mesh-ancestor
111047421|NCT02162693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111047422|NCT02162693|Viscosupplements|viscosupplements|mesh-ancestor
111047423|NCT02162693|Protective Agents|protective agents|mesh-ancestor
111047424|NCT02163161|Abrocitinib|abrocitinib|mesh-list
111047425|NCT02163161|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111047426|NCT02163161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111047427|NCT02163161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111047428|NCT00917293|Pyridoxal|pyridoxal|mesh-list
111047429|NCT00917293|Pyridoxal Phosphate|pyridoxal phosphate|mesh-list
111047430|NCT00917293|Vitamin B Complex|vitamin b complex|mesh-ancestor
111047431|NCT00917293|Vitamins|vitamins|mesh-ancestor
111047432|NCT00917293|Micronutrients|micronutrients|mesh-ancestor
111047433|NCT00917293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111047434|NCT00845299|Benzalkonium Compounds|benzalkonium compounds|mesh-list
111047435|NCT00845299|Latanoprost|latanoprost|mesh-list
111047436|NCT00845299|Lubricant Eye Drops|lubricant eye drops|mesh-list
111047437|NCT00845299|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
111047438|NCT00845299|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111047439|NCT00845299|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111047440|NCT00845299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111047441|NCT02255591|Lidocaine|lidocaine|mesh-list
111047442|NCT02255591|Epinephrine|epinephrine|mesh-list
111047443|NCT02255591|Racepinephrine|racepinephrine|mesh-list
111047444|NCT02255591|Epinephryl borate|epinephryl borate|mesh-list
111047445|NCT02255591|Anesthetics, Local|anesthetics, local|mesh-ancestor
111047446|NCT02255591|Anesthetics|anesthetics|mesh-ancestor
111047447|NCT02255591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111047448|NCT02255591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111047449|NCT02255591|Sensory System Agents|sensory system agents|mesh-ancestor
111047450|NCT02255591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111047451|NCT02255591|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111047452|NCT02255591|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111047453|NCT02255591|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111047454|NCT02255591|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111047455|NCT02255591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111047456|NCT02255591|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111047457|NCT02255591|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111047458|NCT02255591|Adrenergic Agents|adrenergic agents|mesh-ancestor
111047459|NCT02255591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111047460|NCT02255591|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111047461|NCT02255591|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111047462|NCT02255591|Autonomic Agents|autonomic agents|mesh-ancestor
111047463|NCT02255591|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111047464|NCT02255591|Respiratory System Agents|respiratory system agents|mesh-ancestor
111047465|NCT02255591|Mydriatics|mydriatics|mesh-ancestor
111047466|NCT02255591|Sympathomimetics|sympathomimetics|mesh-ancestor
111047467|NCT02255591|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111047468|NCT00913393|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111047469|NCT00913393|Immunologic Factors|immunologic factors|mesh-ancestor
111047470|NCT00913393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111047471|NCT02167061|Metformin|metformin|mesh-list
111047472|NCT02167061|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111047473|NCT02167061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111047474|NCT03715465|Melatonin|melatonin|mesh-list
111047475|NCT03715465|Antioxidants|antioxidants|mesh-ancestor
111047476|NCT03715465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111047477|NCT03715465|Protective Agents|protective agents|mesh-ancestor
111047478|NCT03715465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111047479|NCT03715465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111047480|NCT02171039|Dabigatran|dabigatran|mesh-list
111047481|NCT02171039|Atorvastatin|atorvastatin|mesh-list
111047482|NCT02171039|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111047483|NCT02171039|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110764541|NCT00203411|Growth Inhibitors|growth inhibitors|mesh-ancestor
111047484|NCT02171039|Antimetabolites|antimetabolites|mesh-ancestor
111047485|NCT02171039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111047486|NCT02171039|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111047487|NCT02171039|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111047488|NCT02171039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111047489|NCT02171039|Antithrombins|antithrombins|mesh-ancestor
111047490|NCT02171039|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111047491|NCT02171039|Protease Inhibitors|protease inhibitors|mesh-ancestor
111047492|NCT02171039|Anticoagulants|anticoagulants|mesh-ancestor
111047493|NCT00840073|Trandolapril|trandolapril|mesh-list
111047494|NCT00840073|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
111047495|NCT00840073|Protease Inhibitors|protease inhibitors|mesh-ancestor
111047496|NCT00840073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111047497|NCT00840073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111047498|NCT00840073|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111047499|NCT02261207|Axitinib|axitinib|mesh-list
111047500|NCT02261207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111047501|NCT02261207|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111047502|NCT02261207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111047503|NCT02261207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111047504|NCT00838279|Lamotrigine|lamotrigine|mesh-list
111047505|NCT00838279|Anticonvulsants|anticonvulsants|mesh-ancestor
111047506|NCT00838279|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111047507|NCT00838279|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111047508|NCT00838279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111047509|NCT00838279|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111047510|NCT00838279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111047511|NCT00838279|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111047512|NCT00838279|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110629010|NCT00840918|Sensory System Agents|sensory system agents|mesh-ancestor
111047513|NCT00838279|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111047514|NCT00838279|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111047515|NCT00838279|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111047516|NCT02163707|Psilocybin|psilocybin|mesh-list
111047517|NCT02163707|Hallucinogens|hallucinogens|mesh-ancestor
111047518|NCT02163707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111047519|NCT02163707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111047520|NCT00769795|Goserelin|goserelin|mesh-list
111047521|NCT00769795|Bicalutamide|bicalutamide|mesh-list
111047522|NCT00769795|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111047523|NCT00769795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111047524|NCT00769795|Androgen Antagonists|androgen antagonists|mesh-ancestor
111047525|NCT00769795|Hormone Antagonists|hormone antagonists|mesh-ancestor
111047526|NCT00769795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111047527|NCT00769795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111047528|NCT03134677|Bupivacaine|bupivacaine|mesh-list
111047529|NCT03134677|Sevoflurane|sevoflurane|mesh-list
111047530|NCT03134677|Anesthetics, Local|anesthetics, local|mesh-ancestor
111047531|NCT03134677|Anesthetics|anesthetics|mesh-ancestor
111047532|NCT03134677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111047533|NCT03134677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111047534|NCT03134677|Sensory System Agents|sensory system agents|mesh-ancestor
111047535|NCT03134677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111047536|NCT03134677|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111047537|NCT03134677|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111047538|NCT03134677|Anesthetics, General|anesthetics, general|mesh-ancestor
111047539|NCT00722917|Pioglitazone|pioglitazone|mesh-list
111047540|NCT00722917|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111047541|NCT00722917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111047542|NCT02164097|Heparin|heparin|mesh-list
111047543|NCT02164097|Anticoagulants|anticoagulants|mesh-ancestor
111047544|NCT02164097|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111047545|NCT02164097|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111047546|NCT02164097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111047547|NCT00717457|Exenatide|exenatide|mesh-list
111047548|NCT00717457|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
111047549|NCT00717457|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111047550|NCT00717457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111047551|NCT00717457|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111047552|NCT00717457|Incretins|incretins|mesh-ancestor
111047553|NCT00717457|Hormones|hormones|mesh-ancestor
111047554|NCT00717457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111047555|NCT02171507|Diclofenac|diclofenac|mesh-list
111047556|NCT02171507|Dabigatran|dabigatran|mesh-list
111047557|NCT02171507|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111047558|NCT02171507|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111047559|NCT02171507|Analgesics|analgesics|mesh-ancestor
111047560|NCT02171507|Sensory System Agents|sensory system agents|mesh-ancestor
111047561|NCT02171507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111047562|NCT02171507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111047563|NCT02171507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111047565|NCT02171507|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111047566|NCT02171507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111047567|NCT02171507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111047568|NCT02171507|Antithrombins|antithrombins|mesh-ancestor
111047569|NCT02171507|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111047570|NCT02171507|Protease Inhibitors|protease inhibitors|mesh-ancestor
111047571|NCT02171507|Anticoagulants|anticoagulants|mesh-ancestor
111047572|NCT03539159|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111047573|NCT03539159|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111047574|NCT00758953|Danazol|danazol|mesh-list
111047575|NCT00758953|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111047576|NCT00758953|Hormone Antagonists|hormone antagonists|mesh-ancestor
111047577|NCT00758953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111047578|NCT00758953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111047579|NCT02167685|Brincidofovir|brincidofovir|mesh-list
111047580|NCT02167685|Antiviral Agents|antiviral agents|mesh-ancestor
111047581|NCT02167685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111047582|NCT00758563|Triclosan|triclosan|mesh-list
111047583|NCT00758563|Fluorides|fluorides|mesh-list
111047584|NCT00758563|Cariostatic Agents|cariostatic agents|mesh-ancestor
111047585|NCT00758563|Protective Agents|protective agents|mesh-ancestor
111047586|NCT00758563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111047587|NCT00758563|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111047588|NCT00758563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111047589|NCT00758563|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
111047590|NCT00758563|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111047591|NCT00758563|Antimetabolites|antimetabolites|mesh-ancestor
111047592|NCT00758563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111047593|NCT00758563|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111047594|NCT02171585|Clarithromycin|clarithromycin|mesh-list
111047595|NCT02171585|Dabigatran|dabigatran|mesh-list
111047596|NCT02171585|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111047597|NCT02171585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111047598|NCT02171585|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111047599|NCT02171585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111047600|NCT02171585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111047601|NCT02171585|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111047602|NCT02171585|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111047603|NCT02171585|Antithrombins|antithrombins|mesh-ancestor
111047604|NCT02171585|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111047605|NCT02171585|Protease Inhibitors|protease inhibitors|mesh-ancestor
111047606|NCT02171585|Anticoagulants|anticoagulants|mesh-ancestor
111047607|NCT03134443|Andrographolide|andrographolide|mesh-list
111047608|NCT03134443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111047609|NCT03134443|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111047610|NCT03134443|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111047612|NCT03134443|Sensory System Agents|sensory system agents|mesh-ancestor
111047613|NCT03134443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111047614|NCT03134443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111047615|NCT03134443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111047616|NCT03134443|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111047617|NCT03134443|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111047618|NCT03134443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111047619|NCT03134443|Antiviral Agents|antiviral agents|mesh-ancestor
111047620|NCT03134443|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111047621|NCT02171663|Afatinib|afatinib|mesh-list
111047622|NCT02171663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111047623|NCT02171663|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111047624|NCT02171663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111047625|NCT02171663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111047626|NCT02171741|Docetaxel|docetaxel|mesh-list
111047627|NCT02171741|Afatinib|afatinib|mesh-list
111047628|NCT02171741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111047629|NCT02171741|Tubulin Modulators|tubulin modulators|mesh-ancestor
111047630|NCT02171741|Antimitotic Agents|antimitotic agents|mesh-ancestor
111047631|NCT02171741|Mitosis Modulators|mitosis modulators|mesh-ancestor
111047632|NCT02171741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111047633|NCT02171741|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111047634|NCT02171741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111047635|NCT00835705|Amoxicillin|amoxicillin|mesh-list
111047636|NCT00835705|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
111047638|NCT00835705|Clavulanic Acid|clavulanic acid|mesh-list
111047639|NCT00835705|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111047640|NCT00835705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111047641|NCT00835705|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
111047642|NCT00835705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111047643|NCT00835705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111047644|NCT00713401|Esmolol|esmolol|mesh-list
111047645|NCT00713401|Tecadenoson|tecadenoson|mesh-list
111047646|NCT00713401|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
111047647|NCT00713401|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111047648|NCT00713401|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111047649|NCT00713401|Adrenergic Agents|adrenergic agents|mesh-ancestor
111047650|NCT00713401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111047651|NCT00713401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111047652|NCT00713401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111047653|NCT00713401|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
111047654|NCT00713401|Purinergic Agonists|purinergic agonists|mesh-ancestor
111047655|NCT00713401|Purinergic Agents|purinergic agents|mesh-ancestor
111047656|NCT02171975|Anesthetics|anesthetics|mesh-list
111047657|NCT02171975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111047658|NCT02171975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111047659|NCT00835549|Cefdinir|cefdinir|mesh-list
111047660|NCT00835549|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111047661|NCT00835549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111047662|NCT02164253|Deferiprone|deferiprone|mesh-list
111047663|NCT02164253|Iron Chelating Agents|iron chelating agents|mesh-ancestor
111047664|NCT02164253|Chelating Agents|chelating agents|mesh-ancestor
111047665|NCT02164253|Sequestering Agents|sequestering agents|mesh-ancestor
111047666|NCT02164253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111047667|NCT00755287|Metformin|metformin|mesh-list
111047668|NCT00755287|Insulin Glargine|insulin glargine|mesh-list
111047669|NCT00755287|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
111047670|NCT00755287|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111047671|NCT00755287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111047672|NCT00755287|Incretins|incretins|mesh-ancestor
111047673|NCT00755287|Hormones|hormones|mesh-ancestor
111047674|NCT00755287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111047675|NCT02168075|Mannitol|mannitol|mesh-list
111047676|NCT02168075|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
111047677|NCT02168075|Diuretics|diuretics|mesh-ancestor
111047678|NCT02168075|Natriuretic Agents|natriuretic agents|mesh-ancestor
111047679|NCT02168075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111047680|NCT00712699|Adderall|adderall|mesh-list
111047681|NCT00712699|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111047682|NCT00712699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111047683|NCT03945825|Vaccines|vaccines|mesh-list
111047684|NCT03945825|Immunologic Factors|immunologic factors|mesh-ancestor
111047685|NCT03945825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111047686|NCT02759315|Ruzasvir|ruzasvir|mesh-list
111047687|NCT02759315|Uprifosbuvir|uprifosbuvir|mesh-list
111047688|NCT02759315|Antiviral Agents|antiviral agents|mesh-ancestor
111047689|NCT02759315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111047690|NCT00697099|Enoxaparin|enoxaparin|mesh-list
111047691|NCT00697099|Semuloparin|semuloparin|mesh-list
111047692|NCT00697099|Enoxaparin sodium|enoxaparin sodium|mesh-list
111047693|NCT00697099|Anticoagulants|anticoagulants|mesh-ancestor
111047694|NCT00697099|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111047695|NCT00697099|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111047696|NCT00697099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111047697|NCT02172131|Olodaterol|olodaterol|mesh-list
111047698|NCT02172131|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111047699|NCT02172131|Autonomic Agents|autonomic agents|mesh-ancestor
111047700|NCT02172131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111047701|NCT02172131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111047702|NCT02172131|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111047703|NCT02172131|Respiratory System Agents|respiratory system agents|mesh-ancestor
111047704|NCT05435768|Denosumab|denosumab|mesh-list
111047705|NCT05435768|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111047706|NCT05435768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111047707|NCT00835081|Cefadroxil|cefadroxil|mesh-list
111047708|NCT00835081|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111047709|NCT00835081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111047710|NCT02543918|Ixekizumab|ixekizumab|mesh-list
111047711|NCT02543918|Vaccines|vaccines|mesh-list
110764811|NCT05193604|Paclitaxel|paclitaxel|mesh-list
111047712|NCT02543918|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
111047713|NCT02543918|Immunologic Factors|immunologic factors|mesh-ancestor
111047714|NCT02543918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111047715|NCT02543918|Dermatologic Agents|dermatologic agents|mesh-ancestor
111047716|NCT03539003|Remifentanil|remifentanil|mesh-list
111047718|NCT03539003|Sevoflurane|sevoflurane|mesh-list
111047719|NCT03539003|Desflurane|desflurane|mesh-list
111047720|NCT03539003|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111047721|NCT03539003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111047722|NCT03539003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111047723|NCT03539003|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111047724|NCT03539003|Anesthetics, General|anesthetics, general|mesh-ancestor
111047725|NCT03539003|Anesthetics|anesthetics|mesh-ancestor
111047726|NCT03539003|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111047727|NCT03539003|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111047728|NCT03539003|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111047729|NCT03539003|Narcotics|narcotics|mesh-ancestor
111047730|NCT03539003|Analgesics|analgesics|mesh-ancestor
111047731|NCT03539003|Sensory System Agents|sensory system agents|mesh-ancestor
111047732|NCT03539003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111047733|NCT02164565|Tranexamic Acid|tranexamic acid|mesh-list
111047734|NCT02164565|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111047735|NCT02164565|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111047736|NCT02164565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111047737|NCT02164565|Hemostatics|hemostatics|mesh-ancestor
111047738|NCT02164565|Coagulants|coagulants|mesh-ancestor
111047739|NCT04265534|Folic Acid|folic acid|mesh-list
111047740|NCT04265534|Vitamin B 12|vitamin b 12|mesh-list
111047741|NCT04265534|Dexamethasone|dexamethasone|mesh-list
111047742|NCT04265534|Carboplatin|carboplatin|mesh-list
111047743|NCT04265534|Pembrolizumab|pembrolizumab|mesh-list
111047744|NCT04265534|Pemetrexed|pemetrexed|mesh-list
111047745|NCT04265534|Vitamins|vitamins|mesh-ancestor
110629087|NCT00251719|Lansoprazole|lansoprazole|mesh-list
111047746|NCT04265534|Micronutrients|micronutrients|mesh-ancestor
111047747|NCT04265534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111047748|NCT04265534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111047749|NCT04265534|Antiemetics|antiemetics|mesh-ancestor
111047750|NCT04265534|Autonomic Agents|autonomic agents|mesh-ancestor
111047751|NCT04265534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111047752|NCT04265534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111047753|NCT04265534|Glucocorticoids|glucocorticoids|mesh-ancestor
111047754|NCT04265534|Hormones|hormones|mesh-ancestor
111047755|NCT04265534|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111047756|NCT04265534|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111047757|NCT04265534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111047758|NCT04265534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111047759|NCT04265534|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111047760|NCT04265534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111047761|NCT04265534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111047762|NCT04265534|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111047763|NCT04265534|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111047764|NCT04265534|Hematinics|hematinics|mesh-ancestor
111047765|NCT04265534|Vitamin B Complex|vitamin b complex|mesh-ancestor
111047766|NCT00750295|Ferric Compounds|ferric compounds|mesh-list
111047767|NCT00750295|Hematinics|hematinics|mesh-ancestor
111047768|NCT02172209|Empagliflozin|empagliflozin|mesh-list
111047769|NCT02172209|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111047770|NCT02172209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111047771|NCT02172209|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111047772|NCT02172209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111047773|NCT02168543|Alendronate|alendronate|mesh-list
111047774|NCT02168543|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111047775|NCT02168543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111047776|NCT01372995|Vitamin D|vitamin d|mesh-list
111047777|NCT01372995|Ergocalciferols|ergocalciferols|mesh-list
111047778|NCT01372995|Cholecalciferol|cholecalciferol|mesh-list
111047779|NCT01372995|Vitamins|vitamins|mesh-list
111047780|NCT01372995|Micronutrients|micronutrients|mesh-ancestor
111047781|NCT01372995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111047782|NCT01372995|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111047783|NCT01372995|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111047784|NCT04239859|Cyclosporine|cyclosporine|mesh-list
111047785|NCT04239859|Methotrexate|methotrexate|mesh-list
111047786|NCT04239859|Acitretin|acitretin|mesh-list
111047787|NCT04239859|Cyclosporins|cyclosporins|mesh-list
111047788|NCT04239859|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111047789|NCT04239859|Abortifacient Agents|abortifacient agents|mesh-ancestor
111047790|NCT04239859|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111047791|NCT04239859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111047792|NCT04239859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111047793|NCT04239859|Antimetabolites|antimetabolites|mesh-ancestor
111047794|NCT04239859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111047795|NCT04239859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111047796|NCT04239859|Dermatologic Agents|dermatologic agents|mesh-ancestor
111047797|NCT04239859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111047798|NCT04239859|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111047799|NCT04239859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111047800|NCT04239859|Immunologic Factors|immunologic factors|mesh-ancestor
111047801|NCT04239859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111047802|NCT04239859|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111047803|NCT04239859|Antifungal Agents|antifungal agents|mesh-ancestor
111047804|NCT04239859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111047805|NCT04239859|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111047806|NCT04239859|Keratolytic Agents|keratolytic agents|mesh-ancestor
111047807|NCT02938923|Testosterone|testosterone|mesh-list
111047808|NCT02938923|Androgens|androgens|mesh-ancestor
111047809|NCT02938923|Hormones|hormones|mesh-ancestor
111047810|NCT02938923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111047811|NCT02938923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111047812|NCT02757521|Nitrous Oxide|nitrous oxide|mesh-list
111047813|NCT02757521|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111047814|NCT02757521|Anesthetics, General|anesthetics, general|mesh-ancestor
111047815|NCT02757521|Anesthetics|anesthetics|mesh-ancestor
110629096|NCT00845754|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111047816|NCT02757521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111047817|NCT02757521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111047818|NCT02757521|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111047819|NCT02757521|Analgesics|analgesics|mesh-ancestor
111047820|NCT02757521|Sensory System Agents|sensory system agents|mesh-ancestor
111047821|NCT02757521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111047822|NCT00744367|Metformin|metformin|mesh-list
111047823|NCT00744367|Pioglitazone|pioglitazone|mesh-list
111047824|NCT00744367|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
111047825|NCT00744367|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111047826|NCT00744367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111047828|NCT00744367|Hormones|hormones|mesh-ancestor
111047829|NCT00744367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111047830|NCT02172287|Tiotropium Bromide|tiotropium bromide|mesh-list
111047831|NCT02172287|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
111047832|NCT02172287|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111047833|NCT02172287|Autonomic Agents|autonomic agents|mesh-ancestor
111047834|NCT02172287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111047835|NCT02172287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111047836|NCT02172287|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111047837|NCT02172287|Respiratory System Agents|respiratory system agents|mesh-ancestor
111047838|NCT02172287|Parasympatholytics|parasympatholytics|mesh-ancestor
111047839|NCT02172287|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111047840|NCT02172287|Cholinergic Agents|cholinergic agents|mesh-ancestor
111047841|NCT02172287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111047842|NCT02172287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111047843|NCT02172287|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111047844|NCT02172287|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111047845|NCT02172287|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111047846|NCT02172287|Adrenergic Agents|adrenergic agents|mesh-ancestor
111047847|NCT02261129|Telmisartan|telmisartan|mesh-list
111047848|NCT02261129|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111047849|NCT02261129|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111047850|NCT02261129|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111047851|NCT02261129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111047852|NCT00694135|Dexamethasone|dexamethasone|mesh-list
111047853|NCT00694135|Dexamethasone acetate|dexamethasone acetate|mesh-list
111047854|NCT00694135|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111047855|NCT00694135|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111047856|NCT00694135|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
111047857|NCT00694135|BB 1101|bb 1101|mesh-list
111047858|NCT00694135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111047859|NCT00694135|Antiemetics|antiemetics|mesh-ancestor
111047860|NCT00694135|Autonomic Agents|autonomic agents|mesh-ancestor
111047861|NCT00694135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111047862|NCT00694135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111047863|NCT00694135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111047864|NCT00694135|Glucocorticoids|glucocorticoids|mesh-ancestor
111047866|NCT00694135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111047867|NCT00694135|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111047868|NCT00694135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111047869|NCT00694135|Protease Inhibitors|protease inhibitors|mesh-ancestor
111047870|NCT00694135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111047871|NCT00694135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111047872|NCT03540095|Bupivacaine|bupivacaine|mesh-list
111047873|NCT03540095|Anesthetics, Local|anesthetics, local|mesh-ancestor
111047874|NCT03540095|Anesthetics|anesthetics|mesh-ancestor
111047875|NCT03540095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111047876|NCT03540095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111047877|NCT03540095|Sensory System Agents|sensory system agents|mesh-ancestor
111047878|NCT03540095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111047879|NCT03071185|Dexmedetomidine|dexmedetomidine|mesh-list
111047880|NCT03071185|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111047881|NCT03071185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111047882|NCT03071185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111047883|NCT03071185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111047884|NCT03071185|Analgesics|analgesics|mesh-ancestor
111047885|NCT03071185|Sensory System Agents|sensory system agents|mesh-ancestor
111047886|NCT03071185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111047887|NCT03071185|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111047888|NCT03071185|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111047889|NCT03071185|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111047890|NCT03071185|Adrenergic Agents|adrenergic agents|mesh-ancestor
111047891|NCT03071185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111047892|NCT03071185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111047893|NCT00741715|Atorvastatin|atorvastatin|mesh-list
111047894|NCT00741715|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111047895|NCT00741715|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111047896|NCT00741715|Antimetabolites|antimetabolites|mesh-ancestor
111047897|NCT00741715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111047898|NCT00741715|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111047899|NCT00741715|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111047900|NCT00741715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111047901|NCT02169167|Octenidine|octenidine|mesh-list
111047902|NCT02169167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111047903|NCT02169167|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111047904|NCT02172443|Tiotropium Bromide|tiotropium bromide|mesh-list
111047905|NCT02172443|Ipratropium|ipratropium|mesh-list
111047906|NCT02172443|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111047907|NCT02172443|Autonomic Agents|autonomic agents|mesh-ancestor
111047908|NCT02172443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111047909|NCT02172443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111047910|NCT02172443|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111047911|NCT02172443|Respiratory System Agents|respiratory system agents|mesh-ancestor
111047912|NCT02172443|Parasympatholytics|parasympatholytics|mesh-ancestor
111047913|NCT02172443|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111047914|NCT02172443|Cholinergic Agents|cholinergic agents|mesh-ancestor
111047915|NCT02172443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111047916|NCT02172443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111047917|NCT00834613|Metformin|metformin|mesh-list
111047918|NCT00834613|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111047919|NCT00834613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111047920|NCT02172521|Bromides|bromides|mesh-list
111047921|NCT02172521|Tiotropium Bromide|tiotropium bromide|mesh-list
111047922|NCT02172521|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111047923|NCT02172521|Autonomic Agents|autonomic agents|mesh-ancestor
111047924|NCT02172521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111047925|NCT02172521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111047926|NCT02172521|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111047927|NCT02172521|Respiratory System Agents|respiratory system agents|mesh-ancestor
111047928|NCT02172521|Parasympatholytics|parasympatholytics|mesh-ancestor
111047929|NCT02172521|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111047930|NCT02172521|Cholinergic Agents|cholinergic agents|mesh-ancestor
111047931|NCT02172521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111047932|NCT02172521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111047933|NCT02172521|Anticonvulsants|anticonvulsants|mesh-ancestor
111047934|NCT00834535|Cefdinir|cefdinir|mesh-list
111047935|NCT00834535|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111047936|NCT00834535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111047937|NCT00691717|Hydrocortisone|hydrocortisone|mesh-list
111047938|NCT00691717|Anecortave|anecortave|mesh-list
111047939|NCT00691717|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110629115|NCT00841386|Vitamins|vitamins|mesh-ancestor
111047940|NCT00691717|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111047941|NCT00691717|Growth Substances|growth substances|mesh-ancestor
111047942|NCT00691717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111047943|NCT00691717|Growth Inhibitors|growth inhibitors|mesh-ancestor
111047944|NCT00691717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111047945|NCT00691717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111047946|NCT00834067|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
111047947|NCT00834067|Moexipril|moexipril|mesh-list
111047948|NCT00834067|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111047949|NCT00834067|Diuretics|diuretics|mesh-ancestor
111047950|NCT00834067|Natriuretic Agents|natriuretic agents|mesh-ancestor
111047951|NCT00834067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111047952|NCT00834067|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
111047953|NCT00834067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111047954|NCT00834067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111047955|NCT00834067|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
111047956|NCT00834067|Protease Inhibitors|protease inhibitors|mesh-ancestor
111047957|NCT00834067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111047958|NCT00682981|Carboplatin|carboplatin|mesh-list
111047959|NCT00682981|Etoposide|etoposide|mesh-list
111047960|NCT00682981|Obatoclax|obatoclax|mesh-list
111047961|NCT00682981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111047962|NCT00682981|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111047963|NCT00682981|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111047964|NCT00682981|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111047965|NCT00682981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111047966|NCT00682981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111047967|NCT00833521|Zolpidem|zolpidem|mesh-list
111047968|NCT00833521|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110827606|NCT03714360|Tranexamic Acid|tranexamic acid|mesh-list
111047969|NCT00833521|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111047970|NCT00833521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111047971|NCT00833521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111047972|NCT00833521|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
111047973|NCT00833521|GABA Agonists|gaba agonists|mesh-ancestor
111047975|NCT00833521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111047976|NCT00833521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111047977|NCT00832507|Cicletanine|cicletanine|mesh-list
111047978|NCT00832507|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111047979|NCT00832507|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111047980|NCT00832507|Diuretics|diuretics|mesh-ancestor
111047981|NCT00832507|Natriuretic Agents|natriuretic agents|mesh-ancestor
111047982|NCT00832507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111047983|NCT04862143|Fulvestrant|fulvestrant|mesh-list
111047984|NCT04862143|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111047985|NCT04862143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111047986|NCT04862143|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
111047987|NCT04862143|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111047988|NCT04862143|Hormone Antagonists|hormone antagonists|mesh-ancestor
111047989|NCT04862143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111047990|NCT04862143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111047991|NCT02802943|Imiquimod|imiquimod|mesh-list
111047992|NCT02802943|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111047993|NCT02802943|Immunologic Factors|immunologic factors|mesh-ancestor
111047994|NCT02802943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111047995|NCT02802943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111047996|NCT02802943|Interferon Inducers|interferon inducers|mesh-ancestor
111047997|NCT02165033|Budesonide|budesonide|mesh-list
111047998|NCT02165033|Procaterol|procaterol|mesh-list
111047999|NCT02165033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111048000|NCT02165033|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111048001|NCT02165033|Autonomic Agents|autonomic agents|mesh-ancestor
111048002|NCT02165033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111048003|NCT02165033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111048004|NCT02165033|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111048005|NCT02165033|Respiratory System Agents|respiratory system agents|mesh-ancestor
111048006|NCT02165033|Glucocorticoids|glucocorticoids|mesh-ancestor
111048007|NCT02165033|Hormones|hormones|mesh-ancestor
111048008|NCT02165033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111048009|NCT02165033|Sympathomimetics|sympathomimetics|mesh-ancestor
111048010|NCT02165033|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111048011|NCT02165033|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111048012|NCT02165033|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110765071|NCT01967238|Vaccines|vaccines|mesh-list
111048013|NCT02165033|Adrenergic Agents|adrenergic agents|mesh-ancestor
111048014|NCT02165033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111048015|NCT02165033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111048016|NCT00734461|Naltrexone|naltrexone|mesh-list
111048017|NCT00734461|Oxycodone|oxycodone|mesh-list
111048018|NCT00734461|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111048019|NCT00734461|Narcotics|narcotics|mesh-ancestor
111048020|NCT00734461|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111048021|NCT00734461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111048022|NCT00734461|Analgesics|analgesics|mesh-ancestor
111048023|NCT00734461|Sensory System Agents|sensory system agents|mesh-ancestor
111048024|NCT00734461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111048025|NCT00734461|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111048026|NCT00734461|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111048027|NCT02169713|Tamsulosin|tamsulosin|mesh-list
111048028|NCT02169713|Solifenacin Succinate|solifenacin succinate|mesh-list
111048029|NCT02169713|Mirabegron|mirabegron|mesh-list
111048030|NCT02169713|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111048031|NCT02169713|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111048032|NCT02169713|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111048033|NCT02169713|Adrenergic Agents|adrenergic agents|mesh-ancestor
111048034|NCT02169713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111048035|NCT02169713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111048036|NCT02169713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111048037|NCT02169713|Urological Agents|urological agents|mesh-ancestor
111048038|NCT02169713|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111048039|NCT02169713|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111048040|NCT02169713|Cholinergic Agents|cholinergic agents|mesh-ancestor
111048041|NCT02169713|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
111048042|NCT02169713|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111048043|NCT02169713|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111048044|NCT03980041|Nivolumab|nivolumab|mesh-list
111048045|NCT03980041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111048046|NCT03980041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111048047|NCT03980041|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111048048|NCT03980041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111048049|NCT02756819|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
111048050|NCT02756819|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111048051|NCT02756819|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111048052|NCT02756819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111048053|NCT00829309|Pravastatin|pravastatin|mesh-list
111048054|NCT00829309|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111048055|NCT00829309|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111048056|NCT00829309|Antimetabolites|antimetabolites|mesh-ancestor
111048057|NCT00829309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111048058|NCT00829309|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111048059|NCT00829309|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111048060|NCT00829309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111048061|NCT02165189|Ribavirin|ribavirin|mesh-list
111048062|NCT02165189|Sofosbuvir|sofosbuvir|mesh-list
111048063|NCT02165189|Simeprevir|simeprevir|mesh-list
111048064|NCT02165189|Antimetabolites|antimetabolites|mesh-ancestor
111048065|NCT02165189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111048066|NCT02165189|Antiviral Agents|antiviral agents|mesh-ancestor
111048067|NCT02165189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111048068|NCT02165189|Protease Inhibitors|protease inhibitors|mesh-ancestor
111048069|NCT02165189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111048070|NCT00725881|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
111048071|NCT00725881|Antioxidants|antioxidants|mesh-ancestor
111048072|NCT00725881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111048073|NCT00725881|Protective Agents|protective agents|mesh-ancestor
111048074|NCT00725881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111048075|NCT00725881|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
111048076|NCT00725881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111048077|NCT02292225|Obinutuzumab|obinutuzumab|mesh-list
111048078|NCT02292225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111048079|NCT02292225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111048080|NCT00677053|1-(1-(3-((6-chloronaphthalen-2-yl)sulfonyl)-2-hydroxypropanoyl)piperidin-4-yl)tetrahydropyrimidin-2(1H)-one|1-(1-(3-((6-chloronaphthalen-2-yl)sulfonyl)-2-hydroxypropanoyl)piperidin-4-yl)tetrahydropyrimidin-2(1h)-one|mesh-list
111048081|NCT00677053|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111048082|NCT00677053|Antithrombins|antithrombins|mesh-ancestor
111048083|NCT00677053|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111048084|NCT00677053|Protease Inhibitors|protease inhibitors|mesh-ancestor
111048085|NCT00677053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111048086|NCT00677053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111048087|NCT00677053|Anticoagulants|anticoagulants|mesh-ancestor
111048088|NCT01950403|Linaclotide|linaclotide|mesh-list
111048089|NCT01950403|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
111048090|NCT01950403|Enzyme Activators|enzyme activators|mesh-ancestor
111048091|NCT01950403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111048092|NCT01950403|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111048094|NCT03607539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111048095|NCT03607539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111048096|NCT03607539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111048097|NCT03607539|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111048098|NCT03607539|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111048099|NCT00629941|Azithromycin|azithromycin|mesh-list
111048100|NCT00629941|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111048101|NCT00629941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111048102|NCT02404779|Cisatracurium|cisatracurium|mesh-list
111048103|NCT02404779|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
111048104|NCT02404779|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111048105|NCT02404779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111048106|NCT02404779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111048107|NCT00629551|Paroxetine|paroxetine|mesh-list
111048108|NCT00629551|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111048109|NCT00629551|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111048110|NCT00629551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111048111|NCT00629551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111048112|NCT00629551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111048114|NCT00629551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111048115|NCT00629551|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111048116|NCT00629551|Antidepressive Agents|antidepressive agents|mesh-ancestor
111048117|NCT00629551|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111048118|NCT00629551|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111048119|NCT00629551|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111048120|NCT00629551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111048121|NCT00625651|Bevacizumab|bevacizumab|mesh-list
111048122|NCT00625651|Conatumumab|conatumumab|mesh-list
111048123|NCT00625651|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111048124|NCT00625651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111048125|NCT00625651|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111048126|NCT00625651|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111048127|NCT00625651|Growth Substances|growth substances|mesh-ancestor
111048128|NCT00625651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111048129|NCT00625651|Growth Inhibitors|growth inhibitors|mesh-ancestor
111048130|NCT00672997|Timolol|timolol|mesh-list
111048131|NCT00672997|Travoprost|travoprost|mesh-list
111048132|NCT00672997|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111048133|NCT00672997|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111048134|NCT00672997|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111048135|NCT00672997|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111048136|NCT00672997|Adrenergic Agents|adrenergic agents|mesh-ancestor
111048137|NCT00672997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111048138|NCT00672997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111048139|NCT00672997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111048140|NCT00672997|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111048141|NCT00672997|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111048142|NCT02669043|Ketamine|ketamine|mesh-list
111048143|NCT02669043|Analgesics|analgesics|mesh-ancestor
111048144|NCT02669043|Sensory System Agents|sensory system agents|mesh-ancestor
111048145|NCT02669043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111048146|NCT02669043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111048147|NCT02669043|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111048148|NCT02669043|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111048149|NCT02669043|Anesthetics, General|anesthetics, general|mesh-ancestor
111048150|NCT02669043|Anesthetics|anesthetics|mesh-ancestor
111048151|NCT02669043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111048152|NCT02669043|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111048153|NCT02669043|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111048154|NCT02669043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111048155|NCT02669043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111048156|NCT02281045|Citric Acid|citric acid|mesh-list
111048157|NCT02281045|Sodium Citrate|sodium citrate|mesh-list
111048158|NCT02281045|Anticoagulants|anticoagulants|mesh-ancestor
111048159|NCT02281045|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
111048160|NCT02281045|Chelating Agents|chelating agents|mesh-ancestor
111048161|NCT02281045|Sequestering Agents|sequestering agents|mesh-ancestor
111048162|NCT02281045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111048164|NCT04472689|Anesthetics, Local|anesthetics, local|mesh-ancestor
111048165|NCT04472689|Anesthetics|anesthetics|mesh-ancestor
111048166|NCT04472689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111048167|NCT04472689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111048168|NCT04472689|Sensory System Agents|sensory system agents|mesh-ancestor
111048169|NCT04472689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111048170|NCT04472689|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111048171|NCT04472689|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111048172|NCT04472689|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111048173|NCT04472689|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111048174|NCT04472689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111048175|NCT02405013|Ribavirin|ribavirin|mesh-list
111048176|NCT02405013|Sofosbuvir|sofosbuvir|mesh-list
111048177|NCT02405013|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
111048178|NCT02405013|Ledipasvir|ledipasvir|mesh-list
111048179|NCT02405013|Antimetabolites|antimetabolites|mesh-ancestor
111048180|NCT02405013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111048181|NCT02405013|Antiviral Agents|antiviral agents|mesh-ancestor
111048182|NCT02405013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111048183|NCT02173145|Azithromycin|azithromycin|mesh-list
111048184|NCT02173145|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111048185|NCT02173145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111048186|NCT00670033|Travoprost|travoprost|mesh-list
111048187|NCT00670033|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111048188|NCT00670033|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111048189|NCT00670033|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111048191|NCT02283775|Pomalidomide|pomalidomide|mesh-list
111048192|NCT02283775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111048193|NCT02283775|Antiemetics|antiemetics|mesh-ancestor
111048194|NCT02283775|Autonomic Agents|autonomic agents|mesh-ancestor
111048195|NCT02283775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111048196|NCT02283775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111048197|NCT02283775|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111048198|NCT02283775|Glucocorticoids|glucocorticoids|mesh-ancestor
111048199|NCT02283775|Hormones|hormones|mesh-ancestor
111048200|NCT02283775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111048201|NCT02283775|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111048202|NCT02283775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111048203|NCT02283775|Immunologic Factors|immunologic factors|mesh-ancestor
111048204|NCT02283775|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111048205|NCT02283775|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111048206|NCT02283775|Growth Substances|growth substances|mesh-ancestor
111048207|NCT02283775|Growth Inhibitors|growth inhibitors|mesh-ancestor
111048208|NCT04479891|Itraconazole|itraconazole|mesh-list
111048209|NCT04479891|Antifungal Agents|antifungal agents|mesh-ancestor
111048210|NCT04479891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111048211|NCT04479891|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111048212|NCT04479891|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111048213|NCT04479891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111048214|NCT04479891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111048215|NCT04479891|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111048216|NCT04479891|Hormone Antagonists|hormone antagonists|mesh-ancestor
111048217|NCT04479891|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111048218|NCT04479891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111048219|NCT04479891|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111048220|NCT02281201|Thrombin|thrombin|mesh-list
111048221|NCT02281201|Hemostatics|hemostatics|mesh-ancestor
111048222|NCT02281201|Coagulants|coagulants|mesh-ancestor
111048223|NCT02281279|Rituximab|rituximab|mesh-list
111048224|NCT02281279|Lenalidomide|lenalidomide|mesh-list
111048225|NCT02281279|Romidepsin|romidepsin|mesh-list
111048226|NCT02281279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111048227|NCT02281279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111048228|NCT02281279|Immunologic Factors|immunologic factors|mesh-ancestor
111048229|NCT02281279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111048230|NCT02281279|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111048231|NCT02281279|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111048232|NCT02281279|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111048233|NCT02281279|Growth Substances|growth substances|mesh-ancestor
111048234|NCT02281279|Growth Inhibitors|growth inhibitors|mesh-ancestor
111048235|NCT02281279|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111048236|NCT02281279|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111048237|NCT02281279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111048238|NCT02281279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111048239|NCT02173457|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111048240|NCT02173457|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111048241|NCT02173457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111048243|NCT02173457|Hormones|hormones|mesh-ancestor
111048244|NCT02173457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111048245|NCT02173457|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111048246|NCT02173457|Protease Inhibitors|protease inhibitors|mesh-ancestor
111048247|NCT02173457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111048248|NCT02173457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111048249|NCT00805129|Everolimus|everolimus|mesh-list
111048250|NCT00805129|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111048251|NCT00805129|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111048252|NCT00805129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111048253|NCT00805129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111048254|NCT00805129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111048255|NCT00805129|Immunologic Factors|immunologic factors|mesh-ancestor
111048256|NCT00805129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111048257|NCT00805129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111048258|NCT02165813|Nitazoxanide|nitazoxanide|mesh-list
111048259|NCT02165813|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111048260|NCT02165813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111048262|NCT00501709|Immunosuppressive Agents|immunosuppressive agents|mesh-list
111048263|NCT00501709|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111048264|NCT00501709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111048265|NCT00501709|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111048266|NCT00501709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111048267|NCT00501709|Immunologic Factors|immunologic factors|mesh-ancestor
111048268|NCT00501709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111048269|NCT00501709|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111048270|NCT02273635|Andrographolide|andrographolide|mesh-list
111048271|NCT02273635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111048272|NCT02273635|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111048273|NCT02273635|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111048274|NCT02273635|Analgesics|analgesics|mesh-ancestor
111048275|NCT02273635|Sensory System Agents|sensory system agents|mesh-ancestor
111048276|NCT02273635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111048277|NCT02273635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111048278|NCT02273635|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111048279|NCT02273635|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111048280|NCT02273635|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111048281|NCT02273635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111048282|NCT02273635|Antiviral Agents|antiviral agents|mesh-ancestor
111048283|NCT02273635|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111048284|NCT02170415|Pregabalin|pregabalin|mesh-list
111048285|NCT02170415|Anesthetics|anesthetics|mesh-list
111048286|NCT02170415|Anesthetics, Local|anesthetics, local|mesh-list
111048287|NCT02170415|Analgesics|analgesics|mesh-ancestor
111048288|NCT02170415|Sensory System Agents|sensory system agents|mesh-ancestor
111048289|NCT02170415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111048290|NCT02170415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111048291|NCT02170415|Anticonvulsants|anticonvulsants|mesh-ancestor
111048292|NCT02170415|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111048293|NCT02170415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111048294|NCT02170415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111048295|NCT02170415|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111048296|NCT02170415|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111048297|NCT02170415|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111048298|NCT02170415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111048299|NCT02170415|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111048300|NCT00622063|Beta-lapachone|beta-lapachone|mesh-list
111048301|NCT00622063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111048302|NCT00622063|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111048303|NCT00622063|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111048304|NCT00622063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111048305|NCT00622063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111048306|NCT00622063|Antiviral Agents|antiviral agents|mesh-ancestor
111048307|NCT02173691|Tiotropium Bromide|tiotropium bromide|mesh-list
111048308|NCT02173691|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
111048309|NCT02173691|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111048310|NCT02173691|Autonomic Agents|autonomic agents|mesh-ancestor
111048311|NCT02173691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111048312|NCT02173691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111048313|NCT02173691|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111048314|NCT02173691|Respiratory System Agents|respiratory system agents|mesh-ancestor
111048315|NCT02173691|Parasympatholytics|parasympatholytics|mesh-ancestor
111048316|NCT02173691|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111048317|NCT02173691|Cholinergic Agents|cholinergic agents|mesh-ancestor
111048318|NCT02173691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111048319|NCT02173691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111048320|NCT02173691|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111048321|NCT02173691|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111048322|NCT02173691|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111048323|NCT02173691|Adrenergic Agents|adrenergic agents|mesh-ancestor
111048324|NCT02274259|Ranibizumab|ranibizumab|mesh-list
111048325|NCT02274259|Aflibercept|aflibercept|mesh-list
111048326|NCT02274259|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111048327|NCT02274259|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111048328|NCT02274259|Growth Substances|growth substances|mesh-ancestor
111048329|NCT02274259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111048330|NCT02274259|Growth Inhibitors|growth inhibitors|mesh-ancestor
111048331|NCT02274259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111048332|NCT05571111|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
111048333|NCT05571111|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111048334|NCT05571111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111048336|NCT02404623|Vitamins|vitamins|mesh-ancestor
111048337|NCT02404623|Micronutrients|micronutrients|mesh-ancestor
111048338|NCT02404623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111048339|NCT02404623|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111048340|NCT02170571|Dabigatran|dabigatran|mesh-list
111048341|NCT02170571|Antithrombins|antithrombins|mesh-ancestor
111048342|NCT02170571|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111048343|NCT02170571|Protease Inhibitors|protease inhibitors|mesh-ancestor
111048344|NCT02170571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111048345|NCT02170571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111048346|NCT02170571|Anticoagulants|anticoagulants|mesh-ancestor
111048347|NCT04481841|Vitamins|vitamins|mesh-list
111048348|NCT04481841|Vitamin E|vitamin e|mesh-list
111048349|NCT04481841|Riboflavin|riboflavin|mesh-list
111048350|NCT04481841|Micronutrients|micronutrients|mesh-ancestor
111048351|NCT04481841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111048352|NCT04481841|Vitamin B Complex|vitamin b complex|mesh-ancestor
111048353|NCT04481841|Antioxidants|antioxidants|mesh-ancestor
111048354|NCT04481841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111048355|NCT04481841|Protective Agents|protective agents|mesh-ancestor
111048356|NCT04481841|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111048357|NCT04481841|Dermatologic Agents|dermatologic agents|mesh-ancestor
111048358|NCT02388477|Doxycycline|doxycycline|mesh-list
111048359|NCT02388477|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111048360|NCT02388477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111048361|NCT02388477|Antimalarials|antimalarials|mesh-ancestor
111048362|NCT02388477|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111048363|NCT02388477|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111048364|NCT02166359|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111048365|NCT02166359|Icodextrin|icodextrin|mesh-list
111048366|NCT02166359|Dialysis Solutions|dialysis solutions|mesh-ancestor
111048367|NCT00488839|Baclofen|baclofen|mesh-list
111048368|NCT00488839|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
111048369|NCT00488839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111048370|NCT00488839|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111048371|NCT00488839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111048372|NCT00488839|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
111048373|NCT00488839|GABA Agonists|gaba agonists|mesh-ancestor
111048374|NCT00488839|GABA Agents|gaba agents|mesh-ancestor
111048375|NCT00488839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111048376|NCT00488839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111048377|NCT02255747|Lactulose|lactulose|mesh-list
111048378|NCT02255747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111048379|NCT01654731|Bezafibrate|bezafibrate|mesh-list
111048380|NCT01654731|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111048381|NCT01654731|Antimetabolites|antimetabolites|mesh-ancestor
111048382|NCT01654731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111048383|NCT01654731|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111048384|NCT00485563|Folic Acid|folic acid|mesh-list
111048385|NCT00485563|Vitamin B Complex|vitamin b complex|mesh-list
111048387|NCT00485563|Interferon-alpha|interferon-alpha|mesh-list
111048388|NCT00485563|Interleukin-2|interleukin-2|mesh-list
111048389|NCT00485563|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
111048390|NCT00485563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111048391|NCT00485563|Antiviral Agents|antiviral agents|mesh-ancestor
111048392|NCT00485563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111048393|NCT00485563|Immunologic Factors|immunologic factors|mesh-ancestor
111048394|NCT00485563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111048395|NCT00485563|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111048396|NCT00485563|Analgesics|analgesics|mesh-ancestor
111048397|NCT00485563|Sensory System Agents|sensory system agents|mesh-ancestor
111048398|NCT00485563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111048399|NCT00485563|Hematinics|hematinics|mesh-ancestor
111048400|NCT00485563|Vitamins|vitamins|mesh-ancestor
111048401|NCT00485563|Micronutrients|micronutrients|mesh-ancestor
111048402|NCT00485563|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111048403|NCT02170805|Pantoprazole|pantoprazole|mesh-list
111048404|NCT02170805|Dabigatran|dabigatran|mesh-list
111048405|NCT02170805|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111048406|NCT02170805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111048407|NCT02170805|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111048408|NCT02170805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111048409|NCT02170805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111048410|NCT02170805|Antithrombins|antithrombins|mesh-ancestor
111048411|NCT02170805|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111048412|NCT02170805|Protease Inhibitors|protease inhibitors|mesh-ancestor
111048413|NCT02170805|Anticoagulants|anticoagulants|mesh-ancestor
111048414|NCT00606697|Vofopitant|vofopitant|mesh-list
111048415|NCT00606697|Vestipitant|vestipitant|mesh-list
111048416|NCT00606697|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
111048417|NCT00606697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111048418|NCT00606697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111048419|NCT00606697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111048420|NCT00606697|Antiemetics|antiemetics|mesh-ancestor
111048421|NCT00606697|Autonomic Agents|autonomic agents|mesh-ancestor
111048422|NCT00606697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111048423|NCT00606697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111048424|NCT02404077|Clonidine|clonidine|mesh-list
111048425|NCT02404077|Analgesics|analgesics|mesh-ancestor
111048426|NCT02404077|Sensory System Agents|sensory system agents|mesh-ancestor
111048427|NCT02404077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111048428|NCT02404077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111048429|NCT02404077|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111048430|NCT02404077|Sympatholytics|sympatholytics|mesh-ancestor
111048431|NCT02404077|Autonomic Agents|autonomic agents|mesh-ancestor
111048432|NCT02404077|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111048433|NCT02404077|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111048434|NCT02404077|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111048435|NCT02404077|Adrenergic Agents|adrenergic agents|mesh-ancestor
111048436|NCT02404077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111048437|NCT02404077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111048438|NCT02174939|Cilostazol|cilostazol|mesh-list
111048439|NCT02174939|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111048440|NCT02174939|Autonomic Agents|autonomic agents|mesh-ancestor
111048441|NCT02174939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111048442|NCT02174939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111048443|NCT02174939|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111048444|NCT02174939|Respiratory System Agents|respiratory system agents|mesh-ancestor
111048445|NCT02174939|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111048446|NCT02174939|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111048447|NCT02174939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111048448|NCT02174939|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111048449|NCT02174939|Vasodilator Agents|vasodilator agents|mesh-ancestor
111048450|NCT02174939|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111048451|NCT02174939|Protective Agents|protective agents|mesh-ancestor
111048452|NCT02174939|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
111048453|NCT02174939|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111048454|NCT02174939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111048455|NCT02404233|Darunavir|darunavir|mesh-list
111048456|NCT02404233|Cobicistat|cobicistat|mesh-list
111048457|NCT02404233|Rilpivirine|rilpivirine|mesh-list
111048458|NCT02404233|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
111048459|NCT02404233|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111048460|NCT02404233|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111048461|NCT02404233|Protease Inhibitors|protease inhibitors|mesh-ancestor
111048462|NCT02404233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111048463|NCT02404233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111048464|NCT02404233|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111048465|NCT02404233|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111048466|NCT02404233|Antiviral Agents|antiviral agents|mesh-ancestor
111048467|NCT02404233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111048468|NCT02404233|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111048469|NCT02404233|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111048470|NCT02404233|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111048471|NCT02404233|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111048472|NCT00603577|Xaliproden|xaliproden|mesh-list
111048473|NCT00603577|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111048474|NCT00603577|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111048475|NCT00603577|Serotonin Agents|serotonin agents|mesh-ancestor
111048476|NCT00603577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111048477|NCT00603577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111048478|NCT00603577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111048479|NCT02178293|Ketoprofen|ketoprofen|mesh-list
111048480|NCT02178293|Ketoprofen lysine|ketoprofen lysine|mesh-list
111048481|NCT02178293|Benzydamine|benzydamine|mesh-list
111048482|NCT02178293|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111048483|NCT02178293|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111048484|NCT02178293|Analgesics|analgesics|mesh-ancestor
111048485|NCT02178293|Sensory System Agents|sensory system agents|mesh-ancestor
111048486|NCT02178293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111048487|NCT02178293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111048488|NCT02178293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111048489|NCT02178293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111048490|NCT02178293|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111048491|NCT02178293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111048492|NCT02178293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111048493|NCT03170895|Sorafenib|sorafenib|mesh-list
111048494|NCT03170895|Homoharringtonine|homoharringtonine|mesh-list
111048495|NCT03170895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111048496|NCT03170895|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111048497|NCT03170895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111048498|NCT03170895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111048499|NCT03170895|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111048500|NCT03170895|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111048501|NCT02277847|Cytarabine|cytarabine|mesh-list
111048502|NCT02277847|Idarubicin|idarubicin|mesh-list
111048503|NCT02277847|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111048504|NCT02277847|Antimetabolites|antimetabolites|mesh-ancestor
111048505|NCT02277847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111048506|NCT02277847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111048507|NCT02277847|Antiviral Agents|antiviral agents|mesh-ancestor
111048508|NCT02277847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111048509|NCT02277847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111048510|NCT02277847|Immunologic Factors|immunologic factors|mesh-ancestor
111048511|NCT02277847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111048512|NCT02277847|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111048513|NCT02277847|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111048514|NCT02277847|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111048515|NCT02277847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111048516|NCT01457781|Nitric Oxide|nitric oxide|mesh-list
111048517|NCT01457781|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111048518|NCT01457781|Autonomic Agents|autonomic agents|mesh-ancestor
111048519|NCT01457781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111048520|NCT01457781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111048521|NCT01457781|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110629282|NCT00842400|Uricosuric Agents|uricosuric agents|mesh-ancestor
111048522|NCT01457781|Respiratory System Agents|respiratory system agents|mesh-ancestor
111048523|NCT01457781|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111048524|NCT01457781|Antioxidants|antioxidants|mesh-ancestor
111048525|NCT01457781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111048526|NCT01457781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111048527|NCT01457781|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
111048528|NCT01457781|Vasodilator Agents|vasodilator agents|mesh-ancestor
111048529|NCT01457781|Gasotransmitters|gasotransmitters|mesh-ancestor
111048530|NCT01457781|Protective Agents|protective agents|mesh-ancestor
111048531|NCT00468403|Mycophenolic Acid|mycophenolic acid|mesh-list
111048532|NCT00468403|Abatacept|abatacept|mesh-list
111048533|NCT00468403|Tacrolimus|tacrolimus|mesh-list
110765592|NCT03897660|Vitamins|vitamins|mesh-list
111048534|NCT00468403|Basiliximab|basiliximab|mesh-list
111048535|NCT00468403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111048536|NCT00468403|Immunologic Factors|immunologic factors|mesh-ancestor
111048537|NCT00468403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111048538|NCT00468403|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111048539|NCT00468403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111048540|NCT00468403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111048541|NCT00468403|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111048542|NCT00468403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111048543|NCT00468403|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111048544|NCT00468403|Antitubercular Agents|antitubercular agents|mesh-ancestor
111048545|NCT00468403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111048546|NCT00468403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111048547|NCT00468403|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111048548|NCT00468403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111048549|NCT00468403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111048551|NCT02175017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111048552|NCT02175017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111048553|NCT02175017|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111048554|NCT02175017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111048555|NCT02178449|Dexamethasone|dexamethasone|mesh-list
111048556|NCT02178449|Dexamethasone acetate|dexamethasone acetate|mesh-list
111048557|NCT02178449|Ropivacaine|ropivacaine|mesh-list
111048558|NCT02178449|BB 1101|bb 1101|mesh-list
111048559|NCT02178449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111048560|NCT02178449|Antiemetics|antiemetics|mesh-ancestor
111048561|NCT02178449|Autonomic Agents|autonomic agents|mesh-ancestor
111048562|NCT02178449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111048563|NCT02178449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111048564|NCT02178449|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111048565|NCT02178449|Glucocorticoids|glucocorticoids|mesh-ancestor
111048566|NCT02178449|Hormones|hormones|mesh-ancestor
111048567|NCT02178449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111048568|NCT02178449|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111048569|NCT02178449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111048570|NCT02178449|Anesthetics, Local|anesthetics, local|mesh-ancestor
111048571|NCT02178449|Anesthetics|anesthetics|mesh-ancestor
111048572|NCT02178449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111048573|NCT02178449|Sensory System Agents|sensory system agents|mesh-ancestor
111048574|NCT02178449|Protease Inhibitors|protease inhibitors|mesh-ancestor
111048575|NCT02178449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111048576|NCT02178449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111048577|NCT02387931|Vitamin D|vitamin d|mesh-list
111048578|NCT02387931|Ergocalciferols|ergocalciferols|mesh-list
111048579|NCT02387931|Cholecalciferol|cholecalciferol|mesh-list
111048580|NCT02387931|Vitamins|vitamins|mesh-list
111048581|NCT02387931|Micronutrients|micronutrients|mesh-ancestor
111048582|NCT02387931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111048583|NCT02387931|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111048584|NCT02387931|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111048585|NCT02281669|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
111048586|NCT02281669|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111048587|NCT02281669|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111048588|NCT02281669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111048589|NCT02281669|Schistosomicides|schistosomicides|mesh-ancestor
111048590|NCT02281669|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
111048591|NCT02281669|Anthelmintics|anthelmintics|mesh-ancestor
111048592|NCT02178683|Mycophenolic Acid|mycophenolic acid|mesh-list
111048593|NCT02178683|Tacrolimus|tacrolimus|mesh-list
111048594|NCT02178683|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111048595|NCT02178683|Immunologic Factors|immunologic factors|mesh-ancestor
111048596|NCT02178683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111048597|NCT02178683|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111048598|NCT02178683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111048599|NCT02178683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111048600|NCT02178683|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111048601|NCT02178683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111048602|NCT02178683|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111048603|NCT02178683|Antitubercular Agents|antitubercular agents|mesh-ancestor
111048604|NCT02178683|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111048605|NCT02178683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111048606|NCT03170739|Dopamine|dopamine|mesh-list
111048607|NCT03170739|Dexmedetomidine|dexmedetomidine|mesh-list
111048608|NCT03170739|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111048609|NCT03170739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110765667|NCT01586286|Tocolytic Agents|tocolytic agents|mesh-ancestor
111048610|NCT03170739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111048611|NCT03170739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111048612|NCT03170739|Analgesics|analgesics|mesh-ancestor
111048613|NCT03170739|Sensory System Agents|sensory system agents|mesh-ancestor
111048614|NCT03170739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111048615|NCT03170739|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111048616|NCT03170739|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111048617|NCT03170739|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111048618|NCT03170739|Adrenergic Agents|adrenergic agents|mesh-ancestor
111048619|NCT03170739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111048620|NCT03170739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111048621|NCT03170739|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111048622|NCT03170739|Sympathomimetics|sympathomimetics|mesh-ancestor
111048623|NCT03170739|Autonomic Agents|autonomic agents|mesh-ancestor
111048624|NCT03170739|Dopamine Agents|dopamine agents|mesh-ancestor
111048625|NCT03170739|Protective Agents|protective agents|mesh-ancestor
111048626|NCT00459745|Fenofibrate|fenofibrate|mesh-list
111048627|NCT00459745|Pravastatin|pravastatin|mesh-list
111048628|NCT00459745|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111048629|NCT00459745|Antimetabolites|antimetabolites|mesh-ancestor
111048630|NCT00459745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111048631|NCT00459745|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111048632|NCT00459745|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111048633|NCT00459745|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111048634|NCT00459745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111048635|NCT02178761|Chromium|chromium|mesh-list
111048636|NCT02178761|Everolimus|everolimus|mesh-list
111048637|NCT02178761|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111048638|NCT02178761|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111048639|NCT02178761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111048640|NCT02178761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111048641|NCT02178761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111048642|NCT02178761|Immunologic Factors|immunologic factors|mesh-ancestor
111048643|NCT02178761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111048644|NCT02178761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111048645|NCT02178761|Trace Elements|trace elements|mesh-ancestor
111048646|NCT02178761|Micronutrients|micronutrients|mesh-ancestor
111048647|NCT02742181|Alvimopan|alvimopan|mesh-list
111048648|NCT02742181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111048649|NCT02175407|Itraconazole|itraconazole|mesh-list
111048650|NCT02175407|Antifungal Agents|antifungal agents|mesh-ancestor
111048651|NCT02175407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111048652|NCT02175407|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111048653|NCT02175407|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111048654|NCT02175407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111048655|NCT02175407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111048656|NCT02175407|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111048657|NCT02175407|Hormone Antagonists|hormone antagonists|mesh-ancestor
111048658|NCT02175407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111048659|NCT02175407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111048660|NCT02175407|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111048661|NCT02182193|Nintedanib|nintedanib|mesh-list
111048662|NCT02182193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111048663|NCT02182193|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111048664|NCT02182193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111048665|NCT02182193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111048666|NCT02175485|Fexofenadine|fexofenadine|mesh-list
111048667|NCT02175485|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111048668|NCT02175485|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
111048669|NCT02175485|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111048670|NCT02175485|Histamine Antagonists|histamine antagonists|mesh-ancestor
111048671|NCT02175485|Histamine Agents|histamine agents|mesh-ancestor
111048672|NCT02175485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111048673|NCT02175485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111048674|NCT02175485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111048675|NCT04575779|Cyclosporine|cyclosporine|mesh-list
111048676|NCT04575779|Cyclosporins|cyclosporins|mesh-list
111048677|NCT04575779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111048678|NCT04575779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111048679|NCT04575779|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111048680|NCT04575779|Immunologic Factors|immunologic factors|mesh-ancestor
111048681|NCT04575779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111048682|NCT04575779|Antifungal Agents|antifungal agents|mesh-ancestor
111048683|NCT04575779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111048685|NCT04575779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111048686|NCT04575779|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111048687|NCT02741713|Lidocaine|lidocaine|mesh-list
111048688|NCT02741713|Clonidine|clonidine|mesh-list
111048689|NCT02741713|Epinephrine|epinephrine|mesh-list
111048690|NCT02741713|Racepinephrine|racepinephrine|mesh-list
111048691|NCT02741713|Bupivacaine|bupivacaine|mesh-list
111048692|NCT02741713|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111048693|NCT02741713|Epinephryl borate|epinephryl borate|mesh-list
111048694|NCT02741713|Anesthetics, Local|anesthetics, local|mesh-ancestor
111048695|NCT02741713|Anesthetics|anesthetics|mesh-ancestor
110629333|NCT00853008|Cytarabine|cytarabine|mesh-list
111048696|NCT02741713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111048697|NCT02741713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111048698|NCT02741713|Sensory System Agents|sensory system agents|mesh-ancestor
111048699|NCT02741713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111048700|NCT02741713|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111048701|NCT02741713|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111048702|NCT02741713|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111048703|NCT02741713|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111048704|NCT02741713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111048705|NCT02741713|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111048706|NCT02741713|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111048707|NCT02741713|Adrenergic Agents|adrenergic agents|mesh-ancestor
111048708|NCT02741713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111048709|NCT02741713|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111048710|NCT02741713|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111048711|NCT02741713|Autonomic Agents|autonomic agents|mesh-ancestor
111048712|NCT02741713|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111048713|NCT02741713|Respiratory System Agents|respiratory system agents|mesh-ancestor
111048714|NCT02741713|Mydriatics|mydriatics|mesh-ancestor
111048715|NCT02741713|Sympathomimetics|sympathomimetics|mesh-ancestor
111048716|NCT02741713|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111048717|NCT02741713|Analgesics|analgesics|mesh-ancestor
111048718|NCT02741713|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111048719|NCT02741713|Sympatholytics|sympatholytics|mesh-ancestor
111048720|NCT02741713|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111048721|NCT00459277|Fentanyl|fentanyl|mesh-list
111048722|NCT00459277|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111048723|NCT00459277|Narcotics|narcotics|mesh-ancestor
111048724|NCT00459277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111048725|NCT00459277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111048726|NCT00459277|Analgesics|analgesics|mesh-ancestor
111048727|NCT00459277|Sensory System Agents|sensory system agents|mesh-ancestor
111048728|NCT00459277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111048729|NCT00459277|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111048730|NCT00459277|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111048731|NCT00459277|Anesthetics, General|anesthetics, general|mesh-ancestor
111048732|NCT00459277|Anesthetics|anesthetics|mesh-ancestor
111048733|NCT00602329|Leucovorin|leucovorin|mesh-list
111048734|NCT00602329|Bevacizumab|bevacizumab|mesh-list
111048735|NCT00602329|Fluorouracil|fluorouracil|mesh-list
111048736|NCT00602329|Oxaliplatin|oxaliplatin|mesh-list
111048737|NCT00602329|Calcium|calcium|mesh-list
111048738|NCT00602329|Levoleucovorin|levoleucovorin|mesh-list
111048739|NCT00602329|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111048740|NCT00602329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111048741|NCT00602329|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111048742|NCT00602329|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111048743|NCT00602329|Growth Substances|growth substances|mesh-ancestor
111048744|NCT00602329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111048745|NCT00602329|Growth Inhibitors|growth inhibitors|mesh-ancestor
111048746|NCT00602329|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111048747|NCT00602329|Antimetabolites|antimetabolites|mesh-ancestor
111048748|NCT00602329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111048749|NCT00602329|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111048750|NCT00602329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111048751|NCT00602329|Immunologic Factors|immunologic factors|mesh-ancestor
111048752|NCT00602329|Antidotes|antidotes|mesh-ancestor
110104029|NCT01775891|Anesthetics|anesthetics|mesh-ancestor
111048753|NCT00602329|Protective Agents|protective agents|mesh-ancestor
111048754|NCT00602329|Vitamin B Complex|vitamin b complex|mesh-ancestor
111048755|NCT00602329|Vitamins|vitamins|mesh-ancestor
111048756|NCT00602329|Micronutrients|micronutrients|mesh-ancestor
111048757|NCT02182505|Fenoterol|fenoterol|mesh-list
111048758|NCT02182505|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
111048759|NCT02182505|Ipratropium|ipratropium|mesh-list
111048760|NCT02182505|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111048761|NCT02182505|Autonomic Agents|autonomic agents|mesh-ancestor
111048762|NCT02182505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111048763|NCT02182505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111048764|NCT02182505|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111048765|NCT02182505|Respiratory System Agents|respiratory system agents|mesh-ancestor
111048766|NCT02182505|Sympathomimetics|sympathomimetics|mesh-ancestor
111048767|NCT02182505|Tocolytic Agents|tocolytic agents|mesh-ancestor
111048768|NCT02182505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111048769|NCT02182505|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111048770|NCT02182505|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111048771|NCT02182505|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111048772|NCT02182505|Adrenergic Agents|adrenergic agents|mesh-ancestor
111048773|NCT02182505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111048774|NCT02182505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111048775|NCT02182505|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111048776|NCT02182505|Cholinergic Agents|cholinergic agents|mesh-ancestor
111048777|NCT02387619|Amlodipine|amlodipine|mesh-list
111048778|NCT02387619|Telmisartan|telmisartan|mesh-list
111048779|NCT02387619|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
111048780|NCT02387619|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111048781|NCT02387619|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111048782|NCT02387619|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111048783|NCT02387619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111048784|NCT02387619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111048785|NCT02387619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111048786|NCT02387619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111048787|NCT02387619|Vasodilator Agents|vasodilator agents|mesh-ancestor
111048788|NCT02387619|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111048789|NCT02387619|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111048790|NCT02387619|Antimetabolites|antimetabolites|mesh-ancestor
111048791|NCT02387619|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111048792|NCT02387619|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111048793|NCT02387619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111048794|NCT02387619|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111048795|NCT02387619|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111048796|NCT03537443|Vitamin D|vitamin d|mesh-list
111048797|NCT03537443|Cholecalciferol|cholecalciferol|mesh-list
111048798|NCT03537443|Vitamins|vitamins|mesh-ancestor
111048799|NCT03537443|Micronutrients|micronutrients|mesh-ancestor
111048800|NCT03537443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111048801|NCT03537443|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111048802|NCT03537443|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111048803|NCT00595699|Escitalopram|escitalopram|mesh-list
111048804|NCT00595699|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111048805|NCT00595699|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111048806|NCT00595699|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111048807|NCT00595699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111048808|NCT00595699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111048809|NCT00595699|Serotonin Agents|serotonin agents|mesh-ancestor
111048810|NCT00595699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111048811|NCT02256215|Vitamin D|vitamin d|mesh-list
111048812|NCT02256215|Vitamins|vitamins|mesh-ancestor
111048813|NCT02256215|Micronutrients|micronutrients|mesh-ancestor
111048814|NCT02256215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111048815|NCT02256215|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111048816|NCT02182583|Oxitropium|oxitropium|mesh-list
111048817|NCT02182583|Parasympatholytics|parasympatholytics|mesh-ancestor
111048818|NCT02182583|Autonomic Agents|autonomic agents|mesh-ancestor
111048819|NCT02182583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111048820|NCT02182583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111048821|NCT03133975|Vitamin D|vitamin d|mesh-list
111048822|NCT03133975|Cholecalciferol|cholecalciferol|mesh-list
111048823|NCT03133975|Vitamins|vitamins|mesh-ancestor
111048824|NCT03133975|Micronutrients|micronutrients|mesh-ancestor
111048825|NCT03133975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111048826|NCT03133975|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111048827|NCT03133975|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111048828|NCT02282137|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
111048829|NCT02282137|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111048830|NCT02282137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111048831|NCT02182661|Oxitropium|oxitropium|mesh-list
111048832|NCT02182661|Parasympatholytics|parasympatholytics|mesh-ancestor
111048833|NCT02182661|Autonomic Agents|autonomic agents|mesh-ancestor
111048834|NCT02182661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110765890|NCT05941494|Phenylephrine|phenylephrine|mesh-list
111048835|NCT02182661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111048836|NCT02663271|Bevacizumab|bevacizumab|mesh-list
111048837|NCT02663271|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111048838|NCT02663271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111048839|NCT02663271|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111048840|NCT02663271|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111048841|NCT02663271|Growth Substances|growth substances|mesh-ancestor
111048842|NCT02663271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111048843|NCT02663271|Growth Inhibitors|growth inhibitors|mesh-ancestor
111048844|NCT00659191|Cabotegravir|cabotegravir|mesh-list
111048845|NCT00659191|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111048846|NCT00659191|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111048847|NCT00659191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111048848|NCT00659191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111048849|NCT00659191|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111048850|NCT00659191|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111048851|NCT00659191|Antiviral Agents|antiviral agents|mesh-ancestor
111048852|NCT00659191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111048853|NCT02182739|Meloxicam|meloxicam|mesh-list
111048854|NCT02182739|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111048855|NCT02182739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111048856|NCT02182739|Analgesics|analgesics|mesh-ancestor
111048857|NCT02182739|Sensory System Agents|sensory system agents|mesh-ancestor
111048858|NCT02182739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111048859|NCT02182739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111048860|NCT02182739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111048861|NCT02182739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111048862|NCT02182739|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111048863|NCT02182739|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111048864|NCT02182739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111048865|NCT02182739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111048866|NCT00583609|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
111048868|NCT00583609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111048869|NCT03170115|Aspirin|aspirin|mesh-list
111048870|NCT03170115|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111048871|NCT03170115|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111048872|NCT03170115|Analgesics|analgesics|mesh-ancestor
111048873|NCT03170115|Sensory System Agents|sensory system agents|mesh-ancestor
111048874|NCT03170115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111048875|NCT03170115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111048876|NCT03170115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111048877|NCT03170115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111048878|NCT03170115|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111048879|NCT03170115|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111048880|NCT03170115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111048881|NCT03170115|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111048882|NCT03170115|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111048883|NCT03170115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111048884|NCT03170115|Antipyretics|antipyretics|mesh-ancestor
111048885|NCT03169959|Metformin|metformin|mesh-list
111048886|NCT03169959|Dapagliflozin|dapagliflozin|mesh-list
111048887|NCT03169959|Saxagliptin|saxagliptin|mesh-list
111048888|NCT03169959|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111048889|NCT03169959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111048890|NCT03169959|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111048891|NCT03169959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111048892|NCT03169959|Incretins|incretins|mesh-ancestor
111048893|NCT03169959|Hormones|hormones|mesh-ancestor
111048894|NCT03169959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111048895|NCT03169959|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111048896|NCT03169959|Protease Inhibitors|protease inhibitors|mesh-ancestor
111048897|NCT03169959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111048898|NCT02176187|Fenoterol|fenoterol|mesh-list
111048899|NCT02176187|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
111048900|NCT02176187|Ipratropium|ipratropium|mesh-list
111048901|NCT02176187|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111048902|NCT02176187|Autonomic Agents|autonomic agents|mesh-ancestor
111048903|NCT02176187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111048904|NCT02176187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111048905|NCT02176187|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111048906|NCT02176187|Respiratory System Agents|respiratory system agents|mesh-ancestor
111048907|NCT02176187|Sympathomimetics|sympathomimetics|mesh-ancestor
110765967|NCT05939219|Immunologic Factors|immunologic factors|mesh-ancestor
111048908|NCT02176187|Tocolytic Agents|tocolytic agents|mesh-ancestor
111048909|NCT02176187|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111048910|NCT02176187|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111048911|NCT02176187|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111048912|NCT02176187|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111048913|NCT02176187|Adrenergic Agents|adrenergic agents|mesh-ancestor
111048914|NCT02176187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111048915|NCT02176187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111048916|NCT02176187|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111048917|NCT02176187|Cholinergic Agents|cholinergic agents|mesh-ancestor
111048918|NCT02176499|Telmisartan|telmisartan|mesh-list
111048919|NCT02176499|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111048920|NCT02176499|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111048921|NCT02176499|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111048922|NCT02176499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111048923|NCT02176733|Cyclosporine|cyclosporine|mesh-list
111048924|NCT02176733|Cyclosporins|cyclosporins|mesh-list
111048925|NCT02176733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111048926|NCT02176733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111048927|NCT02176733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111048928|NCT02176733|Immunologic Factors|immunologic factors|mesh-ancestor
111048929|NCT02176733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111048930|NCT02176733|Antifungal Agents|antifungal agents|mesh-ancestor
111048931|NCT02176733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111048932|NCT02176733|Dermatologic Agents|dermatologic agents|mesh-ancestor
111048933|NCT02176733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111048934|NCT02176733|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111048935|NCT03536741|Anesthetics|anesthetics|mesh-list
111048936|NCT03536741|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
111048937|NCT03536741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111048938|NCT03536741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111048939|NCT03536741|Anesthetics, General|anesthetics, general|mesh-ancestor
111048941|NCT02403687|Diclofenac|diclofenac|mesh-list
111048942|NCT02403687|Meloxicam|meloxicam|mesh-list
111048943|NCT02403687|Flurbiprofen|flurbiprofen|mesh-list
111048944|NCT02403687|Lidocaine|lidocaine|mesh-list
111048945|NCT02403687|Clonidine|clonidine|mesh-list
111048946|NCT02403687|Sumatriptan|sumatriptan|mesh-list
111048947|NCT02403687|Ketamine|ketamine|mesh-list
111048948|NCT02403687|Gabapentin|gabapentin|mesh-list
111048949|NCT02403687|Amitriptyline|amitriptyline|mesh-list
111048950|NCT02403687|Tizanidine|tizanidine|mesh-list
111048951|NCT02403687|Bupivacaine|bupivacaine|mesh-list
111048952|NCT02403687|Prilocaine|prilocaine|mesh-list
111048953|NCT02403687|Cyclobenzaprine|cyclobenzaprine|mesh-list
111048954|NCT02403687|Baclofen|baclofen|mesh-list
111048955|NCT02403687|Capsaicin|capsaicin|mesh-list
111048956|NCT02403687|Menthol|menthol|mesh-list
111048957|NCT02403687|Anesthetics, Local|anesthetics, local|mesh-ancestor
111048958|NCT02403687|Anesthetics|anesthetics|mesh-ancestor
111048959|NCT02403687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111048960|NCT02403687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111048961|NCT02403687|Sensory System Agents|sensory system agents|mesh-ancestor
111048962|NCT02403687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111048963|NCT02403687|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111048964|NCT02403687|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111048965|NCT02403687|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111048966|NCT02403687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111048967|NCT02403687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111048968|NCT02403687|Analgesics|analgesics|mesh-ancestor
111048969|NCT02403687|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111048970|NCT02403687|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111048971|NCT02403687|Anesthetics, General|anesthetics, general|mesh-ancestor
111048972|NCT02403687|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111048973|NCT02403687|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111048974|NCT02403687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111048975|NCT02403687|Anticonvulsants|anticonvulsants|mesh-ancestor
111048976|NCT02403687|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111048977|NCT02403687|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111048978|NCT02403687|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111048979|NCT02403687|Antimanic Agents|antimanic agents|mesh-ancestor
111048980|NCT02403687|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111048981|NCT02403687|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111048982|NCT02403687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111048983|NCT02403687|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111048984|NCT02403687|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111048985|NCT02403687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110766040|NCT05889793|Emetine|emetine|mesh-list
111048986|NCT02403687|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111048987|NCT02403687|Antipruritics|antipruritics|mesh-ancestor
111048988|NCT02403687|Dermatologic Agents|dermatologic agents|mesh-ancestor
111048989|NCT02403687|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
111048990|NCT02403687|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111048991|NCT02403687|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
111048992|NCT02403687|GABA Agonists|gaba agonists|mesh-ancestor
111048993|NCT02403687|GABA Agents|gaba agents|mesh-ancestor
111048994|NCT02403687|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111048995|NCT02403687|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111048996|NCT02403687|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111048997|NCT02403687|Serotonin Agents|serotonin agents|mesh-ancestor
111048998|NCT02403687|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111048999|NCT02403687|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
111049000|NCT02403687|Antidepressive Agents|antidepressive agents|mesh-ancestor
111049001|NCT02403687|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111049002|NCT02403687|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111049003|NCT02403687|Adrenergic Agents|adrenergic agents|mesh-ancestor
111049004|NCT02403687|Parasympatholytics|parasympatholytics|mesh-ancestor
111049005|NCT02403687|Autonomic Agents|autonomic agents|mesh-ancestor
111049006|NCT02403687|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111049008|NCT02403687|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110629449|NCT04233216|Islatravir|islatravir|mesh-list
111049009|NCT02403687|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111049010|NCT02403687|Sympatholytics|sympatholytics|mesh-ancestor
111049011|NCT02742649|Timolol|timolol|mesh-list
111049012|NCT02742649|Bimatoprost|bimatoprost|mesh-list
111049013|NCT02742649|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111049014|NCT02742649|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111049015|NCT02742649|Adrenergic Agents|adrenergic agents|mesh-ancestor
111049016|NCT02742649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111049017|NCT02742649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111049018|NCT02742649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111049019|NCT02742649|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111049020|NCT02742649|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111049021|NCT02183051|Ibuprofen|ibuprofen|mesh-list
111049022|NCT02183051|Meloxicam|meloxicam|mesh-list
111049023|NCT02183051|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111049024|NCT02183051|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111049025|NCT02183051|Analgesics|analgesics|mesh-ancestor
111049026|NCT02183051|Sensory System Agents|sensory system agents|mesh-ancestor
111049027|NCT02183051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111049028|NCT02183051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111049029|NCT02183051|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111049030|NCT02183051|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111049031|NCT02183051|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111049032|NCT02183051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111049033|NCT02183051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111049034|NCT02183051|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111049035|NCT03169725|Vaccines|vaccines|mesh-list
111049036|NCT03169725|Immunologic Factors|immunologic factors|mesh-ancestor
111049037|NCT03169725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111049038|NCT02403531|Docetaxel|docetaxel|mesh-list
111049039|NCT02403531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111049040|NCT02403531|Tubulin Modulators|tubulin modulators|mesh-ancestor
111049041|NCT02403531|Antimitotic Agents|antimitotic agents|mesh-ancestor
111049042|NCT02403531|Mitosis Modulators|mitosis modulators|mesh-ancestor
111049043|NCT02403531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111049044|NCT02183129|Diclofenac|diclofenac|mesh-list
111049045|NCT02183129|Meloxicam|meloxicam|mesh-list
111049046|NCT02183129|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111049047|NCT02183129|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111049048|NCT02183129|Analgesics|analgesics|mesh-ancestor
111049049|NCT02183129|Sensory System Agents|sensory system agents|mesh-ancestor
111049050|NCT02183129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111049051|NCT02183129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111049052|NCT02183129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111049053|NCT02183129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111049054|NCT02183129|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111049055|NCT02183129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111049056|NCT02183129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111049057|NCT02183129|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111049058|NCT02279953|Vortioxetine|vortioxetine|mesh-list
111049059|NCT02279953|Antidepressive Agents|antidepressive agents|mesh-ancestor
111049060|NCT02279953|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111049061|NCT02279953|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111049062|NCT02279953|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111049063|NCT02279953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111049064|NCT02279953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111049065|NCT02279953|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110629490|NCT00573768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111049066|NCT02279953|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111049067|NCT02279953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111049068|NCT02279953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111049069|NCT02279953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111049070|NCT02279953|Serotonin Agents|serotonin agents|mesh-ancestor
111049071|NCT02279953|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111049072|NCT02279953|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111049073|NCT02279953|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111049074|NCT02279953|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111049075|NCT00578773|Moxifloxacin|moxifloxacin|mesh-list
111049076|NCT00578773|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111049077|NCT00578773|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111049078|NCT00578773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111049079|NCT00578773|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111049080|NCT00578773|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111049081|NCT00578773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111049082|NCT00578773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111049083|NCT00578773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111049084|NCT02387307|Interferons|interferons|mesh-list
111049085|NCT02387307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111049086|NCT02387307|Antiviral Agents|antiviral agents|mesh-ancestor
111049087|NCT02387307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111049088|NCT02183363|Linagliptin|linagliptin|mesh-list
111049089|NCT02183363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111049090|NCT02183363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111049091|NCT02183363|Incretins|incretins|mesh-ancestor
111049092|NCT02183363|Hormones|hormones|mesh-ancestor
111049093|NCT02183363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111049094|NCT02183363|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111049095|NCT02183363|Protease Inhibitors|protease inhibitors|mesh-ancestor
111049096|NCT02183363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111049097|NCT02183363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111049098|NCT02183441|Linagliptin|linagliptin|mesh-list
111049099|NCT02183441|Ritonavir|ritonavir|mesh-list
111049100|NCT02183441|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111049101|NCT02183441|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111049102|NCT02183441|Protease Inhibitors|protease inhibitors|mesh-ancestor
111049103|NCT02183441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111049104|NCT02183441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111049105|NCT02183441|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111049106|NCT02183441|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111049107|NCT02183441|Antiviral Agents|antiviral agents|mesh-ancestor
111049108|NCT02183441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111049109|NCT02183441|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111049110|NCT02183441|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111049111|NCT02183441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111049112|NCT02183441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111049113|NCT02183441|Incretins|incretins|mesh-ancestor
111049114|NCT02183441|Hormones|hormones|mesh-ancestor
111049115|NCT02183441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111049116|NCT02183441|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111049117|NCT02403219|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111049118|NCT02403219|Botulinum Toxins|botulinum toxins|mesh-list
111049119|NCT02403219|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111049120|NCT02403219|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111049121|NCT02403219|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111049122|NCT02403219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111049123|NCT02403219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111049124|NCT02403219|Cholinergic Agents|cholinergic agents|mesh-ancestor
111049125|NCT02403219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111049126|NCT02403219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111049127|NCT02403219|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111049128|NCT02403219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111049129|NCT03537287|Progesterone|progesterone|mesh-list
111049130|NCT03537287|Dydrogesterone|dydrogesterone|mesh-list
111049131|NCT03537287|Progestins|progestins|mesh-ancestor
111049132|NCT03537287|Hormones|hormones|mesh-ancestor
111049133|NCT03537287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110766197|NCT05536791|Dabigatran|dabigatran|mesh-list
111049134|NCT03537287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111049135|NCT02280031|Aspirin|aspirin|mesh-list
111049136|NCT02280031|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111049137|NCT02280031|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111049138|NCT02280031|Analgesics|analgesics|mesh-ancestor
111049139|NCT02280031|Sensory System Agents|sensory system agents|mesh-ancestor
111049140|NCT02280031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111049141|NCT02280031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111049142|NCT02280031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111049143|NCT02280031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111049144|NCT02280031|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111049145|NCT02280031|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111049146|NCT02280031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111049147|NCT02280031|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111049148|NCT02280031|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111049149|NCT02280031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111049150|NCT02280031|Antipyretics|antipyretics|mesh-ancestor
111049151|NCT00449605|Metformin|metformin|mesh-list
111049152|NCT00449605|Glimepiride|glimepiride|mesh-list
111049153|NCT00449605|Rimonabant|rimonabant|mesh-list
111049154|NCT00449605|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111049155|NCT00449605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111049156|NCT00449605|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111049157|NCT00449605|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111049158|NCT00449605|Immunologic Factors|immunologic factors|mesh-ancestor
111049159|NCT00449605|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111049160|NCT00449605|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
111049161|NCT00449605|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
111049162|NCT00449605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111049163|NCT00449605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111049164|NCT00449605|Hormones|hormones|mesh-ancestor
111049165|NCT00449605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111049166|NCT02774239|Immunoglobulins|immunoglobulins|mesh-list
111049167|NCT02774239|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111049168|NCT02774239|Antibodies|antibodies|mesh-list
111049169|NCT02774239|Immunoglobulin G|immunoglobulin g|mesh-list
111049170|NCT02774239|Immunologic Factors|immunologic factors|mesh-ancestor
111049171|NCT02774239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111049172|NCT02280109|Tenofovir|tenofovir|mesh-list
111049173|NCT02280109|Antiviral Agents|antiviral agents|mesh-ancestor
111049174|NCT02280109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111049175|NCT02280109|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111049176|NCT02280109|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111049177|NCT02280109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111049178|NCT02280109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111049179|NCT02280109|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111049180|NCT02280109|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111049181|NCT00576667|Rimonabant|rimonabant|mesh-list
111049182|NCT00576667|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111049183|NCT00576667|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
111049184|NCT00576667|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
111049185|NCT00576667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111049186|NCT00576667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111049187|NCT00576667|Hormones|hormones|mesh-ancestor
111049188|NCT00576667|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111049189|NCT00576667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111049190|NCT02403063|Neostigmine|neostigmine|mesh-list
111049191|NCT02403063|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111049192|NCT02403063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111049193|NCT02403063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111049194|NCT02403063|Cholinergic Agents|cholinergic agents|mesh-ancestor
111049195|NCT02403063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111049196|NCT02403063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111049197|NCT02403063|Parasympathomimetics|parasympathomimetics|mesh-ancestor
111049198|NCT02403063|Autonomic Agents|autonomic agents|mesh-ancestor
111049199|NCT02403063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111049200|NCT02177357|Pramipexole|pramipexole|mesh-list
111049201|NCT02177357|Antioxidants|antioxidants|mesh-ancestor
111049202|NCT02177357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111049203|NCT02177357|Protective Agents|protective agents|mesh-ancestor
111049204|NCT02177357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111049205|NCT02177357|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111049206|NCT02177357|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111049207|NCT02177357|Dopamine Agonists|dopamine agonists|mesh-ancestor
111049208|NCT02177357|Dopamine Agents|dopamine agents|mesh-ancestor
111049209|NCT02177357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111049210|NCT02386449|Mannitol|mannitol|mesh-list
111049211|NCT02386449|Bisacodyl|bisacodyl|mesh-list
111049212|NCT02386449|Picosulfate sodium|picosulfate sodium|mesh-list
111049213|NCT02386449|Magnesium Oxide|magnesium oxide|mesh-list
111049214|NCT02386449|Citric Acid|citric acid|mesh-list
111049215|NCT02386449|Sodium Citrate|sodium citrate|mesh-list
111049216|NCT02386449|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
111049217|NCT02386449|Diuretics|diuretics|mesh-ancestor
111049218|NCT02386449|Natriuretic Agents|natriuretic agents|mesh-ancestor
111049219|NCT02386449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111049220|NCT02386449|Cathartics|cathartics|mesh-ancestor
111049221|NCT02386449|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111049222|NCT02386449|Laxatives|laxatives|mesh-ancestor
111049223|NCT02386449|Anticoagulants|anticoagulants|mesh-ancestor
111049224|NCT02386449|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
111049225|NCT02386449|Chelating Agents|chelating agents|mesh-ancestor
111049226|NCT02386449|Sequestering Agents|sequestering agents|mesh-ancestor
111049227|NCT02386449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111049229|NCT00656539|Azithromycin|azithromycin|mesh-list
111049230|NCT00656539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111049231|NCT00656539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111049232|NCT02179775|Propranolol|propranolol|mesh-list
111049233|NCT02179775|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111049234|NCT02179775|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111049235|NCT02179775|Adrenergic Agents|adrenergic agents|mesh-ancestor
111049236|NCT02179775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111049237|NCT02179775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111049238|NCT02179775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111049239|NCT02179775|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111049240|NCT02179775|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111049241|NCT02179775|Vasodilator Agents|vasodilator agents|mesh-ancestor
111049242|NCT02177435|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
111049243|NCT02177435|Telmisartan|telmisartan|mesh-list
111049244|NCT02177435|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
111049245|NCT02177435|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111049246|NCT02177435|Diuretics|diuretics|mesh-ancestor
111049247|NCT02177435|Natriuretic Agents|natriuretic agents|mesh-ancestor
111049248|NCT02177435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111049249|NCT02177435|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
111049250|NCT02177435|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111049251|NCT02177435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111049252|NCT02177435|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111049253|NCT02177435|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111049254|NCT02280265|Factor VIII|factor viii|mesh-list
111049255|NCT02280265|Coagulants|coagulants|mesh-ancestor
111049256|NCT02179931|Flupenthixol|flupenthixol|mesh-list
111049257|NCT02179931|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
111049258|NCT02179931|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111049259|NCT02179931|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111049260|NCT02179931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111049261|NCT02179931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111049262|NCT02179931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111049263|NCT02179931|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111049264|NCT02179931|Dopamine Agents|dopamine agents|mesh-ancestor
111049265|NCT02179931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111049266|NCT02179931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111049267|NCT02184065|Meloxicam|meloxicam|mesh-list
111049268|NCT02184065|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111049269|NCT02184065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111049270|NCT02184065|Analgesics|analgesics|mesh-ancestor
111049271|NCT02184065|Sensory System Agents|sensory system agents|mesh-ancestor
111049272|NCT02184065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111049273|NCT02184065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111049274|NCT02184065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111049275|NCT02184065|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111049276|NCT02184065|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111049277|NCT02184065|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111049278|NCT02184065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111049279|NCT02184065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111049280|NCT00564421|Epinastine|epinastine|mesh-list
111049281|NCT00564421|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111049282|NCT00564421|Histamine Antagonists|histamine antagonists|mesh-ancestor
111049283|NCT00564421|Histamine Agents|histamine agents|mesh-ancestor
110766343|NCT05119920|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
111049284|NCT00564421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111049285|NCT00564421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111049286|NCT00564421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111049287|NCT02665689|Ranibizumab|ranibizumab|mesh-list
111049288|NCT02665689|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111049289|NCT02665689|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111049290|NCT02665689|Growth Substances|growth substances|mesh-ancestor
111049291|NCT02665689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111049292|NCT02665689|Growth Inhibitors|growth inhibitors|mesh-ancestor
111049293|NCT02665689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111049294|NCT02386293|Irbesartan|irbesartan|mesh-list
111049295|NCT02386293|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111049296|NCT02386293|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111049297|NCT02386293|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111049298|NCT02386293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111049300|NCT00563563|Bupropion|bupropion|mesh-list
111049301|NCT00563563|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111049302|NCT00563563|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111049303|NCT00563563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111049304|NCT00563563|Sensory System Agents|sensory system agents|mesh-ancestor
111049305|NCT00563563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110629559|NCT00547365|Immunoglobulins|immunoglobulins|mesh-list
111049306|NCT00563563|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111049307|NCT00563563|Antidepressive Agents|antidepressive agents|mesh-ancestor
111049308|NCT00563563|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111049309|NCT00563563|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111049310|NCT00563563|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111049311|NCT00563563|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111049312|NCT00563563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111049313|NCT00563563|Dopamine Agents|dopamine agents|mesh-ancestor
111049314|NCT00563563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111049315|NCT00563563|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111049316|NCT00563563|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111049317|NCT00563563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111049318|NCT05149365|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111049319|NCT05149365|Cyclosporine|cyclosporine|mesh-list
111049320|NCT05149365|Methotrexate|methotrexate|mesh-list
111049321|NCT05149365|Cyclosporins|cyclosporins|mesh-list
111049322|NCT05149365|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111049323|NCT05149365|Abortifacient Agents|abortifacient agents|mesh-ancestor
111049324|NCT05149365|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111049325|NCT05149365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111049326|NCT05149365|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111049327|NCT05149365|Antimetabolites|antimetabolites|mesh-ancestor
111049328|NCT05149365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111049329|NCT05149365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111049330|NCT05149365|Dermatologic Agents|dermatologic agents|mesh-ancestor
111049331|NCT05149365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111049332|NCT05149365|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111049333|NCT05149365|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111049334|NCT05149365|Immunologic Factors|immunologic factors|mesh-ancestor
111049335|NCT05149365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111049336|NCT05149365|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111049337|NCT05149365|Antifungal Agents|antifungal agents|mesh-ancestor
111049338|NCT05149365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111049339|NCT05149365|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111049340|NCT05149365|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111049341|NCT05149365|Incretins|incretins|mesh-ancestor
111049342|NCT05149365|Hormones|hormones|mesh-ancestor
111049343|NCT05149365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111049344|NCT05149365|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111049345|NCT05149365|Protease Inhibitors|protease inhibitors|mesh-ancestor
111049346|NCT02180087|Ketoprofen|ketoprofen|mesh-list
111049347|NCT02180087|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111049348|NCT02180087|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111049349|NCT02180087|Analgesics|analgesics|mesh-ancestor
111049350|NCT02180087|Sensory System Agents|sensory system agents|mesh-ancestor
111049351|NCT02180087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111049352|NCT02180087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111049353|NCT02180087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111049354|NCT02180087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111049355|NCT02180087|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110766417|NCT04909684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111049356|NCT02180087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111049357|NCT02180087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111049359|NCT02184299|Prednisone|prednisone|mesh-list
111049360|NCT02184299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111049361|NCT02184299|Glucocorticoids|glucocorticoids|mesh-ancestor
111049362|NCT02184299|Hormones|hormones|mesh-ancestor
111049363|NCT02184299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111049364|NCT02184299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111049365|NCT02184299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111049366|NCT02184299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111049367|NCT02184299|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111049368|NCT02184299|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111049369|NCT02184299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110827624|NCT01168063|Metronidazole|metronidazole|mesh-list
111049370|NCT02184299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111049371|NCT02184299|Antiviral Agents|antiviral agents|mesh-ancestor
111049372|NCT02184299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111049373|NCT02184299|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111049374|NCT02184299|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111049375|NCT02184299|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111049376|NCT02184299|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111049377|NCT00549679|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|mesh-list
111049378|NCT00549679|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
111049379|NCT00549679|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111049380|NCT00549679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111049381|NCT00549679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111049382|NCT02282371|Cetuximab|cetuximab|mesh-list
111049383|NCT02282371|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111049384|NCT02282371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111049385|NCT02402595|Itraconazole|itraconazole|mesh-list
111049386|NCT02402595|Antifungal Agents|antifungal agents|mesh-ancestor
111049387|NCT02402595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111049388|NCT02402595|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111049389|NCT02402595|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111049390|NCT02402595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111049391|NCT02402595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111049392|NCT02402595|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111049393|NCT02402595|Hormone Antagonists|hormone antagonists|mesh-ancestor
111049394|NCT02402595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111049395|NCT02402595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111049396|NCT02402595|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111049397|NCT02180321|Tranexamic Acid|tranexamic acid|mesh-list
111049398|NCT02180321|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111049399|NCT02180321|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111049400|NCT02180321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111049401|NCT02180321|Hemostatics|hemostatics|mesh-ancestor
111049402|NCT02180321|Coagulants|coagulants|mesh-ancestor
111049403|NCT00547651|Topotecan|topotecan|mesh-list
111049404|NCT00547651|Amrubicin|amrubicin|mesh-list
111049405|NCT00547651|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111049406|NCT00547651|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111049407|NCT00547651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111049408|NCT00547651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111049409|NCT00547651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111049410|NCT00546793|Veltuzumab|veltuzumab|mesh-list
111049411|NCT00546793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111049412|NCT02402283|Metronidazole|metronidazole|mesh-list
111049413|NCT02402283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111049414|NCT02402283|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111049415|NCT02402283|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111049416|NCT02402283|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111049417|NCT02184533|Selenious Acid|selenious acid|mesh-list
111049418|NCT02184533|Sodium Selenite|sodium selenite|mesh-list
111049419|NCT02184533|Trace Elements|trace elements|mesh-ancestor
111049420|NCT02184533|Micronutrients|micronutrients|mesh-ancestor
111049421|NCT02184533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111049422|NCT02386059|Dexamethasone|dexamethasone|mesh-list
111049423|NCT02386059|Dexamethasone acetate|dexamethasone acetate|mesh-list
111049424|NCT02386059|Ondansetron|ondansetron|mesh-list
111049425|NCT02386059|BB 1101|bb 1101|mesh-list
111049426|NCT02386059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111049427|NCT02386059|Antiemetics|antiemetics|mesh-ancestor
110766495|NCT04481048|Antioxidants|antioxidants|mesh-ancestor
111049428|NCT02386059|Autonomic Agents|autonomic agents|mesh-ancestor
111049429|NCT02386059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111049430|NCT02386059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111049431|NCT02386059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111049432|NCT02386059|Glucocorticoids|glucocorticoids|mesh-ancestor
111049433|NCT02386059|Hormones|hormones|mesh-ancestor
111049434|NCT02386059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111049435|NCT02386059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111049436|NCT02386059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111049437|NCT02386059|Protease Inhibitors|protease inhibitors|mesh-ancestor
111049438|NCT02386059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111049439|NCT02386059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111049440|NCT02386059|Antipruritics|antipruritics|mesh-ancestor
111049442|NCT02386059|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111049443|NCT02386059|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111049444|NCT02386059|Serotonin Agents|serotonin agents|mesh-ancestor
111049445|NCT02386059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111049446|NCT00443287|Cilostazol|cilostazol|mesh-list
111049447|NCT00443287|5-chloro-2-(5-chlorothiophene-2-sulfonylamino)-N-(4-(morpholine-4-sulfonyl)phenyl)benzamide|5-chloro-2-(5-chlorothiophene-2-sulfonylamino)-n-(4-(morpholine-4-sulfonyl)phenyl)benzamide|mesh-list
111049448|NCT00443287|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111049449|NCT00443287|Autonomic Agents|autonomic agents|mesh-ancestor
111049450|NCT00443287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111049451|NCT00443287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111049452|NCT00443287|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111049453|NCT00443287|Respiratory System Agents|respiratory system agents|mesh-ancestor
111049454|NCT00443287|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111049455|NCT00443287|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111049456|NCT00443287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111049457|NCT00443287|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111049458|NCT00443287|Vasodilator Agents|vasodilator agents|mesh-ancestor
111049459|NCT00443287|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111049460|NCT00443287|Protective Agents|protective agents|mesh-ancestor
111049461|NCT00443287|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
111049462|NCT00443287|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111049463|NCT00443287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111049464|NCT00443287|Enzyme Activators|enzyme activators|mesh-ancestor
111049465|NCT00442039|Lithium Carbonate|lithium carbonate|mesh-list
111049466|NCT00442039|Antidepressive Agents|antidepressive agents|mesh-ancestor
111049467|NCT00442039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111049468|NCT00442039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111049469|NCT00442039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111049470|NCT00442039|Antimanic Agents|antimanic agents|mesh-ancestor
111049471|NCT00442039|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111049472|NCT00442039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111049473|NCT00442039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111049474|NCT02390739|Aldesleukin|aldesleukin|mesh-list
111049475|NCT02390739|Cyclophosphamide|cyclophosphamide|mesh-list
111049476|NCT02390739|Fludarabine|fludarabine|mesh-list
111049477|NCT02390739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111049478|NCT02390739|Immunologic Factors|immunologic factors|mesh-ancestor
111049479|NCT02390739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111049480|NCT02390739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111049481|NCT02390739|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111049482|NCT02390739|Alkylating Agents|alkylating agents|mesh-ancestor
111049483|NCT02390739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111049484|NCT02390739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111049485|NCT02390739|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111049486|NCT02390739|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111049487|NCT02390739|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111049488|NCT02390739|Antiviral Agents|antiviral agents|mesh-ancestor
111049489|NCT02390739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111049490|NCT02385825|Vaccines|vaccines|mesh-list
111049491|NCT02385825|Immunologic Factors|immunologic factors|mesh-ancestor
111049492|NCT02385825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111049493|NCT02177825|Imatinib Mesylate|imatinib mesylate|mesh-list
111049494|NCT02177825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111049495|NCT02177825|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111049496|NCT02177825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111049497|NCT02177825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111049498|NCT02390817|Neostigmine|neostigmine|mesh-list
111049499|NCT02390817|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110766574|NCT04269408|Nicardipine|nicardipine|mesh-list
111049500|NCT02390817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111049501|NCT02390817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111049502|NCT02390817|Cholinergic Agents|cholinergic agents|mesh-ancestor
111049503|NCT02390817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111049504|NCT02390817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111049505|NCT02390817|Parasympathomimetics|parasympathomimetics|mesh-ancestor
111049506|NCT02390817|Autonomic Agents|autonomic agents|mesh-ancestor
111049507|NCT02390817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111049508|NCT00537043|Carvedilol|carvedilol|mesh-list
111049509|NCT00537043|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111049510|NCT00537043|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111049511|NCT00537043|Adrenergic Agents|adrenergic agents|mesh-ancestor
111049512|NCT00537043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111049513|NCT00537043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111049515|NCT00537043|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111049516|NCT00537043|Antioxidants|antioxidants|mesh-ancestor
111049517|NCT00537043|Protective Agents|protective agents|mesh-ancestor
111049518|NCT00537043|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111049519|NCT00537043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111049520|NCT00537043|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111049521|NCT00537043|Vasodilator Agents|vasodilator agents|mesh-ancestor
111049522|NCT00537043|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111049523|NCT00537043|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111049524|NCT00387907|Trastuzumab|trastuzumab|mesh-list
111049525|NCT00387907|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111049526|NCT00387907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111049527|NCT02180789|Tamsulosin|tamsulosin|mesh-list
111049528|NCT02180789|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111049529|NCT02180789|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111049530|NCT02180789|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111049531|NCT02180789|Adrenergic Agents|adrenergic agents|mesh-ancestor
111049532|NCT02180789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111049533|NCT02180789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111049534|NCT02180789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111049535|NCT02180789|Urological Agents|urological agents|mesh-ancestor
111049536|NCT02282683|Prednisone|prednisone|mesh-list
111049537|NCT02282683|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111049538|NCT02282683|Glucocorticoids|glucocorticoids|mesh-ancestor
111049539|NCT02282683|Hormones|hormones|mesh-ancestor
111049540|NCT02282683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111049541|NCT02282683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111049542|NCT02282683|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111049543|NCT02282683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111049544|NCT02183909|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
111049545|NCT02183909|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111049546|NCT02183909|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111049547|NCT02183909|Antiviral Agents|antiviral agents|mesh-ancestor
111049548|NCT02183909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111049549|NCT00375193|Amrubicin|amrubicin|mesh-list
111049550|NCT00375193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111049551|NCT00151411|Metformin|metformin|mesh-list
111049552|NCT00151411|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111049553|NCT00151411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111049554|NCT04471441|Mycophenolic Acid|mycophenolic acid|mesh-list
111049555|NCT04471441|Everolimus|everolimus|mesh-list
111049556|NCT04471441|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111049557|NCT04471441|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111049558|NCT04471441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111049559|NCT04471441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111049560|NCT04471441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111049561|NCT04471441|Immunologic Factors|immunologic factors|mesh-ancestor
111049562|NCT04471441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111049563|NCT04471441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111049564|NCT04471441|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111049565|NCT04471441|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111049566|NCT04471441|Antitubercular Agents|antitubercular agents|mesh-ancestor
111049567|NCT04471441|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111049568|NCT04471441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111049569|NCT02662569|Atorvastatin|atorvastatin|mesh-list
111049570|NCT02662569|Evolocumab|evolocumab|mesh-list
111049571|NCT02662569|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111049572|NCT02662569|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110766644|NCT03959293|Durvalumab|durvalumab|mesh-list
111049573|NCT02662569|Antimetabolites|antimetabolites|mesh-ancestor
111049574|NCT02662569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111049575|NCT02662569|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111049576|NCT02662569|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111049577|NCT02662569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111049578|NCT02662569|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
111049579|NCT02662569|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111049580|NCT02662569|Protease Inhibitors|protease inhibitors|mesh-ancestor
111049581|NCT02178137|Zinc Sulfate|zinc sulfate|mesh-list
111049582|NCT02178137|Astringents|astringents|mesh-ancestor
111049583|NCT02178137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111049584|NCT02178137|Dermatologic Agents|dermatologic agents|mesh-ancestor
111049585|NCT02181023|Glycopyrrolate|glycopyrrolate|mesh-list
111049586|NCT02181023|Bromides|bromides|mesh-list
111049587|NCT02181023|Anticonvulsants|anticonvulsants|mesh-ancestor
111049588|NCT02181023|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111049589|NCT02181023|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111049590|NCT02181023|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111049591|NCT02181023|Cholinergic Agents|cholinergic agents|mesh-ancestor
111049592|NCT02181023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111049593|NCT02181023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111049594|NCT02181023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111049595|NCT02286973|Tranexamic Acid|tranexamic acid|mesh-list
111049596|NCT02286973|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111049597|NCT02286973|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111049598|NCT02286973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111049599|NCT02286973|Hemostatics|hemostatics|mesh-ancestor
111049600|NCT02286973|Coagulants|coagulants|mesh-ancestor
111049601|NCT02181101|Zoledronic Acid|zoledronic acid|mesh-list
111049602|NCT02181101|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111049603|NCT02181101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111049604|NCT02287129|Paclitaxel|paclitaxel|mesh-list
111049605|NCT02287129|Carboplatin|carboplatin|mesh-list
111049606|NCT02287129|Capecitabine|capecitabine|mesh-list
111049607|NCT02287129|Oxaliplatin|oxaliplatin|mesh-list
111049608|NCT02287129|Epirubicin|epirubicin|mesh-list
111049609|NCT02287129|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111049610|NCT02287129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111049611|NCT02287129|Tubulin Modulators|tubulin modulators|mesh-ancestor
111049612|NCT02287129|Antimitotic Agents|antimitotic agents|mesh-ancestor
111049613|NCT02287129|Mitosis Modulators|mitosis modulators|mesh-ancestor
111049614|NCT02287129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111049615|NCT02287129|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111049616|NCT02287129|Antimetabolites|antimetabolites|mesh-ancestor
111049617|NCT02287129|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111049618|NCT02287129|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111049619|NCT02287129|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111049620|NCT02287129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111049621|NCT02256683|Dabigatran|dabigatran|mesh-list
111049622|NCT02256683|Phenprocoumon|phenprocoumon|mesh-list
111049623|NCT02256683|Antithrombins|antithrombins|mesh-ancestor
111049624|NCT02256683|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111049625|NCT02256683|Protease Inhibitors|protease inhibitors|mesh-ancestor
111049626|NCT02256683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111049627|NCT02256683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111049628|NCT02256683|Anticoagulants|anticoagulants|mesh-ancestor
111049629|NCT00411385|Interferons|interferons|mesh-list
111049630|NCT00411385|Ribavirin|ribavirin|mesh-list
111049631|NCT00411385|Interferon-alpha|interferon-alpha|mesh-list
111049632|NCT00411385|Interferon alpha-2|interferon alpha-2|mesh-list
111049633|NCT00411385|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
111049634|NCT00411385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111049635|NCT00411385|Antiviral Agents|antiviral agents|mesh-ancestor
111049636|NCT00411385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111049637|NCT00411385|Antimetabolites|antimetabolites|mesh-ancestor
111049638|NCT00411385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111049639|NCT00411385|Immunologic Factors|immunologic factors|mesh-ancestor
111049640|NCT00411385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111049641|NCT02385513|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
111049642|NCT02385513|Immunologic Factors|immunologic factors|mesh-ancestor
110766716|NCT03742986|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110766717|NCT03742986|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110766718|NCT03742986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111049643|NCT02385513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111049644|NCT02185547|Sertraline|sertraline|mesh-list
111049645|NCT02185547|Antidepressive Agents|antidepressive agents|mesh-ancestor
111049646|NCT02185547|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111049647|NCT02185547|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111049648|NCT02185547|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111049649|NCT02185547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111049650|NCT02185547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111049651|NCT02185547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111049652|NCT02185547|Serotonin Agents|serotonin agents|mesh-ancestor
111049653|NCT02185547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111049654|NCT02030483|Dexamethasone|dexamethasone|mesh-list
111049655|NCT02030483|Lenalidomide|lenalidomide|mesh-list
111049656|NCT02030483|Palbociclib|palbociclib|mesh-list
111049657|NCT02030483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111049658|NCT02030483|Antiemetics|antiemetics|mesh-ancestor
111049659|NCT02030483|Autonomic Agents|autonomic agents|mesh-ancestor
111049660|NCT02030483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111049661|NCT02030483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111049662|NCT02030483|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111049663|NCT02030483|Glucocorticoids|glucocorticoids|mesh-ancestor
111049664|NCT02030483|Hormones|hormones|mesh-ancestor
111049665|NCT02030483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111049666|NCT02030483|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111049667|NCT02030483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110629634|NCT01095003|Antimetabolites|antimetabolites|mesh-ancestor
111049668|NCT02030483|Immunologic Factors|immunologic factors|mesh-ancestor
111049669|NCT02030483|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111049670|NCT02030483|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111049671|NCT02030483|Growth Substances|growth substances|mesh-ancestor
111049672|NCT02030483|Growth Inhibitors|growth inhibitors|mesh-ancestor
111049673|NCT02030483|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111049674|NCT02030483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111049675|NCT02030483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111049676|NCT00528697|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
111049677|NCT00528697|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111049678|NCT00528697|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111049679|NCT00528697|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111049680|NCT00528697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111049681|NCT00528697|Adrenergic Agents|adrenergic agents|mesh-ancestor
111049682|NCT00528697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111049683|NCT00528697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111049684|NCT02385435|Dexmedetomidine|dexmedetomidine|mesh-list
111049685|NCT02385435|Bupivacaine|bupivacaine|mesh-list
111049686|NCT02385435|Anesthetics, Local|anesthetics, local|mesh-ancestor
111049687|NCT02385435|Anesthetics|anesthetics|mesh-ancestor
111049688|NCT02385435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111049689|NCT02385435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111049690|NCT02385435|Sensory System Agents|sensory system agents|mesh-ancestor
111049691|NCT02385435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111049692|NCT02385435|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111049693|NCT02385435|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111049694|NCT02385435|Analgesics|analgesics|mesh-ancestor
111049695|NCT02385435|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111049696|NCT02385435|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111049697|NCT02385435|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111049698|NCT02385435|Adrenergic Agents|adrenergic agents|mesh-ancestor
111049699|NCT02385435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111049700|NCT02385435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111049701|NCT02753075|Fluorides|fluorides|mesh-list
111049702|NCT02753075|Cariostatic Agents|cariostatic agents|mesh-ancestor
111049703|NCT02753075|Protective Agents|protective agents|mesh-ancestor
111049704|NCT02753075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111049705|NCT03133897|Dexamethasone|dexamethasone|mesh-list
111049706|NCT03133897|Prednisone|prednisone|mesh-list
111049707|NCT03133897|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111049708|NCT03133897|Antiemetics|antiemetics|mesh-ancestor
111049709|NCT03133897|Autonomic Agents|autonomic agents|mesh-ancestor
111049710|NCT03133897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111049711|NCT03133897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111049712|NCT03133897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111049713|NCT03133897|Glucocorticoids|glucocorticoids|mesh-ancestor
111049714|NCT03133897|Hormones|hormones|mesh-ancestor
111049715|NCT03133897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111049716|NCT03133897|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111049717|NCT03133897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111049718|NCT05443425|Cholestyramine Resin|cholestyramine resin|mesh-list
111049719|NCT05443425|Leflunomide|leflunomide|mesh-list
111049720|NCT05443425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111049721|NCT05443425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111049722|NCT05443425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111049723|NCT05443425|Immunologic Factors|immunologic factors|mesh-ancestor
111049724|NCT05443425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111049725|NCT05443425|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111049726|NCT05443425|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111049727|NCT05443425|Antimetabolites|antimetabolites|mesh-ancestor
111049728|NCT05443425|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111049729|NCT02190149|Factor VIII|factor viii|mesh-list
111049730|NCT02190149|Coagulants|coagulants|mesh-ancestor
111049731|NCT00366145|Remestemcel-l|remestemcel-l|mesh-list
111049732|NCT00366145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111049733|NCT00366145|Antiviral Agents|antiviral agents|mesh-ancestor
111049734|NCT00366145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111049735|NCT02185859|Lidocaine|lidocaine|mesh-list
111049736|NCT02185859|Magnesium Sulfate|magnesium sulfate|mesh-list
111049737|NCT02185859|Anesthetics, Local|anesthetics, local|mesh-ancestor
111049738|NCT02185859|Anesthetics|anesthetics|mesh-ancestor
111049739|NCT02185859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111049740|NCT02185859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111049741|NCT02185859|Sensory System Agents|sensory system agents|mesh-ancestor
111049742|NCT02185859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111049743|NCT02185859|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111049744|NCT02185859|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111049745|NCT02185859|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111049746|NCT02185859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111049747|NCT02185859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111049748|NCT02185859|Analgesics|analgesics|mesh-ancestor
111049749|NCT02185859|Anticonvulsants|anticonvulsants|mesh-ancestor
111049750|NCT02185859|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111049751|NCT02185859|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111049752|NCT02185859|Tocolytic Agents|tocolytic agents|mesh-ancestor
111049753|NCT02185859|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111049754|NCT02332720|Ribavirin|ribavirin|mesh-list
111049755|NCT02332720|Grazoprevir|grazoprevir|mesh-list
111049756|NCT02332720|Ruzasvir|ruzasvir|mesh-list
111049757|NCT02332720|Uprifosbuvir|uprifosbuvir|mesh-list
111049758|NCT02332720|Antimetabolites|antimetabolites|mesh-ancestor
111049759|NCT02332720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111049760|NCT02332720|Antiviral Agents|antiviral agents|mesh-ancestor
111049761|NCT02332720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111049762|NCT05089175|Aspirin|aspirin|mesh-list
111049763|NCT05089175|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111049764|NCT05089175|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111049765|NCT05089175|Analgesics|analgesics|mesh-ancestor
111049766|NCT05089175|Sensory System Agents|sensory system agents|mesh-ancestor
111049767|NCT05089175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111049768|NCT05089175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111049769|NCT05089175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111049770|NCT05089175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111049771|NCT05089175|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111049772|NCT05089175|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111049773|NCT05089175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111049774|NCT05089175|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111049775|NCT05089175|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111049776|NCT05089175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111049777|NCT05089175|Antipyretics|antipyretics|mesh-ancestor
111049778|NCT02181335|Budesonide|budesonide|mesh-list
111049779|NCT02181335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111049780|NCT02181335|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111049781|NCT02181335|Autonomic Agents|autonomic agents|mesh-ancestor
111049782|NCT02181335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111049783|NCT02181335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111049784|NCT02181335|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111049785|NCT02181335|Respiratory System Agents|respiratory system agents|mesh-ancestor
111049786|NCT02181335|Glucocorticoids|glucocorticoids|mesh-ancestor
111049787|NCT02181335|Hormones|hormones|mesh-ancestor
111049788|NCT02181335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111049789|NCT00517153|Miglustat|miglustat|mesh-list
111049790|NCT00517153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111049791|NCT00517153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111049792|NCT00517153|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111049793|NCT00517153|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111049794|NCT00517153|Antiviral Agents|antiviral agents|mesh-ancestor
111049795|NCT00517153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111049796|NCT00517153|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
111049797|NCT00517153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111049798|NCT00517153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111049799|NCT02285101|BCT-100|bct-100|mesh-list
111049800|NCT02285101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111049801|NCT00359437|Satavaptan|satavaptan|mesh-list
111049802|NCT00359437|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
111049803|NCT00359437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111049804|NCT00359437|Natriuretic Agents|natriuretic agents|mesh-ancestor
111049805|NCT00359437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111049806|NCT05064449|Itraconazole|itraconazole|mesh-list
111049807|NCT05064449|Mefenamic Acid|mefenamic acid|mesh-list
111049808|NCT05064449|Antifungal Agents|antifungal agents|mesh-ancestor
111049809|NCT05064449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111049810|NCT05064449|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111049811|NCT05064449|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111049812|NCT05064449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111049813|NCT05064449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111049814|NCT05064449|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111049815|NCT05064449|Hormone Antagonists|hormone antagonists|mesh-ancestor
111049816|NCT05064449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111049817|NCT05064449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111049818|NCT05064449|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111049819|NCT05064449|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111049820|NCT05064449|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111049821|NCT05064449|Analgesics|analgesics|mesh-ancestor
111049822|NCT05064449|Sensory System Agents|sensory system agents|mesh-ancestor
111049823|NCT05064449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111049824|NCT05064449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111049825|NCT05064449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111049826|NCT05064449|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111049827|NCT00401011|Dexamethasone|dexamethasone|mesh-list
111049828|NCT00401011|Bortezomib|bortezomib|mesh-list
111049829|NCT00401011|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111049830|NCT00401011|Antiemetics|antiemetics|mesh-ancestor
111049831|NCT00401011|Autonomic Agents|autonomic agents|mesh-ancestor
111049832|NCT00401011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111049833|NCT00401011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111049834|NCT00401011|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111049835|NCT00401011|Glucocorticoids|glucocorticoids|mesh-ancestor
111049836|NCT00401011|Hormones|hormones|mesh-ancestor
111049837|NCT00401011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111049838|NCT00401011|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111049839|NCT00401011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111049840|NCT01645930|Dexamethasone|dexamethasone|mesh-list
111049841|NCT01645930|Lenalidomide|lenalidomide|mesh-list
111049842|NCT01645930|Ixazomib|ixazomib|mesh-list
111049843|NCT01645930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111049844|NCT01645930|Antiemetics|antiemetics|mesh-ancestor
111049845|NCT01645930|Autonomic Agents|autonomic agents|mesh-ancestor
111049846|NCT01645930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111049847|NCT01645930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111049848|NCT01645930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111049849|NCT01645930|Glucocorticoids|glucocorticoids|mesh-ancestor
111049850|NCT01645930|Hormones|hormones|mesh-ancestor
111049851|NCT01645930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111049852|NCT01645930|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111049853|NCT01645930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111049854|NCT01645930|Immunologic Factors|immunologic factors|mesh-ancestor
111049855|NCT01645930|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111049856|NCT01645930|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111049857|NCT01645930|Growth Substances|growth substances|mesh-ancestor
111049858|NCT01645930|Growth Inhibitors|growth inhibitors|mesh-ancestor
111049859|NCT01645930|Protease Inhibitors|protease inhibitors|mesh-ancestor
111049860|NCT01645930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111049861|NCT01645930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111049862|NCT02190695|Carboplatin|carboplatin|mesh-list
111049863|NCT02190695|Decitabine|decitabine|mesh-list
111049864|NCT02190695|Arsenic Trioxide|arsenic trioxide|mesh-list
111049865|NCT02190695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111049866|NCT02190695|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111049867|NCT02190695|Antimetabolites|antimetabolites|mesh-ancestor
111049868|NCT02190695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111049869|NCT02190695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111049870|NCT00514267|Prednisone|prednisone|mesh-list
111049871|NCT00514267|Docetaxel|docetaxel|mesh-list
111049872|NCT00514267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111049873|NCT00514267|Tubulin Modulators|tubulin modulators|mesh-ancestor
111049874|NCT00514267|Antimitotic Agents|antimitotic agents|mesh-ancestor
111049875|NCT00514267|Mitosis Modulators|mitosis modulators|mesh-ancestor
111049876|NCT00514267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110514985|NCT02602509|Rifampin|rifampin|mesh-list
111049877|NCT00514267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111049878|NCT00514267|Glucocorticoids|glucocorticoids|mesh-ancestor
111049879|NCT00514267|Hormones|hormones|mesh-ancestor
111049880|NCT00514267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111049881|NCT00514267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111049882|NCT00514267|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111049883|NCT04199104|Pembrolizumab|pembrolizumab|mesh-list
111049884|NCT04199104|Lenvatinib|lenvatinib|mesh-list
111049885|NCT04199104|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111049886|NCT04199104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111049887|NCT04199104|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111049888|NCT04199104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111049889|NCT04199104|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111049890|NCT04199104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111049891|NCT02384967|Darunavir|darunavir|mesh-list
111049892|NCT02384967|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111049893|NCT02384967|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111049894|NCT02384967|Protease Inhibitors|protease inhibitors|mesh-ancestor
111049895|NCT02384967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111049896|NCT02384967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111049897|NCT02384967|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111049898|NCT02384967|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111049899|NCT02384967|Antiviral Agents|antiviral agents|mesh-ancestor
111049900|NCT02384967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111049901|NCT02186249|Nivolumab|nivolumab|mesh-list
111049902|NCT02186249|Ipilimumab|ipilimumab|mesh-list
111049903|NCT02186249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111049904|NCT02186249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111049905|NCT02186249|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111049906|NCT02186249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111049907|NCT00511459|Paclitaxel|paclitaxel|mesh-list
111049908|NCT00511459|Bevacizumab|bevacizumab|mesh-list
111049909|NCT00511459|Trebananib|trebananib|mesh-list
111049910|NCT00511459|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111049911|NCT00511459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111049912|NCT00511459|Tubulin Modulators|tubulin modulators|mesh-ancestor
111049913|NCT00511459|Antimitotic Agents|antimitotic agents|mesh-ancestor
111049914|NCT00511459|Mitosis Modulators|mitosis modulators|mesh-ancestor
111049915|NCT00511459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111049916|NCT00511459|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111049917|NCT00511459|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111049918|NCT00511459|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111049919|NCT00511459|Growth Substances|growth substances|mesh-ancestor
111049920|NCT00511459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111049921|NCT00511459|Growth Inhibitors|growth inhibitors|mesh-ancestor
111049922|NCT02384889|Eflornithine|eflornithine|mesh-list
111049923|NCT02384889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111049924|NCT02384889|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
111049925|NCT02384889|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111049926|NCT02384889|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111049927|NCT02384889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111049928|NCT02384889|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
111049929|NCT02384889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111049930|NCT02384889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111049931|NCT02299336|Aflibercept|aflibercept|mesh-list
111049932|NCT02299336|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111049933|NCT02299336|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111049934|NCT02299336|Growth Substances|growth substances|mesh-ancestor
111049935|NCT02299336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111049936|NCT02299336|Growth Inhibitors|growth inhibitors|mesh-ancestor
111049937|NCT02299336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111049938|NCT02384655|Fenugreek seed meal|fenugreek seed meal|mesh-list
111049939|NCT02384655|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111049940|NCT02384655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111049941|NCT02186483|Metformin|metformin|mesh-list
111049942|NCT02186483|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111049943|NCT02186483|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111049944|NCT02186483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111049945|NCT02186483|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111049946|NCT02186483|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111049948|NCT02186483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111049949|NCT02186483|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111049950|NCT02186483|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111049951|NCT02186483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111049952|NCT02256605|Vitamin D|vitamin d|mesh-list
111049953|NCT02256605|Cholecalciferol|cholecalciferol|mesh-list
111049954|NCT02256605|Vitamins|vitamins|mesh-ancestor
111049955|NCT02256605|Micronutrients|micronutrients|mesh-ancestor
111049956|NCT02256605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111049957|NCT02256605|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111049958|NCT02256605|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111049959|NCT00393991|Fluticasone|fluticasone|mesh-list
111049960|NCT00393991|Xhance|xhance|mesh-list
111049961|NCT00393991|Formoterol Fumarate|formoterol fumarate|mesh-list
111049962|NCT00393991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111049963|NCT00393991|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111049964|NCT00393991|Autonomic Agents|autonomic agents|mesh-ancestor
111049965|NCT00393991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111049966|NCT00393991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111049967|NCT00393991|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111049968|NCT00393991|Respiratory System Agents|respiratory system agents|mesh-ancestor
111049969|NCT00393991|Dermatologic Agents|dermatologic agents|mesh-ancestor
111049970|NCT00393991|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111049971|NCT00393991|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111049972|NCT00393991|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111049973|NCT00393991|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111049974|NCT00393991|Adrenergic Agents|adrenergic agents|mesh-ancestor
111049975|NCT00393991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111049976|NCT00393991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111049977|NCT02664441|Exenatide|exenatide|mesh-list
111049978|NCT02664441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111049979|NCT02664441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111049980|NCT02664441|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111049981|NCT02664441|Incretins|incretins|mesh-ancestor
111049982|NCT02664441|Hormones|hormones|mesh-ancestor
111049983|NCT02664441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111049984|NCT02191007|Calcitriol|calcitriol|mesh-list
111049985|NCT02191007|Betamethasone|betamethasone|mesh-list
111049986|NCT02191007|Betamethasone Valerate|betamethasone valerate|mesh-list
111049987|NCT02191007|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
111049988|NCT02191007|Betamethasone benzoate|betamethasone benzoate|mesh-list
111049989|NCT02191007|Calcipotriene|calcipotriene|mesh-list
111049990|NCT02191007|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
111049991|NCT02191007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111049992|NCT02191007|Glucocorticoids|glucocorticoids|mesh-ancestor
111049993|NCT02191007|Hormones|hormones|mesh-ancestor
110629677|NCT00958503|Thiamphenicol|thiamphenicol|mesh-list
111049994|NCT02191007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111049995|NCT02191007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111049996|NCT02191007|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111049997|NCT02191007|Respiratory System Agents|respiratory system agents|mesh-ancestor
111049998|NCT02191007|Dermatologic Agents|dermatologic agents|mesh-ancestor
111049999|NCT02191007|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111050000|NCT02191007|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
111050001|NCT02191007|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111050002|NCT02191007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111050003|NCT02191007|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111050004|NCT02191007|Vitamins|vitamins|mesh-ancestor
111050005|NCT02191007|Micronutrients|micronutrients|mesh-ancestor
111050006|NCT02191007|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111050007|NCT02298946|Cyclophosphamide|cyclophosphamide|mesh-list
111050008|NCT02298946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111050009|NCT02298946|Immunologic Factors|immunologic factors|mesh-ancestor
111050010|NCT02298946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111050011|NCT02298946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111050012|NCT02298946|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111050013|NCT02298946|Alkylating Agents|alkylating agents|mesh-ancestor
111050014|NCT02298946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111050015|NCT02298946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111050016|NCT02298946|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111050017|NCT04470115|Anesthetics|anesthetics|mesh-list
111050018|NCT04470115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111050019|NCT04470115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111050020|NCT02384343|Dexmedetomidine|dexmedetomidine|mesh-list
111050021|NCT02384343|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111050022|NCT02384343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111050023|NCT02384343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111050024|NCT02384343|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111050025|NCT02384343|Analgesics|analgesics|mesh-ancestor
111050026|NCT02384343|Sensory System Agents|sensory system agents|mesh-ancestor
111050027|NCT02384343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111050028|NCT02384343|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111050029|NCT02384343|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111050030|NCT02384343|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111050031|NCT02384343|Adrenergic Agents|adrenergic agents|mesh-ancestor
111050032|NCT02384343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111050033|NCT02384343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111050034|NCT05033639|Melatonin|melatonin|mesh-list
111050035|NCT05033639|Antioxidants|antioxidants|mesh-ancestor
111050036|NCT05033639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111050037|NCT05033639|Protective Agents|protective agents|mesh-ancestor
111050038|NCT05033639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111050039|NCT05033639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111050040|NCT02328040|Insulin|insulin|mesh-list
111050041|NCT02328040|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111050042|NCT02328040|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111050043|NCT02328040|Insulin Aspart|insulin aspart|mesh-list
111050044|NCT02328040|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111050045|NCT02328040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111050046|NCT02328040|Incretins|incretins|mesh-ancestor
111050047|NCT02328040|Hormones|hormones|mesh-ancestor
111050048|NCT02328040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111050049|NCT02328040|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111050050|NCT02328040|Protease Inhibitors|protease inhibitors|mesh-ancestor
111050051|NCT02328040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111050052|NCT02328040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111050053|NCT00355849|Insulin|insulin|mesh-list
111050054|NCT00355849|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111050055|NCT00355849|Insulin Glargine|insulin glargine|mesh-list
111050056|NCT00355849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111050057|NCT00355849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111050058|NCT02384499|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
111050059|NCT02384499|Hemostatics|hemostatics|mesh-ancestor
111050060|NCT02384499|Coagulants|coagulants|mesh-ancestor
111050061|NCT02186951|Amoxicillin|amoxicillin|mesh-list
111050062|NCT02186951|Clavulanic Acids|clavulanic acids|mesh-list
111050063|NCT02186951|Clavulanic Acid|clavulanic acid|mesh-list
111050064|NCT02186951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111050065|NCT02186951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111050066|NCT02186951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111050067|NCT02186951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111050068|NCT02186951|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
111050069|NCT02285413|Cisplatin|cisplatin|mesh-list
111050070|NCT02285413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111050071|NCT02381379|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
111050072|NCT02381379|Antiviral Agents|antiviral agents|mesh-ancestor
111050073|NCT02381379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111050074|NCT02187107|Darunavir|darunavir|mesh-list
111050075|NCT02187107|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111050076|NCT02187107|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111050077|NCT02187107|Protease Inhibitors|protease inhibitors|mesh-ancestor
111050078|NCT02187107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111050079|NCT02187107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111050080|NCT02187107|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111050081|NCT02187107|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111050082|NCT02187107|Antiviral Agents|antiviral agents|mesh-ancestor
111050083|NCT02187107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111050084|NCT02285491|Bupivacaine|bupivacaine|mesh-list
111050085|NCT02285491|Anesthetics, Local|anesthetics, local|mesh-ancestor
111050086|NCT02285491|Anesthetics|anesthetics|mesh-ancestor
111050087|NCT02285491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111050088|NCT02285491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111050089|NCT02285491|Sensory System Agents|sensory system agents|mesh-ancestor
111050090|NCT02285491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111050091|NCT02298868|Baclofen|baclofen|mesh-list
111050092|NCT02298868|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110767163|NCT00786019|Vitamins|vitamins|mesh-list
110767164|NCT00786019|Ascorbic Acid|ascorbic acid|mesh-list
110767165|NCT00786019|Micronutrients|micronutrients|mesh-ancestor
110767166|NCT00786019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110767173|NCT00692484|Povidone|povidone|mesh-list
111050093|NCT02298868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111050094|NCT02298868|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111050095|NCT02298868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111050096|NCT02298868|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
111050097|NCT02298868|GABA Agonists|gaba agonists|mesh-ancestor
111050099|NCT02298868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111050100|NCT02298868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111050102|NCT02389179|Cholecalciferol|cholecalciferol|mesh-list
111050103|NCT02389179|Vitamins|vitamins|mesh-ancestor
111050104|NCT02389179|Micronutrients|micronutrients|mesh-ancestor
111050105|NCT02389179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111050106|NCT02389179|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111050107|NCT02389179|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111050108|NCT02285647|Rolapitant|rolapitant|mesh-list
111050109|NCT02285647|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
111050110|NCT02285647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111050111|NCT02285647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111050112|NCT02285647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111050113|NCT02187419|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
111050114|NCT02187419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111050115|NCT02187419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111050116|NCT02187497|Telmisartan|telmisartan|mesh-list
111050117|NCT02187497|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111050118|NCT02187497|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111050119|NCT02187497|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111050120|NCT02187497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111050121|NCT04195750|Everolimus|everolimus|mesh-list
111050122|NCT04195750|Belzutifan|belzutifan|mesh-list
110629701|NCT00966771|Copper|copper|mesh-list
111050123|NCT04195750|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111050124|NCT04195750|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111050125|NCT04195750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111050126|NCT04195750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111050127|NCT04195750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111050128|NCT04195750|Immunologic Factors|immunologic factors|mesh-ancestor
111050129|NCT04195750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111050130|NCT04195750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111050131|NCT00099853|Pioglitazone|pioglitazone|mesh-list
111050132|NCT00099853|Vildagliptin|vildagliptin|mesh-list
111050133|NCT00099853|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111050134|NCT00099853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111050135|NCT00099853|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111050136|NCT00099853|Protease Inhibitors|protease inhibitors|mesh-ancestor
111050137|NCT00099853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111050138|NCT00099853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111050139|NCT02381145|Resveratrol|resveratrol|mesh-list
111050140|NCT02381145|Antioxidants|antioxidants|mesh-ancestor
111050141|NCT02381145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111050142|NCT02381145|Protective Agents|protective agents|mesh-ancestor
111050143|NCT02381145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111050144|NCT02381145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111050145|NCT02381145|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111050146|NCT00097357|Enoxaparin|enoxaparin|mesh-list
111050147|NCT00097357|Warfarin|warfarin|mesh-list
111050148|NCT00097357|Enoxaparin sodium|enoxaparin sodium|mesh-list
111050149|NCT00097357|Apixaban|apixaban|mesh-list
111050150|NCT00097357|Anticoagulants|anticoagulants|mesh-ancestor
111050151|NCT00097357|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111050152|NCT00097357|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111050153|NCT00097357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111050154|NCT00097357|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111050155|NCT00097357|Antithrombins|antithrombins|mesh-ancestor
111050156|NCT00097357|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111050157|NCT00097357|Protease Inhibitors|protease inhibitors|mesh-ancestor
111050158|NCT00097357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111050159|NCT02296840|Acetaminophen|acetaminophen|mesh-list
111050160|NCT02296840|Ibuprofen|ibuprofen|mesh-list
111050161|NCT02296840|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
111050162|NCT02296840|Hydrocodone|hydrocodone|mesh-list
111050163|NCT02296840|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111050164|NCT02296840|Analgesics|analgesics|mesh-ancestor
111050165|NCT02296840|Sensory System Agents|sensory system agents|mesh-ancestor
111050166|NCT02296840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110767241|NCT03896256|Anesthetics|anesthetics|mesh-ancestor
111050168|NCT02296840|Antipyretics|antipyretics|mesh-ancestor
111050169|NCT02296840|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111050170|NCT02296840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111050171|NCT02296840|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111050172|NCT02296840|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111050173|NCT02296840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111050174|NCT02296840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111050175|NCT02296840|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111050176|NCT02296840|Narcotics|narcotics|mesh-ancestor
111050177|NCT02296840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111050178|NCT02296840|Antitussive Agents|antitussive agents|mesh-ancestor
111050179|NCT02296840|Respiratory System Agents|respiratory system agents|mesh-ancestor
111050181|NCT02191319|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111050182|NCT02191319|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111050183|NCT02191319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111050184|NCT02191319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111050185|NCT02191319|Antiviral Agents|antiviral agents|mesh-ancestor
111050186|NCT02191319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111050187|NCT02191319|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111050188|NCT02191319|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111050189|NCT02191319|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110629715|NCT00855114|Everolimus|everolimus|mesh-list
111050190|NCT02191319|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111050191|NCT02191475|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
111050192|NCT02191475|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111050193|NCT02191475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111050194|NCT02191475|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
111050195|NCT02191475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111050196|NCT02191475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111050197|NCT02191709|Dextromethorphan|dextromethorphan|mesh-list
111050198|NCT02191709|Antitussive Agents|antitussive agents|mesh-ancestor
111050199|NCT02191709|Respiratory System Agents|respiratory system agents|mesh-ancestor
111050200|NCT02191709|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111050201|NCT02191709|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111050202|NCT02191709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111050203|NCT02191709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111050204|NCT02191709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111050205|NCT00326287|Ceftriaxone|ceftriaxone|mesh-list
111050206|NCT00326287|Linezolid|linezolid|mesh-list
111050207|NCT00326287|Ceftobiprole|ceftobiprole|mesh-list
111050208|NCT00326287|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
111050209|NCT00326287|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111050210|NCT00326287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111050211|NCT00326287|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111050212|NCT00326287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111050213|NCT00326287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111050214|NCT02191943|Fluorides|fluorides|mesh-list
111050215|NCT02191943|Fluorides, Topical|fluorides, topical|mesh-list
111050216|NCT02191943|Sodium fluoride topical preparation|sodium fluoride topical preparation|mesh-list
111050217|NCT02191943|Cariostatic Agents|cariostatic agents|mesh-ancestor
111050218|NCT02191943|Protective Agents|protective agents|mesh-ancestor
111050219|NCT02191943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111050220|NCT02663895|Treprostinil|treprostinil|mesh-list
111050221|NCT02663895|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111050222|NCT00320203|Hydrocortisone|hydrocortisone|mesh-list
111050223|NCT00320203|Anecortave|anecortave|mesh-list
111050224|NCT00320203|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111050225|NCT00320203|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111050226|NCT00320203|Growth Substances|growth substances|mesh-ancestor
111050227|NCT00320203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111050228|NCT00320203|Growth Inhibitors|growth inhibitors|mesh-ancestor
111050229|NCT00320203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111050230|NCT00320203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111050231|NCT00071461|Bosentan|bosentan|mesh-list
111050232|NCT00071461|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111050233|NCT00071461|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
111050234|NCT00071461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111050235|NCT00069745|Prednisone|prednisone|mesh-list
111050236|NCT00069745|Satraplatin|satraplatin|mesh-list
111050237|NCT00069745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111050238|NCT00069745|Glucocorticoids|glucocorticoids|mesh-ancestor
111050239|NCT00069745|Hormones|hormones|mesh-ancestor
110767317|NCT03899142|Antibodies|antibodies|mesh-list
111050240|NCT00069745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111050241|NCT00069745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111050242|NCT00069745|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111050243|NCT00069745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111050244|NCT02192411|Lidocaine|lidocaine|mesh-list
111050245|NCT02192411|Anesthetics, Local|anesthetics, local|mesh-ancestor
111050246|NCT02192411|Anesthetics|anesthetics|mesh-ancestor
111050247|NCT02192411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111050248|NCT02192411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111050249|NCT02192411|Sensory System Agents|sensory system agents|mesh-ancestor
111050250|NCT02192411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111050251|NCT02192411|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111050252|NCT02192411|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111050253|NCT02192411|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111050254|NCT02192411|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111050255|NCT02192411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111050256|NCT02193893|Coal Tar|coal tar|mesh-list
111050257|NCT02193893|Keratolytic Agents|keratolytic agents|mesh-ancestor
111050258|NCT02193893|Dermatologic Agents|dermatologic agents|mesh-ancestor
111050259|NCT02384187|Gabapentin|gabapentin|mesh-list
111050260|NCT02384187|Analgesics|analgesics|mesh-ancestor
111050261|NCT02384187|Sensory System Agents|sensory system agents|mesh-ancestor
111050262|NCT02384187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111050263|NCT02384187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111050264|NCT02384187|Anticonvulsants|anticonvulsants|mesh-ancestor
111050265|NCT02384187|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111050266|NCT02384187|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111050267|NCT02384187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111050268|NCT02384187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111050269|NCT02384187|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111050270|NCT02384187|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111050271|NCT02384187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111050272|NCT02384187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111050273|NCT02384187|Antimanic Agents|antimanic agents|mesh-ancestor
111050274|NCT02192723|Olanzapine|olanzapine|mesh-list
111050275|NCT02192723|Risperidone|risperidone|mesh-list
111050276|NCT02192723|Aripiprazole|aripiprazole|mesh-list
111050277|NCT02192723|Quetiapine Fumarate|quetiapine fumarate|mesh-list
111050278|NCT02192723|Ziprasidone|ziprasidone|mesh-list
111050279|NCT02192723|Antipsychotic Agents|antipsychotic agents|mesh-list
111050280|NCT02192723|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111050281|NCT02192723|Serotonin Agents|serotonin agents|mesh-ancestor
111050282|NCT02192723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111050283|NCT02192723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111050284|NCT02192723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111050285|NCT02192723|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111050286|NCT02192723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111050287|NCT02192723|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111050288|NCT02192723|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111050289|NCT02192723|Dopamine Agents|dopamine agents|mesh-ancestor
111050290|NCT02192723|Antiemetics|antiemetics|mesh-ancestor
111050291|NCT02192723|Autonomic Agents|autonomic agents|mesh-ancestor
111050292|NCT02192723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111050293|NCT02192723|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111050294|NCT02192723|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111050295|NCT02192723|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111050296|NCT02192723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111050297|NCT02192723|Antidepressive Agents|antidepressive agents|mesh-ancestor
111050298|NCT02192723|Dopamine Agonists|dopamine agonists|mesh-ancestor
111050299|NCT02192723|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111050300|NCT02192723|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111050301|NCT02192723|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111050302|NCT02192723|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111050303|NCT00319969|Topotecan|topotecan|mesh-list
111050304|NCT00319969|Amrubicin|amrubicin|mesh-list
111050305|NCT00319969|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111050306|NCT00319969|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111050307|NCT00319969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111050308|NCT00319969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111050309|NCT00319969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111050310|NCT00317395|Heparin|heparin|mesh-list
111050311|NCT00317395|Calcium heparin|calcium heparin|mesh-list
111050312|NCT00317395|Otamixaban|otamixaban|mesh-list
111050313|NCT00317395|Eptifibatide|eptifibatide|mesh-list
111050316|NCT00317395|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111050317|NCT00317395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111050318|NCT00317395|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111050319|NCT00317395|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111050320|NCT00317395|Antithrombins|antithrombins|mesh-ancestor
111050321|NCT00317395|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111050322|NCT00317395|Protease Inhibitors|protease inhibitors|mesh-ancestor
111050323|NCT00317395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111050324|NCT02383563|Metformin|metformin|mesh-list
111050325|NCT02383563|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111050326|NCT02383563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111050327|NCT03535961|Etoposide|etoposide|mesh-list
111050328|NCT03535961|Apatinib|apatinib|mesh-list
111050329|NCT03535961|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111050330|NCT03535961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111050331|NCT03535961|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111050332|NCT03535961|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111050333|NCT03535961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111050334|NCT03535961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111050335|NCT03535961|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111050336|NCT02380755|Clomiphene|clomiphene|mesh-list
111050337|NCT02380755|Enclomiphene|enclomiphene|mesh-list
111050338|NCT02380755|Zuclomiphene|zuclomiphene|mesh-list
111050339|NCT02380755|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111050340|NCT02380755|Hormone Antagonists|hormone antagonists|mesh-ancestor
111050341|NCT02380755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111050342|NCT02380755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111050343|NCT02380755|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111050344|NCT02380755|Fertility Agents|fertility agents|mesh-ancestor
111050345|NCT02380755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111050346|NCT02380755|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111050347|NCT02380755|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111050348|NCT02188277|Botulinum Toxins|botulinum toxins|mesh-list
111050349|NCT02188277|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111050350|NCT02188277|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111050351|NCT02188277|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
111050352|NCT02188277|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111050353|NCT02188277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111050354|NCT02188277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111050355|NCT02188277|Cholinergic Agents|cholinergic agents|mesh-ancestor
111050356|NCT02188277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111050357|NCT02188277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111050358|NCT02188277|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111050359|NCT02188277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111050360|NCT02380521|Exenatide|exenatide|mesh-list
111050361|NCT02380521|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111050362|NCT02380521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111050363|NCT02380521|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111050364|NCT02380521|Incretins|incretins|mesh-ancestor
111050365|NCT02380521|Hormones|hormones|mesh-ancestor
111050366|NCT02380521|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111050367|NCT00315757|Bortezomib|bortezomib|mesh-list
111050368|NCT00315757|Mapatumumab|mapatumumab|mesh-list
111050369|NCT00315757|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111050370|NCT00315757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111050371|NCT00315757|Immunologic Factors|immunologic factors|mesh-ancestor
111050372|NCT00315757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111050373|NCT02377401|Zanamivir|zanamivir|mesh-list
111050374|NCT02377401|Antiviral Agents|antiviral agents|mesh-ancestor
111050375|NCT02377401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111050376|NCT02377401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111050377|NCT02377401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111050378|NCT00312091|Lamivudine|lamivudine|mesh-list
111050379|NCT00312091|Nevirapine|nevirapine|mesh-list
111050380|NCT00312091|Stavudine|stavudine|mesh-list
111050381|NCT00312091|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111050382|NCT00312091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111050383|NCT00312091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111050384|NCT00312091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111050385|NCT00312091|Antiviral Agents|antiviral agents|mesh-ancestor
111050386|NCT00312091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111050387|NCT00312091|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111050388|NCT00312091|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110026224|NCT00422214|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111050389|NCT00312091|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111050390|NCT00312091|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111050391|NCT00312091|Antimetabolites|antimetabolites|mesh-ancestor
111050392|NCT00389779|Guanfacine|guanfacine|mesh-list
111050393|NCT00389779|Darusentan|darusentan|mesh-list
111050394|NCT00389779|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111050395|NCT00389779|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111050396|NCT00389779|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111050397|NCT00389779|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111050398|NCT00389779|Adrenergic Agents|adrenergic agents|mesh-ancestor
111050399|NCT00389779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111050400|NCT00389779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111050401|NCT00389779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111050402|NCT00389779|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
111050403|NCT00389155|Gemcitabine|gemcitabine|mesh-list
111050404|NCT00389155|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111050405|NCT00389155|Antimetabolites|antimetabolites|mesh-ancestor
111050406|NCT00389155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111050407|NCT00389155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111050408|NCT02188511|Nicotine|nicotine|mesh-list
111050409|NCT02188511|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111050410|NCT02188511|Autonomic Agents|autonomic agents|mesh-ancestor
111050411|NCT02188511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111050412|NCT02188511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111050413|NCT02188511|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111050414|NCT02188511|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111050415|NCT02188511|Cholinergic Agents|cholinergic agents|mesh-ancestor
111050416|NCT02188511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111050417|NCT02188511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111050418|NCT02380131|Capecitabine|capecitabine|mesh-list
111050419|NCT02380131|Oxaliplatin|oxaliplatin|mesh-list
111050420|NCT02380131|Trastuzumab|trastuzumab|mesh-list
111050421|NCT02380131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111050422|NCT02380131|Antimetabolites|antimetabolites|mesh-ancestor
111050423|NCT02380131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111050424|NCT02380131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111050425|NCT02380131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111050426|NCT03535103|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
111050427|NCT03535103|Hormones|hormones|mesh-ancestor
111050428|NCT03535103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111050429|NCT03535103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111050430|NCT04360941|Palbociclib|palbociclib|mesh-list
111050431|NCT04360941|Avelumab|avelumab|mesh-list
111050432|NCT04360941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111050433|NCT04360941|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111050434|NCT04360941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111050435|NCT04360941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111050436|NCT04360941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111050437|NCT04551365|Chitosan|chitosan|mesh-list
111050438|NCT04551365|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111050439|NCT04551365|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111050440|NCT04551365|Antimetabolites|antimetabolites|mesh-ancestor
111050441|NCT04551365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111050442|NCT04551365|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111050443|NCT04551365|Chelating Agents|chelating agents|mesh-ancestor
111050444|NCT04551365|Sequestering Agents|sequestering agents|mesh-ancestor
111050445|NCT04551365|Hemostatics|hemostatics|mesh-ancestor
111050446|NCT04551365|Coagulants|coagulants|mesh-ancestor
111050447|NCT00028639|Bortezomib|bortezomib|mesh-list
111050448|NCT00028639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111050449|NCT02371941|Cromolyn Sodium|cromolyn sodium|mesh-list
111050450|NCT02371941|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
111050451|NCT02371941|Immunologic Factors|immunologic factors|mesh-ancestor
111050452|NCT02371941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111050453|NCT02371941|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111050454|NCT02371941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111050455|NCT02371941|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111050456|NCT02371941|Respiratory System Agents|respiratory system agents|mesh-ancestor
111050457|NCT00298987|Dasatinib|dasatinib|mesh-list
111050458|NCT00298987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111050459|NCT00298987|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111050460|NCT00298987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111050461|NCT00298987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111050462|NCT02380053|Celiprolol|celiprolol|mesh-list
110767541|NCT01260246|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111050463|NCT02380053|Bisoprolol|bisoprolol|mesh-list
111050464|NCT02380053|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111050465|NCT02380053|Sympatholytics|sympatholytics|mesh-ancestor
111050466|NCT02380053|Autonomic Agents|autonomic agents|mesh-ancestor
111050467|NCT02380053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111050468|NCT02380053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111050469|NCT02380053|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
111050470|NCT02380053|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111050471|NCT02380053|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111050472|NCT02380053|Adrenergic Agents|adrenergic agents|mesh-ancestor
111050473|NCT02380053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111050474|NCT02380053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111050475|NCT02380053|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111050476|NCT02380053|Sympathomimetics|sympathomimetics|mesh-ancestor
111050477|NCT02380053|Vasodilator Agents|vasodilator agents|mesh-ancestor
111050478|NCT02371707|(2-(6-fluoro-1H-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|(2-(6-fluoro-1h-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|mesh-list
111050479|NCT02371707|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111050480|NCT02371707|Serotonin Agents|serotonin agents|mesh-ancestor
111050481|NCT02371707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111050482|NCT02371707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111050483|NCT02371707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111050484|NCT02193971|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
111050485|NCT02193971|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111050486|NCT00004915|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
111050487|NCT00004915|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111050488|NCT00004915|Hormone Antagonists|hormone antagonists|mesh-ancestor
111050489|NCT00004915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111050490|NCT00004915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111050491|NCT00004915|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111050492|NCT00004915|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111050493|NCT00004915|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111050495|NCT03535415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111050496|NCT03535415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111050497|NCT02030717|Clonidine|clonidine|mesh-list
111050498|NCT02030717|Anesthetics|anesthetics|mesh-list
111050499|NCT02030717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111050500|NCT02030717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111050501|NCT02030717|Analgesics|analgesics|mesh-ancestor
111050502|NCT02030717|Sensory System Agents|sensory system agents|mesh-ancestor
111050503|NCT02030717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111050504|NCT02030717|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111050505|NCT02030717|Sympatholytics|sympatholytics|mesh-ancestor
111050506|NCT02030717|Autonomic Agents|autonomic agents|mesh-ancestor
111050507|NCT02030717|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111050508|NCT02030717|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111050509|NCT02030717|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111050510|NCT02030717|Adrenergic Agents|adrenergic agents|mesh-ancestor
111050511|NCT02030717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111050512|NCT02030717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111050513|NCT02371473|Acetazolamide|acetazolamide|mesh-list
111050514|NCT02371473|Anticonvulsants|anticonvulsants|mesh-ancestor
111050515|NCT02371473|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
111050516|NCT02371473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111050517|NCT02371473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111050518|NCT02371473|Diuretics|diuretics|mesh-ancestor
111050519|NCT02371473|Natriuretic Agents|natriuretic agents|mesh-ancestor
111050520|NCT02371473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111050521|NCT04301661|Tenofovir|tenofovir|mesh-list
111050522|NCT04301661|Lamivudine|lamivudine|mesh-list
111050523|NCT04301661|Emtricitabine|emtricitabine|mesh-list
111050524|NCT04301661|Abacavir|abacavir|mesh-list
111050525|NCT04301661|Antiviral Agents|antiviral agents|mesh-ancestor
111050526|NCT04301661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111050527|NCT04301661|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111050528|NCT04301661|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111050529|NCT04301661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111050530|NCT04301661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111050531|NCT04301661|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111050532|NCT04301661|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111050533|NCT02194049|Etoposide|etoposide|mesh-list
111050534|NCT02194049|Etoposide phosphate|etoposide phosphate|mesh-list
111050535|NCT02194049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111050536|NCT02194049|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111050537|NCT02194049|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111050538|NCT02194049|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111050539|NCT02194049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111050540|NCT02194049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111050541|NCT02379663|Enoxaparin|enoxaparin|mesh-list
111050542|NCT02379663|Rivaroxaban|rivaroxaban|mesh-list
111050543|NCT02379663|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111050544|NCT02379663|Antithrombins|antithrombins|mesh-ancestor
111050545|NCT02379663|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111050546|NCT02379663|Protease Inhibitors|protease inhibitors|mesh-ancestor
111050547|NCT02379663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111050548|NCT02379663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111050549|NCT02379663|Anticoagulants|anticoagulants|mesh-ancestor
111050550|NCT02379663|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111050551|NCT02379663|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111050552|NCT02030639|ON 01910|on 01910|mesh-list
111050553|NCT02030639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111050554|NCT02030639|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111050555|NCT02030639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111050556|NCT02030639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111050557|NCT00004897|Leucovorin|leucovorin|mesh-list
111050558|NCT00004897|Interferons|interferons|mesh-list
111050559|NCT00004897|Interferon-alpha|interferon-alpha|mesh-list
111050560|NCT00004897|Fluorouracil|fluorouracil|mesh-list
111050561|NCT00004897|Hydroxyurea|hydroxyurea|mesh-list
111050562|NCT00004897|Calcium|calcium|mesh-list
111050563|NCT00004897|Levoleucovorin|levoleucovorin|mesh-list
111050564|NCT00004897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111050565|NCT00004897|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110629768|NCT00973713|Everolimus|everolimus|mesh-list
111050566|NCT00004897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111050567|NCT00004897|Antimetabolites|antimetabolites|mesh-ancestor
111050568|NCT00004897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111050569|NCT00004897|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111050570|NCT00004897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111050571|NCT00004897|Immunologic Factors|immunologic factors|mesh-ancestor
111050572|NCT00004897|Antiviral Agents|antiviral agents|mesh-ancestor
111050573|NCT00004897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111050574|NCT00004897|Antidotes|antidotes|mesh-ancestor
111050575|NCT00004897|Protective Agents|protective agents|mesh-ancestor
111050576|NCT00004897|Vitamin B Complex|vitamin b complex|mesh-ancestor
111050577|NCT00004897|Vitamins|vitamins|mesh-ancestor
111050578|NCT00004897|Micronutrients|micronutrients|mesh-ancestor
111050579|NCT00004897|Antisickling Agents|antisickling agents|mesh-ancestor
111050580|NCT00004897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111050581|NCT00004897|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111050582|NCT00004231|Leucovorin|leucovorin|mesh-list
111050583|NCT00004231|Interferons|interferons|mesh-list
111050584|NCT00004231|Cytarabine|cytarabine|mesh-list
111050585|NCT00004231|Interferon-alpha|interferon-alpha|mesh-list
111050586|NCT00004231|Aldesleukin|aldesleukin|mesh-list
111050587|NCT00004231|Prednisone|prednisone|mesh-list
111050588|NCT00004231|Cyclophosphamide|cyclophosphamide|mesh-list
111050589|NCT00004231|Busulfan|busulfan|mesh-list
111050590|NCT00004231|Doxorubicin|doxorubicin|mesh-list
111050591|NCT00004231|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111050592|NCT00004231|Methotrexate|methotrexate|mesh-list
111050593|NCT00004231|Vincristine|vincristine|mesh-list
111050594|NCT00004231|Teniposide|teniposide|mesh-list
111050595|NCT00004231|Levoleucovorin|levoleucovorin|mesh-list
111050596|NCT00004231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111050597|NCT00004231|Immunologic Factors|immunologic factors|mesh-ancestor
111050598|NCT00004231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111050599|NCT00004231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111050600|NCT00004231|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111050601|NCT00004231|Alkylating Agents|alkylating agents|mesh-ancestor
111050602|NCT00004231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111050603|NCT00004231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111050604|NCT00004231|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111050605|NCT00004231|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111050606|NCT00004231|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111050607|NCT00004231|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111050608|NCT00004231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111050609|NCT00004231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111050610|NCT00004231|Glucocorticoids|glucocorticoids|mesh-ancestor
111050611|NCT00004231|Hormones|hormones|mesh-ancestor
111050612|NCT00004231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110629791|NCT00865176|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
111050613|NCT00004231|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111050614|NCT00004231|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111050615|NCT00004231|Abortifacient Agents|abortifacient agents|mesh-ancestor
111050616|NCT00004231|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111050617|NCT00004231|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111050619|NCT00004231|Dermatologic Agents|dermatologic agents|mesh-ancestor
111050620|NCT00004231|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111050621|NCT00004231|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111050622|NCT00004231|Antiviral Agents|antiviral agents|mesh-ancestor
111050623|NCT00004231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111050624|NCT00004231|Antidotes|antidotes|mesh-ancestor
111050625|NCT00004231|Protective Agents|protective agents|mesh-ancestor
111050626|NCT00004231|Vitamin B Complex|vitamin b complex|mesh-ancestor
111050627|NCT00004231|Vitamins|vitamins|mesh-ancestor
111050628|NCT00004231|Micronutrients|micronutrients|mesh-ancestor
111050629|NCT00004231|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111050630|NCT00004231|Tubulin Modulators|tubulin modulators|mesh-ancestor
111050631|NCT00004231|Antimitotic Agents|antimitotic agents|mesh-ancestor
111050632|NCT00004231|Mitosis Modulators|mitosis modulators|mesh-ancestor
111050633|NCT00004231|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111050634|NCT00004231|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111050635|NCT00004171|Cyclophosphamide|cyclophosphamide|mesh-list
111050636|NCT00004171|Busulfan|busulfan|mesh-list
111050637|NCT00004171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111050638|NCT00004171|Immunologic Factors|immunologic factors|mesh-ancestor
111050639|NCT00004171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111050640|NCT00004171|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111050641|NCT00004171|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111050642|NCT00004171|Alkylating Agents|alkylating agents|mesh-ancestor
111050643|NCT00004171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111050644|NCT00004171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111050645|NCT00004171|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111050646|NCT00004165|Melphalan|melphalan|mesh-list
111050647|NCT00004165|Immunologic Factors|immunologic factors|mesh-ancestor
111050648|NCT00004165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111050649|NCT00004165|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111050650|NCT00004165|Alkylating Agents|alkylating agents|mesh-ancestor
111050651|NCT00004165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111050652|NCT00004165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111050653|NCT00004165|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111050654|NCT00004165|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111050655|NCT00004093|Paclitaxel|paclitaxel|mesh-list
111050656|NCT00004093|Vinorelbine|vinorelbine|mesh-list
111050657|NCT00004093|Carboplatin|carboplatin|mesh-list
111050658|NCT00004093|Gemcitabine|gemcitabine|mesh-list
111050659|NCT00004093|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111050660|NCT00004093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111050661|NCT00004093|Tubulin Modulators|tubulin modulators|mesh-ancestor
111050662|NCT00004093|Antimitotic Agents|antimitotic agents|mesh-ancestor
111050663|NCT00004093|Mitosis Modulators|mitosis modulators|mesh-ancestor
111050664|NCT00004093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111050665|NCT00004093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111050666|NCT00004093|Antimetabolites|antimetabolites|mesh-ancestor
111050667|NCT02193269|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111050668|NCT02193269|Minocycline|minocycline|mesh-list
111050669|NCT02193269|Tetracycline|tetracycline|mesh-list
111050670|NCT02193269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111050671|NCT02193269|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111050672|NCT02193269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111050673|NCT02193269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111050674|NCT00002479|Tretinoin|tretinoin|mesh-list
111050675|NCT00002479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111050676|NCT00002479|Keratolytic Agents|keratolytic agents|mesh-ancestor
111050677|NCT00002479|Dermatologic Agents|dermatologic agents|mesh-ancestor
111050678|NCT00002371|Lamivudine|lamivudine|mesh-list
111050679|NCT00002371|Zidovudine|zidovudine|mesh-list
111050680|NCT00002371|Stavudine|stavudine|mesh-list
111050681|NCT00002371|Indinavir|indinavir|mesh-list
111050682|NCT00002371|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111050683|NCT00002371|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111050684|NCT00002371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111050685|NCT00002371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111050686|NCT00002371|Antiviral Agents|antiviral agents|mesh-ancestor
111050687|NCT00002371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111050688|NCT00002371|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111050689|NCT00002371|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111050690|NCT00002371|Antimetabolites|antimetabolites|mesh-ancestor
111050691|NCT00002371|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111050692|NCT00002371|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111050693|NCT00002371|Protease Inhibitors|protease inhibitors|mesh-ancestor
111050694|NCT02189681|Anesthetics|anesthetics|mesh-list
111050695|NCT02189681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111050696|NCT02189681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111050697|NCT05715385|Bromfenac|bromfenac|mesh-list
111050698|NCT05715385|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111050699|NCT05715385|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111050700|NCT05715385|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111050701|NCT05715385|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111050702|NCT05715385|Analgesics|analgesics|mesh-ancestor
111050703|NCT05715385|Sensory System Agents|sensory system agents|mesh-ancestor
111050704|NCT05715385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111050705|NCT05715385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111050706|NCT05715385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111050707|NCT05715385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111050708|NCT04182633|Vancomycin|vancomycin|mesh-list
111050709|NCT04182633|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
111050710|NCT04182633|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111050711|NCT04182633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111050712|NCT04182633|Laxatives|laxatives|mesh-ancestor
111050713|NCT04182633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111050714|NCT02194283|Ambroxol|ambroxol|mesh-list
111050715|NCT02194283|Expectorants|expectorants|mesh-ancestor
111050716|NCT02194283|Respiratory System Agents|respiratory system agents|mesh-ancestor
111050717|NCT00263341|Contraceptive Agents|contraceptive agents|mesh-list
111050718|NCT00263341|Ethinyl Estradiol|ethinyl estradiol|mesh-list
111050719|NCT00263341|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111050720|NCT00263341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111050721|NCT00263341|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111050722|NCT00263341|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111050723|NCT00263341|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111050724|NCT00263341|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111050725|NCT00263341|Estrogens|estrogens|mesh-ancestor
111050726|NCT00263341|Hormones|hormones|mesh-ancestor
111050727|NCT00263341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111050728|NCT03534869|Analgesics|analgesics|mesh-list
111050729|NCT03534869|Sensory System Agents|sensory system agents|mesh-ancestor
111050730|NCT03534869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111050731|NCT03534869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111050732|NCT02370849|Nimotuzumab|nimotuzumab|mesh-list
111050733|NCT02370849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111050734|NCT02370849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111050735|NCT02378649|Sildenafil Citrate|sildenafil citrate|mesh-list
111050736|NCT02378649|Vasodilator Agents|vasodilator agents|mesh-ancestor
111050737|NCT02378649|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111050738|NCT02378649|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111050739|NCT02378649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111050740|NCT02378649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111050741|NCT02378649|Urological Agents|urological agents|mesh-ancestor
111050742|NCT02197169|Interferons|interferons|mesh-list
111050743|NCT02197169|Interferon-gamma|interferon-gamma|mesh-list
111050744|NCT02197169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111050745|NCT02197169|Antiviral Agents|antiviral agents|mesh-ancestor
111050746|NCT02197169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111050747|NCT02376309|Nandrolone|nandrolone|mesh-list
111050748|NCT02376309|Androgens|androgens|mesh-ancestor
111050749|NCT02376309|Hormones|hormones|mesh-ancestor
111050750|NCT02376309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111050751|NCT02376309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111050752|NCT02376309|Anabolic Agents|anabolic agents|mesh-ancestor
111050753|NCT00232141|Pregabalin|pregabalin|mesh-list
111050754|NCT00232141|Analgesics|analgesics|mesh-ancestor
111050755|NCT00232141|Sensory System Agents|sensory system agents|mesh-ancestor
111050756|NCT00232141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111050757|NCT00232141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111050758|NCT00232141|Anticonvulsants|anticonvulsants|mesh-ancestor
111050759|NCT00232141|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111050760|NCT00232141|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111050761|NCT00232141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111050762|NCT00232141|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111050763|NCT00232141|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110515867|NCT00633698|Niacin|niacin|mesh-list
111050764|NCT00232141|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111050765|NCT00232141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111050766|NCT00232141|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111050767|NCT02378415|Ketamine|ketamine|mesh-list
111050768|NCT02378415|Analgesics|analgesics|mesh-ancestor
111050769|NCT02378415|Sensory System Agents|sensory system agents|mesh-ancestor
111050770|NCT02378415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111050771|NCT02378415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111050772|NCT02378415|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111050773|NCT02378415|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111050774|NCT02378415|Anesthetics, General|anesthetics, general|mesh-ancestor
111050775|NCT02378415|Anesthetics|anesthetics|mesh-ancestor
111050776|NCT02378415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111050777|NCT02378415|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111050778|NCT02378415|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111050779|NCT02378415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111050780|NCT02378415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111050781|NCT02197403|Dexmedetomidine|dexmedetomidine|mesh-list
111050782|NCT02197403|Propofol|propofol|mesh-list
111050783|NCT02197403|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111050784|NCT02197403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111050785|NCT02197403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111050786|NCT02197403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111050787|NCT02197403|Analgesics|analgesics|mesh-ancestor
111050788|NCT02197403|Sensory System Agents|sensory system agents|mesh-ancestor
111050789|NCT02197403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111050790|NCT02197403|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111050791|NCT02197403|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111050792|NCT02197403|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111050793|NCT02197403|Adrenergic Agents|adrenergic agents|mesh-ancestor
111050794|NCT02197403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111050795|NCT02197403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111050796|NCT02197403|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111050797|NCT02197403|Anesthetics, General|anesthetics, general|mesh-ancestor
111050798|NCT02197403|Anesthetics|anesthetics|mesh-ancestor
111050799|NCT02370069|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
111050800|NCT02370069|Immunologic Factors|immunologic factors|mesh-ancestor
111050801|NCT02370069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111050802|NCT02376075|Linagliptin|linagliptin|mesh-list
111050803|NCT02376075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111050804|NCT02376075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111050805|NCT02376075|Incretins|incretins|mesh-ancestor
111050806|NCT02376075|Hormones|hormones|mesh-ancestor
111050807|NCT02376075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111050808|NCT02376075|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111050809|NCT02376075|Protease Inhibitors|protease inhibitors|mesh-ancestor
111050810|NCT02376075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111050811|NCT02376075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111050812|NCT02197637|Vinorelbine|vinorelbine|mesh-list
111050813|NCT02197637|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111050814|NCT02197637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111050815|NCT02197637|Tubulin Modulators|tubulin modulators|mesh-ancestor
111050816|NCT02197637|Antimitotic Agents|antimitotic agents|mesh-ancestor
111050817|NCT02197637|Mitosis Modulators|mitosis modulators|mesh-ancestor
111050818|NCT02197637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111050819|NCT04469413|Acetaminophen|acetaminophen|mesh-list
111050820|NCT04469413|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111050821|NCT04469413|Analgesics|analgesics|mesh-ancestor
111050822|NCT04469413|Sensory System Agents|sensory system agents|mesh-ancestor
111050823|NCT04469413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111050824|NCT04469413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111050825|NCT04469413|Antipyretics|antipyretics|mesh-ancestor
111050826|NCT03532087|Denosumab|denosumab|mesh-list
111050827|NCT03532087|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111050828|NCT03532087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111050829|NCT02288923|Acetaminophen|acetaminophen|mesh-list
111050830|NCT02288923|Ibuprofen|ibuprofen|mesh-list
111050831|NCT02288923|Morphine|morphine|mesh-list
111050832|NCT02288923|Antiemetics|antiemetics|mesh-list
111050833|NCT02288923|Anesthetics|anesthetics|mesh-list
111050834|NCT02288923|Emetics|emetics|mesh-list
111050835|NCT02288923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111050836|NCT02288923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111050837|NCT02288923|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111050838|NCT02288923|Narcotics|narcotics|mesh-ancestor
111050839|NCT02288923|Analgesics|analgesics|mesh-ancestor
111050840|NCT02288923|Sensory System Agents|sensory system agents|mesh-ancestor
111050841|NCT02288923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111050842|NCT02288923|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110629868|NCT00865410|Bupropion|bupropion|mesh-list
111050843|NCT02288923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111050844|NCT02288923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111050845|NCT02288923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111050846|NCT02288923|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111050847|NCT02288923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111050848|NCT02288923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111050849|NCT02288923|Antipyretics|antipyretics|mesh-ancestor
111050850|NCT02288923|Autonomic Agents|autonomic agents|mesh-ancestor
111050851|NCT02288923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111050852|NCT02195375|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
111050853|NCT02195375|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111050854|NCT02195375|Autonomic Agents|autonomic agents|mesh-ancestor
111050855|NCT02195375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111050856|NCT02195375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111050857|NCT02195375|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111050858|NCT02195375|Respiratory System Agents|respiratory system agents|mesh-ancestor
111050859|NCT02195375|Glucocorticoids|glucocorticoids|mesh-ancestor
111050860|NCT02195375|Hormones|hormones|mesh-ancestor
111050861|NCT02195375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111050862|NCT02195375|Sympathomimetics|sympathomimetics|mesh-ancestor
111050863|NCT03531931|Apatinib|apatinib|mesh-list
111050864|NCT03531931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111050865|NCT03531931|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111050866|NCT03531931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111050867|NCT03531931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111050868|NCT03601455|Durvalumab|durvalumab|mesh-list
111050869|NCT03601455|Ipilimumab|ipilimumab|mesh-list
111050870|NCT03601455|Tremelimumab|tremelimumab|mesh-list
111050871|NCT03601455|Immunoglobulins|immunoglobulins|mesh-list
111050872|NCT03601455|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111050873|NCT03601455|Immunoglobulin G|immunoglobulin g|mesh-list
111050874|NCT03601455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111050875|NCT03601455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111050876|NCT03601455|Immunologic Factors|immunologic factors|mesh-ancestor
111050877|NCT03601455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111050878|NCT03601455|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111050879|NCT03601455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111050880|NCT03531697|Loteprednol Etabonate|loteprednol etabonate|mesh-list
111050881|NCT03531697|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111050882|NCT02369133|Acetaminophen|acetaminophen|mesh-list
111050883|NCT02369133|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111050884|NCT02369133|Analgesics|analgesics|mesh-ancestor
111050885|NCT02369133|Sensory System Agents|sensory system agents|mesh-ancestor
111050886|NCT02369133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111050887|NCT02369133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111050888|NCT02369133|Antipyretics|antipyretics|mesh-ancestor
111050889|NCT02377635|Selenious Acid|selenious acid|mesh-list
111050890|NCT02377635|Sodium Selenite|sodium selenite|mesh-list
111050891|NCT02377635|Trace Elements|trace elements|mesh-ancestor
111050892|NCT02377635|Micronutrients|micronutrients|mesh-ancestor
111050893|NCT02377635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111050894|NCT03534479|Immunoglobulins|immunoglobulins|mesh-list
111050895|NCT03534479|Immunologic Factors|immunologic factors|mesh-ancestor
111050896|NCT03534479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111050897|NCT02198027|Bupivacaine|bupivacaine|mesh-list
111050898|NCT02198027|Anesthetics, Local|anesthetics, local|mesh-ancestor
111050899|NCT02198027|Anesthetics|anesthetics|mesh-ancestor
111050900|NCT02198027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111050901|NCT02198027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111050902|NCT02198027|Sensory System Agents|sensory system agents|mesh-ancestor
111050903|NCT02198027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111050904|NCT02257463|Theophylline|theophylline|mesh-list
111050905|NCT02257463|Bronchodilator Agents|bronchodilator agents|mesh-list
111050906|NCT02257463|Autonomic Agents|autonomic agents|mesh-ancestor
111050907|NCT02257463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111050908|NCT02257463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111050909|NCT02257463|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111050910|NCT02257463|Respiratory System Agents|respiratory system agents|mesh-ancestor
111050911|NCT02257463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111050912|NCT02257463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111050913|NCT02257463|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111050914|NCT02257463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111050915|NCT02257463|Vasodilator Agents|vasodilator agents|mesh-ancestor
111050916|NCT02257463|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
111050917|NCT02257463|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111050918|NCT02257463|Purinergic Agents|purinergic agents|mesh-ancestor
111050919|NCT02198261|Minoxidil|minoxidil|mesh-list
111050920|NCT02198261|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111050921|NCT02198261|Vasodilator Agents|vasodilator agents|mesh-ancestor
111050922|NCT03533699|Propranolol|propranolol|mesh-list
111050923|NCT03533699|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111050924|NCT03533699|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111050925|NCT03533699|Adrenergic Agents|adrenergic agents|mesh-ancestor
111050926|NCT03533699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111050927|NCT03533699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111050928|NCT03533699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111050929|NCT03533699|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111050930|NCT03533699|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111050931|NCT03533699|Vasodilator Agents|vasodilator agents|mesh-ancestor
111050932|NCT00135421|Escitalopram|escitalopram|mesh-list
111050933|NCT00135421|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111050934|NCT00135421|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111050935|NCT00135421|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111050936|NCT00135421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111050937|NCT00135421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111050938|NCT00135421|Serotonin Agents|serotonin agents|mesh-ancestor
111050939|NCT00135421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111050940|NCT02200991|Insulin Glargine|insulin glargine|mesh-list
111050941|NCT02200991|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111050942|NCT02200991|Lixisenatide|lixisenatide|mesh-list
111050943|NCT02200991|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111050944|NCT02200991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111050945|NCT02200991|Incretins|incretins|mesh-ancestor
111050946|NCT02200991|Hormones|hormones|mesh-ancestor
111050947|NCT02200991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111050948|NCT02200991|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111050949|NCT02200991|Protease Inhibitors|protease inhibitors|mesh-ancestor
111050950|NCT02200991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111050951|NCT02200991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111050952|NCT01979367|Analgesics|analgesics|mesh-list
111050953|NCT01979367|Sensory System Agents|sensory system agents|mesh-ancestor
111050954|NCT01979367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111050955|NCT01979367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111050956|NCT02368743|Mesalamine|mesalamine|mesh-list
111050957|NCT02368743|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111050958|NCT02368743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111050959|NCT02368743|Analgesics|analgesics|mesh-ancestor
111050960|NCT02368743|Sensory System Agents|sensory system agents|mesh-ancestor
111050961|NCT02368743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111050962|NCT02368743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111050963|NCT02368743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111050964|NCT02368743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111050965|NCT00135343|Ritonavir|ritonavir|mesh-list
111050966|NCT00135343|Atazanavir Sulfate|atazanavir sulfate|mesh-list
111050967|NCT00135343|Efavirenz|efavirenz|mesh-list
111050968|NCT00135343|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111050969|NCT00135343|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110629906|NCT00971685|Hormones|hormones|mesh-ancestor
111050970|NCT00135343|Protease Inhibitors|protease inhibitors|mesh-ancestor
111050971|NCT00135343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111050972|NCT00135343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111050973|NCT00135343|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111050974|NCT00135343|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111050975|NCT00135343|Antiviral Agents|antiviral agents|mesh-ancestor
111050976|NCT00135343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111050977|NCT00135343|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111050978|NCT00135343|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111050979|NCT00135343|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111050980|NCT00135343|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110827647|NCT01168375|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111050981|NCT00135343|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111050982|NCT00135343|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111050983|NCT00135343|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111050984|NCT00135343|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111050985|NCT00135343|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111050987|NCT02201225|Trace Elements|trace elements|mesh-list
111050988|NCT02201225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111050989|NCT02365155|Vitamin D|vitamin d|mesh-list
111050990|NCT02365155|Vitamins|vitamins|mesh-ancestor
111050991|NCT02365155|Micronutrients|micronutrients|mesh-ancestor
111050992|NCT02365155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111050993|NCT02365155|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111050997|NCT05724745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111050998|NCT05724745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111051000|NCT05724745|Respiratory System Agents|respiratory system agents|mesh-ancestor
111051001|NCT05724745|Tocolytic Agents|tocolytic agents|mesh-ancestor
111051002|NCT05724745|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111051003|NCT05724745|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111051004|NCT05724745|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111051005|NCT05724745|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111051006|NCT05724745|Adrenergic Agents|adrenergic agents|mesh-ancestor
111051007|NCT05724745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111051008|NCT05724745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111051009|NCT02198339|Olcegepant|olcegepant|mesh-list
111051010|NCT02198339|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
110629916|NCT03861052|Tirzepatide|tirzepatide|mesh-list
111051011|NCT02198339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111051012|NCT02198339|Analgesics|analgesics|mesh-ancestor
111051013|NCT02198339|Sensory System Agents|sensory system agents|mesh-ancestor
111051014|NCT02198339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111051015|NCT02198339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111051016|NCT02198807|Piperaquine|piperaquine|mesh-list
111051017|NCT02198807|Fosmidomycin|fosmidomycin|mesh-list
111051018|NCT02198807|Antimalarials|antimalarials|mesh-ancestor
111051019|NCT02198807|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111051020|NCT02198807|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111051021|NCT02198807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111051022|NCT02198807|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111051023|NCT02198417|Metformin|metformin|mesh-list
111051024|NCT02198417|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111051025|NCT02198417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111051026|NCT02201459|Interferons|interferons|mesh-list
111051027|NCT02201459|Interferon-alpha|interferon-alpha|mesh-list
111051028|NCT02201459|Interferon alpha-2|interferon alpha-2|mesh-list
111051029|NCT02201459|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
111051030|NCT02201459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111051031|NCT02201459|Antiviral Agents|antiviral agents|mesh-ancestor
111051032|NCT02201459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111051033|NCT02201459|Immunologic Factors|immunologic factors|mesh-ancestor
111051034|NCT02201459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111051038|NCT02198495|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
111051039|NCT02198495|Hematinics|hematinics|mesh-ancestor
111051040|NCT02201849|Dimethyl Fumarate|dimethyl fumarate|mesh-list
111051041|NCT02201849|Dermatologic Agents|dermatologic agents|mesh-ancestor
111051042|NCT02201849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111051043|NCT02201849|Immunologic Factors|immunologic factors|mesh-ancestor
111051044|NCT02201849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111051045|NCT02375217|Glycopyrrolate|glycopyrrolate|mesh-list
111051046|NCT02375217|Neostigmine|neostigmine|mesh-list
111051047|NCT02375217|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111051048|NCT02375217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111051049|NCT02375217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111051050|NCT02375217|Cholinergic Agents|cholinergic agents|mesh-ancestor
111051051|NCT02375217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111051052|NCT02375217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111051053|NCT02375217|Parasympathomimetics|parasympathomimetics|mesh-ancestor
111051054|NCT02375217|Autonomic Agents|autonomic agents|mesh-ancestor
111051055|NCT02375217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111051056|NCT02375217|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111051057|NCT02375217|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111051058|NCT02375217|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111051059|NCT02206295|Selexipag|selexipag|mesh-list
111051060|NCT02206295|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111051061|NCT02375139|Metformin|metformin|mesh-list
111051062|NCT02375139|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110827648|NCT03869281|Pancrelipase|pancrelipase|mesh-list
111051063|NCT02375139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111051064|NCT02202005|Nevirapine|nevirapine|mesh-list
111051065|NCT02202005|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111051066|NCT02202005|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111051067|NCT02202005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111051068|NCT02202005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111051069|NCT02202005|Antiviral Agents|antiviral agents|mesh-ancestor
111051070|NCT02202005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111051071|NCT02202005|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111051072|NCT02202005|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111051073|NCT02202005|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111051074|NCT02202005|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111051075|NCT02741245|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111051076|NCT02741245|Ezetimibe|ezetimibe|mesh-list
111051077|NCT02741245|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111051078|NCT02741245|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111051079|NCT02741245|Antimetabolites|antimetabolites|mesh-ancestor
111051080|NCT02741245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111051081|NCT02741245|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111051082|NCT02741245|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111051083|NCT02741245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111051084|NCT02202239|Fentanyl|fentanyl|mesh-list
111051085|NCT02202239|Midazolam|midazolam|mesh-list
111051086|NCT02202239|Remifentanil|remifentanil|mesh-list
111051087|NCT02202239|Propofol|propofol|mesh-list
111051088|NCT02202239|Etomidate|etomidate|mesh-list
111051089|NCT02202239|Sevoflurane|sevoflurane|mesh-list
111051090|NCT02202239|Cisatracurium|cisatracurium|mesh-list
111051091|NCT02202239|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111051092|NCT02202239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111051093|NCT02202239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111051094|NCT02202239|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111051095|NCT02202239|Anesthetics, General|anesthetics, general|mesh-ancestor
111051096|NCT02202239|Anesthetics|anesthetics|mesh-ancestor
111051097|NCT02202239|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111051098|NCT02202239|Narcotics|narcotics|mesh-ancestor
111051099|NCT02202239|Analgesics|analgesics|mesh-ancestor
111051100|NCT02202239|Sensory System Agents|sensory system agents|mesh-ancestor
111051101|NCT02202239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111051102|NCT02202239|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111051103|NCT02202239|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111051104|NCT02202239|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111051105|NCT02202239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111051106|NCT02202239|GABA Modulators|gaba modulators|mesh-ancestor
111051107|NCT02202239|GABA Agents|gaba agents|mesh-ancestor
111051108|NCT02202239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111051109|NCT02202239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111051110|NCT02202239|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111051111|NCT02202239|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111051112|NCT02202239|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
111051113|NCT02202239|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111051114|NCT02368197|Paclitaxel|paclitaxel|mesh-list
111051115|NCT02368197|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111051116|NCT02368197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111051117|NCT02368197|Tubulin Modulators|tubulin modulators|mesh-ancestor
111051118|NCT02368197|Antimitotic Agents|antimitotic agents|mesh-ancestor
111051119|NCT02368197|Mitosis Modulators|mitosis modulators|mesh-ancestor
111051120|NCT02368197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111051121|NCT02364765|Remifentanil|remifentanil|mesh-list
111051122|NCT02364765|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111051123|NCT02364765|Narcotics|narcotics|mesh-ancestor
111051124|NCT02364765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111051125|NCT02364765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111051126|NCT02364765|Analgesics|analgesics|mesh-ancestor
111051127|NCT02364765|Sensory System Agents|sensory system agents|mesh-ancestor
111051128|NCT02364765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111051129|NCT03529201|Fentanyl|fentanyl|mesh-list
111051130|NCT03529201|Oxycodone|oxycodone|mesh-list
111051131|NCT03529201|Sevoflurane|sevoflurane|mesh-list
111051132|NCT03529201|Rocuronium|rocuronium|mesh-list
111051133|NCT03529201|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111051134|NCT03529201|Narcotics|narcotics|mesh-ancestor
111051135|NCT03529201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111051136|NCT03529201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111051137|NCT03529201|Analgesics|analgesics|mesh-ancestor
111051138|NCT03529201|Sensory System Agents|sensory system agents|mesh-ancestor
111051139|NCT03529201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111051140|NCT03529201|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111051141|NCT03529201|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111051142|NCT03529201|Anesthetics, General|anesthetics, general|mesh-ancestor
111051143|NCT03529201|Anesthetics|anesthetics|mesh-ancestor
111051144|NCT03529201|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111051145|NCT03529201|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111051146|NCT03529201|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
111051147|NCT03529201|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
111051148|NCT03529201|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111051150|NCT04547049|Cyclosporine|cyclosporine|mesh-list
111051151|NCT04547049|Mycophenolic Acid|mycophenolic acid|mesh-list
111051152|NCT04547049|Cyclophosphamide|cyclophosphamide|mesh-list
111051153|NCT04547049|Busulfan|busulfan|mesh-list
111051154|NCT04547049|Cyclosporins|cyclosporins|mesh-list
111051155|NCT04547049|Antilymphocyte Serum|antilymphocyte serum|mesh-list
111051156|NCT04547049|Thymoglobulin|thymoglobulin|mesh-list
111051157|NCT04547049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111051158|NCT04547049|Immunologic Factors|immunologic factors|mesh-ancestor
111051159|NCT04547049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111051160|NCT04547049|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111051161|NCT04547049|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111051162|NCT04547049|Alkylating Agents|alkylating agents|mesh-ancestor
111051163|NCT04547049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111051164|NCT04547049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111051165|NCT04547049|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111051166|NCT04547049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111051167|NCT04547049|Antimetabolites|antimetabolites|mesh-ancestor
111051168|NCT04547049|Antiviral Agents|antiviral agents|mesh-ancestor
111051169|NCT04547049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111051170|NCT04547049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111051171|NCT04547049|Antifungal Agents|antifungal agents|mesh-ancestor
111051172|NCT04547049|Dermatologic Agents|dermatologic agents|mesh-ancestor
111051173|NCT04547049|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111051174|NCT04547049|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111051175|NCT04547049|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111051176|NCT04547049|Antitubercular Agents|antitubercular agents|mesh-ancestor
111051177|NCT04547049|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111051178|NCT05647291|Methylprednisolone|methylprednisolone|mesh-list
111051179|NCT05647291|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111051180|NCT05647291|Antiemetics|antiemetics|mesh-ancestor
111051181|NCT05647291|Autonomic Agents|autonomic agents|mesh-ancestor
111051182|NCT05647291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111051183|NCT05647291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111051184|NCT05647291|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111051185|NCT05647291|Glucocorticoids|glucocorticoids|mesh-ancestor
111051186|NCT05647291|Hormones|hormones|mesh-ancestor
111051187|NCT05647291|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111051188|NCT05647291|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111051189|NCT05647291|Protective Agents|protective agents|mesh-ancestor
111051190|NCT03105765|Ketamine|ketamine|mesh-list
111051191|NCT03105765|Analgesics|analgesics|mesh-ancestor
111051192|NCT03105765|Sensory System Agents|sensory system agents|mesh-ancestor
111051193|NCT03105765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111051194|NCT03105765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111051195|NCT03105765|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111051196|NCT03105765|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111051197|NCT03105765|Anesthetics, General|anesthetics, general|mesh-ancestor
111051198|NCT03105765|Anesthetics|anesthetics|mesh-ancestor
111051199|NCT03105765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111051200|NCT03105765|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111051201|NCT03105765|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111051202|NCT03105765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111051203|NCT03105765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111051204|NCT02202473|Lamivudine|lamivudine|mesh-list
111051205|NCT02202473|Oxymatrine|oxymatrine|mesh-list
111051206|NCT02202473|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111051207|NCT02202473|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111051208|NCT02202473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111051209|NCT02202473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111051210|NCT02202473|Antiviral Agents|antiviral agents|mesh-ancestor
111051211|NCT02202473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111051212|NCT02202473|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111051213|NCT02202473|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111051214|NCT02202473|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111051215|NCT02364531|Abiraterone Acetate|abiraterone acetate|mesh-list
111051216|NCT02364531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111051217|NCT02364531|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111051218|NCT02364531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111051219|NCT02364531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111051220|NCT02364531|Hormone Antagonists|hormone antagonists|mesh-ancestor
111051221|NCT02364531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111051222|NCT02364531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111051223|NCT02364531|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111051224|NCT02206763|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111051225|NCT02206763|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
111051226|NCT02206763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111051227|NCT02206763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111051228|NCT02206763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111051229|NCT02206763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111051230|NCT02202707|Gabapentin|gabapentin|mesh-list
111051231|NCT02202707|Analgesics|analgesics|mesh-ancestor
111051232|NCT02202707|Sensory System Agents|sensory system agents|mesh-ancestor
111051233|NCT02202707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111051234|NCT02202707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111051235|NCT02202707|Anticonvulsants|anticonvulsants|mesh-ancestor
111051236|NCT02202707|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111051237|NCT02202707|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111051238|NCT02202707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111051239|NCT02202707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111051240|NCT02202707|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111051241|NCT02202707|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111051242|NCT02202707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111051243|NCT02202707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111051244|NCT02202707|Antimanic Agents|antimanic agents|mesh-ancestor
111051245|NCT02367807|Tenofovir|tenofovir|mesh-list
111051246|NCT02367807|Emtricitabine|emtricitabine|mesh-list
111051247|NCT02367807|Antiviral Agents|antiviral agents|mesh-ancestor
111051248|NCT02367807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111051249|NCT02367807|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111051250|NCT02367807|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111051251|NCT02367807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111051252|NCT02367807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111051253|NCT02367807|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111051254|NCT02367807|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111051255|NCT02364609|Pembrolizumab|pembrolizumab|mesh-list
111051256|NCT02364609|Afatinib|afatinib|mesh-list
111051257|NCT02364609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111051258|NCT02364609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111051259|NCT02364609|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111051260|NCT02364609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111051261|NCT02364609|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111051262|NCT02364609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111051263|NCT02364453|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
111051264|NCT02364453|Growth Substances|growth substances|mesh-ancestor
111051265|NCT02364453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111051266|NCT02364453|Vasodilator Agents|vasodilator agents|mesh-ancestor
111051267|NCT02364453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111051268|NCT02364453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111051269|NCT02258009|Ranibizumab|ranibizumab|mesh-list
111051270|NCT02258009|Aflibercept|aflibercept|mesh-list
111051271|NCT02258009|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111051272|NCT02258009|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111051273|NCT02258009|Growth Substances|growth substances|mesh-ancestor
111051274|NCT02258009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111051275|NCT02258009|Growth Inhibitors|growth inhibitors|mesh-ancestor
111051276|NCT02258009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111051277|NCT02203097|Propofol|propofol|mesh-list
111051278|NCT02203097|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111051279|NCT02203097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111051280|NCT02203097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111051281|NCT02203097|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111051282|NCT02203097|Anesthetics, General|anesthetics, general|mesh-ancestor
111051283|NCT02203097|Anesthetics|anesthetics|mesh-ancestor
111051284|NCT04439487|Anesthetics|anesthetics|mesh-list
111051285|NCT04439487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111051286|NCT04439487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111051288|NCT03528967|Enoxaparin|enoxaparin|mesh-list
111051289|NCT03528967|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111051290|NCT03528967|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111051291|NCT03528967|Analgesics|analgesics|mesh-ancestor
111051292|NCT03528967|Sensory System Agents|sensory system agents|mesh-ancestor
111051293|NCT03528967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111051294|NCT03528967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111051295|NCT03528967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111051296|NCT03528967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111051297|NCT03528967|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111051298|NCT03528967|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111051299|NCT03528967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111051300|NCT03528967|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111051301|NCT03528967|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111051302|NCT03528967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111051303|NCT03528967|Antipyretics|antipyretics|mesh-ancestor
111051304|NCT03528967|Anticoagulants|anticoagulants|mesh-ancestor
111051305|NCT02363985|Vitamin A|vitamin a|mesh-list
111051306|NCT02363985|Vitamins|vitamins|mesh-ancestor
111051307|NCT02363985|Micronutrients|micronutrients|mesh-ancestor
111051308|NCT02363985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111051309|NCT05723731|Laxatives|laxatives|mesh-list
111051310|NCT05723731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111051311|NCT02363829|Nelfinavir|nelfinavir|mesh-list
111051312|NCT02363829|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111051313|NCT02363829|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111051314|NCT02363829|Protease Inhibitors|protease inhibitors|mesh-ancestor
111051315|NCT02363829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111051316|NCT02363829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111051317|NCT02363829|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111051318|NCT02363829|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111051319|NCT02363829|Antiviral Agents|antiviral agents|mesh-ancestor
111051320|NCT02363829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111051321|NCT03113019|Immunomodulating Agents|immunomodulating agents|mesh-list
111051322|NCT03113019|Immunologic Factors|immunologic factors|mesh-ancestor
111051323|NCT03113019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111051324|NCT02363751|Bevacizumab|bevacizumab|mesh-list
111051325|NCT02363751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111051326|NCT02363751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111051327|NCT02363751|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111051328|NCT02363751|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111051329|NCT02363751|Growth Substances|growth substances|mesh-ancestor
111051330|NCT02363751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111051331|NCT02363751|Growth Inhibitors|growth inhibitors|mesh-ancestor
111051332|NCT03240861|Aldesleukin|aldesleukin|mesh-list
111051333|NCT03240861|Plerixafor|plerixafor|mesh-list
111051334|NCT03240861|Fludarabine|fludarabine|mesh-list
111051335|NCT03240861|Busulfan|busulfan|mesh-list
111051336|NCT03240861|Interleukin-2|interleukin-2|mesh-list
111051337|NCT03240861|Lenograstim|lenograstim|mesh-list
111051338|NCT03240861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111051339|NCT03240861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111051340|NCT03240861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111051341|NCT03240861|Immunologic Factors|immunologic factors|mesh-ancestor
111051342|NCT03240861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111051343|NCT03240861|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111051344|NCT03240861|Alkylating Agents|alkylating agents|mesh-ancestor
111051345|NCT03240861|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111051346|NCT03240861|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111051347|NCT03240861|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111051348|NCT03240861|Analgesics|analgesics|mesh-ancestor
111051349|NCT03240861|Sensory System Agents|sensory system agents|mesh-ancestor
111051350|NCT03240861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111051351|NCT03240861|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111051352|NCT03240861|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111051353|NCT03240861|Antiviral Agents|antiviral agents|mesh-ancestor
111051354|NCT03240861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111051355|NCT03527251|Ipilimumab|ipilimumab|mesh-list
111051356|NCT03527251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111051357|NCT03527251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111051358|NCT03527251|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111051359|NCT03527251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111051360|NCT02363517|Sofosbuvir|sofosbuvir|mesh-list
111051361|NCT02363517|Antiviral Agents|antiviral agents|mesh-ancestor
111051362|NCT02363517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111051363|NCT04467463|Levobupivacaine|levobupivacaine|mesh-list
111051364|NCT04467463|Anesthetics, Local|anesthetics, local|mesh-ancestor
111051365|NCT04467463|Anesthetics|anesthetics|mesh-ancestor
111051366|NCT04467463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111051367|NCT04467463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111051368|NCT04467463|Sensory System Agents|sensory system agents|mesh-ancestor
111051369|NCT04467463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111051370|NCT02363361|Imatinib Mesylate|imatinib mesylate|mesh-list
111051371|NCT02363361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111051372|NCT02363361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111051373|NCT02363361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111051374|NCT02363361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111051376|NCT04594915|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111051377|NCT04594915|Antithrombins|antithrombins|mesh-ancestor
111051378|NCT04594915|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111051379|NCT04594915|Protease Inhibitors|protease inhibitors|mesh-ancestor
111051380|NCT04594915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111051381|NCT04594915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111051382|NCT04594915|Anticoagulants|anticoagulants|mesh-ancestor
111051383|NCT02367027|Rivaroxaban|rivaroxaban|mesh-list
111051384|NCT02367027|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111051385|NCT02367027|Antithrombins|antithrombins|mesh-ancestor
111051386|NCT02367027|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111051387|NCT02367027|Protease Inhibitors|protease inhibitors|mesh-ancestor
111051388|NCT02367027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111051389|NCT02367027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111051390|NCT02367027|Anticoagulants|anticoagulants|mesh-ancestor
111051391|NCT02366949|Paclitaxel|paclitaxel|mesh-list
111051392|NCT02366949|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111051393|NCT02366949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111051394|NCT02366949|Tubulin Modulators|tubulin modulators|mesh-ancestor
111051395|NCT02366949|Antimitotic Agents|antimitotic agents|mesh-ancestor
111051396|NCT02366949|Mitosis Modulators|mitosis modulators|mesh-ancestor
111051397|NCT02366949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111051398|NCT03532919|Cystatins|cystatins|mesh-list
111051399|NCT03532919|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
111051400|NCT03532919|Protease Inhibitors|protease inhibitors|mesh-ancestor
111051401|NCT03532919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111051402|NCT03532919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111051403|NCT05503225|Colchicine|colchicine|mesh-list
111051404|NCT05503225|Gout Suppressants|gout suppressants|mesh-ancestor
111051405|NCT05503225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111051406|NCT05503225|Tubulin Modulators|tubulin modulators|mesh-ancestor
111051407|NCT05503225|Antimitotic Agents|antimitotic agents|mesh-ancestor
111051408|NCT05503225|Mitosis Modulators|mitosis modulators|mesh-ancestor
111051409|NCT05503225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111051410|NCT05503225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111051411|NCT02203175|Fentanyl|fentanyl|mesh-list
111051412|NCT02203175|Propofol|propofol|mesh-list
110629993|NCT05179239|Antimitotic Agents|antimitotic agents|mesh-ancestor
111051413|NCT02203175|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111051414|NCT02203175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111051415|NCT02203175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111051416|NCT02203175|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111051417|NCT02203175|Anesthetics, General|anesthetics, general|mesh-ancestor
111051418|NCT02203175|Anesthetics|anesthetics|mesh-ancestor
111051419|NCT02203175|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111051420|NCT02203175|Narcotics|narcotics|mesh-ancestor
111051421|NCT02203175|Analgesics|analgesics|mesh-ancestor
111051422|NCT02203175|Sensory System Agents|sensory system agents|mesh-ancestor
111051423|NCT02203175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111051424|NCT02203175|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111051425|NCT05791799|Etonogestrel|etonogestrel|mesh-list
111051426|NCT05791799|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111051427|NCT05791799|Contraceptive Agents|contraceptive agents|mesh-ancestor
111051428|NCT05791799|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111051429|NCT05791799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111051430|NCT05791799|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111051431|NCT05791721|Dexamethasone|dexamethasone|mesh-list
111051432|NCT05791721|Etoricoxib|etoricoxib|mesh-list
111051433|NCT05791721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111051434|NCT05791721|Antiemetics|antiemetics|mesh-ancestor
111051435|NCT05791721|Autonomic Agents|autonomic agents|mesh-ancestor
111051436|NCT05791721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111051437|NCT05791721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111051438|NCT05791721|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111051439|NCT05791721|Glucocorticoids|glucocorticoids|mesh-ancestor
111051440|NCT05791721|Hormones|hormones|mesh-ancestor
111051441|NCT05791721|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111051442|NCT05791721|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111051443|NCT05791721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111051444|NCT05791721|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111051445|NCT05791721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111051446|NCT05791721|Analgesics|analgesics|mesh-ancestor
111051447|NCT05791721|Sensory System Agents|sensory system agents|mesh-ancestor
110768505|NCT01269138|Hemostatics|hemostatics|mesh-ancestor
111051448|NCT05791721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111051449|NCT05791721|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111051450|NCT05791721|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111051451|NCT05791721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111051452|NCT05791721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111051453|NCT05791669|Listerine|listerine|mesh-list
111051454|NCT05791669|Fluorides|fluorides|mesh-list
111051455|NCT05791669|Sodium Fluoride|sodium fluoride|mesh-list
111051456|NCT05791669|Fluorides, Topical|fluorides, topical|mesh-list
111051457|NCT05791669|Cariostatic Agents|cariostatic agents|mesh-ancestor
111051458|NCT05791669|Protective Agents|protective agents|mesh-ancestor
111051459|NCT05791669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111051460|NCT05791669|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111051461|NCT05791669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111051462|NCT05791487|Budesonide|budesonide|mesh-list
111051463|NCT05791487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111051464|NCT05791487|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111051465|NCT05791487|Autonomic Agents|autonomic agents|mesh-ancestor
111051466|NCT05791487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111051467|NCT05791487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111051468|NCT05791487|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111051469|NCT05791487|Respiratory System Agents|respiratory system agents|mesh-ancestor
111051470|NCT05791487|Glucocorticoids|glucocorticoids|mesh-ancestor
111051471|NCT05791487|Hormones|hormones|mesh-ancestor
111051472|NCT05791487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111051473|NCT05791409|Venetoclax|venetoclax|mesh-list
111051474|NCT05791409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111051475|NCT05791331|Pulmonary Surfactants|pulmonary surfactants|mesh-list
111051476|NCT05791331|Respiratory System Agents|respiratory system agents|mesh-ancestor
111051477|NCT05791136|Immunomodulating Agents|immunomodulating agents|mesh-list
111051478|NCT05791136|Immunologic Factors|immunologic factors|mesh-ancestor
111051479|NCT05791136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111051480|NCT05791058|Anesthetics|anesthetics|mesh-list
111051481|NCT05791058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111051482|NCT05791058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111051483|NCT05790941|Minoxidil|minoxidil|mesh-list
111051484|NCT05790941|Latanoprost|latanoprost|mesh-list
111051485|NCT05790941|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
111051486|NCT05790941|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111051487|NCT05790941|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111051488|NCT05790941|Vasodilator Agents|vasodilator agents|mesh-ancestor
111051489|NCT05790902|Tamsulosin|tamsulosin|mesh-list
111051490|NCT05790902|Silodosin|silodosin|mesh-list
111051491|NCT05790902|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111051492|NCT05790902|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111051493|NCT05790902|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111051494|NCT05790902|Adrenergic Agents|adrenergic agents|mesh-ancestor
111051495|NCT05790902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111051496|NCT05790902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111051497|NCT05790902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111051498|NCT05790902|Urological Agents|urological agents|mesh-ancestor
111051499|NCT05790720|Propofol|propofol|mesh-list
111051500|NCT05790720|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111051501|NCT05790720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111051502|NCT05790720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111051503|NCT05790720|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111051504|NCT05790720|Anesthetics, General|anesthetics, general|mesh-ancestor
111051505|NCT05790720|Anesthetics|anesthetics|mesh-ancestor
111051506|NCT05790629|Calcium, Dietary|calcium, dietary|mesh-list
111051507|NCT05790629|Calcium|calcium|mesh-list
111051508|NCT05790629|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111051509|NCT05790629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111051510|NCT05790629|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111051511|NCT05790603|Hemostatics|hemostatics|mesh-list
111051512|NCT05790603|Coagulants|coagulants|mesh-ancestor
111051513|NCT05790447|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
111051514|NCT05790447|Thymalfasin|thymalfasin|mesh-list
111051515|NCT05790447|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111051516|NCT05790447|Immunologic Factors|immunologic factors|mesh-ancestor
111051517|NCT05790447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111051518|NCT05790447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111051519|NCT05790447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111051520|NCT05790447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111051521|NCT05790330|Methotrexate|methotrexate|mesh-list
111051522|NCT05790330|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111051523|NCT05790330|Abortifacient Agents|abortifacient agents|mesh-ancestor
111051524|NCT05790330|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111051525|NCT05790330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111051526|NCT05790330|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111051527|NCT05790330|Antimetabolites|antimetabolites|mesh-ancestor
111051528|NCT05790330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111051529|NCT05790330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111051530|NCT05790330|Dermatologic Agents|dermatologic agents|mesh-ancestor
111051531|NCT05790330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111051532|NCT05790330|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111051533|NCT05790330|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111051534|NCT05790330|Immunologic Factors|immunologic factors|mesh-ancestor
111051535|NCT05790330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111051536|NCT05790330|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111051537|NCT05790239|Amphetamine|amphetamine|mesh-list
111051538|NCT05790239|Dextroamphetamine|dextroamphetamine|mesh-list
111051539|NCT05790239|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
111051540|NCT05790239|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111051541|NCT05790239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111051542|NCT05790239|Sympathomimetics|sympathomimetics|mesh-ancestor
111051543|NCT05790239|Autonomic Agents|autonomic agents|mesh-ancestor
111051544|NCT05790239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111051545|NCT05790239|Dopamine Agents|dopamine agents|mesh-ancestor
111051546|NCT05790239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111051547|NCT05790239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111051548|NCT05790239|Adrenergic Agents|adrenergic agents|mesh-ancestor
111051549|NCT05790239|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111051550|NCT05790239|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111051551|NCT05790239|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111051552|NCT05790239|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111051553|NCT05790239|Hallucinogens|hallucinogens|mesh-ancestor
111051554|NCT05790239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111051555|NCT05790239|Serotonin Agents|serotonin agents|mesh-ancestor
111051556|NCT05786716|Trastuzumab|trastuzumab|mesh-list
111051557|NCT05786716|Pertuzumab|pertuzumab|mesh-list
111051558|NCT05786716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111051559|NCT05786716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111051560|NCT05786599|Methadone|methadone|mesh-list
111051561|NCT05786599|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111051562|NCT05786599|Narcotics|narcotics|mesh-ancestor
111051563|NCT05786599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111051564|NCT05786599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111051565|NCT05786599|Analgesics|analgesics|mesh-ancestor
111051566|NCT05786599|Sensory System Agents|sensory system agents|mesh-ancestor
111051567|NCT05786599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111051568|NCT05786599|Antitussive Agents|antitussive agents|mesh-ancestor
111051569|NCT05786599|Respiratory System Agents|respiratory system agents|mesh-ancestor
111051570|NCT05768178|Vemurafenib|vemurafenib|mesh-list
111051571|NCT05768178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111051572|NCT05768178|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111051573|NCT05768178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111051574|NCT05768178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111051575|NCT05683444|Octreotide|octreotide|mesh-list
111051576|NCT05683444|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111051577|NCT05683444|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111051578|NCT05683444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111051579|NCT05669274|Caseins|caseins|mesh-list
111051580|NCT05669274|Chelating Agents|chelating agents|mesh-ancestor
111051581|NCT05669274|Sequestering Agents|sequestering agents|mesh-ancestor
111051582|NCT05669274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111051583|NCT05667090|Vitamin D|vitamin d|mesh-list
111051584|NCT05667090|Vitamins|vitamins|mesh-ancestor
110516688|NCT04238702|Losartan|losartan|mesh-list
111051586|NCT05667090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111051587|NCT05667090|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111051588|NCT05647343|Ciclopirox|ciclopirox|mesh-list
111051589|NCT05647343|Antifungal Agents|antifungal agents|mesh-ancestor
111051590|NCT05647343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111051591|NCT05553392|Petrolatum|petrolatum|mesh-list
111051592|NCT05553392|Emollients|emollients|mesh-ancestor
111051593|NCT05553392|Dermatologic Agents|dermatologic agents|mesh-ancestor
111051594|NCT05530421|Dexamethasone|dexamethasone|mesh-list
111051595|NCT05530421|Venetoclax|venetoclax|mesh-list
111051596|NCT05530421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111051597|NCT05530421|Antiemetics|antiemetics|mesh-ancestor
111051598|NCT05530421|Autonomic Agents|autonomic agents|mesh-ancestor
110768657|NCT01281696|Antimetabolites|antimetabolites|mesh-ancestor
111051599|NCT05530421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111051600|NCT05530421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111051601|NCT05530421|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111051602|NCT05530421|Glucocorticoids|glucocorticoids|mesh-ancestor
111051604|NCT05530421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111051605|NCT05530421|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111051606|NCT05530421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111051607|NCT05523596|Benzonidazole|benzonidazole|mesh-list
111051608|NCT05523596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111051609|NCT05523596|Immunologic Factors|immunologic factors|mesh-ancestor
111051610|NCT05523596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111051611|NCT05523596|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
111051612|NCT05523596|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111051613|NCT05523596|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111051614|NCT05523596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111051615|NCT05518734|Itraconazole|itraconazole|mesh-list
111051616|NCT05518734|Midazolam|midazolam|mesh-list
111051617|NCT05518734|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111051618|NCT05518734|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111051619|NCT05518734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111051620|NCT05518734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111051621|NCT05518734|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111051622|NCT05518734|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111051623|NCT05518734|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111051624|NCT05518734|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111051625|NCT05518734|Anesthetics, General|anesthetics, general|mesh-ancestor
111051626|NCT05518734|Anesthetics|anesthetics|mesh-ancestor
111051627|NCT05518734|GABA Modulators|gaba modulators|mesh-ancestor
111051628|NCT05518734|GABA Agents|gaba agents|mesh-ancestor
111051629|NCT05518734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111051630|NCT05518734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111051631|NCT05518734|Antifungal Agents|antifungal agents|mesh-ancestor
111051632|NCT05518734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111051633|NCT05518734|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111051634|NCT05518734|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111051635|NCT05518734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111051636|NCT05518734|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111051637|NCT05518734|Hormone Antagonists|hormone antagonists|mesh-ancestor
111051638|NCT05518734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111051639|NCT05518734|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111051640|NCT05513365|Goserelin|goserelin|mesh-list
111051641|NCT05513365|Bicalutamide|bicalutamide|mesh-list
111051642|NCT05513365|Dutasteride|dutasteride|mesh-list
111051643|NCT05513365|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111051644|NCT05513365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111051645|NCT05513365|Androgen Antagonists|androgen antagonists|mesh-ancestor
111051646|NCT05513365|Hormone Antagonists|hormone antagonists|mesh-ancestor
111051647|NCT05513365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111051648|NCT05513365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111051649|NCT05513365|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
111051650|NCT05513365|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111051651|NCT05513365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111051652|NCT05513365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111051653|NCT05442749|Niraparib|niraparib|mesh-list
111051654|NCT05442749|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111051655|NCT05442749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111051656|NCT05442749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111051657|NCT05442749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111051658|NCT05361655|Palbociclib|palbociclib|mesh-list
111051659|NCT05361655|Aromatase Inhibitors|aromatase inhibitors|mesh-list
111051660|NCT05361655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111051661|NCT05361655|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111051662|NCT05361655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111051663|NCT05361655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111051664|NCT05361655|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111051665|NCT05361655|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111051666|NCT05361655|Hormone Antagonists|hormone antagonists|mesh-ancestor
111051667|NCT05361655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111051668|NCT05361655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111051670|NCT05355740|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111051671|NCT05355740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111051672|NCT05355740|Disinfectants|disinfectants|mesh-ancestor
111051673|NCT05316831|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
111051674|NCT05316831|Immunologic Factors|immunologic factors|mesh-ancestor
111051675|NCT05316831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111051676|NCT05308056|Anesthetics|anesthetics|mesh-list
111051677|NCT05308056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111051678|NCT05308056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111051679|NCT05276284|Atezolizumab|atezolizumab|mesh-list
111051680|NCT05276284|Mercaptopurine|mercaptopurine|mesh-list
111051681|NCT05276284|Thioguanine|thioguanine|mesh-list
111051682|NCT05276284|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111051683|NCT05276284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111051684|NCT05276284|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111051685|NCT05276284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111051686|NCT05276284|Antimetabolites|antimetabolites|mesh-ancestor
111051687|NCT05276284|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111051688|NCT05276284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111051689|NCT05276284|Immunologic Factors|immunologic factors|mesh-ancestor
111051690|NCT05276284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111051691|NCT05276284|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111051692|NCT05276284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111051693|NCT05237960|Metformin|metformin|mesh-list
111051694|NCT05237960|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111051695|NCT05237960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111051696|NCT05144698|Sirolimus|sirolimus|mesh-list
111051697|NCT05144698|Temsirolimus|temsirolimus|mesh-list
111051698|NCT05144698|MTOR Inhibitors|mtor inhibitors|mesh-list
111051699|NCT05144698|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111051700|NCT05144698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111051701|NCT05144698|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111051702|NCT05144698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111051703|NCT05144698|Antifungal Agents|antifungal agents|mesh-ancestor
111051704|NCT05144698|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111051705|NCT05144698|Immunologic Factors|immunologic factors|mesh-ancestor
111051706|NCT05144698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111051707|NCT05144698|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111051708|NCT05144698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111051709|NCT05144698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111051710|NCT04979442|Trabectedin|trabectedin|mesh-list
111051711|NCT04979442|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110630080|NCT00974961|Bupivacaine|bupivacaine|mesh-list
111051712|NCT04979442|Alkylating Agents|alkylating agents|mesh-ancestor
111051713|NCT04979442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111051714|NCT04979442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111051715|NCT04969133|Levobupivacaine|levobupivacaine|mesh-list
111051716|NCT04969133|Anesthetics, Local|anesthetics, local|mesh-ancestor
111051717|NCT04969133|Anesthetics|anesthetics|mesh-ancestor
111051718|NCT04969133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111051719|NCT04969133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111051720|NCT04969133|Sensory System Agents|sensory system agents|mesh-ancestor
111051721|NCT04969133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111051722|NCT04910061|Niacinamide|niacinamide|mesh-list
111051723|NCT04910061|Niacin|niacin|mesh-list
111051724|NCT04910061|Nicotinic Acids|nicotinic acids|mesh-list
111051725|NCT04910061|Vitamin B Complex|vitamin b complex|mesh-ancestor
111051726|NCT04910061|Vitamins|vitamins|mesh-ancestor
111051727|NCT04910061|Micronutrients|micronutrients|mesh-ancestor
111051728|NCT04910061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111051729|NCT04910061|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111051730|NCT04910061|Antimetabolites|antimetabolites|mesh-ancestor
111051731|NCT04910061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111051732|NCT04910061|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111051733|NCT04910061|Vasodilator Agents|vasodilator agents|mesh-ancestor
111051734|NCT04887467|Apomorphine|apomorphine|mesh-list
111051735|NCT04887467|Emetics|emetics|mesh-ancestor
111051736|NCT04887467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111051737|NCT04887467|Autonomic Agents|autonomic agents|mesh-ancestor
111051738|NCT04887467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111051739|NCT04887467|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111051740|NCT04887467|Dopamine Agonists|dopamine agonists|mesh-ancestor
111051741|NCT04887467|Dopamine Agents|dopamine agents|mesh-ancestor
111051742|NCT04887467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111051743|NCT04887467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111051744|NCT04868409|Rocuronium|rocuronium|mesh-list
111051745|NCT04868409|Succinylcholine|succinylcholine|mesh-list
111051746|NCT04868409|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
111051747|NCT04868409|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110768810|NCT05834231|Memantine|memantine|mesh-list
111051748|NCT04868409|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111051749|NCT04868409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111051750|NCT04868409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111051751|NCT04868409|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
111051753|NCT04861064|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111051754|NCT04861064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111051755|NCT04861064|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111051756|NCT04861064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111051757|NCT04861064|Antifungal Agents|antifungal agents|mesh-ancestor
111051758|NCT04861064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111051759|NCT04861064|Immunologic Factors|immunologic factors|mesh-ancestor
111051760|NCT04861064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111051761|NCT04846335|Doxycycline|doxycycline|mesh-list
111051762|NCT04846335|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111051763|NCT04846335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111051764|NCT04846335|Antimalarials|antimalarials|mesh-ancestor
111051765|NCT04846335|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111051766|NCT04846335|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111051767|NCT04796220|Gemcitabine|gemcitabine|mesh-list
111051768|NCT04796220|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111051769|NCT04796220|Antimetabolites|antimetabolites|mesh-ancestor
111051770|NCT04796220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111051771|NCT04796220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111051772|NCT04777045|Diltiazem|diltiazem|mesh-list
111051773|NCT04777045|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111051774|NCT04777045|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111051775|NCT04777045|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111051776|NCT04777045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111051777|NCT04777045|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111051778|NCT04777045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111051779|NCT04777045|Vasodilator Agents|vasodilator agents|mesh-ancestor
111051780|NCT04632238|Metronidazole|metronidazole|mesh-list
110630088|NCT00511108|Pioglitazone|pioglitazone|mesh-list
111051781|NCT04632238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111051782|NCT04632238|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111051783|NCT04632238|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111051784|NCT04632238|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111051785|NCT04597190|Norepinephrine|norepinephrine|mesh-list
111051786|NCT04597190|Serotonin|serotonin|mesh-list
111051787|NCT04597190|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
111051788|NCT04597190|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111051789|NCT04597190|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111051790|NCT04597190|Adrenergic Agents|adrenergic agents|mesh-ancestor
111051791|NCT04597190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111051792|NCT04597190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111051793|NCT04597190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111051794|NCT04597190|Sympathomimetics|sympathomimetics|mesh-ancestor
111051795|NCT04597190|Autonomic Agents|autonomic agents|mesh-ancestor
111051796|NCT04597190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111051797|NCT04597190|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111051798|NCT04597190|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111051799|NCT04597190|Serotonin Agents|serotonin agents|mesh-ancestor
111051800|NCT04597190|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111051801|NCT04597190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111051802|NCT04577638|Nivolumab|nivolumab|mesh-list
111051803|NCT04577638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110827659|NCT01281943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111051804|NCT04577638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111051805|NCT04577638|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111051806|NCT04577638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111051807|NCT04517799|Cannabidiol|cannabidiol|mesh-list
111051808|NCT04517799|Anticonvulsants|anticonvulsants|mesh-ancestor
111051809|NCT04495296|Paclitaxel|paclitaxel|mesh-list
111051810|NCT04495296|Gemcitabine|gemcitabine|mesh-list
111051811|NCT04495296|Capecitabine|capecitabine|mesh-list
111051812|NCT04495296|Oxaliplatin|oxaliplatin|mesh-list
111051813|NCT04495296|Nivolumab|nivolumab|mesh-list
111051814|NCT04495296|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111051815|NCT04495296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111051816|NCT04495296|Tubulin Modulators|tubulin modulators|mesh-ancestor
111051817|NCT04495296|Antimitotic Agents|antimitotic agents|mesh-ancestor
111051818|NCT04495296|Mitosis Modulators|mitosis modulators|mesh-ancestor
111051819|NCT04495296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111051820|NCT04495296|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111051821|NCT04495296|Antimetabolites|antimetabolites|mesh-ancestor
110768885|NCT05789303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111051822|NCT04495296|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111051823|NCT04495296|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111051824|NCT04404062|Antibodies|antibodies|mesh-list
111051825|NCT04404062|Immunoglobulins|immunoglobulins|mesh-list
111051826|NCT04404062|Immunologic Factors|immunologic factors|mesh-ancestor
111051827|NCT04404062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111051828|NCT04352777|Fulvestrant|fulvestrant|mesh-list
111051829|NCT04352777|Aromatase Inhibitors|aromatase inhibitors|mesh-list
111051830|NCT04352777|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111051831|NCT04352777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111051832|NCT04352777|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
111051833|NCT04352777|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111051834|NCT04352777|Hormone Antagonists|hormone antagonists|mesh-ancestor
111051835|NCT04352777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111051836|NCT04352777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111051837|NCT04352777|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111051838|NCT04352777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111051839|NCT04352777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111051840|NCT04276363|Nicotine|nicotine|mesh-list
111051841|NCT04276363|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111051842|NCT04276363|Autonomic Agents|autonomic agents|mesh-ancestor
111051843|NCT04276363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111051844|NCT04276363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111051845|NCT04276363|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111051846|NCT04276363|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111051847|NCT04276363|Cholinergic Agents|cholinergic agents|mesh-ancestor
111051848|NCT04276363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111051849|NCT04276363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111051850|NCT04260854|Bupivacaine|bupivacaine|mesh-list
111051851|NCT04260854|Anesthetics, Local|anesthetics, local|mesh-ancestor
111051852|NCT04260854|Anesthetics|anesthetics|mesh-ancestor
111051853|NCT04260854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111051854|NCT04260854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111051855|NCT04260854|Sensory System Agents|sensory system agents|mesh-ancestor
111051856|NCT04260854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111051857|NCT04147546|Artenimol|artenimol|mesh-list
111051858|NCT04147546|Antimalarials|antimalarials|mesh-ancestor
111051859|NCT04147546|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111051860|NCT04147546|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111051861|NCT04147546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111051862|NCT04141579|Evolocumab|evolocumab|mesh-list
111051863|NCT04141579|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
111051864|NCT04141579|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111051865|NCT04141579|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111051866|NCT04141579|Antimetabolites|antimetabolites|mesh-ancestor
111051867|NCT04141579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111051868|NCT04141579|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111051869|NCT04141579|Protease Inhibitors|protease inhibitors|mesh-ancestor
111051870|NCT04141579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111051871|NCT04141579|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111051872|NCT04038502|Carboplatin|carboplatin|mesh-list
111051873|NCT04038502|Olaparib|olaparib|mesh-list
111051874|NCT04038502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111051875|NCT04038502|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111051876|NCT04038502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111051877|NCT04038502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111051878|NCT03977493|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
111051879|NCT03977493|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111051880|NCT03977493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111051881|NCT03977493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111051882|NCT03977493|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111051883|NCT03977493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111051884|NCT03977493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111051885|NCT03977493|Cholinergic Agents|cholinergic agents|mesh-ancestor
111051886|NCT03977493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111051887|NCT03867175|Pembrolizumab|pembrolizumab|mesh-list
111051888|NCT03867175|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111051889|NCT03867175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111051890|NCT03867175|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111051891|NCT03867175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111051892|NCT03852433|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
111051893|NCT03852433|Antiviral Agents|antiviral agents|mesh-ancestor
111051894|NCT03852433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110768958|NCT05662865|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111051895|NCT03849469|Pembrolizumab|pembrolizumab|mesh-list
111051896|NCT03849469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111051897|NCT03849469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111051898|NCT03849469|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111051899|NCT03849469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111051900|NCT03805607|Ketorolac|ketorolac|mesh-list
111051901|NCT03805607|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
111051902|NCT03805607|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111051903|NCT03805607|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111051904|NCT03805607|Analgesics|analgesics|mesh-ancestor
110630109|NCT00510952|Insulin|insulin|mesh-list
111051905|NCT03805607|Sensory System Agents|sensory system agents|mesh-ancestor
111051906|NCT03805607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111051907|NCT03805607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111051908|NCT03805607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111051909|NCT03805607|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111051910|NCT03805607|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111051911|NCT03805607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111051912|NCT03805607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111051913|NCT03514368|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
111051914|NCT03514368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111051915|NCT03514368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111051916|NCT03514368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111051917|NCT03496766|Tipifarnib|tipifarnib|mesh-list
111051918|NCT03496766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111051919|NCT03467789|Vitamin D|vitamin d|mesh-list
111051920|NCT03467789|Ergocalciferols|ergocalciferols|mesh-list
111051921|NCT03467789|Cholecalciferol|cholecalciferol|mesh-list
111051922|NCT03467789|Vitamins|vitamins|mesh-list
111051923|NCT03467789|Micronutrients|micronutrients|mesh-ancestor
111051924|NCT03467789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111051925|NCT03467789|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111051926|NCT03467789|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111051927|NCT03406715|Nivolumab|nivolumab|mesh-list
111051928|NCT03406715|Ipilimumab|ipilimumab|mesh-list
111051929|NCT03406715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111051930|NCT03406715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111051931|NCT03406715|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111051932|NCT03406715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111051933|NCT03363763|Sirolimus|sirolimus|mesh-list
111051934|NCT03363763|Temsirolimus|temsirolimus|mesh-list
111051935|NCT03363763|MTOR Inhibitors|mtor inhibitors|mesh-list
111051936|NCT03363763|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111051937|NCT03363763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111051938|NCT03363763|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111051939|NCT03363763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111051940|NCT03363763|Antifungal Agents|antifungal agents|mesh-ancestor
111051941|NCT03363763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111051942|NCT03363763|Immunologic Factors|immunologic factors|mesh-ancestor
111051943|NCT03363763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111051944|NCT03363763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111051945|NCT03363763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111051946|NCT03363763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111051947|NCT03182751|Tranexamic Acid|tranexamic acid|mesh-list
111051948|NCT03182751|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111051949|NCT03182751|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111051950|NCT03182751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111051951|NCT03182751|Hemostatics|hemostatics|mesh-ancestor
111051952|NCT03182751|Coagulants|coagulants|mesh-ancestor
111051953|NCT03105245|Thiopental|thiopental|mesh-list
111051954|NCT03105245|Anesthetics|anesthetics|mesh-list
111051955|NCT03105245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111051956|NCT03105245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111051957|NCT03105245|Anticonvulsants|anticonvulsants|mesh-ancestor
111051958|NCT03105245|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111051959|NCT03105245|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111051960|NCT03105245|Anesthetics, General|anesthetics, general|mesh-ancestor
111051961|NCT03105245|GABA Modulators|gaba modulators|mesh-ancestor
111051962|NCT03105245|GABA Agents|gaba agents|mesh-ancestor
111051963|NCT03105245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111051964|NCT03105245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111051965|NCT03019588|Paclitaxel|paclitaxel|mesh-list
111051966|NCT03019588|Pembrolizumab|pembrolizumab|mesh-list
111051967|NCT03019588|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110630111|NCT00510952|Insulin Glargine|insulin glargine|mesh-list
111051968|NCT03019588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111051969|NCT03019588|Tubulin Modulators|tubulin modulators|mesh-ancestor
111051970|NCT03019588|Antimitotic Agents|antimitotic agents|mesh-ancestor
111051971|NCT03019588|Mitosis Modulators|mitosis modulators|mesh-ancestor
111051972|NCT03019588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111051973|NCT03019588|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111051974|NCT03019588|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111051975|NCT02959944|Prednisone|prednisone|mesh-list
111051976|NCT02959944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111051977|NCT02959944|Glucocorticoids|glucocorticoids|mesh-ancestor
111051978|NCT02959944|Hormones|hormones|mesh-ancestor
111051979|NCT02959944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111051980|NCT02959944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111051981|NCT02959944|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111051982|NCT02959944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111051983|NCT02823002|Lidocaine|lidocaine|mesh-list
111051984|NCT02823002|Anesthetics, Local|anesthetics, local|mesh-ancestor
111051985|NCT02823002|Anesthetics|anesthetics|mesh-ancestor
111051986|NCT02823002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111051987|NCT02823002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111051988|NCT02823002|Sensory System Agents|sensory system agents|mesh-ancestor
111051989|NCT02823002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111051990|NCT02823002|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111051991|NCT02823002|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111051992|NCT02823002|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111051993|NCT02823002|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111051994|NCT02823002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111051995|NCT02806687|Gemcitabine|gemcitabine|mesh-list
111051996|NCT02806687|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111051997|NCT02806687|Antimetabolites|antimetabolites|mesh-ancestor
111051998|NCT02806687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111051999|NCT02806687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111052000|NCT02581137|Metformin|metformin|mesh-list
111052001|NCT02581137|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111052002|NCT02581137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111052003|NCT02559180|Aflibercept|aflibercept|mesh-list
111052004|NCT02559180|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111052005|NCT02559180|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111052006|NCT02559180|Growth Substances|growth substances|mesh-ancestor
111052007|NCT02559180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111052008|NCT02559180|Growth Inhibitors|growth inhibitors|mesh-ancestor
111052009|NCT02559180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111052010|NCT02539966|Sirolimus|sirolimus|mesh-list
111052011|NCT02539966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111052012|NCT02539966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111052013|NCT02539966|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111052014|NCT02539966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111052015|NCT02539966|Antifungal Agents|antifungal agents|mesh-ancestor
111052016|NCT02539966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111052017|NCT02539966|Immunologic Factors|immunologic factors|mesh-ancestor
111052018|NCT02539966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111052019|NCT02525029|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
111052020|NCT02525029|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110827663|NCT01281943|Immunologic Factors|immunologic factors|mesh-ancestor
111052021|NCT02525029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111052022|NCT02455557|Temozolomide|temozolomide|mesh-list
111052023|NCT02455557|Sargramostim|sargramostim|mesh-list
111052024|NCT02455557|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
111052025|NCT02455557|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111052026|NCT02455557|Alkylating Agents|alkylating agents|mesh-ancestor
111052027|NCT02455557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111052028|NCT02455557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111052029|NCT02455557|Immunologic Factors|immunologic factors|mesh-ancestor
111052030|NCT02455557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111052031|NCT02455557|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111052032|NCT02401139|Ketamine|ketamine|mesh-list
111052033|NCT02401139|Analgesics|analgesics|mesh-ancestor
111052034|NCT02401139|Sensory System Agents|sensory system agents|mesh-ancestor
111052035|NCT02401139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111052036|NCT02401139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111052037|NCT02401139|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111052038|NCT02401139|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111052039|NCT02401139|Anesthetics, General|anesthetics, general|mesh-ancestor
111052040|NCT02401139|Anesthetics|anesthetics|mesh-ancestor
111052041|NCT02401139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111052042|NCT02401139|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111052043|NCT02401139|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111052045|NCT02401139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111052046|NCT02390635|Deoxyglucose|deoxyglucose|mesh-list
111052047|NCT02390635|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
111052048|NCT02390635|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111052049|NCT02390635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111052050|NCT02390635|Antimetabolites|antimetabolites|mesh-ancestor
111052051|NCT02390635|Antiviral Agents|antiviral agents|mesh-ancestor
111052052|NCT02390635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111052053|NCT02367846|Contraceptive Agents|contraceptive agents|mesh-list
111052054|NCT02367846|NuvaRing|nuvaring|mesh-list
111052055|NCT02367846|Contraceptives, Oral|contraceptives, oral|mesh-list
111052056|NCT02367846|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
111052057|NCT02367846|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111052058|NCT02367846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111052059|NCT02367846|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111052060|NCT02367846|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111052061|NCT02195895|Calcium, Dietary|calcium, dietary|mesh-list
111052062|NCT02195895|Vitamin D|vitamin d|mesh-list
111052063|NCT02195895|Ergocalciferols|ergocalciferols|mesh-list
111052064|NCT02195895|Cholecalciferol|cholecalciferol|mesh-list
111052065|NCT02195895|Alendronate|alendronate|mesh-list
111052066|NCT02195895|Vitamins|vitamins|mesh-list
111052067|NCT02195895|Calcium Carbonate|calcium carbonate|mesh-list
111052068|NCT02195895|Antacids|antacids|mesh-list
111052069|NCT02195895|Calcium|calcium|mesh-list
111052070|NCT02195895|Micronutrients|micronutrients|mesh-ancestor
111052071|NCT02195895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111052072|NCT02195895|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111052073|NCT02195895|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111052074|NCT02195895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111052075|NCT02195895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111052076|NCT01970722|Paclitaxel|paclitaxel|mesh-list
111052077|NCT01970722|Cisplatin|cisplatin|mesh-list
111052078|NCT01970722|Carboplatin|carboplatin|mesh-list
111052079|NCT01970722|Gemcitabine|gemcitabine|mesh-list
111052080|NCT01970722|Doxorubicin|doxorubicin|mesh-list
111052081|NCT01970722|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111052082|NCT01970722|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111052083|NCT01970722|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111052084|NCT01970722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111052085|NCT01970722|Tubulin Modulators|tubulin modulators|mesh-ancestor
111052086|NCT01970722|Antimitotic Agents|antimitotic agents|mesh-ancestor
111052087|NCT01970722|Mitosis Modulators|mitosis modulators|mesh-ancestor
111052088|NCT01970722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111052089|NCT01970722|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111052090|NCT01970722|Antimetabolites|antimetabolites|mesh-ancestor
111052091|NCT01970722|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111052092|NCT01970722|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111052093|NCT01970722|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111052094|NCT01970722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111052095|NCT01953900|Cyclophosphamide|cyclophosphamide|mesh-list
111052096|NCT01953900|Fludarabine|fludarabine|mesh-list
111052097|NCT01953900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111052098|NCT01953900|Immunologic Factors|immunologic factors|mesh-ancestor
111052099|NCT01953900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111052100|NCT01953900|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111052101|NCT01953900|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111052102|NCT01953900|Alkylating Agents|alkylating agents|mesh-ancestor
111052103|NCT01953900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111052104|NCT01953900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111052105|NCT01953900|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111052106|NCT01913951|Azacitidine|azacitidine|mesh-list
111052107|NCT01913951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111052108|NCT01913951|Antimetabolites|antimetabolites|mesh-ancestor
111052109|NCT01913951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111052110|NCT01913951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111052111|NCT01913951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111052112|NCT01867320|Raltegravir Potassium|raltegravir potassium|mesh-list
111052113|NCT01867320|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111052114|NCT01867320|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111052115|NCT01867320|Antiviral Agents|antiviral agents|mesh-ancestor
111052116|NCT01867320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111052117|NCT01867320|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111052118|NCT01867320|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111052119|NCT01867320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111052120|NCT01867320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111052122|NCT01709136|Temsirolimus|temsirolimus|mesh-list
111052123|NCT01709136|MTOR Inhibitors|mtor inhibitors|mesh-list
111052124|NCT01709136|Tacrolimus|tacrolimus|mesh-list
111052125|NCT01709136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111052126|NCT01709136|Immunologic Factors|immunologic factors|mesh-ancestor
111052127|NCT01709136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111052128|NCT01709136|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111052129|NCT01709136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111052130|NCT01709136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111052131|NCT01709136|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111052132|NCT01709136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111052133|NCT01709136|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111052134|NCT01709136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111052135|NCT01709136|Antifungal Agents|antifungal agents|mesh-ancestor
111052136|NCT01709136|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111052137|NCT01570868|Ponatinib|ponatinib|mesh-list
111052138|NCT01570868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111052139|NCT01570868|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111052140|NCT01570868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111052141|NCT01570868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111052142|NCT01565499|Paclitaxel|paclitaxel|mesh-list
111052143|NCT01565499|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111052144|NCT01565499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111052145|NCT01565499|Tubulin Modulators|tubulin modulators|mesh-ancestor
111052146|NCT01565499|Antimitotic Agents|antimitotic agents|mesh-ancestor
111052147|NCT01565499|Mitosis Modulators|mitosis modulators|mesh-ancestor
111052148|NCT01565499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111052149|NCT01036087|Paclitaxel|paclitaxel|mesh-list
111052150|NCT01036087|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111052151|NCT01036087|Cyclophosphamide|cyclophosphamide|mesh-list
111052152|NCT01036087|Carboplatin|carboplatin|mesh-list
111052153|NCT01036087|Fluorouracil|fluorouracil|mesh-list
111052154|NCT01036087|Epirubicin|epirubicin|mesh-list
111052155|NCT01036087|Panitumumab|panitumumab|mesh-list
111052156|NCT01036087|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111052157|NCT01036087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111052158|NCT01036087|Tubulin Modulators|tubulin modulators|mesh-ancestor
111052159|NCT01036087|Antimitotic Agents|antimitotic agents|mesh-ancestor
111052160|NCT01036087|Mitosis Modulators|mitosis modulators|mesh-ancestor
111052161|NCT01036087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111052162|NCT01036087|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111052163|NCT01036087|Immunologic Factors|immunologic factors|mesh-ancestor
111052164|NCT01036087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111052165|NCT01036087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111052166|NCT01036087|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111052167|NCT01036087|Alkylating Agents|alkylating agents|mesh-ancestor
111052168|NCT01036087|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111052169|NCT01036087|Antimetabolites|antimetabolites|mesh-ancestor
111052170|NCT01036087|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111052171|NCT01036087|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111052172|NCT01036087|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111052173|NCT01036087|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111052174|NCT01036087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111052175|NCT01036087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111052176|NCT00783367|Dexamethasone|dexamethasone|mesh-list
111052177|NCT00783367|Dexamethasone acetate|dexamethasone acetate|mesh-list
111052178|NCT00783367|Rituximab|rituximab|mesh-list
111052179|NCT00783367|Lenalidomide|lenalidomide|mesh-list
111052180|NCT00783367|BB 1101|bb 1101|mesh-list
111052181|NCT00783367|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111052182|NCT00783367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111052183|NCT00783367|Immunologic Factors|immunologic factors|mesh-ancestor
111052184|NCT00783367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111052185|NCT00783367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111052186|NCT00783367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111052187|NCT00783367|Antiemetics|antiemetics|mesh-ancestor
111052188|NCT00783367|Autonomic Agents|autonomic agents|mesh-ancestor
111052189|NCT00783367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111052190|NCT00783367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111052191|NCT00783367|Glucocorticoids|glucocorticoids|mesh-ancestor
111052192|NCT00783367|Hormones|hormones|mesh-ancestor
111052193|NCT00783367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111052194|NCT00783367|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111052195|NCT00783367|Protease Inhibitors|protease inhibitors|mesh-ancestor
111052196|NCT00783367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111052197|NCT00783367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111052198|NCT00783367|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111052199|NCT00783367|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111052200|NCT00783367|Growth Substances|growth substances|mesh-ancestor
111052201|NCT00783367|Growth Inhibitors|growth inhibitors|mesh-ancestor
111052202|NCT00572156|Mecasermin|mecasermin|mesh-list
111052203|NCT00572156|Growth Substances|growth substances|mesh-ancestor
111052204|NCT00572156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111052205|NCT00447772|Botulinum Toxins|botulinum toxins|mesh-list
111052206|NCT00447772|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111052207|NCT00447772|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111052208|NCT00447772|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111052209|NCT00447772|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111052210|NCT00447772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111052211|NCT00447772|Cholinergic Agents|cholinergic agents|mesh-ancestor
111052212|NCT00447772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111052213|NCT00447772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111052214|NCT00447772|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111052215|NCT00447772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111052216|NCT00255216|Policosanol|policosanol|mesh-list
111052217|NCT00255216|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111052218|NCT00255216|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111052219|NCT00255216|Antimetabolites|antimetabolites|mesh-ancestor
111052220|NCT00255216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111052221|NCT00255216|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111052222|NCT00255216|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111052223|NCT03525223|Dialysis Solutions|dialysis solutions|mesh-list
111052224|NCT03525223|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111052225|NCT02257697|Mizoribine|mizoribine|mesh-list
111052226|NCT02257697|Cyclophosphamide|cyclophosphamide|mesh-list
111052227|NCT02257697|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111052228|NCT02257697|Immunologic Factors|immunologic factors|mesh-ancestor
111052229|NCT02257697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111052230|NCT02257697|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111052231|NCT02257697|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111052232|NCT02257697|Alkylating Agents|alkylating agents|mesh-ancestor
111052233|NCT02257697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111052234|NCT02257697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111052235|NCT02257697|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111052236|NCT02257697|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111052237|NCT02257697|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111052238|NCT02257697|Analgesics|analgesics|mesh-ancestor
111052239|NCT02257697|Sensory System Agents|sensory system agents|mesh-ancestor
111052240|NCT02257697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111052241|NCT02257697|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111052242|NCT02257697|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111052243|NCT02257697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111052244|NCT02257697|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111052246|NCT02257697|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111052247|NCT02257697|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111052248|NCT02257697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111052249|NCT04468711|Vitamin D|vitamin d|mesh-list
111052250|NCT04468711|Hydrocortisone|hydrocortisone|mesh-list
111052251|NCT04468711|Vitamins|vitamins|mesh-ancestor
111052252|NCT04468711|Micronutrients|micronutrients|mesh-ancestor
111052253|NCT04468711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111052254|NCT04468711|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111052255|NCT04468711|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111052256|NCT02207387|Rasagiline|rasagiline|mesh-list
111052257|NCT02207387|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
111052258|NCT02207387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111052259|NCT02207387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111052260|NCT02207387|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111052261|NCT02207387|Protective Agents|protective agents|mesh-ancestor
111052262|NCT02207387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111052263|NCT03528421|Cyclophosphamide|cyclophosphamide|mesh-list
111052264|NCT03528421|Fludarabine|fludarabine|mesh-list
111052265|NCT03528421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111052266|NCT03528421|Immunologic Factors|immunologic factors|mesh-ancestor
111052267|NCT03528421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111052268|NCT03528421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111052269|NCT03528421|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110769330|NCT03571321|Dexamethasone|dexamethasone|mesh-list
111052271|NCT03528421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111052272|NCT03528421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111052273|NCT03528421|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111052274|NCT02374047|Atorvastatin|atorvastatin|mesh-list
111052275|NCT02374047|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111052276|NCT02374047|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111052277|NCT02374047|Antimetabolites|antimetabolites|mesh-ancestor
111052278|NCT02374047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111052279|NCT02374047|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111052280|NCT02374047|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111052281|NCT02374047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111052282|NCT02203253|Thalidomide|thalidomide|mesh-list
111052283|NCT02203253|Dexamethasone|dexamethasone|mesh-list
111052284|NCT02203253|Palonosetron|palonosetron|mesh-list
111052285|NCT02203253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111052286|NCT02203253|Antiemetics|antiemetics|mesh-ancestor
111052287|NCT02203253|Autonomic Agents|autonomic agents|mesh-ancestor
110630173|NCT00791960|Antiemetics|antiemetics|mesh-ancestor
111052288|NCT02203253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111052289|NCT02203253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111052290|NCT02203253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111052291|NCT02203253|Glucocorticoids|glucocorticoids|mesh-ancestor
111052292|NCT02203253|Hormones|hormones|mesh-ancestor
111052293|NCT02203253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111052294|NCT02203253|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111052295|NCT02203253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111052296|NCT02203253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111052297|NCT02203253|Immunologic Factors|immunologic factors|mesh-ancestor
111052298|NCT02203253|Leprostatic Agents|leprostatic agents|mesh-ancestor
111052299|NCT02203253|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111052300|NCT02203253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111052301|NCT02203253|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111052302|NCT02203253|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111052303|NCT02203253|Growth Substances|growth substances|mesh-ancestor
111052304|NCT02203253|Growth Inhibitors|growth inhibitors|mesh-ancestor
111052305|NCT02203253|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111052306|NCT02203253|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111052307|NCT02203253|Serotonin Agents|serotonin agents|mesh-ancestor
111052308|NCT02203253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111052309|NCT02203253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111052310|NCT02207699|Moxifloxacin|moxifloxacin|mesh-list
111052311|NCT02207699|Benzonatate|benzonatate|mesh-list
111052312|NCT02207699|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111052313|NCT02207699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111052314|NCT02207699|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111052315|NCT02207699|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111052316|NCT02207699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111052317|NCT02207699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111052318|NCT02207699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111052319|NCT02207699|Antitussive Agents|antitussive agents|mesh-ancestor
111052320|NCT02207699|Respiratory System Agents|respiratory system agents|mesh-ancestor
111052322|NCT02296138|Olodaterol|olodaterol|mesh-list
111052323|NCT02296138|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111052324|NCT02296138|Autonomic Agents|autonomic agents|mesh-ancestor
111052325|NCT02296138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111052326|NCT02296138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111052327|NCT02296138|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111052328|NCT02296138|Respiratory System Agents|respiratory system agents|mesh-ancestor
111052329|NCT02296138|Parasympatholytics|parasympatholytics|mesh-ancestor
111052330|NCT02296138|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111052331|NCT02296138|Cholinergic Agents|cholinergic agents|mesh-ancestor
111052332|NCT02296138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111052333|NCT02296138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111052334|NCT01306942|Paclitaxel|paclitaxel|mesh-list
111052335|NCT01306942|Trastuzumab|trastuzumab|mesh-list
111052336|NCT01306942|Dasatinib|dasatinib|mesh-list
111052337|NCT01306942|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111052338|NCT01306942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111052339|NCT01306942|Tubulin Modulators|tubulin modulators|mesh-ancestor
111052340|NCT01306942|Antimitotic Agents|antimitotic agents|mesh-ancestor
111052341|NCT01306942|Mitosis Modulators|mitosis modulators|mesh-ancestor
111052342|NCT01306942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111052343|NCT01306942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111052344|NCT01306942|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111052345|NCT01306942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111052347|NCT02207855|Anesthetics, Local|anesthetics, local|mesh-ancestor
111052348|NCT02207855|Anesthetics|anesthetics|mesh-ancestor
111052349|NCT02207855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111052350|NCT02207855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111052351|NCT02207855|Sensory System Agents|sensory system agents|mesh-ancestor
111052352|NCT02207855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111052353|NCT01345851|Paclitaxel|paclitaxel|mesh-list
111052354|NCT01345851|Carboplatin|carboplatin|mesh-list
111052355|NCT01345851|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111052356|NCT01345851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111052357|NCT01345851|Tubulin Modulators|tubulin modulators|mesh-ancestor
111052358|NCT01345851|Antimitotic Agents|antimitotic agents|mesh-ancestor
111052359|NCT01345851|Mitosis Modulators|mitosis modulators|mesh-ancestor
111052360|NCT01345851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111052361|NCT03532841|Tramadol|tramadol|mesh-list
111052362|NCT03532841|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111052363|NCT03532841|Narcotics|narcotics|mesh-ancestor
111052364|NCT03532841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111052365|NCT03532841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111052366|NCT03532841|Analgesics|analgesics|mesh-ancestor
111052367|NCT03532841|Sensory System Agents|sensory system agents|mesh-ancestor
111052368|NCT03532841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111052369|NCT02199431|Itraconazole|itraconazole|mesh-list
111052370|NCT02199431|Antifungal Agents|antifungal agents|mesh-ancestor
111052371|NCT02199431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111052372|NCT02199431|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111052373|NCT02199431|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111052374|NCT02199431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111052375|NCT02199431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111052376|NCT02199431|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111052377|NCT02199431|Hormone Antagonists|hormone antagonists|mesh-ancestor
111052378|NCT02199431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111052379|NCT02199431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111052380|NCT02199431|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111052381|NCT02203799|Immunomodulating Agents|immunomodulating agents|mesh-list
111052382|NCT02203799|Immunologic Factors|immunologic factors|mesh-list
111052383|NCT02203799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111052384|NCT03532763|Tocotrienols|tocotrienols|mesh-list
111052385|NCT03532763|Vitamin E|vitamin e|mesh-list
111052386|NCT03532763|Tocopherols|tocopherols|mesh-list
111052387|NCT03532763|Tocovid|tocovid|mesh-list
111052388|NCT03532763|Antioxidants|antioxidants|mesh-ancestor
111052389|NCT03532763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111052390|NCT03532763|Protective Agents|protective agents|mesh-ancestor
111052391|NCT03532763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111052392|NCT03532763|Vitamins|vitamins|mesh-ancestor
111052393|NCT03532763|Micronutrients|micronutrients|mesh-ancestor
111052394|NCT02208245|Ropivacaine|ropivacaine|mesh-list
110827669|NCT03869047|Bupivacaine|bupivacaine|mesh-list
111052395|NCT02208245|Anesthetics, Local|anesthetics, local|mesh-ancestor
111052396|NCT02208245|Anesthetics|anesthetics|mesh-ancestor
111052397|NCT02208245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111052398|NCT02208245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111052399|NCT02208245|Sensory System Agents|sensory system agents|mesh-ancestor
111052400|NCT02208245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111052401|NCT03514901|Pembrolizumab|pembrolizumab|mesh-list
111052402|NCT03514901|Nivolumab|nivolumab|mesh-list
111052403|NCT03514901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111052404|NCT03514901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111052405|NCT03514901|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111052406|NCT03514901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111052407|NCT04441021|Penicillins|penicillins|mesh-list
111052408|NCT04441021|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111052409|NCT04441021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111052410|NCT03533387|Ibudilast|ibudilast|mesh-list
111052411|NCT03533387|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111052412|NCT03533387|Autonomic Agents|autonomic agents|mesh-ancestor
111052413|NCT03533387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111052414|NCT03533387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111052415|NCT03533387|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111052416|NCT03533387|Respiratory System Agents|respiratory system agents|mesh-ancestor
110630194|NCT00792584|Antiviral Agents|antiviral agents|mesh-ancestor
111052417|NCT03533387|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110769480|NCT02969837|Antiemetics|antiemetics|mesh-ancestor
111052418|NCT03533387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111052419|NCT03533387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111052420|NCT03533387|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111052421|NCT03533387|Vasodilator Agents|vasodilator agents|mesh-ancestor
111052423|NCT02324842|Canagliflozin|canagliflozin|mesh-list
111052424|NCT02324842|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111052425|NCT02324842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111052426|NCT02324842|Incretins|incretins|mesh-ancestor
111052427|NCT02324842|Hormones|hormones|mesh-ancestor
111052428|NCT02324842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111052429|NCT02324842|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111052430|NCT02324842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111052431|NCT02295280|Diphenhydramine|diphenhydramine|mesh-list
111052432|NCT02295280|Promethazine|promethazine|mesh-list
111052433|NCT02295280|Codeine|codeine|mesh-list
111052434|NCT02295280|Metoclopramide|metoclopramide|mesh-list
111052435|NCT02295280|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111052436|NCT02295280|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111052437|NCT02295280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111052438|NCT02295280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111052439|NCT02295280|Anesthetics, Local|anesthetics, local|mesh-ancestor
111052440|NCT02295280|Anesthetics|anesthetics|mesh-ancestor
111052441|NCT02295280|Sensory System Agents|sensory system agents|mesh-ancestor
111052442|NCT02295280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111052443|NCT02295280|Antiemetics|antiemetics|mesh-ancestor
111052444|NCT02295280|Autonomic Agents|autonomic agents|mesh-ancestor
111052445|NCT02295280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111052446|NCT02295280|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111052447|NCT02295280|Histamine Antagonists|histamine antagonists|mesh-ancestor
111052448|NCT02295280|Histamine Agents|histamine agents|mesh-ancestor
111052449|NCT02295280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111052450|NCT02295280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111052451|NCT02295280|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111052452|NCT02295280|Antipruritics|antipruritics|mesh-ancestor
111052453|NCT02295280|Dermatologic Agents|dermatologic agents|mesh-ancestor
111052454|NCT02295280|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111052455|NCT02295280|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111052456|NCT02295280|Dopamine Agents|dopamine agents|mesh-ancestor
111052457|NCT02295280|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111052458|NCT02295280|Narcotics|narcotics|mesh-ancestor
111052459|NCT02295280|Analgesics|analgesics|mesh-ancestor
111052460|NCT02295280|Antitussive Agents|antitussive agents|mesh-ancestor
111052461|NCT02295280|Respiratory System Agents|respiratory system agents|mesh-ancestor
111052462|NCT05263505|Methotrexate|methotrexate|mesh-list
111052463|NCT05263505|Azathioprine|azathioprine|mesh-list
111052464|NCT05263505|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111052465|NCT05263505|Abortifacient Agents|abortifacient agents|mesh-ancestor
111052466|NCT05263505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111052467|NCT05263505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111052468|NCT05263505|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111052469|NCT05263505|Antimetabolites|antimetabolites|mesh-ancestor
110026783|NCT01275144|Antiemetics|antiemetics|mesh-ancestor
111052470|NCT05263505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111052471|NCT05263505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111052472|NCT05263505|Dermatologic Agents|dermatologic agents|mesh-ancestor
111052473|NCT05263505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111052474|NCT05263505|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111052475|NCT05263505|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111052476|NCT05263505|Immunologic Factors|immunologic factors|mesh-ancestor
111052477|NCT05263505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111052478|NCT05263505|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111052479|NCT02204501|Midazolam|midazolam|mesh-list
111052480|NCT02204501|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111052481|NCT02204501|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111052482|NCT02204501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111052483|NCT02204501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111052484|NCT02204501|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111052485|NCT02204501|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111052486|NCT02204501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111052487|NCT02204501|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111052488|NCT02204501|Anesthetics, General|anesthetics, general|mesh-ancestor
111052489|NCT02204501|Anesthetics|anesthetics|mesh-ancestor
111052490|NCT02204501|GABA Modulators|gaba modulators|mesh-ancestor
111052491|NCT02204501|GABA Agents|gaba agents|mesh-ancestor
111052492|NCT02204501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110676908|NCT03318900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111052493|NCT02204501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111052494|NCT02294734|Nemiralisib|nemiralisib|mesh-list
111052495|NCT02294734|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111052496|NCT02294734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111052497|NCT02294734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111052498|NCT03533231|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111052499|NCT03533231|Metronidazole|metronidazole|mesh-list
111052500|NCT03533231|Ciprofloxacin|ciprofloxacin|mesh-list
111052501|NCT03533231|Propolis|propolis|mesh-list
111052502|NCT03533231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111052503|NCT03533231|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111052504|NCT03533231|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111052505|NCT03533231|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111052506|NCT03533231|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111052507|NCT03533231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111052508|NCT03533231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111052509|NCT03533231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111052510|NCT03533231|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111052511|NCT03533231|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111052512|NCT02200757|Topotecan|topotecan|mesh-list
111052513|NCT02200757|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111052514|NCT02200757|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111052515|NCT02200757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111052516|NCT02200757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111052517|NCT02200757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111052518|NCT02208791|Sirolimus|sirolimus|mesh-list
111052519|NCT02208791|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111052520|NCT02208791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111052521|NCT02208791|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111052522|NCT02208791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111052523|NCT02208791|Antifungal Agents|antifungal agents|mesh-ancestor
111052524|NCT02208791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111052525|NCT02208791|Immunologic Factors|immunologic factors|mesh-ancestor
111052526|NCT02208791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111052527|NCT05223101|Telmisartan|telmisartan|mesh-list
111052528|NCT05223101|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111052529|NCT05223101|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111052530|NCT05223101|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111052531|NCT05223101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111052532|NCT05438953|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
111052533|NCT05438953|Antiviral Agents|antiviral agents|mesh-ancestor
111052534|NCT05438953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111052535|NCT02852057|Timolol|timolol|mesh-list
111052536|NCT02852057|Dorzolamide|dorzolamide|mesh-list
111052537|NCT02852057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111052538|NCT02852057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111052539|NCT02852057|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111052540|NCT02852057|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111052541|NCT02852057|Adrenergic Agents|adrenergic agents|mesh-ancestor
111052543|NCT02852057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111052544|NCT02852057|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111052545|NCT02852057|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111052546|NCT02852057|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
111052547|NCT04020445|Insulin|insulin|mesh-list
111052548|NCT04020445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111052549|NCT04020445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111052550|NCT03524833|Amoxicillin|amoxicillin|mesh-list
111052551|NCT03524833|Metronidazole|metronidazole|mesh-list
111052552|NCT03524833|Lansoprazole|lansoprazole|mesh-list
111052553|NCT03524833|Dexlansoprazole|dexlansoprazole|mesh-list
111052554|NCT03524833|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111052555|NCT03524833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111052556|NCT03524833|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111052557|NCT03524833|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111052558|NCT03524833|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111052559|NCT03524833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111052560|NCT03524833|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111052561|NCT03524833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111052562|NCT03524833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111052563|NCT02220647|Metformin|metformin|mesh-list
111052564|NCT02220647|Linagliptin|linagliptin|mesh-list
111052565|NCT02220647|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111052566|NCT02220647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111052567|NCT02220647|Incretins|incretins|mesh-ancestor
111052569|NCT02220647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111052570|NCT02220647|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111052571|NCT02220647|Protease Inhibitors|protease inhibitors|mesh-ancestor
111052572|NCT02220647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111052573|NCT02220647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111052574|NCT05426395|Vitamins|vitamins|mesh-list
111052575|NCT05426395|Hydroxocobalamin|hydroxocobalamin|mesh-list
111052576|NCT05426395|Vitamin B 12|vitamin b 12|mesh-list
111052577|NCT05426395|Vitamin B Complex|vitamin b complex|mesh-list
111052578|NCT05426395|Micronutrients|micronutrients|mesh-ancestor
111052579|NCT05426395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111052580|NCT05426395|Hematinics|hematinics|mesh-ancestor
111052581|NCT03544567|Paclitaxel|paclitaxel|mesh-list
111052582|NCT03544567|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111052583|NCT03544567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111052584|NCT03544567|Tubulin Modulators|tubulin modulators|mesh-ancestor
111052585|NCT03544567|Antimitotic Agents|antimitotic agents|mesh-ancestor
111052586|NCT03544567|Mitosis Modulators|mitosis modulators|mesh-ancestor
111052587|NCT03544567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111052588|NCT02209025|Theobromine|theobromine|mesh-list
111052589|NCT02209025|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111052590|NCT02209025|Autonomic Agents|autonomic agents|mesh-ancestor
111052591|NCT02209025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111052592|NCT02209025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111052593|NCT02209025|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111052594|NCT02209025|Respiratory System Agents|respiratory system agents|mesh-ancestor
111052595|NCT02209025|Vasodilator Agents|vasodilator agents|mesh-ancestor
111052596|NCT02220803|Acetazolamide|acetazolamide|mesh-list
111052597|NCT02220803|Anticonvulsants|anticonvulsants|mesh-ancestor
111052598|NCT02220803|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
111052599|NCT02220803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111052600|NCT02220803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111052601|NCT02220803|Diuretics|diuretics|mesh-ancestor
111052602|NCT02220803|Natriuretic Agents|natriuretic agents|mesh-ancestor
111052603|NCT02220803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111052604|NCT02322892|Thiamine|thiamine|mesh-list
111052605|NCT02322892|Vitamins|vitamins|mesh-ancestor
111052606|NCT02322892|Micronutrients|micronutrients|mesh-ancestor
111052607|NCT02322892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111052608|NCT02322892|Vitamin B Complex|vitamin b complex|mesh-ancestor
111052609|NCT03274375|Rituximab|rituximab|mesh-list
111052610|NCT03274375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111052611|NCT03274375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111052612|NCT03274375|Immunologic Factors|immunologic factors|mesh-ancestor
111052613|NCT03274375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111052614|NCT03274375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111052615|NCT02739997|Metronidazole|metronidazole|mesh-list
111052616|NCT02739997|Tazobactam|tazobactam|mesh-list
111052617|NCT02739997|Ceftolozane|ceftolozane|mesh-list
111052618|NCT02739997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111052619|NCT02739997|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111052621|NCT02739997|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111052622|NCT02739997|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
111052623|NCT02739997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111052624|NCT02739997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111052625|NCT04467931|Losartan|losartan|mesh-list
111052626|NCT04467931|Timolol|timolol|mesh-list
111052627|NCT04467931|Propranolol|propranolol|mesh-list
111052628|NCT04467931|Metoprolol|metoprolol|mesh-list
111052629|NCT04467931|Atenolol|atenolol|mesh-list
111052630|NCT04467931|Verapamil|verapamil|mesh-list
111052631|NCT04467931|Felodipine|felodipine|mesh-list
111052632|NCT04467931|Nadolol|nadolol|mesh-list
111052633|NCT04467931|Acebutolol|acebutolol|mesh-list
111052634|NCT04467931|Amlodipine|amlodipine|mesh-list
111052635|NCT04467931|Valsartan|valsartan|mesh-list
111052636|NCT04467931|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
111052637|NCT04467931|Telmisartan|telmisartan|mesh-list
111052638|NCT04467931|Clonidine|clonidine|mesh-list
111052639|NCT04467931|Carvedilol|carvedilol|mesh-list
111052640|NCT04467931|Candesartan|candesartan|mesh-list
111052641|NCT04467931|Candesartan cilexetil|candesartan cilexetil|mesh-list
111052642|NCT04467931|Ramipril|ramipril|mesh-list
111052643|NCT04467931|Olmesartan|olmesartan|mesh-list
111052644|NCT04467931|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
111052645|NCT04467931|Enalapril|enalapril|mesh-list
111052646|NCT04467931|Enalaprilat|enalaprilat|mesh-list
111052647|NCT04467931|Lisinopril|lisinopril|mesh-list
111052648|NCT04467931|Irbesartan|irbesartan|mesh-list
111052649|NCT04467931|Eplerenone|eplerenone|mesh-list
111052650|NCT04467931|Nebivolol|nebivolol|mesh-list
111052651|NCT04467931|Chlorthalidone|chlorthalidone|mesh-list
111052652|NCT04467931|Bisoprolol|bisoprolol|mesh-list
111052653|NCT04467931|Perindopril|perindopril|mesh-list
111052654|NCT04467931|Diltiazem|diltiazem|mesh-list
111052655|NCT04467931|Minoxidil|minoxidil|mesh-list
111052656|NCT04467931|Guanfacine|guanfacine|mesh-list
111052657|NCT04467931|Prazosin|prazosin|mesh-list
111052658|NCT04467931|Doxazosin|doxazosin|mesh-list
111052659|NCT04467931|Benazepril|benazepril|mesh-list
111052660|NCT04467931|Captopril|captopril|mesh-list
111052661|NCT04467931|Labetalol|labetalol|mesh-list
111052662|NCT04467931|Hydralazine|hydralazine|mesh-list
111052663|NCT04467931|Indapamide|indapamide|mesh-list
111052664|NCT04467931|Nicardipine|nicardipine|mesh-list
111052665|NCT04467931|Quinapril|quinapril|mesh-list
111052666|NCT04467931|Metolazone|metolazone|mesh-list
111052667|NCT04467931|Torsemide|torsemide|mesh-list
111052668|NCT04467931|Trandolapril|trandolapril|mesh-list
111052669|NCT04467931|Methyldopa|methyldopa|mesh-list
111052670|NCT04467931|Fosinopril|fosinopril|mesh-list
111052671|NCT04467931|Isradipine|isradipine|mesh-list
111052672|NCT04467931|Pindolol|pindolol|mesh-list
111052673|NCT04467931|Eprosartan|eprosartan|mesh-list
111052674|NCT04467931|Moexipril|moexipril|mesh-list
111052675|NCT04467931|Betaxolol|betaxolol|mesh-list
111052676|NCT04467931|Reserpine|reserpine|mesh-list
111052677|NCT04467931|Chlorothiazide|chlorothiazide|mesh-list
111052678|NCT04467931|Bendroflumethiazide|bendroflumethiazide|mesh-list
111052679|NCT04467931|Guanabenz|guanabenz|mesh-list
111052680|NCT04467931|Nisoldipine|nisoldipine|mesh-list
111052681|NCT04467931|Penbutolol|penbutolol|mesh-list
111052682|NCT04467931|Nifedipine|nifedipine|mesh-list
111052683|NCT04467931|Amiloride|amiloride|mesh-list
111052684|NCT04467931|Triamterene|triamterene|mesh-list
111052685|NCT04467931|Furosemide|furosemide|mesh-list
111052686|NCT04467931|Spironolactone|spironolactone|mesh-list
111052687|NCT04467931|Bumetanide|bumetanide|mesh-list
111052688|NCT04467931|Ethacrynic Acid|ethacrynic acid|mesh-list
111052689|NCT04467931|Terazosin|terazosin|mesh-list
111052690|NCT04467931|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
111052691|NCT04467931|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
111052692|NCT04467931|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111052693|NCT04467931|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111052694|NCT04467931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111052695|NCT04467931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111052696|NCT04467931|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111052697|NCT04467931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111052698|NCT04467931|Vasodilator Agents|vasodilator agents|mesh-ancestor
111052699|NCT04467931|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111052700|NCT04467931|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111052701|NCT04467931|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111052702|NCT04467931|Diuretics|diuretics|mesh-ancestor
111052703|NCT04467931|Natriuretic Agents|natriuretic agents|mesh-ancestor
111052704|NCT04467931|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
111052705|NCT04467931|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111052706|NCT04467931|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111052707|NCT04467931|Adrenergic Agents|adrenergic agents|mesh-ancestor
111052708|NCT04467931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110026784|NCT01275144|Autonomic Agents|autonomic agents|mesh-ancestor
111052709|NCT04467931|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
111052710|NCT04467931|Sympatholytics|sympatholytics|mesh-ancestor
111052711|NCT04467931|Autonomic Agents|autonomic agents|mesh-ancestor
111052712|NCT04467931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111052713|NCT04467931|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
111052715|NCT04467931|Sensory System Agents|sensory system agents|mesh-ancestor
111052716|NCT04467931|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111052717|NCT04467931|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111052718|NCT04467931|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111052719|NCT04467931|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
111052720|NCT04467931|Hormone Antagonists|hormone antagonists|mesh-ancestor
111052721|NCT04467931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111052722|NCT04467931|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
111052723|NCT04467931|Antioxidants|antioxidants|mesh-ancestor
111052724|NCT04467931|Protective Agents|protective agents|mesh-ancestor
111052725|NCT04467931|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111052726|NCT04467931|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111052727|NCT04467931|Protease Inhibitors|protease inhibitors|mesh-ancestor
111052728|NCT04467931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111052729|NCT04467931|Tocolytic Agents|tocolytic agents|mesh-ancestor
111052730|NCT04467931|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111052731|NCT04467931|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111052732|NCT04467931|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
111052733|NCT04467931|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111052734|NCT04467931|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
111052735|NCT04467931|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111052736|NCT04467931|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
111052738|NCT04467931|Urological Agents|urological agents|mesh-ancestor
111052739|NCT04467931|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111052740|NCT04467931|Serotonin Agents|serotonin agents|mesh-ancestor
111052741|NCT04467931|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
111052742|NCT04467931|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111052743|NCT04467931|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111052744|NCT04467931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111052745|NCT04467931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111052746|NCT04467931|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111052747|NCT04467931|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111052748|NCT03705559|Analgesics, Opioid|analgesics, opioid|mesh-list
111052749|NCT03705559|Narcotics|narcotics|mesh-ancestor
111052750|NCT03705559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111052751|NCT03705559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111052752|NCT03705559|Analgesics|analgesics|mesh-ancestor
111052753|NCT03705559|Sensory System Agents|sensory system agents|mesh-ancestor
111052754|NCT03705559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111052755|NCT03522649|Leucovorin|leucovorin|mesh-list
111052756|NCT03522649|Fluorouracil|fluorouracil|mesh-list
111052757|NCT03522649|Irinotecan|irinotecan|mesh-list
111052758|NCT03522649|Antimetabolites|antimetabolites|mesh-ancestor
111052759|NCT03522649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111052760|NCT03522649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111052761|NCT03522649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111052762|NCT03522649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111052763|NCT03522649|Immunologic Factors|immunologic factors|mesh-ancestor
111052764|NCT03522649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111052765|NCT03522649|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111052766|NCT03522649|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111052767|NCT03522649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111052768|NCT03522649|Antidotes|antidotes|mesh-ancestor
111052769|NCT03522649|Protective Agents|protective agents|mesh-ancestor
111052770|NCT03522649|Vitamin B Complex|vitamin b complex|mesh-ancestor
111052771|NCT03522649|Vitamins|vitamins|mesh-ancestor
111052772|NCT03522649|Micronutrients|micronutrients|mesh-ancestor
111052773|NCT02366481|Vitamins|vitamins|mesh-list
111052774|NCT02366481|Vitamin K|vitamin k|mesh-list
111052775|NCT02366481|Vitamin K 2|vitamin k 2|mesh-list
111052776|NCT02366481|Menaquinone 7|menaquinone 7|mesh-list
111052777|NCT02366481|Micronutrients|micronutrients|mesh-ancestor
111052778|NCT02366481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111052779|NCT02366481|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111052780|NCT02366481|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111052781|NCT02366481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111052782|NCT02366481|Hemostatics|hemostatics|mesh-ancestor
111052783|NCT02366481|Coagulants|coagulants|mesh-ancestor
111052784|NCT02366247|Adefovir|adefovir|mesh-list
111052785|NCT02366247|Thymalfasin|thymalfasin|mesh-list
111052786|NCT02366247|Antiviral Agents|antiviral agents|mesh-ancestor
111052787|NCT02366247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111052788|NCT02366247|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111052789|NCT02366247|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111052790|NCT02366247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111052791|NCT02366247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111052792|NCT02366247|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111052793|NCT02366247|Immunologic Factors|immunologic factors|mesh-ancestor
111052794|NCT02366247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111052795|NCT02373735|Mannitol|mannitol|mesh-list
111052796|NCT02373735|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
111052797|NCT02373735|Diuretics|diuretics|mesh-ancestor
111052798|NCT02373735|Natriuretic Agents|natriuretic agents|mesh-ancestor
111052799|NCT02373735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111052800|NCT03526315|Fluorides|fluorides|mesh-list
111052801|NCT03526315|Cariostatic Agents|cariostatic agents|mesh-ancestor
111052802|NCT03526315|Protective Agents|protective agents|mesh-ancestor
111052803|NCT03526315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111052804|NCT03112551|Magnesium Sulfate|magnesium sulfate|mesh-list
111052805|NCT03112551|Analgesics|analgesics|mesh-ancestor
111052806|NCT03112551|Sensory System Agents|sensory system agents|mesh-ancestor
111052807|NCT03112551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111052808|NCT03112551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111052809|NCT03112551|Anesthetics|anesthetics|mesh-ancestor
111052810|NCT03112551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111052811|NCT03112551|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111052812|NCT03112551|Anticonvulsants|anticonvulsants|mesh-ancestor
111052813|NCT03112551|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111052814|NCT03112551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111052815|NCT03112551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111052816|NCT03112551|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111052817|NCT03112551|Tocolytic Agents|tocolytic agents|mesh-ancestor
111052818|NCT03112551|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110630269|NCT00858624|Ketamine|ketamine|mesh-list
111052820|NCT05373433|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111052821|NCT05373433|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111052822|NCT05373433|Protease Inhibitors|protease inhibitors|mesh-ancestor
111052823|NCT05373433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111052824|NCT05373433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111052825|NCT05373433|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111052826|NCT05373433|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111052827|NCT05373433|Antiviral Agents|antiviral agents|mesh-ancestor
111052828|NCT05373433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111052829|NCT05373433|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111052830|NCT05373433|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111052831|NCT02363127|Progesterone|progesterone|mesh-list
111052832|NCT02363127|Progestins|progestins|mesh-ancestor
111052833|NCT02363127|Hormones|hormones|mesh-ancestor
111052834|NCT02363127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111052835|NCT02363127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111052836|NCT03526159|Gentamicins|gentamicins|mesh-list
111052837|NCT03526159|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111052838|NCT03526159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111052839|NCT03526159|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111052840|NCT03526159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111052841|NCT03526159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111052842|NCT03523741|Clozapine|clozapine|mesh-list
111052843|NCT03523741|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111052844|NCT03523741|Serotonin Agents|serotonin agents|mesh-ancestor
111052845|NCT03523741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111052846|NCT03523741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111052847|NCT03523741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111052848|NCT03523741|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111052849|NCT03523741|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111052850|NCT03523741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111052851|NCT03523741|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111052852|NCT03523741|GABA Antagonists|gaba antagonists|mesh-ancestor
111052853|NCT03523741|GABA Agents|gaba agents|mesh-ancestor
111052854|NCT02362581|Factor VIII|factor viii|mesh-list
111052855|NCT02362581|Coagulants|coagulants|mesh-ancestor
111052856|NCT03525925|Nivolumab|nivolumab|mesh-list
111052857|NCT03525925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111052858|NCT03525925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111052859|NCT03525925|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111119157|NCT05306873|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111052860|NCT03525925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111052862|NCT02373579|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111052863|NCT02373579|Abortifacient Agents|abortifacient agents|mesh-ancestor
111052864|NCT02373579|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111052865|NCT02373579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111052866|NCT02373579|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111052867|NCT02373579|Antimetabolites|antimetabolites|mesh-ancestor
111052868|NCT02373579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111052869|NCT02373579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111052870|NCT02373579|Dermatologic Agents|dermatologic agents|mesh-ancestor
111052871|NCT02373579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111052872|NCT02373579|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111052873|NCT02373579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111052874|NCT02373579|Immunologic Factors|immunologic factors|mesh-ancestor
111052875|NCT02373579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111052876|NCT02373579|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111052877|NCT02365857|Dexmedetomidine|dexmedetomidine|mesh-list
111052878|NCT02365857|Bupivacaine|bupivacaine|mesh-list
111052879|NCT02365857|Anesthetics, Local|anesthetics, local|mesh-ancestor
111052880|NCT02365857|Anesthetics|anesthetics|mesh-ancestor
111052881|NCT02365857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111052882|NCT02365857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111052883|NCT02365857|Sensory System Agents|sensory system agents|mesh-ancestor
110769940|NCT01167738|Metformin|metformin|mesh-list
110630277|NCT00858624|Anesthetics|anesthetics|mesh-ancestor
111052884|NCT02365857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111052885|NCT02365857|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111052886|NCT02365857|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111052887|NCT02365857|Analgesics|analgesics|mesh-ancestor
111052888|NCT02365857|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111052889|NCT02365857|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111052890|NCT02365857|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111052891|NCT02365857|Adrenergic Agents|adrenergic agents|mesh-ancestor
111052892|NCT02365857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111052893|NCT02365857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111052894|NCT02365935|Paclitaxel|paclitaxel|mesh-list
111052895|NCT02365935|Cisplatin|cisplatin|mesh-list
111052896|NCT02365935|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111052897|NCT02365935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111052898|NCT02365935|Tubulin Modulators|tubulin modulators|mesh-ancestor
111052899|NCT02365935|Antimitotic Agents|antimitotic agents|mesh-ancestor
111052900|NCT02365935|Mitosis Modulators|mitosis modulators|mesh-ancestor
111052901|NCT02365935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111052902|NCT02365623|Bedaquiline|bedaquiline|mesh-list
111052903|NCT02365623|Diarylquinolines|diarylquinolines|mesh-list
111052904|NCT02365623|Antitubercular Agents|antitubercular agents|mesh-ancestor
111052905|NCT02365623|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111052906|NCT02365623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111052907|NCT03112707|Aspirin|aspirin|mesh-list
111052908|NCT03112707|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111052909|NCT03112707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111052910|NCT03112707|Analgesics|analgesics|mesh-ancestor
111052911|NCT03112707|Sensory System Agents|sensory system agents|mesh-ancestor
111052912|NCT03112707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111052913|NCT03112707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111052914|NCT03112707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111052915|NCT03112707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111052916|NCT03112707|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111052917|NCT03112707|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111052918|NCT03112707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111052919|NCT03112707|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111052920|NCT03112707|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111052921|NCT03112707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111052922|NCT03112707|Antipyretics|antipyretics|mesh-ancestor
111052923|NCT05262413|Lenvatinib|lenvatinib|mesh-list
111052924|NCT05262413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111052925|NCT05262413|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111052926|NCT05262413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111052927|NCT05262413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111052928|NCT02209649|Telmisartan|telmisartan|mesh-list
111052929|NCT02209649|Lacidipine|lacidipine|mesh-list
111052930|NCT02209649|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111052931|NCT02209649|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111052932|NCT02209649|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111052933|NCT02209649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111052934|NCT02209649|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111052935|NCT02209649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111052936|NCT02209649|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111052937|NCT02209649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111052938|NCT02361567|Acetaminophen|acetaminophen|mesh-list
111052939|NCT02361567|Oxycodone|oxycodone|mesh-list
111052940|NCT02361567|Tramadol|tramadol|mesh-list
111052941|NCT02361567|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111052942|NCT02361567|Narcotics|narcotics|mesh-ancestor
111052943|NCT02361567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111052944|NCT02361567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111052945|NCT02361567|Analgesics|analgesics|mesh-ancestor
111052946|NCT02361567|Sensory System Agents|sensory system agents|mesh-ancestor
111052947|NCT02361567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111052948|NCT02361567|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111052949|NCT02361567|Antipyretics|antipyretics|mesh-ancestor
111052950|NCT03112785|Cimetidine|cimetidine|mesh-list
111052951|NCT03112785|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111052952|NCT03112785|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111052953|NCT03112785|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
111052954|NCT03112785|Histamine Antagonists|histamine antagonists|mesh-ancestor
111052955|NCT03112785|Histamine Agents|histamine agents|mesh-ancestor
111052956|NCT03112785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111052957|NCT03112785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111052958|NCT03112785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111052959|NCT03112785|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111052960|NCT03112785|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111052961|NCT03112785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111052962|NCT02361879|Leuprolide|leuprolide|mesh-list
111052963|NCT02361879|Ulipristal acetate|ulipristal acetate|mesh-list
111052964|NCT02361879|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111052965|NCT02361879|Fertility Agents|fertility agents|mesh-ancestor
111052966|NCT02361879|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111052967|NCT02361879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111052968|NCT02361879|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111052969|NCT02361879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111052970|NCT02361879|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111052971|NCT02361879|Contraceptive Agents|contraceptive agents|mesh-ancestor
111052972|NCT02361879|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111052973|NCT05262335|Paclitaxel|paclitaxel|mesh-list
111052974|NCT05262335|Docetaxel|docetaxel|mesh-list
111052975|NCT05262335|Capecitabine|capecitabine|mesh-list
111052976|NCT05262335|Oxaliplatin|oxaliplatin|mesh-list
111052977|NCT05262335|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111052978|NCT05262335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111052979|NCT05262335|Tubulin Modulators|tubulin modulators|mesh-ancestor
111052980|NCT05262335|Antimitotic Agents|antimitotic agents|mesh-ancestor
111052981|NCT05262335|Mitosis Modulators|mitosis modulators|mesh-ancestor
111052982|NCT05262335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111052983|NCT05262335|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111052984|NCT05262335|Antimetabolites|antimetabolites|mesh-ancestor
111052985|NCT02361645|Ketorolac|ketorolac|mesh-list
111052986|NCT02361645|Indomethacin|indomethacin|mesh-list
111052987|NCT02361645|Nepafenac|nepafenac|mesh-list
111052988|NCT02361645|Bromfenac|bromfenac|mesh-list
111052989|NCT02361645|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111052990|NCT02361645|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111052991|NCT02361645|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111052992|NCT02361645|Analgesics|analgesics|mesh-ancestor
111052993|NCT02361645|Sensory System Agents|sensory system agents|mesh-ancestor
111052994|NCT02361645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111052995|NCT02361645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111052996|NCT02361645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111052997|NCT02361645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111052998|NCT02361645|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111052999|NCT02361645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111053000|NCT02361645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111053001|NCT02361645|Gout Suppressants|gout suppressants|mesh-ancestor
111053002|NCT02361645|Tocolytic Agents|tocolytic agents|mesh-ancestor
111053003|NCT02361645|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111053004|NCT02361645|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111053005|NCT03522181|Insulin|insulin|mesh-list
111053006|NCT03522181|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111053007|NCT03522181|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111053008|NCT03522181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111053009|NCT02373033|Folic Acid|folic acid|mesh-list
111053010|NCT02373033|Vitamin B Complex|vitamin b complex|mesh-list
111053011|NCT02373033|Hematinics|hematinics|mesh-ancestor
111053012|NCT02373033|Vitamins|vitamins|mesh-ancestor
111053013|NCT02373033|Micronutrients|micronutrients|mesh-ancestor
111053014|NCT02373033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111053015|NCT05186129|Clopidogrel|clopidogrel|mesh-list
111053016|NCT05186129|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111053017|NCT05186129|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111053018|NCT05186129|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111053019|NCT05186129|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111053020|NCT05186129|Purinergic Agents|purinergic agents|mesh-ancestor
111053021|NCT05186129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111053022|NCT05186129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111053023|NCT05186129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111053024|NCT02361723|Pamiparib|pamiparib|mesh-list
111053025|NCT02361723|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111053026|NCT02361723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111053027|NCT02361723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111053028|NCT02361723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111053029|NCT03596281|Bevacizumab|bevacizumab|mesh-list
111053030|NCT03596281|Pembrolizumab|pembrolizumab|mesh-list
111053031|NCT03596281|Doxorubicin|doxorubicin|mesh-list
111053032|NCT03596281|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111053033|NCT03596281|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111053034|NCT03596281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111053035|NCT03596281|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111053036|NCT03596281|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111053038|NCT03596281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111053039|NCT03596281|Growth Inhibitors|growth inhibitors|mesh-ancestor
111053040|NCT03596281|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111053041|NCT03596281|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111053042|NCT03596281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111053043|NCT03596281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111053044|NCT03596281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111053045|NCT03596281|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111053046|NCT05172167|Antibodies|antibodies|mesh-list
111053047|NCT05172167|Immunologic Factors|immunologic factors|mesh-ancestor
111053048|NCT05172167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111053049|NCT02359149|Endothelial Growth Factors|endothelial growth factors|mesh-list
111053050|NCT02359149|Growth Substances|growth substances|mesh-ancestor
111053051|NCT02359149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111053052|NCT02221583|Mycophenolic Acid|mycophenolic acid|mesh-list
111053053|NCT02221583|Tacrolimus|tacrolimus|mesh-list
111053054|NCT02221583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111053055|NCT02221583|Immunologic Factors|immunologic factors|mesh-ancestor
111053056|NCT02221583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111053057|NCT02221583|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111053058|NCT02221583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111053059|NCT02221583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111053060|NCT02221583|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111053061|NCT02221583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111053062|NCT02221583|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111053063|NCT02221583|Antitubercular Agents|antitubercular agents|mesh-ancestor
111053064|NCT02221583|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111053065|NCT02221583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111053066|NCT03500731|Rituximab|rituximab|mesh-list
111053067|NCT03500731|Alemtuzumab|alemtuzumab|mesh-list
111053068|NCT03500731|Fludarabine|fludarabine|mesh-list
111053069|NCT03500731|Thiotepa|thiotepa|mesh-list
111053070|NCT03500731|Hydroxyurea|hydroxyurea|mesh-list
111053071|NCT03500731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111053072|NCT03500731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111053073|NCT03500731|Immunologic Factors|immunologic factors|mesh-ancestor
111053074|NCT03500731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111053075|NCT03500731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111053076|NCT03500731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111053077|NCT03500731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111053078|NCT03500731|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111053079|NCT03500731|Alkylating Agents|alkylating agents|mesh-ancestor
111053080|NCT03500731|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111053081|NCT03500731|Antisickling Agents|antisickling agents|mesh-ancestor
111053082|NCT03500731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111053083|NCT03500731|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111053084|NCT02751359|Cannabidiol|cannabidiol|mesh-list
111053085|NCT02751359|Anticonvulsants|anticonvulsants|mesh-ancestor
111053086|NCT02358993|Ciprofloxacin|ciprofloxacin|mesh-list
111053087|NCT02358993|Methenamine hippurate|methenamine hippurate|mesh-list
111053088|NCT02358993|Methenamine mandelate|methenamine mandelate|mesh-list
111053089|NCT02358993|Methenamine|methenamine|mesh-list
111053090|NCT02358993|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111053091|NCT02358993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111053092|NCT02358993|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111053093|NCT02358993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111053094|NCT02358993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111053095|NCT02358993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111053096|NCT02358993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111053097|NCT02358993|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111053098|NCT02358993|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111053099|NCT02358993|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111053100|NCT04059445|Calcium, Dietary|calcium, dietary|mesh-list
111053101|NCT04059445|Calcium|calcium|mesh-list
111053102|NCT04059445|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111053103|NCT04059445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111053104|NCT04059445|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111053105|NCT05092841|Naltrexone|naltrexone|mesh-list
111053106|NCT05092841|Baclofen|baclofen|mesh-list
111053107|NCT05092841|Sorbitol|sorbitol|mesh-list
111053108|NCT05092841|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111053109|NCT05092841|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111053110|NCT05092841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111053111|NCT05092841|Sensory System Agents|sensory system agents|mesh-ancestor
111053112|NCT05092841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111053113|NCT05092841|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
111053114|NCT05092841|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111053115|NCT05092841|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
111053116|NCT05092841|GABA Agonists|gaba agonists|mesh-ancestor
111053117|NCT05092841|GABA Agents|gaba agents|mesh-ancestor
111053118|NCT05092841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111053119|NCT05092841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111053120|NCT05092841|Cathartics|cathartics|mesh-ancestor
111053121|NCT05092841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111053122|NCT02224937|Melatonin|melatonin|mesh-list
111053123|NCT02224937|Antioxidants|antioxidants|mesh-ancestor
111053124|NCT02224937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111053125|NCT02224937|Protective Agents|protective agents|mesh-ancestor
111053126|NCT02224937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111053127|NCT02224937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111053128|NCT02290327|Pantoprazole|pantoprazole|mesh-list
111053129|NCT02290327|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111053130|NCT02290327|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111053131|NCT02290327|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111053132|NCT02290327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111053133|NCT02290327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111053134|NCT02372955|Dapagliflozin|dapagliflozin|mesh-list
111053135|NCT02372955|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111053136|NCT02372955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111053137|NCT02372955|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111053138|NCT02372955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111053139|NCT02358057|Dexmedetomidine|dexmedetomidine|mesh-list
111053140|NCT02358057|Alfentanil|alfentanil|mesh-list
111053141|NCT02358057|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111053142|NCT02358057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111053143|NCT02358057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111053144|NCT02358057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111053145|NCT02358057|Analgesics|analgesics|mesh-ancestor
111053146|NCT02358057|Sensory System Agents|sensory system agents|mesh-ancestor
111053147|NCT02358057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111053148|NCT02358057|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111053149|NCT02358057|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111053150|NCT02358057|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111053151|NCT02358057|Adrenergic Agents|adrenergic agents|mesh-ancestor
111053152|NCT02358057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111053153|NCT02358057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111053154|NCT02358057|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111053155|NCT02358057|Narcotics|narcotics|mesh-ancestor
111053156|NCT02358057|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111053157|NCT02358057|Anesthetics, General|anesthetics, general|mesh-ancestor
111053158|NCT02358057|Anesthetics|anesthetics|mesh-ancestor
111053159|NCT02225093|Dextromethorphan|dextromethorphan|mesh-list
111053160|NCT02225093|Caffeine|caffeine|mesh-list
111053161|NCT02225093|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111053162|NCT02225093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111053163|NCT02225093|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111053164|NCT02225093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111053165|NCT02225093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111053166|NCT02225093|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
111053167|NCT02225093|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111053168|NCT02225093|Purinergic Agents|purinergic agents|mesh-ancestor
111053169|NCT02225093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111053170|NCT02225093|Antitussive Agents|antitussive agents|mesh-ancestor
111053171|NCT02225093|Respiratory System Agents|respiratory system agents|mesh-ancestor
111053172|NCT02225093|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111053173|NCT02225093|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111053174|NCT02212535|Plerixafor|plerixafor|mesh-list
111053175|NCT02212535|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111053176|NCT02212535|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111053177|NCT02212535|Antiviral Agents|antiviral agents|mesh-ancestor
111053178|NCT02212535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111053179|NCT02372487|Sildenafil Citrate|sildenafil citrate|mesh-list
111053180|NCT02372487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111053181|NCT02372487|Vasodilator Agents|vasodilator agents|mesh-ancestor
111053182|NCT02372487|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111053183|NCT02372487|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110770236|NCT02526030|Dopamine Agents|dopamine agents|mesh-ancestor
111053185|NCT02372487|Urological Agents|urological agents|mesh-ancestor
111053186|NCT02361177|Oxytocin|oxytocin|mesh-list
111053187|NCT02361177|Oxytocics|oxytocics|mesh-ancestor
111053188|NCT02361177|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111053189|NCT02361177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111053190|NCT05055713|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
111053191|NCT05055713|Somatostatin|somatostatin|mesh-list
111053192|NCT05055713|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111053193|NCT05055713|Adrenergic Agents|adrenergic agents|mesh-ancestor
111053194|NCT05055713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111053195|NCT05055713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111053196|NCT05055713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111053197|NCT05055713|Hormones|hormones|mesh-ancestor
111053198|NCT05055713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111053199|NCT02360709|Sirolimus|sirolimus|mesh-list
111053200|NCT02360709|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111053201|NCT02360709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111053202|NCT02360709|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111053203|NCT02360709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111053204|NCT02360709|Antifungal Agents|antifungal agents|mesh-ancestor
111053205|NCT02360709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111053206|NCT02360709|Immunologic Factors|immunologic factors|mesh-ancestor
111053207|NCT02360709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111053208|NCT04624113|Pembrolizumab|pembrolizumab|mesh-list
111053209|NCT04624113|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111053210|NCT04624113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111053211|NCT04624113|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111053212|NCT04624113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111053213|NCT05030519|Trastuzumab|trastuzumab|mesh-list
111053214|NCT05030519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111053215|NCT05030519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111053216|NCT02357277|Budesonide|budesonide|mesh-list
111053217|NCT02357277|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111053218|NCT02357277|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111053219|NCT02357277|Autonomic Agents|autonomic agents|mesh-ancestor
111053220|NCT02357277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111053221|NCT02357277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111053222|NCT02357277|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111053223|NCT02357277|Respiratory System Agents|respiratory system agents|mesh-ancestor
111053224|NCT02357277|Glucocorticoids|glucocorticoids|mesh-ancestor
111053225|NCT02357277|Hormones|hormones|mesh-ancestor
111053226|NCT02357277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111053227|NCT02222441|Pioglitazone|pioglitazone|mesh-list
111053228|NCT02222441|Palbociclib|palbociclib|mesh-list
111053229|NCT02222441|Modafinil|modafinil|mesh-list
111053230|NCT02222441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111053231|NCT02222441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111053232|NCT02222441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111053233|NCT02222441|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111053234|NCT02222441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111053235|NCT02222441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111053236|NCT02222441|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111053237|NCT02222441|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
111053238|NCT02222441|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111053239|NCT02222441|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111053240|NCT02290717|Fluticasone|fluticasone|mesh-list
111053241|NCT02290717|Xhance|xhance|mesh-list
111053242|NCT02290717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111053243|NCT02290717|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111053244|NCT02290717|Autonomic Agents|autonomic agents|mesh-ancestor
111053245|NCT02290717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111053246|NCT02290717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111053247|NCT02290717|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111053248|NCT02290717|Respiratory System Agents|respiratory system agents|mesh-ancestor
111053249|NCT02290717|Dermatologic Agents|dermatologic agents|mesh-ancestor
111053250|NCT02290717|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111053251|NCT02225795|Cyclophosphamide|cyclophosphamide|mesh-list
111053252|NCT02225795|Antilymphocyte Serum|antilymphocyte serum|mesh-list
111053253|NCT02225795|Thymoglobulin|thymoglobulin|mesh-list
111053254|NCT02225795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111053255|NCT02225795|Immunologic Factors|immunologic factors|mesh-ancestor
110770309|NCT01175772|Celecoxib|celecoxib|mesh-list
111053256|NCT02225795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111053257|NCT02225795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111053258|NCT02225795|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111053259|NCT02225795|Alkylating Agents|alkylating agents|mesh-ancestor
111053260|NCT02225795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111053261|NCT02225795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111053262|NCT02225795|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111053264|NCT02360007|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111053265|NCT02360007|Narcotics|narcotics|mesh-ancestor
111053266|NCT02360007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111053267|NCT02360007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111053268|NCT02360007|Analgesics|analgesics|mesh-ancestor
111053269|NCT02360007|Sensory System Agents|sensory system agents|mesh-ancestor
111053270|NCT02360007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111053271|NCT02360007|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111053272|NCT02294305|Vortioxetine|vortioxetine|mesh-list
111053273|NCT02294305|Antidepressive Agents|antidepressive agents|mesh-ancestor
111053274|NCT02294305|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111053275|NCT02294305|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111053276|NCT02294305|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111053277|NCT02294305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111053278|NCT02294305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111053279|NCT02294305|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111053280|NCT02294305|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111053281|NCT02294305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111053282|NCT02294305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111053283|NCT02294305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111053284|NCT02294305|Serotonin Agents|serotonin agents|mesh-ancestor
111053285|NCT02294305|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111053286|NCT02294305|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111053287|NCT02294305|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111053288|NCT02294305|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111053290|NCT01672255|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111053291|NCT01672255|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111053292|NCT01672255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111053293|NCT01672255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111053294|NCT01672255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111053295|NCT01672255|Serotonin Agents|serotonin agents|mesh-ancestor
111053296|NCT01672255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111053297|NCT01672255|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111053298|NCT01672255|Antidepressive Agents|antidepressive agents|mesh-ancestor
111053299|NCT01672255|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111053300|NCT01672255|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111053301|NCT01672255|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111053302|NCT01672255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111053303|NCT02222519|Bromides|bromides|mesh-list
111053304|NCT02222519|Rocuronium|rocuronium|mesh-list
111053305|NCT02222519|Anticonvulsants|anticonvulsants|mesh-ancestor
111053306|NCT02222519|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
111053307|NCT02222519|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
111053308|NCT02222519|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111053309|NCT02222519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111053310|NCT02222519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111053311|NCT02220023|Nitric Oxide|nitric oxide|mesh-list
111053312|NCT02220023|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111053313|NCT02220023|Autonomic Agents|autonomic agents|mesh-ancestor
111053314|NCT02220023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111053315|NCT02220023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111053316|NCT02220023|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111053317|NCT02220023|Respiratory System Agents|respiratory system agents|mesh-ancestor
111053318|NCT02220023|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111053319|NCT02220023|Antioxidants|antioxidants|mesh-ancestor
111053320|NCT02220023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111053321|NCT02220023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111053322|NCT02220023|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
111053323|NCT02220023|Vasodilator Agents|vasodilator agents|mesh-ancestor
111053324|NCT02220023|Gasotransmitters|gasotransmitters|mesh-ancestor
111053325|NCT02220023|Protective Agents|protective agents|mesh-ancestor
111053326|NCT02356965|Ketamine|ketamine|mesh-list
111053327|NCT02356965|Analgesics|analgesics|mesh-ancestor
111053328|NCT02356965|Sensory System Agents|sensory system agents|mesh-ancestor
111053329|NCT02356965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111053330|NCT02356965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111053331|NCT02356965|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111053332|NCT02356965|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111053333|NCT02356965|Anesthetics, General|anesthetics, general|mesh-ancestor
111053334|NCT02356965|Anesthetics|anesthetics|mesh-ancestor
111053335|NCT02356965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111053336|NCT02356965|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111053337|NCT02356965|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111053338|NCT02356965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111053339|NCT02356965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111053340|NCT02359695|Hormones|hormones|mesh-list
111053341|NCT02359695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111053342|NCT02359695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111053343|NCT02294539|Losartan|losartan|mesh-list
111053344|NCT02294539|Amlodipine|amlodipine|mesh-list
111053345|NCT02294539|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
111053346|NCT02294539|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111053347|NCT02294539|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111053348|NCT02294539|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111053349|NCT02294539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111053350|NCT02294539|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111053351|NCT02294539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111053352|NCT02294539|Vasodilator Agents|vasodilator agents|mesh-ancestor
111053353|NCT02294539|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111053354|NCT02294539|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111053355|NCT02294539|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111053356|NCT02294539|Diuretics|diuretics|mesh-ancestor
111053357|NCT02294539|Natriuretic Agents|natriuretic agents|mesh-ancestor
110518446|NCT01515137|Sulindac|sulindac|mesh-list
111053358|NCT02294539|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
111053359|NCT02359617|Insulin|insulin|mesh-list
111053360|NCT02359617|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111053361|NCT02359617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111053362|NCT03154125|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
111053363|NCT03154125|Medroxyprogesterone|medroxyprogesterone|mesh-list
111053364|NCT03154125|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111053365|NCT03154125|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111053366|NCT03154125|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111053367|NCT03154125|Contraceptive Agents|contraceptive agents|mesh-ancestor
111053368|NCT03154125|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111053369|NCT03154125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111053370|NCT03154125|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111053371|NCT03154125|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111053372|NCT03154125|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
111053373|NCT03154125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111053374|NCT03154125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111053375|NCT02294617|Nicotine|nicotine|mesh-list
111053376|NCT02294617|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111053377|NCT02294617|Autonomic Agents|autonomic agents|mesh-ancestor
111053378|NCT02294617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111053379|NCT02294617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111053380|NCT02294617|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111053381|NCT02294617|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111053382|NCT02294617|Cholinergic Agents|cholinergic agents|mesh-ancestor
111053383|NCT02294617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111053384|NCT02294617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111053385|NCT02291341|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
111053386|NCT02291341|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111053387|NCT02291341|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111053388|NCT02291341|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111053389|NCT02291341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111053390|NCT02291341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111053391|NCT02291341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111053392|NCT02291341|Analgesics|analgesics|mesh-ancestor
111053393|NCT02291341|Sensory System Agents|sensory system agents|mesh-ancestor
111053394|NCT02291341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111053395|NCT02291341|Antidepressive Agents|antidepressive agents|mesh-ancestor
111053396|NCT02291341|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111053397|NCT02291341|Dopamine Agents|dopamine agents|mesh-ancestor
111053398|NCT02352987|Salicylic Acid|salicylic acid|mesh-list
111053399|NCT02352987|Salicylates|salicylates|mesh-list
111053400|NCT02352987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110676909|NCT03318900|Immunologic Factors|immunologic factors|mesh-ancestor
111053401|NCT02352987|Antifungal Agents|antifungal agents|mesh-ancestor
111053402|NCT02352987|Keratolytic Agents|keratolytic agents|mesh-ancestor
111053403|NCT02352987|Dermatologic Agents|dermatologic agents|mesh-ancestor
111053404|NCT02352987|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111053405|NCT02352987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111053406|NCT02352987|Analgesics|analgesics|mesh-ancestor
111053407|NCT02352987|Sensory System Agents|sensory system agents|mesh-ancestor
111053408|NCT02352987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111053409|NCT02352987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111053410|NCT02352987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111053411|NCT02352987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111053412|NCT02352987|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111053413|NCT02352987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111053414|NCT02352987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111053415|NCT02226341|Mycophenolic Acid|mycophenolic acid|mesh-list
111053416|NCT02226341|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
111053417|NCT02226341|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111053418|NCT02226341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111053419|NCT02226341|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111053420|NCT02226341|Antitubercular Agents|antitubercular agents|mesh-ancestor
111053421|NCT02226341|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111053422|NCT02226341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111053423|NCT02226341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111053424|NCT02226341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111053425|NCT02226341|Hormones|hormones|mesh-ancestor
111053426|NCT02226341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111053427|NCT02226341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111053428|NCT02222987|Clopidogrel|clopidogrel|mesh-list
111053429|NCT02222987|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111053430|NCT02222987|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111053431|NCT02222987|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111053432|NCT02222987|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111053433|NCT02222987|Purinergic Agents|purinergic agents|mesh-ancestor
111053434|NCT02222987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111053435|NCT02222987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111053436|NCT02222987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111053437|NCT03521245|Trastuzumab|trastuzumab|mesh-list
111053438|NCT03521245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111053439|NCT03521245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111053440|NCT02481245|Bezafibrate|bezafibrate|mesh-list
111053441|NCT02481245|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111053442|NCT02481245|Antimetabolites|antimetabolites|mesh-ancestor
111053443|NCT02481245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111053444|NCT02481245|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111053445|NCT02352597|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
111053446|NCT02352597|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
111053447|NCT02352597|Clomiphene|clomiphene|mesh-list
111053448|NCT02352597|Enclomiphene|enclomiphene|mesh-list
111053449|NCT02352597|Zuclomiphene|zuclomiphene|mesh-list
111053450|NCT02352597|Estradiol|estradiol|mesh-list
110630364|NCT00792818|Antioxidants|antioxidants|mesh-ancestor
111053451|NCT02352597|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
111053452|NCT02352597|Phytoestrogens|phytoestrogens|mesh-list
111053453|NCT02352597|Estrogens|estrogens|mesh-ancestor
111053454|NCT02352597|Hormones|hormones|mesh-ancestor
111053455|NCT02352597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111053456|NCT02352597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111053457|NCT02352597|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111053458|NCT02352597|Contraceptive Agents|contraceptive agents|mesh-ancestor
111053459|NCT02352597|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111053460|NCT02352597|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111053461|NCT02352597|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111053462|NCT02352597|Hormone Antagonists|hormone antagonists|mesh-ancestor
111053463|NCT02352597|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111053464|NCT02352597|Fertility Agents|fertility agents|mesh-ancestor
111053465|NCT02352597|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111053466|NCT02352597|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111053467|NCT02352597|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
111053468|NCT03521167|Acetaminophen|acetaminophen|mesh-list
111053469|NCT03521167|Lidocaine|lidocaine|mesh-list
111053470|NCT03521167|Dexmedetomidine|dexmedetomidine|mesh-list
111053471|NCT03521167|Ketamine|ketamine|mesh-list
111053472|NCT03521167|Gabapentin|gabapentin|mesh-list
111053473|NCT03521167|Anesthetics, Local|anesthetics, local|mesh-ancestor
111053474|NCT03521167|Anesthetics|anesthetics|mesh-ancestor
111053475|NCT03521167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111053476|NCT03521167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111053477|NCT03521167|Sensory System Agents|sensory system agents|mesh-ancestor
111053478|NCT03521167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111053479|NCT03521167|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111053480|NCT03521167|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111053481|NCT03521167|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111053482|NCT03521167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111053483|NCT03521167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111053484|NCT03521167|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111053485|NCT03521167|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111053486|NCT03521167|Analgesics|analgesics|mesh-ancestor
111053487|NCT03521167|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111053488|NCT03521167|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111053489|NCT03521167|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111053490|NCT03521167|Adrenergic Agents|adrenergic agents|mesh-ancestor
111053491|NCT03521167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111053492|NCT03521167|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111053493|NCT03521167|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111053494|NCT03521167|Anesthetics, General|anesthetics, general|mesh-ancestor
111053495|NCT03521167|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111053496|NCT03521167|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111053497|NCT03521167|Anticonvulsants|anticonvulsants|mesh-ancestor
111053498|NCT03521167|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111053499|NCT03521167|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111053500|NCT03521167|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111053501|NCT03521167|Antimanic Agents|antimanic agents|mesh-ancestor
111053502|NCT03521167|Antipyretics|antipyretics|mesh-ancestor
111053503|NCT02352519|Anesthetics|anesthetics|mesh-list
111053504|NCT02352519|Anesthetics, Local|anesthetics, local|mesh-list
111053505|NCT02352519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111053506|NCT02352519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111053507|NCT02352519|Sensory System Agents|sensory system agents|mesh-ancestor
111053508|NCT02352519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111053509|NCT02356419|Epoetin Alfa|epoetin alfa|mesh-list
111053510|NCT02356419|Hematinics|hematinics|mesh-ancestor
111053511|NCT02220335|Digoxin|digoxin|mesh-list
111053512|NCT02220335|Diuretics|diuretics|mesh-list
111053513|NCT02220335|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
111053514|NCT02220335|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
111053515|NCT02220335|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111053516|NCT02220335|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111053517|NCT02220335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111053518|NCT02220335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111053519|NCT02220335|Protective Agents|protective agents|mesh-ancestor
111053520|NCT02220335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111053521|NCT02220335|Natriuretic Agents|natriuretic agents|mesh-ancestor
111053522|NCT02220335|Protease Inhibitors|protease inhibitors|mesh-ancestor
111053523|NCT02220335|Hormone Antagonists|hormone antagonists|mesh-ancestor
111053524|NCT02220335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111053525|NCT02220335|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
111053526|NCT02291731|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111053527|NCT02291731|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111053528|NCT02223299|Tryptophan|tryptophan|mesh-list
111053529|NCT02223299|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111053530|NCT02223299|Antidepressive Agents|antidepressive agents|mesh-ancestor
111053531|NCT02223299|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111053532|NCT02356341|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111053533|NCT02356341|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111053534|NCT02223377|Morphine|morphine|mesh-list
111053535|NCT02223377|Hydromorphone|hydromorphone|mesh-list
111053536|NCT02223377|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111053537|NCT02223377|Narcotics|narcotics|mesh-ancestor
111053538|NCT02223377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111053539|NCT02223377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111053540|NCT02223377|Analgesics|analgesics|mesh-ancestor
111053541|NCT02223377|Sensory System Agents|sensory system agents|mesh-ancestor
111053542|NCT02223377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111053543|NCT02291887|Ranibizumab|ranibizumab|mesh-list
111053544|NCT02291887|Aflibercept|aflibercept|mesh-list
111053545|NCT02291887|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111053546|NCT02291887|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111053547|NCT02291887|Growth Substances|growth substances|mesh-ancestor
111053548|NCT02291887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111053549|NCT02291887|Growth Inhibitors|growth inhibitors|mesh-ancestor
111053550|NCT02291887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111053552|NCT02352285|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
111053553|NCT02352285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111053554|NCT02352285|Natriuretic Agents|natriuretic agents|mesh-ancestor
111053555|NCT02352285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111053556|NCT03521713|Epoetin Alfa|epoetin alfa|mesh-list
111053557|NCT03521713|Hematinics|hematinics|mesh-ancestor
111053558|NCT02223533|Morphine|morphine|mesh-list
111053559|NCT02223533|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111053560|NCT02223533|Narcotics|narcotics|mesh-ancestor
111053561|NCT02223533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111053562|NCT02223533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111053563|NCT02223533|Analgesics|analgesics|mesh-ancestor
111053564|NCT02223533|Sensory System Agents|sensory system agents|mesh-ancestor
111053565|NCT02223533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111053566|NCT02231021|Pioglitazone|pioglitazone|mesh-list
111053567|NCT02231021|Alogliptin|alogliptin|mesh-list
111053568|NCT02231021|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111053569|NCT02231021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111053570|NCT02231021|Incretins|incretins|mesh-ancestor
111053571|NCT02231021|Hormones|hormones|mesh-ancestor
111053572|NCT02231021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111053573|NCT02231021|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111053574|NCT02231021|Protease Inhibitors|protease inhibitors|mesh-ancestor
111053575|NCT02231021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111119158|NCT05306873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110630398|NCT00793052|Dexamethasone|dexamethasone|mesh-list
111053576|NCT02231021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111053578|NCT04465123|Spironolactone|spironolactone|mesh-list
111053579|NCT04465123|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111053580|NCT04465123|Diuretics|diuretics|mesh-ancestor
111053581|NCT04465123|Natriuretic Agents|natriuretic agents|mesh-ancestor
111053582|NCT04465123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111053583|NCT04465123|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
111053584|NCT04465123|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111053585|NCT04465123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111053586|NCT04465123|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
111053587|NCT04465123|Hormone Antagonists|hormone antagonists|mesh-ancestor
111053588|NCT04465123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111053589|NCT04465123|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
111053590|NCT02401347|Talazoparib|talazoparib|mesh-list
111053591|NCT02401347|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111053592|NCT02401347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111053593|NCT02401347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111053594|NCT02401347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111053595|NCT02231255|Pramipexole|pramipexole|mesh-list
111053596|NCT02231255|Antioxidants|antioxidants|mesh-ancestor
111053597|NCT02231255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111053598|NCT02231255|Protective Agents|protective agents|mesh-ancestor
111053599|NCT02231255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111053600|NCT02231255|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111053601|NCT02231255|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111053602|NCT02231255|Dopamine Agonists|dopamine agonists|mesh-ancestor
111053603|NCT02231255|Dopamine Agents|dopamine agents|mesh-ancestor
111053604|NCT02231255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111053605|NCT02352051|Methylphenidate|methylphenidate|mesh-list
111053606|NCT02352051|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
111053607|NCT02352051|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111053608|NCT02352051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111053609|NCT02352051|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111053610|NCT02352051|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111053611|NCT02352051|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111053612|NCT02352051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111053613|NCT02352051|Dopamine Agents|dopamine agents|mesh-ancestor
111053614|NCT02352051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111053615|NCT02352051|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111053616|NCT02352051|Adrenergic Agents|adrenergic agents|mesh-ancestor
111053617|NCT02227277|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
111053618|NCT02227277|Interferon alpha-2|interferon alpha-2|mesh-list
111053619|NCT02227277|Antiviral Agents|antiviral agents|mesh-ancestor
111053620|NCT02227277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111053621|NCT02227277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111053622|NCT03147183|Thymoglobulin|thymoglobulin|mesh-list
111053623|NCT03147183|Immunologic Factors|immunologic factors|mesh-ancestor
111053624|NCT03147183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111053625|NCT03147183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111053626|NCT02292121|Mannitol|mannitol|mesh-list
111053627|NCT02292121|Lactitol|lactitol|mesh-list
111053628|NCT02292121|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
111053629|NCT02292121|Diuretics|diuretics|mesh-ancestor
111053630|NCT02292121|Natriuretic Agents|natriuretic agents|mesh-ancestor
111053631|NCT02292121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111053632|NCT02292121|Cathartics|cathartics|mesh-ancestor
111053633|NCT02292121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111053634|NCT02223611|Cisplatin|cisplatin|mesh-list
111053635|NCT02223611|Vinorelbine|vinorelbine|mesh-list
111053636|NCT02223611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111053637|NCT02223611|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111053638|NCT02223611|Tubulin Modulators|tubulin modulators|mesh-ancestor
111053639|NCT02223611|Antimitotic Agents|antimitotic agents|mesh-ancestor
111053640|NCT02223611|Mitosis Modulators|mitosis modulators|mesh-ancestor
111053641|NCT02223611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111053642|NCT02231333|Pentoxifylline|pentoxifylline|mesh-list
111053643|NCT02231333|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111053644|NCT02231333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111053645|NCT02231333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111053646|NCT02231333|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111053647|NCT02231333|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111053648|NCT02231333|Protective Agents|protective agents|mesh-ancestor
111053649|NCT02231333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111053650|NCT02231333|Vasodilator Agents|vasodilator agents|mesh-ancestor
111053651|NCT02231333|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111053652|NCT02231333|Antioxidants|antioxidants|mesh-ancestor
111053653|NCT02227433|Brentuximab Vedotin|brentuximab vedotin|mesh-list
111053654|NCT02227433|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111053655|NCT02227433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111053656|NCT02227433|Immunotoxins|immunotoxins|mesh-ancestor
111053657|NCT02227433|Immunoconjugates|immunoconjugates|mesh-ancestor
111053658|NCT02227433|Immunologic Factors|immunologic factors|mesh-ancestor
111053659|NCT02227433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111053660|NCT02351973|Amiloride|amiloride|mesh-list
111053661|NCT02351973|Diuretics|diuretics|mesh-ancestor
111053662|NCT02351973|Natriuretic Agents|natriuretic agents|mesh-ancestor
111053663|NCT02351973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111053664|NCT02351973|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
111053665|NCT02351973|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111053666|NCT02351973|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111053667|NCT02351973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111053668|NCT02351973|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
111053669|NCT02351973|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
111053670|NCT04831619|Deoxyglucose|deoxyglucose|mesh-list
111053671|NCT04831619|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
111053672|NCT04831619|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111053673|NCT04831619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111053674|NCT04831619|Antimetabolites|antimetabolites|mesh-ancestor
111053675|NCT04831619|Antiviral Agents|antiviral agents|mesh-ancestor
111053676|NCT04831619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111053677|NCT03520543|Clonidine|clonidine|mesh-list
111053678|NCT03520543|Yohimbine|yohimbine|mesh-list
111053679|NCT03520543|Analgesics|analgesics|mesh-ancestor
111053680|NCT03520543|Sensory System Agents|sensory system agents|mesh-ancestor
111053681|NCT03520543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111053682|NCT03520543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111053683|NCT03520543|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111053684|NCT03520543|Sympatholytics|sympatholytics|mesh-ancestor
111053685|NCT03520543|Autonomic Agents|autonomic agents|mesh-ancestor
111053686|NCT03520543|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111053687|NCT03520543|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111053688|NCT03520543|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111053689|NCT03520543|Adrenergic Agents|adrenergic agents|mesh-ancestor
111053690|NCT03520543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111053691|NCT03520543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111053692|NCT03520543|Mydriatics|mydriatics|mesh-ancestor
111053693|NCT03520543|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
111053694|NCT03520543|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111053695|NCT03520543|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111053696|NCT03520543|Urological Agents|urological agents|mesh-ancestor
111053697|NCT02355639|Betamethasone|betamethasone|mesh-list
111053698|NCT02355639|Betamethasone Valerate|betamethasone valerate|mesh-list
111053699|NCT02355639|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
111053700|NCT02355639|Betamethasone benzoate|betamethasone benzoate|mesh-list
111053701|NCT02355639|Clobetasol|clobetasol|mesh-list
111053702|NCT02355639|Petrolatum|petrolatum|mesh-list
111053703|NCT02355639|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
111053704|NCT02355639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111053705|NCT02355639|Glucocorticoids|glucocorticoids|mesh-ancestor
111053706|NCT02355639|Hormones|hormones|mesh-ancestor
111053707|NCT02355639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111053708|NCT02355639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111053709|NCT02355639|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111053710|NCT02355639|Respiratory System Agents|respiratory system agents|mesh-ancestor
111053711|NCT02355639|Emollients|emollients|mesh-ancestor
111053712|NCT02355639|Dermatologic Agents|dermatologic agents|mesh-ancestor
111053713|NCT02351895|Copper|copper|mesh-list
111053714|NCT02351895|Trace Elements|trace elements|mesh-ancestor
111053715|NCT02351895|Micronutrients|micronutrients|mesh-ancestor
111053716|NCT02351895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111053717|NCT00503035|Celecoxib|celecoxib|mesh-list
111053718|NCT00503035|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111053719|NCT00503035|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111053720|NCT00503035|Analgesics|analgesics|mesh-ancestor
111053721|NCT00503035|Sensory System Agents|sensory system agents|mesh-ancestor
111053722|NCT00503035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111053723|NCT00503035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111053724|NCT00503035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111053725|NCT00503035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111053726|NCT00503035|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111053727|NCT00503035|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111053728|NCT00503035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111053729|NCT00503035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111053731|NCT02227745|Hyaluronic Acid|hyaluronic acid|mesh-list
111053732|NCT02227745|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111053733|NCT02227745|Immunologic Factors|immunologic factors|mesh-ancestor
111053734|NCT02227745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111053735|NCT02227745|Viscosupplements|viscosupplements|mesh-ancestor
111053736|NCT02227745|Protective Agents|protective agents|mesh-ancestor
111053737|NCT02227745|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111053738|NCT02227745|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
111053739|NCT02227745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111053740|NCT02227745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111053741|NCT03517033|Nebivolol|nebivolol|mesh-list
111053742|NCT03517033|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111053743|NCT03517033|Vasodilator Agents|vasodilator agents|mesh-ancestor
111053744|NCT03517033|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
111053745|NCT03517033|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111053746|NCT03517033|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111053747|NCT03517033|Adrenergic Agents|adrenergic agents|mesh-ancestor
111053748|NCT03517033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111053749|NCT03517033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111053750|NCT03517033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111053751|NCT03516955|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111053752|NCT03516955|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111053753|NCT03516955|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111053754|NCT03516955|Antimetabolites|antimetabolites|mesh-ancestor
111053755|NCT03516955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111053756|NCT03516955|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111053757|NCT03516955|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111053758|NCT03516955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111053759|NCT02259179|Naltrexone|naltrexone|mesh-list
111053760|NCT02259179|Bupropion|bupropion|mesh-list
111053761|NCT02259179|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111053762|NCT02259179|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111053763|NCT02259179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111053764|NCT02259179|Sensory System Agents|sensory system agents|mesh-ancestor
111053765|NCT02259179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111053766|NCT02259179|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111053767|NCT02259179|Antidepressive Agents|antidepressive agents|mesh-ancestor
111053768|NCT02259179|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111053769|NCT02259179|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111053770|NCT02259179|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111053771|NCT02259179|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111053772|NCT02259179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111053773|NCT02259179|Dopamine Agents|dopamine agents|mesh-ancestor
110770833|NCT01179828|Oxycodone|oxycodone|mesh-list
111053774|NCT02259179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111053775|NCT02259179|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111053776|NCT02259179|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111053777|NCT02259179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111053778|NCT02355093|Ropivacaine|ropivacaine|mesh-list
111053779|NCT02355093|Anesthetics, Local|anesthetics, local|mesh-ancestor
111053780|NCT02355093|Anesthetics|anesthetics|mesh-ancestor
111053781|NCT02355093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111053782|NCT02355093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111053783|NCT02355093|Sensory System Agents|sensory system agents|mesh-ancestor
111053784|NCT02355093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111053786|NCT02227823|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
111053787|NCT02227823|Anticonvulsants|anticonvulsants|mesh-ancestor
111053788|NCT02227823|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111053789|NCT02227823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111053790|NCT02227823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111053791|NCT02227823|Cholinergic Agents|cholinergic agents|mesh-ancestor
111053792|NCT02227823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111053793|NCT02227823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111053794|NCT02227901|Temozolomide|temozolomide|mesh-list
111053795|NCT02227901|Tipifarnib|tipifarnib|mesh-list
111053796|NCT02227901|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111053797|NCT02227901|Alkylating Agents|alkylating agents|mesh-ancestor
111053798|NCT02227901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111053799|NCT02227901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111053800|NCT03146793|Sodium thiosulfate|sodium thiosulfate|mesh-list
111053801|NCT03146793|Antidotes|antidotes|mesh-ancestor
111053802|NCT03146793|Protective Agents|protective agents|mesh-ancestor
111053803|NCT03146793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111053804|NCT03146793|Antioxidants|antioxidants|mesh-ancestor
111053805|NCT03146793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111053806|NCT03146793|Antitubercular Agents|antitubercular agents|mesh-ancestor
111053807|NCT03146793|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111053808|NCT03146793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111053809|NCT03146793|Chelating Agents|chelating agents|mesh-ancestor
111053810|NCT03146793|Sequestering Agents|sequestering agents|mesh-ancestor
111053811|NCT03133195|Vitamin D|vitamin d|mesh-list
111053812|NCT03133195|Teriparatide|teriparatide|mesh-list
111053813|NCT03133195|Calcium|calcium|mesh-list
111053814|NCT03133195|Parathyroid Hormone|parathyroid hormone|mesh-list
111053815|NCT03133195|Vitamins|vitamins|mesh-ancestor
111053816|NCT03133195|Micronutrients|micronutrients|mesh-ancestor
111053817|NCT03133195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111053818|NCT03133195|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111053819|NCT03133195|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111053820|NCT03159741|Glucagon|glucagon|mesh-list
111053821|NCT03159741|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
111053822|NCT03159741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111053823|NCT03159741|Hormones|hormones|mesh-ancestor
111053824|NCT03159741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111053825|NCT03159741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111053826|NCT03159741|Incretins|incretins|mesh-ancestor
111053827|NCT02292277|Ticagrelor|ticagrelor|mesh-list
111053828|NCT02292277|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111053829|NCT02292277|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111053830|NCT02292277|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111053831|NCT02292277|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111053832|NCT02292277|Purinergic Agents|purinergic agents|mesh-ancestor
111053833|NCT02292277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111053834|NCT02292277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111053835|NCT02292277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111053836|NCT02228135|Dexamethasone|dexamethasone|mesh-list
111053837|NCT02228135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111053838|NCT02228135|Antiemetics|antiemetics|mesh-ancestor
111053839|NCT02228135|Autonomic Agents|autonomic agents|mesh-ancestor
111053840|NCT02228135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111053841|NCT02228135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111053842|NCT02228135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111053843|NCT02228135|Glucocorticoids|glucocorticoids|mesh-ancestor
111053844|NCT02228135|Hormones|hormones|mesh-ancestor
111053845|NCT02228135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111053846|NCT02228135|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111053847|NCT02228135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111053848|NCT03152877|Bupivacaine|bupivacaine|mesh-list
111053849|NCT03152877|Anesthetics, Local|anesthetics, local|mesh-ancestor
111053850|NCT03152877|Anesthetics|anesthetics|mesh-ancestor
111053851|NCT03152877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111053852|NCT03152877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111053853|NCT03152877|Sensory System Agents|sensory system agents|mesh-ancestor
111053854|NCT03152877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111053855|NCT02295709|Dexamethasone|dexamethasone|mesh-list
111053856|NCT02295709|Dexamethasone acetate|dexamethasone acetate|mesh-list
111053857|NCT02295709|BB 1101|bb 1101|mesh-list
111053858|NCT02295709|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111053859|NCT02295709|Antiemetics|antiemetics|mesh-ancestor
111053860|NCT02295709|Autonomic Agents|autonomic agents|mesh-ancestor
111053861|NCT02295709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111053862|NCT02295709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111053863|NCT02295709|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111053864|NCT02295709|Glucocorticoids|glucocorticoids|mesh-ancestor
111053865|NCT02295709|Hormones|hormones|mesh-ancestor
111053866|NCT02295709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110026954|NCT00242580|Verteporfin|verteporfin|mesh-list
111053867|NCT02295709|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111053868|NCT02295709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111053869|NCT02295709|Protease Inhibitors|protease inhibitors|mesh-ancestor
111053870|NCT02295709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111053871|NCT02295709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111053872|NCT02354937|Cabotegravir|cabotegravir|mesh-list
111053873|NCT02354937|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111053874|NCT02354937|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111053875|NCT02354937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111053876|NCT02354937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111053877|NCT02354937|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111053878|NCT02354937|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111053879|NCT02354937|Antiviral Agents|antiviral agents|mesh-ancestor
111053880|NCT02354937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111053881|NCT02295787|Ketamine|ketamine|mesh-list
111053882|NCT02295787|Analgesics|analgesics|mesh-ancestor
111053883|NCT02295787|Sensory System Agents|sensory system agents|mesh-ancestor
111053884|NCT02295787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111053885|NCT02295787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111053886|NCT02295787|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111053887|NCT02295787|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111053888|NCT02295787|Anesthetics, General|anesthetics, general|mesh-ancestor
111053889|NCT02295787|Anesthetics|anesthetics|mesh-ancestor
111053890|NCT02295787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111053891|NCT02295787|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111053892|NCT02295787|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111053893|NCT02295787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111053894|NCT02295787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111053895|NCT04464967|Trastuzumab|trastuzumab|mesh-list
111053896|NCT04464967|Cetuximab|cetuximab|mesh-list
111053897|NCT04464967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111053898|NCT04464967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111053899|NCT02228369|Osimertinib|osimertinib|mesh-list
111053900|NCT02228369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111053901|NCT02228369|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111053902|NCT02228369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111053903|NCT02228369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111053904|NCT03146871|Azacitidine|azacitidine|mesh-list
111053905|NCT03146871|Decitabine|decitabine|mesh-list
111053906|NCT03146871|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111053907|NCT03146871|Antimetabolites|antimetabolites|mesh-ancestor
111053908|NCT03146871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111053909|NCT03146871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111053910|NCT03146871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111053911|NCT02231957|Vaccines|vaccines|mesh-list
111053912|NCT02231957|Immunologic Factors|immunologic factors|mesh-ancestor
111053913|NCT02231957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111053914|NCT02354547|Cyclophosphamide|cyclophosphamide|mesh-list
111053915|NCT02354547|Topotecan|topotecan|mesh-list
111053916|NCT02354547|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111053917|NCT02354547|Immunologic Factors|immunologic factors|mesh-ancestor
111053918|NCT02354547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111053919|NCT02354547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111053920|NCT02354547|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111053921|NCT02354547|Alkylating Agents|alkylating agents|mesh-ancestor
111053922|NCT02354547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111053923|NCT02354547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111053924|NCT02354547|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111053925|NCT02354547|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111053926|NCT02354547|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111053927|NCT02354547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111053928|NCT02232035|Diazepam|diazepam|mesh-list
111053929|NCT02232035|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111053930|NCT02232035|Anticonvulsants|anticonvulsants|mesh-ancestor
111053931|NCT02232035|Antiemetics|antiemetics|mesh-ancestor
111053932|NCT02232035|Autonomic Agents|autonomic agents|mesh-ancestor
111053933|NCT02232035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111053934|NCT02232035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111053935|NCT02232035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111053936|NCT02232035|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111053937|NCT02232035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111053938|NCT02232035|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
111053939|NCT02232035|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111053940|NCT02232035|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111053941|NCT02232035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111053942|NCT02232035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111053943|NCT02232035|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111053944|NCT02232035|Anesthetics, General|anesthetics, general|mesh-ancestor
111053945|NCT02232035|Anesthetics|anesthetics|mesh-ancestor
111053946|NCT02232035|GABA Modulators|gaba modulators|mesh-ancestor
111053947|NCT02232035|GABA Agents|gaba agents|mesh-ancestor
111053948|NCT02232035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111053949|NCT02232035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111053950|NCT02296021|Amoxicillin|amoxicillin|mesh-list
111053951|NCT02296021|Clarithromycin|clarithromycin|mesh-list
111053952|NCT02296021|Esomeprazole|esomeprazole|mesh-list
111053953|NCT02296021|Bismuth|bismuth|mesh-list
111053954|NCT02296021|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111053955|NCT02296021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111053956|NCT02296021|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111053957|NCT02296021|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111053958|NCT02296021|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111053959|NCT02296021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111053960|NCT02296021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111053961|NCT02296021|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111053962|NCT02296021|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111053963|NCT02296021|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111053964|NCT02296021|Antacids|antacids|mesh-ancestor
111053965|NCT02289391|Anesthetics|anesthetics|mesh-list
111053966|NCT02289391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111053967|NCT02289391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111053968|NCT02354313|Lenalidomide|lenalidomide|mesh-list
111053969|NCT02354313|Immunologic Factors|immunologic factors|mesh-ancestor
111053970|NCT02354313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111053971|NCT02354313|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111053972|NCT02354313|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111053973|NCT02354313|Growth Substances|growth substances|mesh-ancestor
111053974|NCT02354313|Growth Inhibitors|growth inhibitors|mesh-ancestor
111053975|NCT02354313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111053976|NCT02292667|Acetaminophen|acetaminophen|mesh-list
111053977|NCT02292667|Morphine|morphine|mesh-list
111053978|NCT02292667|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111053979|NCT02292667|Narcotics|narcotics|mesh-ancestor
111053980|NCT02292667|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111053981|NCT02292667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111053982|NCT02292667|Analgesics|analgesics|mesh-ancestor
111053983|NCT02292667|Sensory System Agents|sensory system agents|mesh-ancestor
111053984|NCT02292667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111053985|NCT02292667|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110630442|NCT02555852|Antacids|antacids|mesh-ancestor
111053986|NCT02292667|Antipyretics|antipyretics|mesh-ancestor
111053987|NCT02232269|Felodipine|felodipine|mesh-list
111053988|NCT02232269|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111053989|NCT02232269|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111053990|NCT02232269|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111053991|NCT02232269|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111053992|NCT02232269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111053993|NCT02232269|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111053994|NCT02232269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110771059|NCT01187862|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111053995|NCT02232269|Vasodilator Agents|vasodilator agents|mesh-ancestor
111053996|NCT04486313|Nitazoxanide|nitazoxanide|mesh-list
111053997|NCT04486313|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111053998|NCT04486313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111053999|NCT02354001|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
111054000|NCT02354001|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111054001|NCT02354001|Hormone Antagonists|hormone antagonists|mesh-ancestor
111054002|NCT02354001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111054003|NCT02354001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111054004|NCT02354001|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111054005|NCT02354001|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111054006|NCT02354001|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111054008|NCT02347839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111054009|NCT02347839|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111054010|NCT02347839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111054011|NCT02347839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111054012|NCT02289547|Capecitabine|capecitabine|mesh-list
111054013|NCT02289547|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111054014|NCT02289547|Antimetabolites|antimetabolites|mesh-ancestor
111054015|NCT02289547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111054016|NCT02289547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111054018|NCT02351427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111054019|NCT02232971|Glucagon|glucagon|mesh-list
111054020|NCT02232971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111054021|NCT02232971|Hormones|hormones|mesh-ancestor
111054022|NCT02232971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111054023|NCT02232971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111054024|NCT02296333|Ondansetron|ondansetron|mesh-list
111054025|NCT02296333|Antiemetics|antiemetics|mesh-ancestor
111054026|NCT02296333|Autonomic Agents|autonomic agents|mesh-ancestor
111054027|NCT02296333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111054028|NCT02296333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111054029|NCT02296333|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111054030|NCT02296333|Antipruritics|antipruritics|mesh-ancestor
111054031|NCT02296333|Dermatologic Agents|dermatologic agents|mesh-ancestor
111054032|NCT02296333|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111054033|NCT02296333|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111054034|NCT02296333|Serotonin Agents|serotonin agents|mesh-ancestor
111054035|NCT02296333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111054036|NCT02296333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111054037|NCT03149913|Paclitaxel|paclitaxel|mesh-list
111054038|NCT03149913|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111054039|NCT03149913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111054040|NCT03149913|Tubulin Modulators|tubulin modulators|mesh-ancestor
111054041|NCT03149913|Antimitotic Agents|antimitotic agents|mesh-ancestor
111054042|NCT03149913|Mitosis Modulators|mitosis modulators|mesh-ancestor
111054043|NCT03149913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111054044|NCT02289703|Rivaroxaban|rivaroxaban|mesh-list
111054045|NCT02289703|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111054046|NCT02289703|Antithrombins|antithrombins|mesh-ancestor
111054047|NCT02289703|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111054048|NCT02289703|Protease Inhibitors|protease inhibitors|mesh-ancestor
111054049|NCT02289703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111054050|NCT02289703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111054051|NCT02289703|Anticoagulants|anticoagulants|mesh-ancestor
111054052|NCT02232347|Sufentanil|sufentanil|mesh-list
111054053|NCT02232347|Ketamine|ketamine|mesh-list
111054054|NCT02232347|Analgesics|analgesics|mesh-ancestor
111054055|NCT02232347|Sensory System Agents|sensory system agents|mesh-ancestor
111054056|NCT02232347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111054057|NCT02232347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111054058|NCT02232347|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111054059|NCT02232347|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111054060|NCT02232347|Anesthetics, General|anesthetics, general|mesh-ancestor
111054061|NCT02232347|Anesthetics|anesthetics|mesh-ancestor
111054062|NCT02232347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111054063|NCT02232347|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111054064|NCT02232347|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111054065|NCT02232347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111054066|NCT02232347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111054067|NCT02232347|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111054068|NCT02232347|Narcotics|narcotics|mesh-ancestor
111054069|NCT02232347|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111054070|NCT03542669|Doxorubicin|doxorubicin|mesh-list
111054071|NCT03542669|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110771140|NCT01291212|Methyltestosterone|methyltestosterone|mesh-list
111054072|NCT03542669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111054073|NCT03542669|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111054074|NCT03542669|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111054076|NCT03542669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111054077|NCT03146481|Aceclofenac|aceclofenac|mesh-list
111054078|NCT03146481|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111054079|NCT03146481|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111054080|NCT03146481|Analgesics|analgesics|mesh-ancestor
111054081|NCT03146481|Sensory System Agents|sensory system agents|mesh-ancestor
111054082|NCT03146481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111054083|NCT03146481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111054084|NCT03146481|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111054085|NCT03146481|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111054086|NCT03541655|Celecoxib|celecoxib|mesh-list
111054087|NCT03541655|Bupivacaine|bupivacaine|mesh-list
111054088|NCT03541655|Anesthetics, Local|anesthetics, local|mesh-ancestor
111054089|NCT03541655|Anesthetics|anesthetics|mesh-ancestor
111054090|NCT03541655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111054091|NCT03541655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111054093|NCT03541655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111054094|NCT03541655|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111054095|NCT03541655|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111054096|NCT03541655|Analgesics|analgesics|mesh-ancestor
111054097|NCT03541655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111054098|NCT03541655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111054099|NCT03541655|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111054100|NCT03541655|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111054101|NCT03541655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111054102|NCT03541655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111054103|NCT02296411|Glycopyrrolate|glycopyrrolate|mesh-list
111054104|NCT02296411|Bromides|bromides|mesh-list
111054105|NCT02296411|Anticonvulsants|anticonvulsants|mesh-ancestor
111054106|NCT02296411|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111054107|NCT02296411|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111054108|NCT02296411|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111054109|NCT02296411|Cholinergic Agents|cholinergic agents|mesh-ancestor
111054110|NCT02296411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111054111|NCT02296411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111054112|NCT02296411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111054113|NCT04581473|Paclitaxel|paclitaxel|mesh-list
111054114|NCT04581473|Irinotecan|irinotecan|mesh-list
111054115|NCT04581473|Apatinib|apatinib|mesh-list
111054116|NCT04581473|Antibodies|antibodies|mesh-list
111054117|NCT04581473|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111054118|NCT04581473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111054119|NCT04581473|Tubulin Modulators|tubulin modulators|mesh-ancestor
111054120|NCT04581473|Antimitotic Agents|antimitotic agents|mesh-ancestor
110630453|NCT04091009|Naloxone|naloxone|mesh-list
111054121|NCT04581473|Mitosis Modulators|mitosis modulators|mesh-ancestor
111054122|NCT04581473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111054123|NCT04581473|Immunologic Factors|immunologic factors|mesh-ancestor
111054124|NCT04581473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111054125|NCT04581473|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111054126|NCT04581473|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111054127|NCT04581473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111054128|NCT04581473|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111054129|NCT02229617|Methyltestosterone|methyltestosterone|mesh-list
111054130|NCT02229617|Testosterone|testosterone|mesh-list
111054131|NCT02229617|Testosterone undecanoate|testosterone undecanoate|mesh-list
111054132|NCT02229617|Testosterone enanthate|testosterone enanthate|mesh-list
111054133|NCT02229617|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
111054134|NCT02229617|Androgens|androgens|mesh-ancestor
111054135|NCT02229617|Hormones|hormones|mesh-ancestor
111054136|NCT02229617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111054137|NCT02229617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111054138|NCT02229617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111054139|NCT02229617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111054140|NCT02229617|Anabolic Agents|anabolic agents|mesh-ancestor
111054141|NCT02347059|Dopamine|dopamine|mesh-list
111054142|NCT02347059|Levodopa|levodopa|mesh-list
111054143|NCT02347059|Pramipexole|pramipexole|mesh-list
111054144|NCT02347059|Dopamine Agonists|dopamine agonists|mesh-list
111054145|NCT02347059|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111054146|NCT02347059|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111054147|NCT02347059|Dopamine Agents|dopamine agents|mesh-ancestor
111054148|NCT02347059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111054149|NCT02347059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111054150|NCT02347059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111054151|NCT02347059|Antioxidants|antioxidants|mesh-ancestor
111054152|NCT02347059|Protective Agents|protective agents|mesh-ancestor
111054153|NCT02347059|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111054154|NCT02347059|Sympathomimetics|sympathomimetics|mesh-ancestor
111054155|NCT02347059|Autonomic Agents|autonomic agents|mesh-ancestor
111054156|NCT02347059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111054157|NCT02353611|Hydrogen Peroxide|hydrogen peroxide|mesh-list
111054158|NCT02353611|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111054159|NCT02353611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111054160|NCT02296567|Bevacizumab|bevacizumab|mesh-list
111054161|NCT02296567|Ranibizumab|ranibizumab|mesh-list
111054162|NCT02296567|Aflibercept|aflibercept|mesh-list
111054163|NCT02296567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111054164|NCT02296567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111054165|NCT02296567|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111054166|NCT02296567|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111054168|NCT02296567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111054169|NCT02296567|Growth Inhibitors|growth inhibitors|mesh-ancestor
111054170|NCT02296723|Valganciclovir|valganciclovir|mesh-list
111054171|NCT02296723|Antiviral Agents|antiviral agents|mesh-ancestor
111054172|NCT02296723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111054173|NCT02289937|Ropivacaine|ropivacaine|mesh-list
111054174|NCT02289937|Anesthetics, Local|anesthetics, local|mesh-ancestor
111054175|NCT02289937|Anesthetics|anesthetics|mesh-ancestor
111054176|NCT02289937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111054177|NCT02289937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111054178|NCT02289937|Sensory System Agents|sensory system agents|mesh-ancestor
111054179|NCT02289937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111054180|NCT03446807|Droxidopa|droxidopa|mesh-list
111054181|NCT03446807|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111054182|NCT03446807|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111054183|NCT03519061|Budesonide|budesonide|mesh-list
111054184|NCT03519061|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111054185|NCT03519061|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111054186|NCT03519061|Autonomic Agents|autonomic agents|mesh-ancestor
111054187|NCT03519061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111054188|NCT03519061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111054189|NCT03519061|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111054190|NCT03519061|Respiratory System Agents|respiratory system agents|mesh-ancestor
111054191|NCT03519061|Glucocorticoids|glucocorticoids|mesh-ancestor
111054192|NCT03519061|Hormones|hormones|mesh-ancestor
111054193|NCT03519061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111054194|NCT02229773|Pravastatin|pravastatin|mesh-list
111054195|NCT02229773|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111054196|NCT02229773|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111054197|NCT02229773|Antimetabolites|antimetabolites|mesh-ancestor
111054198|NCT02229773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111054199|NCT02229773|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111054200|NCT02229773|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111054201|NCT02229773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111054202|NCT02293291|Lithium Carbonate|lithium carbonate|mesh-list
111054203|NCT02293291|Antidepressive Agents|antidepressive agents|mesh-ancestor
111054204|NCT02293291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111054205|NCT02293291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111054206|NCT02293291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111054207|NCT02293291|Antimanic Agents|antimanic agents|mesh-ancestor
111054208|NCT02293291|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111054209|NCT02293291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111054210|NCT02293291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111054211|NCT03515707|Etoposide|etoposide|mesh-list
111054212|NCT03515707|Podophyllotoxin|podophyllotoxin|mesh-list
111054213|NCT03515707|Etoposide phosphate|etoposide phosphate|mesh-list
111054214|NCT03515707|Busulfan|busulfan|mesh-list
111054215|NCT03515707|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111054216|NCT03515707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111054217|NCT03515707|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111054218|NCT03515707|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111054219|NCT03515707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111054220|NCT03515707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111054221|NCT03515707|Alkylating Agents|alkylating agents|mesh-ancestor
111054222|NCT03515707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111054223|NCT03515707|Immunologic Factors|immunologic factors|mesh-ancestor
110771276|NCT01186146|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111054224|NCT03515707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111054225|NCT03515707|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111054226|NCT03515707|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111054227|NCT03515707|Keratolytic Agents|keratolytic agents|mesh-ancestor
111054228|NCT03515707|Dermatologic Agents|dermatologic agents|mesh-ancestor
111054229|NCT03515707|Tubulin Modulators|tubulin modulators|mesh-ancestor
111054230|NCT03515707|Antimitotic Agents|antimitotic agents|mesh-ancestor
111054231|NCT03515707|Mitosis Modulators|mitosis modulators|mesh-ancestor
111054233|NCT02298205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111054234|NCT02298205|Glucocorticoids|glucocorticoids|mesh-ancestor
111054235|NCT02298205|Hormones|hormones|mesh-ancestor
111054236|NCT02298205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111054237|NCT02298205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111054238|NCT02298205|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111054239|NCT02298205|Respiratory System Agents|respiratory system agents|mesh-ancestor
111054240|NCT03514771|Valacyclovir|valacyclovir|mesh-list
111054241|NCT03514771|Isotretinoin|isotretinoin|mesh-list
111054242|NCT03514771|Antiviral Agents|antiviral agents|mesh-ancestor
111054243|NCT03514771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111054244|NCT03514771|Dermatologic Agents|dermatologic agents|mesh-ancestor
111054245|NCT02298283|Prednisone|prednisone|mesh-list
111054246|NCT02298283|Cyclophosphamide|cyclophosphamide|mesh-list
111054247|NCT02298283|Doxorubicin|doxorubicin|mesh-list
111054248|NCT02298283|Etoposide|etoposide|mesh-list
111054249|NCT02298283|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111054250|NCT02298283|Vincristine|vincristine|mesh-list
111054251|NCT02298283|Bleomycin|bleomycin|mesh-list
111054252|NCT02298283|Brentuximab Vedotin|brentuximab vedotin|mesh-list
111054253|NCT02298283|Procarbazine|procarbazine|mesh-list
111054254|NCT02298283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111054255|NCT02298283|Immunologic Factors|immunologic factors|mesh-ancestor
111054256|NCT02298283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111054257|NCT02298283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111054258|NCT02298283|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111054259|NCT02298283|Alkylating Agents|alkylating agents|mesh-ancestor
111054260|NCT02298283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111054261|NCT02298283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111054262|NCT02298283|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111054263|NCT02298283|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111054264|NCT02298283|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111054265|NCT02298283|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111054266|NCT02298283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111054267|NCT02298283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111054268|NCT02298283|Glucocorticoids|glucocorticoids|mesh-ancestor
111054269|NCT02298283|Hormones|hormones|mesh-ancestor
111054270|NCT02298283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111054271|NCT02298283|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111054272|NCT02298283|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111054273|NCT02298283|Tubulin Modulators|tubulin modulators|mesh-ancestor
111054274|NCT02298283|Antimitotic Agents|antimitotic agents|mesh-ancestor
111054275|NCT02298283|Mitosis Modulators|mitosis modulators|mesh-ancestor
111054276|NCT02298283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111054277|NCT02298283|Immunotoxins|immunotoxins|mesh-ancestor
111054278|NCT02298283|Immunoconjugates|immunoconjugates|mesh-ancestor
111054279|NCT02346357|Ropivacaine|ropivacaine|mesh-list
111054280|NCT02346357|Anesthetics, Local|anesthetics, local|mesh-ancestor
111054281|NCT02346357|Anesthetics|anesthetics|mesh-ancestor
111054282|NCT02346357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111054283|NCT02346357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111054284|NCT02346357|Sensory System Agents|sensory system agents|mesh-ancestor
111054285|NCT02346357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111054286|NCT03146247|Apremilast|apremilast|mesh-list
111054287|NCT03146247|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111054288|NCT03146247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111054289|NCT03146247|Analgesics|analgesics|mesh-ancestor
111054290|NCT03146247|Sensory System Agents|sensory system agents|mesh-ancestor
111054291|NCT03146247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111054292|NCT03146247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111054293|NCT03146247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111054294|NCT03146247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111054295|NCT03146247|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
111054296|NCT03146247|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111054297|NCT03146247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111054298|NCT03146247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111054299|NCT03263273|Minocycline|minocycline|mesh-list
111054300|NCT03263273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111054301|NCT03263273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111054302|NCT03146325|Metronidazole|metronidazole|mesh-list
111054303|NCT03146325|Tetracycline|tetracycline|mesh-list
111054304|NCT03146325|Omeprazole|omeprazole|mesh-list
111054305|NCT03146325|Bismuth|bismuth|mesh-list
111054306|NCT03146325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111054307|NCT03146325|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111054308|NCT03146325|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111054309|NCT03146325|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111054310|NCT03146325|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111054311|NCT03146325|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111054312|NCT03146325|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111054313|NCT03146325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111054314|NCT03146325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111054315|NCT03146325|Antacids|antacids|mesh-ancestor
111054316|NCT03146325|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111054317|NCT02233049|Everolimus|everolimus|mesh-list
111054318|NCT02233049|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111054319|NCT02233049|Dasatinib|dasatinib|mesh-list
111054320|NCT02233049|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111054321|NCT02233049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111054322|NCT02233049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111054323|NCT02233049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111054324|NCT02233049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111054325|NCT02233049|Immunologic Factors|immunologic factors|mesh-ancestor
111054326|NCT02233049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111054327|NCT02233049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111054328|NCT02350725|Furosemide|furosemide|mesh-list
111054329|NCT02350725|Diuretics|diuretics|mesh-ancestor
111054330|NCT02350725|Natriuretic Agents|natriuretic agents|mesh-ancestor
111054331|NCT02350725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111054332|NCT02350725|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
111054333|NCT02350725|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111054334|NCT02350725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111054335|NCT02350959|Atorvastatin|atorvastatin|mesh-list
111054336|NCT02350959|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111054337|NCT02350959|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111054338|NCT02350959|Antimetabolites|antimetabolites|mesh-ancestor
111054339|NCT02350959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111054340|NCT02350959|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111054341|NCT02350959|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111054342|NCT02350959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111054343|NCT02350335|Nicotine|nicotine|mesh-list
111054344|NCT02350335|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111054345|NCT02350335|Autonomic Agents|autonomic agents|mesh-ancestor
111054346|NCT02350335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111054347|NCT02350335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111054348|NCT02350335|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111054349|NCT02350335|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111054350|NCT02350335|Cholinergic Agents|cholinergic agents|mesh-ancestor
111054351|NCT02350335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111054352|NCT02350335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111054353|NCT02293447|Lidocaine|lidocaine|mesh-list
111054354|NCT02293447|Anesthetics, Local|anesthetics, local|mesh-list
111054355|NCT02293447|Anesthetics|anesthetics|mesh-list
111054356|NCT02293447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111054357|NCT02293447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111054358|NCT02293447|Sensory System Agents|sensory system agents|mesh-ancestor
111054359|NCT02293447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111054360|NCT02293447|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111054361|NCT02293447|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111054362|NCT02293447|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111054363|NCT02293447|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111054364|NCT02293447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111054365|NCT04464811|Furosemide|furosemide|mesh-list
111054366|NCT04464811|Diuretics|diuretics|mesh-ancestor
111054367|NCT04464811|Natriuretic Agents|natriuretic agents|mesh-ancestor
111054368|NCT04464811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111054369|NCT04464811|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
111054370|NCT04464811|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111054371|NCT04464811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111054372|NCT02293525|Morphine|morphine|mesh-list
111054373|NCT02293525|Oxycodone|oxycodone|mesh-list
111054374|NCT02293525|Ropivacaine|ropivacaine|mesh-list
111054375|NCT02293525|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111054376|NCT02293525|Narcotics|narcotics|mesh-ancestor
111054377|NCT02293525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111054378|NCT02293525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111054379|NCT02293525|Analgesics|analgesics|mesh-ancestor
111054380|NCT02293525|Sensory System Agents|sensory system agents|mesh-ancestor
111054381|NCT02293525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111054382|NCT02293525|Anesthetics, Local|anesthetics, local|mesh-ancestor
111054383|NCT02293525|Anesthetics|anesthetics|mesh-ancestor
111054384|NCT02298595|Cetuximab|cetuximab|mesh-list
111054385|NCT02298595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111054386|NCT02298595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111054387|NCT02345343|Apixaban|apixaban|mesh-list
111054388|NCT02345343|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111054389|NCT02345343|Antithrombins|antithrombins|mesh-ancestor
111054390|NCT02345343|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111054391|NCT02345343|Protease Inhibitors|protease inhibitors|mesh-ancestor
111054392|NCT02345343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110630485|NCT02597309|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111054393|NCT02345343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111054394|NCT02345343|Anticoagulants|anticoagulants|mesh-ancestor
111054395|NCT03949673|Celecoxib|celecoxib|mesh-list
111054396|NCT03949673|Diclofenac|diclofenac|mesh-list
111054397|NCT03949673|Naproxen|naproxen|mesh-list
111054398|NCT03949673|Fasinumab|fasinumab|mesh-list
111054399|NCT03949673|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111054400|NCT03949673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111054401|NCT03949673|Analgesics|analgesics|mesh-ancestor
111054402|NCT03949673|Sensory System Agents|sensory system agents|mesh-ancestor
111054403|NCT03949673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111054404|NCT03949673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111054405|NCT03949673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111054406|NCT03949673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111054407|NCT03949673|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111054408|NCT03949673|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111054409|NCT03949673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111054410|NCT03949673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111054411|NCT03949673|Gout Suppressants|gout suppressants|mesh-ancestor
111054412|NCT02350179|Tranexamic Acid|tranexamic acid|mesh-list
111054413|NCT02350179|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111054414|NCT02350179|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111054415|NCT02350179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111054416|NCT02350179|Hemostatics|hemostatics|mesh-ancestor
111054417|NCT02350179|Coagulants|coagulants|mesh-ancestor
111054418|NCT02233205|Gemcitabine|gemcitabine|mesh-list
111054419|NCT02233205|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111054420|NCT02233205|Antimetabolites|antimetabolites|mesh-ancestor
111054421|NCT02233205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111054422|NCT02233205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111054423|NCT02843633|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
111054424|NCT02293681|Infliximab|infliximab|mesh-list
111054425|NCT02293681|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111054426|NCT02293681|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111054427|NCT02293681|Dermatologic Agents|dermatologic agents|mesh-ancestor
111054428|NCT02293681|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111054429|NCT02293681|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111054430|NCT02259491|Calcium|calcium|mesh-list
111054431|NCT02259491|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111054432|NCT02259491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111054433|NCT05255523|Capecitabine|capecitabine|mesh-list
111054434|NCT05255523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111054435|NCT05255523|Antimetabolites|antimetabolites|mesh-ancestor
111054436|NCT05255523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111054437|NCT05255523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111054438|NCT03149679|Cyclophosphamide|cyclophosphamide|mesh-list
111054439|NCT03149679|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111054440|NCT03149679|Immunologic Factors|immunologic factors|mesh-ancestor
111054441|NCT03149679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111054442|NCT03149679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111054443|NCT03149679|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111054444|NCT03149679|Alkylating Agents|alkylating agents|mesh-ancestor
111054445|NCT03149679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111054446|NCT03149679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111054447|NCT03149679|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111054448|NCT02298985|Curcumin|curcumin|mesh-list
111054449|NCT02298985|Antipsychotic Agents|antipsychotic agents|mesh-list
111054450|NCT02298985|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111054452|NCT02298985|Analgesics|analgesics|mesh-ancestor
111054453|NCT02298985|Sensory System Agents|sensory system agents|mesh-ancestor
111054454|NCT02298985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111054455|NCT02298985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111054456|NCT02298985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111054457|NCT02298985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111054458|NCT02298985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111054459|NCT02298985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110630491|NCT00863148|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111054460|NCT02298985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111054461|NCT02298985|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111054462|NCT02298985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111054463|NCT02298985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111054465|NCT03149445|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111054466|NCT03149445|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111054467|NCT03149445|Sympatholytics|sympatholytics|mesh-ancestor
111054468|NCT03149445|Autonomic Agents|autonomic agents|mesh-ancestor
111054469|NCT03149445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111054470|NCT03149445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111054471|NCT03149445|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
111054472|NCT03149445|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111054473|NCT03149445|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111054474|NCT03149445|Adrenergic Agents|adrenergic agents|mesh-ancestor
111054475|NCT03149445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111054476|NCT03149445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111054477|NCT02345187|Micronutrients|micronutrients|mesh-list
111054478|NCT02345187|Trace Elements|trace elements|mesh-list
111054479|NCT02345187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111054480|NCT02299063|Dexmedetomidine|dexmedetomidine|mesh-list
111054481|NCT02299063|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111054482|NCT02299063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111054483|NCT02299063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111054484|NCT02299063|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111054485|NCT02299063|Analgesics|analgesics|mesh-ancestor
111054486|NCT02299063|Sensory System Agents|sensory system agents|mesh-ancestor
111054487|NCT02299063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111054488|NCT02299063|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111054489|NCT02299063|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111054490|NCT02299063|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111054491|NCT02299063|Adrenergic Agents|adrenergic agents|mesh-ancestor
111054492|NCT02299063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111054493|NCT02299063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111054494|NCT03149289|Antiviral Agents|antiviral agents|mesh-list
111054495|NCT03149289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111054496|NCT05624801|Vitamin D|vitamin d|mesh-list
111054497|NCT05624801|Vitamins|vitamins|mesh-ancestor
111054498|NCT05624801|Micronutrients|micronutrients|mesh-ancestor
111054499|NCT05624801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111054500|NCT05624801|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111054501|NCT05255211|Propofol|propofol|mesh-list
111054502|NCT05255211|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111054503|NCT05255211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111054504|NCT05255211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111054505|NCT05255211|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111054506|NCT05255211|Anesthetics, General|anesthetics, general|mesh-ancestor
111054507|NCT05255211|Anesthetics|anesthetics|mesh-ancestor
111054508|NCT03514381|Doxorubicin|doxorubicin|mesh-list
111054509|NCT03514381|Ifosfamide|ifosfamide|mesh-list
111054510|NCT03514381|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111054511|NCT03514381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111054512|NCT03514381|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111054513|NCT03514381|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111054514|NCT03514381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111054515|NCT03514381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111054516|NCT03514381|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111054517|NCT03514381|Alkylating Agents|alkylating agents|mesh-ancestor
111054518|NCT02343393|Hydralazine|hydralazine|mesh-list
111054519|NCT02343393|Isosorbide|isosorbide|mesh-list
111054520|NCT02343393|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
111054521|NCT02343393|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
111054522|NCT02343393|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
111054523|NCT02343393|Diuretics|diuretics|mesh-ancestor
111054524|NCT02343393|Natriuretic Agents|natriuretic agents|mesh-ancestor
110771584|NCT01296438|Insulin Aspart|insulin aspart|mesh-list
111054525|NCT02343393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111054526|NCT02343393|Vasodilator Agents|vasodilator agents|mesh-ancestor
111054527|NCT02343393|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
111054528|NCT02343393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111054529|NCT02343393|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111054530|NCT02344875|Dotinurad|dotinurad|mesh-list
111054531|NCT02344875|Uricosuric Agents|uricosuric agents|mesh-ancestor
111054532|NCT02344875|Gout Suppressants|gout suppressants|mesh-ancestor
111054533|NCT02344875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111054534|NCT03145623|Grazoprevir|grazoprevir|mesh-list
111054535|NCT03145623|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
111054537|NCT03145623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111054538|NCT02294071|Acetaminophen|acetaminophen|mesh-list
111054539|NCT02294071|Ibuprofen|ibuprofen|mesh-list
111054540|NCT02294071|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111054541|NCT02294071|Analgesics|analgesics|mesh-ancestor
111054542|NCT02294071|Sensory System Agents|sensory system agents|mesh-ancestor
111054543|NCT02294071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111054544|NCT02294071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111054545|NCT02294071|Antipyretics|antipyretics|mesh-ancestor
111054546|NCT02294071|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111054547|NCT02294071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111054548|NCT02294071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111054549|NCT02294071|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111054550|NCT02294071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111054551|NCT02294071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111054552|NCT02233439|Galactogogues|galactogogues|mesh-list
111054553|NCT02233439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111054554|NCT02350023|Betamethasone|betamethasone|mesh-list
111054555|NCT02350023|Latanoprost|latanoprost|mesh-list
111054556|NCT02350023|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
111054557|NCT02350023|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111054558|NCT02350023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111054559|NCT02350023|Glucocorticoids|glucocorticoids|mesh-ancestor
111054560|NCT02350023|Hormones|hormones|mesh-ancestor
111054561|NCT02350023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111054562|NCT02350023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111054563|NCT02350023|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111054564|NCT02350023|Respiratory System Agents|respiratory system agents|mesh-ancestor
111054565|NCT02342925|Metformin|metformin|mesh-list
111054566|NCT02342925|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111054567|NCT02342925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111054568|NCT03879863|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111054569|NCT03879863|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111054570|NCT02344641|Exenatide|exenatide|mesh-list
111054571|NCT02344641|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111054572|NCT02344641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111054573|NCT02344641|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111054574|NCT02344641|Incretins|incretins|mesh-ancestor
111054575|NCT02344641|Hormones|hormones|mesh-ancestor
111054576|NCT02344641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111054577|NCT03798743|Docetaxel|docetaxel|mesh-list
111054578|NCT03798743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111054579|NCT03798743|Tubulin Modulators|tubulin modulators|mesh-ancestor
111054580|NCT03798743|Antimitotic Agents|antimitotic agents|mesh-ancestor
111054581|NCT03798743|Mitosis Modulators|mitosis modulators|mesh-ancestor
111054582|NCT03798743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111054583|NCT04083183|Mycophenolic Acid|mycophenolic acid|mesh-list
111054584|NCT04083183|Sirolimus|sirolimus|mesh-list
111054585|NCT04083183|Vidarabine|vidarabine|mesh-list
111054586|NCT04083183|Cyclophosphamide|cyclophosphamide|mesh-list
111054587|NCT04083183|Fludarabine|fludarabine|mesh-list
111054588|NCT04083183|Fludarabine phosphate|fludarabine phosphate|mesh-list
111054589|NCT04083183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111054590|NCT04083183|Thymoglobulin|thymoglobulin|mesh-list
111054591|NCT04083183|Antilymphocyte Serum|antilymphocyte serum|mesh-list
111054592|NCT04083183|Antibodies|antibodies|mesh-list
111054593|NCT04083183|Immunoglobulins|immunoglobulins|mesh-list
111054594|NCT04083183|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111054595|NCT04083183|gamma-Globulins|gamma-globulins|mesh-list
111054596|NCT04083183|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111054597|NCT04083183|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
111054598|NCT04083183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111054599|NCT04083183|Immunologic Factors|immunologic factors|mesh-ancestor
111054600|NCT04083183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111054601|NCT04083183|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110771661|NCT01191918|Cholinergic Agents|cholinergic agents|mesh-ancestor
111054614|NCT04083183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111054615|NCT04083183|Antifungal Agents|antifungal agents|mesh-ancestor
111054616|NCT04083183|Antiviral Agents|antiviral agents|mesh-ancestor
111054617|NCT02342769|Dolutegravir|dolutegravir|mesh-list
111054618|NCT02342769|Abacavir|abacavir|mesh-list
111054619|NCT02342769|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111054620|NCT02342769|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111054621|NCT02342769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111054622|NCT02342769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111054623|NCT02342769|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111054625|NCT02342769|Antiviral Agents|antiviral agents|mesh-ancestor
111054626|NCT02342769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111054627|NCT02342769|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111054628|NCT02342769|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111054629|NCT03766295|Gemcitabine|gemcitabine|mesh-list
111054630|NCT03766295|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111054631|NCT03766295|Antimetabolites|antimetabolites|mesh-ancestor
111054632|NCT03766295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111054633|NCT03766295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111054647|NCT02349945|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
111054648|NCT02349945|Hormones|hormones|mesh-ancestor
111054649|NCT02349945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111054650|NCT02349945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111054651|NCT02302495|Prednisone|prednisone|mesh-list
111054652|NCT02302495|Melphalan|melphalan|mesh-list
111054653|NCT02302495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111054654|NCT02302495|Glucocorticoids|glucocorticoids|mesh-ancestor
111054655|NCT02302495|Hormones|hormones|mesh-ancestor
111054656|NCT02302495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111054657|NCT02302495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111054658|NCT02302495|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111054659|NCT02302495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111054660|NCT02302495|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111054661|NCT02302495|Alkylating Agents|alkylating agents|mesh-ancestor
111054662|NCT02302495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111054663|NCT02302495|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111054664|NCT02302495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111054665|NCT02302495|Immunologic Factors|immunologic factors|mesh-ancestor
111054666|NCT02813447|Sertraline|sertraline|mesh-list
111054667|NCT02813447|Antidepressive Agents|antidepressive agents|mesh-ancestor
111054668|NCT02813447|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111054669|NCT02813447|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111054670|NCT02813447|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111054671|NCT02813447|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111054672|NCT02813447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111054673|NCT02813447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110676910|NCT03318900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111054674|NCT02813447|Serotonin Agents|serotonin agents|mesh-ancestor
111054675|NCT02813447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111054676|NCT02342145|Cyclosporine|cyclosporine|mesh-list
111054677|NCT02342145|Mycophenolic Acid|mycophenolic acid|mesh-list
111054678|NCT02342145|Methotrexate|methotrexate|mesh-list
111054679|NCT02342145|Cyclosporins|cyclosporins|mesh-list
111054680|NCT02342145|Basiliximab|basiliximab|mesh-list
111054681|NCT02342145|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111054682|NCT02342145|Abortifacient Agents|abortifacient agents|mesh-ancestor
111054683|NCT02342145|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111054684|NCT02342145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111054685|NCT02342145|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111054686|NCT02342145|Antimetabolites|antimetabolites|mesh-ancestor
111054687|NCT02342145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111054688|NCT02342145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111054689|NCT02342145|Dermatologic Agents|dermatologic agents|mesh-ancestor
111054690|NCT02342145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111054691|NCT02342145|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111054692|NCT02342145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111054693|NCT02342145|Immunologic Factors|immunologic factors|mesh-ancestor
111054694|NCT02342145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111054695|NCT02342145|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111054696|NCT02342145|Antifungal Agents|antifungal agents|mesh-ancestor
111054697|NCT02342145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111054698|NCT02342145|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111054699|NCT02342145|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111054700|NCT02342145|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111054701|NCT02342145|Antitubercular Agents|antitubercular agents|mesh-ancestor
111054702|NCT02342145|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111054703|NCT02349399|Cyproterone Acetate|cyproterone acetate|mesh-list
111054704|NCT02349399|Ethinyl Estradiol|ethinyl estradiol|mesh-list
111054705|NCT02349399|Cyproterone|cyproterone|mesh-list
111054706|NCT02349399|Cyproterone acetate, ethinyl estradiol drug combination|cyproterone acetate, ethinyl estradiol drug combination|mesh-list
111054707|NCT02349399|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111054708|NCT02349399|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111054709|NCT02349399|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111054710|NCT02349399|Contraceptive Agents|contraceptive agents|mesh-ancestor
111054711|NCT02349399|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111054712|NCT02349399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111054713|NCT02349399|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111054714|NCT02349399|Estrogens|estrogens|mesh-ancestor
111054715|NCT02349399|Hormones|hormones|mesh-ancestor
111054716|NCT02349399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111054717|NCT02349399|Androgen Antagonists|androgen antagonists|mesh-ancestor
111054718|NCT02349399|Hormone Antagonists|hormone antagonists|mesh-ancestor
111054719|NCT02349399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111054720|NCT02349399|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
111054721|NCT02306473|Mannitol|mannitol|mesh-list
111054722|NCT02306473|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
111054723|NCT02306473|Diuretics|diuretics|mesh-ancestor
111054724|NCT02306473|Natriuretic Agents|natriuretic agents|mesh-ancestor
111054725|NCT02306473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111054726|NCT03709121|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111054727|NCT03709121|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111054728|NCT02344095|Paclitaxel|paclitaxel|mesh-list
111054729|NCT02344095|Cisplatin|cisplatin|mesh-list
111054730|NCT02344095|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111054731|NCT02344095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111054732|NCT02344095|Tubulin Modulators|tubulin modulators|mesh-ancestor
111054733|NCT02344095|Antimitotic Agents|antimitotic agents|mesh-ancestor
111054734|NCT02344095|Mitosis Modulators|mitosis modulators|mesh-ancestor
111054735|NCT02344095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111054736|NCT00157339|Insulin|insulin|mesh-list
111054737|NCT00157339|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111054738|NCT00157339|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111054739|NCT00157339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111054740|NCT02342067|Pioglitazone|pioglitazone|mesh-list
111054741|NCT02342067|Cenicriviroc|cenicriviroc|mesh-list
111054742|NCT02342067|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111054743|NCT02342067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111054744|NCT02342067|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
111054745|NCT02342067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111054746|NCT02342067|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111054747|NCT02342067|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111054748|NCT02342067|Antiviral Agents|antiviral agents|mesh-ancestor
111054749|NCT02342067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111054750|NCT02344017|Prednisone|prednisone|mesh-list
111054751|NCT02344017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111054752|NCT02344017|Glucocorticoids|glucocorticoids|mesh-ancestor
111054753|NCT02344017|Hormones|hormones|mesh-ancestor
111054754|NCT02344017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111054755|NCT02344017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111054756|NCT02344017|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111054757|NCT02344017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111054758|NCT02343861|Emollients|emollients|mesh-list
111054759|NCT02343861|Dermatologic Agents|dermatologic agents|mesh-ancestor
111054760|NCT03676751|Azithromycin|azithromycin|mesh-list
110630513|NCT00867126|Pioglitazone|pioglitazone|mesh-list
111054761|NCT03676751|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111054762|NCT03676751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111054763|NCT02302729|Micronutrients|micronutrients|mesh-list
111054764|NCT02302729|Trace Elements|trace elements|mesh-list
111054765|NCT02302729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111054766|NCT03513601|Rituximab|rituximab|mesh-list
111054767|NCT03513601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111054768|NCT03513601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111054769|NCT03513601|Immunologic Factors|immunologic factors|mesh-ancestor
111054770|NCT03513601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111054771|NCT03513601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111054772|NCT03647111|Crizotinib|crizotinib|mesh-list
111054773|NCT03647111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111054774|NCT03647111|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111054775|NCT03647111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111054776|NCT03647111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111054777|NCT03507829|Insulin|insulin|mesh-list
111054778|NCT03507829|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111054779|NCT03507829|Insulin Lispro|insulin lispro|mesh-list
111054780|NCT03507829|Isophane Insulin, Human|isophane insulin, human|mesh-list
111054781|NCT03507829|Insulin, Isophane|insulin, isophane|mesh-list
111054782|NCT03507829|Isophane insulin, beef|isophane insulin, beef|mesh-list
111054783|NCT03507829|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111054784|NCT03507829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111054785|NCT02232581|Alovudine|alovudine|mesh-list
111054786|NCT02232581|Dideoxynucleosides|dideoxynucleosides|mesh-list
111054787|NCT02232581|Antiviral Agents|antiviral agents|mesh-ancestor
111054788|NCT02232581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111054789|NCT02232581|Antimetabolites|antimetabolites|mesh-ancestor
111054790|NCT02232581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111054791|NCT02232581|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111054792|NCT02232581|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111054793|NCT02232581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111054794|NCT02341833|Sevoflurane|sevoflurane|mesh-list
111054795|NCT02341833|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111054796|NCT02341833|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111054797|NCT02341833|Anesthetics, General|anesthetics, general|mesh-ancestor
111054798|NCT02341833|Anesthetics|anesthetics|mesh-ancestor
111054799|NCT02341833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111054800|NCT02341833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111054801|NCT02337231|Borage oil|borage oil|mesh-list
111054802|NCT02337231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111054803|NCT03507751|Meropenem|meropenem|mesh-list
111054804|NCT03507751|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111054805|NCT03507751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111054806|NCT02306629|Epratuzumab|epratuzumab|mesh-list
111054807|NCT02306629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111054808|NCT02306629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111054809|NCT03510793|Anesthetics|anesthetics|mesh-list
111054810|NCT03510793|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111054811|NCT03510793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111054812|NCT05230797|Zinc|zinc|mesh-list
111054813|NCT05230797|Propolis|propolis|mesh-list
111054814|NCT05230797|Eugenol|eugenol|mesh-list
111054815|NCT05230797|Zinc Oxide|zinc oxide|mesh-list
111054816|NCT05230797|Trace Elements|trace elements|mesh-ancestor
111054817|NCT05230797|Micronutrients|micronutrients|mesh-ancestor
111054818|NCT05230797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111054819|NCT05230797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111054820|NCT05230797|Dermatologic Agents|dermatologic agents|mesh-ancestor
111054821|NCT05230797|Sunscreening Agents|sunscreening agents|mesh-ancestor
111054822|NCT05230797|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111054823|NCT05230797|Protective Agents|protective agents|mesh-ancestor
111054824|NCT02341365|Vitamin D|vitamin d|mesh-list
111054825|NCT02341365|Vitamins|vitamins|mesh-ancestor
111054826|NCT02341365|Micronutrients|micronutrients|mesh-ancestor
111054827|NCT02341365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111054828|NCT02341365|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111054829|NCT02299687|Omeprazole|omeprazole|mesh-list
111054830|NCT02299687|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111054831|NCT02299687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111054832|NCT02299687|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111054833|NCT02299687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111054834|NCT02299687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111054835|NCT02349243|Entacapone|entacapone|mesh-list
111054836|NCT02349243|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111054837|NCT02349243|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111054838|NCT02349243|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
111054839|NCT02349243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111054840|NCT02349243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111054841|NCT02341209|Doxycycline|doxycycline|mesh-list
111054842|NCT02341209|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111054843|NCT02341209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111054844|NCT02341209|Antimalarials|antimalarials|mesh-ancestor
111054845|NCT02341209|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111054846|NCT02341209|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111054847|NCT02349165|Riboflavin|riboflavin|mesh-list
111054848|NCT02349165|Vitamin B Complex|vitamin b complex|mesh-ancestor
111054849|NCT02349165|Vitamins|vitamins|mesh-ancestor
111054850|NCT02349165|Micronutrients|micronutrients|mesh-ancestor
111054851|NCT02349165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111054852|NCT02349165|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111054853|NCT02349165|Dermatologic Agents|dermatologic agents|mesh-ancestor
111054854|NCT03112005|Mydriatics|mydriatics|mesh-list
111054855|NCT03112005|Autonomic Agents|autonomic agents|mesh-ancestor
111054856|NCT03112005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111054857|NCT03112005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111054858|NCT02306785|Mesalamine|mesalamine|mesh-list
111054859|NCT02306785|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110827715|NCT01587313|Hydralazine|hydralazine|mesh-list
111054860|NCT02306785|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111054861|NCT02306785|Analgesics|analgesics|mesh-ancestor
111054862|NCT02306785|Sensory System Agents|sensory system agents|mesh-ancestor
111054863|NCT02306785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111054864|NCT02306785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111054865|NCT02306785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111054866|NCT02306785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111054867|NCT02299765|Carboplatin|carboplatin|mesh-list
111054868|NCT02299765|Gemcitabine|gemcitabine|mesh-list
111054869|NCT02299765|Gefitinib|gefitinib|mesh-list
111054870|NCT02299765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111054871|NCT02299765|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111054872|NCT02299765|Antimetabolites|antimetabolites|mesh-ancestor
111054873|NCT02299765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111054874|NCT02299765|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111054875|NCT02299765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111054876|NCT04771923|Epinephrine|epinephrine|mesh-list
111054877|NCT04771923|Racepinephrine|racepinephrine|mesh-list
111054878|NCT04771923|Tranexamic Acid|tranexamic acid|mesh-list
111054879|NCT04771923|Epinephryl borate|epinephryl borate|mesh-list
111054880|NCT04771923|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111054881|NCT04771923|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111054882|NCT04771923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111054883|NCT04771923|Hemostatics|hemostatics|mesh-ancestor
111054884|NCT04771923|Coagulants|coagulants|mesh-ancestor
111054885|NCT04771923|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111054886|NCT04771923|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111054887|NCT04771923|Adrenergic Agents|adrenergic agents|mesh-ancestor
111054888|NCT04771923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111054889|NCT04771923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111054890|NCT04771923|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111054891|NCT04771923|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111054892|NCT04771923|Autonomic Agents|autonomic agents|mesh-ancestor
111054893|NCT04771923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111054894|NCT04771923|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111054895|NCT04771923|Respiratory System Agents|respiratory system agents|mesh-ancestor
111054896|NCT04771923|Mydriatics|mydriatics|mesh-ancestor
110630541|NCT00263575|Fentanyl|fentanyl|mesh-list
111054897|NCT04771923|Sympathomimetics|sympathomimetics|mesh-ancestor
111054898|NCT04771923|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111054899|NCT04718415|Paclitaxel|paclitaxel|mesh-list
111054900|NCT04718415|Carboplatin|carboplatin|mesh-list
111054901|NCT04718415|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111054902|NCT04718415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111054903|NCT04718415|Tubulin Modulators|tubulin modulators|mesh-ancestor
111054904|NCT04718415|Antimitotic Agents|antimitotic agents|mesh-ancestor
111054905|NCT04718415|Mitosis Modulators|mitosis modulators|mesh-ancestor
111054906|NCT04718415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111054907|NCT04598321|Talazoparib|talazoparib|mesh-list
111054908|NCT04598321|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111054909|NCT04598321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111054910|NCT04598321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111054911|NCT04598321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111054912|NCT05254899|Gemcitabine|gemcitabine|mesh-list
111054913|NCT05254899|Oxaliplatin|oxaliplatin|mesh-list
111054914|NCT05254899|Tislelizumab|tislelizumab|mesh-list
111054915|NCT05254899|Pegaspargase|pegaspargase|mesh-list
111054916|NCT05254899|Antibodies|antibodies|mesh-list
111054917|NCT05254899|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111054918|NCT05254899|Immunologic Factors|immunologic factors|mesh-ancestor
111054919|NCT05254899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111054920|NCT05254899|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111054921|NCT05254899|Antimetabolites|antimetabolites|mesh-ancestor
111054922|NCT05254899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111054923|NCT05254899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111054924|NCT05254899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111054925|NCT03148509|Risperidone|risperidone|mesh-list
111054926|NCT03148509|Aripiprazole|aripiprazole|mesh-list
111054927|NCT03148509|Bupropion|bupropion|mesh-list
111054928|NCT03148509|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111054929|NCT03148509|Serotonin Agents|serotonin agents|mesh-ancestor
111054930|NCT03148509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111054931|NCT03148509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111054932|NCT03148509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111054933|NCT03148509|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111054934|NCT03148509|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111054935|NCT03148509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111054936|NCT03148509|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111054937|NCT03148509|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111054938|NCT03148509|Dopamine Agents|dopamine agents|mesh-ancestor
111054939|NCT03148509|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111054940|NCT03148509|Antidepressive Agents|antidepressive agents|mesh-ancestor
111054941|NCT03148509|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111054942|NCT03148509|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111054943|NCT03148509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111054944|NCT03148509|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111054945|NCT03148509|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111054946|NCT03148509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111054947|NCT03148509|Dopamine Agonists|dopamine agonists|mesh-ancestor
111054948|NCT03148509|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111054949|NCT03148509|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111054950|NCT03148509|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111054951|NCT03148509|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111054952|NCT05254665|Docetaxel|docetaxel|mesh-list
111054953|NCT05254665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111054954|NCT05254665|Tubulin Modulators|tubulin modulators|mesh-ancestor
111054955|NCT05254665|Antimitotic Agents|antimitotic agents|mesh-ancestor
111054956|NCT05254665|Mitosis Modulators|mitosis modulators|mesh-ancestor
111054957|NCT05254665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111054958|NCT03513055|Insulin|insulin|mesh-list
111054959|NCT03513055|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111054960|NCT03513055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111054961|NCT03510325|Olanzapine|olanzapine|mesh-list
111054962|NCT03510325|Risperidone|risperidone|mesh-list
111054963|NCT03510325|Aripiprazole|aripiprazole|mesh-list
111054964|NCT03510325|Paliperidone Palmitate|paliperidone palmitate|mesh-list
111054965|NCT03510325|Amisulpride|amisulpride|mesh-list
111054966|NCT03510325|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111054967|NCT03510325|Serotonin Agents|serotonin agents|mesh-ancestor
111054968|NCT03510325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111054969|NCT03510325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111054970|NCT03510325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111054971|NCT03510325|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111054972|NCT03510325|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111054973|NCT03510325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111054974|NCT03510325|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111054975|NCT03510325|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111054976|NCT03510325|Dopamine Agents|dopamine agents|mesh-ancestor
111054977|NCT03510325|Antiemetics|antiemetics|mesh-ancestor
111054978|NCT03510325|Autonomic Agents|autonomic agents|mesh-ancestor
111054979|NCT03510325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111054980|NCT03510325|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111054981|NCT03510325|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111054982|NCT03510325|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111054983|NCT03510325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111054984|NCT03510325|Antidepressive Agents|antidepressive agents|mesh-ancestor
111054985|NCT03510325|Dopamine Agonists|dopamine agonists|mesh-ancestor
111054986|NCT03510325|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111054987|NCT03510325|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110827728|NCT01282333|Veliparib|veliparib|mesh-list
111054988|NCT03510325|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111054989|NCT03510325|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111054990|NCT03510325|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111054992|NCT03507127|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111054993|NCT03507127|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111054994|NCT03507127|Cholinergic Agents|cholinergic agents|mesh-ancestor
111054995|NCT03507127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111054996|NCT03507127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111054997|NCT03507127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111054998|NCT03512821|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
111054999|NCT03512821|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
111055000|NCT03512821|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111055001|NCT02336529|Bupivacaine|bupivacaine|mesh-list
111055002|NCT02336529|Anesthetics, Local|anesthetics, local|mesh-ancestor
111055003|NCT02336529|Anesthetics|anesthetics|mesh-ancestor
111055004|NCT02336529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111055005|NCT02336529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111055006|NCT02336529|Sensory System Agents|sensory system agents|mesh-ancestor
111055007|NCT02336529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111055008|NCT02307487|Mitomycins|mitomycins|mesh-list
111055009|NCT02307487|Mitomycin|mitomycin|mesh-list
111055010|NCT02307487|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111055011|NCT02307487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111055012|NCT02307487|Alkylating Agents|alkylating agents|mesh-ancestor
111055013|NCT02307487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111055014|NCT02307487|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111055015|NCT02307487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111055016|NCT02307565|Midodrine|midodrine|mesh-list
111055017|NCT02307565|Sympathomimetics|sympathomimetics|mesh-ancestor
111055018|NCT02307565|Autonomic Agents|autonomic agents|mesh-ancestor
111055019|NCT02307565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111055020|NCT02307565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111055021|NCT02307565|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111055022|NCT02307565|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111055023|NCT02307565|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111055024|NCT02307565|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111055025|NCT02307565|Adrenergic Agents|adrenergic agents|mesh-ancestor
111055026|NCT02307565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111055027|NCT02307565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111055028|NCT03510013|Anesthetics|anesthetics|mesh-list
111055029|NCT03510013|Sevoflurane|sevoflurane|mesh-list
111055030|NCT03510013|Anesthetics, Inhalation|anesthetics, inhalation|mesh-list
111055031|NCT03510013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111055032|NCT03510013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111055033|NCT03510013|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111055034|NCT03510013|Anesthetics, General|anesthetics, general|mesh-ancestor
111055035|NCT02307721|Remifentanil|remifentanil|mesh-list
111055036|NCT02307721|Naloxone|naloxone|mesh-list
111055037|NCT02307721|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111055038|NCT02307721|Narcotics|narcotics|mesh-ancestor
111055039|NCT02307721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111055040|NCT02307721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111055041|NCT02307721|Analgesics|analgesics|mesh-ancestor
111055042|NCT02307721|Sensory System Agents|sensory system agents|mesh-ancestor
111055043|NCT02307721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111055044|NCT02307721|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111055045|NCT03506815|Rivaroxaban|rivaroxaban|mesh-list
111055046|NCT03506815|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111055047|NCT03506815|Antithrombins|antithrombins|mesh-ancestor
111055048|NCT03506815|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111055049|NCT03506815|Protease Inhibitors|protease inhibitors|mesh-ancestor
111055050|NCT03506815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111055051|NCT03506815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111055052|NCT03506815|Anticoagulants|anticoagulants|mesh-ancestor
111055053|NCT05227677|Hypoglycemic Agents|hypoglycemic agents|mesh-list
111055054|NCT05227677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111055055|NCT02348463|Clindamycin|clindamycin|mesh-list
110772116|NCT01198236|Itraconazole|itraconazole|mesh-list
111055056|NCT02348463|Clindamycin palmitate|clindamycin palmitate|mesh-list
111055057|NCT02348463|Clindamycin phosphate|clindamycin phosphate|mesh-list
111055058|NCT02348463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111055059|NCT02348463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111055060|NCT02348463|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111055061|NCT02348463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111055062|NCT02348463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111055063|NCT02340273|Oxymetazoline|oxymetazoline|mesh-list
111055064|NCT02340273|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111055065|NCT02340273|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111055066|NCT02340273|Adrenergic Agents|adrenergic agents|mesh-ancestor
111055067|NCT02340273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111055068|NCT02340273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111055069|NCT02340273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111055070|NCT02340273|Sympathomimetics|sympathomimetics|mesh-ancestor
111055071|NCT02340273|Autonomic Agents|autonomic agents|mesh-ancestor
111055072|NCT02340273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111055073|NCT02340273|Nasal Decongestants|nasal decongestants|mesh-ancestor
111055074|NCT02340273|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111055075|NCT02340273|Respiratory System Agents|respiratory system agents|mesh-ancestor
111055076|NCT02300623|Lamivudine|lamivudine|mesh-list
111055077|NCT02300623|Stavudine|stavudine|mesh-list
111055078|NCT02300623|Indinavir|indinavir|mesh-list
111055079|NCT02300623|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
111055080|NCT02300623|Interleukin-2|interleukin-2|mesh-list
111055081|NCT02300623|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111055082|NCT02300623|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111055083|NCT02300623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111055084|NCT02300623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111055085|NCT02300623|Antiviral Agents|antiviral agents|mesh-ancestor
111055086|NCT02300623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111055087|NCT02300623|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111055088|NCT02300623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111055089|NCT02300623|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111055090|NCT02300623|Analgesics|analgesics|mesh-ancestor
111055091|NCT02300623|Sensory System Agents|sensory system agents|mesh-ancestor
111055092|NCT02300623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111055093|NCT02300623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111055094|NCT02300623|Antimetabolites|antimetabolites|mesh-ancestor
111055095|NCT02300623|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111055096|NCT02300623|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111055097|NCT02300623|Protease Inhibitors|protease inhibitors|mesh-ancestor
111055098|NCT04463953|Dexamethasone|dexamethasone|mesh-list
111055099|NCT04463953|Ixazomib|ixazomib|mesh-list
111055100|NCT04463953|Zanubrutinib|zanubrutinib|mesh-list
111055101|NCT04463953|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111055102|NCT04463953|Antiemetics|antiemetics|mesh-ancestor
111055103|NCT04463953|Autonomic Agents|autonomic agents|mesh-ancestor
111055104|NCT04463953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111055105|NCT04463953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111055106|NCT04463953|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111055107|NCT04463953|Glucocorticoids|glucocorticoids|mesh-ancestor
111055108|NCT04463953|Hormones|hormones|mesh-ancestor
111055109|NCT04463953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111055110|NCT04463953|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111055111|NCT04463953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111055112|NCT04463953|Protease Inhibitors|protease inhibitors|mesh-ancestor
111055113|NCT04463953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111055114|NCT04463953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111055115|NCT04463953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111055116|NCT02307955|Fluorophosphate|fluorophosphate|mesh-list
111055117|NCT02307955|Cariostatic Agents|cariostatic agents|mesh-ancestor
111055118|NCT02307955|Protective Agents|protective agents|mesh-ancestor
111055119|NCT02307955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111055120|NCT03147963|Docetaxel|docetaxel|mesh-list
111055121|NCT03147963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111055122|NCT03147963|Tubulin Modulators|tubulin modulators|mesh-ancestor
111055123|NCT03147963|Antimitotic Agents|antimitotic agents|mesh-ancestor
111055124|NCT03147963|Mitosis Modulators|mitosis modulators|mesh-ancestor
111055125|NCT03147963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111055126|NCT02348307|Dotinurad|dotinurad|mesh-list
111055127|NCT02348307|Uricosuric Agents|uricosuric agents|mesh-ancestor
111055128|NCT02348307|Gout Suppressants|gout suppressants|mesh-ancestor
111055129|NCT02348307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111055130|NCT02340117|Paclitaxel|paclitaxel|mesh-list
111055131|NCT02340117|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111055132|NCT02340117|Gemcitabine|gemcitabine|mesh-list
111055133|NCT02340117|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111055134|NCT02340117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111055135|NCT02340117|Tubulin Modulators|tubulin modulators|mesh-ancestor
111055136|NCT02340117|Antimitotic Agents|antimitotic agents|mesh-ancestor
111055137|NCT02340117|Mitosis Modulators|mitosis modulators|mesh-ancestor
111055138|NCT02340117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111055139|NCT02340117|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111055141|NCT02300701|Omalizumab|omalizumab|mesh-list
111055142|NCT02300701|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111055143|NCT02300701|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111055144|NCT02300701|Respiratory System Agents|respiratory system agents|mesh-ancestor
111055145|NCT02336139|Sofosbuvir|sofosbuvir|mesh-list
111055146|NCT02336139|Velpatasvir|velpatasvir|mesh-list
111055147|NCT02336139|Antiviral Agents|antiviral agents|mesh-ancestor
111055148|NCT02336139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111055149|NCT02340195|(2-(6-fluoro-1H-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|(2-(6-fluoro-1h-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|mesh-list
111055150|NCT02340195|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111055151|NCT02340195|Serotonin Agents|serotonin agents|mesh-ancestor
111055152|NCT02340195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111055153|NCT02340195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111055154|NCT02340195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111055155|NCT02300935|Paclitaxel|paclitaxel|mesh-list
111055156|NCT02300935|Trametinib|trametinib|mesh-list
111055157|NCT02300935|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111055158|NCT02300935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111055159|NCT02300935|Tubulin Modulators|tubulin modulators|mesh-ancestor
111055160|NCT02300935|Antimitotic Agents|antimitotic agents|mesh-ancestor
111055161|NCT02300935|Mitosis Modulators|mitosis modulators|mesh-ancestor
111055162|NCT02300935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111055163|NCT02300935|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111055164|NCT02300935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111055165|NCT02339805|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
111055166|NCT02339805|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111055167|NCT02339805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111055168|NCT02301091|Mitomycins|mitomycins|mesh-list
111055169|NCT02301091|Mitomycin|mitomycin|mesh-list
111055170|NCT02301091|Pirarubicin|pirarubicin|mesh-list
111055171|NCT02301091|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111055172|NCT02301091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111055173|NCT02301091|Alkylating Agents|alkylating agents|mesh-ancestor
111055174|NCT02301091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111055175|NCT02301091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111055176|NCT02301091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111055177|NCT02335593|Zinc Sulfate|zinc sulfate|mesh-list
111055178|NCT02335593|Epoetin Alfa|epoetin alfa|mesh-list
111055179|NCT02335593|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111055180|NCT02335593|Hematinics|hematinics|mesh-ancestor
111055181|NCT02335593|Astringents|astringents|mesh-ancestor
111055182|NCT02335593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111055183|NCT02335593|Dermatologic Agents|dermatologic agents|mesh-ancestor
111055184|NCT02308891|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111055185|NCT02308969|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
111055186|NCT02308969|Hallucinogens|hallucinogens|mesh-ancestor
111055187|NCT02308969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111055188|NCT02308969|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111055189|NCT02308969|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111055190|NCT02308969|Serotonin Agents|serotonin agents|mesh-ancestor
111055191|NCT02308969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111055192|NCT02308969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111055193|NCT02308969|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111055194|NCT02309281|Aflibercept|aflibercept|mesh-list
111055195|NCT02309281|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111055196|NCT02309281|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111055197|NCT02309281|Growth Substances|growth substances|mesh-ancestor
111055198|NCT02309281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111055199|NCT02309281|Growth Inhibitors|growth inhibitors|mesh-ancestor
111055200|NCT02309281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111055202|NCT02335281|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111055203|NCT02335281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111055204|NCT02335281|Analgesics|analgesics|mesh-ancestor
111055205|NCT02335281|Sensory System Agents|sensory system agents|mesh-ancestor
111055206|NCT02335281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111055207|NCT02335281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111055208|NCT02335281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111055209|NCT02335281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111055210|NCT02309437|Oxycodone|oxycodone|mesh-list
111055211|NCT02309437|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111055212|NCT02309437|Narcotics|narcotics|mesh-ancestor
111055213|NCT02309437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111055214|NCT02309437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111055215|NCT02309437|Analgesics|analgesics|mesh-ancestor
111055216|NCT02309437|Sensory System Agents|sensory system agents|mesh-ancestor
111055217|NCT02309437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111055218|NCT02335359|Tranexamic Acid|tranexamic acid|mesh-list
111055219|NCT02335359|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111055220|NCT02335359|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111055221|NCT02335359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111055222|NCT02335359|Hemostatics|hemostatics|mesh-ancestor
111055223|NCT02335359|Coagulants|coagulants|mesh-ancestor
111055224|NCT03511261|Curcumin|curcumin|mesh-list
111055225|NCT03511261|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111055226|NCT03511261|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111055227|NCT03511261|Analgesics|analgesics|mesh-ancestor
111055228|NCT03511261|Sensory System Agents|sensory system agents|mesh-ancestor
111055229|NCT03511261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111055230|NCT03511261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111055231|NCT03511261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111055232|NCT03511261|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111055233|NCT03511261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111055234|NCT03511261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111055235|NCT03511261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111055236|NCT03509701|Antibodies|antibodies|mesh-list
111055237|NCT03509701|Immunologic Factors|immunologic factors|mesh-ancestor
111055238|NCT03509701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111055239|NCT03511183|Bevacizumab|bevacizumab|mesh-list
111055240|NCT03511183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111055241|NCT03511183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111055242|NCT03511183|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111055243|NCT03511183|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111055244|NCT03511183|Growth Substances|growth substances|mesh-ancestor
111055245|NCT03511183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111055246|NCT03511183|Growth Inhibitors|growth inhibitors|mesh-ancestor
111055247|NCT02303587|Methylprednisolone|methylprednisolone|mesh-list
111055248|NCT02303587|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111055249|NCT02303587|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111055250|NCT02303587|Prednisolone|prednisolone|mesh-list
111055251|NCT02303587|Prednisolone acetate|prednisolone acetate|mesh-list
111055252|NCT02303587|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111055253|NCT02303587|Prednisolone phosphate|prednisolone phosphate|mesh-list
111055254|NCT02303587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111055255|NCT02303587|Antiemetics|antiemetics|mesh-ancestor
111055256|NCT02303587|Autonomic Agents|autonomic agents|mesh-ancestor
111055257|NCT02303587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111055258|NCT02303587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111055259|NCT02303587|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111055260|NCT02303587|Glucocorticoids|glucocorticoids|mesh-ancestor
111055261|NCT02303587|Hormones|hormones|mesh-ancestor
111055262|NCT02303587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111055263|NCT02303587|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111055264|NCT02303587|Protective Agents|protective agents|mesh-ancestor
111055265|NCT02303587|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111055266|NCT02303587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111055267|NCT03916419|Paclitaxel|paclitaxel|mesh-list
111055268|NCT03916419|Carboplatin|carboplatin|mesh-list
111055269|NCT03916419|Durvalumab|durvalumab|mesh-list
111055270|NCT03916419|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111055271|NCT03916419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111055272|NCT03916419|Tubulin Modulators|tubulin modulators|mesh-ancestor
111055273|NCT03916419|Antimitotic Agents|antimitotic agents|mesh-ancestor
111055274|NCT03916419|Mitosis Modulators|mitosis modulators|mesh-ancestor
111055275|NCT03916419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111055276|NCT03916419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111055278|NCT02301481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111055279|NCT03107871|Valganciclovir|valganciclovir|mesh-list
111055280|NCT03107871|Antiviral Agents|antiviral agents|mesh-ancestor
111055281|NCT03107871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111055282|NCT03064113|Ipratropium|ipratropium|mesh-list
110676911|NCT03318900|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111055283|NCT03064113|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111055284|NCT03064113|Autonomic Agents|autonomic agents|mesh-ancestor
111055285|NCT03064113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111055286|NCT03064113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111055287|NCT03064113|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111055288|NCT03064113|Respiratory System Agents|respiratory system agents|mesh-ancestor
111055289|NCT03064113|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111055290|NCT03064113|Cholinergic Agents|cholinergic agents|mesh-ancestor
111055291|NCT03064113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111055292|NCT03064113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111055293|NCT02301715|Oxytocin|oxytocin|mesh-list
111055294|NCT02301715|Oxytocics|oxytocics|mesh-ancestor
111055295|NCT02301715|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111055296|NCT02301715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111055297|NCT03509545|Torsemide|torsemide|mesh-list
111055298|NCT03509545|Furosemide|furosemide|mesh-list
111055299|NCT03509545|Diuretics|diuretics|mesh-ancestor
111055300|NCT03509545|Natriuretic Agents|natriuretic agents|mesh-ancestor
111055301|NCT03509545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111055302|NCT03509545|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
111055303|NCT03509545|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111055304|NCT03509545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111055305|NCT03509545|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111055306|NCT02301949|Thalidomide|thalidomide|mesh-list
111055307|NCT02301949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111055308|NCT02301949|Immunologic Factors|immunologic factors|mesh-ancestor
111055309|NCT02301949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111055310|NCT02301949|Leprostatic Agents|leprostatic agents|mesh-ancestor
111055311|NCT02301949|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111055312|NCT02301949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111055313|NCT02301949|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111055314|NCT02301949|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111055315|NCT02301949|Growth Substances|growth substances|mesh-ancestor
111055316|NCT02301949|Growth Inhibitors|growth inhibitors|mesh-ancestor
111055317|NCT02301949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111055318|NCT02335203|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
111055319|NCT02335203|Medroxyprogesterone|medroxyprogesterone|mesh-list
111055320|NCT02335203|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111055321|NCT02335203|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111055322|NCT02335203|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111055323|NCT02335203|Contraceptive Agents|contraceptive agents|mesh-ancestor
110630633|NCT02597153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111055324|NCT02335203|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111055325|NCT02335203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111055326|NCT02335203|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111055327|NCT02335203|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111055328|NCT02335203|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
111055329|NCT02335203|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111055330|NCT02335203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111055331|NCT02303899|Gemcitabine|gemcitabine|mesh-list
111055332|NCT02303899|Imatinib Mesylate|imatinib mesylate|mesh-list
111055333|NCT02303899|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111055334|NCT02303899|Antimetabolites|antimetabolites|mesh-ancestor
111055335|NCT02303899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111055336|NCT02303899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111055337|NCT02303899|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111055338|NCT02303899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111055339|NCT02338635|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
111055340|NCT02338635|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
111055341|NCT02338635|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111055342|NCT03510871|Nivolumab|nivolumab|mesh-list
111055343|NCT03510871|Ipilimumab|ipilimumab|mesh-list
111055344|NCT03510871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111055345|NCT03510871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111055346|NCT03510871|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111055347|NCT03510871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111055348|NCT02331771|Donepezil|donepezil|mesh-list
111055349|NCT02331771|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111055350|NCT02331771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111055351|NCT02331771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111055352|NCT02331771|Cholinergic Agents|cholinergic agents|mesh-ancestor
111055353|NCT02331771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111055354|NCT02331771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111055355|NCT02331771|Nootropic Agents|nootropic agents|mesh-ancestor
111055356|NCT02334501|Lansoprazole|lansoprazole|mesh-list
111055357|NCT02334501|Dexlansoprazole|dexlansoprazole|mesh-list
111055358|NCT02334501|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111055359|NCT02334501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111055360|NCT02334501|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111055361|NCT02334501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111055362|NCT02334501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111055364|NCT02331927|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111055365|NCT02331927|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111055366|NCT02331927|Growth Substances|growth substances|mesh-ancestor
111055367|NCT02331927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111055368|NCT02331927|Growth Inhibitors|growth inhibitors|mesh-ancestor
111055369|NCT02331927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111055370|NCT02322190|Methoxsalen|methoxsalen|mesh-list
111055371|NCT02322190|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111055372|NCT02322190|Dermatologic Agents|dermatologic agents|mesh-ancestor
111055373|NCT02304055|Oxytocin|oxytocin|mesh-list
111055374|NCT02304055|Carbetocin|carbetocin|mesh-list
111055375|NCT02304055|Oxytocics|oxytocics|mesh-ancestor
111055376|NCT02304055|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111055377|NCT02304055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111055378|NCT05012865|Avelumab|avelumab|mesh-list
111055379|NCT05012865|Axitinib|axitinib|mesh-list
111055380|NCT05012865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111055381|NCT05012865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111055382|NCT05012865|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111055383|NCT05012865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111055384|NCT05012865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111055385|NCT03505489|Mannitol|mannitol|mesh-list
111055386|NCT03505489|Methacholine Chloride|methacholine chloride|mesh-list
111055387|NCT03505489|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
111055388|NCT03505489|Diuretics|diuretics|mesh-ancestor
111055389|NCT03505489|Natriuretic Agents|natriuretic agents|mesh-ancestor
111055390|NCT03505489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111055391|NCT03505489|Miotics|miotics|mesh-ancestor
111055392|NCT03505489|Autonomic Agents|autonomic agents|mesh-ancestor
111055393|NCT03505489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111055394|NCT03505489|Parasympathomimetics|parasympathomimetics|mesh-ancestor
111055395|NCT03505489|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
111055396|NCT03505489|Respiratory System Agents|respiratory system agents|mesh-ancestor
111055397|NCT03505489|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
111055398|NCT03505489|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111055399|NCT03505489|Cholinergic Agents|cholinergic agents|mesh-ancestor
111055400|NCT03505489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111055401|NCT03505489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111055402|NCT02310373|Nicotine|nicotine|mesh-list
111055403|NCT02310373|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111055404|NCT02310373|Autonomic Agents|autonomic agents|mesh-ancestor
111055405|NCT02310373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111055406|NCT02310373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111055407|NCT02310373|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111055408|NCT02310373|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111055409|NCT02310373|Cholinergic Agents|cholinergic agents|mesh-ancestor
111055410|NCT02310373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111055411|NCT02310373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111055412|NCT02338323|Febuxostat|febuxostat|mesh-list
111055413|NCT02338323|Benzbromarone|benzbromarone|mesh-list
111055414|NCT02338323|Gout Suppressants|gout suppressants|mesh-ancestor
111055415|NCT02338323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111055416|NCT02338323|Uricosuric Agents|uricosuric agents|mesh-ancestor
111055417|NCT02321800|Imipenem|imipenem|mesh-list
111055418|NCT02321800|Cilastatin|cilastatin|mesh-list
111055419|NCT02321800|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111055420|NCT02321800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111055421|NCT02321800|Protease Inhibitors|protease inhibitors|mesh-ancestor
111055422|NCT02321800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111055423|NCT02321800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111055424|NCT02310295|Triamcinolone|triamcinolone|mesh-list
111055425|NCT02310295|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
111055426|NCT02310295|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
111055427|NCT02310295|Bevacizumab|bevacizumab|mesh-list
111055428|NCT02310295|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
111055429|NCT02310295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111055430|NCT02310295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111055431|NCT02310295|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111055432|NCT02310295|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111055433|NCT02310295|Growth Substances|growth substances|mesh-ancestor
111055434|NCT02310295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111055435|NCT02310295|Growth Inhibitors|growth inhibitors|mesh-ancestor
111055436|NCT02310295|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111055437|NCT02310295|Glucocorticoids|glucocorticoids|mesh-ancestor
111055438|NCT02310295|Hormones|hormones|mesh-ancestor
111055439|NCT02310295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111055440|NCT02310295|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111055441|NCT02310295|Immunologic Factors|immunologic factors|mesh-ancestor
111055442|NCT02310295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111055443|NCT02310295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111055444|NCT02338089|Oxytocin|oxytocin|mesh-list
111055445|NCT02338089|Oxytocics|oxytocics|mesh-ancestor
111055446|NCT02338089|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111055447|NCT02338089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111055448|NCT02338245|Capecitabine|capecitabine|mesh-list
111055449|NCT02338245|Lapatinib|lapatinib|mesh-list
111055450|NCT02338245|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111055451|NCT02338245|Antimetabolites|antimetabolites|mesh-ancestor
111055452|NCT02338245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111055453|NCT02338245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111055454|NCT02338245|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111055455|NCT02338245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111055456|NCT02332005|Choline|choline|mesh-list
111055457|NCT02332005|Lipotropic Agents|lipotropic agents|mesh-ancestor
111055458|NCT02332005|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111055459|NCT02332005|Antimetabolites|antimetabolites|mesh-ancestor
111055460|NCT02332005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111055461|NCT02332005|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111055462|NCT02332005|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111055463|NCT02332005|Nootropic Agents|nootropic agents|mesh-ancestor
111055464|NCT02304211|Insulin|insulin|mesh-list
111055465|NCT02304211|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111055466|NCT02304211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111055467|NCT02311777|Pregabalin|pregabalin|mesh-list
111055468|NCT02311777|Ketamine|ketamine|mesh-list
111055469|NCT02311777|Analgesics|analgesics|mesh-ancestor
111055470|NCT02311777|Sensory System Agents|sensory system agents|mesh-ancestor
111055471|NCT02311777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111055472|NCT02311777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111055473|NCT02311777|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111055474|NCT02311777|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111055475|NCT02311777|Anesthetics, General|anesthetics, general|mesh-ancestor
111055476|NCT02311777|Anesthetics|anesthetics|mesh-ancestor
111055477|NCT02311777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111055478|NCT02311777|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111055479|NCT02311777|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111055480|NCT02311777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111055481|NCT02311777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111055482|NCT02311777|Anticonvulsants|anticonvulsants|mesh-ancestor
111055483|NCT02311777|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111055484|NCT02311777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111055485|NCT02311777|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111055486|NCT02311777|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111055487|NCT02311777|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111055488|NCT02311777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111055489|NCT03504865|Bupivacaine|bupivacaine|mesh-list
111055490|NCT03504865|Anesthetics, Local|anesthetics, local|mesh-ancestor
111055491|NCT03504865|Anesthetics|anesthetics|mesh-ancestor
111055492|NCT03504865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111055493|NCT03504865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111055494|NCT03504865|Sensory System Agents|sensory system agents|mesh-ancestor
111055495|NCT03504865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111055496|NCT02304289|Artesunate|artesunate|mesh-list
111055497|NCT02304289|Antimalarials|antimalarials|mesh-ancestor
111055498|NCT02304289|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111055499|NCT02304289|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111055500|NCT02304289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111055501|NCT02304289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111055502|NCT02304289|Antiviral Agents|antiviral agents|mesh-ancestor
111055503|NCT02304289|Schistosomicides|schistosomicides|mesh-ancestor
111055504|NCT02304289|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
111055505|NCT02304289|Anthelmintics|anthelmintics|mesh-ancestor
111055507|NCT02292784|Hormone Antagonists|hormone antagonists|mesh-ancestor
111055508|NCT02292784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111055509|NCT02292784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111055510|NCT02292784|Tocolytic Agents|tocolytic agents|mesh-ancestor
111055511|NCT02292784|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111055512|NCT02338011|Gefitinib|gefitinib|mesh-list
111055513|NCT02338011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111055514|NCT02338011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111055515|NCT02338011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111055516|NCT02338011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111055517|NCT02337855|Aluminum Hydroxide|aluminum hydroxide|mesh-list
111055518|NCT02337855|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111055519|NCT02337855|Immunologic Factors|immunologic factors|mesh-ancestor
111055520|NCT02337855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111055521|NCT02337855|Antacids|antacids|mesh-ancestor
111055522|NCT02337855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111055523|NCT02337855|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111055524|NCT02320396|Desloratadine|desloratadine|mesh-list
111055525|NCT02320396|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111055526|NCT02320396|Cholinergic Agents|cholinergic agents|mesh-ancestor
111055527|NCT02320396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111055528|NCT02320396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111055529|NCT02320396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111055530|NCT02320396|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
111055531|NCT02320396|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111055532|NCT02320396|Histamine Antagonists|histamine antagonists|mesh-ancestor
111055533|NCT02320396|Histamine Agents|histamine agents|mesh-ancestor
111055534|NCT02312089|Triptorelin Pamoate|triptorelin pamoate|mesh-list
111055535|NCT02312089|Luteolytic Agents|luteolytic agents|mesh-ancestor
111055536|NCT02312089|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111055537|NCT02312089|Contraceptive Agents|contraceptive agents|mesh-ancestor
111055538|NCT02312089|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111055539|NCT02312089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111055540|NCT02312089|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111055541|NCT02312089|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111055542|NCT02312089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111055543|NCT02310997|Cyclophosphamide|cyclophosphamide|mesh-list
111055544|NCT02310997|Melphalan|melphalan|mesh-list
111055545|NCT02310997|Busulfan|busulfan|mesh-list
111055546|NCT02310997|Fludarabine|fludarabine|mesh-list
111055547|NCT02310997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111055548|NCT02310997|Immunologic Factors|immunologic factors|mesh-ancestor
111055549|NCT02310997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111055550|NCT02310997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111055551|NCT02310997|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111055552|NCT02310997|Alkylating Agents|alkylating agents|mesh-ancestor
111055553|NCT02310997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111055554|NCT02310997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111055555|NCT02310997|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111055556|NCT03505411|Melatonin|melatonin|mesh-list
111055557|NCT03505411|Antioxidants|antioxidants|mesh-ancestor
111055558|NCT03505411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111055559|NCT03505411|Protective Agents|protective agents|mesh-ancestor
111055560|NCT03505411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111055561|NCT03505411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111055562|NCT02292238|Benphothiamine|benphothiamine|mesh-list
111055563|NCT02292238|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111055564|NCT02292238|Immunologic Factors|immunologic factors|mesh-ancestor
111055565|NCT02292238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111055566|NCT02292238|Chelating Agents|chelating agents|mesh-ancestor
111055567|NCT02292238|Sequestering Agents|sequestering agents|mesh-ancestor
111055568|NCT02292238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111055569|NCT03867123|Temozolomide|temozolomide|mesh-list
111055570|NCT03867123|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111055571|NCT03867123|Alkylating Agents|alkylating agents|mesh-ancestor
110827755|NCT01311570|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111055572|NCT03867123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111055573|NCT03867123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111055574|NCT03504475|Paroxetine|paroxetine|mesh-list
111055575|NCT03504475|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111055576|NCT03504475|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111055577|NCT03504475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111055578|NCT03504475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111055579|NCT03504475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111055580|NCT03504475|Serotonin Agents|serotonin agents|mesh-ancestor
111055581|NCT03504475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111055582|NCT03504475|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111055583|NCT03504475|Antidepressive Agents|antidepressive agents|mesh-ancestor
111055584|NCT03504475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111055585|NCT03504475|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111055586|NCT03504475|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111055587|NCT03504475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111055588|NCT02327247|Felodipine|felodipine|mesh-list
111055589|NCT02327247|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111055590|NCT02327247|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111055591|NCT02327247|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111055592|NCT02327247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111055593|NCT02327247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111055594|NCT02327247|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111055595|NCT02327247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111055596|NCT02327247|Vasodilator Agents|vasodilator agents|mesh-ancestor
111055597|NCT03505255|Neostigmine|neostigmine|mesh-list
111055598|NCT03505255|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111055599|NCT03505255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111055600|NCT03505255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111055601|NCT03505255|Cholinergic Agents|cholinergic agents|mesh-ancestor
111055602|NCT03505255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111055603|NCT03505255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111055604|NCT03505255|Parasympathomimetics|parasympathomimetics|mesh-ancestor
111055605|NCT03505255|Autonomic Agents|autonomic agents|mesh-ancestor
111055606|NCT03505255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111055607|NCT02333799|Linezolid|linezolid|mesh-list
111055608|NCT02333799|Bedaquiline|bedaquiline|mesh-list
111055609|NCT02333799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111055610|NCT02333799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111055611|NCT02333799|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111055612|NCT02333799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111055613|NCT02333799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111055614|NCT02333799|Antitubercular Agents|antitubercular agents|mesh-ancestor
111055615|NCT02311231|Heparin|heparin|mesh-list
111055616|NCT02311231|Calcium heparin|calcium heparin|mesh-list
111055617|NCT02311231|Bivalirudin|bivalirudin|mesh-list
111055618|NCT02311231|Anticoagulants|anticoagulants|mesh-ancestor
111055619|NCT02311231|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111055620|NCT02311231|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111055621|NCT02311231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111055622|NCT02311231|Antithrombins|antithrombins|mesh-ancestor
111055623|NCT02311231|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111055624|NCT02311231|Protease Inhibitors|protease inhibitors|mesh-ancestor
111055625|NCT02311231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111055626|NCT03508999|Metronidazole|metronidazole|mesh-list
111055627|NCT03508999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111055628|NCT03508999|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111055629|NCT03508999|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111055630|NCT03508999|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111055631|NCT03105375|Omeprazole|omeprazole|mesh-list
111055632|NCT03105375|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111055633|NCT03105375|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111055634|NCT03105375|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111055635|NCT03105375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111055636|NCT03105375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111055637|NCT02304445|Chlorotrianisene|chlorotrianisene|mesh-list
111055638|NCT02304445|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
111055639|NCT02304445|Estrogens|estrogens|mesh-ancestor
111055640|NCT02304445|Hormones|hormones|mesh-ancestor
111055641|NCT02304445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111055642|NCT02304445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110827757|NCT01170325|Anticonvulsants|anticonvulsants|mesh-ancestor
111055643|NCT02304445|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111055644|NCT02304445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111055645|NCT02316301|Misoprostol|misoprostol|mesh-list
111055646|NCT02316301|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111055647|NCT02316301|Abortifacient Agents|abortifacient agents|mesh-ancestor
111055648|NCT02316301|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111055649|NCT02316301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111055650|NCT02316301|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111055651|NCT02316301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111055652|NCT02316301|Oxytocics|oxytocics|mesh-ancestor
111055653|NCT02327091|Alfacalcidol|alfacalcidol|mesh-list
111055654|NCT02327091|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
111055655|NCT02327091|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111055656|NCT02327091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111055657|NCT02327091|Vitamins|vitamins|mesh-ancestor
111055658|NCT02327091|Micronutrients|micronutrients|mesh-ancestor
111055659|NCT02316535|Capecitabine|capecitabine|mesh-list
111055660|NCT02316535|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111055662|NCT02316535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111055663|NCT02316535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111055664|NCT02333253|Cetrorelix|cetrorelix|mesh-list
111055665|NCT02333253|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111055666|NCT02333253|Fertility Agents|fertility agents|mesh-ancestor
111055667|NCT02333253|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111055668|NCT02333253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111055669|NCT02333253|Hormone Antagonists|hormone antagonists|mesh-ancestor
111055670|NCT02333253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111055671|NCT02039661|Lidocaine|lidocaine|mesh-list
111055672|NCT02039661|Anesthetics, Local|anesthetics, local|mesh-ancestor
111055673|NCT02039661|Anesthetics|anesthetics|mesh-ancestor
111055674|NCT02039661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111055675|NCT02039661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111055676|NCT02039661|Sensory System Agents|sensory system agents|mesh-ancestor
111055677|NCT02039661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111055678|NCT02039661|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111055679|NCT02039661|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111055680|NCT02039661|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111055681|NCT02039661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111055682|NCT02039661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111055683|NCT02326779|Aspirin|aspirin|mesh-list
111055684|NCT02326779|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111055685|NCT02326779|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111055686|NCT02326779|Analgesics|analgesics|mesh-ancestor
111055687|NCT02326779|Sensory System Agents|sensory system agents|mesh-ancestor
111055688|NCT02326779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111055689|NCT02326779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111055690|NCT02326779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111055691|NCT02326779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111055692|NCT02326779|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111055693|NCT02326779|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111055694|NCT02326779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111055695|NCT02326779|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111055696|NCT02326779|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111055697|NCT02326779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111055698|NCT02326779|Antipyretics|antipyretics|mesh-ancestor
111055699|NCT02331303|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
111055700|NCT02331303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111055701|NCT02312635|Cycloserine|cycloserine|mesh-list
111055702|NCT02312635|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111055703|NCT02312635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111055704|NCT02312635|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111055705|NCT02312635|Antitubercular Agents|antitubercular agents|mesh-ancestor
111055706|NCT02312635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111055707|NCT02312635|Antimetabolites|antimetabolites|mesh-ancestor
111055708|NCT02312635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111055709|NCT03144453|Atropine|atropine|mesh-list
111055710|NCT03144453|Neostigmine|neostigmine|mesh-list
111055711|NCT03144453|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111055712|NCT03144453|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111055713|NCT03144453|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111055714|NCT03144453|Autonomic Agents|autonomic agents|mesh-ancestor
111055715|NCT03144453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111055716|NCT03144453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111055717|NCT03144453|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111055718|NCT03144453|Respiratory System Agents|respiratory system agents|mesh-ancestor
111055719|NCT03144453|Mydriatics|mydriatics|mesh-ancestor
111055720|NCT03144453|Parasympatholytics|parasympatholytics|mesh-ancestor
111055721|NCT03144453|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111055722|NCT03144453|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111055723|NCT03144453|Cholinergic Agents|cholinergic agents|mesh-ancestor
111055724|NCT03144453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111055725|NCT03144453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111055726|NCT03144453|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111055727|NCT03144453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111055728|NCT03144453|Parasympathomimetics|parasympathomimetics|mesh-ancestor
111055729|NCT02317159|Imatinib Mesylate|imatinib mesylate|mesh-list
111055730|NCT02317159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111055731|NCT02317159|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111055732|NCT02317159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111055733|NCT02317159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111055735|NCT02332941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111055736|NCT02332941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111055737|NCT02332941|Immunologic Factors|immunologic factors|mesh-ancestor
111055738|NCT02332941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111055739|NCT02332941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111055740|NCT03503227|Aspirin|aspirin|mesh-list
111055741|NCT03503227|Salicylic Acid|salicylic acid|mesh-list
111055742|NCT03503227|Prednisolone|prednisolone|mesh-list
111055743|NCT03503227|Salicylates|salicylates|mesh-list
111055744|NCT03503227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111055745|NCT03503227|Glucocorticoids|glucocorticoids|mesh-ancestor
111055746|NCT03503227|Hormones|hormones|mesh-ancestor
111055747|NCT03503227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111055748|NCT03503227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111055749|NCT03503227|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111055750|NCT03503227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111055751|NCT03503227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111055752|NCT03503227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111055753|NCT03503227|Antifungal Agents|antifungal agents|mesh-ancestor
111055754|NCT03503227|Keratolytic Agents|keratolytic agents|mesh-ancestor
111055755|NCT03503227|Dermatologic Agents|dermatologic agents|mesh-ancestor
111055756|NCT03503227|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111055757|NCT03503227|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111055758|NCT03503227|Analgesics|analgesics|mesh-ancestor
111055759|NCT03503227|Sensory System Agents|sensory system agents|mesh-ancestor
111055760|NCT03503227|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111055761|NCT03503227|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111055762|NCT03503227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111055763|NCT03503227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111055764|NCT03503227|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111055765|NCT03503227|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111055766|NCT03503227|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111055767|NCT03503227|Antipyretics|antipyretics|mesh-ancestor
111055768|NCT02305069|Pioglitazone|pioglitazone|mesh-list
111055769|NCT02305069|Octreotide|octreotide|mesh-list
111055770|NCT02305069|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111055771|NCT02305069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111055772|NCT02305069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111055773|NCT02305069|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111055774|NCT02305069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111055775|NCT02317237|Anesthetics|anesthetics|mesh-list
111055776|NCT02317237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111055777|NCT02317237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111055778|NCT02332473|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
111055779|NCT02332473|Molgramostim|molgramostim|mesh-list
111055780|NCT02332473|Sargramostim|sargramostim|mesh-list
111055781|NCT02332473|Antiviral Agents|antiviral agents|mesh-ancestor
111055782|NCT02332473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111055783|NCT02332473|Immunologic Factors|immunologic factors|mesh-ancestor
111055784|NCT02332473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111055785|NCT02332473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111055786|NCT03501433|Niacinamide|niacinamide|mesh-list
111055787|NCT03501433|Niacin|niacin|mesh-list
111055788|NCT03501433|Nicotinic Acids|nicotinic acids|mesh-list
111055789|NCT03501433|Vitamin B Complex|vitamin b complex|mesh-ancestor
111055790|NCT03501433|Vitamins|vitamins|mesh-ancestor
111055791|NCT03501433|Micronutrients|micronutrients|mesh-ancestor
111055792|NCT03501433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111055793|NCT03501433|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111055794|NCT03501433|Antimetabolites|antimetabolites|mesh-ancestor
111055795|NCT03501433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111055796|NCT03501433|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111055797|NCT03501433|Vasodilator Agents|vasodilator agents|mesh-ancestor
111055798|NCT02313103|Lofexidine|lofexidine|mesh-list
111055799|NCT02313103|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111055800|NCT02313103|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111055801|NCT02313103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111055802|NCT02313103|Sensory System Agents|sensory system agents|mesh-ancestor
111055803|NCT02313103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111055804|NCT02313103|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111055805|NCT02313103|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111055806|NCT02313103|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111055807|NCT02313103|Adrenergic Agents|adrenergic agents|mesh-ancestor
111055808|NCT02313103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111055809|NCT02313103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111055811|NCT01959633|Vemurafenib|vemurafenib|mesh-list
111055812|NCT01959633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111055813|NCT01959633|Antiviral Agents|antiviral agents|mesh-ancestor
111055814|NCT01959633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111055815|NCT01959633|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111055816|NCT01959633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111055817|NCT01959633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111055818|NCT02326623|Anesthetics|anesthetics|mesh-list
111055819|NCT02326623|Anesthetics, Local|anesthetics, local|mesh-list
111055820|NCT02326623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111055821|NCT02326623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111055822|NCT02326623|Sensory System Agents|sensory system agents|mesh-ancestor
111055823|NCT02326623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111055824|NCT02317471|Oxaliplatin|oxaliplatin|mesh-list
111055825|NCT02317471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111055826|NCT02332629|Methylprednisolone|methylprednisolone|mesh-list
111055827|NCT02332629|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111055828|NCT02332629|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111055829|NCT02332629|Prednisolone|prednisolone|mesh-list
111055830|NCT02332629|Prednisolone acetate|prednisolone acetate|mesh-list
111055831|NCT02332629|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111055832|NCT02332629|Prednisolone phosphate|prednisolone phosphate|mesh-list
111055833|NCT02332629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111055834|NCT02332629|Antiemetics|antiemetics|mesh-ancestor
111055835|NCT02332629|Autonomic Agents|autonomic agents|mesh-ancestor
111055836|NCT02332629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111055837|NCT02332629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111055838|NCT02332629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111055839|NCT02332629|Glucocorticoids|glucocorticoids|mesh-ancestor
111055840|NCT02332629|Hormones|hormones|mesh-ancestor
111055841|NCT02332629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111055842|NCT02332629|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111055843|NCT02332629|Protective Agents|protective agents|mesh-ancestor
111055844|NCT02332629|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111055845|NCT02332629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111055846|NCT02313337|Fentanyl|fentanyl|mesh-list
111055847|NCT02313337|Midazolam|midazolam|mesh-list
111055848|NCT02313337|Anesthetics|anesthetics|mesh-list
111055849|NCT02313337|Propofol|propofol|mesh-list
111055850|NCT02313337|Atracurium|atracurium|mesh-list
111055851|NCT02313337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111055852|NCT02313337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111055853|NCT02313337|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111055854|NCT02313337|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111055855|NCT02313337|Anesthetics, General|anesthetics, general|mesh-ancestor
111055856|NCT02313337|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111055857|NCT02313337|Narcotics|narcotics|mesh-ancestor
111055858|NCT02313337|Analgesics|analgesics|mesh-ancestor
111055859|NCT02313337|Sensory System Agents|sensory system agents|mesh-ancestor
111055860|NCT02313337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111055861|NCT02313337|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111055862|NCT02313337|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111055863|NCT02313337|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111055864|NCT02313337|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111055865|NCT02313337|GABA Modulators|gaba modulators|mesh-ancestor
111055866|NCT02313337|GABA Agents|gaba agents|mesh-ancestor
111055867|NCT02313337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111055868|NCT02313337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111055869|NCT02313337|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
111055871|NCT02313337|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111055872|NCT02313337|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
111055873|NCT02313337|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111055874|NCT02313337|Cholinergic Agents|cholinergic agents|mesh-ancestor
111055875|NCT02330757|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
111055876|NCT02330757|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
111055877|NCT02330757|Clomiphene|clomiphene|mesh-list
111055878|NCT02330757|Enclomiphene|enclomiphene|mesh-list
111055879|NCT02330757|Zuclomiphene|zuclomiphene|mesh-list
111055880|NCT02330757|Estradiol|estradiol|mesh-list
111055881|NCT02330757|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
111055882|NCT02330757|Estrogens|estrogens|mesh-ancestor
111055883|NCT02330757|Hormones|hormones|mesh-ancestor
111055884|NCT02330757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111055885|NCT02330757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111055886|NCT02330757|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111055887|NCT02330757|Contraceptive Agents|contraceptive agents|mesh-ancestor
111055888|NCT02330757|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111055889|NCT02330757|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111055890|NCT02330757|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111055891|NCT02330757|Hormone Antagonists|hormone antagonists|mesh-ancestor
111055892|NCT02330757|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111055893|NCT02330757|Fertility Agents|fertility agents|mesh-ancestor
111055894|NCT02330757|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111055895|NCT02330757|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111055896|NCT03502993|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111055897|NCT03502993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111055898|NCT02305615|Bevacizumab|bevacizumab|mesh-list
111055899|NCT02305615|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111055900|NCT02305615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111055901|NCT02305615|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111055902|NCT02305615|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111055903|NCT02305615|Growth Substances|growth substances|mesh-ancestor
111055904|NCT02305615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111055905|NCT02305615|Growth Inhibitors|growth inhibitors|mesh-ancestor
111055906|NCT02305693|Letrozole|letrozole|mesh-list
111055907|NCT02305693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111055908|NCT02305693|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111055909|NCT02305693|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111055910|NCT02305693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111055911|NCT02305693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111055912|NCT02305693|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111055913|NCT02305693|Hormone Antagonists|hormone antagonists|mesh-ancestor
111055914|NCT02305693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111055915|NCT02305693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111055916|NCT02317861|Febuxostat|febuxostat|mesh-list
111055917|NCT02317861|Verinurad|verinurad|mesh-list
111055918|NCT02317861|Benzbromarone|benzbromarone|mesh-list
111055919|NCT02317861|Gout Suppressants|gout suppressants|mesh-ancestor
111055920|NCT02317861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111055921|NCT02317861|Uricosuric Agents|uricosuric agents|mesh-ancestor
111055922|NCT02318017|Methylphenidate|methylphenidate|mesh-list
111055923|NCT02318017|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111055924|NCT02318017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111055925|NCT02318017|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111055926|NCT02318017|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111055927|NCT02318017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111055928|NCT02318017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111055929|NCT02318017|Dopamine Agents|dopamine agents|mesh-ancestor
111055930|NCT02318017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111055931|NCT02313727|Pamidronate|pamidronate|mesh-list
111055932|NCT02313727|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111055933|NCT02313727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111055934|NCT02313805|Insulin|insulin|mesh-list
111055935|NCT02313805|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111055936|NCT02313805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111055937|NCT03132493|Nivolumab|nivolumab|mesh-list
111055938|NCT03132493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111055939|NCT03132493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111055940|NCT03132493|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111055941|NCT03132493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111055942|NCT02313883|Taurolidine|taurolidine|mesh-list
111055944|NCT02313883|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111055945|NCT02313883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111055946|NCT03500653|Curcumin|curcumin|mesh-list
111055947|NCT03500653|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111055948|NCT03500653|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111055949|NCT03500653|Analgesics|analgesics|mesh-ancestor
111055950|NCT03500653|Sensory System Agents|sensory system agents|mesh-ancestor
111055951|NCT03500653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111055952|NCT03500653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111055953|NCT03500653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111055954|NCT03500653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111055955|NCT03500653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111055956|NCT03500653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111055957|NCT03500653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111055958|NCT02305927|Vitamin D|vitamin d|mesh-list
111055959|NCT02305927|Cholecalciferol|cholecalciferol|mesh-list
111055961|NCT02305927|Micronutrients|micronutrients|mesh-ancestor
111055962|NCT02305927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111055963|NCT02305927|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111055964|NCT02305927|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111055965|NCT02440009|Itraconazole|itraconazole|mesh-list
111055966|NCT02440009|Glucocorticoids|glucocorticoids|mesh-list
111055967|NCT02440009|Antifungal Agents|antifungal agents|mesh-ancestor
111055968|NCT02440009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111055969|NCT02440009|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111055970|NCT02440009|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111055971|NCT02440009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111055972|NCT02440009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111055973|NCT02440009|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111055974|NCT02440009|Hormone Antagonists|hormone antagonists|mesh-ancestor
111055975|NCT02440009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111055976|NCT02440009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111055977|NCT02440009|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111055978|NCT02440009|Hormones|hormones|mesh-ancestor
111055979|NCT02318563|Cannabidiol|cannabidiol|mesh-list
111055980|NCT02318563|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111055981|NCT02318563|Anticonvulsants|anticonvulsants|mesh-ancestor
111055982|NCT02314195|Serotonin|serotonin|mesh-list
111055983|NCT02314195|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
111055984|NCT02314195|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111055985|NCT02314195|Serotonin Agents|serotonin agents|mesh-ancestor
111055986|NCT02314195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111055987|NCT02314195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111055988|NCT02314195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111055989|NCT02314195|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111055990|NCT02314195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111055991|NCT02314273|Oprelvekin|oprelvekin|mesh-list
111055992|NCT02314273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111055993|NCT02314351|Fentanyl|fentanyl|mesh-list
111055994|NCT02314351|Metoclopramide|metoclopramide|mesh-list
111055995|NCT02314351|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111055996|NCT02314351|Narcotics|narcotics|mesh-ancestor
111055997|NCT02314351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111055998|NCT02314351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111055999|NCT02314351|Analgesics|analgesics|mesh-ancestor
111056000|NCT02314351|Sensory System Agents|sensory system agents|mesh-ancestor
111056001|NCT02314351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111056002|NCT02314351|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111056003|NCT02314351|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111056004|NCT02314351|Anesthetics, General|anesthetics, general|mesh-ancestor
111056005|NCT02314351|Anesthetics|anesthetics|mesh-ancestor
111056006|NCT02314351|Antiemetics|antiemetics|mesh-ancestor
111056007|NCT02314351|Autonomic Agents|autonomic agents|mesh-ancestor
111056008|NCT02314351|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111056009|NCT02314351|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111056010|NCT02314351|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111056011|NCT02314351|Dopamine Agents|dopamine agents|mesh-ancestor
111056012|NCT02314351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111056013|NCT02314351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111056014|NCT04463875|Coenzyme Q10|coenzyme q10|mesh-list
111056015|NCT04463875|Riboflavin|riboflavin|mesh-list
111056016|NCT04463875|Ubiquinone|ubiquinone|mesh-list
111056017|NCT04463875|Andrographolide|andrographolide|mesh-list
111056018|NCT04463875|Vitamins|vitamins|mesh-ancestor
111056019|NCT04463875|Micronutrients|micronutrients|mesh-ancestor
111056020|NCT04463875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111056021|NCT04463875|Vitamin B Complex|vitamin b complex|mesh-ancestor
111056022|NCT04463875|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111056023|NCT04463875|Dermatologic Agents|dermatologic agents|mesh-ancestor
111056024|NCT04463875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111056025|NCT04463875|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111056026|NCT04463875|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111056027|NCT04463875|Analgesics|analgesics|mesh-ancestor
111056028|NCT04463875|Sensory System Agents|sensory system agents|mesh-ancestor
111056029|NCT04463875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111056030|NCT04463875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111056031|NCT04463875|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111056032|NCT04463875|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111056033|NCT04463875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111056034|NCT04463875|Antiviral Agents|antiviral agents|mesh-ancestor
110773085|NCT01303614|Anesthetics, Local|anesthetics, local|mesh-ancestor
111056035|NCT04463875|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111056036|NCT03500029|Antidepressive Agents|antidepressive agents|mesh-list
111056037|NCT03500029|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111056038|NCT04462939|Micronutrients|micronutrients|mesh-list
111056039|NCT04462939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111056040|NCT02306239|Terlipressin|terlipressin|mesh-list
111056041|NCT02306239|Norepinephrine|norepinephrine|mesh-list
111056042|NCT02306239|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111056043|NCT02306239|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111056044|NCT02306239|Adrenergic Agents|adrenergic agents|mesh-ancestor
111056045|NCT02306239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111056046|NCT02306239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111056047|NCT02306239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111056048|NCT02306239|Sympathomimetics|sympathomimetics|mesh-ancestor
111056049|NCT02306239|Autonomic Agents|autonomic agents|mesh-ancestor
111056050|NCT02306239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111056051|NCT02306239|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111056052|NCT02306239|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111056053|NCT02319187|Irinotecan|irinotecan|mesh-list
111056054|NCT02319187|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111056055|NCT02319187|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111056056|NCT02319187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111056057|NCT02319187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111056058|NCT02319187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111056059|NCT02319265|Melatonin|melatonin|mesh-list
111056060|NCT02319265|Antioxidants|antioxidants|mesh-ancestor
111056061|NCT02319265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111056062|NCT02319265|Protective Agents|protective agents|mesh-ancestor
111056063|NCT02319265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111056064|NCT02319265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111056065|NCT02319343|Methylprednisolone|methylprednisolone|mesh-list
111056066|NCT02319343|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111056067|NCT02319343|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111056068|NCT02319343|Prednisolone|prednisolone|mesh-list
111056069|NCT02319343|Prednisolone acetate|prednisolone acetate|mesh-list
111056070|NCT02319343|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111056071|NCT02319343|Prednisolone phosphate|prednisolone phosphate|mesh-list
111056072|NCT02319343|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111056073|NCT02319343|Antiemetics|antiemetics|mesh-ancestor
111056074|NCT02319343|Autonomic Agents|autonomic agents|mesh-ancestor
111056075|NCT02319343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111056076|NCT02319343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111056077|NCT02319343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111056078|NCT02319343|Glucocorticoids|glucocorticoids|mesh-ancestor
111056079|NCT02319343|Hormones|hormones|mesh-ancestor
111056080|NCT02319343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111056081|NCT02319343|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111056082|NCT02319343|Protective Agents|protective agents|mesh-ancestor
111056083|NCT02319343|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111056084|NCT02319343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111056085|NCT02319499|Vitamin A|vitamin a|mesh-list
111056086|NCT02319499|Iron|iron|mesh-list
111056087|NCT02319499|Zinc|zinc|mesh-list
111056088|NCT02319499|Vitamins|vitamins|mesh-ancestor
111056089|NCT02319499|Micronutrients|micronutrients|mesh-ancestor
111056090|NCT02319499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111056091|NCT02319499|Trace Elements|trace elements|mesh-ancestor
111056092|NCT03499639|Ritonavir|ritonavir|mesh-list
111056094|NCT03499639|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111056095|NCT03499639|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111056096|NCT03499639|Protease Inhibitors|protease inhibitors|mesh-ancestor
111056097|NCT03499639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111056098|NCT03499639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111056099|NCT03499639|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111056100|NCT03499639|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111056101|NCT03499639|Antiviral Agents|antiviral agents|mesh-ancestor
111056102|NCT03499639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111056103|NCT03499639|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111056104|NCT03499639|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111056105|NCT03499639|Antimetabolites|antimetabolites|mesh-ancestor
111056106|NCT03502135|Phenylephrine|phenylephrine|mesh-list
111056107|NCT03502135|Oxymetazoline|oxymetazoline|mesh-list
111056108|NCT03502135|Tetracaine|tetracaine|mesh-list
111056109|NCT03502135|Anesthetics, Local|anesthetics, local|mesh-ancestor
111056110|NCT03502135|Anesthetics|anesthetics|mesh-ancestor
111056111|NCT03502135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111056112|NCT03502135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111056113|NCT03502135|Sensory System Agents|sensory system agents|mesh-ancestor
111056114|NCT03502135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111056115|NCT03502135|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111056116|NCT03502135|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111056117|NCT03502135|Adrenergic Agents|adrenergic agents|mesh-ancestor
111056118|NCT03502135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111056119|NCT03502135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111056120|NCT03502135|Sympathomimetics|sympathomimetics|mesh-ancestor
111056121|NCT03502135|Autonomic Agents|autonomic agents|mesh-ancestor
111056122|NCT03502135|Nasal Decongestants|nasal decongestants|mesh-ancestor
111056123|NCT03502135|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111056124|NCT03502135|Respiratory System Agents|respiratory system agents|mesh-ancestor
111056125|NCT03502135|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111056126|NCT03502135|Mydriatics|mydriatics|mesh-ancestor
111056127|NCT03502135|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111056128|NCT03502135|Protective Agents|protective agents|mesh-ancestor
111056129|NCT02315287|Pioglitazone|pioglitazone|mesh-list
111056130|NCT02315287|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111056131|NCT02315287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111056132|NCT02319577|Vinorelbine|vinorelbine|mesh-list
111056133|NCT02319577|Gefitinib|gefitinib|mesh-list
111056134|NCT02319577|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111056135|NCT02319577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111056136|NCT02319577|Tubulin Modulators|tubulin modulators|mesh-ancestor
111056137|NCT02319577|Antimitotic Agents|antimitotic agents|mesh-ancestor
111056138|NCT02319577|Mitosis Modulators|mitosis modulators|mesh-ancestor
111056139|NCT02319577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111056140|NCT02319577|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111056141|NCT02319577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111056142|NCT03501901|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111056143|NCT03501901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111056144|NCT03132259|Dexmedetomidine|dexmedetomidine|mesh-list
111056145|NCT03132259|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111056146|NCT03132259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111056147|NCT03132259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111056148|NCT03132259|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111056149|NCT03132259|Analgesics|analgesics|mesh-ancestor
111056150|NCT03132259|Sensory System Agents|sensory system agents|mesh-ancestor
111056151|NCT03132259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111056152|NCT03132259|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111056153|NCT03132259|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111056154|NCT03132259|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111056155|NCT03132259|Adrenergic Agents|adrenergic agents|mesh-ancestor
111056156|NCT03132259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111056157|NCT03132259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111056158|NCT03499171|Citalopram|citalopram|mesh-list
111056159|NCT03499171|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111056160|NCT03499171|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111056161|NCT03499171|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111056162|NCT03499171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111056163|NCT03499171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111056164|NCT03499171|Serotonin Agents|serotonin agents|mesh-ancestor
111056165|NCT03499171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110521223|NCT02721420|Piperaquine|piperaquine|mesh-list
111056166|NCT03499171|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111056167|NCT03499171|Antidepressive Agents|antidepressive agents|mesh-ancestor
111056169|NCT02447419|Gefitinib|gefitinib|mesh-list
111056170|NCT02447419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111056171|NCT02447419|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111056172|NCT02447419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111056173|NCT02447419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111056174|NCT02319889|Paclitaxel|paclitaxel|mesh-list
111056175|NCT02319889|Carboplatin|carboplatin|mesh-list
111056176|NCT02319889|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111056177|NCT02319889|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111056178|NCT02319889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111056179|NCT02319889|Tubulin Modulators|tubulin modulators|mesh-ancestor
111056180|NCT02319889|Antimitotic Agents|antimitotic agents|mesh-ancestor
111056181|NCT02319889|Mitosis Modulators|mitosis modulators|mesh-ancestor
111056182|NCT02319889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111056183|NCT02324413|Clonidine|clonidine|mesh-list
111056184|NCT02324413|Analgesics|analgesics|mesh-ancestor
111056185|NCT02324413|Sensory System Agents|sensory system agents|mesh-ancestor
110773235|NCT01381354|Vasodilator Agents|vasodilator agents|mesh-ancestor
111056186|NCT02324413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111056187|NCT02324413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111056188|NCT02324413|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111056189|NCT02324413|Sympatholytics|sympatholytics|mesh-ancestor
111056190|NCT02324413|Autonomic Agents|autonomic agents|mesh-ancestor
111056191|NCT02324413|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111056192|NCT02324413|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111056193|NCT02324413|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111056194|NCT02324413|Adrenergic Agents|adrenergic agents|mesh-ancestor
111056195|NCT02324413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111056196|NCT02324413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111056198|NCT03498703|Antimetabolites|antimetabolites|mesh-ancestor
111056199|NCT03498703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111056200|NCT03498703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111056201|NCT03498703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111056202|NCT03498703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111056203|NCT03498703|Immunologic Factors|immunologic factors|mesh-ancestor
111056204|NCT03498703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111056205|NCT03498703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111056206|NCT02324491|CKD732|ckd732|mesh-list
111056207|NCT02324491|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111056208|NCT02324491|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111056209|NCT02324491|Growth Substances|growth substances|mesh-ancestor
111056210|NCT02324491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111056211|NCT02324491|Growth Inhibitors|growth inhibitors|mesh-ancestor
111056212|NCT02324491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111056213|NCT03494257|Brimonidine Tartrate|brimonidine tartrate|mesh-list
111056214|NCT03494257|Brinzolamide|brinzolamide|mesh-list
111056215|NCT03494257|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111056216|NCT03494257|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111056217|NCT03494257|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111056218|NCT03494257|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111056219|NCT03494257|Adrenergic Agents|adrenergic agents|mesh-ancestor
111056220|NCT03494257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111056221|NCT03494257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111056222|NCT03494257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111056223|NCT03494257|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
111056224|NCT03494257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111056225|NCT03132181|Empagliflozin|empagliflozin|mesh-list
111056226|NCT03132181|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111056227|NCT03132181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111056228|NCT03132181|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111056229|NCT03132181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111056230|NCT02320045|Exenatide|exenatide|mesh-list
111056231|NCT02320045|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111056232|NCT02320045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111056233|NCT02320045|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111056234|NCT02320045|Incretins|incretins|mesh-ancestor
111056235|NCT02320045|Hormones|hormones|mesh-ancestor
111056236|NCT02320045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111056237|NCT02320357|Clopidogrel|clopidogrel|mesh-list
110827767|NCT05542446|Colistin|colistin|mesh-list
111056238|NCT02320357|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111056239|NCT02320357|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111056240|NCT02320357|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111056241|NCT02320357|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111056242|NCT02320357|Purinergic Agents|purinergic agents|mesh-ancestor
111056243|NCT02320357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111056244|NCT02320357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111056245|NCT02320357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111056246|NCT03498235|Propofol|propofol|mesh-list
111056247|NCT03498235|Sevoflurane|sevoflurane|mesh-list
111056248|NCT03498235|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111056249|NCT03498235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111056250|NCT03498235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111056251|NCT03498235|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111056252|NCT03498235|Anesthetics, General|anesthetics, general|mesh-ancestor
111056253|NCT03498235|Anesthetics|anesthetics|mesh-ancestor
111056254|NCT03498235|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111056255|NCT03498235|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111056256|NCT03491761|Hyaluronic Acid|hyaluronic acid|mesh-list
111056257|NCT03491761|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111056258|NCT03491761|Immunologic Factors|immunologic factors|mesh-ancestor
111056259|NCT03491761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111056260|NCT03491761|Viscosupplements|viscosupplements|mesh-ancestor
111056261|NCT03491761|Protective Agents|protective agents|mesh-ancestor
111056262|NCT03132103|Vitamin D|vitamin d|mesh-list
111056263|NCT03132103|Ergocalciferols|ergocalciferols|mesh-list
111056264|NCT03132103|Cholecalciferol|cholecalciferol|mesh-list
111056265|NCT03132103|Vitamins|vitamins|mesh-list
111056266|NCT03132103|Micronutrients|micronutrients|mesh-ancestor
111056267|NCT03132103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111056268|NCT03132103|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111056269|NCT03132103|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111056270|NCT04635943|Ivermectin|ivermectin|mesh-list
111056271|NCT04635943|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111056272|NCT04635943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111056273|NCT04461925|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111056274|NCT04461925|Azithromycin|azithromycin|mesh-list
111056275|NCT04461925|Ceftriaxone|ceftriaxone|mesh-list
111056276|NCT04461925|Dexamethasone|dexamethasone|mesh-list
111056277|NCT04461925|Enoxaparin|enoxaparin|mesh-list
111056278|NCT04461925|Anticoagulants|anticoagulants|mesh-list
111056279|NCT04461925|Hormones|hormones|mesh-list
111056280|NCT04461925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111056281|NCT04461925|Antiemetics|antiemetics|mesh-ancestor
111056282|NCT04461925|Autonomic Agents|autonomic agents|mesh-ancestor
111056283|NCT04461925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111056284|NCT04461925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111056285|NCT04461925|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111056286|NCT04461925|Glucocorticoids|glucocorticoids|mesh-ancestor
111056287|NCT04461925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111056288|NCT04461925|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111056289|NCT04461925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111056290|NCT04461925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111056291|NCT04461925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111056292|NCT04461925|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111056293|NCT04461925|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111056294|NCT02325583|Midazolam|midazolam|mesh-list
111056295|NCT02325583|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111056296|NCT02325583|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111056297|NCT02325583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111056298|NCT02325583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111056299|NCT02325583|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111056300|NCT02325583|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111056301|NCT02325583|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111056302|NCT02325583|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111056303|NCT02325583|Anesthetics, General|anesthetics, general|mesh-ancestor
111056304|NCT02325583|Anesthetics|anesthetics|mesh-ancestor
111056305|NCT02325583|GABA Modulators|gaba modulators|mesh-ancestor
111056306|NCT02325583|GABA Agents|gaba agents|mesh-ancestor
111056307|NCT02325583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111056308|NCT02325583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111056309|NCT02321293|Curcumin|curcumin|mesh-list
111056310|NCT02321293|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111056311|NCT02321293|Gefitinib|gefitinib|mesh-list
111056312|NCT02321293|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
110827770|NCT03355326|Glycerol|glycerol|mesh-list
111056313|NCT02321293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111056314|NCT02321293|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111056315|NCT02321293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111056316|NCT02321293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111056317|NCT02321293|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111056318|NCT02321293|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111056319|NCT02321293|Analgesics|analgesics|mesh-ancestor
111056320|NCT02321293|Sensory System Agents|sensory system agents|mesh-ancestor
111056321|NCT02321293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111056322|NCT02321293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111056323|NCT02321293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111056324|NCT02321293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111056325|NCT02321371|Rifaximin|rifaximin|mesh-list
111056326|NCT02321371|Lactulose|lactulose|mesh-list
111056327|NCT02321371|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111056328|NCT02321371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111056329|NCT02321371|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111056330|NCT04002037|Dexamethasone|dexamethasone|mesh-list
111056331|NCT04002037|Triamcinolone|triamcinolone|mesh-list
111056332|NCT04002037|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
111056333|NCT04002037|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
111056334|NCT04002037|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110676912|NCT03318900|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111056335|NCT04002037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111056336|NCT04002037|Antiemetics|antiemetics|mesh-ancestor
111056337|NCT04002037|Autonomic Agents|autonomic agents|mesh-ancestor
111056338|NCT04002037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111056339|NCT04002037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111056340|NCT04002037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111056341|NCT04002037|Glucocorticoids|glucocorticoids|mesh-ancestor
111056342|NCT04002037|Hormones|hormones|mesh-ancestor
111056343|NCT04002037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111056344|NCT04002037|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111056345|NCT04002037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111056346|NCT04002037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111056347|NCT04002037|Immunologic Factors|immunologic factors|mesh-ancestor
111056348|NCT04002037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111056349|NCT04002037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111056350|NCT03491371|Apatinib|apatinib|mesh-list
111056351|NCT03491371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111056352|NCT03491371|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111056353|NCT03491371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111056354|NCT03491371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111056355|NCT03546829|Vancomycin|vancomycin|mesh-list
111056356|NCT03546829|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111056357|NCT03546829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111056358|NCT03284047|Botulinum Toxins|botulinum toxins|mesh-list
111056359|NCT03284047|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111056360|NCT03284047|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111056361|NCT03284047|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111056362|NCT03284047|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111056363|NCT03284047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111056364|NCT03284047|Cholinergic Agents|cholinergic agents|mesh-ancestor
111056365|NCT03284047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111056366|NCT03284047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111056367|NCT03284047|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111056368|NCT03284047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111056369|NCT03493087|Vitamin K|vitamin k|mesh-list
111056370|NCT03493087|Vitamins|vitamins|mesh-ancestor
111056371|NCT03493087|Micronutrients|micronutrients|mesh-ancestor
111056372|NCT03493087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111056373|NCT03493087|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111056374|NCT03493087|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111056375|NCT03493087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111056376|NCT03493087|Hemostatics|hemostatics|mesh-ancestor
111056377|NCT03493087|Coagulants|coagulants|mesh-ancestor
111056378|NCT03136627|Nivolumab|nivolumab|mesh-list
111056379|NCT03136627|Tivozanib|tivozanib|mesh-list
111056380|NCT03136627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111056381|NCT03136627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111056382|NCT03136627|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111056383|NCT03136627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111056384|NCT03136627|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111056385|NCT03136627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111056386|NCT02922985|Acetaminophen|acetaminophen|mesh-list
111056387|NCT02922985|Ketorolac|ketorolac|mesh-list
111056388|NCT02922985|Bupivacaine|bupivacaine|mesh-list
111056389|NCT02922985|Anesthetics, Local|anesthetics, local|mesh-ancestor
111056390|NCT02922985|Anesthetics|anesthetics|mesh-ancestor
111056391|NCT02922985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111056392|NCT02922985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111056393|NCT02922985|Sensory System Agents|sensory system agents|mesh-ancestor
111056394|NCT02922985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111056395|NCT02922985|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111056396|NCT02922985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111056397|NCT02922985|Analgesics|analgesics|mesh-ancestor
111056398|NCT02922985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111056399|NCT02922985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111056400|NCT02922985|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111056401|NCT02922985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111056402|NCT02922985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111056403|NCT02922985|Antipyretics|antipyretics|mesh-ancestor
111056404|NCT04881955|Ecopipam|ecopipam|mesh-list
111056405|NCT04881955|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111056406|NCT04881955|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111056407|NCT04881955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111056408|NCT04881955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111056409|NCT04881955|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110676913|NCT03318900|Alkylating Agents|alkylating agents|mesh-ancestor
111056410|NCT04881955|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111056411|NCT04881955|Dopamine Agents|dopamine agents|mesh-ancestor
111056412|NCT04881955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111056413|NCT04881955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111056414|NCT02234843|Rivaroxaban|rivaroxaban|mesh-list
111056415|NCT02234843|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111056416|NCT02234843|Antithrombins|antithrombins|mesh-ancestor
111056417|NCT02234843|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111056418|NCT02234843|Protease Inhibitors|protease inhibitors|mesh-ancestor
111056419|NCT02234843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111056420|NCT02234843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111056421|NCT02234843|Anticoagulants|anticoagulants|mesh-ancestor
111056422|NCT03492931|Ticagrelor|ticagrelor|mesh-list
111056423|NCT03492931|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111056424|NCT03492931|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111056425|NCT03492931|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111056426|NCT03492931|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111056427|NCT03492931|Purinergic Agents|purinergic agents|mesh-ancestor
111056428|NCT03492931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111056429|NCT03492931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111056430|NCT03492931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111056431|NCT02234921|Cyclophosphamide|cyclophosphamide|mesh-list
111056432|NCT02234921|Imiquimod|imiquimod|mesh-list
111056433|NCT02234921|Vaccines|vaccines|mesh-list
111056434|NCT02234921|Immunologic Factors|immunologic factors|mesh-ancestor
111056435|NCT02234921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111056436|NCT02234921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111056437|NCT02234921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111056438|NCT02234921|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111056439|NCT02234921|Alkylating Agents|alkylating agents|mesh-ancestor
111056440|NCT02234921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111056441|NCT02234921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111056442|NCT02234921|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111056443|NCT02234921|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111056444|NCT02234921|Interferon Inducers|interferon inducers|mesh-ancestor
111056445|NCT02321761|Amantadine|amantadine|mesh-list
111056446|NCT02321761|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111056447|NCT02321761|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111056448|NCT02321761|Antiviral Agents|antiviral agents|mesh-ancestor
111056449|NCT02321761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111056450|NCT02321761|Dopamine Agents|dopamine agents|mesh-ancestor
111056451|NCT02321761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111056452|NCT02321761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111056453|NCT02321761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111056454|NCT02321761|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111056455|NCT02321761|Analgesics|analgesics|mesh-ancestor
111056456|NCT02321761|Sensory System Agents|sensory system agents|mesh-ancestor
111056457|NCT02321761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111056458|NCT04674241|Dexmedetomidine|dexmedetomidine|mesh-list
111056459|NCT04674241|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111056460|NCT04674241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111056461|NCT04674241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111056462|NCT04674241|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111056463|NCT04674241|Analgesics|analgesics|mesh-ancestor
111056464|NCT04674241|Sensory System Agents|sensory system agents|mesh-ancestor
111056465|NCT04674241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111056466|NCT04674241|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111056467|NCT04674241|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111056468|NCT04674241|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111056469|NCT04674241|Adrenergic Agents|adrenergic agents|mesh-ancestor
111056470|NCT04674241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111056471|NCT04674241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111056472|NCT02259647|Sorafenib|sorafenib|mesh-list
111056473|NCT02259647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111056474|NCT02259647|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111056475|NCT02259647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111056476|NCT02259647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111056477|NCT02321839|Ranibizumab|ranibizumab|mesh-list
111056478|NCT02321839|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111056479|NCT02321839|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111056480|NCT02321839|Growth Substances|growth substances|mesh-ancestor
111056481|NCT02321839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111056482|NCT02321839|Growth Inhibitors|growth inhibitors|mesh-ancestor
111056483|NCT02321839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111056485|NCT03490279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111056486|NCT02750345|Nitisinone|nitisinone|mesh-list
111056487|NCT02750345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111056488|NCT02750345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111056489|NCT01329263|Menthol|menthol|mesh-list
111056490|NCT01329263|Antipruritics|antipruritics|mesh-ancestor
111056491|NCT01329263|Dermatologic Agents|dermatologic agents|mesh-ancestor
111056492|NCT03490123|Azithromycin|azithromycin|mesh-list
111056493|NCT03490123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111056494|NCT03490123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111056495|NCT02235233|Technetium Tc 99m mebrofenin|technetium tc 99m mebrofenin|mesh-list
111056496|NCT02235233|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111056497|NCT02235233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111056498|NCT02182687|Doxorubicin|doxorubicin|mesh-list
111056499|NCT02182687|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111056500|NCT02182687|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111056501|NCT02182687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111056502|NCT02182687|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111056503|NCT02182687|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111056504|NCT02182687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111056505|NCT02182687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111056506|NCT02235389|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
111056507|NCT02235389|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111056508|NCT02235389|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111056509|NCT02235389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111056510|NCT03489889|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
111056511|NCT03489889|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
111056512|NCT03489889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111056513|NCT01388491|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
111056514|NCT01388491|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
111056515|NCT01388491|Ethinyl Estradiol|ethinyl estradiol|mesh-list
111056516|NCT01388491|Desogestrel|desogestrel|mesh-list
111056517|NCT01388491|Estradiol|estradiol|mesh-list
111056518|NCT01388491|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
111056519|NCT01388491|Estrogens|estrogens|mesh-ancestor
111056520|NCT01388491|Hormones|hormones|mesh-ancestor
111056521|NCT01388491|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111056522|NCT01388491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111056523|NCT01388491|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111056524|NCT01388491|Contraceptive Agents|contraceptive agents|mesh-ancestor
111056525|NCT01388491|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111056526|NCT01388491|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111056527|NCT01388491|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111056528|NCT01388491|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111056529|NCT01388491|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111056530|NCT01388491|Progestins|progestins|mesh-ancestor
111056531|NCT02236169|Bromides|bromides|mesh-list
111056532|NCT02236169|Norflurane|norflurane|mesh-list
111056533|NCT02236169|Ipratropium|ipratropium|mesh-list
111056534|NCT02236169|Anticonvulsants|anticonvulsants|mesh-ancestor
111056535|NCT02236169|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111056536|NCT02236169|Autonomic Agents|autonomic agents|mesh-ancestor
111056537|NCT02236169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111056538|NCT02236169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111056539|NCT02236169|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111056540|NCT02236169|Respiratory System Agents|respiratory system agents|mesh-ancestor
111056541|NCT02236169|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111056542|NCT02236169|Cholinergic Agents|cholinergic agents|mesh-ancestor
111056543|NCT02236169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111056544|NCT02236169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111056545|NCT02236169|Anesthetics|anesthetics|mesh-ancestor
111056546|NCT02236169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111056547|NCT02749799|Betamethasone|betamethasone|mesh-list
111056548|NCT02749799|Betamethasone Valerate|betamethasone valerate|mesh-list
111056549|NCT02749799|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
111056550|NCT02749799|Betamethasone benzoate|betamethasone benzoate|mesh-list
111056551|NCT02749799|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
111056552|NCT02749799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111056553|NCT02749799|Glucocorticoids|glucocorticoids|mesh-ancestor
111056554|NCT02749799|Hormones|hormones|mesh-ancestor
111056555|NCT02749799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111056556|NCT02749799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111056557|NCT02749799|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111056558|NCT02749799|Respiratory System Agents|respiratory system agents|mesh-ancestor
111056559|NCT03492541|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111056560|NCT03492541|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111056561|NCT03492385|Ticagrelor|ticagrelor|mesh-list
111056562|NCT03492385|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111056563|NCT03492385|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111056564|NCT03492385|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111056565|NCT03492385|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111056566|NCT03492385|Purinergic Agents|purinergic agents|mesh-ancestor
111056567|NCT03492385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111056568|NCT03492385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111056569|NCT03492385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111056570|NCT03736265|Carvedilol|carvedilol|mesh-list
111056571|NCT03736265|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111056572|NCT03736265|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111056573|NCT03736265|Adrenergic Agents|adrenergic agents|mesh-ancestor
111056574|NCT03736265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111056575|NCT03736265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111056576|NCT03736265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111056577|NCT03736265|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111056578|NCT03736265|Antioxidants|antioxidants|mesh-ancestor
111056579|NCT03736265|Protective Agents|protective agents|mesh-ancestor
111056580|NCT03736265|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111056581|NCT03736265|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111056582|NCT03736265|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111056583|NCT03736265|Vasodilator Agents|vasodilator agents|mesh-ancestor
111056584|NCT03736265|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111056585|NCT03736265|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111056586|NCT04939363|Venetoclax|venetoclax|mesh-list
111056587|NCT04939363|Obinutuzumab|obinutuzumab|mesh-list
111056588|NCT04939363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111056589|NCT04939363|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111056590|NCT02236403|Metronidazole|metronidazole|mesh-list
111056591|NCT02236403|Ivermectin|ivermectin|mesh-list
111056592|NCT02236403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111056593|NCT02236403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111056594|NCT02236403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111056595|NCT02236403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111056596|NCT02236481|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
111056597|NCT02236481|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111056598|NCT03491527|Salicylic Acid|salicylic acid|mesh-list
111056599|NCT03491527|Pemetrexed|pemetrexed|mesh-list
111056600|NCT03491527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111056601|NCT03491527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111056602|NCT03491527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111056603|NCT03491527|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111056604|NCT03491527|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111056605|NCT03491527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111056606|NCT03491527|Antifungal Agents|antifungal agents|mesh-ancestor
111056607|NCT03491527|Keratolytic Agents|keratolytic agents|mesh-ancestor
111056608|NCT03491527|Dermatologic Agents|dermatologic agents|mesh-ancestor
111056609|NCT02934529|Leucovorin|leucovorin|mesh-list
111056610|NCT02934529|Folic Acid|folic acid|mesh-list
111056611|NCT02934529|Bevacizumab|bevacizumab|mesh-list
111056612|NCT02934529|Cetuximab|cetuximab|mesh-list
111056613|NCT02934529|Fluorouracil|fluorouracil|mesh-list
111056614|NCT02934529|Capecitabine|capecitabine|mesh-list
111056615|NCT02934529|Irinotecan|irinotecan|mesh-list
111056616|NCT02934529|Levoleucovorin|levoleucovorin|mesh-list
111056617|NCT02934529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111056618|NCT02934529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111056619|NCT02934529|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111056620|NCT02934529|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111056621|NCT02934529|Growth Substances|growth substances|mesh-ancestor
111056622|NCT02934529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111056623|NCT02934529|Growth Inhibitors|growth inhibitors|mesh-ancestor
111056624|NCT02934529|Antimetabolites|antimetabolites|mesh-ancestor
111056625|NCT02934529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111056626|NCT02934529|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111056627|NCT02934529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111056628|NCT02934529|Immunologic Factors|immunologic factors|mesh-ancestor
111056629|NCT02934529|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111056630|NCT02934529|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111056631|NCT02934529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111056632|NCT02934529|Antidotes|antidotes|mesh-ancestor
111056633|NCT02934529|Protective Agents|protective agents|mesh-ancestor
111056634|NCT02934529|Vitamin B Complex|vitamin b complex|mesh-ancestor
111056635|NCT02934529|Vitamins|vitamins|mesh-ancestor
111056636|NCT02934529|Micronutrients|micronutrients|mesh-ancestor
111056637|NCT02934529|Hematinics|hematinics|mesh-ancestor
111056638|NCT02638805|Metformin|metformin|mesh-list
111056639|NCT02638805|Liraglutide|liraglutide|mesh-list
111056640|NCT02638805|Exenatide|exenatide|mesh-list
111056641|NCT02638805|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111056642|NCT02638805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111056643|NCT02638805|Incretins|incretins|mesh-ancestor
111056644|NCT02638805|Hormones|hormones|mesh-ancestor
111056645|NCT02638805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111056646|NCT02638805|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111056647|NCT02261675|Dexmedetomidine|dexmedetomidine|mesh-list
111056648|NCT02261675|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111056649|NCT02261675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111056650|NCT02261675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111056651|NCT02261675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111056652|NCT02261675|Analgesics|analgesics|mesh-ancestor
111056653|NCT02261675|Sensory System Agents|sensory system agents|mesh-ancestor
111056654|NCT02261675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111056655|NCT02261675|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111056656|NCT02261675|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111056657|NCT02261675|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111056658|NCT02261675|Adrenergic Agents|adrenergic agents|mesh-ancestor
111056659|NCT02261675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111056660|NCT02261675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111056661|NCT02262143|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111056662|NCT02262143|Fenofibrate|fenofibrate|mesh-list
111056663|NCT02262143|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111056664|NCT02262143|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111056665|NCT02262143|Antimetabolites|antimetabolites|mesh-ancestor
111056666|NCT02262143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111056667|NCT02262143|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111056668|NCT02262143|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111056669|NCT02262143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111056670|NCT02620553|Insulin|insulin|mesh-list
111056671|NCT02620553|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111056672|NCT02620553|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111056673|NCT02620553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111056674|NCT04588727|Aspirin|aspirin|mesh-list
111056675|NCT04588727|Ticagrelor|ticagrelor|mesh-list
111056676|NCT04588727|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111056677|NCT04588727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111056678|NCT04588727|Analgesics|analgesics|mesh-ancestor
111056679|NCT04588727|Sensory System Agents|sensory system agents|mesh-ancestor
111056680|NCT04588727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111056681|NCT04588727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111056682|NCT04588727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111056683|NCT04588727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111056684|NCT04588727|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111056685|NCT04588727|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111056686|NCT04588727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111056687|NCT04588727|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111056688|NCT04588727|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111056689|NCT04588727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111056690|NCT04588727|Antipyretics|antipyretics|mesh-ancestor
111056691|NCT04588727|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111056692|NCT04588727|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111056693|NCT04588727|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111056694|NCT04588727|Purinergic Agents|purinergic agents|mesh-ancestor
111056695|NCT04588727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111056696|NCT02262299|Pirfenidone|pirfenidone|mesh-list
111056697|NCT02262299|Analgesics|analgesics|mesh-ancestor
111056698|NCT02262299|Sensory System Agents|sensory system agents|mesh-ancestor
111056699|NCT02262299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111056700|NCT02262299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111056701|NCT02262299|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111056702|NCT02262299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111056703|NCT02262299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111056704|NCT02262299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111056705|NCT02262299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111056706|NCT02608697|Atorvastatin|atorvastatin|mesh-list
111056707|NCT02608697|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111056708|NCT02608697|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111056709|NCT02608697|Antimetabolites|antimetabolites|mesh-ancestor
111056710|NCT02608697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111056711|NCT02608697|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111056712|NCT02608697|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111056713|NCT02608697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111056714|NCT02262455|Doxorubicin|doxorubicin|mesh-list
111056715|NCT02262455|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111056716|NCT02262455|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111056717|NCT02262455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111056718|NCT02262455|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111056719|NCT02262455|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111056720|NCT02262455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110630913|NCT00979563|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111056721|NCT02262455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111056722|NCT02262533|Atenolol|atenolol|mesh-list
111056723|NCT02262533|Apixaban|apixaban|mesh-list
111056724|NCT02262533|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111056725|NCT02262533|Antithrombins|antithrombins|mesh-ancestor
111056726|NCT02262533|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111056727|NCT02262533|Protease Inhibitors|protease inhibitors|mesh-ancestor
111056728|NCT02262533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111056729|NCT02262533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111056730|NCT02262533|Anticoagulants|anticoagulants|mesh-ancestor
111056731|NCT02262533|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111056732|NCT02262533|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111056733|NCT02262533|Sympatholytics|sympatholytics|mesh-ancestor
111056734|NCT02262533|Autonomic Agents|autonomic agents|mesh-ancestor
111056735|NCT02262533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111056736|NCT02262533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111056737|NCT02262533|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
111056738|NCT02262533|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111056739|NCT02262533|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111056740|NCT02262533|Adrenergic Agents|adrenergic agents|mesh-ancestor
111056741|NCT02262533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111056742|NCT02262611|Telmisartan|telmisartan|mesh-list
111056743|NCT02262611|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
111056744|NCT02262611|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111056745|NCT02262611|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111056746|NCT02262611|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111056747|NCT02262611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111056748|NCT02262611|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
111056749|NCT02262611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111056751|NCT02262611|Natriuretic Agents|natriuretic agents|mesh-ancestor
111056752|NCT02262611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111056753|NCT02262767|Trimethobenzamide|trimethobenzamide|mesh-list
111056754|NCT02262767|Antiemetics|antiemetics|mesh-ancestor
111056755|NCT02262767|Autonomic Agents|autonomic agents|mesh-ancestor
111056756|NCT02262767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111056757|NCT02262767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111056758|NCT02262767|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111056759|NCT02589275|Cyclobenzaprine|cyclobenzaprine|mesh-list
111056760|NCT02589275|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
111056761|NCT02589275|Antidepressive Agents|antidepressive agents|mesh-ancestor
111056762|NCT02589275|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111056763|NCT02589275|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
111056764|NCT02589275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111056765|NCT02589275|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111056766|NCT02589275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111056767|NCT02589275|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111056768|NCT02589275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111056769|NCT02543567|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
111056770|NCT02543567|Antiviral Agents|antiviral agents|mesh-ancestor
111056771|NCT02543567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111056772|NCT02515175|Vaccines|vaccines|mesh-list
111056773|NCT02515175|Immunologic Factors|immunologic factors|mesh-ancestor
111056774|NCT02515175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111056775|NCT02513303|Sirolimus|sirolimus|mesh-list
111056776|NCT02513303|Temsirolimus|temsirolimus|mesh-list
111056777|NCT02513303|MTOR Inhibitors|mtor inhibitors|mesh-list
111056778|NCT02513303|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111056779|NCT02513303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111056780|NCT02513303|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111056781|NCT02513303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111056782|NCT02513303|Antifungal Agents|antifungal agents|mesh-ancestor
111056783|NCT02513303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111056784|NCT02513303|Immunologic Factors|immunologic factors|mesh-ancestor
111056785|NCT02513303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111056786|NCT02513303|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111056787|NCT02513303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111056788|NCT02513303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111056789|NCT01616303|Paclitaxel|paclitaxel|mesh-list
111056790|NCT01616303|Carboplatin|carboplatin|mesh-list
111056791|NCT01616303|Oregovomab|oregovomab|mesh-list
111056792|NCT01616303|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111056793|NCT01616303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111056794|NCT01616303|Tubulin Modulators|tubulin modulators|mesh-ancestor
111056795|NCT01616303|Antimitotic Agents|antimitotic agents|mesh-ancestor
111056796|NCT01616303|Mitosis Modulators|mitosis modulators|mesh-ancestor
111056797|NCT01616303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111056798|NCT01616303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111056799|NCT01590719|Leucovorin|leucovorin|mesh-list
111056800|NCT01590719|Folic Acid|folic acid|mesh-list
111056801|NCT01590719|Fluorouracil|fluorouracil|mesh-list
111056802|NCT01590719|Oxaliplatin|oxaliplatin|mesh-list
111056803|NCT01590719|Levoleucovorin|levoleucovorin|mesh-list
111056804|NCT01590719|Antimetabolites|antimetabolites|mesh-ancestor
111056805|NCT01590719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111056806|NCT01590719|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111056807|NCT01590719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111056808|NCT01590719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111056809|NCT01590719|Immunologic Factors|immunologic factors|mesh-ancestor
111056810|NCT01590719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111056811|NCT01590719|Antidotes|antidotes|mesh-ancestor
111056812|NCT01590719|Protective Agents|protective agents|mesh-ancestor
111056813|NCT01590719|Vitamin B Complex|vitamin b complex|mesh-ancestor
111056814|NCT01590719|Vitamins|vitamins|mesh-ancestor
111056815|NCT01590719|Micronutrients|micronutrients|mesh-ancestor
111056816|NCT01590719|Hematinics|hematinics|mesh-ancestor
111056817|NCT01536041|Montelukast|montelukast|mesh-list
111056818|NCT01536041|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111056819|NCT01536041|Respiratory System Agents|respiratory system agents|mesh-ancestor
111056820|NCT01536041|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
111056821|NCT01536041|Hormone Antagonists|hormone antagonists|mesh-ancestor
111056822|NCT01536041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111056823|NCT01536041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111056824|NCT01536041|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
111056825|NCT01536041|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111056826|NCT01536041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111056828|NCT01534403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111056829|NCT01534403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111056830|NCT01522469|Crenolanib|crenolanib|mesh-list
111056831|NCT01522469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111056832|NCT02264015|Moxifloxacin|moxifloxacin|mesh-list
111056833|NCT02264015|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111056834|NCT02264015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111056835|NCT02264015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111056836|NCT02264015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111056837|NCT02264015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111056838|NCT02264015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111056839|NCT02264015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111056840|NCT02264093|Propranolol|propranolol|mesh-list
111056841|NCT02264093|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111056842|NCT02264093|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111056843|NCT02264093|Adrenergic Agents|adrenergic agents|mesh-ancestor
111056844|NCT02264093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111056845|NCT02264093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111056846|NCT02264093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111056847|NCT02264093|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111056848|NCT02264093|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111056849|NCT02264093|Vasodilator Agents|vasodilator agents|mesh-ancestor
111056850|NCT01516541|Dalcetrapib|dalcetrapib|mesh-list
111056851|NCT01516541|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111056852|NCT01516541|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111056853|NCT01516541|Antimetabolites|antimetabolites|mesh-ancestor
111056854|NCT01516541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111056855|NCT01516541|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111056856|NCT01516307|Cyclophosphamide|cyclophosphamide|mesh-list
111056857|NCT01516307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111056858|NCT01516307|Immunologic Factors|immunologic factors|mesh-ancestor
111056859|NCT01516307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111056860|NCT01516307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111056861|NCT01516307|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111056862|NCT01516307|Alkylating Agents|alkylating agents|mesh-ancestor
111056863|NCT01516307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111056864|NCT01516307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111056865|NCT01516307|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111056866|NCT01516073|Fluticasone|fluticasone|mesh-list
111056868|NCT01516073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111056869|NCT01516073|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111056870|NCT01516073|Autonomic Agents|autonomic agents|mesh-ancestor
111056871|NCT01516073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111056872|NCT01516073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111056873|NCT01516073|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111056874|NCT01516073|Respiratory System Agents|respiratory system agents|mesh-ancestor
111056875|NCT01516073|Dermatologic Agents|dermatologic agents|mesh-ancestor
111056876|NCT01516073|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111056877|NCT01495247|Paclitaxel|paclitaxel|mesh-list
111056878|NCT01495247|Dactolisib|dactolisib|mesh-list
111056879|NCT01495247|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111056880|NCT01495247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111056881|NCT01495247|Tubulin Modulators|tubulin modulators|mesh-ancestor
111056882|NCT01495247|Antimitotic Agents|antimitotic agents|mesh-ancestor
111056883|NCT01495247|Mitosis Modulators|mitosis modulators|mesh-ancestor
111056884|NCT01495247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111056885|NCT01495013|Glimepiride|glimepiride|mesh-list
111056886|NCT01495013|Atorvastatin|atorvastatin|mesh-list
111056887|NCT01495013|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111056888|NCT01495013|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111056889|NCT01495013|Antimetabolites|antimetabolites|mesh-ancestor
111056890|NCT01495013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111056891|NCT01495013|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111056892|NCT01495013|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111056893|NCT01495013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111056894|NCT01495013|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110521962|NCT04235426|Vitamin B 12|vitamin b 12|mesh-list
111056895|NCT01495013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111056896|NCT01495013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111056897|NCT01495013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111056898|NCT01495013|Immunologic Factors|immunologic factors|mesh-ancestor
111056899|NCT02264171|Ketoconazole|ketoconazole|mesh-list
111056901|NCT02264171|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111056902|NCT02264171|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111056903|NCT02264171|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111056904|NCT02264171|Adrenergic Agents|adrenergic agents|mesh-ancestor
111056905|NCT02264171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111056906|NCT02264171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111056907|NCT02264171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111056908|NCT02264171|Urological Agents|urological agents|mesh-ancestor
111056909|NCT02264171|Antifungal Agents|antifungal agents|mesh-ancestor
111056910|NCT02264171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111056911|NCT02264171|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111056912|NCT02264171|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111056913|NCT02264171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111056914|NCT02264171|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111056915|NCT02264171|Hormone Antagonists|hormone antagonists|mesh-ancestor
111056916|NCT02264171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111056917|NCT02264171|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111056918|NCT01481051|Latanoprost|latanoprost|mesh-list
111056919|NCT01481051|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
111056920|NCT01481051|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111056921|NCT01480583|Alovudine|alovudine|mesh-list
111056922|NCT01480583|Trastuzumab|trastuzumab|mesh-list
111056923|NCT01480583|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111056924|NCT01480583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111056925|NCT01480583|Antiviral Agents|antiviral agents|mesh-ancestor
111056926|NCT01480583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111056927|NCT01470131|Dexamethasone|dexamethasone|mesh-list
111056928|NCT01470131|Bortezomib|bortezomib|mesh-list
111056929|NCT01470131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111056930|NCT01470131|Antiemetics|antiemetics|mesh-ancestor
111056931|NCT01470131|Autonomic Agents|autonomic agents|mesh-ancestor
111056932|NCT01470131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111056933|NCT01470131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111056934|NCT01470131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111056935|NCT01470131|Glucocorticoids|glucocorticoids|mesh-ancestor
111056937|NCT01470131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111056938|NCT01470131|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111056939|NCT01470131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111056940|NCT02264561|Caffeine|caffeine|mesh-list
111056941|NCT02264561|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111056942|NCT02264561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111056943|NCT02264561|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111056944|NCT02264561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111056945|NCT02264561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111056946|NCT02264561|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
111056947|NCT02264561|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111056948|NCT02264561|Purinergic Agents|purinergic agents|mesh-ancestor
111056949|NCT02264561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111056950|NCT01464437|Metformin|metformin|mesh-list
111056951|NCT01464437|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111056952|NCT01464437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111056953|NCT01461317|Etrolizumab|etrolizumab|mesh-list
111056954|NCT01461317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111056955|NCT01461317|Immunologic Factors|immunologic factors|mesh-ancestor
111056956|NCT01461317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111056957|NCT01449071|Epratuzumab|epratuzumab|mesh-list
111056958|NCT01449071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111056959|NCT01449071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111056960|NCT01445795|Ribavirin|ribavirin|mesh-list
111056961|NCT01445795|Antimetabolites|antimetabolites|mesh-ancestor
111056962|NCT01445795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111056963|NCT01445795|Antiviral Agents|antiviral agents|mesh-ancestor
111056964|NCT01445795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111056965|NCT02264795|Lidocaine|lidocaine|mesh-list
111056966|NCT02264795|Anesthetics, Local|anesthetics, local|mesh-ancestor
111056967|NCT02264795|Anesthetics|anesthetics|mesh-ancestor
110522037|NCT00562861|Lamotrigine|lamotrigine|mesh-list
111056968|NCT02264795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111056969|NCT02264795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111056970|NCT02264795|Sensory System Agents|sensory system agents|mesh-ancestor
111056971|NCT02264795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111056972|NCT02264795|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111056973|NCT02264795|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111056974|NCT02264795|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111056975|NCT02264795|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111056976|NCT02264795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111056977|NCT02264873|Decitabine|decitabine|mesh-list
111056978|NCT02264873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111056979|NCT02264873|Antimetabolites|antimetabolites|mesh-ancestor
111056980|NCT02264873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111056981|NCT02264873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111056982|NCT02264873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111056983|NCT00156533|Zolpidem|zolpidem|mesh-list
111056984|NCT00156533|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111056985|NCT00156533|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111056986|NCT00156533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111056987|NCT00156533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111056988|NCT00156533|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
111056989|NCT00156533|GABA Agonists|gaba agonists|mesh-ancestor
111056990|NCT00156533|GABA Agents|gaba agents|mesh-ancestor
111056991|NCT00156533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111056992|NCT00156533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111056993|NCT01410695|Methotrexate|methotrexate|mesh-list
111056994|NCT01410695|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111056995|NCT01410695|Abortifacient Agents|abortifacient agents|mesh-ancestor
111056996|NCT01410695|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111056997|NCT01410695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111056998|NCT01410695|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111056999|NCT01410695|Antimetabolites|antimetabolites|mesh-ancestor
111057000|NCT01410695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111057001|NCT01410695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111057002|NCT01410695|Dermatologic Agents|dermatologic agents|mesh-ancestor
111057003|NCT01410695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111057004|NCT01410695|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111057005|NCT01410695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111057006|NCT01410695|Immunologic Factors|immunologic factors|mesh-ancestor
111057007|NCT01410695|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111057008|NCT01410695|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111057010|NCT01660022|Artefenomel|artefenomel|mesh-list
111057011|NCT01660022|Antimalarials|antimalarials|mesh-ancestor
111057012|NCT01660022|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111057013|NCT01660022|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111057014|NCT01660022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111057015|NCT02265575|Hyaluronic Acid|hyaluronic acid|mesh-list
111057016|NCT02265575|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111057017|NCT02265575|Immunologic Factors|immunologic factors|mesh-ancestor
111057018|NCT02265575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111057019|NCT02265575|Viscosupplements|viscosupplements|mesh-ancestor
111057020|NCT02265575|Protective Agents|protective agents|mesh-ancestor
111057021|NCT02265731|Rituximab|rituximab|mesh-list
111057022|NCT02265731|Venetoclax|venetoclax|mesh-list
111057023|NCT02265731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111057024|NCT02265731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111057025|NCT02265731|Immunologic Factors|immunologic factors|mesh-ancestor
111057026|NCT02265731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111057027|NCT02265731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111057028|NCT02265809|Aldesleukin|aldesleukin|mesh-list
111057029|NCT02265809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111057030|NCT02265809|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111057031|NCT02265809|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111057032|NCT02265809|Antiviral Agents|antiviral agents|mesh-ancestor
111057033|NCT02265809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111057034|NCT01372475|Hyaluronic Acid|hyaluronic acid|mesh-list
111057035|NCT01372475|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111057036|NCT01372475|Immunologic Factors|immunologic factors|mesh-ancestor
111057037|NCT01372475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111057038|NCT01372475|Viscosupplements|viscosupplements|mesh-ancestor
111057039|NCT01372475|Protective Agents|protective agents|mesh-ancestor
111057040|NCT00156065|Haloperidol|haloperidol|mesh-list
111057041|NCT00156065|Haloperidol decanoate|haloperidol decanoate|mesh-list
111057042|NCT00156065|Asenapine|asenapine|mesh-list
111057043|NCT00156065|Antiemetics|antiemetics|mesh-ancestor
111057045|NCT00156065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111057046|NCT00156065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111057047|NCT00156065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111057048|NCT00156065|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111057049|NCT00156065|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111057050|NCT00156065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111057051|NCT00156065|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111057052|NCT00156065|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111057053|NCT00156065|Dopamine Agents|dopamine agents|mesh-ancestor
111057054|NCT00156065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111057055|NCT00156065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111057056|NCT00156065|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111057057|NCT01554956|Plasminogen|plasminogen|mesh-list
111057058|NCT01554956|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111057059|NCT01554956|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111057060|NCT01554956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111057061|NCT01360853|Gemcitabine|gemcitabine|mesh-list
111057062|NCT01360853|ON 01910|on 01910|mesh-list
111057063|NCT01360853|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111057064|NCT01360853|Antimetabolites|antimetabolites|mesh-ancestor
111057065|NCT01360853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111057066|NCT01360853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111057067|NCT01360853|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111057068|NCT01360853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111057069|NCT01355393|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
111057070|NCT01355393|Sargramostim|sargramostim|mesh-list
111057071|NCT01355393|Immunologic Factors|immunologic factors|mesh-ancestor
111057072|NCT01355393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111057073|NCT01355393|Antiviral Agents|antiviral agents|mesh-ancestor
111057074|NCT01355393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111057075|NCT02266355|Omalizumab|omalizumab|mesh-list
111057076|NCT02266355|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111057077|NCT02266355|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111057078|NCT02266355|Respiratory System Agents|respiratory system agents|mesh-ancestor
111057079|NCT02266511|Tamsulosin|tamsulosin|mesh-list
111057080|NCT02266511|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111057081|NCT02266511|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111057082|NCT02266511|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111057083|NCT02266511|Adrenergic Agents|adrenergic agents|mesh-ancestor
111057084|NCT02266511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110774139|NCT03783312|Analgesics|analgesics|mesh-ancestor
111057085|NCT02266511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111057086|NCT02266511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111057087|NCT02266511|Urological Agents|urological agents|mesh-ancestor
111057088|NCT02266589|Hydrocortisone|hydrocortisone|mesh-list
111057089|NCT02266589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111057090|NCT01330979|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111057091|NCT01330979|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111057092|NCT01298687|Travoprost|travoprost|mesh-list
111057093|NCT01298687|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111057094|NCT01298687|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111057095|NCT01298687|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111057096|NCT02267057|Acetaminophen|acetaminophen|mesh-list
111057097|NCT02267057|Buprenorphine|buprenorphine|mesh-list
111057098|NCT02267057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111057099|NCT02267057|Analgesics|analgesics|mesh-ancestor
111057100|NCT02267057|Sensory System Agents|sensory system agents|mesh-ancestor
111057101|NCT02267057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111057102|NCT02267057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111057103|NCT02267057|Antipyretics|antipyretics|mesh-ancestor
111057104|NCT02267057|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111057105|NCT02267057|Narcotics|narcotics|mesh-ancestor
111057106|NCT02267057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111057107|NCT02267057|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111057108|NCT05260541|Pramoxine|pramoxine|mesh-list
111057109|NCT05260541|Anesthetics, Local|anesthetics, local|mesh-ancestor
111057110|NCT05260541|Anesthetics|anesthetics|mesh-ancestor
111057111|NCT05260541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111057112|NCT05260541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111057113|NCT05260541|Sensory System Agents|sensory system agents|mesh-ancestor
111057114|NCT05260541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111057115|NCT01262261|Buprenorphine|buprenorphine|mesh-list
111057116|NCT01262261|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111057117|NCT01262261|Narcotics|narcotics|mesh-ancestor
110522189|NCT00637988|Rofecoxib|rofecoxib|mesh-list
111057118|NCT01262261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111057119|NCT01262261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111057120|NCT01262261|Analgesics|analgesics|mesh-ancestor
111057121|NCT01262261|Sensory System Agents|sensory system agents|mesh-ancestor
111057122|NCT01262261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111057123|NCT01262261|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111057125|NCT02267681|Alfentanil|alfentanil|mesh-list
111057126|NCT02267681|Propofol|propofol|mesh-list
111057127|NCT02267681|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111057128|NCT02267681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111057129|NCT02267681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111057130|NCT02267681|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111057131|NCT02267681|Anesthetics, General|anesthetics, general|mesh-ancestor
111057132|NCT02267681|Anesthetics|anesthetics|mesh-ancestor
111057133|NCT02267681|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111057134|NCT02267681|Narcotics|narcotics|mesh-ancestor
111057135|NCT02267681|Analgesics|analgesics|mesh-ancestor
111057136|NCT02267681|Sensory System Agents|sensory system agents|mesh-ancestor
111057137|NCT02267681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111057138|NCT02267681|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111057139|NCT05177939|Methylprednisolone|methylprednisolone|mesh-list
111057140|NCT05177939|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111057141|NCT05177939|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111057142|NCT05177939|Prednisolone|prednisolone|mesh-list
111057143|NCT05177939|Prednisolone acetate|prednisolone acetate|mesh-list
111057144|NCT05177939|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111057145|NCT05177939|Prednisolone phosphate|prednisolone phosphate|mesh-list
111057146|NCT05177939|Immunoglobulins|immunoglobulins|mesh-list
111057147|NCT05177939|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111057148|NCT05177939|gamma-Globulins|gamma-globulins|mesh-list
111057149|NCT05177939|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
111057150|NCT05177939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111057151|NCT05177939|Antiemetics|antiemetics|mesh-ancestor
111057152|NCT05177939|Autonomic Agents|autonomic agents|mesh-ancestor
111057153|NCT05177939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111057154|NCT05177939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111057155|NCT05177939|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111057156|NCT05177939|Glucocorticoids|glucocorticoids|mesh-ancestor
111057157|NCT05177939|Hormones|hormones|mesh-ancestor
111057158|NCT05177939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111057159|NCT05177939|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111057160|NCT05177939|Protective Agents|protective agents|mesh-ancestor
111057161|NCT05177939|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111057162|NCT05177939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111057163|NCT05177939|Immunologic Factors|immunologic factors|mesh-ancestor
111057164|NCT05174507|Empagliflozin|empagliflozin|mesh-list
111057165|NCT05174507|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
111057166|NCT05174507|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111057167|NCT05174507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111057168|NCT05174507|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111057169|NCT05174507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111057170|NCT05174507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111057171|NCT01480154|Hydroxychloroquine|hydroxychloroquine|mesh-list
111057172|NCT01480154|Antimalarials|antimalarials|mesh-ancestor
111057173|NCT01480154|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111057174|NCT01480154|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111057175|NCT01480154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111057176|NCT01480154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111057177|NCT01480154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111057178|NCT01480154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111057179|NCT02267915|Rituximab|rituximab|mesh-list
111057180|NCT02267915|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111057181|NCT02267915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111057182|NCT02267915|Immunologic Factors|immunologic factors|mesh-ancestor
111057183|NCT02267915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111057184|NCT02267915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111057185|NCT02268071|Antihypertensive Agents|antihypertensive agents|mesh-list
111057186|NCT02268149|Prednisone|prednisone|mesh-list
111057187|NCT02268149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111057188|NCT02268149|Glucocorticoids|glucocorticoids|mesh-ancestor
111057189|NCT02268149|Hormones|hormones|mesh-ancestor
111057190|NCT02268149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111057191|NCT02268149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110522259|NCT00942565|Analgesics|analgesics|mesh-ancestor
111057192|NCT02268149|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111057194|NCT01258907|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111057195|NCT01258907|Immunologic Factors|immunologic factors|mesh-ancestor
111057196|NCT01258907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111057197|NCT01255709|Epinephrine|epinephrine|mesh-list
111057198|NCT01255709|Racepinephrine|racepinephrine|mesh-list
111057199|NCT01255709|Epinephryl borate|epinephryl borate|mesh-list
111057200|NCT01255709|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111057201|NCT01255709|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111057202|NCT01255709|Adrenergic Agents|adrenergic agents|mesh-ancestor
111057203|NCT01255709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111057204|NCT01255709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111057205|NCT01255709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111057206|NCT01255709|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111057207|NCT01255709|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111057208|NCT01255709|Autonomic Agents|autonomic agents|mesh-ancestor
111057209|NCT01255709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111057210|NCT01255709|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111057211|NCT01255709|Respiratory System Agents|respiratory system agents|mesh-ancestor
111057212|NCT01255709|Mydriatics|mydriatics|mesh-ancestor
111057213|NCT01255709|Sympathomimetics|sympathomimetics|mesh-ancestor
111057214|NCT01255709|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111057215|NCT02233907|Oxitropium|oxitropium|mesh-list
111057216|NCT02233907|Parasympatholytics|parasympatholytics|mesh-ancestor
111057217|NCT02233907|Autonomic Agents|autonomic agents|mesh-ancestor
111057218|NCT02233907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111057219|NCT02233907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111057220|NCT01253603|Fluticasone|fluticasone|mesh-list
111057221|NCT01253603|Xhance|xhance|mesh-list
111057222|NCT01253603|Indoleacetic Acids|indoleacetic acids|mesh-list
111057223|NCT01253603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111057224|NCT01253603|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111057225|NCT01253603|Autonomic Agents|autonomic agents|mesh-ancestor
111057226|NCT01253603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111057227|NCT01253603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111057228|NCT01253603|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111057229|NCT01253603|Respiratory System Agents|respiratory system agents|mesh-ancestor
111057230|NCT01253603|Dermatologic Agents|dermatologic agents|mesh-ancestor
111057231|NCT01253603|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111057232|NCT01253603|Plant Growth Regulators|plant growth regulators|mesh-ancestor
111057233|NCT01253603|Growth Substances|growth substances|mesh-ancestor
111057234|NCT02268305|Dimethyl sulfone|dimethyl sulfone|mesh-list
111057235|NCT02268305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111057236|NCT02268383|Luspatercept|luspatercept|mesh-list
111057237|NCT02268383|Hematinics|hematinics|mesh-ancestor
111057238|NCT01329419|Adefovir|adefovir|mesh-list
111057239|NCT01329419|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
111057241|NCT01329419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111057242|NCT01329419|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111057243|NCT01329419|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111057244|NCT01329419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111057245|NCT01329419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111057246|NCT01235039|Insulin|insulin|mesh-list
111057247|NCT01235039|Insulin Lispro|insulin lispro|mesh-list
111057248|NCT01235039|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111057249|NCT01235039|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111057250|NCT01235039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111057251|NCT01234025|Prednisone|prednisone|mesh-list
111057252|NCT01234025|Docetaxel|docetaxel|mesh-list
111057253|NCT01234025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111057254|NCT01234025|Tubulin Modulators|tubulin modulators|mesh-ancestor
111057255|NCT01234025|Antimitotic Agents|antimitotic agents|mesh-ancestor
111057256|NCT01234025|Mitosis Modulators|mitosis modulators|mesh-ancestor
111057257|NCT01234025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111057258|NCT01234025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111057259|NCT01234025|Glucocorticoids|glucocorticoids|mesh-ancestor
111057260|NCT01234025|Hormones|hormones|mesh-ancestor
111057261|NCT01234025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111057262|NCT01234025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111057263|NCT01234025|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111057264|NCT01221077|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111057265|NCT01221077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111057266|NCT01221077|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111057267|NCT01221077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111057268|NCT01221077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111057270|NCT01207115|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111057271|NCT01207115|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111057272|NCT01207115|Analgesics|analgesics|mesh-ancestor
111057273|NCT01207115|Sensory System Agents|sensory system agents|mesh-ancestor
111057274|NCT01207115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111057275|NCT01207115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111057276|NCT01207115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111057277|NCT01207115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111057278|NCT01207115|Gout Suppressants|gout suppressants|mesh-ancestor
111057279|NCT01207115|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111057280|NCT01207115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111057281|NCT01207115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111057282|NCT01186991|Paclitaxel|paclitaxel|mesh-list
111057283|NCT01186991|Bevacizumab|bevacizumab|mesh-list
111057284|NCT01186991|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111057285|NCT01186991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111057286|NCT01186991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111057287|NCT01186991|Tubulin Modulators|tubulin modulators|mesh-ancestor
111057288|NCT01186991|Antimitotic Agents|antimitotic agents|mesh-ancestor
111057289|NCT01186991|Mitosis Modulators|mitosis modulators|mesh-ancestor
111057290|NCT01186991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111057291|NCT01186991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111057292|NCT01186991|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111057293|NCT01186991|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111057294|NCT01186991|Growth Substances|growth substances|mesh-ancestor
111057295|NCT01186991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111057296|NCT01186991|Growth Inhibitors|growth inhibitors|mesh-ancestor
111057297|NCT01186991|Immunologic Factors|immunologic factors|mesh-ancestor
111057298|NCT02268773|Aspirin|aspirin|mesh-list
111057299|NCT02268773|Dipyridamole|dipyridamole|mesh-list
111057300|NCT02268773|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
111057301|NCT02268773|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111057302|NCT02268773|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111057303|NCT02268773|Analgesics|analgesics|mesh-ancestor
111057304|NCT02268773|Sensory System Agents|sensory system agents|mesh-ancestor
111057305|NCT02268773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111057306|NCT02268773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111057307|NCT02268773|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111057308|NCT02268773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111057309|NCT02268773|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111057310|NCT02268773|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111057311|NCT02268773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111057312|NCT02268773|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111057313|NCT02268773|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111057314|NCT02268773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111057315|NCT02268773|Antipyretics|antipyretics|mesh-ancestor
111057316|NCT02268773|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111057317|NCT02268773|Vasodilator Agents|vasodilator agents|mesh-ancestor
111057318|NCT01183949|Bortezomib|bortezomib|mesh-list
111057319|NCT01183949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111057320|NCT01092065|Levodopa|levodopa|mesh-list
111057321|NCT01092065|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111057322|NCT01092065|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111057323|NCT01092065|Dopamine Agents|dopamine agents|mesh-ancestor
111057324|NCT01092065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111057325|NCT01092065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111057326|NCT01092065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111057327|NCT05626829|Tranilast|tranilast|mesh-list
111057328|NCT05626829|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111057329|NCT05626829|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111057330|NCT05626829|Analgesics|analgesics|mesh-ancestor
111057331|NCT05626829|Sensory System Agents|sensory system agents|mesh-ancestor
111057332|NCT05626829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111057333|NCT05626829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111057334|NCT05626829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111057335|NCT05626829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111057336|NCT05626829|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111057337|NCT05626829|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111057338|NCT05626829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110827788|NCT01170637|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111057339|NCT05626829|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111057340|NCT05626829|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111057341|NCT05626829|Histamine Antagonists|histamine antagonists|mesh-ancestor
111057342|NCT05626829|Histamine Agents|histamine agents|mesh-ancestor
111057343|NCT05626829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111057344|NCT05626829|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111057345|NCT05626829|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111057346|NCT01173497|Irinotecan|irinotecan|mesh-list
111057347|NCT01173497|Iniparib|iniparib|mesh-list
111057348|NCT01173497|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111057349|NCT01173497|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111057350|NCT01173497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111057351|NCT01173497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111057352|NCT01173497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111057353|NCT01173497|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111057354|NCT01171313|Carbidopa|carbidopa|mesh-list
111057355|NCT01171313|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
111057356|NCT01171313|Levodopa|levodopa|mesh-list
111057357|NCT01171313|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111057358|NCT01171313|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111057359|NCT01171313|Dopamine Agents|dopamine agents|mesh-ancestor
111057360|NCT01171313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111057361|NCT01171313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111057362|NCT01171313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111057363|NCT01171313|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
111057364|NCT01171313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111057365|NCT01171313|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111057366|NCT01171313|Immunologic Factors|immunologic factors|mesh-ancestor
111057367|NCT01171313|Dopamine Agonists|dopamine agonists|mesh-ancestor
111057368|NCT01071239|Cyclophosphamide|cyclophosphamide|mesh-list
111057369|NCT01071239|Busulfan|busulfan|mesh-list
111057370|NCT01071239|Fludarabine|fludarabine|mesh-list
111057371|NCT01071239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111057372|NCT01071239|Immunologic Factors|immunologic factors|mesh-ancestor
111057373|NCT01071239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111057374|NCT01071239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111057375|NCT01071239|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111057376|NCT01071239|Alkylating Agents|alkylating agents|mesh-ancestor
111057377|NCT01071239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111057378|NCT01071239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111057379|NCT01071239|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111057380|NCT01156415|Agomelatine|agomelatine|mesh-list
111057381|NCT01156415|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111057382|NCT01156415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111057383|NCT01156415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111057384|NCT01057667|Ribavirin|ribavirin|mesh-list
111057385|NCT01057667|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
111057386|NCT01057667|Antimetabolites|antimetabolites|mesh-ancestor
110774454|NCT05211622|Vitamins|vitamins|mesh-ancestor
111057387|NCT01057667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111057388|NCT01057667|Antiviral Agents|antiviral agents|mesh-ancestor
111057389|NCT01057667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111057390|NCT01027013|Rebamipide|rebamipide|mesh-list
111057391|NCT01027013|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111057392|NCT01027013|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111057393|NCT01027013|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111057394|NCT01027013|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111057395|NCT01027013|Antioxidants|antioxidants|mesh-ancestor
111057396|NCT01027013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111057397|NCT01027013|Protective Agents|protective agents|mesh-ancestor
111057398|NCT01027013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111057399|NCT01027013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111057400|NCT04197076|Immunomodulating Agents|immunomodulating agents|mesh-list
111057401|NCT04197076|Immunologic Factors|immunologic factors|mesh-ancestor
111057402|NCT04197076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111057403|NCT01138163|Docetaxel|docetaxel|mesh-list
111057404|NCT01138163|Bavituximab|bavituximab|mesh-list
111057405|NCT01138163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111057406|NCT01138163|Tubulin Modulators|tubulin modulators|mesh-ancestor
111057407|NCT01138163|Antimitotic Agents|antimitotic agents|mesh-ancestor
111057408|NCT01138163|Mitosis Modulators|mitosis modulators|mesh-ancestor
111057409|NCT01138163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111057410|NCT01138163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111057411|NCT01022801|Entecavir|entecavir|mesh-list
111057412|NCT01022801|Antiviral Agents|antiviral agents|mesh-ancestor
111057413|NCT01022801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111057414|NCT05628467|Antidepressive Agents|antidepressive agents|mesh-list
111057415|NCT05628467|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111057416|NCT05628389|Nicotine|nicotine|mesh-list
111057417|NCT05628389|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111057418|NCT05628389|Autonomic Agents|autonomic agents|mesh-ancestor
111057419|NCT05628389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111057420|NCT05628389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111057421|NCT05628389|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111057422|NCT05628389|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111057423|NCT05628389|Cholinergic Agents|cholinergic agents|mesh-ancestor
111057424|NCT05628389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111057425|NCT05628389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111057426|NCT01128335|Tacrolimus|tacrolimus|mesh-list
111057427|NCT01128335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111057428|NCT01128335|Immunologic Factors|immunologic factors|mesh-ancestor
111057429|NCT01128335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111057430|NCT01128335|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111057431|NCT01128335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111057432|NCT01128335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111057433|NCT01012895|Interferons|interferons|mesh-list
111057434|NCT01012895|Ribavirin|ribavirin|mesh-list
111057435|NCT01012895|Interferon-alpha|interferon-alpha|mesh-list
111057436|NCT01012895|Interferon alpha-2|interferon alpha-2|mesh-list
111057437|NCT01012895|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
111057438|NCT01012895|Asunaprevir|asunaprevir|mesh-list
111057439|NCT01012895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111057440|NCT01012895|Antiviral Agents|antiviral agents|mesh-ancestor
111057441|NCT01012895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111057442|NCT01012895|Antimetabolites|antimetabolites|mesh-ancestor
111057443|NCT01012895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111057444|NCT01012895|Immunologic Factors|immunologic factors|mesh-ancestor
111057445|NCT01012895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111057446|NCT01012895|Protease Inhibitors|protease inhibitors|mesh-ancestor
111057447|NCT01012895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111057448|NCT01009775|Docetaxel|docetaxel|mesh-list
111057449|NCT01009775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111057450|NCT01009775|Tubulin Modulators|tubulin modulators|mesh-ancestor
111057451|NCT01009775|Antimitotic Agents|antimitotic agents|mesh-ancestor
111057452|NCT01009775|Mitosis Modulators|mitosis modulators|mesh-ancestor
111057453|NCT01009775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111057454|NCT02319148|Itraconazole|itraconazole|mesh-list
111057455|NCT02319148|Verapamil|verapamil|mesh-list
111057456|NCT02319148|Diltiazem|diltiazem|mesh-list
111057457|NCT02319148|Antifungal Agents|antifungal agents|mesh-ancestor
111057458|NCT02319148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111057459|NCT02319148|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111057460|NCT02319148|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111057461|NCT02319148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111057462|NCT02319148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111057463|NCT02319148|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111057464|NCT02319148|Hormone Antagonists|hormone antagonists|mesh-ancestor
111057465|NCT02319148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111057466|NCT02319148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111057467|NCT02319148|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111057468|NCT02319148|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111057469|NCT02319148|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111057470|NCT02319148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111057471|NCT02319148|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111057472|NCT02319148|Vasodilator Agents|vasodilator agents|mesh-ancestor
111057473|NCT02319148|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111057474|NCT02526212|Buprenorphine|buprenorphine|mesh-list
111057475|NCT02526212|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111057476|NCT02526212|Narcotics|narcotics|mesh-ancestor
111057477|NCT02526212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111057478|NCT02526212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111057479|NCT02526212|Analgesics|analgesics|mesh-ancestor
111057480|NCT02526212|Sensory System Agents|sensory system agents|mesh-ancestor
111057481|NCT02526212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111057482|NCT02526212|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111057483|NCT05627843|Curcumin|curcumin|mesh-list
111057484|NCT05627843|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111057485|NCT05627843|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111057486|NCT05627843|Analgesics|analgesics|mesh-ancestor
110027035|NCT03800550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111057487|NCT05627843|Sensory System Agents|sensory system agents|mesh-ancestor
111057488|NCT05627843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111057489|NCT05627843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111057490|NCT05627843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111057491|NCT05627843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111057492|NCT05627843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111057493|NCT05627843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111057494|NCT05627843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111057495|NCT01004081|Exemestane|exemestane|mesh-list
111057496|NCT01004081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111057497|NCT01004081|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111057498|NCT01004081|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111057499|NCT01004081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111057500|NCT01004081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111057501|NCT01004081|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111057502|NCT01004081|Hormone Antagonists|hormone antagonists|mesh-ancestor
111057503|NCT01004081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111057504|NCT01004081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111057505|NCT01113593|Formoterol Fumarate|formoterol fumarate|mesh-list
111057506|NCT01113593|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111057507|NCT01113593|Autonomic Agents|autonomic agents|mesh-ancestor
111057508|NCT01113593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111057509|NCT01113593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111057510|NCT01113593|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111057511|NCT01113593|Respiratory System Agents|respiratory system agents|mesh-ancestor
111057512|NCT01113593|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111057513|NCT01113593|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111057514|NCT01113593|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111057515|NCT01113593|Adrenergic Agents|adrenergic agents|mesh-ancestor
111057516|NCT01113593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111057517|NCT01113593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111057518|NCT04137224|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111057519|NCT04137224|Immunologic Factors|immunologic factors|mesh-ancestor
111057520|NCT04137224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111057521|NCT02532374|Nicotine|nicotine|mesh-list
111057522|NCT02532374|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111057523|NCT02532374|Autonomic Agents|autonomic agents|mesh-ancestor
111057524|NCT02532374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111057525|NCT02532374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111057526|NCT02532374|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111057527|NCT02532374|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111057528|NCT02532374|Cholinergic Agents|cholinergic agents|mesh-ancestor
111057529|NCT02532374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111057530|NCT02532374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111057531|NCT05398874|Acetaminophen|acetaminophen|mesh-list
111057532|NCT05398874|Diclofenac|diclofenac|mesh-list
111057533|NCT05398874|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111057534|NCT05398874|Analgesics|analgesics|mesh-ancestor
111057535|NCT05398874|Sensory System Agents|sensory system agents|mesh-ancestor
111057536|NCT05398874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111057537|NCT05398874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111057538|NCT05398874|Antipyretics|antipyretics|mesh-ancestor
111057539|NCT05398874|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111057540|NCT05398874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111057541|NCT05398874|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111057542|NCT05398874|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111057543|NCT05398874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111057544|NCT05398874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111057545|NCT02525744|Insulin Lispro|insulin lispro|mesh-list
111057546|NCT02525744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111057547|NCT02525744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111057548|NCT05360732|Folfirinox|folfirinox|mesh-list
111057549|NCT05360732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111057550|NCT00152477|Paclitaxel|paclitaxel|mesh-list
111057551|NCT00152477|Carboplatin|carboplatin|mesh-list
111057552|NCT00152477|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111057553|NCT00152477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111057554|NCT00152477|Tubulin Modulators|tubulin modulators|mesh-ancestor
111057555|NCT00152477|Antimitotic Agents|antimitotic agents|mesh-ancestor
111057556|NCT00152477|Mitosis Modulators|mitosis modulators|mesh-ancestor
111057557|NCT00152477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111057558|NCT01111955|Metformin|metformin|mesh-list
111057559|NCT01111955|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111057560|NCT01111955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111057561|NCT01106807|Adapalene|adapalene|mesh-list
111057562|NCT01106807|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
111057563|NCT01106807|Benzoyl Peroxide|benzoyl peroxide|mesh-list
111057564|NCT01106807|Dermatologic Agents|dermatologic agents|mesh-ancestor
111057565|NCT01106807|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111057566|NCT01106807|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111057567|NCT01106807|Analgesics|analgesics|mesh-ancestor
111057568|NCT01106807|Sensory System Agents|sensory system agents|mesh-ancestor
111057569|NCT01106807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111057570|NCT01106807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111057571|NCT01106807|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111057572|NCT01106807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111057573|NCT05533229|Fentanyl|fentanyl|mesh-list
111057574|NCT05533229|Morphine|morphine|mesh-list
111057575|NCT05533229|Bupivacaine|bupivacaine|mesh-list
111057576|NCT05533229|Anesthetics, Local|anesthetics, local|mesh-ancestor
111057577|NCT05533229|Anesthetics|anesthetics|mesh-ancestor
111057578|NCT05533229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111057579|NCT05533229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111057580|NCT05533229|Sensory System Agents|sensory system agents|mesh-ancestor
111057581|NCT05533229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111057582|NCT05533229|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111057583|NCT05533229|Narcotics|narcotics|mesh-ancestor
111057584|NCT05533229|Analgesics|analgesics|mesh-ancestor
111057585|NCT05533229|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111057586|NCT05533229|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111057587|NCT05533229|Anesthetics, General|anesthetics, general|mesh-ancestor
111057588|NCT00153179|Acipimox|acipimox|mesh-list
111057589|NCT00153179|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111057590|NCT00153179|Antimetabolites|antimetabolites|mesh-ancestor
111057591|NCT00153179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111057592|NCT00153179|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111057593|NCT02743949|Esomeprazole|esomeprazole|mesh-list
111057594|NCT02743949|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111057595|NCT02743949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111057596|NCT02743949|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111057597|NCT02743949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111057598|NCT02743949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111057599|NCT02531438|Moxifloxacin|moxifloxacin|mesh-list
111057600|NCT02531438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111057601|NCT02531438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111057602|NCT02531438|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111057603|NCT02531438|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111057604|NCT02531438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111057605|NCT02531438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111057606|NCT02531438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111057607|NCT02289898|Gemcitabine|gemcitabine|mesh-list
111057608|NCT02289898|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111057609|NCT02289898|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111057610|NCT02289898|Antimetabolites|antimetabolites|mesh-ancestor
111057611|NCT02289898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111057612|NCT02289898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111057613|NCT01659554|Cisplatin|cisplatin|mesh-list
111057614|NCT01659554|Doxorubicin|doxorubicin|mesh-list
111057615|NCT01659554|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111057616|NCT01659554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111057617|NCT01659554|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111057618|NCT01659554|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111057619|NCT01659554|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111057620|NCT01659554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111057621|NCT01659554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111057622|NCT05355350|Meropenem|meropenem|mesh-list
111057623|NCT05355350|Tazobactam|tazobactam|mesh-list
111057624|NCT05355350|Piperacillin|piperacillin|mesh-list
111057625|NCT05355350|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
111057626|NCT05355350|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111057627|NCT05355350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111057628|NCT05355350|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110827795|NCT01170637|Sympathomimetics|sympathomimetics|mesh-ancestor
111057629|NCT05355350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111057630|NCT05355350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111057631|NCT01054196|Lenalidomide|lenalidomide|mesh-list
111057632|NCT01054196|Melphalan|melphalan|mesh-list
111057633|NCT01054196|Immunologic Factors|immunologic factors|mesh-ancestor
111057634|NCT01054196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111057635|NCT01054196|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111057636|NCT01054196|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111057637|NCT01054196|Growth Substances|growth substances|mesh-ancestor
111057638|NCT01054196|Growth Inhibitors|growth inhibitors|mesh-ancestor
111057639|NCT01054196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111057640|NCT01054196|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111057641|NCT01054196|Alkylating Agents|alkylating agents|mesh-ancestor
111057642|NCT01054196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111057643|NCT01054196|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111057644|NCT01054196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111057645|NCT01659320|Minocycline|minocycline|mesh-list
111057646|NCT01659320|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111057647|NCT01659320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111057648|NCT05414084|Phenol|phenol|mesh-list
111057649|NCT05414084|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111057650|NCT05414084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111057651|NCT05414084|Disinfectants|disinfectants|mesh-ancestor
111057652|NCT05414084|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
111057653|NCT05414084|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111057654|NCT01660334|Voriconazole|voriconazole|mesh-list
111057655|NCT01660334|Antifungal Agents|antifungal agents|mesh-ancestor
111057656|NCT01660334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111057657|NCT01660334|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111057658|NCT01660334|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111057659|NCT01660334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111057660|NCT01660334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111057661|NCT01660334|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111057662|NCT01660334|Hormone Antagonists|hormone antagonists|mesh-ancestor
111057663|NCT01660334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111057664|NCT01660334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111057665|NCT01660334|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111057666|NCT01660256|Rebamipide|rebamipide|mesh-list
111057667|NCT01660256|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111057668|NCT01660256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111057669|NCT01660256|Antioxidants|antioxidants|mesh-ancestor
111057670|NCT01660256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111057671|NCT01660256|Protective Agents|protective agents|mesh-ancestor
111057672|NCT01660256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111057673|NCT01660256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111057674|NCT04968938|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
111057675|NCT04968938|Hallucinogens|hallucinogens|mesh-ancestor
111057676|NCT04968938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111057677|NCT04968938|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111057678|NCT04968938|Serotonin Agents|serotonin agents|mesh-ancestor
111057679|NCT04968938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111057680|NCT04968938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111057681|NCT04968938|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111057682|NCT04968938|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111057683|NCT04968938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111057684|NCT04968938|Adrenergic Agents|adrenergic agents|mesh-ancestor
111057685|NCT05412758|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
111057686|NCT05412758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111057687|NCT02330367|Abivertinib|abivertinib|mesh-list
111057688|NCT02330367|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111057689|NCT02330367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111057690|NCT02330367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111057691|NCT02318602|Cannabidiol|cannabidiol|mesh-list
111057692|NCT02318602|Anticonvulsants|anticonvulsants|mesh-ancestor
111057693|NCT02330679|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
111057694|NCT02330679|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111057695|NCT02330679|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111057696|NCT02330679|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111057697|NCT02330679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111057698|NCT02330679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110027112|NCT02017704|Immunologic Factors|immunologic factors|mesh-ancestor
111057699|NCT02330679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111057700|NCT02330679|Antidepressive Agents|antidepressive agents|mesh-ancestor
111057701|NCT02330679|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111057702|NCT05559008|Azacitidine|azacitidine|mesh-list
111057703|NCT05559008|Apatinib|apatinib|mesh-list
111057704|NCT05559008|Dasatinib|dasatinib|mesh-list
111057705|NCT05559008|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111057706|NCT05559008|Antimetabolites|antimetabolites|mesh-ancestor
111057707|NCT05559008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111057708|NCT05559008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111057709|NCT05559008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111057710|NCT05559008|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111057711|NCT02318368|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111057712|NCT02318368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111057713|NCT02318368|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111057714|NCT02318368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111057715|NCT02318368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111057716|NCT05053425|Cytarabine|cytarabine|mesh-list
111057717|NCT05053425|Azacitidine|azacitidine|mesh-list
111057718|NCT05053425|Venetoclax|venetoclax|mesh-list
111057719|NCT05053425|Idarubicin|idarubicin|mesh-list
111057720|NCT05053425|Cladribine|cladribine|mesh-list
111057721|NCT05053425|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111057722|NCT05053425|Antimetabolites|antimetabolites|mesh-ancestor
111057723|NCT05053425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111057724|NCT05053425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111057725|NCT05053425|Antiviral Agents|antiviral agents|mesh-ancestor
111057726|NCT05053425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111057727|NCT05053425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111057728|NCT05053425|Immunologic Factors|immunologic factors|mesh-ancestor
111057729|NCT05053425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111057730|NCT05053425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111057731|NCT05053425|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111057732|NCT05053425|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111057733|NCT05053425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111057734|NCT02317510|Anesthetics|anesthetics|mesh-list
111057735|NCT02317510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111057736|NCT02317510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111057737|NCT05350124|Vitamins|vitamins|mesh-list
111057738|NCT05350124|Ascorbic Acid|ascorbic acid|mesh-list
111057739|NCT05350124|Vitamin E|vitamin e|mesh-list
111057740|NCT05350124|Tocopherols|tocopherols|mesh-list
111057741|NCT05350124|Micronutrients|micronutrients|mesh-ancestor
111057742|NCT05350124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111057743|NCT05350124|Antioxidants|antioxidants|mesh-ancestor
111057744|NCT05350124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111057745|NCT05350124|Protective Agents|protective agents|mesh-ancestor
111057746|NCT04925427|Naloxone|naloxone|mesh-list
111057747|NCT04925427|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111057748|NCT04925427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111057749|NCT04925427|Sensory System Agents|sensory system agents|mesh-ancestor
111057750|NCT04925427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111057751|NCT00494234|Olaparib|olaparib|mesh-list
111057752|NCT00494234|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
111057753|NCT00494234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111057754|NCT00494234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111057755|NCT00494234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111057756|NCT05554406|Cytarabine|cytarabine|mesh-list
111057757|NCT05554406|Azacitidine|azacitidine|mesh-list
111057758|NCT05554406|Daunorubicin|daunorubicin|mesh-list
111057759|NCT05554406|Venetoclax|venetoclax|mesh-list
111057760|NCT05554406|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111057761|NCT05554406|Antimetabolites|antimetabolites|mesh-ancestor
111057762|NCT05554406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111057763|NCT05554406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111057764|NCT05554406|Antiviral Agents|antiviral agents|mesh-ancestor
111057765|NCT05554406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111057766|NCT05554406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111057767|NCT05554406|Immunologic Factors|immunologic factors|mesh-ancestor
111057768|NCT05554406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111057769|NCT05554406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111057770|NCT05554406|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111057771|NCT05554406|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111057772|NCT05554406|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111057773|NCT04803591|Tranexamic Acid|tranexamic acid|mesh-list
111057774|NCT04803591|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111057775|NCT04803591|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111057776|NCT04803591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111057777|NCT04803591|Hemostatics|hemostatics|mesh-ancestor
111057778|NCT04803591|Coagulants|coagulants|mesh-ancestor
111057779|NCT04735263|Atorvastatin|atorvastatin|mesh-list
111057780|NCT04735263|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111057781|NCT04735263|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111057782|NCT04735263|Antimetabolites|antimetabolites|mesh-ancestor
111057783|NCT04735263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111057784|NCT04735263|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111057785|NCT04735263|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111057786|NCT04735263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111057787|NCT00493298|Natalizumab|natalizumab|mesh-list
111057788|NCT00493298|Immunologic Factors|immunologic factors|mesh-ancestor
111057789|NCT00493298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111057790|NCT02329197|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
111057791|NCT02329197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111057792|NCT02329197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111057793|NCT04662723|Dapagliflozin|dapagliflozin|mesh-list
111057794|NCT04662723|Empagliflozin|empagliflozin|mesh-list
111057795|NCT04662723|Canagliflozin|canagliflozin|mesh-list
111057796|NCT04662723|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
111057797|NCT04662723|Methylprednisolone|methylprednisolone|mesh-list
111057798|NCT04662723|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111057799|NCT04662723|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111057800|NCT04662723|Prednisolone|prednisolone|mesh-list
111057801|NCT04662723|Prednisolone acetate|prednisolone acetate|mesh-list
111057803|NCT04662723|Ramipril|ramipril|mesh-list
111057804|NCT04662723|Lisinopril|lisinopril|mesh-list
111057805|NCT04662723|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111057806|NCT04662723|Prednisolone phosphate|prednisolone phosphate|mesh-list
111057807|NCT04662723|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111057808|NCT04662723|Antiemetics|antiemetics|mesh-ancestor
111057809|NCT04662723|Autonomic Agents|autonomic agents|mesh-ancestor
111057810|NCT04662723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111057811|NCT04662723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111057812|NCT04662723|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111057813|NCT04662723|Glucocorticoids|glucocorticoids|mesh-ancestor
111057814|NCT04662723|Hormones|hormones|mesh-ancestor
111057815|NCT04662723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111057816|NCT04662723|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111057817|NCT04662723|Protective Agents|protective agents|mesh-ancestor
111057818|NCT04662723|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111057819|NCT04662723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111057820|NCT04662723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111057821|NCT04662723|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111057822|NCT04662723|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111057823|NCT04662723|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111057824|NCT04662723|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111057825|NCT04662723|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111057826|NCT04662723|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
111057827|NCT04662723|Protease Inhibitors|protease inhibitors|mesh-ancestor
111057828|NCT04662723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111057829|NCT04662723|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111057830|NCT05307926|Lenvatinib|lenvatinib|mesh-list
111057831|NCT05307926|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
111057832|NCT05307926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111057833|NCT05307926|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111057834|NCT05307926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111057835|NCT05307926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111057836|NCT05307926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111057837|NCT04026945|Lidocaine|lidocaine|mesh-list
110774895|NCT05223244|Hormones|hormones|mesh-ancestor
111057838|NCT04026945|Anesthetics, Local|anesthetics, local|mesh-ancestor
111057839|NCT04026945|Anesthetics|anesthetics|mesh-ancestor
111057840|NCT04026945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111057841|NCT04026945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111057842|NCT04026945|Sensory System Agents|sensory system agents|mesh-ancestor
111057843|NCT04026945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111057844|NCT04026945|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111057845|NCT04026945|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111057846|NCT04026945|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110522922|NCT05874219|Mupirocin|mupirocin|mesh-list
111057847|NCT04026945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111057848|NCT04026945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111057849|NCT02328729|Epinephrine|epinephrine|mesh-list
111057850|NCT02328729|Racepinephrine|racepinephrine|mesh-list
111057851|NCT02328729|Epinephryl borate|epinephryl borate|mesh-list
111057852|NCT02328729|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111057853|NCT02328729|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111057854|NCT02328729|Adrenergic Agents|adrenergic agents|mesh-ancestor
111057855|NCT02328729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111057856|NCT02328729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111057857|NCT02328729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111057858|NCT02328729|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111057859|NCT02328729|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111057860|NCT02328729|Autonomic Agents|autonomic agents|mesh-ancestor
111057861|NCT02328729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111057862|NCT02328729|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111057863|NCT02328729|Respiratory System Agents|respiratory system agents|mesh-ancestor
111057864|NCT02328729|Mydriatics|mydriatics|mesh-ancestor
111057865|NCT02328729|Sympathomimetics|sympathomimetics|mesh-ancestor
111057866|NCT02328729|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111057867|NCT02328963|Mycophenolic Acid|mycophenolic acid|mesh-list
111057869|NCT02328963|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111057870|NCT02328963|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111057871|NCT02328963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111057872|NCT02328963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111057873|NCT02328963|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111057874|NCT02328963|Immunologic Factors|immunologic factors|mesh-ancestor
111057875|NCT02328963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111057876|NCT02328963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111057877|NCT02328963|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111057878|NCT02328963|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111057879|NCT02328963|Antitubercular Agents|antitubercular agents|mesh-ancestor
111057880|NCT02328963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111057881|NCT02328963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111057882|NCT03353259|Tranexamic Acid|tranexamic acid|mesh-list
111057883|NCT03353259|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111057884|NCT03353259|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111057885|NCT03353259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111057886|NCT03353259|Hemostatics|hemostatics|mesh-ancestor
111057887|NCT03353259|Coagulants|coagulants|mesh-ancestor
111057888|NCT02328651|Ribavirin|ribavirin|mesh-list
111057889|NCT02328651|Antimetabolites|antimetabolites|mesh-ancestor
111057890|NCT02328651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111057891|NCT02328651|Antiviral Agents|antiviral agents|mesh-ancestor
111057892|NCT02328651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111057893|NCT02289352|Brimonidine Tartrate|brimonidine tartrate|mesh-list
111057894|NCT02289352|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111057895|NCT02289352|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111057896|NCT02289352|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111057897|NCT02289352|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111057898|NCT02289352|Adrenergic Agents|adrenergic agents|mesh-ancestor
111057899|NCT02289352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111057900|NCT02289352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111057901|NCT02289352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111057902|NCT05337566|Azithromycin|azithromycin|mesh-list
111057903|NCT05337566|Cefuroxime|cefuroxime|mesh-list
111057904|NCT05337566|Cefuroxime axetil|cefuroxime axetil|mesh-list
111057905|NCT05337566|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111057906|NCT05337566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111057907|NCT02328495|Misoprostol|misoprostol|mesh-list
111057908|NCT02328495|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111057909|NCT02328495|Abortifacient Agents|abortifacient agents|mesh-ancestor
111057910|NCT02328495|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111057911|NCT02328495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110774973|NCT03120780|Fentanyl|fentanyl|mesh-list
111057912|NCT02328495|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111057913|NCT02328495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111057914|NCT02328495|Oxytocics|oxytocics|mesh-ancestor
111057915|NCT02287402|Voglibose|voglibose|mesh-list
111057916|NCT02287402|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111057917|NCT02287402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111057918|NCT02287402|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
111057919|NCT02287402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111057920|NCT02287402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111057922|NCT02913495|Progestins|progestins|mesh-ancestor
111057923|NCT02913495|Hormones|hormones|mesh-ancestor
111057924|NCT02913495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111057925|NCT02913495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111057926|NCT03111069|Doxorubicin|doxorubicin|mesh-list
111057927|NCT03111069|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111057928|NCT03111069|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111057929|NCT03111069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111057930|NCT03111069|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111057931|NCT03111069|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111057932|NCT03111069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111057933|NCT03111069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111057934|NCT03110757|Aluminum Hydroxide|aluminum hydroxide|mesh-list
111057935|NCT03110757|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111057936|NCT03110757|Immunologic Factors|immunologic factors|mesh-ancestor
111057937|NCT03110757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111057938|NCT03110757|Antacids|antacids|mesh-ancestor
111057939|NCT03110757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111057940|NCT03110757|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111057941|NCT05080569|Progesterone|progesterone|mesh-list
111057942|NCT05080569|Progestins|progestins|mesh-ancestor
111057943|NCT05080569|Hormones|hormones|mesh-ancestor
111057944|NCT05080569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110631035|NCT00864162|Ramipril|ramipril|mesh-list
111057945|NCT05080569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111057946|NCT03145467|Acetaminophen|acetaminophen|mesh-list
111057947|NCT03145467|Zolmitriptan|zolmitriptan|mesh-list
111057948|NCT03145467|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111057949|NCT03145467|Analgesics|analgesics|mesh-ancestor
111057950|NCT03145467|Sensory System Agents|sensory system agents|mesh-ancestor
111057951|NCT03145467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111057952|NCT03145467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111057953|NCT03145467|Antipyretics|antipyretics|mesh-ancestor
111057954|NCT03145467|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111057955|NCT03145467|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111057956|NCT03145467|Serotonin Agents|serotonin agents|mesh-ancestor
111057957|NCT03145467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111057958|NCT03145467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111057959|NCT05302856|Antibodies|antibodies|mesh-list
111057960|NCT05302856|Testosterone|testosterone|mesh-list
111057961|NCT05302856|Immunologic Factors|immunologic factors|mesh-ancestor
111057962|NCT05302856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111057963|NCT05302856|Androgens|androgens|mesh-ancestor
111057964|NCT05302856|Hormones|hormones|mesh-ancestor
111057965|NCT05302856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111057966|NCT02328183|Polymyxins|polymyxins|mesh-list
111057967|NCT02328183|Polymyxin B|polymyxin b|mesh-list
111057968|NCT02328183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111057969|NCT02328183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111057970|NCT05610488|Faricimab|faricimab|mesh-list
111057971|NCT05610488|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111057972|NCT05610488|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111057973|NCT05610488|Growth Substances|growth substances|mesh-ancestor
111057974|NCT05610488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111057975|NCT05610488|Growth Inhibitors|growth inhibitors|mesh-ancestor
111057976|NCT05610488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111057977|NCT01646398|Vaccines|vaccines|mesh-list
111057978|NCT01646398|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
111057979|NCT01646398|Immunologic Factors|immunologic factors|mesh-ancestor
111057980|NCT01646398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111057981|NCT05382104|Maribavir|maribavir|mesh-list
111057982|NCT05382104|Antiviral Agents|antiviral agents|mesh-ancestor
111057983|NCT05382104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111057984|NCT01646320|Metformin|metformin|mesh-list
111057985|NCT01646320|Dapagliflozin|dapagliflozin|mesh-list
111057986|NCT01646320|Saxagliptin|saxagliptin|mesh-list
111057987|NCT01646320|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111057988|NCT01646320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111057994|NCT01646320|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111057995|NCT01646320|Protease Inhibitors|protease inhibitors|mesh-ancestor
111057996|NCT01646320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111057997|NCT03141645|Ondansetron|ondansetron|mesh-list
111057998|NCT03141645|Antiemetics|antiemetics|mesh-ancestor
111057999|NCT03141645|Autonomic Agents|autonomic agents|mesh-ancestor
111058000|NCT03141645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111058001|NCT03141645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110523069|NCT05685342|Ibuprofen|ibuprofen|mesh-list
111058003|NCT03141645|Antipruritics|antipruritics|mesh-ancestor
111058004|NCT03141645|Dermatologic Agents|dermatologic agents|mesh-ancestor
111058005|NCT03141645|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111058006|NCT03141645|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111058007|NCT03141645|Serotonin Agents|serotonin agents|mesh-ancestor
111058008|NCT03141645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111058009|NCT03141645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111058011|NCT05327426|Immunologic Factors|immunologic factors|mesh-ancestor
111058012|NCT05327426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111058018|NCT01658150|Isradipine|isradipine|mesh-list
111058019|NCT01658150|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111058020|NCT01658150|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111058021|NCT01658150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111058022|NCT01658150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111058023|NCT01658150|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111058024|NCT01658150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111058025|NCT01658150|Vasodilator Agents|vasodilator agents|mesh-ancestor
111058026|NCT02285998|Vaccines|vaccines|mesh-list
111058027|NCT02285998|Immunologic Factors|immunologic factors|mesh-ancestor
111058028|NCT02285998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111058029|NCT02285920|Spironolactone|spironolactone|mesh-list
111058030|NCT02285920|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
111058031|NCT02285920|Hormone Antagonists|hormone antagonists|mesh-ancestor
111058032|NCT02285920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111058033|NCT02285920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111058034|NCT02285920|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
111058035|NCT02285920|Diuretics|diuretics|mesh-ancestor
111058036|NCT02285920|Natriuretic Agents|natriuretic agents|mesh-ancestor
111058037|NCT05292872|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
111058038|NCT05292872|Cathartics|cathartics|mesh-ancestor
111058039|NCT05292872|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111058040|NCT02035137|Irinotecan|irinotecan|mesh-list
111058041|NCT02035137|Vincristine|vincristine|mesh-list
111058042|NCT02035137|Vorinostat|vorinostat|mesh-list
111058043|NCT02035137|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
111058044|NCT02035137|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111058045|NCT02035137|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111058046|NCT02035137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111058047|NCT02035137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111058048|NCT02035137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111058049|NCT02035137|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111058050|NCT02035137|Tubulin Modulators|tubulin modulators|mesh-ancestor
111058051|NCT02035137|Antimitotic Agents|antimitotic agents|mesh-ancestor
111058052|NCT02035137|Mitosis Modulators|mitosis modulators|mesh-ancestor
111058053|NCT02035137|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111058054|NCT02035137|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111058055|NCT05321810|Warfarin|warfarin|mesh-list
111058056|NCT05321810|Apixaban|apixaban|mesh-list
111058057|NCT05321810|Anticoagulants|anticoagulants|mesh-ancestor
111058058|NCT05321810|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111058059|NCT05321810|Antithrombins|antithrombins|mesh-ancestor
111058060|NCT05321810|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111058061|NCT05321810|Protease Inhibitors|protease inhibitors|mesh-ancestor
111058062|NCT05321810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111058063|NCT05321810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111058064|NCT05264870|Norepinephrine|norepinephrine|mesh-list
111058065|NCT05264870|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111058066|NCT05264870|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111058067|NCT05264870|Adrenergic Agents|adrenergic agents|mesh-ancestor
111058068|NCT05264870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111058069|NCT05264870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111058070|NCT05264870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111058071|NCT05264870|Sympathomimetics|sympathomimetics|mesh-ancestor
111058072|NCT05264870|Autonomic Agents|autonomic agents|mesh-ancestor
111058073|NCT05264870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111058074|NCT05264870|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111058075|NCT04249232|Abaloparatide|abaloparatide|mesh-list
111058076|NCT04249232|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111058077|NCT04249232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111058078|NCT05079087|Midazolam|midazolam|mesh-list
111058079|NCT05079087|Ketamine|ketamine|mesh-list
111058080|NCT05079087|Analgesics|analgesics|mesh-ancestor
111058081|NCT05079087|Sensory System Agents|sensory system agents|mesh-ancestor
111058082|NCT05079087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111058083|NCT05079087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111058084|NCT05079087|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111058085|NCT05079087|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111058086|NCT05079087|Anesthetics, General|anesthetics, general|mesh-ancestor
111058087|NCT05079087|Anesthetics|anesthetics|mesh-ancestor
111058088|NCT05079087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111058089|NCT05079087|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111058090|NCT05079087|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111058091|NCT05079087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111058092|NCT05079087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111058093|NCT05079087|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111058094|NCT05079087|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111058095|NCT05079087|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111058096|NCT05079087|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111058097|NCT05079087|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111058098|NCT05079087|GABA Modulators|gaba modulators|mesh-ancestor
111058099|NCT05079087|GABA Agents|gaba agents|mesh-ancestor
111058100|NCT02522780|Mesalamine|mesalamine|mesh-list
111058101|NCT02522780|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111058102|NCT02522780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111058103|NCT02522780|Analgesics|analgesics|mesh-ancestor
111058104|NCT02522780|Sensory System Agents|sensory system agents|mesh-ancestor
111058105|NCT02522780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111058106|NCT02522780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111058107|NCT02522780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111058108|NCT02522780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111058109|NCT03618225|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
111058110|NCT03618225|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111058111|NCT03618225|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111058112|NCT03618225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111058113|NCT03618225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111058114|NCT03618225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111058115|NCT03618225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111058116|NCT03618225|Analgesics|analgesics|mesh-ancestor
111058117|NCT03618225|Sensory System Agents|sensory system agents|mesh-ancestor
111058118|NCT03618225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111058119|NCT03618225|Antidepressive Agents|antidepressive agents|mesh-ancestor
111058120|NCT03618225|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111058121|NCT03618225|Dopamine Agents|dopamine agents|mesh-ancestor
111058122|NCT03566199|Panobinostat|panobinostat|mesh-list
111058123|NCT03566199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111058124|NCT03566199|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111058125|NCT03566199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111058126|NCT03566199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111058127|NCT03561831|Propofol|propofol|mesh-list
111058128|NCT03561831|Sevoflurane|sevoflurane|mesh-list
111058129|NCT03561831|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111058130|NCT03561831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111058131|NCT03561831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111058132|NCT03561831|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111058133|NCT03561831|Anesthetics, General|anesthetics, general|mesh-ancestor
111058134|NCT03561831|Anesthetics|anesthetics|mesh-ancestor
111058135|NCT03561831|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111058136|NCT03561831|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111058138|NCT03144843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111058139|NCT03144843|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111058140|NCT03144843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111058141|NCT03144843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111058142|NCT05288348|Sufentanil|sufentanil|mesh-list
111058143|NCT05288348|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111058144|NCT05288348|Narcotics|narcotics|mesh-ancestor
111058145|NCT05288348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111058146|NCT05288348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111058147|NCT05288348|Analgesics|analgesics|mesh-ancestor
111058148|NCT05288348|Sensory System Agents|sensory system agents|mesh-ancestor
111058149|NCT05288348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111058150|NCT05288348|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111058151|NCT05288348|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111058152|NCT05288348|Anesthetics, General|anesthetics, general|mesh-ancestor
111058153|NCT05288348|Anesthetics|anesthetics|mesh-ancestor
111058154|NCT03111615|Aromatase Inhibitors|aromatase inhibitors|mesh-list
111058155|NCT03111615|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111058156|NCT03111615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111058157|NCT03111615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111058158|NCT03111615|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111058159|NCT03111615|Hormone Antagonists|hormone antagonists|mesh-ancestor
111058160|NCT03111615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111058161|NCT03111615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111058162|NCT03199755|Lumefantrine|lumefantrine|mesh-list
111058163|NCT03199755|Artemether|artemether|mesh-list
111058164|NCT03199755|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
111058165|NCT03199755|Antimalarials|antimalarials|mesh-ancestor
111058166|NCT03199755|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111058167|NCT03199755|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111058168|NCT03199755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111058169|NCT05318066|Norepinephrine|norepinephrine|mesh-list
111058170|NCT05318066|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111058171|NCT05318066|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111058172|NCT05318066|Adrenergic Agents|adrenergic agents|mesh-ancestor
111058173|NCT05318066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111058174|NCT05318066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111058175|NCT05318066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111058176|NCT05318066|Sympathomimetics|sympathomimetics|mesh-ancestor
111058177|NCT05318066|Autonomic Agents|autonomic agents|mesh-ancestor
111058178|NCT05318066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111058179|NCT05318066|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111058180|NCT02327793|Labetalol|labetalol|mesh-list
111058181|NCT02327793|Nitroglycerin|nitroglycerin|mesh-list
111058182|NCT02327793|Vasodilator Agents|vasodilator agents|mesh-ancestor
111058183|NCT02327793|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111058184|NCT02327793|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111058185|NCT02327793|Adrenergic Agents|adrenergic agents|mesh-ancestor
111058186|NCT02327793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111058187|NCT02327793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111058188|NCT02327793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111058189|NCT02327793|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111058190|NCT02327793|Sympathomimetics|sympathomimetics|mesh-ancestor
111058191|NCT02327793|Autonomic Agents|autonomic agents|mesh-ancestor
111058192|NCT02327793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111058193|NCT02327793|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111058194|NCT02327793|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111058195|NCT02327715|Emtricitabine|emtricitabine|mesh-list
111058196|NCT02327715|Antiviral Agents|antiviral agents|mesh-ancestor
111058197|NCT02327715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111058198|NCT02327715|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111058199|NCT02327715|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111058200|NCT02327715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111058201|NCT02327715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111058202|NCT02327715|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111058203|NCT02327715|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111058204|NCT02951013|Chrysarobin|chrysarobin|mesh-list
111058205|NCT02951013|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111058206|NCT02951013|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111058207|NCT02951013|Analgesics|analgesics|mesh-ancestor
111058208|NCT02951013|Sensory System Agents|sensory system agents|mesh-ancestor
111058209|NCT02951013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110775273|NCT03749408|Anesthetics|anesthetics|mesh-ancestor
111058210|NCT02951013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111058211|NCT02951013|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111058212|NCT02951013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111058213|NCT02285062|Prednisone|prednisone|mesh-list
111058214|NCT02285062|Cyclophosphamide|cyclophosphamide|mesh-list
111058215|NCT02285062|Rituximab|rituximab|mesh-list
111058216|NCT02285062|Doxorubicin|doxorubicin|mesh-list
111058217|NCT02285062|Vincristine|vincristine|mesh-list
111058218|NCT02285062|Lenalidomide|lenalidomide|mesh-list
111058219|NCT02285062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111058220|NCT02285062|Immunologic Factors|immunologic factors|mesh-ancestor
111058221|NCT02285062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111058222|NCT02285062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111058223|NCT02285062|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111058224|NCT02285062|Alkylating Agents|alkylating agents|mesh-ancestor
110631066|NCT00864240|Hormones|hormones|mesh-ancestor
111058225|NCT02285062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111058226|NCT02285062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111058227|NCT02285062|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111058228|NCT02285062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111058229|NCT02285062|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111058230|NCT02285062|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111058231|NCT02285062|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111058232|NCT02285062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111058233|NCT02285062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111058235|NCT02285062|Hormones|hormones|mesh-ancestor
111058236|NCT02285062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111058237|NCT02285062|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111058238|NCT02285062|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111058239|NCT02285062|Tubulin Modulators|tubulin modulators|mesh-ancestor
111058240|NCT02285062|Antimitotic Agents|antimitotic agents|mesh-ancestor
111058241|NCT02285062|Mitosis Modulators|mitosis modulators|mesh-ancestor
111058242|NCT02285062|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111058243|NCT02285062|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111058244|NCT02285062|Growth Substances|growth substances|mesh-ancestor
111058245|NCT02285062|Growth Inhibitors|growth inhibitors|mesh-ancestor
111058246|NCT02431767|Interleukin-12|interleukin-12|mesh-list
111058247|NCT02431767|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111058248|NCT02431767|Immunologic Factors|immunologic factors|mesh-ancestor
111058249|NCT02431767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111058250|NCT02431767|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111058251|NCT02431767|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111058252|NCT02431767|Growth Substances|growth substances|mesh-ancestor
111058253|NCT02431767|Growth Inhibitors|growth inhibitors|mesh-ancestor
111058254|NCT02431767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111058255|NCT04571697|Methotrexate|methotrexate|mesh-list
111058256|NCT04571697|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111058257|NCT04571697|Abortifacient Agents|abortifacient agents|mesh-ancestor
111058258|NCT04571697|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111058259|NCT04571697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111058260|NCT04571697|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111058261|NCT04571697|Antimetabolites|antimetabolites|mesh-ancestor
111058262|NCT04571697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111058263|NCT04571697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111058264|NCT04571697|Dermatologic Agents|dermatologic agents|mesh-ancestor
111058265|NCT04571697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111058266|NCT04571697|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111058267|NCT04571697|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111058268|NCT04571697|Immunologic Factors|immunologic factors|mesh-ancestor
111058269|NCT04571697|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111058270|NCT04571697|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111058271|NCT05482334|Molgramostim|molgramostim|mesh-list
111058272|NCT05482334|Sargramostim|sargramostim|mesh-list
111058273|NCT05482334|Immunologic Factors|immunologic factors|mesh-ancestor
111058274|NCT05482334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111058275|NCT05482334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111058276|NCT05253794|Colchicine|colchicine|mesh-list
111058277|NCT05253794|Gout Suppressants|gout suppressants|mesh-ancestor
111058278|NCT05253794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111058279|NCT05253794|Tubulin Modulators|tubulin modulators|mesh-ancestor
111058280|NCT05253794|Antimitotic Agents|antimitotic agents|mesh-ancestor
111058281|NCT05253794|Mitosis Modulators|mitosis modulators|mesh-ancestor
111058282|NCT05253794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111058283|NCT05253794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111058284|NCT03140943|Thalidomide|thalidomide|mesh-list
111058285|NCT03140943|Dexamethasone|dexamethasone|mesh-list
111058286|NCT03140943|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111058287|NCT03140943|Antiemetics|antiemetics|mesh-ancestor
111058288|NCT03140943|Autonomic Agents|autonomic agents|mesh-ancestor
111058289|NCT03140943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111058290|NCT03140943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111058291|NCT03140943|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111058292|NCT03140943|Glucocorticoids|glucocorticoids|mesh-ancestor
111058293|NCT03140943|Hormones|hormones|mesh-ancestor
111058294|NCT03140943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111058295|NCT03140943|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111058296|NCT03140943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111058297|NCT03140943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111058298|NCT03140943|Immunologic Factors|immunologic factors|mesh-ancestor
111058299|NCT03140943|Leprostatic Agents|leprostatic agents|mesh-ancestor
111058300|NCT03140943|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111058301|NCT03140943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111058302|NCT03140943|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111058303|NCT03140943|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111058304|NCT03140943|Growth Substances|growth substances|mesh-ancestor
111058305|NCT03140943|Growth Inhibitors|growth inhibitors|mesh-ancestor
111058307|NCT02038257|Emollients|emollients|mesh-ancestor
111058308|NCT02038257|Dermatologic Agents|dermatologic agents|mesh-ancestor
111058309|NCT05311436|Iron|iron|mesh-list
111058310|NCT05311436|Folic Acid|folic acid|mesh-list
111058311|NCT05311436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111058312|NCT05311436|Trace Elements|trace elements|mesh-ancestor
111058313|NCT05311436|Micronutrients|micronutrients|mesh-ancestor
111058314|NCT05311436|Hematinics|hematinics|mesh-ancestor
111058315|NCT05311436|Vitamin B Complex|vitamin b complex|mesh-ancestor
111058316|NCT05311436|Vitamins|vitamins|mesh-ancestor
111058317|NCT01352741|Pregabalin|pregabalin|mesh-list
111058318|NCT01352741|Tapentadol|tapentadol|mesh-list
111058319|NCT01352741|Analgesics|analgesics|mesh-ancestor
111058320|NCT01352741|Sensory System Agents|sensory system agents|mesh-ancestor
111058321|NCT01352741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111058322|NCT01352741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111058323|NCT01352741|Anticonvulsants|anticonvulsants|mesh-ancestor
111058324|NCT01352741|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111058325|NCT01352741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111058326|NCT01352741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111058327|NCT01352741|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111058328|NCT01352741|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111058329|NCT01352741|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111058330|NCT01352741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111058331|NCT01352741|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111058332|NCT01352741|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111058333|NCT01352741|Narcotics|narcotics|mesh-ancestor
111058334|NCT01352741|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111058335|NCT01352741|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111058336|NCT01352741|Adrenergic Agents|adrenergic agents|mesh-ancestor
111058337|NCT01352741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111058338|NCT03973593|Contraceptive Agents|contraceptive agents|mesh-list
111058339|NCT03973593|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111058340|NCT03973593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111058341|NCT00911963|Ribavirin|ribavirin|mesh-list
111058342|NCT00911963|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
111058343|NCT00911963|Antimetabolites|antimetabolites|mesh-ancestor
111058344|NCT00911963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111058345|NCT00911963|Antiviral Agents|antiviral agents|mesh-ancestor
111058346|NCT00911963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111058347|NCT01657292|Octenidine|octenidine|mesh-list
111058348|NCT01657292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111058349|NCT01657292|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111058350|NCT04167033|Hormones|hormones|mesh-list
111058351|NCT04167033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111058352|NCT04167033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111058353|NCT00907907|Mycophenolic Acid|mycophenolic acid|mesh-list
111058354|NCT00907907|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111058355|NCT00907907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111058356|NCT00907907|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111058357|NCT00907907|Antitubercular Agents|antitubercular agents|mesh-ancestor
111058358|NCT00907907|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111058359|NCT00907907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111058360|NCT00907907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111058361|NCT00907907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111058362|NCT03140553|Cyclophosphamide|cyclophosphamide|mesh-list
111058364|NCT03140553|Docetaxel|docetaxel|mesh-list
111058365|NCT03140553|Trastuzumab|trastuzumab|mesh-list
111058366|NCT03140553|Epirubicin|epirubicin|mesh-list
111058367|NCT03140553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111058368|NCT03140553|Immunologic Factors|immunologic factors|mesh-ancestor
111058369|NCT03140553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111058370|NCT03140553|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111058371|NCT03140553|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111058372|NCT03140553|Alkylating Agents|alkylating agents|mesh-ancestor
111058373|NCT03140553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111058374|NCT03140553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111058375|NCT03140553|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111058376|NCT03140553|Tubulin Modulators|tubulin modulators|mesh-ancestor
111058377|NCT03140553|Antimitotic Agents|antimitotic agents|mesh-ancestor
111058378|NCT03140553|Mitosis Modulators|mitosis modulators|mesh-ancestor
111058379|NCT03140553|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111058380|NCT03140553|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111058381|NCT03140553|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111058382|NCT03140553|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111058383|NCT03140553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111058384|NCT00905567|Topiramate|topiramate|mesh-list
111058385|NCT00905567|Anticonvulsants|anticonvulsants|mesh-ancestor
111058386|NCT00905567|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111058387|NCT00905567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111058388|NCT05277896|Ketamine|ketamine|mesh-list
111058389|NCT05277896|Etomidate|etomidate|mesh-list
111058390|NCT05277896|Analgesics|analgesics|mesh-ancestor
111058391|NCT05277896|Sensory System Agents|sensory system agents|mesh-ancestor
111058392|NCT05277896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111058393|NCT05277896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111058394|NCT05277896|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111058395|NCT05277896|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111058396|NCT05277896|Anesthetics, General|anesthetics, general|mesh-ancestor
111058397|NCT05277896|Anesthetics|anesthetics|mesh-ancestor
111058398|NCT05277896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111058399|NCT05277896|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111058400|NCT05277896|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111058401|NCT05277896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111058402|NCT05277896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111058403|NCT05277896|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111058404|NCT02282020|Olaparib|olaparib|mesh-list
111058405|NCT02282020|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111058406|NCT02282020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111058407|NCT02282020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111058408|NCT02282020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111058409|NCT05249972|Calcitriol|calcitriol|mesh-list
111058410|NCT05249972|Betamethasone|betamethasone|mesh-list
111058411|NCT05249972|Betamethasone Valerate|betamethasone valerate|mesh-list
111058412|NCT05249972|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
111058413|NCT05249972|Betamethasone benzoate|betamethasone benzoate|mesh-list
111058414|NCT05249972|Calcipotriene|calcipotriene|mesh-list
111058415|NCT05249972|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
111058416|NCT05249972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111058417|NCT05249972|Glucocorticoids|glucocorticoids|mesh-ancestor
111058418|NCT05249972|Hormones|hormones|mesh-ancestor
111058419|NCT05249972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111058420|NCT05249972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111058421|NCT05249972|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111058422|NCT05249972|Respiratory System Agents|respiratory system agents|mesh-ancestor
111058423|NCT05249972|Dermatologic Agents|dermatologic agents|mesh-ancestor
111058424|NCT05249972|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111058425|NCT05249972|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
111058426|NCT05249972|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111058427|NCT05249972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111058428|NCT05249972|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111058429|NCT05249972|Vitamins|vitamins|mesh-ancestor
111058430|NCT05249972|Micronutrients|micronutrients|mesh-ancestor
111058431|NCT05249972|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111058432|NCT00904943|Topiramate|topiramate|mesh-list
111058433|NCT00904943|Anticonvulsants|anticonvulsants|mesh-ancestor
111058434|NCT00904943|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111058435|NCT00904943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111058436|NCT00902291|Gemcitabine|gemcitabine|mesh-list
111058437|NCT00902291|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111058438|NCT00902291|Antimetabolites|antimetabolites|mesh-ancestor
111058439|NCT00902291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111058440|NCT00902291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111058441|NCT05217680|Bevacizumab|bevacizumab|mesh-list
111058442|NCT05217680|Ranibizumab|ranibizumab|mesh-list
111058443|NCT05217680|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111058444|NCT05217680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111058445|NCT05217680|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111058446|NCT05217680|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111058447|NCT05217680|Growth Substances|growth substances|mesh-ancestor
111058448|NCT05217680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111058449|NCT05217680|Growth Inhibitors|growth inhibitors|mesh-ancestor
111058450|NCT02281552|Tofacitinib|tofacitinib|mesh-list
111058451|NCT02281552|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
111058452|NCT02281552|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111058453|NCT02281552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111058454|NCT02281552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111058455|NCT03832647|Salicylic Acid|salicylic acid|mesh-list
111058456|NCT03832647|Salicylates|salicylates|mesh-list
111058457|NCT03832647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111058458|NCT03832647|Antifungal Agents|antifungal agents|mesh-ancestor
111058459|NCT03832647|Keratolytic Agents|keratolytic agents|mesh-ancestor
111058460|NCT03832647|Dermatologic Agents|dermatologic agents|mesh-ancestor
111058461|NCT03832647|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111058462|NCT03832647|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111058463|NCT03832647|Analgesics|analgesics|mesh-ancestor
111058464|NCT03832647|Sensory System Agents|sensory system agents|mesh-ancestor
111058465|NCT03832647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111058466|NCT03832647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111058467|NCT03832647|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111058468|NCT03832647|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111058469|NCT03832647|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111058470|NCT03832647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111058471|NCT03832647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111058472|NCT00901979|Metformin|metformin|mesh-list
111058473|NCT00901979|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111058474|NCT00901979|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111058475|NCT00901979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111058476|NCT00901979|Incretins|incretins|mesh-ancestor
111058477|NCT00901979|Hormones|hormones|mesh-ancestor
111058478|NCT00901979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111058479|NCT00901979|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110523591|NCT04149210|Hormones|hormones|mesh-ancestor
111058480|NCT00901979|Protease Inhibitors|protease inhibitors|mesh-ancestor
111058481|NCT00901979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111058482|NCT00901979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111058483|NCT03778671|Fentanyl|fentanyl|mesh-list
111058484|NCT03778671|Dexmedetomidine|dexmedetomidine|mesh-list
111058485|NCT03778671|Levobupivacaine|levobupivacaine|mesh-list
111058486|NCT03778671|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111058487|NCT03778671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111058488|NCT03778671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111058489|NCT03778671|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111058490|NCT03778671|Analgesics|analgesics|mesh-ancestor
111058491|NCT03778671|Sensory System Agents|sensory system agents|mesh-ancestor
111058492|NCT03778671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111058493|NCT03778671|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111058494|NCT03778671|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111058495|NCT03778671|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111058496|NCT03778671|Adrenergic Agents|adrenergic agents|mesh-ancestor
111058497|NCT03778671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111058498|NCT03778671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111058499|NCT03778671|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111058500|NCT03778671|Narcotics|narcotics|mesh-ancestor
111058501|NCT03778671|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111058502|NCT03778671|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111058503|NCT03778671|Anesthetics, General|anesthetics, general|mesh-ancestor
111058504|NCT03778671|Anesthetics|anesthetics|mesh-ancestor
111058505|NCT03778671|Anesthetics, Local|anesthetics, local|mesh-ancestor
111058506|NCT00978497|Ribavirin|ribavirin|mesh-list
111058507|NCT00978497|Antimetabolites|antimetabolites|mesh-ancestor
111058508|NCT00978497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111058509|NCT00978497|Antiviral Agents|antiviral agents|mesh-ancestor
111058510|NCT00978497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111058511|NCT03692715|Ciprofloxacin|ciprofloxacin|mesh-list
111058512|NCT03692715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111058513|NCT03692715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111058515|NCT03692715|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111058516|NCT03692715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111058517|NCT03692715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111058518|NCT03692715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111058519|NCT03692715|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111058520|NCT03692715|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111058521|NCT03558789|Lactoferrin|lactoferrin|mesh-list
111058522|NCT03558789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111058523|NCT00890591|Amlodipine|amlodipine|mesh-list
111058524|NCT00890591|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
111058525|NCT00890591|Olmesartan|olmesartan|mesh-list
111058526|NCT00890591|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
111058527|NCT00890591|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111058528|NCT00890591|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111058529|NCT00890591|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111058530|NCT00890591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111058531|NCT00890591|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111058532|NCT00890591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111058533|NCT00890591|Vasodilator Agents|vasodilator agents|mesh-ancestor
111058534|NCT00890591|Diuretics|diuretics|mesh-ancestor
111058535|NCT00890591|Natriuretic Agents|natriuretic agents|mesh-ancestor
111058536|NCT00890591|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
111058537|NCT00890591|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111058538|NCT00890591|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111058539|NCT05248334|Ranibizumab|ranibizumab|mesh-list
111058540|NCT05248334|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111058541|NCT05248334|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111058542|NCT05248334|Growth Substances|growth substances|mesh-ancestor
111058543|NCT05248334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111058544|NCT05248334|Growth Inhibitors|growth inhibitors|mesh-ancestor
111058545|NCT05248334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111058546|NCT03140787|Lidocaine|lidocaine|mesh-list
111058547|NCT03140787|Anesthetics, Local|anesthetics, local|mesh-ancestor
111058548|NCT03140787|Anesthetics|anesthetics|mesh-ancestor
111058549|NCT03140787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111058550|NCT03140787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111058551|NCT03140787|Sensory System Agents|sensory system agents|mesh-ancestor
111058552|NCT03140787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111058553|NCT03140787|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110523657|NCT03962465|Glucocorticoids|glucocorticoids|mesh-ancestor
111058554|NCT03140787|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111058555|NCT03140787|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111058556|NCT03140787|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111058557|NCT03140787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111058558|NCT00889967|Ciprofloxacin|ciprofloxacin|mesh-list
111058559|NCT00889967|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111058560|NCT00889967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111058561|NCT00889967|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111058562|NCT00889967|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111058563|NCT00889967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111058564|NCT00889967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111058565|NCT00889967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111058566|NCT00889967|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111058567|NCT00889967|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111058568|NCT03317223|Amoxicillin|amoxicillin|mesh-list
111058569|NCT03317223|Clarithromycin|clarithromycin|mesh-list
111058570|NCT03317223|Lansoprazole|lansoprazole|mesh-list
111058571|NCT03317223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111058572|NCT03317223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111058573|NCT03317223|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111058574|NCT03317223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111058575|NCT03317223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111058576|NCT03317223|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111058577|NCT03317223|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111058578|NCT03317223|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111058579|NCT03317223|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111058580|NCT03317223|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111058581|NCT02284906|Pioglitazone|pioglitazone|mesh-list
111058582|NCT02284906|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111058583|NCT02284906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111058584|NCT02566863|Dexmedetomidine|dexmedetomidine|mesh-list
111058585|NCT02566863|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111058586|NCT02566863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111058587|NCT02566863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111058588|NCT02566863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111058589|NCT02566863|Analgesics|analgesics|mesh-ancestor
111058590|NCT02566863|Sensory System Agents|sensory system agents|mesh-ancestor
111058591|NCT02566863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111058592|NCT02566863|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111058593|NCT02566863|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111058594|NCT02566863|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111058595|NCT02566863|Adrenergic Agents|adrenergic agents|mesh-ancestor
111058596|NCT02566863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111058597|NCT02566863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111058598|NCT05137847|Denileukin diftitox|denileukin diftitox|mesh-list
111058599|NCT05137847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111058600|NCT00968825|Botulinum Toxins|botulinum toxins|mesh-list
111058601|NCT00968825|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111058602|NCT00968825|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111058603|NCT00968825|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111058604|NCT00968825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111058605|NCT00968825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111058606|NCT00968825|Cholinergic Agents|cholinergic agents|mesh-ancestor
111058607|NCT00968825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111058608|NCT00968825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111058609|NCT00968825|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111058610|NCT00968825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111058611|NCT04474457|Favipiravir|favipiravir|mesh-list
111058612|NCT04474457|Antiviral Agents|antiviral agents|mesh-ancestor
111058613|NCT04474457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111058614|NCT03139383|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111058615|NCT00880217|Methylphenidate|methylphenidate|mesh-list
111058616|NCT00880217|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
111058617|NCT00880217|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111058618|NCT00880217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111058619|NCT00880217|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111058620|NCT00880217|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111058621|NCT00880217|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111058622|NCT00880217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111058623|NCT00880217|Dopamine Agents|dopamine agents|mesh-ancestor
111058624|NCT00880217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111058625|NCT00880217|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111058626|NCT00880217|Adrenergic Agents|adrenergic agents|mesh-ancestor
111058628|NCT01657760|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111058629|NCT01657760|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111058630|NCT01657760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111058631|NCT01657760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111058632|NCT01657760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111058633|NCT01657760|Serotonin Agents|serotonin agents|mesh-ancestor
111058634|NCT01657760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111058635|NCT01657760|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111058636|NCT01657760|Antidepressive Agents|antidepressive agents|mesh-ancestor
111058637|NCT01657760|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111058638|NCT00966953|Honokiol|honokiol|mesh-list
111058639|NCT00966953|Triclosan|triclosan|mesh-list
111058640|NCT00966953|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111058641|NCT00966953|Fluorides|fluorides|mesh-list
111058642|NCT00966953|Cariostatic Agents|cariostatic agents|mesh-ancestor
111058643|NCT00966953|Protective Agents|protective agents|mesh-ancestor
111058644|NCT00966953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111058645|NCT00966953|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111058646|NCT00966953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111058647|NCT00966953|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
111058648|NCT00966953|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111058649|NCT00966953|Antimetabolites|antimetabolites|mesh-ancestor
111058650|NCT00966953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111058651|NCT00966953|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111058652|NCT00966953|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111058653|NCT00966953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111058654|NCT00966953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111058655|NCT00966953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111058656|NCT00966953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111058657|NCT00966953|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111058658|NCT00966953|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111058659|NCT00966953|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111058660|NCT00966953|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111058661|NCT00966953|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111058662|NCT05084079|Insulin|insulin|mesh-list
111058663|NCT05084079|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111058664|NCT05084079|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111058665|NCT05084079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111058666|NCT05084001|Listerine|listerine|mesh-list
111058667|NCT05084001|Fluorides|fluorides|mesh-list
111058668|NCT05084001|Sodium Fluoride|sodium fluoride|mesh-list
111058669|NCT05084001|Fluorides, Topical|fluorides, topical|mesh-list
111058670|NCT05084001|Cariostatic Agents|cariostatic agents|mesh-ancestor
111058671|NCT05084001|Protective Agents|protective agents|mesh-ancestor
111058672|NCT05084001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111058673|NCT05084001|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111058674|NCT05084001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111058675|NCT00875459|Insulin|insulin|mesh-list
111058676|NCT00875459|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110827831|NCT03868111|Anesthetics|anesthetics|mesh-ancestor
111058678|NCT00875459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111058679|NCT03837353|Docetaxel|docetaxel|mesh-list
111058680|NCT03837353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111058681|NCT03837353|Tubulin Modulators|tubulin modulators|mesh-ancestor
111058682|NCT03837353|Antimitotic Agents|antimitotic agents|mesh-ancestor
111058683|NCT03837353|Mitosis Modulators|mitosis modulators|mesh-ancestor
111058684|NCT03837353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111058685|NCT03140709|Oxytocin|oxytocin|mesh-list
111058686|NCT03140709|Oxytocics|oxytocics|mesh-ancestor
111058687|NCT03140709|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111058688|NCT03140709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111058689|NCT02283658|Everolimus|everolimus|mesh-list
111058690|NCT02283658|Letrozole|letrozole|mesh-list
111058691|NCT02283658|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111058692|NCT02283658|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111058693|NCT02283658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111058694|NCT02283658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111058695|NCT02283658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111058696|NCT02283658|Immunologic Factors|immunologic factors|mesh-ancestor
111058697|NCT02283658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111058698|NCT02283658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111058699|NCT02283658|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111058700|NCT02283658|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111058701|NCT02283658|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111058702|NCT02283658|Hormone Antagonists|hormone antagonists|mesh-ancestor
111058703|NCT02283658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111058704|NCT00872885|Morphine|morphine|mesh-list
111058705|NCT00872885|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111058706|NCT00872885|Narcotics|narcotics|mesh-ancestor
111058707|NCT00872885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111058708|NCT00872885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111058709|NCT00872885|Analgesics|analgesics|mesh-ancestor
111058710|NCT00872885|Sensory System Agents|sensory system agents|mesh-ancestor
111058711|NCT00872885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111058712|NCT00871481|Aldesleukin|aldesleukin|mesh-list
111058713|NCT00871481|Cyclophosphamide|cyclophosphamide|mesh-list
111058714|NCT00871481|Ipilimumab|ipilimumab|mesh-list
111058715|NCT00871481|Interleukin-2|interleukin-2|mesh-list
111058716|NCT00871481|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111058717|NCT00871481|Antibodies|antibodies|mesh-list
111058718|NCT00871481|Immunoglobulins|immunoglobulins|mesh-list
111058719|NCT00871481|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111058720|NCT00871481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111058721|NCT00871481|Immunologic Factors|immunologic factors|mesh-ancestor
111058722|NCT00871481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111058723|NCT00871481|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110631167|NCT00980109|Oseltamivir|oseltamivir|mesh-list
111058724|NCT00871481|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111058725|NCT00871481|Alkylating Agents|alkylating agents|mesh-ancestor
111058726|NCT00871481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111058727|NCT00871481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111058728|NCT00871481|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111058729|NCT00871481|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111058730|NCT00871481|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111058731|NCT00871481|Analgesics|analgesics|mesh-ancestor
111058732|NCT00871481|Sensory System Agents|sensory system agents|mesh-ancestor
110775801|NCT04177862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111058733|NCT00871481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111058734|NCT00871481|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111058735|NCT00871481|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111058736|NCT00871481|Antiviral Agents|antiviral agents|mesh-ancestor
111058737|NCT00871481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111058739|NCT05456165|Atezolizumab|atezolizumab|mesh-list
111058740|NCT05456165|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111058741|NCT05456165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111058742|NCT05456165|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111058743|NCT05456165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111058744|NCT05083689|Bevacizumab|bevacizumab|mesh-list
111058745|NCT05083689|Timolol|timolol|mesh-list
111058746|NCT05083689|Dorzolamide|dorzolamide|mesh-list
111058747|NCT05083689|Lubricant Eye Drops|lubricant eye drops|mesh-list
111058748|NCT05083689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111058749|NCT05083689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111058750|NCT05083689|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111058751|NCT05083689|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111058752|NCT05083689|Growth Substances|growth substances|mesh-ancestor
111058753|NCT05083689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111058754|NCT05083689|Growth Inhibitors|growth inhibitors|mesh-ancestor
111058755|NCT05083689|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111058756|NCT05083689|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111058757|NCT05083689|Adrenergic Agents|adrenergic agents|mesh-ancestor
111058758|NCT05083689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111058759|NCT05083689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111058760|NCT05083689|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111058761|NCT05083689|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111058762|NCT05083689|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
111058763|NCT05083689|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111058764|NCT05083689|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
111058765|NCT05083689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111058767|NCT05165966|Immunologic Factors|immunologic factors|mesh-ancestor
111058768|NCT05165966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111058769|NCT05165732|Vaccines|vaccines|mesh-list
111058770|NCT05165732|Immunologic Factors|immunologic factors|mesh-ancestor
111058771|NCT05165732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111058772|NCT04477083|Hydroxychloroquine|hydroxychloroquine|mesh-list
111058773|NCT04477083|Antimalarials|antimalarials|mesh-ancestor
111058774|NCT04477083|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111058775|NCT04477083|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111058776|NCT04477083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111058777|NCT04477083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111058778|NCT04477083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111058779|NCT04477083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111058780|NCT03138759|Probenecid|probenecid|mesh-list
111058781|NCT03138759|Uricosuric Agents|uricosuric agents|mesh-ancestor
111058782|NCT03138759|Gout Suppressants|gout suppressants|mesh-ancestor
111058783|NCT03138759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111058784|NCT03079921|Propranolol|propranolol|mesh-list
111058785|NCT03079921|Phentolamine|phentolamine|mesh-list
111058786|NCT03079921|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111058787|NCT03079921|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111058788|NCT03079921|Adrenergic Agents|adrenergic agents|mesh-ancestor
111058789|NCT03079921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111058790|NCT03079921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111058791|NCT03079921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111058792|NCT03079921|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111058793|NCT03079921|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111058794|NCT03079921|Vasodilator Agents|vasodilator agents|mesh-ancestor
111058795|NCT03079921|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111058796|NCT04473989|Teriparatide|teriparatide|mesh-list
111058797|NCT04473989|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111058798|NCT04473989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111058799|NCT04473989|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111058800|NCT05209490|Iodine|iodine|mesh-list
111058801|NCT05209490|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111058802|NCT05209490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111058803|NCT05209490|Trace Elements|trace elements|mesh-ancestor
111058804|NCT05209490|Micronutrients|micronutrients|mesh-ancestor
111058805|NCT05209490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111058806|NCT04473911|Mycophenolic Acid|mycophenolic acid|mesh-list
111058807|NCT04473911|Sirolimus|sirolimus|mesh-list
111058808|NCT04473911|Cyclophosphamide|cyclophosphamide|mesh-list
111058809|NCT04473911|Melphalan|melphalan|mesh-list
111058810|NCT04473911|Fludarabine|fludarabine|mesh-list
111058811|NCT04473911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111058812|NCT04473911|Immunologic Factors|immunologic factors|mesh-ancestor
111058813|NCT04473911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111058814|NCT04473911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111058815|NCT04473911|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111058816|NCT04473911|Alkylating Agents|alkylating agents|mesh-ancestor
111058817|NCT04473911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111058818|NCT04473911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111058819|NCT04473911|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111058820|NCT04473911|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111058821|NCT04473911|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111058822|NCT04473911|Antitubercular Agents|antitubercular agents|mesh-ancestor
111058823|NCT04473911|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111058824|NCT04473911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111058825|NCT04473911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111058826|NCT04473911|Antifungal Agents|antifungal agents|mesh-ancestor
111058828|NCT05162222|Diltiazem|diltiazem|mesh-list
111058829|NCT05162222|Antifungal Agents|antifungal agents|mesh-ancestor
111058830|NCT05162222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111058831|NCT05162222|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111058832|NCT05162222|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111058833|NCT05162222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111058834|NCT05162222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111058835|NCT05162222|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111058836|NCT05162222|Hormone Antagonists|hormone antagonists|mesh-ancestor
111058837|NCT05162222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111058838|NCT05162222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111058839|NCT05162222|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111058840|NCT05162222|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111058841|NCT05162222|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111058842|NCT05162222|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111058843|NCT05162222|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111058844|NCT05162222|Vasodilator Agents|vasodilator agents|mesh-ancestor
111058845|NCT05088057|Cyclophosphamide|cyclophosphamide|mesh-list
111058846|NCT05088057|Docetaxel|docetaxel|mesh-list
111058847|NCT05088057|Doxorubicin|doxorubicin|mesh-list
111058848|NCT05088057|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111058849|NCT05088057|Immunologic Factors|immunologic factors|mesh-ancestor
111058850|NCT05088057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111058851|NCT05088057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111058852|NCT05088057|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111058853|NCT05088057|Alkylating Agents|alkylating agents|mesh-ancestor
111058854|NCT05088057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111058855|NCT05088057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111058856|NCT05088057|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111058857|NCT05088057|Tubulin Modulators|tubulin modulators|mesh-ancestor
111058858|NCT05088057|Antimitotic Agents|antimitotic agents|mesh-ancestor
111058859|NCT05088057|Mitosis Modulators|mitosis modulators|mesh-ancestor
111058860|NCT05088057|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111058861|NCT05088057|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111058862|NCT05088057|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111058863|NCT05088057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111058864|NCT03132025|Capecitabine|capecitabine|mesh-list
111058865|NCT03132025|Apatinib|apatinib|mesh-list
111058866|NCT03132025|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111058867|NCT03132025|Antimetabolites|antimetabolites|mesh-ancestor
111058868|NCT03132025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111058869|NCT03132025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111058870|NCT03132025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111058871|NCT03132025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111058872|NCT00857285|Losartan|losartan|mesh-list
111058873|NCT00857285|Olmesartan|olmesartan|mesh-list
111058874|NCT00857285|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
111058875|NCT00857285|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111058876|NCT00857285|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111058877|NCT00857285|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111058878|NCT00857285|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111058879|NCT00857285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111058880|NCT04461379|Vaccines|vaccines|mesh-list
111058881|NCT04461379|BCG Vaccine|bcg vaccine|mesh-list
111058882|NCT04461379|Immunologic Factors|immunologic factors|mesh-ancestor
111058883|NCT04461379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111058884|NCT04461379|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111058885|NCT00854945|ON 01910|on 01910|mesh-list
111058886|NCT00854945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111058887|NCT00854945|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111058888|NCT00854945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111058889|NCT00854945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111058890|NCT04876534|Methylprednisolone|methylprednisolone|mesh-list
111058891|NCT04876534|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110631343|NCT00788606|Immunologic Factors|immunologic factors|mesh-ancestor
111058892|NCT04876534|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111058893|NCT04876534|Prednisolone|prednisolone|mesh-list
111058894|NCT04876534|Prednisolone acetate|prednisolone acetate|mesh-list
111058895|NCT04876534|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111058896|NCT04876534|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111058898|NCT04876534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111058899|NCT04876534|Antiemetics|antiemetics|mesh-ancestor
111058900|NCT04876534|Autonomic Agents|autonomic agents|mesh-ancestor
111058901|NCT04876534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111058902|NCT04876534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111058903|NCT04876534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111058904|NCT04876534|Glucocorticoids|glucocorticoids|mesh-ancestor
111058905|NCT04876534|Hormones|hormones|mesh-ancestor
111058906|NCT04876534|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111058907|NCT04876534|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111058908|NCT04876534|Protective Agents|protective agents|mesh-ancestor
111058909|NCT04876534|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111058910|NCT04876534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111058911|NCT02443831|Cyclophosphamide|cyclophosphamide|mesh-list
111058912|NCT02443831|Fludarabine|fludarabine|mesh-list
111058913|NCT02443831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111058914|NCT02443831|Immunologic Factors|immunologic factors|mesh-ancestor
111058915|NCT02443831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111058916|NCT02443831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111058917|NCT02443831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111058918|NCT02443831|Alkylating Agents|alkylating agents|mesh-ancestor
111058919|NCT02443831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111058920|NCT02443831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111058921|NCT02443831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111058922|NCT00851045|Leucovorin|leucovorin|mesh-list
111058923|NCT00851045|Bevacizumab|bevacizumab|mesh-list
111058924|NCT00851045|Fluorouracil|fluorouracil|mesh-list
111058925|NCT00851045|Irinotecan|irinotecan|mesh-list
111058926|NCT00851045|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111058927|NCT00851045|Calcium|calcium|mesh-list
111058928|NCT00851045|Levoleucovorin|levoleucovorin|mesh-list
111058929|NCT00851045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111058930|NCT00851045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111058931|NCT00851045|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111058932|NCT00851045|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111058933|NCT00851045|Growth Substances|growth substances|mesh-ancestor
111058934|NCT00851045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111058935|NCT00851045|Growth Inhibitors|growth inhibitors|mesh-ancestor
111058936|NCT00851045|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111058937|NCT00851045|Antimetabolites|antimetabolites|mesh-ancestor
111058938|NCT00851045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111058939|NCT00851045|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111058940|NCT00851045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111058941|NCT00851045|Immunologic Factors|immunologic factors|mesh-ancestor
111058942|NCT00851045|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111058943|NCT00851045|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111058944|NCT00851045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111058945|NCT00851045|Antidotes|antidotes|mesh-ancestor
111058946|NCT00851045|Protective Agents|protective agents|mesh-ancestor
111058947|NCT00851045|Vitamin B Complex|vitamin b complex|mesh-ancestor
111058948|NCT00851045|Vitamins|vitamins|mesh-ancestor
111058949|NCT00851045|Micronutrients|micronutrients|mesh-ancestor
111058950|NCT00850577|Paclitaxel|paclitaxel|mesh-list
111058951|NCT00850577|Bevacizumab|bevacizumab|mesh-list
111058952|NCT00850577|Carboplatin|carboplatin|mesh-list
111058953|NCT00850577|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111058954|NCT00850577|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111058955|NCT00850577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111058956|NCT00850577|Tubulin Modulators|tubulin modulators|mesh-ancestor
111058957|NCT00850577|Antimitotic Agents|antimitotic agents|mesh-ancestor
111058958|NCT00850577|Mitosis Modulators|mitosis modulators|mesh-ancestor
111058959|NCT00850577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111058960|NCT00850577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110776027|NCT03743870|Anesthetics|anesthetics|mesh-ancestor
111058961|NCT00850577|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111058962|NCT00850577|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111058963|NCT00850577|Growth Substances|growth substances|mesh-ancestor
111058964|NCT00850577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111058965|NCT00850577|Growth Inhibitors|growth inhibitors|mesh-ancestor
111058966|NCT00838981|Methadone|methadone|mesh-list
111058967|NCT00838981|Modafinil|modafinil|mesh-list
111058968|NCT00838981|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110631425|NCT00796250|Hormones|hormones|mesh-ancestor
111058969|NCT00838981|Narcotics|narcotics|mesh-ancestor
110524114|NCT01241708|Bortezomib|bortezomib|mesh-list
111058970|NCT00838981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111058971|NCT00838981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111058972|NCT00838981|Analgesics|analgesics|mesh-ancestor
111058973|NCT00838981|Sensory System Agents|sensory system agents|mesh-ancestor
111058974|NCT00838981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111058975|NCT00838981|Antitussive Agents|antitussive agents|mesh-ancestor
111058976|NCT00838981|Respiratory System Agents|respiratory system agents|mesh-ancestor
111058977|NCT00838981|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111058978|NCT00838981|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
111058979|NCT00838981|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111058980|NCT00838981|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111058981|NCT00838981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111058982|NCT00849797|Oxcarbazepine|oxcarbazepine|mesh-list
111058983|NCT00849797|Anticonvulsants|anticonvulsants|mesh-ancestor
111058984|NCT00849797|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111058985|NCT00849797|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111058986|NCT00849797|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111058987|NCT00849797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111058988|NCT00849797|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111058989|NCT00849797|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111058990|NCT05082441|Bupivacaine|bupivacaine|mesh-list
111058991|NCT05082441|Anesthetics, Local|anesthetics, local|mesh-ancestor
111058992|NCT05082441|Anesthetics|anesthetics|mesh-ancestor
111058993|NCT05082441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111058994|NCT05082441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111058995|NCT05082441|Sensory System Agents|sensory system agents|mesh-ancestor
111058996|NCT05082441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111058997|NCT00950885|Melatonin|melatonin|mesh-list
111058998|NCT00950885|Antioxidants|antioxidants|mesh-ancestor
111058999|NCT00950885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111059000|NCT00950885|Protective Agents|protective agents|mesh-ancestor
111059001|NCT00950885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111059002|NCT00950885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111059003|NCT00849485|Levetiracetam|levetiracetam|mesh-list
111059004|NCT00849485|Anticonvulsants|anticonvulsants|mesh-ancestor
111059005|NCT00849485|Nootropic Agents|nootropic agents|mesh-ancestor
111059006|NCT03140397|8-prenylnaringenin|8-prenylnaringenin|mesh-list
111059007|NCT03140397|Phytoestrogens|phytoestrogens|mesh-ancestor
111059008|NCT03140397|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
111059009|NCT03140397|Estrogens|estrogens|mesh-ancestor
111059010|NCT03140397|Hormones|hormones|mesh-ancestor
111059011|NCT03140397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111059012|NCT03140397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111059013|NCT05047445|Vaccines|vaccines|mesh-list
111059014|NCT05047445|Immunologic Factors|immunologic factors|mesh-ancestor
111059015|NCT05047445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111059016|NCT05235542|Paclitaxel|paclitaxel|mesh-list
111059017|NCT05235542|Docetaxel|docetaxel|mesh-list
111059018|NCT05235542|Capecitabine|capecitabine|mesh-list
111059019|NCT05235542|Oxaliplatin|oxaliplatin|mesh-list
111059020|NCT05235542|Irinotecan|irinotecan|mesh-list
111059021|NCT05235542|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111059022|NCT05235542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111059023|NCT05235542|Tubulin Modulators|tubulin modulators|mesh-ancestor
111059024|NCT05235542|Antimitotic Agents|antimitotic agents|mesh-ancestor
111059025|NCT05235542|Mitosis Modulators|mitosis modulators|mesh-ancestor
111059026|NCT05235542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111059027|NCT05235542|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111059028|NCT05235542|Antimetabolites|antimetabolites|mesh-ancestor
111059029|NCT05235542|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111059030|NCT05235542|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111059031|NCT05235542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111059032|NCT00840281|Cefprozil|cefprozil|mesh-list
111059033|NCT00840281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111059034|NCT00840281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111059035|NCT00840203|Mesalamine|mesalamine|mesh-list
111059036|NCT00840203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111059037|NCT00840203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111059038|NCT00840203|Analgesics|analgesics|mesh-ancestor
111059039|NCT00840203|Sensory System Agents|sensory system agents|mesh-ancestor
111059040|NCT00840203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111059041|NCT00840203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111059042|NCT00840203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111059043|NCT00840203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111059045|NCT00838799|Analgesics|analgesics|mesh-ancestor
111059046|NCT00838799|Sensory System Agents|sensory system agents|mesh-ancestor
111059047|NCT00838799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111059048|NCT00838799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111059049|NCT00838799|Anticonvulsants|anticonvulsants|mesh-ancestor
111059050|NCT00838799|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111059051|NCT00838799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111059052|NCT00838799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111059053|NCT00838799|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111059054|NCT00838799|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111059055|NCT00838799|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111059056|NCT00838799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111059057|NCT00838799|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111059058|NCT05025735|Dapagliflozin|dapagliflozin|mesh-list
111059059|NCT05025735|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111059060|NCT05025735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111059061|NCT05025735|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111059062|NCT05025735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111059063|NCT00836069|Paroxetine|paroxetine|mesh-list
111059064|NCT00836069|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111059065|NCT00836069|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111059066|NCT00836069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111059067|NCT00836069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111059068|NCT00836069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111059069|NCT00836069|Serotonin Agents|serotonin agents|mesh-ancestor
111059070|NCT00836069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111059071|NCT00836069|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111059072|NCT00836069|Antidepressive Agents|antidepressive agents|mesh-ancestor
111059073|NCT00836069|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111059074|NCT00836069|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111059075|NCT00836069|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111059076|NCT00836069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111059077|NCT03134729|Ropivacaine|ropivacaine|mesh-list
111059078|NCT03134729|Anesthetics, Local|anesthetics, local|mesh-ancestor
111059079|NCT03134729|Anesthetics|anesthetics|mesh-ancestor
111059080|NCT03134729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111059081|NCT03134729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111059082|NCT03134729|Sensory System Agents|sensory system agents|mesh-ancestor
111059083|NCT03134729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111059084|NCT03134651|Propofol|propofol|mesh-list
111059085|NCT03134651|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111059086|NCT03134651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111059087|NCT03134651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111059088|NCT03134651|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111059089|NCT03134651|Anesthetics, General|anesthetics, general|mesh-ancestor
111059090|NCT03134651|Anesthetics|anesthetics|mesh-ancestor
111059091|NCT05202860|Vaccines|vaccines|mesh-list
111059092|NCT05202860|Immunologic Factors|immunologic factors|mesh-ancestor
111059093|NCT05202860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111059094|NCT05202782|Zanubrutinib|zanubrutinib|mesh-list
111059095|NCT05202782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111059096|NCT05202782|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111059097|NCT05202782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111059098|NCT05202782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111059099|NCT05202080|Analgesics, Opioid|analgesics, opioid|mesh-list
111059100|NCT05202080|Narcotics|narcotics|mesh-ancestor
111059101|NCT05202080|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111059102|NCT05202080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111059103|NCT05202080|Analgesics|analgesics|mesh-ancestor
111059104|NCT05202080|Sensory System Agents|sensory system agents|mesh-ancestor
110631519|NCT00864864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111059105|NCT05202080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111059106|NCT00935987|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
111059107|NCT00935987|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111059108|NCT00935987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111059109|NCT00935987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111059110|NCT05155124|Cetuximab|cetuximab|mesh-list
111059111|NCT05155124|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111059112|NCT05155124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111059113|NCT00927641|Ketoprofen|ketoprofen|mesh-list
111059114|NCT00927641|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111059115|NCT00927641|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111059117|NCT00927641|Sensory System Agents|sensory system agents|mesh-ancestor
111059118|NCT00927641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111059119|NCT00927641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111059120|NCT00927641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111059121|NCT00927641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111059122|NCT00927641|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111059123|NCT00927641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111059124|NCT00927641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111059125|NCT05200364|Bevacizumab|bevacizumab|mesh-list
111059126|NCT05200364|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111059127|NCT05200364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111059128|NCT05200364|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111059129|NCT05200364|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111059130|NCT05200364|Growth Substances|growth substances|mesh-ancestor
111059131|NCT05200364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111059132|NCT05200364|Growth Inhibitors|growth inhibitors|mesh-ancestor
111059133|NCT00835991|Metformin|metformin|mesh-list
111059134|NCT00835991|Glyburide|glyburide|mesh-list
111059135|NCT00835991|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111059136|NCT00835991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111059137|NCT05200052|Colchicine|colchicine|mesh-list
111059138|NCT05200052|Gout Suppressants|gout suppressants|mesh-ancestor
111059139|NCT05200052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111059140|NCT05200052|Tubulin Modulators|tubulin modulators|mesh-ancestor
111059141|NCT05200052|Antimitotic Agents|antimitotic agents|mesh-ancestor
111059142|NCT05200052|Mitosis Modulators|mitosis modulators|mesh-ancestor
111059143|NCT05200052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111059144|NCT05200052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111059145|NCT00925535|Rifabutin|rifabutin|mesh-list
111059146|NCT00925535|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111059147|NCT00925535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111059148|NCT00925535|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111059149|NCT00925535|Antitubercular Agents|antitubercular agents|mesh-ancestor
111059150|NCT02276872|Treprostinil|treprostinil|mesh-list
111059151|NCT02276872|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111059152|NCT00835367|Amlodipine|amlodipine|mesh-list
111059153|NCT00835367|Benazepril|benazepril|mesh-list
111059154|NCT00835367|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111059155|NCT00835367|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111059156|NCT00835367|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111059157|NCT00835367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111059158|NCT00835367|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111059159|NCT00835367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111059160|NCT00835367|Vasodilator Agents|vasodilator agents|mesh-ancestor
111059161|NCT00835367|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
111059162|NCT00835367|Protease Inhibitors|protease inhibitors|mesh-ancestor
111059163|NCT00835367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111059164|NCT02276560|Paclitaxel|paclitaxel|mesh-list
111059165|NCT02276560|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111059166|NCT02276560|Cisplatin|cisplatin|mesh-list
111059167|NCT02276560|Gemcitabine|gemcitabine|mesh-list
111059168|NCT02276560|Pemetrexed|pemetrexed|mesh-list
111059169|NCT02276560|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111059170|NCT02276560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111059171|NCT02276560|Tubulin Modulators|tubulin modulators|mesh-ancestor
111059172|NCT02276560|Antimitotic Agents|antimitotic agents|mesh-ancestor
111059173|NCT02276560|Mitosis Modulators|mitosis modulators|mesh-ancestor
111059174|NCT02276560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111059175|NCT02276560|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111059176|NCT02276560|Antimetabolites|antimetabolites|mesh-ancestor
111059177|NCT02276560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111059178|NCT02276560|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111059179|NCT02276560|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111059180|NCT02276482|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111059181|NCT02276482|Metronidazole|metronidazole|mesh-list
111059182|NCT02276482|Vancomycin|vancomycin|mesh-list
111059183|NCT02276482|Clindamycin|clindamycin|mesh-list
111059184|NCT02276482|Cefazolin|cefazolin|mesh-list
111059185|NCT02276482|Linezolid|linezolid|mesh-list
111059186|NCT02276482|Cephalexin|cephalexin|mesh-list
111059187|NCT02276482|Aztreonam|aztreonam|mesh-list
111059188|NCT02276482|Tedizolid|tedizolid|mesh-list
111059189|NCT02276482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111059190|NCT02276482|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111059191|NCT02276482|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111059192|NCT02276482|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111059193|NCT02276482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111059194|NCT02276482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111059196|NCT00924833|Nebivolol|nebivolol|mesh-list
111059197|NCT00924833|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111059198|NCT00924833|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111059199|NCT00924833|Adrenergic Agents|adrenergic agents|mesh-ancestor
111059200|NCT00924833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111059201|NCT00924833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111059202|NCT00924833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111059203|NCT00924833|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111059204|NCT00924833|Antioxidants|antioxidants|mesh-ancestor
111059205|NCT00924833|Protective Agents|protective agents|mesh-ancestor
111059206|NCT00924833|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111059207|NCT00924833|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111059208|NCT00924833|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111059209|NCT00924833|Vasodilator Agents|vasodilator agents|mesh-ancestor
111059210|NCT00924833|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111059211|NCT00924833|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111059212|NCT00924833|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
111059213|NCT00924833|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111059214|NCT00924833|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111059215|NCT00835211|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
111059216|NCT00835211|Hemostatics|hemostatics|mesh-ancestor
111059217|NCT00835211|Coagulants|coagulants|mesh-ancestor
111059218|NCT00835211|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
111059219|NCT00835211|Natriuretic Agents|natriuretic agents|mesh-ancestor
111059220|NCT00835211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111059221|NCT00834977|Amlodipine|amlodipine|mesh-list
111059222|NCT00834977|Benazepril|benazepril|mesh-list
111059223|NCT00834977|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111059224|NCT00834977|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111059225|NCT00834977|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111059226|NCT00834977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111059227|NCT00834977|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111059228|NCT00834977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111059229|NCT00834977|Vasodilator Agents|vasodilator agents|mesh-ancestor
111059230|NCT00834977|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
111059231|NCT00834977|Protease Inhibitors|protease inhibitors|mesh-ancestor
111059232|NCT00834977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111059233|NCT05227664|Paclitaxel|paclitaxel|mesh-list
111059234|NCT05227664|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111059235|NCT05227664|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111059236|NCT05227664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111059237|NCT05227664|Tubulin Modulators|tubulin modulators|mesh-ancestor
111059238|NCT05227664|Antimitotic Agents|antimitotic agents|mesh-ancestor
111059239|NCT05227664|Mitosis Modulators|mitosis modulators|mesh-ancestor
111059240|NCT05227664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111059241|NCT00834743|Metformin|metformin|mesh-list
111059242|NCT00834743|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111059243|NCT00834743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111059244|NCT00834587|Metformin|metformin|mesh-list
111059245|NCT00834587|Glipizide|glipizide|mesh-list
111059246|NCT00834587|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111059247|NCT00834587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111059248|NCT00834431|Famciclovir|famciclovir|mesh-list
111059249|NCT00834431|Antiviral Agents|antiviral agents|mesh-ancestor
111059250|NCT00834431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111059251|NCT00834431|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111059252|NCT00834431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111059253|NCT00834431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111059254|NCT04875767|Coal Tar|coal tar|mesh-list
111059255|NCT04875767|Keratolytic Agents|keratolytic agents|mesh-ancestor
111059256|NCT04875767|Dermatologic Agents|dermatologic agents|mesh-ancestor
111059257|NCT05191940|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
111059258|NCT05191940|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111059259|NCT05191940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111059260|NCT00834275|Cefadroxil|cefadroxil|mesh-list
110776327|NCT04400682|Favipiravir|favipiravir|mesh-list
111059261|NCT00834275|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111059262|NCT00834275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110524415|NCT02787746|Donepezil|donepezil|mesh-list
111059264|NCT05191472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111059265|NCT05191472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111059266|NCT05191472|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111059267|NCT05191472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111059268|NCT00834197|Mirtazapine|mirtazapine|mesh-list
111059269|NCT00834197|Antidepressive Agents|antidepressive agents|mesh-ancestor
111059270|NCT00834197|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111059271|NCT00834197|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111059272|NCT00834197|Histamine Antagonists|histamine antagonists|mesh-ancestor
111059273|NCT00834197|Histamine Agents|histamine agents|mesh-ancestor
111059274|NCT00834197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111059275|NCT00834197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111059276|NCT00834197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111059277|NCT00834197|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111059278|NCT00834197|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111059279|NCT00834197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111059280|NCT00834197|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
111059281|NCT00834197|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111059282|NCT00834197|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111059283|NCT00834197|Adrenergic Agents|adrenergic agents|mesh-ancestor
111059284|NCT00834197|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111059285|NCT00834197|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111059286|NCT00834197|Serotonin Agents|serotonin agents|mesh-ancestor
111059287|NCT00834197|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111059288|NCT00833495|Prednisolone|prednisolone|mesh-list
111059289|NCT00833495|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111059290|NCT00833495|Methylprednisolone|methylprednisolone|mesh-list
111059291|NCT00833495|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111059292|NCT00833495|Prednisolone acetate|prednisolone acetate|mesh-list
111059293|NCT00833495|Prednisone|prednisone|mesh-list
111059294|NCT00833495|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111059295|NCT00833495|Prednisolone phosphate|prednisolone phosphate|mesh-list
111059296|NCT00833495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111059297|NCT00833495|Glucocorticoids|glucocorticoids|mesh-ancestor
111059298|NCT00833495|Hormones|hormones|mesh-ancestor
111059299|NCT00833495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111059300|NCT00833495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111059301|NCT00833495|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111059302|NCT00833495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111059303|NCT00833495|Antiemetics|antiemetics|mesh-ancestor
111059304|NCT00833495|Autonomic Agents|autonomic agents|mesh-ancestor
111059305|NCT00833495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111059306|NCT00833495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111059307|NCT00833495|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111059308|NCT00833495|Protective Agents|protective agents|mesh-ancestor
111059309|NCT00830219|Ropinirole|ropinirole|mesh-list
111059310|NCT00830219|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111059311|NCT00830219|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111059312|NCT00830219|Dopamine Agonists|dopamine agonists|mesh-ancestor
110631677|NCT00869310|Aprepitant|aprepitant|mesh-list
111059313|NCT00830219|Dopamine Agents|dopamine agents|mesh-ancestor
111059314|NCT00830219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111059315|NCT00830219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111059316|NCT00830219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111059317|NCT02274766|Amantadine|amantadine|mesh-list
111059318|NCT02274766|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111059319|NCT02274766|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111059320|NCT02274766|Antiviral Agents|antiviral agents|mesh-ancestor
111059321|NCT02274766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111059322|NCT02274766|Dopamine Agents|dopamine agents|mesh-ancestor
111059323|NCT02274766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111059324|NCT02274766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111059325|NCT02274766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111059326|NCT02274766|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111059327|NCT02274766|Analgesics|analgesics|mesh-ancestor
111059328|NCT02274766|Sensory System Agents|sensory system agents|mesh-ancestor
111059329|NCT02274766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111059330|NCT04757363|Oxaliplatin|oxaliplatin|mesh-list
111059331|NCT04757363|Nivolumab|nivolumab|mesh-list
110776402|NCT03647488|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110776403|NCT03693950|Darbepoetin alfa|darbepoetin alfa|mesh-list
110776404|NCT03693950|Hematinics|hematinics|mesh-ancestor
110776446|NCT03447262|VX-659|vx-659|mesh-list
111059332|NCT04757363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111059333|NCT04757363|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111059334|NCT04757363|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111059335|NCT04757363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111059336|NCT00829673|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
111059337|NCT00829673|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111059338|NCT00829673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111059339|NCT00829673|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111059340|NCT00829673|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111059341|NCT00829673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111059342|NCT00829673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111059343|NCT00829673|Dopamine Agents|dopamine agents|mesh-ancestor
111059344|NCT00829673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111059346|NCT05221658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111059347|NCT05132114|Lugol's solution|lugol's solution|mesh-list
111059348|NCT05132114|Hemostatics|hemostatics|mesh-ancestor
111059349|NCT05132114|Coagulants|coagulants|mesh-ancestor
111059350|NCT02370238|Paclitaxel|paclitaxel|mesh-list
111059351|NCT02370238|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111059352|NCT02370238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111059353|NCT02370238|Tubulin Modulators|tubulin modulators|mesh-ancestor
111059354|NCT02370238|Antimitotic Agents|antimitotic agents|mesh-ancestor
111059355|NCT02370238|Mitosis Modulators|mitosis modulators|mesh-ancestor
111059356|NCT02370238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111059357|NCT05109104|Sunscreening Agents|sunscreening agents|mesh-list
111059358|NCT05109104|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111059359|NCT05109104|Protective Agents|protective agents|mesh-ancestor
111059360|NCT05109104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111059361|NCT05109104|Dermatologic Agents|dermatologic agents|mesh-ancestor
111059362|NCT05126342|Niraparib|niraparib|mesh-list
111059363|NCT05126342|Dostarlimab|dostarlimab|mesh-list
111059364|NCT05126342|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111059365|NCT05126342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111059366|NCT05126342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111059367|NCT05126342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111059368|NCT05126108|Parathyroid Hormone|parathyroid hormone|mesh-list
111059369|NCT05126108|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111059370|NCT05126108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111059371|NCT05473910|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
111059372|NCT05473910|Antioxidants|antioxidants|mesh-ancestor
111059373|NCT05473910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111059374|NCT05473910|Protective Agents|protective agents|mesh-ancestor
111059375|NCT05473910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111059376|NCT05473910|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
111059377|NCT05473910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111059378|NCT05180708|Sirolimus|sirolimus|mesh-list
111059379|NCT05180708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111059380|NCT05180708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111059381|NCT05180708|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111059382|NCT05180708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111059383|NCT05180708|Antifungal Agents|antifungal agents|mesh-ancestor
111059384|NCT05180708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111059385|NCT05180708|Immunologic Factors|immunologic factors|mesh-ancestor
111059386|NCT05180708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111059387|NCT02273752|Everolimus|everolimus|mesh-list
111059388|NCT02273752|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111059389|NCT02273752|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111059390|NCT02273752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111059391|NCT02273752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111059392|NCT02273752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111059393|NCT02273752|Immunologic Factors|immunologic factors|mesh-ancestor
111059394|NCT02273752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111059395|NCT02273752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111059396|NCT05102552|Huperzine A|huperzine a|mesh-list
111059397|NCT05102552|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111059398|NCT05102552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111059399|NCT05102552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111059400|NCT05102552|Cholinergic Agents|cholinergic agents|mesh-ancestor
111059401|NCT05102552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110631787|NCT00739973|Vasodilator Agents|vasodilator agents|mesh-ancestor
111059402|NCT05102552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111059403|NCT05102552|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111059404|NCT05102552|Protective Agents|protective agents|mesh-ancestor
111059406|NCT05096390|Axitinib|axitinib|mesh-list
111059407|NCT05096390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111059408|NCT05096390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111059409|NCT05096390|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111059410|NCT05096390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111059411|NCT05096390|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111059412|NCT05096390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111059414|NCT02273050|Saxagliptin|saxagliptin|mesh-list
111059415|NCT02273050|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111059416|NCT02273050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111059417|NCT02273050|Incretins|incretins|mesh-ancestor
111059418|NCT02273050|Hormones|hormones|mesh-ancestor
111059419|NCT02273050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111059420|NCT02273050|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111059421|NCT02273050|Protease Inhibitors|protease inhibitors|mesh-ancestor
111059422|NCT02273050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111059423|NCT02273050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111059424|NCT02272816|Carboplatin|carboplatin|mesh-list
111059425|NCT02272816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111059426|NCT05170256|Trastuzumab|trastuzumab|mesh-list
111059427|NCT05170256|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111059428|NCT05170256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111059429|NCT05386979|Analgesics, Opioid|analgesics, opioid|mesh-list
111059430|NCT05386979|Anesthetics|anesthetics|mesh-list
111059431|NCT05386979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111059432|NCT05386979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111059433|NCT05386979|Narcotics|narcotics|mesh-ancestor
111059434|NCT05386979|Analgesics|analgesics|mesh-ancestor
111059435|NCT05386979|Sensory System Agents|sensory system agents|mesh-ancestor
111059436|NCT05386979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111059437|NCT02367352|Paclitaxel|paclitaxel|mesh-list
111059438|NCT02367352|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111059439|NCT02367352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111059440|NCT02367352|Tubulin Modulators|tubulin modulators|mesh-ancestor
111059441|NCT02367352|Antimitotic Agents|antimitotic agents|mesh-ancestor
111059442|NCT02367352|Mitosis Modulators|mitosis modulators|mesh-ancestor
111059443|NCT02367352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111059444|NCT02270944|Vaccines|vaccines|mesh-list
111059445|NCT02270944|Immunologic Factors|immunologic factors|mesh-ancestor
111059446|NCT02270944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111059447|NCT05648734|Pirfenidone|pirfenidone|mesh-list
111059448|NCT05648734|Colchicine|colchicine|mesh-list
111059449|NCT05648734|Gout Suppressants|gout suppressants|mesh-ancestor
111059450|NCT05648734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111059451|NCT05648734|Tubulin Modulators|tubulin modulators|mesh-ancestor
111059452|NCT05648734|Antimitotic Agents|antimitotic agents|mesh-ancestor
111059453|NCT05648734|Mitosis Modulators|mitosis modulators|mesh-ancestor
111059454|NCT05648734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111059455|NCT05648734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111059456|NCT05648734|Analgesics|analgesics|mesh-ancestor
111059457|NCT05648734|Sensory System Agents|sensory system agents|mesh-ancestor
111059458|NCT05648734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111059459|NCT05648734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111059460|NCT05648734|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111059461|NCT05648734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111059462|NCT05648734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111059463|NCT02365558|Omeprazole|omeprazole|mesh-list
111059464|NCT02365558|Evacetrapib|evacetrapib|mesh-list
111059465|NCT02365558|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111059466|NCT02365558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111059467|NCT02365558|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111059468|NCT02365558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111059469|NCT02365558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111059470|NCT02365558|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111059471|NCT02365558|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111059472|NCT02365558|Antimetabolites|antimetabolites|mesh-ancestor
111059473|NCT02365558|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111059474|NCT05050214|Obinutuzumab|obinutuzumab|mesh-list
111059475|NCT05050214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111059476|NCT05050214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111059477|NCT02270242|Aspirin|aspirin|mesh-list
111059478|NCT02270242|Ticagrelor|ticagrelor|mesh-list
111059479|NCT02270242|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110776555|NCT00826462|Naproxen|naproxen|mesh-list
111059480|NCT02270242|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111059481|NCT02270242|Analgesics|analgesics|mesh-ancestor
111059482|NCT02270242|Sensory System Agents|sensory system agents|mesh-ancestor
111059483|NCT02270242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111059484|NCT02270242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111059485|NCT02270242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111059486|NCT02270242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111059487|NCT02270242|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111059488|NCT02270242|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111059489|NCT02270242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111059490|NCT02270242|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111059491|NCT02270242|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111059492|NCT02270242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111059493|NCT02270242|Antipyretics|antipyretics|mesh-ancestor
111059494|NCT02270242|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111059495|NCT02270242|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111059496|NCT02270242|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111059497|NCT02270242|Purinergic Agents|purinergic agents|mesh-ancestor
111059498|NCT02270242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111059499|NCT04869124|Dapagliflozin|dapagliflozin|mesh-list
111059500|NCT04869124|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111059501|NCT04869124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111059502|NCT04869124|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111059503|NCT04869124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111059504|NCT05648266|Analgesics|analgesics|mesh-list
111059505|NCT05648266|Sensory System Agents|sensory system agents|mesh-ancestor
111059506|NCT05648266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111059507|NCT05648266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111059508|NCT05047094|Pembrolizumab|pembrolizumab|mesh-list
111059509|NCT05047094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111059510|NCT05047094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111059511|NCT05047094|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111059512|NCT05047094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111059513|NCT04993352|Antibodies|antibodies|mesh-list
111059514|NCT04993352|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111059515|NCT04993352|Mitogens|mitogens|mesh-list
111059516|NCT04993352|Endothelial Growth Factors|endothelial growth factors|mesh-list
111059517|NCT04993352|Immunologic Factors|immunologic factors|mesh-ancestor
111059518|NCT04993352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111059519|NCT04993352|Mitosis Modulators|mitosis modulators|mesh-ancestor
111059520|NCT04993352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111059521|NCT04993352|Growth Substances|growth substances|mesh-ancestor
111059522|NCT04992026|Prednisone|prednisone|mesh-list
111059523|NCT04992026|Abiraterone Acetate|abiraterone acetate|mesh-list
111059524|NCT04992026|Hormones|hormones|mesh-list
111059525|NCT04992026|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
111059526|NCT04992026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111059527|NCT04992026|Glucocorticoids|glucocorticoids|mesh-ancestor
111059528|NCT04992026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111059529|NCT04992026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111059530|NCT04992026|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111059531|NCT04992026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111059532|NCT04992026|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111059533|NCT04992026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111059534|NCT04992026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111059535|NCT04992026|Hormone Antagonists|hormone antagonists|mesh-ancestor
111059536|NCT04992026|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111059537|NCT05042102|Donepezil|donepezil|mesh-list
111059538|NCT05042102|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111059539|NCT05042102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111059540|NCT05042102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111059541|NCT05042102|Cholinergic Agents|cholinergic agents|mesh-ancestor
111059542|NCT05042102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111059543|NCT05042102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111059544|NCT05042102|Nootropic Agents|nootropic agents|mesh-ancestor
111059545|NCT05074940|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
111059546|NCT05074940|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111059547|NCT05074940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111059548|NCT05036798|Lenvatinib|lenvatinib|mesh-list
111059549|NCT05036798|Tislelizumab|tislelizumab|mesh-list
111059550|NCT05036798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111059551|NCT05036798|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110776633|NCT05081206|Anesthetics|anesthetics|mesh-ancestor
111059552|NCT05036798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111059553|NCT05036798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111059554|NCT05036798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111059555|NCT04209218|Dexamethasone|dexamethasone|mesh-list
111059556|NCT04209218|Glucocorticoids|glucocorticoids|mesh-list
111059557|NCT04209218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111059558|NCT04209218|Antiemetics|antiemetics|mesh-ancestor
111059559|NCT04209218|Autonomic Agents|autonomic agents|mesh-ancestor
111059560|NCT04209218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111059561|NCT04209218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111059562|NCT04209218|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111059563|NCT04209218|Hormones|hormones|mesh-ancestor
111059564|NCT04209218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111059565|NCT04209218|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111059566|NCT04209218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111059567|NCT04218968|Carvedilol|carvedilol|mesh-list
111059568|NCT04218968|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111059569|NCT04218968|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111059570|NCT04218968|Adrenergic Agents|adrenergic agents|mesh-ancestor
111059571|NCT04218968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111059572|NCT04218968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111059573|NCT04218968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111059574|NCT04218968|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111059575|NCT04218968|Antioxidants|antioxidants|mesh-ancestor
111059576|NCT04218968|Protective Agents|protective agents|mesh-ancestor
111059577|NCT04218968|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111059578|NCT04218968|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111059579|NCT04218968|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111059580|NCT04218968|Vasodilator Agents|vasodilator agents|mesh-ancestor
111059581|NCT04218968|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111059582|NCT04218968|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111059583|NCT02268214|Dapagliflozin|dapagliflozin|mesh-list
111059584|NCT02268214|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111059585|NCT02268214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111059586|NCT02268214|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111059587|NCT02268214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111059588|NCT04421300|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111059589|NCT04421300|Hyaluronic Acid|hyaluronic acid|mesh-list
111059590|NCT04421300|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111059591|NCT04421300|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111059592|NCT04421300|Immunologic Factors|immunologic factors|mesh-ancestor
111059593|NCT04421300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111059594|NCT04421300|Viscosupplements|viscosupplements|mesh-ancestor
111059595|NCT04421300|Protective Agents|protective agents|mesh-ancestor
111059596|NCT05026736|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111059597|NCT05026736|Antibodies|antibodies|mesh-list
111059598|NCT05026736|Immunoglobulins|immunoglobulins|mesh-list
111059599|NCT05026736|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111059600|NCT05026736|Immunologic Factors|immunologic factors|mesh-ancestor
111059601|NCT05026736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111059602|NCT05026736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111059603|NCT02268058|Acetaminophen|acetaminophen|mesh-list
111059604|NCT02268058|Ibuprofen|ibuprofen|mesh-list
111059605|NCT02268058|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111059606|NCT02268058|Analgesics|analgesics|mesh-ancestor
111059607|NCT02268058|Sensory System Agents|sensory system agents|mesh-ancestor
111059608|NCT02268058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111059609|NCT02268058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111059610|NCT02268058|Antipyretics|antipyretics|mesh-ancestor
111059611|NCT02268058|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111059612|NCT02268058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111059613|NCT02268058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111059614|NCT02268058|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111059615|NCT02268058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111059616|NCT02268058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111059617|NCT02267746|Nicotinic Acids|nicotinic acids|mesh-list
111059618|NCT02267746|Tazarotene|tazarotene|mesh-list
111059619|NCT02267746|Dermatologic Agents|dermatologic agents|mesh-ancestor
111059620|NCT02267746|Keratolytic Agents|keratolytic agents|mesh-ancestor
111059621|NCT02267746|Vitamin B Complex|vitamin b complex|mesh-ancestor
111059622|NCT02267746|Vitamins|vitamins|mesh-ancestor
111059623|NCT02267746|Micronutrients|micronutrients|mesh-ancestor
111059624|NCT02267746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111059625|NCT04421534|Lactoferrin|lactoferrin|mesh-list
111059626|NCT04421534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111059627|NCT05059028|Oxytocin|oxytocin|mesh-list
111059628|NCT05059028|Oxytocics|oxytocics|mesh-ancestor
111059629|NCT05059028|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111059630|NCT05059028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111059631|NCT02517866|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
111059632|NCT02517866|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111059633|NCT02517866|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111059634|NCT02517866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111059635|NCT04215848|Budesonide|budesonide|mesh-list
111059636|NCT04215848|Formoterol Fumarate|formoterol fumarate|mesh-list
111059637|NCT04215848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111059638|NCT04215848|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111059639|NCT04215848|Autonomic Agents|autonomic agents|mesh-ancestor
111059640|NCT04215848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111059641|NCT04215848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111059642|NCT04215848|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111059643|NCT04215848|Respiratory System Agents|respiratory system agents|mesh-ancestor
111059644|NCT04215848|Glucocorticoids|glucocorticoids|mesh-ancestor
111059645|NCT04215848|Hormones|hormones|mesh-ancestor
111059646|NCT04215848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111059647|NCT04215848|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111059648|NCT04215848|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111059649|NCT04215848|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111059650|NCT04215848|Adrenergic Agents|adrenergic agents|mesh-ancestor
111059651|NCT04215848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111059652|NCT04215848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111059653|NCT04215146|Paclitaxel|paclitaxel|mesh-list
111059654|NCT04215146|Avelumab|avelumab|mesh-list
111059655|NCT04215146|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111059656|NCT04215146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111059657|NCT04215146|Tubulin Modulators|tubulin modulators|mesh-ancestor
111059658|NCT04215146|Antimitotic Agents|antimitotic agents|mesh-ancestor
111059659|NCT04215146|Mitosis Modulators|mitosis modulators|mesh-ancestor
111059660|NCT04215146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111059661|NCT04215146|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111059662|NCT05010200|Poly ICLC|poly iclc|mesh-list
111059663|NCT05010200|Interferon Inducers|interferon inducers|mesh-ancestor
111059664|NCT05010200|Immunologic Factors|immunologic factors|mesh-ancestor
111059665|NCT05010200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111059666|NCT04959266|Itraconazole|itraconazole|mesh-list
111059667|NCT04959266|Rifampin|rifampin|mesh-list
111059668|NCT04959266|Omeprazole|omeprazole|mesh-list
111059669|NCT04959266|Adavosertib|adavosertib|mesh-list
111059670|NCT04959266|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111059671|NCT04959266|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111059672|NCT04959266|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111059673|NCT04959266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111059674|NCT04959266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111059675|NCT04959266|Antifungal Agents|antifungal agents|mesh-ancestor
111059676|NCT04959266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111059677|NCT04959266|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111059678|NCT04959266|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111059679|NCT04959266|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111059680|NCT04959266|Hormone Antagonists|hormone antagonists|mesh-ancestor
111059681|NCT04959266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111059682|NCT04959266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111059683|NCT04959266|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110632028|NCT00977145|Interferon-gamma|interferon-gamma|mesh-list
111059684|NCT04959266|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111059685|NCT04959266|Antitubercular Agents|antitubercular agents|mesh-ancestor
111059686|NCT04959266|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111059687|NCT04959266|Leprostatic Agents|leprostatic agents|mesh-ancestor
111059688|NCT04959266|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111059689|NCT04959266|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111059690|NCT04959266|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111059691|NCT04959266|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
111059692|NCT04959266|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
111059693|NCT04959266|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110776780|NCT03855046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110776781|NCT03855046|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110776782|NCT03855046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110776783|NCT03855046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110776784|NCT03855046|Cholinergic Agents|cholinergic agents|mesh-ancestor
111059694|NCT04959266|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111059695|NCT04946864|Palbociclib|palbociclib|mesh-list
111059696|NCT04946864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111059697|NCT04946864|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111059698|NCT04946864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111059699|NCT04946864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111059700|NCT04945148|Metformin|metformin|mesh-list
111059701|NCT04945148|Temozolomide|temozolomide|mesh-list
111059702|NCT04945148|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111059703|NCT04945148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110632072|NCT04045730|Paclitaxel|paclitaxel|mesh-list
111059704|NCT04945148|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111059705|NCT04945148|Alkylating Agents|alkylating agents|mesh-ancestor
111059706|NCT04945148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111059707|NCT04945148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111059708|NCT02516306|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111059709|NCT02516306|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111059710|NCT05003570|Fentanyl|fentanyl|mesh-list
111059711|NCT05003570|Remifentanil|remifentanil|mesh-list
111059712|NCT05003570|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111059713|NCT05003570|Narcotics|narcotics|mesh-ancestor
111059714|NCT05003570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111059715|NCT05003570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111059716|NCT05003570|Analgesics|analgesics|mesh-ancestor
111059717|NCT05003570|Sensory System Agents|sensory system agents|mesh-ancestor
111059718|NCT05003570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111059719|NCT05003570|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111059720|NCT05003570|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111059721|NCT05003570|Anesthetics, General|anesthetics, general|mesh-ancestor
111059722|NCT05003570|Anesthetics|anesthetics|mesh-ancestor
111059723|NCT04999592|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111059724|NCT04999592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111059725|NCT02483078|Leronlimab|leronlimab|mesh-list
111059726|NCT02483078|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
111059727|NCT02483078|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
111059728|NCT02483078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111059729|NCT02483078|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111059730|NCT02483078|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111059731|NCT02483078|Antiviral Agents|antiviral agents|mesh-ancestor
111059732|NCT02483078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111059733|NCT02452190|Reslizumab|reslizumab|mesh-list
111059734|NCT02452190|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111059735|NCT02452190|Respiratory System Agents|respiratory system agents|mesh-ancestor
111059736|NCT02514122|Ketamine|ketamine|mesh-list
111059737|NCT02514122|Analgesics|analgesics|mesh-ancestor
111059738|NCT02514122|Sensory System Agents|sensory system agents|mesh-ancestor
111059739|NCT02514122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111059740|NCT02514122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111059741|NCT02514122|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111059742|NCT02514122|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111059743|NCT02514122|Anesthetics, General|anesthetics, general|mesh-ancestor
111059744|NCT02514122|Anesthetics|anesthetics|mesh-ancestor
111059745|NCT02514122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111059746|NCT02514122|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111059747|NCT02514122|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111059748|NCT02514122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111059749|NCT02514122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111059750|NCT00730639|Nivolumab|nivolumab|mesh-list
111059751|NCT00730639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111059752|NCT00730639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111059753|NCT00730639|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111059754|NCT00730639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111059755|NCT03964207|Tiotropium Bromide|tiotropium bromide|mesh-list
111059756|NCT03964207|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111059757|NCT03964207|Autonomic Agents|autonomic agents|mesh-ancestor
111059758|NCT03964207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111059759|NCT03964207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111059760|NCT03964207|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111059761|NCT03964207|Respiratory System Agents|respiratory system agents|mesh-ancestor
111059762|NCT03964207|Parasympatholytics|parasympatholytics|mesh-ancestor
111059763|NCT03964207|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111059764|NCT03964207|Cholinergic Agents|cholinergic agents|mesh-ancestor
111059765|NCT03964207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111059766|NCT03964207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110776864|NCT04369742|Calcium|calcium|mesh-list
111059768|NCT04462003|Apixaban|apixaban|mesh-list
111059769|NCT04462003|Anticoagulants|anticoagulants|mesh-ancestor
111059770|NCT04462003|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111059771|NCT04462003|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111059772|NCT04462003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111059773|NCT04462003|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111059774|NCT04462003|Antithrombins|antithrombins|mesh-ancestor
111059775|NCT04462003|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111059776|NCT04462003|Protease Inhibitors|protease inhibitors|mesh-ancestor
111059777|NCT04462003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111059778|NCT03489265|Eluxadoline|eluxadoline|mesh-list
111059779|NCT03489265|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111059780|NCT03344341|Dapagliflozin|dapagliflozin|mesh-list
111059781|NCT03344341|Acarbose|acarbose|mesh-list
111059782|NCT03344341|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111059783|NCT03344341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111059784|NCT03344341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111059785|NCT03344341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111059786|NCT03344341|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
111059787|NCT03344341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111059788|NCT03260881|Liraglutide|liraglutide|mesh-list
111059789|NCT03260881|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111059790|NCT03260881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111059791|NCT03260881|Incretins|incretins|mesh-ancestor
111059792|NCT03260881|Hormones|hormones|mesh-ancestor
111059793|NCT03260881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111059794|NCT03238495|Metformin|metformin|mesh-list
111059795|NCT03238495|Carboplatin|carboplatin|mesh-list
111059796|NCT03238495|Docetaxel|docetaxel|mesh-list
111059797|NCT03238495|Trastuzumab|trastuzumab|mesh-list
111059798|NCT03238495|Pertuzumab|pertuzumab|mesh-list
111059799|NCT03238495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111059800|NCT03238495|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111059801|NCT03238495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111059802|NCT03238495|Tubulin Modulators|tubulin modulators|mesh-ancestor
111059803|NCT03238495|Antimitotic Agents|antimitotic agents|mesh-ancestor
111059804|NCT03238495|Mitosis Modulators|mitosis modulators|mesh-ancestor
111059805|NCT03238495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111059806|NCT03238495|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111059807|NCT02536339|Trastuzumab|trastuzumab|mesh-list
111059808|NCT02536339|Pertuzumab|pertuzumab|mesh-list
111059809|NCT02536339|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111059810|NCT02536339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111059811|NCT01869361|Indomethacin|indomethacin|mesh-list
111059812|NCT01869361|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111059813|NCT01869361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111059814|NCT01869361|Analgesics|analgesics|mesh-ancestor
111059815|NCT01869361|Sensory System Agents|sensory system agents|mesh-ancestor
111059816|NCT01869361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111059817|NCT01869361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111059818|NCT01869361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111059819|NCT01869361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111059820|NCT01869361|Gout Suppressants|gout suppressants|mesh-ancestor
111059821|NCT01869361|Tocolytic Agents|tocolytic agents|mesh-ancestor
111059822|NCT01869361|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111059823|NCT01869361|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111059824|NCT01869361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111059825|NCT01869361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111059826|NCT02322619|Moxifloxacin|moxifloxacin|mesh-list
111059827|NCT02322619|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111059828|NCT02322619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111059829|NCT02322619|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111059830|NCT02322619|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111059831|NCT02322619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111059832|NCT02322619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111059833|NCT02322619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111059834|NCT01578967|Brentuximab Vedotin|brentuximab vedotin|mesh-list
111059835|NCT01578967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111059836|NCT01578967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111059837|NCT01578967|Immunotoxins|immunotoxins|mesh-ancestor
111059838|NCT01578967|Immunoconjugates|immunoconjugates|mesh-ancestor
111059839|NCT01578967|Immunologic Factors|immunologic factors|mesh-ancestor
111059840|NCT01578967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111059841|NCT01186003|Insulin Detemir|insulin detemir|mesh-list
111059842|NCT01186003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111059843|NCT01186003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111059844|NCT02322853|Tamoxifen|tamoxifen|mesh-list
111059845|NCT02322853|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111059846|NCT02322853|Hormone Antagonists|hormone antagonists|mesh-ancestor
111059847|NCT02322853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111059848|NCT02322853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111059849|NCT02322853|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110632232|NCT05279391|Dexamethasone|dexamethasone|mesh-list
111059850|NCT02322853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111059851|NCT02322853|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111059852|NCT02322853|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111059853|NCT02322853|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111059854|NCT03488719|Metoprolol|metoprolol|mesh-list
111059855|NCT03488719|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111059856|NCT03488719|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111059857|NCT03488719|Sympatholytics|sympatholytics|mesh-ancestor
111059858|NCT03488719|Autonomic Agents|autonomic agents|mesh-ancestor
111059859|NCT03488719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111059860|NCT03488719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111059861|NCT03488719|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
111059862|NCT03488719|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111059863|NCT03488719|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111059864|NCT03488719|Adrenergic Agents|adrenergic agents|mesh-ancestor
111059865|NCT03488719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111059866|NCT03488719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111059867|NCT03496831|Adalimumab|adalimumab|mesh-list
111059868|NCT03496831|Infliximab|infliximab|mesh-list
111059869|NCT03496831|Golimumab|golimumab|mesh-list
111059870|NCT03496831|Etanercept|etanercept|mesh-list
111059871|NCT03496831|Abatacept|abatacept|mesh-list
111059872|NCT03496831|Ustekinumab|ustekinumab|mesh-list
111059873|NCT03496831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111059874|NCT03496831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111059875|NCT03496831|Immunologic Factors|immunologic factors|mesh-ancestor
111059876|NCT03496831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111059877|NCT03496831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111059878|NCT03496831|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111059879|NCT03496831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111059880|NCT03496831|Dermatologic Agents|dermatologic agents|mesh-ancestor
111059881|NCT03496831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111059882|NCT03496831|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111059883|NCT03496831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111059884|NCT03496831|Analgesics|analgesics|mesh-ancestor
111059885|NCT03496831|Sensory System Agents|sensory system agents|mesh-ancestor
111059886|NCT03496831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111059887|NCT03496831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111059888|NCT03496831|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111059889|NCT03496831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111059890|NCT03488485|Sofosbuvir|sofosbuvir|mesh-list
111059891|NCT03488485|Antiviral Agents|antiviral agents|mesh-list
111059892|NCT03488485|Ledipasvir|ledipasvir|mesh-list
111059893|NCT03488485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111059894|NCT00821249|Dexamethasone|dexamethasone|mesh-list
111059895|NCT00821249|Filanesib|filanesib|mesh-list
111059896|NCT00821249|Lenograstim|lenograstim|mesh-list
111059897|NCT00821249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111059898|NCT00821249|Antiemetics|antiemetics|mesh-ancestor
111059899|NCT00821249|Autonomic Agents|autonomic agents|mesh-ancestor
111059900|NCT00821249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111059901|NCT00821249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111059902|NCT00821249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111059903|NCT00821249|Glucocorticoids|glucocorticoids|mesh-ancestor
111059904|NCT00821249|Hormones|hormones|mesh-ancestor
111059905|NCT00821249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111059906|NCT00821249|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110827873|NCT00025259|Cisplatin|cisplatin|mesh-list
111059907|NCT00821249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111059908|NCT00821249|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111059909|NCT00821249|Immunologic Factors|immunologic factors|mesh-ancestor
111059910|NCT00821249|Antimitotic Agents|antimitotic agents|mesh-ancestor
111059911|NCT00821249|Mitosis Modulators|mitosis modulators|mesh-ancestor
111059912|NCT00821249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111059913|NCT03752723|Cyclophosphamide|cyclophosphamide|mesh-list
111059914|NCT03752723|Pembrolizumab|pembrolizumab|mesh-list
111059915|NCT03752723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111059916|NCT03752723|Immunologic Factors|immunologic factors|mesh-ancestor
111059917|NCT03752723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111059918|NCT03752723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110777006|NCT05052970|Mitoxantrone|mitoxantrone|mesh-list
111059919|NCT03752723|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111059920|NCT03752723|Alkylating Agents|alkylating agents|mesh-ancestor
111059921|NCT03752723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111059922|NCT03752723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111059923|NCT03752723|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111059924|NCT03752723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111059925|NCT03752723|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111059926|NCT04472585|Ivermectin|ivermectin|mesh-list
111059927|NCT04472585|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111059928|NCT04472585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111059929|NCT03496519|Durvalumab|durvalumab|mesh-list
111059930|NCT03496519|Trabectedin|trabectedin|mesh-list
111059931|NCT03496519|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111059932|NCT03496519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111059933|NCT03496519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111059934|NCT03496519|Immunologic Factors|immunologic factors|mesh-ancestor
111059935|NCT03496519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111059936|NCT03496519|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111059937|NCT03496519|Alkylating Agents|alkylating agents|mesh-ancestor
111059938|NCT03496519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111059939|NCT00813605|Conatumumab|conatumumab|mesh-list
111059940|NCT00813605|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111059941|NCT00813605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111059942|NCT00724841|Temozolomide|temozolomide|mesh-list
111059943|NCT00724841|Obatoclax|obatoclax|mesh-list
111059944|NCT00724841|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111059945|NCT00724841|Alkylating Agents|alkylating agents|mesh-ancestor
110632367|NCT00978159|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111059946|NCT00724841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111059947|NCT00724841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111059948|NCT00724841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111059949|NCT03131791|Botulinum Toxins|botulinum toxins|mesh-list
111059950|NCT03131791|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111059951|NCT03131791|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111059952|NCT03131791|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111059953|NCT03131791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111059954|NCT03131791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111059955|NCT03131791|Cholinergic Agents|cholinergic agents|mesh-ancestor
111059956|NCT03131791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111059957|NCT03131791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111059958|NCT03131791|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111059959|NCT03131791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111059960|NCT00805805|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
111059961|NCT00805805|Chelating Agents|chelating agents|mesh-ancestor
111059962|NCT00805805|Sequestering Agents|sequestering agents|mesh-ancestor
111059963|NCT00805805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111059964|NCT00805805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111059965|NCT00805805|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111059966|NCT00805805|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111059967|NCT00805805|Growth Substances|growth substances|mesh-ancestor
111059968|NCT00805805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111059969|NCT00805805|Growth Inhibitors|growth inhibitors|mesh-ancestor
111059970|NCT00805805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111059971|NCT03488173|Lansoprazole|lansoprazole|mesh-list
111059972|NCT03488173|Dexlansoprazole|dexlansoprazole|mesh-list
111059973|NCT03488173|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111059974|NCT03488173|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111059975|NCT03488173|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111059976|NCT03488173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111059977|NCT03488173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111059978|NCT03420521|Nivolumab|nivolumab|mesh-list
111059979|NCT03420521|Ipilimumab|ipilimumab|mesh-list
110027268|NCT03214770|Calcium|calcium|mesh-list
111059980|NCT03420521|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111059981|NCT03420521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111059982|NCT03420521|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111059983|NCT03420521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111059984|NCT04750759|Niclosamide|niclosamide|mesh-list
111059985|NCT04750759|Camostat|camostat|mesh-list
111059986|NCT04750759|Protease Inhibitors|protease inhibitors|mesh-ancestor
111059987|NCT04750759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111059988|NCT04750759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111059989|NCT04750759|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
111059990|NCT04750759|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111059991|NCT04750759|Anticestodal Agents|anticestodal agents|mesh-ancestor
110777092|NCT04963816|Dexamethasone|dexamethasone|mesh-list
111059992|NCT04750759|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
111059993|NCT04750759|Anthelmintics|anthelmintics|mesh-ancestor
111059994|NCT04750759|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111059995|NCT04750759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111059996|NCT04750759|Antinematodal Agents|antinematodal agents|mesh-ancestor
111059998|NCT03382925|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
111059999|NCT03382925|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
111060000|NCT03382925|Lidocaine|lidocaine|mesh-list
111060001|NCT03382925|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
111060002|NCT03382925|Anesthetics, Local|anesthetics, local|mesh-ancestor
111060003|NCT03382925|Anesthetics|anesthetics|mesh-ancestor
111060004|NCT03382925|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111060005|NCT03382925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111060006|NCT03382925|Sensory System Agents|sensory system agents|mesh-ancestor
111060007|NCT03382925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111060008|NCT03382925|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111060009|NCT03382925|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111060010|NCT03382925|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111060011|NCT03382925|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111060012|NCT03382925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111060013|NCT03382925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111060014|NCT03382925|Glucocorticoids|glucocorticoids|mesh-ancestor
111060015|NCT03382925|Hormones|hormones|mesh-ancestor
111060016|NCT03382925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111060017|NCT03382925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111060018|NCT03382925|Immunologic Factors|immunologic factors|mesh-ancestor
111060019|NCT03382925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111060020|NCT03487939|Fluorouracil|fluorouracil|mesh-list
111060021|NCT03487939|Oxaliplatin|oxaliplatin|mesh-list
111060022|NCT03487939|Irinotecan|irinotecan|mesh-list
111060023|NCT03487939|Antimetabolites|antimetabolites|mesh-ancestor
111060024|NCT03487939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111060025|NCT03487939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111060026|NCT03487939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111060027|NCT03487939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111060028|NCT03487939|Immunologic Factors|immunologic factors|mesh-ancestor
111060029|NCT03487939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111060030|NCT03487939|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111060031|NCT03487939|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111060032|NCT03487939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111060033|NCT00796289|Citric Acid|citric acid|mesh-list
111060034|NCT00796289|Sodium Citrate|sodium citrate|mesh-list
111060035|NCT00796289|Clomiphene|clomiphene|mesh-list
111060036|NCT00796289|Enclomiphene|enclomiphene|mesh-list
111060037|NCT00796289|Zuclomiphene|zuclomiphene|mesh-list
111060038|NCT00796289|Hormones|hormones|mesh-list
111060039|NCT00796289|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
111060040|NCT00796289|Anticoagulants|anticoagulants|mesh-ancestor
111060041|NCT00796289|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
111060042|NCT00796289|Chelating Agents|chelating agents|mesh-ancestor
111060043|NCT00796289|Sequestering Agents|sequestering agents|mesh-ancestor
111060044|NCT00796289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111060045|NCT00796289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111060046|NCT00796289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111060047|NCT00796289|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111060048|NCT00796289|Hormone Antagonists|hormone antagonists|mesh-ancestor
111060049|NCT00796289|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111060050|NCT00796289|Fertility Agents|fertility agents|mesh-ancestor
111060051|NCT00796289|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111060052|NCT00796289|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110827876|NCT00025259|Etoposide|etoposide|mesh-list
111060053|NCT00796289|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111060054|NCT04460443|Sofosbuvir|sofosbuvir|mesh-list
111060055|NCT04460443|Antiviral Agents|antiviral agents|mesh-ancestor
111060056|NCT04460443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111060057|NCT04460521|Acetylcysteine|acetylcysteine|mesh-list
111060058|NCT04460521|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111060059|NCT04460521|Antiviral Agents|antiviral agents|mesh-ancestor
111060060|NCT04460521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111060061|NCT04460521|Expectorants|expectorants|mesh-ancestor
111060062|NCT04460521|Respiratory System Agents|respiratory system agents|mesh-ancestor
111060063|NCT04460521|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111060064|NCT04460521|Antioxidants|antioxidants|mesh-ancestor
111060065|NCT04460521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110777161|NCT01317472|Dexlansoprazole|dexlansoprazole|mesh-list
111060066|NCT04460521|Protective Agents|protective agents|mesh-ancestor
111060067|NCT04460521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111060068|NCT04460521|Antidotes|antidotes|mesh-ancestor
111060069|NCT00698789|Metformin|metformin|mesh-list
111060070|NCT00698789|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111060071|NCT00698789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111060072|NCT03487783|Aripiprazole|aripiprazole|mesh-list
111060073|NCT03487783|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111060074|NCT03487783|Antidepressive Agents|antidepressive agents|mesh-ancestor
111060075|NCT03487783|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111060076|NCT03487783|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111060077|NCT03487783|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111060078|NCT03487783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111060079|NCT03487783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111060080|NCT03487783|Dopamine Agonists|dopamine agonists|mesh-ancestor
111060081|NCT03487783|Dopamine Agents|dopamine agents|mesh-ancestor
111060082|NCT03487783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111060083|NCT03487783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111060084|NCT03487783|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111060085|NCT03487783|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111060086|NCT03487783|Serotonin Agents|serotonin agents|mesh-ancestor
111060087|NCT03487783|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111060088|NCT03487783|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111060089|NCT03487783|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111060090|NCT03487783|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111060091|NCT03495739|Dabigatran|dabigatran|mesh-list
111060092|NCT03495739|Antithrombins|antithrombins|mesh-ancestor
111060093|NCT03495739|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111060094|NCT03495739|Protease Inhibitors|protease inhibitors|mesh-ancestor
111060095|NCT03495739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111060096|NCT03495739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111060097|NCT03495739|Anticoagulants|anticoagulants|mesh-ancestor
111060098|NCT03298061|Prednisolone|prednisolone|mesh-list
111060099|NCT03298061|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111060100|NCT03298061|Glucocorticoids|glucocorticoids|mesh-ancestor
111060101|NCT03298061|Hormones|hormones|mesh-ancestor
111060102|NCT03298061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111060103|NCT03298061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111060104|NCT03298061|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111060105|NCT03298061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111060106|NCT04071613|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
111060107|NCT04071613|Plasminogen|plasminogen|mesh-list
111060108|NCT04071613|Tenecteplase|tenecteplase|mesh-list
111060109|NCT04071613|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111060110|NCT04071613|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111060111|NCT04071613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111060112|NCT00678119|Sunitinib|sunitinib|mesh-list
111060113|NCT00678119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111060114|NCT00678119|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111060115|NCT00678119|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111060116|NCT00678119|Growth Substances|growth substances|mesh-ancestor
111060117|NCT00678119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111060118|NCT00678119|Growth Inhibitors|growth inhibitors|mesh-ancestor
111060119|NCT00678119|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111060120|NCT00678119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111060121|NCT00678119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111060122|NCT02812667|Nivolumab|nivolumab|mesh-list
111060123|NCT02812667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111060124|NCT02812667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111060125|NCT02812667|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111060126|NCT02812667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111060127|NCT02799095|Pembrolizumab|pembrolizumab|mesh-list
111060128|NCT02799095|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111060129|NCT02799095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111060130|NCT02799095|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111060131|NCT02799095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111060132|NCT02011321|Clevidipine|clevidipine|mesh-list
111060133|NCT02011321|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110632607|NCT00656084|Rituximab|rituximab|mesh-list
111060134|NCT02011321|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111060135|NCT02011321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111060136|NCT02011321|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111060137|NCT02011321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111060138|NCT01352585|Anagrelide|anagrelide|mesh-list
111060139|NCT01352585|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111060140|NCT01352585|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111060141|NCT01352585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111060142|NCT01352585|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111060143|NCT03484507|Chlorhexidine|chlorhexidine|mesh-list
111060144|NCT03484507|Povidone-Iodine|povidone-iodine|mesh-list
111060145|NCT03484507|Prednisolone|prednisolone|mesh-list
111060146|NCT03484507|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111060147|NCT03484507|Methylprednisolone|methylprednisolone|mesh-list
111060148|NCT03484507|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111060149|NCT03484507|Prednisolone acetate|prednisolone acetate|mesh-list
111060150|NCT03484507|Povidone|povidone|mesh-list
111060151|NCT03484507|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111060152|NCT03484507|Prednisolone phosphate|prednisolone phosphate|mesh-list
111060153|NCT03484507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111060154|NCT03484507|Glucocorticoids|glucocorticoids|mesh-ancestor
111060155|NCT03484507|Hormones|hormones|mesh-ancestor
111060156|NCT03484507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111060157|NCT03484507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111060158|NCT03484507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111060159|NCT03484507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111060160|NCT03484507|Antiemetics|antiemetics|mesh-ancestor
111060161|NCT03484507|Autonomic Agents|autonomic agents|mesh-ancestor
111060162|NCT03484507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111060163|NCT03484507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111060164|NCT03484507|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111060165|NCT03484507|Protective Agents|protective agents|mesh-ancestor
111060166|NCT03484507|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111060167|NCT03484507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111060168|NCT03484507|Disinfectants|disinfectants|mesh-ancestor
111060169|NCT03484507|Plasma Substitutes|plasma substitutes|mesh-ancestor
111060170|NCT03484507|Blood Substitutes|blood substitutes|mesh-ancestor
111060171|NCT02773355|Liraglutide|liraglutide|mesh-list
111060172|NCT02773355|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111060173|NCT02773355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111060174|NCT02773355|Incretins|incretins|mesh-ancestor
111060175|NCT02773355|Hormones|hormones|mesh-ancestor
111060176|NCT02773355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111060177|NCT02744183|Benzocaine|benzocaine|mesh-list
111060178|NCT02744183|Anesthetics, Local|anesthetics, local|mesh-ancestor
111060179|NCT02744183|Anesthetics|anesthetics|mesh-ancestor
111060180|NCT02744183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111060181|NCT02744183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111060182|NCT02744183|Sensory System Agents|sensory system agents|mesh-ancestor
111060183|NCT02744183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111060184|NCT03484195|Fluorouracil|fluorouracil|mesh-list
111060185|NCT03484195|Oxaliplatin|oxaliplatin|mesh-list
111060186|NCT03484195|Irinotecan|irinotecan|mesh-list
111060187|NCT03484195|Antimetabolites|antimetabolites|mesh-ancestor
111060188|NCT03484195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111060189|NCT03484195|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111060190|NCT03484195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111060191|NCT03484195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111060192|NCT03484195|Immunologic Factors|immunologic factors|mesh-ancestor
111060193|NCT03484195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111060194|NCT03484195|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111060195|NCT03484195|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111060196|NCT03484195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111060197|NCT02713607|Doxycycline|doxycycline|mesh-list
111060198|NCT02713607|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111060199|NCT02713607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111060200|NCT02713607|Antimalarials|antimalarials|mesh-ancestor
111060201|NCT02713607|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111060202|NCT02713607|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111060203|NCT04526821|Lactoferrin|lactoferrin|mesh-list
111060204|NCT04526821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111060205|NCT02681549|Bevacizumab|bevacizumab|mesh-list
111060206|NCT02681549|Pembrolizumab|pembrolizumab|mesh-list
111060207|NCT02681549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111060208|NCT02681549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111060209|NCT02681549|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111060210|NCT02681549|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111060211|NCT02681549|Growth Substances|growth substances|mesh-ancestor
111060212|NCT02681549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111060213|NCT02681549|Growth Inhibitors|growth inhibitors|mesh-ancestor
111060214|NCT02681549|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111060215|NCT02681549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111060216|NCT02323399|Phenylephrine|phenylephrine|mesh-list
111060217|NCT02323399|Oxymetazoline|oxymetazoline|mesh-list
111060218|NCT02323399|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111060219|NCT02323399|Mydriatics|mydriatics|mesh-ancestor
111060220|NCT02323399|Autonomic Agents|autonomic agents|mesh-ancestor
111060221|NCT02323399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111060222|NCT02323399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111060223|NCT02323399|Sympathomimetics|sympathomimetics|mesh-ancestor
111060224|NCT02323399|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111060225|NCT02323399|Nasal Decongestants|nasal decongestants|mesh-ancestor
111060226|NCT02323399|Respiratory System Agents|respiratory system agents|mesh-ancestor
111060227|NCT02323399|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111060228|NCT02323399|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111060229|NCT02323399|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111060230|NCT02323399|Adrenergic Agents|adrenergic agents|mesh-ancestor
111060231|NCT02323399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111060232|NCT02323399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111060233|NCT02323399|Protective Agents|protective agents|mesh-ancestor
111060234|NCT01352507|Sildenafil Citrate|sildenafil citrate|mesh-list
111060235|NCT01352507|Tadalafil|tadalafil|mesh-list
111060236|NCT01352507|Vasodilator Agents|vasodilator agents|mesh-ancestor
111060237|NCT01352507|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111060238|NCT01352507|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111060239|NCT01352507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111060240|NCT01352507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111060241|NCT01352507|Urological Agents|urological agents|mesh-ancestor
111060242|NCT04460963|Adrenomedullin|adrenomedullin|mesh-list
111060243|NCT04460963|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111060244|NCT04460963|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111060245|NCT04460963|Autonomic Agents|autonomic agents|mesh-ancestor
111060246|NCT04460963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111060247|NCT04460963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111060248|NCT04460963|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111060249|NCT04460963|Respiratory System Agents|respiratory system agents|mesh-ancestor
111060250|NCT04460963|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111060251|NCT04460963|Vasodilator Agents|vasodilator agents|mesh-ancestor
111060252|NCT04460963|Protective Agents|protective agents|mesh-ancestor
111060253|NCT00873275|Leucovorin|leucovorin|mesh-list
111060254|NCT00873275|Bevacizumab|bevacizumab|mesh-list
111060255|NCT00873275|Fluorouracil|fluorouracil|mesh-list
111060256|NCT00873275|Oxaliplatin|oxaliplatin|mesh-list
111060257|NCT00873275|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
111060258|NCT00873275|Calcium|calcium|mesh-list
111060259|NCT00873275|Levoleucovorin|levoleucovorin|mesh-list
111060260|NCT00873275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111060261|NCT00873275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111060262|NCT00873275|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111060263|NCT00873275|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111060264|NCT00873275|Growth Substances|growth substances|mesh-ancestor
111060265|NCT00873275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111060266|NCT00873275|Growth Inhibitors|growth inhibitors|mesh-ancestor
111060267|NCT00873275|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111060268|NCT00873275|Antimetabolites|antimetabolites|mesh-ancestor
111060269|NCT00873275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111060270|NCT00873275|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111060271|NCT00873275|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111060272|NCT00873275|Immunologic Factors|immunologic factors|mesh-ancestor
111060273|NCT00873275|Antidotes|antidotes|mesh-ancestor
111060275|NCT00873275|Vitamin B Complex|vitamin b complex|mesh-ancestor
111060276|NCT00873275|Vitamins|vitamins|mesh-ancestor
111060277|NCT00873275|Micronutrients|micronutrients|mesh-ancestor
111060278|NCT00873275|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
111060279|NCT00873275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111060280|NCT04403243|Colchicine|colchicine|mesh-list
111060281|NCT04403243|Gout Suppressants|gout suppressants|mesh-ancestor
111060282|NCT04403243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111060283|NCT04403243|Tubulin Modulators|tubulin modulators|mesh-ancestor
111060284|NCT04403243|Antimitotic Agents|antimitotic agents|mesh-ancestor
111060285|NCT04403243|Mitosis Modulators|mitosis modulators|mesh-ancestor
111060286|NCT04403243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111060287|NCT04403243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111060288|NCT05648032|Triamcinolone|triamcinolone|mesh-list
111060289|NCT05648032|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
111060290|NCT05648032|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110777385|NCT05280028|Tibolone|tibolone|mesh-list
111060291|NCT05648032|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
111060292|NCT05648032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111060293|NCT05648032|Glucocorticoids|glucocorticoids|mesh-ancestor
111060294|NCT05648032|Hormones|hormones|mesh-ancestor
111060295|NCT05648032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111060296|NCT05648032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111060297|NCT05648032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111060298|NCT05648032|Immunologic Factors|immunologic factors|mesh-ancestor
111060299|NCT05648032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111060300|NCT05648032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111060301|NCT00774761|Fluticasone|fluticasone|mesh-list
111060302|NCT00774761|Xhance|xhance|mesh-list
111060303|NCT00774761|Formoterol Fumarate|formoterol fumarate|mesh-list
111060304|NCT00774761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111060305|NCT00774761|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111060306|NCT00774761|Autonomic Agents|autonomic agents|mesh-ancestor
111060307|NCT00774761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111060308|NCT00774761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111060309|NCT00774761|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111060310|NCT00774761|Respiratory System Agents|respiratory system agents|mesh-ancestor
111060311|NCT00774761|Dermatologic Agents|dermatologic agents|mesh-ancestor
111060312|NCT00774761|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111060313|NCT00774761|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111060314|NCT00774761|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111060315|NCT00774761|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111060316|NCT00774761|Adrenergic Agents|adrenergic agents|mesh-ancestor
111060317|NCT00774761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111060318|NCT00774761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111060319|NCT00772343|Vaccines|vaccines|mesh-list
111060320|NCT00772343|Immunologic Factors|immunologic factors|mesh-ancestor
111060321|NCT00772343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111060322|NCT05647954|Pembrolizumab|pembrolizumab|mesh-list
111060323|NCT05647954|Temozolomide|temozolomide|mesh-list
111060324|NCT05647954|Chlorotrianisene|chlorotrianisene|mesh-list
111060325|NCT05647954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111060326|NCT05647954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111060327|NCT05647954|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111060328|NCT05647954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111060329|NCT05647954|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111060330|NCT05647954|Alkylating Agents|alkylating agents|mesh-ancestor
111060331|NCT05647954|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
111060332|NCT05647954|Estrogens|estrogens|mesh-ancestor
111060333|NCT05647954|Hormones|hormones|mesh-ancestor
111060334|NCT05647954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111060335|NCT05647954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111060336|NCT05647954|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111060337|NCT00770081|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111060338|NCT00770081|Vildagliptin|vildagliptin|mesh-list
111060339|NCT00770081|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111060340|NCT00770081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111060341|NCT00770081|Incretins|incretins|mesh-ancestor
111060342|NCT00770081|Hormones|hormones|mesh-ancestor
111060343|NCT00770081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111060344|NCT00770081|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111060345|NCT00770081|Protease Inhibitors|protease inhibitors|mesh-ancestor
111060346|NCT00770081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110827884|NCT00025259|Immunologic Factors|immunologic factors|mesh-ancestor
111060347|NCT00770081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111060348|NCT02360098|Anesthetics|anesthetics|mesh-list
111060349|NCT02360098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111060350|NCT02360098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111060351|NCT02273609|Vitamin K|vitamin k|mesh-list
111060352|NCT02273609|Warfarin|warfarin|mesh-list
111060353|NCT02273609|Acenocoumarol|acenocoumarol|mesh-list
111060354|NCT02273609|Vitamins|vitamins|mesh-ancestor
111060355|NCT02273609|Micronutrients|micronutrients|mesh-ancestor
111060356|NCT02273609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111060357|NCT02273609|Anticoagulants|anticoagulants|mesh-ancestor
111060358|NCT02273609|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111060359|NCT02273609|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111060360|NCT02273609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111060361|NCT02273609|Hemostatics|hemostatics|mesh-ancestor
111060362|NCT02273609|Coagulants|coagulants|mesh-ancestor
111060363|NCT02273843|Vitamin D|vitamin d|mesh-list
111060364|NCT02273843|Ergocalciferols|ergocalciferols|mesh-list
111060365|NCT02273843|Cholecalciferol|cholecalciferol|mesh-list
111060366|NCT02273843|Vitamins|vitamins|mesh-list
111060367|NCT02273843|Micronutrients|micronutrients|mesh-ancestor
110777476|NCT05517928|Omeprazole|omeprazole|mesh-list
111060368|NCT02273843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111060369|NCT02273843|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111060370|NCT02273843|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111060371|NCT00666497|Azacitidine|azacitidine|mesh-list
111060372|NCT00666497|Mocetinostat|mocetinostat|mesh-list
111060373|NCT00666497|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111060374|NCT00666497|Antimetabolites|antimetabolites|mesh-ancestor
111060375|NCT00666497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111060376|NCT00666497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111060377|NCT00666497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111060378|NCT00666497|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111060379|NCT02274077|Bupivacaine|bupivacaine|mesh-list
111060380|NCT02274077|Anesthetics, Local|anesthetics, local|mesh-ancestor
111060381|NCT02274077|Anesthetics|anesthetics|mesh-ancestor
111060382|NCT02274077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111060383|NCT02274077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111060384|NCT02274077|Sensory System Agents|sensory system agents|mesh-ancestor
111060385|NCT02274077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111060386|NCT00765323|Octreotide|octreotide|mesh-list
111060387|NCT00765323|Somatostatin|somatostatin|mesh-list
111060388|NCT00765323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111060389|NCT00765323|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111060390|NCT00765323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111060391|NCT00765323|Hormones|hormones|mesh-ancestor
111060392|NCT00765323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111060393|NCT00765323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111060394|NCT02277587|Hydrocortisone|hydrocortisone|mesh-list
111060395|NCT02277587|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
111060396|NCT02277587|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
111060397|NCT02277587|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
111060398|NCT02277587|Cortisone|cortisone|mesh-list
111060399|NCT02277587|Glucocorticoids|glucocorticoids|mesh-list
111060400|NCT02277587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111060401|NCT02277587|Hormones|hormones|mesh-ancestor
111060402|NCT02277587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111060403|NCT02277587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111060404|NCT00663767|Celecoxib|celecoxib|mesh-list
111060405|NCT00663767|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
111060406|NCT00663767|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111060407|NCT00663767|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111060408|NCT00663767|Analgesics|analgesics|mesh-ancestor
111060409|NCT00663767|Sensory System Agents|sensory system agents|mesh-ancestor
111060410|NCT00663767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111060411|NCT00663767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111060412|NCT00663767|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111060413|NCT00663767|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111060414|NCT00663767|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111060415|NCT00663767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110632924|NCT00725621|Infliximab|infliximab|mesh-list
111060416|NCT00663767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111060417|NCT00662597|Paclitaxel|paclitaxel|mesh-list
111060418|NCT00662597|Carboplatin|carboplatin|mesh-list
111060419|NCT00662597|Vadimezan|vadimezan|mesh-list
110525583|NCT00744627|Serotonin Agents|serotonin agents|mesh-ancestor
111060420|NCT00662597|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111060421|NCT00662597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111060422|NCT00662597|Tubulin Modulators|tubulin modulators|mesh-ancestor
111060423|NCT00662597|Antimitotic Agents|antimitotic agents|mesh-ancestor
111060424|NCT00662597|Mitosis Modulators|mitosis modulators|mesh-ancestor
111060425|NCT00662597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111060427|NCT02266888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111060428|NCT02266888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111060429|NCT02266888|Immunologic Factors|immunologic factors|mesh-ancestor
111060430|NCT02266888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111060431|NCT02266888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111060432|NCT01641952|Rituximab|rituximab|mesh-list
111060433|NCT01641952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111060434|NCT01641952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111060435|NCT01641952|Immunologic Factors|immunologic factors|mesh-ancestor
111060436|NCT01641952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111060437|NCT01641952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111060438|NCT00660881|Epratuzumab|epratuzumab|mesh-list
111060439|NCT00660881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111060440|NCT00660881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111060441|NCT02359552|Rasagiline|rasagiline|mesh-list
111060442|NCT02359552|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
110777555|NCT04047446|Hormones|hormones|mesh-ancestor
111060443|NCT02359552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111060444|NCT02359552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111060445|NCT02359552|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111060446|NCT02359552|Protective Agents|protective agents|mesh-ancestor
111060447|NCT02359552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111060448|NCT02279537|Aflibercept|aflibercept|mesh-list
111060449|NCT02279537|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111060450|NCT02279537|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111060451|NCT02279537|Growth Substances|growth substances|mesh-ancestor
111060452|NCT02279537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111060453|NCT02279537|Growth Inhibitors|growth inhibitors|mesh-ancestor
111060454|NCT02279537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111060455|NCT02280083|Botulinum Toxins|botulinum toxins|mesh-list
111060456|NCT02280083|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111060457|NCT02280083|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111060458|NCT02280083|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111060459|NCT02280083|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111060460|NCT02280083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111060461|NCT02280083|Cholinergic Agents|cholinergic agents|mesh-ancestor
111060462|NCT02280083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111060463|NCT02280083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111060464|NCT02280083|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111060465|NCT02280083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111060466|NCT00752297|Botulinum Toxins|botulinum toxins|mesh-list
111060467|NCT00752297|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111060468|NCT00752297|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111060469|NCT00752297|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111060470|NCT00752297|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111060471|NCT00752297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111060472|NCT00752297|Cholinergic Agents|cholinergic agents|mesh-ancestor
111060473|NCT00752297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111060474|NCT00752297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111060475|NCT00752297|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111060476|NCT00752297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111060477|NCT00656357|Cocaine|cocaine|mesh-list
111060478|NCT00656357|Anesthetics, Local|anesthetics, local|mesh-ancestor
111060479|NCT00656357|Anesthetics|anesthetics|mesh-ancestor
111060480|NCT00656357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111060481|NCT00656357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111060482|NCT00656357|Sensory System Agents|sensory system agents|mesh-ancestor
111060483|NCT00656357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111060484|NCT00656357|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111060485|NCT00656357|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111060486|NCT00656357|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111060487|NCT00656357|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111060488|NCT00656357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111060489|NCT00656357|Dopamine Agents|dopamine agents|mesh-ancestor
111060490|NCT00656357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111060491|NCT02280629|Mesalamine|mesalamine|mesh-list
111060492|NCT02280629|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111060493|NCT02280629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111060495|NCT02280629|Sensory System Agents|sensory system agents|mesh-ancestor
111060496|NCT02280629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111060497|NCT02280629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111060498|NCT02280629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111060499|NCT02280629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111060500|NCT03134573|Interferons|interferons|mesh-list
111060501|NCT03134573|Interferon-beta|interferon-beta|mesh-list
111060502|NCT03134573|Interferon beta-1b|interferon beta-1b|mesh-list
111060503|NCT03134573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111060504|NCT03134573|Antiviral Agents|antiviral agents|mesh-ancestor
111060505|NCT03134573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111060506|NCT03134573|Immunologic Factors|immunologic factors|mesh-ancestor
111060507|NCT03134573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111060508|NCT03134573|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111060509|NCT00743795|Ribavirin|ribavirin|mesh-list
111060510|NCT00743795|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
111060511|NCT00743795|Antimetabolites|antimetabolites|mesh-ancestor
111060512|NCT00743795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111060513|NCT00743795|Antiviral Agents|antiviral agents|mesh-ancestor
111060514|NCT00743795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111060515|NCT04232033|Mitogens|mitogens|mesh-list
111060516|NCT04232033|Mitosis Modulators|mitosis modulators|mesh-ancestor
111060517|NCT04232033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111060518|NCT03134417|Vitamin D|vitamin d|mesh-list
111060519|NCT03134417|Ergocalciferols|ergocalciferols|mesh-list
111060520|NCT03134417|Cholecalciferol|cholecalciferol|mesh-list
111060521|NCT03134417|Vitamins|vitamins|mesh-list
111060522|NCT03134417|Micronutrients|micronutrients|mesh-ancestor
111060523|NCT03134417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111060524|NCT03134417|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111060525|NCT03134417|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111060526|NCT00649025|Fluticasone|fluticasone|mesh-list
111060527|NCT00649025|Xhance|xhance|mesh-list
111060528|NCT00649025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111060529|NCT00649025|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111060530|NCT00649025|Autonomic Agents|autonomic agents|mesh-ancestor
111060531|NCT00649025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111060532|NCT00649025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111060533|NCT00649025|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111060534|NCT00649025|Respiratory System Agents|respiratory system agents|mesh-ancestor
111060535|NCT00649025|Dermatologic Agents|dermatologic agents|mesh-ancestor
111060536|NCT00649025|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111060537|NCT00647231|Ketoprofen|ketoprofen|mesh-list
111060538|NCT00647231|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111060539|NCT00647231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111060540|NCT00647231|Analgesics|analgesics|mesh-ancestor
111060541|NCT00647231|Sensory System Agents|sensory system agents|mesh-ancestor
111060542|NCT00647231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111060543|NCT00647231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111060544|NCT00647231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111060545|NCT00647231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111060546|NCT00647231|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111060547|NCT00647231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111060548|NCT00647231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111060549|NCT00739349|Cyclosporine|cyclosporine|mesh-list
111060550|NCT00739349|Cyclosporins|cyclosporins|mesh-list
111060551|NCT00739349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111060552|NCT00739349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111060553|NCT00739349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111060554|NCT00739349|Immunologic Factors|immunologic factors|mesh-ancestor
111060555|NCT00739349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111060556|NCT00739349|Antifungal Agents|antifungal agents|mesh-ancestor
111060557|NCT00739349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111060558|NCT00739349|Dermatologic Agents|dermatologic agents|mesh-ancestor
111060559|NCT00739349|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111060560|NCT00739349|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111060561|NCT00152009|Guanfacine|guanfacine|mesh-list
111060562|NCT00152009|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111060563|NCT00152009|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111060564|NCT00152009|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111060565|NCT00152009|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111060566|NCT00152009|Adrenergic Agents|adrenergic agents|mesh-ancestor
111060567|NCT00152009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111060568|NCT00152009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111060569|NCT00152009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111060570|NCT02280785|Brentuximab Vedotin|brentuximab vedotin|mesh-list
111060571|NCT02280785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111060572|NCT02280785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111060573|NCT02280785|Immunotoxins|immunotoxins|mesh-ancestor
111060574|NCT02280785|Immunoconjugates|immunoconjugates|mesh-ancestor
111060575|NCT02280785|Immunologic Factors|immunologic factors|mesh-ancestor
111060576|NCT02280785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111060577|NCT04158635|Paclitaxel|paclitaxel|mesh-list
111060578|NCT04158635|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111060579|NCT04158635|Gemcitabine|gemcitabine|mesh-list
111060580|NCT04158635|Bosentan|bosentan|mesh-list
111060581|NCT04158635|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111060582|NCT04158635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111060583|NCT04158635|Tubulin Modulators|tubulin modulators|mesh-ancestor
111060584|NCT04158635|Antimitotic Agents|antimitotic agents|mesh-ancestor
111060585|NCT04158635|Mitosis Modulators|mitosis modulators|mesh-ancestor
111060586|NCT04158635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111060587|NCT04158635|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111060588|NCT04158635|Antimetabolites|antimetabolites|mesh-ancestor
111060589|NCT04158635|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111060590|NCT04158635|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
111060591|NCT00734435|Zonisamide|zonisamide|mesh-list
111060592|NCT00734435|Olanzapine|olanzapine|mesh-list
111060594|NCT00734435|Autonomic Agents|autonomic agents|mesh-ancestor
111060595|NCT00734435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111060596|NCT00734435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111060597|NCT00734435|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111060598|NCT00734435|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111060599|NCT00734435|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111060600|NCT00734435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111060601|NCT00734435|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111060602|NCT00734435|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111060603|NCT00734435|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111060604|NCT00734435|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111060605|NCT00734435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111060606|NCT00734435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111060607|NCT00734435|Serotonin Agents|serotonin agents|mesh-ancestor
111060608|NCT00734435|Anticonvulsants|anticonvulsants|mesh-ancestor
111060609|NCT00734435|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111060610|NCT00734435|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111060611|NCT00728351|Metformin|metformin|mesh-list
111060612|NCT00728351|Vildagliptin|vildagliptin|mesh-list
111060613|NCT00728351|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111060614|NCT00728351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111060615|NCT00728351|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111060616|NCT00728351|Protease Inhibitors|protease inhibitors|mesh-ancestor
111060617|NCT00728351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111060618|NCT00728351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111060619|NCT00616811|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111060620|NCT00616811|Vildagliptin|vildagliptin|mesh-list
111060621|NCT00616811|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111060622|NCT00616811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111060623|NCT00616811|Incretins|incretins|mesh-ancestor
111060624|NCT00616811|Hormones|hormones|mesh-ancestor
111060625|NCT00616811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111060626|NCT00616811|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111060627|NCT00616811|Protease Inhibitors|protease inhibitors|mesh-ancestor
111060628|NCT00616811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111060629|NCT00616811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111060630|NCT00615251|Progesterone|progesterone|mesh-list
111060631|NCT00615251|Progestins|progestins|mesh-ancestor
111060632|NCT00615251|Hormones|hormones|mesh-ancestor
111060633|NCT00615251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111060634|NCT00615251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111060635|NCT02265796|Ranolazine|ranolazine|mesh-list
111060636|NCT02265796|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111060637|NCT02265796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111060638|NCT02265796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111060639|NCT05647642|Midazolam|midazolam|mesh-list
111060640|NCT05647642|Dexmedetomidine|dexmedetomidine|mesh-list
111060641|NCT05647642|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111060642|NCT05647642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111060643|NCT05647642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111060644|NCT05647642|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111060645|NCT05647642|Analgesics|analgesics|mesh-ancestor
111060646|NCT05647642|Sensory System Agents|sensory system agents|mesh-ancestor
111060647|NCT05647642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111060648|NCT05647642|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111060649|NCT05647642|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111060650|NCT05647642|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111060651|NCT05647642|Adrenergic Agents|adrenergic agents|mesh-ancestor
111060652|NCT05647642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111060653|NCT05647642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111060654|NCT05647642|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111060655|NCT05647642|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111060656|NCT05647642|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111060657|NCT05647642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111060658|NCT05647642|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111060659|NCT05647642|Anesthetics, General|anesthetics, general|mesh-ancestor
111060660|NCT05647642|Anesthetics|anesthetics|mesh-ancestor
111060661|NCT05647642|GABA Modulators|gaba modulators|mesh-ancestor
111060662|NCT05647642|GABA Agents|gaba agents|mesh-ancestor
111060663|NCT02357368|Copper|copper|mesh-list
111060664|NCT02357368|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
111060665|NCT02357368|Contraceptive Agents|contraceptive agents|mesh-list
111060666|NCT02357368|Levonorgestrel|levonorgestrel|mesh-list
111060667|NCT02357368|Medroxyprogesterone|medroxyprogesterone|mesh-list
111060668|NCT02357368|Etonogestrel|etonogestrel|mesh-list
111060669|NCT02357368|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111060670|NCT02357368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111060671|NCT02357368|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111060672|NCT02357368|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111060673|NCT02357368|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111060674|NCT02357368|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111060675|NCT02357368|Trace Elements|trace elements|mesh-ancestor
111060676|NCT02357368|Micronutrients|micronutrients|mesh-ancestor
111060677|NCT02357368|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111060678|NCT02357368|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
111060679|NCT02357368|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111060680|NCT02357368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111060681|NCT04873570|Moxifloxacin|moxifloxacin|mesh-list
111060682|NCT04873570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111060683|NCT04873570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111060684|NCT04873570|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111060685|NCT04873570|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111060686|NCT04873570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111060687|NCT04873570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111060688|NCT04873570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111060689|NCT05647408|Dexamethasone|dexamethasone|mesh-list
111060690|NCT05647408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111060691|NCT05647408|Antiemetics|antiemetics|mesh-ancestor
111060692|NCT05647408|Autonomic Agents|autonomic agents|mesh-ancestor
111060693|NCT05647408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111060694|NCT05647408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111060695|NCT05647408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111060696|NCT05647408|Glucocorticoids|glucocorticoids|mesh-ancestor
111060697|NCT05647408|Hormones|hormones|mesh-ancestor
111060698|NCT05647408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111060699|NCT05647408|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111060700|NCT05647408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111060701|NCT05984953|Evolocumab|evolocumab|mesh-list
111060702|NCT05984953|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
111060703|NCT05984953|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111060704|NCT05984953|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111060705|NCT05984953|Antimetabolites|antimetabolites|mesh-ancestor
111060706|NCT05984953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111060707|NCT05984953|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111060708|NCT05984953|Protease Inhibitors|protease inhibitors|mesh-ancestor
111060709|NCT05984953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111060710|NCT05984953|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111060711|NCT05984745|Ubiquinone|ubiquinone|mesh-list
111060712|NCT05984745|Coenzyme Q10|coenzyme q10|mesh-list
111060713|NCT05984745|Micronutrients|micronutrients|mesh-ancestor
111060714|NCT05984745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111060715|NCT05984745|Vitamins|vitamins|mesh-ancestor
111060716|NCT05984602|Paclitaxel|paclitaxel|mesh-list
111060717|NCT05984602|Gemcitabine|gemcitabine|mesh-list
111060718|NCT05984602|Tislelizumab|tislelizumab|mesh-list
111060719|NCT05984602|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111060720|NCT05984602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111060721|NCT05984602|Tubulin Modulators|tubulin modulators|mesh-ancestor
111060722|NCT05984602|Antimitotic Agents|antimitotic agents|mesh-ancestor
111060723|NCT05984602|Mitosis Modulators|mitosis modulators|mesh-ancestor
111060724|NCT05984602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111060725|NCT05984602|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111060726|NCT05984602|Antimetabolites|antimetabolites|mesh-ancestor
111060727|NCT05984602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111060728|NCT05984537|Heparin|heparin|mesh-list
111060729|NCT05984537|Calcium heparin|calcium heparin|mesh-list
111060730|NCT05984537|Hirudins|hirudins|mesh-list
111060731|NCT05984537|Bivalirudin|bivalirudin|mesh-list
111060732|NCT05984537|Anticoagulants|anticoagulants|mesh-ancestor
111060733|NCT05984537|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111060734|NCT05984537|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111060735|NCT05984537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111060736|NCT05984537|Antithrombins|antithrombins|mesh-ancestor
111060737|NCT05984537|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111060738|NCT05984537|Protease Inhibitors|protease inhibitors|mesh-ancestor
110633204|NCT00810680|Valproic Acid|valproic acid|mesh-list
111060739|NCT05984537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111060740|NCT05984420|Emollients|emollients|mesh-list
111060741|NCT05984420|Dermatologic Agents|dermatologic agents|mesh-ancestor
111060742|NCT05984342|Paclitaxel|paclitaxel|mesh-list
111060743|NCT05984342|Cisplatin|cisplatin|mesh-list
111060744|NCT05984342|Tislelizumab|tislelizumab|mesh-list
111060745|NCT05984342|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111060746|NCT05984342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111060747|NCT05984342|Tubulin Modulators|tubulin modulators|mesh-ancestor
111060748|NCT05984342|Antimitotic Agents|antimitotic agents|mesh-ancestor
111060749|NCT05984342|Mitosis Modulators|mitosis modulators|mesh-ancestor
111060750|NCT05984342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111060751|NCT05984342|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111060752|NCT05984277|Paclitaxel|paclitaxel|mesh-list
111060753|NCT05984277|Carboplatin|carboplatin|mesh-list
111060754|NCT05984277|Pembrolizumab|pembrolizumab|mesh-list
111060755|NCT05984277|Pemetrexed|pemetrexed|mesh-list
111060756|NCT05984277|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111060757|NCT05984277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111060758|NCT05984277|Tubulin Modulators|tubulin modulators|mesh-ancestor
111060759|NCT05984277|Antimitotic Agents|antimitotic agents|mesh-ancestor
111060760|NCT05984277|Mitosis Modulators|mitosis modulators|mesh-ancestor
111060761|NCT05984277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111060762|NCT05984277|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111060763|NCT05984277|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111060764|NCT05984277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111060765|NCT05984277|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111060766|NCT05984277|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111060767|NCT05984264|Lidocaine|lidocaine|mesh-list
111060768|NCT05984264|Prilocaine|prilocaine|mesh-list
111060769|NCT05984264|Anesthetics, Local|anesthetics, local|mesh-ancestor
111060770|NCT05984264|Anesthetics|anesthetics|mesh-ancestor
111060771|NCT05984264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111060772|NCT05984264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111060773|NCT05984264|Sensory System Agents|sensory system agents|mesh-ancestor
111060774|NCT05984264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111060775|NCT05984264|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111060776|NCT05984264|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111060777|NCT05984264|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111060778|NCT05984264|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111060779|NCT05984264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111060780|NCT05984212|Dexmedetomidine|dexmedetomidine|mesh-list
111060781|NCT05984212|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111060782|NCT05984212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111060783|NCT05984212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111060784|NCT05984212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111060785|NCT05984212|Analgesics|analgesics|mesh-ancestor
111060786|NCT05984212|Sensory System Agents|sensory system agents|mesh-ancestor
111060787|NCT05984212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111060788|NCT05984212|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111060789|NCT05984212|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111060790|NCT05984212|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111060791|NCT05984212|Adrenergic Agents|adrenergic agents|mesh-ancestor
111060792|NCT05984212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111060793|NCT05984212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111060795|NCT05984173|Tocopherols|tocopherols|mesh-list
111060796|NCT05984173|Vitamins|vitamins|mesh-ancestor
111060797|NCT05984173|Micronutrients|micronutrients|mesh-ancestor
111060798|NCT05984173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111060799|NCT05984173|Antioxidants|antioxidants|mesh-ancestor
111060800|NCT05984173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111060801|NCT05984173|Protective Agents|protective agents|mesh-ancestor
111060802|NCT05983874|MEDI9197|medi9197|mesh-list
111060803|NCT05983874|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111060804|NCT05983874|Immunologic Factors|immunologic factors|mesh-ancestor
111060805|NCT05983874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111060806|NCT05983783|Docetaxel|docetaxel|mesh-list
111060807|NCT05983783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111060808|NCT05983783|Tubulin Modulators|tubulin modulators|mesh-ancestor
111060809|NCT05983783|Antimitotic Agents|antimitotic agents|mesh-ancestor
111060810|NCT05983783|Mitosis Modulators|mitosis modulators|mesh-ancestor
111060811|NCT05983783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111060812|NCT05983770|Tacrolimus|tacrolimus|mesh-list
111060813|NCT05983770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111060814|NCT05983770|Immunologic Factors|immunologic factors|mesh-ancestor
111060815|NCT05983770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111060816|NCT05983770|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111060817|NCT05983770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111060818|NCT05983770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111060819|NCT05983588|Glycerol|glycerol|mesh-list
111060820|NCT05983588|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
111060821|NCT05983588|Protective Agents|protective agents|mesh-ancestor
111060822|NCT05983588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111060823|NCT05983471|Suplatast tosilate|suplatast tosilate|mesh-list
111060824|NCT05983471|Histamine Antagonists|histamine antagonists|mesh-ancestor
111060825|NCT05983471|Histamine Agents|histamine agents|mesh-ancestor
111060826|NCT05983471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111060827|NCT05983471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111060828|NCT05983471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111060829|NCT05983471|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111060830|NCT05983445|Betamethasone dipropionate, betamethasone sodium phosphate drug combination|betamethasone dipropionate, betamethasone sodium phosphate drug combination|mesh-list
111060831|NCT05983445|Betamethasone|betamethasone|mesh-list
110633274|NCT00807326|Antidiarrheals|antidiarrheals|mesh-list
111060832|NCT05983445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111060833|NCT05983445|Glucocorticoids|glucocorticoids|mesh-ancestor
111060834|NCT05983445|Hormones|hormones|mesh-ancestor
111060835|NCT05983445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111060836|NCT05983445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111060837|NCT05983445|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111060838|NCT05983445|Respiratory System Agents|respiratory system agents|mesh-ancestor
111060839|NCT05983276|Paclitaxel|paclitaxel|mesh-list
111060840|NCT05983276|Carboplatin|carboplatin|mesh-list
111060841|NCT05983276|Decitabine|decitabine|mesh-list
111060842|NCT05983276|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111060843|NCT05983276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111060844|NCT05983276|Tubulin Modulators|tubulin modulators|mesh-ancestor
111060845|NCT05983276|Antimitotic Agents|antimitotic agents|mesh-ancestor
111060846|NCT05983276|Mitosis Modulators|mitosis modulators|mesh-ancestor
111060847|NCT05983276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111060848|NCT05983276|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111060849|NCT05983276|Antimetabolites|antimetabolites|mesh-ancestor
111060850|NCT05983276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111060851|NCT05983263|Capsaicin|capsaicin|mesh-list
111060852|NCT05983263|Antipruritics|antipruritics|mesh-ancestor
111060853|NCT05983263|Dermatologic Agents|dermatologic agents|mesh-ancestor
111060854|NCT05983263|Sensory System Agents|sensory system agents|mesh-ancestor
111060855|NCT05983263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111060856|NCT05983263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111060857|NCT05983107|Everolimus|everolimus|mesh-list
111060858|NCT05983107|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111060859|NCT05983107|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111060860|NCT05983107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111060861|NCT05983107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111060862|NCT05983107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111060863|NCT05983107|Immunologic Factors|immunologic factors|mesh-ancestor
111060864|NCT05983107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110526030|NCT04179266|Ketamine|ketamine|mesh-list
111060865|NCT05983107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111060866|NCT05983094|Carboplatin|carboplatin|mesh-list
111060867|NCT05983094|Trastuzumab|trastuzumab|mesh-list
111060868|NCT05983094|Epirubicin|epirubicin|mesh-list
111060869|NCT05983094|Pertuzumab|pertuzumab|mesh-list
111060870|NCT05983094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111060871|NCT05983094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111060872|NCT05983094|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111060873|NCT05983094|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111060874|NCT05983094|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111060875|NCT05983094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111060876|NCT05983094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111060877|NCT05983042|Ibuprofen|ibuprofen|mesh-list
111060878|NCT05983042|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111060879|NCT05983042|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111060880|NCT05983042|Analgesics|analgesics|mesh-ancestor
111060881|NCT05983042|Sensory System Agents|sensory system agents|mesh-ancestor
111060882|NCT05983042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111060883|NCT05983042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111060884|NCT05983042|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111060885|NCT05983042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111060886|NCT05983042|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111060887|NCT05983042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111060888|NCT05983042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111060889|NCT05982834|Tislelizumab|tislelizumab|mesh-list
111060890|NCT05982834|Disitamab vedotin|disitamab vedotin|mesh-list
111060891|NCT05982834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111060892|NCT05982834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111060893|NCT05982834|Immunoconjugates|immunoconjugates|mesh-ancestor
111060894|NCT05982834|Immunologic Factors|immunologic factors|mesh-ancestor
111060895|NCT05982834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111060896|NCT05982756|Bortezomib|bortezomib|mesh-list
111060897|NCT05982756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111060898|NCT05980091|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
111060899|NCT05980091|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
111060900|NCT05980091|Estradiol|estradiol|mesh-list
111060901|NCT05980091|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
111060902|NCT05980091|Progesterone|progesterone|mesh-list
111060903|NCT05980091|Estrogens|estrogens|mesh-ancestor
111060904|NCT05980091|Hormones|hormones|mesh-ancestor
111060905|NCT05980091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111060906|NCT05980091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111060907|NCT05980091|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111060908|NCT05980091|Contraceptive Agents|contraceptive agents|mesh-ancestor
111060909|NCT05980091|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111060910|NCT05980091|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111060911|NCT05980091|Progestins|progestins|mesh-ancestor
111060912|NCT05969626|Vaccines|vaccines|mesh-list
111060913|NCT05969626|Immunologic Factors|immunologic factors|mesh-ancestor
111060914|NCT05969626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111060915|NCT05961124|Niraparib|niraparib|mesh-list
111060916|NCT05961124|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111060917|NCT05961124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111060918|NCT05961124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111060919|NCT05961124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111060920|NCT05953584|Hydroxyurea|hydroxyurea|mesh-list
111060921|NCT05953584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111060922|NCT05953584|Antisickling Agents|antisickling agents|mesh-ancestor
111060923|NCT05953584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111060924|NCT05953584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111060925|NCT05953584|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111060926|NCT05929716|Rituximab|rituximab|mesh-list
111060927|NCT05929716|Magrolimab|magrolimab|mesh-list
111060928|NCT05929716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111060929|NCT05929716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111060930|NCT05929716|Immunologic Factors|immunologic factors|mesh-ancestor
111060931|NCT05929716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111060932|NCT05929716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111060933|NCT05913284|Morphine|morphine|mesh-list
111060934|NCT05913284|Methadone|methadone|mesh-list
111060935|NCT05913284|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111060936|NCT05913284|Narcotics|narcotics|mesh-ancestor
111060937|NCT05913284|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111060938|NCT05913284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111060939|NCT05913284|Analgesics|analgesics|mesh-ancestor
110027571|NCT01834248|Immunologic Factors|immunologic factors|mesh-ancestor
111060940|NCT05913284|Sensory System Agents|sensory system agents|mesh-ancestor
111060941|NCT05913284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111060942|NCT05913284|Antitussive Agents|antitussive agents|mesh-ancestor
111060943|NCT05913284|Respiratory System Agents|respiratory system agents|mesh-ancestor
111060944|NCT05904106|Azacitidine|azacitidine|mesh-list
111060945|NCT05904106|Venetoclax|venetoclax|mesh-list
111060946|NCT05904106|Gemtuzumab|gemtuzumab|mesh-list
111060947|NCT05904106|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111060948|NCT05904106|Antimetabolites|antimetabolites|mesh-ancestor
110633309|NCT02552342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111060949|NCT05904106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111060950|NCT05904106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111060951|NCT05904106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111060952|NCT05904106|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111060953|NCT05904106|Immunotoxins|immunotoxins|mesh-ancestor
111060954|NCT05904106|Immunoconjugates|immunoconjugates|mesh-ancestor
111060955|NCT05904106|Immunologic Factors|immunologic factors|mesh-ancestor
111060956|NCT05904106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111060957|NCT05901545|Panitumumab|panitumumab|mesh-list
111060958|NCT05901545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111060959|NCT05901545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111060960|NCT05854966|Metformin|metformin|mesh-list
111060961|NCT05854966|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111060962|NCT05854966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111060963|NCT05847686|Psilocybin|psilocybin|mesh-list
111060964|NCT05847686|Hallucinogens|hallucinogens|mesh-ancestor
111060965|NCT05847686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111060966|NCT05847686|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111060967|NCT05831774|Vancomycin|vancomycin|mesh-list
111060968|NCT05831774|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111060969|NCT05831774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111060970|NCT05824299|Anesthetics|anesthetics|mesh-list
111060971|NCT05824299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111060972|NCT05824299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111060973|NCT05817461|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111060974|NCT05815173|Sotorasib|sotorasib|mesh-list
111060975|NCT05815173|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111060976|NCT05815173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110633332|NCT00875238|Doxorubicin|doxorubicin|mesh-list
111060977|NCT05815173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111060978|NCT05815173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111060979|NCT05784753|8-chloro-cyclic adenosine monophosphate|8-chloro-cyclic adenosine monophosphate|mesh-list
111060980|NCT05784753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111060981|NCT05784753|Immunologic Factors|immunologic factors|mesh-ancestor
111060982|NCT05784753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111060983|NCT05782972|Dapagliflozin|dapagliflozin|mesh-list
111060984|NCT05782972|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111060985|NCT05782972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111060986|NCT05782972|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111060987|NCT05782972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111060988|NCT05738148|Vasopressins|vasopressins|mesh-list
111060989|NCT05738148|Arginine Vasopressin|arginine vasopressin|mesh-list
111060990|NCT05738148|Epinephrine|epinephrine|mesh-list
111060991|NCT05738148|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111060992|NCT05738148|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111060993|NCT05738148|Adrenergic Agents|adrenergic agents|mesh-ancestor
111060994|NCT05738148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111060995|NCT05738148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111060996|NCT05738148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111060997|NCT05738148|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111060998|NCT05738148|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111060999|NCT05738148|Autonomic Agents|autonomic agents|mesh-ancestor
111061000|NCT05738148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111061001|NCT05738148|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111061002|NCT05738148|Respiratory System Agents|respiratory system agents|mesh-ancestor
111061003|NCT05738148|Mydriatics|mydriatics|mesh-ancestor
111061004|NCT05738148|Sympathomimetics|sympathomimetics|mesh-ancestor
111061005|NCT05738148|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111061006|NCT05738148|Hemostatics|hemostatics|mesh-ancestor
111061007|NCT05738148|Coagulants|coagulants|mesh-ancestor
111061008|NCT05738148|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
111061009|NCT05738148|Natriuretic Agents|natriuretic agents|mesh-ancestor
111061010|NCT05736419|Mycophenolic Acid|mycophenolic acid|mesh-list
111061011|NCT05736419|Dexamethasone|dexamethasone|mesh-list
111061012|NCT05736419|Cyclophosphamide|cyclophosphamide|mesh-list
111061013|NCT05736419|Rituximab|rituximab|mesh-list
111061014|NCT05736419|Fludarabine|fludarabine|mesh-list
111061015|NCT05736419|Bortezomib|bortezomib|mesh-list
111061016|NCT05736419|Tacrolimus|tacrolimus|mesh-list
111061017|NCT05736419|Thymoglobulin|thymoglobulin|mesh-list
111061019|NCT05736419|Immunologic Factors|immunologic factors|mesh-ancestor
111061020|NCT05736419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111061021|NCT05736419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111061022|NCT05736419|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111061023|NCT05736419|Alkylating Agents|alkylating agents|mesh-ancestor
111061024|NCT05736419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110633377|NCT00799838|Amoxicillin|amoxicillin|mesh-list
111061025|NCT05736419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111061026|NCT05736419|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111061027|NCT05736419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111061028|NCT05736419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111061029|NCT05736419|Antiemetics|antiemetics|mesh-ancestor
111061030|NCT05736419|Autonomic Agents|autonomic agents|mesh-ancestor
111061031|NCT05736419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111061032|NCT05736419|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111061033|NCT05736419|Glucocorticoids|glucocorticoids|mesh-ancestor
111061034|NCT05736419|Hormones|hormones|mesh-ancestor
111061035|NCT05736419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111061036|NCT05736419|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111061037|NCT05736419|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111061038|NCT05736419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111061039|NCT05736419|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111061040|NCT05736419|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111061041|NCT05736419|Antitubercular Agents|antitubercular agents|mesh-ancestor
111061042|NCT05736419|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111061043|NCT05736419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111061044|NCT05729139|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
111061045|NCT05729139|Interferon alpha-2|interferon alpha-2|mesh-list
111061046|NCT05729139|Cemiplimab|cemiplimab|mesh-list
111061047|NCT05729139|Antiviral Agents|antiviral agents|mesh-ancestor
111061048|NCT05729139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111061049|NCT05729139|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111061050|NCT05729139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111061051|NCT05726344|Lactulose|lactulose|mesh-list
111061052|NCT05726344|Bisacodyl|bisacodyl|mesh-list
111061053|NCT05726344|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
111061054|NCT05726344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111061055|NCT05726344|Cathartics|cathartics|mesh-ancestor
111061056|NCT05726344|Laxatives|laxatives|mesh-ancestor
111061057|NCT05694260|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
111061058|NCT05694260|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111061059|NCT05694260|Antimetabolites|antimetabolites|mesh-ancestor
111061060|NCT05694260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111061061|NCT05694260|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111061062|NCT05694260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111061063|NCT05694260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111061064|NCT05694260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111061065|NCT05688020|Epinephrine|epinephrine|mesh-list
111061066|NCT05688020|Tranexamic Acid|tranexamic acid|mesh-list
111061067|NCT05688020|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111061068|NCT05688020|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111061069|NCT05688020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111061070|NCT05688020|Hemostatics|hemostatics|mesh-ancestor
111061071|NCT05688020|Coagulants|coagulants|mesh-ancestor
111061072|NCT05688020|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111061073|NCT05688020|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111061074|NCT05688020|Adrenergic Agents|adrenergic agents|mesh-ancestor
111061075|NCT05688020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111061076|NCT05688020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111061077|NCT05688020|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111061078|NCT05688020|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111061079|NCT05688020|Autonomic Agents|autonomic agents|mesh-ancestor
111061080|NCT05688020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111061081|NCT05688020|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111061082|NCT05688020|Respiratory System Agents|respiratory system agents|mesh-ancestor
111061083|NCT05688020|Mydriatics|mydriatics|mesh-ancestor
111061084|NCT05688020|Sympathomimetics|sympathomimetics|mesh-ancestor
111061085|NCT05688020|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111061086|NCT05681195|Pemetrexed|pemetrexed|mesh-list
111061087|NCT05681195|Zanubrutinib|zanubrutinib|mesh-list
111061088|NCT05681195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111061089|NCT05681195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111061090|NCT05681195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111061091|NCT05681195|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110526251|NCT04181385|Dopamine Agonists|dopamine agonists|mesh-ancestor
111061092|NCT05681195|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111061093|NCT05681195|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111061094|NCT05668455|Dexamethasone|dexamethasone|mesh-list
111061095|NCT05668455|Hydrocortisone|hydrocortisone|mesh-list
111061096|NCT05668455|Povidone|povidone|mesh-list
111061097|NCT05668455|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111061098|NCT05668455|Antiemetics|antiemetics|mesh-ancestor
111061099|NCT05668455|Autonomic Agents|autonomic agents|mesh-ancestor
111061100|NCT05668455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111061101|NCT05668455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111061102|NCT05668455|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111061103|NCT05668455|Glucocorticoids|glucocorticoids|mesh-ancestor
111061104|NCT05668455|Hormones|hormones|mesh-ancestor
111061105|NCT05668455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111061106|NCT05668455|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111061107|NCT05668455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111061108|NCT05668455|Plasma Substitutes|plasma substitutes|mesh-ancestor
111061109|NCT05668455|Blood Substitutes|blood substitutes|mesh-ancestor
111061110|NCT05653492|Sulforaphane|sulforaphane|mesh-list
111061111|NCT05653492|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
111061112|NCT05653492|Protective Agents|protective agents|mesh-ancestor
111061113|NCT05653492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111061114|NCT05653492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111061115|NCT05630872|Lamivudine|lamivudine|mesh-list
111061116|NCT05630872|Dolutegravir|dolutegravir|mesh-list
111061117|NCT05630872|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111061118|NCT05630872|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111061119|NCT05630872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111061120|NCT05630872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111061121|NCT05630872|Antiviral Agents|antiviral agents|mesh-ancestor
111061122|NCT05630872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111061123|NCT05630872|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111061124|NCT05630872|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111061125|NCT05630872|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111061126|NCT05630872|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111061127|NCT05623319|Pembrolizumab|pembrolizumab|mesh-list
111061128|NCT05623319|Olaparib|olaparib|mesh-list
111061129|NCT05623319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111061130|NCT05623319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111061131|NCT05623319|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111061132|NCT05623319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111061133|NCT05623319|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111061134|NCT05623319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111061135|NCT05592418|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
111061136|NCT05592418|Poly I-C|poly i-c|mesh-list
111061137|NCT05592418|Antiviral Agents|antiviral agents|mesh-ancestor
111061138|NCT05592418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111061139|NCT05592418|Interferon Inducers|interferon inducers|mesh-ancestor
111061140|NCT05592418|Immunologic Factors|immunologic factors|mesh-ancestor
111061141|NCT05592418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111061142|NCT05571059|Ifetroban|ifetroban|mesh-list
111061143|NCT05571059|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111061144|NCT05546242|Dolutegravir|dolutegravir|mesh-list
111061145|NCT05546242|Cabotegravir|cabotegravir|mesh-list
111061146|NCT05546242|Rilpivirine|rilpivirine|mesh-list
111061147|NCT05546242|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
111061148|NCT05546242|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111061149|NCT05546242|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111061150|NCT05546242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111061151|NCT05546242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111061152|NCT05546242|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111061153|NCT05546242|Antiviral Agents|antiviral agents|mesh-ancestor
111061154|NCT05546242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111061155|NCT05546242|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111061156|NCT05546242|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111061157|NCT05517668|Acetylcysteine|acetylcysteine|mesh-list
111061158|NCT05517668|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111061159|NCT05517668|Fomepizole|fomepizole|mesh-list
111061160|NCT05517668|Antiviral Agents|antiviral agents|mesh-ancestor
111061161|NCT05517668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111061162|NCT05517668|Expectorants|expectorants|mesh-ancestor
111061163|NCT05517668|Respiratory System Agents|respiratory system agents|mesh-ancestor
111061164|NCT05517668|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111061165|NCT05517668|Antioxidants|antioxidants|mesh-ancestor
111061166|NCT05517668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110526327|NCT00924287|Mesna|mesna|mesh-list
111061167|NCT05517668|Protective Agents|protective agents|mesh-ancestor
111061168|NCT05517668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111061169|NCT05517668|Antidotes|antidotes|mesh-ancestor
111061170|NCT05517668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111061171|NCT05494697|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
111061172|NCT05494697|Antiviral Agents|antiviral agents|mesh-ancestor
111061173|NCT05494697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111061174|NCT05445804|Cannabidiol|cannabidiol|mesh-list
111061175|NCT05445804|Anticonvulsants|anticonvulsants|mesh-ancestor
111061176|NCT05435729|Levodopa|levodopa|mesh-list
110633580|NCT00882570|Cefdinir|cefdinir|mesh-list
111061177|NCT05435729|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111061178|NCT05435729|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111061179|NCT05435729|Dopamine Agents|dopamine agents|mesh-ancestor
111061180|NCT05435729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111061181|NCT05435729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111061182|NCT05435729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111061183|NCT05430750|Nitrous Oxide|nitrous oxide|mesh-list
111061184|NCT05430750|Sevoflurane|sevoflurane|mesh-list
111061185|NCT05430750|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111061186|NCT05430750|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111061187|NCT05430750|Anesthetics, General|anesthetics, general|mesh-ancestor
111061188|NCT05430750|Anesthetics|anesthetics|mesh-ancestor
111061189|NCT05430750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111061190|NCT05430750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111061191|NCT05430750|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111061192|NCT05430750|Analgesics|analgesics|mesh-ancestor
111061193|NCT05430750|Sensory System Agents|sensory system agents|mesh-ancestor
111061194|NCT05430750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111061195|NCT05429593|Dapagliflozin|dapagliflozin|mesh-list
111061196|NCT05429593|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111061197|NCT05429593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111061198|NCT05429593|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111061199|NCT05429593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110633632|NCT00236899|Antimetabolites|antimetabolites|mesh-ancestor
111061200|NCT05403476|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
111061201|NCT05403476|Hormones|hormones|mesh-ancestor
111061244|NCT05326776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111061246|NCT05302804|Antipruritics|antipruritics|mesh-ancestor
111061247|NCT05302804|Dermatologic Agents|dermatologic agents|mesh-ancestor
111061248|NCT05298202|Capsaicin|capsaicin|mesh-list
111061249|NCT05298202|Antipruritics|antipruritics|mesh-ancestor
111061250|NCT05298202|Dermatologic Agents|dermatologic agents|mesh-ancestor
111061251|NCT05298202|Sensory System Agents|sensory system agents|mesh-ancestor
111061252|NCT05298202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111061253|NCT05298202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111061254|NCT05285644|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111061255|NCT05285644|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111061256|NCT05283304|Buprenorphine|buprenorphine|mesh-list
111061257|NCT05283304|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111061258|NCT05283304|Narcotics|narcotics|mesh-ancestor
111061259|NCT05283304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111061260|NCT05283304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111061261|NCT05283304|Analgesics|analgesics|mesh-ancestor
111061262|NCT05283304|Sensory System Agents|sensory system agents|mesh-ancestor
111061263|NCT05283304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111061264|NCT05283304|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111061265|NCT05208307|Dexamethasone|dexamethasone|mesh-list
111061266|NCT05208307|Dexamethasone acetate|dexamethasone acetate|mesh-list
111061267|NCT05208307|Pomalidomide|pomalidomide|mesh-list
111061268|NCT05208307|Ichthammol|ichthammol|mesh-list
111061269|NCT05208307|BB 1101|bb 1101|mesh-list
111061270|NCT05208307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111061271|NCT05208307|Antiemetics|antiemetics|mesh-ancestor
111061272|NCT05208307|Autonomic Agents|autonomic agents|mesh-ancestor
111061273|NCT05208307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111061274|NCT05208307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111061275|NCT05208307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110778370|NCT03036124|Dapagliflozin|dapagliflozin|mesh-list
111061276|NCT05208307|Glucocorticoids|glucocorticoids|mesh-ancestor
111061277|NCT05208307|Hormones|hormones|mesh-ancestor
111061278|NCT05208307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111061279|NCT05208307|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111061280|NCT05208307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111061281|NCT05208307|Protease Inhibitors|protease inhibitors|mesh-ancestor
111061282|NCT05208307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111061283|NCT05208307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111061284|NCT05208307|Immunologic Factors|immunologic factors|mesh-ancestor
111061285|NCT05208307|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111061286|NCT05208307|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111061287|NCT05208307|Growth Substances|growth substances|mesh-ancestor
111061288|NCT05208307|Growth Inhibitors|growth inhibitors|mesh-ancestor
111061289|NCT05208307|Dermatologic Agents|dermatologic agents|mesh-ancestor
111061291|NCT05201248|Cyclophosphamide|cyclophosphamide|mesh-list
111061292|NCT05201248|Rituximab|rituximab|mesh-list
111061293|NCT05201248|Doxorubicin|doxorubicin|mesh-list
111061294|NCT05201248|Vincristine|vincristine|mesh-list
111061295|NCT05201248|Lenalidomide|lenalidomide|mesh-list
111061296|NCT05201248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111061297|NCT05201248|Immunologic Factors|immunologic factors|mesh-ancestor
111061298|NCT05201248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111061299|NCT05201248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111061300|NCT05201248|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111061301|NCT05201248|Alkylating Agents|alkylating agents|mesh-ancestor
111061302|NCT05201248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110633792|NCT00883818|Azithromycin|azithromycin|mesh-list
111061303|NCT05201248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111061304|NCT05201248|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111061305|NCT05201248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111061306|NCT05201248|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111061307|NCT05201248|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111061308|NCT05201248|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111061309|NCT05201248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111061310|NCT05201248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111061311|NCT05201248|Glucocorticoids|glucocorticoids|mesh-ancestor
111061312|NCT05201248|Hormones|hormones|mesh-ancestor
111061313|NCT05201248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111061314|NCT05201248|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111061315|NCT05201248|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111061316|NCT05201248|Tubulin Modulators|tubulin modulators|mesh-ancestor
111061317|NCT05201248|Antimitotic Agents|antimitotic agents|mesh-ancestor
111061318|NCT05201248|Mitosis Modulators|mitosis modulators|mesh-ancestor
111061319|NCT05201248|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111061320|NCT05201248|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110633865|NCT00736853|Acetaminophen|acetaminophen|mesh-list
111061321|NCT05201248|Growth Substances|growth substances|mesh-ancestor
111061322|NCT05201248|Growth Inhibitors|growth inhibitors|mesh-ancestor
111061323|NCT05172258|Pembrolizumab|pembrolizumab|mesh-list
111061324|NCT05172258|Ipatasertib|ipatasertib|mesh-list
111061325|NCT05172258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111061326|NCT05172258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111061327|NCT05172258|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111061328|NCT05172258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111061329|NCT05172258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111061330|NCT05172258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111061331|NCT05171816|Olaparib|olaparib|mesh-list
111061332|NCT05171816|Abiraterone Acetate|abiraterone acetate|mesh-list
111061333|NCT05171816|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111061334|NCT05171816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111061335|NCT05171816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111061336|NCT05171816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111061337|NCT05171816|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111061338|NCT05171816|Hormone Antagonists|hormone antagonists|mesh-ancestor
111061339|NCT05171816|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111061340|NCT05171816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111061341|NCT05171816|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111061342|NCT05169866|Amiodarone|amiodarone|mesh-list
111061343|NCT05169866|Nifekalant|nifekalant|mesh-list
111061344|NCT05169866|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111061345|NCT05169866|Vasodilator Agents|vasodilator agents|mesh-ancestor
111061346|NCT05169866|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
111061347|NCT05169866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111061348|NCT05169866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111061349|NCT05169866|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111061350|NCT05169866|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111061351|NCT05169866|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111061352|NCT05169866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111061353|NCT05169866|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111061354|NCT05169866|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111061355|NCT05169866|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111061356|NCT05156658|Etonogestrel|etonogestrel|mesh-list
111061357|NCT05156658|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111061359|NCT05156658|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111061360|NCT05156658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111061361|NCT05156658|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111061362|NCT05095961|Prednisone|prednisone|mesh-list
111061363|NCT05095961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111061364|NCT05095961|Glucocorticoids|glucocorticoids|mesh-ancestor
111061365|NCT05095961|Hormones|hormones|mesh-ancestor
111061366|NCT05095961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111061367|NCT05095961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111061368|NCT05095961|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111061369|NCT05095961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111061370|NCT05052957|Temozolomide|temozolomide|mesh-list
111061371|NCT05052957|Carmustine|carmustine|mesh-list
111061372|NCT05052957|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
111061373|NCT05052957|Lenograstim|lenograstim|mesh-list
111061374|NCT05052957|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111061375|NCT05052957|Immunologic Factors|immunologic factors|mesh-ancestor
111061376|NCT05052957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111061377|NCT05052957|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111061378|NCT05052957|Alkylating Agents|alkylating agents|mesh-ancestor
111061379|NCT05052957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111061380|NCT05052957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111061381|NCT05052957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111061382|NCT04999020|Ravulizumab|ravulizumab|mesh-list
111061383|NCT04999020|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
111061384|NCT04999020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111061385|NCT04999020|Immunologic Factors|immunologic factors|mesh-ancestor
111061386|NCT04999020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111061387|NCT04998617|Curcumin|curcumin|mesh-list
111061388|NCT04998617|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111061389|NCT04998617|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111061390|NCT04998617|Analgesics|analgesics|mesh-ancestor
111061391|NCT04998617|Sensory System Agents|sensory system agents|mesh-ancestor
111061392|NCT04998617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111061393|NCT04998617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111061394|NCT04998617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111061395|NCT04998617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111061396|NCT04998617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111061397|NCT04998617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111061398|NCT04998617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111061399|NCT04952597|Tislelizumab|tislelizumab|mesh-list
111061400|NCT04952597|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111061401|NCT04952597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111061402|NCT04933266|Levobupivacaine|levobupivacaine|mesh-list
111061403|NCT04933266|Anesthetics, Local|anesthetics, local|mesh-ancestor
111061404|NCT04933266|Anesthetics|anesthetics|mesh-ancestor
111061405|NCT04933266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111061406|NCT04933266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111061407|NCT04933266|Sensory System Agents|sensory system agents|mesh-ancestor
111061408|NCT04933266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111061409|NCT04914247|Selexipag|selexipag|mesh-list
111061410|NCT04914247|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110633984|NCT00278161|Rituximab|rituximab|mesh-list
111061411|NCT04908449|Bupivacaine|bupivacaine|mesh-list
111061412|NCT04908449|Anesthetics, Local|anesthetics, local|mesh-ancestor
111061413|NCT04908449|Anesthetics|anesthetics|mesh-ancestor
111061414|NCT04908449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111061415|NCT04908449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111061416|NCT04908449|Sensory System Agents|sensory system agents|mesh-ancestor
111061417|NCT04908449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111061418|NCT04889287|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111061419|NCT04889287|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111061420|NCT04889287|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111061421|NCT04889287|Antimetabolites|antimetabolites|mesh-ancestor
111061422|NCT04889287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111061423|NCT04889287|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111061424|NCT04889287|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111061425|NCT04889287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111061434|NCT04883281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111061435|NCT04883281|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111061437|NCT04877522|Imatinib Mesylate|imatinib mesylate|mesh-list
111061438|NCT04877522|Dasatinib|dasatinib|mesh-list
111061439|NCT04877522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111061440|NCT04877522|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111061441|NCT04877522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111061442|NCT04877522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111061443|NCT04877522|Vitamin B Complex|vitamin b complex|mesh-ancestor
111061444|NCT04877522|Vitamins|vitamins|mesh-ancestor
111061445|NCT04877522|Micronutrients|micronutrients|mesh-ancestor
111061446|NCT04877522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111061447|NCT04862663|Fulvestrant|fulvestrant|mesh-list
111061448|NCT04862663|Palbociclib|palbociclib|mesh-list
111061449|NCT04862663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111061450|NCT04862663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111061451|NCT04862663|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
111061452|NCT04862663|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111061453|NCT04862663|Hormone Antagonists|hormone antagonists|mesh-ancestor
110634044|NCT03973957|Anesthetics|anesthetics|mesh-ancestor
111061454|NCT04862663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111061455|NCT04862663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111061456|NCT04862663|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111061457|NCT04862663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111061458|NCT04862663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111061466|NCT04797780|Azacitidine|azacitidine|mesh-list
111061467|NCT04797780|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111061468|NCT04797780|Antimetabolites|antimetabolites|mesh-ancestor
111061469|NCT04797780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111061470|NCT04797780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111061471|NCT04797780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111061472|NCT04791176|Lenvatinib|lenvatinib|mesh-list
111061473|NCT04791176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111061474|NCT04791176|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111061475|NCT04791176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111061476|NCT04791176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111061477|NCT04748419|Durvalumab|durvalumab|mesh-list
111061478|NCT04748419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111061479|NCT04748419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111061480|NCT04709380|Sorafenib|sorafenib|mesh-list
111061481|NCT04709380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111061482|NCT04709380|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111061483|NCT04709380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111061484|NCT04709380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111061485|NCT04673617|Cyclophosphamide|cyclophosphamide|mesh-list
111061486|NCT04673617|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
111061487|NCT04673617|Rituximab|rituximab|mesh-list
111061488|NCT04673617|Fludarabine|fludarabine|mesh-list
111061489|NCT04673617|Interleukin-2|interleukin-2|mesh-list
111061490|NCT04673617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111061491|NCT04673617|Immunologic Factors|immunologic factors|mesh-ancestor
111061492|NCT04673617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111061493|NCT04673617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111061494|NCT04673617|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111061495|NCT04673617|Alkylating Agents|alkylating agents|mesh-ancestor
111061496|NCT04673617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111061497|NCT04673617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111061498|NCT04673617|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110778579|NCT04987372|Anesthetics, General|anesthetics, general|mesh-ancestor
111061499|NCT04673617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111061501|NCT04673617|Analgesics|analgesics|mesh-ancestor
111061502|NCT04673617|Sensory System Agents|sensory system agents|mesh-ancestor
111061503|NCT04673617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111061504|NCT04657068|Gemcitabine|gemcitabine|mesh-list
111061505|NCT04657068|Irinotecan|irinotecan|mesh-list
111061506|NCT04657068|Camptothecin|camptothecin|mesh-list
111061507|NCT04657068|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111061508|NCT04657068|Antimetabolites|antimetabolites|mesh-ancestor
111061509|NCT04657068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111061510|NCT04657068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111061511|NCT04657068|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111061512|NCT04657068|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111061513|NCT04657068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111061514|NCT04657068|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111061515|NCT04640636|Midazolam|midazolam|mesh-list
111061516|NCT04640636|Ketamine|ketamine|mesh-list
111061517|NCT04640636|Analgesics|analgesics|mesh-ancestor
111061518|NCT04640636|Sensory System Agents|sensory system agents|mesh-ancestor
111061519|NCT04640636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111061520|NCT04640636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111061521|NCT04640636|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111061522|NCT04640636|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111061523|NCT04640636|Anesthetics, General|anesthetics, general|mesh-ancestor
111061524|NCT04640636|Anesthetics|anesthetics|mesh-ancestor
111061525|NCT04640636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111061526|NCT04640636|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111061527|NCT04640636|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111061528|NCT04640636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111061529|NCT04640636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111061530|NCT04640636|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111061531|NCT04640636|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111061532|NCT04640636|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111061533|NCT04640636|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111061534|NCT04640636|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111061535|NCT04640636|GABA Modulators|gaba modulators|mesh-ancestor
111061536|NCT04640636|GABA Agents|gaba agents|mesh-ancestor
111061537|NCT04603651|Bamlanivimab|bamlanivimab|mesh-list
111061538|NCT04603651|Antiviral Agents|antiviral agents|mesh-ancestor
111061539|NCT04603651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111061540|NCT04577326|Cyclophosphamide|cyclophosphamide|mesh-list
111061541|NCT04577326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111061542|NCT04577326|Immunologic Factors|immunologic factors|mesh-ancestor
111061543|NCT04577326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110634133|NCT00891306|Hormones|hormones|mesh-ancestor
111061544|NCT04577326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111061545|NCT04577326|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111061546|NCT04577326|Alkylating Agents|alkylating agents|mesh-ancestor
111061547|NCT04577326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111061548|NCT04577326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111061549|NCT04577326|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111061551|NCT04573946|Ergocalciferols|ergocalciferols|mesh-list
111061552|NCT04573946|Cholecalciferol|cholecalciferol|mesh-list
111061553|NCT04573946|Vitamins|vitamins|mesh-list
111061554|NCT04573946|Micronutrients|micronutrients|mesh-ancestor
111061555|NCT04573946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111061556|NCT04573946|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111061557|NCT04573946|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111061558|NCT04558359|Angiotensin II|angiotensin ii|mesh-list
111061559|NCT04558359|Giapreza|giapreza|mesh-list
111061560|NCT04558359|Angiotensinogen|angiotensinogen|mesh-list
111061561|NCT04558359|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111061562|NCT04558359|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111061563|NCT04558359|Protease Inhibitors|protease inhibitors|mesh-ancestor
111061564|NCT04558359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111061565|NCT04558359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111061566|NCT04538053|Cefazolin|cefazolin|mesh-list
111061567|NCT04538053|Cephalexin|cephalexin|mesh-list
111061568|NCT04538053|Floxacillin|floxacillin|mesh-list
111061569|NCT04538053|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111061570|NCT04538053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111061571|NCT04495179|Durvalumab|durvalumab|mesh-list
111061572|NCT04495179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111061573|NCT04495179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111061574|NCT04413123|Nivolumab|nivolumab|mesh-list
111061575|NCT04413123|Ipilimumab|ipilimumab|mesh-list
111061576|NCT04413123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111061577|NCT04413123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111061578|NCT04413123|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111061579|NCT04413123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111061580|NCT04385290|Cytarabine|cytarabine|mesh-list
111061581|NCT04385290|Daunorubicin|daunorubicin|mesh-list
111061582|NCT04385290|Gemtuzumab|gemtuzumab|mesh-list
111061583|NCT04385290|Midostaurin|midostaurin|mesh-list
111061584|NCT04385290|Staurosporine|staurosporine|mesh-list
111061585|NCT04385290|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111061586|NCT04385290|Antimetabolites|antimetabolites|mesh-ancestor
111061587|NCT04385290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111061588|NCT04385290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111061589|NCT04385290|Antiviral Agents|antiviral agents|mesh-ancestor
111061590|NCT04385290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111061591|NCT04385290|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111061592|NCT04385290|Immunologic Factors|immunologic factors|mesh-ancestor
111061593|NCT04385290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111061594|NCT04385290|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111061595|NCT04385290|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111061596|NCT04385290|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111061597|NCT04385290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111061598|NCT04385290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111061599|NCT04385290|Immunotoxins|immunotoxins|mesh-ancestor
111061600|NCT04385290|Immunoconjugates|immunoconjugates|mesh-ancestor
111061601|NCT04385290|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111061602|NCT04336241|Nivolumab|nivolumab|mesh-list
111061603|NCT04336241|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111061604|NCT04336241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111061605|NCT04336241|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111061606|NCT04336241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111061607|NCT04313712|Ibogaine|ibogaine|mesh-list
111061608|NCT04313712|Hallucinogens|hallucinogens|mesh-ancestor
111061609|NCT04313712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111061610|NCT04313712|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111061611|NCT04313712|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111061612|NCT04313712|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111061613|NCT04313712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111061614|NCT04313712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111061615|NCT04272242|Pyridoxine|pyridoxine|mesh-list
111061616|NCT04272242|Pyridoxal|pyridoxal|mesh-list
111061617|NCT04272242|Vitamin B 6|vitamin b 6|mesh-list
111061618|NCT04272242|Isoniazid|isoniazid|mesh-list
111061619|NCT04272242|Rifapentine|rifapentine|mesh-list
111061620|NCT04272242|Dolutegravir|dolutegravir|mesh-list
111061621|NCT04272242|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
111061622|NCT04272242|Vitamins|vitamins|mesh-ancestor
111061623|NCT04272242|Micronutrients|micronutrients|mesh-ancestor
111061624|NCT04272242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111061625|NCT04272242|Vitamin B Complex|vitamin b complex|mesh-ancestor
111061626|NCT04272242|Antitubercular Agents|antitubercular agents|mesh-ancestor
111061627|NCT04272242|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111061628|NCT04272242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111061629|NCT04272242|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
111061630|NCT04272242|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111061631|NCT04272242|Antimetabolites|antimetabolites|mesh-ancestor
111061632|NCT04272242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111061633|NCT04272242|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111061634|NCT04272242|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111061635|NCT04272242|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110634197|NCT00649220|Memantine|memantine|mesh-list
111061636|NCT04272242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111061637|NCT04272242|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111061638|NCT04272242|Antiviral Agents|antiviral agents|mesh-ancestor
111061639|NCT04272242|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111061640|NCT04272242|Leprostatic Agents|leprostatic agents|mesh-ancestor
111061641|NCT04241549|Azacitidine|azacitidine|mesh-list
111061642|NCT04241549|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111061643|NCT04241549|Antimetabolites|antimetabolites|mesh-ancestor
111061644|NCT04241549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111061645|NCT04241549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111061646|NCT04241549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111061647|NCT04240626|Acetaminophen|acetaminophen|mesh-list
111061648|NCT04240626|Scopolamine|scopolamine|mesh-list
111061649|NCT04240626|Oxycodone|oxycodone|mesh-list
111061650|NCT04240626|Gabapentin|gabapentin|mesh-list
111061651|NCT04240626|Hydromorphone|hydromorphone|mesh-list
111061652|NCT04240626|Hydrocodone|hydrocodone|mesh-list
111061653|NCT04240626|Bupivacaine|bupivacaine|mesh-list
111061655|NCT04240626|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
111061656|NCT04240626|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111061657|NCT04240626|Analgesics|analgesics|mesh-ancestor
111061658|NCT04240626|Sensory System Agents|sensory system agents|mesh-ancestor
111061659|NCT04240626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111061660|NCT04240626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111061661|NCT04240626|Antipyretics|antipyretics|mesh-ancestor
111061662|NCT04240626|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111061663|NCT04240626|Narcotics|narcotics|mesh-ancestor
111061664|NCT04240626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111061665|NCT04240626|Anticonvulsants|anticonvulsants|mesh-ancestor
111061666|NCT04240626|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111061667|NCT04240626|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111061668|NCT04240626|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111061669|NCT04240626|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111061670|NCT04240626|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111061671|NCT04240626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111061672|NCT04240626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111061673|NCT04240626|Antimanic Agents|antimanic agents|mesh-ancestor
111061674|NCT04240626|Anesthetics, Local|anesthetics, local|mesh-ancestor
111061676|NCT04240626|Antiemetics|antiemetics|mesh-ancestor
111061677|NCT04240626|Autonomic Agents|autonomic agents|mesh-ancestor
111061678|NCT04240626|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111061679|NCT04240626|Antitussive Agents|antitussive agents|mesh-ancestor
111061680|NCT04240626|Respiratory System Agents|respiratory system agents|mesh-ancestor
111061681|NCT04240626|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111061682|NCT04240626|Mydriatics|mydriatics|mesh-ancestor
111061683|NCT04240626|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111061684|NCT04240626|Cholinergic Agents|cholinergic agents|mesh-ancestor
111061685|NCT04240626|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111061686|NCT04240626|Parasympatholytics|parasympatholytics|mesh-ancestor
111061687|NCT04240626|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
111061688|NCT04240626|Antidepressive Agents|antidepressive agents|mesh-ancestor
111061689|NCT04240626|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
111061690|NCT04240626|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111061691|NCT04231318|Triamcinolone|triamcinolone|mesh-list
111061692|NCT04231318|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
111061693|NCT04231318|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
111061694|NCT04231318|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
111061695|NCT04231318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111061696|NCT04231318|Glucocorticoids|glucocorticoids|mesh-ancestor
111061697|NCT04231318|Hormones|hormones|mesh-ancestor
111061698|NCT04231318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111061699|NCT04231318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111061700|NCT04231318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111061701|NCT04231318|Immunologic Factors|immunologic factors|mesh-ancestor
110634321|NCT00646958|Linezolid|linezolid|mesh-list
111061702|NCT04231318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111061703|NCT04231318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111061704|NCT04201262|Ravulizumab|ravulizumab|mesh-list
111061705|NCT04201262|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
111061706|NCT04201262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111061707|NCT04201262|Immunologic Factors|immunologic factors|mesh-ancestor
111061708|NCT04201262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111061709|NCT04150887|Azacitidine|azacitidine|mesh-list
111061710|NCT04150887|Venetoclax|venetoclax|mesh-list
111061711|NCT04150887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111061712|NCT04150887|Antimetabolites|antimetabolites|mesh-ancestor
111061713|NCT04150887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111061714|NCT04150887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111061715|NCT04150887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111061716|NCT04072445|Trifluridine|trifluridine|mesh-list
111061717|NCT04072445|Irinotecan|irinotecan|mesh-list
111061718|NCT04072445|Camptothecin|camptothecin|mesh-list
111061719|NCT04072445|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111061720|NCT04072445|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110634379|NCT00817622|Antioxidants|antioxidants|mesh-ancestor
111061721|NCT04072445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111061722|NCT04072445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111061723|NCT04072445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111061724|NCT04072445|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111061725|NCT04072445|Antimetabolites|antimetabolites|mesh-ancestor
111061726|NCT04072445|Antiviral Agents|antiviral agents|mesh-ancestor
110778807|NCT03725228|Sensory System Agents|sensory system agents|mesh-ancestor
111061727|NCT04072445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111061728|NCT04050540|Doxycycline|doxycycline|mesh-list
111061729|NCT04050540|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111061730|NCT04050540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111061731|NCT04050540|Antimalarials|antimalarials|mesh-ancestor
111061732|NCT04050540|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111061733|NCT04050540|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111061734|NCT04023526|Azacitidine|azacitidine|mesh-list
111061735|NCT04023526|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111061736|NCT04023526|Antimetabolites|antimetabolites|mesh-ancestor
111061737|NCT04023526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111061738|NCT04023526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111061739|NCT04023526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111061740|NCT04020913|Hormones|hormones|mesh-list
111061741|NCT04020913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111061742|NCT04020913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111061743|NCT04004442|Avelumab|avelumab|mesh-list
111061744|NCT04004442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111061745|NCT04004442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111061746|NCT03957551|Pembrolizumab|pembrolizumab|mesh-list
111061747|NCT03957551|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111061748|NCT03957551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111061749|NCT03957551|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111061750|NCT03957551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111061751|NCT03945513|Dienogest|dienogest|mesh-list
111061752|NCT03945513|Ethinyl Estradiol|ethinyl estradiol|mesh-list
111061753|NCT03945513|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111061754|NCT03945513|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111061755|NCT03945513|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111061756|NCT03945513|Contraceptive Agents|contraceptive agents|mesh-ancestor
111061757|NCT03945513|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111061758|NCT03945513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111061759|NCT03945513|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111061760|NCT03945513|Estrogens|estrogens|mesh-ancestor
111061761|NCT03945513|Hormones|hormones|mesh-ancestor
111061762|NCT03945513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111061763|NCT03945513|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
111061764|NCT03945513|Hormone Antagonists|hormone antagonists|mesh-ancestor
111061765|NCT03945513|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111061766|NCT03945513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111061767|NCT03932643|TIC10 compound|tic10 compound|mesh-list
111061768|NCT03932643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111061769|NCT03897127|Cytarabine|cytarabine|mesh-list
111061770|NCT03897127|Daunorubicin|daunorubicin|mesh-list
111061771|NCT03897127|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111061772|NCT03897127|Antimetabolites|antimetabolites|mesh-ancestor
111061773|NCT03897127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111061774|NCT03897127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111061775|NCT03897127|Antiviral Agents|antiviral agents|mesh-ancestor
111061776|NCT03897127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111061777|NCT03897127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111061778|NCT03897127|Immunologic Factors|immunologic factors|mesh-ancestor
111061779|NCT03897127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111061780|NCT03897127|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111061781|NCT03897127|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111061782|NCT03897127|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111061783|NCT03897127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111061784|NCT03863288|Oxytocin|oxytocin|mesh-list
111061785|NCT03863288|Oxytocics|oxytocics|mesh-ancestor
111061786|NCT03863288|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111061787|NCT03863288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111061788|NCT03862495|Azithromycin|azithromycin|mesh-list
111061789|NCT03862495|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111061790|NCT03862495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111061791|NCT03793478|Cytarabine|cytarabine|mesh-list
111061792|NCT03793478|Fludarabine|fludarabine|mesh-list
111061793|NCT03793478|Etoposide|etoposide|mesh-list
111061794|NCT03793478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111061795|NCT03793478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111061796|NCT03793478|Antimetabolites|antimetabolites|mesh-ancestor
111061797|NCT03793478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111061798|NCT03793478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111061799|NCT03793478|Immunologic Factors|immunologic factors|mesh-ancestor
111061800|NCT03793478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111061801|NCT03793478|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111061802|NCT03793478|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111061803|NCT03793478|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111061804|NCT03793478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111061805|NCT03793478|Antiviral Agents|antiviral agents|mesh-ancestor
111061806|NCT03793478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111061807|NCT03785405|Valsartan|valsartan|mesh-list
111061808|NCT03785405|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
111061809|NCT03785405|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111061810|NCT03785405|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111061811|NCT03785405|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111061812|NCT03785405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111061813|NCT03728673|Dexetimide|dexetimide|mesh-list
111061814|NCT03728673|Citalopram|citalopram|mesh-list
111061815|NCT03728673|Escitalopram|escitalopram|mesh-list
111061816|NCT03728673|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111061817|NCT03728673|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111061818|NCT03728673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111061819|NCT03728673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110827898|NCT00025259|Hormones|hormones|mesh-ancestor
111061820|NCT03728673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111061821|NCT03728673|Serotonin Agents|serotonin agents|mesh-ancestor
111061822|NCT03728673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111061823|NCT03728673|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111061824|NCT03728673|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111061825|NCT03728673|Parasympatholytics|parasympatholytics|mesh-ancestor
111061826|NCT03728673|Autonomic Agents|autonomic agents|mesh-ancestor
111061827|NCT03728673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111061828|NCT03728673|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111061829|NCT03728673|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111061830|NCT03728673|Cholinergic Agents|cholinergic agents|mesh-ancestor
111061831|NCT03728673|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111061832|NCT03728673|Antidepressive Agents|antidepressive agents|mesh-ancestor
111061833|NCT03728673|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111061835|NCT03691662|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111061836|NCT03691662|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111061837|NCT03691662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111061838|NCT03691662|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111061839|NCT03691662|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111061840|NCT03691662|Adrenergic Agents|adrenergic agents|mesh-ancestor
111061841|NCT03691662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111061842|NCT03691662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111061843|NCT03691662|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111061844|NCT03691662|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111061845|NCT03689244|Selexipag|selexipag|mesh-list
111061846|NCT03689244|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111061847|NCT03594175|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
111061848|NCT03594175|Reteplase|reteplase|mesh-list
111061849|NCT03594175|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111061850|NCT03594175|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111061851|NCT03594175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111061852|NCT03587038|Temozolomide|temozolomide|mesh-list
111061853|NCT03587038|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111061854|NCT03587038|Alkylating Agents|alkylating agents|mesh-ancestor
111061855|NCT03587038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111061856|NCT03587038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111061857|NCT03568630|Chrysarobin|chrysarobin|mesh-list
111061858|NCT03568630|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111061859|NCT03568630|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111061860|NCT03568630|Analgesics|analgesics|mesh-ancestor
111061861|NCT03568630|Sensory System Agents|sensory system agents|mesh-ancestor
111061862|NCT03568630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111061863|NCT03568630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111061864|NCT03568630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111061865|NCT03568630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111061866|NCT03414229|Pembrolizumab|pembrolizumab|mesh-list
111061867|NCT03414229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111061868|NCT03414229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111061869|NCT03414229|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110634600|NCT00585689|Carboplatin|carboplatin|mesh-list
111061870|NCT03414229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111061871|NCT03338959|Pembrolizumab|pembrolizumab|mesh-list
111061872|NCT03338959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111061873|NCT03338959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111061874|NCT03338959|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111061875|NCT03338959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111061876|NCT03288545|Carboplatin|carboplatin|mesh-list
111061877|NCT03288545|Gemcitabine|gemcitabine|mesh-list
111061878|NCT03288545|Pembrolizumab|pembrolizumab|mesh-list
111061879|NCT03288545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111061880|NCT03288545|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111061881|NCT03288545|Antimetabolites|antimetabolites|mesh-ancestor
111061882|NCT03288545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111061883|NCT03288545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111061884|NCT03288545|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111061885|NCT03278782|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111061886|NCT03278782|Pembrolizumab|pembrolizumab|mesh-list
111061887|NCT03278782|Romidepsin|romidepsin|mesh-list
111061888|NCT03278782|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111061889|NCT03278782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111061890|NCT03278782|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111061891|NCT03278782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111061892|NCT03278782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111061893|NCT03278782|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111061894|NCT03278782|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111061895|NCT03278782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111061896|NCT03104491|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
111061897|NCT03104491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111061898|NCT03104491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111061899|NCT03104491|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111061900|NCT03104491|Immunotoxins|immunotoxins|mesh-ancestor
111061901|NCT03104491|Immunoconjugates|immunoconjugates|mesh-ancestor
111061902|NCT03104491|Immunologic Factors|immunologic factors|mesh-ancestor
111061903|NCT03104491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111061904|NCT02977780|Temozolomide|temozolomide|mesh-list
111061905|NCT02977780|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111061906|NCT02977780|Alkylating Agents|alkylating agents|mesh-ancestor
111061907|NCT02977780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111061908|NCT02977780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111061909|NCT02897063|Midodrine|midodrine|mesh-list
111061910|NCT02897063|Droxidopa|droxidopa|mesh-list
111061911|NCT02897063|Sympathomimetics|sympathomimetics|mesh-ancestor
111061912|NCT02897063|Autonomic Agents|autonomic agents|mesh-ancestor
111061913|NCT02897063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111061914|NCT02897063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111061915|NCT02897063|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111061916|NCT02897063|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111061917|NCT02897063|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111061918|NCT02897063|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111061919|NCT02897063|Adrenergic Agents|adrenergic agents|mesh-ancestor
111061920|NCT02897063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111061921|NCT02897063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111061922|NCT02897063|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111061923|NCT02897063|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111061924|NCT02888743|Durvalumab|durvalumab|mesh-list
111061925|NCT02888743|Ipilimumab|ipilimumab|mesh-list
111061926|NCT02888743|Tremelimumab|tremelimumab|mesh-list
111061927|NCT02888743|Immunoglobulins|immunoglobulins|mesh-list
111061928|NCT02888743|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111061929|NCT02888743|Immunoglobulin G|immunoglobulin g|mesh-list
111061930|NCT02888743|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111061931|NCT02888743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111061932|NCT02888743|Immunologic Factors|immunologic factors|mesh-ancestor
111061933|NCT02888743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111061934|NCT02888743|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111061935|NCT02888743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111061936|NCT02804022|Morphine|morphine|mesh-list
111061937|NCT02804022|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111061938|NCT02804022|Narcotics|narcotics|mesh-ancestor
111061939|NCT02804022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111061940|NCT02804022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111061941|NCT02804022|Analgesics|analgesics|mesh-ancestor
111061942|NCT02804022|Sensory System Agents|sensory system agents|mesh-ancestor
111061943|NCT02804022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111061944|NCT02792413|Denosumab|denosumab|mesh-list
111061945|NCT02792413|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111061946|NCT02792413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111061947|NCT02719574|Cytarabine|cytarabine|mesh-list
111061948|NCT02719574|Azacitidine|azacitidine|mesh-list
111061949|NCT02719574|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111061950|NCT02719574|Antimetabolites|antimetabolites|mesh-ancestor
111061951|NCT02719574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111061952|NCT02719574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111061953|NCT02719574|Antiviral Agents|antiviral agents|mesh-ancestor
111061954|NCT02719574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111061955|NCT02719574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111061956|NCT02719574|Immunologic Factors|immunologic factors|mesh-ancestor
111061957|NCT02719574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111061958|NCT02719574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111061959|NCT02717624|Acalabrutinib|acalabrutinib|mesh-list
111061960|NCT02717624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111061961|NCT02714439|Proflavine|proflavine|mesh-list
111061962|NCT02714439|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111061963|NCT02714439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111061964|NCT02654119|Paclitaxel|paclitaxel|mesh-list
111061965|NCT02654119|Cyclophosphamide|cyclophosphamide|mesh-list
111061966|NCT02654119|Trastuzumab|trastuzumab|mesh-list
111061967|NCT02654119|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111061968|NCT02654119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111061969|NCT02654119|Antibodies|antibodies|mesh-list
111061970|NCT02654119|Immunoglobulins|immunoglobulins|mesh-list
111061971|NCT02654119|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111061972|NCT02654119|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111061973|NCT02654119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111061974|NCT02654119|Tubulin Modulators|tubulin modulators|mesh-ancestor
111061975|NCT02654119|Antimitotic Agents|antimitotic agents|mesh-ancestor
111061976|NCT02654119|Mitosis Modulators|mitosis modulators|mesh-ancestor
111061977|NCT02654119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111061978|NCT02654119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111061979|NCT02654119|Immunologic Factors|immunologic factors|mesh-ancestor
111061980|NCT02654119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111061981|NCT02654119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111061982|NCT02654119|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111061983|NCT02654119|Alkylating Agents|alkylating agents|mesh-ancestor
111061984|NCT02654119|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111061985|NCT02567422|Cisplatin|cisplatin|mesh-list
111061986|NCT02567422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111061987|NCT02543879|Azacitidine|azacitidine|mesh-list
111061988|NCT02543879|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111061989|NCT02543879|Antimetabolites|antimetabolites|mesh-ancestor
111061990|NCT02543879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111061991|NCT02543879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111061992|NCT02543879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111061993|NCT02307812|Paclitaxel|paclitaxel|mesh-list
111061994|NCT02307812|Ramucirumab|ramucirumab|mesh-list
111061995|NCT02307812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111061996|NCT02307812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111061997|NCT02307812|Tubulin Modulators|tubulin modulators|mesh-ancestor
111061998|NCT02307812|Antimitotic Agents|antimitotic agents|mesh-ancestor
111061999|NCT02307812|Mitosis Modulators|mitosis modulators|mesh-ancestor
111062000|NCT02307812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111062001|NCT02220985|Mycophenolic Acid|mycophenolic acid|mesh-list
111062002|NCT02220985|Cyclophosphamide|cyclophosphamide|mesh-list
111062003|NCT02220985|Thiotepa|thiotepa|mesh-list
111062004|NCT02220985|Methotrexate|methotrexate|mesh-list
111062005|NCT02220985|Fludarabine|fludarabine|mesh-list
111062006|NCT02220985|Fludarabine phosphate|fludarabine phosphate|mesh-list
111062007|NCT02220985|Tacrolimus|tacrolimus|mesh-list
111062008|NCT02220985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111062009|NCT02220985|Immunologic Factors|immunologic factors|mesh-ancestor
111062010|NCT02220985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111062011|NCT02220985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111062012|NCT02220985|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111062013|NCT02220985|Alkylating Agents|alkylating agents|mesh-ancestor
111062014|NCT02220985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111062015|NCT02220985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111062016|NCT02220985|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111062017|NCT02220985|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111062018|NCT02220985|Abortifacient Agents|abortifacient agents|mesh-ancestor
111062019|NCT02220985|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111062020|NCT02220985|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111062021|NCT02220985|Antimetabolites|antimetabolites|mesh-ancestor
111062022|NCT02220985|Dermatologic Agents|dermatologic agents|mesh-ancestor
111062023|NCT02220985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111062024|NCT02220985|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111062025|NCT02220985|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111062026|NCT02220985|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111062027|NCT02220985|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111062028|NCT02220985|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111062029|NCT02220985|Antitubercular Agents|antitubercular agents|mesh-ancestor
111062030|NCT02220985|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111062031|NCT02220985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111062032|NCT02193191|Plerixafor|plerixafor|mesh-list
111062033|NCT02193191|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111062034|NCT02193191|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111062035|NCT02193191|Antiviral Agents|antiviral agents|mesh-ancestor
111062036|NCT02193191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111062037|NCT02133573|Progesterone|progesterone|mesh-list
111062038|NCT02133573|Progestins|progestins|mesh-ancestor
111062039|NCT02133573|Hormones|hormones|mesh-ancestor
111062040|NCT02133573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111062041|NCT02133573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111062042|NCT02073994|Ivosidenib|ivosidenib|mesh-list
111062043|NCT02073994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111062044|NCT02073994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111062045|NCT02073994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111062046|NCT02065765|Ramucirumab|ramucirumab|mesh-list
111062047|NCT02065765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111062048|NCT01878669|Acetylcysteine|acetylcysteine|mesh-list
111062049|NCT01878669|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111062050|NCT01878669|Antiviral Agents|antiviral agents|mesh-ancestor
111062051|NCT01878669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111062052|NCT01878669|Expectorants|expectorants|mesh-ancestor
111062053|NCT01878669|Respiratory System Agents|respiratory system agents|mesh-ancestor
111062054|NCT01878669|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111062055|NCT01878669|Antioxidants|antioxidants|mesh-ancestor
111062056|NCT01878669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111062057|NCT01878669|Protective Agents|protective agents|mesh-ancestor
111062058|NCT01878669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111062059|NCT01878669|Antidotes|antidotes|mesh-ancestor
111062060|NCT01861314|Bortezomib|bortezomib|mesh-list
111062061|NCT01861314|Sorafenib|sorafenib|mesh-list
111062062|NCT01861314|Decitabine|decitabine|mesh-list
111062063|NCT01861314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111062064|NCT01861314|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111062065|NCT01861314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111062066|NCT01861314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111062067|NCT01861314|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111062068|NCT01861314|Antimetabolites|antimetabolites|mesh-ancestor
111062069|NCT01704859|Vitamin D|vitamin d|mesh-list
111062070|NCT01704859|Ergocalciferols|ergocalciferols|mesh-list
111062071|NCT01704859|Cholecalciferol|cholecalciferol|mesh-list
111062072|NCT01704859|Vitamins|vitamins|mesh-list
111062073|NCT01704859|Micronutrients|micronutrients|mesh-ancestor
111062074|NCT01704859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111062075|NCT01704859|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111062076|NCT01704859|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111062077|NCT01585805|Cisplatin|cisplatin|mesh-list
111062078|NCT01585805|Gemcitabine|gemcitabine|mesh-list
111062079|NCT01585805|Veliparib|veliparib|mesh-list
111062080|NCT01585805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111062081|NCT01585805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111062082|NCT01585805|Antimetabolites|antimetabolites|mesh-ancestor
111062083|NCT01585805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111062084|NCT01585805|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111062085|NCT01585805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111062086|NCT00869232|Thalidomide|thalidomide|mesh-list
111062087|NCT00869232|Dexamethasone|dexamethasone|mesh-list
111062088|NCT00869232|Cyclophosphamide|cyclophosphamide|mesh-list
111062089|NCT00869232|Melphalan|melphalan|mesh-list
111062090|NCT00869232|Doxorubicin|doxorubicin|mesh-list
111062091|NCT00869232|Etoposide|etoposide|mesh-list
111062092|NCT00869232|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111062093|NCT00869232|Bortezomib|bortezomib|mesh-list
111062094|NCT00869232|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111062095|NCT00869232|Immunologic Factors|immunologic factors|mesh-ancestor
111062096|NCT00869232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111062097|NCT00869232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111062098|NCT00869232|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111062099|NCT00869232|Alkylating Agents|alkylating agents|mesh-ancestor
111062100|NCT00869232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111062101|NCT00869232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111062102|NCT00869232|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111062103|NCT00869232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111062104|NCT00869232|Antiemetics|antiemetics|mesh-ancestor
111062105|NCT00869232|Autonomic Agents|autonomic agents|mesh-ancestor
111062106|NCT00869232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111062107|NCT00869232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111062108|NCT00869232|Glucocorticoids|glucocorticoids|mesh-ancestor
111062109|NCT00869232|Hormones|hormones|mesh-ancestor
111062110|NCT00869232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111062111|NCT00869232|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111062112|NCT00869232|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111062113|NCT00869232|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111062114|NCT00869232|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111062115|NCT00869232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111062116|NCT00869232|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111062117|NCT00869232|Leprostatic Agents|leprostatic agents|mesh-ancestor
111062119|NCT00869232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111062120|NCT00869232|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111062121|NCT00869232|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111062122|NCT00869232|Growth Substances|growth substances|mesh-ancestor
111062123|NCT00869232|Growth Inhibitors|growth inhibitors|mesh-ancestor
111062124|NCT00765765|Hydroxychloroquine|hydroxychloroquine|mesh-list
111062125|NCT00765765|Antimalarials|antimalarials|mesh-ancestor
111062126|NCT00765765|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111062127|NCT00765765|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111062128|NCT00765765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111062129|NCT00765765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111062130|NCT00765765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110634830|NCT00609336|Gemcitabine|gemcitabine|mesh-list
111062131|NCT00765765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111062132|NCT00734877|Thalidomide|thalidomide|mesh-list
111062133|NCT00734877|Dexamethasone|dexamethasone|mesh-list
111062134|NCT00734877|Dexamethasone acetate|dexamethasone acetate|mesh-list
111062135|NCT00734877|Cyclophosphamide|cyclophosphamide|mesh-list
111062136|NCT00734877|Melphalan|melphalan|mesh-list
111062137|NCT00734877|Cisplatin|cisplatin|mesh-list
111062138|NCT00734877|Etoposide|etoposide|mesh-list
111062139|NCT00734877|Etoposide phosphate|etoposide phosphate|mesh-list
111062140|NCT00734877|Doxorubicin|doxorubicin|mesh-list
111062141|NCT00734877|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111062142|NCT00734877|Bortezomib|bortezomib|mesh-list
111062143|NCT00734877|BB 1101|bb 1101|mesh-list
111062144|NCT00734877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111062145|NCT00734877|Immunologic Factors|immunologic factors|mesh-ancestor
111062146|NCT00734877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111062147|NCT00734877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111062148|NCT00734877|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111062149|NCT00734877|Alkylating Agents|alkylating agents|mesh-ancestor
111062150|NCT00734877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111062151|NCT00734877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111062152|NCT00734877|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111062153|NCT00734877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111062154|NCT00734877|Antiemetics|antiemetics|mesh-ancestor
111062155|NCT00734877|Autonomic Agents|autonomic agents|mesh-ancestor
111062156|NCT00734877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111062157|NCT00734877|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111062158|NCT00734877|Glucocorticoids|glucocorticoids|mesh-ancestor
111062159|NCT00734877|Hormones|hormones|mesh-ancestor
111062160|NCT00734877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111062161|NCT00734877|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111062162|NCT00734877|Protease Inhibitors|protease inhibitors|mesh-ancestor
111062163|NCT00734877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111062164|NCT00734877|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111062165|NCT00734877|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111062166|NCT00734877|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111062167|NCT00734877|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111062168|NCT00734877|Leprostatic Agents|leprostatic agents|mesh-ancestor
111062169|NCT00734877|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111062170|NCT00734877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111062171|NCT00734877|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111062172|NCT00734877|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111062173|NCT00734877|Growth Substances|growth substances|mesh-ancestor
111062174|NCT00734877|Growth Inhibitors|growth inhibitors|mesh-ancestor
111062175|NCT00686595|Infliximab|infliximab|mesh-list
111062176|NCT00686595|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111062177|NCT00686595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111062178|NCT00686595|Dermatologic Agents|dermatologic agents|mesh-ancestor
111062179|NCT00686595|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111062180|NCT00686595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111062181|NCT00640159|Selegiline|selegiline|mesh-list
111062182|NCT00640159|Antidepressive Agents|antidepressive agents|mesh-ancestor
111062183|NCT00640159|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111062184|NCT00640159|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111062185|NCT00640159|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111062186|NCT00640159|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
111062187|NCT00640159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111062188|NCT00640159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111062189|NCT00640159|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111062190|NCT00640159|Protective Agents|protective agents|mesh-ancestor
111062191|NCT00640159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111062192|NCT00071708|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
111062193|NCT00071708|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111062194|NCT00071708|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110634899|NCT00640328|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111062195|NCT00071708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111062196|NCT00071708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111062197|NCT00071708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111062198|NCT00071708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111062199|NCT00071708|Analgesics|analgesics|mesh-ancestor
111062200|NCT00071708|Sensory System Agents|sensory system agents|mesh-ancestor
111062201|NCT00071708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111062202|NCT00071708|Antidepressive Agents|antidepressive agents|mesh-ancestor
111062203|NCT00071708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111062204|NCT00071708|Dopamine Agents|dopamine agents|mesh-ancestor
111062205|NCT03483415|Morphine|morphine|mesh-list
111062206|NCT03483415|Bupivacaine|bupivacaine|mesh-list
111062207|NCT03483415|Anesthetics, Local|anesthetics, local|mesh-ancestor
111062208|NCT03483415|Anesthetics|anesthetics|mesh-ancestor
111062209|NCT03483415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111062210|NCT03483415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111062211|NCT03483415|Sensory System Agents|sensory system agents|mesh-ancestor
111062212|NCT03483415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111062213|NCT03483415|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111062214|NCT03483415|Narcotics|narcotics|mesh-ancestor
111062215|NCT03483415|Analgesics|analgesics|mesh-ancestor
111062216|NCT03487003|Bromides|bromides|mesh-list
111062217|NCT03487003|Rocuronium|rocuronium|mesh-list
111062218|NCT03487003|Anticonvulsants|anticonvulsants|mesh-ancestor
111062219|NCT03487003|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
111062220|NCT03487003|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
111062221|NCT03487003|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111062222|NCT03487003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111062223|NCT03487003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111062224|NCT03486925|Oxytocin|oxytocin|mesh-list
111062225|NCT03486925|Oxytocics|oxytocics|mesh-ancestor
111062226|NCT03486925|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111062227|NCT03486925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111062228|NCT02262754|Naproxen|naproxen|mesh-list
111062229|NCT02262754|PF-06372865|pf-06372865|mesh-list
111062230|NCT02262754|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111062231|NCT02262754|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111062232|NCT02262754|Analgesics|analgesics|mesh-ancestor
111062233|NCT02262754|Sensory System Agents|sensory system agents|mesh-ancestor
111062234|NCT02262754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111062235|NCT02262754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111062236|NCT02262754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111062237|NCT02262754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111062238|NCT02262754|Gout Suppressants|gout suppressants|mesh-ancestor
111062239|NCT02262754|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111062240|NCT02262754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111062241|NCT02262754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111062242|NCT02262754|GABA Modulators|gaba modulators|mesh-ancestor
111062243|NCT02262754|GABA Agents|gaba agents|mesh-ancestor
111062244|NCT02262754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111062245|NCT03483181|Enoxaparin|enoxaparin|mesh-list
111062246|NCT03483181|Rivaroxaban|rivaroxaban|mesh-list
111062247|NCT03483181|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111062248|NCT03483181|Antithrombins|antithrombins|mesh-ancestor
111062249|NCT03483181|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111062250|NCT03483181|Protease Inhibitors|protease inhibitors|mesh-ancestor
111062251|NCT03483181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111062252|NCT03483181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111062253|NCT03483181|Anticoagulants|anticoagulants|mesh-ancestor
111062254|NCT03483181|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111062255|NCT03483181|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111062256|NCT02356588|Sufentanil|sufentanil|mesh-list
111062257|NCT02356588|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111062259|NCT02356588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111062260|NCT02356588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111062262|NCT02356588|Sensory System Agents|sensory system agents|mesh-ancestor
111062263|NCT02356588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111062264|NCT02356588|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111062265|NCT02356588|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111062266|NCT02356588|Anesthetics, General|anesthetics, general|mesh-ancestor
111062267|NCT02356588|Anesthetics|anesthetics|mesh-ancestor
111062268|NCT04445389|Vaccines|vaccines|mesh-list
111062269|NCT04445389|Immunologic Factors|immunologic factors|mesh-ancestor
111062270|NCT04445389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111062271|NCT02355028|Ranibizumab|ranibizumab|mesh-list
111062272|NCT02355028|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111062273|NCT02355028|Acrizanib|acrizanib|mesh-list
111062274|NCT02355028|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111062275|NCT02355028|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111062276|NCT02355028|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111062277|NCT02355028|Growth Substances|growth substances|mesh-ancestor
111062278|NCT02355028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111062279|NCT02355028|Growth Inhibitors|growth inhibitors|mesh-ancestor
111062280|NCT02355028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111062281|NCT02355028|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111062282|NCT02355028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111062283|NCT02355028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111062284|NCT05647330|Hydroxychloroquine|hydroxychloroquine|mesh-list
111062285|NCT05647330|Chloroquine|chloroquine|mesh-list
111062286|NCT05647330|Gemcitabine|gemcitabine|mesh-list
111062287|NCT05647330|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111062288|NCT05647330|Antimetabolites|antimetabolites|mesh-ancestor
111062289|NCT05647330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111062290|NCT05647330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111062291|NCT05647330|Antimalarials|antimalarials|mesh-ancestor
111062292|NCT05647330|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111062293|NCT05647330|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111062294|NCT05647330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111062295|NCT05647330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111062296|NCT05647330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111062297|NCT05647330|Amebicides|amebicides|mesh-ancestor
111062298|NCT01643668|Busulfan|busulfan|mesh-list
111062299|NCT01643668|Clofarabine|clofarabine|mesh-list
111062300|NCT01643668|Alkylating Agents|alkylating agents|mesh-ancestor
111062301|NCT01643668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111062302|NCT01643668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110635088|NCT04035330|Eusol|eusol|mesh-list
111062303|NCT01643668|Immunologic Factors|immunologic factors|mesh-ancestor
111062304|NCT01643668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111062305|NCT01643668|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111062306|NCT01643668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111062307|NCT01643668|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111062308|NCT01643668|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111062309|NCT01643668|Antimetabolites|antimetabolites|mesh-ancestor
111062310|NCT02260882|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
111062311|NCT02260882|Immunologic Factors|immunologic factors|mesh-ancestor
111062312|NCT02260882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111062313|NCT00112411|Bronchodilator Agents|bronchodilator agents|mesh-list
111062314|NCT00112411|Autonomic Agents|autonomic agents|mesh-ancestor
111062315|NCT00112411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111062316|NCT00112411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111062317|NCT00112411|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111062318|NCT00112411|Respiratory System Agents|respiratory system agents|mesh-ancestor
111062319|NCT02260804|Rituximab|rituximab|mesh-list
111062320|NCT02260804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111062321|NCT02260804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111062322|NCT02260804|Immunologic Factors|immunologic factors|mesh-ancestor
111062323|NCT02260804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111062324|NCT02260804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111062325|NCT03486457|Tofacitinib|tofacitinib|mesh-list
111062326|NCT03486457|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
111062327|NCT03486457|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111062328|NCT03486457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111062329|NCT03486457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111062330|NCT02260648|Atorvastatin|atorvastatin|mesh-list
111062331|NCT02260648|Ezetimibe|ezetimibe|mesh-list
111062332|NCT02260648|Evacetrapib|evacetrapib|mesh-list
111062333|NCT02260648|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110527425|NCT00648141|Celecoxib|celecoxib|mesh-list
111062334|NCT02260648|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111062335|NCT02260648|Antimetabolites|antimetabolites|mesh-ancestor
111062336|NCT02260648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111062337|NCT02260648|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111062338|NCT02260648|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111062339|NCT02260648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111062341|NCT04179019|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111062342|NCT04179019|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111062343|NCT04179019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111062344|NCT04179019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111062345|NCT04179019|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111062346|NCT04179019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111062347|NCT04179019|Vasodilator Agents|vasodilator agents|mesh-ancestor
111062348|NCT02260492|Fluticasone|fluticasone|mesh-list
111062349|NCT02260492|Xhance|xhance|mesh-list
111062350|NCT02260492|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
111062351|NCT02260492|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
111062352|NCT02260492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111062353|NCT02260492|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111062354|NCT02260492|Autonomic Agents|autonomic agents|mesh-ancestor
111062355|NCT02260492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110635173|NCT00901524|Antiviral Agents|antiviral agents|mesh-ancestor
111062356|NCT02260492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111062357|NCT02260492|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111062358|NCT02260492|Respiratory System Agents|respiratory system agents|mesh-ancestor
111062359|NCT02260492|Dermatologic Agents|dermatologic agents|mesh-ancestor
111062360|NCT02260492|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111062361|NCT02260492|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111062362|NCT02260492|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111062363|NCT02260492|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111062364|NCT02260492|Adrenergic Agents|adrenergic agents|mesh-ancestor
111062365|NCT02260492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111062366|NCT02260492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111062367|NCT02260492|Glucocorticoids|glucocorticoids|mesh-ancestor
111062368|NCT02260492|Hormones|hormones|mesh-ancestor
111062369|NCT02260492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111062370|NCT02260492|Sympathomimetics|sympathomimetics|mesh-ancestor
111062371|NCT03966625|Autoantibodies|autoantibodies|mesh-list
111062372|NCT03966625|Immunologic Factors|immunologic factors|mesh-ancestor
111062373|NCT03966625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111062374|NCT02260258|Rocuronium|rocuronium|mesh-list
111062375|NCT02260258|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
111062376|NCT02260258|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
111062377|NCT02260258|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111062378|NCT02260258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111062379|NCT02260258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111062380|NCT05151679|Iron|iron|mesh-list
111062381|NCT05151679|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
111062382|NCT05151679|Iron Chelating Agents|iron chelating agents|mesh-list
111062383|NCT05151679|Trace Elements|trace elements|mesh-ancestor
111062384|NCT05151679|Micronutrients|micronutrients|mesh-ancestor
111062385|NCT05151679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111062386|NCT05151679|Hematinics|hematinics|mesh-ancestor
111062387|NCT05151679|Chelating Agents|chelating agents|mesh-ancestor
111062388|NCT05151679|Sequestering Agents|sequestering agents|mesh-ancestor
111062389|NCT05151679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111062390|NCT02324257|Obinutuzumab|obinutuzumab|mesh-list
111062391|NCT02324257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111062392|NCT02324257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111062393|NCT02353468|Dexamethasone|dexamethasone|mesh-list
111062394|NCT02353468|Lenalidomide|lenalidomide|mesh-list
111062395|NCT02353468|Bortezomib|bortezomib|mesh-list
111062396|NCT02353468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111062397|NCT02353468|Antiemetics|antiemetics|mesh-ancestor
111062398|NCT02353468|Autonomic Agents|autonomic agents|mesh-ancestor
111062399|NCT02353468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111062400|NCT02353468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111062401|NCT02353468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111062402|NCT02353468|Glucocorticoids|glucocorticoids|mesh-ancestor
111062403|NCT02353468|Hormones|hormones|mesh-ancestor
111062404|NCT02353468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110779477|NCT03701698|Glucocorticoids|glucocorticoids|mesh-ancestor
110779478|NCT03701698|Hormones|hormones|mesh-ancestor
110779479|NCT03701698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110779480|NCT03701698|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110779481|NCT03701698|Protective Agents|protective agents|mesh-ancestor
111062405|NCT02353468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111062406|NCT02353468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111062407|NCT02353468|Immunologic Factors|immunologic factors|mesh-ancestor
111062408|NCT02353468|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111062409|NCT02353468|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111062410|NCT02353468|Growth Substances|growth substances|mesh-ancestor
111062411|NCT02353468|Growth Inhibitors|growth inhibitors|mesh-ancestor
111062412|NCT04459663|Axitinib|axitinib|mesh-list
111062413|NCT04459663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111062414|NCT04459663|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111062415|NCT04459663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111062416|NCT04459663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111062417|NCT05150899|Fexofenadine|fexofenadine|mesh-list
111062418|NCT05150899|Tamsulosin|tamsulosin|mesh-list
111062419|NCT05150899|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111062420|NCT05150899|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111062421|NCT05150899|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111062422|NCT05150899|Adrenergic Agents|adrenergic agents|mesh-ancestor
111062423|NCT05150899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111062424|NCT05150899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111062425|NCT05150899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111062426|NCT05150899|Urological Agents|urological agents|mesh-ancestor
111062427|NCT05150899|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111062428|NCT05150899|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
111062429|NCT05150899|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111062430|NCT05150899|Histamine Antagonists|histamine antagonists|mesh-ancestor
111062431|NCT05150899|Histamine Agents|histamine agents|mesh-ancestor
111062432|NCT01530997|Cisplatin|cisplatin|mesh-list
111062433|NCT01530997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111062434|NCT00593905|Bosentan|bosentan|mesh-list
111062435|NCT00593905|Ambrisentan|ambrisentan|mesh-list
111062436|NCT00593905|Sitaxsentan|sitaxsentan|mesh-list
111062437|NCT00593905|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111062438|NCT00593905|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
111062439|NCT00593905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111062440|NCT02259088|Ranibizumab|ranibizumab|mesh-list
111062441|NCT02259088|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111062442|NCT02259088|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111062443|NCT02259088|Growth Substances|growth substances|mesh-ancestor
111062444|NCT02259088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111062445|NCT02259088|Growth Inhibitors|growth inhibitors|mesh-ancestor
111062446|NCT02259088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111062447|NCT02830477|Factor VIII|factor viii|mesh-list
111062448|NCT02830477|Coagulants|coagulants|mesh-ancestor
111062449|NCT02259010|Itraconazole|itraconazole|mesh-list
111062450|NCT02259010|Antifungal Agents|antifungal agents|mesh-ancestor
111062451|NCT02259010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111062452|NCT02259010|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111062453|NCT02259010|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111062454|NCT02259010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111062455|NCT02259010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111062456|NCT02259010|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111062457|NCT02259010|Hormone Antagonists|hormone antagonists|mesh-ancestor
110635358|NCT00893958|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111062458|NCT02259010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111062459|NCT02259010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111062460|NCT02259010|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111062461|NCT02021773|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111062462|NCT02021773|Immunologic Factors|immunologic factors|mesh-ancestor
111062463|NCT02021773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111062464|NCT05153785|Lidocaine|lidocaine|mesh-list
111062465|NCT05153785|Anesthetics, Local|anesthetics, local|mesh-ancestor
111062466|NCT05153785|Anesthetics|anesthetics|mesh-ancestor
111062467|NCT05153785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111062468|NCT05153785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111062469|NCT05153785|Sensory System Agents|sensory system agents|mesh-ancestor
111062470|NCT05153785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111062471|NCT05153785|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111062472|NCT05153785|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111062473|NCT05153785|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110779550|NCT00038103|Celecoxib|celecoxib|mesh-list
110779551|NCT00038103|Exemestane|exemestane|mesh-list
111062474|NCT05153785|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110779552|NCT00038103|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110779553|NCT00038103|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110635413|NCT00569582|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111062475|NCT05153785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111062476|NCT00151775|Olmesartan|olmesartan|mesh-list
111062477|NCT00151775|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
111062478|NCT00151775|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111062479|NCT00151775|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111062480|NCT00151775|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111062481|NCT00151775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111062482|NCT02258464|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
111062483|NCT02258464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111062484|NCT03476941|Clindamycin|clindamycin|mesh-list
111062485|NCT03476941|Clindamycin palmitate|clindamycin palmitate|mesh-list
111062486|NCT03476941|Clindamycin phosphate|clindamycin phosphate|mesh-list
111062487|NCT03476941|Gentamicins|gentamicins|mesh-list
111062488|NCT03476941|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111062489|NCT03476941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111062490|NCT03476941|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111062491|NCT03476941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111062492|NCT03476941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111062493|NCT00609323|Lidocaine|lidocaine|mesh-list
111062494|NCT00609323|Tetracaine|tetracaine|mesh-list
111062495|NCT00609323|Anesthetics, Local|anesthetics, local|mesh-ancestor
111062496|NCT00609323|Anesthetics|anesthetics|mesh-ancestor
111062497|NCT00609323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111062498|NCT00609323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111062499|NCT00609323|Sensory System Agents|sensory system agents|mesh-ancestor
111062500|NCT00609323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111062501|NCT00609323|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111062502|NCT00609323|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111062503|NCT00609323|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111062504|NCT00609323|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111062505|NCT00609323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111062506|NCT02682901|Bromocriptine|bromocriptine|mesh-list
111062507|NCT02682901|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111062508|NCT02682901|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111062509|NCT02682901|Hormone Antagonists|hormone antagonists|mesh-ancestor
111062510|NCT02682901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111062511|NCT02682901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111062512|NCT02682901|Dopamine Agonists|dopamine agonists|mesh-ancestor
111062513|NCT02682901|Dopamine Agents|dopamine agents|mesh-ancestor
111062514|NCT02682901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111062515|NCT02682901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111062516|NCT02258074|Niacinamide|niacinamide|mesh-list
111062518|NCT02258074|Nicotinic Acids|nicotinic acids|mesh-list
111062519|NCT02258074|Vitamin B Complex|vitamin b complex|mesh-ancestor
111062520|NCT02258074|Vitamins|vitamins|mesh-ancestor
111062521|NCT02258074|Micronutrients|micronutrients|mesh-ancestor
111062522|NCT02258074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111062523|NCT02258074|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111062524|NCT02258074|Antimetabolites|antimetabolites|mesh-ancestor
111062525|NCT02258074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111062526|NCT02258074|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111062527|NCT02258074|Vasodilator Agents|vasodilator agents|mesh-ancestor
111062528|NCT04473053|Nafamostat|nafamostat|mesh-list
111062529|NCT04473053|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111062530|NCT04473053|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111062531|NCT04473053|Analgesics|analgesics|mesh-ancestor
111062532|NCT04473053|Sensory System Agents|sensory system agents|mesh-ancestor
111062533|NCT04473053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111062534|NCT04473053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111062535|NCT04473053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111062536|NCT04473053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111062537|NCT04473053|Anticoagulants|anticoagulants|mesh-ancestor
111062538|NCT04473053|Protease Inhibitors|protease inhibitors|mesh-ancestor
111062539|NCT04473053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111062540|NCT04473053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111062541|NCT04473053|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
111062542|NCT04473053|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111062543|NCT04473053|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
111062544|NCT04473053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111062545|NCT04473053|Immunologic Factors|immunologic factors|mesh-ancestor
111062546|NCT02281643|Doxycycline|doxycycline|mesh-list
111062547|NCT02281643|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111062548|NCT02281643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111062549|NCT02281643|Antimalarials|antimalarials|mesh-ancestor
111062550|NCT02281643|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111062551|NCT02281643|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111062552|NCT02281721|Calcium Carbonate|calcium carbonate|mesh-list
111062554|NCT02281721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111062555|NCT02281721|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111062556|NCT01642732|Everolimus|everolimus|mesh-list
111062557|NCT01642732|Leuprolide|leuprolide|mesh-list
111062558|NCT01642732|Bicalutamide|bicalutamide|mesh-list
111062559|NCT01642732|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111062560|NCT01642732|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111062561|NCT01642732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111062562|NCT01642732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111062563|NCT01642732|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111062564|NCT01642732|Immunologic Factors|immunologic factors|mesh-ancestor
111062565|NCT01642732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111062566|NCT01642732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111062567|NCT01642732|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111062568|NCT01642732|Fertility Agents|fertility agents|mesh-ancestor
111062569|NCT01642732|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111062570|NCT01642732|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111062571|NCT01642732|Androgen Antagonists|androgen antagonists|mesh-ancestor
111062572|NCT01642732|Hormone Antagonists|hormone antagonists|mesh-ancestor
111062573|NCT01642732|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111062574|NCT02281799|Mercaptopurine|mercaptopurine|mesh-list
111062575|NCT02281799|Azathioprine|azathioprine|mesh-list
111062576|NCT02281799|Antimetabolites|antimetabolites|mesh-ancestor
111062577|NCT02281799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111062578|NCT02281799|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111062579|NCT02281799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111062580|NCT02281799|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111062581|NCT02281799|Immunologic Factors|immunologic factors|mesh-ancestor
111062582|NCT02281799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111062583|NCT02281799|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111062584|NCT02281799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111062585|NCT02281799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110635743|NCT02540070|Epinephrine|epinephrine|mesh-list
111062586|NCT02283515|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111062587|NCT02283515|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111062588|NCT02283515|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111062589|NCT02283515|Antimetabolites|antimetabolites|mesh-ancestor
111062590|NCT02283515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111062591|NCT02283515|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111062592|NCT02283515|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111062593|NCT02283515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111062594|NCT00589823|Fentanyl|fentanyl|mesh-list
111062595|NCT00589823|Morphine|morphine|mesh-list
111062596|NCT00589823|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111062597|NCT00589823|Narcotics|narcotics|mesh-ancestor
111062598|NCT00589823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111062599|NCT00589823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111062600|NCT00589823|Analgesics|analgesics|mesh-ancestor
111062601|NCT00589823|Sensory System Agents|sensory system agents|mesh-ancestor
111062602|NCT00589823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110635805|NCT00906048|Rifampin|rifampin|mesh-list
111062603|NCT00589823|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111062604|NCT00589823|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111062605|NCT00589823|Anesthetics, General|anesthetics, general|mesh-ancestor
111062606|NCT00589823|Anesthetics|anesthetics|mesh-ancestor
111062607|NCT02190721|Lenograstim|lenograstim|mesh-list
111062608|NCT02190721|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111062609|NCT02190721|Immunologic Factors|immunologic factors|mesh-ancestor
111062610|NCT02190721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111062611|NCT00581477|Droxidopa|droxidopa|mesh-list
111062612|NCT00581477|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111062613|NCT00581477|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111062614|NCT03134339|Nicotine|nicotine|mesh-list
110527707|NCT02462538|Immunotoxins|immunotoxins|mesh-ancestor
111062615|NCT03134339|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111062616|NCT03134339|Autonomic Agents|autonomic agents|mesh-ancestor
111062617|NCT03134339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111062618|NCT03134339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111062619|NCT03134339|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111062620|NCT03134339|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110779702|NCT04817410|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111062621|NCT03134339|Cholinergic Agents|cholinergic agents|mesh-ancestor
111062622|NCT03134339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111062623|NCT03134339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111062624|NCT02282267|Gefitinib|gefitinib|mesh-list
111062625|NCT02282267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111062626|NCT02282267|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111062627|NCT02282267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111062628|NCT02282267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111062629|NCT02283905|Voriconazole|voriconazole|mesh-list
111062630|NCT02283905|Amphotericin B|amphotericin b|mesh-list
111062631|NCT02283905|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
111062632|NCT02283905|Antifungal Agents|antifungal agents|mesh-ancestor
111062633|NCT02283905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111062634|NCT02283905|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111062635|NCT02283905|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111062636|NCT02283905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111062637|NCT02283905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111062638|NCT02283905|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111062639|NCT02283905|Hormone Antagonists|hormone antagonists|mesh-ancestor
111062640|NCT02283905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111062641|NCT02283905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111062642|NCT02283905|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111062643|NCT02283905|Amebicides|amebicides|mesh-ancestor
111062644|NCT02283905|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111062645|NCT02283905|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111062646|NCT02283905|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111062647|NCT03480997|Bromides|bromides|mesh-list
111062648|NCT03480997|Albuterol|albuterol|mesh-list
111062649|NCT03480997|Ipratropium|ipratropium|mesh-list
111062650|NCT03480997|Anticonvulsants|anticonvulsants|mesh-ancestor
111062651|NCT03480997|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111062652|NCT03480997|Autonomic Agents|autonomic agents|mesh-ancestor
111062653|NCT03480997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111062654|NCT03480997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111062655|NCT03480997|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111062656|NCT03480997|Respiratory System Agents|respiratory system agents|mesh-ancestor
111062657|NCT03480997|Tocolytic Agents|tocolytic agents|mesh-ancestor
111062658|NCT03480997|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111062659|NCT03480997|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111062660|NCT03480997|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110635973|NCT00909168|Immunotoxins|immunotoxins|mesh-ancestor
111062661|NCT03480997|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111062662|NCT03480997|Adrenergic Agents|adrenergic agents|mesh-ancestor
111062663|NCT03480997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111062664|NCT03480997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111062665|NCT03480997|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111062666|NCT03480997|Cholinergic Agents|cholinergic agents|mesh-ancestor
111062667|NCT04660747|Anticoagulants|anticoagulants|mesh-list
111062668|NCT02348008|Bevacizumab|bevacizumab|mesh-list
111062669|NCT02348008|Pembrolizumab|pembrolizumab|mesh-list
111062670|NCT02348008|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111062671|NCT02348008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111062672|NCT02348008|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111062673|NCT02348008|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111062674|NCT02348008|Growth Substances|growth substances|mesh-ancestor
111062675|NCT02348008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111062676|NCT02348008|Growth Inhibitors|growth inhibitors|mesh-ancestor
111062677|NCT02348008|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111062678|NCT02348008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111062679|NCT00569387|Vaccines|vaccines|mesh-list
111062680|NCT00569387|Immunologic Factors|immunologic factors|mesh-ancestor
111062681|NCT00569387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111062682|NCT04468087|Atazanavir Sulfate|atazanavir sulfate|mesh-list
111062683|NCT04468087|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111062684|NCT04468087|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111062685|NCT04468087|Protease Inhibitors|protease inhibitors|mesh-ancestor
111062686|NCT04468087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111062687|NCT04468087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111062688|NCT04468087|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111062689|NCT04468087|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111062690|NCT04468087|Antiviral Agents|antiviral agents|mesh-ancestor
111062691|NCT04468087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111062693|NCT05944783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111062694|NCT05944783|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111062695|NCT05944783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111062696|NCT05944783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111062697|NCT05944458|Acetylcysteine|acetylcysteine|mesh-list
111062698|NCT05944458|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111062699|NCT05944458|Antiviral Agents|antiviral agents|mesh-ancestor
111062700|NCT05944458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111062701|NCT05944458|Expectorants|expectorants|mesh-ancestor
111062702|NCT05944458|Respiratory System Agents|respiratory system agents|mesh-ancestor
111062703|NCT05944458|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111062704|NCT05944458|Antioxidants|antioxidants|mesh-ancestor
111062705|NCT05944458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111062706|NCT05944458|Protective Agents|protective agents|mesh-ancestor
111062707|NCT05944458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111062708|NCT05944458|Antidotes|antidotes|mesh-ancestor
111062709|NCT05944393|Ropivacaine|ropivacaine|mesh-list
111062710|NCT05944393|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111062711|NCT05944393|Anesthetics, Local|anesthetics, local|mesh-ancestor
111062712|NCT05944393|Anesthetics|anesthetics|mesh-ancestor
111062713|NCT05944393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111062714|NCT05944393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111062715|NCT05944393|Sensory System Agents|sensory system agents|mesh-ancestor
111062716|NCT05944393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111062717|NCT05944380|Ropivacaine|ropivacaine|mesh-list
111062718|NCT05944380|Anesthetics, Local|anesthetics, local|mesh-ancestor
111062719|NCT05944380|Anesthetics|anesthetics|mesh-ancestor
111062720|NCT05944380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111062721|NCT05944380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111062722|NCT05944380|Sensory System Agents|sensory system agents|mesh-ancestor
111062723|NCT05944380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111062724|NCT05944341|Lidocaine|lidocaine|mesh-list
111062725|NCT05944341|Epinephrine|epinephrine|mesh-list
111062726|NCT05944341|Racepinephrine|racepinephrine|mesh-list
111062727|NCT05944341|Carticaine|carticaine|mesh-list
111062728|NCT05944341|Epinephryl borate|epinephryl borate|mesh-list
111062729|NCT05944341|Anesthetics, Local|anesthetics, local|mesh-ancestor
111062730|NCT05944341|Anesthetics|anesthetics|mesh-ancestor
111062731|NCT05944341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111062732|NCT05944341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111062733|NCT05944341|Sensory System Agents|sensory system agents|mesh-ancestor
111062734|NCT05944341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111062735|NCT05944341|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111062736|NCT05944341|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111062737|NCT05944341|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111062738|NCT05944341|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111062739|NCT05944341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111062740|NCT05944341|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111062741|NCT05944341|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111062742|NCT05944341|Adrenergic Agents|adrenergic agents|mesh-ancestor
111062743|NCT05944341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111062744|NCT05944341|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111062745|NCT05944341|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111062746|NCT05944341|Autonomic Agents|autonomic agents|mesh-ancestor
111062747|NCT05944341|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111062748|NCT05944341|Respiratory System Agents|respiratory system agents|mesh-ancestor
111062749|NCT05944341|Mydriatics|mydriatics|mesh-ancestor
111062750|NCT05944341|Sympathomimetics|sympathomimetics|mesh-ancestor
111062751|NCT05944341|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111062752|NCT05944146|Dobutamine|dobutamine|mesh-list
111062753|NCT05944146|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111062754|NCT05944146|Sympathomimetics|sympathomimetics|mesh-ancestor
111062755|NCT05944146|Autonomic Agents|autonomic agents|mesh-ancestor
111062756|NCT05944146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111062757|NCT05944146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111062758|NCT05944146|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
111062759|NCT05944146|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111062760|NCT05944146|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111062761|NCT05944146|Adrenergic Agents|adrenergic agents|mesh-ancestor
111062762|NCT05944146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111062763|NCT05944146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111062764|NCT05944146|Protective Agents|protective agents|mesh-ancestor
111062766|NCT05943990|Fludarabine|fludarabine|mesh-list
111062767|NCT05943990|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111062768|NCT05943990|Immunologic Factors|immunologic factors|mesh-ancestor
111062769|NCT05943990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111062770|NCT05943990|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111062771|NCT05943990|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111062772|NCT05943990|Alkylating Agents|alkylating agents|mesh-ancestor
111062773|NCT05943990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110779861|NCT03731442|Paclitaxel|paclitaxel|mesh-list
111062774|NCT05943990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111062775|NCT05943990|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111062776|NCT05943821|Allopurinol|allopurinol|mesh-list
111062777|NCT05943821|Antimetabolites|antimetabolites|mesh-ancestor
111062778|NCT05943821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111062779|NCT05943821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111062780|NCT05943821|Gout Suppressants|gout suppressants|mesh-ancestor
111062781|NCT05943821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111062782|NCT05943821|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111062783|NCT05943821|Antioxidants|antioxidants|mesh-ancestor
111062784|NCT05943821|Protective Agents|protective agents|mesh-ancestor
111062785|NCT05943821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111062786|NCT05943613|Clonidine|clonidine|mesh-list
111062787|NCT05943613|Analgesics|analgesics|mesh-ancestor
111062788|NCT05943613|Sensory System Agents|sensory system agents|mesh-ancestor
111062789|NCT05943613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111062790|NCT05943613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111062791|NCT05943613|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111062792|NCT05943613|Sympatholytics|sympatholytics|mesh-ancestor
111062793|NCT05943613|Autonomic Agents|autonomic agents|mesh-ancestor
111062794|NCT05943613|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111062795|NCT05943613|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111062796|NCT05943613|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111062797|NCT05943613|Adrenergic Agents|adrenergic agents|mesh-ancestor
111062798|NCT05943613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111062799|NCT05943613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111062800|NCT05943470|Icodextrin|icodextrin|mesh-list
111062801|NCT05943470|Dialysis Solutions|dialysis solutions|mesh-list
111062802|NCT05943470|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111062803|NCT05943457|Vitamin K|vitamin k|mesh-list
111062804|NCT05943457|Vitamin K 2|vitamin k 2|mesh-list
111062805|NCT05943457|Menaquinone 7|menaquinone 7|mesh-list
111062806|NCT05943457|Vitamins|vitamins|mesh-ancestor
111062807|NCT05943457|Micronutrients|micronutrients|mesh-ancestor
111062808|NCT05943457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111062809|NCT05943457|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111062810|NCT05943457|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111062811|NCT05943457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111062812|NCT05943457|Hemostatics|hemostatics|mesh-ancestor
111062813|NCT05943457|Coagulants|coagulants|mesh-ancestor
111062814|NCT05943379|Gemcitabine|gemcitabine|mesh-list
111062815|NCT05943379|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111062816|NCT05943379|Antimetabolites|antimetabolites|mesh-ancestor
111062817|NCT05943379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111062818|NCT05943379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111062819|NCT05943353|Pentoxifylline|pentoxifylline|mesh-list
111062820|NCT05943353|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111062821|NCT05943353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111062822|NCT05943353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111062823|NCT05943353|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111062824|NCT05943353|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111062825|NCT05943353|Protective Agents|protective agents|mesh-ancestor
111062826|NCT05943353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111062827|NCT05943353|Vasodilator Agents|vasodilator agents|mesh-ancestor
111062828|NCT05943353|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111062829|NCT05943353|Antioxidants|antioxidants|mesh-ancestor
111062830|NCT05943223|Metronidazole|metronidazole|mesh-list
111062831|NCT05943223|Ceftriaxone|ceftriaxone|mesh-list
111062832|NCT05943223|Tazobactam|tazobactam|mesh-list
111062833|NCT05943223|Piperacillin|piperacillin|mesh-list
111062834|NCT05943223|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
111062835|NCT05943223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111062836|NCT05943223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111062837|NCT05943223|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111062838|NCT05943223|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111062839|NCT05943223|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
111062840|NCT05943223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111062841|NCT05943223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111062843|NCT05943158|Vitamin B Complex|vitamin b complex|mesh-list
111062844|NCT05943158|Inositol|inositol|mesh-list
111062845|NCT05943158|Hematinics|hematinics|mesh-ancestor
111062846|NCT05943158|Vitamins|vitamins|mesh-ancestor
110636323|NCT00568958|Naltrexone|naltrexone|mesh-list
111062847|NCT05943158|Micronutrients|micronutrients|mesh-ancestor
111062848|NCT05943158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111062849|NCT05941949|Vitamins|vitamins|mesh-list
111062850|NCT05941949|Vitamin E|vitamin e|mesh-list
111062851|NCT05941949|Tocopherols|tocopherols|mesh-list
111062852|NCT05941949|Tocotrienols|tocotrienols|mesh-list
111062853|NCT05941949|alpha-Tocopherol|alpha-tocopherol|mesh-list
111062854|NCT05941949|Micronutrients|micronutrients|mesh-ancestor
111062855|NCT05941949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111062856|NCT05941949|Antioxidants|antioxidants|mesh-ancestor
111062857|NCT05941949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111062858|NCT05941949|Protective Agents|protective agents|mesh-ancestor
111062859|NCT05939674|Flumazenil|flumazenil|mesh-list
111062860|NCT05939674|Antidotes|antidotes|mesh-ancestor
111062861|NCT05939674|Protective Agents|protective agents|mesh-ancestor
111062862|NCT05939674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111062863|NCT05939674|GABA Modulators|gaba modulators|mesh-ancestor
111062864|NCT05939674|GABA Agents|gaba agents|mesh-ancestor
111062865|NCT05939674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111062866|NCT05939674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111062867|NCT05939635|Morphine|morphine|mesh-list
111062868|NCT05939635|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111062869|NCT05939635|Narcotics|narcotics|mesh-ancestor
111062870|NCT05939635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111062871|NCT05939635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111062872|NCT05939635|Analgesics|analgesics|mesh-ancestor
111062873|NCT05939635|Sensory System Agents|sensory system agents|mesh-ancestor
111062874|NCT05939635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111062875|NCT05939622|3-(2,2,2-trimethylhydrazine)propionate|3-(2,2,2-trimethylhydrazine)propionate|mesh-list
111062876|NCT05939622|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111062877|NCT05939622|Immunologic Factors|immunologic factors|mesh-ancestor
111062878|NCT05939622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111062879|NCT05939544|Milk fat globule|milk fat globule|mesh-list
111062880|NCT05939544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111062881|NCT05939193|Furosemide|furosemide|mesh-list
111062882|NCT05939193|Diuretics|diuretics|mesh-ancestor
111062883|NCT05939193|Natriuretic Agents|natriuretic agents|mesh-ancestor
111062884|NCT05939193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111062885|NCT05939193|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
111062886|NCT05939193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111062887|NCT05939193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111062888|NCT05920213|Lactulose|lactulose|mesh-list
111062889|NCT05920213|N-Methylaspartate|n-methylaspartate|mesh-list
111062890|NCT05920213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111062891|NCT05920213|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
111062892|NCT05920213|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111062893|NCT05920213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111062894|NCT05920213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111062895|NCT05920213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111062896|NCT05901714|Phenytoin|phenytoin|mesh-list
111062897|NCT05901714|Midazolam|midazolam|mesh-list
111062898|NCT05901714|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111062899|NCT05901714|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111062900|NCT05901714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111062901|NCT05901714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111062902|NCT05901714|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111062903|NCT05901714|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111062904|NCT05901714|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111062905|NCT05901714|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111062906|NCT05901714|Anesthetics, General|anesthetics, general|mesh-ancestor
111062907|NCT05901714|Anesthetics|anesthetics|mesh-ancestor
111062908|NCT05901714|GABA Modulators|gaba modulators|mesh-ancestor
111062909|NCT05901714|GABA Agents|gaba agents|mesh-ancestor
111062910|NCT05901714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111062911|NCT05901714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111062912|NCT05901714|Anticonvulsants|anticonvulsants|mesh-ancestor
111062913|NCT05901714|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110528006|NCT02698098|Methadone|methadone|mesh-list
111062915|NCT05901714|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111062916|NCT05901714|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
111062917|NCT05901714|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111062918|NCT05898399|Olaparib|olaparib|mesh-list
111062919|NCT05898399|Talazoparib|talazoparib|mesh-list
111062920|NCT05898399|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111062921|NCT05898399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111062922|NCT05898399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111062923|NCT05898399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111062924|NCT05838391|Fluorouracil|fluorouracil|mesh-list
111062925|NCT05838391|Capecitabine|capecitabine|mesh-list
111062926|NCT05838391|Mitomycins|mitomycins|mesh-list
111062927|NCT05838391|Mitomycin|mitomycin|mesh-list
111062928|NCT05838391|Antimetabolites|antimetabolites|mesh-ancestor
111062929|NCT05838391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111062930|NCT05838391|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111062931|NCT05838391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111062932|NCT05838391|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111062933|NCT05838391|Immunologic Factors|immunologic factors|mesh-ancestor
111062934|NCT05838391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110636540|NCT00147745|Insulin Glargine|insulin glargine|mesh-list
111062935|NCT05838391|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111062936|NCT05838391|Alkylating Agents|alkylating agents|mesh-ancestor
111062937|NCT05838391|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111062938|NCT05838391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111062939|NCT05797506|Sulforaphane|sulforaphane|mesh-list
111062940|NCT05797506|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
111062941|NCT05797506|Protective Agents|protective agents|mesh-ancestor
111062942|NCT05797506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111062943|NCT05797506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111062944|NCT05768360|Metformin|metformin|mesh-list
111062945|NCT05768360|Digoxin|digoxin|mesh-list
111062946|NCT05768360|Furosemide|furosemide|mesh-list
111062947|NCT05768360|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111062948|NCT05768360|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111062949|NCT05768360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111062950|NCT05768360|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111062951|NCT05768360|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111062952|NCT05768360|Antimetabolites|antimetabolites|mesh-ancestor
111062953|NCT05768360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111062954|NCT05768360|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111062955|NCT05768360|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111062956|NCT05768360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111062957|NCT05768360|Diuretics|diuretics|mesh-ancestor
111062958|NCT05768360|Natriuretic Agents|natriuretic agents|mesh-ancestor
111062959|NCT05768360|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
111062960|NCT05768360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111062961|NCT05768360|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111062962|NCT05768360|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111062963|NCT05768360|Protective Agents|protective agents|mesh-ancestor
111062964|NCT05756972|Carboplatin|carboplatin|mesh-list
111062965|NCT05756972|Pemetrexed|pemetrexed|mesh-list
111062966|NCT05756972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111062967|NCT05756972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111062968|NCT05756972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111062969|NCT05756972|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111062970|NCT05756972|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111062971|NCT05708950|Pembrolizumab|pembrolizumab|mesh-list
111062972|NCT05708950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111062973|NCT05708950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111062974|NCT05708950|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111062975|NCT05708950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111062976|NCT05689827|3-(2,2,2-trimethylhydrazine)propionate|3-(2,2,2-trimethylhydrazine)propionate|mesh-list
111062977|NCT05689827|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111062978|NCT05689827|Immunologic Factors|immunologic factors|mesh-ancestor
111062979|NCT05689827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111062980|NCT05682443|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
111062981|NCT05682443|Chelating Agents|chelating agents|mesh-ancestor
111062982|NCT05682443|Sequestering Agents|sequestering agents|mesh-ancestor
111062983|NCT05682443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111062984|NCT05653050|Insulin|insulin|mesh-list
111062985|NCT05653050|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111062986|NCT05653050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111062987|NCT05651607|Cannabidiol|cannabidiol|mesh-list
111062988|NCT05651607|Anticonvulsants|anticonvulsants|mesh-ancestor
111062989|NCT05650736|Abrocitinib|abrocitinib|mesh-list
111062990|NCT05650736|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111062991|NCT05650736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111062992|NCT05650736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111062993|NCT05648006|Bevacizumab|bevacizumab|mesh-list
111062994|NCT05648006|Capecitabine|capecitabine|mesh-list
111062995|NCT05648006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111062996|NCT05648006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111062997|NCT05648006|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111062998|NCT05648006|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111062999|NCT05648006|Growth Substances|growth substances|mesh-ancestor
111063000|NCT05648006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111063001|NCT05648006|Growth Inhibitors|growth inhibitors|mesh-ancestor
110780087|NCT03955809|Ketamine|ketamine|mesh-list
111063002|NCT05648006|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111063003|NCT05648006|Antimetabolites|antimetabolites|mesh-ancestor
111063004|NCT05648006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111063005|NCT05644626|Tislelizumab|tislelizumab|mesh-list
111063006|NCT05644626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110636647|NCT00907764|Regadenoson|regadenoson|mesh-list
111063007|NCT05644626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111063008|NCT05624528|Tolcapone|tolcapone|mesh-list
111063009|NCT05624528|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111063010|NCT05624528|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111063011|NCT05624528|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
111063012|NCT05624528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111063013|NCT05624528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111063014|NCT05602818|Alprazolam|alprazolam|mesh-list
111063015|NCT05602818|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111063016|NCT05602818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111063017|NCT05602818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111063018|NCT05602818|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111063019|NCT05602818|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111063020|NCT05602818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111063021|NCT05602818|GABA Modulators|gaba modulators|mesh-ancestor
111063022|NCT05602818|GABA Agents|gaba agents|mesh-ancestor
111063023|NCT05602818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111063024|NCT05602818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111063025|NCT05569954|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
111063026|NCT05569954|Immunologic Factors|immunologic factors|mesh-ancestor
111063027|NCT05569954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111063028|NCT05568407|Avelumab|avelumab|mesh-list
111063029|NCT05568407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111063030|NCT05568407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111063031|NCT05550246|Oxybutynin|oxybutynin|mesh-list
111063032|NCT05550246|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
111063033|NCT05550246|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111063034|NCT05550246|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111063035|NCT05550246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111063036|NCT05550246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111063037|NCT05550246|Adrenergic Agents|adrenergic agents|mesh-ancestor
111063038|NCT05550246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111063039|NCT05550246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111063040|NCT05550246|Parasympatholytics|parasympatholytics|mesh-ancestor
111063041|NCT05550246|Autonomic Agents|autonomic agents|mesh-ancestor
111063042|NCT05550246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111063043|NCT05550246|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111063044|NCT05550246|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111063045|NCT05550246|Cholinergic Agents|cholinergic agents|mesh-ancestor
111063046|NCT05550246|Urological Agents|urological agents|mesh-ancestor
111063047|NCT05463744|Insulin|insulin|mesh-list
111063048|NCT05463744|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111063049|NCT05463744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111063050|NCT05463744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111063051|NCT05430399|Docetaxel|docetaxel|mesh-list
111063052|NCT05430399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111063053|NCT05430399|Tubulin Modulators|tubulin modulators|mesh-ancestor
111063054|NCT05430399|Antimitotic Agents|antimitotic agents|mesh-ancestor
111063055|NCT05430399|Mitosis Modulators|mitosis modulators|mesh-ancestor
111063056|NCT05430399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111063057|NCT05399329|Palbociclib|palbociclib|mesh-list
111063058|NCT05399329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111063059|NCT05399329|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111063060|NCT05399329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111063061|NCT05399329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111063062|NCT05386888|Paclitaxel|paclitaxel|mesh-list
111063063|NCT05386888|Carboplatin|carboplatin|mesh-list
111063064|NCT05386888|Pemetrexed|pemetrexed|mesh-list
111063065|NCT05386888|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111063066|NCT05386888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111063067|NCT05386888|Tubulin Modulators|tubulin modulators|mesh-ancestor
111063068|NCT05386888|Antimitotic Agents|antimitotic agents|mesh-ancestor
111063069|NCT05386888|Mitosis Modulators|mitosis modulators|mesh-ancestor
111063070|NCT05386888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111063071|NCT05386888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111063072|NCT05386888|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111063073|NCT05386888|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111063074|NCT05374291|Dapagliflozin|dapagliflozin|mesh-list
111063075|NCT05374291|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111063083|NCT05354674|Bevacizumab|bevacizumab|mesh-list
111063084|NCT05354674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111063085|NCT05354674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111063086|NCT05354674|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111063087|NCT05354674|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111063088|NCT05354674|Growth Substances|growth substances|mesh-ancestor
111063089|NCT05354674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111063090|NCT05354674|Growth Inhibitors|growth inhibitors|mesh-ancestor
111063091|NCT05334329|Cyclophosphamide|cyclophosphamide|mesh-list
111063092|NCT05334329|Fludarabine|fludarabine|mesh-list
111063093|NCT05334329|Atezolizumab|atezolizumab|mesh-list
111063094|NCT05334329|Antineoplastic Agents|antineoplastic agents|mesh-list
111063095|NCT05334329|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111063096|NCT05334329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111063097|NCT05334329|Immunologic Factors|immunologic factors|mesh-ancestor
111063098|NCT05334329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111063099|NCT05334329|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111063100|NCT05334329|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111063101|NCT05334329|Alkylating Agents|alkylating agents|mesh-ancestor
111063102|NCT05334329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111063103|NCT05334329|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111063104|NCT05334329|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111063105|NCT05334329|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111063106|NCT05293041|Arginine Vasopressin|arginine vasopressin|mesh-list
111063107|NCT05293041|Hemostatics|hemostatics|mesh-ancestor
111063108|NCT05293041|Coagulants|coagulants|mesh-ancestor
111063109|NCT05293041|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111063110|NCT05293041|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
111063111|NCT05293041|Natriuretic Agents|natriuretic agents|mesh-ancestor
111063112|NCT05293041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111063113|NCT05255653|Cisplatin|cisplatin|mesh-list
111063114|NCT05255653|Carboplatin|carboplatin|mesh-list
111063115|NCT05255653|Durvalumab|durvalumab|mesh-list
111063116|NCT05255653|Olaparib|olaparib|mesh-list
111063117|NCT05255653|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
111063118|NCT05255653|Megestrol|megestrol|mesh-list
111063119|NCT05255653|Megestrol Acetate|megestrol acetate|mesh-list
111063120|NCT05255653|Medroxyprogesterone|medroxyprogesterone|mesh-list
111063121|NCT05255653|Progestins|progestins|mesh-list
111063122|NCT05255653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111063123|NCT05255653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111063124|NCT05255653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111063125|NCT05255653|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111063126|NCT05255653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111063127|NCT05255653|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111063128|NCT05255653|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111063129|NCT05255653|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111063130|NCT05255653|Contraceptive Agents|contraceptive agents|mesh-ancestor
111063131|NCT05255653|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111063132|NCT05255653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111063133|NCT05255653|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111063134|NCT05255653|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111063135|NCT05255653|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
111063136|NCT05255653|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111063137|NCT05255653|Appetite Stimulants|appetite stimulants|mesh-ancestor
111063138|NCT05255653|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111063139|NCT05255653|Hormones|hormones|mesh-ancestor
111063140|NCT05255653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111063141|NCT05239182|Gemcitabine|gemcitabine|mesh-list
111063142|NCT05239182|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111063143|NCT05239182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111063144|NCT05239182|Antimetabolites|antimetabolites|mesh-ancestor
111063145|NCT05239182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111063146|NCT05239182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111063147|NCT05236894|Nicotine|nicotine|mesh-list
111063148|NCT05236894|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111063149|NCT05236894|Autonomic Agents|autonomic agents|mesh-ancestor
111063150|NCT05236894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111063151|NCT05236894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111063152|NCT05236894|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111063153|NCT05236894|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111063154|NCT05236894|Cholinergic Agents|cholinergic agents|mesh-ancestor
111063155|NCT05236894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111063156|NCT05236894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111063157|NCT05153226|Cyclophosphamide|cyclophosphamide|mesh-list
111063158|NCT05153226|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111063159|NCT05153226|Immunologic Factors|immunologic factors|mesh-ancestor
111063160|NCT05153226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111063161|NCT05153226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111063162|NCT05153226|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111063163|NCT05153226|Alkylating Agents|alkylating agents|mesh-ancestor
111063164|NCT05153226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111063165|NCT05153226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111063166|NCT05153226|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111063167|NCT05109052|Bevacizumab|bevacizumab|mesh-list
111063168|NCT05109052|Atezolizumab|atezolizumab|mesh-list
111063169|NCT05109052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111063170|NCT05109052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111063171|NCT05109052|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111063172|NCT05109052|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111063173|NCT05109052|Growth Substances|growth substances|mesh-ancestor
111063174|NCT05109052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111063175|NCT05109052|Growth Inhibitors|growth inhibitors|mesh-ancestor
111063176|NCT05109052|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111063177|NCT05109052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111063178|NCT05104866|Gemcitabine|gemcitabine|mesh-list
111063179|NCT05104866|Capecitabine|capecitabine|mesh-list
111063180|NCT05104866|Vinorelbine|vinorelbine|mesh-list
111063181|NCT05104866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111063182|NCT05104866|Antimetabolites|antimetabolites|mesh-ancestor
111063183|NCT05104866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111063184|NCT05104866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111063185|NCT05104866|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111063186|NCT05104866|Tubulin Modulators|tubulin modulators|mesh-ancestor
111063187|NCT05104866|Antimitotic Agents|antimitotic agents|mesh-ancestor
111063188|NCT05104866|Mitosis Modulators|mitosis modulators|mesh-ancestor
111063189|NCT05103358|Sirolimus|sirolimus|mesh-list
111063190|NCT05103358|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111063191|NCT05103358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111063192|NCT05103358|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111063193|NCT05103358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111063194|NCT05103358|Antifungal Agents|antifungal agents|mesh-ancestor
111063195|NCT05103358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111063196|NCT05103358|Immunologic Factors|immunologic factors|mesh-ancestor
111063197|NCT05103358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111063198|NCT05072314|Lidocaine|lidocaine|mesh-list
111063199|NCT05072314|Anesthetics, Local|anesthetics, local|mesh-ancestor
111063200|NCT05072314|Anesthetics|anesthetics|mesh-ancestor
111063201|NCT05072314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111063202|NCT05072314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111063203|NCT05072314|Sensory System Agents|sensory system agents|mesh-ancestor
111063204|NCT05072314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111063205|NCT05072314|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111063206|NCT05072314|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111063207|NCT05072314|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111063208|NCT05072314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111063209|NCT05072314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111063211|NCT05060315|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111063212|NCT05006079|Morphine|morphine|mesh-list
111063213|NCT05006079|Alprazolam|alprazolam|mesh-list
111063214|NCT05006079|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111063215|NCT05006079|Narcotics|narcotics|mesh-ancestor
111063216|NCT05006079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111063217|NCT05006079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111063218|NCT05006079|Analgesics|analgesics|mesh-ancestor
111063219|NCT05006079|Sensory System Agents|sensory system agents|mesh-ancestor
111063220|NCT05006079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111063221|NCT05006079|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111063222|NCT05006079|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111063223|NCT05006079|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111063224|NCT05006079|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111063225|NCT05006079|GABA Modulators|gaba modulators|mesh-ancestor
111063227|NCT05006079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111063228|NCT05006079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111063229|NCT04962022|Ritonavir|ritonavir|mesh-list
111063230|NCT04962022|Itraconazole|itraconazole|mesh-list
111063231|NCT04962022|Nirmatrelvir|nirmatrelvir|mesh-list
111063232|NCT04962022|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111063233|NCT04962022|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111063234|NCT04962022|Protease Inhibitors|protease inhibitors|mesh-ancestor
111063235|NCT04962022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111063236|NCT04962022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111063237|NCT04962022|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111063238|NCT04962022|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111063239|NCT04962022|Antiviral Agents|antiviral agents|mesh-ancestor
111063240|NCT04962022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111063241|NCT04962022|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111063242|NCT04962022|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111063243|NCT04962022|Antifungal Agents|antifungal agents|mesh-ancestor
111063244|NCT04962022|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111063245|NCT04962022|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111063246|NCT04962022|Hormone Antagonists|hormone antagonists|mesh-ancestor
111063247|NCT04962022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111063248|NCT04962022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111063249|NCT04929808|Emollients|emollients|mesh-list
111063250|NCT04929808|Dermatologic Agents|dermatologic agents|mesh-ancestor
111063251|NCT04910386|Cisplatin|cisplatin|mesh-list
111063252|NCT04910386|Gemcitabine|gemcitabine|mesh-list
111063253|NCT04910386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111063254|NCT04910386|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111063255|NCT04910386|Antimetabolites|antimetabolites|mesh-ancestor
111063256|NCT04910386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111063257|NCT04903223|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111063258|NCT04903223|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111063259|NCT04903223|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111063260|NCT04903223|Antimetabolites|antimetabolites|mesh-ancestor
111063261|NCT04903223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111063262|NCT04903223|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111063263|NCT04903223|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111063264|NCT04903223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111063265|NCT04895748|Everolimus|everolimus|mesh-list
111063266|NCT04895748|Spartalizumab|spartalizumab|mesh-list
111063267|NCT04895748|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111063268|NCT04895748|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111063269|NCT04895748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111063270|NCT04895748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111063271|NCT04895748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111063272|NCT04895748|Immunologic Factors|immunologic factors|mesh-ancestor
111063273|NCT04895748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111063274|NCT04895748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111063275|NCT04895748|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111063276|NCT04895748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111063277|NCT04895137|Bevacizumab|bevacizumab|mesh-list
111063278|NCT04895137|Antibodies|antibodies|mesh-list
111063279|NCT04895137|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111063280|NCT04895137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111063281|NCT04895137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111063282|NCT04895137|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110028087|NCT03402048|Gemcitabine|gemcitabine|mesh-list
111063283|NCT04895137|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111063284|NCT04895137|Growth Substances|growth substances|mesh-ancestor
111063285|NCT04895137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111063286|NCT04895137|Growth Inhibitors|growth inhibitors|mesh-ancestor
111063287|NCT04895137|Immunologic Factors|immunologic factors|mesh-ancestor
111063288|NCT04852224|Leuprolide|leuprolide|mesh-list
111063289|NCT04852224|Goserelin|goserelin|mesh-list
111063290|NCT04852224|Androgens|androgens|mesh-list
111063291|NCT04852224|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111063292|NCT04852224|Fertility Agents|fertility agents|mesh-ancestor
111063293|NCT04852224|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111063294|NCT04852224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111063295|NCT04852224|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111063296|NCT04852224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111063297|NCT04852224|Hormones|hormones|mesh-ancestor
111063298|NCT04852224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111063299|NCT04827953|Paclitaxel|paclitaxel|mesh-list
111063300|NCT04827953|Gemcitabine|gemcitabine|mesh-list
111063316|NCT04744545|Curcumin|curcumin|mesh-list
111063317|NCT04744545|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111063318|NCT04744545|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111063319|NCT04744545|Analgesics|analgesics|mesh-ancestor
111063320|NCT04744545|Sensory System Agents|sensory system agents|mesh-ancestor
111063321|NCT04744545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111063322|NCT04744545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111063323|NCT04744545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111063324|NCT04744545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111063325|NCT04744545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111063326|NCT04744545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111063327|NCT04744545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111063328|NCT04742751|Metformin|metformin|mesh-list
111063329|NCT04742751|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111063330|NCT04742751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111063331|NCT04740905|Aflibercept|aflibercept|mesh-list
111063332|NCT04740905|Faricimab|faricimab|mesh-list
111063333|NCT04740905|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111063334|NCT04740905|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111063335|NCT04740905|Growth Substances|growth substances|mesh-ancestor
111063336|NCT04740905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111063337|NCT04740905|Growth Inhibitors|growth inhibitors|mesh-ancestor
111063338|NCT04740905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111063339|NCT04667949|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
111063340|NCT04667949|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
111063341|NCT04667949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111063342|NCT04667949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111063343|NCT04667949|Immunologic Factors|immunologic factors|mesh-ancestor
111063344|NCT04667949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111063345|NCT04667117|Ofatumumab|ofatumumab|mesh-list
111063346|NCT04667117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111063347|NCT04650893|Dexamethasone|dexamethasone|mesh-list
111063348|NCT04650893|Ketorolac|ketorolac|mesh-list
111063349|NCT04650893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111063350|NCT04650893|Antiemetics|antiemetics|mesh-ancestor
111063351|NCT04650893|Autonomic Agents|autonomic agents|mesh-ancestor
111063352|NCT04650893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111063353|NCT04650893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111063354|NCT04650893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111063355|NCT04650893|Glucocorticoids|glucocorticoids|mesh-ancestor
111063356|NCT04650893|Hormones|hormones|mesh-ancestor
111063357|NCT04650893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111063358|NCT04650893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111063359|NCT04650893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111063360|NCT04650893|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111063361|NCT04650893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111063362|NCT04650893|Analgesics|analgesics|mesh-ancestor
111063363|NCT04650893|Sensory System Agents|sensory system agents|mesh-ancestor
111063364|NCT04650893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111063365|NCT04650893|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111063366|NCT04650893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111063367|NCT04650893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111063368|NCT04632927|Ustekinumab|ustekinumab|mesh-list
111063369|NCT04632927|Dermatologic Agents|dermatologic agents|mesh-ancestor
111063370|NCT04594551|Vaccines|vaccines|mesh-list
111063371|NCT04594551|Immunoglobulins|immunoglobulins|mesh-list
111063372|NCT04594551|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111063373|NCT04594551|Antibodies|antibodies|mesh-list
111063374|NCT04594551|Immunologic Factors|immunologic factors|mesh-ancestor
111063375|NCT04594551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111063376|NCT04548349|Benzoyl Peroxide|benzoyl peroxide|mesh-list
111063377|NCT04548349|Dermatologic Agents|dermatologic agents|mesh-ancestor
111063378|NCT04510194|Metformin|metformin|mesh-list
111063379|NCT04510194|Ivermectin|ivermectin|mesh-list
111063380|NCT04510194|Fluvoxamine|fluvoxamine|mesh-list
111063381|NCT04510194|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111063382|NCT04510194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111063383|NCT04510194|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111063384|NCT04510194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111063385|NCT04510194|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111063386|NCT04510194|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111063387|NCT04510194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111063388|NCT04510194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111063389|NCT04510194|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111063390|NCT04510194|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111063391|NCT04510194|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111063392|NCT04510194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111063393|NCT04510194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111063394|NCT04510194|Serotonin Agents|serotonin agents|mesh-ancestor
111063395|NCT04510194|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111063396|NCT04510194|Antidepressive Agents|antidepressive agents|mesh-ancestor
111063397|NCT04510194|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111063398|NCT04510194|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111063399|NCT04510194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111063400|NCT04510194|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111063401|NCT04502966|Immunomodulating Agents|immunomodulating agents|mesh-list
111063402|NCT04502966|Immunologic Factors|immunologic factors|mesh-list
111063403|NCT04502966|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111063404|NCT04502966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111063405|NCT04482803|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
111063406|NCT04482803|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
111063407|NCT04482803|beta-Endorphin|beta-endorphin|mesh-list
111063408|NCT04482803|Hormones|hormones|mesh-ancestor
111063409|NCT04482803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111063410|NCT04482803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111063411|NCT04482803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111063412|NCT04482803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111063413|NCT04419519|Venetoclax|venetoclax|mesh-list
111063414|NCT04419519|Antibodies|antibodies|mesh-list
111063415|NCT04419519|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111063416|NCT04419519|Immunologic Factors|immunologic factors|mesh-ancestor
111063417|NCT04419519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111063418|NCT04419519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111063419|NCT04406272|Bevacizumab|bevacizumab|mesh-list
111063420|NCT04406272|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111063421|NCT04406272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111063422|NCT04406272|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111063423|NCT04406272|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111063424|NCT04406272|Growth Substances|growth substances|mesh-ancestor
111063425|NCT04406272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111063426|NCT04406272|Growth Inhibitors|growth inhibitors|mesh-ancestor
111063427|NCT04396535|Docetaxel|docetaxel|mesh-list
111063428|NCT04396535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111063429|NCT04396535|Tubulin Modulators|tubulin modulators|mesh-ancestor
111063430|NCT04396535|Antimitotic Agents|antimitotic agents|mesh-ancestor
111063431|NCT04396535|Mitosis Modulators|mitosis modulators|mesh-ancestor
111063432|NCT04396535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111063433|NCT04390009|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
111063434|NCT04390009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111063435|NCT04357366|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
111063436|NCT04357366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111063437|NCT04335461|Anesthetics|anesthetics|mesh-list
111063438|NCT04335461|Anesthetics, Local|anesthetics, local|mesh-list
111063439|NCT04335461|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111063440|NCT04335461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111063441|NCT04335461|Sensory System Agents|sensory system agents|mesh-ancestor
111063442|NCT04335461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111063443|NCT04332211|Pseudoephedrine|pseudoephedrine|mesh-list
111063444|NCT04332211|Ephedrine|ephedrine|mesh-list
111063445|NCT04332211|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111063446|NCT04332211|Autonomic Agents|autonomic agents|mesh-ancestor
110780526|NCT02955186|Saracatinib|saracatinib|mesh-list
111063447|NCT04332211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111063448|NCT04332211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111063449|NCT04332211|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111063450|NCT04332211|Respiratory System Agents|respiratory system agents|mesh-ancestor
111063451|NCT04332211|Nasal Decongestants|nasal decongestants|mesh-ancestor
111063452|NCT04332211|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111063453|NCT04332211|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111063454|NCT04332211|Sympathomimetics|sympathomimetics|mesh-ancestor
111063455|NCT04332211|Adrenergic Agents|adrenergic agents|mesh-ancestor
111063456|NCT04332211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111063457|NCT04332211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111063458|NCT04300192|Vaccines|vaccines|mesh-list
111063459|NCT04300192|Immunologic Factors|immunologic factors|mesh-ancestor
111063460|NCT04300192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111063461|NCT04278898|Acetylcysteine|acetylcysteine|mesh-list
111063462|NCT04278898|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111063463|NCT04278898|Antiviral Agents|antiviral agents|mesh-ancestor
111063464|NCT04278898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111063465|NCT04278898|Expectorants|expectorants|mesh-ancestor
111063466|NCT04278898|Respiratory System Agents|respiratory system agents|mesh-ancestor
111063467|NCT04278898|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111063468|NCT04278898|Antioxidants|antioxidants|mesh-ancestor
111063469|NCT04278898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111063470|NCT04278898|Protective Agents|protective agents|mesh-ancestor
111063471|NCT04278898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111063472|NCT04278898|Antidotes|antidotes|mesh-ancestor
111063473|NCT04188665|Lectins|lectins|mesh-list
111063474|NCT04188665|Agglutinins|agglutinins|mesh-ancestor
111063475|NCT04188665|Immunologic Factors|immunologic factors|mesh-ancestor
111063476|NCT04188665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111063477|NCT04188665|Coagulants|coagulants|mesh-ancestor
111063478|NCT04141995|Leucovorin|leucovorin|mesh-list
111063479|NCT04141995|Fluorouracil|fluorouracil|mesh-list
111063480|NCT04141995|Oxaliplatin|oxaliplatin|mesh-list
111063481|NCT04141995|Irinotecan|irinotecan|mesh-list
111063482|NCT04141995|Camptothecin|camptothecin|mesh-list
111063483|NCT04141995|Digoxin|digoxin|mesh-list
111063484|NCT04141995|Calcium|calcium|mesh-list
111063485|NCT04141995|Levoleucovorin|levoleucovorin|mesh-list
111063486|NCT04141995|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111063487|NCT04141995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111063488|NCT04141995|Antimetabolites|antimetabolites|mesh-ancestor
111063489|NCT04141995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111063490|NCT04141995|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111063491|NCT04141995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111063492|NCT04141995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111063493|NCT04141995|Immunologic Factors|immunologic factors|mesh-ancestor
111063494|NCT04141995|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111063495|NCT04141995|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111063496|NCT04141995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111063497|NCT04141995|Antidotes|antidotes|mesh-ancestor
111063498|NCT04141995|Protective Agents|protective agents|mesh-ancestor
111063499|NCT04141995|Vitamin B Complex|vitamin b complex|mesh-ancestor
111063500|NCT04141995|Vitamins|vitamins|mesh-ancestor
111063501|NCT04141995|Micronutrients|micronutrients|mesh-ancestor
111063502|NCT04141995|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111063503|NCT04141995|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111063504|NCT04141995|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111063505|NCT04068597|Dexamethasone|dexamethasone|mesh-list
111063506|NCT04068597|Azacitidine|azacitidine|mesh-list
111063507|NCT04068597|Venetoclax|venetoclax|mesh-list
111063508|NCT04068597|Pomalidomide|pomalidomide|mesh-list
111063509|NCT04068597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111063510|NCT04068597|Antiemetics|antiemetics|mesh-ancestor
111063511|NCT04068597|Autonomic Agents|autonomic agents|mesh-ancestor
111063512|NCT04068597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111063513|NCT04068597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111063514|NCT04068597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111063515|NCT04068597|Glucocorticoids|glucocorticoids|mesh-ancestor
111063516|NCT04068597|Hormones|hormones|mesh-ancestor
111063517|NCT04068597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111063518|NCT04068597|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111063519|NCT04068597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111063520|NCT04068597|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110780602|NCT03690622|Analgesics|analgesics|mesh-ancestor
111063522|NCT04068597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111063523|NCT04068597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111063524|NCT04068597|Immunologic Factors|immunologic factors|mesh-ancestor
111063525|NCT04068597|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111063526|NCT04068597|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111063527|NCT04068597|Growth Substances|growth substances|mesh-ancestor
111063528|NCT04068597|Growth Inhibitors|growth inhibitors|mesh-ancestor
111063529|NCT04064294|Levodopa|levodopa|mesh-list
111063530|NCT04064294|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111063531|NCT04064294|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111063532|NCT04064294|Dopamine Agents|dopamine agents|mesh-ancestor
111063533|NCT04064294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111063534|NCT04064294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111063535|NCT04064294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111063536|NCT04009044|Tamoxifen|tamoxifen|mesh-list
111063537|NCT04009044|Afimoxifene|afimoxifene|mesh-list
111063538|NCT04009044|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111063539|NCT04009044|Hormone Antagonists|hormone antagonists|mesh-ancestor
111063540|NCT04009044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111063541|NCT04009044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111063542|NCT04009044|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111063543|NCT04009044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111063544|NCT04009044|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111063545|NCT04009044|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111063546|NCT04009044|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111063547|NCT03928210|Digoxin|digoxin|mesh-list
111063548|NCT03928210|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111063549|NCT03928210|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111063550|NCT03928210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111063551|NCT03928210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111063552|NCT03928210|Protective Agents|protective agents|mesh-ancestor
111063553|NCT03928210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111063554|NCT03867201|Erenumab|erenumab|mesh-list
111063555|NCT03867201|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
111063556|NCT03867201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111063557|NCT03867201|Analgesics|analgesics|mesh-ancestor
111063558|NCT03867201|Sensory System Agents|sensory system agents|mesh-ancestor
111063559|NCT03867201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111063560|NCT03867201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111063561|NCT03805932|Rituximab|rituximab|mesh-list
111063562|NCT03805932|Immunotoxin HA22|immunotoxin ha22|mesh-list
111063563|NCT03805932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111063564|NCT03805932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111063565|NCT03805932|Immunologic Factors|immunologic factors|mesh-ancestor
111063566|NCT03805932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111063567|NCT03805932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111063568|NCT03805932|Immunotoxins|immunotoxins|mesh-ancestor
111063569|NCT03805932|Immunoconjugates|immunoconjugates|mesh-ancestor
111063570|NCT03790670|Sargramostim|sargramostim|mesh-list
111063571|NCT03790670|Immunologic Factors|immunologic factors|mesh-ancestor
111063572|NCT03790670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111063573|NCT03720990|Cholic Acids|cholic acids|mesh-list
111063574|NCT03720990|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111063575|NCT03699319|Leucovorin|leucovorin|mesh-list
111063576|NCT03699319|Folic Acid|folic acid|mesh-list
111063577|NCT03699319|Oxaliplatin|oxaliplatin|mesh-list
111063578|NCT03699319|Irinotecan|irinotecan|mesh-list
111063579|NCT03699319|Levoleucovorin|levoleucovorin|mesh-list
111063580|NCT03699319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111063581|NCT03699319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111063582|NCT03699319|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111063583|NCT03699319|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111063584|NCT03699319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111063585|NCT03699319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111063586|NCT03699319|Antidotes|antidotes|mesh-ancestor
111063587|NCT03699319|Protective Agents|protective agents|mesh-ancestor
111063588|NCT03699319|Vitamin B Complex|vitamin b complex|mesh-ancestor
111063589|NCT03699319|Vitamins|vitamins|mesh-ancestor
111063590|NCT03699319|Micronutrients|micronutrients|mesh-ancestor
111063591|NCT03699319|Hematinics|hematinics|mesh-ancestor
111063592|NCT03677141|Prednisone|prednisone|mesh-list
111063593|NCT03677141|Cyclophosphamide|cyclophosphamide|mesh-list
111063594|NCT03677141|Doxorubicin|doxorubicin|mesh-list
111063595|NCT03677141|Vincristine|vincristine|mesh-list
110528658|NCT00615810|Efavirenz|efavirenz|mesh-list
111063597|NCT03677141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111063598|NCT03677141|Immunologic Factors|immunologic factors|mesh-ancestor
111063599|NCT03677141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111063600|NCT03677141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111063601|NCT03677141|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111063602|NCT03677141|Alkylating Agents|alkylating agents|mesh-ancestor
111063603|NCT03677141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111063604|NCT03677141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111063605|NCT03677141|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111063606|NCT03677141|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111063607|NCT03677141|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111063608|NCT03677141|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111063609|NCT03677141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111063610|NCT03677141|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111063612|NCT03677141|Hormones|hormones|mesh-ancestor
111063613|NCT03677141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111063614|NCT03677141|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111063615|NCT03677141|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111063616|NCT03677141|Tubulin Modulators|tubulin modulators|mesh-ancestor
111063617|NCT03677141|Antimitotic Agents|antimitotic agents|mesh-ancestor
111063618|NCT03677141|Mitosis Modulators|mitosis modulators|mesh-ancestor
111063619|NCT03677141|Immunoconjugates|immunoconjugates|mesh-ancestor
111063620|NCT03651271|Nivolumab|nivolumab|mesh-list
111063621|NCT03651271|Ipilimumab|ipilimumab|mesh-list
111063622|NCT03651271|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111063623|NCT03651271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111063624|NCT03651271|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111063625|NCT03651271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111063626|NCT03635892|Nivolumab|nivolumab|mesh-list
111063627|NCT03635892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111063628|NCT03635892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111063629|NCT03635892|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111063630|NCT03635892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111063631|NCT03594435|Ibudilast|ibudilast|mesh-list
111063632|NCT03594435|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111063633|NCT03594435|Autonomic Agents|autonomic agents|mesh-ancestor
111063634|NCT03594435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111063635|NCT03594435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111063636|NCT03594435|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111063637|NCT03594435|Respiratory System Agents|respiratory system agents|mesh-ancestor
111063638|NCT03594435|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111063639|NCT03594435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111063640|NCT03594435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111063641|NCT03594435|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111063642|NCT03594435|Vasodilator Agents|vasodilator agents|mesh-ancestor
111063643|NCT03563729|Pembrolizumab|pembrolizumab|mesh-list
111063644|NCT03563729|Nivolumab|nivolumab|mesh-list
111063645|NCT03563729|Ipilimumab|ipilimumab|mesh-list
111063646|NCT03563729|Trametinib|trametinib|mesh-list
111063647|NCT03563729|Dabrafenib|dabrafenib|mesh-list
111063648|NCT03563729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111063649|NCT03563729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111063650|NCT03563729|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111063651|NCT03563729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111063652|NCT03563729|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111063653|NCT03563729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111063654|NCT03539822|Durvalumab|durvalumab|mesh-list
111063655|NCT03539822|Tremelimumab|tremelimumab|mesh-list
111063656|NCT03539822|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
111063657|NCT03539822|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
111063658|NCT03539822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111063659|NCT03539822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111063660|NCT03539822|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111063661|NCT03539822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111063662|NCT03539822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111063663|NCT03325101|Pembrolizumab|pembrolizumab|mesh-list
111063664|NCT03325101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111063665|NCT03325101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111063666|NCT03325101|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111063667|NCT03325101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111063668|NCT03323463|Carboplatin|carboplatin|mesh-list
111063669|NCT03323463|Fluorouracil|fluorouracil|mesh-list
111063670|NCT03323463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111063671|NCT03323463|Antimetabolites|antimetabolites|mesh-ancestor
111063672|NCT03323463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111063673|NCT03323463|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111063674|NCT03323463|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110780747|NCT03728946|Bupivacaine|bupivacaine|mesh-list
111063675|NCT03323463|Immunologic Factors|immunologic factors|mesh-ancestor
111063676|NCT03323463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111063677|NCT03291028|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
111063678|NCT03291028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111063679|NCT03291028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111063680|NCT03291028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111063682|NCT03287908|Pomalidomide|pomalidomide|mesh-list
111063683|NCT03287908|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111063684|NCT03287908|Antiemetics|antiemetics|mesh-ancestor
111063685|NCT03287908|Autonomic Agents|autonomic agents|mesh-ancestor
111063686|NCT03287908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111063687|NCT03287908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111063688|NCT03287908|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111063689|NCT03287908|Glucocorticoids|glucocorticoids|mesh-ancestor
111063690|NCT03287908|Hormones|hormones|mesh-ancestor
111063691|NCT03287908|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111063692|NCT03287908|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111063693|NCT03287908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111063694|NCT03287908|Immunologic Factors|immunologic factors|mesh-ancestor
111063695|NCT03287908|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111063696|NCT03287908|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111063697|NCT03287908|Growth Substances|growth substances|mesh-ancestor
111063698|NCT03287908|Growth Inhibitors|growth inhibitors|mesh-ancestor
111063699|NCT03257163|Pembrolizumab|pembrolizumab|mesh-list
111063700|NCT03257163|Capecitabine|capecitabine|mesh-list
111063701|NCT03257163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111063702|NCT03257163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111063703|NCT03257163|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111063704|NCT03257163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111063705|NCT03257163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111063706|NCT03257163|Antimetabolites|antimetabolites|mesh-ancestor
111063707|NCT03091192|Sunitinib|sunitinib|mesh-list
111063708|NCT03091192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111063709|NCT03091192|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111063710|NCT03091192|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111063711|NCT03091192|Growth Substances|growth substances|mesh-ancestor
111063712|NCT03091192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111063713|NCT03091192|Growth Inhibitors|growth inhibitors|mesh-ancestor
111063714|NCT03091192|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111063715|NCT03091192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111063716|NCT03091192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111063717|NCT03027388|LB100|lb100|mesh-list
111063718|NCT03027388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111063719|NCT03027388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111063720|NCT03027388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111063721|NCT03004287|Thalidomide|thalidomide|mesh-list
111063722|NCT03004287|Dexamethasone|dexamethasone|mesh-list
111063723|NCT03004287|Cyclophosphamide|cyclophosphamide|mesh-list
111063724|NCT03004287|Melphalan|melphalan|mesh-list
111063725|NCT03004287|Doxorubicin|doxorubicin|mesh-list
111063726|NCT03004287|Etoposide|etoposide|mesh-list
111063727|NCT03004287|Lenalidomide|lenalidomide|mesh-list
111063728|NCT03004287|Bortezomib|bortezomib|mesh-list
111063729|NCT03004287|Daratumumab|daratumumab|mesh-list
111063730|NCT03004287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111063731|NCT03004287|Immunologic Factors|immunologic factors|mesh-ancestor
111063732|NCT03004287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111063733|NCT03004287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111063734|NCT03004287|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111063735|NCT03004287|Alkylating Agents|alkylating agents|mesh-ancestor
111063736|NCT03004287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111063737|NCT03004287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111063738|NCT03004287|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111063739|NCT03004287|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111063740|NCT03004287|Antiemetics|antiemetics|mesh-ancestor
111063741|NCT03004287|Autonomic Agents|autonomic agents|mesh-ancestor
111063742|NCT03004287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111063743|NCT03004287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111063745|NCT03004287|Hormones|hormones|mesh-ancestor
111063746|NCT03004287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111063747|NCT03004287|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111063748|NCT03004287|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111063749|NCT03004287|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111063750|NCT03004287|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111063751|NCT03004287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111063752|NCT03004287|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111063753|NCT03004287|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111063754|NCT03004287|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111063755|NCT03004287|Growth Substances|growth substances|mesh-ancestor
111063756|NCT03004287|Growth Inhibitors|growth inhibitors|mesh-ancestor
111063757|NCT03004287|Leprostatic Agents|leprostatic agents|mesh-ancestor
111063758|NCT03004287|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111063759|NCT03004287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111063760|NCT02885974|Celecoxib|celecoxib|mesh-list
111063761|NCT02885974|Gemcitabine|gemcitabine|mesh-list
111063762|NCT02885974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111063763|NCT02885974|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111063764|NCT02885974|Antimetabolites|antimetabolites|mesh-ancestor
111063765|NCT02885974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111063766|NCT02885974|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111063767|NCT02885974|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111063768|NCT02885974|Analgesics|analgesics|mesh-ancestor
111063769|NCT02885974|Sensory System Agents|sensory system agents|mesh-ancestor
111063770|NCT02885974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111063771|NCT02885974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111063772|NCT02885974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111063773|NCT02885974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111063774|NCT02885974|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111063775|NCT02885974|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111063776|NCT02885974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111063777|NCT02861300|Capecitabine|capecitabine|mesh-list
111063778|NCT02861300|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111063779|NCT02861300|Antimetabolites|antimetabolites|mesh-ancestor
111063780|NCT02861300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111063781|NCT02861300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111063782|NCT02838420|Crizotinib|crizotinib|mesh-list
111063783|NCT02838420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111063784|NCT02838420|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111063785|NCT02838420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111063786|NCT02838420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111063787|NCT02611960|Gemcitabine|gemcitabine|mesh-list
111063788|NCT02611960|Capecitabine|capecitabine|mesh-list
111063789|NCT02611960|Docetaxel|docetaxel|mesh-list
111063790|NCT02611960|Pembrolizumab|pembrolizumab|mesh-list
111063791|NCT02611960|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111063792|NCT02611960|Antimetabolites|antimetabolites|mesh-ancestor
111063793|NCT02611960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111063794|NCT02611960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111063795|NCT02611960|Tubulin Modulators|tubulin modulators|mesh-ancestor
111063796|NCT02611960|Antimitotic Agents|antimitotic agents|mesh-ancestor
111063797|NCT02611960|Mitosis Modulators|mitosis modulators|mesh-ancestor
111063798|NCT02611960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111063799|NCT02611960|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111063800|NCT02603146|Hydroxychloroquine|hydroxychloroquine|mesh-list
111063801|NCT02603146|Antimalarials|antimalarials|mesh-ancestor
111063802|NCT02603146|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111063803|NCT02603146|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111063804|NCT02603146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111063805|NCT02603146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111063806|NCT02603146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111063807|NCT02603146|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111063808|NCT02358850|Acetaminophen|acetaminophen|mesh-list
111063809|NCT02358850|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
111063810|NCT02358850|Oxycodone|oxycodone|mesh-list
111063811|NCT02358850|Hydromorphone|hydromorphone|mesh-list
111063812|NCT02358850|Hydrocodone|hydrocodone|mesh-list
111063813|NCT02358850|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111063814|NCT02358850|Analgesics|analgesics|mesh-ancestor
111063815|NCT02358850|Sensory System Agents|sensory system agents|mesh-ancestor
111063816|NCT02358850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110827942|NCT02526199|Epinephrine|epinephrine|mesh-list
111063817|NCT02358850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111063818|NCT02358850|Antipyretics|antipyretics|mesh-ancestor
111063819|NCT02358850|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111063820|NCT02358850|Narcotics|narcotics|mesh-ancestor
111063821|NCT02358850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111063822|NCT02358850|Antitussive Agents|antitussive agents|mesh-ancestor
111063823|NCT02358850|Respiratory System Agents|respiratory system agents|mesh-ancestor
111063824|NCT02358850|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111063825|NCT02358850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111063826|NCT02358850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111063827|NCT01784159|Aspirin|aspirin|mesh-list
111063828|NCT01784159|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111063829|NCT01784159|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111063830|NCT01784159|Analgesics|analgesics|mesh-ancestor
111063831|NCT01784159|Sensory System Agents|sensory system agents|mesh-ancestor
111063832|NCT01784159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111063833|NCT01784159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111063834|NCT01784159|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111063835|NCT01784159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111063836|NCT01784159|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111063837|NCT01784159|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111063838|NCT01784159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111063839|NCT01784159|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111063840|NCT01784159|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111063841|NCT01784159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111063842|NCT01784159|Antipyretics|antipyretics|mesh-ancestor
111063843|NCT01749969|Dexamethasone|dexamethasone|mesh-list
111063844|NCT01749969|Lenalidomide|lenalidomide|mesh-list
111063845|NCT01749969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111063846|NCT01749969|Antiemetics|antiemetics|mesh-ancestor
111063847|NCT01749969|Autonomic Agents|autonomic agents|mesh-ancestor
111063848|NCT01749969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111063849|NCT01749969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111063850|NCT01749969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111063851|NCT01749969|Glucocorticoids|glucocorticoids|mesh-ancestor
111063852|NCT01749969|Hormones|hormones|mesh-ancestor
111063853|NCT01749969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111063854|NCT01749969|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111063855|NCT01749969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111063856|NCT01749969|Immunologic Factors|immunologic factors|mesh-ancestor
111063857|NCT01749969|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111063858|NCT01749969|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111063859|NCT01749969|Growth Substances|growth substances|mesh-ancestor
111063860|NCT01749969|Growth Inhibitors|growth inhibitors|mesh-ancestor
111063861|NCT01458327|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
111063862|NCT01458327|Hallucinogens|hallucinogens|mesh-ancestor
111063863|NCT01458327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111063864|NCT01458327|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111063865|NCT01458327|Serotonin Agents|serotonin agents|mesh-ancestor
111063866|NCT01458327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111063867|NCT01458327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111063868|NCT01458327|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111063869|NCT01458327|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111063870|NCT01458327|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111063871|NCT01458327|Adrenergic Agents|adrenergic agents|mesh-ancestor
111063872|NCT01203020|Fludarabine|fludarabine|mesh-list
111063873|NCT01203020|Fludarabine phosphate|fludarabine phosphate|mesh-list
111063874|NCT01203020|Busulfan|busulfan|mesh-list
111063875|NCT01203020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111063876|NCT01203020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111063877|NCT01203020|Antimetabolites|antimetabolites|mesh-ancestor
111063878|NCT01203020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111063879|NCT01203020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111063880|NCT01203020|Immunologic Factors|immunologic factors|mesh-ancestor
111063881|NCT01203020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111063882|NCT01203020|Alkylating Agents|alkylating agents|mesh-ancestor
111063883|NCT01203020|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111063884|NCT01203020|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111063885|NCT00006256|Paclitaxel|paclitaxel|mesh-list
111063886|NCT00006256|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111063887|NCT00006256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111063888|NCT00006256|Tubulin Modulators|tubulin modulators|mesh-ancestor
111063889|NCT00006256|Antimitotic Agents|antimitotic agents|mesh-ancestor
111063890|NCT00006256|Mitosis Modulators|mitosis modulators|mesh-ancestor
111063891|NCT00006256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111063892|NCT00495131|Interferons|interferons|mesh-list
111063893|NCT00495131|Ribavirin|ribavirin|mesh-list
111063894|NCT00495131|Interferon-alpha|interferon-alpha|mesh-list
111063895|NCT00495131|Interferon alpha-2|interferon alpha-2|mesh-list
111063896|NCT00495131|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
111063897|NCT00495131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111063898|NCT00495131|Antiviral Agents|antiviral agents|mesh-ancestor
111063899|NCT00495131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111063900|NCT00495131|Antimetabolites|antimetabolites|mesh-ancestor
111063901|NCT00495131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111063902|NCT00495131|Immunologic Factors|immunologic factors|mesh-ancestor
111063903|NCT00495131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111063904|NCT02257372|Albuterol|albuterol|mesh-list
111063905|NCT02257372|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111063906|NCT02257372|Autonomic Agents|autonomic agents|mesh-ancestor
111063907|NCT02257372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111063908|NCT02257372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111063909|NCT02257372|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111063910|NCT02257372|Respiratory System Agents|respiratory system agents|mesh-ancestor
111063911|NCT02257372|Tocolytic Agents|tocolytic agents|mesh-ancestor
111063912|NCT02257372|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111063913|NCT02257372|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111063914|NCT02257372|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111063915|NCT02257372|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111063916|NCT02257372|Adrenergic Agents|adrenergic agents|mesh-ancestor
111063917|NCT02257372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111063918|NCT02257372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111063919|NCT02256982|Cisplatin|cisplatin|mesh-list
111063920|NCT02256982|Gemcitabine|gemcitabine|mesh-list
111063921|NCT02256982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111063922|NCT02256982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111063923|NCT02256982|Antimetabolites|antimetabolites|mesh-ancestor
111063924|NCT02256982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111063925|NCT03480607|Dexamethasone|dexamethasone|mesh-list
111063926|NCT03480607|Dexmedetomidine|dexmedetomidine|mesh-list
111063927|NCT03480607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111063928|NCT03480607|Antiemetics|antiemetics|mesh-ancestor
111063929|NCT03480607|Autonomic Agents|autonomic agents|mesh-ancestor
111063930|NCT03480607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111063931|NCT03480607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111063932|NCT03480607|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111063933|NCT03480607|Glucocorticoids|glucocorticoids|mesh-ancestor
111063934|NCT03480607|Hormones|hormones|mesh-ancestor
111063935|NCT03480607|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111063936|NCT03480607|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111063937|NCT03480607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111063938|NCT03480607|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111063939|NCT03480607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110636796|NCT00817466|Epinephrine|epinephrine|mesh-list
111063940|NCT03480607|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111063941|NCT03480607|Analgesics|analgesics|mesh-ancestor
111063942|NCT03480607|Sensory System Agents|sensory system agents|mesh-ancestor
111063943|NCT03480607|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111063944|NCT03480607|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111063945|NCT03480607|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111063946|NCT03480607|Adrenergic Agents|adrenergic agents|mesh-ancestor
111063947|NCT03480607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111063948|NCT03480607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111063949|NCT00489203|Beclomethasone|beclomethasone|mesh-list
111063950|NCT00489203|Methotrexate|methotrexate|mesh-list
111063951|NCT00489203|Tacrolimus|tacrolimus|mesh-list
111063952|NCT00489203|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111063953|NCT00489203|Abortifacient Agents|abortifacient agents|mesh-ancestor
111063954|NCT00489203|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111063955|NCT00489203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111063956|NCT00489203|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111063957|NCT00489203|Antimetabolites|antimetabolites|mesh-ancestor
111063958|NCT00489203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111063959|NCT00489203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111063960|NCT00489203|Dermatologic Agents|dermatologic agents|mesh-ancestor
111063961|NCT00489203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111063962|NCT00489203|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111063963|NCT00489203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111063964|NCT00489203|Immunologic Factors|immunologic factors|mesh-ancestor
111063965|NCT00489203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111063966|NCT00489203|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111063967|NCT00489203|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111063968|NCT00489203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111063969|NCT00489203|Glucocorticoids|glucocorticoids|mesh-ancestor
111063970|NCT00489203|Hormones|hormones|mesh-ancestor
111063971|NCT00489203|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111063972|NCT00489203|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111063973|NCT00489203|Respiratory System Agents|respiratory system agents|mesh-ancestor
111063974|NCT05646394|Aspirin|aspirin|mesh-list
111063975|NCT05646394|Vitamins|vitamins|mesh-list
111063976|NCT05646394|Vitamin K|vitamin k|mesh-list
111063977|NCT05646394|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
111063978|NCT05646394|Micronutrients|micronutrients|mesh-ancestor
111063979|NCT05646394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111063980|NCT05646394|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111063981|NCT05646394|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111063982|NCT05646394|Analgesics|analgesics|mesh-ancestor
111063983|NCT05646394|Sensory System Agents|sensory system agents|mesh-ancestor
111063984|NCT05646394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111063985|NCT05646394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111063986|NCT05646394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111063987|NCT05646394|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111063988|NCT05646394|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111063989|NCT05646394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111063990|NCT05646394|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111063991|NCT05646394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111063992|NCT05646394|Antipyretics|antipyretics|mesh-ancestor
111063993|NCT05646394|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111063994|NCT05646394|Hemostatics|hemostatics|mesh-ancestor
111063995|NCT05646394|Coagulants|coagulants|mesh-ancestor
111063996|NCT00563459|Topiramate|topiramate|mesh-list
111063997|NCT00563459|Levetiracetam|levetiracetam|mesh-list
111063998|NCT00563459|Anticonvulsants|anticonvulsants|mesh-ancestor
111063999|NCT00563459|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111064000|NCT00563459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111064001|NCT00563459|Nootropic Agents|nootropic agents|mesh-ancestor
111064002|NCT00561743|Dexamethasone|dexamethasone|mesh-list
111064003|NCT00561743|Doxorubicin|doxorubicin|mesh-list
111064004|NCT00561743|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111064005|NCT00561743|Bortezomib|bortezomib|mesh-list
111064006|NCT00561743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111064007|NCT00561743|Antiemetics|antiemetics|mesh-ancestor
111064008|NCT00561743|Autonomic Agents|autonomic agents|mesh-ancestor
111064009|NCT00561743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111064010|NCT00561743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111064011|NCT00561743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111064012|NCT00561743|Glucocorticoids|glucocorticoids|mesh-ancestor
111064013|NCT00561743|Hormones|hormones|mesh-ancestor
111064014|NCT00561743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111064015|NCT00561743|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111064016|NCT00561743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111064017|NCT00561743|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111064018|NCT00561743|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111064019|NCT00561743|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111064020|NCT00561743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111064021|NCT00561743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111064022|NCT00488267|Ketoprofen|ketoprofen|mesh-list
111064023|NCT00488267|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111064024|NCT00488267|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111064025|NCT00488267|Analgesics|analgesics|mesh-ancestor
111064026|NCT00488267|Sensory System Agents|sensory system agents|mesh-ancestor
111064027|NCT00488267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111064028|NCT00488267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111064029|NCT00488267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111064030|NCT00488267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111064031|NCT00488267|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111064032|NCT00488267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111064033|NCT00488267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111064034|NCT00560183|Morphine|morphine|mesh-list
111064035|NCT00560183|Oxycodone|oxycodone|mesh-list
111064036|NCT00560183|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111064037|NCT00560183|Narcotics|narcotics|mesh-ancestor
111064038|NCT00560183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111064039|NCT00560183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111064040|NCT00560183|Analgesics|analgesics|mesh-ancestor
111064041|NCT00560183|Sensory System Agents|sensory system agents|mesh-ancestor
111064042|NCT00560183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111064043|NCT02736721|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
111064044|NCT02736721|Antiviral Agents|antiviral agents|mesh-ancestor
111064045|NCT02736721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111064047|NCT00542633|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111064048|NCT00542633|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111064049|NCT00542633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111064050|NCT02523547|Entecavir|entecavir|mesh-list
111064051|NCT02523547|Antiviral Agents|antiviral agents|mesh-ancestor
111064052|NCT02523547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111064053|NCT00483977|Oxycodone|oxycodone|mesh-list
111064054|NCT00483977|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111064055|NCT00483977|Narcotics|narcotics|mesh-ancestor
111064056|NCT00483977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111064057|NCT00483977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111064058|NCT00483977|Analgesics|analgesics|mesh-ancestor
111064059|NCT00483977|Sensory System Agents|sensory system agents|mesh-ancestor
111064060|NCT00483977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111064061|NCT00481325|Escitalopram|escitalopram|mesh-list
111064062|NCT00481325|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111064063|NCT00481325|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111064064|NCT00481325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111064065|NCT00481325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111064066|NCT00481325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111064067|NCT00481325|Serotonin Agents|serotonin agents|mesh-ancestor
111064068|NCT00481325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111064069|NCT02523703|N-Methylaspartate|n-methylaspartate|mesh-list
111064070|NCT02523703|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
111064071|NCT02523703|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111064072|NCT02523703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111064073|NCT02523703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111064074|NCT02523703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111064075|NCT03480295|Hyaluronic Acid|hyaluronic acid|mesh-list
111064076|NCT03480295|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111064077|NCT03480295|Immunologic Factors|immunologic factors|mesh-ancestor
111064078|NCT03480295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111064079|NCT03480295|Viscosupplements|viscosupplements|mesh-ancestor
111064080|NCT03480295|Protective Agents|protective agents|mesh-ancestor
111064081|NCT03472963|Darunavir|darunavir|mesh-list
111064082|NCT03472963|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
111064083|NCT03472963|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111064084|NCT03472963|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111064085|NCT03472963|Protease Inhibitors|protease inhibitors|mesh-ancestor
111064086|NCT03472963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111064087|NCT03472963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111064088|NCT03472963|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111064089|NCT03472963|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111064090|NCT03472963|Antiviral Agents|antiviral agents|mesh-ancestor
111064091|NCT03472963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111064092|NCT02282657|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
111064093|NCT02282657|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111064094|NCT02282657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111064095|NCT02282657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111064096|NCT00465959|Trospium chloride|trospium chloride|mesh-list
111064097|NCT00465959|Parasympatholytics|parasympatholytics|mesh-ancestor
111064098|NCT00465959|Autonomic Agents|autonomic agents|mesh-ancestor
111064099|NCT00465959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111064100|NCT00465959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111064101|NCT00465959|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111064102|NCT00465959|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111064103|NCT00465959|Cholinergic Agents|cholinergic agents|mesh-ancestor
111064104|NCT00465959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111064105|NCT00465959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111064106|NCT00465959|Urological Agents|urological agents|mesh-ancestor
111064107|NCT00465803|Timolol|timolol|mesh-list
111064108|NCT00465803|Travoprost|travoprost|mesh-list
111064109|NCT00465803|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111064110|NCT00465803|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111064111|NCT00465803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111064112|NCT00465803|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111064113|NCT00465803|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111064114|NCT00465803|Adrenergic Agents|adrenergic agents|mesh-ancestor
111064115|NCT00465803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111064116|NCT00465803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111064117|NCT00465803|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111064118|NCT00465803|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111064119|NCT02282891|Ketamine|ketamine|mesh-list
111064120|NCT02282891|Propofol|propofol|mesh-list
111064121|NCT02282891|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111064122|NCT02282891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111064123|NCT02282891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111064124|NCT02282891|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111064125|NCT02282891|Anesthetics, General|anesthetics, general|mesh-ancestor
111064126|NCT02282891|Anesthetics|anesthetics|mesh-ancestor
111064127|NCT02282891|Analgesics|analgesics|mesh-ancestor
111064128|NCT02282891|Sensory System Agents|sensory system agents|mesh-ancestor
111064129|NCT02282891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111064130|NCT02282891|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111064131|NCT02282891|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111064132|NCT02282891|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111064133|NCT02282891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111064134|NCT02282891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111064135|NCT00464633|Alvocidib|alvocidib|mesh-list
111064136|NCT00464633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111064137|NCT00464633|Growth Inhibitors|growth inhibitors|mesh-ancestor
111064138|NCT00464633|Growth Substances|growth substances|mesh-ancestor
111064139|NCT00464633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111064140|NCT00464633|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110636824|NCT00930072|Sympatholytics|sympatholytics|mesh-ancestor
111064141|NCT00464633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111064142|NCT00464633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111064143|NCT00464555|Sirolimus|sirolimus|mesh-list
111064144|NCT00464555|Lisofylline|lisofylline|mesh-list
111064145|NCT00464555|Tacrolimus|tacrolimus|mesh-list
111064146|NCT00464555|Antilymphocyte Serum|antilymphocyte serum|mesh-list
111064147|NCT00464555|Basiliximab|basiliximab|mesh-list
111064148|NCT00464555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111064149|NCT00464555|Immunologic Factors|immunologic factors|mesh-ancestor
111064150|NCT00464555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111064151|NCT00464555|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111064152|NCT00464555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111064153|NCT00464555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111064154|NCT00464555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111064155|NCT00464555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111064156|NCT00464555|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111064157|NCT00464555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111064158|NCT00464555|Antifungal Agents|antifungal agents|mesh-ancestor
111064159|NCT00464555|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111064160|NCT00464555|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111064161|NCT00464555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111064162|NCT00464555|Analgesics|analgesics|mesh-ancestor
111064163|NCT00464555|Sensory System Agents|sensory system agents|mesh-ancestor
111064164|NCT00464555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111064165|NCT00464555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111064166|NCT00464555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111064167|NCT00464243|Volinanserin|volinanserin|mesh-list
111064168|NCT00464243|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111064169|NCT00464243|Serotonin Agents|serotonin agents|mesh-ancestor
111064170|NCT00464243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111064171|NCT00464243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111064172|NCT00464243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111064173|NCT03336541|Ketamine|ketamine|mesh-list
111064174|NCT03336541|Analgesics|analgesics|mesh-ancestor
111064175|NCT03336541|Sensory System Agents|sensory system agents|mesh-ancestor
111064176|NCT03336541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111064177|NCT03336541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111064178|NCT03336541|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111064179|NCT03336541|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111064180|NCT03336541|Anesthetics, General|anesthetics, general|mesh-ancestor
111064181|NCT03336541|Anesthetics|anesthetics|mesh-ancestor
111064182|NCT03336541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110028089|NCT03402048|Pemetrexed|pemetrexed|mesh-list
111064183|NCT03336541|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111064185|NCT03336541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111064186|NCT03336541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111064187|NCT00525941|Indiplon|indiplon|mesh-list
111064188|NCT00525941|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111064189|NCT00525941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111064190|NCT00525941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111064191|NCT00525941|GABA Modulators|gaba modulators|mesh-ancestor
111064192|NCT00525941|GABA Agents|gaba agents|mesh-ancestor
111064193|NCT00525941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111064194|NCT00525941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111064195|NCT03476083|Tenofovir|tenofovir|mesh-list
111064196|NCT03476083|Antiviral Agents|antiviral agents|mesh-ancestor
111064197|NCT03476083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111064198|NCT03476083|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111064199|NCT03476083|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111064200|NCT03476083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111064201|NCT03476083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111064202|NCT03476083|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111064203|NCT03476083|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111064204|NCT02738203|Lidocaine|lidocaine|mesh-list
111064205|NCT02738203|Anesthetics, Local|anesthetics, local|mesh-ancestor
111064206|NCT02738203|Anesthetics|anesthetics|mesh-ancestor
111064207|NCT02738203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111064208|NCT02738203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111064209|NCT02738203|Sensory System Agents|sensory system agents|mesh-ancestor
111064210|NCT02738203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111064211|NCT02738203|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111064212|NCT02738203|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111064213|NCT02738203|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111064214|NCT02738203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111064215|NCT02738203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111064216|NCT00457457|Tamsulosin|tamsulosin|mesh-list
111064217|NCT00457457|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111064218|NCT00457457|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111064219|NCT00457457|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111064220|NCT00457457|Adrenergic Agents|adrenergic agents|mesh-ancestor
111064221|NCT00457457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111064222|NCT00457457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111064223|NCT00457457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111064224|NCT00457457|Urological Agents|urological agents|mesh-ancestor
111064225|NCT00517439|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
111064226|NCT00517439|Interferon-alpha|interferon-alpha|mesh-list
111064227|NCT00517439|Antiviral Agents|antiviral agents|mesh-ancestor
111064228|NCT00517439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111064229|NCT00517439|Immunologic Factors|immunologic factors|mesh-ancestor
111064230|NCT00517439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111064231|NCT03472651|Flupenthixol|flupenthixol|mesh-list
111064232|NCT03472651|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
111064233|NCT03472651|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111064234|NCT03472651|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111064235|NCT03472651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111064236|NCT03472651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111064237|NCT03472651|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111064238|NCT03472651|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111064239|NCT03472651|Dopamine Agents|dopamine agents|mesh-ancestor
111064240|NCT03472651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111064241|NCT03472651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111064242|NCT00517049|Rituximab|rituximab|mesh-list
111064243|NCT00517049|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111064244|NCT00517049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111064245|NCT00517049|Immunologic Factors|immunologic factors|mesh-ancestor
111064246|NCT00517049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111064247|NCT00517049|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111064248|NCT02283203|Acetaminophen|acetaminophen|mesh-list
111064249|NCT02283203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111064250|NCT02283203|Analgesics|analgesics|mesh-ancestor
111064251|NCT02283203|Sensory System Agents|sensory system agents|mesh-ancestor
111064252|NCT02283203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111064253|NCT02283203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111064254|NCT02283203|Antipyretics|antipyretics|mesh-ancestor
111064255|NCT02523313|Nivolumab|nivolumab|mesh-list
111064257|NCT02523313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111064258|NCT02523313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111064259|NCT02523313|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111064260|NCT02523313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111064261|NCT02452034|Posaconazole|posaconazole|mesh-list
111064262|NCT02452034|Antifungal Agents|antifungal agents|mesh-ancestor
111064263|NCT02452034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111064264|NCT02452034|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
111064265|NCT02452034|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111064266|NCT02452034|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111064267|NCT02452034|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111064268|NCT02452034|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111064269|NCT02452034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111064270|NCT02452034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111064271|NCT02452034|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111064272|NCT02452034|Hormone Antagonists|hormone antagonists|mesh-ancestor
111064273|NCT02452034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111064274|NCT02452034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111064276|NCT02283359|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111064277|NCT02283359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111064278|NCT02283359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111064279|NCT02283359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111064280|NCT02283359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111064281|NCT00511043|Vatalanib|vatalanib|mesh-list
111064282|NCT00511043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111064283|NCT00511043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111064284|NCT00511043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111064285|NCT00508625|Paclitaxel|paclitaxel|mesh-list
111064286|NCT00508625|Bevacizumab|bevacizumab|mesh-list
111064287|NCT00508625|Carboplatin|carboplatin|mesh-list
111064288|NCT00508625|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111064289|NCT00508625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111064290|NCT00508625|Tubulin Modulators|tubulin modulators|mesh-ancestor
111064291|NCT00508625|Antimitotic Agents|antimitotic agents|mesh-ancestor
111064292|NCT00508625|Mitosis Modulators|mitosis modulators|mesh-ancestor
111064293|NCT00508625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111064294|NCT00508625|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111064295|NCT00508625|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111064296|NCT00508625|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111064297|NCT00508625|Growth Substances|growth substances|mesh-ancestor
111064298|NCT00508625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111064299|NCT00508625|Growth Inhibitors|growth inhibitors|mesh-ancestor
111064300|NCT02284529|Leucovorin|leucovorin|mesh-list
111064301|NCT02284529|Fluorouracil|fluorouracil|mesh-list
111064302|NCT02284529|Antimetabolites|antimetabolites|mesh-ancestor
111064303|NCT02284529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111064304|NCT02284529|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111064305|NCT02284529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111064306|NCT02284529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111064307|NCT02284529|Immunologic Factors|immunologic factors|mesh-ancestor
111064308|NCT02284529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111064309|NCT02284529|Antidotes|antidotes|mesh-ancestor
111064310|NCT02284529|Protective Agents|protective agents|mesh-ancestor
111064311|NCT02284529|Vitamin B Complex|vitamin b complex|mesh-ancestor
111064312|NCT02284529|Vitamins|vitamins|mesh-ancestor
111064313|NCT02284529|Micronutrients|micronutrients|mesh-ancestor
111064314|NCT02482298|Ticagrelor|ticagrelor|mesh-list
111064315|NCT02482298|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111064316|NCT02482298|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111064317|NCT02482298|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111064318|NCT02482298|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111064319|NCT02482298|Purinergic Agents|purinergic agents|mesh-ancestor
111064320|NCT02482298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111064321|NCT02482298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111064322|NCT02482298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111064323|NCT04470479|Pilocarpine|pilocarpine|mesh-list
111064324|NCT04470479|Miotics|miotics|mesh-ancestor
111064325|NCT04470479|Autonomic Agents|autonomic agents|mesh-ancestor
111064326|NCT04470479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111064327|NCT04470479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111064328|NCT04470479|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
111064329|NCT04470479|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111064330|NCT04470479|Cholinergic Agents|cholinergic agents|mesh-ancestor
111064331|NCT04470479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111064332|NCT04470479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111064333|NCT00383513|Epratuzumab|epratuzumab|mesh-list
111064334|NCT00383513|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111064335|NCT00383513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111064336|NCT00382811|Carboplatin|carboplatin|mesh-list
111064337|NCT00382811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111064338|NCT02286635|Clarithromycin|clarithromycin|mesh-list
111064339|NCT02286635|Rifampin|rifampin|mesh-list
111064340|NCT02286635|Deflazacort|deflazacort|mesh-list
111064341|NCT02286635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111064342|NCT02286635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111064343|NCT02286635|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111064344|NCT02286635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111064345|NCT02286635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111064346|NCT02286635|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111064347|NCT02286635|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111064348|NCT02286635|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111064349|NCT02286635|Antitubercular Agents|antitubercular agents|mesh-ancestor
111064350|NCT02286635|Leprostatic Agents|leprostatic agents|mesh-ancestor
111064351|NCT02286635|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111064352|NCT02286635|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111064353|NCT02286635|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111064354|NCT02286635|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
111064355|NCT02286635|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
111064356|NCT02286635|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
111064357|NCT02286635|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111064358|NCT02286635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111064359|NCT02286635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111064360|NCT02286635|Immunologic Factors|immunologic factors|mesh-ancestor
111064361|NCT02286635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111064362|NCT00440531|Vaccines|vaccines|mesh-list
111064363|NCT00440531|Immunologic Factors|immunologic factors|mesh-ancestor
111064364|NCT00440531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111064365|NCT00437021|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
111064366|NCT00437021|Antiviral Agents|antiviral agents|mesh-ancestor
111064367|NCT00437021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111064368|NCT00375791|Dexamethasone|dexamethasone|mesh-list
111064369|NCT00375791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111064370|NCT00375791|Antiemetics|antiemetics|mesh-ancestor
111064371|NCT00375791|Autonomic Agents|autonomic agents|mesh-ancestor
111064372|NCT00375791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111064373|NCT00375791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111064374|NCT00375791|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111064375|NCT00375791|Glucocorticoids|glucocorticoids|mesh-ancestor
111064376|NCT00375791|Hormones|hormones|mesh-ancestor
111064377|NCT00375791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111064378|NCT00375791|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111064379|NCT00375791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111064380|NCT00431873|Mocetinostat|mocetinostat|mesh-list
111064381|NCT00431873|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111064382|NCT00431873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111064383|NCT00431873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111064384|NCT02287181|Remifentanil|remifentanil|mesh-list
111064385|NCT02287181|Propofol|propofol|mesh-list
111064386|NCT02287181|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111064387|NCT02287181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111064388|NCT02287181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111064389|NCT02287181|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111064390|NCT02287181|Anesthetics, General|anesthetics, general|mesh-ancestor
111064391|NCT02287181|Anesthetics|anesthetics|mesh-ancestor
111064392|NCT02287181|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111064393|NCT02287181|Narcotics|narcotics|mesh-ancestor
111064394|NCT02287181|Analgesics|analgesics|mesh-ancestor
111064395|NCT02287181|Sensory System Agents|sensory system agents|mesh-ancestor
111064396|NCT02287181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111064397|NCT02287259|Olanzapine|olanzapine|mesh-list
111064398|NCT02287259|Antiemetics|antiemetics|mesh-ancestor
111064399|NCT02287259|Autonomic Agents|autonomic agents|mesh-ancestor
111064400|NCT02287259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111064401|NCT02287259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111064402|NCT02287259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111064403|NCT02287259|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111064404|NCT02287259|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111064405|NCT02287259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111064406|NCT02287259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111064407|NCT02287259|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111064408|NCT02287259|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111064409|NCT02287259|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111064410|NCT02287259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111064411|NCT02287259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111064412|NCT02287259|Serotonin Agents|serotonin agents|mesh-ancestor
111064413|NCT00429923|Fluprednisolone|fluprednisolone|mesh-list
111064414|NCT00429923|Difluprednate|difluprednate|mesh-list
111064415|NCT00429923|Glucocorticoids|glucocorticoids|mesh-ancestor
111064416|NCT00429923|Hormones|hormones|mesh-ancestor
111064417|NCT00429923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111064418|NCT00429923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111064419|NCT00429923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111064420|NCT04470557|Fibrin fragment D|fibrin fragment d|mesh-list
111064421|NCT04470557|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111064422|NCT04470557|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111064423|NCT04470557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111064424|NCT04470557|Hemostatics|hemostatics|mesh-ancestor
111064425|NCT04470557|Coagulants|coagulants|mesh-ancestor
111064426|NCT00372437|Gemcitabine|gemcitabine|mesh-list
111064427|NCT00372437|Mocetinostat|mocetinostat|mesh-list
111064428|NCT00372437|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111064429|NCT00372437|Antimetabolites|antimetabolites|mesh-ancestor
111064430|NCT00372437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111064431|NCT00372437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111064432|NCT00372437|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111064433|NCT00372437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111064434|NCT00369473|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111064435|NCT00369473|Immunologic Factors|immunologic factors|mesh-ancestor
111064436|NCT00369473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111064437|NCT04470791|Antivenins|antivenins|mesh-list
111064438|NCT04470791|Immunologic Factors|immunologic factors|mesh-ancestor
111064439|NCT04470791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111064440|NCT00364247|Tapentadol|tapentadol|mesh-list
111064441|NCT00364247|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111064442|NCT00364247|Narcotics|narcotics|mesh-ancestor
111064443|NCT00364247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111064444|NCT00364247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111064445|NCT00364247|Analgesics|analgesics|mesh-ancestor
111064446|NCT00364247|Sensory System Agents|sensory system agents|mesh-ancestor
111064447|NCT00364247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111064448|NCT00364247|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111064449|NCT00364247|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111064450|NCT00364247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111064451|NCT00364247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111064452|NCT00364247|Adrenergic Agents|adrenergic agents|mesh-ancestor
111064453|NCT00364247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111064454|NCT00424697|Lorazepam|lorazepam|mesh-list
111064455|NCT00424697|Anticonvulsants|anticonvulsants|mesh-ancestor
111064456|NCT00424697|Antiemetics|antiemetics|mesh-ancestor
111064457|NCT00424697|Autonomic Agents|autonomic agents|mesh-ancestor
111064458|NCT00424697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111064459|NCT00424697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111064460|NCT00424697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111064461|NCT00424697|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111064462|NCT00424697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111064463|NCT00424697|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111064464|NCT00424697|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111064465|NCT00424697|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111064466|NCT00424697|GABA Modulators|gaba modulators|mesh-ancestor
111064467|NCT00424697|GABA Agents|gaba agents|mesh-ancestor
111064468|NCT00424697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111064469|NCT00424697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111064470|NCT00360035|Obatoclax|obatoclax|mesh-list
111064471|NCT00360035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111064472|NCT00360035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111064473|NCT00356681|Niacinamide|niacinamide|mesh-list
111064474|NCT00356681|Paclitaxel|paclitaxel|mesh-list
111064475|NCT00356681|Bevacizumab|bevacizumab|mesh-list
111064477|NCT00356681|Imetelstat|imetelstat|mesh-list
111064478|NCT00356681|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111064479|NCT00356681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111064480|NCT00356681|Tubulin Modulators|tubulin modulators|mesh-ancestor
111064481|NCT00356681|Antimitotic Agents|antimitotic agents|mesh-ancestor
111064482|NCT00356681|Mitosis Modulators|mitosis modulators|mesh-ancestor
111064483|NCT00356681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111064484|NCT00356681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110119388|NCT01894815|Dexetimide|dexetimide|mesh-list
111064485|NCT00356681|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111064486|NCT00356681|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111064487|NCT00356681|Growth Substances|growth substances|mesh-ancestor
111064488|NCT00356681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111064489|NCT00356681|Growth Inhibitors|growth inhibitors|mesh-ancestor
111064490|NCT00356681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111064491|NCT00356681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111064492|NCT00356681|Vitamin B Complex|vitamin b complex|mesh-ancestor
111064493|NCT00356681|Vitamins|vitamins|mesh-ancestor
111064494|NCT00356681|Micronutrients|micronutrients|mesh-ancestor
111064495|NCT00417209|Fluorouracil|fluorouracil|mesh-list
111064496|NCT00417209|Capecitabine|capecitabine|mesh-list
111064497|NCT00417209|Antimetabolites|antimetabolites|mesh-ancestor
111064498|NCT00417209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111064499|NCT00417209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111064500|NCT00417209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111064501|NCT00417209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111064502|NCT00417209|Immunologic Factors|immunologic factors|mesh-ancestor
111064503|NCT00417209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111064504|NCT04470401|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111064505|NCT04470401|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111064506|NCT04470401|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111064507|NCT04470401|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111064508|NCT04470401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111064509|NCT04470401|Cholinergic Agents|cholinergic agents|mesh-ancestor
111064510|NCT04470401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111064511|NCT04470401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111064512|NCT04470401|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111064513|NCT04470401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111064514|NCT00355355|Talaporfin|talaporfin|mesh-list
111064515|NCT00355355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111064516|NCT00355355|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111064517|NCT00355355|Dermatologic Agents|dermatologic agents|mesh-ancestor
111064518|NCT00407303|Bortezomib|bortezomib|mesh-list
111064519|NCT00407303|Obatoclax|obatoclax|mesh-list
111064520|NCT00407303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111064521|NCT00407303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111064522|NCT00407303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111064523|NCT00344045|Acetaminophen|acetaminophen|mesh-list
111064524|NCT00344045|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111064525|NCT00344045|Analgesics|analgesics|mesh-ancestor
111064526|NCT00344045|Sensory System Agents|sensory system agents|mesh-ancestor
111064527|NCT00344045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111064528|NCT00344045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111064529|NCT00344045|Antipyretics|antipyretics|mesh-ancestor
111064530|NCT02256436|Paclitaxel|paclitaxel|mesh-list
111064531|NCT02256436|Docetaxel|docetaxel|mesh-list
111064532|NCT02256436|Pembrolizumab|pembrolizumab|mesh-list
111064533|NCT02256436|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111064534|NCT02256436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111064535|NCT02256436|Tubulin Modulators|tubulin modulators|mesh-ancestor
111064536|NCT02256436|Antimitotic Agents|antimitotic agents|mesh-ancestor
111064537|NCT02256436|Mitosis Modulators|mitosis modulators|mesh-ancestor
111064538|NCT02256436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111064539|NCT02256436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111064540|NCT02256436|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111064541|NCT00343109|Sargramostim|sargramostim|mesh-list
111064542|NCT00343109|Vaccines|vaccines|mesh-list
111064543|NCT00343109|Immunologic Factors|immunologic factors|mesh-ancestor
111064544|NCT00343109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111064545|NCT00405743|Cytarabine|cytarabine|mesh-list
111064546|NCT00405743|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111064547|NCT00405743|Antimetabolites|antimetabolites|mesh-ancestor
111064548|NCT00405743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110636856|NCT00931398|Methylphenidate|methylphenidate|mesh-list
111064549|NCT00405743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111064550|NCT00405743|Antiviral Agents|antiviral agents|mesh-ancestor
111064551|NCT00405743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111064552|NCT00405743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111064553|NCT00405743|Immunologic Factors|immunologic factors|mesh-ancestor
111064554|NCT00405743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111064555|NCT00403169|Lenalidomide|lenalidomide|mesh-list
111064556|NCT00403169|Immunologic Factors|immunologic factors|mesh-ancestor
111064557|NCT00403169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111064558|NCT00403169|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111064559|NCT00403169|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111064560|NCT00403169|Growth Substances|growth substances|mesh-ancestor
111064561|NCT00403169|Growth Inhibitors|growth inhibitors|mesh-ancestor
111064562|NCT00403169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111064563|NCT00332657|Hydrocortisone|hydrocortisone|mesh-list
111064565|NCT00332657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111064566|NCT00332657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111064567|NCT00332657|Growth Substances|growth substances|mesh-ancestor
111064568|NCT00332657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111064569|NCT00332657|Growth Inhibitors|growth inhibitors|mesh-ancestor
111064570|NCT00332657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111064571|NCT00332657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111064572|NCT00330473|Insulin|insulin|mesh-list
111064573|NCT00330473|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111064574|NCT00330473|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111064575|NCT00330473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111064576|NCT00327743|Capecitabine|capecitabine|mesh-list
111064577|NCT00327743|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111064578|NCT00327743|Antimetabolites|antimetabolites|mesh-ancestor
111064579|NCT00327743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111064580|NCT00327743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111064581|NCT02285075|Temocillin|temocillin|mesh-list
111064582|NCT02285075|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111064583|NCT02285075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111064584|NCT00321815|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111064585|NCT00321815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111064586|NCT00321815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111064587|NCT00321815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111064588|NCT00321815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111064589|NCT00398879|Capecitabine|capecitabine|mesh-list
111064590|NCT00398879|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111064591|NCT00398879|Antimetabolites|antimetabolites|mesh-ancestor
111064592|NCT00398879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111064593|NCT00398879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111064594|NCT00309179|Cetuximab|cetuximab|mesh-list
111064595|NCT00309179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111064596|NCT00309179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111064597|NCT00394199|Fluticasone|fluticasone|mesh-list
111064599|NCT00394199|Formoterol Fumarate|formoterol fumarate|mesh-list
111064600|NCT00394199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111064601|NCT00394199|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111064602|NCT00394199|Autonomic Agents|autonomic agents|mesh-ancestor
111064603|NCT00394199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111064604|NCT00394199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111064605|NCT00394199|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111064606|NCT00394199|Respiratory System Agents|respiratory system agents|mesh-ancestor
111064607|NCT00394199|Dermatologic Agents|dermatologic agents|mesh-ancestor
111064608|NCT00394199|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111064609|NCT00394199|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111064610|NCT00394199|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111064611|NCT00394199|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111064612|NCT00394199|Adrenergic Agents|adrenergic agents|mesh-ancestor
111064613|NCT00394199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111064614|NCT00394199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111064615|NCT00394121|Fluticasone|fluticasone|mesh-list
111064616|NCT00394121|Xhance|xhance|mesh-list
111064617|NCT00394121|Formoterol Fumarate|formoterol fumarate|mesh-list
111064618|NCT00394121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111064619|NCT00394121|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111064620|NCT00394121|Autonomic Agents|autonomic agents|mesh-ancestor
111064621|NCT00394121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111064622|NCT00394121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111064623|NCT00394121|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111064624|NCT00394121|Respiratory System Agents|respiratory system agents|mesh-ancestor
111064625|NCT00394121|Dermatologic Agents|dermatologic agents|mesh-ancestor
111064626|NCT00394121|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111064627|NCT00394121|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111064628|NCT00394121|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111064629|NCT00394121|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111064630|NCT00394121|Adrenergic Agents|adrenergic agents|mesh-ancestor
111064631|NCT00394121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111064632|NCT00394121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111064633|NCT02480114|Acetaminophen|acetaminophen|mesh-list
111064634|NCT02480114|Ibuprofen|ibuprofen|mesh-list
111064635|NCT02480114|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
111064636|NCT02480114|Fentanyl|fentanyl|mesh-list
111064637|NCT02480114|Oxycodone|oxycodone|mesh-list
111064638|NCT02480114|Hydrocodone|hydrocodone|mesh-list
111064639|NCT02480114|Gabapentin|gabapentin|mesh-list
111064640|NCT02480114|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111064641|NCT02480114|Narcotics|narcotics|mesh-ancestor
111064642|NCT02480114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111064643|NCT02480114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111064644|NCT02480114|Analgesics|analgesics|mesh-ancestor
111064645|NCT02480114|Sensory System Agents|sensory system agents|mesh-ancestor
111064646|NCT02480114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110781725|NCT03020914|Sympathomimetics|sympathomimetics|mesh-ancestor
111064647|NCT02480114|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111064648|NCT02480114|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111064649|NCT02480114|Anesthetics, General|anesthetics, general|mesh-ancestor
111064650|NCT02480114|Anesthetics|anesthetics|mesh-ancestor
111064651|NCT02480114|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111064652|NCT02480114|Antipyretics|antipyretics|mesh-ancestor
111064653|NCT02480114|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111064654|NCT02480114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111064655|NCT02480114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111064656|NCT02480114|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111064657|NCT02480114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111064658|NCT02480114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111064659|NCT02480114|Anticonvulsants|anticonvulsants|mesh-ancestor
111064660|NCT02480114|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111064661|NCT02480114|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111064662|NCT02480114|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111064663|NCT02480114|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111064664|NCT02480114|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111064665|NCT02480114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111064666|NCT02480114|Antimanic Agents|antimanic agents|mesh-ancestor
111064667|NCT02480114|Antitussive Agents|antitussive agents|mesh-ancestor
111064668|NCT02480114|Respiratory System Agents|respiratory system agents|mesh-ancestor
111064669|NCT00299507|Hydrocortisone|hydrocortisone|mesh-list
111064670|NCT00299507|Anecortave|anecortave|mesh-list
111064671|NCT00299507|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111064672|NCT00299507|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111064673|NCT00299507|Growth Substances|growth substances|mesh-ancestor
111064674|NCT00299507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111064675|NCT00299507|Growth Inhibitors|growth inhibitors|mesh-ancestor
111064676|NCT00299507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111064677|NCT00299507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111064678|NCT02285309|Enoximone|enoximone|mesh-list
111064679|NCT02285309|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111064680|NCT02285309|Vasodilator Agents|vasodilator agents|mesh-ancestor
111064681|NCT02285309|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
111064682|NCT02285309|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111064683|NCT02285309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111064684|NCT02285309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111064685|NCT02285309|Protective Agents|protective agents|mesh-ancestor
111064686|NCT02285309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111064687|NCT02479880|Tenofovir|tenofovir|mesh-list
111064688|NCT02479880|Antiviral Agents|antiviral agents|mesh-ancestor
111064689|NCT02479880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111064690|NCT02479880|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111064691|NCT02479880|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111064692|NCT02479880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111064693|NCT02479880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111064694|NCT02479880|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111064695|NCT02479880|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111064696|NCT00297401|Ruboxistaurin|ruboxistaurin|mesh-list
111064697|NCT00297401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111064698|NCT00297401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111064699|NCT00297089|Pemetrexed|pemetrexed|mesh-list
111064700|NCT00297089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111064701|NCT00297089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111064702|NCT00297089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111064703|NCT00297089|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111064704|NCT00297089|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111064705|NCT00286793|Gossypol acetic acid|gossypol acetic acid|mesh-list
111064706|NCT00286793|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111064707|NCT00286793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111064708|NCT00286793|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111064709|NCT00286793|Contraceptive Agents|contraceptive agents|mesh-ancestor
111064710|NCT00286793|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111064711|NCT00286793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111064712|NCT00286793|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
111064713|NCT00286793|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
111064714|NCT00286793|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
111064715|NCT02285699|Fluvoxamine|fluvoxamine|mesh-list
111064716|NCT02285699|Citalopram|citalopram|mesh-list
111064717|NCT02285699|Fluoxetine|fluoxetine|mesh-list
111064718|NCT02285699|Paroxetine|paroxetine|mesh-list
111064719|NCT02285699|Sertraline|sertraline|mesh-list
111064720|NCT02285699|Escitalopram|escitalopram|mesh-list
111064721|NCT02285699|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110781802|NCT03955497|Viscosupplements|viscosupplements|mesh-ancestor
111064722|NCT02285699|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111064723|NCT02285699|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111064724|NCT02285699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111064725|NCT02285699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111064726|NCT02285699|Serotonin Agents|serotonin agents|mesh-ancestor
111064727|NCT02285699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111064728|NCT02285699|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111064729|NCT02285699|Antidepressive Agents|antidepressive agents|mesh-ancestor
111064730|NCT02285699|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111064731|NCT02285699|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111064732|NCT02285699|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111064733|NCT02285699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111064734|NCT02285699|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111064735|NCT02285699|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111064736|NCT02285699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111064737|NCT02285699|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111064738|NCT02285699|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111064739|NCT02288429|Colistin|colistin|mesh-list
111064740|NCT02288429|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111064741|NCT02288429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111064742|NCT03133637|Ceftriaxone|ceftriaxone|mesh-list
111064743|NCT03133637|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111064744|NCT03133637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111064745|NCT00265655|Satraplatin|satraplatin|mesh-list
111064746|NCT00265655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111064747|NCT00254891|Paclitaxel|paclitaxel|mesh-list
111064748|NCT00254891|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111064749|NCT00254891|Carboplatin|carboplatin|mesh-list
111064750|NCT00254891|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111064751|NCT00254891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111064752|NCT00254891|Tubulin Modulators|tubulin modulators|mesh-ancestor
111064753|NCT00254891|Antimitotic Agents|antimitotic agents|mesh-ancestor
111064754|NCT00254891|Mitosis Modulators|mitosis modulators|mesh-ancestor
111064755|NCT00254891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111064756|NCT02479412|Albuterol|albuterol|mesh-list
111064757|NCT02479412|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111064758|NCT02479412|Autonomic Agents|autonomic agents|mesh-ancestor
111064759|NCT02479412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111064760|NCT02479412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111064761|NCT02479412|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111064762|NCT02479412|Respiratory System Agents|respiratory system agents|mesh-ancestor
111064763|NCT02479412|Tocolytic Agents|tocolytic agents|mesh-ancestor
111064764|NCT02479412|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111064765|NCT02479412|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111064766|NCT02479412|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111064767|NCT02479412|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111064769|NCT02479412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111064770|NCT02479412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111064771|NCT00254579|Tremelimumab|tremelimumab|mesh-list
111064772|NCT00254579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111064773|NCT00252005|Apixaban|apixaban|mesh-list
111064774|NCT00252005|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111064775|NCT00252005|Antithrombins|antithrombins|mesh-ancestor
111064776|NCT00252005|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111064777|NCT00252005|Protease Inhibitors|protease inhibitors|mesh-ancestor
111064778|NCT00252005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111064779|NCT00252005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111064780|NCT00252005|Anticoagulants|anticoagulants|mesh-ancestor
111064781|NCT02288507|Sorafenib|sorafenib|mesh-list
111064782|NCT02288507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111064783|NCT02288507|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111064784|NCT02288507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111064785|NCT02288507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111064786|NCT00231257|Sirolimus|sirolimus|mesh-list
111064787|NCT00231257|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111064788|NCT00231257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111064789|NCT00231257|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111064790|NCT00231257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111064791|NCT00231257|Antifungal Agents|antifungal agents|mesh-ancestor
111064792|NCT00231257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111064793|NCT00231257|Immunologic Factors|immunologic factors|mesh-ancestor
111064794|NCT00231257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111064795|NCT00224003|Ferric gluconate|ferric gluconate|mesh-list
111064796|NCT00224003|Hematinics|hematinics|mesh-ancestor
111064797|NCT00216593|Galantamine|galantamine|mesh-list
111064798|NCT00216593|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111064799|NCT00216593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111064800|NCT00216593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111064801|NCT00216593|Cholinergic Agents|cholinergic agents|mesh-ancestor
111064802|NCT00216593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111064803|NCT00216593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111064804|NCT00216593|Parasympathomimetics|parasympathomimetics|mesh-ancestor
111064805|NCT00216593|Autonomic Agents|autonomic agents|mesh-ancestor
111064806|NCT00216593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111064807|NCT00216593|Nootropic Agents|nootropic agents|mesh-ancestor
111064808|NCT00389675|Guanfacine|guanfacine|mesh-list
111064809|NCT00389675|Darusentan|darusentan|mesh-list
111064810|NCT00389675|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111064811|NCT00389675|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111064812|NCT00389675|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111064813|NCT00389675|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111064814|NCT00389675|Adrenergic Agents|adrenergic agents|mesh-ancestor
111064815|NCT00389675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111064816|NCT00389675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111064817|NCT00389675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111064818|NCT00389675|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
111064819|NCT02288741|Dexamethasone|dexamethasone|mesh-list
111064820|NCT02288741|Dexamethasone acetate|dexamethasone acetate|mesh-list
111064821|NCT02288741|Melphalan|melphalan|mesh-list
111064822|NCT02288741|BB 1101|bb 1101|mesh-list
111064823|NCT02288741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111064824|NCT02288741|Antiemetics|antiemetics|mesh-ancestor
111064825|NCT02288741|Autonomic Agents|autonomic agents|mesh-ancestor
111064826|NCT02288741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111064827|NCT02288741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111064828|NCT02288741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111064829|NCT02288741|Glucocorticoids|glucocorticoids|mesh-ancestor
111064830|NCT02288741|Hormones|hormones|mesh-ancestor
111064831|NCT02288741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111064832|NCT02288741|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111064833|NCT02288741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111064834|NCT02288741|Protease Inhibitors|protease inhibitors|mesh-ancestor
111064835|NCT02288741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111064836|NCT02288741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111064837|NCT02288741|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111064838|NCT02288741|Alkylating Agents|alkylating agents|mesh-ancestor
111064839|NCT02288741|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111064840|NCT02288741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111064841|NCT02288741|Immunologic Factors|immunologic factors|mesh-ancestor
111064842|NCT02450552|Ezogabine|ezogabine|mesh-list
111064843|NCT02450552|Anticonvulsants|anticonvulsants|mesh-ancestor
111064844|NCT02450552|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111064845|NCT02450552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111064846|NCT02508428|Methyclothiazide|methyclothiazide|mesh-list
111064847|NCT02508428|Diuretics|diuretics|mesh-ancestor
111064848|NCT02508428|Natriuretic Agents|natriuretic agents|mesh-ancestor
111064849|NCT02508428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111064850|NCT02508428|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
111064851|NCT02508428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111064852|NCT02508428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111064853|NCT02448446|Ranibizumab|ranibizumab|mesh-list
111064854|NCT02448446|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111064855|NCT02448446|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111064856|NCT02448446|Growth Substances|growth substances|mesh-ancestor
111064857|NCT02448446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111064858|NCT02448446|Growth Inhibitors|growth inhibitors|mesh-ancestor
111064859|NCT02448446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111064860|NCT02478398|Mometasone Furoate|mometasone furoate|mesh-list
111064861|NCT02478398|Loratadine|loratadine|mesh-list
111064862|NCT02478398|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
111064863|NCT02478398|Epinephrine|epinephrine|mesh-list
111064864|NCT02478398|Albuterol|albuterol|mesh-list
111064865|NCT02478398|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111064866|NCT02478398|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111064867|NCT02478398|Adrenergic Agents|adrenergic agents|mesh-ancestor
111064868|NCT02478398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111064869|NCT02478398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111064870|NCT02478398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111064871|NCT02478398|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110781951|NCT03012334|GABA Agents|gaba agents|mesh-ancestor
111064872|NCT02478398|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111064873|NCT02478398|Autonomic Agents|autonomic agents|mesh-ancestor
111064874|NCT02478398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111064875|NCT02478398|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111064876|NCT02478398|Respiratory System Agents|respiratory system agents|mesh-ancestor
111064877|NCT02478398|Mydriatics|mydriatics|mesh-ancestor
111064878|NCT02478398|Sympathomimetics|sympathomimetics|mesh-ancestor
111064879|NCT02478398|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111064880|NCT02478398|Tocolytic Agents|tocolytic agents|mesh-ancestor
111064881|NCT02478398|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111064882|NCT02478398|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111064883|NCT02478398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111064884|NCT02478398|Dermatologic Agents|dermatologic agents|mesh-ancestor
111064885|NCT02478398|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111064886|NCT02478398|Antipruritics|antipruritics|mesh-ancestor
111064887|NCT02478398|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
111064888|NCT02478398|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111064889|NCT02478398|Histamine Antagonists|histamine antagonists|mesh-ancestor
111064890|NCT02478398|Histamine Agents|histamine agents|mesh-ancestor
111064891|NCT02478398|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111064892|NCT02478398|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111064893|NCT02478398|Analgesics|analgesics|mesh-ancestor
111064894|NCT02478398|Sensory System Agents|sensory system agents|mesh-ancestor
111064895|NCT02478398|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111064896|NCT02478164|Ponatinib|ponatinib|mesh-list
111064897|NCT02478164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111064898|NCT02478164|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111064899|NCT02478164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111064900|NCT02478164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111064901|NCT02476994|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
111064902|NCT02476994|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
111064903|NCT02476994|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
111064904|NCT02476994|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111064905|NCT02318329|Bemarituzumab|bemarituzumab|mesh-list
111064906|NCT02318329|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111064907|NCT02318329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111064908|NCT05259319|Atezolizumab|atezolizumab|mesh-list
111064909|NCT05259319|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111064910|NCT05259319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111064911|NCT05259319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111064912|NCT05259319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111064914|NCT05259007|Clarithromycin|clarithromycin|mesh-list
111064915|NCT05259007|Propolis|propolis|mesh-list
111064916|NCT05259007|Lansoprazole|lansoprazole|mesh-list
111064917|NCT05259007|Dexlansoprazole|dexlansoprazole|mesh-list
111064918|NCT05259007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111064919|NCT05259007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111064920|NCT05259007|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111064921|NCT05259007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111064922|NCT05259007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111064923|NCT05259007|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111064924|NCT05259007|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111064925|NCT05259007|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111064926|NCT05259007|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111064927|NCT05259007|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111064928|NCT02255656|Alemtuzumab|alemtuzumab|mesh-list
111064929|NCT02255656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111064930|NCT02255656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111064931|NCT00380653|Sapacitabine|sapacitabine|mesh-list
111064932|NCT00380653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111064933|NCT03472339|Diclofenac|diclofenac|mesh-list
111064934|NCT03472339|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111064935|NCT03472339|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111064936|NCT03472339|Analgesics|analgesics|mesh-ancestor
111064937|NCT03472339|Sensory System Agents|sensory system agents|mesh-ancestor
111064938|NCT03472339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111064939|NCT03472339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111064940|NCT03472339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111064941|NCT03472339|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111064942|NCT03472339|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111064943|NCT03472339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111064944|NCT03472339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111064945|NCT03472261|Botulinum Toxins|botulinum toxins|mesh-list
111064946|NCT03472261|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111064947|NCT03472261|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111064948|NCT03472261|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111064949|NCT03472261|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111064950|NCT03472261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111064951|NCT03472261|Cholinergic Agents|cholinergic agents|mesh-ancestor
111064952|NCT03472261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111064953|NCT03472261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111064954|NCT03472261|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111064955|NCT03472261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111064956|NCT03951025|Melatonin|melatonin|mesh-list
111064957|NCT03951025|Antioxidants|antioxidants|mesh-ancestor
111064958|NCT03951025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111064959|NCT03951025|Protective Agents|protective agents|mesh-ancestor
111064960|NCT03951025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111064961|NCT03951025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111064962|NCT02255500|Bupivacaine|bupivacaine|mesh-list
111064963|NCT02255500|Anesthetics, Local|anesthetics, local|mesh-ancestor
111064964|NCT02255500|Anesthetics|anesthetics|mesh-ancestor
111064965|NCT02255500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111064966|NCT02255500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111064967|NCT02255500|Sensory System Agents|sensory system agents|mesh-ancestor
111064968|NCT02255500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111064969|NCT03475693|Acetaminophen|acetaminophen|mesh-list
111064970|NCT03475693|Ondansetron|ondansetron|mesh-list
111064971|NCT03475693|Magnesium Oxide|magnesium oxide|mesh-list
111064972|NCT03475693|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111064973|NCT03475693|Analgesics|analgesics|mesh-ancestor
111064974|NCT03475693|Sensory System Agents|sensory system agents|mesh-ancestor
111064975|NCT03475693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111064976|NCT03475693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111064977|NCT03475693|Antipyretics|antipyretics|mesh-ancestor
111064978|NCT03475693|Antiemetics|antiemetics|mesh-ancestor
111064979|NCT03475693|Autonomic Agents|autonomic agents|mesh-ancestor
111064980|NCT03475693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111064981|NCT03475693|Antipruritics|antipruritics|mesh-ancestor
111064982|NCT03475693|Dermatologic Agents|dermatologic agents|mesh-ancestor
111064983|NCT03475693|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111064984|NCT03475693|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111064985|NCT03475693|Serotonin Agents|serotonin agents|mesh-ancestor
111064986|NCT03475693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111064987|NCT03475693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111064988|NCT03475693|Antacids|antacids|mesh-ancestor
111064989|NCT05156749|Calpastatin|calpastatin|mesh-list
111064990|NCT05156749|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
111064991|NCT05156749|Protease Inhibitors|protease inhibitors|mesh-ancestor
111064992|NCT05156749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111064993|NCT05156749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111064994|NCT03475615|Paclitaxel|paclitaxel|mesh-list
111064995|NCT03475615|Oxaliplatin|oxaliplatin|mesh-list
111064996|NCT03475615|Tegafur|tegafur|mesh-list
111064997|NCT03475615|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111064998|NCT03475615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111064999|NCT03475615|Tubulin Modulators|tubulin modulators|mesh-ancestor
111065000|NCT03475615|Antimitotic Agents|antimitotic agents|mesh-ancestor
111065001|NCT03475615|Mitosis Modulators|mitosis modulators|mesh-ancestor
111065002|NCT03475615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111065003|NCT03475615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111065004|NCT03475615|Antimetabolites|antimetabolites|mesh-ancestor
111065005|NCT03478423|Oxycodone|oxycodone|mesh-list
111065006|NCT03478423|Hydromorphone|hydromorphone|mesh-list
111065007|NCT03478423|Codeine|codeine|mesh-list
111065008|NCT03478423|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111065009|NCT03478423|Narcotics|narcotics|mesh-ancestor
111065010|NCT03478423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111065011|NCT03478423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111065012|NCT03478423|Analgesics|analgesics|mesh-ancestor
111065013|NCT03478423|Sensory System Agents|sensory system agents|mesh-ancestor
110636924|NCT00827450|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111065014|NCT03478423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111065015|NCT03478423|Antitussive Agents|antitussive agents|mesh-ancestor
111065016|NCT03478423|Respiratory System Agents|respiratory system agents|mesh-ancestor
111065017|NCT03478345|Endocrine Disruptors|endocrine disruptors|mesh-list
111065018|NCT03478345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111065019|NCT03130933|Amoxicillin|amoxicillin|mesh-list
111065020|NCT03130933|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111065021|NCT03130933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111065022|NCT05155969|Ketamine|ketamine|mesh-list
111065023|NCT05155969|Esketamine|esketamine|mesh-list
111065024|NCT05155969|Analgesics|analgesics|mesh-ancestor
111065025|NCT05155969|Sensory System Agents|sensory system agents|mesh-ancestor
111065026|NCT05155969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111065027|NCT05155969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111065028|NCT05155969|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111065029|NCT05155969|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111065030|NCT05155969|Anesthetics, General|anesthetics, general|mesh-ancestor
111065031|NCT05155969|Anesthetics|anesthetics|mesh-ancestor
111065032|NCT05155969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111065033|NCT05155969|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111065034|NCT05155969|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111065035|NCT05155969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111065036|NCT05155969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111065037|NCT05155969|Antidepressive Agents|antidepressive agents|mesh-ancestor
111065038|NCT05155969|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111065039|NCT05112913|Vaccines|vaccines|mesh-list
111065040|NCT05112913|Immunologic Factors|immunologic factors|mesh-ancestor
111065041|NCT05112913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111065042|NCT03475459|Melatonin|melatonin|mesh-list
111065043|NCT03475459|Antioxidants|antioxidants|mesh-ancestor
111065044|NCT03475459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111065045|NCT03475459|Protective Agents|protective agents|mesh-ancestor
111065046|NCT03475459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111065047|NCT03475459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111065048|NCT03478111|Infliximab|infliximab|mesh-list
111065049|NCT03478111|Methotrexate|methotrexate|mesh-list
111065050|NCT03478111|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111065051|NCT03478111|Abortifacient Agents|abortifacient agents|mesh-ancestor
111065052|NCT03478111|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110827975|NCT03863977|Dexamethasone|dexamethasone|mesh-list
111065053|NCT03478111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111065054|NCT03478111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111065055|NCT03478111|Antimetabolites|antimetabolites|mesh-ancestor
111065056|NCT03478111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111065057|NCT03478111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111065058|NCT03478111|Dermatologic Agents|dermatologic agents|mesh-ancestor
111065059|NCT03478111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111065060|NCT03478111|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111065061|NCT03478111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111065062|NCT03478111|Immunologic Factors|immunologic factors|mesh-ancestor
111065063|NCT03478111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111065064|NCT03478111|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111065065|NCT03478111|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111065066|NCT03478111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111065067|NCT03478111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111065068|NCT03478033|Rifampin|rifampin|mesh-list
111065069|NCT03478033|Rifabutin|rifabutin|mesh-list
111065070|NCT03478033|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111065071|NCT03478033|Antitubercular Agents|antitubercular agents|mesh-ancestor
111065072|NCT03478033|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111065073|NCT03478033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111065074|NCT03478033|Leprostatic Agents|leprostatic agents|mesh-ancestor
111065075|NCT03478033|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111065076|NCT03478033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111065077|NCT03478033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111065078|NCT03478033|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111065079|NCT03478033|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111065080|NCT03478033|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110636927|NCT00930306|Tolbutamide|tolbutamide|mesh-list
111065081|NCT03478033|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
111065082|NCT03478033|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
111065083|NCT03478033|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111065084|NCT03477955|Silicon|silicon|mesh-list
111065085|NCT03477955|Trace Elements|trace elements|mesh-ancestor
111065086|NCT03477955|Micronutrients|micronutrients|mesh-ancestor
111065087|NCT03477955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111065088|NCT05189197|Zanubrutinib|zanubrutinib|mesh-list
111065089|NCT05189197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111065090|NCT05189197|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111065091|NCT05189197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111065092|NCT05189197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111065093|NCT05084599|Metaraminol|metaraminol|mesh-list
111065094|NCT05084599|Sympathomimetics|sympathomimetics|mesh-ancestor
111065095|NCT05084599|Autonomic Agents|autonomic agents|mesh-ancestor
111065096|NCT05084599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110782183|NCT03487666|Capecitabine|capecitabine|mesh-list
111065097|NCT05084599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111065098|NCT05084599|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111065099|NCT05084599|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111065100|NCT05084599|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111065101|NCT05084599|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111065102|NCT05084599|Adrenergic Agents|adrenergic agents|mesh-ancestor
111065103|NCT05084599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111065104|NCT05084599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111065105|NCT02505542|Certolizumab Pegol|certolizumab pegol|mesh-list
111065106|NCT02505542|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111065107|NCT02505542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111065108|NCT02505542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111065109|NCT02505542|Immunologic Factors|immunologic factors|mesh-ancestor
111065110|NCT02505542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111065111|NCT02505542|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111065112|NCT00701623|Heparin|heparin|mesh-list
111065113|NCT00701623|Calcium heparin|calcium heparin|mesh-list
111065114|NCT00701623|Anticoagulants|anticoagulants|mesh-ancestor
111065115|NCT00701623|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111065116|NCT00701623|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111065117|NCT00701623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111065118|NCT04456153|Atovaquone|atovaquone|mesh-list
111065119|NCT04456153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111065120|NCT04456153|Antimalarials|antimalarials|mesh-ancestor
111065121|NCT04456153|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111065122|NCT04456153|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111065123|NCT04456153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111065124|NCT04456153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111065125|NCT04403971|Chlorhexidine|chlorhexidine|mesh-list
111065126|NCT04403971|Listerine|listerine|mesh-list
111065127|NCT04403971|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111065128|NCT04403971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111065129|NCT04403971|Disinfectants|disinfectants|mesh-ancestor
111065131|NCT02447432|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
111065132|NCT02447432|Immunologic Factors|immunologic factors|mesh-ancestor
111065133|NCT02447432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111065134|NCT02446886|Hormones|hormones|mesh-list
111065135|NCT02446886|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
111065136|NCT02446886|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
111065137|NCT02446886|beta-Endorphin|beta-endorphin|mesh-list
111065138|NCT02446886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111065139|NCT02446886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111065140|NCT02446886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111065141|NCT02446886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111065142|NCT04351243|Gimsilumab|gimsilumab|mesh-list
111065143|NCT04351243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111065144|NCT04351243|Antiviral Agents|antiviral agents|mesh-ancestor
111065145|NCT04351243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111065146|NCT05008003|Vitamin D|vitamin d|mesh-list
111065147|NCT05008003|Cholecalciferol|cholecalciferol|mesh-list
111065148|NCT05008003|Vitamins|vitamins|mesh-ancestor
111065149|NCT05008003|Micronutrients|micronutrients|mesh-ancestor
111065150|NCT05008003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111065151|NCT05008003|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111065152|NCT05008003|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111065153|NCT03475225|Cholecalciferol|cholecalciferol|mesh-list
111065154|NCT03475225|Vitamin D|vitamin d|mesh-list
111065155|NCT03475225|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111065156|NCT03475225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111065157|NCT03475225|Vitamins|vitamins|mesh-ancestor
111065158|NCT03475225|Micronutrients|micronutrients|mesh-ancestor
111065159|NCT03475225|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111065160|NCT03448939|Benzoyl Peroxide|benzoyl peroxide|mesh-list
111065161|NCT03448939|Dermatologic Agents|dermatologic agents|mesh-ancestor
111065162|NCT02504294|Epoetin Alfa|epoetin alfa|mesh-list
111065163|NCT02504294|Hematinics|hematinics|mesh-ancestor
111065164|NCT02446418|Fluticasone|fluticasone|mesh-list
111065165|NCT02446418|Xhance|xhance|mesh-list
111065166|NCT02446418|Budesonide|budesonide|mesh-list
111065167|NCT02446418|Formoterol Fumarate|formoterol fumarate|mesh-list
111065168|NCT02446418|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
111065169|NCT02446418|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111065170|NCT02446418|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111065171|NCT02446418|Autonomic Agents|autonomic agents|mesh-ancestor
111065172|NCT02446418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111065173|NCT02446418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111065174|NCT02446418|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111065175|NCT02446418|Respiratory System Agents|respiratory system agents|mesh-ancestor
111065176|NCT02446418|Dermatologic Agents|dermatologic agents|mesh-ancestor
111065177|NCT02446418|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111065178|NCT02446418|Glucocorticoids|glucocorticoids|mesh-ancestor
111065179|NCT02446418|Hormones|hormones|mesh-ancestor
111065180|NCT02446418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111065181|NCT02446418|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111065182|NCT02446418|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111065183|NCT02446418|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111065184|NCT02446418|Adrenergic Agents|adrenergic agents|mesh-ancestor
111065185|NCT02446418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111065186|NCT02446418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111065187|NCT04859062|Lidocaine|lidocaine|mesh-list
111065188|NCT04859062|Anesthetics, Local|anesthetics, local|mesh-ancestor
111065189|NCT04859062|Anesthetics|anesthetics|mesh-ancestor
111065190|NCT04859062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111065191|NCT04859062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111065192|NCT04859062|Sensory System Agents|sensory system agents|mesh-ancestor
111065193|NCT04859062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111065194|NCT04859062|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111065195|NCT04859062|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111065196|NCT04859062|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111065197|NCT04859062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111065198|NCT04859062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111065199|NCT01641640|Sofosbuvir|sofosbuvir|mesh-list
111065200|NCT01641640|Ribavirin|ribavirin|mesh-list
111065201|NCT01641640|Antiviral Agents|antiviral agents|mesh-ancestor
111065202|NCT01641640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111065203|NCT01641640|Antimetabolites|antimetabolites|mesh-ancestor
111065204|NCT01641640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111065205|NCT05650216|Paclitaxel|paclitaxel|mesh-list
111065206|NCT05650216|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111065207|NCT05650216|Carboplatin|carboplatin|mesh-list
111065208|NCT05650216|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111065209|NCT05650216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111065210|NCT05650216|Tubulin Modulators|tubulin modulators|mesh-ancestor
111065211|NCT05650216|Antimitotic Agents|antimitotic agents|mesh-ancestor
111065212|NCT05650216|Mitosis Modulators|mitosis modulators|mesh-ancestor
111065213|NCT05650216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111065214|NCT04848688|Ivermectin|ivermectin|mesh-list
111065215|NCT04848688|Moxidectin|moxidectin|mesh-list
111065216|NCT04848688|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111065217|NCT04848688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111065218|NCT04848688|Anthelmintics|anthelmintics|mesh-ancestor
111065219|NCT04848688|Antinematodal Agents|antinematodal agents|mesh-ancestor
111065220|NCT05369650|Lidocaine|lidocaine|mesh-list
111065221|NCT05369650|Anesthetics, Local|anesthetics, local|mesh-ancestor
111065222|NCT05369650|Anesthetics|anesthetics|mesh-ancestor
111065223|NCT05369650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111065224|NCT05369650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111065225|NCT05369650|Sensory System Agents|sensory system agents|mesh-ancestor
111065226|NCT05369650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111065227|NCT05369650|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111065228|NCT05369650|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111065229|NCT05369650|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111065230|NCT05369650|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111065231|NCT05369650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111065232|NCT05071612|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
111065233|NCT05071612|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111065234|NCT05071612|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111065235|NCT05071612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111065236|NCT05071612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111065237|NCT05071612|Adrenergic Agents|adrenergic agents|mesh-ancestor
111065238|NCT05071612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111065239|NCT05071612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111065240|NCT05069740|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
111065241|NCT05069740|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111065242|NCT05069740|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111065243|NCT05069740|Analgesics|analgesics|mesh-ancestor
111065244|NCT05069740|Sensory System Agents|sensory system agents|mesh-ancestor
111065245|NCT05069740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111065246|NCT05069740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111065247|NCT05069740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111065248|NCT05069740|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111065250|NCT01601626|Vitamin B 6|vitamin b 6|mesh-list
111065251|NCT01601626|Ritonavir|ritonavir|mesh-list
111065252|NCT01601626|Lopinavir|lopinavir|mesh-list
111065253|NCT01601626|Raltegravir Potassium|raltegravir potassium|mesh-list
111065254|NCT01601626|Rifampin|rifampin|mesh-list
111065255|NCT01601626|Isoniazid|isoniazid|mesh-list
111065256|NCT01601626|Pyrazinamide|pyrazinamide|mesh-list
111065257|NCT01601626|Ethambutol|ethambutol|mesh-list
111065258|NCT01601626|Rifabutin|rifabutin|mesh-list
111065259|NCT01601626|Vitamins|vitamins|mesh-ancestor
111065260|NCT01601626|Micronutrients|micronutrients|mesh-ancestor
111065261|NCT01601626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111065262|NCT01601626|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111065263|NCT01601626|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111065264|NCT01601626|Protease Inhibitors|protease inhibitors|mesh-ancestor
111065265|NCT01601626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111065266|NCT01601626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111065267|NCT01601626|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111065268|NCT01601626|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111065269|NCT01601626|Antiviral Agents|antiviral agents|mesh-ancestor
111065270|NCT01601626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111065271|NCT01601626|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111065272|NCT01601626|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111065273|NCT01601626|Vitamin B Complex|vitamin b complex|mesh-ancestor
111065274|NCT01601626|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111065275|NCT01601626|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111065276|NCT01601626|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111065277|NCT01601626|Antitubercular Agents|antitubercular agents|mesh-ancestor
111065278|NCT01601626|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111065279|NCT01601626|Leprostatic Agents|leprostatic agents|mesh-ancestor
111065280|NCT01601626|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111065281|NCT01601626|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111065282|NCT01601626|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111065283|NCT01601626|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
111065284|NCT01601626|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
111065285|NCT01601626|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
111065286|NCT01601626|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111065287|NCT01601626|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
111065288|NCT01601626|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111065289|NCT01601626|Antimetabolites|antimetabolites|mesh-ancestor
111065290|NCT01601626|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111065291|NCT05428150|Pirfenidone|pirfenidone|mesh-list
111065292|NCT05428150|Analgesics|analgesics|mesh-ancestor
111065293|NCT05428150|Sensory System Agents|sensory system agents|mesh-ancestor
111065294|NCT05428150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111065295|NCT05428150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111065296|NCT05428150|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111065297|NCT05428150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111065298|NCT05428150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111065299|NCT05428150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111065300|NCT05428150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111065301|NCT02737501|Crizotinib|crizotinib|mesh-list
111065302|NCT02737501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111065303|NCT02737501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111065304|NCT02737501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111065305|NCT02737501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111065306|NCT04848220|APD791|apd791|mesh-list
111065307|NCT04848220|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111065308|NCT04848220|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111065309|NCT04848220|Serotonin Agents|serotonin agents|mesh-ancestor
111065310|NCT04848220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111065311|NCT04848220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111065312|NCT04848220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111065313|NCT05642182|Vitamin D|vitamin d|mesh-list
111065314|NCT05642182|Ergocalciferols|ergocalciferols|mesh-list
111065315|NCT05642182|Cholecalciferol|cholecalciferol|mesh-list
111065316|NCT05642182|Vitamins|vitamins|mesh-list
111065317|NCT05642182|Micronutrients|micronutrients|mesh-ancestor
111065318|NCT05642182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111065319|NCT05642182|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111065320|NCT05642182|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111065321|NCT03471559|Cannabidiol|cannabidiol|mesh-list
111065322|NCT03471559|Anticonvulsants|anticonvulsants|mesh-ancestor
111065323|NCT05641480|Donepezil|donepezil|mesh-list
111065324|NCT05641480|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111065325|NCT05641480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111065326|NCT05641480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111065327|NCT05641480|Cholinergic Agents|cholinergic agents|mesh-ancestor
111065328|NCT05641480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111065329|NCT05641480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111065331|NCT03377803|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111065332|NCT03377803|Cantharidin|cantharidin|mesh-list
111065333|NCT03377803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111065334|NCT03377803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111065335|NCT03471325|Methamphetamine|methamphetamine|mesh-list
111065336|NCT03471325|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111065337|NCT03471325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111065338|NCT03471325|Sympathomimetics|sympathomimetics|mesh-ancestor
111065339|NCT03471325|Autonomic Agents|autonomic agents|mesh-ancestor
111065340|NCT03471325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111065341|NCT03471325|Dopamine Agents|dopamine agents|mesh-ancestor
111065342|NCT03471325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111065343|NCT03471325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111065344|NCT03471325|Adrenergic Agents|adrenergic agents|mesh-ancestor
111065345|NCT03471325|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111065346|NCT03471325|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111065347|NCT03471325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111065348|NCT03471325|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111065349|NCT04844164|Cholecalciferol|cholecalciferol|mesh-list
111065350|NCT04844164|Vitamin D|vitamin d|mesh-list
111065351|NCT04844164|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111065352|NCT04844164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111065353|NCT04844164|Vitamins|vitamins|mesh-ancestor
111065354|NCT04844164|Micronutrients|micronutrients|mesh-ancestor
111065355|NCT04844164|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111065356|NCT05392972|Anesthetics|anesthetics|mesh-list
111065357|NCT05392972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111065358|NCT05392972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111065359|NCT03474601|Hormones|hormones|mesh-list
110636952|NCT00930306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111065360|NCT03474601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111065361|NCT03474601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111065362|NCT04988308|Adalimumab|adalimumab|mesh-list
111065363|NCT04988308|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111065364|NCT04988308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111065365|NCT04988308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111065366|NCT04984798|Vitamin E|vitamin e|mesh-list
111065367|NCT04984798|Tocopherols|tocopherols|mesh-list
111065368|NCT04984798|alpha-Tocopherol|alpha-tocopherol|mesh-list
111065369|NCT04984798|Vitamins|vitamins|mesh-ancestor
111065370|NCT04984798|Micronutrients|micronutrients|mesh-ancestor
111065371|NCT04984798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111065372|NCT04984798|Antioxidants|antioxidants|mesh-ancestor
111065373|NCT04984798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111065374|NCT04984798|Protective Agents|protective agents|mesh-ancestor
111065375|NCT02230163|Immunoglobulins|immunoglobulins|mesh-list
111065376|NCT02230163|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111065377|NCT02230163|Antibodies|antibodies|mesh-list
111065378|NCT02230163|Immunologic Factors|immunologic factors|mesh-ancestor
111065379|NCT02230163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111065380|NCT02230319|Paclitaxel|paclitaxel|mesh-list
111065381|NCT02230319|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111065382|NCT02230319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111065383|NCT02230319|Tubulin Modulators|tubulin modulators|mesh-ancestor
111065384|NCT02230319|Antimitotic Agents|antimitotic agents|mesh-ancestor
111065385|NCT02230319|Mitosis Modulators|mitosis modulators|mesh-ancestor
111065386|NCT02230319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111065387|NCT00135395|Ritonavir|ritonavir|mesh-list
111065388|NCT00135395|Lopinavir|lopinavir|mesh-list
111065389|NCT00135395|Atazanavir Sulfate|atazanavir sulfate|mesh-list
111065390|NCT00135395|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111065391|NCT00135395|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111065392|NCT00135395|Protease Inhibitors|protease inhibitors|mesh-ancestor
111065393|NCT00135395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111065394|NCT00135395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111065395|NCT00135395|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111065396|NCT00135395|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111065397|NCT00135395|Antiviral Agents|antiviral agents|mesh-ancestor
111065398|NCT00135395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111065399|NCT00135395|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111065400|NCT00135395|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111065401|NCT02230553|Lapatinib|lapatinib|mesh-list
111065402|NCT02230553|Trametinib|trametinib|mesh-list
111065403|NCT02230553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111065404|NCT02230553|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111065405|NCT02230553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111065406|NCT02230553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111065407|NCT04261049|Triamcinolone|triamcinolone|mesh-list
111065408|NCT04261049|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
111065409|NCT04261049|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
111065410|NCT04261049|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
111065411|NCT04261049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111065412|NCT04261049|Glucocorticoids|glucocorticoids|mesh-ancestor
111065413|NCT04261049|Hormones|hormones|mesh-ancestor
111065414|NCT04261049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111065415|NCT04261049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111065416|NCT04261049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111065417|NCT04261049|Immunologic Factors|immunologic factors|mesh-ancestor
111065418|NCT04261049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111065419|NCT04261049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111065420|NCT00057473|Carboplatin|carboplatin|mesh-list
111065421|NCT00057473|Irinotecan|irinotecan|mesh-list
111065422|NCT00057473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111065423|NCT00057473|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111065424|NCT00057473|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111065425|NCT00057473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111065426|NCT00057473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111065427|NCT00035789|Entecavir|entecavir|mesh-list
111065428|NCT00035789|Antiviral Agents|antiviral agents|mesh-ancestor
111065429|NCT00035789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111065430|NCT00035633|Entecavir|entecavir|mesh-list
111065431|NCT00035633|Antiviral Agents|antiviral agents|mesh-ancestor
111065432|NCT00035633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111065433|NCT00028301|Ritonavir|ritonavir|mesh-list
111065434|NCT00028301|Lopinavir|lopinavir|mesh-list
111065435|NCT00028301|Atazanavir Sulfate|atazanavir sulfate|mesh-list
111065436|NCT00028301|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111065437|NCT00028301|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111065438|NCT00028301|Protease Inhibitors|protease inhibitors|mesh-ancestor
111065439|NCT00028301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111065440|NCT00028301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111065441|NCT00028301|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111065442|NCT00028301|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111065443|NCT00028301|Antiviral Agents|antiviral agents|mesh-ancestor
111065444|NCT00028301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111065445|NCT00028301|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111065446|NCT00028301|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111065447|NCT00028067|Atazanavir Sulfate|atazanavir sulfate|mesh-list
111065448|NCT00028067|Nelfinavir|nelfinavir|mesh-list
111065449|NCT00028067|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111065450|NCT00028067|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111065451|NCT00028067|Protease Inhibitors|protease inhibitors|mesh-ancestor
111065452|NCT00028067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111065453|NCT00028067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111065454|NCT00028067|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111065455|NCT00028067|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111065456|NCT00028067|Antiviral Agents|antiviral agents|mesh-ancestor
111065457|NCT00028067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111065458|NCT00005795|Arsenic Trioxide|arsenic trioxide|mesh-list
111065459|NCT00005795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111065460|NCT00004907|Cyclophosphamide|cyclophosphamide|mesh-list
111065461|NCT00004907|Busulfan|busulfan|mesh-list
111065462|NCT00004907|Etoposide|etoposide|mesh-list
111065463|NCT00004907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111065464|NCT00004907|Immunologic Factors|immunologic factors|mesh-ancestor
111065465|NCT00004907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111065466|NCT00004907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111065467|NCT00004907|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111065468|NCT00004907|Alkylating Agents|alkylating agents|mesh-ancestor
111065469|NCT00004907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111065470|NCT00004907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111065471|NCT00004907|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111065472|NCT00004907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111065473|NCT00004907|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111065474|NCT00004907|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111065475|NCT00004907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111065476|NCT04469777|Epoetin Alfa|epoetin alfa|mesh-list
111065477|NCT04469777|Hematinics|hematinics|mesh-ancestor
111065478|NCT00004895|Octreotide|octreotide|mesh-list
111065479|NCT00004895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111065480|NCT00004895|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111065481|NCT00004895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111065482|NCT00004181|Cyclophosphamide|cyclophosphamide|mesh-list
111065483|NCT00004181|Busulfan|busulfan|mesh-list
111065484|NCT00004181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111065485|NCT00004181|Immunologic Factors|immunologic factors|mesh-ancestor
110636974|NCT00931788|Antihypertensive Agents|antihypertensive agents|mesh-list
111065486|NCT00004181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111065487|NCT00004181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111065488|NCT00004181|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111065489|NCT00004181|Alkylating Agents|alkylating agents|mesh-ancestor
111065490|NCT00004181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111065491|NCT00004181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111065492|NCT00004181|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111065493|NCT00004175|Cyclophosphamide|cyclophosphamide|mesh-list
111065494|NCT00004175|Docetaxel|docetaxel|mesh-list
111065495|NCT00004175|Doxorubicin|doxorubicin|mesh-list
111065496|NCT00004175|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111065497|NCT00004175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111065498|NCT00004175|Immunologic Factors|immunologic factors|mesh-ancestor
111065499|NCT00004175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111065500|NCT00004175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111065501|NCT00004175|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111065502|NCT00004175|Alkylating Agents|alkylating agents|mesh-ancestor
110028090|NCT03402048|Vinorelbine|vinorelbine|mesh-list
111065503|NCT00004175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111065504|NCT00004175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111065505|NCT00004175|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111065506|NCT00004175|Tubulin Modulators|tubulin modulators|mesh-ancestor
111065507|NCT00004175|Antimitotic Agents|antimitotic agents|mesh-ancestor
111065508|NCT00004175|Mitosis Modulators|mitosis modulators|mesh-ancestor
111065509|NCT00004175|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111065510|NCT00004175|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111065511|NCT00004175|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111065512|NCT00004175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111065513|NCT05708573|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111065514|NCT05708573|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111065515|NCT05708573|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111065516|NCT05708573|Antimetabolites|antimetabolites|mesh-ancestor
111065517|NCT05708573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111065518|NCT05708573|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111065519|NCT05708573|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111065520|NCT05708573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111065521|NCT00004169|Cyclophosphamide|cyclophosphamide|mesh-list
111065522|NCT00004169|Carboplatin|carboplatin|mesh-list
111065523|NCT00004169|Etoposide|etoposide|mesh-list
111065524|NCT00004169|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111065525|NCT00004169|Immunologic Factors|immunologic factors|mesh-ancestor
111065526|NCT00004169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111065527|NCT00004169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111065528|NCT00004169|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111065529|NCT00004169|Alkylating Agents|alkylating agents|mesh-ancestor
111065530|NCT00004169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111065531|NCT00004169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111065532|NCT00004169|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111065533|NCT00004169|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111065534|NCT00004169|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111065535|NCT00004169|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111065536|NCT00004169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111065537|NCT00002429|Lamivudine|lamivudine|mesh-list
111065538|NCT00002429|Zidovudine|zidovudine|mesh-list
111065539|NCT00002429|Stavudine|stavudine|mesh-list
111065540|NCT00002429|Didanosine|didanosine|mesh-list
111065541|NCT00002429|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
111065542|NCT00002429|Nelfinavir|nelfinavir|mesh-list
111065543|NCT00002429|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111065544|NCT00002429|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111065545|NCT00002429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111065546|NCT00002429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111065547|NCT00002429|Antiviral Agents|antiviral agents|mesh-ancestor
111065548|NCT00002429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111065549|NCT00002429|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111065550|NCT00002429|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111065551|NCT00002429|Antimetabolites|antimetabolites|mesh-ancestor
111065552|NCT00002429|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111065553|NCT00002429|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111065554|NCT00002429|Protease Inhibitors|protease inhibitors|mesh-ancestor
111065555|NCT00002411|Lamivudine|lamivudine|mesh-list
111065556|NCT00002411|Zidovudine|zidovudine|mesh-list
111065557|NCT00002411|Stavudine|stavudine|mesh-list
111065558|NCT00002411|Didanosine|didanosine|mesh-list
111065559|NCT00002411|Nelfinavir|nelfinavir|mesh-list
111065560|NCT00002411|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111065561|NCT00002411|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111065562|NCT00002411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111065563|NCT00002411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111065564|NCT00002411|Antiviral Agents|antiviral agents|mesh-ancestor
111065565|NCT00002411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111065566|NCT00002411|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111065567|NCT00002411|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111065568|NCT00002411|Antimetabolites|antimetabolites|mesh-ancestor
111065569|NCT00002411|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111065570|NCT00002411|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111065571|NCT00002411|Protease Inhibitors|protease inhibitors|mesh-ancestor
111065572|NCT03530033|Lidocaine|lidocaine|mesh-list
111065573|NCT03530033|Anesthetics, Local|anesthetics, local|mesh-ancestor
111065574|NCT03530033|Anesthetics|anesthetics|mesh-ancestor
111065575|NCT03530033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111065576|NCT03530033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111065577|NCT03530033|Sensory System Agents|sensory system agents|mesh-ancestor
111065578|NCT03530033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111065579|NCT03530033|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111065580|NCT03530033|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111065581|NCT03530033|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111065582|NCT03530033|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111065583|NCT03530033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111065585|NCT03529643|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111065586|NCT03529643|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111065587|NCT03529643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111065588|NCT03529643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111065589|NCT03529643|Analgesics|analgesics|mesh-ancestor
111065590|NCT03529643|Sensory System Agents|sensory system agents|mesh-ancestor
111065591|NCT03529643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111065592|NCT03529643|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111065593|NCT03529643|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111065594|NCT03529643|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111065595|NCT03529643|Adrenergic Agents|adrenergic agents|mesh-ancestor
111065596|NCT03529643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111065597|NCT03529643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111065598|NCT03529331|Acetaminophen|acetaminophen|mesh-list
111065599|NCT03529331|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
111065600|NCT03529331|Morphine|morphine|mesh-list
111065601|NCT03529331|Oxycodone|oxycodone|mesh-list
111065602|NCT03529331|Hydrocodone|hydrocodone|mesh-list
111065603|NCT03529331|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111065604|NCT03529331|Narcotics|narcotics|mesh-ancestor
111065605|NCT03529331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111065606|NCT03529331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111065607|NCT03529331|Analgesics|analgesics|mesh-ancestor
111065608|NCT03529331|Sensory System Agents|sensory system agents|mesh-ancestor
111065609|NCT03529331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111065610|NCT03529331|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111065611|NCT03529331|Antipyretics|antipyretics|mesh-ancestor
111065612|NCT03529331|Antitussive Agents|antitussive agents|mesh-ancestor
111065613|NCT03529331|Respiratory System Agents|respiratory system agents|mesh-ancestor
111065614|NCT03529331|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111065615|NCT03529331|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111065616|NCT03529331|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111065617|NCT03529253|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111065618|NCT03529253|Alirocumab|alirocumab|mesh-list
111065619|NCT03529253|Calcium|calcium|mesh-list
111065620|NCT03529253|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111065621|NCT03529253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111065622|NCT03529253|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111065623|NCT03529253|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111065624|NCT03529253|Antimetabolites|antimetabolites|mesh-ancestor
111065625|NCT03529253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110782740|NCT05973552|Iron|iron|mesh-list
111065626|NCT03529253|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111065627|NCT03529253|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111065628|NCT03529253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111065629|NCT03529253|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
111065630|NCT03529253|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111065631|NCT03529253|Protease Inhibitors|protease inhibitors|mesh-ancestor
111065632|NCT03529175|Paclitaxel|paclitaxel|mesh-list
111065633|NCT03529175|Gemcitabine|gemcitabine|mesh-list
111065634|NCT03529175|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111065635|NCT03529175|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111065636|NCT03529175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111065637|NCT03529175|Tubulin Modulators|tubulin modulators|mesh-ancestor
111065638|NCT03529175|Antimitotic Agents|antimitotic agents|mesh-ancestor
111065639|NCT03529175|Mitosis Modulators|mitosis modulators|mesh-ancestor
111065640|NCT03529175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111065641|NCT03529175|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111065642|NCT03529175|Antimetabolites|antimetabolites|mesh-ancestor
111065643|NCT00002207|Stavudine|stavudine|mesh-list
111065644|NCT00002207|Didanosine|didanosine|mesh-list
111065645|NCT00002207|Antimetabolites|antimetabolites|mesh-ancestor
111065646|NCT00002207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111065647|NCT00002207|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111065648|NCT00002207|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111065649|NCT00002207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111065650|NCT00002207|Antiviral Agents|antiviral agents|mesh-ancestor
111065651|NCT00002207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111065652|NCT00002207|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111065653|NCT00002207|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111065654|NCT03529097|Dipyrone|dipyrone|mesh-list
111065655|NCT03529097|Diclofenac|diclofenac|mesh-list
111065656|NCT03529097|Morphine|morphine|mesh-list
111065657|NCT03529097|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111065658|NCT03529097|Narcotics|narcotics|mesh-ancestor
111065659|NCT03529097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111065660|NCT03529097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111065661|NCT03529097|Analgesics|analgesics|mesh-ancestor
111065662|NCT03529097|Sensory System Agents|sensory system agents|mesh-ancestor
111065663|NCT03529097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111065664|NCT03529097|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111065665|NCT03529097|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111065666|NCT03529097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111065667|NCT03529097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111065668|NCT03529097|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111065669|NCT03529097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111065670|NCT03529097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111065671|NCT03529097|Antipyretics|antipyretics|mesh-ancestor
111065672|NCT03531749|Ascorbic Acid|ascorbic acid|mesh-list
111065673|NCT03531749|Antioxidants|antioxidants|mesh-ancestor
111065674|NCT03531749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111065675|NCT03531749|Protective Agents|protective agents|mesh-ancestor
111065676|NCT03531749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111065677|NCT03531749|Vitamins|vitamins|mesh-ancestor
111065678|NCT03531749|Micronutrients|micronutrients|mesh-ancestor
111065679|NCT03528785|Leucovorin|leucovorin|mesh-list
111065680|NCT03528785|Oxaliplatin|oxaliplatin|mesh-list
111065681|NCT03528785|Irinotecan|irinotecan|mesh-list
111065682|NCT03528785|Levoleucovorin|levoleucovorin|mesh-list
111065683|NCT03528785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111065684|NCT03528785|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111065685|NCT03528785|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111065686|NCT03528785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111065687|NCT03528785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111065688|NCT03528785|Antidotes|antidotes|mesh-ancestor
111065689|NCT03528785|Protective Agents|protective agents|mesh-ancestor
111065690|NCT03528785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111065691|NCT03528785|Vitamin B Complex|vitamin b complex|mesh-ancestor
111065692|NCT03528785|Vitamins|vitamins|mesh-ancestor
111065693|NCT03528785|Micronutrients|micronutrients|mesh-ancestor
111065694|NCT03531437|Ethinyl Estradiol|ethinyl estradiol|mesh-list
111065695|NCT03531437|Gestodene|gestodene|mesh-list
111065696|NCT03531437|Estradiol|estradiol|mesh-list
111065697|NCT03531437|Estrogens|estrogens|mesh-ancestor
111065698|NCT03531437|Hormones|hormones|mesh-ancestor
111065699|NCT03531437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111065700|NCT03531437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110120622|NCT01907204|Budesonide|budesonide|mesh-list
111065701|NCT03531437|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111065702|NCT03531437|Contraceptive Agents|contraceptive agents|mesh-ancestor
111065703|NCT03531437|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111065704|NCT03531437|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111065705|NCT03531437|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111065706|NCT03531437|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111065707|NCT03531437|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111065708|NCT03531437|Progestins|progestins|mesh-ancestor
111065709|NCT03527381|Nitric Oxide|nitric oxide|mesh-list
111065710|NCT03527381|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111065711|NCT03527381|Autonomic Agents|autonomic agents|mesh-ancestor
111065712|NCT03527381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111065713|NCT03527381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111065714|NCT03527381|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111065715|NCT03527381|Respiratory System Agents|respiratory system agents|mesh-ancestor
111065716|NCT03527381|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111065717|NCT03527381|Antioxidants|antioxidants|mesh-ancestor
111065718|NCT03527381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111065719|NCT03527381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111065720|NCT03527381|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
111065721|NCT03527381|Vasodilator Agents|vasodilator agents|mesh-ancestor
111065722|NCT03527381|Gasotransmitters|gasotransmitters|mesh-ancestor
111065723|NCT03527381|Protective Agents|protective agents|mesh-ancestor
111065724|NCT04441385|Maraviroc|maraviroc|mesh-list
111065725|NCT04441385|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
111065726|NCT04441385|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
111065727|NCT04441385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111065728|NCT04441385|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111065729|NCT04441385|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111065730|NCT04441385|Antiviral Agents|antiviral agents|mesh-ancestor
111065731|NCT04441385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111065732|NCT04441385|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
111065733|NCT03531359|Midazolam|midazolam|mesh-list
111065734|NCT03531359|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111065735|NCT03531359|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111065736|NCT03531359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111065737|NCT03531359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111065738|NCT03531359|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111065739|NCT03531359|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111065740|NCT03531359|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111065741|NCT03531359|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111065742|NCT03531359|Anesthetics, General|anesthetics, general|mesh-ancestor
111065743|NCT03531359|Anesthetics|anesthetics|mesh-ancestor
111065744|NCT03531359|GABA Modulators|gaba modulators|mesh-ancestor
111065745|NCT03531359|GABA Agents|gaba agents|mesh-ancestor
111065746|NCT03531359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111065747|NCT03531359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111065748|NCT03531281|Sirolimus|sirolimus|mesh-list
111065749|NCT03531281|Cyclophosphamide|cyclophosphamide|mesh-list
111065750|NCT03531281|Etoposide|etoposide|mesh-list
111065751|NCT03531281|Etoposide phosphate|etoposide phosphate|mesh-list
111065752|NCT03531281|Podophyllotoxin|podophyllotoxin|mesh-list
111065753|NCT03531281|Tacrolimus|tacrolimus|mesh-list
111065754|NCT03531281|Mitogens|mitogens|mesh-list
111065755|NCT03531281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111065756|NCT03531281|Immunologic Factors|immunologic factors|mesh-ancestor
111065757|NCT03531281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111065758|NCT03531281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111065759|NCT03531281|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111065760|NCT03531281|Alkylating Agents|alkylating agents|mesh-ancestor
111065761|NCT03531281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111065762|NCT03531281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111065763|NCT03531281|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111065764|NCT03531281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111065765|NCT03531281|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111065766|NCT03531281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111065767|NCT03531281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111065768|NCT03531281|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111065769|NCT03531281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111065770|NCT03531281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111065771|NCT03531281|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111065772|NCT03531281|Antifungal Agents|antifungal agents|mesh-ancestor
111065773|NCT03531281|Mitosis Modulators|mitosis modulators|mesh-ancestor
111065774|NCT03531281|Keratolytic Agents|keratolytic agents|mesh-ancestor
111065775|NCT03531281|Dermatologic Agents|dermatologic agents|mesh-ancestor
111065776|NCT03531281|Tubulin Modulators|tubulin modulators|mesh-ancestor
111065777|NCT03531281|Antimitotic Agents|antimitotic agents|mesh-ancestor
111065778|NCT04468685|Ondansetron|ondansetron|mesh-list
111065779|NCT04468685|Antiemetics|antiemetics|mesh-ancestor
111065780|NCT04468685|Autonomic Agents|autonomic agents|mesh-ancestor
111065782|NCT04468685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111065783|NCT04468685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111065784|NCT04468685|Antipruritics|antipruritics|mesh-ancestor
111065785|NCT04468685|Dermatologic Agents|dermatologic agents|mesh-ancestor
111065786|NCT04468685|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111065787|NCT04468685|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111065788|NCT04468685|Serotonin Agents|serotonin agents|mesh-ancestor
111065789|NCT04468685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111065790|NCT04468685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111065791|NCT03531047|Riboflavin|riboflavin|mesh-list
111065792|NCT03531047|Vitamin B Complex|vitamin b complex|mesh-ancestor
111065793|NCT03531047|Vitamins|vitamins|mesh-ancestor
111065794|NCT03531047|Micronutrients|micronutrients|mesh-ancestor
111065795|NCT03531047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111065796|NCT03531047|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111065797|NCT03531047|Dermatologic Agents|dermatologic agents|mesh-ancestor
111065798|NCT04440917|Apatinib|apatinib|mesh-list
111065799|NCT04440917|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
111065800|NCT04440917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111065801|NCT04440917|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111065802|NCT04440917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111065803|NCT04440917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111065804|NCT04440917|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111065806|NCT05455931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111065807|NCT05062031|Atropine|atropine|mesh-list
111065808|NCT05062031|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111065809|NCT05062031|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111065810|NCT05062031|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111065811|NCT05062031|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111065812|NCT05062031|Autonomic Agents|autonomic agents|mesh-ancestor
111065813|NCT05062031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111065814|NCT05062031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111065815|NCT05062031|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111065816|NCT05062031|Respiratory System Agents|respiratory system agents|mesh-ancestor
111065817|NCT05062031|Mydriatics|mydriatics|mesh-ancestor
111065818|NCT05062031|Parasympatholytics|parasympatholytics|mesh-ancestor
111065819|NCT05062031|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111065820|NCT05062031|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111065821|NCT05062031|Cholinergic Agents|cholinergic agents|mesh-ancestor
111065822|NCT05062031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111065823|NCT05062031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111065824|NCT05062031|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111065825|NCT05446571|Valacyclovir|valacyclovir|mesh-list
111065826|NCT05446571|Letermovir|letermovir|mesh-list
111065827|NCT05446571|Antiviral Agents|antiviral agents|mesh-ancestor
111065828|NCT05446571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110636996|NCT00927030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111065829|NCT05446571|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111065830|NCT05446571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111065831|NCT05446571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111065832|NCT05446571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111065833|NCT05439005|Dexmedetomidine|dexmedetomidine|mesh-list
111065834|NCT05439005|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111065835|NCT05439005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111065836|NCT05439005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111065837|NCT05439005|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111065838|NCT05439005|Analgesics|analgesics|mesh-ancestor
111065839|NCT05439005|Sensory System Agents|sensory system agents|mesh-ancestor
111065840|NCT05439005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111065841|NCT05439005|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111065842|NCT05439005|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111065843|NCT05439005|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111065844|NCT05439005|Adrenergic Agents|adrenergic agents|mesh-ancestor
111065845|NCT05439005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111065846|NCT05439005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111065847|NCT04468139|Quercetin|quercetin|mesh-list
111065848|NCT04468139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111065849|NCT04468139|Antioxidants|antioxidants|mesh-ancestor
111065850|NCT04468139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111065851|NCT04468139|Protective Agents|protective agents|mesh-ancestor
111065852|NCT03526445|Glucagon|glucagon|mesh-list
111065853|NCT03526445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111065854|NCT03526445|Hormones|hormones|mesh-ancestor
111065855|NCT03526445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111065856|NCT03526445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111065858|NCT04939649|Ketamine|ketamine|mesh-list
111065859|NCT04939649|Analgesics|analgesics|mesh-ancestor
111065860|NCT04939649|Sensory System Agents|sensory system agents|mesh-ancestor
111065861|NCT04939649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111065862|NCT04939649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111065863|NCT04939649|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111065864|NCT04939649|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111065865|NCT04939649|Anesthetics, General|anesthetics, general|mesh-ancestor
111065866|NCT04939649|Anesthetics|anesthetics|mesh-ancestor
111065867|NCT04939649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111065868|NCT04939649|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111065869|NCT04939649|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111065870|NCT04939649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111065871|NCT04939649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111065872|NCT04939649|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111065873|NCT04939649|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111065874|NCT04939649|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111065875|NCT04939649|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111065876|NCT04939649|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111065877|NCT04939649|GABA Modulators|gaba modulators|mesh-ancestor
111065878|NCT04939649|GABA Agents|gaba agents|mesh-ancestor
111065879|NCT04927949|Cangrelor|cangrelor|mesh-list
111065880|NCT04927949|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111065881|NCT04927949|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111065882|NCT04927949|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111065883|NCT04927949|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111065884|NCT04927949|Purinergic Agents|purinergic agents|mesh-ancestor
111065885|NCT04927949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111065886|NCT04927949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111065887|NCT04927949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111065888|NCT04589819|Teriparatide|teriparatide|mesh-list
111065889|NCT04589819|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111065890|NCT04589819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111065891|NCT04589819|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111065892|NCT03526367|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111065893|NCT03526367|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111065894|NCT03526367|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111065895|NCT03526367|Antimetabolites|antimetabolites|mesh-ancestor
111065896|NCT03526367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111065897|NCT03526367|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111065898|NCT03526367|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111065899|NCT03526367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111065900|NCT04467983|Denosumab|denosumab|mesh-list
111065901|NCT04467983|Abaloparatide|abaloparatide|mesh-list
111065902|NCT04467983|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111065903|NCT04467983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111065904|NCT04839731|Fluorouracil|fluorouracil|mesh-list
111065905|NCT04839731|Calcipotriene|calcipotriene|mesh-list
111065906|NCT04839731|Antimetabolites|antimetabolites|mesh-ancestor
111065907|NCT04839731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111065908|NCT04839731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111065909|NCT04839731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111065910|NCT04839731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111065911|NCT04839731|Immunologic Factors|immunologic factors|mesh-ancestor
111065912|NCT04839731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111065913|NCT04839731|Dermatologic Agents|dermatologic agents|mesh-ancestor
111065914|NCT03525509|Morphine|morphine|mesh-list
111065915|NCT03525509|Methadone|methadone|mesh-list
111065916|NCT03525509|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111065917|NCT03525509|Narcotics|narcotics|mesh-ancestor
111065918|NCT03525509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111065919|NCT03525509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111065920|NCT03525509|Analgesics|analgesics|mesh-ancestor
111065921|NCT03525509|Sensory System Agents|sensory system agents|mesh-ancestor
111065922|NCT03525509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111065923|NCT03525509|Antitussive Agents|antitussive agents|mesh-ancestor
111065924|NCT03525509|Respiratory System Agents|respiratory system agents|mesh-ancestor
111065925|NCT04699721|Paclitaxel|paclitaxel|mesh-list
111065926|NCT04699721|Carboplatin|carboplatin|mesh-list
111065927|NCT04699721|Nivolumab|nivolumab|mesh-list
111065928|NCT04699721|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111065929|NCT04699721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111065930|NCT04699721|Tubulin Modulators|tubulin modulators|mesh-ancestor
111065931|NCT04699721|Antimitotic Agents|antimitotic agents|mesh-ancestor
111065932|NCT04699721|Mitosis Modulators|mitosis modulators|mesh-ancestor
111065933|NCT04699721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111065934|NCT04699721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111065935|NCT04699721|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111065936|NCT05179499|Norepinephrine|norepinephrine|mesh-list
111065937|NCT05179499|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111065938|NCT05179499|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111065939|NCT05179499|Adrenergic Agents|adrenergic agents|mesh-ancestor
111065940|NCT05179499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111065941|NCT05179499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111065942|NCT05179499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111065943|NCT05179499|Sympathomimetics|sympathomimetics|mesh-ancestor
111065944|NCT05179499|Autonomic Agents|autonomic agents|mesh-ancestor
111065945|NCT05179499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111065946|NCT05179499|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111065947|NCT03525821|Ketamine|ketamine|mesh-list
111065948|NCT03525821|Analgesics|analgesics|mesh-ancestor
111065949|NCT03525821|Sensory System Agents|sensory system agents|mesh-ancestor
111065950|NCT03525821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111065951|NCT03525821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111065952|NCT03525821|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111065953|NCT03525821|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111065954|NCT03525821|Anesthetics, General|anesthetics, general|mesh-ancestor
111065955|NCT03525821|Anesthetics|anesthetics|mesh-ancestor
111065956|NCT03525821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111065957|NCT03525821|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111065958|NCT03525821|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111065959|NCT03525821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111065960|NCT03525821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111065961|NCT04221035|Cyclophosphamide|cyclophosphamide|mesh-list
111065962|NCT04221035|Temozolomide|temozolomide|mesh-list
111065963|NCT04221035|Melphalan|melphalan|mesh-list
111065964|NCT04221035|Busulfan|busulfan|mesh-list
111065965|NCT04221035|Ifosfamide|ifosfamide|mesh-list
111065966|NCT04221035|Thiotepa|thiotepa|mesh-list
111065967|NCT04221035|Dacarbazine|dacarbazine|mesh-list
111065968|NCT04221035|Carboplatin|carboplatin|mesh-list
111065969|NCT04221035|Doxorubicin|doxorubicin|mesh-list
111065970|NCT04221035|Irinotecan|irinotecan|mesh-list
111065971|NCT04221035|Etoposide|etoposide|mesh-list
111065972|NCT04221035|Vincristine|vincristine|mesh-list
111065973|NCT04221035|Vindesine|vindesine|mesh-list
111065974|NCT04221035|Dinutuximab|dinutuximab|mesh-list
111065975|NCT04221035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111065976|NCT04221035|Immunologic Factors|immunologic factors|mesh-ancestor
111065977|NCT04221035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111065978|NCT04221035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111065979|NCT04221035|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111065980|NCT04221035|Alkylating Agents|alkylating agents|mesh-ancestor
111065981|NCT04221035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111065982|NCT04221035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111065983|NCT04221035|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111065984|NCT04221035|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111065985|NCT04221035|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111065986|NCT04221035|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111065987|NCT04221035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111065988|NCT04221035|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111065989|NCT04221035|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111065990|NCT04221035|Tubulin Modulators|tubulin modulators|mesh-ancestor
111065991|NCT04221035|Antimitotic Agents|antimitotic agents|mesh-ancestor
111065992|NCT04221035|Mitosis Modulators|mitosis modulators|mesh-ancestor
111065993|NCT01601704|Bupropion hydrochloride, naltrexone hydrochoride drug combination|bupropion hydrochloride, naltrexone hydrochoride drug combination|mesh-list
111065994|NCT01601704|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111065995|NCT04842682|Diazepam|diazepam|mesh-list
111065996|NCT04842682|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111065997|NCT04842682|Anticonvulsants|anticonvulsants|mesh-ancestor
110783072|NCT04863950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110783073|NCT04863950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110783074|NCT04863950|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110783075|NCT04863950|Antidepressive Agents|antidepressive agents|mesh-ancestor
110783076|NCT04863950|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110783080|NCT04863950|Adrenergic Agents|adrenergic agents|mesh-ancestor
111065998|NCT04842682|Antiemetics|antiemetics|mesh-ancestor
111065999|NCT04842682|Autonomic Agents|autonomic agents|mesh-ancestor
111066000|NCT04842682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111066001|NCT04842682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111066002|NCT04842682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111066003|NCT04842682|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111066004|NCT04842682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111066005|NCT04842682|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
111066006|NCT04842682|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111066007|NCT04842682|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111066008|NCT04842682|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111066009|NCT04842682|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111066010|NCT04842682|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111066011|NCT04842682|Anesthetics, General|anesthetics, general|mesh-ancestor
111066012|NCT04842682|Anesthetics|anesthetics|mesh-ancestor
111066013|NCT04842682|GABA Modulators|gaba modulators|mesh-ancestor
111066014|NCT04842682|GABA Agents|gaba agents|mesh-ancestor
111066015|NCT04842682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111066016|NCT04842682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111066018|NCT04969276|Immunologic Factors|immunologic factors|mesh-ancestor
111066019|NCT04969276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111066020|NCT04969198|Nicotine|nicotine|mesh-list
111066021|NCT04969198|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111066022|NCT04969198|Autonomic Agents|autonomic agents|mesh-ancestor
111066023|NCT04969198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111066024|NCT04969198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111066025|NCT04969198|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111066026|NCT04969198|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111066027|NCT04969198|Cholinergic Agents|cholinergic agents|mesh-ancestor
111066028|NCT04969198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111066029|NCT04969198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111066031|NCT04666636|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
111066032|NCT04666636|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111066033|NCT04666636|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111066034|NCT04666636|Adrenergic Agents|adrenergic agents|mesh-ancestor
111066035|NCT04666636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111066036|NCT04666636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111066037|NCT04666636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111066038|NCT04666636|Urological Agents|urological agents|mesh-ancestor
111066039|NCT04890106|Bimatoprost|bimatoprost|mesh-list
111066040|NCT04890106|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111066041|NCT04890106|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111066042|NCT04890106|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111066043|NCT04640194|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
111066044|NCT04640194|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111066045|NCT04640194|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111066046|NCT04640194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111066047|NCT05214664|Anesthetics|anesthetics|mesh-list
111066048|NCT05214664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111066049|NCT05214664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111066050|NCT05198362|Metoprolol|metoprolol|mesh-list
111066051|NCT05198362|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111066052|NCT05198362|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111066053|NCT05198362|Sympatholytics|sympatholytics|mesh-ancestor
111066054|NCT05198362|Autonomic Agents|autonomic agents|mesh-ancestor
111066055|NCT05198362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111066056|NCT05198362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111066057|NCT05198362|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
111066058|NCT05198362|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111066059|NCT05198362|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111066060|NCT05198362|Adrenergic Agents|adrenergic agents|mesh-ancestor
111066061|NCT05198362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111066062|NCT05198362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111066063|NCT04810156|Mycophenolic Acid|mycophenolic acid|mesh-list
111066064|NCT04810156|Prednisone|prednisone|mesh-list
111066065|NCT04810156|Methylprednisolone|methylprednisolone|mesh-list
111066066|NCT04810156|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111066067|NCT04810156|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111066068|NCT04810156|Prednisolone|prednisolone|mesh-list
111066069|NCT04810156|Prednisolone acetate|prednisolone acetate|mesh-list
111066070|NCT04810156|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
111066071|NCT04810156|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111066072|NCT04810156|Prednisolone phosphate|prednisolone phosphate|mesh-list
111066073|NCT04810156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111066075|NCT04810156|Hormones|hormones|mesh-ancestor
111066076|NCT04810156|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111066077|NCT04810156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111066078|NCT04810156|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111066079|NCT04810156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111066080|NCT04810156|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111066081|NCT04810156|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111066082|NCT04810156|Antitubercular Agents|antitubercular agents|mesh-ancestor
111066083|NCT04810156|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111066084|NCT04810156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111066085|NCT04810156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111066086|NCT04810156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111066087|NCT04810156|Antiemetics|antiemetics|mesh-ancestor
111066088|NCT04810156|Autonomic Agents|autonomic agents|mesh-ancestor
111066089|NCT04810156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111066090|NCT04810156|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111066091|NCT04810156|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111066092|NCT04810156|Protective Agents|protective agents|mesh-ancestor
111066093|NCT04810156|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
111066094|NCT04837924|Acetaminophen|acetaminophen|mesh-list
111066095|NCT04837924|Tramadol|tramadol|mesh-list
111066096|NCT04837924|Analgesics|analgesics|mesh-list
111066097|NCT04837924|Levobupivacaine|levobupivacaine|mesh-list
111066098|NCT04837924|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111066099|NCT04837924|Sensory System Agents|sensory system agents|mesh-ancestor
111066100|NCT04837924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111066101|NCT04837924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111066103|NCT04837924|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111066104|NCT04837924|Narcotics|narcotics|mesh-ancestor
111066105|NCT04837924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111066106|NCT04837924|Anesthetics, Local|anesthetics, local|mesh-ancestor
111066107|NCT04837924|Anesthetics|anesthetics|mesh-ancestor
111066108|NCT05406466|Lenvatinib|lenvatinib|mesh-list
111066109|NCT05406466|Tislelizumab|tislelizumab|mesh-list
111066110|NCT05406466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111066111|NCT05406466|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111066112|NCT05406466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111066113|NCT05406466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111066114|NCT05406466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111066115|NCT05152420|Rivaroxaban|rivaroxaban|mesh-list
111066116|NCT05152420|Apixaban|apixaban|mesh-list
111066117|NCT05152420|Edoxaban|edoxaban|mesh-list
111066118|NCT05152420|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111066119|NCT05152420|Antithrombins|antithrombins|mesh-ancestor
111066120|NCT05152420|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111066121|NCT05152420|Protease Inhibitors|protease inhibitors|mesh-ancestor
111066122|NCT05152420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111066123|NCT05152420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111066124|NCT05152420|Anticoagulants|anticoagulants|mesh-ancestor
111066125|NCT01601470|Sildenafil Citrate|sildenafil citrate|mesh-list
111066126|NCT01601470|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
111066127|NCT01601470|Vasodilator Agents|vasodilator agents|mesh-ancestor
111066128|NCT01601470|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111066129|NCT01601470|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111066130|NCT01601470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111066131|NCT01601470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111066132|NCT01601470|Urological Agents|urological agents|mesh-ancestor
111066133|NCT01601470|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111066134|NCT04418908|Cetrorelix|cetrorelix|mesh-list
111066135|NCT04418908|Estradiol|estradiol|mesh-list
111066136|NCT04418908|Estrogens|estrogens|mesh-ancestor
111066137|NCT04418908|Hormones|hormones|mesh-ancestor
111066138|NCT04418908|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111066139|NCT04418908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111066140|NCT04418908|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111066141|NCT04418908|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111066142|NCT04418908|Fertility Agents|fertility agents|mesh-ancestor
111066143|NCT04418908|Hormone Antagonists|hormone antagonists|mesh-ancestor
111066144|NCT04546126|Dexamethasone|dexamethasone|mesh-list
111066145|NCT04546126|Cosyntropin|cosyntropin|mesh-list
111066146|NCT04546126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111066147|NCT04546126|Antiemetics|antiemetics|mesh-ancestor
111066148|NCT04546126|Autonomic Agents|autonomic agents|mesh-ancestor
111066149|NCT04546126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111066150|NCT04546126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111066151|NCT04546126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111066152|NCT04546126|Glucocorticoids|glucocorticoids|mesh-ancestor
111066153|NCT04546126|Hormones|hormones|mesh-ancestor
111066154|NCT04546126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111066155|NCT04546126|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111066156|NCT04546126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111066157|NCT04831450|Cemiplimab|cemiplimab|mesh-list
111066158|NCT04831450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111066159|NCT04831450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111066160|NCT04830982|Diazoxide|diazoxide|mesh-list
111066161|NCT04830982|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111066162|NCT04830982|Vasodilator Agents|vasodilator agents|mesh-ancestor
111066163|NCT04466423|Sulfamethazine|sulfamethazine|mesh-list
111066164|NCT04466423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110637046|NCT00932100|Heparin|heparin|mesh-list
111066165|NCT04508140|Pembrolizumab|pembrolizumab|mesh-list
111066166|NCT04508140|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111066167|NCT04508140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111066168|NCT04508140|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111066169|NCT04508140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111066170|NCT04820452|Aflibercept|aflibercept|mesh-list
111066171|NCT04820452|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111066172|NCT04820452|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111066173|NCT04820452|Growth Substances|growth substances|mesh-ancestor
111066174|NCT04820452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111066175|NCT04820452|Growth Inhibitors|growth inhibitors|mesh-ancestor
111066176|NCT04820452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111066177|NCT01637272|Pasireotide|pasireotide|mesh-list
111066178|NCT01637272|Hormones|hormones|mesh-ancestor
111066179|NCT01637272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111066180|NCT01637272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111066181|NCT04458922|Atezolizumab|atezolizumab|mesh-list
111066182|NCT04458922|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111066183|NCT04458922|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111066184|NCT04458922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111066185|NCT04458922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111066186|NCT04458922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111066187|NCT04458922|Immunologic Factors|immunologic factors|mesh-ancestor
111066188|NCT04458922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111066189|NCT03178864|Heparin|heparin|mesh-list
111066190|NCT03178864|Rivaroxaban|rivaroxaban|mesh-list
111066191|NCT03178864|Anticoagulants|anticoagulants|mesh-ancestor
111066192|NCT03178864|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111066193|NCT03178864|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111066194|NCT03178864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111066195|NCT03178864|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111066196|NCT03178864|Antithrombins|antithrombins|mesh-ancestor
111066197|NCT03178864|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111066198|NCT03178864|Protease Inhibitors|protease inhibitors|mesh-ancestor
111066199|NCT03178864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111066200|NCT01636960|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
111066201|NCT01636960|Antiviral Agents|antiviral agents|mesh-ancestor
111066202|NCT01636960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111066203|NCT04009876|Oxaliplatin|oxaliplatin|mesh-list
111066204|NCT04009876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111066205|NCT05309902|Moxifloxacin|moxifloxacin|mesh-list
111066206|NCT05309902|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111066207|NCT05309902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111066208|NCT05309902|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111066209|NCT05309902|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111066210|NCT05309902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111066211|NCT05309902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111066212|NCT05309902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111066213|NCT02987686|Infliximab|infliximab|mesh-list
111066214|NCT02987686|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111066215|NCT02987686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111066216|NCT02987686|Dermatologic Agents|dermatologic agents|mesh-ancestor
111066217|NCT02987686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111066218|NCT02987686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111066219|NCT02504216|Rivaroxaban|rivaroxaban|mesh-list
111066220|NCT02504216|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111066221|NCT02504216|Antithrombins|antithrombins|mesh-ancestor
111066222|NCT02504216|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110783298|NCT04186559|Antioxidants|antioxidants|mesh-ancestor
111066223|NCT02504216|Protease Inhibitors|protease inhibitors|mesh-ancestor
111066224|NCT02504216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111066225|NCT02504216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111066226|NCT02504216|Anticoagulants|anticoagulants|mesh-ancestor
111066227|NCT05277922|Nitroprusside|nitroprusside|mesh-list
111066228|NCT05277922|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111066229|NCT05277922|Vasodilator Agents|vasodilator agents|mesh-ancestor
111066230|NCT05277922|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
111066231|NCT05277922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111066232|NCT04354870|Hydroxychloroquine|hydroxychloroquine|mesh-list
111066233|NCT04354870|Antimalarials|antimalarials|mesh-ancestor
111066234|NCT04354870|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111066235|NCT04354870|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111066236|NCT04354870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111066237|NCT04354870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111066238|NCT04354870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111066239|NCT04354870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111066240|NCT02917096|Vidarabine|vidarabine|mesh-list
111066241|NCT02917096|Sirolimus|sirolimus|mesh-list
111066242|NCT02917096|Fludarabine|fludarabine|mesh-list
111066243|NCT02917096|Fludarabine phosphate|fludarabine phosphate|mesh-list
111066244|NCT02917096|Melphalan|melphalan|mesh-list
111066245|NCT02917096|Mechlorethamine|mechlorethamine|mesh-list
111066246|NCT02917096|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
111066247|NCT02917096|Tacrolimus|tacrolimus|mesh-list
111066248|NCT02917096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111066249|NCT02917096|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111066250|NCT02917096|Antimetabolites|antimetabolites|mesh-ancestor
111066251|NCT02917096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111066252|NCT02917096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111066253|NCT02917096|Immunologic Factors|immunologic factors|mesh-ancestor
111066254|NCT02917096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111066255|NCT02917096|Antiviral Agents|antiviral agents|mesh-ancestor
111066256|NCT02917096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111066257|NCT02917096|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111066258|NCT02917096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111066259|NCT02917096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111066260|NCT02917096|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111066261|NCT02917096|Antifungal Agents|antifungal agents|mesh-ancestor
111066262|NCT02917096|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111066263|NCT02917096|Alkylating Agents|alkylating agents|mesh-ancestor
111066264|NCT02917096|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111066265|NCT04194424|Metformin|metformin|mesh-list
111066266|NCT04194424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111066267|NCT04194424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111066268|NCT02473640|Ceftriaxone|ceftriaxone|mesh-list
111066269|NCT02473640|Esomeprazole|esomeprazole|mesh-list
111066270|NCT02473640|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111066271|NCT02473640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111066272|NCT02473640|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111066273|NCT02473640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111066274|NCT02473640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111066275|NCT02473640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111066276|NCT02473640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111066277|NCT01637584|Prazosin|prazosin|mesh-list
111066278|NCT01637584|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111066279|NCT01637584|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111066280|NCT01637584|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111066281|NCT01637584|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111066282|NCT01637584|Adrenergic Agents|adrenergic agents|mesh-ancestor
111066283|NCT01637584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111066284|NCT01637584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111066285|NCT01637584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111066286|NCT03875092|Paclitaxel|paclitaxel|mesh-list
111066287|NCT03875092|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111066288|NCT03875092|Carboplatin|carboplatin|mesh-list
111066289|NCT03875092|Pembrolizumab|pembrolizumab|mesh-list
111066290|NCT03875092|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111066291|NCT03875092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111066292|NCT03875092|Tubulin Modulators|tubulin modulators|mesh-ancestor
111066293|NCT03875092|Antimitotic Agents|antimitotic agents|mesh-ancestor
111066294|NCT03875092|Mitosis Modulators|mitosis modulators|mesh-ancestor
111066295|NCT03875092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111066296|NCT03875092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111066297|NCT03875092|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111066298|NCT02728102|Lenalidomide|lenalidomide|mesh-list
111066299|NCT02728102|Melphalan|melphalan|mesh-list
111066300|NCT02728102|Molgramostim|molgramostim|mesh-list
111066301|NCT02728102|Vaccines|vaccines|mesh-list
111066302|NCT02728102|Sargramostim|sargramostim|mesh-list
111066303|NCT02728102|Immunologic Factors|immunologic factors|mesh-ancestor
111066304|NCT02728102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111066305|NCT02728102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111066306|NCT02728102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111066307|NCT02728102|Growth Substances|growth substances|mesh-ancestor
111066308|NCT02728102|Growth Inhibitors|growth inhibitors|mesh-ancestor
110637058|NCT00828230|Autonomic Agents|autonomic agents|mesh-ancestor
111066309|NCT02728102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111066310|NCT02728102|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111066311|NCT02728102|Alkylating Agents|alkylating agents|mesh-ancestor
111066312|NCT02728102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111066313|NCT02728102|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111066314|NCT02728102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111066315|NCT02502734|Fluticasone|fluticasone|mesh-list
111066317|NCT02502734|Albuterol|albuterol|mesh-list
111066318|NCT02502734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111066319|NCT02502734|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111066320|NCT02502734|Autonomic Agents|autonomic agents|mesh-ancestor
111066321|NCT02502734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111066322|NCT02502734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111066323|NCT02502734|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111066324|NCT02502734|Respiratory System Agents|respiratory system agents|mesh-ancestor
111066325|NCT02502734|Dermatologic Agents|dermatologic agents|mesh-ancestor
111066326|NCT02502734|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111066327|NCT02502734|Tocolytic Agents|tocolytic agents|mesh-ancestor
111066328|NCT02502734|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111066329|NCT02502734|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111066330|NCT02502734|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111066331|NCT02502734|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111066332|NCT02502734|Adrenergic Agents|adrenergic agents|mesh-ancestor
111066333|NCT02502734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111066334|NCT02502734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111066335|NCT04193878|Budesonide|budesonide|mesh-list
111066336|NCT04193878|Formoterol Fumarate|formoterol fumarate|mesh-list
111066337|NCT04193878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111066338|NCT04193878|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111066339|NCT04193878|Autonomic Agents|autonomic agents|mesh-ancestor
111066340|NCT04193878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111066341|NCT04193878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111066342|NCT04193878|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111066343|NCT04193878|Respiratory System Agents|respiratory system agents|mesh-ancestor
111066344|NCT04193878|Glucocorticoids|glucocorticoids|mesh-ancestor
111066345|NCT04193878|Hormones|hormones|mesh-ancestor
111066346|NCT04193878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111066347|NCT04193878|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111066348|NCT04193878|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111066349|NCT04193878|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111066350|NCT04193878|Adrenergic Agents|adrenergic agents|mesh-ancestor
111066351|NCT04193878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111066352|NCT04193878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111066353|NCT02473250|Fluoxetine|fluoxetine|mesh-list
111066354|NCT02473250|Citalopram|citalopram|mesh-list
111066355|NCT02473250|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111066356|NCT02473250|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111066357|NCT02473250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111066358|NCT02473250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111066359|NCT02473250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111066360|NCT02473250|Serotonin Agents|serotonin agents|mesh-ancestor
111066361|NCT02473250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111066362|NCT02473250|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111066363|NCT02473250|Antidepressive Agents|antidepressive agents|mesh-ancestor
111066364|NCT02473250|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111066365|NCT02473250|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111066366|NCT02473250|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111066367|NCT02473250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111066368|NCT04253626|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
111066369|NCT04253626|Hematinics|hematinics|mesh-ancestor
111066370|NCT04253626|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
111066371|NCT04253626|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111066372|NCT03840148|Meropenem|meropenem|mesh-list
111066373|NCT03840148|Cefepime|cefepime|mesh-list
111066374|NCT03840148|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111066375|NCT03840148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111066376|NCT04821778|Paclitaxel|paclitaxel|mesh-list
111066377|NCT04821778|Nimotuzumab|nimotuzumab|mesh-list
111066378|NCT04821778|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111066379|NCT04821778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111066380|NCT04821778|Tubulin Modulators|tubulin modulators|mesh-ancestor
111066381|NCT04821778|Antimitotic Agents|antimitotic agents|mesh-ancestor
111066382|NCT04821778|Mitosis Modulators|mitosis modulators|mesh-ancestor
111066383|NCT04821778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111066384|NCT04821778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111066385|NCT02611024|Irinotecan|irinotecan|mesh-list
111066386|NCT02611024|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111066387|NCT02611024|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111066388|NCT02611024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111066389|NCT02611024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111066390|NCT02611024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111066391|NCT04222504|Tenofovir|tenofovir|mesh-list
111066392|NCT04222504|Emtricitabine|emtricitabine|mesh-list
111066393|NCT04222504|Antiviral Agents|antiviral agents|mesh-ancestor
111066394|NCT04222504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111066395|NCT04222504|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111066396|NCT04222504|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111066397|NCT04222504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111066398|NCT04222504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111066399|NCT04222504|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111066400|NCT04222504|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111066401|NCT02500706|Insulin|insulin|mesh-list
111066402|NCT02500706|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111066403|NCT02500706|Insulin Aspart|insulin aspart|mesh-list
111066404|NCT02500706|Insulin, Long-Acting|insulin, long-acting|mesh-list
111066405|NCT02500706|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
111066406|NCT02500706|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111066407|NCT02500706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111066408|NCT04201496|Empagliflozin|empagliflozin|mesh-list
111066409|NCT04201496|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111066410|NCT04201496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111066411|NCT04201496|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111066412|NCT04201496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111066413|NCT02456974|Amoxicillin|amoxicillin|mesh-list
111066414|NCT02456974|Vancomycin|vancomycin|mesh-list
111066415|NCT02456974|Ciprofloxacin|ciprofloxacin|mesh-list
111066416|NCT02456974|Meropenem|meropenem|mesh-list
111066417|NCT02456974|Tazobactam|tazobactam|mesh-list
111066418|NCT02456974|Clavulanic Acid|clavulanic acid|mesh-list
111066419|NCT02456974|Amikacin|amikacin|mesh-list
111066420|NCT02456974|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
111066421|NCT02456974|Teicoplanin|teicoplanin|mesh-list
111066422|NCT02456974|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111066423|NCT02456974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111066424|NCT02456974|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111066425|NCT02456974|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111066426|NCT02456974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111066427|NCT02456974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111066428|NCT02456974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111066429|NCT02456974|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111066430|NCT02456974|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111066431|NCT02456974|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
111066432|NCT04797286|Sildenafil Citrate|sildenafil citrate|mesh-list
111066433|NCT04797286|Vasodilator Agents|vasodilator agents|mesh-ancestor
111066434|NCT04797286|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111066435|NCT04797286|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111066436|NCT04797286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111066437|NCT04797286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111066438|NCT04797286|Urological Agents|urological agents|mesh-ancestor
111066439|NCT03682276|Nivolumab|nivolumab|mesh-list
111066440|NCT03682276|Ipilimumab|ipilimumab|mesh-list
111066441|NCT03682276|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111066442|NCT03682276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111066443|NCT03682276|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111066444|NCT03682276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111066445|NCT05653024|Albuterol|albuterol|mesh-list
111066446|NCT05653024|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111066447|NCT05653024|Autonomic Agents|autonomic agents|mesh-ancestor
111066448|NCT05653024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111066449|NCT05653024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111066450|NCT05653024|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111066451|NCT05653024|Respiratory System Agents|respiratory system agents|mesh-ancestor
111066452|NCT05653024|Tocolytic Agents|tocolytic agents|mesh-ancestor
111066453|NCT05653024|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111066454|NCT05653024|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111066455|NCT05653024|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111066456|NCT05653024|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111066457|NCT05653024|Adrenergic Agents|adrenergic agents|mesh-ancestor
111066458|NCT05653024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111066459|NCT05653024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111066460|NCT02499770|Carboplatin|carboplatin|mesh-list
111066461|NCT02499770|Etoposide|etoposide|mesh-list
111066462|NCT02499770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111066463|NCT02499770|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111066464|NCT02499770|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111066465|NCT02499770|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111066466|NCT02499770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111066467|NCT02499770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111066468|NCT04418674|Fentanyl|fentanyl|mesh-list
111066469|NCT04418674|Ketamine|ketamine|mesh-list
111066470|NCT04418674|Analgesics|analgesics|mesh-ancestor
111066471|NCT04418674|Sensory System Agents|sensory system agents|mesh-ancestor
111066472|NCT04418674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111066473|NCT04418674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111066474|NCT04418674|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111066475|NCT04418674|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111066476|NCT04418674|Anesthetics, General|anesthetics, general|mesh-ancestor
111066477|NCT04418674|Anesthetics|anesthetics|mesh-ancestor
111066478|NCT04418674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111066479|NCT04418674|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111066480|NCT04418674|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111066481|NCT04418674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111066482|NCT04418674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111066483|NCT04418674|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111066484|NCT04418674|Narcotics|narcotics|mesh-ancestor
111066485|NCT04418674|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111066486|NCT02442284|Ritonavir|ritonavir|mesh-list
111066487|NCT02442284|Ribavirin|ribavirin|mesh-list
111066488|NCT02442284|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111066489|NCT02442284|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111066490|NCT02442284|Protease Inhibitors|protease inhibitors|mesh-ancestor
111066491|NCT02442284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111066492|NCT02442284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111066493|NCT02442284|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111066494|NCT02442284|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111066495|NCT02442284|Antiviral Agents|antiviral agents|mesh-ancestor
111066496|NCT02442284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110783593|NCT01936532|Lenalidomide|lenalidomide|mesh-list
110783594|NCT01936532|Ixazomib|ixazomib|mesh-list
110783595|NCT01936532|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110783596|NCT01936532|Antiemetics|antiemetics|mesh-ancestor
110783597|NCT01936532|Autonomic Agents|autonomic agents|mesh-ancestor
110783598|NCT01936532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110783599|NCT01936532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110783600|NCT01936532|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110783601|NCT01936532|Glucocorticoids|glucocorticoids|mesh-ancestor
110783602|NCT01936532|Hormones|hormones|mesh-ancestor
110783603|NCT01936532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110783604|NCT01936532|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110783605|NCT01936532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110783606|NCT01936532|Immunologic Factors|immunologic factors|mesh-ancestor
110783607|NCT01936532|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110783608|NCT01936532|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110783609|NCT01936532|Growth Substances|growth substances|mesh-ancestor
110783610|NCT01936532|Growth Inhibitors|growth inhibitors|mesh-ancestor
110783611|NCT01936532|Protease Inhibitors|protease inhibitors|mesh-ancestor
110783612|NCT01936532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110783613|NCT01936532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110783644|NCT01054625|Zalutumumab|zalutumumab|mesh-list
110783645|NCT01054625|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110783646|NCT01054625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110783647|NCT01038778|Aldesleukin|aldesleukin|mesh-list
110783648|NCT01038778|Deoxyglucose|deoxyglucose|mesh-list
110783649|NCT01038778|Interleukin-2|interleukin-2|mesh-list
110783650|NCT01038778|Entinostat|entinostat|mesh-list
110783651|NCT01038778|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
111066497|NCT02442284|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111066498|NCT02442284|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111066499|NCT02442284|Antimetabolites|antimetabolites|mesh-ancestor
111066500|NCT03781960|Nivolumab|nivolumab|mesh-list
111066501|NCT03781960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111066502|NCT03781960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111066503|NCT03781960|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111066504|NCT03781960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111066505|NCT02499146|Letrozole|letrozole|mesh-list
111066506|NCT02499146|Palbociclib|palbociclib|mesh-list
111066507|NCT02499146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111066508|NCT02499146|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111066509|NCT02499146|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111066510|NCT02499146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111066511|NCT02499146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111066512|NCT02499146|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111066513|NCT02499146|Hormone Antagonists|hormone antagonists|mesh-ancestor
111066514|NCT02499146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111066515|NCT02499146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111066516|NCT02499146|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111066517|NCT01634854|Misoprostol|misoprostol|mesh-list
111066518|NCT01634854|Oxytocin|oxytocin|mesh-list
111066519|NCT01634854|Oxytocics|oxytocics|mesh-ancestor
111066520|NCT01634854|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111066521|NCT01634854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111066522|NCT01634854|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111066523|NCT01634854|Abortifacient Agents|abortifacient agents|mesh-ancestor
111066524|NCT01634854|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111066525|NCT01634854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111066526|NCT05651464|Vancomycin|vancomycin|mesh-list
111066527|NCT05651464|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111066528|NCT05651464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111066529|NCT01897480|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111066530|NCT01897480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111066531|NCT01897480|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111066532|NCT01897480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111066533|NCT01897480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111066534|NCT02441114|Fluticasone|fluticasone|mesh-list
111066535|NCT02441114|Tiotropium Bromide|tiotropium bromide|mesh-list
111066536|NCT02441114|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
111066537|NCT02441114|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
111066538|NCT02441114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111066539|NCT02441114|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111066540|NCT02441114|Autonomic Agents|autonomic agents|mesh-ancestor
111066541|NCT02441114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111066542|NCT02441114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111066543|NCT02441114|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111066544|NCT02441114|Respiratory System Agents|respiratory system agents|mesh-ancestor
111066545|NCT02441114|Dermatologic Agents|dermatologic agents|mesh-ancestor
111066546|NCT02441114|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111066547|NCT02441114|Parasympatholytics|parasympatholytics|mesh-ancestor
111066548|NCT02441114|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111066549|NCT02441114|Cholinergic Agents|cholinergic agents|mesh-ancestor
111066550|NCT02441114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111066551|NCT02441114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111066552|NCT02441114|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111066553|NCT02441114|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111066554|NCT02441114|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111066555|NCT02441114|Adrenergic Agents|adrenergic agents|mesh-ancestor
111066556|NCT02441114|Glucocorticoids|glucocorticoids|mesh-ancestor
111066557|NCT02441114|Hormones|hormones|mesh-ancestor
111066558|NCT02441114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111066559|NCT02441114|Sympathomimetics|sympathomimetics|mesh-ancestor
111066560|NCT02498444|Treprostinil|treprostinil|mesh-list
111066561|NCT02498444|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111066562|NCT05235256|Dexamethasone|dexamethasone|mesh-list
111066563|NCT05235256|Lidocaine|lidocaine|mesh-list
111066564|NCT05235256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111066565|NCT05235256|Antiemetics|antiemetics|mesh-ancestor
111066566|NCT05235256|Autonomic Agents|autonomic agents|mesh-ancestor
111066567|NCT05235256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111066568|NCT05235256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111066569|NCT05235256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111066570|NCT05235256|Glucocorticoids|glucocorticoids|mesh-ancestor
110783670|NCT00542308|Zalutumumab|zalutumumab|mesh-list
111066572|NCT05235256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111066573|NCT05235256|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111066574|NCT05235256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111066575|NCT05235256|Anesthetics, Local|anesthetics, local|mesh-ancestor
111066576|NCT05235256|Anesthetics|anesthetics|mesh-ancestor
111066577|NCT05235256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111066578|NCT05235256|Sensory System Agents|sensory system agents|mesh-ancestor
111066579|NCT05235256|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111066580|NCT05235256|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111066581|NCT05235256|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111066582|NCT05235256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111066583|NCT05235256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111066584|NCT02497976|Certolizumab Pegol|certolizumab pegol|mesh-list
111066585|NCT02497976|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111066586|NCT02497976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111066587|NCT02497976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111066588|NCT02497976|Immunologic Factors|immunologic factors|mesh-ancestor
111066589|NCT02497976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111066591|NCT04810546|Lactoferrin|lactoferrin|mesh-list
111066592|NCT04810546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111066593|NCT04596826|Dronabinol|dronabinol|mesh-list
111066594|NCT04596826|Hallucinogens|hallucinogens|mesh-ancestor
111066595|NCT04596826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111066596|NCT04596826|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111066597|NCT04596826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111066598|NCT04596826|Analgesics|analgesics|mesh-ancestor
111066599|NCT04596826|Sensory System Agents|sensory system agents|mesh-ancestor
111066600|NCT04596826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111066601|NCT04596826|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
111066602|NCT04596826|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
111066603|NCT04596826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111066604|NCT04596826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111066605|NCT04596826|Hormones|hormones|mesh-ancestor
111066606|NCT04596826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111066607|NCT02440568|Cytarabine|cytarabine|mesh-list
111066608|NCT02440568|Idarubicin|idarubicin|mesh-list
111066609|NCT02440568|Homoharringtonine|homoharringtonine|mesh-list
111066610|NCT02440568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111066611|NCT02440568|Antimetabolites|antimetabolites|mesh-ancestor
111066612|NCT02440568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111066613|NCT02440568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111066614|NCT02440568|Antiviral Agents|antiviral agents|mesh-ancestor
111066615|NCT02440568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111066616|NCT02440568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111066617|NCT02440568|Immunologic Factors|immunologic factors|mesh-ancestor
111066618|NCT02440568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111066619|NCT02440568|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111066620|NCT02440568|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111066621|NCT02440568|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111066622|NCT02440568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111066623|NCT02440568|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111066624|NCT02440568|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111066625|NCT00679120|Cimetidine|cimetidine|mesh-list
111066626|NCT00679120|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111066627|NCT00679120|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111066628|NCT00679120|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
111066629|NCT00679120|Histamine Antagonists|histamine antagonists|mesh-ancestor
111066630|NCT00679120|Histamine Agents|histamine agents|mesh-ancestor
111066631|NCT00679120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111066632|NCT00679120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111066633|NCT00679120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111066634|NCT00679120|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111066635|NCT00679120|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111066636|NCT00679120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111066637|NCT04420624|Colchicine|colchicine|mesh-list
111066638|NCT04420624|Gout Suppressants|gout suppressants|mesh-ancestor
111066639|NCT04420624|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111066640|NCT04420624|Tubulin Modulators|tubulin modulators|mesh-ancestor
111066641|NCT04420624|Antimitotic Agents|antimitotic agents|mesh-ancestor
111066642|NCT04420624|Mitosis Modulators|mitosis modulators|mesh-ancestor
110783752|NCT03660436|Mycophenolic Acid|mycophenolic acid|mesh-list
111066643|NCT04420624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111066644|NCT04420624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111066645|NCT04782778|Bupivacaine|bupivacaine|mesh-list
111066646|NCT04782778|Anesthetics, Local|anesthetics, local|mesh-ancestor
111066647|NCT04782778|Anesthetics|anesthetics|mesh-ancestor
111066648|NCT04782778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111066649|NCT04782778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111066650|NCT04782778|Sensory System Agents|sensory system agents|mesh-ancestor
111066651|NCT04782778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111066652|NCT00434434|Omalizumab|omalizumab|mesh-list
111066653|NCT00434434|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111066654|NCT00434434|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111066655|NCT00434434|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111066656|NCT00434434|Respiratory System Agents|respiratory system agents|mesh-ancestor
111066657|NCT00434434|Immunologic Factors|immunologic factors|mesh-ancestor
111066658|NCT00434434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111066659|NCT04002401|Cyclophosphamide|cyclophosphamide|mesh-list
111066660|NCT04002401|Rituximab|rituximab|mesh-list
111066661|NCT04002401|Fludarabine|fludarabine|mesh-list
111066662|NCT04002401|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
111066663|NCT04002401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111066665|NCT04002401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111066666|NCT04002401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111066667|NCT04002401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111066668|NCT04002401|Alkylating Agents|alkylating agents|mesh-ancestor
111066669|NCT04002401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111066670|NCT04002401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111066671|NCT04002401|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111066672|NCT04002401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111066673|NCT03046511|Cefazolin|cefazolin|mesh-list
111066674|NCT03046511|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111066675|NCT03046511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111066676|NCT02439320|Lasmiditan|lasmiditan|mesh-list
111066677|NCT02439320|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111066678|NCT02439320|Serotonin Agents|serotonin agents|mesh-ancestor
111066679|NCT02439320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111066680|NCT02439320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111066681|NCT02439320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111066682|NCT02468648|Sofosbuvir|sofosbuvir|mesh-list
111066683|NCT02468648|Velpatasvir|velpatasvir|mesh-list
111066684|NCT02468648|Antiviral Agents|antiviral agents|mesh-ancestor
111066685|NCT02468648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111066686|NCT02466386|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
111066687|NCT02466386|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111066688|NCT02466386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111066689|NCT02466386|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111066690|NCT02466386|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111066691|NCT02466386|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111066692|NCT02466386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111066693|NCT02466386|Dopamine Agents|dopamine agents|mesh-ancestor
111066694|NCT02466386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111066695|NCT01633060|Fulvestrant|fulvestrant|mesh-list
111066696|NCT01633060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111066697|NCT01633060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111066698|NCT01633060|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
111066699|NCT01633060|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111066700|NCT01633060|Hormone Antagonists|hormone antagonists|mesh-ancestor
111066701|NCT01633060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111066702|NCT01633060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111066703|NCT03906695|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
111066704|NCT03906695|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111066705|NCT03906695|Antimetabolites|antimetabolites|mesh-ancestor
111066706|NCT03906695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111066707|NCT03906695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111066708|NCT02819141|Dexmedetomidine|dexmedetomidine|mesh-list
111066709|NCT02819141|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111066710|NCT02819141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111066711|NCT02819141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111066712|NCT02819141|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111066713|NCT02819141|Analgesics|analgesics|mesh-ancestor
111066714|NCT02819141|Sensory System Agents|sensory system agents|mesh-ancestor
111066715|NCT02819141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111066716|NCT02819141|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111066717|NCT02819141|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111066718|NCT02819141|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111066719|NCT02819141|Adrenergic Agents|adrenergic agents|mesh-ancestor
111066720|NCT02819141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111066721|NCT02819141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111066722|NCT01632904|Hydroxyurea|hydroxyurea|mesh-list
111066723|NCT01632904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111066724|NCT01632904|Antisickling Agents|antisickling agents|mesh-ancestor
111066725|NCT01632904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111066726|NCT01632904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111066727|NCT01632904|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111066728|NCT04240756|Amphetamine|amphetamine|mesh-list
111066729|NCT04240756|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111066730|NCT04240756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111066731|NCT04240756|Sympathomimetics|sympathomimetics|mesh-ancestor
111066732|NCT04240756|Autonomic Agents|autonomic agents|mesh-ancestor
111066733|NCT04240756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111066734|NCT04240756|Dopamine Agents|dopamine agents|mesh-ancestor
111066735|NCT04240756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111066736|NCT04240756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111066737|NCT04240756|Adrenergic Agents|adrenergic agents|mesh-ancestor
111066738|NCT04240756|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111066739|NCT04240756|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111066740|NCT04240756|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111066741|NCT04240756|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111066742|NCT04467125|Lidocaine|lidocaine|mesh-list
111066743|NCT04467125|Prilocaine|prilocaine|mesh-list
111066744|NCT04467125|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
111066745|NCT04467125|Anesthetics, Local|anesthetics, local|mesh-ancestor
111066746|NCT04467125|Anesthetics|anesthetics|mesh-ancestor
111066747|NCT04467125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111066748|NCT04467125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111066749|NCT04467125|Sensory System Agents|sensory system agents|mesh-ancestor
111066750|NCT04467125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111066751|NCT04467125|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111066752|NCT04467125|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111066753|NCT04467125|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111066754|NCT04467125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111066755|NCT04467125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111066756|NCT04467125|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
111066757|NCT02692313|Epinephrine|epinephrine|mesh-list
111066758|NCT02692313|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111066759|NCT02692313|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111066760|NCT02692313|Adrenergic Agents|adrenergic agents|mesh-ancestor
111066761|NCT02692313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111066762|NCT02692313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111066763|NCT02692313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111066764|NCT02692313|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111066765|NCT02692313|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111066766|NCT02692313|Autonomic Agents|autonomic agents|mesh-ancestor
111066767|NCT02692313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111066768|NCT02692313|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111066769|NCT02692313|Respiratory System Agents|respiratory system agents|mesh-ancestor
111066770|NCT02692313|Mydriatics|mydriatics|mesh-ancestor
111066771|NCT02692313|Sympathomimetics|sympathomimetics|mesh-ancestor
111066772|NCT02692313|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111066773|NCT02465528|Ceritinib|ceritinib|mesh-list
111066774|NCT02465528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111066775|NCT02465528|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111066776|NCT02465528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111066777|NCT02465528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111066778|NCT03524261|Antibodies|antibodies|mesh-list
111066779|NCT03524261|Antibodies, Bispecific|antibodies, bispecific|mesh-list
111066780|NCT03524261|Immunologic Factors|immunologic factors|mesh-ancestor
111066781|NCT03524261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111066782|NCT03386721|Gemcitabine|gemcitabine|mesh-list
111066783|NCT03386721|Atezolizumab|atezolizumab|mesh-list
111066784|NCT03386721|Vinorelbine|vinorelbine|mesh-list
111066785|NCT03386721|Antibodies|antibodies|mesh-list
111066786|NCT03386721|Immunologic Factors|immunologic factors|mesh-ancestor
111066787|NCT03386721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111066788|NCT03386721|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110783936|NCT04438330|Nickel|nickel|mesh-list
111066789|NCT03386721|Antimetabolites|antimetabolites|mesh-ancestor
111066790|NCT03386721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111066791|NCT03386721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111066792|NCT03386721|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111066793|NCT03386721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111066794|NCT03386721|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111066795|NCT03386721|Tubulin Modulators|tubulin modulators|mesh-ancestor
111066796|NCT03386721|Antimitotic Agents|antimitotic agents|mesh-ancestor
111066797|NCT03386721|Mitosis Modulators|mitosis modulators|mesh-ancestor
111066799|NCT02462720|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
111066800|NCT02462720|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111066801|NCT02246218|Glycerol|glycerol|mesh-list
111066802|NCT02246218|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
111066804|NCT02246218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111066805|NCT05073939|Oxytocin|oxytocin|mesh-list
111066806|NCT05073939|Oxytocics|oxytocics|mesh-ancestor
111066807|NCT05073939|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111066808|NCT05073939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111066809|NCT04192630|Hyaluronic Acid|hyaluronic acid|mesh-list
111066810|NCT04192630|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111066811|NCT04192630|Immunologic Factors|immunologic factors|mesh-ancestor
111066812|NCT04192630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111066813|NCT04192630|Viscosupplements|viscosupplements|mesh-ancestor
111066814|NCT04192630|Protective Agents|protective agents|mesh-ancestor
111066815|NCT00159783|Olanzapine|olanzapine|mesh-list
111066816|NCT00159783|Asenapine|asenapine|mesh-list
111066817|NCT00159783|Antiemetics|antiemetics|mesh-ancestor
111066818|NCT00159783|Autonomic Agents|autonomic agents|mesh-ancestor
111066819|NCT00159783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111066820|NCT00159783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111066821|NCT00159783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111066822|NCT00159783|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111066823|NCT00159783|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111066824|NCT00159783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111066825|NCT00159783|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111066826|NCT00159783|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111066827|NCT00159783|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111066828|NCT00159783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111066829|NCT00159783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111066830|NCT00159783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111066831|NCT00159783|Serotonin Agents|serotonin agents|mesh-ancestor
111066832|NCT01023737|Hydroxychloroquine|hydroxychloroquine|mesh-list
111066833|NCT01023737|Vorinostat|vorinostat|mesh-list
111066834|NCT01023737|Antimalarials|antimalarials|mesh-ancestor
111066835|NCT01023737|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111066836|NCT01023737|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111066837|NCT01023737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111066838|NCT01023737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111066839|NCT01023737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111066840|NCT01023737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111066841|NCT01023737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111066842|NCT01023737|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111066843|NCT00646204|Memantine|memantine|mesh-list
111066844|NCT00646204|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111066845|NCT00646204|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111066846|NCT00646204|Dopamine Agents|dopamine agents|mesh-ancestor
111066847|NCT00646204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111066848|NCT00646204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111066849|NCT00646204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111066850|NCT00646204|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111066851|NCT00646204|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111066852|NCT04105270|Carboplatin|carboplatin|mesh-list
111066853|NCT04105270|Pemetrexed|pemetrexed|mesh-list
111066854|NCT04105270|Durvalumab|durvalumab|mesh-list
111066855|NCT04105270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111066856|NCT04105270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111066857|NCT04105270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111066858|NCT04105270|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111066859|NCT04105270|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111066860|NCT04105270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111066861|NCT02243176|Saxagliptin|saxagliptin|mesh-list
111066862|NCT02243176|Acarbose|acarbose|mesh-list
111066863|NCT02243176|Incretins|incretins|mesh-ancestor
111066864|NCT02243176|Hormones|hormones|mesh-ancestor
111066865|NCT02243176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111066866|NCT02243176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111066867|NCT02243176|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111066868|NCT02243176|Protease Inhibitors|protease inhibitors|mesh-ancestor
111066869|NCT02243176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111066870|NCT02243176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111066871|NCT02243176|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111066872|NCT02243176|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
111066873|NCT00692939|Cyclophosphamide|cyclophosphamide|mesh-list
111066874|NCT00692939|Melphalan|melphalan|mesh-list
111066875|NCT00692939|Thiotepa|thiotepa|mesh-list
111066876|NCT00692939|Rituximab|rituximab|mesh-list
111066877|NCT00692939|Alemtuzumab|alemtuzumab|mesh-list
111066878|NCT00692939|Thymoglobulin|thymoglobulin|mesh-list
111066880|NCT00692939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111066881|NCT00692939|Immunologic Factors|immunologic factors|mesh-ancestor
111066882|NCT00692939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111066883|NCT00692939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111066884|NCT00692939|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111066885|NCT00692939|Alkylating Agents|alkylating agents|mesh-ancestor
111066886|NCT00692939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111066887|NCT00692939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111066888|NCT00692939|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111066889|NCT00692939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111066890|NCT04551261|Ritonavir|ritonavir|mesh-list
111066891|NCT04551261|Tenofovir|tenofovir|mesh-list
111066892|NCT04551261|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111066893|NCT04551261|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111066894|NCT04551261|Protease Inhibitors|protease inhibitors|mesh-ancestor
111066895|NCT04551261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111066896|NCT04551261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111066897|NCT04551261|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111066898|NCT04551261|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111066899|NCT04551261|Antiviral Agents|antiviral agents|mesh-ancestor
111066900|NCT04551261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111066901|NCT04551261|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111066902|NCT04551261|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111066903|NCT04551261|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111066904|NCT04551261|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111066905|NCT04534257|Sirolimus|sirolimus|mesh-list
111066906|NCT04534257|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111066907|NCT04534257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111066908|NCT04534257|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111066909|NCT04534257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111066910|NCT04534257|Antifungal Agents|antifungal agents|mesh-ancestor
111066911|NCT04534257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111066912|NCT04534257|Immunologic Factors|immunologic factors|mesh-ancestor
111066913|NCT04534257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111066914|NCT03522935|Elafin|elafin|mesh-list
111066915|NCT03522935|Protease Inhibitors|protease inhibitors|mesh-ancestor
111066916|NCT03522935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111066917|NCT03522935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111066918|NCT03138681|Phosphocreatine|phosphocreatine|mesh-list
111066919|NCT03138681|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111066920|NCT03138681|Protective Agents|protective agents|mesh-ancestor
111066921|NCT03138681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111066922|NCT05392257|Rituximab|rituximab|mesh-list
111066923|NCT05392257|Lenalidomide|lenalidomide|mesh-list
111066924|NCT05392257|Zanubrutinib|zanubrutinib|mesh-list
111066925|NCT05392257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111066926|NCT05392257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111066927|NCT05392257|Immunologic Factors|immunologic factors|mesh-ancestor
111066928|NCT05392257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111066929|NCT05392257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111066930|NCT05392257|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111066931|NCT05392257|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111066932|NCT05392257|Growth Substances|growth substances|mesh-ancestor
111066933|NCT05392257|Growth Inhibitors|growth inhibitors|mesh-ancestor
111066934|NCT05392257|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111066935|NCT05392257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111066936|NCT05392257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111066937|NCT02240680|Linagliptin|linagliptin|mesh-list
111066938|NCT02240680|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111066939|NCT02240680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111066940|NCT02240680|Incretins|incretins|mesh-ancestor
111066941|NCT02240680|Hormones|hormones|mesh-ancestor
111066942|NCT02240680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111066943|NCT02240680|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111066944|NCT02240680|Protease Inhibitors|protease inhibitors|mesh-ancestor
111066945|NCT02240680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111066946|NCT02240680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111066947|NCT05391867|Sorafenib|sorafenib|mesh-list
111066948|NCT05391867|Lenvatinib|lenvatinib|mesh-list
111066949|NCT05391867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111066950|NCT05391867|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111066951|NCT05391867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111119159|NCT05306873|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111066952|NCT05391867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111066954|NCT03110679|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111066955|NCT03110679|Immunologic Factors|immunologic factors|mesh-ancestor
111066956|NCT03110679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111066957|NCT03110679|Viscosupplements|viscosupplements|mesh-ancestor
111066958|NCT03110679|Protective Agents|protective agents|mesh-ancestor
111066959|NCT05391789|Urinastatin|urinastatin|mesh-list
111066960|NCT05391789|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
111066961|NCT05391789|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111066962|NCT05391789|Protease Inhibitors|protease inhibitors|mesh-ancestor
111066963|NCT05391789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111066964|NCT05391789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111066965|NCT04699071|Pembrolizumab|pembrolizumab|mesh-list
111066966|NCT04699071|Lenvatinib|lenvatinib|mesh-list
111066967|NCT04699071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111066968|NCT04699071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111066969|NCT04699071|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111066970|NCT04699071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111066971|NCT04699071|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111066972|NCT04699071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111066973|NCT03139851|Cyclophosphamide|cyclophosphamide|mesh-list
111066974|NCT03139851|Pembrolizumab|pembrolizumab|mesh-list
111066975|NCT03139851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111066976|NCT03139851|Immunologic Factors|immunologic factors|mesh-ancestor
111066977|NCT03139851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111066978|NCT03139851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111066979|NCT03139851|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111066980|NCT03139851|Alkylating Agents|alkylating agents|mesh-ancestor
111066981|NCT03139851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111066982|NCT03139851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111066983|NCT03139851|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111066984|NCT03139851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111066985|NCT03139851|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111066986|NCT03967288|Bupivacaine|bupivacaine|mesh-list
111066987|NCT03967288|Chloroprocaine|chloroprocaine|mesh-list
111066988|NCT03967288|Procaine|procaine|mesh-list
111066989|NCT03967288|Anesthetics, Local|anesthetics, local|mesh-ancestor
111066990|NCT03967288|Anesthetics|anesthetics|mesh-ancestor
111066991|NCT03967288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111066992|NCT03967288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111066993|NCT03967288|Sensory System Agents|sensory system agents|mesh-ancestor
111066994|NCT03967288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111066995|NCT03962062|Moxidectin|moxidectin|mesh-list
111066996|NCT03962062|Anthelmintics|anthelmintics|mesh-ancestor
111066997|NCT03962062|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111066998|NCT03962062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111066999|NCT03962062|Antinematodal Agents|antinematodal agents|mesh-ancestor
111067000|NCT03140085|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111067001|NCT03140085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111067002|NCT02239510|Linaclotide|linaclotide|mesh-list
111067003|NCT02239510|Sennosides|sennosides|mesh-list
111067004|NCT02239510|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
111067005|NCT02239510|Enzyme Activators|enzyme activators|mesh-ancestor
111067006|NCT02239510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111067007|NCT02239510|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111067008|NCT02239510|Laxatives|laxatives|mesh-ancestor
111067009|NCT04507581|Anesthetics|anesthetics|mesh-list
111067010|NCT04507581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111067011|NCT04507581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111067012|NCT02291471|T0001|t0001|mesh-list
111067013|NCT02291471|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
111067014|NCT02291471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111067015|NCT02291471|Immunologic Factors|immunologic factors|mesh-ancestor
111067016|NCT02291471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111067017|NCT03899961|Oxytocin|oxytocin|mesh-list
111067018|NCT03899961|Carbetocin|carbetocin|mesh-list
111067019|NCT03899961|Oxytocics|oxytocics|mesh-ancestor
111067020|NCT03899961|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111067021|NCT03899961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111067022|NCT02462486|Ranibizumab|ranibizumab|mesh-list
111067023|NCT02462486|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111067024|NCT02462486|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111067025|NCT02462486|Growth Substances|growth substances|mesh-ancestor
110532119|NCT02699138|Trazodone|trazodone|mesh-list
111067026|NCT02462486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111067027|NCT02462486|Growth Inhibitors|growth inhibitors|mesh-ancestor
111067028|NCT02462486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111067029|NCT03521219|Apatinib|apatinib|mesh-list
111067030|NCT03521219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111067031|NCT03521219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111067032|NCT03521219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111067033|NCT03521219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111067034|NCT05318157|Emedastine|emedastine|mesh-list
111067035|NCT05318157|Budesonide|budesonide|mesh-list
111067036|NCT05318157|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111067037|NCT05318157|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111067038|NCT05318157|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111067039|NCT05318157|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111067040|NCT05318157|Autonomic Agents|autonomic agents|mesh-ancestor
111067041|NCT05318157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111067042|NCT05318157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111067043|NCT05318157|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111067044|NCT05318157|Respiratory System Agents|respiratory system agents|mesh-ancestor
111067045|NCT05318157|Glucocorticoids|glucocorticoids|mesh-ancestor
111067046|NCT05318157|Hormones|hormones|mesh-ancestor
111067047|NCT05318157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111067048|NCT05318157|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111067049|NCT05318157|Histamine Antagonists|histamine antagonists|mesh-ancestor
111067050|NCT05318157|Histamine Agents|histamine agents|mesh-ancestor
111067051|NCT05318157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111067052|NCT05318157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111067053|NCT05318157|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111067054|NCT02294279|Beclomethasone|beclomethasone|mesh-list
111067055|NCT02294279|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111067056|NCT02294279|Glucocorticoids|glucocorticoids|mesh-ancestor
111067057|NCT02294279|Hormones|hormones|mesh-ancestor
111067058|NCT02294279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111067059|NCT02294279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111067060|NCT02294279|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111067061|NCT02294279|Respiratory System Agents|respiratory system agents|mesh-ancestor
111067062|NCT02294357|Dexamethasone|dexamethasone|mesh-list
111067063|NCT02294357|Dexamethasone acetate|dexamethasone acetate|mesh-list
111067064|NCT02294357|Prednisone|prednisone|mesh-list
111067065|NCT02294357|Methylprednisolone|methylprednisolone|mesh-list
111067066|NCT02294357|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111067067|NCT02294357|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111067068|NCT02294357|Prednisolone|prednisolone|mesh-list
111067069|NCT02294357|Prednisolone acetate|prednisolone acetate|mesh-list
111067070|NCT02294357|Lenalidomide|lenalidomide|mesh-list
111067071|NCT02294357|Pomalidomide|pomalidomide|mesh-list
111067072|NCT02294357|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111067073|NCT02294357|Prednisolone phosphate|prednisolone phosphate|mesh-list
111067074|NCT02294357|BB 1101|bb 1101|mesh-list
111067075|NCT02294357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111067076|NCT02294357|Antiemetics|antiemetics|mesh-ancestor
111067077|NCT02294357|Autonomic Agents|autonomic agents|mesh-ancestor
111067078|NCT02294357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111067079|NCT02294357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111067080|NCT02294357|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111067081|NCT02294357|Glucocorticoids|glucocorticoids|mesh-ancestor
111067082|NCT02294357|Hormones|hormones|mesh-ancestor
111067083|NCT02294357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111067084|NCT02294357|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111067085|NCT02294357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111067086|NCT02294357|Protease Inhibitors|protease inhibitors|mesh-ancestor
111067087|NCT02294357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111067088|NCT02294357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111067089|NCT02294357|Immunologic Factors|immunologic factors|mesh-ancestor
111067090|NCT02294357|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111067091|NCT02294357|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110784196|NCT01103115|Vitamins|vitamins|mesh-ancestor
111067092|NCT02294357|Growth Substances|growth substances|mesh-ancestor
111067093|NCT02294357|Growth Inhibitors|growth inhibitors|mesh-ancestor
111067094|NCT02294357|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111067095|NCT02294357|Protective Agents|protective agents|mesh-ancestor
111067096|NCT03880539|Vancomycin|vancomycin|mesh-list
111067097|NCT03880539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111067098|NCT03880539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111067099|NCT03518021|Naloxone|naloxone|mesh-list
111067100|NCT03518021|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111067101|NCT03518021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111067102|NCT03518021|Sensory System Agents|sensory system agents|mesh-ancestor
111067103|NCT03518021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111067104|NCT02495948|Hydrogen Peroxide|hydrogen peroxide|mesh-list
111067105|NCT02495948|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111067106|NCT02495948|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111067107|NCT02495948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111067108|NCT02294591|Acetylcysteine|acetylcysteine|mesh-list
111067109|NCT02294591|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111067110|NCT02294591|Antiviral Agents|antiviral agents|mesh-ancestor
111067111|NCT02294591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111067112|NCT02294591|Expectorants|expectorants|mesh-ancestor
111067113|NCT02294591|Respiratory System Agents|respiratory system agents|mesh-ancestor
111067114|NCT02294591|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111067115|NCT02294591|Antioxidants|antioxidants|mesh-ancestor
111067116|NCT02294591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111067117|NCT02294591|Protective Agents|protective agents|mesh-ancestor
111067118|NCT02294591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111067119|NCT02294591|Antidotes|antidotes|mesh-ancestor
111067120|NCT03521063|Budesonide|budesonide|mesh-list
111067121|NCT03521063|Poractant alfa|poractant alfa|mesh-list
111067122|NCT03521063|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111067123|NCT03521063|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111067124|NCT03521063|Autonomic Agents|autonomic agents|mesh-ancestor
111067125|NCT03521063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111067126|NCT03521063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111067127|NCT03521063|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111067128|NCT03521063|Respiratory System Agents|respiratory system agents|mesh-ancestor
111067129|NCT03521063|Glucocorticoids|glucocorticoids|mesh-ancestor
111067130|NCT03521063|Hormones|hormones|mesh-ancestor
111067131|NCT03521063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111067132|NCT03521063|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
111067133|NCT03520985|Dexamethasone|dexamethasone|mesh-list
111067134|NCT03520985|Pomalidomide|pomalidomide|mesh-list
111067135|NCT03520985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111067136|NCT03520985|Antiemetics|antiemetics|mesh-ancestor
111067137|NCT03520985|Autonomic Agents|autonomic agents|mesh-ancestor
111067138|NCT03520985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111067139|NCT03520985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111067140|NCT03520985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111067141|NCT03520985|Glucocorticoids|glucocorticoids|mesh-ancestor
111067142|NCT03520985|Hormones|hormones|mesh-ancestor
111067143|NCT03520985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111067144|NCT03520985|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111067145|NCT03520985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111067146|NCT03520985|Immunologic Factors|immunologic factors|mesh-ancestor
111067147|NCT03520985|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111067148|NCT03520985|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111067149|NCT03520985|Growth Substances|growth substances|mesh-ancestor
111067150|NCT03520985|Growth Inhibitors|growth inhibitors|mesh-ancestor
111067151|NCT03517943|Loratadine|loratadine|mesh-list
111067152|NCT03517943|Pseudoephedrine|pseudoephedrine|mesh-list
111067153|NCT03517943|Ephedrine|ephedrine|mesh-list
111067154|NCT03517943|Antipruritics|antipruritics|mesh-ancestor
111067155|NCT03517943|Dermatologic Agents|dermatologic agents|mesh-ancestor
111067156|NCT03517943|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111067157|NCT03517943|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
111067158|NCT03517943|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111067159|NCT03517943|Histamine Antagonists|histamine antagonists|mesh-ancestor
111067160|NCT03517943|Histamine Agents|histamine agents|mesh-ancestor
111067161|NCT03517943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111067162|NCT03517943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111067163|NCT03517943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111067164|NCT03517943|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111067165|NCT03517943|Autonomic Agents|autonomic agents|mesh-ancestor
111067166|NCT03517943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111067167|NCT03517943|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111067168|NCT03517943|Respiratory System Agents|respiratory system agents|mesh-ancestor
111067169|NCT03517943|Nasal Decongestants|nasal decongestants|mesh-ancestor
111067170|NCT03517943|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111067171|NCT03517943|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111067172|NCT03517943|Sympathomimetics|sympathomimetics|mesh-ancestor
111067173|NCT03517943|Adrenergic Agents|adrenergic agents|mesh-ancestor
111067174|NCT03823521|Cardioplegic Solutions|cardioplegic solutions|mesh-list
111067175|NCT03823521|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111067176|NCT03136341|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111067177|NCT03136341|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111067178|NCT03136341|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111067179|NCT03136341|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111067180|NCT03136341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111067181|NCT03136341|Cholinergic Agents|cholinergic agents|mesh-ancestor
111067182|NCT03136341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111067183|NCT03136341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111067184|NCT03136341|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111067185|NCT03136341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111067186|NCT04465175|Magnesium Sulfate|magnesium sulfate|mesh-list
111067187|NCT04465175|Analgesics|analgesics|mesh-ancestor
111067188|NCT04465175|Sensory System Agents|sensory system agents|mesh-ancestor
111067189|NCT04465175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111067190|NCT04465175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111067191|NCT04465175|Anesthetics|anesthetics|mesh-ancestor
111067192|NCT04465175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111067193|NCT04465175|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111067194|NCT04465175|Anticonvulsants|anticonvulsants|mesh-ancestor
111067195|NCT04465175|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111067196|NCT04465175|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111067197|NCT04465175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111067198|NCT04465175|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111067199|NCT04465175|Tocolytic Agents|tocolytic agents|mesh-ancestor
111067200|NCT04465175|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111067201|NCT03158883|Avelumab|avelumab|mesh-list
111067202|NCT03158883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111067203|NCT03158883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111067204|NCT03138447|Insulin|insulin|mesh-list
111067205|NCT03138447|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111067206|NCT03138447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111067207|NCT03109977|Pertuzumab|pertuzumab|mesh-list
111067208|NCT03109977|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111067209|NCT03109977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111067210|NCT03520595|Diclofenac|diclofenac|mesh-list
111067211|NCT03520595|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111067212|NCT03520595|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111067213|NCT03520595|Analgesics|analgesics|mesh-ancestor
111067214|NCT03520595|Sensory System Agents|sensory system agents|mesh-ancestor
111067215|NCT03520595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111067216|NCT03520595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111067217|NCT03520595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111067218|NCT03520595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111067219|NCT03520595|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111067220|NCT03520595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111067221|NCT03520595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111067222|NCT03520439|Mifepristone|mifepristone|mesh-list
111067223|NCT03520439|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
111067224|NCT03520439|Abortifacient Agents|abortifacient agents|mesh-ancestor
111067225|NCT03520439|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110637157|NCT00931086|Belimumab|belimumab|mesh-list
111067226|NCT03520439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111067227|NCT03520439|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111067228|NCT03520439|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111067229|NCT03520439|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111067230|NCT03520439|Contraceptive Agents|contraceptive agents|mesh-ancestor
111067231|NCT03520439|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
111067232|NCT03520439|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
111067233|NCT03520439|Hormone Antagonists|hormone antagonists|mesh-ancestor
111067234|NCT03520439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111067235|NCT03520439|Luteolytic Agents|luteolytic agents|mesh-ancestor
111067236|NCT03520439|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111067237|NCT03520439|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
111067238|NCT04543227|Analgesics, Opioid|analgesics, opioid|mesh-list
111067239|NCT04543227|Narcotics|narcotics|mesh-ancestor
111067240|NCT04543227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111067241|NCT04543227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111067242|NCT04543227|Analgesics|analgesics|mesh-ancestor
111067243|NCT04543227|Sensory System Agents|sensory system agents|mesh-ancestor
111067244|NCT04543227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111067245|NCT04542993|Zinc|zinc|mesh-list
111067246|NCT04542993|Resveratrol|resveratrol|mesh-list
111067247|NCT04542993|Picolinic acid|picolinic acid|mesh-list
111067248|NCT04542993|Trace Elements|trace elements|mesh-ancestor
111067249|NCT04542993|Micronutrients|micronutrients|mesh-ancestor
111067250|NCT04542993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111067252|NCT04542993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111067253|NCT04542993|Protective Agents|protective agents|mesh-ancestor
111067254|NCT04542993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111067255|NCT04542993|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111067256|NCT04542993|Iron Chelating Agents|iron chelating agents|mesh-ancestor
111067257|NCT04542993|Chelating Agents|chelating agents|mesh-ancestor
111067258|NCT04542993|Sequestering Agents|sequestering agents|mesh-ancestor
111067259|NCT03520361|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111067260|NCT02292173|Sorafenib|sorafenib|mesh-list
111067261|NCT02292173|Trametinib|trametinib|mesh-list
111067262|NCT02292173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111067263|NCT02292173|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111067264|NCT02292173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111067265|NCT02292173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111067266|NCT03517319|Botulinum Toxins|botulinum toxins|mesh-list
111067267|NCT03517319|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111067268|NCT03517319|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111067269|NCT03517319|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111067270|NCT03517319|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111067271|NCT03517319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111067272|NCT03517319|Cholinergic Agents|cholinergic agents|mesh-ancestor
111067273|NCT03517319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111067274|NCT03517319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111067275|NCT03517319|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111067276|NCT03517319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111067277|NCT03520049|Oseltamivir|oseltamivir|mesh-list
111067278|NCT03520049|Antiviral Agents|antiviral agents|mesh-ancestor
111067279|NCT03520049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111067280|NCT03520049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111067281|NCT03520049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111067282|NCT03517631|Busulfan|busulfan|mesh-list
111067283|NCT03517631|Alkylating Agents|alkylating agents|mesh-ancestor
111067284|NCT03517631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111067285|NCT03517631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111067286|NCT03517631|Immunologic Factors|immunologic factors|mesh-ancestor
111067287|NCT03517631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111067288|NCT03517631|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111067289|NCT03517631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111067290|NCT03517631|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111067291|NCT03516773|Parathyroid Hormone|parathyroid hormone|mesh-list
111067292|NCT03516773|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111067293|NCT03516773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111067294|NCT02461160|Midazolam|midazolam|mesh-list
111067295|NCT02461160|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111067296|NCT02461160|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111067297|NCT02461160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111067298|NCT02461160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111067299|NCT02461160|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111067300|NCT02461160|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111067301|NCT02461160|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111067302|NCT02461160|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111067303|NCT02461160|Anesthetics, General|anesthetics, general|mesh-ancestor
111067304|NCT02461160|Anesthetics|anesthetics|mesh-ancestor
111067305|NCT02461160|GABA Modulators|gaba modulators|mesh-ancestor
111067306|NCT02461160|GABA Agents|gaba agents|mesh-ancestor
111067307|NCT02461160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111067308|NCT02461160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111067309|NCT02296073|Fentanyl|fentanyl|mesh-list
111067310|NCT02296073|Midazolam|midazolam|mesh-list
111067311|NCT02296073|Dexmedetomidine|dexmedetomidine|mesh-list
111067312|NCT02296073|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111067313|NCT02296073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111067314|NCT02296073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110784423|NCT03652480|Glucocorticoids|glucocorticoids|mesh-ancestor
111067315|NCT02296073|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111067316|NCT02296073|Analgesics|analgesics|mesh-ancestor
111067317|NCT02296073|Sensory System Agents|sensory system agents|mesh-ancestor
111067318|NCT02296073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111067319|NCT02296073|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111067320|NCT02296073|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111067321|NCT02296073|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111067322|NCT02296073|Adrenergic Agents|adrenergic agents|mesh-ancestor
111067323|NCT02296073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111067324|NCT02296073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111067325|NCT02296073|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111067326|NCT02296073|Narcotics|narcotics|mesh-ancestor
111067327|NCT02296073|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111067328|NCT02296073|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111067329|NCT02296073|Anesthetics, General|anesthetics, general|mesh-ancestor
111067330|NCT02296073|Anesthetics|anesthetics|mesh-ancestor
111067331|NCT02296073|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111067332|NCT02296073|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111067333|NCT02296073|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111067334|NCT02296073|GABA Modulators|gaba modulators|mesh-ancestor
111067335|NCT02296073|GABA Agents|gaba agents|mesh-ancestor
111067336|NCT03132779|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
111067337|NCT03132779|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
111067338|NCT03132779|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
111067339|NCT03132779|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111067341|NCT02293187|Cholecalciferol|cholecalciferol|mesh-list
111067342|NCT02293187|Vitamins|vitamins|mesh-ancestor
111067343|NCT02293187|Micronutrients|micronutrients|mesh-ancestor
111067344|NCT02293187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111067345|NCT02293187|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111067346|NCT02293187|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111067347|NCT02296463|Vaccines|vaccines|mesh-list
111067348|NCT02296463|Immunologic Factors|immunologic factors|mesh-ancestor
111067349|NCT02296463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111067350|NCT02495168|Budesonide|budesonide|mesh-list
111067351|NCT02495168|Formoterol Fumarate|formoterol fumarate|mesh-list
111067352|NCT02495168|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
111067353|NCT02495168|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111067354|NCT02495168|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111067355|NCT02495168|Autonomic Agents|autonomic agents|mesh-ancestor
111067356|NCT02495168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111067357|NCT02495168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111067358|NCT02495168|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111067359|NCT02495168|Respiratory System Agents|respiratory system agents|mesh-ancestor
111067360|NCT02495168|Glucocorticoids|glucocorticoids|mesh-ancestor
111067361|NCT02495168|Hormones|hormones|mesh-ancestor
111067362|NCT02495168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111067363|NCT02495168|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111067364|NCT02495168|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111067365|NCT02495168|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111067366|NCT02495168|Adrenergic Agents|adrenergic agents|mesh-ancestor
111067367|NCT02495168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111067368|NCT02495168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111067369|NCT04934072|Denosumab|denosumab|mesh-list
111067370|NCT04934072|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111067371|NCT04934072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111067372|NCT03518489|Lappaconitine|lappaconitine|mesh-list
111067373|NCT03518489|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111067374|NCT03518489|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111067375|NCT03518489|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111067376|NCT03518489|Analgesics|analgesics|mesh-ancestor
111067377|NCT03518489|Sensory System Agents|sensory system agents|mesh-ancestor
111067378|NCT03518489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111067379|NCT03518489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111067380|NCT04933526|Dasatinib|dasatinib|mesh-list
111067381|NCT04933526|Flumatinib|flumatinib|mesh-list
111067382|NCT04933526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111067383|NCT04933526|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111067384|NCT04933526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111067385|NCT04933526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111067386|NCT02293889|Vitamin D|vitamin d|mesh-list
111067387|NCT02293889|Ergocalciferols|ergocalciferols|mesh-list
111067388|NCT02293889|Cholecalciferol|cholecalciferol|mesh-list
111067389|NCT02293889|Vitamins|vitamins|mesh-list
111067390|NCT02293889|Micronutrients|micronutrients|mesh-ancestor
111067391|NCT02293889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110784496|NCT03652714|Anesthetics|anesthetics|mesh-list
111067392|NCT02293889|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111067393|NCT02293889|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111067394|NCT02298335|Prednisone|prednisone|mesh-list
111067395|NCT02298335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111067396|NCT02298335|Glucocorticoids|glucocorticoids|mesh-ancestor
111067397|NCT02298335|Hormones|hormones|mesh-ancestor
111067398|NCT02298335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111067399|NCT02298335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111067400|NCT02298335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111067401|NCT02298335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111067402|NCT03514667|Curcumin|curcumin|mesh-list
111067403|NCT03514667|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111067404|NCT03514667|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111067405|NCT03514667|Analgesics|analgesics|mesh-ancestor
111067406|NCT03514667|Sensory System Agents|sensory system agents|mesh-ancestor
111067407|NCT03514667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111067408|NCT03514667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111067409|NCT03514667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111067410|NCT03514667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111067411|NCT03514667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111067412|NCT03514667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111067413|NCT03514667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111067414|NCT04465097|Exemestane|exemestane|mesh-list
111067415|NCT04465097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111067416|NCT04465097|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111067417|NCT04465097|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111067418|NCT04465097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111067419|NCT04465097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111067420|NCT04465097|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111067421|NCT04465097|Hormone Antagonists|hormone antagonists|mesh-ancestor
111067422|NCT04465097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111067423|NCT04465097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111067424|NCT02493764|Tazobactam|tazobactam|mesh-list
111067425|NCT02493764|Linezolid|linezolid|mesh-list
111067426|NCT02493764|Piperacillin|piperacillin|mesh-list
111067427|NCT02493764|Imipenem|imipenem|mesh-list
111067428|NCT02493764|Relebactam|relebactam|mesh-list
111067429|NCT02493764|Cilastatin|cilastatin|mesh-list
111067430|NCT02493764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111067431|NCT02493764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111067432|NCT02493764|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
111067433|NCT02493764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111067434|NCT02493764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111067435|NCT02493764|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111067436|NCT02493764|Protease Inhibitors|protease inhibitors|mesh-ancestor
111067437|NCT02297477|Artesunate|artesunate|mesh-list
111067438|NCT02297477|Atovaquone|atovaquone|mesh-list
111067439|NCT02297477|Proguanil|proguanil|mesh-list
111067440|NCT02297477|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
111067441|NCT02297477|Antimalarials|antimalarials|mesh-ancestor
111067442|NCT02297477|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111067443|NCT02297477|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111067444|NCT02297477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111067445|NCT02297477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111067446|NCT02297477|Antiviral Agents|antiviral agents|mesh-ancestor
111067447|NCT02297477|Schistosomicides|schistosomicides|mesh-ancestor
111067448|NCT02297477|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
111067449|NCT02297477|Anthelmintics|anthelmintics|mesh-ancestor
111067450|NCT02297477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111067451|NCT02297477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111067452|NCT02297477|Antimetabolites|antimetabolites|mesh-ancestor
111067453|NCT02460380|Vitamin D|vitamin d|mesh-list
111067454|NCT02460380|Cholecalciferol|cholecalciferol|mesh-list
111067455|NCT02460380|Vitamins|vitamins|mesh-ancestor
111067456|NCT02460380|Micronutrients|micronutrients|mesh-ancestor
111067457|NCT02460380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111067458|NCT02460380|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111067459|NCT02460380|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111067460|NCT02299115|Prednisolone|prednisolone|mesh-list
111067461|NCT02299115|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111067462|NCT02299115|Methylprednisolone|methylprednisolone|mesh-list
111067463|NCT02299115|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111067464|NCT02299115|Prednisolone acetate|prednisolone acetate|mesh-list
111067465|NCT02299115|Vigabatrin|vigabatrin|mesh-list
111067466|NCT02299115|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111067467|NCT02299115|Prednisolone phosphate|prednisolone phosphate|mesh-list
111067468|NCT02299115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111067470|NCT02299115|Hormones|hormones|mesh-ancestor
111067471|NCT02299115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111067472|NCT02299115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111067473|NCT02299115|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111067474|NCT02299115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111067475|NCT02299115|Antiemetics|antiemetics|mesh-ancestor
111067476|NCT02299115|Autonomic Agents|autonomic agents|mesh-ancestor
111067477|NCT02299115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111067478|NCT02299115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111067479|NCT02299115|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111067480|NCT02299115|Protective Agents|protective agents|mesh-ancestor
111067481|NCT02299115|Anticonvulsants|anticonvulsants|mesh-ancestor
111067482|NCT02299115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111067483|NCT02299115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111067484|NCT02299115|GABA Agents|gaba agents|mesh-ancestor
111067485|NCT02299115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111067486|NCT02297945|Metyrapone|metyrapone|mesh-list
111067487|NCT02297945|Antimetabolites|antimetabolites|mesh-ancestor
111067488|NCT02297945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111067489|NCT02297945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111067490|NCT02492984|Factor VIII|factor viii|mesh-list
111067491|NCT02492984|Coagulants|coagulants|mesh-ancestor
111067492|NCT03132623|Andrographolide|andrographolide|mesh-list
111067493|NCT03132623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111067494|NCT03132623|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111067495|NCT03132623|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111067496|NCT03132623|Analgesics|analgesics|mesh-ancestor
111067497|NCT03132623|Sensory System Agents|sensory system agents|mesh-ancestor
111067498|NCT03132623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111067499|NCT03132623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111067500|NCT03132623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111067501|NCT03132623|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111067502|NCT03132623|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111067503|NCT03132623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111067504|NCT03132623|Antiviral Agents|antiviral agents|mesh-ancestor
111067505|NCT03132623|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111067506|NCT03514979|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
111067507|NCT03514979|Immunologic Factors|immunologic factors|mesh-ancestor
111067508|NCT03514979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111067509|NCT02298101|Edetic Acid|edetic acid|mesh-list
111067510|NCT02298101|Pentetic Acid|pentetic acid|mesh-list
111067511|NCT02298101|Antidotes|antidotes|mesh-ancestor
111067512|NCT02298101|Protective Agents|protective agents|mesh-ancestor
111067513|NCT02298101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111067514|NCT02298101|Chelating Agents|chelating agents|mesh-ancestor
111067515|NCT02298101|Sequestering Agents|sequestering agents|mesh-ancestor
111067516|NCT02298101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111067517|NCT02298101|Iron Chelating Agents|iron chelating agents|mesh-ancestor
111067518|NCT02298101|Anticoagulants|anticoagulants|mesh-ancestor
111067519|NCT02298101|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
111067520|NCT02491892|Pertuzumab|pertuzumab|mesh-list
111067521|NCT02491892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111067522|NCT02491892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111067523|NCT03476811|Analgesics|analgesics|mesh-list
111067524|NCT03476811|Bupivacaine|bupivacaine|mesh-list
111067525|NCT03476811|Anesthetics, Local|anesthetics, local|mesh-ancestor
111067526|NCT03476811|Anesthetics|anesthetics|mesh-ancestor
111067527|NCT03476811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111067528|NCT03476811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111067529|NCT03476811|Sensory System Agents|sensory system agents|mesh-ancestor
111067530|NCT03476811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111067531|NCT02834403|Aspirin|aspirin|mesh-list
111067532|NCT02834403|Docetaxel|docetaxel|mesh-list
111067533|NCT02834403|Amlodipine|amlodipine|mesh-list
111067534|NCT02834403|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
111067535|NCT02834403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111067536|NCT02834403|Tubulin Modulators|tubulin modulators|mesh-ancestor
111067537|NCT02834403|Antimitotic Agents|antimitotic agents|mesh-ancestor
111067538|NCT02834403|Mitosis Modulators|mitosis modulators|mesh-ancestor
111067539|NCT02834403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111067540|NCT02834403|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111067541|NCT02834403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111067542|NCT02834403|Analgesics|analgesics|mesh-ancestor
111067543|NCT02834403|Sensory System Agents|sensory system agents|mesh-ancestor
111067544|NCT02834403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111067545|NCT02834403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111067547|NCT02834403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111067548|NCT02834403|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111067549|NCT02834403|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111067550|NCT02834403|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111067552|NCT02834403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111067553|NCT02834403|Antipyretics|antipyretics|mesh-ancestor
111067554|NCT02834403|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111067555|NCT02834403|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111067556|NCT02834403|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111067557|NCT02834403|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111067558|NCT02834403|Vasodilator Agents|vasodilator agents|mesh-ancestor
111067559|NCT02299271|Ropivacaine|ropivacaine|mesh-list
111067560|NCT02299271|Anesthetics, Local|anesthetics, local|mesh-ancestor
111067561|NCT02299271|Anesthetics|anesthetics|mesh-ancestor
111067562|NCT02299271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111067563|NCT02299271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111067564|NCT02299271|Sensory System Agents|sensory system agents|mesh-ancestor
111067565|NCT02299271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111067566|NCT02302469|Lenalidomide|lenalidomide|mesh-list
111067567|NCT02302469|Immunologic Factors|immunologic factors|mesh-ancestor
111067568|NCT02302469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111067569|NCT02302469|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111067570|NCT02302469|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111067571|NCT02302469|Growth Substances|growth substances|mesh-ancestor
111067572|NCT02302469|Growth Inhibitors|growth inhibitors|mesh-ancestor
111067573|NCT02302469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111067574|NCT02302547|Ritonavir|ritonavir|mesh-list
111067575|NCT02302547|Lopinavir|lopinavir|mesh-list
111067576|NCT02302547|Atazanavir Sulfate|atazanavir sulfate|mesh-list
111067577|NCT02302547|Darunavir|darunavir|mesh-list
111067578|NCT02302547|Indinavir|indinavir|mesh-list
111067579|NCT02302547|Saquinavir|saquinavir|mesh-list
111067580|NCT02302547|Fosamprenavir|fosamprenavir|mesh-list
111067581|NCT02302547|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
111067582|NCT02302547|Tenofovir|tenofovir|mesh-list
111067583|NCT02302547|Emtricitabine|emtricitabine|mesh-list
111067584|NCT02302547|Raltegravir Potassium|raltegravir potassium|mesh-list
111067585|NCT02302547|Nevirapine|nevirapine|mesh-list
111067586|NCT02302547|Dolutegravir|dolutegravir|mesh-list
111067587|NCT02302547|Maraviroc|maraviroc|mesh-list
111067588|NCT02302547|Cobicistat|cobicistat|mesh-list
111067589|NCT02302547|Rilpivirine|rilpivirine|mesh-list
111067590|NCT02302547|Tipranavir|tipranavir|mesh-list
111067591|NCT02302547|Enfuvirtide|enfuvirtide|mesh-list
111067592|NCT02302547|Elvitegravir|elvitegravir|mesh-list
111067593|NCT02302547|Efavirenz|efavirenz|mesh-list
111067594|NCT02302547|Etravirine|etravirine|mesh-list
111067595|NCT02302547|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
111067596|NCT02302547|Protease Inhibitors|protease inhibitors|mesh-list
111067597|NCT02302547|Integrase Inhibitors|integrase inhibitors|mesh-list
111067598|NCT02302547|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111067599|NCT02302547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111067600|NCT02302547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111067601|NCT02302547|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111067602|NCT02302547|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111067603|NCT02302547|Antiviral Agents|antiviral agents|mesh-ancestor
111067604|NCT02302547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111067605|NCT02302547|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111067606|NCT02302547|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111067607|NCT02302547|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111067608|NCT02302547|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111067609|NCT02302547|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111067610|NCT02302547|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111067611|NCT02302547|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110637229|NCT00933426|Paclitaxel|paclitaxel|mesh-list
111067612|NCT02302547|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111067613|NCT02302547|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111067614|NCT02302547|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
111067615|NCT02302547|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
111067616|NCT02302547|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
111067617|NCT01190787|Prednisone|prednisone|mesh-list
111067618|NCT01190787|Cyclophosphamide|cyclophosphamide|mesh-list
111067619|NCT01190787|Melphalan|melphalan|mesh-list
110784725|NCT01104987|Alendronate|alendronate|mesh-list
111067620|NCT01190787|Bortezomib|bortezomib|mesh-list
111067621|NCT01190787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111067622|NCT01190787|Immunologic Factors|immunologic factors|mesh-ancestor
111067623|NCT01190787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111067624|NCT01190787|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110828014|NCT01171885|Anesthetics, Local|anesthetics, local|mesh-ancestor
111067625|NCT01190787|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111067626|NCT01190787|Alkylating Agents|alkylating agents|mesh-ancestor
111067627|NCT01190787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111067628|NCT01190787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111067629|NCT01190787|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111067630|NCT01190787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111067632|NCT01190787|Hormones|hormones|mesh-ancestor
111067633|NCT01190787|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111067634|NCT01190787|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111067635|NCT03515369|Liver Extracts|liver extracts|mesh-list
111067636|NCT03515369|Hematinics|hematinics|mesh-ancestor
111067637|NCT02634411|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111067638|NCT02634411|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
111067639|NCT02634411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111067640|NCT02634411|Antitubercular Agents|antitubercular agents|mesh-ancestor
111067641|NCT03513575|Chlorhexidine|chlorhexidine|mesh-list
111067642|NCT03513575|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111067643|NCT03513575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111067644|NCT03513575|Disinfectants|disinfectants|mesh-ancestor
111067645|NCT03334461|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
111067646|NCT03334461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111067647|NCT03252093|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
111067648|NCT03252093|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111067649|NCT03252093|Vasodilator Agents|vasodilator agents|mesh-ancestor
111067650|NCT03510611|Ensartinib|ensartinib|mesh-list
111067651|NCT03510611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111067652|NCT03510611|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111067653|NCT03510611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111067654|NCT03510611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111067655|NCT02299817|Denosumab|denosumab|mesh-list
111067656|NCT02299817|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111067657|NCT02299817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111067658|NCT01679613|Ketoconazole|ketoconazole|mesh-list
111067659|NCT01679613|Nintedanib|nintedanib|mesh-list
111067660|NCT01679613|Antifungal Agents|antifungal agents|mesh-ancestor
111067661|NCT01679613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111067662|NCT01679613|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111067663|NCT01679613|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111067664|NCT01679613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111067665|NCT01679613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111067666|NCT01679613|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111067667|NCT01679613|Hormone Antagonists|hormone antagonists|mesh-ancestor
111067668|NCT01679613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111067669|NCT01679613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111067670|NCT01679613|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111067671|NCT01679613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111067672|NCT01679613|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111067673|NCT02489630|Ketamine|ketamine|mesh-list
111067674|NCT02489630|Analgesics|analgesics|mesh-list
111067675|NCT02489630|Sensory System Agents|sensory system agents|mesh-ancestor
111067676|NCT02489630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111067677|NCT02489630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111067678|NCT02489630|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111067679|NCT02489630|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111067680|NCT02489630|Anesthetics, General|anesthetics, general|mesh-ancestor
111067681|NCT02489630|Anesthetics|anesthetics|mesh-ancestor
111067682|NCT02489630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111067683|NCT02489630|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111067684|NCT02489630|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111067685|NCT02489630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111067686|NCT02489630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111067687|NCT05089539|Valsartan|valsartan|mesh-list
111067688|NCT05089539|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
111067689|NCT05089539|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111067690|NCT05089539|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111067691|NCT05089539|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111067692|NCT05089539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111067693|NCT05089383|Progesterone|progesterone|mesh-list
111067694|NCT05089383|Progestins|progestins|mesh-ancestor
111067695|NCT05089383|Hormones|hormones|mesh-ancestor
111067696|NCT05089383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111067697|NCT05089383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111067698|NCT03510533|Autoantibodies|autoantibodies|mesh-list
111067700|NCT03510533|Immunologic Factors|immunologic factors|mesh-ancestor
111067701|NCT03510533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111067702|NCT03510533|Hormones|hormones|mesh-ancestor
111067703|NCT03510533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111067704|NCT03512873|Tranilast|tranilast|mesh-list
111067705|NCT03512873|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111067706|NCT03512873|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111067707|NCT03512873|Analgesics|analgesics|mesh-ancestor
111067708|NCT03512873|Sensory System Agents|sensory system agents|mesh-ancestor
111067709|NCT03512873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111067710|NCT03512873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111067711|NCT03512873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111067712|NCT03512873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111067713|NCT03512873|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111067714|NCT03512873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111067715|NCT03512873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111067716|NCT03512873|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111067717|NCT03512873|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111067718|NCT03512873|Histamine Antagonists|histamine antagonists|mesh-ancestor
111067719|NCT03512873|Histamine Agents|histamine agents|mesh-ancestor
111067720|NCT03512873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111067721|NCT03512873|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111067722|NCT03512873|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111067723|NCT01678911|Gabapentin|gabapentin|mesh-list
111067724|NCT01678911|Analgesics|analgesics|mesh-ancestor
111067725|NCT01678911|Sensory System Agents|sensory system agents|mesh-ancestor
111067726|NCT01678911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111067727|NCT01678911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111067728|NCT01678911|Anticonvulsants|anticonvulsants|mesh-ancestor
111067729|NCT01678911|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111067730|NCT01678911|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111067731|NCT01678911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111067732|NCT01678911|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111067733|NCT01678911|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111067734|NCT01678911|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111067735|NCT01678911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111067736|NCT01678911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111067737|NCT01678911|Antimanic Agents|antimanic agents|mesh-ancestor
111067738|NCT03132701|Magnesium Sulfate|magnesium sulfate|mesh-list
111067739|NCT03132701|Analgesics|analgesics|mesh-ancestor
111067740|NCT03132701|Sensory System Agents|sensory system agents|mesh-ancestor
111067741|NCT03132701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111067742|NCT03132701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111067743|NCT03132701|Anesthetics|anesthetics|mesh-ancestor
111067744|NCT03132701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111067745|NCT03132701|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111067746|NCT03132701|Anticonvulsants|anticonvulsants|mesh-ancestor
111067747|NCT03132701|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111067748|NCT03132701|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111067749|NCT03132701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111067750|NCT03132701|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111067751|NCT03132701|Tocolytic Agents|tocolytic agents|mesh-ancestor
111067752|NCT03132701|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111067753|NCT02322099|Alendronate|alendronate|mesh-list
111067754|NCT02322099|Cholecalciferol|cholecalciferol|mesh-list
111067755|NCT02322099|Vitamin D|vitamin d|mesh-list
111067756|NCT02322099|Tenofovir|tenofovir|mesh-list
111067757|NCT02322099|Calcium Carbonate|calcium carbonate|mesh-list
111067758|NCT02322099|Calcium|calcium|mesh-list
111067759|NCT02322099|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111067760|NCT02322099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111067761|NCT02322099|Antiviral Agents|antiviral agents|mesh-ancestor
111067762|NCT02322099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111067763|NCT02322099|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111067764|NCT02322099|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111067765|NCT02322099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111067766|NCT02322099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111067767|NCT02322099|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111067768|NCT02322099|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110784871|NCT04537923|Insulin Lispro|insulin lispro|mesh-list
111067769|NCT02322099|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111067771|NCT02322099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111067772|NCT02322099|Vitamins|vitamins|mesh-ancestor
111067773|NCT02322099|Micronutrients|micronutrients|mesh-ancestor
111067774|NCT02487446|Glycopyrrolate|glycopyrrolate|mesh-list
111067775|NCT02487446|Bromides|bromides|mesh-list
111067776|NCT02487446|Anticonvulsants|anticonvulsants|mesh-ancestor
111067777|NCT02487446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111067778|NCT02487446|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111067779|NCT02487446|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111067780|NCT02487446|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111067781|NCT02487446|Cholinergic Agents|cholinergic agents|mesh-ancestor
111067782|NCT02487446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111067783|NCT02487446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111067784|NCT05081349|Hydroxyurea|hydroxyurea|mesh-list
111067785|NCT05081349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111067786|NCT05081349|Antisickling Agents|antisickling agents|mesh-ancestor
111067787|NCT05081349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111067788|NCT05081349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111067789|NCT05081349|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111067790|NCT02303327|Androgens|androgens|mesh-list
111067791|NCT02303327|Hormones|hormones|mesh-ancestor
111067792|NCT02303327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111067793|NCT02303327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111067794|NCT03510221|Antioxidants|antioxidants|mesh-list
111067795|NCT03510221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111067796|NCT03510221|Protective Agents|protective agents|mesh-ancestor
111067797|NCT03510221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111067798|NCT03509831|Irsogladine|irsogladine|mesh-list
111067799|NCT03509831|Nizatidine|nizatidine|mesh-list
111067800|NCT03509831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111067801|NCT03509831|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111067802|NCT03509831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111067803|NCT03509831|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
111067804|NCT03509831|Histamine Antagonists|histamine antagonists|mesh-ancestor
111067805|NCT03509831|Histamine Agents|histamine agents|mesh-ancestor
111067806|NCT03509831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111067807|NCT03509831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111067808|NCT03509831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111067809|NCT03509831|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111067810|NCT03509831|Protective Agents|protective agents|mesh-ancestor
111067811|NCT03509831|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
111067812|NCT02303483|Niacinamide|niacinamide|mesh-list
111067813|NCT02303483|Niacin|niacin|mesh-list
111067814|NCT02303483|Nicotinic Acids|nicotinic acids|mesh-list
111067815|NCT02303483|Vitamin B Complex|vitamin b complex|mesh-ancestor
111067816|NCT02303483|Vitamins|vitamins|mesh-ancestor
111067817|NCT02303483|Micronutrients|micronutrients|mesh-ancestor
111067818|NCT02303483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111067819|NCT02303483|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111067820|NCT02303483|Antimetabolites|antimetabolites|mesh-ancestor
111067821|NCT02303483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111067822|NCT02303483|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111067823|NCT02303483|Vasodilator Agents|vasodilator agents|mesh-ancestor
111067824|NCT05378061|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
111067825|NCT05378061|Growth Substances|growth substances|mesh-ancestor
111067826|NCT05378061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111067827|NCT05378061|Vasodilator Agents|vasodilator agents|mesh-ancestor
111067828|NCT05378061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111067829|NCT05378061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111067830|NCT02303639|Amiodarone|amiodarone|mesh-list
111067831|NCT02303639|Sotalol|sotalol|mesh-list
111067832|NCT02303639|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
111067833|NCT02303639|Vasodilator Agents|vasodilator agents|mesh-ancestor
111067834|NCT02303639|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
111067835|NCT02303639|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111067836|NCT02303639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111067837|NCT02303639|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111067838|NCT02303639|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111067839|NCT02303639|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111067840|NCT02303639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111067841|NCT02303639|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111067842|NCT02303639|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111067843|NCT02303639|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111067844|NCT02303639|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111067845|NCT02303639|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111067846|NCT02303639|Adrenergic Agents|adrenergic agents|mesh-ancestor
111067847|NCT02303639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111067848|NCT02303639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111067849|NCT02303639|Sympatholytics|sympatholytics|mesh-ancestor
111067850|NCT02303639|Autonomic Agents|autonomic agents|mesh-ancestor
111067851|NCT02303639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111067852|NCT02303873|Alendronate|alendronate|mesh-list
111067853|NCT02303873|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111067854|NCT02303873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111067855|NCT04757493|Prucalopride|prucalopride|mesh-list
111067856|NCT04757493|Laxatives|laxatives|mesh-ancestor
111067857|NCT04757493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111067858|NCT04757493|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
111067859|NCT04757493|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111067860|NCT04757493|Serotonin Agents|serotonin agents|mesh-ancestor
111067861|NCT04757493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111067862|NCT04757493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111067863|NCT04757493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111067864|NCT02303951|Atezolizumab|atezolizumab|mesh-list
111067865|NCT02303951|Vemurafenib|vemurafenib|mesh-list
111067866|NCT02303951|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111067867|NCT02303951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111067868|NCT02303951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111067869|NCT02303951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111067870|NCT02303951|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111067871|NCT02303951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111067873|NCT04406415|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111067874|NCT04406415|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111067875|NCT04406415|Analgesics|analgesics|mesh-ancestor
111067876|NCT04406415|Sensory System Agents|sensory system agents|mesh-ancestor
111067877|NCT04406415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111067878|NCT04406415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111067879|NCT04406415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111067880|NCT04406415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111067881|NCT04406415|Anticoagulants|anticoagulants|mesh-ancestor
111067882|NCT04406415|Protease Inhibitors|protease inhibitors|mesh-ancestor
111067883|NCT04406415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111067884|NCT04406415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111067885|NCT04406415|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
111067886|NCT04406415|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111067887|NCT04406415|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
111067888|NCT04406415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111067889|NCT04406415|Immunologic Factors|immunologic factors|mesh-ancestor
111067890|NCT02304107|Letrozole|letrozole|mesh-list
111067891|NCT02304107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111067892|NCT02304107|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111067893|NCT02304107|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111067894|NCT02304107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111067895|NCT02304107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111067896|NCT02304107|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111067897|NCT02304107|Hormone Antagonists|hormone antagonists|mesh-ancestor
111067898|NCT02304107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111067899|NCT02304107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111067900|NCT03509285|Cenobamate|cenobamate|mesh-list
111067901|NCT03509285|Alprazolam|alprazolam|mesh-list
111067902|NCT03509285|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111067903|NCT03509285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111067904|NCT03509285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111067905|NCT03509285|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111067906|NCT03509285|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111067907|NCT03509285|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111067908|NCT03509285|GABA Modulators|gaba modulators|mesh-ancestor
111067909|NCT03509285|GABA Agents|gaba agents|mesh-ancestor
111067910|NCT03509285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111067911|NCT03509285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111067912|NCT03509285|Anticonvulsants|anticonvulsants|mesh-ancestor
111067913|NCT02300363|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
111067914|NCT02300363|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110785020|NCT03942861|Antiemetics|antiemetics|mesh-ancestor
111067915|NCT02300363|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111067916|NCT02300363|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111067917|NCT02300363|Antimetabolites|antimetabolites|mesh-ancestor
111067918|NCT02300363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111067919|NCT02300363|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111067920|NCT02300363|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111067921|NCT02300363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111067922|NCT02300363|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111067923|NCT02300363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111067924|NCT02300363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111067926|NCT03135795|Sufentanil|sufentanil|mesh-list
111067927|NCT03135795|Dexmedetomidine|dexmedetomidine|mesh-list
111067928|NCT03135795|Remifentanil|remifentanil|mesh-list
111067929|NCT03135795|Dsuvia|dsuvia|mesh-list
111067930|NCT03135795|Bromides|bromides|mesh-list
111067931|NCT03135795|Propofol|propofol|mesh-list
111067932|NCT03135795|Sevoflurane|sevoflurane|mesh-list
111067933|NCT03135795|Citric Acid|citric acid|mesh-list
111067934|NCT03135795|Sodium Citrate|sodium citrate|mesh-list
111067935|NCT03135795|Rocuronium|rocuronium|mesh-list
111067936|NCT03135795|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111067937|NCT03135795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111067938|NCT03135795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111067939|NCT03135795|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111067940|NCT03135795|Analgesics|analgesics|mesh-ancestor
111067941|NCT03135795|Sensory System Agents|sensory system agents|mesh-ancestor
111067942|NCT03135795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111067943|NCT03135795|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111067944|NCT03135795|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111067945|NCT03135795|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111067946|NCT03135795|Adrenergic Agents|adrenergic agents|mesh-ancestor
111067947|NCT03135795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111067948|NCT03135795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111067949|NCT03135795|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111067950|NCT03135795|Anesthetics, General|anesthetics, general|mesh-ancestor
111067951|NCT03135795|Anesthetics|anesthetics|mesh-ancestor
111067952|NCT03135795|Anticoagulants|anticoagulants|mesh-ancestor
111067953|NCT03135795|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
111067954|NCT03135795|Chelating Agents|chelating agents|mesh-ancestor
111067955|NCT03135795|Sequestering Agents|sequestering agents|mesh-ancestor
111067956|NCT03135795|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111067957|NCT03135795|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111067958|NCT03135795|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111067959|NCT03135795|Narcotics|narcotics|mesh-ancestor
111067960|NCT03135795|Anticonvulsants|anticonvulsants|mesh-ancestor
111067961|NCT03135795|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
111067962|NCT03135795|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
111067963|NCT03135795|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111067964|NCT03135795|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111067965|NCT03135795|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111067966|NCT03135795|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111067967|NCT03135795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111067968|NCT03135795|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111067969|NCT03135795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111067970|NCT03135795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111067971|NCT04958967|Aflutinib|aflutinib|mesh-list
111067972|NCT04958967|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111067973|NCT04958967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111067974|NCT04958967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111067975|NCT03469531|Cisplatin|cisplatin|mesh-list
111067976|NCT03469531|Nimotuzumab|nimotuzumab|mesh-list
111067977|NCT03469531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111067978|NCT03469531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111067979|NCT03309007|Metformin|metformin|mesh-list
111067980|NCT03309007|Calcium Carbonate|calcium carbonate|mesh-list
111067981|NCT03309007|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111067982|NCT03309007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111067983|NCT03309007|Antacids|antacids|mesh-ancestor
111067984|NCT03309007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111067985|NCT03309007|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111067986|NCT03508817|Atropine|atropine|mesh-list
111067987|NCT03508817|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111067988|NCT03508817|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111067989|NCT03508817|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111067990|NCT03508817|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110637291|NCT01563939|Analgesics|analgesics|mesh-ancestor
111067991|NCT03508817|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111067992|NCT03508817|Autonomic Agents|autonomic agents|mesh-ancestor
111067993|NCT03508817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111067994|NCT03508817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111067995|NCT03508817|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111067996|NCT03508817|Respiratory System Agents|respiratory system agents|mesh-ancestor
111067998|NCT03508817|Parasympatholytics|parasympatholytics|mesh-ancestor
111067999|NCT03508817|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111068000|NCT03508817|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111068001|NCT03508817|Cholinergic Agents|cholinergic agents|mesh-ancestor
111068002|NCT03508817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111068003|NCT03508817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111068004|NCT05158777|Vaccines|vaccines|mesh-list
111068005|NCT05158777|Immunologic Factors|immunologic factors|mesh-ancestor
111068006|NCT05158777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111068007|NCT01678209|Methylphenidate|methylphenidate|mesh-list
111068008|NCT01678209|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
111068009|NCT01678209|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111068010|NCT01678209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111068011|NCT01678209|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111068012|NCT01678209|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111068013|NCT01678209|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111068014|NCT01678209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111068015|NCT01678209|Dopamine Agents|dopamine agents|mesh-ancestor
111068016|NCT01678209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111068017|NCT01678209|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111068018|NCT01678209|Adrenergic Agents|adrenergic agents|mesh-ancestor
111068019|NCT02239120|Dabigatran|dabigatran|mesh-list
111068020|NCT02239120|Antithrombins|antithrombins|mesh-ancestor
111068021|NCT02239120|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111068022|NCT02239120|Protease Inhibitors|protease inhibitors|mesh-ancestor
111068023|NCT02239120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111068024|NCT02239120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111068025|NCT02239120|Anticoagulants|anticoagulants|mesh-ancestor
111068026|NCT04464863|Metronidazole|metronidazole|mesh-list
111068027|NCT04464863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111068028|NCT04464863|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111068029|NCT04464863|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111068030|NCT04464863|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111068031|NCT05158699|Dexamethasone|dexamethasone|mesh-list
111068032|NCT05158699|Dexamethasone acetate|dexamethasone acetate|mesh-list
111068033|NCT05158699|Triamcinolone|triamcinolone|mesh-list
111068034|NCT05158699|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
111068035|NCT05158699|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
111068036|NCT05158699|Ketorolac|ketorolac|mesh-list
111068037|NCT05158699|Bromfenac|bromfenac|mesh-list
111068038|NCT05158699|Phenylephrine|phenylephrine|mesh-list
111068039|NCT05158699|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111068040|NCT05158699|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111068041|NCT05158699|BB 1101|bb 1101|mesh-list
111068042|NCT05158699|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
111068043|NCT05158699|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111068044|NCT05158699|Antiemetics|antiemetics|mesh-ancestor
111068045|NCT05158699|Autonomic Agents|autonomic agents|mesh-ancestor
111068046|NCT05158699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111068047|NCT05158699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111068048|NCT05158699|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111068049|NCT05158699|Glucocorticoids|glucocorticoids|mesh-ancestor
111068050|NCT05158699|Hormones|hormones|mesh-ancestor
111068051|NCT05158699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111068052|NCT05158699|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111068053|NCT05158699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111068054|NCT05158699|Protease Inhibitors|protease inhibitors|mesh-ancestor
111068055|NCT05158699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111068056|NCT05158699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111068057|NCT05158699|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111068058|NCT05158699|Immunologic Factors|immunologic factors|mesh-ancestor
111068059|NCT05158699|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111068060|NCT05158699|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111068061|NCT05158699|Analgesics|analgesics|mesh-ancestor
111068062|NCT05158699|Sensory System Agents|sensory system agents|mesh-ancestor
111068063|NCT05158699|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111068064|NCT05158699|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111068066|NCT05158699|Mydriatics|mydriatics|mesh-ancestor
111068067|NCT05158699|Sympathomimetics|sympathomimetics|mesh-ancestor
111068068|NCT05158699|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111068069|NCT05158699|Nasal Decongestants|nasal decongestants|mesh-ancestor
111068070|NCT05158699|Respiratory System Agents|respiratory system agents|mesh-ancestor
111068071|NCT05158699|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111068072|NCT05158699|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111068073|NCT05158699|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111068074|NCT05158699|Adrenergic Agents|adrenergic agents|mesh-ancestor
111068075|NCT05158699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111068076|NCT05158699|Protective Agents|protective agents|mesh-ancestor
111068077|NCT02304887|Denosumab|denosumab|mesh-list
111068078|NCT02304887|Teriparatide|teriparatide|mesh-list
111068079|NCT02304887|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111068080|NCT02304887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111068081|NCT02304887|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111068082|NCT03474133|Brentuximab Vedotin|brentuximab vedotin|mesh-list
111068083|NCT03474133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111068084|NCT03474133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111068085|NCT03474133|Immunotoxins|immunotoxins|mesh-ancestor
111068086|NCT03474133|Immunoconjugates|immunoconjugates|mesh-ancestor
111068087|NCT03474133|Immunologic Factors|immunologic factors|mesh-ancestor
111068088|NCT03474133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111068089|NCT03512171|Amphetamine|amphetamine|mesh-list
111068090|NCT03512171|Dextroamphetamine|dextroamphetamine|mesh-list
111068091|NCT03512171|Fallypride|fallypride|mesh-list
111068092|NCT03512171|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111068093|NCT03512171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111068094|NCT03512171|Sympathomimetics|sympathomimetics|mesh-ancestor
111068095|NCT03512171|Autonomic Agents|autonomic agents|mesh-ancestor
111068096|NCT03512171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111068097|NCT03512171|Dopamine Agents|dopamine agents|mesh-ancestor
111068098|NCT03512171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111068099|NCT03512171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111068100|NCT03512171|Adrenergic Agents|adrenergic agents|mesh-ancestor
111068101|NCT03512171|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111068102|NCT03512171|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111068103|NCT03512171|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111068104|NCT03512171|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111068105|NCT03512171|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111068106|NCT03512171|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111068107|NCT03739099|Pancrelipase|pancrelipase|mesh-list
111068108|NCT03739099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111068109|NCT02305199|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111068110|NCT03469375|Folfirinox|folfirinox|mesh-list
111068111|NCT03469375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111068112|NCT01603407|Prednisone|prednisone|mesh-list
111068113|NCT01603407|Deflazacort|deflazacort|mesh-list
111068114|NCT01603407|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111068115|NCT01603407|Glucocorticoids|glucocorticoids|mesh-ancestor
111068116|NCT01603407|Hormones|hormones|mesh-ancestor
111068117|NCT01603407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111068118|NCT01603407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111068119|NCT01603407|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111068120|NCT01603407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111068121|NCT01603407|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111068122|NCT01603407|Immunologic Factors|immunologic factors|mesh-ancestor
111068123|NCT02305355|Atorvastatin|atorvastatin|mesh-list
110637311|NCT00990639|Candesartan|candesartan|mesh-list
111068124|NCT02305355|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111068125|NCT02305355|Simvastatin|simvastatin|mesh-list
111068126|NCT02305355|Pravastatin|pravastatin|mesh-list
111068127|NCT02305355|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111068128|NCT02305355|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111068129|NCT02305355|Antimetabolites|antimetabolites|mesh-ancestor
111068130|NCT02305355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111068131|NCT02305355|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111068132|NCT02305355|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111068133|NCT02305355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111068134|NCT03511703|Apatinib|apatinib|mesh-list
111068135|NCT03511703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111068136|NCT03511703|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111068137|NCT03511703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111068138|NCT03511703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111068139|NCT05157295|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111068140|NCT05157295|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111068141|NCT05157295|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111068142|NCT05157295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110785247|NCT01113489|Beclomethasone|beclomethasone|mesh-list
111068143|NCT05157295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111068144|NCT05157295|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111068145|NCT05157295|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111068146|NCT05157295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111068147|NCT05157295|Cholinergic Agents|cholinergic agents|mesh-ancestor
111068148|NCT05157295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111068150|NCT02301221|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111068151|NCT02301221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111068152|NCT03122431|Hydroxychloroquine|hydroxychloroquine|mesh-list
111068153|NCT03122431|Thalidomide|thalidomide|mesh-list
111068154|NCT03122431|Antimalarials|antimalarials|mesh-ancestor
111068155|NCT03122431|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111068156|NCT03122431|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111068157|NCT03122431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111068158|NCT03122431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111068159|NCT03122431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111068160|NCT03122431|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111068161|NCT03122431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111068162|NCT03122431|Immunologic Factors|immunologic factors|mesh-ancestor
111068163|NCT03122431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111068164|NCT03122431|Leprostatic Agents|leprostatic agents|mesh-ancestor
111068165|NCT03122431|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111068166|NCT03122431|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111068167|NCT03122431|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111068168|NCT03122431|Growth Substances|growth substances|mesh-ancestor
111068169|NCT03122431|Growth Inhibitors|growth inhibitors|mesh-ancestor
111068170|NCT03122431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111068171|NCT05248360|Hydrogen Peroxide|hydrogen peroxide|mesh-list
111068172|NCT05248360|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111068173|NCT05248360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111068174|NCT02305823|Aripiprazole|aripiprazole|mesh-list
111068175|NCT02305823|Quetiapine Fumarate|quetiapine fumarate|mesh-list
111068176|NCT02305823|Ziprasidone|ziprasidone|mesh-list
111068177|NCT02305823|Antidepressive Agents|antidepressive agents|mesh-ancestor
111068178|NCT02305823|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111068179|NCT02305823|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111068180|NCT02305823|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111068181|NCT02305823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111068182|NCT02305823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111068183|NCT02305823|Dopamine Agonists|dopamine agonists|mesh-ancestor
111068184|NCT02305823|Dopamine Agents|dopamine agents|mesh-ancestor
111068185|NCT02305823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111068186|NCT02305823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111068187|NCT02305823|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111068188|NCT02305823|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111068189|NCT02305823|Serotonin Agents|serotonin agents|mesh-ancestor
110637317|NCT03742947|Hemostatics|hemostatics|mesh-list
111068190|NCT02305823|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111068191|NCT02305823|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111068192|NCT02305823|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111068193|NCT02305823|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111068194|NCT05376189|Vitamin D|vitamin d|mesh-list
111068195|NCT05376189|Ergocalciferols|ergocalciferols|mesh-list
111068196|NCT05376189|Cholecalciferol|cholecalciferol|mesh-list
111068197|NCT05376189|Vitamins|vitamins|mesh-list
111068198|NCT05376189|Micronutrients|micronutrients|mesh-ancestor
111068199|NCT05376189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111068200|NCT05376189|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111068201|NCT05376189|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111068202|NCT02235298|Metformin|metformin|mesh-list
111068203|NCT02235298|Dapagliflozin|dapagliflozin|mesh-list
111068204|NCT02235298|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111068205|NCT02235298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111068206|NCT02235298|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111068207|NCT02235298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111068208|NCT02305901|Repaglinide|repaglinide|mesh-list
111068209|NCT02305901|Bupropion|bupropion|mesh-list
111068210|NCT02305901|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111068211|NCT02305901|Antidepressive Agents|antidepressive agents|mesh-ancestor
111068212|NCT02305901|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111068213|NCT02305901|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111068214|NCT02305901|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111068215|NCT02305901|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111068216|NCT02305901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111068217|NCT02305901|Dopamine Agents|dopamine agents|mesh-ancestor
111068218|NCT02305901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111068219|NCT02305901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111068220|NCT02305901|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111068221|NCT02305901|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111068222|NCT02305901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111068223|NCT02305901|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111068224|NCT03942887|Methylprednisolone|methylprednisolone|mesh-list
111068225|NCT03942887|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111068226|NCT03942887|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111068227|NCT03942887|Prednisolone|prednisolone|mesh-list
111068228|NCT03942887|Prednisolone acetate|prednisolone acetate|mesh-list
111068229|NCT03942887|Cyclophosphamide|cyclophosphamide|mesh-list
111068230|NCT03942887|Rituximab|rituximab|mesh-list
111068231|NCT03942887|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111068232|NCT03942887|Prednisolone phosphate|prednisolone phosphate|mesh-list
111068233|NCT03942887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111068234|NCT03942887|Immunologic Factors|immunologic factors|mesh-ancestor
111068235|NCT03942887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111068236|NCT03942887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111068237|NCT03942887|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111068238|NCT03942887|Alkylating Agents|alkylating agents|mesh-ancestor
111068239|NCT03942887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111068240|NCT03942887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111068241|NCT03942887|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111068242|NCT03942887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111068243|NCT03942887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111068244|NCT03942887|Antiemetics|antiemetics|mesh-ancestor
111068245|NCT03942887|Autonomic Agents|autonomic agents|mesh-ancestor
111068246|NCT03942887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111068247|NCT03942887|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111068248|NCT03942887|Glucocorticoids|glucocorticoids|mesh-ancestor
111068249|NCT03942887|Hormones|hormones|mesh-ancestor
111068250|NCT03942887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111068251|NCT03942887|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111068252|NCT03942887|Protective Agents|protective agents|mesh-ancestor
111068253|NCT03942887|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111068254|NCT02234596|Nintedanib|nintedanib|mesh-list
111068255|NCT02234596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110637325|NCT00990795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111068256|NCT02234596|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111068257|NCT02234596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111068258|NCT02234596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111068259|NCT02305979|Loratadine|loratadine|mesh-list
111068260|NCT02305979|Antipruritics|antipruritics|mesh-ancestor
111068261|NCT02305979|Dermatologic Agents|dermatologic agents|mesh-ancestor
111068262|NCT02305979|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111068263|NCT02305979|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
111068264|NCT02305979|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111068265|NCT02305979|Histamine Antagonists|histamine antagonists|mesh-ancestor
111068266|NCT02305979|Histamine Agents|histamine agents|mesh-ancestor
111068267|NCT02305979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111068268|NCT02305979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111068269|NCT02305979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111068270|NCT04539951|Memantine|memantine|mesh-list
111068271|NCT04539951|Aripiprazole|aripiprazole|mesh-list
111068272|NCT04539951|Fluvoxamine|fluvoxamine|mesh-list
111068273|NCT04539951|Sertraline|sertraline|mesh-list
111068274|NCT04539951|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
111068275|NCT04539951|Antidepressive Agents|antidepressive agents|mesh-ancestor
111068276|NCT04539951|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111068277|NCT04539951|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111068278|NCT04539951|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111068279|NCT04539951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111068280|NCT04539951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111068281|NCT04539951|Dopamine Agonists|dopamine agonists|mesh-ancestor
111068282|NCT04539951|Dopamine Agents|dopamine agents|mesh-ancestor
111068283|NCT04539951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111068284|NCT04539951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111068285|NCT04539951|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111068286|NCT04539951|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111068287|NCT04539951|Serotonin Agents|serotonin agents|mesh-ancestor
111068288|NCT04539951|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111068289|NCT04539951|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111068290|NCT04539951|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111068291|NCT04539951|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111068292|NCT04539951|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111068293|NCT04539951|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111068294|NCT04539951|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111068295|NCT04539951|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111068296|NCT04539951|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111068297|NCT04539951|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111068298|NCT04539951|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111068299|NCT04539951|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111068300|NCT04539951|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111068301|NCT04539951|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111068302|NCT04539951|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111068303|NCT04539951|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111068304|NCT04539951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111068305|NCT04539951|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111068307|NCT04539327|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111068308|NCT04539327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111068309|NCT04539327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111068310|NCT04539327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111068311|NCT02234362|Vortioxetine|vortioxetine|mesh-list
111068312|NCT02234362|Antidepressive Agents|antidepressive agents|mesh-ancestor
111068313|NCT02234362|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111068314|NCT02234362|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111068315|NCT02234362|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111068316|NCT02234362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111068317|NCT02234362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111068318|NCT02234362|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111068319|NCT02234362|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111068320|NCT02234362|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111068321|NCT02234362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111068322|NCT02234362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111068323|NCT02234362|Serotonin Agents|serotonin agents|mesh-ancestor
111068324|NCT02234362|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111068325|NCT02234362|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111068326|NCT02234362|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111068327|NCT02234362|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111068328|NCT05091177|Acetylcholine|acetylcholine|mesh-list
111068329|NCT05091177|Antibodies|antibodies|mesh-list
111068330|NCT05091177|Neostigmine|neostigmine|mesh-list
111068331|NCT05091177|Immunologic Factors|immunologic factors|mesh-ancestor
111068332|NCT05091177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111068333|NCT05091177|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111068334|NCT05091177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111068335|NCT05091177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111068336|NCT05091177|Cholinergic Agents|cholinergic agents|mesh-ancestor
111068337|NCT05091177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111068338|NCT05091177|Parasympathomimetics|parasympathomimetics|mesh-ancestor
111068339|NCT05091177|Autonomic Agents|autonomic agents|mesh-ancestor
111068340|NCT05091177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111068341|NCT05091177|Vasodilator Agents|vasodilator agents|mesh-ancestor
111068342|NCT05091177|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111068343|NCT05091099|Zoledronic Acid|zoledronic acid|mesh-list
111068344|NCT05091099|Alendronate|alendronate|mesh-list
111068345|NCT05091099|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111068346|NCT05091099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111068347|NCT03505151|BI 409306|bi 409306|mesh-list
111068348|NCT03505151|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111068349|NCT03505151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111068350|NCT03505151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111068351|NCT02232880|Abatacept|abatacept|mesh-list
111068352|NCT02232880|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111068353|NCT02232880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111068354|NCT02232880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110533448|NCT00212771|Olanzapine|olanzapine|mesh-list
111068355|NCT02232880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111068356|NCT02232880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111068357|NCT02232880|Immunologic Factors|immunologic factors|mesh-ancestor
111068358|NCT02232880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111068359|NCT02232880|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111068360|NCT02896855|Docetaxel|docetaxel|mesh-list
111068361|NCT02896855|Trastuzumab|trastuzumab|mesh-list
111068362|NCT02896855|Pertuzumab|pertuzumab|mesh-list
111068363|NCT02896855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111068364|NCT02896855|Tubulin Modulators|tubulin modulators|mesh-ancestor
111068365|NCT02896855|Antimitotic Agents|antimitotic agents|mesh-ancestor
111068366|NCT02896855|Mitosis Modulators|mitosis modulators|mesh-ancestor
111068367|NCT02896855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111068368|NCT02896855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111068370|NCT02311439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111068371|NCT02311517|Ropivacaine|ropivacaine|mesh-list
111068372|NCT02311517|Anesthetics, Local|anesthetics, local|mesh-ancestor
111068373|NCT02311517|Anesthetics|anesthetics|mesh-ancestor
111068374|NCT02311517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111068375|NCT02311517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111068376|NCT02311517|Sensory System Agents|sensory system agents|mesh-ancestor
111068377|NCT02311517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111068378|NCT02232802|Enoxaparin|enoxaparin|mesh-list
111068379|NCT02232802|Enoxaparin sodium|enoxaparin sodium|mesh-list
111068380|NCT02232802|Anticoagulants|anticoagulants|mesh-ancestor
111068381|NCT02232802|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111068382|NCT02232802|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111068383|NCT02232802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111068384|NCT04463459|Vitamins|vitamins|mesh-list
111068385|NCT04463459|Vitamin E|vitamin e|mesh-list
111068386|NCT04463459|Micronutrients|micronutrients|mesh-ancestor
111068387|NCT04463459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111068388|NCT04463459|Antioxidants|antioxidants|mesh-ancestor
111068389|NCT04463459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111068390|NCT04463459|Protective Agents|protective agents|mesh-ancestor
111068391|NCT02434328|Aflibercept|aflibercept|mesh-list
111068392|NCT02434328|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111068393|NCT02434328|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111068394|NCT02434328|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111068395|NCT02434328|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111068396|NCT02434328|Growth Substances|growth substances|mesh-ancestor
111068397|NCT02434328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111068398|NCT02434328|Growth Inhibitors|growth inhibitors|mesh-ancestor
111068399|NCT02434328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111068400|NCT04785274|Chrysarobin|chrysarobin|mesh-list
111068401|NCT04785274|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111068402|NCT04785274|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111068403|NCT04785274|Analgesics|analgesics|mesh-ancestor
111068404|NCT04785274|Sensory System Agents|sensory system agents|mesh-ancestor
111068405|NCT04785274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111068406|NCT04785274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111068407|NCT04785274|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111068408|NCT04785274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111068409|NCT04778176|Levodopa|levodopa|mesh-list
111068410|NCT04778176|Carbidopa|carbidopa|mesh-list
111068411|NCT04778176|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111068412|NCT04778176|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111068413|NCT04778176|Dopamine Agents|dopamine agents|mesh-ancestor
111068414|NCT04778176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111068415|NCT04778176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111068416|NCT04778176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110828027|NCT01172041|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
111068417|NCT04778176|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
111068418|NCT04778176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111068419|NCT05174026|Deoxyglucose|deoxyglucose|mesh-list
111068420|NCT05174026|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
111068421|NCT05174026|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111068422|NCT05174026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111068423|NCT05174026|Antimetabolites|antimetabolites|mesh-ancestor
111068424|NCT05174026|Antiviral Agents|antiviral agents|mesh-ancestor
111068425|NCT05174026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111068426|NCT05076253|Ivermectin|ivermectin|mesh-list
111068427|NCT05076253|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111068428|NCT05076253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111068429|NCT05077839|Trifluridine|trifluridine|mesh-list
111068430|NCT05077839|Antimetabolites|antimetabolites|mesh-ancestor
111068431|NCT05077839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111068432|NCT05077839|Antiviral Agents|antiviral agents|mesh-ancestor
111068433|NCT05077839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111068434|NCT03132233|Calcium|calcium|mesh-list
111068435|NCT03132233|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111068436|NCT03132233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111068437|NCT02307227|Paclitaxel|paclitaxel|mesh-list
111068438|NCT02307227|Docetaxel|docetaxel|mesh-list
111068439|NCT02307227|Trastuzumab|trastuzumab|mesh-list
111068440|NCT02307227|Epirubicin|epirubicin|mesh-list
111068441|NCT02307227|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111068442|NCT02307227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111068443|NCT02307227|Tubulin Modulators|tubulin modulators|mesh-ancestor
111068444|NCT02307227|Antimitotic Agents|antimitotic agents|mesh-ancestor
111068445|NCT02307227|Mitosis Modulators|mitosis modulators|mesh-ancestor
111068446|NCT02307227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111068447|NCT02307227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111068448|NCT02307227|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111068449|NCT02307227|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111068450|NCT02307227|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111068451|NCT02307227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111068452|NCT02307305|Acetaminophen|acetaminophen|mesh-list
111068453|NCT02307305|Celecoxib|celecoxib|mesh-list
111068454|NCT02307305|Naproxen|naproxen|mesh-list
111068455|NCT02307305|Oxycodone|oxycodone|mesh-list
111068456|NCT02307305|Tramadol|tramadol|mesh-list
111068457|NCT02307305|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
111068458|NCT02307305|Naloxone|naloxone|mesh-list
111068459|NCT02307305|Esomeprazole|esomeprazole|mesh-list
111068460|NCT02307305|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111068461|NCT02307305|Analgesics|analgesics|mesh-ancestor
111068462|NCT02307305|Sensory System Agents|sensory system agents|mesh-ancestor
111068463|NCT02307305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111068464|NCT02307305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111068465|NCT02307305|Antipyretics|antipyretics|mesh-ancestor
111068466|NCT02307305|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111068467|NCT02307305|Narcotics|narcotics|mesh-ancestor
111068468|NCT02307305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111068469|NCT02307305|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111068470|NCT02307305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111068471|NCT02307305|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111068472|NCT02307305|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111068473|NCT02307305|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111068474|NCT02307305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111068475|NCT02307305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111068476|NCT02307305|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111068477|NCT02307305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111068478|NCT02307305|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111068479|NCT02307305|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111068480|NCT02307305|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111068481|NCT02307305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111068482|NCT02307305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111068483|NCT02307305|Antidepressive Agents|antidepressive agents|mesh-ancestor
111068484|NCT02307305|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111068485|NCT02307305|Dopamine Agents|dopamine agents|mesh-ancestor
111068486|NCT02307305|Gout Suppressants|gout suppressants|mesh-ancestor
111068487|NCT02307305|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111068488|NCT02660229|Morphine|morphine|mesh-list
111068489|NCT02660229|Oxycodone|oxycodone|mesh-list
111068490|NCT02660229|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111068491|NCT02660229|Narcotics|narcotics|mesh-ancestor
111068492|NCT02660229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111068493|NCT02660229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111068494|NCT02660229|Analgesics|analgesics|mesh-ancestor
111068495|NCT02660229|Sensory System Agents|sensory system agents|mesh-ancestor
111068496|NCT02660229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111068497|NCT02307383|Lactitol|lactitol|mesh-list
111068498|NCT02307383|Cathartics|cathartics|mesh-ancestor
111068499|NCT02307383|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111068500|NCT02232178|Bupivacaine|bupivacaine|mesh-list
111068501|NCT02232178|Anesthetics, Local|anesthetics, local|mesh-ancestor
111068502|NCT02232178|Anesthetics|anesthetics|mesh-ancestor
111068503|NCT02232178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111068504|NCT02232178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111068505|NCT02232178|Sensory System Agents|sensory system agents|mesh-ancestor
111068506|NCT02232178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111068507|NCT04457323|Metoprolol|metoprolol|mesh-list
111068508|NCT04457323|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111068509|NCT04457323|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111068510|NCT04457323|Sympatholytics|sympatholytics|mesh-ancestor
111068511|NCT04457323|Autonomic Agents|autonomic agents|mesh-ancestor
111068512|NCT04457323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111068513|NCT04457323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110637363|NCT00828776|Heparin|heparin|mesh-list
111068514|NCT04457323|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
111068515|NCT04457323|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111068516|NCT04457323|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111068517|NCT04457323|Adrenergic Agents|adrenergic agents|mesh-ancestor
111068518|NCT04457323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111068519|NCT04457323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111068520|NCT04448431|Vortioxetine|vortioxetine|mesh-list
111068521|NCT04448431|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
111068522|NCT04448431|Antidepressive Agents|antidepressive agents|mesh-ancestor
111068523|NCT04448431|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111068524|NCT04448431|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111068525|NCT04448431|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111068526|NCT04448431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111068527|NCT04448431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111068528|NCT04448431|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111068529|NCT04448431|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111068530|NCT04448431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111068531|NCT04448431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111068532|NCT04448431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111068533|NCT04448431|Serotonin Agents|serotonin agents|mesh-ancestor
111068534|NCT04448431|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111068535|NCT04448431|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111068536|NCT04448431|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111068537|NCT04448431|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111068538|NCT04448431|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111068539|NCT05713149|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111068540|NCT05713149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111068541|NCT02307695|Saxagliptin|saxagliptin|mesh-list
111068542|NCT02307695|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
111068543|NCT02307695|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111068544|NCT02307695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111068545|NCT02307695|Incretins|incretins|mesh-ancestor
111068546|NCT02307695|Hormones|hormones|mesh-ancestor
111068547|NCT02307695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111068548|NCT02307695|Protease Inhibitors|protease inhibitors|mesh-ancestor
111068549|NCT02307695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111068550|NCT02307695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111068551|NCT05161975|Vitamin K|vitamin k|mesh-list
111068552|NCT05161975|Vitamin K 2|vitamin k 2|mesh-list
111068553|NCT05161975|Vitamins|vitamins|mesh-ancestor
111068554|NCT05161975|Micronutrients|micronutrients|mesh-ancestor
111068555|NCT05161975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111068556|NCT05161975|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111068557|NCT05161975|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111068558|NCT05161975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111068559|NCT05161975|Hemostatics|hemostatics|mesh-ancestor
111068560|NCT05161975|Coagulants|coagulants|mesh-ancestor
111068561|NCT03504527|Budesonide|budesonide|mesh-list
111068562|NCT03504527|Bromides|bromides|mesh-list
111068563|NCT03504527|Tiotropium Bromide|tiotropium bromide|mesh-list
111068564|NCT03504527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111068565|NCT03504527|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111068566|NCT03504527|Autonomic Agents|autonomic agents|mesh-ancestor
111068567|NCT03504527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111068568|NCT03504527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111068569|NCT03504527|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111068570|NCT03504527|Respiratory System Agents|respiratory system agents|mesh-ancestor
111068571|NCT03504527|Glucocorticoids|glucocorticoids|mesh-ancestor
111068572|NCT03504527|Hormones|hormones|mesh-ancestor
111068573|NCT03504527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111068574|NCT03504527|Parasympatholytics|parasympatholytics|mesh-ancestor
110637379|NCT04043858|Midodrine|midodrine|mesh-list
111068575|NCT03504527|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111068576|NCT03504527|Cholinergic Agents|cholinergic agents|mesh-ancestor
111068577|NCT03504527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111068578|NCT03504527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111068579|NCT03504527|Anticonvulsants|anticonvulsants|mesh-ancestor
111068580|NCT01678131|Ribavirin|ribavirin|mesh-list
111068581|NCT01678131|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
111068582|NCT01678131|Interferon alpha-2|interferon alpha-2|mesh-list
111068583|NCT01678131|Liver Extracts|liver extracts|mesh-list
111068584|NCT01678131|Antimetabolites|antimetabolites|mesh-ancestor
111068585|NCT01678131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111068586|NCT01678131|Antiviral Agents|antiviral agents|mesh-ancestor
111068587|NCT01678131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111068588|NCT01678131|Hematinics|hematinics|mesh-ancestor
111068589|NCT01678131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111068590|NCT04579783|Triamcinolone|triamcinolone|mesh-list
111068591|NCT04579783|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110785711|NCT01125033|Vitamins|vitamins|mesh-list
111068592|NCT04579783|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
111068593|NCT04579783|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
111068594|NCT04579783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111068595|NCT04579783|Glucocorticoids|glucocorticoids|mesh-ancestor
111068596|NCT04579783|Hormones|hormones|mesh-ancestor
111068597|NCT04579783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111068598|NCT04579783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111068599|NCT04579783|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111068600|NCT04579783|Immunologic Factors|immunologic factors|mesh-ancestor
111068601|NCT04579783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111068602|NCT04579783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111068603|NCT02231164|Docetaxel|docetaxel|mesh-list
111068604|NCT02231164|Nintedanib|nintedanib|mesh-list
111068605|NCT02231164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111068606|NCT02231164|Tubulin Modulators|tubulin modulators|mesh-ancestor
111068607|NCT02231164|Antimitotic Agents|antimitotic agents|mesh-ancestor
111068608|NCT02231164|Mitosis Modulators|mitosis modulators|mesh-ancestor
111068609|NCT02231164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111068610|NCT02231164|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111068611|NCT02231164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111068612|NCT03506789|Dexamethasone|dexamethasone|mesh-list
111068613|NCT03506789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111068614|NCT03506789|Antiemetics|antiemetics|mesh-ancestor
111068615|NCT03506789|Autonomic Agents|autonomic agents|mesh-ancestor
111068616|NCT03506789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111068617|NCT03506789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111068618|NCT03506789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111068619|NCT03506789|Glucocorticoids|glucocorticoids|mesh-ancestor
111068620|NCT03506789|Hormones|hormones|mesh-ancestor
111068621|NCT03506789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111068622|NCT03506789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111068623|NCT03506789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111068624|NCT02312297|Minocycline|minocycline|mesh-list
111068625|NCT02312297|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111068626|NCT02312297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111068627|NCT05108974|Choline|choline|mesh-list
111068628|NCT05108974|Lipotropic Agents|lipotropic agents|mesh-ancestor
111068629|NCT05108974|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111068630|NCT05108974|Antimetabolites|antimetabolites|mesh-ancestor
111068631|NCT05108974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111068632|NCT05108974|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111068633|NCT05108974|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111068634|NCT05108974|Nootropic Agents|nootropic agents|mesh-ancestor
111068635|NCT03473431|Ketamine|ketamine|mesh-list
111068636|NCT03473431|Analgesics|analgesics|mesh-ancestor
111068637|NCT03473431|Sensory System Agents|sensory system agents|mesh-ancestor
111068638|NCT03473431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111068639|NCT03473431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111068640|NCT03473431|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111068641|NCT03473431|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111068642|NCT03473431|Anesthetics, General|anesthetics, general|mesh-ancestor
111068643|NCT03473431|Anesthetics|anesthetics|mesh-ancestor
111068644|NCT03473431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111068645|NCT03473431|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111068646|NCT03473431|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111068647|NCT03473431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111068648|NCT03473431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111068649|NCT02378805|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
111068650|NCT02378805|Ramipril|ramipril|mesh-list
111068651|NCT02378805|Spironolactone|spironolactone|mesh-list
111068652|NCT02378805|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
111068653|NCT02378805|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
111068654|NCT02378805|Hormone Antagonists|hormone antagonists|mesh-ancestor
111068655|NCT02378805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111068656|NCT02378805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111068657|NCT02378805|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
111068658|NCT02378805|Diuretics|diuretics|mesh-ancestor
111068659|NCT02378805|Natriuretic Agents|natriuretic agents|mesh-ancestor
111068660|NCT02378805|Protease Inhibitors|protease inhibitors|mesh-ancestor
111068661|NCT02378805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111068662|NCT02378805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111068663|NCT02378805|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111068664|NCT02378805|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110785780|NCT01121055|GABA Modulators|gaba modulators|mesh-ancestor
111068666|NCT05094375|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111068667|NCT05094375|Abortifacient Agents|abortifacient agents|mesh-ancestor
111068668|NCT05094375|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111068669|NCT05094375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111068670|NCT05094375|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111068671|NCT05094375|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111068672|NCT05094375|Oxytocics|oxytocics|mesh-ancestor
111068673|NCT04345861|Azithromycin|azithromycin|mesh-list
111068674|NCT04345861|Hydroxychloroquine|hydroxychloroquine|mesh-list
111068675|NCT04345861|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111068676|NCT04345861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111068677|NCT04345861|Antimalarials|antimalarials|mesh-ancestor
111068678|NCT04345861|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111068679|NCT04345861|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111068680|NCT04345861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111068681|NCT04345861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111068682|NCT04345861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111068683|NCT02067819|Salicylic Acid|salicylic acid|mesh-list
111068684|NCT02067819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111068685|NCT02067819|Antifungal Agents|antifungal agents|mesh-ancestor
111068686|NCT02067819|Keratolytic Agents|keratolytic agents|mesh-ancestor
111068687|NCT02067819|Dermatologic Agents|dermatologic agents|mesh-ancestor
111068688|NCT02230306|Vemurafenib|vemurafenib|mesh-list
111068689|NCT02230306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111068690|NCT02230306|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111068691|NCT02230306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111068692|NCT02230306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111068693|NCT04266379|Insulin|insulin|mesh-list
111068694|NCT04266379|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111068695|NCT04266379|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111068696|NCT04266379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111068697|NCT02308319|Tenofovir|tenofovir|mesh-list
111068698|NCT02308319|Antiviral Agents|antiviral agents|mesh-ancestor
111068699|NCT02308319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110637394|NCT00823862|Ribavirin|ribavirin|mesh-list
111068700|NCT02308319|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111068701|NCT02308319|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111068702|NCT02308319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111068703|NCT02308319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111068704|NCT02308319|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111068705|NCT02308319|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111068706|NCT02312375|Amlodipine|amlodipine|mesh-list
111068707|NCT02312375|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111068708|NCT02312375|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111068709|NCT02312375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111068710|NCT02312375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110828049|NCT00024167|Hormones|hormones|mesh-ancestor
111068711|NCT02312375|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111068712|NCT02312375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111068713|NCT02312375|Vasodilator Agents|vasodilator agents|mesh-ancestor
111068714|NCT05062174|Mifepristone|mifepristone|mesh-list
111068715|NCT05062174|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
111068716|NCT05062174|Abortifacient Agents|abortifacient agents|mesh-ancestor
111068717|NCT05062174|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111068718|NCT05062174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111068719|NCT05062174|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111068720|NCT05062174|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111068721|NCT05062174|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111068722|NCT05062174|Contraceptive Agents|contraceptive agents|mesh-ancestor
111068723|NCT05062174|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
111068724|NCT05062174|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
111068725|NCT05062174|Hormone Antagonists|hormone antagonists|mesh-ancestor
111068726|NCT05062174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111068727|NCT05062174|Luteolytic Agents|luteolytic agents|mesh-ancestor
111068728|NCT05062174|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111068729|NCT05062174|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
111068731|NCT05095467|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111068732|NCT05095467|Tegafur|tegafur|mesh-list
111068733|NCT05095467|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111068734|NCT05095467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111068735|NCT05095467|Tubulin Modulators|tubulin modulators|mesh-ancestor
111068736|NCT05095467|Antimitotic Agents|antimitotic agents|mesh-ancestor
111068737|NCT05095467|Mitosis Modulators|mitosis modulators|mesh-ancestor
110785852|NCT03934203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111068738|NCT05095467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111068739|NCT05095467|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111068740|NCT05095467|Antimetabolites|antimetabolites|mesh-ancestor
111068741|NCT02312531|Immunoglobulins|immunoglobulins|mesh-list
111068742|NCT02312531|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111068743|NCT02312531|Antibodies|antibodies|mesh-list
111068744|NCT02312531|Immunologic Factors|immunologic factors|mesh-ancestor
111068745|NCT02312531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111068746|NCT04234477|Metoprolol|metoprolol|mesh-list
111068747|NCT04234477|Verapamil|verapamil|mesh-list
111068748|NCT04234477|Diltiazem|diltiazem|mesh-list
111068749|NCT04234477|Calcium Channel Blockers|calcium channel blockers|mesh-list
111068750|NCT04234477|Calcium|calcium|mesh-list
111068751|NCT04234477|Esmolol|esmolol|mesh-list
111068752|NCT04234477|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
111068753|NCT04234477|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111068754|NCT04234477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111068755|NCT04234477|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111068756|NCT04234477|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111068757|NCT04234477|Sympatholytics|sympatholytics|mesh-ancestor
111068758|NCT04234477|Autonomic Agents|autonomic agents|mesh-ancestor
111068759|NCT04234477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111068760|NCT04234477|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
111068761|NCT04234477|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111068762|NCT04234477|Adrenergic Agents|adrenergic agents|mesh-ancestor
111068763|NCT04234477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111068764|NCT04234477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111068765|NCT04234477|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111068766|NCT04234477|Vasodilator Agents|vasodilator agents|mesh-ancestor
111068767|NCT02449031|Tobramycin|tobramycin|mesh-list
111068768|NCT02449031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111068769|NCT02449031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111068770|NCT01680861|Mycophenolic Acid|mycophenolic acid|mesh-list
111068771|NCT01680861|Methylprednisolone|methylprednisolone|mesh-list
111068772|NCT01680861|Everolimus|everolimus|mesh-list
111068773|NCT01680861|Tacrolimus|tacrolimus|mesh-list
111068774|NCT01680861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111068775|NCT01680861|Immunologic Factors|immunologic factors|mesh-ancestor
111068776|NCT01680861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111068777|NCT01680861|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111068778|NCT01680861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111068779|NCT01680861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111068780|NCT01680861|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111068781|NCT01680861|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111068782|NCT01680861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111068783|NCT01680861|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111068784|NCT01680861|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111068785|NCT01680861|Antitubercular Agents|antitubercular agents|mesh-ancestor
111068786|NCT01680861|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111068787|NCT01680861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111068788|NCT01680861|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111068789|NCT01680861|Antiemetics|antiemetics|mesh-ancestor
111068790|NCT01680861|Autonomic Agents|autonomic agents|mesh-ancestor
111068791|NCT01680861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111068792|NCT01680861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111068793|NCT01680861|Glucocorticoids|glucocorticoids|mesh-ancestor
111068794|NCT01680861|Hormones|hormones|mesh-ancestor
111068795|NCT01680861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111068796|NCT01680861|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111068797|NCT01680861|Protective Agents|protective agents|mesh-ancestor
111068798|NCT02229214|Topiramate|topiramate|mesh-list
111068799|NCT02229214|Phentermine|phentermine|mesh-list
111068800|NCT02229214|Anticonvulsants|anticonvulsants|mesh-ancestor
111068801|NCT02229214|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111068802|NCT02229214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111068803|NCT02229214|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111068804|NCT02229214|Appetite Depressants|appetite depressants|mesh-ancestor
111068805|NCT02229214|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111068806|NCT02229214|Sympathomimetics|sympathomimetics|mesh-ancestor
111068807|NCT02229214|Autonomic Agents|autonomic agents|mesh-ancestor
111068808|NCT02229214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111068809|NCT02229214|Adrenergic Agents|adrenergic agents|mesh-ancestor
111068810|NCT02229214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111068811|NCT02229214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111068812|NCT02308553|Paclitaxel|paclitaxel|mesh-list
111068813|NCT02308553|Nintedanib|nintedanib|mesh-list
111068814|NCT02308553|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111068815|NCT02308553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111068816|NCT02308553|Tubulin Modulators|tubulin modulators|mesh-ancestor
111068817|NCT02308553|Antimitotic Agents|antimitotic agents|mesh-ancestor
111068818|NCT02308553|Mitosis Modulators|mitosis modulators|mesh-ancestor
111068819|NCT02308553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111068820|NCT02308553|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111068821|NCT02308553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111068822|NCT05093907|Capecitabine|capecitabine|mesh-list
111068823|NCT05093907|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111068824|NCT05093907|Antimetabolites|antimetabolites|mesh-ancestor
111068825|NCT05093907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111068826|NCT05093907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111068827|NCT02228980|Vaccines|vaccines|mesh-list
111068828|NCT02228980|Immunologic Factors|immunologic factors|mesh-ancestor
110637414|NCT00823940|Glucagon|glucagon|mesh-list
111068829|NCT02228980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111068830|NCT03783091|Hydroxocobalamin|hydroxocobalamin|mesh-list
111068831|NCT03783091|Vitamin B 12|vitamin b 12|mesh-list
111068832|NCT03783091|Hematinics|hematinics|mesh-ancestor
111068833|NCT03783091|Vitamin B Complex|vitamin b complex|mesh-ancestor
111068834|NCT03783091|Vitamins|vitamins|mesh-ancestor
111068835|NCT03783091|Micronutrients|micronutrients|mesh-ancestor
111068836|NCT03783091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111068837|NCT05057481|Mycophenolic Acid|mycophenolic acid|mesh-list
111068838|NCT05057481|Rituximab|rituximab|mesh-list
111068839|NCT05057481|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111068840|NCT05057481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111068841|NCT05057481|Immunologic Factors|immunologic factors|mesh-ancestor
111068842|NCT05057481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111068843|NCT05057481|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111068844|NCT05057481|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111068845|NCT05057481|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111068846|NCT05057481|Antitubercular Agents|antitubercular agents|mesh-ancestor
111068847|NCT05057481|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111068848|NCT05057481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111068849|NCT05057481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111068850|NCT05057481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111068851|NCT02312609|Minocycline|minocycline|mesh-list
111068852|NCT02312609|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111068853|NCT02312609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111068854|NCT03506399|Levonorgestrel|levonorgestrel|mesh-list
111068855|NCT03506399|Ethinyl Estradiol|ethinyl estradiol|mesh-list
111068856|NCT03506399|Contraceptive Agents|contraceptive agents|mesh-list
111068857|NCT03506399|Contraceptives, Oral|contraceptives, oral|mesh-list
111068858|NCT03506399|Estradiol|estradiol|mesh-list
111068859|NCT03506399|Estrogens|estrogens|mesh-ancestor
111068860|NCT03506399|Hormones|hormones|mesh-ancestor
111068861|NCT03506399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111068862|NCT03506399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111068863|NCT03506399|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111068864|NCT03506399|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111068865|NCT03506399|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111068866|NCT03506399|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111068867|NCT03506399|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111068868|NCT02228590|Apomorphine|apomorphine|mesh-list
111068870|NCT02228590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111068871|NCT02228590|Autonomic Agents|autonomic agents|mesh-ancestor
111068872|NCT02228590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111068873|NCT02228590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111068874|NCT02228590|Dopamine Agonists|dopamine agonists|mesh-ancestor
111068875|NCT02228590|Dopamine Agents|dopamine agents|mesh-ancestor
111068876|NCT02228590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111068877|NCT02228590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111068878|NCT03503201|Chromium|chromium|mesh-list
111068879|NCT03503201|Trace Elements|trace elements|mesh-ancestor
111068880|NCT03503201|Micronutrients|micronutrients|mesh-ancestor
111068881|NCT03503201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111068882|NCT05095077|Tadalafil|tadalafil|mesh-list
111068883|NCT05095077|Vasodilator Agents|vasodilator agents|mesh-ancestor
111068884|NCT05095077|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111068885|NCT05095077|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111068886|NCT05095077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111068887|NCT05095077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111068888|NCT05095077|Urological Agents|urological agents|mesh-ancestor
111068889|NCT02309177|Paclitaxel|paclitaxel|mesh-list
111068890|NCT02309177|Carboplatin|carboplatin|mesh-list
111068891|NCT02309177|Gemcitabine|gemcitabine|mesh-list
111068892|NCT02309177|Nivolumab|nivolumab|mesh-list
111068893|NCT02309177|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111068894|NCT02309177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111068895|NCT02309177|Tubulin Modulators|tubulin modulators|mesh-ancestor
111068896|NCT02309177|Antimitotic Agents|antimitotic agents|mesh-ancestor
111068897|NCT02309177|Mitosis Modulators|mitosis modulators|mesh-ancestor
111068898|NCT02309177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111068899|NCT02309177|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111068900|NCT02309177|Antimetabolites|antimetabolites|mesh-ancestor
111068901|NCT02309177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111068902|NCT02309177|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111068903|NCT02227108|Immunotoxin HA22|immunotoxin ha22|mesh-list
111068904|NCT02227108|Immunotoxins|immunotoxins|mesh-ancestor
111068905|NCT02227108|Immunoconjugates|immunoconjugates|mesh-ancestor
111068906|NCT02227108|Immunologic Factors|immunologic factors|mesh-ancestor
111068907|NCT02227108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111068908|NCT02227108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111068909|NCT03564145|Benzoyl Peroxide|benzoyl peroxide|mesh-list
111068910|NCT03564145|Dermatologic Agents|dermatologic agents|mesh-ancestor
111068911|NCT02312999|Plasma-lyte 148|plasma-lyte 148|mesh-list
111068912|NCT02312999|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
111068913|NCT02312999|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111068914|NCT04863261|Cabotegravir, rilpivirine drug combination|cabotegravir, rilpivirine drug combination|mesh-list
111068915|NCT04863261|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111068916|NCT04863261|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111068917|NCT04863261|Antiviral Agents|antiviral agents|mesh-ancestor
111068918|NCT04863261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111068919|NCT02313077|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
111068920|NCT02313077|Antiviral Agents|antiviral agents|mesh-ancestor
111068921|NCT02313077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111068922|NCT03423355|Dapagliflozin|dapagliflozin|mesh-list
111068923|NCT03423355|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
111068924|NCT03423355|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111068925|NCT03423355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111068926|NCT03423355|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111068927|NCT03423355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111068928|NCT03423355|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111068929|NCT03423355|Diuretics|diuretics|mesh-ancestor
111068930|NCT03423355|Natriuretic Agents|natriuretic agents|mesh-ancestor
111068931|NCT03423355|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
111068932|NCT03423355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111068933|NCT02226562|Listerine|listerine|mesh-list
111068934|NCT02226562|Fluorides|fluorides|mesh-list
111068935|NCT02226562|Sodium Fluoride|sodium fluoride|mesh-list
111068936|NCT02226562|Cariostatic Agents|cariostatic agents|mesh-ancestor
111068937|NCT02226562|Protective Agents|protective agents|mesh-ancestor
111068938|NCT02226562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111068939|NCT02226562|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111068940|NCT02226562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111068941|NCT04430985|Leucovorin|leucovorin|mesh-list
111068942|NCT04430985|Fluorouracil|fluorouracil|mesh-list
111068943|NCT04430985|Oxaliplatin|oxaliplatin|mesh-list
111068944|NCT04430985|Nivolumab|nivolumab|mesh-list
111068945|NCT04430985|Ipilimumab|ipilimumab|mesh-list
111068946|NCT04430985|Antimetabolites|antimetabolites|mesh-ancestor
111068947|NCT04430985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111068948|NCT04430985|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111068949|NCT04430985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111068950|NCT04430985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111068951|NCT04430985|Immunologic Factors|immunologic factors|mesh-ancestor
111068952|NCT04430985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111068953|NCT04430985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111068954|NCT04430985|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111068955|NCT04430985|Antidotes|antidotes|mesh-ancestor
111068956|NCT04430985|Protective Agents|protective agents|mesh-ancestor
111068957|NCT04430985|Vitamin B Complex|vitamin b complex|mesh-ancestor
111068958|NCT04430985|Vitamins|vitamins|mesh-ancestor
111068959|NCT04430985|Micronutrients|micronutrients|mesh-ancestor
111068960|NCT03365635|Ribavirin|ribavirin|mesh-list
111068961|NCT03365635|Grazoprevir|grazoprevir|mesh-list
111068962|NCT03365635|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
111068963|NCT03365635|Antimetabolites|antimetabolites|mesh-ancestor
111068964|NCT03365635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111068965|NCT03365635|Antiviral Agents|antiviral agents|mesh-ancestor
111068966|NCT03365635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111068967|NCT04658277|Clarithromycin|clarithromycin|mesh-list
111068968|NCT04658277|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111068969|NCT04658277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111068970|NCT04658277|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111068971|NCT04658277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111068972|NCT04658277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111068973|NCT04658277|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111068974|NCT04658277|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111068975|NCT04456777|Vortioxetine|vortioxetine|mesh-list
111068976|NCT04456777|Antidepressive Agents|antidepressive agents|mesh-ancestor
111068977|NCT04456777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111068978|NCT04456777|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111068979|NCT04456777|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111068980|NCT04456777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111068981|NCT04456777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111068982|NCT04456777|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111068983|NCT04456777|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111068984|NCT04456777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111068985|NCT04456777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111068986|NCT04456777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111068987|NCT04456777|Serotonin Agents|serotonin agents|mesh-ancestor
111068988|NCT04456777|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111068989|NCT04456777|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111068990|NCT04456777|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111068991|NCT04456777|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111068992|NCT02874430|Metformin|metformin|mesh-list
111068993|NCT02874430|Doxycycline|doxycycline|mesh-list
111068994|NCT02874430|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111068995|NCT02874430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111068996|NCT02874430|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111068997|NCT02874430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111068998|NCT02874430|Antimalarials|antimalarials|mesh-ancestor
111068999|NCT02874430|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111069000|NCT02874430|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111069001|NCT05160727|Irinotecan|irinotecan|mesh-list
111069002|NCT05160727|Tislelizumab|tislelizumab|mesh-list
111069003|NCT05160727|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111069004|NCT05160727|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111069005|NCT05160727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111069006|NCT05160727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111069007|NCT05160727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111069008|NCT05160727|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111069009|NCT03506009|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
111069011|NCT03506009|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111069012|NCT03506009|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111069013|NCT03506009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111069014|NCT03506009|Antithrombins|antithrombins|mesh-ancestor
111069015|NCT03506009|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111069016|NCT03506009|Protease Inhibitors|protease inhibitors|mesh-ancestor
111069017|NCT03506009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111069018|NCT03506009|Anticoagulants|anticoagulants|mesh-ancestor
111069019|NCT03506009|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111069020|NCT03130855|Carticaine|carticaine|mesh-list
111069021|NCT03130855|Anesthetics, Local|anesthetics, local|mesh-ancestor
111069022|NCT03130855|Anesthetics|anesthetics|mesh-ancestor
111069023|NCT03130855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111069024|NCT03130855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111069025|NCT03130855|Sensory System Agents|sensory system agents|mesh-ancestor
111069026|NCT03130855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111069027|NCT02309801|Daidzin|daidzin|mesh-list
111069028|NCT02309801|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111069029|NCT02309801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111069030|NCT02309801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111069031|NCT02309879|Lidocaine|lidocaine|mesh-list
111069032|NCT02309879|Magnesium Sulfate|magnesium sulfate|mesh-list
111069033|NCT02309879|Remifentanil|remifentanil|mesh-list
111069034|NCT02309879|Anesthetics, Local|anesthetics, local|mesh-ancestor
111069035|NCT02309879|Anesthetics|anesthetics|mesh-ancestor
111069036|NCT02309879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111069037|NCT02309879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111069038|NCT02309879|Sensory System Agents|sensory system agents|mesh-ancestor
111069039|NCT02309879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111069040|NCT02309879|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111069041|NCT02309879|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111069042|NCT02309879|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111069043|NCT02309879|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111069044|NCT02309879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111069045|NCT02309879|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111069046|NCT02309879|Narcotics|narcotics|mesh-ancestor
111069047|NCT02309879|Analgesics|analgesics|mesh-ancestor
111069048|NCT02309879|Anticonvulsants|anticonvulsants|mesh-ancestor
111069049|NCT02309879|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111069050|NCT02309879|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111069051|NCT02309879|Tocolytic Agents|tocolytic agents|mesh-ancestor
111069052|NCT02309879|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111069053|NCT02476786|Tamoxifen|tamoxifen|mesh-list
111069054|NCT02476786|Fulvestrant|fulvestrant|mesh-list
111069055|NCT02476786|Anastrozole|anastrozole|mesh-list
111069056|NCT02476786|Goserelin|goserelin|mesh-list
111069057|NCT02476786|Exemestane|exemestane|mesh-list
111069058|NCT02476786|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111069059|NCT02476786|Hormone Antagonists|hormone antagonists|mesh-ancestor
111069060|NCT02476786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111069061|NCT02476786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111069062|NCT02476786|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111069063|NCT02476786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111069064|NCT02476786|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111069065|NCT02476786|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111069066|NCT02476786|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111069067|NCT02476786|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
111069068|NCT02476786|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111069069|NCT02476786|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111069070|NCT02476786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111069071|NCT02476786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111069072|NCT02820961|Exemestane|exemestane|mesh-list
111069073|NCT02820961|Entinostat|entinostat|mesh-list
111069074|NCT02820961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111069075|NCT02820961|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111069076|NCT02820961|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111069077|NCT02820961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111069078|NCT02820961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111069079|NCT02820961|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111069080|NCT02820961|Hormone Antagonists|hormone antagonists|mesh-ancestor
111069081|NCT02820961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111069082|NCT02820961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111069083|NCT02820961|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111069084|NCT04658173|Alfentanil|alfentanil|mesh-list
111069085|NCT04658173|Propofol|propofol|mesh-list
111069086|NCT04658173|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111069087|NCT04658173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111069088|NCT04658173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111069089|NCT04658173|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111069090|NCT04658173|Anesthetics, General|anesthetics, general|mesh-ancestor
111069091|NCT04658173|Anesthetics|anesthetics|mesh-ancestor
111069092|NCT04658173|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111069093|NCT04658173|Narcotics|narcotics|mesh-ancestor
111069094|NCT04658173|Analgesics|analgesics|mesh-ancestor
111069095|NCT04658173|Sensory System Agents|sensory system agents|mesh-ancestor
111069096|NCT04658173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111069097|NCT02399410|Bevacizumab|bevacizumab|mesh-list
111069098|NCT02399410|Oxaliplatin|oxaliplatin|mesh-list
111069099|NCT02399410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111069100|NCT02399410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111069101|NCT02399410|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111069102|NCT02399410|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111069103|NCT02399410|Growth Substances|growth substances|mesh-ancestor
111069104|NCT02399410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111069105|NCT02399410|Growth Inhibitors|growth inhibitors|mesh-ancestor
111069106|NCT03636165|Methylprednisolone|methylprednisolone|mesh-list
111069107|NCT03636165|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111069108|NCT03636165|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111069109|NCT03636165|Prednisolone|prednisolone|mesh-list
111069110|NCT03636165|Prednisolone acetate|prednisolone acetate|mesh-list
111069111|NCT03636165|Ropivacaine|ropivacaine|mesh-list
111069112|NCT03636165|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111069113|NCT03636165|Prednisolone phosphate|prednisolone phosphate|mesh-list
111069114|NCT03636165|Anesthetics, Local|anesthetics, local|mesh-ancestor
111069115|NCT03636165|Anesthetics|anesthetics|mesh-ancestor
111069116|NCT03636165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111069117|NCT03636165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111069118|NCT03636165|Sensory System Agents|sensory system agents|mesh-ancestor
111069119|NCT03636165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111069120|NCT03636165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111069121|NCT03636165|Antiemetics|antiemetics|mesh-ancestor
111069122|NCT03636165|Autonomic Agents|autonomic agents|mesh-ancestor
111069123|NCT03636165|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111069124|NCT03636165|Glucocorticoids|glucocorticoids|mesh-ancestor
111069125|NCT03636165|Hormones|hormones|mesh-ancestor
111069126|NCT03636165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111069127|NCT03636165|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111069128|NCT03636165|Protective Agents|protective agents|mesh-ancestor
111069129|NCT03636165|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111069130|NCT03636165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111069131|NCT02310347|Dronabinol|dronabinol|mesh-list
111069132|NCT02310347|Hallucinogens|hallucinogens|mesh-ancestor
111069133|NCT02310347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111069134|NCT02310347|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111069135|NCT02310347|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111069136|NCT02310347|Analgesics|analgesics|mesh-ancestor
111069137|NCT02310347|Sensory System Agents|sensory system agents|mesh-ancestor
111069138|NCT02310347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111069139|NCT02310347|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
111069140|NCT02310347|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
111069141|NCT02310347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111069142|NCT02310347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111069143|NCT02310347|Hormones|hormones|mesh-ancestor
111069144|NCT02310347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111069145|NCT04429425|Anesthetics|anesthetics|mesh-list
111069146|NCT04429425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111069147|NCT04429425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111069148|NCT03502889|Ropivacaine|ropivacaine|mesh-list
111069149|NCT03502889|Anesthetics, Local|anesthetics, local|mesh-ancestor
111069150|NCT03502889|Anesthetics|anesthetics|mesh-ancestor
111069151|NCT03502889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111069152|NCT03502889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111069153|NCT03502889|Sensory System Agents|sensory system agents|mesh-ancestor
111069154|NCT03502889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111069155|NCT05098353|Quetiapine Fumarate|quetiapine fumarate|mesh-list
111069156|NCT05098353|Antidepressive Agents|antidepressive agents|mesh-ancestor
111069157|NCT05098353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111069159|NCT05098353|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111069160|NCT05098353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111069161|NCT05098353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111069162|NCT05098119|Paclitaxel|paclitaxel|mesh-list
111069163|NCT05098119|Carboplatin|carboplatin|mesh-list
111069164|NCT05098119|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111069165|NCT05098119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111069166|NCT05098119|Tubulin Modulators|tubulin modulators|mesh-ancestor
111069167|NCT05098119|Antimitotic Agents|antimitotic agents|mesh-ancestor
111069168|NCT05098119|Mitosis Modulators|mitosis modulators|mesh-ancestor
111069169|NCT05098119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111069170|NCT02738879|Metformin|metformin|mesh-list
111069171|NCT02738879|Insulin Glargine|insulin glargine|mesh-list
111069172|NCT02738879|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111069173|NCT02738879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111069174|NCT02738879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111069175|NCT02738879|Incretins|incretins|mesh-ancestor
111069176|NCT02738879|Hormones|hormones|mesh-ancestor
111069177|NCT02738879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111069178|NCT02738879|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111069179|NCT02738879|Protease Inhibitors|protease inhibitors|mesh-ancestor
111069180|NCT02738879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111069181|NCT02738879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111069182|NCT03253913|Sirolimus|sirolimus|mesh-list
111069183|NCT03253913|Resveratrol|resveratrol|mesh-list
111069184|NCT03253913|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111069185|NCT03253913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111069186|NCT03253913|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111069187|NCT03253913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111069188|NCT03253913|Antifungal Agents|antifungal agents|mesh-ancestor
111069189|NCT03253913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111069190|NCT03253913|Immunologic Factors|immunologic factors|mesh-ancestor
111069191|NCT03253913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111069192|NCT03253913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110786300|NCT03740373|Budesonide|budesonide|mesh-list
111069193|NCT03253913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111069194|NCT03253913|Antioxidants|antioxidants|mesh-ancestor
111069195|NCT03253913|Protective Agents|protective agents|mesh-ancestor
111069196|NCT03253913|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111069197|NCT03237819|Magnesium Sulfate|magnesium sulfate|mesh-list
111069198|NCT03237819|Analgesics|analgesics|mesh-ancestor
111069199|NCT03237819|Sensory System Agents|sensory system agents|mesh-ancestor
111069200|NCT03237819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111069201|NCT03237819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111069202|NCT03237819|Anesthetics|anesthetics|mesh-ancestor
111069203|NCT03237819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111069204|NCT03237819|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111069205|NCT03237819|Anticonvulsants|anticonvulsants|mesh-ancestor
111069206|NCT03237819|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111069207|NCT03237819|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111069208|NCT03237819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111069209|NCT03237819|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111069210|NCT03237819|Tocolytic Agents|tocolytic agents|mesh-ancestor
111069211|NCT03237819|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111069212|NCT03468907|Tenofovir|tenofovir|mesh-list
111069213|NCT03468907|Telbivudine|telbivudine|mesh-list
111069214|NCT03468907|Antiviral Agents|antiviral agents|mesh-ancestor
111069215|NCT03468907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111069216|NCT03468907|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111069217|NCT03468907|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111069218|NCT03468907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111069219|NCT03468907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111069220|NCT03468907|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111069221|NCT03468907|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111069222|NCT05089851|Sunscreening Agents|sunscreening agents|mesh-list
111069223|NCT05089851|Botulinum Toxins|botulinum toxins|mesh-list
111069224|NCT05089851|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111069225|NCT05089851|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111069226|NCT05089851|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111069227|NCT05089851|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111069228|NCT05089851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111069229|NCT05089851|Cholinergic Agents|cholinergic agents|mesh-ancestor
111069230|NCT05089851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111069231|NCT05089851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111069232|NCT05089851|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111069233|NCT05089851|Protective Agents|protective agents|mesh-ancestor
111069234|NCT05089851|Dermatologic Agents|dermatologic agents|mesh-ancestor
111069235|NCT05089851|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111069236|NCT05089851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111069237|NCT04657809|Insulin|insulin|mesh-list
111069238|NCT04657809|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111069239|NCT04657809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111069240|NCT05350917|Tislelizumab|tislelizumab|mesh-list
111069241|NCT05350917|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111069242|NCT05350917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111069243|NCT02311205|Sorafenib|sorafenib|mesh-list
111069244|NCT02311205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111069245|NCT02311205|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111069246|NCT02311205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111069247|NCT02311205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111069248|NCT05390749|Rituximab|rituximab|mesh-list
111069249|NCT05390749|Methotrexate|methotrexate|mesh-list
111069250|NCT05390749|Pomalidomide|pomalidomide|mesh-list
111069251|NCT05390749|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111069252|NCT05390749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111069253|NCT05390749|Immunologic Factors|immunologic factors|mesh-ancestor
111069254|NCT05390749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111069255|NCT05390749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111069256|NCT05390749|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111069257|NCT05390749|Abortifacient Agents|abortifacient agents|mesh-ancestor
111069258|NCT05390749|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111069259|NCT05390749|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111069260|NCT05390749|Antimetabolites|antimetabolites|mesh-ancestor
111069261|NCT05390749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111069262|NCT05390749|Dermatologic Agents|dermatologic agents|mesh-ancestor
111069263|NCT05390749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111069264|NCT05390749|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111069265|NCT05390749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111069266|NCT05390749|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111069267|NCT05390749|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111069268|NCT05390749|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111069269|NCT05390749|Growth Substances|growth substances|mesh-ancestor
111069270|NCT05390749|Growth Inhibitors|growth inhibitors|mesh-ancestor
111069272|NCT02813655|Hormones|hormones|mesh-ancestor
111069273|NCT02813655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111069274|NCT02813655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111069275|NCT03468829|Gontivimab|gontivimab|mesh-list
111069276|NCT03468829|Antiviral Agents|antiviral agents|mesh-ancestor
111069277|NCT03468829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111069278|NCT04912791|Anesthetics|anesthetics|mesh-list
111069279|NCT04912791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111069280|NCT04912791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111069281|NCT02316197|Peposertib|peposertib|mesh-list
111069282|NCT02316197|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111069283|NCT02316197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111069284|NCT02316197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111069285|NCT02314013|Metronidazole|metronidazole|mesh-list
111069286|NCT02314013|Cephalosporins|cephalosporins|mesh-list
111069287|NCT02314013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111069288|NCT02314013|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111069289|NCT02314013|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111069290|NCT02314013|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111069291|NCT01677195|Calcium Carbonate|calcium carbonate|mesh-list
111069292|NCT01677195|Antacids|antacids|mesh-ancestor
111069293|NCT01677195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111069294|NCT01677195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111069295|NCT05331807|Vitamin D|vitamin d|mesh-list
111069296|NCT05331807|Ergocalciferols|ergocalciferols|mesh-list
111069297|NCT05331807|Cholecalciferol|cholecalciferol|mesh-list
111069298|NCT05331807|Vitamins|vitamins|mesh-list
111069299|NCT05331807|Micronutrients|micronutrients|mesh-ancestor
111069300|NCT05331807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111069301|NCT05331807|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111069302|NCT05331807|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111069303|NCT02314325|Factor VIII|factor viii|mesh-list
111069304|NCT02314325|Coagulants|coagulants|mesh-ancestor
111069305|NCT04707261|Dapagliflozin|dapagliflozin|mesh-list
111069306|NCT04707261|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111069307|NCT04707261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111069308|NCT04707261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111069309|NCT04707261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111069310|NCT02314481|Trastuzumab|trastuzumab|mesh-list
111069311|NCT02314481|Atezolizumab|atezolizumab|mesh-list
111069312|NCT02314481|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
111069313|NCT02314481|Vemurafenib|vemurafenib|mesh-list
111069314|NCT02314481|Maytansine|maytansine|mesh-list
111069315|NCT02314481|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111069316|NCT02314481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111069317|NCT02314481|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111069318|NCT02314481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111069319|NCT02314481|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111069320|NCT02314481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111069321|NCT02314481|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111069322|NCT02314481|Tubulin Modulators|tubulin modulators|mesh-ancestor
111069323|NCT02314481|Antimitotic Agents|antimitotic agents|mesh-ancestor
111069324|NCT02314481|Mitosis Modulators|mitosis modulators|mesh-ancestor
111069325|NCT02314481|Immunotoxins|immunotoxins|mesh-ancestor
111069326|NCT02314481|Immunoconjugates|immunoconjugates|mesh-ancestor
111069327|NCT02314481|Immunologic Factors|immunologic factors|mesh-ancestor
111069328|NCT02314481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111069329|NCT03502421|Ketamine|ketamine|mesh-list
111069330|NCT03502421|Analgesics|analgesics|mesh-ancestor
110637514|NCT00832442|Bisoprolol|bisoprolol|mesh-list
111069331|NCT03502421|Sensory System Agents|sensory system agents|mesh-ancestor
111069332|NCT03502421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111069333|NCT03502421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111069334|NCT03502421|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111069335|NCT03502421|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111069336|NCT03502421|Anesthetics, General|anesthetics, general|mesh-ancestor
111069337|NCT03502421|Anesthetics|anesthetics|mesh-ancestor
111069338|NCT03502421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111069339|NCT03502421|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111069340|NCT03502421|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111069341|NCT03502421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110786447|NCT01228617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111069342|NCT03502421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111069344|NCT03502343|Gemcitabine|gemcitabine|mesh-list
111069345|NCT03502343|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111069346|NCT03502343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111069347|NCT03502343|Tubulin Modulators|tubulin modulators|mesh-ancestor
111069348|NCT03502343|Antimitotic Agents|antimitotic agents|mesh-ancestor
111069349|NCT03502343|Mitosis Modulators|mitosis modulators|mesh-ancestor
111069350|NCT03502343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111069351|NCT03502343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111069352|NCT03502343|Antimetabolites|antimetabolites|mesh-ancestor
111069353|NCT04345887|Spironolactone|spironolactone|mesh-list
111069354|NCT04345887|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
111069355|NCT04345887|Hormone Antagonists|hormone antagonists|mesh-ancestor
111069356|NCT04345887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111069357|NCT04345887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111069358|NCT04345887|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
111069359|NCT04345887|Diuretics|diuretics|mesh-ancestor
111069360|NCT04345887|Natriuretic Agents|natriuretic agents|mesh-ancestor
111069361|NCT02316899|Linaclotide|linaclotide|mesh-list
111069362|NCT02316899|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
111069363|NCT02316899|Enzyme Activators|enzyme activators|mesh-ancestor
111069364|NCT02316899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111069365|NCT02316899|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111069366|NCT02314871|Morphine|morphine|mesh-list
111069367|NCT02314871|Pirinitramide|pirinitramide|mesh-list
111069368|NCT02314871|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111069369|NCT02314871|Narcotics|narcotics|mesh-ancestor
111069370|NCT02314871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111069371|NCT02314871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111069372|NCT02314871|Analgesics|analgesics|mesh-ancestor
111069373|NCT02314871|Sensory System Agents|sensory system agents|mesh-ancestor
111069374|NCT02314871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111069375|NCT02224846|Tadalafil|tadalafil|mesh-list
111069376|NCT02224846|Vasodilator Agents|vasodilator agents|mesh-ancestor
111069377|NCT02224846|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111069378|NCT02224846|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111069379|NCT02224846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111069380|NCT02224846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111069381|NCT02224846|Urological Agents|urological agents|mesh-ancestor
111069382|NCT03470077|Nalbuphine|nalbuphine|mesh-list
111069383|NCT03470077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111069384|NCT03470077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111069385|NCT03470077|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111069386|NCT03470077|Narcotics|narcotics|mesh-ancestor
111069387|NCT03470077|Analgesics|analgesics|mesh-ancestor
111069388|NCT03470077|Sensory System Agents|sensory system agents|mesh-ancestor
111069389|NCT03470077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111069390|NCT02224690|Cannabidiol|cannabidiol|mesh-list
111069391|NCT02224690|Anticonvulsants|anticonvulsants|mesh-ancestor
111069392|NCT03501251|Albendazole|albendazole|mesh-list
111069393|NCT03501251|Moxidectin|moxidectin|mesh-list
111069394|NCT03501251|Anthelmintics|anthelmintics|mesh-ancestor
111069395|NCT03501251|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111069396|NCT03501251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111069397|NCT03501251|Anticestodal Agents|anticestodal agents|mesh-ancestor
111069398|NCT03501251|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
111069399|NCT03501251|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111069400|NCT03501251|Tubulin Modulators|tubulin modulators|mesh-ancestor
111069401|NCT03501251|Antimitotic Agents|antimitotic agents|mesh-ancestor
111069402|NCT03501251|Mitosis Modulators|mitosis modulators|mesh-ancestor
111069403|NCT03501251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111069404|NCT03501251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111069405|NCT03501251|Antinematodal Agents|antinematodal agents|mesh-ancestor
111069406|NCT05163691|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
111069407|NCT05163691|Hallucinogens|hallucinogens|mesh-ancestor
111069408|NCT05163691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111069409|NCT05163691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111069410|NCT05163691|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111069411|NCT05163691|Serotonin Agents|serotonin agents|mesh-ancestor
111069412|NCT05163691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111069413|NCT05163691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111069414|NCT05163691|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111069415|NCT05390203|Testosterone|testosterone|mesh-list
111069416|NCT05390203|Androgens|androgens|mesh-ancestor
111069417|NCT05390203|Hormones|hormones|mesh-ancestor
111069418|NCT05390203|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111069419|NCT05390203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111069420|NCT01634152|Tiotropium Bromide|tiotropium bromide|mesh-list
111069421|NCT01634152|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111069422|NCT01634152|Autonomic Agents|autonomic agents|mesh-ancestor
111069423|NCT01634152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111069424|NCT01634152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111069425|NCT01634152|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111069426|NCT01634152|Respiratory System Agents|respiratory system agents|mesh-ancestor
111069427|NCT01634152|Parasympatholytics|parasympatholytics|mesh-ancestor
111069428|NCT01634152|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111069429|NCT01634152|Cholinergic Agents|cholinergic agents|mesh-ancestor
111069430|NCT01634152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111069431|NCT01634152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111069432|NCT02315495|Saxagliptin|saxagliptin|mesh-list
111069433|NCT02315495|Acarbose|acarbose|mesh-list
111069434|NCT02315495|Incretins|incretins|mesh-ancestor
111069435|NCT02315495|Hormones|hormones|mesh-ancestor
111069436|NCT02315495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111069437|NCT02315495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111069438|NCT02315495|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111069439|NCT02315495|Protease Inhibitors|protease inhibitors|mesh-ancestor
111069440|NCT02315495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111069441|NCT02315495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111069442|NCT02315495|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111069443|NCT02315495|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
111069444|NCT02317601|Methylprednisolone|methylprednisolone|mesh-list
111069445|NCT02317601|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111069446|NCT02317601|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111069447|NCT02317601|Prednisolone|prednisolone|mesh-list
111069448|NCT02317601|Prednisolone acetate|prednisolone acetate|mesh-list
111069449|NCT02317601|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111069450|NCT02317601|Prednisolone phosphate|prednisolone phosphate|mesh-list
111069451|NCT02317601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111069452|NCT02317601|Antiemetics|antiemetics|mesh-ancestor
111069453|NCT02317601|Autonomic Agents|autonomic agents|mesh-ancestor
111069454|NCT02317601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111069455|NCT02317601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111069456|NCT02317601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111069457|NCT02317601|Glucocorticoids|glucocorticoids|mesh-ancestor
111069458|NCT02317601|Hormones|hormones|mesh-ancestor
111069459|NCT02317601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111069460|NCT02317601|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111069461|NCT02317601|Protective Agents|protective agents|mesh-ancestor
111069462|NCT02317601|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111069463|NCT02317601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111069464|NCT05101785|Lidocaine|lidocaine|mesh-list
111069465|NCT05101785|Epinephrine|epinephrine|mesh-list
111069466|NCT05101785|Racepinephrine|racepinephrine|mesh-list
111069467|NCT05101785|Carticaine|carticaine|mesh-list
111069468|NCT05101785|Epinephryl borate|epinephryl borate|mesh-list
111069469|NCT05101785|Anesthetics, Local|anesthetics, local|mesh-ancestor
111069470|NCT05101785|Anesthetics|anesthetics|mesh-ancestor
111069471|NCT05101785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111069472|NCT05101785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111069473|NCT05101785|Sensory System Agents|sensory system agents|mesh-ancestor
111069474|NCT05101785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111069475|NCT05101785|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111069476|NCT05101785|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111069477|NCT05101785|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111069478|NCT05101785|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111069479|NCT05101785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111069480|NCT05101785|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111069481|NCT05101785|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111069482|NCT05101785|Adrenergic Agents|adrenergic agents|mesh-ancestor
111069483|NCT05101785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111069484|NCT05101785|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111069485|NCT05101785|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111069486|NCT05101785|Autonomic Agents|autonomic agents|mesh-ancestor
111069487|NCT05101785|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111069488|NCT05101785|Respiratory System Agents|respiratory system agents|mesh-ancestor
111069489|NCT05101785|Mydriatics|mydriatics|mesh-ancestor
111069490|NCT05101785|Sympathomimetics|sympathomimetics|mesh-ancestor
111069491|NCT05101785|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111069492|NCT02315573|Lidocaine|lidocaine|mesh-list
111069493|NCT02315573|Epinephrine|epinephrine|mesh-list
111069494|NCT02315573|Racepinephrine|racepinephrine|mesh-list
111069495|NCT02315573|Bupivacaine|bupivacaine|mesh-list
111069496|NCT02315573|Epinephryl borate|epinephryl borate|mesh-list
111069497|NCT02315573|Anesthetics, Local|anesthetics, local|mesh-ancestor
111069498|NCT02315573|Anesthetics|anesthetics|mesh-ancestor
111069499|NCT02315573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111069500|NCT02315573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111069501|NCT02315573|Sensory System Agents|sensory system agents|mesh-ancestor
111069502|NCT02315573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111069503|NCT02315573|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111069504|NCT02315573|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111069505|NCT02315573|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111069506|NCT02315573|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111069507|NCT02315573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111069508|NCT02315573|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111069509|NCT02315573|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111069510|NCT02315573|Adrenergic Agents|adrenergic agents|mesh-ancestor
111069511|NCT02315573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111069512|NCT02315573|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111069513|NCT02315573|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111069514|NCT02315573|Autonomic Agents|autonomic agents|mesh-ancestor
111069515|NCT02315573|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111069516|NCT02315573|Respiratory System Agents|respiratory system agents|mesh-ancestor
111069517|NCT02315573|Mydriatics|mydriatics|mesh-ancestor
111069518|NCT02315573|Sympathomimetics|sympathomimetics|mesh-ancestor
111069519|NCT02315573|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111069520|NCT02724241|Nicotine|nicotine|mesh-list
111069521|NCT02724241|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111069522|NCT02724241|Autonomic Agents|autonomic agents|mesh-ancestor
111069523|NCT02724241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111069524|NCT02724241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111069525|NCT02724241|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111069526|NCT02724241|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111069527|NCT02724241|Cholinergic Agents|cholinergic agents|mesh-ancestor
111069528|NCT02724241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111069529|NCT02724241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111069530|NCT02315651|Ubiquinone|ubiquinone|mesh-list
111069531|NCT02315651|Coenzyme Q10|coenzyme q10|mesh-list
111069532|NCT02315651|Micronutrients|micronutrients|mesh-ancestor
111069533|NCT02315651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111069534|NCT02315651|Vitamins|vitamins|mesh-ancestor
111069535|NCT05366725|Avelumab|avelumab|mesh-list
111069536|NCT05366725|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111069537|NCT05366725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111069538|NCT04437693|Hydroxychloroquine|hydroxychloroquine|mesh-list
111069539|NCT04437693|Antimalarials|antimalarials|mesh-ancestor
111069540|NCT04437693|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111069541|NCT04437693|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111069542|NCT04437693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111069543|NCT04437693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111069544|NCT04437693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111069545|NCT04437693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111069546|NCT02317679|Bosentan|bosentan|mesh-list
111069547|NCT02317679|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111069548|NCT02317679|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
111069549|NCT02317679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111069550|NCT03475381|Ivacaftor|ivacaftor|mesh-list
111069551|NCT03475381|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
111069552|NCT03475381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111069553|NCT03475381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111069554|NCT04462757|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
111069555|NCT04462757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111069556|NCT04535505|Erythromycin|erythromycin|mesh-list
111069557|NCT04535505|Erythromycin Estolate|erythromycin estolate|mesh-list
111069558|NCT04535505|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
111069559|NCT04535505|Erythromycin stearate|erythromycin stearate|mesh-list
111069560|NCT04535505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111069561|NCT04535505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111069562|NCT04535505|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111069563|NCT04535505|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111069564|NCT04535505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111069565|NCT04535505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111069566|NCT03500783|Nitric Oxide|nitric oxide|mesh-list
111069567|NCT03500783|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110786675|NCT03925233|Letrozole|letrozole|mesh-list
111069568|NCT03500783|Autonomic Agents|autonomic agents|mesh-ancestor
111069569|NCT03500783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111069570|NCT03500783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111069571|NCT03500783|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111069572|NCT03500783|Respiratory System Agents|respiratory system agents|mesh-ancestor
111069573|NCT03500783|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111069574|NCT03500783|Antioxidants|antioxidants|mesh-ancestor
110828078|NCT00022763|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111069575|NCT03500783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111069576|NCT03500783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111069577|NCT03500783|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
111069578|NCT03500783|Vasodilator Agents|vasodilator agents|mesh-ancestor
111069579|NCT03500783|Gasotransmitters|gasotransmitters|mesh-ancestor
111069580|NCT03500783|Protective Agents|protective agents|mesh-ancestor
111069582|NCT03353233|Anesthetics, Local|anesthetics, local|mesh-ancestor
111069583|NCT03353233|Anesthetics|anesthetics|mesh-ancestor
111069584|NCT03353233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111069585|NCT03353233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111069586|NCT03353233|Sensory System Agents|sensory system agents|mesh-ancestor
111069587|NCT03353233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111069588|NCT02320877|Methaqualone|methaqualone|mesh-list
111069589|NCT02320877|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111069590|NCT02320877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111069591|NCT02320877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111069592|NCT01322971|Metronidazole|metronidazole|mesh-list
111069593|NCT01322971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111069594|NCT01322971|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111069595|NCT01322971|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111069596|NCT01322971|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111069597|NCT04454281|Naloxone|naloxone|mesh-list
111069598|NCT04454281|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111069599|NCT04454281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111069600|NCT04454281|Sensory System Agents|sensory system agents|mesh-ancestor
111069601|NCT04454281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111069602|NCT02318225|Misoprostol|misoprostol|mesh-list
111069603|NCT02318225|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111069604|NCT02318225|Abortifacient Agents|abortifacient agents|mesh-ancestor
111069605|NCT02318225|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111069606|NCT02318225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111069607|NCT02318225|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111069608|NCT02318225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111069609|NCT02318225|Oxytocics|oxytocics|mesh-ancestor
111069610|NCT01378429|Ciclesonide|ciclesonide|mesh-list
111069611|NCT01378429|Glucocorticoids|glucocorticoids|mesh-ancestor
111069612|NCT01378429|Hormones|hormones|mesh-ancestor
111069613|NCT01378429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111069614|NCT01378429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111069615|NCT01378429|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111069616|NCT01599754|Axitinib|axitinib|mesh-list
111069617|NCT01599754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111069618|NCT01599754|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111069619|NCT01599754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111069620|NCT01599754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111069621|NCT02321267|Ranibizumab|ranibizumab|mesh-list
111069622|NCT02321267|Aflibercept|aflibercept|mesh-list
111069623|NCT02321267|Verteporfin|verteporfin|mesh-list
111069624|NCT02321267|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111069625|NCT02321267|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111069626|NCT02321267|Growth Substances|growth substances|mesh-ancestor
111069627|NCT02321267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111069628|NCT02321267|Growth Inhibitors|growth inhibitors|mesh-ancestor
111069629|NCT02321267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111069630|NCT02321267|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111069631|NCT02321267|Dermatologic Agents|dermatologic agents|mesh-ancestor
111069632|NCT02318537|Cannabidiol|cannabidiol|mesh-list
111069633|NCT02318537|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111069634|NCT02318537|Anticonvulsants|anticonvulsants|mesh-ancestor
111069635|NCT04642261|Empagliflozin|empagliflozin|mesh-list
110828084|NCT01285141|Immunologic Factors|immunologic factors|mesh-ancestor
111069636|NCT04642261|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111069637|NCT04642261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111069638|NCT04642261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111069639|NCT04642261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111069640|NCT02318771|Pembrolizumab|pembrolizumab|mesh-list
111069641|NCT02318771|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110786753|NCT01345162|Narcotics|narcotics|mesh-ancestor
111069642|NCT02318771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111069643|NCT02318771|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111069644|NCT02318771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111069645|NCT04936399|Nivolumab|nivolumab|mesh-list
111069646|NCT04936399|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111069647|NCT04936399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111069648|NCT04936399|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111069649|NCT04936399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111069650|NCT02319161|Calcium Channel Blockers|calcium channel blockers|mesh-list
111069651|NCT02319161|Calcium|calcium|mesh-list
111069652|NCT02319161|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
111069653|NCT02319161|Esmolol|esmolol|mesh-list
111069654|NCT02319161|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111069655|NCT02319161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111069656|NCT02319161|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111069657|NCT02319161|Adrenergic Agents|adrenergic agents|mesh-ancestor
111069658|NCT02319161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111069659|NCT02319161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111069660|NCT02319161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111069661|NCT02319161|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
111069662|NCT02321579|Vitamin B 6|vitamin b 6|mesh-list
111069663|NCT02321579|Pyridoxal|pyridoxal|mesh-list
111069664|NCT02321579|Pyridoxine|pyridoxine|mesh-list
111069665|NCT02321579|Vitamins|vitamins|mesh-ancestor
111069666|NCT02321579|Micronutrients|micronutrients|mesh-ancestor
111069667|NCT02321579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111069668|NCT02321579|Vitamin B Complex|vitamin b complex|mesh-ancestor
111069669|NCT01584934|Sodium Oxybate|sodium oxybate|mesh-list
111069670|NCT01584934|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111069671|NCT01584934|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111069672|NCT01584934|Anesthetics, General|anesthetics, general|mesh-ancestor
111069673|NCT01584934|Anesthetics|anesthetics|mesh-ancestor
111069674|NCT01584934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111069675|NCT01584934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111069676|NCT03109691|Dexamethasone|dexamethasone|mesh-list
111069677|NCT03109691|Bupivacaine|bupivacaine|mesh-list
111069678|NCT03109691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111069679|NCT03109691|Antiemetics|antiemetics|mesh-ancestor
111069680|NCT03109691|Autonomic Agents|autonomic agents|mesh-ancestor
111069681|NCT03109691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111069682|NCT03109691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111069683|NCT03109691|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111069684|NCT03109691|Glucocorticoids|glucocorticoids|mesh-ancestor
111069685|NCT03109691|Hormones|hormones|mesh-ancestor
111069686|NCT03109691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111069687|NCT03109691|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111069688|NCT03109691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111069689|NCT03109691|Anesthetics, Local|anesthetics, local|mesh-ancestor
111069690|NCT03109691|Anesthetics|anesthetics|mesh-ancestor
111069691|NCT03109691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111069692|NCT03109691|Sensory System Agents|sensory system agents|mesh-ancestor
111069693|NCT03497351|Nicardipine|nicardipine|mesh-list
111069694|NCT03497351|Urapidil|urapidil|mesh-list
111069695|NCT03497351|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111069696|NCT03497351|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111069697|NCT03497351|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111069698|NCT03497351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111069699|NCT03497351|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111069700|NCT03497351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111069701|NCT03497351|Vasodilator Agents|vasodilator agents|mesh-ancestor
111069702|NCT03497351|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111069703|NCT03497351|Serotonin Agents|serotonin agents|mesh-ancestor
111069704|NCT03497351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111069705|NCT03497351|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111069706|NCT03497351|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111069707|NCT03497351|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111069708|NCT03497351|Adrenergic Agents|adrenergic agents|mesh-ancestor
111069709|NCT02223364|Bupivacaine|bupivacaine|mesh-list
111069710|NCT02223364|Ropivacaine|ropivacaine|mesh-list
111069711|NCT02223364|Anesthetics, Local|anesthetics, local|mesh-ancestor
111069712|NCT02223364|Anesthetics|anesthetics|mesh-ancestor
111069713|NCT02223364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111069714|NCT02223364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111069715|NCT02223364|Sensory System Agents|sensory system agents|mesh-ancestor
111069716|NCT02223364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111069717|NCT01378975|Vemurafenib|vemurafenib|mesh-list
111069718|NCT01378975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111069719|NCT01378975|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111069720|NCT01378975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111069721|NCT01378975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111069722|NCT02222896|Chlorhexidine|chlorhexidine|mesh-list
111069723|NCT02222896|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
111069724|NCT02222896|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111069725|NCT02222896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111069726|NCT02222896|Disinfectants|disinfectants|mesh-ancestor
111069727|NCT02222896|Dermatologic Agents|dermatologic agents|mesh-ancestor
111069728|NCT03499457|Amoxicillin|amoxicillin|mesh-list
111069729|NCT03499457|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111069730|NCT03499457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111069731|NCT03499379|Levonorgestrel|levonorgestrel|mesh-list
111069732|NCT03499379|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111069733|NCT03499379|Contraceptive Agents|contraceptive agents|mesh-ancestor
111069734|NCT03499379|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111069735|NCT03499379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111069736|NCT03499379|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111069737|NCT03499379|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111069738|NCT03499379|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111069739|NCT02322203|Niacin|niacin|mesh-list
111069740|NCT02322203|Niacinamide|niacinamide|mesh-list
111069741|NCT02322203|Nicotinic Acids|nicotinic acids|mesh-list
111069742|NCT02322203|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111069743|NCT02322203|Antimetabolites|antimetabolites|mesh-ancestor
111069744|NCT02322203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111069745|NCT02322203|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111069746|NCT02322203|Vasodilator Agents|vasodilator agents|mesh-ancestor
111069747|NCT02322203|Vitamin B Complex|vitamin b complex|mesh-ancestor
111069748|NCT02322203|Vitamins|vitamins|mesh-ancestor
111069749|NCT02322203|Micronutrients|micronutrients|mesh-ancestor
111069750|NCT02322203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111069751|NCT04638751|Immunomodulating Agents|immunomodulating agents|mesh-list
111069752|NCT04638751|Immunologic Factors|immunologic factors|mesh-ancestor
111069753|NCT04638751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111069754|NCT02319629|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
111069755|NCT02319629|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
111069756|NCT02319629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111069757|NCT04691362|Tranexamic Acid|tranexamic acid|mesh-list
111069758|NCT04691362|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111069759|NCT04691362|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111069760|NCT04691362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111069761|NCT04691362|Hemostatics|hemostatics|mesh-ancestor
111069762|NCT04691362|Coagulants|coagulants|mesh-ancestor
111069763|NCT03499223|Ranibizumab|ranibizumab|mesh-list
111069764|NCT03499223|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111069765|NCT03499223|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111069766|NCT03499223|Growth Substances|growth substances|mesh-ancestor
111069767|NCT03499223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111069768|NCT03499223|Growth Inhibitors|growth inhibitors|mesh-ancestor
111069769|NCT03499223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111069770|NCT02319707|Oxytocin|oxytocin|mesh-list
111069771|NCT02319707|Oxytocics|oxytocics|mesh-ancestor
111069772|NCT02319707|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111069773|NCT02319707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111069774|NCT05398861|Bevacizumab|bevacizumab|mesh-list
111069775|NCT05398861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111069776|NCT05398861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111069777|NCT05398861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111069778|NCT05398861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111069779|NCT05398861|Growth Substances|growth substances|mesh-ancestor
111069780|NCT05398861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111069781|NCT05398861|Growth Inhibitors|growth inhibitors|mesh-ancestor
111069782|NCT02448329|Paclitaxel|paclitaxel|mesh-list
111069783|NCT02448329|Adavosertib|adavosertib|mesh-list
110534870|NCT00910416|Propofol|propofol|mesh-list
111069784|NCT02448329|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111069785|NCT02448329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111069786|NCT02448329|Tubulin Modulators|tubulin modulators|mesh-ancestor
111069787|NCT02448329|Antimitotic Agents|antimitotic agents|mesh-ancestor
111069788|NCT02448329|Mitosis Modulators|mitosis modulators|mesh-ancestor
111069789|NCT02448329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111069790|NCT02448329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111069791|NCT05398393|Tenofovir|tenofovir|mesh-list
111069792|NCT05398393|Amlodipine|amlodipine|mesh-list
111069793|NCT05398393|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
111069794|NCT05398393|Atorvastatin|atorvastatin|mesh-list
111069795|NCT05398393|Hypolipidemic Agents|hypolipidemic agents|mesh-list
111069796|NCT05398393|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111069797|NCT05398393|Antimetabolites|antimetabolites|mesh-ancestor
111069798|NCT05398393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111069799|NCT05398393|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111069800|NCT05398393|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111069801|NCT05398393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111069802|NCT05398393|Antiviral Agents|antiviral agents|mesh-ancestor
111069803|NCT05398393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111069804|NCT05398393|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111069805|NCT05398393|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111069806|NCT05398393|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111069807|NCT05398393|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111069808|NCT05398393|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111069809|NCT05398393|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111069810|NCT05398393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111069811|NCT05398393|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111069812|NCT05398393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111069813|NCT05398393|Vasodilator Agents|vasodilator agents|mesh-ancestor
111069814|NCT01356628|Palbociclib|palbociclib|mesh-list
111069815|NCT01356628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111069816|NCT01356628|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111069817|NCT01356628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111069818|NCT01356628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111069819|NCT02319941|Clopidogrel|clopidogrel|mesh-list
111069820|NCT02319941|Ticagrelor|ticagrelor|mesh-list
111069821|NCT02319941|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111069822|NCT02319941|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111069823|NCT02319941|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111069824|NCT02319941|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111069825|NCT02319941|Purinergic Agents|purinergic agents|mesh-ancestor
111069826|NCT02319941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111069827|NCT02319941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111069828|NCT02319941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111069829|NCT05164627|Magnesium Sulfate|magnesium sulfate|mesh-list
111069830|NCT05164627|Dexmedetomidine|dexmedetomidine|mesh-list
111069831|NCT05164627|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111069832|NCT05164627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111069833|NCT05164627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111069834|NCT05164627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111069835|NCT05164627|Analgesics|analgesics|mesh-ancestor
111069836|NCT05164627|Sensory System Agents|sensory system agents|mesh-ancestor
111069837|NCT05164627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111069838|NCT05164627|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111069839|NCT05164627|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111069840|NCT05164627|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111069841|NCT05164627|Adrenergic Agents|adrenergic agents|mesh-ancestor
111069842|NCT05164627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110157449|NCT00846235|Glycerol|glycerol|mesh-list
111069843|NCT05164627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111069844|NCT05164627|Anesthetics|anesthetics|mesh-ancestor
111069845|NCT05164627|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111069846|NCT05164627|Anticonvulsants|anticonvulsants|mesh-ancestor
111069847|NCT05164627|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111069848|NCT05164627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111069849|NCT05164627|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111069850|NCT05164627|Tocolytic Agents|tocolytic agents|mesh-ancestor
111069851|NCT05164627|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111069852|NCT02322671|Montelukast|montelukast|mesh-list
111069853|NCT02322671|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111069854|NCT02322671|Respiratory System Agents|respiratory system agents|mesh-ancestor
111069855|NCT02322671|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
111069856|NCT02322671|Hormone Antagonists|hormone antagonists|mesh-ancestor
111069857|NCT02322671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111069858|NCT02322671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111069859|NCT02322671|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
111069860|NCT02322671|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111069861|NCT02322671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111069862|NCT05096143|Valsartan|valsartan|mesh-list
111069863|NCT05096143|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
111069864|NCT05096143|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111069865|NCT05096143|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111069866|NCT05096143|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111069867|NCT05096143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111069868|NCT03494387|Ascorbic Acid|ascorbic acid|mesh-list
111069869|NCT03494387|Acetylcysteine|acetylcysteine|mesh-list
111069870|NCT03494387|Antioxidants|antioxidants|mesh-list
111069871|NCT03494387|Antiviral Agents|antiviral agents|mesh-ancestor
111069872|NCT03494387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111069873|NCT03494387|Expectorants|expectorants|mesh-ancestor
111069874|NCT03494387|Respiratory System Agents|respiratory system agents|mesh-ancestor
111069875|NCT03494387|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111069876|NCT03494387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111069877|NCT03494387|Protective Agents|protective agents|mesh-ancestor
111069878|NCT03494387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111069879|NCT03494387|Vitamins|vitamins|mesh-ancestor
111069880|NCT03494387|Micronutrients|micronutrients|mesh-ancestor
111069881|NCT03496649|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111069882|NCT03496649|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111069883|NCT03496649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111069884|NCT03496649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111069885|NCT03496649|Cholinergic Agents|cholinergic agents|mesh-ancestor
111069886|NCT03496649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111069887|NCT03496649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111069888|NCT02324621|TIC10 compound|tic10 compound|mesh-list
111069889|NCT02324621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111069890|NCT03821545|Lidocaine|lidocaine|mesh-list
111069891|NCT03821545|Ketamine|ketamine|mesh-list
111069892|NCT03821545|Anesthetics, Local|anesthetics, local|mesh-ancestor
111069893|NCT03821545|Anesthetics|anesthetics|mesh-ancestor
111069894|NCT03821545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111069895|NCT03821545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111069896|NCT03821545|Sensory System Agents|sensory system agents|mesh-ancestor
111069897|NCT03821545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111069898|NCT03821545|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111069899|NCT03821545|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111069900|NCT03821545|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111069901|NCT03821545|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111069902|NCT03821545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111069903|NCT03821545|Analgesics|analgesics|mesh-ancestor
111069904|NCT03821545|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111069905|NCT03821545|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111069906|NCT03821545|Anesthetics, General|anesthetics, general|mesh-ancestor
111069907|NCT03821545|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111069908|NCT03821545|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111069909|NCT03821545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111069910|NCT02324933|Fentanyl|fentanyl|mesh-list
111069911|NCT02324933|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111069912|NCT02324933|Narcotics|narcotics|mesh-ancestor
111069913|NCT02324933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111069914|NCT02324933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111069915|NCT02324933|Analgesics|analgesics|mesh-ancestor
111069916|NCT02324933|Sensory System Agents|sensory system agents|mesh-ancestor
111069917|NCT02324933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111069918|NCT02324933|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111069919|NCT02324933|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111069920|NCT02324933|Anesthetics, General|anesthetics, general|mesh-ancestor
111069921|NCT02324933|Anesthetics|anesthetics|mesh-ancestor
111069922|NCT01378117|Insulin Glargine|insulin glargine|mesh-list
111069923|NCT01378117|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111069924|NCT01378117|Insulin Lispro|insulin lispro|mesh-list
111069925|NCT01378117|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111069926|NCT01378117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111069927|NCT01378117|Incretins|incretins|mesh-ancestor
111069928|NCT01378117|Hormones|hormones|mesh-ancestor
111069929|NCT01378117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111069930|NCT01378117|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111069931|NCT01378117|Protease Inhibitors|protease inhibitors|mesh-ancestor
111069932|NCT01378117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111069933|NCT01378117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111069934|NCT02323139|Azacitidine|azacitidine|mesh-list
111069935|NCT02323139|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111069936|NCT02323139|Antimetabolites|antimetabolites|mesh-ancestor
111069937|NCT02323139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111069938|NCT02323139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111069939|NCT02323139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111069940|NCT02325245|Metformin|metformin|mesh-list
111069941|NCT02325245|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111069942|NCT02325245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111069943|NCT02323373|Tranexamic Acid|tranexamic acid|mesh-list
111069944|NCT02323373|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111069945|NCT02323373|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111069946|NCT02323373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111069947|NCT02323373|Hemostatics|hemostatics|mesh-ancestor
111069948|NCT02323373|Coagulants|coagulants|mesh-ancestor
111069949|NCT02325479|Enoxaparin|enoxaparin|mesh-list
111069950|NCT02325479|Anticoagulants|anticoagulants|mesh-ancestor
111069951|NCT02325479|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111069952|NCT02325479|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111069953|NCT02325479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111069954|NCT05236231|Tadalafil|tadalafil|mesh-list
111069955|NCT05236231|Macitentan|macitentan|mesh-list
111069956|NCT05236231|Vasodilator Agents|vasodilator agents|mesh-ancestor
111069957|NCT05236231|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111069958|NCT05236231|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111069959|NCT05236231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111069960|NCT05236231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111069961|NCT05236231|Urological Agents|urological agents|mesh-ancestor
111069962|NCT05236231|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
111069963|NCT05236231|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
111069964|NCT05236231|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
111069965|NCT02325557|Pembrolizumab|pembrolizumab|mesh-list
111069966|NCT02325557|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111069967|NCT02325557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111069968|NCT02325557|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111069969|NCT02325557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111069970|NCT03495323|Prexasertib|prexasertib|mesh-list
111069971|NCT03495323|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111069972|NCT03495323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111069973|NCT03495323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111069974|NCT02323451|Chitosan|chitosan|mesh-list
111069975|NCT02323451|Hyaluronic Acid|hyaluronic acid|mesh-list
111069976|NCT02323451|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111069977|NCT02323451|Immunologic Factors|immunologic factors|mesh-ancestor
110637621|NCT00838370|Immunologic Factors|immunologic factors|mesh-ancestor
111069978|NCT02323451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111069979|NCT02323451|Viscosupplements|viscosupplements|mesh-ancestor
111069980|NCT02323451|Protective Agents|protective agents|mesh-ancestor
111069981|NCT02323451|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111069982|NCT02323451|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111069983|NCT02323451|Antimetabolites|antimetabolites|mesh-ancestor
111069984|NCT02323451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111069985|NCT02323451|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111069986|NCT02323451|Chelating Agents|chelating agents|mesh-ancestor
111069987|NCT02323451|Sequestering Agents|sequestering agents|mesh-ancestor
111069988|NCT02323451|Hemostatics|hemostatics|mesh-ancestor
111069989|NCT02323451|Coagulants|coagulants|mesh-ancestor
111069990|NCT02323529|Nitisinone|nitisinone|mesh-list
111069991|NCT02323529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111069992|NCT02323529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111069993|NCT02323607|Cytarabine|cytarabine|mesh-list
111069994|NCT02323607|Decitabine|decitabine|mesh-list
111069995|NCT02323607|Daunorubicin|daunorubicin|mesh-list
111069996|NCT02323607|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111069997|NCT02323607|Antimetabolites|antimetabolites|mesh-ancestor
111069998|NCT02323607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111069999|NCT02323607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111070000|NCT02323607|Antiviral Agents|antiviral agents|mesh-ancestor
111070001|NCT02323607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111070002|NCT02323607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111070003|NCT02323607|Immunologic Factors|immunologic factors|mesh-ancestor
111070004|NCT02323607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111070005|NCT02323607|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111070006|NCT02323607|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111070007|NCT02323607|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111070008|NCT02323607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111070009|NCT03493841|Thioctic Acid|thioctic acid|mesh-list
111070010|NCT03493841|Antioxidants|antioxidants|mesh-ancestor
111070011|NCT03493841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111070012|NCT03493841|Protective Agents|protective agents|mesh-ancestor
111070013|NCT03493841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111070014|NCT03493841|Vitamin B Complex|vitamin b complex|mesh-ancestor
111070015|NCT03493841|Vitamins|vitamins|mesh-ancestor
111070016|NCT03493841|Micronutrients|micronutrients|mesh-ancestor
111070017|NCT05118737|Colchicine|colchicine|mesh-list
111070018|NCT05118737|Gout Suppressants|gout suppressants|mesh-ancestor
111070019|NCT05118737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111070020|NCT05118737|Tubulin Modulators|tubulin modulators|mesh-ancestor
111070021|NCT05118737|Antimitotic Agents|antimitotic agents|mesh-ancestor
111070022|NCT05118737|Mitosis Modulators|mitosis modulators|mesh-ancestor
111070023|NCT05118737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111070024|NCT05118737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111070025|NCT04987931|Talazoparib|talazoparib|mesh-list
111070026|NCT04987931|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111070027|NCT04987931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111070028|NCT04987931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111070029|NCT04987931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111070030|NCT03492827|Chlorhexidine|chlorhexidine|mesh-list
111070031|NCT03492827|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
111070032|NCT03492827|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111070033|NCT03492827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111070034|NCT03492827|Disinfectants|disinfectants|mesh-ancestor
111070035|NCT03492827|Dermatologic Agents|dermatologic agents|mesh-ancestor
111070036|NCT03491579|Cytarabine|cytarabine|mesh-list
111070037|NCT03491579|Cladribine|cladribine|mesh-list
111070038|NCT03491579|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111070039|NCT03491579|Antimetabolites|antimetabolites|mesh-ancestor
111070040|NCT03491579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111070041|NCT03491579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111070042|NCT03491579|Antiviral Agents|antiviral agents|mesh-ancestor
111070043|NCT03491579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111070044|NCT03491579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111070045|NCT03491579|Immunologic Factors|immunologic factors|mesh-ancestor
111070046|NCT03491579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111070047|NCT04600895|Favipiravir|favipiravir|mesh-list
111070048|NCT04600895|Antiviral Agents|antiviral agents|mesh-ancestor
111070049|NCT04600895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111070050|NCT03492593|Beta Carotene|beta carotene|mesh-list
111070051|NCT03492593|Lycopene|lycopene|mesh-list
111070052|NCT03492593|Carotenoids|carotenoids|mesh-list
111070053|NCT03492593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111070054|NCT03492593|Antioxidants|antioxidants|mesh-ancestor
111070055|NCT03492593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111070056|NCT03492593|Protective Agents|protective agents|mesh-ancestor
111070057|NCT03492593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111070058|NCT03492593|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111070059|NCT03492593|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
111070060|NCT03492593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111070061|NCT03492593|Provitamins|provitamins|mesh-ancestor
111070062|NCT03492593|Vitamins|vitamins|mesh-ancestor
111070063|NCT03492593|Micronutrients|micronutrients|mesh-ancestor
111070064|NCT04461353|Hydroxychloroquine|hydroxychloroquine|mesh-list
111070065|NCT04461353|Antimalarials|antimalarials|mesh-ancestor
111070066|NCT04461353|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111070067|NCT04461353|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111070068|NCT04461353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111070069|NCT04461353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111070070|NCT04461353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111070071|NCT04461353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111070072|NCT04034459|Leucovorin|leucovorin|mesh-list
111070073|NCT04034459|Folic Acid|folic acid|mesh-list
111070074|NCT04034459|Bevacizumab|bevacizumab|mesh-list
111070075|NCT04034459|Cetuximab|cetuximab|mesh-list
111070076|NCT04034459|Oxaliplatin|oxaliplatin|mesh-list
111070077|NCT04034459|Irinotecan|irinotecan|mesh-list
111070078|NCT04034459|Levoleucovorin|levoleucovorin|mesh-list
111070079|NCT04034459|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111070080|NCT04034459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111070081|NCT04034459|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111070082|NCT04034459|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111070083|NCT04034459|Growth Substances|growth substances|mesh-ancestor
111070084|NCT04034459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111070085|NCT04034459|Growth Inhibitors|growth inhibitors|mesh-ancestor
111070086|NCT04034459|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111070087|NCT04034459|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111070088|NCT04034459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111070089|NCT04034459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111070090|NCT04034459|Antidotes|antidotes|mesh-ancestor
111070091|NCT04034459|Protective Agents|protective agents|mesh-ancestor
111070092|NCT04034459|Vitamin B Complex|vitamin b complex|mesh-ancestor
111070093|NCT04034459|Vitamins|vitamins|mesh-ancestor
111070094|NCT04034459|Micronutrients|micronutrients|mesh-ancestor
111070095|NCT04034459|Hematinics|hematinics|mesh-ancestor
111070096|NCT03914885|Fludarabine|fludarabine|mesh-list
111070097|NCT03914885|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
111070098|NCT03914885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111070099|NCT03914885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111070100|NCT03914885|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111070101|NCT03914885|Alkylating Agents|alkylating agents|mesh-ancestor
111070102|NCT03779243|Melatonin|melatonin|mesh-list
111070103|NCT03779243|Antioxidants|antioxidants|mesh-ancestor
111070104|NCT03779243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111070105|NCT03779243|Protective Agents|protective agents|mesh-ancestor
111070106|NCT03779243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111070107|NCT03779243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111070108|NCT03757013|Apremilast|apremilast|mesh-list
111070109|NCT03757013|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111070110|NCT03757013|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111070111|NCT03757013|Analgesics|analgesics|mesh-ancestor
111070112|NCT03757013|Sensory System Agents|sensory system agents|mesh-ancestor
111070113|NCT03757013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111070114|NCT03757013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111070115|NCT03757013|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111070116|NCT03757013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111070117|NCT03757013|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
111070118|NCT03757013|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111070119|NCT03757013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111070120|NCT03757013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111070121|NCT02736409|Budesonide|budesonide|mesh-list
111070122|NCT02736409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111070123|NCT02736409|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111070124|NCT02736409|Autonomic Agents|autonomic agents|mesh-ancestor
111070125|NCT02736409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111070126|NCT02736409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111070127|NCT02736409|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111070128|NCT02736409|Respiratory System Agents|respiratory system agents|mesh-ancestor
111070129|NCT02736409|Glucocorticoids|glucocorticoids|mesh-ancestor
111070130|NCT02736409|Hormones|hormones|mesh-ancestor
111070131|NCT02736409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111070132|NCT05396677|Acetaminophen|acetaminophen|mesh-list
111070133|NCT05396677|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111070134|NCT05396677|Analgesics|analgesics|mesh-ancestor
111070135|NCT05396677|Sensory System Agents|sensory system agents|mesh-ancestor
111070136|NCT05396677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111070137|NCT05396677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111070138|NCT05396677|Antipyretics|antipyretics|mesh-ancestor
111070139|NCT05131867|Nimodipine|nimodipine|mesh-list
111070140|NCT05131867|Milrinone|milrinone|mesh-list
111070141|NCT05131867|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111070142|NCT05131867|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111070143|NCT05131867|Vasodilator Agents|vasodilator agents|mesh-ancestor
111070144|NCT05131867|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
111070145|NCT05131867|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111070146|NCT05131867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111070147|NCT05131867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111070148|NCT05131867|Protective Agents|protective agents|mesh-ancestor
111070149|NCT05131867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111070150|NCT05131867|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111070151|NCT05131867|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111070152|NCT05131867|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111070153|NCT05131867|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111070154|NCT02837783|Linaclotide|linaclotide|mesh-list
111070155|NCT02837783|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
111070156|NCT02837783|Enzyme Activators|enzyme activators|mesh-ancestor
111070157|NCT02837783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111070158|NCT02837783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111070159|NCT02221648|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111070160|NCT02221648|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111070161|NCT02221648|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111070162|NCT02221648|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111070163|NCT02221648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111070164|NCT02221648|Cholinergic Agents|cholinergic agents|mesh-ancestor
111070165|NCT02221648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111070166|NCT02221648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111070167|NCT02221648|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110787295|NCT01135563|Sirolimus|sirolimus|mesh-list
111070168|NCT02221648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111070169|NCT05007145|Paclitaxel|paclitaxel|mesh-list
111070170|NCT05007145|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111070171|NCT05007145|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
111070172|NCT05007145|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111070173|NCT05007145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111070174|NCT05007145|Tubulin Modulators|tubulin modulators|mesh-ancestor
111070175|NCT05007145|Antimitotic Agents|antimitotic agents|mesh-ancestor
111070176|NCT05007145|Mitosis Modulators|mitosis modulators|mesh-ancestor
111070177|NCT05007145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111070178|NCT05007145|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111070179|NCT04952857|Vitamin D|vitamin d|mesh-list
111070180|NCT04952857|Cholecalciferol|cholecalciferol|mesh-list
111070181|NCT04952857|Vitamins|vitamins|mesh-ancestor
111070182|NCT04952857|Micronutrients|micronutrients|mesh-ancestor
111070183|NCT04952857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111070184|NCT04952857|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111070185|NCT04952857|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111070186|NCT02220712|Aripiprazole|aripiprazole|mesh-list
111070187|NCT02220712|Antidepressive Agents|antidepressive agents|mesh-ancestor
111070188|NCT02220712|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111070189|NCT02220712|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111070190|NCT02220712|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111070191|NCT02220712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111070192|NCT02220712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111070193|NCT02220712|Dopamine Agonists|dopamine agonists|mesh-ancestor
111070194|NCT02220712|Dopamine Agents|dopamine agents|mesh-ancestor
111070195|NCT02220712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111070196|NCT02220712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111070197|NCT02220712|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111070198|NCT02220712|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111070199|NCT02220712|Serotonin Agents|serotonin agents|mesh-ancestor
111070200|NCT02220712|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111070201|NCT02220712|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111070202|NCT02220712|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111070203|NCT02220712|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111070204|NCT04923295|Dapagliflozin|dapagliflozin|mesh-list
111070205|NCT04923295|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111070206|NCT04923295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111070207|NCT04923295|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111070208|NCT04923295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111070209|NCT05396209|Dimenhydrinate|dimenhydrinate|mesh-list
111070210|NCT05396209|Antiemetics|antiemetics|mesh-ancestor
111070211|NCT05396209|Autonomic Agents|autonomic agents|mesh-ancestor
111070212|NCT05396209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111070213|NCT05396209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111070214|NCT05396209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111070215|NCT05396209|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111070216|NCT05396209|Histamine Antagonists|histamine antagonists|mesh-ancestor
111070217|NCT05396209|Histamine Agents|histamine agents|mesh-ancestor
111070218|NCT05396209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111070219|NCT05396209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111070220|NCT02219932|4-Aminopyridine|4-aminopyridine|mesh-list
111070221|NCT02219932|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
111070222|NCT02219932|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111070223|NCT02219932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111070224|NCT00846430|Interferons|interferons|mesh-list
111070225|NCT00846430|Interferon-alpha|interferon-alpha|mesh-list
111070226|NCT00846430|Interferon alpha-2|interferon alpha-2|mesh-list
111070227|NCT00846430|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
111070228|NCT00846430|Celecoxib|celecoxib|mesh-list
111070229|NCT00846430|Vincristine|vincristine|mesh-list
111070230|NCT00846430|Temozolomide|temozolomide|mesh-list
111070231|NCT00846430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111070232|NCT00846430|Antiviral Agents|antiviral agents|mesh-ancestor
111070233|NCT00846430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111070234|NCT00846430|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111070235|NCT00846430|Tubulin Modulators|tubulin modulators|mesh-ancestor
111070236|NCT00846430|Antimitotic Agents|antimitotic agents|mesh-ancestor
111070237|NCT00846430|Mitosis Modulators|mitosis modulators|mesh-ancestor
111070238|NCT00846430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111070239|NCT00846430|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111070240|NCT00846430|Alkylating Agents|alkylating agents|mesh-ancestor
111070241|NCT00846430|Immunologic Factors|immunologic factors|mesh-ancestor
111070242|NCT00846430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111070243|NCT00846430|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111070245|NCT00846430|Analgesics|analgesics|mesh-ancestor
111070246|NCT00846430|Sensory System Agents|sensory system agents|mesh-ancestor
111070247|NCT00846430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111070248|NCT00846430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111070249|NCT00846430|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111070250|NCT00846430|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111070251|NCT00846430|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111070252|NCT00846430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111070253|NCT05439577|Heparinoids|heparinoids|mesh-list
111070254|NCT05439577|Glucocorticoids|glucocorticoids|mesh-list
111070255|NCT05439577|Hormones|hormones|mesh-ancestor
111070256|NCT05439577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111070257|NCT05439577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111070258|NCT05439577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111070259|NCT05439577|Anticoagulants|anticoagulants|mesh-ancestor
111070260|NCT05385523|Dexamethasone|dexamethasone|mesh-list
111070261|NCT05385523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111070262|NCT05385523|Antiemetics|antiemetics|mesh-ancestor
111070263|NCT05385523|Autonomic Agents|autonomic agents|mesh-ancestor
111070264|NCT05385523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111070265|NCT05385523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111070266|NCT05385523|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111070267|NCT05385523|Glucocorticoids|glucocorticoids|mesh-ancestor
111070268|NCT05385523|Hormones|hormones|mesh-ancestor
111070269|NCT05385523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111070270|NCT05385523|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111070271|NCT05385523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111070272|NCT03910621|Miglustat|miglustat|mesh-list
111070273|NCT03910621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111070274|NCT03910621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111070275|NCT03910621|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111070276|NCT03910621|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111070277|NCT03910621|Antiviral Agents|antiviral agents|mesh-ancestor
111070278|NCT03910621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111070279|NCT03910621|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
111070280|NCT03910621|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111070281|NCT03910621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111070282|NCT02218372|Vancomycin|vancomycin|mesh-list
111070283|NCT02218372|Fidaxomicin|fidaxomicin|mesh-list
111070284|NCT02218372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111070285|NCT02218372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111070286|NCT02217982|Simethicone|simethicone|mesh-list
111070287|NCT02217982|Loperamide|loperamide|mesh-list
111070288|NCT02217982|Antidiarrheals|antidiarrheals|mesh-list
111070289|NCT02217982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111070290|NCT02217982|Antifoaming Agents|antifoaming agents|mesh-ancestor
111070291|NCT02217982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111070292|NCT02217982|Emollients|emollients|mesh-ancestor
111070293|NCT02217982|Dermatologic Agents|dermatologic agents|mesh-ancestor
111070294|NCT02207608|Hyaluronic Acid|hyaluronic acid|mesh-list
111070295|NCT02207608|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111070296|NCT02207608|Immunologic Factors|immunologic factors|mesh-ancestor
111070297|NCT02207608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111070298|NCT02207608|Viscosupplements|viscosupplements|mesh-ancestor
111070299|NCT02207608|Protective Agents|protective agents|mesh-ancestor
111070300|NCT03530995|Itraconazole|itraconazole|mesh-list
111070301|NCT03530995|Rifampin|rifampin|mesh-list
111070302|NCT03530995|Omeprazole|omeprazole|mesh-list
111070303|NCT03530995|Rabeprazole|rabeprazole|mesh-list
111070304|NCT03530995|Belumosudil|belumosudil|mesh-list
111070305|NCT03530995|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111070306|NCT03530995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111070307|NCT03530995|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111070308|NCT03530995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111070309|NCT03530995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111070310|NCT03530995|Antifungal Agents|antifungal agents|mesh-ancestor
111070311|NCT03530995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111070312|NCT03530995|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111070313|NCT03530995|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111070314|NCT03530995|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111070315|NCT03530995|Hormone Antagonists|hormone antagonists|mesh-ancestor
111070316|NCT03530995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110787424|NCT03739671|Vitamin D|vitamin d|mesh-list
111070317|NCT03530995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111070318|NCT03530995|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111070319|NCT03530995|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111070320|NCT03530995|Antitubercular Agents|antitubercular agents|mesh-ancestor
111070321|NCT03530995|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111070322|NCT03530995|Leprostatic Agents|leprostatic agents|mesh-ancestor
111070323|NCT03530995|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111070324|NCT03530995|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111070325|NCT03530995|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111070326|NCT03530995|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
111070327|NCT03530995|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
111070328|NCT03530995|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
111070329|NCT03530995|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111070330|NCT03530995|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111070331|NCT05438875|Tretinoin|tretinoin|mesh-list
111070332|NCT05438875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111070333|NCT05438875|Keratolytic Agents|keratolytic agents|mesh-ancestor
111070334|NCT05438875|Dermatologic Agents|dermatologic agents|mesh-ancestor
111070335|NCT04740307|Pembrolizumab|pembrolizumab|mesh-list
111070336|NCT04740307|Lenvatinib|lenvatinib|mesh-list
111070337|NCT04740307|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111070338|NCT04740307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111070339|NCT04740307|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111070340|NCT04740307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111070341|NCT04740307|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111070342|NCT04740307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111070343|NCT02207530|Durvalumab|durvalumab|mesh-list
111070344|NCT02207530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111070345|NCT02207530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111070346|NCT05359315|Interferons|interferons|mesh-list
111070347|NCT05359315|Interferon-gamma|interferon-gamma|mesh-list
111070348|NCT05359315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111070349|NCT05359315|Antiviral Agents|antiviral agents|mesh-ancestor
111070350|NCT05359315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111070351|NCT02616055|XL647|xl647|mesh-list
111070352|NCT02616055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111070353|NCT02616055|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111070354|NCT02616055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111070355|NCT02616055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111070356|NCT02207374|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
111070357|NCT02207374|Protease Inhibitors|protease inhibitors|mesh-ancestor
111070358|NCT02207374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111070359|NCT02207374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111070360|NCT02207374|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111070361|NCT02207374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111070362|NCT02786537|Ritonavir|ritonavir|mesh-list
111070363|NCT02786537|Ribavirin|ribavirin|mesh-list
111070364|NCT02786537|Sofosbuvir|sofosbuvir|mesh-list
111070365|NCT02786537|Grazoprevir|grazoprevir|mesh-list
111070366|NCT02786537|Ledipasvir|ledipasvir|mesh-list
111070367|NCT02786537|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
111070368|NCT02786537|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111070369|NCT02786537|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111070370|NCT02786537|Protease Inhibitors|protease inhibitors|mesh-ancestor
111070371|NCT02786537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111070372|NCT02786537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111070373|NCT02786537|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111070374|NCT02786537|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111070375|NCT02786537|Antiviral Agents|antiviral agents|mesh-ancestor
111070376|NCT02786537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111070377|NCT02786537|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111070378|NCT02786537|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111070379|NCT02786537|Antimetabolites|antimetabolites|mesh-ancestor
111070380|NCT03307759|Pembrolizumab|pembrolizumab|mesh-list
111070381|NCT03307759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111070382|NCT03307759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111070383|NCT03307759|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111070384|NCT03307759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111070385|NCT03466645|Vancomycin|vancomycin|mesh-list
111070386|NCT03466645|Cefazolin|cefazolin|mesh-list
111070387|NCT03466645|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111070388|NCT03466645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111070389|NCT04461665|Vitamin D|vitamin d|mesh-list
111070390|NCT04461665|Ergocalciferols|ergocalciferols|mesh-list
111070391|NCT04461665|Cholecalciferol|cholecalciferol|mesh-list
111070392|NCT04461665|Vitamins|vitamins|mesh-list
111070393|NCT04461665|Micronutrients|micronutrients|mesh-ancestor
111070394|NCT04461665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111070395|NCT04461665|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111070396|NCT04461665|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111070397|NCT02252536|Gabapentin|gabapentin|mesh-list
111070398|NCT02252536|Analgesics|analgesics|mesh-ancestor
111070399|NCT02252536|Sensory System Agents|sensory system agents|mesh-ancestor
111070400|NCT02252536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111070401|NCT02252536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111070402|NCT02252536|Anticonvulsants|anticonvulsants|mesh-ancestor
111070403|NCT02252536|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111070404|NCT02252536|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111070405|NCT02252536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111070406|NCT02252536|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111070407|NCT02252536|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111070408|NCT02252536|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111070409|NCT02252536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111070410|NCT02252536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111070411|NCT02252536|Antimanic Agents|antimanic agents|mesh-ancestor
111070412|NCT03490487|Prednisolone|prednisolone|mesh-list
111070413|NCT03490487|Carbamazepine|carbamazepine|mesh-list
111070414|NCT03490487|Oxcarbazepine|oxcarbazepine|mesh-list
111070415|NCT03490487|Levetiracetam|levetiracetam|mesh-list
111070416|NCT03490487|Valproic Acid|valproic acid|mesh-list
111070417|NCT03490487|Anticonvulsants|anticonvulsants|mesh-list
111070418|NCT03490487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111070419|NCT03490487|Glucocorticoids|glucocorticoids|mesh-ancestor
111070420|NCT03490487|Hormones|hormones|mesh-ancestor
111070421|NCT03490487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111070422|NCT03490487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111070423|NCT03490487|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111070424|NCT03490487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111070425|NCT03490487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111070426|NCT03490487|Nootropic Agents|nootropic agents|mesh-ancestor
111070427|NCT03490487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111070428|NCT03490487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111070429|NCT03490487|GABA Agents|gaba agents|mesh-ancestor
111070430|NCT03490487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111070431|NCT03490487|Antimanic Agents|antimanic agents|mesh-ancestor
111070432|NCT03490487|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111070433|NCT03490487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111070434|NCT03490487|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111070435|NCT03490487|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111070436|NCT03490487|Analgesics|analgesics|mesh-ancestor
111070437|NCT03490487|Sensory System Agents|sensory system agents|mesh-ancestor
111070438|NCT03490487|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111070439|NCT03490487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111070440|NCT03490487|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111070441|NCT03490487|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111070442|NCT03490487|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111070443|NCT05271331|Anesthetics|anesthetics|mesh-list
111070444|NCT05271331|Anesthetics, Local|anesthetics, local|mesh-list
111070445|NCT05271331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111070446|NCT05271331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111070447|NCT05271331|Sensory System Agents|sensory system agents|mesh-ancestor
111070448|NCT05271331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111070449|NCT03466567|Cyclosporine|cyclosporine|mesh-list
111070450|NCT03466567|Probenecid|probenecid|mesh-list
111070451|NCT03466567|Cyclosporins|cyclosporins|mesh-list
111070452|NCT03466567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111070453|NCT03466567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111070454|NCT03466567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111070455|NCT03466567|Immunologic Factors|immunologic factors|mesh-ancestor
111070456|NCT03466567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111070457|NCT03466567|Antifungal Agents|antifungal agents|mesh-ancestor
111070458|NCT03466567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111070459|NCT03466567|Dermatologic Agents|dermatologic agents|mesh-ancestor
111070460|NCT03466567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111070461|NCT03466567|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111070462|NCT03466567|Uricosuric Agents|uricosuric agents|mesh-ancestor
111070463|NCT03466567|Gout Suppressants|gout suppressants|mesh-ancestor
111070464|NCT03130153|Aspirin|aspirin|mesh-list
111070465|NCT03130153|Salicylic Acid|salicylic acid|mesh-list
111070466|NCT03130153|Salicylates|salicylates|mesh-list
110787575|NCT01138839|Hormones|hormones|mesh-ancestor
111070467|NCT03130153|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111070468|NCT03130153|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111070470|NCT03130153|Sensory System Agents|sensory system agents|mesh-ancestor
111070471|NCT03130153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111070472|NCT03130153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111070473|NCT03130153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111070474|NCT03130153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111070475|NCT03130153|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111070476|NCT03130153|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111070477|NCT03130153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111070478|NCT03130153|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111070479|NCT03130153|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111070480|NCT03130153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111070481|NCT03130153|Antipyretics|antipyretics|mesh-ancestor
111070482|NCT03130153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111070483|NCT03130153|Antifungal Agents|antifungal agents|mesh-ancestor
111070484|NCT03130153|Keratolytic Agents|keratolytic agents|mesh-ancestor
111070485|NCT03130153|Dermatologic Agents|dermatologic agents|mesh-ancestor
111070486|NCT03466333|Enalapril|enalapril|mesh-list
111070487|NCT03466333|Enalaprilat|enalaprilat|mesh-list
111070488|NCT03466333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111070489|NCT03466333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111070490|NCT03466333|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
111070491|NCT03466333|Protease Inhibitors|protease inhibitors|mesh-ancestor
111070492|NCT03466333|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111070493|NCT05382715|Ozanimod|ozanimod|mesh-list
111070494|NCT05382715|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
111070495|NCT05382715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111070496|NCT05382715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111070497|NCT05382715|Immunologic Factors|immunologic factors|mesh-ancestor
111070498|NCT05382715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111070499|NCT03492047|Acetylcysteine|acetylcysteine|mesh-list
111070500|NCT03492047|Paclitaxel|paclitaxel|mesh-list
111070501|NCT03492047|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111070502|NCT03492047|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111070503|NCT03492047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111070504|NCT03492047|Tubulin Modulators|tubulin modulators|mesh-ancestor
111070505|NCT03492047|Antimitotic Agents|antimitotic agents|mesh-ancestor
111070506|NCT03492047|Mitosis Modulators|mitosis modulators|mesh-ancestor
111070507|NCT03492047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111070508|NCT03492047|Antiviral Agents|antiviral agents|mesh-ancestor
111070509|NCT03492047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111070510|NCT03492047|Expectorants|expectorants|mesh-ancestor
111070511|NCT03492047|Respiratory System Agents|respiratory system agents|mesh-ancestor
111070512|NCT03492047|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111070513|NCT03492047|Antioxidants|antioxidants|mesh-ancestor
111070514|NCT03492047|Protective Agents|protective agents|mesh-ancestor
111070515|NCT03492047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111070516|NCT03492047|Antidotes|antidotes|mesh-ancestor
111070517|NCT02251990|Grazoprevir|grazoprevir|mesh-list
111070518|NCT02251990|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
111070519|NCT02251990|Antiviral Agents|antiviral agents|mesh-ancestor
111070520|NCT02251990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111070521|NCT03490097|Sofosbuvir|sofosbuvir|mesh-list
111070522|NCT03490097|Simvastatin|simvastatin|mesh-list
111070523|NCT03490097|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111070524|NCT03490097|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111070525|NCT03490097|Antimetabolites|antimetabolites|mesh-ancestor
111070526|NCT03490097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111070527|NCT03490097|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111070528|NCT03490097|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111070529|NCT03490097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111070530|NCT03490097|Antiviral Agents|antiviral agents|mesh-ancestor
111070531|NCT03490097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111070532|NCT04453735|Atorvastatin|atorvastatin|mesh-list
111070533|NCT04453735|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111070534|NCT04453735|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111070535|NCT04453735|Antimetabolites|antimetabolites|mesh-ancestor
111070536|NCT04453735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111070537|NCT04453735|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111070538|NCT04453735|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111070539|NCT04453735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111070540|NCT03490019|Metformin|metformin|mesh-list
111070541|NCT03490019|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110787648|NCT01234935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111070542|NCT03490019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111070543|NCT03491969|Thioctic Acid|thioctic acid|mesh-list
111070544|NCT03491969|Antioxidants|antioxidants|mesh-ancestor
111070545|NCT03491969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111070546|NCT03491969|Protective Agents|protective agents|mesh-ancestor
111070547|NCT03491969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111070548|NCT03491969|Vitamin B Complex|vitamin b complex|mesh-ancestor
111070550|NCT03491969|Micronutrients|micronutrients|mesh-ancestor
111070551|NCT05349409|Fluzoparib|fluzoparib|mesh-list
111070552|NCT05349409|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111070553|NCT05349409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111070554|NCT05349409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111070555|NCT05349409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111070556|NCT02251912|Oxytocin|oxytocin|mesh-list
111070557|NCT02251912|Oxytocics|oxytocics|mesh-ancestor
111070558|NCT02251912|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111070559|NCT02251912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111070560|NCT01976273|Glycolic acid|glycolic acid|mesh-list
111070561|NCT01976273|Keratolytic Agents|keratolytic agents|mesh-ancestor
111070562|NCT01976273|Dermatologic Agents|dermatologic agents|mesh-ancestor
111070563|NCT02206048|Proflavine|proflavine|mesh-list
111070564|NCT02206048|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111070565|NCT02206048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111070566|NCT03466021|Liraglutide|liraglutide|mesh-list
111070567|NCT03466021|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111070568|NCT03466021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111070569|NCT03466021|Incretins|incretins|mesh-ancestor
111070570|NCT03466021|Hormones|hormones|mesh-ancestor
111070571|NCT03466021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111070572|NCT04112407|Benzoyl Peroxide|benzoyl peroxide|mesh-list
111070573|NCT04112407|Dermatologic Agents|dermatologic agents|mesh-ancestor
111070574|NCT02205814|(4-amino-5-(4-(4-(2,4-dichloro-3-(2,4-dimethyl-8-quinolyloxymethyl)phenylsulfonamido)tetrahydro-2H-4-pyranoylcarbonyl)piperazino)-5-oxopentyl)(trimethyl)ammonium|(4-amino-5-(4-(4-(2,4-dichloro-3-(2,4-dimethyl-8-quinolyloxymethyl)phenylsulfonamido)tetrahydro-2h-4-pyranoylcarbonyl)piperazino)-5-oxopentyl)(trimethyl)ammonium|mesh-list
111070575|NCT02205814|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
111070576|NCT02205814|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
111070577|NCT02205814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111070578|NCT02205814|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
111070579|NCT02205814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111070580|NCT02205814|Immunologic Factors|immunologic factors|mesh-ancestor
111070581|NCT02205814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111070582|NCT02662985|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111070583|NCT02662985|Immunologic Factors|immunologic factors|mesh-ancestor
111070584|NCT02662985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111070585|NCT04080271|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
111070586|NCT04080271|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111070587|NCT04080271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111070588|NCT03489005|Moxifloxacin|moxifloxacin|mesh-list
111070589|NCT03489005|Zamicastat|zamicastat|mesh-list
111070590|NCT03489005|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111070591|NCT03489005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111070592|NCT03489005|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111070593|NCT03489005|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111070594|NCT03489005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110028166|NCT02241096|Anesthetics|anesthetics|mesh-ancestor
111070595|NCT03489005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111070596|NCT03489005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111070598|NCT02215252|Analgesics|analgesics|mesh-ancestor
111070599|NCT02215252|Sensory System Agents|sensory system agents|mesh-ancestor
111070600|NCT02215252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111070601|NCT02215252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111070602|NCT02215252|Anticonvulsants|anticonvulsants|mesh-ancestor
111070603|NCT02215252|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111070604|NCT02215252|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111070605|NCT02215252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111070606|NCT02215252|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111070607|NCT02215252|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111070608|NCT02215252|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111070609|NCT02215252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111070610|NCT02215252|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111070611|NCT04894721|Ivermectin|ivermectin|mesh-list
111070612|NCT04894721|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111070613|NCT04894721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111070614|NCT02204410|Methylphenidate|methylphenidate|mesh-list
111070615|NCT02204410|Amphetamine|amphetamine|mesh-list
111070616|NCT02204410|Adderall|adderall|mesh-list
111070617|NCT02204410|Dextroamphetamine|dextroamphetamine|mesh-list
111070618|NCT02204410|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111070619|NCT02204410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111070620|NCT02204410|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111070621|NCT02204410|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111070622|NCT02204410|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111070623|NCT02204410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111070624|NCT02204410|Dopamine Agents|dopamine agents|mesh-ancestor
111070625|NCT02204410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111070626|NCT02204410|Sympathomimetics|sympathomimetics|mesh-ancestor
111070627|NCT02204410|Autonomic Agents|autonomic agents|mesh-ancestor
111070628|NCT02204410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111070629|NCT02204410|Adrenergic Agents|adrenergic agents|mesh-ancestor
111070630|NCT02204410|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111070631|NCT03465397|Immunosuppressive Agents|immunosuppressive agents|mesh-list
111070632|NCT03465397|Immunologic Factors|immunologic factors|mesh-ancestor
111070633|NCT03465397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111070634|NCT03461575|Cyclosporine|cyclosporine|mesh-list
111070635|NCT03461575|Cyclosporins|cyclosporins|mesh-list
111070636|NCT03461575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111070637|NCT03461575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111070638|NCT03461575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111070639|NCT03461575|Immunologic Factors|immunologic factors|mesh-ancestor
111070640|NCT03461575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111070641|NCT03461575|Antifungal Agents|antifungal agents|mesh-ancestor
111070642|NCT03461575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111070643|NCT03461575|Dermatologic Agents|dermatologic agents|mesh-ancestor
111070644|NCT03461575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111070645|NCT03461575|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111070646|NCT03131843|Ethanol|ethanol|mesh-list
111070647|NCT03131843|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111070648|NCT03131843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111070649|NCT03131843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111070650|NCT03131843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111070651|NCT02213380|Anesthetics|anesthetics|mesh-list
111070652|NCT02213380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111070653|NCT02213380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111070654|NCT03488147|Esomeprazole|esomeprazole|mesh-list
111070655|NCT03488147|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111070656|NCT03488147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111070657|NCT03488147|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111070658|NCT03488147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111070659|NCT03488147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111070660|NCT03797261|Venetoclax|venetoclax|mesh-list
111070661|NCT03797261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111070662|NCT02202850|Etanercept|etanercept|mesh-list
111070663|NCT02202850|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111070664|NCT02202850|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111070665|NCT02202850|Analgesics|analgesics|mesh-ancestor
111070666|NCT02202850|Sensory System Agents|sensory system agents|mesh-ancestor
111070667|NCT02202850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111070668|NCT02202850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111070669|NCT02202850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111070670|NCT02202850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111070671|NCT02202850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111070672|NCT02202850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111070673|NCT02202850|Immunologic Factors|immunologic factors|mesh-ancestor
111070675|NCT03489395|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111070676|NCT03489395|Antithrombins|antithrombins|mesh-ancestor
111070677|NCT03489395|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111070678|NCT03489395|Protease Inhibitors|protease inhibitors|mesh-ancestor
111070679|NCT03489395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111070680|NCT03489395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111070681|NCT03489395|Anticoagulants|anticoagulants|mesh-ancestor
111070682|NCT03489317|Metformin|metformin|mesh-list
111070683|NCT03489317|Amlodipine|amlodipine|mesh-list
111070684|NCT03489317|Simvastatin|simvastatin|mesh-list
111070685|NCT03489317|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111070686|NCT03489317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111070687|NCT03489317|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111070688|NCT03489317|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111070689|NCT03489317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111070690|NCT03489317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111070691|NCT03489317|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111070692|NCT03489317|Vasodilator Agents|vasodilator agents|mesh-ancestor
111070693|NCT03489317|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111070694|NCT03489317|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111070695|NCT03489317|Antimetabolites|antimetabolites|mesh-ancestor
111070696|NCT03489317|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111070697|NCT03489317|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111070698|NCT03489317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111070699|NCT02212678|Acetylcysteine|acetylcysteine|mesh-list
111070700|NCT02212678|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111070701|NCT02212678|Antiviral Agents|antiviral agents|mesh-ancestor
111070702|NCT02212678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111070703|NCT02212678|Expectorants|expectorants|mesh-ancestor
111070704|NCT02212678|Respiratory System Agents|respiratory system agents|mesh-ancestor
111070705|NCT02212678|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111070706|NCT02212678|Antioxidants|antioxidants|mesh-ancestor
111070707|NCT02212678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111070708|NCT02212678|Protective Agents|protective agents|mesh-ancestor
111070709|NCT02212678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111070710|NCT02212678|Antidotes|antidotes|mesh-ancestor
111070711|NCT03489239|Tenofovir|tenofovir|mesh-list
111070712|NCT03489239|Antiviral Agents|antiviral agents|mesh-ancestor
111070713|NCT03489239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111070714|NCT03489239|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110637704|NCT03791398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111070715|NCT03489239|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111070716|NCT03489239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111070717|NCT03489239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111070718|NCT03489239|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111070719|NCT03489239|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111070720|NCT03489161|Buprenorphine|buprenorphine|mesh-list
111070721|NCT03489161|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111070722|NCT03489161|Narcotics|narcotics|mesh-ancestor
111070723|NCT03489161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111070724|NCT03489161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111070725|NCT03489161|Analgesics|analgesics|mesh-ancestor
111070726|NCT03489161|Sensory System Agents|sensory system agents|mesh-ancestor
111070727|NCT03489161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111070728|NCT03489161|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111070729|NCT04804709|Panobinostat|panobinostat|mesh-list
111070730|NCT04804709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111070731|NCT04804709|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111070732|NCT04804709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111070733|NCT04804709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111070734|NCT04690673|Acetaminophen|acetaminophen|mesh-list
111070735|NCT04690673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111070736|NCT04690673|Analgesics|analgesics|mesh-ancestor
111070737|NCT04690673|Sensory System Agents|sensory system agents|mesh-ancestor
111070738|NCT04690673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111070739|NCT04690673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111070740|NCT04690673|Antipyretics|antipyretics|mesh-ancestor
111070741|NCT03104075|Vaccines|vaccines|mesh-list
110828112|NCT01172509|Baclofen|baclofen|mesh-list
111070742|NCT03104075|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
111070743|NCT03104075|Immunologic Factors|immunologic factors|mesh-ancestor
111070744|NCT03104075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111070745|NCT04388501|Atorvastatin|atorvastatin|mesh-list
111070746|NCT04388501|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111070747|NCT04388501|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111070748|NCT04388501|Antimetabolites|antimetabolites|mesh-ancestor
111070749|NCT04388501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111070750|NCT04388501|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111070751|NCT04388501|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111070752|NCT04388501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111070753|NCT02249182|Ribavirin|ribavirin|mesh-list
111070754|NCT02249182|Sofosbuvir|sofosbuvir|mesh-list
111070755|NCT02249182|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
111070756|NCT02249182|Ledipasvir|ledipasvir|mesh-list
111070757|NCT02249182|Antimetabolites|antimetabolites|mesh-ancestor
111070758|NCT02249182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111070759|NCT02249182|Antiviral Agents|antiviral agents|mesh-ancestor
111070760|NCT02249182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111070761|NCT04006769|Imatinib Mesylate|imatinib mesylate|mesh-list
111070762|NCT04006769|Entacapone|entacapone|mesh-list
111070763|NCT04006769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111070764|NCT04006769|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111070765|NCT04006769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111070766|NCT04006769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111070768|NCT04006769|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111070769|NCT04006769|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
111070770|NCT03487211|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
111070771|NCT03487211|Escitalopram|escitalopram|mesh-list
111070772|NCT03487211|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111070773|NCT03487211|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111070774|NCT03487211|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110637712|NCT00838838|Androgens|androgens|mesh-ancestor
111070775|NCT03487211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111070776|NCT03487211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111070777|NCT03487211|Serotonin Agents|serotonin agents|mesh-ancestor
111070778|NCT03487211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111070779|NCT03487211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111070780|NCT03487211|Antidepressive Agents|antidepressive agents|mesh-ancestor
111070781|NCT03487211|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111070782|NCT03487211|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111070783|NCT03487211|Analgesics|analgesics|mesh-ancestor
111070784|NCT03487211|Sensory System Agents|sensory system agents|mesh-ancestor
111070785|NCT03487211|Dopamine Agents|dopamine agents|mesh-ancestor
111070786|NCT03487133|Dexamethasone|dexamethasone|mesh-list
111070787|NCT03487133|Bortezomib|bortezomib|mesh-list
111070788|NCT03487133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111070789|NCT03487133|Antiemetics|antiemetics|mesh-ancestor
111070790|NCT03487133|Autonomic Agents|autonomic agents|mesh-ancestor
111070791|NCT03487133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111070792|NCT03487133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111070793|NCT03487133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111070794|NCT03487133|Glucocorticoids|glucocorticoids|mesh-ancestor
111070795|NCT03487133|Hormones|hormones|mesh-ancestor
111070796|NCT03487133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111070797|NCT03487133|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111070798|NCT03487133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111070799|NCT02248480|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
111070800|NCT02248480|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111070801|NCT02248480|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111070802|NCT02248480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111070803|NCT02248480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111070804|NCT02248480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111070805|NCT02248480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111070806|NCT02248480|Analgesics|analgesics|mesh-ancestor
111070807|NCT02248480|Sensory System Agents|sensory system agents|mesh-ancestor
111070808|NCT02248480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111070809|NCT02248480|Antidepressive Agents|antidepressive agents|mesh-ancestor
111070810|NCT02248480|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111070811|NCT02248480|Dopamine Agents|dopamine agents|mesh-ancestor
111070812|NCT01653158|Docetaxel|docetaxel|mesh-list
111070813|NCT01653158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111070814|NCT01653158|Tubulin Modulators|tubulin modulators|mesh-ancestor
111070815|NCT01653158|Antimitotic Agents|antimitotic agents|mesh-ancestor
111070816|NCT01653158|Mitosis Modulators|mitosis modulators|mesh-ancestor
111070817|NCT01653158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111070819|NCT00701207|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111070820|NCT00701207|Autonomic Agents|autonomic agents|mesh-ancestor
111070821|NCT00701207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111070822|NCT00701207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111070823|NCT00701207|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111070824|NCT00701207|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111070825|NCT00701207|Cholinergic Agents|cholinergic agents|mesh-ancestor
111070826|NCT00701207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111070827|NCT00701207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111070828|NCT02247466|Rocuronium|rocuronium|mesh-list
111070829|NCT02247466|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
111070830|NCT02247466|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
111070831|NCT02247466|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111070832|NCT02247466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111070833|NCT02247466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111070834|NCT03417479|Gabapentin|gabapentin|mesh-list
111070835|NCT03417479|Analgesics|analgesics|mesh-ancestor
111070836|NCT03417479|Sensory System Agents|sensory system agents|mesh-ancestor
110787945|NCT03611920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111070838|NCT03417479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111070839|NCT03417479|Anticonvulsants|anticonvulsants|mesh-ancestor
111070840|NCT03417479|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111070841|NCT03417479|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111070842|NCT03417479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111070843|NCT03417479|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111070844|NCT03417479|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111070845|NCT03417479|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111070846|NCT03417479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111070847|NCT03417479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111070848|NCT03417479|Antimanic Agents|antimanic agents|mesh-ancestor
111070849|NCT03317795|Tranexamic Acid|tranexamic acid|mesh-list
111070850|NCT03317795|Levonorgestrel|levonorgestrel|mesh-list
111070851|NCT03317795|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111070852|NCT03317795|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111070853|NCT03317795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111070854|NCT03317795|Hemostatics|hemostatics|mesh-ancestor
111070855|NCT03317795|Coagulants|coagulants|mesh-ancestor
111070856|NCT03317795|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111070857|NCT03317795|Contraceptive Agents|contraceptive agents|mesh-ancestor
111070858|NCT03317795|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111070859|NCT03317795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111070860|NCT03317795|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111070861|NCT03317795|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111070862|NCT03317795|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111070863|NCT02202616|Glycopyrrolate|glycopyrrolate|mesh-list
111070864|NCT02202616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111070865|NCT02202616|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111070866|NCT02202616|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111070867|NCT02202616|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111070868|NCT02202616|Cholinergic Agents|cholinergic agents|mesh-ancestor
111070869|NCT02202616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111070870|NCT02202616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111070871|NCT03876119|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
111070872|NCT03876119|Plasminogen|plasminogen|mesh-list
111070873|NCT03876119|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111070874|NCT03876119|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111070875|NCT03876119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111070876|NCT02455076|Exenatide|exenatide|mesh-list
111070877|NCT02455076|Insulin, Short-Acting|insulin, short-acting|mesh-list
111070878|NCT02455076|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111070879|NCT02455076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111070880|NCT02455076|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111070881|NCT02455076|Incretins|incretins|mesh-ancestor
111070882|NCT02455076|Hormones|hormones|mesh-ancestor
111070883|NCT02455076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111070884|NCT02432846|Sunitinib|sunitinib|mesh-list
111070885|NCT02432846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111070886|NCT02432846|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111070887|NCT02432846|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111070888|NCT02432846|Growth Substances|growth substances|mesh-ancestor
111070889|NCT02432846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111070890|NCT02432846|Growth Inhibitors|growth inhibitors|mesh-ancestor
111070891|NCT02432846|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111070892|NCT02432846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111070893|NCT02432846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111070894|NCT03486509|Afatinib|afatinib|mesh-list
111070895|NCT03486509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111070896|NCT03486509|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111070897|NCT03486509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111070898|NCT03486509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111070899|NCT04460807|Exemestane|exemestane|mesh-list
111070900|NCT04460807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111070901|NCT04460807|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111070902|NCT04460807|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111070903|NCT04460807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111070904|NCT04460807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111070905|NCT04460807|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111070906|NCT04460807|Hormone Antagonists|hormone antagonists|mesh-ancestor
111070907|NCT04460807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111070908|NCT04460807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111070909|NCT02246998|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
111070910|NCT02246998|Antiviral Agents|antiviral agents|mesh-ancestor
111070911|NCT02246998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111070912|NCT02246998|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111070913|NCT02246998|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111070914|NCT04928222|Doxorubicin|doxorubicin|mesh-list
111070915|NCT04928222|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111070916|NCT04928222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111070917|NCT04928222|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111070918|NCT04928222|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111070919|NCT04928222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111070920|NCT04928222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111070921|NCT00805961|Bevacizumab|bevacizumab|mesh-list
111070922|NCT00805961|Everolimus|everolimus|mesh-list
111070923|NCT00805961|Temozolomide|temozolomide|mesh-list
111070924|NCT00805961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111070925|NCT00805961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111070926|NCT00805961|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111070927|NCT00805961|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111070928|NCT00805961|Growth Substances|growth substances|mesh-ancestor
111070929|NCT00805961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111070930|NCT00805961|Growth Inhibitors|growth inhibitors|mesh-ancestor
111070931|NCT00805961|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111070932|NCT00805961|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111070933|NCT00805961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111070934|NCT00805961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111070935|NCT00805961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111070936|NCT00805961|Immunologic Factors|immunologic factors|mesh-ancestor
111070937|NCT00805961|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111070938|NCT00805961|Alkylating Agents|alkylating agents|mesh-ancestor
111070939|NCT02454608|Verapamil|verapamil|mesh-list
111070940|NCT02454608|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111070941|NCT02454608|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111070942|NCT02454608|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111070943|NCT02454608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111070944|NCT02454608|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111070945|NCT02454608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111070946|NCT02454608|Vasodilator Agents|vasodilator agents|mesh-ancestor
111070947|NCT05152355|Budesonide|budesonide|mesh-list
111070948|NCT05152355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111070949|NCT05152355|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111070950|NCT05152355|Autonomic Agents|autonomic agents|mesh-ancestor
111070951|NCT05152355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111070952|NCT05152355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111070953|NCT05152355|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111070954|NCT05152355|Respiratory System Agents|respiratory system agents|mesh-ancestor
111070955|NCT05152355|Glucocorticoids|glucocorticoids|mesh-ancestor
111070956|NCT05152355|Hormones|hormones|mesh-ancestor
111070957|NCT05152355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111070958|NCT02246764|Timolol|timolol|mesh-list
111070959|NCT02246764|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111070960|NCT02246764|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111070961|NCT02246764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111070962|NCT02246764|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111070963|NCT02246764|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111070964|NCT02246764|Adrenergic Agents|adrenergic agents|mesh-ancestor
111070965|NCT02246764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111070966|NCT02246764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111070967|NCT02246764|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111070968|NCT02246764|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111070970|NCT03484091|Viscosupplements|viscosupplements|mesh-ancestor
111070971|NCT03484091|Protective Agents|protective agents|mesh-ancestor
111070972|NCT03484091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111070973|NCT03486353|Azacitidine|azacitidine|mesh-list
111070974|NCT03486353|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111070975|NCT03486353|Antimetabolites|antimetabolites|mesh-ancestor
111070976|NCT03486353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111070977|NCT03486353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111070978|NCT03486353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111070979|NCT04460651|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
110788096|NCT01237119|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111070980|NCT04460651|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111070981|NCT04460651|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111070982|NCT04492241|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111070983|NCT02431676|Metformin|metformin|mesh-list
111070984|NCT02431676|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111070985|NCT02431676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111070986|NCT03483545|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
111070987|NCT03483545|Hormones|hormones|mesh-ancestor
111070988|NCT03483545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111070989|NCT03483545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111070990|NCT03483389|Ethanol|ethanol|mesh-list
111070991|NCT03483389|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111070992|NCT03483389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111070993|NCT03483389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111070994|NCT03483389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111070995|NCT03486119|Nivolumab|nivolumab|mesh-list
111070996|NCT03486119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111070997|NCT03486119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111070998|NCT03486119|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111070999|NCT03486119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111071000|NCT02523833|Albuterol|albuterol|mesh-list
111071001|NCT02523833|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111071002|NCT02523833|Autonomic Agents|autonomic agents|mesh-ancestor
111071003|NCT02523833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111071004|NCT02523833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111071005|NCT02523833|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111071006|NCT02523833|Respiratory System Agents|respiratory system agents|mesh-ancestor
111071007|NCT02523833|Tocolytic Agents|tocolytic agents|mesh-ancestor
111071008|NCT02523833|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111071009|NCT02523833|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111071010|NCT02523833|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111071011|NCT02523833|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111071012|NCT02523833|Adrenergic Agents|adrenergic agents|mesh-ancestor
111071013|NCT02523833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111071014|NCT02523833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111071015|NCT04234529|Caffeine|caffeine|mesh-list
111071016|NCT04234529|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111071017|NCT04234529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111071018|NCT04234529|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111071019|NCT04234529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111071020|NCT04234529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111071021|NCT04234529|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
111071022|NCT04234529|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111071023|NCT04234529|Purinergic Agents|purinergic agents|mesh-ancestor
111071024|NCT04234529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111071025|NCT01652690|Denosumab|denosumab|mesh-list
111071026|NCT01652690|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111071027|NCT01652690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111071028|NCT03481517|Bupivacaine|bupivacaine|mesh-list
111071029|NCT03481517|Anesthetics, Local|anesthetics, local|mesh-ancestor
111071030|NCT03481517|Anesthetics|anesthetics|mesh-ancestor
111071031|NCT03481517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111071032|NCT03481517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111071033|NCT03481517|Sensory System Agents|sensory system agents|mesh-ancestor
111071034|NCT03481517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111071035|NCT02429258|Metformin|metformin|mesh-list
111071036|NCT02429258|Dapagliflozin|dapagliflozin|mesh-list
111071037|NCT02429258|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111071038|NCT02429258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111071039|NCT02429258|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111071040|NCT02429258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111071041|NCT02201524|Abrocitinib|abrocitinib|mesh-list
111071042|NCT02201524|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111071043|NCT02201524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111071044|NCT02201524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111071045|NCT05153603|Olaparib|olaparib|mesh-list
111071046|NCT05153603|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111071047|NCT05153603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111071048|NCT05153603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111071049|NCT05153603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111071050|NCT02137252|Naltrexone|naltrexone|mesh-list
111071051|NCT02137252|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111071052|NCT02137252|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111071053|NCT02137252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111071054|NCT02137252|Sensory System Agents|sensory system agents|mesh-ancestor
111071055|NCT02137252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111071056|NCT05152667|Dienogest|dienogest|mesh-list
111071057|NCT05152667|Levonorgestrel|levonorgestrel|mesh-list
111071058|NCT05152667|Progestins|progestins|mesh-list
111071059|NCT05152667|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111071060|NCT05152667|Contraceptive Agents|contraceptive agents|mesh-ancestor
111071061|NCT05152667|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111071062|NCT05152667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111071063|NCT05152667|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111071064|NCT05152667|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111071065|NCT05152667|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111071066|NCT05152667|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
111071067|NCT05152667|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111071068|NCT05152667|Hormone Antagonists|hormone antagonists|mesh-ancestor
111071069|NCT05152667|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111071070|NCT05152667|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111071071|NCT05152667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111071072|NCT05152667|Hormones|hormones|mesh-ancestor
111071073|NCT05152511|Pentoxifylline|pentoxifylline|mesh-list
111071074|NCT05152511|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111071075|NCT05152511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111071076|NCT05152511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111071077|NCT05152511|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111071078|NCT05152511|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111071079|NCT05152511|Protective Agents|protective agents|mesh-ancestor
111071080|NCT05152511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111071081|NCT05152511|Vasodilator Agents|vasodilator agents|mesh-ancestor
111071082|NCT05152511|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111071083|NCT05152511|Antioxidants|antioxidants|mesh-ancestor
111071084|NCT02568449|Nintedanib|nintedanib|mesh-list
111071085|NCT02568449|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
111071086|NCT02568449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111071087|NCT02568449|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111071088|NCT02568449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111071089|NCT02568449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111071090|NCT02738333|Sofosbuvir|sofosbuvir|mesh-list
111071091|NCT02738333|Antiviral Agents|antiviral agents|mesh-ancestor
111071092|NCT02738333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111071093|NCT04884893|Nitrous Oxide|nitrous oxide|mesh-list
111071094|NCT04884893|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111071095|NCT04884893|Anesthetics, General|anesthetics, general|mesh-ancestor
111071096|NCT04884893|Anesthetics|anesthetics|mesh-ancestor
111071097|NCT04884893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111071098|NCT04884893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111071099|NCT04884893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111071100|NCT04884893|Analgesics|analgesics|mesh-ancestor
111071101|NCT04884893|Sensory System Agents|sensory system agents|mesh-ancestor
111071102|NCT04884893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111071103|NCT03479879|Misoprostol|misoprostol|mesh-list
111071104|NCT03479879|Estradiol|estradiol|mesh-list
111071105|NCT03479879|Estrogens|estrogens|mesh-ancestor
111071106|NCT03479879|Hormones|hormones|mesh-ancestor
111071107|NCT03479879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111071108|NCT03479879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111071109|NCT03479879|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111071110|NCT03479879|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111071111|NCT03479879|Abortifacient Agents|abortifacient agents|mesh-ancestor
111071112|NCT03479879|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111071113|NCT03479879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111071114|NCT03479879|Oxytocics|oxytocics|mesh-ancestor
111071115|NCT03479411|Itraconazole|itraconazole|mesh-list
111071116|NCT03479411|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
111071117|NCT03479411|Antifungal Agents|antifungal agents|mesh-ancestor
111071118|NCT03479411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111071119|NCT03479411|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111071120|NCT03479411|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111071121|NCT03479411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111071122|NCT03479411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111071123|NCT03479411|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111071124|NCT03479411|Hormone Antagonists|hormone antagonists|mesh-ancestor
111071125|NCT03479411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111071126|NCT03479411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111071127|NCT03479411|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111071128|NCT03131375|Dexmedetomidine|dexmedetomidine|mesh-list
111071129|NCT03131375|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111071130|NCT03131375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111071131|NCT03131375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111071132|NCT03131375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111071133|NCT03131375|Analgesics|analgesics|mesh-ancestor
111071134|NCT03131375|Sensory System Agents|sensory system agents|mesh-ancestor
111071135|NCT03131375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111071136|NCT03131375|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111071137|NCT03131375|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111071138|NCT03131375|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111071139|NCT03131375|Adrenergic Agents|adrenergic agents|mesh-ancestor
111071140|NCT03131375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111071141|NCT03131375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111071142|NCT03475589|Apatinib|apatinib|mesh-list
111071143|NCT03475589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111071144|NCT03475589|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111071145|NCT03475589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111071146|NCT03475589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111071147|NCT03478709|Norepinephrine|norepinephrine|mesh-list
111071148|NCT03478709|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111071149|NCT03478709|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111071150|NCT03478709|Adrenergic Agents|adrenergic agents|mesh-ancestor
111071151|NCT03478709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111071152|NCT03478709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111071153|NCT03478709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111071154|NCT03478709|Sympathomimetics|sympathomimetics|mesh-ancestor
111071155|NCT03478709|Autonomic Agents|autonomic agents|mesh-ancestor
111071156|NCT03478709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111071157|NCT03478709|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111071158|NCT03478475|Cholecalciferol|cholecalciferol|mesh-list
111071159|NCT03478475|Vitamin D|vitamin d|mesh-list
111071160|NCT03478475|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111071161|NCT03478475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111071162|NCT03478475|Vitamins|vitamins|mesh-ancestor
111071163|NCT03478475|Micronutrients|micronutrients|mesh-ancestor
111071164|NCT03478475|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111071165|NCT03475121|Topotecan|topotecan|mesh-list
111071166|NCT03475121|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111071167|NCT03475121|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111071168|NCT03475121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111071169|NCT03475121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111071170|NCT03475121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111071171|NCT03131063|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111071172|NCT03131063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111071173|NCT02523755|Ropivacaine|ropivacaine|mesh-list
111071174|NCT02523755|Anesthetics, Local|anesthetics, local|mesh-ancestor
111071175|NCT02523755|Anesthetics|anesthetics|mesh-ancestor
111071176|NCT02523755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111071177|NCT02523755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111071178|NCT02523755|Sensory System Agents|sensory system agents|mesh-ancestor
111071179|NCT02523755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111071180|NCT02168842|Isradipine|isradipine|mesh-list
111071181|NCT02168842|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111071182|NCT02168842|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111071183|NCT02168842|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111071184|NCT02168842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111071185|NCT02168842|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111071186|NCT02168842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111071187|NCT02168842|Vasodilator Agents|vasodilator agents|mesh-ancestor
111071188|NCT03347123|Nivolumab|nivolumab|mesh-list
111071189|NCT03347123|Ipilimumab|ipilimumab|mesh-list
111071190|NCT03347123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111071191|NCT03347123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111071192|NCT03347123|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111071193|NCT03347123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111071194|NCT03131141|Lefamulin|lefamulin|mesh-list
111071195|NCT03131141|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111071196|NCT03131141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111071197|NCT05258045|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
111071198|NCT05258045|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111071199|NCT05258045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111071200|NCT03477929|Cetrorelix|cetrorelix|mesh-list
111071201|NCT03477929|Ganirelix|ganirelix|mesh-list
111071202|NCT03477929|Hormone Antagonists|hormone antagonists|mesh-ancestor
111071203|NCT03477929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111071204|NCT03477929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111071205|NCT03477929|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111071206|NCT03477929|Fertility Agents|fertility agents|mesh-ancestor
111071207|NCT03477929|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111071208|NCT03474341|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
111071209|NCT03474341|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111071210|NCT03474341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111071212|NCT03474263|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111071213|NCT03474263|Immunologic Factors|immunologic factors|mesh-ancestor
111071214|NCT03474263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111071215|NCT03477461|Terlipressin|terlipressin|mesh-list
111071216|NCT03477461|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111071217|NCT03477461|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111071218|NCT02553161|Escitalopram|escitalopram|mesh-list
111071219|NCT02553161|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111071220|NCT02553161|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111071221|NCT02553161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111071222|NCT02553161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111071223|NCT02553161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111071224|NCT02553161|Serotonin Agents|serotonin agents|mesh-ancestor
111071225|NCT02553161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111071226|NCT03473093|Pregabalin|pregabalin|mesh-list
111071227|NCT03473093|Morphine|morphine|mesh-list
111071228|NCT03473093|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111071229|NCT03473093|Narcotics|narcotics|mesh-ancestor
111071230|NCT03473093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111071231|NCT03473093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111071232|NCT03473093|Analgesics|analgesics|mesh-ancestor
111071233|NCT03473093|Sensory System Agents|sensory system agents|mesh-ancestor
111071234|NCT03473093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111071235|NCT03473093|Anticonvulsants|anticonvulsants|mesh-ancestor
111071236|NCT03473093|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111071237|NCT03473093|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111071238|NCT03473093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111071239|NCT03473093|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111071240|NCT03473093|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111071241|NCT03473093|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111071242|NCT03473093|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111071243|NCT02523131|Insulin|insulin|mesh-list
111071244|NCT02523131|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111071245|NCT02523131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111071246|NCT04339049|Lidocaine|lidocaine|mesh-list
111071247|NCT04339049|Misoprostol|misoprostol|mesh-list
111071248|NCT04339049|Anesthetics, Local|anesthetics, local|mesh-ancestor
111071249|NCT04339049|Anesthetics|anesthetics|mesh-ancestor
111071250|NCT04339049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111071251|NCT04339049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111071252|NCT04339049|Sensory System Agents|sensory system agents|mesh-ancestor
111071253|NCT04339049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111071254|NCT04339049|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111071255|NCT04339049|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111071256|NCT04339049|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111071257|NCT04339049|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111071258|NCT04339049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111071259|NCT04339049|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111071260|NCT04339049|Abortifacient Agents|abortifacient agents|mesh-ancestor
111071261|NCT04339049|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111071262|NCT04339049|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111071263|NCT04339049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111071264|NCT04339049|Oxytocics|oxytocics|mesh-ancestor
111071265|NCT02133664|Thioctic Acid|thioctic acid|mesh-list
111071266|NCT02133664|Antioxidants|antioxidants|mesh-ancestor
111071267|NCT02133664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111071268|NCT02133664|Protective Agents|protective agents|mesh-ancestor
111071269|NCT02133664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111071270|NCT02133664|Vitamin B Complex|vitamin b complex|mesh-ancestor
111071271|NCT02133664|Vitamins|vitamins|mesh-ancestor
111071272|NCT02133664|Micronutrients|micronutrients|mesh-ancestor
111071273|NCT02133352|Ranolazine|ranolazine|mesh-list
111071274|NCT02133352|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111071275|NCT02133352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111071276|NCT02133352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111071278|NCT04418128|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111071279|NCT04418128|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111071280|NCT04418128|Analgesics|analgesics|mesh-ancestor
111071281|NCT04418128|Sensory System Agents|sensory system agents|mesh-ancestor
111071282|NCT04418128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111071283|NCT04418128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111071284|NCT04418128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111071285|NCT04418128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111071286|NCT04418128|Anticoagulants|anticoagulants|mesh-ancestor
111071287|NCT04418128|Protease Inhibitors|protease inhibitors|mesh-ancestor
111071288|NCT04418128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111071289|NCT04418128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111071290|NCT04418128|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
111071291|NCT04418128|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111071292|NCT04418128|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
111071293|NCT04418128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111071294|NCT04418128|Immunologic Factors|immunologic factors|mesh-ancestor
111071295|NCT02555657|Gemcitabine|gemcitabine|mesh-list
111071296|NCT02555657|Capecitabine|capecitabine|mesh-list
111071297|NCT02555657|Pembrolizumab|pembrolizumab|mesh-list
111071298|NCT02555657|Vinorelbine|vinorelbine|mesh-list
111071299|NCT02555657|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111071300|NCT02555657|Antimetabolites|antimetabolites|mesh-ancestor
111071301|NCT02555657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111071302|NCT02555657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111071303|NCT02555657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111071304|NCT02555657|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111071305|NCT02555657|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111071306|NCT02555657|Tubulin Modulators|tubulin modulators|mesh-ancestor
111071307|NCT02555657|Antimitotic Agents|antimitotic agents|mesh-ancestor
111071308|NCT02555657|Mitosis Modulators|mitosis modulators|mesh-ancestor
111071309|NCT02195518|Tenofovir|tenofovir|mesh-list
111071310|NCT02195518|Antiviral Agents|antiviral agents|mesh-ancestor
111071311|NCT02195518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111071312|NCT02195518|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111071313|NCT02195518|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111071314|NCT02195518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111071315|NCT02195518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111071316|NCT02195518|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111071317|NCT02195518|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111071318|NCT03990077|Docetaxel|docetaxel|mesh-list
111071319|NCT03990077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111071320|NCT03990077|Tubulin Modulators|tubulin modulators|mesh-ancestor
111071321|NCT03990077|Antimitotic Agents|antimitotic agents|mesh-ancestor
111071322|NCT03990077|Mitosis Modulators|mitosis modulators|mesh-ancestor
111071323|NCT03990077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111071325|NCT05134415|Antipruritics|antipruritics|mesh-ancestor
111071326|NCT05134415|Dermatologic Agents|dermatologic agents|mesh-ancestor
111071327|NCT03380507|Thiamine|thiamine|mesh-list
111071328|NCT03380507|Hydrocortisone|hydrocortisone|mesh-list
111071329|NCT03380507|Vitamins|vitamins|mesh-ancestor
111071330|NCT03380507|Micronutrients|micronutrients|mesh-ancestor
111071331|NCT03380507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111071332|NCT03380507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111071333|NCT03380507|Vitamin B Complex|vitamin b complex|mesh-ancestor
111071334|NCT03471455|Itraconazole|itraconazole|mesh-list
111071335|NCT03471455|Terbinafine|terbinafine|mesh-list
111071336|NCT03471455|Isotretinoin|isotretinoin|mesh-list
111071337|NCT03471455|Antifungal Agents|antifungal agents|mesh-ancestor
111071338|NCT03471455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111071339|NCT03471455|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111071340|NCT03471455|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111071341|NCT03471455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111071342|NCT03471455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111071343|NCT03471455|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111071344|NCT03471455|Hormone Antagonists|hormone antagonists|mesh-ancestor
111071345|NCT03471455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111071346|NCT03471455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111071347|NCT03471455|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111071348|NCT03471455|Dermatologic Agents|dermatologic agents|mesh-ancestor
111071349|NCT02824679|Scopolamine|scopolamine|mesh-list
111071350|NCT02824679|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
111071351|NCT02824679|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111071352|NCT02824679|Antiemetics|antiemetics|mesh-ancestor
111071353|NCT02824679|Autonomic Agents|autonomic agents|mesh-ancestor
111071354|NCT02824679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111071355|NCT02824679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111071356|NCT02824679|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111071357|NCT02824679|Mydriatics|mydriatics|mesh-ancestor
111071358|NCT02824679|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111071359|NCT02824679|Cholinergic Agents|cholinergic agents|mesh-ancestor
111071360|NCT02824679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111071361|NCT02824679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111071362|NCT02824679|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111071363|NCT02824679|Parasympatholytics|parasympatholytics|mesh-ancestor
111071364|NCT03202667|Empagliflozin|empagliflozin|mesh-list
111071365|NCT03202667|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111071366|NCT03202667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111071367|NCT03202667|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111071368|NCT03202667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111071369|NCT02133742|Pembrolizumab|pembrolizumab|mesh-list
111071370|NCT02133742|Axitinib|axitinib|mesh-list
111071371|NCT02133742|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111071372|NCT02133742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111071373|NCT02133742|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111071374|NCT02133742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111071375|NCT02133742|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111071376|NCT02133742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111071377|NCT05157893|Analgesics|analgesics|mesh-list
111071378|NCT05157893|Sensory System Agents|sensory system agents|mesh-ancestor
111071379|NCT05157893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111071380|NCT05157893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111071381|NCT02523053|Fluorouracil|fluorouracil|mesh-list
111071382|NCT02523053|Antimetabolites|antimetabolites|mesh-ancestor
111071383|NCT02523053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111071384|NCT02523053|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111071385|NCT02523053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111071386|NCT02523053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111071387|NCT02523053|Immunologic Factors|immunologic factors|mesh-ancestor
111071388|NCT02523053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111071389|NCT04457609|Azithromycin|azithromycin|mesh-list
111071390|NCT04457609|Oseltamivir|oseltamivir|mesh-list
111071391|NCT04457609|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111071392|NCT04457609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111071393|NCT04457609|Antiviral Agents|antiviral agents|mesh-ancestor
111071394|NCT04457609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111071395|NCT04457609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111071396|NCT05157269|Nitazoxanide|nitazoxanide|mesh-list
111071397|NCT05157269|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110536506|NCT00651690|Botulinum Toxins|botulinum toxins|mesh-list
111071398|NCT05157269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111071399|NCT04457765|Povidone-Iodine|povidone-iodine|mesh-list
111071400|NCT04457765|Povidone|povidone|mesh-list
111071401|NCT04457765|Plasma Substitutes|plasma substitutes|mesh-ancestor
111071402|NCT04457765|Blood Substitutes|blood substitutes|mesh-ancestor
111071403|NCT04457765|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111071404|NCT04457765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111071405|NCT03795233|Vancomycin|vancomycin|mesh-list
111071406|NCT03795233|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111071407|NCT03795233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111071408|NCT03645863|Iron|iron|mesh-list
111071409|NCT03645863|Trace Elements|trace elements|mesh-ancestor
111071410|NCT03645863|Micronutrients|micronutrients|mesh-ancestor
111071411|NCT03645863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111071412|NCT03564119|Benzoyl Peroxide|benzoyl peroxide|mesh-list
111071413|NCT03564119|Dermatologic Agents|dermatologic agents|mesh-ancestor
111071414|NCT04503707|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
111071415|NCT04503707|Hormones|hormones|mesh-ancestor
111071416|NCT04503707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111071417|NCT04503707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111071418|NCT03470597|Iodine|iodine|mesh-list
111071419|NCT03470597|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111071420|NCT03470597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111071421|NCT03470597|Trace Elements|trace elements|mesh-ancestor
111071422|NCT03470597|Micronutrients|micronutrients|mesh-ancestor
111071423|NCT03470597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111071424|NCT02522897|Ranibizumab|ranibizumab|mesh-list
111071425|NCT02522897|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111071426|NCT02522897|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111071427|NCT02522897|Growth Substances|growth substances|mesh-ancestor
111071428|NCT02522897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111071429|NCT02522897|Growth Inhibitors|growth inhibitors|mesh-ancestor
111071430|NCT02522897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111071431|NCT04351061|Acetazolamide|acetazolamide|mesh-list
111071432|NCT04351061|Anticonvulsants|anticonvulsants|mesh-ancestor
111071433|NCT04351061|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
111071434|NCT04351061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111071435|NCT04351061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111071436|NCT04351061|Diuretics|diuretics|mesh-ancestor
111071437|NCT04351061|Natriuretic Agents|natriuretic agents|mesh-ancestor
111071438|NCT04351061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111071439|NCT03130829|Fucoidan|fucoidan|mesh-list
111071440|NCT03130829|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111071441|NCT03130829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111071442|NCT03130829|Anticoagulants|anticoagulants|mesh-ancestor
111071443|NCT03130829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111071444|NCT04318145|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111071445|NCT04206761|Mometasone Furoate|mometasone furoate|mesh-list
111071446|NCT04206761|Glycopyrrolate|glycopyrrolate|mesh-list
111071447|NCT04206761|Bromides|bromides|mesh-list
111071448|NCT04206761|Anticonvulsants|anticonvulsants|mesh-ancestor
111071449|NCT04206761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111071450|NCT04206761|Dermatologic Agents|dermatologic agents|mesh-ancestor
111071451|NCT04206761|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111071452|NCT04206761|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111071453|NCT04206761|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111071454|NCT04206761|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111071455|NCT04206761|Cholinergic Agents|cholinergic agents|mesh-ancestor
111071456|NCT04206761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111071457|NCT04206761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111071458|NCT04206761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111071459|NCT03181529|Psilocybin|psilocybin|mesh-list
111071460|NCT03181529|Hallucinogens|hallucinogens|mesh-ancestor
111071461|NCT03181529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111071462|NCT03181529|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111071463|NCT03668639|Dexamethasone|dexamethasone|mesh-list
111071464|NCT03668639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111071465|NCT03668639|Antiemetics|antiemetics|mesh-ancestor
111071466|NCT03668639|Autonomic Agents|autonomic agents|mesh-ancestor
111071467|NCT03668639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111071468|NCT03668639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111071469|NCT03668639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111071470|NCT03668639|Glucocorticoids|glucocorticoids|mesh-ancestor
111071471|NCT03668639|Hormones|hormones|mesh-ancestor
111071472|NCT03668639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111071473|NCT03668639|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111071474|NCT03668639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111071476|NCT03470363|Bupivacaine|bupivacaine|mesh-list
111071477|NCT03470363|Sevoflurane|sevoflurane|mesh-list
111071478|NCT03470363|Anesthetics, Local|anesthetics, local|mesh-ancestor
111071479|NCT03470363|Anesthetics|anesthetics|mesh-ancestor
111071480|NCT03470363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111071481|NCT03470363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111071482|NCT03470363|Sensory System Agents|sensory system agents|mesh-ancestor
111071483|NCT03470363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111071484|NCT03470363|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111071485|NCT03470363|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111071486|NCT03470363|Anesthetics, General|anesthetics, general|mesh-ancestor
111071487|NCT03470363|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111071488|NCT03470363|Narcotics|narcotics|mesh-ancestor
111071489|NCT03470363|Analgesics|analgesics|mesh-ancestor
111071490|NCT03470363|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111071491|NCT03470363|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111071492|NCT03469895|Idelalisib|idelalisib|mesh-list
111071493|NCT03469895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111071494|NCT03469895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111071495|NCT03469895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111071496|NCT05160623|Povidone-Iodine|povidone-iodine|mesh-list
111071497|NCT05160623|Povidone|povidone|mesh-list
111071498|NCT05160623|Plasma Substitutes|plasma substitutes|mesh-ancestor
111071499|NCT05160623|Blood Substitutes|blood substitutes|mesh-ancestor
111071500|NCT05160623|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111071501|NCT05160623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111071502|NCT04713137|Erythritol|erythritol|mesh-list
111071503|NCT04713137|Vasodilator Agents|vasodilator agents|mesh-ancestor
111071504|NCT04456985|Folic Acid|folic acid|mesh-list
111071505|NCT04456985|Vitamin B 12|vitamin b 12|mesh-list
111071506|NCT04456985|Hydroxocobalamin|hydroxocobalamin|mesh-list
111071507|NCT04456985|Vitamins|vitamins|mesh-ancestor
111071508|NCT04456985|Micronutrients|micronutrients|mesh-ancestor
111071509|NCT04456985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111071510|NCT04456985|Hematinics|hematinics|mesh-ancestor
111071511|NCT04456985|Vitamin B Complex|vitamin b complex|mesh-ancestor
111071512|NCT03469583|Entecavir|entecavir|mesh-list
111071513|NCT03469583|Antiviral Agents|antiviral agents|mesh-ancestor
111071514|NCT03469583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111071515|NCT05096039|Valsartan|valsartan|mesh-list
111071516|NCT05096039|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
111071517|NCT05096039|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111071518|NCT05096039|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111071519|NCT05096039|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111071520|NCT05096039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111071521|NCT05604131|Deferiprone|deferiprone|mesh-list
111071522|NCT05604131|Iron Chelating Agents|iron chelating agents|mesh-ancestor
111071523|NCT05604131|Chelating Agents|chelating agents|mesh-ancestor
111071524|NCT05604131|Sequestering Agents|sequestering agents|mesh-ancestor
111071525|NCT05604131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111071526|NCT03361865|Pembrolizumab|pembrolizumab|mesh-list
111071527|NCT03361865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111071528|NCT03361865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111071529|NCT03361865|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111071530|NCT03361865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111071531|NCT02982083|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
111071532|NCT02982083|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111071533|NCT02982083|Hormone Antagonists|hormone antagonists|mesh-ancestor
111071534|NCT02982083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111071535|NCT02982083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111071536|NCT02982083|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111071537|NCT02982083|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111071538|NCT02982083|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111071539|NCT02421341|Fentanyl|fentanyl|mesh-list
111071540|NCT02421341|Analgesics, Opioid|analgesics, opioid|mesh-list
111071541|NCT02421341|Analgesics|analgesics|mesh-list
111071542|NCT02421341|Narcotics|narcotics|mesh-ancestor
111071543|NCT02421341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111071544|NCT02421341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111071545|NCT02421341|Sensory System Agents|sensory system agents|mesh-ancestor
111071546|NCT02421341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111071547|NCT02421341|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111071548|NCT02421341|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111071549|NCT02421341|Anesthetics, General|anesthetics, general|mesh-ancestor
111071550|NCT02421341|Anesthetics|anesthetics|mesh-ancestor
111071551|NCT02149121|Rituximab|rituximab|mesh-list
111071552|NCT02149121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111071553|NCT02149121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111071554|NCT02149121|Immunologic Factors|immunologic factors|mesh-ancestor
111071555|NCT02149121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111071556|NCT02149121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111071557|NCT05162417|Tolonium Chloride|tolonium chloride|mesh-list
111071558|NCT05162417|Methylene Blue|methylene blue|mesh-list
111071559|NCT05162417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111071560|NCT05162417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111071561|NCT05162417|Hemostatics|hemostatics|mesh-ancestor
111071562|NCT05162417|Coagulants|coagulants|mesh-ancestor
111071563|NCT05162417|Heparin Antagonists|heparin antagonists|mesh-ancestor
111071564|NCT05161403|Hyaluronic Acid|hyaluronic acid|mesh-list
111071565|NCT05161403|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111071566|NCT05161403|Immunologic Factors|immunologic factors|mesh-ancestor
111071567|NCT05161403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111071568|NCT05161403|Viscosupplements|viscosupplements|mesh-ancestor
111071569|NCT05161403|Protective Agents|protective agents|mesh-ancestor
111071570|NCT03205553|Dialysis Solutions|dialysis solutions|mesh-list
111071571|NCT03205553|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111071572|NCT03166085|Paclitaxel|paclitaxel|mesh-list
111071573|NCT03166085|9H-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-N-(1-methylethyl)-|9h-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-n-(1-methylethyl)-|mesh-list
111071574|NCT03166085|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111071575|NCT03166085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111071576|NCT03166085|Tubulin Modulators|tubulin modulators|mesh-ancestor
111071577|NCT03166085|Antimitotic Agents|antimitotic agents|mesh-ancestor
111071578|NCT03166085|Mitosis Modulators|mitosis modulators|mesh-ancestor
111071579|NCT03166085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111071580|NCT05390255|Mometasone Furoate|mometasone furoate|mesh-list
111071581|NCT05390255|Omalizumab|omalizumab|mesh-list
111071582|NCT05390255|Hormones|hormones|mesh-list
111071583|NCT05390255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111071584|NCT05390255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111071585|NCT05390255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111071586|NCT05390255|Dermatologic Agents|dermatologic agents|mesh-ancestor
111071587|NCT05390255|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111071588|NCT05390255|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111071589|NCT05390255|Respiratory System Agents|respiratory system agents|mesh-ancestor
111071590|NCT04456829|Resveratrol|resveratrol|mesh-list
111071591|NCT04456829|Antioxidants|antioxidants|mesh-ancestor
111071592|NCT04456829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111071593|NCT04456829|Protective Agents|protective agents|mesh-ancestor
111071594|NCT04456829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111071595|NCT04456829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111071596|NCT04456829|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111071597|NCT02458313|3-(2,4-dimethoxybenzylidene)anabaseine|3-(2,4-dimethoxybenzylidene)anabaseine|mesh-list
111071598|NCT02458313|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111071599|NCT02458313|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111071600|NCT02458313|Cholinergic Agents|cholinergic agents|mesh-ancestor
111071601|NCT02458313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111071602|NCT02458313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111071603|NCT02458313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111071604|NCT02522221|Warfarin|warfarin|mesh-list
111071605|NCT02522221|Anticoagulants|anticoagulants|mesh-ancestor
111071606|NCT05389943|Vitamin D|vitamin d|mesh-list
111071607|NCT05389943|Ergocalciferols|ergocalciferols|mesh-list
111071608|NCT05389943|Cholecalciferol|cholecalciferol|mesh-list
111071609|NCT05389943|Vitamins|vitamins|mesh-list
111071610|NCT05389943|Micronutrients|micronutrients|mesh-ancestor
111071611|NCT05389943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111071612|NCT05389943|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111071613|NCT05389943|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111071614|NCT04575961|Pembrolizumab|pembrolizumab|mesh-list
111071615|NCT04575961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111071616|NCT04575961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111071617|NCT04575961|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111071618|NCT04575961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111071619|NCT02522975|Epoetin Alfa|epoetin alfa|mesh-list
111071620|NCT02522975|Hematinics|hematinics|mesh-ancestor
111071621|NCT04508803|Trastuzumab|trastuzumab|mesh-list
111071622|NCT04508803|Niraparib|niraparib|mesh-list
111071623|NCT04508803|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111071624|NCT04508803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111071625|NCT04508803|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111071626|NCT04508803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111071627|NCT04508803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111071628|NCT04492033|Paclitaxel|paclitaxel|mesh-list
111071629|NCT04492033|Irinotecan|irinotecan|mesh-list
111071630|NCT04492033|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111071631|NCT04492033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111071632|NCT04492033|Tubulin Modulators|tubulin modulators|mesh-ancestor
111071633|NCT04492033|Antimitotic Agents|antimitotic agents|mesh-ancestor
111071634|NCT04492033|Mitosis Modulators|mitosis modulators|mesh-ancestor
111071635|NCT04492033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111071636|NCT04492033|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111071637|NCT04492033|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111071638|NCT04492033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111071639|NCT03461185|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
111071640|NCT03461185|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111071641|NCT03461185|Growth Substances|growth substances|mesh-ancestor
111071642|NCT03461185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111071643|NCT03461185|Growth Inhibitors|growth inhibitors|mesh-ancestor
111071644|NCT03461185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111071645|NCT04453423|Carboplatin|carboplatin|mesh-list
111071646|NCT04453423|Pemetrexed|pemetrexed|mesh-list
111071647|NCT04453423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111071648|NCT04453423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111071649|NCT04453423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111071650|NCT04453423|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111071651|NCT04453423|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111071652|NCT04453189|Lansoprazole|lansoprazole|mesh-list
111071653|NCT04453189|Dexlansoprazole|dexlansoprazole|mesh-list
111071654|NCT04453189|Famotidine|famotidine|mesh-list
111071655|NCT04453189|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111071656|NCT04453189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111071657|NCT04453189|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111071658|NCT04453189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111071659|NCT04453189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111071660|NCT04453189|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
111071661|NCT04453189|Histamine Antagonists|histamine antagonists|mesh-ancestor
111071662|NCT04453189|Histamine Agents|histamine agents|mesh-ancestor
111071663|NCT04453189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111071664|NCT04453189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111071666|NCT03465085|Calcium heparin|calcium heparin|mesh-list
111071667|NCT03465085|Streptokinase|streptokinase|mesh-list
111071668|NCT03465085|Anticoagulants|anticoagulants|mesh-ancestor
111071669|NCT03465085|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111071670|NCT03465085|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111071671|NCT03465085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111071672|NCT03465007|Hydrocortisone|hydrocortisone|mesh-list
111071673|NCT03465007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111071674|NCT05030155|Cyclophosphamide|cyclophosphamide|mesh-list
111071675|NCT05030155|Azathioprine|azathioprine|mesh-list
111071676|NCT05030155|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111071677|NCT05030155|Immunologic Factors|immunologic factors|mesh-ancestor
111071678|NCT05030155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111071679|NCT05030155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111071680|NCT05030155|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111071681|NCT05030155|Alkylating Agents|alkylating agents|mesh-ancestor
111071682|NCT05030155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111071683|NCT05030155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111071684|NCT05030155|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111071685|NCT05030155|Antimetabolites|antimetabolites|mesh-ancestor
111071686|NCT05030155|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111071687|NCT04453111|Hyaluronic Acid|hyaluronic acid|mesh-list
111071688|NCT04453111|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111071689|NCT04453111|Immunologic Factors|immunologic factors|mesh-ancestor
111071690|NCT04453111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111071691|NCT04453111|Viscosupplements|viscosupplements|mesh-ancestor
111071692|NCT04453111|Protective Agents|protective agents|mesh-ancestor
111071693|NCT03468595|Listerine|listerine|mesh-list
111071694|NCT03468595|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111071695|NCT03468595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111071696|NCT04453345|Thalidomide|thalidomide|mesh-list
111071697|NCT04453345|Prednisone|prednisone|mesh-list
111071698|NCT04453345|Methotrexate|methotrexate|mesh-list
111071699|NCT04453345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111071700|NCT04453345|Glucocorticoids|glucocorticoids|mesh-ancestor
111071701|NCT04453345|Hormones|hormones|mesh-ancestor
111071702|NCT04453345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111071703|NCT04453345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111071704|NCT04453345|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111071705|NCT04453345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111071706|NCT04453345|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111071707|NCT04453345|Abortifacient Agents|abortifacient agents|mesh-ancestor
111071708|NCT04453345|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111071709|NCT04453345|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111071710|NCT04453345|Antimetabolites|antimetabolites|mesh-ancestor
111071711|NCT04453345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111071712|NCT04453345|Dermatologic Agents|dermatologic agents|mesh-ancestor
111071713|NCT04453345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111071714|NCT04453345|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111071715|NCT04453345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111071716|NCT04453345|Immunologic Factors|immunologic factors|mesh-ancestor
111071717|NCT04453345|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111071718|NCT04453345|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111071719|NCT04453345|Leprostatic Agents|leprostatic agents|mesh-ancestor
111071720|NCT04453345|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111071721|NCT04453345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111071722|NCT04453345|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111071723|NCT04453345|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111071724|NCT04453345|Growth Substances|growth substances|mesh-ancestor
111071725|NCT04453345|Growth Inhibitors|growth inhibitors|mesh-ancestor
111071726|NCT02322593|Oxaliplatin|oxaliplatin|mesh-list
111071727|NCT02322593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111071728|NCT03464539|Chitosan|chitosan|mesh-list
111071729|NCT03464539|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111071730|NCT03464539|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111071731|NCT03464539|Antimetabolites|antimetabolites|mesh-ancestor
111071732|NCT03464539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111071733|NCT03464539|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111071734|NCT03464539|Chelating Agents|chelating agents|mesh-ancestor
111071735|NCT03464539|Sequestering Agents|sequestering agents|mesh-ancestor
111071736|NCT03464539|Hemostatics|hemostatics|mesh-ancestor
111071737|NCT03464539|Coagulants|coagulants|mesh-ancestor
111071738|NCT03460405|Vaccines|vaccines|mesh-list
111071739|NCT03460405|Immunologic Factors|immunologic factors|mesh-ancestor
111071740|NCT03460405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111071741|NCT05166005|Vitamin D|vitamin d|mesh-list
111071742|NCT05166005|Vitamins|vitamins|mesh-ancestor
111071743|NCT05166005|Micronutrients|micronutrients|mesh-ancestor
111071744|NCT05166005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111071745|NCT05166005|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111071746|NCT03464305|Aspirin|aspirin|mesh-list
111071747|NCT03464305|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111071748|NCT03464305|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111071749|NCT03464305|Analgesics|analgesics|mesh-ancestor
111071750|NCT03464305|Sensory System Agents|sensory system agents|mesh-ancestor
111071751|NCT03464305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111071752|NCT03464305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111071753|NCT03464305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111071754|NCT03464305|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111071755|NCT03464305|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111071756|NCT03464305|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111071757|NCT03464305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111071758|NCT03464305|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111071759|NCT03464305|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111071760|NCT03464305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111071761|NCT03464305|Antipyretics|antipyretics|mesh-ancestor
111071762|NCT05165615|Insulin|insulin|mesh-list
111071763|NCT05165615|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111071764|NCT05165615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111071765|NCT03468439|Phenol|phenol|mesh-list
111071766|NCT03468439|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111071767|NCT03468439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111071768|NCT03468439|Disinfectants|disinfectants|mesh-ancestor
111071769|NCT03468439|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
111071770|NCT03468439|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111071771|NCT05165303|Lidocaine|lidocaine|mesh-list
111071772|NCT05165303|Propofol|propofol|mesh-list
111071773|NCT05165303|Anesthetics, Local|anesthetics, local|mesh-ancestor
111071774|NCT05165303|Anesthetics|anesthetics|mesh-ancestor
111071775|NCT05165303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111071776|NCT05165303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111071777|NCT05165303|Sensory System Agents|sensory system agents|mesh-ancestor
111071778|NCT05165303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111071779|NCT05165303|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111071780|NCT05165303|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111071781|NCT05165303|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111071782|NCT05165303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111071783|NCT05165303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111071784|NCT05165303|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111071785|NCT05165303|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111071786|NCT05165303|Anesthetics, General|anesthetics, general|mesh-ancestor
111071787|NCT03376763|Aripiprazole|aripiprazole|mesh-list
111071788|NCT03376763|Antidepressive Agents|antidepressive agents|mesh-ancestor
111071789|NCT03376763|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111071790|NCT03376763|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111071791|NCT03376763|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111071792|NCT03376763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111071793|NCT03376763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111071794|NCT03376763|Dopamine Agonists|dopamine agonists|mesh-ancestor
111071795|NCT03376763|Dopamine Agents|dopamine agents|mesh-ancestor
111071796|NCT03376763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111071797|NCT03376763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111071798|NCT03376763|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111071799|NCT03376763|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111071800|NCT03376763|Serotonin Agents|serotonin agents|mesh-ancestor
111071801|NCT03376763|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111071802|NCT03376763|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110638007|NCT00537303|Insulin Detemir|insulin detemir|mesh-list
111071803|NCT03376763|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111071804|NCT03376763|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111071805|NCT05153135|Palbociclib|palbociclib|mesh-list
110788919|NCT03899428|Sorafenib|sorafenib|mesh-list
111071806|NCT05153135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111071807|NCT05153135|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111071808|NCT05153135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111071809|NCT05153135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111071810|NCT02616185|Tremelimumab|tremelimumab|mesh-list
111071811|NCT02616185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111071812|NCT04857307|Alprazolam|alprazolam|mesh-list
111071813|NCT04857307|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111071814|NCT04857307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111071815|NCT04857307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111071816|NCT04857307|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111071817|NCT04857307|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111071818|NCT04857307|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111071819|NCT04857307|GABA Modulators|gaba modulators|mesh-ancestor
111071820|NCT04857307|GABA Agents|gaba agents|mesh-ancestor
111071821|NCT04857307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111071822|NCT04857307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111071823|NCT03467893|Antacids|antacids|mesh-list
111071824|NCT03467893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111071825|NCT03467893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111071826|NCT05170711|Antihypertensive Agents|antihypertensive agents|mesh-list
111071827|NCT05170711|Anesthetics|anesthetics|mesh-list
111071828|NCT05170711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111071829|NCT05170711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111071830|NCT03454945|Doxycycline|doxycycline|mesh-list
111071831|NCT03454945|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111071832|NCT03454945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111071833|NCT03454945|Antimalarials|antimalarials|mesh-ancestor
111071834|NCT03454945|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111071835|NCT03454945|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111071836|NCT01857115|Dexamethasone|dexamethasone|mesh-list
111071837|NCT01857115|Cyclophosphamide|cyclophosphamide|mesh-list
111071838|NCT01857115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111071839|NCT01857115|Immunologic Factors|immunologic factors|mesh-ancestor
111071840|NCT01857115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111071841|NCT01857115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111071842|NCT01857115|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111071843|NCT01857115|Alkylating Agents|alkylating agents|mesh-ancestor
111071844|NCT01857115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111071845|NCT01857115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111071846|NCT01857115|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111071847|NCT01857115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111071848|NCT01857115|Antiemetics|antiemetics|mesh-ancestor
111071849|NCT01857115|Autonomic Agents|autonomic agents|mesh-ancestor
111071850|NCT01857115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111071851|NCT01857115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111071852|NCT01857115|Glucocorticoids|glucocorticoids|mesh-ancestor
111071853|NCT01857115|Hormones|hormones|mesh-ancestor
111071854|NCT01857115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111071855|NCT01857115|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111071856|NCT03453541|Ketorolac|ketorolac|mesh-list
111071857|NCT03453541|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
111071858|NCT03453541|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111071859|NCT03453541|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111071860|NCT03453541|Analgesics|analgesics|mesh-ancestor
111071861|NCT03453541|Sensory System Agents|sensory system agents|mesh-ancestor
111071862|NCT03453541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111071863|NCT03453541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111071864|NCT03453541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111071865|NCT03453541|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111071866|NCT03453541|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111071867|NCT03453541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110638047|NCT04696575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111071868|NCT03453541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111071869|NCT00893789|Modafinil|modafinil|mesh-list
111071870|NCT00893789|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111071871|NCT00893789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111071872|NCT00893789|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
111071873|NCT00893789|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111071874|NCT00893789|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111071875|NCT00893789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111071876|NCT03449251|Verapamil|verapamil|mesh-list
111071877|NCT03449251|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
111071878|NCT03449251|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111071879|NCT03449251|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111071880|NCT03449251|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111071881|NCT03449251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111071882|NCT03449251|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111071883|NCT03449251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111071884|NCT03449251|Vasodilator Agents|vasodilator agents|mesh-ancestor
111071885|NCT03449251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111071886|NCT05322499|Paclitaxel|paclitaxel|mesh-list
111071887|NCT05322499|Docetaxel|docetaxel|mesh-list
111071888|NCT05322499|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111071889|NCT05322499|Irinotecan|irinotecan|mesh-list
111071890|NCT05322499|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111071891|NCT05322499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111071892|NCT05322499|Tubulin Modulators|tubulin modulators|mesh-ancestor
111071893|NCT05322499|Antimitotic Agents|antimitotic agents|mesh-ancestor
111071894|NCT05322499|Mitosis Modulators|mitosis modulators|mesh-ancestor
111071895|NCT05322499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111071896|NCT05322499|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111071897|NCT05322499|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111071898|NCT05322499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111071899|NCT03449173|Sunitinib|sunitinib|mesh-list
111071900|NCT03449173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111071901|NCT03449173|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111071902|NCT03449173|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111071903|NCT03449173|Growth Substances|growth substances|mesh-ancestor
111071904|NCT03449173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111071905|NCT03449173|Growth Inhibitors|growth inhibitors|mesh-ancestor
111071906|NCT03449173|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111071907|NCT03449173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111071908|NCT03449173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111071909|NCT04760041|Midazolam|midazolam|mesh-list
111071910|NCT04760041|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111071911|NCT04760041|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111071912|NCT04760041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111071913|NCT04760041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111071914|NCT04760041|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111071915|NCT04760041|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111071916|NCT04760041|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111071917|NCT04760041|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111071918|NCT04760041|Anesthetics, General|anesthetics, general|mesh-ancestor
111071919|NCT04760041|Anesthetics|anesthetics|mesh-ancestor
111071920|NCT04760041|GABA Modulators|gaba modulators|mesh-ancestor
111071921|NCT04760041|GABA Agents|gaba agents|mesh-ancestor
111071922|NCT04760041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111071923|NCT04760041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111071924|NCT04754035|Venetoclax|venetoclax|mesh-list
111071925|NCT04754035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111071926|NCT05322265|Epinephrine|epinephrine|mesh-list
111071927|NCT05322265|Racepinephrine|racepinephrine|mesh-list
111071928|NCT05322265|Epinephryl borate|epinephryl borate|mesh-list
111071929|NCT05322265|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111071930|NCT05322265|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111071931|NCT05322265|Adrenergic Agents|adrenergic agents|mesh-ancestor
111071932|NCT05322265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111071933|NCT05322265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111071934|NCT05322265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111071935|NCT05322265|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111071936|NCT05322265|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111071937|NCT05322265|Autonomic Agents|autonomic agents|mesh-ancestor
111071938|NCT05322265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111071939|NCT05322265|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111071940|NCT05322265|Respiratory System Agents|respiratory system agents|mesh-ancestor
111071941|NCT05322265|Mydriatics|mydriatics|mesh-ancestor
111071942|NCT05322265|Sympathomimetics|sympathomimetics|mesh-ancestor
111071943|NCT05322265|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111071944|NCT02164864|Aspirin|aspirin|mesh-list
111071945|NCT02164864|Warfarin|warfarin|mesh-list
111071946|NCT02164864|Dabigatran|dabigatran|mesh-list
111071947|NCT02164864|Clopidogrel|clopidogrel|mesh-list
111071948|NCT02164864|Ticagrelor|ticagrelor|mesh-list
111071949|NCT02164864|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111071950|NCT02164864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111071951|NCT02164864|Analgesics|analgesics|mesh-ancestor
111071952|NCT02164864|Sensory System Agents|sensory system agents|mesh-ancestor
111071953|NCT02164864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111071954|NCT02164864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111071955|NCT02164864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111071956|NCT02164864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111071957|NCT02164864|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111071958|NCT02164864|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111071959|NCT02164864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111071960|NCT02164864|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111071961|NCT02164864|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111071962|NCT02164864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111071963|NCT02164864|Antipyretics|antipyretics|mesh-ancestor
111071964|NCT02164864|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111071965|NCT02164864|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111071966|NCT02164864|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111071967|NCT02164864|Purinergic Agents|purinergic agents|mesh-ancestor
111071968|NCT02164864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111071969|NCT02164864|Anticoagulants|anticoagulants|mesh-ancestor
111071970|NCT02164864|Antithrombins|antithrombins|mesh-ancestor
111071971|NCT02164864|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111071972|NCT02164864|Protease Inhibitors|protease inhibitors|mesh-ancestor
111071973|NCT05579249|Liraglutide|liraglutide|mesh-list
111071975|NCT05579249|Orlistat|orlistat|mesh-list
111071976|NCT05579249|Phentermine|phentermine|mesh-list
111071977|NCT05579249|Naltrexone|naltrexone|mesh-list
111071978|NCT05579249|Bupropion|bupropion|mesh-list
111071979|NCT05579249|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111071980|NCT05579249|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111071981|NCT05579249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111071982|NCT05579249|Sensory System Agents|sensory system agents|mesh-ancestor
111071983|NCT05579249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111071984|NCT05579249|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111071985|NCT05579249|Incretins|incretins|mesh-ancestor
111071986|NCT05579249|Hormones|hormones|mesh-ancestor
111071987|NCT05579249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111071988|NCT05579249|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111071989|NCT05579249|Antidepressive Agents|antidepressive agents|mesh-ancestor
111071990|NCT05579249|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111071991|NCT05579249|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111071992|NCT05579249|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111071993|NCT05579249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111071994|NCT05579249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111071996|NCT05579249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111071997|NCT05579249|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111071998|NCT05579249|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111071999|NCT05579249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111072000|NCT05579249|Anticonvulsants|anticonvulsants|mesh-ancestor
111072001|NCT05579249|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111072002|NCT05579249|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111072003|NCT05579249|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111072004|NCT05579249|Appetite Depressants|appetite depressants|mesh-ancestor
111072005|NCT05579249|Sympathomimetics|sympathomimetics|mesh-ancestor
111072006|NCT05579249|Autonomic Agents|autonomic agents|mesh-ancestor
111072007|NCT05579249|Adrenergic Agents|adrenergic agents|mesh-ancestor
111072008|NCT02419807|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111072009|NCT02419807|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
111072010|NCT02419807|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111072011|NCT02419807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111072012|NCT05386589|Molnupiravir|molnupiravir|mesh-list
111072013|NCT05386589|Antiviral Agents|antiviral agents|mesh-ancestor
111072014|NCT05386589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111072015|NCT01998529|Cisplatin|cisplatin|mesh-list
111072016|NCT01998529|Amifostine|amifostine|mesh-list
111072017|NCT01998529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111072018|NCT01998529|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111072019|NCT01998529|Protective Agents|protective agents|mesh-ancestor
111072020|NCT01998529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111072021|NCT03448705|Vaccines|vaccines|mesh-list
111072022|NCT03448705|Immunologic Factors|immunologic factors|mesh-ancestor
111072023|NCT03448705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111072024|NCT04637425|Broncho-Vaxom|broncho-vaxom|mesh-list
111072025|NCT04637425|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111072026|NCT04637425|Immunologic Factors|immunologic factors|mesh-ancestor
111072027|NCT04637425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111072028|NCT03448549|Capecitabine|capecitabine|mesh-list
111072029|NCT03448549|Tegafur|tegafur|mesh-list
111072030|NCT03448549|Oxaliplatin|oxaliplatin|mesh-list
111072031|NCT03448549|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111072032|NCT03448549|Antimetabolites|antimetabolites|mesh-ancestor
111072033|NCT03448549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111072034|NCT03448549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111072035|NCT03679091|Clopidogrel|clopidogrel|mesh-list
111072036|NCT03679091|Ticagrelor|ticagrelor|mesh-list
111072037|NCT03679091|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111072038|NCT03679091|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111072039|NCT03679091|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111072040|NCT03679091|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111072041|NCT03679091|Purinergic Agents|purinergic agents|mesh-ancestor
111072042|NCT03679091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111072043|NCT03679091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111072044|NCT03679091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111072045|NCT01628926|Ropinirole|ropinirole|mesh-list
111072046|NCT01628926|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111072047|NCT01628926|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111072048|NCT01628926|Dopamine Agonists|dopamine agonists|mesh-ancestor
111072049|NCT01628926|Dopamine Agents|dopamine agents|mesh-ancestor
111072050|NCT01628926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111072051|NCT01628926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111072052|NCT01628926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111072053|NCT05313659|Ketamine|ketamine|mesh-list
111072054|NCT05313659|Analgesics|analgesics|mesh-ancestor
111072055|NCT05313659|Sensory System Agents|sensory system agents|mesh-ancestor
111072056|NCT05313659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111072057|NCT05313659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111072058|NCT05313659|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111072059|NCT05313659|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111072060|NCT05313659|Anesthetics, General|anesthetics, general|mesh-ancestor
111072061|NCT05313659|Anesthetics|anesthetics|mesh-ancestor
111072062|NCT05313659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111072063|NCT05313659|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111072064|NCT05313659|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111072065|NCT05313659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111072066|NCT05313659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111072067|NCT05322187|Pembrolizumab|pembrolizumab|mesh-list
111072068|NCT05322187|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
111072069|NCT05322187|Lenvatinib|lenvatinib|mesh-list
111072070|NCT05322187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111072071|NCT05322187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111072072|NCT05322187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111072073|NCT05322187|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111072074|NCT05322187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111072075|NCT02164318|Nitroglycerin|nitroglycerin|mesh-list
111072076|NCT02164318|Vasodilator Agents|vasodilator agents|mesh-ancestor
111072077|NCT03436199|Amantadine|amantadine|mesh-list
111072078|NCT03436199|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111072079|NCT03436199|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111072080|NCT03436199|Antiviral Agents|antiviral agents|mesh-ancestor
111072081|NCT03436199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111072082|NCT03436199|Dopamine Agents|dopamine agents|mesh-ancestor
111072083|NCT03436199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111072084|NCT03436199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111072085|NCT03436199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111072086|NCT03436199|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111072087|NCT03436199|Analgesics|analgesics|mesh-ancestor
111072088|NCT03436199|Sensory System Agents|sensory system agents|mesh-ancestor
111072089|NCT03436199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111072090|NCT02131324|Clobetasol|clobetasol|mesh-list
111072091|NCT02131324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111072092|NCT02131324|Glucocorticoids|glucocorticoids|mesh-ancestor
111072093|NCT02131324|Hormones|hormones|mesh-ancestor
111072094|NCT02131324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111072095|NCT02131324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111072096|NCT04749394|Apatinib|apatinib|mesh-list
111072097|NCT04749394|Antibodies|antibodies|mesh-list
111072098|NCT04749394|Immunoglobulins|immunoglobulins|mesh-list
111072099|NCT04749394|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111072100|NCT04749394|Immunologic Factors|immunologic factors|mesh-ancestor
111072101|NCT04749394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111072102|NCT04749394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111072103|NCT04749394|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111072104|NCT04749394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111072105|NCT04749394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111072106|NCT02193880|Cyclophosphamide|cyclophosphamide|mesh-list
111072107|NCT02193880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111072108|NCT02193880|Immunologic Factors|immunologic factors|mesh-ancestor
111072109|NCT02193880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111072110|NCT02193880|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111072111|NCT02193880|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111072112|NCT02193880|Alkylating Agents|alkylating agents|mesh-ancestor
111072113|NCT02193880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111072114|NCT02193880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111072115|NCT02193880|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111072116|NCT05159219|Colchicine|colchicine|mesh-list
111072117|NCT05159219|Gout Suppressants|gout suppressants|mesh-ancestor
111072118|NCT05159219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111072119|NCT05159219|Tubulin Modulators|tubulin modulators|mesh-ancestor
111072120|NCT05159219|Antimitotic Agents|antimitotic agents|mesh-ancestor
111072121|NCT05159219|Mitosis Modulators|mitosis modulators|mesh-ancestor
111072122|NCT05159219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111072123|NCT05159219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111072124|NCT05321329|Capecitabine|capecitabine|mesh-list
111072125|NCT05321329|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111072126|NCT05321329|Antimetabolites|antimetabolites|mesh-ancestor
111072127|NCT05321329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111072128|NCT05321329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111072129|NCT02521831|Bupivacaine|bupivacaine|mesh-list
111072130|NCT02521831|Anesthetics|anesthetics|mesh-list
111072131|NCT02521831|Isoflurane|isoflurane|mesh-list
111072132|NCT02521831|Anesthetics, Local|anesthetics, local|mesh-ancestor
111072133|NCT02521831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111072134|NCT02521831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111072135|NCT02521831|Sensory System Agents|sensory system agents|mesh-ancestor
111072136|NCT02521831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111072137|NCT02521831|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111072138|NCT02521831|Anesthetics, General|anesthetics, general|mesh-ancestor
111072139|NCT01425541|Progesterone|progesterone|mesh-list
111072140|NCT01425541|Estradiol|estradiol|mesh-list
111072141|NCT01425541|Estrogens|estrogens|mesh-list
111072142|NCT01425541|Progestins|progestins|mesh-ancestor
111072143|NCT01425541|Hormones|hormones|mesh-ancestor
111072144|NCT01425541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111072145|NCT01425541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111072146|NCT03447925|Salicylic Acid|salicylic acid|mesh-list
111072147|NCT03447925|Salicylates|salicylates|mesh-list
111072148|NCT03447925|Petrolatum|petrolatum|mesh-list
111072149|NCT03447925|Emollients|emollients|mesh-ancestor
111072150|NCT03447925|Dermatologic Agents|dermatologic agents|mesh-ancestor
111072151|NCT03447925|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111072152|NCT03447925|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111072153|NCT03447925|Analgesics|analgesics|mesh-ancestor
111072154|NCT03447925|Sensory System Agents|sensory system agents|mesh-ancestor
111072155|NCT03447925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111072156|NCT03447925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111072157|NCT03447925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111072158|NCT03447925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111072159|NCT03447925|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111072160|NCT03447925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111072161|NCT03447925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111072162|NCT03447925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111072163|NCT03447925|Antifungal Agents|antifungal agents|mesh-ancestor
111072164|NCT03447925|Keratolytic Agents|keratolytic agents|mesh-ancestor
111072165|NCT04928183|Nitroprusside|nitroprusside|mesh-list
111072166|NCT04928183|Phenylephrine|phenylephrine|mesh-list
111072167|NCT04928183|Oxymetazoline|oxymetazoline|mesh-list
111072168|NCT04928183|Carbon Monoxide|carbon monoxide|mesh-list
111072169|NCT04928183|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111072170|NCT04928183|Mydriatics|mydriatics|mesh-ancestor
111072171|NCT04928183|Autonomic Agents|autonomic agents|mesh-ancestor
111072172|NCT04928183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111072173|NCT04928183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111072174|NCT04928183|Sympathomimetics|sympathomimetics|mesh-ancestor
111072175|NCT04928183|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111072176|NCT04928183|Nasal Decongestants|nasal decongestants|mesh-ancestor
111072177|NCT04928183|Respiratory System Agents|respiratory system agents|mesh-ancestor
111072178|NCT04928183|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111072179|NCT04928183|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111072180|NCT04928183|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111072181|NCT04928183|Adrenergic Agents|adrenergic agents|mesh-ancestor
111072182|NCT04928183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111072183|NCT04928183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111072184|NCT04928183|Protective Agents|protective agents|mesh-ancestor
111072185|NCT04928183|Antimetabolites|antimetabolites|mesh-ancestor
111072186|NCT04928183|Gasotransmitters|gasotransmitters|mesh-ancestor
111072187|NCT04928183|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111072188|NCT04928183|Vasodilator Agents|vasodilator agents|mesh-ancestor
111072189|NCT04928183|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
111072190|NCT03447691|Remifentanil|remifentanil|mesh-list
111072191|NCT03447691|Anesthetics|anesthetics|mesh-list
111072192|NCT03447691|Propofol|propofol|mesh-list
111072193|NCT03447691|Desflurane|desflurane|mesh-list
111072194|NCT03447691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111072195|NCT03447691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111072196|NCT03447691|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111072197|NCT03447691|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111072198|NCT03447691|Anesthetics, General|anesthetics, general|mesh-ancestor
111072199|NCT03447691|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111072200|NCT03447691|Narcotics|narcotics|mesh-ancestor
111072201|NCT03447691|Analgesics|analgesics|mesh-ancestor
111072202|NCT03447691|Sensory System Agents|sensory system agents|mesh-ancestor
111072203|NCT03447691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111072204|NCT03447691|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111072205|NCT04923659|Nimodipine|nimodipine|mesh-list
111072206|NCT04923659|Carbamazepine|carbamazepine|mesh-list
111072207|NCT04923659|Lorazepam|lorazepam|mesh-list
111072208|NCT04923659|Dextromethorphan|dextromethorphan|mesh-list
111072209|NCT04923659|Antitussive Agents|antitussive agents|mesh-ancestor
111072210|NCT04923659|Respiratory System Agents|respiratory system agents|mesh-ancestor
111072211|NCT04923659|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111072212|NCT04923659|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111072213|NCT04923659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111072214|NCT04923659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111072215|NCT04923659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111072216|NCT04923659|Anticonvulsants|anticonvulsants|mesh-ancestor
111072217|NCT04923659|Antiemetics|antiemetics|mesh-ancestor
111072218|NCT04923659|Autonomic Agents|autonomic agents|mesh-ancestor
111072219|NCT04923659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111072220|NCT04923659|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111072221|NCT04923659|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111072222|NCT04923659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111072223|NCT04923659|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111072224|NCT04923659|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111072225|NCT04923659|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111072226|NCT04923659|GABA Modulators|gaba modulators|mesh-ancestor
111072227|NCT04923659|GABA Agents|gaba agents|mesh-ancestor
111072228|NCT04923659|Antimanic Agents|antimanic agents|mesh-ancestor
111072229|NCT04923659|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111072230|NCT04923659|Analgesics|analgesics|mesh-ancestor
111072231|NCT04923659|Sensory System Agents|sensory system agents|mesh-ancestor
111072232|NCT04923659|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111072233|NCT04923659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111072234|NCT04923659|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111072235|NCT04923659|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111072236|NCT04923659|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111072237|NCT04923659|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111072238|NCT04923659|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111072239|NCT04923659|Vasodilator Agents|vasodilator agents|mesh-ancestor
111072240|NCT05398679|Amoxicillin|amoxicillin|mesh-list
111072241|NCT05398679|Moxifloxacin|moxifloxacin|mesh-list
111072242|NCT05398679|Ciprofloxacin|ciprofloxacin|mesh-list
111072243|NCT05398679|Levofloxacin|levofloxacin|mesh-list
111072244|NCT05398679|Ofloxacin|ofloxacin|mesh-list
111072245|NCT05398679|Clindamycin|clindamycin|mesh-list
111072246|NCT05398679|Clindamycin palmitate|clindamycin palmitate|mesh-list
111072247|NCT05398679|Clindamycin phosphate|clindamycin phosphate|mesh-list
111072248|NCT05398679|Rifampin|rifampin|mesh-list
111072249|NCT05398679|Linezolid|linezolid|mesh-list
111072250|NCT05398679|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
111072251|NCT05398679|Tedizolid|tedizolid|mesh-list
111072252|NCT05398679|Fusidic Acid|fusidic acid|mesh-list
111072253|NCT05398679|Dicloxacillin|dicloxacillin|mesh-list
111072254|NCT05398679|Cefaclor|cefaclor|mesh-list
111072255|NCT05398679|Trimethoprim|trimethoprim|mesh-list
111072256|NCT05398679|Sulfamethoxazole|sulfamethoxazole|mesh-list
111072257|NCT05398679|Oxazolidinones|oxazolidinones|mesh-list
111072258|NCT05398679|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
111072259|NCT05398679|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110789370|NCT03572686|BB 1101|bb 1101|mesh-list
111072260|NCT05398679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111072261|NCT05398679|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111072262|NCT05398679|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111072263|NCT05398679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111072264|NCT05398679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111072265|NCT05398679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111072266|NCT05398679|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111072267|NCT05398679|Contraceptive Agents|contraceptive agents|mesh-ancestor
111072268|NCT05398679|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111072269|NCT05398679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111072270|NCT05398679|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
111072271|NCT05398679|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111072272|NCT05398679|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111072273|NCT05398679|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111072274|NCT05398679|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111072275|NCT05398679|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111072276|NCT05398679|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111072277|NCT05398679|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111072278|NCT05398679|Antitubercular Agents|antitubercular agents|mesh-ancestor
111072279|NCT05398679|Leprostatic Agents|leprostatic agents|mesh-ancestor
111072280|NCT05398679|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111072281|NCT05398679|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111072282|NCT05398679|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111072283|NCT05398679|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
111072284|NCT05398679|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
111072285|NCT05398679|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
111072286|NCT05398679|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111072287|NCT05398679|Antimalarials|antimalarials|mesh-ancestor
111072288|NCT05398679|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111072289|NCT05398679|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111072290|NCT05398679|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111072291|NCT05398679|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111072292|NCT05398679|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
111072293|NCT04817501|Edetic Acid|edetic acid|mesh-list
111072294|NCT04817501|Anticoagulants|anticoagulants|mesh-ancestor
111072295|NCT04817501|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
111072296|NCT04817501|Chelating Agents|chelating agents|mesh-ancestor
111072297|NCT04817501|Sequestering Agents|sequestering agents|mesh-ancestor
111072298|NCT04817501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111072300|NCT05398055|Doxycycline|doxycycline|mesh-list
111072301|NCT05398055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111072302|NCT05398055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111072303|NCT05398055|Antimalarials|antimalarials|mesh-ancestor
111072304|NCT05398055|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111072305|NCT05398055|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111072306|NCT01378325|Phenylephrine|phenylephrine|mesh-list
111072307|NCT01378325|Oxymetazoline|oxymetazoline|mesh-list
111072308|NCT01378325|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111072309|NCT01378325|Mydriatics|mydriatics|mesh-ancestor
111072310|NCT01378325|Autonomic Agents|autonomic agents|mesh-ancestor
111072311|NCT01378325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111072312|NCT01378325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111072313|NCT01378325|Sympathomimetics|sympathomimetics|mesh-ancestor
111072314|NCT01378325|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111072315|NCT01378325|Nasal Decongestants|nasal decongestants|mesh-ancestor
111072316|NCT01378325|Respiratory System Agents|respiratory system agents|mesh-ancestor
111072317|NCT01378325|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111072318|NCT01378325|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111072319|NCT01378325|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111072320|NCT01378325|Adrenergic Agents|adrenergic agents|mesh-ancestor
111072321|NCT01378325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111072322|NCT01378325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111072323|NCT01378325|Protective Agents|protective agents|mesh-ancestor
111072324|NCT03854903|Fulvestrant|fulvestrant|mesh-list
111072325|NCT03854903|Palbociclib|palbociclib|mesh-list
111072326|NCT03854903|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111072327|NCT03854903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111072328|NCT03854903|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
111072329|NCT03854903|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111072330|NCT03854903|Hormone Antagonists|hormone antagonists|mesh-ancestor
111072331|NCT03854903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111072332|NCT03854903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111072333|NCT03854903|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111072334|NCT03854903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111072335|NCT03854903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111072336|NCT01093573|Azacitidine|azacitidine|mesh-list
111072337|NCT01093573|Midostaurin|midostaurin|mesh-list
110789446|NCT03709082|Trastuzumab|trastuzumab|mesh-list
111072338|NCT01093573|Staurosporine|staurosporine|mesh-list
111072339|NCT01093573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111072340|NCT01093573|Antimetabolites|antimetabolites|mesh-ancestor
111072341|NCT01093573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111072342|NCT01093573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111072343|NCT01093573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111072344|NCT01093573|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111072345|NCT05174845|Ascorbic Acid|ascorbic acid|mesh-list
111072346|NCT05174845|Antioxidants|antioxidants|mesh-ancestor
111072347|NCT05174845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111072348|NCT05174845|Protective Agents|protective agents|mesh-ancestor
111072349|NCT05174845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111072351|NCT05174845|Micronutrients|micronutrients|mesh-ancestor
111072352|NCT04155203|Calcium, Dietary|calcium, dietary|mesh-list
111072353|NCT04155203|Mupirocin|mupirocin|mesh-list
111072354|NCT04155203|Calcium|calcium|mesh-list
111072355|NCT04155203|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111072356|NCT04155203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111072357|NCT04155203|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111072358|NCT04155203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111072359|NCT04155203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111072360|NCT04155203|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111072361|NCT04155203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111072362|NCT04155203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111072363|NCT04238143|Complement Factor H|complement factor h|mesh-list
111072364|NCT04238143|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
111072365|NCT04238143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111072366|NCT04238143|Immunologic Factors|immunologic factors|mesh-ancestor
111072367|NCT04238143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111072368|NCT03057613|Pembrolizumab|pembrolizumab|mesh-list
111072369|NCT03057613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110537453|NCT02642484|Gabapentin|gabapentin|mesh-list
111072370|NCT03057613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111072371|NCT03057613|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111072372|NCT03057613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111072373|NCT03446911|Pembrolizumab|pembrolizumab|mesh-list
110638143|NCT02548052|Respiratory System Agents|respiratory system agents|mesh-ancestor
111072374|NCT03446911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111072375|NCT03446911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111072376|NCT03446911|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111072377|NCT03446911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111072378|NCT03446599|Hydroxocobalamin|hydroxocobalamin|mesh-list
111072379|NCT03446599|Vitamin B 12|vitamin b 12|mesh-list
111072380|NCT03446599|Methylene Blue|methylene blue|mesh-list
111072381|NCT03446599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111072382|NCT03446599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111072383|NCT03446599|Hematinics|hematinics|mesh-ancestor
111072384|NCT03446599|Vitamin B Complex|vitamin b complex|mesh-ancestor
111072385|NCT03446599|Vitamins|vitamins|mesh-ancestor
111072386|NCT03446599|Micronutrients|micronutrients|mesh-ancestor
111072387|NCT03446599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111072388|NCT02856451|Nivolumab|nivolumab|mesh-list
111072389|NCT02856451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111072390|NCT02856451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111072391|NCT02856451|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111072392|NCT02856451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111072393|NCT03446443|Metronidazole|metronidazole|mesh-list
111072394|NCT03446443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111072395|NCT03446443|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111072396|NCT03446443|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111072397|NCT03446443|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111072398|NCT05102071|Metformin|metformin|mesh-list
111072399|NCT05102071|Empagliflozin|empagliflozin|mesh-list
111072400|NCT05102071|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111072401|NCT05102071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111072402|NCT05102071|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111072403|NCT05102071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111072404|NCT03130517|Immunoglobulins|immunoglobulins|mesh-list
111072405|NCT03130517|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111072406|NCT03130517|Antibodies|antibodies|mesh-list
111072407|NCT03130517|gamma-Globulins|gamma-globulins|mesh-list
111072408|NCT03130517|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
111072409|NCT03130517|Immunologic Factors|immunologic factors|mesh-ancestor
111072410|NCT03130517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111072411|NCT03445897|Miltefosine|miltefosine|mesh-list
111072412|NCT03445897|Pentamidine|pentamidine|mesh-list
111072414|NCT03445897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111072415|NCT03445897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111072416|NCT03445897|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111072417|NCT03445897|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111072418|NCT03445897|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
111072419|NCT03237611|Dexamethasone|dexamethasone|mesh-list
111072420|NCT03237611|Ondansetron|ondansetron|mesh-list
111072421|NCT03237611|Aprepitant|aprepitant|mesh-list
111072422|NCT03237611|Fosaprepitant|fosaprepitant|mesh-list
111072423|NCT03237611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111072424|NCT03237611|Antiemetics|antiemetics|mesh-ancestor
111072425|NCT03237611|Autonomic Agents|autonomic agents|mesh-ancestor
111072426|NCT03237611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111072427|NCT03237611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111072428|NCT03237611|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111072429|NCT03237611|Glucocorticoids|glucocorticoids|mesh-ancestor
111072430|NCT03237611|Hormones|hormones|mesh-ancestor
111072431|NCT03237611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111072432|NCT03237611|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111072433|NCT03237611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111072434|NCT03237611|Antipruritics|antipruritics|mesh-ancestor
111072435|NCT03237611|Dermatologic Agents|dermatologic agents|mesh-ancestor
111072436|NCT03237611|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111072437|NCT03237611|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111072438|NCT03237611|Serotonin Agents|serotonin agents|mesh-ancestor
111072439|NCT03237611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111072440|NCT03237611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111072441|NCT03237611|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
111072442|NCT03234491|Insulin|insulin|mesh-list
111072443|NCT03234491|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111072444|NCT03234491|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111072445|NCT03234491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111072446|NCT01961063|Busulfan|busulfan|mesh-list
111072447|NCT01961063|Alkylating Agents|alkylating agents|mesh-ancestor
111072448|NCT01961063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111072449|NCT01961063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111072450|NCT01961063|Immunologic Factors|immunologic factors|mesh-ancestor
111072451|NCT01961063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111072452|NCT01961063|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111072453|NCT01961063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111072454|NCT01961063|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111072455|NCT02951377|Dexamethasone|dexamethasone|mesh-list
111072456|NCT02951377|Lidocaine|lidocaine|mesh-list
111072457|NCT02951377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111072458|NCT02951377|Antiemetics|antiemetics|mesh-ancestor
111072459|NCT02951377|Autonomic Agents|autonomic agents|mesh-ancestor
111072460|NCT02951377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111072461|NCT02951377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111072462|NCT02951377|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111072463|NCT02951377|Glucocorticoids|glucocorticoids|mesh-ancestor
111072464|NCT02951377|Hormones|hormones|mesh-ancestor
111072465|NCT02951377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111072466|NCT02951377|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111072467|NCT02951377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111072468|NCT02951377|Anesthetics, Local|anesthetics, local|mesh-ancestor
111072469|NCT02951377|Anesthetics|anesthetics|mesh-ancestor
111072470|NCT02951377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111072471|NCT02951377|Sensory System Agents|sensory system agents|mesh-ancestor
111072472|NCT02951377|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111072473|NCT02951377|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111072474|NCT02951377|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111072475|NCT02951377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111072476|NCT02951377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111072477|NCT03109717|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-list
111072478|NCT03109717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111072479|NCT03109717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111072480|NCT03442621|Cortisone|cortisone|mesh-list
111072481|NCT03442621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111072482|NCT03444649|Cytarabine|cytarabine|mesh-list
111072483|NCT03444649|Daunorubicin|daunorubicin|mesh-list
111072484|NCT03444649|Idarubicin|idarubicin|mesh-list
111072485|NCT03444649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111072486|NCT03444649|Antimetabolites|antimetabolites|mesh-ancestor
110789593|NCT03710330|Coagulants|coagulants|mesh-ancestor
111072487|NCT03444649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111072488|NCT03444649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111072489|NCT03444649|Antiviral Agents|antiviral agents|mesh-ancestor
111072490|NCT03444649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111072491|NCT03444649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111072492|NCT03444649|Immunologic Factors|immunologic factors|mesh-ancestor
111072493|NCT03444649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111072494|NCT03444649|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111072495|NCT03444649|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111072496|NCT03444649|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111072497|NCT03444649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111072498|NCT01328951|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111072499|NCT01328951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111072500|NCT01328951|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111072501|NCT01328951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111072502|NCT01328951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111072503|NCT03466775|Angiotensin II|angiotensin ii|mesh-list
111072504|NCT03466775|Giapreza|giapreza|mesh-list
111072505|NCT03466775|Antibodies|antibodies|mesh-list
111072506|NCT03466775|Angiotensinogen|angiotensinogen|mesh-list
111072507|NCT03466775|Immunologic Factors|immunologic factors|mesh-ancestor
111072508|NCT03466775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111072509|NCT03466775|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111072510|NCT03466775|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111072511|NCT03466775|Protease Inhibitors|protease inhibitors|mesh-ancestor
111072512|NCT03466775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111072513|NCT03466775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111072514|NCT02611817|Vedolizumab|vedolizumab|mesh-list
111072515|NCT02611817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111072516|NCT05430893|Botulinum Toxins|botulinum toxins|mesh-list
111072517|NCT05430893|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111072518|NCT05430893|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111072519|NCT05430893|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111072520|NCT05430893|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111072521|NCT05430893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111072522|NCT05430893|Cholinergic Agents|cholinergic agents|mesh-ancestor
111072523|NCT05430893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111072524|NCT05430893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111072525|NCT05430893|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111072526|NCT05430893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111072527|NCT02557139|Belumosudil|belumosudil|mesh-list
111072528|NCT02557139|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111072529|NCT02557139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111072530|NCT02557139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111072531|NCT01677741|Dabrafenib|dabrafenib|mesh-list
111072532|NCT01677741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111072533|NCT01677741|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111072534|NCT01677741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111072535|NCT01677741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111072536|NCT02457221|Prednisone|prednisone|mesh-list
111072537|NCT02457221|Cyclophosphamide|cyclophosphamide|mesh-list
111072538|NCT02457221|Tacrolimus|tacrolimus|mesh-list
111072539|NCT02457221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111072540|NCT02457221|Immunologic Factors|immunologic factors|mesh-ancestor
111072541|NCT02457221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111072542|NCT02457221|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111072543|NCT02457221|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111072544|NCT02457221|Alkylating Agents|alkylating agents|mesh-ancestor
111072545|NCT02457221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111072546|NCT02457221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111072547|NCT02457221|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111072548|NCT02457221|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111072549|NCT02457221|Glucocorticoids|glucocorticoids|mesh-ancestor
111072550|NCT02457221|Hormones|hormones|mesh-ancestor
111072551|NCT02457221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111072552|NCT02457221|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111072553|NCT02457221|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111072554|NCT02457221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111072555|NCT05263895|Ritonavir|ritonavir|mesh-list
111072556|NCT05263895|Nirmatrelvir|nirmatrelvir|mesh-list
111072557|NCT05263895|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111072558|NCT05263895|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111072559|NCT05263895|Protease Inhibitors|protease inhibitors|mesh-ancestor
111072560|NCT05263895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110789674|NCT01145859|Rivaroxaban|rivaroxaban|mesh-list
111072561|NCT05263895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111072562|NCT05263895|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111072563|NCT05263895|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111072564|NCT05263895|Antiviral Agents|antiviral agents|mesh-ancestor
111072565|NCT05263895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111072566|NCT05263895|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111072567|NCT05263895|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111072568|NCT01709981|Colchicine|colchicine|mesh-list
111072569|NCT01709981|Gout Suppressants|gout suppressants|mesh-ancestor
111072570|NCT01709981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111072571|NCT01709981|Tubulin Modulators|tubulin modulators|mesh-ancestor
111072572|NCT01709981|Antimitotic Agents|antimitotic agents|mesh-ancestor
111072573|NCT01709981|Mitosis Modulators|mitosis modulators|mesh-ancestor
111072574|NCT01709981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111072575|NCT01709981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111072576|NCT03268083|Vaccines|vaccines|mesh-list
111072577|NCT03268083|Immunologic Factors|immunologic factors|mesh-ancestor
111072578|NCT03268083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111072579|NCT03465059|Zanubrutinib|zanubrutinib|mesh-list
111072580|NCT03465059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111072581|NCT03465059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111072582|NCT03465059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111072583|NCT03465059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111072584|NCT03170817|Regadenoson|regadenoson|mesh-list
111072585|NCT03170817|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
111072586|NCT03170817|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
111072587|NCT03170817|Purinergic Agonists|purinergic agonists|mesh-ancestor
111072588|NCT03170817|Purinergic Agents|purinergic agents|mesh-ancestor
111072589|NCT03170817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111072590|NCT03170817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111072591|NCT03170817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111072593|NCT05101005|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111072594|NCT05101005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111072595|NCT05101005|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111072596|NCT05101005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111072597|NCT05101005|Antifungal Agents|antifungal agents|mesh-ancestor
111072598|NCT05101005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111072599|NCT05101005|Immunologic Factors|immunologic factors|mesh-ancestor
111072600|NCT05101005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111072601|NCT03130205|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
111072602|NCT03130205|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111072603|NCT03130205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111072604|NCT05015387|Proanthocyanidin|proanthocyanidin|mesh-list
111072605|NCT05015387|Procyanidin|procyanidin|mesh-list
111072606|NCT05015387|Antioxidants|antioxidants|mesh-ancestor
111072607|NCT05015387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111072608|NCT05015387|Protective Agents|protective agents|mesh-ancestor
111072609|NCT05015387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111072610|NCT05015387|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111072611|NCT05015387|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111072612|NCT05015387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111072613|NCT00003857|Tamoxifen|tamoxifen|mesh-list
111072614|NCT00003857|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111072615|NCT00003857|Hormone Antagonists|hormone antagonists|mesh-ancestor
111072616|NCT00003857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111072617|NCT00003857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111072618|NCT00003857|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111072619|NCT00003857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111072620|NCT00003857|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111072621|NCT00003857|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111072622|NCT00003857|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111072623|NCT03464435|Loteprednol Etabonate|loteprednol etabonate|mesh-list
111072624|NCT03464435|Tobramycin|tobramycin|mesh-list
111072625|NCT03464435|Tacrolimus|tacrolimus|mesh-list
111072626|NCT03464435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111072627|NCT03464435|Immunologic Factors|immunologic factors|mesh-ancestor
111072628|NCT03464435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111072629|NCT03464435|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111072630|NCT03464435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111072631|NCT03464435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111072632|NCT03464435|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111072633|NCT03464435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111072634|NCT03464435|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111072635|NCT03464279|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111072636|NCT03464279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111072638|NCT03463967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111072639|NCT03463967|Antioxidants|antioxidants|mesh-ancestor
111072640|NCT03463967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111072641|NCT03463967|Protective Agents|protective agents|mesh-ancestor
111072642|NCT03463967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111072643|NCT03463967|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111072644|NCT03463967|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
111072645|NCT03463967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111072646|NCT03463733|Temozolomide|temozolomide|mesh-list
111072647|NCT03463733|Hydroxyurea|hydroxyurea|mesh-list
111072648|NCT03463733|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111072649|NCT03463733|Alkylating Agents|alkylating agents|mesh-ancestor
111072650|NCT03463733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111072651|NCT03463733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111072652|NCT03463733|Antisickling Agents|antisickling agents|mesh-ancestor
111072653|NCT03463733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111072654|NCT03463733|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111072655|NCT04222595|Vaccines|vaccines|mesh-list
111072656|NCT04222595|Immunologic Factors|immunologic factors|mesh-ancestor
111072657|NCT04222595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111072658|NCT03468023|Calpastatin|calpastatin|mesh-list
111072659|NCT03468023|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
111072660|NCT03468023|Protease Inhibitors|protease inhibitors|mesh-ancestor
111072661|NCT03468023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111072662|NCT03468023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111072663|NCT04830215|Brexpiprazole|brexpiprazole|mesh-list
111072664|NCT04830215|Serotonin Agents|serotonin agents|mesh-ancestor
111072665|NCT04830215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110537742|NCT02821559|Antimetabolites|antimetabolites|mesh-ancestor
110638224|NCT02547116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111072666|NCT04830215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111072667|NCT04830215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111072669|NCT04830215|Dopamine Agents|dopamine agents|mesh-ancestor
111072670|NCT05100303|Cytarabine|cytarabine|mesh-list
111072671|NCT05100303|Mitoxantrone|mitoxantrone|mesh-list
111072672|NCT05100303|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111072673|NCT05100303|Antimetabolites|antimetabolites|mesh-ancestor
111072674|NCT05100303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111072675|NCT05100303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111072676|NCT05100303|Antiviral Agents|antiviral agents|mesh-ancestor
111072677|NCT05100303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111072678|NCT05100303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111072679|NCT05100303|Immunologic Factors|immunologic factors|mesh-ancestor
111072680|NCT05100303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111072681|NCT05100303|Analgesics|analgesics|mesh-ancestor
111072682|NCT05100303|Sensory System Agents|sensory system agents|mesh-ancestor
111072683|NCT05100303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111072684|NCT05100303|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111072685|NCT05100303|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111072686|NCT05100303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111072687|NCT03462173|Yimitasvir|yimitasvir|mesh-list
111072688|NCT03462173|Antiviral Agents|antiviral agents|mesh-ancestor
111072689|NCT03462173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111072690|NCT05096715|Bevacizumab|bevacizumab|mesh-list
111072691|NCT05096715|Atezolizumab|atezolizumab|mesh-list
111072692|NCT05096715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111072693|NCT05096715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111072694|NCT05096715|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111072695|NCT05096715|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111072696|NCT05096715|Growth Substances|growth substances|mesh-ancestor
111072697|NCT05096715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111072698|NCT05096715|Growth Inhibitors|growth inhibitors|mesh-ancestor
111072699|NCT05096715|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111072700|NCT05096715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111072701|NCT04984889|Protein C|protein c|mesh-list
111072702|NCT04984889|Anticoagulants|anticoagulants|mesh-ancestor
111072703|NCT04984889|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111072704|NCT04984889|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111072705|NCT04984889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111072706|NCT05099601|Silymarin|silymarin|mesh-list
111072707|NCT05099601|Antioxidants|antioxidants|mesh-ancestor
111072708|NCT05099601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111072709|NCT05099601|Protective Agents|protective agents|mesh-ancestor
111072710|NCT05099601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111072711|NCT03461783|Charcoal|charcoal|mesh-list
111072712|NCT03461783|Antidotes|antidotes|mesh-ancestor
111072713|NCT03461783|Protective Agents|protective agents|mesh-ancestor
111072714|NCT03461783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111072715|NCT01677507|Timolol|timolol|mesh-list
111072716|NCT01677507|Latanoprost|latanoprost|mesh-list
111072717|NCT01677507|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111072718|NCT01677507|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111072719|NCT01677507|Adrenergic Agents|adrenergic agents|mesh-ancestor
111072720|NCT01677507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111072721|NCT01677507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111072722|NCT01677507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111072723|NCT01677507|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111072724|NCT01677507|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111072725|NCT01677507|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
111072726|NCT01677507|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111072727|NCT04796363|Anesthetics|anesthetics|mesh-list
111072728|NCT04796363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111072729|NCT04796363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111072730|NCT03593109|Immunomodulating Agents|immunomodulating agents|mesh-list
111072731|NCT03593109|Immunologic Factors|immunologic factors|mesh-ancestor
111072732|NCT03593109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111072733|NCT05103813|Beraprost|beraprost|mesh-list
111072734|NCT05103813|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111072735|NCT05103813|Vasodilator Agents|vasodilator agents|mesh-ancestor
111072736|NCT03461627|Fluticasone|fluticasone|mesh-list
111072737|NCT03461627|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
111072738|NCT03461627|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
111072739|NCT03461627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111072741|NCT03461627|Autonomic Agents|autonomic agents|mesh-ancestor
111072742|NCT03461627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111072743|NCT03461627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111072744|NCT03461627|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111072745|NCT03461627|Respiratory System Agents|respiratory system agents|mesh-ancestor
111072746|NCT03461627|Dermatologic Agents|dermatologic agents|mesh-ancestor
111072747|NCT03461627|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111072748|NCT03461627|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111072749|NCT03461627|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111072750|NCT03461627|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111072751|NCT03461627|Adrenergic Agents|adrenergic agents|mesh-ancestor
111072752|NCT03461627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111072753|NCT03461627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111072754|NCT03461627|Glucocorticoids|glucocorticoids|mesh-ancestor
111072755|NCT03461627|Hormones|hormones|mesh-ancestor
111072756|NCT03461627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111072757|NCT03461627|Sympathomimetics|sympathomimetics|mesh-ancestor
111072758|NCT04452929|Calcitonin|calcitonin|mesh-list
111072759|NCT04452929|Salmon calcitonin|salmon calcitonin|mesh-list
111072760|NCT04452929|Cilostazol|cilostazol|mesh-list
111072761|NCT04452929|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
111072762|NCT04452929|Erenumab|erenumab|mesh-list
111072763|NCT04452929|Katacalcin|katacalcin|mesh-list
111072764|NCT04452929|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111072765|NCT04452929|Autonomic Agents|autonomic agents|mesh-ancestor
111072766|NCT04452929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111072767|NCT04452929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111072768|NCT04452929|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111072769|NCT04452929|Respiratory System Agents|respiratory system agents|mesh-ancestor
111072770|NCT04452929|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111072771|NCT04452929|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111072772|NCT04452929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111072773|NCT04452929|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111072774|NCT04452929|Vasodilator Agents|vasodilator agents|mesh-ancestor
111072775|NCT04452929|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111072776|NCT04452929|Protective Agents|protective agents|mesh-ancestor
111072777|NCT04452929|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
111072778|NCT04452929|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111072779|NCT04452929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111072780|NCT04452929|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
111072781|NCT04452929|Analgesics|analgesics|mesh-ancestor
111072782|NCT04452929|Sensory System Agents|sensory system agents|mesh-ancestor
111072783|NCT04452929|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111072784|NCT04452929|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111072785|NCT05103501|Pembrolizumab|pembrolizumab|mesh-list
111072786|NCT05103501|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
111072787|NCT05103501|Fluorouracil|fluorouracil|mesh-list
111072788|NCT05103501|Cisplatin|cisplatin|mesh-list
111072789|NCT05103501|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111072790|NCT05103501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111072791|NCT05103501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111072792|NCT05103501|Antimetabolites|antimetabolites|mesh-ancestor
111072793|NCT05103501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111072794|NCT05103501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111072795|NCT05103501|Immunologic Factors|immunologic factors|mesh-ancestor
111072796|NCT05103501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111072797|NCT02522117|Atorvastatin|atorvastatin|mesh-list
111072798|NCT02522117|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111072799|NCT02522117|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111072800|NCT02522117|Antimetabolites|antimetabolites|mesh-ancestor
111072801|NCT02522117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111072802|NCT02522117|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111072803|NCT02522117|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111072804|NCT02522117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111072805|NCT05087199|Fibrin fragment D|fibrin fragment d|mesh-list
111072806|NCT05087199|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111072807|NCT05087199|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111072808|NCT05087199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111072809|NCT05087199|Hemostatics|hemostatics|mesh-ancestor
111072810|NCT05087199|Coagulants|coagulants|mesh-ancestor
111072811|NCT04628429|Erenumab|erenumab|mesh-list
111072812|NCT04628429|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
111072813|NCT04628429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111072815|NCT04628429|Sensory System Agents|sensory system agents|mesh-ancestor
111072816|NCT04628429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111072817|NCT04628429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111072818|NCT03461081|Amlodipine|amlodipine|mesh-list
111072819|NCT03461081|Telmisartan|telmisartan|mesh-list
111072820|NCT03461081|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
111072821|NCT03461081|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
111072822|NCT03461081|Atorvastatin|atorvastatin|mesh-list
111072823|NCT03461081|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111072824|NCT03461081|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111072825|NCT03461081|Antimetabolites|antimetabolites|mesh-ancestor
111072826|NCT03461081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111072827|NCT03461081|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111072828|NCT03461081|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111072829|NCT03461081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111072830|NCT03461081|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111072831|NCT03461081|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111072832|NCT03461081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111072833|NCT03461081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111072834|NCT03461081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111072835|NCT03461081|Vasodilator Agents|vasodilator agents|mesh-ancestor
111072836|NCT03461081|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111072837|NCT03461081|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111072838|NCT02522039|Timolol|timolol|mesh-list
111072839|NCT02522039|Dorzolamide|dorzolamide|mesh-list
111072840|NCT02522039|Latanoprost|latanoprost|mesh-list
111072841|NCT02522039|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111072842|NCT02522039|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111072843|NCT02522039|Adrenergic Agents|adrenergic agents|mesh-ancestor
111072844|NCT02522039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110638262|NCT00843362|Dinoprostone|dinoprostone|mesh-list
111072845|NCT02522039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111072846|NCT02522039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111072847|NCT02522039|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111072848|NCT02522039|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111072849|NCT02522039|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
111072850|NCT02522039|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111072851|NCT02522039|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
111072852|NCT02522039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111072853|NCT05107791|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111072854|NCT05107791|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111072855|NCT04430699|Cisplatin|cisplatin|mesh-list
111072856|NCT04430699|Pembrolizumab|pembrolizumab|mesh-list
110789992|NCT03910803|Brodalumab|brodalumab|mesh-list
111072857|NCT04430699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111072858|NCT04430699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111072859|NCT04430699|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111072860|NCT04430699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111072861|NCT05111769|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
111072862|NCT05111769|Natriuretic Agents|natriuretic agents|mesh-ancestor
111072863|NCT05111769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111072864|NCT04358003|Coal Tar|coal tar|mesh-list
111072865|NCT04358003|Keratolytic Agents|keratolytic agents|mesh-ancestor
111072866|NCT04358003|Dermatologic Agents|dermatologic agents|mesh-ancestor
111072867|NCT04519905|Paclitaxel|paclitaxel|mesh-list
111072868|NCT04519905|Carboplatin|carboplatin|mesh-list
111072869|NCT04519905|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111072870|NCT04519905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111072871|NCT04519905|Tubulin Modulators|tubulin modulators|mesh-ancestor
111072872|NCT04519905|Antimitotic Agents|antimitotic agents|mesh-ancestor
111072873|NCT04519905|Mitosis Modulators|mitosis modulators|mesh-ancestor
111072874|NCT04519905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111072875|NCT04423341|Cannabidiol|cannabidiol|mesh-list
111072876|NCT04423341|Anticonvulsants|anticonvulsants|mesh-ancestor
111072877|NCT03378479|Posaconazole|posaconazole|mesh-list
111072878|NCT03378479|Antifungal Agents|antifungal agents|mesh-ancestor
111072879|NCT03378479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111072880|NCT03378479|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
111072881|NCT03378479|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111072882|NCT03378479|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111072883|NCT03378479|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111072884|NCT03378479|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111072885|NCT03378479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111072886|NCT03378479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111072887|NCT03378479|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111072888|NCT03378479|Hormone Antagonists|hormone antagonists|mesh-ancestor
111072889|NCT03378479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111072890|NCT03378479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111072891|NCT03460145|Propofol|propofol|mesh-list
111072892|NCT03460145|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111072893|NCT03460145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111072894|NCT03460145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111072895|NCT03460145|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111072896|NCT03460145|Anesthetics, General|anesthetics, general|mesh-ancestor
111072897|NCT03460145|Anesthetics|anesthetics|mesh-ancestor
111072898|NCT04125771|Diclofenac|diclofenac|mesh-list
111072899|NCT04125771|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111072900|NCT04125771|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111072901|NCT04125771|Analgesics|analgesics|mesh-ancestor
111072902|NCT04125771|Sensory System Agents|sensory system agents|mesh-ancestor
111072903|NCT04125771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111072904|NCT04125771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111072905|NCT04125771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111072906|NCT04125771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111072907|NCT04125771|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111072908|NCT04125771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111072909|NCT04125771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111072910|NCT05115123|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
111072911|NCT05115123|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111072912|NCT05115123|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111072913|NCT05115123|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111072914|NCT05115123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111072915|NCT05115123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111072916|NCT05115123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111072917|NCT05115123|Analgesics|analgesics|mesh-ancestor
111072918|NCT05115123|Sensory System Agents|sensory system agents|mesh-ancestor
111072919|NCT05115123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111072920|NCT05115123|Antidepressive Agents|antidepressive agents|mesh-ancestor
111072921|NCT05115123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111072922|NCT05115123|Dopamine Agents|dopamine agents|mesh-ancestor
111072923|NCT04636671|Dexamethasone|dexamethasone|mesh-list
111072924|NCT04636671|Methylprednisolone|methylprednisolone|mesh-list
111072925|NCT04636671|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111072926|NCT04636671|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111072927|NCT04636671|Prednisolone|prednisolone|mesh-list
111072928|NCT04636671|Prednisolone acetate|prednisolone acetate|mesh-list
111072929|NCT04636671|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111072930|NCT04636671|Prednisolone phosphate|prednisolone phosphate|mesh-list
111072931|NCT04636671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111072932|NCT04636671|Antiemetics|antiemetics|mesh-ancestor
111072933|NCT04636671|Autonomic Agents|autonomic agents|mesh-ancestor
111072934|NCT04636671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111072935|NCT04636671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111072936|NCT04636671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111072937|NCT04636671|Glucocorticoids|glucocorticoids|mesh-ancestor
111072938|NCT04636671|Hormones|hormones|mesh-ancestor
111072939|NCT04636671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111072940|NCT04636671|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111072941|NCT04636671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111072942|NCT04636671|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111072943|NCT04636671|Protective Agents|protective agents|mesh-ancestor
111072944|NCT03459599|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111072945|NCT03459599|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
111072946|NCT03459599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111072947|NCT03459599|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
111072948|NCT03459599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111072949|NCT03459599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111072950|NCT03645603|Dexmedetomidine|dexmedetomidine|mesh-list
111072951|NCT03645603|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111072952|NCT03645603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111072953|NCT03645603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111072954|NCT03645603|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111072955|NCT03645603|Analgesics|analgesics|mesh-ancestor
111072956|NCT03645603|Sensory System Agents|sensory system agents|mesh-ancestor
111072957|NCT03645603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111072958|NCT03645603|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111072959|NCT03645603|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111072960|NCT03645603|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111072961|NCT03645603|Adrenergic Agents|adrenergic agents|mesh-ancestor
111072962|NCT03645603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111072963|NCT03645603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111072964|NCT04019873|Lamivudine|lamivudine|mesh-list
111072965|NCT04019873|Rilpivirine|rilpivirine|mesh-list
111072966|NCT04019873|Dolutegravir|dolutegravir|mesh-list
110127951|NCT05874700|Sivelestat|sivelestat|mesh-list
111072967|NCT04019873|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111072968|NCT04019873|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111072969|NCT04019873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111072970|NCT04019873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111072971|NCT04019873|Antiviral Agents|antiviral agents|mesh-ancestor
111072972|NCT04019873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111072973|NCT04019873|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111072974|NCT04019873|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111072975|NCT04019873|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111072976|NCT04019873|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111072977|NCT04771689|Buprenorphine|buprenorphine|mesh-list
111072978|NCT04771689|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
111072979|NCT04771689|Naloxone|naloxone|mesh-list
111072980|NCT04771689|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111072981|NCT04771689|Narcotics|narcotics|mesh-ancestor
111072982|NCT04771689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111072983|NCT04771689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111072984|NCT04771689|Analgesics|analgesics|mesh-ancestor
111072985|NCT04771689|Sensory System Agents|sensory system agents|mesh-ancestor
111072986|NCT04771689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111072987|NCT04771689|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111072988|NCT04674345|Sorafenib|sorafenib|mesh-list
111072989|NCT04674345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111072990|NCT04674345|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111072991|NCT04674345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111072992|NCT04674345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111072993|NCT04165239|6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid|6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid|mesh-list
111072994|NCT04165239|Antioxidants|antioxidants|mesh-ancestor
111072995|NCT04165239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111072996|NCT04165239|Protective Agents|protective agents|mesh-ancestor
111072997|NCT04165239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111072998|NCT03756311|Paclitaxel|paclitaxel|mesh-list
111072999|NCT03756311|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111073000|NCT03756311|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111073001|NCT03756311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111073002|NCT03756311|Tubulin Modulators|tubulin modulators|mesh-ancestor
111073003|NCT03756311|Antimitotic Agents|antimitotic agents|mesh-ancestor
111073004|NCT03756311|Mitosis Modulators|mitosis modulators|mesh-ancestor
110790130|NCT03902925|Lidocaine|lidocaine|mesh-list
111073005|NCT03756311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111073006|NCT04576767|Anesthetics|anesthetics|mesh-list
111073007|NCT04576767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111073008|NCT04576767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111073009|NCT03248531|Adalimumab|adalimumab|mesh-list
111073010|NCT03248531|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111073011|NCT03248531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111073012|NCT03248531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111073013|NCT03866525|Irinotecan|irinotecan|mesh-list
111073014|NCT03866525|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111073015|NCT03866525|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111073016|NCT03866525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111073017|NCT03866525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111073018|NCT03866525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111073019|NCT03129347|Nalmefene|nalmefene|mesh-list
111073020|NCT03129347|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111073021|NCT03129347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111073022|NCT03129347|Sensory System Agents|sensory system agents|mesh-ancestor
111073023|NCT03129347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111073024|NCT02262923|Metoclopramide|metoclopramide|mesh-list
111073025|NCT02262923|Antiemetics|antiemetics|mesh-ancestor
111073026|NCT02262923|Autonomic Agents|autonomic agents|mesh-ancestor
111073027|NCT02262923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111073028|NCT02262923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111073029|NCT02262923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111073030|NCT02262923|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111073031|NCT02262923|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111073032|NCT02262923|Dopamine Agents|dopamine agents|mesh-ancestor
111073033|NCT02262923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111073034|NCT02262923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111073035|NCT02194595|Insulin|insulin|mesh-list
111073036|NCT02194595|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111073037|NCT02194595|Insulin Glargine|insulin glargine|mesh-list
111073038|NCT02194595|Exenatide|exenatide|mesh-list
111073039|NCT02194595|Insulin Lispro|insulin lispro|mesh-list
111073040|NCT02194595|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111073041|NCT02194595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111073042|NCT02194595|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111073043|NCT02194595|Incretins|incretins|mesh-ancestor
111073044|NCT02194595|Hormones|hormones|mesh-ancestor
111073045|NCT02194595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111073046|NCT02656329|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
111073047|NCT02656329|Lugol's solution|lugol's solution|mesh-list
111073048|NCT02656329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111073049|NCT02656329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111073050|NCT02656329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111073051|NCT02656329|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111073052|NCT02656329|Hemostatics|hemostatics|mesh-ancestor
111073053|NCT02656329|Coagulants|coagulants|mesh-ancestor
111073054|NCT02712905|Nivolumab|nivolumab|mesh-list
111073055|NCT02712905|Azacitidine|azacitidine|mesh-list
111073056|NCT02712905|Tretinoin|tretinoin|mesh-list
111073057|NCT02712905|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111073058|NCT02712905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111073059|NCT02712905|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111073060|NCT02712905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111073061|NCT02712905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111073062|NCT02712905|Antimetabolites|antimetabolites|mesh-ancestor
111073063|NCT02712905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111073064|NCT02712905|Keratolytic Agents|keratolytic agents|mesh-ancestor
111073065|NCT02712905|Dermatologic Agents|dermatologic agents|mesh-ancestor
111073066|NCT01166633|Atorvastatin|atorvastatin|mesh-list
111073067|NCT01166633|Pitavastatin|pitavastatin|mesh-list
111073068|NCT01166633|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111073069|NCT01166633|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111073070|NCT01166633|Antimetabolites|antimetabolites|mesh-ancestor
111073071|NCT01166633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111073072|NCT01166633|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111073073|NCT01166633|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111073074|NCT01166633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111073075|NCT04315311|Pancrelipase|pancrelipase|mesh-list
111073076|NCT04315311|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110790203|NCT03905967|Lenvatinib|lenvatinib|mesh-list
111073077|NCT03596073|Calcipotriene|calcipotriene|mesh-list
111073078|NCT03596073|Petrolatum|petrolatum|mesh-list
111073079|NCT03596073|Dermatologic Agents|dermatologic agents|mesh-ancestor
111073080|NCT03596073|Emollients|emollients|mesh-ancestor
111073081|NCT05320757|Olaparib|olaparib|mesh-list
111073082|NCT05320757|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111073083|NCT05320757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110638302|NCT00843440|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111073084|NCT05320757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111073085|NCT05320757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111073086|NCT03449693|Magnesium Oxide|magnesium oxide|mesh-list
111073087|NCT03449693|Antacids|antacids|mesh-ancestor
111073088|NCT03449693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111073089|NCT03449693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111073090|NCT03449537|Caseins|caseins|mesh-list
111073091|NCT03449537|Chelating Agents|chelating agents|mesh-ancestor
111073092|NCT03449537|Sequestering Agents|sequestering agents|mesh-ancestor
111073093|NCT03449537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111073094|NCT02237183|Iloprost|iloprost|mesh-list
111073095|NCT02237183|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111073096|NCT02237183|Vasodilator Agents|vasodilator agents|mesh-ancestor
111073097|NCT03371979|Pembrolizumab|pembrolizumab|mesh-list
111073098|NCT03371979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111073099|NCT03371979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111073100|NCT03371979|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111073101|NCT03371979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111073102|NCT05104437|Vaccines|vaccines|mesh-list
111073103|NCT05104437|Immunologic Factors|immunologic factors|mesh-ancestor
111073104|NCT05104437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111073105|NCT03179943|Atezolizumab|atezolizumab|mesh-list
111073106|NCT03179943|Guadecitabine|guadecitabine|mesh-list
111073107|NCT03179943|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111073108|NCT03179943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111073109|NCT03179943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111073110|NCT03179943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111073111|NCT05114499|Donepezil|donepezil|mesh-list
111073112|NCT05114499|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111073113|NCT05114499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111073114|NCT05114499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111073115|NCT05114499|Cholinergic Agents|cholinergic agents|mesh-ancestor
111073116|NCT05114499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111073117|NCT05114499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111073118|NCT05114499|Nootropic Agents|nootropic agents|mesh-ancestor
111073119|NCT04520997|Hyaluronic Acid|hyaluronic acid|mesh-list
111073120|NCT04520997|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111073121|NCT04520997|Immunologic Factors|immunologic factors|mesh-ancestor
111073122|NCT04520997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111073123|NCT04520997|Viscosupplements|viscosupplements|mesh-ancestor
111073124|NCT04520997|Protective Agents|protective agents|mesh-ancestor
111073125|NCT05109585|Antibodies|antibodies|mesh-list
111073126|NCT05109585|Immunoglobulins|immunoglobulins|mesh-list
111073127|NCT05109585|Immunoglobulin G|immunoglobulin g|mesh-list
111073128|NCT05109585|Immunologic Factors|immunologic factors|mesh-ancestor
111073129|NCT05109585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111073130|NCT02142803|Bevacizumab|bevacizumab|mesh-list
111073131|NCT02142803|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111073132|NCT02142803|Endothelial Growth Factors|endothelial growth factors|mesh-list
111073133|NCT02142803|Antibodies|antibodies|mesh-list
111073134|NCT02142803|Immunoglobulins|immunoglobulins|mesh-list
111073135|NCT02142803|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111073136|NCT02142803|Immunoglobulin G|immunoglobulin g|mesh-list
111073137|NCT02142803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111073138|NCT02142803|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111073139|NCT02142803|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111073140|NCT02142803|Growth Substances|growth substances|mesh-ancestor
111073141|NCT02142803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111073142|NCT02142803|Growth Inhibitors|growth inhibitors|mesh-ancestor
111073143|NCT02142803|Immunologic Factors|immunologic factors|mesh-ancestor
111073144|NCT05283161|Dronabinol|dronabinol|mesh-list
111073145|NCT05283161|Cannabidiol|cannabidiol|mesh-list
111073146|NCT05283161|Anticonvulsants|anticonvulsants|mesh-ancestor
111073147|NCT05283161|Hallucinogens|hallucinogens|mesh-ancestor
111073148|NCT05283161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111073149|NCT05283161|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111073150|NCT05283161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111073151|NCT05283161|Analgesics|analgesics|mesh-ancestor
111073152|NCT05283161|Sensory System Agents|sensory system agents|mesh-ancestor
111073153|NCT05283161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111073154|NCT05283161|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
111073155|NCT05283161|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
111073156|NCT05283161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111073157|NCT05283161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111073159|NCT05283161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111073160|NCT03691311|Denosumab|denosumab|mesh-list
111073161|NCT03691311|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111073162|NCT03691311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111073163|NCT03448835|Docetaxel|docetaxel|mesh-list
111073164|NCT03448835|Capecitabine|capecitabine|mesh-list
111073165|NCT03448835|Oxaliplatin|oxaliplatin|mesh-list
111073166|NCT03448835|Atezolizumab|atezolizumab|mesh-list
111073167|NCT03448835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111073168|NCT03448835|Tubulin Modulators|tubulin modulators|mesh-ancestor
111073169|NCT03448835|Antimitotic Agents|antimitotic agents|mesh-ancestor
111073170|NCT03448835|Mitosis Modulators|mitosis modulators|mesh-ancestor
111073171|NCT03448835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111073172|NCT03448835|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111073173|NCT03448835|Antimetabolites|antimetabolites|mesh-ancestor
111073174|NCT03448835|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111073175|NCT03448835|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111073176|NCT03690453|Ivermectin|ivermectin|mesh-list
111073177|NCT03690453|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111073178|NCT03690453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111073179|NCT05211635|Vitamin D|vitamin d|mesh-list
111073180|NCT05211635|Vitamins|vitamins|mesh-ancestor
111073181|NCT05211635|Micronutrients|micronutrients|mesh-ancestor
111073182|NCT05211635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111073183|NCT05211635|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111073185|NCT05184335|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111073186|NCT05184335|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111073187|NCT05184335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111073188|NCT05184335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111073189|NCT05184335|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111073190|NCT05184335|Serotonin Agents|serotonin agents|mesh-ancestor
111073191|NCT05184335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111073192|NCT05184335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111073193|NCT03443609|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
111073194|NCT03443609|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111073195|NCT03443609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111073196|NCT01709123|Chromium|chromium|mesh-list
111073197|NCT01709123|Trace Elements|trace elements|mesh-ancestor
111073198|NCT01709123|Micronutrients|micronutrients|mesh-ancestor
111073199|NCT01709123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111073200|NCT01301807|Panobinostat|panobinostat|mesh-list
111073201|NCT01301807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111073202|NCT01301807|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111073203|NCT01301807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111073204|NCT01301807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111073205|NCT04962893|Vaccines|vaccines|mesh-list
111073206|NCT04962893|Immunologic Factors|immunologic factors|mesh-ancestor
111073207|NCT04962893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111073208|NCT03443141|Vitamin E|vitamin e|mesh-list
111073209|NCT03443141|Vitamins|vitamins|mesh-ancestor
111073210|NCT03443141|Micronutrients|micronutrients|mesh-ancestor
111073211|NCT03443141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110638351|NCT00536991|Calcitriol|calcitriol|mesh-list
111073212|NCT03443141|Antioxidants|antioxidants|mesh-ancestor
111073213|NCT03443141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111073214|NCT03443141|Protective Agents|protective agents|mesh-ancestor
111073215|NCT04937543|Beclomethasone|beclomethasone|mesh-list
111073216|NCT04937543|Glycopyrrolate|glycopyrrolate|mesh-list
111073217|NCT04937543|Formoterol Fumarate|formoterol fumarate|mesh-list
111073218|NCT04937543|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111073219|NCT04937543|Autonomic Agents|autonomic agents|mesh-ancestor
111073220|NCT04937543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111073221|NCT04937543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111073222|NCT04937543|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111073223|NCT04937543|Respiratory System Agents|respiratory system agents|mesh-ancestor
111073224|NCT04937543|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111073225|NCT04937543|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111073226|NCT04937543|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111073227|NCT04937543|Adrenergic Agents|adrenergic agents|mesh-ancestor
111073228|NCT04937543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111073229|NCT04937543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111073230|NCT04937543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111073231|NCT04937543|Glucocorticoids|glucocorticoids|mesh-ancestor
111073232|NCT04937543|Hormones|hormones|mesh-ancestor
111073233|NCT04937543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111073234|NCT04937543|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111073235|NCT04937543|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111073236|NCT04937543|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111073237|NCT04937543|Cholinergic Agents|cholinergic agents|mesh-ancestor
111073238|NCT03442907|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
111073239|NCT04923737|Dexmedetomidine|dexmedetomidine|mesh-list
111073240|NCT04923737|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111073241|NCT04923737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111073242|NCT04923737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111073243|NCT04923737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111073244|NCT04923737|Analgesics|analgesics|mesh-ancestor
111073245|NCT04923737|Sensory System Agents|sensory system agents|mesh-ancestor
111073246|NCT04923737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111073247|NCT04923737|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111073248|NCT04923737|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111073249|NCT04923737|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111073250|NCT04923737|Adrenergic Agents|adrenergic agents|mesh-ancestor
111073251|NCT04923737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111073252|NCT04923737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111073253|NCT02452424|Pembrolizumab|pembrolizumab|mesh-list
111073254|NCT02452424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111073255|NCT02452424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111073256|NCT02452424|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111073257|NCT02452424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111073258|NCT04921943|Azithromycin|azithromycin|mesh-list
111073260|NCT04921943|Ethambutol|ethambutol|mesh-list
111073261|NCT04921943|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111073262|NCT04921943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111073263|NCT04921943|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111073264|NCT04921943|Antitubercular Agents|antitubercular agents|mesh-ancestor
111073265|NCT04921943|Leprostatic Agents|leprostatic agents|mesh-ancestor
111073266|NCT04921943|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111073267|NCT04921943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111073268|NCT04921943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111073269|NCT04921943|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111073270|NCT04921943|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111073271|NCT04921943|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
111073272|NCT04921943|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
111073273|NCT04921943|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
111073274|NCT04921943|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111073275|NCT02419508|Brimonidine Tartrate|brimonidine tartrate|mesh-list
111073276|NCT02419508|Bimatoprost|bimatoprost|mesh-list
111073277|NCT02419508|Travoprost|travoprost|mesh-list
111073278|NCT02419508|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111073279|NCT02419508|Latanoprost|latanoprost|mesh-list
111073280|NCT02419508|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111073281|NCT02419508|Brinzolamide|brinzolamide|mesh-list
111073282|NCT02419508|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111073283|NCT02419508|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111073284|NCT02419508|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111073285|NCT02419508|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111073286|NCT02419508|Adrenergic Agents|adrenergic agents|mesh-ancestor
111073287|NCT02419508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111073288|NCT02419508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111073289|NCT02419508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111073290|NCT02419508|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
111073291|NCT02419508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111073292|NCT03442283|Vitamins|vitamins|mesh-list
111073293|NCT03442283|Micronutrients|micronutrients|mesh-ancestor
111073294|NCT03442283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111073295|NCT03441815|Histamine|histamine|mesh-list
111073296|NCT03441815|Glutarimide|glutarimide|mesh-list
111073297|NCT03441815|Histamine Agonists|histamine agonists|mesh-ancestor
111073298|NCT03441815|Histamine Agents|histamine agents|mesh-ancestor
111073299|NCT03441815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111073300|NCT03441815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111073301|NCT03441815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111073302|NCT03441815|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111073303|NCT03441815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111073304|NCT02426918|Vancomycin|vancomycin|mesh-list
111073305|NCT02426918|Linezolid|linezolid|mesh-list
111073306|NCT02426918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111073307|NCT02426918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111073308|NCT02426918|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111073309|NCT02426918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111073310|NCT02426918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111073311|NCT02387762|Methotrexate|methotrexate|mesh-list
111073312|NCT02387762|Acalabrutinib|acalabrutinib|mesh-list
111073313|NCT02387762|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111073314|NCT02387762|Abortifacient Agents|abortifacient agents|mesh-ancestor
111073315|NCT02387762|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111073316|NCT02387762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111073317|NCT02387762|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111073318|NCT02387762|Antimetabolites|antimetabolites|mesh-ancestor
111073319|NCT02387762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111073320|NCT02387762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111073321|NCT02387762|Dermatologic Agents|dermatologic agents|mesh-ancestor
111073322|NCT02387762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111073323|NCT02387762|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111073324|NCT02387762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111073325|NCT02387762|Immunologic Factors|immunologic factors|mesh-ancestor
111073326|NCT02387762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111073327|NCT02387762|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111073329|NCT02418182|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111073330|NCT02418182|Analgesics|analgesics|mesh-ancestor
111073331|NCT02418182|Sensory System Agents|sensory system agents|mesh-ancestor
111073332|NCT02418182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111073333|NCT02418182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111073334|NCT02418182|Antipyretics|antipyretics|mesh-ancestor
111073335|NCT02387372|Tazobactam|tazobactam|mesh-list
111073336|NCT02387372|Ceftolozane|ceftolozane|mesh-list
111073337|NCT02387372|Cephalosporins|cephalosporins|mesh-list
111073338|NCT02387372|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
111073339|NCT02387372|Penicillanic Acid|penicillanic acid|mesh-list
111073340|NCT02387372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111073341|NCT02387372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111073342|NCT02387372|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
111073343|NCT02387372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111073344|NCT02387372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111073345|NCT02387372|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111073346|NCT03446495|Trabectedin|trabectedin|mesh-list
111073347|NCT03446495|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111073348|NCT03446495|Alkylating Agents|alkylating agents|mesh-ancestor
111073349|NCT03446495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111073350|NCT03446495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111073351|NCT03441035|Anesthetics|anesthetics|mesh-list
111073352|NCT03441035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111073353|NCT03441035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111073354|NCT05105633|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
111073355|NCT05105633|Tenecteplase|tenecteplase|mesh-list
111073356|NCT05105633|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111073357|NCT05105633|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111073358|NCT05105633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111073359|NCT04807673|Paclitaxel|paclitaxel|mesh-list
111073360|NCT04807673|Pembrolizumab|pembrolizumab|mesh-list
111073361|NCT04807673|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111073362|NCT04807673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111073363|NCT04807673|Tubulin Modulators|tubulin modulators|mesh-ancestor
111073364|NCT04807673|Antimitotic Agents|antimitotic agents|mesh-ancestor
111073365|NCT04807673|Mitosis Modulators|mitosis modulators|mesh-ancestor
111073366|NCT04807673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111073367|NCT04807673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111073368|NCT04807673|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111073369|NCT02656173|Tamsulosin|tamsulosin|mesh-list
111073370|NCT02656173|Mirabegron|mirabegron|mesh-list
111073371|NCT02656173|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111073372|NCT02656173|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111073373|NCT02656173|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111073374|NCT02656173|Adrenergic Agents|adrenergic agents|mesh-ancestor
111073375|NCT02656173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111073376|NCT02656173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111073377|NCT02656173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111073378|NCT02656173|Urological Agents|urological agents|mesh-ancestor
111073379|NCT02656173|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
111073380|NCT02656173|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111073381|NCT02656173|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111073382|NCT03440333|Pulmonary Surfactants|pulmonary surfactants|mesh-list
111073383|NCT03440333|Respiratory System Agents|respiratory system agents|mesh-ancestor
111073384|NCT04418895|Leucovorin|leucovorin|mesh-list
111073385|NCT04418895|Fluorouracil|fluorouracil|mesh-list
111073386|NCT04418895|Capecitabine|capecitabine|mesh-list
111073387|NCT04418895|Oxaliplatin|oxaliplatin|mesh-list
111073388|NCT04418895|Levoleucovorin|levoleucovorin|mesh-list
111073389|NCT04418895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111073390|NCT04418895|Antimetabolites|antimetabolites|mesh-ancestor
111073391|NCT04418895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111073392|NCT04418895|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111073393|NCT04418895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111073394|NCT04418895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111073395|NCT04418895|Immunologic Factors|immunologic factors|mesh-ancestor
111073396|NCT04418895|Antidotes|antidotes|mesh-ancestor
111073397|NCT04418895|Protective Agents|protective agents|mesh-ancestor
111073398|NCT04418895|Vitamin B Complex|vitamin b complex|mesh-ancestor
111073399|NCT04418895|Vitamins|vitamins|mesh-ancestor
111073400|NCT04418895|Micronutrients|micronutrients|mesh-ancestor
111073401|NCT04715633|Apatinib|apatinib|mesh-list
111073402|NCT04715633|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
111073403|NCT04715633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111073404|NCT04715633|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111073405|NCT04715633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111073406|NCT04715633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111073407|NCT04715633|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111073408|NCT03439943|Lixisenatide|lixisenatide|mesh-list
111073409|NCT03439943|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111073410|NCT03439943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111073411|NCT03439787|Epinephrine|epinephrine|mesh-list
111073412|NCT03439787|Bupivacaine|bupivacaine|mesh-list
111073413|NCT03439787|Anesthetics, Local|anesthetics, local|mesh-ancestor
111073414|NCT03439787|Anesthetics|anesthetics|mesh-ancestor
111073415|NCT03439787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111073416|NCT03439787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111073417|NCT03439787|Sensory System Agents|sensory system agents|mesh-ancestor
111073418|NCT03439787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111073419|NCT03439787|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111073420|NCT03439787|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111073421|NCT03439787|Adrenergic Agents|adrenergic agents|mesh-ancestor
111073422|NCT03439787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111073423|NCT03439787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111073424|NCT03439787|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111073425|NCT03439787|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111073426|NCT03439787|Autonomic Agents|autonomic agents|mesh-ancestor
111073427|NCT03439787|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111073428|NCT03439787|Respiratory System Agents|respiratory system agents|mesh-ancestor
111073429|NCT03439787|Mydriatics|mydriatics|mesh-ancestor
111073430|NCT03439787|Sympathomimetics|sympathomimetics|mesh-ancestor
111073431|NCT03439787|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111073432|NCT05082155|Bupivacaine|bupivacaine|mesh-list
111073433|NCT05082155|Anesthetics, Local|anesthetics, local|mesh-ancestor
111073434|NCT05082155|Anesthetics|anesthetics|mesh-ancestor
111073435|NCT05082155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111073436|NCT05082155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111073437|NCT05082155|Sensory System Agents|sensory system agents|mesh-ancestor
111073438|NCT05082155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111073439|NCT02656017|Metformin|metformin|mesh-list
111073440|NCT02656017|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111073441|NCT02656017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111073442|NCT03439709|Lanreotide|lanreotide|mesh-list
111073443|NCT03439709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111073444|NCT04451447|SMOFlipid|smoflipid|mesh-list
111073445|NCT04451447|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
111073446|NCT04451447|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
111073447|NCT04451447|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111073448|NCT04516941|Colchicine|colchicine|mesh-list
111073449|NCT04516941|Edoxaban|edoxaban|mesh-list
111073450|NCT04516941|Gout Suppressants|gout suppressants|mesh-ancestor
111073451|NCT04516941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111073452|NCT04516941|Tubulin Modulators|tubulin modulators|mesh-ancestor
111073453|NCT04516941|Antimitotic Agents|antimitotic agents|mesh-ancestor
111073454|NCT04516941|Mitosis Modulators|mitosis modulators|mesh-ancestor
111073455|NCT04516941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111073456|NCT04516941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111073457|NCT04516941|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111073458|NCT04516941|Antithrombins|antithrombins|mesh-ancestor
111073459|NCT04516941|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111073460|NCT04516941|Protease Inhibitors|protease inhibitors|mesh-ancestor
111073461|NCT04516941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111073462|NCT04516941|Anticoagulants|anticoagulants|mesh-ancestor
111073463|NCT03444467|Glucagon|glucagon|mesh-list
111073464|NCT03444467|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111073465|NCT03444467|Hormones|hormones|mesh-ancestor
111073466|NCT03444467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111073467|NCT03444467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111073468|NCT02657343|Trastuzumab|trastuzumab|mesh-list
111073469|NCT02657343|Fulvestrant|fulvestrant|mesh-list
111073470|NCT02657343|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111073471|NCT02657343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111073472|NCT02657343|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111073473|NCT02657343|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
111073474|NCT02657343|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111073475|NCT02657343|Hormone Antagonists|hormone antagonists|mesh-ancestor
111073476|NCT02657343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111073477|NCT02657343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111073478|NCT03445169|Belzutifan|belzutifan|mesh-list
111073480|NCT04542837|Lenvatinib|lenvatinib|mesh-list
111073481|NCT04542837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111073482|NCT04542837|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111073483|NCT04542837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111073484|NCT04542837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111073485|NCT02655237|Leuprolide|leuprolide|mesh-list
111073486|NCT02655237|Relugolix|relugolix|mesh-list
111073487|NCT02655237|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111073488|NCT02655237|Fertility Agents|fertility agents|mesh-ancestor
111073489|NCT02655237|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111073490|NCT02655237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111073491|NCT02655237|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111073492|NCT02655237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111073493|NCT02655237|Androgen Antagonists|androgen antagonists|mesh-ancestor
111073494|NCT02655237|Hormone Antagonists|hormone antagonists|mesh-ancestor
111073495|NCT02655237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111073496|NCT03890133|Pregabalin|pregabalin|mesh-list
111073497|NCT03890133|Analgesics|analgesics|mesh-ancestor
111073498|NCT03890133|Sensory System Agents|sensory system agents|mesh-ancestor
111073499|NCT03890133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111073500|NCT03890133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111073501|NCT03890133|Anticonvulsants|anticonvulsants|mesh-ancestor
111073502|NCT03890133|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111073503|NCT03890133|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111073504|NCT03890133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111073505|NCT03890133|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111073506|NCT03890133|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111073507|NCT03890133|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111073508|NCT03890133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111073509|NCT03890133|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111073510|NCT03871647|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
111073511|NCT03871647|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111073512|NCT03871647|Adrenergic Agents|adrenergic agents|mesh-ancestor
111073513|NCT03871647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111073514|NCT03871647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111073515|NCT03871647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111073516|NCT03443921|Paclitaxel|paclitaxel|mesh-list
111073517|NCT03443921|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111073518|NCT03443921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111073519|NCT03443921|Tubulin Modulators|tubulin modulators|mesh-ancestor
111073520|NCT03443921|Antimitotic Agents|antimitotic agents|mesh-ancestor
111073521|NCT03443921|Mitosis Modulators|mitosis modulators|mesh-ancestor
111073522|NCT03443921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111073523|NCT03443843|Fluticasone|fluticasone|mesh-list
111073525|NCT03443843|Loratadine|loratadine|mesh-list
111073526|NCT03443843|Pseudoephedrine|pseudoephedrine|mesh-list
111073527|NCT03443843|Ephedrine|ephedrine|mesh-list
111073528|NCT03443843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111073529|NCT03443843|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111073530|NCT03443843|Autonomic Agents|autonomic agents|mesh-ancestor
111073531|NCT03443843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111073532|NCT03443843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111073533|NCT03443843|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111073534|NCT03443843|Respiratory System Agents|respiratory system agents|mesh-ancestor
111073535|NCT03443843|Dermatologic Agents|dermatologic agents|mesh-ancestor
111073536|NCT03443843|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111073537|NCT03443843|Antipruritics|antipruritics|mesh-ancestor
111073538|NCT03443843|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
111073539|NCT03443843|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111073540|NCT03443843|Histamine Antagonists|histamine antagonists|mesh-ancestor
111073541|NCT03443843|Histamine Agents|histamine agents|mesh-ancestor
111073542|NCT03443843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111073543|NCT03443843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111073544|NCT03443843|Nasal Decongestants|nasal decongestants|mesh-ancestor
110638394|NCT03902613|Dopamine Agents|dopamine agents|mesh-ancestor
111073545|NCT03443843|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111073546|NCT03443843|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111073547|NCT03443843|Sympathomimetics|sympathomimetics|mesh-ancestor
111073548|NCT03443843|Adrenergic Agents|adrenergic agents|mesh-ancestor
111073549|NCT03438227|Dextrans|dextrans|mesh-list
111073550|NCT03438227|Iron-Dextran Complex|iron-dextran complex|mesh-list
111073551|NCT03438227|Anticoagulants|anticoagulants|mesh-ancestor
111073552|NCT03438227|Plasma Substitutes|plasma substitutes|mesh-ancestor
111073553|NCT03438227|Blood Substitutes|blood substitutes|mesh-ancestor
111073554|NCT03438227|Hematinics|hematinics|mesh-ancestor
111073555|NCT03433235|Edoxaban|edoxaban|mesh-list
111073556|NCT03433235|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111073557|NCT03433235|Antithrombins|antithrombins|mesh-ancestor
111073558|NCT03433235|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111073559|NCT03433235|Protease Inhibitors|protease inhibitors|mesh-ancestor
111073560|NCT03433235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111073561|NCT03433235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111073562|NCT03433235|Anticoagulants|anticoagulants|mesh-ancestor
111073563|NCT03342417|Nivolumab|nivolumab|mesh-list
111073564|NCT03342417|Ipilimumab|ipilimumab|mesh-list
111073565|NCT03342417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111073566|NCT03342417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111073567|NCT03342417|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111073568|NCT03342417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111073569|NCT03234309|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
111073570|NCT03234309|Hematinics|hematinics|mesh-ancestor
111073571|NCT03234309|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
111073572|NCT03234309|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111073573|NCT02657031|Diphenhydramine|diphenhydramine|mesh-list
111073574|NCT02657031|Promethazine|promethazine|mesh-list
111073575|NCT02657031|Ketamine|ketamine|mesh-list
111073576|NCT02657031|Ondansetron|ondansetron|mesh-list
111073577|NCT02657031|Prochlorperazine|prochlorperazine|mesh-list
111073578|NCT02657031|Analgesics|analgesics|mesh-ancestor
111073579|NCT02657031|Sensory System Agents|sensory system agents|mesh-ancestor
111073580|NCT02657031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111073581|NCT02657031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111073582|NCT02657031|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111073583|NCT02657031|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111073584|NCT02657031|Anesthetics, General|anesthetics, general|mesh-ancestor
111073585|NCT02657031|Anesthetics|anesthetics|mesh-ancestor
111073586|NCT02657031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111073587|NCT02657031|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111073588|NCT02657031|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111073589|NCT02657031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111073590|NCT02657031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111073591|NCT02657031|Antiemetics|antiemetics|mesh-ancestor
111073592|NCT02657031|Autonomic Agents|autonomic agents|mesh-ancestor
111073593|NCT02657031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111073594|NCT02657031|Antipruritics|antipruritics|mesh-ancestor
111073595|NCT02657031|Dermatologic Agents|dermatologic agents|mesh-ancestor
111073596|NCT02657031|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111073597|NCT02657031|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111073598|NCT02657031|Serotonin Agents|serotonin agents|mesh-ancestor
111073599|NCT02657031|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111073600|NCT02657031|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111073601|NCT02657031|Anesthetics, Local|anesthetics, local|mesh-ancestor
111073602|NCT02657031|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111073603|NCT02657031|Histamine Antagonists|histamine antagonists|mesh-ancestor
111073604|NCT02657031|Histamine Agents|histamine agents|mesh-ancestor
111073605|NCT02657031|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111073606|NCT02657031|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111073607|NCT02657031|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111073608|NCT02657031|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111073609|NCT02657031|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111073610|NCT02657031|Dopamine Agents|dopamine agents|mesh-ancestor
111073611|NCT04944953|Botulinum Toxins|botulinum toxins|mesh-list
111073612|NCT04944953|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111073613|NCT04944953|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111073614|NCT04944953|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111073615|NCT04944953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111073616|NCT04944953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111073617|NCT04944953|Cholinergic Agents|cholinergic agents|mesh-ancestor
111073618|NCT04944953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111073619|NCT04944953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111073620|NCT04944953|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111073621|NCT04944953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111073622|NCT03433001|Dexamethasone|dexamethasone|mesh-list
111073623|NCT03433001|Lenalidomide|lenalidomide|mesh-list
111073624|NCT03433001|Ixazomib|ixazomib|mesh-list
111073625|NCT03433001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111073626|NCT03433001|Antiemetics|antiemetics|mesh-ancestor
111073627|NCT03433001|Autonomic Agents|autonomic agents|mesh-ancestor
111073628|NCT03433001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111073629|NCT03433001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111073631|NCT03433001|Glucocorticoids|glucocorticoids|mesh-ancestor
111073632|NCT03433001|Hormones|hormones|mesh-ancestor
111073633|NCT03433001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111073634|NCT03433001|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111073635|NCT03433001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111073636|NCT03433001|Immunologic Factors|immunologic factors|mesh-ancestor
111073637|NCT03433001|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111073638|NCT03433001|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111073639|NCT03433001|Growth Substances|growth substances|mesh-ancestor
111073640|NCT03433001|Growth Inhibitors|growth inhibitors|mesh-ancestor
111073641|NCT03433001|Protease Inhibitors|protease inhibitors|mesh-ancestor
111073642|NCT03433001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111073643|NCT03433001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111073644|NCT03797469|Niacinamide|niacinamide|mesh-list
111073645|NCT03797469|Niacin|niacin|mesh-list
111073646|NCT03797469|Nicotinic Acids|nicotinic acids|mesh-list
111073647|NCT03797469|Vitamins|vitamins|mesh-ancestor
111073648|NCT03797469|Micronutrients|micronutrients|mesh-ancestor
111073649|NCT03797469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111073650|NCT03797469|Vitamin B Complex|vitamin b complex|mesh-ancestor
111073651|NCT03797469|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111073652|NCT03797469|Antimetabolites|antimetabolites|mesh-ancestor
111073653|NCT03797469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111073654|NCT03797469|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111073655|NCT03797469|Vasodilator Agents|vasodilator agents|mesh-ancestor
111073656|NCT03432923|Benzocaine|benzocaine|mesh-list
111073657|NCT03432923|Anesthetics, Local|anesthetics, local|mesh-ancestor
111073658|NCT03432923|Anesthetics|anesthetics|mesh-ancestor
111073659|NCT03432923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111073660|NCT03432923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111073661|NCT03432923|Sensory System Agents|sensory system agents|mesh-ancestor
111073662|NCT03432923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111073663|NCT02384577|Budesonide|budesonide|mesh-list
111073664|NCT02384577|Formoterol Fumarate|formoterol fumarate|mesh-list
111073665|NCT02384577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111073666|NCT02384577|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111073667|NCT02384577|Autonomic Agents|autonomic agents|mesh-ancestor
111073668|NCT02384577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111073669|NCT02384577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111073670|NCT02384577|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111073671|NCT02384577|Respiratory System Agents|respiratory system agents|mesh-ancestor
111073672|NCT02384577|Glucocorticoids|glucocorticoids|mesh-ancestor
111073673|NCT02384577|Hormones|hormones|mesh-ancestor
111073674|NCT02384577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111073675|NCT02384577|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111073676|NCT02384577|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111073677|NCT02384577|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111073678|NCT02384577|Adrenergic Agents|adrenergic agents|mesh-ancestor
111073679|NCT02384577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111073680|NCT02384577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111073681|NCT03437213|Anesthetics|anesthetics|mesh-list
111073682|NCT03437213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111073683|NCT03437213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111073684|NCT02030457|Beclomethasone|beclomethasone|mesh-list
111073685|NCT02030457|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111073686|NCT02030457|Glucocorticoids|glucocorticoids|mesh-ancestor
111073687|NCT02030457|Hormones|hormones|mesh-ancestor
111073688|NCT02030457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111073689|NCT02030457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111073690|NCT02030457|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111073691|NCT02030457|Respiratory System Agents|respiratory system agents|mesh-ancestor
111073692|NCT03432767|Chrysarobin|chrysarobin|mesh-list
111073693|NCT03432767|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111073694|NCT03432767|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111073695|NCT03432767|Analgesics|analgesics|mesh-ancestor
111073696|NCT03432767|Sensory System Agents|sensory system agents|mesh-ancestor
111073697|NCT03432767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111073698|NCT03432767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111073699|NCT03432767|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111073700|NCT03432767|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111073701|NCT03437057|Aspirin|aspirin|mesh-list
111073702|NCT03437057|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111073703|NCT03437057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111073704|NCT03437057|Analgesics|analgesics|mesh-ancestor
111073705|NCT03437057|Sensory System Agents|sensory system agents|mesh-ancestor
111073706|NCT03437057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111073707|NCT03437057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111073708|NCT03437057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111073709|NCT03437057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111073710|NCT03437057|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111073711|NCT03437057|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111073712|NCT03437057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111073713|NCT03437057|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111073714|NCT03437057|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111073715|NCT03437057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111073716|NCT03437057|Antipyretics|antipyretics|mesh-ancestor
111073717|NCT03579693|Niacinamide|niacinamide|mesh-list
111073718|NCT03579693|Niacin|niacin|mesh-list
111073719|NCT03579693|Nicotinic Acids|nicotinic acids|mesh-list
111073720|NCT03579693|Coenzyme Q10|coenzyme q10|mesh-list
111073721|NCT03579693|Vitamin B Complex|vitamin b complex|mesh-ancestor
111073722|NCT03579693|Vitamins|vitamins|mesh-ancestor
111073723|NCT03579693|Micronutrients|micronutrients|mesh-ancestor
111073724|NCT03579693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111073725|NCT03579693|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111073726|NCT03579693|Antimetabolites|antimetabolites|mesh-ancestor
111073727|NCT03579693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111073728|NCT03579693|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111073729|NCT03579693|Vasodilator Agents|vasodilator agents|mesh-ancestor
111073730|NCT03432689|Cycloserine|cycloserine|mesh-list
111073731|NCT03432689|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111073732|NCT03432689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111073733|NCT03432689|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111073734|NCT03432689|Antitubercular Agents|antitubercular agents|mesh-ancestor
111073735|NCT03432689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111073736|NCT03432689|Antimetabolites|antimetabolites|mesh-ancestor
111073737|NCT03432689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111073738|NCT02991807|Everolimus|everolimus|mesh-list
111073739|NCT02991807|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111073740|NCT02991807|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111073741|NCT02991807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111073742|NCT02991807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111073743|NCT02991807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111073744|NCT02991807|Immunologic Factors|immunologic factors|mesh-ancestor
111073745|NCT02991807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111073746|NCT02991807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111073747|NCT04380311|Tacrolimus|tacrolimus|mesh-list
111073748|NCT04380311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111073749|NCT04380311|Immunologic Factors|immunologic factors|mesh-ancestor
111073750|NCT04380311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111073751|NCT04380311|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111073752|NCT04380311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111073753|NCT04380311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111073754|NCT05018013|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
111073755|NCT05018013|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111073756|NCT05018013|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111073757|NCT05018013|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111073758|NCT05018013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111073759|NCT05018013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111073760|NCT05018013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111073761|NCT05018013|Analgesics|analgesics|mesh-ancestor
111073762|NCT05018013|Sensory System Agents|sensory system agents|mesh-ancestor
111073763|NCT05018013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111073764|NCT05018013|Antidepressive Agents|antidepressive agents|mesh-ancestor
111073765|NCT05018013|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111073766|NCT05018013|Dopamine Agents|dopamine agents|mesh-ancestor
111073767|NCT03432221|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
111073768|NCT03432221|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111073769|NCT03432221|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111073770|NCT03432221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111073771|NCT03432221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111073772|NCT03432221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110677037|NCT03077451|Protease Inhibitors|protease inhibitors|mesh-ancestor
111073773|NCT03432221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111073774|NCT03432221|Antidepressive Agents|antidepressive agents|mesh-ancestor
111073775|NCT03432221|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111073777|NCT05112471|Vasodilator Agents|vasodilator agents|mesh-ancestor
111073778|NCT02387216|Docetaxel|docetaxel|mesh-list
111073779|NCT02387216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111073780|NCT02387216|Tubulin Modulators|tubulin modulators|mesh-ancestor
111073781|NCT02387216|Antimitotic Agents|antimitotic agents|mesh-ancestor
111073782|NCT02387216|Mitosis Modulators|mitosis modulators|mesh-ancestor
111073783|NCT02387216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111073784|NCT03431909|Aspirin|aspirin|mesh-list
111073785|NCT03431909|Kallikreins|kallikreins|mesh-list
111073786|NCT03431909|Clopidogrel|clopidogrel|mesh-list
111073787|NCT03431909|Atorvastatin|atorvastatin|mesh-list
111073788|NCT03431909|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111073789|NCT03431909|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111073790|NCT03431909|Analgesics|analgesics|mesh-ancestor
111073791|NCT03431909|Sensory System Agents|sensory system agents|mesh-ancestor
111073792|NCT03431909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111073793|NCT03431909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111073794|NCT03431909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111073795|NCT03431909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111073796|NCT03431909|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111073797|NCT03431909|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111073798|NCT03431909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111073799|NCT03431909|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111073800|NCT03431909|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111073801|NCT03431909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111073802|NCT03431909|Antipyretics|antipyretics|mesh-ancestor
111073803|NCT03431909|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111073804|NCT03431909|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111073805|NCT03431909|Antimetabolites|antimetabolites|mesh-ancestor
111073806|NCT03431909|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111073807|NCT03431909|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111073808|NCT03431909|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111073809|NCT03431909|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111073810|NCT03431909|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111073811|NCT03431909|Purinergic Agents|purinergic agents|mesh-ancestor
111073812|NCT03431909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111073813|NCT03431909|Coagulants|coagulants|mesh-ancestor
111073814|NCT03431909|Fertility Agents, Male|fertility agents, male|mesh-ancestor
111073815|NCT03431909|Fertility Agents|fertility agents|mesh-ancestor
111073816|NCT03431909|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111073817|NCT03436121|Midazolam|midazolam|mesh-list
111073818|NCT03436121|Ketamine|ketamine|mesh-list
111073819|NCT03436121|Analgesics|analgesics|mesh-ancestor
111073820|NCT03436121|Sensory System Agents|sensory system agents|mesh-ancestor
111073821|NCT03436121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111073822|NCT03436121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111073823|NCT03436121|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111073824|NCT03436121|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111073825|NCT03436121|Anesthetics, General|anesthetics, general|mesh-ancestor
111073826|NCT03436121|Anesthetics|anesthetics|mesh-ancestor
111073827|NCT03436121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111073828|NCT03436121|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111073829|NCT03436121|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111073830|NCT03436121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111073831|NCT03436121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111073832|NCT03436121|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111073833|NCT03436121|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111073834|NCT03436121|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111073835|NCT03436121|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111073836|NCT03436121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111073837|NCT03436121|GABA Modulators|gaba modulators|mesh-ancestor
111073838|NCT03436121|GABA Agents|gaba agents|mesh-ancestor
111073839|NCT02417246|Metoprolol|metoprolol|mesh-list
111073840|NCT02417246|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111073841|NCT02417246|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111073842|NCT02417246|Sympatholytics|sympatholytics|mesh-ancestor
111073843|NCT02417246|Autonomic Agents|autonomic agents|mesh-ancestor
111073844|NCT02417246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111073845|NCT02417246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111073846|NCT02417246|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110028620|NCT00557466|Formoterol Fumarate|formoterol fumarate|mesh-list
111073847|NCT02417246|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111073848|NCT02417246|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111073849|NCT02417246|Adrenergic Agents|adrenergic agents|mesh-ancestor
111073850|NCT02417246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111073851|NCT02417246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111073852|NCT03431675|Ciprofloxacin|ciprofloxacin|mesh-list
111073853|NCT03431675|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111073854|NCT03431675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111073855|NCT03431675|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111073856|NCT03431675|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111073857|NCT03431675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111073858|NCT03431675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111073859|NCT03431675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111073860|NCT03431675|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111073861|NCT03431675|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111073862|NCT02424734|Ampicillin|ampicillin|mesh-list
111073863|NCT02424734|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
111073864|NCT02424734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111073865|NCT02424734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111073866|NCT03431597|Micronutrients|micronutrients|mesh-list
111073867|NCT03431597|Trace Elements|trace elements|mesh-list
111073868|NCT03431597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111073869|NCT02424578|Diclofenac|diclofenac|mesh-list
111073870|NCT02424578|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111073871|NCT02424578|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111073872|NCT02424578|Analgesics|analgesics|mesh-ancestor
111073873|NCT02424578|Sensory System Agents|sensory system agents|mesh-ancestor
111073874|NCT02424578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111073875|NCT02424578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111073876|NCT02424578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111073877|NCT02424578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111073878|NCT02424578|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111073879|NCT02424578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111073880|NCT02424578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111073881|NCT03431285|Ketamine|ketamine|mesh-list
111073882|NCT03431285|Morphine|morphine|mesh-list
111073883|NCT03431285|Analgesics|analgesics|mesh-ancestor
111073884|NCT03431285|Sensory System Agents|sensory system agents|mesh-ancestor
111073885|NCT03431285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111073886|NCT03431285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111073887|NCT03431285|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111073888|NCT03431285|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111073889|NCT03431285|Anesthetics, General|anesthetics, general|mesh-ancestor
111073890|NCT03431285|Anesthetics|anesthetics|mesh-ancestor
111073891|NCT03431285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111073892|NCT03431285|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111073893|NCT03431285|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111073894|NCT03431285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111073895|NCT03431285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111073896|NCT03431285|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111073897|NCT03431285|Narcotics|narcotics|mesh-ancestor
111073898|NCT02416934|Dexamethasone|dexamethasone|mesh-list
111073899|NCT02416934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111073900|NCT02416934|Antiemetics|antiemetics|mesh-ancestor
111073901|NCT02416934|Autonomic Agents|autonomic agents|mesh-ancestor
111073902|NCT02416934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111073903|NCT02416934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111073904|NCT02416934|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111073905|NCT02416934|Glucocorticoids|glucocorticoids|mesh-ancestor
111073906|NCT02416934|Hormones|hormones|mesh-ancestor
111073907|NCT02416934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111073908|NCT02416934|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111073909|NCT02416934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111073910|NCT02819635|Upadacitinib|upadacitinib|mesh-list
111073911|NCT02819635|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
111073912|NCT02819635|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111073913|NCT02819635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111073914|NCT02819635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111073915|NCT02819635|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111073916|NCT03874325|Durvalumab|durvalumab|mesh-list
111073917|NCT03874325|Letrozole|letrozole|mesh-list
111073918|NCT03874325|Anastrozole|anastrozole|mesh-list
111073919|NCT03874325|Exemestane|exemestane|mesh-list
110677040|NCT03077451|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111073920|NCT03874325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111073922|NCT03874325|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111073923|NCT03874325|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111073924|NCT03874325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111073925|NCT03874325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111073926|NCT03874325|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111073927|NCT03874325|Hormone Antagonists|hormone antagonists|mesh-ancestor
111073928|NCT03874325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111073929|NCT03874325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111073930|NCT03874325|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111073931|NCT02424344|Formoterol Fumarate|formoterol fumarate|mesh-list
111073932|NCT02424344|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111073933|NCT02424344|Autonomic Agents|autonomic agents|mesh-ancestor
111073934|NCT02424344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111073935|NCT02424344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111073936|NCT02424344|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111073937|NCT02424344|Respiratory System Agents|respiratory system agents|mesh-ancestor
111073938|NCT02424344|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111073939|NCT02424344|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111073940|NCT02424344|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111073941|NCT02424344|Adrenergic Agents|adrenergic agents|mesh-ancestor
111073942|NCT02424344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111073943|NCT02424344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111073944|NCT03861611|Ibuprofen|ibuprofen|mesh-list
111073945|NCT03861611|Diclofenac|diclofenac|mesh-list
111073946|NCT03861611|Ketorolac|ketorolac|mesh-list
111073947|NCT03861611|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111073948|NCT03861611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111073949|NCT03861611|Analgesics|analgesics|mesh-ancestor
111073950|NCT03861611|Sensory System Agents|sensory system agents|mesh-ancestor
110638434|NCT00509236|Incretins|incretins|mesh-ancestor
111073951|NCT03861611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111073952|NCT03861611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111073953|NCT03861611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111073954|NCT03861611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111073955|NCT03861611|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111073956|NCT03861611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111073957|NCT03861611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111073958|NCT03430817|Amantadine|amantadine|mesh-list
111073959|NCT03430817|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
111073960|NCT03430817|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111073961|NCT03430817|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111073962|NCT03430817|Antiviral Agents|antiviral agents|mesh-ancestor
111073963|NCT03430817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111073964|NCT03430817|Dopamine Agents|dopamine agents|mesh-ancestor
111073965|NCT03430817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111073966|NCT03430817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111073967|NCT03430817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111073968|NCT03430817|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111073969|NCT03430817|Analgesics|analgesics|mesh-ancestor
111073970|NCT03430817|Sensory System Agents|sensory system agents|mesh-ancestor
111073971|NCT03430817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111073972|NCT03430817|Nootropic Agents|nootropic agents|mesh-ancestor
111073973|NCT02383940|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
111073974|NCT02383940|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111073975|NCT02383940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111073976|NCT02383940|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111073977|NCT02383940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111073978|NCT03799835|Atezolizumab|atezolizumab|mesh-list
111073979|NCT03799835|BCG Vaccine|bcg vaccine|mesh-list
111073980|NCT03799835|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111073981|NCT03799835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111073982|NCT03799835|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111073983|NCT03799835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110791099|NCT03885141|GABA Agents|gaba agents|mesh-ancestor
111073984|NCT03799835|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111073985|NCT03799835|Immunologic Factors|immunologic factors|mesh-ancestor
111073986|NCT03799835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111073987|NCT03430505|Albuterol|albuterol|mesh-list
111073988|NCT03430505|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111073989|NCT03430505|Autonomic Agents|autonomic agents|mesh-ancestor
111073990|NCT03430505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111073991|NCT03430505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111073993|NCT03430505|Respiratory System Agents|respiratory system agents|mesh-ancestor
111073994|NCT03430505|Tocolytic Agents|tocolytic agents|mesh-ancestor
111073995|NCT03430505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111073996|NCT03430505|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111073997|NCT03430505|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111073998|NCT03430505|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111073999|NCT03430505|Adrenergic Agents|adrenergic agents|mesh-ancestor
111074000|NCT03430505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111074001|NCT03430505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111074002|NCT03434951|Morphine|morphine|mesh-list
111074003|NCT03434951|Bupivacaine|bupivacaine|mesh-list
111074004|NCT03434951|Anesthetics, Local|anesthetics, local|mesh-ancestor
111074005|NCT03434951|Anesthetics|anesthetics|mesh-ancestor
111074006|NCT03434951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111074007|NCT03434951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111074008|NCT03434951|Sensory System Agents|sensory system agents|mesh-ancestor
111074009|NCT03434951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111074010|NCT03434951|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111074011|NCT03434951|Narcotics|narcotics|mesh-ancestor
111074012|NCT03434951|Analgesics|analgesics|mesh-ancestor
111074013|NCT02234323|Factor VIII|factor viii|mesh-list
111074014|NCT02234323|Coagulants|coagulants|mesh-ancestor
111074015|NCT03434405|Psychotropic Drugs|psychotropic drugs|mesh-list
111074016|NCT02413346|Sarecycline|sarecycline|mesh-list
111074017|NCT02413346|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111074018|NCT02413346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111074019|NCT02413346|Dermatologic Agents|dermatologic agents|mesh-ancestor
111074020|NCT03433859|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111074021|NCT03433859|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111074022|NCT03433859|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111074023|NCT03433859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111074024|NCT03433859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111074025|NCT03433859|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111074026|NCT03433859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111074027|NCT03433859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111074028|NCT03433859|Cholinergic Agents|cholinergic agents|mesh-ancestor
111074029|NCT03433859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111074030|NCT03429179|Butorphanol|butorphanol|mesh-list
111074031|NCT03429179|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111074032|NCT03429179|Narcotics|narcotics|mesh-ancestor
111074033|NCT03429179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111074034|NCT03429179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111074035|NCT03429179|Analgesics|analgesics|mesh-ancestor
111074036|NCT03429179|Sensory System Agents|sensory system agents|mesh-ancestor
111074037|NCT03429179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111074038|NCT03429179|Antitussive Agents|antitussive agents|mesh-ancestor
111074039|NCT03429179|Respiratory System Agents|respiratory system agents|mesh-ancestor
111074040|NCT03429179|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111074041|NCT03429101|Trastuzumab|trastuzumab|mesh-list
111074042|NCT03429101|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
111074043|NCT03429101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111074044|NCT03429101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111074045|NCT03429101|Tubulin Modulators|tubulin modulators|mesh-ancestor
111074046|NCT03429101|Antimitotic Agents|antimitotic agents|mesh-ancestor
111074047|NCT03429101|Mitosis Modulators|mitosis modulators|mesh-ancestor
111074048|NCT03429101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111074049|NCT03429101|Immunotoxins|immunotoxins|mesh-ancestor
111074050|NCT03429101|Immunoconjugates|immunoconjugates|mesh-ancestor
111074051|NCT03429101|Immunologic Factors|immunologic factors|mesh-ancestor
111074052|NCT03429101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111074053|NCT04048343|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111074054|NCT04048343|Immunologic Factors|immunologic factors|mesh-ancestor
111074055|NCT04048343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111074056|NCT04016753|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
111074057|NCT04016753|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110791184|NCT01264497|Tesamorelin|tesamorelin|mesh-list
111074058|NCT04016753|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111074059|NCT04016753|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111074060|NCT04016753|Contraceptive Agents|contraceptive agents|mesh-ancestor
111074061|NCT04016753|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111074062|NCT04016753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111074063|NCT04016753|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111074064|NCT04016753|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111074065|NCT04016753|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
111074066|NCT04016753|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111074067|NCT02732639|Interferons|interferons|mesh-list
111074068|NCT02732639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111074069|NCT02732639|Antiviral Agents|antiviral agents|mesh-ancestor
111074070|NCT02732639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111074071|NCT03428633|Morphine|morphine|mesh-list
111074072|NCT03428633|Ropivacaine|ropivacaine|mesh-list
111074073|NCT03428633|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111074074|NCT03428633|Narcotics|narcotics|mesh-ancestor
111074075|NCT03428633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111074076|NCT03428633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111074077|NCT03428633|Analgesics|analgesics|mesh-ancestor
111074078|NCT03428633|Sensory System Agents|sensory system agents|mesh-ancestor
111074079|NCT03428633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111074080|NCT03428633|Anesthetics, Local|anesthetics, local|mesh-ancestor
111074081|NCT03428633|Anesthetics|anesthetics|mesh-ancestor
111074082|NCT02412878|Dexamethasone|dexamethasone|mesh-list
111074083|NCT02412878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111074084|NCT02412878|Antiemetics|antiemetics|mesh-ancestor
111074085|NCT02412878|Autonomic Agents|autonomic agents|mesh-ancestor
110638443|NCT00842894|Insulin Aspart|insulin aspart|mesh-list
111074086|NCT02412878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111074087|NCT02412878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111074088|NCT02412878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111074089|NCT02412878|Glucocorticoids|glucocorticoids|mesh-ancestor
111074090|NCT02412878|Hormones|hormones|mesh-ancestor
111074091|NCT02412878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111074092|NCT02412878|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111074093|NCT02412878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111074094|NCT03423329|Ibuprofen|ibuprofen|mesh-list
111074095|NCT03423329|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111074096|NCT03423329|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111074097|NCT03423329|Analgesics|analgesics|mesh-ancestor
111074098|NCT03423329|Sensory System Agents|sensory system agents|mesh-ancestor
111074099|NCT03423329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111074100|NCT03423329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111074101|NCT03423329|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111074102|NCT03423329|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111074103|NCT03423329|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111074104|NCT03423329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111074105|NCT03423329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111074106|NCT02380742|Lidocaine|lidocaine|mesh-list
111074107|NCT02380742|Prilocaine|prilocaine|mesh-list
111074108|NCT02380742|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
111074109|NCT02380742|Anesthetics, Local|anesthetics, local|mesh-ancestor
111074110|NCT02380742|Anesthetics|anesthetics|mesh-ancestor
111074111|NCT02380742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111074112|NCT02380742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111074113|NCT02380742|Sensory System Agents|sensory system agents|mesh-ancestor
111074114|NCT02380742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111074115|NCT02380742|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111074116|NCT02380742|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111074117|NCT02380742|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111074118|NCT02380742|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111074119|NCT02380742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111074120|NCT02380742|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
111074121|NCT02944019|Edoxaban|edoxaban|mesh-list
111074122|NCT02944019|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111074123|NCT02944019|Antithrombins|antithrombins|mesh-ancestor
111074124|NCT02944019|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111074125|NCT02944019|Protease Inhibitors|protease inhibitors|mesh-ancestor
111074126|NCT02944019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111074127|NCT02944019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111074128|NCT02944019|Anticoagulants|anticoagulants|mesh-ancestor
111074129|NCT02022059|Lidocaine|lidocaine|mesh-list
111074130|NCT02022059|Anesthetics, Local|anesthetics, local|mesh-ancestor
111074131|NCT02022059|Anesthetics|anesthetics|mesh-ancestor
111074132|NCT02022059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111074133|NCT02022059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111074135|NCT02022059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111074136|NCT02022059|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111074137|NCT02022059|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111074138|NCT02022059|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111074139|NCT02022059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111074140|NCT02022059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111074141|NCT02922725|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
111074142|NCT02922725|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111074143|NCT02922725|Antidepressive Agents|antidepressive agents|mesh-ancestor
111074144|NCT02922725|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111074145|NCT03422315|Propofol|propofol|mesh-list
111074146|NCT03422315|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111074147|NCT03422315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111074148|NCT03422315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111074149|NCT03422315|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111074150|NCT03422315|Anesthetics, General|anesthetics, general|mesh-ancestor
111074151|NCT03422315|Anesthetics|anesthetics|mesh-ancestor
111074152|NCT03427385|Ropivacaine|ropivacaine|mesh-list
111074153|NCT03427385|Anesthetics, Local|anesthetics, local|mesh-ancestor
111074154|NCT03427385|Anesthetics|anesthetics|mesh-ancestor
111074155|NCT03427385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111074156|NCT03427385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111074157|NCT03427385|Sensory System Agents|sensory system agents|mesh-ancestor
111074158|NCT03427385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111074159|NCT03427229|Vancomycin|vancomycin|mesh-list
111074160|NCT03427229|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111074161|NCT03427229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111074162|NCT04449185|Amoxicillin|amoxicillin|mesh-list
111074163|NCT04449185|Clarithromycin|clarithromycin|mesh-list
111074164|NCT04449185|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111074165|NCT04449185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111074166|NCT04449185|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111074167|NCT04449185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111074168|NCT04449185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111074169|NCT04449185|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111074170|NCT04449185|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111074171|NCT03426761|Vancomycin|vancomycin|mesh-list
111074172|NCT03426761|Cefazolin|cefazolin|mesh-list
111074173|NCT03426761|Daptomycin|daptomycin|mesh-list
111074174|NCT03426761|Dalbavancin|dalbavancin|mesh-list
111074175|NCT03426761|Nafcillin|nafcillin|mesh-list
111074176|NCT03426761|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111074177|NCT03426761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111074178|NCT03426527|Dexmedetomidine|dexmedetomidine|mesh-list
111074179|NCT03426527|Levobupivacaine|levobupivacaine|mesh-list
111074180|NCT03426527|Anesthetics|anesthetics|mesh-ancestor
111074181|NCT03426527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111074182|NCT03426527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111074183|NCT03426527|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111074184|NCT03426527|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111074185|NCT03426527|Analgesics|analgesics|mesh-ancestor
111074186|NCT03426527|Sensory System Agents|sensory system agents|mesh-ancestor
111074187|NCT03426527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111074188|NCT03426527|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111074189|NCT03426527|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111074190|NCT03426527|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111074191|NCT03426527|Adrenergic Agents|adrenergic agents|mesh-ancestor
111074192|NCT03426527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111074193|NCT03426527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111074194|NCT03426527|Anesthetics, Local|anesthetics, local|mesh-ancestor
111074195|NCT02805257|Mitomycins|mitomycins|mesh-list
111074196|NCT02805257|Mitomycin|mitomycin|mesh-list
111074197|NCT02805257|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111074198|NCT02805257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111074199|NCT02805257|Alkylating Agents|alkylating agents|mesh-ancestor
111074200|NCT02805257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111074201|NCT02805257|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111074202|NCT02805257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111074203|NCT02636387|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
111074204|NCT02636387|Hemostatics|hemostatics|mesh-ancestor
111074205|NCT02636387|Coagulants|coagulants|mesh-ancestor
111074206|NCT02636387|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
111074207|NCT02636387|Natriuretic Agents|natriuretic agents|mesh-ancestor
111074208|NCT02636387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111074209|NCT03425747|Calcium, Dietary|calcium, dietary|mesh-list
111074210|NCT03425747|Calcium Carbonate|calcium carbonate|mesh-list
111074211|NCT03425747|Calcium|calcium|mesh-list
111074212|NCT03425747|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111074213|NCT03425747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111074214|NCT03425747|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111074215|NCT03425747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111074216|NCT03425747|Antacids|antacids|mesh-ancestor
111074217|NCT03425747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111074218|NCT03425669|Methylphenidate|methylphenidate|mesh-list
111074219|NCT03425669|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111074220|NCT03425669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111074221|NCT03425669|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111074222|NCT03425669|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111074223|NCT03425669|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111074224|NCT03425669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111074225|NCT03425669|Dopamine Agents|dopamine agents|mesh-ancestor
111074226|NCT03425669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111074227|NCT03424889|Xylometazoline|xylometazoline|mesh-list
111074228|NCT03424889|Nasal Decongestants|nasal decongestants|mesh-ancestor
111074229|NCT03424889|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111074230|NCT03424889|Respiratory System Agents|respiratory system agents|mesh-ancestor
111074231|NCT03424733|Acetaminophen|acetaminophen|mesh-list
111074232|NCT03424733|Interferons|interferons|mesh-list
111074233|NCT03424733|Interferon-beta|interferon-beta|mesh-list
111074234|NCT03424733|Interferon beta-1a|interferon beta-1a|mesh-list
111074235|NCT03424733|Prednisone|prednisone|mesh-list
111074236|NCT03424733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111074237|NCT03424733|Glucocorticoids|glucocorticoids|mesh-ancestor
111074238|NCT03424733|Hormones|hormones|mesh-ancestor
111074239|NCT03424733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111074240|NCT03424733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111074241|NCT03424733|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111074242|NCT03424733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111074243|NCT03424733|Antiviral Agents|antiviral agents|mesh-ancestor
111074244|NCT03424733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111074245|NCT03424733|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111074246|NCT03424733|Analgesics|analgesics|mesh-ancestor
111074247|NCT03424733|Sensory System Agents|sensory system agents|mesh-ancestor
111074248|NCT03424733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111074249|NCT03424733|Antipyretics|antipyretics|mesh-ancestor
111074250|NCT03424733|Immunologic Factors|immunologic factors|mesh-ancestor
111074251|NCT03424733|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111074252|NCT03423797|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111074253|NCT03441841|Lidocaine|lidocaine|mesh-list
111074254|NCT03441841|Prilocaine|prilocaine|mesh-list
111074255|NCT03441841|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
111074256|NCT03441841|Anesthetics, Local|anesthetics, local|mesh-ancestor
111074257|NCT03441841|Anesthetics|anesthetics|mesh-ancestor
111074258|NCT03441841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111074259|NCT03441841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111074260|NCT03441841|Sensory System Agents|sensory system agents|mesh-ancestor
111074261|NCT03441841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111074262|NCT03441841|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111074263|NCT03441841|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111074264|NCT03441841|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111074265|NCT03441841|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111074266|NCT03441841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111074267|NCT03441841|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
111074268|NCT02692339|Dexamethasone|dexamethasone|mesh-list
111074269|NCT02692339|Lenalidomide|lenalidomide|mesh-list
111074270|NCT02692339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111074271|NCT02692339|Antiemetics|antiemetics|mesh-ancestor
111074272|NCT02692339|Autonomic Agents|autonomic agents|mesh-ancestor
111074273|NCT02692339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111074274|NCT02692339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111074275|NCT02692339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111074276|NCT02692339|Glucocorticoids|glucocorticoids|mesh-ancestor
111074277|NCT02692339|Hormones|hormones|mesh-ancestor
111074278|NCT02692339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111074279|NCT02692339|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111074280|NCT02692339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111074281|NCT02692339|Immunologic Factors|immunologic factors|mesh-ancestor
111074282|NCT02692339|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111074283|NCT02692339|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111074285|NCT02692339|Growth Inhibitors|growth inhibitors|mesh-ancestor
111074286|NCT03444025|Goserelin|goserelin|mesh-list
111074287|NCT03444025|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111074288|NCT03444025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111074289|NCT03438253|Anesthetics|anesthetics|mesh-list
111074290|NCT03438253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111074291|NCT03438253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111074292|NCT02535325|Cisplatin|cisplatin|mesh-list
111074293|NCT02535325|Pemetrexed|pemetrexed|mesh-list
111074294|NCT02535325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111074295|NCT02535325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111074296|NCT02535325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111074297|NCT02535325|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111074298|NCT02535325|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111074299|NCT03441529|Tazobactam|tazobactam|mesh-list
111074300|NCT03441529|Piperacillin|piperacillin|mesh-list
111074301|NCT03441529|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
111074302|NCT03441529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111074303|NCT03441529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111074304|NCT03441529|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
111074305|NCT03441529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111074306|NCT03441529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111074307|NCT03441373|Histamine|histamine|mesh-list
111074308|NCT03441373|Histamine phosphate|histamine phosphate|mesh-list
111074309|NCT03441373|Glutarimide|glutarimide|mesh-list
111074310|NCT03441373|Histamine Agonists|histamine agonists|mesh-ancestor
111074311|NCT03441373|Histamine Agents|histamine agents|mesh-ancestor
111074312|NCT03441373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111074313|NCT03441373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111074314|NCT03441373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111074315|NCT03441373|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111074316|NCT03441373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111074317|NCT03449797|Hydrocortisone|hydrocortisone|mesh-list
111074318|NCT03449797|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
111074319|NCT03449797|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
111074320|NCT03449797|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
111074321|NCT03449797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111074322|NCT03449719|Abiraterone Acetate|abiraterone acetate|mesh-list
111074323|NCT03449719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111074324|NCT03449719|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111074325|NCT03449719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111074326|NCT03449719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111074327|NCT03449719|Hormone Antagonists|hormone antagonists|mesh-ancestor
111074328|NCT03449719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111074329|NCT03449719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111074330|NCT03449719|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111074331|NCT03437785|Ethanol|ethanol|mesh-list
111074332|NCT03437785|Rebamipide|rebamipide|mesh-list
111074333|NCT03437785|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111074334|NCT03437785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111074335|NCT03437785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111074336|NCT03437785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111074337|NCT03437785|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111074338|NCT03437785|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111074339|NCT03437785|Antioxidants|antioxidants|mesh-ancestor
111074340|NCT03437785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111074341|NCT03437785|Protective Agents|protective agents|mesh-ancestor
111074342|NCT03437785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111074343|NCT03437707|Acetaminophen|acetaminophen|mesh-list
111074344|NCT03437707|Ibuprofen|ibuprofen|mesh-list
111074345|NCT03437707|Morphine|morphine|mesh-list
111074346|NCT03437707|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111074347|NCT03437707|Narcotics|narcotics|mesh-ancestor
111074348|NCT03437707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111074349|NCT03437707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111074350|NCT03437707|Analgesics|analgesics|mesh-ancestor
111074351|NCT03437707|Sensory System Agents|sensory system agents|mesh-ancestor
111074352|NCT03437707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111074353|NCT03437707|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111074354|NCT03437707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111074355|NCT03437707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111074356|NCT03437707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111074357|NCT03437707|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111074358|NCT03437707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111074359|NCT03437707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111074360|NCT03437707|Antipyretics|antipyretics|mesh-ancestor
111074361|NCT03437629|Calcium|calcium|mesh-list
111074362|NCT03437629|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111074363|NCT03437629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111074364|NCT03437473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
111074365|NCT03437473|Cholinergic Agents|cholinergic agents|mesh-list
111074366|NCT03437473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111074367|NCT03437473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111074368|NCT03437473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111074369|NCT03441217|Scopolamine|scopolamine|mesh-list
111074370|NCT03441217|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
111074371|NCT03441217|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111074372|NCT03441217|Antiemetics|antiemetics|mesh-ancestor
111074373|NCT03441217|Autonomic Agents|autonomic agents|mesh-ancestor
111074374|NCT03441217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111074375|NCT03441217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111074376|NCT03441217|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111074377|NCT03441217|Mydriatics|mydriatics|mesh-ancestor
111074378|NCT03441217|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111074379|NCT03441217|Cholinergic Agents|cholinergic agents|mesh-ancestor
111074380|NCT03441217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111074381|NCT03441217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111074382|NCT03441217|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111074383|NCT03441217|Parasympatholytics|parasympatholytics|mesh-ancestor
111074384|NCT03128515|Hydroxyurea|hydroxyurea|mesh-list
111074385|NCT03128515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111074386|NCT03128515|Antisickling Agents|antisickling agents|mesh-ancestor
111074387|NCT03128515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111074388|NCT03128515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111074389|NCT03128515|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111074390|NCT02521441|Lenograstim|lenograstim|mesh-list
111074391|NCT02521441|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111074392|NCT02521441|Immunologic Factors|immunologic factors|mesh-ancestor
111074393|NCT02521441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111074394|NCT04451239|Cyclosporine|cyclosporine|mesh-list
111074395|NCT04451239|Cyclosporins|cyclosporins|mesh-list
111074396|NCT04451239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110638485|NCT04688788|Hormones|hormones|mesh-ancestor
111074397|NCT04451239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111074398|NCT04451239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111074399|NCT04451239|Immunologic Factors|immunologic factors|mesh-ancestor
111074400|NCT04451239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111074401|NCT04451239|Antifungal Agents|antifungal agents|mesh-ancestor
111074402|NCT04451239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111074403|NCT04451239|Dermatologic Agents|dermatologic agents|mesh-ancestor
111074404|NCT04451239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111074405|NCT04451239|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111074406|NCT03440515|Prednisone|prednisone|mesh-list
111074407|NCT03440515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111074408|NCT03440515|Glucocorticoids|glucocorticoids|mesh-ancestor
111074409|NCT03440515|Hormones|hormones|mesh-ancestor
111074410|NCT03440515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111074411|NCT03440515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111074412|NCT03440515|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111074413|NCT03440515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111074414|NCT03432793|Itraconazole|itraconazole|mesh-list
111074415|NCT03432793|Fluvoxamine|fluvoxamine|mesh-list
111074416|NCT03432793|Caffeine|caffeine|mesh-list
111074417|NCT03432793|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111074418|NCT03432793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111074419|NCT03432793|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111074420|NCT03432793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111074421|NCT03432793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111074422|NCT03432793|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
111074423|NCT03432793|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111074424|NCT03432793|Purinergic Agents|purinergic agents|mesh-ancestor
111074425|NCT03432793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111074426|NCT03432793|Antifungal Agents|antifungal agents|mesh-ancestor
111074427|NCT03432793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111074428|NCT03432793|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111074429|NCT03432793|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111074430|NCT03432793|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111074431|NCT03432793|Hormone Antagonists|hormone antagonists|mesh-ancestor
111074432|NCT03432793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111074433|NCT03432793|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111074434|NCT03432793|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111074435|NCT03432793|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111074436|NCT03432793|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111074437|NCT03432793|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111074438|NCT03432793|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111074439|NCT03432793|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111074440|NCT03432793|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111074442|NCT03432793|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111074443|NCT03432793|Antidepressive Agents|antidepressive agents|mesh-ancestor
111074444|NCT03432793|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111074445|NCT03432793|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111074446|NCT03436693|Canagliflozin|canagliflozin|mesh-list
111074447|NCT03436693|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111074448|NCT03436693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110638519|NCT00837044|Naproxen|naproxen|mesh-list
111074449|NCT03436693|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111074450|NCT03436693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111074451|NCT03432637|Anesthetics|anesthetics|mesh-list
111074452|NCT03432637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111074453|NCT03432637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111074454|NCT03436303|Dydrogesterone|dydrogesterone|mesh-list
111074455|NCT03436303|Progestins|progestins|mesh-ancestor
111074456|NCT03436303|Hormones|hormones|mesh-ancestor
111074457|NCT03436303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111074458|NCT03436303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111074459|NCT03436225|Dexamethasone|dexamethasone|mesh-list
111074460|NCT03436225|Dexamethasone acetate|dexamethasone acetate|mesh-list
111074461|NCT03436225|Budesonide|budesonide|mesh-list
111074462|NCT03436225|Albuterol|albuterol|mesh-list
111074463|NCT03436225|BB 1101|bb 1101|mesh-list
111074464|NCT03436225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111074465|NCT03436225|Antiemetics|antiemetics|mesh-ancestor
111074466|NCT03436225|Autonomic Agents|autonomic agents|mesh-ancestor
111074467|NCT03436225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111074468|NCT03436225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111074469|NCT03436225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111074470|NCT03436225|Glucocorticoids|glucocorticoids|mesh-ancestor
111074471|NCT03436225|Hormones|hormones|mesh-ancestor
111074472|NCT03436225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111074473|NCT03436225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111074474|NCT03436225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111074475|NCT03436225|Protease Inhibitors|protease inhibitors|mesh-ancestor
111074476|NCT03436225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111074477|NCT03436225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111074478|NCT03436225|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111074479|NCT03436225|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111074480|NCT03436225|Respiratory System Agents|respiratory system agents|mesh-ancestor
111074481|NCT03436225|Tocolytic Agents|tocolytic agents|mesh-ancestor
111074482|NCT03436225|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111074483|NCT03436225|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111074484|NCT03436225|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111074485|NCT03436225|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111074486|NCT03436225|Adrenergic Agents|adrenergic agents|mesh-ancestor
111074487|NCT03436225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111074488|NCT03440359|Letrozole|letrozole|mesh-list
111074489|NCT03440359|Progesterone|progesterone|mesh-list
111074490|NCT03440359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111074491|NCT03440359|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111074492|NCT03440359|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111074493|NCT03440359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111074494|NCT03440359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111074495|NCT03440359|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111074496|NCT03440359|Hormone Antagonists|hormone antagonists|mesh-ancestor
111074497|NCT03440359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111074498|NCT03440359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111074499|NCT03440359|Progestins|progestins|mesh-ancestor
111074500|NCT03440359|Hormones|hormones|mesh-ancestor
111074501|NCT03431701|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111074502|NCT03431701|Chlorhexidine|chlorhexidine|mesh-list
111074503|NCT03431701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110539589|NCT02690129|Progesterone|progesterone|mesh-list
111074505|NCT03431701|Disinfectants|disinfectants|mesh-ancestor
111074506|NCT03431623|Darbepoetin alfa|darbepoetin alfa|mesh-list
111074507|NCT03431623|Hematinics|hematinics|mesh-ancestor
111074508|NCT04451395|Micronutrients|micronutrients|mesh-list
111074509|NCT04451395|Trace Elements|trace elements|mesh-list
111074510|NCT04451395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111074511|NCT04451083|Camostat|camostat|mesh-list
111074512|NCT04451083|Protease Inhibitors|protease inhibitors|mesh-ancestor
111074513|NCT04451083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111074514|NCT04451083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111074515|NCT04451083|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
111074516|NCT04451083|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111074517|NCT03435289|Paclitaxel|paclitaxel|mesh-list
111074518|NCT03435289|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111074519|NCT03435289|Gemcitabine|gemcitabine|mesh-list
111074520|NCT03435289|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111074521|NCT03435289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111074522|NCT03435289|Tubulin Modulators|tubulin modulators|mesh-ancestor
111074523|NCT03435289|Antimitotic Agents|antimitotic agents|mesh-ancestor
111074524|NCT03435289|Mitosis Modulators|mitosis modulators|mesh-ancestor
111074525|NCT03435289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111074526|NCT03435289|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111074527|NCT03435289|Antimetabolites|antimetabolites|mesh-ancestor
111074528|NCT03435133|Ticagrelor|ticagrelor|mesh-list
111074529|NCT03435133|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
111074530|NCT03435133|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111074531|NCT03435133|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111074532|NCT03435133|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111074533|NCT03435133|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111074534|NCT03435133|Purinergic Agents|purinergic agents|mesh-ancestor
111074535|NCT03435133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111074536|NCT03435133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111074537|NCT03435133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111074538|NCT03431077|Angiotensin II|angiotensin ii|mesh-list
111074539|NCT03431077|Giapreza|giapreza|mesh-list
111074540|NCT03431077|Angiotensinogen|angiotensinogen|mesh-list
111074541|NCT03431077|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111074542|NCT03431077|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111074543|NCT03431077|Protease Inhibitors|protease inhibitors|mesh-ancestor
111074544|NCT03431077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111074545|NCT03431077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111074546|NCT03439501|Avelumab|avelumab|mesh-list
111074547|NCT03439501|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111074548|NCT03439501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111074549|NCT03430687|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
111074550|NCT03430687|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111074551|NCT03430687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111074552|NCT04255381|Pancrelipase|pancrelipase|mesh-list
111074553|NCT04255381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111074554|NCT03757897|Dexmedetomidine|dexmedetomidine|mesh-list
111074555|NCT03757897|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111074556|NCT03757897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111074557|NCT03757897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111074558|NCT03757897|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111074559|NCT03757897|Analgesics|analgesics|mesh-ancestor
111074560|NCT03757897|Sensory System Agents|sensory system agents|mesh-ancestor
111074561|NCT03757897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111074562|NCT03757897|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111074563|NCT03757897|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111074564|NCT03757897|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111074565|NCT03757897|Adrenergic Agents|adrenergic agents|mesh-ancestor
111074566|NCT03757897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111074567|NCT03757897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111074568|NCT03434197|Diclofenac|diclofenac|mesh-list
111074569|NCT03434197|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111074570|NCT03434197|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111074571|NCT03434197|Analgesics|analgesics|mesh-ancestor
111074572|NCT03434197|Sensory System Agents|sensory system agents|mesh-ancestor
111074573|NCT03434197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110638552|NCT04232085|Alemtuzumab|alemtuzumab|mesh-list
111074574|NCT03434197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111074575|NCT03434197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111074576|NCT03434197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110791704|NCT02527005|Sulfadoxine|sulfadoxine|mesh-list
111074578|NCT03434197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111074579|NCT03434197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111074580|NCT03430609|Hormones|hormones|mesh-list
111074581|NCT03430609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111074582|NCT03430609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111074583|NCT03438955|Telmisartan|telmisartan|mesh-list
111074584|NCT03438955|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111074585|NCT03438955|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111074586|NCT03438955|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111074587|NCT03438955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111074588|NCT04219735|Minocycline|minocycline|mesh-list
111074589|NCT04219735|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111074590|NCT04219735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111074591|NCT04449757|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111074592|NCT03621553|Vitamin D|vitamin d|mesh-list
111074593|NCT03621553|Ergocalciferols|ergocalciferols|mesh-list
111074594|NCT03621553|Cholecalciferol|cholecalciferol|mesh-list
111074595|NCT03621553|Vitamins|vitamins|mesh-list
111074596|NCT03621553|Micronutrients|micronutrients|mesh-ancestor
111074597|NCT03621553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111074598|NCT03621553|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111074599|NCT03621553|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111074600|NCT01559363|XL647|xl647|mesh-list
111074601|NCT01559363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111074602|NCT01559363|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111074603|NCT01559363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111074604|NCT01559363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111074605|NCT03569839|Propofol|propofol|mesh-list
111074606|NCT03569839|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111074607|NCT03569839|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111074608|NCT03569839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111074609|NCT03569839|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111074610|NCT03569839|Anesthetics, General|anesthetics, general|mesh-ancestor
111074611|NCT03569839|Anesthetics|anesthetics|mesh-ancestor
111074612|NCT01504919|Nicotine|nicotine|mesh-list
111074613|NCT01504919|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111074614|NCT01504919|Autonomic Agents|autonomic agents|mesh-ancestor
111074615|NCT01504919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111074616|NCT01504919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111074617|NCT01504919|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111074618|NCT01504919|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111074619|NCT01504919|Cholinergic Agents|cholinergic agents|mesh-ancestor
111074620|NCT01504919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111074621|NCT01504919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111074622|NCT02732327|Vancomycin|vancomycin|mesh-list
111074623|NCT02732327|Meropenem|meropenem|mesh-list
111074624|NCT02732327|Tazobactam|tazobactam|mesh-list
111074625|NCT02732327|Linezolid|linezolid|mesh-list
111074626|NCT02732327|Piperacillin|piperacillin|mesh-list
111074627|NCT02732327|Cefepime|cefepime|mesh-list
111074628|NCT02732327|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
111074629|NCT02732327|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111074630|NCT02732327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111074631|NCT02732327|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
111074632|NCT02732327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111074633|NCT02732327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111074634|NCT02732327|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111074635|NCT03428503|Acetaminophen|acetaminophen|mesh-list
111074636|NCT03428503|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
111074637|NCT03428503|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111074638|NCT03428503|Analgesics|analgesics|mesh-ancestor
111074639|NCT03428503|Sensory System Agents|sensory system agents|mesh-ancestor
111074640|NCT03428503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111074641|NCT03428503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111074642|NCT03428503|Antipyretics|antipyretics|mesh-ancestor
111074643|NCT03428503|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111074644|NCT03428503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111074645|NCT03428503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111074646|NCT03428425|Paclitaxel|paclitaxel|mesh-list
111074647|NCT03428425|Apatinib|apatinib|mesh-list
111074648|NCT03428425|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111074649|NCT03428425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111074650|NCT03428425|Tubulin Modulators|tubulin modulators|mesh-ancestor
111074651|NCT03428425|Antimitotic Agents|antimitotic agents|mesh-ancestor
111074653|NCT03428425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111074654|NCT03428425|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111074655|NCT03428425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111074656|NCT03416777|Tocopherols|tocopherols|mesh-list
111074657|NCT03416777|Vitamin E|vitamin e|mesh-list
111074658|NCT03416777|Tocotrienols|tocotrienols|mesh-list
111074659|NCT03416777|alpha-Tocopherol|alpha-tocopherol|mesh-list
111074660|NCT03416777|Antioxidants|antioxidants|mesh-ancestor
111074661|NCT03416777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111074662|NCT03416777|Protective Agents|protective agents|mesh-ancestor
111074663|NCT03416777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111074664|NCT03416777|Vitamins|vitamins|mesh-ancestor
111074665|NCT03416777|Micronutrients|micronutrients|mesh-ancestor
111074666|NCT03429439|Antiviral Agents|antiviral agents|mesh-list
111074667|NCT03429439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111074668|NCT03422887|Flurbiprofen|flurbiprofen|mesh-list
111074669|NCT03422887|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
111074670|NCT03422887|Nalbuphine|nalbuphine|mesh-list
111074671|NCT03422887|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111074672|NCT03422887|Narcotics|narcotics|mesh-ancestor
111074673|NCT03422887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111074674|NCT03422887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111074675|NCT03422887|Analgesics|analgesics|mesh-ancestor
111074676|NCT03422887|Sensory System Agents|sensory system agents|mesh-ancestor
111074677|NCT03422887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111074678|NCT03422887|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111074679|NCT03422887|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111074680|NCT03422887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111074681|NCT03422887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111074682|NCT03422887|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111074683|NCT03422887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111074684|NCT03422887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111074685|NCT02521207|Ibuprofen|ibuprofen|mesh-list
111074686|NCT02521207|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111074687|NCT02521207|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111074688|NCT02521207|Analgesics|analgesics|mesh-ancestor
111074689|NCT02521207|Sensory System Agents|sensory system agents|mesh-ancestor
111074690|NCT02521207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111074691|NCT02521207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111074692|NCT02521207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111074693|NCT02521207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111074694|NCT02521207|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111074695|NCT02521207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111074696|NCT02521207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111074697|NCT03179605|Clobetasol|clobetasol|mesh-list
111074698|NCT03179605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111074699|NCT03179605|Glucocorticoids|glucocorticoids|mesh-ancestor
111074700|NCT03179605|Hormones|hormones|mesh-ancestor
111074701|NCT03179605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111074702|NCT03179605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111074703|NCT03173053|Chlorhexidine|chlorhexidine|mesh-list
111074704|NCT03173053|Povidone-Iodine|povidone-iodine|mesh-list
111074705|NCT03173053|Clarithromycin|clarithromycin|mesh-list
111074706|NCT03173053|Doxycycline|doxycycline|mesh-list
111074707|NCT03173053|Ciprofloxacin|ciprofloxacin|mesh-list
111074708|NCT03173053|Rifampin|rifampin|mesh-list
111074709|NCT03173053|Clindamycin|clindamycin|mesh-list
111074710|NCT03173053|Trimethoprim|trimethoprim|mesh-list
111074711|NCT03173053|Sulfamethoxazole|sulfamethoxazole|mesh-list
111074712|NCT03173053|Mupirocin|mupirocin|mesh-list
111074713|NCT03173053|Fusidic Acid|fusidic acid|mesh-list
111074714|NCT03173053|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
111074715|NCT03173053|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111074716|NCT03173053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111074717|NCT03173053|Disinfectants|disinfectants|mesh-ancestor
111074718|NCT03173053|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111074719|NCT03173053|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111074720|NCT03173053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111074721|NCT03173053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111074722|NCT03173053|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111074723|NCT03173053|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111074724|NCT03173053|Antimalarials|antimalarials|mesh-ancestor
111074725|NCT03173053|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111074726|NCT03173053|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111074727|NCT03173053|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111074729|NCT03173053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111074730|NCT03173053|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111074731|NCT03173053|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111074732|NCT03173053|Antitubercular Agents|antitubercular agents|mesh-ancestor
111074733|NCT03173053|Leprostatic Agents|leprostatic agents|mesh-ancestor
111074734|NCT03173053|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111074735|NCT03173053|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111074736|NCT03173053|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111074737|NCT03173053|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
111074738|NCT03173053|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
111074739|NCT03173053|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
111074740|NCT03173053|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111074741|NCT03173053|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111074742|NCT03173053|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111074743|NCT03173053|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111074744|NCT03173053|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
111074745|NCT03429127|Plasma-lyte 148|plasma-lyte 148|mesh-list
111074746|NCT03429127|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
111074747|NCT03429127|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111074748|NCT03428191|Dexmedetomidine|dexmedetomidine|mesh-list
111074749|NCT03428191|Remifentanil|remifentanil|mesh-list
111074750|NCT03428191|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111074751|NCT03428191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111074752|NCT03428191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111074753|NCT03428191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111074754|NCT03428191|Analgesics|analgesics|mesh-ancestor
111074755|NCT03428191|Sensory System Agents|sensory system agents|mesh-ancestor
111074756|NCT03428191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111074757|NCT03428191|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111074758|NCT03428191|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111074759|NCT03428191|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111074760|NCT03428191|Adrenergic Agents|adrenergic agents|mesh-ancestor
111074761|NCT03428191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111074762|NCT03428191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111074763|NCT03428191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111074764|NCT03428191|Narcotics|narcotics|mesh-ancestor
111074765|NCT03422575|Etoricoxib|etoricoxib|mesh-list
111074766|NCT03422575|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111074767|NCT03422575|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111074768|NCT03422575|Analgesics|analgesics|mesh-ancestor
111074769|NCT03422575|Sensory System Agents|sensory system agents|mesh-ancestor
111074770|NCT03422575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111074771|NCT03422575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111074772|NCT03422575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111074773|NCT03422575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111074774|NCT03422575|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111074775|NCT03422575|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111074776|NCT03422575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111074777|NCT03422575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111074778|NCT02412722|Paclitaxel|paclitaxel|mesh-list
111074779|NCT02412722|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111074780|NCT02412722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111074781|NCT02412722|Tubulin Modulators|tubulin modulators|mesh-ancestor
111074782|NCT02412722|Antimitotic Agents|antimitotic agents|mesh-ancestor
111074783|NCT02412722|Mitosis Modulators|mitosis modulators|mesh-ancestor
111074784|NCT02412722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111074785|NCT03422419|Heparin|heparin|mesh-list
111074786|NCT03422419|Anticoagulants|anticoagulants|mesh-ancestor
111074787|NCT03422419|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111074788|NCT03422419|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111074789|NCT03422419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111074790|NCT04449289|Lidocaine|lidocaine|mesh-list
111074791|NCT04449289|Ropivacaine|ropivacaine|mesh-list
111074792|NCT04449289|Anesthetics, Local|anesthetics, local|mesh-ancestor
111074793|NCT04449289|Anesthetics|anesthetics|mesh-ancestor
111074794|NCT04449289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111074795|NCT04449289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111074796|NCT04449289|Sensory System Agents|sensory system agents|mesh-ancestor
111074797|NCT04449289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111074798|NCT04449289|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111074799|NCT04449289|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111074800|NCT04449289|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111074801|NCT04449289|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111074802|NCT04449289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111074803|NCT03128203|Oxytocin|oxytocin|mesh-list
111074805|NCT03128203|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111074806|NCT03128203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111074807|NCT03469999|Botulinum Toxins|botulinum toxins|mesh-list
111074808|NCT03469999|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111074809|NCT03469999|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111074810|NCT03469999|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111074811|NCT03469999|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111074812|NCT03469999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111074813|NCT03469999|Cholinergic Agents|cholinergic agents|mesh-ancestor
111074814|NCT03469999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111074815|NCT03469999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111074816|NCT03469999|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111074817|NCT03469999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111074818|NCT02935309|Capecitabine|capecitabine|mesh-list
111074819|NCT02935309|Lenvatinib|lenvatinib|mesh-list
111074820|NCT02935309|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111074821|NCT02935309|Antimetabolites|antimetabolites|mesh-ancestor
111074822|NCT02935309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111074823|NCT02935309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111074824|NCT02935309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111074825|NCT02935309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111074826|NCT03463993|Tranexamic Acid|tranexamic acid|mesh-list
111074827|NCT03463993|Oxytocin|oxytocin|mesh-list
111074828|NCT03463993|Oxytocics|oxytocics|mesh-ancestor
111074829|NCT03463993|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111074830|NCT03463993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111074831|NCT03463993|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111074832|NCT03463993|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111074833|NCT03463993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111074834|NCT03463993|Hemostatics|hemostatics|mesh-ancestor
111074835|NCT03463993|Coagulants|coagulants|mesh-ancestor
111074836|NCT03422029|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
111074837|NCT03422029|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111074838|NCT03422029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111074839|NCT03417037|Nivolumab|nivolumab|mesh-list
111074840|NCT03417037|Linrodostat|linrodostat|mesh-list
111074841|NCT03417037|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111074842|NCT03417037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111074843|NCT03417037|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111074844|NCT03417037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111074845|NCT03417037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111074846|NCT02378480|Linezolid|linezolid|mesh-list
111074847|NCT02378480|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111074848|NCT02378480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111074849|NCT02378480|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111074850|NCT02378480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111074851|NCT02378480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111074852|NCT03421717|Chitosan|chitosan|mesh-list
111074853|NCT03421717|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111074854|NCT03421717|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111074855|NCT03421717|Antimetabolites|antimetabolites|mesh-ancestor
111074856|NCT03421717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111074857|NCT03421717|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111074858|NCT03421717|Chelating Agents|chelating agents|mesh-ancestor
111074859|NCT03421717|Sequestering Agents|sequestering agents|mesh-ancestor
111074860|NCT03421717|Hemostatics|hemostatics|mesh-ancestor
111074861|NCT03421717|Coagulants|coagulants|mesh-ancestor
111074862|NCT03427801|Hematinics|hematinics|mesh-list
111074863|NCT03416569|Prazosin|prazosin|mesh-list
111074864|NCT03416569|Nicotine|nicotine|mesh-list
111074865|NCT03416569|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111074866|NCT03416569|Autonomic Agents|autonomic agents|mesh-ancestor
111074867|NCT03416569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111074868|NCT03416569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111074869|NCT03416569|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111074870|NCT03416569|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111074871|NCT03416569|Cholinergic Agents|cholinergic agents|mesh-ancestor
111074872|NCT03416569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111119160|NCT05306873|Antitubercular Agents|antitubercular agents|mesh-ancestor
111074873|NCT03416569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111074874|NCT03416569|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111074875|NCT03416569|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111074876|NCT03416569|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111074877|NCT03416569|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111074878|NCT03416569|Adrenergic Agents|adrenergic agents|mesh-ancestor
111074880|NCT01004029|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
111074881|NCT01004029|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111074882|NCT01004029|Hormone Antagonists|hormone antagonists|mesh-ancestor
111074883|NCT01004029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111074884|NCT01004029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111074885|NCT01004029|Progestins|progestins|mesh-ancestor
111074886|NCT01004029|Hormones|hormones|mesh-ancestor
111074887|NCT03416491|Sofosbuvir|sofosbuvir|mesh-list
111074888|NCT03416491|Antiviral Agents|antiviral agents|mesh-ancestor
111074889|NCT03416491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111074890|NCT03420937|Atropine|atropine|mesh-list
111074891|NCT03420937|Neostigmine|neostigmine|mesh-list
111074892|NCT03420937|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111074893|NCT03420937|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111074894|NCT03420937|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111074895|NCT03420937|Autonomic Agents|autonomic agents|mesh-ancestor
111074896|NCT03420937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111074897|NCT03420937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111074898|NCT03420937|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111074899|NCT03420937|Respiratory System Agents|respiratory system agents|mesh-ancestor
111074900|NCT03420937|Mydriatics|mydriatics|mesh-ancestor
111074901|NCT03420937|Parasympatholytics|parasympatholytics|mesh-ancestor
111074902|NCT03420937|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111074903|NCT03420937|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111074904|NCT03420937|Cholinergic Agents|cholinergic agents|mesh-ancestor
111074905|NCT03420937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111074906|NCT03420937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111074907|NCT03420937|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111074908|NCT03420937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111074909|NCT03420937|Parasympathomimetics|parasympathomimetics|mesh-ancestor
111074910|NCT02900443|Mycophenolic Acid|mycophenolic acid|mesh-list
111074911|NCT02900443|Azathioprine|azathioprine|mesh-list
111074912|NCT02900443|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111074913|NCT02900443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111074914|NCT02900443|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111074915|NCT02900443|Antitubercular Agents|antitubercular agents|mesh-ancestor
111074916|NCT02900443|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111074917|NCT02900443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111074918|NCT02900443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111074919|NCT02900443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111074920|NCT02900443|Antimetabolites|antimetabolites|mesh-ancestor
111074921|NCT02900443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111074922|NCT02900443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111074923|NCT02900443|Immunologic Factors|immunologic factors|mesh-ancestor
111074924|NCT02900443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111074925|NCT02900443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111074926|NCT04594213|Botulinum Toxins|botulinum toxins|mesh-list
111074927|NCT04594213|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111074928|NCT04594213|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111074929|NCT04594213|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
111074930|NCT04594213|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111074931|NCT04594213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111074932|NCT04594213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111074933|NCT04594213|Cholinergic Agents|cholinergic agents|mesh-ancestor
111074934|NCT04594213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111074935|NCT04594213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111074936|NCT04594213|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111074937|NCT04594213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111074938|NCT03420703|Morphine|morphine|mesh-list
111074939|NCT03420703|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111074940|NCT03420703|Narcotics|narcotics|mesh-ancestor
111074941|NCT03420703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111074942|NCT03420703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111074943|NCT03420703|Analgesics|analgesics|mesh-ancestor
111074944|NCT03420703|Sensory System Agents|sensory system agents|mesh-ancestor
111074945|NCT03420703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111074946|NCT03420469|Bupropion|bupropion|mesh-list
111074947|NCT03420469|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111074948|NCT03420469|Antidepressive Agents|antidepressive agents|mesh-ancestor
111074949|NCT03420469|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111074950|NCT03420469|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111074951|NCT03420469|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111074952|NCT03420469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111074953|NCT03420469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111074954|NCT03420469|Dopamine Agents|dopamine agents|mesh-ancestor
111074955|NCT03420469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111074956|NCT03420469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110285881|NCT00234390|Budesonide|budesonide|mesh-list
111074957|NCT03420469|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111074958|NCT03420469|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111074959|NCT03420469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111074960|NCT03427021|Oxaliplatin|oxaliplatin|mesh-list
111074961|NCT03427021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111074962|NCT03415711|Mesalamine|mesalamine|mesh-list
111074963|NCT03415711|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111074964|NCT03415711|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111074965|NCT03415711|Analgesics|analgesics|mesh-ancestor
111074966|NCT03415711|Sensory System Agents|sensory system agents|mesh-ancestor
111074967|NCT03415711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111074968|NCT03415711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111074969|NCT03415711|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111074970|NCT03415711|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111074971|NCT03420313|Buprenorphine|buprenorphine|mesh-list
111074972|NCT03420313|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
111074973|NCT03420313|Naloxone|naloxone|mesh-list
111074974|NCT03420313|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111074975|NCT03420313|Narcotics|narcotics|mesh-ancestor
111074976|NCT03420313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111074977|NCT03420313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111074978|NCT03420313|Analgesics|analgesics|mesh-ancestor
111074979|NCT03420313|Sensory System Agents|sensory system agents|mesh-ancestor
111074980|NCT03420313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111074981|NCT03420313|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111074982|NCT03415555|Acetaminophen|acetaminophen|mesh-list
111074983|NCT03415555|Oxycodone|oxycodone|mesh-list
111074984|NCT03415555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111074985|NCT03415555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111074986|NCT03415555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111074987|NCT03415555|Analgesics|analgesics|mesh-ancestor
111074988|NCT03415555|Sensory System Agents|sensory system agents|mesh-ancestor
111074989|NCT03415555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111074990|NCT03415555|Antipyretics|antipyretics|mesh-ancestor
111074991|NCT03415555|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111074992|NCT03415555|Narcotics|narcotics|mesh-ancestor
111074993|NCT03415477|Denosumab|denosumab|mesh-list
111074994|NCT03415477|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111074995|NCT03415477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111074996|NCT02345252|Emtricitabine, Rilpivirine, Tenofovir Drug Combination|emtricitabine, rilpivirine, tenofovir drug combination|mesh-list
111074997|NCT02345252|Antiviral Agents|antiviral agents|mesh-ancestor
111074998|NCT02345252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111074999|NCT02345252|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111075000|NCT02345252|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111075001|NCT02345252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111075002|NCT02345252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111075003|NCT02345252|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111075004|NCT02345252|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111075005|NCT03419923|Citric Acid|citric acid|mesh-list
111075006|NCT03419923|Sodium Citrate|sodium citrate|mesh-list
111075007|NCT03419923|Anticoagulants|anticoagulants|mesh-ancestor
111075008|NCT03419923|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
111075009|NCT03419923|Chelating Agents|chelating agents|mesh-ancestor
111075010|NCT03419923|Sequestering Agents|sequestering agents|mesh-ancestor
111075011|NCT03419923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111075012|NCT03426553|Riboflavin|riboflavin|mesh-list
111075013|NCT03426553|Vitamin B Complex|vitamin b complex|mesh-ancestor
111075014|NCT03426553|Vitamins|vitamins|mesh-ancestor
111075015|NCT03426553|Micronutrients|micronutrients|mesh-ancestor
111075016|NCT03426553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111075017|NCT03426553|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111075018|NCT03426553|Dermatologic Agents|dermatologic agents|mesh-ancestor
111075019|NCT03415087|Fentanyl|fentanyl|mesh-list
111075020|NCT03415087|Bupivacaine|bupivacaine|mesh-list
111075021|NCT03415087|Anesthetics, Local|anesthetics, local|mesh-ancestor
111075023|NCT03415087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111075024|NCT03415087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111075025|NCT03415087|Sensory System Agents|sensory system agents|mesh-ancestor
111075026|NCT03415087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111075027|NCT03415087|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111075028|NCT03415087|Narcotics|narcotics|mesh-ancestor
111075029|NCT03415087|Analgesics|analgesics|mesh-ancestor
111075030|NCT03415087|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111075031|NCT03415087|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111075032|NCT03415087|Anesthetics, General|anesthetics, general|mesh-ancestor
111075033|NCT02833753|Oxaliplatin|oxaliplatin|mesh-list
111075034|NCT02833753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111075035|NCT03419767|Melatonin|melatonin|mesh-list
111075036|NCT03419767|Antioxidants|antioxidants|mesh-ancestor
111075037|NCT03419767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111075038|NCT03419767|Protective Agents|protective agents|mesh-ancestor
111075039|NCT03419767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111075040|NCT03419767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111075041|NCT03414931|Sertraline|sertraline|mesh-list
111075042|NCT03414931|Antidepressive Agents|antidepressive agents|mesh-ancestor
111075043|NCT03414931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111075044|NCT03414931|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111075045|NCT03414931|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111075046|NCT03414931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111075047|NCT03414931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111075048|NCT03414931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111075049|NCT03414931|Serotonin Agents|serotonin agents|mesh-ancestor
111075050|NCT03414931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111075051|NCT04448821|Metformin|metformin|mesh-list
111075052|NCT04448821|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111075053|NCT04448821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111075054|NCT02835157|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111075055|NCT04448977|Ocrelizumab|ocrelizumab|mesh-list
111075056|NCT04448977|Immunologic Factors|immunologic factors|mesh-ancestor
111075057|NCT04448977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111075058|NCT03418831|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
111075059|NCT03418831|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111075060|NCT03418831|Hormone Antagonists|hormone antagonists|mesh-ancestor
111075061|NCT03418831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111075062|NCT03418831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111075063|NCT03418831|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111075064|NCT03418831|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111075065|NCT03418831|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111075066|NCT04448587|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111075067|NCT04448587|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111075068|NCT04448587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111075069|NCT04448587|Incretins|incretins|mesh-ancestor
111075070|NCT04448587|Hormones|hormones|mesh-ancestor
111075071|NCT04448587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111075072|NCT04448587|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111075073|NCT04448587|Protease Inhibitors|protease inhibitors|mesh-ancestor
111075074|NCT04448587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111075075|NCT04448587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111075076|NCT03426085|Liraglutide|liraglutide|mesh-list
111075077|NCT03426085|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111075078|NCT03426085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111075079|NCT03426085|Incretins|incretins|mesh-ancestor
111075080|NCT03426085|Hormones|hormones|mesh-ancestor
111075081|NCT03426085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111075082|NCT03418597|Anesthetics|anesthetics|mesh-list
111075083|NCT03418597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111075084|NCT03418597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111075085|NCT03425929|Oxytocin|oxytocin|mesh-list
111075086|NCT03425929|Oxytocics|oxytocics|mesh-ancestor
111075087|NCT03425929|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111075088|NCT03425929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111075089|NCT03127189|Rilpivirine|rilpivirine|mesh-list
111075090|NCT03127189|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110677059|NCT02947685|Palbociclib|palbociclib|mesh-list
111075091|NCT03127189|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111075092|NCT03127189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111075093|NCT03127189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111075094|NCT03127189|Antiviral Agents|antiviral agents|mesh-ancestor
111075095|NCT03127189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111075096|NCT03127189|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111075097|NCT03127189|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111075098|NCT02521051|Bevacizumab|bevacizumab|mesh-list
111075099|NCT02521051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111075100|NCT02521051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111075101|NCT02521051|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111075102|NCT02521051|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111075103|NCT02521051|Growth Substances|growth substances|mesh-ancestor
111075104|NCT02521051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111075105|NCT02521051|Growth Inhibitors|growth inhibitors|mesh-ancestor
111075106|NCT01239797|Dexamethasone|dexamethasone|mesh-list
111075107|NCT01239797|Dexamethasone acetate|dexamethasone acetate|mesh-list
111075108|NCT01239797|Lenalidomide|lenalidomide|mesh-list
111075110|NCT01239797|BB 1101|bb 1101|mesh-list
111075111|NCT01239797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111075112|NCT01239797|Antiemetics|antiemetics|mesh-ancestor
111075113|NCT01239797|Autonomic Agents|autonomic agents|mesh-ancestor
111075114|NCT01239797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111075115|NCT01239797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111075116|NCT01239797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111075117|NCT01239797|Glucocorticoids|glucocorticoids|mesh-ancestor
111075118|NCT01239797|Hormones|hormones|mesh-ancestor
111075119|NCT01239797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111075120|NCT01239797|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111075121|NCT01239797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111075122|NCT01239797|Protease Inhibitors|protease inhibitors|mesh-ancestor
111075123|NCT01239797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111075124|NCT01239797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111075125|NCT01239797|Immunologic Factors|immunologic factors|mesh-ancestor
111075126|NCT01239797|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111075127|NCT01239797|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111075128|NCT01239797|Growth Substances|growth substances|mesh-ancestor
111075129|NCT01239797|Growth Inhibitors|growth inhibitors|mesh-ancestor
111075130|NCT01092143|Fluticasone|fluticasone|mesh-list
111075131|NCT01092143|Xhance|xhance|mesh-list
111075132|NCT01092143|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111075133|NCT01092143|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111075134|NCT01092143|Autonomic Agents|autonomic agents|mesh-ancestor
111075135|NCT01092143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111075136|NCT01092143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111075137|NCT01092143|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111075138|NCT01092143|Respiratory System Agents|respiratory system agents|mesh-ancestor
111075139|NCT01092143|Dermatologic Agents|dermatologic agents|mesh-ancestor
111075140|NCT01092143|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111075141|NCT00950989|Folic Acid|folic acid|mesh-list
111075142|NCT00950989|Methotrexate|methotrexate|mesh-list
111075143|NCT00950989|Brodalumab|brodalumab|mesh-list
111075144|NCT00950989|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111075145|NCT00950989|Abortifacient Agents|abortifacient agents|mesh-ancestor
111075146|NCT00950989|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111075147|NCT00950989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111075148|NCT00950989|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111075149|NCT00950989|Antimetabolites|antimetabolites|mesh-ancestor
111075150|NCT00950989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111075151|NCT00950989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111075152|NCT00950989|Dermatologic Agents|dermatologic agents|mesh-ancestor
111075153|NCT00950989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111075154|NCT00950989|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111075155|NCT00950989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111075156|NCT00950989|Immunologic Factors|immunologic factors|mesh-ancestor
111075157|NCT00950989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111075158|NCT00950989|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111075159|NCT00950989|Hematinics|hematinics|mesh-ancestor
111075160|NCT00950989|Vitamin B Complex|vitamin b complex|mesh-ancestor
111075161|NCT00950989|Vitamins|vitamins|mesh-ancestor
111075162|NCT00950989|Micronutrients|micronutrients|mesh-ancestor
111075163|NCT03420911|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
111075164|NCT03420911|Midazolam|midazolam|mesh-list
111075165|NCT03420911|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111075166|NCT03420911|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111075167|NCT03420911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110028766|NCT04270344|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111075168|NCT03420911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111075169|NCT03420911|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111075170|NCT03420911|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111075171|NCT03420911|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111075172|NCT03420911|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111075173|NCT03420911|Anesthetics, General|anesthetics, general|mesh-ancestor
111075174|NCT03420911|Anesthetics|anesthetics|mesh-ancestor
111075175|NCT03420911|GABA Modulators|gaba modulators|mesh-ancestor
111075176|NCT03420911|GABA Agents|gaba agents|mesh-ancestor
111075177|NCT03420911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111075178|NCT03420911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111075179|NCT03420911|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111075180|NCT03420911|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111075182|NCT03420911|Sensory System Agents|sensory system agents|mesh-ancestor
111075183|NCT03420911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111075184|NCT03420911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111075185|NCT03420911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111075186|NCT03416231|Docetaxel|docetaxel|mesh-list
111075187|NCT03416231|Apatinib|apatinib|mesh-list
111075188|NCT03416231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111075189|NCT03416231|Tubulin Modulators|tubulin modulators|mesh-ancestor
111075190|NCT03416231|Antimitotic Agents|antimitotic agents|mesh-ancestor
111075191|NCT03416231|Mitosis Modulators|mitosis modulators|mesh-ancestor
111075192|NCT03416231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111075193|NCT03416231|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111075194|NCT03416231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111075195|NCT03415763|Leucovorin|leucovorin|mesh-list
111075196|NCT03415763|Capecitabine|capecitabine|mesh-list
111075197|NCT03415763|Oxaliplatin|oxaliplatin|mesh-list
111075198|NCT03415763|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111075199|NCT03415763|Antimetabolites|antimetabolites|mesh-ancestor
111075200|NCT03415763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111075201|NCT03415763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111075202|NCT03415763|Antidotes|antidotes|mesh-ancestor
111075203|NCT03415763|Protective Agents|protective agents|mesh-ancestor
111075204|NCT03415763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111075205|NCT03415763|Vitamin B Complex|vitamin b complex|mesh-ancestor
111075206|NCT03415763|Vitamins|vitamins|mesh-ancestor
111075207|NCT03415763|Micronutrients|micronutrients|mesh-ancestor
111075208|NCT00593567|Levofloxacin|levofloxacin|mesh-list
111075209|NCT00593567|Gentamicins|gentamicins|mesh-list
111075210|NCT00593567|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111075211|NCT00593567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111075212|NCT00593567|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111075213|NCT00593567|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111075214|NCT00593567|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111075215|NCT00593567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111075216|NCT00593567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111075217|NCT00593567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111075218|NCT00593567|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111075219|NCT00593567|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111075220|NCT00593567|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111075221|NCT03419975|Latanoprost|latanoprost|mesh-list
111075222|NCT03419975|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
111075223|NCT03419975|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111075224|NCT00006455|Leucovorin|leucovorin|mesh-list
111075225|NCT00006455|Cytarabine|cytarabine|mesh-list
111075226|NCT00006455|Dexamethasone|dexamethasone|mesh-list
111075227|NCT00006455|Hydrocortisone|hydrocortisone|mesh-list
111075228|NCT00006455|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
111075229|NCT00006455|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
111075230|NCT00006455|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
111075231|NCT00006455|Cyclophosphamide|cyclophosphamide|mesh-list
111075232|NCT00006455|Ifosfamide|ifosfamide|mesh-list
111075233|NCT00006455|Doxorubicin|doxorubicin|mesh-list
111075234|NCT00006455|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111075235|NCT00006455|Methotrexate|methotrexate|mesh-list
111075236|NCT00006455|Etoposide|etoposide|mesh-list
111075237|NCT00006455|Vinblastine|vinblastine|mesh-list
111075238|NCT00006455|Levoleucovorin|levoleucovorin|mesh-list
111075239|NCT00006455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111075240|NCT00006455|Immunologic Factors|immunologic factors|mesh-ancestor
111075241|NCT00006455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111075242|NCT00006455|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111075243|NCT00006455|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111075244|NCT00006455|Alkylating Agents|alkylating agents|mesh-ancestor
111075245|NCT00006455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111075246|NCT00006455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111075247|NCT00006455|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111075248|NCT00006455|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111075249|NCT00006455|Antiemetics|antiemetics|mesh-ancestor
111075250|NCT00006455|Autonomic Agents|autonomic agents|mesh-ancestor
111075251|NCT00006455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111075252|NCT00006455|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111075253|NCT00006455|Glucocorticoids|glucocorticoids|mesh-ancestor
111075254|NCT00006455|Hormones|hormones|mesh-ancestor
111075255|NCT00006455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111075256|NCT00006455|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110792374|NCT01166451|Iron|iron|mesh-list
111075257|NCT00006455|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111075258|NCT00006455|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111075259|NCT00006455|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111075260|NCT00006455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111075261|NCT00006455|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111075262|NCT00006455|Abortifacient Agents|abortifacient agents|mesh-ancestor
111075263|NCT00006455|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111075264|NCT00006455|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111075265|NCT00006455|Antimetabolites|antimetabolites|mesh-ancestor
111075266|NCT00006455|Dermatologic Agents|dermatologic agents|mesh-ancestor
111075267|NCT00006455|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110638663|NCT01011010|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111075268|NCT00006455|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111075269|NCT00006455|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111075270|NCT00006455|Antiviral Agents|antiviral agents|mesh-ancestor
111075271|NCT00006455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111075272|NCT00006455|Antidotes|antidotes|mesh-ancestor
111075273|NCT00006455|Protective Agents|protective agents|mesh-ancestor
111075274|NCT00006455|Vitamin B Complex|vitamin b complex|mesh-ancestor
111075275|NCT00006455|Vitamins|vitamins|mesh-ancestor
111075276|NCT00006455|Micronutrients|micronutrients|mesh-ancestor
111075277|NCT00006455|Tubulin Modulators|tubulin modulators|mesh-ancestor
111075278|NCT00006455|Antimitotic Agents|antimitotic agents|mesh-ancestor
111075279|NCT00006455|Mitosis Modulators|mitosis modulators|mesh-ancestor
111075280|NCT01602315|Cetuximab|cetuximab|mesh-list
111075281|NCT01602315|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111075282|NCT01602315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111075283|NCT02537197|Naltrexone|naltrexone|mesh-list
111075284|NCT02537197|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111075285|NCT02537197|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111075286|NCT02537197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111075287|NCT02537197|Sensory System Agents|sensory system agents|mesh-ancestor
111075288|NCT02537197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111075289|NCT03127345|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
111075290|NCT03127345|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
111075291|NCT03127345|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
111075292|NCT03127345|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111075293|NCT03413371|Acetaminophen|acetaminophen|mesh-list
111075294|NCT03413371|Lidocaine|lidocaine|mesh-list
111075295|NCT03413371|Bupivacaine|bupivacaine|mesh-list
111075296|NCT03413371|Ropivacaine|ropivacaine|mesh-list
111075297|NCT03413371|Anesthetics, Local|anesthetics, local|mesh-ancestor
111075298|NCT03413371|Anesthetics|anesthetics|mesh-ancestor
111075299|NCT03413371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111075300|NCT03413371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111075301|NCT03413371|Sensory System Agents|sensory system agents|mesh-ancestor
111075302|NCT03413371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111075303|NCT03413371|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111075304|NCT03413371|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111075305|NCT03413371|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111075306|NCT03413371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111075307|NCT03413371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111075308|NCT03413371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111075309|NCT03413371|Analgesics|analgesics|mesh-ancestor
111075310|NCT03413371|Antipyretics|antipyretics|mesh-ancestor
111075311|NCT02344004|Amikacin|amikacin|mesh-list
111075312|NCT02344004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111075313|NCT02344004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111075314|NCT03677115|Dexmedetomidine|dexmedetomidine|mesh-list
111075315|NCT03677115|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111075316|NCT03677115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111075317|NCT03677115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111075318|NCT03677115|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111075319|NCT03677115|Analgesics|analgesics|mesh-ancestor
110540406|NCT00960739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111075320|NCT03677115|Sensory System Agents|sensory system agents|mesh-ancestor
111075321|NCT03677115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111075322|NCT03677115|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111075323|NCT03677115|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111075324|NCT03677115|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111075325|NCT03677115|Adrenergic Agents|adrenergic agents|mesh-ancestor
111075326|NCT03677115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111075327|NCT03677115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111075328|NCT05116371|Levonorgestrel|levonorgestrel|mesh-list
111075329|NCT05116371|Ethinyl Estradiol|ethinyl estradiol|mesh-list
111075330|NCT05116371|Contraceptive Agents|contraceptive agents|mesh-list
111075331|NCT05116371|Contraceptives, Oral|contraceptives, oral|mesh-list
111075332|NCT05116371|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
111075333|NCT05116371|Estradiol|estradiol|mesh-list
111075334|NCT05116371|Estrogens|estrogens|mesh-ancestor
111075335|NCT05116371|Hormones|hormones|mesh-ancestor
111075336|NCT05116371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111075337|NCT05116371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111075338|NCT05116371|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111075339|NCT05116371|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111075340|NCT05116371|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111075341|NCT05116371|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111075342|NCT05116371|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111075343|NCT01328093|Aripiprazole|aripiprazole|mesh-list
111075344|NCT01328093|Antidepressive Agents|antidepressive agents|mesh-ancestor
111075345|NCT01328093|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111075346|NCT01328093|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111075347|NCT01328093|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111075348|NCT01328093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111075349|NCT01328093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111075350|NCT01328093|Dopamine Agonists|dopamine agonists|mesh-ancestor
111075351|NCT01328093|Dopamine Agents|dopamine agents|mesh-ancestor
111075352|NCT01328093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111075353|NCT01328093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111075354|NCT01328093|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111075355|NCT01328093|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111075356|NCT01328093|Serotonin Agents|serotonin agents|mesh-ancestor
111075357|NCT01328093|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111075358|NCT01328093|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111075359|NCT01328093|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111075360|NCT01328093|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111075361|NCT03417427|Cytarabine|cytarabine|mesh-list
111075362|NCT03417427|Decitabine|decitabine|mesh-list
111075363|NCT03417427|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111075364|NCT03417427|Antimetabolites|antimetabolites|mesh-ancestor
111075365|NCT03417427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111075366|NCT03417427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111075367|NCT03417427|Antiviral Agents|antiviral agents|mesh-ancestor
111075368|NCT03417427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111075369|NCT03417427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111075370|NCT03417427|Immunologic Factors|immunologic factors|mesh-ancestor
111075371|NCT03417427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111075372|NCT03417427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111075373|NCT03425617|Tiotropium Bromide|tiotropium bromide|mesh-list
111075374|NCT03425617|Olodaterol|olodaterol|mesh-list
111075375|NCT03425617|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111075376|NCT03425617|Autonomic Agents|autonomic agents|mesh-ancestor
111075377|NCT03425617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111075378|NCT03425617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111075379|NCT03425617|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111075380|NCT03425617|Respiratory System Agents|respiratory system agents|mesh-ancestor
111075381|NCT03425617|Parasympatholytics|parasympatholytics|mesh-ancestor
111075382|NCT03425617|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111075383|NCT03425617|Cholinergic Agents|cholinergic agents|mesh-ancestor
111075384|NCT03425617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111075385|NCT03425617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111075386|NCT03419429|Simvastatin|simvastatin|mesh-list
111075387|NCT03419429|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111075388|NCT03419429|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111075389|NCT03419429|Antimetabolites|antimetabolites|mesh-ancestor
111075390|NCT03419429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111075391|NCT03419429|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111075392|NCT03419429|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111075393|NCT03419429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111075395|NCT02654145|Albuterol|albuterol|mesh-list
111075396|NCT02654145|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111075397|NCT02654145|Autonomic Agents|autonomic agents|mesh-ancestor
111075398|NCT02654145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111075399|NCT02654145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111075400|NCT02654145|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111075401|NCT02654145|Respiratory System Agents|respiratory system agents|mesh-ancestor
111075402|NCT02654145|Tocolytic Agents|tocolytic agents|mesh-ancestor
111075403|NCT02654145|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111075404|NCT02654145|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111075405|NCT02654145|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111075406|NCT02654145|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111075407|NCT02654145|Adrenergic Agents|adrenergic agents|mesh-ancestor
111075408|NCT02654145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111075409|NCT02654145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111075410|NCT02654145|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111075411|NCT05122455|Edoxaban|edoxaban|mesh-list
111075412|NCT05122455|Clopidogrel|clopidogrel|mesh-list
111075413|NCT05122455|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111075414|NCT05122455|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111075415|NCT05122455|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111075416|NCT05122455|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111075417|NCT05122455|Purinergic Agents|purinergic agents|mesh-ancestor
111075418|NCT05122455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111075419|NCT05122455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111075420|NCT05122455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111075421|NCT05122455|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111075422|NCT05122455|Antithrombins|antithrombins|mesh-ancestor
111075423|NCT05122455|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111075424|NCT05122455|Protease Inhibitors|protease inhibitors|mesh-ancestor
111075425|NCT05122455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111075426|NCT05122455|Anticoagulants|anticoagulants|mesh-ancestor
111075427|NCT03413059|Triamcinolone|triamcinolone|mesh-list
111075428|NCT03413059|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
111075429|NCT03413059|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
111075430|NCT03413059|Morphine|morphine|mesh-list
111075431|NCT03413059|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
111075432|NCT03413059|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111075433|NCT03413059|Narcotics|narcotics|mesh-ancestor
111075434|NCT03413059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111075435|NCT03413059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111075436|NCT03413059|Analgesics|analgesics|mesh-ancestor
111075437|NCT03413059|Sensory System Agents|sensory system agents|mesh-ancestor
111075438|NCT03413059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111075439|NCT03413059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111075440|NCT03413059|Glucocorticoids|glucocorticoids|mesh-ancestor
111075441|NCT03413059|Hormones|hormones|mesh-ancestor
111075442|NCT03413059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111075443|NCT03413059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111075444|NCT03413059|Immunologic Factors|immunologic factors|mesh-ancestor
111075445|NCT03413059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111075446|NCT03413059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111075447|NCT05122377|Goserelin|goserelin|mesh-list
111075448|NCT05122377|Leuprolide|leuprolide|mesh-list
111075449|NCT05122377|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111075450|NCT05122377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111075451|NCT05122377|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111075452|NCT05122377|Fertility Agents|fertility agents|mesh-ancestor
111075453|NCT05122377|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111075454|NCT05122377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111075455|NCT03425461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111075456|NCT03425461|Nivolumab|nivolumab|mesh-list
111075457|NCT03425461|Ipilimumab|ipilimumab|mesh-list
111075458|NCT03425461|Antibodies|antibodies|mesh-list
111075459|NCT03425461|Immunoglobulins|immunoglobulins|mesh-list
111075460|NCT03425461|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111075461|NCT03425461|Immunologic Factors|immunologic factors|mesh-ancestor
111075462|NCT03425461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111075463|NCT03425461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111075464|NCT03425461|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111075465|NCT03425461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111075467|NCT03411109|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111075468|NCT03411109|Narcotics|narcotics|mesh-ancestor
111075469|NCT03411109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111075470|NCT03411109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111075471|NCT03411109|Analgesics|analgesics|mesh-ancestor
111075472|NCT03411109|Sensory System Agents|sensory system agents|mesh-ancestor
111075473|NCT03411109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111075474|NCT01111565|Aripiprazole|aripiprazole|mesh-list
111075475|NCT01111565|Escitalopram|escitalopram|mesh-list
111075476|NCT01111565|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111075477|NCT01111565|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111075478|NCT01111565|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111075479|NCT01111565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111075480|NCT01111565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111075481|NCT01111565|Serotonin Agents|serotonin agents|mesh-ancestor
111075482|NCT01111565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111075483|NCT01111565|Antidepressive Agents|antidepressive agents|mesh-ancestor
111075484|NCT01111565|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111075485|NCT01111565|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111075486|NCT01111565|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111075487|NCT01111565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111075488|NCT01111565|Dopamine Agonists|dopamine agonists|mesh-ancestor
111075489|NCT01111565|Dopamine Agents|dopamine agents|mesh-ancestor
111075490|NCT01111565|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111075491|NCT01111565|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111075492|NCT01111565|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111075493|NCT01111565|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111075494|NCT01111565|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111075495|NCT01111565|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111075496|NCT04564365|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
111075497|NCT04564365|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111075498|NCT04564365|Adrenergic Agents|adrenergic agents|mesh-ancestor
111075499|NCT04564365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110638759|NCT00851864|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111075500|NCT04564365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111075501|NCT04564365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111075502|NCT03412513|Mirabegron|mirabegron|mesh-list
111075503|NCT03412513|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
111075504|NCT03412513|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111075505|NCT03412513|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111075506|NCT03412513|Adrenergic Agents|adrenergic agents|mesh-ancestor
111075507|NCT03412513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111075508|NCT03412513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111075509|NCT03412513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111075510|NCT03412513|Urological Agents|urological agents|mesh-ancestor
111075511|NCT04370379|Aflibercept|aflibercept|mesh-list
111075512|NCT04370379|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111075513|NCT04370379|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111075514|NCT04370379|Growth Substances|growth substances|mesh-ancestor
111075515|NCT04370379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111075516|NCT04370379|Growth Inhibitors|growth inhibitors|mesh-ancestor
111075517|NCT04370379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111075518|NCT03413891|Tranexamic Acid|tranexamic acid|mesh-list
111075519|NCT03413891|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111075520|NCT03413891|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111075521|NCT03413891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111075522|NCT03413891|Hemostatics|hemostatics|mesh-ancestor
111075523|NCT03413891|Coagulants|coagulants|mesh-ancestor
111075524|NCT03317613|Capsaicin|capsaicin|mesh-list
111075525|NCT03317613|Antipruritics|antipruritics|mesh-ancestor
111075526|NCT03317613|Dermatologic Agents|dermatologic agents|mesh-ancestor
111075527|NCT03317613|Sensory System Agents|sensory system agents|mesh-ancestor
111075528|NCT03317613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111075529|NCT03317613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111075530|NCT03126877|Mitomycins|mitomycins|mesh-list
111075531|NCT03126877|Mitomycin|mitomycin|mesh-list
111075532|NCT03126877|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111075533|NCT03126877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111075534|NCT03126877|Alkylating Agents|alkylating agents|mesh-ancestor
111075535|NCT03126877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111075536|NCT03126877|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111075537|NCT03126877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111075538|NCT04260477|Rifampin|rifampin|mesh-list
111075539|NCT04260477|Isoniazid|isoniazid|mesh-list
111075541|NCT04260477|Ethambutol|ethambutol|mesh-list
111075542|NCT04260477|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111075543|NCT04260477|Antitubercular Agents|antitubercular agents|mesh-ancestor
111075544|NCT04260477|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111075545|NCT04260477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111075546|NCT04260477|Leprostatic Agents|leprostatic agents|mesh-ancestor
111075547|NCT04260477|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111075548|NCT04260477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111075549|NCT04260477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111075550|NCT04260477|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111075551|NCT04260477|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111075552|NCT04260477|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
111075553|NCT04260477|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
111075554|NCT04260477|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110792675|NCT01173003|Oxytocics|oxytocics|mesh-ancestor
111075555|NCT04260477|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111075556|NCT04260477|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
111075558|NCT04260477|Antimetabolites|antimetabolites|mesh-ancestor
111075559|NCT04260477|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111075560|NCT02343458|Glycopyrrolate|glycopyrrolate|mesh-list
111075561|NCT02343458|Formoterol Fumarate|formoterol fumarate|mesh-list
111075562|NCT02343458|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111075563|NCT02343458|Autonomic Agents|autonomic agents|mesh-ancestor
111075564|NCT02343458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111075565|NCT02343458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111075566|NCT02343458|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111075567|NCT02343458|Respiratory System Agents|respiratory system agents|mesh-ancestor
111075568|NCT02343458|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111075569|NCT02343458|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111075570|NCT02343458|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111075571|NCT02343458|Adrenergic Agents|adrenergic agents|mesh-ancestor
111075572|NCT02343458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111075573|NCT02343458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111075574|NCT02343458|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111075575|NCT02343458|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111075576|NCT02343458|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111075577|NCT02343458|Cholinergic Agents|cholinergic agents|mesh-ancestor
111075578|NCT03424759|Osimertinib|osimertinib|mesh-list
111075579|NCT03424759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111075580|NCT03424759|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111075581|NCT03424759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111075582|NCT03424759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111075583|NCT03413579|Nimotuzumab|nimotuzumab|mesh-list
111075584|NCT03413579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111075585|NCT03413579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111075586|NCT04814745|Morphine|morphine|mesh-list
111075587|NCT04814745|Tramadol|tramadol|mesh-list
111075588|NCT04814745|Ropivacaine|ropivacaine|mesh-list
111075589|NCT04814745|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111075590|NCT04814745|Narcotics|narcotics|mesh-ancestor
111075591|NCT04814745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111075592|NCT04814745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111075593|NCT04814745|Analgesics|analgesics|mesh-ancestor
111075594|NCT04814745|Sensory System Agents|sensory system agents|mesh-ancestor
111075595|NCT04814745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111075596|NCT04814745|Anesthetics, Local|anesthetics, local|mesh-ancestor
111075597|NCT04814745|Anesthetics|anesthetics|mesh-ancestor
111075598|NCT04640571|Metformin|metformin|mesh-list
111075599|NCT04640571|Valacyclovir|valacyclovir|mesh-list
111075600|NCT04640571|Enalaprilat|enalaprilat|mesh-list
111075601|NCT04640571|Enalapril|enalapril|mesh-list
111075602|NCT04640571|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
111075603|NCT04640571|Pravastatin|pravastatin|mesh-list
111075604|NCT04640571|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111075605|NCT04640571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111075606|NCT04640571|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111075607|NCT04640571|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111075608|NCT04640571|Antimetabolites|antimetabolites|mesh-ancestor
111075609|NCT04640571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111075610|NCT04640571|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111075611|NCT04640571|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111075612|NCT04640571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111075613|NCT04640571|Antiviral Agents|antiviral agents|mesh-ancestor
111075614|NCT04640571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111075616|NCT04640571|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111075617|NCT04640571|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
111075618|NCT04640571|Protease Inhibitors|protease inhibitors|mesh-ancestor
111075619|NCT04640571|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111075620|NCT04431141|Empagliflozin|empagliflozin|mesh-list
110638769|NCT02545634|Sulfalene|sulfalene|mesh-list
111075621|NCT04431141|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111075622|NCT04431141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111075623|NCT04431141|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111075624|NCT04431141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111075625|NCT05229627|Methylphenidate|methylphenidate|mesh-list
111075626|NCT05229627|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
111075627|NCT05229627|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111075628|NCT05229627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111075629|NCT05229627|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111075630|NCT05229627|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111075631|NCT05229627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111075632|NCT05229627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111075633|NCT05229627|Dopamine Agents|dopamine agents|mesh-ancestor
111075634|NCT05229627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111075635|NCT05229627|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111075636|NCT05229627|Adrenergic Agents|adrenergic agents|mesh-ancestor
111075637|NCT01976169|Palbociclib|palbociclib|mesh-list
111075638|NCT01976169|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
111075639|NCT01976169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111075640|NCT01976169|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111075641|NCT01976169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111075642|NCT01976169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111075643|NCT01976169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111075644|NCT01976169|Immunotoxins|immunotoxins|mesh-ancestor
111075645|NCT01976169|Immunoconjugates|immunoconjugates|mesh-ancestor
111075646|NCT01976169|Immunologic Factors|immunologic factors|mesh-ancestor
111075647|NCT01976169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111075648|NCT01976169|Tubulin Modulators|tubulin modulators|mesh-ancestor
111075649|NCT01976169|Antimitotic Agents|antimitotic agents|mesh-ancestor
111075650|NCT01976169|Mitosis Modulators|mitosis modulators|mesh-ancestor
111075651|NCT00148629|Mebendazole|mebendazole|mesh-list
111075652|NCT00148629|Piperazine|piperazine|mesh-list
111075653|NCT00148629|Piperazine citrate|piperazine citrate|mesh-list
111075654|NCT00148629|DMP 777|dmp 777|mesh-list
111075655|NCT00148629|Antinematodal Agents|antinematodal agents|mesh-ancestor
111075656|NCT00148629|Anthelmintics|anthelmintics|mesh-ancestor
111075657|NCT00148629|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111075658|NCT00148629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111075659|NCT00148629|Tubulin Modulators|tubulin modulators|mesh-ancestor
111075660|NCT00148629|Antimitotic Agents|antimitotic agents|mesh-ancestor
111075661|NCT00148629|Mitosis Modulators|mitosis modulators|mesh-ancestor
111075662|NCT00148629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111075663|NCT00148629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111075664|NCT00148629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111075665|NCT04448015|Analgesics, Opioid|analgesics, opioid|mesh-list
111075666|NCT04448015|Narcotics|narcotics|mesh-ancestor
111075667|NCT04448015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111075668|NCT04448015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111075669|NCT04448015|Analgesics|analgesics|mesh-ancestor
111075670|NCT04448015|Sensory System Agents|sensory system agents|mesh-ancestor
111075671|NCT04448015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111075672|NCT01328041|Dolutegravir|dolutegravir|mesh-list
111075673|NCT01328041|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111075674|NCT01328041|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111075675|NCT01328041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111075676|NCT01328041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111075677|NCT01328041|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111075678|NCT01328041|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111075679|NCT01328041|Antiviral Agents|antiviral agents|mesh-ancestor
111075680|NCT01328041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111075681|NCT03412721|Analgesics|analgesics|mesh-list
111075682|NCT03412721|Sensory System Agents|sensory system agents|mesh-ancestor
111075683|NCT03412721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111075684|NCT03412721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111075685|NCT03418337|Lansoprazole|lansoprazole|mesh-list
111075686|NCT03418337|Dexlansoprazole|dexlansoprazole|mesh-list
111075687|NCT03418337|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111075688|NCT03418337|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110029372|NCT05019638|Mydriatics|mydriatics|mesh-ancestor
111075689|NCT03418337|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111075690|NCT03418337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111075691|NCT03418337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111075692|NCT03411967|Docetaxel|docetaxel|mesh-list
111075693|NCT03411967|Apatinib|apatinib|mesh-list
111075694|NCT03411967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111075695|NCT03411967|Tubulin Modulators|tubulin modulators|mesh-ancestor
111075696|NCT03411967|Antimitotic Agents|antimitotic agents|mesh-ancestor
111075697|NCT03411967|Mitosis Modulators|mitosis modulators|mesh-ancestor
111075698|NCT03411967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111075699|NCT03411967|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111075700|NCT03411967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111075701|NCT03412409|Cytarabine|cytarabine|mesh-list
111075702|NCT03412409|Cyclophosphamide|cyclophosphamide|mesh-list
111075703|NCT03412409|Busulfan|busulfan|mesh-list
111075704|NCT03412409|Semustine|semustine|mesh-list
111075705|NCT03412409|Fludarabine|fludarabine|mesh-list
111075706|NCT03412409|Antilymphocyte Serum|antilymphocyte serum|mesh-list
111075707|NCT03412409|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111075708|NCT03412409|Immunologic Factors|immunologic factors|mesh-ancestor
111075709|NCT03412409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111075710|NCT03412409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111075711|NCT03412409|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111075712|NCT03412409|Alkylating Agents|alkylating agents|mesh-ancestor
111075713|NCT03412409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111075714|NCT03412409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111075715|NCT03412409|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111075716|NCT03412409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111075717|NCT03412409|Antimetabolites|antimetabolites|mesh-ancestor
111075718|NCT03412409|Antiviral Agents|antiviral agents|mesh-ancestor
111075719|NCT03412409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111075720|NCT02410772|Moxifloxacin|moxifloxacin|mesh-list
111075721|NCT02410772|Rifapentine|rifapentine|mesh-list
111075722|NCT02410772|Rifampin|rifampin|mesh-list
111075723|NCT02410772|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111075724|NCT02410772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111075725|NCT02410772|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111075726|NCT02410772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111075727|NCT02410772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111075728|NCT02410772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111075729|NCT02410772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111075730|NCT02410772|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111075731|NCT02410772|Antitubercular Agents|antitubercular agents|mesh-ancestor
111075732|NCT02410772|Leprostatic Agents|leprostatic agents|mesh-ancestor
111075733|NCT02410772|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111075734|NCT02410772|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111075735|NCT02410772|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111075736|NCT02410772|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
111075737|NCT02410772|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
111075738|NCT02410772|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
111075739|NCT02410772|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111075740|NCT03814317|Treprostinil|treprostinil|mesh-list
111075741|NCT03814317|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111075742|NCT03127319|Docetaxel|docetaxel|mesh-list
111075743|NCT03127319|Apatinib|apatinib|mesh-list
111075744|NCT03127319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111075745|NCT03127319|Tubulin Modulators|tubulin modulators|mesh-ancestor
111075746|NCT03127319|Antimitotic Agents|antimitotic agents|mesh-ancestor
111075747|NCT03127319|Mitosis Modulators|mitosis modulators|mesh-ancestor
111075748|NCT03127319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111075749|NCT03127319|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111075750|NCT03127319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111075751|NCT03417947|Vitamin D|vitamin d|mesh-list
111075752|NCT03417947|Cholecalciferol|cholecalciferol|mesh-list
111075753|NCT03417947|Vitamins|vitamins|mesh-ancestor
111075754|NCT03417947|Micronutrients|micronutrients|mesh-ancestor
111075755|NCT03417947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111075756|NCT03417947|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111075757|NCT03417947|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111075758|NCT03905811|Terazosin|terazosin|mesh-list
111075759|NCT03905811|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111075760|NCT03905811|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111075761|NCT03905811|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111075762|NCT03905811|Adrenergic Agents|adrenergic agents|mesh-ancestor
111075763|NCT03905811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111075764|NCT03905811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111075765|NCT03905811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111075766|NCT03905811|Urological Agents|urological agents|mesh-ancestor
111075767|NCT01648790|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
111075768|NCT01648790|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111075769|NCT05171309|Apatinib|apatinib|mesh-list
111075770|NCT05171309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111075771|NCT05171309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111075772|NCT05171309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111075773|NCT05171309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111075774|NCT03409237|Mannitol|mannitol|mesh-list
111075775|NCT03409237|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
111075776|NCT03409237|Diuretics|diuretics|mesh-ancestor
111075777|NCT03409237|Natriuretic Agents|natriuretic agents|mesh-ancestor
111075778|NCT03409237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111075779|NCT03408847|Beclomethasone|beclomethasone|mesh-list
111075780|NCT03408847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111075781|NCT03408847|Glucocorticoids|glucocorticoids|mesh-ancestor
111075782|NCT03408847|Hormones|hormones|mesh-ancestor
111075783|NCT03408847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111075784|NCT03408847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111075785|NCT03408847|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111075786|NCT03408847|Respiratory System Agents|respiratory system agents|mesh-ancestor
111075788|NCT03424291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111075789|NCT03424291|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111075790|NCT03424291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111075791|NCT03424291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111075792|NCT04412889|Immunomodulating Agents|immunomodulating agents|mesh-list
111075793|NCT04412889|Immunologic Factors|immunologic factors|mesh-ancestor
111075794|NCT04412889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111075795|NCT03407521|Isosorbide|isosorbide|mesh-list
111075796|NCT03407521|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
111075797|NCT03407521|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
111075798|NCT03407521|Misoprostol|misoprostol|mesh-list
111075799|NCT03407521|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111075800|NCT03407521|Abortifacient Agents|abortifacient agents|mesh-ancestor
111075801|NCT03407521|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111075802|NCT03407521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111075803|NCT03407521|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111075804|NCT03407521|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111075805|NCT03407521|Oxytocics|oxytocics|mesh-ancestor
111075806|NCT03407521|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
111075807|NCT03407521|Diuretics|diuretics|mesh-ancestor
111075808|NCT03407521|Natriuretic Agents|natriuretic agents|mesh-ancestor
111075809|NCT03407521|Vasodilator Agents|vasodilator agents|mesh-ancestor
111075810|NCT03407521|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
111075811|NCT03407521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111075812|NCT03424135|Diphenhydramine|diphenhydramine|mesh-list
111075813|NCT03424135|Promethazine|promethazine|mesh-list
111075814|NCT03424135|Naproxen|naproxen|mesh-list
111075815|NCT03424135|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111075816|NCT03424135|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111075817|NCT03424135|Analgesics|analgesics|mesh-ancestor
111075818|NCT03424135|Sensory System Agents|sensory system agents|mesh-ancestor
111075819|NCT03424135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111075820|NCT03424135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111075821|NCT03424135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111075822|NCT03424135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111075823|NCT03424135|Gout Suppressants|gout suppressants|mesh-ancestor
111075824|NCT03424135|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111075825|NCT03424135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111075826|NCT03424135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111075827|NCT03424135|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111075828|NCT03424135|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111075829|NCT03424135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111075830|NCT03424135|Anesthetics, Local|anesthetics, local|mesh-ancestor
111075831|NCT03424135|Anesthetics|anesthetics|mesh-ancestor
111075832|NCT03424135|Antiemetics|antiemetics|mesh-ancestor
111075833|NCT03424135|Autonomic Agents|autonomic agents|mesh-ancestor
111075834|NCT03424135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111075835|NCT03424135|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111075836|NCT03424135|Histamine Antagonists|histamine antagonists|mesh-ancestor
111075837|NCT03424135|Histamine Agents|histamine agents|mesh-ancestor
111075838|NCT03424135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111075839|NCT03424135|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111075840|NCT03424135|Antipruritics|antipruritics|mesh-ancestor
111075841|NCT03424135|Dermatologic Agents|dermatologic agents|mesh-ancestor
111075843|NCT03411941|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111075844|NCT03411941|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111075845|NCT03411941|Growth Substances|growth substances|mesh-ancestor
111075846|NCT03411941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111075847|NCT03411941|Growth Inhibitors|growth inhibitors|mesh-ancestor
111075848|NCT03411941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111075849|NCT05170555|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
111075850|NCT05170555|177Lu-EB-PSMA-617|177lu-eb-psma-617|mesh-list
111075851|NCT05170555|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111075852|NCT05170555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111075853|NCT03406819|Nitroprusside|nitroprusside|mesh-list
111075854|NCT03406819|Tirofiban|tirofiban|mesh-list
111075855|NCT03406819|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111075856|NCT03406819|Vasodilator Agents|vasodilator agents|mesh-ancestor
110792973|NCT01169415|BB 1101|bb 1101|mesh-list
111075857|NCT03406819|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
111075858|NCT03406819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111075859|NCT03406819|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111075860|NCT03406819|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111075861|NCT03406819|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111075863|NCT05170217|Anticonvulsants|anticonvulsants|mesh-ancestor
111075864|NCT03411551|Anesthetics|anesthetics|mesh-list
111075865|NCT03411551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111075866|NCT03411551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111075867|NCT05170061|Valsartan|valsartan|mesh-list
111075868|NCT05170061|Nebivolol|nebivolol|mesh-list
111075869|NCT05170061|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111075870|NCT05170061|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111075871|NCT05170061|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111075872|NCT05170061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111075873|NCT05170061|Vasodilator Agents|vasodilator agents|mesh-ancestor
111075874|NCT05170061|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
111075875|NCT05170061|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111075876|NCT05170061|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111075877|NCT05170061|Adrenergic Agents|adrenergic agents|mesh-ancestor
111075878|NCT05170061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111075879|NCT05170061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111075880|NCT04235205|Cholestyramine Resin|cholestyramine resin|mesh-list
111075881|NCT04235205|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111075882|NCT04235205|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111075883|NCT04235205|Antimetabolites|antimetabolites|mesh-ancestor
111075884|NCT04235205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111075885|NCT04235205|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111075886|NCT02520635|Temozolomide|temozolomide|mesh-list
111075887|NCT02520635|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111075888|NCT02520635|Alkylating Agents|alkylating agents|mesh-ancestor
111075889|NCT02520635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111075890|NCT02520635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111075891|NCT03404947|Ethanol|ethanol|mesh-list
111075892|NCT03404947|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111075893|NCT03404947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111075894|NCT03404947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111075895|NCT03404947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111075896|NCT03411473|Pembrolizumab|pembrolizumab|mesh-list
111075897|NCT03411473|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111075898|NCT03411473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111075899|NCT03411473|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111075900|NCT03411473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111075901|NCT03423823|Ranibizumab|ranibizumab|mesh-list
111075902|NCT03423823|Aflibercept|aflibercept|mesh-list
111075903|NCT03423823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111075904|NCT03423823|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111075905|NCT03423823|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111075906|NCT03423823|Growth Substances|growth substances|mesh-ancestor
111075907|NCT03423823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111075908|NCT03423823|Growth Inhibitors|growth inhibitors|mesh-ancestor
111075909|NCT03411161|Paclitaxel|paclitaxel|mesh-list
111075910|NCT03411161|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111075911|NCT03411161|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111075912|NCT03411161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111075913|NCT03411161|Tubulin Modulators|tubulin modulators|mesh-ancestor
111075914|NCT03411161|Antimitotic Agents|antimitotic agents|mesh-ancestor
111075915|NCT03411161|Mitosis Modulators|mitosis modulators|mesh-ancestor
111075916|NCT03411161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111075917|NCT05168137|Colchicine|colchicine|mesh-list
111075918|NCT05168137|Gout Suppressants|gout suppressants|mesh-ancestor
111075919|NCT05168137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111075920|NCT05168137|Tubulin Modulators|tubulin modulators|mesh-ancestor
111075921|NCT05168137|Antimitotic Agents|antimitotic agents|mesh-ancestor
111075922|NCT05168137|Mitosis Modulators|mitosis modulators|mesh-ancestor
111075923|NCT05168137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111075924|NCT05168137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111075925|NCT03410771|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111075926|NCT03410771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111075927|NCT05168059|Clevidipine|clevidipine|mesh-list
111075928|NCT05168059|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111075929|NCT05168059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111075930|NCT05168059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111075931|NCT05168059|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111075932|NCT05168059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111075933|NCT02375295|Ciprofloxacin|ciprofloxacin|mesh-list
111075934|NCT02375295|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
111075935|NCT02375295|Nitrofurantoin|nitrofurantoin|mesh-list
111075936|NCT02375295|Trimethoprim|trimethoprim|mesh-list
111075937|NCT02375295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111075938|NCT02375295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111075939|NCT02375295|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111075940|NCT02375295|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111075941|NCT02375295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111075942|NCT02375295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111075943|NCT02375295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111075944|NCT02375295|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111075945|NCT02375295|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111075946|NCT02375295|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111075947|NCT02375295|Antimalarials|antimalarials|mesh-ancestor
111075948|NCT02375295|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111075949|NCT02375295|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111075950|NCT02375295|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111075951|NCT02375295|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111075952|NCT02375295|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
111075954|NCT03394105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111075955|NCT03394105|Tubulin Modulators|tubulin modulators|mesh-ancestor
111075956|NCT03394105|Antimitotic Agents|antimitotic agents|mesh-ancestor
111075957|NCT03394105|Mitosis Modulators|mitosis modulators|mesh-ancestor
111075958|NCT03394105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111075959|NCT03393949|Methylprednisolone|methylprednisolone|mesh-list
111075960|NCT03393949|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111075961|NCT03393949|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111075962|NCT03393949|Prednisolone|prednisolone|mesh-list
111075963|NCT03393949|Prednisolone acetate|prednisolone acetate|mesh-list
111075964|NCT03393949|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111075965|NCT03393949|Prednisolone phosphate|prednisolone phosphate|mesh-list
111075966|NCT03393949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111075967|NCT03393949|Antiemetics|antiemetics|mesh-ancestor
111075968|NCT03393949|Autonomic Agents|autonomic agents|mesh-ancestor
111075969|NCT03393949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111075970|NCT03393949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111075971|NCT03393949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111075972|NCT03393949|Glucocorticoids|glucocorticoids|mesh-ancestor
111075973|NCT03393949|Hormones|hormones|mesh-ancestor
111075974|NCT03393949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111075975|NCT03393949|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111075976|NCT03393949|Protective Agents|protective agents|mesh-ancestor
111075977|NCT03393949|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111075978|NCT03393949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111075979|NCT05169125|Dialysis Solutions|dialysis solutions|mesh-list
111075980|NCT05169125|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111075981|NCT03397615|Povidone-Iodine|povidone-iodine|mesh-list
111075982|NCT03397615|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111075983|NCT03397615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111075984|NCT04435743|Lenalidomide|lenalidomide|mesh-list
111075985|NCT04435743|Immunologic Factors|immunologic factors|mesh-ancestor
111075986|NCT04435743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111075987|NCT04435743|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111075988|NCT04435743|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111075989|NCT04435743|Growth Substances|growth substances|mesh-ancestor
111075990|NCT04435743|Growth Inhibitors|growth inhibitors|mesh-ancestor
111075991|NCT04435743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111075992|NCT03393715|Perindopril|perindopril|mesh-list
111075993|NCT03393715|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
111075994|NCT03393715|Protease Inhibitors|protease inhibitors|mesh-ancestor
111075995|NCT03393715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111075996|NCT03393715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111075997|NCT03393715|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111075999|NCT03397537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111076000|NCT03397537|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111076001|NCT03397537|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111076002|NCT03397537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111076003|NCT03397537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111076004|NCT03397537|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111076005|NCT03397537|Hormone Antagonists|hormone antagonists|mesh-ancestor
111076006|NCT03397537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111076007|NCT03397537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111076008|NCT03612921|Amantadine|amantadine|mesh-list
111076009|NCT03612921|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111076010|NCT03612921|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111076011|NCT03612921|Antiviral Agents|antiviral agents|mesh-ancestor
111076012|NCT03612921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111076013|NCT03612921|Dopamine Agents|dopamine agents|mesh-ancestor
111076014|NCT03612921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111076015|NCT03612921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111076016|NCT03612921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111076017|NCT03612921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111076018|NCT03612921|Analgesics|analgesics|mesh-ancestor
111076019|NCT03612921|Sensory System Agents|sensory system agents|mesh-ancestor
111076020|NCT03612921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111076021|NCT03393481|Enoxaparin|enoxaparin|mesh-list
111076022|NCT03393481|Anticoagulants|anticoagulants|mesh-ancestor
111076023|NCT03393481|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111076024|NCT03393481|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111076025|NCT03393481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111076026|NCT01936857|Buprenorphine|buprenorphine|mesh-list
111076027|NCT01936857|Methadone|methadone|mesh-list
111076028|NCT01936857|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
111076029|NCT01936857|Naloxone|naloxone|mesh-list
111076030|NCT01936857|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111076031|NCT01936857|Narcotics|narcotics|mesh-ancestor
111076032|NCT01936857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111076033|NCT01936857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111076034|NCT01936857|Analgesics|analgesics|mesh-ancestor
111076035|NCT01936857|Sensory System Agents|sensory system agents|mesh-ancestor
111076036|NCT01936857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111076037|NCT01936857|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111076038|NCT01936857|Antitussive Agents|antitussive agents|mesh-ancestor
111076039|NCT01936857|Respiratory System Agents|respiratory system agents|mesh-ancestor
111076040|NCT03393403|Dexmedetomidine|dexmedetomidine|mesh-list
111076041|NCT03393403|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111076042|NCT03393403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111076043|NCT03393403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111076044|NCT03393403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111076045|NCT03393403|Analgesics|analgesics|mesh-ancestor
111076046|NCT03393403|Sensory System Agents|sensory system agents|mesh-ancestor
111076047|NCT03393403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111076048|NCT03393403|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111076049|NCT03393403|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111076050|NCT03393403|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111076051|NCT03393403|Adrenergic Agents|adrenergic agents|mesh-ancestor
111076052|NCT03393403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111076053|NCT03393403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111076054|NCT03399955|Amphotericin B|amphotericin b|mesh-list
111076055|NCT03399955|Paromomycin|paromomycin|mesh-list
111076056|NCT03399955|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
111076057|NCT03399955|Miltefosine|miltefosine|mesh-list
111076058|NCT03399955|Amebicides|amebicides|mesh-ancestor
111076059|NCT03399955|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111076060|NCT03399955|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111076061|NCT03399955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111076062|NCT03399955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111076063|NCT03399955|Antifungal Agents|antifungal agents|mesh-ancestor
111076064|NCT03399955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111076065|NCT03397199|Apatinib|apatinib|mesh-list
111076066|NCT03397199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111076067|NCT03397199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111076068|NCT03397199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111076069|NCT03397199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111076070|NCT05188053|Ketorolac|ketorolac|mesh-list
111076071|NCT05188053|Epinephrine|epinephrine|mesh-list
111076072|NCT05188053|Ropivacaine|ropivacaine|mesh-list
111076073|NCT05188053|Anesthetics, Local|anesthetics, local|mesh-ancestor
111076074|NCT05188053|Anesthetics|anesthetics|mesh-ancestor
111076075|NCT05188053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111076076|NCT05188053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111076077|NCT05188053|Sensory System Agents|sensory system agents|mesh-ancestor
111076078|NCT05188053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111076079|NCT05188053|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111076080|NCT05188053|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111076081|NCT05188053|Adrenergic Agents|adrenergic agents|mesh-ancestor
111076082|NCT05188053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111076083|NCT05188053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111076084|NCT05188053|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111076085|NCT05188053|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111076086|NCT05188053|Autonomic Agents|autonomic agents|mesh-ancestor
111076087|NCT05188053|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111076088|NCT05188053|Respiratory System Agents|respiratory system agents|mesh-ancestor
111076089|NCT05188053|Mydriatics|mydriatics|mesh-ancestor
111076090|NCT05188053|Sympathomimetics|sympathomimetics|mesh-ancestor
111076091|NCT05188053|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111076092|NCT05188053|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111076093|NCT05188053|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111076094|NCT05188053|Analgesics|analgesics|mesh-ancestor
111076095|NCT05188053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111076096|NCT05188053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111076097|NCT05188053|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111076098|NCT05188053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111076099|NCT03393325|Tadalafil|tadalafil|mesh-list
111076100|NCT03393325|Vasodilator Agents|vasodilator agents|mesh-ancestor
111076101|NCT03393325|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111076102|NCT03393325|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111076103|NCT03393325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111076104|NCT03393325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111076105|NCT03393325|Urological Agents|urological agents|mesh-ancestor
111076106|NCT03399643|Atezolizumab|atezolizumab|mesh-list
111076107|NCT03399643|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111076108|NCT03399643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111076109|NCT03399643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111076110|NCT03399643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111076111|NCT03393247|Infliximab|infliximab|mesh-list
111076112|NCT03393247|Azathioprine|azathioprine|mesh-list
111076113|NCT03393247|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111076114|NCT03393247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111076115|NCT03393247|Dermatologic Agents|dermatologic agents|mesh-ancestor
111076116|NCT03393247|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111076117|NCT03393247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111076118|NCT03393247|Antimetabolites|antimetabolites|mesh-ancestor
111076119|NCT03393247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111076120|NCT03393247|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111076121|NCT03393247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111076122|NCT03393247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111076123|NCT03393247|Immunologic Factors|immunologic factors|mesh-ancestor
111076124|NCT03393247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111076125|NCT03407027|Triamcinolone|triamcinolone|mesh-list
111076126|NCT03407027|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
111076127|NCT03407027|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
111076128|NCT03407027|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
111076129|NCT03407027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111076130|NCT03407027|Glucocorticoids|glucocorticoids|mesh-ancestor
111076131|NCT03407027|Hormones|hormones|mesh-ancestor
111076132|NCT03407027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111076133|NCT03407027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111076134|NCT03407027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111076136|NCT03407027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111076137|NCT03407027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111076138|NCT03343197|Ivosidenib|ivosidenib|mesh-list
111076139|NCT03343197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111076140|NCT03343197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111076141|NCT03343197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111076142|NCT01602224|Dexamethasone|dexamethasone|mesh-list
111076143|NCT01602224|Bortezomib|bortezomib|mesh-list
111076144|NCT01602224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111076145|NCT01602224|Antiemetics|antiemetics|mesh-ancestor
111076146|NCT01602224|Autonomic Agents|autonomic agents|mesh-ancestor
111076147|NCT01602224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111076148|NCT01602224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111076149|NCT01602224|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111076150|NCT01602224|Glucocorticoids|glucocorticoids|mesh-ancestor
111076151|NCT01602224|Hormones|hormones|mesh-ancestor
111076152|NCT01602224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111076153|NCT01602224|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111076154|NCT01602224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111076155|NCT03399487|Ceritinib|ceritinib|mesh-list
111076156|NCT03399487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111076157|NCT03399487|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111076159|NCT03399487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111076160|NCT05161429|Insulin|insulin|mesh-list
111076161|NCT05161429|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111076162|NCT05161429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111076163|NCT03984045|Lidocaine|lidocaine|mesh-list
111076164|NCT03984045|Prochlorperazine|prochlorperazine|mesh-list
111076165|NCT03984045|Anesthetics, Local|anesthetics, local|mesh-ancestor
111076166|NCT03984045|Anesthetics|anesthetics|mesh-ancestor
111076167|NCT03984045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111076168|NCT03984045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111076169|NCT03984045|Sensory System Agents|sensory system agents|mesh-ancestor
111076170|NCT03984045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111076171|NCT03984045|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111076172|NCT03984045|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111076173|NCT03984045|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111076174|NCT03984045|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111076175|NCT03984045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111076176|NCT03984045|Antiemetics|antiemetics|mesh-ancestor
111076177|NCT03984045|Autonomic Agents|autonomic agents|mesh-ancestor
111076178|NCT03984045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111076179|NCT03984045|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111076180|NCT03984045|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111076181|NCT03984045|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111076182|NCT03984045|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111076183|NCT03984045|Dopamine Agents|dopamine agents|mesh-ancestor
111076184|NCT03984045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111076185|NCT03661047|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
111076186|NCT03661047|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111076187|NCT03661047|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111076188|NCT05060991|Antimetabolites|antimetabolites|mesh-list
111076189|NCT05060991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111076190|NCT03399409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
111076191|NCT03397069|Midazolam|midazolam|mesh-list
111076192|NCT03397069|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111076193|NCT03397069|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111076194|NCT03397069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111076195|NCT03397069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111076196|NCT03397069|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111076197|NCT03397069|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111076198|NCT03397069|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111076199|NCT03397069|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111076200|NCT03397069|Anesthetics, General|anesthetics, general|mesh-ancestor
111076201|NCT03397069|Anesthetics|anesthetics|mesh-ancestor
111076202|NCT03397069|GABA Modulators|gaba modulators|mesh-ancestor
111076203|NCT03397069|GABA Agents|gaba agents|mesh-ancestor
111076204|NCT03397069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111076205|NCT03397069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111076206|NCT03396497|Pembrolizumab|pembrolizumab|mesh-list
111076207|NCT03396497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111076208|NCT03396497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111076209|NCT03396497|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111076210|NCT03396497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111076211|NCT03399019|Midazolam|midazolam|mesh-list
111076212|NCT03399019|Dexmedetomidine|dexmedetomidine|mesh-list
111076213|NCT03399019|Propofol|propofol|mesh-list
111076214|NCT03399019|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111076215|NCT03399019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111076216|NCT03399019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111076217|NCT03399019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111076218|NCT03399019|Analgesics|analgesics|mesh-ancestor
111076219|NCT03399019|Sensory System Agents|sensory system agents|mesh-ancestor
111076220|NCT03399019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111076221|NCT03399019|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111076222|NCT03399019|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111076223|NCT03399019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111076224|NCT03399019|Adrenergic Agents|adrenergic agents|mesh-ancestor
111076225|NCT03399019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111076226|NCT03399019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111076227|NCT03399019|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111076228|NCT03399019|Anesthetics, General|anesthetics, general|mesh-ancestor
111076229|NCT03399019|Anesthetics|anesthetics|mesh-ancestor
111076230|NCT03399019|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111076231|NCT03399019|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111076232|NCT03399019|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111076233|NCT03399019|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111076234|NCT03399019|GABA Modulators|gaba modulators|mesh-ancestor
111076235|NCT03399019|GABA Agents|gaba agents|mesh-ancestor
111076236|NCT04452383|Ketamine|ketamine|mesh-list
111076237|NCT04452383|Propofol|propofol|mesh-list
111076238|NCT04452383|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111076239|NCT04452383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111076240|NCT04452383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111076241|NCT04452383|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111076242|NCT04452383|Anesthetics, General|anesthetics, general|mesh-ancestor
111076243|NCT04452383|Anesthetics|anesthetics|mesh-ancestor
111076244|NCT04452383|Analgesics|analgesics|mesh-ancestor
111076245|NCT04452383|Sensory System Agents|sensory system agents|mesh-ancestor
111076246|NCT04452383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111076247|NCT04452383|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111076248|NCT04452383|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111076249|NCT04452383|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111076250|NCT04452383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110131384|NCT01968005|Etodolac|etodolac|mesh-list
111076251|NCT04452383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111076252|NCT02520479|Pegaspargase|pegaspargase|mesh-list
111076253|NCT02520479|Asparaginase|asparaginase|mesh-list
111076254|NCT02520479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111076255|NCT02520947|Desflurane|desflurane|mesh-list
111076256|NCT02520947|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111076257|NCT02520947|Anesthetics, General|anesthetics, general|mesh-ancestor
111076258|NCT02520947|Anesthetics|anesthetics|mesh-ancestor
111076259|NCT02520947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111076260|NCT02520947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111076261|NCT03398941|Octreotide|octreotide|mesh-list
111076262|NCT03398941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111076263|NCT03398941|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111076264|NCT03398941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111076265|NCT03396601|Ketamine|ketamine|mesh-list
111076266|NCT03396601|Analgesics|analgesics|mesh-ancestor
111076267|NCT03396601|Sensory System Agents|sensory system agents|mesh-ancestor
111076268|NCT03396601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111076269|NCT03396601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111076270|NCT03396601|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111076271|NCT03396601|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111076272|NCT03396601|Anesthetics, General|anesthetics, general|mesh-ancestor
111076273|NCT03396601|Anesthetics|anesthetics|mesh-ancestor
111076274|NCT03396601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111076275|NCT03396601|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111076276|NCT03396601|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111076277|NCT03396601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111076278|NCT03396601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111076279|NCT03392623|Niacinamide|niacinamide|mesh-list
111076280|NCT03392623|Niacin|niacin|mesh-list
111076281|NCT03392623|Nicotinic Acids|nicotinic acids|mesh-list
111076283|NCT03392623|Sunscreening Agents|sunscreening agents|mesh-list
111076284|NCT03392623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111076285|NCT03392623|Keratolytic Agents|keratolytic agents|mesh-ancestor
111076286|NCT03392623|Dermatologic Agents|dermatologic agents|mesh-ancestor
111076287|NCT03392623|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111076288|NCT03392623|Protective Agents|protective agents|mesh-ancestor
111076289|NCT03392623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111076290|NCT03392623|Vitamin B Complex|vitamin b complex|mesh-ancestor
111076291|NCT03392623|Vitamins|vitamins|mesh-ancestor
111076292|NCT03392623|Micronutrients|micronutrients|mesh-ancestor
111076293|NCT03392623|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111076294|NCT03392623|Antimetabolites|antimetabolites|mesh-ancestor
111076295|NCT03392623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111076296|NCT03392623|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111076297|NCT03392623|Vasodilator Agents|vasodilator agents|mesh-ancestor
111076298|NCT03396107|Dexamethasone|dexamethasone|mesh-list
111076299|NCT03396107|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111076300|NCT03396107|Antiemetics|antiemetics|mesh-ancestor
111076301|NCT03396107|Autonomic Agents|autonomic agents|mesh-ancestor
111076302|NCT03396107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111076303|NCT03396107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111076304|NCT03396107|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111076305|NCT03396107|Glucocorticoids|glucocorticoids|mesh-ancestor
111076306|NCT03396107|Hormones|hormones|mesh-ancestor
111076307|NCT03396107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111076308|NCT03396107|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111076309|NCT03396107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111076310|NCT03398785|Epinephrine|epinephrine|mesh-list
111076311|NCT03398785|Racepinephrine|racepinephrine|mesh-list
111076312|NCT03398785|Epinephryl borate|epinephryl borate|mesh-list
111076313|NCT03398785|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111076314|NCT03398785|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111076315|NCT03398785|Adrenergic Agents|adrenergic agents|mesh-ancestor
111076316|NCT03398785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111076317|NCT03398785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111076318|NCT03398785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111076319|NCT03398785|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111076320|NCT03398785|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111076321|NCT03398785|Autonomic Agents|autonomic agents|mesh-ancestor
111076322|NCT03398785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111076323|NCT03398785|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111076324|NCT03398785|Respiratory System Agents|respiratory system agents|mesh-ancestor
111076325|NCT03398785|Mydriatics|mydriatics|mesh-ancestor
111076326|NCT03398785|Sympathomimetics|sympathomimetics|mesh-ancestor
111076327|NCT03398785|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111076328|NCT03392545|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
111076329|NCT03392545|Immunologic Factors|immunologic factors|mesh-ancestor
111076330|NCT03392545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111076331|NCT03126695|Ticagrelor|ticagrelor|mesh-list
111076332|NCT03126695|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111076333|NCT03126695|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111076334|NCT03126695|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111076335|NCT03126695|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111076336|NCT03126695|Purinergic Agents|purinergic agents|mesh-ancestor
111076337|NCT03126695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111076338|NCT03126695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111076339|NCT03126695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111076340|NCT04647643|Paclitaxel|paclitaxel|mesh-list
111076341|NCT04647643|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111076342|NCT04647643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111076343|NCT04647643|Tubulin Modulators|tubulin modulators|mesh-ancestor
111076344|NCT04647643|Antimitotic Agents|antimitotic agents|mesh-ancestor
111076345|NCT04647643|Mitosis Modulators|mitosis modulators|mesh-ancestor
111076346|NCT04647643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111076347|NCT04167761|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
111076348|NCT04167761|Ertugliflozin|ertugliflozin|mesh-list
111076349|NCT04167761|Glipizide|glipizide|mesh-list
111076350|NCT04167761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111076351|NCT04167761|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111076352|NCT04167761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111076353|NCT03401177|Naproxen|naproxen|mesh-list
111076354|NCT03401177|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111076355|NCT03401177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111076356|NCT03401177|Analgesics|analgesics|mesh-ancestor
111076358|NCT03401177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111076359|NCT03401177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111076360|NCT03401177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111076361|NCT03401177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111076362|NCT03401177|Gout Suppressants|gout suppressants|mesh-ancestor
111076363|NCT03401177|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111076364|NCT03401177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111076365|NCT03401177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111076366|NCT04446715|Sufentanil|sufentanil|mesh-list
111076367|NCT04446715|Meperidine|meperidine|mesh-list
111076368|NCT04446715|Bupivacaine|bupivacaine|mesh-list
111076369|NCT04446715|Anesthetics, Local|anesthetics, local|mesh-ancestor
111076370|NCT04446715|Anesthetics|anesthetics|mesh-ancestor
111076371|NCT04446715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111076372|NCT04446715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111076373|NCT04446715|Sensory System Agents|sensory system agents|mesh-ancestor
111076374|NCT04446715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111076375|NCT04446715|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111076376|NCT04446715|Narcotics|narcotics|mesh-ancestor
111076377|NCT04446715|Analgesics|analgesics|mesh-ancestor
111076378|NCT04446715|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111076379|NCT04446715|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111076380|NCT04446715|Anesthetics, General|anesthetics, general|mesh-ancestor
111076381|NCT03398473|Epoetin Alfa|epoetin alfa|mesh-list
111076382|NCT03398473|Hematinics|hematinics|mesh-ancestor
111076383|NCT03395951|Diuretics|diuretics|mesh-list
111076384|NCT03395951|Natriuretic Agents|natriuretic agents|mesh-ancestor
111076385|NCT03395951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111076386|NCT04535791|Vitamin D|vitamin d|mesh-list
111076387|NCT04535791|Cholecalciferol|cholecalciferol|mesh-list
111076388|NCT04535791|Vitamins|vitamins|mesh-ancestor
111076389|NCT04535791|Micronutrients|micronutrients|mesh-ancestor
111076390|NCT04535791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111076391|NCT04535791|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111076392|NCT04535791|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111076393|NCT03395873|Decitabine|decitabine|mesh-list
111076394|NCT03395873|Avelumab|avelumab|mesh-list
111076395|NCT03395873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111076396|NCT03395873|Antimetabolites|antimetabolites|mesh-ancestor
111076397|NCT03395873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111076398|NCT03395873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111076399|NCT03395873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111076400|NCT03395873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111076401|NCT04447625|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111076402|NCT04447625|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
111076403|NCT04447625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111076404|NCT04447625|Antitubercular Agents|antitubercular agents|mesh-ancestor
111076405|NCT03396523|Losartan|losartan|mesh-list
111076406|NCT03396523|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111076407|NCT03396523|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111076408|NCT03396523|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111076409|NCT03396523|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111076410|NCT03396523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111076411|NCT03126097|Drospirenone|drospirenone|mesh-list
111076412|NCT03126097|Ethinyl Estradiol|ethinyl estradiol|mesh-list
111076413|NCT03126097|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
111076414|NCT03126097|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111076415|NCT03126097|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111076416|NCT03126097|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111076417|NCT03126097|Contraceptive Agents|contraceptive agents|mesh-ancestor
111076418|NCT03126097|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111076419|NCT03126097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111076420|NCT03126097|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111076421|NCT03126097|Estrogens|estrogens|mesh-ancestor
111076422|NCT03126097|Hormones|hormones|mesh-ancestor
111076423|NCT03126097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111076424|NCT03126097|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
111076425|NCT03126097|Hormone Antagonists|hormone antagonists|mesh-ancestor
111076426|NCT03126097|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
111076427|NCT03126097|Diuretics|diuretics|mesh-ancestor
111076428|NCT03126097|Natriuretic Agents|natriuretic agents|mesh-ancestor
111076429|NCT03398083|Alprazolam|alprazolam|mesh-list
111076430|NCT03398083|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110131541|NCT01969019|Hormones|hormones|mesh-ancestor
111076431|NCT03398083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111076432|NCT03398083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111076433|NCT03398083|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111076434|NCT03398083|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111076435|NCT03398083|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111076436|NCT03398083|GABA Modulators|gaba modulators|mesh-ancestor
111076437|NCT03398083|GABA Agents|gaba agents|mesh-ancestor
111076438|NCT03398083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111076439|NCT03398083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111076440|NCT03126721|Midazolam|midazolam|mesh-list
111076441|NCT03126721|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111076442|NCT03126721|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111076443|NCT03126721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111076444|NCT03126721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111076445|NCT03126721|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111076446|NCT03126721|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111076447|NCT03126721|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111076448|NCT03126721|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111076449|NCT03126721|Anesthetics, General|anesthetics, general|mesh-ancestor
111076450|NCT03126721|Anesthetics|anesthetics|mesh-ancestor
111076451|NCT03126721|GABA Modulators|gaba modulators|mesh-ancestor
111076452|NCT03126721|GABA Agents|gaba agents|mesh-ancestor
111076453|NCT03126721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111076454|NCT03126721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111076455|NCT04928521|Bupivacaine|bupivacaine|mesh-list
111076456|NCT04928521|Anesthetics, Local|anesthetics, local|mesh-ancestor
111076457|NCT04928521|Anesthetics|anesthetics|mesh-ancestor
111076458|NCT04928521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111076459|NCT04928521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111076460|NCT04928521|Sensory System Agents|sensory system agents|mesh-ancestor
111076461|NCT04928521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111076462|NCT02823847|Carbon Monoxide|carbon monoxide|mesh-list
111076463|NCT02823847|Antimetabolites|antimetabolites|mesh-ancestor
111076464|NCT02823847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111076465|NCT02823847|Gasotransmitters|gasotransmitters|mesh-ancestor
111076466|NCT02823847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111076467|NCT02823847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111076468|NCT03391843|Cetuximab|cetuximab|mesh-list
111076469|NCT03391843|Oxaliplatin|oxaliplatin|mesh-list
111076470|NCT03391843|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111076471|NCT03391843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111076472|NCT03389659|Vitamin D|vitamin d|mesh-list
111076473|NCT03389659|Cholecalciferol|cholecalciferol|mesh-list
111076474|NCT03389659|Vitamins|vitamins|mesh-ancestor
111076475|NCT03389659|Micronutrients|micronutrients|mesh-ancestor
111076476|NCT03389659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111076477|NCT03389659|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111076478|NCT03389659|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111076479|NCT04446637|Albuterol|albuterol|mesh-list
111076480|NCT04446637|Ipratropium|ipratropium|mesh-list
111076481|NCT04446637|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111076482|NCT04446637|Autonomic Agents|autonomic agents|mesh-ancestor
111076483|NCT04446637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111076484|NCT04446637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111076485|NCT04446637|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111076486|NCT04446637|Respiratory System Agents|respiratory system agents|mesh-ancestor
111076487|NCT04446637|Tocolytic Agents|tocolytic agents|mesh-ancestor
111076488|NCT04446637|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111076489|NCT04446637|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111076490|NCT04446637|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111076491|NCT04446637|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111076492|NCT04446637|Adrenergic Agents|adrenergic agents|mesh-ancestor
111076493|NCT04446637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111076494|NCT04446637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111076495|NCT04446637|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111076496|NCT04446637|Cholinergic Agents|cholinergic agents|mesh-ancestor
111076497|NCT03395171|Vitamin D|vitamin d|mesh-list
111076498|NCT03395171|Cholecalciferol|cholecalciferol|mesh-list
111076499|NCT03395171|Vitamins|vitamins|mesh-ancestor
111076500|NCT03395171|Micronutrients|micronutrients|mesh-ancestor
111076501|NCT03395171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111076502|NCT03395171|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111076503|NCT03395171|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111076504|NCT03395977|Febuxostat|febuxostat|mesh-list
111076505|NCT03395977|Rasburicase|rasburicase|mesh-list
111076506|NCT03395977|Gout Suppressants|gout suppressants|mesh-ancestor
111076507|NCT03395977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111076508|NCT02678143|Mycophenolic Acid|mycophenolic acid|mesh-list
111076509|NCT02678143|Sirolimus|sirolimus|mesh-list
111076510|NCT02678143|Cyclophosphamide|cyclophosphamide|mesh-list
111076511|NCT02678143|Fludarabine|fludarabine|mesh-list
111076512|NCT02678143|Alemtuzumab|alemtuzumab|mesh-list
111076513|NCT02678143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111076514|NCT02678143|Immunologic Factors|immunologic factors|mesh-ancestor
111076515|NCT02678143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111076516|NCT02678143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111076517|NCT02678143|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111076518|NCT02678143|Alkylating Agents|alkylating agents|mesh-ancestor
111076519|NCT02678143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111076520|NCT02678143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111076521|NCT02678143|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111076522|NCT02678143|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111076523|NCT02678143|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111076524|NCT02678143|Antitubercular Agents|antitubercular agents|mesh-ancestor
111076525|NCT02678143|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111076526|NCT02678143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111076527|NCT02678143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111076528|NCT02678143|Antifungal Agents|antifungal agents|mesh-ancestor
111076529|NCT02678143|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111076530|NCT03395093|Fentanyl|fentanyl|mesh-list
111076531|NCT03395093|Midazolam|midazolam|mesh-list
111076532|NCT03395093|Propofol|propofol|mesh-list
111076533|NCT03395093|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111076534|NCT03395093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111076535|NCT03395093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111076536|NCT03395093|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111076537|NCT03395093|Anesthetics, General|anesthetics, general|mesh-ancestor
111076538|NCT03395093|Anesthetics|anesthetics|mesh-ancestor
111076539|NCT03395093|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111076540|NCT03395093|Narcotics|narcotics|mesh-ancestor
111076541|NCT03395093|Analgesics|analgesics|mesh-ancestor
111076542|NCT03395093|Sensory System Agents|sensory system agents|mesh-ancestor
111076543|NCT03395093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111076544|NCT03395093|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111076545|NCT03395093|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111076546|NCT03395093|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111076547|NCT03395093|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111076548|NCT03395093|GABA Modulators|gaba modulators|mesh-ancestor
111076549|NCT03395093|GABA Agents|gaba agents|mesh-ancestor
111076550|NCT03395093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111076551|NCT03395093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111076552|NCT03389191|Acyclovir|acyclovir|mesh-list
111076553|NCT03389191|Antiviral Agents|antiviral agents|mesh-ancestor
111076554|NCT03389191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111076555|NCT04330183|Ketamine|ketamine|mesh-list
111076556|NCT04330183|Analgesics|analgesics|mesh-ancestor
111076557|NCT04330183|Sensory System Agents|sensory system agents|mesh-ancestor
111076558|NCT04330183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111076559|NCT04330183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111076560|NCT04330183|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111076561|NCT04330183|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111076562|NCT04330183|Anesthetics, General|anesthetics, general|mesh-ancestor
111076563|NCT04330183|Anesthetics|anesthetics|mesh-ancestor
111076564|NCT04330183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111076565|NCT04330183|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111076566|NCT04330183|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111076567|NCT04330183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111076568|NCT04330183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111076569|NCT03398993|Clomiphene|clomiphene|mesh-list
111076570|NCT03398993|Enclomiphene|enclomiphene|mesh-list
111076571|NCT03398993|Zuclomiphene|zuclomiphene|mesh-list
111076572|NCT03398993|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
111076573|NCT03398993|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111076574|NCT03398993|Hormone Antagonists|hormone antagonists|mesh-ancestor
111076575|NCT03398993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111076576|NCT03398993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111076577|NCT03398993|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111076578|NCT03398993|Fertility Agents|fertility agents|mesh-ancestor
111076579|NCT03398993|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111076580|NCT03398993|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111076581|NCT03398993|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111076583|NCT04249297|Progestins|progestins|mesh-ancestor
111076584|NCT04249297|Hormones|hormones|mesh-ancestor
111076585|NCT04249297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111076586|NCT04249297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111076587|NCT03391609|Dexmedetomidine|dexmedetomidine|mesh-list
111076588|NCT03391609|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111076589|NCT03391609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111076590|NCT03391609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111076591|NCT03391609|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111076592|NCT03391609|Analgesics|analgesics|mesh-ancestor
111076593|NCT03391609|Sensory System Agents|sensory system agents|mesh-ancestor
111076594|NCT03391609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111076595|NCT03391609|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111076596|NCT03391609|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111076597|NCT03391609|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111076598|NCT03391609|Adrenergic Agents|adrenergic agents|mesh-ancestor
111076599|NCT03391609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111076600|NCT03391609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111076601|NCT03398837|Dronabinol|dronabinol|mesh-list
111076602|NCT03398837|Lenabasum|lenabasum|mesh-list
111076603|NCT03398837|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
111076604|NCT03398837|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
111076605|NCT03398837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111076606|NCT03398837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111076607|NCT03398837|Hormones|hormones|mesh-ancestor
111076608|NCT03398837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111076609|NCT03398837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111076610|NCT03398837|Hallucinogens|hallucinogens|mesh-ancestor
111076611|NCT03398837|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111076612|NCT03398837|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111076613|NCT03398837|Analgesics|analgesics|mesh-ancestor
111076614|NCT03398837|Sensory System Agents|sensory system agents|mesh-ancestor
111076615|NCT03398837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111076616|NCT03398759|Butorphanol|butorphanol|mesh-list
111076617|NCT03398759|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111076618|NCT03398759|Narcotics|narcotics|mesh-ancestor
111076619|NCT03398759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111076620|NCT03398759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111076621|NCT03398759|Analgesics|analgesics|mesh-ancestor
111076622|NCT03398759|Sensory System Agents|sensory system agents|mesh-ancestor
111076623|NCT03398759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111076624|NCT03398759|Antitussive Agents|antitussive agents|mesh-ancestor
111076625|NCT03398759|Respiratory System Agents|respiratory system agents|mesh-ancestor
111076626|NCT03398759|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111076627|NCT03391219|Bevacizumab|bevacizumab|mesh-list
111076628|NCT03391219|Fasudil|fasudil|mesh-list
111076629|NCT03391219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111076630|NCT03391219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111076631|NCT03391219|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111076632|NCT03391219|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111076633|NCT03391219|Growth Substances|growth substances|mesh-ancestor
111076634|NCT03391219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111076635|NCT03391219|Growth Inhibitors|growth inhibitors|mesh-ancestor
111076636|NCT03391219|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111076637|NCT03391219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111076638|NCT03391219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111076639|NCT03391219|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111076640|NCT03391219|Vasodilator Agents|vasodilator agents|mesh-ancestor
111076641|NCT03391219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111076642|NCT03391219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111076643|NCT04446923|Propranolol|propranolol|mesh-list
111076644|NCT04446923|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111076645|NCT04446923|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111076646|NCT04446923|Adrenergic Agents|adrenergic agents|mesh-ancestor
111076647|NCT04446923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111076648|NCT04446923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111076649|NCT04446923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111076650|NCT04446923|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111076651|NCT04446923|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111076652|NCT04446923|Vasodilator Agents|vasodilator agents|mesh-ancestor
111076653|NCT05237843|Hydroxychloroquine|hydroxychloroquine|mesh-list
111076654|NCT05237843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111076655|NCT05237843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111076656|NCT05237843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111076657|NCT05237843|Antimalarials|antimalarials|mesh-ancestor
111076658|NCT05237843|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111076659|NCT05237843|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111076660|NCT05237843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111076661|NCT04447105|Anesthetics|anesthetics|mesh-list
111076662|NCT04447105|Propofol|propofol|mesh-list
111076663|NCT04447105|Desflurane|desflurane|mesh-list
111076664|NCT04447105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111076665|NCT04447105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111076666|NCT04447105|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111076667|NCT04447105|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111076668|NCT04447105|Anesthetics, General|anesthetics, general|mesh-ancestor
111076669|NCT04447105|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111076670|NCT03126461|Nivolumab|nivolumab|mesh-list
111076671|NCT03126461|Ipilimumab|ipilimumab|mesh-list
111076672|NCT03126461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111076673|NCT03126461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111076674|NCT03126461|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111076675|NCT03126461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111076676|NCT03389789|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111076677|NCT03394001|Ketorolac|ketorolac|mesh-list
111076678|NCT03394001|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
111076679|NCT03394001|Lidocaine|lidocaine|mesh-list
111076680|NCT03394001|Anesthetics, Local|anesthetics, local|mesh-ancestor
111076681|NCT03394001|Anesthetics|anesthetics|mesh-ancestor
111076682|NCT03394001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111076683|NCT03394001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111076684|NCT03394001|Sensory System Agents|sensory system agents|mesh-ancestor
111076685|NCT03394001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111076686|NCT03394001|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111076687|NCT03394001|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111076688|NCT03394001|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111076689|NCT03394001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111076690|NCT03394001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111076691|NCT03394001|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111076692|NCT03394001|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111076693|NCT03394001|Analgesics|analgesics|mesh-ancestor
111076694|NCT03394001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111076695|NCT03394001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111076696|NCT03394001|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111076697|NCT03394001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111076698|NCT03393767|Ranibizumab|ranibizumab|mesh-list
111076699|NCT03393767|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111076700|NCT03393767|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111076701|NCT03393767|Growth Substances|growth substances|mesh-ancestor
111076702|NCT03393767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111076703|NCT03393767|Growth Inhibitors|growth inhibitors|mesh-ancestor
111076704|NCT03393767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111076705|NCT03389321|Macitentan|macitentan|mesh-list
111076706|NCT03389321|Riociguat|riociguat|mesh-list
111076707|NCT03389321|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
111076708|NCT03389321|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
111076709|NCT03389321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111076710|NCT03389321|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
111076711|NCT03389321|Enzyme Activators|enzyme activators|mesh-ancestor
111076712|NCT03393377|Valsartan|valsartan|mesh-list
111076713|NCT03393377|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111076714|NCT03393377|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111076715|NCT03393377|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111076716|NCT03393377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111076717|NCT02421263|Psilocybin|psilocybin|mesh-list
111076718|NCT02421263|Hallucinogens|hallucinogens|mesh-ancestor
111076719|NCT02421263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111076720|NCT02421263|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111076721|NCT01889303|Docetaxel|docetaxel|mesh-list
111076722|NCT01889303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111076723|NCT01889303|Tubulin Modulators|tubulin modulators|mesh-ancestor
111076724|NCT01889303|Antimitotic Agents|antimitotic agents|mesh-ancestor
111076725|NCT01889303|Mitosis Modulators|mitosis modulators|mesh-ancestor
111076726|NCT01889303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111076727|NCT00783263|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111076728|NCT00783263|Ezetimibe|ezetimibe|mesh-list
111076729|NCT00783263|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111076730|NCT00783263|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111076731|NCT00783263|Antimetabolites|antimetabolites|mesh-ancestor
111076732|NCT00783263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111076733|NCT00783263|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111076734|NCT00783263|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111076735|NCT00783263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111076736|NCT00664937|Montelukast|montelukast|mesh-list
111076737|NCT00664937|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111076738|NCT00664937|Respiratory System Agents|respiratory system agents|mesh-ancestor
111076739|NCT00664937|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
111076740|NCT00664937|Hormone Antagonists|hormone antagonists|mesh-ancestor
111076741|NCT00664937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111076742|NCT00664937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111076743|NCT00664937|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
111076744|NCT00664937|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111076745|NCT00664937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111076746|NCT00540839|Fluticasone|fluticasone|mesh-list
111076747|NCT00540839|Xhance|xhance|mesh-list
111076748|NCT00540839|Montelukast|montelukast|mesh-list
111076749|NCT00540839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111076750|NCT00540839|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111076751|NCT00540839|Autonomic Agents|autonomic agents|mesh-ancestor
111076752|NCT00540839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111076753|NCT00540839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111076754|NCT00540839|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111076755|NCT00540839|Respiratory System Agents|respiratory system agents|mesh-ancestor
111076756|NCT00540839|Dermatologic Agents|dermatologic agents|mesh-ancestor
111076757|NCT00540839|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111076758|NCT00540839|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
111076759|NCT00540839|Hormone Antagonists|hormone antagonists|mesh-ancestor
111076760|NCT00540839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111076761|NCT00540839|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
111076762|NCT00540839|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111076763|NCT00540839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111076764|NCT03389087|Etoposide|etoposide|mesh-list
111076765|NCT03389087|Apatinib|apatinib|mesh-list
111076766|NCT03389087|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111076767|NCT03389087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111076768|NCT03389087|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111076769|NCT03389087|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111076770|NCT03389087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111076771|NCT03389087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111076772|NCT03389087|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111076773|NCT03388853|Acetylcysteine|acetylcysteine|mesh-list
111076774|NCT03388853|Doxofylline|doxofylline|mesh-list
111076775|NCT03388853|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111076776|NCT03388853|Antiviral Agents|antiviral agents|mesh-ancestor
111076777|NCT03388853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111076778|NCT03388853|Expectorants|expectorants|mesh-ancestor
111076779|NCT03388853|Respiratory System Agents|respiratory system agents|mesh-ancestor
111076780|NCT03388853|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111076781|NCT03388853|Antioxidants|antioxidants|mesh-ancestor
111076782|NCT03388853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111076783|NCT03388853|Protective Agents|protective agents|mesh-ancestor
111076784|NCT03388853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111076785|NCT03388853|Antidotes|antidotes|mesh-ancestor
111076786|NCT03388853|Antitussive Agents|antitussive agents|mesh-ancestor
111076787|NCT03388853|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111076788|NCT03388853|Autonomic Agents|autonomic agents|mesh-ancestor
111076789|NCT03388853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111076790|NCT03388853|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111076791|NCT03388853|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111076792|NCT03388853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111076793|NCT00380705|Montelukast|montelukast|mesh-list
111076794|NCT00380705|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111076795|NCT00380705|Respiratory System Agents|respiratory system agents|mesh-ancestor
111076796|NCT00380705|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
111076797|NCT00380705|Hormone Antagonists|hormone antagonists|mesh-ancestor
111076798|NCT00380705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110677077|NCT02824276|Morphine|morphine|mesh-list
111076799|NCT00380705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111076800|NCT00380705|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
111076801|NCT00380705|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111076802|NCT00380705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111076803|NCT03388697|Insulin|insulin|mesh-list
111076804|NCT03388697|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111076805|NCT03388697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111076806|NCT03987919|Tirzepatide|tirzepatide|mesh-list
111076807|NCT03987919|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111076808|NCT03987919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111076809|NCT03987919|Incretins|incretins|mesh-ancestor
111076810|NCT03987919|Hormones|hormones|mesh-ancestor
111076811|NCT03987919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111076812|NCT03388957|Propranolol|propranolol|mesh-list
111076813|NCT03388957|Midazolam|midazolam|mesh-list
111076814|NCT03388957|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111076815|NCT03388957|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111076816|NCT03388957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111076817|NCT03388957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111076818|NCT03388957|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111076819|NCT03388957|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111076820|NCT03388957|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111076821|NCT03388957|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111076822|NCT03388957|Anesthetics, General|anesthetics, general|mesh-ancestor
111076823|NCT03388957|Anesthetics|anesthetics|mesh-ancestor
111076824|NCT03388957|GABA Modulators|gaba modulators|mesh-ancestor
111076825|NCT03388957|GABA Agents|gaba agents|mesh-ancestor
111076826|NCT03388957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111076827|NCT03388957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111076828|NCT03388957|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111076829|NCT03388957|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111076830|NCT03388957|Adrenergic Agents|adrenergic agents|mesh-ancestor
111076831|NCT03388957|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111076832|NCT03388957|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111076833|NCT03388957|Vasodilator Agents|vasodilator agents|mesh-ancestor
111076834|NCT03395665|Estradiol|estradiol|mesh-list
111076835|NCT03395665|Progesterone|progesterone|mesh-list
111076836|NCT03395665|Estrogens|estrogens|mesh-ancestor
111076837|NCT03395665|Hormones|hormones|mesh-ancestor
111076838|NCT03395665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111076839|NCT03395665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111076840|NCT03395665|Progestins|progestins|mesh-ancestor
111076841|NCT00535405|Atorvastatin|atorvastatin|mesh-list
111076842|NCT00535405|Simvastatin|simvastatin|mesh-list
111076843|NCT00535405|Ezetimibe|ezetimibe|mesh-list
111076844|NCT00535405|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111076845|NCT00535405|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111076846|NCT00535405|Antimetabolites|antimetabolites|mesh-ancestor
111076847|NCT00535405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111076848|NCT00535405|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111076849|NCT00535405|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111076850|NCT00535405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111076851|NCT03390595|Carboplatin|carboplatin|mesh-list
111076852|NCT03390595|Gemcitabine|gemcitabine|mesh-list
111076853|NCT03390595|Avelumab|avelumab|mesh-list
111076854|NCT03390595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111076855|NCT03390595|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111076856|NCT03390595|Antimetabolites|antimetabolites|mesh-ancestor
111076857|NCT03390595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111076858|NCT03390595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111076859|NCT00271817|Niacin|niacin|mesh-list
111076860|NCT00271817|Niacinamide|niacinamide|mesh-list
111076861|NCT00271817|Nicotinic Acids|nicotinic acids|mesh-list
111076862|NCT00271817|Simvastatin|simvastatin|mesh-list
111076863|NCT00271817|Ezetimibe|ezetimibe|mesh-list
111076864|NCT00271817|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
111076865|NCT00271817|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111076866|NCT00271817|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111076867|NCT00271817|Antimetabolites|antimetabolites|mesh-ancestor
111076868|NCT00271817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111076869|NCT00271817|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111076870|NCT00271817|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111076871|NCT00271817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110677080|NCT02824276|Narcotics|narcotics|mesh-ancestor
111076872|NCT00271817|Vasodilator Agents|vasodilator agents|mesh-ancestor
111076873|NCT00271817|Vitamin B Complex|vitamin b complex|mesh-ancestor
111076874|NCT00271817|Vitamins|vitamins|mesh-ancestor
111076875|NCT00271817|Micronutrients|micronutrients|mesh-ancestor
111076876|NCT00271817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111076877|NCT03388541|Dexmedetomidine|dexmedetomidine|mesh-list
111076878|NCT03388541|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111076879|NCT03388541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111076880|NCT03388541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111076881|NCT03388541|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111076882|NCT03388541|Analgesics|analgesics|mesh-ancestor
111076883|NCT03388541|Sensory System Agents|sensory system agents|mesh-ancestor
111076884|NCT03388541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111076885|NCT03388541|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111076886|NCT03388541|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111076887|NCT03388541|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111076888|NCT03388541|Adrenergic Agents|adrenergic agents|mesh-ancestor
111076889|NCT03388541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111076890|NCT03388541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111076891|NCT00092989|Montelukast|montelukast|mesh-list
111076892|NCT00092989|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111076893|NCT00092989|Respiratory System Agents|respiratory system agents|mesh-ancestor
111076894|NCT00092989|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
111076895|NCT00092989|Hormone Antagonists|hormone antagonists|mesh-ancestor
111076896|NCT00092989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111076897|NCT00092989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111076898|NCT00092989|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
111076899|NCT00092989|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111076900|NCT00092989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111076901|NCT03388463|Omeprazole|omeprazole|mesh-list
111076902|NCT03388463|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111076903|NCT03388463|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111076904|NCT03388463|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111076905|NCT03388463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111076906|NCT03388463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111076908|NCT03858049|Progestins|progestins|mesh-ancestor
111076909|NCT03858049|Hormones|hormones|mesh-ancestor
111076910|NCT03858049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111076911|NCT03858049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111076912|NCT03388151|Midazolam|midazolam|mesh-list
111076913|NCT03388151|Propofol|propofol|mesh-list
111076914|NCT03388151|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111076915|NCT03388151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111076916|NCT03388151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111076917|NCT03388151|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111076918|NCT03388151|Anesthetics, General|anesthetics, general|mesh-ancestor
111076919|NCT03388151|Anesthetics|anesthetics|mesh-ancestor
111076920|NCT03388151|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111076921|NCT03388151|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111076922|NCT03388151|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111076923|NCT03388151|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111076924|NCT03388151|GABA Modulators|gaba modulators|mesh-ancestor
111076925|NCT03388151|GABA Agents|gaba agents|mesh-ancestor
111076926|NCT03388151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111076927|NCT03388151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111076928|NCT03392909|Gentamicins|gentamicins|mesh-list
111076929|NCT03392909|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111076930|NCT03392909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111076931|NCT03392909|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111076932|NCT03392909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111076933|NCT03392909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111076934|NCT04501211|Granisetron|granisetron|mesh-list
111076935|NCT04501211|Antiemetics|antiemetics|mesh-ancestor
111076936|NCT04501211|Autonomic Agents|autonomic agents|mesh-ancestor
111076937|NCT04501211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111076938|NCT04501211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111076939|NCT04501211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111076940|NCT04501211|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111076941|NCT04501211|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111076942|NCT04501211|Serotonin Agents|serotonin agents|mesh-ancestor
111076943|NCT04501211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111076944|NCT04501211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111076945|NCT03126071|Bevacizumab|bevacizumab|mesh-list
111076946|NCT03126071|Oxaliplatin|oxaliplatin|mesh-list
111076947|NCT03126071|Irinotecan|irinotecan|mesh-list
111076948|NCT03126071|Raltitrexed|raltitrexed|mesh-list
111076949|NCT03126071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111076950|NCT03126071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111076951|NCT03126071|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111076952|NCT03126071|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111076953|NCT03126071|Growth Substances|growth substances|mesh-ancestor
111076954|NCT03126071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111076955|NCT03126071|Growth Inhibitors|growth inhibitors|mesh-ancestor
111076956|NCT03126071|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111076957|NCT03126071|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111076958|NCT03126071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111076959|NCT03126071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111076960|NCT03126071|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111076961|NCT03126071|Antimetabolites|antimetabolites|mesh-ancestor
111076962|NCT03126071|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111076963|NCT03392051|Clopidogrel|clopidogrel|mesh-list
111076964|NCT03392051|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111076965|NCT03392051|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111076966|NCT03392051|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111076967|NCT03392051|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111076968|NCT03392051|Purinergic Agents|purinergic agents|mesh-ancestor
111076969|NCT03392051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111076970|NCT03392051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111076971|NCT03392051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111076972|NCT04446533|Chlorhexidine|chlorhexidine|mesh-list
111076973|NCT04446533|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
111076974|NCT04446533|Hydrogen Peroxide|hydrogen peroxide|mesh-list
111076975|NCT04446533|Hyaluronic Acid|hyaluronic acid|mesh-list
111076976|NCT04446533|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111076977|NCT04446533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111076978|NCT04446533|Disinfectants|disinfectants|mesh-ancestor
111076979|NCT04446533|Dermatologic Agents|dermatologic agents|mesh-ancestor
111076980|NCT04446533|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111076981|NCT04446533|Immunologic Factors|immunologic factors|mesh-ancestor
111076982|NCT04446533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111076983|NCT04446533|Viscosupplements|viscosupplements|mesh-ancestor
111076984|NCT04446533|Protective Agents|protective agents|mesh-ancestor
111076986|NCT03386591|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111076987|NCT03386591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111076988|NCT03386591|Sensory System Agents|sensory system agents|mesh-ancestor
111076989|NCT03386591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111076990|NCT03386279|Moxifloxacin|moxifloxacin|mesh-list
111076991|NCT03386279|Abrocitinib|abrocitinib|mesh-list
111076992|NCT03386279|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111076993|NCT03386279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111076994|NCT03386279|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111076995|NCT03386279|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111076996|NCT03386279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111076997|NCT03386279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111076998|NCT03386279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111076999|NCT03386279|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111077000|NCT03386201|Methylene Blue|methylene blue|mesh-list
111077001|NCT03386201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111077002|NCT03386201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111077003|NCT03268811|Teduglutide|teduglutide|mesh-list
111077004|NCT03268811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111077005|NCT03268811|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111077006|NCT03268811|Protective Agents|protective agents|mesh-ancestor
111077007|NCT03268811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111077008|NCT03385967|Dexmedetomidine|dexmedetomidine|mesh-list
111077009|NCT03385967|Ropivacaine|ropivacaine|mesh-list
111077010|NCT03385967|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111077011|NCT03385967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111077012|NCT03385967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111077013|NCT03385967|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111077014|NCT03385967|Analgesics|analgesics|mesh-ancestor
111077015|NCT03385967|Sensory System Agents|sensory system agents|mesh-ancestor
111077016|NCT03385967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111077017|NCT03385967|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111077018|NCT03385967|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111077019|NCT03385967|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111077020|NCT03385967|Adrenergic Agents|adrenergic agents|mesh-ancestor
111077021|NCT03385967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111077022|NCT03385967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111077023|NCT03385967|Anesthetics, Local|anesthetics, local|mesh-ancestor
111077024|NCT03385967|Anesthetics|anesthetics|mesh-ancestor
111077025|NCT02732015|Dexamethasone|dexamethasone|mesh-list
111077026|NCT02732015|Dexamethasone acetate|dexamethasone acetate|mesh-list
111077027|NCT02732015|Doxorubicin|doxorubicin|mesh-list
111077028|NCT02732015|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111077029|NCT02732015|Vincristine|vincristine|mesh-list
111077030|NCT02732015|Daunorubicin|daunorubicin|mesh-list
111077031|NCT02732015|Ifosfamide|ifosfamide|mesh-list
111077032|NCT02732015|Isophosphamide mustard|isophosphamide mustard|mesh-list
111077033|NCT02732015|Ondansetron|ondansetron|mesh-list
111077034|NCT02732015|Fosaprepitant|fosaprepitant|mesh-list
111077035|NCT02732015|Aprepitant|aprepitant|mesh-list
111077036|NCT02732015|BB 1101|bb 1101|mesh-list
111077037|NCT02732015|Rolapitant|rolapitant|mesh-list
111077038|NCT02732015|Mesna|mesna|mesh-list
111077039|NCT02732015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111077040|NCT02732015|Antiemetics|antiemetics|mesh-ancestor
111077041|NCT02732015|Autonomic Agents|autonomic agents|mesh-ancestor
111077042|NCT02732015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111077043|NCT02732015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111077044|NCT02732015|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111077045|NCT02732015|Glucocorticoids|glucocorticoids|mesh-ancestor
111077046|NCT02732015|Hormones|hormones|mesh-ancestor
111077047|NCT02732015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111077048|NCT02732015|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111077049|NCT02732015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111077050|NCT02732015|Protease Inhibitors|protease inhibitors|mesh-ancestor
111077051|NCT02732015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111077052|NCT02732015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111077053|NCT02732015|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111077054|NCT02732015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111077055|NCT02732015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111077056|NCT02732015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111077057|NCT02732015|Tubulin Modulators|tubulin modulators|mesh-ancestor
111077058|NCT02732015|Antimitotic Agents|antimitotic agents|mesh-ancestor
111077059|NCT02732015|Mitosis Modulators|mitosis modulators|mesh-ancestor
111077060|NCT02732015|Antipruritics|antipruritics|mesh-ancestor
111077061|NCT02732015|Dermatologic Agents|dermatologic agents|mesh-ancestor
111077062|NCT02732015|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111077063|NCT02732015|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111077064|NCT02732015|Serotonin Agents|serotonin agents|mesh-ancestor
111077065|NCT02732015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111077066|NCT02732015|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111077067|NCT02732015|Alkylating Agents|alkylating agents|mesh-ancestor
111077068|NCT02732015|Protective Agents|protective agents|mesh-ancestor
111077069|NCT02732015|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
111077071|NCT02520245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111077072|NCT02520245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111077073|NCT03537833|Pemetrexed|pemetrexed|mesh-list
111077074|NCT03537833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111077075|NCT03537833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111077076|NCT03537833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111077077|NCT03537833|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111077078|NCT03537833|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111077079|NCT03439085|Durvalumab|durvalumab|mesh-list
111077080|NCT03439085|Interleukin-12|interleukin-12|mesh-list
111077081|NCT03439085|Vaccines|vaccines|mesh-list
111077082|NCT03439085|Immunoglobulins|immunoglobulins|mesh-list
111077083|NCT03439085|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111077084|NCT03439085|Immunoglobulin G|immunoglobulin g|mesh-list
111077085|NCT03439085|Immunologic Factors|immunologic factors|mesh-ancestor
111077086|NCT03439085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111077087|NCT03439085|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111077088|NCT03439085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110639060|NCT00845780|Amiodarone|amiodarone|mesh-list
111077089|NCT03439085|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111077090|NCT03439085|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111077091|NCT03439085|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111077092|NCT03439085|Growth Substances|growth substances|mesh-ancestor
111077093|NCT03439085|Growth Inhibitors|growth inhibitors|mesh-ancestor
111077094|NCT01964807|Nicotine|nicotine|mesh-list
111077095|NCT01964807|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111077096|NCT01964807|Autonomic Agents|autonomic agents|mesh-ancestor
111077097|NCT01964807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111077098|NCT01964807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111077099|NCT01964807|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111077100|NCT01964807|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111077101|NCT01964807|Cholinergic Agents|cholinergic agents|mesh-ancestor
111077102|NCT01964807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111077103|NCT01964807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111077104|NCT00999401|Roscovitine|roscovitine|mesh-list
111077105|NCT00999401|Sapacitabine|sapacitabine|mesh-list
111077106|NCT00999401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111077107|NCT00999401|Antiviral Agents|antiviral agents|mesh-ancestor
111077108|NCT00999401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111077109|NCT00999401|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111077110|NCT00999401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111077111|NCT00999401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111077112|NCT04446065|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
111077113|NCT04446065|Antioxidants|antioxidants|mesh-ancestor
111077114|NCT04446065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111077115|NCT04446065|Protective Agents|protective agents|mesh-ancestor
111077116|NCT04446065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111077117|NCT04446065|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
111077118|NCT04446065|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
111077119|NCT04446065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111077120|NCT04446065|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111077121|NCT00225095|Hyaluronic Acid|hyaluronic acid|mesh-list
111077122|NCT00225095|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111077123|NCT00225095|Immunologic Factors|immunologic factors|mesh-ancestor
111077124|NCT00225095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111077125|NCT00225095|Viscosupplements|viscosupplements|mesh-ancestor
111077126|NCT00225095|Protective Agents|protective agents|mesh-ancestor
111077127|NCT02732119|Everolimus|everolimus|mesh-list
111077128|NCT02732119|Exemestane|exemestane|mesh-list
111077129|NCT02732119|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111077130|NCT02732119|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111077131|NCT02732119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111077132|NCT02732119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111077133|NCT02732119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111077134|NCT02732119|Immunologic Factors|immunologic factors|mesh-ancestor
111077135|NCT02732119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111077136|NCT02732119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111077137|NCT02732119|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111077138|NCT02732119|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111077139|NCT02732119|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111077140|NCT02732119|Hormone Antagonists|hormone antagonists|mesh-ancestor
111077141|NCT02732119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111077143|NCT04448717|Immunologic Factors|immunologic factors|mesh-ancestor
111077144|NCT04448717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111077145|NCT05174195|Desogestrel|desogestrel|mesh-list
111077146|NCT05174195|Etonogestrel|etonogestrel|mesh-list
111077147|NCT05174195|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111077148|NCT05174195|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111077149|NCT05174195|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111077150|NCT05174195|Contraceptive Agents|contraceptive agents|mesh-ancestor
111077151|NCT05174195|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111077152|NCT05174195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111077153|NCT05174195|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111077154|NCT05174195|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111077155|NCT05174195|Progestins|progestins|mesh-ancestor
111077156|NCT05174195|Hormones|hormones|mesh-ancestor
111077157|NCT05174195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111077158|NCT05238727|Carticaine|carticaine|mesh-list
111077159|NCT05238727|Mepivacaine|mepivacaine|mesh-list
111077160|NCT05238727|Anesthetics, Local|anesthetics, local|mesh-ancestor
111077161|NCT05238727|Anesthetics|anesthetics|mesh-ancestor
111077162|NCT05238727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111077163|NCT05238727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111077164|NCT05238727|Sensory System Agents|sensory system agents|mesh-ancestor
111077165|NCT05238727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111077166|NCT03754153|Atropine|atropine|mesh-list
111077167|NCT03754153|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111077168|NCT03754153|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111077169|NCT03754153|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111077170|NCT03754153|Autonomic Agents|autonomic agents|mesh-ancestor
111077171|NCT03754153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111077172|NCT03754153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111077173|NCT03754153|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111077174|NCT03754153|Respiratory System Agents|respiratory system agents|mesh-ancestor
111077176|NCT03754153|Parasympatholytics|parasympatholytics|mesh-ancestor
111077177|NCT03754153|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111077178|NCT03754153|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111077179|NCT03754153|Cholinergic Agents|cholinergic agents|mesh-ancestor
111077180|NCT03754153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111077181|NCT03754153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111077182|NCT03380039|Cyclophosphamide|cyclophosphamide|mesh-list
111077183|NCT03380039|Fludarabine|fludarabine|mesh-list
111077184|NCT03380039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111077185|NCT03380039|Immunologic Factors|immunologic factors|mesh-ancestor
111077186|NCT03380039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111077187|NCT03380039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111077188|NCT03380039|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111077189|NCT03380039|Alkylating Agents|alkylating agents|mesh-ancestor
111077190|NCT03380039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111077191|NCT03380039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111077192|NCT03380039|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111077193|NCT03125213|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
111077194|NCT03125213|Antiviral Agents|antiviral agents|mesh-ancestor
111077195|NCT03125213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111077196|NCT02520817|Vitamins|vitamins|mesh-list
111077197|NCT02520817|Vitamin E|vitamin e|mesh-list
111077198|NCT02520817|Vitamin A|vitamin a|mesh-list
111077199|NCT02520817|Lactulose|lactulose|mesh-list
111077200|NCT02520817|Micronutrients|micronutrients|mesh-ancestor
111077201|NCT02520817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111077202|NCT02520817|Antioxidants|antioxidants|mesh-ancestor
111077203|NCT02520817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111077204|NCT02520817|Protective Agents|protective agents|mesh-ancestor
111077205|NCT02520817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111077206|NCT03387943|Cisplatin|cisplatin|mesh-list
111077207|NCT03387943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111077208|NCT03384095|Hyaluronic Acid|hyaluronic acid|mesh-list
111077209|NCT03384095|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111077210|NCT03384095|Immunologic Factors|immunologic factors|mesh-ancestor
111077211|NCT03384095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111077212|NCT03384095|Viscosupplements|viscosupplements|mesh-ancestor
111077213|NCT03384095|Protective Agents|protective agents|mesh-ancestor
111077214|NCT03379181|Propranolol|propranolol|mesh-list
111077215|NCT03379181|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111077216|NCT03379181|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111077217|NCT03379181|Adrenergic Agents|adrenergic agents|mesh-ancestor
111077218|NCT03379181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111077219|NCT03379181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111077220|NCT03379181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111077221|NCT03379181|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111077222|NCT03379181|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111077223|NCT03379181|Vasodilator Agents|vasodilator agents|mesh-ancestor
111077224|NCT03383939|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
111077225|NCT03383939|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
111077226|NCT03383939|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111077227|NCT03383939|Protease Inhibitors|protease inhibitors|mesh-ancestor
111077228|NCT03383939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111077229|NCT03383939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111077230|NCT03379103|Propofol|propofol|mesh-list
111077231|NCT03379103|Sevoflurane|sevoflurane|mesh-list
111077232|NCT03379103|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111077233|NCT03379103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111077234|NCT03379103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111077235|NCT03379103|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111077236|NCT03379103|Anesthetics, General|anesthetics, general|mesh-ancestor
111077237|NCT03379103|Anesthetics|anesthetics|mesh-ancestor
111077238|NCT03379103|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111077239|NCT03379103|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111077240|NCT03387631|Lumefantrine|lumefantrine|mesh-list
111077241|NCT03387631|Artemether|artemether|mesh-list
111077242|NCT03387631|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
111077243|NCT03387631|Antimalarials|antimalarials|mesh-ancestor
111077244|NCT03387631|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111077245|NCT03387631|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111077246|NCT03387631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111077247|NCT03383393|Adenosine|adenosine|mesh-list
111077248|NCT03383393|Eptifibatide|eptifibatide|mesh-list
111077249|NCT03383393|Analgesics|analgesics|mesh-ancestor
111077250|NCT03383393|Sensory System Agents|sensory system agents|mesh-ancestor
111077251|NCT03383393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111077252|NCT03383393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111077253|NCT03383393|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111077254|NCT03383393|Vasodilator Agents|vasodilator agents|mesh-ancestor
111077255|NCT03383393|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
111077256|NCT03383393|Purinergic Agonists|purinergic agonists|mesh-ancestor
111077257|NCT03383393|Purinergic Agents|purinergic agents|mesh-ancestor
111077258|NCT03383393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111077259|NCT03383393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111077260|NCT03383393|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111077261|NCT03394807|Levobupivacaine|levobupivacaine|mesh-list
111077262|NCT03394807|Anesthetics, Local|anesthetics, local|mesh-ancestor
111077263|NCT03394807|Anesthetics|anesthetics|mesh-ancestor
111077264|NCT03394807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111077265|NCT03394807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111077266|NCT03394807|Sensory System Agents|sensory system agents|mesh-ancestor
111077267|NCT03394807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111077268|NCT03383315|Tramadol|tramadol|mesh-list
111077269|NCT03383315|Metoclopramide|metoclopramide|mesh-list
111077270|NCT03383315|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111077271|NCT03383315|Narcotics|narcotics|mesh-ancestor
111077272|NCT03383315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111077273|NCT03383315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111077274|NCT03383315|Analgesics|analgesics|mesh-ancestor
111077275|NCT03383315|Sensory System Agents|sensory system agents|mesh-ancestor
111077276|NCT03383315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111077277|NCT03383315|Antiemetics|antiemetics|mesh-ancestor
111077278|NCT03383315|Autonomic Agents|autonomic agents|mesh-ancestor
111077279|NCT03383315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111077280|NCT03383315|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111077281|NCT03383315|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111077282|NCT03383315|Dopamine Agents|dopamine agents|mesh-ancestor
111077283|NCT03383315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111077284|NCT03383315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111077285|NCT03394729|Propolis|propolis|mesh-list
111077286|NCT03394729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111077287|NCT03252925|Acetylcysteine|acetylcysteine|mesh-list
111077288|NCT03252925|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111077289|NCT03252925|Antiviral Agents|antiviral agents|mesh-ancestor
111077290|NCT03252925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111077291|NCT03252925|Expectorants|expectorants|mesh-ancestor
111077292|NCT03252925|Respiratory System Agents|respiratory system agents|mesh-ancestor
111077293|NCT03252925|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111077294|NCT03252925|Antioxidants|antioxidants|mesh-ancestor
111077295|NCT03252925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111077296|NCT03252925|Protective Agents|protective agents|mesh-ancestor
111077297|NCT03252925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111077298|NCT03252925|Antidotes|antidotes|mesh-ancestor
111077300|NCT03383237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111077301|NCT03383237|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111077302|NCT03383237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111077303|NCT03383237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111077304|NCT03387241|Fluticasone|fluticasone|mesh-list
111077305|NCT03387241|Xhance|xhance|mesh-list
111077306|NCT03387241|Formoterol Fumarate|formoterol fumarate|mesh-list
111077307|NCT03387241|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
111077308|NCT03387241|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
111077309|NCT03387241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111077310|NCT03387241|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111077311|NCT03387241|Autonomic Agents|autonomic agents|mesh-ancestor
111077312|NCT03387241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111077313|NCT03387241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111077314|NCT03387241|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111077315|NCT03387241|Respiratory System Agents|respiratory system agents|mesh-ancestor
111077316|NCT03387241|Dermatologic Agents|dermatologic agents|mesh-ancestor
111077317|NCT03387241|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111077318|NCT03387241|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111077319|NCT03387241|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111077320|NCT03387241|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111077321|NCT03387241|Adrenergic Agents|adrenergic agents|mesh-ancestor
111077322|NCT03387241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111077323|NCT03387241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111077324|NCT03387241|Glucocorticoids|glucocorticoids|mesh-ancestor
111077325|NCT03387241|Hormones|hormones|mesh-ancestor
111077326|NCT03387241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111077327|NCT03387241|Sympathomimetics|sympathomimetics|mesh-ancestor
111077328|NCT03378791|Ferrous fumarate|ferrous fumarate|mesh-list
111077329|NCT03378791|Trace Elements|trace elements|mesh-ancestor
111077330|NCT03378791|Micronutrients|micronutrients|mesh-ancestor
111077331|NCT03378791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111077332|NCT03383003|Amoxicillin|amoxicillin|mesh-list
111077333|NCT03383003|Metronidazole|metronidazole|mesh-list
111077334|NCT03383003|Clarithromycin|clarithromycin|mesh-list
111077335|NCT03383003|Esomeprazole|esomeprazole|mesh-list
111077336|NCT03383003|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111077337|NCT03383003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111077338|NCT03383003|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111077339|NCT03383003|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111077340|NCT03383003|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111077341|NCT03383003|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111077342|NCT03383003|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111077343|NCT03383003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111077344|NCT03383003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111077345|NCT03383003|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111077346|NCT03383003|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111077347|NCT03383003|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111077348|NCT03378713|Methyltestosterone|methyltestosterone|mesh-list
111077349|NCT03378713|Testosterone|testosterone|mesh-list
111077350|NCT03378713|Testosterone undecanoate|testosterone undecanoate|mesh-list
111077351|NCT03378713|Testosterone enanthate|testosterone enanthate|mesh-list
111077352|NCT03378713|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
111077353|NCT03378713|Androgens|androgens|mesh-ancestor
111077354|NCT03378713|Hormones|hormones|mesh-ancestor
111077355|NCT03378713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111077356|NCT03378713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111077357|NCT03378713|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111077358|NCT03378713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111077359|NCT03378713|Anabolic Agents|anabolic agents|mesh-ancestor
111077360|NCT03378401|Octenidine|octenidine|mesh-list
111077361|NCT03378401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111077362|NCT03378401|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111077363|NCT03378323|Anesthetics|anesthetics|mesh-list
111077364|NCT03378323|Anesthetics, Local|anesthetics, local|mesh-list
111077365|NCT03378323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111077366|NCT03378323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111077367|NCT03378323|Sensory System Agents|sensory system agents|mesh-ancestor
111077368|NCT03378323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111077369|NCT01327885|Dacarbazine|dacarbazine|mesh-list
111077370|NCT01327885|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111077371|NCT01327885|Alkylating Agents|alkylating agents|mesh-ancestor
111077372|NCT01327885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111077373|NCT01327885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111077374|NCT03381833|Hepcidins|hepcidins|mesh-list
111077375|NCT03381833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111077376|NCT02976337|Naloxone|naloxone|mesh-list
111077377|NCT02976337|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111077378|NCT02976337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111077379|NCT02976337|Sensory System Agents|sensory system agents|mesh-ancestor
111077380|NCT02976337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111077381|NCT03377465|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
111077382|NCT03377465|N,N-dimethylarginine|n,n-dimethylarginine|mesh-list
111077383|NCT03377465|Natriuretic Agents|natriuretic agents|mesh-ancestor
111077384|NCT03377465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111077385|NCT03377465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111077386|NCT03377465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111077387|NCT03381755|Ticagrelor|ticagrelor|mesh-list
111077388|NCT03381755|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111077389|NCT03381755|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111077390|NCT03381755|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111077391|NCT03381755|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111077392|NCT03381755|Purinergic Agents|purinergic agents|mesh-ancestor
111077393|NCT03381755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111077394|NCT03381755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111077395|NCT03381755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111077396|NCT03387163|Valsartan|valsartan|mesh-list
111077397|NCT03387163|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
110677087|NCT02813135|Dexamethasone|dexamethasone|mesh-list
111077398|NCT03387163|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111077399|NCT03387163|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111077400|NCT03387163|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111077401|NCT03387163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111077402|NCT04446403|Anesthetics|anesthetics|mesh-list
111077403|NCT04446403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111077404|NCT04446403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111077405|NCT05237791|Magnesium Sulfate|magnesium sulfate|mesh-list
111077406|NCT05237791|Analgesics|analgesics|mesh-ancestor
111077407|NCT05237791|Sensory System Agents|sensory system agents|mesh-ancestor
111077408|NCT05237791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111077409|NCT05237791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111077410|NCT05237791|Anesthetics|anesthetics|mesh-ancestor
111077411|NCT05237791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111077412|NCT05237791|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111077413|NCT05237791|Anticonvulsants|anticonvulsants|mesh-ancestor
111077414|NCT05237791|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111077415|NCT05237791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111077416|NCT05237791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111077417|NCT05237791|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111077418|NCT05237791|Tocolytic Agents|tocolytic agents|mesh-ancestor
111077419|NCT05237791|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111077420|NCT03381599|Lenograstim|lenograstim|mesh-list
111077421|NCT03381599|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111077422|NCT03381599|Immunologic Factors|immunologic factors|mesh-ancestor
111077423|NCT03381599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111077424|NCT03394573|Aflibercept|aflibercept|mesh-list
111077425|NCT03394573|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111077426|NCT03394573|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111077427|NCT03394573|Growth Substances|growth substances|mesh-ancestor
111077428|NCT03394573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111077429|NCT03394573|Growth Inhibitors|growth inhibitors|mesh-ancestor
111077430|NCT03394573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111077431|NCT03381053|Imatinib Mesylate|imatinib mesylate|mesh-list
111077432|NCT03381053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111077433|NCT03381053|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110794554|NCT04240821|Respiratory System Agents|respiratory system agents|mesh-ancestor
111077434|NCT03381053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111077435|NCT03381053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111077436|NCT03380975|Montelukast|montelukast|mesh-list
111077437|NCT03380975|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111077438|NCT03380975|Respiratory System Agents|respiratory system agents|mesh-ancestor
111077439|NCT03380975|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
111077440|NCT03380975|Hormone Antagonists|hormone antagonists|mesh-ancestor
111077441|NCT03380975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111077442|NCT03380975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111077443|NCT03380975|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
111077444|NCT03380975|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111077445|NCT03380975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111077446|NCT03460015|Propofol|propofol|mesh-list
111077447|NCT03460015|Sevoflurane|sevoflurane|mesh-list
111077448|NCT03460015|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111077449|NCT03460015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111077450|NCT03460015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111077451|NCT03460015|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111077452|NCT03460015|Anesthetics, General|anesthetics, general|mesh-ancestor
111077453|NCT03460015|Anesthetics|anesthetics|mesh-ancestor
111077454|NCT03460015|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111077455|NCT03460015|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111077456|NCT03376841|Cenicriviroc|cenicriviroc|mesh-list
111077457|NCT03376841|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
111077458|NCT03376841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111077459|NCT03376841|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111077460|NCT03376841|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111077461|NCT03376841|Antiviral Agents|antiviral agents|mesh-ancestor
111077462|NCT03376841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111077463|NCT03375515|Hydromorphone|hydromorphone|mesh-list
111077464|NCT03375515|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111077465|NCT03375515|Narcotics|narcotics|mesh-ancestor
111077466|NCT03375515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111077467|NCT03375515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111077468|NCT03375515|Analgesics|analgesics|mesh-ancestor
111077469|NCT03375515|Sensory System Agents|sensory system agents|mesh-ancestor
111077470|NCT03375515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111077471|NCT03099863|Bacitracin zinc, neomycin sulfate, polymyxin B, drug combination|bacitracin zinc, neomycin sulfate, polymyxin b, drug combination|mesh-list
111077472|NCT03099863|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111077473|NCT03099863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111077474|NCT03099863|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111077475|NCT03374501|PAZ320|paz320|mesh-list
111077476|NCT03374501|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111077477|NCT03374501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111077478|NCT03374345|Juzentaihoto|juzentaihoto|mesh-list
111077479|NCT03374345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111077480|NCT03374345|Mitogens|mitogens|mesh-ancestor
111077481|NCT03374345|Mitosis Modulators|mitosis modulators|mesh-ancestor
111077482|NCT03374345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111077483|NCT03373955|Pembrolizumab|pembrolizumab|mesh-list
111077484|NCT03373955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111077485|NCT03373955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111077486|NCT03373955|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111077487|NCT03373955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111077488|NCT02814695|Ascorbic Acid|ascorbic acid|mesh-list
111077489|NCT02814695|Antioxidants|antioxidants|mesh-ancestor
111077490|NCT02814695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111077491|NCT02814695|Protective Agents|protective agents|mesh-ancestor
111077492|NCT02814695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111077493|NCT02814695|Vitamins|vitamins|mesh-ancestor
111077494|NCT02814695|Micronutrients|micronutrients|mesh-ancestor
111077495|NCT03386305|Tacrolimus|tacrolimus|mesh-list
111077496|NCT03386305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111077497|NCT03386305|Immunologic Factors|immunologic factors|mesh-ancestor
111077498|NCT03386305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111077499|NCT03386305|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111077500|NCT03386305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111077501|NCT03386305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111077502|NCT03386227|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111077503|NCT03386227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111077504|NCT05237323|Mycophenolic Acid|mycophenolic acid|mesh-list
111077505|NCT05237323|Azathioprine|azathioprine|mesh-list
111077506|NCT05237323|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111077507|NCT05237323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111077508|NCT05237323|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111077509|NCT05237323|Antitubercular Agents|antitubercular agents|mesh-ancestor
111077510|NCT05237323|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111077511|NCT05237323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111077512|NCT05237323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111077513|NCT05237323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111077514|NCT05237323|Antimetabolites|antimetabolites|mesh-ancestor
111077515|NCT05237323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111077516|NCT05237323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111077517|NCT05237323|Immunologic Factors|immunologic factors|mesh-ancestor
111077518|NCT05237323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111077519|NCT05237323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111077521|NCT02520505|Sodium Citrate|sodium citrate|mesh-list
111077522|NCT02520505|Clomiphene|clomiphene|mesh-list
111077523|NCT02520505|Enclomiphene|enclomiphene|mesh-list
111077524|NCT02520505|Zuclomiphene|zuclomiphene|mesh-list
111077525|NCT02520505|Anticoagulants|anticoagulants|mesh-ancestor
111077526|NCT02520505|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
111077527|NCT02520505|Chelating Agents|chelating agents|mesh-ancestor
111077528|NCT02520505|Sequestering Agents|sequestering agents|mesh-ancestor
111077529|NCT02520505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111077530|NCT02520505|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111077531|NCT02520505|Hormone Antagonists|hormone antagonists|mesh-ancestor
111077532|NCT02520505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111077533|NCT02520505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111077534|NCT02520505|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111077535|NCT02520505|Fertility Agents|fertility agents|mesh-ancestor
111077536|NCT02520505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111077537|NCT02520505|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111077538|NCT02520505|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111077539|NCT03380689|Bevacizumab|bevacizumab|mesh-list
111077540|NCT03380689|Irinotecan|irinotecan|mesh-list
111077541|NCT03380689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111077542|NCT03380689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111077543|NCT03380689|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111077544|NCT03380689|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111077545|NCT03380689|Growth Substances|growth substances|mesh-ancestor
111077546|NCT03380689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111077547|NCT03380689|Growth Inhibitors|growth inhibitors|mesh-ancestor
111077548|NCT03380689|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111077549|NCT03380689|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111077550|NCT03380689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111077551|NCT03380689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111077552|NCT03380533|Buprenorphine|buprenorphine|mesh-list
111077553|NCT03380533|Tramadol|tramadol|mesh-list
111077554|NCT03380533|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111077555|NCT03380533|Narcotics|narcotics|mesh-ancestor
111077556|NCT03380533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111077557|NCT03380533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111077558|NCT03380533|Analgesics|analgesics|mesh-ancestor
111077559|NCT03380533|Sensory System Agents|sensory system agents|mesh-ancestor
111077560|NCT03380533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111077561|NCT03380533|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111077562|NCT03386149|Loxoprofen|loxoprofen|mesh-list
111077563|NCT03386149|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111077564|NCT03386149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111077565|NCT03386149|Analgesics|analgesics|mesh-ancestor
111077566|NCT03386149|Sensory System Agents|sensory system agents|mesh-ancestor
111077567|NCT03386149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111077568|NCT03386149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111077569|NCT03386149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111077570|NCT03386149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111077571|NCT03386071|Trametinib|trametinib|mesh-list
111077572|NCT03386071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111077573|NCT03386071|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111077574|NCT03386071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111077575|NCT03386071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111077576|NCT03231085|Ferrous fumarate|ferrous fumarate|mesh-list
111077577|NCT03231085|Trace Elements|trace elements|mesh-ancestor
111077578|NCT03231085|Micronutrients|micronutrients|mesh-ancestor
111077579|NCT03231085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111077580|NCT03385135|Allopurinol|allopurinol|mesh-list
111077581|NCT03385135|Antimetabolites|antimetabolites|mesh-ancestor
111077582|NCT03385135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111077584|NCT03385135|Gout Suppressants|gout suppressants|mesh-ancestor
111077585|NCT03385135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111077586|NCT03385135|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111077587|NCT03385135|Antioxidants|antioxidants|mesh-ancestor
111077588|NCT03385135|Protective Agents|protective agents|mesh-ancestor
111077589|NCT03385135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111077590|NCT00462943|Homoharringtonine|homoharringtonine|mesh-list
111077591|NCT00462943|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111077592|NCT00462943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111077593|NCT00462943|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111077594|NCT00462943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111077595|NCT00462943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111077596|NCT04436965|Cisplatin|cisplatin|mesh-list
111077597|NCT04436965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111077598|NCT04420741|Iloprost|iloprost|mesh-list
111077599|NCT04420741|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111077600|NCT04420741|Vasodilator Agents|vasodilator agents|mesh-ancestor
111077601|NCT04409041|Naltrexone|naltrexone|mesh-list
111077602|NCT04409041|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111077603|NCT04409041|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111077604|NCT04409041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111077605|NCT04409041|Sensory System Agents|sensory system agents|mesh-ancestor
111077606|NCT04409041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111077607|NCT03090997|Vitamins|vitamins|mesh-list
111077608|NCT03090997|Ascorbic Acid|ascorbic acid|mesh-list
111077609|NCT03090997|Resveratrol|resveratrol|mesh-list
111077610|NCT03090997|Micronutrients|micronutrients|mesh-ancestor
111077611|NCT03090997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111077612|NCT03090997|Antioxidants|antioxidants|mesh-ancestor
111077613|NCT03090997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111077614|NCT03090997|Protective Agents|protective agents|mesh-ancestor
111077615|NCT03090997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111077616|NCT03090997|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111077617|NCT04446091|Irinotecan|irinotecan|mesh-list
111077618|NCT04446091|Apatinib|apatinib|mesh-list
111077619|NCT04446091|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
111077620|NCT04446091|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111077621|NCT04446091|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111077622|NCT04446091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111077623|NCT04446091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111077624|NCT04446091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111077625|NCT04446091|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111077626|NCT04446091|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111077627|NCT04446091|Growth Substances|growth substances|mesh-ancestor
111077628|NCT04446091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111077629|NCT04446091|Growth Inhibitors|growth inhibitors|mesh-ancestor
111077630|NCT04445935|Bivalirudin|bivalirudin|mesh-list
111077631|NCT04445935|Antithrombins|antithrombins|mesh-ancestor
111077632|NCT04445935|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111077633|NCT04445935|Protease Inhibitors|protease inhibitors|mesh-ancestor
111077634|NCT04445935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111077635|NCT04445935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111077636|NCT04445935|Anticoagulants|anticoagulants|mesh-ancestor
111077637|NCT03385057|Acetaminophen|acetaminophen|mesh-list
111077639|NCT03385057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111077640|NCT03385057|Analgesics|analgesics|mesh-ancestor
111077641|NCT03385057|Sensory System Agents|sensory system agents|mesh-ancestor
111077642|NCT03385057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111077643|NCT03385057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111077644|NCT03385057|Antipyretics|antipyretics|mesh-ancestor
111077645|NCT03385057|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111077646|NCT03385057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111077647|NCT03385057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111077648|NCT03385057|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111077649|NCT03385057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111077650|NCT03385057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111077651|NCT02051309|Guanfacine|guanfacine|mesh-list
111077652|NCT02051309|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111077653|NCT02051309|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111077654|NCT02051309|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111077655|NCT02051309|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111077656|NCT02051309|Adrenergic Agents|adrenergic agents|mesh-ancestor
111077657|NCT02051309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110794777|NCT02754765|Linezolid|linezolid|mesh-list
110639164|NCT00854204|Darunavir|darunavir|mesh-list
111077658|NCT02051309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111077659|NCT02051309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111077660|NCT00372073|Roscovitine|roscovitine|mesh-list
111077661|NCT00372073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111077662|NCT00372073|Antiviral Agents|antiviral agents|mesh-ancestor
111077663|NCT00372073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111077664|NCT00372073|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111077665|NCT00372073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111077666|NCT00372073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111077667|NCT03373409|Albuterol|albuterol|mesh-list
111077668|NCT03373409|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111077669|NCT03373409|Autonomic Agents|autonomic agents|mesh-ancestor
111077670|NCT03373409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111077671|NCT03373409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111077672|NCT03373409|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111077673|NCT03373409|Respiratory System Agents|respiratory system agents|mesh-ancestor
111077674|NCT03373409|Tocolytic Agents|tocolytic agents|mesh-ancestor
111077675|NCT03373409|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111077676|NCT03373409|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111077677|NCT03373409|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111077678|NCT03373409|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111077679|NCT03373409|Adrenergic Agents|adrenergic agents|mesh-ancestor
111077680|NCT03373409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111077681|NCT03373409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111077682|NCT03379987|Morphine|morphine|mesh-list
111077683|NCT03379987|Bupivacaine|bupivacaine|mesh-list
111077684|NCT03379987|Anesthetics, Local|anesthetics, local|mesh-ancestor
111077685|NCT03379987|Anesthetics|anesthetics|mesh-ancestor
111077686|NCT03379987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111077687|NCT03379987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111077688|NCT03379987|Sensory System Agents|sensory system agents|mesh-ancestor
111077689|NCT03379987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111077690|NCT03379987|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111077691|NCT03379987|Narcotics|narcotics|mesh-ancestor
111077692|NCT03379987|Analgesics|analgesics|mesh-ancestor
111077693|NCT02730793|Aztreonam|aztreonam|mesh-list
111077694|NCT02730793|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111077695|NCT02730793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111077696|NCT02678533|Plerixafor|plerixafor|mesh-list
111077697|NCT02678533|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111077698|NCT02678533|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111077699|NCT02678533|Antiviral Agents|antiviral agents|mesh-ancestor
111077700|NCT02678533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111077701|NCT03379441|Pembrolizumab|pembrolizumab|mesh-list
111077702|NCT03379441|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111077703|NCT03379441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111077704|NCT03379441|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111077705|NCT03379441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111077706|NCT03384511|Apatinib|apatinib|mesh-list
111077707|NCT03384511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111077708|NCT03384511|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111077709|NCT03384511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111077710|NCT03384511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111077711|NCT03385525|Valproic Acid|valproic acid|mesh-list
111077712|NCT03385525|Anticonvulsants|anticonvulsants|mesh-ancestor
111077713|NCT03385525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111077714|NCT03385525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111077715|NCT03385525|GABA Agents|gaba agents|mesh-ancestor
111077716|NCT03385525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111077717|NCT03385525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111077718|NCT03385525|Antimanic Agents|antimanic agents|mesh-ancestor
111077719|NCT03385525|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111077720|NCT03385525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111077721|NCT03385525|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111077722|NCT05172739|Analgesics, Opioid|analgesics, opioid|mesh-list
111077723|NCT05172739|Anesthetics|anesthetics|mesh-list
111077724|NCT05172739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111077725|NCT05172739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111077726|NCT05172739|Narcotics|narcotics|mesh-ancestor
111077727|NCT05172739|Analgesics|analgesics|mesh-ancestor
111077728|NCT05172739|Sensory System Agents|sensory system agents|mesh-ancestor
111077729|NCT05172739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111077730|NCT03375463|Tirzepatide|tirzepatide|mesh-list
111077731|NCT03375463|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111077732|NCT03375463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111077733|NCT03375463|Incretins|incretins|mesh-ancestor
111077735|NCT03375463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111077736|NCT04445623|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
111077737|NCT04445623|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111077738|NCT04445311|Ivermectin|ivermectin|mesh-list
111077739|NCT04445311|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111077740|NCT04445311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111077741|NCT03384121|Rifampin|rifampin|mesh-list
111077742|NCT03384121|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111077743|NCT03384121|Antitubercular Agents|antitubercular agents|mesh-ancestor
111077744|NCT03384121|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111077745|NCT03384121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111077746|NCT03384121|Leprostatic Agents|leprostatic agents|mesh-ancestor
111077747|NCT03384121|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111077748|NCT03384121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111077749|NCT03384121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111077750|NCT03384121|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111077751|NCT03384121|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111077752|NCT03384121|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
111077753|NCT03384121|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
111077754|NCT03384121|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
111077755|NCT03384121|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111077756|NCT03378661|Benzonidazole|benzonidazole|mesh-list
111077757|NCT03378661|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111077758|NCT03378661|Immunologic Factors|immunologic factors|mesh-ancestor
111077759|NCT03378661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111077760|NCT03378661|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
111077761|NCT03378661|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111077762|NCT03378661|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111077763|NCT03378661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111077764|NCT03378427|Doxycycline|doxycycline|mesh-list
111077765|NCT03378427|Ciprofloxacin|ciprofloxacin|mesh-list
111077766|NCT03378427|Levofloxacin|levofloxacin|mesh-list
111077767|NCT03378427|Ofloxacin|ofloxacin|mesh-list
111077768|NCT03378427|Minocycline|minocycline|mesh-list
111077769|NCT03378427|Rifampin|rifampin|mesh-list
111077770|NCT03378427|Clindamycin|clindamycin|mesh-list
110677092|NCT02813135|Irinotecan|irinotecan|mesh-list
111077771|NCT03378427|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
111077772|NCT03378427|Tedizolid|tedizolid|mesh-list
111077773|NCT03378427|Teicoplanin|teicoplanin|mesh-list
111077774|NCT03378427|Fusidic Acid|fusidic acid|mesh-list
111077775|NCT03378427|Tedizolid phosphate|tedizolid phosphate|mesh-list
111077776|NCT03378427|Trimethoprim|trimethoprim|mesh-list
111077777|NCT03378427|Sulfamethoxazole|sulfamethoxazole|mesh-list
111077778|NCT03378427|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111077779|NCT03378427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111077780|NCT03378427|Antimalarials|antimalarials|mesh-ancestor
110639195|NCT02545244|Chlorhexidine|chlorhexidine|mesh-list
111077781|NCT03378427|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111077782|NCT03378427|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111077783|NCT03378427|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111077784|NCT03378427|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111077785|NCT03378427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111077786|NCT03378427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111077787|NCT03378427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111077788|NCT03378427|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111077789|NCT03378427|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111077790|NCT03378427|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111077791|NCT03378427|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111077792|NCT03378427|Antitubercular Agents|antitubercular agents|mesh-ancestor
111077793|NCT03378427|Leprostatic Agents|leprostatic agents|mesh-ancestor
111077794|NCT03378427|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111077795|NCT03378427|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111077796|NCT03378427|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111077797|NCT03378427|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
111077798|NCT03378427|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
111077799|NCT03378427|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
111077800|NCT03378427|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111077801|NCT03378427|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111077802|NCT03378427|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111077803|NCT03378427|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111077804|NCT03378427|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
111077805|NCT05172115|Heparin|heparin|mesh-list
111077806|NCT05172115|Enoxaparin|enoxaparin|mesh-list
111077807|NCT05172115|Plasminogen|plasminogen|mesh-list
110794932|NCT01185015|Nicorandil|nicorandil|mesh-list
111077808|NCT05172115|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
111077809|NCT05172115|Tinzaparin|tinzaparin|mesh-list
111077810|NCT05172115|Dalteparin|dalteparin|mesh-list
111077811|NCT05172115|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
111077812|NCT05172115|Anticoagulants|anticoagulants|mesh-ancestor
111077813|NCT05172115|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111077814|NCT05172115|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111077815|NCT05172115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111077816|NCT03383185|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
111077817|NCT03383185|Contraceptive Agents|contraceptive agents|mesh-list
111077818|NCT03383185|Medroxyprogesterone|medroxyprogesterone|mesh-list
111077819|NCT03383185|Contraceptives, Oral|contraceptives, oral|mesh-list
111077820|NCT03383185|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
111077821|NCT03383185|Progestins|progestins|mesh-list
111077822|NCT03383185|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111077823|NCT03383185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111077824|NCT03383185|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111077825|NCT03383185|Hormones|hormones|mesh-ancestor
111077826|NCT03383185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111077827|NCT03383185|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111077828|NCT03383185|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110542921|NCT00867087|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
111077829|NCT03383185|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111077830|NCT03383185|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
111077831|NCT03383185|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111077832|NCT03383185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111077833|NCT03374293|Antibodies|antibodies|mesh-list
111077834|NCT03374293|Immunologic Factors|immunologic factors|mesh-ancestor
111077835|NCT03374293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111077836|NCT02730871|Timolol|timolol|mesh-list
111077837|NCT02730871|Brimonidine Tartrate|brimonidine tartrate|mesh-list
111077838|NCT02730871|Travoprost|travoprost|mesh-list
111077839|NCT02730871|Brinzolamide|brinzolamide|mesh-list
111077840|NCT02730871|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111077841|NCT02730871|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111077842|NCT02730871|Adrenergic Agents|adrenergic agents|mesh-ancestor
111077843|NCT02730871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111077844|NCT02730871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111077845|NCT02730871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111077846|NCT02730871|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111077847|NCT02730871|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111077848|NCT02730871|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111077849|NCT02730871|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111077850|NCT02730871|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111077851|NCT02730871|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
111077852|NCT02730871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111077853|NCT03377335|Metformin|metformin|mesh-list
111077854|NCT03377335|Dapagliflozin|dapagliflozin|mesh-list
111077855|NCT03377335|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111077856|NCT03377335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111077857|NCT03377335|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111077858|NCT03377335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111077859|NCT03377257|Oxazolidinones|oxazolidinones|mesh-list
111077860|NCT03377257|Zolmitriptan|zolmitriptan|mesh-list
111077861|NCT03377257|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111077862|NCT03377257|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111077863|NCT03377257|Serotonin Agents|serotonin agents|mesh-ancestor
111077864|NCT03377257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111077865|NCT03377257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111077866|NCT03377257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111077867|NCT03377257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111077868|NCT03377257|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111077869|NCT03377257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111077870|NCT03373903|Everolimus|everolimus|mesh-list
111077871|NCT03373903|Dactolisib|dactolisib|mesh-list
111077872|NCT03373903|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111077873|NCT03373903|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111077874|NCT03373903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111077875|NCT03373903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111077876|NCT03373903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111077877|NCT03373903|Immunologic Factors|immunologic factors|mesh-ancestor
111077878|NCT03373903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111077879|NCT03373903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111077880|NCT04445857|Calcitonin|calcitonin|mesh-list
111077881|NCT04445857|Salmon calcitonin|salmon calcitonin|mesh-list
111077882|NCT04445857|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
111077883|NCT04445857|Katacalcin|katacalcin|mesh-list
111077884|NCT04445857|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111077885|NCT04445857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111077886|NCT04445857|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111077887|NCT04445857|Vasodilator Agents|vasodilator agents|mesh-ancestor
111077888|NCT03373825|Fentanyl|fentanyl|mesh-list
111077889|NCT03373825|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111077890|NCT03373825|Narcotics|narcotics|mesh-ancestor
111077891|NCT03373825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111077892|NCT03373825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111077893|NCT03373825|Analgesics|analgesics|mesh-ancestor
111077894|NCT03373825|Sensory System Agents|sensory system agents|mesh-ancestor
111077895|NCT03373825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111077896|NCT03373825|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111077897|NCT03373825|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111077898|NCT03373825|Anesthetics, General|anesthetics, general|mesh-ancestor
111077899|NCT03373825|Anesthetics|anesthetics|mesh-ancestor
111077900|NCT04445779|Ubiquinone|ubiquinone|mesh-list
111077901|NCT04445779|Coenzyme Q10|coenzyme q10|mesh-list
111077902|NCT04445779|Micronutrients|micronutrients|mesh-ancestor
111077903|NCT04445779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111077904|NCT04445779|Vitamins|vitamins|mesh-ancestor
111077905|NCT03377101|Fulvestrant|fulvestrant|mesh-list
111077906|NCT03377101|Palbociclib|palbociclib|mesh-list
111077907|NCT03377101|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111077908|NCT03377101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111077909|NCT03377101|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
111077910|NCT03377101|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111077911|NCT03377101|Hormone Antagonists|hormone antagonists|mesh-ancestor
111077912|NCT03377101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111077913|NCT03377101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111077914|NCT03377101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111077915|NCT03377101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111077916|NCT03377101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111077917|NCT04445467|Favipiravir|favipiravir|mesh-list
111077918|NCT04445467|Antiviral Agents|antiviral agents|mesh-ancestor
111077919|NCT04445467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111077920|NCT03373669|Vaccines|vaccines|mesh-list
111077921|NCT03373669|Immunologic Factors|immunologic factors|mesh-ancestor
111077922|NCT03373669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111077923|NCT03382717|Amorolfine|amorolfine|mesh-list
111077924|NCT03382717|Antifungal Agents|antifungal agents|mesh-ancestor
111077925|NCT03382717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111077926|NCT03125473|Vaccines|vaccines|mesh-list
111077927|NCT03125473|Immunologic Factors|immunologic factors|mesh-ancestor
111077928|NCT03125473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111077929|NCT03376789|MYL-1501D|myl-1501d|mesh-list
111077930|NCT03376789|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111077931|NCT03376789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111077932|NCT03376555|Nitroglycerin|nitroglycerin|mesh-list
111077933|NCT03376555|Acetylcholine|acetylcholine|mesh-list
111077934|NCT03376555|Vasodilator Agents|vasodilator agents|mesh-ancestor
111077935|NCT03376555|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111077936|NCT03376555|Cholinergic Agents|cholinergic agents|mesh-ancestor
111077937|NCT03376555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111077938|NCT03376555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111077939|NCT03376555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111077940|NCT03376243|Emollients|emollients|mesh-list
111077941|NCT03376243|Dermatologic Agents|dermatologic agents|mesh-ancestor
111077942|NCT03381859|Grazoprevir|grazoprevir|mesh-list
111077943|NCT03381859|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
111077944|NCT03381859|Antiviral Agents|antiviral agents|mesh-ancestor
111077945|NCT03381859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111077946|NCT03381781|Cytarabine|cytarabine|mesh-list
111077947|NCT03381781|Decitabine|decitabine|mesh-list
111077948|NCT03381781|Arsenic Trioxide|arsenic trioxide|mesh-list
111077949|NCT03381781|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111077950|NCT03381781|Antimetabolites|antimetabolites|mesh-ancestor
111077951|NCT03381781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111077952|NCT03381781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111077953|NCT03381781|Antiviral Agents|antiviral agents|mesh-ancestor
111077954|NCT03381781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111077955|NCT03381781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111077956|NCT03381781|Immunologic Factors|immunologic factors|mesh-ancestor
111077957|NCT03381781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111077958|NCT03381781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111077959|NCT03381703|YH12852|yh12852|mesh-list
111077960|NCT03381703|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
111077961|NCT03381703|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111077962|NCT03381703|Serotonin Agents|serotonin agents|mesh-ancestor
111077963|NCT03381703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111077964|NCT03381703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111077965|NCT03381703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111077966|NCT03372265|Ropivacaine|ropivacaine|mesh-list
111077967|NCT03372265|Anesthetics, Local|anesthetics, local|mesh-ancestor
111077968|NCT03372265|Anesthetics|anesthetics|mesh-ancestor
111077969|NCT03372265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111077970|NCT03372265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111077971|NCT03372265|Sensory System Agents|sensory system agents|mesh-ancestor
111077972|NCT03372265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111077973|NCT03372109|Calcium|calcium|mesh-list
111077974|NCT03372109|Turmeric extract|turmeric extract|mesh-list
111077975|NCT03372109|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111077976|NCT03372109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111077977|NCT03372109|Antioxidants|antioxidants|mesh-ancestor
111077978|NCT03372109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111077979|NCT03372109|Protective Agents|protective agents|mesh-ancestor
111077980|NCT03371953|Atracurium|atracurium|mesh-list
111077982|NCT03371953|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
111077983|NCT03371953|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
111077984|NCT03371953|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111077985|NCT03371953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111077986|NCT03371953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111077987|NCT03371953|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
111077988|NCT03371953|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111077989|NCT03371953|Cholinergic Agents|cholinergic agents|mesh-ancestor
111077990|NCT03371953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111077991|NCT03371953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111077992|NCT03371797|Amlodipine|amlodipine|mesh-list
111077993|NCT03371797|Valsartan|valsartan|mesh-list
111077994|NCT03371797|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111077995|NCT03371797|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111077996|NCT03371797|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111077997|NCT03371797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111077998|NCT03371797|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111077999|NCT03371797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111078000|NCT03371797|Vasodilator Agents|vasodilator agents|mesh-ancestor
111078001|NCT03371797|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111078002|NCT03371797|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111078003|NCT02520115|Dexamethasone|dexamethasone|mesh-list
110639271|NCT00859118|Axitinib|axitinib|mesh-list
111078004|NCT02520115|Dexamethasone acetate|dexamethasone acetate|mesh-list
111078005|NCT02520115|Valproic Acid|valproic acid|mesh-list
111078006|NCT02520115|Ichthammol|ichthammol|mesh-list
111078007|NCT02520115|BB 1101|bb 1101|mesh-list
111078008|NCT02520115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111078009|NCT02520115|Antiemetics|antiemetics|mesh-ancestor
111078010|NCT02520115|Autonomic Agents|autonomic agents|mesh-ancestor
111078011|NCT02520115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111078012|NCT02520115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111078013|NCT02520115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111078014|NCT02520115|Glucocorticoids|glucocorticoids|mesh-ancestor
111078015|NCT02520115|Hormones|hormones|mesh-ancestor
111078016|NCT02520115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111078017|NCT02520115|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111078018|NCT02520115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111078019|NCT02520115|Protease Inhibitors|protease inhibitors|mesh-ancestor
111078020|NCT02520115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111078021|NCT02520115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111078022|NCT02520115|Anticonvulsants|anticonvulsants|mesh-ancestor
111078023|NCT02520115|GABA Agents|gaba agents|mesh-ancestor
111078024|NCT02520115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111078025|NCT02520115|Antimanic Agents|antimanic agents|mesh-ancestor
111078026|NCT02520115|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111078027|NCT02520115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111078028|NCT02520115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111078029|NCT02520115|Dermatologic Agents|dermatologic agents|mesh-ancestor
111078030|NCT03375775|Immunomodulating Agents|immunomodulating agents|mesh-list
111078031|NCT03375775|Immunologic Factors|immunologic factors|mesh-list
111078032|NCT03375775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111078033|NCT04527133|Aprotinin|aprotinin|mesh-list
111078034|NCT04527133|Hemostatics|hemostatics|mesh-ancestor
111078035|NCT04527133|Coagulants|coagulants|mesh-ancestor
111078036|NCT04527133|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
111078037|NCT04527133|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111078038|NCT04527133|Protease Inhibitors|protease inhibitors|mesh-ancestor
111078039|NCT04527133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111078040|NCT04527133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111078041|NCT03371563|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111078042|NCT03371563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111078043|NCT03369925|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
111078044|NCT03369925|Nootropic Agents|nootropic agents|mesh-ancestor
111078045|NCT03369847|Budesonide|budesonide|mesh-list
111078046|NCT03369847|Beclomethasone|beclomethasone|mesh-list
111078047|NCT03369847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111078048|NCT03369847|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111078049|NCT03369847|Autonomic Agents|autonomic agents|mesh-ancestor
111078050|NCT03369847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111078051|NCT03369847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111078052|NCT03369847|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111078053|NCT03369847|Respiratory System Agents|respiratory system agents|mesh-ancestor
111078054|NCT03369847|Glucocorticoids|glucocorticoids|mesh-ancestor
111078056|NCT03369847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111078057|NCT04526353|Oxybutynin|oxybutynin|mesh-list
111078058|NCT04526353|Parasympatholytics|parasympatholytics|mesh-ancestor
111078059|NCT04526353|Autonomic Agents|autonomic agents|mesh-ancestor
111078060|NCT04526353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111078061|NCT04526353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111078062|NCT04526353|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111078063|NCT04526353|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111078064|NCT04526353|Cholinergic Agents|cholinergic agents|mesh-ancestor
111078065|NCT04526353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111078066|NCT04526353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111078067|NCT04526353|Urological Agents|urological agents|mesh-ancestor
111078068|NCT03371173|Ferric maltol|ferric maltol|mesh-list
111078069|NCT03371173|Hematinics|hematinics|mesh-ancestor
111078070|NCT03371095|Infliximab|infliximab|mesh-list
111078071|NCT03371095|Cyclophosphamide|cyclophosphamide|mesh-list
111078072|NCT03371095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111078073|NCT03371095|Immunologic Factors|immunologic factors|mesh-ancestor
111078074|NCT03371095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111078075|NCT03371095|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111078076|NCT03371095|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111078077|NCT03371095|Alkylating Agents|alkylating agents|mesh-ancestor
111078078|NCT03371095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111078079|NCT03371095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111078080|NCT03371095|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111078081|NCT03371095|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111078082|NCT03371095|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111078083|NCT03371095|Dermatologic Agents|dermatologic agents|mesh-ancestor
111078084|NCT03371095|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111078085|NCT03363451|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111078086|NCT03363451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111078087|NCT03363295|Moxifloxacin|moxifloxacin|mesh-list
111078088|NCT03363295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111078089|NCT03363295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111078090|NCT03363295|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111078091|NCT03363295|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111078092|NCT03363295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111078093|NCT03363295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111078094|NCT03363295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111078095|NCT03370861|Immunomodulating Agents|immunomodulating agents|mesh-list
111078096|NCT03370861|Immunologic Factors|immunologic factors|mesh-ancestor
111078097|NCT03370861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111078098|NCT03370705|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
111078099|NCT03370705|Acetylsalicylic acid lysinate|acetylsalicylic acid lysinate|mesh-list
111078100|NCT03370705|Captopril|captopril|mesh-list
111078101|NCT03370705|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
111078102|NCT03370705|Atorvastatin|atorvastatin|mesh-list
111078103|NCT03370705|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
111078104|NCT03370705|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111078105|NCT03370705|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111078106|NCT03370705|Antimetabolites|antimetabolites|mesh-ancestor
111078107|NCT03370705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111078108|NCT03370705|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111078109|NCT03370705|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111078110|NCT03370705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111078111|NCT03370705|Protease Inhibitors|protease inhibitors|mesh-ancestor
111078112|NCT03370705|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111078113|NCT03370705|Anticoagulants|anticoagulants|mesh-ancestor
111078114|NCT03370705|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111078115|NCT03370705|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111078116|NCT03370705|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111078117|NCT03370705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111078118|NCT03370705|Analgesics|analgesics|mesh-ancestor
111078119|NCT03370705|Sensory System Agents|sensory system agents|mesh-ancestor
111078120|NCT03370705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111078121|NCT03370705|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111078122|NCT03370705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111078123|NCT03370705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111078124|NCT03370705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111078125|NCT03370705|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111078126|NCT03369379|Cholecalciferol|cholecalciferol|mesh-list
111078127|NCT03369379|Vitamins|vitamins|mesh-ancestor
111078128|NCT03369379|Micronutrients|micronutrients|mesh-ancestor
111078129|NCT03369379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111078130|NCT03369379|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111078131|NCT03369379|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111078132|NCT03362905|Lidocaine|lidocaine|mesh-list
111078133|NCT03362905|Anesthetics, Local|anesthetics, local|mesh-ancestor
111078134|NCT03362905|Anesthetics|anesthetics|mesh-ancestor
111078135|NCT03362905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111078136|NCT03362905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111078137|NCT03362905|Sensory System Agents|sensory system agents|mesh-ancestor
111078138|NCT03362905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111078139|NCT03362905|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111078140|NCT03362905|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111078141|NCT03362905|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111078142|NCT03362905|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111078143|NCT03362905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111078144|NCT03370159|Thioctic Acid|thioctic acid|mesh-list
111078145|NCT03370159|Docetaxel|docetaxel|mesh-list
111078146|NCT03370159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111078147|NCT03370159|Tubulin Modulators|tubulin modulators|mesh-ancestor
111078148|NCT03370159|Antimitotic Agents|antimitotic agents|mesh-ancestor
111078149|NCT03370159|Mitosis Modulators|mitosis modulators|mesh-ancestor
111078150|NCT03370159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111078151|NCT03370159|Antioxidants|antioxidants|mesh-ancestor
111078152|NCT03370159|Protective Agents|protective agents|mesh-ancestor
111078153|NCT03370159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111078154|NCT03370159|Vitamin B Complex|vitamin b complex|mesh-ancestor
111078155|NCT03370159|Vitamins|vitamins|mesh-ancestor
111078156|NCT03370159|Micronutrients|micronutrients|mesh-ancestor
111078157|NCT04522297|Octreotide|octreotide|mesh-list
111078158|NCT04522297|Epinephrine|epinephrine|mesh-list
111078159|NCT04522297|Midodrine|midodrine|mesh-list
111078160|NCT04522297|Norepinephrine|norepinephrine|mesh-list
111078161|NCT04522297|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111078162|NCT04522297|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111078163|NCT04522297|Adrenergic Agents|adrenergic agents|mesh-ancestor
111078164|NCT04522297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111078165|NCT04522297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111078166|NCT04522297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111078167|NCT04522297|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111078168|NCT04522297|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111078169|NCT04522297|Autonomic Agents|autonomic agents|mesh-ancestor
111078170|NCT04522297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111078171|NCT04522297|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111078172|NCT04522297|Respiratory System Agents|respiratory system agents|mesh-ancestor
111078173|NCT04522297|Mydriatics|mydriatics|mesh-ancestor
111078174|NCT04522297|Sympathomimetics|sympathomimetics|mesh-ancestor
111078175|NCT04522297|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111078176|NCT04522297|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111078177|NCT04522297|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111078178|NCT04522297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111078179|NCT04522297|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111078180|NCT03369067|Insulin|insulin|mesh-list
111078181|NCT03369067|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111078182|NCT03369067|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111078183|NCT03369067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111078184|NCT03368989|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
111078185|NCT03368989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111078186|NCT04525729|Rituximab|rituximab|mesh-list
111078187|NCT04525729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111078188|NCT04525729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111078189|NCT04525729|Immunologic Factors|immunologic factors|mesh-ancestor
111078190|NCT04525729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111078191|NCT04525729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111078192|NCT04525495|Dopamine|dopamine|mesh-list
111078193|NCT04525495|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111078194|NCT04525495|Sympathomimetics|sympathomimetics|mesh-ancestor
111078195|NCT04525495|Autonomic Agents|autonomic agents|mesh-ancestor
111078196|NCT04525495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111078197|NCT04525495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111078198|NCT04525495|Dopamine Agents|dopamine agents|mesh-ancestor
111078199|NCT04525495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111078200|NCT04525495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111078201|NCT04525495|Protective Agents|protective agents|mesh-ancestor
111078203|NCT03362359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111078204|NCT03362359|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111078205|NCT03362281|Amoxicillin|amoxicillin|mesh-list
111078206|NCT03362281|Clarithromycin|clarithromycin|mesh-list
111078207|NCT03362281|Omeprazole|omeprazole|mesh-list
111078208|NCT03362281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111078209|NCT03362281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111078210|NCT03362281|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111078211|NCT03362281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111078212|NCT03362281|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111078213|NCT03362281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111078214|NCT03362281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111078215|NCT03362281|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111078216|NCT03362281|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111078217|NCT03362281|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111078218|NCT02518789|Fentanyl|fentanyl|mesh-list
111078219|NCT02518789|Midazolam|midazolam|mesh-list
111078220|NCT02518789|Dexmedetomidine|dexmedetomidine|mesh-list
111078221|NCT02518789|Remifentanil|remifentanil|mesh-list
111078222|NCT02518789|Propofol|propofol|mesh-list
111078223|NCT02518789|Etomidate|etomidate|mesh-list
111078224|NCT02518789|Atracurium|atracurium|mesh-list
111078225|NCT02518789|Rocuronium|rocuronium|mesh-list
111078226|NCT02518789|Cisatracurium|cisatracurium|mesh-list
111078227|NCT02518789|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111078228|NCT02518789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111078229|NCT02518789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111078230|NCT02518789|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111078231|NCT02518789|Analgesics|analgesics|mesh-ancestor
111078232|NCT02518789|Sensory System Agents|sensory system agents|mesh-ancestor
111078233|NCT02518789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111078234|NCT02518789|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111078235|NCT02518789|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111078236|NCT02518789|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111078237|NCT02518789|Adrenergic Agents|adrenergic agents|mesh-ancestor
111078238|NCT02518789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111078239|NCT02518789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111078240|NCT02518789|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111078241|NCT02518789|Anesthetics, General|anesthetics, general|mesh-ancestor
111078242|NCT02518789|Anesthetics|anesthetics|mesh-ancestor
111078243|NCT02518789|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111078244|NCT02518789|Narcotics|narcotics|mesh-ancestor
111078245|NCT02518789|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111078246|NCT02518789|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111078247|NCT02518789|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111078248|NCT02518789|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111078249|NCT02518789|GABA Modulators|gaba modulators|mesh-ancestor
111078250|NCT02518789|GABA Agents|gaba agents|mesh-ancestor
111078251|NCT02518789|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
111078252|NCT02518789|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
111078253|NCT02518789|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111078254|NCT02518789|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
111078255|NCT02518789|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111078256|NCT02518789|Cholinergic Agents|cholinergic agents|mesh-ancestor
111078257|NCT03357757|Avelumab|avelumab|mesh-list
111078258|NCT03357757|Valproic Acid|valproic acid|mesh-list
111078259|NCT03357757|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111078260|NCT03357757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111078261|NCT03357757|Anticonvulsants|anticonvulsants|mesh-ancestor
111078262|NCT03357757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111078263|NCT03357757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111078264|NCT03357757|GABA Agents|gaba agents|mesh-ancestor
111078265|NCT03357757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111078266|NCT03357757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111078267|NCT03357757|Antimanic Agents|antimanic agents|mesh-ancestor
111078268|NCT03357757|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111078269|NCT03357757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111078270|NCT03357757|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111078271|NCT02929485|Bromocriptine|bromocriptine|mesh-list
111078273|NCT02929485|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111078274|NCT02929485|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111078275|NCT02929485|Hormone Antagonists|hormone antagonists|mesh-ancestor
110639309|NCT00861926|Beclomethasone|beclomethasone|mesh-list
111078276|NCT02929485|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111078277|NCT02929485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110543370|NCT00973219|Tenofovir|tenofovir|mesh-list
111078279|NCT02929485|Dopamine Agents|dopamine agents|mesh-ancestor
111078280|NCT02929485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111078281|NCT02929485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111078282|NCT02929485|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
111078283|NCT02929485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111078284|NCT04523623|Ibuprofen|ibuprofen|mesh-list
111078285|NCT04523623|Oxycodone|oxycodone|mesh-list
111078286|NCT04523623|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111078287|NCT04523623|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111078288|NCT04523623|Analgesics|analgesics|mesh-ancestor
111078289|NCT04523623|Sensory System Agents|sensory system agents|mesh-ancestor
111078290|NCT04523623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111078291|NCT04523623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111078292|NCT04523623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111078293|NCT04523623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111078294|NCT04523623|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111078295|NCT04523623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111078296|NCT04523623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111078297|NCT04523623|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111078298|NCT04523623|Narcotics|narcotics|mesh-ancestor
111078299|NCT04523623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111078300|NCT03357289|Immunomodulating Agents|immunomodulating agents|mesh-list
111078301|NCT03357289|Immunologic Factors|immunologic factors|mesh-ancestor
111078302|NCT03357289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111078303|NCT03368131|Capecitabine|capecitabine|mesh-list
111078304|NCT03368131|Oxaliplatin|oxaliplatin|mesh-list
111078305|NCT03368131|Trastuzumab|trastuzumab|mesh-list
111078306|NCT03368131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111078307|NCT03368131|Antimetabolites|antimetabolites|mesh-ancestor
111078308|NCT03368131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111078309|NCT03368131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111078310|NCT03368131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111078311|NCT04521751|Acarbose|acarbose|mesh-list
111078312|NCT04521751|Orlistat|orlistat|mesh-list
111078313|NCT04521751|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
111078314|NCT04521751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111078315|NCT04521751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111078316|NCT04521751|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111078317|NCT04521751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111078318|NCT04521751|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111078319|NCT04521751|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111078320|NCT04521517|Imidacloprid|imidacloprid|mesh-list
111078321|NCT04521517|Cholinergic Agents|cholinergic agents|mesh-ancestor
111078322|NCT04521517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111078323|NCT04521517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111078324|NCT04521517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111078325|NCT01675167|Buprenorphine|buprenorphine|mesh-list
111078326|NCT01675167|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111078327|NCT01675167|Narcotics|narcotics|mesh-ancestor
111078328|NCT01675167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111078329|NCT01675167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111078330|NCT01675167|Analgesics|analgesics|mesh-ancestor
111078331|NCT01675167|Sensory System Agents|sensory system agents|mesh-ancestor
111078332|NCT01675167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111078333|NCT01675167|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111078334|NCT03370627|Antibodies|antibodies|mesh-list
111078335|NCT03370627|Immunologic Factors|immunologic factors|mesh-ancestor
111078336|NCT03370627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111078337|NCT03367663|Prednisone|prednisone|mesh-list
111078338|NCT03367663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111078339|NCT03367663|Glucocorticoids|glucocorticoids|mesh-ancestor
111078340|NCT03367663|Hormones|hormones|mesh-ancestor
111078341|NCT03367663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111078342|NCT03367663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111078343|NCT03367663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111078344|NCT03367663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111078345|NCT03123289|Gallium citrate|gallium citrate|mesh-list
111078346|NCT03123289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111078347|NCT03123289|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111078348|NCT04521049|Saxagliptin|saxagliptin|mesh-list
111078349|NCT04521049|Incretins|incretins|mesh-ancestor
111078350|NCT04521049|Hormones|hormones|mesh-ancestor
111078351|NCT04521049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111078352|NCT04521049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111078353|NCT04521049|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111078355|NCT04521049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111078356|NCT04521049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111078357|NCT04521049|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111078358|NCT02267343|Nivolumab|nivolumab|mesh-list
111078359|NCT02267343|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111078360|NCT02267343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111078361|NCT02267343|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111078362|NCT02267343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111078363|NCT03123445|Gemcitabine|gemcitabine|mesh-list
111078364|NCT03123445|Endostar protein|endostar protein|mesh-list
111078365|NCT03123445|Endostatins|endostatins|mesh-list
111078366|NCT03123445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111078367|NCT03123445|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111078368|NCT03123445|Antimetabolites|antimetabolites|mesh-ancestor
111078369|NCT03123445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111078370|NCT03123445|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111078371|NCT03123445|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111078372|NCT03123445|Growth Substances|growth substances|mesh-ancestor
111078373|NCT03123445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111078374|NCT03123445|Growth Inhibitors|growth inhibitors|mesh-ancestor
111078375|NCT03357133|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
111078376|NCT03357133|Tirofiban|tirofiban|mesh-list
111078377|NCT03357133|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111078378|NCT03357133|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111078379|NCT03357133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111078380|NCT03357133|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111078381|NCT03357055|Ketamine|ketamine|mesh-list
111078382|NCT03357055|Analgesics|analgesics|mesh-ancestor
111078383|NCT03357055|Sensory System Agents|sensory system agents|mesh-ancestor
111078384|NCT03357055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111078385|NCT03357055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111078386|NCT03357055|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111078387|NCT03357055|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111078388|NCT03357055|Anesthetics, General|anesthetics, general|mesh-ancestor
111078389|NCT03357055|Anesthetics|anesthetics|mesh-ancestor
111078390|NCT03357055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111078391|NCT03357055|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111078392|NCT03357055|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111078393|NCT03357055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111078394|NCT03357055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111078395|NCT03367585|Vitamin D|vitamin d|mesh-list
111078396|NCT03367585|Cholecalciferol|cholecalciferol|mesh-list
111078397|NCT03367585|Vitamins|vitamins|mesh-ancestor
111078398|NCT03367585|Micronutrients|micronutrients|mesh-ancestor
111078399|NCT03367585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111078400|NCT03367585|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111078401|NCT03367585|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111078402|NCT03360955|Anesthetics|anesthetics|mesh-list
111078403|NCT03360955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111078404|NCT03360955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111078405|NCT00584025|Levetiracetam|levetiracetam|mesh-list
111078406|NCT00584025|Anticonvulsants|anticonvulsants|mesh-ancestor
111078407|NCT00584025|Nootropic Agents|nootropic agents|mesh-ancestor
111078408|NCT01735461|Calcium Carbonate|calcium carbonate|mesh-list
111078409|NCT01735461|Calcium|calcium|mesh-list
111078410|NCT01735461|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111078411|NCT01735461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111078412|NCT01735461|Antacids|antacids|mesh-ancestor
111078413|NCT01735461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111078414|NCT01735461|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111078415|NCT01595841|Sirolimus|sirolimus|mesh-list
111078416|NCT01595841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111078417|NCT01595841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111078418|NCT01595841|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111078419|NCT01595841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111078420|NCT01595841|Antifungal Agents|antifungal agents|mesh-ancestor
111078421|NCT01595841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111078422|NCT01595841|Immunologic Factors|immunologic factors|mesh-ancestor
111078423|NCT01595841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111078424|NCT05405049|Lidocaine|lidocaine|mesh-list
111078425|NCT05405049|Fentanyl|fentanyl|mesh-list
111078426|NCT05405049|Morphine|morphine|mesh-list
111078427|NCT05405049|Bupivacaine|bupivacaine|mesh-list
111078428|NCT05405049|Anesthetics, Local|anesthetics, local|mesh-ancestor
111078429|NCT05405049|Anesthetics|anesthetics|mesh-ancestor
111078430|NCT05405049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111078431|NCT05405049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111078432|NCT05405049|Sensory System Agents|sensory system agents|mesh-ancestor
111078433|NCT05405049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111078434|NCT05405049|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111078435|NCT05405049|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111078436|NCT05405049|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111078437|NCT05405049|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111078438|NCT05405049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111078439|NCT05405049|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111078440|NCT05405049|Narcotics|narcotics|mesh-ancestor
111078441|NCT05405049|Analgesics|analgesics|mesh-ancestor
111078442|NCT05405049|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111078443|NCT05405049|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111078444|NCT05405049|Anesthetics, General|anesthetics, general|mesh-ancestor
111078445|NCT04520503|Propofol|propofol|mesh-list
111078446|NCT04520503|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111078447|NCT04520503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111078448|NCT04520503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111078449|NCT04520503|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111078450|NCT04520503|Anesthetics, General|anesthetics, general|mesh-ancestor
111078451|NCT04520503|Anesthetics|anesthetics|mesh-ancestor
111078452|NCT02871843|Temozolomide|temozolomide|mesh-list
111078453|NCT02871843|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111078454|NCT02871843|Alkylating Agents|alkylating agents|mesh-ancestor
111078455|NCT02871843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111078456|NCT02871843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111078457|NCT03356899|Bupivacaine|bupivacaine|mesh-list
111078458|NCT03356899|Anesthetics|anesthetics|mesh-list
111078459|NCT03356899|Anesthetics, Local|anesthetics, local|mesh-ancestor
111078460|NCT03356899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111078461|NCT03356899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111078462|NCT03356899|Sensory System Agents|sensory system agents|mesh-ancestor
111078463|NCT03356899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111078464|NCT04523467|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
111078465|NCT04523467|Ginsenoside Rg3|ginsenoside rg3|mesh-list
111078466|NCT04523467|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111078467|NCT04523467|Growth Substances|growth substances|mesh-ancestor
111078468|NCT04523467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111078469|NCT04523467|Growth Inhibitors|growth inhibitors|mesh-ancestor
111078470|NCT04523467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111078471|NCT04523467|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111078472|NCT02801097|Irinotecan|irinotecan|mesh-list
111078473|NCT02801097|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111078474|NCT02801097|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111078475|NCT02801097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111078476|NCT02801097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111078477|NCT02801097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111078478|NCT03367195|Omeprazole|omeprazole|mesh-list
111078479|NCT03367195|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111078480|NCT03367195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111078481|NCT03367195|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111078482|NCT03367195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111078483|NCT03367195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111078484|NCT05123781|Metformin|metformin|mesh-list
111078485|NCT05123781|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111078486|NCT05123781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111078487|NCT04523233|Vitamins|vitamins|mesh-list
111078488|NCT04523233|Micronutrients|micronutrients|mesh-ancestor
111078489|NCT04523233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111078491|NCT05127369|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111078492|NCT05127369|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111078493|NCT05127369|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111078494|NCT05127369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111078495|NCT05127369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111078496|NCT05127369|Serotonin Agents|serotonin agents|mesh-ancestor
111078497|NCT05127369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111078498|NCT05127369|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111078499|NCT05127369|Antidepressive Agents|antidepressive agents|mesh-ancestor
111078500|NCT05127369|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111078501|NCT05127369|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111078502|NCT05127369|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111078503|NCT05127369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111078504|NCT05126901|Ferric maltol|ferric maltol|mesh-list
111078505|NCT05126901|Hematinics|hematinics|mesh-ancestor
111078506|NCT03356353|Sildenafil Citrate|sildenafil citrate|mesh-list
111078507|NCT03356353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111078508|NCT03356353|Vasodilator Agents|vasodilator agents|mesh-ancestor
111078509|NCT03356353|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111078510|NCT03356353|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111078511|NCT03356353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111078512|NCT03356353|Urological Agents|urological agents|mesh-ancestor
111078513|NCT04520035|Paclitaxel|paclitaxel|mesh-list
111078514|NCT04520035|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111078515|NCT04520035|Cisplatin|cisplatin|mesh-list
110133650|NCT01985087|Temozolomide|temozolomide|mesh-list
111078516|NCT04520035|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111078517|NCT04520035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111078518|NCT04520035|Tubulin Modulators|tubulin modulators|mesh-ancestor
111078519|NCT04520035|Antimitotic Agents|antimitotic agents|mesh-ancestor
111078520|NCT04520035|Mitosis Modulators|mitosis modulators|mesh-ancestor
111078521|NCT04520035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111078522|NCT04208997|Amiodarone|amiodarone|mesh-list
111078523|NCT04208997|Sotalol|sotalol|mesh-list
111078524|NCT04208997|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
111078525|NCT04208997|Vasodilator Agents|vasodilator agents|mesh-ancestor
111078526|NCT04208997|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
111078527|NCT04208997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111078528|NCT04208997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111078529|NCT04208997|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111078530|NCT04208997|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111078531|NCT04208997|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111078532|NCT04208997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111078533|NCT04208997|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111078534|NCT04208997|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111078535|NCT04208997|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111078536|NCT04208997|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111078537|NCT04208997|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111078538|NCT04208997|Adrenergic Agents|adrenergic agents|mesh-ancestor
111078539|NCT04208997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111078540|NCT04208997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111078541|NCT04208997|Sympatholytics|sympatholytics|mesh-ancestor
111078542|NCT04208997|Autonomic Agents|autonomic agents|mesh-ancestor
111078543|NCT04208997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111078544|NCT03355963|Botulinum Toxins|botulinum toxins|mesh-list
111078545|NCT03355963|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111078546|NCT03355963|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111078547|NCT03355963|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111078548|NCT03355963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111078549|NCT03355963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111078550|NCT03355963|Cholinergic Agents|cholinergic agents|mesh-ancestor
111078551|NCT03355963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111078552|NCT03355963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111078553|NCT03355963|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111078554|NCT03355963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111078555|NCT04518475|Rituximab|rituximab|mesh-list
111078556|NCT04518475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111078557|NCT04518475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111078558|NCT04518475|Immunologic Factors|immunologic factors|mesh-ancestor
111078559|NCT04518475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111078560|NCT04518475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111078561|NCT04278651|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
111078563|NCT04278651|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
111078564|NCT04278651|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111078565|NCT05125575|Metformin|metformin|mesh-list
111078566|NCT05125575|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111078567|NCT05125575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111078568|NCT03366883|Paclitaxel|paclitaxel|mesh-list
111078569|NCT03366883|Cisplatin|cisplatin|mesh-list
111078570|NCT03366883|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111078571|NCT03366883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111078572|NCT03366883|Tubulin Modulators|tubulin modulators|mesh-ancestor
111078573|NCT03366883|Antimitotic Agents|antimitotic agents|mesh-ancestor
111078574|NCT03366883|Mitosis Modulators|mitosis modulators|mesh-ancestor
111078575|NCT03366883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111078576|NCT03366571|Entecavir|entecavir|mesh-list
111078577|NCT03366571|Antiviral Agents|antiviral agents|mesh-ancestor
111078578|NCT03366571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111078579|NCT05124951|Carboplatin|carboplatin|mesh-list
111078580|NCT05124951|Etoposide|etoposide|mesh-list
111078581|NCT05124951|Etoposide phosphate|etoposide phosphate|mesh-list
111078582|NCT05124951|Ifosfamide|ifosfamide|mesh-list
110639372|NCT00850382|Cytarabine|cytarabine|mesh-list
111078583|NCT05124951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111078584|NCT05124951|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111078585|NCT05124951|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111078586|NCT05124951|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111078587|NCT05124951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111078588|NCT05124951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111078589|NCT05124951|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111078590|NCT05124951|Alkylating Agents|alkylating agents|mesh-ancestor
111078591|NCT04523077|Antibodies|antibodies|mesh-list
111078592|NCT04523077|Hormones|hormones|mesh-list
111078593|NCT04523077|Immunologic Factors|immunologic factors|mesh-ancestor
111078594|NCT04523077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111078595|NCT04523077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111078596|NCT05124717|Metformin|metformin|mesh-list
111078597|NCT05124717|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111078598|NCT05124717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111078599|NCT04139655|Colchicine|colchicine|mesh-list
111078600|NCT04139655|Gout Suppressants|gout suppressants|mesh-ancestor
111078601|NCT04139655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111078602|NCT04139655|Tubulin Modulators|tubulin modulators|mesh-ancestor
111078603|NCT04139655|Antimitotic Agents|antimitotic agents|mesh-ancestor
111078604|NCT04139655|Mitosis Modulators|mitosis modulators|mesh-ancestor
111078605|NCT04139655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111078606|NCT04139655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111078607|NCT03366259|Misoprostol|misoprostol|mesh-list
111078608|NCT03366259|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111078609|NCT03366259|Abortifacient Agents|abortifacient agents|mesh-ancestor
111078610|NCT03366259|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111078611|NCT03366259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111078612|NCT03366259|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111078613|NCT03366259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111078614|NCT03366259|Oxytocics|oxytocics|mesh-ancestor
111078615|NCT03366025|Progesterone|progesterone|mesh-list
111078616|NCT03366025|Progestins|progestins|mesh-ancestor
111078617|NCT03366025|Hormones|hormones|mesh-ancestor
111078618|NCT03366025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111078619|NCT03366025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111078620|NCT05115591|Anesthetics|anesthetics|mesh-list
111078621|NCT05115591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111078622|NCT05115591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111078623|NCT05403099|Hyaluronic Acid|hyaluronic acid|mesh-list
111078624|NCT05403099|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111078625|NCT05403099|Immunologic Factors|immunologic factors|mesh-ancestor
111078626|NCT05403099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111078627|NCT05403099|Viscosupplements|viscosupplements|mesh-ancestor
111078628|NCT05403099|Protective Agents|protective agents|mesh-ancestor
111078629|NCT03365869|Sirolimus|sirolimus|mesh-list
111078630|NCT03365869|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111078631|NCT03365869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111078632|NCT03365869|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110543729|NCT04006639|Analgesics|analgesics|mesh-list
111078633|NCT03365869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111078634|NCT03365869|Antifungal Agents|antifungal agents|mesh-ancestor
111078635|NCT03365869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111078636|NCT03365869|Immunologic Factors|immunologic factors|mesh-ancestor
111078637|NCT03365869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111078638|NCT04932213|Tropicamide|tropicamide|mesh-list
111078639|NCT04932213|Mydriatics|mydriatics|mesh-ancestor
111078640|NCT04932213|Autonomic Agents|autonomic agents|mesh-ancestor
111078641|NCT04932213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111078642|NCT04932213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111078643|NCT04932213|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111078644|NCT04932213|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111078645|NCT04932213|Cholinergic Agents|cholinergic agents|mesh-ancestor
111078646|NCT04932213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111078647|NCT04932213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111078648|NCT03684213|Ascorbic Acid|ascorbic acid|mesh-list
111078649|NCT03684213|Norepinephrine|norepinephrine|mesh-list
111078650|NCT03684213|NG-Nitroarginine Methyl Ester|ng-nitroarginine methyl ester|mesh-list
111078651|NCT03684213|Antioxidants|antioxidants|mesh-ancestor
111078652|NCT03684213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111078653|NCT03684213|Protective Agents|protective agents|mesh-ancestor
111078654|NCT03684213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111078655|NCT03684213|Vitamins|vitamins|mesh-ancestor
111078656|NCT03684213|Micronutrients|micronutrients|mesh-ancestor
111078657|NCT03684213|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111078658|NCT03684213|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111078659|NCT03684213|Adrenergic Agents|adrenergic agents|mesh-ancestor
111078660|NCT03684213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111078661|NCT03684213|Sympathomimetics|sympathomimetics|mesh-ancestor
111078662|NCT03684213|Autonomic Agents|autonomic agents|mesh-ancestor
111078663|NCT03684213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111078664|NCT03684213|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111078665|NCT03684213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111078666|NCT03365479|Iloprost|iloprost|mesh-list
111078667|NCT03365479|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111078668|NCT03365479|Vasodilator Agents|vasodilator agents|mesh-ancestor
111078669|NCT03355027|Atorvastatin|atorvastatin|mesh-list
111078670|NCT03355027|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111078671|NCT03355027|Simvastatin|simvastatin|mesh-list
111078672|NCT03355027|Ezetimibe|ezetimibe|mesh-list
111078673|NCT03355027|Alirocumab|alirocumab|mesh-list
111078674|NCT03355027|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111078675|NCT03355027|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111078676|NCT03355027|Antimetabolites|antimetabolites|mesh-ancestor
111078677|NCT03355027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111078678|NCT03355027|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111078679|NCT03355027|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111078680|NCT03355027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111078681|NCT03355027|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
111078682|NCT03355027|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111078683|NCT03355027|Protease Inhibitors|protease inhibitors|mesh-ancestor
111078684|NCT03828045|Apremilast|apremilast|mesh-list
111078685|NCT03828045|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111078686|NCT03828045|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111078687|NCT03828045|Analgesics|analgesics|mesh-ancestor
111078688|NCT03828045|Sensory System Agents|sensory system agents|mesh-ancestor
111078689|NCT03828045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111078690|NCT03828045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111078691|NCT03828045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111078692|NCT03828045|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111078693|NCT03828045|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
111078694|NCT03828045|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111078695|NCT03828045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111078696|NCT03828045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111078697|NCT03123679|Technetium Tc 99m Aggregated Albumin|technetium tc 99m aggregated albumin|mesh-list
111078698|NCT03123679|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111078699|NCT03123679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111078700|NCT02519413|Dimethyl Fumarate|dimethyl fumarate|mesh-list
111078701|NCT02519413|Dermatologic Agents|dermatologic agents|mesh-ancestor
111078702|NCT02519413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111078703|NCT02519413|Immunologic Factors|immunologic factors|mesh-ancestor
111078704|NCT02519413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111078705|NCT02519335|Dexrazoxane|dexrazoxane|mesh-list
111078706|NCT02519335|Razoxane|razoxane|mesh-list
111078707|NCT02519335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111078709|NCT02519335|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111078710|NCT02519335|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111078711|NCT02519335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111078712|NCT02519335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111078713|NCT02519335|Protective Agents|protective agents|mesh-ancestor
111078714|NCT02519335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111078716|NCT02519335|Mitosis Modulators|mitosis modulators|mesh-ancestor
111078717|NCT04509583|Vitamin E|vitamin e|mesh-list
111078718|NCT04509583|Vitamins|vitamins|mesh-ancestor
111078719|NCT04509583|Micronutrients|micronutrients|mesh-ancestor
111078720|NCT04509583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111078721|NCT04509583|Antioxidants|antioxidants|mesh-ancestor
111078722|NCT04509583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111078723|NCT04509583|Protective Agents|protective agents|mesh-ancestor
111078724|NCT04509661|Bronchodilator Agents|bronchodilator agents|mesh-list
111078725|NCT04509661|Autonomic Agents|autonomic agents|mesh-ancestor
111078726|NCT04509661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111078727|NCT04509661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111078728|NCT04509661|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111078729|NCT04509661|Respiratory System Agents|respiratory system agents|mesh-ancestor
111078730|NCT03350737|Heparin|heparin|mesh-list
111078731|NCT03350737|Anticoagulants|anticoagulants|mesh-ancestor
111078732|NCT03350737|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111078733|NCT03350737|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111078734|NCT03350737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111078735|NCT03350659|Midodrine|midodrine|mesh-list
111078736|NCT03350659|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
111078737|NCT03350659|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111078738|NCT03350659|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111078739|NCT03350659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111078740|NCT03350659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111078741|NCT03350659|Adrenergic Agents|adrenergic agents|mesh-ancestor
111078742|NCT03350659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111078743|NCT03350659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111078744|NCT03350659|Sympathomimetics|sympathomimetics|mesh-ancestor
111078745|NCT03350659|Autonomic Agents|autonomic agents|mesh-ancestor
111078746|NCT03350659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111078747|NCT03350659|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111078748|NCT03350659|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111078749|NCT03350659|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111078750|NCT03350659|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111078751|NCT04443517|Propofol|propofol|mesh-list
111078752|NCT04443517|Anesthetics|anesthetics|mesh-ancestor
111078753|NCT04443517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111078754|NCT04443517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111078755|NCT04443517|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111078756|NCT04443517|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111078757|NCT04443517|Anesthetics, General|anesthetics, general|mesh-ancestor
111078758|NCT03350347|Darbepoetin alfa|darbepoetin alfa|mesh-list
111078759|NCT03350347|Hematinics|hematinics|mesh-ancestor
111078760|NCT03350191|Exenatide|exenatide|mesh-list
111078761|NCT03350191|Glucagon|glucagon|mesh-list
111078762|NCT03350191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111078763|NCT03350191|Hormones|hormones|mesh-ancestor
111078764|NCT03350191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111078765|NCT03350191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111078766|NCT03350191|Incretins|incretins|mesh-ancestor
111078767|NCT03350191|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111078768|NCT03350191|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111078769|NCT02649231|Ketamine|ketamine|mesh-list
111078770|NCT02649231|Analgesics|analgesics|mesh-ancestor
111078771|NCT02649231|Sensory System Agents|sensory system agents|mesh-ancestor
111078772|NCT02649231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111078773|NCT02649231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111078774|NCT02649231|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111078775|NCT02649231|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111078776|NCT02649231|Anesthetics, General|anesthetics, general|mesh-ancestor
111078777|NCT02649231|Anesthetics|anesthetics|mesh-ancestor
111078778|NCT02649231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111078779|NCT02649231|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111078780|NCT02649231|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111078781|NCT02649231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110677120|NCT02813135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111078782|NCT02649231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111078783|NCT03364075|Propranolol|propranolol|mesh-list
111078784|NCT03364075|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
111078785|NCT03364075|Serotonin|serotonin|mesh-list
111078786|NCT03364075|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111078787|NCT03364075|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110795900|NCT01190241|Sorafenib|sorafenib|mesh-list
111078788|NCT03364075|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111078789|NCT03364075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111078790|NCT03364075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111078791|NCT03364075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111078793|NCT03364075|Sensory System Agents|sensory system agents|mesh-ancestor
111078794|NCT03364075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111078795|NCT03364075|Antidepressive Agents|antidepressive agents|mesh-ancestor
111078796|NCT03364075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111078797|NCT03364075|Dopamine Agents|dopamine agents|mesh-ancestor
111078798|NCT03364075|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111078799|NCT03364075|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111078800|NCT03364075|Adrenergic Agents|adrenergic agents|mesh-ancestor
111078801|NCT03364075|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111078802|NCT03364075|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111078803|NCT03364075|Vasodilator Agents|vasodilator agents|mesh-ancestor
111078804|NCT03364075|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111078805|NCT03364075|Serotonin Agents|serotonin agents|mesh-ancestor
111078806|NCT03349957|Idarubicin|idarubicin|mesh-list
111078807|NCT03349957|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111078808|NCT03349957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111078809|NCT03349957|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111078810|NCT03349957|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111078811|NCT03349957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111078812|NCT03349957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111078813|NCT04524169|Thymalfasin|thymalfasin|mesh-list
111078814|NCT04524169|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111078815|NCT04524169|Immunologic Factors|immunologic factors|mesh-ancestor
111078816|NCT04524169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111078817|NCT03568929|Idelalisib|idelalisib|mesh-list
111078818|NCT03568929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111078819|NCT03568929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111078820|NCT03568929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111078821|NCT04503967|Nivolumab|nivolumab|mesh-list
111078822|NCT04503967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111078823|NCT04503967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111078824|NCT04503967|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111078825|NCT04503967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111078826|NCT04841499|Niacinamide|niacinamide|mesh-list
111078827|NCT04841499|Niacin|niacin|mesh-list
111078828|NCT04841499|Nicotinic Acids|nicotinic acids|mesh-list
111078829|NCT04841499|Vitamin B Complex|vitamin b complex|mesh-ancestor
111078830|NCT04841499|Vitamins|vitamins|mesh-ancestor
111078831|NCT04841499|Micronutrients|micronutrients|mesh-ancestor
111078832|NCT04841499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111078833|NCT04841499|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111078834|NCT04841499|Antimetabolites|antimetabolites|mesh-ancestor
111078835|NCT04841499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111078836|NCT04841499|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111078837|NCT04841499|Vasodilator Agents|vasodilator agents|mesh-ancestor
111078838|NCT04773405|Lidocaine|lidocaine|mesh-list
111078839|NCT04773405|Epinephrine|epinephrine|mesh-list
111078840|NCT04773405|Levobupivacaine|levobupivacaine|mesh-list
111078841|NCT04773405|Anesthetics, Local|anesthetics, local|mesh-ancestor
111078842|NCT04773405|Anesthetics|anesthetics|mesh-ancestor
111078843|NCT04773405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111078844|NCT04773405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110639486|NCT00502996|Antimetabolites|antimetabolites|mesh-ancestor
111078845|NCT04773405|Sensory System Agents|sensory system agents|mesh-ancestor
111078846|NCT04773405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111078847|NCT04773405|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111078848|NCT04773405|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111078849|NCT04773405|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111078850|NCT04773405|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111078851|NCT04773405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111078852|NCT04773405|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111078853|NCT04773405|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111078854|NCT04773405|Adrenergic Agents|adrenergic agents|mesh-ancestor
111078855|NCT04773405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111078856|NCT04773405|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111078857|NCT04773405|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111078858|NCT04773405|Autonomic Agents|autonomic agents|mesh-ancestor
111078859|NCT04773405|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111078860|NCT04773405|Respiratory System Agents|respiratory system agents|mesh-ancestor
111078861|NCT04773405|Mydriatics|mydriatics|mesh-ancestor
110795977|NCT03850587|Narcotics|narcotics|mesh-ancestor
111078863|NCT04773405|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111078864|NCT04991571|Dapagliflozin|dapagliflozin|mesh-list
111078865|NCT04991571|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111078866|NCT04991571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111078867|NCT04991571|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111078868|NCT04991571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111078869|NCT01376245|Fluticasone|fluticasone|mesh-list
111078870|NCT01376245|Xhance|xhance|mesh-list
111078871|NCT01376245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111078872|NCT01376245|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111078873|NCT01376245|Autonomic Agents|autonomic agents|mesh-ancestor
111078874|NCT01376245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111078875|NCT01376245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111078876|NCT01376245|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111078877|NCT01376245|Respiratory System Agents|respiratory system agents|mesh-ancestor
111078878|NCT01376245|Dermatologic Agents|dermatologic agents|mesh-ancestor
111078879|NCT01376245|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111078880|NCT04754061|Psilocybin|psilocybin|mesh-list
111078881|NCT04754061|Hallucinogens|hallucinogens|mesh-ancestor
111078882|NCT04754061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111078883|NCT04754061|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111078884|NCT03349489|Insulin|insulin|mesh-list
111078885|NCT03349489|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111078886|NCT03349489|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111078887|NCT03349489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111078888|NCT04584567|Doxycycline|doxycycline|mesh-list
111078889|NCT04584567|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111078890|NCT04584567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111078891|NCT04584567|Antimalarials|antimalarials|mesh-ancestor
111078892|NCT04584567|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111078893|NCT04584567|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111078894|NCT03349177|Cyclophosphamide|cyclophosphamide|mesh-list
111078895|NCT03349177|Docetaxel|docetaxel|mesh-list
111078896|NCT03349177|Fluorouracil|fluorouracil|mesh-list
111078897|NCT03349177|Epirubicin|epirubicin|mesh-list
111078898|NCT03349177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111078899|NCT03349177|Immunologic Factors|immunologic factors|mesh-ancestor
111078900|NCT03349177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111078901|NCT03349177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111078902|NCT03349177|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111078903|NCT03349177|Alkylating Agents|alkylating agents|mesh-ancestor
111078904|NCT03349177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111078905|NCT03349177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111078906|NCT03349177|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111078907|NCT03349177|Tubulin Modulators|tubulin modulators|mesh-ancestor
111078908|NCT03349177|Antimitotic Agents|antimitotic agents|mesh-ancestor
111078909|NCT03349177|Mitosis Modulators|mitosis modulators|mesh-ancestor
111078910|NCT03349177|Antimetabolites|antimetabolites|mesh-ancestor
111078911|NCT03349177|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111078912|NCT03349177|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111078913|NCT03349177|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111078914|NCT03349177|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111078915|NCT03349177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111078916|NCT04691505|Hydroxychloroquine|hydroxychloroquine|mesh-list
111078917|NCT04691505|Methotrexate|methotrexate|mesh-list
111078918|NCT04691505|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111078919|NCT04691505|Abortifacient Agents|abortifacient agents|mesh-ancestor
111078920|NCT04691505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111078921|NCT04691505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111078922|NCT04691505|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111078923|NCT04691505|Antimetabolites|antimetabolites|mesh-ancestor
111078924|NCT04691505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111078925|NCT04691505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111078926|NCT04691505|Dermatologic Agents|dermatologic agents|mesh-ancestor
111078927|NCT04691505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111078928|NCT04691505|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111078929|NCT04691505|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111078930|NCT04691505|Immunologic Factors|immunologic factors|mesh-ancestor
111078931|NCT04691505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111078932|NCT04691505|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111078933|NCT04691505|Antimalarials|antimalarials|mesh-ancestor
111078934|NCT04691505|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111078935|NCT04691505|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111078936|NCT04691505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111078937|NCT05364619|Bismuth|bismuth|mesh-list
111078938|NCT05364619|Antacids|antacids|mesh-ancestor
111078939|NCT05364619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111078940|NCT05364619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111078942|NCT03353857|Dienogest|dienogest|mesh-list
111078943|NCT03353857|Drospirenone|drospirenone|mesh-list
111078944|NCT03353857|Midazolam|midazolam|mesh-list
111078945|NCT03353857|Levonorgestrel|levonorgestrel|mesh-list
111078946|NCT03353857|Ethinyl Estradiol|ethinyl estradiol|mesh-list
111078947|NCT03353857|Norethindrone|norethindrone|mesh-list
111078948|NCT03353857|Norethindrone Acetate|norethindrone acetate|mesh-list
111078949|NCT03353857|Desogestrel|desogestrel|mesh-list
111078950|NCT03353857|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111078951|NCT03353857|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111078952|NCT03353857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111078953|NCT03353857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111078954|NCT03353857|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111078955|NCT03353857|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111078956|NCT03353857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111078957|NCT03353857|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111078958|NCT03353857|Anesthetics, General|anesthetics, general|mesh-ancestor
111078959|NCT03353857|Anesthetics|anesthetics|mesh-ancestor
111078960|NCT03353857|GABA Modulators|gaba modulators|mesh-ancestor
111078961|NCT03353857|GABA Agents|gaba agents|mesh-ancestor
111078962|NCT03353857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110639509|NCT00864110|Deoxyglucose|deoxyglucose|mesh-list
111078963|NCT03353857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111078964|NCT03353857|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111078965|NCT03353857|Contraceptive Agents|contraceptive agents|mesh-ancestor
111078966|NCT03353857|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111078967|NCT03353857|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111078968|NCT03353857|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111078969|NCT03353857|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111078970|NCT03353857|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111078971|NCT03353857|Antitubercular Agents|antitubercular agents|mesh-ancestor
111078972|NCT03353857|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111078973|NCT03353857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111078974|NCT03353857|Leprostatic Agents|leprostatic agents|mesh-ancestor
111078975|NCT03353857|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111078976|NCT03353857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111078977|NCT03353857|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111078978|NCT03353857|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111078979|NCT03353857|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
111078980|NCT03353857|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
111078981|NCT03353857|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
111078982|NCT03353857|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111078983|NCT03353857|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111078984|NCT03353857|Estrogens|estrogens|mesh-ancestor
111078985|NCT03353857|Hormones|hormones|mesh-ancestor
111078986|NCT03353857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111078987|NCT03353857|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
111078988|NCT03353857|Hormone Antagonists|hormone antagonists|mesh-ancestor
111078989|NCT03353857|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
111078990|NCT03353857|Diuretics|diuretics|mesh-ancestor
111078991|NCT03353857|Natriuretic Agents|natriuretic agents|mesh-ancestor
111078992|NCT03353857|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
111078993|NCT03353857|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111078994|NCT03353857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111078995|NCT03353857|Progestins|progestins|mesh-ancestor
111078996|NCT04499859|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111078997|NCT04499859|Ezetimibe|ezetimibe|mesh-list
111078998|NCT04499859|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111078999|NCT04499859|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111079000|NCT04499859|Antimetabolites|antimetabolites|mesh-ancestor
111079001|NCT04499859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111079002|NCT04499859|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111079003|NCT04499859|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111079004|NCT04499859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111079005|NCT05306899|Ketamine|ketamine|mesh-list
111079006|NCT05306899|Analgesics|analgesics|mesh-ancestor
111079007|NCT05306899|Sensory System Agents|sensory system agents|mesh-ancestor
111079008|NCT05306899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111079009|NCT05306899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111079010|NCT05306899|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111079011|NCT05306899|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111079012|NCT05306899|Anesthetics, General|anesthetics, general|mesh-ancestor
111079013|NCT05306899|Anesthetics|anesthetics|mesh-ancestor
111079014|NCT05306899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111079015|NCT05306899|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111079016|NCT05306899|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111079017|NCT05306899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111079018|NCT05306899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111079019|NCT00807651|Insulin|insulin|mesh-list
111079020|NCT00807651|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111079021|NCT00807651|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111079022|NCT00807651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111079023|NCT00700791|Vitamins|vitamins|mesh-list
111079024|NCT00700791|Vitamin E|vitamin e|mesh-list
111079025|NCT00700791|Tocopherols|tocopherols|mesh-list
111079026|NCT00700791|Tocotrienols|tocotrienols|mesh-list
111079027|NCT00700791|alpha-Tocopherol|alpha-tocopherol|mesh-list
111079028|NCT00700791|Micronutrients|micronutrients|mesh-ancestor
111079029|NCT00700791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111079030|NCT00700791|Antioxidants|antioxidants|mesh-ancestor
111079031|NCT00700791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111079032|NCT00700791|Protective Agents|protective agents|mesh-ancestor
111079033|NCT05344365|Iloperidone|iloperidone|mesh-list
111079034|NCT05344365|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111079035|NCT05344365|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111079036|NCT05344365|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111079037|NCT05344365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111079038|NCT05344365|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111079039|NCT04373733|Favipiravir|favipiravir|mesh-list
111079040|NCT04373733|Antiviral Agents|antiviral agents|mesh-ancestor
111079041|NCT04373733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111079042|NCT05403489|Dimercaprol|dimercaprol|mesh-list
111079043|NCT05403489|Chelating Agents|chelating agents|mesh-ancestor
111079044|NCT05403489|Sequestering Agents|sequestering agents|mesh-ancestor
111079045|NCT05403489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111079046|NCT04969731|Gemcitabine|gemcitabine|mesh-list
111079047|NCT04969731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111079048|NCT04969731|Antimetabolites|antimetabolites|mesh-ancestor
111079049|NCT04969731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111079050|NCT04969731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111079051|NCT02045901|Dicyclomine, doxylamine, pyridoxine drug combination|dicyclomine, doxylamine, pyridoxine drug combination|mesh-list
111079052|NCT02045901|Antiemetics|antiemetics|mesh-ancestor
111079053|NCT02045901|Autonomic Agents|autonomic agents|mesh-ancestor
111079054|NCT02045901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111079055|NCT02045901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111079056|NCT02045901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111079057|NCT02045901|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111079058|NCT02045901|Histamine Antagonists|histamine antagonists|mesh-ancestor
111079059|NCT02045901|Histamine Agents|histamine agents|mesh-ancestor
111079060|NCT02045901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111079061|NCT02045901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111079062|NCT01674621|Abaloparatide|abaloparatide|mesh-list
111079063|NCT01674621|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
111079064|NCT01674621|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111079065|NCT01674621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111079066|NCT01674621|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111079067|NCT04644705|Niclosamide|niclosamide|mesh-list
111079068|NCT04644705|Anticestodal Agents|anticestodal agents|mesh-ancestor
111079069|NCT04644705|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
111079070|NCT04644705|Anthelmintics|anthelmintics|mesh-ancestor
111079071|NCT04644705|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111079072|NCT04644705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111079073|NCT04644705|Antinematodal Agents|antinematodal agents|mesh-ancestor
111079074|NCT04038489|Aspirin|aspirin|mesh-list
111079075|NCT04038489|Tamoxifen|tamoxifen|mesh-list
111079076|NCT04038489|Paclitaxel|paclitaxel|mesh-list
111079077|NCT04038489|Cyclophosphamide|cyclophosphamide|mesh-list
111079078|NCT04038489|Doxorubicin|doxorubicin|mesh-list
111079079|NCT04038489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111079080|NCT04038489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111079081|NCT04038489|Tubulin Modulators|tubulin modulators|mesh-ancestor
111079082|NCT04038489|Antimitotic Agents|antimitotic agents|mesh-ancestor
111079083|NCT04038489|Mitosis Modulators|mitosis modulators|mesh-ancestor
111079084|NCT04038489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111079085|NCT04038489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111079086|NCT04038489|Immunologic Factors|immunologic factors|mesh-ancestor
111079087|NCT04038489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110796200|NCT01201239|Raltegravir Potassium|raltegravir potassium|mesh-list
111079088|NCT04038489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111079089|NCT04038489|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111079090|NCT04038489|Alkylating Agents|alkylating agents|mesh-ancestor
111079091|NCT04038489|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111079092|NCT04038489|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111079093|NCT04038489|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111079094|NCT04038489|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111079095|NCT04038489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111079096|NCT04038489|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111079097|NCT04038489|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111079098|NCT04038489|Analgesics|analgesics|mesh-ancestor
111079099|NCT04038489|Sensory System Agents|sensory system agents|mesh-ancestor
111079100|NCT04038489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111079101|NCT04038489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111079102|NCT04038489|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111079103|NCT04038489|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111079104|NCT04038489|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111079105|NCT04038489|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111079106|NCT04038489|Antipyretics|antipyretics|mesh-ancestor
111079107|NCT04038489|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111079108|NCT04038489|Hormone Antagonists|hormone antagonists|mesh-ancestor
111079109|NCT04038489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111079110|NCT04038489|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111079111|NCT04038489|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111079112|NCT04038489|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111079113|NCT04038489|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111079114|NCT04468425|Tofacitinib|tofacitinib|mesh-list
110639568|NCT00864812|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111079115|NCT04468425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111079116|NCT04468425|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
111079117|NCT04468425|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111079118|NCT04468425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111079119|NCT04287855|Dexamethasone|dexamethasone|mesh-list
111079120|NCT04287855|Pomalidomide|pomalidomide|mesh-list
111079121|NCT04287855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111079122|NCT04287855|Antiemetics|antiemetics|mesh-ancestor
111079123|NCT04287855|Autonomic Agents|autonomic agents|mesh-ancestor
111079124|NCT04287855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111079125|NCT04287855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111079126|NCT04287855|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111079127|NCT04287855|Glucocorticoids|glucocorticoids|mesh-ancestor
111079128|NCT04287855|Hormones|hormones|mesh-ancestor
111079129|NCT04287855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111079130|NCT04287855|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111079131|NCT04287855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111079132|NCT04287855|Immunologic Factors|immunologic factors|mesh-ancestor
111079133|NCT04287855|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111079134|NCT04287855|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111079135|NCT04287855|Growth Substances|growth substances|mesh-ancestor
111079136|NCT04287855|Growth Inhibitors|growth inhibitors|mesh-ancestor
111079137|NCT04435587|Ritonavir|ritonavir|mesh-list
111079138|NCT04435587|Darunavir|darunavir|mesh-list
111079139|NCT04435587|Hydroxychloroquine|hydroxychloroquine|mesh-list
111079140|NCT04435587|Ivermectin|ivermectin|mesh-list
111079141|NCT04435587|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111079142|NCT04435587|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111079143|NCT04435587|Protease Inhibitors|protease inhibitors|mesh-ancestor
111079144|NCT04435587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111079145|NCT04435587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111079146|NCT04435587|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111079147|NCT04435587|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111079148|NCT04435587|Antiviral Agents|antiviral agents|mesh-ancestor
111079149|NCT04435587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111079150|NCT04435587|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111079151|NCT04435587|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111079153|NCT04435587|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111079154|NCT04435587|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111079155|NCT04435587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111079156|NCT05131893|Tamoxifen|tamoxifen|mesh-list
111079157|NCT05131893|Docetaxel|docetaxel|mesh-list
111079158|NCT05131893|Cyclophosphamide|cyclophosphamide|mesh-list
111079159|NCT05131893|Capecitabine|capecitabine|mesh-list
111079160|NCT05131893|Trastuzumab|trastuzumab|mesh-list
111079161|NCT05131893|Letrozole|letrozole|mesh-list
111079162|NCT05131893|Epirubicin|epirubicin|mesh-list
111079163|NCT05131893|Pertuzumab|pertuzumab|mesh-list
111079164|NCT05131893|Goserelin|goserelin|mesh-list
111079165|NCT05131893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111079166|NCT05131893|Tubulin Modulators|tubulin modulators|mesh-ancestor
111079167|NCT05131893|Antimitotic Agents|antimitotic agents|mesh-ancestor
111079168|NCT05131893|Mitosis Modulators|mitosis modulators|mesh-ancestor
111079169|NCT05131893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111079170|NCT05131893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111079171|NCT05131893|Immunologic Factors|immunologic factors|mesh-ancestor
111079172|NCT05131893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111079173|NCT05131893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111079174|NCT05131893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111079175|NCT05131893|Alkylating Agents|alkylating agents|mesh-ancestor
111079176|NCT05131893|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111079177|NCT05131893|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111079178|NCT05131893|Antimetabolites|antimetabolites|mesh-ancestor
111079179|NCT05131893|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111079180|NCT05131893|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111079181|NCT05131893|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111079182|NCT05131893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111079183|NCT05131893|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111079184|NCT05131893|Hormone Antagonists|hormone antagonists|mesh-ancestor
111079185|NCT05131893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111079186|NCT05131893|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111079187|NCT05131893|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111079188|NCT05131893|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111079189|NCT05131893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111079190|NCT05131893|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111079191|NCT05131893|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111079192|NCT05131893|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111079193|NCT02889237|Calcium, Dietary|calcium, dietary|mesh-list
111079194|NCT02889237|Vitamin D|vitamin d|mesh-list
111079195|NCT02889237|Ergocalciferols|ergocalciferols|mesh-list
111079196|NCT02889237|Cholecalciferol|cholecalciferol|mesh-list
111079197|NCT02889237|Vitamins|vitamins|mesh-list
111079198|NCT02889237|Calcium|calcium|mesh-list
111079199|NCT02889237|Micronutrients|micronutrients|mesh-ancestor
111079200|NCT02889237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111079201|NCT02889237|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111079202|NCT02889237|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111079203|NCT02689167|Sunitinib|sunitinib|mesh-list
111079204|NCT02689167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111079205|NCT02689167|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111079206|NCT02689167|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111079207|NCT02689167|Growth Substances|growth substances|mesh-ancestor
111079208|NCT02689167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111079209|NCT02689167|Growth Inhibitors|growth inhibitors|mesh-ancestor
111079210|NCT02689167|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111079211|NCT02689167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111079212|NCT02689167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111079213|NCT02582697|Cisplatin|cisplatin|mesh-list
111079214|NCT02582697|Etoposide|etoposide|mesh-list
111079215|NCT02582697|Etoposide phosphate|etoposide phosphate|mesh-list
111079216|NCT02582697|Bleomycin|bleomycin|mesh-list
111079217|NCT02582697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111079218|NCT02582697|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111079219|NCT02582697|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111079220|NCT02582697|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111079221|NCT02582697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111079222|NCT02582697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111079223|NCT02582697|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111079224|NCT01503489|Norepinephrine|norepinephrine|mesh-list
111079225|NCT01503489|Antidepressive Agents|antidepressive agents|mesh-list
111079226|NCT01503489|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-list
111079227|NCT01503489|Serotonin|serotonin|mesh-list
111079228|NCT01503489|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
111079229|NCT01503489|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111079230|NCT01503489|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111079231|NCT01503489|Adrenergic Agents|adrenergic agents|mesh-ancestor
111079232|NCT01503489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111079233|NCT01503489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111079234|NCT01503489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111079235|NCT01503489|Sympathomimetics|sympathomimetics|mesh-ancestor
111079236|NCT01503489|Autonomic Agents|autonomic agents|mesh-ancestor
111079237|NCT01503489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111079238|NCT01503489|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111079239|NCT01503489|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111079240|NCT01503489|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111079241|NCT01503489|Serotonin Agents|serotonin agents|mesh-ancestor
111079242|NCT01503489|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111079243|NCT01503489|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111079244|NCT05059587|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111079245|NCT05059587|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111079246|NCT05059587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111079247|NCT05059587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111079248|NCT05059587|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111079249|NCT05059587|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111079250|NCT05059587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111079251|NCT05059587|Cholinergic Agents|cholinergic agents|mesh-ancestor
111079252|NCT05059587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111079253|NCT05137197|Antidepressive Agents|antidepressive agents|mesh-list
111079254|NCT05137197|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111079255|NCT05135715|Trastuzumab|trastuzumab|mesh-list
111079256|NCT05135715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111079257|NCT05135715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111079258|NCT05185167|Propofol|propofol|mesh-list
111079259|NCT05185167|Anesthetics|anesthetics|mesh-list
111079260|NCT05185167|Desflurane|desflurane|mesh-list
111079261|NCT05185167|Anesthetics, General|anesthetics, general|mesh-list
111079262|NCT05185167|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111079263|NCT05185167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111079264|NCT05185167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111079265|NCT05185167|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111079266|NCT05185167|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111079267|NCT05133453|Pirfenidone|pirfenidone|mesh-list
111079268|NCT05133453|Analgesics|analgesics|mesh-ancestor
111079269|NCT05133453|Sensory System Agents|sensory system agents|mesh-ancestor
111079270|NCT05133453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111079271|NCT05133453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111079272|NCT05133453|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111079273|NCT05133453|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111079274|NCT05133453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111079275|NCT05133453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111079276|NCT05133453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111079277|NCT05125185|Insulin|insulin|mesh-list
111079278|NCT05125185|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111079279|NCT05125185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111079280|NCT04244877|Rifaximin|rifaximin|mesh-list
111079281|NCT04244877|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111079282|NCT04244877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111079283|NCT04244877|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111079284|NCT05118945|Insulin|insulin|mesh-list
111079285|NCT05118945|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111079286|NCT05118945|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111079287|NCT05118945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111079288|NCT05305131|Bevacizumab|bevacizumab|mesh-list
111079289|NCT05305131|Pembrolizumab|pembrolizumab|mesh-list
111079290|NCT05305131|Cisplatin|cisplatin|mesh-list
111079291|NCT05305131|Gemcitabine|gemcitabine|mesh-list
111079292|NCT05305131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111079293|NCT05305131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111079294|NCT05305131|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111079295|NCT05305131|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111079296|NCT05305131|Growth Substances|growth substances|mesh-ancestor
111079297|NCT05305131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111079298|NCT05305131|Growth Inhibitors|growth inhibitors|mesh-ancestor
111079299|NCT05305131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111079300|NCT05305131|Antimetabolites|antimetabolites|mesh-ancestor
111079301|NCT05305131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110677128|NCT02732288|Melatonin|melatonin|mesh-list
111079302|NCT05305131|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111079303|NCT03122665|Nefopam|nefopam|mesh-list
111079304|NCT03122665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111079305|NCT03122665|Analgesics|analgesics|mesh-ancestor
111079306|NCT03122665|Sensory System Agents|sensory system agents|mesh-ancestor
111079307|NCT03122665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111079308|NCT03122665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111079309|NCT05099913|Flupenthixol|flupenthixol|mesh-list
111079310|NCT05099913|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111079311|NCT05099913|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111079312|NCT05099913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111079313|NCT05099913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111079314|NCT05099913|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111079315|NCT05099913|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111079316|NCT05099913|Dopamine Agents|dopamine agents|mesh-ancestor
111079317|NCT05099913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111079318|NCT05099913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111079319|NCT03346993|Bupivacaine|bupivacaine|mesh-list
111079320|NCT03346993|Anesthetics, Local|anesthetics, local|mesh-ancestor
111079321|NCT03346993|Anesthetics|anesthetics|mesh-ancestor
111079322|NCT03346993|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111079323|NCT03346993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111079324|NCT03346993|Sensory System Agents|sensory system agents|mesh-ancestor
111079325|NCT03346993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111079326|NCT03346837|Itraconazole|itraconazole|mesh-list
111079327|NCT03346837|Rifampin|rifampin|mesh-list
111079328|NCT03346837|Linrodostat|linrodostat|mesh-list
111079329|NCT03346837|Antifungal Agents|antifungal agents|mesh-ancestor
111079330|NCT03346837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111079331|NCT03346837|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111079332|NCT03346837|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111079333|NCT03346837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111079334|NCT03346837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111079335|NCT03346837|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111079336|NCT03346837|Hormone Antagonists|hormone antagonists|mesh-ancestor
111079337|NCT03346837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111079338|NCT03346837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111079339|NCT03346837|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111079340|NCT03346837|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111079341|NCT03346837|Antitubercular Agents|antitubercular agents|mesh-ancestor
111079342|NCT03346837|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111079343|NCT03346837|Leprostatic Agents|leprostatic agents|mesh-ancestor
111079344|NCT03346837|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110639665|NCT00514540|Docetaxel|docetaxel|mesh-list
111079345|NCT03346837|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111079346|NCT03346837|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111079347|NCT03346837|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
111079348|NCT03346837|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
111079349|NCT03346837|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
111079350|NCT03346837|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111079351|NCT04564521|Nitroglycerin|nitroglycerin|mesh-list
111079352|NCT04564521|Vasodilator Agents|vasodilator agents|mesh-ancestor
111079353|NCT05303961|Rebamipide|rebamipide|mesh-list
111079354|NCT05303961|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111079355|NCT05303961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111079356|NCT05303961|Antioxidants|antioxidants|mesh-ancestor
111079357|NCT05303961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111079358|NCT05303961|Protective Agents|protective agents|mesh-ancestor
111079359|NCT05303961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111079360|NCT05303961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111079361|NCT03122353|Calcitriol|calcitriol|mesh-list
111079362|NCT03122353|Betamethasone|betamethasone|mesh-list
111079363|NCT03122353|Betamethasone Valerate|betamethasone valerate|mesh-list
111079364|NCT03122353|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
111079365|NCT03122353|Betamethasone benzoate|betamethasone benzoate|mesh-list
111079366|NCT03122353|Calcipotriene|calcipotriene|mesh-list
111079367|NCT03122353|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
111079368|NCT03122353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111079369|NCT03122353|Glucocorticoids|glucocorticoids|mesh-ancestor
111079370|NCT03122353|Hormones|hormones|mesh-ancestor
111079371|NCT03122353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111079372|NCT03122353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111079373|NCT03122353|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111079374|NCT03122353|Respiratory System Agents|respiratory system agents|mesh-ancestor
111079375|NCT03122353|Dermatologic Agents|dermatologic agents|mesh-ancestor
111079376|NCT03122353|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111079377|NCT03122353|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
111079378|NCT03122353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111079379|NCT03122353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111079380|NCT03122353|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111079381|NCT03122353|Vitamins|vitamins|mesh-ancestor
111079382|NCT03122353|Micronutrients|micronutrients|mesh-ancestor
111079383|NCT03122353|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111079384|NCT05303259|Bevacizumab|bevacizumab|mesh-list
111079385|NCT05303259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111079386|NCT05303259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111079387|NCT05303259|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110796497|NCT03292016|Apomorphine|apomorphine|mesh-list
111079388|NCT05303259|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111079389|NCT05303259|Growth Substances|growth substances|mesh-ancestor
111079390|NCT05303259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111079391|NCT05303259|Growth Inhibitors|growth inhibitors|mesh-ancestor
111079392|NCT03121963|Acetaminophen|acetaminophen|mesh-list
111079393|NCT03121963|Celecoxib|celecoxib|mesh-list
111079394|NCT03121963|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
111079395|NCT03121963|Oxycodone|oxycodone|mesh-list
111079396|NCT03121963|Gabapentin|gabapentin|mesh-list
111079397|NCT03121963|Hydrocodone|hydrocodone|mesh-list
111079398|NCT03121963|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111079399|NCT03121963|Analgesics|analgesics|mesh-ancestor
111079400|NCT03121963|Sensory System Agents|sensory system agents|mesh-ancestor
111079401|NCT03121963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111079402|NCT03121963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111079403|NCT03121963|Antipyretics|antipyretics|mesh-ancestor
111079404|NCT03121963|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111079405|NCT03121963|Narcotics|narcotics|mesh-ancestor
111079406|NCT03121963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111079407|NCT03121963|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111079408|NCT03121963|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111079409|NCT03121963|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111079410|NCT03121963|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111079411|NCT03121963|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111079412|NCT03121963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111079413|NCT03121963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111079414|NCT03121963|Anticonvulsants|anticonvulsants|mesh-ancestor
111079415|NCT03121963|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111079416|NCT03121963|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111079417|NCT03121963|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111079418|NCT03121963|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111079419|NCT03121963|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111079420|NCT03121963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111079421|NCT03121963|Antimanic Agents|antimanic agents|mesh-ancestor
111079422|NCT03121963|Antitussive Agents|antitussive agents|mesh-ancestor
111079423|NCT03121963|Respiratory System Agents|respiratory system agents|mesh-ancestor
111079424|NCT04502251|Naltrexone|naltrexone|mesh-list
111079425|NCT04502251|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111079426|NCT04502251|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111079427|NCT04502251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111079428|NCT04502251|Sensory System Agents|sensory system agents|mesh-ancestor
111079429|NCT04502251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111079430|NCT02648217|Insulin|insulin|mesh-list
111079431|NCT02648217|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111079432|NCT02648217|Insulin Aspart|insulin aspart|mesh-list
111079433|NCT02648217|Insulin, Long-Acting|insulin, long-acting|mesh-list
111079434|NCT02648217|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
111079435|NCT02648217|Biphasic Insulins|biphasic insulins|mesh-list
111079436|NCT02648217|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111079437|NCT02648217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111079438|NCT03122041|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111079439|NCT03122041|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111079440|NCT03122041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111079441|NCT03122041|Incretins|incretins|mesh-ancestor
111079442|NCT03122041|Hormones|hormones|mesh-ancestor
111079443|NCT03122041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111079444|NCT03122041|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111079445|NCT03122041|Protease Inhibitors|protease inhibitors|mesh-ancestor
111079446|NCT03122041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111079447|NCT03122041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111079448|NCT04943679|Interferons|interferons|mesh-list
111079449|NCT04943679|Interferon-alpha|interferon-alpha|mesh-list
111079450|NCT04943679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111079452|NCT04943679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111079453|NCT04943679|Immunologic Factors|immunologic factors|mesh-ancestor
111079454|NCT04943679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111079455|NCT04507165|Analgesics, Opioid|analgesics, opioid|mesh-list
111079456|NCT04507165|Anesthetics|anesthetics|mesh-list
111079457|NCT04507165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111079458|NCT04507165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111079459|NCT04507165|Narcotics|narcotics|mesh-ancestor
111079460|NCT04507165|Analgesics|analgesics|mesh-ancestor
111079461|NCT04507165|Sensory System Agents|sensory system agents|mesh-ancestor
110796575|NCT01298505|Fexofenadine|fexofenadine|mesh-list
111079462|NCT04507165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111079463|NCT04475991|Maraviroc|maraviroc|mesh-list
111079465|NCT04475991|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
111079466|NCT04475991|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
111079467|NCT04475991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111079468|NCT04475991|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111079469|NCT04475991|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111079470|NCT04475991|Antiviral Agents|antiviral agents|mesh-ancestor
111079471|NCT04475991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111079472|NCT04475991|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
111079473|NCT03387475|Deferasirox|deferasirox|mesh-list
111079474|NCT03387475|Iron Chelating Agents|iron chelating agents|mesh-ancestor
111079475|NCT03387475|Chelating Agents|chelating agents|mesh-ancestor
111079476|NCT03387475|Sequestering Agents|sequestering agents|mesh-ancestor
111079477|NCT03387475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111079478|NCT04502017|Clopidogrel|clopidogrel|mesh-list
111079479|NCT04502017|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111079480|NCT04502017|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111079481|NCT04502017|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111079482|NCT04502017|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111079483|NCT04502017|Purinergic Agents|purinergic agents|mesh-ancestor
111079484|NCT04502017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111079485|NCT04502017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111079486|NCT04502017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111079487|NCT05302713|Calcium, Dietary|calcium, dietary|mesh-list
111079488|NCT05302713|Calcium Carbonate|calcium carbonate|mesh-list
111079489|NCT05302713|Calcium|calcium|mesh-list
111079490|NCT05302713|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111079491|NCT05302713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111079492|NCT05302713|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111079493|NCT05302713|Antacids|antacids|mesh-ancestor
111079494|NCT05302713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111079495|NCT05302713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111079496|NCT04921033|Prednisolone|prednisolone|mesh-list
111079497|NCT04921033|Budesonide|budesonide|mesh-list
111079498|NCT04921033|Azathioprine|azathioprine|mesh-list
111079499|NCT04921033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111079500|NCT04921033|Glucocorticoids|glucocorticoids|mesh-ancestor
111079501|NCT04921033|Hormones|hormones|mesh-ancestor
111079502|NCT04921033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111079503|NCT04921033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111079504|NCT04921033|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111079505|NCT04921033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111079506|NCT04921033|Autonomic Agents|autonomic agents|mesh-ancestor
111079507|NCT04921033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111079508|NCT04921033|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111079509|NCT04921033|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111079510|NCT04921033|Respiratory System Agents|respiratory system agents|mesh-ancestor
111079511|NCT04921033|Antimetabolites|antimetabolites|mesh-ancestor
111079512|NCT04921033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111079513|NCT04921033|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111079514|NCT04921033|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111079515|NCT04921033|Immunologic Factors|immunologic factors|mesh-ancestor
111079516|NCT04921033|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111079517|NCT03346681|Acetylcysteine|acetylcysteine|mesh-list
111079518|NCT03346681|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111079519|NCT03346681|Antiviral Agents|antiviral agents|mesh-ancestor
111079520|NCT03346681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111079521|NCT03346681|Expectorants|expectorants|mesh-ancestor
111079522|NCT03346681|Respiratory System Agents|respiratory system agents|mesh-ancestor
111079523|NCT03346681|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111079524|NCT03346681|Antioxidants|antioxidants|mesh-ancestor
111079525|NCT03346681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111079526|NCT03346681|Protective Agents|protective agents|mesh-ancestor
111079527|NCT03346681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111079528|NCT03346681|Antidotes|antidotes|mesh-ancestor
111079529|NCT04488315|Dexamethasone|dexamethasone|mesh-list
111079530|NCT04488315|Ropivacaine|ropivacaine|mesh-list
111079531|NCT04488315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111079532|NCT04488315|Antiemetics|antiemetics|mesh-ancestor
111079533|NCT04488315|Autonomic Agents|autonomic agents|mesh-ancestor
111079534|NCT04488315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111079535|NCT04488315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111079536|NCT04488315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111079537|NCT04488315|Glucocorticoids|glucocorticoids|mesh-ancestor
111079538|NCT04488315|Hormones|hormones|mesh-ancestor
111079539|NCT04488315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111079540|NCT04488315|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111079541|NCT04488315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111079542|NCT04488315|Anesthetics, Local|anesthetics, local|mesh-ancestor
111079543|NCT04488315|Anesthetics|anesthetics|mesh-ancestor
111079544|NCT04488315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111079545|NCT04488315|Sensory System Agents|sensory system agents|mesh-ancestor
111079546|NCT00709735|Propranolol|propranolol|mesh-list
111079547|NCT00709735|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111079548|NCT00709735|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111079549|NCT00709735|Adrenergic Agents|adrenergic agents|mesh-ancestor
111079550|NCT00709735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111079551|NCT00709735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111079552|NCT00709735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111079553|NCT00709735|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111079554|NCT00709735|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111079555|NCT00709735|Vasodilator Agents|vasodilator agents|mesh-ancestor
111079556|NCT04505995|Azacitidine|azacitidine|mesh-list
111079557|NCT04505995|Homoharringtonine|homoharringtonine|mesh-list
111079558|NCT04505995|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111079559|NCT04505995|Antimetabolites|antimetabolites|mesh-ancestor
111079560|NCT04505995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111079561|NCT04505995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111079562|NCT04505995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111079563|NCT04505995|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111079564|NCT04505995|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111079565|NCT04486911|Letrozole|letrozole|mesh-list
111079566|NCT04486911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111079567|NCT04486911|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111079568|NCT04486911|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111079569|NCT04486911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111079570|NCT04486911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111079571|NCT04486911|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111079572|NCT04486911|Hormone Antagonists|hormone antagonists|mesh-ancestor
111079573|NCT04486911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111079574|NCT04486911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111079575|NCT05135013|Drospirenone|drospirenone|mesh-list
111079576|NCT05135013|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
111079577|NCT05135013|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
111079578|NCT05135013|Ethinyl Estradiol|ethinyl estradiol|mesh-list
111079579|NCT05135013|Norethindrone|norethindrone|mesh-list
111079580|NCT05135013|Norethindrone Acetate|norethindrone acetate|mesh-list
111079581|NCT05135013|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
111079582|NCT05135013|Estradiol|estradiol|mesh-list
111079583|NCT05135013|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
111079584|NCT05135013|Dydrogesterone|dydrogesterone|mesh-list
111079585|NCT05135013|Estrogens|estrogens|mesh-ancestor
111079586|NCT05135013|Hormones|hormones|mesh-ancestor
111079587|NCT05135013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111079588|NCT05135013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111079589|NCT05135013|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111079590|NCT05135013|Contraceptive Agents|contraceptive agents|mesh-ancestor
111079591|NCT05135013|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111079592|NCT05135013|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111079593|NCT05135013|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111079594|NCT05135013|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111079595|NCT05135013|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
111079596|NCT05135013|Hormone Antagonists|hormone antagonists|mesh-ancestor
110029373|NCT05019638|Sympathomimetics|sympathomimetics|mesh-ancestor
111079597|NCT05135013|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
111079598|NCT05135013|Diuretics|diuretics|mesh-ancestor
111079599|NCT05135013|Natriuretic Agents|natriuretic agents|mesh-ancestor
111079600|NCT05135013|Progestins|progestins|mesh-ancestor
111079601|NCT05135013|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111079602|NCT04516161|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
111079603|NCT04516161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111079604|NCT04505917|Misoprostol|misoprostol|mesh-list
111079605|NCT04505917|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111079606|NCT04505917|Abortifacient Agents|abortifacient agents|mesh-ancestor
111079607|NCT04505917|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111079608|NCT04505917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111079609|NCT04505917|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111079610|NCT04505917|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111079611|NCT04505917|Oxytocics|oxytocics|mesh-ancestor
111079612|NCT04505683|Ertapenem|ertapenem|mesh-list
111079613|NCT04505683|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111079614|NCT04505683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111079615|NCT05576155|Compound 21|compound 21|mesh-list
111079616|NCT05576155|Losartan|losartan|mesh-list
111079617|NCT05576155|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111079618|NCT05576155|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111079619|NCT05576155|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111079620|NCT05576155|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111079621|NCT05576155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111079622|NCT05576155|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111079623|NCT04501783|Favipiravir|favipiravir|mesh-list
111079624|NCT04501783|Antiviral Agents|antiviral agents|mesh-ancestor
111079625|NCT04501783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111079626|NCT03351751|PF-06372865|pf-06372865|mesh-list
111079627|NCT03351751|GABA Modulators|gaba modulators|mesh-ancestor
111079628|NCT03351751|GABA Agents|gaba agents|mesh-ancestor
111079629|NCT03351751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111079630|NCT03351751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111079631|NCT03351751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111079632|NCT03347461|Ciprofloxacin|ciprofloxacin|mesh-list
111079633|NCT03347461|Dexamethasone|dexamethasone|mesh-list
111079634|NCT03347461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111079635|NCT03347461|Antiemetics|antiemetics|mesh-ancestor
111079636|NCT03347461|Autonomic Agents|autonomic agents|mesh-ancestor
111079637|NCT03347461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111079638|NCT03347461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111079639|NCT03347461|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111079640|NCT03347461|Glucocorticoids|glucocorticoids|mesh-ancestor
111079641|NCT03347461|Hormones|hormones|mesh-ancestor
111079642|NCT03347461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111079643|NCT03347461|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111079644|NCT03347461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111079645|NCT03347461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111079646|NCT03347461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111079647|NCT03347461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111079648|NCT03347461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111079649|NCT03347461|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111079650|NCT03347461|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111079651|NCT03347461|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111079652|NCT03347461|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111079653|NCT03351517|Tapentadol|tapentadol|mesh-list
111079654|NCT03351517|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111079655|NCT03351517|Narcotics|narcotics|mesh-ancestor
111079656|NCT03351517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111079657|NCT03351517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111079658|NCT03351517|Analgesics|analgesics|mesh-ancestor
111079659|NCT03351517|Sensory System Agents|sensory system agents|mesh-ancestor
111079660|NCT03351517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111079661|NCT03351517|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111079662|NCT03351517|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111079663|NCT03351517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111079664|NCT03351517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111079665|NCT03351517|Adrenergic Agents|adrenergic agents|mesh-ancestor
111079666|NCT03351517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111079668|NCT03346525|Penicillin G|penicillin g|mesh-list
111079669|NCT03346525|Penicillin G Benzathine|penicillin g benzathine|mesh-list
111079670|NCT03346525|Penicillin G Procaine|penicillin g procaine|mesh-list
111079671|NCT03346525|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111079672|NCT03346525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111079673|NCT05060523|Tolvaptan|tolvaptan|mesh-list
111079674|NCT05060523|Midodrine|midodrine|mesh-list
111079675|NCT05060523|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
111079676|NCT05060523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111079677|NCT05060523|Natriuretic Agents|natriuretic agents|mesh-ancestor
111079678|NCT05060523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111079679|NCT05060523|Sympathomimetics|sympathomimetics|mesh-ancestor
111079680|NCT05060523|Autonomic Agents|autonomic agents|mesh-ancestor
111079681|NCT05060523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111079682|NCT05060523|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111079683|NCT05060523|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111079684|NCT05060523|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111079685|NCT05060523|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111079686|NCT05060523|Adrenergic Agents|adrenergic agents|mesh-ancestor
111079687|NCT05060523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111079688|NCT04502641|Docetaxel|docetaxel|mesh-list
111079689|NCT04502641|Fluorouracil|fluorouracil|mesh-list
111079690|NCT04502641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111079691|NCT04502641|Tubulin Modulators|tubulin modulators|mesh-ancestor
111079692|NCT04502641|Antimitotic Agents|antimitotic agents|mesh-ancestor
111079693|NCT04502641|Mitosis Modulators|mitosis modulators|mesh-ancestor
111079694|NCT04502641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111079695|NCT04502641|Antimetabolites|antimetabolites|mesh-ancestor
111079696|NCT04502641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111079697|NCT04502641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111079698|NCT04502641|Immunologic Factors|immunologic factors|mesh-ancestor
111079699|NCT04502641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111079700|NCT05555797|Betamethasone|betamethasone|mesh-list
111079701|NCT05555797|Betamethasone Valerate|betamethasone valerate|mesh-list
111079702|NCT05555797|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
111079703|NCT05555797|Betamethasone benzoate|betamethasone benzoate|mesh-list
111079704|NCT05555797|Tazarotene|tazarotene|mesh-list
111079705|NCT05555797|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
111079706|NCT05555797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111079707|NCT05555797|Glucocorticoids|glucocorticoids|mesh-ancestor
111079708|NCT05555797|Hormones|hormones|mesh-ancestor
111079709|NCT05555797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111079710|NCT05555797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111079711|NCT05555797|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111079712|NCT05555797|Respiratory System Agents|respiratory system agents|mesh-ancestor
111079713|NCT05555797|Dermatologic Agents|dermatologic agents|mesh-ancestor
111079714|NCT05555797|Keratolytic Agents|keratolytic agents|mesh-ancestor
111079715|NCT03955575|Liraglutide|liraglutide|mesh-list
111079716|NCT03955575|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
111079717|NCT03955575|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111079718|NCT03955575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111079719|NCT03955575|Incretins|incretins|mesh-ancestor
111079720|NCT03955575|Hormones|hormones|mesh-ancestor
111079721|NCT03955575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111079722|NCT03955575|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111079723|NCT03955575|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111079724|NCT03955575|Antimetabolites|antimetabolites|mesh-ancestor
111079725|NCT03955575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111079726|NCT03955575|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111079727|NCT04163419|Tanezumab|tanezumab|mesh-list
111079728|NCT04163419|Analgesics|analgesics|mesh-ancestor
111079729|NCT04163419|Sensory System Agents|sensory system agents|mesh-ancestor
111079730|NCT04163419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111079731|NCT04163419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111079732|NCT03351205|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
111079733|NCT03351205|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
111079734|NCT03351205|Estradiol|estradiol|mesh-list
111079735|NCT03351205|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
111079736|NCT03351205|Dydrogesterone|dydrogesterone|mesh-list
111079737|NCT03351205|Estrogens|estrogens|mesh-ancestor
111079738|NCT03351205|Hormones|hormones|mesh-ancestor
111079739|NCT03351205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110544825|NCT00668538|Hormone Antagonists|hormone antagonists|mesh-ancestor
111079740|NCT03351205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111079741|NCT03351205|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111079742|NCT03351205|Contraceptive Agents|contraceptive agents|mesh-ancestor
111079743|NCT03351205|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111079744|NCT03351205|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111079745|NCT03351205|Progestins|progestins|mesh-ancestor
111079746|NCT04698057|Amoxicillin|amoxicillin|mesh-list
111079747|NCT04698057|Ciprofloxacin|ciprofloxacin|mesh-list
111079748|NCT04698057|Clavulanic Acid|clavulanic acid|mesh-list
111079749|NCT04698057|Clavulanic Acids|clavulanic acids|mesh-list
111079750|NCT04698057|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
111079751|NCT04698057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111079752|NCT04698057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111079753|NCT04698057|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111079754|NCT04698057|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111079755|NCT04698057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111079756|NCT04698057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111079757|NCT04698057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111079758|NCT04698057|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111079759|NCT04698057|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111079760|NCT04698057|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
111079761|NCT02449005|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
111079762|NCT02449005|Hemostatics|hemostatics|mesh-ancestor
111079763|NCT02449005|Coagulants|coagulants|mesh-ancestor
111079764|NCT04132791|Aspirin|aspirin|mesh-list
111079765|NCT04132791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111079766|NCT04132791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111079767|NCT04132791|Analgesics|analgesics|mesh-ancestor
111079768|NCT04132791|Sensory System Agents|sensory system agents|mesh-ancestor
111079769|NCT04132791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111079770|NCT04132791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111079771|NCT04132791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111079772|NCT04132791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111079773|NCT04132791|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111079774|NCT04132791|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111079775|NCT04132791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111079776|NCT04132791|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111079777|NCT04132791|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111079778|NCT04132791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111079779|NCT04132791|Antipyretics|antipyretics|mesh-ancestor
111079780|NCT04065009|Ropivacaine|ropivacaine|mesh-list
111079781|NCT04065009|Anesthetics, Local|anesthetics, local|mesh-ancestor
111079782|NCT04065009|Anesthetics|anesthetics|mesh-ancestor
111079783|NCT04065009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111079784|NCT04065009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111079785|NCT04065009|Sensory System Agents|sensory system agents|mesh-ancestor
111079786|NCT04065009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111079787|NCT04250493|Insulin|insulin|mesh-list
111079788|NCT04250493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111079789|NCT04250493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111079790|NCT04147221|Imipenem|imipenem|mesh-list
111079791|NCT04147221|Relebactam|relebactam|mesh-list
111079792|NCT04147221|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111079793|NCT04147221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111079794|NCT04147221|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
111079795|NCT04147221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111079796|NCT04147221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111079797|NCT02517619|Dexamethasone|dexamethasone|mesh-list
111079798|NCT02517619|Prednisolone|prednisolone|mesh-list
111079799|NCT02517619|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111079800|NCT02517619|Methylprednisolone|methylprednisolone|mesh-list
111079801|NCT02517619|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111079802|NCT02517619|Prednisolone acetate|prednisolone acetate|mesh-list
111079803|NCT02517619|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111079804|NCT02517619|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111079805|NCT02517619|Prednisolone phosphate|prednisolone phosphate|mesh-list
111079806|NCT02517619|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
111079807|NCT02517619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111079808|NCT02517619|Antiemetics|antiemetics|mesh-ancestor
111079809|NCT02517619|Autonomic Agents|autonomic agents|mesh-ancestor
111079810|NCT02517619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111079811|NCT02517619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111079812|NCT02517619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111079813|NCT02517619|Glucocorticoids|glucocorticoids|mesh-ancestor
111079814|NCT02517619|Hormones|hormones|mesh-ancestor
111079815|NCT02517619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111079816|NCT02517619|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111079818|NCT02517619|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111079819|NCT02517619|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111079820|NCT02517619|Protective Agents|protective agents|mesh-ancestor
111079821|NCT03892395|Vitamin D|vitamin d|mesh-list
111079822|NCT03892395|Vitamins|vitamins|mesh-list
111079823|NCT03892395|Vitamin B Complex|vitamin b complex|mesh-list
111079824|NCT03892395|Micronutrients|micronutrients|mesh-ancestor
111079825|NCT03892395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111079826|NCT03892395|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111079827|NCT04481451|Ropivacaine|ropivacaine|mesh-list
111079828|NCT04481451|Anesthetics, Local|anesthetics, local|mesh-ancestor
111079829|NCT04481451|Anesthetics|anesthetics|mesh-ancestor
111079830|NCT04481451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111079831|NCT04481451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111079832|NCT04481451|Sensory System Agents|sensory system agents|mesh-ancestor
111079833|NCT04481451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111079834|NCT03376659|Bevacizumab|bevacizumab|mesh-list
111079835|NCT03376659|Durvalumab|durvalumab|mesh-list
111079836|NCT03376659|Capecitabine|capecitabine|mesh-list
111079837|NCT03376659|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111079838|NCT03376659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111079839|NCT03376659|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111079840|NCT03376659|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111079841|NCT03376659|Growth Substances|growth substances|mesh-ancestor
111079842|NCT03376659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111079843|NCT03376659|Growth Inhibitors|growth inhibitors|mesh-ancestor
111079844|NCT03376659|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111079845|NCT03376659|Antimetabolites|antimetabolites|mesh-ancestor
111079846|NCT03376659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111079847|NCT04102371|Plasma-lyte 148|plasma-lyte 148|mesh-list
111079848|NCT04102371|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
111079849|NCT04102371|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111079850|NCT04086147|Tenecteplase|tenecteplase|mesh-list
111079851|NCT04086147|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111079852|NCT04086147|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111079853|NCT04086147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111079854|NCT03161223|Azacitidine|azacitidine|mesh-list
111079856|NCT03161223|Romidepsin|romidepsin|mesh-list
111079857|NCT03161223|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111079858|NCT03161223|Antimetabolites|antimetabolites|mesh-ancestor
111079859|NCT03161223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111079860|NCT03161223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111079861|NCT03161223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111079862|NCT03161223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111079863|NCT03161223|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111079864|NCT03161223|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111079865|NCT03660813|Triptorelin Pamoate|triptorelin pamoate|mesh-list
111079866|NCT03660813|Luteolytic Agents|luteolytic agents|mesh-ancestor
111079867|NCT03660813|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111079868|NCT03660813|Contraceptive Agents|contraceptive agents|mesh-ancestor
111079869|NCT03660813|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111079870|NCT03660813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111079871|NCT03660813|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111079872|NCT03660813|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111079873|NCT03660813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111079874|NCT01285557|Cisplatin|cisplatin|mesh-list
111079875|NCT01285557|Fluorouracil|fluorouracil|mesh-list
111079876|NCT01285557|Tegafur|tegafur|mesh-list
111079877|NCT01285557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111079878|NCT01285557|Antimetabolites|antimetabolites|mesh-ancestor
111079879|NCT01285557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111079880|NCT01285557|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111079881|NCT01285557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111079882|NCT01285557|Immunologic Factors|immunologic factors|mesh-ancestor
111079883|NCT01285557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111079884|NCT03083067|Budesonide|budesonide|mesh-list
111079885|NCT03083067|Bromides|bromides|mesh-list
111079886|NCT03083067|Formoterol Fumarate|formoterol fumarate|mesh-list
111079887|NCT03083067|Tiotropium Bromide|tiotropium bromide|mesh-list
111079888|NCT03083067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111079889|NCT03083067|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111079890|NCT03083067|Autonomic Agents|autonomic agents|mesh-ancestor
111079891|NCT03083067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111079892|NCT03083067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111079893|NCT03083067|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111079894|NCT03083067|Respiratory System Agents|respiratory system agents|mesh-ancestor
111079895|NCT03083067|Glucocorticoids|glucocorticoids|mesh-ancestor
111079896|NCT03083067|Hormones|hormones|mesh-ancestor
111079897|NCT03083067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111079898|NCT03083067|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111079899|NCT03083067|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111079900|NCT03083067|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111079901|NCT03083067|Adrenergic Agents|adrenergic agents|mesh-ancestor
111079902|NCT03083067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111079903|NCT03083067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111079904|NCT03083067|Parasympatholytics|parasympatholytics|mesh-ancestor
111079905|NCT03083067|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111079906|NCT03083067|Cholinergic Agents|cholinergic agents|mesh-ancestor
111079907|NCT03083067|Anticonvulsants|anticonvulsants|mesh-ancestor
111079908|NCT05638399|Zoledronic Acid|zoledronic acid|mesh-list
111079909|NCT05638399|Denosumab|denosumab|mesh-list
111079910|NCT05638399|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111079911|NCT05638399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111079912|NCT02512471|Ropivacaine|ropivacaine|mesh-list
111079913|NCT02512471|Anesthetics, Local|anesthetics, local|mesh-ancestor
110797028|NCT03805035|Antipruritics|antipruritics|mesh-ancestor
111079914|NCT02512471|Anesthetics|anesthetics|mesh-ancestor
111079915|NCT02512471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111079916|NCT02512471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111079917|NCT02512471|Sensory System Agents|sensory system agents|mesh-ancestor
111079918|NCT02512471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111079919|NCT02507479|Thiotepa|thiotepa|mesh-list
111079920|NCT02507479|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111079921|NCT02507479|Alkylating Agents|alkylating agents|mesh-ancestor
111079922|NCT02507479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111079923|NCT02507479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111079924|NCT02507479|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111079925|NCT02507479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111079926|NCT02507479|Immunologic Factors|immunologic factors|mesh-ancestor
111079927|NCT02507479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111079928|NCT02512315|Cisplatin|cisplatin|mesh-list
111079929|NCT02512315|Docetaxel|docetaxel|mesh-list
111079930|NCT02512315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111079931|NCT02512315|Tubulin Modulators|tubulin modulators|mesh-ancestor
111079932|NCT02512315|Antimitotic Agents|antimitotic agents|mesh-ancestor
111079933|NCT02512315|Mitosis Modulators|mitosis modulators|mesh-ancestor
111079934|NCT02512315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111079935|NCT02507323|Ticagrelor|ticagrelor|mesh-list
111079936|NCT02507323|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
111079937|NCT02507323|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111079938|NCT02507323|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111079939|NCT02507323|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111079940|NCT02507323|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111079941|NCT02507323|Purinergic Agents|purinergic agents|mesh-ancestor
111079942|NCT02507323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111079943|NCT02507323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111079944|NCT02507323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111079945|NCT05431413|Phosphocreatine|phosphocreatine|mesh-list
111079946|NCT05431413|Fluoxetine|fluoxetine|mesh-list
111079947|NCT05431413|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111079948|NCT05431413|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111079949|NCT05431413|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111079950|NCT05431413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111079951|NCT05431413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111079952|NCT05431413|Serotonin Agents|serotonin agents|mesh-ancestor
111079953|NCT05431413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111079954|NCT05431413|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111079955|NCT05431413|Antidepressive Agents|antidepressive agents|mesh-ancestor
111079956|NCT05431413|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111079957|NCT05431413|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111079958|NCT05431413|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111079959|NCT05431413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111079960|NCT05431413|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111079961|NCT05431413|Protective Agents|protective agents|mesh-ancestor
111079962|NCT02507245|Hormones|hormones|mesh-list
111079963|NCT02507245|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
111079964|NCT02507245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111079965|NCT02507245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111079966|NCT02517307|Heparin|heparin|mesh-list
111079967|NCT02517307|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
111079968|NCT02517307|Glycerol|glycerol|mesh-list
111079969|NCT02517307|Anticoagulants|anticoagulants|mesh-ancestor
111079970|NCT02517307|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111079971|NCT02517307|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111079972|NCT02517307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111079973|NCT02517307|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
111079974|NCT02517307|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
111079975|NCT02517307|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111079976|NCT02517307|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
111079977|NCT02517307|Protective Agents|protective agents|mesh-ancestor
111079978|NCT02517307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111079979|NCT05431257|Venetoclax|venetoclax|mesh-list
111079980|NCT05431257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111079981|NCT05431023|Lactoferrin|lactoferrin|mesh-list
111079982|NCT05431023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111079983|NCT02507167|Rifampin|rifampin|mesh-list
111079984|NCT02507167|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111079985|NCT02507167|Antitubercular Agents|antitubercular agents|mesh-ancestor
111079986|NCT02507167|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111079987|NCT02507167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111079988|NCT02507167|Leprostatic Agents|leprostatic agents|mesh-ancestor
111079989|NCT02507167|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111079990|NCT02507167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111079991|NCT02507167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111079992|NCT02507167|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111079993|NCT02507167|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111079994|NCT02507167|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
111079995|NCT02507167|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
111079996|NCT02507167|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
111079997|NCT02507167|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111079999|NCT01376167|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
111080000|NCT01376167|Primaquine|primaquine|mesh-list
111080001|NCT01376167|Tafenoquine|tafenoquine|mesh-list
111080002|NCT01376167|Amebicides|amebicides|mesh-ancestor
111080003|NCT01376167|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111080004|NCT01376167|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111080005|NCT01376167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111080006|NCT01376167|Antimalarials|antimalarials|mesh-ancestor
111080007|NCT01376167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111080008|NCT01376167|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111080009|NCT01376167|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111080010|NCT01376167|Analgesics|analgesics|mesh-ancestor
111080011|NCT01376167|Sensory System Agents|sensory system agents|mesh-ancestor
111080012|NCT01376167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111080013|NCT01376167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111080014|NCT01376167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111080015|NCT01376167|Filaricides|filaricides|mesh-ancestor
111080016|NCT01376167|Antinematodal Agents|antinematodal agents|mesh-ancestor
111080017|NCT01376167|Anthelmintics|anthelmintics|mesh-ancestor
111080018|NCT02511613|Squalamine|squalamine|mesh-list
111080019|NCT02511613|Ranibizumab|ranibizumab|mesh-list
111080020|NCT02511613|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111080021|NCT02511613|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111080022|NCT02511613|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111080023|NCT02511613|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111080024|NCT02511613|Growth Substances|growth substances|mesh-ancestor
111080025|NCT02511613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111080026|NCT02511613|Growth Inhibitors|growth inhibitors|mesh-ancestor
111080027|NCT02511613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111080028|NCT02511613|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111080029|NCT02511613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111080030|NCT02511613|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
111080031|NCT02511613|Protective Agents|protective agents|mesh-ancestor
111080032|NCT02506699|Analgesics|analgesics|mesh-list
111080033|NCT02506699|Sensory System Agents|sensory system agents|mesh-ancestor
111080034|NCT02506699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111080035|NCT02506699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111080036|NCT02506777|Metformin|metformin|mesh-list
111080037|NCT02506777|Cyclophosphamide|cyclophosphamide|mesh-list
111080039|NCT02506777|Fluorouracil|fluorouracil|mesh-list
111080040|NCT02506777|Melatonin|melatonin|mesh-list
111080041|NCT02506777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111080042|NCT02506777|Immunologic Factors|immunologic factors|mesh-ancestor
111080043|NCT02506777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111080044|NCT02506777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111080045|NCT02506777|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111080046|NCT02506777|Alkylating Agents|alkylating agents|mesh-ancestor
111080047|NCT02506777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111080048|NCT02506777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111080049|NCT02506777|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111080050|NCT02506777|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111080051|NCT02506777|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111080052|NCT02506777|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111080053|NCT02506777|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111080054|NCT02506777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111080055|NCT02506777|Antioxidants|antioxidants|mesh-ancestor
111080056|NCT02506777|Protective Agents|protective agents|mesh-ancestor
111080057|NCT02506777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111080058|NCT02506777|Antimetabolites|antimetabolites|mesh-ancestor
111080059|NCT02506777|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111080060|NCT02516527|Ipilimumab|ipilimumab|mesh-list
111080061|NCT02516527|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111080062|NCT02516527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111080063|NCT02516527|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111080064|NCT02516527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111080065|NCT02511847|Afatinib|afatinib|mesh-list
111080066|NCT02511847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111080067|NCT02511847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111080068|NCT02511847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111080069|NCT02511847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111080070|NCT02506855|Ropivacaine|ropivacaine|mesh-list
111080071|NCT02506855|Anesthetics, Local|anesthetics, local|mesh-ancestor
111080072|NCT02506855|Anesthetics|anesthetics|mesh-ancestor
111080073|NCT02506855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111080074|NCT02506855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111080075|NCT02506855|Sensory System Agents|sensory system agents|mesh-ancestor
111080076|NCT02506855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111080077|NCT02511223|Olaparib|olaparib|mesh-list
111080078|NCT02511223|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111080079|NCT02511223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111080080|NCT02511223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111080081|NCT02511223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111080082|NCT02516059|Oxycodone|oxycodone|mesh-list
111080083|NCT02516059|Naloxone|naloxone|mesh-list
111080084|NCT02516059|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111080085|NCT02516059|Narcotics|narcotics|mesh-ancestor
111080086|NCT02516059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111080087|NCT02516059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111080088|NCT02516059|Analgesics|analgesics|mesh-ancestor
111080089|NCT02516059|Sensory System Agents|sensory system agents|mesh-ancestor
111080090|NCT02516059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111080091|NCT02516059|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111080092|NCT02506231|Leucovorin|leucovorin|mesh-list
111080093|NCT02506231|Folic Acid|folic acid|mesh-list
111080094|NCT02506231|Levoleucovorin|levoleucovorin|mesh-list
111080095|NCT02506231|Antidotes|antidotes|mesh-ancestor
111080096|NCT02506231|Protective Agents|protective agents|mesh-ancestor
111080097|NCT02506231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111080098|NCT02506231|Vitamin B Complex|vitamin b complex|mesh-ancestor
111080099|NCT02506231|Vitamins|vitamins|mesh-ancestor
111080100|NCT02506231|Micronutrients|micronutrients|mesh-ancestor
111080101|NCT02506231|Hematinics|hematinics|mesh-ancestor
111080102|NCT02511145|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
111080103|NCT02511145|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111080104|NCT02511145|Dermatologic Agents|dermatologic agents|mesh-ancestor
111080105|NCT02505997|Delafloxacin|delafloxacin|mesh-list
111080106|NCT02505997|Midazolam|midazolam|mesh-list
111080107|NCT02505997|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111080108|NCT02505997|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111080109|NCT02505997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111080110|NCT02505997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111080111|NCT02505997|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111080112|NCT02505997|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111080114|NCT02505997|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111080115|NCT02505997|Anesthetics, General|anesthetics, general|mesh-ancestor
111080116|NCT02505997|Anesthetics|anesthetics|mesh-ancestor
111080117|NCT02505997|GABA Modulators|gaba modulators|mesh-ancestor
111080118|NCT02505997|GABA Agents|gaba agents|mesh-ancestor
111080119|NCT02505997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111080120|NCT02505997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111080121|NCT02505997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111080122|NCT02505841|Ropivacaine|ropivacaine|mesh-list
111080123|NCT02505841|Succinylcholine|succinylcholine|mesh-list
111080124|NCT02505841|Curare|curare|mesh-list
111080125|NCT02505841|Anesthetics, Local|anesthetics, local|mesh-ancestor
111080126|NCT02505841|Anesthetics|anesthetics|mesh-ancestor
111080127|NCT02505841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111080128|NCT02505841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111080129|NCT02505841|Sensory System Agents|sensory system agents|mesh-ancestor
111080130|NCT02505841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111080131|NCT02505841|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
111080132|NCT02505841|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
111080133|NCT02505841|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111080134|NCT02505841|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
111080135|NCT02505841|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
111080136|NCT02505841|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111080137|NCT02505841|Cholinergic Agents|cholinergic agents|mesh-ancestor
111080138|NCT02505841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111080139|NCT02505841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111080140|NCT03345667|Ranibizumab|ranibizumab|mesh-list
111080141|NCT03345667|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111080142|NCT03345667|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111080143|NCT03345667|Growth Substances|growth substances|mesh-ancestor
111080144|NCT03345667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111080145|NCT03345667|Growth Inhibitors|growth inhibitors|mesh-ancestor
111080146|NCT03345667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111080147|NCT04499989|Isoniazid|isoniazid|mesh-list
111080148|NCT04499989|Antitubercular Agents|antitubercular agents|mesh-ancestor
111080149|NCT04499989|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111080150|NCT04499989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111080151|NCT04499989|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
111080152|NCT04499989|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111080153|NCT04499989|Antimetabolites|antimetabolites|mesh-ancestor
111080154|NCT04499989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111080155|NCT04499989|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111080156|NCT04500067|Immunoglobulins|immunoglobulins|mesh-list
111080157|NCT04500067|Immunologic Factors|immunologic factors|mesh-ancestor
111080158|NCT04500067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111080159|NCT04497649|Sofosbuvir|sofosbuvir|mesh-list
111080160|NCT04497649|Antiviral Agents|antiviral agents|mesh-ancestor
111080161|NCT04497649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111080162|NCT02505451|Dobutamine|dobutamine|mesh-list
111080163|NCT02505451|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111080164|NCT02505451|Sympathomimetics|sympathomimetics|mesh-ancestor
111080165|NCT02505451|Autonomic Agents|autonomic agents|mesh-ancestor
111080166|NCT02505451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111080167|NCT02505451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111080168|NCT02505451|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
111080169|NCT02505451|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111080170|NCT02505451|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111080171|NCT02505451|Adrenergic Agents|adrenergic agents|mesh-ancestor
111080172|NCT02505451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111080173|NCT02505451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111080174|NCT02505451|Protective Agents|protective agents|mesh-ancestor
111080175|NCT02505295|Selenium|selenium|mesh-list
111080176|NCT02505295|Antioxidants|antioxidants|mesh-ancestor
111080177|NCT02505295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111080178|NCT02505295|Protective Agents|protective agents|mesh-ancestor
111080179|NCT02505295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110639738|NCT05684705|Rifabutin|rifabutin|mesh-list
111080180|NCT02505295|Trace Elements|trace elements|mesh-ancestor
111080181|NCT02505295|Micronutrients|micronutrients|mesh-ancestor
111080182|NCT02510911|Caffeine|caffeine|mesh-list
111080183|NCT02510911|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111080184|NCT02510911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111080185|NCT02510911|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111080186|NCT02510911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111119161|NCT05306873|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111080187|NCT02510911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111080188|NCT02510911|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
111080189|NCT02510911|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111080190|NCT02510911|Purinergic Agents|purinergic agents|mesh-ancestor
111080191|NCT02510911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111080192|NCT03121807|Leucovorin|leucovorin|mesh-list
111080193|NCT03121807|Fluorouracil|fluorouracil|mesh-list
111080194|NCT03121807|Oxaliplatin|oxaliplatin|mesh-list
111080195|NCT03121807|Antimetabolites|antimetabolites|mesh-ancestor
111080196|NCT03121807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111080197|NCT03121807|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111080198|NCT03121807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111080199|NCT03121807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111080200|NCT03121807|Immunologic Factors|immunologic factors|mesh-ancestor
111080201|NCT03121807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111080202|NCT03121807|Antidotes|antidotes|mesh-ancestor
111080203|NCT03121807|Protective Agents|protective agents|mesh-ancestor
111080204|NCT03121807|Vitamin B Complex|vitamin b complex|mesh-ancestor
111080205|NCT03121807|Vitamins|vitamins|mesh-ancestor
111080206|NCT03121807|Micronutrients|micronutrients|mesh-ancestor
111080207|NCT03343873|Midazolam|midazolam|mesh-list
111080208|NCT03343873|Dexmedetomidine|dexmedetomidine|mesh-list
111080209|NCT03343873|Propofol|propofol|mesh-list
111080210|NCT03343873|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111080211|NCT03343873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111080212|NCT03343873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111080213|NCT03343873|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111080214|NCT03343873|Analgesics|analgesics|mesh-ancestor
111080215|NCT03343873|Sensory System Agents|sensory system agents|mesh-ancestor
111080216|NCT03343873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111080217|NCT03343873|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111080219|NCT03343873|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111080220|NCT03343873|Adrenergic Agents|adrenergic agents|mesh-ancestor
111080221|NCT03343873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111080222|NCT03343873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111080223|NCT03343873|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111080224|NCT03343873|Anesthetics, General|anesthetics, general|mesh-ancestor
111080225|NCT03343873|Anesthetics|anesthetics|mesh-ancestor
111080226|NCT03343873|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111080227|NCT03343873|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111080228|NCT03343873|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111080229|NCT03343873|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111080230|NCT03343873|GABA Modulators|gaba modulators|mesh-ancestor
111080231|NCT03343873|GABA Agents|gaba agents|mesh-ancestor
111080232|NCT03343795|Progesterone|progesterone|mesh-list
111080233|NCT03343795|Progestins|progestins|mesh-ancestor
111080234|NCT03343795|Hormones|hormones|mesh-ancestor
111080235|NCT03343795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111080236|NCT03343795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111080237|NCT02510287|Lidocaine|lidocaine|mesh-list
111080238|NCT02510287|Fentanyl|fentanyl|mesh-list
111080239|NCT02510287|Bupivacaine|bupivacaine|mesh-list
111080240|NCT02510287|Anesthetics, Local|anesthetics, local|mesh-ancestor
111080241|NCT02510287|Anesthetics|anesthetics|mesh-ancestor
111080242|NCT02510287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111080243|NCT02510287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111080244|NCT02510287|Sensory System Agents|sensory system agents|mesh-ancestor
111080245|NCT02510287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111080246|NCT02510287|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111080247|NCT02510287|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111080248|NCT02510287|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111080249|NCT02510287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111080250|NCT02510287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111080251|NCT02510287|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111080252|NCT02510287|Narcotics|narcotics|mesh-ancestor
111080253|NCT02510287|Analgesics|analgesics|mesh-ancestor
111080254|NCT02510287|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111080255|NCT02510287|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111080256|NCT02510287|Anesthetics, General|anesthetics, general|mesh-ancestor
111080257|NCT02515435|Apatinib|apatinib|mesh-list
111080258|NCT02515435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111080259|NCT02515435|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111080260|NCT02515435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111080261|NCT02515435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111080262|NCT02515201|Taurolidine|taurolidine|mesh-list
111080263|NCT02515201|Heparin|heparin|mesh-list
111080264|NCT02515201|Calcium heparin|calcium heparin|mesh-list
111080265|NCT02515201|Anticoagulants|anticoagulants|mesh-ancestor
111080266|NCT02515201|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111080267|NCT02515201|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111080268|NCT02515201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111080269|NCT02515201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111080270|NCT02515201|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111080271|NCT02515201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111080272|NCT02504983|Sorafenib|sorafenib|mesh-list
111080273|NCT02504983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111080274|NCT02504983|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111080275|NCT02504983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111080276|NCT02504983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111080277|NCT02510053|Caspofungin|caspofungin|mesh-list
111080278|NCT02510053|Antifungal Agents|antifungal agents|mesh-ancestor
111080279|NCT02510053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111080280|NCT02510053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111080281|NCT02510053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111080282|NCT02504359|Cytarabine|cytarabine|mesh-list
111080283|NCT02504359|Methotrexate|methotrexate|mesh-list
111080284|NCT02504359|Etoposide|etoposide|mesh-list
111080285|NCT02504359|Etoposide phosphate|etoposide phosphate|mesh-list
111080286|NCT02504359|Melphalan|melphalan|mesh-list
111080287|NCT02504359|Mechlorethamine|mechlorethamine|mesh-list
111080288|NCT02504359|Carmustine|carmustine|mesh-list
111080289|NCT02504359|Ixazomib|ixazomib|mesh-list
111080290|NCT02504359|Podophyllotoxin|podophyllotoxin|mesh-list
111080291|NCT02504359|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
110797411|NCT02051530|Tryptophan|tryptophan|mesh-list
111080292|NCT02504359|Tacrolimus|tacrolimus|mesh-list
111080293|NCT02504359|Glycine|glycine|mesh-list
111080294|NCT02504359|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111080295|NCT02504359|Abortifacient Agents|abortifacient agents|mesh-ancestor
111080296|NCT02504359|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111080297|NCT02504359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111080298|NCT02504359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111080299|NCT02504359|Antimetabolites|antimetabolites|mesh-ancestor
111080300|NCT02504359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111080301|NCT02504359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111080302|NCT02504359|Dermatologic Agents|dermatologic agents|mesh-ancestor
110639755|NCT05238233|Mydriatics|mydriatics|mesh-ancestor
111080303|NCT02504359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111080304|NCT02504359|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111080305|NCT02504359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111080306|NCT02504359|Immunologic Factors|immunologic factors|mesh-ancestor
111080307|NCT02504359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111080308|NCT02504359|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111080309|NCT02504359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111080310|NCT02504359|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111080311|NCT02504359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111080312|NCT02504359|Antiviral Agents|antiviral agents|mesh-ancestor
111080313|NCT02504359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111080314|NCT02504359|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111080315|NCT02504359|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111080316|NCT02504359|Alkylating Agents|alkylating agents|mesh-ancestor
111080317|NCT02504359|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111080318|NCT02504359|Protease Inhibitors|protease inhibitors|mesh-ancestor
111080319|NCT02504359|Keratolytic Agents|keratolytic agents|mesh-ancestor
111080320|NCT02504359|Tubulin Modulators|tubulin modulators|mesh-ancestor
111080321|NCT02504359|Antimitotic Agents|antimitotic agents|mesh-ancestor
111080322|NCT02504359|Mitosis Modulators|mitosis modulators|mesh-ancestor
111080323|NCT02504359|Glycine Agents|glycine agents|mesh-ancestor
111080324|NCT02504359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111080325|NCT02729545|Cyproterone Acetate|cyproterone acetate|mesh-list
111080326|NCT02729545|Ethinyl Estradiol|ethinyl estradiol|mesh-list
111080327|NCT02729545|Cyproterone|cyproterone|mesh-list
111080328|NCT02729545|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111080329|NCT02729545|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111080330|NCT02729545|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111080331|NCT02729545|Contraceptive Agents|contraceptive agents|mesh-ancestor
111080332|NCT02729545|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111080333|NCT02729545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111080334|NCT02729545|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111080335|NCT02729545|Estrogens|estrogens|mesh-ancestor
111080337|NCT02729545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111080338|NCT02729545|Androgen Antagonists|androgen antagonists|mesh-ancestor
111080339|NCT02729545|Hormone Antagonists|hormone antagonists|mesh-ancestor
111080340|NCT02729545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111080341|NCT02729545|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
111080342|NCT02504125|Tranexamic Acid|tranexamic acid|mesh-list
111080343|NCT02504125|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111080344|NCT02504125|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111080345|NCT02504125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111080347|NCT02504125|Coagulants|coagulants|mesh-ancestor
111080348|NCT02509429|Insulin|insulin|mesh-list
111080349|NCT02509429|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111080350|NCT02509429|Insulin Aspart|insulin aspart|mesh-list
111080351|NCT02509429|Insulin, Long-Acting|insulin, long-acting|mesh-list
111080352|NCT02509429|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
111080353|NCT02509429|Insulin Lispro|insulin lispro|mesh-list
111080354|NCT02509429|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111080355|NCT02509429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111080356|NCT02509273|Clonidine|clonidine|mesh-list
111080357|NCT02509273|Midazolam|midazolam|mesh-list
111080358|NCT02509273|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111080359|NCT02509273|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111080360|NCT02509273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111080361|NCT02509273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111080362|NCT02509273|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111080363|NCT02509273|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111080364|NCT02509273|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111080365|NCT02509273|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111080366|NCT02509273|Anesthetics, General|anesthetics, general|mesh-ancestor
111080367|NCT02509273|Anesthetics|anesthetics|mesh-ancestor
111080368|NCT02509273|GABA Modulators|gaba modulators|mesh-ancestor
111080369|NCT02509273|GABA Agents|gaba agents|mesh-ancestor
111080370|NCT02509273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111080371|NCT02509273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111080372|NCT02509273|Analgesics|analgesics|mesh-ancestor
111080373|NCT02509273|Sensory System Agents|sensory system agents|mesh-ancestor
111080374|NCT02509273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111080375|NCT02509273|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111080376|NCT02509273|Sympatholytics|sympatholytics|mesh-ancestor
111080377|NCT02509273|Autonomic Agents|autonomic agents|mesh-ancestor
111080378|NCT02509273|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111080379|NCT02509273|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111080380|NCT02509273|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111080381|NCT02509273|Adrenergic Agents|adrenergic agents|mesh-ancestor
111080382|NCT02514343|Magnesium Sulfate|magnesium sulfate|mesh-list
111080383|NCT02514343|Bupivacaine|bupivacaine|mesh-list
111080384|NCT02514343|Anesthetics, Local|anesthetics, local|mesh-ancestor
111080385|NCT02514343|Anesthetics|anesthetics|mesh-ancestor
111080386|NCT02514343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111080387|NCT02514343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111080388|NCT02514343|Sensory System Agents|sensory system agents|mesh-ancestor
111080389|NCT02514343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111080390|NCT02514343|Analgesics|analgesics|mesh-ancestor
111080391|NCT02514343|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111080392|NCT02514343|Anticonvulsants|anticonvulsants|mesh-ancestor
111080393|NCT02514343|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111080394|NCT02514343|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111080395|NCT02514343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111080396|NCT02514343|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111080397|NCT02514343|Tocolytic Agents|tocolytic agents|mesh-ancestor
111080398|NCT02514343|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111080399|NCT02514421|Paclitaxel|paclitaxel|mesh-list
111080400|NCT02514421|Gemcitabine|gemcitabine|mesh-list
111080401|NCT02514421|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111080402|NCT02514421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111080403|NCT02514421|Tubulin Modulators|tubulin modulators|mesh-ancestor
111080404|NCT02514421|Antimitotic Agents|antimitotic agents|mesh-ancestor
111080405|NCT02514421|Mitosis Modulators|mitosis modulators|mesh-ancestor
111080406|NCT02514421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111080407|NCT02514421|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111080408|NCT02514421|Antimetabolites|antimetabolites|mesh-ancestor
111080409|NCT04499209|Naproxen|naproxen|mesh-list
111080410|NCT04499209|Pregabalin|pregabalin|mesh-list
111080411|NCT04499209|Analgesics|analgesics|mesh-ancestor
111080412|NCT04499209|Sensory System Agents|sensory system agents|mesh-ancestor
111080413|NCT04499209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111080414|NCT04499209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111080415|NCT04499209|Anticonvulsants|anticonvulsants|mesh-ancestor
111080416|NCT04499209|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111080417|NCT04499209|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111080418|NCT04499209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111080419|NCT04499209|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111080420|NCT04499209|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111080421|NCT04499209|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111080422|NCT04499209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111080423|NCT04499209|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111080424|NCT04499209|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111080425|NCT04499209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111080426|NCT04499209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111080427|NCT04499209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111080428|NCT04499209|Gout Suppressants|gout suppressants|mesh-ancestor
111080429|NCT04499209|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111080430|NCT04499209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111080431|NCT02509351|Misoprostol|misoprostol|mesh-list
111080432|NCT02509351|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111080433|NCT02509351|Abortifacient Agents|abortifacient agents|mesh-ancestor
111080434|NCT02509351|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111080435|NCT02509351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111080436|NCT02509351|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111080437|NCT02509351|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111080438|NCT02509351|Oxytocics|oxytocics|mesh-ancestor
111080440|NCT02509195|Abacavir|abacavir|mesh-list
111080441|NCT02509195|Dolutegravir|dolutegravir|mesh-list
111080442|NCT02509195|Abacavir, dolutegravir, and lamivudine drug combination|abacavir, dolutegravir, and lamivudine drug combination|mesh-list
111080443|NCT02509195|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110797558|NCT03796533|Posaconazole|posaconazole|mesh-list
111080444|NCT02509195|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111080445|NCT02509195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111080446|NCT02509195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111080447|NCT02509195|Antiviral Agents|antiviral agents|mesh-ancestor
111080448|NCT02509195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111080449|NCT02509195|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111080450|NCT02509195|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111080451|NCT02509195|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111080452|NCT02509195|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111080453|NCT02508805|Diclofenac|diclofenac|mesh-list
111080454|NCT02508805|Tizanidine|tizanidine|mesh-list
111080455|NCT02508805|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111080456|NCT02508805|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111080457|NCT02508805|Analgesics|analgesics|mesh-ancestor
111080458|NCT02508805|Sensory System Agents|sensory system agents|mesh-ancestor
111080459|NCT02508805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111080460|NCT02508805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111080461|NCT02508805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111080462|NCT02508805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111080463|NCT02508805|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111080464|NCT02508805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111080465|NCT02508805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111080466|NCT02508805|Anticonvulsants|anticonvulsants|mesh-ancestor
111080467|NCT02508805|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
111080468|NCT02508805|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111080469|NCT02508805|Parasympatholytics|parasympatholytics|mesh-ancestor
111080470|NCT02508805|Autonomic Agents|autonomic agents|mesh-ancestor
111080471|NCT02508805|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111080472|NCT02508805|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111080473|NCT02508805|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111080474|NCT02508805|Adrenergic Agents|adrenergic agents|mesh-ancestor
111080475|NCT02508805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111080476|NCT03121573|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
111080477|NCT03121573|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111080478|NCT03121573|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111080479|NCT03121573|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111080480|NCT03121573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111080481|NCT03121573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111080482|NCT03121573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111080483|NCT03121573|Analgesics|analgesics|mesh-ancestor
111080484|NCT03121573|Sensory System Agents|sensory system agents|mesh-ancestor
111080485|NCT03121573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110545568|NCT02653898|Artesunate|artesunate|mesh-list
111080486|NCT03121573|Antidepressive Agents|antidepressive agents|mesh-ancestor
111080487|NCT03121573|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111080488|NCT03121573|Dopamine Agents|dopamine agents|mesh-ancestor
111080489|NCT03121417|Nivolumab|nivolumab|mesh-list
111080490|NCT03121417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111080491|NCT03121417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111080492|NCT03121417|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111080493|NCT03121417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111080494|NCT02503189|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111080495|NCT02503189|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111080496|NCT02502643|Picibanil|picibanil|mesh-list
111080497|NCT02502643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111080498|NCT02502565|Uric Acid|uric acid|mesh-list
111080499|NCT02502565|Antioxidants|antioxidants|mesh-ancestor
111080500|NCT02502565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111080501|NCT02502565|Protective Agents|protective agents|mesh-ancestor
111080502|NCT02502565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111080503|NCT04498897|Acamprosate|acamprosate|mesh-list
111080504|NCT04498897|Vortioxetine|vortioxetine|mesh-list
111080505|NCT04498897|Antidepressive Agents|antidepressive agents|mesh-ancestor
111080506|NCT04498897|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111080507|NCT04498897|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111080508|NCT04498897|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111080509|NCT04498897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111080510|NCT04498897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111080511|NCT04498897|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111080512|NCT04498897|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111080513|NCT04498897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111080514|NCT04498897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111080515|NCT04498897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111080516|NCT04498897|Serotonin Agents|serotonin agents|mesh-ancestor
111080517|NCT04498897|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111080518|NCT04498897|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111080519|NCT04498897|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111080520|NCT04498897|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111080521|NCT04498897|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111080522|NCT02502877|Midazolam|midazolam|mesh-list
111080523|NCT02502877|Propofol|propofol|mesh-list
111080524|NCT02502877|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111080525|NCT02502877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111080526|NCT02502877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111080527|NCT02502877|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111080528|NCT02502877|Anesthetics, General|anesthetics, general|mesh-ancestor
111080529|NCT02502877|Anesthetics|anesthetics|mesh-ancestor
111080530|NCT02502877|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111080531|NCT02502877|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111080532|NCT02502877|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111080533|NCT02502877|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111080534|NCT02502877|GABA Modulators|gaba modulators|mesh-ancestor
111080535|NCT02502877|GABA Agents|gaba agents|mesh-ancestor
111080536|NCT02502877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111080537|NCT02502877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111080538|NCT03121339|Vaccines|vaccines|mesh-list
111080539|NCT03121339|Immunologic Factors|immunologic factors|mesh-ancestor
111080540|NCT03121339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111080541|NCT03343327|Hydrocortisone|hydrocortisone|mesh-list
111080542|NCT03343327|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111080543|NCT02502175|Methadone|methadone|mesh-list
111080544|NCT02502175|Opium|opium|mesh-list
111080545|NCT02502175|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111080546|NCT02502175|Narcotics|narcotics|mesh-ancestor
111080547|NCT02502175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111080548|NCT02502175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111080549|NCT02502175|Analgesics|analgesics|mesh-ancestor
111080550|NCT02502175|Sensory System Agents|sensory system agents|mesh-ancestor
111080551|NCT02502175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111080552|NCT02502175|Antitussive Agents|antitussive agents|mesh-ancestor
111080553|NCT02502175|Respiratory System Agents|respiratory system agents|mesh-ancestor
111080554|NCT02502175|Antidiarrheals|antidiarrheals|mesh-ancestor
111080555|NCT02502175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111080556|NCT02501941|Ketamine|ketamine|mesh-list
111080557|NCT02501941|Analgesics|analgesics|mesh-ancestor
111080558|NCT02501941|Sensory System Agents|sensory system agents|mesh-ancestor
111080559|NCT02501941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111080560|NCT02501941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111080561|NCT02501941|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111080562|NCT02501941|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111080563|NCT02501941|Anesthetics, General|anesthetics, general|mesh-ancestor
111080564|NCT02501941|Anesthetics|anesthetics|mesh-ancestor
111080565|NCT02501941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111080566|NCT02501941|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111080567|NCT02501941|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111080568|NCT02501941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111080569|NCT02501941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111080570|NCT02500927|Naquotinib|naquotinib|mesh-list
111080571|NCT02500927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111080572|NCT02500927|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111080573|NCT02500927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111080574|NCT02500927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111080575|NCT02501863|Fentanyl|fentanyl|mesh-list
111080576|NCT02501863|Ropivacaine|ropivacaine|mesh-list
111080577|NCT02501863|Anesthetics, Local|anesthetics, local|mesh-ancestor
111080578|NCT02501863|Anesthetics|anesthetics|mesh-ancestor
111080579|NCT02501863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111080580|NCT02501863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111080581|NCT02501863|Sensory System Agents|sensory system agents|mesh-ancestor
111080582|NCT02501863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111080583|NCT02501863|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111080584|NCT02501863|Narcotics|narcotics|mesh-ancestor
111080585|NCT02501863|Analgesics|analgesics|mesh-ancestor
111080586|NCT02501863|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111080587|NCT02501863|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111080588|NCT02501863|Anesthetics, General|anesthetics, general|mesh-ancestor
111080589|NCT02500459|Topotecan|topotecan|mesh-list
111080590|NCT02500459|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111080591|NCT02500459|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111080592|NCT02500459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111080593|NCT02500459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111080594|NCT02500459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111080595|NCT02500225|Sevoflurane|sevoflurane|mesh-list
111080596|NCT02500225|Etomidate|etomidate|mesh-list
111080597|NCT02500225|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111080598|NCT02500225|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111080599|NCT02500225|Anesthetics, General|anesthetics, general|mesh-ancestor
111080600|NCT02500225|Anesthetics|anesthetics|mesh-ancestor
111080601|NCT02500225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111080602|NCT02500225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111080603|NCT02500225|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111080604|NCT02500225|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111080605|NCT02507635|Levocetirizine|levocetirizine|mesh-list
111080606|NCT02507635|Desloratadine|desloratadine|mesh-list
111080607|NCT02507635|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
111080608|NCT02507635|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111080609|NCT02507635|Histamine Antagonists|histamine antagonists|mesh-ancestor
111080610|NCT02507635|Histamine Agents|histamine agents|mesh-ancestor
111080611|NCT02507635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111080612|NCT02507635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111080613|NCT02507635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111080614|NCT02507635|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111080615|NCT02507635|Cholinergic Agents|cholinergic agents|mesh-ancestor
111080616|NCT04495933|Vaccines|vaccines|mesh-list
111080617|NCT04495933|MF59 oil emulsion|mf59 oil emulsion|mesh-list
111080618|NCT04495933|Immunologic Factors|immunologic factors|mesh-ancestor
111080619|NCT04495933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111080620|NCT04495933|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111080621|NCT02500069|Caseins|caseins|mesh-list
111080622|NCT02500069|Chelating Agents|chelating agents|mesh-ancestor
111080623|NCT02500069|Sequestering Agents|sequestering agents|mesh-ancestor
111080624|NCT02500069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111080625|NCT03344029|Vaccines|vaccines|mesh-list
111080626|NCT03344029|Immunologic Factors|immunologic factors|mesh-ancestor
111080627|NCT03344029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111080628|NCT03120637|Methylene Blue|methylene blue|mesh-list
111080629|NCT03120637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111080630|NCT03120637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111080632|NCT02499757|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111080633|NCT02499757|Autonomic Agents|autonomic agents|mesh-ancestor
111080634|NCT02499757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111080635|NCT02499757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111080636|NCT02499757|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111080637|NCT02499757|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111080638|NCT02499757|Cholinergic Agents|cholinergic agents|mesh-ancestor
111080639|NCT02499757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111080640|NCT02499757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111080641|NCT00706849|Mipomersen|mipomersen|mesh-list
111080642|NCT00706849|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111080643|NCT00706849|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111080644|NCT00706849|Antimetabolites|antimetabolites|mesh-ancestor
111080645|NCT00706849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111080646|NCT00706849|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111080647|NCT02499445|Sufentanil|sufentanil|mesh-list
111080648|NCT02499445|Remifentanil|remifentanil|mesh-list
111080649|NCT02499445|Propofol|propofol|mesh-list
111080650|NCT02499445|Sevoflurane|sevoflurane|mesh-list
111080651|NCT02499445|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111080652|NCT02499445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111080653|NCT02499445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111080654|NCT02499445|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111080655|NCT02499445|Anesthetics, General|anesthetics, general|mesh-ancestor
111080656|NCT02499445|Anesthetics|anesthetics|mesh-ancestor
111080657|NCT02499445|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111080658|NCT02499445|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111080659|NCT02499445|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111080660|NCT02499445|Narcotics|narcotics|mesh-ancestor
111080661|NCT02499445|Analgesics|analgesics|mesh-ancestor
111080662|NCT02499445|Sensory System Agents|sensory system agents|mesh-ancestor
111080663|NCT02499445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111080664|NCT02499445|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111080665|NCT04443049|Mebendazole|mebendazole|mesh-list
111080666|NCT04443049|Piperazine|piperazine|mesh-list
111080667|NCT04443049|Piperazine citrate|piperazine citrate|mesh-list
111080668|NCT04443049|Lenvatinib|lenvatinib|mesh-list
111080669|NCT04443049|DMP 777|dmp 777|mesh-list
111080670|NCT04443049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111080671|NCT04443049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111080672|NCT04443049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111080673|NCT04443049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111080674|NCT04443049|Antinematodal Agents|antinematodal agents|mesh-ancestor
111080675|NCT04443049|Anthelmintics|anthelmintics|mesh-ancestor
111080676|NCT04443049|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111080677|NCT04443049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111080678|NCT04443049|Tubulin Modulators|tubulin modulators|mesh-ancestor
111080679|NCT04443049|Antimitotic Agents|antimitotic agents|mesh-ancestor
111080680|NCT04443049|Mitosis Modulators|mitosis modulators|mesh-ancestor
111080681|NCT02494999|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
111080682|NCT02494999|Immunologic Factors|immunologic factors|mesh-ancestor
111080683|NCT02494999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111080684|NCT03341845|Avelumab|avelumab|mesh-list
111080685|NCT03341845|Axitinib|axitinib|mesh-list
111080686|NCT03341845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111080687|NCT03341845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111080688|NCT03341845|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111080689|NCT03341845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111080690|NCT03341845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111080691|NCT02498977|Cyclosporine|cyclosporine|mesh-list
111080692|NCT02498977|Mycophenolic Acid|mycophenolic acid|mesh-list
111080693|NCT02498977|Azathioprine|azathioprine|mesh-list
111080694|NCT02498977|Tacrolimus|tacrolimus|mesh-list
111080695|NCT02498977|Cyclosporins|cyclosporins|mesh-list
111080696|NCT02498977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111080697|NCT02498977|Immunologic Factors|immunologic factors|mesh-ancestor
111080698|NCT02498977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111080699|NCT02498977|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111080700|NCT02498977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111080701|NCT02498977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111080702|NCT02498977|Antifungal Agents|antifungal agents|mesh-ancestor
111080703|NCT02498977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111080704|NCT02498977|Dermatologic Agents|dermatologic agents|mesh-ancestor
111080705|NCT02498977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111080706|NCT02498977|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111080707|NCT02498977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110545793|NCT02768519|OTS167|ots167|mesh-list
111080708|NCT02498977|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111080709|NCT02498977|Antitubercular Agents|antitubercular agents|mesh-ancestor
111080710|NCT02498977|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111080711|NCT02498977|Antimetabolites|antimetabolites|mesh-ancestor
111080712|NCT02498977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111080713|NCT02494687|Domperidone|domperidone|mesh-list
111080714|NCT02494687|Antiemetics|antiemetics|mesh-ancestor
111080715|NCT02494687|Autonomic Agents|autonomic agents|mesh-ancestor
111080716|NCT02494687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111080717|NCT02494687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111080718|NCT02494687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111080719|NCT02494687|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111080720|NCT02494687|Dopamine Agents|dopamine agents|mesh-ancestor
111080721|NCT02494687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111080722|NCT02494687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110799541|NCT05320107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111080723|NCT02494609|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
111080724|NCT02494609|Contraceptive Agents|contraceptive agents|mesh-list
111080725|NCT02494609|Contraceptives, Oral|contraceptives, oral|mesh-list
111080726|NCT02494609|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111080727|NCT02494609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111080728|NCT02494609|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111080729|NCT02494609|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111080730|NCT02494609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111080731|NCT02494609|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111080732|NCT03341767|Clofazimine|clofazimine|mesh-list
111080733|NCT03341767|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111080734|NCT03341767|Leprostatic Agents|leprostatic agents|mesh-ancestor
111080735|NCT03341767|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111080736|NCT03341767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111080737|NCT02498509|Mometasone Furoate|mometasone furoate|mesh-list
111080738|NCT02498509|Levocabastine|levocabastine|mesh-list
111080739|NCT02498509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111080740|NCT02498509|Dermatologic Agents|dermatologic agents|mesh-ancestor
111080741|NCT02498509|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111080742|NCT02498509|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
111080743|NCT02498509|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111080744|NCT02498509|Histamine Antagonists|histamine antagonists|mesh-ancestor
111080745|NCT02498509|Histamine Agents|histamine agents|mesh-ancestor
111080746|NCT02498509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111080747|NCT02498509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111080748|NCT02498509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111080750|NCT03342859|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111080751|NCT03342859|Contraceptive Agents|contraceptive agents|mesh-ancestor
111080752|NCT03342859|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111080753|NCT03342859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111080754|NCT03342859|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111080756|NCT02493283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111080757|NCT02493283|Antimalarials|antimalarials|mesh-ancestor
111080758|NCT02493283|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111080759|NCT02493283|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111080760|NCT02493283|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111080761|NCT02493283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111080762|NCT02493283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111080763|NCT02493283|Leprostatic Agents|leprostatic agents|mesh-ancestor
111080764|NCT02493283|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111080765|NCT03335527|Dexmedetomidine|dexmedetomidine|mesh-list
111080766|NCT03335527|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111080767|NCT03335527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111080768|NCT03335527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111080769|NCT03335527|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111080770|NCT03335527|Analgesics|analgesics|mesh-ancestor
111080771|NCT03335527|Sensory System Agents|sensory system agents|mesh-ancestor
111080772|NCT03335527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111080773|NCT03335527|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111080774|NCT03335527|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111080775|NCT03335527|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111080776|NCT03335527|Adrenergic Agents|adrenergic agents|mesh-ancestor
111080777|NCT03335527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111080778|NCT03335527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111080780|NCT02493049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111080781|NCT02493049|Antiemetics|antiemetics|mesh-ancestor
111080782|NCT02493049|Autonomic Agents|autonomic agents|mesh-ancestor
111080783|NCT02493049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111080784|NCT02493049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111080785|NCT02493049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111080786|NCT02493049|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111080787|NCT02493049|Dopamine Agents|dopamine agents|mesh-ancestor
111080788|NCT02493049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111080789|NCT03120715|Heparin|heparin|mesh-list
111080790|NCT03120715|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
111080791|NCT03120715|Tinzaparin|tinzaparin|mesh-list
111080792|NCT03120715|Dalteparin|dalteparin|mesh-list
111080793|NCT03120715|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
111080794|NCT03120715|Progesterone|progesterone|mesh-list
111080795|NCT03120715|Estrogens|estrogens|mesh-list
111080796|NCT03120715|Anticoagulants|anticoagulants|mesh-ancestor
111080797|NCT03120715|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111080798|NCT03120715|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111080799|NCT03120715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111080800|NCT03120715|Progestins|progestins|mesh-ancestor
111080801|NCT03120715|Hormones|hormones|mesh-ancestor
111080802|NCT03120715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111080803|NCT03120715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111080804|NCT03120715|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111080805|NCT03120403|Morphine|morphine|mesh-list
111080806|NCT03120403|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111080807|NCT03120403|Narcotics|narcotics|mesh-ancestor
111080808|NCT03120403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111080809|NCT03120403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111080810|NCT03120403|Analgesics|analgesics|mesh-ancestor
111080811|NCT03120403|Sensory System Agents|sensory system agents|mesh-ancestor
111080812|NCT03120403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111080813|NCT03335293|Epinephrine|epinephrine|mesh-list
111080814|NCT03335293|Racepinephrine|racepinephrine|mesh-list
111080815|NCT03335293|Epinephryl borate|epinephryl borate|mesh-list
111080816|NCT03335293|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111080817|NCT03335293|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111080818|NCT03335293|Adrenergic Agents|adrenergic agents|mesh-ancestor
111080819|NCT03335293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111080820|NCT03335293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111080821|NCT03335293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111080822|NCT03335293|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111080823|NCT03335293|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111080824|NCT03335293|Autonomic Agents|autonomic agents|mesh-ancestor
111080825|NCT03335293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111080826|NCT03335293|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111080827|NCT03335293|Respiratory System Agents|respiratory system agents|mesh-ancestor
111080828|NCT03335293|Mydriatics|mydriatics|mesh-ancestor
111080829|NCT03335293|Sympathomimetics|sympathomimetics|mesh-ancestor
111080830|NCT03335293|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111080831|NCT03340753|Mineralocorticoids|mineralocorticoids|mesh-list
111080832|NCT03340753|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
111080834|NCT03340753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111080835|NCT03340753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111080836|NCT03340753|Hormone Antagonists|hormone antagonists|mesh-ancestor
111080837|NCT03340753|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
111080838|NCT03340753|Diuretics|diuretics|mesh-ancestor
111080839|NCT03340753|Natriuretic Agents|natriuretic agents|mesh-ancestor
111080840|NCT02494531|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
111080841|NCT02494531|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111080842|NCT02494531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111080843|NCT03340597|Olorofim|olorofim|mesh-list
111080844|NCT03340597|Antifungal Agents|antifungal agents|mesh-ancestor
111080845|NCT03340597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111080846|NCT00707161|Cisplatin|cisplatin|mesh-list
111080847|NCT00707161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111080848|NCT03120247|Dexmedetomidine|dexmedetomidine|mesh-list
111080849|NCT03120247|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111080850|NCT03120247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111080851|NCT03120247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111080852|NCT03120247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111080853|NCT03120247|Analgesics|analgesics|mesh-ancestor
111080854|NCT03120247|Sensory System Agents|sensory system agents|mesh-ancestor
110677151|NCT02476279|Sensory System Agents|sensory system agents|mesh-ancestor
111080855|NCT03120247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111080856|NCT03120247|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111080857|NCT03120247|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111080858|NCT03120247|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111080859|NCT03120247|Adrenergic Agents|adrenergic agents|mesh-ancestor
111080860|NCT03120247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111080861|NCT03120247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111080863|NCT03335059|Mitomycin|mitomycin|mesh-list
111080864|NCT03335059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111080865|NCT03335059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111080866|NCT03335059|Alkylating Agents|alkylating agents|mesh-ancestor
111080867|NCT03335059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111080868|NCT03335059|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111080869|NCT03335059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111080870|NCT03334981|Buprenorphine|buprenorphine|mesh-list
111080871|NCT03334981|Methadone|methadone|mesh-list
111080872|NCT03334981|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111080873|NCT03334981|Narcotics|narcotics|mesh-ancestor
111080874|NCT03334981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111080875|NCT03334981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111080876|NCT03334981|Analgesics|analgesics|mesh-ancestor
111080877|NCT03334981|Sensory System Agents|sensory system agents|mesh-ancestor
111080878|NCT03334981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111080879|NCT03334981|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111080880|NCT03334981|Antitussive Agents|antitussive agents|mesh-ancestor
111080881|NCT03334981|Respiratory System Agents|respiratory system agents|mesh-ancestor
111080882|NCT02492503|Paclitaxel|paclitaxel|mesh-list
111080883|NCT02492503|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111080884|NCT02492503|Carboplatin|carboplatin|mesh-list
111080885|NCT02492503|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111080886|NCT02492503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111080887|NCT02492503|Tubulin Modulators|tubulin modulators|mesh-ancestor
111080888|NCT02492503|Antimitotic Agents|antimitotic agents|mesh-ancestor
111080889|NCT02492503|Mitosis Modulators|mitosis modulators|mesh-ancestor
111080890|NCT02492503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111080891|NCT03334591|Apatinib|apatinib|mesh-list
111080892|NCT03334591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111080893|NCT03334591|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111080894|NCT03334591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111080895|NCT03334591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111080896|NCT03334513|Bevacizumab|bevacizumab|mesh-list
111080897|NCT03334513|Ranibizumab|ranibizumab|mesh-list
111080898|NCT03334513|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111080899|NCT03334513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111080900|NCT03334513|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111080901|NCT03334513|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111080902|NCT03334513|Growth Substances|growth substances|mesh-ancestor
111080903|NCT03334513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111080904|NCT03334513|Growth Inhibitors|growth inhibitors|mesh-ancestor
111080905|NCT02130466|Pembrolizumab|pembrolizumab|mesh-list
111080906|NCT02130466|Trametinib|trametinib|mesh-list
111080907|NCT02130466|Dabrafenib|dabrafenib|mesh-list
111080908|NCT02130466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111080909|NCT02130466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111080910|NCT02130466|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111080911|NCT02130466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111080912|NCT02130466|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111080913|NCT02130466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111080914|NCT03339427|Vitamin D|vitamin d|mesh-list
111080915|NCT03339427|Vitamins|vitamins|mesh-ancestor
111080916|NCT03339427|Micronutrients|micronutrients|mesh-ancestor
111080917|NCT03339427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111080918|NCT03339427|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111080919|NCT03339349|Enoxaparin|enoxaparin|mesh-list
111080920|NCT03339349|Anticoagulants|anticoagulants|mesh-ancestor
111080921|NCT03339349|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111080922|NCT03339349|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111080923|NCT03339349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111080924|NCT02496715|Fluticasone|fluticasone|mesh-list
111080925|NCT02496715|Xhance|xhance|mesh-list
111080926|NCT02496715|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
111080927|NCT02496715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111080928|NCT02496715|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111080929|NCT02496715|Autonomic Agents|autonomic agents|mesh-ancestor
111080930|NCT02496715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111080931|NCT02496715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111080932|NCT02496715|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111080933|NCT02496715|Respiratory System Agents|respiratory system agents|mesh-ancestor
111080934|NCT02496715|Dermatologic Agents|dermatologic agents|mesh-ancestor
111080935|NCT02496715|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111080936|NCT02496715|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111080937|NCT02496715|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111080938|NCT02496715|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111080939|NCT02496715|Adrenergic Agents|adrenergic agents|mesh-ancestor
111080940|NCT02496715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111080941|NCT02496715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111080942|NCT02492581|Nalmefene|nalmefene|mesh-list
111080943|NCT02492581|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111080944|NCT02492581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111080945|NCT02492581|Sensory System Agents|sensory system agents|mesh-ancestor
111080946|NCT02492581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111080947|NCT03342079|Nitrous Oxide|nitrous oxide|mesh-list
111080948|NCT03342079|Anesthetics|anesthetics|mesh-list
111080949|NCT03342079|Anesthetics, Local|anesthetics, local|mesh-list
111080950|NCT03342079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111080951|NCT03342079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111080952|NCT03342079|Sensory System Agents|sensory system agents|mesh-ancestor
111080953|NCT03342079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111080954|NCT03342079|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111080955|NCT03342079|Anesthetics, General|anesthetics, general|mesh-ancestor
111080956|NCT03342079|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111080957|NCT03342079|Analgesics|analgesics|mesh-ancestor
111080958|NCT04494763|Propranolol|propranolol|mesh-list
111080959|NCT04494763|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111080960|NCT04494763|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111080961|NCT04494763|Adrenergic Agents|adrenergic agents|mesh-ancestor
111080962|NCT04494763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111080963|NCT04494763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111080964|NCT04494763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111080965|NCT04494763|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111080966|NCT04494763|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111080967|NCT04494763|Vasodilator Agents|vasodilator agents|mesh-ancestor
111080968|NCT02162758|Dexlansoprazole|dexlansoprazole|mesh-list
111080969|NCT02162758|Lansoprazole|lansoprazole|mesh-list
110798083|NCT03790215|Hormones|hormones|mesh-ancestor
111080970|NCT02162758|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111080971|NCT02162758|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111080972|NCT02162758|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111080974|NCT02162758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111080975|NCT03333499|Trimetazidine|trimetazidine|mesh-list
111080976|NCT03333499|Vasodilator Agents|vasodilator agents|mesh-ancestor
111080977|NCT02491879|Ketoprofen|ketoprofen|mesh-list
111080978|NCT02491879|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111080979|NCT02491879|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111080980|NCT02491879|Analgesics|analgesics|mesh-ancestor
111080981|NCT02491879|Sensory System Agents|sensory system agents|mesh-ancestor
111080982|NCT02491879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111080983|NCT02491879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111080984|NCT02491879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111080985|NCT02491879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111080986|NCT02491879|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111080987|NCT02491879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111080988|NCT02491879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111080989|NCT03332953|Nicotine|nicotine|mesh-list
111080990|NCT03332953|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111080991|NCT03332953|Autonomic Agents|autonomic agents|mesh-ancestor
111080992|NCT03332953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111080993|NCT03332953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111080994|NCT03332953|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111080995|NCT03332953|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111080996|NCT03332953|Cholinergic Agents|cholinergic agents|mesh-ancestor
111080997|NCT03332953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111080998|NCT03332953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111080999|NCT02491723|Azithromycin|azithromycin|mesh-list
111081000|NCT02491723|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111081001|NCT02491723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111081002|NCT03332719|Etanercept|etanercept|mesh-list
111081003|NCT03332719|Methotrexate|methotrexate|mesh-list
111081004|NCT03332719|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111081005|NCT03332719|Abortifacient Agents|abortifacient agents|mesh-ancestor
111081006|NCT03332719|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111081007|NCT03332719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111081008|NCT03332719|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111081009|NCT03332719|Antimetabolites|antimetabolites|mesh-ancestor
111081010|NCT03332719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111081011|NCT03332719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111081012|NCT03332719|Dermatologic Agents|dermatologic agents|mesh-ancestor
111081013|NCT03332719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111081014|NCT03332719|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111081015|NCT03332719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111081016|NCT03332719|Immunologic Factors|immunologic factors|mesh-ancestor
111081017|NCT03332719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111081018|NCT03332719|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111081019|NCT03332719|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111081020|NCT03332719|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111081021|NCT03332719|Analgesics|analgesics|mesh-ancestor
111081022|NCT03332719|Sensory System Agents|sensory system agents|mesh-ancestor
111081023|NCT03332719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111081024|NCT03332719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111081025|NCT03332719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111081026|NCT03330769|Antirheumatic Agents|antirheumatic agents|mesh-list
111081027|NCT03330613|Anesthetics|anesthetics|mesh-list
111081028|NCT03330613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111081029|NCT03330613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111081030|NCT03332329|Entecavir|entecavir|mesh-list
111081031|NCT03332329|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
111081032|NCT03332329|Molgramostim|molgramostim|mesh-list
111081033|NCT03332329|Vaccines|vaccines|mesh-list
111081034|NCT03332329|Sargramostim|sargramostim|mesh-list
111081035|NCT03332329|Immunologic Factors|immunologic factors|mesh-ancestor
111081036|NCT03332329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111081037|NCT03332329|Antiviral Agents|antiviral agents|mesh-ancestor
111081038|NCT03332329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111081039|NCT03332329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111081040|NCT03330223|Clopidogrel|clopidogrel|mesh-list
111081041|NCT03330223|Ticagrelor|ticagrelor|mesh-list
111081042|NCT03330223|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111081043|NCT03330223|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111081044|NCT03330223|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111081045|NCT03330223|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111081046|NCT03330223|Purinergic Agents|purinergic agents|mesh-ancestor
111081047|NCT03330223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111081048|NCT03330223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111081049|NCT03330223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111081050|NCT03331861|Metformin|metformin|mesh-list
111081051|NCT03331861|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111081052|NCT03331861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111081053|NCT03329443|Spironolactone|spironolactone|mesh-list
111081054|NCT03329443|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
111081055|NCT03329443|Hormone Antagonists|hormone antagonists|mesh-ancestor
111081056|NCT03329443|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111081057|NCT03329443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111081058|NCT03329443|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
111081059|NCT03329443|Diuretics|diuretics|mesh-ancestor
111081060|NCT03329443|Natriuretic Agents|natriuretic agents|mesh-ancestor
111081061|NCT03328975|Dexamethasone|dexamethasone|mesh-list
111081062|NCT03328975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111081063|NCT03328975|Antiemetics|antiemetics|mesh-ancestor
111081064|NCT03328975|Autonomic Agents|autonomic agents|mesh-ancestor
111081065|NCT03328975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111081066|NCT03328975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111081067|NCT03328975|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111081068|NCT03328975|Glucocorticoids|glucocorticoids|mesh-ancestor
111081069|NCT03328975|Hormones|hormones|mesh-ancestor
111081070|NCT03328975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111081071|NCT03328975|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111081072|NCT03328975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111081073|NCT05430711|Dinoprostone|dinoprostone|mesh-list
111081074|NCT05430711|Oxytocics|oxytocics|mesh-ancestor
111081075|NCT05430711|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111081076|NCT05430711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111081077|NCT03324685|Levonorgestrel|levonorgestrel|mesh-list
111081078|NCT03324685|Ethinyl Estradiol|ethinyl estradiol|mesh-list
111081079|NCT03324685|Estradiol|estradiol|mesh-list
111081080|NCT03324685|Estrogens|estrogens|mesh-ancestor
111081081|NCT03324685|Hormones|hormones|mesh-ancestor
111081082|NCT03324685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111081083|NCT03324685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111081084|NCT03324685|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111081085|NCT03324685|Contraceptive Agents|contraceptive agents|mesh-ancestor
111081086|NCT03324685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111081087|NCT03324685|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111081088|NCT03324685|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111081089|NCT03324685|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111081090|NCT03324685|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111081091|NCT03324139|Heparin|heparin|mesh-list
111081092|NCT03324139|Calcium heparin|calcium heparin|mesh-list
111081093|NCT03324139|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
111081094|NCT03324139|Tinzaparin|tinzaparin|mesh-list
111081095|NCT03324139|Dalteparin|dalteparin|mesh-list
111081096|NCT03324139|Anticoagulants|anticoagulants|mesh-ancestor
111081097|NCT03324139|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111081098|NCT03324139|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111081099|NCT03324139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111081100|NCT03324061|Fulvestrant|fulvestrant|mesh-list
111081101|NCT03324061|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111081102|NCT03324061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111081103|NCT03324061|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
111081104|NCT03324061|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111081105|NCT03324061|Hormone Antagonists|hormone antagonists|mesh-ancestor
111081106|NCT03324061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111081107|NCT03324061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111081108|NCT02488603|Tamoxifen|tamoxifen|mesh-list
111081109|NCT02488603|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111081110|NCT02488603|Hormone Antagonists|hormone antagonists|mesh-ancestor
111081111|NCT02488603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111081112|NCT02488603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111081113|NCT02488603|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111081114|NCT02488603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111081115|NCT02488603|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111081116|NCT02488603|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111081117|NCT02488603|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111081118|NCT03328117|Imatinib Mesylate|imatinib mesylate|mesh-list
111081119|NCT03328117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111081120|NCT03328117|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111081121|NCT03328117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111081122|NCT03328117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111081123|NCT05430087|Vitamin D|vitamin d|mesh-list
111081124|NCT05430087|Cholecalciferol|cholecalciferol|mesh-list
111081125|NCT05430087|Curcumin|curcumin|mesh-list
111081126|NCT05430087|Piperine|piperine|mesh-list
111081127|NCT05430087|Vitamins|vitamins|mesh-ancestor
111081128|NCT05430087|Micronutrients|micronutrients|mesh-ancestor
111081129|NCT05430087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111081130|NCT05430087|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111081131|NCT05430087|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110799542|NCT03752931|Celiprolol|celiprolol|mesh-list
111081132|NCT05430087|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111081133|NCT05430087|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111081134|NCT05430087|Analgesics|analgesics|mesh-ancestor
111081135|NCT05430087|Sensory System Agents|sensory system agents|mesh-ancestor
111081136|NCT05430087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111081137|NCT05430087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111081138|NCT05430087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111081139|NCT05430087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111081140|NCT05430087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111081141|NCT05430087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111081142|NCT05430087|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111081143|NCT03327727|Voriconazole|voriconazole|mesh-list
111081144|NCT03327727|Amphotericin B|amphotericin b|mesh-list
111081145|NCT03327727|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
111081146|NCT03327727|Isavuconazole|isavuconazole|mesh-list
111081147|NCT03327727|VL-2397|vl-2397|mesh-list
111081148|NCT03327727|Antifungal Agents|antifungal agents|mesh-ancestor
111081149|NCT03327727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111081150|NCT03327727|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111081151|NCT03327727|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111081152|NCT03327727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111081153|NCT03327727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111081154|NCT03327727|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111081155|NCT03327727|Hormone Antagonists|hormone antagonists|mesh-ancestor
111081156|NCT03327727|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111081157|NCT03327727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111081158|NCT03327727|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111081160|NCT03327727|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111081161|NCT03327727|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111081162|NCT03327727|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111081163|NCT03323671|Mefenamic Acid|mefenamic acid|mesh-list
111081164|NCT03323671|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111081165|NCT03323671|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111081166|NCT03323671|Analgesics|analgesics|mesh-ancestor
111081167|NCT03323671|Sensory System Agents|sensory system agents|mesh-ancestor
111081168|NCT03323671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111081169|NCT03323671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111081170|NCT03323671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111081171|NCT03323671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111081172|NCT03323671|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111081173|NCT03323671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111081174|NCT03323671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111081175|NCT03323593|Dexmedetomidine|dexmedetomidine|mesh-list
111081176|NCT03323593|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111081177|NCT03323593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111081178|NCT03323593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111081179|NCT03323593|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111081180|NCT03323593|Analgesics|analgesics|mesh-ancestor
111081181|NCT03323593|Sensory System Agents|sensory system agents|mesh-ancestor
111081182|NCT03323593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111081183|NCT03323593|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111081184|NCT03323593|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111081185|NCT03323593|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111081186|NCT03323593|Adrenergic Agents|adrenergic agents|mesh-ancestor
111081187|NCT03323593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111081188|NCT03323593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111081189|NCT02499003|Obinutuzumab|obinutuzumab|mesh-list
111081190|NCT02499003|Pixantrone|pixantrone|mesh-list
111081191|NCT02499003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111081192|NCT02499003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111081193|NCT02499003|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111081194|NCT02499003|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111081195|NCT02499003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111081196|NCT02499003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111081198|NCT04492813|Propofol|propofol|mesh-list
111081199|NCT04492813|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111081200|NCT04492813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111081201|NCT04492813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111081202|NCT04492813|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111081203|NCT04492813|Anesthetics, General|anesthetics, general|mesh-ancestor
111081204|NCT04492813|Anesthetics|anesthetics|mesh-ancestor
111081205|NCT04492813|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111081206|NCT04492813|Narcotics|narcotics|mesh-ancestor
111081207|NCT04492813|Analgesics|analgesics|mesh-ancestor
111081208|NCT04492813|Sensory System Agents|sensory system agents|mesh-ancestor
111081209|NCT04492813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111081210|NCT03102801|Insulin|insulin|mesh-list
111081211|NCT03102801|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111081212|NCT03102801|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111081213|NCT03102801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111081214|NCT02488057|Liraglutide|liraglutide|mesh-list
111081215|NCT02488057|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111081216|NCT02488057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111081217|NCT02488057|Incretins|incretins|mesh-ancestor
111081218|NCT02488057|Hormones|hormones|mesh-ancestor
111081219|NCT02488057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111081220|NCT04039347|Cyclosporine|cyclosporine|mesh-list
111081221|NCT04039347|Cyclosporins|cyclosporins|mesh-list
111081222|NCT04039347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111081223|NCT04039347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111081224|NCT04039347|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111081225|NCT04039347|Immunologic Factors|immunologic factors|mesh-ancestor
111081226|NCT04039347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111081227|NCT04039347|Antifungal Agents|antifungal agents|mesh-ancestor
111081228|NCT04039347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111081229|NCT04039347|Dermatologic Agents|dermatologic agents|mesh-ancestor
111081230|NCT04039347|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111081231|NCT04039347|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111081233|NCT02488291|Dsuvia|dsuvia|mesh-list
111081234|NCT02488291|Ropivacaine|ropivacaine|mesh-list
111081235|NCT02488291|Anesthetics, Local|anesthetics, local|mesh-list
111081236|NCT02488291|Anesthetics|anesthetics|mesh-list
111081237|NCT02488291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111081238|NCT02488291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111081239|NCT02488291|Sensory System Agents|sensory system agents|mesh-ancestor
111081240|NCT02488291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111081241|NCT02488291|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111081242|NCT02488291|Narcotics|narcotics|mesh-ancestor
111081243|NCT02488291|Analgesics|analgesics|mesh-ancestor
111081244|NCT02488291|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111081245|NCT02488291|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111081246|NCT02488291|Anesthetics, General|anesthetics, general|mesh-ancestor
111081247|NCT03323047|Acetaminophen|acetaminophen|mesh-list
111081248|NCT03323047|Dexamethasone|dexamethasone|mesh-list
111081249|NCT03323047|Dexamethasone acetate|dexamethasone acetate|mesh-list
111081250|NCT03323047|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
111081251|NCT03323047|BB 1101|bb 1101|mesh-list
111081252|NCT03323047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111081253|NCT03323047|Antiemetics|antiemetics|mesh-ancestor
111081254|NCT03323047|Autonomic Agents|autonomic agents|mesh-ancestor
111081255|NCT03323047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111081256|NCT03323047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111081257|NCT03323047|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111081258|NCT03323047|Glucocorticoids|glucocorticoids|mesh-ancestor
111081259|NCT03323047|Hormones|hormones|mesh-ancestor
111081260|NCT03323047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111081261|NCT03323047|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111081262|NCT03323047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111081263|NCT03323047|Protease Inhibitors|protease inhibitors|mesh-ancestor
111081264|NCT03323047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111081265|NCT03323047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111081266|NCT03323047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111081267|NCT03323047|Analgesics|analgesics|mesh-ancestor
111081268|NCT03323047|Sensory System Agents|sensory system agents|mesh-ancestor
111081269|NCT03323047|Antipyretics|antipyretics|mesh-ancestor
111081270|NCT03322969|Paclitaxel|paclitaxel|mesh-list
111081271|NCT03322969|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111081272|NCT03322969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111081273|NCT03322969|Tubulin Modulators|tubulin modulators|mesh-ancestor
111081274|NCT03322969|Antimitotic Agents|antimitotic agents|mesh-ancestor
111081275|NCT03322969|Mitosis Modulators|mitosis modulators|mesh-ancestor
111081276|NCT03322969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111081277|NCT05464303|Antibodies|antibodies|mesh-list
111081278|NCT05464303|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111081279|NCT05464303|gamma-Globulins|gamma-globulins|mesh-list
111081280|NCT05464303|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
111081281|NCT05464303|Immunologic Factors|immunologic factors|mesh-ancestor
111081282|NCT05464303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111081283|NCT03322735|Cyclophosphamide|cyclophosphamide|mesh-list
111081284|NCT03322735|Fludarabine|fludarabine|mesh-list
111081285|NCT03322735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111081286|NCT03322735|Immunologic Factors|immunologic factors|mesh-ancestor
111081287|NCT03322735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111081288|NCT03322735|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111081289|NCT03322735|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111081290|NCT03322735|Alkylating Agents|alkylating agents|mesh-ancestor
111081291|NCT03322735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111081292|NCT03322735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111081293|NCT03322735|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111081294|NCT02487823|Bicalutamide|bicalutamide|mesh-list
111081295|NCT02487823|Buserelin|buserelin|mesh-list
111081296|NCT02487823|Androgen Antagonists|androgen antagonists|mesh-ancestor
111081297|NCT02487823|Hormone Antagonists|hormone antagonists|mesh-ancestor
111119162|NCT05306873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111081298|NCT02487823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111081299|NCT02487823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111081301|NCT02487823|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111081302|NCT02487823|Fertility Agents|fertility agents|mesh-ancestor
111081303|NCT02487823|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111081304|NCT05463913|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
111081305|NCT05463913|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111081306|NCT05463913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111081307|NCT02487433|Tofacitinib|tofacitinib|mesh-list
111081308|NCT02487433|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
111081309|NCT02487433|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111081310|NCT02487433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111081311|NCT02487433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111081312|NCT04493125|Mosapride|mosapride|mesh-list
111081313|NCT04493125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111081314|NCT04493125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111081315|NCT04493125|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111081316|NCT04493125|Serotonin Agents|serotonin agents|mesh-ancestor
111081317|NCT04493125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111081318|NCT04493125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111081319|NCT03318835|Thalidomide|thalidomide|mesh-list
111081320|NCT03318835|Prednisone|prednisone|mesh-list
111081321|NCT03318835|Cyclophosphamide|cyclophosphamide|mesh-list
111081322|NCT03318835|Vincristine|vincristine|mesh-list
111081323|NCT03318835|Rituximab|rituximab|mesh-list
111081324|NCT03318835|Doxorubicin|doxorubicin|mesh-list
111081325|NCT03318835|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111081326|NCT03318835|Immunologic Factors|immunologic factors|mesh-ancestor
111081327|NCT03318835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111081328|NCT03318835|Leprostatic Agents|leprostatic agents|mesh-ancestor
111081329|NCT03318835|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111081330|NCT03318835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111081331|NCT03318835|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111081332|NCT03318835|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111081333|NCT03318835|Growth Substances|growth substances|mesh-ancestor
111081334|NCT03318835|Growth Inhibitors|growth inhibitors|mesh-ancestor
111081335|NCT03318835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111081336|NCT03318835|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111081337|NCT03318835|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111081338|NCT03318835|Alkylating Agents|alkylating agents|mesh-ancestor
111081339|NCT03318835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111081340|NCT03318835|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111081341|NCT03318835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111081342|NCT03318835|Glucocorticoids|glucocorticoids|mesh-ancestor
111081343|NCT03318835|Hormones|hormones|mesh-ancestor
111081344|NCT03318835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111081345|NCT03318835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111081346|NCT03318835|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111081347|NCT03318835|Tubulin Modulators|tubulin modulators|mesh-ancestor
111081348|NCT03318835|Antimitotic Agents|antimitotic agents|mesh-ancestor
111081349|NCT03318835|Mitosis Modulators|mitosis modulators|mesh-ancestor
111081350|NCT03318835|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111081351|NCT03318835|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111081352|NCT03318835|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111081353|NCT03318835|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111081354|NCT03318835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111081355|NCT03318757|Bupivacaine|bupivacaine|mesh-list
111081356|NCT03318757|Anesthetics, Local|anesthetics, local|mesh-ancestor
111081357|NCT03318757|Anesthetics|anesthetics|mesh-ancestor
111081358|NCT03318757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111081359|NCT03318757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111081360|NCT03318757|Sensory System Agents|sensory system agents|mesh-ancestor
111081361|NCT03318757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111081362|NCT02487355|Magnesium Sulfate|magnesium sulfate|mesh-list
111081363|NCT02487355|Dexmedetomidine|dexmedetomidine|mesh-list
111081364|NCT02487355|Bupivacaine|bupivacaine|mesh-list
111081365|NCT02487355|Anesthetics, Local|anesthetics, local|mesh-ancestor
111081366|NCT02487355|Anesthetics|anesthetics|mesh-ancestor
111081367|NCT02487355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111081368|NCT02487355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111081369|NCT02487355|Sensory System Agents|sensory system agents|mesh-ancestor
111081370|NCT02487355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111081371|NCT02487355|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111081372|NCT02487355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111081373|NCT02487355|Analgesics|analgesics|mesh-ancestor
111081374|NCT02487355|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111081375|NCT02487355|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111081376|NCT02487355|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111081377|NCT02487355|Adrenergic Agents|adrenergic agents|mesh-ancestor
111081378|NCT02487355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111081379|NCT02487355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111081380|NCT02487355|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111081381|NCT02487355|Anticonvulsants|anticonvulsants|mesh-ancestor
111081382|NCT02487355|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111081383|NCT02487355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111081384|NCT02487355|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111081385|NCT02487355|Tocolytic Agents|tocolytic agents|mesh-ancestor
111081386|NCT02487355|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111081387|NCT03325465|Pembrolizumab|pembrolizumab|mesh-list
111081388|NCT03325465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111081389|NCT03325465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111081390|NCT03325465|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111081391|NCT03325465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111081392|NCT01876953|Cytarabine|cytarabine|mesh-list
111081393|NCT01876953|Dasatinib|dasatinib|mesh-list
111081394|NCT01876953|Idarubicin|idarubicin|mesh-list
111081395|NCT01876953|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111081396|NCT01876953|Antimetabolites|antimetabolites|mesh-ancestor
111081397|NCT01876953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111081398|NCT01876953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111081399|NCT01876953|Antiviral Agents|antiviral agents|mesh-ancestor
111081400|NCT01876953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111081401|NCT01876953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111081402|NCT01876953|Immunologic Factors|immunologic factors|mesh-ancestor
111081403|NCT01876953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110136541|NCT02005302|Vitamin D|vitamin d|mesh-list
111081404|NCT01876953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111081405|NCT01876953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111081406|NCT01876953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111081407|NCT01876953|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111081408|NCT01876953|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111081409|NCT03321955|Ziconotide|ziconotide|mesh-list
111081410|NCT03321955|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111081411|NCT03321955|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111081412|NCT03321955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111081413|NCT03321955|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111081414|NCT03321955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111081415|NCT03321955|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111081416|NCT03321955|Protective Agents|protective agents|mesh-ancestor
111081417|NCT03321955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111081418|NCT03321955|Analgesics|analgesics|mesh-ancestor
111081419|NCT03321955|Sensory System Agents|sensory system agents|mesh-ancestor
111081420|NCT03321955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110798539|NCT03778359|Leuprolide|leuprolide|mesh-list
111081421|NCT04493281|Edaravone|edaravone|mesh-list
111081422|NCT04493281|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111081423|NCT04493281|Antioxidants|antioxidants|mesh-ancestor
111081424|NCT04493281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111081425|NCT04493281|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111081426|NCT04493281|Protective Agents|protective agents|mesh-ancestor
111081427|NCT04493281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111081428|NCT01764711|Cosyntropin|cosyntropin|mesh-list
111081429|NCT01764711|Hormones|hormones|mesh-ancestor
111081430|NCT01764711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111081431|NCT01764711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111081432|NCT04493515|Oxytocin|oxytocin|mesh-list
111081433|NCT04493515|Oxytocics|oxytocics|mesh-ancestor
111081434|NCT04493515|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111081435|NCT04493515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111081436|NCT03318445|Irinotecan|irinotecan|mesh-list
111081437|NCT03318445|Rucaparib|rucaparib|mesh-list
111081438|NCT03318445|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111081439|NCT03318445|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111081440|NCT03318445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111119163|NCT05306873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111081441|NCT03318445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111081442|NCT03318445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111081443|NCT03318445|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111081444|NCT02485015|Apatinib|apatinib|mesh-list
111081445|NCT02485015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111081446|NCT02485015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111081447|NCT02485015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111081448|NCT02485015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111081449|NCT03316339|Dexmedetomidine|dexmedetomidine|mesh-list
111081450|NCT03316339|Remifentanil|remifentanil|mesh-list
111081451|NCT03316339|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111081452|NCT03316339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111081453|NCT03316339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111081454|NCT03316339|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111081455|NCT03316339|Analgesics|analgesics|mesh-ancestor
111081456|NCT03316339|Sensory System Agents|sensory system agents|mesh-ancestor
111081457|NCT03316339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111081458|NCT03316339|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111081459|NCT03316339|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111081460|NCT03316339|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111081461|NCT03316339|Adrenergic Agents|adrenergic agents|mesh-ancestor
111081462|NCT03316339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111081463|NCT03316339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111081464|NCT03316339|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111081465|NCT03316339|Narcotics|narcotics|mesh-ancestor
111081466|NCT02490865|RNS60|rns60|mesh-list
111081467|NCT02490865|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111081468|NCT02490865|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111081469|NCT02490865|Analgesics|analgesics|mesh-ancestor
111081470|NCT02490865|Sensory System Agents|sensory system agents|mesh-ancestor
111081471|NCT02490865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111081472|NCT02490865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111081473|NCT02490865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111081474|NCT02490865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111081475|NCT02490865|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111081476|NCT03318211|Magnesium Sulfate|magnesium sulfate|mesh-list
111081477|NCT03318211|Analgesics|analgesics|mesh-ancestor
111081478|NCT03318211|Sensory System Agents|sensory system agents|mesh-ancestor
111081479|NCT03318211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111081480|NCT03318211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111081481|NCT03318211|Anesthetics|anesthetics|mesh-ancestor
111081482|NCT03318211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111081483|NCT03318211|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111081484|NCT03318211|Anticonvulsants|anticonvulsants|mesh-ancestor
111081485|NCT03318211|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111081486|NCT03318211|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111081487|NCT03318211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111081488|NCT03318211|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111081489|NCT03318211|Tocolytic Agents|tocolytic agents|mesh-ancestor
111081490|NCT03318211|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111081491|NCT02483767|Goserelin|goserelin|mesh-list
111081492|NCT02483767|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111081493|NCT02483767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111081494|NCT02483845|Natalizumab|natalizumab|mesh-list
111081495|NCT02483845|Immunologic Factors|immunologic factors|mesh-ancestor
111081496|NCT02483845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111081497|NCT02486341|Insulin|insulin|mesh-list
111081498|NCT02486341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111081499|NCT02486341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111081500|NCT02484001|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
111081501|NCT02484001|Anticonvulsants|anticonvulsants|mesh-ancestor
111081502|NCT02484001|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111081503|NCT02484001|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111081504|NCT02484001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111081505|NCT02484001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111081506|NCT02483923|Ropivacaine|ropivacaine|mesh-list
111081507|NCT02483923|Anesthetics, Local|anesthetics, local|mesh-ancestor
111081508|NCT02483923|Anesthetics|anesthetics|mesh-ancestor
111081509|NCT02483923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111081510|NCT02483923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111081511|NCT02483923|Sensory System Agents|sensory system agents|mesh-ancestor
111081512|NCT02483923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111081514|NCT02483689|Anesthetics, Local|anesthetics, local|mesh-list
111081515|NCT02483689|Anesthetics|anesthetics|mesh-list
111081516|NCT02483689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111081517|NCT02483689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111081518|NCT02483689|Sensory System Agents|sensory system agents|mesh-ancestor
111081519|NCT02483689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111081520|NCT02490085|Insulin|insulin|mesh-list
111081521|NCT02490085|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111081522|NCT02490085|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111081523|NCT02490085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111081524|NCT03102021|Epoetin Alfa|epoetin alfa|mesh-list
111081525|NCT03102021|Hematinics|hematinics|mesh-ancestor
111081526|NCT04916691|Ropivacaine|ropivacaine|mesh-list
111081527|NCT04916691|Anesthetics, Local|anesthetics, local|mesh-ancestor
111081528|NCT04916691|Anesthetics|anesthetics|mesh-ancestor
111081529|NCT04916691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111081530|NCT04916691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111081531|NCT04916691|Sensory System Agents|sensory system agents|mesh-ancestor
111081532|NCT04916691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111081533|NCT05105139|Triclosan|triclosan|mesh-list
111081534|NCT05105139|Coal Tar|coal tar|mesh-list
111081535|NCT05105139|Allantoin|allantoin|mesh-list
111081536|NCT05105139|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111081537|NCT05105139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111081538|NCT05105139|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
111081539|NCT05105139|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111081540|NCT05105139|Antimetabolites|antimetabolites|mesh-ancestor
111081541|NCT05105139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111081542|NCT05105139|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111081543|NCT05105139|Keratolytic Agents|keratolytic agents|mesh-ancestor
111081544|NCT05105139|Dermatologic Agents|dermatologic agents|mesh-ancestor
111081545|NCT03862833|Zoledronic Acid|zoledronic acid|mesh-list
111081546|NCT03862833|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111081547|NCT03862833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111081548|NCT03317275|Fluorides|fluorides|mesh-list
111081549|NCT03317275|Cariostatic Agents|cariostatic agents|mesh-ancestor
111081550|NCT03317275|Protective Agents|protective agents|mesh-ancestor
111081551|NCT03317275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111081552|NCT03317197|Vasopressins|vasopressins|mesh-list
111081553|NCT03317197|Arginine Vasopressin|arginine vasopressin|mesh-list
111081554|NCT03317197|Epinephrine|epinephrine|mesh-list
111081555|NCT03317197|Racepinephrine|racepinephrine|mesh-list
111081556|NCT03317197|Epinephryl borate|epinephryl borate|mesh-list
111081557|NCT03317197|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111081558|NCT03317197|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111081559|NCT03317197|Adrenergic Agents|adrenergic agents|mesh-ancestor
111081560|NCT03317197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111081561|NCT03317197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111081562|NCT03317197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111081563|NCT03317197|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111081564|NCT03317197|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111081565|NCT03317197|Autonomic Agents|autonomic agents|mesh-ancestor
111081566|NCT03317197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111081567|NCT03317197|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111081568|NCT03317197|Respiratory System Agents|respiratory system agents|mesh-ancestor
111081569|NCT03317197|Mydriatics|mydriatics|mesh-ancestor
111081570|NCT03317197|Sympathomimetics|sympathomimetics|mesh-ancestor
111081571|NCT03317197|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110798690|NCT03777033|Calcium|calcium|mesh-list
111081572|NCT03317197|Hemostatics|hemostatics|mesh-ancestor
111081573|NCT03317197|Coagulants|coagulants|mesh-ancestor
111081574|NCT03317197|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
111081575|NCT03317197|Natriuretic Agents|natriuretic agents|mesh-ancestor
111081576|NCT02483299|Metformin|metformin|mesh-list
111081577|NCT02483299|Liraglutide|liraglutide|mesh-list
111081578|NCT02483299|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111081579|NCT02483299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111081580|NCT02483299|Incretins|incretins|mesh-ancestor
111081581|NCT02483299|Hormones|hormones|mesh-ancestor
111081582|NCT02483299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111081583|NCT01597479|Anesthetics|anesthetics|mesh-list
111081584|NCT01597479|Levobupivacaine|levobupivacaine|mesh-list
111081585|NCT01597479|Anesthetics, Local|anesthetics, local|mesh-list
111081586|NCT01597479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111081587|NCT01597479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111081588|NCT01597479|Sensory System Agents|sensory system agents|mesh-ancestor
111081589|NCT01597479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111081590|NCT03316963|Neostigmine|neostigmine|mesh-list
111081591|NCT03316963|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111081592|NCT03316963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111081593|NCT03316963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111081594|NCT03316963|Cholinergic Agents|cholinergic agents|mesh-ancestor
111081595|NCT03316963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111081596|NCT03316963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111081597|NCT03316963|Parasympathomimetics|parasympathomimetics|mesh-ancestor
111081598|NCT03316963|Autonomic Agents|autonomic agents|mesh-ancestor
111081599|NCT03316963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111081600|NCT02489929|Azacitidine|azacitidine|mesh-list
111081601|NCT02489929|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111081602|NCT02489929|Antimetabolites|antimetabolites|mesh-ancestor
111081603|NCT02489929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111081604|NCT02489929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111081605|NCT02489929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111081606|NCT05154903|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
111081607|NCT05154903|Nootropic Agents|nootropic agents|mesh-ancestor
111081608|NCT02483143|Acetylcysteine|acetylcysteine|mesh-list
111081609|NCT02483143|Antiviral Agents|antiviral agents|mesh-ancestor
111081610|NCT02483143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111081611|NCT02483143|Expectorants|expectorants|mesh-ancestor
111081612|NCT02483143|Respiratory System Agents|respiratory system agents|mesh-ancestor
111081613|NCT02483143|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111081614|NCT02483143|Antioxidants|antioxidants|mesh-ancestor
111081615|NCT02483143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111081616|NCT02483143|Protective Agents|protective agents|mesh-ancestor
111081617|NCT02483143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111081618|NCT02483221|Morphine|morphine|mesh-list
111081619|NCT02483221|Hydromorphone|hydromorphone|mesh-list
111081620|NCT02483221|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111081621|NCT02483221|Narcotics|narcotics|mesh-ancestor
111081622|NCT02483221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111081623|NCT02483221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111081624|NCT02483221|Analgesics|analgesics|mesh-ancestor
111081625|NCT02483221|Sensory System Agents|sensory system agents|mesh-ancestor
111081626|NCT02483221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111081627|NCT02489461|Efavirenz|efavirenz|mesh-list
111081628|NCT02489461|Elsulfavirine|elsulfavirine|mesh-list
111081629|NCT02489461|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
111081630|NCT02489461|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111081631|NCT02489461|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111081632|NCT02489461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111081633|NCT02489461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111081634|NCT02489461|Antiviral Agents|antiviral agents|mesh-ancestor
111081635|NCT02489461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111081636|NCT02489461|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111081637|NCT02489461|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111081638|NCT02489461|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111081639|NCT02489461|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111081640|NCT02489461|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111081641|NCT02489461|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111081642|NCT02489461|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111081643|NCT05129475|Ritonavir|ritonavir|mesh-list
111081644|NCT05129475|Nirmatrelvir|nirmatrelvir|mesh-list
111081645|NCT05129475|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111081646|NCT05129475|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111081647|NCT05129475|Protease Inhibitors|protease inhibitors|mesh-ancestor
111081648|NCT05129475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111081649|NCT05129475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111081650|NCT05129475|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111081651|NCT05129475|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111081652|NCT05129475|Antiviral Agents|antiviral agents|mesh-ancestor
111081653|NCT05129475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111081654|NCT05129475|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111081655|NCT05129475|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111081656|NCT02485873|Vitamin K|vitamin k|mesh-list
111081657|NCT02485873|Rivaroxaban|rivaroxaban|mesh-list
111081658|NCT02485873|Vitamins|vitamins|mesh-ancestor
111081659|NCT02485873|Micronutrients|micronutrients|mesh-ancestor
111081660|NCT02485873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111081661|NCT02485873|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111081662|NCT02485873|Antithrombins|antithrombins|mesh-ancestor
111081663|NCT02485873|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111081665|NCT02485873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111081666|NCT02485873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111081667|NCT02485873|Anticoagulants|anticoagulants|mesh-ancestor
111081668|NCT02485873|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111081669|NCT02485873|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111081670|NCT02485873|Hemostatics|hemostatics|mesh-ancestor
111081671|NCT02485873|Coagulants|coagulants|mesh-ancestor
111081672|NCT04412421|Vitamins|vitamins|mesh-list
111081673|NCT04412421|Micronutrients|micronutrients|mesh-ancestor
111081674|NCT04412421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111081675|NCT03315091|Adavosertib|adavosertib|mesh-list
111081676|NCT03315091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111081677|NCT03315091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111081678|NCT02488993|Rifaximin|rifaximin|mesh-list
111081679|NCT02488993|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111081680|NCT02488993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111081681|NCT02488993|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111081682|NCT02485327|Insulin|insulin|mesh-list
111081683|NCT02485327|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111081684|NCT02485327|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111081685|NCT02485327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111081686|NCT02485249|Dexamethasone|dexamethasone|mesh-list
111081687|NCT02485249|Dexamethasone acetate|dexamethasone acetate|mesh-list
111081688|NCT02485249|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
111081689|NCT02485249|BB 1101|bb 1101|mesh-list
111081690|NCT02485249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111081691|NCT02485249|Antiemetics|antiemetics|mesh-ancestor
111081692|NCT02485249|Autonomic Agents|autonomic agents|mesh-ancestor
111081693|NCT02485249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111081694|NCT02485249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111081695|NCT02485249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111081696|NCT02485249|Glucocorticoids|glucocorticoids|mesh-ancestor
111081697|NCT02485249|Hormones|hormones|mesh-ancestor
111081698|NCT02485249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111081699|NCT02485249|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111081700|NCT02485249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111081701|NCT02485249|Protease Inhibitors|protease inhibitors|mesh-ancestor
111081702|NCT02485249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111081703|NCT02485249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111081704|NCT03320707|Daratumumab|daratumumab|mesh-list
111081705|NCT03320707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111081706|NCT03320629|Apatinib|apatinib|mesh-list
111081707|NCT03320629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111081708|NCT03320629|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111081709|NCT03320629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111081710|NCT03320629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111081711|NCT03316417|Immunomodulating Agents|immunomodulating agents|mesh-list
111081712|NCT03316417|Immunologic Factors|immunologic factors|mesh-ancestor
111081713|NCT03316417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111081714|NCT02482207|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111081715|NCT02482207|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111081716|NCT02482207|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111081717|NCT02482207|Antimetabolites|antimetabolites|mesh-ancestor
111081718|NCT02482207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111081719|NCT02482207|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111081720|NCT02482207|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111081721|NCT02482207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111081722|NCT02476981|Ephedrine|ephedrine|mesh-list
111081723|NCT02476981|Midazolam|midazolam|mesh-list
110798837|NCT01320111|Paclitaxel|paclitaxel|mesh-list
111081724|NCT02476981|Dexmedetomidine|dexmedetomidine|mesh-list
111081726|NCT02476981|Propofol|propofol|mesh-list
111081727|NCT02476981|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111081728|NCT02476981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111081729|NCT02476981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111081730|NCT02476981|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111081731|NCT02476981|Analgesics|analgesics|mesh-ancestor
111081732|NCT02476981|Sensory System Agents|sensory system agents|mesh-ancestor
111081733|NCT02476981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111081734|NCT02476981|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111081735|NCT02476981|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111081736|NCT02476981|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111081737|NCT02476981|Adrenergic Agents|adrenergic agents|mesh-ancestor
111081738|NCT02476981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111081740|NCT02476981|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111081741|NCT02476981|Anesthetics, General|anesthetics, general|mesh-ancestor
111081742|NCT02476981|Anesthetics|anesthetics|mesh-ancestor
111081743|NCT02476981|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111081744|NCT02476981|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111081745|NCT02476981|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111081746|NCT02476981|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111081747|NCT02476981|GABA Modulators|gaba modulators|mesh-ancestor
111081748|NCT02476981|GABA Agents|gaba agents|mesh-ancestor
111081749|NCT02476981|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111081750|NCT02476981|Narcotics|narcotics|mesh-ancestor
111081751|NCT02476981|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111081752|NCT02476981|Sympathomimetics|sympathomimetics|mesh-ancestor
111081753|NCT02476981|Autonomic Agents|autonomic agents|mesh-ancestor
111081754|NCT02476981|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111081755|NCT04248465|Ravulizumab|ravulizumab|mesh-list
111081756|NCT04248465|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
111081757|NCT04248465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111081758|NCT04248465|Immunologic Factors|immunologic factors|mesh-ancestor
111081759|NCT04248465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111081760|NCT02480335|Bosentan|bosentan|mesh-list
111081761|NCT02480335|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111081762|NCT02480335|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
111081763|NCT02480335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111081764|NCT05456269|Cytarabine|cytarabine|mesh-list
111081765|NCT05456269|Decitabine|decitabine|mesh-list
111081766|NCT05456269|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
111081767|NCT05456269|Bisantrene|bisantrene|mesh-list
111081768|NCT05456269|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111081769|NCT05456269|Antimetabolites|antimetabolites|mesh-ancestor
111081770|NCT05456269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111081771|NCT05456269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111081772|NCT05456269|Antiviral Agents|antiviral agents|mesh-ancestor
111081773|NCT05456269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111081774|NCT05456269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111081775|NCT05456269|Immunologic Factors|immunologic factors|mesh-ancestor
111081776|NCT05456269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111081777|NCT05456269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111081778|NCT05456269|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111081779|NCT02476825|Fluticasone|fluticasone|mesh-list
111081780|NCT02476825|Xhance|xhance|mesh-list
111081781|NCT02476825|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111081782|NCT02476825|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111081783|NCT02476825|Autonomic Agents|autonomic agents|mesh-ancestor
111081784|NCT02476825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111081785|NCT02476825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111081786|NCT02476825|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111081787|NCT02476825|Respiratory System Agents|respiratory system agents|mesh-ancestor
111081788|NCT02476825|Dermatologic Agents|dermatologic agents|mesh-ancestor
111081789|NCT02476825|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111081790|NCT05245227|Misoprostol|misoprostol|mesh-list
111081791|NCT05245227|Oxytocin|oxytocin|mesh-list
111081792|NCT05245227|Oxytocics|oxytocics|mesh-ancestor
111081793|NCT05245227|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111081794|NCT05245227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111081795|NCT05245227|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111081796|NCT05245227|Abortifacient Agents|abortifacient agents|mesh-ancestor
111081797|NCT05245227|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111081798|NCT05245227|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111081799|NCT02479867|Cefadroxil|cefadroxil|mesh-list
111081800|NCT02479867|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111081801|NCT02479867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111081802|NCT05244837|Paclitaxel|paclitaxel|mesh-list
111081803|NCT05244837|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111081804|NCT05244837|Carboplatin|carboplatin|mesh-list
111081805|NCT05244837|Pemetrexed|pemetrexed|mesh-list
111081806|NCT05244837|Tislelizumab|tislelizumab|mesh-list
111081807|NCT05244837|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111081808|NCT05244837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111081809|NCT05244837|Tubulin Modulators|tubulin modulators|mesh-ancestor
111081810|NCT05244837|Antimitotic Agents|antimitotic agents|mesh-ancestor
111081811|NCT05244837|Mitosis Modulators|mitosis modulators|mesh-ancestor
111081812|NCT05244837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111081813|NCT05244837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111081814|NCT05244837|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110677170|NCT02425852|Infliximab|infliximab|mesh-list
111081815|NCT05244837|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111081816|NCT05244837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111081818|NCT03103893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111081819|NCT03103893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111081820|NCT03103893|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111081821|NCT03103893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111081822|NCT03103893|Antifungal Agents|antifungal agents|mesh-ancestor
111081823|NCT03103893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111081824|NCT03103893|Immunologic Factors|immunologic factors|mesh-ancestor
111081825|NCT03103893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111081826|NCT02479789|Lidocaine|lidocaine|mesh-list
111081827|NCT02479789|Anesthetics, Local|anesthetics, local|mesh-ancestor
111081828|NCT02479789|Anesthetics|anesthetics|mesh-ancestor
111081829|NCT02479789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111081830|NCT02479789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111081831|NCT02479789|Sensory System Agents|sensory system agents|mesh-ancestor
111081832|NCT02479789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111081833|NCT02479789|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111081834|NCT02479789|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111081835|NCT02479789|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111081836|NCT02479789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111081837|NCT02479789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111081838|NCT02726113|Vitamin D|vitamin d|mesh-list
111081839|NCT02726113|Cholecalciferol|cholecalciferol|mesh-list
111081840|NCT02726113|Vitamins|vitamins|mesh-ancestor
111081841|NCT02726113|Micronutrients|micronutrients|mesh-ancestor
111081842|NCT02726113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111081843|NCT02726113|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111081844|NCT02726113|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111081845|NCT05243355|Endostatins|endostatins|mesh-list
111081846|NCT05243355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111081847|NCT05243355|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111081848|NCT05243355|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111081849|NCT05243355|Growth Substances|growth substances|mesh-ancestor
111081850|NCT05243355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111081851|NCT05243355|Growth Inhibitors|growth inhibitors|mesh-ancestor
111081852|NCT02479711|Methamphetamine|methamphetamine|mesh-list
111081853|NCT02479711|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111081854|NCT02479711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111081855|NCT02479711|Sympathomimetics|sympathomimetics|mesh-ancestor
111081856|NCT02479711|Autonomic Agents|autonomic agents|mesh-ancestor
111081857|NCT02479711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111081858|NCT02479711|Dopamine Agents|dopamine agents|mesh-ancestor
111081859|NCT02479711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111081860|NCT02479711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111081861|NCT02479711|Adrenergic Agents|adrenergic agents|mesh-ancestor
111081862|NCT02479711|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111081863|NCT02479711|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111081864|NCT02479711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111081865|NCT02479711|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111081866|NCT05196945|Amoxicillin|amoxicillin|mesh-list
111081867|NCT05196945|Clarithromycin|clarithromycin|mesh-list
111081868|NCT05196945|Potassium Citrate|potassium citrate|mesh-list
111081869|NCT05196945|Esomeprazole|esomeprazole|mesh-list
111081870|NCT05196945|Bismuth|bismuth|mesh-list
111081871|NCT05196945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111081872|NCT05196945|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111081873|NCT05196945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111081874|NCT05196945|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111081875|NCT05196945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111081876|NCT05196945|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111081877|NCT05196945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111081878|NCT05196945|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111081879|NCT05196945|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111081880|NCT05196945|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111081881|NCT05196945|Antacids|antacids|mesh-ancestor
111081882|NCT05196945|Diuretics|diuretics|mesh-ancestor
111081883|NCT05196945|Natriuretic Agents|natriuretic agents|mesh-ancestor
111081884|NCT05196945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111081885|NCT05196945|Expectorants|expectorants|mesh-ancestor
111081886|NCT05196945|Respiratory System Agents|respiratory system agents|mesh-ancestor
111081887|NCT03800979|Tofacitinib|tofacitinib|mesh-list
111081888|NCT03800979|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
111081889|NCT03800979|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111081890|NCT03800979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111081891|NCT03800979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111081892|NCT02476123|Nivolumab|nivolumab|mesh-list
111081893|NCT02476123|Mogamulizumab|mogamulizumab|mesh-list
111081894|NCT02476123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111081895|NCT02476123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111081896|NCT02476123|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111081897|NCT02476123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111081898|NCT02481193|Cisatracurium|cisatracurium|mesh-list
111081899|NCT02481193|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
111081900|NCT02481193|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111081901|NCT02481193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111081902|NCT02481193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111081903|NCT03101709|Cyclophosphamide|cyclophosphamide|mesh-list
111081904|NCT03101709|Fludarabine|fludarabine|mesh-list
110799543|NCT03752931|Diltiazem|diltiazem|mesh-list
111081905|NCT03101709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111081906|NCT03101709|Immunologic Factors|immunologic factors|mesh-ancestor
111081907|NCT03101709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111081908|NCT03101709|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111081909|NCT03101709|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111081910|NCT03101709|Alkylating Agents|alkylating agents|mesh-ancestor
111081911|NCT03101709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111081912|NCT03101709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111081913|NCT03101709|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111081914|NCT03101319|Vitamin D|vitamin d|mesh-list
111081915|NCT03101319|Cholecalciferol|cholecalciferol|mesh-list
111081916|NCT03101319|Vitamins|vitamins|mesh-ancestor
111081917|NCT03101319|Micronutrients|micronutrients|mesh-ancestor
111081918|NCT03101319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111081919|NCT03101319|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111081920|NCT03101319|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111081921|NCT02479555|Dexamethasone|dexamethasone|mesh-list
111081922|NCT02479555|Dexamethasone acetate|dexamethasone acetate|mesh-list
111081923|NCT02479555|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
111081924|NCT02479555|BB 1101|bb 1101|mesh-list
111081925|NCT02479555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111081926|NCT02479555|Antiemetics|antiemetics|mesh-ancestor
111081927|NCT02479555|Autonomic Agents|autonomic agents|mesh-ancestor
111081928|NCT02479555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111081929|NCT02479555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111081930|NCT02479555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111081931|NCT02479555|Glucocorticoids|glucocorticoids|mesh-ancestor
111081932|NCT02479555|Hormones|hormones|mesh-ancestor
111081933|NCT02479555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111081934|NCT02479555|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111081935|NCT02479555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111081936|NCT02479555|Protease Inhibitors|protease inhibitors|mesh-ancestor
111081937|NCT02479555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111081938|NCT02479555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111081939|NCT02476045|Leucovorin|leucovorin|mesh-list
111081940|NCT02476045|Fluorouracil|fluorouracil|mesh-list
111081941|NCT02476045|Oxaliplatin|oxaliplatin|mesh-list
111081942|NCT02476045|Panitumumab|panitumumab|mesh-list
111081943|NCT02476045|Levoleucovorin|levoleucovorin|mesh-list
111081944|NCT02476045|Antimetabolites|antimetabolites|mesh-ancestor
111081945|NCT02476045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111081946|NCT02476045|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111081947|NCT02476045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111081948|NCT02476045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111081949|NCT02476045|Immunologic Factors|immunologic factors|mesh-ancestor
110799063|NCT03270644|Lasmiditan|lasmiditan|mesh-list
111081950|NCT02476045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111081951|NCT02476045|Antidotes|antidotes|mesh-ancestor
111081952|NCT02476045|Protective Agents|protective agents|mesh-ancestor
111081953|NCT02476045|Vitamin B Complex|vitamin b complex|mesh-ancestor
111081954|NCT02476045|Vitamins|vitamins|mesh-ancestor
111081955|NCT02476045|Micronutrients|micronutrients|mesh-ancestor
111081956|NCT02476045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111081957|NCT02479399|Ipragliflozin|ipragliflozin|mesh-list
111081958|NCT02479399|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111081959|NCT02479399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111081960|NCT02479399|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111081961|NCT02479399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111081962|NCT03885921|Atorvastatin|atorvastatin|mesh-list
111081963|NCT03885921|Simvastatin|simvastatin|mesh-list
111081964|NCT03885921|Ezetimibe|ezetimibe|mesh-list
111081965|NCT03885921|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111081966|NCT03885921|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111081967|NCT03885921|Antimetabolites|antimetabolites|mesh-ancestor
111081968|NCT03885921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111081969|NCT03885921|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111081970|NCT03885921|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111081971|NCT03885921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111081972|NCT02480881|Fostemsavir|fostemsavir|mesh-list
111081973|NCT02480881|Contraceptive Agents|contraceptive agents|mesh-list
111081974|NCT02480881|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
111081975|NCT02480881|Contraceptives, Oral|contraceptives, oral|mesh-list
111081976|NCT02480881|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111081977|NCT02480881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111081978|NCT02480881|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111081979|NCT02480881|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
111081980|NCT02480881|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111081981|NCT02480881|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111081982|NCT02480881|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
111081983|NCT02480881|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111081984|NCT02480881|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111081985|NCT02480881|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111081986|NCT02480881|Antiviral Agents|antiviral agents|mesh-ancestor
111081987|NCT02480881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111081988|NCT02480881|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
111081989|NCT02480881|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
111081990|NCT02480881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111081991|NCT02480647|Levonorgestrel|levonorgestrel|mesh-list
111081992|NCT02480647|Etonogestrel|etonogestrel|mesh-list
111081993|NCT02480647|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111081994|NCT02480647|Contraceptive Agents|contraceptive agents|mesh-ancestor
111081995|NCT02480647|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111081996|NCT02480647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111081997|NCT02480647|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111081998|NCT02480647|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111081999|NCT02480647|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111082000|NCT03100071|Apixaban|apixaban|mesh-list
111082001|NCT03100071|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111082002|NCT03100071|Antithrombins|antithrombins|mesh-ancestor
111082003|NCT03100071|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111082004|NCT03100071|Protease Inhibitors|protease inhibitors|mesh-ancestor
111082005|NCT03100071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111082006|NCT03100071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111082007|NCT03100071|Anticoagulants|anticoagulants|mesh-ancestor
111082008|NCT02479165|Oxycodone|oxycodone|mesh-list
111082009|NCT02479165|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111082010|NCT02479165|Narcotics|narcotics|mesh-ancestor
111082011|NCT02479165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111082012|NCT02479165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111082013|NCT02479165|Analgesics|analgesics|mesh-ancestor
111082014|NCT02479165|Sensory System Agents|sensory system agents|mesh-ancestor
111082015|NCT02479165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111082016|NCT05072691|Immunoglobulins|immunoglobulins|mesh-list
111082017|NCT05072691|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111082018|NCT05072691|Antibodies|antibodies|mesh-list
111082019|NCT05072691|Immunologic Factors|immunologic factors|mesh-ancestor
111082020|NCT05072691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111082021|NCT05714839|Dexamethasone|dexamethasone|mesh-list
111082022|NCT05714839|Lenalidomide|lenalidomide|mesh-list
111082023|NCT05714839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111082024|NCT05714839|Antiemetics|antiemetics|mesh-ancestor
111082025|NCT05714839|Autonomic Agents|autonomic agents|mesh-ancestor
111082026|NCT05714839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110677182|NCT02425852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111082027|NCT05714839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111082028|NCT05714839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111082030|NCT05714839|Hormones|hormones|mesh-ancestor
111082031|NCT05714839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111082032|NCT05714839|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111082033|NCT05714839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111082034|NCT05714839|Immunologic Factors|immunologic factors|mesh-ancestor
111082035|NCT05714839|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111082036|NCT05714839|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111082037|NCT05714839|Growth Substances|growth substances|mesh-ancestor
111082038|NCT05714839|Growth Inhibitors|growth inhibitors|mesh-ancestor
111082039|NCT05378425|Pembrolizumab|pembrolizumab|mesh-list
111082040|NCT05378425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111082041|NCT05378425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111082042|NCT05378425|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111082043|NCT05378425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111082044|NCT05377255|Naloxone|naloxone|mesh-list
111082045|NCT05377255|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111082046|NCT05377255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111082047|NCT05377255|Sensory System Agents|sensory system agents|mesh-ancestor
111082048|NCT05377255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111082049|NCT02475499|Metformin|metformin|mesh-list
111082050|NCT02475499|Pioglitazone|pioglitazone|mesh-list
111082051|NCT02475499|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111082052|NCT02475499|Liraglutide|liraglutide|mesh-list
111082053|NCT02475499|Exenatide|exenatide|mesh-list
111082054|NCT02475499|Glimepiride|glimepiride|mesh-list
111082055|NCT02475499|Rosiglitazone|rosiglitazone|mesh-list
111082056|NCT02475499|Vildagliptin|vildagliptin|mesh-list
111082057|NCT02475499|Saxagliptin|saxagliptin|mesh-list
111082058|NCT02475499|Acarbose|acarbose|mesh-list
111082059|NCT02475499|Hypoglycemic Agents|hypoglycemic agents|mesh-list
111082060|NCT02475499|Repaglinide|repaglinide|mesh-list
111082061|NCT02475499|Gliclazide|gliclazide|mesh-list
111082062|NCT02475499|Glipizide|glipizide|mesh-list
111082063|NCT02475499|Biguanides|biguanides|mesh-list
111082064|NCT02475499|Tolbutamide|tolbutamide|mesh-list
111082065|NCT02475499|Voglibose|voglibose|mesh-list
111082066|NCT02475499|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
111082067|NCT02475499|Nateglinide|nateglinide|mesh-list
111082068|NCT02475499|Miglitol|miglitol|mesh-list
111082069|NCT02475499|Troglitazone|troglitazone|mesh-list
111082070|NCT02475499|Meglitinide|meglitinide|mesh-list
111082071|NCT02475499|Acetohexamide|acetohexamide|mesh-list
111082072|NCT02475499|Buformin|buformin|mesh-list
111082073|NCT02475499|Phenformin|phenformin|mesh-list
111082074|NCT02475499|Chlorpropamide|chlorpropamide|mesh-list
111082075|NCT02475499|Gliquidone|gliquidone|mesh-list
111082076|NCT02475499|Carbutamide|carbutamide|mesh-list
111082077|NCT02475499|Tolazamide|tolazamide|mesh-list
111082078|NCT02475499|Glibornuride|glibornuride|mesh-list
111082079|NCT02475499|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
111082080|NCT02475499|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
111082081|NCT02475499|Incretins|incretins|mesh-list
111082082|NCT02475499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111082083|NCT02475499|Hormones|hormones|mesh-ancestor
111082084|NCT02475499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111082085|NCT02475499|Protease Inhibitors|protease inhibitors|mesh-ancestor
111082086|NCT02475499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111082087|NCT02475499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111082088|NCT02475499|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111082089|NCT02475499|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111082090|NCT02475499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111082091|NCT02475499|Immunologic Factors|immunologic factors|mesh-ancestor
110639922|NCT00876824|Amphotericin B|amphotericin b|mesh-list
111082092|NCT03375645|Analgesics, Opioid|analgesics, opioid|mesh-list
111082093|NCT03375645|Narcotics|narcotics|mesh-ancestor
111082094|NCT03375645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111082095|NCT03375645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111082096|NCT03375645|Analgesics|analgesics|mesh-ancestor
111082097|NCT03375645|Sensory System Agents|sensory system agents|mesh-ancestor
111082098|NCT03375645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111082099|NCT03136809|Copper|copper|mesh-list
111082100|NCT03136809|Trace Elements|trace elements|mesh-ancestor
111082101|NCT03136809|Micronutrients|micronutrients|mesh-ancestor
111082102|NCT03136809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111082103|NCT02475421|Glucagon|glucagon|mesh-list
111082104|NCT02475421|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111082105|NCT02475421|Hormones|hormones|mesh-ancestor
111082106|NCT02475421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111082107|NCT02475421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111082108|NCT02475343|Riboflavin|riboflavin|mesh-list
111082109|NCT02475343|Vitamin B Complex|vitamin b complex|mesh-ancestor
111082110|NCT02475343|Vitamins|vitamins|mesh-ancestor
111082111|NCT02475343|Micronutrients|micronutrients|mesh-ancestor
111082112|NCT02475343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111082113|NCT02475343|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111082114|NCT02475343|Dermatologic Agents|dermatologic agents|mesh-ancestor
111082115|NCT02475109|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111082116|NCT02475109|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111082117|NCT04492501|Remdesivir|remdesivir|mesh-list
111082118|NCT04492501|Antimetabolites|antimetabolites|mesh-ancestor
111082119|NCT04492501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111082120|NCT04492501|Antiviral Agents|antiviral agents|mesh-ancestor
111082121|NCT04492501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111082122|NCT03101085|Equol|equol|mesh-list
111082123|NCT03101085|Phytoestrogens|phytoestrogens|mesh-ancestor
111082124|NCT03101085|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
111082125|NCT03101085|Estrogens|estrogens|mesh-ancestor
111082126|NCT03101085|Hormones|hormones|mesh-ancestor
111082127|NCT03101085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111082128|NCT03101085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111082129|NCT05070195|Midazolam|midazolam|mesh-list
111082130|NCT05070195|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111082131|NCT05070195|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111082132|NCT05070195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111082133|NCT05070195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111082134|NCT05070195|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111082135|NCT05070195|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111082136|NCT05070195|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111082137|NCT05070195|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111082138|NCT05070195|Anesthetics, General|anesthetics, general|mesh-ancestor
111082139|NCT05070195|Anesthetics|anesthetics|mesh-ancestor
111082140|NCT05070195|GABA Modulators|gaba modulators|mesh-ancestor
111082141|NCT05070195|GABA Agents|gaba agents|mesh-ancestor
111082142|NCT05070195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111082143|NCT05070195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111082144|NCT02474953|Curcumin|curcumin|mesh-list
111082145|NCT02474953|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110639950|NCT00993057|Insulin|insulin|mesh-list
111082146|NCT02474953|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111082147|NCT02474953|Analgesics|analgesics|mesh-ancestor
111082148|NCT02474953|Sensory System Agents|sensory system agents|mesh-ancestor
111082149|NCT02474953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111082150|NCT02474953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111082151|NCT02474953|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111082152|NCT02474953|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111082153|NCT02474953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111082154|NCT02474953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111082155|NCT02474953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111082156|NCT05714371|Pembrolizumab|pembrolizumab|mesh-list
111082157|NCT05714371|Nivolumab|nivolumab|mesh-list
111082158|NCT05714371|Ipilimumab|ipilimumab|mesh-list
111082159|NCT05714371|Trametinib|trametinib|mesh-list
111082160|NCT05714371|Dabrafenib|dabrafenib|mesh-list
111082161|NCT05714371|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111082162|NCT05714371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111082163|NCT05714371|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111082164|NCT05714371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111082165|NCT05714371|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111082166|NCT05714371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111082167|NCT02472613|Fluoxetine|fluoxetine|mesh-list
111082168|NCT02472613|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111082169|NCT02472613|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111082170|NCT02472613|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111082171|NCT02472613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111082172|NCT02472613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111082173|NCT02472613|Serotonin Agents|serotonin agents|mesh-ancestor
110677188|NCT02382549|Vaccines|vaccines|mesh-list
111082174|NCT02472613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111082175|NCT02472613|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111082176|NCT02472613|Antidepressive Agents|antidepressive agents|mesh-ancestor
111082178|NCT02472613|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111082179|NCT02472613|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111082180|NCT02472613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111082181|NCT00783237|Mometasone Furoate|mometasone furoate|mesh-list
111082182|NCT00783237|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111082183|NCT00783237|Dermatologic Agents|dermatologic agents|mesh-ancestor
111082184|NCT00783237|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111082185|NCT02478229|Sofosbuvir|sofosbuvir|mesh-list
111082186|NCT02478229|Ledipasvir|ledipasvir|mesh-list
111082187|NCT02478229|Antiviral Agents|antiviral agents|mesh-ancestor
111082188|NCT02478229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111082189|NCT04879615|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
111082190|NCT04879615|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111082191|NCT04879615|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111082192|NCT04879615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111082193|NCT05713045|Vitamin K 1|vitamin k 1|mesh-list
111082194|NCT05713045|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111082195|NCT05713045|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111082196|NCT05713045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111082197|NCT05713045|Hemostatics|hemostatics|mesh-ancestor
111082198|NCT05713045|Coagulants|coagulants|mesh-ancestor
111082199|NCT05713045|Vitamins|vitamins|mesh-ancestor
111082200|NCT05713045|Micronutrients|micronutrients|mesh-ancestor
111082201|NCT05713045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111082202|NCT00653835|Simvastatin|simvastatin|mesh-list
111082203|NCT00653835|Ezetimibe|ezetimibe|mesh-list
111082204|NCT00653835|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111082205|NCT00653835|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111082206|NCT00653835|Antimetabolites|antimetabolites|mesh-ancestor
111082207|NCT00653835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111082208|NCT00653835|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111082209|NCT00653835|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111082210|NCT00653835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111082211|NCT03099759|Vitamin D|vitamin d|mesh-list
111082212|NCT03099759|Cholecalciferol|cholecalciferol|mesh-list
111082213|NCT03099759|Ergocalciferols|ergocalciferols|mesh-list
111082214|NCT03099759|Vitamins|vitamins|mesh-ancestor
111082215|NCT03099759|Micronutrients|micronutrients|mesh-ancestor
111082216|NCT03099759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111082217|NCT03099759|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111082218|NCT03099759|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111082219|NCT05244577|Olanzapine|olanzapine|mesh-list
111082220|NCT05244577|Antiemetics|antiemetics|mesh-ancestor
111082221|NCT05244577|Autonomic Agents|autonomic agents|mesh-ancestor
111082222|NCT05244577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111082223|NCT05244577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111082224|NCT05244577|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111082225|NCT05244577|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111082226|NCT05244577|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111082227|NCT05244577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111082228|NCT05244577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111082229|NCT05244577|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111082230|NCT05244577|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111082231|NCT05244577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111082232|NCT05244577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111082233|NCT05244577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111082234|NCT05244577|Serotonin Agents|serotonin agents|mesh-ancestor
111082235|NCT05067699|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
111082236|NCT05067699|Calcifediol|calcifediol|mesh-list
111082237|NCT05067699|Vitamins|vitamins|mesh-ancestor
111082238|NCT05067699|Micronutrients|micronutrients|mesh-ancestor
111082239|NCT05067699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111082240|NCT05067699|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111082241|NCT05067153|Heparin|heparin|mesh-list
111082242|NCT05067153|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
111082243|NCT05067153|Tinzaparin|tinzaparin|mesh-list
111082244|NCT05067153|Dalteparin|dalteparin|mesh-list
111082245|NCT05067153|Anticoagulants|anticoagulants|mesh-ancestor
111082246|NCT05067153|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111082247|NCT05067153|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111082248|NCT05067153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111082249|NCT05067309|Letrozole|letrozole|mesh-list
111082250|NCT05067309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111082251|NCT05067309|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111082252|NCT05067309|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111082253|NCT05067309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111082254|NCT05067309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111082255|NCT05067309|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111082256|NCT05067309|Hormone Antagonists|hormone antagonists|mesh-ancestor
111082257|NCT05067309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111082258|NCT05067309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111082259|NCT02474563|Prednisone|prednisone|mesh-list
111082260|NCT02474563|Bortezomib|bortezomib|mesh-list
111082261|NCT02474563|Melphalan|melphalan|mesh-list
111082262|NCT02474563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111082263|NCT02474563|Glucocorticoids|glucocorticoids|mesh-ancestor
111082264|NCT02474563|Hormones|hormones|mesh-ancestor
111082265|NCT02474563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111082266|NCT02474563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111082267|NCT02474563|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111082268|NCT02474563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111082269|NCT02474563|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111082270|NCT02474563|Alkylating Agents|alkylating agents|mesh-ancestor
111082271|NCT02474563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111082272|NCT02474563|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111082273|NCT02474563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111082274|NCT02474563|Immunologic Factors|immunologic factors|mesh-ancestor
111082275|NCT02477995|Vaccines|vaccines|mesh-list
111082276|NCT02477995|Immunologic Factors|immunologic factors|mesh-ancestor
111082277|NCT02477995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111082278|NCT03098823|Prednisone|prednisone|mesh-list
111082279|NCT03098823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111082280|NCT03098823|Glucocorticoids|glucocorticoids|mesh-ancestor
111082281|NCT03098823|Hormones|hormones|mesh-ancestor
111082282|NCT03098823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111082283|NCT03098823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111082284|NCT03098823|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111082285|NCT03098823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111082286|NCT03108937|Dexmedetomidine|dexmedetomidine|mesh-list
111082287|NCT03108937|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111082288|NCT03108937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111082289|NCT03108937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111082290|NCT03108937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111082291|NCT03108937|Analgesics|analgesics|mesh-ancestor
111082292|NCT03108937|Sensory System Agents|sensory system agents|mesh-ancestor
111082293|NCT03108937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111082294|NCT03108937|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111082295|NCT03108937|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111082296|NCT03108937|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111082297|NCT03108937|Adrenergic Agents|adrenergic agents|mesh-ancestor
111082298|NCT03108937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111082299|NCT03108937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111082300|NCT03913845|Lidocaine|lidocaine|mesh-list
111082301|NCT03913845|Epinephrine|epinephrine|mesh-list
111082302|NCT03913845|Racepinephrine|racepinephrine|mesh-list
111082303|NCT03913845|Epinephryl borate|epinephryl borate|mesh-list
111082304|NCT03913845|Anesthetics, Local|anesthetics, local|mesh-ancestor
111082305|NCT03913845|Anesthetics|anesthetics|mesh-ancestor
111082306|NCT03913845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111082307|NCT03913845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111082308|NCT03913845|Sensory System Agents|sensory system agents|mesh-ancestor
111082309|NCT03913845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111082310|NCT03913845|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111082311|NCT03913845|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111082312|NCT03913845|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111082313|NCT03913845|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111082314|NCT03913845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111082315|NCT03913845|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111082316|NCT03913845|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111082317|NCT03913845|Adrenergic Agents|adrenergic agents|mesh-ancestor
111082318|NCT03913845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111082319|NCT03913845|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111082320|NCT03913845|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111082321|NCT03913845|Autonomic Agents|autonomic agents|mesh-ancestor
111082322|NCT03913845|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111082323|NCT03913845|Respiratory System Agents|respiratory system agents|mesh-ancestor
111082324|NCT03913845|Mydriatics|mydriatics|mesh-ancestor
111082325|NCT03913845|Sympathomimetics|sympathomimetics|mesh-ancestor
111082326|NCT03913845|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111082327|NCT00705523|Varenicline|varenicline|mesh-list
111082328|NCT00705523|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111082329|NCT00705523|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111082330|NCT00705523|Cholinergic Agents|cholinergic agents|mesh-ancestor
111082331|NCT00705523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110799440|NCT03764241|Hemostatics|hemostatics|mesh-ancestor
111082332|NCT00705523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111082333|NCT00705523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111082334|NCT03903939|Iloprost|iloprost|mesh-list
111082335|NCT03903939|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111082336|NCT03903939|Vasodilator Agents|vasodilator agents|mesh-ancestor
111082337|NCT05065905|Interferons|interferons|mesh-list
111082338|NCT05065905|Interferon-gamma|interferon-gamma|mesh-list
111082339|NCT05065905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111082340|NCT05065905|Antiviral Agents|antiviral agents|mesh-ancestor
111082341|NCT05065905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111082342|NCT02725411|Celecoxib|celecoxib|mesh-list
111082343|NCT02725411|Tanezumab|tanezumab|mesh-list
111082344|NCT02725411|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111082345|NCT02725411|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111082346|NCT02725411|Analgesics|analgesics|mesh-ancestor
111082347|NCT02725411|Sensory System Agents|sensory system agents|mesh-ancestor
111082348|NCT02725411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111082349|NCT02725411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111082350|NCT02725411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111082351|NCT02725411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111082352|NCT02725411|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111082353|NCT02725411|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111082354|NCT02725411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111082355|NCT02725411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111082356|NCT05058105|Meropenem|meropenem|mesh-list
111082357|NCT05058105|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111082358|NCT05058105|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111082359|NCT05649943|Androgens|androgens|mesh-list
111082360|NCT05649943|Hormones|hormones|mesh-ancestor
111082361|NCT05649943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111082362|NCT05649943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111082363|NCT05046015|Carbamide Peroxide|carbamide peroxide|mesh-list
111082364|NCT05046015|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111082365|NCT05046015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111082366|NCT04652557|4-Aminopyridine|4-aminopyridine|mesh-list
111082367|NCT04652557|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
111082368|NCT04652557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111082369|NCT04652557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111082370|NCT03099213|Ramipril|ramipril|mesh-list
111082371|NCT03099213|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
111082372|NCT03099213|Protease Inhibitors|protease inhibitors|mesh-ancestor
111082373|NCT03099213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111082374|NCT03099213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111082375|NCT03099213|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111082376|NCT05061147|Azacitidine|azacitidine|mesh-list
111082377|NCT05061147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111082378|NCT05061147|Antimetabolites|antimetabolites|mesh-ancestor
111082379|NCT05061147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111082380|NCT05061147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111082381|NCT05061147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111082382|NCT02127970|Dalbavancin|dalbavancin|mesh-list
111082383|NCT02127970|Teicoplanin|teicoplanin|mesh-list
111082384|NCT02127970|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111082385|NCT02127970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111082386|NCT05056389|Oxaliplatin|oxaliplatin|mesh-list
111082387|NCT05056389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111082388|NCT02471677|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
111082389|NCT02471677|Hormones|hormones|mesh-ancestor
111082390|NCT02471677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111082391|NCT02471677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111082392|NCT04755634|Hyaluronic Acid|hyaluronic acid|mesh-list
111082393|NCT04755634|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111082394|NCT04755634|Immunologic Factors|immunologic factors|mesh-ancestor
111082395|NCT04755634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111082396|NCT04755634|Viscosupplements|viscosupplements|mesh-ancestor
111082397|NCT04755634|Protective Agents|protective agents|mesh-ancestor
111082398|NCT05395507|Interferons|interferons|mesh-list
111082399|NCT05395507|Interferon-alpha|interferon-alpha|mesh-list
111082400|NCT05395507|Interferon alpha-2|interferon alpha-2|mesh-list
111082401|NCT05395507|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
111082402|NCT05395507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111082403|NCT05395507|Antiviral Agents|antiviral agents|mesh-ancestor
111082404|NCT05395507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111082405|NCT05395507|Immunologic Factors|immunologic factors|mesh-ancestor
110799510|NCT03758469|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111082406|NCT05395507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111082407|NCT04470843|Acetazolamide|acetazolamide|mesh-list
111082408|NCT04470843|Anticonvulsants|anticonvulsants|mesh-ancestor
111082409|NCT04470843|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
111082410|NCT04470843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111082411|NCT04470843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111082412|NCT04470843|Diuretics|diuretics|mesh-ancestor
111082413|NCT04470843|Natriuretic Agents|natriuretic agents|mesh-ancestor
111082414|NCT04470843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111082416|NCT05161741|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111082417|NCT05161741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111082418|NCT02473627|Pioglitazone|pioglitazone|mesh-list
111082419|NCT02473627|Tolbutamide|tolbutamide|mesh-list
111082420|NCT02473627|DS-1971a|ds-1971a|mesh-list
111082421|NCT02473627|Midazolam|midazolam|mesh-list
111082422|NCT02473627|Omeprazole|omeprazole|mesh-list
111082423|NCT02473627|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111082424|NCT02473627|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111082425|NCT02473627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111082426|NCT02473627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111082427|NCT02473627|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111082428|NCT02473627|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111082429|NCT02473627|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111082430|NCT02473627|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111082431|NCT02473627|Anesthetics, General|anesthetics, general|mesh-ancestor
111082432|NCT02473627|Anesthetics|anesthetics|mesh-ancestor
111082433|NCT02473627|GABA Modulators|gaba modulators|mesh-ancestor
111082434|NCT02473627|GABA Agents|gaba agents|mesh-ancestor
111082435|NCT02473627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111082436|NCT02473627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111082437|NCT02473627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111082438|NCT02473627|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111082439|NCT02473627|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111082440|NCT02473627|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111082441|NCT02473627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111082442|NCT02473627|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111082443|NCT02473627|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111082444|NCT02473627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111082445|NCT03095703|Sirolimus|sirolimus|mesh-list
111082446|NCT03095703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111082447|NCT03095703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111082448|NCT03095703|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111082449|NCT03095703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111082450|NCT03095703|Antifungal Agents|antifungal agents|mesh-ancestor
111082451|NCT03095703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111082452|NCT03095703|Immunologic Factors|immunologic factors|mesh-ancestor
111082453|NCT03095703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111082454|NCT05035953|Edaravone|edaravone|mesh-list
111082455|NCT05035953|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111082456|NCT05035953|Antioxidants|antioxidants|mesh-ancestor
111082457|NCT05035953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111082458|NCT05035953|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111082459|NCT05035953|Protective Agents|protective agents|mesh-ancestor
111082460|NCT05035953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111082461|NCT02471209|Sevoflurane|sevoflurane|mesh-list
111082462|NCT02471209|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111082463|NCT02471209|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111082464|NCT02471209|Anesthetics, General|anesthetics, general|mesh-ancestor
111082465|NCT02471209|Anesthetics|anesthetics|mesh-ancestor
111082466|NCT02471209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111082467|NCT02471209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111082468|NCT02476903|Hyaluronic Acid|hyaluronic acid|mesh-list
111082469|NCT02476903|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111082470|NCT02476903|Immunologic Factors|immunologic factors|mesh-ancestor
111082471|NCT02476903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111082472|NCT02476903|Viscosupplements|viscosupplements|mesh-ancestor
111082473|NCT02476903|Protective Agents|protective agents|mesh-ancestor
110639998|NCT00871910|Ondansetron|ondansetron|mesh-list
111082474|NCT02473237|Tiotropium Bromide|tiotropium bromide|mesh-list
111082475|NCT02473237|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111082476|NCT02473237|Autonomic Agents|autonomic agents|mesh-ancestor
111082477|NCT02473237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111082478|NCT02473237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111082479|NCT02473237|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111082480|NCT02473237|Respiratory System Agents|respiratory system agents|mesh-ancestor
111082481|NCT02473237|Parasympatholytics|parasympatholytics|mesh-ancestor
111082482|NCT02473237|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111082483|NCT02473237|Cholinergic Agents|cholinergic agents|mesh-ancestor
111082484|NCT02473237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111082485|NCT02473237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111082487|NCT04220125|Ketamine|ketamine|mesh-list
111082488|NCT04220125|Analgesics|analgesics|mesh-ancestor
111082489|NCT04220125|Sensory System Agents|sensory system agents|mesh-ancestor
111082490|NCT04220125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111082491|NCT04220125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111082492|NCT04220125|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111082493|NCT04220125|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111082494|NCT04220125|Anesthetics, General|anesthetics, general|mesh-ancestor
111082495|NCT04220125|Anesthetics|anesthetics|mesh-ancestor
111082496|NCT04220125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111082497|NCT04220125|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111082498|NCT04220125|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111082499|NCT04220125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111082500|NCT04220125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111082501|NCT04220125|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111082502|NCT04220125|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111082503|NCT04220125|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111082504|NCT04220125|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111082505|NCT04220125|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111082506|NCT04220125|GABA Modulators|gaba modulators|mesh-ancestor
111082507|NCT04220125|GABA Agents|gaba agents|mesh-ancestor
111082508|NCT02472691|Lenalidomide|lenalidomide|mesh-list
111082509|NCT02472691|Azacitidine|azacitidine|mesh-list
111082510|NCT02472691|Immunologic Factors|immunologic factors|mesh-ancestor
111082511|NCT02472691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111082512|NCT02472691|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111082513|NCT02472691|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111082514|NCT02472691|Growth Substances|growth substances|mesh-ancestor
111082515|NCT02472691|Growth Inhibitors|growth inhibitors|mesh-ancestor
111082516|NCT02472691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111082517|NCT02472691|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111082518|NCT02472691|Antimetabolites|antimetabolites|mesh-ancestor
111082519|NCT02472691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111082520|NCT02472691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111082521|NCT02470663|Calcium Carbonate|calcium carbonate|mesh-list
111082522|NCT02470663|Calcium|calcium|mesh-list
111082523|NCT02470663|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111082524|NCT02470663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111082525|NCT02470663|Antacids|antacids|mesh-ancestor
111082526|NCT02470663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111082527|NCT02470663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111082528|NCT00705367|Abatacept|abatacept|mesh-list
111082529|NCT00705367|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111082530|NCT00705367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111082531|NCT00705367|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111082532|NCT00705367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111082533|NCT00705367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111082534|NCT00705367|Immunologic Factors|immunologic factors|mesh-ancestor
111082535|NCT00705367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111082536|NCT00705367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111082538|NCT03043729|Oxaliplatin|oxaliplatin|mesh-list
111082539|NCT03043729|Aflibercept|aflibercept|mesh-list
111082540|NCT03043729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111082541|NCT03043729|Antidotes|antidotes|mesh-ancestor
111082542|NCT03043729|Protective Agents|protective agents|mesh-ancestor
111082543|NCT03043729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111082544|NCT03043729|Vitamin B Complex|vitamin b complex|mesh-ancestor
111082545|NCT03043729|Vitamins|vitamins|mesh-ancestor
111082546|NCT03043729|Micronutrients|micronutrients|mesh-ancestor
111082547|NCT03043729|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111082548|NCT03043729|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111082549|NCT03043729|Growth Substances|growth substances|mesh-ancestor
111082550|NCT03043729|Growth Inhibitors|growth inhibitors|mesh-ancestor
111082551|NCT05306431|Biguanides|biguanides|mesh-list
111082552|NCT05306431|Sodium Hypochlorite|sodium hypochlorite|mesh-list
111082553|NCT05306431|Polihexanide|polihexanide|mesh-list
111082554|NCT05306431|Eusol|eusol|mesh-list
111082555|NCT05306431|Disinfectants|disinfectants|mesh-ancestor
111082556|NCT05306431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111082557|NCT05306431|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111082558|NCT05306431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111082559|NCT03108313|Fluorides|fluorides|mesh-list
110799666|NCT03758079|Antimanic Agents|antimanic agents|mesh-ancestor
111082560|NCT03108313|Cariostatic Agents|cariostatic agents|mesh-ancestor
111082561|NCT03108313|Protective Agents|protective agents|mesh-ancestor
111082562|NCT03108313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111082564|NCT03108625|Antidepressive Agents|antidepressive agents|mesh-ancestor
111082565|NCT03108625|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111082566|NCT03108625|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111082567|NCT03108625|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111082568|NCT03108625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111082569|NCT03108625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111082570|NCT03108625|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111082571|NCT03108625|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111082572|NCT03108625|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111082573|NCT03108625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111082574|NCT03108625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111082575|NCT03108625|Serotonin Agents|serotonin agents|mesh-ancestor
111082576|NCT03108625|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111082577|NCT03108625|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111082578|NCT03108625|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111082579|NCT03108625|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111082580|NCT03310567|Pembrolizumab|pembrolizumab|mesh-list
111082581|NCT03310567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111082582|NCT03310567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111082583|NCT03310567|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111082584|NCT03310567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111082585|NCT03900949|Cytarabine|cytarabine|mesh-list
111082586|NCT03900949|Daunorubicin|daunorubicin|mesh-list
111082587|NCT03900949|Gemtuzumab|gemtuzumab|mesh-list
111082588|NCT03900949|Midostaurin|midostaurin|mesh-list
111082589|NCT03900949|Calicheamicins|calicheamicins|mesh-list
111082590|NCT03900949|Staurosporine|staurosporine|mesh-list
111082591|NCT03900949|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111082592|NCT03900949|Antimetabolites|antimetabolites|mesh-ancestor
111082593|NCT03900949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111082594|NCT03900949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111082595|NCT03900949|Antiviral Agents|antiviral agents|mesh-ancestor
111082596|NCT03900949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111082597|NCT03900949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111082598|NCT03900949|Immunologic Factors|immunologic factors|mesh-ancestor
111082599|NCT03900949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111082600|NCT03900949|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111082601|NCT03900949|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111082602|NCT03900949|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111082603|NCT03900949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111082604|NCT03900949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111082605|NCT03900949|Immunotoxins|immunotoxins|mesh-ancestor
111082606|NCT03900949|Immunoconjugates|immunoconjugates|mesh-ancestor
111082607|NCT03900949|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111082608|NCT02468791|Rituximab|rituximab|mesh-list
111082609|NCT02468791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111082610|NCT02468791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111082611|NCT02468791|Immunologic Factors|immunologic factors|mesh-ancestor
111082612|NCT02468791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110547695|NCT02736071|Tramadol|tramadol|mesh-list
111082613|NCT02468791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111082615|NCT02693821|Analgesics|analgesics|mesh-ancestor
111082616|NCT02693821|Sensory System Agents|sensory system agents|mesh-ancestor
111082617|NCT02693821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111082618|NCT02693821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111082619|NCT02693821|Anticonvulsants|anticonvulsants|mesh-ancestor
111082620|NCT02693821|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111082621|NCT02693821|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111082622|NCT02693821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111082623|NCT02693821|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111082624|NCT02693821|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111082625|NCT02693821|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111082626|NCT02693821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111082627|NCT02693821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111082628|NCT02693821|Antimanic Agents|antimanic agents|mesh-ancestor
111082629|NCT02470117|Antacids|antacids|mesh-list
111082630|NCT02470117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111082631|NCT02470117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111082632|NCT03310333|Dinoprostone|dinoprostone|mesh-list
111082633|NCT03310333|Oxytocics|oxytocics|mesh-ancestor
111082634|NCT03310333|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110799734|NCT04558125|Tinzaparin|tinzaparin|mesh-list
111082635|NCT03310333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111082637|NCT02299999|Vinorelbine|vinorelbine|mesh-list
111082638|NCT02299999|Vinblastine|vinblastine|mesh-list
111082639|NCT02299999|Docetaxel|docetaxel|mesh-list
111082640|NCT02299999|Vinca Alkaloids|vinca alkaloids|mesh-list
111082641|NCT02299999|Cyclophosphamide|cyclophosphamide|mesh-list
111082642|NCT02299999|Bevacizumab|bevacizumab|mesh-list
111082643|NCT02299999|Cisplatin|cisplatin|mesh-list
111082644|NCT02299999|Carboplatin|carboplatin|mesh-list
111082645|NCT02299999|Gemcitabine|gemcitabine|mesh-list
111082646|NCT02299999|Doxorubicin|doxorubicin|mesh-list
111082647|NCT02299999|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111082648|NCT02299999|Capecitabine|capecitabine|mesh-list
111082649|NCT02299999|Methotrexate|methotrexate|mesh-list
111082650|NCT02299999|Durvalumab|durvalumab|mesh-list
111082651|NCT02299999|Epirubicin|epirubicin|mesh-list
111082652|NCT02299999|Olaparib|olaparib|mesh-list
111082653|NCT02299999|Mitomycins|mitomycins|mesh-list
111082654|NCT02299999|Mitomycin|mitomycin|mesh-list
111082655|NCT02299999|Bicalutamide|bicalutamide|mesh-list
111082656|NCT02299999|Taxane|taxane|mesh-list
111082657|NCT02299999|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111082658|NCT02299999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111082659|NCT02299999|Tubulin Modulators|tubulin modulators|mesh-ancestor
111082660|NCT02299999|Antimitotic Agents|antimitotic agents|mesh-ancestor
111082661|NCT02299999|Mitosis Modulators|mitosis modulators|mesh-ancestor
111082662|NCT02299999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111082663|NCT02299999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111082664|NCT02299999|Immunologic Factors|immunologic factors|mesh-ancestor
111082665|NCT02299999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111082666|NCT02299999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111082667|NCT02299999|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111082668|NCT02299999|Alkylating Agents|alkylating agents|mesh-ancestor
111082669|NCT02299999|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111082670|NCT02299999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111082671|NCT02299999|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111082672|NCT02299999|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111082673|NCT02299999|Growth Substances|growth substances|mesh-ancestor
111082674|NCT02299999|Growth Inhibitors|growth inhibitors|mesh-ancestor
111082675|NCT02299999|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111082676|NCT02299999|Antimetabolites|antimetabolites|mesh-ancestor
111082677|NCT02299999|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111082678|NCT02299999|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111082679|NCT02299999|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111082680|NCT02299999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111082681|NCT02299999|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111082682|NCT02299999|Abortifacient Agents|abortifacient agents|mesh-ancestor
111082683|NCT02299999|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111082684|NCT02299999|Dermatologic Agents|dermatologic agents|mesh-ancestor
111082685|NCT02299999|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111082686|NCT02299999|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111082687|NCT02299999|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111082688|NCT02299999|Androgen Antagonists|androgen antagonists|mesh-ancestor
111082689|NCT02299999|Hormone Antagonists|hormone antagonists|mesh-ancestor
111082690|NCT02299999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111082691|NCT00705289|Infliximab|infliximab|mesh-list
111082692|NCT00705289|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111082693|NCT00705289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111082694|NCT00705289|Dermatologic Agents|dermatologic agents|mesh-ancestor
111082695|NCT00705289|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111082696|NCT00705289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111082697|NCT02263729|Losartan|losartan|mesh-list
111082698|NCT02263729|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111082699|NCT02263729|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111082700|NCT02263729|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111082701|NCT02263729|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111082702|NCT02263729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111082703|NCT03309865|Vedolizumab|vedolizumab|mesh-list
111082704|NCT03309865|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111082705|NCT02038777|Cytarabine|cytarabine|mesh-list
111082706|NCT02038777|Azacitidine|azacitidine|mesh-list
111082707|NCT02038777|Daunorubicin|daunorubicin|mesh-list
111082708|NCT02038777|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111082709|NCT02038777|Antimetabolites|antimetabolites|mesh-ancestor
111082710|NCT02038777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110799810|NCT02260336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111082711|NCT02038777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111082712|NCT02038777|Antiviral Agents|antiviral agents|mesh-ancestor
111082713|NCT02038777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111082714|NCT02038777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111082715|NCT02038777|Immunologic Factors|immunologic factors|mesh-ancestor
111082716|NCT02038777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111082717|NCT02038777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111082718|NCT02038777|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111082719|NCT02038777|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111082720|NCT02038777|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111082721|NCT03309709|Progesterone|progesterone|mesh-list
111082722|NCT03309709|Progestins|progestins|mesh-ancestor
111082723|NCT03309709|Hormones|hormones|mesh-ancestor
111082724|NCT03309709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111082725|NCT03309709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111082726|NCT01720147|Quercetin|quercetin|mesh-list
111082727|NCT01720147|Antioxidants|antioxidants|mesh-ancestor
111082728|NCT01720147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111082729|NCT01720147|Protective Agents|protective agents|mesh-ancestor
111082730|NCT01720147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111082731|NCT03309319|Rosiglitazone|rosiglitazone|mesh-list
111082732|NCT03309319|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111082733|NCT03309319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111082734|NCT03309163|Tramadol|tramadol|mesh-list
111082735|NCT03309163|Hydromorphone|hydromorphone|mesh-list
111082736|NCT03309163|Ropivacaine|ropivacaine|mesh-list
111082737|NCT03309163|Anesthetics, Local|anesthetics, local|mesh-ancestor
111082738|NCT03309163|Anesthetics|anesthetics|mesh-ancestor
111082739|NCT03309163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111082740|NCT03309163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111082741|NCT03309163|Sensory System Agents|sensory system agents|mesh-ancestor
111082742|NCT03309163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111082743|NCT03309163|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111082744|NCT03309163|Narcotics|narcotics|mesh-ancestor
111082745|NCT03309163|Analgesics|analgesics|mesh-ancestor
111082746|NCT03174847|Eplerenone|eplerenone|mesh-list
111082747|NCT03174847|Amiloride|amiloride|mesh-list
111082748|NCT03174847|Spironolactone|spironolactone|mesh-list
111082749|NCT03174847|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
111082750|NCT03174847|Mineralocorticoids|mineralocorticoids|mesh-list
111082751|NCT03174847|Hormone Antagonists|hormone antagonists|mesh-ancestor
111082752|NCT03174847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111082753|NCT03174847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111082754|NCT03174847|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
111082755|NCT03174847|Diuretics|diuretics|mesh-ancestor
111082756|NCT03174847|Natriuretic Agents|natriuretic agents|mesh-ancestor
111082757|NCT03174847|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111082758|NCT03174847|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
111082759|NCT03174847|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111082760|NCT03174847|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111082761|NCT03174847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111082762|NCT03174847|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
111082764|NCT03313531|Thrombin|thrombin|mesh-list
111082765|NCT03313531|Hemostatics|hemostatics|mesh-ancestor
111082766|NCT03313531|Coagulants|coagulants|mesh-ancestor
111082767|NCT02468167|Polidocanol|polidocanol|mesh-list
111082768|NCT02468167|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
111082769|NCT02468167|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111082770|NCT03308149|Triamcinolone|triamcinolone|mesh-list
111082771|NCT03308149|Bupivacaine|bupivacaine|mesh-list
111082772|NCT03308149|Anesthetics, Local|anesthetics, local|mesh-ancestor
111082773|NCT03308149|Anesthetics|anesthetics|mesh-ancestor
111082774|NCT03308149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111082775|NCT03308149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111082776|NCT03308149|Sensory System Agents|sensory system agents|mesh-ancestor
111082777|NCT03308149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111082778|NCT03308149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111082779|NCT03308149|Glucocorticoids|glucocorticoids|mesh-ancestor
111082780|NCT03308149|Hormones|hormones|mesh-ancestor
111082781|NCT03308149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111082782|NCT03303235|Methylergonovine|methylergonovine|mesh-list
111082783|NCT03303235|Oxytocics|oxytocics|mesh-ancestor
111082784|NCT03303235|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111082785|NCT03303235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111082786|NCT03307993|(2-(6-fluoro-1H-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|(2-(6-fluoro-1h-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|mesh-list
111082787|NCT03307993|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111082788|NCT03307993|Serotonin Agents|serotonin agents|mesh-ancestor
111082789|NCT03307993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111082790|NCT03307993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111082791|NCT03307993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111082792|NCT03302845|Omeprazole|omeprazole|mesh-list
111082793|NCT03302845|Famotidine|famotidine|mesh-list
111082794|NCT03302845|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111082795|NCT03302845|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111082796|NCT03302845|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111082797|NCT03302845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111082798|NCT03302845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111082799|NCT03302845|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
111082800|NCT03302845|Histamine Antagonists|histamine antagonists|mesh-ancestor
111082801|NCT03302845|Histamine Agents|histamine agents|mesh-ancestor
111082802|NCT03302845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111082803|NCT03302845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111082804|NCT03302689|Ropivacaine|ropivacaine|mesh-list
111082805|NCT03302689|Levobupivacaine|levobupivacaine|mesh-list
111082806|NCT03302689|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111082807|NCT03302689|Anesthetics, Local|anesthetics, local|mesh-ancestor
111082808|NCT03302689|Anesthetics|anesthetics|mesh-ancestor
111082809|NCT03302689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111082810|NCT03302689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111082811|NCT03302689|Sensory System Agents|sensory system agents|mesh-ancestor
111082812|NCT03302689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111082813|NCT03307603|Nivolumab|nivolumab|mesh-list
111082814|NCT03307603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111082815|NCT03307603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111082816|NCT03307603|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111082817|NCT03307603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111082818|NCT02468323|Ondansetron|ondansetron|mesh-list
111082819|NCT02468323|Palonosetron|palonosetron|mesh-list
111082820|NCT02468323|Antiemetics|antiemetics|mesh-ancestor
111082821|NCT02468323|Autonomic Agents|autonomic agents|mesh-ancestor
111082822|NCT02468323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111082823|NCT02468323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111082825|NCT02468323|Antipruritics|antipruritics|mesh-ancestor
111082826|NCT02468323|Dermatologic Agents|dermatologic agents|mesh-ancestor
110640030|NCT05213481|Tepotinib|tepotinib|mesh-list
111082827|NCT02468323|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111082828|NCT02468323|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111082829|NCT02468323|Serotonin Agents|serotonin agents|mesh-ancestor
111082830|NCT02468323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111082831|NCT02468323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111082832|NCT02469259|Oxytocin|oxytocin|mesh-list
111082833|NCT02469259|Oxytocics|oxytocics|mesh-ancestor
111082834|NCT02469259|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111082835|NCT02469259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111082836|NCT03307213|Sirolimus|sirolimus|mesh-list
111082837|NCT03307213|Umirolimus|umirolimus|mesh-list
111082838|NCT03307213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111082839|NCT03307213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111082840|NCT03307213|Immunologic Factors|immunologic factors|mesh-ancestor
111082841|NCT03307213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111082842|NCT03307213|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111082843|NCT03307213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111082844|NCT03307213|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111082845|NCT03307213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111082846|NCT03307213|Antifungal Agents|antifungal agents|mesh-ancestor
111082847|NCT03302299|Pyridoxine|pyridoxine|mesh-list
111082848|NCT03302299|Vitamin B 6|vitamin b 6|mesh-list
111082849|NCT03302299|Isoniazid|isoniazid|mesh-list
111082850|NCT03302299|Vitamins|vitamins|mesh-ancestor
111082851|NCT03302299|Micronutrients|micronutrients|mesh-ancestor
111082852|NCT03302299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111082853|NCT03302299|Vitamin B Complex|vitamin b complex|mesh-ancestor
111082854|NCT03302299|Antitubercular Agents|antitubercular agents|mesh-ancestor
111082855|NCT03302299|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111082856|NCT03302299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111082857|NCT03302299|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
111082858|NCT03302299|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111082859|NCT03302299|Antimetabolites|antimetabolites|mesh-ancestor
111082860|NCT03302299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111082861|NCT03302299|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111082862|NCT03302221|Ropivacaine|ropivacaine|mesh-list
111082863|NCT03302221|Anesthetics|anesthetics|mesh-ancestor
111082864|NCT03302221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111082865|NCT03302221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111082866|NCT03302221|Anesthetics, Local|anesthetics, local|mesh-ancestor
111082867|NCT03302221|Sensory System Agents|sensory system agents|mesh-ancestor
111082868|NCT03302221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111082869|NCT03302065|Tiotropium Bromide|tiotropium bromide|mesh-list
111082870|NCT03302065|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111082871|NCT03302065|Autonomic Agents|autonomic agents|mesh-ancestor
111082872|NCT03302065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111082873|NCT03302065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111082874|NCT03302065|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111082875|NCT03302065|Respiratory System Agents|respiratory system agents|mesh-ancestor
111082876|NCT03302065|Parasympatholytics|parasympatholytics|mesh-ancestor
111082877|NCT03302065|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111082878|NCT03302065|Cholinergic Agents|cholinergic agents|mesh-ancestor
111082879|NCT03302065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111082880|NCT03302065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111082881|NCT03306745|Folic Acid|folic acid|mesh-list
111082882|NCT03306745|Hematinics|hematinics|mesh-ancestor
111082883|NCT03306745|Vitamin B Complex|vitamin b complex|mesh-ancestor
111082884|NCT03306745|Vitamins|vitamins|mesh-ancestor
111082885|NCT03306745|Micronutrients|micronutrients|mesh-ancestor
111082886|NCT03306745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111082887|NCT03306667|Dotinurad|dotinurad|mesh-list
111082888|NCT03306667|Uricosuric Agents|uricosuric agents|mesh-ancestor
111082889|NCT03306667|Gout Suppressants|gout suppressants|mesh-ancestor
111082890|NCT03306667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111082891|NCT03312283|Ranibizumab|ranibizumab|mesh-list
111082892|NCT03312283|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111082893|NCT03312283|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111082894|NCT03312283|Growth Substances|growth substances|mesh-ancestor
111082895|NCT03312283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111082896|NCT03312283|Growth Inhibitors|growth inhibitors|mesh-ancestor
111082897|NCT03312283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111082898|NCT03301285|Zoledronic Acid|zoledronic acid|mesh-list
111082899|NCT03301285|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111082901|NCT03301207|Midazolam|midazolam|mesh-list
111082902|NCT03301207|Bupropion|bupropion|mesh-list
111082903|NCT03301207|Levonorgestrel|levonorgestrel|mesh-list
111082904|NCT03301207|Ethinyl Estradiol|ethinyl estradiol|mesh-list
111082905|NCT03301207|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
111082906|NCT03301207|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111082907|NCT03301207|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111082908|NCT03301207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111082909|NCT03301207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111082910|NCT03301207|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111082911|NCT03301207|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111082912|NCT03301207|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111082913|NCT03301207|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111082914|NCT03301207|Anesthetics, General|anesthetics, general|mesh-ancestor
111082915|NCT03301207|Anesthetics|anesthetics|mesh-ancestor
111082916|NCT03301207|GABA Modulators|gaba modulators|mesh-ancestor
111082917|NCT03301207|GABA Agents|gaba agents|mesh-ancestor
111082918|NCT03301207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111082919|NCT03301207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111082920|NCT03301207|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111082921|NCT03301207|Antidepressive Agents|antidepressive agents|mesh-ancestor
111082922|NCT03301207|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111082923|NCT03301207|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111082924|NCT03301207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111082925|NCT03301207|Dopamine Agents|dopamine agents|mesh-ancestor
111082926|NCT03301207|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111082927|NCT03301207|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111082928|NCT03301207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111082929|NCT03301207|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111082930|NCT03301207|Contraceptive Agents|contraceptive agents|mesh-ancestor
111082931|NCT03301207|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111082932|NCT03301207|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111082933|NCT03301207|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111082934|NCT03301207|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111082935|NCT03301207|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111082936|NCT03301207|Estrogens|estrogens|mesh-ancestor
111082937|NCT03301207|Hormones|hormones|mesh-ancestor
111082938|NCT03301207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111082939|NCT03301207|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
111082940|NCT03311971|Methamphetamine|methamphetamine|mesh-list
111082941|NCT03311971|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111082942|NCT03311971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111082943|NCT03311971|Sympathomimetics|sympathomimetics|mesh-ancestor
111082944|NCT03311971|Autonomic Agents|autonomic agents|mesh-ancestor
111082945|NCT03311971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111082946|NCT03311971|Dopamine Agents|dopamine agents|mesh-ancestor
111082947|NCT03311971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111082948|NCT03311971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111082949|NCT03311971|Adrenergic Agents|adrenergic agents|mesh-ancestor
111082950|NCT03311971|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111082951|NCT03311971|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111082952|NCT03311971|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111082953|NCT03311971|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111082954|NCT03311737|Anesthetics|anesthetics|mesh-list
111082955|NCT03311737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111082956|NCT03311737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111082957|NCT02467543|Ethanol|ethanol|mesh-list
111082958|NCT02467543|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111082959|NCT02467543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111082960|NCT02467543|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111082961|NCT02467543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111082962|NCT03311581|Propofol|propofol|mesh-list
111082963|NCT03311581|Sevoflurane|sevoflurane|mesh-list
111082964|NCT03311581|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111082965|NCT03311581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111082966|NCT03311581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111082967|NCT03311581|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111082968|NCT03311581|Anesthetics, General|anesthetics, general|mesh-ancestor
111082969|NCT03311581|Anesthetics|anesthetics|mesh-ancestor
111082970|NCT03311581|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111082971|NCT03311581|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111082972|NCT03311425|Dexamethasone|dexamethasone|mesh-list
111082973|NCT03311425|Methylprednisolone|methylprednisolone|mesh-list
111082974|NCT03311425|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111082975|NCT03311425|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111082976|NCT03311425|Prednisolone|prednisolone|mesh-list
111082977|NCT03311425|Prednisolone acetate|prednisolone acetate|mesh-list
111082978|NCT03311425|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111082979|NCT03311425|Prednisolone phosphate|prednisolone phosphate|mesh-list
111082980|NCT03311425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111082981|NCT03311425|Antiemetics|antiemetics|mesh-ancestor
111082982|NCT03311425|Autonomic Agents|autonomic agents|mesh-ancestor
111082983|NCT03311425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111082984|NCT03311425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111082985|NCT03311425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111082986|NCT03311425|Glucocorticoids|glucocorticoids|mesh-ancestor
111082987|NCT03311425|Hormones|hormones|mesh-ancestor
111082988|NCT03311425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111082989|NCT03311425|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111082990|NCT03311425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111082991|NCT03311425|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111082992|NCT03311425|Protective Agents|protective agents|mesh-ancestor
111082993|NCT03305263|Hydroxychloroquine|hydroxychloroquine|mesh-list
111082994|NCT03305263|Antimalarials|antimalarials|mesh-ancestor
111082995|NCT03305263|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111082996|NCT03305263|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111082997|NCT03305263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111082998|NCT03305263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111082999|NCT03305263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111083000|NCT03305263|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111083001|NCT03300115|Abivertinib|abivertinib|mesh-list
111083002|NCT03300115|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111083003|NCT03300115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111083004|NCT03300115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111083005|NCT02916979|Methotrexate|methotrexate|mesh-list
111083006|NCT02916979|Fludarabine|fludarabine|mesh-list
111083007|NCT02916979|Busulfan|busulfan|mesh-list
111083008|NCT02916979|Thymoglobulin|thymoglobulin|mesh-list
111083009|NCT02916979|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111083010|NCT02916979|Abortifacient Agents|abortifacient agents|mesh-ancestor
111083011|NCT02916979|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111083012|NCT02916979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111083013|NCT02916979|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110800113|NCT02079298|Analgesics|analgesics|mesh-ancestor
111083014|NCT02916979|Antimetabolites|antimetabolites|mesh-ancestor
111083015|NCT02916979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111083016|NCT02916979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111083017|NCT02916979|Dermatologic Agents|dermatologic agents|mesh-ancestor
111083018|NCT02916979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111083019|NCT02916979|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111083020|NCT02916979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111083021|NCT02916979|Immunologic Factors|immunologic factors|mesh-ancestor
111083022|NCT02916979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111083023|NCT02916979|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111083024|NCT02916979|Alkylating Agents|alkylating agents|mesh-ancestor
111083025|NCT02916979|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111083026|NCT02916979|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111083027|NCT00702949|Pregabalin|pregabalin|mesh-list
111083028|NCT00702949|Analgesics|analgesics|mesh-ancestor
111083029|NCT00702949|Sensory System Agents|sensory system agents|mesh-ancestor
111083030|NCT00702949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111083031|NCT00702949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111083032|NCT00702949|Anticonvulsants|anticonvulsants|mesh-ancestor
111083033|NCT00702949|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111083034|NCT00702949|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111083035|NCT00702949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111083036|NCT00702949|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111083037|NCT00702949|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111083038|NCT00702949|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110677226|NCT02177578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111083039|NCT00702949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111083041|NCT04791475|Dexamethasone|dexamethasone|mesh-list
111083042|NCT04791475|Dexmedetomidine|dexmedetomidine|mesh-list
111083043|NCT04791475|Bupivacaine|bupivacaine|mesh-list
111083044|NCT04791475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111083045|NCT04791475|Antiemetics|antiemetics|mesh-ancestor
111083046|NCT04791475|Autonomic Agents|autonomic agents|mesh-ancestor
111083047|NCT04791475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111083048|NCT04791475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111083049|NCT04791475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111083050|NCT04791475|Glucocorticoids|glucocorticoids|mesh-ancestor
111083051|NCT04791475|Hormones|hormones|mesh-ancestor
111083052|NCT04791475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111083053|NCT04791475|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111083054|NCT04791475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111083055|NCT04791475|Anesthetics, Local|anesthetics, local|mesh-ancestor
111083056|NCT04791475|Anesthetics|anesthetics|mesh-ancestor
111083057|NCT04791475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111083058|NCT04791475|Sensory System Agents|sensory system agents|mesh-ancestor
111083059|NCT04791475|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111083060|NCT04791475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111083061|NCT04791475|Analgesics|analgesics|mesh-ancestor
111083062|NCT04791475|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111083063|NCT04791475|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111083064|NCT04791475|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111083065|NCT04791475|Adrenergic Agents|adrenergic agents|mesh-ancestor
111083066|NCT04791475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111083067|NCT04791475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111083068|NCT03299725|Bismuth|bismuth|mesh-list
111083069|NCT03299725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111083070|NCT03299725|Antacids|antacids|mesh-ancestor
111083071|NCT03299725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111083072|NCT02466997|Tacrolimus|tacrolimus|mesh-list
111083073|NCT02466997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111083074|NCT02466997|Immunologic Factors|immunologic factors|mesh-ancestor
111083075|NCT02466997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111083076|NCT02466997|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111083077|NCT02466997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111083078|NCT02466997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111083079|NCT04939909|Botulinum Toxins|botulinum toxins|mesh-list
111083080|NCT04939909|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111083081|NCT04939909|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111083082|NCT04939909|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111083083|NCT04939909|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111083084|NCT04939909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111083085|NCT04939909|Cholinergic Agents|cholinergic agents|mesh-ancestor
111083086|NCT04939909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111083087|NCT04939909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111083088|NCT04939909|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111083089|NCT04939909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111083090|NCT03299257|Donepezil|donepezil|mesh-list
111083091|NCT03299257|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111083092|NCT03299257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111083093|NCT03299257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111083094|NCT03299257|Cholinergic Agents|cholinergic agents|mesh-ancestor
111083095|NCT03299257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111083096|NCT03299257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111083097|NCT03299257|Nootropic Agents|nootropic agents|mesh-ancestor
111083098|NCT02466373|Clonidine|clonidine|mesh-list
111083099|NCT02466373|Analgesics|analgesics|mesh-ancestor
111083100|NCT02466373|Sensory System Agents|sensory system agents|mesh-ancestor
111083101|NCT02466373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111083102|NCT02466373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111083103|NCT02466373|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111083104|NCT02466373|Sympatholytics|sympatholytics|mesh-ancestor
111083105|NCT02466373|Autonomic Agents|autonomic agents|mesh-ancestor
111083106|NCT02466373|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111083107|NCT02466373|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111083108|NCT02466373|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111083109|NCT02466373|Adrenergic Agents|adrenergic agents|mesh-ancestor
111083110|NCT02466373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111083111|NCT02466373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111083112|NCT02466919|Amoxicillin|amoxicillin|mesh-list
111083114|NCT02466919|Clarithromycin|clarithromycin|mesh-list
111083115|NCT02466919|Levofloxacin|levofloxacin|mesh-list
111083116|NCT02466919|Pantoprazole|pantoprazole|mesh-list
111083117|NCT02466919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111083118|NCT02466919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111083119|NCT02466919|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111083120|NCT02466919|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111083121|NCT02466919|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111083122|NCT02466919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111083123|NCT02466919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111083124|NCT02466919|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111083125|NCT02466919|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111083126|NCT02466919|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111083127|NCT02466919|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111083128|NCT02466919|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111083129|NCT02466919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111083130|NCT02466919|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111083131|NCT02466919|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111083132|NCT02466919|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111083133|NCT02466919|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111083134|NCT05727163|Leucovorin|leucovorin|mesh-list
111083135|NCT05727163|Dexamethasone|dexamethasone|mesh-list
111083136|NCT05727163|Anisodamine|anisodamine|mesh-list
111083137|NCT05727163|Bevacizumab|bevacizumab|mesh-list
111083138|NCT05727163|Fluorouracil|fluorouracil|mesh-list
111083139|NCT05727163|Oxaliplatin|oxaliplatin|mesh-list
111083140|NCT05727163|Irinotecan|irinotecan|mesh-list
111083141|NCT05727163|Levoleucovorin|levoleucovorin|mesh-list
111083142|NCT05727163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111083143|NCT05727163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111083144|NCT05727163|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111083145|NCT05727163|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111083146|NCT05727163|Growth Substances|growth substances|mesh-ancestor
111083147|NCT05727163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111083148|NCT05727163|Growth Inhibitors|growth inhibitors|mesh-ancestor
111083149|NCT05727163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111083150|NCT05727163|Antiemetics|antiemetics|mesh-ancestor
111083151|NCT05727163|Autonomic Agents|autonomic agents|mesh-ancestor
111083152|NCT05727163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111083153|NCT05727163|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111083154|NCT05727163|Glucocorticoids|glucocorticoids|mesh-ancestor
111083155|NCT05727163|Hormones|hormones|mesh-ancestor
111083156|NCT05727163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111083157|NCT05727163|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111083158|NCT05727163|Antimetabolites|antimetabolites|mesh-ancestor
110640079|NCT03892707|Hematinics|hematinics|mesh-ancestor
111083159|NCT05727163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111083160|NCT05727163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111083161|NCT05727163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111083162|NCT05727163|Immunologic Factors|immunologic factors|mesh-ancestor
111083163|NCT05727163|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111083164|NCT05727163|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111083165|NCT05727163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111083166|NCT05727163|Antidotes|antidotes|mesh-ancestor
111083167|NCT05727163|Protective Agents|protective agents|mesh-ancestor
111083168|NCT05727163|Vitamin B Complex|vitamin b complex|mesh-ancestor
111083169|NCT05727163|Vitamins|vitamins|mesh-ancestor
111083170|NCT05727163|Micronutrients|micronutrients|mesh-ancestor
111083171|NCT05727163|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111083172|NCT05727163|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111083173|NCT05727163|Adrenergic Agents|adrenergic agents|mesh-ancestor
111083174|NCT05727163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111083175|NCT05727163|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111083176|NCT05727163|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111083177|NCT05727163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111083178|NCT05727163|Analgesics|analgesics|mesh-ancestor
111083179|NCT05727163|Sensory System Agents|sensory system agents|mesh-ancestor
111083180|NCT05727163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111083181|NCT05727163|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111083182|NCT05727163|Parasympatholytics|parasympatholytics|mesh-ancestor
111083183|NCT05727163|Vasodilator Agents|vasodilator agents|mesh-ancestor
111083184|NCT05727163|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111083185|NCT05727163|Antioxidants|antioxidants|mesh-ancestor
111083186|NCT05259709|Cemiplimab|cemiplimab|mesh-list
111083187|NCT05259709|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111083188|NCT05259709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111083189|NCT05302531|Amoxicillin|amoxicillin|mesh-list
111083190|NCT05302531|Levofloxacin|levofloxacin|mesh-list
111083191|NCT05302531|Ofloxacin|ofloxacin|mesh-list
111083192|NCT05302531|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
111083193|NCT05302531|Trimethoprim|trimethoprim|mesh-list
111083194|NCT05302531|Sulfamethoxazole|sulfamethoxazole|mesh-list
111083195|NCT05302531|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111083196|NCT05302531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111083197|NCT05302531|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111083198|NCT05302531|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111083199|NCT05302531|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111083200|NCT05302531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111083201|NCT05302531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111083202|NCT05302531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111083203|NCT05302531|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111083204|NCT05302531|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111083205|NCT05302531|Antimalarials|antimalarials|mesh-ancestor
111083206|NCT05302531|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111083207|NCT05302531|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111083208|NCT05302531|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111083209|NCT05302531|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111083210|NCT05302531|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
111083211|NCT00702403|Imatinib Mesylate|imatinib mesylate|mesh-list
111083212|NCT00702403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111083213|NCT00702403|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111083214|NCT00702403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111083215|NCT00702403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111083216|NCT00702325|Budesonide|budesonide|mesh-list
111083217|NCT00702325|Formoterol Fumarate|formoterol fumarate|mesh-list
111083218|NCT00702325|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
111083219|NCT00702325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111083220|NCT00702325|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111083221|NCT00702325|Autonomic Agents|autonomic agents|mesh-ancestor
111083222|NCT00702325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111083223|NCT00702325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111083224|NCT00702325|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111083225|NCT00702325|Respiratory System Agents|respiratory system agents|mesh-ancestor
111083226|NCT00702325|Glucocorticoids|glucocorticoids|mesh-ancestor
111083227|NCT00702325|Hormones|hormones|mesh-ancestor
111083228|NCT00702325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111083229|NCT00702325|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111083230|NCT00702325|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111083231|NCT00702325|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111083232|NCT00702325|Adrenergic Agents|adrenergic agents|mesh-ancestor
111083233|NCT00702325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111083234|NCT00702325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111083235|NCT02719171|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111083236|NCT02719171|Immunologic Factors|immunologic factors|mesh-ancestor
111083237|NCT02719171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111083238|NCT02464813|Pregabalin|pregabalin|mesh-list
111083239|NCT02464813|Oxycodone|oxycodone|mesh-list
110800343|NCT04940338|Analgesics|analgesics|mesh-ancestor
111083240|NCT02464813|Analgesics|analgesics|mesh-ancestor
111083241|NCT02464813|Sensory System Agents|sensory system agents|mesh-ancestor
111083242|NCT02464813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111083243|NCT02464813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111083244|NCT02464813|Anticonvulsants|anticonvulsants|mesh-ancestor
111083245|NCT02464813|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111083246|NCT02464813|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111083247|NCT02464813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111083248|NCT02464813|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111083249|NCT02464813|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111083250|NCT02464813|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111083251|NCT02464813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111083252|NCT02464813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111083253|NCT02464813|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111083254|NCT02464813|Narcotics|narcotics|mesh-ancestor
111083255|NCT05726929|Capsaicin|capsaicin|mesh-list
111083256|NCT05726929|Antipruritics|antipruritics|mesh-ancestor
111083257|NCT05726929|Dermatologic Agents|dermatologic agents|mesh-ancestor
111083258|NCT05726929|Sensory System Agents|sensory system agents|mesh-ancestor
111083259|NCT05726929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110677232|NCT02166463|Prednisolone acetate|prednisolone acetate|mesh-list
111083260|NCT05726929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111083261|NCT05122351|Acetaminophen|acetaminophen|mesh-list
111083262|NCT05122351|Bupivacaine|bupivacaine|mesh-list
111083263|NCT05122351|Anesthetics, Local|anesthetics, local|mesh-ancestor
111083264|NCT05122351|Anesthetics|anesthetics|mesh-ancestor
111083265|NCT05122351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111083266|NCT05122351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111083267|NCT05122351|Sensory System Agents|sensory system agents|mesh-ancestor
111083268|NCT05122351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111083269|NCT05122351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111083270|NCT05122351|Analgesics|analgesics|mesh-ancestor
111083271|NCT05122351|Antipyretics|antipyretics|mesh-ancestor
111083272|NCT02464501|Paclitaxel|paclitaxel|mesh-list
111083273|NCT02464501|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111083274|NCT02464501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111083275|NCT02464501|Tubulin Modulators|tubulin modulators|mesh-ancestor
111083276|NCT02464501|Antimitotic Agents|antimitotic agents|mesh-ancestor
111083277|NCT02464501|Mitosis Modulators|mitosis modulators|mesh-ancestor
111083278|NCT02464501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111083279|NCT02465827|Ropivacaine|ropivacaine|mesh-list
111083280|NCT02465827|Anesthetics, Local|anesthetics, local|mesh-ancestor
111083281|NCT02465827|Anesthetics|anesthetics|mesh-ancestor
111083282|NCT02465827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111083283|NCT02465827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111083284|NCT02465827|Sensory System Agents|sensory system agents|mesh-ancestor
111083285|NCT02465827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111083286|NCT04368403|Brodalumab|brodalumab|mesh-list
111083287|NCT04368403|Dermatologic Agents|dermatologic agents|mesh-ancestor
111083288|NCT04298203|Topiramate|topiramate|mesh-list
111083289|NCT04298203|Phentermine|phentermine|mesh-list
111083290|NCT04298203|Anticonvulsants|anticonvulsants|mesh-ancestor
111083291|NCT04298203|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111083292|NCT04298203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111083293|NCT04298203|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111083294|NCT04298203|Appetite Depressants|appetite depressants|mesh-ancestor
111083295|NCT04298203|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111083296|NCT04298203|Sympathomimetics|sympathomimetics|mesh-ancestor
111083297|NCT04298203|Autonomic Agents|autonomic agents|mesh-ancestor
111083298|NCT04298203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111083299|NCT04298203|Adrenergic Agents|adrenergic agents|mesh-ancestor
111083300|NCT04298203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111083301|NCT04298203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111083302|NCT05679661|Chlorhexidine|chlorhexidine|mesh-list
111083303|NCT05679661|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111083304|NCT05679661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111083305|NCT05679661|Disinfectants|disinfectants|mesh-ancestor
111083306|NCT02465983|Cyclophosphamide|cyclophosphamide|mesh-list
111083307|NCT02465983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111083308|NCT02465983|Immunologic Factors|immunologic factors|mesh-ancestor
111083309|NCT02465983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111083310|NCT02465983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111083311|NCT02465983|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111083312|NCT02465983|Alkylating Agents|alkylating agents|mesh-ancestor
111083313|NCT02465983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111083314|NCT02465983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111083315|NCT02465983|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111083316|NCT02465749|Vitamins|vitamins|mesh-list
111083317|NCT02465749|Micronutrients|micronutrients|mesh-ancestor
111083318|NCT02465749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111083319|NCT00701779|Tamsulosin|tamsulosin|mesh-list
111083320|NCT00701779|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111083321|NCT00701779|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111083322|NCT00701779|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111083323|NCT00701779|Adrenergic Agents|adrenergic agents|mesh-ancestor
111083324|NCT00701779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111083325|NCT00701779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111083326|NCT00701779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111083327|NCT00701779|Urological Agents|urological agents|mesh-ancestor
111083328|NCT02463643|Rabeprazole|rabeprazole|mesh-list
111083329|NCT02463643|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111083330|NCT02463643|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111083331|NCT02463643|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111083332|NCT02463643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111083333|NCT02463643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110548424|NCT00722098|Vaccines|vaccines|mesh-list
111083334|NCT04913467|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
111083335|NCT04150861|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
111083336|NCT04150861|Hormones|hormones|mesh-ancestor
111083337|NCT04150861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111083338|NCT04150861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111083339|NCT02465359|Immunoglobulins|immunoglobulins|mesh-list
111083340|NCT02465359|Antibodies|antibodies|mesh-list
111083341|NCT02465359|gamma-Globulins|gamma-globulins|mesh-list
111083342|NCT02465359|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111083343|NCT02465359|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
111083344|NCT02465359|Immunologic Factors|immunologic factors|mesh-ancestor
111083345|NCT02465359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111083346|NCT02463019|Tenofovir|tenofovir|mesh-list
111083347|NCT02463019|Antiviral Agents|antiviral agents|mesh-ancestor
111083348|NCT02463019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111083349|NCT02463019|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111083350|NCT02463019|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111083351|NCT02463019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111083352|NCT02463019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111083353|NCT02463019|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111083354|NCT02463019|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111083355|NCT02462941|Adenosine|adenosine|mesh-list
111083356|NCT02462941|Analgesics|analgesics|mesh-ancestor
111083357|NCT02462941|Sensory System Agents|sensory system agents|mesh-ancestor
111083358|NCT02462941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111083359|NCT02462941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111083360|NCT02462941|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111083361|NCT02462941|Vasodilator Agents|vasodilator agents|mesh-ancestor
111083362|NCT02462941|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
111083363|NCT02462941|Purinergic Agonists|purinergic agonists|mesh-ancestor
111083364|NCT02462941|Purinergic Agents|purinergic agents|mesh-ancestor
111083365|NCT02462941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111083366|NCT02462941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111083367|NCT02462707|Nirogacestat|nirogacestat|mesh-list
111083368|NCT02462707|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
111083369|NCT02462707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111083370|NCT02462707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111083371|NCT02463175|Plasma-lyte 148|plasma-lyte 148|mesh-list
111083372|NCT02463175|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
111083373|NCT02463175|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111083374|NCT03297073|Acetaminophen|acetaminophen|mesh-list
111083375|NCT03297073|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111083376|NCT03297073|Analgesics|analgesics|mesh-ancestor
111083377|NCT03297073|Sensory System Agents|sensory system agents|mesh-ancestor
111083378|NCT03297073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111083379|NCT03297073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111083380|NCT03297073|Antipyretics|antipyretics|mesh-ancestor
111083381|NCT02462317|Baclofen|baclofen|mesh-list
111083382|NCT02462317|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111083383|NCT02462317|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111083384|NCT02462317|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
111083385|NCT02462317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111083386|NCT02462317|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111083387|NCT02462317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111083388|NCT02462317|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
111083389|NCT02462317|GABA Agonists|gaba agonists|mesh-ancestor
111083390|NCT02462317|GABA Agents|gaba agents|mesh-ancestor
111083391|NCT02462317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111083392|NCT02462317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111083393|NCT02462317|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111083394|NCT02462317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111083395|NCT02462317|Cholinergic Agents|cholinergic agents|mesh-ancestor
111083396|NCT02461069|Dimethyl Fumarate|dimethyl fumarate|mesh-list
111083397|NCT02461069|Dermatologic Agents|dermatologic agents|mesh-ancestor
111083398|NCT02461069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111083399|NCT02461069|Immunologic Factors|immunologic factors|mesh-ancestor
111083400|NCT02461069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111083401|NCT03332095|Tenofovir|tenofovir|mesh-list
111083402|NCT03332095|Lamivudine|lamivudine|mesh-list
111083403|NCT03332095|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
111083404|NCT03332095|Antiviral Agents|antiviral agents|mesh-ancestor
110640131|NCT00872378|Exenatide|exenatide|mesh-list
111083405|NCT03332095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111083406|NCT03332095|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111083407|NCT03332095|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111083409|NCT03332095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111083410|NCT03332095|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111083411|NCT04489381|Nitazoxanide|nitazoxanide|mesh-list
111083412|NCT04489381|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111083413|NCT04489381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111083414|NCT04489849|Apixaban|apixaban|mesh-list
111083415|NCT04489849|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111083416|NCT04489849|Antithrombins|antithrombins|mesh-ancestor
111083417|NCT04489849|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111083418|NCT04489849|Protease Inhibitors|protease inhibitors|mesh-ancestor
111083419|NCT04489849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111083420|NCT04489849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111083421|NCT04489849|Anticoagulants|anticoagulants|mesh-ancestor
111083422|NCT04488367|Tranexamic Acid|tranexamic acid|mesh-list
111083423|NCT04488367|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111083424|NCT04488367|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111083425|NCT04488367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111083426|NCT04488367|Hemostatics|hemostatics|mesh-ancestor
111083427|NCT04488367|Coagulants|coagulants|mesh-ancestor
111083428|NCT03734653|Testosterone|testosterone|mesh-list
111083429|NCT03734653|Androgens|androgens|mesh-ancestor
111083430|NCT03734653|Hormones|hormones|mesh-ancestor
111083431|NCT03734653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111083432|NCT03734653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111083433|NCT04489459|Meropenem|meropenem|mesh-list
111083434|NCT04489459|Colistin|colistin|mesh-list
111083435|NCT04489459|Tigecycline|tigecycline|mesh-list
111083436|NCT04489459|Polymyxins|polymyxins|mesh-list
111083437|NCT04489459|Polymyxin B|polymyxin b|mesh-list
111083438|NCT04489459|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111083439|NCT04489459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111083440|NCT04489459|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111083441|NCT04489459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111083442|NCT04489459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111083443|NCT03296137|Aldesleukin|aldesleukin|mesh-list
111083444|NCT03296137|Cyclophosphamide|cyclophosphamide|mesh-list
111083445|NCT03296137|Nivolumab|nivolumab|mesh-list
111083446|NCT03296137|Ipilimumab|ipilimumab|mesh-list
111083447|NCT03296137|Fludarabine phosphate|fludarabine phosphate|mesh-list
111083448|NCT03296137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111083449|NCT03296137|Immunologic Factors|immunologic factors|mesh-ancestor
111083450|NCT03296137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111083451|NCT03296137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111083452|NCT03296137|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111083453|NCT03296137|Alkylating Agents|alkylating agents|mesh-ancestor
111083454|NCT03296137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111083455|NCT03296137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111083456|NCT03296137|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111083457|NCT03296137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111083458|NCT03296137|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111083459|NCT03296137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111083460|NCT03296137|Antimetabolites|antimetabolites|mesh-ancestor
111083461|NCT03296137|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111083462|NCT03296137|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111083463|NCT03296137|Antiviral Agents|antiviral agents|mesh-ancestor
111083464|NCT03296137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111083465|NCT03295903|Cannabidiol|cannabidiol|mesh-list
110800570|NCT02082496|Hormones|hormones|mesh-ancestor
111083466|NCT03295903|Anticonvulsants|anticonvulsants|mesh-ancestor
111083467|NCT02460913|Morphine|morphine|mesh-list
111083468|NCT02460913|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111083469|NCT02460913|Narcotics|narcotics|mesh-ancestor
111083470|NCT02460913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111083471|NCT02460913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111083472|NCT02460913|Analgesics|analgesics|mesh-ancestor
111083473|NCT02460913|Sensory System Agents|sensory system agents|mesh-ancestor
111083474|NCT02460913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111083475|NCT02973997|Pembrolizumab|pembrolizumab|mesh-list
111083476|NCT02973997|Lenvatinib|lenvatinib|mesh-list
111083477|NCT02973997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111083478|NCT02973997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111083479|NCT02973997|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111083480|NCT02973997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111083481|NCT02973997|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111083482|NCT02973997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111083484|NCT03295825|Anticoagulants|anticoagulants|mesh-ancestor
111083485|NCT03295825|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111083486|NCT03295825|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111083487|NCT03295825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111083488|NCT03290365|Hyaluronic Acid|hyaluronic acid|mesh-list
111083489|NCT03290365|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111083490|NCT03290365|Immunologic Factors|immunologic factors|mesh-ancestor
111083491|NCT03290365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111083492|NCT03290365|Viscosupplements|viscosupplements|mesh-ancestor
111083493|NCT03290365|Protective Agents|protective agents|mesh-ancestor
111083494|NCT02764489|Thrombin|thrombin|mesh-list
111083495|NCT02764489|Anti-inhibitor coagulant complex|anti-inhibitor coagulant complex|mesh-list
111083496|NCT02764489|Coagulants|coagulants|mesh-list
111083497|NCT02764489|Hemostatics|hemostatics|mesh-ancestor
111083498|NCT02462161|Insulin|insulin|mesh-list
111083499|NCT02462161|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111083500|NCT02462161|Insulin Aspart|insulin aspart|mesh-list
111083501|NCT02462161|Insulin, Long-Acting|insulin, long-acting|mesh-list
111083502|NCT02462161|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
111083503|NCT02462161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111083504|NCT02462161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111083505|NCT03289819|Paclitaxel|paclitaxel|mesh-list
111083506|NCT03289819|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111083507|NCT03289819|Cyclophosphamide|cyclophosphamide|mesh-list
111083508|NCT03289819|Pembrolizumab|pembrolizumab|mesh-list
111083509|NCT03289819|Epirubicin|epirubicin|mesh-list
111083510|NCT03289819|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111083511|NCT03289819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111083512|NCT03289819|Tubulin Modulators|tubulin modulators|mesh-ancestor
111083513|NCT03289819|Antimitotic Agents|antimitotic agents|mesh-ancestor
111083514|NCT03289819|Mitosis Modulators|mitosis modulators|mesh-ancestor
111083515|NCT03289819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111083516|NCT03289819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111083517|NCT03289819|Immunologic Factors|immunologic factors|mesh-ancestor
111083518|NCT03289819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111083519|NCT03289819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111083520|NCT03289819|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111083521|NCT03289819|Alkylating Agents|alkylating agents|mesh-ancestor
111083522|NCT03289819|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111083523|NCT03289819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111083524|NCT03289819|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111083525|NCT03289819|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111083526|NCT03289819|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111083527|NCT03289819|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111083528|NCT03289819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111083529|NCT02001623|Tisotumab vedotin|tisotumab vedotin|mesh-list
111083530|NCT02001623|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111083531|NCT02001623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111083532|NCT02713867|Nivolumab|nivolumab|mesh-list
111083533|NCT02713867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111083534|NCT02713867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111083535|NCT02713867|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111083536|NCT02713867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111083537|NCT03372785|Aspirin|aspirin|mesh-list
111083538|NCT03372785|Metoprolol|metoprolol|mesh-list
111083539|NCT03372785|Clopidogrel|clopidogrel|mesh-list
111083540|NCT03372785|Ticagrelor|ticagrelor|mesh-list
111083541|NCT03372785|Atorvastatin|atorvastatin|mesh-list
111083542|NCT03372785|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111083543|NCT03372785|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111083544|NCT03372785|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111083545|NCT03372785|Analgesics|analgesics|mesh-ancestor
111083546|NCT03372785|Sensory System Agents|sensory system agents|mesh-ancestor
111083547|NCT03372785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111083548|NCT03372785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111083549|NCT03372785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111083550|NCT03372785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111083551|NCT03372785|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111083552|NCT03372785|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111083553|NCT03372785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111083554|NCT03372785|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111083555|NCT03372785|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111083556|NCT03372785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111083557|NCT03372785|Antipyretics|antipyretics|mesh-ancestor
111083558|NCT03372785|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111083559|NCT03372785|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111083560|NCT03372785|Antimetabolites|antimetabolites|mesh-ancestor
111083561|NCT03372785|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111083562|NCT03372785|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111083563|NCT03372785|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111083564|NCT03372785|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111083565|NCT03372785|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111083566|NCT03372785|Purinergic Agents|purinergic agents|mesh-ancestor
111083567|NCT03372785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111083568|NCT03372785|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111083569|NCT03372785|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111083570|NCT03372785|Sympatholytics|sympatholytics|mesh-ancestor
111083571|NCT03372785|Autonomic Agents|autonomic agents|mesh-ancestor
111083572|NCT03372785|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
111083573|NCT03372785|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111083574|NCT03372785|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111083575|NCT03372785|Adrenergic Agents|adrenergic agents|mesh-ancestor
111083577|NCT03372473|Montelukast|montelukast|mesh-list
111083578|NCT03372473|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111083579|NCT03372473|Respiratory System Agents|respiratory system agents|mesh-ancestor
111083580|NCT03372473|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
111083581|NCT03372473|Hormone Antagonists|hormone antagonists|mesh-ancestor
111083582|NCT03372473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111083583|NCT03372473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111083584|NCT03372473|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
111083585|NCT03372473|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111083586|NCT03372473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111083587|NCT03372473|Antipruritics|antipruritics|mesh-ancestor
111083588|NCT03372473|Dermatologic Agents|dermatologic agents|mesh-ancestor
111083589|NCT03372473|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111083590|NCT03372473|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
111083591|NCT03372473|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111083592|NCT03372473|Histamine Antagonists|histamine antagonists|mesh-ancestor
111083593|NCT03372473|Histamine Agents|histamine agents|mesh-ancestor
111083594|NCT03372473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111083595|NCT03289429|Magnesium Sulfate|magnesium sulfate|mesh-list
111083596|NCT03289429|Atorvastatin|atorvastatin|mesh-list
111083597|NCT03289429|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111083598|NCT03289429|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111083599|NCT03289429|Antimetabolites|antimetabolites|mesh-ancestor
110640159|NCT04039880|Olorofim|olorofim|mesh-list
111083600|NCT03289429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111083601|NCT03289429|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111083602|NCT03289429|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111083603|NCT03289429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111083604|NCT03289429|Analgesics|analgesics|mesh-ancestor
111083605|NCT03289429|Sensory System Agents|sensory system agents|mesh-ancestor
111083606|NCT03289429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111083607|NCT03289429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111083608|NCT03289429|Anesthetics|anesthetics|mesh-ancestor
111083609|NCT03289429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111083610|NCT03289429|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111083611|NCT03289429|Anticonvulsants|anticonvulsants|mesh-ancestor
111083612|NCT03289429|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111083613|NCT03289429|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111083614|NCT03289429|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111083615|NCT03289429|Tocolytic Agents|tocolytic agents|mesh-ancestor
111083616|NCT03289429|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111083617|NCT03372239|Tryptophan|tryptophan|mesh-list
111083618|NCT03372239|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111083619|NCT03372239|Antidepressive Agents|antidepressive agents|mesh-ancestor
111083620|NCT03372239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111083621|NCT03294967|Vitamin E|vitamin e|mesh-list
111083622|NCT03294967|Caffeine|caffeine|mesh-list
111083623|NCT03294967|Vitamins|vitamins|mesh-ancestor
111083624|NCT03294967|Micronutrients|micronutrients|mesh-ancestor
111083625|NCT03294967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111083626|NCT03294967|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111083627|NCT03294967|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111083628|NCT03294967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111083629|NCT03294967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111083630|NCT03294967|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
111083631|NCT03294967|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111083632|NCT03294967|Purinergic Agents|purinergic agents|mesh-ancestor
111083633|NCT03294967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111083634|NCT03294967|Antioxidants|antioxidants|mesh-ancestor
111083635|NCT03294967|Protective Agents|protective agents|mesh-ancestor
111083636|NCT03371849|Montelukast|montelukast|mesh-list
111083637|NCT03371849|Levocetirizine|levocetirizine|mesh-list
111083638|NCT03371849|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111083639|NCT03371849|Respiratory System Agents|respiratory system agents|mesh-ancestor
111083640|NCT03371849|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
111083641|NCT03371849|Hormone Antagonists|hormone antagonists|mesh-ancestor
111083642|NCT03371849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111083643|NCT03371849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111083644|NCT03371849|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
111083645|NCT03371849|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111083646|NCT03371849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111083647|NCT03371849|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
111083648|NCT03371849|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111083649|NCT03371849|Histamine Antagonists|histamine antagonists|mesh-ancestor
111083650|NCT03371849|Histamine Agents|histamine agents|mesh-ancestor
111083651|NCT03371849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111083652|NCT04307329|Trastuzumab|trastuzumab|mesh-list
111083653|NCT04307329|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111083654|NCT04307329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111083655|NCT03371069|Methylphenidate|methylphenidate|mesh-list
111083656|NCT03371069|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111083657|NCT03371069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111083658|NCT03371069|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111083659|NCT03371069|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111083660|NCT03371069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111083661|NCT03371069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111083662|NCT03371069|Dopamine Agents|dopamine agents|mesh-ancestor
111083663|NCT03371069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111083664|NCT03294577|Cyclophosphamide|cyclophosphamide|mesh-list
111083665|NCT03294577|Docetaxel|docetaxel|mesh-list
111083666|NCT03294577|Doxorubicin|doxorubicin|mesh-list
111083667|NCT03294577|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111083668|NCT03294577|Immunologic Factors|immunologic factors|mesh-ancestor
111083669|NCT03294577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111083670|NCT03294577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111083671|NCT03294577|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111083672|NCT03294577|Alkylating Agents|alkylating agents|mesh-ancestor
111083673|NCT03294577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111083674|NCT03294577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111083675|NCT03294577|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111083676|NCT03294577|Tubulin Modulators|tubulin modulators|mesh-ancestor
111083677|NCT03294577|Antimitotic Agents|antimitotic agents|mesh-ancestor
111083678|NCT03294577|Mitosis Modulators|mitosis modulators|mesh-ancestor
111083679|NCT03294577|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111083680|NCT03294577|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111083681|NCT03294577|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111083682|NCT03294577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111083683|NCT03370835|Metoprolol|metoprolol|mesh-list
111083684|NCT03370835|Carvedilol|carvedilol|mesh-list
111083685|NCT03370835|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111083686|NCT03370835|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111083687|NCT03370835|Sympatholytics|sympatholytics|mesh-ancestor
111083688|NCT03370835|Autonomic Agents|autonomic agents|mesh-ancestor
111083689|NCT03370835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110800794|NCT02087020|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111083690|NCT03370835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111083691|NCT03370835|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
111083692|NCT03370835|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111083693|NCT03370835|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111083694|NCT03370835|Adrenergic Agents|adrenergic agents|mesh-ancestor
111083695|NCT03370835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111083696|NCT03370835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111083697|NCT03370835|Antioxidants|antioxidants|mesh-ancestor
111083698|NCT03370835|Protective Agents|protective agents|mesh-ancestor
111083699|NCT03370835|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111083700|NCT03370835|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111083701|NCT03370835|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111083702|NCT03370835|Vasodilator Agents|vasodilator agents|mesh-ancestor
111083703|NCT03370835|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111083704|NCT03370835|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111083705|NCT02460367|Docetaxel|docetaxel|mesh-list
111083706|NCT02460367|Tryptophan|tryptophan|mesh-list
111083707|NCT02460367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111083708|NCT02460367|Tubulin Modulators|tubulin modulators|mesh-ancestor
111083709|NCT02460367|Antimitotic Agents|antimitotic agents|mesh-ancestor
111083710|NCT02460367|Mitosis Modulators|mitosis modulators|mesh-ancestor
111083711|NCT02460367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111083712|NCT02460367|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111083713|NCT02460367|Antidepressive Agents|antidepressive agents|mesh-ancestor
111083714|NCT02460367|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111083715|NCT03370601|Infliximab|infliximab|mesh-list
111083716|NCT03370601|Mercaptopurine|mercaptopurine|mesh-list
111083717|NCT03370601|Azathioprine|azathioprine|mesh-list
111083718|NCT03370601|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111083719|NCT03370601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111083720|NCT03370601|Dermatologic Agents|dermatologic agents|mesh-ancestor
111083721|NCT03370601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111083722|NCT03370601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111083723|NCT03370601|Antimetabolites|antimetabolites|mesh-ancestor
111083724|NCT03370601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111083725|NCT03370601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111083726|NCT03370601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111083727|NCT03370601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111083728|NCT03370601|Immunologic Factors|immunologic factors|mesh-ancestor
111083729|NCT03370601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111083730|NCT03370601|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111083731|NCT03370601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111083732|NCT03376529|Tazobactam|tazobactam|mesh-list
111083733|NCT03376529|Piperacillin|piperacillin|mesh-list
111083734|NCT03376529|Ceftazidime|ceftazidime|mesh-list
111083735|NCT03376529|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
111083736|NCT03376529|Aztreonam|aztreonam|mesh-list
111083737|NCT03376529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111083738|NCT03376529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111083739|NCT03376529|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
111083740|NCT03376529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111083741|NCT03376529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111083742|NCT04132661|Bisacodyl|bisacodyl|mesh-list
111083743|NCT04132661|Cathartics|cathartics|mesh-ancestor
111083744|NCT04132661|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111083745|NCT04132661|Laxatives|laxatives|mesh-ancestor
111083746|NCT02460211|Vitamin D|vitamin d|mesh-list
111083747|NCT02460211|Cholecalciferol|cholecalciferol|mesh-list
111083748|NCT02460211|Vitamins|vitamins|mesh-ancestor
111083749|NCT02460211|Micronutrients|micronutrients|mesh-ancestor
111083750|NCT02460211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111083751|NCT02460211|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111083752|NCT02460211|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111083753|NCT03288259|Anesthetics|anesthetics|mesh-list
111083754|NCT03288259|Anesthetics, Local|anesthetics, local|mesh-list
111083755|NCT03288259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111083756|NCT03288259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111083757|NCT03288259|Sensory System Agents|sensory system agents|mesh-ancestor
111083758|NCT03288259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111083759|NCT01653925|Dutasteride|dutasteride|mesh-list
111083760|NCT01653925|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
111083761|NCT01653925|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111083762|NCT01653925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111083763|NCT01653925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111083764|NCT01653925|Hormone Antagonists|hormone antagonists|mesh-ancestor
111083765|NCT01653925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111083766|NCT01653925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111083767|NCT02730455|Natalizumab|natalizumab|mesh-list
111083768|NCT02730455|Immunologic Factors|immunologic factors|mesh-ancestor
111083769|NCT02730455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111083770|NCT03376139|Zonisamide|zonisamide|mesh-list
111083771|NCT03376139|Anticonvulsants|anticonvulsants|mesh-ancestor
111083772|NCT03376139|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111083773|NCT03376139|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111083774|NCT03376139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111083775|NCT03376139|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111083776|NCT03376139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111083778|NCT03369119|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111083779|NCT03369119|Respiratory System Agents|respiratory system agents|mesh-ancestor
111083780|NCT03369119|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
111083781|NCT03369119|Hormone Antagonists|hormone antagonists|mesh-ancestor
111083782|NCT03369119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111083783|NCT03369119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111083784|NCT03369119|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
111083785|NCT03369119|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111083786|NCT03369119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111083787|NCT03287011|Listerine|listerine|mesh-list
111083788|NCT03287011|Sodium Fluoride|sodium fluoride|mesh-list
111083789|NCT03287011|Cariostatic Agents|cariostatic agents|mesh-ancestor
111083790|NCT03287011|Protective Agents|protective agents|mesh-ancestor
111083791|NCT03287011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111083792|NCT03287011|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111083793|NCT03287011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111083794|NCT03293641|Folic Acid|folic acid|mesh-list
111083795|NCT03293641|Penicillins|penicillins|mesh-list
111083796|NCT03293641|Penicillin V|penicillin v|mesh-list
111083797|NCT03293641|Proguanil|proguanil|mesh-list
111083798|NCT03293641|Hydroxyurea|hydroxyurea|mesh-list
111083799|NCT03293641|Zinc Sulfate|zinc sulfate|mesh-list
111083800|NCT03293641|Hematinics|hematinics|mesh-ancestor
111083801|NCT03293641|Vitamin B Complex|vitamin b complex|mesh-ancestor
111083802|NCT03293641|Vitamins|vitamins|mesh-ancestor
111083803|NCT03293641|Micronutrients|micronutrients|mesh-ancestor
111083804|NCT03293641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111083805|NCT03293641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111083806|NCT03293641|Antisickling Agents|antisickling agents|mesh-ancestor
111083807|NCT03293641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111083808|NCT03293641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111083809|NCT03293641|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111083810|NCT03293641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111083811|NCT03293641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111083812|NCT03293641|Astringents|astringents|mesh-ancestor
111083813|NCT03293641|Dermatologic Agents|dermatologic agents|mesh-ancestor
111083814|NCT03293641|Antimalarials|antimalarials|mesh-ancestor
111083815|NCT03293641|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111083816|NCT03293641|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111083817|NCT03293641|Antimetabolites|antimetabolites|mesh-ancestor
111083818|NCT02519543|Metformin|metformin|mesh-list
111083819|NCT02519543|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111083820|NCT02519543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111083821|NCT03293407|Iloprost|iloprost|mesh-list
111083822|NCT03293407|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111083823|NCT03293407|Vasodilator Agents|vasodilator agents|mesh-ancestor
111083824|NCT02519699|Norepinephrine|norepinephrine|mesh-list
111083825|NCT02519699|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111083826|NCT02519699|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111083827|NCT02519699|Adrenergic Agents|adrenergic agents|mesh-ancestor
111083828|NCT02519699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111083829|NCT02519699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111083830|NCT02519699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111083831|NCT02519699|Sympathomimetics|sympathomimetics|mesh-ancestor
111083832|NCT02519699|Autonomic Agents|autonomic agents|mesh-ancestor
111083833|NCT02519699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111083834|NCT02519699|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111083835|NCT00701311|Apremilast|apremilast|mesh-list
111083836|NCT00701311|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111083837|NCT00701311|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111083838|NCT00701311|Analgesics|analgesics|mesh-ancestor
111083839|NCT00701311|Sensory System Agents|sensory system agents|mesh-ancestor
111083840|NCT00701311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111083841|NCT00701311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111083842|NCT00701311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111083843|NCT00701311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111083844|NCT00701311|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
111083845|NCT00701311|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111083846|NCT00701311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110677244|NCT02166463|Antibodies|antibodies|mesh-list
111083847|NCT00701311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111083848|NCT03375671|Midazolam|midazolam|mesh-list
111083849|NCT03375671|Ketamine|ketamine|mesh-list
111083850|NCT03375671|Haloperidol|haloperidol|mesh-list
111083851|NCT03375671|Haloperidol decanoate|haloperidol decanoate|mesh-list
111083852|NCT03375671|Analgesics|analgesics|mesh-ancestor
111083853|NCT03375671|Sensory System Agents|sensory system agents|mesh-ancestor
111083854|NCT03375671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111083855|NCT03375671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111083856|NCT03375671|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111083857|NCT03375671|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111083858|NCT03375671|Anesthetics, General|anesthetics, general|mesh-ancestor
111083859|NCT03375671|Anesthetics|anesthetics|mesh-ancestor
111083860|NCT03375671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110640199|NCT00995241|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111083861|NCT03375671|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111083862|NCT03375671|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111083863|NCT03375671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111083864|NCT03375671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111083865|NCT03375671|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111083866|NCT03375671|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111083867|NCT03375671|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111083868|NCT03375671|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111083869|NCT03375671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111083870|NCT03375671|GABA Modulators|gaba modulators|mesh-ancestor
111083871|NCT03375671|GABA Agents|gaba agents|mesh-ancestor
111083872|NCT03375671|Antiemetics|antiemetics|mesh-ancestor
111083873|NCT03375671|Autonomic Agents|autonomic agents|mesh-ancestor
111083874|NCT03375671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111083875|NCT03375671|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111083876|NCT03375671|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111083877|NCT03375671|Dopamine Agents|dopamine agents|mesh-ancestor
111083878|NCT03375671|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111083879|NCT03375593|Acetaminophen|acetaminophen|mesh-list
111083880|NCT03375593|Ibuprofen|ibuprofen|mesh-list
111083881|NCT03375593|Oxycodone|oxycodone|mesh-list
111083882|NCT03375593|Hydrocodone|hydrocodone|mesh-list
111083883|NCT03375593|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111083884|NCT03375593|Analgesics|analgesics|mesh-ancestor
111083885|NCT03375593|Sensory System Agents|sensory system agents|mesh-ancestor
111083886|NCT03375593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111083887|NCT03375593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111083888|NCT03375593|Antipyretics|antipyretics|mesh-ancestor
111083889|NCT03375593|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111083890|NCT03375593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111083891|NCT03375593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111083892|NCT03375593|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111083893|NCT03375593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111083894|NCT03375593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111083895|NCT03375593|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111083896|NCT03375593|Narcotics|narcotics|mesh-ancestor
111083897|NCT03375593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111083898|NCT03375593|Antitussive Agents|antitussive agents|mesh-ancestor
111083899|NCT03375593|Respiratory System Agents|respiratory system agents|mesh-ancestor
111083900|NCT04525235|Tolbutamide|tolbutamide|mesh-list
111083901|NCT04525235|Rifampin|rifampin|mesh-list
111083902|NCT04525235|Digoxin|digoxin|mesh-list
111083903|NCT04525235|Midazolam|midazolam|mesh-list
111083904|NCT04525235|Dextromethorphan|dextromethorphan|mesh-list
111083905|NCT04525235|Caffeine|caffeine|mesh-list
111083906|NCT04525235|Omeprazole|omeprazole|mesh-list
111083907|NCT04525235|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111083908|NCT04525235|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111083909|NCT04525235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111083910|NCT04525235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111083911|NCT04525235|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111083912|NCT04525235|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111083913|NCT04525235|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111083914|NCT04525235|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111083915|NCT04525235|Anesthetics, General|anesthetics, general|mesh-ancestor
111083916|NCT04525235|Anesthetics|anesthetics|mesh-ancestor
111083917|NCT04525235|GABA Modulators|gaba modulators|mesh-ancestor
111083918|NCT04525235|GABA Agents|gaba agents|mesh-ancestor
111083919|NCT04525235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111083920|NCT04525235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111083921|NCT04525235|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111083922|NCT04525235|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111083923|NCT04525235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111083924|NCT04525235|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
111083926|NCT04525235|Purinergic Agents|purinergic agents|mesh-ancestor
111083927|NCT04525235|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111083928|NCT04525235|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111083929|NCT04525235|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111083930|NCT04525235|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111083931|NCT04525235|Antitubercular Agents|antitubercular agents|mesh-ancestor
111083932|NCT04525235|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111083933|NCT04525235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111083934|NCT04525235|Leprostatic Agents|leprostatic agents|mesh-ancestor
111083935|NCT04525235|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111083936|NCT04525235|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111083937|NCT04525235|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111083938|NCT04525235|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
111083939|NCT04525235|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
111083940|NCT04525235|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
111083941|NCT04525235|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111083942|NCT04525235|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111083943|NCT04525235|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111083944|NCT04525235|Protective Agents|protective agents|mesh-ancestor
111083945|NCT04525235|Antitussive Agents|antitussive agents|mesh-ancestor
111083946|NCT04525235|Respiratory System Agents|respiratory system agents|mesh-ancestor
111083947|NCT04525235|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111083948|NCT04525235|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111083949|NCT04525235|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111083950|NCT03363815|Vitamin K|vitamin k|mesh-list
111083951|NCT03363815|Metformin|metformin|mesh-list
111083952|NCT03363815|Nintedanib|nintedanib|mesh-list
111083953|NCT03363815|Digoxin|digoxin|mesh-list
111083954|NCT03363815|Midazolam|midazolam|mesh-list
111083955|NCT03363815|Omeprazole|omeprazole|mesh-list
111083956|NCT03363815|Warfarin|warfarin|mesh-list
111083957|NCT03363815|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111083958|NCT03363815|Vitamins|vitamins|mesh-ancestor
111083959|NCT03363815|Micronutrients|micronutrients|mesh-ancestor
111083960|NCT03363815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111083961|NCT03363815|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111083962|NCT03363815|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111083963|NCT03363815|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111083964|NCT03363815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111083965|NCT03363815|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111083966|NCT03363815|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111083967|NCT03363815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111083968|NCT03363815|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111083969|NCT03363815|Anesthetics, General|anesthetics, general|mesh-ancestor
111083970|NCT03363815|Anesthetics|anesthetics|mesh-ancestor
111083971|NCT03363815|GABA Modulators|gaba modulators|mesh-ancestor
111083972|NCT03363815|GABA Agents|gaba agents|mesh-ancestor
111083973|NCT03363815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111083974|NCT03363815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111083975|NCT03363815|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111083976|NCT03363815|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111083977|NCT03363815|Antimetabolites|antimetabolites|mesh-ancestor
111083978|NCT03363815|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111083979|NCT03363815|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111083980|NCT03363815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111083981|NCT03363815|Anticoagulants|anticoagulants|mesh-ancestor
111083982|NCT03363815|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111083983|NCT03363815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111083984|NCT03363815|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111083985|NCT03363815|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111083986|NCT03363815|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111083987|NCT03363815|Protective Agents|protective agents|mesh-ancestor
111083988|NCT03363815|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111083989|NCT03363815|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111083990|NCT03363815|Hemostatics|hemostatics|mesh-ancestor
111083991|NCT03363815|Coagulants|coagulants|mesh-ancestor
111083992|NCT03363815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111083993|NCT03363815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111083994|NCT03363425|Lidocaine|lidocaine|mesh-list
111083995|NCT03363425|Dexmedetomidine|dexmedetomidine|mesh-list
111083996|NCT03363425|Anesthetics, Local|anesthetics, local|mesh-ancestor
111083997|NCT03363425|Anesthetics|anesthetics|mesh-ancestor
111083998|NCT03363425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111083999|NCT03363425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111084000|NCT03363425|Sensory System Agents|sensory system agents|mesh-ancestor
111084001|NCT03363425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111084002|NCT03363425|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111084003|NCT03363425|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111084004|NCT03363425|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111084005|NCT03363425|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111084006|NCT03363425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111084007|NCT03363425|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111084008|NCT03363425|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111084009|NCT03363425|Analgesics|analgesics|mesh-ancestor
111084010|NCT03363425|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111084011|NCT03363425|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111084012|NCT03363425|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111084013|NCT03363425|Adrenergic Agents|adrenergic agents|mesh-ancestor
111084014|NCT03363425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111084015|NCT02459977|Basiliximab|basiliximab|mesh-list
111084016|NCT02459977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111084017|NCT02459977|Immunologic Factors|immunologic factors|mesh-ancestor
111084018|NCT02459977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111084019|NCT02519153|Sildenafil Citrate|sildenafil citrate|mesh-list
111084020|NCT02519153|Vasodilator Agents|vasodilator agents|mesh-ancestor
111084021|NCT02519153|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111084022|NCT02519153|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111084023|NCT02519153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110799544|NCT03752931|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111084024|NCT02519153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111084025|NCT02519153|Urological Agents|urological agents|mesh-ancestor
111084026|NCT04523987|Ciprofloxacin|ciprofloxacin|mesh-list
111084027|NCT04523987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111084028|NCT04523987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111084029|NCT04523987|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111084030|NCT04523987|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111084031|NCT04523987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111084032|NCT04523987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111084033|NCT04523987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111084034|NCT04523987|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111084035|NCT04523987|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111084036|NCT03363191|Fluticasone|fluticasone|mesh-list
111084037|NCT03363191|Xhance|xhance|mesh-list
111084038|NCT03363191|Albuterol|albuterol|mesh-list
111084039|NCT03363191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111084040|NCT03363191|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111084041|NCT03363191|Autonomic Agents|autonomic agents|mesh-ancestor
111084042|NCT03363191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111084043|NCT03363191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111084044|NCT03363191|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111084045|NCT03363191|Respiratory System Agents|respiratory system agents|mesh-ancestor
111084046|NCT03363191|Dermatologic Agents|dermatologic agents|mesh-ancestor
111084047|NCT03363191|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111084048|NCT03363191|Tocolytic Agents|tocolytic agents|mesh-ancestor
111084049|NCT03363191|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111084050|NCT03363191|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111084051|NCT03363191|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111084052|NCT03363191|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111084053|NCT03363191|Adrenergic Agents|adrenergic agents|mesh-ancestor
111084054|NCT03363191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111084055|NCT03363191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111084056|NCT03363113|Botulinum Toxins|botulinum toxins|mesh-list
111084057|NCT03363113|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111084058|NCT03363113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111084059|NCT03363113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111084060|NCT03363113|Cholinergic Agents|cholinergic agents|mesh-ancestor
111084061|NCT03363113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111084062|NCT03363113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111084063|NCT03285607|Paclitaxel|paclitaxel|mesh-list
111084064|NCT03285607|Cyclophosphamide|cyclophosphamide|mesh-list
111084065|NCT03285607|Doxorubicin|doxorubicin|mesh-list
111084066|NCT03285607|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111084067|NCT03285607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111084068|NCT03285607|Tubulin Modulators|tubulin modulators|mesh-ancestor
111084069|NCT03285607|Antimitotic Agents|antimitotic agents|mesh-ancestor
111084070|NCT03285607|Mitosis Modulators|mitosis modulators|mesh-ancestor
111084071|NCT03285607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111084072|NCT03285607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111084073|NCT03285607|Immunologic Factors|immunologic factors|mesh-ancestor
111084074|NCT03285607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111084075|NCT03285607|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111084076|NCT03285607|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111084077|NCT03285607|Alkylating Agents|alkylating agents|mesh-ancestor
111084078|NCT03285607|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111084079|NCT03285607|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111084080|NCT03285607|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111084081|NCT03285607|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111084082|NCT03285607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111084083|NCT03298321|Azacitidine|azacitidine|mesh-list
111084084|NCT03298321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111084085|NCT03298321|Antimetabolites|antimetabolites|mesh-ancestor
111084086|NCT03298321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111084087|NCT03298321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111084088|NCT03298321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111084089|NCT04527055|Metronidazole|metronidazole|mesh-list
111084090|NCT04527055|Tetracycline|tetracycline|mesh-list
111084091|NCT04527055|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
111084092|NCT04527055|Esomeprazole|esomeprazole|mesh-list
111084093|NCT04527055|Bismuth|bismuth|mesh-list
111084094|NCT04527055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111084095|NCT04527055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111084096|NCT04527055|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111084097|NCT04527055|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111084098|NCT04527055|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111084099|NCT04527055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111084100|NCT04527055|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111084101|NCT04527055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111084102|NCT04527055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111084103|NCT04527055|Antacids|antacids|mesh-ancestor
111084104|NCT04527055|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111084105|NCT02518763|Vitamin D|vitamin d|mesh-list
111084106|NCT02518763|Ergocalciferols|ergocalciferols|mesh-list
111084107|NCT02518763|Cholecalciferol|cholecalciferol|mesh-list
111084108|NCT02518763|Vitamins|vitamins|mesh-list
111084109|NCT02518763|Micronutrients|micronutrients|mesh-ancestor
111084110|NCT02518763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111084111|NCT02518763|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111084112|NCT02518763|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111084113|NCT03362411|Linrodostat|linrodostat|mesh-list
111084114|NCT03362411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111084115|NCT03362411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111084116|NCT03291457|Glucocorticoids|glucocorticoids|mesh-list
111084117|NCT03291457|Hormones|hormones|mesh-ancestor
111084118|NCT03291457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111084119|NCT03291457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111084120|NCT03361709|Dexamethasone|dexamethasone|mesh-list
111084121|NCT03361709|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111084122|NCT03361709|Antiemetics|antiemetics|mesh-ancestor
111084123|NCT03361709|Autonomic Agents|autonomic agents|mesh-ancestor
111084124|NCT03361709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111084125|NCT03361709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111084126|NCT03361709|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111084127|NCT03361709|Glucocorticoids|glucocorticoids|mesh-ancestor
111084128|NCT03361709|Hormones|hormones|mesh-ancestor
111084129|NCT03361709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111084130|NCT03361709|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111084131|NCT03361709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111084132|NCT03284749|Copper|copper|mesh-list
111084133|NCT03284749|Trace Elements|trace elements|mesh-ancestor
111084134|NCT03284749|Micronutrients|micronutrients|mesh-ancestor
111084135|NCT03284749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111084136|NCT04523675|Acetylcysteine|acetylcysteine|mesh-list
111084137|NCT04523675|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111084138|NCT04523675|Antiviral Agents|antiviral agents|mesh-ancestor
111084139|NCT04523675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111084140|NCT04523675|Expectorants|expectorants|mesh-ancestor
111084141|NCT04523675|Respiratory System Agents|respiratory system agents|mesh-ancestor
111084142|NCT04523675|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111084143|NCT04523675|Antioxidants|antioxidants|mesh-ancestor
111084144|NCT04523675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111084145|NCT04523675|Protective Agents|protective agents|mesh-ancestor
111084146|NCT04523675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111084147|NCT04523675|Antidotes|antidotes|mesh-ancestor
111084148|NCT03298009|Canagliflozin|canagliflozin|mesh-list
111084149|NCT03298009|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111084150|NCT03298009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111084151|NCT03298009|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111084152|NCT03298009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111084153|NCT03291145|Spironolactone|spironolactone|mesh-list
111084154|NCT03291145|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
111084155|NCT03291145|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
111084156|NCT03291145|Hormone Antagonists|hormone antagonists|mesh-ancestor
111084157|NCT03291145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111084158|NCT03291145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111084159|NCT03291145|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
111084160|NCT03291145|Diuretics|diuretics|mesh-ancestor
111084161|NCT03291145|Natriuretic Agents|natriuretic agents|mesh-ancestor
111084162|NCT03291145|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111084163|NCT03291145|Adrenergic Agents|adrenergic agents|mesh-ancestor
111084164|NCT03291145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111084165|NCT03291145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111084166|NCT03297931|Iproplatin|iproplatin|mesh-list
111084167|NCT03297931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111084168|NCT03284593|Azacitidine|azacitidine|mesh-list
111084169|NCT03284593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111084170|NCT03284593|Antimetabolites|antimetabolites|mesh-ancestor
111084171|NCT03284593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111084172|NCT03284593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111084173|NCT03284593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111084174|NCT03361397|Lidocaine|lidocaine|mesh-list
111084175|NCT03361397|Anesthetics, Local|anesthetics, local|mesh-ancestor
111084176|NCT03361397|Anesthetics|anesthetics|mesh-ancestor
111084177|NCT03361397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111084178|NCT03361397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111084179|NCT03361397|Sensory System Agents|sensory system agents|mesh-ancestor
111084180|NCT03361397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111084181|NCT03361397|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111084182|NCT03361397|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111084183|NCT03361397|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111084184|NCT03361397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111084185|NCT03361397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111084186|NCT03109379|Trospium chloride|trospium chloride|mesh-list
111084187|NCT03109379|Parasympatholytics|parasympatholytics|mesh-ancestor
111084188|NCT03109379|Autonomic Agents|autonomic agents|mesh-ancestor
111084189|NCT03109379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111084190|NCT03109379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111084191|NCT03109379|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111084192|NCT03109379|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111084193|NCT03109379|Cholinergic Agents|cholinergic agents|mesh-ancestor
111084194|NCT03109379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111084195|NCT03109379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111084196|NCT03109379|Urological Agents|urological agents|mesh-ancestor
111084197|NCT03361319|Paclitaxel|paclitaxel|mesh-list
111084198|NCT03361319|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111084199|NCT03361319|Nintedanib|nintedanib|mesh-list
111084200|NCT03361319|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111084201|NCT03361319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111084202|NCT03361319|Tubulin Modulators|tubulin modulators|mesh-ancestor
111084203|NCT03361319|Antimitotic Agents|antimitotic agents|mesh-ancestor
111084204|NCT03361319|Mitosis Modulators|mitosis modulators|mesh-ancestor
111084205|NCT03361319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111084206|NCT03361319|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111084207|NCT03361319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111084208|NCT04489147|Metformin|metformin|mesh-list
111084209|NCT04489147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111084210|NCT04489147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111084211|NCT03365999|Tranexamic Acid|tranexamic acid|mesh-list
111084212|NCT03365999|Aminocaproic Acid|aminocaproic acid|mesh-list
111084213|NCT03365999|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111084214|NCT03365999|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111084215|NCT03365999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111084216|NCT03365999|Hemostatics|hemostatics|mesh-ancestor
111084217|NCT03365999|Coagulants|coagulants|mesh-ancestor
111084218|NCT02460055|Dexamethasone|dexamethasone|mesh-list
111084219|NCT02460055|Fentanyl|fentanyl|mesh-list
111084220|NCT02460055|Nitrous Oxide|nitrous oxide|mesh-list
111084221|NCT02460055|Ondansetron|ondansetron|mesh-list
111084222|NCT02460055|Propofol|propofol|mesh-list
111084223|NCT02460055|Sevoflurane|sevoflurane|mesh-list
111084224|NCT02460055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111084225|NCT02460055|Antiemetics|antiemetics|mesh-ancestor
111084226|NCT02460055|Autonomic Agents|autonomic agents|mesh-ancestor
111084227|NCT02460055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111084228|NCT02460055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111084229|NCT02460055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111084230|NCT02460055|Glucocorticoids|glucocorticoids|mesh-ancestor
111084231|NCT02460055|Hormones|hormones|mesh-ancestor
111084232|NCT02460055|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111084233|NCT02460055|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111084234|NCT02460055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111084235|NCT02460055|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111084236|NCT02460055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111084237|NCT02460055|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111084238|NCT02460055|Anesthetics, General|anesthetics, general|mesh-ancestor
111084239|NCT02460055|Anesthetics|anesthetics|mesh-ancestor
111084240|NCT02460055|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111084241|NCT02460055|Narcotics|narcotics|mesh-ancestor
111084242|NCT02460055|Analgesics|analgesics|mesh-ancestor
111084243|NCT02460055|Sensory System Agents|sensory system agents|mesh-ancestor
111084244|NCT02460055|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111084245|NCT02460055|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111084246|NCT02460055|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111084247|NCT02460055|Antipruritics|antipruritics|mesh-ancestor
111084248|NCT02460055|Dermatologic Agents|dermatologic agents|mesh-ancestor
111084249|NCT02460055|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111084250|NCT02460055|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111084251|NCT02460055|Serotonin Agents|serotonin agents|mesh-ancestor
111084252|NCT02460055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111084253|NCT02460055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111084254|NCT02460055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111084255|NCT03361163|Bromoacetylalprenololmenthane|bromoacetylalprenololmenthane|mesh-list
111084256|NCT03361163|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111084257|NCT03361163|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111084258|NCT03361163|Adrenergic Agents|adrenergic agents|mesh-ancestor
111084259|NCT03361163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111084260|NCT03361163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111084261|NCT03361163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111084262|NCT03361163|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111084263|NCT03361163|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111084264|NCT03365765|Fluorouracil|fluorouracil|mesh-list
111084265|NCT03365765|Oxaliplatin|oxaliplatin|mesh-list
111084266|NCT03365765|Apatinib|apatinib|mesh-list
111084267|NCT03365765|Antimetabolites|antimetabolites|mesh-ancestor
111084268|NCT03365765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111084269|NCT03365765|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111084270|NCT03365765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111084271|NCT03365765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111084272|NCT03365765|Immunologic Factors|immunologic factors|mesh-ancestor
111084273|NCT03365765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111084274|NCT03365765|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111084275|NCT03365765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111084276|NCT03297463|Ipilimumab|ipilimumab|mesh-list
111084277|NCT03297463|Interleukin-2|interleukin-2|mesh-list
111084278|NCT03297463|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111084279|NCT03297463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111084280|NCT03297463|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111084281|NCT03297463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111084282|NCT03297463|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111084283|NCT03297463|Analgesics|analgesics|mesh-ancestor
111084284|NCT03297463|Sensory System Agents|sensory system agents|mesh-ancestor
111084285|NCT03297463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111084286|NCT03297463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111084287|NCT03282643|Heparin|heparin|mesh-list
111084288|NCT03282643|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
111084289|NCT03282643|Tinzaparin|tinzaparin|mesh-list
111084290|NCT03282643|Dalteparin|dalteparin|mesh-list
111084291|NCT03282643|Rivaroxaban|rivaroxaban|mesh-list
111084292|NCT03282643|Anticoagulants|anticoagulants|mesh-ancestor
111084293|NCT03282643|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111084294|NCT03282643|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111084295|NCT03282643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111084296|NCT03282643|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111084297|NCT03282643|Antithrombins|antithrombins|mesh-ancestor
111084298|NCT03282643|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111084300|NCT03282643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111084301|NCT03282487|Hydrocortisone|hydrocortisone|mesh-list
111084302|NCT03282487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111084303|NCT02458729|Tranylcypromine|tranylcypromine|mesh-list
111084304|NCT02458729|Rivaroxaban|rivaroxaban|mesh-list
111084305|NCT02458729|Tranexamic Acid|tranexamic acid|mesh-list
111084306|NCT02458729|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111084307|NCT02458729|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111084308|NCT02458729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111084309|NCT02458729|Hemostatics|hemostatics|mesh-ancestor
111084310|NCT02458729|Coagulants|coagulants|mesh-ancestor
111084311|NCT02458729|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111084312|NCT02458729|Antithrombins|antithrombins|mesh-ancestor
111084313|NCT02458729|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111084314|NCT02458729|Protease Inhibitors|protease inhibitors|mesh-ancestor
111084315|NCT02458729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111084316|NCT02458729|Anticoagulants|anticoagulants|mesh-ancestor
111084317|NCT02458729|Antidepressive Agents|antidepressive agents|mesh-ancestor
111084318|NCT02458729|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111084319|NCT02458729|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
111084320|NCT02458729|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111084321|NCT02458729|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110640345|NCT01014364|Hydrocortisone|hydrocortisone|mesh-list
111084322|NCT02458729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111084323|NCT02458729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111084324|NCT03920527|Itraconazole|itraconazole|mesh-list
111084325|NCT03920527|Antifungal Agents|antifungal agents|mesh-ancestor
111084326|NCT03920527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111084327|NCT03920527|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111084328|NCT03920527|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111084329|NCT03920527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111084330|NCT03920527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111084331|NCT03920527|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111084332|NCT03920527|Hormone Antagonists|hormone antagonists|mesh-ancestor
111084333|NCT03920527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111084334|NCT03920527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111084335|NCT03920527|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111084336|NCT03536455|Acetazolamide|acetazolamide|mesh-list
111084337|NCT03536455|Anticonvulsants|anticonvulsants|mesh-ancestor
111084338|NCT03536455|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
111084339|NCT03536455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111084340|NCT03536455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111084341|NCT03536455|Diuretics|diuretics|mesh-ancestor
111084342|NCT03536455|Natriuretic Agents|natriuretic agents|mesh-ancestor
111084343|NCT03536455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111084344|NCT03529825|Rifaximin|rifaximin|mesh-list
111084345|NCT03529825|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111084346|NCT03529825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111084347|NCT03529825|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111084348|NCT03281941|Capsaicin|capsaicin|mesh-list
111084349|NCT03281941|Antipruritics|antipruritics|mesh-ancestor
111084350|NCT03281941|Dermatologic Agents|dermatologic agents|mesh-ancestor
111084351|NCT03281941|Sensory System Agents|sensory system agents|mesh-ancestor
111084352|NCT03281941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111084353|NCT03281941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111084354|NCT02459509|Dexmedetomidine|dexmedetomidine|mesh-list
111084355|NCT02459509|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111084356|NCT02459509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111084357|NCT02459509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111084358|NCT02459509|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111084359|NCT02459509|Analgesics|analgesics|mesh-ancestor
111084360|NCT02459509|Sensory System Agents|sensory system agents|mesh-ancestor
111084361|NCT02459509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111084362|NCT02459509|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111084363|NCT02459509|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111084364|NCT02459509|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111084365|NCT02459509|Adrenergic Agents|adrenergic agents|mesh-ancestor
111084366|NCT02459509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110683009|NCT00904631|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111084367|NCT02459509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110801471|NCT05423392|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111084369|NCT03264781|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
111084370|NCT03264781|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111084371|NCT03264781|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111084372|NCT03264781|Contraceptive Agents|contraceptive agents|mesh-ancestor
111084373|NCT03264781|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111084374|NCT03264781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111084375|NCT03264781|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111084376|NCT03264781|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111084377|NCT03281863|Antibodies|antibodies|mesh-list
111084378|NCT03281863|Antistreptolysin|antistreptolysin|mesh-list
111084379|NCT03281863|Immunologic Factors|immunologic factors|mesh-ancestor
111084380|NCT03281863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111084381|NCT03264625|Vitamin D|vitamin d|mesh-list
111084382|NCT03264625|Cholecalciferol|cholecalciferol|mesh-list
111084383|NCT03264625|Vitamins|vitamins|mesh-ancestor
111084384|NCT03264625|Micronutrients|micronutrients|mesh-ancestor
111084385|NCT03264625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111084386|NCT03264625|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111084387|NCT03264625|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111084388|NCT03269929|Midazolam|midazolam|mesh-list
111084389|NCT03269929|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111084390|NCT03269929|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111084391|NCT03269929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111084392|NCT03269929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111084393|NCT03269929|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111084394|NCT03269929|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111084395|NCT03269929|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111084396|NCT03269929|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111084397|NCT03269929|Anesthetics, General|anesthetics, general|mesh-ancestor
111084398|NCT03269929|Anesthetics|anesthetics|mesh-ancestor
111084399|NCT03269929|GABA Modulators|gaba modulators|mesh-ancestor
111084400|NCT03269929|GABA Agents|gaba agents|mesh-ancestor
111084401|NCT03269929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111084402|NCT03269929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111084403|NCT02730377|Liraglutide|liraglutide|mesh-list
111084404|NCT02730377|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
111084405|NCT02730377|Meglitinide|meglitinide|mesh-list
111084406|NCT02730377|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
111084407|NCT02730377|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
111084408|NCT02730377|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
111084409|NCT02730377|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111084410|NCT02730377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111084411|NCT02730377|Incretins|incretins|mesh-ancestor
111084412|NCT02730377|Hormones|hormones|mesh-ancestor
111084413|NCT02730377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111084414|NCT02730377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111084415|NCT02730377|Protease Inhibitors|protease inhibitors|mesh-ancestor
111084416|NCT02730377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111084417|NCT03264547|Paclitaxel|paclitaxel|mesh-list
111084418|NCT03264547|Docetaxel|docetaxel|mesh-list
111084419|NCT03264547|Trastuzumab|trastuzumab|mesh-list
111084420|NCT03264547|Pertuzumab|pertuzumab|mesh-list
111084421|NCT03264547|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111084422|NCT03264547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111084423|NCT03264547|Tubulin Modulators|tubulin modulators|mesh-ancestor
111084424|NCT03264547|Antimitotic Agents|antimitotic agents|mesh-ancestor
111084425|NCT03264547|Mitosis Modulators|mitosis modulators|mesh-ancestor
111084426|NCT03264547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111084427|NCT03264547|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111084428|NCT03365141|Triamcinolone|triamcinolone|mesh-list
111084429|NCT03365141|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
111084430|NCT03365141|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
111084431|NCT03365141|Tacrolimus|tacrolimus|mesh-list
111084432|NCT03365141|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
111084433|NCT03365141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111084434|NCT03365141|Immunologic Factors|immunologic factors|mesh-ancestor
111084435|NCT03365141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111084436|NCT03365141|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111084437|NCT03365141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111084438|NCT03365141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111084439|NCT03365141|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111084441|NCT03365141|Hormones|hormones|mesh-ancestor
111084442|NCT03365141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111084443|NCT03364985|Dapagliflozin|dapagliflozin|mesh-list
111084444|NCT03364985|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111084445|NCT03364985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111084446|NCT03364985|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111084447|NCT03364985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111084449|NCT03364829|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111084450|NCT03364829|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111084451|NCT03364829|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111084452|NCT03364829|Cholinergic Agents|cholinergic agents|mesh-ancestor
111084453|NCT03364829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111084454|NCT03364829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111084455|NCT03364829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111084456|NCT03359837|Insulin|insulin|mesh-list
111084457|NCT03359837|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111084458|NCT03359837|Metformin|metformin|mesh-list
111084459|NCT03359837|Insulin Glargine|insulin glargine|mesh-list
111084460|NCT03359837|Insulin Aspart|insulin aspart|mesh-list
111084461|NCT03359837|Biphasic Insulins|biphasic insulins|mesh-list
111084462|NCT03359837|Acarbose|acarbose|mesh-list
111084463|NCT03359837|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
111084464|NCT03359837|Insulin glulisine|insulin glulisine|mesh-list
111084465|NCT03359837|Repaglinide|repaglinide|mesh-list
111084466|NCT03359837|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111084467|NCT03359837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111084468|NCT03359837|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
111084469|NCT03359837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111084470|NCT03359837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111084471|NCT03359681|Metformin|metformin|mesh-list
111084472|NCT03359681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111084473|NCT03359681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111084474|NCT03359525|Tranexamic Acid|tranexamic acid|mesh-list
111084475|NCT03359525|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111084476|NCT03359525|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111084477|NCT03359525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111084478|NCT03359525|Hemostatics|hemostatics|mesh-ancestor
111084479|NCT03359525|Coagulants|coagulants|mesh-ancestor
111084480|NCT03358433|Antidepressive Agents|antidepressive agents|mesh-list
111084481|NCT03358433|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111084482|NCT03359291|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111084483|NCT03359291|Macitentan|macitentan|mesh-list
111084484|NCT03359291|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111084485|NCT03359291|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111084486|NCT03359291|Antimetabolites|antimetabolites|mesh-ancestor
111084487|NCT03359291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111084488|NCT03359291|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111084489|NCT03359291|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111084490|NCT03359291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111084491|NCT03359291|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
111084492|NCT03359291|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
111084493|NCT03359291|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
111084494|NCT03358277|Methylphenidate|methylphenidate|mesh-list
111084495|NCT03358277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111084496|NCT03358277|Dopamine Agents|dopamine agents|mesh-ancestor
111084497|NCT03358277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111084498|NCT03358277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111084499|NCT03358277|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111084500|NCT03358277|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111084501|NCT03358277|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111084502|NCT03358277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111084503|NCT03359057|Folic Acid|folic acid|mesh-list
111084504|NCT03359057|Vitamin B Complex|vitamin b complex|mesh-list
111084505|NCT03359057|Levonorgestrel|levonorgestrel|mesh-list
111084506|NCT03359057|Ethinyl Estradiol|ethinyl estradiol|mesh-list
111084507|NCT03359057|Estradiol|estradiol|mesh-list
111084508|NCT03359057|Estrogens|estrogens|mesh-ancestor
111084509|NCT03359057|Hormones|hormones|mesh-ancestor
111084510|NCT03359057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111084511|NCT03359057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110677257|NCT02166463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111084512|NCT03359057|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111084513|NCT03359057|Contraceptive Agents|contraceptive agents|mesh-ancestor
111084514|NCT03359057|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111084515|NCT03359057|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111084516|NCT03359057|Hematinics|hematinics|mesh-ancestor
111084517|NCT03359057|Vitamins|vitamins|mesh-ancestor
111084518|NCT03359057|Micronutrients|micronutrients|mesh-ancestor
111084519|NCT03359057|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111084520|NCT03359057|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111084521|NCT03359057|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111084522|NCT02714569|Atorvastatin|atorvastatin|mesh-list
111084523|NCT02714569|Simvastatin|simvastatin|mesh-list
111084524|NCT02714569|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111084525|NCT02714569|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111084526|NCT02714569|Antimetabolites|antimetabolites|mesh-ancestor
111084527|NCT02714569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111084528|NCT02714569|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111084529|NCT02714569|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111084530|NCT02714569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111084531|NCT04522037|Morphine|morphine|mesh-list
111084532|NCT04522037|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111084533|NCT04522037|Narcotics|narcotics|mesh-ancestor
111084534|NCT04522037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111084535|NCT04522037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111084536|NCT04522037|Analgesics|analgesics|mesh-ancestor
111084537|NCT04522037|Sensory System Agents|sensory system agents|mesh-ancestor
111084538|NCT04522037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111084539|NCT03357653|Losartan|losartan|mesh-list
111084540|NCT03357653|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111084541|NCT03357653|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111084542|NCT03357653|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111084543|NCT03357653|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111084544|NCT03357653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111084545|NCT04522661|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111084546|NCT04522661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111084547|NCT03357575|Hyaluronic Acid|hyaluronic acid|mesh-list
111084548|NCT03357575|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111084549|NCT03357575|Immunologic Factors|immunologic factors|mesh-ancestor
111084550|NCT03357575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111084551|NCT03357575|Viscosupplements|viscosupplements|mesh-ancestor
111084552|NCT03357575|Protective Agents|protective agents|mesh-ancestor
111084553|NCT03280927|Efinaconazole|efinaconazole|mesh-list
111084554|NCT03280927|Antifungal Agents|antifungal agents|mesh-ancestor
111084555|NCT03280927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111084556|NCT03269383|Bupivacaine|bupivacaine|mesh-list
111084557|NCT03269383|Anesthetics, Local|anesthetics, local|mesh-ancestor
111084558|NCT03269383|Anesthetics|anesthetics|mesh-ancestor
111084559|NCT03269383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111084560|NCT03269383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111084561|NCT03269383|Sensory System Agents|sensory system agents|mesh-ancestor
111084562|NCT03269383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111084563|NCT03280849|Chitosan|chitosan|mesh-list
111084564|NCT03280849|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111084565|NCT03280849|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111084566|NCT03280849|Antimetabolites|antimetabolites|mesh-ancestor
111084567|NCT03280849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111084568|NCT03280849|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111084569|NCT03280849|Chelating Agents|chelating agents|mesh-ancestor
111084570|NCT03280849|Sequestering Agents|sequestering agents|mesh-ancestor
111084571|NCT03280849|Hemostatics|hemostatics|mesh-ancestor
111084572|NCT03280849|Coagulants|coagulants|mesh-ancestor
111084573|NCT04521491|Leucovorin|leucovorin|mesh-list
111084574|NCT04521491|Fluorouracil|fluorouracil|mesh-list
111084575|NCT04521491|Oxaliplatin|oxaliplatin|mesh-list
111084576|NCT04521491|Antimetabolites|antimetabolites|mesh-ancestor
111084577|NCT04521491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111084578|NCT04521491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111084579|NCT04521491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111084580|NCT04521491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111084581|NCT04521491|Immunologic Factors|immunologic factors|mesh-ancestor
111084582|NCT04521491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111084583|NCT04521491|Antidotes|antidotes|mesh-ancestor
111084584|NCT04521491|Protective Agents|protective agents|mesh-ancestor
111084585|NCT04521491|Vitamin B Complex|vitamin b complex|mesh-ancestor
111084586|NCT04521491|Vitamins|vitamins|mesh-ancestor
111084587|NCT04521491|Micronutrients|micronutrients|mesh-ancestor
111084588|NCT04509635|Cetuximab|cetuximab|mesh-list
111084589|NCT04509635|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111084590|NCT04509635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111084591|NCT04444817|Tacrolimus|tacrolimus|mesh-list
111084592|NCT04444817|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111084593|NCT04444817|Immunologic Factors|immunologic factors|mesh-ancestor
111084594|NCT04444817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111084595|NCT04444817|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111084596|NCT04444817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111084597|NCT04444817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111084599|NCT03264079|Antifungal Agents|antifungal agents|mesh-ancestor
111084600|NCT03264079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111084601|NCT03264079|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111084602|NCT03264079|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111084603|NCT03264079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111084604|NCT03264079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111084605|NCT03264079|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111084606|NCT03264079|Hormone Antagonists|hormone antagonists|mesh-ancestor
111084607|NCT03264079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111084608|NCT03264079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111084609|NCT03264079|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111084610|NCT04509323|Huperzine A|huperzine a|mesh-list
111084611|NCT04509323|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111084612|NCT04509323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111084613|NCT04509323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111084614|NCT04509323|Cholinergic Agents|cholinergic agents|mesh-ancestor
111084615|NCT04509323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111084616|NCT04509323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111084617|NCT04509323|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111084618|NCT04509323|Protective Agents|protective agents|mesh-ancestor
111084619|NCT04443647|Oxytocin|oxytocin|mesh-list
111084620|NCT04443647|Oxytocics|oxytocics|mesh-ancestor
111084621|NCT04443647|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111084622|NCT04443647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111084623|NCT04443881|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
111084624|NCT04443881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111084625|NCT02458339|Methotrexate|methotrexate|mesh-list
111084626|NCT02458339|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111084627|NCT02458339|Abortifacient Agents|abortifacient agents|mesh-ancestor
111084628|NCT02458339|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111084629|NCT02458339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111084630|NCT02458339|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111084631|NCT02458339|Antimetabolites|antimetabolites|mesh-ancestor
111084632|NCT02458339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111084633|NCT02458339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111084634|NCT02458339|Dermatologic Agents|dermatologic agents|mesh-ancestor
111084635|NCT02458339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111084636|NCT02458339|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111084637|NCT02458339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111084638|NCT02458339|Immunologic Factors|immunologic factors|mesh-ancestor
111084639|NCT02458339|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111084640|NCT02458339|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111084641|NCT03268525|Bupivacaine|bupivacaine|mesh-list
111084642|NCT03268525|Anesthetics, Local|anesthetics, local|mesh-ancestor
111084643|NCT03268525|Anesthetics|anesthetics|mesh-ancestor
111084644|NCT03268525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111084645|NCT03268525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111084646|NCT03268525|Sensory System Agents|sensory system agents|mesh-ancestor
111084647|NCT03268525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111084648|NCT02456935|Esomeprazole|esomeprazole|mesh-list
111084649|NCT02456935|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111084650|NCT02456935|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111084651|NCT02456935|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111084652|NCT02456935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111084653|NCT02456935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111084654|NCT03280147|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111084655|NCT03280147|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
111084656|NCT03280147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111084657|NCT03280147|Antitubercular Agents|antitubercular agents|mesh-ancestor
111084658|NCT03263689|Morphine|morphine|mesh-list
111084659|NCT03263689|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111084660|NCT03263689|Narcotics|narcotics|mesh-ancestor
111084661|NCT03263689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111084662|NCT03263689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111084663|NCT03263689|Analgesics|analgesics|mesh-ancestor
111084664|NCT03263689|Sensory System Agents|sensory system agents|mesh-ancestor
111084665|NCT03263689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111084666|NCT03279679|Ropivacaine|ropivacaine|mesh-list
111084667|NCT03279679|Anesthetics, Local|anesthetics, local|mesh-ancestor
111084668|NCT03279679|Anesthetics|anesthetics|mesh-ancestor
111084669|NCT03279679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111084670|NCT03279679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111084671|NCT03279679|Sensory System Agents|sensory system agents|mesh-ancestor
111084672|NCT03279679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111084673|NCT02518451|Valsartan|valsartan|mesh-list
111084674|NCT02518451|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111084675|NCT02518451|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111084676|NCT02518451|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111084677|NCT02518451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111084678|NCT03263299|Aspirin|aspirin|mesh-list
111084679|NCT03263299|Cabergoline|cabergoline|mesh-list
111084680|NCT03263299|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111084681|NCT03263299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111084682|NCT03263299|Analgesics|analgesics|mesh-ancestor
111084683|NCT03263299|Sensory System Agents|sensory system agents|mesh-ancestor
111084684|NCT03263299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111084685|NCT03263299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111084686|NCT03263299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111084687|NCT03263299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111084688|NCT03263299|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111084689|NCT03263299|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111084690|NCT03263299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111084691|NCT03263299|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111084692|NCT03263299|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111084693|NCT03263299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111084694|NCT03263299|Antipyretics|antipyretics|mesh-ancestor
111084695|NCT03263299|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111084696|NCT03263299|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111084697|NCT03263299|Dopamine Agonists|dopamine agonists|mesh-ancestor
111084698|NCT03263299|Dopamine Agents|dopamine agents|mesh-ancestor
111084699|NCT03263299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111084700|NCT04444349|Ubiquinone|ubiquinone|mesh-list
111084701|NCT04444349|Coenzyme Q10|coenzyme q10|mesh-list
111084702|NCT04444349|Micronutrients|micronutrients|mesh-ancestor
111084703|NCT04444349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111084704|NCT04444349|Vitamins|vitamins|mesh-ancestor
111084705|NCT03263533|Vorinostat|vorinostat|mesh-list
111084706|NCT03263533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111084707|NCT03263533|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111084708|NCT03263533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111084709|NCT03263533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111084710|NCT03123107|Ascorbic Acid|ascorbic acid|mesh-list
111084711|NCT03123107|Vitamins|vitamins|mesh-ancestor
111084712|NCT03123107|Micronutrients|micronutrients|mesh-ancestor
111084713|NCT03123107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111084714|NCT03123107|Antioxidants|antioxidants|mesh-ancestor
111084715|NCT03123107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111084716|NCT03123107|Protective Agents|protective agents|mesh-ancestor
111084717|NCT04516655|Rituximab|rituximab|mesh-list
111084718|NCT04516655|Methotrexate|methotrexate|mesh-list
111084719|NCT04516655|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111084720|NCT04516655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111084721|NCT04516655|Immunologic Factors|immunologic factors|mesh-ancestor
111084722|NCT04516655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111084723|NCT04516655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111084724|NCT04516655|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111084725|NCT04516655|Abortifacient Agents|abortifacient agents|mesh-ancestor
111084726|NCT04516655|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111084727|NCT04516655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111084728|NCT04516655|Antimetabolites|antimetabolites|mesh-ancestor
111084729|NCT04516655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111084730|NCT04516655|Dermatologic Agents|dermatologic agents|mesh-ancestor
111084731|NCT04516655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111084732|NCT04516655|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111084733|NCT04516655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111084734|NCT04516655|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111084735|NCT02458183|Vaccines|vaccines|mesh-list
111084736|NCT02458183|Immunologic Factors|immunologic factors|mesh-ancestor
111084737|NCT02458183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111084738|NCT04444193|Durvalumab|durvalumab|mesh-list
111084739|NCT04444193|Lenvatinib|lenvatinib|mesh-list
111084740|NCT04444193|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111084741|NCT04444193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111084742|NCT04444193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111084743|NCT04444193|Immunologic Factors|immunologic factors|mesh-ancestor
111084744|NCT04444193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111084745|NCT04444193|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111084746|NCT04444193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111084747|NCT04444193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111084748|NCT03984955|Mannitol|mannitol|mesh-list
111084749|NCT03984955|Hyaluronic Acid|hyaluronic acid|mesh-list
111084750|NCT03984955|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
111084751|NCT03984955|Diuretics|diuretics|mesh-ancestor
111084752|NCT03984955|Natriuretic Agents|natriuretic agents|mesh-ancestor
111084753|NCT03984955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111084754|NCT03984955|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111084755|NCT03984955|Immunologic Factors|immunologic factors|mesh-ancestor
111084756|NCT03984955|Viscosupplements|viscosupplements|mesh-ancestor
111084757|NCT03984955|Protective Agents|protective agents|mesh-ancestor
111084758|NCT03946969|Paclitaxel|paclitaxel|mesh-list
111084759|NCT03946969|Cisplatin|cisplatin|mesh-list
111084760|NCT03946969|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111084761|NCT03946969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111084762|NCT03946969|Tubulin Modulators|tubulin modulators|mesh-ancestor
111084763|NCT03946969|Antimitotic Agents|antimitotic agents|mesh-ancestor
111084764|NCT03946969|Mitosis Modulators|mitosis modulators|mesh-ancestor
111084765|NCT03946969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111084766|NCT03277573|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
111084767|NCT03277573|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111084768|NCT03277573|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111084769|NCT03277573|Analgesics|analgesics|mesh-ancestor
111084770|NCT03277573|Sensory System Agents|sensory system agents|mesh-ancestor
111084771|NCT03277573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111084772|NCT03277573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111084773|NCT03277573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111084774|NCT03277573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111084775|NCT03353909|Hyaluronic Acid|hyaluronic acid|mesh-list
111084776|NCT03353909|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111084777|NCT03353909|Immunologic Factors|immunologic factors|mesh-ancestor
111084778|NCT03353909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111084779|NCT03353909|Viscosupplements|viscosupplements|mesh-ancestor
111084780|NCT03353909|Protective Agents|protective agents|mesh-ancestor
111084781|NCT02459353|Dapagliflozin|dapagliflozin|mesh-list
111084782|NCT02459353|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110640402|NCT00919919|Progesterone|progesterone|mesh-list
111084783|NCT02459353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111084784|NCT02459353|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111084785|NCT02459353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111084786|NCT04508231|Hormones|hormones|mesh-list
111084787|NCT04508231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111084788|NCT04508231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111084789|NCT03263065|Psyllium|psyllium|mesh-list
111084790|NCT03263065|Cathartics|cathartics|mesh-ancestor
111084791|NCT03263065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111084792|NCT02518373|Omeprazole|omeprazole|mesh-list
111084793|NCT02518373|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111084794|NCT02518373|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111084795|NCT02518373|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111084796|NCT02518373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111084797|NCT02518373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111084798|NCT03266965|Carbidopa|carbidopa|mesh-list
111084799|NCT03266965|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111084800|NCT03266965|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111084801|NCT03266965|Dopamine Agents|dopamine agents|mesh-ancestor
111084802|NCT03266965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111084803|NCT03266965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111084804|NCT03266965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111084805|NCT03266965|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
111084806|NCT03266965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111084807|NCT03266731|Aspirin|aspirin|mesh-list
111084808|NCT03266731|Clopidogrel|clopidogrel|mesh-list
111084809|NCT03266731|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111084810|NCT03266731|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111084811|NCT03266731|Analgesics|analgesics|mesh-ancestor
111084812|NCT03266731|Sensory System Agents|sensory system agents|mesh-ancestor
111084813|NCT03266731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111084814|NCT03266731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111084815|NCT03266731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111084816|NCT03266731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111084817|NCT03266731|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111084818|NCT03266731|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111084819|NCT03266731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111084820|NCT03266731|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111084821|NCT03266731|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111084822|NCT03266731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111084823|NCT03266731|Antipyretics|antipyretics|mesh-ancestor
111084824|NCT03266731|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111084825|NCT03266731|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111084826|NCT03266731|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111084827|NCT03266731|Purinergic Agents|purinergic agents|mesh-ancestor
111084828|NCT03266731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111084829|NCT02458963|Menotropins|menotropins|mesh-list
111084830|NCT02458963|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111084831|NCT02458963|Fertility Agents|fertility agents|mesh-ancestor
111084832|NCT02458963|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111084833|NCT02458963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111084834|NCT04507607|Tenofovir|tenofovir|mesh-list
111084835|NCT04507607|Antiviral Agents|antiviral agents|mesh-ancestor
111084836|NCT04507607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111084837|NCT04507607|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111084838|NCT04507607|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111084839|NCT04507607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111084840|NCT04507607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111084841|NCT04507607|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111084842|NCT04507607|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111084843|NCT03353441|Glycine|glycine|mesh-list
111084844|NCT03353441|Glycine Agents|glycine agents|mesh-ancestor
111084845|NCT03353441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111084846|NCT03353441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111084847|NCT03353441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111084848|NCT03353363|Bupivacaine|bupivacaine|mesh-list
111084849|NCT03353363|Anesthetics, Local|anesthetics, local|mesh-ancestor
111084850|NCT03353363|Anesthetics|anesthetics|mesh-ancestor
111084851|NCT03353363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111084852|NCT03353363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111084853|NCT03353363|Sensory System Agents|sensory system agents|mesh-ancestor
111084854|NCT03353363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111084855|NCT04511195|Diclofenac|diclofenac|mesh-list
111084856|NCT04511195|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111084857|NCT04511195|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111084858|NCT04511195|Analgesics|analgesics|mesh-ancestor
111084859|NCT04511195|Sensory System Agents|sensory system agents|mesh-ancestor
111084860|NCT04511195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111084861|NCT04511195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111084862|NCT04511195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111084863|NCT04511195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111084864|NCT04511195|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111084865|NCT04511195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111084866|NCT04511195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111084867|NCT04443725|Hydroxychloroquine|hydroxychloroquine|mesh-list
111084868|NCT04443725|Sofosbuvir|sofosbuvir|mesh-list
111084869|NCT04443725|Antimalarials|antimalarials|mesh-ancestor
111084870|NCT04443725|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111084871|NCT04443725|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111084872|NCT04443725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111084873|NCT04443725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111084874|NCT04443725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111084875|NCT04443725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111084876|NCT04443725|Antiviral Agents|antiviral agents|mesh-ancestor
111084877|NCT03262363|Curcumin|curcumin|mesh-list
111084878|NCT03262363|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111084879|NCT03262363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111084880|NCT03262363|Analgesics|analgesics|mesh-ancestor
111084881|NCT03262363|Sensory System Agents|sensory system agents|mesh-ancestor
111084882|NCT03262363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111084883|NCT03262363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111084884|NCT03262363|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111084885|NCT03262363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111084886|NCT03262363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111084887|NCT03262363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111084888|NCT03262363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111084889|NCT04506827|Hyaluronic Acid|hyaluronic acid|mesh-list
111084890|NCT04506827|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111084891|NCT04506827|Immunologic Factors|immunologic factors|mesh-ancestor
111084892|NCT04506827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111084893|NCT04506827|Viscosupplements|viscosupplements|mesh-ancestor
111084894|NCT04506827|Protective Agents|protective agents|mesh-ancestor
111084895|NCT03352895|Grape Seed Extract|grape seed extract|mesh-list
111084896|NCT03352895|Resveratrol|resveratrol|mesh-list
111084897|NCT03352895|Antioxidants|antioxidants|mesh-ancestor
111084898|NCT03352895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111084899|NCT03352895|Protective Agents|protective agents|mesh-ancestor
111084900|NCT03352895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111084901|NCT03352895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111084902|NCT03352895|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111084903|NCT03352895|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111084904|NCT03352895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111084905|NCT05074147|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111084906|NCT05074147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111084907|NCT03350633|Azathioprine|azathioprine|mesh-list
111084908|NCT03350633|Antimetabolites|antimetabolites|mesh-ancestor
111084909|NCT03350633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111084910|NCT03350633|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111084911|NCT03350633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110640422|NCT02586311|Amlodipine|amlodipine|mesh-list
111084912|NCT03350633|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111084913|NCT03350633|Immunologic Factors|immunologic factors|mesh-ancestor
111084914|NCT03350633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111084915|NCT03350633|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111084916|NCT03265795|Ether|ether|mesh-list
111084917|NCT03265795|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111084918|NCT03265795|Anesthetics, General|anesthetics, general|mesh-ancestor
111084919|NCT03265795|Anesthetics|anesthetics|mesh-ancestor
111084920|NCT03265795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111084921|NCT03265795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111084922|NCT03350399|Mitogens|mitogens|mesh-list
111084923|NCT03350399|Mitosis Modulators|mitosis modulators|mesh-ancestor
111084924|NCT03350399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111084925|NCT03350321|Darbepoetin alfa|darbepoetin alfa|mesh-list
111084926|NCT03350321|Hematinics|hematinics|mesh-ancestor
111084927|NCT03352349|Terlipressin|terlipressin|mesh-list
111084928|NCT03352349|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111084929|NCT03352349|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111084930|NCT03265171|Plasminogen|plasminogen|mesh-list
111084931|NCT03265171|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111084932|NCT03265171|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111084933|NCT03265171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111084934|NCT04933669|Imatinib Mesylate|imatinib mesylate|mesh-list
111084935|NCT04933669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111084936|NCT04933669|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111084937|NCT04933669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111084938|NCT04933669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111084939|NCT04669561|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111084940|NCT04669561|Lifitegrast|lifitegrast|mesh-list
111084941|NCT04669561|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111084942|NCT02729909|Lubiprostone|lubiprostone|mesh-list
111084943|NCT02729909|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
111084944|NCT02729909|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111084945|NCT02729909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111084946|NCT03352115|Prednisolone|prednisolone|mesh-list
111084947|NCT03352115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111084948|NCT03352115|Glucocorticoids|glucocorticoids|mesh-ancestor
111084949|NCT03352115|Hormones|hormones|mesh-ancestor
111084950|NCT03352115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111084951|NCT03352115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111084952|NCT03352115|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111084953|NCT03352115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111084954|NCT03252457|Dexamethasone|dexamethasone|mesh-list
111084955|NCT03252457|Hydrocortisone|hydrocortisone|mesh-list
111084956|NCT03252457|Decitabine|decitabine|mesh-list
111084957|NCT03252457|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111084958|NCT03252457|Antiemetics|antiemetics|mesh-ancestor
111084959|NCT03252457|Autonomic Agents|autonomic agents|mesh-ancestor
111084960|NCT03252457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111084961|NCT03252457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111084962|NCT03252457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111084963|NCT03252457|Glucocorticoids|glucocorticoids|mesh-ancestor
111084964|NCT03252457|Hormones|hormones|mesh-ancestor
111084965|NCT03252457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111084966|NCT03252457|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111084967|NCT03252457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111084968|NCT03252457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111084969|NCT03252457|Antimetabolites|antimetabolites|mesh-ancestor
111084970|NCT03252457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111084971|NCT03252457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110802066|NCT04473716|Paclitaxel|paclitaxel|mesh-list
111084973|NCT03258931|Midostaurin|midostaurin|mesh-list
111084974|NCT03258931|Crenolanib|crenolanib|mesh-list
111084975|NCT03258931|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111084976|NCT03258931|Antimetabolites|antimetabolites|mesh-ancestor
111084977|NCT03258931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111084978|NCT03258931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111084979|NCT03258931|Antiviral Agents|antiviral agents|mesh-ancestor
111084980|NCT03258931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111084981|NCT03258931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111084982|NCT03258931|Immunologic Factors|immunologic factors|mesh-ancestor
111084983|NCT03258931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111084984|NCT03258931|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111084985|NCT03258931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111084986|NCT03261349|Sofosbuvir|sofosbuvir|mesh-list
111084987|NCT03261349|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
111084988|NCT03261349|Ledipasvir|ledipasvir|mesh-list
111084989|NCT03261349|Antiviral Agents|antiviral agents|mesh-ancestor
111084990|NCT03261349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111084991|NCT02455609|Dexmedetomidine|dexmedetomidine|mesh-list
111084992|NCT02455609|Ketamine|ketamine|mesh-list
111084993|NCT02455609|Bupivacaine|bupivacaine|mesh-list
111084994|NCT02455609|Anesthetics, Local|anesthetics, local|mesh-ancestor
111084995|NCT02455609|Anesthetics|anesthetics|mesh-ancestor
111084996|NCT02455609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111084997|NCT02455609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111084998|NCT02455609|Sensory System Agents|sensory system agents|mesh-ancestor
111084999|NCT02455609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111085000|NCT02455609|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111085001|NCT02455609|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111085002|NCT02455609|Analgesics|analgesics|mesh-ancestor
111085003|NCT02455609|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111085004|NCT02455609|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111085005|NCT02455609|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111085006|NCT02455609|Adrenergic Agents|adrenergic agents|mesh-ancestor
111085007|NCT02455609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111085008|NCT02455609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111085009|NCT02455609|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111085010|NCT02455609|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111085011|NCT02455609|Anesthetics, General|anesthetics, general|mesh-ancestor
111085012|NCT02455609|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111085013|NCT02455609|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111085014|NCT05723627|Propofol|propofol|mesh-list
111085015|NCT05723627|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111085016|NCT05723627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111085017|NCT05723627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111085018|NCT05723627|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111085019|NCT05723627|Anesthetics, General|anesthetics, general|mesh-ancestor
111085020|NCT05723627|Anesthetics|anesthetics|mesh-ancestor
111085021|NCT03349619|Resveratrol|resveratrol|mesh-list
111085022|NCT03349619|Antioxidants|antioxidants|mesh-ancestor
111085023|NCT03349619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111085024|NCT03349619|Protective Agents|protective agents|mesh-ancestor
111085025|NCT03349619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111085026|NCT03349619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111085027|NCT03349619|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111085028|NCT04505657|Celecoxib|celecoxib|mesh-list
111085029|NCT04505657|Lidocaine|lidocaine|mesh-list
111085030|NCT04505657|Anesthetics, Local|anesthetics, local|mesh-ancestor
111085031|NCT04505657|Anesthetics|anesthetics|mesh-ancestor
111085032|NCT04505657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111085033|NCT04505657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111085034|NCT04505657|Sensory System Agents|sensory system agents|mesh-ancestor
111085035|NCT04505657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111085036|NCT04505657|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111085037|NCT04505657|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111085038|NCT04505657|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111085039|NCT04505657|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111085040|NCT04505657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111085041|NCT04505657|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111085042|NCT04505657|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111085043|NCT04505657|Analgesics|analgesics|mesh-ancestor
111085044|NCT04505657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111085045|NCT04505657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111085046|NCT04505657|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111085047|NCT04505657|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111085048|NCT04505657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111085049|NCT03259243|Bupivacaine|bupivacaine|mesh-list
111085050|NCT03259243|Anesthetics, Local|anesthetics, local|mesh-ancestor
111085051|NCT03259243|Anesthetics|anesthetics|mesh-ancestor
111085052|NCT03259243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111085053|NCT03259243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111085054|NCT03259243|Sensory System Agents|sensory system agents|mesh-ancestor
111085055|NCT03259243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111085056|NCT03258697|Levobupivacaine|levobupivacaine|mesh-list
111085057|NCT03258697|Anesthetics, Local|anesthetics, local|mesh-ancestor
111085058|NCT03258697|Anesthetics|anesthetics|mesh-ancestor
111085059|NCT03258697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111085060|NCT03258697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111085061|NCT03258697|Sensory System Agents|sensory system agents|mesh-ancestor
111085062|NCT03258697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111085063|NCT02456701|Vemurafenib|vemurafenib|mesh-list
111085064|NCT02456701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111085065|NCT02456701|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111085066|NCT02456701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111085067|NCT02456701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111085068|NCT03252067|Azithromycin|azithromycin|mesh-list
111085069|NCT03252067|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111085070|NCT03252067|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111085071|NCT03252067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111085072|NCT03252067|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111085073|NCT03252223|Hormones|hormones|mesh-list
111085074|NCT03252223|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
111085075|NCT03252223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111085076|NCT03252223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111085077|NCT05513807|Niacinamide|niacinamide|mesh-list
111085078|NCT05513807|Niacin|niacin|mesh-list
111085079|NCT05513807|Nicotinic Acids|nicotinic acids|mesh-list
111085080|NCT05513807|Vitamin B Complex|vitamin b complex|mesh-ancestor
111085081|NCT05513807|Vitamins|vitamins|mesh-ancestor
111085082|NCT05513807|Micronutrients|micronutrients|mesh-ancestor
111085083|NCT05513807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111085084|NCT05513807|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111085085|NCT05513807|Antimetabolites|antimetabolites|mesh-ancestor
111085086|NCT05513807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111085087|NCT05513807|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111085088|NCT05513807|Vasodilator Agents|vasodilator agents|mesh-ancestor
111085089|NCT04504877|Cannabidiol|cannabidiol|mesh-list
111085090|NCT04504877|Anticonvulsants|anticonvulsants|mesh-ancestor
111085091|NCT02518295|Sulfalene|sulfalene|mesh-list
111085092|NCT02518295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111085093|NCT02518295|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111085094|NCT02518295|Antimalarials|antimalarials|mesh-ancestor
111085095|NCT02518295|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111085096|NCT02518295|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111085097|NCT03257683|Ranolazine|ranolazine|mesh-list
111085098|NCT03257683|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111085099|NCT03257683|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111085100|NCT03257683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111085101|NCT03251521|Botulinum Toxins|botulinum toxins|mesh-list
111085102|NCT03251521|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111085103|NCT03251521|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110029451|NCT04677959|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111085104|NCT03251521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111085105|NCT03251521|Cholinergic Agents|cholinergic agents|mesh-ancestor
111085106|NCT03251521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111085107|NCT03251521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111085108|NCT03351569|Immunoglobulins|immunoglobulins|mesh-list
111085109|NCT03351569|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111085110|NCT03351569|Antibodies|antibodies|mesh-list
111085111|NCT03351569|gamma-Globulins|gamma-globulins|mesh-list
111085112|NCT03351569|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
111085113|NCT03351569|Immunologic Factors|immunologic factors|mesh-ancestor
111085114|NCT03351569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111085115|NCT03348917|Chlorhexidine|chlorhexidine|mesh-list
111085116|NCT03348917|Povidone-Iodine|povidone-iodine|mesh-list
111085117|NCT03348917|Povidone|povidone|mesh-list
111085118|NCT03348917|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111085119|NCT03348917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111085120|NCT03348917|Disinfectants|disinfectants|mesh-ancestor
111085121|NCT03348917|Plasma Substitutes|plasma substitutes|mesh-ancestor
111085122|NCT03348917|Blood Substitutes|blood substitutes|mesh-ancestor
111085123|NCT03251599|Nitroglycerin|nitroglycerin|mesh-list
111085124|NCT03251599|Vasodilator Agents|vasodilator agents|mesh-ancestor
111085125|NCT03251365|Gemcitabine|gemcitabine|mesh-list
111085126|NCT03251365|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111085127|NCT03251365|Antimetabolites|antimetabolites|mesh-ancestor
111085128|NCT03251365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111085129|NCT03251365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111085130|NCT03251443|Apatinib|apatinib|mesh-list
111085131|NCT03251443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111085132|NCT03251443|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111085133|NCT03251443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111085134|NCT03251443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111085135|NCT04502303|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
111085136|NCT04502303|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111085137|NCT04502303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111085138|NCT05350943|Gemcitabine|gemcitabine|mesh-list
111085139|NCT05350943|Oxaliplatin|oxaliplatin|mesh-list
111085140|NCT05350943|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111085141|NCT05350943|Antimetabolites|antimetabolites|mesh-ancestor
111085142|NCT05350943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111085143|NCT05350943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111085144|NCT03261427|Pregabalin|pregabalin|mesh-list
111085145|NCT03261427|Analgesics|analgesics|mesh-ancestor
111085146|NCT03261427|Sensory System Agents|sensory system agents|mesh-ancestor
111085147|NCT03261427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111085148|NCT03261427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111085149|NCT03261427|Anticonvulsants|anticonvulsants|mesh-ancestor
111085150|NCT03261427|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111085151|NCT03261427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111085152|NCT03261427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111085153|NCT03261427|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111085154|NCT03261427|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111085155|NCT03261427|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111085156|NCT03261427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111085157|NCT03261427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111085158|NCT03261115|Anesthetics|anesthetics|mesh-list
111085159|NCT03261115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111085160|NCT03261115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111085161|NCT03348527|Hydroxyflutamide|hydroxyflutamide|mesh-list
110396029|NCT01326546|Entecavir|entecavir|mesh-list
111085162|NCT03348527|Androgen Antagonists|androgen antagonists|mesh-ancestor
111085163|NCT03348527|Hormone Antagonists|hormone antagonists|mesh-ancestor
111085164|NCT03348527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111085165|NCT03348527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111085166|NCT05320133|Bismuth|bismuth|mesh-list
111085167|NCT05320133|Antacids|antacids|mesh-ancestor
111085168|NCT05320133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111085169|NCT05320133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111085170|NCT03122561|Acetaminophen|acetaminophen|mesh-list
111085171|NCT03122561|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111085172|NCT03122561|Analgesics|analgesics|mesh-ancestor
111085173|NCT03122561|Sensory System Agents|sensory system agents|mesh-ancestor
111085174|NCT03122561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111085175|NCT03122561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111085176|NCT03122561|Antipyretics|antipyretics|mesh-ancestor
111085177|NCT04503629|Rabeprazole|rabeprazole|mesh-list
111085178|NCT04503629|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111085179|NCT04503629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111085180|NCT04503629|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111085181|NCT04503629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111085182|NCT04503629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111085183|NCT03256981|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
111085184|NCT03256981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111085185|NCT03256981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111085186|NCT03256981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111085187|NCT03256903|Methoxyflurane|methoxyflurane|mesh-list
111085188|NCT03256903|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111085189|NCT03256903|Anesthetics, General|anesthetics, general|mesh-ancestor
111085190|NCT03256903|Anesthetics|anesthetics|mesh-ancestor
111085191|NCT03256903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111085192|NCT03256903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111085193|NCT03256825|Anti-Infective Agents|anti-infective agents|mesh-list
111085194|NCT03256825|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111085195|NCT03348371|Ethanol|ethanol|mesh-list
111085196|NCT03348371|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111085197|NCT03348371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111085198|NCT03348371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111085199|NCT03348371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111085200|NCT05231603|Ivermectin|ivermectin|mesh-list
111085201|NCT05231603|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111085202|NCT05231603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111085203|NCT05196191|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
111085204|NCT05196191|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111085205|NCT05196191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111085206|NCT05196191|Dermatologic Agents|dermatologic agents|mesh-ancestor
111085207|NCT03467113|Cannabidiol|cannabidiol|mesh-list
111085208|NCT03467113|Anticonvulsants|anticonvulsants|mesh-ancestor
111085209|NCT03434041|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
111085210|NCT03434041|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
111085211|NCT03434041|Sertraline|sertraline|mesh-list
111085212|NCT03434041|Antidepressive Agents|antidepressive agents|mesh-list
111085213|NCT03434041|Esketamine|esketamine|mesh-list
111085214|NCT03434041|Escitalopram|escitalopram|mesh-list
111085215|NCT03434041|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111085216|NCT03434041|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111085217|NCT03434041|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111085218|NCT03434041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111085219|NCT03434041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111085220|NCT03434041|Serotonin Agents|serotonin agents|mesh-ancestor
111085221|NCT03434041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111085222|NCT03434041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111085223|NCT03434041|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111085224|NCT03434041|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111085225|NCT03434041|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111085226|NCT03434041|Analgesics|analgesics|mesh-ancestor
111085227|NCT03434041|Sensory System Agents|sensory system agents|mesh-ancestor
111085228|NCT03434041|Dopamine Agents|dopamine agents|mesh-ancestor
111085229|NCT03250741|Rotigotine|rotigotine|mesh-list
111085230|NCT03250741|Dopamine Agonists|dopamine agonists|mesh-ancestor
111085231|NCT03250741|Dopamine Agents|dopamine agents|mesh-ancestor
111085232|NCT03250741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111085233|NCT03250741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111085234|NCT03250741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111085235|NCT03255811|Apatinib|apatinib|mesh-list
111085236|NCT03255811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111085237|NCT03255811|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111085238|NCT03255811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111085239|NCT03255811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111085240|NCT01842035|Regadenoson|regadenoson|mesh-list
111085241|NCT01842035|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
111085242|NCT01842035|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
111085243|NCT01842035|Purinergic Agonists|purinergic agonists|mesh-ancestor
111085244|NCT01842035|Purinergic Agents|purinergic agents|mesh-ancestor
111085245|NCT01842035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111085246|NCT01842035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111085247|NCT01842035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111085248|NCT03348059|Antiviral Agents|antiviral agents|mesh-list
111085249|NCT03348059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111085250|NCT05585177|Hormones|hormones|mesh-list
111085251|NCT05585177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111085252|NCT05585177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111085253|NCT03250039|Abrocitinib|abrocitinib|mesh-list
111085254|NCT03250039|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111085255|NCT03250039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111085256|NCT03250039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111085257|NCT02517827|Paclitaxel|paclitaxel|mesh-list
111085258|NCT02517827|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111085259|NCT02517827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111085260|NCT02517827|Tubulin Modulators|tubulin modulators|mesh-ancestor
111085261|NCT02517827|Antimitotic Agents|antimitotic agents|mesh-ancestor
111085262|NCT02517827|Mitosis Modulators|mitosis modulators|mesh-ancestor
111085263|NCT02517827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111085264|NCT05045183|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111085265|NCT05045183|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
111085266|NCT05045183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111085267|NCT03246451|Metformin|metformin|mesh-list
111085268|NCT03246451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111085269|NCT03246451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111085270|NCT05013437|Acetaminophen|acetaminophen|mesh-list
111085271|NCT05013437|Diphenhydramine|diphenhydramine|mesh-list
111085273|NCT05013437|Melphalan|melphalan|mesh-list
111085274|NCT05013437|Prochlorperazine|prochlorperazine|mesh-list
111085275|NCT05013437|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111085276|NCT05013437|Analgesics|analgesics|mesh-ancestor
111085277|NCT05013437|Sensory System Agents|sensory system agents|mesh-ancestor
111085278|NCT05013437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111085279|NCT05013437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111085280|NCT05013437|Antipyretics|antipyretics|mesh-ancestor
111085281|NCT05013437|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111085282|NCT05013437|Alkylating Agents|alkylating agents|mesh-ancestor
111085283|NCT05013437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111085284|NCT05013437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111085285|NCT05013437|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111085286|NCT05013437|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111085287|NCT05013437|Immunologic Factors|immunologic factors|mesh-ancestor
111085288|NCT05013437|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111085289|NCT05013437|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111085290|NCT05013437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111085291|NCT05013437|Anesthetics, Local|anesthetics, local|mesh-ancestor
111085292|NCT05013437|Anesthetics|anesthetics|mesh-ancestor
111085293|NCT05013437|Antiemetics|antiemetics|mesh-ancestor
111085294|NCT05013437|Autonomic Agents|autonomic agents|mesh-ancestor
111085295|NCT05013437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111085296|NCT05013437|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111085297|NCT05013437|Histamine Antagonists|histamine antagonists|mesh-ancestor
111085298|NCT05013437|Histamine Agents|histamine agents|mesh-ancestor
111085299|NCT05013437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111085300|NCT05013437|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111085301|NCT05013437|Antipruritics|antipruritics|mesh-ancestor
111085302|NCT05013437|Dermatologic Agents|dermatologic agents|mesh-ancestor
111085303|NCT05013437|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111085304|NCT05013437|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111085305|NCT05013437|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111085306|NCT05013437|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111085307|NCT05013437|Dopamine Agents|dopamine agents|mesh-ancestor
111085308|NCT03246295|Insulin|insulin|mesh-list
111085309|NCT03246295|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111085310|NCT03246295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111085311|NCT03346733|Psyllium|psyllium|mesh-list
111085312|NCT03346733|Cathartics|cathartics|mesh-ancestor
111085313|NCT03346733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111085314|NCT03249337|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111085315|NCT03249337|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111085316|NCT03346187|Atorvastatin|atorvastatin|mesh-list
111085317|NCT03346187|Fenofibrate|fenofibrate|mesh-list
111085318|NCT03346187|Calcium|calcium|mesh-list
111085319|NCT03346187|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111085320|NCT03346187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111085321|NCT03346187|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111085322|NCT03346187|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111085323|NCT03346187|Antimetabolites|antimetabolites|mesh-ancestor
111085324|NCT03346187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111085325|NCT03346187|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111085326|NCT03346187|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111085327|NCT03346187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111085328|NCT04487743|Liraglutide|liraglutide|mesh-list
111085329|NCT04487743|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111085330|NCT04487743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111085331|NCT04487743|Incretins|incretins|mesh-ancestor
111085332|NCT04487743|Hormones|hormones|mesh-ancestor
111085333|NCT04487743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111085334|NCT05010629|Carboplatin|carboplatin|mesh-list
111085335|NCT05010629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111085336|NCT05584631|Immunoglobulins|immunoglobulins|mesh-list
111085337|NCT05584631|Antibodies|antibodies|mesh-list
111085338|NCT05584631|gamma-Globulins|gamma-globulins|mesh-list
111085339|NCT05584631|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111085340|NCT05584631|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
111085341|NCT05584631|Immunoglobulin G|immunoglobulin g|mesh-list
111085342|NCT05584631|Immunologic Factors|immunologic factors|mesh-ancestor
110802440|NCT04647500|Methylphenidate|methylphenidate|mesh-list
111085343|NCT05584631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111085344|NCT03249259|Choline|choline|mesh-list
111085345|NCT03249259|Lipotropic Agents|lipotropic agents|mesh-ancestor
111085346|NCT03249259|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111085347|NCT03249259|Antimetabolites|antimetabolites|mesh-ancestor
111085348|NCT03249259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111085349|NCT03249259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111085350|NCT03249259|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111085351|NCT03249259|Nootropic Agents|nootropic agents|mesh-ancestor
111085352|NCT04487587|Olaparib|olaparib|mesh-list
111085353|NCT04487587|Cediranib|cediranib|mesh-list
111085354|NCT04487587|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111085355|NCT04487587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111085356|NCT04487587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111085357|NCT04487587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111085358|NCT04487587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111085359|NCT04833413|Insulin|insulin|mesh-list
111085360|NCT04833413|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111085361|NCT04833413|Hypoglycemic Agents|hypoglycemic agents|mesh-list
111085362|NCT04833413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111085363|NCT02454751|Fentanyl|fentanyl|mesh-list
111085364|NCT02454751|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111085365|NCT02454751|Narcotics|narcotics|mesh-ancestor
111085366|NCT02454751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111085367|NCT02454751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111085368|NCT02454751|Analgesics|analgesics|mesh-ancestor
111085369|NCT02454751|Sensory System Agents|sensory system agents|mesh-ancestor
111085370|NCT02454751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111085371|NCT02454751|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111085372|NCT02454751|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111085373|NCT02454751|Anesthetics, General|anesthetics, general|mesh-ancestor
111085374|NCT02454751|Anesthetics|anesthetics|mesh-ancestor
111085375|NCT02455921|Atropine|atropine|mesh-list
111085376|NCT02455921|Neostigmine|neostigmine|mesh-list
111085377|NCT02455921|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111085378|NCT02455921|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111085379|NCT02455921|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111085380|NCT02455921|Autonomic Agents|autonomic agents|mesh-ancestor
111085381|NCT02455921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111085382|NCT02455921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111085383|NCT02455921|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111085384|NCT02455921|Respiratory System Agents|respiratory system agents|mesh-ancestor
111085385|NCT02455921|Mydriatics|mydriatics|mesh-ancestor
111085386|NCT02455921|Parasympatholytics|parasympatholytics|mesh-ancestor
111085387|NCT02455921|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111085388|NCT02455921|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111085389|NCT02455921|Cholinergic Agents|cholinergic agents|mesh-ancestor
111085390|NCT02455921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111085391|NCT02455921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111085392|NCT02455921|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111085393|NCT02455921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111085394|NCT02455921|Parasympathomimetics|parasympathomimetics|mesh-ancestor
111085395|NCT04786613|Hyaluronic Acid|hyaluronic acid|mesh-list
111085396|NCT04786613|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111085397|NCT04786613|Immunologic Factors|immunologic factors|mesh-ancestor
111085398|NCT04786613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111085399|NCT04786613|Viscosupplements|viscosupplements|mesh-ancestor
111085400|NCT04786613|Protective Agents|protective agents|mesh-ancestor
111085401|NCT04767191|Lumefantrine|lumefantrine|mesh-list
111085402|NCT04767191|Artemether|artemether|mesh-list
111085403|NCT04767191|Piperaquine|piperaquine|mesh-list
111085404|NCT04767191|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
111085405|NCT04767191|Artenimol|artenimol|mesh-list
111085406|NCT04767191|Antimalarials|antimalarials|mesh-ancestor
111085407|NCT04767191|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111085408|NCT04767191|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111085409|NCT04767191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111085410|NCT00700999|Paroxetine|paroxetine|mesh-list
111085411|NCT00700999|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111085412|NCT00700999|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111085413|NCT00700999|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110799545|NCT03752931|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111085414|NCT00700999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111085415|NCT00700999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111085416|NCT00700999|Serotonin Agents|serotonin agents|mesh-ancestor
111085417|NCT00700999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111085418|NCT00700999|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111085419|NCT00700999|Antidepressive Agents|antidepressive agents|mesh-ancestor
111085420|NCT00700999|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111085421|NCT00700999|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111085422|NCT00700999|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111085423|NCT00700999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111085424|NCT04502771|Antifungal Agents|antifungal agents|mesh-list
111085425|NCT04502771|Clotrimazole|clotrimazole|mesh-list
111085426|NCT04502771|Miconazole|miconazole|mesh-list
111085427|NCT04502771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111085428|NCT04502771|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111085429|NCT04502771|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111085430|NCT04502771|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111085431|NCT04502771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111085432|NCT04502771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111085433|NCT04502771|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111085434|NCT04502771|Hormone Antagonists|hormone antagonists|mesh-ancestor
111085435|NCT04502771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111085436|NCT04502771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111085437|NCT04502771|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111085438|NCT04502771|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111085439|NCT04761887|Ropivacaine|ropivacaine|mesh-list
111085440|NCT04761887|Anesthetics, Local|anesthetics, local|mesh-ancestor
111085441|NCT04761887|Anesthetics|anesthetics|mesh-ancestor
111085442|NCT04761887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111085443|NCT04761887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111085444|NCT04761887|Sensory System Agents|sensory system agents|mesh-ancestor
111085445|NCT04761887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111085446|NCT03249025|Lidocaine|lidocaine|mesh-list
111085447|NCT03249025|Ketamine|ketamine|mesh-list
111085448|NCT03249025|Anesthetics, Local|anesthetics, local|mesh-ancestor
111085449|NCT03249025|Anesthetics|anesthetics|mesh-ancestor
111085450|NCT03249025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111085451|NCT03249025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111085452|NCT03249025|Sensory System Agents|sensory system agents|mesh-ancestor
111085453|NCT03249025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111085454|NCT03249025|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111085455|NCT03249025|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111085456|NCT03249025|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111085457|NCT03249025|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111085458|NCT03249025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111085459|NCT03249025|Analgesics|analgesics|mesh-ancestor
111085460|NCT03249025|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111085461|NCT03249025|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111085462|NCT03249025|Anesthetics, General|anesthetics, general|mesh-ancestor
111085463|NCT03249025|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111085464|NCT03249025|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111085465|NCT03249025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111085466|NCT03248713|Mifepristone|mifepristone|mesh-list
111085467|NCT03248713|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
111085468|NCT03248713|Abortifacient Agents|abortifacient agents|mesh-ancestor
111085469|NCT03248713|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111085470|NCT03248713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111085471|NCT03248713|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111085472|NCT03248713|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111085473|NCT03248713|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111085474|NCT03248713|Contraceptive Agents|contraceptive agents|mesh-ancestor
111085475|NCT03248713|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
111085476|NCT03248713|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
111085477|NCT03248713|Hormone Antagonists|hormone antagonists|mesh-ancestor
111085478|NCT03248713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111085479|NCT03248713|Luteolytic Agents|luteolytic agents|mesh-ancestor
111085480|NCT03248713|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111085481|NCT03248713|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
111085482|NCT03245671|Dexamethasone|dexamethasone|mesh-list
111085483|NCT03245671|Dexamethasone acetate|dexamethasone acetate|mesh-list
111085484|NCT03245671|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
111085485|NCT03245671|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
111085486|NCT03245671|BB 1101|bb 1101|mesh-list
111085487|NCT03245671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111085488|NCT03245671|Antiemetics|antiemetics|mesh-ancestor
111085489|NCT03245671|Autonomic Agents|autonomic agents|mesh-ancestor
111085490|NCT03245671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111085491|NCT03245671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111085492|NCT03245671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111085493|NCT03245671|Glucocorticoids|glucocorticoids|mesh-ancestor
111085494|NCT03245671|Hormones|hormones|mesh-ancestor
111085495|NCT03245671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111085496|NCT03245671|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111085497|NCT03245671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111085498|NCT03245671|Protease Inhibitors|protease inhibitors|mesh-ancestor
111085499|NCT03245671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111085500|NCT03245671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111085501|NCT03245671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111085502|NCT03245671|Immunologic Factors|immunologic factors|mesh-ancestor
111085503|NCT03254641|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
111085504|NCT03254641|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111085505|NCT03254641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111085506|NCT04627571|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111085507|NCT04627571|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111085508|NCT03245515|Branebrutinib|branebrutinib|mesh-list
111085509|NCT03245515|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111085510|NCT03245515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111085511|NCT03245515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111085512|NCT03363503|Fluticasone|fluticasone|mesh-list
111085514|NCT03363503|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
111085515|NCT03363503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111085516|NCT03363503|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111085517|NCT03363503|Autonomic Agents|autonomic agents|mesh-ancestor
111085518|NCT03363503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111085519|NCT03363503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111085520|NCT03363503|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111085521|NCT03363503|Respiratory System Agents|respiratory system agents|mesh-ancestor
111085522|NCT03363503|Dermatologic Agents|dermatologic agents|mesh-ancestor
111085523|NCT03363503|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111085524|NCT03363503|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111085525|NCT03363503|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111085526|NCT03363503|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111085527|NCT03363503|Adrenergic Agents|adrenergic agents|mesh-ancestor
111085528|NCT03363503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111085529|NCT03363503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111085530|NCT03248791|Phenylephrine|phenylephrine|mesh-list
111085531|NCT03248791|Oxymetazoline|oxymetazoline|mesh-list
111085532|NCT03248791|Norepinephrine|norepinephrine|mesh-list
111085533|NCT03248791|Bupivacaine|bupivacaine|mesh-list
111085534|NCT03248791|Anesthetics, Local|anesthetics, local|mesh-ancestor
111085535|NCT03248791|Anesthetics|anesthetics|mesh-ancestor
111085536|NCT03248791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111085537|NCT03248791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111085538|NCT03248791|Sensory System Agents|sensory system agents|mesh-ancestor
111085539|NCT03248791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111085540|NCT03248791|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111085541|NCT03248791|Mydriatics|mydriatics|mesh-ancestor
111085542|NCT03248791|Autonomic Agents|autonomic agents|mesh-ancestor
111085543|NCT03248791|Sympathomimetics|sympathomimetics|mesh-ancestor
111085544|NCT03248791|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111085545|NCT03248791|Nasal Decongestants|nasal decongestants|mesh-ancestor
111085546|NCT03248791|Respiratory System Agents|respiratory system agents|mesh-ancestor
111085547|NCT03248791|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111085548|NCT03248791|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111085549|NCT03248791|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111085550|NCT03248791|Adrenergic Agents|adrenergic agents|mesh-ancestor
111085551|NCT03248791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111085552|NCT03248791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111085553|NCT03248791|Protective Agents|protective agents|mesh-ancestor
111085554|NCT03254173|Mirtazapine|mirtazapine|mesh-list
111085555|NCT03254173|Antidepressive Agents|antidepressive agents|mesh-ancestor
111085556|NCT03254173|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111085557|NCT03254173|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111085558|NCT03254173|Histamine Antagonists|histamine antagonists|mesh-ancestor
111085559|NCT03254173|Histamine Agents|histamine agents|mesh-ancestor
111085560|NCT03254173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111085561|NCT03254173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111085562|NCT03254173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111085563|NCT03254173|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111085564|NCT03254173|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111085565|NCT03254173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111085566|NCT03254173|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
111085567|NCT03254173|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111085568|NCT03254173|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111085569|NCT03254173|Adrenergic Agents|adrenergic agents|mesh-ancestor
111085570|NCT03254173|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111085571|NCT03254173|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111085572|NCT03254173|Serotonin Agents|serotonin agents|mesh-ancestor
111085573|NCT03254173|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111085574|NCT03248401|Aspirin|aspirin|mesh-list
111085575|NCT03248401|Cilostazol|cilostazol|mesh-list
111085576|NCT03248401|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111085577|NCT03248401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111085578|NCT03248401|Analgesics|analgesics|mesh-ancestor
111085579|NCT03248401|Sensory System Agents|sensory system agents|mesh-ancestor
111085580|NCT03248401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111085581|NCT03248401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111085582|NCT03248401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111085583|NCT03248401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111085584|NCT03248401|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111085585|NCT03248401|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111085586|NCT03248401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111085587|NCT03248401|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111085588|NCT03248401|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111085589|NCT03248401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111085590|NCT03248401|Antipyretics|antipyretics|mesh-ancestor
111085591|NCT03248401|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111085592|NCT03248401|Autonomic Agents|autonomic agents|mesh-ancestor
111085593|NCT03248401|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111085594|NCT03248401|Respiratory System Agents|respiratory system agents|mesh-ancestor
111085595|NCT03248401|Vasodilator Agents|vasodilator agents|mesh-ancestor
111085596|NCT03248401|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111085597|NCT03248401|Protective Agents|protective agents|mesh-ancestor
111085598|NCT03248401|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
111085599|NCT03248401|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111085600|NCT02516423|Zoledronic Acid|zoledronic acid|mesh-list
111085601|NCT02516423|Dexamethasone|dexamethasone|mesh-list
111085602|NCT02516423|Lenalidomide|lenalidomide|mesh-list
111085603|NCT02516423|Ixazomib|ixazomib|mesh-list
111085604|NCT02516423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111085605|NCT02516423|Antiemetics|antiemetics|mesh-ancestor
111085606|NCT02516423|Autonomic Agents|autonomic agents|mesh-ancestor
110640554|NCT05683301|Perindopril|perindopril|mesh-list
111085607|NCT02516423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111085608|NCT02516423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111085609|NCT02516423|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111085610|NCT02516423|Glucocorticoids|glucocorticoids|mesh-ancestor
111085611|NCT02516423|Hormones|hormones|mesh-ancestor
111085612|NCT02516423|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111085613|NCT02516423|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111085614|NCT02516423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111085615|NCT02516423|Immunologic Factors|immunologic factors|mesh-ancestor
111085616|NCT02516423|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111085617|NCT02516423|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111085618|NCT02516423|Growth Substances|growth substances|mesh-ancestor
111085619|NCT02516423|Growth Inhibitors|growth inhibitors|mesh-ancestor
111085620|NCT02516423|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111085621|NCT02516423|Protease Inhibitors|protease inhibitors|mesh-ancestor
111085622|NCT02516423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111085623|NCT02516423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111085625|NCT03245281|Natriuretic Agents|natriuretic agents|mesh-ancestor
111085626|NCT03245281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111085627|NCT02515955|Minocycline|minocycline|mesh-list
111085628|NCT02515955|Amphetamine|amphetamine|mesh-list
111085629|NCT02515955|Dextroamphetamine|dextroamphetamine|mesh-list
111085630|NCT02515955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111085631|NCT02515955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111085632|NCT02515955|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111085633|NCT02515955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111085634|NCT02515955|Sympathomimetics|sympathomimetics|mesh-ancestor
111085635|NCT02515955|Autonomic Agents|autonomic agents|mesh-ancestor
111085636|NCT02515955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111085637|NCT02515955|Dopamine Agents|dopamine agents|mesh-ancestor
111085638|NCT02515955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111085639|NCT02515955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111085640|NCT02515955|Adrenergic Agents|adrenergic agents|mesh-ancestor
111085641|NCT02515955|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111085642|NCT02515955|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111085643|NCT02515955|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111085644|NCT02515955|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111085645|NCT03345797|Testosterone|testosterone|mesh-list
111085646|NCT03345797|Androgens|androgens|mesh-ancestor
111085647|NCT03345797|Hormones|hormones|mesh-ancestor
111085648|NCT03345797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111085649|NCT03345797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111085650|NCT04500743|Leuprolide|leuprolide|mesh-list
111085651|NCT04500743|Dienogest|dienogest|mesh-list
111085652|NCT04500743|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111085653|NCT04500743|Fertility Agents|fertility agents|mesh-ancestor
111085654|NCT04500743|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111085655|NCT04500743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111085656|NCT04500743|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111085657|NCT04500743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111085658|NCT04500743|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
111085659|NCT04500743|Contraceptive Agents|contraceptive agents|mesh-ancestor
111085660|NCT04500743|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111085661|NCT04500743|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111085662|NCT04500743|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111085663|NCT04500743|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111085664|NCT04500743|Hormone Antagonists|hormone antagonists|mesh-ancestor
111085665|NCT04500743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111085666|NCT04501991|Hypoglycemic Agents|hypoglycemic agents|mesh-list
111085667|NCT04501991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111085668|NCT03239353|Entecavir|entecavir|mesh-list
111085669|NCT03239353|Antiviral Agents|antiviral agents|mesh-ancestor
111085670|NCT03239353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111085671|NCT03347591|polysaccharide-K|polysaccharide-k|mesh-list
111085672|NCT03347591|Hemostatics|hemostatics|mesh-list
111085673|NCT03347591|Coagulants|coagulants|mesh-ancestor
111085674|NCT03347591|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111085675|NCT03347591|Immunologic Factors|immunologic factors|mesh-ancestor
111085676|NCT03347591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111085677|NCT03347591|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111085678|NCT03347591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111085679|NCT03347591|Antiviral Agents|antiviral agents|mesh-ancestor
111085680|NCT03347591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111085681|NCT03347591|Interferon Inducers|interferon inducers|mesh-ancestor
111085682|NCT03347591|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111085683|NCT03347591|Protective Agents|protective agents|mesh-ancestor
111085684|NCT04486651|Irinotecan|irinotecan|mesh-list
111085685|NCT04486651|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111085686|NCT04486651|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111085687|NCT04486651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111085688|NCT04486651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111085689|NCT04486651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111085690|NCT03347513|Glycine|glycine|mesh-list
111085691|NCT03347513|Glycine Agents|glycine agents|mesh-ancestor
111085692|NCT03347513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111085693|NCT03347513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111085694|NCT03347513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111085695|NCT04088591|Ascorbic Acid|ascorbic acid|mesh-list
111085696|NCT04088591|Antioxidants|antioxidants|mesh-ancestor
111085697|NCT04088591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111085698|NCT04088591|Protective Agents|protective agents|mesh-ancestor
111085699|NCT04088591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111085700|NCT04088591|Vitamins|vitamins|mesh-ancestor
111085701|NCT04088591|Micronutrients|micronutrients|mesh-ancestor
111085702|NCT04501289|Magnesium Sulfate|magnesium sulfate|mesh-list
111085703|NCT04501289|Analgesics|analgesics|mesh-ancestor
111085704|NCT04501289|Sensory System Agents|sensory system agents|mesh-ancestor
111085705|NCT04501289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111085706|NCT04501289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111085707|NCT04501289|Anesthetics|anesthetics|mesh-ancestor
111085708|NCT04501289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111085709|NCT04501289|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111085710|NCT04501289|Anticonvulsants|anticonvulsants|mesh-ancestor
111085711|NCT04501289|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111085712|NCT04501289|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111085713|NCT04501289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111085714|NCT04501289|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111085715|NCT04501289|Tocolytic Agents|tocolytic agents|mesh-ancestor
111085716|NCT04501289|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111085717|NCT03244423|Tranexamic Acid|tranexamic acid|mesh-list
111085718|NCT03244423|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111085719|NCT03244423|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111085720|NCT03244423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111085721|NCT03244423|Hemostatics|hemostatics|mesh-ancestor
111085722|NCT03244423|Coagulants|coagulants|mesh-ancestor
111085723|NCT03347357|Tacrolimus|tacrolimus|mesh-list
111085724|NCT03347357|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111085725|NCT03347357|Immunologic Factors|immunologic factors|mesh-ancestor
111085726|NCT03347357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111085727|NCT03347357|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111085728|NCT03347357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111085729|NCT03347357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111085730|NCT02325349|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
111085731|NCT02325349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111085732|NCT02515877|Carboplatin|carboplatin|mesh-list
111085733|NCT02515877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111085734|NCT03952091|Dexamethasone|dexamethasone|mesh-list
111085735|NCT03952091|Dexamethasone acetate|dexamethasone acetate|mesh-list
111085736|NCT03952091|Lenalidomide|lenalidomide|mesh-list
111085737|NCT03952091|BB 1101|bb 1101|mesh-list
111085738|NCT03952091|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111085739|NCT03952091|Antiemetics|antiemetics|mesh-ancestor
111085740|NCT03952091|Autonomic Agents|autonomic agents|mesh-ancestor
111085741|NCT03952091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111085742|NCT03952091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111085743|NCT03952091|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111085744|NCT03952091|Glucocorticoids|glucocorticoids|mesh-ancestor
111085745|NCT03952091|Hormones|hormones|mesh-ancestor
111085746|NCT03952091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111085747|NCT03952091|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111085748|NCT03952091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111085749|NCT03952091|Protease Inhibitors|protease inhibitors|mesh-ancestor
111085750|NCT03952091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111085751|NCT03952091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111085752|NCT03952091|Immunologic Factors|immunologic factors|mesh-ancestor
111085753|NCT03952091|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111085754|NCT03952091|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111085755|NCT03952091|Growth Substances|growth substances|mesh-ancestor
111085756|NCT03952091|Growth Inhibitors|growth inhibitors|mesh-ancestor
111085757|NCT03246919|Oxytocin|oxytocin|mesh-list
111085758|NCT03246919|Oxytocics|oxytocics|mesh-ancestor
111085759|NCT03246919|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111085760|NCT03246919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111085761|NCT04502537|Epoetin Alfa|epoetin alfa|mesh-list
111085762|NCT04502537|Hematinics|hematinics|mesh-ancestor
111085763|NCT02453659|Nicotine|nicotine|mesh-list
111085764|NCT02453659|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111085765|NCT02453659|Autonomic Agents|autonomic agents|mesh-ancestor
111085766|NCT02453659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111085767|NCT02453659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111085768|NCT02453659|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111085769|NCT02453659|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111085770|NCT02453659|Cholinergic Agents|cholinergic agents|mesh-ancestor
111085771|NCT02453659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111085772|NCT02453659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111085773|NCT02513147|Lopinavir|lopinavir|mesh-list
111085774|NCT02513147|Atazanavir Sulfate|atazanavir sulfate|mesh-list
111085775|NCT02513147|Darunavir|darunavir|mesh-list
111085776|NCT02513147|Fosamprenavir|fosamprenavir|mesh-list
111085777|NCT02513147|Dolutegravir|dolutegravir|mesh-list
111085778|NCT02513147|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111085779|NCT02513147|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111085780|NCT02513147|Protease Inhibitors|protease inhibitors|mesh-ancestor
111085781|NCT02513147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111085782|NCT02513147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111085783|NCT02513147|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111085784|NCT02513147|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111085785|NCT02513147|Antiviral Agents|antiviral agents|mesh-ancestor
111085786|NCT02513147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111085787|NCT02513147|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111085788|NCT02513147|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111085789|NCT02513147|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111085790|NCT02513147|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111085791|NCT03246685|Pembrolizumab|pembrolizumab|mesh-list
111085792|NCT03246685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111085793|NCT03246685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111085794|NCT03246685|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111085795|NCT03246685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111085796|NCT02453893|Risperidone|risperidone|mesh-list
111085797|NCT02453893|Iloperidone|iloperidone|mesh-list
111085798|NCT02453893|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111085799|NCT02453893|Serotonin Agents|serotonin agents|mesh-ancestor
111085800|NCT02453893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111085801|NCT02453893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111085802|NCT02453893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111085803|NCT02453893|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111085804|NCT02453893|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111085805|NCT02453893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111085806|NCT02453893|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111085807|NCT02453893|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111085808|NCT02453893|Dopamine Agents|dopamine agents|mesh-ancestor
111085809|NCT03664895|Goserelin|goserelin|mesh-list
111085810|NCT03664895|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111085811|NCT03664895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111085812|NCT02513069|Nicotine|nicotine|mesh-list
111085813|NCT02513069|Carbon Monoxide|carbon monoxide|mesh-list
111085814|NCT02513069|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111085815|NCT02513069|Autonomic Agents|autonomic agents|mesh-ancestor
111085816|NCT02513069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111085817|NCT02513069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111085818|NCT02513069|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111085819|NCT02513069|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111085820|NCT02513069|Cholinergic Agents|cholinergic agents|mesh-ancestor
111085821|NCT02513069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111085822|NCT02513069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111085823|NCT02513069|Antimetabolites|antimetabolites|mesh-ancestor
111085824|NCT02513069|Gasotransmitters|gasotransmitters|mesh-ancestor
111085825|NCT02454205|Moxifloxacin|moxifloxacin|mesh-list
111085826|NCT02454205|Levofloxacin|levofloxacin|mesh-list
111085827|NCT02454205|Isoniazid|isoniazid|mesh-list
111085828|NCT02454205|Linezolid|linezolid|mesh-list
111085829|NCT02454205|Pyrazinamide|pyrazinamide|mesh-list
111085830|NCT02454205|Bedaquiline|bedaquiline|mesh-list
111085831|NCT02454205|Kanamycin|kanamycin|mesh-list
111085832|NCT02454205|Ethionamide|ethionamide|mesh-list
111085833|NCT02454205|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111085834|NCT02454205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111085835|NCT02454205|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111085836|NCT02454205|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111085837|NCT02454205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111085838|NCT02454205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111085839|NCT02454205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111085840|NCT02454205|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111085841|NCT02454205|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111085843|NCT02454205|Antitubercular Agents|antitubercular agents|mesh-ancestor
111085844|NCT02454205|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
111085845|NCT02454205|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111085846|NCT02454205|Antimetabolites|antimetabolites|mesh-ancestor
111085847|NCT02454205|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111085848|NCT02454205|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111085849|NCT03235141|Azithromycin|azithromycin|mesh-list
111085850|NCT03235141|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111085851|NCT03235141|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111085852|NCT03235141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111085853|NCT03235141|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111085854|NCT03234751|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
111085855|NCT03234751|Natriuretic Agents|natriuretic agents|mesh-ancestor
111085856|NCT03234751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111085857|NCT03107689|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
111085858|NCT03107689|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
111085859|NCT03107689|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111085860|NCT03234673|Calcipotriene|calcipotriene|mesh-list
111085861|NCT03234673|Tacrolimus|tacrolimus|mesh-list
111085862|NCT03234673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111085863|NCT03234673|Immunologic Factors|immunologic factors|mesh-ancestor
111085864|NCT03234673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111085865|NCT03234673|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111085866|NCT03234673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111085867|NCT03234673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111085868|NCT03234673|Dermatologic Agents|dermatologic agents|mesh-ancestor
111085869|NCT03148613|Carbon Monoxide|carbon monoxide|mesh-list
111085870|NCT03148613|Antimetabolites|antimetabolites|mesh-ancestor
111085871|NCT03148613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111085872|NCT03148613|Gasotransmitters|gasotransmitters|mesh-ancestor
111085873|NCT03148613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111085874|NCT03148613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111085875|NCT03243643|Apatinib|apatinib|mesh-list
111085876|NCT03243643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111085877|NCT03243643|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111085878|NCT03243643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111085879|NCT03243643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111085880|NCT03234517|Clindamycin|clindamycin|mesh-list
111085881|NCT03234517|Clindamycin palmitate|clindamycin palmitate|mesh-list
111085882|NCT03234517|Clindamycin phosphate|clindamycin phosphate|mesh-list
111085883|NCT03234517|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111085884|NCT03234517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111085885|NCT03234517|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111085886|NCT03234517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111085887|NCT03234517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111085888|NCT03238183|Hyaluronic Acid|hyaluronic acid|mesh-list
111085889|NCT03238183|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111085890|NCT03238183|Immunologic Factors|immunologic factors|mesh-ancestor
111085891|NCT03238183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111085892|NCT03238183|Viscosupplements|viscosupplements|mesh-ancestor
111085893|NCT03238183|Protective Agents|protective agents|mesh-ancestor
111085894|NCT02729051|Albuterol|albuterol|mesh-list
111085895|NCT02729051|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111085896|NCT02729051|Autonomic Agents|autonomic agents|mesh-ancestor
111085897|NCT02729051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111085898|NCT02729051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111085899|NCT02729051|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111085900|NCT02729051|Respiratory System Agents|respiratory system agents|mesh-ancestor
111085901|NCT02729051|Tocolytic Agents|tocolytic agents|mesh-ancestor
111085902|NCT02729051|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111085903|NCT02729051|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111085904|NCT02729051|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111085905|NCT02729051|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111085906|NCT02729051|Adrenergic Agents|adrenergic agents|mesh-ancestor
111085907|NCT02729051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111085908|NCT02729051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111085909|NCT03237637|Propranolol|propranolol|mesh-list
111085910|NCT03237637|Atenolol|atenolol|mesh-list
111085911|NCT03237637|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111085912|NCT03237637|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111085913|NCT03237637|Adrenergic Agents|adrenergic agents|mesh-ancestor
111085914|NCT03237637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111085915|NCT03237637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111085916|NCT03237637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111085918|NCT03237637|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111085919|NCT03237637|Vasodilator Agents|vasodilator agents|mesh-ancestor
111085920|NCT03237637|Sympatholytics|sympatholytics|mesh-ancestor
111085921|NCT03237637|Autonomic Agents|autonomic agents|mesh-ancestor
111085922|NCT03237637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111085923|NCT03237637|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
111085924|NCT03243331|Gedatolisib|gedatolisib|mesh-list
111085925|NCT03243331|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111085926|NCT03243331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111085927|NCT03243331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111085928|NCT03237715|Bilirubin|bilirubin|mesh-list
111085929|NCT03237715|Antioxidants|antioxidants|mesh-ancestor
111085930|NCT03237715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111085931|NCT03237715|Protective Agents|protective agents|mesh-ancestor
111085932|NCT03237715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111085933|NCT02515565|Erythromycin|erythromycin|mesh-list
111085934|NCT02515565|Erythromycin Estolate|erythromycin estolate|mesh-list
111085935|NCT02515565|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
111085936|NCT02515565|Erythromycin stearate|erythromycin stearate|mesh-list
111085937|NCT02515565|Cephalosporins|cephalosporins|mesh-list
111085938|NCT02515565|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111085939|NCT02515565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111085940|NCT02515565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111085941|NCT02515565|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111085942|NCT02515565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111085943|NCT02515565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111085944|NCT05600075|Insulin|insulin|mesh-list
111085945|NCT05600075|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111085946|NCT05600075|Glycolic acid|glycolic acid|mesh-list
111085947|NCT05600075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111085948|NCT05600075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111085949|NCT05600075|Keratolytic Agents|keratolytic agents|mesh-ancestor
111085950|NCT05600075|Dermatologic Agents|dermatologic agents|mesh-ancestor
111085951|NCT02512601|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
111085953|NCT02512601|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111085954|NCT02512601|Antimetabolites|antimetabolites|mesh-ancestor
111085955|NCT02512601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111085956|NCT02512601|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111085957|NCT02512601|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111085958|NCT02512601|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111085959|NCT02512601|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111085960|NCT02512601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111085961|NCT03233815|Propofol|propofol|mesh-list
111085962|NCT03233815|Sevoflurane|sevoflurane|mesh-list
111085963|NCT03233815|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111085964|NCT03233815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111085965|NCT03233815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111085966|NCT03233815|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111085967|NCT03233815|Anesthetics, General|anesthetics, general|mesh-ancestor
111085968|NCT03233815|Anesthetics|anesthetics|mesh-ancestor
111085969|NCT03233815|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111085970|NCT03233815|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111085971|NCT02507609|Rocuronium|rocuronium|mesh-list
111085972|NCT02507609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111085973|NCT02507609|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
111085974|NCT02507609|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
111085975|NCT02507609|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111085976|NCT02507609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111085977|NCT02512523|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111085978|NCT02512523|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111085979|NCT02512523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111085980|NCT02512523|Incretins|incretins|mesh-ancestor
111085981|NCT02512523|Hormones|hormones|mesh-ancestor
111085982|NCT02512523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111085983|NCT02512523|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111085984|NCT02512523|Protease Inhibitors|protease inhibitors|mesh-ancestor
111085985|NCT02512523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111085986|NCT02512523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111085987|NCT03233893|Calcium, Dietary|calcium, dietary|mesh-list
111085988|NCT03233893|Calcium|calcium|mesh-list
111085989|NCT03233893|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110677279|NCT02166463|Keratolytic Agents|keratolytic agents|mesh-ancestor
111085990|NCT03233893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111085991|NCT03233893|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111085992|NCT05597813|Timolol|timolol|mesh-list
111085993|NCT05597813|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111085994|NCT05597813|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111085995|NCT05597813|Adrenergic Agents|adrenergic agents|mesh-ancestor
111085996|NCT05597813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111085997|NCT05597813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111085998|NCT05597813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111085999|NCT05597813|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111086000|NCT05597813|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111086001|NCT03242707|Hyaluronic Acid|hyaluronic acid|mesh-list
111086002|NCT03242707|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111086003|NCT03242707|Immunologic Factors|immunologic factors|mesh-ancestor
111086004|NCT03242707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111086005|NCT03242707|Viscosupplements|viscosupplements|mesh-ancestor
111086006|NCT03242707|Protective Agents|protective agents|mesh-ancestor
111086007|NCT03242629|Chloral Hydrate|chloral hydrate|mesh-list
111086008|NCT03242629|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111086009|NCT03242629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111086010|NCT03242629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111086011|NCT02512055|Atropine|atropine|mesh-list
111086012|NCT02512055|Ketamine|ketamine|mesh-list
111086013|NCT02512055|Analgesics|analgesics|mesh-ancestor
111086014|NCT02512055|Sensory System Agents|sensory system agents|mesh-ancestor
111086015|NCT02512055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111086016|NCT02512055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111086017|NCT02512055|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111086018|NCT02512055|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111086019|NCT02512055|Anesthetics, General|anesthetics, general|mesh-ancestor
111086020|NCT02512055|Anesthetics|anesthetics|mesh-ancestor
111086021|NCT02512055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111086022|NCT02512055|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111086023|NCT02512055|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111086024|NCT02512055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110803116|NCT00130247|Rifampin|rifampin|mesh-list
111086025|NCT02512055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111086026|NCT02512055|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111086027|NCT02512055|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111086028|NCT02512055|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111086029|NCT02512055|Autonomic Agents|autonomic agents|mesh-ancestor
111086030|NCT02512055|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111086031|NCT02512055|Respiratory System Agents|respiratory system agents|mesh-ancestor
111086032|NCT02512055|Mydriatics|mydriatics|mesh-ancestor
111086033|NCT02512055|Parasympatholytics|parasympatholytics|mesh-ancestor
111086034|NCT02512055|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111086035|NCT02512055|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111086036|NCT02512055|Cholinergic Agents|cholinergic agents|mesh-ancestor
111086037|NCT02514941|Acetaminophen|acetaminophen|mesh-list
111086038|NCT02514941|Amoxicillin|amoxicillin|mesh-list
111086039|NCT02514941|Talinolol|talinolol|mesh-list
111086040|NCT02514941|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111086041|NCT02514941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111086042|NCT02514941|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111086043|NCT02514941|Analgesics|analgesics|mesh-ancestor
111086044|NCT02514941|Sensory System Agents|sensory system agents|mesh-ancestor
111086045|NCT02514941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111086046|NCT02514941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111086047|NCT02514941|Antipyretics|antipyretics|mesh-ancestor
111086048|NCT02514941|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111086049|NCT02514941|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111086050|NCT02514941|Adrenergic Agents|adrenergic agents|mesh-ancestor
111086051|NCT02514941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111086052|NCT02514941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111086053|NCT02514941|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111086054|NCT02514941|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111086055|NCT02511665|Metformin|metformin|mesh-list
111086056|NCT02511665|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111086057|NCT02511665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111086058|NCT02514629|Metformin|metformin|mesh-list
111086059|NCT02514629|Methyltestosterone|methyltestosterone|mesh-list
111086060|NCT02514629|Testosterone|testosterone|mesh-list
111086061|NCT02514629|Testosterone undecanoate|testosterone undecanoate|mesh-list
111086062|NCT02514629|Testosterone enanthate|testosterone enanthate|mesh-list
111086063|NCT02514629|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
111086064|NCT02514629|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111086065|NCT02514629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111086066|NCT02514629|Androgens|androgens|mesh-ancestor
111086067|NCT02514629|Hormones|hormones|mesh-ancestor
111086068|NCT02514629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111086069|NCT02514629|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111086070|NCT02514629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111086071|NCT02514629|Anabolic Agents|anabolic agents|mesh-ancestor
111086072|NCT02511353|Ivermectin|ivermectin|mesh-list
111086073|NCT02511353|Piperaquine|piperaquine|mesh-list
111086074|NCT02511353|Artenimol|artenimol|mesh-list
111086075|NCT02511353|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111086076|NCT02511353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111086077|NCT02511353|Antimalarials|antimalarials|mesh-ancestor
111086078|NCT02511353|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111086079|NCT03242317|Mitomycins|mitomycins|mesh-list
111086080|NCT03242317|Mitomycin|mitomycin|mesh-list
111086081|NCT03242317|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111086082|NCT03242317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111086083|NCT03242317|Alkylating Agents|alkylating agents|mesh-ancestor
111086084|NCT03242317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111086085|NCT03242317|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111086086|NCT03242317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111086087|NCT02453503|Triamcinolone|triamcinolone|mesh-list
111086088|NCT02453503|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
111086089|NCT02453503|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
111086090|NCT02453503|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
111086091|NCT02453503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111086092|NCT02453503|Glucocorticoids|glucocorticoids|mesh-ancestor
111086093|NCT02453503|Hormones|hormones|mesh-ancestor
111086094|NCT02453503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111086095|NCT02453503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111086096|NCT02453503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111086097|NCT02453503|Immunologic Factors|immunologic factors|mesh-ancestor
111086098|NCT02453503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111086099|NCT02453503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111086100|NCT04499885|Mineral Oil|mineral oil|mesh-list
111086101|NCT04499885|Emollients|emollients|mesh-ancestor
111086102|NCT04499885|Dermatologic Agents|dermatologic agents|mesh-ancestor
111086103|NCT02453425|Norepinephrine|norepinephrine|mesh-list
111086104|NCT02453425|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111086105|NCT02453425|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111086106|NCT02453425|Adrenergic Agents|adrenergic agents|mesh-ancestor
111086107|NCT02453425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111086108|NCT02453425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111086109|NCT02453425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111086110|NCT02453425|Sympathomimetics|sympathomimetics|mesh-ancestor
111086111|NCT02453425|Autonomic Agents|autonomic agents|mesh-ancestor
111086112|NCT02453425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111086113|NCT02453425|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111086114|NCT03233035|Ketamine|ketamine|mesh-list
111086115|NCT03233035|Analgesics|analgesics|mesh-ancestor
111086116|NCT03233035|Sensory System Agents|sensory system agents|mesh-ancestor
111086117|NCT03233035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111086118|NCT03233035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111086119|NCT03233035|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111086120|NCT03233035|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111086121|NCT03233035|Anesthetics, General|anesthetics, general|mesh-ancestor
111086122|NCT03233035|Anesthetics|anesthetics|mesh-ancestor
111086123|NCT03233035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111086124|NCT03233035|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111086125|NCT03233035|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111086126|NCT03233035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111086127|NCT03233035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111086128|NCT03242239|Trastuzumab|trastuzumab|mesh-list
111086129|NCT03242239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111086130|NCT03242239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111086131|NCT03232957|Morphine|morphine|mesh-list
111086132|NCT03232957|Bupivacaine|bupivacaine|mesh-list
111086133|NCT03232957|Anesthetics, Local|anesthetics, local|mesh-ancestor
111086134|NCT03232957|Anesthetics|anesthetics|mesh-ancestor
111086135|NCT03232957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111086136|NCT03232957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111086137|NCT03232957|Sensory System Agents|sensory system agents|mesh-ancestor
111086138|NCT03232957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111086139|NCT03232957|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111086140|NCT03232957|Narcotics|narcotics|mesh-ancestor
111086141|NCT03232957|Analgesics|analgesics|mesh-ancestor
111086142|NCT02513849|Tamoxifen|tamoxifen|mesh-list
111086143|NCT02513849|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111086144|NCT02513849|Hormone Antagonists|hormone antagonists|mesh-ancestor
111086145|NCT02513849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111086146|NCT02513849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111086147|NCT02513849|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111086148|NCT02513849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111086149|NCT02513849|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111086150|NCT02513849|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111086151|NCT02513849|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111086152|NCT02513927|Metoprolol|metoprolol|mesh-list
111086153|NCT02513927|Nifedipine|nifedipine|mesh-list
111086154|NCT02513927|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111086155|NCT02513927|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111086156|NCT02513927|Sympatholytics|sympatholytics|mesh-ancestor
111086157|NCT02513927|Autonomic Agents|autonomic agents|mesh-ancestor
111086158|NCT02513927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111086159|NCT02513927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111086160|NCT02513927|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
111086161|NCT02513927|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111086162|NCT02513927|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111086163|NCT02513927|Adrenergic Agents|adrenergic agents|mesh-ancestor
111086164|NCT02513927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111086165|NCT02513927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111086166|NCT02513927|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111086167|NCT02513927|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111086168|NCT02513927|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111086169|NCT02513927|Vasodilator Agents|vasodilator agents|mesh-ancestor
111086170|NCT02513927|Tocolytic Agents|tocolytic agents|mesh-ancestor
111086171|NCT02513927|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111086172|NCT03236623|Menthol|menthol|mesh-list
111086173|NCT03236623|Antipruritics|antipruritics|mesh-ancestor
111086174|NCT03236623|Dermatologic Agents|dermatologic agents|mesh-ancestor
111086175|NCT03121313|Tegafur|tegafur|mesh-list
111086176|NCT03121313|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111086177|NCT03121313|Antimetabolites|antimetabolites|mesh-ancestor
111086178|NCT03121313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111086179|NCT03121313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111086180|NCT03236233|PC-786|pc-786|mesh-list
111086181|NCT03236233|Antiviral Agents|antiviral agents|mesh-ancestor
111086182|NCT03236233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111086183|NCT03236233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111086184|NCT03236233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111086185|NCT02513693|Rocuronium|rocuronium|mesh-list
111086186|NCT02513693|Neostigmine|neostigmine|mesh-list
111086187|NCT02513693|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
111086188|NCT02513693|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
111086189|NCT02513693|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111086190|NCT02513693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111086191|NCT02513693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111086192|NCT02513693|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111086193|NCT02513693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111086194|NCT02513693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111086195|NCT02513693|Cholinergic Agents|cholinergic agents|mesh-ancestor
111086196|NCT02513693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111086197|NCT02513693|Parasympathomimetics|parasympathomimetics|mesh-ancestor
111086198|NCT02513693|Autonomic Agents|autonomic agents|mesh-ancestor
111086199|NCT03121547|Tramadol|tramadol|mesh-list
111086200|NCT03121547|Tapentadol|tapentadol|mesh-list
111086201|NCT03121547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111086202|NCT03121547|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111086203|NCT03121547|Narcotics|narcotics|mesh-ancestor
111086204|NCT03121547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111086205|NCT03121547|Analgesics|analgesics|mesh-ancestor
111086206|NCT03121547|Sensory System Agents|sensory system agents|mesh-ancestor
111086207|NCT03121547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111086208|NCT03121547|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111086209|NCT03121547|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111086210|NCT03121547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111086211|NCT03121547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111086212|NCT03121547|Adrenergic Agents|adrenergic agents|mesh-ancestor
111086213|NCT03121547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111086215|NCT03241381|Vitamins|vitamins|mesh-ancestor
111086216|NCT03241381|Micronutrients|micronutrients|mesh-ancestor
111086217|NCT03241381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111086218|NCT03241381|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111086219|NCT03241303|Acarbose|acarbose|mesh-list
111086220|NCT03241303|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
111086221|NCT03241303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111086222|NCT03241303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111086223|NCT03241303|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110640684|NCT02585531|Sympathomimetics|sympathomimetics|mesh-ancestor
111086224|NCT03241303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111086225|NCT02510963|Tenofovir|tenofovir|mesh-list
111086226|NCT02510963|Antiviral Agents|antiviral agents|mesh-ancestor
111086227|NCT02510963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111086228|NCT02510963|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111086229|NCT02510963|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111086230|NCT02510963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111086231|NCT02510963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111086232|NCT02510963|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111086233|NCT02510963|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111086234|NCT02513381|Vitamin D|vitamin d|mesh-list
111086235|NCT02513381|Cholecalciferol|cholecalciferol|mesh-list
111086236|NCT02513381|Vitamins|vitamins|mesh-ancestor
111086237|NCT02513381|Micronutrients|micronutrients|mesh-ancestor
111086238|NCT02513381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111086239|NCT02513381|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111086240|NCT02513381|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111086241|NCT03235921|Nitroglycerin|nitroglycerin|mesh-list
111086242|NCT03235921|Vasodilator Agents|vasodilator agents|mesh-ancestor
111086243|NCT03232021|Pregabalin|pregabalin|mesh-list
111086244|NCT03232021|Analgesics|analgesics|mesh-ancestor
111086245|NCT03232021|Sensory System Agents|sensory system agents|mesh-ancestor
111086246|NCT03232021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111086247|NCT03232021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111086248|NCT03232021|Anticonvulsants|anticonvulsants|mesh-ancestor
111086249|NCT03232021|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111086250|NCT03232021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111086251|NCT03232021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111086252|NCT03232021|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111086253|NCT03232021|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111086254|NCT03232021|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111086255|NCT03232021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111086256|NCT03232021|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111086257|NCT03235609|Fentanyl|fentanyl|mesh-list
111086258|NCT03235609|Ketamine|ketamine|mesh-list
111086259|NCT03235609|Analgesics|analgesics|mesh-ancestor
111086260|NCT03235609|Sensory System Agents|sensory system agents|mesh-ancestor
111086261|NCT03235609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111086262|NCT03235609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111086263|NCT03235609|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111086264|NCT03235609|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111086265|NCT03235609|Anesthetics, General|anesthetics, general|mesh-ancestor
111086266|NCT03235609|Anesthetics|anesthetics|mesh-ancestor
111086267|NCT03235609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111086268|NCT03235609|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111086269|NCT03235609|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111086270|NCT03235609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111086271|NCT03235609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111086272|NCT03235609|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111086273|NCT03235609|Narcotics|narcotics|mesh-ancestor
111086274|NCT03235609|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111086275|NCT02509949|Dexmedetomidine|dexmedetomidine|mesh-list
111086276|NCT02509949|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111086277|NCT02509949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111086278|NCT02509949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111086279|NCT02509949|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111086280|NCT02509949|Analgesics|analgesics|mesh-ancestor
111086281|NCT02509949|Sensory System Agents|sensory system agents|mesh-ancestor
111086282|NCT02509949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111086283|NCT02509949|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111086284|NCT02509949|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111086285|NCT02509949|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110677284|NCT02094794|Etoposide|etoposide|mesh-list
111086286|NCT02509949|Adrenergic Agents|adrenergic agents|mesh-ancestor
111086287|NCT02509949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111086288|NCT02509949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111086289|NCT03344705|Cyclophosphamide|cyclophosphamide|mesh-list
111086290|NCT03344705|Fludarabine|fludarabine|mesh-list
111086291|NCT03344705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111086292|NCT03344705|Immunologic Factors|immunologic factors|mesh-ancestor
111086293|NCT03344705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111086294|NCT03344705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111086295|NCT03344705|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111086296|NCT03344705|Alkylating Agents|alkylating agents|mesh-ancestor
111086297|NCT03344705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111086298|NCT03344705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111086299|NCT03344705|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111086300|NCT02501603|Paclitaxel|paclitaxel|mesh-list
111086301|NCT02501603|Afatinib|afatinib|mesh-list
111086302|NCT02501603|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111086303|NCT02501603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111086304|NCT02501603|Tubulin Modulators|tubulin modulators|mesh-ancestor
111086305|NCT02501603|Antimitotic Agents|antimitotic agents|mesh-ancestor
111086306|NCT02501603|Mitosis Modulators|mitosis modulators|mesh-ancestor
111086307|NCT02501603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111086308|NCT02501603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111086309|NCT02501603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111086310|NCT03344627|Meropenem|meropenem|mesh-list
111086311|NCT03344627|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111086312|NCT03344627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111086313|NCT02501213|Furosemide|furosemide|mesh-list
111086314|NCT02501213|Spironolactone|spironolactone|mesh-list
111086315|NCT02501213|Diuretics|diuretics|mesh-ancestor
111086316|NCT02501213|Natriuretic Agents|natriuretic agents|mesh-ancestor
111086317|NCT02501213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111086318|NCT02501213|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
111086319|NCT02501213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111086320|NCT02501213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111086321|NCT02501213|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
111086322|NCT02501213|Hormone Antagonists|hormone antagonists|mesh-ancestor
111086323|NCT02501213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111086324|NCT02501213|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
111086325|NCT02501291|Thalidomide|thalidomide|mesh-list
111086326|NCT02501291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111086327|NCT02501291|Immunologic Factors|immunologic factors|mesh-ancestor
111086328|NCT02501291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111086329|NCT02501291|Leprostatic Agents|leprostatic agents|mesh-ancestor
111086330|NCT02501291|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111086331|NCT02501291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111086332|NCT02501291|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111086333|NCT02501291|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111086334|NCT02501291|Growth Substances|growth substances|mesh-ancestor
111086335|NCT02501291|Growth Inhibitors|growth inhibitors|mesh-ancestor
111086336|NCT02501291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111086337|NCT02509559|Propranolol|propranolol|mesh-list
111086338|NCT02509559|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111086339|NCT02509559|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111086340|NCT02509559|Adrenergic Agents|adrenergic agents|mesh-ancestor
111086341|NCT02509559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111086342|NCT02509559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111086343|NCT02509559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111086344|NCT02509559|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111086345|NCT02509559|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111086346|NCT02509559|Vasodilator Agents|vasodilator agents|mesh-ancestor
111086347|NCT00707993|Alogliptin|alogliptin|mesh-list
111086348|NCT00707993|Glipizide|glipizide|mesh-list
111086349|NCT00707993|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111086350|NCT00707993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111086351|NCT00707993|Incretins|incretins|mesh-ancestor
111086352|NCT00707993|Hormones|hormones|mesh-ancestor
111086353|NCT00707993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111086354|NCT00707993|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111086355|NCT00707993|Protease Inhibitors|protease inhibitors|mesh-ancestor
111086356|NCT00707993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111086357|NCT00707993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111086358|NCT02509091|Amikacin|amikacin|mesh-list
110640703|NCT00920153|Antiemetics|antiemetics|mesh-ancestor
111086360|NCT02509091|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111086361|NCT02509091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111086362|NCT02509091|Chelating Agents|chelating agents|mesh-ancestor
111086363|NCT02509091|Sequestering Agents|sequestering agents|mesh-ancestor
111086364|NCT02509091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111086365|NCT02508857|Ketorolac|ketorolac|mesh-list
111086366|NCT02508857|Magnesium Sulfate|magnesium sulfate|mesh-list
111086367|NCT02508857|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111086368|NCT02508857|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111086369|NCT02508857|Analgesics|analgesics|mesh-ancestor
111086370|NCT02508857|Sensory System Agents|sensory system agents|mesh-ancestor
111086371|NCT02508857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111086372|NCT02508857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111086373|NCT02508857|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111086374|NCT02508857|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111086375|NCT02508857|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111086376|NCT02508857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111086377|NCT02508857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111086378|NCT02508857|Anesthetics|anesthetics|mesh-ancestor
111086379|NCT02508857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111086380|NCT02508857|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111086381|NCT02508857|Anticonvulsants|anticonvulsants|mesh-ancestor
111086382|NCT02508857|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111086383|NCT02508857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111086384|NCT02508857|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111086385|NCT02508857|Tocolytic Agents|tocolytic agents|mesh-ancestor
111086386|NCT02508857|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111086387|NCT02508623|Rifaximin|rifaximin|mesh-list
111086388|NCT02508623|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111086389|NCT02508623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111086390|NCT02508623|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111086391|NCT02500667|Rifampin|rifampin|mesh-list
111086392|NCT02500667|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111086393|NCT02500667|Antitubercular Agents|antitubercular agents|mesh-ancestor
111086394|NCT02500667|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111086395|NCT02500667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111086396|NCT02500667|Leprostatic Agents|leprostatic agents|mesh-ancestor
111086397|NCT02500667|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111086398|NCT02500667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111086399|NCT02500667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111086400|NCT02500667|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111086401|NCT02500667|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111086402|NCT02500667|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
111086403|NCT02500667|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
111086404|NCT02500667|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
111086405|NCT02500667|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111086406|NCT02500511|Vaccines|vaccines|mesh-list
111086407|NCT02500511|Immunologic Factors|immunologic factors|mesh-ancestor
111086408|NCT02500511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111086409|NCT03344393|Ketamine|ketamine|mesh-list
111086410|NCT03344393|Analgesics|analgesics|mesh-ancestor
111086411|NCT03344393|Sensory System Agents|sensory system agents|mesh-ancestor
111086412|NCT03344393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111086413|NCT03344393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111086414|NCT03344393|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111086415|NCT03344393|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111086416|NCT03344393|Anesthetics, General|anesthetics, general|mesh-ancestor
111086417|NCT03344393|Anesthetics|anesthetics|mesh-ancestor
111086418|NCT03344393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111086419|NCT03344393|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111086420|NCT03344393|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111086421|NCT03344393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111086422|NCT03344393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111086423|NCT04498793|Paclitaxel|paclitaxel|mesh-list
111086424|NCT04498793|Cyclophosphamide|cyclophosphamide|mesh-list
111086425|NCT04498793|Doxorubicin|doxorubicin|mesh-list
111086426|NCT04498793|Epirubicin|epirubicin|mesh-list
111086427|NCT04498793|Tislelizumab|tislelizumab|mesh-list
111086428|NCT04498793|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111086429|NCT04498793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111086430|NCT04498793|Tubulin Modulators|tubulin modulators|mesh-ancestor
111086431|NCT04498793|Antimitotic Agents|antimitotic agents|mesh-ancestor
111086432|NCT04498793|Mitosis Modulators|mitosis modulators|mesh-ancestor
111086433|NCT04498793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111086434|NCT04498793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111086435|NCT04498793|Immunologic Factors|immunologic factors|mesh-ancestor
111086436|NCT04498793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111086437|NCT04498793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111086438|NCT04498793|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111086439|NCT04498793|Alkylating Agents|alkylating agents|mesh-ancestor
111086440|NCT04498793|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111086441|NCT04498793|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111086442|NCT04498793|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111086443|NCT04498793|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111086444|NCT04498793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111086445|NCT04498793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111086446|NCT04498325|Antibodies|antibodies|mesh-list
111086447|NCT04498325|Immunologic Factors|immunologic factors|mesh-ancestor
111086448|NCT04498325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111086449|NCT02507843|Vitamin D|vitamin d|mesh-list
111086450|NCT02507843|Cholecalciferol|cholecalciferol|mesh-list
111086451|NCT02507843|Vitamins|vitamins|mesh-ancestor
111086452|NCT02507843|Micronutrients|micronutrients|mesh-ancestor
111086453|NCT02507843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111086454|NCT02507843|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111086455|NCT02507843|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111086456|NCT02425891|Paclitaxel|paclitaxel|mesh-list
111086457|NCT02425891|Atezolizumab|atezolizumab|mesh-list
111086458|NCT02425891|Antibodies|antibodies|mesh-list
111086459|NCT02425891|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111086460|NCT02425891|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111086461|NCT02425891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111086462|NCT02425891|Tubulin Modulators|tubulin modulators|mesh-ancestor
111086463|NCT02425891|Antimitotic Agents|antimitotic agents|mesh-ancestor
111086464|NCT02425891|Mitosis Modulators|mitosis modulators|mesh-ancestor
111086465|NCT02425891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111086466|NCT02425891|Immunologic Factors|immunologic factors|mesh-ancestor
111086467|NCT02425891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111086468|NCT02425891|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111086469|NCT02425891|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111086470|NCT02499965|Anesthetics|anesthetics|mesh-list
111086471|NCT02499965|Ethyl Chloride|ethyl chloride|mesh-list
111086472|NCT02499965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111086473|NCT02499965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111086474|NCT02499965|Anesthetics, Local|anesthetics, local|mesh-ancestor
111086475|NCT02499965|Sensory System Agents|sensory system agents|mesh-ancestor
111086476|NCT02499965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111086477|NCT05504057|Amantadine|amantadine|mesh-list
111086478|NCT05504057|Histamine Antagonists|histamine antagonists|mesh-list
111086479|NCT05504057|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
111086480|NCT05504057|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111086481|NCT05504057|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111086482|NCT05504057|Antiviral Agents|antiviral agents|mesh-ancestor
111086483|NCT05504057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111086484|NCT05504057|Dopamine Agents|dopamine agents|mesh-ancestor
111086485|NCT05504057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111086486|NCT05504057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111086487|NCT05504057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111086488|NCT05504057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111086489|NCT05504057|Analgesics|analgesics|mesh-ancestor
111086490|NCT05504057|Sensory System Agents|sensory system agents|mesh-ancestor
111086491|NCT05504057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111086492|NCT05504057|Histamine Agents|histamine agents|mesh-ancestor
111086493|NCT03344003|Factor VIII|factor viii|mesh-list
111086494|NCT03344003|Coagulants|coagulants|mesh-ancestor
111086495|NCT03235531|Valproic Acid|valproic acid|mesh-list
111086496|NCT03235531|Lorazepam|lorazepam|mesh-list
111086497|NCT03235531|Anticonvulsants|anticonvulsants|mesh-ancestor
111086498|NCT03235531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111086499|NCT03235531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111086500|NCT03235531|GABA Agents|gaba agents|mesh-ancestor
111086501|NCT03235531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111086502|NCT03235531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111086503|NCT03235531|Antimanic Agents|antimanic agents|mesh-ancestor
111086504|NCT03235531|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111086505|NCT03235531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111086506|NCT03235531|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111086507|NCT03235531|Antiemetics|antiemetics|mesh-ancestor
111086508|NCT03235531|Autonomic Agents|autonomic agents|mesh-ancestor
111086509|NCT03235531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111086510|NCT03235531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111086511|NCT03235531|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111086512|NCT03235531|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111086513|NCT03235531|GABA Modulators|gaba modulators|mesh-ancestor
111086514|NCT02506829|Nicotine|nicotine|mesh-list
111086515|NCT02506829|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111086516|NCT02506829|Autonomic Agents|autonomic agents|mesh-ancestor
111086517|NCT02506829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111086518|NCT02506829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111086519|NCT02506829|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111086520|NCT02506829|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111086521|NCT02506829|Cholinergic Agents|cholinergic agents|mesh-ancestor
111086522|NCT02506829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111086523|NCT02506829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111086524|NCT02506439|Vitamin D|vitamin d|mesh-list
111086525|NCT02506439|Ergocalciferols|ergocalciferols|mesh-list
111086526|NCT02506439|Cholecalciferol|cholecalciferol|mesh-list
111086527|NCT02506439|Vitamins|vitamins|mesh-list
111086528|NCT02506439|Micronutrients|micronutrients|mesh-ancestor
111086529|NCT02506439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111086530|NCT02506439|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111086531|NCT02506439|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111086532|NCT02495519|Imatinib Mesylate|imatinib mesylate|mesh-list
111086533|NCT02495519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111086534|NCT02495519|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111086535|NCT02495519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111086536|NCT02495519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111086537|NCT02499341|Ketamine|ketamine|mesh-list
111086538|NCT02499341|Tramadol|tramadol|mesh-list
111086539|NCT02499341|Analgesics|analgesics|mesh-ancestor
111086540|NCT02499341|Sensory System Agents|sensory system agents|mesh-ancestor
111086541|NCT02499341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111086542|NCT02499341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111086543|NCT02499341|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111086544|NCT02499341|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111086545|NCT02499341|Anesthetics, General|anesthetics, general|mesh-ancestor
111086546|NCT02499341|Anesthetics|anesthetics|mesh-ancestor
111086547|NCT02499341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111086548|NCT02499341|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111086549|NCT02499341|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111086550|NCT02499341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111086551|NCT02499341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111086552|NCT02499341|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111086553|NCT02499341|Narcotics|narcotics|mesh-ancestor
111086554|NCT02495285|Polygeline|polygeline|mesh-list
110640721|NCT00920153|Antiviral Agents|antiviral agents|mesh-ancestor
111086555|NCT02495285|Plasma Substitutes|plasma substitutes|mesh-ancestor
111086556|NCT02495285|Blood Substitutes|blood substitutes|mesh-ancestor
111086557|NCT02495363|Bupivacaine|bupivacaine|mesh-list
111086558|NCT02495363|Anesthetics, Local|anesthetics, local|mesh-ancestor
111086559|NCT02495363|Anesthetics|anesthetics|mesh-ancestor
111086560|NCT02495363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111086561|NCT02495363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111086562|NCT02495363|Sensory System Agents|sensory system agents|mesh-ancestor
111086563|NCT02495363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111086564|NCT03121079|Interferons|interferons|mesh-list
111086565|NCT03121079|Interferon-alpha|interferon-alpha|mesh-list
111086566|NCT03121079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111086567|NCT03121079|Antiviral Agents|antiviral agents|mesh-ancestor
111086568|NCT03121079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111086569|NCT03121079|Immunologic Factors|immunologic factors|mesh-ancestor
111086570|NCT03121079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111086571|NCT02494895|Aspirin|aspirin|mesh-list
111086572|NCT02494895|Ticagrelor|ticagrelor|mesh-list
111086573|NCT02494895|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111086574|NCT02494895|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111086575|NCT02494895|Analgesics|analgesics|mesh-ancestor
111086576|NCT02494895|Sensory System Agents|sensory system agents|mesh-ancestor
111086577|NCT02494895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111086578|NCT02494895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111086579|NCT02494895|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111086580|NCT02494895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111086581|NCT02494895|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111086582|NCT02494895|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111086583|NCT02494895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111086584|NCT02494895|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111086585|NCT02494895|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111086586|NCT02494895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111086587|NCT02494895|Antipyretics|antipyretics|mesh-ancestor
111086588|NCT02494895|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111086589|NCT02494895|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111086590|NCT02494895|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111086591|NCT02494895|Purinergic Agents|purinergic agents|mesh-ancestor
111086592|NCT02494895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111086593|NCT03341741|Tobramycin|tobramycin|mesh-list
111086594|NCT03341741|Colistin|colistin|mesh-list
111086595|NCT03341741|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111086596|NCT03341741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111086597|NCT01597245|Etanercept|etanercept|mesh-list
111086598|NCT01597245|Ixekizumab|ixekizumab|mesh-list
111086599|NCT01597245|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111086600|NCT01597245|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111086601|NCT01597245|Analgesics|analgesics|mesh-ancestor
111086602|NCT01597245|Sensory System Agents|sensory system agents|mesh-ancestor
111086603|NCT01597245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111086604|NCT01597245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111086605|NCT01597245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111086606|NCT01597245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111086607|NCT01597245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111086608|NCT01597245|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111086609|NCT01597245|Immunologic Factors|immunologic factors|mesh-ancestor
111086610|NCT01597245|Dermatologic Agents|dermatologic agents|mesh-ancestor
111086611|NCT03341429|Liraglutide|liraglutide|mesh-list
111086612|NCT03341429|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111086613|NCT03341429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111086614|NCT03341429|Incretins|incretins|mesh-ancestor
111086615|NCT03341429|Hormones|hormones|mesh-ancestor
111086616|NCT03341429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111086617|NCT04494659|Rifampin|rifampin|mesh-list
111086618|NCT04494659|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111086619|NCT04494659|Antitubercular Agents|antitubercular agents|mesh-ancestor
111086620|NCT04494659|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111086621|NCT04494659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111086622|NCT04494659|Leprostatic Agents|leprostatic agents|mesh-ancestor
111086623|NCT04494659|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111086624|NCT04494659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111086625|NCT04494659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111086626|NCT04494659|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111086627|NCT04494659|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111086628|NCT04494659|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
111086629|NCT04494659|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
111086630|NCT04494659|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
111086631|NCT04494659|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111086632|NCT03342599|Thioctic Acid|thioctic acid|mesh-list
111086633|NCT03342599|Antioxidants|antioxidants|mesh-ancestor
111086634|NCT03342599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111086635|NCT03342599|Protective Agents|protective agents|mesh-ancestor
111086636|NCT03342599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111086637|NCT03342599|Vitamin B Complex|vitamin b complex|mesh-ancestor
111086638|NCT03342599|Vitamins|vitamins|mesh-ancestor
111086639|NCT03342599|Micronutrients|micronutrients|mesh-ancestor
111086640|NCT03341117|Aspirin|aspirin|mesh-list
111086641|NCT03341117|Magnesium Oxide|magnesium oxide|mesh-list
111086642|NCT03341117|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111086643|NCT03341117|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111086644|NCT03341117|Analgesics|analgesics|mesh-ancestor
111086645|NCT03341117|Sensory System Agents|sensory system agents|mesh-ancestor
111086646|NCT03341117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111086647|NCT03341117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111086648|NCT03341117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111086649|NCT03341117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111086650|NCT03341117|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111086651|NCT03341117|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111086652|NCT03341117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111086653|NCT03341117|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111086654|NCT03341117|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111086655|NCT03341117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111086656|NCT03341117|Antipyretics|antipyretics|mesh-ancestor
111086657|NCT03341117|Antacids|antacids|mesh-ancestor
111086658|NCT03341117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111086659|NCT02498171|Fentanyl|fentanyl|mesh-list
111086660|NCT02498171|Morphine|morphine|mesh-list
111086661|NCT02498171|Bupivacaine|bupivacaine|mesh-list
111086662|NCT02498171|Anesthetics, Local|anesthetics, local|mesh-ancestor
111086663|NCT02498171|Anesthetics|anesthetics|mesh-ancestor
111086664|NCT02498171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111086665|NCT02498171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111086666|NCT02498171|Sensory System Agents|sensory system agents|mesh-ancestor
111086667|NCT02498171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111086668|NCT02498171|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111086669|NCT02498171|Narcotics|narcotics|mesh-ancestor
111086670|NCT02498171|Analgesics|analgesics|mesh-ancestor
111086671|NCT02498171|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110640751|NCT04080323|Dinoprostone|dinoprostone|mesh-list
111086672|NCT02498171|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111086673|NCT02498171|Anesthetics, General|anesthetics, general|mesh-ancestor
111086674|NCT03120533|Treprostinil|treprostinil|mesh-list
111086675|NCT03120533|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111086676|NCT03342443|Memantine|memantine|mesh-list
111086677|NCT03342443|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111086678|NCT03342443|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111086679|NCT03342443|Dopamine Agents|dopamine agents|mesh-ancestor
111086680|NCT03342443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111086681|NCT03342443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111086682|NCT03342443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111086683|NCT03342443|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111086684|NCT03342443|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111086685|NCT05035485|Phenylephrine|phenylephrine|mesh-list
111086686|NCT05035485|Oxymetazoline|oxymetazoline|mesh-list
111086687|NCT05035485|Norepinephrine|norepinephrine|mesh-list
111086688|NCT05035485|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
111086689|NCT05035485|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111086690|NCT05035485|Mydriatics|mydriatics|mesh-ancestor
111086691|NCT05035485|Autonomic Agents|autonomic agents|mesh-ancestor
111086692|NCT05035485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111086693|NCT05035485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111086694|NCT05035485|Sympathomimetics|sympathomimetics|mesh-ancestor
111086695|NCT05035485|Nasal Decongestants|nasal decongestants|mesh-ancestor
111086696|NCT05035485|Respiratory System Agents|respiratory system agents|mesh-ancestor
111086697|NCT05035485|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111086698|NCT05035485|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111086699|NCT05035485|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111086700|NCT05035485|Adrenergic Agents|adrenergic agents|mesh-ancestor
111086701|NCT05035485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111086702|NCT05035485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111086703|NCT05035485|Protective Agents|protective agents|mesh-ancestor
111086704|NCT02498015|Ribavirin|ribavirin|mesh-list
111086705|NCT02498015|Antimetabolites|antimetabolites|mesh-ancestor
111086706|NCT02498015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111086707|NCT02498015|Antiviral Agents|antiviral agents|mesh-ancestor
111086708|NCT02498015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111086709|NCT02494505|Mycophenolic Acid|mycophenolic acid|mesh-list
111086710|NCT02494505|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111086711|NCT02494505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111086712|NCT02494505|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111086713|NCT02494505|Antitubercular Agents|antitubercular agents|mesh-ancestor
111086714|NCT02494505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111086715|NCT02494505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111086716|NCT02494505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111086717|NCT02494505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111086718|NCT03340493|Tenecteplase|tenecteplase|mesh-list
111086719|NCT03340493|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111086720|NCT03340493|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111086721|NCT03340493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111086722|NCT03098199|Menotropins|menotropins|mesh-list
111086723|NCT03098199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111086724|NCT03098199|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111086725|NCT03098199|Fertility Agents|fertility agents|mesh-ancestor
111086726|NCT03098199|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111086727|NCT00707057|Ibuprofen|ibuprofen|mesh-list
111086728|NCT00707057|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111086729|NCT00707057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111086730|NCT00707057|Analgesics|analgesics|mesh-ancestor
111086731|NCT00707057|Sensory System Agents|sensory system agents|mesh-ancestor
111086732|NCT00707057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111086733|NCT00707057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111086734|NCT00707057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111086735|NCT00707057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111086736|NCT00707057|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111086737|NCT00707057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111086738|NCT00707057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111086739|NCT02494349|Tamsulosin|tamsulosin|mesh-list
111086740|NCT02494349|Solifenacin Succinate|solifenacin succinate|mesh-list
111086741|NCT02494349|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111086742|NCT02494349|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111086743|NCT02494349|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111086744|NCT02494349|Adrenergic Agents|adrenergic agents|mesh-ancestor
111086745|NCT02494349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111086746|NCT02494349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111086747|NCT02494349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111086748|NCT02494349|Urological Agents|urological agents|mesh-ancestor
111086749|NCT02494349|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111086750|NCT02494349|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111086751|NCT02494349|Cholinergic Agents|cholinergic agents|mesh-ancestor
111086752|NCT03095469|Dexmedetomidine|dexmedetomidine|mesh-list
111086753|NCT03095469|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111086754|NCT03095469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111086755|NCT03095469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111086756|NCT03095469|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111086757|NCT03095469|Analgesics|analgesics|mesh-ancestor
111086758|NCT03095469|Sensory System Agents|sensory system agents|mesh-ancestor
111086759|NCT03095469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111086760|NCT03095469|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111086761|NCT03095469|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111086762|NCT03095469|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111086763|NCT03095469|Adrenergic Agents|adrenergic agents|mesh-ancestor
111086764|NCT03095469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111086765|NCT03095469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111086766|NCT02497547|Oxytocin|oxytocin|mesh-list
111086767|NCT02497547|Oxytocics|oxytocics|mesh-ancestor
111086768|NCT02497547|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111086769|NCT02497547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111086770|NCT05043129|Vaccines|vaccines|mesh-list
111086771|NCT05043129|Immunologic Factors|immunologic factors|mesh-ancestor
111086772|NCT05043129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111086773|NCT02497313|Metformin|metformin|mesh-list
111086774|NCT02497313|Cholecystokinin|cholecystokinin|mesh-list
111086775|NCT02497313|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111086776|NCT02497313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111086777|NCT02497313|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
110803887|NCT02253784|Hormones|hormones|mesh-ancestor
111086778|NCT02497313|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111086779|NCT02497157|Leucovorin|leucovorin|mesh-list
111086780|NCT02497157|Bevacizumab|bevacizumab|mesh-list
111086781|NCT02497157|Fluorouracil|fluorouracil|mesh-list
111086782|NCT02497157|Oxaliplatin|oxaliplatin|mesh-list
111086783|NCT02497157|Irinotecan|irinotecan|mesh-list
111086784|NCT02497157|Calcium|calcium|mesh-list
111086785|NCT02497157|Levoleucovorin|levoleucovorin|mesh-list
111086786|NCT02497157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111086787|NCT02497157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111086788|NCT02497157|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111086789|NCT02497157|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111086790|NCT02497157|Growth Substances|growth substances|mesh-ancestor
111086791|NCT02497157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111086792|NCT02497157|Growth Inhibitors|growth inhibitors|mesh-ancestor
111086793|NCT02497157|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111086794|NCT02497157|Antimetabolites|antimetabolites|mesh-ancestor
111086795|NCT02497157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111086796|NCT02497157|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111086797|NCT02497157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111086798|NCT02497157|Immunologic Factors|immunologic factors|mesh-ancestor
111086799|NCT02497157|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111086800|NCT02497157|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111086801|NCT02497157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111086802|NCT02497157|Antidotes|antidotes|mesh-ancestor
111086803|NCT02497157|Protective Agents|protective agents|mesh-ancestor
111086804|NCT02497157|Vitamin B Complex|vitamin b complex|mesh-ancestor
111086805|NCT02497157|Vitamins|vitamins|mesh-ancestor
111086806|NCT02497157|Micronutrients|micronutrients|mesh-ancestor
111086807|NCT03095079|Endostatins|endostatins|mesh-list
111086808|NCT03095079|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111086809|NCT03095079|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111086810|NCT03095079|Growth Substances|growth substances|mesh-ancestor
111086811|NCT03095079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111086812|NCT03095079|Growth Inhibitors|growth inhibitors|mesh-ancestor
111086813|NCT03095079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111086814|NCT03120923|Triamcinolone|triamcinolone|mesh-list
111086815|NCT03120923|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
111086816|NCT03120923|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
111086817|NCT03120923|Lidocaine|lidocaine|mesh-list
111086818|NCT03120923|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
111086819|NCT03120923|Anesthetics, Local|anesthetics, local|mesh-ancestor
111086820|NCT03120923|Anesthetics|anesthetics|mesh-ancestor
111086821|NCT03120923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111086822|NCT03120923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111086823|NCT03120923|Sensory System Agents|sensory system agents|mesh-ancestor
111086824|NCT03120923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111086825|NCT03120923|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111086826|NCT03120923|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111086827|NCT03120923|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111086828|NCT03120923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111086829|NCT03120923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111086830|NCT03120923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111086831|NCT03120923|Glucocorticoids|glucocorticoids|mesh-ancestor
111086832|NCT03120923|Hormones|hormones|mesh-ancestor
111086833|NCT03120923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111086834|NCT03120923|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111086835|NCT03120923|Immunologic Factors|immunologic factors|mesh-ancestor
111086836|NCT03120923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111086837|NCT02497079|Formaldehyde|formaldehyde|mesh-list
111086838|NCT02497079|Disinfectants|disinfectants|mesh-ancestor
111086839|NCT02497079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111086840|NCT04135677|Rivaroxaban|rivaroxaban|mesh-list
111086841|NCT04135677|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111086842|NCT04135677|Antithrombins|antithrombins|mesh-ancestor
111086843|NCT04135677|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111086844|NCT04135677|Protease Inhibitors|protease inhibitors|mesh-ancestor
111086845|NCT04135677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111086846|NCT04135677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111086847|NCT04135677|Anticoagulants|anticoagulants|mesh-ancestor
111086848|NCT02639247|Sofosbuvir|sofosbuvir|mesh-list
111086849|NCT02639247|Velpatasvir|velpatasvir|mesh-list
111086850|NCT02639247|Antiviral Agents|antiviral agents|mesh-ancestor
111086851|NCT02639247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111086852|NCT05033535|Olmesartan|olmesartan|mesh-list
111086853|NCT05033535|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
111086854|NCT05033535|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111086855|NCT05033535|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111086856|NCT05033535|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111086857|NCT05033535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111086858|NCT05053893|Valsartan|valsartan|mesh-list
111086859|NCT05053893|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
111086860|NCT05053893|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111086861|NCT05053893|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111086862|NCT05053893|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111086863|NCT05053893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111086864|NCT03096327|Montelukast|montelukast|mesh-list
111086865|NCT03096327|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111086866|NCT03096327|Respiratory System Agents|respiratory system agents|mesh-ancestor
111086867|NCT03096327|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
111086868|NCT03096327|Hormone Antagonists|hormone antagonists|mesh-ancestor
110799546|NCT03752931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111086869|NCT03096327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111086870|NCT03096327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111086871|NCT03096327|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
111086872|NCT03096327|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111086873|NCT03096327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111086874|NCT03098121|Grazoprevir|grazoprevir|mesh-list
111086875|NCT03098121|Antiviral Agents|antiviral agents|mesh-ancestor
111086876|NCT03098121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111086877|NCT03095001|Paclitaxel|paclitaxel|mesh-list
111086878|NCT03095001|Bevacizumab|bevacizumab|mesh-list
111086879|NCT03095001|Carboplatin|carboplatin|mesh-list
111086880|NCT03095001|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111086881|NCT03095001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111086882|NCT03095001|Tubulin Modulators|tubulin modulators|mesh-ancestor
111086883|NCT03095001|Antimitotic Agents|antimitotic agents|mesh-ancestor
111086884|NCT03095001|Mitosis Modulators|mitosis modulators|mesh-ancestor
111086885|NCT03095001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111086886|NCT03095001|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111086887|NCT03095001|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111086888|NCT03095001|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111086889|NCT03095001|Growth Substances|growth substances|mesh-ancestor
111086890|NCT03095001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111086891|NCT03095001|Growth Inhibitors|growth inhibitors|mesh-ancestor
111086892|NCT05042271|Meropenem|meropenem|mesh-list
111086893|NCT05042271|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111086894|NCT05042271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111086895|NCT02138955|Curcumin|curcumin|mesh-list
111086896|NCT02138955|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111086897|NCT02138955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111086898|NCT02138955|Analgesics|analgesics|mesh-ancestor
111086899|NCT02138955|Sensory System Agents|sensory system agents|mesh-ancestor
111086900|NCT02138955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111086901|NCT02138955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111086902|NCT02138955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111086903|NCT02138955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111086904|NCT02138955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111086905|NCT02138955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111086906|NCT02138955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111086907|NCT03096405|Methicillin|methicillin|mesh-list
111086908|NCT03096405|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111086909|NCT03096405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111086910|NCT05032287|Tamsulosin|tamsulosin|mesh-list
111086911|NCT05032287|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111086912|NCT05032287|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111086913|NCT05032287|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111086914|NCT05032287|Adrenergic Agents|adrenergic agents|mesh-ancestor
111086915|NCT05032287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111086916|NCT05032287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111086917|NCT05032287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111086918|NCT05032287|Urological Agents|urological agents|mesh-ancestor
111086919|NCT02493959|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111086920|NCT02493959|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111086921|NCT02493959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111086922|NCT02493959|Incretins|incretins|mesh-ancestor
111086923|NCT02493959|Hormones|hormones|mesh-ancestor
111086924|NCT02493959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111086925|NCT02493959|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111086926|NCT02493959|Protease Inhibitors|protease inhibitors|mesh-ancestor
111086927|NCT02493959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111086928|NCT02493959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111086929|NCT02496377|Epoetin Alfa|epoetin alfa|mesh-list
111086931|NCT02496377|Hematinics|hematinics|mesh-ancestor
111086932|NCT02496377|Glycine Agents|glycine agents|mesh-ancestor
111086933|NCT02496377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111086934|NCT02496377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111086935|NCT02496377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111086936|NCT02496455|Tramadol|tramadol|mesh-list
111086937|NCT02496455|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111086938|NCT02496455|Narcotics|narcotics|mesh-ancestor
111086939|NCT02496455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111086940|NCT02496455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111086941|NCT02496455|Analgesics|analgesics|mesh-ancestor
111086942|NCT02496455|Sensory System Agents|sensory system agents|mesh-ancestor
111086943|NCT02496455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111086944|NCT02496299|Dexamethasone|dexamethasone|mesh-list
111086945|NCT02496299|Bupivacaine|bupivacaine|mesh-list
111086946|NCT02496299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111086947|NCT02496299|Antiemetics|antiemetics|mesh-ancestor
111086948|NCT02496299|Autonomic Agents|autonomic agents|mesh-ancestor
111086949|NCT02496299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111086950|NCT02496299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111086951|NCT02496299|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111086952|NCT02496299|Glucocorticoids|glucocorticoids|mesh-ancestor
111086953|NCT02496299|Hormones|hormones|mesh-ancestor
111086954|NCT02496299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111086955|NCT02496299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111086956|NCT02496299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111086957|NCT02496299|Anesthetics, Local|anesthetics, local|mesh-ancestor
111086958|NCT02496299|Anesthetics|anesthetics|mesh-ancestor
111086959|NCT02496299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111086960|NCT02496299|Sensory System Agents|sensory system agents|mesh-ancestor
111086961|NCT02493725|Eculizumab|eculizumab|mesh-list
111086962|NCT02493725|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
111086963|NCT02493725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111086964|NCT02493725|Immunologic Factors|immunologic factors|mesh-ancestor
111086965|NCT02493725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111086966|NCT04467957|Xenon|xenon|mesh-list
111086967|NCT04467957|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111086968|NCT04467957|Anesthetics, General|anesthetics, general|mesh-ancestor
111086969|NCT04467957|Anesthetics|anesthetics|mesh-ancestor
111086970|NCT04467957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111086971|NCT04467957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111086972|NCT02121405|Capecitabine|capecitabine|mesh-list
111086973|NCT02121405|Oxaliplatin|oxaliplatin|mesh-list
111086974|NCT02121405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111086975|NCT02121405|Antimetabolites|antimetabolites|mesh-ancestor
111086976|NCT02121405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111086977|NCT02121405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111086978|NCT03337841|Pembrolizumab|pembrolizumab|mesh-list
111086979|NCT03337841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111086980|NCT03337841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111086981|NCT03337841|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111086982|NCT03337841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111086983|NCT02493335|Budesonide|budesonide|mesh-list
111086984|NCT02493335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111086985|NCT02493335|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111086986|NCT02493335|Autonomic Agents|autonomic agents|mesh-ancestor
111086987|NCT02493335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111086988|NCT02493335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111086989|NCT02493335|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111086990|NCT02493335|Respiratory System Agents|respiratory system agents|mesh-ancestor
111086991|NCT02493335|Glucocorticoids|glucocorticoids|mesh-ancestor
111086992|NCT02493335|Hormones|hormones|mesh-ancestor
111086993|NCT02493335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111086994|NCT03336593|Vaccines|vaccines|mesh-list
111086995|NCT03336593|Immunologic Factors|immunologic factors|mesh-ancestor
111086996|NCT03336593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111086997|NCT03337607|Celecoxib|celecoxib|mesh-list
111086998|NCT03337607|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
111086999|NCT03337607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
111087000|NCT03337607|Eperisone|eperisone|mesh-list
111087001|NCT03337607|Parasympatholytics|parasympatholytics|mesh-list
111087002|NCT03337607|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111087003|NCT03337607|Analgesics|analgesics|mesh-ancestor
111087004|NCT03337607|Sensory System Agents|sensory system agents|mesh-ancestor
111087005|NCT03337607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111087006|NCT03337607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110142297|NCT02018367|Proflavine|proflavine|mesh-list
111087007|NCT03337607|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111087008|NCT03337607|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111087009|NCT03337607|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111087010|NCT03337607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111087011|NCT03337607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111087012|NCT03337607|Anticonvulsants|anticonvulsants|mesh-ancestor
111087013|NCT03337607|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111087014|NCT03337607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111087015|NCT03337607|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111087016|NCT03337607|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
111087017|NCT03337607|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111087018|NCT03337607|Autonomic Agents|autonomic agents|mesh-ancestor
111087019|NCT03337607|Vasodilator Agents|vasodilator agents|mesh-ancestor
111087020|NCT02493179|Serratiopeptidase|serratiopeptidase|mesh-list
111087021|NCT02493179|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111087022|NCT02493179|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111087023|NCT02493179|Analgesics|analgesics|mesh-ancestor
111087024|NCT02493179|Sensory System Agents|sensory system agents|mesh-ancestor
111087025|NCT02493179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111087026|NCT02493179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111087027|NCT02493179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111087028|NCT02493179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111087029|NCT03336437|Estradiol|estradiol|mesh-list
111087030|NCT03336437|Estrogens|estrogens|mesh-ancestor
111087031|NCT03336437|Hormones|hormones|mesh-ancestor
111087032|NCT03336437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111087033|NCT03336437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111087034|NCT03337373|Cisatracurium|cisatracurium|mesh-list
111087035|NCT03337373|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
111087036|NCT03337373|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111087037|NCT03337373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111087038|NCT03337373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111087039|NCT03336281|Ustekinumab|ustekinumab|mesh-list
111087040|NCT03336281|Dermatologic Agents|dermatologic agents|mesh-ancestor
111087041|NCT03336125|Vitamin D|vitamin d|mesh-list
111087042|NCT03336125|Vitamins|vitamins|mesh-ancestor
111087043|NCT03336125|Micronutrients|micronutrients|mesh-ancestor
111087044|NCT03336125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111087045|NCT03336125|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111087046|NCT05051163|Gentamicins|gentamicins|mesh-list
111087047|NCT05051163|Ceftriaxone|ceftriaxone|mesh-list
111087048|NCT05051163|Ampicillin|ampicillin|mesh-list
111087049|NCT05051163|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111087050|NCT05051163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111087051|NCT05051163|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111087052|NCT05051163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111087053|NCT05051163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111087054|NCT03331211|Dasatinib|dasatinib|mesh-list
111087055|NCT03331211|Ponatinib|ponatinib|mesh-list
111087056|NCT03331211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111087057|NCT03331211|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111087058|NCT03331211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111087059|NCT03331211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111087060|NCT01929915|Fentanyl|fentanyl|mesh-list
111087061|NCT01929915|Morphine|morphine|mesh-list
111087062|NCT01929915|Bupivacaine|bupivacaine|mesh-list
111087063|NCT01929915|Anesthetics, Local|anesthetics, local|mesh-ancestor
111087064|NCT01929915|Anesthetics|anesthetics|mesh-ancestor
111087065|NCT01929915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111087066|NCT01929915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111087067|NCT01929915|Sensory System Agents|sensory system agents|mesh-ancestor
111087068|NCT01929915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111087069|NCT01929915|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111087070|NCT01929915|Narcotics|narcotics|mesh-ancestor
111087071|NCT01929915|Analgesics|analgesics|mesh-ancestor
111087072|NCT01929915|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111087073|NCT01929915|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111087074|NCT01929915|Anesthetics, General|anesthetics, general|mesh-ancestor
111087075|NCT05464745|Perindopril|perindopril|mesh-list
111087076|NCT05464745|Indapamide|indapamide|mesh-list
111087077|NCT05464745|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110804194|NCT04130464|Ketorolac|ketorolac|mesh-list
111087078|NCT05464745|Protease Inhibitors|protease inhibitors|mesh-ancestor
111087079|NCT05464745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111087080|NCT05464745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111087081|NCT05464745|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111087082|NCT05464745|Diuretics|diuretics|mesh-ancestor
111087083|NCT05464745|Natriuretic Agents|natriuretic agents|mesh-ancestor
111087084|NCT05464745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111087085|NCT05464745|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
111087086|NCT05464745|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111087087|NCT03094533|Propofol|propofol|mesh-list
111087088|NCT03094533|Sevoflurane|sevoflurane|mesh-list
111087089|NCT03094533|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111087090|NCT03094533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111087091|NCT03094533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111087092|NCT03094533|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111087093|NCT03094533|Anesthetics, General|anesthetics, general|mesh-ancestor
111087094|NCT03094533|Anesthetics|anesthetics|mesh-ancestor
111087095|NCT03094533|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111087096|NCT03094533|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111087097|NCT05028231|Immunomodulating Agents|immunomodulating agents|mesh-list
111087098|NCT05028231|Immunologic Factors|immunologic factors|mesh-ancestor
111087099|NCT05028231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111087100|NCT03335579|Sufentanil|sufentanil|mesh-list
111087101|NCT03335579|Remifentanil|remifentanil|mesh-list
111087102|NCT03335579|Propofol|propofol|mesh-list
111087103|NCT03335579|Anesthetics|anesthetics|mesh-ancestor
111087104|NCT03335579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111087105|NCT03335579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111087106|NCT03335579|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111087107|NCT03335579|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111087108|NCT03335579|Anesthetics, General|anesthetics, general|mesh-ancestor
111087109|NCT03335579|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111087110|NCT03335579|Narcotics|narcotics|mesh-ancestor
111087111|NCT03335579|Analgesics|analgesics|mesh-ancestor
111087112|NCT03335579|Sensory System Agents|sensory system agents|mesh-ancestor
111087113|NCT03335579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111087114|NCT03335579|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111087115|NCT05050071|Calcium, Dietary|calcium, dietary|mesh-list
111087116|NCT05050071|Calcium|calcium|mesh-list
111087117|NCT05050071|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111087118|NCT05050071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111087119|NCT05050071|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111087120|NCT03335501|Pancrelipase|pancrelipase|mesh-list
111087121|NCT03335501|Hormones|hormones|mesh-list
111087122|NCT03335501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111087123|NCT03335501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111087124|NCT03335501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111087125|NCT02492945|Lidocaine|lidocaine|mesh-list
111087126|NCT02492945|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111087127|NCT02492945|Anesthetics, Local|anesthetics, local|mesh-ancestor
111087128|NCT02492945|Anesthetics|anesthetics|mesh-ancestor
111087129|NCT02492945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111087130|NCT02492945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111087131|NCT02492945|Sensory System Agents|sensory system agents|mesh-ancestor
111087132|NCT02492945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111087133|NCT02492945|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111087134|NCT02492945|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111087135|NCT02492945|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111087136|NCT02492945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111087137|NCT02492945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111087138|NCT03335423|Metformin|metformin|mesh-list
111087139|NCT03335423|Codeine|codeine|mesh-list
111087140|NCT03335423|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111087141|NCT03335423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111087142|NCT03335423|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111087143|NCT03335423|Narcotics|narcotics|mesh-ancestor
111087144|NCT03335423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111087145|NCT03335423|Analgesics|analgesics|mesh-ancestor
111087146|NCT03335423|Sensory System Agents|sensory system agents|mesh-ancestor
111087147|NCT03335423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111087148|NCT03335423|Antitussive Agents|antitussive agents|mesh-ancestor
111087149|NCT03335423|Respiratory System Agents|respiratory system agents|mesh-ancestor
111087150|NCT05038605|Metronidazole|metronidazole|mesh-list
111087151|NCT05038605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111087152|NCT05038605|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111087153|NCT05038605|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111087154|NCT05038605|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111087155|NCT03329729|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111087156|NCT03329729|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111087157|NCT03329729|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111087158|NCT03329729|Antimetabolites|antimetabolites|mesh-ancestor
111087159|NCT03329729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111087160|NCT03329729|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111087161|NCT03329729|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111087162|NCT03329729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111087163|NCT02492477|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
111087164|NCT02492477|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111087165|NCT02492477|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111087166|NCT02492477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111087167|NCT03095547|Cyclosporine|cyclosporine|mesh-list
111087168|NCT03095547|Posaconazole|posaconazole|mesh-list
111087169|NCT03095547|Olorofim|olorofim|mesh-list
111087170|NCT03095547|Pantoprazole|pantoprazole|mesh-list
111087171|NCT03095547|Tacrolimus|tacrolimus|mesh-list
111087172|NCT03095547|Cyclosporins|cyclosporins|mesh-list
111087173|NCT03095547|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111087174|NCT03095547|Immunologic Factors|immunologic factors|mesh-ancestor
111087175|NCT03095547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111087176|NCT03095547|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111087177|NCT03095547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111087178|NCT03095547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111087179|NCT03095547|Antifungal Agents|antifungal agents|mesh-ancestor
111087180|NCT03095547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111087181|NCT03095547|Dermatologic Agents|dermatologic agents|mesh-ancestor
111087182|NCT03095547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111087183|NCT03095547|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111087184|NCT03095547|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111087185|NCT03095547|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111087186|NCT03095547|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
111087187|NCT03095547|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111087188|NCT03095547|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111087189|NCT03095547|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111087190|NCT03095547|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111087191|NCT03095547|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111087192|NCT03095547|Hormone Antagonists|hormone antagonists|mesh-ancestor
111087193|NCT03095547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111087194|NCT03329651|Metformin|metformin|mesh-list
111087195|NCT03329651|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111087196|NCT03329651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111087197|NCT03334877|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
111087198|NCT03334877|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111087199|NCT03334877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111087200|NCT05049681|Apatinib|apatinib|mesh-list
111087201|NCT05049681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111087202|NCT05049681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111087203|NCT05049681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111087204|NCT05049681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111087205|NCT03334487|Dexamethasone|dexamethasone|mesh-list
111087206|NCT03334487|Rovalpituzumab tesirine|rovalpituzumab tesirine|mesh-list
111087207|NCT03334487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111087208|NCT03334487|Antiemetics|antiemetics|mesh-ancestor
111087209|NCT03334487|Autonomic Agents|autonomic agents|mesh-ancestor
111087210|NCT03334487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111087211|NCT03334487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111087212|NCT03334487|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111087213|NCT03334487|Glucocorticoids|glucocorticoids|mesh-ancestor
111087214|NCT03334487|Hormones|hormones|mesh-ancestor
111087215|NCT03334487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111087216|NCT03334487|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111087217|NCT03334487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111087218|NCT03334487|Immunoconjugates|immunoconjugates|mesh-ancestor
111087219|NCT03334487|Immunologic Factors|immunologic factors|mesh-ancestor
111087220|NCT05038449|Colchicine|colchicine|mesh-list
111087221|NCT05038449|Gout Suppressants|gout suppressants|mesh-ancestor
111087222|NCT05038449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111087223|NCT05038449|Tubulin Modulators|tubulin modulators|mesh-ancestor
111087224|NCT05038449|Antimitotic Agents|antimitotic agents|mesh-ancestor
111087225|NCT05038449|Mitosis Modulators|mitosis modulators|mesh-ancestor
111087226|NCT05038449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111087227|NCT05038449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111087228|NCT05038059|Acetic Acid|acetic acid|mesh-list
111087229|NCT05038059|Retinol acetate|retinol acetate|mesh-list
111087230|NCT05038059|Ethylene|ethylene|mesh-list
111087231|NCT05038059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111087232|NCT05038059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111087233|NCT05038059|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111087234|NCT05038059|Immunologic Factors|immunologic factors|mesh-ancestor
111087235|NCT05038059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111087236|NCT05038059|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
111087237|NCT05038059|Protective Agents|protective agents|mesh-ancestor
111087238|NCT05038059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111087239|NCT05038059|Plant Growth Regulators|plant growth regulators|mesh-ancestor
111087240|NCT05038059|Growth Substances|growth substances|mesh-ancestor
111087241|NCT01236547|Paclitaxel|paclitaxel|mesh-list
111087242|NCT01236547|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111087243|NCT01236547|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111087244|NCT01236547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111087245|NCT01236547|Tubulin Modulators|tubulin modulators|mesh-ancestor
111087246|NCT01236547|Antimitotic Agents|antimitotic agents|mesh-ancestor
111087247|NCT01236547|Mitosis Modulators|mitosis modulators|mesh-ancestor
111087248|NCT01236547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111087250|NCT03329339|Antioxidants|antioxidants|mesh-ancestor
111087251|NCT03329339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111087252|NCT03329339|Protective Agents|protective agents|mesh-ancestor
111087253|NCT03329339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111087254|NCT03329339|Vitamins|vitamins|mesh-ancestor
111087255|NCT03329339|Micronutrients|micronutrients|mesh-ancestor
111087256|NCT03329261|Clopidogrel|clopidogrel|mesh-list
111087257|NCT03329261|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111087258|NCT03329261|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111087259|NCT03329261|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111087260|NCT03329261|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111087261|NCT03329261|Purinergic Agents|purinergic agents|mesh-ancestor
111087262|NCT03329261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111087263|NCT03329261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111087264|NCT03329261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111087265|NCT03329183|Irinotecan|irinotecan|mesh-list
111087266|NCT03329183|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111087267|NCT03329183|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111087268|NCT03329183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111087269|NCT03329183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111087270|NCT03329183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111087271|NCT05048511|Vitamin D|vitamin d|mesh-list
111087272|NCT05048511|Vitamins|vitamins|mesh-ancestor
111087273|NCT05048511|Micronutrients|micronutrients|mesh-ancestor
111087274|NCT05048511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111087275|NCT05048511|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111087276|NCT02167945|Ritonavir|ritonavir|mesh-list
111087277|NCT02167945|Ribavirin|ribavirin|mesh-list
111087278|NCT02167945|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111087279|NCT02167945|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111087280|NCT02167945|Protease Inhibitors|protease inhibitors|mesh-ancestor
111087281|NCT02167945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111087282|NCT02167945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111087283|NCT02167945|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111087284|NCT02167945|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111087285|NCT02167945|Antiviral Agents|antiviral agents|mesh-ancestor
111087286|NCT02167945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111087287|NCT02167945|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111087288|NCT02167945|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111087289|NCT02167945|Antimetabolites|antimetabolites|mesh-ancestor
111087290|NCT03328481|Anesthetics|anesthetics|mesh-list
111087291|NCT03328481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111087292|NCT03328481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111087293|NCT02452879|Solifenacin Succinate|solifenacin succinate|mesh-list
111087294|NCT02452879|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111087295|NCT02452879|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111087296|NCT02452879|Cholinergic Agents|cholinergic agents|mesh-ancestor
111087297|NCT02452879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111087298|NCT02452879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111087299|NCT02452879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111087300|NCT02452879|Urological Agents|urological agents|mesh-ancestor
111087301|NCT05024799|Fentanyl|fentanyl|mesh-list
111087302|NCT05024799|Butorphanol|butorphanol|mesh-list
111087303|NCT05024799|Propofol|propofol|mesh-list
110804391|NCT02142166|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111087304|NCT05024799|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111087305|NCT05024799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111087306|NCT05024799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111087307|NCT05024799|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111087308|NCT05024799|Anesthetics, General|anesthetics, general|mesh-ancestor
111087310|NCT05024799|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111087311|NCT05024799|Narcotics|narcotics|mesh-ancestor
111087312|NCT05024799|Analgesics|analgesics|mesh-ancestor
111087313|NCT05024799|Sensory System Agents|sensory system agents|mesh-ancestor
111087314|NCT05024799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111087315|NCT05024799|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111087316|NCT05024799|Antitussive Agents|antitussive agents|mesh-ancestor
111087317|NCT05024799|Respiratory System Agents|respiratory system agents|mesh-ancestor
111087318|NCT05024799|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111087319|NCT05018637|Teriparatide|teriparatide|mesh-list
111087320|NCT05018637|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111087321|NCT05018637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111087322|NCT05018637|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111087323|NCT03327701|Benralizumab|benralizumab|mesh-list
111087324|NCT03327701|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111087325|NCT03327701|Respiratory System Agents|respiratory system agents|mesh-ancestor
111087326|NCT03327389|Dexmedetomidine|dexmedetomidine|mesh-list
111087327|NCT03327389|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111087328|NCT03327389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111087329|NCT03327389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111087330|NCT03327389|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111087331|NCT03327389|Analgesics|analgesics|mesh-ancestor
111087332|NCT03327389|Sensory System Agents|sensory system agents|mesh-ancestor
111087333|NCT03327389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111087334|NCT03327389|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111087335|NCT03327389|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111087336|NCT03327389|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111087337|NCT03327389|Adrenergic Agents|adrenergic agents|mesh-ancestor
111087338|NCT03327389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111087339|NCT03327389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111087340|NCT03333083|Lamivudine|lamivudine|mesh-list
111087341|NCT03333083|Raltegravir Potassium|raltegravir potassium|mesh-list
111087342|NCT03333083|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111087343|NCT03333083|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111087344|NCT03333083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111087345|NCT03333083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111087346|NCT03333083|Antiviral Agents|antiviral agents|mesh-ancestor
111087347|NCT03333083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111087348|NCT03333083|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111087349|NCT03333083|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111087350|NCT03333083|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111087351|NCT03333083|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111087352|NCT03093597|Petrolatum|petrolatum|mesh-list
111087353|NCT03093597|Emollients|emollients|mesh-ancestor
111087354|NCT03093597|Dermatologic Agents|dermatologic agents|mesh-ancestor
111087355|NCT03327155|Tenofovir|tenofovir|mesh-list
111087356|NCT03327155|Emtricitabine|emtricitabine|mesh-list
111087357|NCT03327155|Antiviral Agents|antiviral agents|mesh-ancestor
111087358|NCT03327155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111087359|NCT03327155|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111087360|NCT03327155|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111087361|NCT03327155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111087362|NCT03327155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111087363|NCT03327155|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111087364|NCT03327155|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111087365|NCT05024877|Stanozolol|stanozolol|mesh-list
111087366|NCT05024877|Androgens|androgens|mesh-ancestor
111087367|NCT05024877|Hormones|hormones|mesh-ancestor
111087368|NCT05024877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111087369|NCT05024877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111087370|NCT05024877|Anabolic Agents|anabolic agents|mesh-ancestor
111087371|NCT03079557|Botulinum Toxins|botulinum toxins|mesh-list
111087372|NCT03079557|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111087373|NCT03079557|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111087374|NCT03079557|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111087375|NCT03079557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111087376|NCT03079557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111087377|NCT03079557|Cholinergic Agents|cholinergic agents|mesh-ancestor
111087378|NCT03079557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110804467|NCT02145832|Fluconazole|fluconazole|mesh-list
111087379|NCT03079557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111087380|NCT03079557|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111087381|NCT03079557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111087382|NCT03230851|Aspirin|aspirin|mesh-list
111087383|NCT03230851|Indobufen|indobufen|mesh-list
111087384|NCT03230851|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111087385|NCT03230851|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111087386|NCT03230851|Analgesics|analgesics|mesh-ancestor
111087387|NCT03230851|Sensory System Agents|sensory system agents|mesh-ancestor
111087388|NCT03230851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111087389|NCT03230851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111087390|NCT03230851|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111087391|NCT03230851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111087392|NCT03230851|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111087393|NCT03230851|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111087394|NCT03230851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111087395|NCT03230851|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111087396|NCT03230851|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111087397|NCT03230851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111087398|NCT03230851|Antipyretics|antipyretics|mesh-ancestor
111087399|NCT05464433|Tislelizumab|tislelizumab|mesh-list
111087400|NCT05464433|Mitoxantrone|mitoxantrone|mesh-list
111087401|NCT05464433|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111087402|NCT05464433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111087403|NCT05464433|Analgesics|analgesics|mesh-ancestor
111087404|NCT05464433|Sensory System Agents|sensory system agents|mesh-ancestor
111087405|NCT05464433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111087406|NCT05464433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111087407|NCT05464433|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111087408|NCT05464433|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111087409|NCT05464433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111087410|NCT05464433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111087411|NCT03229135|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111087412|NCT03229135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111087413|NCT05024565|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111087414|NCT05024565|Lactams|lactams|mesh-list
111087415|NCT05024565|beta-Lactams|beta-lactams|mesh-list
111087416|NCT05024565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111087417|NCT03228901|Oxytocin|oxytocin|mesh-list
111087418|NCT03228901|Oxytocics|oxytocics|mesh-ancestor
111087419|NCT03228901|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111087420|NCT03228901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111087421|NCT03228823|Amiodarone|amiodarone|mesh-list
111087422|NCT03228823|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
111087423|NCT03228823|Vasodilator Agents|vasodilator agents|mesh-ancestor
111087424|NCT03228823|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
111087425|NCT03228823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111087426|NCT03228823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111087427|NCT03228823|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111087428|NCT03228823|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111087429|NCT03228823|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111087430|NCT03228823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111087431|NCT03228823|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111087432|NCT03228823|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111087433|NCT03228823|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111087434|NCT03332225|Interferons|interferons|mesh-list
111087435|NCT03332225|Interferon-gamma|interferon-gamma|mesh-list
111087436|NCT03332225|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
111087437|NCT03332225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111087438|NCT03332225|Antiviral Agents|antiviral agents|mesh-ancestor
111087439|NCT03332225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111087440|NCT03332225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111087441|NCT05023941|Acetazolamide|acetazolamide|mesh-list
111087442|NCT05023941|Anticonvulsants|anticonvulsants|mesh-ancestor
111087443|NCT05023941|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
111087444|NCT05023941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111087445|NCT05023941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111087446|NCT05023941|Diuretics|diuretics|mesh-ancestor
111087447|NCT05023941|Natriuretic Agents|natriuretic agents|mesh-ancestor
111087448|NCT05023941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111087449|NCT03332069|Cisplatin|cisplatin|mesh-list
111087450|NCT03332069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111087451|NCT03090087|Regadenoson|regadenoson|mesh-list
111087452|NCT03090087|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
111087453|NCT03090087|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
111087454|NCT03090087|Purinergic Agonists|purinergic agonists|mesh-ancestor
111087455|NCT03090087|Purinergic Agents|purinergic agents|mesh-ancestor
111087456|NCT03090087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111087457|NCT03090087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111087458|NCT03090087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111087459|NCT03326609|Ropivacaine|ropivacaine|mesh-list
111087460|NCT03326609|Anesthetics, Local|anesthetics, local|mesh-ancestor
111087461|NCT03326609|Anesthetics|anesthetics|mesh-ancestor
111087462|NCT03326609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111087463|NCT03326609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111087464|NCT03326609|Sensory System Agents|sensory system agents|mesh-ancestor
111087465|NCT03326609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111087466|NCT03331913|Botulinum Toxins|botulinum toxins|mesh-list
111087467|NCT03331913|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111087468|NCT03331913|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111087469|NCT03331913|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111087470|NCT03331913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111087471|NCT03331913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111087472|NCT03331913|Cholinergic Agents|cholinergic agents|mesh-ancestor
111087473|NCT03331913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111087474|NCT03331913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111087475|NCT03331913|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111087476|NCT03331913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111087477|NCT03090009|Flurbiprofen|flurbiprofen|mesh-list
111087478|NCT03090009|Analgesics|analgesics|mesh-ancestor
111087479|NCT03090009|Sensory System Agents|sensory system agents|mesh-ancestor
111087480|NCT03090009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111087481|NCT03090009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111087482|NCT03090009|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111087483|NCT03090009|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111087484|NCT03090009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111087485|NCT03090009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111087486|NCT03090009|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111087487|NCT03090009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111087488|NCT03090009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111087489|NCT02492087|Tranexamic Acid|tranexamic acid|mesh-list
111087490|NCT02492087|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111087491|NCT02492087|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111087492|NCT02492087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111087493|NCT02492087|Hemostatics|hemostatics|mesh-ancestor
111087494|NCT02492087|Coagulants|coagulants|mesh-ancestor
111087495|NCT03093129|Artesunate|artesunate|mesh-list
111087496|NCT03093129|Antimalarials|antimalarials|mesh-ancestor
111087497|NCT03093129|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111087498|NCT03093129|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111087499|NCT03093129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111087500|NCT03093129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111087501|NCT03093129|Antiviral Agents|antiviral agents|mesh-ancestor
111087502|NCT03093129|Schistosomicides|schistosomicides|mesh-ancestor
111087503|NCT03093129|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
111087504|NCT03093129|Anthelmintics|anthelmintics|mesh-ancestor
111087505|NCT02491697|Capecitabine|capecitabine|mesh-list
111087506|NCT02491697|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111087507|NCT02491697|Antimetabolites|antimetabolites|mesh-ancestor
111087508|NCT02491697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111087509|NCT02491697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111087510|NCT05024019|Nimotuzumab|nimotuzumab|mesh-list
111087511|NCT05024019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111087512|NCT05024019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111087513|NCT05008731|Botulinum Toxins|botulinum toxins|mesh-list
111087514|NCT05008731|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111087515|NCT05008731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111087516|NCT05008731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111087517|NCT05008731|Cholinergic Agents|cholinergic agents|mesh-ancestor
111087518|NCT05008731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111087519|NCT05008731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111087520|NCT03331523|Betamethasone|betamethasone|mesh-list
111087521|NCT03331523|Betamethasone Valerate|betamethasone valerate|mesh-list
110640883|NCT04515329|Cyclosporine|cyclosporine|mesh-list
111087522|NCT03331523|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
111087523|NCT03331523|Betamethasone benzoate|betamethasone benzoate|mesh-list
111087524|NCT03331523|Calcipotriene|calcipotriene|mesh-list
111087525|NCT03331523|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
111087526|NCT03331523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111087527|NCT03331523|Glucocorticoids|glucocorticoids|mesh-ancestor
111087528|NCT03331523|Hormones|hormones|mesh-ancestor
111087529|NCT03331523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111087530|NCT03331523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111087531|NCT03331523|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111087532|NCT03331523|Respiratory System Agents|respiratory system agents|mesh-ancestor
111087533|NCT03331523|Dermatologic Agents|dermatologic agents|mesh-ancestor
111087534|NCT05023863|Thioctic Acid|thioctic acid|mesh-list
111087535|NCT05023863|Antioxidants|antioxidants|mesh-ancestor
111087536|NCT05023863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111087537|NCT05023863|Protective Agents|protective agents|mesh-ancestor
111087538|NCT05023863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111087539|NCT05023863|Vitamin B Complex|vitamin b complex|mesh-ancestor
111087540|NCT05023863|Vitamins|vitamins|mesh-ancestor
111087541|NCT05023863|Micronutrients|micronutrients|mesh-ancestor
111087542|NCT05463809|Oxycodone|oxycodone|mesh-list
111087543|NCT05463809|Analgesics|analgesics|mesh-list
111087544|NCT05463809|Ropivacaine|ropivacaine|mesh-list
111087545|NCT05463809|Anesthetics, Local|anesthetics, local|mesh-ancestor
111087546|NCT05463809|Anesthetics|anesthetics|mesh-ancestor
111087547|NCT05463809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111087548|NCT05463809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111087549|NCT05463809|Sensory System Agents|sensory system agents|mesh-ancestor
111087550|NCT05463809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111087551|NCT05463809|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111087552|NCT05463809|Narcotics|narcotics|mesh-ancestor
111087553|NCT03331445|Nitric Oxide|nitric oxide|mesh-list
111087554|NCT03331445|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111087555|NCT03331445|Autonomic Agents|autonomic agents|mesh-ancestor
111087556|NCT03331445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111087557|NCT03331445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111087558|NCT03331445|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111087559|NCT03331445|Respiratory System Agents|respiratory system agents|mesh-ancestor
111087560|NCT03331445|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111087561|NCT03331445|Antioxidants|antioxidants|mesh-ancestor
111087562|NCT03331445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111087563|NCT03331445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111087564|NCT03331445|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
111087565|NCT03331445|Vasodilator Agents|vasodilator agents|mesh-ancestor
111087566|NCT03331445|Gasotransmitters|gasotransmitters|mesh-ancestor
111087567|NCT03331445|Protective Agents|protective agents|mesh-ancestor
111087568|NCT05008029|Anesthetics|anesthetics|mesh-list
111087569|NCT05008029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111087570|NCT05008029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111087571|NCT05008263|Liver Extracts|liver extracts|mesh-list
111087572|NCT05008263|Technetium Tc 99m mebrofenin|technetium tc 99m mebrofenin|mesh-list
111087573|NCT05008263|Hematinics|hematinics|mesh-ancestor
111087574|NCT05008263|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111087575|NCT05008263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111087576|NCT03325127|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
111087577|NCT03325127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111087578|NCT05016063|Fludarabine|fludarabine|mesh-list
111087579|NCT05016063|Cyclophosphamide|cyclophosphamide|mesh-list
111087580|NCT05016063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111087581|NCT05016063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111087582|NCT05016063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111087583|NCT05016063|Immunologic Factors|immunologic factors|mesh-ancestor
111087584|NCT05016063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111087585|NCT05016063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111087586|NCT05016063|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111087587|NCT05016063|Alkylating Agents|alkylating agents|mesh-ancestor
111087588|NCT05016063|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111087589|NCT03078933|Nitric Oxide|nitric oxide|mesh-list
111087590|NCT03078933|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111087591|NCT03078933|Autonomic Agents|autonomic agents|mesh-ancestor
111087592|NCT03078933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111087593|NCT03078933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111087594|NCT03078933|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111087595|NCT03078933|Respiratory System Agents|respiratory system agents|mesh-ancestor
111087596|NCT03078933|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111087597|NCT03078933|Antioxidants|antioxidants|mesh-ancestor
111087598|NCT03078933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111087599|NCT03078933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111087600|NCT03078933|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
111087601|NCT03078933|Vasodilator Agents|vasodilator agents|mesh-ancestor
111087602|NCT03078933|Gasotransmitters|gasotransmitters|mesh-ancestor
111087603|NCT03078933|Protective Agents|protective agents|mesh-ancestor
111087605|NCT03092193|Esomeprazole|esomeprazole|mesh-list
111087606|NCT03092193|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111087607|NCT03092193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111087608|NCT03092193|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111087609|NCT03092193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111087610|NCT03092193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111087611|NCT03092193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111087612|NCT03092193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111087613|NCT03092193|Analgesics|analgesics|mesh-ancestor
111087614|NCT03092193|Sensory System Agents|sensory system agents|mesh-ancestor
111087615|NCT03092193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111087616|NCT03092193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111087617|NCT03092193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111087618|NCT03092193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111087619|NCT03092193|Gout Suppressants|gout suppressants|mesh-ancestor
111087620|NCT03092193|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111087621|NCT05015907|Ropivacaine|ropivacaine|mesh-list
111087622|NCT05015907|Anesthetics, Local|anesthetics, local|mesh-ancestor
111087623|NCT05015907|Anesthetics|anesthetics|mesh-ancestor
111087624|NCT05015907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111087625|NCT05015907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111087626|NCT05015907|Sensory System Agents|sensory system agents|mesh-ancestor
111087627|NCT05015907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111087628|NCT05015595|Memantine|memantine|mesh-list
111087629|NCT05015595|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111087630|NCT05015595|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111087631|NCT05015595|Dopamine Agents|dopamine agents|mesh-ancestor
111087632|NCT05015595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111087633|NCT05015595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111087634|NCT05015595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111087635|NCT05015595|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111087636|NCT05015595|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111087637|NCT05015829|Dobutamine|dobutamine|mesh-list
111087638|NCT05015829|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111087639|NCT05015829|Sympathomimetics|sympathomimetics|mesh-ancestor
111087640|NCT05015829|Autonomic Agents|autonomic agents|mesh-ancestor
111087641|NCT05015829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111087642|NCT05015829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111087643|NCT05015829|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
111087644|NCT05015829|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111087645|NCT05015829|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111087646|NCT05015829|Adrenergic Agents|adrenergic agents|mesh-ancestor
111087647|NCT05015829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111087648|NCT05015829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111087649|NCT05015829|Protective Agents|protective agents|mesh-ancestor
111087650|NCT05015361|Propofol|propofol|mesh-list
111087651|NCT05015361|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111087652|NCT05015361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111087653|NCT05015361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111087654|NCT05015361|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111087655|NCT05015361|Anesthetics, General|anesthetics, general|mesh-ancestor
111087656|NCT05015361|Anesthetics|anesthetics|mesh-ancestor
111087657|NCT01375075|Atorvastatin|atorvastatin|mesh-list
111087658|NCT01375075|Evacetrapib|evacetrapib|mesh-list
111087659|NCT01375075|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111087660|NCT01375075|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111087661|NCT01375075|Antimetabolites|antimetabolites|mesh-ancestor
111087662|NCT01375075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111087663|NCT01375075|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111087664|NCT01375075|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111087665|NCT01375075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111087666|NCT00706433|Aminolevulinic Acid|aminolevulinic acid|mesh-list
111087667|NCT00706433|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111087668|NCT00706433|Dermatologic Agents|dermatologic agents|mesh-ancestor
111087669|NCT03240055|Etomidate|etomidate|mesh-list
111087670|NCT03240055|Anesthetics|anesthetics|mesh-ancestor
111087671|NCT03240055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111087672|NCT03240055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111087673|NCT03240055|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111087674|NCT03240055|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111087675|NCT03240055|Anesthetics, General|anesthetics, general|mesh-ancestor
111087676|NCT03087201|Nabiximols|nabiximols|mesh-list
111087677|NCT03087201|Analgesics|analgesics|mesh-ancestor
111087678|NCT03087201|Sensory System Agents|sensory system agents|mesh-ancestor
111087679|NCT03087201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111087680|NCT03087201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111087681|NCT03230539|Ulipristal acetate|ulipristal acetate|mesh-list
111087682|NCT03230539|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111087683|NCT03230539|Contraceptive Agents|contraceptive agents|mesh-ancestor
111087684|NCT03230539|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111087685|NCT03230539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111087686|NCT03230539|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111087687|NCT03239743|Midazolam|midazolam|mesh-list
111087688|NCT03239743|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111087689|NCT03239743|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111087690|NCT03239743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111087691|NCT03239743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111087692|NCT03239743|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111087693|NCT03239743|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111087694|NCT03239743|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111087695|NCT03239743|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111087696|NCT03239743|Anesthetics, General|anesthetics, general|mesh-ancestor
111087697|NCT03239743|Anesthetics|anesthetics|mesh-ancestor
111087698|NCT03239743|GABA Modulators|gaba modulators|mesh-ancestor
111087699|NCT03239743|GABA Agents|gaba agents|mesh-ancestor
111087700|NCT03239743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111087701|NCT03239743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111087703|NCT03239821|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111087704|NCT03239821|Narcotics|narcotics|mesh-ancestor
111087705|NCT03239821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111087706|NCT03239821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111087707|NCT03239821|Analgesics|analgesics|mesh-ancestor
111087708|NCT03239821|Sensory System Agents|sensory system agents|mesh-ancestor
111087709|NCT03239821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111087710|NCT03239821|Antitussive Agents|antitussive agents|mesh-ancestor
111087711|NCT03239821|Respiratory System Agents|respiratory system agents|mesh-ancestor
111087712|NCT03230227|Bupivacaine|bupivacaine|mesh-list
111087713|NCT03230227|Anesthetics, Local|anesthetics, local|mesh-ancestor
111087714|NCT03230227|Anesthetics|anesthetics|mesh-ancestor
111087715|NCT03230227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111087716|NCT03230227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111087717|NCT03230227|Sensory System Agents|sensory system agents|mesh-ancestor
111087718|NCT03230227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111087719|NCT03078465|Clopidogrel|clopidogrel|mesh-list
111087720|NCT03078465|Ticagrelor|ticagrelor|mesh-list
111087721|NCT03078465|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111087722|NCT03078465|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111087723|NCT03078465|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111087724|NCT03078465|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111087725|NCT03078465|Purinergic Agents|purinergic agents|mesh-ancestor
111087726|NCT03078465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111087727|NCT03078465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111087728|NCT03078465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111087729|NCT03324815|Morphine|morphine|mesh-list
111087730|NCT03324815|Methadone|methadone|mesh-list
111087731|NCT03324815|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111087732|NCT03324815|Narcotics|narcotics|mesh-ancestor
111087733|NCT03324815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111087734|NCT03324815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111087735|NCT03324815|Analgesics|analgesics|mesh-ancestor
111087736|NCT03324815|Sensory System Agents|sensory system agents|mesh-ancestor
111087737|NCT03324815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111087738|NCT03324815|Antitussive Agents|antitussive agents|mesh-ancestor
111087739|NCT03324815|Respiratory System Agents|respiratory system agents|mesh-ancestor
111087740|NCT05006469|Dexamethasone|dexamethasone|mesh-list
111087741|NCT05006469|Doxorubicin|doxorubicin|mesh-list
111087742|NCT05006469|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111087743|NCT05006469|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
111087744|NCT05006469|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111087745|NCT05006469|Antiemetics|antiemetics|mesh-ancestor
111087746|NCT05006469|Autonomic Agents|autonomic agents|mesh-ancestor
111087747|NCT05006469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111087748|NCT05006469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111087749|NCT05006469|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110804840|NCT02155504|Itraconazole|itraconazole|mesh-list
111087750|NCT05006469|Glucocorticoids|glucocorticoids|mesh-ancestor
111087751|NCT05006469|Hormones|hormones|mesh-ancestor
111087752|NCT05006469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111087753|NCT05006469|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111087754|NCT05006469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111087755|NCT05006469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111087756|NCT05006469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111087757|NCT05006469|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111087758|NCT05006469|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111087759|NCT05006469|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111087760|NCT05006469|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111087761|NCT05006469|Alkylating Agents|alkylating agents|mesh-ancestor
111087763|NCT03084783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111087764|NCT03084783|Antiemetics|antiemetics|mesh-ancestor
111087765|NCT03084783|Autonomic Agents|autonomic agents|mesh-ancestor
111087766|NCT03084783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111087767|NCT03084783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111087768|NCT03084783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111087769|NCT03084783|Glucocorticoids|glucocorticoids|mesh-ancestor
111087770|NCT03084783|Hormones|hormones|mesh-ancestor
111087771|NCT03084783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111087772|NCT03084783|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111087773|NCT03084783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111087774|NCT03228355|Cromakalim|cromakalim|mesh-list
111087775|NCT03228355|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111087776|NCT03228355|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111087777|NCT03228355|Autonomic Agents|autonomic agents|mesh-ancestor
111087778|NCT03228355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111087779|NCT03228355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111087780|NCT03228355|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111087781|NCT03228355|Respiratory System Agents|respiratory system agents|mesh-ancestor
111087782|NCT03228355|Parasympatholytics|parasympatholytics|mesh-ancestor
111087783|NCT03228355|Vasodilator Agents|vasodilator agents|mesh-ancestor
111087784|NCT03324503|Prednisone|prednisone|mesh-list
111087785|NCT03324503|Prednisolone|prednisolone|mesh-list
111087786|NCT03324503|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111087787|NCT03324503|Methylprednisolone|methylprednisolone|mesh-list
111087788|NCT03324503|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111087789|NCT03324503|Prednisolone acetate|prednisolone acetate|mesh-list
111087790|NCT03324503|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111087791|NCT03324503|Prednisolone phosphate|prednisolone phosphate|mesh-list
111087792|NCT03324503|Glucocorticoids|glucocorticoids|mesh-list
111087793|NCT03324503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111087794|NCT03324503|Hormones|hormones|mesh-ancestor
111087795|NCT03324503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111087796|NCT03324503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111087797|NCT03324503|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111087798|NCT03324503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111087799|NCT03324503|Antiemetics|antiemetics|mesh-ancestor
111087800|NCT03324503|Autonomic Agents|autonomic agents|mesh-ancestor
111087801|NCT03324503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111087802|NCT03324503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111087803|NCT03324503|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111087804|NCT03324503|Protective Agents|protective agents|mesh-ancestor
111087805|NCT05006001|Colchicine|colchicine|mesh-list
111087806|NCT05006001|Gout Suppressants|gout suppressants|mesh-ancestor
111087807|NCT05006001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111087808|NCT05006001|Tubulin Modulators|tubulin modulators|mesh-ancestor
111087809|NCT05006001|Antimitotic Agents|antimitotic agents|mesh-ancestor
111087810|NCT05006001|Mitosis Modulators|mitosis modulators|mesh-ancestor
111087811|NCT05006001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111087812|NCT05006001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111087813|NCT04493489|Propranolol|propranolol|mesh-list
111087814|NCT04493489|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111087815|NCT04493489|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111087816|NCT04493489|Adrenergic Agents|adrenergic agents|mesh-ancestor
111087817|NCT04493489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111087818|NCT04493489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111087819|NCT04493489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111087820|NCT04493489|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111087821|NCT04493489|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111087822|NCT04493489|Vasodilator Agents|vasodilator agents|mesh-ancestor
111087823|NCT03228043|Apatinib|apatinib|mesh-list
111087824|NCT03228043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111087825|NCT03228043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111087826|NCT03228043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111087827|NCT03228043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111087828|NCT03119857|Docetaxel|docetaxel|mesh-list
111087830|NCT03119857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111087831|NCT03119857|Tubulin Modulators|tubulin modulators|mesh-ancestor
111087832|NCT03119857|Antimitotic Agents|antimitotic agents|mesh-ancestor
111087833|NCT03119857|Mitosis Modulators|mitosis modulators|mesh-ancestor
111087834|NCT03119857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111087835|NCT03119857|Hormone Antagonists|hormone antagonists|mesh-ancestor
111087836|NCT03119857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111087837|NCT03119857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111087838|NCT03320603|Thrombin|thrombin|mesh-list
111087839|NCT03320603|Hemostatics|hemostatics|mesh-ancestor
111087840|NCT03320603|Coagulants|coagulants|mesh-ancestor
111087841|NCT03227653|Ritonavir|ritonavir|mesh-list
111087842|NCT03227653|Lopinavir|lopinavir|mesh-list
111087844|NCT03227653|Efavirenz|efavirenz|mesh-list
111087845|NCT03227653|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111087846|NCT03227653|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111087847|NCT03227653|Protease Inhibitors|protease inhibitors|mesh-ancestor
111087848|NCT03227653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111087849|NCT03227653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111087850|NCT03227653|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111087851|NCT03227653|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111087852|NCT03227653|Antiviral Agents|antiviral agents|mesh-ancestor
111087853|NCT03227653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111087854|NCT03227653|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111087855|NCT03227653|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111087856|NCT03227653|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111087857|NCT03227653|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111087858|NCT03227653|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111087859|NCT03227653|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111087860|NCT03227653|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111087861|NCT03227653|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111087862|NCT03227653|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111087863|NCT03320447|Lidocaine|lidocaine|mesh-list
111087864|NCT03320447|Prilocaine|prilocaine|mesh-list
111087865|NCT03320447|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
111087866|NCT03320447|Aminolevulinic Acid|aminolevulinic acid|mesh-list
111087867|NCT03320447|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
111087868|NCT03320447|Anesthetics, Local|anesthetics, local|mesh-ancestor
111087869|NCT03320447|Anesthetics|anesthetics|mesh-ancestor
111087870|NCT03320447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111087871|NCT03320447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111087872|NCT03320447|Sensory System Agents|sensory system agents|mesh-ancestor
111087873|NCT03320447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111087874|NCT03320447|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111087875|NCT03320447|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111087876|NCT03320447|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111087877|NCT03320447|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111087878|NCT03320447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111087879|NCT03320447|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111087880|NCT03320447|Dermatologic Agents|dermatologic agents|mesh-ancestor
111087881|NCT03320447|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
111087882|NCT04434105|Triamcinolone|triamcinolone|mesh-list
111087883|NCT04434105|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
111087884|NCT04434105|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
111087885|NCT04434105|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
111087886|NCT04434105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111087887|NCT04434105|Glucocorticoids|glucocorticoids|mesh-ancestor
111087888|NCT04434105|Hormones|hormones|mesh-ancestor
111087889|NCT04434105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111087890|NCT04434105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111087891|NCT04434105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111087892|NCT04434105|Immunologic Factors|immunologic factors|mesh-ancestor
111087893|NCT04434105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111087894|NCT04434105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111087895|NCT03078777|Fexofenadine|fexofenadine|mesh-list
111087896|NCT03078777|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111087897|NCT03078777|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
111087898|NCT03078777|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111087899|NCT03078777|Histamine Antagonists|histamine antagonists|mesh-ancestor
111087900|NCT03078777|Histamine Agents|histamine agents|mesh-ancestor
111087901|NCT03078777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111087902|NCT03078777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111087903|NCT03078777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111087905|NCT03078309|Anticonvulsants|anticonvulsants|mesh-ancestor
111087906|NCT03208309|Diacerein|diacerein|mesh-list
111087907|NCT03208309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111087908|NCT03091803|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
111087909|NCT03091803|Chelating Agents|chelating agents|mesh-ancestor
111087910|NCT03091803|Sequestering Agents|sequestering agents|mesh-ancestor
111087911|NCT03091803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111087912|NCT03323567|Lidocaine|lidocaine|mesh-list
111087913|NCT03323567|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110677307|NCT01806571|Cytarabine|cytarabine|mesh-list
111087914|NCT03323567|Anesthetics, Local|anesthetics, local|mesh-ancestor
111087915|NCT03323567|Anesthetics|anesthetics|mesh-ancestor
111087916|NCT03323567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111087917|NCT03323567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111087918|NCT03323567|Sensory System Agents|sensory system agents|mesh-ancestor
111087919|NCT03323567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111087920|NCT03323567|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111087921|NCT03323567|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111087922|NCT03323567|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111087923|NCT03323567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111087924|NCT03323567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111087925|NCT04492709|Midazolam|midazolam|mesh-list
111087926|NCT04492709|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111087927|NCT04492709|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111087928|NCT04492709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111087929|NCT04492709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111087930|NCT04492709|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111087931|NCT04492709|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111087932|NCT04492709|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111087933|NCT04492709|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111087934|NCT04492709|Anesthetics, General|anesthetics, general|mesh-ancestor
111087935|NCT04492709|Anesthetics|anesthetics|mesh-ancestor
111087936|NCT04492709|GABA Modulators|gaba modulators|mesh-ancestor
111087937|NCT04492709|GABA Agents|gaba agents|mesh-ancestor
111087938|NCT04492709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111087939|NCT04492709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111087940|NCT05006235|Epinephrine|epinephrine|mesh-list
111087941|NCT05006235|Albuterol|albuterol|mesh-list
111087942|NCT05006235|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111087943|NCT05006235|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111087944|NCT05006235|Adrenergic Agents|adrenergic agents|mesh-ancestor
111087945|NCT05006235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111087946|NCT05006235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111087947|NCT05006235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111087948|NCT05006235|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111087949|NCT05006235|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111087950|NCT05006235|Autonomic Agents|autonomic agents|mesh-ancestor
111087951|NCT05006235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111087952|NCT05006235|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111087953|NCT05006235|Respiratory System Agents|respiratory system agents|mesh-ancestor
111087954|NCT05006235|Mydriatics|mydriatics|mesh-ancestor
111087955|NCT05006235|Sympathomimetics|sympathomimetics|mesh-ancestor
111087956|NCT05006235|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111087957|NCT05006235|Tocolytic Agents|tocolytic agents|mesh-ancestor
111087958|NCT05006235|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111087959|NCT05006235|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111087960|NCT03319823|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
111087961|NCT03319823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111087962|NCT03319823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111087963|NCT03319823|Diuretics|diuretics|mesh-ancestor
111087964|NCT03319823|Natriuretic Agents|natriuretic agents|mesh-ancestor
111087965|NCT03319823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111087966|NCT02487953|Nicotine|nicotine|mesh-list
111087967|NCT02487953|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111087968|NCT02487953|Autonomic Agents|autonomic agents|mesh-ancestor
111087969|NCT02487953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111087970|NCT02487953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111087971|NCT02487953|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111087972|NCT02487953|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111087973|NCT02487953|Cholinergic Agents|cholinergic agents|mesh-ancestor
111087974|NCT02487953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111087975|NCT02487953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111087976|NCT03091569|Vitamin K|vitamin k|mesh-list
111087977|NCT03091569|Vitamins|vitamins|mesh-ancestor
111087978|NCT03091569|Micronutrients|micronutrients|mesh-ancestor
111087979|NCT03091569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111087980|NCT03091569|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111087981|NCT03091569|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111087982|NCT03091569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111087983|NCT03091569|Hemostatics|hemostatics|mesh-ancestor
111087984|NCT03091569|Coagulants|coagulants|mesh-ancestor
111087985|NCT04948749|Sirolimus|sirolimus|mesh-list
111087986|NCT04948749|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111087987|NCT04948749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111087988|NCT04948749|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111087989|NCT04948749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111087990|NCT04948749|Antifungal Agents|antifungal agents|mesh-ancestor
111087991|NCT04948749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111087992|NCT04948749|Immunologic Factors|immunologic factors|mesh-ancestor
111087993|NCT04948749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111087994|NCT03226717|Antiviral Agents|antiviral agents|mesh-list
111087995|NCT03226717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111087996|NCT02487719|Teferrol|teferrol|mesh-list
111087997|NCT02487719|Hematinics|hematinics|mesh-ancestor
111087998|NCT03207295|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
111087999|NCT03207295|Natriuretic Agents|natriuretic agents|mesh-ancestor
111088000|NCT03207295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111088001|NCT04940871|Favipiravir|favipiravir|mesh-list
111088002|NCT04940871|Antiviral Agents|antiviral agents|mesh-ancestor
111088003|NCT04940871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111088004|NCT03207139|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
111088005|NCT03207139|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111088006|NCT03207139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111088007|NCT03080415|Sofosbuvir|sofosbuvir|mesh-list
111088008|NCT03080415|Antiviral Agents|antiviral agents|mesh-ancestor
111088009|NCT03080415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111088010|NCT03221881|Docetaxel|docetaxel|mesh-list
111088011|NCT03221881|Doxorubicin|doxorubicin|mesh-list
111088012|NCT03221881|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111088013|NCT03221881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111088014|NCT03221881|Tubulin Modulators|tubulin modulators|mesh-ancestor
111088015|NCT03221881|Antimitotic Agents|antimitotic agents|mesh-ancestor
111088016|NCT03221881|Mitosis Modulators|mitosis modulators|mesh-ancestor
111088017|NCT03221881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111088018|NCT03221881|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111088019|NCT03221881|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111088020|NCT03221881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111088021|NCT03221881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111088022|NCT03091257|Trametinib|trametinib|mesh-list
111088023|NCT03091257|Dabrafenib|dabrafenib|mesh-list
111088024|NCT03091257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111088025|NCT03091257|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111088026|NCT03091257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111088027|NCT03091257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111088028|NCT03206671|Cytarabine|cytarabine|mesh-list
111088029|NCT03206671|Dexamethasone|dexamethasone|mesh-list
111088030|NCT03206671|Prednisolone|prednisolone|mesh-list
111088031|NCT03206671|Cyclophosphamide|cyclophosphamide|mesh-list
111088032|NCT03206671|Ifosfamide|ifosfamide|mesh-list
111088033|NCT03206671|Rituximab|rituximab|mesh-list
111088034|NCT03206671|Doxorubicin|doxorubicin|mesh-list
111088035|NCT03206671|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111088036|NCT03206671|Methotrexate|methotrexate|mesh-list
111088037|NCT03206671|Etoposide|etoposide|mesh-list
111088038|NCT03206671|Vincristine|vincristine|mesh-list
111088039|NCT03206671|Vindesine|vindesine|mesh-list
111088040|NCT03206671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111088041|NCT03206671|Immunologic Factors|immunologic factors|mesh-ancestor
111088042|NCT03206671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111088043|NCT03206671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111088044|NCT03206671|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111088045|NCT03206671|Alkylating Agents|alkylating agents|mesh-ancestor
111088046|NCT03206671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111088047|NCT03206671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111088048|NCT03206671|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111088049|NCT03206671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111088050|NCT03206671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110805145|NCT04804696|Paclitaxel|paclitaxel|mesh-list
111088051|NCT03206671|Antiemetics|antiemetics|mesh-ancestor
111088052|NCT03206671|Autonomic Agents|autonomic agents|mesh-ancestor
111088053|NCT03206671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111088054|NCT03206671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111088055|NCT03206671|Glucocorticoids|glucocorticoids|mesh-ancestor
111088056|NCT03206671|Hormones|hormones|mesh-ancestor
111088057|NCT03206671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111088058|NCT03206671|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111088059|NCT03206671|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111088060|NCT03206671|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111088061|NCT03206671|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111088062|NCT03206671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110677309|NCT01806571|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111088063|NCT03206671|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111088064|NCT03206671|Abortifacient Agents|abortifacient agents|mesh-ancestor
111088065|NCT03206671|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111088066|NCT03206671|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111088067|NCT03206671|Antimetabolites|antimetabolites|mesh-ancestor
111088068|NCT03206671|Dermatologic Agents|dermatologic agents|mesh-ancestor
111088069|NCT03206671|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111088070|NCT03206671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111088071|NCT03206671|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111088072|NCT03206671|Antiviral Agents|antiviral agents|mesh-ancestor
111088073|NCT03206671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111088074|NCT03206671|Tubulin Modulators|tubulin modulators|mesh-ancestor
111088075|NCT03206671|Antimitotic Agents|antimitotic agents|mesh-ancestor
111088076|NCT03206671|Mitosis Modulators|mitosis modulators|mesh-ancestor
111088077|NCT03078231|Mydriatics|mydriatics|mesh-list
111088078|NCT03078231|Autonomic Agents|autonomic agents|mesh-ancestor
111088079|NCT03078231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111088080|NCT03078231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111088081|NCT03319121|Theophylline|theophylline|mesh-list
111088082|NCT03319121|Dexlansoprazole|dexlansoprazole|mesh-list
111088083|NCT03319121|Lansoprazole|lansoprazole|mesh-list
111088084|NCT03319121|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111088085|NCT03319121|Autonomic Agents|autonomic agents|mesh-ancestor
111088086|NCT03319121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111088087|NCT03319121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111088088|NCT03319121|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111088089|NCT03319121|Respiratory System Agents|respiratory system agents|mesh-ancestor
111088090|NCT03319121|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111088091|NCT03319121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111088092|NCT03319121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111088093|NCT03319121|Vasodilator Agents|vasodilator agents|mesh-ancestor
111088094|NCT03319121|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
111088095|NCT03319121|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111088096|NCT03319121|Purinergic Agents|purinergic agents|mesh-ancestor
111088097|NCT03319121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111088098|NCT03319121|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111088099|NCT03319121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111088100|NCT03319121|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111088101|NCT02487407|Simendan|simendan|mesh-list
111088102|NCT02487407|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111088103|NCT02487407|Vasodilator Agents|vasodilator agents|mesh-ancestor
111088104|NCT02487407|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
111088105|NCT02487407|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111088106|NCT02487407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111088107|NCT02487407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111088108|NCT02487407|Protective Agents|protective agents|mesh-ancestor
111088109|NCT02487407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111088110|NCT03221569|Ketorolac|ketorolac|mesh-list
111088111|NCT03221569|Ketamine|ketamine|mesh-list
111088112|NCT03221569|Analgesics|analgesics|mesh-ancestor
111088113|NCT03221569|Sensory System Agents|sensory system agents|mesh-ancestor
111088114|NCT03221569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111088115|NCT03221569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111088116|NCT03221569|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111088117|NCT03221569|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111088118|NCT03221569|Anesthetics, General|anesthetics, general|mesh-ancestor
111088119|NCT03221569|Anesthetics|anesthetics|mesh-ancestor
111088120|NCT03221569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111088121|NCT03221569|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111088122|NCT03221569|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111088123|NCT03221569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111088124|NCT03221569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111088125|NCT03221569|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111088126|NCT03221569|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111088127|NCT03221569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111088129|NCT03221569|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111088130|NCT03221569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111088131|NCT03319043|Budesonide|budesonide|mesh-list
111088132|NCT03319043|Formoterol Fumarate|formoterol fumarate|mesh-list
111088133|NCT03319043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111088134|NCT03319043|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111088135|NCT03319043|Autonomic Agents|autonomic agents|mesh-ancestor
111088136|NCT03319043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111088137|NCT03319043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111088138|NCT03319043|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111088139|NCT03319043|Respiratory System Agents|respiratory system agents|mesh-ancestor
111088140|NCT03319043|Glucocorticoids|glucocorticoids|mesh-ancestor
111088141|NCT03319043|Hormones|hormones|mesh-ancestor
111088142|NCT03319043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111088143|NCT03319043|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111088144|NCT03319043|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111088145|NCT03319043|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111088146|NCT03319043|Adrenergic Agents|adrenergic agents|mesh-ancestor
111088147|NCT03319043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111088148|NCT03319043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111088149|NCT02451475|Amitriptyline|amitriptyline|mesh-list
111088150|NCT02451475|Paroxetine|paroxetine|mesh-list
111088151|NCT02451475|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
111088152|NCT02451475|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111088153|NCT02451475|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111088154|NCT02451475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111088155|NCT02451475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111088156|NCT02451475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111088157|NCT02451475|Serotonin Agents|serotonin agents|mesh-ancestor
111088158|NCT02451475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111088159|NCT02451475|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111088160|NCT02451475|Antidepressive Agents|antidepressive agents|mesh-ancestor
111088161|NCT02451475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111088162|NCT02451475|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111088163|NCT02451475|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111088164|NCT02451475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111088165|NCT02451475|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111088166|NCT02451475|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
111088167|NCT02451475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111088168|NCT02451475|Analgesics|analgesics|mesh-ancestor
111088169|NCT02451475|Sensory System Agents|sensory system agents|mesh-ancestor
111088170|NCT02451475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111088171|NCT02451475|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111088172|NCT02451475|Adrenergic Agents|adrenergic agents|mesh-ancestor
111088173|NCT05019417|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
111088174|NCT05019417|Glycerol|glycerol|mesh-list
111088175|NCT05019417|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
111088176|NCT05019417|Protective Agents|protective agents|mesh-ancestor
111088177|NCT05019417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111088178|NCT05019417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111088179|NCT03225937|Trastuzumab|trastuzumab|mesh-list
111088180|NCT03225937|Pertuzumab|pertuzumab|mesh-list
111088181|NCT03225937|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
111088182|NCT03225937|Lapatinib|lapatinib|mesh-list
111088183|NCT03225937|Maytansine|maytansine|mesh-list
111088184|NCT03225937|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111088185|NCT03225937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111088186|NCT03225937|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111088187|NCT03225937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111088188|NCT03225937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111088189|NCT03225937|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111088190|NCT03225937|Tubulin Modulators|tubulin modulators|mesh-ancestor
111088191|NCT03225937|Antimitotic Agents|antimitotic agents|mesh-ancestor
111088192|NCT03225937|Mitosis Modulators|mitosis modulators|mesh-ancestor
111088193|NCT03225937|Immunotoxins|immunotoxins|mesh-ancestor
111088194|NCT03225937|Immunoconjugates|immunoconjugates|mesh-ancestor
111088195|NCT03225937|Immunologic Factors|immunologic factors|mesh-ancestor
111088196|NCT03225937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111088197|NCT03318887|Ribavirin|ribavirin|mesh-list
111088198|NCT03318887|Sofosbuvir|sofosbuvir|mesh-list
111088199|NCT03318887|Antimetabolites|antimetabolites|mesh-ancestor
111088200|NCT03318887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111088201|NCT03318887|Antiviral Agents|antiviral agents|mesh-ancestor
111088202|NCT03318887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111088203|NCT03119077|Itraconazole|itraconazole|mesh-list
111088204|NCT03119077|Antifungal Agents|antifungal agents|mesh-ancestor
111088205|NCT03119077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111088206|NCT03119077|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111088207|NCT03119077|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111088208|NCT03119077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111088209|NCT03119077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111088210|NCT03119077|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111088211|NCT03119077|Hormone Antagonists|hormone antagonists|mesh-ancestor
111088212|NCT03119077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111088213|NCT03119077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111088214|NCT03119077|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111088215|NCT02487329|Calcium, Dietary|calcium, dietary|mesh-list
111088216|NCT02487329|Calcium|calcium|mesh-list
111088217|NCT02487329|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111088218|NCT02487329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111088219|NCT02487329|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111088220|NCT03318731|Fenugreek seed meal|fenugreek seed meal|mesh-list
111088221|NCT03318731|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111088222|NCT03318731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111088223|NCT03080103|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110640940|NCT00996177|Anesthetics|anesthetics|mesh-ancestor
111088224|NCT03080103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111088225|NCT04493099|Decitabine|decitabine|mesh-list
111088226|NCT04493099|Venetoclax|venetoclax|mesh-list
111088227|NCT04493099|Alvocidib|alvocidib|mesh-list
111088228|NCT04493099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111088229|NCT04493099|Antimetabolites|antimetabolites|mesh-ancestor
111088230|NCT04493099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111088231|NCT04493099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111088232|NCT04493099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111088233|NCT04493099|Growth Inhibitors|growth inhibitors|mesh-ancestor
111088234|NCT04493099|Growth Substances|growth substances|mesh-ancestor
111088235|NCT04493099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111088236|NCT04493099|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111088237|NCT05004909|Tretinoin|tretinoin|mesh-list
111088238|NCT05004909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111088239|NCT05004909|Keratolytic Agents|keratolytic agents|mesh-ancestor
111088240|NCT05004909|Dermatologic Agents|dermatologic agents|mesh-ancestor
111088241|NCT03119623|Valsartan|valsartan|mesh-list
111088242|NCT03119623|Enalapril|enalapril|mesh-list
111088243|NCT03119623|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
111088244|NCT03119623|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111088245|NCT03119623|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111088246|NCT03119623|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111088247|NCT03119623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111088248|NCT03119623|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
111088249|NCT03119623|Protease Inhibitors|protease inhibitors|mesh-ancestor
111088250|NCT03119623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111088251|NCT03318419|Cytarabine|cytarabine|mesh-list
111088252|NCT03318419|Pegaspargase|pegaspargase|mesh-list
111088253|NCT03318419|Asparaginase|asparaginase|mesh-list
111088254|NCT03318419|Cladribine|cladribine|mesh-list
111088255|NCT03318419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111088256|NCT03318419|Antimetabolites|antimetabolites|mesh-ancestor
111088257|NCT03318419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111088258|NCT03318419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111088259|NCT03318419|Antiviral Agents|antiviral agents|mesh-ancestor
111088260|NCT03318419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111088261|NCT03318419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111088262|NCT03318419|Immunologic Factors|immunologic factors|mesh-ancestor
111088263|NCT03318419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111088264|NCT03321773|Amoxicillin|amoxicillin|mesh-list
111088265|NCT03321773|Metronidazole|metronidazole|mesh-list
111088266|NCT03321773|Clarithromycin|clarithromycin|mesh-list
111088267|NCT03321773|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
111088268|NCT03321773|Pantoprazole|pantoprazole|mesh-list
111088269|NCT03321773|Bismuth|bismuth|mesh-list
111088270|NCT03321773|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111088271|NCT03321773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111088272|NCT03321773|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111088273|NCT03321773|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111088274|NCT03321773|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111088275|NCT03321773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111088276|NCT03321773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111088277|NCT03321773|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111088278|NCT03321773|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111088279|NCT03321773|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111088280|NCT03321773|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111088281|NCT03321773|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111088282|NCT03321773|Antacids|antacids|mesh-ancestor
111088283|NCT03077217|Rifaximin|rifaximin|mesh-list
111088284|NCT03077217|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111088285|NCT03077217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111088286|NCT03077217|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111088287|NCT05001243|Bromfenac|bromfenac|mesh-list
111088288|NCT05001243|Brimonidine Tartrate|brimonidine tartrate|mesh-list
111088289|NCT05001243|Phenylephrine|phenylephrine|mesh-list
111088290|NCT05001243|Oxymetazoline|oxymetazoline|mesh-list
111088291|NCT05001243|Hyaluronic Acid|hyaluronic acid|mesh-list
111088292|NCT05001243|Pilocarpine|pilocarpine|mesh-list
111088293|NCT05001243|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111088294|NCT05001243|Immunologic Factors|immunologic factors|mesh-ancestor
111088295|NCT05001243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111088296|NCT05001243|Viscosupplements|viscosupplements|mesh-ancestor
111088297|NCT05001243|Protective Agents|protective agents|mesh-ancestor
111088298|NCT05001243|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111088299|NCT05001243|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111088300|NCT05001243|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111088301|NCT05001243|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111088302|NCT05001243|Adrenergic Agents|adrenergic agents|mesh-ancestor
111088303|NCT05001243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111088304|NCT05001243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111088305|NCT05001243|Sympathomimetics|sympathomimetics|mesh-ancestor
111088306|NCT05001243|Autonomic Agents|autonomic agents|mesh-ancestor
111088307|NCT05001243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111088308|NCT05001243|Nasal Decongestants|nasal decongestants|mesh-ancestor
111088309|NCT05001243|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111088310|NCT05001243|Respiratory System Agents|respiratory system agents|mesh-ancestor
111088311|NCT05001243|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111088312|NCT05001243|Mydriatics|mydriatics|mesh-ancestor
111088313|NCT05001243|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111088314|NCT05001243|Miotics|miotics|mesh-ancestor
111088315|NCT05001243|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
111088316|NCT05001243|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111088317|NCT05001243|Cholinergic Agents|cholinergic agents|mesh-ancestor
111088318|NCT05001243|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111088319|NCT05001243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111088320|NCT05001243|Analgesics|analgesics|mesh-ancestor
111088321|NCT05001243|Sensory System Agents|sensory system agents|mesh-ancestor
111088322|NCT05001243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111088323|NCT05001243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111088324|NCT03225781|Bleomycin|bleomycin|mesh-list
111088325|NCT03225781|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111088326|NCT03225781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111088327|NCT03205891|Brentuximab Vedotin|brentuximab vedotin|mesh-list
111088328|NCT03205891|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111088329|NCT03205891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111088330|NCT03205891|Immunotoxins|immunotoxins|mesh-ancestor
111088331|NCT03205891|Immunoconjugates|immunoconjugates|mesh-ancestor
111088332|NCT03205891|Immunologic Factors|immunologic factors|mesh-ancestor
111088333|NCT03205891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111088334|NCT03221023|Vancomycin|vancomycin|mesh-list
111088335|NCT03221023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111088336|NCT03221023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111088337|NCT02490839|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111088338|NCT02490839|Amoxicillin|amoxicillin|mesh-list
111088339|NCT02490839|Metronidazole|metronidazole|mesh-list
111088340|NCT02490839|Tetracycline|tetracycline|mesh-list
111088341|NCT02490839|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
111088342|NCT02490839|Rabeprazole|rabeprazole|mesh-list
111088343|NCT02490839|Bismuth|bismuth|mesh-list
111088344|NCT02490839|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
111088345|NCT02490839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111088346|NCT02490839|Antitubercular Agents|antitubercular agents|mesh-ancestor
111088347|NCT02490839|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111088348|NCT02490839|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111088349|NCT02490839|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111088350|NCT02490839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111088351|NCT02490839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111088352|NCT02490839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111088353|NCT02490839|Antacids|antacids|mesh-ancestor
111088354|NCT02490839|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111088355|NCT02490527|Simvastatin|simvastatin|mesh-list
111088357|NCT02490527|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111088358|NCT02490527|Antimetabolites|antimetabolites|mesh-ancestor
111088359|NCT02490527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111088360|NCT02490527|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111088361|NCT02490527|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111088362|NCT02490527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111088363|NCT02490449|Dexlansoprazole|dexlansoprazole|mesh-list
111088364|NCT02490449|Lansoprazole|lansoprazole|mesh-list
111088365|NCT02490449|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111088366|NCT02490449|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111088367|NCT02490449|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111088368|NCT02490449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111088369|NCT02490449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111088370|NCT02452177|Vitamin D|vitamin d|mesh-list
111088371|NCT02452177|Vitamins|vitamins|mesh-ancestor
111088372|NCT02452177|Micronutrients|micronutrients|mesh-ancestor
111088373|NCT02452177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111088374|NCT02452177|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111088375|NCT05000697|Oxaliplatin|oxaliplatin|mesh-list
111088376|NCT05000697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111088377|NCT03224923|Aspirin|aspirin|mesh-list
111088378|NCT03224923|Clopidogrel|clopidogrel|mesh-list
111088379|NCT03224923|Ticagrelor|ticagrelor|mesh-list
111088380|NCT03224923|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111088381|NCT03224923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111088382|NCT03224923|Analgesics|analgesics|mesh-ancestor
111088383|NCT03224923|Sensory System Agents|sensory system agents|mesh-ancestor
111088384|NCT03224923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111088385|NCT03224923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111088386|NCT03224923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111088387|NCT03224923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111088388|NCT03224923|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111088389|NCT03224923|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111088390|NCT03224923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111088391|NCT03224923|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111088392|NCT03224923|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111088393|NCT03224923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111088394|NCT03224923|Antipyretics|antipyretics|mesh-ancestor
111088395|NCT03224923|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111088396|NCT03224923|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111088397|NCT03224923|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111088398|NCT03224923|Purinergic Agents|purinergic agents|mesh-ancestor
111088399|NCT03224923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111088400|NCT05004753|Artemisinins|artemisinins|mesh-list
111088401|NCT05004753|Artemisinin|artemisinin|mesh-list
111088402|NCT05004753|Dexamethasone|dexamethasone|mesh-list
111088403|NCT05004753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111088404|NCT05004753|Antiemetics|antiemetics|mesh-ancestor
111088405|NCT05004753|Autonomic Agents|autonomic agents|mesh-ancestor
111088406|NCT05004753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111088407|NCT05004753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111088408|NCT05004753|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111088409|NCT05004753|Glucocorticoids|glucocorticoids|mesh-ancestor
111088410|NCT05004753|Hormones|hormones|mesh-ancestor
111088411|NCT05004753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111088412|NCT05004753|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111088413|NCT05004753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111088414|NCT05004753|Antimalarials|antimalarials|mesh-ancestor
111088415|NCT05004753|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111088416|NCT05004753|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111088417|NCT05004753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111088418|NCT02486549|Bupivacaine|bupivacaine|mesh-list
111088419|NCT02486549|Anesthetics, Local|anesthetics, local|mesh-ancestor
111088420|NCT02486549|Anesthetics|anesthetics|mesh-ancestor
111088421|NCT02486549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111088422|NCT02486549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111088423|NCT02486549|Sensory System Agents|sensory system agents|mesh-ancestor
111088424|NCT02486549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111088425|NCT02490605|Salicylic Acid|salicylic acid|mesh-list
111088426|NCT02490605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111088427|NCT02490605|Antifungal Agents|antifungal agents|mesh-ancestor
111088428|NCT02490605|Keratolytic Agents|keratolytic agents|mesh-ancestor
110805514|NCT01310283|Fluorides, Topical|fluorides, topical|mesh-list
111088429|NCT02490605|Dermatologic Agents|dermatologic agents|mesh-ancestor
111088430|NCT04485403|Ibuprofen|ibuprofen|mesh-list
111088431|NCT04485403|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111088432|NCT04485403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111088433|NCT04485403|Analgesics|analgesics|mesh-ancestor
111088434|NCT04485403|Sensory System Agents|sensory system agents|mesh-ancestor
111088435|NCT04485403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111088436|NCT04485403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111088437|NCT04485403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111088438|NCT04485403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111088439|NCT04485403|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111088440|NCT04485403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111088441|NCT04485403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111088442|NCT03220867|Risperidone|risperidone|mesh-list
111088443|NCT03220867|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111088444|NCT03220867|Serotonin Agents|serotonin agents|mesh-ancestor
111088445|NCT03220867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111088446|NCT03220867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111088447|NCT03220867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111088448|NCT03220867|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111088449|NCT03220867|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111088450|NCT03220867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111088451|NCT03220867|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111088452|NCT03220867|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111088453|NCT03220867|Dopamine Agents|dopamine agents|mesh-ancestor
111088455|NCT03318029|Vitamins|vitamins|mesh-ancestor
111088456|NCT03318029|Micronutrients|micronutrients|mesh-ancestor
111088457|NCT03318029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111088458|NCT03318029|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111088459|NCT03076281|Metformin|metformin|mesh-list
111088460|NCT03076281|Doxycycline|doxycycline|mesh-list
111088461|NCT03076281|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111088462|NCT03076281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111088463|NCT03076281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111088464|NCT03076281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111088465|NCT03076281|Antimalarials|antimalarials|mesh-ancestor
111088466|NCT03076281|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111088467|NCT03076281|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111088468|NCT02452255|Propranolol|propranolol|mesh-list
111088469|NCT02452255|Metoprolol|metoprolol|mesh-list
111088470|NCT02452255|Fenofibrate|fenofibrate|mesh-list
111088471|NCT02452255|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111088472|NCT02452255|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111088473|NCT02452255|Adrenergic Agents|adrenergic agents|mesh-ancestor
111088474|NCT02452255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111088475|NCT02452255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111088476|NCT02452255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111088477|NCT02452255|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111088478|NCT02452255|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111088479|NCT02452255|Vasodilator Agents|vasodilator agents|mesh-ancestor
111088480|NCT02452255|Sympatholytics|sympatholytics|mesh-ancestor
111088481|NCT02452255|Autonomic Agents|autonomic agents|mesh-ancestor
111088482|NCT02452255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111088483|NCT02452255|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
111088484|NCT02452255|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111088485|NCT02452255|Antimetabolites|antimetabolites|mesh-ancestor
111088486|NCT02452255|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111088487|NCT03205033|Melatonin|melatonin|mesh-list
111088488|NCT03205033|Antioxidants|antioxidants|mesh-ancestor
111088489|NCT03205033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111088490|NCT03205033|Protective Agents|protective agents|mesh-ancestor
111088491|NCT03205033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111088492|NCT03205033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111088493|NCT03076905|Olorofim|olorofim|mesh-list
111088494|NCT03076905|Antifungal Agents|antifungal agents|mesh-ancestor
111088495|NCT03076905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111088496|NCT02452099|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
111088497|NCT02452099|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
111088498|NCT02452099|Protective Agents|protective agents|mesh-ancestor
111088499|NCT02452099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111088500|NCT02452099|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111088501|NCT02452099|Antioxidants|antioxidants|mesh-ancestor
111088502|NCT02452099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111088503|NCT03317717|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111088504|NCT03317717|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111088505|NCT03317717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111088506|NCT03317717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111088507|NCT03317717|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111088508|NCT03317717|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111088509|NCT03317717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111088510|NCT03317717|Cholinergic Agents|cholinergic agents|mesh-ancestor
111088511|NCT03317717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111088512|NCT03220789|Methamphetamine|methamphetamine|mesh-list
111088513|NCT03220789|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111088514|NCT03220789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111088515|NCT03220789|Sympathomimetics|sympathomimetics|mesh-ancestor
111088516|NCT03220789|Autonomic Agents|autonomic agents|mesh-ancestor
111088517|NCT03220789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111088518|NCT03220789|Dopamine Agents|dopamine agents|mesh-ancestor
111088519|NCT03220789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111088520|NCT03220789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111088521|NCT03220789|Adrenergic Agents|adrenergic agents|mesh-ancestor
111088522|NCT03220789|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111088523|NCT03220789|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111088524|NCT03220789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111088525|NCT03220789|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111088527|NCT03220555|Prilocaine|prilocaine|mesh-list
111088528|NCT03220555|Anesthetics, Local|anesthetics, local|mesh-ancestor
111088529|NCT03220555|Anesthetics|anesthetics|mesh-ancestor
111088530|NCT03220555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111088531|NCT03220555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111088532|NCT03220555|Sensory System Agents|sensory system agents|mesh-ancestor
111088533|NCT03220555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111088534|NCT03220555|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111088535|NCT03220555|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111088536|NCT03220555|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111088537|NCT03220555|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111088538|NCT03220555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111088539|NCT03204877|Melatonin|melatonin|mesh-list
111088540|NCT03204877|Antioxidants|antioxidants|mesh-ancestor
111088541|NCT03204877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111088542|NCT03204877|Protective Agents|protective agents|mesh-ancestor
111088543|NCT03204877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111088544|NCT03204877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111088545|NCT03204799|Metformin|metformin|mesh-list
111088546|NCT03204799|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
111088547|NCT03204799|Ezetimibe|ezetimibe|mesh-list
111088548|NCT03204799|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111088549|NCT03204799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111088550|NCT03204799|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111088551|NCT03204799|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111088552|NCT03204799|Antimetabolites|antimetabolites|mesh-ancestor
111088553|NCT03204799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111088554|NCT03204799|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111088555|NCT03317327|Nivolumab|nivolumab|mesh-list
111088556|NCT03317327|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111088557|NCT03317327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111088558|NCT03317327|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111088559|NCT03317327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111088560|NCT03204331|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
111088561|NCT03204331|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
111088562|NCT03204331|Norethindrone|norethindrone|mesh-list
111088563|NCT03204331|Norethindrone Acetate|norethindrone acetate|mesh-list
111088564|NCT03204331|Estradiol|estradiol|mesh-list
111088565|NCT03204331|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
111088566|NCT03204331|Relugolix|relugolix|mesh-list
111088567|NCT03204331|Estrogens|estrogens|mesh-ancestor
111088568|NCT03204331|Hormones|hormones|mesh-ancestor
111088569|NCT03204331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111088570|NCT03204331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111088571|NCT03204331|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111088572|NCT03204331|Contraceptive Agents|contraceptive agents|mesh-ancestor
111088573|NCT03204331|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111088574|NCT03204331|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111088575|NCT03204331|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111088576|NCT03204331|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111088577|NCT03204331|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111088578|NCT03204331|Androgen Antagonists|androgen antagonists|mesh-ancestor
111088579|NCT03204331|Hormone Antagonists|hormone antagonists|mesh-ancestor
111088580|NCT03072849|Fluticasone|fluticasone|mesh-list
111088581|NCT03072849|Azithromycin|azithromycin|mesh-list
111088582|NCT03072849|Montelukast|montelukast|mesh-list
111088583|NCT03072849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111088584|NCT03072849|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111088585|NCT03072849|Autonomic Agents|autonomic agents|mesh-ancestor
111088586|NCT03072849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111088587|NCT03072849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111088588|NCT03072849|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111088589|NCT03072849|Respiratory System Agents|respiratory system agents|mesh-ancestor
111088590|NCT03072849|Dermatologic Agents|dermatologic agents|mesh-ancestor
111088591|NCT03072849|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111088592|NCT03072849|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111088593|NCT03072849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111088594|NCT03072849|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
111088595|NCT03072849|Hormone Antagonists|hormone antagonists|mesh-ancestor
111088596|NCT03072849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111088597|NCT03072849|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
111088598|NCT03072849|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111088599|NCT03072849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111088600|NCT03220321|Lithium Carbonate|lithium carbonate|mesh-list
111088601|NCT03220321|Antidepressive Agents|antidepressive agents|mesh-ancestor
111088602|NCT03220321|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111088603|NCT03220321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111088604|NCT03220321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111088605|NCT03220321|Antimanic Agents|antimanic agents|mesh-ancestor
111088606|NCT03220321|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111088607|NCT03220321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111088608|NCT03220321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111088609|NCT03075657|Haloperidol|haloperidol|mesh-list
111088610|NCT03075657|Risperidone|risperidone|mesh-list
111088611|NCT03075657|Haloperidol decanoate|haloperidol decanoate|mesh-list
111088612|NCT03075657|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111088613|NCT03075657|Serotonin Agents|serotonin agents|mesh-ancestor
111088614|NCT03075657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111088615|NCT03075657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111088616|NCT03075657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111088617|NCT03075657|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111088618|NCT03075657|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111088619|NCT03075657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111088620|NCT03075657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111088621|NCT03075657|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111088622|NCT03075657|Dopamine Agents|dopamine agents|mesh-ancestor
111088623|NCT03075657|Antiemetics|antiemetics|mesh-ancestor
111088624|NCT03075657|Autonomic Agents|autonomic agents|mesh-ancestor
111088625|NCT03075657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111088626|NCT03075657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111088627|NCT03075657|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111088628|NCT02451865|Docetaxel|docetaxel|mesh-list
111088629|NCT02451865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111088630|NCT02451865|Tubulin Modulators|tubulin modulators|mesh-ancestor
111088631|NCT02451865|Antimitotic Agents|antimitotic agents|mesh-ancestor
111088632|NCT02451865|Mitosis Modulators|mitosis modulators|mesh-ancestor
111088633|NCT02451865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111088634|NCT05004207|Lactulose|lactulose|mesh-list
111088635|NCT05004207|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111088636|NCT03317093|Ceftobiprole|ceftobiprole|mesh-list
111088637|NCT03317093|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
111088638|NCT03317093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111088639|NCT03317093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111088640|NCT02489513|Ivosidenib|ivosidenib|mesh-list
111088641|NCT02489513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111088642|NCT02489513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111088643|NCT02489513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111088644|NCT03317015|Fluticasone|fluticasone|mesh-list
111088645|NCT03317015|Triamcinolone|triamcinolone|mesh-list
111088646|NCT03317015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111088647|NCT03317015|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111088648|NCT03317015|Autonomic Agents|autonomic agents|mesh-ancestor
111088649|NCT03317015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111088650|NCT03317015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111088651|NCT03317015|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111088652|NCT03317015|Respiratory System Agents|respiratory system agents|mesh-ancestor
110805736|NCT03546621|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111088653|NCT03317015|Dermatologic Agents|dermatologic agents|mesh-ancestor
111088654|NCT03317015|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111088655|NCT03317015|Glucocorticoids|glucocorticoids|mesh-ancestor
111088656|NCT03317015|Hormones|hormones|mesh-ancestor
111088657|NCT03317015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111088658|NCT03204565|Hyaluronic Acid|hyaluronic acid|mesh-list
111088659|NCT03204565|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111088660|NCT03204565|Immunologic Factors|immunologic factors|mesh-ancestor
111088661|NCT03204565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111088662|NCT03204565|Viscosupplements|viscosupplements|mesh-ancestor
111088663|NCT03204565|Protective Agents|protective agents|mesh-ancestor
111088664|NCT03224377|Antibodies|antibodies|mesh-list
111088665|NCT03224377|Immunoglobulins|immunoglobulins|mesh-list
111088666|NCT03224377|Immunologic Factors|immunologic factors|mesh-ancestor
111088667|NCT03224377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111088668|NCT02451787|Vitamin D|vitamin d|mesh-list
111088669|NCT02451787|Cholecalciferol|cholecalciferol|mesh-list
111088670|NCT02451787|Vitamins|vitamins|mesh-ancestor
111088671|NCT02451787|Micronutrients|micronutrients|mesh-ancestor
111088672|NCT02451787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111088673|NCT02451787|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111088674|NCT02451787|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111088675|NCT03224221|Fluorouracil|fluorouracil|mesh-list
111088676|NCT03224221|Apatinib|apatinib|mesh-list
111088677|NCT03224221|Antimetabolites|antimetabolites|mesh-ancestor
111088678|NCT03224221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111088679|NCT03224221|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111088680|NCT03224221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111088681|NCT03224221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111088682|NCT03224221|Immunologic Factors|immunologic factors|mesh-ancestor
111088683|NCT03224221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111088684|NCT03224221|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111088685|NCT03224221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111088686|NCT03204097|Alendronate|alendronate|mesh-list
111088687|NCT03204097|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111088688|NCT03204097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111088689|NCT03223519|Ibuprofen|ibuprofen|mesh-list
111088690|NCT03223519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111088691|NCT03223519|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111088692|NCT03223519|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111088693|NCT03223519|Analgesics|analgesics|mesh-ancestor
111088694|NCT03223519|Sensory System Agents|sensory system agents|mesh-ancestor
111088695|NCT03223519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111088696|NCT03223519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111088697|NCT03223519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111088698|NCT03223519|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111088699|NCT03223519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111088700|NCT03223519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111088701|NCT03320915|Cholecalciferol|cholecalciferol|mesh-list
111088702|NCT03320915|Vitamin D|vitamin d|mesh-list
111088703|NCT03320915|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111088704|NCT03320915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111088705|NCT03320915|Vitamins|vitamins|mesh-ancestor
111088706|NCT03320915|Micronutrients|micronutrients|mesh-ancestor
111088707|NCT03320915|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111088708|NCT02488889|Ethanol|ethanol|mesh-list
111088709|NCT02488889|Varenicline|varenicline|mesh-list
111088710|NCT02488889|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111088711|NCT02488889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111088712|NCT02488889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111088713|NCT02488889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111088714|NCT02488889|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111088715|NCT02488889|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111088716|NCT02488889|Cholinergic Agents|cholinergic agents|mesh-ancestor
111088717|NCT02488889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111088718|NCT02488889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111088719|NCT03220009|Nivolumab|nivolumab|mesh-list
111088720|NCT03220009|Ipilimumab|ipilimumab|mesh-list
111088721|NCT03220009|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111088722|NCT03220009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111088723|NCT03220009|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111088724|NCT03220009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111088725|NCT02485613|Dexamethasone|dexamethasone|mesh-list
111088726|NCT02485613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111088727|NCT02485613|Antiemetics|antiemetics|mesh-ancestor
111088728|NCT02485613|Autonomic Agents|autonomic agents|mesh-ancestor
111088729|NCT02485613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111088730|NCT02485613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111088731|NCT02485613|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111088732|NCT02485613|Glucocorticoids|glucocorticoids|mesh-ancestor
111088733|NCT02485613|Hormones|hormones|mesh-ancestor
111088734|NCT02485613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111088735|NCT02485613|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111088736|NCT02485613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111088737|NCT02484833|Cetuximab|cetuximab|mesh-list
111088738|NCT02484833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111088739|NCT02484833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111088740|NCT03204019|Thalidomide|thalidomide|mesh-list
111088741|NCT03204019|Temozolomide|temozolomide|mesh-list
111088742|NCT03204019|Tegafur|tegafur|mesh-list
111088743|NCT03204019|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111088744|NCT03204019|Alkylating Agents|alkylating agents|mesh-ancestor
111088745|NCT03204019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111088746|NCT03204019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111088747|NCT03204019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111088748|NCT03204019|Immunologic Factors|immunologic factors|mesh-ancestor
111088749|NCT03204019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111088750|NCT03204019|Leprostatic Agents|leprostatic agents|mesh-ancestor
111088751|NCT03204019|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111088752|NCT03204019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111088753|NCT03204019|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111088754|NCT03204019|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111088755|NCT03204019|Growth Substances|growth substances|mesh-ancestor
111088756|NCT03204019|Growth Inhibitors|growth inhibitors|mesh-ancestor
111088757|NCT03204019|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111088758|NCT03204019|Antimetabolites|antimetabolites|mesh-ancestor
111088759|NCT02485145|Diclofenac|diclofenac|mesh-list
111088760|NCT02485145|Orphenadrine|orphenadrine|mesh-list
111088761|NCT02485145|Bupivacaine|bupivacaine|mesh-list
111088762|NCT02485145|Baclofen|baclofen|mesh-list
111088763|NCT02485145|Anesthetics, Local|anesthetics, local|mesh-ancestor
111088764|NCT02485145|Anesthetics|anesthetics|mesh-ancestor
111088765|NCT02485145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111088766|NCT02485145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111088767|NCT02485145|Sensory System Agents|sensory system agents|mesh-ancestor
111088768|NCT02485145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111088769|NCT02485145|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111088770|NCT02485145|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111088771|NCT02485145|Analgesics|analgesics|mesh-ancestor
111088772|NCT02485145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111088773|NCT02485145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111088774|NCT02485145|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111088775|NCT02485145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111088776|NCT02485145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111088777|NCT02485145|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
111088778|NCT02485145|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111088779|NCT02485145|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
111088780|NCT02485145|GABA Agonists|gaba agonists|mesh-ancestor
111088781|NCT02485145|GABA Agents|gaba agents|mesh-ancestor
111088782|NCT02485145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111088783|NCT02485145|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111088784|NCT02485145|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111088785|NCT02485145|Parasympatholytics|parasympatholytics|mesh-ancestor
111088786|NCT02485145|Autonomic Agents|autonomic agents|mesh-ancestor
111088787|NCT02485145|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111088788|NCT02485145|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111088789|NCT02485145|Cholinergic Agents|cholinergic agents|mesh-ancestor
111088790|NCT02485145|Cytochrome P-450 CYP2B6 Inhibitors|cytochrome p-450 cyp2b6 inhibitors|mesh-ancestor
111088791|NCT02485145|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111088792|NCT02484755|Gefitinib|gefitinib|mesh-list
111088793|NCT02484755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111088794|NCT02484755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111088795|NCT02484755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111088796|NCT02484755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111088797|NCT03316469|Clomiphene|clomiphene|mesh-list
111088798|NCT03316469|Enclomiphene|enclomiphene|mesh-list
111088799|NCT03316469|Zuclomiphene|zuclomiphene|mesh-list
111088800|NCT03316469|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111088801|NCT03316469|Hormone Antagonists|hormone antagonists|mesh-ancestor
111088802|NCT03316469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111088803|NCT03316469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111088804|NCT03316469|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110805891|NCT00293813|Denosumab|denosumab|mesh-list
111088805|NCT03316469|Fertility Agents|fertility agents|mesh-ancestor
111088806|NCT03316469|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111088807|NCT03316469|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111088808|NCT03316469|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111088809|NCT02485067|Tolterodine Tartrate|tolterodine tartrate|mesh-list
111088810|NCT02485067|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111088811|NCT02485067|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111088812|NCT02485067|Cholinergic Agents|cholinergic agents|mesh-ancestor
111088813|NCT02485067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111088814|NCT02485067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111088815|NCT02485067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111088816|NCT02485067|Urological Agents|urological agents|mesh-ancestor
111088817|NCT03075579|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
111088818|NCT03075579|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111088819|NCT03075579|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111088820|NCT03075579|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111088821|NCT03075579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111088822|NCT03075579|Adrenergic Agents|adrenergic agents|mesh-ancestor
111088823|NCT03075579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111088824|NCT03075579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111088826|NCT03203317|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111088827|NCT03203317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111088828|NCT03316313|Antibodies|antibodies|mesh-list
111088829|NCT03316313|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
111088830|NCT03316313|Immunologic Factors|immunologic factors|mesh-ancestor
111088831|NCT03316313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111088832|NCT03201601|Inositol|inositol|mesh-list
111088833|NCT03201601|Vitamin B Complex|vitamin b complex|mesh-ancestor
111088834|NCT03201601|Vitamins|vitamins|mesh-ancestor
111088835|NCT03201601|Micronutrients|micronutrients|mesh-ancestor
111088836|NCT03201601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111088837|NCT02480387|Sofosbuvir|sofosbuvir|mesh-list
111088838|NCT02480387|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
111088839|NCT02480387|Ledipasvir|ledipasvir|mesh-list
111088840|NCT02480387|Antiviral Agents|antiviral agents|mesh-ancestor
111088841|NCT02480387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111088842|NCT04999293|Clopidogrel|clopidogrel|mesh-list
111088843|NCT04999293|Ticagrelor|ticagrelor|mesh-list
111088844|NCT04999293|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111088845|NCT04999293|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111088846|NCT04999293|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111088847|NCT04999293|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111088848|NCT04999293|Purinergic Agents|purinergic agents|mesh-ancestor
111088849|NCT04999293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111088850|NCT04999293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111088851|NCT04999293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111088852|NCT03315923|Rituximab|rituximab|mesh-list
111088853|NCT03315923|Glatiramer Acetate|glatiramer acetate|mesh-list
111088854|NCT03315923|(T,G)-A-L|(t,g)-a-l|mesh-list
111088855|NCT03315923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111088856|NCT03315923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111088857|NCT03315923|Immunologic Factors|immunologic factors|mesh-ancestor
111088858|NCT03315923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111088859|NCT03315923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111088860|NCT03315923|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111088861|NCT03315923|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111088862|NCT03315845|Anesthetics|anesthetics|mesh-list
111088863|NCT03315845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111088864|NCT03315845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111088865|NCT03201367|Rivaroxaban|rivaroxaban|mesh-list
111088866|NCT03201367|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111088867|NCT03201367|Antithrombins|antithrombins|mesh-ancestor
111088868|NCT03201367|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111088869|NCT03201367|Protease Inhibitors|protease inhibitors|mesh-ancestor
111088870|NCT03201367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111088871|NCT03201367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111088872|NCT03201367|Anticoagulants|anticoagulants|mesh-ancestor
111088873|NCT04998903|Dimercaprol|dimercaprol|mesh-list
111088874|NCT04998903|Chelating Agents|chelating agents|mesh-ancestor
111088875|NCT04998903|Sequestering Agents|sequestering agents|mesh-ancestor
111088876|NCT04998903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111088877|NCT04991961|Antihypertensive Agents|antihypertensive agents|mesh-list
111088878|NCT03203005|Cyclophosphamide|cyclophosphamide|mesh-list
111088879|NCT03203005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111088880|NCT03203005|Immunologic Factors|immunologic factors|mesh-ancestor
111088881|NCT03203005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111088882|NCT03203005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111088883|NCT03203005|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111088884|NCT03203005|Alkylating Agents|alkylating agents|mesh-ancestor
111088885|NCT03203005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111088886|NCT03203005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111088887|NCT03203005|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111088888|NCT02484209|Metformin|metformin|mesh-list
111088889|NCT02484209|Glimepiride|glimepiride|mesh-list
111088890|NCT02484209|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111088891|NCT02484209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111088892|NCT02484209|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111088893|NCT02484209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111088894|NCT02484209|Immunologic Factors|immunologic factors|mesh-ancestor
111088895|NCT04999137|Vitamins|vitamins|mesh-list
111088896|NCT04999137|Thiamine|thiamine|mesh-list
111088897|NCT04999137|Micronutrients|micronutrients|mesh-ancestor
111088898|NCT04999137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111088899|NCT04999137|Vitamin B Complex|vitamin b complex|mesh-ancestor
111088900|NCT02484053|Rituximab|rituximab|mesh-list
111088901|NCT02484053|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111088902|NCT02484053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111088903|NCT02484053|Immunologic Factors|immunologic factors|mesh-ancestor
111088904|NCT02484053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111088905|NCT02484053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111088906|NCT03200821|Gemcitabine|gemcitabine|mesh-list
111088907|NCT03200821|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111088908|NCT03200821|Antimetabolites|antimetabolites|mesh-ancestor
111088909|NCT03200821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111088910|NCT03200821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111088911|NCT02483897|Tetracaine|tetracaine|mesh-list
111088912|NCT02483897|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111088913|NCT02483897|Anesthetics, Local|anesthetics, local|mesh-ancestor
111088914|NCT02483897|Anesthetics|anesthetics|mesh-ancestor
111088915|NCT02483897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111088916|NCT02483897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111088917|NCT02483897|Sensory System Agents|sensory system agents|mesh-ancestor
111088918|NCT02483897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111088919|NCT02483897|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111088920|NCT01374919|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
111088921|NCT01374919|Hematinics|hematinics|mesh-ancestor
111088922|NCT01374919|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
111088923|NCT01374919|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111088924|NCT03202615|Lactoferrin|lactoferrin|mesh-list
111088925|NCT03202615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111088926|NCT03202459|Pregabalin|pregabalin|mesh-list
111088927|NCT03202459|Gabapentin|gabapentin|mesh-list
111088928|NCT03202459|Analgesics|analgesics|mesh-ancestor
111088929|NCT03202459|Sensory System Agents|sensory system agents|mesh-ancestor
111088930|NCT03202459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111088931|NCT03202459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111088932|NCT03202459|Anticonvulsants|anticonvulsants|mesh-ancestor
111088933|NCT03202459|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111088934|NCT03202459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111088935|NCT03202459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111088936|NCT03202459|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111088937|NCT03202459|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111088938|NCT03202459|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111088939|NCT03202459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111088940|NCT03202459|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111088941|NCT03202459|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111088942|NCT03202459|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111088943|NCT03202459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111088944|NCT03202459|Antimanic Agents|antimanic agents|mesh-ancestor
111088945|NCT04991181|Zamicastat|zamicastat|mesh-list
111088946|NCT04991181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111088947|NCT04991181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111088948|NCT04492319|Neostigmine|neostigmine|mesh-list
111088949|NCT04492319|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111088950|NCT04492319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111088951|NCT04492319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111088952|NCT04492319|Cholinergic Agents|cholinergic agents|mesh-ancestor
111088953|NCT04492319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111088954|NCT04492319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111088955|NCT04492319|Parasympathomimetics|parasympathomimetics|mesh-ancestor
111088956|NCT04492319|Autonomic Agents|autonomic agents|mesh-ancestor
111088957|NCT04492319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111088959|NCT04456959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111088960|NCT04456959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111088961|NCT04456959|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111088962|NCT04456959|Immunotoxins|immunotoxins|mesh-ancestor
111088963|NCT04456959|Immunoconjugates|immunoconjugates|mesh-ancestor
111088964|NCT04456959|Immunologic Factors|immunologic factors|mesh-ancestor
111088965|NCT04456959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111088967|NCT05713721|Dopamine Agonists|dopamine agonists|mesh-list
111088968|NCT05713721|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111088969|NCT05713721|Sympathomimetics|sympathomimetics|mesh-ancestor
111088970|NCT05713721|Autonomic Agents|autonomic agents|mesh-ancestor
111088971|NCT05713721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111088972|NCT05713721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111088973|NCT05713721|Dopamine Agents|dopamine agents|mesh-ancestor
111088974|NCT05713721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111088975|NCT05713721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111088976|NCT05713721|Protective Agents|protective agents|mesh-ancestor
111088977|NCT05002725|Lidocaine|lidocaine|mesh-list
111088978|NCT05002725|Anesthetics, Local|anesthetics, local|mesh-ancestor
111088979|NCT05002725|Anesthetics|anesthetics|mesh-ancestor
111088980|NCT05002725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111088981|NCT05002725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111088982|NCT05002725|Sensory System Agents|sensory system agents|mesh-ancestor
111088983|NCT05002725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111088984|NCT05002725|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111088985|NCT05002725|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111088986|NCT05002725|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111088987|NCT05002725|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111088988|NCT05002725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111088989|NCT03315533|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
111088990|NCT03315533|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111088991|NCT03315533|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111088992|NCT03315533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111088993|NCT03315533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111088994|NCT03315533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111088995|NCT03315533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111088996|NCT03315533|Analgesics|analgesics|mesh-ancestor
111088997|NCT03315533|Sensory System Agents|sensory system agents|mesh-ancestor
111088998|NCT03315533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111088999|NCT03315533|Antidepressive Agents|antidepressive agents|mesh-ancestor
111089000|NCT03315533|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111089001|NCT03315533|Dopamine Agents|dopamine agents|mesh-ancestor
111089002|NCT05437835|Ropivacaine|ropivacaine|mesh-list
111089003|NCT05437835|Anesthetics, Local|anesthetics, local|mesh-ancestor
111089004|NCT05437835|Anesthetics|anesthetics|mesh-ancestor
111089005|NCT05437835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111089006|NCT05437835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111089007|NCT05437835|Sensory System Agents|sensory system agents|mesh-ancestor
111089008|NCT05437835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111089009|NCT03200197|Menthol|menthol|mesh-list
111089010|NCT03200197|Antipruritics|antipruritics|mesh-ancestor
111089011|NCT03200197|Dermatologic Agents|dermatologic agents|mesh-ancestor
111089012|NCT04997967|Ketamine|ketamine|mesh-list
111089013|NCT04997967|Propofol|propofol|mesh-list
111089014|NCT04997967|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111089015|NCT04997967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111089016|NCT04997967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111089017|NCT04997967|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111089018|NCT04997967|Anesthetics, General|anesthetics, general|mesh-ancestor
111089019|NCT04997967|Anesthetics|anesthetics|mesh-ancestor
111089020|NCT04997967|Analgesics|analgesics|mesh-ancestor
111089021|NCT04997967|Sensory System Agents|sensory system agents|mesh-ancestor
110641034|NCT05304533|Hormone Antagonists|hormone antagonists|mesh-ancestor
111089022|NCT04997967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111089023|NCT04997967|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111089024|NCT04997967|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111089025|NCT04997967|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111089026|NCT04997967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111089027|NCT04997967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111089028|NCT02483195|Minoxidil|minoxidil|mesh-list
111089029|NCT02483195|Spironolactone|spironolactone|mesh-list
111089030|NCT02483195|Finasteride|finasteride|mesh-list
111089031|NCT02483195|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
111089032|NCT02483195|Hormone Antagonists|hormone antagonists|mesh-ancestor
111089033|NCT02483195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111089034|NCT02483195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111089035|NCT02483195|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
111089037|NCT02483195|Natriuretic Agents|natriuretic agents|mesh-ancestor
111089038|NCT02483195|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111089039|NCT02483195|Vasodilator Agents|vasodilator agents|mesh-ancestor
111089040|NCT02483195|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
111089041|NCT02483195|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111089042|NCT02483195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111089043|NCT02483195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111089044|NCT02483195|Urological Agents|urological agents|mesh-ancestor
111089045|NCT02450149|Sorafenib|sorafenib|mesh-list
111089046|NCT02450149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111089047|NCT02450149|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111089048|NCT02450149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111089049|NCT02450149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111089050|NCT02479217|Docetaxel|docetaxel|mesh-list
111089051|NCT02479217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111089052|NCT02479217|Tubulin Modulators|tubulin modulators|mesh-ancestor
111089053|NCT02479217|Antimitotic Agents|antimitotic agents|mesh-ancestor
111089054|NCT02479217|Mitosis Modulators|mitosis modulators|mesh-ancestor
111089055|NCT02479217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111089056|NCT02479529|Norepinephrine|norepinephrine|mesh-list
111089057|NCT02479529|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111089058|NCT02479529|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111089059|NCT02479529|Adrenergic Agents|adrenergic agents|mesh-ancestor
111089060|NCT02479529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111089061|NCT02479529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111089062|NCT02479529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111089063|NCT02479529|Sympathomimetics|sympathomimetics|mesh-ancestor
111089064|NCT02479529|Autonomic Agents|autonomic agents|mesh-ancestor
111089065|NCT02479529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111089066|NCT02479529|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111089067|NCT03202147|Cromolyn Sodium|cromolyn sodium|mesh-list
111089068|NCT03202147|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
111089069|NCT03202147|Immunologic Factors|immunologic factors|mesh-ancestor
111089070|NCT03202147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111089071|NCT03202147|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111089072|NCT03202147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111089073|NCT03202147|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111089074|NCT03202147|Respiratory System Agents|respiratory system agents|mesh-ancestor
111089075|NCT03213769|Ubiquinone|ubiquinone|mesh-list
111089076|NCT03213769|Coenzyme Q10|coenzyme q10|mesh-list
111089077|NCT03213769|Micronutrients|micronutrients|mesh-ancestor
111089078|NCT03213769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111089079|NCT03213769|Vitamins|vitamins|mesh-ancestor
111089080|NCT05002101|Zinc|zinc|mesh-list
111089081|NCT05002101|Zinc Sulfate|zinc sulfate|mesh-list
111089082|NCT05002101|Trace Elements|trace elements|mesh-ancestor
111089083|NCT05002101|Micronutrients|micronutrients|mesh-ancestor
111089084|NCT05002101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111089085|NCT05002101|Astringents|astringents|mesh-ancestor
111089086|NCT05002101|Dermatologic Agents|dermatologic agents|mesh-ancestor
111089087|NCT03201913|Estrogens|estrogens|mesh-list
111089088|NCT03201913|Hormones|hormones|mesh-ancestor
111089089|NCT03201913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111089090|NCT03201913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111089091|NCT03199729|Triptorelin Pamoate|triptorelin pamoate|mesh-list
111089092|NCT03199729|Luteolytic Agents|luteolytic agents|mesh-ancestor
111089093|NCT03199729|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111089094|NCT03199729|Contraceptive Agents|contraceptive agents|mesh-ancestor
111089095|NCT03199729|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111089096|NCT03199729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111089097|NCT03199729|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111089098|NCT03199729|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111089099|NCT03199729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111089100|NCT03212677|Iron|iron|mesh-list
111089101|NCT03212677|Trace Elements|trace elements|mesh-ancestor
111089102|NCT03212677|Micronutrients|micronutrients|mesh-ancestor
111089103|NCT03212677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111089104|NCT03199339|Midazolam|midazolam|mesh-list
111089105|NCT03199339|Bupropion|bupropion|mesh-list
111089106|NCT03199339|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111089107|NCT03199339|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111089108|NCT03199339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111089109|NCT03199339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111089110|NCT03199339|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111089111|NCT03199339|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111089112|NCT03199339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111089113|NCT03199339|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111089114|NCT03199339|Anesthetics, General|anesthetics, general|mesh-ancestor
111089115|NCT03199339|Anesthetics|anesthetics|mesh-ancestor
111089116|NCT03199339|GABA Modulators|gaba modulators|mesh-ancestor
111089117|NCT03199339|GABA Agents|gaba agents|mesh-ancestor
111089118|NCT03199339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111089119|NCT03199339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111089120|NCT03199339|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111089121|NCT03199339|Antidepressive Agents|antidepressive agents|mesh-ancestor
111089122|NCT03199339|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111089123|NCT03199339|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111089124|NCT03199339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111089125|NCT03199339|Dopamine Agents|dopamine agents|mesh-ancestor
111089126|NCT03199339|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111089127|NCT03199339|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111089128|NCT03199339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111089129|NCT03071679|Antimicrobial Cationic Peptides|antimicrobial cationic peptides|mesh-list
111089130|NCT03071679|Imiquimod|imiquimod|mesh-list
111089131|NCT03071679|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111089132|NCT03071679|Immunologic Factors|immunologic factors|mesh-ancestor
111089133|NCT03071679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111089134|NCT03071679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111089135|NCT03071679|Interferon Inducers|interferon inducers|mesh-ancestor
111089136|NCT03071679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111089137|NCT03199261|Exenatide|exenatide|mesh-list
111089138|NCT03199261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111089139|NCT03199261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111089140|NCT03199261|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111089141|NCT03199261|Incretins|incretins|mesh-ancestor
111089142|NCT03199261|Hormones|hormones|mesh-ancestor
111089143|NCT03199261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111089144|NCT02482961|Colistin|colistin|mesh-list
111089145|NCT02482961|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111089146|NCT02482961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111089147|NCT04990713|Ropivacaine|ropivacaine|mesh-list
111089148|NCT04990713|Anesthetics, Local|anesthetics, local|mesh-list
111089149|NCT04990713|Anesthetics|anesthetics|mesh-list
111089150|NCT04990713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111089151|NCT04990713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111089152|NCT04990713|Sensory System Agents|sensory system agents|mesh-ancestor
111089153|NCT04990713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111089154|NCT04990791|Aspirin|aspirin|mesh-list
111089155|NCT04990791|Rivaroxaban|rivaroxaban|mesh-list
111089156|NCT04990791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111089157|NCT04990791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111089158|NCT04990791|Analgesics|analgesics|mesh-ancestor
111089159|NCT04990791|Sensory System Agents|sensory system agents|mesh-ancestor
111089160|NCT04990791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111089161|NCT04990791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111089162|NCT04990791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111089163|NCT04990791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111089164|NCT04990791|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111089165|NCT04990791|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111089166|NCT04990791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111089167|NCT04990791|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111089168|NCT04990791|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111089169|NCT04990791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111089170|NCT04990791|Antipyretics|antipyretics|mesh-ancestor
111089171|NCT04990791|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111089172|NCT04990791|Antithrombins|antithrombins|mesh-ancestor
111089173|NCT04990791|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111089174|NCT04990791|Protease Inhibitors|protease inhibitors|mesh-ancestor
111089175|NCT04990791|Anticoagulants|anticoagulants|mesh-ancestor
111089176|NCT03201835|Nabiximols|nabiximols|mesh-list
111089177|NCT03201835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111089178|NCT03201835|Analgesics|analgesics|mesh-ancestor
111089179|NCT03201835|Sensory System Agents|sensory system agents|mesh-ancestor
111089180|NCT03201835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111089181|NCT02478515|Ranibizumab|ranibizumab|mesh-list
110806264|NCT02165644|Nimodipine|nimodipine|mesh-list
111089182|NCT02478515|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111089183|NCT02478515|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111089185|NCT02478515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111089186|NCT02478515|Growth Inhibitors|growth inhibitors|mesh-ancestor
111089187|NCT02478515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111089188|NCT02448199|Meloxicam|meloxicam|mesh-list
111089189|NCT02448199|Antirheumatic Agents|antirheumatic agents|mesh-list
111089190|NCT02448199|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111089191|NCT02448199|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111089192|NCT02448199|Analgesics|analgesics|mesh-ancestor
111089193|NCT02448199|Sensory System Agents|sensory system agents|mesh-ancestor
111089194|NCT02448199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111089195|NCT02448199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111089196|NCT02448199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111089197|NCT02448199|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111089198|NCT02448199|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111089199|NCT02448199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111089200|NCT02448199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111089201|NCT03071289|Cisplatin|cisplatin|mesh-list
111089202|NCT03071289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111089203|NCT03199105|Tetracaine|tetracaine|mesh-list
111089204|NCT03199105|Anesthetics, Local|anesthetics, local|mesh-ancestor
111089205|NCT03199105|Anesthetics|anesthetics|mesh-ancestor
111089206|NCT03199105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111089207|NCT03199105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111089208|NCT03199105|Sensory System Agents|sensory system agents|mesh-ancestor
111089209|NCT03199105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111089210|NCT02482649|Methylphenidate|methylphenidate|mesh-list
111089211|NCT02482649|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
111089212|NCT02482649|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111089213|NCT02482649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111089214|NCT02482649|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111089215|NCT02482649|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111089216|NCT02482649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111089217|NCT02482649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111089218|NCT02482649|Dopamine Agents|dopamine agents|mesh-ancestor
111089219|NCT02482649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111089220|NCT02482649|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111089221|NCT02482649|Adrenergic Agents|adrenergic agents|mesh-ancestor
111089222|NCT03198637|Cisatracurium|cisatracurium|mesh-list
111089223|NCT03198637|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
111089224|NCT03198637|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111089225|NCT03198637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111089226|NCT03198637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111089227|NCT02478281|Methylene Blue|methylene blue|mesh-list
111089228|NCT02478281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111089229|NCT02478281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111089230|NCT02478125|Docetaxel|docetaxel|mesh-list
111089231|NCT02478125|Lenograstim|lenograstim|mesh-list
111089232|NCT02478125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111089233|NCT02478125|Tubulin Modulators|tubulin modulators|mesh-ancestor
111089234|NCT02478125|Antimitotic Agents|antimitotic agents|mesh-ancestor
111089235|NCT02478125|Mitosis Modulators|mitosis modulators|mesh-ancestor
111089236|NCT02478125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111089237|NCT02478125|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111089238|NCT02478125|Immunologic Factors|immunologic factors|mesh-ancestor
111089239|NCT02478125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111089240|NCT02478047|Dexamethasone|dexamethasone|mesh-list
111089241|NCT02478047|Ramosetron|ramosetron|mesh-list
111089242|NCT02478047|Antiemetics|antiemetics|mesh-list
111089243|NCT02478047|Tropisetron|tropisetron|mesh-list
111089244|NCT02478047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111089245|NCT02478047|Autonomic Agents|autonomic agents|mesh-ancestor
111089246|NCT02478047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111089247|NCT02478047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111089248|NCT02478047|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111089249|NCT02478047|Glucocorticoids|glucocorticoids|mesh-ancestor
111089250|NCT02478047|Hormones|hormones|mesh-ancestor
111089251|NCT02478047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111089252|NCT02478047|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111089253|NCT02478047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111089254|NCT02478047|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111089255|NCT02478047|Serotonin Agents|serotonin agents|mesh-ancestor
111089256|NCT02478047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111089257|NCT02478047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111089258|NCT02478047|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111089260|NCT04996485|Dermatologic Agents|dermatologic agents|mesh-ancestor
111089261|NCT02447965|Bupivacaine|bupivacaine|mesh-list
111089262|NCT02447965|Anesthetics, Local|anesthetics, local|mesh-ancestor
111089263|NCT02447965|Anesthetics|anesthetics|mesh-ancestor
111089264|NCT02447965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111089265|NCT02447965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111089266|NCT02447965|Sensory System Agents|sensory system agents|mesh-ancestor
111089267|NCT02447965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111089268|NCT03070275|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
111089269|NCT03070275|Hemostatics|hemostatics|mesh-ancestor
111089270|NCT03070275|Coagulants|coagulants|mesh-ancestor
111089271|NCT05713019|Adenosine|adenosine|mesh-list
111089272|NCT05713019|Capsaicin|capsaicin|mesh-list
111089273|NCT05713019|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111089274|NCT05713019|Antipruritics|antipruritics|mesh-ancestor
111089275|NCT05713019|Dermatologic Agents|dermatologic agents|mesh-ancestor
111089276|NCT05713019|Sensory System Agents|sensory system agents|mesh-ancestor
111089277|NCT05713019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111089278|NCT05713019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111089279|NCT05713019|Analgesics|analgesics|mesh-ancestor
111089280|NCT05713019|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111089281|NCT05713019|Vasodilator Agents|vasodilator agents|mesh-ancestor
111089282|NCT05713019|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
111089283|NCT05713019|Purinergic Agonists|purinergic agonists|mesh-ancestor
111089284|NCT05713019|Purinergic Agents|purinergic agents|mesh-ancestor
111089285|NCT05713019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111089286|NCT05713019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111089287|NCT03198403|Epinephrine|epinephrine|mesh-list
111089288|NCT03198403|Bupivacaine|bupivacaine|mesh-list
111089289|NCT03198403|Anesthetics, Local|anesthetics, local|mesh-ancestor
111089290|NCT03198403|Anesthetics|anesthetics|mesh-ancestor
111089291|NCT03198403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111089292|NCT03198403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111089293|NCT03198403|Sensory System Agents|sensory system agents|mesh-ancestor
111089294|NCT03198403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111089295|NCT03198403|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111089296|NCT03198403|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111089297|NCT03198403|Adrenergic Agents|adrenergic agents|mesh-ancestor
111089298|NCT03198403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111089299|NCT03198403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111089300|NCT03198403|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111089301|NCT03198403|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111089302|NCT03198403|Autonomic Agents|autonomic agents|mesh-ancestor
111089303|NCT03198403|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111089304|NCT03198403|Respiratory System Agents|respiratory system agents|mesh-ancestor
111089305|NCT03198403|Mydriatics|mydriatics|mesh-ancestor
111089306|NCT03198403|Sympathomimetics|sympathomimetics|mesh-ancestor
111089307|NCT03198403|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111089308|NCT03198949|Everolimus|everolimus|mesh-list
111089309|NCT03198949|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111089310|NCT03198949|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111089311|NCT03198949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111089312|NCT03198949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111089313|NCT03198949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111089314|NCT03198949|Immunologic Factors|immunologic factors|mesh-ancestor
111089315|NCT03198949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111089316|NCT03198949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111089317|NCT02447809|Aspirin|aspirin|mesh-list
111089318|NCT02447809|Clopidogrel|clopidogrel|mesh-list
111089319|NCT02447809|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111089320|NCT02447809|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111089321|NCT02447809|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111089322|NCT02447809|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111089323|NCT02447809|Purinergic Agents|purinergic agents|mesh-ancestor
111089324|NCT02447809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111089325|NCT02447809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111089326|NCT02447809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111089327|NCT02447809|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111089328|NCT02447809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111089329|NCT02447809|Analgesics|analgesics|mesh-ancestor
110806411|NCT02172586|Diuretics|diuretics|mesh-ancestor
111089330|NCT02447809|Sensory System Agents|sensory system agents|mesh-ancestor
111089331|NCT02447809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111089332|NCT02447809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111089333|NCT02447809|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111089334|NCT02447809|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111089335|NCT02447809|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111089336|NCT02447809|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111089337|NCT02447809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111089338|NCT02447809|Antipyretics|antipyretics|mesh-ancestor
111089339|NCT04989855|Tislelizumab|tislelizumab|mesh-list
111089340|NCT04989855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111089341|NCT04989855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111089342|NCT04915287|Maleic acid|maleic acid|mesh-list
111089343|NCT04915287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111089344|NCT04915287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111089345|NCT05709353|Methamphetamine|methamphetamine|mesh-list
111089346|NCT05709353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111089347|NCT05709353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111089348|NCT05709353|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111089349|NCT05709353|Sympathomimetics|sympathomimetics|mesh-ancestor
111089350|NCT05709353|Autonomic Agents|autonomic agents|mesh-ancestor
111089351|NCT05709353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111089352|NCT05709353|Dopamine Agents|dopamine agents|mesh-ancestor
111089353|NCT05709353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111089354|NCT05709353|Adrenergic Agents|adrenergic agents|mesh-ancestor
111089355|NCT05709353|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111089356|NCT05709353|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111089357|NCT05709353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111089358|NCT05709353|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111089359|NCT03195673|Terazosin|terazosin|mesh-list
111089360|NCT03195673|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111089361|NCT03195673|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111089362|NCT03195673|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111089363|NCT03195673|Adrenergic Agents|adrenergic agents|mesh-ancestor
111089364|NCT03195673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111089365|NCT03195673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111089366|NCT03195673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111089367|NCT03195673|Urological Agents|urological agents|mesh-ancestor
111089368|NCT02481791|Remifentanil|remifentanil|mesh-list
111089369|NCT02481791|Propofol|propofol|mesh-list
111089370|NCT02481791|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111089371|NCT02481791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111089372|NCT02481791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111089373|NCT02481791|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111089374|NCT02481791|Anesthetics, General|anesthetics, general|mesh-ancestor
111089375|NCT02481791|Anesthetics|anesthetics|mesh-ancestor
111089376|NCT02481791|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111089377|NCT02481791|Narcotics|narcotics|mesh-ancestor
111089378|NCT02481791|Analgesics|analgesics|mesh-ancestor
111089379|NCT02481791|Sensory System Agents|sensory system agents|mesh-ancestor
111089380|NCT02481791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111089381|NCT04484467|Menthol|menthol|mesh-list
111089382|NCT04484467|Antipruritics|antipruritics|mesh-ancestor
111089383|NCT04484467|Dermatologic Agents|dermatologic agents|mesh-ancestor
111089384|NCT03198169|Anti-Infective Agents|anti-infective agents|mesh-list
111089385|NCT03198169|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111089386|NCT02726399|Capecitabine|capecitabine|mesh-list
111089387|NCT02726399|Trastuzumab|trastuzumab|mesh-list
111089388|NCT02726399|Ramucirumab|ramucirumab|mesh-list
111089389|NCT02726399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111089390|NCT02726399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111089391|NCT02726399|Antimetabolites|antimetabolites|mesh-ancestor
111089392|NCT02726399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111089393|NCT02726399|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111089394|NCT02477969|Metformin|metformin|mesh-list
111089395|NCT02477969|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111089396|NCT02477969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111089397|NCT03195205|Antibodies|antibodies|mesh-list
111089398|NCT03195205|Immunologic Factors|immunologic factors|mesh-ancestor
111089399|NCT03195205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111089400|NCT03209011|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
111089401|NCT03209011|Antiviral Agents|antiviral agents|mesh-ancestor
111089402|NCT03209011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111089403|NCT02481323|Cilostazol|cilostazol|mesh-list
111089404|NCT02481323|Isosorbide|isosorbide|mesh-list
111089405|NCT02481323|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
111089406|NCT02481323|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
111089407|NCT02481323|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111089408|NCT02481323|Autonomic Agents|autonomic agents|mesh-ancestor
111089409|NCT02481323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111089410|NCT02481323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111089411|NCT02481323|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111089412|NCT02481323|Respiratory System Agents|respiratory system agents|mesh-ancestor
111089413|NCT02481323|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111089414|NCT02481323|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111089415|NCT02481323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111089416|NCT02481323|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111089417|NCT02481323|Vasodilator Agents|vasodilator agents|mesh-ancestor
111089418|NCT02481323|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111089419|NCT02481323|Protective Agents|protective agents|mesh-ancestor
111089420|NCT02481323|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
111089421|NCT02481323|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111089422|NCT02481323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111089423|NCT02481323|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
111089424|NCT02481323|Diuretics|diuretics|mesh-ancestor
111089425|NCT02481323|Natriuretic Agents|natriuretic agents|mesh-ancestor
111089426|NCT02481323|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
111089427|NCT03197779|Aspirin|aspirin|mesh-list
111089428|NCT03197779|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111089429|NCT03197779|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111089430|NCT03197779|Analgesics|analgesics|mesh-ancestor
111089431|NCT03197779|Sensory System Agents|sensory system agents|mesh-ancestor
111089432|NCT03197779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111089433|NCT03197779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111089434|NCT03197779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111089435|NCT03197779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111089436|NCT03197779|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111089437|NCT03197779|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111089438|NCT03197779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111089439|NCT03197779|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111089440|NCT03197779|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111089441|NCT03197779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111089442|NCT03197779|Antipyretics|antipyretics|mesh-ancestor
111089443|NCT03197623|Alendronate|alendronate|mesh-list
111089444|NCT03197623|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111089445|NCT03197623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111089446|NCT02449603|Insulin Aspart|insulin aspart|mesh-list
111089447|NCT02449603|Exenatide|exenatide|mesh-list
111089448|NCT02449603|Biphasic Insulins|biphasic insulins|mesh-list
111089449|NCT02449603|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
111089450|NCT02449603|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111089451|NCT02449603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111089452|NCT02449603|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111089453|NCT02449603|Incretins|incretins|mesh-ancestor
111089454|NCT02449603|Hormones|hormones|mesh-ancestor
111089455|NCT02449603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111089456|NCT02481479|Saxagliptin|saxagliptin|mesh-list
111089457|NCT02481479|Incretins|incretins|mesh-ancestor
111089458|NCT02481479|Hormones|hormones|mesh-ancestor
111089459|NCT02481479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111089460|NCT02481479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111089461|NCT02481479|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111089462|NCT02481479|Protease Inhibitors|protease inhibitors|mesh-ancestor
111089463|NCT02481479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111089464|NCT02481479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111089465|NCT02481479|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111089466|NCT03195049|Bilirubin|bilirubin|mesh-list
111089467|NCT03195049|Antioxidants|antioxidants|mesh-ancestor
111089468|NCT03195049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111089469|NCT03195049|Protective Agents|protective agents|mesh-ancestor
111089470|NCT03195049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111089471|NCT03198013|Prednisolone|prednisolone|mesh-list
111089472|NCT03198013|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111089473|NCT03198013|Glucocorticoids|glucocorticoids|mesh-ancestor
111089474|NCT03198013|Hormones|hormones|mesh-ancestor
111089475|NCT03198013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110554585|NCT02632916|Denosumab|denosumab|mesh-list
111089476|NCT03198013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111089477|NCT03198013|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111089478|NCT03198013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111089479|NCT05651399|Propofol|propofol|mesh-list
110806560|NCT02173990|Aflibercept|aflibercept|mesh-list
111089480|NCT05651399|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111089481|NCT05651399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111089482|NCT05651399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111089483|NCT05651399|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111089484|NCT05651399|Anesthetics, General|anesthetics, general|mesh-ancestor
111089485|NCT05651399|Anesthetics|anesthetics|mesh-ancestor
111089486|NCT02477891|Daratumumab|daratumumab|mesh-list
111089487|NCT02477891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111089488|NCT02477813|Temozolomide|temozolomide|mesh-list
111089489|NCT02477813|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111089490|NCT02477813|Alkylating Agents|alkylating agents|mesh-ancestor
111089491|NCT02477813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111089492|NCT02477813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111089493|NCT02480543|Misoprostol|misoprostol|mesh-list
111089494|NCT02480543|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111089495|NCT02480543|Abortifacient Agents|abortifacient agents|mesh-ancestor
111089496|NCT02480543|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111089497|NCT02480543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111089498|NCT02480543|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111089499|NCT02480543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111089500|NCT02480543|Oxytocics|oxytocics|mesh-ancestor
111089501|NCT03197233|Vitamin D|vitamin d|mesh-list
111089502|NCT03197233|Vitamins|vitamins|mesh-list
111089503|NCT03197233|Vitamin A|vitamin a|mesh-list
111089504|NCT03197233|Retinol palmitate|retinol palmitate|mesh-list
111089505|NCT03197233|Micronutrients|micronutrients|mesh-ancestor
111089506|NCT03197233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111089507|NCT03197233|Antioxidants|antioxidants|mesh-ancestor
111089508|NCT03197233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111089509|NCT03197233|Protective Agents|protective agents|mesh-ancestor
111089510|NCT03197233|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
111089511|NCT03197233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111089512|NCT03197233|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111089513|NCT02447185|Triamcinolone|triamcinolone|mesh-list
111089514|NCT02447185|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
111089515|NCT02447185|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
111089516|NCT02447185|Ranibizumab|ranibizumab|mesh-list
111089517|NCT02447185|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
111089518|NCT02447185|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111089519|NCT02447185|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111089520|NCT02447185|Growth Substances|growth substances|mesh-ancestor
111089521|NCT02447185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111089522|NCT02447185|Growth Inhibitors|growth inhibitors|mesh-ancestor
111089523|NCT02447185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111089524|NCT02447185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111089525|NCT02447185|Glucocorticoids|glucocorticoids|mesh-ancestor
111089526|NCT02447185|Hormones|hormones|mesh-ancestor
111089527|NCT02447185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111089528|NCT02447185|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111089529|NCT02447185|Immunologic Factors|immunologic factors|mesh-ancestor
111089530|NCT02447185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111089531|NCT02447185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111089532|NCT03196921|Amphotericin B|amphotericin b|mesh-list
111089533|NCT03196921|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
111089534|NCT03196921|Amebicides|amebicides|mesh-ancestor
111089535|NCT03196921|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111089536|NCT03196921|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111089537|NCT03196921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111089538|NCT03196921|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111089539|NCT03196921|Antifungal Agents|antifungal agents|mesh-ancestor
111089540|NCT02480465|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111089541|NCT02480465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111089542|NCT02480465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111089543|NCT02480465|Incretins|incretins|mesh-ancestor
111089544|NCT02480465|Hormones|hormones|mesh-ancestor
111089545|NCT02480465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111089546|NCT02480465|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111089547|NCT02480465|Protease Inhibitors|protease inhibitors|mesh-ancestor
111089548|NCT02480465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110677330|NCT01517451|Androgens|androgens|mesh-list
111089549|NCT02480465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111089550|NCT03208465|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111089551|NCT03208465|Empagliflozin|empagliflozin|mesh-list
111089552|NCT03208465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111089553|NCT03208465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111089554|NCT03208465|Incretins|incretins|mesh-ancestor
110806635|NCT02182102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111089555|NCT03208465|Hormones|hormones|mesh-ancestor
111089556|NCT03208465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111089557|NCT03208465|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111089558|NCT03208465|Protease Inhibitors|protease inhibitors|mesh-ancestor
111089559|NCT03208465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111089560|NCT03208465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111089561|NCT03208465|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111089562|NCT03197155|Antiviral Agents|antiviral agents|mesh-list
111089563|NCT03197155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111089564|NCT04484779|Insulin|insulin|mesh-list
111089565|NCT04484779|Insulin Glargine|insulin glargine|mesh-list
111089566|NCT04484779|Insulin Lispro|insulin lispro|mesh-list
111089567|NCT04484779|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111089568|NCT04484779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111089569|NCT02477501|Norepinephrine|norepinephrine|mesh-list
111089570|NCT02477501|Ephedrine|ephedrine|mesh-list
111089571|NCT02477501|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111089572|NCT02477501|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111089573|NCT02477501|Adrenergic Agents|adrenergic agents|mesh-ancestor
111089574|NCT02477501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111089575|NCT02477501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111089576|NCT02477501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111089577|NCT02477501|Sympathomimetics|sympathomimetics|mesh-ancestor
111089578|NCT02477501|Autonomic Agents|autonomic agents|mesh-ancestor
111089579|NCT02477501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111089580|NCT02477501|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111089581|NCT02477501|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111089582|NCT02446795|Sunitinib|sunitinib|mesh-list
111089583|NCT02446795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111089584|NCT02446795|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111089585|NCT02446795|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111089586|NCT02446795|Growth Substances|growth substances|mesh-ancestor
111089587|NCT02446795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111089588|NCT02446795|Growth Inhibitors|growth inhibitors|mesh-ancestor
111089589|NCT02446795|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111089590|NCT02446795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111089591|NCT02446795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111089592|NCT02477267|Buprenorphine|buprenorphine|mesh-list
111089593|NCT02477267|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
111089594|NCT02477267|Naloxone|naloxone|mesh-list
111089595|NCT02477267|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111089596|NCT02477267|Narcotics|narcotics|mesh-ancestor
111089597|NCT02477267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111089598|NCT02477267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111089599|NCT02477267|Analgesics|analgesics|mesh-ancestor
111089600|NCT02477267|Sensory System Agents|sensory system agents|mesh-ancestor
111089601|NCT02477267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111089602|NCT02477267|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111089603|NCT03196843|Raltitrexed|raltitrexed|mesh-list
111089604|NCT03196843|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111089605|NCT03196843|Antimetabolites|antimetabolites|mesh-ancestor
111089606|NCT03196843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111089607|NCT03196843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111089608|NCT03196843|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111089609|NCT03196843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111089610|NCT02476955|Paclitaxel|paclitaxel|mesh-list
111089611|NCT02476955|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111089612|NCT02476955|Carboplatin|carboplatin|mesh-list
111089613|NCT02476955|Anastrozole|anastrozole|mesh-list
111089614|NCT02476955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111089615|NCT02476955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111089616|NCT02476955|Tubulin Modulators|tubulin modulators|mesh-ancestor
111089617|NCT02476955|Antimitotic Agents|antimitotic agents|mesh-ancestor
111089618|NCT02476955|Mitosis Modulators|mitosis modulators|mesh-ancestor
111089619|NCT02476955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111089620|NCT02476955|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111089621|NCT02476955|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111089622|NCT02476955|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111089623|NCT02476955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111089624|NCT02476955|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111089625|NCT02476955|Hormone Antagonists|hormone antagonists|mesh-ancestor
111089626|NCT02476955|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111089627|NCT02476955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110806713|NCT02182648|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111089628|NCT02634801|Methotrexate|methotrexate|mesh-list
111089629|NCT02634801|Ixekizumab|ixekizumab|mesh-list
111089630|NCT02634801|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111089631|NCT02634801|Abortifacient Agents|abortifacient agents|mesh-ancestor
111089632|NCT02634801|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110641172|NCT00997269|Ubiquinone|ubiquinone|mesh-list
111089633|NCT02634801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111089634|NCT02634801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111089635|NCT02634801|Antimetabolites|antimetabolites|mesh-ancestor
111089636|NCT02634801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111089637|NCT02634801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111089638|NCT02634801|Dermatologic Agents|dermatologic agents|mesh-ancestor
111089639|NCT02634801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111089640|NCT02634801|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111089641|NCT02634801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111089642|NCT02634801|Immunologic Factors|immunologic factors|mesh-ancestor
111089643|NCT02634801|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111089644|NCT02634801|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111089645|NCT03196531|Loratadine|loratadine|mesh-list
111089646|NCT03196531|Antipruritics|antipruritics|mesh-ancestor
111089647|NCT03196531|Dermatologic Agents|dermatologic agents|mesh-ancestor
111089648|NCT03196531|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111089649|NCT03196531|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
111089650|NCT03196531|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111089651|NCT03196531|Histamine Antagonists|histamine antagonists|mesh-ancestor
111089652|NCT03196531|Histamine Agents|histamine agents|mesh-ancestor
111089653|NCT03196531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111089654|NCT03196531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111089655|NCT03196531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111089656|NCT02476799|Ketorolac|ketorolac|mesh-list
111089657|NCT02476799|Fentanyl|fentanyl|mesh-list
111089658|NCT02476799|Ropivacaine|ropivacaine|mesh-list
111089659|NCT02476799|Anesthetics, Local|anesthetics, local|mesh-ancestor
111089660|NCT02476799|Anesthetics|anesthetics|mesh-ancestor
111089661|NCT02476799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111089662|NCT02476799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111089663|NCT02476799|Sensory System Agents|sensory system agents|mesh-ancestor
111089664|NCT02476799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111089665|NCT02476799|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111089666|NCT02476799|Narcotics|narcotics|mesh-ancestor
111089667|NCT02476799|Analgesics|analgesics|mesh-ancestor
111089668|NCT02476799|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111089669|NCT02476799|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111089670|NCT02476799|Anesthetics, General|anesthetics, general|mesh-ancestor
111089671|NCT02476799|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111089672|NCT02476799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111089673|NCT02476799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111089674|NCT02476799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111089675|NCT02476799|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111089676|NCT02476799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111089677|NCT02476799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111089678|NCT02449369|Acetaminophen|acetaminophen|mesh-list
111089679|NCT02449369|Oxycodone|oxycodone|mesh-list
111089680|NCT02449369|Hydromorphone|hydromorphone|mesh-list
111089681|NCT02449369|Orphenadrine|orphenadrine|mesh-list
111089682|NCT02449369|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111089683|NCT02449369|Analgesics|analgesics|mesh-ancestor
111089684|NCT02449369|Sensory System Agents|sensory system agents|mesh-ancestor
111089685|NCT02449369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111089686|NCT02449369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111089687|NCT02449369|Antipyretics|antipyretics|mesh-ancestor
111089688|NCT02449369|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111089689|NCT02449369|Narcotics|narcotics|mesh-ancestor
111089690|NCT02449369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111089691|NCT02449369|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111089692|NCT02449369|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111089693|NCT02449369|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
111089694|NCT02449369|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111089695|NCT02449369|Parasympatholytics|parasympatholytics|mesh-ancestor
111089696|NCT02449369|Autonomic Agents|autonomic agents|mesh-ancestor
111089697|NCT02449369|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111089698|NCT02449369|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111089699|NCT02449369|Cholinergic Agents|cholinergic agents|mesh-ancestor
111089700|NCT02449369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111089701|NCT02449369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111089702|NCT02449369|Cytochrome P-450 CYP2B6 Inhibitors|cytochrome p-450 cyp2b6 inhibitors|mesh-ancestor
111089703|NCT02449369|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111089704|NCT02449369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111089705|NCT03192943|Nivolumab|nivolumab|mesh-list
111089706|NCT03192943|Linrodostat|linrodostat|mesh-list
111089707|NCT03192943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111089708|NCT03192943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111089709|NCT03192943|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111089710|NCT03192943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111089711|NCT03192943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111089712|NCT04986813|Tranexamic Acid|tranexamic acid|mesh-list
111089713|NCT04986813|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111089714|NCT04986813|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111089715|NCT04986813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111089716|NCT04986813|Hemostatics|hemostatics|mesh-ancestor
111089717|NCT04986813|Coagulants|coagulants|mesh-ancestor
111089718|NCT04986735|Empagliflozin|empagliflozin|mesh-list
111089719|NCT04986735|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111089720|NCT04986735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111089721|NCT04986735|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111089722|NCT04986735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111089723|NCT02475863|Warfarin|warfarin|mesh-list
111089724|NCT02475863|Anticoagulants|anticoagulants|mesh-ancestor
111089725|NCT03071055|Ranibizumab|ranibizumab|mesh-list
111089726|NCT03071055|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111089727|NCT03071055|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111089728|NCT03071055|Growth Substances|growth substances|mesh-ancestor
111089729|NCT03071055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111089730|NCT03071055|Growth Inhibitors|growth inhibitors|mesh-ancestor
111089731|NCT03071055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111089732|NCT04433559|Tadalafil|tadalafil|mesh-list
111089733|NCT04433559|Vasodilator Agents|vasodilator agents|mesh-ancestor
111089734|NCT04433559|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111089735|NCT04433559|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111089736|NCT04433559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111089737|NCT04433559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111089738|NCT04433559|Urological Agents|urological agents|mesh-ancestor
111089739|NCT04911959|Lenvatinib|lenvatinib|mesh-list
111089740|NCT04911959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111089741|NCT04911959|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111089742|NCT04911959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111089743|NCT04911959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111089744|NCT03070665|Norepinephrine|norepinephrine|mesh-list
111089745|NCT03070665|Ephedrine|ephedrine|mesh-list
111089746|NCT03070665|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111089747|NCT03070665|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111089748|NCT03070665|Adrenergic Agents|adrenergic agents|mesh-ancestor
111089749|NCT03070665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111089750|NCT03070665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111089751|NCT03070665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111089752|NCT03070665|Sympathomimetics|sympathomimetics|mesh-ancestor
111089753|NCT03070665|Autonomic Agents|autonomic agents|mesh-ancestor
111089754|NCT03070665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111089755|NCT03070665|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111089756|NCT03070665|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111089757|NCT02472509|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
111089758|NCT02472509|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
111089759|NCT02472509|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111089760|NCT02475161|Rabeprazole|rabeprazole|mesh-list
111089761|NCT02475161|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111089762|NCT02475161|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111089763|NCT02475161|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111089764|NCT02475161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111089765|NCT02475161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111089766|NCT03074097|Bupivacaine|bupivacaine|mesh-list
111089767|NCT03074097|Anesthetics, Local|anesthetics, local|mesh-ancestor
111089768|NCT03074097|Anesthetics|anesthetics|mesh-ancestor
111089769|NCT03074097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111089770|NCT03074097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111089771|NCT03074097|Sensory System Agents|sensory system agents|mesh-ancestor
111089772|NCT03074097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111089773|NCT04433481|Dabigatran|dabigatran|mesh-list
111089774|NCT04433481|Antithrombins|antithrombins|mesh-ancestor
111089775|NCT04433481|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111089776|NCT04433481|Protease Inhibitors|protease inhibitors|mesh-ancestor
111089777|NCT04433481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111089778|NCT04433481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111089780|NCT04860635|Celecoxib|celecoxib|mesh-list
111089781|NCT04860635|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111089782|NCT04860635|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111089783|NCT04860635|Analgesics|analgesics|mesh-ancestor
111089784|NCT04860635|Sensory System Agents|sensory system agents|mesh-ancestor
111089785|NCT04860635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111089786|NCT04860635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111089787|NCT04860635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111089788|NCT04860635|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111089789|NCT04860635|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111089790|NCT04860635|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111089791|NCT04860635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111089792|NCT04860635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111089793|NCT04988607|Bevacizumab|bevacizumab|mesh-list
111089794|NCT04988607|Osimertinib|osimertinib|mesh-list
111089795|NCT04988607|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111089796|NCT04988607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111089797|NCT04988607|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111089798|NCT04988607|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111089799|NCT04988607|Growth Substances|growth substances|mesh-ancestor
111089800|NCT04988607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111089801|NCT04988607|Growth Inhibitors|growth inhibitors|mesh-ancestor
111089802|NCT04988607|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111089803|NCT04988607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111089804|NCT04988607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111089805|NCT02475317|Volixibat|volixibat|mesh-list
111089806|NCT02475317|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111089807|NCT03070509|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
111089808|NCT03070509|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111089809|NCT03070509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111089810|NCT03070509|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111089811|NCT03070509|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111089812|NCT03070509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111089813|NCT03070509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111089814|NCT03070509|Dopamine Agents|dopamine agents|mesh-ancestor
111089815|NCT03070509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111089816|NCT05322473|Adalimumab|adalimumab|mesh-list
111089817|NCT05322473|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111089818|NCT05322473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111089819|NCT05322473|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111089820|NCT02472275|Ascorbic Acid|ascorbic acid|mesh-list
111089821|NCT02472275|Methyltestosterone|methyltestosterone|mesh-list
111089822|NCT02472275|Hormones|hormones|mesh-list
111089823|NCT02472275|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
111089824|NCT02472275|Androgens|androgens|mesh-list
111089825|NCT02472275|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
111089826|NCT02472275|Androgen Antagonists|androgen antagonists|mesh-list
111089827|NCT02472275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111089828|NCT02472275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111089829|NCT02472275|Antioxidants|antioxidants|mesh-ancestor
111089830|NCT02472275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111089831|NCT02472275|Protective Agents|protective agents|mesh-ancestor
111089832|NCT02472275|Vitamins|vitamins|mesh-ancestor
111089833|NCT02472275|Micronutrients|micronutrients|mesh-ancestor
111089834|NCT02472275|Estrogens|estrogens|mesh-ancestor
111089835|NCT02472275|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111089836|NCT02472275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111089837|NCT02472275|Anabolic Agents|anabolic agents|mesh-ancestor
111089838|NCT02472275|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111089839|NCT02472275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111089840|NCT02472275|Hormone Antagonists|hormone antagonists|mesh-ancestor
111089841|NCT04491773|Tadalafil|tadalafil|mesh-list
111089842|NCT04491773|Vasodilator Agents|vasodilator agents|mesh-ancestor
111089843|NCT04491773|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111089844|NCT04491773|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111089845|NCT04491773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111089846|NCT04491773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111089847|NCT04491773|Urological Agents|urological agents|mesh-ancestor
111089848|NCT03070353|Dextrans|dextrans|mesh-list
111089849|NCT03070353|Anticoagulants|anticoagulants|mesh-ancestor
111089850|NCT03070353|Plasma Substitutes|plasma substitutes|mesh-ancestor
111089851|NCT03070353|Blood Substitutes|blood substitutes|mesh-ancestor
111089852|NCT03073863|Atorvastatin|atorvastatin|mesh-list
110806964|NCT01083329|Niacin|niacin|mesh-list
111089853|NCT03073863|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111089854|NCT03073863|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111089855|NCT03073863|Antimetabolites|antimetabolites|mesh-ancestor
111089856|NCT03073863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111089857|NCT03073863|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111089858|NCT03073863|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111089859|NCT03073863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111089860|NCT02471963|Empagliflozin|empagliflozin|mesh-list
111089861|NCT02471963|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111089862|NCT02471963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111089863|NCT02471963|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111089864|NCT02471963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111089865|NCT01375751|Evolocumab|evolocumab|mesh-list
111089866|NCT01375751|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
111089867|NCT01375751|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111089868|NCT01375751|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111089869|NCT01375751|Antimetabolites|antimetabolites|mesh-ancestor
111089870|NCT01375751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111089871|NCT01375751|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111089872|NCT01375751|Protease Inhibitors|protease inhibitors|mesh-ancestor
111089873|NCT01375751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111089874|NCT01375751|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111089875|NCT05249621|Mannitol|mannitol|mesh-list
111089876|NCT05249621|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
111089877|NCT05249621|Diuretics|diuretics|mesh-ancestor
111089878|NCT05249621|Natriuretic Agents|natriuretic agents|mesh-ancestor
111089879|NCT05249621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111089880|NCT00705575|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
111089881|NCT00705575|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111089882|NCT00705575|Diuretics|diuretics|mesh-ancestor
111089883|NCT00705575|Natriuretic Agents|natriuretic agents|mesh-ancestor
111089884|NCT00705575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111089885|NCT00705575|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
111089886|NCT00705575|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111089887|NCT00705575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111089888|NCT03068247|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
111089889|NCT03068247|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111089890|NCT03068247|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111089891|NCT03068247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111089892|NCT03068247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111089893|NCT03068247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111089894|NCT03068247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111089895|NCT03068247|Analgesics|analgesics|mesh-ancestor
111089896|NCT03068247|Sensory System Agents|sensory system agents|mesh-ancestor
111089897|NCT03068247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111089898|NCT03068247|Antidepressive Agents|antidepressive agents|mesh-ancestor
111089899|NCT03068247|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111089900|NCT03068247|Dopamine Agents|dopamine agents|mesh-ancestor
111089901|NCT03108833|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
111089902|NCT03108833|Saruplase|saruplase|mesh-list
111089903|NCT03108833|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111089904|NCT03108833|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111089905|NCT03108833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111089906|NCT02636361|Insulin Lispro|insulin lispro|mesh-list
111089907|NCT02636361|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111089908|NCT02636361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111089909|NCT02636283|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
111089910|NCT02636283|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111089911|NCT02636283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111089912|NCT04450953|Eplerenone|eplerenone|mesh-list
111089913|NCT04450953|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
111089914|NCT04450953|Hormone Antagonists|hormone antagonists|mesh-ancestor
111089915|NCT04450953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111089916|NCT04450953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111089917|NCT04450953|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
111089918|NCT04450953|Diuretics|diuretics|mesh-ancestor
111089919|NCT04450953|Natriuretic Agents|natriuretic agents|mesh-ancestor
111089920|NCT04450953|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111089921|NCT04983849|Metronidazole|metronidazole|mesh-list
111089922|NCT04983849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111089923|NCT04983849|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111089924|NCT04983849|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111089925|NCT04983849|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111089926|NCT02474303|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
111089927|NCT02474303|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111089928|NCT02474303|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111089929|NCT02474303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111089930|NCT02474303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111089931|NCT02474303|Antiviral Agents|antiviral agents|mesh-ancestor
111089932|NCT02474303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111089933|NCT02474303|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111089934|NCT02474303|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111089935|NCT02474225|Bevacizumab|bevacizumab|mesh-list
111089936|NCT02474225|Ranibizumab|ranibizumab|mesh-list
111089937|NCT02474225|Endothelial Growth Factors|endothelial growth factors|mesh-list
111089938|NCT02474225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111089939|NCT02474225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111089940|NCT02474225|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111089941|NCT02474225|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111089942|NCT02474225|Growth Substances|growth substances|mesh-ancestor
111089943|NCT02474225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111089944|NCT02474225|Growth Inhibitors|growth inhibitors|mesh-ancestor
111089945|NCT04430855|Upadacitinib|upadacitinib|mesh-list
111089946|NCT04430855|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
111089947|NCT04430855|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111089948|NCT04430855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111089949|NCT04430855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111089950|NCT04430855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111089951|NCT02471105|Bimatoprost|bimatoprost|mesh-list
111089952|NCT02471105|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111089953|NCT03108989|Neostigmine|neostigmine|mesh-list
111089954|NCT03108989|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111089955|NCT03108989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111089956|NCT03108989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111089957|NCT03108989|Cholinergic Agents|cholinergic agents|mesh-ancestor
111089958|NCT03108989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111089959|NCT03108989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111089960|NCT03108989|Parasympathomimetics|parasympathomimetics|mesh-ancestor
111089961|NCT03108989|Autonomic Agents|autonomic agents|mesh-ancestor
111089962|NCT03108989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111089963|NCT02473601|Mivacurium|mivacurium|mesh-list
111089964|NCT02473601|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
111089965|NCT02473601|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
111089966|NCT02473601|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111089967|NCT02473601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111089968|NCT02473601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111089969|NCT04359017|Lidocaine|lidocaine|mesh-list
111089970|NCT04359017|Anesthetics, Local|anesthetics, local|mesh-ancestor
111089971|NCT04359017|Anesthetics|anesthetics|mesh-ancestor
111089972|NCT04359017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111089973|NCT04359017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111089974|NCT04359017|Sensory System Agents|sensory system agents|mesh-ancestor
111089975|NCT04359017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111089976|NCT04359017|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111089977|NCT04359017|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111089978|NCT04359017|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111089979|NCT04359017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111089980|NCT04359017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111089981|NCT02470559|Aldesleukin|aldesleukin|mesh-list
111089982|NCT02470559|Interleukin-2|interleukin-2|mesh-list
111089983|NCT02470559|Sargramostim|sargramostim|mesh-list
111089984|NCT02470559|Antibodies, Bispecific|antibodies, bispecific|mesh-list
111089985|NCT02470559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111089986|NCT02470559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111089988|NCT02470559|Sensory System Agents|sensory system agents|mesh-ancestor
111089989|NCT02470559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111089990|NCT02470559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111089991|NCT02470559|Immunologic Factors|immunologic factors|mesh-ancestor
111089992|NCT02470559|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111089993|NCT02470559|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111089994|NCT02470559|Antiviral Agents|antiviral agents|mesh-ancestor
111089995|NCT02470559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111089996|NCT02473211|Sofosbuvir|sofosbuvir|mesh-list
111089997|NCT02473211|Antiviral Agents|antiviral agents|mesh-ancestor
111089998|NCT02473211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111089999|NCT02470637|Insulin|insulin|mesh-list
111090000|NCT02470637|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111090002|NCT02470637|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111090003|NCT02470637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111090004|NCT03652961|Abatacept|abatacept|mesh-list
111090005|NCT03652961|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111090006|NCT03652961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111090007|NCT03652961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111090008|NCT03652961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111090009|NCT03652961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111090010|NCT03652961|Immunologic Factors|immunologic factors|mesh-ancestor
111090011|NCT03652961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111090012|NCT03652961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111090013|NCT03948347|Liraglutide|liraglutide|mesh-list
111090014|NCT03948347|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111090015|NCT03948347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111090016|NCT03948347|Incretins|incretins|mesh-ancestor
111090017|NCT03948347|Hormones|hormones|mesh-ancestor
111090018|NCT03948347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111090019|NCT02723591|Tacrolimus|tacrolimus|mesh-list
111090020|NCT02723591|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111090021|NCT02723591|Immunologic Factors|immunologic factors|mesh-ancestor
111090022|NCT02723591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111090023|NCT02723591|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111090024|NCT02723591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111090025|NCT02723591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111090026|NCT00705341|Fluticasone|fluticasone|mesh-list
111090027|NCT00705341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111090028|NCT00705341|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111090029|NCT00705341|Autonomic Agents|autonomic agents|mesh-ancestor
111090030|NCT00705341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111090031|NCT00705341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111090032|NCT00705341|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111090033|NCT00705341|Respiratory System Agents|respiratory system agents|mesh-ancestor
111090034|NCT00705341|Dermatologic Agents|dermatologic agents|mesh-ancestor
111090035|NCT00705341|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111090036|NCT03193931|Pembrolizumab|pembrolizumab|mesh-list
111090037|NCT03193931|Methotrexate|methotrexate|mesh-list
111090038|NCT03193931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111090039|NCT03193931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111090040|NCT03193931|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111090041|NCT03193931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111090042|NCT03193931|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111090043|NCT03193931|Abortifacient Agents|abortifacient agents|mesh-ancestor
111090044|NCT03193931|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111090045|NCT03193931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111090046|NCT03193931|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111090047|NCT03193931|Antimetabolites|antimetabolites|mesh-ancestor
111090048|NCT03193931|Dermatologic Agents|dermatologic agents|mesh-ancestor
111090049|NCT03193931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111090050|NCT03193931|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111090051|NCT03193931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111090052|NCT03193931|Immunologic Factors|immunologic factors|mesh-ancestor
111090053|NCT03193931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111090054|NCT03193931|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111090055|NCT00705263|Ribavirin|ribavirin|mesh-list
111090056|NCT00705263|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
111090057|NCT00705263|Antimetabolites|antimetabolites|mesh-ancestor
111090058|NCT00705263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111090059|NCT00705263|Antiviral Agents|antiviral agents|mesh-ancestor
111090060|NCT00705263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111090062|NCT02767427|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
111090063|NCT02767427|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111090064|NCT02767427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111090065|NCT02767427|Disinfectants|disinfectants|mesh-ancestor
111090066|NCT02767427|Dermatologic Agents|dermatologic agents|mesh-ancestor
111090067|NCT03310463|Durlobactam|durlobactam|mesh-list
111090068|NCT03310463|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
111090069|NCT03310463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111090070|NCT03310463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111090071|NCT03310463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111090072|NCT03310463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111090073|NCT00704405|Interferons|interferons|mesh-list
111090074|NCT00704405|Ribavirin|ribavirin|mesh-list
111090075|NCT00704405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111090076|NCT00704405|Antiviral Agents|antiviral agents|mesh-ancestor
111090077|NCT00704405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111090078|NCT00704405|Antimetabolites|antimetabolites|mesh-ancestor
111090079|NCT00704405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111090080|NCT01470755|Albuterol|albuterol|mesh-list
111090081|NCT01470755|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111090082|NCT01470755|Autonomic Agents|autonomic agents|mesh-ancestor
111090083|NCT01470755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111090084|NCT01470755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111090085|NCT01470755|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111090086|NCT01470755|Respiratory System Agents|respiratory system agents|mesh-ancestor
111090087|NCT01470755|Tocolytic Agents|tocolytic agents|mesh-ancestor
111090088|NCT01470755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111090089|NCT01470755|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111090090|NCT01470755|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111090091|NCT01470755|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111090092|NCT01470755|Adrenergic Agents|adrenergic agents|mesh-ancestor
111090093|NCT01470755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111090094|NCT01470755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111090095|NCT03310073|Vaccines|vaccines|mesh-list
111090096|NCT03310073|Immunologic Factors|immunologic factors|mesh-ancestor
111090097|NCT03310073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111090098|NCT03309527|Diphenhydramine|diphenhydramine|mesh-list
110145419|NCT02047175|Niacin|niacin|mesh-list
111090099|NCT03309527|Promethazine|promethazine|mesh-list
111090100|NCT03309527|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111090101|NCT03309527|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111090102|NCT03309527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111090103|NCT03309527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111090104|NCT03309527|Anesthetics, Local|anesthetics, local|mesh-ancestor
111090105|NCT03309527|Anesthetics|anesthetics|mesh-ancestor
111090106|NCT03309527|Sensory System Agents|sensory system agents|mesh-ancestor
111090107|NCT03309527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111090108|NCT03309527|Antiemetics|antiemetics|mesh-ancestor
111090109|NCT03309527|Autonomic Agents|autonomic agents|mesh-ancestor
111090110|NCT03309527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111090111|NCT03309527|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111090112|NCT03309527|Histamine Antagonists|histamine antagonists|mesh-ancestor
111090113|NCT03309527|Histamine Agents|histamine agents|mesh-ancestor
111090114|NCT03309527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111090115|NCT03309527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111090116|NCT03309527|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111090117|NCT03309527|Antipruritics|antipruritics|mesh-ancestor
111090118|NCT03309527|Dermatologic Agents|dermatologic agents|mesh-ancestor
111090119|NCT03313661|Gliclazide|gliclazide|mesh-list
111090120|NCT03313661|Cabergoline|cabergoline|mesh-list
111090121|NCT03313661|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111090122|NCT03313661|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111090123|NCT03313661|Dopamine Agonists|dopamine agonists|mesh-ancestor
111090124|NCT03313661|Dopamine Agents|dopamine agents|mesh-ancestor
111090125|NCT03313661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111090126|NCT03313661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111090127|NCT03313661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111090128|NCT03313661|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111090129|NCT00703781|Bromfenac|bromfenac|mesh-list
111090130|NCT00703781|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111090131|NCT00703781|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111090132|NCT00703781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111090133|NCT00703781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111090134|NCT00703781|Analgesics|analgesics|mesh-ancestor
111090135|NCT00703781|Sensory System Agents|sensory system agents|mesh-ancestor
111090136|NCT00703781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111090137|NCT00703781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111090138|NCT00703781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111090139|NCT00703781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111090140|NCT03309215|Nickel|nickel|mesh-list
111090141|NCT03309215|Trace Elements|trace elements|mesh-ancestor
111090142|NCT03309215|Micronutrients|micronutrients|mesh-ancestor
111090143|NCT03309215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111090144|NCT03309059|Zinc Oxide|zinc oxide|mesh-list
111090145|NCT03309059|Dermatologic Agents|dermatologic agents|mesh-ancestor
111090146|NCT03309059|Sunscreening Agents|sunscreening agents|mesh-ancestor
111090147|NCT03309059|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111090148|NCT03309059|Protective Agents|protective agents|mesh-ancestor
111090149|NCT03309059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110807248|NCT01084031|Propofol|propofol|mesh-list
111090150|NCT02469545|Sertraline|sertraline|mesh-list
111090152|NCT02469545|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111090153|NCT02469545|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111090154|NCT02469545|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111090155|NCT02469545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111090156|NCT02469545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111090157|NCT02469545|Serotonin Agents|serotonin agents|mesh-ancestor
111090158|NCT02469545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111090159|NCT02469545|Antidepressive Agents|antidepressive agents|mesh-ancestor
111090160|NCT02469545|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111090161|NCT03308357|Infliximab|infliximab|mesh-list
111090162|NCT03308357|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111090163|NCT03308357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111090164|NCT03308357|Dermatologic Agents|dermatologic agents|mesh-ancestor
111090165|NCT03308357|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111090166|NCT03308357|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111090167|NCT02469311|Chlorhexidine|chlorhexidine|mesh-list
111090168|NCT02469311|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111090169|NCT02469311|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111090170|NCT02469311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111090171|NCT02469311|Disinfectants|disinfectants|mesh-ancestor
111090172|NCT03308201|Letrozole|letrozole|mesh-list
111090173|NCT03308201|Fulvestrant|fulvestrant|mesh-list
111090174|NCT03308201|Exemestane|exemestane|mesh-list
111090175|NCT03308201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111090176|NCT03308201|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111090177|NCT03308201|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111090178|NCT03308201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111090179|NCT03308201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111090180|NCT03308201|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111090181|NCT03308201|Hormone Antagonists|hormone antagonists|mesh-ancestor
111090182|NCT03308201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111090183|NCT03308201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111090184|NCT03308201|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111090185|NCT03308201|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
111090186|NCT03312413|Dexmedetomidine|dexmedetomidine|mesh-list
111090187|NCT03312413|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111090188|NCT03312413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111090189|NCT03312413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111090190|NCT03312413|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111090191|NCT03312413|Analgesics|analgesics|mesh-ancestor
111090192|NCT03312413|Sensory System Agents|sensory system agents|mesh-ancestor
111090193|NCT03312413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111090194|NCT03312413|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111090195|NCT03312413|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111090196|NCT03312413|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111090197|NCT03312413|Adrenergic Agents|adrenergic agents|mesh-ancestor
111090198|NCT03312413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111090199|NCT03312413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111090200|NCT02722967|Aripiprazole|aripiprazole|mesh-list
111090201|NCT02722967|Antidepressive Agents|antidepressive agents|mesh-ancestor
111090202|NCT02722967|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111090203|NCT02722967|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111090204|NCT02722967|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111090205|NCT02722967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111090206|NCT02722967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111090207|NCT02722967|Dopamine Agonists|dopamine agonists|mesh-ancestor
111090208|NCT02722967|Dopamine Agents|dopamine agents|mesh-ancestor
111090209|NCT02722967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110555313|NCT02630264|Paclitaxel|paclitaxel|mesh-list
111090210|NCT02722967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111090211|NCT02722967|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111090212|NCT02722967|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111090213|NCT02722967|Serotonin Agents|serotonin agents|mesh-ancestor
111090214|NCT02722967|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111090215|NCT02722967|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111090216|NCT02722967|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111090217|NCT02722967|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111090218|NCT04442633|Miconazole|miconazole|mesh-list
111090219|NCT04442633|Antifungal Agents|antifungal agents|mesh-ancestor
111090220|NCT04442633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111090221|NCT04442633|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111090222|NCT04442633|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111090223|NCT04442633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111090224|NCT04442633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111090225|NCT04442633|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111090226|NCT04442633|Hormone Antagonists|hormone antagonists|mesh-ancestor
111090227|NCT04442633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111090228|NCT04442633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111090229|NCT04442633|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111090230|NCT04442633|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111090231|NCT03312335|Aldesleukin|aldesleukin|mesh-list
111090232|NCT03312335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111090233|NCT03312335|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111090234|NCT03312335|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111090235|NCT03312335|Antiviral Agents|antiviral agents|mesh-ancestor
111090236|NCT03312335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111090237|NCT03312179|Incretins|incretins|mesh-list
111090238|NCT03312179|Hormones|hormones|mesh-ancestor
111090239|NCT03312179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111090240|NCT03312179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111090241|NCT02468531|Xenon|xenon|mesh-list
111090242|NCT02468531|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111090243|NCT02468531|Anesthetics, General|anesthetics, general|mesh-ancestor
111090244|NCT02468531|Anesthetics|anesthetics|mesh-ancestor
111090245|NCT02468531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111090246|NCT02468531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111090247|NCT03311945|Lamivudine|lamivudine|mesh-list
111090248|NCT03311945|Raltegravir Potassium|raltegravir potassium|mesh-list
111090249|NCT03311945|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111090250|NCT03311945|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111090251|NCT03311945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111090252|NCT03311945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111090253|NCT03311945|Antiviral Agents|antiviral agents|mesh-ancestor
111090254|NCT03311945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111090255|NCT03311945|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111090256|NCT03311945|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111090257|NCT03311945|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111090258|NCT03311945|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111090259|NCT03311789|Gemcitabine|gemcitabine|mesh-list
111090260|NCT03311789|Nivolumab|nivolumab|mesh-list
111090261|NCT03311789|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
111090262|NCT03311789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111090263|NCT03311789|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111090264|NCT03311789|Antimetabolites|antimetabolites|mesh-ancestor
111090265|NCT03311789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111090266|NCT03311789|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111090267|NCT02468999|Insulin|insulin|mesh-list
111090268|NCT02468999|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111090269|NCT02468999|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111090270|NCT02468999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111090271|NCT03311321|Vitamin K|vitamin k|mesh-list
111090272|NCT03311321|Vitamin K 2|vitamin k 2|mesh-list
111090273|NCT03311321|Menaquinone 7|menaquinone 7|mesh-list
111090274|NCT03311321|Vitamins|vitamins|mesh-ancestor
111090275|NCT03311321|Micronutrients|micronutrients|mesh-ancestor
111090276|NCT03311321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111090277|NCT03311321|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111090278|NCT03311321|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111090279|NCT03311321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111090280|NCT03311321|Hemostatics|hemostatics|mesh-ancestor
111090281|NCT03311321|Coagulants|coagulants|mesh-ancestor
111090282|NCT02468297|Ibuprofen|ibuprofen|mesh-list
110828150|NCT05625893|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111090283|NCT02468297|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111090285|NCT02468297|Analgesics|analgesics|mesh-ancestor
111090286|NCT02468297|Sensory System Agents|sensory system agents|mesh-ancestor
111090287|NCT02468297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111090288|NCT02468297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111090289|NCT02468297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111090290|NCT02468297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111090291|NCT02468297|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111090292|NCT02468297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111090293|NCT02468297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111090294|NCT02468375|Mirabegron|mirabegron|mesh-list
111090295|NCT02468375|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
111090296|NCT02468375|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111090297|NCT02468375|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111090298|NCT02468375|Adrenergic Agents|adrenergic agents|mesh-ancestor
111090299|NCT02468375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111090300|NCT02468375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111090301|NCT02468375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111090302|NCT02468375|Urological Agents|urological agents|mesh-ancestor
111090303|NCT03304457|Olanzapine|olanzapine|mesh-list
111090304|NCT03304457|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
111090305|NCT03304457|Antiemetics|antiemetics|mesh-ancestor
111090306|NCT03304457|Autonomic Agents|autonomic agents|mesh-ancestor
111090307|NCT03304457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111090308|NCT03304457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111090309|NCT03304457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111090310|NCT03304457|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111090311|NCT03304457|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111090312|NCT03304457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111090313|NCT03304457|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111090314|NCT03304457|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111090315|NCT03304457|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111090316|NCT03304457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111090317|NCT03304457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111090318|NCT03304457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111090319|NCT03304457|Serotonin Agents|serotonin agents|mesh-ancestor
111090320|NCT03304457|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
111090321|NCT03304457|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111090322|NCT03304457|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111090323|NCT03304457|Adrenergic Agents|adrenergic agents|mesh-ancestor
111090324|NCT03304457|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111090325|NCT03304457|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111090326|NCT03304457|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111090327|NCT03304457|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111090328|NCT03304457|Dopamine Agents|dopamine agents|mesh-ancestor
111090329|NCT04490837|Antibodies|antibodies|mesh-list
111090330|NCT04490837|Immunologic Factors|immunologic factors|mesh-ancestor
111090331|NCT04490837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111090332|NCT03305471|Sevelamer|sevelamer|mesh-list
111090333|NCT03305471|Chelating Agents|chelating agents|mesh-ancestor
111090334|NCT03305471|Sequestering Agents|sequestering agents|mesh-ancestor
111090335|NCT03305471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111090336|NCT03303677|Vancomycin|vancomycin|mesh-list
111090337|NCT03303677|Ciprofloxacin|ciprofloxacin|mesh-list
111090338|NCT03303677|Gentamicins|gentamicins|mesh-list
111090339|NCT03303677|Mupirocin|mupirocin|mesh-list
111090340|NCT03303677|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111090341|NCT03303677|Trimethoprim|trimethoprim|mesh-list
111090342|NCT03303677|Sulfamethoxazole|sulfamethoxazole|mesh-list
111090343|NCT03303677|Budesonide|budesonide|mesh-list
111090344|NCT03303677|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111090345|NCT03303677|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111090346|NCT03303677|Autonomic Agents|autonomic agents|mesh-ancestor
111090347|NCT03303677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111090348|NCT03303677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111090349|NCT03303677|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111090350|NCT03303677|Respiratory System Agents|respiratory system agents|mesh-ancestor
111090351|NCT03303677|Glucocorticoids|glucocorticoids|mesh-ancestor
111090352|NCT03303677|Hormones|hormones|mesh-ancestor
111090353|NCT03303677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111090354|NCT03303677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111090355|NCT03303677|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111090356|NCT03303677|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111090357|NCT03303677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111090358|NCT03303677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111090359|NCT03303677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111090360|NCT03303677|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111090361|NCT03303677|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111090362|NCT03303677|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111090363|NCT03303677|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111090364|NCT03303677|Antimalarials|antimalarials|mesh-ancestor
111090365|NCT03303677|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111090366|NCT03303677|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111090367|NCT03303677|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111090368|NCT03303677|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111090369|NCT03303677|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
111090370|NCT02468063|Terlipressin|terlipressin|mesh-list
111090371|NCT02468063|Norepinephrine|norepinephrine|mesh-list
110396200|NCT04309357|Plasminogen|plasminogen|mesh-list
111090372|NCT02468063|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110807523|NCT03535870|Xhance|xhance|mesh-list
111090373|NCT02468063|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111090374|NCT02468063|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111090375|NCT02468063|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111090376|NCT02468063|Adrenergic Agents|adrenergic agents|mesh-ancestor
111090377|NCT02468063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111090378|NCT02468063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111090379|NCT02468063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111090380|NCT02468063|Sympathomimetics|sympathomimetics|mesh-ancestor
111090381|NCT02468063|Autonomic Agents|autonomic agents|mesh-ancestor
111090382|NCT02468063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111090383|NCT04490681|Ertugliflozin|ertugliflozin|mesh-list
111090384|NCT04490681|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111090385|NCT04490681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111090386|NCT04490681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111090387|NCT04490681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111090388|NCT03303209|Analgesics, Opioid|analgesics, opioid|mesh-list
111090389|NCT03303209|Narcotics|narcotics|mesh-ancestor
111090390|NCT03303209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111090391|NCT03303209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111090392|NCT03303209|Analgesics|analgesics|mesh-ancestor
111090393|NCT03303209|Sensory System Agents|sensory system agents|mesh-ancestor
111090394|NCT03303209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111090395|NCT03303053|Prednisolone|prednisolone|mesh-list
111090396|NCT03303053|Cholestyramine Resin|cholestyramine resin|mesh-list
111090397|NCT03303053|Carbimazole|carbimazole|mesh-list
111090398|NCT03303053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111090399|NCT03303053|Glucocorticoids|glucocorticoids|mesh-ancestor
111090400|NCT03303053|Hormones|hormones|mesh-ancestor
111090401|NCT03303053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111090402|NCT03303053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111090403|NCT03303053|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111090404|NCT03303053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111090405|NCT03303053|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111090406|NCT03303053|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111090407|NCT03303053|Antimetabolites|antimetabolites|mesh-ancestor
111090408|NCT03303053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111090409|NCT03303053|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111090410|NCT03303053|Antithyroid Agents|antithyroid agents|mesh-ancestor
111090411|NCT03303053|Hormone Antagonists|hormone antagonists|mesh-ancestor
111090412|NCT02467907|Paclitaxel|paclitaxel|mesh-list
111090413|NCT02467907|Bevacizumab|bevacizumab|mesh-list
111090414|NCT02467907|Carboplatin|carboplatin|mesh-list
111090415|NCT02467907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111090416|NCT02467907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111090417|NCT02467907|Tubulin Modulators|tubulin modulators|mesh-ancestor
111090418|NCT02467907|Antimitotic Agents|antimitotic agents|mesh-ancestor
111090419|NCT02467907|Mitosis Modulators|mitosis modulators|mesh-ancestor
111090420|NCT02467907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111090421|NCT02467907|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111090422|NCT02467907|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111090423|NCT02467907|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111090424|NCT02467907|Growth Substances|growth substances|mesh-ancestor
111090425|NCT02467907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111090426|NCT02467907|Growth Inhibitors|growth inhibitors|mesh-ancestor
111090427|NCT02467127|Vitamin D|vitamin d|mesh-list
111090428|NCT02467127|Vitamins|vitamins|mesh-ancestor
111090429|NCT02467127|Micronutrients|micronutrients|mesh-ancestor
111090430|NCT02467127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111090431|NCT02467127|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111090432|NCT03302585|Vitamin D|vitamin d|mesh-list
111090433|NCT03302585|Ergocalciferols|ergocalciferols|mesh-list
111090434|NCT03302585|Cholecalciferol|cholecalciferol|mesh-list
111090435|NCT03302585|Vitamins|vitamins|mesh-list
111090436|NCT03302585|Micronutrients|micronutrients|mesh-ancestor
111090437|NCT03302585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111090438|NCT03302585|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111090439|NCT03302585|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111090440|NCT05727761|Metformin|metformin|mesh-list
111090441|NCT05727761|Pioglitazone|pioglitazone|mesh-list
111090442|NCT05727761|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111090443|NCT05727761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111090444|NCT03302351|Dexmedetomidine|dexmedetomidine|mesh-list
111090445|NCT03302351|Ketamine|ketamine|mesh-list
111090446|NCT03302351|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111090447|NCT03302351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111090448|NCT03302351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111090449|NCT03302351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111090450|NCT03302351|Analgesics|analgesics|mesh-ancestor
111090451|NCT03302351|Sensory System Agents|sensory system agents|mesh-ancestor
111090452|NCT03302351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111090453|NCT03302351|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111090454|NCT03302351|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111090455|NCT03302351|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111090456|NCT03302351|Adrenergic Agents|adrenergic agents|mesh-ancestor
111090457|NCT03302351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111090458|NCT03302351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111090459|NCT03302351|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111090460|NCT03302351|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111090461|NCT03302351|Anesthetics, General|anesthetics, general|mesh-ancestor
111090462|NCT03302351|Anesthetics|anesthetics|mesh-ancestor
111090463|NCT03302351|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111090464|NCT03302351|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111090465|NCT05727683|Cyclophosphamide|cyclophosphamide|mesh-list
111090466|NCT05727683|Fludarabine|fludarabine|mesh-list
111090467|NCT05727683|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111090468|NCT05727683|Immunologic Factors|immunologic factors|mesh-ancestor
111090469|NCT05727683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111090470|NCT05727683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111090471|NCT05727683|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111090472|NCT05727683|Alkylating Agents|alkylating agents|mesh-ancestor
111090473|NCT05727683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111090474|NCT05727683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111090475|NCT05727683|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111090476|NCT03302039|Phenylephrine|phenylephrine|mesh-list
111090477|NCT03302039|Oxymetazoline|oxymetazoline|mesh-list
111090478|NCT03302039|Bupivacaine|bupivacaine|mesh-list
111090479|NCT03302039|Anesthetics, Local|anesthetics, local|mesh-ancestor
111090480|NCT03302039|Anesthetics|anesthetics|mesh-ancestor
111090481|NCT03302039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111090482|NCT03302039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111090483|NCT03302039|Sensory System Agents|sensory system agents|mesh-ancestor
111090484|NCT03302039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111090485|NCT03302039|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111090486|NCT03302039|Mydriatics|mydriatics|mesh-ancestor
111090487|NCT03302039|Autonomic Agents|autonomic agents|mesh-ancestor
111090488|NCT03302039|Sympathomimetics|sympathomimetics|mesh-ancestor
111090489|NCT03302039|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111090490|NCT03302039|Nasal Decongestants|nasal decongestants|mesh-ancestor
111090491|NCT03302039|Respiratory System Agents|respiratory system agents|mesh-ancestor
111090492|NCT03302039|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111090493|NCT03302039|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111090494|NCT03302039|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111090495|NCT03302039|Adrenergic Agents|adrenergic agents|mesh-ancestor
111090496|NCT03302039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111090497|NCT03302039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111090498|NCT03302039|Protective Agents|protective agents|mesh-ancestor
111090499|NCT02721875|Azacitidine|azacitidine|mesh-list
111090500|NCT02721875|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111090501|NCT02721875|Antimetabolites|antimetabolites|mesh-ancestor
111090502|NCT02721875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111090503|NCT02721875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111090504|NCT02721875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111090505|NCT02466503|Fluticasone|fluticasone|mesh-list
111090506|NCT02466503|Xhance|xhance|mesh-list
111090507|NCT02466503|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
111090508|NCT02466503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111090509|NCT02466503|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111090510|NCT02466503|Autonomic Agents|autonomic agents|mesh-ancestor
111090511|NCT02466503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111090512|NCT02466503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111090513|NCT02466503|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111090514|NCT02466503|Respiratory System Agents|respiratory system agents|mesh-ancestor
111090515|NCT02466503|Dermatologic Agents|dermatologic agents|mesh-ancestor
111090516|NCT02466503|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111090517|NCT02466503|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111090518|NCT02466503|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111090519|NCT02466503|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111090520|NCT02466503|Adrenergic Agents|adrenergic agents|mesh-ancestor
111090521|NCT02466503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111090522|NCT02466503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111090523|NCT03301181|Itraconazole|itraconazole|mesh-list
111090525|NCT03301181|Zanubrutinib|zanubrutinib|mesh-list
111090526|NCT03301181|Antifungal Agents|antifungal agents|mesh-ancestor
111090527|NCT03301181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111090528|NCT03301181|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111090529|NCT03301181|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111090530|NCT03301181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111090531|NCT03301181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111090532|NCT03301181|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111090533|NCT03301181|Hormone Antagonists|hormone antagonists|mesh-ancestor
111090534|NCT03301181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111090535|NCT03301181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111090536|NCT03301181|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111090537|NCT03301181|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111090538|NCT03301181|Antitubercular Agents|antitubercular agents|mesh-ancestor
111090539|NCT03301181|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111090540|NCT03301181|Leprostatic Agents|leprostatic agents|mesh-ancestor
111090541|NCT03301181|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111090542|NCT03301181|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111090543|NCT03301181|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111090544|NCT03301181|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
111090545|NCT03301181|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
111090546|NCT03301181|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
111090547|NCT03301181|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111090548|NCT03301181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111090549|NCT03301181|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111090550|NCT00702221|Vaccines|vaccines|mesh-list
111090551|NCT00702221|Immunologic Factors|immunologic factors|mesh-ancestor
111090552|NCT00702221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111090553|NCT03301025|Pregabalin|pregabalin|mesh-list
111090554|NCT03301025|Analgesics|analgesics|mesh-ancestor
111090555|NCT03301025|Sensory System Agents|sensory system agents|mesh-ancestor
111090556|NCT03301025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111090557|NCT03301025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111090558|NCT03301025|Anticonvulsants|anticonvulsants|mesh-ancestor
111090559|NCT03301025|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111090560|NCT03301025|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111090561|NCT03301025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111090562|NCT03301025|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111090563|NCT03301025|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111090564|NCT03301025|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111090565|NCT03301025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111090566|NCT03301025|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111090567|NCT05726903|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
111090568|NCT05726903|Medroxyprogesterone|medroxyprogesterone|mesh-list
111090569|NCT05726903|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111090570|NCT05726903|Contraceptive Agents|contraceptive agents|mesh-ancestor
111090571|NCT05726903|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111090572|NCT05726903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111090573|NCT05726903|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111090574|NCT05726903|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
111090575|NCT05726903|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111090576|NCT05726903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111090577|NCT05726903|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111090578|NCT05726903|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111090579|NCT05726903|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111090580|NCT02467595|Fentanyl|fentanyl|mesh-list
111090581|NCT02467595|Bromides|bromides|mesh-list
111090582|NCT02467595|Propofol|propofol|mesh-list
111090583|NCT02467595|Sevoflurane|sevoflurane|mesh-list
111090584|NCT02467595|Rocuronium|rocuronium|mesh-list
111090585|NCT02467595|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111090586|NCT02467595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111090587|NCT02467595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111090588|NCT02467595|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111090589|NCT02467595|Anesthetics, General|anesthetics, general|mesh-ancestor
111090590|NCT02467595|Anesthetics|anesthetics|mesh-ancestor
111090591|NCT02467595|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111090592|NCT02467595|Narcotics|narcotics|mesh-ancestor
111090593|NCT02467595|Analgesics|analgesics|mesh-ancestor
111090594|NCT02467595|Sensory System Agents|sensory system agents|mesh-ancestor
111090595|NCT02467595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111090596|NCT02467595|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111090597|NCT02467595|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111090598|NCT02467595|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111090599|NCT02467595|Anticonvulsants|anticonvulsants|mesh-ancestor
111090600|NCT02467595|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
111090601|NCT02467595|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
111090602|NCT02467595|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111090603|NCT02467517|Magnesium Sulfate|magnesium sulfate|mesh-list
111090604|NCT02467517|Ketamine|ketamine|mesh-list
111090605|NCT02467517|Analgesics|analgesics|mesh-ancestor
111090606|NCT02467517|Sensory System Agents|sensory system agents|mesh-ancestor
111090607|NCT02467517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111090608|NCT02467517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111090609|NCT02467517|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111090610|NCT02467517|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111090611|NCT02467517|Anesthetics, General|anesthetics, general|mesh-ancestor
111090612|NCT02467517|Anesthetics|anesthetics|mesh-ancestor
111090613|NCT02467517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111090614|NCT02467517|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111090615|NCT02467517|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111090616|NCT02467517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111090617|NCT02467517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111090618|NCT02467517|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111090619|NCT02467517|Anticonvulsants|anticonvulsants|mesh-ancestor
111090620|NCT02467517|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111090621|NCT02467517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111090622|NCT02467517|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111090623|NCT02467517|Tocolytic Agents|tocolytic agents|mesh-ancestor
111090624|NCT02467517|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111090625|NCT02467673|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
111090626|NCT02467673|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
111090627|NCT02467673|Estradiol|estradiol|mesh-list
111090628|NCT02467673|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
111090629|NCT02467673|Progesterone|progesterone|mesh-list
111090630|NCT02467673|Estrogens|estrogens|mesh-ancestor
111090631|NCT02467673|Hormones|hormones|mesh-ancestor
111090632|NCT02467673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111090633|NCT02467673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111090634|NCT02467673|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111090635|NCT02467673|Contraceptive Agents|contraceptive agents|mesh-ancestor
111090636|NCT02467673|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111090637|NCT02467673|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111090638|NCT02467673|Progestins|progestins|mesh-ancestor
111090639|NCT02953145|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
111090640|NCT02953145|Hemostatics|hemostatics|mesh-ancestor
111090641|NCT02953145|Coagulants|coagulants|mesh-ancestor
111090642|NCT03300089|Anesthetics|anesthetics|mesh-list
111090643|NCT03300089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111090644|NCT03300089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111090645|NCT04983615|Fentanyl|fentanyl|mesh-list
111090646|NCT04983615|Midazolam|midazolam|mesh-list
111090647|NCT04983615|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111090648|NCT04983615|Narcotics|narcotics|mesh-ancestor
111090649|NCT04983615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111090650|NCT04983615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111090651|NCT04983615|Analgesics|analgesics|mesh-ancestor
111090652|NCT04983615|Sensory System Agents|sensory system agents|mesh-ancestor
111090653|NCT04983615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111090654|NCT04983615|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111090655|NCT04983615|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111090656|NCT04983615|Anesthetics, General|anesthetics, general|mesh-ancestor
111090657|NCT04983615|Anesthetics|anesthetics|mesh-ancestor
111090658|NCT04983615|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111090659|NCT04983615|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111090660|NCT04983615|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111090661|NCT04983615|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111090662|NCT04983615|GABA Modulators|gaba modulators|mesh-ancestor
111090663|NCT04983615|GABA Agents|gaba agents|mesh-ancestor
111090664|NCT04983615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111090665|NCT04983615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111090666|NCT00702923|Tremelimumab|tremelimumab|mesh-list
111090667|NCT00702923|Bicalutamide|bicalutamide|mesh-list
110807761|NCT00095147|Antimetabolites|antimetabolites|mesh-ancestor
111090669|NCT00702923|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111090670|NCT00702923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111090671|NCT00702923|Immunologic Factors|immunologic factors|mesh-ancestor
111090672|NCT00702923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111090673|NCT00702923|Androgen Antagonists|androgen antagonists|mesh-ancestor
111090674|NCT00702923|Hormone Antagonists|hormone antagonists|mesh-ancestor
111090675|NCT00702923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111090676|NCT00702923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111090677|NCT00702923|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111090678|NCT00702923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111090680|NCT05294055|Etoposide|etoposide|mesh-list
111090681|NCT05294055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111090682|NCT05294055|Immunologic Factors|immunologic factors|mesh-ancestor
111090683|NCT05294055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111090684|NCT05294055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111090685|NCT05294055|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111090686|NCT05294055|Alkylating Agents|alkylating agents|mesh-ancestor
111090687|NCT05294055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111090688|NCT05294055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111090689|NCT05294055|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111090690|NCT05294055|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111090691|NCT05294055|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111090692|NCT05294055|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111090693|NCT05294055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111090694|NCT03299621|Rocuronium|rocuronium|mesh-list
111090695|NCT03299621|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
111090696|NCT03299621|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
111090697|NCT03299621|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111090698|NCT03299621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111090699|NCT03299621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111090700|NCT05718167|Tislelizumab|tislelizumab|mesh-list
111090701|NCT05718167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111090702|NCT05718167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111090703|NCT03299387|Gentamicins|gentamicins|mesh-list
111090704|NCT03299387|Nitrofurantoin|nitrofurantoin|mesh-list
111090705|NCT03299387|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111090706|NCT03299387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111090707|NCT03299387|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111090708|NCT03299387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111090709|NCT03299387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111090710|NCT03299387|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111090711|NCT04954313|Chlorhexidine|chlorhexidine|mesh-list
110641298|NCT01000233|Micronutrients|micronutrients|mesh-ancestor
111090712|NCT04954313|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111090713|NCT04954313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111090714|NCT04954313|Disinfectants|disinfectants|mesh-ancestor
111090715|NCT02658981|Nivolumab|nivolumab|mesh-list
111090716|NCT02658981|Relatlimab|relatlimab|mesh-list
111090717|NCT02658981|Antibodies|antibodies|mesh-list
111090718|NCT02658981|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111090719|NCT02658981|Immunologic Factors|immunologic factors|mesh-ancestor
111090720|NCT02658981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111090721|NCT02658981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111090722|NCT02658981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111090723|NCT02658981|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111090724|NCT02658981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111090725|NCT04794699|Paclitaxel|paclitaxel|mesh-list
111090726|NCT04794699|Docetaxel|docetaxel|mesh-list
111090727|NCT04794699|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111090728|NCT04794699|Gemcitabine|gemcitabine|mesh-list
111090729|NCT04794699|Pemetrexed|pemetrexed|mesh-list
111090730|NCT04794699|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111090731|NCT04794699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111090732|NCT04794699|Tubulin Modulators|tubulin modulators|mesh-ancestor
111090733|NCT04794699|Antimitotic Agents|antimitotic agents|mesh-ancestor
111090734|NCT04794699|Mitosis Modulators|mitosis modulators|mesh-ancestor
111090735|NCT04794699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111090736|NCT04794699|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111090737|NCT04794699|Antimetabolites|antimetabolites|mesh-ancestor
111090738|NCT04794699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111090739|NCT04794699|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111090740|NCT04794699|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111090741|NCT04782687|Dexamethasone|dexamethasone|mesh-list
111090742|NCT04782687|Lenalidomide|lenalidomide|mesh-list
111090743|NCT04782687|Daratumumab|daratumumab|mesh-list
111090744|NCT04782687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111090745|NCT04782687|Antiemetics|antiemetics|mesh-ancestor
111090746|NCT04782687|Autonomic Agents|autonomic agents|mesh-ancestor
110807849|NCT02201602|Gliclazide|gliclazide|mesh-list
111090747|NCT04782687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111090748|NCT04782687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111090749|NCT04782687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111090750|NCT04782687|Glucocorticoids|glucocorticoids|mesh-ancestor
111090751|NCT04782687|Hormones|hormones|mesh-ancestor
111090752|NCT04782687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111090753|NCT04782687|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111090754|NCT04782687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111090755|NCT04782687|Immunologic Factors|immunologic factors|mesh-ancestor
111090756|NCT04782687|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111090757|NCT04782687|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111090758|NCT04782687|Growth Substances|growth substances|mesh-ancestor
111090759|NCT04782687|Growth Inhibitors|growth inhibitors|mesh-ancestor
111090760|NCT05655689|Moxifloxacin|moxifloxacin|mesh-list
111090761|NCT05655689|Vancomycin|vancomycin|mesh-list
111090762|NCT05655689|Gentamicins|gentamicins|mesh-list
111090763|NCT05655689|Ceftazidime|ceftazidime|mesh-list
111090764|NCT05655689|Natamycin|natamycin|mesh-list
111090765|NCT05655689|Voriconazole|voriconazole|mesh-list
111090766|NCT05655689|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111090767|NCT05655689|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111090768|NCT05655689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111090769|NCT05655689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111090770|NCT05655689|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111090771|NCT05655689|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111090772|NCT05655689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111090773|NCT05655689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111090774|NCT05655689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111090775|NCT05655689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111090776|NCT05655689|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111090777|NCT05655689|Antifungal Agents|antifungal agents|mesh-ancestor
111090778|NCT05655689|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111090779|NCT05655689|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111090780|NCT05655689|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111090781|NCT05655689|Hormone Antagonists|hormone antagonists|mesh-ancestor
111090782|NCT05655689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111090783|NCT05655689|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111090784|NCT05655689|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111090785|NCT02466347|Fluticasone|fluticasone|mesh-list
111090786|NCT02466347|Xhance|xhance|mesh-list
111090787|NCT02466347|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
111090788|NCT02466347|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111090789|NCT02466347|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111090790|NCT02466347|Autonomic Agents|autonomic agents|mesh-ancestor
111090791|NCT02466347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111090792|NCT02466347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111090793|NCT02466347|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111090794|NCT02466347|Respiratory System Agents|respiratory system agents|mesh-ancestor
111090795|NCT02466347|Dermatologic Agents|dermatologic agents|mesh-ancestor
111090796|NCT02466347|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111090797|NCT02466347|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111090798|NCT02466347|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111090799|NCT02466347|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111090800|NCT02466347|Adrenergic Agents|adrenergic agents|mesh-ancestor
111090801|NCT02466347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111090802|NCT02466347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111090803|NCT03067935|Glembatumumab vedotin|glembatumumab vedotin|mesh-list
111090805|NCT03067935|Immunologic Factors|immunologic factors|mesh-ancestor
111090806|NCT03067935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111090807|NCT03067935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111090808|NCT03067935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111090809|NCT02466191|Gabapentin|gabapentin|mesh-list
111090810|NCT02466191|Memantine|memantine|mesh-list
111090811|NCT02466191|Analgesics|analgesics|mesh-ancestor
111090812|NCT02466191|Sensory System Agents|sensory system agents|mesh-ancestor
111090813|NCT02466191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111090814|NCT02466191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111090815|NCT02466191|Anticonvulsants|anticonvulsants|mesh-ancestor
111090816|NCT02466191|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111090817|NCT02466191|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111090818|NCT02466191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111090819|NCT02466191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111090820|NCT02466191|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111090821|NCT02466191|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111090822|NCT02466191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111090823|NCT02466191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111090824|NCT02466191|Antimanic Agents|antimanic agents|mesh-ancestor
111090825|NCT02466191|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111090826|NCT02466191|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111090827|NCT02466191|Dopamine Agents|dopamine agents|mesh-ancestor
111090828|NCT05555069|Menthol|menthol|mesh-list
111090829|NCT05555069|Antipruritics|antipruritics|mesh-ancestor
111090830|NCT05555069|Dermatologic Agents|dermatologic agents|mesh-ancestor
111090831|NCT03067701|Carbon Monoxide|carbon monoxide|mesh-list
111090832|NCT03067701|Antimetabolites|antimetabolites|mesh-ancestor
111090833|NCT03067701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111090834|NCT03067701|Gasotransmitters|gasotransmitters|mesh-ancestor
111090835|NCT03067701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111090836|NCT03067701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111090837|NCT03069339|Carvedilol|carvedilol|mesh-list
111090838|NCT03069339|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111090839|NCT03069339|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111090840|NCT03069339|Adrenergic Agents|adrenergic agents|mesh-ancestor
111090841|NCT03069339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110641313|NCT04075955|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111090842|NCT03069339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111090843|NCT03069339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111090844|NCT03069339|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111090845|NCT03069339|Antioxidants|antioxidants|mesh-ancestor
111090846|NCT03069339|Protective Agents|protective agents|mesh-ancestor
111090847|NCT03069339|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111090848|NCT03069339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111090849|NCT03069339|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111090850|NCT03069339|Vasodilator Agents|vasodilator agents|mesh-ancestor
111090851|NCT03069339|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111090852|NCT03069339|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111090853|NCT05542589|Phenytoin|phenytoin|mesh-list
111090854|NCT05542589|Anticonvulsants|anticonvulsants|mesh-ancestor
111090855|NCT05542589|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111090856|NCT05542589|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111090857|NCT05542589|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111090858|NCT05542589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111090859|NCT05542589|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
111090860|NCT05542589|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111090861|NCT03069027|Lidocaine|lidocaine|mesh-list
111090862|NCT03069027|Epinephrine|epinephrine|mesh-list
111090863|NCT03069027|Racepinephrine|racepinephrine|mesh-list
111090864|NCT03069027|Epinephryl borate|epinephryl borate|mesh-list
111090865|NCT03069027|Anesthetics, Local|anesthetics, local|mesh-ancestor
111090866|NCT03069027|Anesthetics|anesthetics|mesh-ancestor
111090867|NCT03069027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111090868|NCT03069027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111090869|NCT03069027|Sensory System Agents|sensory system agents|mesh-ancestor
111090870|NCT03069027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111090871|NCT03069027|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111090872|NCT03069027|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111090873|NCT03069027|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111090874|NCT03069027|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111090875|NCT03069027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111090876|NCT03069027|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111090877|NCT03069027|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111090878|NCT03069027|Adrenergic Agents|adrenergic agents|mesh-ancestor
111090879|NCT03069027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111090880|NCT03069027|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111090881|NCT03069027|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111090882|NCT03069027|Autonomic Agents|autonomic agents|mesh-ancestor
111090883|NCT03069027|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111090884|NCT03069027|Respiratory System Agents|respiratory system agents|mesh-ancestor
111090885|NCT03069027|Mydriatics|mydriatics|mesh-ancestor
111090886|NCT03069027|Sympathomimetics|sympathomimetics|mesh-ancestor
111090887|NCT03069027|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111090888|NCT05635071|Nintedanib|nintedanib|mesh-list
111090889|NCT05635071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111090890|NCT05635071|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111090891|NCT05635071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111090892|NCT05635071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111090893|NCT04489979|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111090894|NCT04489979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111090895|NCT02720081|Albuterol|albuterol|mesh-list
111090896|NCT02720081|Montelukast|montelukast|mesh-list
111090897|NCT02720081|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111090898|NCT02720081|Respiratory System Agents|respiratory system agents|mesh-ancestor
111090899|NCT02720081|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
111090900|NCT02720081|Hormone Antagonists|hormone antagonists|mesh-ancestor
111090901|NCT02720081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111090902|NCT02720081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111090903|NCT02720081|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
111090904|NCT02720081|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111090905|NCT02720081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111090906|NCT02720081|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111090907|NCT02720081|Autonomic Agents|autonomic agents|mesh-ancestor
111090908|NCT02720081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111090909|NCT02720081|Tocolytic Agents|tocolytic agents|mesh-ancestor
111090910|NCT02720081|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111090911|NCT02720081|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111090912|NCT02720081|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111090913|NCT02720081|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111090914|NCT02720081|Adrenergic Agents|adrenergic agents|mesh-ancestor
111090915|NCT02720081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111090916|NCT04552197|Tofacitinib|tofacitinib|mesh-list
111090917|NCT04552197|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
111090918|NCT04552197|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111090919|NCT04552197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111090920|NCT04552197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111090921|NCT05244473|Brentuximab Vedotin|brentuximab vedotin|mesh-list
111090922|NCT05244473|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111090923|NCT05244473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111090924|NCT05244473|Immunotoxins|immunotoxins|mesh-ancestor
111090925|NCT05244473|Immunoconjugates|immunoconjugates|mesh-ancestor
111090926|NCT05244473|Immunologic Factors|immunologic factors|mesh-ancestor
111090927|NCT05244473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111090928|NCT05634759|Azithromycin|azithromycin|mesh-list
111090929|NCT05634759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111090930|NCT05634759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111090931|NCT04809233|Tipifarnib|tipifarnib|mesh-list
111090932|NCT04809233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111090933|NCT02310269|Pasireotide|pasireotide|mesh-list
111090934|NCT02310269|Hormones|hormones|mesh-ancestor
111090935|NCT02310269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111090936|NCT02310269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111090937|NCT03069183|Ropivacaine|ropivacaine|mesh-list
111090938|NCT03069183|Anesthetics, Local|anesthetics, local|mesh-ancestor
111090939|NCT03069183|Anesthetics|anesthetics|mesh-ancestor
111090940|NCT03069183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111090941|NCT03069183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111090942|NCT03069183|Sensory System Agents|sensory system agents|mesh-ancestor
111090943|NCT03069183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111090944|NCT04489745|Androgens|androgens|mesh-list
111090945|NCT04489745|Hormones|hormones|mesh-ancestor
111090946|NCT04489745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111090947|NCT04489745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111090948|NCT02464865|Thiamine|thiamine|mesh-list
111090949|NCT02464865|Vitamin B Complex|vitamin b complex|mesh-ancestor
111090950|NCT02464865|Vitamins|vitamins|mesh-ancestor
111090951|NCT02464865|Micronutrients|micronutrients|mesh-ancestor
111090952|NCT02464865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111090953|NCT02466035|Caseins|caseins|mesh-list
111090954|NCT02466035|Chelating Agents|chelating agents|mesh-ancestor
111090955|NCT02466035|Sequestering Agents|sequestering agents|mesh-ancestor
111090956|NCT02466035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111090957|NCT05173337|Nefopam|nefopam|mesh-list
111090958|NCT05173337|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111090959|NCT05173337|Analgesics|analgesics|mesh-ancestor
111090960|NCT05173337|Sensory System Agents|sensory system agents|mesh-ancestor
111090961|NCT05173337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111090962|NCT05173337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111090963|NCT02464631|Ribavirin|ribavirin|mesh-list
111090964|NCT02464631|Sofosbuvir|sofosbuvir|mesh-list
111090965|NCT02464631|Antimetabolites|antimetabolites|mesh-ancestor
111090966|NCT02464631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111090967|NCT02464631|Antiviral Agents|antiviral agents|mesh-ancestor
111090968|NCT02464631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111090969|NCT04880577|Tenofovir|tenofovir|mesh-list
111090970|NCT04880577|Rituximab|rituximab|mesh-list
111090971|NCT04880577|Ocrelizumab|ocrelizumab|mesh-list
111090972|NCT04880577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111090973|NCT04880577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111090974|NCT04880577|Immunologic Factors|immunologic factors|mesh-ancestor
111090975|NCT04880577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111090976|NCT04880577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111090977|NCT04880577|Antiviral Agents|antiviral agents|mesh-ancestor
111090978|NCT04880577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111090979|NCT04880577|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111090980|NCT04880577|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111090981|NCT04880577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111090982|NCT04880577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111090983|NCT04880577|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111090984|NCT04880577|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111090985|NCT04490213|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
111090986|NCT04490213|Laxatives|laxatives|mesh-ancestor
111090987|NCT04490213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111090988|NCT04562597|Acetylcysteine|acetylcysteine|mesh-list
111090989|NCT04562597|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111090990|NCT04562597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111090991|NCT04562597|Antiviral Agents|antiviral agents|mesh-ancestor
111090992|NCT04562597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111090993|NCT04562597|Expectorants|expectorants|mesh-ancestor
111090994|NCT04562597|Respiratory System Agents|respiratory system agents|mesh-ancestor
111090995|NCT04562597|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111090996|NCT04562597|Antioxidants|antioxidants|mesh-ancestor
111090997|NCT04562597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111090998|NCT04562597|Protective Agents|protective agents|mesh-ancestor
111090999|NCT04562597|Antidotes|antidotes|mesh-ancestor
111091000|NCT04504175|Ketamine|ketamine|mesh-list
111091001|NCT04504175|Analgesics|analgesics|mesh-ancestor
111091002|NCT04504175|Sensory System Agents|sensory system agents|mesh-ancestor
111091003|NCT04504175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111091004|NCT04504175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111091005|NCT04504175|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111091006|NCT04504175|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111091007|NCT04504175|Anesthetics, General|anesthetics, general|mesh-ancestor
111091008|NCT04504175|Anesthetics|anesthetics|mesh-ancestor
111091009|NCT04504175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111091010|NCT04504175|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111091011|NCT04504175|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111091012|NCT04504175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111091013|NCT04504175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111091014|NCT05723367|Anesthetics|anesthetics|mesh-list
111091015|NCT05723367|Anesthetics, Local|anesthetics, local|mesh-list
111091016|NCT05723367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111091017|NCT05723367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111091018|NCT05723367|Sensory System Agents|sensory system agents|mesh-ancestor
111091019|NCT05723367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111091020|NCT03853395|Antibodies|antibodies|mesh-list
111091021|NCT03853395|Immunologic Factors|immunologic factors|mesh-ancestor
111091022|NCT03853395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111091023|NCT04433169|Tretinoin|tretinoin|mesh-list
111091024|NCT04433169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111091025|NCT04433169|Keratolytic Agents|keratolytic agents|mesh-ancestor
111091026|NCT04433169|Dermatologic Agents|dermatologic agents|mesh-ancestor
111091027|NCT02717195|Olanzapine|olanzapine|mesh-list
111091028|NCT02717195|Risperidone|risperidone|mesh-list
111091029|NCT02717195|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111091030|NCT02717195|Serotonin Agents|serotonin agents|mesh-ancestor
111091031|NCT02717195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111091032|NCT02717195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111091033|NCT02717195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111091034|NCT02717195|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111091035|NCT02717195|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111091036|NCT02717195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111091037|NCT02717195|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111091038|NCT02717195|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111091039|NCT02717195|Dopamine Agents|dopamine agents|mesh-ancestor
111091040|NCT02717195|Antiemetics|antiemetics|mesh-ancestor
111091041|NCT02717195|Autonomic Agents|autonomic agents|mesh-ancestor
111091042|NCT02717195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111091043|NCT02717195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111091044|NCT02717195|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111091045|NCT02717195|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111091046|NCT02717195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111091047|NCT05582811|Riociguat|riociguat|mesh-list
111091048|NCT05582811|Enzyme Activators|enzyme activators|mesh-ancestor
111091049|NCT05582811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111091050|NCT05582031|Tislelizumab|tislelizumab|mesh-list
111091051|NCT05582031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111091052|NCT05582031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111091053|NCT04424225|Niacin|niacin|mesh-list
111091054|NCT04424225|Psilocybin|psilocybin|mesh-list
111091055|NCT04424225|Vitamins|vitamins|mesh-ancestor
111091056|NCT04424225|Micronutrients|micronutrients|mesh-ancestor
111091057|NCT04424225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111091058|NCT04424225|Vitamin B Complex|vitamin b complex|mesh-ancestor
111091059|NCT04424225|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111091060|NCT04424225|Antimetabolites|antimetabolites|mesh-ancestor
111091061|NCT04424225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111091062|NCT04424225|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111091063|NCT04424225|Vasodilator Agents|vasodilator agents|mesh-ancestor
111091064|NCT04424225|Hallucinogens|hallucinogens|mesh-ancestor
111091065|NCT04424225|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111091066|NCT05581719|Nivolumab|nivolumab|mesh-list
111091067|NCT05581719|Tislelizumab|tislelizumab|mesh-list
111091068|NCT05581719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111091069|NCT05581719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111091070|NCT05581719|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111091071|NCT05581719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111091072|NCT05626101|Gemcitabine|gemcitabine|mesh-list
111091073|NCT05626101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111091074|NCT05626101|Antimetabolites|antimetabolites|mesh-ancestor
111091075|NCT05626101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111091076|NCT05626101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111091077|NCT02465801|Lenograstim|lenograstim|mesh-list
111091078|NCT02465801|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111091079|NCT02465801|Immunologic Factors|immunologic factors|mesh-ancestor
111091080|NCT02465801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111091081|NCT02465645|Carvedilol|carvedilol|mesh-list
111091082|NCT02465645|Simvastatin|simvastatin|mesh-list
111091083|NCT02465645|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111091084|NCT02465645|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111091085|NCT02465645|Antimetabolites|antimetabolites|mesh-ancestor
111091086|NCT02465645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111091087|NCT02465645|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111091088|NCT02465645|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111091089|NCT02465645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111091090|NCT02465645|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111091091|NCT02465645|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111091092|NCT02465645|Adrenergic Agents|adrenergic agents|mesh-ancestor
111091093|NCT02465645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111091094|NCT02465645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111091095|NCT02465645|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111091096|NCT02465645|Antioxidants|antioxidants|mesh-ancestor
111091097|NCT02465645|Protective Agents|protective agents|mesh-ancestor
111091098|NCT02465645|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111091099|NCT02465645|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111091100|NCT02465645|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111091101|NCT02465645|Vasodilator Agents|vasodilator agents|mesh-ancestor
111091102|NCT02465645|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111091103|NCT02465645|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111091105|NCT04872257|Vitamins|vitamins|mesh-ancestor
111091106|NCT04872257|Micronutrients|micronutrients|mesh-ancestor
111091107|NCT04872257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111091108|NCT04872257|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111091109|NCT04970121|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
111091110|NCT04970121|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111091111|NCT04970121|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111091112|NCT04970121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111091113|NCT04970121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111091114|NCT04970121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111091115|NCT04970121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111091116|NCT04970121|Analgesics|analgesics|mesh-ancestor
111091117|NCT04970121|Sensory System Agents|sensory system agents|mesh-ancestor
111091118|NCT04970121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111091119|NCT04970121|Antidepressive Agents|antidepressive agents|mesh-ancestor
111091120|NCT04970121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111091121|NCT04970121|Dopamine Agents|dopamine agents|mesh-ancestor
111091122|NCT02463929|Diphenhydramine|diphenhydramine|mesh-list
110808249|NCT02205892|Lupeol|lupeol|mesh-list
111091123|NCT02463929|Promethazine|promethazine|mesh-list
111091124|NCT02463929|Ketamine|ketamine|mesh-list
111091125|NCT02463929|Bupivacaine|bupivacaine|mesh-list
111091126|NCT02463929|Sevoflurane|sevoflurane|mesh-list
111091127|NCT02463929|Anesthetics, Local|anesthetics, local|mesh-ancestor
111091128|NCT02463929|Anesthetics|anesthetics|mesh-ancestor
111091129|NCT02463929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111091130|NCT02463929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111091131|NCT02463929|Sensory System Agents|sensory system agents|mesh-ancestor
111091132|NCT02463929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111091133|NCT02463929|Analgesics|analgesics|mesh-ancestor
111091134|NCT02463929|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111091135|NCT02463929|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111091136|NCT02463929|Anesthetics, General|anesthetics, general|mesh-ancestor
111091137|NCT02463929|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111091138|NCT02463929|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111091139|NCT02463929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111091140|NCT02463929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111091141|NCT02463929|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111091142|NCT02463929|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111091143|NCT02463929|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111091144|NCT02463929|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111091145|NCT02463929|Antiemetics|antiemetics|mesh-ancestor
111091146|NCT02463929|Autonomic Agents|autonomic agents|mesh-ancestor
111091147|NCT02463929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111091148|NCT02463929|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111091149|NCT02463929|Histamine Antagonists|histamine antagonists|mesh-ancestor
111091150|NCT02463929|Histamine Agents|histamine agents|mesh-ancestor
111091151|NCT02463929|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111091152|NCT02463929|Antipruritics|antipruritics|mesh-ancestor
111091153|NCT02463929|Dermatologic Agents|dermatologic agents|mesh-ancestor
111091154|NCT02465255|Acetaminophen|acetaminophen|mesh-list
111091155|NCT02465255|Ketorolac|ketorolac|mesh-list
111091156|NCT02465255|Tramadol|tramadol|mesh-list
111091157|NCT02465255|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111091158|NCT02465255|Analgesics|analgesics|mesh-ancestor
111091159|NCT02465255|Sensory System Agents|sensory system agents|mesh-ancestor
111091160|NCT02465255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111091161|NCT02465255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111091162|NCT02465255|Antipyretics|antipyretics|mesh-ancestor
111091163|NCT02465255|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111091164|NCT02465255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111091165|NCT02465255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111091166|NCT02465255|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111091167|NCT02465255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111091168|NCT02465255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111091169|NCT02465255|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111091170|NCT02465255|Narcotics|narcotics|mesh-ancestor
111091171|NCT02465255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111091172|NCT02464709|Aminolevulinic Acid|aminolevulinic acid|mesh-list
111091173|NCT02464709|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
111091174|NCT02464709|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111091175|NCT02464709|Dermatologic Agents|dermatologic agents|mesh-ancestor
111091176|NCT02462915|Lidocaine|lidocaine|mesh-list
111091177|NCT02462915|Fentanyl|fentanyl|mesh-list
111091178|NCT02462915|Propofol|propofol|mesh-list
111091179|NCT02462915|Cisatracurium|cisatracurium|mesh-list
111091180|NCT02462915|Anesthetics, Local|anesthetics, local|mesh-ancestor
111091181|NCT02462915|Anesthetics|anesthetics|mesh-ancestor
111091182|NCT02462915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111091183|NCT02462915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111091184|NCT02462915|Sensory System Agents|sensory system agents|mesh-ancestor
111091185|NCT02462915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111091186|NCT02462915|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111091187|NCT02462915|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111091188|NCT02462915|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111091189|NCT02462915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111091190|NCT02462915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111091191|NCT02462915|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111091192|NCT02462915|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111091193|NCT02462915|Anesthetics, General|anesthetics, general|mesh-ancestor
111091194|NCT02462915|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111091195|NCT02462915|Narcotics|narcotics|mesh-ancestor
111091196|NCT02462915|Analgesics|analgesics|mesh-ancestor
111091197|NCT02462915|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111091198|NCT02462915|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
111091199|NCT02462915|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111091200|NCT05505123|Propofol|propofol|mesh-list
111091201|NCT05505123|Sevoflurane|sevoflurane|mesh-list
111091202|NCT05505123|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111091203|NCT05505123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111091204|NCT05505123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111091205|NCT05505123|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111091206|NCT05505123|Anesthetics, General|anesthetics, general|mesh-ancestor
111091207|NCT05505123|Anesthetics|anesthetics|mesh-ancestor
111091208|NCT05505123|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111091209|NCT05505123|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111091210|NCT02462525|Dexamethasone|dexamethasone|mesh-list
111091211|NCT02462525|Pomalidomide|pomalidomide|mesh-list
111091212|NCT02462525|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111091213|NCT02462525|Antiemetics|antiemetics|mesh-ancestor
111091214|NCT02462525|Autonomic Agents|autonomic agents|mesh-ancestor
111091215|NCT02462525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111091216|NCT02462525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111091217|NCT02462525|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111091218|NCT02462525|Glucocorticoids|glucocorticoids|mesh-ancestor
111091219|NCT02462525|Hormones|hormones|mesh-ancestor
111091220|NCT02462525|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111091221|NCT02462525|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111091222|NCT02462525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111091223|NCT02462525|Immunologic Factors|immunologic factors|mesh-ancestor
111091224|NCT02462525|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111091225|NCT02462525|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111091226|NCT02462525|Growth Substances|growth substances|mesh-ancestor
111091227|NCT02462525|Growth Inhibitors|growth inhibitors|mesh-ancestor
111091228|NCT04111419|Amlodipine|amlodipine|mesh-list
111091229|NCT04111419|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
111091230|NCT04111419|Atorvastatin|atorvastatin|mesh-list
111091231|NCT04111419|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111091232|NCT04111419|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111091233|NCT04111419|Antimetabolites|antimetabolites|mesh-ancestor
111091234|NCT04111419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111091235|NCT04111419|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111091236|NCT04111419|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111091237|NCT04111419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111091238|NCT04111419|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111091239|NCT04111419|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111091240|NCT04111419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111091241|NCT04111419|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111091242|NCT04111419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111091243|NCT04111419|Vasodilator Agents|vasodilator agents|mesh-ancestor
111091244|NCT02462447|Choline|choline|mesh-list
111091245|NCT02462447|Lipotropic Agents|lipotropic agents|mesh-ancestor
111091246|NCT02462447|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111091247|NCT02462447|Antimetabolites|antimetabolites|mesh-ancestor
111091248|NCT02462447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111091249|NCT02462447|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111091250|NCT02462447|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111091251|NCT02462447|Nootropic Agents|nootropic agents|mesh-ancestor
111091253|NCT02462681|Analgesics|analgesics|mesh-ancestor
111091254|NCT02462681|Sensory System Agents|sensory system agents|mesh-ancestor
111091255|NCT02462681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111091256|NCT02462681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111091257|NCT02462681|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111091258|NCT02462681|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111091259|NCT02462681|Anesthetics, General|anesthetics, general|mesh-ancestor
111091260|NCT02462681|Anesthetics|anesthetics|mesh-ancestor
111091261|NCT02462681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111091262|NCT02462681|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111091263|NCT02462681|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111091264|NCT02462681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111091265|NCT02462681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111091266|NCT04129151|Palbociclib|palbociclib|mesh-list
111091267|NCT04129151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111091268|NCT04129151|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111091269|NCT04129151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111091270|NCT04129151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111091271|NCT02462369|Glimepiride|glimepiride|mesh-list
111091272|NCT02462369|Saxagliptin|saxagliptin|mesh-list
111091273|NCT02462369|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111091274|NCT02462369|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111091275|NCT02462369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111091276|NCT02462369|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111091277|NCT02462369|Immunologic Factors|immunologic factors|mesh-ancestor
111091278|NCT02462369|Incretins|incretins|mesh-ancestor
111091280|NCT02462369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111091281|NCT02462369|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111091282|NCT02462369|Protease Inhibitors|protease inhibitors|mesh-ancestor
111091283|NCT02462369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111091284|NCT02462369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111091285|NCT04072835|Etripamil|etripamil|mesh-list
111091286|NCT04072835|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111091287|NCT04072835|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111091288|NCT04072835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111091289|NCT04072835|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111091290|NCT04072835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111091291|NCT04083963|Paclitaxel|paclitaxel|mesh-list
111091292|NCT04083963|Cyclophosphamide|cyclophosphamide|mesh-list
111091293|NCT04083963|Carboplatin|carboplatin|mesh-list
111091294|NCT04083963|Doxorubicin|doxorubicin|mesh-list
111091295|NCT04083963|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111091296|NCT04083963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111091297|NCT04083963|Tubulin Modulators|tubulin modulators|mesh-ancestor
111091298|NCT04083963|Antimitotic Agents|antimitotic agents|mesh-ancestor
111091299|NCT04083963|Mitosis Modulators|mitosis modulators|mesh-ancestor
111091300|NCT04083963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111091301|NCT04083963|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111091302|NCT04083963|Immunologic Factors|immunologic factors|mesh-ancestor
111091303|NCT04083963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111091304|NCT04083963|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111091305|NCT04083963|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111091306|NCT04083963|Alkylating Agents|alkylating agents|mesh-ancestor
111091307|NCT04083963|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111091308|NCT04083963|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111091309|NCT04083963|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111091310|NCT04083963|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111091311|NCT04083963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111091312|NCT02463383|Ibuprofen|ibuprofen|mesh-list
111091313|NCT02463383|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111091314|NCT02463383|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111091315|NCT02463383|Analgesics|analgesics|mesh-ancestor
111091316|NCT02463383|Sensory System Agents|sensory system agents|mesh-ancestor
111091317|NCT02463383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110641366|NCT01019278|Cisplatin|cisplatin|mesh-list
111091318|NCT02463383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111091319|NCT02463383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111091320|NCT02463383|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111091321|NCT02463383|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111091322|NCT02463383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111091323|NCT02463383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111091324|NCT03433469|Osimertinib|osimertinib|mesh-list
111091325|NCT03433469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111091326|NCT03433469|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111091327|NCT03433469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111091328|NCT03433469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111091329|NCT03108365|Hemostatics|hemostatics|mesh-list
111091330|NCT03108365|Chitosan|chitosan|mesh-list
111091331|NCT03108365|Coagulants|coagulants|mesh-ancestor
111091332|NCT03108365|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111091333|NCT03108365|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111091334|NCT03108365|Antimetabolites|antimetabolites|mesh-ancestor
111091335|NCT03108365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111091336|NCT03108365|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111091337|NCT03108365|Chelating Agents|chelating agents|mesh-ancestor
111091338|NCT03108365|Sequestering Agents|sequestering agents|mesh-ancestor
111091339|NCT05345457|Amoxicillin|amoxicillin|mesh-list
111091340|NCT05345457|Azithromycin|azithromycin|mesh-list
111091341|NCT05345457|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111091342|NCT05345457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111091343|NCT03922139|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111091344|NCT03922139|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111091345|NCT03922139|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111091346|NCT03922139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111091347|NCT03922139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111091348|NCT03922139|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111091349|NCT03922139|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111091350|NCT03922139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111091351|NCT03922139|Cholinergic Agents|cholinergic agents|mesh-ancestor
111091352|NCT03922139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111091353|NCT04729179|Cannabidiol|cannabidiol|mesh-list
111091354|NCT04729179|Anticonvulsants|anticonvulsants|mesh-ancestor
111091355|NCT04706715|Cemiplimab|cemiplimab|mesh-list
111091356|NCT04706715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111091357|NCT04706715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111091358|NCT03064191|Calcium, Dietary|calcium, dietary|mesh-list
111091359|NCT03064191|Chlorhexidine|chlorhexidine|mesh-list
111091360|NCT03064191|Calcium|calcium|mesh-list
111091361|NCT03064191|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111091362|NCT03064191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111091363|NCT03064191|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111091364|NCT03064191|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111091365|NCT03064191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111091366|NCT03064191|Disinfectants|disinfectants|mesh-ancestor
111091367|NCT02629965|Tiotropium Bromide|tiotropium bromide|mesh-list
111091368|NCT02629965|Olodaterol|olodaterol|mesh-list
111091369|NCT02629965|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111091370|NCT02629965|Autonomic Agents|autonomic agents|mesh-ancestor
111091371|NCT02629965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111091372|NCT02629965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111091373|NCT02629965|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111091374|NCT02629965|Respiratory System Agents|respiratory system agents|mesh-ancestor
111091375|NCT02629965|Parasympatholytics|parasympatholytics|mesh-ancestor
111091376|NCT02629965|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111091377|NCT02629965|Cholinergic Agents|cholinergic agents|mesh-ancestor
111091378|NCT02629965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111091379|NCT02629965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111091380|NCT03062787|Triamcinolone|triamcinolone|mesh-list
111091381|NCT03062787|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
111091382|NCT03062787|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
111091383|NCT03062787|Hyaluronic Acid|hyaluronic acid|mesh-list
111091384|NCT03062787|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
111091385|NCT03062787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111091386|NCT03062787|Glucocorticoids|glucocorticoids|mesh-ancestor
111091387|NCT03062787|Hormones|hormones|mesh-ancestor
111091388|NCT03062787|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111091389|NCT03062787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111091390|NCT03062787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111091391|NCT03062787|Immunologic Factors|immunologic factors|mesh-ancestor
111091392|NCT03062787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111091393|NCT03062787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111091394|NCT03062787|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111091395|NCT03062787|Viscosupplements|viscosupplements|mesh-ancestor
111091396|NCT03062787|Protective Agents|protective agents|mesh-ancestor
111091397|NCT04601883|Colchicine|colchicine|mesh-list
111091398|NCT04601883|Gout Suppressants|gout suppressants|mesh-ancestor
111091399|NCT04601883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111091400|NCT04601883|Tubulin Modulators|tubulin modulators|mesh-ancestor
111091401|NCT04601883|Antimitotic Agents|antimitotic agents|mesh-ancestor
111091402|NCT04601883|Mitosis Modulators|mitosis modulators|mesh-ancestor
111091403|NCT04601883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111091404|NCT04601883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111091405|NCT05223075|Lidocaine|lidocaine|mesh-list
111091406|NCT05223075|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
111091407|NCT05223075|Carticaine|carticaine|mesh-list
111091408|NCT05223075|Anesthetics, Local|anesthetics, local|mesh-ancestor
111091409|NCT05223075|Anesthetics|anesthetics|mesh-ancestor
111091410|NCT05223075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111091411|NCT05223075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111091412|NCT05223075|Sensory System Agents|sensory system agents|mesh-ancestor
111091413|NCT05223075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111091414|NCT05223075|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111091415|NCT05223075|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111091416|NCT05223075|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111091417|NCT05223075|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111091418|NCT05223075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111091419|NCT03719313|Interferons|interferons|mesh-list
111091420|NCT03719313|Ritonavir|ritonavir|mesh-list
111091421|NCT03719313|Interferon-alpha|interferon-alpha|mesh-list
111091422|NCT03719313|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
111091423|NCT03719313|Interferon alpha-2|interferon alpha-2|mesh-list
111091424|NCT03719313|Lonafarnib|lonafarnib|mesh-list
111091425|NCT03719313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111091426|NCT03719313|Antiviral Agents|antiviral agents|mesh-ancestor
111091427|NCT03719313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111091428|NCT03719313|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111091429|NCT03719313|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111091430|NCT03719313|Protease Inhibitors|protease inhibitors|mesh-ancestor
111091431|NCT03719313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111091432|NCT03719313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111091433|NCT03719313|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111091434|NCT03719313|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111091435|NCT03719313|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111091436|NCT03719313|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111091437|NCT03719313|Immunologic Factors|immunologic factors|mesh-ancestor
111091438|NCT03719313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111091439|NCT03063879|Sofosbuvir|sofosbuvir|mesh-list
111091440|NCT03063879|Antiviral Agents|antiviral agents|mesh-ancestor
111091441|NCT03063879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111091442|NCT03063723|Sofosbuvir|sofosbuvir|mesh-list
111091443|NCT03063723|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
111091444|NCT03063723|Ledipasvir|ledipasvir|mesh-list
111091445|NCT03063723|Antiviral Agents|antiviral agents|mesh-ancestor
111091446|NCT03063723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111091447|NCT04338321|Quetiapine Fumarate|quetiapine fumarate|mesh-list
111091448|NCT04338321|Esketamine|esketamine|mesh-list
111091449|NCT04338321|Antidepressive Agents|antidepressive agents|mesh-ancestor
111091450|NCT04338321|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111091451|NCT04338321|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111091452|NCT04338321|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111091453|NCT04338321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111091454|NCT04338321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111091455|NCT00379041|Prednisone|prednisone|mesh-list
111091456|NCT00379041|Doxorubicin|doxorubicin|mesh-list
111091457|NCT00379041|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111091458|NCT00379041|Bleomycin|bleomycin|mesh-list
111091459|NCT00379041|Vincristine|vincristine|mesh-list
111091460|NCT00379041|Vinblastine|vinblastine|mesh-list
111091461|NCT00379041|Procarbazine|procarbazine|mesh-list
111091462|NCT00379041|Mechlorethamine|mechlorethamine|mesh-list
111091463|NCT00379041|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111091464|NCT00379041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111091465|NCT00379041|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111091466|NCT00379041|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111091467|NCT00379041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111091468|NCT00379041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111091469|NCT00379041|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111091470|NCT00379041|Glucocorticoids|glucocorticoids|mesh-ancestor
111091472|NCT00379041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111091473|NCT00379041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111091474|NCT00379041|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111091475|NCT00379041|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111091476|NCT00379041|Tubulin Modulators|tubulin modulators|mesh-ancestor
111091477|NCT00379041|Antimitotic Agents|antimitotic agents|mesh-ancestor
111091478|NCT00379041|Mitosis Modulators|mitosis modulators|mesh-ancestor
111091479|NCT00379041|Alkylating Agents|alkylating agents|mesh-ancestor
111091480|NCT00379041|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111091481|NCT03063489|Loteprednol Etabonate|loteprednol etabonate|mesh-list
111091482|NCT03063489|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111091483|NCT03305445|Nivolumab|nivolumab|mesh-list
111091484|NCT03305445|Ipilimumab|ipilimumab|mesh-list
111091485|NCT03305445|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111091486|NCT03305445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111091487|NCT03305445|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111091488|NCT03305445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111091489|NCT04436913|Fluorides|fluorides|mesh-list
111091490|NCT04436913|Fluorides, Topical|fluorides, topical|mesh-list
111091491|NCT04436913|Cariostatic Agents|cariostatic agents|mesh-ancestor
111091492|NCT04436913|Protective Agents|protective agents|mesh-ancestor
111091493|NCT04436913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111091494|NCT02487095|Topotecan|topotecan|mesh-list
111091495|NCT02487095|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111091496|NCT02487095|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111091497|NCT02487095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111091498|NCT02487095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111091499|NCT02487095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111091500|NCT03756077|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
111091501|NCT03756077|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111091502|NCT03756077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111091504|NCT03742193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111091505|NCT03742193|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111091506|NCT03742193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111091507|NCT03742193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111091508|NCT03108287|Amoxicillin|amoxicillin|mesh-list
111091509|NCT03108287|Clarithromycin|clarithromycin|mesh-list
111091510|NCT03108287|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
111091511|NCT03108287|Rabeprazole|rabeprazole|mesh-list
111091512|NCT03108287|Bismuth|bismuth|mesh-list
111091513|NCT03108287|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111091514|NCT03108287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111091515|NCT03108287|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111091516|NCT03108287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111091517|NCT03108287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111091518|NCT03108287|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111091519|NCT03108287|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111091520|NCT03108287|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111091521|NCT03108287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111091522|NCT03108287|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111091523|NCT03108287|Antacids|antacids|mesh-ancestor
111091524|NCT02461121|Cyclosporine|cyclosporine|mesh-list
111091525|NCT02461121|Mycophenolic Acid|mycophenolic acid|mesh-list
111091526|NCT02461121|Cyclophosphamide|cyclophosphamide|mesh-list
111091527|NCT02461121|Fludarabine|fludarabine|mesh-list
111091528|NCT02461121|Cyclosporins|cyclosporins|mesh-list
111091529|NCT02461121|Antilymphocyte Serum|antilymphocyte serum|mesh-list
111091530|NCT02461121|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111091531|NCT02461121|Immunologic Factors|immunologic factors|mesh-ancestor
111091532|NCT02461121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111091533|NCT02461121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111091534|NCT02461121|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111091535|NCT02461121|Alkylating Agents|alkylating agents|mesh-ancestor
111091536|NCT02461121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111091537|NCT02461121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111091538|NCT02461121|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111091539|NCT02461121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111091540|NCT02461121|Antifungal Agents|antifungal agents|mesh-ancestor
111091541|NCT02461121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111091542|NCT02461121|Dermatologic Agents|dermatologic agents|mesh-ancestor
111091543|NCT02461121|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111091544|NCT02461121|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110556646|NCT04060888|Ustekinumab|ustekinumab|mesh-list
111091545|NCT02461121|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111091546|NCT02461121|Antitubercular Agents|antitubercular agents|mesh-ancestor
111091547|NCT02461121|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111091549|NCT00701363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111091550|NCT02461043|Paclitaxel|paclitaxel|mesh-list
111091551|NCT02461043|Cisplatin|cisplatin|mesh-list
111091552|NCT02461043|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111091553|NCT02461043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111091554|NCT02461043|Tubulin Modulators|tubulin modulators|mesh-ancestor
111091555|NCT02461043|Antimitotic Agents|antimitotic agents|mesh-ancestor
111091556|NCT02461043|Mitosis Modulators|mitosis modulators|mesh-ancestor
111091557|NCT02461043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111091558|NCT03296657|Fluorides|fluorides|mesh-list
111091559|NCT03296657|Tin Fluorides|tin fluorides|mesh-list
111091560|NCT03296657|Cariostatic Agents|cariostatic agents|mesh-ancestor
111091561|NCT03296657|Protective Agents|protective agents|mesh-ancestor
111091562|NCT03296657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111091563|NCT03296579|Magnesium Sulfate|magnesium sulfate|mesh-list
111091564|NCT03296579|Aminophylline|aminophylline|mesh-list
111091565|NCT03296579|Albuterol|albuterol|mesh-list
111091566|NCT03296579|Ipratropium|ipratropium|mesh-list
111091567|NCT03296579|Analgesics|analgesics|mesh-ancestor
111091568|NCT03296579|Sensory System Agents|sensory system agents|mesh-ancestor
111091569|NCT03296579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111091570|NCT03296579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111091571|NCT03296579|Anesthetics|anesthetics|mesh-ancestor
111091572|NCT03296579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111091573|NCT03296579|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111091574|NCT03296579|Anticonvulsants|anticonvulsants|mesh-ancestor
111091575|NCT03296579|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111091576|NCT03296579|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111091577|NCT03296579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111091578|NCT03296579|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111091579|NCT03296579|Tocolytic Agents|tocolytic agents|mesh-ancestor
111091580|NCT03296579|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111091581|NCT03296579|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111091582|NCT03296579|Autonomic Agents|autonomic agents|mesh-ancestor
111091583|NCT03296579|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111091584|NCT03296579|Respiratory System Agents|respiratory system agents|mesh-ancestor
111091585|NCT03296579|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111091586|NCT03296579|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111091587|NCT03296579|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111091588|NCT03296579|Adrenergic Agents|adrenergic agents|mesh-ancestor
111091589|NCT03296579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111091590|NCT03296579|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111091591|NCT03296579|Cholinergic Agents|cholinergic agents|mesh-ancestor
111091592|NCT03296579|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111091593|NCT03296579|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111091594|NCT03296579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111091595|NCT03296579|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
111091596|NCT03296579|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111091597|NCT03296579|Purinergic Agents|purinergic agents|mesh-ancestor
111091598|NCT03296579|Protective Agents|protective agents|mesh-ancestor
111091599|NCT02461667|Alendronate|alendronate|mesh-list
111091600|NCT02461667|Metformin|metformin|mesh-list
111091601|NCT02461667|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111091602|NCT02461667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111091603|NCT02461667|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111091604|NCT01670877|Trastuzumab|trastuzumab|mesh-list
111091605|NCT01670877|Fulvestrant|fulvestrant|mesh-list
111091606|NCT01670877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111091607|NCT01670877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111091608|NCT01670877|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111091609|NCT01670877|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
111091610|NCT01670877|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111091611|NCT01670877|Hormone Antagonists|hormone antagonists|mesh-ancestor
111091612|NCT01670877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111091613|NCT01670877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111091614|NCT00701129|Rituximab|rituximab|mesh-list
111091615|NCT00701129|Methotrexate|methotrexate|mesh-list
111091616|NCT00701129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111091617|NCT00701129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111091618|NCT00701129|Immunologic Factors|immunologic factors|mesh-ancestor
111091619|NCT00701129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111091620|NCT00701129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111091621|NCT00701129|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111091622|NCT00701129|Abortifacient Agents|abortifacient agents|mesh-ancestor
111091623|NCT00701129|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111091624|NCT00701129|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111091625|NCT00701129|Antimetabolites|antimetabolites|mesh-ancestor
111091626|NCT00701129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111091627|NCT00701129|Dermatologic Agents|dermatologic agents|mesh-ancestor
111091628|NCT00701129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111091629|NCT00701129|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111091630|NCT00701129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111091631|NCT00701129|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111091632|NCT03296189|Dexamethasone|dexamethasone|mesh-list
111091633|NCT03296189|Dexamethasone acetate|dexamethasone acetate|mesh-list
111091634|NCT03296189|Levobupivacaine|levobupivacaine|mesh-list
111091635|NCT03296189|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
111091636|NCT03296189|BB 1101|bb 1101|mesh-list
111091637|NCT03296189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111091638|NCT03296189|Antiemetics|antiemetics|mesh-ancestor
111091639|NCT03296189|Autonomic Agents|autonomic agents|mesh-ancestor
111091640|NCT03296189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111091641|NCT03296189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111091642|NCT03296189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111091643|NCT03296189|Glucocorticoids|glucocorticoids|mesh-ancestor
111091644|NCT03296189|Hormones|hormones|mesh-ancestor
111091645|NCT03296189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111091646|NCT03296189|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111091647|NCT03296189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111091648|NCT03296189|Anesthetics, Local|anesthetics, local|mesh-ancestor
111091649|NCT03296189|Anesthetics|anesthetics|mesh-ancestor
111091650|NCT03296189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111091651|NCT03296189|Sensory System Agents|sensory system agents|mesh-ancestor
111091652|NCT03296189|Protease Inhibitors|protease inhibitors|mesh-ancestor
111091653|NCT03296189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111091654|NCT03296189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111091655|NCT03295955|Amoxicillin|amoxicillin|mesh-list
111091656|NCT03295955|Clavulanic Acid|clavulanic acid|mesh-list
111091657|NCT03295955|Clavulanic Acids|clavulanic acids|mesh-list
111091658|NCT03295955|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
111091659|NCT03295955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111091660|NCT03295955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111091661|NCT03295955|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
111091662|NCT03295955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111091663|NCT03295955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111091664|NCT03298373|Nandrolone Decanoate|nandrolone decanoate|mesh-list
111091665|NCT03298373|Nandrolone|nandrolone|mesh-list
111091666|NCT03298373|Nandrolone phenpropionate|nandrolone phenpropionate|mesh-list
111091667|NCT03298373|Androgens|androgens|mesh-ancestor
111091668|NCT03298373|Hormones|hormones|mesh-ancestor
111091669|NCT03298373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111091670|NCT03298373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111091671|NCT03298373|Anabolic Agents|anabolic agents|mesh-ancestor
111091672|NCT03298373|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111091673|NCT01670721|Leucovorin|leucovorin|mesh-list
111091674|NCT01670721|Fluorouracil|fluorouracil|mesh-list
111091675|NCT01670721|Irinotecan|irinotecan|mesh-list
111091676|NCT01670721|Aflibercept|aflibercept|mesh-list
111091677|NCT01670721|Antimetabolites|antimetabolites|mesh-ancestor
111091678|NCT01670721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111091679|NCT01670721|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111091680|NCT01670721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111091681|NCT01670721|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111091682|NCT01670721|Immunologic Factors|immunologic factors|mesh-ancestor
111091683|NCT01670721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111091684|NCT01670721|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111091685|NCT01670721|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111091686|NCT01670721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111091687|NCT01670721|Antidotes|antidotes|mesh-ancestor
111091688|NCT01670721|Protective Agents|protective agents|mesh-ancestor
111091689|NCT01670721|Vitamin B Complex|vitamin b complex|mesh-ancestor
111091690|NCT01670721|Vitamins|vitamins|mesh-ancestor
111091691|NCT01670721|Micronutrients|micronutrients|mesh-ancestor
111091692|NCT01670721|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111091693|NCT01670721|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111091694|NCT01670721|Growth Substances|growth substances|mesh-ancestor
111091695|NCT01670721|Growth Inhibitors|growth inhibitors|mesh-ancestor
111091697|NCT03287427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111091698|NCT03287427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111091699|NCT04491695|Tirofiban|tirofiban|mesh-list
111091700|NCT04491695|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111091701|NCT04491695|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111091702|NCT04491695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111091703|NCT04491695|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111091704|NCT04982055|Nadroparin|nadroparin|mesh-list
111091705|NCT04982055|Anticoagulants|anticoagulants|mesh-ancestor
111091706|NCT04982055|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111091707|NCT04982055|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111091708|NCT04982055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111091709|NCT04981743|Vitamin D|vitamin d|mesh-list
111091710|NCT04981743|Vitamins|vitamins|mesh-ancestor
111091711|NCT04981743|Micronutrients|micronutrients|mesh-ancestor
111091712|NCT04981743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111091713|NCT04981743|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111091714|NCT04489121|Omalizumab|omalizumab|mesh-list
111091715|NCT04489121|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111091716|NCT04489121|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111091717|NCT04489121|Respiratory System Agents|respiratory system agents|mesh-ancestor
111091718|NCT04973787|Antirheumatic Agents|antirheumatic agents|mesh-list
111091719|NCT04982211|Propranolol|propranolol|mesh-list
111091720|NCT04982211|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111091721|NCT04982211|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111091722|NCT04982211|Adrenergic Agents|adrenergic agents|mesh-ancestor
111091723|NCT04982211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111091724|NCT04982211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111091725|NCT04982211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111091726|NCT04982211|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111091727|NCT04982211|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111091728|NCT04982211|Vasodilator Agents|vasodilator agents|mesh-ancestor
111091729|NCT03290963|Ketamine|ketamine|mesh-list
111091730|NCT03290963|Analgesics|analgesics|mesh-ancestor
111091731|NCT03290963|Sensory System Agents|sensory system agents|mesh-ancestor
111091732|NCT03290963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111091733|NCT03290963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111091734|NCT03290963|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111091735|NCT03290963|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111091736|NCT03290963|Anesthetics, General|anesthetics, general|mesh-ancestor
111091737|NCT03290963|Anesthetics|anesthetics|mesh-ancestor
111091738|NCT03290963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111091739|NCT03290963|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111091740|NCT03290963|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111091741|NCT03290963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111091742|NCT03290963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111091743|NCT03294707|Coal Tar|coal tar|mesh-list
111091744|NCT03294707|Keratolytic Agents|keratolytic agents|mesh-ancestor
111091745|NCT03294707|Dermatologic Agents|dermatologic agents|mesh-ancestor
111091746|NCT03062319|Anticoagulants|anticoagulants|mesh-list
111091747|NCT03062319|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
111091748|NCT03290495|Ketamine|ketamine|mesh-list
111091749|NCT03290495|Analgesics|analgesics|mesh-ancestor
111091750|NCT03290495|Sensory System Agents|sensory system agents|mesh-ancestor
111091751|NCT03290495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111091752|NCT03290495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111091753|NCT03290495|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111091754|NCT03290495|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111091755|NCT03290495|Anesthetics, General|anesthetics, general|mesh-ancestor
111091756|NCT03290495|Anesthetics|anesthetics|mesh-ancestor
111091757|NCT03290495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111091758|NCT03290495|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111091759|NCT03290495|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111091760|NCT03290495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111091761|NCT03290495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111091762|NCT04429893|Magnesium Sulfate|magnesium sulfate|mesh-list
111091763|NCT04429893|Bupivacaine|bupivacaine|mesh-list
111091764|NCT04429893|Anesthetics, Local|anesthetics, local|mesh-ancestor
111091765|NCT04429893|Anesthetics|anesthetics|mesh-ancestor
111091766|NCT04429893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111091767|NCT04429893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111091768|NCT04429893|Sensory System Agents|sensory system agents|mesh-ancestor
111091769|NCT04429893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111091770|NCT04429893|Analgesics|analgesics|mesh-ancestor
111091771|NCT04429893|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111091772|NCT04429893|Anticonvulsants|anticonvulsants|mesh-ancestor
111091773|NCT04429893|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111091774|NCT04429893|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111091775|NCT04429893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111091776|NCT04429893|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111091777|NCT04429893|Tocolytic Agents|tocolytic agents|mesh-ancestor
111091778|NCT04429893|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111091779|NCT03290417|Vitamin D|vitamin d|mesh-list
111091780|NCT03290417|Ergocalciferols|ergocalciferols|mesh-list
111091781|NCT03290417|Cholecalciferol|cholecalciferol|mesh-list
111091782|NCT03290417|Vitamins|vitamins|mesh-list
111091783|NCT03290417|Curcumin|curcumin|mesh-list
111091784|NCT03290417|Turmeric extract|turmeric extract|mesh-list
111091785|NCT03290417|Micronutrients|micronutrients|mesh-ancestor
111091786|NCT03290417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111091787|NCT03290417|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111091788|NCT03290417|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111091789|NCT03290417|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111091790|NCT03290417|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111091791|NCT03290417|Analgesics|analgesics|mesh-ancestor
111091792|NCT03290417|Sensory System Agents|sensory system agents|mesh-ancestor
111091793|NCT03290417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111091794|NCT03290417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111091795|NCT03290417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111091796|NCT03290417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111091797|NCT03290417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111091798|NCT03290417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111091799|NCT03290417|Antioxidants|antioxidants|mesh-ancestor
111091800|NCT03290417|Protective Agents|protective agents|mesh-ancestor
111091801|NCT04429347|Gabapentin|gabapentin|mesh-list
111091802|NCT04429347|Tizanidine|tizanidine|mesh-list
111091803|NCT04429347|Analgesics|analgesics|mesh-ancestor
111091804|NCT04429347|Sensory System Agents|sensory system agents|mesh-ancestor
110808912|NCT01085981|Niacin|niacin|mesh-list
111091805|NCT04429347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111091806|NCT04429347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111091808|NCT04429347|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111091809|NCT04429347|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111091810|NCT04429347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111091811|NCT04429347|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111091812|NCT04429347|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111091813|NCT04429347|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111091814|NCT04429347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111091815|NCT04429347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111091816|NCT04429347|Antimanic Agents|antimanic agents|mesh-ancestor
111091817|NCT04429347|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
111091818|NCT04429347|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111091819|NCT04429347|Parasympatholytics|parasympatholytics|mesh-ancestor
111091820|NCT04429347|Autonomic Agents|autonomic agents|mesh-ancestor
111091821|NCT04429347|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111091822|NCT04429347|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111091823|NCT04429347|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111091824|NCT04429347|Adrenergic Agents|adrenergic agents|mesh-ancestor
111091825|NCT03294551|Vaccines|vaccines|mesh-list
111091826|NCT03294551|Immunologic Factors|immunologic factors|mesh-ancestor
111091827|NCT03294551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111091828|NCT04156581|Dexamethasone|dexamethasone|mesh-list
111091829|NCT04156581|Bupivacaine|bupivacaine|mesh-list
111091830|NCT04156581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111091831|NCT04156581|Antiemetics|antiemetics|mesh-ancestor
111091832|NCT04156581|Autonomic Agents|autonomic agents|mesh-ancestor
111091833|NCT04156581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111091834|NCT04156581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111091835|NCT04156581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111091836|NCT04156581|Glucocorticoids|glucocorticoids|mesh-ancestor
111091837|NCT04156581|Hormones|hormones|mesh-ancestor
111091838|NCT04156581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111091839|NCT04156581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111091840|NCT04156581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111091841|NCT04156581|Anesthetics, Local|anesthetics, local|mesh-ancestor
111091842|NCT04156581|Anesthetics|anesthetics|mesh-ancestor
111091843|NCT04156581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111091844|NCT04156581|Sensory System Agents|sensory system agents|mesh-ancestor
111091845|NCT02983071|Fulvestrant|fulvestrant|mesh-list
111091846|NCT02983071|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111091847|NCT02983071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111091848|NCT02983071|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
111091849|NCT02983071|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111091850|NCT02983071|Hormone Antagonists|hormone antagonists|mesh-ancestor
110641423|NCT01019590|Olmesartan|olmesartan|mesh-list
111091851|NCT02983071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111091852|NCT02983071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111091853|NCT03294395|Gentamicins|gentamicins|mesh-list
111091854|NCT03294395|Ceftriaxone|ceftriaxone|mesh-list
111091855|NCT03294395|Ertapenem|ertapenem|mesh-list
111091856|NCT03294395|Fosfomycin|fosfomycin|mesh-list
111091857|NCT03294395|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111091858|NCT03294395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111091859|NCT03294395|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111091860|NCT03294395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111091861|NCT03294395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111091862|NCT04980105|Methylprednisolone|methylprednisolone|mesh-list
111091863|NCT04980105|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111091864|NCT04980105|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111091865|NCT04980105|Prednisolone|prednisolone|mesh-list
111091866|NCT04980105|Prednisolone acetate|prednisolone acetate|mesh-list
111091867|NCT04980105|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111091868|NCT04980105|Prednisolone phosphate|prednisolone phosphate|mesh-list
111091869|NCT04980105|Hyaluronic Acid|hyaluronic acid|mesh-list
111091870|NCT04980105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111091871|NCT04980105|Antiemetics|antiemetics|mesh-ancestor
111091872|NCT04980105|Autonomic Agents|autonomic agents|mesh-ancestor
111091873|NCT04980105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111091874|NCT04980105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111091875|NCT04980105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111091876|NCT04980105|Glucocorticoids|glucocorticoids|mesh-ancestor
111091877|NCT04980105|Hormones|hormones|mesh-ancestor
111091878|NCT04980105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111091879|NCT04980105|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111091881|NCT04980105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111091882|NCT04980105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111091883|NCT04980105|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111091884|NCT04980105|Immunologic Factors|immunologic factors|mesh-ancestor
111091885|NCT04980105|Viscosupplements|viscosupplements|mesh-ancestor
111091886|NCT04973319|Trastuzumab|trastuzumab|mesh-list
111091887|NCT04973319|Pertuzumab|pertuzumab|mesh-list
111091888|NCT04973319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111091889|NCT04973319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111091890|NCT03294161|Meglumine Antimoniate|meglumine antimoniate|mesh-list
111091891|NCT03294161|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111091892|NCT03294161|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111091893|NCT03294161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111091894|NCT03289871|Amorolfine|amorolfine|mesh-list
111091895|NCT03289871|Antifungal Agents|antifungal agents|mesh-ancestor
111091896|NCT03289871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111091897|NCT03289637|Vitamin D|vitamin d|mesh-list
111091898|NCT03289637|Vitamins|vitamins|mesh-ancestor
111091899|NCT03289637|Micronutrients|micronutrients|mesh-ancestor
111091900|NCT03289637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111091901|NCT03289637|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111091902|NCT04854837|Remdesivir|remdesivir|mesh-list
111091903|NCT04854837|Antimetabolites|antimetabolites|mesh-ancestor
111091904|NCT04854837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111091905|NCT04854837|Antiviral Agents|antiviral agents|mesh-ancestor
111091906|NCT04854837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111091907|NCT03289559|Testosterone|testosterone|mesh-list
111091908|NCT03289559|Aromatase Inhibitors|aromatase inhibitors|mesh-list
111091909|NCT03289559|Androgens|androgens|mesh-ancestor
111091910|NCT03289559|Hormones|hormones|mesh-ancestor
111091911|NCT03289559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111091912|NCT03289559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111091913|NCT03289559|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111091914|NCT03289559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111091915|NCT03289559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111091916|NCT03289559|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111091917|NCT03289559|Hormone Antagonists|hormone antagonists|mesh-ancestor
111091918|NCT03293927|Fentanyl|fentanyl|mesh-list
111091919|NCT03293927|Dexmedetomidine|dexmedetomidine|mesh-list
111091920|NCT03293927|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111091921|NCT03293927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111091922|NCT03293927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111091924|NCT03293927|Analgesics|analgesics|mesh-ancestor
111091925|NCT03293927|Sensory System Agents|sensory system agents|mesh-ancestor
111091926|NCT03293927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111091927|NCT03293927|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111091928|NCT03293927|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111091929|NCT03293927|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111091930|NCT03293927|Adrenergic Agents|adrenergic agents|mesh-ancestor
111091931|NCT03293927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111091932|NCT03293927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111091933|NCT03293927|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111091934|NCT03293927|Narcotics|narcotics|mesh-ancestor
111091935|NCT03293927|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111091936|NCT03293927|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111091937|NCT03293927|Anesthetics, General|anesthetics, general|mesh-ancestor
111091938|NCT03293927|Anesthetics|anesthetics|mesh-ancestor
111091939|NCT02730429|Letrozole|letrozole|mesh-list
111091940|NCT02730429|Palbociclib|palbociclib|mesh-list
111091941|NCT02730429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111091942|NCT02730429|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111091943|NCT02730429|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111091944|NCT02730429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111091945|NCT02730429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111091946|NCT02730429|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111091947|NCT02730429|Hormone Antagonists|hormone antagonists|mesh-ancestor
111091948|NCT02730429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111091949|NCT02730429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111091950|NCT02730429|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111091951|NCT04971759|Fentanyl|fentanyl|mesh-list
111091952|NCT04971759|Dexmedetomidine|dexmedetomidine|mesh-list
111091953|NCT04971759|Levobupivacaine|levobupivacaine|mesh-list
111091954|NCT04971759|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111091955|NCT04971759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111091956|NCT04971759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111091957|NCT04971759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111091958|NCT04971759|Analgesics|analgesics|mesh-ancestor
111091959|NCT04971759|Sensory System Agents|sensory system agents|mesh-ancestor
111091960|NCT04971759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111091961|NCT04971759|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111091962|NCT04971759|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111091963|NCT04971759|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111091964|NCT04971759|Adrenergic Agents|adrenergic agents|mesh-ancestor
111091965|NCT04971759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111091966|NCT04971759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111091967|NCT04971759|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111091968|NCT04971759|Narcotics|narcotics|mesh-ancestor
111091969|NCT04971759|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111091970|NCT04971759|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111091971|NCT04971759|Anesthetics, General|anesthetics, general|mesh-ancestor
111091972|NCT04971759|Anesthetics|anesthetics|mesh-ancestor
111091973|NCT04971759|Anesthetics, Local|anesthetics, local|mesh-ancestor
111091974|NCT03289169|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111091975|NCT03289169|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111091976|NCT03289169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111091977|NCT03289169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111091978|NCT03289169|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110641452|NCT00532155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111091979|NCT03289169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111091980|NCT03289169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111091981|NCT03289169|Cholinergic Agents|cholinergic agents|mesh-ancestor
111091982|NCT03289169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111091983|NCT04979091|Hormones|hormones|mesh-list
111091984|NCT04979091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110677343|NCT01409200|Antioxidants|antioxidants|mesh-ancestor
111091985|NCT04979091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111091987|NCT04971291|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111091988|NCT04971291|Antidepressive Agents|antidepressive agents|mesh-ancestor
111091989|NCT04971291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111091990|NCT04971291|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111091991|NCT04971291|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111091992|NCT04971291|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111091993|NCT04971291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111091994|NCT04971291|Dopamine Agents|dopamine agents|mesh-ancestor
111091995|NCT04971291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111091996|NCT04971291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111091997|NCT04971291|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111091998|NCT04971291|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111091999|NCT04971291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111092000|NCT03107507|Levetiracetam|levetiracetam|mesh-list
111092001|NCT03107507|Phenobarbital|phenobarbital|mesh-list
111092002|NCT03107507|Anticonvulsants|anticonvulsants|mesh-ancestor
111092003|NCT03107507|Nootropic Agents|nootropic agents|mesh-ancestor
111092004|NCT03107507|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111092005|NCT03107507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111092006|NCT03107507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111092007|NCT03107507|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111092008|NCT03107507|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111092009|NCT03107507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111092010|NCT03107507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111092011|NCT03107507|GABA Modulators|gaba modulators|mesh-ancestor
111092012|NCT03107507|GABA Agents|gaba agents|mesh-ancestor
111092013|NCT03107507|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111092014|NCT03107507|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111092015|NCT03107507|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111092016|NCT02711137|Paclitaxel|paclitaxel|mesh-list
111092017|NCT02711137|Gemcitabine|gemcitabine|mesh-list
111092018|NCT02711137|Azacitidine|azacitidine|mesh-list
111092019|NCT02711137|Rucaparib|rucaparib|mesh-list
111092020|NCT02711137|INCB057643|incb057643|mesh-list
111092021|NCT02711137|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111092022|NCT02711137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111092023|NCT02711137|Tubulin Modulators|tubulin modulators|mesh-ancestor
111092024|NCT02711137|Antimitotic Agents|antimitotic agents|mesh-ancestor
111092025|NCT02711137|Mitosis Modulators|mitosis modulators|mesh-ancestor
111092026|NCT02711137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111092027|NCT02711137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111092028|NCT02711137|Antimetabolites|antimetabolites|mesh-ancestor
111092029|NCT02711137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111092030|NCT02711137|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111092031|NCT04155411|Dasatinib|dasatinib|mesh-list
111092032|NCT04155411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111092033|NCT04155411|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111092034|NCT04155411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111092035|NCT04155411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111092036|NCT04970667|Flupenthixol|flupenthixol|mesh-list
111092037|NCT04970667|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
111092038|NCT04970667|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111092039|NCT04970667|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111092040|NCT04970667|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111092041|NCT04970667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111092042|NCT04970667|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111092043|NCT04970667|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111092044|NCT04970667|Dopamine Agents|dopamine agents|mesh-ancestor
111092045|NCT04970667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111092046|NCT04970667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111092047|NCT03288233|Carbon Monoxide|carbon monoxide|mesh-list
111092048|NCT03288233|Antimetabolites|antimetabolites|mesh-ancestor
111092049|NCT03288233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111092050|NCT03288233|Gasotransmitters|gasotransmitters|mesh-ancestor
111092051|NCT03288233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111092052|NCT03288233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111092053|NCT03288077|Tryptophan|tryptophan|mesh-list
111092054|NCT03288077|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111092055|NCT03288077|Antidepressive Agents|antidepressive agents|mesh-ancestor
111092056|NCT03288077|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111092058|NCT00777127|Imiquimod|imiquimod|mesh-list
111092059|NCT00777127|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111092060|NCT00777127|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111092061|NCT00777127|Analgesics|analgesics|mesh-ancestor
111092062|NCT00777127|Sensory System Agents|sensory system agents|mesh-ancestor
111092063|NCT00777127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111092064|NCT00777127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111092065|NCT00777127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111092066|NCT00777127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111092067|NCT00777127|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111092068|NCT00777127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111092069|NCT00777127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111092070|NCT00777127|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111092071|NCT00777127|Immunologic Factors|immunologic factors|mesh-ancestor
111092072|NCT00777127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111092073|NCT00777127|Interferon Inducers|interferon inducers|mesh-ancestor
111092074|NCT00761371|Imiquimod|imiquimod|mesh-list
111092075|NCT00761371|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111092076|NCT00761371|Immunologic Factors|immunologic factors|mesh-ancestor
111092077|NCT00761371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111092078|NCT00761371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111092079|NCT00761371|Interferon Inducers|interferon inducers|mesh-ancestor
111092080|NCT03287921|Bronchodilator Agents|bronchodilator agents|mesh-list
111092081|NCT03287921|Autonomic Agents|autonomic agents|mesh-ancestor
111092082|NCT03287921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111092083|NCT03287921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111092084|NCT03287921|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111092085|NCT03287921|Respiratory System Agents|respiratory system agents|mesh-ancestor
111092086|NCT03287609|Evolocumab|evolocumab|mesh-list
111092087|NCT03287609|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
111092088|NCT03287609|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111092089|NCT03287609|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111092090|NCT03287609|Antimetabolites|antimetabolites|mesh-ancestor
111092091|NCT03287609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111092092|NCT03287609|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111092093|NCT03287609|Protease Inhibitors|protease inhibitors|mesh-ancestor
111092094|NCT03287609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111092095|NCT03287609|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111092096|NCT03291899|Folfirinox|folfirinox|mesh-list
111092097|NCT03291899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111092098|NCT03194815|Rituximab|rituximab|mesh-list
111092099|NCT03194815|Immunoglobulins|immunoglobulins|mesh-list
111092100|NCT03194815|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111092101|NCT03194815|Antibodies|antibodies|mesh-list
111092102|NCT03194815|gamma-Globulins|gamma-globulins|mesh-list
111092103|NCT03194815|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
111092104|NCT03194815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111092106|NCT03194815|Immunologic Factors|immunologic factors|mesh-ancestor
111092107|NCT03194815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111092108|NCT03194815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111092109|NCT03291821|Triptorelin Pamoate|triptorelin pamoate|mesh-list
111092110|NCT03291821|Cetrorelix|cetrorelix|mesh-list
111092111|NCT03291821|Menotropins|menotropins|mesh-list
111092112|NCT03291821|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
111092113|NCT03291821|Ganirelix|ganirelix|mesh-list
111092114|NCT03291821|Hormones|hormones|mesh-ancestor
111092115|NCT03291821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111092116|NCT03291821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111092117|NCT03291821|Luteolytic Agents|luteolytic agents|mesh-ancestor
111092118|NCT03291821|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111092119|NCT03291821|Contraceptive Agents|contraceptive agents|mesh-ancestor
111092120|NCT03291821|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111092121|NCT03291821|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111092122|NCT03291821|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111092123|NCT03291821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111092124|NCT03291821|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111092125|NCT03291821|Fertility Agents|fertility agents|mesh-ancestor
111092126|NCT03291821|Hormone Antagonists|hormone antagonists|mesh-ancestor
111092127|NCT02448901|Edoxaban|edoxaban|mesh-list
111092128|NCT02448901|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111092129|NCT02448901|Antithrombins|antithrombins|mesh-ancestor
111092130|NCT02448901|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111092131|NCT02448901|Protease Inhibitors|protease inhibitors|mesh-ancestor
111092132|NCT02448901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110677354|NCT01409200|Hormone Antagonists|hormone antagonists|mesh-ancestor
111092133|NCT02448901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111092134|NCT02448901|Anticoagulants|anticoagulants|mesh-ancestor
111092135|NCT03291353|Pembrolizumab|pembrolizumab|mesh-list
111092136|NCT03291353|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111092137|NCT03291353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111092138|NCT03291353|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111092139|NCT03291353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111092140|NCT02460341|Ondansetron|ondansetron|mesh-list
111092141|NCT02460341|Antiemetics|antiemetics|mesh-ancestor
111092142|NCT02460341|Autonomic Agents|autonomic agents|mesh-ancestor
111092143|NCT02460341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111092144|NCT02460341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111092145|NCT02460341|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111092146|NCT02460341|Antipruritics|antipruritics|mesh-ancestor
111092147|NCT02460341|Dermatologic Agents|dermatologic agents|mesh-ancestor
111092148|NCT02460341|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111092149|NCT02460341|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111092150|NCT02460341|Serotonin Agents|serotonin agents|mesh-ancestor
111092151|NCT02460341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111092152|NCT02460341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111092153|NCT00189319|Flecainide|flecainide|mesh-list
111092154|NCT00189319|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111092155|NCT00189319|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111092156|NCT00189319|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111092157|NCT00189319|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111092158|NCT00189319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111092159|NCT00189241|Imiquimod|imiquimod|mesh-list
111092160|NCT00189241|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111092161|NCT00189241|Immunologic Factors|immunologic factors|mesh-ancestor
111092162|NCT00189241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111092163|NCT00189241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111092164|NCT00189241|Interferon Inducers|interferon inducers|mesh-ancestor
111092165|NCT02460107|Botulinum Toxins|botulinum toxins|mesh-list
111092166|NCT02460107|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111092167|NCT02460107|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111092168|NCT02460107|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111092169|NCT02460107|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111092170|NCT02460107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111092171|NCT02460107|Cholinergic Agents|cholinergic agents|mesh-ancestor
111092172|NCT02460107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111092173|NCT02460107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111092174|NCT02460107|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111092175|NCT02460107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111092176|NCT03286673|Calcium, Dietary|calcium, dietary|mesh-list
111092177|NCT03286673|Calcium Carbonate|calcium carbonate|mesh-list
111092178|NCT03286673|Calcium|calcium|mesh-list
111092179|NCT03286673|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111092181|NCT03286673|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111092182|NCT03286673|Antacids|antacids|mesh-ancestor
111092183|NCT03286673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111092184|NCT03286673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111092185|NCT02448589|TAS-119|tas-119|mesh-list
111092186|NCT02448589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111092187|NCT02448589|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111092188|NCT02448589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111092189|NCT02448589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111092190|NCT02445703|Vaccines|vaccines|mesh-list
111092191|NCT02445703|Immunologic Factors|immunologic factors|mesh-ancestor
111092192|NCT02445703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111092193|NCT03194659|Choline|choline|mesh-list
111092194|NCT03194659|Lipotropic Agents|lipotropic agents|mesh-ancestor
111092195|NCT03194659|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111092196|NCT03194659|Antimetabolites|antimetabolites|mesh-ancestor
111092197|NCT03194659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111092198|NCT03194659|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111092199|NCT03194659|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111092200|NCT03194659|Nootropic Agents|nootropic agents|mesh-ancestor
111092201|NCT02445547|Hormones|hormones|mesh-list
111092202|NCT02445547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111092203|NCT02445547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111092204|NCT03190603|Celecoxib|celecoxib|mesh-list
111092205|NCT03190603|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111092206|NCT03190603|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111092207|NCT03190603|Analgesics|analgesics|mesh-ancestor
111092208|NCT03190603|Sensory System Agents|sensory system agents|mesh-ancestor
111092209|NCT03190603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111092210|NCT03190603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111092211|NCT03190603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111092212|NCT03190603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111092213|NCT03190603|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111092214|NCT03190603|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111092215|NCT03190603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111092216|NCT03190603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111092217|NCT03285503|Aripiprazole|aripiprazole|mesh-list
111092218|NCT03285503|Antidepressive Agents|antidepressive agents|mesh-ancestor
111092219|NCT03285503|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111092220|NCT03285503|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111092221|NCT03285503|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111092222|NCT03285503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111092223|NCT03285503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111092224|NCT03285503|Dopamine Agonists|dopamine agonists|mesh-ancestor
111092225|NCT03285503|Dopamine Agents|dopamine agents|mesh-ancestor
111092226|NCT03285503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111092227|NCT03285503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111092228|NCT03285503|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111092229|NCT03285503|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111092230|NCT03285503|Serotonin Agents|serotonin agents|mesh-ancestor
111092231|NCT03285503|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111092232|NCT03285503|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111092233|NCT03285503|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111092234|NCT03285503|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111092235|NCT02439697|Darbepoetin alfa|darbepoetin alfa|mesh-list
111092236|NCT02439697|Hematinics|hematinics|mesh-ancestor
111092237|NCT03284645|Tenofovir|tenofovir|mesh-list
111092238|NCT03284645|Lamivudine|lamivudine|mesh-list
111092239|NCT03284645|Zidovudine|zidovudine|mesh-list
111092240|NCT03284645|Efavirenz|efavirenz|mesh-list
111092241|NCT03284645|Abacavir|abacavir|mesh-list
111092242|NCT03284645|Antiviral Agents|antiviral agents|mesh-ancestor
111092243|NCT03284645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111092244|NCT03284645|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111092245|NCT03284645|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111092246|NCT03284645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111092247|NCT03284645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111092248|NCT03284645|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111092249|NCT03284645|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111092250|NCT03284645|Antimetabolites|antimetabolites|mesh-ancestor
111092251|NCT03284645|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110809343|NCT01090895|Ascorbic Acid|ascorbic acid|mesh-list
111092252|NCT03284645|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111092253|NCT03284645|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111092254|NCT03284645|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111092255|NCT03284645|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111092256|NCT03284645|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111092257|NCT03190447|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
111092258|NCT03190447|Laxatives|laxatives|mesh-ancestor
111092259|NCT03190447|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111092260|NCT03284177|Calcium|calcium|mesh-list
111092261|NCT03284177|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111092262|NCT03284177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111092263|NCT03192709|Sildenafil Citrate|sildenafil citrate|mesh-list
111092264|NCT03192709|Vasodilator Agents|vasodilator agents|mesh-ancestor
111092265|NCT03192709|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111092266|NCT03192709|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111092267|NCT03192709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111092268|NCT03192709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111092269|NCT03192709|Urological Agents|urological agents|mesh-ancestor
111092270|NCT03283943|Durvalumab|durvalumab|mesh-list
111092271|NCT03283943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111092272|NCT03283943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111092273|NCT02710045|Vaccines|vaccines|mesh-list
111092274|NCT02710045|Immunologic Factors|immunologic factors|mesh-ancestor
111092275|NCT02710045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111092276|NCT02444767|Bimatoprost|bimatoprost|mesh-list
111092277|NCT02444767|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111092278|NCT02443285|Ceftriaxone|ceftriaxone|mesh-list
111092280|NCT02443285|Cefoxitin|cefoxitin|mesh-list
111092281|NCT02443285|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111092282|NCT02443285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111092283|NCT03193957|Etanercept|etanercept|mesh-list
111092284|NCT03193957|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111092285|NCT03193957|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111092286|NCT03193957|Analgesics|analgesics|mesh-ancestor
111092287|NCT03193957|Sensory System Agents|sensory system agents|mesh-ancestor
111092288|NCT03193957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111092289|NCT03193957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111092290|NCT03193957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111092291|NCT03193957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111092292|NCT03193957|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111092293|NCT03193957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111092294|NCT03193957|Immunologic Factors|immunologic factors|mesh-ancestor
111092295|NCT03281681|Dianhydrogalactitol|dianhydrogalactitol|mesh-list
111092296|NCT03281681|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111092297|NCT03281681|Alkylating Agents|alkylating agents|mesh-ancestor
111092298|NCT03281681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111092299|NCT03281681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111092300|NCT02444611|Vaccines|vaccines|mesh-list
111092301|NCT02444611|BCG Vaccine|bcg vaccine|mesh-list
111092302|NCT02444611|Immunologic Factors|immunologic factors|mesh-ancestor
111092303|NCT02444611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111092304|NCT02444611|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111092305|NCT02438761|Gedatolisib|gedatolisib|mesh-list
111092306|NCT02438761|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111092307|NCT02438761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111092308|NCT02438761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111092309|NCT03536429|Acetazolamide|acetazolamide|mesh-list
111092310|NCT03536429|Anticonvulsants|anticonvulsants|mesh-ancestor
111092311|NCT03536429|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
111092312|NCT03536429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111092313|NCT03536429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111092314|NCT03536429|Diuretics|diuretics|mesh-ancestor
111092315|NCT03536429|Natriuretic Agents|natriuretic agents|mesh-ancestor
111092316|NCT03536429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111092317|NCT02438683|BI 409306|bi 409306|mesh-list
111092318|NCT02438683|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111092319|NCT02438683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111092320|NCT02438683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111092321|NCT03270839|Meclizine|meclizine|mesh-list
111092322|NCT03270839|Scopolamine|scopolamine|mesh-list
111092323|NCT03270839|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111092324|NCT03270839|Antiemetics|antiemetics|mesh-ancestor
111092325|NCT03270839|Autonomic Agents|autonomic agents|mesh-ancestor
110809418|NCT00054275|Docetaxel|docetaxel|mesh-list
111092326|NCT03270839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111092327|NCT03270839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111092328|NCT03270839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111092329|NCT03270839|Mydriatics|mydriatics|mesh-ancestor
111092330|NCT03270839|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111092331|NCT03270839|Cholinergic Agents|cholinergic agents|mesh-ancestor
111092332|NCT03270839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111092333|NCT03270839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111092334|NCT03270839|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111092335|NCT03270839|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111092336|NCT03270839|Histamine Antagonists|histamine antagonists|mesh-ancestor
111092337|NCT03270839|Histamine Agents|histamine agents|mesh-ancestor
111092338|NCT03270839|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111092339|NCT02458547|Bupivacaine|bupivacaine|mesh-list
111092340|NCT02458547|Propofol|propofol|mesh-list
111092341|NCT02458547|Desflurane|desflurane|mesh-list
111092342|NCT02458547|Anesthetics, Local|anesthetics, local|mesh-ancestor
111092343|NCT02458547|Anesthetics|anesthetics|mesh-ancestor
111092344|NCT02458547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111092345|NCT02458547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111092346|NCT02458547|Sensory System Agents|sensory system agents|mesh-ancestor
111092347|NCT02458547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111092348|NCT02458547|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111092349|NCT02458547|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111092350|NCT02458547|Anesthetics, General|anesthetics, general|mesh-ancestor
111092351|NCT02458547|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111092352|NCT02458625|Iron|iron|mesh-list
111092353|NCT02458625|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
111092354|NCT02458625|Trace Elements|trace elements|mesh-ancestor
111092355|NCT02458625|Micronutrients|micronutrients|mesh-ancestor
111092356|NCT02458625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111092357|NCT02458625|Hematinics|hematinics|mesh-ancestor
111092358|NCT04978155|Anesthetics|anesthetics|mesh-list
111092359|NCT04978155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111092360|NCT04978155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111092361|NCT04970043|Pemetrexed|pemetrexed|mesh-list
111092362|NCT04970043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111092363|NCT04970043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111092364|NCT04970043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111092365|NCT04970043|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111092366|NCT04970043|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111092367|NCT04977843|Dimercaprol|dimercaprol|mesh-list
111092368|NCT04977843|Chelating Agents|chelating agents|mesh-ancestor
111092369|NCT04977843|Sequestering Agents|sequestering agents|mesh-ancestor
111092370|NCT04977843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111092371|NCT04432233|Metronidazole|metronidazole|mesh-list
111092372|NCT04432233|Levofloxacin|levofloxacin|mesh-list
111092373|NCT04432233|Esomeprazole|esomeprazole|mesh-list
111092374|NCT04432233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111092375|NCT04432233|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111092376|NCT04432233|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111092377|NCT04432233|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111092378|NCT04432233|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111092379|NCT04432233|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111092380|NCT04432233|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111092381|NCT04432233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111092382|NCT04432233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111092383|NCT04432233|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111092384|NCT04432233|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111092385|NCT04432233|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111092386|NCT04432233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111092387|NCT04432233|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111092388|NCT04432233|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111092389|NCT03269747|Prednisone|prednisone|mesh-list
111092390|NCT03269747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111092391|NCT03269747|Glucocorticoids|glucocorticoids|mesh-ancestor
111092392|NCT03269747|Hormones|hormones|mesh-ancestor
111092393|NCT03269747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111092394|NCT03269747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111092395|NCT03269747|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111092396|NCT03269747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111092397|NCT04369469|Ravulizumab|ravulizumab|mesh-list
111092398|NCT04369469|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
111092399|NCT04369469|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111092400|NCT04369469|Immunologic Factors|immunologic factors|mesh-ancestor
111092401|NCT04369469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110809500|NCT01091753|Amlodipine|amlodipine|mesh-list
111092402|NCT03269591|Diclofenac|diclofenac|mesh-list
111092403|NCT03269591|Progesterone|progesterone|mesh-list
111092404|NCT03269591|Progestins|progestins|mesh-ancestor
111092405|NCT03269591|Hormones|hormones|mesh-ancestor
111092406|NCT03269591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111092407|NCT03269591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111092408|NCT03269591|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111092409|NCT03269591|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111092410|NCT03269591|Analgesics|analgesics|mesh-ancestor
111092411|NCT03269591|Sensory System Agents|sensory system agents|mesh-ancestor
111092412|NCT03269591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111092413|NCT03269591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111092414|NCT03269591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111092415|NCT03269591|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111092416|NCT03269591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111092417|NCT03269591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111092418|NCT03989609|Midazolam|midazolam|mesh-list
111092419|NCT03989609|Dexmedetomidine|dexmedetomidine|mesh-list
111092420|NCT03989609|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111092421|NCT03989609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111092422|NCT03989609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111092423|NCT03989609|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111092424|NCT03989609|Analgesics|analgesics|mesh-ancestor
111092425|NCT03989609|Sensory System Agents|sensory system agents|mesh-ancestor
111092426|NCT03989609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111092427|NCT03989609|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111092428|NCT03989609|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111092429|NCT03989609|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111092430|NCT03989609|Adrenergic Agents|adrenergic agents|mesh-ancestor
111092431|NCT03989609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111092432|NCT03989609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111092433|NCT03989609|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111092434|NCT03989609|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111092435|NCT03989609|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111092436|NCT03989609|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111092437|NCT03989609|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111092438|NCT03989609|Anesthetics, General|anesthetics, general|mesh-ancestor
111092439|NCT03989609|Anesthetics|anesthetics|mesh-ancestor
111092440|NCT03989609|GABA Modulators|gaba modulators|mesh-ancestor
111092441|NCT03989609|GABA Agents|gaba agents|mesh-ancestor
111092442|NCT03988205|Cytarabine|cytarabine|mesh-list
111092443|NCT03988205|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111092444|NCT03988205|Antimetabolites|antimetabolites|mesh-ancestor
111092445|NCT03988205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111092446|NCT03988205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111092447|NCT03988205|Antiviral Agents|antiviral agents|mesh-ancestor
111092448|NCT03988205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111092449|NCT03988205|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111092450|NCT03988205|Immunologic Factors|immunologic factors|mesh-ancestor
111092451|NCT03988205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111092452|NCT03280277|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
111092453|NCT03280277|Hematinics|hematinics|mesh-ancestor
111092454|NCT03280277|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
111092455|NCT03280277|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111092456|NCT03269357|Contraceptive Agents|contraceptive agents|mesh-list
111092457|NCT03269357|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111092458|NCT03269357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111092459|NCT03269279|Misoprostol|misoprostol|mesh-list
111092460|NCT03269279|Mifepristone|mifepristone|mesh-list
111092461|NCT03269279|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111092462|NCT03269279|Abortifacient Agents|abortifacient agents|mesh-ancestor
111092463|NCT03269279|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111092464|NCT03269279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111092465|NCT03269279|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111092466|NCT03269279|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111092467|NCT03269279|Oxytocics|oxytocics|mesh-ancestor
111092468|NCT03269279|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
111092469|NCT03269279|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111092470|NCT03269279|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111092471|NCT03269279|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111092472|NCT03269279|Contraceptive Agents|contraceptive agents|mesh-ancestor
111092473|NCT03269279|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
111092474|NCT03269279|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
111092475|NCT03269279|Hormone Antagonists|hormone antagonists|mesh-ancestor
111092476|NCT03269279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111092477|NCT03269279|Luteolytic Agents|luteolytic agents|mesh-ancestor
111092478|NCT03269279|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111092479|NCT03269279|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
111092480|NCT03278483|Rifampin|rifampin|mesh-list
111092481|NCT03278483|Isoniazid|isoniazid|mesh-list
111092482|NCT03278483|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111092483|NCT03278483|Antitubercular Agents|antitubercular agents|mesh-ancestor
111092484|NCT03278483|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111092485|NCT03278483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111092486|NCT03278483|Leprostatic Agents|leprostatic agents|mesh-ancestor
111092487|NCT03278483|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111092488|NCT03278483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111092489|NCT03278483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111092490|NCT03278483|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111092491|NCT03278483|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111092492|NCT03278483|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
111092493|NCT03278483|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
111092494|NCT03278483|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
111092495|NCT03278483|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111092496|NCT03278483|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
111092497|NCT03278483|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111092498|NCT03278483|Antimetabolites|antimetabolites|mesh-ancestor
110029452|NCT04677959|Adrenergic Agents|adrenergic agents|mesh-ancestor
111092499|NCT03278483|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111092501|NCT03268733|Hematinics|hematinics|mesh-ancestor
111092502|NCT03268733|Vitamin B Complex|vitamin b complex|mesh-ancestor
111092503|NCT03268733|Vitamins|vitamins|mesh-ancestor
111092504|NCT03268733|Micronutrients|micronutrients|mesh-ancestor
111092505|NCT03268733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111092506|NCT03277391|Droperidol|droperidol|mesh-list
111092507|NCT03277391|Morphine|morphine|mesh-list
111092508|NCT03277391|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111092509|NCT03277391|Narcotics|narcotics|mesh-ancestor
111092510|NCT03277391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111092511|NCT03277391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111092512|NCT03277391|Analgesics|analgesics|mesh-ancestor
111092513|NCT03277391|Sensory System Agents|sensory system agents|mesh-ancestor
111092514|NCT03277391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111092515|NCT03277391|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111092516|NCT03277391|Antiemetics|antiemetics|mesh-ancestor
111092517|NCT03277391|Autonomic Agents|autonomic agents|mesh-ancestor
111092518|NCT03277391|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111092519|NCT03277391|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111092520|NCT03277391|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111092521|NCT03277391|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111092522|NCT03277391|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111092523|NCT03277391|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111092524|NCT03277391|Dopamine Agents|dopamine agents|mesh-ancestor
111092525|NCT03277391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111092526|NCT03277391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111092527|NCT03277001|Enoxaparin|enoxaparin|mesh-list
111092528|NCT03277001|Rivaroxaban|rivaroxaban|mesh-list
111092529|NCT03277001|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111092530|NCT03277001|Antithrombins|antithrombins|mesh-ancestor
111092531|NCT03277001|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111092532|NCT03277001|Protease Inhibitors|protease inhibitors|mesh-ancestor
111092533|NCT03277001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111092534|NCT03277001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111092535|NCT03277001|Anticoagulants|anticoagulants|mesh-ancestor
111092536|NCT03277001|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111092537|NCT03277001|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111092538|NCT03273881|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111092539|NCT03272711|Vortioxetine|vortioxetine|mesh-list
111092540|NCT03272711|Antidepressive Agents|antidepressive agents|mesh-ancestor
111092541|NCT03272711|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111092542|NCT03272711|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111092543|NCT03272711|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111092544|NCT03272711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111092545|NCT03272711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111092546|NCT03272711|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111092547|NCT03272711|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111092548|NCT03272711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111092549|NCT03272711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111092550|NCT03272711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111092552|NCT03272711|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111092553|NCT03272711|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111092554|NCT03272711|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111092555|NCT03272711|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111092556|NCT03961919|Fludarabine|fludarabine|mesh-list
111092557|NCT03961919|Treosulfan|treosulfan|mesh-list
111092558|NCT03961919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111092559|NCT03961919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111092560|NCT03961919|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111092561|NCT03961919|Alkylating Agents|alkylating agents|mesh-ancestor
111092562|NCT03267407|Fluconazole|fluconazole|mesh-list
111092563|NCT03267407|Antifungal Agents|antifungal agents|mesh-ancestor
111092564|NCT03267407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111092565|NCT03267407|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111092566|NCT03267407|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111092567|NCT03267407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111092568|NCT03267407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111092569|NCT03267407|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111092570|NCT03267407|Hormone Antagonists|hormone antagonists|mesh-ancestor
111092571|NCT03267407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111092572|NCT03267407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111092573|NCT03267407|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111092574|NCT03267407|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111092575|NCT03267329|Telmisartan|telmisartan|mesh-list
111092576|NCT03267329|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111092577|NCT03267329|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111092578|NCT03267329|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111092579|NCT03267329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111092580|NCT05074043|Antiviral Agents|antiviral agents|mesh-list
111092581|NCT05074043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111092582|NCT05073965|Vitamin D|vitamin d|mesh-list
111092583|NCT05073965|Vitamins|vitamins|mesh-ancestor
111092584|NCT05073965|Micronutrients|micronutrients|mesh-ancestor
111092585|NCT05073965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111092586|NCT05073965|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111092587|NCT03266549|Botulinum Toxins|botulinum toxins|mesh-list
111092588|NCT03266549|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111092589|NCT03266549|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111092590|NCT03266549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111092591|NCT03266549|Cholinergic Agents|cholinergic agents|mesh-ancestor
111092592|NCT03266549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111092593|NCT03266549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111092594|NCT05065775|Dexmedetomidine|dexmedetomidine|mesh-list
111092595|NCT05065775|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111092596|NCT05065775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111092597|NCT05065775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111092598|NCT05065775|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111092599|NCT05065775|Analgesics|analgesics|mesh-ancestor
111092600|NCT05065775|Sensory System Agents|sensory system agents|mesh-ancestor
111092601|NCT05065775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111092602|NCT05065775|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111092603|NCT05065775|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111092604|NCT05065775|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111092605|NCT05065775|Adrenergic Agents|adrenergic agents|mesh-ancestor
111092606|NCT05065775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111092607|NCT05065775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111092608|NCT03266159|Trametinib|trametinib|mesh-list
111092609|NCT03266159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111092610|NCT03266159|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111092611|NCT03266159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111092612|NCT03266159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111092613|NCT02458781|Metronidazole|metronidazole|mesh-list
111092614|NCT02458781|Ciprofloxacin|ciprofloxacin|mesh-list
111092615|NCT02458781|Fluoroquinolones|fluoroquinolones|mesh-list
111092616|NCT02458781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111092617|NCT02458781|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111092618|NCT02458781|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111092619|NCT02458781|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111092620|NCT02458781|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110809728|NCT01096199|Cisplatin|cisplatin|mesh-list
111092621|NCT02458781|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111092622|NCT02458781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111092623|NCT02458781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111092624|NCT02458781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111092625|NCT02458781|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111092626|NCT02458781|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111092627|NCT02458781|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111092628|NCT04647383|Lemborexant|lemborexant|mesh-list
111092629|NCT04647383|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
111092630|NCT04647383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111092631|NCT04647383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111092632|NCT04647383|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111092633|NCT04647383|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111092634|NCT04647383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111092635|NCT04647383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111092636|NCT02458157|Furosemide|furosemide|mesh-list
111092637|NCT02458157|Diuretics|diuretics|mesh-ancestor
111092638|NCT02458157|Natriuretic Agents|natriuretic agents|mesh-ancestor
111092639|NCT02458157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111092640|NCT02458157|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
111092641|NCT02458157|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110677364|NCT01104350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111092642|NCT02458157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111092644|NCT02458079|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111092645|NCT02458079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111092646|NCT02458079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111092647|NCT02458079|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111092648|NCT02458079|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111092649|NCT02458079|Protective Agents|protective agents|mesh-ancestor
111092650|NCT02458079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111092651|NCT02458079|Vasodilator Agents|vasodilator agents|mesh-ancestor
111092652|NCT02458079|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111092653|NCT02458079|Antioxidants|antioxidants|mesh-ancestor
111092654|NCT03264911|Amoxicillin|amoxicillin|mesh-list
111092655|NCT03264911|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111092656|NCT03264911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111092657|NCT03265223|Ropivacaine|ropivacaine|mesh-list
111092658|NCT03265223|Anesthetics, Local|anesthetics, local|mesh-ancestor
111092659|NCT03265223|Anesthetics|anesthetics|mesh-ancestor
111092660|NCT03265223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111092661|NCT03265223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111092662|NCT03265223|Sensory System Agents|sensory system agents|mesh-ancestor
111092663|NCT03265223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111092664|NCT02456363|Sulfasalazine|sulfasalazine|mesh-list
111092665|NCT02456363|Adalimumab|adalimumab|mesh-list
111092666|NCT02456363|Golimumab|golimumab|mesh-list
111092667|NCT02456363|Etanercept|etanercept|mesh-list
111092668|NCT02456363|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111092669|NCT02456363|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111092670|NCT02456363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111092671|NCT02456363|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111092672|NCT02456363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111092673|NCT02456363|Analgesics|analgesics|mesh-ancestor
111092674|NCT02456363|Sensory System Agents|sensory system agents|mesh-ancestor
111092675|NCT02456363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111092676|NCT02456363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111092677|NCT02456363|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111092678|NCT02456363|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111092679|NCT02456363|Immunologic Factors|immunologic factors|mesh-ancestor
111092680|NCT02456363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111092681|NCT03259607|Nicotine|nicotine|mesh-list
111092682|NCT03259607|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111092683|NCT03259607|Autonomic Agents|autonomic agents|mesh-ancestor
111092684|NCT03259607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111092685|NCT03259607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111092686|NCT03259607|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111092687|NCT03259607|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111092688|NCT03259607|Cholinergic Agents|cholinergic agents|mesh-ancestor
111092689|NCT03259607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111092690|NCT03259607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111092691|NCT02456129|Itraconazole|itraconazole|mesh-list
111092692|NCT02456129|Antifungal Agents|antifungal agents|mesh-ancestor
111092693|NCT02456129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111092694|NCT02456129|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111092695|NCT02456129|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111092696|NCT02456129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111092697|NCT02456129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111092698|NCT02456129|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111092699|NCT02456129|Hormone Antagonists|hormone antagonists|mesh-ancestor
111092700|NCT02456129|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111092701|NCT02456129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110641556|NCT01004445|Amikacin|amikacin|mesh-list
111092702|NCT02456129|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111092704|NCT03263741|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111092705|NCT03263741|Oxaliplatin|oxaliplatin|mesh-list
111092706|NCT03263741|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111092707|NCT03263741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111092708|NCT03263741|Tubulin Modulators|tubulin modulators|mesh-ancestor
111092709|NCT03263741|Antimitotic Agents|antimitotic agents|mesh-ancestor
111092710|NCT03263741|Mitosis Modulators|mitosis modulators|mesh-ancestor
111092711|NCT03263741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111092712|NCT02456207|Rituximab|rituximab|mesh-list
111092713|NCT02456207|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111092714|NCT02456207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111092715|NCT02456207|Immunologic Factors|immunologic factors|mesh-ancestor
111092716|NCT02456207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111092717|NCT02456207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111092718|NCT03258749|Formoterol Fumarate|formoterol fumarate|mesh-list
111092719|NCT03258749|Tiotropium Bromide|tiotropium bromide|mesh-list
111092720|NCT03258749|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111092721|NCT03258749|Autonomic Agents|autonomic agents|mesh-ancestor
111092722|NCT03258749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111092723|NCT03258749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111092724|NCT03258749|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111092725|NCT03258749|Respiratory System Agents|respiratory system agents|mesh-ancestor
111092726|NCT03258749|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111092727|NCT03258749|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111092728|NCT03258749|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111092729|NCT03258749|Adrenergic Agents|adrenergic agents|mesh-ancestor
111092730|NCT03258749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111092731|NCT03258749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111092732|NCT03258749|Parasympatholytics|parasympatholytics|mesh-ancestor
111092733|NCT03258749|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111092734|NCT03258749|Cholinergic Agents|cholinergic agents|mesh-ancestor
111092735|NCT03258515|Moxifloxacin|moxifloxacin|mesh-list
111092736|NCT03258515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111092737|NCT03258515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111092738|NCT03258515|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111092739|NCT03258515|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111092740|NCT03258515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111092741|NCT03258515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111092742|NCT03258515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111092743|NCT04976673|Triamcinolone|triamcinolone|mesh-list
111092744|NCT04976673|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
111092745|NCT04976673|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
111092746|NCT04976673|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
111092747|NCT04976673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111092748|NCT04976673|Glucocorticoids|glucocorticoids|mesh-ancestor
111092749|NCT04976673|Hormones|hormones|mesh-ancestor
111092750|NCT04976673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111092751|NCT04976673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111092752|NCT04976673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110641566|NCT02581553|Lesinurad|lesinurad|mesh-list
111092753|NCT04976673|Immunologic Factors|immunologic factors|mesh-ancestor
111092754|NCT04976673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111092755|NCT04976673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111092756|NCT04969497|Zolmitriptan|zolmitriptan|mesh-list
111092757|NCT04969497|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111092758|NCT04969497|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111092759|NCT04969497|Serotonin Agents|serotonin agents|mesh-ancestor
111092760|NCT04969497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111092761|NCT04969497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111092762|NCT04969497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111092763|NCT04976829|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111092764|NCT04976829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111092765|NCT03263039|Pembrolizumab|pembrolizumab|mesh-list
111092766|NCT03263039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111092767|NCT03263039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111092768|NCT03263039|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111092769|NCT03263039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111092771|NCT03262961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111092772|NCT03262961|Vasodilator Agents|vasodilator agents|mesh-ancestor
111092773|NCT03262961|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111092774|NCT03262961|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111092775|NCT03262961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111092776|NCT03262961|Urological Agents|urological agents|mesh-ancestor
111092777|NCT01670097|Dexamethasone|dexamethasone|mesh-list
111092778|NCT01670097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111092779|NCT01670097|Antiemetics|antiemetics|mesh-ancestor
111092780|NCT01670097|Autonomic Agents|autonomic agents|mesh-ancestor
111092781|NCT01670097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111092782|NCT01670097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111092783|NCT01670097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111092784|NCT01670097|Glucocorticoids|glucocorticoids|mesh-ancestor
111092785|NCT01670097|Hormones|hormones|mesh-ancestor
111092786|NCT01670097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111092787|NCT01670097|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111092788|NCT01670097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111092789|NCT03257423|Moxifloxacin|moxifloxacin|mesh-list
111092790|NCT03257423|Metronidazole|metronidazole|mesh-list
111092791|NCT03257423|Levofloxacin|levofloxacin|mesh-list
111092792|NCT03257423|Ertapenem|ertapenem|mesh-list
111092793|NCT03257423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111092794|NCT03257423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111092795|NCT03257423|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111092796|NCT03257423|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111092797|NCT03257423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111092798|NCT03257423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111092799|NCT03257423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111092800|NCT03257423|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111092801|NCT03257423|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111092802|NCT03257423|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111092803|NCT03257423|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111092804|NCT03257423|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111092805|NCT01670019|Asenapine|asenapine|mesh-list
111092806|NCT01670019|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111092807|NCT01670019|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111092808|NCT01670019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111092809|NCT01670019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111092810|NCT01670019|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111092811|NCT03262727|Deucravacitinib|deucravacitinib|mesh-list
111092812|NCT03262727|Ethinyl Estradiol|ethinyl estradiol|mesh-list
111092813|NCT03262727|Norethindrone|norethindrone|mesh-list
111092814|NCT03262727|Norethindrone Acetate|norethindrone acetate|mesh-list
111092815|NCT03262727|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
111092816|NCT03262727|Estradiol|estradiol|mesh-list
111092817|NCT03262727|Estrogens|estrogens|mesh-ancestor
111092818|NCT03262727|Hormones|hormones|mesh-ancestor
111092819|NCT03262727|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111092820|NCT03262727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111092821|NCT03262727|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111092822|NCT03262727|Contraceptive Agents|contraceptive agents|mesh-ancestor
111092823|NCT03262727|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111092824|NCT03262727|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111092825|NCT03262727|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111092826|NCT03262727|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111092827|NCT03262727|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111092828|NCT03262727|Dermatologic Agents|dermatologic agents|mesh-ancestor
111092829|NCT03262727|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111092830|NCT03262727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111092831|NCT03262727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111092832|NCT03262727|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
111092833|NCT03262727|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
111092834|NCT04975971|Dexamethasone|dexamethasone|mesh-list
111092835|NCT04975971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111092836|NCT04975971|Antiemetics|antiemetics|mesh-ancestor
111092837|NCT04975971|Autonomic Agents|autonomic agents|mesh-ancestor
111092838|NCT04975971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111092839|NCT04975971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111092840|NCT04975971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111092841|NCT04975971|Glucocorticoids|glucocorticoids|mesh-ancestor
111092842|NCT04975971|Hormones|hormones|mesh-ancestor
111092843|NCT04975971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111092844|NCT04975971|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111092845|NCT04975971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111092846|NCT03062163|Thioctic Acid|thioctic acid|mesh-list
111092847|NCT03062163|Resveratrol|resveratrol|mesh-list
111092848|NCT03062163|Antioxidants|antioxidants|mesh-ancestor
111092849|NCT03062163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111092850|NCT03062163|Protective Agents|protective agents|mesh-ancestor
111092851|NCT03062163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111092852|NCT03062163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111092853|NCT03062163|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111092854|NCT03062163|Vitamin B Complex|vitamin b complex|mesh-ancestor
111092855|NCT03062163|Vitamins|vitamins|mesh-ancestor
111092856|NCT03062163|Micronutrients|micronutrients|mesh-ancestor
111092857|NCT02456597|Lidocaine|lidocaine|mesh-list
111092858|NCT02456597|Anesthetics, Local|anesthetics, local|mesh-ancestor
111092859|NCT02456597|Anesthetics|anesthetics|mesh-ancestor
111092860|NCT02456597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111092861|NCT02456597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111092862|NCT02456597|Sensory System Agents|sensory system agents|mesh-ancestor
111092863|NCT02456597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111092864|NCT02456597|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111092865|NCT02456597|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111092866|NCT02456597|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111092867|NCT02456597|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111092868|NCT02456597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111092869|NCT03261635|Indomethacin|indomethacin|mesh-list
111092870|NCT03261635|Ranibizumab|ranibizumab|mesh-list
111092871|NCT03261635|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111092872|NCT03261635|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111092873|NCT03261635|Growth Substances|growth substances|mesh-ancestor
111092874|NCT03261635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111092875|NCT03261635|Growth Inhibitors|growth inhibitors|mesh-ancestor
111092876|NCT03261635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111092877|NCT03261635|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111092878|NCT03261635|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111092879|NCT03261635|Analgesics|analgesics|mesh-ancestor
111092880|NCT03261635|Sensory System Agents|sensory system agents|mesh-ancestor
111092881|NCT03261635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111092882|NCT03261635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111092883|NCT03261635|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111092884|NCT03261635|Gout Suppressants|gout suppressants|mesh-ancestor
111092885|NCT03261635|Tocolytic Agents|tocolytic agents|mesh-ancestor
111092886|NCT03261635|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111092887|NCT03261635|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111092888|NCT03261635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111092889|NCT03261635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111092890|NCT03059979|Methylprednisolone|methylprednisolone|mesh-list
111092891|NCT03059979|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111092892|NCT03059979|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111092893|NCT03059979|Prednisolone|prednisolone|mesh-list
111092894|NCT03059979|Prednisolone acetate|prednisolone acetate|mesh-list
111092895|NCT03059979|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111092896|NCT03059979|Prednisolone phosphate|prednisolone phosphate|mesh-list
111092897|NCT03059979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111092898|NCT03059979|Antiemetics|antiemetics|mesh-ancestor
111092899|NCT03059979|Autonomic Agents|autonomic agents|mesh-ancestor
111092900|NCT03059979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111092901|NCT03059979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111092902|NCT03059979|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111092903|NCT03059979|Glucocorticoids|glucocorticoids|mesh-ancestor
111092904|NCT03059979|Hormones|hormones|mesh-ancestor
111092905|NCT03059979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111092906|NCT03059979|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111092907|NCT03059979|Protective Agents|protective agents|mesh-ancestor
111092908|NCT03059979|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111092909|NCT03059979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111092910|NCT03256721|Docetaxel|docetaxel|mesh-list
111092911|NCT03256721|Pemetrexed|pemetrexed|mesh-list
111092912|NCT03256721|Apatinib|apatinib|mesh-list
111092913|NCT03256721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111092914|NCT03256721|Tubulin Modulators|tubulin modulators|mesh-ancestor
111092915|NCT03256721|Antimitotic Agents|antimitotic agents|mesh-ancestor
111092916|NCT03256721|Mitosis Modulators|mitosis modulators|mesh-ancestor
111092917|NCT03256721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111092918|NCT03256721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111092919|NCT03256721|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111092920|NCT03256721|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111092921|NCT03256721|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111092922|NCT04967859|Gentamicins|gentamicins|mesh-list
111092923|NCT04967859|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111092924|NCT04967859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111092925|NCT04967859|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111092926|NCT04967859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111092927|NCT04967859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111092928|NCT03256487|Morphine|morphine|mesh-list
111092929|NCT03256487|Buprenorphine|buprenorphine|mesh-list
111092930|NCT03256487|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111092931|NCT03256487|Narcotics|narcotics|mesh-ancestor
111092932|NCT03256487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111092933|NCT03256487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111092934|NCT03256487|Analgesics|analgesics|mesh-ancestor
110677369|NCT01025089|Doxorubicin|doxorubicin|mesh-list
111092935|NCT03256487|Sensory System Agents|sensory system agents|mesh-ancestor
111092936|NCT03256487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111092937|NCT03256487|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111092938|NCT03061227|Glucagon|glucagon|mesh-list
111092939|NCT03061227|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111092940|NCT03061227|Hormones|hormones|mesh-ancestor
111092941|NCT03061227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111092942|NCT03061227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111092943|NCT03261791|Apatinib|apatinib|mesh-list
111092944|NCT03261791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111092945|NCT03261791|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111092946|NCT03261791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111092947|NCT03261791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111092948|NCT03643367|Propofol|propofol|mesh-list
111092949|NCT03643367|Sevoflurane|sevoflurane|mesh-list
111092950|NCT03643367|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111092951|NCT03643367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111092952|NCT03643367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111092953|NCT03643367|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111092954|NCT03643367|Anesthetics, General|anesthetics, general|mesh-ancestor
111092955|NCT03643367|Anesthetics|anesthetics|mesh-ancestor
111092956|NCT03643367|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111092957|NCT03643367|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111092958|NCT03060603|Epoetin Alfa|epoetin alfa|mesh-list
111092959|NCT03060603|Hematinics|hematinics|mesh-ancestor
111092960|NCT04488107|Letrozole|letrozole|mesh-list
111092961|NCT04488107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111092962|NCT04488107|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111092963|NCT04488107|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111092964|NCT04488107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111092965|NCT04488107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111092966|NCT04488107|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111092967|NCT04488107|Hormone Antagonists|hormone antagonists|mesh-ancestor
111092968|NCT04488107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111092969|NCT04488107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111092970|NCT04974723|Teriparatide|teriparatide|mesh-list
111092971|NCT04974723|Abaloparatide|abaloparatide|mesh-list
111092972|NCT04974723|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111092973|NCT04974723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111092974|NCT04974723|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111092975|NCT03060681|Bupivacaine|bupivacaine|mesh-list
111092976|NCT03060681|Anesthetics, Local|anesthetics, local|mesh-ancestor
111092977|NCT03060681|Anesthetics|anesthetics|mesh-ancestor
111092978|NCT03060681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111092979|NCT03060681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111092980|NCT03060681|Sensory System Agents|sensory system agents|mesh-ancestor
111092981|NCT03060681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111092982|NCT04967469|Calcitriol|calcitriol|mesh-list
111092983|NCT04967469|Alfacalcidol|alfacalcidol|mesh-list
111092984|NCT04967469|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
111092985|NCT04967469|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111092986|NCT04967469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111092987|NCT04967469|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
111092988|NCT04967469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111092989|NCT04967469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111092990|NCT04967469|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111092991|NCT04967469|Vitamins|vitamins|mesh-ancestor
111092992|NCT04967469|Micronutrients|micronutrients|mesh-ancestor
111092993|NCT04967469|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111092994|NCT03254849|Empagliflozin|empagliflozin|mesh-list
111092995|NCT03254849|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
111092996|NCT03254849|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111092997|NCT03254849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111092998|NCT03254849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111092999|NCT03254849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111093000|NCT03254849|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111093001|NCT03254849|Diuretics|diuretics|mesh-ancestor
111093002|NCT03254849|Natriuretic Agents|natriuretic agents|mesh-ancestor
111093003|NCT03254849|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
111093004|NCT03254849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111093005|NCT04963881|Antibodies|antibodies|mesh-list
111093006|NCT04963881|Immunologic Factors|immunologic factors|mesh-ancestor
111093007|NCT04963881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111093008|NCT04432155|Xenon|xenon|mesh-list
111093009|NCT04432155|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111093010|NCT04432155|Anesthetics, General|anesthetics, general|mesh-ancestor
111093011|NCT04432155|Anesthetics|anesthetics|mesh-ancestor
111093012|NCT04432155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111093013|NCT04432155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111093014|NCT04487951|Vitamin D|vitamin d|mesh-list
111093015|NCT04487951|Vitamins|vitamins|mesh-ancestor
111093016|NCT04487951|Micronutrients|micronutrients|mesh-ancestor
111093017|NCT04487951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111093018|NCT04487951|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111093019|NCT04963257|Aripiprazole|aripiprazole|mesh-list
111093020|NCT04963257|Fluvoxamine|fluvoxamine|mesh-list
111093021|NCT04963257|Sertraline|sertraline|mesh-list
111093022|NCT04963257|Antidepressive Agents|antidepressive agents|mesh-ancestor
111093023|NCT04963257|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111093024|NCT04963257|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111093025|NCT04963257|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111093026|NCT04963257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111093027|NCT04963257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111093028|NCT04963257|Dopamine Agonists|dopamine agonists|mesh-ancestor
111093029|NCT04963257|Dopamine Agents|dopamine agents|mesh-ancestor
111093030|NCT04963257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111093031|NCT04963257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111093032|NCT04963257|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111093033|NCT04963257|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111093034|NCT04963257|Serotonin Agents|serotonin agents|mesh-ancestor
111093035|NCT04963257|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111093036|NCT04963257|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111093037|NCT04963257|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111093038|NCT04963257|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111093039|NCT04963257|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111093040|NCT04963257|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111093041|NCT04963257|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111093042|NCT04963257|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111093043|NCT04963257|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111093044|NCT04963257|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111093045|NCT04963257|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111093046|NCT04963257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111093047|NCT04963257|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111093048|NCT04966845|Carbon Monoxide|carbon monoxide|mesh-list
111093049|NCT04966845|Antimetabolites|antimetabolites|mesh-ancestor
111093050|NCT04966845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111093051|NCT04966845|Gasotransmitters|gasotransmitters|mesh-ancestor
111093052|NCT04966845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111093053|NCT04966845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111093054|NCT04953741|Fluticasone|fluticasone|mesh-list
111093055|NCT04953741|Xhance|xhance|mesh-list
111093056|NCT04953741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111093057|NCT04953741|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111093058|NCT04953741|Autonomic Agents|autonomic agents|mesh-ancestor
111093059|NCT04953741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111093060|NCT04953741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111093061|NCT04953741|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111093062|NCT04953741|Respiratory System Agents|respiratory system agents|mesh-ancestor
111093063|NCT04953741|Dermatologic Agents|dermatologic agents|mesh-ancestor
111093064|NCT04953741|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111093065|NCT03259919|Metformin|metformin|mesh-list
111093066|NCT03259919|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111093067|NCT03259919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111093068|NCT04965831|Aflutinib|aflutinib|mesh-list
111093069|NCT04965831|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111093070|NCT04965831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111093071|NCT04965831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111093072|NCT04953117|Paclitaxel|paclitaxel|mesh-list
111093073|NCT04953117|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111093074|NCT04953117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111093075|NCT04953117|Tubulin Modulators|tubulin modulators|mesh-ancestor
111093076|NCT04953117|Antimitotic Agents|antimitotic agents|mesh-ancestor
111093077|NCT04953117|Mitosis Modulators|mitosis modulators|mesh-ancestor
111093078|NCT04953117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111093079|NCT03259529|Rituximab|rituximab|mesh-list
111093080|NCT03259529|Nivolumab|nivolumab|mesh-list
111093081|NCT03259529|Gemcitabine|gemcitabine|mesh-list
111093082|NCT03259529|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
111093083|NCT03259529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111093084|NCT03259529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111093085|NCT03259529|Immunologic Factors|immunologic factors|mesh-ancestor
111093086|NCT03259529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111093087|NCT03259529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111093088|NCT03259529|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111093089|NCT03259529|Antimetabolites|antimetabolites|mesh-ancestor
111093090|NCT03259529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111093091|NCT03259529|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111093092|NCT03259529|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111093093|NCT03259529|Alkylating Agents|alkylating agents|mesh-ancestor
111093094|NCT03252665|Nicorandil|nicorandil|mesh-list
111093095|NCT03252665|Nitroglycerin|nitroglycerin|mesh-list
111093096|NCT03252665|Alprostadil|alprostadil|mesh-list
111093097|NCT03252665|Vasodilator Agents|vasodilator agents|mesh-ancestor
111093098|NCT03252665|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111093099|NCT03252665|Urological Agents|urological agents|mesh-ancestor
111093100|NCT03252665|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111093101|NCT03252665|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111093102|NCT03252665|Vitamin B Complex|vitamin b complex|mesh-ancestor
111093103|NCT03252665|Vitamins|vitamins|mesh-ancestor
111093104|NCT03252665|Micronutrients|micronutrients|mesh-ancestor
111093105|NCT03252665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111093106|NCT03059667|Carboplatin|carboplatin|mesh-list
111093107|NCT03059667|Etoposide|etoposide|mesh-list
111093108|NCT03059667|Atezolizumab|atezolizumab|mesh-list
111093109|NCT03059667|Topotecan|topotecan|mesh-list
111093110|NCT03059667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111093111|NCT03059667|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111093112|NCT03059667|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111093113|NCT03059667|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111093114|NCT03059667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111093115|NCT03059667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111093116|NCT03059667|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111093117|NCT03059667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111093118|NCT03059667|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111093119|NCT03058419|Midazolam|midazolam|mesh-list
111093120|NCT03058419|Dextromethorphan|dextromethorphan|mesh-list
111093121|NCT03058419|Caffeine|caffeine|mesh-list
111093122|NCT03058419|Bupropion|bupropion|mesh-list
111093123|NCT03058419|Omeprazole|omeprazole|mesh-list
111093124|NCT03058419|Warfarin|warfarin|mesh-list
111093125|NCT03058419|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111093126|NCT03058419|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111093127|NCT03058419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111093128|NCT03058419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111093129|NCT03058419|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111093130|NCT03058419|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111093131|NCT03058419|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111093132|NCT03058419|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111093133|NCT03058419|Anesthetics, General|anesthetics, general|mesh-ancestor
111093134|NCT03058419|Anesthetics|anesthetics|mesh-ancestor
111093135|NCT03058419|GABA Modulators|gaba modulators|mesh-ancestor
111093136|NCT03058419|GABA Agents|gaba agents|mesh-ancestor
111093137|NCT03058419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111093138|NCT03058419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111093139|NCT03058419|Anticoagulants|anticoagulants|mesh-ancestor
111093140|NCT03058419|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111093141|NCT03058419|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111093142|NCT03058419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111093143|NCT03058419|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
111093144|NCT03058419|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111093145|NCT03058419|Purinergic Agents|purinergic agents|mesh-ancestor
111093146|NCT03058419|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111093147|NCT03058419|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111093148|NCT03058419|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111093149|NCT03058419|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111093150|NCT03058419|Antidepressive Agents|antidepressive agents|mesh-ancestor
111093151|NCT03058419|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111093152|NCT03058419|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111093153|NCT03058419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111093154|NCT03058419|Dopamine Agents|dopamine agents|mesh-ancestor
111093155|NCT03058419|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111093156|NCT03058419|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111093157|NCT03058419|Antitussive Agents|antitussive agents|mesh-ancestor
111093158|NCT03058419|Respiratory System Agents|respiratory system agents|mesh-ancestor
111093159|NCT03058419|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111093160|NCT03058419|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111093161|NCT04965051|Insulin|insulin|mesh-list
111093162|NCT04965051|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111093163|NCT04965051|Insulin Aspart|insulin aspart|mesh-list
111093164|NCT04965051|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111093165|NCT04965051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111093166|NCT02455271|Eszopiclone|eszopiclone|mesh-list
111093167|NCT02455271|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111093168|NCT02455271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111093169|NCT02455271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111093170|NCT04964583|Azithromycin|azithromycin|mesh-list
111093171|NCT04964583|Hydroxychloroquine|hydroxychloroquine|mesh-list
111093172|NCT04964583|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111093173|NCT04964583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111093174|NCT04964583|Antimalarials|antimalarials|mesh-ancestor
111093175|NCT04964583|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111093176|NCT04964583|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111093177|NCT04964583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111093178|NCT04964583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111093179|NCT04964583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111093180|NCT03251417|Irinotecan|irinotecan|mesh-list
111093181|NCT03251417|Apatinib|apatinib|mesh-list
111093182|NCT03251417|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111093183|NCT03251417|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111093184|NCT03251417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111093185|NCT03251417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111093186|NCT03251417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111093187|NCT03251417|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111093188|NCT04961931|Empagliflozin|empagliflozin|mesh-list
111093189|NCT04961931|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111093190|NCT04961931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111093191|NCT04961931|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111093192|NCT04961931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111093193|NCT02454881|Dexmedetomidine|dexmedetomidine|mesh-list
111093194|NCT02454881|Oxycodone|oxycodone|mesh-list
111093195|NCT02454881|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111093196|NCT02454881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111093197|NCT02454881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111093198|NCT02454881|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111093199|NCT02454881|Analgesics|analgesics|mesh-ancestor
111093200|NCT02454881|Sensory System Agents|sensory system agents|mesh-ancestor
111093201|NCT02454881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111093202|NCT02454881|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111093203|NCT02454881|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111093204|NCT02454881|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111093205|NCT02454881|Adrenergic Agents|adrenergic agents|mesh-ancestor
111093206|NCT02454881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111093207|NCT02454881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111093208|NCT02454881|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111093209|NCT02454881|Narcotics|narcotics|mesh-ancestor
111093210|NCT03058341|Propofol|propofol|mesh-list
111093211|NCT03058341|Sevoflurane|sevoflurane|mesh-list
111093212|NCT03058341|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111093213|NCT03058341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111093214|NCT03058341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111093215|NCT03058341|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111093216|NCT03058341|Anesthetics, General|anesthetics, general|mesh-ancestor
111093217|NCT03058341|Anesthetics|anesthetics|mesh-ancestor
111093218|NCT03058341|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111093219|NCT03058341|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111093220|NCT04951791|SMOFlipid|smoflipid|mesh-list
111093221|NCT04951791|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
111093222|NCT04951791|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
111093223|NCT04951791|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111093224|NCT04951713|Clarithromycin|clarithromycin|mesh-list
111093225|NCT04951713|Rifampin|rifampin|mesh-list
111093226|NCT04951713|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111093227|NCT04951713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111093228|NCT04951713|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111093229|NCT04951713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111093230|NCT04951713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111093231|NCT04951713|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111093232|NCT04951713|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111093234|NCT04951713|Antitubercular Agents|antitubercular agents|mesh-ancestor
111093235|NCT04951713|Leprostatic Agents|leprostatic agents|mesh-ancestor
111093236|NCT04951713|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111093237|NCT04951713|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111093238|NCT04951713|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111093239|NCT04951713|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
111093240|NCT04951713|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
111093241|NCT04951713|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
111093242|NCT04951713|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111093243|NCT04944069|Bevacizumab|bevacizumab|mesh-list
111093244|NCT04944069|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111093245|NCT04944069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111093246|NCT04944069|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111093247|NCT04944069|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111093248|NCT04944069|Growth Substances|growth substances|mesh-ancestor
111093249|NCT04944069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111093250|NCT04944069|Growth Inhibitors|growth inhibitors|mesh-ancestor
111093251|NCT04951167|Norepinephrine|norepinephrine|mesh-list
111093252|NCT04951167|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111093253|NCT04951167|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111093254|NCT04951167|Adrenergic Agents|adrenergic agents|mesh-ancestor
111093255|NCT04951167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111093256|NCT04951167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111093257|NCT04951167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111093258|NCT04951167|Sympathomimetics|sympathomimetics|mesh-ancestor
111093259|NCT04951167|Autonomic Agents|autonomic agents|mesh-ancestor
111093260|NCT04951167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111093261|NCT04951167|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111093262|NCT04950933|Riluzole|riluzole|mesh-list
111093263|NCT04950933|Anticonvulsants|anticonvulsants|mesh-ancestor
111093264|NCT04950933|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111093265|NCT04950933|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111093266|NCT04950933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111093267|NCT04950933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111093268|NCT04950933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111093269|NCT04950933|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111093270|NCT04950933|Protective Agents|protective agents|mesh-ancestor
111093271|NCT04961307|Trastuzumab|trastuzumab|mesh-list
111093272|NCT04961307|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111093273|NCT04961307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111093274|NCT03058263|Neostigmine|neostigmine|mesh-list
111093275|NCT03058263|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111093276|NCT03058263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111093277|NCT03058263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111093278|NCT03058263|Cholinergic Agents|cholinergic agents|mesh-ancestor
111093279|NCT03058263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111093280|NCT03058263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111093281|NCT03058263|Parasympathomimetics|parasympathomimetics|mesh-ancestor
111093282|NCT03058263|Autonomic Agents|autonomic agents|mesh-ancestor
111093283|NCT03058263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111093284|NCT04415853|Irinotecan|irinotecan|mesh-list
111093285|NCT04415853|Tegafur|tegafur|mesh-list
111093286|NCT04415853|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111093287|NCT04415853|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111093288|NCT04415853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111093289|NCT04415853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111093290|NCT04415853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111093291|NCT04415853|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111093292|NCT04415853|Antimetabolites|antimetabolites|mesh-ancestor
111093293|NCT04415151|Tofacitinib|tofacitinib|mesh-list
111093294|NCT04415151|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
111093295|NCT04415151|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111093296|NCT04415151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111093297|NCT04415151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111093298|NCT03059277|Aflibercept|aflibercept|mesh-list
111093299|NCT03059277|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111093300|NCT03059277|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111093301|NCT03059277|Growth Substances|growth substances|mesh-ancestor
111093302|NCT03059277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111093303|NCT03059277|Growth Inhibitors|growth inhibitors|mesh-ancestor
111093304|NCT03059277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111093305|NCT00700817|Metformin|metformin|mesh-list
111093306|NCT00700817|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111093307|NCT00700817|Liraglutide|liraglutide|mesh-list
111093308|NCT00700817|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111093309|NCT00700817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111093310|NCT00700817|Incretins|incretins|mesh-ancestor
111093311|NCT00700817|Hormones|hormones|mesh-ancestor
111093312|NCT00700817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111093313|NCT00700817|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111093314|NCT00700817|Protease Inhibitors|protease inhibitors|mesh-ancestor
111093315|NCT00700817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111093316|NCT00700817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111093317|NCT04960293|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
111093318|NCT04960293|Hemostatics|hemostatics|mesh-ancestor
111093319|NCT04960293|Coagulants|coagulants|mesh-ancestor
111093320|NCT04941417|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
111093321|NCT04941417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111093322|NCT04941417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111093323|NCT04941417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111093324|NCT04948125|Apatinib|apatinib|mesh-list
111093325|NCT04948125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111093326|NCT04948125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111093327|NCT04948125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111093328|NCT04948125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111093329|NCT02455115|Chromium|chromium|mesh-list
111093330|NCT02455115|Norepinephrine|norepinephrine|mesh-list
111093331|NCT02455115|Edetic Acid|edetic acid|mesh-list
111093332|NCT02455115|Pentetic Acid|pentetic acid|mesh-list
111093333|NCT02455115|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111093334|NCT02455115|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111093335|NCT02455115|Adrenergic Agents|adrenergic agents|mesh-ancestor
111093336|NCT02455115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111093337|NCT02455115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111093338|NCT02455115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111093339|NCT02455115|Sympathomimetics|sympathomimetics|mesh-ancestor
111093340|NCT02455115|Autonomic Agents|autonomic agents|mesh-ancestor
111093341|NCT02455115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111093342|NCT02455115|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111093343|NCT02455115|Trace Elements|trace elements|mesh-ancestor
111093344|NCT02455115|Micronutrients|micronutrients|mesh-ancestor
111093345|NCT02455115|Anticoagulants|anticoagulants|mesh-ancestor
111093346|NCT02455115|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
111093347|NCT02455115|Chelating Agents|chelating agents|mesh-ancestor
111093348|NCT02455115|Sequestering Agents|sequestering agents|mesh-ancestor
111093349|NCT02455115|Antidotes|antidotes|mesh-ancestor
111093350|NCT02455115|Protective Agents|protective agents|mesh-ancestor
111093351|NCT02455115|Iron Chelating Agents|iron chelating agents|mesh-ancestor
111093352|NCT03094247|Amoxicillin|amoxicillin|mesh-list
111093353|NCT03094247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111093354|NCT03094247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111093355|NCT04947423|Scopolamine|scopolamine|mesh-list
111093356|NCT04947423|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111093357|NCT04947423|Antiemetics|antiemetics|mesh-ancestor
111093358|NCT04947423|Autonomic Agents|autonomic agents|mesh-ancestor
111093359|NCT04947423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111093360|NCT04947423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111093361|NCT04947423|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111093362|NCT04947423|Mydriatics|mydriatics|mesh-ancestor
111093363|NCT04947423|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111093364|NCT04947423|Cholinergic Agents|cholinergic agents|mesh-ancestor
111093365|NCT04947423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111093366|NCT04947423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111093367|NCT04947423|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111093368|NCT03250481|Oxycodone|oxycodone|mesh-list
111093369|NCT03250481|Propofol|propofol|mesh-list
111093370|NCT03250481|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111093371|NCT03250481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111093372|NCT03250481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111093373|NCT03250481|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111093374|NCT03250481|Anesthetics, General|anesthetics, general|mesh-ancestor
111093375|NCT03250481|Anesthetics|anesthetics|mesh-ancestor
111093376|NCT03250481|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111093377|NCT03250481|Narcotics|narcotics|mesh-ancestor
111093378|NCT03250481|Analgesics|analgesics|mesh-ancestor
111093379|NCT03250481|Sensory System Agents|sensory system agents|mesh-ancestor
111093380|NCT03250481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111093381|NCT04947267|Epinephrine|epinephrine|mesh-list
111093382|NCT04947267|Mepivacaine|mepivacaine|mesh-list
111093383|NCT04947267|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111093384|NCT04947267|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111093385|NCT04947267|Adrenergic Agents|adrenergic agents|mesh-ancestor
111093386|NCT04947267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111093387|NCT04947267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111093388|NCT04947267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111093389|NCT04947267|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111093390|NCT04947267|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111093391|NCT04947267|Autonomic Agents|autonomic agents|mesh-ancestor
111093392|NCT04947267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111093393|NCT04947267|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111093394|NCT04947267|Respiratory System Agents|respiratory system agents|mesh-ancestor
111093395|NCT04947267|Mydriatics|mydriatics|mesh-ancestor
111093396|NCT04947267|Sympathomimetics|sympathomimetics|mesh-ancestor
111093397|NCT04947267|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111093398|NCT04947267|Anesthetics, Local|anesthetics, local|mesh-ancestor
111093399|NCT04947267|Anesthetics|anesthetics|mesh-ancestor
111093400|NCT04947267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111093401|NCT04947267|Sensory System Agents|sensory system agents|mesh-ancestor
111093402|NCT04941885|Cyclophosphamide|cyclophosphamide|mesh-list
111093403|NCT04941885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111093404|NCT04941885|Immunologic Factors|immunologic factors|mesh-ancestor
111093405|NCT04941885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111093406|NCT04941885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111093407|NCT04941885|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111093408|NCT04941885|Alkylating Agents|alkylating agents|mesh-ancestor
111093409|NCT04941885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111093410|NCT04941885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111093411|NCT04941885|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111093412|NCT04423731|Leucovorin|leucovorin|mesh-list
111093413|NCT04423731|Paclitaxel|paclitaxel|mesh-list
111093414|NCT04423731|Gemcitabine|gemcitabine|mesh-list
111093415|NCT04423731|Fluorouracil|fluorouracil|mesh-list
111093416|NCT04423731|Folfirinox|folfirinox|mesh-list
111093417|NCT04423731|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111093418|NCT04423731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111093419|NCT04423731|Tubulin Modulators|tubulin modulators|mesh-ancestor
111093420|NCT04423731|Antimitotic Agents|antimitotic agents|mesh-ancestor
111093421|NCT04423731|Mitosis Modulators|mitosis modulators|mesh-ancestor
111093422|NCT04423731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111093423|NCT04423731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111093424|NCT04423731|Antimetabolites|antimetabolites|mesh-ancestor
111093425|NCT04423731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111093426|NCT04423731|Immunologic Factors|immunologic factors|mesh-ancestor
111093427|NCT04423731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111093428|NCT04423731|Antidotes|antidotes|mesh-ancestor
111093429|NCT04423731|Protective Agents|protective agents|mesh-ancestor
111093430|NCT04423731|Vitamin B Complex|vitamin b complex|mesh-ancestor
111093431|NCT04423731|Vitamins|vitamins|mesh-ancestor
111093432|NCT04423731|Micronutrients|micronutrients|mesh-ancestor
111093433|NCT04947111|Antibodies|antibodies|mesh-list
111093434|NCT04947111|Immunoglobulins|immunoglobulins|mesh-list
111093435|NCT04947111|Antibodies, Blocking|antibodies, blocking|mesh-list
111093436|NCT04947111|Immunologic Factors|immunologic factors|mesh-ancestor
111093437|NCT04947111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111093438|NCT04947345|Propofol|propofol|mesh-list
111093439|NCT04947345|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111093440|NCT04947345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111093441|NCT04947345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111093442|NCT04947345|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111093443|NCT04947345|Anesthetics, General|anesthetics, general|mesh-ancestor
111093444|NCT04947345|Anesthetics|anesthetics|mesh-ancestor
111093445|NCT04947189|Dexamethasone|dexamethasone|mesh-list
111093446|NCT04947189|Docetaxel|docetaxel|mesh-list
111093447|NCT04947189|Seviteronel|seviteronel|mesh-list
111093448|NCT04947189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111093449|NCT04947189|Antiemetics|antiemetics|mesh-ancestor
111093450|NCT04947189|Autonomic Agents|autonomic agents|mesh-ancestor
111093451|NCT04947189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111093452|NCT04947189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111093453|NCT04947189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111093454|NCT04947189|Glucocorticoids|glucocorticoids|mesh-ancestor
111093456|NCT04947189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111093457|NCT04947189|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111093458|NCT04947189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111093459|NCT04947189|Tubulin Modulators|tubulin modulators|mesh-ancestor
111093460|NCT04947189|Antimitotic Agents|antimitotic agents|mesh-ancestor
111093461|NCT04947189|Mitosis Modulators|mitosis modulators|mesh-ancestor
111093462|NCT04947189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111093463|NCT04947189|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111093464|NCT04947189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111093465|NCT03249311|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
111093466|NCT03249311|Milnacipran|milnacipran|mesh-list
111093467|NCT03249311|Levomilnacipran|levomilnacipran|mesh-list
111093468|NCT03249311|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111093469|NCT03249311|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111093470|NCT03249311|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111093471|NCT03249311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111093472|NCT03249311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111093473|NCT03249311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111093474|NCT03249311|Analgesics|analgesics|mesh-ancestor
111093475|NCT03249311|Sensory System Agents|sensory system agents|mesh-ancestor
111093476|NCT03249311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111093477|NCT03249311|Antidepressive Agents|antidepressive agents|mesh-ancestor
111093478|NCT03249311|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111093479|NCT03249311|Dopamine Agents|dopamine agents|mesh-ancestor
111093480|NCT03249311|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111093481|NCT02454491|Verapamil|verapamil|mesh-list
111093482|NCT02454491|Heparin|heparin|mesh-list
111093483|NCT02454491|Anticoagulants|anticoagulants|mesh-ancestor
111093484|NCT02454491|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111093485|NCT02454491|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111093486|NCT02454491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111093487|NCT02454491|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111093488|NCT02454491|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111093489|NCT02454491|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111093490|NCT02454491|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111093491|NCT02454491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111093492|NCT02454491|Vasodilator Agents|vasodilator agents|mesh-ancestor
111093493|NCT03248765|Analgesics, Opioid|analgesics, opioid|mesh-list
111093494|NCT03248765|Narcotics|narcotics|mesh-ancestor
111093495|NCT03248765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111093496|NCT03248765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111093497|NCT03248765|Analgesics|analgesics|mesh-ancestor
111093498|NCT03248765|Sensory System Agents|sensory system agents|mesh-ancestor
111093499|NCT03248765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111093500|NCT04939857|Trimetazidine|trimetazidine|mesh-list
111093501|NCT04939857|Vasodilator Agents|vasodilator agents|mesh-ancestor
111093502|NCT04939779|Delpazolid|delpazolid|mesh-list
111093503|NCT04939779|Oxazolidinones|oxazolidinones|mesh-list
111093504|NCT04939779|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111093505|NCT04939779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111093506|NCT04939779|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111093507|NCT04939779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111093508|NCT04939779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111093509|NCT03247595|Magnesium citrate|magnesium citrate|mesh-list
111093510|NCT03247595|Bisacodyl|bisacodyl|mesh-list
111093511|NCT03247595|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
111093512|NCT03247595|Cathartics|cathartics|mesh-ancestor
111093513|NCT03247595|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111093514|NCT03247595|Laxatives|laxatives|mesh-ancestor
111093515|NCT03247283|Linrodostat|linrodostat|mesh-list
111093516|NCT03247283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111093517|NCT03247283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111093518|NCT04938297|Rituximab|rituximab|mesh-list
111093519|NCT04938297|Lenalidomide|lenalidomide|mesh-list
111093520|NCT04938297|Zanubrutinib|zanubrutinib|mesh-list
111093521|NCT04938297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111093522|NCT04938297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111093523|NCT04938297|Immunologic Factors|immunologic factors|mesh-ancestor
111093524|NCT04938297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111093525|NCT04938297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111093526|NCT04938297|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111093527|NCT04938297|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111093528|NCT04938297|Growth Substances|growth substances|mesh-ancestor
111093529|NCT04938297|Growth Inhibitors|growth inhibitors|mesh-ancestor
111093530|NCT04938297|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111093531|NCT04938297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111093532|NCT04938297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111093533|NCT04937907|Hydroxychloroquine|hydroxychloroquine|mesh-list
111093534|NCT04937907|Benazepril|benazepril|mesh-list
111093535|NCT04937907|Antimalarials|antimalarials|mesh-ancestor
111093536|NCT04937907|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111093537|NCT04937907|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111093538|NCT04937907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111093539|NCT04937907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111093540|NCT04937907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111093541|NCT04937907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111093542|NCT04937907|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
111093543|NCT04937907|Protease Inhibitors|protease inhibitors|mesh-ancestor
111093544|NCT04937907|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111093545|NCT02625909|Sofosbuvir|sofosbuvir|mesh-list
111093546|NCT02625909|Velpatasvir|velpatasvir|mesh-list
111093547|NCT02625909|Antiviral Agents|antiviral agents|mesh-ancestor
111093548|NCT02625909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111093549|NCT03246659|Polygeline|polygeline|mesh-list
111093550|NCT03246659|Gastrins|gastrins|mesh-list
111093551|NCT03246659|Plasma Substitutes|plasma substitutes|mesh-ancestor
111093552|NCT03246659|Blood Substitutes|blood substitutes|mesh-ancestor
111093553|NCT03246659|Hormones|hormones|mesh-ancestor
111093554|NCT03246659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111093555|NCT03246659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111093556|NCT03246581|Tiotropium Bromide|tiotropium bromide|mesh-list
111093557|NCT03246581|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111093558|NCT03246581|Autonomic Agents|autonomic agents|mesh-ancestor
111093559|NCT03246581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111093560|NCT03246581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111093561|NCT03246581|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111093562|NCT03246581|Respiratory System Agents|respiratory system agents|mesh-ancestor
111093563|NCT03246581|Parasympatholytics|parasympatholytics|mesh-ancestor
111093564|NCT03246581|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111093565|NCT03246581|Cholinergic Agents|cholinergic agents|mesh-ancestor
111093566|NCT03246581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111093567|NCT03246581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111093568|NCT03246113|Temozolomide|temozolomide|mesh-list
111093569|NCT03246113|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111093570|NCT03246113|Alkylating Agents|alkylating agents|mesh-ancestor
111093571|NCT03246113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111093572|NCT03246113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111093573|NCT04937673|Paclitaxel|paclitaxel|mesh-list
111093574|NCT04937673|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111093575|NCT04937673|Cisplatin|cisplatin|mesh-list
111093576|NCT04937673|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111093577|NCT04937673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111093578|NCT04937673|Tubulin Modulators|tubulin modulators|mesh-ancestor
111093579|NCT04937673|Antimitotic Agents|antimitotic agents|mesh-ancestor
111093580|NCT04937673|Mitosis Modulators|mitosis modulators|mesh-ancestor
111093581|NCT04937673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111093582|NCT04944381|Vaccines|vaccines|mesh-list
111093583|NCT04944381|Immunologic Factors|immunologic factors|mesh-ancestor
111093584|NCT04944381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111093585|NCT03245177|Pembrolizumab|pembrolizumab|mesh-list
111093586|NCT03245177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111093587|NCT03245177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111093588|NCT03245177|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111093589|NCT03245177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111093590|NCT03245333|Hormones|hormones|mesh-list
111093591|NCT03245333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111093592|NCT03245333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111093593|NCT04958187|Mitogens|mitogens|mesh-list
111093594|NCT04958187|Mitosis Modulators|mitosis modulators|mesh-ancestor
110810692|NCT03894046|Durlobactam|durlobactam|mesh-list
111093595|NCT04958187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111093596|NCT03244319|Warfarin|warfarin|mesh-list
111093597|NCT03244319|Edoxaban|edoxaban|mesh-list
111093598|NCT03244319|Anticoagulants|anticoagulants|mesh-list
111093599|NCT03244319|Coagulants|coagulants|mesh-list
111093600|NCT03244319|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111093601|NCT03244319|Antithrombins|antithrombins|mesh-ancestor
111093602|NCT03244319|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111093603|NCT03244319|Protease Inhibitors|protease inhibitors|mesh-ancestor
111093604|NCT03244319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111093605|NCT03244319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111093606|NCT03244553|Prucalopride|prucalopride|mesh-list
111093607|NCT03244553|Laxatives|laxatives|mesh-ancestor
111093608|NCT03244553|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111093609|NCT03244553|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
111093610|NCT03244553|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111093611|NCT03244553|Serotonin Agents|serotonin agents|mesh-ancestor
111093612|NCT03244553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111093613|NCT03244553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111093614|NCT03244553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111093615|NCT03244241|Insulin|insulin|mesh-list
111093616|NCT03244241|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111093617|NCT03244241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111093618|NCT03243851|Metformin|metformin|mesh-list
111093619|NCT03243851|Temozolomide|temozolomide|mesh-list
111093620|NCT03243851|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111093621|NCT03243851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111093622|NCT03243851|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111093623|NCT03243851|Alkylating Agents|alkylating agents|mesh-ancestor
111093624|NCT03243851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111093625|NCT03243851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111093626|NCT02623959|Doxycycline|doxycycline|mesh-list
111093627|NCT02623959|Fentanyl|fentanyl|mesh-list
111093628|NCT02623959|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111093629|NCT02623959|Narcotics|narcotics|mesh-ancestor
111093630|NCT02623959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111093631|NCT02623959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111093632|NCT02623959|Analgesics|analgesics|mesh-ancestor
111093633|NCT02623959|Sensory System Agents|sensory system agents|mesh-ancestor
111093634|NCT02623959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111093635|NCT02623959|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111093636|NCT02623959|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111093637|NCT02623959|Anesthetics, General|anesthetics, general|mesh-ancestor
111093638|NCT02623959|Anesthetics|anesthetics|mesh-ancestor
111093639|NCT02623959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111093640|NCT02623959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111093641|NCT02623959|Antimalarials|antimalarials|mesh-ancestor
111093642|NCT02623959|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111093643|NCT02623959|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111093644|NCT03242993|Folic Acid|folic acid|mesh-list
111093645|NCT03242993|Hematinics|hematinics|mesh-ancestor
111093646|NCT03242993|Vitamin B Complex|vitamin b complex|mesh-ancestor
111093647|NCT03242993|Vitamins|vitamins|mesh-ancestor
111093648|NCT03242993|Micronutrients|micronutrients|mesh-ancestor
111093649|NCT03242993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111093650|NCT04487093|Vaccines|vaccines|mesh-list
111093651|NCT04487093|Immunologic Factors|immunologic factors|mesh-ancestor
111093652|NCT04487093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111093653|NCT04936971|Mycophenolic Acid|mycophenolic acid|mesh-list
111093654|NCT04936971|Everolimus|everolimus|mesh-list
111093655|NCT04936971|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111093656|NCT04936971|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111093657|NCT04936971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111093658|NCT04936971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111093659|NCT04936971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111093660|NCT04936971|Immunologic Factors|immunologic factors|mesh-ancestor
111093661|NCT04936971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111093662|NCT04936971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111093663|NCT04936971|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111093664|NCT04936971|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111093665|NCT04936971|Antitubercular Agents|antitubercular agents|mesh-ancestor
111093666|NCT04936971|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111093667|NCT04936971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111093668|NCT04931433|Lidocaine|lidocaine|mesh-list
111093669|NCT04931433|Anesthetics, Local|anesthetics, local|mesh-ancestor
111093670|NCT04931433|Anesthetics|anesthetics|mesh-ancestor
111093671|NCT04931433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111093672|NCT04931433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111093673|NCT04931433|Sensory System Agents|sensory system agents|mesh-ancestor
111093674|NCT04931433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111093675|NCT04931433|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111093676|NCT04931433|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110029846|NCT02995252|Tenofovir|tenofovir|mesh-list
111093677|NCT04931433|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111093678|NCT04931433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111093679|NCT04931433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111093680|NCT04931121|Viscosupplements|viscosupplements|mesh-list
111093681|NCT04931121|Protective Agents|protective agents|mesh-ancestor
111093682|NCT04931121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111093683|NCT03241901|Lumefantrine|lumefantrine|mesh-list
111093684|NCT03241901|Artemether|artemether|mesh-list
111093685|NCT03241901|Primaquine|primaquine|mesh-list
111093686|NCT03241901|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
111093687|NCT03241901|Antimalarials|antimalarials|mesh-ancestor
111093688|NCT03241901|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111093689|NCT03241901|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111093690|NCT03241901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111093691|NCT03241199|Imatinib Mesylate|imatinib mesylate|mesh-list
111093692|NCT03241199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111093693|NCT03241199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111093694|NCT03241199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111093695|NCT03241199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111093696|NCT03241043|Tacrolimus|tacrolimus|mesh-list
111093697|NCT03241043|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111093698|NCT03241043|Immunologic Factors|immunologic factors|mesh-ancestor
111093699|NCT03241043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111093700|NCT03241043|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111093701|NCT03241043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111093702|NCT03241043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111093703|NCT02453867|Tacrolimus|tacrolimus|mesh-list
111093704|NCT02453867|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111093705|NCT02453867|Immunologic Factors|immunologic factors|mesh-ancestor
111093706|NCT02453867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111093707|NCT02453867|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111093708|NCT02453867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111093709|NCT02453867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111093710|NCT03057561|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
111093711|NCT03057561|Chelating Agents|chelating agents|mesh-ancestor
111093712|NCT03057561|Sequestering Agents|sequestering agents|mesh-ancestor
111093713|NCT03057561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111093714|NCT03239327|Alprostadil|alprostadil|mesh-list
111093715|NCT03239327|Misoprostol|misoprostol|mesh-list
111093716|NCT03239327|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111093717|NCT03239327|Abortifacient Agents|abortifacient agents|mesh-ancestor
111093718|NCT03239327|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111093719|NCT03239327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111093720|NCT03239327|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111093721|NCT03239327|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111093722|NCT03239327|Oxytocics|oxytocics|mesh-ancestor
111093723|NCT03239327|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111093724|NCT03239327|Vasodilator Agents|vasodilator agents|mesh-ancestor
111093725|NCT03239327|Urological Agents|urological agents|mesh-ancestor
111093726|NCT04930185|Vaccines|vaccines|mesh-list
111093727|NCT04930185|Immunologic Factors|immunologic factors|mesh-ancestor
111093728|NCT04930185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111093729|NCT02314559|Propofol|propofol|mesh-list
111093730|NCT02314559|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111093731|NCT02314559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111093732|NCT02314559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111093733|NCT02314559|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111093734|NCT02314559|Anesthetics, General|anesthetics, general|mesh-ancestor
111093735|NCT02314559|Anesthetics|anesthetics|mesh-ancestor
111093736|NCT03238703|Tamoxifen|tamoxifen|mesh-list
111093737|NCT03238703|Toremifene|toremifene|mesh-list
111093738|NCT03238703|Letrozole|letrozole|mesh-list
111093739|NCT03238703|Anastrozole|anastrozole|mesh-list
111093740|NCT03238703|Exemestane|exemestane|mesh-list
111093741|NCT03238703|Citric Acid|citric acid|mesh-list
111093742|NCT03238703|Sodium Citrate|sodium citrate|mesh-list
111093743|NCT03238703|Anticoagulants|anticoagulants|mesh-ancestor
111093744|NCT03238703|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
111093745|NCT03238703|Chelating Agents|chelating agents|mesh-ancestor
111093746|NCT03238703|Sequestering Agents|sequestering agents|mesh-ancestor
110810841|NCT00978016|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111093747|NCT03238703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111093748|NCT03238703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111093749|NCT03238703|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111093750|NCT03238703|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111093751|NCT03238703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111093752|NCT03238703|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111093753|NCT03238703|Hormone Antagonists|hormone antagonists|mesh-ancestor
111093754|NCT03238703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111093755|NCT03238703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111093756|NCT03238703|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111093757|NCT03238703|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111093758|NCT03238703|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111093759|NCT03238703|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111093760|NCT03238625|Lidocaine|lidocaine|mesh-list
111093761|NCT03238625|Anesthetics, Local|anesthetics, local|mesh-ancestor
111093762|NCT03238625|Anesthetics|anesthetics|mesh-ancestor
111093763|NCT03238625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111093764|NCT03238625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111093765|NCT03238625|Sensory System Agents|sensory system agents|mesh-ancestor
111093766|NCT03238625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111093767|NCT03238625|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111093768|NCT03238625|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111093769|NCT03238625|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111093770|NCT03238625|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111093771|NCT03238625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111093772|NCT03238079|Immunoglobulins|immunoglobulins|mesh-list
111093773|NCT03238079|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111093774|NCT03238079|Immunologic Factors|immunologic factors|mesh-ancestor
111093775|NCT03238079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111093776|NCT05387681|Endostatins|endostatins|mesh-list
111093777|NCT05387681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111093778|NCT05387681|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111093779|NCT05387681|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111093780|NCT05387681|Growth Substances|growth substances|mesh-ancestor
111093781|NCT05387681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111093782|NCT05387681|Growth Inhibitors|growth inhibitors|mesh-ancestor
111093783|NCT03238157|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
111093784|NCT03238157|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111093785|NCT03238157|Glucocorticoids|glucocorticoids|mesh-ancestor
111093786|NCT03238157|Hormones|hormones|mesh-ancestor
111093787|NCT03238157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111093788|NCT03238157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111093789|NCT04485845|Metformin|metformin|mesh-list
111093790|NCT04485845|Vildagliptin|vildagliptin|mesh-list
111093791|NCT04485845|Captopril|captopril|mesh-list
111093792|NCT04485845|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111093793|NCT04485845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111093794|NCT04485845|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111093795|NCT04485845|Protease Inhibitors|protease inhibitors|mesh-ancestor
111093796|NCT04485845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111093797|NCT04485845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111093798|NCT04485845|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
111093799|NCT04485845|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111093800|NCT00700427|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
111093801|NCT00700427|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111093802|NCT00700427|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111093803|NCT00700427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111093804|NCT00700427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111093805|NCT00700427|Adrenergic Agents|adrenergic agents|mesh-ancestor
111093806|NCT00700427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111093807|NCT00700427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111093808|NCT03237533|Promethazine|promethazine|mesh-list
111093809|NCT03237533|Doxycycline|doxycycline|mesh-list
111093810|NCT03237533|Nystatin|nystatin|mesh-list
111093811|NCT03237533|Dexamethasone|dexamethasone|mesh-list
111093812|NCT03237533|Triamcinolone|triamcinolone|mesh-list
111093813|NCT03237533|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111093814|NCT03237533|Antiemetics|antiemetics|mesh-ancestor
111093815|NCT03237533|Autonomic Agents|autonomic agents|mesh-ancestor
111093816|NCT03237533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110677385|NCT00999037|Sevelamer|sevelamer|mesh-list
111093817|NCT03237533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111093818|NCT03237533|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111093819|NCT03237533|Glucocorticoids|glucocorticoids|mesh-ancestor
111093820|NCT03237533|Hormones|hormones|mesh-ancestor
111093821|NCT03237533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111093822|NCT03237533|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111093823|NCT03237533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111093824|NCT03237533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111093825|NCT03237533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111093826|NCT03237533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111093827|NCT03237533|Antimalarials|antimalarials|mesh-ancestor
111093828|NCT03237533|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111093829|NCT03237533|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111093830|NCT03237533|Antipruritics|antipruritics|mesh-ancestor
111093831|NCT03237533|Dermatologic Agents|dermatologic agents|mesh-ancestor
111093832|NCT03237533|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111093833|NCT03237533|Histamine Antagonists|histamine antagonists|mesh-ancestor
111093834|NCT03237533|Histamine Agents|histamine agents|mesh-ancestor
111093835|NCT03237533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111093836|NCT03237533|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111093837|NCT03237533|Antifungal Agents|antifungal agents|mesh-ancestor
111093838|NCT03237533|Ionophores|ionophores|mesh-ancestor
111093839|NCT03237533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111093840|NCT03235973|Fludarabine|fludarabine|mesh-list
111093841|NCT03235973|Busulfan|busulfan|mesh-list
111093842|NCT03235973|Cladribine|cladribine|mesh-list
111093843|NCT03235973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111093844|NCT03235973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111093845|NCT03235973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111093846|NCT03235973|Immunologic Factors|immunologic factors|mesh-ancestor
111093847|NCT03235973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111093848|NCT03235973|Alkylating Agents|alkylating agents|mesh-ancestor
111093849|NCT03235973|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111093850|NCT03235973|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111093851|NCT02453087|Rituximab|rituximab|mesh-list
111093852|NCT02453087|Obinutuzumab|obinutuzumab|mesh-list
111093853|NCT02453087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111093854|NCT02453087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111093855|NCT02453087|Immunologic Factors|immunologic factors|mesh-ancestor
111093856|NCT02453087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111093857|NCT02453087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111093858|NCT02124772|Trametinib|trametinib|mesh-list
111093859|NCT02124772|Dabrafenib|dabrafenib|mesh-list
111093860|NCT02124772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111093861|NCT02124772|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111093862|NCT02124772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111093863|NCT02124772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111093864|NCT02159482|Interferons|interferons|mesh-list
111093865|NCT02159482|Interferon-alpha|interferon-alpha|mesh-list
111093866|NCT02159482|Interferon alpha-2|interferon alpha-2|mesh-list
111093867|NCT02159482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111093868|NCT02159482|Antiviral Agents|antiviral agents|mesh-ancestor
111093869|NCT02159482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111093870|NCT02159482|Immunologic Factors|immunologic factors|mesh-ancestor
111093871|NCT02159482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111093872|NCT05269030|Ivermectin|ivermectin|mesh-list
111093873|NCT05269030|Budesonide|budesonide|mesh-list
111093874|NCT05269030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111093875|NCT05269030|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111093876|NCT05269030|Autonomic Agents|autonomic agents|mesh-ancestor
111093877|NCT05269030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111093878|NCT05269030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111093879|NCT05269030|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111093880|NCT05269030|Respiratory System Agents|respiratory system agents|mesh-ancestor
111093881|NCT05269030|Glucocorticoids|glucocorticoids|mesh-ancestor
111093882|NCT05269030|Hormones|hormones|mesh-ancestor
111093883|NCT05269030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111093884|NCT05269030|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111093885|NCT05269030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111093886|NCT02622321|Anti-inhibitor coagulant complex|anti-inhibitor coagulant complex|mesh-list
111093887|NCT02622321|Coagulants|coagulants|mesh-ancestor
111093888|NCT02187172|Ustekinumab|ustekinumab|mesh-list
111093889|NCT02187172|Dermatologic Agents|dermatologic agents|mesh-ancestor
111093890|NCT03057015|Dexamethasone|dexamethasone|mesh-list
111093891|NCT03057015|Clonidine|clonidine|mesh-list
111093892|NCT03057015|Epinephrine|epinephrine|mesh-list
111093893|NCT03057015|Ropivacaine|ropivacaine|mesh-list
111093894|NCT03057015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111093895|NCT03057015|Antiemetics|antiemetics|mesh-ancestor
111093896|NCT03057015|Autonomic Agents|autonomic agents|mesh-ancestor
111093897|NCT03057015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111093898|NCT03057015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111093899|NCT03057015|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111093900|NCT03057015|Glucocorticoids|glucocorticoids|mesh-ancestor
111093901|NCT03057015|Hormones|hormones|mesh-ancestor
111093902|NCT03057015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111093903|NCT03057015|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111093904|NCT03057015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111093905|NCT03057015|Anesthetics, Local|anesthetics, local|mesh-ancestor
111093906|NCT03057015|Anesthetics|anesthetics|mesh-ancestor
111093907|NCT03057015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111093908|NCT03057015|Sensory System Agents|sensory system agents|mesh-ancestor
111093909|NCT03057015|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111093910|NCT03057015|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111093911|NCT03057015|Adrenergic Agents|adrenergic agents|mesh-ancestor
111093912|NCT03057015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111093913|NCT03057015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111093914|NCT03057015|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111093915|NCT03057015|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111093916|NCT03057015|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111093917|NCT03057015|Respiratory System Agents|respiratory system agents|mesh-ancestor
111093918|NCT03057015|Mydriatics|mydriatics|mesh-ancestor
111093919|NCT03057015|Sympathomimetics|sympathomimetics|mesh-ancestor
111093920|NCT03057015|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111093921|NCT03057015|Analgesics|analgesics|mesh-ancestor
111093922|NCT03057015|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111093923|NCT03057015|Sympatholytics|sympatholytics|mesh-ancestor
111093924|NCT03057015|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111093925|NCT04934475|Lenalidomide|lenalidomide|mesh-list
111093926|NCT04934475|Immunologic Factors|immunologic factors|mesh-ancestor
111093927|NCT04934475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111093928|NCT04934475|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111093929|NCT04934475|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111093930|NCT04934475|Growth Substances|growth substances|mesh-ancestor
111093931|NCT04934475|Growth Inhibitors|growth inhibitors|mesh-ancestor
111093932|NCT04934475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111093933|NCT03057483|Vaccines|vaccines|mesh-list
111093934|NCT03057483|Immunologic Factors|immunologic factors|mesh-ancestor
111093935|NCT03057483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111093936|NCT04922151|Ranibizumab|ranibizumab|mesh-list
111093937|NCT04922151|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111093938|NCT04922151|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111093939|NCT04922151|Growth Substances|growth substances|mesh-ancestor
111093940|NCT04922151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111093941|NCT04922151|Growth Inhibitors|growth inhibitors|mesh-ancestor
111093942|NCT04922151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111093943|NCT04928313|Glatiramer Acetate|glatiramer acetate|mesh-list
111093944|NCT04928313|(T,G)-A-L|(t,g)-a-l|mesh-list
111093945|NCT04928313|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111093946|NCT04928313|Immunologic Factors|immunologic factors|mesh-ancestor
111093947|NCT04928313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111093948|NCT04928313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111093949|NCT04928313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111093950|NCT04928079|Antiparkinson Agents|antiparkinson agents|mesh-list
111093951|NCT04928079|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111093952|NCT04920747|Taxane|taxane|mesh-list
111093953|NCT04920747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111093954|NCT04927299|Losartan|losartan|mesh-list
111093955|NCT04927299|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
111093956|NCT04927299|Chlorthalidone|chlorthalidone|mesh-list
111093957|NCT04927299|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111093958|NCT04927299|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111093959|NCT04927299|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111093960|NCT04927299|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111093961|NCT04927299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111093962|NCT04927299|Diuretics|diuretics|mesh-ancestor
111093963|NCT04927299|Natriuretic Agents|natriuretic agents|mesh-ancestor
111093964|NCT04927299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111093965|NCT04927299|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
111093966|NCT04927299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111093967|NCT03056625|Vitamin A|vitamin a|mesh-list
111093968|NCT03056625|Vitamins|vitamins|mesh-ancestor
111093969|NCT03056625|Micronutrients|micronutrients|mesh-ancestor
111093970|NCT03056625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111093971|NCT04913103|Rituximab|rituximab|mesh-list
111093972|NCT04913103|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
111093973|NCT04913103|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
111093974|NCT04913103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111093975|NCT04913103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111093976|NCT04913103|Immunologic Factors|immunologic factors|mesh-ancestor
111093977|NCT04913103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111093978|NCT04913103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111093979|NCT04913103|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111093980|NCT04913103|Alkylating Agents|alkylating agents|mesh-ancestor
111093981|NCT04913103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111093982|NCT04913103|Immunoconjugates|immunoconjugates|mesh-ancestor
111093983|NCT04920669|Dexmedetomidine|dexmedetomidine|mesh-list
111093984|NCT04920669|Bupivacaine|bupivacaine|mesh-list
111093985|NCT04920669|Anesthetics, Local|anesthetics, local|mesh-ancestor
111093986|NCT04920669|Anesthetics|anesthetics|mesh-ancestor
111093987|NCT04920669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111093988|NCT04920669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111093989|NCT04920669|Sensory System Agents|sensory system agents|mesh-ancestor
111093990|NCT04920669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111093991|NCT04920669|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111093992|NCT04920669|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111093993|NCT04920669|Analgesics|analgesics|mesh-ancestor
111093994|NCT04920669|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111093995|NCT04920669|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111093996|NCT04920669|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111093997|NCT04920669|Adrenergic Agents|adrenergic agents|mesh-ancestor
111093998|NCT04920669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111093999|NCT04920669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111094000|NCT04926753|Fluorouracil|fluorouracil|mesh-list
111094001|NCT04926753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111094002|NCT04926753|Antimetabolites|antimetabolites|mesh-ancestor
111094003|NCT04926753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111094004|NCT04926753|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111094005|NCT04926753|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111094006|NCT04926753|Immunologic Factors|immunologic factors|mesh-ancestor
111094007|NCT04926753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111094008|NCT02621931|Calcitonin|calcitonin|mesh-list
111094009|NCT02621931|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
111094010|NCT02621931|Katacalcin|katacalcin|mesh-list
111094011|NCT02621931|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111094012|NCT02621931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111094013|NCT02621931|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111094014|NCT02621931|Vasodilator Agents|vasodilator agents|mesh-ancestor
111094015|NCT04925973|Tofacitinib|tofacitinib|mesh-list
111094016|NCT04925973|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
111094017|NCT04925973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111094018|NCT04925973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111094019|NCT04925973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111094020|NCT04912167|Valsartan|valsartan|mesh-list
111094021|NCT04912167|Enalapril|enalapril|mesh-list
111094022|NCT04912167|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
111094023|NCT04912167|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111094024|NCT04912167|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111094025|NCT04912167|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111094026|NCT04912167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111094027|NCT04912167|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
111094028|NCT04912167|Protease Inhibitors|protease inhibitors|mesh-ancestor
111094029|NCT04912167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111094030|NCT03056703|Aspirin|aspirin|mesh-list
111094031|NCT03056703|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111094032|NCT03056703|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111094033|NCT03056703|Analgesics|analgesics|mesh-ancestor
111094034|NCT03056703|Sensory System Agents|sensory system agents|mesh-ancestor
111094035|NCT03056703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111094036|NCT03056703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111094037|NCT03056703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111094038|NCT03056703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111094039|NCT03056703|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111094040|NCT03056703|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111094041|NCT03056703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111094042|NCT03056703|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111094043|NCT03056703|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111094044|NCT03056703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111094045|NCT03056703|Antipyretics|antipyretics|mesh-ancestor
111094046|NCT02158936|Azacitidine|azacitidine|mesh-list
110811140|NCT03135106|Fluconazole|fluconazole|mesh-list
110641725|NCT01005381|Calcium, Dietary|calcium, dietary|mesh-list
111094047|NCT02158936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111094048|NCT02158936|Antimetabolites|antimetabolites|mesh-ancestor
111094049|NCT02158936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111094050|NCT02158936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111094051|NCT02158936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111094052|NCT04924647|Dexamethasone|dexamethasone|mesh-list
111094053|NCT04924647|Lenalidomide|lenalidomide|mesh-list
111094054|NCT04924647|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111094055|NCT04924647|Antiemetics|antiemetics|mesh-ancestor
111094056|NCT04924647|Autonomic Agents|autonomic agents|mesh-ancestor
111094057|NCT04924647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111094058|NCT04924647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111094059|NCT04924647|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111094060|NCT04924647|Glucocorticoids|glucocorticoids|mesh-ancestor
111094061|NCT04924647|Hormones|hormones|mesh-ancestor
111094062|NCT04924647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111094063|NCT04924647|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111094064|NCT04924647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111094065|NCT04924647|Immunologic Factors|immunologic factors|mesh-ancestor
111094066|NCT04924647|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111094067|NCT04924647|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111094068|NCT04924647|Growth Substances|growth substances|mesh-ancestor
111094069|NCT04924647|Growth Inhibitors|growth inhibitors|mesh-ancestor
111094070|NCT04912011|Canrenoic Acid|canrenoic acid|mesh-list
111094071|NCT04912011|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
111094072|NCT04912011|Hormone Antagonists|hormone antagonists|mesh-ancestor
111094073|NCT04912011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111094074|NCT04912011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111094075|NCT04912011|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
111094076|NCT04912011|Diuretics|diuretics|mesh-ancestor
111094077|NCT04912011|Natriuretic Agents|natriuretic agents|mesh-ancestor
111094078|NCT04918719|Acetylcysteine|acetylcysteine|mesh-list
111094079|NCT04918719|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111094080|NCT04918719|Antiviral Agents|antiviral agents|mesh-ancestor
111094081|NCT04918719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111094082|NCT04918719|Expectorants|expectorants|mesh-ancestor
111094083|NCT04918719|Respiratory System Agents|respiratory system agents|mesh-ancestor
111094084|NCT04918719|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111094085|NCT04918719|Antioxidants|antioxidants|mesh-ancestor
111094086|NCT04918719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111094087|NCT04918719|Protective Agents|protective agents|mesh-ancestor
111094088|NCT04918719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111094089|NCT04918719|Antidotes|antidotes|mesh-ancestor
111094090|NCT03056391|Acetaminophen|acetaminophen|mesh-list
111094091|NCT03056391|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111094092|NCT03056391|Analgesics|analgesics|mesh-ancestor
111094093|NCT03056391|Sensory System Agents|sensory system agents|mesh-ancestor
111094094|NCT03056391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111094095|NCT03056391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111094096|NCT03056391|Antipyretics|antipyretics|mesh-ancestor
111094097|NCT04924413|Tislelizumab|tislelizumab|mesh-list
111094098|NCT04924413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111094099|NCT04924413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111094100|NCT04747054|Pembrolizumab|pembrolizumab|mesh-list
111094101|NCT04747054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111094102|NCT04747054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111094103|NCT04747054|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111094104|NCT04747054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111094105|NCT04918563|Nitroglycerin|nitroglycerin|mesh-list
111094106|NCT04918563|Acetylcholine|acetylcholine|mesh-list
111094107|NCT04918563|Vasodilator Agents|vasodilator agents|mesh-ancestor
111094108|NCT04918563|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111094109|NCT04918563|Cholinergic Agents|cholinergic agents|mesh-ancestor
111094110|NCT04918563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111094111|NCT04918563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110559243|NCT00498355|Ranibizumab|ranibizumab|mesh-list
111094112|NCT04918563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111094113|NCT02123446|Cephalexin|cephalexin|mesh-list
111094114|NCT02123446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111094115|NCT02123446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111094116|NCT04918953|Methylprednisolone|methylprednisolone|mesh-list
111094117|NCT04918953|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111094118|NCT04918953|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111094119|NCT04918953|Prednisolone|prednisolone|mesh-list
111094120|NCT04918953|Prednisolone acetate|prednisolone acetate|mesh-list
111094121|NCT04918953|Budesonide|budesonide|mesh-list
111094122|NCT04918953|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111094123|NCT04918953|Prednisolone phosphate|prednisolone phosphate|mesh-list
111094124|NCT04918953|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111094125|NCT04918953|Antiemetics|antiemetics|mesh-ancestor
111094126|NCT04918953|Autonomic Agents|autonomic agents|mesh-ancestor
111094127|NCT04918953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111094128|NCT04918953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111094129|NCT04918953|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111094130|NCT04918953|Glucocorticoids|glucocorticoids|mesh-ancestor
111094131|NCT04918953|Hormones|hormones|mesh-ancestor
111094132|NCT04918953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111094133|NCT04918953|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111094134|NCT04918953|Protective Agents|protective agents|mesh-ancestor
111094135|NCT04918953|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111094136|NCT04918953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111094137|NCT04918953|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111094138|NCT04918953|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111094139|NCT04918953|Respiratory System Agents|respiratory system agents|mesh-ancestor
111094140|NCT02123134|Deoxycholic Acid|deoxycholic acid|mesh-list
111094141|NCT02123134|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
111094142|NCT02123134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111094143|NCT03054207|Clopidogrel|clopidogrel|mesh-list
111094144|NCT03054207|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
111094145|NCT03054207|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111094146|NCT03054207|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111094147|NCT03054207|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111094148|NCT03054207|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111094149|NCT03054207|Purinergic Agents|purinergic agents|mesh-ancestor
111094150|NCT03054207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111094151|NCT03054207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111094152|NCT03054207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111094153|NCT02185534|Clopidogrel|clopidogrel|mesh-list
111094154|NCT02185534|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111094155|NCT02185534|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111094156|NCT02185534|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111094157|NCT02185534|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111094158|NCT02185534|Purinergic Agents|purinergic agents|mesh-ancestor
111094159|NCT02185534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111094160|NCT02185534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111094161|NCT02185534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111094162|NCT03056079|Aflibercept|aflibercept|mesh-list
111094163|NCT03056079|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111094164|NCT03056079|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111094165|NCT03056079|Growth Substances|growth substances|mesh-ancestor
111094166|NCT03056079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111094167|NCT03056079|Growth Inhibitors|growth inhibitors|mesh-ancestor
111094168|NCT03056079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111094169|NCT03055767|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111094170|NCT03055767|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111094171|NCT03055767|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111094172|NCT03055767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111094173|NCT03055767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111094174|NCT03055767|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111094175|NCT03055767|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111094176|NCT03055767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111094177|NCT03055767|Cholinergic Agents|cholinergic agents|mesh-ancestor
111094178|NCT03055767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111094179|NCT02157376|Esomeprazole|esomeprazole|mesh-list
111094180|NCT02157376|Cimetidine|cimetidine|mesh-list
111094181|NCT02157376|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111094182|NCT02157376|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111094183|NCT02157376|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111094184|NCT02157376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111094185|NCT02157376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111094187|NCT02157376|Histamine Antagonists|histamine antagonists|mesh-ancestor
111094188|NCT02157376|Histamine Agents|histamine agents|mesh-ancestor
111094189|NCT02157376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111094190|NCT02157376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111094191|NCT02157376|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111094192|NCT02157376|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111094193|NCT04922541|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
111094194|NCT04922541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110811289|NCT04473820|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
111094195|NCT04922541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111094196|NCT04922541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111094197|NCT02157298|Dapagliflozin|dapagliflozin|mesh-list
111094198|NCT02157298|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111094199|NCT02157298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111094200|NCT02157298|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111094201|NCT02157298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111094202|NCT03054285|Levetiracetam|levetiracetam|mesh-list
111094203|NCT03054285|Anticonvulsants|anticonvulsants|mesh-ancestor
111094204|NCT03054285|Nootropic Agents|nootropic agents|mesh-ancestor
111094205|NCT04917627|Vancomycin|vancomycin|mesh-list
111094206|NCT04917627|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111094207|NCT04917627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111094208|NCT04903743|Magnesium Sulfate|magnesium sulfate|mesh-list
111094209|NCT04903743|Bupivacaine|bupivacaine|mesh-list
111094210|NCT04903743|Anesthetics, Local|anesthetics, local|mesh-ancestor
111094211|NCT04903743|Anesthetics|anesthetics|mesh-ancestor
111094212|NCT04903743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111094213|NCT04903743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111094214|NCT04903743|Sensory System Agents|sensory system agents|mesh-ancestor
111094215|NCT04903743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111094216|NCT04903743|Analgesics|analgesics|mesh-ancestor
111094217|NCT04903743|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111094218|NCT04903743|Anticonvulsants|anticonvulsants|mesh-ancestor
111094219|NCT04903743|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111094220|NCT04903743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111094221|NCT04903743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111094222|NCT04903743|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111094223|NCT04903743|Tocolytic Agents|tocolytic agents|mesh-ancestor
111094224|NCT04903743|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111094225|NCT04753840|Antihypertensive Agents|antihypertensive agents|mesh-list
111094226|NCT04903275|Fluorides|fluorides|mesh-list
111094227|NCT04903275|Fluorides, Topical|fluorides, topical|mesh-list
111094228|NCT04903275|Cariostatic Agents|cariostatic agents|mesh-ancestor
111094229|NCT04903275|Protective Agents|protective agents|mesh-ancestor
111094230|NCT04903275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111094231|NCT02121262|Dexamethasone|dexamethasone|mesh-list
111094232|NCT02121262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111094233|NCT02121262|Antiemetics|antiemetics|mesh-ancestor
111094234|NCT02121262|Autonomic Agents|autonomic agents|mesh-ancestor
111094235|NCT02121262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111094236|NCT02121262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111094237|NCT02121262|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111094238|NCT02121262|Glucocorticoids|glucocorticoids|mesh-ancestor
111094239|NCT02121262|Hormones|hormones|mesh-ancestor
111094240|NCT02121262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111094241|NCT02121262|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111094242|NCT02121262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111094243|NCT03053739|Bosentan|bosentan|mesh-list
111094244|NCT03053739|Sildenafil Citrate|sildenafil citrate|mesh-list
111094245|NCT03053739|Vasodilator Agents|vasodilator agents|mesh-ancestor
111094246|NCT03053739|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111094247|NCT03053739|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111094248|NCT03053739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111094249|NCT03053739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111094250|NCT03053739|Urological Agents|urological agents|mesh-ancestor
111094251|NCT03053739|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111094252|NCT03053739|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
111094253|NCT04916925|Vitamin D|vitamin d|mesh-list
111094254|NCT04916925|Vitamins|vitamins|mesh-ancestor
111094255|NCT04916925|Micronutrients|micronutrients|mesh-ancestor
110677396|NCT00861705|Paclitaxel|paclitaxel|mesh-list
111094256|NCT04916925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111094257|NCT04916925|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111094258|NCT04902027|Mitoxantrone|mitoxantrone|mesh-list
111094259|NCT04902027|Analgesics|analgesics|mesh-ancestor
111094260|NCT04902027|Sensory System Agents|sensory system agents|mesh-ancestor
111094261|NCT04902027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111094262|NCT04902027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111094263|NCT04902027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111094264|NCT04902027|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111094265|NCT04902027|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111094266|NCT04902027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111094267|NCT04902027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111094268|NCT04902105|Mefenamic Acid|mefenamic acid|mesh-list
111094269|NCT04902105|Valproic Acid|valproic acid|mesh-list
111094270|NCT04902105|Ecopipam|ecopipam|mesh-list
111094271|NCT04902105|Anticonvulsants|anticonvulsants|mesh-ancestor
111094272|NCT04902105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111094273|NCT04902105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111094274|NCT04902105|GABA Agents|gaba agents|mesh-ancestor
111094275|NCT04902105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111094276|NCT04902105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111094277|NCT04902105|Antimanic Agents|antimanic agents|mesh-ancestor
111094278|NCT04902105|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111094279|NCT04902105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111094280|NCT04902105|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111094281|NCT04902105|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111094282|NCT04902105|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111094283|NCT04902105|Dopamine Agents|dopamine agents|mesh-ancestor
111094284|NCT04902105|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111094285|NCT04902105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111094286|NCT04902105|Analgesics|analgesics|mesh-ancestor
111094287|NCT04902105|Sensory System Agents|sensory system agents|mesh-ancestor
111094288|NCT04902105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111094289|NCT04902105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111094290|NCT04902105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111094291|NCT04902105|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111094292|NCT02120950|Aflibercept|aflibercept|mesh-list
111094293|NCT02120950|Verteporfin|verteporfin|mesh-list
111094294|NCT02120950|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111094295|NCT02120950|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111094296|NCT02120950|Growth Substances|growth substances|mesh-ancestor
111094297|NCT02120950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111094298|NCT02120950|Growth Inhibitors|growth inhibitors|mesh-ancestor
111094299|NCT02120950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111094300|NCT02120950|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111094301|NCT02120950|Dermatologic Agents|dermatologic agents|mesh-ancestor
111094302|NCT02120794|Insulin|insulin|mesh-list
111094303|NCT02120794|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111094304|NCT02120794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111094305|NCT03053583|Pyrithione zinc|pyrithione zinc|mesh-list
111094306|NCT03053583|Keratolytic Agents|keratolytic agents|mesh-ancestor
111094307|NCT03053583|Dermatologic Agents|dermatologic agents|mesh-ancestor
111094308|NCT04900311|Paclitaxel|paclitaxel|mesh-list
111094309|NCT04900311|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111094310|NCT04900311|Trastuzumab|trastuzumab|mesh-list
111094311|NCT04900311|Pertuzumab|pertuzumab|mesh-list
111094312|NCT04900311|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111094313|NCT04900311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111094314|NCT04900311|Tubulin Modulators|tubulin modulators|mesh-ancestor
111094315|NCT04900311|Antimitotic Agents|antimitotic agents|mesh-ancestor
111094316|NCT04900311|Mitosis Modulators|mitosis modulators|mesh-ancestor
111094317|NCT04900311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111094318|NCT04900311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111094319|NCT04900155|Atorvastatin|atorvastatin|mesh-list
111094320|NCT04900155|Ezetimibe|ezetimibe|mesh-list
111094321|NCT04900155|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111094322|NCT04900155|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111094323|NCT04900155|Antimetabolites|antimetabolites|mesh-ancestor
111094324|NCT04900155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111094325|NCT04900155|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111094326|NCT04900155|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111094327|NCT04900155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111094328|NCT02155738|Acetaminophen|acetaminophen|mesh-list
111094329|NCT02155738|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111094330|NCT02155738|Analgesics|analgesics|mesh-ancestor
111094331|NCT02155738|Sensory System Agents|sensory system agents|mesh-ancestor
111094332|NCT02155738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111094333|NCT02155738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111094335|NCT03053505|Vancomycin|vancomycin|mesh-list
111094336|NCT03053505|Fidaxomicin|fidaxomicin|mesh-list
111094337|NCT03053505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111094338|NCT03053505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111094339|NCT02181790|Acitretin|acitretin|mesh-list
111094340|NCT02181790|Keratolytic Agents|keratolytic agents|mesh-ancestor
111094341|NCT02181790|Dermatologic Agents|dermatologic agents|mesh-ancestor
111094342|NCT03051945|Ketamine|ketamine|mesh-list
111094343|NCT03051945|Analgesics|analgesics|mesh-ancestor
111094344|NCT03051945|Sensory System Agents|sensory system agents|mesh-ancestor
110811435|NCT03005522|Glucocorticoids|glucocorticoids|mesh-ancestor
111094345|NCT03051945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111094346|NCT03051945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111094347|NCT03051945|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111094348|NCT03051945|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111094349|NCT03051945|Anesthetics, General|anesthetics, general|mesh-ancestor
111094350|NCT03051945|Anesthetics|anesthetics|mesh-ancestor
111094351|NCT03051945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111094352|NCT03051945|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111094353|NCT03051945|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111094354|NCT03051945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111094355|NCT03051945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111094356|NCT04899765|Vaccines|vaccines|mesh-list
111094357|NCT04899765|BCG Vaccine|bcg vaccine|mesh-list
111094358|NCT04899765|Immunologic Factors|immunologic factors|mesh-ancestor
111094359|NCT04899765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111094360|NCT04899765|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111094361|NCT04899453|Rituximab|rituximab|mesh-list
111094362|NCT04899453|Methotrexate|methotrexate|mesh-list
111094363|NCT04899453|Zanubrutinib|zanubrutinib|mesh-list
111094364|NCT04899453|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111094365|NCT04899453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111094366|NCT04899453|Immunologic Factors|immunologic factors|mesh-ancestor
111094367|NCT04899453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111094368|NCT04899453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111094369|NCT04899453|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111094370|NCT04899453|Abortifacient Agents|abortifacient agents|mesh-ancestor
111094371|NCT04899453|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111094372|NCT04899453|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111094373|NCT04899453|Antimetabolites|antimetabolites|mesh-ancestor
111094374|NCT04899453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111094375|NCT04899453|Dermatologic Agents|dermatologic agents|mesh-ancestor
111094376|NCT04899453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111094377|NCT04899453|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111094378|NCT04899453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111094379|NCT04899453|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111094380|NCT04899453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111094381|NCT03051555|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
111094382|NCT03051555|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111094383|NCT03051555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111094384|NCT04898751|Pembrolizumab|pembrolizumab|mesh-list
111094385|NCT04898751|Nivolumab|nivolumab|mesh-list
111094386|NCT04898751|Ipilimumab|ipilimumab|mesh-list
111094387|NCT04898751|Atezolizumab|atezolizumab|mesh-list
111094388|NCT04898751|Durvalumab|durvalumab|mesh-list
111094389|NCT04898751|Avelumab|avelumab|mesh-list
111094390|NCT04898751|Cemiplimab|cemiplimab|mesh-list
111094391|NCT04898751|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
111094392|NCT04898751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111094393|NCT04898751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111094394|NCT04898751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111094395|NCT04898907|Moxifloxacin|moxifloxacin|mesh-list
111094396|NCT04898907|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
111094397|NCT04898907|Mitogens|mitogens|mesh-list
111094398|NCT04898907|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111094399|NCT04898907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111094400|NCT04898907|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111094401|NCT04898907|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111094402|NCT04898907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111094403|NCT04898907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111094404|NCT04898907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111094405|NCT04898907|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111094406|NCT04898907|Contraceptive Agents|contraceptive agents|mesh-ancestor
111094407|NCT04898907|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111094408|NCT04898907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111094409|NCT04898907|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
111094410|NCT04898907|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111094411|NCT04898907|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111094412|NCT04898907|Mitosis Modulators|mitosis modulators|mesh-ancestor
111094413|NCT04908813|Capecitabine|capecitabine|mesh-list
111094414|NCT04908813|Oxaliplatin|oxaliplatin|mesh-list
111094415|NCT04908813|Trastuzumab|trastuzumab|mesh-list
111094416|NCT04908813|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111094417|NCT04908813|Antimetabolites|antimetabolites|mesh-ancestor
111094418|NCT04908813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111094419|NCT04908813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111094420|NCT04908813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111094421|NCT04913571|Tislelizumab|tislelizumab|mesh-list
111094422|NCT04913571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111094423|NCT04913571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111094425|NCT03051711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111094426|NCT03051711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111094427|NCT04908345|Fentanyl|fentanyl|mesh-list
111094428|NCT04908345|Methadone|methadone|mesh-list
111094429|NCT04908345|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111094430|NCT04908345|Narcotics|narcotics|mesh-ancestor
111094431|NCT04908345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111094432|NCT04908345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111094433|NCT04908345|Analgesics|analgesics|mesh-ancestor
111094434|NCT04908345|Sensory System Agents|sensory system agents|mesh-ancestor
111094435|NCT04908345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111094436|NCT04908345|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111094437|NCT04908345|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111094438|NCT04908345|Anesthetics, General|anesthetics, general|mesh-ancestor
111094439|NCT04908345|Anesthetics|anesthetics|mesh-ancestor
111094440|NCT04908345|Antitussive Agents|antitussive agents|mesh-ancestor
111094441|NCT04908345|Respiratory System Agents|respiratory system agents|mesh-ancestor
111094442|NCT04893993|Thiamine|thiamine|mesh-list
111094443|NCT04893993|Vitamin B Complex|vitamin b complex|mesh-ancestor
111094444|NCT04893993|Vitamins|vitamins|mesh-ancestor
111094445|NCT04893993|Micronutrients|micronutrients|mesh-ancestor
111094446|NCT04893993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111094447|NCT03051243|Insulin|insulin|mesh-list
111094448|NCT03051243|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111094449|NCT03051243|Linagliptin|linagliptin|mesh-list
111094450|NCT03051243|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111094451|NCT03051243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111094452|NCT03051243|Incretins|incretins|mesh-ancestor
111094453|NCT03051243|Hormones|hormones|mesh-ancestor
111094454|NCT03051243|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111094455|NCT03051243|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111094456|NCT03051243|Protease Inhibitors|protease inhibitors|mesh-ancestor
111094457|NCT03051243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111094458|NCT03051243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111094459|NCT04897737|Tenofovir|tenofovir|mesh-list
111094460|NCT04897737|Antiviral Agents|antiviral agents|mesh-ancestor
111094461|NCT04897737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111094462|NCT04897737|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111094463|NCT04897737|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111094464|NCT04897737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111094465|NCT04897737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111094466|NCT04897737|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111094467|NCT04897737|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111094468|NCT04148781|4-Aminopyridine|4-aminopyridine|mesh-list
111094469|NCT04148781|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
111094470|NCT04148781|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111094471|NCT04148781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111094472|NCT04897269|Progesterone|progesterone|mesh-list
111094473|NCT04897269|Progestins|progestins|mesh-ancestor
111094474|NCT04897269|Hormones|hormones|mesh-ancestor
111094475|NCT04897269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111094476|NCT04897269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111094477|NCT04891497|Dimethyl Fumarate|dimethyl fumarate|mesh-list
111094478|NCT04891497|Dermatologic Agents|dermatologic agents|mesh-ancestor
111094479|NCT04891497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111094480|NCT04891497|Immunologic Factors|immunologic factors|mesh-ancestor
111094481|NCT04891497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111094482|NCT04896177|Sirolimus|sirolimus|mesh-list
111094483|NCT04896177|Paclitaxel|paclitaxel|mesh-list
111094484|NCT04896177|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111094485|NCT04896177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111094486|NCT04896177|Tubulin Modulators|tubulin modulators|mesh-ancestor
111094487|NCT04896177|Antimitotic Agents|antimitotic agents|mesh-ancestor
111094488|NCT04896177|Mitosis Modulators|mitosis modulators|mesh-ancestor
111094489|NCT04896177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111094490|NCT04896177|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111094491|NCT04896177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111094492|NCT04896177|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111094493|NCT04896177|Antifungal Agents|antifungal agents|mesh-ancestor
111094494|NCT04896177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111094495|NCT04896177|Immunologic Factors|immunologic factors|mesh-ancestor
111094496|NCT04896177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111094497|NCT03052569|Agerafenib|agerafenib|mesh-list
111094498|NCT03052569|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111094499|NCT03052569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111094500|NCT03052569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111094501|NCT04906317|Midazolam|midazolam|mesh-list
111094502|NCT04906317|Dezocine|dezocine|mesh-list
111094503|NCT04906317|Propofol|propofol|mesh-list
111094504|NCT04906317|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111094505|NCT04906317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111094506|NCT04906317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111094507|NCT04906317|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111094508|NCT04906317|Anesthetics, General|anesthetics, general|mesh-ancestor
111094509|NCT04906317|Anesthetics|anesthetics|mesh-ancestor
111094510|NCT04906317|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111094511|NCT04906317|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111094512|NCT04906317|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111094513|NCT04906317|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111094514|NCT04906317|GABA Modulators|gaba modulators|mesh-ancestor
111094515|NCT04906317|GABA Agents|gaba agents|mesh-ancestor
111094516|NCT04906317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111094517|NCT04906317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111094518|NCT04906317|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111094519|NCT04906317|Narcotics|narcotics|mesh-ancestor
111094520|NCT04906317|Analgesics|analgesics|mesh-ancestor
111094521|NCT04906317|Sensory System Agents|sensory system agents|mesh-ancestor
111094522|NCT04906317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111094523|NCT03051087|Ganirelix|ganirelix|mesh-list
111094524|NCT03051087|Hormone Antagonists|hormone antagonists|mesh-ancestor
111094525|NCT03051087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111094526|NCT03051087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111094527|NCT04430361|Dexamethasone|dexamethasone|mesh-list
111094528|NCT04430361|Megestrol|megestrol|mesh-list
111094529|NCT04430361|Megestrol Acetate|megestrol acetate|mesh-list
111094530|NCT04430361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111094531|NCT04430361|Antiemetics|antiemetics|mesh-ancestor
111094532|NCT04430361|Autonomic Agents|autonomic agents|mesh-ancestor
111094533|NCT04430361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111094534|NCT04430361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111094535|NCT04430361|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111094536|NCT04430361|Glucocorticoids|glucocorticoids|mesh-ancestor
111094537|NCT04430361|Hormones|hormones|mesh-ancestor
111094538|NCT04430361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111094539|NCT04430361|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111094540|NCT04430361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111094541|NCT04430361|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111094542|NCT04430361|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111094543|NCT04430361|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111094544|NCT04430361|Contraceptive Agents|contraceptive agents|mesh-ancestor
111094545|NCT04430361|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111094546|NCT04430361|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111094547|NCT04430361|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111094548|NCT04430361|Appetite Stimulants|appetite stimulants|mesh-ancestor
111094549|NCT04430361|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111094550|NCT04906083|Mitogens|mitogens|mesh-list
111094551|NCT04906083|Mitosis Modulators|mitosis modulators|mesh-ancestor
111094552|NCT04906083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111094553|NCT02616783|Lamivudine|lamivudine|mesh-list
111094554|NCT02616783|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111094555|NCT02616783|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111094556|NCT02616783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111094557|NCT02616783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111094558|NCT02616783|Antiviral Agents|antiviral agents|mesh-ancestor
111094559|NCT02616783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111094560|NCT02616783|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111094561|NCT02616783|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111094562|NCT04895007|Vaccines|vaccines|mesh-list
111094563|NCT04895007|Immunologic Factors|immunologic factors|mesh-ancestor
111094564|NCT04895007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111094565|NCT04890561|Lemborexant|lemborexant|mesh-list
111094566|NCT04890561|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
111094567|NCT04890561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111094568|NCT04890561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111094569|NCT04890561|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111094570|NCT04890561|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111094571|NCT04890561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111094572|NCT04890561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111094573|NCT04894617|Amantadine|amantadine|mesh-list
111094574|NCT04894617|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111094575|NCT04894617|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111094576|NCT04894617|Antiviral Agents|antiviral agents|mesh-ancestor
111094577|NCT04894617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111094578|NCT04894617|Dopamine Agents|dopamine agents|mesh-ancestor
111094579|NCT04894617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111094580|NCT04894617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111094581|NCT04894617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111094582|NCT04894617|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111094584|NCT04894617|Sensory System Agents|sensory system agents|mesh-ancestor
111094585|NCT04894617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111094586|NCT04398537|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
111094587|NCT04398537|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
111094588|NCT04398537|beta-Endorphin|beta-endorphin|mesh-list
111094589|NCT04398537|Hormones|hormones|mesh-ancestor
111094590|NCT04398537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111094591|NCT04398537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111094592|NCT04398537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111094593|NCT04398537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111094594|NCT04397991|Furosemide|furosemide|mesh-list
111094595|NCT04397991|Diuretics|diuretics|mesh-ancestor
111094596|NCT04397991|Natriuretic Agents|natriuretic agents|mesh-ancestor
111094597|NCT04397991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111094598|NCT04397991|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
111094599|NCT04397991|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111094600|NCT04397991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111094601|NCT04906161|Vitamin D|vitamin d|mesh-list
111094602|NCT04906161|Calcium|calcium|mesh-list
111094603|NCT04906161|Vitamins|vitamins|mesh-ancestor
111094604|NCT04906161|Micronutrients|micronutrients|mesh-ancestor
111094605|NCT04906161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111094606|NCT04906161|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111094607|NCT04906161|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111094608|NCT03051009|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
111094609|NCT03051009|Hemostatics|hemostatics|mesh-ancestor
111094610|NCT03051009|Coagulants|coagulants|mesh-ancestor
111094611|NCT03051009|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
111094612|NCT03051009|Natriuretic Agents|natriuretic agents|mesh-ancestor
111094613|NCT03051009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111094614|NCT04889781|Dexamethasone|dexamethasone|mesh-list
111094615|NCT04889781|Dexamethasone acetate|dexamethasone acetate|mesh-list
111094616|NCT04889781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111094617|NCT04889781|Antiemetics|antiemetics|mesh-ancestor
111094618|NCT04889781|Autonomic Agents|autonomic agents|mesh-ancestor
111094619|NCT04889781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111094620|NCT04889781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111094621|NCT04889781|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111094622|NCT04889781|Glucocorticoids|glucocorticoids|mesh-ancestor
111094623|NCT04889781|Hormones|hormones|mesh-ancestor
111094624|NCT04889781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111094625|NCT04889781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111094626|NCT04889781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111094627|NCT02616393|XL647|xl647|mesh-list
111094628|NCT02616393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111094629|NCT02616393|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111094630|NCT02616393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111094631|NCT02616393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111094632|NCT04905147|Mosapride|mosapride|mesh-list
111094633|NCT04905147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111094634|NCT04905147|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111094635|NCT04905147|Serotonin Agents|serotonin agents|mesh-ancestor
111094636|NCT04905147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111094637|NCT04905147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111094638|NCT04905147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111094639|NCT03050229|Empagliflozin|empagliflozin|mesh-list
111094640|NCT03050229|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111094641|NCT03050229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111094642|NCT03050229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111094643|NCT03050229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111094644|NCT04882683|Prednisone|prednisone|mesh-list
111094645|NCT04882683|Adalimumab|adalimumab|mesh-list
111094646|NCT04882683|Azathioprine|azathioprine|mesh-list
111094647|NCT04882683|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111094648|NCT04882683|Glucocorticoids|glucocorticoids|mesh-ancestor
111094649|NCT04882683|Hormones|hormones|mesh-ancestor
111094650|NCT04882683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111094651|NCT04882683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111094652|NCT04882683|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111094653|NCT04882683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111094654|NCT04882683|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111094655|NCT04882683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111094656|NCT04882683|Antimetabolites|antimetabolites|mesh-ancestor
111094657|NCT04882683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111094658|NCT04882683|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111094659|NCT04882683|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111094660|NCT04882683|Immunologic Factors|immunologic factors|mesh-ancestor
111094661|NCT02155660|Benralizumab|benralizumab|mesh-list
111094662|NCT02155660|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111094663|NCT02155660|Respiratory System Agents|respiratory system agents|mesh-ancestor
111094664|NCT05154123|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111094665|NCT05154123|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111094666|NCT05154123|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111094667|NCT05154123|Antimetabolites|antimetabolites|mesh-ancestor
111094668|NCT05154123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111094669|NCT05154123|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111094670|NCT05154123|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111094671|NCT05154123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111094672|NCT04880811|Afatinib|afatinib|mesh-list
111094673|NCT04880811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111094674|NCT04880811|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111094675|NCT04880811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111094676|NCT04880811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111094677|NCT02181634|Paclitaxel|paclitaxel|mesh-list
111094678|NCT02181634|Gemcitabine|gemcitabine|mesh-list
111094679|NCT02181634|Antimetabolites|antimetabolites|mesh-list
111094680|NCT02181634|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111094681|NCT02181634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111094682|NCT02181634|Tubulin Modulators|tubulin modulators|mesh-ancestor
111094683|NCT02181634|Antimitotic Agents|antimitotic agents|mesh-ancestor
111094684|NCT02181634|Mitosis Modulators|mitosis modulators|mesh-ancestor
111094685|NCT02181634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111094686|NCT02181634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111094687|NCT04569045|Lidocaine|lidocaine|mesh-list
111094688|NCT04569045|Anesthetics, Local|anesthetics, local|mesh-ancestor
111094689|NCT04569045|Anesthetics|anesthetics|mesh-ancestor
111094690|NCT04569045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111094691|NCT04569045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111094692|NCT04569045|Sensory System Agents|sensory system agents|mesh-ancestor
111094693|NCT04569045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111094694|NCT04569045|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111094695|NCT04569045|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111094696|NCT04569045|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111094697|NCT04569045|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111094698|NCT04569045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111094699|NCT04425291|Vaccines|vaccines|mesh-list
111094700|NCT04425291|Immunologic Factors|immunologic factors|mesh-ancestor
111094701|NCT04425291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111094703|NCT04886193|Docetaxel|docetaxel|mesh-list
111094704|NCT04886193|Oxaliplatin|oxaliplatin|mesh-list
111094705|NCT04886193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111094706|NCT04886193|Tubulin Modulators|tubulin modulators|mesh-ancestor
111094707|NCT04886193|Antimitotic Agents|antimitotic agents|mesh-ancestor
111094708|NCT04886193|Mitosis Modulators|mitosis modulators|mesh-ancestor
111094709|NCT04886193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111094710|NCT04886193|Antidotes|antidotes|mesh-ancestor
111094711|NCT04886193|Protective Agents|protective agents|mesh-ancestor
111094712|NCT04886193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111094713|NCT04886193|Vitamin B Complex|vitamin b complex|mesh-ancestor
111094714|NCT04886193|Vitamins|vitamins|mesh-ancestor
111094715|NCT04886193|Micronutrients|micronutrients|mesh-ancestor
111094716|NCT04337073|Propofol|propofol|mesh-list
111094717|NCT04337073|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111094718|NCT04337073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111094719|NCT04337073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111094720|NCT04337073|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111094721|NCT04337073|Anesthetics, General|anesthetics, general|mesh-ancestor
111094722|NCT04337073|Anesthetics|anesthetics|mesh-ancestor
111094724|NCT04885803|Ergocalciferols|ergocalciferols|mesh-list
111094725|NCT04885803|Cholecalciferol|cholecalciferol|mesh-list
111094726|NCT04885803|Vitamins|vitamins|mesh-list
111094727|NCT04885803|Micronutrients|micronutrients|mesh-ancestor
111094728|NCT04885803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111094729|NCT04885803|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111094730|NCT04885803|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111094731|NCT03049059|Hydroquinone|hydroquinone|mesh-list
111094732|NCT03049059|Antioxidants|antioxidants|mesh-ancestor
111094733|NCT03049059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111094734|NCT03049059|Protective Agents|protective agents|mesh-ancestor
111094735|NCT03049059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111094736|NCT03049059|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111094737|NCT04885413|Niraparib|niraparib|mesh-list
111094738|NCT04885413|Antibodies|antibodies|mesh-list
111094739|NCT04885413|Immunologic Factors|immunologic factors|mesh-ancestor
111094740|NCT04885413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111094741|NCT04885413|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111094742|NCT04885413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111094743|NCT04885413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111094744|NCT04885413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111094745|NCT03049293|Midazolam|midazolam|mesh-list
111094746|NCT03049293|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111094747|NCT03049293|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111094748|NCT03049293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111094749|NCT03049293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111094750|NCT03049293|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111094751|NCT03049293|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111094752|NCT03049293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111094753|NCT03049293|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111094754|NCT03049293|Anesthetics, General|anesthetics, general|mesh-ancestor
111094755|NCT03049293|Anesthetics|anesthetics|mesh-ancestor
111094756|NCT03049293|GABA Modulators|gaba modulators|mesh-ancestor
111094757|NCT03049293|GABA Agents|gaba agents|mesh-ancestor
111094758|NCT03049293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111094759|NCT03049293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111094760|NCT01595529|Trimethoprim|trimethoprim|mesh-list
111094761|NCT01595529|Sulfamethoxazole|sulfamethoxazole|mesh-list
111094762|NCT01595529|Cephalexin|cephalexin|mesh-list
111094763|NCT01595529|Cefixime|cefixime|mesh-list
111094764|NCT01595529|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111094765|NCT01595529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111094766|NCT01595529|Antimalarials|antimalarials|mesh-ancestor
111094767|NCT01595529|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111094768|NCT01595529|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111094769|NCT01595529|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111094770|NCT01595529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111094771|NCT01595529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111094772|NCT01595529|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111094773|NCT01595529|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
111094774|NCT01595529|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111094775|NCT01595529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111094776|NCT04368507|Monoclonal antibody YYB-101|monoclonal antibody yyb-101|mesh-list
111094777|NCT04368507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111094779|NCT05257395|Anastrozole|anastrozole|mesh-list
111094780|NCT05257395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111094781|NCT05257395|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111094782|NCT05257395|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111094783|NCT05257395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111094784|NCT05257395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111094785|NCT05257395|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111094786|NCT05257395|Hormone Antagonists|hormone antagonists|mesh-ancestor
111094787|NCT05257395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111094788|NCT05257395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111094789|NCT05257395|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111094790|NCT05256693|Vancomycin|vancomycin|mesh-list
111094791|NCT05256693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111094792|NCT05256693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111094793|NCT03046953|Avelumab|avelumab|mesh-list
111094794|NCT03046953|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111094795|NCT03046953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111094796|NCT03047109|Phenylephrine|phenylephrine|mesh-list
111094797|NCT03047109|Oxymetazoline|oxymetazoline|mesh-list
111094798|NCT03047109|Ephedrine|ephedrine|mesh-list
111094799|NCT03047109|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111094800|NCT03047109|Mydriatics|mydriatics|mesh-ancestor
111094801|NCT03047109|Autonomic Agents|autonomic agents|mesh-ancestor
111094802|NCT03047109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111094803|NCT03047109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111094804|NCT03047109|Sympathomimetics|sympathomimetics|mesh-ancestor
111094805|NCT03047109|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111094806|NCT03047109|Nasal Decongestants|nasal decongestants|mesh-ancestor
111094807|NCT03047109|Respiratory System Agents|respiratory system agents|mesh-ancestor
111094808|NCT03047109|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111094809|NCT03047109|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111094810|NCT03047109|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111094811|NCT03047109|Adrenergic Agents|adrenergic agents|mesh-ancestor
111094812|NCT03047109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111094813|NCT03047109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111094814|NCT03047109|Protective Agents|protective agents|mesh-ancestor
111094815|NCT03047109|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111094816|NCT03047265|Paclitaxel|paclitaxel|mesh-list
111094817|NCT03047265|Cisplatin|cisplatin|mesh-list
111094818|NCT03047265|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111094819|NCT03047265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111094820|NCT03047265|Tubulin Modulators|tubulin modulators|mesh-ancestor
111094821|NCT03047265|Antimitotic Agents|antimitotic agents|mesh-ancestor
111094822|NCT03047265|Mitosis Modulators|mitosis modulators|mesh-ancestor
111094823|NCT03047265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111094824|NCT05256147|Ibuprofen|ibuprofen|mesh-list
111094825|NCT05256147|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111094826|NCT05256147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111094827|NCT05256147|Analgesics|analgesics|mesh-ancestor
111094828|NCT05256147|Sensory System Agents|sensory system agents|mesh-ancestor
111094829|NCT05256147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111094830|NCT05256147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111094831|NCT05256147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111094832|NCT05256147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111094833|NCT05256147|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111094834|NCT05256147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111094835|NCT05256147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111094836|NCT05214417|Ketamine|ketamine|mesh-list
111094837|NCT05214417|Analgesics|analgesics|mesh-ancestor
111094838|NCT05214417|Sensory System Agents|sensory system agents|mesh-ancestor
111094839|NCT05214417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111094840|NCT05214417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111094841|NCT05214417|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111094842|NCT05214417|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111094843|NCT05214417|Anesthetics, General|anesthetics, general|mesh-ancestor
111094844|NCT05214417|Anesthetics|anesthetics|mesh-ancestor
111094845|NCT05214417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111094846|NCT05214417|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111094847|NCT05214417|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111094848|NCT05214417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111094849|NCT05214417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111094850|NCT04870671|Tenofovir|tenofovir|mesh-list
111094851|NCT04870671|Antiviral Agents|antiviral agents|mesh-ancestor
111094852|NCT04870671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111094853|NCT04870671|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111094854|NCT04870671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111094855|NCT04870671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111094856|NCT04870671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111094857|NCT04870671|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111094858|NCT04870671|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111094859|NCT04387461|Pembrolizumab|pembrolizumab|mesh-list
111094860|NCT04387461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111094861|NCT04387461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111094862|NCT04387461|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111094863|NCT04387461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111094864|NCT03046719|Bupivacaine|bupivacaine|mesh-list
111094865|NCT03046719|Anesthetics, Local|anesthetics, local|mesh-ancestor
111094866|NCT03046719|Anesthetics|anesthetics|mesh-ancestor
111094867|NCT03046719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111094868|NCT03046719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111094869|NCT03046719|Sensory System Agents|sensory system agents|mesh-ancestor
111094870|NCT03046719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111094871|NCT04876755|TEMPO|tempo|mesh-list
111094872|NCT04876755|TEMPOL-H|tempol-h|mesh-list
111094873|NCT04876755|Antioxidants|antioxidants|mesh-ancestor
111094874|NCT04876755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111094875|NCT04876755|Protective Agents|protective agents|mesh-ancestor
111094876|NCT04876755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111094877|NCT04876755|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111094879|NCT04876521|Amisulpride|amisulpride|mesh-list
111094880|NCT04876521|Fluoxetine|fluoxetine|mesh-list
111094881|NCT04876521|Antiemetics|antiemetics|mesh-ancestor
111094882|NCT04876521|Autonomic Agents|autonomic agents|mesh-ancestor
111094883|NCT04876521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111094884|NCT04876521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111094885|NCT04876521|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111094886|NCT04876521|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111094887|NCT04876521|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111094888|NCT04876521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111094889|NCT04876521|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111094890|NCT04876521|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111094891|NCT04876521|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111094892|NCT04876521|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111094893|NCT04876521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111094894|NCT04876521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111094895|NCT04876521|Serotonin Agents|serotonin agents|mesh-ancestor
111094896|NCT04876521|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111094897|NCT04876521|Antidepressive Agents|antidepressive agents|mesh-ancestor
111094898|NCT04876521|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111094899|NCT04876521|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111094900|NCT04876521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111094901|NCT04876521|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111094902|NCT04876521|Dopamine Agents|dopamine agents|mesh-ancestor
111094903|NCT02119156|Belimumab|belimumab|mesh-list
111094904|NCT02119156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111094905|NCT02119156|Immunologic Factors|immunologic factors|mesh-ancestor
111094906|NCT02119156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111094907|NCT02181556|Aflibercept|aflibercept|mesh-list
111094908|NCT02181556|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111094909|NCT02181556|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111094910|NCT02181556|Growth Substances|growth substances|mesh-ancestor
111094911|NCT02181556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111094912|NCT02181556|Growth Inhibitors|growth inhibitors|mesh-ancestor
111094913|NCT02181556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111094914|NCT04865991|Propofol|propofol|mesh-list
111094915|NCT04865991|Sevoflurane|sevoflurane|mesh-list
111094916|NCT04865991|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111094917|NCT04865991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111094918|NCT04865991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111094919|NCT04865991|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111094920|NCT04865991|Anesthetics, General|anesthetics, general|mesh-ancestor
111094921|NCT04865991|Anesthetics|anesthetics|mesh-ancestor
111094922|NCT04865991|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111094924|NCT04865211|Bupivacaine|bupivacaine|mesh-list
111094925|NCT04865211|Anesthetics, Local|anesthetics, local|mesh-ancestor
111094926|NCT04865211|Anesthetics|anesthetics|mesh-ancestor
111094927|NCT04865211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111094928|NCT04865211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111094929|NCT04865211|Sensory System Agents|sensory system agents|mesh-ancestor
111094930|NCT04865211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111094931|NCT04865445|Midazolam|midazolam|mesh-list
111094932|NCT04865445|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111094933|NCT04865445|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111094934|NCT04865445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111094935|NCT04865445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111094936|NCT04865445|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111094937|NCT04865445|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111094938|NCT04865445|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111094939|NCT04865445|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111094940|NCT04865445|Anesthetics, General|anesthetics, general|mesh-ancestor
111094941|NCT04865445|Anesthetics|anesthetics|mesh-ancestor
111094942|NCT04865445|GABA Modulators|gaba modulators|mesh-ancestor
111094943|NCT04865445|GABA Agents|gaba agents|mesh-ancestor
111094944|NCT04865445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111094945|NCT04865445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111094946|NCT04875819|Vaccines|vaccines|mesh-list
111094947|NCT04875819|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
111094949|NCT04875819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111094950|NCT04864977|Insulin|insulin|mesh-list
111094951|NCT04864977|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111094952|NCT04864977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111094953|NCT03046173|Mitogens|mitogens|mesh-list
111094954|NCT03046173|Mitosis Modulators|mitosis modulators|mesh-ancestor
111094955|NCT03046173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111094956|NCT04869579|Selenium|selenium|mesh-list
111094957|NCT04869579|Selenious Acid|selenious acid|mesh-list
111094958|NCT04869579|Antioxidants|antioxidants|mesh-ancestor
111094959|NCT04869579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111094960|NCT04869579|Protective Agents|protective agents|mesh-ancestor
111094961|NCT04869579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111094962|NCT04869579|Trace Elements|trace elements|mesh-ancestor
111094963|NCT04869579|Micronutrients|micronutrients|mesh-ancestor
111094964|NCT03235037|Levodopa|levodopa|mesh-list
111094965|NCT03235037|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111094966|NCT03235037|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111094967|NCT03235037|Dopamine Agents|dopamine agents|mesh-ancestor
111094968|NCT03235037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111094969|NCT03235037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111094970|NCT03235037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111094971|NCT00700271|Amlodipine|amlodipine|mesh-list
111094972|NCT00700271|Valsartan|valsartan|mesh-list
111094973|NCT00700271|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111094974|NCT00700271|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111094975|NCT00700271|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111094976|NCT00700271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111094977|NCT00700271|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111094978|NCT00700271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111094979|NCT00700271|Vasodilator Agents|vasodilator agents|mesh-ancestor
111094980|NCT00700271|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111094981|NCT00700271|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111094982|NCT03228797|Ropivacaine|ropivacaine|mesh-list
111094983|NCT03228797|Anesthetics, Local|anesthetics, local|mesh-ancestor
111094984|NCT03228797|Anesthetics|anesthetics|mesh-ancestor
111094985|NCT03228797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111094986|NCT03228797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111094987|NCT03228797|Sensory System Agents|sensory system agents|mesh-ancestor
111094988|NCT03228797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111094989|NCT03044379|Dapivirine|dapivirine|mesh-list
111094990|NCT03044379|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111094991|NCT03044379|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111094992|NCT03044379|Antiviral Agents|antiviral agents|mesh-ancestor
111094993|NCT03044379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111094994|NCT04864509|Melatonin|melatonin|mesh-list
111094995|NCT04864509|Antioxidants|antioxidants|mesh-ancestor
111094996|NCT04864509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111094997|NCT04864509|Protective Agents|protective agents|mesh-ancestor
111094998|NCT04864509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111094999|NCT04864509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111095000|NCT04875039|Dexamethasone|dexamethasone|mesh-list
111095001|NCT04875039|Dexamethasone acetate|dexamethasone acetate|mesh-list
111095002|NCT04875039|Dexmedetomidine|dexmedetomidine|mesh-list
111095003|NCT04875039|BB 1101|bb 1101|mesh-list
111095004|NCT04875039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111095005|NCT04875039|Antiemetics|antiemetics|mesh-ancestor
111095006|NCT04875039|Autonomic Agents|autonomic agents|mesh-ancestor
111095007|NCT04875039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111095008|NCT04875039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111095009|NCT04875039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111095010|NCT04875039|Glucocorticoids|glucocorticoids|mesh-ancestor
111095011|NCT04875039|Hormones|hormones|mesh-ancestor
111095012|NCT04875039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111095013|NCT04875039|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111095014|NCT04875039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111095015|NCT04875039|Protease Inhibitors|protease inhibitors|mesh-ancestor
111095016|NCT04875039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111095017|NCT04875039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111095018|NCT04875039|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111095019|NCT04875039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111095020|NCT04875039|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111095021|NCT04875039|Analgesics|analgesics|mesh-ancestor
111095022|NCT04875039|Sensory System Agents|sensory system agents|mesh-ancestor
111095023|NCT04875039|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111095024|NCT04875039|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111095025|NCT04875039|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111095026|NCT04875039|Adrenergic Agents|adrenergic agents|mesh-ancestor
111095027|NCT04875039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111095028|NCT02452385|Vorolanib|vorolanib|mesh-list
111095029|NCT02452385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111095030|NCT02452385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111095031|NCT02452385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111095032|NCT03045783|Cefotiam|cefotiam|mesh-list
111095033|NCT03045783|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111095034|NCT03045783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111095035|NCT01375049|Aztreonam|aztreonam|mesh-list
111095036|NCT01375049|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111095037|NCT01375049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111095038|NCT04146207|Prednisone|prednisone|mesh-list
111095039|NCT04146207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111095040|NCT04146207|Glucocorticoids|glucocorticoids|mesh-ancestor
111095041|NCT04146207|Hormones|hormones|mesh-ancestor
111095042|NCT04146207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111095043|NCT04146207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111095044|NCT04146207|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111095045|NCT04146207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111095046|NCT04863807|Anesthetics|anesthetics|mesh-list
111095047|NCT04863807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111095048|NCT04863807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111095049|NCT02452307|Imiquimod|imiquimod|mesh-list
111095050|NCT02452307|Molgramostim|molgramostim|mesh-list
111095051|NCT02452307|Protamines|protamines|mesh-list
111095052|NCT02452307|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
111095053|NCT02452307|Sargramostim|sargramostim|mesh-list
111095054|NCT02452307|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111095055|NCT02452307|Immunologic Factors|immunologic factors|mesh-ancestor
111095056|NCT02452307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111095057|NCT02452307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111095058|NCT02452307|Interferon Inducers|interferon inducers|mesh-ancestor
111095059|NCT02452307|Heparin Antagonists|heparin antagonists|mesh-ancestor
111095060|NCT02452307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111095061|NCT02452307|Coagulants|coagulants|mesh-ancestor
111095062|NCT02452151|Infliximab|infliximab|mesh-list
111095063|NCT02452151|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111095064|NCT02452151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111095065|NCT02452151|Dermatologic Agents|dermatologic agents|mesh-ancestor
111095066|NCT02452151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111095067|NCT02452151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111095068|NCT04485299|Listerine|listerine|mesh-list
111095069|NCT04485299|Fluorides|fluorides|mesh-list
111095070|NCT04485299|Sodium Fluoride|sodium fluoride|mesh-list
111095071|NCT04485299|Fluorides, Topical|fluorides, topical|mesh-list
111095072|NCT04485299|Cariostatic Agents|cariostatic agents|mesh-ancestor
111095073|NCT04485299|Protective Agents|protective agents|mesh-ancestor
110677410|NCT00861705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111095074|NCT04485299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111095075|NCT04485299|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111095076|NCT04485299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111095077|NCT01594749|Dexamethasone|dexamethasone|mesh-list
111095078|NCT01594749|Dexamethasone acetate|dexamethasone acetate|mesh-list
111095079|NCT01594749|Ondansetron|ondansetron|mesh-list
111095080|NCT01594749|Fosaprepitant|fosaprepitant|mesh-list
111095081|NCT01594749|Aprepitant|aprepitant|mesh-list
111095082|NCT01594749|BB 1101|bb 1101|mesh-list
111095083|NCT01594749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111095084|NCT01594749|Antiemetics|antiemetics|mesh-ancestor
111095085|NCT01594749|Autonomic Agents|autonomic agents|mesh-ancestor
111095086|NCT01594749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111095087|NCT01594749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111095088|NCT01594749|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111095089|NCT01594749|Glucocorticoids|glucocorticoids|mesh-ancestor
111095090|NCT01594749|Hormones|hormones|mesh-ancestor
111095091|NCT01594749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111095092|NCT01594749|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111095093|NCT01594749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111095094|NCT01594749|Protease Inhibitors|protease inhibitors|mesh-ancestor
111095095|NCT01594749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111095096|NCT01594749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111095097|NCT01594749|Antipruritics|antipruritics|mesh-ancestor
111095098|NCT01594749|Dermatologic Agents|dermatologic agents|mesh-ancestor
111095099|NCT01594749|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111095100|NCT01594749|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111095101|NCT01594749|Serotonin Agents|serotonin agents|mesh-ancestor
111095102|NCT01594749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111095103|NCT01594749|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
111095104|NCT03226145|Scopolamine|scopolamine|mesh-list
111095105|NCT03226145|Bisacodyl|bisacodyl|mesh-list
111095106|NCT03226145|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
111095107|NCT03226145|Cathartics|cathartics|mesh-ancestor
111095108|NCT03226145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111095109|NCT03226145|Laxatives|laxatives|mesh-ancestor
111095110|NCT03226145|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111095111|NCT03226145|Antiemetics|antiemetics|mesh-ancestor
111095112|NCT03226145|Autonomic Agents|autonomic agents|mesh-ancestor
111095113|NCT03226145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111095114|NCT03226145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111095115|NCT03226145|Mydriatics|mydriatics|mesh-ancestor
111095116|NCT03226145|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111095117|NCT03226145|Cholinergic Agents|cholinergic agents|mesh-ancestor
111095118|NCT03226145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111095119|NCT03226145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111095120|NCT03226145|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111095121|NCT03226145|Parasympatholytics|parasympatholytics|mesh-ancestor
111095122|NCT04863183|Triamcinolone|triamcinolone|mesh-list
111095123|NCT04863183|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
111095124|NCT04863183|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
111095125|NCT04863183|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
111095126|NCT04863183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111095127|NCT04863183|Glucocorticoids|glucocorticoids|mesh-ancestor
111095128|NCT04863183|Hormones|hormones|mesh-ancestor
111095129|NCT04863183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111095130|NCT04863183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111095131|NCT04863183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111095132|NCT04863183|Immunologic Factors|immunologic factors|mesh-ancestor
111095133|NCT04863183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111095134|NCT04863183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111095135|NCT03234413|Botulinum Toxins|botulinum toxins|mesh-list
111095136|NCT03234413|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111095137|NCT03234413|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111095138|NCT03234413|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111095139|NCT03234413|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111095140|NCT03234413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111095141|NCT03234413|Cholinergic Agents|cholinergic agents|mesh-ancestor
111095142|NCT03234413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111095143|NCT03234413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111095144|NCT03234413|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111095145|NCT03234413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111095146|NCT04380753|Sotorasib|sotorasib|mesh-list
111095147|NCT04380753|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110677412|NCT00861705|Antimitotic Agents|antimitotic agents|mesh-ancestor
111095148|NCT04380753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111095149|NCT04380753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111095150|NCT04380753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111095151|NCT04379973|Ethiodized Oil|ethiodized oil|mesh-list
111095152|NCT04379973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111095153|NCT02453009|Prednisone|prednisone|mesh-list
111095154|NCT02453009|Docetaxel|docetaxel|mesh-list
111095155|NCT02453009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111095156|NCT02453009|Tubulin Modulators|tubulin modulators|mesh-ancestor
111095157|NCT02453009|Antimitotic Agents|antimitotic agents|mesh-ancestor
111095158|NCT02453009|Mitosis Modulators|mitosis modulators|mesh-ancestor
111095159|NCT02453009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111095160|NCT02453009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111095161|NCT02453009|Glucocorticoids|glucocorticoids|mesh-ancestor
111095162|NCT02453009|Hormones|hormones|mesh-ancestor
111095163|NCT02453009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111095164|NCT02453009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111095165|NCT02453009|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111095166|NCT04868175|Timolol|timolol|mesh-list
111095167|NCT04868175|Travoprost|travoprost|mesh-list
111095168|NCT04868175|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111095169|NCT04868175|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111095170|NCT04868175|Adrenergic Agents|adrenergic agents|mesh-ancestor
111095171|NCT04868175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111095172|NCT04868175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111095173|NCT04868175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111095174|NCT04868175|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110812256|NCT01100359|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111095175|NCT04868175|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111095176|NCT02452775|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
111095177|NCT02452775|Poly ICLC|poly iclc|mesh-list
111095178|NCT02452775|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111095179|NCT02452775|Immunologic Factors|immunologic factors|mesh-ancestor
111095180|NCT02452775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111095181|NCT02452775|Interferon Inducers|interferon inducers|mesh-ancestor
111095182|NCT03045627|Cytarabine|cytarabine|mesh-list
111095183|NCT03045627|Aclarubicin|aclarubicin|mesh-list
111095184|NCT03045627|Lenograstim|lenograstim|mesh-list
111095185|NCT03045627|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111095186|NCT03045627|Antimetabolites|antimetabolites|mesh-ancestor
111095187|NCT03045627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111095188|NCT03045627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111095189|NCT03045627|Antiviral Agents|antiviral agents|mesh-ancestor
111095190|NCT03045627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111095191|NCT03045627|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111095192|NCT03045627|Immunologic Factors|immunologic factors|mesh-ancestor
111095193|NCT03045627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111095194|NCT03045627|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111095195|NCT03045627|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111095196|NCT03045627|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111095197|NCT03045627|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111095198|NCT03045627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111095199|NCT04868019|Fenofibrate|fenofibrate|mesh-list
111095200|NCT04868019|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111095201|NCT04868019|Antimetabolites|antimetabolites|mesh-ancestor
111095202|NCT04868019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111095203|NCT04868019|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111095204|NCT04863105|Abiraterone Acetate|abiraterone acetate|mesh-list
111095205|NCT04863105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111095206|NCT04863105|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111095207|NCT04863105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111095208|NCT04863105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111095209|NCT04863105|Hormone Antagonists|hormone antagonists|mesh-ancestor
111095210|NCT04863105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110641914|NCT00874172|Analgesics|analgesics|mesh-list
111095211|NCT04863105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111095212|NCT04863105|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111095213|NCT02179918|Pembrolizumab|pembrolizumab|mesh-list
111095214|NCT02179918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111095215|NCT02179918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111095216|NCT02179918|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111095217|NCT02179918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111095218|NCT03233321|Heparin|heparin|mesh-list
111095219|NCT03233321|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
111095220|NCT03233321|Tinzaparin|tinzaparin|mesh-list
111095221|NCT03233321|Dalteparin|dalteparin|mesh-list
111095222|NCT03233321|Anticoagulants|anticoagulants|mesh-ancestor
111095223|NCT03233321|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111095224|NCT03233321|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111095225|NCT03233321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111095226|NCT04868253|Oxazepam|oxazepam|mesh-list
111095227|NCT04868253|Metyrapone|metyrapone|mesh-list
111095228|NCT04868253|Antimetabolites|antimetabolites|mesh-ancestor
111095229|NCT04868253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111095230|NCT04868253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111095231|NCT04868253|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111095232|NCT04868253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111095233|NCT04868253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111095234|NCT04868253|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111095235|NCT04868253|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111095236|NCT04868253|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111095237|NCT04868253|GABA Modulators|gaba modulators|mesh-ancestor
111095238|NCT04868253|GABA Agents|gaba agents|mesh-ancestor
111095239|NCT04868253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111095240|NCT02153788|Temazepam|temazepam|mesh-list
111095241|NCT02153788|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111095242|NCT02153788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111095243|NCT02153788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111095244|NCT02153788|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111095245|NCT02153788|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111095246|NCT02153788|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111095247|NCT02153788|GABA Modulators|gaba modulators|mesh-ancestor
111095248|NCT02153788|GABA Agents|gaba agents|mesh-ancestor
111095249|NCT02153788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111095250|NCT02153788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111095251|NCT03224039|Sufentanil|sufentanil|mesh-list
111095252|NCT03224039|Morphine|morphine|mesh-list
111095253|NCT03224039|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111095254|NCT03224039|Narcotics|narcotics|mesh-ancestor
111095255|NCT03224039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111095256|NCT03224039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111095257|NCT03224039|Analgesics|analgesics|mesh-ancestor
111095258|NCT03224039|Sensory System Agents|sensory system agents|mesh-ancestor
111095259|NCT03224039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111095260|NCT03224039|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111095261|NCT03224039|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111095262|NCT03224039|Anesthetics, General|anesthetics, general|mesh-ancestor
111095263|NCT03224039|Anesthetics|anesthetics|mesh-ancestor
111095264|NCT04862091|Abiraterone Acetate|abiraterone acetate|mesh-list
111095265|NCT04862091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111095266|NCT04862091|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111095267|NCT04862091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111095268|NCT04862091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111095269|NCT04862091|Hormone Antagonists|hormone antagonists|mesh-ancestor
111095270|NCT04862091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111095271|NCT04862091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110396369|NCT04328480|Colchicine|colchicine|mesh-list
111095272|NCT04862091|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111095273|NCT03223961|Epoetin Alfa|epoetin alfa|mesh-list
111095274|NCT03223961|Hematinics|hematinics|mesh-ancestor
111095275|NCT03045471|Prednisolone|prednisolone|mesh-list
111095276|NCT03045471|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111095277|NCT03045471|Methylprednisolone|methylprednisolone|mesh-list
111095278|NCT03045471|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111095279|NCT03045471|Prednisolone acetate|prednisolone acetate|mesh-list
111095280|NCT03045471|Cyclophosphamide|cyclophosphamide|mesh-list
111095281|NCT03045471|Rituximab|rituximab|mesh-list
111095282|NCT03045471|Etoposide|etoposide|mesh-list
111095283|NCT03045471|Vincristine|vincristine|mesh-list
111095284|NCT03045471|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111095285|NCT03045471|Prednisolone phosphate|prednisolone phosphate|mesh-list
111095286|NCT03045471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111095287|NCT03045471|Immunologic Factors|immunologic factors|mesh-ancestor
111095288|NCT03045471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111095289|NCT03045471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111095290|NCT03045471|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111095291|NCT03045471|Alkylating Agents|alkylating agents|mesh-ancestor
111095292|NCT03045471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111095293|NCT03045471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111095294|NCT03045471|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111095295|NCT03045471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111095296|NCT03045471|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111095297|NCT03045471|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111095298|NCT03045471|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111095299|NCT03045471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111095300|NCT03045471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111095301|NCT03045471|Glucocorticoids|glucocorticoids|mesh-ancestor
111095302|NCT03045471|Hormones|hormones|mesh-ancestor
111095303|NCT03045471|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111095304|NCT03045471|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111095305|NCT03045471|Antiemetics|antiemetics|mesh-ancestor
111095306|NCT03045471|Autonomic Agents|autonomic agents|mesh-ancestor
111095307|NCT03045471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111095308|NCT03045471|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111095309|NCT03045471|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111095310|NCT03045471|Protective Agents|protective agents|mesh-ancestor
111095311|NCT03045471|Tubulin Modulators|tubulin modulators|mesh-ancestor
111095312|NCT03045471|Antimitotic Agents|antimitotic agents|mesh-ancestor
111095313|NCT03045471|Mitosis Modulators|mitosis modulators|mesh-ancestor
111095314|NCT03047499|Botulinum Toxins|botulinum toxins|mesh-list
111095315|NCT03047499|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111095316|NCT03047499|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111095317|NCT03047499|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111095318|NCT03047499|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111095319|NCT03047499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111095320|NCT03047499|Cholinergic Agents|cholinergic agents|mesh-ancestor
111095321|NCT03047499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111095322|NCT03047499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111095323|NCT03047499|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111095324|NCT03047499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111095325|NCT04867941|Acalabrutinib|acalabrutinib|mesh-list
111095326|NCT04867941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111095327|NCT04873479|Ketamine|ketamine|mesh-list
111095328|NCT04873479|Esketamine|esketamine|mesh-list
111095329|NCT04873479|Analgesics|analgesics|mesh-ancestor
111095330|NCT04873479|Sensory System Agents|sensory system agents|mesh-ancestor
111095331|NCT04873479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111095332|NCT04873479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111095333|NCT04873479|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111095334|NCT04873479|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111095335|NCT04873479|Anesthetics, General|anesthetics, general|mesh-ancestor
111095336|NCT04873479|Anesthetics|anesthetics|mesh-ancestor
111095337|NCT04873479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111095338|NCT04873479|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111095339|NCT04873479|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111095340|NCT04873479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111095341|NCT04873479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111095342|NCT04873479|Antidepressive Agents|antidepressive agents|mesh-ancestor
111095343|NCT04873479|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111095344|NCT02451527|Digoxin|digoxin|mesh-list
111095345|NCT02451527|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111095346|NCT02451527|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111095347|NCT02451527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111095348|NCT02451527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111095349|NCT02451527|Protective Agents|protective agents|mesh-ancestor
111095350|NCT02451527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111095351|NCT04873011|Quinine|quinine|mesh-list
111095352|NCT04873011|Antimalarials|antimalarials|mesh-ancestor
111095353|NCT04873011|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111095354|NCT04873011|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111095355|NCT04873011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111095356|NCT04873011|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
111095357|NCT04873011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111095358|NCT04873011|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111095359|NCT04873011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111095360|NCT04873011|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111095361|NCT04873011|Analgesics|analgesics|mesh-ancestor
111095362|NCT04873011|Sensory System Agents|sensory system agents|mesh-ancestor
111095363|NCT02451605|Analgesics|analgesics|mesh-list
111095364|NCT02451605|Ropivacaine|ropivacaine|mesh-list
111095365|NCT02451605|Anesthetics, Local|anesthetics, local|mesh-ancestor
111095366|NCT02451605|Anesthetics|anesthetics|mesh-ancestor
111095367|NCT02451605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111095368|NCT02451605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111095369|NCT02451605|Sensory System Agents|sensory system agents|mesh-ancestor
111095370|NCT02451605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111095371|NCT03222323|Dexmedetomidine|dexmedetomidine|mesh-list
111095372|NCT03222323|Ropivacaine|ropivacaine|mesh-list
111095373|NCT03222323|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111095374|NCT03222323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111095375|NCT03222323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111095376|NCT03222323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111095377|NCT03222323|Analgesics|analgesics|mesh-ancestor
111095378|NCT03222323|Sensory System Agents|sensory system agents|mesh-ancestor
111095379|NCT03222323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111095380|NCT03222323|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111095381|NCT03222323|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111095382|NCT03222323|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111095383|NCT03222323|Adrenergic Agents|adrenergic agents|mesh-ancestor
111095384|NCT03222323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111095385|NCT03222323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111095386|NCT03222323|Anesthetics, Local|anesthetics, local|mesh-ancestor
111095387|NCT03222323|Anesthetics|anesthetics|mesh-ancestor
111095388|NCT03043677|Adalimumab|adalimumab|mesh-list
111095389|NCT03043677|Infliximab|infliximab|mesh-list
111095390|NCT03043677|Golimumab|golimumab|mesh-list
111095391|NCT03043677|Ustekinumab|ustekinumab|mesh-list
111095392|NCT03043677|Vedolizumab|vedolizumab|mesh-list
111095393|NCT03043677|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111095394|NCT03043677|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111095395|NCT03043677|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111095396|NCT03043677|Dermatologic Agents|dermatologic agents|mesh-ancestor
111095397|NCT03043677|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111095398|NCT03043677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111095399|NCT03043677|Immunologic Factors|immunologic factors|mesh-ancestor
111095400|NCT03043677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111095401|NCT03222089|Leucovorin|leucovorin|mesh-list
111095402|NCT03222089|Fluorouracil|fluorouracil|mesh-list
111095404|NCT03222089|Irinotecan|irinotecan|mesh-list
111095405|NCT03222089|Interleukin-2|interleukin-2|mesh-list
111095406|NCT03222089|Molgramostim|molgramostim|mesh-list
111095407|NCT03222089|Sargramostim|sargramostim|mesh-list
111095408|NCT03222089|Levoleucovorin|levoleucovorin|mesh-list
111095409|NCT03222089|Antimetabolites|antimetabolites|mesh-ancestor
111095410|NCT03222089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111095411|NCT03222089|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111095412|NCT03222089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111095413|NCT03222089|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111095414|NCT03222089|Immunologic Factors|immunologic factors|mesh-ancestor
111095415|NCT03222089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111095416|NCT03222089|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111095417|NCT03222089|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111095418|NCT03222089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111095419|NCT03222089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111095420|NCT03222089|Analgesics|analgesics|mesh-ancestor
111095421|NCT03222089|Sensory System Agents|sensory system agents|mesh-ancestor
111095422|NCT03222089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111095423|NCT03222089|Antidotes|antidotes|mesh-ancestor
111095424|NCT03222089|Protective Agents|protective agents|mesh-ancestor
111095425|NCT03222089|Vitamin B Complex|vitamin b complex|mesh-ancestor
111095426|NCT03222089|Vitamins|vitamins|mesh-ancestor
111095427|NCT03222089|Micronutrients|micronutrients|mesh-ancestor
111095428|NCT03043989|Clarithromycin|clarithromycin|mesh-list
111095429|NCT03043989|Docetaxel|docetaxel|mesh-list
111095430|NCT03043989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111095431|NCT03043989|Tubulin Modulators|tubulin modulators|mesh-ancestor
111095432|NCT03043989|Antimitotic Agents|antimitotic agents|mesh-ancestor
111095433|NCT03043989|Mitosis Modulators|mitosis modulators|mesh-ancestor
111095434|NCT03043989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111095435|NCT03043989|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111095436|NCT03043989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111095437|NCT03043989|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111095438|NCT03043989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111095439|NCT03043989|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111095440|NCT03043989|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111095441|NCT03222167|Grazoprevir|grazoprevir|mesh-list
111095442|NCT03222167|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
111095443|NCT03222167|Antiviral Agents|antiviral agents|mesh-ancestor
111095444|NCT03222167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111095445|NCT03221855|Domperidone|domperidone|mesh-list
111095446|NCT03221855|Antiemetics|antiemetics|mesh-ancestor
111095447|NCT03221855|Autonomic Agents|autonomic agents|mesh-ancestor
111095448|NCT03221855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111095449|NCT03221855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111095450|NCT03221855|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111095451|NCT03221855|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111095452|NCT03221855|Dopamine Agents|dopamine agents|mesh-ancestor
111095453|NCT03221855|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111095454|NCT03221855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111095455|NCT03043521|Dexlansoprazole|dexlansoprazole|mesh-list
111095456|NCT03043521|Lansoprazole|lansoprazole|mesh-list
111095457|NCT03043521|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111095458|NCT03043521|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111095459|NCT03043521|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111095460|NCT03043521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111095461|NCT03043521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111095463|NCT03047733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111095464|NCT03047733|Immunologic Factors|immunologic factors|mesh-ancestor
111095465|NCT03047733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111095466|NCT03047733|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111095467|NCT03047733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111095468|NCT03047733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111095469|NCT03221231|Acetylcysteine|acetylcysteine|mesh-list
111095470|NCT03221231|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111095471|NCT03221231|Antiviral Agents|antiviral agents|mesh-ancestor
111095472|NCT03221231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111095473|NCT03221231|Expectorants|expectorants|mesh-ancestor
111095474|NCT03221231|Respiratory System Agents|respiratory system agents|mesh-ancestor
111095475|NCT03221231|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111095476|NCT03221231|Antioxidants|antioxidants|mesh-ancestor
111095477|NCT03221231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110812556|NCT01335074|Immunologic Factors|immunologic factors|mesh-ancestor
111095478|NCT03221231|Protective Agents|protective agents|mesh-ancestor
111095479|NCT03221231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111095480|NCT03221231|Antidotes|antidotes|mesh-ancestor
111095481|NCT03221621|Adalimumab|adalimumab|mesh-list
111095482|NCT03221621|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111095483|NCT03221621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111095484|NCT03221621|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111095485|NCT03220841|Adalimumab|adalimumab|mesh-list
111095486|NCT03220841|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111095487|NCT03220841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111095488|NCT03220841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111095489|NCT03045393|Maytansine|maytansine|mesh-list
111095490|NCT03045393|Mirvetuximab soravtansine|mirvetuximab soravtansine|mesh-list
111095491|NCT03045393|Immunoconjugates|immunoconjugates|mesh-ancestor
111095492|NCT03045393|Immunologic Factors|immunologic factors|mesh-ancestor
111095493|NCT03045393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111095494|NCT03045393|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111095495|NCT03045393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111095496|NCT03045393|Tubulin Modulators|tubulin modulators|mesh-ancestor
111095497|NCT03045393|Antimitotic Agents|antimitotic agents|mesh-ancestor
111095498|NCT03045393|Mitosis Modulators|mitosis modulators|mesh-ancestor
111095499|NCT03045393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111095500|NCT01374971|Certolizumab Pegol|certolizumab pegol|mesh-list
111095501|NCT01374971|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111095502|NCT01374971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111095503|NCT01374971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111095504|NCT01374971|Immunologic Factors|immunologic factors|mesh-ancestor
111095505|NCT01374971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111095506|NCT01374971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111095507|NCT02505815|Hydrocortisone|hydrocortisone|mesh-list
111095508|NCT02505815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111095509|NCT02505971|Propranolol|propranolol|mesh-list
111095510|NCT02505971|Nadolol|nadolol|mesh-list
111095511|NCT02505971|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111095512|NCT02505971|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111095513|NCT02505971|Adrenergic Agents|adrenergic agents|mesh-ancestor
111095514|NCT02505971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111095515|NCT02505971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111095516|NCT02505971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111095517|NCT02505971|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111095518|NCT02505971|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111095519|NCT02505971|Vasodilator Agents|vasodilator agents|mesh-ancestor
111095520|NCT02505971|Sympatholytics|sympatholytics|mesh-ancestor
111095521|NCT02505971|Autonomic Agents|autonomic agents|mesh-ancestor
110683385|NCT00504894|Thiopental|thiopental|mesh-list
111095522|NCT02505971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111095524|NCT02505581|Ciprofloxacin|ciprofloxacin|mesh-list
111095525|NCT02505581|Cefuroxime|cefuroxime|mesh-list
111095526|NCT02505581|Cefuroxime axetil|cefuroxime axetil|mesh-list
111095527|NCT02505581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111095528|NCT02505581|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111095529|NCT02505581|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111095530|NCT02505581|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111095531|NCT02505581|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111095532|NCT02505581|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111095533|NCT02505581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111095534|NCT02505581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111095535|NCT02505581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111095536|NCT02505581|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111095537|NCT02505581|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111095538|NCT02451293|Melatonin|melatonin|mesh-list
111095539|NCT02451293|Antioxidants|antioxidants|mesh-ancestor
111095540|NCT02451293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111095541|NCT02451293|Protective Agents|protective agents|mesh-ancestor
111095542|NCT02451293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111095543|NCT02451293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111095544|NCT02505113|Montelukast|montelukast|mesh-list
111095545|NCT02505113|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111095546|NCT02505113|Respiratory System Agents|respiratory system agents|mesh-ancestor
111095547|NCT02505113|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
111095548|NCT02505113|Hormone Antagonists|hormone antagonists|mesh-ancestor
111095549|NCT02505113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111095550|NCT02505113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111095551|NCT02505113|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
111095552|NCT02505113|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111095553|NCT02505113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111095554|NCT02504801|Budesonide|budesonide|mesh-list
111095555|NCT02504801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111095556|NCT02504801|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111095557|NCT02504801|Autonomic Agents|autonomic agents|mesh-ancestor
111095558|NCT02504801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111095559|NCT02504801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111095560|NCT02504801|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111095561|NCT02504801|Respiratory System Agents|respiratory system agents|mesh-ancestor
111095562|NCT02504801|Glucocorticoids|glucocorticoids|mesh-ancestor
111095563|NCT02504801|Hormones|hormones|mesh-ancestor
111095564|NCT02504801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111095565|NCT02504333|Paclitaxel|paclitaxel|mesh-list
111095566|NCT02504333|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111095567|NCT02504333|Gemcitabine|gemcitabine|mesh-list
111095568|NCT02504333|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111095569|NCT02504333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111095570|NCT02504333|Tubulin Modulators|tubulin modulators|mesh-ancestor
111095571|NCT02504333|Antimitotic Agents|antimitotic agents|mesh-ancestor
111095572|NCT02504333|Mitosis Modulators|mitosis modulators|mesh-ancestor
111095573|NCT02504333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111095574|NCT02504333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111095575|NCT02504333|Antimetabolites|antimetabolites|mesh-ancestor
111095576|NCT02504177|Anticoagulants|anticoagulants|mesh-list
111095577|NCT02450981|Bevacizumab|bevacizumab|mesh-list
111095578|NCT02450981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110642007|NCT05172401|Glucocorticoids|glucocorticoids|mesh-ancestor
111095579|NCT02450981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111095580|NCT02450981|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111095581|NCT02450981|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111095582|NCT02450981|Growth Substances|growth substances|mesh-ancestor
111095583|NCT02450981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111095584|NCT02450981|Growth Inhibitors|growth inhibitors|mesh-ancestor
111095585|NCT02503943|Metformin|metformin|mesh-list
111095586|NCT02503943|Liraglutide|liraglutide|mesh-list
111095587|NCT02503943|Mitiglinide|mitiglinide|mesh-list
111095588|NCT02503943|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111095589|NCT02503943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111095590|NCT02503943|Incretins|incretins|mesh-ancestor
111095591|NCT02503943|Hormones|hormones|mesh-ancestor
111095592|NCT02503943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111095593|NCT03213743|Dexmedetomidine|dexmedetomidine|mesh-list
111095594|NCT03213743|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110677416|NCT00861705|Immunologic Factors|immunologic factors|mesh-ancestor
111095595|NCT03213743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111095596|NCT03213743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111095598|NCT03213743|Analgesics|analgesics|mesh-ancestor
111095599|NCT03213743|Sensory System Agents|sensory system agents|mesh-ancestor
111095600|NCT03213743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111095601|NCT03213743|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111095602|NCT03213743|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111095603|NCT03213743|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111095604|NCT03213743|Adrenergic Agents|adrenergic agents|mesh-ancestor
111095605|NCT03213743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111095606|NCT03213743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111095607|NCT03212495|Neostigmine|neostigmine|mesh-list
111095608|NCT03212495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111095609|NCT03212495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111095610|NCT03212495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111095611|NCT03212495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111095612|NCT03212495|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111095613|NCT03212495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111095614|NCT03212495|Cholinergic Agents|cholinergic agents|mesh-ancestor
111095615|NCT03212495|Parasympathomimetics|parasympathomimetics|mesh-ancestor
111095616|NCT03212495|Autonomic Agents|autonomic agents|mesh-ancestor
111095617|NCT02503319|Tranexamic Acid|tranexamic acid|mesh-list
111095618|NCT02503319|Oxytocin|oxytocin|mesh-list
111095619|NCT02503319|Oxytocics|oxytocics|mesh-ancestor
111095620|NCT02503319|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111095621|NCT02503319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111095622|NCT02503319|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111095623|NCT02503319|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111095624|NCT02503319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111095625|NCT02503319|Hemostatics|hemostatics|mesh-ancestor
111095626|NCT02503319|Coagulants|coagulants|mesh-ancestor
111095627|NCT02610777|Azacitidine|azacitidine|mesh-list
111095628|NCT02610777|Pevonedistat|pevonedistat|mesh-list
111095629|NCT02610777|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111095630|NCT02610777|Antimetabolites|antimetabolites|mesh-ancestor
111095631|NCT02610777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111095632|NCT02610777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111095633|NCT02610777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111095634|NCT01628692|Ribavirin|ribavirin|mesh-list
111095635|NCT01628692|Simeprevir|simeprevir|mesh-list
111095636|NCT01628692|Antimetabolites|antimetabolites|mesh-ancestor
111095637|NCT01628692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111095638|NCT01628692|Antiviral Agents|antiviral agents|mesh-ancestor
111095639|NCT01628692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111095640|NCT01628692|Protease Inhibitors|protease inhibitors|mesh-ancestor
111095641|NCT01628692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111095642|NCT02503163|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111095643|NCT02503163|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111095644|NCT04496921|Vitamins|vitamins|mesh-list
111095645|NCT04496921|Vitamin K|vitamin k|mesh-list
111095646|NCT04496921|Micronutrients|micronutrients|mesh-ancestor
111095647|NCT04496921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111095648|NCT04496921|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111095649|NCT04496921|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111095650|NCT04496921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111095651|NCT04496921|Hemostatics|hemostatics|mesh-ancestor
111095652|NCT04496921|Coagulants|coagulants|mesh-ancestor
111095653|NCT03043287|Botulinum Toxins|botulinum toxins|mesh-list
111095654|NCT03043287|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111095655|NCT03043287|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111095656|NCT03043287|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111095657|NCT03043287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111095658|NCT03043287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111095659|NCT03043287|Cholinergic Agents|cholinergic agents|mesh-ancestor
111095660|NCT03043287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111095661|NCT03043287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111095662|NCT03043287|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111095663|NCT03043287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111095664|NCT03043443|Melatonin|melatonin|mesh-list
111095665|NCT03043443|Antioxidants|antioxidants|mesh-ancestor
111095666|NCT03043443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111095667|NCT03043443|Protective Agents|protective agents|mesh-ancestor
111095668|NCT03043443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111095669|NCT03043443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111095670|NCT04383795|Antithyroid Agents|antithyroid agents|mesh-list
111095671|NCT04383795|Hormone Antagonists|hormone antagonists|mesh-ancestor
111095672|NCT04383795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111095673|NCT04383795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111095674|NCT03043131|Plasma-lyte 148|plasma-lyte 148|mesh-list
111095675|NCT03043131|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
111095676|NCT03043131|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111095678|NCT03209297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111095679|NCT03209297|Antifungal Agents|antifungal agents|mesh-ancestor
111095680|NCT03209297|Keratolytic Agents|keratolytic agents|mesh-ancestor
111095681|NCT03209297|Dermatologic Agents|dermatologic agents|mesh-ancestor
111095682|NCT03209219|Interferons|interferons|mesh-list
111095683|NCT03209219|Interferon-alpha|interferon-alpha|mesh-list
111095684|NCT03209219|Interferon alpha-2|interferon alpha-2|mesh-list
111095685|NCT03209219|Cyclosporine|cyclosporine|mesh-list
111095686|NCT03209219|Cyclosporins|cyclosporins|mesh-list
111095687|NCT03209219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111095688|NCT03209219|Antiviral Agents|antiviral agents|mesh-ancestor
111095689|NCT03209219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111095690|NCT03209219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111095691|NCT03209219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111095692|NCT03209219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111095693|NCT03209219|Immunologic Factors|immunologic factors|mesh-ancestor
111095694|NCT03209219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111095695|NCT03209219|Antifungal Agents|antifungal agents|mesh-ancestor
111095696|NCT03209219|Dermatologic Agents|dermatologic agents|mesh-ancestor
111095697|NCT03209219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111095698|NCT03209219|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111095699|NCT04872231|Voriconazole|voriconazole|mesh-list
111095700|NCT04872231|Antifungal Agents|antifungal agents|mesh-ancestor
111095701|NCT04872231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111095702|NCT04872231|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111095703|NCT04872231|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111095704|NCT04872231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111095705|NCT04872231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111095706|NCT04872231|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111095707|NCT04872231|Hormone Antagonists|hormone antagonists|mesh-ancestor
111095708|NCT04872231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111095709|NCT04872231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111095710|NCT04872231|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111095711|NCT04860531|Betamethasone|betamethasone|mesh-list
111095712|NCT04860531|Lidocaine|lidocaine|mesh-list
111095713|NCT04860531|Anesthetics, Local|anesthetics, local|mesh-ancestor
111095714|NCT04860531|Anesthetics|anesthetics|mesh-ancestor
111095715|NCT04860531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111095716|NCT04860531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111095717|NCT04860531|Sensory System Agents|sensory system agents|mesh-ancestor
111095718|NCT04860531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111095719|NCT04860531|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111095720|NCT04860531|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111095721|NCT04860531|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111095722|NCT04860531|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111095723|NCT04860531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111095724|NCT04860531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111095725|NCT04860531|Glucocorticoids|glucocorticoids|mesh-ancestor
111095726|NCT04860531|Hormones|hormones|mesh-ancestor
111095727|NCT04860531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111095728|NCT04860531|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111095729|NCT04860531|Respiratory System Agents|respiratory system agents|mesh-ancestor
111095730|NCT01594827|Chlorhexidine|chlorhexidine|mesh-list
111095731|NCT01594827|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
111095732|NCT01594827|Vancomycin|vancomycin|mesh-list
111095733|NCT01594827|Doxycycline|doxycycline|mesh-list
111095734|NCT01594827|Rifampin|rifampin|mesh-list
111095735|NCT01594827|Trimethoprim|trimethoprim|mesh-list
111095736|NCT01594827|Sulfamethoxazole|sulfamethoxazole|mesh-list
111095737|NCT01594827|Mupirocin|mupirocin|mesh-list
111095738|NCT01594827|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111095739|NCT01594827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111095740|NCT01594827|Disinfectants|disinfectants|mesh-ancestor
111095741|NCT01594827|Dermatologic Agents|dermatologic agents|mesh-ancestor
111095742|NCT01594827|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111095743|NCT01594827|Antimalarials|antimalarials|mesh-ancestor
111095744|NCT01594827|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111095745|NCT01594827|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111095746|NCT01594827|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111095747|NCT01594827|Antitubercular Agents|antitubercular agents|mesh-ancestor
111095748|NCT01594827|Leprostatic Agents|leprostatic agents|mesh-ancestor
111095749|NCT01594827|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111095750|NCT01594827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111095751|NCT01594827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111095752|NCT01594827|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111095753|NCT01594827|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111095754|NCT01594827|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
111095755|NCT01594827|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
111095756|NCT01594827|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
111095757|NCT01594827|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111095758|NCT01594827|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111095759|NCT01594827|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111095760|NCT01594827|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111095761|NCT01594827|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
111095762|NCT01594827|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111095763|NCT01594827|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111095765|NCT04429191|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111095766|NCT04429191|Immunologic Factors|immunologic factors|mesh-ancestor
111095767|NCT04429191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111095768|NCT02610231|Istradefylline|istradefylline|mesh-list
111095769|NCT02610231|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
111095770|NCT02610231|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
111095771|NCT02610231|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111095772|NCT02610231|Purinergic Agents|purinergic agents|mesh-ancestor
111095773|NCT02610231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111095774|NCT02610231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111095775|NCT02610231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111095776|NCT04850157|Tislelizumab|tislelizumab|mesh-list
111095777|NCT04850157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111095778|NCT04850157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111095779|NCT04849533|Mycophenolic Acid|mycophenolic acid|mesh-list
111095780|NCT04849533|Prednisone|prednisone|mesh-list
111095781|NCT04849533|Everolimus|everolimus|mesh-list
111095782|NCT04849533|Abatacept|abatacept|mesh-list
111095783|NCT04849533|Thymoglobulin|thymoglobulin|mesh-list
111095784|NCT04849533|Antilymphocyte Serum|antilymphocyte serum|mesh-list
111095785|NCT04849533|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111095786|NCT04849533|Glucocorticoids|glucocorticoids|mesh-ancestor
111095787|NCT04849533|Hormones|hormones|mesh-ancestor
111095788|NCT04849533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111095789|NCT04849533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111095790|NCT04849533|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111095791|NCT04849533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111095792|NCT04849533|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111095793|NCT04849533|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111095794|NCT04849533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111095795|NCT04849533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111095796|NCT04849533|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111095797|NCT04849533|Immunologic Factors|immunologic factors|mesh-ancestor
111095798|NCT04849533|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111095799|NCT04849533|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111095800|NCT04849533|Antitubercular Agents|antitubercular agents|mesh-ancestor
111095801|NCT04849533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111095802|NCT04849533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111095803|NCT04849533|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111095804|NCT04849533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111095805|NCT04849533|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111095806|NCT03040635|Risdiplam|risdiplam|mesh-list
111095807|NCT03040635|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111095808|NCT03040635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111095809|NCT03040635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111095810|NCT02178358|Sorafenib|sorafenib|mesh-list
111095811|NCT02178358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111095812|NCT02178358|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111095813|NCT02178358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111095814|NCT02178358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111095815|NCT01598896|Clonidine|clonidine|mesh-list
111095816|NCT01598896|Dronabinol|dronabinol|mesh-list
111095817|NCT01598896|Analgesics|analgesics|mesh-ancestor
111095818|NCT01598896|Sensory System Agents|sensory system agents|mesh-ancestor
111095819|NCT01598896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111095820|NCT01598896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111095821|NCT01598896|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111095822|NCT01598896|Sympatholytics|sympatholytics|mesh-ancestor
111095823|NCT01598896|Autonomic Agents|autonomic agents|mesh-ancestor
111095824|NCT01598896|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111095825|NCT01598896|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111095826|NCT01598896|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111095827|NCT01598896|Adrenergic Agents|adrenergic agents|mesh-ancestor
111095828|NCT01598896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111095829|NCT01598896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111095830|NCT01598896|Hallucinogens|hallucinogens|mesh-ancestor
111095831|NCT01598896|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111095832|NCT01598896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111095833|NCT01598896|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
111095834|NCT01598896|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
111095835|NCT01598896|Hormones|hormones|mesh-ancestor
111095836|NCT01598896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111095837|NCT01598662|Levonorgestrel|levonorgestrel|mesh-list
111095838|NCT01598662|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111095839|NCT01598662|Contraceptive Agents|contraceptive agents|mesh-ancestor
111095840|NCT01598662|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111095841|NCT01598662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111095842|NCT01598662|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111095843|NCT01598662|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111095844|NCT01598662|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111095845|NCT03042429|Cyclophosphamide|cyclophosphamide|mesh-list
111095846|NCT03042429|Ifosfamide|ifosfamide|mesh-list
111095847|NCT03042429|Cisplatin|cisplatin|mesh-list
111095848|NCT03042429|Doxorubicin|doxorubicin|mesh-list
111095849|NCT03042429|Etoposide|etoposide|mesh-list
111095850|NCT03042429|Topotecan|topotecan|mesh-list
111095851|NCT03042429|Vindesine|vindesine|mesh-list
111095852|NCT03042429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111095853|NCT03042429|Immunologic Factors|immunologic factors|mesh-ancestor
111095854|NCT03042429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110812939|NCT00743002|Metformin|metformin|mesh-list
111095855|NCT03042429|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111095856|NCT03042429|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111095857|NCT03042429|Alkylating Agents|alkylating agents|mesh-ancestor
111095858|NCT03042429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111095859|NCT03042429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111095860|NCT03042429|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111095861|NCT03042429|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111095862|NCT03042429|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111095863|NCT03042429|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111095864|NCT03042429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111095865|NCT03042429|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111095866|NCT03042429|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111095867|NCT03042429|Tubulin Modulators|tubulin modulators|mesh-ancestor
111095868|NCT03042429|Antimitotic Agents|antimitotic agents|mesh-ancestor
111095869|NCT03042429|Mitosis Modulators|mitosis modulators|mesh-ancestor
111095870|NCT04849299|Cyclosporine|cyclosporine|mesh-list
111095871|NCT04849299|Cyclosporins|cyclosporins|mesh-list
111095872|NCT04849299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111095873|NCT04849299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111095874|NCT04849299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111095875|NCT04849299|Immunologic Factors|immunologic factors|mesh-ancestor
111095876|NCT04849299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111095877|NCT04849299|Antifungal Agents|antifungal agents|mesh-ancestor
111095878|NCT04849299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111095879|NCT04849299|Dermatologic Agents|dermatologic agents|mesh-ancestor
111095880|NCT04849299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111095881|NCT04849299|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111095882|NCT02117050|Interferons|interferons|mesh-list
111095883|NCT02117050|Interferon-beta|interferon-beta|mesh-list
111095884|NCT02117050|Interferon beta-1a|interferon beta-1a|mesh-list
111095885|NCT02117050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111095886|NCT02117050|Antiviral Agents|antiviral agents|mesh-ancestor
111095887|NCT02117050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111095888|NCT02117050|Immunologic Factors|immunologic factors|mesh-ancestor
111095889|NCT02117050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111095891|NCT04860219|Lactoferrin|lactoferrin|mesh-list
111095892|NCT04860219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111095893|NCT02728895|Vedolizumab|vedolizumab|mesh-list
111095894|NCT02728895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111095895|NCT04847895|Ranibizumab|ranibizumab|mesh-list
111095896|NCT04847895|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111095897|NCT04847895|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111095898|NCT04847895|Growth Substances|growth substances|mesh-ancestor
111095899|NCT04847895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111095900|NCT04847895|Growth Inhibitors|growth inhibitors|mesh-ancestor
111095901|NCT04847895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111095902|NCT02450513|Adalimumab|adalimumab|mesh-list
111095903|NCT02450513|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111095904|NCT02450513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111095905|NCT02450513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111095906|NCT04859283|Dexmedetomidine|dexmedetomidine|mesh-list
111095907|NCT04859283|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111095908|NCT04859283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111095909|NCT04859283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111095910|NCT04859283|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111095911|NCT04859283|Analgesics|analgesics|mesh-ancestor
111095912|NCT04859283|Sensory System Agents|sensory system agents|mesh-ancestor
111095913|NCT04859283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111095914|NCT04859283|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111095915|NCT04859283|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111095916|NCT04859283|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111095917|NCT04859283|Adrenergic Agents|adrenergic agents|mesh-ancestor
111095918|NCT04859283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111095919|NCT04859283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111095920|NCT04857801|Teduglutide|teduglutide|mesh-list
110642043|NCT01006863|Protective Agents|protective agents|mesh-ancestor
111095921|NCT04857801|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111095922|NCT04857801|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111095923|NCT04857801|Protective Agents|protective agents|mesh-ancestor
111095924|NCT04857801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111095925|NCT03208361|Amoxicillin|amoxicillin|mesh-list
111095926|NCT03208361|Penicillins|penicillins|mesh-list
111095927|NCT03208361|Penicillin V|penicillin v|mesh-list
111095928|NCT03208361|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111095929|NCT03208361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111095930|NCT02501837|Oxytocin|oxytocin|mesh-list
111095931|NCT02501837|Oxytocics|oxytocics|mesh-ancestor
111095932|NCT02501837|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111095933|NCT02501837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111095934|NCT04859361|Imiquimod|imiquimod|mesh-list
111095935|NCT04859361|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111095936|NCT04859361|Immunologic Factors|immunologic factors|mesh-ancestor
111095937|NCT04859361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111095938|NCT04859361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111095939|NCT04859361|Interferon Inducers|interferon inducers|mesh-ancestor
111095940|NCT04496141|Antibodies|antibodies|mesh-list
111095941|NCT04496141|Immunologic Factors|immunologic factors|mesh-ancestor
111095942|NCT04496141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111095943|NCT03039075|Metformin|metformin|mesh-list
111095944|NCT03039075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111095945|NCT03039075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111095946|NCT04857177|Ranibizumab|ranibizumab|mesh-list
111095947|NCT04857177|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111095948|NCT04857177|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111095949|NCT04857177|Growth Substances|growth substances|mesh-ancestor
111095950|NCT04857177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111095951|NCT04857177|Growth Inhibitors|growth inhibitors|mesh-ancestor
111095952|NCT04857177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111095953|NCT02606877|Pirfenidone|pirfenidone|mesh-list
111095954|NCT02606877|Nintedanib|nintedanib|mesh-list
111095955|NCT02606877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111095956|NCT02606877|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111095957|NCT02606877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111095958|NCT02606877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111095959|NCT02606877|Analgesics|analgesics|mesh-ancestor
111095960|NCT02606877|Sensory System Agents|sensory system agents|mesh-ancestor
111095961|NCT02606877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111095962|NCT02606877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111095963|NCT02606877|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111095964|NCT02606877|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111095965|NCT02606877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111095966|NCT02606877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111095967|NCT03206957|Endostatins|endostatins|mesh-list
111095968|NCT03206957|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-list
111095969|NCT03206957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111095970|NCT03206957|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111095971|NCT03206957|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111095972|NCT03206957|Growth Substances|growth substances|mesh-ancestor
111095973|NCT03206957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111095974|NCT03206957|Growth Inhibitors|growth inhibitors|mesh-ancestor
111095975|NCT03206723|Hydrocodone|hydrocodone|mesh-list
111095976|NCT03206723|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111095977|NCT03206723|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111095978|NCT03206723|Narcotics|narcotics|mesh-ancestor
111095979|NCT03206723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111095980|NCT03206723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111095981|NCT03206723|Analgesics|analgesics|mesh-ancestor
111095982|NCT03206723|Sensory System Agents|sensory system agents|mesh-ancestor
111095983|NCT03206723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111095984|NCT03206723|Antitussive Agents|antitussive agents|mesh-ancestor
111095985|NCT03206723|Respiratory System Agents|respiratory system agents|mesh-ancestor
111095986|NCT03206723|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111095987|NCT03201185|Ramipril|ramipril|mesh-list
111095988|NCT03201185|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
111095989|NCT03201185|Protease Inhibitors|protease inhibitors|mesh-ancestor
111095990|NCT03201185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111095991|NCT03201185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111095992|NCT03201185|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111095993|NCT04856787|Fluorouracil|fluorouracil|mesh-list
111095994|NCT04856787|Antimetabolites|antimetabolites|mesh-ancestor
111095995|NCT04856787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111095996|NCT04856787|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111095997|NCT04856787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111095998|NCT04856787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111095999|NCT04856787|Immunologic Factors|immunologic factors|mesh-ancestor
111096000|NCT04856787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111096001|NCT03206177|Paclitaxel|paclitaxel|mesh-list
111096002|NCT03206177|Carboplatin|carboplatin|mesh-list
111096003|NCT03206177|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111096004|NCT03206177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111096005|NCT03206177|Tubulin Modulators|tubulin modulators|mesh-ancestor
111096006|NCT03206177|Antimitotic Agents|antimitotic agents|mesh-ancestor
111096007|NCT03206177|Mitosis Modulators|mitosis modulators|mesh-ancestor
111096008|NCT03206177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111096010|NCT04839471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111096011|NCT04839471|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111096012|NCT04839471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111096013|NCT04839471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111096014|NCT04839237|Metformin|metformin|mesh-list
111096015|NCT04839237|Liraglutide|liraglutide|mesh-list
111096016|NCT04839237|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111096017|NCT04839237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111096018|NCT04839237|Incretins|incretins|mesh-ancestor
111096019|NCT04839237|Hormones|hormones|mesh-ancestor
111096020|NCT04839237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111096021|NCT03038607|Aspirin|aspirin|mesh-list
111096022|NCT03038607|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111096023|NCT03038607|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111096024|NCT03038607|Analgesics|analgesics|mesh-ancestor
111096025|NCT03038607|Sensory System Agents|sensory system agents|mesh-ancestor
111096026|NCT03038607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111096027|NCT03038607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111096028|NCT03038607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111096029|NCT03038607|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111096030|NCT03038607|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111096031|NCT03038607|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111096032|NCT03038607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111096033|NCT03038607|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111096034|NCT03038607|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111096035|NCT03038607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111096036|NCT03038607|Antipyretics|antipyretics|mesh-ancestor
111096037|NCT03038451|Amlodipine|amlodipine|mesh-list
111096038|NCT03038451|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111096039|NCT03038451|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111096040|NCT03038451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111096041|NCT03038451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111096042|NCT03038451|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111096043|NCT03038451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111096044|NCT03038451|Vasodilator Agents|vasodilator agents|mesh-ancestor
111096045|NCT03040401|Aldesleukin|aldesleukin|mesh-list
111096046|NCT03040401|Interleukin-2|interleukin-2|mesh-list
111096047|NCT03040401|Histamine|histamine|mesh-list
111096048|NCT03040401|Histamine phosphate|histamine phosphate|mesh-list
111096049|NCT03040401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111096050|NCT03040401|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111096051|NCT03040401|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111096052|NCT03040401|Antiviral Agents|antiviral agents|mesh-ancestor
111096053|NCT03040401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111096054|NCT03040401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111096055|NCT03040401|Analgesics|analgesics|mesh-ancestor
111096056|NCT03040401|Sensory System Agents|sensory system agents|mesh-ancestor
111096057|NCT03040401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111096058|NCT03040401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111096059|NCT03040401|Histamine Agonists|histamine agonists|mesh-ancestor
111096060|NCT03040401|Histamine Agents|histamine agents|mesh-ancestor
111096061|NCT03040401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111096062|NCT03040401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111096063|NCT03038295|Propranolol|propranolol|mesh-list
111096064|NCT03038295|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111096065|NCT03038295|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111096066|NCT03038295|Adrenergic Agents|adrenergic agents|mesh-ancestor
111096067|NCT03038295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111096068|NCT03038295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111096069|NCT03038295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111096070|NCT03038295|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111096071|NCT03038295|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111096072|NCT03038295|Vasodilator Agents|vasodilator agents|mesh-ancestor
111096073|NCT03038217|Capecitabine|capecitabine|mesh-list
111096074|NCT03038217|Oxaliplatin|oxaliplatin|mesh-list
111096075|NCT03038217|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111096076|NCT03038217|Antimetabolites|antimetabolites|mesh-ancestor
111096077|NCT03038217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111096078|NCT03038217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111096079|NCT02609607|Bisacodyl|bisacodyl|mesh-list
111096080|NCT02609607|Cathartics|cathartics|mesh-ancestor
111096081|NCT02609607|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111096082|NCT02609607|Laxatives|laxatives|mesh-ancestor
111096084|NCT03040167|Bupivacaine|bupivacaine|mesh-list
111096085|NCT03040167|Anesthetics, Local|anesthetics, local|mesh-ancestor
111096086|NCT03040167|Anesthetics|anesthetics|mesh-ancestor
111096087|NCT03040167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111096088|NCT03040167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111096089|NCT03040167|Sensory System Agents|sensory system agents|mesh-ancestor
111096090|NCT03040167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111096091|NCT03040167|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111096092|NCT03040167|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111096093|NCT03040167|Adrenergic Agents|adrenergic agents|mesh-ancestor
111096094|NCT03040167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111096095|NCT03040167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111096096|NCT03040167|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111096097|NCT03040167|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111096098|NCT03040167|Autonomic Agents|autonomic agents|mesh-ancestor
111096099|NCT03040167|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111096100|NCT03040167|Respiratory System Agents|respiratory system agents|mesh-ancestor
111096101|NCT03040167|Mydriatics|mydriatics|mesh-ancestor
111096102|NCT03040167|Sympathomimetics|sympathomimetics|mesh-ancestor
111096103|NCT03040167|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111096104|NCT04843839|Nepafenac|nepafenac|mesh-list
111096105|NCT04843839|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
111096106|NCT04843839|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111096107|NCT04843839|Lubricant Eye Drops|lubricant eye drops|mesh-list
111096108|NCT04843839|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111096109|NCT04843839|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111096110|NCT04843839|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111096111|NCT04843839|Analgesics|analgesics|mesh-ancestor
111096112|NCT04843839|Sensory System Agents|sensory system agents|mesh-ancestor
111096113|NCT04843839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111096114|NCT04843839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111096115|NCT04843839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111096116|NCT04843839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111096117|NCT04843839|Laxatives|laxatives|mesh-ancestor
110642075|NCT00142909|Lofexidine|lofexidine|mesh-list
111096118|NCT04843839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111096120|NCT04838145|Pleconaril|pleconaril|mesh-list
111096121|NCT04838145|Antimetabolites|antimetabolites|mesh-ancestor
111096122|NCT04838145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111096123|NCT04838145|Antiviral Agents|antiviral agents|mesh-ancestor
111096124|NCT04838145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111096125|NCT04855383|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
111096126|NCT04855383|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111096127|NCT04855383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111096128|NCT03041259|Ascorbic acid, magnesium sulfate heptahydrate, cyanocobalamin, thiamine hydrochloride, riboflavin 5' phosphate, niacinamide, pyridoxine hydrochloride, and calcium D-pantothenate drug combination|ascorbic acid, magnesium sulfate heptahydrate, cyanocobalamin, thiamine hydrochloride, riboflavin 5' phosphate, niacinamide, pyridoxine hydrochloride, and calcium d-pantothenate drug combination|mesh-list
111096129|NCT03041259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111096130|NCT03041259|Antioxidants|antioxidants|mesh-ancestor
111096131|NCT03041259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111096132|NCT03041259|Protective Agents|protective agents|mesh-ancestor
111096133|NCT03041259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111096134|NCT04429035|Vitamin K|vitamin k|mesh-list
111096135|NCT04429035|Vitamin K 2|vitamin k 2|mesh-list
111096136|NCT04429035|Vitamins|vitamins|mesh-ancestor
111096137|NCT04429035|Micronutrients|micronutrients|mesh-ancestor
111096138|NCT04429035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111096139|NCT04429035|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111096140|NCT04429035|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111096141|NCT04429035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111096142|NCT04429035|Hemostatics|hemostatics|mesh-ancestor
111096143|NCT04429035|Coagulants|coagulants|mesh-ancestor
111096144|NCT04843449|Itraconazole|itraconazole|mesh-list
111096145|NCT04843449|Rifampin|rifampin|mesh-list
111096146|NCT04843449|Antifungal Agents|antifungal agents|mesh-ancestor
111096147|NCT04843449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111096148|NCT04843449|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111096149|NCT04843449|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111096150|NCT04843449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111096151|NCT04843449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111096152|NCT04843449|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111096153|NCT04843449|Hormone Antagonists|hormone antagonists|mesh-ancestor
111096154|NCT04843449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111096155|NCT04843449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111096156|NCT04843449|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111096157|NCT04843449|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111096158|NCT04843449|Antitubercular Agents|antitubercular agents|mesh-ancestor
111096159|NCT04843449|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111096160|NCT04843449|Leprostatic Agents|leprostatic agents|mesh-ancestor
111096161|NCT04843449|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111096162|NCT04843449|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111096163|NCT04843449|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111096164|NCT04843449|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
111096165|NCT04843449|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
111096166|NCT04843449|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
111096167|NCT04843449|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111096168|NCT03037593|Vitamin D|vitamin d|mesh-list
111096169|NCT03037593|Cholecalciferol|cholecalciferol|mesh-list
111096170|NCT03037593|Vitamins|vitamins|mesh-ancestor
111096171|NCT03037593|Micronutrients|micronutrients|mesh-ancestor
111096172|NCT03037593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111096173|NCT03037593|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111096174|NCT03037593|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111096175|NCT03037515|Tranexamic Acid|tranexamic acid|mesh-list
111096176|NCT03037515|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111096177|NCT03037515|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111096178|NCT03037515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111096179|NCT03037515|Hemostatics|hemostatics|mesh-ancestor
111096180|NCT03037515|Coagulants|coagulants|mesh-ancestor
111096181|NCT04842825|Cetrorelix|cetrorelix|mesh-list
110642077|NCT00142909|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111096182|NCT04842825|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
111096183|NCT04842825|Hormones|hormones|mesh-ancestor
111096184|NCT04842825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111096185|NCT04842825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111096186|NCT04842825|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111096187|NCT04842825|Fertility Agents|fertility agents|mesh-ancestor
111096188|NCT04842825|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111096189|NCT04842825|Hormone Antagonists|hormone antagonists|mesh-ancestor
111096190|NCT02606253|Metolazone|metolazone|mesh-list
111096191|NCT02606253|Chlorothiazide|chlorothiazide|mesh-list
111096192|NCT02606253|Tolvaptan|tolvaptan|mesh-list
111096193|NCT02606253|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
111096194|NCT02606253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111096195|NCT02606253|Natriuretic Agents|natriuretic agents|mesh-ancestor
111096196|NCT02606253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111096197|NCT02606253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111096198|NCT02606253|Diuretics|diuretics|mesh-ancestor
111096199|NCT02606253|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
111096200|NCT02606253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111096201|NCT04779645|Volagidemab|volagidemab|mesh-list
111096202|NCT04779645|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111096203|NCT04779645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111096204|NCT04854759|Amantadine|amantadine|mesh-list
111096205|NCT04854759|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111096206|NCT04854759|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111096207|NCT04854759|Antiviral Agents|antiviral agents|mesh-ancestor
111096208|NCT04854759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111096209|NCT04854759|Dopamine Agents|dopamine agents|mesh-ancestor
111096210|NCT04854759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111096211|NCT04854759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111096212|NCT04854759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111096213|NCT04854759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111096214|NCT04854759|Analgesics|analgesics|mesh-ancestor
111096215|NCT04854759|Sensory System Agents|sensory system agents|mesh-ancestor
111096216|NCT04854759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111096217|NCT04842435|Immunoglobulins|immunoglobulins|mesh-list
111096218|NCT04842435|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111096219|NCT04842435|Immunologic Factors|immunologic factors|mesh-ancestor
111096220|NCT04842435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111096221|NCT04774419|Dostarlimab|dostarlimab|mesh-list
111096222|NCT04774419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111096223|NCT02607735|Sofosbuvir|sofosbuvir|mesh-list
111096224|NCT02607735|Velpatasvir|velpatasvir|mesh-list
111096225|NCT02607735|Antiviral Agents|antiviral agents|mesh-ancestor
111096226|NCT02607735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111096227|NCT04772313|Methotrexate|methotrexate|mesh-list
111096228|NCT04772313|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111096229|NCT04772313|Abortifacient Agents|abortifacient agents|mesh-ancestor
111096230|NCT04772313|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111096231|NCT04772313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111096232|NCT04772313|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111096233|NCT04772313|Antimetabolites|antimetabolites|mesh-ancestor
111096234|NCT04772313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111096235|NCT04772313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111096236|NCT04772313|Dermatologic Agents|dermatologic agents|mesh-ancestor
111096237|NCT04772313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111096238|NCT04772313|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111096239|NCT04772313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110642093|NCT03508739|Valsartan|valsartan|mesh-list
111096240|NCT04772313|Immunologic Factors|immunologic factors|mesh-ancestor
111096241|NCT04772313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111096242|NCT04772313|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111096243|NCT03040791|Nivolumab|nivolumab|mesh-list
111096244|NCT03040791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111096245|NCT03040791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111096246|NCT03040791|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111096247|NCT03040791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111096248|NCT04428879|Topotecan|topotecan|mesh-list
111096249|NCT04428879|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111096250|NCT04428879|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111096251|NCT04428879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111096252|NCT04428879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111096253|NCT04428879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111096254|NCT04836819|Lidocaine|lidocaine|mesh-list
111096255|NCT04836819|Dexmedetomidine|dexmedetomidine|mesh-list
111096256|NCT04836819|Ketamine|ketamine|mesh-list
111096257|NCT04836819|Anesthetics, Local|anesthetics, local|mesh-ancestor
111096258|NCT04836819|Anesthetics|anesthetics|mesh-ancestor
111096259|NCT04836819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111096260|NCT04836819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111096261|NCT04836819|Sensory System Agents|sensory system agents|mesh-ancestor
111096262|NCT04836819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111096264|NCT04836819|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111096265|NCT04836819|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111096266|NCT04836819|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111096267|NCT04836819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111096268|NCT04836819|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111096269|NCT04836819|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111096270|NCT04836819|Analgesics|analgesics|mesh-ancestor
111096271|NCT04836819|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111096272|NCT04836819|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111096273|NCT04836819|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111096274|NCT04836819|Adrenergic Agents|adrenergic agents|mesh-ancestor
111096275|NCT04836819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111096276|NCT04836819|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111096277|NCT04836819|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111096278|NCT04836819|Anesthetics, General|anesthetics, general|mesh-ancestor
111096279|NCT04836819|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111096280|NCT04836819|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111096281|NCT04836507|Cyclophosphamide|cyclophosphamide|mesh-list
111096282|NCT04836507|Fludarabine|fludarabine|mesh-list
111096283|NCT04836507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111096284|NCT04836507|Immunologic Factors|immunologic factors|mesh-ancestor
111096285|NCT04836507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111096286|NCT04836507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111096287|NCT04836507|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111096288|NCT04836507|Alkylating Agents|alkylating agents|mesh-ancestor
111096289|NCT04836507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111096290|NCT04836507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111096291|NCT04836507|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111096292|NCT04835259|Selenium|selenium|mesh-list
111096293|NCT04835259|Antioxidants|antioxidants|mesh-ancestor
111096294|NCT04835259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111096295|NCT04835259|Protective Agents|protective agents|mesh-ancestor
111096296|NCT04835259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111096297|NCT04835259|Trace Elements|trace elements|mesh-ancestor
111096298|NCT04835259|Micronutrients|micronutrients|mesh-ancestor
111096299|NCT04853901|Remdesivir|remdesivir|mesh-list
111096300|NCT04853901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111096301|NCT04853901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111096302|NCT04853901|Antimetabolites|antimetabolites|mesh-ancestor
111096303|NCT04853901|Antiviral Agents|antiviral agents|mesh-ancestor
111096304|NCT01668537|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
111096305|NCT01668537|Antiviral Agents|antiviral agents|mesh-ancestor
111096306|NCT01668537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111096307|NCT04834791|Letrozole|letrozole|mesh-list
111096308|NCT04834791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111096309|NCT04834791|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111096310|NCT04834791|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111096311|NCT04834791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111096312|NCT04834791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111096313|NCT04834791|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111096314|NCT04834791|Hormone Antagonists|hormone antagonists|mesh-ancestor
111096315|NCT04834791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111096316|NCT04834791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111096317|NCT04835025|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
111096318|NCT04835025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111096319|NCT04835025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111096320|NCT04835025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111096321|NCT03038919|Methyltestosterone|methyltestosterone|mesh-list
111096322|NCT03038919|Testosterone|testosterone|mesh-list
111096323|NCT03038919|Testosterone undecanoate|testosterone undecanoate|mesh-list
111096324|NCT03038919|Testosterone enanthate|testosterone enanthate|mesh-list
111096325|NCT03038919|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
111096326|NCT03038919|Androgens|androgens|mesh-ancestor
111096327|NCT03038919|Hormones|hormones|mesh-ancestor
111096328|NCT03038919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111096329|NCT03038919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111096330|NCT03038919|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111096331|NCT03038919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111096333|NCT03036891|Naloxegol|naloxegol|mesh-list
111096334|NCT03036891|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111096335|NCT03036891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111096336|NCT03036891|Sensory System Agents|sensory system agents|mesh-ancestor
111096337|NCT03036891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111096338|NCT01668147|Ritonavir|ritonavir|mesh-list
111096339|NCT01668147|Efavirenz|efavirenz|mesh-list
111096340|NCT01668147|Loperamide|loperamide|mesh-list
111096341|NCT01668147|Antidiarrheals|antidiarrheals|mesh-list
111096342|NCT01668147|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111096343|NCT01668147|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111096344|NCT01668147|Protease Inhibitors|protease inhibitors|mesh-ancestor
111096345|NCT01668147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111096346|NCT01668147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111096347|NCT01668147|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111096348|NCT01668147|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111096349|NCT01668147|Antiviral Agents|antiviral agents|mesh-ancestor
111096350|NCT01668147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111096351|NCT01668147|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111096352|NCT01668147|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111096353|NCT01668147|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111096354|NCT01668147|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111096355|NCT01668147|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111096356|NCT01668147|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111096357|NCT01668147|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111096358|NCT01668147|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111096359|NCT01668147|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111096360|NCT01668147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111096361|NCT04833777|Lidocaine|lidocaine|mesh-list
111096362|NCT04833777|Bupivacaine|bupivacaine|mesh-list
111096363|NCT04833777|Anesthetics, Local|anesthetics, local|mesh-list
111096364|NCT04833777|Anesthetics|anesthetics|mesh-list
111096365|NCT04833777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111096366|NCT04833777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111096367|NCT04833777|Sensory System Agents|sensory system agents|mesh-ancestor
111096368|NCT04833777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111096369|NCT04833777|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111096370|NCT04833777|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111096371|NCT04833777|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111096372|NCT04833777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111096373|NCT04833777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111096374|NCT03036501|Risdiplam|risdiplam|mesh-list
111096375|NCT03036501|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111096376|NCT03036501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111096377|NCT03036501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111096378|NCT04851015|Trimethoprim|trimethoprim|mesh-list
111096379|NCT04851015|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
111096380|NCT04851015|Sulfamethoxazole|sulfamethoxazole|mesh-list
111096381|NCT04851015|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111096382|NCT04851015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111096383|NCT04851015|Antimalarials|antimalarials|mesh-ancestor
111096384|NCT04851015|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111096385|NCT04851015|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111096386|NCT04851015|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111096387|NCT04851015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111096388|NCT04851015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111096389|NCT04851015|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111096390|NCT04851015|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
111096391|NCT04851015|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111096392|NCT04851015|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111096393|NCT04365933|Interferons|interferons|mesh-list
111096394|NCT04365933|Interferon-alpha|interferon-alpha|mesh-list
111096395|NCT04365933|Interferon alpha-2|interferon alpha-2|mesh-list
111096396|NCT04365933|Entecavir|entecavir|mesh-list
111096397|NCT04365933|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
111096398|NCT04365933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111096399|NCT04365933|Antiviral Agents|antiviral agents|mesh-ancestor
111096400|NCT04365933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111096401|NCT04365933|Immunologic Factors|immunologic factors|mesh-ancestor
111096402|NCT04365933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111096403|NCT04824261|Clotrimazole|clotrimazole|mesh-list
111096404|NCT04824261|Miconazole|miconazole|mesh-list
111096405|NCT04824261|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111096406|NCT04824261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111096407|NCT04824261|Antifungal Agents|antifungal agents|mesh-ancestor
111096408|NCT04824261|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111096409|NCT04824261|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111096410|NCT04824261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111096411|NCT04824261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111096412|NCT04824261|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111096413|NCT04824261|Hormone Antagonists|hormone antagonists|mesh-ancestor
111096414|NCT04824261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111096415|NCT04824261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111096416|NCT04824261|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111096417|NCT04824261|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111096418|NCT04850235|Paclitaxel|paclitaxel|mesh-list
111096419|NCT04850235|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111096420|NCT04850235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111096421|NCT04850235|Tubulin Modulators|tubulin modulators|mesh-ancestor
111096422|NCT04850235|Antimitotic Agents|antimitotic agents|mesh-ancestor
111096423|NCT04850235|Mitosis Modulators|mitosis modulators|mesh-ancestor
111096424|NCT04850235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111096425|NCT04850001|Aspirin|aspirin|mesh-list
111096426|NCT04850001|Clopidogrel|clopidogrel|mesh-list
111096427|NCT04850001|Atorvastatin|atorvastatin|mesh-list
111096428|NCT04850001|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111096429|NCT04850001|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111096430|NCT04850001|Analgesics|analgesics|mesh-ancestor
111096431|NCT04850001|Sensory System Agents|sensory system agents|mesh-ancestor
111096432|NCT04850001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111096433|NCT04850001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111096434|NCT04850001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111096435|NCT04850001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111096436|NCT04850001|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111096437|NCT04850001|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111096438|NCT04850001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111096439|NCT04850001|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111096440|NCT04850001|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111096441|NCT04850001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111096442|NCT04850001|Antipyretics|antipyretics|mesh-ancestor
111096443|NCT04850001|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111096444|NCT04850001|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111096445|NCT04850001|Antimetabolites|antimetabolites|mesh-ancestor
111096446|NCT04850001|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111096447|NCT04850001|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111096448|NCT04850001|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111096449|NCT04850001|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111096450|NCT04850001|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111096451|NCT04850001|Purinergic Agents|purinergic agents|mesh-ancestor
111096452|NCT04850001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111096453|NCT03036111|Trimebutine|trimebutine|mesh-list
111096454|NCT03036111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111096455|NCT03036111|Parasympatholytics|parasympatholytics|mesh-ancestor
111096456|NCT03036111|Autonomic Agents|autonomic agents|mesh-ancestor
111096457|NCT03036111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111096458|NCT03036111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111096459|NCT04830579|Etoricoxib|etoricoxib|mesh-list
111096460|NCT04830579|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111096461|NCT04830579|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111096462|NCT04830579|Analgesics|analgesics|mesh-ancestor
111096463|NCT04830579|Sensory System Agents|sensory system agents|mesh-ancestor
111096464|NCT04830579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111096465|NCT04830579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111096466|NCT04830579|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111096467|NCT04830579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111096468|NCT04830579|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111096469|NCT04830579|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111096470|NCT04830579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111096471|NCT04830579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111096472|NCT04816461|Piperaquine|piperaquine|mesh-list
111096473|NCT04816461|Sulfadoxine|sulfadoxine|mesh-list
111096474|NCT04816461|Amodiaquine|amodiaquine|mesh-list
111096475|NCT04816461|Artenimol|artenimol|mesh-list
111096476|NCT04816461|Antimalarials|antimalarials|mesh-ancestor
111096477|NCT04816461|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111096478|NCT04816461|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111096479|NCT04816461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111096480|NCT04816461|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111096482|NCT04427865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111096483|NCT02600559|Ciprofloxacin|ciprofloxacin|mesh-list
111096484|NCT02600559|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111096485|NCT02600559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111096486|NCT02600559|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111096487|NCT02600559|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111096488|NCT02600559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111096489|NCT02600559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111096490|NCT02600559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111096491|NCT02600559|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111096492|NCT02600559|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111096493|NCT04427787|Lanreotide|lanreotide|mesh-list
111096494|NCT04427787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111096495|NCT04821843|Paclitaxel|paclitaxel|mesh-list
111096496|NCT04821843|Nimotuzumab|nimotuzumab|mesh-list
111096497|NCT04821843|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111096498|NCT04821843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111096499|NCT04821843|Tubulin Modulators|tubulin modulators|mesh-ancestor
111096500|NCT04821843|Antimitotic Agents|antimitotic agents|mesh-ancestor
111096501|NCT04821843|Mitosis Modulators|mitosis modulators|mesh-ancestor
111096502|NCT04821843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111096503|NCT04821843|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111096504|NCT04829487|Vitamin D|vitamin d|mesh-list
111096505|NCT04829487|Ergocalciferols|ergocalciferols|mesh-list
111096506|NCT04829487|Vitamins|vitamins|mesh-ancestor
111096507|NCT04829487|Micronutrients|micronutrients|mesh-ancestor
111096508|NCT04829487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111096509|NCT04829487|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111096510|NCT04829487|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110813616|NCT02284204|GABA Modulators|gaba modulators|mesh-ancestor
111096511|NCT04829565|Botulinum Toxins|botulinum toxins|mesh-list
111096512|NCT04829565|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111096513|NCT04829565|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111096514|NCT04829565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111096515|NCT04829565|Cholinergic Agents|cholinergic agents|mesh-ancestor
111096516|NCT04829565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111096517|NCT04829565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111096518|NCT04821765|Paclitaxel|paclitaxel|mesh-list
111096519|NCT04821765|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111096520|NCT04821765|Antibodies|antibodies|mesh-list
111096521|NCT04821765|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111096522|NCT04821765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111096523|NCT04821765|Tubulin Modulators|tubulin modulators|mesh-ancestor
111096524|NCT04821765|Antimitotic Agents|antimitotic agents|mesh-ancestor
111096525|NCT04821765|Mitosis Modulators|mitosis modulators|mesh-ancestor
111096526|NCT04821765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111096527|NCT04821765|Immunologic Factors|immunologic factors|mesh-ancestor
111096528|NCT04821765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111096529|NCT04829097|Temozolomide|temozolomide|mesh-list
111096530|NCT04829097|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111096531|NCT04829097|Alkylating Agents|alkylating agents|mesh-ancestor
111096532|NCT04829097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111096533|NCT04829097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111096534|NCT04829019|Osimertinib|osimertinib|mesh-list
111096535|NCT04829019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111096536|NCT04829019|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111096537|NCT04829019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111096538|NCT04829019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111096539|NCT04821063|Moxifloxacin|moxifloxacin|mesh-list
111096540|NCT04821063|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
111096541|NCT04821063|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
111096542|NCT04821063|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111096543|NCT04821063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111096544|NCT04821063|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111096545|NCT04821063|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111096546|NCT04821063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111096547|NCT04821063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111096548|NCT04821063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110677429|NCT00861705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111096549|NCT04821063|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111096550|NCT04821063|Contraceptive Agents|contraceptive agents|mesh-ancestor
111096551|NCT04821063|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111096552|NCT04821063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111096553|NCT04821063|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
111096554|NCT04821063|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111096555|NCT04821063|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111096556|NCT04821063|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111096557|NCT03976245|Etanercept|etanercept|mesh-list
111096558|NCT03976245|Tofacitinib|tofacitinib|mesh-list
111096559|NCT03976245|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111096560|NCT03976245|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111096561|NCT03976245|Analgesics|analgesics|mesh-ancestor
111096562|NCT03976245|Sensory System Agents|sensory system agents|mesh-ancestor
111096563|NCT03976245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111096564|NCT03976245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111096565|NCT03976245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111096566|NCT03976245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111096567|NCT03976245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111096568|NCT03976245|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111096569|NCT03976245|Immunologic Factors|immunologic factors|mesh-ancestor
111096570|NCT03976245|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
111096571|NCT03976245|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111096572|NCT03976245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111096573|NCT03976245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111096574|NCT04820751|Cyproheptadine|cyproheptadine|mesh-list
111096575|NCT04820751|Antipruritics|antipruritics|mesh-ancestor
111096576|NCT04820751|Dermatologic Agents|dermatologic agents|mesh-ancestor
111096577|NCT04820751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111096578|NCT04820751|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111096579|NCT04820751|Histamine Antagonists|histamine antagonists|mesh-ancestor
111096580|NCT04820751|Histamine Agents|histamine agents|mesh-ancestor
111096581|NCT04820751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111096582|NCT04820751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111096583|NCT04820751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111096584|NCT04820751|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111096585|NCT04820751|Serotonin Agents|serotonin agents|mesh-ancestor
111096586|NCT04820751|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111096588|NCT04828395|Etoposide|etoposide|mesh-list
111096589|NCT04828395|Cisplatin|cisplatin|mesh-list
111096590|NCT04828395|Carboplatin|carboplatin|mesh-list
111096591|NCT04828395|Pemetrexed|pemetrexed|mesh-list
111096592|NCT04828395|Fluzoparib|fluzoparib|mesh-list
111096593|NCT04828395|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111096594|NCT04828395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111096595|NCT04828395|Tubulin Modulators|tubulin modulators|mesh-ancestor
111096596|NCT04828395|Antimitotic Agents|antimitotic agents|mesh-ancestor
111096597|NCT04828395|Mitosis Modulators|mitosis modulators|mesh-ancestor
111096598|NCT04828395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111096599|NCT04828395|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111096600|NCT04828395|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111096601|NCT04828395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111096602|NCT04828395|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111096603|NCT04828395|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111096604|NCT04828395|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111096605|NCT04820439|Pertuzumab|pertuzumab|mesh-list
111096606|NCT04820439|Antibodies|antibodies|mesh-list
111096607|NCT04820439|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111096608|NCT04820439|Mitogens|mitogens|mesh-list
111096609|NCT04820439|Immunologic Factors|immunologic factors|mesh-ancestor
111096610|NCT04820439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111096611|NCT04820439|Mitosis Modulators|mitosis modulators|mesh-ancestor
111096612|NCT04820439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111096613|NCT04820439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111096614|NCT04820439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111096615|NCT05619315|Calcium Carbonate|calcium carbonate|mesh-list
111096616|NCT05619315|Calcium|calcium|mesh-list
111096617|NCT05619315|Charcoal|charcoal|mesh-list
111096618|NCT05619315|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111096619|NCT05619315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111096620|NCT05619315|Antacids|antacids|mesh-ancestor
111096621|NCT05619315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111096622|NCT05619315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111096623|NCT05619315|Antidotes|antidotes|mesh-ancestor
111096624|NCT05619315|Protective Agents|protective agents|mesh-ancestor
111096625|NCT04814511|Permethrin|permethrin|mesh-list
111096626|NCT04814511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111096627|NCT04814511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111096628|NCT04814043|Lenvatinib|lenvatinib|mesh-list
111096629|NCT04814043|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
111096630|NCT04814043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111096631|NCT04814043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111096632|NCT04814043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111096633|NCT04814043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111096634|NCT04814043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111096635|NCT04814589|Ezetimibe|ezetimibe|mesh-list
111096636|NCT04814589|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111096637|NCT04814589|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111096638|NCT04814589|Antimetabolites|antimetabolites|mesh-ancestor
111096639|NCT04814589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111096640|NCT04814589|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111096641|NCT04819503|Anesthetics|anesthetics|mesh-list
111096642|NCT04819503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111096643|NCT04819503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111096644|NCT04826679|Paclitaxel|paclitaxel|mesh-list
111096645|NCT04826679|Cisplatin|cisplatin|mesh-list
111096646|NCT04826679|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111096647|NCT04826679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111096648|NCT04826679|Tubulin Modulators|tubulin modulators|mesh-ancestor
111096649|NCT04826679|Antimitotic Agents|antimitotic agents|mesh-ancestor
111096650|NCT04826679|Mitosis Modulators|mitosis modulators|mesh-ancestor
111096651|NCT04826679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111096652|NCT02601573|Ribavirin|ribavirin|mesh-list
111096653|NCT02601573|Sofosbuvir|sofosbuvir|mesh-list
111096654|NCT02601573|Grazoprevir|grazoprevir|mesh-list
111096655|NCT02601573|Antimetabolites|antimetabolites|mesh-ancestor
111096656|NCT02601573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111096657|NCT02601573|Antiviral Agents|antiviral agents|mesh-ancestor
111096658|NCT02601573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111096659|NCT04818723|Montelukast|montelukast|mesh-list
111096660|NCT04818723|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110813761|NCT04470076|Pemetrexed|pemetrexed|mesh-list
111096661|NCT04818723|Respiratory System Agents|respiratory system agents|mesh-ancestor
111096662|NCT04818723|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
111096663|NCT04818723|Hormone Antagonists|hormone antagonists|mesh-ancestor
111096664|NCT04818723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111096665|NCT04818723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111096666|NCT04818723|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
111096667|NCT04818723|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111096668|NCT04818723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111096669|NCT02601027|Acetaminophen|acetaminophen|mesh-list
111096670|NCT02601027|Oxycodone|oxycodone|mesh-list
111096671|NCT02601027|Hydromorphone|hydromorphone|mesh-list
111096672|NCT02601027|Ondansetron|ondansetron|mesh-list
111096673|NCT02601027|Bupivacaine|bupivacaine|mesh-list
111096674|NCT02601027|Anesthetics, Local|anesthetics, local|mesh-ancestor
111096675|NCT02601027|Anesthetics|anesthetics|mesh-ancestor
111096676|NCT02601027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111096677|NCT02601027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111096678|NCT02601027|Sensory System Agents|sensory system agents|mesh-ancestor
111096679|NCT02601027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111096680|NCT02601027|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111096681|NCT02601027|Narcotics|narcotics|mesh-ancestor
111096682|NCT02601027|Analgesics|analgesics|mesh-ancestor
111096683|NCT02601027|Antiemetics|antiemetics|mesh-ancestor
111096684|NCT02601027|Autonomic Agents|autonomic agents|mesh-ancestor
111096685|NCT02601027|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111096686|NCT02601027|Antipruritics|antipruritics|mesh-ancestor
111096687|NCT02601027|Dermatologic Agents|dermatologic agents|mesh-ancestor
111096688|NCT02601027|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111096689|NCT02601027|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111096690|NCT02601027|Serotonin Agents|serotonin agents|mesh-ancestor
111096691|NCT02601027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111096692|NCT02601027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111096693|NCT02601027|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111096694|NCT02601027|Antipyretics|antipyretics|mesh-ancestor
111096695|NCT04411875|Amlodipine|amlodipine|mesh-list
111096696|NCT04411875|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111096697|NCT04411875|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111096698|NCT04411875|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111096699|NCT04411875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111096700|NCT04411875|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111096701|NCT04411875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111096702|NCT04411875|Vasodilator Agents|vasodilator agents|mesh-ancestor
111096703|NCT02600871|Povidone-Iodine|povidone-iodine|mesh-list
111096704|NCT02600871|Povidone|povidone|mesh-list
111096705|NCT02600871|Plasma Substitutes|plasma substitutes|mesh-ancestor
111096706|NCT02600871|Blood Substitutes|blood substitutes|mesh-ancestor
111096707|NCT02600871|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111096708|NCT02600871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111096709|NCT04817865|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111096710|NCT04817865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111096711|NCT04818099|Vortioxetine|vortioxetine|mesh-list
111096712|NCT04818099|Antidepressive Agents|antidepressive agents|mesh-ancestor
111096713|NCT04818099|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111096714|NCT04818099|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111096715|NCT04818099|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111096716|NCT04818099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111096717|NCT04818099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111096718|NCT04818099|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111096719|NCT04818099|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111096720|NCT04818099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111096721|NCT04818099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111096722|NCT04818099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111096723|NCT04818099|Serotonin Agents|serotonin agents|mesh-ancestor
111096724|NCT04818099|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111096725|NCT04818099|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111096726|NCT04818099|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111096727|NCT04818099|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111096728|NCT04357899|Hypolipidemic Agents|hypolipidemic agents|mesh-list
111096729|NCT04357899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111096730|NCT04357899|Antimetabolites|antimetabolites|mesh-ancestor
111096731|NCT04357899|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111096732|NCT04807569|Tamsulosin|tamsulosin|mesh-list
111096733|NCT04807569|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111096734|NCT04807569|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111096735|NCT04807569|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111096736|NCT04807569|Adrenergic Agents|adrenergic agents|mesh-ancestor
111096737|NCT04807569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111096738|NCT04807569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111096739|NCT04807569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111096740|NCT04807569|Urological Agents|urological agents|mesh-ancestor
111096741|NCT04807413|Nitric Oxide|nitric oxide|mesh-list
111096742|NCT04807413|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111096743|NCT04807413|Autonomic Agents|autonomic agents|mesh-ancestor
111096744|NCT04807413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111096745|NCT04807413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111096746|NCT04807413|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111096747|NCT04807413|Respiratory System Agents|respiratory system agents|mesh-ancestor
111096748|NCT04807413|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111096749|NCT04807413|Antioxidants|antioxidants|mesh-ancestor
111096750|NCT04807413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111096751|NCT04807413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111096752|NCT04807413|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
111096753|NCT04807413|Vasodilator Agents|vasodilator agents|mesh-ancestor
111096754|NCT04807413|Gasotransmitters|gasotransmitters|mesh-ancestor
111096755|NCT04807413|Protective Agents|protective agents|mesh-ancestor
111096756|NCT04807335|Sufentanil|sufentanil|mesh-list
111096757|NCT04807335|Ketamine|ketamine|mesh-list
111096758|NCT04807335|Analgesics|analgesics|mesh-ancestor
111096759|NCT04807335|Sensory System Agents|sensory system agents|mesh-ancestor
111096760|NCT04807335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111096761|NCT04807335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111096762|NCT04807335|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111096763|NCT04807335|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111096764|NCT04807335|Anesthetics, General|anesthetics, general|mesh-ancestor
111096765|NCT04807335|Anesthetics|anesthetics|mesh-ancestor
111096766|NCT04807335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111096767|NCT04807335|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111096768|NCT04807335|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111096769|NCT04807335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111096770|NCT04807335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111096771|NCT04807335|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111096772|NCT04807335|Narcotics|narcotics|mesh-ancestor
111096773|NCT04807335|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111096774|NCT05616507|Fucoidan|fucoidan|mesh-list
111096775|NCT05616507|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111096776|NCT05616507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111096777|NCT05616507|Anticoagulants|anticoagulants|mesh-ancestor
111096778|NCT05616507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111096779|NCT04806945|Paclitaxel|paclitaxel|mesh-list
111096780|NCT04806945|Carboplatin|carboplatin|mesh-list
111096781|NCT04806945|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111096782|NCT04806945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111096783|NCT04806945|Tubulin Modulators|tubulin modulators|mesh-ancestor
111096784|NCT04806945|Antimitotic Agents|antimitotic agents|mesh-ancestor
111096785|NCT04806945|Mitosis Modulators|mitosis modulators|mesh-ancestor
111096786|NCT04806945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111096787|NCT04806633|Dapagliflozin|dapagliflozin|mesh-list
111096788|NCT04806633|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111096789|NCT04806633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111096790|NCT04806633|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111096791|NCT04806633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111096792|NCT04805229|Analgesics, Opioid|analgesics, opioid|mesh-list
111096793|NCT04805229|Narcotics|narcotics|mesh-ancestor
111096794|NCT04805229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111096795|NCT04805229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111096796|NCT04805229|Analgesics|analgesics|mesh-ancestor
111096797|NCT04805229|Sensory System Agents|sensory system agents|mesh-ancestor
111096798|NCT04805229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111096799|NCT04811313|Bupivacaine|bupivacaine|mesh-list
111096800|NCT04811313|Tranexamic Acid|tranexamic acid|mesh-list
111096801|NCT04811313|Anesthetics, Local|anesthetics, local|mesh-ancestor
111096802|NCT04811313|Anesthetics|anesthetics|mesh-ancestor
111096803|NCT04811313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111096804|NCT04811313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111096805|NCT04811313|Sensory System Agents|sensory system agents|mesh-ancestor
111096806|NCT04811313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111096807|NCT04811313|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111096808|NCT04811313|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110813907|NCT05982197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111096809|NCT04811313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111096810|NCT04811313|Hemostatics|hemostatics|mesh-ancestor
111096811|NCT04811313|Coagulants|coagulants|mesh-ancestor
111096812|NCT04352439|Aspirin|aspirin|mesh-list
111096813|NCT04352439|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111096814|NCT04352439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111096815|NCT04352439|Analgesics|analgesics|mesh-ancestor
111096816|NCT04352439|Sensory System Agents|sensory system agents|mesh-ancestor
111096817|NCT04352439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111096818|NCT04352439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111096819|NCT04352439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111096820|NCT04352439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111096821|NCT04352439|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111096822|NCT04352439|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111096823|NCT04352439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111096824|NCT04352439|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111096825|NCT04352439|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111096826|NCT04352439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111096827|NCT04352439|Antipyretics|antipyretics|mesh-ancestor
111096828|NCT04796025|Bevacizumab|bevacizumab|mesh-list
111096829|NCT04796025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111096830|NCT04796025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111096831|NCT04796025|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111096832|NCT04796025|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111096833|NCT04796025|Growth Substances|growth substances|mesh-ancestor
111096834|NCT04796025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111096835|NCT04796025|Growth Inhibitors|growth inhibitors|mesh-ancestor
111096836|NCT04795479|Moxifloxacin|moxifloxacin|mesh-list
111096837|NCT04795479|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111096838|NCT04795479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111096839|NCT04795479|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111096840|NCT04795479|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111096841|NCT04795479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111096842|NCT04795479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111096843|NCT04795479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111096844|NCT02595723|Megestrol|megestrol|mesh-list
111096845|NCT02595723|Megestrol Acetate|megestrol acetate|mesh-list
111096846|NCT02595723|Phenytoin|phenytoin|mesh-list
111096847|NCT02595723|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111096848|NCT02595723|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111096849|NCT02595723|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111096850|NCT02595723|Contraceptive Agents|contraceptive agents|mesh-ancestor
111096851|NCT02595723|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111096852|NCT02595723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111096853|NCT02595723|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111096854|NCT02595723|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111096855|NCT02595723|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111096856|NCT02595723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111096857|NCT02595723|Appetite Stimulants|appetite stimulants|mesh-ancestor
111096858|NCT02595723|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111096859|NCT02595723|Anticonvulsants|anticonvulsants|mesh-ancestor
111096860|NCT02595723|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111096861|NCT02595723|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111096862|NCT02595723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111096863|NCT02595723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111096864|NCT02595723|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
111096865|NCT02595723|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111096866|NCT01667679|Sumatriptan|sumatriptan|mesh-list
111096867|NCT01667679|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111096868|NCT01667679|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111096869|NCT01667679|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111096870|NCT01667679|Serotonin Agents|serotonin agents|mesh-ancestor
111096871|NCT01667679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111096872|NCT01667679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111096873|NCT01667679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111096874|NCT02597049|Metformin|metformin|mesh-list
111096875|NCT02597049|Dapagliflozin|dapagliflozin|mesh-list
111096876|NCT02597049|Empagliflozin|empagliflozin|mesh-list
111096877|NCT02597049|Canagliflozin|canagliflozin|mesh-list
111096878|NCT02597049|Dulaglutide|dulaglutide|mesh-list
111096879|NCT02597049|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
111096880|NCT02597049|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111096881|NCT02597049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111096882|NCT02597049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111096883|NCT04809675|Salicylic Acid|salicylic acid|mesh-list
111096884|NCT04809675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111096885|NCT04809675|Antifungal Agents|antifungal agents|mesh-ancestor
111096886|NCT04809675|Keratolytic Agents|keratolytic agents|mesh-ancestor
111096887|NCT04809675|Dermatologic Agents|dermatologic agents|mesh-ancestor
111096888|NCT04802967|Ketoprofen|ketoprofen|mesh-list
111096889|NCT04802967|Ketoprofen lysine|ketoprofen lysine|mesh-list
111096890|NCT04802967|Gabapentin|gabapentin|mesh-list
111096891|NCT04802967|Analgesics|analgesics|mesh-ancestor
111096892|NCT04802967|Sensory System Agents|sensory system agents|mesh-ancestor
111096893|NCT04802967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111096894|NCT04802967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111096895|NCT04802967|Anticonvulsants|anticonvulsants|mesh-ancestor
111096896|NCT04802967|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111096897|NCT04802967|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111096898|NCT04802967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111096899|NCT04802967|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111096900|NCT04802967|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111096901|NCT04802967|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111096902|NCT04802967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111096903|NCT04802967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111096904|NCT04802967|Antimanic Agents|antimanic agents|mesh-ancestor
111096905|NCT04802967|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111096906|NCT04802967|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111096907|NCT04802967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111096908|NCT04802967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111096909|NCT04802967|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111096910|NCT04802967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111096911|NCT04282785|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111096912|NCT04282785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111096913|NCT05616117|Vitamin D|vitamin d|mesh-list
111096914|NCT05616117|Vitamins|vitamins|mesh-list
111096915|NCT05616117|Micronutrients|micronutrients|mesh-ancestor
111096916|NCT05616117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111096917|NCT05616117|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111096918|NCT02594163|Rituximab|rituximab|mesh-list
110311387|NCT00417716|Bevacizumab|bevacizumab|mesh-list
111096919|NCT02594163|Brentuximab Vedotin|brentuximab vedotin|mesh-list
111096920|NCT02594163|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
111096921|NCT02594163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111096922|NCT02594163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111096923|NCT02594163|Immunologic Factors|immunologic factors|mesh-ancestor
111096924|NCT02594163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111096925|NCT02594163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111096926|NCT02594163|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111096927|NCT02594163|Alkylating Agents|alkylating agents|mesh-ancestor
111096928|NCT02594163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111096929|NCT02594163|Immunotoxins|immunotoxins|mesh-ancestor
111096930|NCT02594163|Immunoconjugates|immunoconjugates|mesh-ancestor
111096931|NCT03206255|Vaccines|vaccines|mesh-list
111096932|NCT03206255|Immunologic Factors|immunologic factors|mesh-ancestor
111096933|NCT03206255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111096934|NCT03206411|Hormones|hormones|mesh-list
111096935|NCT03206411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111096936|NCT03206411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111096937|NCT03206021|Carboplatin|carboplatin|mesh-list
111096938|NCT03206021|Azacitidine|azacitidine|mesh-list
111096939|NCT03206021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111096940|NCT03206021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111096941|NCT03206021|Antimetabolites|antimetabolites|mesh-ancestor
111096942|NCT03206021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111096943|NCT03206021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111096944|NCT03200561|Prednisolone|prednisolone|mesh-list
111096945|NCT03200561|Immunoglobulins|immunoglobulins|mesh-list
111096946|NCT03200561|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111096947|NCT03200561|Antibodies|antibodies|mesh-list
111096948|NCT03200561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111096949|NCT03200561|Glucocorticoids|glucocorticoids|mesh-ancestor
111096950|NCT03200561|Hormones|hormones|mesh-ancestor
111096951|NCT03200561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111096952|NCT03200561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111096953|NCT03200561|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111096954|NCT03200561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111096955|NCT03200561|Immunologic Factors|immunologic factors|mesh-ancestor
111096956|NCT02449811|Amlodipine|amlodipine|mesh-list
111096957|NCT02449811|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
111096958|NCT02449811|Olmesartan|olmesartan|mesh-list
111096959|NCT02449811|Perindopril|perindopril|mesh-list
111096960|NCT02449811|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111096961|NCT02449811|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111096962|NCT02449811|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111096963|NCT02449811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111096964|NCT02449811|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111096965|NCT02449811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111096966|NCT02449811|Vasodilator Agents|vasodilator agents|mesh-ancestor
111096967|NCT02449811|Diuretics|diuretics|mesh-ancestor
111096968|NCT02449811|Natriuretic Agents|natriuretic agents|mesh-ancestor
111096969|NCT02449811|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
111096970|NCT02449811|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111096971|NCT02449811|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111096972|NCT02449811|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
111096973|NCT02449811|Protease Inhibitors|protease inhibitors|mesh-ancestor
111096974|NCT02449811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111096975|NCT03200093|Vancomycin|vancomycin|mesh-list
111096976|NCT03200093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111096977|NCT03200093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111096978|NCT03204929|Copper|copper|mesh-list
111096979|NCT03204929|Trace Elements|trace elements|mesh-ancestor
111096980|NCT03204929|Micronutrients|micronutrients|mesh-ancestor
111096981|NCT03204929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111096982|NCT02596971|Prednisone|prednisone|mesh-list
111096983|NCT02596971|Cyclophosphamide|cyclophosphamide|mesh-list
111096984|NCT02596971|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
111096985|NCT02596971|Rituximab|rituximab|mesh-list
111096986|NCT02596971|Doxorubicin|doxorubicin|mesh-list
111096987|NCT02596971|Vincristine|vincristine|mesh-list
111096988|NCT02596971|Atezolizumab|atezolizumab|mesh-list
111096989|NCT02596971|Obinutuzumab|obinutuzumab|mesh-list
111096990|NCT02596971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111096991|NCT02596971|Immunologic Factors|immunologic factors|mesh-ancestor
111096992|NCT02596971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111096993|NCT02596971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111096994|NCT02596971|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111096995|NCT02596971|Alkylating Agents|alkylating agents|mesh-ancestor
111096996|NCT02596971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111096997|NCT02596971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111096998|NCT02596971|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111096999|NCT02596971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111097000|NCT02596971|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111097001|NCT02596971|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111097002|NCT02596971|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111097003|NCT02596971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111097004|NCT02596971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111097005|NCT02596971|Glucocorticoids|glucocorticoids|mesh-ancestor
111097006|NCT02596971|Hormones|hormones|mesh-ancestor
111097007|NCT02596971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111097008|NCT02596971|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111097009|NCT02596971|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111097010|NCT02596971|Tubulin Modulators|tubulin modulators|mesh-ancestor
111097011|NCT02596971|Antimitotic Agents|antimitotic agents|mesh-ancestor
111097012|NCT02596971|Mitosis Modulators|mitosis modulators|mesh-ancestor
111097013|NCT02596971|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111097014|NCT04808739|Adalimumab|adalimumab|mesh-list
111097015|NCT04808739|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111097016|NCT04808739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111097017|NCT04808739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111097018|NCT04808895|Aspirin|aspirin|mesh-list
111097019|NCT04808895|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111097020|NCT04808895|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111097021|NCT04808895|Analgesics|analgesics|mesh-ancestor
111097022|NCT04808895|Sensory System Agents|sensory system agents|mesh-ancestor
111097023|NCT04808895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111097024|NCT04808895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111097025|NCT04808895|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111097026|NCT04808895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111097027|NCT04808895|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111097028|NCT04808895|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111097029|NCT04808895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111097030|NCT04808895|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111097031|NCT04808895|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111097032|NCT04808895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111097033|NCT04808895|Antipyretics|antipyretics|mesh-ancestor
111097034|NCT04485689|Capsaicin|capsaicin|mesh-list
111097035|NCT04485689|Antipruritics|antipruritics|mesh-ancestor
111097036|NCT04485689|Dermatologic Agents|dermatologic agents|mesh-ancestor
111097037|NCT04485689|Sensory System Agents|sensory system agents|mesh-ancestor
111097038|NCT04485689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111097039|NCT04485689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111097040|NCT03204071|Metformin|metformin|mesh-list
111097041|NCT03204071|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111097042|NCT03204071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111097043|NCT04801017|Artemisinins|artemisinins|mesh-list
111097044|NCT04801017|Artemisinin|artemisinin|mesh-list
111097045|NCT04801017|Trabedersen|trabedersen|mesh-list
111097046|NCT04801017|Antimalarials|antimalarials|mesh-ancestor
111097047|NCT04801017|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111097048|NCT04801017|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111097049|NCT04801017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111097050|NCT04801017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111097051|NCT03107429|Acetazolamide|acetazolamide|mesh-list
111097052|NCT03107429|Anticonvulsants|anticonvulsants|mesh-ancestor
111097053|NCT03107429|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
111097054|NCT03107429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111097055|NCT03107429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111097056|NCT03107429|Diuretics|diuretics|mesh-ancestor
111097057|NCT03107429|Natriuretic Agents|natriuretic agents|mesh-ancestor
111097058|NCT03107429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111097059|NCT04794231|Chlorhexidine|chlorhexidine|mesh-list
111097060|NCT04794231|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
111097061|NCT04794231|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111097062|NCT04794231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111097063|NCT04794231|Disinfectants|disinfectants|mesh-ancestor
111097064|NCT04794231|Dermatologic Agents|dermatologic agents|mesh-ancestor
111097065|NCT04800081|Valsartan|valsartan|mesh-list
111097066|NCT04800081|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
111097067|NCT04800081|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111097068|NCT04800081|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111097069|NCT04800081|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111097070|NCT04800081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111097072|NCT03202979|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111097073|NCT03202979|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111097074|NCT03202979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111097075|NCT03202979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111097076|NCT03202979|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111097077|NCT03202979|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111097078|NCT03202979|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111097079|NCT03202979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111097080|NCT03202979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111097081|NCT03202979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111097082|NCT03202979|Serotonin Agents|serotonin agents|mesh-ancestor
111097083|NCT03202979|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111097084|NCT03202979|Antidepressive Agents|antidepressive agents|mesh-ancestor
111097085|NCT04799925|Febuxostat|febuxostat|mesh-list
111097086|NCT04799925|Gout Suppressants|gout suppressants|mesh-ancestor
111097087|NCT04799925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111097088|NCT03232307|Dexamethasone|dexamethasone|mesh-list
111097089|NCT03232307|Dexamethasone acetate|dexamethasone acetate|mesh-list
111097090|NCT03232307|Rituximab|rituximab|mesh-list
111097091|NCT03232307|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111097092|NCT03232307|Lenalidomide|lenalidomide|mesh-list
111097093|NCT03232307|Antibodies|antibodies|mesh-list
111097094|NCT03232307|Immunoglobulins|immunoglobulins|mesh-list
111097095|NCT03232307|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111097096|NCT03232307|BB 1101|bb 1101|mesh-list
111097097|NCT03232307|Immunologic Factors|immunologic factors|mesh-ancestor
111097098|NCT03232307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111097099|NCT03232307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111097100|NCT03232307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111097101|NCT03232307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111097102|NCT03232307|Antiemetics|antiemetics|mesh-ancestor
111097103|NCT03232307|Autonomic Agents|autonomic agents|mesh-ancestor
111097104|NCT03232307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111097105|NCT03232307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110642173|NCT02798471|Heparin|heparin|mesh-list
111097106|NCT03232307|Glucocorticoids|glucocorticoids|mesh-ancestor
111097107|NCT03232307|Hormones|hormones|mesh-ancestor
111097108|NCT03232307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111097109|NCT03232307|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111097110|NCT03232307|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111097111|NCT03232307|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111097112|NCT03232307|Growth Substances|growth substances|mesh-ancestor
111097113|NCT03232307|Growth Inhibitors|growth inhibitors|mesh-ancestor
111097114|NCT03232307|Protease Inhibitors|protease inhibitors|mesh-ancestor
111097115|NCT03232307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111097116|NCT03232307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111097117|NCT05615727|Dexmedetomidine|dexmedetomidine|mesh-list
111097118|NCT05615727|Zolpidem|zolpidem|mesh-list
111097119|NCT05615727|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111097120|NCT05615727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111097121|NCT05615727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111097122|NCT05615727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111097123|NCT05615727|Analgesics|analgesics|mesh-ancestor
111097124|NCT05615727|Sensory System Agents|sensory system agents|mesh-ancestor
111097125|NCT05615727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111097126|NCT05615727|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111097127|NCT05615727|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111097128|NCT05615727|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111097129|NCT05615727|Adrenergic Agents|adrenergic agents|mesh-ancestor
111097130|NCT05615727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111097131|NCT05615727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111097132|NCT05615727|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111097133|NCT05615727|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
111097134|NCT05615727|GABA Agonists|gaba agonists|mesh-ancestor
111097135|NCT05615727|GABA Agents|gaba agents|mesh-ancestor
111097136|NCT02450279|Edetic Acid|edetic acid|mesh-list
111097137|NCT02450279|Pentetic Acid|pentetic acid|mesh-list
111097138|NCT02450279|Antidotes|antidotes|mesh-ancestor
111097139|NCT02450279|Protective Agents|protective agents|mesh-ancestor
111097140|NCT02450279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111097141|NCT02450279|Chelating Agents|chelating agents|mesh-ancestor
111097142|NCT02450279|Sequestering Agents|sequestering agents|mesh-ancestor
111097143|NCT02450279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111097144|NCT02450279|Iron Chelating Agents|iron chelating agents|mesh-ancestor
111097146|NCT02450279|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
111097147|NCT03231683|Ketamine|ketamine|mesh-list
111097148|NCT03231683|Remifentanil|remifentanil|mesh-list
111097149|NCT03231683|Propofol|propofol|mesh-list
111097150|NCT03231683|Esketamine|esketamine|mesh-list
111097151|NCT03231683|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111097152|NCT03231683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111097153|NCT03231683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111097154|NCT03231683|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111097155|NCT03231683|Anesthetics, General|anesthetics, general|mesh-ancestor
111097156|NCT03231683|Anesthetics|anesthetics|mesh-ancestor
111097157|NCT03231683|Analgesics|analgesics|mesh-ancestor
111097158|NCT03231683|Sensory System Agents|sensory system agents|mesh-ancestor
111097159|NCT03231683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111097160|NCT03231683|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111097161|NCT03231683|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111097162|NCT03231683|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111097163|NCT03231683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111097164|NCT03231683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111097165|NCT03231683|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111097166|NCT03231683|Narcotics|narcotics|mesh-ancestor
111097167|NCT03231683|Antidepressive Agents|antidepressive agents|mesh-ancestor
111097168|NCT03231683|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111097169|NCT02593773|Interferons|interferons|mesh-list
111097170|NCT02593773|Interferon-gamma|interferon-gamma|mesh-list
111097171|NCT02593773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111097172|NCT02593773|Antiviral Agents|antiviral agents|mesh-ancestor
111097173|NCT02593773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110642196|NCT03441893|Nitazoxanide|nitazoxanide|mesh-list
111097174|NCT04798443|Hyaluronic Acid|hyaluronic acid|mesh-list
111097175|NCT04798443|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111097176|NCT04798443|Immunologic Factors|immunologic factors|mesh-ancestor
111097177|NCT04798443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111097178|NCT04798443|Viscosupplements|viscosupplements|mesh-ancestor
111097179|NCT04798443|Protective Agents|protective agents|mesh-ancestor
111097180|NCT02450045|Bupivacaine|bupivacaine|mesh-list
111097181|NCT02450045|Ropivacaine|ropivacaine|mesh-list
111097182|NCT02450045|Anesthetics, Local|anesthetics, local|mesh-list
111097183|NCT02450045|Anesthetics|anesthetics|mesh-list
111097184|NCT02450045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111097185|NCT02450045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111097186|NCT02450045|Sensory System Agents|sensory system agents|mesh-ancestor
111097187|NCT02450045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111097189|NCT02593539|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111097190|NCT02593539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111097191|NCT02593539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111097192|NCT02593305|Methamphetamine|methamphetamine|mesh-list
111097193|NCT02593305|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111097194|NCT02593305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111097195|NCT02593305|Sympathomimetics|sympathomimetics|mesh-ancestor
111097196|NCT02593305|Autonomic Agents|autonomic agents|mesh-ancestor
111097197|NCT02593305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111097198|NCT02593305|Dopamine Agents|dopamine agents|mesh-ancestor
111097199|NCT02593305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111097200|NCT02593305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111097201|NCT02593305|Adrenergic Agents|adrenergic agents|mesh-ancestor
111097202|NCT02593305|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111097203|NCT02593305|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111097204|NCT02593305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111097205|NCT02593305|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111097206|NCT04389411|Montelukast|montelukast|mesh-list
111097207|NCT04389411|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111097208|NCT04389411|Respiratory System Agents|respiratory system agents|mesh-ancestor
111097209|NCT04389411|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
111097210|NCT04389411|Hormone Antagonists|hormone antagonists|mesh-ancestor
111097211|NCT04389411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111097212|NCT04389411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111097213|NCT04389411|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
111097214|NCT04389411|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111097215|NCT04389411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111097216|NCT02448251|Abivertinib|abivertinib|mesh-list
111097217|NCT02448251|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111097218|NCT02448251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111097219|NCT02448251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111097220|NCT03195569|Paclitaxel|paclitaxel|mesh-list
111097221|NCT03195569|Bevacizumab|bevacizumab|mesh-list
111097222|NCT03195569|Carboplatin|carboplatin|mesh-list
111097223|NCT03195569|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111097224|NCT03195569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111097225|NCT03195569|Tubulin Modulators|tubulin modulators|mesh-ancestor
111097226|NCT03195569|Antimitotic Agents|antimitotic agents|mesh-ancestor
111097227|NCT03195569|Mitosis Modulators|mitosis modulators|mesh-ancestor
111097228|NCT03195569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111097229|NCT03195569|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111097230|NCT03195569|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111097231|NCT03195569|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111097232|NCT03195569|Growth Substances|growth substances|mesh-ancestor
111097233|NCT03195569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111097234|NCT03195569|Growth Inhibitors|growth inhibitors|mesh-ancestor
111097235|NCT02447939|Trametinib|trametinib|mesh-list
111097236|NCT02447939|Dabrafenib|dabrafenib|mesh-list
111097237|NCT02447939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111097238|NCT02447939|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111097239|NCT02447939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111097240|NCT02447939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111097241|NCT04785183|Melatonin|melatonin|mesh-list
111097242|NCT04785183|Antioxidants|antioxidants|mesh-ancestor
111097243|NCT04785183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111097244|NCT04785183|Protective Agents|protective agents|mesh-ancestor
111097245|NCT04785183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111097246|NCT04785183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111097247|NCT03195491|Nivolumab|nivolumab|mesh-list
111097248|NCT03195491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111097249|NCT03195491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111097250|NCT03195491|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111097251|NCT03195491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111097252|NCT03195413|Lidocaine|lidocaine|mesh-list
111097253|NCT03195413|Epinephrine|epinephrine|mesh-list
111097254|NCT03195413|Racepinephrine|racepinephrine|mesh-list
111097255|NCT03195413|Bupivacaine|bupivacaine|mesh-list
111097256|NCT03195413|Epinephryl borate|epinephryl borate|mesh-list
111097257|NCT03195413|Anesthetics, Local|anesthetics, local|mesh-ancestor
111097258|NCT03195413|Anesthetics|anesthetics|mesh-ancestor
110814365|NCT05659914|Durvalumab|durvalumab|mesh-list
111097259|NCT03195413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111097260|NCT03195413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111097261|NCT03195413|Sensory System Agents|sensory system agents|mesh-ancestor
111097262|NCT03195413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111097263|NCT03195413|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111097264|NCT03195413|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111097265|NCT03195413|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111097266|NCT03195413|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111097267|NCT03195413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111097268|NCT03195413|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111097269|NCT03195413|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111097270|NCT03195413|Adrenergic Agents|adrenergic agents|mesh-ancestor
111097271|NCT03195413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111097272|NCT03195413|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111097273|NCT03195413|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111097274|NCT03195413|Autonomic Agents|autonomic agents|mesh-ancestor
111097275|NCT03195413|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111097276|NCT03195413|Respiratory System Agents|respiratory system agents|mesh-ancestor
111097277|NCT03195413|Mydriatics|mydriatics|mesh-ancestor
111097278|NCT03195413|Sympathomimetics|sympathomimetics|mesh-ancestor
111097279|NCT03195413|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111097280|NCT04338399|Paclitaxel|paclitaxel|mesh-list
111097281|NCT04338399|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111097282|NCT04338399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111097283|NCT04338399|Tubulin Modulators|tubulin modulators|mesh-ancestor
111097284|NCT04338399|Antimitotic Agents|antimitotic agents|mesh-ancestor
111097285|NCT04338399|Mitosis Modulators|mitosis modulators|mesh-ancestor
111097286|NCT04338399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111097287|NCT02447705|Telbivudine|telbivudine|mesh-list
111097288|NCT02447705|Antiviral Agents|antiviral agents|mesh-ancestor
111097289|NCT02447705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111097290|NCT02447705|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111097291|NCT02447705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111097292|NCT02447705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111097293|NCT03195257|Glucagon|glucagon|mesh-list
111097294|NCT03195257|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
111097295|NCT03195257|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
111097296|NCT03195257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111097297|NCT03195257|Hormones|hormones|mesh-ancestor
111097298|NCT03195257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111097299|NCT03195257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111097300|NCT03195257|Incretins|incretins|mesh-ancestor
111097301|NCT02447393|Cetirizine|cetirizine|mesh-list
111097302|NCT02447393|Levocetirizine|levocetirizine|mesh-list
111097303|NCT02447393|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111097304|NCT02447393|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
111097305|NCT02447393|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111097306|NCT02447393|Histamine Antagonists|histamine antagonists|mesh-ancestor
111097307|NCT02447393|Histamine Agents|histamine agents|mesh-ancestor
111097308|NCT02447393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111097309|NCT02447393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111097310|NCT02447393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111097311|NCT02447315|Pilocarpine|pilocarpine|mesh-list
111097312|NCT02447315|Miotics|miotics|mesh-ancestor
111097313|NCT02447315|Autonomic Agents|autonomic agents|mesh-ancestor
111097314|NCT02447315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111097315|NCT02447315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111097316|NCT02447315|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
111097317|NCT02447315|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111097318|NCT02447315|Cholinergic Agents|cholinergic agents|mesh-ancestor
111097319|NCT02447315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111097320|NCT02447315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111097321|NCT04792515|Apatinib|apatinib|mesh-list
111097322|NCT04792515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111097323|NCT04792515|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111097324|NCT04792515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111097325|NCT04792515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111097326|NCT02446379|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
111097327|NCT02446379|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111097328|NCT02446379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111097329|NCT03195023|Amlodipine|amlodipine|mesh-list
111097330|NCT03195023|Lisinopril|lisinopril|mesh-list
110814431|NCT05384119|Palbociclib|palbociclib|mesh-list
111097331|NCT03195023|Lercanidipine|lercanidipine|mesh-list
111097332|NCT03195023|Furosemide|furosemide|mesh-list
111097333|NCT03195023|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
111097334|NCT03195023|Enzyme Inhibitors|enzyme inhibitors|mesh-list
111097335|NCT03195023|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111097336|NCT03195023|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111097337|NCT03195023|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111097338|NCT03195023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111097339|NCT03195023|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111097340|NCT03195023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111097341|NCT03195023|Vasodilator Agents|vasodilator agents|mesh-ancestor
111097343|NCT03195023|Natriuretic Agents|natriuretic agents|mesh-ancestor
111097344|NCT03195023|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
111097345|NCT03195023|Protease Inhibitors|protease inhibitors|mesh-ancestor
111097346|NCT03195023|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111097347|NCT03195023|Protective Agents|protective agents|mesh-ancestor
111097348|NCT02446301|Nalbuphine|nalbuphine|mesh-list
111097349|NCT02446301|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111097350|NCT02446301|Narcotics|narcotics|mesh-ancestor
111097351|NCT02446301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111097352|NCT02446301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111097353|NCT02446301|Analgesics|analgesics|mesh-ancestor
111097354|NCT02446301|Sensory System Agents|sensory system agents|mesh-ancestor
111097355|NCT02446301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111097356|NCT04791345|Dexamethasone|dexamethasone|mesh-list
111097357|NCT04791345|Dexamethasone acetate|dexamethasone acetate|mesh-list
111097358|NCT04791345|Methylprednisolone|methylprednisolone|mesh-list
111097359|NCT04791345|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111097360|NCT04791345|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111097361|NCT04791345|Prednisolone|prednisolone|mesh-list
111097362|NCT04791345|Prednisolone acetate|prednisolone acetate|mesh-list
111097364|NCT04791345|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111097365|NCT04791345|Prednisolone phosphate|prednisolone phosphate|mesh-list
111097366|NCT04791345|BB 1101|bb 1101|mesh-list
111097367|NCT04791345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111097368|NCT04791345|Antiemetics|antiemetics|mesh-ancestor
111097369|NCT04791345|Autonomic Agents|autonomic agents|mesh-ancestor
111097370|NCT04791345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111097371|NCT04791345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111097372|NCT04791345|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111097373|NCT04791345|Glucocorticoids|glucocorticoids|mesh-ancestor
111097374|NCT04791345|Hormones|hormones|mesh-ancestor
111097375|NCT04791345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111097376|NCT04791345|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111097377|NCT04791345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111097378|NCT04791345|Protease Inhibitors|protease inhibitors|mesh-ancestor
111097379|NCT04791345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111097380|NCT04791345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110642214|NCT00489736|Amiodarone|amiodarone|mesh-list
111097381|NCT04791345|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111097382|NCT04791345|Protective Agents|protective agents|mesh-ancestor
111097383|NCT04791345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111097384|NCT04791345|Immunologic Factors|immunologic factors|mesh-ancestor
111097385|NCT02445989|Contraceptive Agents|contraceptive agents|mesh-list
111097386|NCT02445989|NuvaRing|nuvaring|mesh-list
111097387|NCT02445989|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111097388|NCT02445989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111097389|NCT02445989|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111097390|NCT03674853|Gamma-oryzanol|gamma-oryzanol|mesh-list
111097391|NCT03674853|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111097392|NCT03674853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111097393|NCT03674853|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111097394|NCT03674853|Antimetabolites|antimetabolites|mesh-ancestor
111097395|NCT03674853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111097396|NCT03674853|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111097397|NCT03231215|Dexamethasone|dexamethasone|mesh-list
111097398|NCT03231215|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111097399|NCT03231215|Antiemetics|antiemetics|mesh-ancestor
111097400|NCT03231215|Autonomic Agents|autonomic agents|mesh-ancestor
111097401|NCT03231215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111097402|NCT03231215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111097403|NCT03231215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111097404|NCT03231215|Glucocorticoids|glucocorticoids|mesh-ancestor
111097405|NCT03231215|Hormones|hormones|mesh-ancestor
111097406|NCT03231215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111097407|NCT03231215|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111097408|NCT03231215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111097409|NCT04784481|Ivermectin|ivermectin|mesh-list
111097410|NCT04784481|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111097411|NCT04784481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111097412|NCT03230825|Contraceptive Agents|contraceptive agents|mesh-list
111097413|NCT03230825|Contraceptives, Oral|contraceptives, oral|mesh-list
111097414|NCT03230825|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111097415|NCT03230825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111097416|NCT03230825|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111097417|NCT03526185|Nivolumab|nivolumab|mesh-list
111097418|NCT03526185|Ipilimumab|ipilimumab|mesh-list
111097419|NCT03526185|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111097420|NCT03526185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111097421|NCT03526185|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111097422|NCT03526185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111097423|NCT02445599|Dipyrone|dipyrone|mesh-list
111097424|NCT02445599|Diclofenac|diclofenac|mesh-list
111097425|NCT02445599|Atropine|atropine|mesh-list
111097426|NCT02445599|Fentanyl|fentanyl|mesh-list
111097427|NCT02445599|Midazolam|midazolam|mesh-list
111097428|NCT02445599|Tramadol|tramadol|mesh-list
111097429|NCT02445599|Nalbuphine|nalbuphine|mesh-list
111097430|NCT02445599|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111097431|NCT02445599|Narcotics|narcotics|mesh-ancestor
111097432|NCT02445599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111097433|NCT02445599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111097434|NCT02445599|Analgesics|analgesics|mesh-ancestor
111097435|NCT02445599|Sensory System Agents|sensory system agents|mesh-ancestor
111097436|NCT02445599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111097437|NCT02445599|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111097438|NCT02445599|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111097439|NCT02445599|Anesthetics, General|anesthetics, general|mesh-ancestor
111097440|NCT02445599|Anesthetics|anesthetics|mesh-ancestor
111097441|NCT02445599|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111097442|NCT02445599|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111097443|NCT02445599|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111097444|NCT02445599|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111097445|NCT02445599|GABA Modulators|gaba modulators|mesh-ancestor
111097446|NCT02445599|GABA Agents|gaba agents|mesh-ancestor
111097447|NCT02445599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111097448|NCT02445599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111097449|NCT02445599|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110642224|NCT00489736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111097450|NCT02445599|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111097451|NCT02445599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111097452|NCT02445599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111097453|NCT02445599|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111097454|NCT02445599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111097455|NCT02445599|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111097456|NCT02445599|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111097457|NCT02445599|Autonomic Agents|autonomic agents|mesh-ancestor
111097458|NCT02445599|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111097459|NCT02445599|Respiratory System Agents|respiratory system agents|mesh-ancestor
111097460|NCT02445599|Mydriatics|mydriatics|mesh-ancestor
111097461|NCT02445599|Parasympatholytics|parasympatholytics|mesh-ancestor
111097462|NCT02445599|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111097463|NCT02445599|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111097464|NCT02445599|Cholinergic Agents|cholinergic agents|mesh-ancestor
111097465|NCT02445599|Antipyretics|antipyretics|mesh-ancestor
111097466|NCT03194633|Nifedipine|nifedipine|mesh-list
111097467|NCT03194633|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111097468|NCT03194633|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111097469|NCT03194633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111097470|NCT03194633|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111097471|NCT03194633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111097472|NCT03194633|Vasodilator Agents|vasodilator agents|mesh-ancestor
111097473|NCT03194633|Tocolytic Agents|tocolytic agents|mesh-ancestor
111097474|NCT03194633|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111097475|NCT03194555|Acetaminophen|acetaminophen|mesh-list
111097476|NCT03194555|Naltrexone|naltrexone|mesh-list
111097477|NCT03194555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111097478|NCT03194555|Analgesics|analgesics|mesh-ancestor
111097479|NCT03194555|Sensory System Agents|sensory system agents|mesh-ancestor
111097480|NCT03194555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111097481|NCT03194555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111097482|NCT03194555|Antipyretics|antipyretics|mesh-ancestor
111097483|NCT03194555|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111097484|NCT03194555|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110814583|NCT05238831|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111097485|NCT04344717|Apixaban|apixaban|mesh-list
111097486|NCT04344717|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111097487|NCT04344717|Antithrombins|antithrombins|mesh-ancestor
111097488|NCT04344717|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111097489|NCT04344717|Protease Inhibitors|protease inhibitors|mesh-ancestor
111097490|NCT04344717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111097491|NCT04344717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111097492|NCT04344717|Anticoagulants|anticoagulants|mesh-ancestor
111097493|NCT04790487|Chlorpheniramine|chlorpheniramine|mesh-list
111097494|NCT04790487|Antipruritics|antipruritics|mesh-ancestor
111097495|NCT04790487|Dermatologic Agents|dermatologic agents|mesh-ancestor
111097496|NCT04790487|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111097497|NCT04790487|Histamine Antagonists|histamine antagonists|mesh-ancestor
111097498|NCT04790487|Histamine Agents|histamine agents|mesh-ancestor
111097499|NCT04790487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111097500|NCT04790487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111097501|NCT04790487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111097502|NCT04790487|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111097503|NCT04790331|Verapamil|verapamil|mesh-list
111097504|NCT04790331|Diltiazem|diltiazem|mesh-list
111097505|NCT04790331|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111097506|NCT04790331|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111097507|NCT04790331|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111097508|NCT04790331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111097509|NCT04790331|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111097510|NCT04790331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111097511|NCT04790331|Vasodilator Agents|vasodilator agents|mesh-ancestor
111097513|NCT04789941|Irinotecan|irinotecan|mesh-list
111097514|NCT04789941|Cisplatin|cisplatin|mesh-list
111097515|NCT04789941|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111097516|NCT04789941|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111097517|NCT04789941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111097518|NCT04789941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111097519|NCT04789941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111097520|NCT02445053|Ivacaftor|ivacaftor|mesh-list
111097521|NCT02445053|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
111097522|NCT02445053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111097523|NCT02445053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111097524|NCT02444897|Fentanyl|fentanyl|mesh-list
111097525|NCT02444897|Nefopam|nefopam|mesh-list
111097526|NCT02444897|Ramosetron|ramosetron|mesh-list
111097527|NCT02444897|Ropivacaine|ropivacaine|mesh-list
111097528|NCT02444897|Anesthetics, Local|anesthetics, local|mesh-ancestor
111097529|NCT02444897|Anesthetics|anesthetics|mesh-ancestor
111097530|NCT02444897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111097531|NCT02444897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111097532|NCT02444897|Sensory System Agents|sensory system agents|mesh-ancestor
111097533|NCT02444897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111097534|NCT02444897|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111097535|NCT02444897|Narcotics|narcotics|mesh-ancestor
111097536|NCT02444897|Analgesics|analgesics|mesh-ancestor
111097537|NCT02444897|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111097538|NCT02444897|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111097539|NCT02444897|Anesthetics, General|anesthetics, general|mesh-ancestor
111097540|NCT02444897|Antiemetics|antiemetics|mesh-ancestor
111097541|NCT02444897|Autonomic Agents|autonomic agents|mesh-ancestor
111097542|NCT02444897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111097543|NCT02444897|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111097544|NCT02444897|Serotonin Agents|serotonin agents|mesh-ancestor
111097545|NCT02444897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111097546|NCT02444897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111097547|NCT02444897|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111097548|NCT03016533|Lamivudine|lamivudine|mesh-list
111097549|NCT03016533|Dolutegravir|dolutegravir|mesh-list
111097550|NCT03016533|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111097551|NCT03016533|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111097552|NCT03016533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111097553|NCT03016533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111097554|NCT03016533|Antiviral Agents|antiviral agents|mesh-ancestor
111097555|NCT03016533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111097556|NCT03016533|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111097557|NCT03016533|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111097558|NCT03016533|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111097559|NCT03016533|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111097560|NCT03229889|Tadalafil|tadalafil|mesh-list
111097561|NCT03229889|Tamsulosin|tamsulosin|mesh-list
111097562|NCT03229889|Vasodilator Agents|vasodilator agents|mesh-ancestor
111097563|NCT03229889|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111097564|NCT03229889|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111097565|NCT03229889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111097566|NCT03229889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111097567|NCT03229889|Urological Agents|urological agents|mesh-ancestor
111097568|NCT03229889|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111097569|NCT03229889|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111097570|NCT03229889|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111097571|NCT03229889|Adrenergic Agents|adrenergic agents|mesh-ancestor
111097572|NCT03229889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111097573|NCT03229889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111097574|NCT02444585|Denosumab|denosumab|mesh-list
111097575|NCT02444585|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111097576|NCT02444585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111097578|NCT03120221|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111097579|NCT03120221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111097580|NCT03120221|Trace Elements|trace elements|mesh-ancestor
111097581|NCT03120221|Micronutrients|micronutrients|mesh-ancestor
111097582|NCT03120221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111097583|NCT03193073|Mitogens|mitogens|mesh-list
111097584|NCT03193073|Mitosis Modulators|mitosis modulators|mesh-ancestor
111097585|NCT03193073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111097586|NCT02444507|Esomeprazole|esomeprazole|mesh-list
111097587|NCT02444507|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111097588|NCT02444507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111097589|NCT02444507|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111097590|NCT02444507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111097591|NCT02444507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111097592|NCT01626352|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
111097593|NCT01626352|Ofatumumab|ofatumumab|mesh-list
111097594|NCT01626352|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111097595|NCT01626352|Alkylating Agents|alkylating agents|mesh-ancestor
111097596|NCT01626352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111097597|NCT01626352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111097598|NCT02080767|Tecovirimat|tecovirimat|mesh-list
111097599|NCT02080767|Antiviral Agents|antiviral agents|mesh-ancestor
111097600|NCT02080767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111097601|NCT01626118|Indomethacin|indomethacin|mesh-list
111097602|NCT01626118|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111097603|NCT01626118|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111097604|NCT01626118|Analgesics|analgesics|mesh-ancestor
111097605|NCT01626118|Sensory System Agents|sensory system agents|mesh-ancestor
111097606|NCT01626118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111097607|NCT01626118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111097608|NCT01626118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111097609|NCT01626118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111097610|NCT01626118|Gout Suppressants|gout suppressants|mesh-ancestor
111097611|NCT01626118|Tocolytic Agents|tocolytic agents|mesh-ancestor
111097612|NCT01626118|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111097613|NCT01626118|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111097614|NCT01626118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111097615|NCT01626118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111097616|NCT04789005|Phenylephrine|phenylephrine|mesh-list
111097617|NCT04789005|Oxymetazoline|oxymetazoline|mesh-list
111097618|NCT04789005|Norepinephrine|norepinephrine|mesh-list
111097619|NCT04789005|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111097620|NCT04789005|Mydriatics|mydriatics|mesh-ancestor
111097621|NCT04789005|Autonomic Agents|autonomic agents|mesh-ancestor
111097622|NCT04789005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111097623|NCT04789005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111097624|NCT04789005|Sympathomimetics|sympathomimetics|mesh-ancestor
111097625|NCT04789005|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111097626|NCT04789005|Nasal Decongestants|nasal decongestants|mesh-ancestor
111097627|NCT04789005|Respiratory System Agents|respiratory system agents|mesh-ancestor
111097628|NCT04789005|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111097629|NCT04789005|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111097630|NCT04789005|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111097631|NCT04789005|Adrenergic Agents|adrenergic agents|mesh-ancestor
111097632|NCT04789005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111097633|NCT04789005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111097634|NCT04789005|Protective Agents|protective agents|mesh-ancestor
111097635|NCT02152384|Insulin|insulin|mesh-list
111097636|NCT02152384|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111097637|NCT02152384|Insulin Glargine|insulin glargine|mesh-list
111097638|NCT02152384|Insulin Lispro|insulin lispro|mesh-list
111097639|NCT02152384|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111097640|NCT02152384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111097641|NCT05469243|Hallucinogens|hallucinogens|mesh-list
111097642|NCT05469243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111097643|NCT05469243|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111097644|NCT02177266|Colchicine|colchicine|mesh-list
111097645|NCT02177266|Gout Suppressants|gout suppressants|mesh-ancestor
111097646|NCT02177266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111097647|NCT02177266|Tubulin Modulators|tubulin modulators|mesh-ancestor
111097648|NCT02177266|Antimitotic Agents|antimitotic agents|mesh-ancestor
111097649|NCT02177266|Mitosis Modulators|mitosis modulators|mesh-ancestor
111097650|NCT02177266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111097651|NCT02177266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111097652|NCT04788381|Bevacizumab|bevacizumab|mesh-list
110642245|NCT01016860|Irinotecan|irinotecan|mesh-list
111097653|NCT04788381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111097654|NCT04788381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111097655|NCT04788381|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111097656|NCT04788381|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111097657|NCT04788381|Growth Substances|growth substances|mesh-ancestor
111097658|NCT04788381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111097659|NCT04788381|Growth Inhibitors|growth inhibitors|mesh-ancestor
111097660|NCT05474937|Midazolam|midazolam|mesh-list
111097661|NCT05474937|Ketamine|ketamine|mesh-list
111097662|NCT05474937|Propofol|propofol|mesh-list
111097663|NCT05474937|Sevoflurane|sevoflurane|mesh-list
111097664|NCT05474937|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111097665|NCT05474937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111097666|NCT05474937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111097667|NCT05474937|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111097668|NCT05474937|Anesthetics, General|anesthetics, general|mesh-ancestor
111097669|NCT05474937|Anesthetics|anesthetics|mesh-ancestor
111097670|NCT05474937|Analgesics|analgesics|mesh-ancestor
111097671|NCT05474937|Sensory System Agents|sensory system agents|mesh-ancestor
111097672|NCT05474937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111097673|NCT05474937|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111097674|NCT05474937|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111097675|NCT05474937|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111097676|NCT05474937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111097677|NCT05474937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111097678|NCT05474937|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111097679|NCT05474937|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111097680|NCT05474937|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111097681|NCT05474937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111097682|NCT05474937|GABA Modulators|gaba modulators|mesh-ancestor
111097683|NCT05474937|GABA Agents|gaba agents|mesh-ancestor
111097684|NCT05474937|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111097685|NCT05474937|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111097686|NCT05474781|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
111097687|NCT05474781|Antiviral Agents|antiviral agents|mesh-ancestor
111097688|NCT05474781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111097689|NCT02177032|Vaccines|vaccines|mesh-list
111097690|NCT02177032|Immunoglobulins|immunoglobulins|mesh-list
111097691|NCT02177032|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111097692|NCT02177032|Antibodies|antibodies|mesh-list
111097693|NCT02177032|Immunologic Factors|immunologic factors|mesh-ancestor
111097694|NCT02177032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111097695|NCT02116972|FX006|fx006|mesh-list
111097696|NCT02116972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111097697|NCT02116972|Glucocorticoids|glucocorticoids|mesh-ancestor
111097698|NCT02116972|Hormones|hormones|mesh-ancestor
111097699|NCT02116972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111097700|NCT02116972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111097701|NCT02116972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111097702|NCT02116972|Immunologic Factors|immunologic factors|mesh-ancestor
111097703|NCT02176642|Oxybutynin|oxybutynin|mesh-list
111097704|NCT02176642|Parasympatholytics|parasympatholytics|mesh-ancestor
111097705|NCT02176642|Autonomic Agents|autonomic agents|mesh-ancestor
111097706|NCT02176642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111097707|NCT02176642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111097708|NCT02176642|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111097709|NCT02176642|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111097710|NCT02176642|Cholinergic Agents|cholinergic agents|mesh-ancestor
111097711|NCT02176642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111097712|NCT02176642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111097713|NCT02176642|Urological Agents|urological agents|mesh-ancestor
110814809|NCT04879823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111097714|NCT02116660|Ritonavir|ritonavir|mesh-list
111097715|NCT02116660|Lopinavir|lopinavir|mesh-list
111097716|NCT02116660|Atazanavir Sulfate|atazanavir sulfate|mesh-list
111097717|NCT02116660|Darunavir|darunavir|mesh-list
111097718|NCT02116660|Tenofovir|tenofovir|mesh-list
111097719|NCT02116660|Lamivudine|lamivudine|mesh-list
111097720|NCT02116660|Emtricitabine|emtricitabine|mesh-list
111097721|NCT02116660|Raltegravir Potassium|raltegravir potassium|mesh-list
111097722|NCT02116660|Nevirapine|nevirapine|mesh-list
111097723|NCT02116660|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111097724|NCT02116660|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111097725|NCT02116660|Protease Inhibitors|protease inhibitors|mesh-ancestor
111097726|NCT02116660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111097727|NCT02116660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111097728|NCT02116660|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111097729|NCT02116660|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111097730|NCT02116660|Antiviral Agents|antiviral agents|mesh-ancestor
111097731|NCT02116660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111097732|NCT02116660|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111097733|NCT02116660|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111097734|NCT02116660|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111097735|NCT02116660|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111097736|NCT02116660|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111097737|NCT02116660|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111097738|NCT02116660|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110029847|NCT02995252|Liver Extracts|liver extracts|mesh-list
111097739|NCT02116660|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111097740|NCT02589405|Benzoyl Peroxide|benzoyl peroxide|mesh-list
111097741|NCT02589405|Dermatologic Agents|dermatologic agents|mesh-ancestor
111097742|NCT02176018|Quinidine|quinidine|mesh-list
111097743|NCT02176018|Dextromethorphan|dextromethorphan|mesh-list
111097744|NCT02176018|Antitussive Agents|antitussive agents|mesh-ancestor
111097745|NCT02176018|Respiratory System Agents|respiratory system agents|mesh-ancestor
111097746|NCT02176018|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111097747|NCT02176018|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111097748|NCT02176018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111097749|NCT02176018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111097750|NCT02176018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111097751|NCT02176018|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111097752|NCT02176018|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111097753|NCT02176018|Adrenergic Agents|adrenergic agents|mesh-ancestor
111097754|NCT02176018|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111097755|NCT02176018|Antimalarials|antimalarials|mesh-ancestor
111097756|NCT02176018|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111097757|NCT02176018|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111097758|NCT02176018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111097759|NCT02176018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111097760|NCT02176018|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111097761|NCT02176018|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111097762|NCT02176018|Cholinergic Agents|cholinergic agents|mesh-ancestor
111097763|NCT02176018|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111097764|NCT02176018|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111097765|NCT02176018|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111097766|NCT02176018|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111097767|NCT02176018|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111097768|NCT05611827|Quercetin|quercetin|mesh-list
111097769|NCT05611827|Antioxidants|antioxidants|mesh-ancestor
111097770|NCT05611827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111097771|NCT05611827|Protective Agents|protective agents|mesh-ancestor
111097772|NCT05611827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111097773|NCT05612607|Immunoglobulins|immunoglobulins|mesh-list
111097774|NCT05612607|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111097775|NCT05612607|Antibodies|antibodies|mesh-list
111097776|NCT05612607|Immunologic Factors|immunologic factors|mesh-ancestor
111097777|NCT05612607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111097778|NCT02589639|Empagliflozin|empagliflozin|mesh-list
111097779|NCT02589639|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111097780|NCT02589639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111097781|NCT02589639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111097782|NCT02589639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111097783|NCT05611749|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
111097784|NCT05611749|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111097785|NCT05611749|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111097786|NCT05611749|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111097787|NCT05611749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111097788|NCT05611749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110642258|NCT00489424|Acetaminophen|acetaminophen|mesh-list
111097789|NCT05611749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111097790|NCT05611749|Analgesics|analgesics|mesh-ancestor
111097791|NCT05611749|Sensory System Agents|sensory system agents|mesh-ancestor
111097792|NCT05611749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111097793|NCT05611749|Antidepressive Agents|antidepressive agents|mesh-ancestor
111097794|NCT05611749|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111097795|NCT05611749|Dopamine Agents|dopamine agents|mesh-ancestor
111097796|NCT05611593|Finasteride|finasteride|mesh-list
111097797|NCT05611593|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
111097798|NCT05611593|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111097799|NCT05611593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111097800|NCT05611593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111097801|NCT05611593|Hormone Antagonists|hormone antagonists|mesh-ancestor
111097802|NCT05611593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111097803|NCT05611593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111097804|NCT05611593|Urological Agents|urological agents|mesh-ancestor
111097805|NCT05612451|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111097806|NCT05612451|Calcium|calcium|mesh-list
111097807|NCT05612451|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111097808|NCT05612451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111097809|NCT05612451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111097810|NCT02151682|Morphine|morphine|mesh-list
111097811|NCT02151682|Tapentadol|tapentadol|mesh-list
111097812|NCT02151682|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111097813|NCT02151682|Narcotics|narcotics|mesh-ancestor
111097814|NCT02151682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111097815|NCT02151682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111097816|NCT02151682|Analgesics|analgesics|mesh-ancestor
111097817|NCT02151682|Sensory System Agents|sensory system agents|mesh-ancestor
111097818|NCT02151682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111097819|NCT02151682|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111097820|NCT02151682|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111097821|NCT02151682|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111097822|NCT02151682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111097823|NCT02151682|Adrenergic Agents|adrenergic agents|mesh-ancestor
111097824|NCT02151682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111097825|NCT04331691|Amiloride|amiloride|mesh-list
111097826|NCT04331691|Spironolactone|spironolactone|mesh-list
111097827|NCT04331691|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
111097828|NCT04331691|Hormone Antagonists|hormone antagonists|mesh-ancestor
111097829|NCT04331691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111097830|NCT04331691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111097831|NCT04331691|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
111097832|NCT04331691|Diuretics|diuretics|mesh-ancestor
111097833|NCT04331691|Natriuretic Agents|natriuretic agents|mesh-ancestor
111097834|NCT04331691|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
111097835|NCT04331691|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111097836|NCT04331691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111097837|NCT04331691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111097838|NCT04331691|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
111097839|NCT02174848|Deferiprone|deferiprone|mesh-list
111097840|NCT02174848|Iron Chelating Agents|iron chelating agents|mesh-ancestor
111097841|NCT02174848|Chelating Agents|chelating agents|mesh-ancestor
111097842|NCT02174848|Sequestering Agents|sequestering agents|mesh-ancestor
111097843|NCT02174848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111097844|NCT02151058|Listerine|listerine|mesh-list
111097845|NCT02151058|Sodium Fluoride|sodium fluoride|mesh-list
111097846|NCT02151058|Cariostatic Agents|cariostatic agents|mesh-ancestor
111097847|NCT02151058|Protective Agents|protective agents|mesh-ancestor
111097848|NCT02151058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111097849|NCT02151058|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111097850|NCT02151058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111097851|NCT05205759|Sotrovimab|sotrovimab|mesh-list
111097852|NCT05205759|Bamlanivimab|bamlanivimab|mesh-list
111097853|NCT05205759|Casirivimab and imdevimab drug combination|casirivimab and imdevimab drug combination|mesh-list
111097854|NCT05205759|Antiviral Agents|antiviral agents|mesh-ancestor
111097855|NCT05205759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111097856|NCT02149264|Testosterone|testosterone|mesh-list
111097857|NCT02149264|Androgens|androgens|mesh-ancestor
111097858|NCT02149264|Hormones|hormones|mesh-ancestor
111097859|NCT02149264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110814961|NCT04569032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111097860|NCT02149264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111097861|NCT05610969|Midazolam|midazolam|mesh-list
111097862|NCT05610969|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111097863|NCT05610969|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111097864|NCT05610969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111097865|NCT05610969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111097866|NCT05610969|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111097867|NCT05610969|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111097868|NCT05610969|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111097869|NCT05610969|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111097870|NCT05610969|Anesthetics, General|anesthetics, general|mesh-ancestor
111097871|NCT05610969|Anesthetics|anesthetics|mesh-ancestor
111097872|NCT05610969|GABA Modulators|gaba modulators|mesh-ancestor
111097873|NCT05610969|GABA Agents|gaba agents|mesh-ancestor
111097874|NCT05610969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111097875|NCT05610969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111097876|NCT05557149|Cocaine|cocaine|mesh-list
111097877|NCT05557149|Anesthetics, Local|anesthetics, local|mesh-ancestor
111097878|NCT05557149|Anesthetics|anesthetics|mesh-ancestor
111097879|NCT05557149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111097880|NCT05557149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111097881|NCT05557149|Sensory System Agents|sensory system agents|mesh-ancestor
111097882|NCT05557149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111097883|NCT05557149|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111097884|NCT05557149|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111097885|NCT05557149|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111097886|NCT05557149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111097887|NCT05557149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111097888|NCT05557149|Dopamine Agents|dopamine agents|mesh-ancestor
111097889|NCT05557149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111097890|NCT02115256|Nitroglycerin|nitroglycerin|mesh-list
111097891|NCT02115256|Terbutaline|terbutaline|mesh-list
111097892|NCT02115256|Vasodilator Agents|vasodilator agents|mesh-ancestor
111097893|NCT02115256|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111097894|NCT02115256|Autonomic Agents|autonomic agents|mesh-ancestor
111097895|NCT02115256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111097896|NCT02115256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111097897|NCT02115256|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111097898|NCT02115256|Respiratory System Agents|respiratory system agents|mesh-ancestor
111097899|NCT02115256|Sympathomimetics|sympathomimetics|mesh-ancestor
111097900|NCT02115256|Tocolytic Agents|tocolytic agents|mesh-ancestor
111097901|NCT02115256|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111097902|NCT02115256|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111097903|NCT02115256|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111097904|NCT02115256|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111097905|NCT02115256|Adrenergic Agents|adrenergic agents|mesh-ancestor
111097906|NCT02115256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111097907|NCT02115256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111097908|NCT02173054|Adapalene|adapalene|mesh-list
111097909|NCT02173054|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111097910|NCT02173054|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111097911|NCT02173054|Analgesics|analgesics|mesh-ancestor
111097912|NCT02173054|Sensory System Agents|sensory system agents|mesh-ancestor
111097913|NCT02173054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111097914|NCT02173054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111097915|NCT02173054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111097916|NCT02173054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111097917|NCT02173054|Dermatologic Agents|dermatologic agents|mesh-ancestor
111097918|NCT04225221|Leuprolide|leuprolide|mesh-list
111097919|NCT04225221|Estradiol|estradiol|mesh-list
111097920|NCT04225221|Progesterone|progesterone|mesh-list
111097921|NCT04225221|Estrogens|estrogens|mesh-ancestor
111097922|NCT04225221|Hormones|hormones|mesh-ancestor
110642273|NCT05127304|Bromides|bromides|mesh-list
111097923|NCT04225221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111097924|NCT04225221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111097925|NCT04225221|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111097926|NCT04225221|Progestins|progestins|mesh-ancestor
111097927|NCT04225221|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111097928|NCT04225221|Fertility Agents|fertility agents|mesh-ancestor
111097929|NCT04225221|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111097930|NCT04225221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111097931|NCT04425993|Indomethacin|indomethacin|mesh-list
111097932|NCT04425993|Isosorbide|isosorbide|mesh-list
111097933|NCT04425993|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
111097934|NCT04425993|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
111097935|NCT04425993|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111097936|NCT04425993|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111097937|NCT04425993|Analgesics|analgesics|mesh-ancestor
111097938|NCT04425993|Sensory System Agents|sensory system agents|mesh-ancestor
111097939|NCT04425993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111097940|NCT04425993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111097941|NCT04425993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111097942|NCT04425993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111097943|NCT04425993|Gout Suppressants|gout suppressants|mesh-ancestor
111097944|NCT04425993|Tocolytic Agents|tocolytic agents|mesh-ancestor
111097945|NCT04425993|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111097946|NCT04425993|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111097947|NCT04425993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111097948|NCT04425993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111097949|NCT04425993|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
111097950|NCT04425993|Diuretics|diuretics|mesh-ancestor
111097951|NCT04425993|Natriuretic Agents|natriuretic agents|mesh-ancestor
111097952|NCT04425993|Vasodilator Agents|vasodilator agents|mesh-ancestor
111097953|NCT04425993|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
111097954|NCT03971643|Vilobelimab|vilobelimab|mesh-list
111097955|NCT03971643|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
111097956|NCT03971643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111097957|NCT03971643|Immunologic Factors|immunologic factors|mesh-ancestor
111097958|NCT03971643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111097959|NCT02149108|Nintedanib|nintedanib|mesh-list
111097960|NCT02149108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111097961|NCT02149108|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111097962|NCT02149108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111097963|NCT02149108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111097964|NCT02148718|Adalimumab|adalimumab|mesh-list
111097965|NCT02148718|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111097966|NCT02148718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111097967|NCT02148718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111097968|NCT03397953|Vinorelbine|vinorelbine|mesh-list
111097969|NCT03397953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111097970|NCT03397953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111097971|NCT03397953|Tubulin Modulators|tubulin modulators|mesh-ancestor
111097972|NCT03397953|Antimitotic Agents|antimitotic agents|mesh-ancestor
111097973|NCT03397953|Mitosis Modulators|mitosis modulators|mesh-ancestor
111097974|NCT03397953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111097975|NCT05549973|Dexamethasone|dexamethasone|mesh-list
111097976|NCT05549973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111097977|NCT05549973|Antiemetics|antiemetics|mesh-ancestor
111097978|NCT05549973|Autonomic Agents|autonomic agents|mesh-ancestor
111097979|NCT05549973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111097980|NCT05549973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111097981|NCT05549973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111097982|NCT05549973|Glucocorticoids|glucocorticoids|mesh-ancestor
111097983|NCT05549973|Hormones|hormones|mesh-ancestor
111097984|NCT05549973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111097985|NCT05549973|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111097986|NCT05549973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111097987|NCT02148250|Insulin|insulin|mesh-list
111097988|NCT02148250|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111097989|NCT02148250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111097990|NCT02148250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111097991|NCT04870359|Prednisolone|prednisolone|mesh-list
111097992|NCT04870359|Immunosuppressive Agents|immunosuppressive agents|mesh-list
111097993|NCT04870359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111097994|NCT04870359|Glucocorticoids|glucocorticoids|mesh-ancestor
111097995|NCT04870359|Hormones|hormones|mesh-ancestor
111097996|NCT04870359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111097997|NCT04870359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111097998|NCT04870359|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111097999|NCT04870359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111098000|NCT04870359|Immunologic Factors|immunologic factors|mesh-ancestor
111098001|NCT02705859|Trastuzumab|trastuzumab|mesh-list
111098002|NCT02705859|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111098003|NCT02705859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111098004|NCT05549583|Metformin|metformin|mesh-list
111098005|NCT05549583|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111098006|NCT05549583|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111098007|NCT05549583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111098008|NCT05549583|Incretins|incretins|mesh-ancestor
111098009|NCT05549583|Hormones|hormones|mesh-ancestor
111098010|NCT05549583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111098011|NCT05549583|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110815111|NCT04164732|Valsartan|valsartan|mesh-list
111098012|NCT05549583|Protease Inhibitors|protease inhibitors|mesh-ancestor
111098013|NCT05549583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111098014|NCT05549583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111098015|NCT05554731|Hemostatics|hemostatics|mesh-list
111098016|NCT05554731|Coagulants|coagulants|mesh-ancestor
111098017|NCT02172040|Celecoxib|celecoxib|mesh-list
111098018|NCT02172040|Amlodipine|amlodipine|mesh-list
111098019|NCT02172040|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111098020|NCT02172040|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111098021|NCT02172040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111098022|NCT02172040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111098023|NCT02172040|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111098024|NCT02172040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111098025|NCT02172040|Vasodilator Agents|vasodilator agents|mesh-ancestor
111098026|NCT02172040|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111098027|NCT02172040|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111098028|NCT02172040|Analgesics|analgesics|mesh-ancestor
111098029|NCT02172040|Sensory System Agents|sensory system agents|mesh-ancestor
111098030|NCT02172040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111098031|NCT02172040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111098032|NCT02172040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111098033|NCT02172040|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111098034|NCT02172040|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111098035|NCT02172040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111098036|NCT02367105|Testosterone|testosterone|mesh-list
111098037|NCT02367105|Androgens|androgens|mesh-ancestor
111098038|NCT02367105|Hormones|hormones|mesh-ancestor
111098039|NCT02367105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111098040|NCT02367105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111098041|NCT05554185|Aspirin|aspirin|mesh-list
111098042|NCT05554185|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111098043|NCT05554185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111098044|NCT05554185|Analgesics|analgesics|mesh-ancestor
111098045|NCT05554185|Sensory System Agents|sensory system agents|mesh-ancestor
111098046|NCT05554185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111098047|NCT05554185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111098048|NCT05554185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111098049|NCT05554185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111098050|NCT05554185|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111098051|NCT05554185|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111098052|NCT05554185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111098053|NCT05554185|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111098054|NCT05554185|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110642288|NCT00880412|Etazolate|etazolate|mesh-list
111098055|NCT05554185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111098056|NCT05554185|Antipyretics|antipyretics|mesh-ancestor
111098057|NCT05558397|Morphine|morphine|mesh-list
111098058|NCT05558397|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111098059|NCT05558397|Narcotics|narcotics|mesh-ancestor
111098060|NCT05558397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111098061|NCT05558397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111098062|NCT05558397|Analgesics|analgesics|mesh-ancestor
111098063|NCT05558397|Sensory System Agents|sensory system agents|mesh-ancestor
111098064|NCT05558397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111098065|NCT05558319|Dexamethasone|dexamethasone|mesh-list
111098066|NCT05558319|Lenalidomide|lenalidomide|mesh-list
111098067|NCT05558319|Bortezomib|bortezomib|mesh-list
111098068|NCT05558319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111098069|NCT05558319|Antiemetics|antiemetics|mesh-ancestor
111098070|NCT05558319|Autonomic Agents|autonomic agents|mesh-ancestor
111098071|NCT05558319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111098072|NCT05558319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111098073|NCT05558319|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111098074|NCT05558319|Glucocorticoids|glucocorticoids|mesh-ancestor
111098075|NCT05558319|Hormones|hormones|mesh-ancestor
111098076|NCT05558319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111098077|NCT05558319|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111098078|NCT05558319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111098079|NCT05558319|Immunologic Factors|immunologic factors|mesh-ancestor
111098080|NCT05558319|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111098081|NCT05558319|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111098082|NCT05558319|Growth Substances|growth substances|mesh-ancestor
111098083|NCT05558319|Growth Inhibitors|growth inhibitors|mesh-ancestor
111098084|NCT05553717|Carvedilol|carvedilol|mesh-list
111098085|NCT05553717|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111098086|NCT05553717|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111098087|NCT05553717|Adrenergic Agents|adrenergic agents|mesh-ancestor
111098088|NCT05553717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111098089|NCT05553717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111098090|NCT05553717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111098091|NCT05553717|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111098092|NCT05553717|Antioxidants|antioxidants|mesh-ancestor
111098093|NCT05553717|Protective Agents|protective agents|mesh-ancestor
111098094|NCT05553717|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111098095|NCT05553717|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111098096|NCT05553717|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111098097|NCT05553717|Vasodilator Agents|vasodilator agents|mesh-ancestor
111098098|NCT05553717|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111098099|NCT05553717|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111098100|NCT02147158|Ulipristal acetate|ulipristal acetate|mesh-list
111098101|NCT02147158|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111098102|NCT02147158|Contraceptive Agents|contraceptive agents|mesh-ancestor
111098103|NCT02147158|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111098104|NCT02147158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111098105|NCT02147158|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111098106|NCT05553093|Insulin|insulin|mesh-list
111098107|NCT05553093|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111098108|NCT05553093|Insulin Glargine|insulin glargine|mesh-list
111098109|NCT05553093|Tirzepatide|tirzepatide|mesh-list
111098110|NCT05553093|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111098111|NCT05553093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111098112|NCT05553093|Incretins|incretins|mesh-ancestor
111098113|NCT05553093|Hormones|hormones|mesh-ancestor
111098114|NCT05553093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111098115|NCT04757740|Methylprednisolone|methylprednisolone|mesh-list
111098116|NCT04757740|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111098117|NCT04757740|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111098118|NCT04757740|Prednisolone|prednisolone|mesh-list
111098119|NCT04757740|Prednisolone acetate|prednisolone acetate|mesh-list
111098120|NCT04757740|Lidocaine|lidocaine|mesh-list
111098121|NCT04757740|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111098122|NCT04757740|Prednisolone phosphate|prednisolone phosphate|mesh-list
110642297|NCT01020136|Axitinib|axitinib|mesh-list
111098123|NCT04757740|Anesthetics, Local|anesthetics, local|mesh-ancestor
111098124|NCT04757740|Anesthetics|anesthetics|mesh-ancestor
111098125|NCT04757740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111098126|NCT04757740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111098127|NCT04757740|Sensory System Agents|sensory system agents|mesh-ancestor
111098128|NCT04757740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111098129|NCT04757740|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111098130|NCT04757740|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111098131|NCT04757740|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111098132|NCT04757740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111098133|NCT04757740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111098134|NCT04757740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111098135|NCT04757740|Antiemetics|antiemetics|mesh-ancestor
111098136|NCT04757740|Autonomic Agents|autonomic agents|mesh-ancestor
111098137|NCT04757740|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111098138|NCT04757740|Glucocorticoids|glucocorticoids|mesh-ancestor
111098139|NCT04757740|Hormones|hormones|mesh-ancestor
111098140|NCT04757740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111098141|NCT04757740|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111098142|NCT04757740|Protective Agents|protective agents|mesh-ancestor
111098143|NCT04757740|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111098144|NCT04757740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111098145|NCT05552937|Lenalidomide|lenalidomide|mesh-list
111098146|NCT05552937|Immunologic Factors|immunologic factors|mesh-ancestor
111098147|NCT05552937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111098148|NCT05552937|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111098149|NCT05552937|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111098150|NCT05552937|Growth Substances|growth substances|mesh-ancestor
111098151|NCT05552937|Growth Inhibitors|growth inhibitors|mesh-ancestor
111098152|NCT05552937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111098153|NCT02112448|Acetaminophen|acetaminophen|mesh-list
111098154|NCT02112448|Ketorolac|ketorolac|mesh-list
111098155|NCT02112448|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
111098156|NCT02112448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111098157|NCT02112448|Analgesics|analgesics|mesh-ancestor
111098158|NCT02112448|Sensory System Agents|sensory system agents|mesh-ancestor
111098159|NCT02112448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111098160|NCT02112448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111098161|NCT02112448|Antipyretics|antipyretics|mesh-ancestor
111098162|NCT02112448|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111098163|NCT02112448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111098164|NCT02112448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111098165|NCT02112448|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111098166|NCT02112448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111098167|NCT02112448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111098168|NCT02109562|Risperidone|risperidone|mesh-list
111098169|NCT02109562|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111098170|NCT02109562|Serotonin Agents|serotonin agents|mesh-ancestor
111098171|NCT02109562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111098172|NCT02109562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111098173|NCT02109562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111098174|NCT02109562|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111098175|NCT02109562|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111098176|NCT02109562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111098177|NCT02109562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111098178|NCT02109562|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111098179|NCT02109562|Dopamine Agents|dopamine agents|mesh-ancestor
111098181|NCT02109484|Immunologic Factors|immunologic factors|mesh-ancestor
111098182|NCT02109484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111098183|NCT05134792|Immunoglobulins|immunoglobulins|mesh-list
111098184|NCT05134792|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111098185|NCT05134792|Antibodies|antibodies|mesh-list
111098186|NCT05134792|gamma-Globulins|gamma-globulins|mesh-list
111098187|NCT05134792|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
111098188|NCT05134792|Immunologic Factors|immunologic factors|mesh-ancestor
111098189|NCT05134792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111098190|NCT02105974|Fluticasone|fluticasone|mesh-list
111098191|NCT02105974|Xhance|xhance|mesh-list
111098192|NCT02105974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111098193|NCT02105974|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111098194|NCT02105974|Autonomic Agents|autonomic agents|mesh-ancestor
111098195|NCT02105974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111098196|NCT02105974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111098197|NCT02105974|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111098198|NCT02105974|Respiratory System Agents|respiratory system agents|mesh-ancestor
111098199|NCT02105974|Dermatologic Agents|dermatologic agents|mesh-ancestor
111098200|NCT02105974|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111098201|NCT02105662|Grazoprevir|grazoprevir|mesh-list
111098202|NCT02105662|Antiviral Agents|antiviral agents|mesh-ancestor
111098203|NCT02105662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111098204|NCT02142712|Diphenhydramine|diphenhydramine|mesh-list
111098205|NCT02142712|Promethazine|promethazine|mesh-list
111098206|NCT02142712|Dextromethorphan|dextromethorphan|mesh-list
111098207|NCT02142712|Pantoprazole|pantoprazole|mesh-list
111098208|NCT02142712|Famotidine|famotidine|mesh-list
111098209|NCT02142712|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111098210|NCT02142712|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111098211|NCT02142712|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111098212|NCT02142712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111098213|NCT02142712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111098214|NCT02142712|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111098215|NCT02142712|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111098216|NCT02142712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111098217|NCT02142712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111098218|NCT02142712|Anesthetics, Local|anesthetics, local|mesh-ancestor
111098219|NCT02142712|Anesthetics|anesthetics|mesh-ancestor
111098220|NCT02142712|Sensory System Agents|sensory system agents|mesh-ancestor
111098221|NCT02142712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111098222|NCT02142712|Antiemetics|antiemetics|mesh-ancestor
111098223|NCT02142712|Autonomic Agents|autonomic agents|mesh-ancestor
111098224|NCT02142712|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111098225|NCT02142712|Histamine Antagonists|histamine antagonists|mesh-ancestor
111098226|NCT02142712|Histamine Agents|histamine agents|mesh-ancestor
111098227|NCT02142712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111098228|NCT02142712|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111098229|NCT02142712|Antipruritics|antipruritics|mesh-ancestor
111098230|NCT02142712|Dermatologic Agents|dermatologic agents|mesh-ancestor
111098231|NCT02142712|Antitussive Agents|antitussive agents|mesh-ancestor
111098232|NCT02142712|Respiratory System Agents|respiratory system agents|mesh-ancestor
111098233|NCT02142712|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111098234|NCT02142712|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111098235|NCT02142712|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
111098236|NCT02105272|Carteolol|carteolol|mesh-list
111098237|NCT02105272|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111098238|NCT02105272|Latanoprost|latanoprost|mesh-list
111098239|NCT02105272|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111098240|NCT02105272|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111098241|NCT02105272|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111098242|NCT02105272|Adrenergic Agents|adrenergic agents|mesh-ancestor
111098243|NCT02105272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111098244|NCT02105272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111098245|NCT02105272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111098246|NCT02105272|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111098247|NCT02105272|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111098248|NCT02105272|Sympatholytics|sympatholytics|mesh-ancestor
111098249|NCT02105272|Autonomic Agents|autonomic agents|mesh-ancestor
111098250|NCT02105272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111098251|NCT02141854|Fluticasone|fluticasone|mesh-list
111098252|NCT02141854|Xhance|xhance|mesh-list
111098253|NCT02141854|Albuterol|albuterol|mesh-list
111098254|NCT02141854|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
111098255|NCT02141854|Adrenergic Agonists|adrenergic agonists|mesh-list
111098256|NCT02141854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111098257|NCT02141854|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111098258|NCT02141854|Autonomic Agents|autonomic agents|mesh-ancestor
111098259|NCT02141854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111098260|NCT02141854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111098261|NCT02141854|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111098262|NCT02141854|Respiratory System Agents|respiratory system agents|mesh-ancestor
111098263|NCT02141854|Dermatologic Agents|dermatologic agents|mesh-ancestor
111098264|NCT02141854|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111098265|NCT02141854|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111098266|NCT02141854|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111098267|NCT02141854|Adrenergic Agents|adrenergic agents|mesh-ancestor
111098268|NCT02141854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111098269|NCT02141854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111098270|NCT02141854|Tocolytic Agents|tocolytic agents|mesh-ancestor
111098271|NCT02141854|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111098272|NCT02141620|Acetylcysteine|acetylcysteine|mesh-list
111098273|NCT02141620|Cocaine|cocaine|mesh-list
111098274|NCT02141620|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111098275|NCT02141620|Antiviral Agents|antiviral agents|mesh-ancestor
111098276|NCT02141620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111098277|NCT02141620|Expectorants|expectorants|mesh-ancestor
111098278|NCT02141620|Respiratory System Agents|respiratory system agents|mesh-ancestor
111098279|NCT02141620|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111098280|NCT02141620|Antioxidants|antioxidants|mesh-ancestor
111098281|NCT02141620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111098282|NCT02141620|Protective Agents|protective agents|mesh-ancestor
111098283|NCT02141620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111098284|NCT02141620|Antidotes|antidotes|mesh-ancestor
111098285|NCT02141620|Anesthetics, Local|anesthetics, local|mesh-ancestor
111098286|NCT02141620|Anesthetics|anesthetics|mesh-ancestor
111098287|NCT02141620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111098288|NCT02141620|Sensory System Agents|sensory system agents|mesh-ancestor
111098289|NCT02141620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111098290|NCT02141620|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111098291|NCT02141620|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111098292|NCT02141620|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111098293|NCT02141620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111098294|NCT02141620|Dopamine Agents|dopamine agents|mesh-ancestor
111098295|NCT02141620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111098296|NCT01664949|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
111098297|NCT01664949|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111098298|NCT01664949|Lubricant Eye Drops|lubricant eye drops|mesh-list
111098299|NCT01664949|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111098300|NCT01664949|Laxatives|laxatives|mesh-ancestor
111098301|NCT01664949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111098302|NCT02587143|Ethyl Chloride|ethyl chloride|mesh-list
111098303|NCT02587143|Anesthetics, Local|anesthetics, local|mesh-ancestor
111098304|NCT02587143|Anesthetics|anesthetics|mesh-ancestor
111098305|NCT02587143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111098306|NCT02587143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111098307|NCT02587143|Sensory System Agents|sensory system agents|mesh-ancestor
111098308|NCT02587143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111098309|NCT02106832|Ciprofloxacin|ciprofloxacin|mesh-list
111098310|NCT02106832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111098311|NCT02106832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111098312|NCT02106832|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111098313|NCT02106832|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111098314|NCT02106832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111098315|NCT02106832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111098316|NCT02106832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111098317|NCT02106832|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111098318|NCT02106832|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111098319|NCT05552391|Dexmedetomidine|dexmedetomidine|mesh-list
111098320|NCT05552391|Ketamine|ketamine|mesh-list
111098321|NCT05552391|Bupivacaine|bupivacaine|mesh-list
111098322|NCT05552391|Anesthetics, Local|anesthetics, local|mesh-ancestor
111098323|NCT05552391|Anesthetics|anesthetics|mesh-ancestor
111098324|NCT05552391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111098325|NCT05552391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111098326|NCT05552391|Sensory System Agents|sensory system agents|mesh-ancestor
111098327|NCT05552391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111098328|NCT05552391|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111098329|NCT05552391|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111098330|NCT05552391|Analgesics|analgesics|mesh-ancestor
111098331|NCT05552391|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111098332|NCT05552391|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111098333|NCT05552391|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111098334|NCT05552391|Adrenergic Agents|adrenergic agents|mesh-ancestor
111098335|NCT05552391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111098336|NCT05552391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111098337|NCT05552391|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111098338|NCT05552391|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111098339|NCT05552391|Anesthetics, General|anesthetics, general|mesh-ancestor
111098340|NCT05552391|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111098341|NCT05552391|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111098342|NCT02106442|Risedronic Acid|risedronic acid|mesh-list
111098343|NCT02106442|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111098344|NCT02106442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111098345|NCT02106442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111098346|NCT02106442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111098347|NCT02106442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111098348|NCT02106442|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111098349|NCT04740814|Certolizumab Pegol|certolizumab pegol|mesh-list
111098350|NCT04740814|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111098351|NCT04740814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111098352|NCT04740814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111098353|NCT04740814|Immunologic Factors|immunologic factors|mesh-ancestor
111098354|NCT04740814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111098355|NCT04740814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111098356|NCT02105116|Cytarabine|cytarabine|mesh-list
111098357|NCT02105116|Fludarabine|fludarabine|mesh-list
111098358|NCT02105116|Fludarabine phosphate|fludarabine phosphate|mesh-list
111098359|NCT02105116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111098360|NCT02105116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111098361|NCT02105116|Antimetabolites|antimetabolites|mesh-ancestor
111098362|NCT02105116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111098363|NCT02105116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111098364|NCT02105116|Immunologic Factors|immunologic factors|mesh-ancestor
111098365|NCT02105116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111098366|NCT02105116|Antiviral Agents|antiviral agents|mesh-ancestor
111098367|NCT02105116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111098368|NCT05551767|Cisplatin|cisplatin|mesh-list
111098369|NCT05551767|Pembrolizumab|pembrolizumab|mesh-list
111098370|NCT05551767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111098371|NCT05551767|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111098372|NCT05551767|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111098373|NCT05551767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111098374|NCT05551689|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
111098375|NCT05551689|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111098376|NCT05551689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111098377|NCT05551689|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111098378|NCT05551689|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111098379|NCT05551689|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111098380|NCT05551689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111098381|NCT05551689|Dopamine Agents|dopamine agents|mesh-ancestor
111098382|NCT05551689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111098383|NCT05547789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
111098384|NCT05547789|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
111098385|NCT05547789|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111098386|NCT05547789|Analgesics|analgesics|mesh-ancestor
111098387|NCT05547789|Sensory System Agents|sensory system agents|mesh-ancestor
111098388|NCT05547789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111098389|NCT05547789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111098390|NCT05547789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111098391|NCT05542095|Simvastatin|simvastatin|mesh-list
111098392|NCT05542095|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111098393|NCT05542095|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111098394|NCT05542095|Antimetabolites|antimetabolites|mesh-ancestor
111098395|NCT05542095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111098396|NCT05542095|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111098397|NCT05542095|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111098398|NCT05542095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111098400|NCT05551221|Silodosin|silodosin|mesh-list
111098401|NCT05551221|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111098402|NCT05551221|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111098403|NCT05551221|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111098404|NCT05551221|Adrenergic Agents|adrenergic agents|mesh-ancestor
111098405|NCT05551221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111098406|NCT05551221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111098407|NCT05551221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111098408|NCT05551221|Urological Agents|urological agents|mesh-ancestor
111098409|NCT02104804|Insulin|insulin|mesh-list
111098410|NCT02104804|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111098411|NCT02104804|Metformin|metformin|mesh-list
111098412|NCT02104804|Saxagliptin|saxagliptin|mesh-list
111098413|NCT02104804|Insulin, Short-Acting|insulin, short-acting|mesh-list
111098414|NCT02104804|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111098415|NCT02104804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111098416|NCT02104804|Incretins|incretins|mesh-ancestor
111098417|NCT02104804|Hormones|hormones|mesh-ancestor
111098418|NCT02104804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111098419|NCT02104804|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111098420|NCT02104804|Protease Inhibitors|protease inhibitors|mesh-ancestor
111098421|NCT02104804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111098422|NCT02104804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111098423|NCT05550441|Dapagliflozin|dapagliflozin|mesh-list
111098424|NCT05550441|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111098425|NCT05550441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111098426|NCT05550441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111098427|NCT05550441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111098428|NCT05546853|Leucovorin|leucovorin|mesh-list
111098429|NCT05546853|Oxaliplatin|oxaliplatin|mesh-list
111098430|NCT05546853|Irinotecan|irinotecan|mesh-list
111098431|NCT05546853|Calcium|calcium|mesh-list
111098432|NCT05546853|Levoleucovorin|levoleucovorin|mesh-list
111098433|NCT05546853|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111098434|NCT05546853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111098435|NCT05546853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111098436|NCT05546853|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111098437|NCT05546853|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111098438|NCT05546853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111098439|NCT05546853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111098440|NCT05546853|Antidotes|antidotes|mesh-ancestor
111098441|NCT05546853|Protective Agents|protective agents|mesh-ancestor
111098442|NCT05546853|Vitamin B Complex|vitamin b complex|mesh-ancestor
111098443|NCT05546853|Vitamins|vitamins|mesh-ancestor
111098444|NCT05546853|Micronutrients|micronutrients|mesh-ancestor
111098445|NCT05546619|Tislelizumab|tislelizumab|mesh-list
111098446|NCT05546619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111098447|NCT05546619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111098448|NCT05540145|Paclitaxel|paclitaxel|mesh-list
111098449|NCT05540145|Antibodies|antibodies|mesh-list
111098450|NCT05540145|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111098451|NCT05540145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111098452|NCT05540145|Tubulin Modulators|tubulin modulators|mesh-ancestor
111098453|NCT05540145|Antimitotic Agents|antimitotic agents|mesh-ancestor
111098454|NCT05540145|Mitosis Modulators|mitosis modulators|mesh-ancestor
111098455|NCT05540145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111098456|NCT05540145|Immunologic Factors|immunologic factors|mesh-ancestor
111098457|NCT05540145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111098458|NCT05592327|Citric Acid|citric acid|mesh-list
111098459|NCT05592327|Sodium Citrate|sodium citrate|mesh-list
111098460|NCT05592327|Anticoagulants|anticoagulants|mesh-ancestor
111098461|NCT05592327|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
111098462|NCT05592327|Chelating Agents|chelating agents|mesh-ancestor
111098463|NCT05592327|Sequestering Agents|sequestering agents|mesh-ancestor
111098464|NCT05592327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111098466|NCT05592171|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
111098467|NCT05592171|Estrogens|estrogens|mesh-ancestor
111098468|NCT05592171|Hormones|hormones|mesh-ancestor
111098469|NCT05592171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111098470|NCT05592171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111098471|NCT05592171|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111098472|NCT05592171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111098473|NCT05539521|Propofol|propofol|mesh-list
111098474|NCT05539521|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111098476|NCT05539521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111098477|NCT05539521|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111098478|NCT05539521|Anesthetics, General|anesthetics, general|mesh-ancestor
111098479|NCT05539521|Anesthetics|anesthetics|mesh-ancestor
111098480|NCT05592015|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
111098481|NCT05592015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111098482|NCT05592015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111098483|NCT05592015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111098484|NCT05538507|Memantine|memantine|mesh-list
111098485|NCT05538507|Donepezil|donepezil|mesh-list
111098486|NCT05538507|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111098487|NCT05538507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111098488|NCT05538507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111098489|NCT05538507|Cholinergic Agents|cholinergic agents|mesh-ancestor
111098490|NCT05538507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111098491|NCT05538507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111098492|NCT05538507|Nootropic Agents|nootropic agents|mesh-ancestor
111098493|NCT05538507|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111098494|NCT05538507|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111098495|NCT05538507|Dopamine Agents|dopamine agents|mesh-ancestor
111098496|NCT05538507|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111098497|NCT05538507|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111098498|NCT05591235|Metformin|metformin|mesh-list
111098499|NCT05591235|Pioglitazone|pioglitazone|mesh-list
111098500|NCT05591235|Dapagliflozin|dapagliflozin|mesh-list
111098501|NCT05591235|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111098502|NCT05591235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111098503|NCT05591235|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111098504|NCT05591235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111098505|NCT05545527|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
111098506|NCT05545527|Ferric Compounds|ferric compounds|mesh-list
111098507|NCT05545527|Hematinics|hematinics|mesh-ancestor
111098508|NCT01666119|Buprenorphine|buprenorphine|mesh-list
111098509|NCT01666119|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111098510|NCT01666119|Narcotics|narcotics|mesh-ancestor
111098511|NCT01666119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111098512|NCT01666119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111098513|NCT01666119|Analgesics|analgesics|mesh-ancestor
111098514|NCT01666119|Sensory System Agents|sensory system agents|mesh-ancestor
111098515|NCT01666119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111098516|NCT01666119|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111098517|NCT05361993|Aripiprazole|aripiprazole|mesh-list
111098518|NCT05361993|Antidepressive Agents|antidepressive agents|mesh-ancestor
111098519|NCT05361993|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111098520|NCT05361993|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111098521|NCT05361993|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111098522|NCT05361993|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111098523|NCT05361993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111098524|NCT05361993|Dopamine Agonists|dopamine agonists|mesh-ancestor
111098525|NCT05361993|Dopamine Agents|dopamine agents|mesh-ancestor
111098526|NCT05361993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111098527|NCT05361993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111098528|NCT05361993|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111098529|NCT05361993|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111098530|NCT05361993|Serotonin Agents|serotonin agents|mesh-ancestor
111098531|NCT05361993|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111098532|NCT05361993|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111098533|NCT05361993|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111098534|NCT05361993|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111098535|NCT04425681|Bevacizumab|bevacizumab|mesh-list
111098536|NCT04425681|Osimertinib|osimertinib|mesh-list
110815639|NCT01342562|Anesthetics|anesthetics|mesh-list
111098537|NCT04425681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111098538|NCT04425681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111098539|NCT04425681|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111098540|NCT04425681|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111098541|NCT04425681|Growth Substances|growth substances|mesh-ancestor
111098542|NCT04425681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111098543|NCT04425681|Growth Inhibitors|growth inhibitors|mesh-ancestor
111098544|NCT04425681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111098545|NCT04425681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111098546|NCT04425681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111098547|NCT05545059|Amlodipine|amlodipine|mesh-list
111098549|NCT05545059|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
111098550|NCT05545059|Spironolactone|spironolactone|mesh-list
111098551|NCT05545059|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
111098552|NCT05545059|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111098553|NCT05545059|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111098554|NCT05545059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111098555|NCT05545059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111098556|NCT05545059|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111098557|NCT05545059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111098558|NCT05545059|Vasodilator Agents|vasodilator agents|mesh-ancestor
111098559|NCT05545059|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111098560|NCT05545059|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111098561|NCT05545059|Diuretics|diuretics|mesh-ancestor
111098562|NCT05545059|Natriuretic Agents|natriuretic agents|mesh-ancestor
111098563|NCT05545059|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
111098564|NCT05545059|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
111098565|NCT05545059|Hormone Antagonists|hormone antagonists|mesh-ancestor
111098566|NCT05545059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111098567|NCT05545059|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
111098568|NCT05128773|Tamoxifen|tamoxifen|mesh-list
111098569|NCT05128773|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111098570|NCT05128773|Hormone Antagonists|hormone antagonists|mesh-ancestor
111098571|NCT05128773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111098572|NCT05128773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111098573|NCT05128773|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111098574|NCT05128773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111098575|NCT05128773|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111098576|NCT05128773|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111098577|NCT05128773|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111098578|NCT05536011|Sodium Oxybate|sodium oxybate|mesh-list
111098579|NCT05536011|Methylphenidate|methylphenidate|mesh-list
111098580|NCT05536011|Modafinil|modafinil|mesh-list
111098581|NCT05536011|Amphetamine|amphetamine|mesh-list
111098582|NCT05536011|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111098583|NCT05536011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111098584|NCT05536011|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111098585|NCT05536011|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111098586|NCT05536011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111098587|NCT05536011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111098588|NCT05536011|Dopamine Agents|dopamine agents|mesh-ancestor
111098589|NCT05536011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111098590|NCT05536011|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
111098591|NCT05536011|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111098592|NCT05536011|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111098593|NCT05536011|Sympathomimetics|sympathomimetics|mesh-ancestor
111098594|NCT05536011|Autonomic Agents|autonomic agents|mesh-ancestor
110642352|NCT00564486|Acetaminophen|acetaminophen|mesh-list
111098595|NCT05536011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111098596|NCT05536011|Adrenergic Agents|adrenergic agents|mesh-ancestor
111098597|NCT05536011|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111098598|NCT05536011|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111098599|NCT05536011|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111098600|NCT05536011|Anesthetics, General|anesthetics, general|mesh-ancestor
111098601|NCT05536011|Anesthetics|anesthetics|mesh-ancestor
111098602|NCT05536011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111098603|NCT04809051|Metronidazole|metronidazole|mesh-list
111098604|NCT04809051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111098605|NCT04809051|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111098606|NCT04809051|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111098607|NCT04809051|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111098608|NCT04015869|Pregnanolone|pregnanolone|mesh-list
111098609|NCT04015869|Anesthetics|anesthetics|mesh-ancestor
110815709|NCT02284984|Immunologic Factors|immunologic factors|mesh-ancestor
111098610|NCT04015869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111098611|NCT04015869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111098612|NCT04677855|Prednisone|prednisone|mesh-list
111098613|NCT04677855|Dutasteride|dutasteride|mesh-list
111098614|NCT04677855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111098615|NCT04677855|Glucocorticoids|glucocorticoids|mesh-ancestor
111098616|NCT04677855|Hormones|hormones|mesh-ancestor
111098617|NCT04677855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111098618|NCT04677855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111098620|NCT04677855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111098621|NCT04677855|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
111098622|NCT04677855|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111098623|NCT04677855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111098624|NCT04677855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111098625|NCT04677855|Hormone Antagonists|hormone antagonists|mesh-ancestor
111098626|NCT02584959|Complement C1s|complement c1s|mesh-list
111098627|NCT02584959|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
111098628|NCT02584959|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
111098629|NCT02584959|Immunologic Factors|immunologic factors|mesh-ancestor
111098630|NCT02584959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111098631|NCT02584959|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
111098632|NCT02584959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111098633|NCT05544045|Calcium Carbonate|calcium carbonate|mesh-list
111098634|NCT05544045|Antacids|antacids|mesh-ancestor
111098635|NCT05544045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111098636|NCT05544045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111098637|NCT02584257|Albuterol|albuterol|mesh-list
111098638|NCT02584257|Procaterol|procaterol|mesh-list
111098639|NCT02584257|Methacholine Chloride|methacholine chloride|mesh-list
111098640|NCT02584257|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111098641|NCT02584257|Autonomic Agents|autonomic agents|mesh-ancestor
111098642|NCT02584257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111098643|NCT02584257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111098644|NCT02584257|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111098645|NCT02584257|Respiratory System Agents|respiratory system agents|mesh-ancestor
111098646|NCT02584257|Tocolytic Agents|tocolytic agents|mesh-ancestor
111098647|NCT02584257|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111098648|NCT02584257|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111098649|NCT02584257|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111098650|NCT02584257|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111098651|NCT02584257|Adrenergic Agents|adrenergic agents|mesh-ancestor
111098652|NCT02584257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111098653|NCT02584257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111098654|NCT02584257|Miotics|miotics|mesh-ancestor
111098655|NCT02584257|Parasympathomimetics|parasympathomimetics|mesh-ancestor
111098656|NCT02584257|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
111098657|NCT02584257|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
111098658|NCT02584257|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111098659|NCT02584257|Cholinergic Agents|cholinergic agents|mesh-ancestor
111098660|NCT02584257|Sympathomimetics|sympathomimetics|mesh-ancestor
111098661|NCT04090203|Immunomodulating Agents|immunomodulating agents|mesh-list
111098662|NCT04090203|Immunologic Factors|immunologic factors|mesh-ancestor
111098663|NCT04090203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111098664|NCT04062201|Levofloxacin|levofloxacin|mesh-list
111098665|NCT04062201|Ofloxacin|ofloxacin|mesh-list
111098666|NCT04062201|Isoniazid|isoniazid|mesh-list
111098667|NCT04062201|Linezolid|linezolid|mesh-list
111098668|NCT04062201|Pyrazinamide|pyrazinamide|mesh-list
111098669|NCT04062201|Ethambutol|ethambutol|mesh-list
111098670|NCT04062201|Bedaquiline|bedaquiline|mesh-list
111098671|NCT04062201|Clofazimine|clofazimine|mesh-list
111098672|NCT04062201|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111098673|NCT04062201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111098674|NCT04062201|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111098675|NCT04062201|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111098676|NCT04062201|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111098677|NCT04062201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111098678|NCT04062201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111098679|NCT04062201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111098680|NCT04062201|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111098681|NCT04062201|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111098682|NCT04062201|Antitubercular Agents|antitubercular agents|mesh-ancestor
110815798|NCT00393952|Xhance|xhance|mesh-list
111098683|NCT04062201|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
111098684|NCT04062201|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111098686|NCT04062201|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111098687|NCT04062201|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111098688|NCT04062201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111098689|NCT04062201|Leprostatic Agents|leprostatic agents|mesh-ancestor
111098690|NCT02583477|Paclitaxel|paclitaxel|mesh-list
111098691|NCT02583477|Gemcitabine|gemcitabine|mesh-list
111098692|NCT02583477|Durvalumab|durvalumab|mesh-list
111098693|NCT02583477|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111098694|NCT02583477|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111098696|NCT02583477|Tubulin Modulators|tubulin modulators|mesh-ancestor
111098697|NCT02583477|Antimitotic Agents|antimitotic agents|mesh-ancestor
111098698|NCT02583477|Mitosis Modulators|mitosis modulators|mesh-ancestor
111098699|NCT02583477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111098700|NCT02583477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111098701|NCT02583477|Antimetabolites|antimetabolites|mesh-ancestor
111098702|NCT02583477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111098703|NCT02583477|Immunologic Factors|immunologic factors|mesh-ancestor
111098704|NCT02583477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111098705|NCT02583399|Ibuprofen|ibuprofen|mesh-list
111098706|NCT02583399|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111098707|NCT02583399|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111098708|NCT02583399|Analgesics|analgesics|mesh-ancestor
111098709|NCT02583399|Sensory System Agents|sensory system agents|mesh-ancestor
111098710|NCT02583399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111098711|NCT02583399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111098712|NCT02583399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111098713|NCT02583399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111098714|NCT02583399|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111098715|NCT02583399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111098716|NCT02583399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111098717|NCT02580591|Empagliflozin|empagliflozin|mesh-list
111098718|NCT02580591|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111098719|NCT02580591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111098720|NCT02580591|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111098721|NCT02580591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111098722|NCT05319249|Talazoparib|talazoparib|mesh-list
110642364|NCT00481078|Tubulin Modulators|tubulin modulators|mesh-ancestor
111098723|NCT05319249|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111098724|NCT05319249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111098725|NCT05319249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111098726|NCT05319249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111098727|NCT03849885|Benzoyl Peroxide|benzoyl peroxide|mesh-list
111098728|NCT03849885|Dermatologic Agents|dermatologic agents|mesh-ancestor
111098729|NCT02577315|Metformin|metformin|mesh-list
111098730|NCT02577315|Empagliflozin|empagliflozin|mesh-list
111098731|NCT02577315|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111098732|NCT02577315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111098733|NCT02577315|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111098734|NCT02577315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111098735|NCT01582269|Lomustine|lomustine|mesh-list
111098736|NCT01582269|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111098737|NCT01582269|Alkylating Agents|alkylating agents|mesh-ancestor
111098738|NCT01582269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111098739|NCT01582269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111098740|NCT03526887|Pembrolizumab|pembrolizumab|mesh-list
111098741|NCT03526887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111098742|NCT03526887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111098743|NCT03526887|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111098744|NCT03526887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111098745|NCT03496779|Gemcitabine|gemcitabine|mesh-list
111098746|NCT03496779|Brentuximab Vedotin|brentuximab vedotin|mesh-list
111098747|NCT03496779|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111098748|NCT03496779|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111098749|NCT03496779|Antimetabolites|antimetabolites|mesh-ancestor
111098750|NCT03496779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111098751|NCT03496779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111098752|NCT03496779|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111098753|NCT03496779|Immunotoxins|immunotoxins|mesh-ancestor
111098754|NCT03496779|Immunoconjugates|immunoconjugates|mesh-ancestor
111098755|NCT03496779|Immunologic Factors|immunologic factors|mesh-ancestor
111098756|NCT03496779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111098757|NCT03398655|Paclitaxel|paclitaxel|mesh-list
111098758|NCT03398655|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111098759|NCT03398655|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111098760|NCT03398655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111098761|NCT03398655|Tubulin Modulators|tubulin modulators|mesh-ancestor
111098762|NCT03398655|Antimitotic Agents|antimitotic agents|mesh-ancestor
111098763|NCT03398655|Mitosis Modulators|mitosis modulators|mesh-ancestor
111098764|NCT03398655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111098766|NCT05695287|Sevoflurane|sevoflurane|mesh-list
111098767|NCT05695287|Isoflurane|isoflurane|mesh-list
111098768|NCT05695287|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111098769|NCT05695287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111098770|NCT05695287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111098771|NCT05695287|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111098772|NCT05695287|Anesthetics, General|anesthetics, general|mesh-ancestor
111098773|NCT05695287|Anesthetics|anesthetics|mesh-ancestor
111098774|NCT05695287|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111098775|NCT05695287|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111098776|NCT00591227|Insulin|insulin|mesh-list
111098777|NCT00591227|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111098778|NCT00591227|Insulin Aspart|insulin aspart|mesh-list
111098779|NCT00591227|Insulin Detemir|insulin detemir|mesh-list
111098780|NCT00591227|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111098781|NCT00591227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111098782|NCT00408473|Flecainide|flecainide|mesh-list
111098783|NCT00408473|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111098784|NCT00408473|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111098785|NCT00408473|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111098786|NCT00408473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111098787|NCT00408473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111098788|NCT00328601|Thioctic Acid|thioctic acid|mesh-list
111098789|NCT00328601|Antioxidants|antioxidants|mesh-ancestor
111098790|NCT00328601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111098791|NCT00328601|Protective Agents|protective agents|mesh-ancestor
111098792|NCT00328601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111098793|NCT00328601|Vitamin B Complex|vitamin b complex|mesh-ancestor
111098794|NCT00328601|Vitamins|vitamins|mesh-ancestor
111098795|NCT00328601|Micronutrients|micronutrients|mesh-ancestor
111098796|NCT00189293|Imiquimod|imiquimod|mesh-list
111098797|NCT00189293|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111098798|NCT00189293|Immunologic Factors|immunologic factors|mesh-ancestor
111098799|NCT00189293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111098800|NCT00189293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111098801|NCT00189293|Interferon Inducers|interferon inducers|mesh-ancestor
111098802|NCT03194009|Metformin|metformin|mesh-list
111098803|NCT03194009|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111098804|NCT03194009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111098805|NCT02581995|Aflibercept|aflibercept|mesh-list
111098806|NCT02581995|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111098807|NCT02581995|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111098808|NCT02581995|Growth Substances|growth substances|mesh-ancestor
111098809|NCT02581995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111098810|NCT02581995|Growth Inhibitors|growth inhibitors|mesh-ancestor
111098811|NCT02581995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111098812|NCT03193307|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
111098813|NCT03193307|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
111098814|NCT03193307|BI 409306|bi 409306|mesh-list
111098815|NCT03193307|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111098816|NCT03193307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111098817|NCT03193307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111098818|NCT03193307|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111098819|NCT03193307|Contraceptive Agents|contraceptive agents|mesh-ancestor
111098820|NCT03193307|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111098821|NCT03193307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111098822|NCT03193307|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
111098823|NCT03193307|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111098824|NCT03193307|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111098825|NCT03193307|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111098826|NCT03193307|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111098827|NCT03193307|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
111098828|NCT03193307|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
111098829|NCT03193307|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
111098830|NCT02910843|Capecitabine|capecitabine|mesh-list
111098831|NCT02910843|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111098832|NCT02910843|Antimetabolites|antimetabolites|mesh-ancestor
111098833|NCT02910843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111098834|NCT02910843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111098835|NCT03192527|Triptorelin Pamoate|triptorelin pamoate|mesh-list
111098836|NCT03192527|Luteolytic Agents|luteolytic agents|mesh-ancestor
111098837|NCT03192527|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111098838|NCT03192527|Contraceptive Agents|contraceptive agents|mesh-ancestor
111098839|NCT03192527|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111098840|NCT03192527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111098841|NCT03192527|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111098842|NCT03192527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111098843|NCT03192527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111098845|NCT02444351|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111098846|NCT02444351|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111098847|NCT02444351|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111098848|NCT02444351|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111098849|NCT02444351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111098850|NCT02444351|Cholinergic Agents|cholinergic agents|mesh-ancestor
111098851|NCT02444351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111098852|NCT02444351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111098853|NCT02444351|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111098854|NCT02444351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111098855|NCT03193463|Topotecan|topotecan|mesh-list
111098856|NCT03193463|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111098857|NCT03193463|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111098858|NCT03193463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110642384|NCT00480532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111098859|NCT03193463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111098860|NCT03193463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111098861|NCT02577003|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111098862|NCT02577003|Ipragliflozin|ipragliflozin|mesh-list
111098863|NCT02577003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111098864|NCT02577003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111098865|NCT02577003|Incretins|incretins|mesh-ancestor
111098866|NCT02577003|Hormones|hormones|mesh-ancestor
111098867|NCT02577003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111098868|NCT02577003|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111098869|NCT02577003|Protease Inhibitors|protease inhibitors|mesh-ancestor
111098870|NCT02577003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111098871|NCT02577003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111098872|NCT02577003|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111098873|NCT05487417|Minocycline|minocycline|mesh-list
111098874|NCT05487417|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111098875|NCT05487417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111098876|NCT03471611|Lenograstim|lenograstim|mesh-list
111098877|NCT03471611|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111098878|NCT03471611|Immunologic Factors|immunologic factors|mesh-ancestor
111098879|NCT03471611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111098880|NCT02600897|Rituximab|rituximab|mesh-list
111098881|NCT02600897|Obinutuzumab|obinutuzumab|mesh-list
111098882|NCT02600897|Lenalidomide|lenalidomide|mesh-list
111098883|NCT02600897|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
111098884|NCT02600897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111098885|NCT02600897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111098886|NCT02600897|Immunologic Factors|immunologic factors|mesh-ancestor
111098887|NCT02600897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111098888|NCT02600897|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111098889|NCT02600897|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111098890|NCT02600897|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111098891|NCT02600897|Growth Substances|growth substances|mesh-ancestor
111098892|NCT02600897|Growth Inhibitors|growth inhibitors|mesh-ancestor
111098893|NCT02600897|Immunoconjugates|immunoconjugates|mesh-ancestor
111098894|NCT05674305|Cisplatin|cisplatin|mesh-list
111098895|NCT05674305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111098896|NCT03192449|Albendazole|albendazole|mesh-list
111098897|NCT03192449|Anthelmintics|anthelmintics|mesh-ancestor
111098898|NCT03192449|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111098899|NCT03192449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111098900|NCT03192449|Anticestodal Agents|anticestodal agents|mesh-ancestor
111098901|NCT03192449|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
111098902|NCT03192449|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111098903|NCT03192449|Tubulin Modulators|tubulin modulators|mesh-ancestor
111098904|NCT03192449|Antimitotic Agents|antimitotic agents|mesh-ancestor
111098905|NCT03192449|Mitosis Modulators|mitosis modulators|mesh-ancestor
111098906|NCT03192449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111098907|NCT03192449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111098908|NCT05691933|Morphine|morphine|mesh-list
111098909|NCT05691933|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111098910|NCT05691933|Narcotics|narcotics|mesh-ancestor
111098911|NCT05691933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111098912|NCT05691933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111098913|NCT05691933|Analgesics|analgesics|mesh-ancestor
111098914|NCT05691933|Sensory System Agents|sensory system agents|mesh-ancestor
111098915|NCT05691933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111098917|NCT00977483|Antioxidants|antioxidants|mesh-ancestor
111098918|NCT00977483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111098919|NCT00977483|Protective Agents|protective agents|mesh-ancestor
111098920|NCT00977483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111098921|NCT00977483|Vitamin B Complex|vitamin b complex|mesh-ancestor
111098922|NCT00977483|Vitamins|vitamins|mesh-ancestor
111098923|NCT00977483|Micronutrients|micronutrients|mesh-ancestor
111098924|NCT02439905|Dexmedetomidine|dexmedetomidine|mesh-list
111098925|NCT02439905|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111098926|NCT02439905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111098927|NCT02439905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111098928|NCT02439905|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111098929|NCT02439905|Analgesics|analgesics|mesh-ancestor
111098930|NCT02439905|Sensory System Agents|sensory system agents|mesh-ancestor
111098931|NCT02439905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111098932|NCT02439905|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111098933|NCT02439905|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111098934|NCT02439905|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111098935|NCT02439905|Adrenergic Agents|adrenergic agents|mesh-ancestor
111098936|NCT02439905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111098937|NCT02439905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111098938|NCT03192371|Vaccines|vaccines|mesh-list
111098939|NCT03192371|Immunologic Factors|immunologic factors|mesh-ancestor
111098940|NCT03192371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111098941|NCT02709785|Chlorhexidine|chlorhexidine|mesh-list
111098942|NCT02709785|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111098943|NCT02709785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111098944|NCT02709785|Disinfectants|disinfectants|mesh-ancestor
111098945|NCT02442791|Exenatide|exenatide|mesh-list
111098946|NCT02442791|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111098947|NCT02442791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111098948|NCT02442791|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111098949|NCT02442791|Incretins|incretins|mesh-ancestor
111098950|NCT02442791|Hormones|hormones|mesh-ancestor
111098951|NCT02442791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111098952|NCT04756557|Fluorides|fluorides|mesh-list
111098953|NCT04756557|Sodium Fluoride|sodium fluoride|mesh-list
111098954|NCT04756557|Cariostatic Agents|cariostatic agents|mesh-ancestor
111098955|NCT04756557|Protective Agents|protective agents|mesh-ancestor
111098956|NCT04756557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111098957|NCT02442713|Fluvoxamine|fluvoxamine|mesh-list
111098958|NCT02442713|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111098959|NCT02442713|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111098960|NCT02442713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111098961|NCT02442713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111098962|NCT02442713|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111098963|NCT02442713|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111098964|NCT02442713|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111098965|NCT02442713|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111098966|NCT02442713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111098967|NCT02442713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111098968|NCT02442713|Serotonin Agents|serotonin agents|mesh-ancestor
111098969|NCT02442713|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111098970|NCT02442713|Antidepressive Agents|antidepressive agents|mesh-ancestor
111098971|NCT02442713|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111098972|NCT02442713|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111098973|NCT02442713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111098974|NCT02442713|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111098975|NCT03189953|Exenatide|exenatide|mesh-list
111098976|NCT03189953|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111098977|NCT03189953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111098978|NCT03189953|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111098979|NCT03189953|Incretins|incretins|mesh-ancestor
111098980|NCT03189953|Hormones|hormones|mesh-ancestor
111098981|NCT03189953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111098982|NCT02204085|Decitabine|decitabine|mesh-list
111098983|NCT02204085|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111098984|NCT02204085|Antimetabolites|antimetabolites|mesh-ancestor
111098985|NCT02204085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111098986|NCT02204085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111098987|NCT02204085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111098988|NCT04314843|Lenzilumab|lenzilumab|mesh-list
111098990|NCT04314843|Fludarabine|fludarabine|mesh-list
111098991|NCT04314843|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
111098992|NCT04314843|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111098993|NCT04314843|Immunologic Factors|immunologic factors|mesh-ancestor
111098994|NCT04314843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111098995|NCT04314843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111098996|NCT04314843|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111098997|NCT04314843|Alkylating Agents|alkylating agents|mesh-ancestor
111098998|NCT04314843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111098999|NCT04314843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111099000|NCT04314843|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111099001|NCT04314843|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111099002|NCT04314843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111099003|NCT03192293|Metformin|metformin|mesh-list
111099004|NCT03192293|Fulvestrant|fulvestrant|mesh-list
111099005|NCT03192293|Simvastatin|simvastatin|mesh-list
111099006|NCT03192293|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111099007|NCT03192293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111099008|NCT03192293|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111099009|NCT03192293|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111099010|NCT03192293|Antimetabolites|antimetabolites|mesh-ancestor
111099011|NCT03192293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111099012|NCT03192293|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111099013|NCT03192293|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111099014|NCT03192293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111099015|NCT03192293|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111099016|NCT03192293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111099017|NCT03192293|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
111099018|NCT03192293|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111099019|NCT03192293|Hormone Antagonists|hormone antagonists|mesh-ancestor
111099020|NCT03192293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111099021|NCT02439125|Eltoprazine|eltoprazine|mesh-list
111099022|NCT02439125|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111099023|NCT02439125|Serotonin Agents|serotonin agents|mesh-ancestor
111099024|NCT02439125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111099025|NCT02439125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111099026|NCT02439125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111099027|NCT02441933|Carboplatin|carboplatin|mesh-list
111099028|NCT02441933|Taxane|taxane|mesh-list
111099029|NCT02441933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111099030|NCT01604265|Nabiximols|nabiximols|mesh-list
111099031|NCT01604265|Analgesics|analgesics|mesh-ancestor
111099032|NCT01604265|Sensory System Agents|sensory system agents|mesh-ancestor
111099033|NCT01604265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111099034|NCT01604265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111099035|NCT04483427|Ketorolac|ketorolac|mesh-list
111099036|NCT04483427|Nalbuphine|nalbuphine|mesh-list
111099037|NCT04483427|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111099038|NCT04483427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111099039|NCT04483427|Analgesics|analgesics|mesh-ancestor
111099040|NCT04483427|Sensory System Agents|sensory system agents|mesh-ancestor
111099041|NCT04483427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111099042|NCT04483427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111099043|NCT04483427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111099044|NCT04483427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111099045|NCT04483427|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111099046|NCT04483427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111099047|NCT04483427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111099048|NCT04483427|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111099049|NCT04483427|Narcotics|narcotics|mesh-ancestor
111099050|NCT04483427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111099051|NCT01664247|Liraglutide|liraglutide|mesh-list
111099052|NCT01664247|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111099053|NCT01664247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111099054|NCT01664247|Incretins|incretins|mesh-ancestor
111099055|NCT01664247|Hormones|hormones|mesh-ancestor
111099056|NCT01664247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111099058|NCT02441465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111099059|NCT02441465|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111099060|NCT02441465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111099061|NCT02441465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111099062|NCT02438657|Lidocaine|lidocaine|mesh-list
111099063|NCT02438657|Epinephrine|epinephrine|mesh-list
111099064|NCT02438657|Anesthetics, Local|anesthetics, local|mesh-ancestor
111099065|NCT02438657|Anesthetics|anesthetics|mesh-ancestor
111099066|NCT02438657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111099067|NCT02438657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111099068|NCT02438657|Sensory System Agents|sensory system agents|mesh-ancestor
111099069|NCT02438657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111099070|NCT02438657|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111099071|NCT02438657|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111099072|NCT02438657|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111099073|NCT02438657|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111099074|NCT02438657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111099075|NCT02438657|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111099076|NCT02438657|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111099077|NCT02438657|Adrenergic Agents|adrenergic agents|mesh-ancestor
111099078|NCT02438657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111099079|NCT02438657|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111099080|NCT02438657|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111099081|NCT02438657|Autonomic Agents|autonomic agents|mesh-ancestor
111099082|NCT02438657|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111099083|NCT02438657|Respiratory System Agents|respiratory system agents|mesh-ancestor
111099084|NCT02438657|Mydriatics|mydriatics|mesh-ancestor
111099085|NCT02438657|Sympathomimetics|sympathomimetics|mesh-ancestor
111099086|NCT02438657|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111099087|NCT02441387|Antidepressive Agents|antidepressive agents|mesh-list
111099088|NCT02441387|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111099089|NCT01441947|Fulvestrant|fulvestrant|mesh-list
111099090|NCT01441947|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111099091|NCT01441947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111099092|NCT01441947|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
111099093|NCT01441947|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111099094|NCT01441947|Hormone Antagonists|hormone antagonists|mesh-ancestor
111099095|NCT01441947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111099096|NCT01441947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111099097|NCT03192059|Aspirin|aspirin|mesh-list
111099098|NCT03192059|Vitamin D|vitamin d|mesh-list
111099099|NCT03192059|Curcumin|curcumin|mesh-list
111099100|NCT03192059|Cyclophosphamide|cyclophosphamide|mesh-list
111099101|NCT03192059|Pembrolizumab|pembrolizumab|mesh-list
111099102|NCT03192059|Lansoprazole|lansoprazole|mesh-list
111099103|NCT03192059|Dexlansoprazole|dexlansoprazole|mesh-list
111099104|NCT03192059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111099105|NCT03192059|Immunologic Factors|immunologic factors|mesh-ancestor
111099106|NCT03192059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111099107|NCT03192059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111099108|NCT03192059|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111099109|NCT03192059|Alkylating Agents|alkylating agents|mesh-ancestor
111099110|NCT03192059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111099111|NCT03192059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111099112|NCT03192059|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111099113|NCT03192059|Vitamins|vitamins|mesh-ancestor
111099114|NCT03192059|Micronutrients|micronutrients|mesh-ancestor
111099115|NCT03192059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111099116|NCT03192059|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111099117|NCT03192059|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111099118|NCT03192059|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111099119|NCT03192059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111099120|NCT03192059|Analgesics|analgesics|mesh-ancestor
111099121|NCT03192059|Sensory System Agents|sensory system agents|mesh-ancestor
111099122|NCT03192059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111099123|NCT03192059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111099124|NCT03192059|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111099125|NCT03192059|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111099126|NCT03192059|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111099127|NCT03192059|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111099128|NCT03192059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111099129|NCT03192059|Antipyretics|antipyretics|mesh-ancestor
111099130|NCT03192059|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111099131|NCT03192059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111099132|NCT03192059|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111099133|NCT02441075|Ethanol|ethanol|mesh-list
111099134|NCT02441075|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111099135|NCT02441075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111099136|NCT02441075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111099137|NCT02441075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111099138|NCT05562999|Bromides|bromides|mesh-list
111099139|NCT05562999|Rocuronium|rocuronium|mesh-list
111099141|NCT05562999|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
111099142|NCT05562999|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
111099143|NCT05562999|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111099144|NCT05562999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111099145|NCT05562999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111099146|NCT02438345|Leronlimab|leronlimab|mesh-list
111099147|NCT02438345|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
111099148|NCT02438345|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
111099149|NCT02438345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111099150|NCT02438345|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111099151|NCT02438345|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111099152|NCT02438345|Antiviral Agents|antiviral agents|mesh-ancestor
111099153|NCT02438345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111099154|NCT03191981|Cyclophosphamide|cyclophosphamide|mesh-list
111099155|NCT03191981|Pembrolizumab|pembrolizumab|mesh-list
111099156|NCT03191981|Lenalidomide|lenalidomide|mesh-list
111099157|NCT03191981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111099158|NCT03191981|Immunologic Factors|immunologic factors|mesh-ancestor
111099159|NCT03191981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111099160|NCT03191981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111099161|NCT03191981|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111099162|NCT03191981|Alkylating Agents|alkylating agents|mesh-ancestor
111099163|NCT03191981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111099164|NCT03191981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111099165|NCT03191981|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111099166|NCT03191981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111099167|NCT03191981|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111099168|NCT03191981|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111099169|NCT03191981|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111099170|NCT03191981|Growth Substances|growth substances|mesh-ancestor
111099171|NCT03191981|Growth Inhibitors|growth inhibitors|mesh-ancestor
111099172|NCT05535075|Vancomycin|vancomycin|mesh-list
111099173|NCT05535075|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111099174|NCT05535075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111099175|NCT05530785|Bevacizumab|bevacizumab|mesh-list
111099176|NCT05530785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111099177|NCT05530785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111099178|NCT05530785|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111099179|NCT05530785|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111099180|NCT05530785|Growth Substances|growth substances|mesh-ancestor
111099181|NCT05530785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111099182|NCT05530785|Growth Inhibitors|growth inhibitors|mesh-ancestor
111099183|NCT05530395|Testosterone|testosterone|mesh-list
111099184|NCT05530395|Androgens|androgens|mesh-ancestor
111099185|NCT05530395|Hormones|hormones|mesh-ancestor
111099186|NCT05530395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111099187|NCT05530395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111099188|NCT04529265|Methylene Blue|methylene blue|mesh-list
111099189|NCT04529265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111099190|NCT04529265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111099191|NCT03191903|Triamcinolone|triamcinolone|mesh-list
111099192|NCT03191903|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110642427|NCT00934830|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111099193|NCT03191903|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
111099194|NCT03191903|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
111099195|NCT03191903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111099196|NCT03191903|Glucocorticoids|glucocorticoids|mesh-ancestor
111099197|NCT03191903|Hormones|hormones|mesh-ancestor
111099198|NCT03191903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111099199|NCT03191903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111099200|NCT03191903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111099201|NCT03191903|Immunologic Factors|immunologic factors|mesh-ancestor
111099202|NCT03191903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111099203|NCT03191903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111099204|NCT05534685|Budesonide|budesonide|mesh-list
111099205|NCT05534685|Pulmonary Surfactants|pulmonary surfactants|mesh-list
111099206|NCT05534685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111099207|NCT05534685|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111099208|NCT05534685|Autonomic Agents|autonomic agents|mesh-ancestor
111099209|NCT05534685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111099210|NCT05534685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111099211|NCT05534685|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110687124|NCT01011062|Losartan|losartan|mesh-list
111099212|NCT05534685|Respiratory System Agents|respiratory system agents|mesh-ancestor
111099213|NCT05534685|Glucocorticoids|glucocorticoids|mesh-ancestor
111099215|NCT05534685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111099216|NCT02437955|Ferrous fumarate|ferrous fumarate|mesh-list
111099217|NCT02437955|Trace Elements|trace elements|mesh-ancestor
111099218|NCT02437955|Micronutrients|micronutrients|mesh-ancestor
111099219|NCT02437955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111099220|NCT05529927|Dextroamphetamine|dextroamphetamine|mesh-list
111099221|NCT05529927|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111099222|NCT05529927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111099223|NCT05529927|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111099224|NCT05529927|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111099225|NCT05529927|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111099226|NCT05529927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111099227|NCT05529927|Dopamine Agents|dopamine agents|mesh-ancestor
111099228|NCT05529927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111099229|NCT02437721|Folic Acid|folic acid|mesh-list
111099230|NCT02437721|Vitamin B Complex|vitamin b complex|mesh-list
111099231|NCT02437721|Hematinics|hematinics|mesh-ancestor
111099232|NCT02437721|Vitamins|vitamins|mesh-ancestor
111099233|NCT02437721|Micronutrients|micronutrients|mesh-ancestor
111099234|NCT02437721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111099235|NCT02437565|Salicylic Acid|salicylic acid|mesh-list
111099236|NCT02437565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111099237|NCT02437565|Antifungal Agents|antifungal agents|mesh-ancestor
111099238|NCT02437565|Keratolytic Agents|keratolytic agents|mesh-ancestor
111099239|NCT02437565|Dermatologic Agents|dermatologic agents|mesh-ancestor
111099240|NCT05533983|Nivolumab|nivolumab|mesh-list
111099241|NCT05533983|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111099242|NCT05533983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111099243|NCT05533983|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111099244|NCT05533983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111099245|NCT02436395|Povidone-Iodine|povidone-iodine|mesh-list
111099246|NCT02436395|Povidone|povidone|mesh-list
111099247|NCT02436395|Plasma Substitutes|plasma substitutes|mesh-ancestor
111099248|NCT02436395|Blood Substitutes|blood substitutes|mesh-ancestor
111099249|NCT02436395|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111099250|NCT02436395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111099251|NCT02436083|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111099252|NCT02436083|Cefuroxime|cefuroxime|mesh-list
111099253|NCT02436083|Cefuroxime axetil|cefuroxime axetil|mesh-list
111099254|NCT02436083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111099255|NCT03117335|Endostatins|endostatins|mesh-list
111099256|NCT03117335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111099257|NCT03117335|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111099258|NCT03117335|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111099259|NCT03117335|Growth Substances|growth substances|mesh-ancestor
111099260|NCT03117335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111099261|NCT03117335|Growth Inhibitors|growth inhibitors|mesh-ancestor
111099262|NCT02435927|Leucovorin|leucovorin|mesh-list
110642436|NCT00564018|Protamines|protamines|mesh-list
111099263|NCT02435927|Fluorouracil|fluorouracil|mesh-list
111099264|NCT02435927|Capecitabine|capecitabine|mesh-list
111099265|NCT02435927|Oxaliplatin|oxaliplatin|mesh-list
111099266|NCT02435927|Antimetabolites|antimetabolites|mesh-ancestor
111099267|NCT02435927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111099268|NCT02435927|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111099269|NCT02435927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111099270|NCT02435927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111099271|NCT02435927|Immunologic Factors|immunologic factors|mesh-ancestor
111099272|NCT02435927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111099273|NCT02435927|Antidotes|antidotes|mesh-ancestor
111099274|NCT02435927|Protective Agents|protective agents|mesh-ancestor
111099275|NCT02435927|Vitamin B Complex|vitamin b complex|mesh-ancestor
111099276|NCT02435927|Vitamins|vitamins|mesh-ancestor
111099277|NCT02435927|Micronutrients|micronutrients|mesh-ancestor
111099278|NCT02435771|Ergocalciferols|ergocalciferols|mesh-list
111099279|NCT02435771|Vitamin D|vitamin d|mesh-list
111099280|NCT02435771|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111099281|NCT02435771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111099282|NCT02435771|Vitamins|vitamins|mesh-ancestor
111099283|NCT02435771|Micronutrients|micronutrients|mesh-ancestor
111099284|NCT02435771|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111099285|NCT02440841|Itraconazole|itraconazole|mesh-list
111099286|NCT02440841|Rifampin|rifampin|mesh-list
111099287|NCT02440841|Antifungal Agents|antifungal agents|mesh-ancestor
111099288|NCT02440841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111099289|NCT02440841|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111099290|NCT02440841|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111099291|NCT02440841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111099292|NCT02440841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111099293|NCT02440841|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111099294|NCT02440841|Hormone Antagonists|hormone antagonists|mesh-ancestor
111099295|NCT02440841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111099296|NCT02440841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111099297|NCT02440841|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111099298|NCT02440841|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111099299|NCT02440841|Antitubercular Agents|antitubercular agents|mesh-ancestor
111099300|NCT02440841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111099301|NCT02440841|Leprostatic Agents|leprostatic agents|mesh-ancestor
111099302|NCT02440841|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111099303|NCT02440841|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111099304|NCT02440841|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111099305|NCT02440841|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
111099306|NCT02440841|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
111099307|NCT02440841|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
111099308|NCT02440841|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111099309|NCT02576145|Daclizumab|daclizumab|mesh-list
111099310|NCT02576145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111099311|NCT02576145|Immunologic Factors|immunologic factors|mesh-ancestor
111099312|NCT02576145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111099313|NCT02435537|Dexmedetomidine|dexmedetomidine|mesh-list
111099314|NCT02435537|Morphine|morphine|mesh-list
111099315|NCT02435537|Bupivacaine|bupivacaine|mesh-list
111099316|NCT02435537|Anesthetics, Local|anesthetics, local|mesh-ancestor
111099317|NCT02435537|Anesthetics|anesthetics|mesh-ancestor
111099318|NCT02435537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111099319|NCT02435537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111099320|NCT02435537|Sensory System Agents|sensory system agents|mesh-ancestor
111099321|NCT02435537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111099322|NCT02435537|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111099323|NCT02435537|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111099324|NCT02435537|Analgesics|analgesics|mesh-ancestor
111099325|NCT02435537|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111099326|NCT02435537|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111099327|NCT02435537|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111099328|NCT02435537|Adrenergic Agents|adrenergic agents|mesh-ancestor
111099329|NCT02435537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111099330|NCT02435537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111099331|NCT02435537|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111099332|NCT02435537|Narcotics|narcotics|mesh-ancestor
111099333|NCT02576067|Methotrexate|methotrexate|mesh-list
111099334|NCT02576067|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111099335|NCT02576067|Abortifacient Agents|abortifacient agents|mesh-ancestor
111099336|NCT02576067|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111099337|NCT02576067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111099338|NCT02576067|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111099339|NCT02576067|Antimetabolites|antimetabolites|mesh-ancestor
111099340|NCT02576067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111099341|NCT02576067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111099342|NCT02576067|Dermatologic Agents|dermatologic agents|mesh-ancestor
111099343|NCT02576067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111099344|NCT02576067|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111099345|NCT02576067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111099346|NCT02576067|Immunologic Factors|immunologic factors|mesh-ancestor
111099347|NCT02576067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111099348|NCT02576067|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111099349|NCT02435459|Calcium|calcium|mesh-list
111099350|NCT02435459|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111099351|NCT02435459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111099352|NCT05199909|Zanubrutinib|zanubrutinib|mesh-list
111099353|NCT05199909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111099354|NCT05199909|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111099355|NCT05199909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111099356|NCT05199909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111099357|NCT02435303|Sildenafil Citrate|sildenafil citrate|mesh-list
111099358|NCT02435303|Vasodilator Agents|vasodilator agents|mesh-ancestor
111099359|NCT02435303|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111099360|NCT02435303|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111099361|NCT02435303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111099362|NCT02435303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111099363|NCT02435303|Urological Agents|urological agents|mesh-ancestor
111099364|NCT02434757|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
111099365|NCT02434757|Hormones|hormones|mesh-ancestor
111099366|NCT02434757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111099367|NCT02434757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111099368|NCT03189329|Lidocaine|lidocaine|mesh-list
111099369|NCT03189329|Levobupivacaine|levobupivacaine|mesh-list
111099370|NCT03189329|Anesthetics, Local|anesthetics, local|mesh-ancestor
111099371|NCT03189329|Anesthetics|anesthetics|mesh-ancestor
111099372|NCT03189329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111099373|NCT03189329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111099374|NCT03189329|Sensory System Agents|sensory system agents|mesh-ancestor
111099375|NCT03189329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111099376|NCT03189329|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111099377|NCT03189329|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111099378|NCT03189329|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111099379|NCT03189329|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111099380|NCT03189329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111099381|NCT02575833|Erenumab|erenumab|mesh-list
111099382|NCT02575833|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
111099383|NCT02575833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111099384|NCT02575833|Analgesics|analgesics|mesh-ancestor
111099385|NCT02575833|Sensory System Agents|sensory system agents|mesh-ancestor
111099386|NCT02575833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111099387|NCT02575833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111099388|NCT02709083|Imatinib Mesylate|imatinib mesylate|mesh-list
111099389|NCT02709083|Dasatinib|dasatinib|mesh-list
111099390|NCT02709083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111099391|NCT02709083|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111099392|NCT02709083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111099393|NCT02709083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111099394|NCT02709005|Monolaurin|monolaurin|mesh-list
111099395|NCT02709005|Cariostatic Agents|cariostatic agents|mesh-ancestor
111099396|NCT02709005|Protective Agents|protective agents|mesh-ancestor
111099397|NCT02709005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111099398|NCT05353335|Antihypertensive Agents|antihypertensive agents|mesh-list
111099399|NCT03188471|Aspirin|aspirin|mesh-list
111099400|NCT03188471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111099401|NCT03188471|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111099402|NCT03188471|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111099403|NCT03188471|Analgesics|analgesics|mesh-ancestor
111099404|NCT03188471|Sensory System Agents|sensory system agents|mesh-ancestor
111099405|NCT03188471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111099406|NCT03188471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111099407|NCT03188471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111099408|NCT03188471|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111099409|NCT03188471|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111099410|NCT03188471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111099411|NCT03188471|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111099412|NCT03188471|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111099413|NCT03188471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111099414|NCT03188471|Antipyretics|antipyretics|mesh-ancestor
111099415|NCT04650087|Apixaban|apixaban|mesh-list
111099416|NCT04650087|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111099417|NCT04650087|Antithrombins|antithrombins|mesh-ancestor
111099418|NCT04650087|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111099419|NCT04650087|Protease Inhibitors|protease inhibitors|mesh-ancestor
111099420|NCT04650087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111099421|NCT04650087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111099422|NCT04650087|Anticoagulants|anticoagulants|mesh-ancestor
111099423|NCT03188159|Vinorelbine|vinorelbine|mesh-list
111099424|NCT03188159|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111099425|NCT03188159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111099426|NCT03188159|Tubulin Modulators|tubulin modulators|mesh-ancestor
111099427|NCT03188159|Antimitotic Agents|antimitotic agents|mesh-ancestor
111099428|NCT03188159|Mitosis Modulators|mitosis modulators|mesh-ancestor
111099429|NCT03188159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111099430|NCT05532501|Oxytocin|oxytocin|mesh-list
111099432|NCT05532501|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111099433|NCT05532501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111099434|NCT05524857|Decitabine|decitabine|mesh-list
111099435|NCT05524857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111099436|NCT05524857|Antimetabolites|antimetabolites|mesh-ancestor
111099437|NCT05524857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111099438|NCT05524857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111099439|NCT05524857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111099440|NCT05327439|Nicotine|nicotine|mesh-list
111099441|NCT05327439|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111099442|NCT05327439|Autonomic Agents|autonomic agents|mesh-ancestor
111099443|NCT05327439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111099444|NCT05327439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111099445|NCT05327439|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111099446|NCT05327439|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111099447|NCT05327439|Cholinergic Agents|cholinergic agents|mesh-ancestor
111099448|NCT05327439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111099449|NCT05327439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111099450|NCT03187691|Amphotericin B|amphotericin b|mesh-list
111099451|NCT03187691|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
111099452|NCT03187691|Amebicides|amebicides|mesh-ancestor
111099453|NCT03187691|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111099454|NCT03187691|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111099455|NCT03187691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111099456|NCT03187691|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111099457|NCT03187691|Antifungal Agents|antifungal agents|mesh-ancestor
111099458|NCT02433899|Chlorhexidine|chlorhexidine|mesh-list
111099459|NCT02433899|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
111099460|NCT02433899|Dexamethasone|dexamethasone|mesh-list
111099461|NCT02433899|Epinephrine|epinephrine|mesh-list
111099462|NCT02433899|Mepivacaine|mepivacaine|mesh-list
111099463|NCT02433899|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111099464|NCT02433899|Antiemetics|antiemetics|mesh-ancestor
111099465|NCT02433899|Autonomic Agents|autonomic agents|mesh-ancestor
111099466|NCT02433899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111099467|NCT02433899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111099468|NCT02433899|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111099469|NCT02433899|Glucocorticoids|glucocorticoids|mesh-ancestor
111099470|NCT02433899|Hormones|hormones|mesh-ancestor
111099471|NCT02433899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111099472|NCT02433899|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111099473|NCT02433899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111099474|NCT02433899|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111099475|NCT02433899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111099476|NCT02433899|Disinfectants|disinfectants|mesh-ancestor
111099477|NCT02433899|Dermatologic Agents|dermatologic agents|mesh-ancestor
111099478|NCT02433899|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111099479|NCT02433899|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111099480|NCT02433899|Adrenergic Agents|adrenergic agents|mesh-ancestor
111099481|NCT02433899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111099482|NCT02433899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111099483|NCT02433899|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111099484|NCT02433899|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111099485|NCT02433899|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111099486|NCT02433899|Respiratory System Agents|respiratory system agents|mesh-ancestor
111099487|NCT02433899|Mydriatics|mydriatics|mesh-ancestor
111099488|NCT02433899|Sympathomimetics|sympathomimetics|mesh-ancestor
111099489|NCT02433899|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111099490|NCT02433899|Anesthetics, Local|anesthetics, local|mesh-ancestor
111099491|NCT02433899|Anesthetics|anesthetics|mesh-ancestor
111099492|NCT02433899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111099493|NCT02433899|Sensory System Agents|sensory system agents|mesh-ancestor
111099494|NCT05532267|Ciprofloxacin|ciprofloxacin|mesh-list
111099495|NCT05532267|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111099496|NCT05532267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111099497|NCT05532267|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111099498|NCT05532267|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111099499|NCT05532267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111099500|NCT05532267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111099501|NCT05532267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111099502|NCT05532267|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111099503|NCT05532267|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111099504|NCT03187457|Metronidazole|metronidazole|mesh-list
111099505|NCT03187457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110816605|NCT01213849|Xhance|xhance|mesh-list
111099506|NCT03187457|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111099507|NCT03187457|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111099508|NCT03187457|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111099509|NCT03187223|Melphalan|melphalan|mesh-list
111099510|NCT03187223|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
111099511|NCT03187223|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111099512|NCT03187223|Alkylating Agents|alkylating agents|mesh-ancestor
111099513|NCT03187223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111099514|NCT03187223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111099515|NCT03187223|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111099516|NCT03187223|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111099517|NCT03187223|Immunologic Factors|immunologic factors|mesh-ancestor
111099518|NCT03187223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111099519|NCT05532111|Cyclophosphamide|cyclophosphamide|mesh-list
111099520|NCT05532111|Rituximab|rituximab|mesh-list
111099521|NCT05532111|Tacrolimus|tacrolimus|mesh-list
111099522|NCT05532111|Glucocorticoids|glucocorticoids|mesh-list
111099523|NCT05532111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111099524|NCT05532111|Immunologic Factors|immunologic factors|mesh-ancestor
111099525|NCT05532111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111099526|NCT05532111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111099527|NCT05532111|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111099528|NCT05532111|Alkylating Agents|alkylating agents|mesh-ancestor
111099529|NCT05532111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111099530|NCT05532111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111099531|NCT05532111|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111099532|NCT05532111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111099533|NCT05532111|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111099534|NCT05532111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111099535|NCT05532111|Hormones|hormones|mesh-ancestor
111099536|NCT05532111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111099537|NCT05524077|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
111099538|NCT04299867|Metronidazole|metronidazole|mesh-list
111099539|NCT04299867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110642457|NCT00935610|Chelating Agents|chelating agents|mesh-ancestor
111099540|NCT04299867|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111099541|NCT04299867|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111099542|NCT04299867|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111099543|NCT02433587|Aspirin|aspirin|mesh-list
111099544|NCT02433587|Clopidogrel|clopidogrel|mesh-list
111099545|NCT02433587|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111099546|NCT02433587|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111099547|NCT02433587|Analgesics|analgesics|mesh-ancestor
111099548|NCT02433587|Sensory System Agents|sensory system agents|mesh-ancestor
111099549|NCT02433587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111099550|NCT02433587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111099551|NCT02433587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111099552|NCT02433587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111099553|NCT02433587|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111099554|NCT02433587|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111099555|NCT02433587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111099556|NCT02433587|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111099557|NCT02433587|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111099558|NCT02433587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111099559|NCT02433587|Antipyretics|antipyretics|mesh-ancestor
111099560|NCT02433587|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111099561|NCT02433587|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111099562|NCT02433587|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111099563|NCT02433587|Purinergic Agents|purinergic agents|mesh-ancestor
111099564|NCT02433587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111099565|NCT02433353|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
111099566|NCT02433353|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111099567|NCT02433353|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111099568|NCT02433353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111099569|NCT02433353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111099570|NCT02433353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111099571|NCT02433353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111099572|NCT02433353|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111099573|NCT02433353|Antidepressive Agents|antidepressive agents|mesh-ancestor
111099574|NCT02433353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111099575|NCT03190733|Fludarabine|fludarabine|mesh-list
111099576|NCT03190733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111099577|NCT04425135|Carboplatin|carboplatin|mesh-list
111099578|NCT04425135|Apatinib|apatinib|mesh-list
110816688|NCT01216267|Lansoprazole|lansoprazole|mesh-list
111099579|NCT04425135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111099580|NCT04425135|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111099581|NCT04425135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111099582|NCT04425135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111099584|NCT02573883|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111099585|NCT02573883|Glucocorticoids|glucocorticoids|mesh-ancestor
111099586|NCT02573883|Hormones|hormones|mesh-ancestor
111099587|NCT02573883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111099588|NCT02573883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111099589|NCT02432885|Enalapril|enalapril|mesh-list
111099590|NCT02432885|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
111099591|NCT02432885|Protease Inhibitors|protease inhibitors|mesh-ancestor
111099592|NCT02432885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111099593|NCT02432885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111099594|NCT02432885|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111099595|NCT02433041|Ketamine|ketamine|mesh-list
111099596|NCT02433041|Haloperidol|haloperidol|mesh-list
111099597|NCT02433041|Haloperidol decanoate|haloperidol decanoate|mesh-list
111099598|NCT02433041|Analgesics|analgesics|mesh-ancestor
111099599|NCT02433041|Sensory System Agents|sensory system agents|mesh-ancestor
111099600|NCT02433041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111099601|NCT02433041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111099602|NCT02433041|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111099603|NCT02433041|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111099604|NCT02433041|Anesthetics, General|anesthetics, general|mesh-ancestor
111099605|NCT02433041|Anesthetics|anesthetics|mesh-ancestor
111099606|NCT02433041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111099607|NCT02433041|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111099608|NCT02433041|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111099609|NCT02433041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111099610|NCT02433041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111099611|NCT02433041|Antiemetics|antiemetics|mesh-ancestor
111099612|NCT02433041|Autonomic Agents|autonomic agents|mesh-ancestor
111099613|NCT02433041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111099614|NCT02433041|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111099615|NCT02433041|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111099616|NCT02433041|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111099617|NCT02433041|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111099618|NCT02433041|Dopamine Agents|dopamine agents|mesh-ancestor
111099619|NCT02433041|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111099620|NCT02429921|Selenium|selenium|mesh-list
111099621|NCT02429921|Antioxidants|antioxidants|mesh-ancestor
111099622|NCT02429921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111099623|NCT02429921|Protective Agents|protective agents|mesh-ancestor
111099624|NCT02429921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111099625|NCT02429921|Trace Elements|trace elements|mesh-ancestor
111099626|NCT02429921|Micronutrients|micronutrients|mesh-ancestor
111099627|NCT02575365|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
111099628|NCT02575365|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
111099629|NCT02575365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111099630|NCT02575365|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111099631|NCT02575365|Immunologic Factors|immunologic factors|mesh-ancestor
111099632|NCT02575365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111099633|NCT02432807|Vancomycin|vancomycin|mesh-list
111099634|NCT02432807|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111099635|NCT02432807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111099636|NCT05527275|Mitoxantrone|mitoxantrone|mesh-list
111099637|NCT05527275|Analgesics|analgesics|mesh-ancestor
111099638|NCT05527275|Sensory System Agents|sensory system agents|mesh-ancestor
111099639|NCT05527275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111099640|NCT05527275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111099641|NCT05527275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111099642|NCT05527275|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111099643|NCT05527275|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111099644|NCT05527275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111099645|NCT05527275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111099646|NCT02429765|Formoterol Fumarate|formoterol fumarate|mesh-list
111099647|NCT02429765|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111099648|NCT02429765|Autonomic Agents|autonomic agents|mesh-ancestor
111099649|NCT02429765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111099650|NCT02429765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111099651|NCT02429765|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111099652|NCT02429765|Respiratory System Agents|respiratory system agents|mesh-ancestor
110816752|NCT01120015|Diacerein|diacerein|mesh-list
111099653|NCT02429765|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111099654|NCT02429765|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111099656|NCT02429765|Adrenergic Agents|adrenergic agents|mesh-ancestor
111099657|NCT02429765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111099658|NCT02429765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111099659|NCT03186053|Phosphocreatine|phosphocreatine|mesh-list
111099660|NCT03186053|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111099661|NCT03186053|Protective Agents|protective agents|mesh-ancestor
111099662|NCT03186053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111099663|NCT02429219|Ethanol|ethanol|mesh-list
111099664|NCT02429219|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111099665|NCT02429219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111099666|NCT02429219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111099667|NCT02429219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111099668|NCT02429531|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
111099669|NCT02429531|Immunologic Factors|immunologic factors|mesh-ancestor
111099670|NCT02429531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111099671|NCT02429453|Thrombin|thrombin|mesh-list
111099672|NCT02429453|Hemostatics|hemostatics|mesh-ancestor
111099673|NCT02429453|Coagulants|coagulants|mesh-ancestor
111099674|NCT02428751|Prednisone|prednisone|mesh-list
111099675|NCT02428751|Rituximab|rituximab|mesh-list
111099676|NCT02428751|Doxorubicin|doxorubicin|mesh-list
111099677|NCT02428751|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111099678|NCT02428751|Vincristine|vincristine|mesh-list
111099679|NCT02428751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111099680|NCT02428751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111099681|NCT02428751|Immunologic Factors|immunologic factors|mesh-ancestor
111099682|NCT02428751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111099683|NCT02428751|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111099684|NCT02428751|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111099685|NCT02428751|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111099686|NCT02428751|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111099687|NCT02428751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111099688|NCT02428751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111099689|NCT02428751|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111099690|NCT02428751|Glucocorticoids|glucocorticoids|mesh-ancestor
111099691|NCT02428751|Hormones|hormones|mesh-ancestor
111099692|NCT02428751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111099693|NCT02428751|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111099694|NCT02428751|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111099695|NCT02428751|Tubulin Modulators|tubulin modulators|mesh-ancestor
111099696|NCT02428751|Antimitotic Agents|antimitotic agents|mesh-ancestor
111099697|NCT02428751|Mitosis Modulators|mitosis modulators|mesh-ancestor
111099698|NCT05526807|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
111099699|NCT05526807|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
111099700|NCT05526807|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111099701|NCT03185195|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111099702|NCT03186365|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
111099703|NCT03186365|Antiviral Agents|antiviral agents|mesh-ancestor
111099704|NCT03186365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111099705|NCT02432651|Xanthohumol|xanthohumol|mesh-list
111099706|NCT02432651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111099707|NCT02432651|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111099708|NCT02432651|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111099709|NCT02432651|Growth Substances|growth substances|mesh-ancestor
111099710|NCT02432651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111099711|NCT02432651|Growth Inhibitors|growth inhibitors|mesh-ancestor
111099712|NCT02707757|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
111099713|NCT02707757|Hematinics|hematinics|mesh-ancestor
111099714|NCT02432339|Mycophenolic Acid|mycophenolic acid|mesh-list
111099715|NCT02432339|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111099716|NCT02432339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111099717|NCT02432339|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111099718|NCT02432339|Antitubercular Agents|antitubercular agents|mesh-ancestor
111099719|NCT02432339|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111099720|NCT02432339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111099721|NCT02432339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111099722|NCT02432339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111099723|NCT03184805|Aspirin|aspirin|mesh-list
111099724|NCT03184805|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111099725|NCT03184805|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111099726|NCT03184805|Analgesics|analgesics|mesh-ancestor
110816861|NCT01116193|Hormones|hormones|mesh-ancestor
111099727|NCT03184805|Sensory System Agents|sensory system agents|mesh-ancestor
111099728|NCT03184805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111099729|NCT03184805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111099730|NCT03184805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111099731|NCT03184805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111099732|NCT03184805|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111099733|NCT03184805|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111099734|NCT03184805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111099735|NCT03184805|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111099736|NCT03184805|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111099737|NCT03184805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111099738|NCT03184805|Antipyretics|antipyretics|mesh-ancestor
111099739|NCT05518383|Cytarabine|cytarabine|mesh-list
111099740|NCT05518383|Dexamethasone|dexamethasone|mesh-list
111099741|NCT05518383|Dexamethasone acetate|dexamethasone acetate|mesh-list
111099742|NCT05518383|Cyclophosphamide|cyclophosphamide|mesh-list
111099743|NCT05518383|Melphalan|melphalan|mesh-list
111099744|NCT05518383|Ifosfamide|ifosfamide|mesh-list
111099745|NCT05518383|Isophosphamide mustard|isophosphamide mustard|mesh-list
111099746|NCT05518383|Doxorubicin|doxorubicin|mesh-list
111099747|NCT05518383|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111099748|NCT05518383|Methotrexate|methotrexate|mesh-list
111099749|NCT05518383|Etoposide|etoposide|mesh-list
111099750|NCT05518383|Etoposide phosphate|etoposide phosphate|mesh-list
111099751|NCT05518383|Vincristine|vincristine|mesh-list
111099752|NCT05518383|Idarubicin|idarubicin|mesh-list
111099753|NCT05518383|Carboplatin|carboplatin|mesh-list
111099754|NCT05518383|BB 1101|bb 1101|mesh-list
111099755|NCT05518383|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111099756|NCT05518383|Immunologic Factors|immunologic factors|mesh-ancestor
111099757|NCT05518383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111099758|NCT05518383|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111099759|NCT05518383|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111099760|NCT05518383|Alkylating Agents|alkylating agents|mesh-ancestor
111099761|NCT05518383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111099762|NCT05518383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111099763|NCT05518383|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111099764|NCT05518383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111099765|NCT05518383|Antiemetics|antiemetics|mesh-ancestor
111099766|NCT05518383|Autonomic Agents|autonomic agents|mesh-ancestor
111099767|NCT05518383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111099768|NCT05518383|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111099769|NCT05518383|Glucocorticoids|glucocorticoids|mesh-ancestor
111099770|NCT05518383|Hormones|hormones|mesh-ancestor
111099771|NCT05518383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111099772|NCT05518383|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111099773|NCT05518383|Protease Inhibitors|protease inhibitors|mesh-ancestor
111099774|NCT05518383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111099775|NCT05518383|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111099776|NCT05518383|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111099777|NCT05518383|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111099778|NCT05518383|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111099779|NCT05518383|Abortifacient Agents|abortifacient agents|mesh-ancestor
111099780|NCT05518383|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111099781|NCT05518383|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111099782|NCT05518383|Antimetabolites|antimetabolites|mesh-ancestor
111099783|NCT05518383|Dermatologic Agents|dermatologic agents|mesh-ancestor
111099784|NCT05518383|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111099785|NCT05518383|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111099786|NCT05518383|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111099787|NCT05518383|Antiviral Agents|antiviral agents|mesh-ancestor
111099788|NCT05518383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111099789|NCT05518383|Tubulin Modulators|tubulin modulators|mesh-ancestor
111099790|NCT05518383|Antimitotic Agents|antimitotic agents|mesh-ancestor
111099791|NCT05518383|Mitosis Modulators|mitosis modulators|mesh-ancestor
111099792|NCT02432027|Betamethasone|betamethasone|mesh-list
111099793|NCT02432027|Calcipotriene|calcipotriene|mesh-list
111099794|NCT02432027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111099795|NCT02432027|Glucocorticoids|glucocorticoids|mesh-ancestor
111099796|NCT02432027|Hormones|hormones|mesh-ancestor
111099797|NCT02432027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111099798|NCT02432027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111099799|NCT02432027|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111099800|NCT02432027|Respiratory System Agents|respiratory system agents|mesh-ancestor
111099802|NCT02428439|Lamotrigine|lamotrigine|mesh-list
111099803|NCT02428439|Bupropion|bupropion|mesh-list
111099804|NCT02428439|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111099805|NCT02428439|Antidepressive Agents|antidepressive agents|mesh-ancestor
111099806|NCT02428439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111099807|NCT02428439|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111099808|NCT02428439|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111099809|NCT02428439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111099810|NCT02428439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111099811|NCT02428439|Dopamine Agents|dopamine agents|mesh-ancestor
111099812|NCT02428439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111099813|NCT02428439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110642483|NCT00563784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111099814|NCT02428439|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111099815|NCT02428439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111099816|NCT02428439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111099817|NCT02428439|Anticonvulsants|anticonvulsants|mesh-ancestor
111099818|NCT02428439|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111099819|NCT02428439|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111099820|NCT02428439|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111099821|NCT02428439|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111099822|NCT02428439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111099823|NCT02428439|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111099824|NCT03186443|Pregabalin|pregabalin|mesh-list
111099825|NCT03186443|Gabapentin|gabapentin|mesh-list
111099826|NCT03186443|Analgesics|analgesics|mesh-ancestor
111099827|NCT03186443|Sensory System Agents|sensory system agents|mesh-ancestor
111099828|NCT03186443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111099829|NCT03186443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111099830|NCT03186443|Anticonvulsants|anticonvulsants|mesh-ancestor
111099831|NCT03186443|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111099832|NCT03186443|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111099833|NCT03186443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111099834|NCT03186443|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111099835|NCT03186443|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111099836|NCT03186443|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111099837|NCT03186443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111099838|NCT03186443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111099839|NCT03186443|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111099840|NCT03186443|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111099841|NCT03186443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111099842|NCT03186443|Antimanic Agents|antimanic agents|mesh-ancestor
111099843|NCT03186131|Vitamin D|vitamin d|mesh-list
111099844|NCT03186131|Ibandronic Acid|ibandronic acid|mesh-list
111099845|NCT03186131|Vitamins|vitamins|mesh-ancestor
111099846|NCT03186131|Micronutrients|micronutrients|mesh-ancestor
111099847|NCT03186131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111099848|NCT03186131|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111099849|NCT03184649|Acetaminophen|acetaminophen|mesh-list
111099850|NCT03184649|Ibuprofen|ibuprofen|mesh-list
111099851|NCT03184649|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111099852|NCT03184649|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111099853|NCT03184649|Analgesics|analgesics|mesh-ancestor
111099854|NCT03184649|Sensory System Agents|sensory system agents|mesh-ancestor
111099855|NCT03184649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111099856|NCT03184649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111099857|NCT03184649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111099858|NCT03184649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111099859|NCT03184649|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111099860|NCT03184649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111099861|NCT03184649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111099862|NCT03184649|Antipyretics|antipyretics|mesh-ancestor
111099863|NCT02432261|Methyltestosterone|methyltestosterone|mesh-list
111099864|NCT02432261|ST 1435|st 1435|mesh-list
111099865|NCT02432261|Testosterone|testosterone|mesh-list
111099866|NCT02432261|Testosterone undecanoate|testosterone undecanoate|mesh-list
111099867|NCT02432261|Testosterone enanthate|testosterone enanthate|mesh-list
111099868|NCT02432261|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
111099869|NCT02432261|Androgens|androgens|mesh-ancestor
111099870|NCT02432261|Hormones|hormones|mesh-ancestor
111099871|NCT02432261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111099872|NCT02432261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111099873|NCT02432261|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110405670|NCT01030666|Disinfectants|disinfectants|mesh-ancestor
111099874|NCT02432261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111099875|NCT02432261|Anabolic Agents|anabolic agents|mesh-ancestor
111099876|NCT02432261|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111099877|NCT02432261|Contraceptive Agents|contraceptive agents|mesh-ancestor
111099878|NCT02432261|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111099879|NCT02432261|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111099880|NCT02428283|Remifentanil|remifentanil|mesh-list
111099881|NCT02428283|Ropivacaine|ropivacaine|mesh-list
111099882|NCT02428283|Sevoflurane|sevoflurane|mesh-list
111099883|NCT02428283|Anesthetics, Local|anesthetics, local|mesh-ancestor
111099884|NCT02428283|Anesthetics|anesthetics|mesh-ancestor
111099885|NCT02428283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111099886|NCT02428283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111099887|NCT02428283|Sensory System Agents|sensory system agents|mesh-ancestor
111099888|NCT02428283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111099889|NCT02428283|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111099890|NCT02428283|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111099891|NCT02428283|Anesthetics, General|anesthetics, general|mesh-ancestor
111099892|NCT02428283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111099893|NCT02428283|Narcotics|narcotics|mesh-ancestor
111099894|NCT02428283|Analgesics|analgesics|mesh-ancestor
111099895|NCT02427893|Vemurafenib|vemurafenib|mesh-list
111099896|NCT02427893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111099897|NCT02427893|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111099898|NCT02427893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111099899|NCT02427893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111099900|NCT03184493|Metformin|metformin|mesh-list
111099901|NCT03184493|Celecoxib|celecoxib|mesh-list
111099902|NCT03184493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111099903|NCT03184493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111099904|NCT03184493|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111099905|NCT03184493|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111099906|NCT03184493|Analgesics|analgesics|mesh-ancestor
111099907|NCT03184493|Sensory System Agents|sensory system agents|mesh-ancestor
111099908|NCT03184493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111099909|NCT03184493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111099910|NCT03184493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111099911|NCT03184493|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111099912|NCT03184493|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111099913|NCT03184493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111099914|NCT03184493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111099915|NCT02431403|Imatinib Mesylate|imatinib mesylate|mesh-list
111099916|NCT02431403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111099917|NCT02431403|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111099918|NCT02431403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111099919|NCT02431403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111099920|NCT02431325|Teduglutide|teduglutide|mesh-list
111099921|NCT02431325|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111099922|NCT02431325|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111099923|NCT02431325|Protective Agents|protective agents|mesh-ancestor
111099924|NCT02431325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111099925|NCT03184103|Complement System Proteins|complement system proteins|mesh-list
111099926|NCT03184103|Antistreptolysin|antistreptolysin|mesh-list
111099927|NCT03184103|Immunologic Factors|immunologic factors|mesh-ancestor
111099928|NCT03184103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111099929|NCT02103478|Decitabine|decitabine|mesh-list
111099930|NCT02103478|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
111099931|NCT02103478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111099932|NCT02103478|Antimetabolites|antimetabolites|mesh-ancestor
111099933|NCT02103478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111099934|NCT02103478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111099935|NCT02103478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111099936|NCT02431013|Cilostazol|cilostazol|mesh-list
111099937|NCT02431013|Simvastatin|simvastatin|mesh-list
111099938|NCT02431013|Pravastatin|pravastatin|mesh-list
111099939|NCT02431013|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111099940|NCT02431013|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111099941|NCT02431013|Antimetabolites|antimetabolites|mesh-ancestor
111099942|NCT02431013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111099943|NCT02431013|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111099944|NCT02431013|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111099945|NCT02431013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111099946|NCT02431013|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111099947|NCT02431013|Autonomic Agents|autonomic agents|mesh-ancestor
111099948|NCT02431013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111099949|NCT02431013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111099950|NCT02431013|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111099951|NCT02431013|Respiratory System Agents|respiratory system agents|mesh-ancestor
111099952|NCT02431013|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110642490|NCT00203047|Prednisone|prednisone|mesh-list
111099953|NCT02431013|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111099954|NCT02431013|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111099955|NCT02431013|Vasodilator Agents|vasodilator agents|mesh-ancestor
111099956|NCT02431013|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111099957|NCT02431013|Protective Agents|protective agents|mesh-ancestor
111099958|NCT02431013|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
111099959|NCT02431013|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111099960|NCT03185429|Cyclophosphamide|cyclophosphamide|mesh-list
111099961|NCT03185429|Immunologic Factors|immunologic factors|mesh-ancestor
111099962|NCT03185429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111099963|NCT03185429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111099964|NCT03185429|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111099965|NCT03185429|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111099966|NCT03185429|Alkylating Agents|alkylating agents|mesh-ancestor
111099967|NCT03185429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111099968|NCT03185429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111099969|NCT03185429|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111099970|NCT02430545|Rifampin|rifampin|mesh-list
111099971|NCT02430545|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111099972|NCT02430545|Antitubercular Agents|antitubercular agents|mesh-ancestor
111099973|NCT02430545|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111099974|NCT02430545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111099975|NCT02430545|Leprostatic Agents|leprostatic agents|mesh-ancestor
111099976|NCT02430545|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111099977|NCT02430545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111099978|NCT02430545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111099979|NCT02430545|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111099980|NCT02430545|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111099981|NCT02430545|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
111099982|NCT02430545|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
111099983|NCT02430545|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
111099984|NCT02430545|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111099985|NCT03117725|Melatonin|melatonin|mesh-list
111099986|NCT03117725|Antioxidants|antioxidants|mesh-ancestor
111099987|NCT03117725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111099988|NCT03117725|Protective Agents|protective agents|mesh-ancestor
111099989|NCT03117725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111099990|NCT03117725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111099991|NCT03185351|Midazolam|midazolam|mesh-list
111099992|NCT03185351|Bupivacaine|bupivacaine|mesh-list
111099993|NCT03185351|Anesthetics, Local|anesthetics, local|mesh-ancestor
111099994|NCT03185351|Anesthetics|anesthetics|mesh-ancestor
111099995|NCT03185351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111099996|NCT03185351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111099997|NCT03185351|Sensory System Agents|sensory system agents|mesh-ancestor
111099998|NCT03185351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111099999|NCT03185351|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111100000|NCT03185351|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111100001|NCT03185351|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111100002|NCT03185351|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111100003|NCT03185351|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111100004|NCT03185351|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111100005|NCT03185351|Anesthetics, General|anesthetics, general|mesh-ancestor
111100006|NCT03185351|GABA Modulators|gaba modulators|mesh-ancestor
111100007|NCT03185351|GABA Agents|gaba agents|mesh-ancestor
111100008|NCT03185351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111100009|NCT03185351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111100010|NCT02707601|Sofosbuvir|sofosbuvir|mesh-list
111100011|NCT02707601|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
111100012|NCT02707601|Ledipasvir|ledipasvir|mesh-list
111100013|NCT02707601|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
111100014|NCT02707601|Antiviral Agents|antiviral agents|mesh-ancestor
111100015|NCT02707601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111100016|NCT02707601|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111100017|NCT02707601|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111100018|NCT03183557|Vitamin D|vitamin d|mesh-list
111100020|NCT03183557|Alfacalcidol|alfacalcidol|mesh-list
111100021|NCT03183557|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
111100022|NCT03183557|Vitamins|vitamins|mesh-ancestor
111100023|NCT03183557|Micronutrients|micronutrients|mesh-ancestor
111100024|NCT03183557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110817161|NCT04001894|Ticagrelor|ticagrelor|mesh-list
111100025|NCT03183557|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111100026|NCT02426723|Dexamethasone|dexamethasone|mesh-list
111100027|NCT02426723|Lenalidomide|lenalidomide|mesh-list
111100028|NCT02426723|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111100029|NCT02426723|Antiemetics|antiemetics|mesh-ancestor
111100030|NCT02426723|Autonomic Agents|autonomic agents|mesh-ancestor
111100031|NCT02426723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111100032|NCT02426723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111100033|NCT02426723|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111100034|NCT02426723|Glucocorticoids|glucocorticoids|mesh-ancestor
111100035|NCT02426723|Hormones|hormones|mesh-ancestor
111100036|NCT02426723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111100037|NCT02426723|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111100038|NCT02426723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111100039|NCT02426723|Immunologic Factors|immunologic factors|mesh-ancestor
111100040|NCT02426723|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111100041|NCT02426723|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111100042|NCT02426723|Growth Substances|growth substances|mesh-ancestor
111100043|NCT02426723|Growth Inhibitors|growth inhibitors|mesh-ancestor
111100044|NCT02425241|Vaccines|vaccines|mesh-list
111100045|NCT02425241|Immunologic Factors|immunologic factors|mesh-ancestor
111100046|NCT02425241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111100047|NCT03182855|Ticagrelor|ticagrelor|mesh-list
111100048|NCT03182855|Cangrelor|cangrelor|mesh-list
111100049|NCT03182855|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111100050|NCT03182855|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111100051|NCT03182855|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111100052|NCT03182855|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111100053|NCT03182855|Purinergic Agents|purinergic agents|mesh-ancestor
111100054|NCT03182855|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111100055|NCT03182855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111100056|NCT03182855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111100057|NCT02426333|Abiraterone Acetate|abiraterone acetate|mesh-list
111100058|NCT02426333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111100059|NCT02426333|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111100060|NCT02426333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111100061|NCT02426333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111100062|NCT02426333|Hormone Antagonists|hormone antagonists|mesh-ancestor
111100063|NCT02426333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111100064|NCT02426333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111100065|NCT02426333|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111100066|NCT02426177|Labetalol|labetalol|mesh-list
111100067|NCT02426177|Nifedipine|nifedipine|mesh-list
111100068|NCT02426177|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111100069|NCT02426177|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111100070|NCT02426177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111100071|NCT02426177|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111100072|NCT02426177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111100073|NCT02426177|Vasodilator Agents|vasodilator agents|mesh-ancestor
111100074|NCT02426177|Tocolytic Agents|tocolytic agents|mesh-ancestor
111100075|NCT02426177|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111100076|NCT02426177|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111100077|NCT02426177|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111100078|NCT02426177|Adrenergic Agents|adrenergic agents|mesh-ancestor
111100079|NCT02426177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111100080|NCT02426177|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111100081|NCT02426177|Sympathomimetics|sympathomimetics|mesh-ancestor
111100082|NCT02426177|Autonomic Agents|autonomic agents|mesh-ancestor
111100083|NCT02426177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111100084|NCT02426177|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111100085|NCT02426177|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111100086|NCT02426099|Antihypertensive Agents|antihypertensive agents|mesh-list
111100087|NCT02426099|Spironolactone|spironolactone|mesh-list
111100088|NCT02426099|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
111100089|NCT02426099|Hormone Antagonists|hormone antagonists|mesh-ancestor
111100090|NCT02426099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111100091|NCT02426099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111100092|NCT02426099|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
111100093|NCT02426099|Diuretics|diuretics|mesh-ancestor
111100094|NCT02426099|Natriuretic Agents|natriuretic agents|mesh-ancestor
111100095|NCT02426021|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111100096|NCT02426021|Immunologic Factors|immunologic factors|mesh-ancestor
111100097|NCT02426021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111100098|NCT02425709|Diclofenac|diclofenac|mesh-list
111100099|NCT02425709|Tramadol|tramadol|mesh-list
111100100|NCT02425709|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111100101|NCT02425709|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111100102|NCT02425709|Analgesics|analgesics|mesh-ancestor
111100103|NCT02425709|Sensory System Agents|sensory system agents|mesh-ancestor
111100104|NCT02425709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111100105|NCT02425709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111100106|NCT02425709|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111100107|NCT02425709|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111100108|NCT02425709|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111100109|NCT02425709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111100110|NCT02425709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111100111|NCT02425709|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111100112|NCT02425709|Narcotics|narcotics|mesh-ancestor
111100113|NCT02425709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111100114|NCT02073682|Heparin|heparin|mesh-list
111100115|NCT02073682|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
111100116|NCT02073682|Tinzaparin|tinzaparin|mesh-list
111100117|NCT02073682|Dalteparin|dalteparin|mesh-list
111100118|NCT02073682|Edoxaban|edoxaban|mesh-list
111100119|NCT02073682|Anticoagulants|anticoagulants|mesh-ancestor
111100120|NCT02073682|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111100121|NCT02073682|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111100122|NCT02073682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111100123|NCT02073682|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111100124|NCT02073682|Antithrombins|antithrombins|mesh-ancestor
111100125|NCT02073682|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111100126|NCT02073682|Protease Inhibitors|protease inhibitors|mesh-ancestor
111100127|NCT02073682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111100128|NCT03181919|Letrozole|letrozole|mesh-list
111100129|NCT03181919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111100130|NCT03181919|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111100131|NCT03181919|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111100132|NCT03181919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111100133|NCT03181919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111100134|NCT03181919|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111100135|NCT03181919|Hormone Antagonists|hormone antagonists|mesh-ancestor
111100136|NCT03181919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111100137|NCT03181919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111100138|NCT02706899|Azacitidine|azacitidine|mesh-list
111100139|NCT02706899|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111100140|NCT02706899|Antimetabolites|antimetabolites|mesh-ancestor
111100141|NCT02706899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111100142|NCT02706899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111100143|NCT02706899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111100144|NCT02421575|Hydroxychloroquine|hydroxychloroquine|mesh-list
111100145|NCT02421575|Antimalarials|antimalarials|mesh-ancestor
111100146|NCT02421575|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111100147|NCT02421575|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111100148|NCT02421575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111100149|NCT02421575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111100150|NCT02421575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111100151|NCT02421575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111100152|NCT02424695|Gabapentin|gabapentin|mesh-list
111100153|NCT02424695|Analgesics|analgesics|mesh-ancestor
111100154|NCT02424695|Sensory System Agents|sensory system agents|mesh-ancestor
111100155|NCT02424695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111100156|NCT02424695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111100157|NCT02424695|Anticonvulsants|anticonvulsants|mesh-ancestor
111100158|NCT02424695|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111100159|NCT02424695|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111100160|NCT02424695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111100161|NCT02424695|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111100162|NCT02424695|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111100163|NCT02424695|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111100164|NCT02424695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111100165|NCT02424695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111100166|NCT02424695|Antimanic Agents|antimanic agents|mesh-ancestor
111100167|NCT02422277|Sildenafil Citrate|sildenafil citrate|mesh-list
111100168|NCT02422277|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
111100169|NCT02422277|Vasodilator Agents|vasodilator agents|mesh-ancestor
111100170|NCT02422277|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111100171|NCT02422277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111100172|NCT02422277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111100173|NCT02422277|Urological Agents|urological agents|mesh-ancestor
111100175|NCT02422121|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111100176|NCT02422121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111100177|NCT02422121|Analgesics|analgesics|mesh-ancestor
111100178|NCT02422121|Sensory System Agents|sensory system agents|mesh-ancestor
111100179|NCT02422121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111100180|NCT02422121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111100181|NCT02422121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111100182|NCT02422121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111100183|NCT02422121|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111100184|NCT02424461|Ceftriaxone|ceftriaxone|mesh-list
111100185|NCT02424461|Ofloxacin|ofloxacin|mesh-list
111100186|NCT02424461|Levofloxacin|levofloxacin|mesh-list
111100187|NCT02424461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111100188|NCT02424461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111100189|NCT02424461|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111100190|NCT02424461|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111100191|NCT02424461|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111100192|NCT02424461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111100193|NCT02424461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111100194|NCT02424461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111100195|NCT02424461|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111100196|NCT02424461|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111100197|NCT02072824|Pregabalin|pregabalin|mesh-list
111100198|NCT02072824|Analgesics|analgesics|mesh-ancestor
111100199|NCT02072824|Sensory System Agents|sensory system agents|mesh-ancestor
111100200|NCT02072824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111100201|NCT02072824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111100202|NCT02072824|Anticonvulsants|anticonvulsants|mesh-ancestor
111100203|NCT02072824|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111100204|NCT02072824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111100205|NCT02072824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111100206|NCT02072824|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111100207|NCT02072824|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111100208|NCT02072824|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111100209|NCT02072824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111100210|NCT02072824|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111100211|NCT03117257|Cisplatin|cisplatin|mesh-list
111100212|NCT03117257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111100213|NCT02072668|Rivaroxaban|rivaroxaban|mesh-list
111100214|NCT02072668|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111100215|NCT02072668|Antithrombins|antithrombins|mesh-ancestor
111100216|NCT02072668|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111100217|NCT02072668|Protease Inhibitors|protease inhibitors|mesh-ancestor
111100218|NCT02072668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111100219|NCT02072668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111100220|NCT02072668|Anticoagulants|anticoagulants|mesh-ancestor
111100221|NCT03181685|Cetrorelix|cetrorelix|mesh-list
111100222|NCT03181685|Progesterone|progesterone|mesh-list
111100223|NCT03181685|Progestins|progestins|mesh-ancestor
111100224|NCT03181685|Hormones|hormones|mesh-ancestor
111100225|NCT03181685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111100226|NCT03181685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111100227|NCT03181685|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111100228|NCT03181685|Fertility Agents|fertility agents|mesh-ancestor
111100229|NCT03181685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111100230|NCT03181685|Hormone Antagonists|hormone antagonists|mesh-ancestor
111100231|NCT02424071|Melatonin|melatonin|mesh-list
111100232|NCT02424071|Antioxidants|antioxidants|mesh-ancestor
111100233|NCT02424071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111100234|NCT02424071|Protective Agents|protective agents|mesh-ancestor
111100235|NCT02424071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110677467|NCT00128310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111100236|NCT02424071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111100238|NCT03178955|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111100239|NCT03178955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111100240|NCT03178955|Analgesics|analgesics|mesh-ancestor
111100241|NCT03178955|Sensory System Agents|sensory system agents|mesh-ancestor
111100242|NCT03178955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111100243|NCT03178955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111100244|NCT03178955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110817348|NCT03934411|Analgesics|analgesics|mesh-ancestor
111100245|NCT03178955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111100246|NCT03178955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111100247|NCT03178955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111100248|NCT03178955|Immunologic Factors|immunologic factors|mesh-ancestor
111100249|NCT01598506|Hydromorphone|hydromorphone|mesh-list
111100250|NCT01598506|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111100251|NCT01598506|Narcotics|narcotics|mesh-ancestor
111100252|NCT01598506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111100253|NCT01598506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111100254|NCT01598506|Analgesics|analgesics|mesh-ancestor
111100255|NCT01598506|Sensory System Agents|sensory system agents|mesh-ancestor
111100256|NCT01598506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111100257|NCT02423915|Mycophenolic Acid|mycophenolic acid|mesh-list
111100258|NCT02423915|Sirolimus|sirolimus|mesh-list
111100259|NCT02423915|Cyclophosphamide|cyclophosphamide|mesh-list
111100260|NCT02423915|Rituximab|rituximab|mesh-list
111100261|NCT02423915|Fludarabine|fludarabine|mesh-list
111100262|NCT02423915|Fludarabine phosphate|fludarabine phosphate|mesh-list
111100263|NCT02423915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111100264|NCT02423915|Immunologic Factors|immunologic factors|mesh-ancestor
111100265|NCT02423915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111100266|NCT02423915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111100267|NCT02423915|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111100268|NCT02423915|Alkylating Agents|alkylating agents|mesh-ancestor
111100269|NCT02423915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111100270|NCT02423915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111100271|NCT02423915|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111100272|NCT02423915|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111100273|NCT02423915|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111100274|NCT02423915|Antimetabolites|antimetabolites|mesh-ancestor
111100275|NCT02423915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111100276|NCT02423915|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111100277|NCT02423915|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111100278|NCT02423915|Antitubercular Agents|antitubercular agents|mesh-ancestor
111100279|NCT02423915|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111100280|NCT02423915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111100281|NCT02423915|Antifungal Agents|antifungal agents|mesh-ancestor
111100282|NCT02423837|Rituximab|rituximab|mesh-list
111100283|NCT02423837|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
111100284|NCT02423837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111100285|NCT02423837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111100286|NCT02423837|Immunologic Factors|immunologic factors|mesh-ancestor
111100287|NCT02423837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111100288|NCT02423837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111100289|NCT02423837|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111100290|NCT02423837|Alkylating Agents|alkylating agents|mesh-ancestor
111100291|NCT02423837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111100292|NCT02140060|Travoprost|travoprost|mesh-list
111100293|NCT02140060|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111100294|NCT02140060|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111100295|NCT02140060|Brinzolamide|brinzolamide|mesh-list
111100296|NCT02140060|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111100297|NCT02140060|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
111100298|NCT02140060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111100299|NCT02140060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111100300|NCT03178721|Calcium|calcium|mesh-list
111100301|NCT03178721|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111100302|NCT03178721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111100303|NCT02421029|Calcium, Dietary|calcium, dietary|mesh-list
111100304|NCT02421029|Edetic Acid|edetic acid|mesh-list
111100305|NCT02421029|Calcium|calcium|mesh-list
111100306|NCT02421029|Pentetic Acid|pentetic acid|mesh-list
111100307|NCT02421029|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111100308|NCT02421029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111100309|NCT02421029|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111100310|NCT02421029|Anticoagulants|anticoagulants|mesh-ancestor
111100311|NCT02421029|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
111100312|NCT02421029|Chelating Agents|chelating agents|mesh-ancestor
111100313|NCT02421029|Sequestering Agents|sequestering agents|mesh-ancestor
111100314|NCT02421029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111100315|NCT02421029|Antidotes|antidotes|mesh-ancestor
111100316|NCT02421029|Protective Agents|protective agents|mesh-ancestor
111100317|NCT02421029|Iron Chelating Agents|iron chelating agents|mesh-ancestor
111100318|NCT02139982|Ropivacaine|ropivacaine|mesh-list
111100319|NCT02139982|Anesthetics, Local|anesthetics, local|mesh-ancestor
111100320|NCT02139982|Anesthetics|anesthetics|mesh-ancestor
111100321|NCT02139982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111100322|NCT02139982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110817419|NCT01123915|Antioxidants|antioxidants|mesh-ancestor
111100323|NCT02139982|Sensory System Agents|sensory system agents|mesh-ancestor
111100324|NCT02139982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111100325|NCT03178643|Piperaquine|piperaquine|mesh-list
111100326|NCT03178643|Sulfadoxine|sulfadoxine|mesh-list
111100327|NCT03178643|Amodiaquine|amodiaquine|mesh-list
111100328|NCT03178643|Artenimol|artenimol|mesh-list
111100329|NCT03178643|Proguanil|proguanil|mesh-list
111100330|NCT03178643|Antimalarials|antimalarials|mesh-ancestor
111100331|NCT03178643|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111100332|NCT03178643|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111100333|NCT03178643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111100334|NCT03178643|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111100335|NCT03178643|Antimetabolites|antimetabolites|mesh-ancestor
111100336|NCT03178643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111100337|NCT02139592|Brentuximab Vedotin|brentuximab vedotin|mesh-list
111100338|NCT02139592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111100339|NCT02139592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111100340|NCT02139592|Immunotoxins|immunotoxins|mesh-ancestor
111100341|NCT02139592|Immunoconjugates|immunoconjugates|mesh-ancestor
111100342|NCT02139592|Immunologic Factors|immunologic factors|mesh-ancestor
111100343|NCT02139592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111100344|NCT02139280|Cyclophosphamide|cyclophosphamide|mesh-list
111100345|NCT02139280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111100346|NCT02139280|Immunologic Factors|immunologic factors|mesh-ancestor
111100347|NCT02139280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111100348|NCT02139280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111100349|NCT02139280|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111100350|NCT02139280|Alkylating Agents|alkylating agents|mesh-ancestor
111100351|NCT02139280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111100352|NCT02139280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111100353|NCT02139280|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111100354|NCT02072434|Enoxaparin|enoxaparin|mesh-list
111100355|NCT02072434|Warfarin|warfarin|mesh-list
111100356|NCT02072434|Edoxaban|edoxaban|mesh-list
111100357|NCT02072434|Anticoagulants|anticoagulants|mesh-ancestor
111100358|NCT02072434|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111100359|NCT02072434|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111100360|NCT02072434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111100361|NCT02072434|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111100362|NCT02072434|Antithrombins|antithrombins|mesh-ancestor
111100363|NCT02072434|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111100364|NCT02072434|Protease Inhibitors|protease inhibitors|mesh-ancestor
111100365|NCT02072434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111100366|NCT04725994|Irinotecan|irinotecan|mesh-list
111100367|NCT04725994|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111100368|NCT04725994|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111100369|NCT04725994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111100370|NCT04725994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111100371|NCT04725994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111100372|NCT02139046|Naproxen|naproxen|mesh-list
111100373|NCT02139046|Colchicine|colchicine|mesh-list
111100374|NCT02139046|Febuxostat|febuxostat|mesh-list
111100375|NCT02139046|Lansoprazole|lansoprazole|mesh-list
111100376|NCT02139046|Dexlansoprazole|dexlansoprazole|mesh-list
111100377|NCT02139046|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111100378|NCT02139046|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111100379|NCT02139046|Analgesics|analgesics|mesh-ancestor
111100380|NCT02139046|Sensory System Agents|sensory system agents|mesh-ancestor
111100381|NCT02139046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111100382|NCT02139046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111100383|NCT02139046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111100384|NCT02139046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111100385|NCT02139046|Gout Suppressants|gout suppressants|mesh-ancestor
111100386|NCT02139046|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111100387|NCT02139046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111100388|NCT02139046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111100389|NCT02139046|Tubulin Modulators|tubulin modulators|mesh-ancestor
111100390|NCT02139046|Antimitotic Agents|antimitotic agents|mesh-ancestor
111100391|NCT02139046|Mitosis Modulators|mitosis modulators|mesh-ancestor
111100392|NCT02139046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111100393|NCT02139046|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111100394|NCT02139046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111100395|NCT02139046|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111100396|NCT04734262|Paclitaxel|paclitaxel|mesh-list
111100397|NCT04734262|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111100398|NCT04734262|Tislelizumab|tislelizumab|mesh-list
111100399|NCT04734262|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111100400|NCT04734262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111100401|NCT04734262|Tubulin Modulators|tubulin modulators|mesh-ancestor
111100402|NCT04734262|Antimitotic Agents|antimitotic agents|mesh-ancestor
111100403|NCT04734262|Mitosis Modulators|mitosis modulators|mesh-ancestor
111100404|NCT04734262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111100405|NCT04734262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111100406|NCT02100670|Diclofenac|diclofenac|mesh-list
111100407|NCT02100670|Menthol|menthol|mesh-list
111100408|NCT02100670|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111100409|NCT02100670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111100410|NCT02100670|Analgesics|analgesics|mesh-ancestor
111100411|NCT02100670|Sensory System Agents|sensory system agents|mesh-ancestor
111100412|NCT02100670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111100413|NCT02100670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111100414|NCT02100670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111100415|NCT02100670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111100416|NCT02100670|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111100417|NCT02100670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111100418|NCT02100670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111100419|NCT02100670|Antipruritics|antipruritics|mesh-ancestor
111100420|NCT02100670|Dermatologic Agents|dermatologic agents|mesh-ancestor
111100421|NCT02100514|Bococizumab|bococizumab|mesh-list
111100422|NCT02100514|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111100423|NCT02100514|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111100424|NCT02100514|Antimetabolites|antimetabolites|mesh-ancestor
111100425|NCT02100514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111100426|NCT02100514|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111100427|NCT02069392|Nicotine|nicotine|mesh-list
111100428|NCT02069392|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111100429|NCT02069392|Autonomic Agents|autonomic agents|mesh-ancestor
111100430|NCT02069392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111100431|NCT02069392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111100432|NCT02069392|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111100433|NCT02069392|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111100434|NCT02069392|Cholinergic Agents|cholinergic agents|mesh-ancestor
111100435|NCT02069392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111100436|NCT02069392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111100437|NCT05522361|Risdiplam|risdiplam|mesh-list
111100438|NCT05522361|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111100439|NCT05522361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111100440|NCT05522361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111100441|NCT02100124|Contraceptive Agents|contraceptive agents|mesh-list
111100442|NCT02100124|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111100443|NCT02100124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111100444|NCT02046616|Methotrexate|methotrexate|mesh-list
111100445|NCT02046616|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111100446|NCT02046616|Abortifacient Agents|abortifacient agents|mesh-ancestor
111100447|NCT02046616|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111100448|NCT02046616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111100449|NCT02046616|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111100450|NCT02046616|Antimetabolites|antimetabolites|mesh-ancestor
111100451|NCT02046616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111100452|NCT02046616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111100453|NCT02046616|Dermatologic Agents|dermatologic agents|mesh-ancestor
111100454|NCT02046616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111100455|NCT02046616|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111100456|NCT02046616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111100457|NCT02046616|Immunologic Factors|immunologic factors|mesh-ancestor
111100458|NCT02046616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111100459|NCT02046616|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111100460|NCT05525481|Tamoxifen|tamoxifen|mesh-list
111100461|NCT05525481|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111100462|NCT05525481|Hormone Antagonists|hormone antagonists|mesh-ancestor
111100463|NCT05525481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111100464|NCT05525481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111100465|NCT05525481|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111100466|NCT05525481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111100467|NCT05525481|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111100468|NCT05525481|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111100469|NCT05525481|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111100470|NCT02068222|Ritonavir|ritonavir|mesh-list
111100471|NCT02068222|Ribavirin|ribavirin|mesh-list
111100472|NCT02068222|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111100473|NCT02068222|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111100474|NCT02068222|Protease Inhibitors|protease inhibitors|mesh-ancestor
111100475|NCT02068222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111100476|NCT02068222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111100477|NCT02068222|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111100478|NCT02068222|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111100479|NCT02068222|Antiviral Agents|antiviral agents|mesh-ancestor
111100480|NCT02068222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111100481|NCT02068222|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111100482|NCT02068222|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111100483|NCT02068222|Antimetabolites|antimetabolites|mesh-ancestor
111100484|NCT05517213|Cyclophosphamide|cyclophosphamide|mesh-list
111100485|NCT05517213|Etoposide|etoposide|mesh-list
111100486|NCT05517213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111100487|NCT05517213|Immunologic Factors|immunologic factors|mesh-ancestor
111100488|NCT05517213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111100489|NCT05517213|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111100490|NCT05517213|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111100491|NCT05517213|Alkylating Agents|alkylating agents|mesh-ancestor
111100492|NCT05517213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111100493|NCT05517213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111100494|NCT05517213|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110642550|NCT03713294|Elotuzumab|elotuzumab|mesh-list
111100495|NCT05517213|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111100496|NCT05517213|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111100497|NCT05517213|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111100498|NCT05517213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111100499|NCT05516745|Respiratory System Agents|respiratory system agents|mesh-list
111100500|NCT05516589|Paclitaxel|paclitaxel|mesh-list
111100501|NCT05516589|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111100502|NCT05516589|Tislelizumab|tislelizumab|mesh-list
111100503|NCT05516589|Afatinib|afatinib|mesh-list
111100504|NCT05516589|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111100505|NCT05516589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111100506|NCT05516589|Tubulin Modulators|tubulin modulators|mesh-ancestor
111100507|NCT05516589|Antimitotic Agents|antimitotic agents|mesh-ancestor
111100508|NCT05516589|Mitosis Modulators|mitosis modulators|mesh-ancestor
111100509|NCT05516589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111100510|NCT05516589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111100511|NCT05516589|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111100512|NCT05516589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111100513|NCT02099110|Metformin|metformin|mesh-list
111100514|NCT02099110|Insulin Glargine|insulin glargine|mesh-list
111100515|NCT02099110|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111100516|NCT02099110|Glimepiride|glimepiride|mesh-list
111100517|NCT02099110|Ertugliflozin|ertugliflozin|mesh-list
111100518|NCT02099110|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111100519|NCT02099110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111100520|NCT02099110|Incretins|incretins|mesh-ancestor
111100521|NCT02099110|Hormones|hormones|mesh-ancestor
111100522|NCT02099110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111100523|NCT02099110|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111100524|NCT02099110|Protease Inhibitors|protease inhibitors|mesh-ancestor
111100525|NCT02099110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111100526|NCT02099110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111100527|NCT02099110|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111100528|NCT02099110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111100529|NCT02099110|Immunologic Factors|immunologic factors|mesh-ancestor
111100530|NCT02099110|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111100531|NCT02098876|Everolimus|everolimus|mesh-list
111100532|NCT02098876|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111100533|NCT02098876|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111100534|NCT02098876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111100535|NCT02098876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111100536|NCT02098876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111100537|NCT02098876|Immunologic Factors|immunologic factors|mesh-ancestor
111100538|NCT02098876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111100539|NCT02098876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111100540|NCT01624090|Plicamycin|plicamycin|mesh-list
111100541|NCT01624090|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111100542|NCT01624090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111100543|NCT01624090|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111100544|NCT01624090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111100545|NCT01624090|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111100546|NCT01624090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111100547|NCT01624090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111100548|NCT01624090|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111100550|NCT02571777|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
111100551|NCT02571777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111100552|NCT02571777|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111100553|NCT02571777|Autonomic Agents|autonomic agents|mesh-ancestor
111100554|NCT02571777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111100555|NCT02571777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111100556|NCT02571777|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110642551|NCT03713294|Ichthammol|ichthammol|mesh-list
111100557|NCT02571777|Respiratory System Agents|respiratory system agents|mesh-ancestor
111100558|NCT02571777|Dermatologic Agents|dermatologic agents|mesh-ancestor
111100559|NCT02571777|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111100560|NCT02571777|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111100561|NCT02571777|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111100562|NCT02571777|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111100563|NCT02571777|Adrenergic Agents|adrenergic agents|mesh-ancestor
111100564|NCT02571777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111100565|NCT02571777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111100566|NCT05511831|Ketotifen|ketotifen|mesh-list
111100567|NCT05511831|Antipruritics|antipruritics|mesh-ancestor
111100568|NCT05511831|Dermatologic Agents|dermatologic agents|mesh-ancestor
111100569|NCT05511831|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111100570|NCT05511831|Histamine Antagonists|histamine antagonists|mesh-ancestor
111100571|NCT05511831|Histamine Agents|histamine agents|mesh-ancestor
111100572|NCT05511831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111100573|NCT05511831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111100574|NCT05511831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111100575|NCT05511831|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111100576|NCT02705105|Nivolumab|nivolumab|mesh-list
111100577|NCT02705105|Mogamulizumab|mogamulizumab|mesh-list
111100578|NCT02705105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111100579|NCT02705105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111100580|NCT02705105|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111100581|NCT02705105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111100582|NCT05521347|Caffeine|caffeine|mesh-list
111100583|NCT05521347|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111100584|NCT05521347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111100585|NCT05521347|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111100586|NCT05521347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111100587|NCT05521347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111100588|NCT05521347|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
111100589|NCT05521347|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111100590|NCT05521347|Purinergic Agents|purinergic agents|mesh-ancestor
111100591|NCT05521347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111100592|NCT02097472|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
111100593|NCT02097472|Immunologic Factors|immunologic factors|mesh-ancestor
111100594|NCT02097472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111100595|NCT03180671|Salicylic Acid|salicylic acid|mesh-list
111100596|NCT03180671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111100597|NCT03180671|Antifungal Agents|antifungal agents|mesh-ancestor
111100598|NCT03180671|Keratolytic Agents|keratolytic agents|mesh-ancestor
111100599|NCT03180671|Dermatologic Agents|dermatologic agents|mesh-ancestor
111100600|NCT05093517|Volagidemab|volagidemab|mesh-list
111100601|NCT05093517|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111100602|NCT05093517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111100603|NCT02420171|Insulin|insulin|mesh-list
111100604|NCT02420171|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111100605|NCT02420171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111100606|NCT03180593|Valsartan|valsartan|mesh-list
111100607|NCT03180593|Nebivolol|nebivolol|mesh-list
111100608|NCT03180593|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111100609|NCT03180593|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111100610|NCT03180593|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111100611|NCT03180593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111100612|NCT03180593|Vasodilator Agents|vasodilator agents|mesh-ancestor
111100613|NCT03180593|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
111100614|NCT03180593|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111100615|NCT03180593|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111100616|NCT03180593|Adrenergic Agents|adrenergic agents|mesh-ancestor
111100617|NCT03180593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111100618|NCT03180593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111100619|NCT02423759|Ciprofloxacin|ciprofloxacin|mesh-list
111100620|NCT02423759|Gentamicins|gentamicins|mesh-list
111100621|NCT02423759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111100622|NCT02423759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111100623|NCT02423759|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111100624|NCT02423759|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111100625|NCT02423759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111100626|NCT02423759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111100627|NCT02423759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111100628|NCT02423759|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111100629|NCT02423759|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111100630|NCT02423759|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111100631|NCT01623310|Fluticasone|fluticasone|mesh-list
111100632|NCT01623310|Xhance|xhance|mesh-list
111100633|NCT01623310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111100634|NCT01623310|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111100635|NCT01623310|Autonomic Agents|autonomic agents|mesh-ancestor
111100636|NCT01623310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111100637|NCT01623310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111100638|NCT01623310|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111100639|NCT01623310|Respiratory System Agents|respiratory system agents|mesh-ancestor
111100640|NCT01623310|Dermatologic Agents|dermatologic agents|mesh-ancestor
111100641|NCT01623310|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111100642|NCT03180125|Lidocaine|lidocaine|mesh-list
111100643|NCT03180125|Hyaluronic Acid|hyaluronic acid|mesh-list
111100644|NCT03180125|Anesthetics, Local|anesthetics, local|mesh-ancestor
111100645|NCT03180125|Anesthetics|anesthetics|mesh-ancestor
111100646|NCT03180125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111100647|NCT03180125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111100648|NCT03180125|Sensory System Agents|sensory system agents|mesh-ancestor
111100649|NCT03180125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111100650|NCT03180125|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111100651|NCT03180125|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111100652|NCT03180125|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111100653|NCT03180125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111100654|NCT03180125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111100655|NCT03180125|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111100656|NCT03180125|Immunologic Factors|immunologic factors|mesh-ancestor
111100657|NCT03180125|Viscosupplements|viscosupplements|mesh-ancestor
111100658|NCT03180125|Protective Agents|protective agents|mesh-ancestor
111100659|NCT02423603|Paclitaxel|paclitaxel|mesh-list
111100660|NCT02423603|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111100661|NCT02423603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111100662|NCT02423603|Tubulin Modulators|tubulin modulators|mesh-ancestor
111100663|NCT02423603|Antimitotic Agents|antimitotic agents|mesh-ancestor
111100664|NCT02423603|Mitosis Modulators|mitosis modulators|mesh-ancestor
111100665|NCT02423603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111100666|NCT03178409|Liver Extracts|liver extracts|mesh-list
111100667|NCT03178409|Hematinics|hematinics|mesh-ancestor
111100668|NCT03180281|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111100669|NCT03180281|Glimepiride|glimepiride|mesh-list
111100670|NCT03180281|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111100671|NCT03180281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111100672|NCT03180281|Incretins|incretins|mesh-ancestor
111100673|NCT03180281|Hormones|hormones|mesh-ancestor
111100674|NCT03180281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111100675|NCT03180281|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111100676|NCT03180281|Protease Inhibitors|protease inhibitors|mesh-ancestor
111100677|NCT03180281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110029848|NCT02995252|Antiviral Agents|antiviral agents|mesh-ancestor
111100678|NCT03180281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111100679|NCT03180281|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111100680|NCT03180281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111100681|NCT03180281|Immunologic Factors|immunologic factors|mesh-ancestor
111100682|NCT03116945|Gallium citrate|gallium citrate|mesh-list
111100683|NCT03116945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111100684|NCT03116945|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111100685|NCT03117023|Dexmedetomidine|dexmedetomidine|mesh-list
111100686|NCT03117023|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111100687|NCT03117023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111100688|NCT03117023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111100689|NCT03117023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111100690|NCT03117023|Analgesics|analgesics|mesh-ancestor
111100691|NCT03117023|Sensory System Agents|sensory system agents|mesh-ancestor
111100692|NCT03117023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111100693|NCT03117023|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111100694|NCT03117023|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111100695|NCT03117023|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111100696|NCT03117023|Adrenergic Agents|adrenergic agents|mesh-ancestor
111100697|NCT03117023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111100698|NCT03117023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111100699|NCT02097238|Halichondrin B|halichondrin b|mesh-list
111100700|NCT02097238|Tubulin Modulators|tubulin modulators|mesh-ancestor
111100701|NCT02097238|Antimitotic Agents|antimitotic agents|mesh-ancestor
111100702|NCT02097238|Mitosis Modulators|mitosis modulators|mesh-ancestor
111100703|NCT02097238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111100704|NCT02097238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111100705|NCT03179813|Hydrocortisone|hydrocortisone|mesh-list
111100706|NCT03179813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111100707|NCT03179735|Cetylpyridinium|cetylpyridinium|mesh-list
111100708|NCT03179735|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111100709|NCT03179735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111100710|NCT02419859|Insulin|insulin|mesh-list
111100711|NCT02419859|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111100712|NCT02419859|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111100713|NCT02419859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111100714|NCT02419391|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
111100715|NCT02419391|Antiviral Agents|antiviral agents|mesh-ancestor
111100716|NCT02419391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111100717|NCT02419235|Ethanol|ethanol|mesh-list
111100718|NCT02419235|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111100719|NCT02419235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111100720|NCT02419235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111100721|NCT02419235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111100722|NCT02422823|Epinephrine|epinephrine|mesh-list
111100723|NCT02422823|Carticaine|carticaine|mesh-list
111100724|NCT02422823|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111100725|NCT02422823|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111100726|NCT02422823|Adrenergic Agents|adrenergic agents|mesh-ancestor
111100727|NCT02422823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111100728|NCT02422823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111100729|NCT02422823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111100730|NCT02422823|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111100731|NCT02422823|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111100732|NCT02422823|Autonomic Agents|autonomic agents|mesh-ancestor
111100733|NCT02422823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111100734|NCT02422823|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111100735|NCT02422823|Respiratory System Agents|respiratory system agents|mesh-ancestor
111100736|NCT02422823|Mydriatics|mydriatics|mesh-ancestor
111100737|NCT02422823|Sympathomimetics|sympathomimetics|mesh-ancestor
111100738|NCT02422823|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111100739|NCT02422823|Anesthetics, Local|anesthetics, local|mesh-ancestor
111100740|NCT02422823|Anesthetics|anesthetics|mesh-ancestor
111100741|NCT02422823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111100742|NCT02422823|Sensory System Agents|sensory system agents|mesh-ancestor
111100743|NCT02422589|Ceritinib|ceritinib|mesh-list
111100744|NCT02422589|Midazolam|midazolam|mesh-list
111100745|NCT02422589|Warfarin|warfarin|mesh-list
111100746|NCT02422589|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111100747|NCT02422589|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111100748|NCT02422589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111100749|NCT02422589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110406547|NCT00997243|Azacitidine|azacitidine|mesh-list
111100750|NCT02422589|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111100751|NCT02422589|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111100752|NCT02422589|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111100753|NCT02422589|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111100754|NCT02422589|Anesthetics, General|anesthetics, general|mesh-ancestor
111100755|NCT02422589|Anesthetics|anesthetics|mesh-ancestor
111100756|NCT02422589|GABA Modulators|gaba modulators|mesh-ancestor
111100757|NCT02422589|GABA Agents|gaba agents|mesh-ancestor
111100758|NCT02422589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111100759|NCT02422589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111100760|NCT02422589|Anticoagulants|anticoagulants|mesh-ancestor
111100761|NCT02422589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111100762|NCT02422589|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111100763|NCT02422589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111100764|NCT02422199|Capecitabine|capecitabine|mesh-list
111100765|NCT02422199|Lapatinib|lapatinib|mesh-list
111100766|NCT02422199|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111100767|NCT02422199|Antimetabolites|antimetabolites|mesh-ancestor
111100768|NCT02422199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111100769|NCT02422199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111100770|NCT02422199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111100771|NCT02422199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111100772|NCT02416739|Niacinamide|niacinamide|mesh-list
111100773|NCT02416739|Niacin|niacin|mesh-list
111100774|NCT02416739|Nicotinic Acids|nicotinic acids|mesh-list
111100775|NCT02416739|Vitamin B Complex|vitamin b complex|mesh-ancestor
111100776|NCT02416739|Vitamins|vitamins|mesh-ancestor
111100777|NCT02416739|Micronutrients|micronutrients|mesh-ancestor
111100778|NCT02416739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111100779|NCT02416739|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111100780|NCT02416739|Antimetabolites|antimetabolites|mesh-ancestor
111100781|NCT02416739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111100782|NCT02416739|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111100783|NCT02416739|Vasodilator Agents|vasodilator agents|mesh-ancestor
111100784|NCT02416583|Oxytocin|oxytocin|mesh-list
111100785|NCT02416583|Dinoprostone|dinoprostone|mesh-list
111100786|NCT02416583|Oxytocics|oxytocics|mesh-ancestor
111100787|NCT02416583|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111100788|NCT02416583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111100789|NCT02416427|Atorvastatin|atorvastatin|mesh-list
111100790|NCT02416427|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111100791|NCT02416427|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111100792|NCT02416427|Antimetabolites|antimetabolites|mesh-ancestor
111100793|NCT02416427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111100794|NCT02416427|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111100795|NCT02416427|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111100796|NCT02416427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111100797|NCT02416271|Vitamin D|vitamin d|mesh-list
111100798|NCT02416271|Alendronate|alendronate|mesh-list
111100799|NCT02416271|Teriparatide|teriparatide|mesh-list
111100800|NCT02416271|Calcium|calcium|mesh-list
111100801|NCT02416271|Vitamins|vitamins|mesh-ancestor
111100802|NCT02416271|Micronutrients|micronutrients|mesh-ancestor
111100803|NCT02416271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111100804|NCT02416271|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111100805|NCT02416271|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111100806|NCT02416115|Morphine|morphine|mesh-list
111100807|NCT02416115|Ramosetron|ramosetron|mesh-list
111100808|NCT02416115|Naloxone|naloxone|mesh-list
111100809|NCT02416115|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111100810|NCT02416115|Narcotics|narcotics|mesh-ancestor
111100811|NCT02416115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111100812|NCT02416115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111100813|NCT02416115|Analgesics|analgesics|mesh-ancestor
111100814|NCT02416115|Sensory System Agents|sensory system agents|mesh-ancestor
111100815|NCT02416115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111100816|NCT02416115|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111100817|NCT02416115|Antiemetics|antiemetics|mesh-ancestor
111100818|NCT02416115|Autonomic Agents|autonomic agents|mesh-ancestor
111100819|NCT02416115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111100820|NCT02416115|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111100821|NCT02416115|Serotonin Agents|serotonin agents|mesh-ancestor
111100822|NCT02416115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110642594|NCT01075945|Artemether|artemether|mesh-list
111100823|NCT02416115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111100824|NCT02415881|Panitumumab|panitumumab|mesh-list
111100825|NCT02415881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111100826|NCT02415881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111100828|NCT02415803|Ticagrelor|ticagrelor|mesh-list
111100829|NCT02415803|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111100830|NCT02415803|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111100831|NCT02415803|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111100832|NCT02415803|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111100833|NCT02415803|Purinergic Agents|purinergic agents|mesh-ancestor
111100834|NCT02415803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111100835|NCT02415803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111100836|NCT02415803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111100837|NCT04482881|Isosorbide|isosorbide|mesh-list
111100838|NCT04482881|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
111100839|NCT04482881|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
111100840|NCT04482881|Misoprostol|misoprostol|mesh-list
111100841|NCT04482881|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111100842|NCT04482881|Abortifacient Agents|abortifacient agents|mesh-ancestor
111100843|NCT04482881|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111100844|NCT04482881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111100845|NCT04482881|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111100846|NCT04482881|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111100847|NCT04482881|Oxytocics|oxytocics|mesh-ancestor
110817943|NCT05788900|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111100848|NCT04482881|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
111100849|NCT04482881|Diuretics|diuretics|mesh-ancestor
111100850|NCT04482881|Natriuretic Agents|natriuretic agents|mesh-ancestor
111100851|NCT04482881|Vasodilator Agents|vasodilator agents|mesh-ancestor
111100852|NCT04482881|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
111100853|NCT04482881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111100854|NCT03176693|Doxazosin|doxazosin|mesh-list
111100855|NCT03176693|Phenoxybenzamine|phenoxybenzamine|mesh-list
111100856|NCT03176693|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111100857|NCT03176693|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111100858|NCT03176693|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111100859|NCT03176693|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111100860|NCT03176693|Adrenergic Agents|adrenergic agents|mesh-ancestor
111100861|NCT03176693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111100862|NCT03176693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111100863|NCT03176693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111100864|NCT03176693|Vasodilator Agents|vasodilator agents|mesh-ancestor
111100865|NCT02415569|Bisacodyl|bisacodyl|mesh-list
111100866|NCT02415569|Cathartics|cathartics|mesh-ancestor
111100867|NCT02415569|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111100868|NCT02415569|Laxatives|laxatives|mesh-ancestor
111100869|NCT02415335|Dexamethasone|dexamethasone|mesh-list
111100870|NCT02415335|Dexamethasone acetate|dexamethasone acetate|mesh-list
111100871|NCT02415335|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
111100872|NCT02415335|BB 1101|bb 1101|mesh-list
111100873|NCT02415335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111100874|NCT02415335|Antiemetics|antiemetics|mesh-ancestor
111100875|NCT02415335|Autonomic Agents|autonomic agents|mesh-ancestor
111100876|NCT02415335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111100877|NCT02415335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111100878|NCT02415335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111100879|NCT02415335|Glucocorticoids|glucocorticoids|mesh-ancestor
111100880|NCT02415335|Hormones|hormones|mesh-ancestor
111100881|NCT02415335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111100882|NCT02415335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111100883|NCT02415335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111100884|NCT02415335|Protease Inhibitors|protease inhibitors|mesh-ancestor
111100885|NCT02415335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111100886|NCT02415335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111100887|NCT02415257|Gentamicins|gentamicins|mesh-list
111100888|NCT02415257|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111100889|NCT02415257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111100890|NCT02415257|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111100891|NCT02415257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111100892|NCT02415257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111100893|NCT02415179|Fluticasone|fluticasone|mesh-list
111100894|NCT02415179|Mometasone Furoate|mometasone furoate|mesh-list
111100895|NCT02415179|Formoterol Fumarate|formoterol fumarate|mesh-list
111100896|NCT02415179|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
111100897|NCT02415179|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
111100898|NCT02415179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111100899|NCT02415179|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111100900|NCT02415179|Autonomic Agents|autonomic agents|mesh-ancestor
111100901|NCT02415179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111100902|NCT02415179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111100903|NCT02415179|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111100904|NCT02415179|Respiratory System Agents|respiratory system agents|mesh-ancestor
111100905|NCT02415179|Dermatologic Agents|dermatologic agents|mesh-ancestor
111100906|NCT02415179|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111100907|NCT02415179|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111100908|NCT02415179|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111100909|NCT02415179|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111100910|NCT02415179|Adrenergic Agents|adrenergic agents|mesh-ancestor
111100911|NCT02415179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111100912|NCT02415179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111100913|NCT02415179|Glucocorticoids|glucocorticoids|mesh-ancestor
111100914|NCT02415179|Hormones|hormones|mesh-ancestor
111100915|NCT02415179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111100916|NCT02415179|Sympathomimetics|sympathomimetics|mesh-ancestor
111100917|NCT02415023|Paclitaxel|paclitaxel|mesh-list
111100918|NCT02415023|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111100919|NCT02415023|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111100920|NCT02415023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111100921|NCT02415023|Tubulin Modulators|tubulin modulators|mesh-ancestor
111100922|NCT02415023|Antimitotic Agents|antimitotic agents|mesh-ancestor
111100923|NCT02415023|Mitosis Modulators|mitosis modulators|mesh-ancestor
111100924|NCT02415023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111100925|NCT02414945|Cyclophosphamide|cyclophosphamide|mesh-list
111100927|NCT02414945|Interleukin-2|interleukin-2|mesh-list
111100928|NCT02414945|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111100929|NCT02414945|Immunologic Factors|immunologic factors|mesh-ancestor
111100930|NCT02414945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111100931|NCT02414945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111100932|NCT02414945|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111100933|NCT02414945|Alkylating Agents|alkylating agents|mesh-ancestor
111100934|NCT02414945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111100935|NCT02414945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111100936|NCT02414945|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111100937|NCT02414945|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111100938|NCT02414945|Analgesics|analgesics|mesh-ancestor
111100939|NCT02414945|Sensory System Agents|sensory system agents|mesh-ancestor
111100940|NCT02414945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111100941|NCT02414555|Phenylephrine|phenylephrine|mesh-list
111100942|NCT02414555|Norepinephrine|norepinephrine|mesh-list
111100943|NCT02414555|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
111100944|NCT02414555|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111100945|NCT02414555|Mydriatics|mydriatics|mesh-ancestor
111100946|NCT02414555|Autonomic Agents|autonomic agents|mesh-ancestor
111100947|NCT02414555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111100948|NCT02414555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111100949|NCT02414555|Sympathomimetics|sympathomimetics|mesh-ancestor
111100950|NCT02414555|Nasal Decongestants|nasal decongestants|mesh-ancestor
111100951|NCT02414555|Respiratory System Agents|respiratory system agents|mesh-ancestor
111100952|NCT02414555|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111100953|NCT02414555|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111100954|NCT02414555|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111100955|NCT02414555|Adrenergic Agents|adrenergic agents|mesh-ancestor
111100956|NCT02414555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111100957|NCT02414555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111100958|NCT02414555|Protective Agents|protective agents|mesh-ancestor
111100959|NCT02414399|Azithromycin|azithromycin|mesh-list
111100960|NCT02414399|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111100961|NCT02414399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111100962|NCT02046070|Dexamethasone|dexamethasone|mesh-list
111100963|NCT02046070|Cyclophosphamide|cyclophosphamide|mesh-list
111100964|NCT02046070|Ixazomib|ixazomib|mesh-list
111100965|NCT02046070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111100966|NCT02046070|Immunologic Factors|immunologic factors|mesh-ancestor
111100967|NCT02046070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111100968|NCT02046070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111100969|NCT02046070|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111100970|NCT02046070|Alkylating Agents|alkylating agents|mesh-ancestor
111100971|NCT02046070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111100972|NCT02046070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111100973|NCT02046070|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111100974|NCT02046070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111100975|NCT02046070|Antiemetics|antiemetics|mesh-ancestor
111100976|NCT02046070|Autonomic Agents|autonomic agents|mesh-ancestor
111100977|NCT02046070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111100978|NCT02046070|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111100979|NCT02046070|Glucocorticoids|glucocorticoids|mesh-ancestor
111100980|NCT02046070|Hormones|hormones|mesh-ancestor
111100981|NCT02046070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111100982|NCT02046070|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111100983|NCT02046070|Protease Inhibitors|protease inhibitors|mesh-ancestor
111100984|NCT02046070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111100985|NCT01663857|Carboplatin|carboplatin|mesh-list
111100986|NCT01663857|Gemcitabine|gemcitabine|mesh-list
111100987|NCT01663857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111100988|NCT01663857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111100989|NCT01663857|Antimetabolites|antimetabolites|mesh-ancestor
111100990|NCT01663857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111100991|NCT02414165|Flucytosine|flucytosine|mesh-list
111100992|NCT02414165|Bevacizumab|bevacizumab|mesh-list
111100993|NCT02414165|Temozolomide|temozolomide|mesh-list
111100994|NCT02414165|Lomustine|lomustine|mesh-list
111100995|NCT02414165|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111100996|NCT02414165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111100997|NCT02414165|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111100998|NCT02414165|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111100999|NCT02414165|Growth Substances|growth substances|mesh-ancestor
111101000|NCT02414165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111101001|NCT02414165|Growth Inhibitors|growth inhibitors|mesh-ancestor
111101002|NCT02414165|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111101003|NCT02414165|Alkylating Agents|alkylating agents|mesh-ancestor
111101004|NCT02414165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111101005|NCT02414165|Antifungal Agents|antifungal agents|mesh-ancestor
111101006|NCT02414165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111101007|NCT02414165|Antimetabolites|antimetabolites|mesh-ancestor
111101008|NCT02094898|Ketamine|ketamine|mesh-list
111101009|NCT02094898|Analgesics|analgesics|mesh-ancestor
111101010|NCT02094898|Sensory System Agents|sensory system agents|mesh-ancestor
111101011|NCT02094898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111101012|NCT02094898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111101013|NCT02094898|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111101014|NCT02094898|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111101015|NCT02094898|Anesthetics, General|anesthetics, general|mesh-ancestor
111101016|NCT02094898|Anesthetics|anesthetics|mesh-ancestor
111101017|NCT02094898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111101018|NCT02094898|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111101019|NCT02094898|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111101020|NCT02094898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111101021|NCT02094898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111101022|NCT02414009|Leucovorin|leucovorin|mesh-list
111101023|NCT02414009|Fluorouracil|fluorouracil|mesh-list
111101024|NCT02414009|Capecitabine|capecitabine|mesh-list
111101025|NCT02414009|Irinotecan|irinotecan|mesh-list
111101026|NCT02414009|Temozolomide|temozolomide|mesh-list
111101027|NCT02414009|Antimetabolites|antimetabolites|mesh-ancestor
111101028|NCT02414009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111101029|NCT02414009|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111101030|NCT02414009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111101031|NCT02414009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111101032|NCT02414009|Immunologic Factors|immunologic factors|mesh-ancestor
111101033|NCT02414009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111101034|NCT02414009|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111101035|NCT02414009|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111101036|NCT02414009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111101037|NCT02414009|Antidotes|antidotes|mesh-ancestor
111101038|NCT02414009|Protective Agents|protective agents|mesh-ancestor
111101039|NCT02414009|Vitamin B Complex|vitamin b complex|mesh-ancestor
111101040|NCT02414009|Vitamins|vitamins|mesh-ancestor
111101041|NCT02414009|Micronutrients|micronutrients|mesh-ancestor
111101042|NCT02414009|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111101043|NCT02414009|Alkylating Agents|alkylating agents|mesh-ancestor
111101044|NCT02413853|Leucovorin|leucovorin|mesh-list
111101045|NCT02413853|Bevacizumab|bevacizumab|mesh-list
111101046|NCT02413853|Fluorouracil|fluorouracil|mesh-list
111101047|NCT02413853|Oxaliplatin|oxaliplatin|mesh-list
111101049|NCT02413853|Levoleucovorin|levoleucovorin|mesh-list
111101050|NCT02413853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111101051|NCT02413853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111101052|NCT02413853|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111101053|NCT02413853|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111101054|NCT02413853|Growth Substances|growth substances|mesh-ancestor
111101055|NCT02413853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111101056|NCT02413853|Growth Inhibitors|growth inhibitors|mesh-ancestor
111101057|NCT02413853|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111101058|NCT02413853|Antimetabolites|antimetabolites|mesh-ancestor
111101059|NCT02413853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111101060|NCT02413853|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111101061|NCT02413853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111101062|NCT02413853|Immunologic Factors|immunologic factors|mesh-ancestor
111101063|NCT02413853|Antidotes|antidotes|mesh-ancestor
111101064|NCT02413853|Protective Agents|protective agents|mesh-ancestor
111101065|NCT02413853|Vitamin B Complex|vitamin b complex|mesh-ancestor
111101066|NCT02413853|Vitamins|vitamins|mesh-ancestor
111101067|NCT02413853|Micronutrients|micronutrients|mesh-ancestor
111101068|NCT00704483|Ferric Compounds|ferric compounds|mesh-list
111101069|NCT00704483|Sevelamer|sevelamer|mesh-list
111101070|NCT00704483|Chelating Agents|chelating agents|mesh-ancestor
111101071|NCT00704483|Sequestering Agents|sequestering agents|mesh-ancestor
111101072|NCT00704483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111101073|NCT00704483|Hematinics|hematinics|mesh-ancestor
111101074|NCT04596189|Mometasone Furoate|mometasone furoate|mesh-list
111101075|NCT04596189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111101076|NCT04596189|Dermatologic Agents|dermatologic agents|mesh-ancestor
111101077|NCT04596189|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111101078|NCT03176537|Testosterone|testosterone|mesh-list
111101079|NCT03176537|Androgens|androgens|mesh-ancestor
111101080|NCT03176537|Hormones|hormones|mesh-ancestor
111101081|NCT03176537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111101082|NCT03176537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111101083|NCT05511441|Aspirin|aspirin|mesh-list
111101084|NCT05511441|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111101085|NCT05511441|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111101086|NCT05511441|Analgesics|analgesics|mesh-ancestor
111101087|NCT05511441|Sensory System Agents|sensory system agents|mesh-ancestor
111101088|NCT05511441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111101089|NCT05511441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111101090|NCT05511441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111101091|NCT05511441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111101092|NCT05511441|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111101093|NCT05511441|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111101094|NCT05511441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111101095|NCT05511441|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111101096|NCT05511441|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111101097|NCT05511441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111101098|NCT05511441|Antipyretics|antipyretics|mesh-ancestor
111101099|NCT05515731|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111101100|NCT05515731|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111101101|NCT02413541|Polymyxins|polymyxins|mesh-list
111101102|NCT02413541|Polymyxin B|polymyxin b|mesh-list
111101103|NCT02413541|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111101104|NCT02413541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111101105|NCT02045836|Vaccines|vaccines|mesh-list
111101106|NCT02045836|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
111101107|NCT02045836|Immunologic Factors|immunologic factors|mesh-ancestor
111101108|NCT02045836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111101109|NCT02412917|Valacyclovir|valacyclovir|mesh-list
111101110|NCT02412917|Antiviral Agents|antiviral agents|mesh-ancestor
111101111|NCT02412917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111101112|NCT02412683|Oxaliplatin|oxaliplatin|mesh-list
111101113|NCT02412683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111101114|NCT02569437|Fluticasone|fluticasone|mesh-list
111101115|NCT02569437|Doxycycline|doxycycline|mesh-list
111101116|NCT02569437|Methylprednisolone|methylprednisolone|mesh-list
111101117|NCT02569437|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111101118|NCT02569437|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111101119|NCT02569437|Prednisolone|prednisolone|mesh-list
111101120|NCT02569437|Prednisolone acetate|prednisolone acetate|mesh-list
111101121|NCT02569437|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111101122|NCT02569437|Prednisolone phosphate|prednisolone phosphate|mesh-list
111101123|NCT02569437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111101124|NCT02569437|Antiemetics|antiemetics|mesh-ancestor
110406916|NCT00989833|Budesonide|budesonide|mesh-list
111101125|NCT02569437|Autonomic Agents|autonomic agents|mesh-ancestor
111101126|NCT02569437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111101127|NCT02569437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111101128|NCT02569437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111101129|NCT02569437|Glucocorticoids|glucocorticoids|mesh-ancestor
111101131|NCT02569437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111101132|NCT02569437|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111101133|NCT02569437|Protective Agents|protective agents|mesh-ancestor
111101134|NCT02569437|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111101135|NCT02569437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111101136|NCT02569437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111101137|NCT02569437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111101138|NCT02569437|Antimalarials|antimalarials|mesh-ancestor
111101139|NCT02569437|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111101140|NCT02569437|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111101141|NCT02569437|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111101142|NCT02569437|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111101143|NCT02569437|Respiratory System Agents|respiratory system agents|mesh-ancestor
111101144|NCT02569437|Dermatologic Agents|dermatologic agents|mesh-ancestor
111101145|NCT02569437|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111101146|NCT02412449|Glycine|glycine|mesh-list
111101147|NCT02412449|Glycine Agents|glycine agents|mesh-ancestor
111101148|NCT02412449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111101149|NCT02412449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111101150|NCT02412449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111101151|NCT02412059|Prednisolone|prednisolone|mesh-list
111101152|NCT02412059|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111101153|NCT02412059|Methylprednisolone|methylprednisolone|mesh-list
111101154|NCT02412059|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111101155|NCT02412059|Prednisolone acetate|prednisolone acetate|mesh-list
110818239|NCT05040984|Solifenacin Succinate|solifenacin succinate|mesh-list
111101156|NCT02412059|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111101157|NCT02412059|Prednisolone phosphate|prednisolone phosphate|mesh-list
111101158|NCT02412059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111101159|NCT02412059|Glucocorticoids|glucocorticoids|mesh-ancestor
111101160|NCT02412059|Hormones|hormones|mesh-ancestor
111101161|NCT02412059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111101162|NCT02412059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111101163|NCT02412059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111101164|NCT02412059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111101165|NCT02412059|Antiemetics|antiemetics|mesh-ancestor
111101166|NCT02412059|Autonomic Agents|autonomic agents|mesh-ancestor
111101167|NCT02412059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111101168|NCT02412059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111101169|NCT02412059|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111101170|NCT02412059|Protective Agents|protective agents|mesh-ancestor
111101171|NCT03175679|Interleukin-2|interleukin-2|mesh-list
111101172|NCT03175679|Tegafur|tegafur|mesh-list
111101173|NCT03175679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111101174|NCT03175679|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111101175|NCT03175679|Analgesics|analgesics|mesh-ancestor
111101176|NCT03175679|Sensory System Agents|sensory system agents|mesh-ancestor
111101177|NCT03175679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111101178|NCT03175679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111101179|NCT03175679|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111101180|NCT03175679|Antimetabolites|antimetabolites|mesh-ancestor
111101181|NCT03175679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111101182|NCT05520645|Propofol|propofol|mesh-list
111101183|NCT05520645|Etomidate|etomidate|mesh-list
111101184|NCT05520645|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111101185|NCT05520645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111101186|NCT05520645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111101187|NCT05520645|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111101188|NCT05520645|Anesthetics, General|anesthetics, general|mesh-ancestor
111101189|NCT05520645|Anesthetics|anesthetics|mesh-ancestor
111101190|NCT03175835|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111101191|NCT03175835|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111101192|NCT03175835|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111101193|NCT03175835|Antimetabolites|antimetabolites|mesh-ancestor
111101194|NCT03175835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111101195|NCT03175835|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111101196|NCT03175835|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111101197|NCT03175835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111101198|NCT05515185|Cyclophosphamide|cyclophosphamide|mesh-list
111101199|NCT05515185|Fludarabine|fludarabine|mesh-list
111101200|NCT05515185|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111101201|NCT05515185|Immunologic Factors|immunologic factors|mesh-ancestor
111101202|NCT05515185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111101203|NCT05515185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111101204|NCT05515185|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111101205|NCT05515185|Alkylating Agents|alkylating agents|mesh-ancestor
111101206|NCT05515185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111101207|NCT05515185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111101208|NCT05515185|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111101210|NCT02044822|Idelalisib|idelalisib|mesh-list
111101211|NCT02044822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111101212|NCT02044822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111101213|NCT02044822|Immunologic Factors|immunologic factors|mesh-ancestor
111101214|NCT02044822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111101215|NCT02044822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111101216|NCT02044822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111101217|NCT02044822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111101218|NCT03116555|Irinotecan|irinotecan|mesh-list
111101219|NCT03116555|Apatinib|apatinib|mesh-list
111101220|NCT03116555|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111101221|NCT03116555|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111101222|NCT03116555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111101223|NCT03116555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111101224|NCT03116555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111101225|NCT03116555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111101226|NCT02044510|Mirabegron|mirabegron|mesh-list
111101227|NCT02044510|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
111101228|NCT02044510|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110818316|NCT04849013|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111101229|NCT02044510|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111101230|NCT02044510|Adrenergic Agents|adrenergic agents|mesh-ancestor
111101231|NCT02044510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111101232|NCT02044510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111101233|NCT02044510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111101234|NCT02044510|Urological Agents|urological agents|mesh-ancestor
111101235|NCT02411903|Clopidogrel|clopidogrel|mesh-list
111101236|NCT02411903|Atorvastatin|atorvastatin|mesh-list
111101237|NCT02411903|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111101238|NCT02411903|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111101239|NCT02411903|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111101240|NCT02411903|Antimetabolites|antimetabolites|mesh-ancestor
111101241|NCT02411903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111101242|NCT02411903|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111101243|NCT02411903|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111101244|NCT02411903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111101245|NCT02411903|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111101246|NCT02411903|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111101247|NCT02411903|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111101248|NCT02411903|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111101249|NCT02411903|Purinergic Agents|purinergic agents|mesh-ancestor
111101250|NCT02411903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111101251|NCT02411903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111101252|NCT02411825|Metformin|metformin|mesh-list
111101253|NCT02411825|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111101254|NCT02411825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111101255|NCT05514405|Propofol|propofol|mesh-list
111101256|NCT05514405|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111101257|NCT05514405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111101258|NCT05514405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111101259|NCT05514405|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111101260|NCT05514405|Anesthetics, General|anesthetics, general|mesh-ancestor
111101261|NCT05514405|Anesthetics|anesthetics|mesh-ancestor
111101262|NCT02410655|Oxytocin|oxytocin|mesh-list
111101263|NCT02410655|Oxytocics|oxytocics|mesh-ancestor
111101264|NCT02410655|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111101265|NCT02410655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111101266|NCT02410499|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111101267|NCT02410499|Immunologic Factors|immunologic factors|mesh-ancestor
111101268|NCT02410499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111101269|NCT05510505|Antibodies|antibodies|mesh-list
111101270|NCT05510505|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110407131|NCT04290793|Taxane|taxane|mesh-list
111101271|NCT05510505|Immunologic Factors|immunologic factors|mesh-ancestor
111101272|NCT05510505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111101273|NCT05514015|Cyclophosphamide|cyclophosphamide|mesh-list
111101275|NCT05514015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111101276|NCT05514015|Immunologic Factors|immunologic factors|mesh-ancestor
111101277|NCT05514015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111101278|NCT05514015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111101279|NCT05514015|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111101280|NCT05514015|Alkylating Agents|alkylating agents|mesh-ancestor
111101281|NCT05514015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111101282|NCT05514015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111101283|NCT05514015|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111101284|NCT05514015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111101285|NCT03174821|Insulin|insulin|mesh-list
111101286|NCT03174821|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111101287|NCT03174821|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111101288|NCT03174821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111101289|NCT05520021|Magnesium Sulfate|magnesium sulfate|mesh-list
111101290|NCT05520021|Nifedipine|nifedipine|mesh-list
111101291|NCT05520021|Analgesics|analgesics|mesh-ancestor
111101292|NCT05520021|Sensory System Agents|sensory system agents|mesh-ancestor
111101293|NCT05520021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111101294|NCT05520021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111101295|NCT05520021|Anesthetics|anesthetics|mesh-ancestor
111101296|NCT05520021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111101297|NCT05520021|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111101298|NCT05520021|Anticonvulsants|anticonvulsants|mesh-ancestor
111101299|NCT05520021|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111101300|NCT05520021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111101301|NCT05520021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111101302|NCT05520021|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111101303|NCT05520021|Tocolytic Agents|tocolytic agents|mesh-ancestor
111101304|NCT05520021|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111101305|NCT05520021|Vasodilator Agents|vasodilator agents|mesh-ancestor
111101306|NCT02410031|Cyproterone Acetate|cyproterone acetate|mesh-list
111101307|NCT02410031|Ethinyl Estradiol|ethinyl estradiol|mesh-list
111101308|NCT02410031|Cyproterone|cyproterone|mesh-list
111101309|NCT02410031|Cyproterone acetate, ethinyl estradiol drug combination|cyproterone acetate, ethinyl estradiol drug combination|mesh-list
111101310|NCT02410031|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111101311|NCT02410031|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111101312|NCT02410031|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111101313|NCT02410031|Contraceptive Agents|contraceptive agents|mesh-ancestor
111101314|NCT02410031|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111101315|NCT02410031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111101316|NCT02410031|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111101317|NCT02410031|Estrogens|estrogens|mesh-ancestor
111101318|NCT02410031|Hormones|hormones|mesh-ancestor
111101319|NCT02410031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111101320|NCT02410031|Androgen Antagonists|androgen antagonists|mesh-ancestor
111101321|NCT02410031|Hormone Antagonists|hormone antagonists|mesh-ancestor
111101322|NCT02410031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111101323|NCT02410031|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
111101324|NCT02409641|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111101325|NCT02409641|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111101326|NCT02067676|Aluminum Hydroxide|aluminum hydroxide|mesh-list
111101327|NCT02067676|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111101328|NCT02067676|Immunologic Factors|immunologic factors|mesh-ancestor
111101329|NCT02067676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111101330|NCT02067676|Antacids|antacids|mesh-ancestor
111101331|NCT02067676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111101332|NCT02067676|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111101333|NCT02409407|Alprostadil|alprostadil|mesh-list
111101334|NCT02409407|Misoprostol|misoprostol|mesh-list
111101335|NCT02409407|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111101336|NCT02409407|Abortifacient Agents|abortifacient agents|mesh-ancestor
111101337|NCT02409407|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111101338|NCT02409407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111101339|NCT02409407|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111101340|NCT02409407|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111101341|NCT02409407|Oxytocics|oxytocics|mesh-ancestor
111101342|NCT02409407|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111101343|NCT02409407|Vasodilator Agents|vasodilator agents|mesh-ancestor
111101344|NCT02409407|Urological Agents|urological agents|mesh-ancestor
111101345|NCT02409563|Budesonide|budesonide|mesh-list
111101346|NCT02409563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111101347|NCT02409563|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111101348|NCT02409563|Autonomic Agents|autonomic agents|mesh-ancestor
111101349|NCT02409563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111101350|NCT02409563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111101351|NCT02409563|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111101352|NCT02409563|Respiratory System Agents|respiratory system agents|mesh-ancestor
111101353|NCT02409563|Glucocorticoids|glucocorticoids|mesh-ancestor
111101354|NCT02409563|Hormones|hormones|mesh-ancestor
111101355|NCT02409563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111101356|NCT05513313|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
111101357|NCT05513313|Antiviral Agents|antiviral agents|mesh-ancestor
111101358|NCT05513313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111101359|NCT02409017|Insulin|insulin|mesh-list
111101360|NCT02409017|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111101361|NCT02409017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111101362|NCT00702689|Imatinib Mesylate|imatinib mesylate|mesh-list
111101363|NCT00702689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111101364|NCT00702689|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111101365|NCT00702689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111101366|NCT00702689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111101367|NCT02065570|Adalimumab|adalimumab|mesh-list
111101368|NCT02065570|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111101369|NCT02065570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111101370|NCT02065570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111101371|NCT02408705|Acetaminophen|acetaminophen|mesh-list
111101372|NCT02408705|Liraglutide|liraglutide|mesh-list
111101373|NCT02408705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111101374|NCT02408705|Analgesics|analgesics|mesh-ancestor
111101375|NCT02408705|Sensory System Agents|sensory system agents|mesh-ancestor
111101376|NCT02408705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110818464|NCT04247815|Abortifacient Agents|abortifacient agents|mesh-ancestor
111101377|NCT02408705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111101378|NCT02408705|Antipyretics|antipyretics|mesh-ancestor
111101379|NCT02408705|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111101380|NCT02408705|Incretins|incretins|mesh-ancestor
111101382|NCT02408705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111101383|NCT02408939|Hydrocortisone|hydrocortisone|mesh-list
111101384|NCT02408939|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
111101385|NCT02408939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111101386|NCT05507697|Thioctic Acid|thioctic acid|mesh-list
111101387|NCT05507697|Antioxidants|antioxidants|mesh-ancestor
111101388|NCT05507697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111101389|NCT05507697|Protective Agents|protective agents|mesh-ancestor
111101390|NCT05507697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111101391|NCT05507697|Vitamin B Complex|vitamin b complex|mesh-ancestor
111101392|NCT05507697|Vitamins|vitamins|mesh-ancestor
111101393|NCT05507697|Micronutrients|micronutrients|mesh-ancestor
111101394|NCT04292223|Pimavanserin|pimavanserin|mesh-list
111101395|NCT04292223|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111101396|NCT04292223|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111101397|NCT04292223|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111101398|NCT04292223|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111101399|NCT04292223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111101400|NCT04292223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111101401|NCT04292223|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111101402|NCT04292223|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111101403|NCT04292223|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111101404|NCT04292223|Serotonin Agents|serotonin agents|mesh-ancestor
111101405|NCT04292223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111101406|NCT04292223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111101407|NCT03116321|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
111101408|NCT03116321|Anticonvulsants|anticonvulsants|mesh-ancestor
111101409|NCT03116321|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111101410|NCT03116321|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111101411|NCT03116321|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111101412|NCT03116321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111101413|NCT03174041|Itraconazole|itraconazole|mesh-list
111101414|NCT03174041|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
111101415|NCT03174041|Midazolam|midazolam|mesh-list
111101416|NCT03174041|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111101417|NCT03174041|Simvastatin|simvastatin|mesh-list
111101418|NCT03174041|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111101419|NCT03174041|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111101420|NCT03174041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111101421|NCT03174041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111101422|NCT03174041|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111101423|NCT03174041|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111101424|NCT03174041|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111101425|NCT03174041|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111101426|NCT03174041|Anesthetics, General|anesthetics, general|mesh-ancestor
111101427|NCT03174041|Anesthetics|anesthetics|mesh-ancestor
111101428|NCT03174041|GABA Modulators|gaba modulators|mesh-ancestor
111101429|NCT03174041|GABA Agents|gaba agents|mesh-ancestor
111101430|NCT03174041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111101431|NCT03174041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111101432|NCT03174041|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111101433|NCT03174041|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111101434|NCT03174041|Antimetabolites|antimetabolites|mesh-ancestor
111101435|NCT03174041|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111101436|NCT03174041|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111101437|NCT03174041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111101438|NCT03174041|Antifungal Agents|antifungal agents|mesh-ancestor
111101439|NCT03174041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111101440|NCT03174041|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111101441|NCT03174041|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111101442|NCT03174041|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111101443|NCT03174041|Hormone Antagonists|hormone antagonists|mesh-ancestor
111101444|NCT03174041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111101445|NCT03174041|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111101446|NCT02566005|Misoprostol|misoprostol|mesh-list
111101447|NCT02566005|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111101448|NCT02566005|Abortifacient Agents|abortifacient agents|mesh-ancestor
111101449|NCT02566005|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111101450|NCT02566005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111101451|NCT02566005|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111101452|NCT02566005|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111101453|NCT02566005|Oxytocics|oxytocics|mesh-ancestor
111101454|NCT02408393|Ropivacaine|ropivacaine|mesh-list
111101455|NCT02408393|Anesthetics, Local|anesthetics, local|mesh-ancestor
111101456|NCT02408393|Anesthetics|anesthetics|mesh-ancestor
111101457|NCT02408393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111101458|NCT02408393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111101459|NCT02408393|Sensory System Agents|sensory system agents|mesh-ancestor
111101460|NCT02408393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111101461|NCT03173963|Empagliflozin|empagliflozin|mesh-list
111101462|NCT03173963|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111101463|NCT03173963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111101464|NCT03173963|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111101465|NCT03173963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111101466|NCT05507229|Vaccines|vaccines|mesh-list
111101467|NCT05507229|Immunologic Factors|immunologic factors|mesh-ancestor
111101468|NCT05507229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111101469|NCT03173417|Cyclophosphamide|cyclophosphamide|mesh-list
111101470|NCT03173417|Fludarabine|fludarabine|mesh-list
111101471|NCT03173417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111101472|NCT03173417|Immunologic Factors|immunologic factors|mesh-ancestor
111101473|NCT03173417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111101474|NCT03173417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111101475|NCT03173417|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111101476|NCT03173417|Alkylating Agents|alkylating agents|mesh-ancestor
111101477|NCT03173417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111101478|NCT03173417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111101479|NCT03173417|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111101480|NCT03173339|Remifentanil|remifentanil|mesh-list
111101481|NCT03173339|Sevoflurane|sevoflurane|mesh-list
111101482|NCT03173339|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111101483|NCT03173339|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111101484|NCT03173339|Anesthetics, General|anesthetics, general|mesh-ancestor
111101485|NCT03173339|Anesthetics|anesthetics|mesh-ancestor
111101486|NCT03173339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111101487|NCT03173339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111101488|NCT03173339|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111101489|NCT03173339|Narcotics|narcotics|mesh-ancestor
111101490|NCT03173339|Analgesics|analgesics|mesh-ancestor
110029930|NCT02689778|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111101491|NCT03173339|Sensory System Agents|sensory system agents|mesh-ancestor
111101492|NCT03173339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111101493|NCT03172871|Aripiprazole|aripiprazole|mesh-list
111101494|NCT03172871|Antidepressive Agents|antidepressive agents|mesh-ancestor
111101495|NCT03172871|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111101496|NCT03172871|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111101497|NCT03172871|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111101498|NCT03172871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111101499|NCT03172871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111101500|NCT03172871|Dopamine Agonists|dopamine agonists|mesh-ancestor
111101501|NCT03172871|Dopamine Agents|dopamine agents|mesh-ancestor
111101502|NCT03172871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111101503|NCT03172871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111101504|NCT03172871|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111101505|NCT03172871|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111101506|NCT03172871|Serotonin Agents|serotonin agents|mesh-ancestor
111101507|NCT03172871|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111101508|NCT03172871|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111101509|NCT03172871|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111101510|NCT03172871|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111101511|NCT02065336|Chlorpheniramine|chlorpheniramine|mesh-list
111101512|NCT02065336|Entecavir|entecavir|mesh-list
111101513|NCT02065336|Antiviral Agents|antiviral agents|mesh-ancestor
111101514|NCT02065336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111101515|NCT02065336|Antipruritics|antipruritics|mesh-ancestor
111101516|NCT02065336|Dermatologic Agents|dermatologic agents|mesh-ancestor
111101517|NCT02065336|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111101518|NCT02065336|Histamine Antagonists|histamine antagonists|mesh-ancestor
111101519|NCT02065336|Histamine Agents|histamine agents|mesh-ancestor
111101520|NCT02065336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111101521|NCT02065336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110642651|NCT00883064|Protective Agents|protective agents|mesh-ancestor
111101522|NCT02065336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111101523|NCT02065336|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111101524|NCT02408003|Simendan|simendan|mesh-list
111101525|NCT02408003|Milrinone|milrinone|mesh-list
111101526|NCT02408003|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111101527|NCT02408003|Vasodilator Agents|vasodilator agents|mesh-ancestor
111101528|NCT02408003|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
111101529|NCT02408003|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111101530|NCT02408003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111101531|NCT02408003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111101532|NCT02408003|Protective Agents|protective agents|mesh-ancestor
111101533|NCT02408003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111101534|NCT02408003|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111101536|NCT02406911|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111101537|NCT02406911|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111101538|NCT02406911|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111101539|NCT02406911|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111101540|NCT02406911|Purinergic Agents|purinergic agents|mesh-ancestor
111101541|NCT02406911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111101542|NCT02406911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111101543|NCT02406911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111101544|NCT03172793|Telavancin|telavancin|mesh-list
111101545|NCT03172793|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111101546|NCT03172793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111101547|NCT03116087|Methyltestosterone|methyltestosterone|mesh-list
111101548|NCT03116087|Testosterone|testosterone|mesh-list
111101549|NCT03116087|Testosterone undecanoate|testosterone undecanoate|mesh-list
111101550|NCT03116087|Testosterone enanthate|testosterone enanthate|mesh-list
111101551|NCT03116087|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
111101552|NCT03116087|Androgens|androgens|mesh-ancestor
111101553|NCT03116087|Hormones|hormones|mesh-ancestor
111101554|NCT03116087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111101555|NCT03116087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111101556|NCT03116087|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111101557|NCT03116087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111101558|NCT03116087|Anabolic Agents|anabolic agents|mesh-ancestor
111101559|NCT02701985|Petesicatib|petesicatib|mesh-list
111101560|NCT02701985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111101561|NCT02701985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111101562|NCT02406521|Sorafenib|sorafenib|mesh-list
111101563|NCT02406521|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
111101564|NCT02406521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111101565|NCT02406521|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111101566|NCT02406521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111101567|NCT02406521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111101568|NCT02406287|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111101569|NCT02406287|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111101570|NCT02406053|Antioxidants|antioxidants|mesh-list
111101571|NCT02406053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111101572|NCT02406053|Protective Agents|protective agents|mesh-ancestor
111101573|NCT02406053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111101574|NCT02064166|Insulin|insulin|mesh-list
111101575|NCT02064166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111101576|NCT02064166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111101577|NCT03171623|Globalagliatin|globalagliatin|mesh-list
111101578|NCT03171623|Enzyme Activators|enzyme activators|mesh-ancestor
111101579|NCT03171623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111101580|NCT03171389|Ponatinib|ponatinib|mesh-list
110642656|NCT01077505|rGLP-1 protein|rglp-1 protein|mesh-list
111101581|NCT03171389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111101582|NCT03171389|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111101583|NCT03171389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111101584|NCT03171389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111101585|NCT05508633|Mebeverine|mebeverine|mesh-list
111101586|NCT05508633|Alverine|alverine|mesh-list
111101587|NCT05508633|Parasympatholytics|parasympatholytics|mesh-ancestor
111101588|NCT05508633|Autonomic Agents|autonomic agents|mesh-ancestor
111101589|NCT05508633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111101590|NCT05508633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111101591|NCT05508633|Anticonvulsants|anticonvulsants|mesh-ancestor
111101592|NCT04482257|Irinotecan|irinotecan|mesh-list
111101593|NCT04482257|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111101594|NCT04482257|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111101595|NCT04482257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111101596|NCT04482257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111101597|NCT04482257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111101598|NCT05502705|Lidocaine|lidocaine|mesh-list
111101599|NCT05502705|Anesthetics, Local|anesthetics, local|mesh-ancestor
111101600|NCT05502705|Anesthetics|anesthetics|mesh-ancestor
111101601|NCT05502705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111101602|NCT05502705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111101603|NCT05502705|Sensory System Agents|sensory system agents|mesh-ancestor
111101604|NCT05502705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111101605|NCT05502705|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111101606|NCT05502705|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111101607|NCT05502705|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111101608|NCT05502705|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111101609|NCT05502705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111101610|NCT05506137|Pilocarpine|pilocarpine|mesh-list
111101611|NCT05506137|Miotics|miotics|mesh-ancestor
111101612|NCT05506137|Autonomic Agents|autonomic agents|mesh-ancestor
111101613|NCT05506137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111101614|NCT05506137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111101615|NCT05506137|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
111101616|NCT05506137|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111101617|NCT05506137|Cholinergic Agents|cholinergic agents|mesh-ancestor
111101618|NCT05506137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111101619|NCT05506137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111101620|NCT04742283|Timolol|timolol|mesh-list
111101621|NCT04742283|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111101622|NCT04742283|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111101623|NCT04742283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111101624|NCT04742283|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111101625|NCT04742283|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111101626|NCT04742283|Adrenergic Agents|adrenergic agents|mesh-ancestor
111101627|NCT04742283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111101628|NCT04742283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111101629|NCT04742283|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111101630|NCT04742283|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111101632|NCT04289805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111101633|NCT04289805|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111101634|NCT04289805|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111101635|NCT04289805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111101636|NCT04289805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111101637|NCT04289805|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111101638|NCT04289805|Hormone Antagonists|hormone antagonists|mesh-ancestor
111101639|NCT04289805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111101640|NCT04289805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111101641|NCT05505591|Cangrelor|cangrelor|mesh-list
111101642|NCT05505591|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111101643|NCT05505591|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111101644|NCT05505591|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111101645|NCT05505591|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111101646|NCT05505591|Purinergic Agents|purinergic agents|mesh-ancestor
111101647|NCT05505591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110642668|NCT01073995|Triamcinolone|triamcinolone|mesh-list
111101648|NCT05505591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111101649|NCT05505591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111101650|NCT05448807|Phentolamine|phentolamine|mesh-list
111101651|NCT05448807|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111101652|NCT05448807|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111101653|NCT05448807|Adrenergic Agents|adrenergic agents|mesh-ancestor
111101654|NCT05448807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111101655|NCT05448807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111101656|NCT05448807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111101657|NCT05448807|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111101658|NCT01662999|Dapagliflozin|dapagliflozin|mesh-list
111101659|NCT01662999|Saxagliptin|saxagliptin|mesh-list
111101660|NCT01662999|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111101661|NCT01662999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111101662|NCT01662999|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111101663|NCT01662999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111101664|NCT01662999|Incretins|incretins|mesh-ancestor
111101665|NCT01662999|Hormones|hormones|mesh-ancestor
111101666|NCT01662999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111101667|NCT01662999|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111101668|NCT01662999|Protease Inhibitors|protease inhibitors|mesh-ancestor
111101669|NCT01662999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111101670|NCT05366283|Sargramostim|sargramostim|mesh-list
111101671|NCT05366283|Immunologic Factors|immunologic factors|mesh-ancestor
111101672|NCT05366283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111101673|NCT02565381|Nicotine|nicotine|mesh-list
111101674|NCT02565381|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111101675|NCT02565381|Autonomic Agents|autonomic agents|mesh-ancestor
111101676|NCT02565381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111101677|NCT02565381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111101678|NCT02565381|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111101679|NCT02565381|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111101680|NCT02565381|Cholinergic Agents|cholinergic agents|mesh-ancestor
111101681|NCT02565381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111101682|NCT02565381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111101683|NCT02063854|Risedronic Acid|risedronic acid|mesh-list
111101684|NCT02063854|Etidronic Acid|etidronic acid|mesh-list
111101685|NCT02063854|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111101686|NCT02063854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111101687|NCT02063854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111101688|NCT02063854|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111101689|NCT02063854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111101690|NCT02063854|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111101691|NCT02063698|Auranofin|auranofin|mesh-list
111101692|NCT02063698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111101693|NCT04701333|Cabergoline|cabergoline|mesh-list
111101694|NCT04701333|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111101695|NCT04701333|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111101696|NCT04701333|Dopamine Agonists|dopamine agonists|mesh-ancestor
111101697|NCT04701333|Dopamine Agents|dopamine agents|mesh-ancestor
111101698|NCT04701333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111101699|NCT04701333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111101700|NCT04701333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111101701|NCT04701034|Prednisolone|prednisolone|mesh-list
111101702|NCT04701034|Immunoglobulins|immunoglobulins|mesh-list
111101703|NCT04701034|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111101704|NCT04701034|Antibodies|antibodies|mesh-list
111101705|NCT04701034|gamma-Globulins|gamma-globulins|mesh-list
111101706|NCT04701034|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
111101707|NCT04701034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111101708|NCT04701034|Glucocorticoids|glucocorticoids|mesh-ancestor
111101709|NCT04701034|Hormones|hormones|mesh-ancestor
111101710|NCT04701034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111101711|NCT04701034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110642674|NCT01073995|Anesthetics|anesthetics|mesh-ancestor
111101712|NCT04701034|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111101713|NCT04701034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111101714|NCT04701034|Immunologic Factors|immunologic factors|mesh-ancestor
111101715|NCT01663623|Azathioprine|azathioprine|mesh-list
111101716|NCT01663623|Belimumab|belimumab|mesh-list
111101717|NCT01663623|Antimetabolites|antimetabolites|mesh-ancestor
111101718|NCT01663623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111101719|NCT01663623|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111101720|NCT01663623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111101721|NCT01663623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111101722|NCT01663623|Immunologic Factors|immunologic factors|mesh-ancestor
111101723|NCT01663623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111101724|NCT01663623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111101725|NCT04582305|Bleomycin|bleomycin|mesh-list
111101726|NCT04582305|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111101727|NCT04582305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111101728|NCT05504967|Dexamethasone|dexamethasone|mesh-list
111101729|NCT05504967|Ropivacaine|ropivacaine|mesh-list
111101730|NCT05504967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111101731|NCT05504967|Antiemetics|antiemetics|mesh-ancestor
111101732|NCT05504967|Autonomic Agents|autonomic agents|mesh-ancestor
111101733|NCT05504967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111101734|NCT05504967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111101735|NCT05504967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111101736|NCT05504967|Glucocorticoids|glucocorticoids|mesh-ancestor
111101737|NCT05504967|Hormones|hormones|mesh-ancestor
111101738|NCT05504967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111101739|NCT05504967|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111101740|NCT05504967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111101741|NCT05504967|Anesthetics, Local|anesthetics, local|mesh-ancestor
111101742|NCT05504967|Anesthetics|anesthetics|mesh-ancestor
111101743|NCT05504967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111101744|NCT05504967|Sensory System Agents|sensory system agents|mesh-ancestor
111101745|NCT02565147|Heparin|heparin|mesh-list
111101746|NCT02565147|Bivalirudin|bivalirudin|mesh-list
111101747|NCT02565147|Anticoagulants|anticoagulants|mesh-ancestor
111101748|NCT02565147|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111101749|NCT02565147|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111101750|NCT02565147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111101751|NCT02565147|Antithrombins|antithrombins|mesh-ancestor
111101752|NCT02565147|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111101753|NCT02565147|Protease Inhibitors|protease inhibitors|mesh-ancestor
111101754|NCT02565147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111101755|NCT02061280|Fluticasone|fluticasone|mesh-list
111101756|NCT02061280|Xhance|xhance|mesh-list
111101757|NCT02061280|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
111101758|NCT02061280|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
111101759|NCT02061280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111101760|NCT02061280|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111101761|NCT02061280|Autonomic Agents|autonomic agents|mesh-ancestor
111101762|NCT02061280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111101763|NCT02061280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111101764|NCT02061280|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111101765|NCT02061280|Respiratory System Agents|respiratory system agents|mesh-ancestor
111101766|NCT02061280|Dermatologic Agents|dermatologic agents|mesh-ancestor
111101767|NCT02061280|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111101768|NCT02061280|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111101769|NCT02061280|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111101770|NCT02061280|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111101771|NCT02061280|Adrenergic Agents|adrenergic agents|mesh-ancestor
111101772|NCT02061280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111101773|NCT02061280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111101774|NCT02061280|Glucocorticoids|glucocorticoids|mesh-ancestor
111101775|NCT02061280|Hormones|hormones|mesh-ancestor
111101776|NCT02061280|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111101777|NCT02061280|Sympathomimetics|sympathomimetics|mesh-ancestor
111101778|NCT02061202|Mometasone Furoate|mometasone furoate|mesh-list
111101779|NCT02061202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111101780|NCT02061202|Dermatologic Agents|dermatologic agents|mesh-ancestor
111101781|NCT02061202|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111101782|NCT04664361|Niacinamide|niacinamide|mesh-list
111101783|NCT04664361|Niacin|niacin|mesh-list
111101784|NCT04664361|Nicotinic Acids|nicotinic acids|mesh-list
111101785|NCT04664361|Vitamin B Complex|vitamin b complex|mesh-ancestor
111101786|NCT04664361|Vitamins|vitamins|mesh-ancestor
111101787|NCT04664361|Micronutrients|micronutrients|mesh-ancestor
111101788|NCT04664361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111101789|NCT04664361|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111101790|NCT04664361|Antimetabolites|antimetabolites|mesh-ancestor
111101791|NCT04664361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111101792|NCT04664361|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111101793|NCT04664361|Vasodilator Agents|vasodilator agents|mesh-ancestor
111101794|NCT04698850|Ranibizumab|ranibizumab|mesh-list
111101795|NCT04698850|Aflibercept|aflibercept|mesh-list
111101796|NCT04698850|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111101797|NCT04698850|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111101798|NCT04698850|Growth Substances|growth substances|mesh-ancestor
111101799|NCT04698850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111101800|NCT04698850|Growth Inhibitors|growth inhibitors|mesh-ancestor
111101801|NCT04698850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111101802|NCT04698226|Temazepam|temazepam|mesh-list
111101803|NCT04698226|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111101804|NCT04698226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110642774|NCT00141271|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111101805|NCT04698226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111101806|NCT04698226|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111101807|NCT04698226|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111101808|NCT04698226|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111101809|NCT04698226|GABA Modulators|gaba modulators|mesh-ancestor
111101810|NCT04698226|GABA Agents|gaba agents|mesh-ancestor
111101811|NCT04698226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111101812|NCT04698226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111101813|NCT05504577|Tranylcypromine|tranylcypromine|mesh-list
111101814|NCT05504577|Tranexamic Acid|tranexamic acid|mesh-list
111101815|NCT05504577|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111101816|NCT05504577|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111101817|NCT05504577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111101818|NCT05504577|Hemostatics|hemostatics|mesh-ancestor
111101819|NCT05504577|Coagulants|coagulants|mesh-ancestor
111101820|NCT05504577|Antidepressive Agents|antidepressive agents|mesh-ancestor
111101821|NCT05504577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111101822|NCT05504577|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
111101823|NCT05504577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111101824|NCT05504577|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111101825|NCT05504577|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111101826|NCT05504577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111101827|NCT05504577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111101828|NCT05016297|Hydroxychloroquine|hydroxychloroquine|mesh-list
111101829|NCT05016297|Antimalarials|antimalarials|mesh-ancestor
111101830|NCT05016297|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111101831|NCT05016297|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111101832|NCT05016297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111101833|NCT05016297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110642817|NCT04387240|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111101834|NCT05016297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111101835|NCT05016297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111101836|NCT05504265|Flurbiprofen|flurbiprofen|mesh-list
111101837|NCT05504265|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
111101838|NCT05504265|Analgesics|analgesics|mesh-ancestor
111101839|NCT05504265|Sensory System Agents|sensory system agents|mesh-ancestor
111101840|NCT05504265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111101841|NCT05504265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111101842|NCT05504265|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111101843|NCT05504265|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111101844|NCT05504265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111101845|NCT05504265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111101846|NCT05504265|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111101847|NCT05504265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111101848|NCT05504265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111101849|NCT01625338|Sofosbuvir|sofosbuvir|mesh-list
111101850|NCT01625338|Antiviral Agents|antiviral agents|mesh-ancestor
111101851|NCT01625338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111101852|NCT04740099|Naloxone|naloxone|mesh-list
111101853|NCT04740099|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111101854|NCT04740099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111101855|NCT04740099|Sensory System Agents|sensory system agents|mesh-ancestor
111101856|NCT04740099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111101857|NCT02560389|Levodopa|levodopa|mesh-list
111101858|NCT02560389|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111101859|NCT02560389|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111101860|NCT02560389|Dopamine Agents|dopamine agents|mesh-ancestor
111101861|NCT02560389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111101862|NCT02560389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111101863|NCT02560389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111101864|NCT02564211|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111101865|NCT02564211|Ipragliflozin|ipragliflozin|mesh-list
111101866|NCT02564211|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110642868|NCT00883532|Hormones|hormones|mesh-ancestor
111101867|NCT02564211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111101868|NCT02564211|Incretins|incretins|mesh-ancestor
111101869|NCT02564211|Hormones|hormones|mesh-ancestor
111101870|NCT02564211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111101871|NCT02564211|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111101872|NCT02564211|Protease Inhibitors|protease inhibitors|mesh-ancestor
111101873|NCT02564211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111101874|NCT02564211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111101875|NCT02564211|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111101876|NCT04596579|Antibodies|antibodies|mesh-list
111101877|NCT04596579|Immunologic Factors|immunologic factors|mesh-ancestor
111101878|NCT04596579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111101879|NCT04465383|Propofol|propofol|mesh-list
111101880|NCT04465383|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111101881|NCT04465383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111101882|NCT04465383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111101883|NCT04465383|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111101884|NCT04465383|Anesthetics, General|anesthetics, general|mesh-ancestor
111101885|NCT04465383|Anesthetics|anesthetics|mesh-ancestor
111101886|NCT05500677|Lidocaine|lidocaine|mesh-list
111101887|NCT05500677|Fentanyl|fentanyl|mesh-list
111101888|NCT05500677|Tramadol|tramadol|mesh-list
111101889|NCT05500677|Anesthetics, Local|anesthetics, local|mesh-ancestor
111101890|NCT05500677|Anesthetics|anesthetics|mesh-ancestor
111101891|NCT05500677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111101892|NCT05500677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111101893|NCT05500677|Sensory System Agents|sensory system agents|mesh-ancestor
111101894|NCT05500677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111101895|NCT05500677|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111101896|NCT05500677|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111101897|NCT05500677|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111101898|NCT05500677|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111101899|NCT05500677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111101900|NCT05500677|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111101901|NCT05500677|Narcotics|narcotics|mesh-ancestor
111101902|NCT05500677|Analgesics|analgesics|mesh-ancestor
110818996|NCT01329289|Dexamethasone|dexamethasone|mesh-list
111101903|NCT05500677|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111101904|NCT05500677|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111101905|NCT05500677|Anesthetics, General|anesthetics, general|mesh-ancestor
111101906|NCT02093026|Folic Acid|folic acid|mesh-list
111101907|NCT02093026|Methylprednisolone|methylprednisolone|mesh-list
111101908|NCT02093026|Rituximab|rituximab|mesh-list
111101909|NCT02093026|Methotrexate|methotrexate|mesh-list
111101910|NCT02093026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111101911|NCT02093026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111101912|NCT02093026|Immunologic Factors|immunologic factors|mesh-ancestor
111101913|NCT02093026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111101914|NCT02093026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111101915|NCT02093026|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111101916|NCT02093026|Abortifacient Agents|abortifacient agents|mesh-ancestor
111101917|NCT02093026|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111101918|NCT02093026|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111101919|NCT02093026|Antimetabolites|antimetabolites|mesh-ancestor
111101920|NCT02093026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111101921|NCT02093026|Dermatologic Agents|dermatologic agents|mesh-ancestor
111101922|NCT02093026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111101923|NCT02093026|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111101924|NCT02093026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111101925|NCT02093026|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111101926|NCT02093026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111101927|NCT02093026|Antiemetics|antiemetics|mesh-ancestor
111101928|NCT02093026|Autonomic Agents|autonomic agents|mesh-ancestor
111101929|NCT02093026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111101930|NCT02093026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111101931|NCT02093026|Glucocorticoids|glucocorticoids|mesh-ancestor
111101932|NCT02093026|Hormones|hormones|mesh-ancestor
111101933|NCT02093026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111101934|NCT02093026|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111101935|NCT02093026|Protective Agents|protective agents|mesh-ancestor
111101936|NCT02093026|Hematinics|hematinics|mesh-ancestor
111101937|NCT02093026|Vitamin B Complex|vitamin b complex|mesh-ancestor
111101938|NCT02093026|Vitamins|vitamins|mesh-ancestor
111101939|NCT02093026|Micronutrients|micronutrients|mesh-ancestor
111101940|NCT04697602|Colchicine|colchicine|mesh-list
111101941|NCT04697602|Febuxostat|febuxostat|mesh-list
111101942|NCT04697602|Gout Suppressants|gout suppressants|mesh-ancestor
111101943|NCT04697602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111101944|NCT04697602|Tubulin Modulators|tubulin modulators|mesh-ancestor
111101945|NCT04697602|Antimitotic Agents|antimitotic agents|mesh-ancestor
111101946|NCT04697602|Mitosis Modulators|mitosis modulators|mesh-ancestor
111101947|NCT04697602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111101948|NCT04697602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111101949|NCT02059174|Insulin Aspart|insulin aspart|mesh-list
111101950|NCT02059174|MK-1293|mk-1293|mesh-list
111101951|NCT02059174|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111101952|NCT02059174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111101953|NCT02059174|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111101954|NCT02059174|Antimetabolites|antimetabolites|mesh-ancestor
111101955|NCT02059174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111101956|NCT02059174|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111101957|NCT04417582|Liraglutide|liraglutide|mesh-list
111101958|NCT04417582|Orlistat|orlistat|mesh-list
111101959|NCT04417582|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111101960|NCT04417582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111101961|NCT04417582|Incretins|incretins|mesh-ancestor
111101962|NCT04417582|Hormones|hormones|mesh-ancestor
111101963|NCT04417582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111101964|NCT04417582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111101965|NCT04417582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111101966|NCT04417582|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111101967|NCT04417582|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111101968|NCT02040766|Beclomethasone|beclomethasone|mesh-list
111101969|NCT02040766|Albuterol|albuterol|mesh-list
111101970|NCT02040766|Bronchodilator Agents|bronchodilator agents|mesh-list
111101971|NCT02040766|Autonomic Agents|autonomic agents|mesh-ancestor
111101972|NCT02040766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111101973|NCT02040766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111101974|NCT02040766|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111101975|NCT02040766|Respiratory System Agents|respiratory system agents|mesh-ancestor
111101976|NCT02040766|Tocolytic Agents|tocolytic agents|mesh-ancestor
111101977|NCT02040766|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111101978|NCT02040766|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111101979|NCT02040766|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111101980|NCT02040766|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111101981|NCT02040766|Adrenergic Agents|adrenergic agents|mesh-ancestor
111101982|NCT02040766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111101983|NCT02040766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111101984|NCT02040766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111101985|NCT02040766|Glucocorticoids|glucocorticoids|mesh-ancestor
111101986|NCT02040766|Hormones|hormones|mesh-ancestor
111101987|NCT02040766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111101988|NCT02040532|Gabapentin|gabapentin|mesh-list
111101989|NCT02040532|Analgesics|analgesics|mesh-ancestor
111101990|NCT02040532|Sensory System Agents|sensory system agents|mesh-ancestor
111101991|NCT02040532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111101992|NCT02040532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111101993|NCT02040532|Anticonvulsants|anticonvulsants|mesh-ancestor
111101994|NCT02040532|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111101995|NCT02040532|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111101996|NCT02040532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111101997|NCT02040532|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111101998|NCT02040532|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111101999|NCT02040532|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111102000|NCT02040532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111102001|NCT02040532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111102003|NCT02039908|Methylphenidate|methylphenidate|mesh-list
111102004|NCT02039908|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111102005|NCT02039908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111102006|NCT02039908|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111102007|NCT02039908|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111102008|NCT02039908|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111102009|NCT02039908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111102010|NCT02039908|Dopamine Agents|dopamine agents|mesh-ancestor
111102011|NCT02039908|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111102012|NCT04417348|Tretinoin|tretinoin|mesh-list
111102013|NCT04417348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111102014|NCT04417348|Keratolytic Agents|keratolytic agents|mesh-ancestor
111102015|NCT04417348|Dermatologic Agents|dermatologic agents|mesh-ancestor
111102016|NCT02058940|Exenatide|exenatide|mesh-list
111102017|NCT02058940|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111102018|NCT02058940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111102019|NCT02058940|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111102020|NCT02058940|Incretins|incretins|mesh-ancestor
111102021|NCT02058940|Hormones|hormones|mesh-ancestor
111102022|NCT02058940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111102023|NCT02058628|Clindamycin|clindamycin|mesh-list
111102024|NCT02058628|Clindamycin palmitate|clindamycin palmitate|mesh-list
111102025|NCT02058628|Clindamycin phosphate|clindamycin phosphate|mesh-list
111102026|NCT02058628|Azelaic acid|azelaic acid|mesh-list
111102027|NCT02058628|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111102028|NCT02058628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111102029|NCT02058628|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111102030|NCT02058628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111102031|NCT02058628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111102032|NCT02058628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111102033|NCT02058628|Dermatologic Agents|dermatologic agents|mesh-ancestor
111102034|NCT02058160|Insulin|insulin|mesh-list
111102035|NCT02058160|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111102036|NCT02058160|Metformin|metformin|mesh-list
111102037|NCT02058160|Insulin Glargine|insulin glargine|mesh-list
111102038|NCT02058160|Lixisenatide|lixisenatide|mesh-list
111102039|NCT02058160|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111102040|NCT02058160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111102041|NCT02090764|Ozenoxacin|ozenoxacin|mesh-list
111102042|NCT02090764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111102043|NCT02090764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111102044|NCT02090764|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111102045|NCT02090764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111102046|NCT02090764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111102047|NCT02090764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111102048|NCT02088034|Metformin|metformin|mesh-list
111102049|NCT02088034|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111102050|NCT02088034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111102051|NCT02037256|Bortezomib|bortezomib|mesh-list
111102052|NCT02037256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111102053|NCT02035696|Vaccines|vaccines|mesh-list
110819139|NCT03927313|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111102054|NCT02035696|Immunologic Factors|immunologic factors|mesh-ancestor
111102055|NCT02035696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111102057|NCT02057458|Vasodilator Agents|vasodilator agents|mesh-ancestor
111102058|NCT02057458|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111102059|NCT02057458|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111102060|NCT02057458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111102061|NCT02057458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111102062|NCT02057458|Urological Agents|urological agents|mesh-ancestor
111102063|NCT02087176|Antimitotic Agents|antimitotic agents|mesh-list
111102064|NCT02087176|Adavosertib|adavosertib|mesh-list
111102065|NCT02087176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111102066|NCT02087176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111102067|NCT02087176|Mitosis Modulators|mitosis modulators|mesh-ancestor
111102068|NCT02087176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111102069|NCT02056288|Fentanyl|fentanyl|mesh-list
111102070|NCT02056288|Ropivacaine|ropivacaine|mesh-list
111102071|NCT02056288|Anesthetics, Local|anesthetics, local|mesh-ancestor
111102072|NCT02056288|Anesthetics|anesthetics|mesh-ancestor
111102073|NCT02056288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111102074|NCT02056288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111102075|NCT02056288|Sensory System Agents|sensory system agents|mesh-ancestor
111102076|NCT02056288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111102077|NCT02056288|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111102079|NCT02056288|Analgesics|analgesics|mesh-ancestor
111102080|NCT02056288|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111102081|NCT02056288|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111102082|NCT02056288|Anesthetics, General|anesthetics, general|mesh-ancestor
111102083|NCT03115697|Rifaximin|rifaximin|mesh-list
111102084|NCT03115697|Lactulose|lactulose|mesh-list
111102085|NCT03115697|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111102086|NCT03115697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111102087|NCT03115697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111102088|NCT03115775|Vitamin D|vitamin d|mesh-list
111102089|NCT03115775|Ergocalciferols|ergocalciferols|mesh-list
111102090|NCT03115775|Cholecalciferol|cholecalciferol|mesh-list
111102091|NCT03115775|Vitamins|vitamins|mesh-list
111102092|NCT03115775|Micronutrients|micronutrients|mesh-ancestor
111102093|NCT03115775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111102094|NCT03115775|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111102095|NCT03115775|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111102096|NCT02404259|Ritonavir|ritonavir|mesh-list
111102097|NCT02404259|Lopinavir|lopinavir|mesh-list
111102098|NCT02404259|Atazanavir Sulfate|atazanavir sulfate|mesh-list
111102099|NCT02404259|Tenofovir|tenofovir|mesh-list
111102100|NCT02404259|Efavirenz|efavirenz|mesh-list
111102101|NCT02404259|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111102102|NCT02404259|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111102103|NCT02404259|Protease Inhibitors|protease inhibitors|mesh-ancestor
111102104|NCT02404259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111102105|NCT02404259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111102106|NCT02404259|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111102107|NCT02404259|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110396793|NCT02891967|Z 350|z 350|mesh-list
111102108|NCT02404259|Antiviral Agents|antiviral agents|mesh-ancestor
111102109|NCT02404259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111102110|NCT02404259|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111102111|NCT02404259|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111102112|NCT02404259|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111102113|NCT02404259|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111102114|NCT02404259|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111102115|NCT02404259|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111102116|NCT02404259|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111102117|NCT02404259|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111102118|NCT02404259|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111102119|NCT03170687|Calpastatin|calpastatin|mesh-list
111102120|NCT03170687|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
111102121|NCT03170687|Protease Inhibitors|protease inhibitors|mesh-ancestor
111102122|NCT03170687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111102123|NCT03170687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111102124|NCT03169751|Caffeine|caffeine|mesh-list
111102125|NCT03169751|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111102126|NCT03169751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111102127|NCT03169751|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111102128|NCT03169751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111102129|NCT03169751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111102130|NCT03169751|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
111102131|NCT03169751|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111102132|NCT03169751|Purinergic Agents|purinergic agents|mesh-ancestor
110643197|NCT00886106|Midazolam|midazolam|mesh-list
111102133|NCT03169751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111102134|NCT02403713|Fluticasone|fluticasone|mesh-list
111102135|NCT02403713|Xhance|xhance|mesh-list
111102136|NCT02403713|Formoterol Fumarate|formoterol fumarate|mesh-list
111102137|NCT02403713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111102138|NCT02403713|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111102139|NCT02403713|Autonomic Agents|autonomic agents|mesh-ancestor
111102140|NCT02403713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111102141|NCT02403713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111102142|NCT02403713|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111102143|NCT02403713|Respiratory System Agents|respiratory system agents|mesh-ancestor
111102144|NCT02403713|Dermatologic Agents|dermatologic agents|mesh-ancestor
111102145|NCT02403713|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111102146|NCT02403713|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111102147|NCT02403713|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111102148|NCT02403713|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111102149|NCT02403713|Adrenergic Agents|adrenergic agents|mesh-ancestor
111102150|NCT02403713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111102151|NCT02403713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111102152|NCT02700815|Diclofenac|diclofenac|mesh-list
111102153|NCT02700815|Capsaicin|capsaicin|mesh-list
111102154|NCT02700815|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111102155|NCT02700815|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111102156|NCT02700815|Analgesics|analgesics|mesh-ancestor
111102157|NCT02700815|Sensory System Agents|sensory system agents|mesh-ancestor
111102158|NCT02700815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111102159|NCT02700815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111102160|NCT02700815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111102161|NCT02700815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111102162|NCT02700815|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111102163|NCT02700815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111102164|NCT02700815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111102165|NCT02700815|Antipruritics|antipruritics|mesh-ancestor
111102166|NCT02700815|Dermatologic Agents|dermatologic agents|mesh-ancestor
111102167|NCT02403401|Levonorgestrel|levonorgestrel|mesh-list
111102168|NCT02403401|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111102169|NCT02403401|Contraceptive Agents|contraceptive agents|mesh-ancestor
111102170|NCT02403401|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111102171|NCT02403401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111102172|NCT02403401|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111102173|NCT02403401|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111102174|NCT02403401|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111102175|NCT02402621|Fentanyl|fentanyl|mesh-list
111102176|NCT02402621|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111102177|NCT02402621|Narcotics|narcotics|mesh-ancestor
111102178|NCT02402621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111102179|NCT02402621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111102180|NCT02402621|Analgesics|analgesics|mesh-ancestor
111102181|NCT02402621|Sensory System Agents|sensory system agents|mesh-ancestor
111102182|NCT02402621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111102183|NCT02402621|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111102184|NCT02402621|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111102185|NCT02402621|Anesthetics, General|anesthetics, general|mesh-ancestor
111102186|NCT02402621|Anesthetics|anesthetics|mesh-ancestor
111102187|NCT04481789|Furosemide|furosemide|mesh-list
111102188|NCT04481789|Sildenafil Citrate|sildenafil citrate|mesh-list
111102189|NCT04481789|Edaravone|edaravone|mesh-list
111102190|NCT04481789|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111102191|NCT04481789|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111102192|NCT04481789|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111102193|NCT04481789|Antimetabolites|antimetabolites|mesh-ancestor
111102194|NCT04481789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111102195|NCT04481789|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111102196|NCT04481789|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111102197|NCT04481789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111102198|NCT04481789|Vasodilator Agents|vasodilator agents|mesh-ancestor
111102199|NCT04481789|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111102200|NCT04481789|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111102201|NCT04481789|Urological Agents|urological agents|mesh-ancestor
111102202|NCT04481789|Diuretics|diuretics|mesh-ancestor
111102203|NCT04481789|Natriuretic Agents|natriuretic agents|mesh-ancestor
111102204|NCT04481789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110643288|NCT00609674|Xhance|xhance|mesh-list
111102205|NCT04481789|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
111102206|NCT04481789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111102207|NCT04481789|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111102208|NCT04481789|Antioxidants|antioxidants|mesh-ancestor
111102209|NCT04481789|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111102210|NCT04481789|Protective Agents|protective agents|mesh-ancestor
111102211|NCT02402465|Fluticasone|fluticasone|mesh-list
111102213|NCT02402465|Azelastine|azelastine|mesh-list
111102214|NCT02402465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111102215|NCT02402465|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111102216|NCT02402465|Autonomic Agents|autonomic agents|mesh-ancestor
111102217|NCT02402465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111102218|NCT02402465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111102219|NCT02402465|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111102220|NCT02402465|Respiratory System Agents|respiratory system agents|mesh-ancestor
111102221|NCT02402465|Dermatologic Agents|dermatologic agents|mesh-ancestor
111102222|NCT02402465|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111102223|NCT02402465|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
111102224|NCT02402465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111102225|NCT02402465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111102226|NCT02402465|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
111102227|NCT02402465|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111102228|NCT02402465|Histamine Antagonists|histamine antagonists|mesh-ancestor
111102229|NCT02402465|Histamine Agents|histamine agents|mesh-ancestor
111102230|NCT02402465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111102231|NCT02402231|Omalizumab|omalizumab|mesh-list
111102232|NCT02402231|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111102233|NCT02402231|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111102234|NCT02402231|Respiratory System Agents|respiratory system agents|mesh-ancestor
111102235|NCT02402543|Acetaminophen|acetaminophen|mesh-list
111102236|NCT02402543|Dexamethasone|dexamethasone|mesh-list
111102237|NCT02402543|Ketamine|ketamine|mesh-list
111102238|NCT02402543|Gabapentin|gabapentin|mesh-list
110643324|NCT00890318|Hormone Antagonists|hormone antagonists|mesh-ancestor
111102239|NCT02402543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111102240|NCT02402543|Antiemetics|antiemetics|mesh-ancestor
111102241|NCT02402543|Autonomic Agents|autonomic agents|mesh-ancestor
111102242|NCT02402543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111102243|NCT02402543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111102244|NCT02402543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111102245|NCT02402543|Glucocorticoids|glucocorticoids|mesh-ancestor
111102246|NCT02402543|Hormones|hormones|mesh-ancestor
111102247|NCT02402543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111102248|NCT02402543|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111102249|NCT02402543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111102250|NCT02402543|Analgesics|analgesics|mesh-ancestor
111102251|NCT02402543|Sensory System Agents|sensory system agents|mesh-ancestor
111102252|NCT02402543|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111102253|NCT02402543|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111102254|NCT02402543|Anesthetics, General|anesthetics, general|mesh-ancestor
111102255|NCT02402543|Anesthetics|anesthetics|mesh-ancestor
111102256|NCT02402543|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111102257|NCT02402543|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111102258|NCT02402543|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111102259|NCT02402543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111102260|NCT02402543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111102261|NCT02402543|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111102262|NCT02402543|Antipyretics|antipyretics|mesh-ancestor
111102263|NCT02402543|Anticonvulsants|anticonvulsants|mesh-ancestor
111102264|NCT02402543|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111102265|NCT02402543|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111102266|NCT02402543|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111102267|NCT02402543|Antimanic Agents|antimanic agents|mesh-ancestor
111102268|NCT02401295|Itraconazole|itraconazole|mesh-list
111102269|NCT02401295|Celecoxib|celecoxib|mesh-list
111102270|NCT02401295|Tretinoin|tretinoin|mesh-list
111102271|NCT02401295|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111102272|NCT02401295|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111102273|NCT02401295|Analgesics|analgesics|mesh-ancestor
111102274|NCT02401295|Sensory System Agents|sensory system agents|mesh-ancestor
111102275|NCT02401295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111102276|NCT02401295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111102277|NCT02401295|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111102278|NCT02401295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111102279|NCT02401295|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111102280|NCT02401295|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110819366|NCT03926377|Clobetasol|clobetasol|mesh-list
111102281|NCT02401295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111102282|NCT02401295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111102283|NCT02401295|Antifungal Agents|antifungal agents|mesh-ancestor
111102284|NCT02401295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111102285|NCT02401295|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111102286|NCT02401295|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111102287|NCT02401295|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111102288|NCT02401295|Hormone Antagonists|hormone antagonists|mesh-ancestor
111102289|NCT02401295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111102290|NCT02401295|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111102291|NCT02401295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111102292|NCT02401295|Keratolytic Agents|keratolytic agents|mesh-ancestor
111102293|NCT02401295|Dermatologic Agents|dermatologic agents|mesh-ancestor
111102294|NCT00708305|Listerine|listerine|mesh-list
111102295|NCT00708305|Fluorides|fluorides|mesh-list
111102296|NCT00708305|Sodium Fluoride|sodium fluoride|mesh-list
111102297|NCT00708305|Cariostatic Agents|cariostatic agents|mesh-ancestor
111102298|NCT00708305|Protective Agents|protective agents|mesh-ancestor
111102299|NCT00708305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111102300|NCT00708305|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111102301|NCT00708305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111102302|NCT03169127|Ibuprofen|ibuprofen|mesh-list
111102303|NCT03169127|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111102304|NCT03169127|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111102305|NCT03169127|Analgesics|analgesics|mesh-ancestor
111102306|NCT03169127|Sensory System Agents|sensory system agents|mesh-ancestor
111102307|NCT03169127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111102308|NCT03169127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111102309|NCT03169127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111102310|NCT03169127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111102311|NCT03169127|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111102312|NCT03169127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111102313|NCT03169127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111102314|NCT03115307|Triptorelin Pamoate|triptorelin pamoate|mesh-list
111102315|NCT03115307|Luteolytic Agents|luteolytic agents|mesh-ancestor
111102316|NCT03115307|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111102317|NCT03115307|Contraceptive Agents|contraceptive agents|mesh-ancestor
111102318|NCT03115307|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111102319|NCT03115307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111102320|NCT03115307|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111102321|NCT03115307|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111102322|NCT03115307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111102323|NCT02418533|Menotropins|menotropins|mesh-list
111102324|NCT02418533|Hormones|hormones|mesh-list
111102325|NCT02418533|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
111102326|NCT02418533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111102327|NCT02418533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111102328|NCT02418533|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111102329|NCT02418533|Fertility Agents|fertility agents|mesh-ancestor
111102330|NCT02418533|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111102331|NCT02418065|Testosterone|testosterone|mesh-list
111102332|NCT02418065|Androgens|androgens|mesh-ancestor
111102333|NCT02418065|Hormones|hormones|mesh-ancestor
111102334|NCT02418065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111102335|NCT02418065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111102336|NCT05058443|Denosumab|denosumab|mesh-list
111102337|NCT05058443|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111102338|NCT05058443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111102339|NCT02400281|Cytarabine|cytarabine|mesh-list
111102340|NCT02400281|Fludarabine|fludarabine|mesh-list
111102341|NCT02400281|Fludarabine phosphate|fludarabine phosphate|mesh-list
111102342|NCT02400281|Etoposide|etoposide|mesh-list
111102343|NCT02400281|Etoposide phosphate|etoposide phosphate|mesh-list
111102344|NCT02400281|Azacitidine|azacitidine|mesh-list
111102345|NCT02400281|Mitoxantrone|mitoxantrone|mesh-list
111102346|NCT02400281|Idarubicin|idarubicin|mesh-list
111102347|NCT02400281|Crenolanib|crenolanib|mesh-list
111102348|NCT02400281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111102349|NCT02400281|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111102350|NCT02400281|Antimetabolites|antimetabolites|mesh-ancestor
111102351|NCT02400281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111102352|NCT02400281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111102353|NCT02400281|Immunologic Factors|immunologic factors|mesh-ancestor
111102354|NCT02400281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111102355|NCT02400281|Antiviral Agents|antiviral agents|mesh-ancestor
111102356|NCT02400281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111102357|NCT02400281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111102358|NCT02400281|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111102359|NCT02400281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111102360|NCT02400281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111102361|NCT02400281|Analgesics|analgesics|mesh-ancestor
111102362|NCT02400281|Sensory System Agents|sensory system agents|mesh-ancestor
111102363|NCT02400281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111102364|NCT02400281|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111102365|NCT02055976|Ezetimibe|ezetimibe|mesh-list
111102366|NCT02055976|Bococizumab|bococizumab|mesh-list
111102367|NCT02055976|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111102368|NCT02055976|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111102369|NCT02055976|Antimetabolites|antimetabolites|mesh-ancestor
111102370|NCT02055976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111102372|NCT02055898|Sodium Oxybate|sodium oxybate|mesh-list
111102373|NCT02055898|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111102374|NCT02055898|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111102375|NCT02055898|Anesthetics, General|anesthetics, general|mesh-ancestor
111102376|NCT02055898|Anesthetics|anesthetics|mesh-ancestor
111102377|NCT02055898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111102378|NCT02055898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111102379|NCT04406259|Verapamil|verapamil|mesh-list
111102380|NCT04406259|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111102381|NCT04406259|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111102382|NCT04406259|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111102383|NCT04406259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111102384|NCT04406259|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111102385|NCT04406259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111102386|NCT04406259|Vasodilator Agents|vasodilator agents|mesh-ancestor
111102387|NCT05498025|Charcoal|charcoal|mesh-list
111102388|NCT05498025|Antidotes|antidotes|mesh-ancestor
111102389|NCT05498025|Protective Agents|protective agents|mesh-ancestor
111102390|NCT05498025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111102391|NCT03972111|Tecovirimat|tecovirimat|mesh-list
111102392|NCT03972111|Antiviral Agents|antiviral agents|mesh-ancestor
111102393|NCT03972111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111102394|NCT02699099|Vitamin A|vitamin a|mesh-list
111102395|NCT02699099|Vaccines|vaccines|mesh-list
111102396|NCT02699099|Immunologic Factors|immunologic factors|mesh-ancestor
111102397|NCT02699099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111102398|NCT02699099|Vitamins|vitamins|mesh-ancestor
111102399|NCT02699099|Micronutrients|micronutrients|mesh-ancestor
111102400|NCT02400047|Dexamethasone|dexamethasone|mesh-list
111102401|NCT02400047|Dexamethasone acetate|dexamethasone acetate|mesh-list
111102402|NCT02400047|Ketoprofen|ketoprofen|mesh-list
111102403|NCT02400047|BB 1101|bb 1101|mesh-list
111102404|NCT02400047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111102405|NCT02400047|Antiemetics|antiemetics|mesh-ancestor
111102406|NCT02400047|Autonomic Agents|autonomic agents|mesh-ancestor
111102407|NCT02400047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111102408|NCT02400047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111102409|NCT02400047|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111102410|NCT02400047|Glucocorticoids|glucocorticoids|mesh-ancestor
111102411|NCT02400047|Hormones|hormones|mesh-ancestor
111102412|NCT02400047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111102413|NCT02400047|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111102414|NCT02400047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111102415|NCT02400047|Protease Inhibitors|protease inhibitors|mesh-ancestor
111102416|NCT02400047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110677513|NCT00530348|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110677543|NCT00530270|Dexamethasone|dexamethasone|mesh-list
111102417|NCT02400047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111102418|NCT02400047|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110352107|NCT01268059|Paclitaxel|paclitaxel|mesh-list
111102419|NCT02400047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111102420|NCT02400047|Analgesics|analgesics|mesh-ancestor
111102421|NCT02400047|Sensory System Agents|sensory system agents|mesh-ancestor
111102422|NCT02400047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111102423|NCT02400047|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111102424|NCT02698865|Hyaluronic Acid|hyaluronic acid|mesh-list
111102425|NCT02698865|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111102426|NCT02698865|Immunologic Factors|immunologic factors|mesh-ancestor
111102427|NCT02698865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111102428|NCT02698865|Viscosupplements|viscosupplements|mesh-ancestor
111102429|NCT02698865|Protective Agents|protective agents|mesh-ancestor
111102431|NCT05499897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111102432|NCT05499897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111102433|NCT02417207|Entecavir|entecavir|mesh-list
111102434|NCT02417207|Antiviral Agents|antiviral agents|mesh-ancestor
111102435|NCT02417207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111102436|NCT02698475|Ustekinumab|ustekinumab|mesh-list
111102437|NCT02698475|Dermatologic Agents|dermatologic agents|mesh-ancestor
111102438|NCT02399657|Dexamethasone|dexamethasone|mesh-list
111102439|NCT02399657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111102440|NCT02399657|Antiemetics|antiemetics|mesh-ancestor
111102441|NCT02399657|Autonomic Agents|autonomic agents|mesh-ancestor
110678124|NCT01565096|Metformin|metformin|mesh-list
110678199|NCT00520676|Mitosis Modulators|mitosis modulators|mesh-ancestor
111102443|NCT02399657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111102444|NCT02399657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111102446|NCT02399657|Hormones|hormones|mesh-ancestor
110678344|NCT00890747|Growth Substances|growth substances|mesh-ancestor
110643496|NCT01007799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111102447|NCT02399657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111102448|NCT02399657|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111102450|NCT02559687|Pembrolizumab|pembrolizumab|mesh-list
110678644|NCT06050954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111102451|NCT02559687|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111102452|NCT02559687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110678797|NCT06049758|Enoxaparin|enoxaparin|mesh-list
110678867|NCT06048614|Glycerol|glycerol|mesh-list
110678941|NCT06042569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111102454|NCT02559687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110679154|NCT05846646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110679234|NCT05670106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110679236|NCT05669989|Lenalidomide|lenalidomide|mesh-list
110679237|NCT05669989|Pomalidomide|pomalidomide|mesh-list
110679238|NCT05669989|Cemiplimab|cemiplimab|mesh-list
110679239|NCT05669989|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111102456|NCT03177317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111102457|NCT03177317|Antiemetics|antiemetics|mesh-ancestor
111102458|NCT03177317|Autonomic Agents|autonomic agents|mesh-ancestor
111102459|NCT03177317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111102460|NCT03177317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111102461|NCT03177317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111102462|NCT03177317|Glucocorticoids|glucocorticoids|mesh-ancestor
111102463|NCT03177317|Hormones|hormones|mesh-ancestor
111102464|NCT03177317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111102465|NCT03177317|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111102466|NCT03177317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111102467|NCT03177239|Nivolumab|nivolumab|mesh-list
111102468|NCT03177239|Ipilimumab|ipilimumab|mesh-list
111102469|NCT03177239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111102470|NCT03177239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111102471|NCT03177239|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110679566|NCT05384262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110679640|NCT05233956|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110679721|NCT05116995|Antithrombins|antithrombins|mesh-ancestor
110679845|NCT04996004|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110679846|NCT04996004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110679847|NCT04996004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110679848|NCT04977167|Antibodies|antibodies|mesh-list
110679849|NCT04977167|Immunologic Factors|immunologic factors|mesh-ancestor
110679925|NCT04762498|Methotrexate|methotrexate|mesh-list
110679926|NCT04762498|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110679944|NCT04741997|Nivolumab|nivolumab|mesh-list
111102472|NCT03177239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111102473|NCT04480775|Methylprednisolone|methylprednisolone|mesh-list
111102474|NCT04480775|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111102475|NCT04480775|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111102476|NCT04480775|Prednisolone|prednisolone|mesh-list
111102477|NCT04480775|Prednisolone acetate|prednisolone acetate|mesh-list
111102478|NCT04480775|Triamcinolone|triamcinolone|mesh-list
111102479|NCT04480775|Bupivacaine|bupivacaine|mesh-list
111102480|NCT04480775|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111102481|NCT04480775|Prednisolone phosphate|prednisolone phosphate|mesh-list
111102482|NCT04480775|Anesthetics, Local|anesthetics, local|mesh-ancestor
111102483|NCT04480775|Anesthetics|anesthetics|mesh-ancestor
110680073|NCT04589611|GABA Agents|gaba agents|mesh-ancestor
111102484|NCT04480775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111102485|NCT04480775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110680153|NCT04505410|Ustekinumab|ustekinumab|mesh-list
111102486|NCT04480775|Sensory System Agents|sensory system agents|mesh-ancestor
111102487|NCT04480775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111102488|NCT04480775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111102489|NCT04480775|Antiemetics|antiemetics|mesh-ancestor
111102490|NCT04480775|Autonomic Agents|autonomic agents|mesh-ancestor
111102491|NCT04480775|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111102492|NCT04480775|Glucocorticoids|glucocorticoids|mesh-ancestor
111102494|NCT04480775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111102495|NCT04480775|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111102496|NCT04480775|Protective Agents|protective agents|mesh-ancestor
111102497|NCT04480775|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111102498|NCT04480775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111102499|NCT02416817|Thrombin|thrombin|mesh-list
111102501|NCT02416817|Coagulants|coagulants|mesh-ancestor
111102502|NCT02399189|Methotrexate|methotrexate|mesh-list
111102503|NCT02399189|Temozolomide|temozolomide|mesh-list
110819591|NCT03513874|Metformin|metformin|mesh-list
111102504|NCT02399189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111102505|NCT02399189|Immunologic Factors|immunologic factors|mesh-ancestor
111102506|NCT02399189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110681023|NCT02252172|Dexamethasone|dexamethasone|mesh-list
110681086|NCT01336933|Etoposide|etoposide|mesh-list
111102507|NCT02399189|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110681161|NCT00262470|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
110681313|NCT00429273|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111102508|NCT02399189|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111102509|NCT02399189|Abortifacient Agents|abortifacient agents|mesh-ancestor
111102510|NCT02399189|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111102511|NCT02399189|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111102512|NCT02399189|Antimetabolites|antimetabolites|mesh-ancestor
111102513|NCT02399189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111102514|NCT02399189|Dermatologic Agents|dermatologic agents|mesh-ancestor
111102515|NCT02399189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111102516|NCT02399189|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111102517|NCT02399189|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111102518|NCT02399189|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111102519|NCT02399189|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111102520|NCT02399189|Alkylating Agents|alkylating agents|mesh-ancestor
111102522|NCT03176849|Ergocalciferols|ergocalciferols|mesh-list
111102523|NCT03176849|Cholecalciferol|cholecalciferol|mesh-list
111102524|NCT03176849|Vitamins|vitamins|mesh-list
111102525|NCT03176849|Micronutrients|micronutrients|mesh-ancestor
111102526|NCT03176849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111102527|NCT03176849|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111102528|NCT03176849|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111102529|NCT03106571|Methamphetamine|methamphetamine|mesh-list
110681443|NCT01057030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111102530|NCT03106571|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111102531|NCT03106571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110681518|NCT03742258|Prednisone|prednisone|mesh-list
111102532|NCT03106571|Sympathomimetics|sympathomimetics|mesh-ancestor
111102533|NCT03106571|Autonomic Agents|autonomic agents|mesh-ancestor
110681596|NCT00354172|Hormones|hormones|mesh-ancestor
111102534|NCT03106571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111102535|NCT03106571|Dopamine Agents|dopamine agents|mesh-ancestor
111102536|NCT03106571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111102537|NCT03106571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111102538|NCT03106571|Adrenergic Agents|adrenergic agents|mesh-ancestor
111102539|NCT03106571|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111102540|NCT03106571|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111102541|NCT03106571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111102542|NCT03106571|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111102543|NCT03177083|Interferons|interferons|mesh-list
111102544|NCT03177083|Interferon-beta|interferon-beta|mesh-list
111102545|NCT03177083|Interferon beta-1a|interferon beta-1a|mesh-list
111102546|NCT03177083|Interferon beta-1b|interferon beta-1b|mesh-list
111102547|NCT03177083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111102548|NCT03177083|Antiviral Agents|antiviral agents|mesh-ancestor
110681825|NCT01033305|Cyclosporine|cyclosporine|mesh-list
111102549|NCT03177083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111102550|NCT03177083|Immunologic Factors|immunologic factors|mesh-ancestor
111102551|NCT03177083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111102552|NCT03177083|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111102553|NCT03629925|Carboplatin|carboplatin|mesh-list
111102554|NCT03629925|Gemcitabine|gemcitabine|mesh-list
110682250|NCT00609167|Bortezomib|bortezomib|mesh-list
111102555|NCT03629925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111102556|NCT03629925|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111102557|NCT03629925|Antimetabolites|antimetabolites|mesh-ancestor
110682400|NCT00513474|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110682474|NCT01011036|Clonazepam|clonazepam|mesh-list
111102558|NCT03629925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111479312|NCT05012631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111102559|NCT02398487|Nicotine|nicotine|mesh-list
111479313|NCT04989218|Cisplatin|cisplatin|mesh-list
111479314|NCT04989218|Gemcitabine|gemcitabine|mesh-list
111479315|NCT04989218|Durvalumab|durvalumab|mesh-list
111479316|NCT04989218|Tremelimumab|tremelimumab|mesh-list
111479317|NCT04989218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111479318|NCT04989218|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111479319|NCT04989218|Antimetabolites|antimetabolites|mesh-ancestor
111479320|NCT04989218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111479321|NCT04989218|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111479322|NCT04964544|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111479323|NCT04964544|Calcium|calcium|mesh-list
111479324|NCT04964544|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111479325|NCT04964544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111479326|NCT04964544|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111479327|NCT04964544|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111479328|NCT04964544|Antimetabolites|antimetabolites|mesh-ancestor
111479329|NCT04964544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111479330|NCT04964544|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111479331|NCT04964544|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111479332|NCT04964544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111479333|NCT04954196|Amlodipine|amlodipine|mesh-list
111479334|NCT04954196|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111479335|NCT04954196|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111479336|NCT04954196|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111479337|NCT04954196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111479338|NCT04954196|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111479339|NCT04954196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111479340|NCT04954196|Vasodilator Agents|vasodilator agents|mesh-ancestor
111479341|NCT04944290|Brimonidine Tartrate|brimonidine tartrate|mesh-list
111479342|NCT04944290|Brinzolamide|brinzolamide|mesh-list
111479343|NCT04944290|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111479344|NCT04944290|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111479345|NCT04944290|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111479346|NCT04944290|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111479347|NCT04944290|Adrenergic Agents|adrenergic agents|mesh-ancestor
111479348|NCT04944290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111479349|NCT04944290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111479350|NCT04944290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111479351|NCT04944290|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
111479352|NCT04944290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111479353|NCT04937166|Azacitidine|azacitidine|mesh-list
111479354|NCT04937166|Venetoclax|venetoclax|mesh-list
111479355|NCT04937166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111479356|NCT04937166|Antimetabolites|antimetabolites|mesh-ancestor
111479357|NCT04937166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111479358|NCT04937166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111479359|NCT04937166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111479360|NCT04920032|Irinotecan|irinotecan|mesh-list
111479361|NCT04920032|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111479362|NCT04920032|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111479363|NCT04920032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111479364|NCT04920032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111479365|NCT04920032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111479366|NCT04908176|Midazolam|midazolam|mesh-list
111479367|NCT04908176|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111479368|NCT04908176|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111479369|NCT04908176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111479370|NCT04908176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111479371|NCT04908176|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111479372|NCT04908176|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111479373|NCT04908176|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111479374|NCT04908176|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111479375|NCT04908176|Anesthetics, General|anesthetics, general|mesh-ancestor
111479376|NCT04908176|Anesthetics|anesthetics|mesh-ancestor
111479377|NCT04908176|GABA Modulators|gaba modulators|mesh-ancestor
111479378|NCT04908176|GABA Agents|gaba agents|mesh-ancestor
111479379|NCT04908176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111479380|NCT04908176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111479381|NCT04893109|Paclitaxel|paclitaxel|mesh-list
111479382|NCT04893109|Maytansine|maytansine|mesh-list
111479383|NCT04893109|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
111102560|NCT02398487|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111479384|NCT04893109|Trastuzumab|trastuzumab|mesh-list
111479385|NCT04893109|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111479386|NCT04893109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111479387|NCT04893109|Tubulin Modulators|tubulin modulators|mesh-ancestor
111479388|NCT04893109|Antimitotic Agents|antimitotic agents|mesh-ancestor
111479389|NCT04893109|Mitosis Modulators|mitosis modulators|mesh-ancestor
111479390|NCT04893109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111479391|NCT04893109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111479392|NCT04893109|Immunotoxins|immunotoxins|mesh-ancestor
111479393|NCT04893109|Immunoconjugates|immunoconjugates|mesh-ancestor
111479394|NCT04893109|Immunologic Factors|immunologic factors|mesh-ancestor
111479395|NCT04893109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111479396|NCT04882540|Brivaracetam|brivaracetam|mesh-list
111479397|NCT04882540|Anticonvulsants|anticonvulsants|mesh-ancestor
111479398|NCT04859829|Immunoglobulins|immunoglobulins|mesh-list
111479399|NCT04859829|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111479400|NCT04859829|Antibodies|antibodies|mesh-list
111479401|NCT04859829|gamma-Globulins|gamma-globulins|mesh-list
111479402|NCT04859829|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
111479403|NCT04859829|Immunologic Factors|immunologic factors|mesh-ancestor
111479404|NCT04859829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111479405|NCT04851158|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111479406|NCT04851158|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
111479407|NCT04851158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111479408|NCT04851158|Antitubercular Agents|antitubercular agents|mesh-ancestor
111479409|NCT04788043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111479410|NCT04788043|Pembrolizumab|pembrolizumab|mesh-list
111479411|NCT04788043|Magrolimab|magrolimab|mesh-list
111479412|NCT04788043|Antibodies|antibodies|mesh-list
111479413|NCT04788043|Immunoglobulins|immunoglobulins|mesh-list
111479414|NCT04788043|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111479415|NCT04788043|Immunologic Factors|immunologic factors|mesh-ancestor
111479416|NCT04788043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111479417|NCT04788043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111479418|NCT04788043|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111479419|NCT04788043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111479420|NCT04778267|Dexamethasone|dexamethasone|mesh-list
111479421|NCT04778267|Bupivacaine|bupivacaine|mesh-list
111479422|NCT04778267|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
111479423|NCT04778267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111479424|NCT04778267|Antiemetics|antiemetics|mesh-ancestor
111479425|NCT04778267|Autonomic Agents|autonomic agents|mesh-ancestor
111479426|NCT04778267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111479427|NCT04778267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111479428|NCT04778267|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111479429|NCT04778267|Glucocorticoids|glucocorticoids|mesh-ancestor
111479430|NCT04778267|Hormones|hormones|mesh-ancestor
111479431|NCT04778267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111479432|NCT04778267|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111479433|NCT04778267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111479434|NCT04778267|Anesthetics, Local|anesthetics, local|mesh-ancestor
111479435|NCT04778267|Anesthetics|anesthetics|mesh-ancestor
111479436|NCT04778267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111479437|NCT04778267|Sensory System Agents|sensory system agents|mesh-ancestor
111479438|NCT04761627|Ustekinumab|ustekinumab|mesh-list
111479439|NCT04761627|Dermatologic Agents|dermatologic agents|mesh-ancestor
111479440|NCT04760691|Tenofovir|tenofovir|mesh-list
111479441|NCT04760691|Emtricitabine|emtricitabine|mesh-list
110799547|NCT03752931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111479442|NCT04760691|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
111479443|NCT04760691|Leuprolide|leuprolide|mesh-list
111479444|NCT04760691|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
111102561|NCT02398487|Autonomic Agents|autonomic agents|mesh-ancestor
111102562|NCT02398487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111102563|NCT02398487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111102564|NCT02398487|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111102565|NCT02398487|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111102566|NCT02398487|Cholinergic Agents|cholinergic agents|mesh-ancestor
111102567|NCT02398487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111102568|NCT02398487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111102569|NCT03250299|Lisavanbulin|lisavanbulin|mesh-list
111102570|NCT03250299|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110682637|NCT03063762|Bevacizumab|bevacizumab|mesh-list
111479445|NCT04760691|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
111479446|NCT04760691|Estradiol|estradiol|mesh-list
111479447|NCT04760691|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
111479448|NCT04760691|Estrogens|estrogens|mesh-list
111479449|NCT04760691|Antiviral Agents|antiviral agents|mesh-ancestor
111102571|NCT03250299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111479450|NCT04760691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111479451|NCT04760691|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111479452|NCT04760691|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111479453|NCT04760691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111479454|NCT04760691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111479455|NCT04760691|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111479456|NCT04760691|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111479457|NCT04760691|Hormones|hormones|mesh-ancestor
111479458|NCT04760691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111479459|NCT04760691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111479460|NCT04760691|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111479461|NCT04760691|Contraceptive Agents|contraceptive agents|mesh-ancestor
111479462|NCT04760691|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111479463|NCT04760691|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111479464|NCT04760691|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111479465|NCT04760691|Fertility Agents|fertility agents|mesh-ancestor
111479466|NCT04760691|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111479467|NCT04760691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111479468|NCT04735471|Cyclophosphamide|cyclophosphamide|mesh-list
111479469|NCT04735471|Fludarabine|fludarabine|mesh-list
111479470|NCT04735471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111479471|NCT04735471|Immunologic Factors|immunologic factors|mesh-ancestor
111479472|NCT04735471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111479473|NCT04735471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111479474|NCT04735471|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111479475|NCT04735471|Alkylating Agents|alkylating agents|mesh-ancestor
111479476|NCT04735471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111479477|NCT04735471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111479478|NCT04735471|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111479479|NCT04718181|Omeprazole|omeprazole|mesh-list
111479480|NCT04718181|Risdiplam|risdiplam|mesh-list
111479481|NCT04718181|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111479482|NCT04718181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111479483|NCT04718181|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111479484|NCT04718181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111479485|NCT04718181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111479486|NCT04718181|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111479487|NCT04718181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111479488|NCT04718181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111479489|NCT04713735|Lactoferrin|lactoferrin|mesh-list
111479490|NCT04713735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111479491|NCT04682366|Tamsulosin|tamsulosin|mesh-list
111479492|NCT04682366|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111479493|NCT04682366|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111479494|NCT04682366|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111479495|NCT04682366|Adrenergic Agents|adrenergic agents|mesh-ancestor
111479496|NCT04682366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111479497|NCT04682366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111479498|NCT04682366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111479499|NCT04682366|Urological Agents|urological agents|mesh-ancestor
111479500|NCT04656301|Psilocybin|psilocybin|mesh-list
111479501|NCT04656301|Hallucinogens|hallucinogens|mesh-ancestor
111479502|NCT04656301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111479503|NCT04656301|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111479504|NCT04573504|Clindamycin|clindamycin|mesh-list
111479505|NCT04573504|Clindamycin palmitate|clindamycin palmitate|mesh-list
111479506|NCT04573504|Clindamycin phosphate|clindamycin phosphate|mesh-list
111479507|NCT04573504|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
111479508|NCT04573504|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111479509|NCT04573504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111479510|NCT04573504|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111479511|NCT04573504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111479512|NCT04573504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111479513|NCT04573504|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
111479514|NCT04560972|Carboplatin|carboplatin|mesh-list
111479515|NCT04560972|Etoposide|etoposide|mesh-list
111479516|NCT04560972|Etoposide phosphate|etoposide phosphate|mesh-list
111479517|NCT04560972|Atezolizumab|atezolizumab|mesh-list
111479518|NCT04560972|Podophyllotoxin|podophyllotoxin|mesh-list
111479519|NCT04560972|LB100|lb100|mesh-list
111479520|NCT04560972|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111479521|NCT04560972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111479522|NCT04560972|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111479523|NCT04560972|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111479524|NCT04560972|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111479525|NCT04560972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111479526|NCT04560972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111479527|NCT04560972|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111479528|NCT04560972|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111479529|NCT04560972|Immunologic Factors|immunologic factors|mesh-ancestor
111479530|NCT04560972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111479531|NCT04560972|Keratolytic Agents|keratolytic agents|mesh-ancestor
111479532|NCT04560972|Dermatologic Agents|dermatologic agents|mesh-ancestor
111479533|NCT04560972|Tubulin Modulators|tubulin modulators|mesh-ancestor
111479534|NCT04560972|Antimitotic Agents|antimitotic agents|mesh-ancestor
111479535|NCT04560972|Mitosis Modulators|mitosis modulators|mesh-ancestor
111479536|NCT04521335|Copper|copper|mesh-list
111479537|NCT04521335|Disulfiram|disulfiram|mesh-list
111479538|NCT04521335|Trace Elements|trace elements|mesh-ancestor
111479539|NCT04521335|Micronutrients|micronutrients|mesh-ancestor
111479540|NCT04521335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111479541|NCT04521335|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111479542|NCT04521335|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
111479543|NCT04521335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111479544|NCT04521335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111479545|NCT04515615|Oxaliplatin|oxaliplatin|mesh-list
111479546|NCT04515615|Tegafur|tegafur|mesh-list
111479547|NCT04515615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111479548|NCT04515615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111479549|NCT04515615|Antimetabolites|antimetabolites|mesh-ancestor
111479550|NCT04515615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111479551|NCT04280692|Lumefantrine|lumefantrine|mesh-list
111479552|NCT04280692|Artemether|artemether|mesh-list
111479553|NCT04280692|Pyrimethamine|pyrimethamine|mesh-list
111479554|NCT04280692|Primaquine|primaquine|mesh-list
111479555|NCT04280692|Piperaquine|piperaquine|mesh-list
111479556|NCT04280692|Sulfadoxine|sulfadoxine|mesh-list
111479557|NCT04280692|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
111479558|NCT04280692|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
111479559|NCT04280692|Antimalarials|antimalarials|mesh-ancestor
111479560|NCT04280692|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111479561|NCT04280692|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111479562|NCT04280692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111479563|NCT04280692|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111479564|NCT04280692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110643920|NCT00527787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111479565|NCT04280692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111479566|NCT04280692|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111479567|NCT04247126|Paclitaxel|paclitaxel|mesh-list
111479568|NCT04247126|Gemcitabine|gemcitabine|mesh-list
111479569|NCT04247126|Fulvestrant|fulvestrant|mesh-list
111479570|NCT04247126|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111479571|NCT04247126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111479572|NCT04247126|Tubulin Modulators|tubulin modulators|mesh-ancestor
111479573|NCT04247126|Antimitotic Agents|antimitotic agents|mesh-ancestor
111479574|NCT04247126|Mitosis Modulators|mitosis modulators|mesh-ancestor
111479575|NCT04247126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111479576|NCT04247126|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111479577|NCT04247126|Antimetabolites|antimetabolites|mesh-ancestor
111479578|NCT04247126|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111479579|NCT04247126|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
111479580|NCT04247126|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111479581|NCT04247126|Hormone Antagonists|hormone antagonists|mesh-ancestor
111479582|NCT04247126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111479583|NCT04247126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111479584|NCT04179162|Gemcitabine|gemcitabine|mesh-list
111479585|NCT04179162|BCG Vaccine|bcg vaccine|mesh-list
111479586|NCT04179162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111479587|NCT04179162|Antimetabolites|antimetabolites|mesh-ancestor
111479588|NCT04179162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111479589|NCT04179162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111479590|NCT04179162|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111479591|NCT04179162|Immunologic Factors|immunologic factors|mesh-ancestor
111479592|NCT04179162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111479593|NCT04163432|Carboplatin|carboplatin|mesh-list
111479594|NCT04163432|Pemetrexed|pemetrexed|mesh-list
111479595|NCT04163432|Durvalumab|durvalumab|mesh-list
111479596|NCT04163432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111102572|NCT03250299|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111479597|NCT04163432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111102573|NCT03250299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111479598|NCT04163432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111479599|NCT04163432|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110643962|NCT00943176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111479600|NCT04163432|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111479601|NCT04163432|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111479602|NCT04151706|Cyclophosphamide|cyclophosphamide|mesh-list
111479603|NCT04151706|Busulfan|busulfan|mesh-list
111479604|NCT04151706|Thiotepa|thiotepa|mesh-list
111479605|NCT04151706|Fludarabine|fludarabine|mesh-list
111479606|NCT04151706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111479607|NCT04151706|Immunologic Factors|immunologic factors|mesh-ancestor
111479608|NCT04151706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111479609|NCT04151706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111479610|NCT04151706|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111479611|NCT04151706|Alkylating Agents|alkylating agents|mesh-ancestor
111479612|NCT04151706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111479613|NCT04151706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111479614|NCT04151706|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111479615|NCT04119453|Apatinib|apatinib|mesh-list
111479616|NCT04119453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111479617|NCT04119453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111479618|NCT04119453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111479619|NCT04119453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111479620|NCT04068610|Leucovorin|leucovorin|mesh-list
111479621|NCT04068610|Durvalumab|durvalumab|mesh-list
111479622|NCT04068610|Fluorouracil|fluorouracil|mesh-list
111479623|NCT04068610|Oxaliplatin|oxaliplatin|mesh-list
111479624|NCT04068610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111479625|NCT04068610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111479626|NCT04068610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111479627|NCT04068610|Antimetabolites|antimetabolites|mesh-ancestor
111479628|NCT04068610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111479629|NCT04068610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111479630|NCT04068610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111479631|NCT04068610|Immunologic Factors|immunologic factors|mesh-ancestor
111479632|NCT04068610|Antidotes|antidotes|mesh-ancestor
111479633|NCT04068610|Protective Agents|protective agents|mesh-ancestor
111479634|NCT04068610|Vitamin B Complex|vitamin b complex|mesh-ancestor
111479635|NCT04068610|Vitamins|vitamins|mesh-ancestor
111479636|NCT04068610|Micronutrients|micronutrients|mesh-ancestor
111479637|NCT04006119|Cemiplimab|cemiplimab|mesh-list
111479638|NCT04006119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111479639|NCT04006119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111479640|NCT04004793|Dapagliflozin|dapagliflozin|mesh-list
111479641|NCT04004793|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111479642|NCT04004793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111479643|NCT04004793|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111479644|NCT04004793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111479645|NCT04002011|Warfarin|warfarin|mesh-list
111479646|NCT04002011|Rivaroxaban|rivaroxaban|mesh-list
111479647|NCT04002011|Dabigatran|dabigatran|mesh-list
111479648|NCT04002011|Apixaban|apixaban|mesh-list
111479649|NCT04002011|Edoxaban|edoxaban|mesh-list
111479650|NCT04002011|Anticoagulants|anticoagulants|mesh-ancestor
111479651|NCT04002011|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111479652|NCT04002011|Antithrombins|antithrombins|mesh-ancestor
111479653|NCT04002011|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111479654|NCT04002011|Protease Inhibitors|protease inhibitors|mesh-ancestor
111479655|NCT04002011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111479656|NCT04002011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111479657|NCT03903692|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
111479658|NCT03903692|Laxatives|laxatives|mesh-ancestor
111479659|NCT03903692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111479660|NCT03884998|Nivolumab|nivolumab|mesh-list
111479661|NCT03884998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111479662|NCT03884998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111479663|NCT03884998|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111479664|NCT03884998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111479665|NCT03831711|Gastrin-Releasing Peptide|gastrin-releasing peptide|mesh-list
111479666|NCT03831711|Bombesin|bombesin|mesh-list
111479667|NCT03831711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111479668|NCT03831711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111479669|NCT03831711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111479670|NCT03831711|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111479671|NCT03789591|Hydroxyurea|hydroxyurea|mesh-list
111479672|NCT03789591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111479673|NCT03789591|Antisickling Agents|antisickling agents|mesh-ancestor
111479674|NCT03789591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111479675|NCT03789591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111479676|NCT03789591|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111479678|NCT03783026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111479679|NCT03783026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111479680|NCT03783026|Analgesics|analgesics|mesh-ancestor
111479681|NCT03783026|Sensory System Agents|sensory system agents|mesh-ancestor
111479682|NCT03783026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111479683|NCT03783026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111479684|NCT03783026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110644026|NCT00186121|Anastrozole|anastrozole|mesh-list
111479685|NCT03783026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111479686|NCT03783026|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
111479687|NCT03783026|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111479688|NCT03783026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111479689|NCT03783026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111479690|NCT03775460|Prednisolone|prednisolone|mesh-list
111479691|NCT03775460|Methotrexate|methotrexate|mesh-list
111479692|NCT03775460|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111479693|NCT03775460|Abortifacient Agents|abortifacient agents|mesh-ancestor
111479694|NCT03775460|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111479695|NCT03775460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111479696|NCT03775460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111479697|NCT03775460|Antimetabolites|antimetabolites|mesh-ancestor
111479698|NCT03775460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111479699|NCT03775460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111479700|NCT03775460|Dermatologic Agents|dermatologic agents|mesh-ancestor
111479701|NCT03775460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111479702|NCT03775460|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111479703|NCT03775460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111479704|NCT03775460|Immunologic Factors|immunologic factors|mesh-ancestor
111479705|NCT03775460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111479706|NCT03775460|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111479707|NCT03775460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111479708|NCT03775460|Glucocorticoids|glucocorticoids|mesh-ancestor
111479709|NCT03775460|Hormones|hormones|mesh-ancestor
111479710|NCT03775460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111479711|NCT03775460|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111479712|NCT03591731|Nivolumab|nivolumab|mesh-list
111479713|NCT03591731|Ipilimumab|ipilimumab|mesh-list
111479714|NCT03591731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111479715|NCT03591731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111479716|NCT03591731|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110644065|NCT00186043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111479717|NCT03591731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111479718|NCT03538691|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
111479719|NCT03538691|Dexetimide|dexetimide|mesh-list
111479720|NCT03538691|Citalopram|citalopram|mesh-list
111479721|NCT03538691|Fluoxetine|fluoxetine|mesh-list
111479722|NCT03538691|Paroxetine|paroxetine|mesh-list
111479723|NCT03538691|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
111479724|NCT03538691|Sertraline|sertraline|mesh-list
111479725|NCT03538691|Escitalopram|escitalopram|mesh-list
111479726|NCT03538691|Brexpiprazole|brexpiprazole|mesh-list
111479727|NCT03538691|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111479728|NCT03538691|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111479729|NCT03538691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111479730|NCT03538691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111479731|NCT03538691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111479732|NCT03538691|Serotonin Agents|serotonin agents|mesh-ancestor
111479733|NCT03538691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111479734|NCT03538691|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111479735|NCT03538691|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111479736|NCT03538691|Parasympatholytics|parasympatholytics|mesh-ancestor
111479737|NCT03538691|Autonomic Agents|autonomic agents|mesh-ancestor
111479738|NCT03538691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111479739|NCT03538691|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111479740|NCT03538691|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111479741|NCT03538691|Cholinergic Agents|cholinergic agents|mesh-ancestor
111479742|NCT03538691|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111479743|NCT03538691|Antidepressive Agents|antidepressive agents|mesh-ancestor
111102575|NCT02697617|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110687807|NCT00467142|Irinotecan|irinotecan|mesh-list
111102576|NCT02697617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111479744|NCT03538691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111479745|NCT03538691|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111479746|NCT03538691|Analgesics|analgesics|mesh-ancestor
111479747|NCT03538691|Sensory System Agents|sensory system agents|mesh-ancestor
111479748|NCT03538691|Dopamine Agents|dopamine agents|mesh-ancestor
111479749|NCT03538691|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111479750|NCT03538691|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111479751|NCT03538691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111479752|NCT03538691|Dopamine Agonists|dopamine agonists|mesh-ancestor
111479753|NCT03489018|Vaccines|vaccines|mesh-list
111479754|NCT03489018|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
111479755|NCT03489018|Immunologic Factors|immunologic factors|mesh-ancestor
111479756|NCT03489018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111479757|NCT03439033|Edetic Acid|edetic acid|mesh-list
111479758|NCT03439033|N,N'-bis(2-hydroxybenzyl)ethylenediamine-N,N'-diacetic acid|n,n'-bis(2-hydroxybenzyl)ethylenediamine-n,n'-diacetic acid|mesh-list
111479759|NCT03439033|Chelating Agents|chelating agents|mesh-ancestor
111479760|NCT03439033|Sequestering Agents|sequestering agents|mesh-ancestor
111479761|NCT03439033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111479762|NCT03439033|Anticoagulants|anticoagulants|mesh-ancestor
111479763|NCT03439033|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
111479764|NCT03330886|Atezolizumab|atezolizumab|mesh-list
111479765|NCT03330886|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111479766|NCT03330886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111479767|NCT03330886|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111479768|NCT03330886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111479769|NCT03282799|Etonogestrel|etonogestrel|mesh-list
111479770|NCT03282799|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111479771|NCT03282799|Contraceptive Agents|contraceptive agents|mesh-ancestor
111479772|NCT03282799|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111479773|NCT03282799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111479774|NCT03282799|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111479775|NCT03125928|Paclitaxel|paclitaxel|mesh-list
111479776|NCT03125928|Trastuzumab|trastuzumab|mesh-list
111479777|NCT03125928|Atezolizumab|atezolizumab|mesh-list
111479778|NCT03125928|Pertuzumab|pertuzumab|mesh-list
111479779|NCT03125928|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111479780|NCT03125928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111479781|NCT03125928|Tubulin Modulators|tubulin modulators|mesh-ancestor
111479782|NCT03125928|Antimitotic Agents|antimitotic agents|mesh-ancestor
111479783|NCT03125928|Mitosis Modulators|mitosis modulators|mesh-ancestor
111479784|NCT03125928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110644143|NCT00945360|Aromatase Inhibitors|aromatase inhibitors|mesh-list
111479785|NCT03125928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111479786|NCT03125928|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111479787|NCT02987543|Olaparib|olaparib|mesh-list
111479788|NCT02987543|Abiraterone Acetate|abiraterone acetate|mesh-list
111479789|NCT02987543|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111479790|NCT02987543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111479791|NCT02987543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111479792|NCT02987543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111479793|NCT02987543|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111479794|NCT02987543|Hormone Antagonists|hormone antagonists|mesh-ancestor
111479795|NCT02987543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111479796|NCT02987543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111479797|NCT02987543|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111479798|NCT02983045|Paclitaxel|paclitaxel|mesh-list
111479799|NCT02983045|Cisplatin|cisplatin|mesh-list
111479800|NCT02983045|Carboplatin|carboplatin|mesh-list
111479801|NCT02983045|Nivolumab|nivolumab|mesh-list
111479802|NCT02983045|Pemetrexed|pemetrexed|mesh-list
111479803|NCT02983045|Ipilimumab|ipilimumab|mesh-list
111479804|NCT02983045|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111479805|NCT02983045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111479806|NCT02983045|Tubulin Modulators|tubulin modulators|mesh-ancestor
111479807|NCT02983045|Antimitotic Agents|antimitotic agents|mesh-ancestor
111479808|NCT02983045|Mitosis Modulators|mitosis modulators|mesh-ancestor
111479809|NCT02983045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111479810|NCT02983045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111479811|NCT02983045|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111479812|NCT02983045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111479813|NCT02983045|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111479814|NCT02983045|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111479815|NCT02894398|Letrozole|letrozole|mesh-list
111479816|NCT02894398|Fulvestrant|fulvestrant|mesh-list
111479817|NCT02894398|Palbociclib|palbociclib|mesh-list
111479818|NCT02894398|Anastrozole|anastrozole|mesh-list
111479819|NCT02894398|Exemestane|exemestane|mesh-list
111479820|NCT02894398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111479821|NCT02894398|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111479822|NCT02894398|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111479823|NCT02894398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110644184|NCT00943956|Leuprolide|leuprolide|mesh-list
111479824|NCT02894398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111479825|NCT02894398|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111479826|NCT02894398|Hormone Antagonists|hormone antagonists|mesh-ancestor
111479827|NCT02894398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111479828|NCT02894398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111479829|NCT02894398|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111479830|NCT02894398|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
111479831|NCT02894398|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111479832|NCT02678052|Vedolizumab|vedolizumab|mesh-list
111479833|NCT02678052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111479834|NCT02576717|Ozanimod|ozanimod|mesh-list
111479835|NCT02576717|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
111479836|NCT02576717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111479837|NCT02576717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111479838|NCT02576717|Immunologic Factors|immunologic factors|mesh-ancestor
111479839|NCT02576717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111479840|NCT02564263|Paclitaxel|paclitaxel|mesh-list
111479841|NCT02564263|Docetaxel|docetaxel|mesh-list
111479842|NCT02564263|Pembrolizumab|pembrolizumab|mesh-list
111479843|NCT02564263|Irinotecan|irinotecan|mesh-list
111479844|NCT02564263|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111479845|NCT02564263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111479846|NCT02564263|Tubulin Modulators|tubulin modulators|mesh-ancestor
111479847|NCT02564263|Antimitotic Agents|antimitotic agents|mesh-ancestor
111479848|NCT02564263|Mitosis Modulators|mitosis modulators|mesh-ancestor
111479849|NCT02564263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111479850|NCT02564263|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111479851|NCT02564263|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111479852|NCT02564263|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111479853|NCT02564263|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111479854|NCT02564263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111479855|NCT02540018|Paclitaxel|paclitaxel|mesh-list
111479856|NCT02540018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111479857|NCT02540018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111479858|NCT02540018|Tubulin Modulators|tubulin modulators|mesh-ancestor
111479859|NCT02540018|Antimitotic Agents|antimitotic agents|mesh-ancestor
111479860|NCT02540018|Mitosis Modulators|mitosis modulators|mesh-ancestor
111479861|NCT02540018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111479862|NCT02423265|Ranolazine|ranolazine|mesh-list
111479863|NCT02423265|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111479864|NCT02423265|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110644220|NCT00940836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111479865|NCT02423265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111479866|NCT02368886|Clobetasol|clobetasol|mesh-list
111479867|NCT02368886|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111479868|NCT02368886|Glucocorticoids|glucocorticoids|mesh-ancestor
111479869|NCT02368886|Hormones|hormones|mesh-ancestor
111479870|NCT02368886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111479871|NCT02368886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111479872|NCT02301286|Aspirin|aspirin|mesh-list
111479873|NCT02301286|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111479874|NCT02301286|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111479875|NCT02301286|Analgesics|analgesics|mesh-ancestor
111479876|NCT02301286|Sensory System Agents|sensory system agents|mesh-ancestor
111479877|NCT02301286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111479878|NCT02301286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111479879|NCT02301286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111479880|NCT02301286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111479881|NCT02301286|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111479882|NCT02301286|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111479883|NCT02301286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111479884|NCT02301286|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111479885|NCT02301286|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111479886|NCT02301286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111479887|NCT02301286|Antipyretics|antipyretics|mesh-ancestor
111479888|NCT02126969|Carboplatin|carboplatin|mesh-list
111479889|NCT02126969|Docetaxel|docetaxel|mesh-list
111479890|NCT02126969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111102577|NCT02396225|Voriconazole|voriconazole|mesh-list
111102578|NCT02396225|Antifungal Agents|antifungal agents|mesh-ancestor
111479891|NCT02126969|Tubulin Modulators|tubulin modulators|mesh-ancestor
111479892|NCT02126969|Antimitotic Agents|antimitotic agents|mesh-ancestor
111479893|NCT02126969|Mitosis Modulators|mitosis modulators|mesh-ancestor
111479894|NCT02126969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111479895|NCT02099188|Leucovorin|leucovorin|mesh-list
111479896|NCT02099188|Docetaxel|docetaxel|mesh-list
111479897|NCT02099188|Doxorubicin|doxorubicin|mesh-list
111479898|NCT02099188|Fluorouracil|fluorouracil|mesh-list
111479899|NCT02099188|Etoposide|etoposide|mesh-list
111479900|NCT02099188|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111479901|NCT02099188|Ifosfamide|ifosfamide|mesh-list
111479902|NCT02099188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111479903|NCT02099188|Tubulin Modulators|tubulin modulators|mesh-ancestor
111479904|NCT02099188|Antimitotic Agents|antimitotic agents|mesh-ancestor
111479905|NCT02099188|Mitosis Modulators|mitosis modulators|mesh-ancestor
111479906|NCT02099188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111479907|NCT02099188|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111479908|NCT02099188|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111479909|NCT02099188|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111479910|NCT02099188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111479911|NCT02099188|Antimetabolites|antimetabolites|mesh-ancestor
111479912|NCT02099188|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111479913|NCT02099188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111479914|NCT02099188|Immunologic Factors|immunologic factors|mesh-ancestor
111479915|NCT02099188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111479916|NCT02099188|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111479917|NCT02099188|Antidotes|antidotes|mesh-ancestor
111479918|NCT02099188|Protective Agents|protective agents|mesh-ancestor
111479919|NCT02099188|Vitamin B Complex|vitamin b complex|mesh-ancestor
111479920|NCT02099188|Vitamins|vitamins|mesh-ancestor
111479921|NCT02099188|Micronutrients|micronutrients|mesh-ancestor
111479922|NCT02099188|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111479923|NCT02099188|Alkylating Agents|alkylating agents|mesh-ancestor
111479924|NCT02099175|Leucovorin|leucovorin|mesh-list
111479925|NCT02099175|Docetaxel|docetaxel|mesh-list
110644298|NCT00950196|Amantadine|amantadine|mesh-list
111479926|NCT02099175|Doxorubicin|doxorubicin|mesh-list
111479927|NCT02099175|Fluorouracil|fluorouracil|mesh-list
111479928|NCT02099175|Etoposide|etoposide|mesh-list
111479929|NCT02099175|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111479930|NCT02099175|Ifosfamide|ifosfamide|mesh-list
111479931|NCT02099175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111479932|NCT02099175|Tubulin Modulators|tubulin modulators|mesh-ancestor
111479933|NCT02099175|Antimitotic Agents|antimitotic agents|mesh-ancestor
111479934|NCT02099175|Mitosis Modulators|mitosis modulators|mesh-ancestor
111479935|NCT02099175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111479936|NCT02099175|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111479937|NCT02099175|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111479938|NCT02099175|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111479939|NCT02099175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111479940|NCT02099175|Antimetabolites|antimetabolites|mesh-ancestor
111479941|NCT02099175|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111479942|NCT02099175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111479943|NCT02099175|Immunologic Factors|immunologic factors|mesh-ancestor
111479944|NCT02099175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111479945|NCT02099175|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111479946|NCT02099175|Antidotes|antidotes|mesh-ancestor
111479947|NCT02099175|Protective Agents|protective agents|mesh-ancestor
111479948|NCT02099175|Vitamin B Complex|vitamin b complex|mesh-ancestor
111479949|NCT02099175|Vitamins|vitamins|mesh-ancestor
111479950|NCT02099175|Micronutrients|micronutrients|mesh-ancestor
111479951|NCT02099175|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111479952|NCT02099175|Alkylating Agents|alkylating agents|mesh-ancestor
111479953|NCT01946074|Paclitaxel|paclitaxel|mesh-list
111479954|NCT01946074|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110644355|NCT01326325|Ketamine|ketamine|mesh-list
111479955|NCT01946074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111479956|NCT01946074|Tubulin Modulators|tubulin modulators|mesh-ancestor
111479957|NCT01946074|Antimitotic Agents|antimitotic agents|mesh-ancestor
111479958|NCT01946074|Mitosis Modulators|mitosis modulators|mesh-ancestor
111479959|NCT01946074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111479960|NCT01715285|Prednisone|prednisone|mesh-list
111479961|NCT01715285|Abiraterone Acetate|abiraterone acetate|mesh-list
111479962|NCT01715285|Androgens|androgens|mesh-list
111479963|NCT01715285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111479964|NCT01715285|Glucocorticoids|glucocorticoids|mesh-ancestor
111479965|NCT01715285|Hormones|hormones|mesh-ancestor
111479966|NCT01715285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111479967|NCT01715285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111479968|NCT01715285|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111479969|NCT01715285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111479970|NCT01715285|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111479971|NCT01715285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111479972|NCT01715285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111479973|NCT01715285|Hormone Antagonists|hormone antagonists|mesh-ancestor
111479974|NCT01715285|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111479975|NCT01705184|Bevacizumab|bevacizumab|mesh-list
111479976|NCT01705184|Pemetrexed|pemetrexed|mesh-list
111479977|NCT01705184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111479978|NCT01705184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111479979|NCT01705184|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111479980|NCT01705184|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111479981|NCT01705184|Growth Substances|growth substances|mesh-ancestor
111479982|NCT01705184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111479983|NCT01705184|Growth Inhibitors|growth inhibitors|mesh-ancestor
111479984|NCT01705184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110644388|NCT00520845|Analgesics|analgesics|mesh-ancestor
111479985|NCT01705184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111479986|NCT01705184|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111479987|NCT01705184|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111479988|NCT01285817|Celecoxib|celecoxib|mesh-list
111479989|NCT01285817|Cyclophosphamide|cyclophosphamide|mesh-list
111479990|NCT01285817|Methotrexate|methotrexate|mesh-list
111479991|NCT01285817|Vinblastine|vinblastine|mesh-list
111479992|NCT01285817|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111479993|NCT01285817|Immunologic Factors|immunologic factors|mesh-ancestor
111479994|NCT01285817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111479995|NCT01285817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111479996|NCT01285817|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111479997|NCT01285817|Alkylating Agents|alkylating agents|mesh-ancestor
111479998|NCT01285817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111479999|NCT01285817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111480000|NCT01285817|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111480001|NCT01285817|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111480002|NCT01285817|Abortifacient Agents|abortifacient agents|mesh-ancestor
111480003|NCT01285817|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111480004|NCT01285817|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111480005|NCT01285817|Antimetabolites|antimetabolites|mesh-ancestor
111480006|NCT01285817|Dermatologic Agents|dermatologic agents|mesh-ancestor
111480007|NCT01285817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111480008|NCT01285817|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111480009|NCT01285817|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111480010|NCT01285817|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111480011|NCT01285817|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111480012|NCT01285817|Analgesics|analgesics|mesh-ancestor
111480013|NCT01285817|Sensory System Agents|sensory system agents|mesh-ancestor
111480014|NCT01285817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111480015|NCT01285817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111480016|NCT01285817|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111480017|NCT01285817|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111480018|NCT01285817|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111480019|NCT01285817|Tubulin Modulators|tubulin modulators|mesh-ancestor
111480020|NCT01285817|Antimitotic Agents|antimitotic agents|mesh-ancestor
111480021|NCT01285817|Mitosis Modulators|mitosis modulators|mesh-ancestor
111480022|NCT01285479|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
111480023|NCT01285479|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
111480024|NCT01285479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111480025|NCT01285479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111480026|NCT01285479|Immunologic Factors|immunologic factors|mesh-ancestor
111480027|NCT01285479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111480028|NCT01250496|Aminophylline|aminophylline|mesh-list
111480029|NCT01250496|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111480030|NCT01250496|Autonomic Agents|autonomic agents|mesh-ancestor
111480031|NCT01250496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111480032|NCT01250496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111480033|NCT01250496|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111480034|NCT01250496|Respiratory System Agents|respiratory system agents|mesh-ancestor
111480035|NCT01250496|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111480036|NCT01250496|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111480037|NCT01250496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111102580|NCT02396225|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110819663|NCT01130779|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111102581|NCT02396225|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111480038|NCT01250496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111480039|NCT01250496|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
111480040|NCT01250496|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111480041|NCT01250496|Purinergic Agents|purinergic agents|mesh-ancestor
111480042|NCT01250496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111480043|NCT01250496|Protective Agents|protective agents|mesh-ancestor
111480044|NCT01105975|Atorvastatin|atorvastatin|mesh-list
111480045|NCT01105975|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111480046|NCT01105975|Simvastatin|simvastatin|mesh-list
111480047|NCT01105975|Evacetrapib|evacetrapib|mesh-list
111480048|NCT01105975|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111480049|NCT01105975|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111480050|NCT01105975|Antimetabolites|antimetabolites|mesh-ancestor
111480051|NCT01105975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111480052|NCT01105975|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111480053|NCT01105975|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111480054|NCT01105975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111480055|NCT00651456|Bevacizumab|bevacizumab|mesh-list
111480056|NCT00651456|Cisplatin|cisplatin|mesh-list
111480057|NCT00651456|Pemetrexed|pemetrexed|mesh-list
111480058|NCT00651456|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111480059|NCT00651456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111480060|NCT00651456|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111480061|NCT00651456|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111480062|NCT00651456|Growth Substances|growth substances|mesh-ancestor
111480063|NCT00651456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111480064|NCT00651456|Growth Inhibitors|growth inhibitors|mesh-ancestor
111480065|NCT00651456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111480066|NCT00651456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111480067|NCT00651456|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111480068|NCT00651456|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111480069|NCT00280202|Dimercaprol|dimercaprol|mesh-list
111480070|NCT00280202|Chelating Agents|chelating agents|mesh-ancestor
111480071|NCT00280202|Sequestering Agents|sequestering agents|mesh-ancestor
111480072|NCT00280202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111480073|NCT00079417|Iodine|iodine|mesh-list
111480074|NCT00079417|Cadexomer iodine|cadexomer iodine|mesh-list
111480075|NCT00079417|Carboplatin|carboplatin|mesh-list
111480076|NCT00079417|Vincristine|vincristine|mesh-list
111480077|NCT00079417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111480078|NCT00079417|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111480079|NCT00079417|Tubulin Modulators|tubulin modulators|mesh-ancestor
111480080|NCT00079417|Antimitotic Agents|antimitotic agents|mesh-ancestor
111480081|NCT00079417|Mitosis Modulators|mitosis modulators|mesh-ancestor
111480082|NCT00079417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111480083|NCT00079417|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111480084|NCT00079417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111480085|NCT00079417|Trace Elements|trace elements|mesh-ancestor
111480086|NCT00079417|Micronutrients|micronutrients|mesh-ancestor
111480087|NCT00079417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111480088|NCT04387500|Axitinib|axitinib|mesh-list
111480089|NCT04387500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111480090|NCT04387500|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111480091|NCT04387500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111480092|NCT04387500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111480093|NCT04386876|Ritonavir|ritonavir|mesh-list
111480094|NCT04386876|Lopinavir|lopinavir|mesh-list
111480095|NCT04386876|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111480096|NCT04386876|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111480097|NCT04386876|Protease Inhibitors|protease inhibitors|mesh-ancestor
111480098|NCT04386876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111480099|NCT04386876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111480100|NCT04386876|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111480101|NCT04386876|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111480102|NCT04386876|Antiviral Agents|antiviral agents|mesh-ancestor
111480103|NCT04386876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111480104|NCT04386876|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111480105|NCT04386876|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111480106|NCT04386642|Tranexamic Acid|tranexamic acid|mesh-list
111480107|NCT04386642|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111480108|NCT04386642|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111480109|NCT04386642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111102582|NCT02396225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110688166|NCT00953537|Capecitabine|capecitabine|mesh-list
111480110|NCT04386642|Hemostatics|hemostatics|mesh-ancestor
111480111|NCT04386642|Coagulants|coagulants|mesh-ancestor
111480113|NCT04385550|Docetaxel|docetaxel|mesh-list
110644490|NCT04073537|Carboplatin|carboplatin|mesh-list
111480114|NCT04385550|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111480115|NCT04385550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111480116|NCT04385550|Tubulin Modulators|tubulin modulators|mesh-ancestor
111480117|NCT04385550|Antimitotic Agents|antimitotic agents|mesh-ancestor
111480118|NCT04385550|Mitosis Modulators|mitosis modulators|mesh-ancestor
111480119|NCT04385550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111480120|NCT04384380|Hydroxychloroquine|hydroxychloroquine|mesh-list
111480121|NCT04384380|Antimalarials|antimalarials|mesh-ancestor
111480122|NCT04384380|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111480123|NCT04384380|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111480124|NCT04384380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111480125|NCT04384380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111480126|NCT04384380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111480127|NCT04384380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111480128|NCT04384458|Hydroxychloroquine|hydroxychloroquine|mesh-list
111480129|NCT04384458|Ivermectin|ivermectin|mesh-list
111480130|NCT04384458|Antimalarials|antimalarials|mesh-ancestor
111480131|NCT04384458|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111480132|NCT04384458|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111480133|NCT04384458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111480134|NCT04384458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111480135|NCT04384458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111480136|NCT04384458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111480137|NCT04383990|Insulin|insulin|mesh-list
111480138|NCT04383990|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111480139|NCT04383990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111480140|NCT04381884|Ivermectin|ivermectin|mesh-list
111480141|NCT04381884|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111480142|NCT04381884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111480143|NCT04381962|Azithromycin|azithromycin|mesh-list
111480144|NCT04381962|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111480145|NCT04381962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111480146|NCT04381104|Acetaminophen|acetaminophen|mesh-list
111480147|NCT04381104|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111480148|NCT04381104|Analgesics|analgesics|mesh-ancestor
111480149|NCT04381104|Sensory System Agents|sensory system agents|mesh-ancestor
111480150|NCT04381104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111480151|NCT04381104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111480152|NCT04381104|Antipyretics|antipyretics|mesh-ancestor
111480153|NCT04380402|Atorvastatin|atorvastatin|mesh-list
111480154|NCT04380402|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111480155|NCT04380402|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111480156|NCT04380402|Antimetabolites|antimetabolites|mesh-ancestor
111480157|NCT04380402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111480158|NCT04380402|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111480159|NCT04380402|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111480160|NCT04380402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111480161|NCT04380012|Trastuzumab|trastuzumab|mesh-list
111480162|NCT04380012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111480163|NCT04380012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111480164|NCT04379310|Calcium Channel Blockers|calcium channel blockers|mesh-list
111480165|NCT04379310|Calcium|calcium|mesh-list
111480166|NCT04379310|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
111480167|NCT04379310|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111480168|NCT04379310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111480169|NCT04379310|Protease Inhibitors|protease inhibitors|mesh-ancestor
111480170|NCT04379310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111480171|NCT04379310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111480172|NCT04379310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111480173|NCT04378608|Ribavirin|ribavirin|mesh-list
111480174|NCT04378608|Antimetabolites|antimetabolites|mesh-ancestor
111480175|NCT04378608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111480176|NCT04378608|Antiviral Agents|antiviral agents|mesh-ancestor
111480177|NCT04378608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111480178|NCT04376970|Fluorometholone|fluorometholone|mesh-list
111480179|NCT04376970|Cyclosporine|cyclosporine|mesh-list
111480180|NCT04376970|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111480181|NCT04376970|Cyclosporins|cyclosporins|mesh-list
111480182|NCT04376970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111480183|NCT04376970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111480184|NCT04376970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111102583|NCT02396225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111102584|NCT02396225|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111102585|NCT02396225|Hormone Antagonists|hormone antagonists|mesh-ancestor
111480185|NCT04376970|Immunologic Factors|immunologic factors|mesh-ancestor
111480186|NCT04376970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111480187|NCT04376970|Antifungal Agents|antifungal agents|mesh-ancestor
111480188|NCT04376970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111480189|NCT04376970|Dermatologic Agents|dermatologic agents|mesh-ancestor
111480190|NCT04376970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111480191|NCT04376970|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111480192|NCT04376970|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111480193|NCT04376970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111480194|NCT04376970|Glucocorticoids|glucocorticoids|mesh-ancestor
111480195|NCT04376970|Hormones|hormones|mesh-ancestor
111480196|NCT04376970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111480197|NCT04376970|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111480198|NCT04377048|Gemcitabine|gemcitabine|mesh-list
111480199|NCT04377048|Tegafur|tegafur|mesh-list
111480200|NCT04377048|Nivolumab|nivolumab|mesh-list
111480201|NCT04377048|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111480202|NCT04377048|Antimetabolites|antimetabolites|mesh-ancestor
111480203|NCT04377048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111480204|NCT04377048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111480205|NCT04377048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110644553|NCT00127855|Vaccines|vaccines|mesh-list
111480206|NCT04377048|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111480207|NCT04376814|Ritonavir|ritonavir|mesh-list
111480208|NCT04376814|Lopinavir|lopinavir|mesh-list
111480209|NCT04376814|Hydroxychloroquine|hydroxychloroquine|mesh-list
111480210|NCT04376814|Favipiravir|favipiravir|mesh-list
111480211|NCT04376814|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111480212|NCT04376814|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111480213|NCT04376814|Protease Inhibitors|protease inhibitors|mesh-ancestor
111480214|NCT04376814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111480215|NCT04376814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111480216|NCT04376814|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111480217|NCT04376814|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111480218|NCT04376814|Antiviral Agents|antiviral agents|mesh-ancestor
111480219|NCT04376814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111480220|NCT04376814|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111480221|NCT04376814|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111480222|NCT04376814|Antimalarials|antimalarials|mesh-ancestor
111480223|NCT04376814|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111480224|NCT04376814|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111480225|NCT04376814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111480226|NCT04374942|Hydroxychloroquine|hydroxychloroquine|mesh-list
111480227|NCT04374942|Antimalarials|antimalarials|mesh-ancestor
111480228|NCT04374942|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111480229|NCT04374942|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111480230|NCT04374942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111480231|NCT04374942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111480232|NCT04374942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111480233|NCT04374942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111480234|NCT04374318|Dexmedetomidine|dexmedetomidine|mesh-list
111480235|NCT04374318|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111480236|NCT04374318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111480237|NCT04374318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111480238|NCT04374318|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111480239|NCT04374318|Analgesics|analgesics|mesh-ancestor
111480240|NCT04374318|Sensory System Agents|sensory system agents|mesh-ancestor
111480241|NCT04374318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111480242|NCT04374318|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111480243|NCT04374318|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111480244|NCT04374318|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111480245|NCT04374318|Adrenergic Agents|adrenergic agents|mesh-ancestor
111480246|NCT04374318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111480247|NCT04374318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111480248|NCT04374552|Azithromycin|azithromycin|mesh-list
111480249|NCT04374552|Hydroxychloroquine|hydroxychloroquine|mesh-list
111480250|NCT04374552|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111480251|NCT04374552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111480252|NCT04374552|Antimalarials|antimalarials|mesh-ancestor
111480253|NCT04374552|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111480254|NCT04374552|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110688310|NCT00443430|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111480255|NCT04374552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111480256|NCT04374552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111480257|NCT04374552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110644577|NCT03965767|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111102586|NCT02396225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111102587|NCT02396225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111480258|NCT04374006|Propolis|propolis|mesh-list
111480259|NCT04374006|Dienogest|dienogest|mesh-list
111480260|NCT04374006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111480261|NCT04374006|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
111480262|NCT04374006|Contraceptive Agents|contraceptive agents|mesh-ancestor
111480263|NCT04374006|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111480264|NCT04374006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111480265|NCT04374006|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111480266|NCT04374006|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111480267|NCT04374006|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111480268|NCT04374006|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111480269|NCT04374006|Hormone Antagonists|hormone antagonists|mesh-ancestor
111480270|NCT04374006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111480271|NCT04374006|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111480272|NCT04374006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111480273|NCT04372836|Vasopressins|vasopressins|mesh-list
111480274|NCT04372836|Arginine Vasopressin|arginine vasopressin|mesh-list
111480275|NCT04372836|Hemostatics|hemostatics|mesh-ancestor
111480276|NCT04372836|Coagulants|coagulants|mesh-ancestor
111480277|NCT04372836|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111480278|NCT04372836|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
111480279|NCT04372836|Natriuretic Agents|natriuretic agents|mesh-ancestor
111480280|NCT04372836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111480281|NCT04371978|Linagliptin|linagliptin|mesh-list
111480282|NCT04371978|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111480283|NCT04371978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111480284|NCT04371978|Incretins|incretins|mesh-ancestor
111480285|NCT04371978|Hormones|hormones|mesh-ancestor
111480286|NCT04371978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111480287|NCT04371978|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111480288|NCT04371978|Protease Inhibitors|protease inhibitors|mesh-ancestor
111480289|NCT04371978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111480290|NCT04371978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111480291|NCT04371822|Protoporphyrin IX|protoporphyrin ix|mesh-list
111480292|NCT04371822|Tin protoporphyrin IX|tin protoporphyrin ix|mesh-list
111480293|NCT04371822|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111480294|NCT04371822|Dermatologic Agents|dermatologic agents|mesh-ancestor
111480295|NCT04371822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111480296|NCT04371822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111480297|NCT04370262|Famotidine|famotidine|mesh-list
111480298|NCT04370262|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111480299|NCT04370262|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111480300|NCT04370262|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
111480301|NCT04370262|Histamine Antagonists|histamine antagonists|mesh-ancestor
111480302|NCT04370262|Histamine Agents|histamine agents|mesh-ancestor
111480303|NCT04370262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111480304|NCT04370262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111480305|NCT04370262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111480306|NCT04368546|Sunitinib|sunitinib|mesh-list
111480307|NCT04368546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111480308|NCT04368546|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111480309|NCT04368546|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111480310|NCT04368546|Growth Substances|growth substances|mesh-ancestor
111480311|NCT04368546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111480312|NCT04368546|Growth Inhibitors|growth inhibitors|mesh-ancestor
111480313|NCT04368546|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111480314|NCT04368546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111480315|NCT04368546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111480316|NCT04366596|Paclitaxel|paclitaxel|mesh-list
111480317|NCT04366596|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111480318|NCT04366596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111480319|NCT04366596|Tubulin Modulators|tubulin modulators|mesh-ancestor
111480320|NCT04366596|Antimitotic Agents|antimitotic agents|mesh-ancestor
111480321|NCT04366596|Mitosis Modulators|mitosis modulators|mesh-ancestor
111480322|NCT04366596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111480323|NCT04366128|Immunomodulating Agents|immunomodulating agents|mesh-list
111480324|NCT04366128|Immunologic Factors|immunologic factors|mesh-ancestor
111480325|NCT04366128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111480326|NCT04365582|Ritonavir|ritonavir|mesh-list
111102588|NCT02396225|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111480327|NCT04365582|Lopinavir|lopinavir|mesh-list
111480328|NCT04365582|Azithromycin|azithromycin|mesh-list
111480329|NCT04365582|Hydroxychloroquine|hydroxychloroquine|mesh-list
111480330|NCT04365582|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111480331|NCT04365582|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111480332|NCT04365582|Protease Inhibitors|protease inhibitors|mesh-ancestor
111480333|NCT04365582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111480334|NCT04365582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111480335|NCT04365582|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111480336|NCT04365582|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111480337|NCT04365582|Antiviral Agents|antiviral agents|mesh-ancestor
111480338|NCT04365582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111480339|NCT04365582|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111480340|NCT04365582|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111480341|NCT04365582|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111480342|NCT04365582|Antimalarials|antimalarials|mesh-ancestor
111480343|NCT04365582|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111480344|NCT04365582|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111480345|NCT04365582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111480346|NCT04365270|Chlorhexidine|chlorhexidine|mesh-list
111480347|NCT04365270|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
111480348|NCT04365270|Titanium dioxide|titanium dioxide|mesh-list
111480349|NCT04365270|Chitosan|chitosan|mesh-list
111480350|NCT04365270|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111480351|NCT04365270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111480352|NCT04365270|Disinfectants|disinfectants|mesh-ancestor
111480353|NCT04365270|Dermatologic Agents|dermatologic agents|mesh-ancestor
111480354|NCT04365270|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111480355|NCT04365270|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111480356|NCT04365270|Antimetabolites|antimetabolites|mesh-ancestor
111480357|NCT04365270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111480358|NCT04365270|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111480359|NCT04365270|Chelating Agents|chelating agents|mesh-ancestor
111480360|NCT04365270|Sequestering Agents|sequestering agents|mesh-ancestor
111480361|NCT04365270|Hemostatics|hemostatics|mesh-ancestor
111480362|NCT04365270|Coagulants|coagulants|mesh-ancestor
111480363|NCT04365270|Sunscreening Agents|sunscreening agents|mesh-ancestor
111480364|NCT04365270|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111480365|NCT04365270|Protective Agents|protective agents|mesh-ancestor
111480366|NCT04365270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111480367|NCT04365270|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111480368|NCT04365426|Contraceptive Agents|contraceptive agents|mesh-list
111480369|NCT04365426|Contraceptives, Oral|contraceptives, oral|mesh-list
111480370|NCT04365426|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111480371|NCT04365426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111480372|NCT04365426|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111480373|NCT04365036|Gemcitabine|gemcitabine|mesh-list
111480374|NCT04365036|Oxaliplatin|oxaliplatin|mesh-list
111480375|NCT04365036|Pegaspargase|pegaspargase|mesh-list
111480376|NCT04365036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111480377|NCT04365036|Antimetabolites|antimetabolites|mesh-ancestor
111480378|NCT04365036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111480379|NCT04365036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111480380|NCT04364022|Ritonavir|ritonavir|mesh-list
111480381|NCT04364022|Lopinavir|lopinavir|mesh-list
111480382|NCT04364022|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111480383|NCT04364022|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111480384|NCT04364022|Protease Inhibitors|protease inhibitors|mesh-ancestor
111480385|NCT04364022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111480386|NCT04364022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111480387|NCT04364022|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111480388|NCT04364022|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111480389|NCT04364022|Antiviral Agents|antiviral agents|mesh-ancestor
111480390|NCT04364022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111480391|NCT04364022|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111480392|NCT04364022|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111480393|NCT04363866|Hydroxychloroquine|hydroxychloroquine|mesh-list
111480394|NCT04363866|Antimalarials|antimalarials|mesh-ancestor
111480395|NCT04363866|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111480396|NCT04363866|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111480397|NCT04363866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111480398|NCT04363866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111480399|NCT04363866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111480400|NCT04363866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111102590|NCT04272801|Letrozole|letrozole|mesh-list
111480401|NCT04362384|Vitamin E|vitamin e|mesh-list
111480402|NCT04362384|Prednisolone|prednisolone|mesh-list
111480403|NCT04362384|Vitamins|vitamins|mesh-ancestor
111480404|NCT04362384|Micronutrients|micronutrients|mesh-ancestor
111480405|NCT04362384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111480406|NCT04362384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111480408|NCT04362384|Hormones|hormones|mesh-ancestor
111480409|NCT04362384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111480410|NCT04362384|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111480411|NCT04362384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111480412|NCT04362384|Protective Agents|protective agents|mesh-ancestor
111480413|NCT04362384|Antioxidants|antioxidants|mesh-ancestor
111480414|NCT04362384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111480415|NCT04361214|Leflunomide|leflunomide|mesh-list
111480416|NCT04361214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111480417|NCT04361214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111480418|NCT04361214|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111480419|NCT04361214|Immunologic Factors|immunologic factors|mesh-ancestor
111480420|NCT04361214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111480421|NCT04361370|Bevacizumab|bevacizumab|mesh-list
111480422|NCT04361370|Pembrolizumab|pembrolizumab|mesh-list
111480423|NCT04361370|Olaparib|olaparib|mesh-list
111480424|NCT04361370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111480425|NCT04361370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111480426|NCT04361370|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111480427|NCT04361370|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111480428|NCT04361370|Growth Substances|growth substances|mesh-ancestor
111480429|NCT04361370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111480430|NCT04361370|Growth Inhibitors|growth inhibitors|mesh-ancestor
111480431|NCT04361370|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111480432|NCT04361370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111480433|NCT04361370|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111480434|NCT04361370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111480435|NCT04361058|Nivolumab|nivolumab|mesh-list
111480436|NCT04361058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111480437|NCT04361058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111480438|NCT04361058|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111480439|NCT04361058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111480440|NCT04359966|Amoxicillin|amoxicillin|mesh-list
111480441|NCT04359966|Metronidazole|metronidazole|mesh-list
111480442|NCT04359966|Clarithromycin|clarithromycin|mesh-list
111480443|NCT04359966|Levofloxacin|levofloxacin|mesh-list
111480444|NCT04359966|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
111480445|NCT04359966|Esomeprazole|esomeprazole|mesh-list
111480446|NCT04359966|Bismuth|bismuth|mesh-list
111480447|NCT04359966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111480448|NCT04359966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111480449|NCT04359966|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111480450|NCT04359966|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111480451|NCT04359966|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111480452|NCT04359966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111480453|NCT04359966|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111480454|NCT04359966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111480455|NCT04359966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111480456|NCT04359966|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111480457|NCT04359966|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111480458|NCT04359966|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111480459|NCT04359966|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111480460|NCT04359966|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111480461|NCT04359966|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111480462|NCT04359966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111480463|NCT04359966|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111480464|NCT04359966|Antacids|antacids|mesh-ancestor
111480465|NCT04360122|Levamisole|levamisole|mesh-list
111480466|NCT04360122|Inosine Pranobex|inosine pranobex|mesh-list
111480467|NCT04360122|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111480468|NCT04360122|Immunologic Factors|immunologic factors|mesh-ancestor
111480469|NCT04360122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111480470|NCT04360122|Antinematodal Agents|antinematodal agents|mesh-ancestor
111480471|NCT04360122|Anthelmintics|anthelmintics|mesh-ancestor
111480472|NCT04360122|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111480473|NCT04360122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111480474|NCT04360122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111480475|NCT04360122|Antiviral Agents|antiviral agents|mesh-ancestor
111480476|NCT04360356|Ivermectin|ivermectin|mesh-list
111480477|NCT04360356|Nitazoxanide|nitazoxanide|mesh-list
110688524|NCT03440892|Sulfasalazine|sulfasalazine|mesh-list
110688525|NCT03440892|Methotrexate|methotrexate|mesh-list
110688526|NCT03440892|Abatacept|abatacept|mesh-list
110688527|NCT03440892|Tofacitinib|tofacitinib|mesh-list
111102591|NCT04272801|Anastrozole|anastrozole|mesh-list
111480478|NCT04360356|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111480479|NCT04360356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111480480|NCT04359576|Hemostatics|hemostatics|mesh-list
111480481|NCT04359576|Coagulants|coagulants|mesh-ancestor
111480483|NCT04358796|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111480484|NCT04358718|Anesthetics|anesthetics|mesh-list
111480485|NCT04358718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111480486|NCT04358718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111480487|NCT04358562|Gefitinib|gefitinib|mesh-list
111480488|NCT04358562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111480489|NCT04358562|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111480490|NCT04358562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111480491|NCT04358562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111480492|NCT04357860|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111480493|NCT04358016|Terlipressin|terlipressin|mesh-list
111480494|NCT04358016|Somatostatin|somatostatin|mesh-list
111480495|NCT04358016|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111480496|NCT04358016|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111480497|NCT04358016|Hormones|hormones|mesh-ancestor
111480498|NCT04358016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111480499|NCT04358016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111480500|NCT04357392|Hypoglycemic Agents|hypoglycemic agents|mesh-list
111480501|NCT04357392|Prednisone|prednisone|mesh-list
111480502|NCT04357392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111480503|NCT04357392|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111480504|NCT04357392|Glucocorticoids|glucocorticoids|mesh-ancestor
111480505|NCT04357392|Hormones|hormones|mesh-ancestor
111480506|NCT04357392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111480507|NCT04357392|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111480508|NCT04357392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111480509|NCT04357002|Tranexamic Acid|tranexamic acid|mesh-list
111480510|NCT04357002|Dinoprostone|dinoprostone|mesh-list
111480511|NCT04357002|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111480512|NCT04357002|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111480513|NCT04357002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111480514|NCT04357002|Hemostatics|hemostatics|mesh-ancestor
111480515|NCT04357002|Coagulants|coagulants|mesh-ancestor
111480516|NCT04357002|Oxytocics|oxytocics|mesh-ancestor
111480517|NCT04357002|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111480518|NCT04357002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111480519|NCT04356222|Methotrexate|methotrexate|mesh-list
111480520|NCT04356222|Durvalumab|durvalumab|mesh-list
111480521|NCT04356222|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111480522|NCT04356222|Abortifacient Agents|abortifacient agents|mesh-ancestor
111480523|NCT04356222|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111480524|NCT04356222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111480525|NCT04356222|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111480526|NCT04356222|Antimetabolites|antimetabolites|mesh-ancestor
111480527|NCT04356222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111480528|NCT04356222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111480529|NCT04356222|Dermatologic Agents|dermatologic agents|mesh-ancestor
111480530|NCT04356222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111480531|NCT04356222|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111480532|NCT04356222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111480533|NCT04356222|Immunologic Factors|immunologic factors|mesh-ancestor
111480534|NCT04356222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111480535|NCT04356222|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111480536|NCT04356222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111480537|NCT04356144|Thrombin|thrombin|mesh-list
111480538|NCT04356144|Hemostatics|hemostatics|mesh-ancestor
111480539|NCT04356144|Coagulants|coagulants|mesh-ancestor
111480540|NCT04355598|Lidocaine|lidocaine|mesh-list
111480541|NCT04355598|Nitroglycerin|nitroglycerin|mesh-list
111480542|NCT04355598|Prilocaine|prilocaine|mesh-list
111480543|NCT04355598|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
111480544|NCT04355598|Anesthetics, Local|anesthetics, local|mesh-ancestor
111480545|NCT04355598|Anesthetics|anesthetics|mesh-ancestor
111480546|NCT04355598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111480547|NCT04355598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111480548|NCT04355598|Sensory System Agents|sensory system agents|mesh-ancestor
111480549|NCT04355598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111480550|NCT04355598|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111102592|NCT04272801|Exemestane|exemestane|mesh-list
111480551|NCT04355598|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110688601|NCT00312208|Docetaxel|docetaxel|mesh-list
111102593|NCT04272801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111480552|NCT04355598|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111480553|NCT04355598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111480554|NCT04355598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111480555|NCT04355598|Vasodilator Agents|vasodilator agents|mesh-ancestor
111480556|NCT04355598|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
111480557|NCT04355520|Fulvestrant|fulvestrant|mesh-list
111480558|NCT04355520|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111480559|NCT04355520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111480560|NCT04355520|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
111480561|NCT04355520|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111480562|NCT04355520|Hormone Antagonists|hormone antagonists|mesh-ancestor
111480563|NCT04355520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111480564|NCT04355520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111480565|NCT04355052|Azithromycin|azithromycin|mesh-list
111480566|NCT04355052|Hydroxychloroquine|hydroxychloroquine|mesh-list
111480568|NCT04355052|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111480569|NCT04355052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111480570|NCT04355052|Antimalarials|antimalarials|mesh-ancestor
111480571|NCT04355052|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111480572|NCT04355052|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111480573|NCT04355052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111480574|NCT04355052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111480575|NCT04355052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111480576|NCT04355052|Protease Inhibitors|protease inhibitors|mesh-ancestor
111480577|NCT04355052|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
111480578|NCT04355052|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111480579|NCT04354662|Leucovorin|leucovorin|mesh-list
111480580|NCT04354662|Docetaxel|docetaxel|mesh-list
111480581|NCT04354662|Fluorouracil|fluorouracil|mesh-list
111480582|NCT04354662|Oxaliplatin|oxaliplatin|mesh-list
111480583|NCT04354662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111480584|NCT04354662|Tubulin Modulators|tubulin modulators|mesh-ancestor
111480585|NCT04354662|Antimitotic Agents|antimitotic agents|mesh-ancestor
111480586|NCT04354662|Mitosis Modulators|mitosis modulators|mesh-ancestor
111480587|NCT04354662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111480588|NCT04354662|Antimetabolites|antimetabolites|mesh-ancestor
111480589|NCT04354662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111480590|NCT04354662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111480591|NCT04354662|Immunologic Factors|immunologic factors|mesh-ancestor
111480592|NCT04354662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111480593|NCT04354662|Antidotes|antidotes|mesh-ancestor
111480594|NCT04354662|Protective Agents|protective agents|mesh-ancestor
111480595|NCT04354662|Vitamin B Complex|vitamin b complex|mesh-ancestor
111480596|NCT04354662|Vitamins|vitamins|mesh-ancestor
111480597|NCT04354662|Micronutrients|micronutrients|mesh-ancestor
111480598|NCT04354350|Telmisartan|telmisartan|mesh-list
111480599|NCT04354350|Ramipril|ramipril|mesh-list
111480600|NCT04354350|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111480601|NCT04354350|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111480602|NCT04354350|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111480603|NCT04354350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111480604|NCT04354350|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
111480605|NCT04354350|Protease Inhibitors|protease inhibitors|mesh-ancestor
111480606|NCT04354350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111480607|NCT04353336|Hydroxychloroquine|hydroxychloroquine|mesh-list
111480608|NCT04353336|Chloroquine|chloroquine|mesh-list
111480609|NCT04353336|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
111480610|NCT04353336|Antimalarials|antimalarials|mesh-ancestor
111480611|NCT04353336|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111480612|NCT04353336|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111480613|NCT04353336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111480614|NCT04353336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111480615|NCT04353336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111480616|NCT04353336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111480617|NCT04353336|Amebicides|amebicides|mesh-ancestor
111480618|NCT04353336|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111480619|NCT04353336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111480620|NCT04353336|Analgesics|analgesics|mesh-ancestor
111480621|NCT04353336|Sensory System Agents|sensory system agents|mesh-ancestor
111480622|NCT04353336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111102594|NCT04272801|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111480623|NCT04353336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111480624|NCT04353336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111480625|NCT04353336|Filaricides|filaricides|mesh-ancestor
111480626|NCT04353336|Antinematodal Agents|antinematodal agents|mesh-ancestor
111480627|NCT04353336|Anthelmintics|anthelmintics|mesh-ancestor
111480628|NCT04353180|Tretinoin|tretinoin|mesh-list
111480629|NCT04353180|Isotretinoin|isotretinoin|mesh-list
111480630|NCT04353180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111480631|NCT04353180|Keratolytic Agents|keratolytic agents|mesh-ancestor
111480632|NCT04353180|Dermatologic Agents|dermatologic agents|mesh-ancestor
111480633|NCT04352946|Hydroxychloroquine|hydroxychloroquine|mesh-list
111480634|NCT04352946|Antimalarials|antimalarials|mesh-ancestor
111480635|NCT04352946|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111480636|NCT04352946|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111480637|NCT04352946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111480638|NCT04352946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111480639|NCT04352946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111480640|NCT04352946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111480641|NCT04352400|Nafamostat|nafamostat|mesh-list
111480642|NCT04352400|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111480643|NCT04352400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111480644|NCT04352400|Analgesics|analgesics|mesh-ancestor
111480645|NCT04352400|Sensory System Agents|sensory system agents|mesh-ancestor
111480646|NCT04352400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111480647|NCT04352400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111480648|NCT04352400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111480649|NCT04352400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111480650|NCT04352400|Anticoagulants|anticoagulants|mesh-ancestor
111480651|NCT04352400|Protease Inhibitors|protease inhibitors|mesh-ancestor
111480652|NCT04352400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111480653|NCT04352400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111480654|NCT04352400|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
111480655|NCT04352400|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111480656|NCT04352400|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
111480657|NCT04352400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111480658|NCT04352400|Immunologic Factors|immunologic factors|mesh-ancestor
111480659|NCT04351308|Apatinib|apatinib|mesh-list
111480660|NCT04351308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111480661|NCT04351308|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111480662|NCT04351308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111480663|NCT04351308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111480664|NCT04351152|Lenzilumab|lenzilumab|mesh-list
111480665|NCT04351152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111480666|NCT04350528|Pentobarbital|pentobarbital|mesh-list
111480667|NCT04350528|Chlorpromazine|chlorpromazine|mesh-list
111480668|NCT04350528|Antiemetics|antiemetics|mesh-ancestor
111480669|NCT04350528|Autonomic Agents|autonomic agents|mesh-ancestor
111480670|NCT04350528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111480671|NCT04350528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111480672|NCT04350528|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111480673|NCT04350528|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111480674|NCT04350528|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111480675|NCT04350528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111480676|NCT04350528|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111480677|NCT04350528|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111480678|NCT04350528|Dopamine Agents|dopamine agents|mesh-ancestor
111480679|NCT04350528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111480680|NCT04350528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111480681|NCT04350528|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111480682|NCT04350528|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111480683|NCT04350528|GABA Modulators|gaba modulators|mesh-ancestor
111480684|NCT04350528|GABA Agents|gaba agents|mesh-ancestor
111480685|NCT04350684|Interferons|interferons|mesh-list
111480686|NCT04350684|Ritonavir|ritonavir|mesh-list
111480687|NCT04350684|Lopinavir|lopinavir|mesh-list
111480688|NCT04350684|Interferon-beta|interferon-beta|mesh-list
111480689|NCT04350684|Interferon beta-1a|interferon beta-1a|mesh-list
111480690|NCT04350684|Hydroxychloroquine|hydroxychloroquine|mesh-list
111480691|NCT04350684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111480692|NCT04350684|Antiviral Agents|antiviral agents|mesh-ancestor
111480693|NCT04350684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111480694|NCT04350684|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111480695|NCT04350684|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111480696|NCT04350684|Protease Inhibitors|protease inhibitors|mesh-ancestor
111480697|NCT04350684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110644902|NCT05927142|Durvalumab|durvalumab|mesh-list
111102595|NCT04272801|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111480698|NCT04350684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111102596|NCT04272801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111480699|NCT04350684|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111480700|NCT04350684|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111480701|NCT04350684|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111480702|NCT04350684|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111480703|NCT04350684|Antimalarials|antimalarials|mesh-ancestor
111480704|NCT04350684|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111480705|NCT04350684|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111480706|NCT04350684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111480707|NCT04350684|Immunologic Factors|immunologic factors|mesh-ancestor
111480708|NCT04350684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111480709|NCT04350684|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111480710|NCT04350450|Hydroxychloroquine|hydroxychloroquine|mesh-list
111480711|NCT04350450|Antimalarials|antimalarials|mesh-ancestor
111480712|NCT04350450|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111480713|NCT04350450|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111480714|NCT04350450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111480715|NCT04350450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111480716|NCT04350450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111480717|NCT04350450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111480718|NCT04349592|Azithromycin|azithromycin|mesh-list
111480719|NCT04349592|Hydroxychloroquine|hydroxychloroquine|mesh-list
111480720|NCT04349592|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111480721|NCT04349592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111480722|NCT04349592|Antimalarials|antimalarials|mesh-ancestor
111480723|NCT04349592|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111480724|NCT04349592|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111480725|NCT04349592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111480726|NCT04349592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111480727|NCT04349592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111480728|NCT04347252|Glucagon|glucagon|mesh-list
111480729|NCT04347252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111480730|NCT04347252|Hormones|hormones|mesh-ancestor
111480731|NCT04347252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111480732|NCT04347252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111480733|NCT04346862|Acetylcarnitine|acetylcarnitine|mesh-list
111480734|NCT04346862|Vitamin B Complex|vitamin b complex|mesh-ancestor
111480735|NCT04346862|Vitamins|vitamins|mesh-ancestor
111480736|NCT04346862|Micronutrients|micronutrients|mesh-ancestor
111480737|NCT04346862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111480738|NCT04346862|Nootropic Agents|nootropic agents|mesh-ancestor
111480739|NCT04345848|Heparin|heparin|mesh-list
111480740|NCT04345848|Enoxaparin|enoxaparin|mesh-list
111480741|NCT04345848|Calcium heparin|calcium heparin|mesh-list
111480742|NCT04345848|Anticoagulants|anticoagulants|mesh-ancestor
111480743|NCT04345848|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111480744|NCT04345848|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111480745|NCT04345848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111480746|NCT04345692|Hydroxychloroquine|hydroxychloroquine|mesh-list
111480747|NCT04345692|Antimalarials|antimalarials|mesh-ancestor
111480748|NCT04345692|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111480749|NCT04345692|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111480750|NCT04345692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111480751|NCT04345692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111480752|NCT04345692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111480753|NCT04345692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111480754|NCT04345458|Etanercept|etanercept|mesh-list
111480755|NCT04345458|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111480756|NCT04345458|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111480757|NCT04345458|Analgesics|analgesics|mesh-ancestor
111480758|NCT04345458|Sensory System Agents|sensory system agents|mesh-ancestor
111480759|NCT04345458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111480760|NCT04345458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111480761|NCT04345458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111480762|NCT04345458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111480763|NCT04345458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111480764|NCT04345458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111480765|NCT04345458|Immunologic Factors|immunologic factors|mesh-ancestor
111480766|NCT04344756|Heparin|heparin|mesh-list
111480767|NCT04344756|Calcium heparin|calcium heparin|mesh-list
111480768|NCT04344756|Tinzaparin|tinzaparin|mesh-list
111480769|NCT04344756|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
111480770|NCT04344756|Dalteparin|dalteparin|mesh-list
111480771|NCT04344756|Anticoagulants|anticoagulants|mesh-ancestor
111480772|NCT04344756|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111480773|NCT04344756|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111480774|NCT04344756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111480775|NCT04344288|Prednisone|prednisone|mesh-list
111480776|NCT04344288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111480777|NCT04344288|Glucocorticoids|glucocorticoids|mesh-ancestor
111480778|NCT04344288|Hormones|hormones|mesh-ancestor
111480779|NCT04344288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111102597|NCT04272801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111480780|NCT04344288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111480781|NCT04344288|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111480782|NCT04344288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111480783|NCT04343742|Chlorine dioxide|chlorine dioxide|mesh-list
111480784|NCT04343742|Dental Disinfectants|dental disinfectants|mesh-ancestor
111480785|NCT04343742|Disinfectants|disinfectants|mesh-ancestor
111480786|NCT04343742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111480787|NCT04342728|Vitamins|vitamins|mesh-list
111480788|NCT04342728|Ascorbic Acid|ascorbic acid|mesh-list
111480789|NCT04342728|Zinc|zinc|mesh-list
111480790|NCT04342728|Micronutrients|micronutrients|mesh-ancestor
111480791|NCT04342728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111480792|NCT04342728|Trace Elements|trace elements|mesh-ancestor
111480793|NCT04342728|Antioxidants|antioxidants|mesh-ancestor
111480794|NCT04342728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111480795|NCT04342728|Protective Agents|protective agents|mesh-ancestor
111480796|NCT04342650|Chloroquine|chloroquine|mesh-list
111480797|NCT04342650|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
111480798|NCT04342650|Amebicides|amebicides|mesh-ancestor
111480799|NCT04342650|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111480800|NCT04342650|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111480801|NCT04342650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111480802|NCT04342650|Antimalarials|antimalarials|mesh-ancestor
111480803|NCT04342650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111480804|NCT04342650|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111480805|NCT04342650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111480806|NCT04342650|Analgesics|analgesics|mesh-ancestor
111480807|NCT04342650|Sensory System Agents|sensory system agents|mesh-ancestor
111480808|NCT04342650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111480809|NCT04342650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111480810|NCT04342650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111480811|NCT04342650|Filaricides|filaricides|mesh-ancestor
111480812|NCT04342650|Antinematodal Agents|antinematodal agents|mesh-ancestor
111480813|NCT04342650|Anthelmintics|anthelmintics|mesh-ancestor
111480814|NCT04341402|Antifungal Agents|antifungal agents|mesh-list
111480815|NCT04341402|Clotrimazole|clotrimazole|mesh-list
111480816|NCT04341402|Miconazole|miconazole|mesh-list
111480817|NCT04341402|Diclofenac|diclofenac|mesh-list
111480818|NCT04341402|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111480819|NCT04341402|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111480820|NCT04341402|Analgesics|analgesics|mesh-ancestor
111480821|NCT04341402|Sensory System Agents|sensory system agents|mesh-ancestor
111480822|NCT04341402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111102598|NCT04272801|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111480823|NCT04341402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111480824|NCT04341402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111480825|NCT04341402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111480826|NCT04341402|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111480827|NCT04341402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111480828|NCT04341402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111480829|NCT04341402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111480830|NCT04341402|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111480831|NCT04341402|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111480832|NCT04341402|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111480833|NCT04341402|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111480834|NCT04341402|Hormone Antagonists|hormone antagonists|mesh-ancestor
111480835|NCT04341402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111480836|NCT04341402|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111480837|NCT04341402|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111480838|NCT04340544|Hydroxychloroquine|hydroxychloroquine|mesh-list
111480839|NCT04340544|Antimalarials|antimalarials|mesh-ancestor
111480840|NCT04340544|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111480841|NCT04340544|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111480842|NCT04340544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111480843|NCT04340544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111480844|NCT04340544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111480845|NCT04340544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111480846|NCT04340778|Lidocaine|lidocaine|mesh-list
111480847|NCT04340778|Prilocaine|prilocaine|mesh-list
111480848|NCT04340778|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
111480849|NCT04340778|Dinoprostone|dinoprostone|mesh-list
111102599|NCT04272801|Hormone Antagonists|hormone antagonists|mesh-ancestor
110688893|NCT02748707|Celecoxib|celecoxib|mesh-list
111480850|NCT04340778|Anesthetics, Local|anesthetics, local|mesh-ancestor
111480851|NCT04340778|Anesthetics|anesthetics|mesh-ancestor
111480852|NCT04340778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111119164|NCT05306873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111480853|NCT04340778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111480854|NCT04340778|Sensory System Agents|sensory system agents|mesh-ancestor
111480855|NCT04340778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111480856|NCT04340778|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111480857|NCT04340778|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111480858|NCT04340778|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111480859|NCT04340778|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111480860|NCT04340778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111480861|NCT04340778|Oxytocics|oxytocics|mesh-ancestor
111480862|NCT04340778|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111480863|NCT04340778|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
111480864|NCT04340388|Tenofovir|tenofovir|mesh-list
111480865|NCT04340388|Lamivudine|lamivudine|mesh-list
111480866|NCT04340388|Zidovudine|zidovudine|mesh-list
111480867|NCT04340388|Dolutegravir|dolutegravir|mesh-list
111480868|NCT04340388|Darunavir|darunavir|mesh-list
111480869|NCT04340388|Abacavir|abacavir|mesh-list
111480870|NCT04340388|Cobicistat|cobicistat|mesh-list
111480871|NCT04340388|Rilpivirine|rilpivirine|mesh-list
111480872|NCT04340388|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
111480873|NCT04340388|Antiviral Agents|antiviral agents|mesh-ancestor
111480874|NCT04340388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111480875|NCT04340388|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111480876|NCT04340388|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111480877|NCT04340388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111480878|NCT04340388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111480879|NCT04340388|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111480880|NCT04340388|Antimetabolites|antimetabolites|mesh-ancestor
111480881|NCT04340388|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111480882|NCT04340388|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111480883|NCT04340388|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111480884|NCT04340388|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111480885|NCT04340388|Protease Inhibitors|protease inhibitors|mesh-ancestor
111480886|NCT04340388|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111480887|NCT04340388|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111480888|NCT04338906|Hydroxychloroquine|hydroxychloroquine|mesh-list
111480889|NCT04338906|Camostat|camostat|mesh-list
111480890|NCT04338906|Antimalarials|antimalarials|mesh-ancestor
111480891|NCT04338906|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111480892|NCT04338906|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111480893|NCT04338906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111480894|NCT04338906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111480895|NCT04338906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111480896|NCT04338906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111480897|NCT04338906|Protease Inhibitors|protease inhibitors|mesh-ancestor
111480898|NCT04338906|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
111480899|NCT04338906|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111480900|NCT04338438|Apatinib|apatinib|mesh-list
111480901|NCT04338438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111480902|NCT04338438|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111480903|NCT04338438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111480904|NCT04338438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111480905|NCT04338126|Tranexamic Acid|tranexamic acid|mesh-list
111480906|NCT04338126|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111480907|NCT04338126|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110645006|NCT05794503|Neostigmine|neostigmine|mesh-list
111480908|NCT04338126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111480909|NCT04338126|Hemostatics|hemostatics|mesh-ancestor
111480910|NCT04338126|Coagulants|coagulants|mesh-ancestor
111480911|NCT04337658|Capecitabine|capecitabine|mesh-list
111480912|NCT04337658|Trastuzumab|trastuzumab|mesh-list
111480913|NCT04337658|Fulvestrant|fulvestrant|mesh-list
111480914|NCT04337658|Pertuzumab|pertuzumab|mesh-list
111480915|NCT04337658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111480916|NCT04337658|Antimetabolites|antimetabolites|mesh-ancestor
111480917|NCT04337658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111480918|NCT04337658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111480919|NCT04337658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111480920|NCT04337658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111480921|NCT04337658|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
111480922|NCT04337658|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111480923|NCT04337658|Hormone Antagonists|hormone antagonists|mesh-ancestor
111480924|NCT04337658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111480925|NCT04337658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111480926|NCT04337268|Glucagon|glucagon|mesh-list
111480927|NCT04337268|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
111480928|NCT04337268|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111480929|NCT04337268|Hormones|hormones|mesh-ancestor
111480930|NCT04337268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111480931|NCT04337268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111480932|NCT04337268|Incretins|incretins|mesh-ancestor
111480933|NCT04336566|Melatonin|melatonin|mesh-list
111480934|NCT04336566|Antioxidants|antioxidants|mesh-ancestor
111480935|NCT04336566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111480936|NCT04336566|Protective Agents|protective agents|mesh-ancestor
111480937|NCT04336566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111480938|NCT04336566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111480939|NCT04336488|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
111480940|NCT04336488|Matrix Metalloproteinase Inhibitors|matrix metalloproteinase inhibitors|mesh-list
111480941|NCT04336488|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111480942|NCT04336488|Glucocorticoids|glucocorticoids|mesh-ancestor
111480943|NCT04336488|Hormones|hormones|mesh-ancestor
111480944|NCT04336488|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111480945|NCT04336488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111480946|NCT04336488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111480947|NCT04336488|Immunologic Factors|immunologic factors|mesh-ancestor
111480948|NCT04336488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111480949|NCT04336488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111480950|NCT04336488|Protease Inhibitors|protease inhibitors|mesh-ancestor
111480951|NCT04335786|Valsartan|valsartan|mesh-list
111480952|NCT04335786|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111480953|NCT04335786|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111480954|NCT04335786|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111480955|NCT04335786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111480956|NCT04334928|Tenofovir|tenofovir|mesh-list
111480957|NCT04334928|Emtricitabine|emtricitabine|mesh-list
111480958|NCT04334928|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
111480959|NCT04334928|Hydroxychloroquine|hydroxychloroquine|mesh-list
111480960|NCT04334928|Antiviral Agents|antiviral agents|mesh-ancestor
111480961|NCT04334928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111480962|NCT04334928|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111480963|NCT04334928|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111480964|NCT04334928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111480965|NCT04334928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111480966|NCT04334928|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111480967|NCT04334928|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111480968|NCT04334928|Antimalarials|antimalarials|mesh-ancestor
111480969|NCT04334928|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111480970|NCT04334928|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111480971|NCT04334928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111480972|NCT04334850|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111480973|NCT04334850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111102600|NCT04272801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111480974|NCT04334382|Azithromycin|azithromycin|mesh-list
111480975|NCT04334382|Hydroxychloroquine|hydroxychloroquine|mesh-list
111480976|NCT04334382|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111480977|NCT04334382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111480978|NCT04334382|Antimalarials|antimalarials|mesh-ancestor
111480979|NCT04334382|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111480980|NCT04334382|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111480981|NCT04334382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111480982|NCT04334382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111480983|NCT04334382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111480984|NCT04333992|Remifentanil|remifentanil|mesh-list
111480985|NCT04333992|Propofol|propofol|mesh-list
111480986|NCT04333992|Sevoflurane|sevoflurane|mesh-list
111480987|NCT04333992|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111480988|NCT04333992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111480989|NCT04333992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111480990|NCT04333992|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111480991|NCT04333992|Anesthetics, General|anesthetics, general|mesh-ancestor
111480992|NCT04333992|Anesthetics|anesthetics|mesh-ancestor
111480993|NCT04333992|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111480994|NCT04333992|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111480995|NCT04333992|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111480996|NCT04333992|Narcotics|narcotics|mesh-ancestor
111480997|NCT04333992|Analgesics|analgesics|mesh-ancestor
111480998|NCT04333992|Sensory System Agents|sensory system agents|mesh-ancestor
111480999|NCT04333992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110689047|NCT00959075|Thiamine|thiamine|mesh-list
111481000|NCT04332978|Fluticasone|fluticasone|mesh-list
111102601|NCT04272801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111481001|NCT04332978|Xhance|xhance|mesh-list
111481002|NCT04332978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111481003|NCT04332978|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111481004|NCT04332978|Autonomic Agents|autonomic agents|mesh-ancestor
111481005|NCT04332978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111481006|NCT04332978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111481007|NCT04332978|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111481008|NCT04332978|Respiratory System Agents|respiratory system agents|mesh-ancestor
111481009|NCT04332978|Dermatologic Agents|dermatologic agents|mesh-ancestor
111481010|NCT04332978|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111481011|NCT04332666|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
111481012|NCT04332666|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111481013|NCT04332666|Vasodilator Agents|vasodilator agents|mesh-ancestor
111481014|NCT04332276|Dopamine|dopamine|mesh-list
111481015|NCT04332276|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111481016|NCT04332276|Sympathomimetics|sympathomimetics|mesh-ancestor
111481017|NCT04332276|Autonomic Agents|autonomic agents|mesh-ancestor
111481018|NCT04332276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111481019|NCT04332276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111481020|NCT04332276|Dopamine Agents|dopamine agents|mesh-ancestor
111481021|NCT04332276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111481022|NCT04332276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111481023|NCT04332276|Protective Agents|protective agents|mesh-ancestor
111481024|NCT04332042|Tofacitinib|tofacitinib|mesh-list
111481025|NCT04332042|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
111481026|NCT04332042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111481027|NCT04332042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111481028|NCT04332042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111481029|NCT04341870|Azithromycin|azithromycin|mesh-list
111481030|NCT04341870|Hydroxychloroquine|hydroxychloroquine|mesh-list
111481031|NCT04341870|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111481032|NCT04341870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111481033|NCT04341870|Antimalarials|antimalarials|mesh-ancestor
111481034|NCT04341870|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111481035|NCT04341870|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111481036|NCT04341870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111481037|NCT04341870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111481038|NCT04341870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111481039|NCT04331418|Dexmedetomidine|dexmedetomidine|mesh-list
111481040|NCT04331418|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111481041|NCT04331418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111481042|NCT04331418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111481043|NCT04331418|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111481044|NCT04331418|Analgesics|analgesics|mesh-ancestor
111481045|NCT04331418|Sensory System Agents|sensory system agents|mesh-ancestor
111481046|NCT04331418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111481047|NCT04331418|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111481048|NCT04331418|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111481049|NCT04331418|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111481050|NCT04331418|Adrenergic Agents|adrenergic agents|mesh-ancestor
111481051|NCT04331418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111481052|NCT04331418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111481053|NCT04330872|Aspirin|aspirin|mesh-list
111481054|NCT04330872|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111481055|NCT04330872|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111481056|NCT04330872|Analgesics|analgesics|mesh-ancestor
111481057|NCT04330872|Sensory System Agents|sensory system agents|mesh-ancestor
111481058|NCT04330872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111481059|NCT04330872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111481060|NCT04330872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111481061|NCT04330872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111481062|NCT04330872|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111481063|NCT04330872|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111481064|NCT04330872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111481065|NCT04330872|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111481066|NCT04330872|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111481067|NCT04330872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111481068|NCT04330872|Antipyretics|antipyretics|mesh-ancestor
111481069|NCT04330326|Sorbitol|sorbitol|mesh-list
111102602|NCT04272801|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111102603|NCT04272801|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111481070|NCT04330326|Cathartics|cathartics|mesh-ancestor
111481071|NCT04330326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111481072|NCT04329858|Methamphetamine|methamphetamine|mesh-list
111481073|NCT04329858|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111481074|NCT04329858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111481075|NCT04329858|Sympathomimetics|sympathomimetics|mesh-ancestor
111481076|NCT04329858|Autonomic Agents|autonomic agents|mesh-ancestor
111481077|NCT04329858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111481078|NCT04329858|Dopamine Agents|dopamine agents|mesh-ancestor
111481079|NCT04329858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111481080|NCT04329858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111481081|NCT04329858|Adrenergic Agents|adrenergic agents|mesh-ancestor
111481082|NCT04329858|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111481083|NCT04329858|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111481084|NCT04329858|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111481085|NCT04329858|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111481087|NCT00704106|Antiviral Agents|antiviral agents|mesh-ancestor
111481088|NCT00704106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111481089|NCT05614752|Fexuprazan|fexuprazan|mesh-list
111481090|NCT05614752|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111481091|NCT05508594|Sufentanil|sufentanil|mesh-list
111481092|NCT05508594|Ketamine|ketamine|mesh-list
111481093|NCT05508594|Analgesics|analgesics|mesh-ancestor
111481094|NCT05508594|Sensory System Agents|sensory system agents|mesh-ancestor
111481095|NCT05508594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111481096|NCT05508594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111481097|NCT05508594|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111481098|NCT05508594|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111481099|NCT05508594|Anesthetics, General|anesthetics, general|mesh-ancestor
111481100|NCT05508594|Anesthetics|anesthetics|mesh-ancestor
111481101|NCT05508594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111481102|NCT05508594|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111481103|NCT05508594|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111481104|NCT05508594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111481105|NCT05508594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111481106|NCT05508594|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111481107|NCT05508594|Narcotics|narcotics|mesh-ancestor
111481108|NCT05508594|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111481109|NCT05417100|Methadone|methadone|mesh-list
111481110|NCT05417100|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111481111|NCT05417100|Narcotics|narcotics|mesh-ancestor
111481112|NCT05417100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111481113|NCT05417100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111481114|NCT05417100|Analgesics|analgesics|mesh-ancestor
111481115|NCT05417100|Sensory System Agents|sensory system agents|mesh-ancestor
111481116|NCT05417100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111481117|NCT05417100|Antitussive Agents|antitussive agents|mesh-ancestor
111481118|NCT05417100|Respiratory System Agents|respiratory system agents|mesh-ancestor
111481119|NCT05278884|Anesthetics|anesthetics|mesh-list
111481120|NCT05278884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111481121|NCT05278884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111481122|NCT05136690|Nicotine|nicotine|mesh-list
111481123|NCT05136690|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111481124|NCT05136690|Autonomic Agents|autonomic agents|mesh-ancestor
111481125|NCT05136690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111481126|NCT05136690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111481127|NCT05136690|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111481128|NCT05136690|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111481129|NCT05136690|Cholinergic Agents|cholinergic agents|mesh-ancestor
111481130|NCT05136690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111481131|NCT05136690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111481132|NCT05035680|Vaccines|vaccines|mesh-list
111481133|NCT05035680|Immunologic Factors|immunologic factors|mesh-ancestor
111481134|NCT05035680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111481135|NCT04831320|Paclitaxel|paclitaxel|mesh-list
111481136|NCT04831320|Nivolumab|nivolumab|mesh-list
111481137|NCT04831320|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111481138|NCT04831320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111481139|NCT04831320|Tubulin Modulators|tubulin modulators|mesh-ancestor
111481140|NCT04831320|Antimitotic Agents|antimitotic agents|mesh-ancestor
111481141|NCT04831320|Mitosis Modulators|mitosis modulators|mesh-ancestor
111481142|NCT04831320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111481143|NCT04831320|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111481144|NCT04831320|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111481145|NCT03063450|Nivolumab|nivolumab|mesh-list
111481146|NCT03063450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111119165|NCT05306873|Antifungal Agents|antifungal agents|mesh-ancestor
111481147|NCT03063450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111481148|NCT03063450|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111481149|NCT03063450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111481151|NCT01326000|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111481152|NCT01326000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111481153|NCT03035214|Dexamethasone|dexamethasone|mesh-list
111481154|NCT03035214|Dexamethasone acetate|dexamethasone acetate|mesh-list
111481155|NCT03035214|BB 1101|bb 1101|mesh-list
111481156|NCT03035214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111481157|NCT03035214|Antiemetics|antiemetics|mesh-ancestor
111481158|NCT03035214|Autonomic Agents|autonomic agents|mesh-ancestor
111481159|NCT03035214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111481160|NCT03035214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111481161|NCT03035214|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111481162|NCT03035214|Glucocorticoids|glucocorticoids|mesh-ancestor
111481163|NCT03035214|Hormones|hormones|mesh-ancestor
111481164|NCT03035214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111481165|NCT03035214|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111481166|NCT03035214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111481167|NCT03035214|Protease Inhibitors|protease inhibitors|mesh-ancestor
111481168|NCT03035214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111481169|NCT03035214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111481170|NCT03035058|Vedolizumab|vedolizumab|mesh-list
111481171|NCT03035058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111481172|NCT03033654|Sunscreening Agents|sunscreening agents|mesh-list
111481173|NCT03033654|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111481174|NCT03033654|Protective Agents|protective agents|mesh-ancestor
111481175|NCT03033654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111481176|NCT03033654|Dermatologic Agents|dermatologic agents|mesh-ancestor
111481177|NCT03033732|Buprenorphine|buprenorphine|mesh-list
111481178|NCT03033732|Methadone|methadone|mesh-list
111481179|NCT03033732|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
111481180|NCT03033732|Naloxone|naloxone|mesh-list
111481181|NCT03033732|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111481182|NCT03033732|Narcotics|narcotics|mesh-ancestor
111481183|NCT03033732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111481184|NCT03033732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111481185|NCT03033732|Analgesics|analgesics|mesh-ancestor
111481186|NCT03033732|Sensory System Agents|sensory system agents|mesh-ancestor
110645215|NCT05557578|Gemcitabine|gemcitabine|mesh-list
111481187|NCT03033732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111481188|NCT03033732|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111481189|NCT03033732|Antitussive Agents|antitussive agents|mesh-ancestor
111481190|NCT03033732|Respiratory System Agents|respiratory system agents|mesh-ancestor
111481191|NCT03033264|Dinoprostone|dinoprostone|mesh-list
111481192|NCT03033264|Oxytocics|oxytocics|mesh-ancestor
111481193|NCT03033264|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111481194|NCT03033264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111481195|NCT03033342|Omeprazole|omeprazole|mesh-list
111481196|NCT03033342|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111481197|NCT03033342|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111481198|NCT03033342|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111481199|NCT03033342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111481200|NCT03033342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111481201|NCT03030768|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
111481202|NCT03030768|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111481203|NCT03030768|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111481204|NCT03030768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111481205|NCT03030768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111481206|NCT03030768|Antiviral Agents|antiviral agents|mesh-ancestor
111481207|NCT03030768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111481208|NCT03030768|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111481209|NCT03030768|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111481210|NCT03030690|Methamphetamine|methamphetamine|mesh-list
111481211|NCT03030690|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111481212|NCT03030690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111481213|NCT03030690|Sympathomimetics|sympathomimetics|mesh-ancestor
111481214|NCT03030690|Autonomic Agents|autonomic agents|mesh-ancestor
111481215|NCT03030690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111481216|NCT03030690|Dopamine Agents|dopamine agents|mesh-ancestor
111481217|NCT03030690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111481218|NCT03030690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111481219|NCT03030690|Adrenergic Agents|adrenergic agents|mesh-ancestor
111102604|NCT04272801|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111481220|NCT03030690|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111481221|NCT03030690|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111481222|NCT03030690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111481223|NCT03030690|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111481225|NCT03030300|Pioglitazone|pioglitazone|mesh-list
111481226|NCT03030300|Insulin|insulin|mesh-list
111481227|NCT03030300|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111481228|NCT03030300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111481229|NCT03029442|Denosumab|denosumab|mesh-list
111481230|NCT03029442|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111481231|NCT03029442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111481232|NCT03023514|Thioctic Acid|thioctic acid|mesh-list
111481233|NCT03023514|Progesterone|progesterone|mesh-list
111481234|NCT03023514|Progestins|progestins|mesh-ancestor
111481235|NCT03023514|Hormones|hormones|mesh-ancestor
111481236|NCT03023514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111481237|NCT03023514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111481238|NCT03023514|Antioxidants|antioxidants|mesh-ancestor
111481239|NCT03023514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111481240|NCT03023514|Protective Agents|protective agents|mesh-ancestor
111481241|NCT03023514|Vitamin B Complex|vitamin b complex|mesh-ancestor
111481242|NCT03023514|Vitamins|vitamins|mesh-ancestor
111481243|NCT03023514|Micronutrients|micronutrients|mesh-ancestor
111481244|NCT03019926|Hydroxychloroquine|hydroxychloroquine|mesh-list
111481245|NCT03019926|Antimalarials|antimalarials|mesh-ancestor
111481246|NCT03019926|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111481247|NCT03019926|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111481248|NCT03019926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111481249|NCT03019926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111481250|NCT03019926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111481251|NCT03019926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111481252|NCT03019848|Curcumin|curcumin|mesh-list
111481253|NCT03019848|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111481254|NCT03019848|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111481255|NCT03019848|Analgesics|analgesics|mesh-ancestor
111481256|NCT03019848|Sensory System Agents|sensory system agents|mesh-ancestor
111481257|NCT03019848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111481258|NCT03019848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111481259|NCT03019848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111481260|NCT03019848|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111481261|NCT03019848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111481262|NCT03019848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111481263|NCT03019848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111481264|NCT03019614|Hydrocortisone|hydrocortisone|mesh-list
111481265|NCT03019614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111481266|NCT03019536|Flutemetamol|flutemetamol|mesh-list
111481267|NCT03019536|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111481268|NCT03019536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111481269|NCT03019224|Hydrogen Peroxide|hydrogen peroxide|mesh-list
111481270|NCT03019224|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111481271|NCT03019224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111481272|NCT03018990|Ethanol|ethanol|mesh-list
111481273|NCT03018990|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111481274|NCT03018990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111481275|NCT03018990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111481276|NCT03018990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111481277|NCT03018756|Fentanyl|fentanyl|mesh-list
111481278|NCT03018756|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111481279|NCT03018756|Narcotics|narcotics|mesh-ancestor
111481280|NCT03018756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111481281|NCT03018756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111481282|NCT03018756|Analgesics|analgesics|mesh-ancestor
111481283|NCT03018756|Sensory System Agents|sensory system agents|mesh-ancestor
111481284|NCT03018756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111481285|NCT03018756|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111481286|NCT03018756|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111481287|NCT03018756|Anesthetics, General|anesthetics, general|mesh-ancestor
111481288|NCT03018756|Anesthetics|anesthetics|mesh-ancestor
111481289|NCT03018444|Atorvastatin|atorvastatin|mesh-list
111481290|NCT03018444|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111481291|NCT03018444|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111481292|NCT03018444|Antimetabolites|antimetabolites|mesh-ancestor
111102605|NCT04272801|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111102606|NCT02396303|Carbetocin|carbetocin|mesh-list
111481293|NCT03018444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111481294|NCT03018444|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111481295|NCT03018444|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111481296|NCT03018444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111481297|NCT03017430|Ketorolac|ketorolac|mesh-list
111481298|NCT03017430|Phenazepam|phenazepam|mesh-list
111481299|NCT03017430|Clonidine|clonidine|mesh-list
111481300|NCT03017430|Pregabalin|pregabalin|mesh-list
111481301|NCT03017430|Metoclopramide|metoclopramide|mesh-list
111481302|NCT03017430|Loperamide|loperamide|mesh-list
111481303|NCT03017430|Antidiarrheals|antidiarrheals|mesh-list
111481304|NCT03017430|Analgesics|analgesics|mesh-ancestor
111481305|NCT03017430|Sensory System Agents|sensory system agents|mesh-ancestor
111481306|NCT03017430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111481307|NCT03017430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111481308|NCT03017430|Anticonvulsants|anticonvulsants|mesh-ancestor
111481309|NCT03017430|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111481310|NCT03017430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111481311|NCT03017430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111481312|NCT03017430|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111481313|NCT03017430|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111481314|NCT03017430|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111481315|NCT03017430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111481316|NCT03017430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111481317|NCT03017430|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111481318|NCT03017430|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111481319|NCT03017430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111481320|NCT03017430|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111481321|NCT03017430|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111481322|NCT03017430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111481323|NCT03017430|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111481324|NCT03017430|Sympatholytics|sympatholytics|mesh-ancestor
111481325|NCT03017430|Autonomic Agents|autonomic agents|mesh-ancestor
111481326|NCT03017430|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111481327|NCT03017430|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111481328|NCT03017430|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111481329|NCT03017430|Adrenergic Agents|adrenergic agents|mesh-ancestor
111481330|NCT03017430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111481331|NCT03017430|Antiemetics|antiemetics|mesh-ancestor
111481332|NCT03017430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111481333|NCT03017430|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111481334|NCT03017430|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111481335|NCT03017430|Dopamine Agents|dopamine agents|mesh-ancestor
111481336|NCT03017430|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111481337|NCT03017430|Immunologic Factors|immunologic factors|mesh-ancestor
111481338|NCT03017430|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111481339|NCT03017430|GABA Agents|gaba agents|mesh-ancestor
111481340|NCT03017352|Exenatide|exenatide|mesh-list
111481341|NCT03017352|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111481342|NCT03017352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111481343|NCT03017352|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111481344|NCT03017352|Incretins|incretins|mesh-ancestor
111481345|NCT03017352|Hormones|hormones|mesh-ancestor
111481346|NCT03017352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111481347|NCT03016884|Vaccines|vaccines|mesh-list
111481348|NCT03016884|Immunologic Factors|immunologic factors|mesh-ancestor
111481349|NCT03016884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111481350|NCT03016806|Cyclophosphamide|cyclophosphamide|mesh-list
111481351|NCT03016806|Melphalan|melphalan|mesh-list
111481352|NCT03016806|Busulfan|busulfan|mesh-list
111481353|NCT03016806|Fludarabine|fludarabine|mesh-list
111481354|NCT03016806|Mesna|mesna|mesh-list
111481355|NCT03016806|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111481356|NCT03016806|Immunologic Factors|immunologic factors|mesh-ancestor
111481357|NCT03016806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111481358|NCT03016806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111481359|NCT03016806|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111481360|NCT03016806|Alkylating Agents|alkylating agents|mesh-ancestor
111481361|NCT03016806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111481362|NCT03016806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111481363|NCT03016806|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111481364|NCT03016806|Protective Agents|protective agents|mesh-ancestor
111481365|NCT03016650|Acetaminophen|acetaminophen|mesh-list
111481366|NCT03016650|Ibuprofen|ibuprofen|mesh-list
111102608|NCT02396303|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111481367|NCT03016650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111481368|NCT03016650|Analgesics|analgesics|mesh-ancestor
111481369|NCT03016650|Sensory System Agents|sensory system agents|mesh-ancestor
111481370|NCT03016650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111481371|NCT03016650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111481372|NCT03016650|Antipyretics|antipyretics|mesh-ancestor
111481373|NCT03016650|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111481374|NCT03016650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111481375|NCT03016650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111481376|NCT03016650|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111481377|NCT03016650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111481378|NCT03016650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111481379|NCT03016260|Adalimumab|adalimumab|mesh-list
111481380|NCT03016260|Infliximab|infliximab|mesh-list
111481381|NCT03016260|Golimumab|golimumab|mesh-list
111481382|NCT03016260|Certolizumab Pegol|certolizumab pegol|mesh-list
111481383|NCT03016260|Etanercept|etanercept|mesh-list
111481384|NCT03016260|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110645261|NCT05501678|Antiemetics|antiemetics|mesh-ancestor
111481385|NCT03016260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111481386|NCT03016260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111481387|NCT03016260|Dermatologic Agents|dermatologic agents|mesh-ancestor
111481388|NCT03016260|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111481389|NCT03016260|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111481390|NCT03016260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111481391|NCT03016260|Analgesics|analgesics|mesh-ancestor
111481392|NCT03016260|Sensory System Agents|sensory system agents|mesh-ancestor
111481393|NCT03016260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111481394|NCT03016260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111481395|NCT03016260|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111481396|NCT03016260|Immunologic Factors|immunologic factors|mesh-ancestor
111481397|NCT03015246|Morphine|morphine|mesh-list
111481398|NCT03015246|Buprenorphine|buprenorphine|mesh-list
111481399|NCT03015246|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
111481400|NCT03015246|Naloxone|naloxone|mesh-list
111481401|NCT03015246|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111481402|NCT03015246|Narcotics|narcotics|mesh-ancestor
111481403|NCT03015246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111481404|NCT03015246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111481405|NCT03015246|Analgesics|analgesics|mesh-ancestor
111481406|NCT03015246|Sensory System Agents|sensory system agents|mesh-ancestor
111481407|NCT03015246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111481408|NCT03015246|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111481409|NCT03015168|Capecitabine|capecitabine|mesh-list
111481410|NCT03015168|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111481411|NCT03015168|Antimetabolites|antimetabolites|mesh-ancestor
111481412|NCT03015168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111481413|NCT03015168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111481414|NCT03014778|Chlorhexidine|chlorhexidine|mesh-list
111481415|NCT03014778|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
111481416|NCT03014778|Povidone-Iodine|povidone-iodine|mesh-list
111481417|NCT03014778|Povidone|povidone|mesh-list
111481418|NCT03014778|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111481419|NCT03014778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111481420|NCT03014778|Disinfectants|disinfectants|mesh-ancestor
111481421|NCT03014778|Dermatologic Agents|dermatologic agents|mesh-ancestor
111481422|NCT03014778|Plasma Substitutes|plasma substitutes|mesh-ancestor
111481423|NCT03014778|Blood Substitutes|blood substitutes|mesh-ancestor
111481424|NCT03014076|Trastuzumab|trastuzumab|mesh-list
111481425|NCT03014076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111481426|NCT03014076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111481427|NCT03013140|Anesthetics|anesthetics|mesh-list
111481428|NCT03013140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111481429|NCT03013140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111481430|NCT03011970|Oxytocin|oxytocin|mesh-list
111481431|NCT03011970|Oxytocics|oxytocics|mesh-ancestor
111481432|NCT03011970|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111481433|NCT03011970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111481434|NCT03010098|Remifentanil|remifentanil|mesh-list
111481435|NCT03010098|Propofol|propofol|mesh-list
111481436|NCT03010098|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111481437|NCT03010098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111481438|NCT03010098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111481439|NCT03010098|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111481440|NCT03010098|Anesthetics, General|anesthetics, general|mesh-ancestor
111102609|NCT02396303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111102610|NCT01918527|Capecitabine|capecitabine|mesh-list
111481441|NCT03010098|Anesthetics|anesthetics|mesh-ancestor
111481442|NCT03010098|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111102611|NCT01918527|Oxaliplatin|oxaliplatin|mesh-list
111481443|NCT03010098|Narcotics|narcotics|mesh-ancestor
111481444|NCT03010098|Analgesics|analgesics|mesh-ancestor
111481445|NCT03010098|Sensory System Agents|sensory system agents|mesh-ancestor
111481446|NCT03010098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111481447|NCT03009474|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
111481448|NCT03009474|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111481449|NCT03009474|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111481450|NCT03009474|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111481451|NCT03009474|Antimetabolites|antimetabolites|mesh-ancestor
111481452|NCT03009474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111481453|NCT03009474|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111481454|NCT03009474|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111481455|NCT03009474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111481456|NCT03009474|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111481457|NCT03009006|Calcium, Dietary|calcium, dietary|mesh-list
111481458|NCT03009006|Chlorhexidine|chlorhexidine|mesh-list
111481459|NCT03009006|Calcium|calcium|mesh-list
111481460|NCT03009006|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111481461|NCT03009006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111481462|NCT03009006|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111481463|NCT03009006|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111481464|NCT03009006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111481465|NCT03009006|Disinfectants|disinfectants|mesh-ancestor
111481466|NCT03008148|Temozolomide|temozolomide|mesh-list
111481467|NCT03008148|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111481468|NCT03008148|Alkylating Agents|alkylating agents|mesh-ancestor
111481469|NCT03008148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111481470|NCT03008148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111481471|NCT03007992|Vinorelbine|vinorelbine|mesh-list
111481472|NCT03007992|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111481473|NCT03007992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111481474|NCT03007992|Tubulin Modulators|tubulin modulators|mesh-ancestor
111481475|NCT03007992|Antimitotic Agents|antimitotic agents|mesh-ancestor
111481476|NCT03007992|Mitosis Modulators|mitosis modulators|mesh-ancestor
111481477|NCT03007992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111481478|NCT03007446|Oxaliplatin|oxaliplatin|mesh-list
111481479|NCT03007446|Apatinib|apatinib|mesh-list
111481480|NCT03007446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111481481|NCT03007446|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111481482|NCT03007446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111481483|NCT03007446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111481484|NCT03007524|Calcium, Dietary|calcium, dietary|mesh-list
111481485|NCT03007524|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111481486|NCT03007524|Calcium|calcium|mesh-list
111481487|NCT03007524|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111481488|NCT03007524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111481489|NCT03007524|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111481490|NCT03007524|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111481491|NCT03007524|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111481492|NCT03007524|Antimetabolites|antimetabolites|mesh-ancestor
111481493|NCT03007524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111481494|NCT03007524|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111481495|NCT03007524|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111481496|NCT03007524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111481497|NCT03006042|Bupivacaine|bupivacaine|mesh-list
111481498|NCT03006042|Anesthetics, Local|anesthetics, local|mesh-ancestor
111481499|NCT03006042|Anesthetics|anesthetics|mesh-ancestor
111481500|NCT03006042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111481501|NCT03006042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111481502|NCT03006042|Sensory System Agents|sensory system agents|mesh-ancestor
111481503|NCT03006042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111481504|NCT03005496|Vitamin D|vitamin d|mesh-list
111481505|NCT03005496|Cholecalciferol|cholecalciferol|mesh-list
111481506|NCT03005496|Beta Carotene|beta carotene|mesh-list
111481508|NCT03005496|Dexamethasone|dexamethasone|mesh-list
111481509|NCT03005496|Dexamethasone acetate|dexamethasone acetate|mesh-list
111481510|NCT03005496|Nifedipine|nifedipine|mesh-list
111481511|NCT03005496|BB 1101|bb 1101|mesh-list
111481512|NCT03005496|Carotenoids|carotenoids|mesh-list
111481513|NCT03005496|Picolinic acid|picolinic acid|mesh-list
111481514|NCT03005496|Vitamins|vitamins|mesh-ancestor
111102612|NCT01918527|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111102613|NCT01918527|Antimetabolites|antimetabolites|mesh-ancestor
110689550|NCT00970931|Amiloride|amiloride|mesh-list
111481515|NCT03005496|Micronutrients|micronutrients|mesh-ancestor
111481516|NCT03005496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111481517|NCT03005496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111481518|NCT03005496|Antiemetics|antiemetics|mesh-ancestor
111481519|NCT03005496|Autonomic Agents|autonomic agents|mesh-ancestor
111481520|NCT03005496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111481521|NCT03005496|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111481522|NCT03005496|Glucocorticoids|glucocorticoids|mesh-ancestor
111481523|NCT03005496|Hormones|hormones|mesh-ancestor
111481524|NCT03005496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111481525|NCT03005496|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111481526|NCT03005496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111481527|NCT03005496|Protease Inhibitors|protease inhibitors|mesh-ancestor
111481528|NCT03005496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111481529|NCT03005496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111481530|NCT03005496|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111481531|NCT03005496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111481532|NCT03005496|Trace Elements|trace elements|mesh-ancestor
111481533|NCT03005496|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111481534|NCT03005496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111481535|NCT03005496|Vasodilator Agents|vasodilator agents|mesh-ancestor
111481536|NCT03005496|Tocolytic Agents|tocolytic agents|mesh-ancestor
111481537|NCT03005496|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111481538|NCT03005496|Antioxidants|antioxidants|mesh-ancestor
111481539|NCT03005496|Protective Agents|protective agents|mesh-ancestor
111481540|NCT03005496|Provitamins|provitamins|mesh-ancestor
111481541|NCT03005496|Iron Chelating Agents|iron chelating agents|mesh-ancestor
111481542|NCT03005496|Chelating Agents|chelating agents|mesh-ancestor
111481543|NCT03005496|Sequestering Agents|sequestering agents|mesh-ancestor
111481544|NCT03005808|Ropivacaine|ropivacaine|mesh-list
111481545|NCT03005808|Anesthetics, Local|anesthetics, local|mesh-ancestor
111481546|NCT03005808|Anesthetics|anesthetics|mesh-ancestor
111481547|NCT03005808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111481548|NCT03005808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110645288|NCT05488405|Analgesics|analgesics|mesh-ancestor
111481549|NCT03005808|Sensory System Agents|sensory system agents|mesh-ancestor
111481550|NCT03005808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111481551|NCT03005340|Cholecalciferol|cholecalciferol|mesh-list
111481552|NCT03005340|Vitamin D|vitamin d|mesh-list
111481553|NCT03005340|Bazedoxifene|bazedoxifene|mesh-list
111481554|NCT03005340|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111481555|NCT03005340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111481556|NCT03005340|Vitamins|vitamins|mesh-ancestor
111481557|NCT03005340|Micronutrients|micronutrients|mesh-ancestor
111481558|NCT03005340|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111481559|NCT03005340|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111481560|NCT03005340|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111481561|NCT03005340|Hormone Antagonists|hormone antagonists|mesh-ancestor
111481562|NCT03005340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111481563|NCT03005184|Icatibant|icatibant|mesh-list
111481564|NCT03005184|Valsartan|valsartan|mesh-list
111481565|NCT03005184|Enalapril|enalapril|mesh-list
111481566|NCT03005184|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
111481567|NCT03005184|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111481568|NCT03005184|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111481569|NCT03005184|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111481570|NCT03005184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111481571|NCT03005184|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
111481572|NCT03005184|Protease Inhibitors|protease inhibitors|mesh-ancestor
111481573|NCT03005184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111481574|NCT03005184|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111481575|NCT03005184|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111481576|NCT03005184|Analgesics|analgesics|mesh-ancestor
111481577|NCT03005184|Sensory System Agents|sensory system agents|mesh-ancestor
111481578|NCT03005184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111481579|NCT03005184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111481580|NCT03005184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111481581|NCT03005184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111481582|NCT03005184|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
111481583|NCT03005184|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
111481584|NCT03005184|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
111481585|NCT03005184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111481586|NCT03005184|Immunologic Factors|immunologic factors|mesh-ancestor
111481587|NCT03004014|Propofol|propofol|mesh-list
111481588|NCT03004014|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111481589|NCT03004014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111102614|NCT01918527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111102615|NCT01918527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111481590|NCT03004014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111481591|NCT03004014|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111481592|NCT03004014|Anesthetics, General|anesthetics, general|mesh-ancestor
111481593|NCT03004014|Anesthetics|anesthetics|mesh-ancestor
111481594|NCT03002844|Carboplatin|carboplatin|mesh-list
111481595|NCT03002844|Gemcitabine|gemcitabine|mesh-list
111481596|NCT03002844|Pemetrexed|pemetrexed|mesh-list
111481597|NCT03002844|Gefitinib|gefitinib|mesh-list
111481598|NCT03002844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111481599|NCT03002844|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111481600|NCT03002844|Antimetabolites|antimetabolites|mesh-ancestor
111481601|NCT03002844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111481602|NCT03002844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111481603|NCT03002844|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111481604|NCT03002844|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111481605|NCT03002844|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111481606|NCT03002376|Cemiplimab|cemiplimab|mesh-list
111481607|NCT03002376|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111481608|NCT03002376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111481609|NCT03002064|Docetaxel|docetaxel|mesh-list
111481610|NCT03002064|Fluorouracil|fluorouracil|mesh-list
111481611|NCT03002064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111481612|NCT03002064|Tubulin Modulators|tubulin modulators|mesh-ancestor
111481613|NCT03002064|Antimitotic Agents|antimitotic agents|mesh-ancestor
111481614|NCT03002064|Mitosis Modulators|mitosis modulators|mesh-ancestor
111481615|NCT03002064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111481616|NCT03002064|Antimetabolites|antimetabolites|mesh-ancestor
111481617|NCT03002064|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111481618|NCT03002064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111481619|NCT03002064|Immunologic Factors|immunologic factors|mesh-ancestor
111481620|NCT03002064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111481621|NCT03001128|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
111481622|NCT03001128|Antiviral Agents|antiviral agents|mesh-ancestor
111481623|NCT03001128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111481624|NCT03000660|Dexamethasone|dexamethasone|mesh-list
111481625|NCT03000660|Venetoclax|venetoclax|mesh-list
111481626|NCT03000660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111481627|NCT03000660|Antiemetics|antiemetics|mesh-ancestor
111481628|NCT03000660|Autonomic Agents|autonomic agents|mesh-ancestor
111481629|NCT03000660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111481630|NCT03000660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111481631|NCT03000660|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111481632|NCT03000660|Glucocorticoids|glucocorticoids|mesh-ancestor
111481633|NCT03000660|Hormones|hormones|mesh-ancestor
111481634|NCT03000660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111481635|NCT03000660|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111481636|NCT03000660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111481637|NCT03000036|Doxorubicin|doxorubicin|mesh-list
111481638|NCT03000036|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
111481639|NCT03000036|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111481640|NCT03000036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111481641|NCT03000036|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111481642|NCT03000036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111481643|NCT03000036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111481644|NCT03000036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111481645|NCT03000036|Chelating Agents|chelating agents|mesh-ancestor
111481646|NCT03000036|Sequestering Agents|sequestering agents|mesh-ancestor
111481647|NCT02995824|Raltegravir Potassium|raltegravir potassium|mesh-list
111481648|NCT02995824|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
111481649|NCT02995824|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111481650|NCT02995824|Antiviral Agents|antiviral agents|mesh-ancestor
111481651|NCT02995824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111481652|NCT02995824|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111481653|NCT02995824|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111481654|NCT02995824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111481655|NCT02995824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111481656|NCT02989272|Magnesium Sulfate|magnesium sulfate|mesh-list
111481657|NCT02989272|Analgesics|analgesics|mesh-ancestor
111481658|NCT02989272|Sensory System Agents|sensory system agents|mesh-ancestor
111481659|NCT02989272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111481660|NCT02989272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111481661|NCT02989272|Anesthetics|anesthetics|mesh-ancestor
111481662|NCT02989272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111481663|NCT02989272|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111481664|NCT02989272|Anticonvulsants|anticonvulsants|mesh-ancestor
111102616|NCT02397863|Cannabidiol|cannabidiol|mesh-list
111102617|NCT02397863|Anticonvulsants|anticonvulsants|mesh-ancestor
111481665|NCT02989272|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111481666|NCT02989272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111481667|NCT02989272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111481668|NCT02989272|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111481669|NCT02989272|Tocolytic Agents|tocolytic agents|mesh-ancestor
111481670|NCT02989272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111481671|NCT02989038|Nicotine|nicotine|mesh-list
111481672|NCT02989038|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111481673|NCT02989038|Autonomic Agents|autonomic agents|mesh-ancestor
111481674|NCT02989038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111481675|NCT02989038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111481676|NCT02989038|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111481677|NCT02989038|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111481678|NCT02989038|Cholinergic Agents|cholinergic agents|mesh-ancestor
111481679|NCT02989038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111481680|NCT02989038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111481681|NCT02988024|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
111481682|NCT02988024|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111481683|NCT02988024|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111481684|NCT02988024|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111481685|NCT02988024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111481686|NCT02988024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111481687|NCT02988024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111481688|NCT02988024|Antidepressive Agents|antidepressive agents|mesh-ancestor
111481689|NCT02988024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111481690|NCT02987556|Insulin|insulin|mesh-list
111481691|NCT02987556|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111481692|NCT02987556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111481693|NCT02987400|Venetoclax|venetoclax|mesh-list
111481694|NCT02987400|Obinutuzumab|obinutuzumab|mesh-list
111481695|NCT02987400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111481696|NCT02987400|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111481697|NCT02987244|Prednisone|prednisone|mesh-list
111481698|NCT02987244|Cyclophosphamide|cyclophosphamide|mesh-list
111481699|NCT02987244|Etoposide|etoposide|mesh-list
111481700|NCT02987244|Epirubicin|epirubicin|mesh-list
111481701|NCT02987244|Vindesine|vindesine|mesh-list
111481702|NCT02987244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111481703|NCT02987244|Immunologic Factors|immunologic factors|mesh-ancestor
111481704|NCT02987244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111481705|NCT02987244|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111481706|NCT02987244|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111481707|NCT02987244|Alkylating Agents|alkylating agents|mesh-ancestor
111481708|NCT02987244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111481709|NCT02987244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111481710|NCT02987244|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111481711|NCT02987244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111481712|NCT02987244|Glucocorticoids|glucocorticoids|mesh-ancestor
111481713|NCT02987244|Hormones|hormones|mesh-ancestor
111481714|NCT02987244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111481715|NCT02987244|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111481716|NCT02987244|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111481717|NCT02987244|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111481718|NCT02987244|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111481719|NCT02987244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111481720|NCT02987244|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111481721|NCT02987244|Tubulin Modulators|tubulin modulators|mesh-ancestor
111481722|NCT02987244|Antimitotic Agents|antimitotic agents|mesh-ancestor
111481723|NCT02987244|Mitosis Modulators|mitosis modulators|mesh-ancestor
111481724|NCT02987166|Pembrolizumab|pembrolizumab|mesh-list
111481725|NCT02987166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111481726|NCT02987166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111481727|NCT02987166|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111481728|NCT02987166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111481729|NCT02982486|Nivolumab|nivolumab|mesh-list
111481730|NCT02982486|Ipilimumab|ipilimumab|mesh-list
111481731|NCT02982486|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111481732|NCT02982486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111481733|NCT02982486|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111481734|NCT02982486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111481735|NCT02981784|Ponatinib|ponatinib|mesh-list
111102618|NCT03168035|NC-4016|nc-4016|mesh-list
111481736|NCT02981784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111481737|NCT02981784|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111481738|NCT02981784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111481739|NCT02981784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111481740|NCT02980926|Bupivacaine|bupivacaine|mesh-list
111481741|NCT02980926|Mepivacaine|mepivacaine|mesh-list
111481742|NCT02980926|Anesthetics, Local|anesthetics, local|mesh-ancestor
111481743|NCT02980926|Anesthetics|anesthetics|mesh-ancestor
111481744|NCT02980926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111481745|NCT02980926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111481746|NCT02980926|Sensory System Agents|sensory system agents|mesh-ancestor
111481747|NCT02980926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111481748|NCT02980458|Deferiprone|deferiprone|mesh-list
111481749|NCT02980458|Iron Chelating Agents|iron chelating agents|mesh-ancestor
111481750|NCT02980458|Chelating Agents|chelating agents|mesh-ancestor
111481751|NCT02980458|Sequestering Agents|sequestering agents|mesh-ancestor
111481752|NCT02980458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111481753|NCT02978976|Betamethasone|betamethasone|mesh-list
111481754|NCT02978976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111481755|NCT02978976|Glucocorticoids|glucocorticoids|mesh-ancestor
111481756|NCT02978976|Hormones|hormones|mesh-ancestor
111481757|NCT02978976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111481758|NCT02978976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111481759|NCT02978976|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111481760|NCT02978976|Respiratory System Agents|respiratory system agents|mesh-ancestor
111481761|NCT02979132|Iron|iron|mesh-list
111481762|NCT02979132|Trace Elements|trace elements|mesh-ancestor
111481763|NCT02979132|Micronutrients|micronutrients|mesh-ancestor
111481764|NCT02979132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111481765|NCT02978040|Tirofiban|tirofiban|mesh-list
111481766|NCT02978040|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
111481767|NCT02978040|Cangrelor|cangrelor|mesh-list
111481768|NCT02978040|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111481769|NCT02978040|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111481770|NCT02978040|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111481771|NCT02978040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111481772|NCT02978040|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111481773|NCT02978040|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111481774|NCT02978040|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111481775|NCT02978040|Purinergic Agents|purinergic agents|mesh-ancestor
111481776|NCT02978040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111481777|NCT02978040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111481778|NCT02976246|Vitamin K|vitamin k|mesh-list
111481779|NCT02976246|Vitamin K 2|vitamin k 2|mesh-list
111481780|NCT02976246|Vitamins|vitamins|mesh-ancestor
111481781|NCT02976246|Micronutrients|micronutrients|mesh-ancestor
111481782|NCT02976246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111481783|NCT02976246|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111481784|NCT02976246|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111481785|NCT02976246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111481786|NCT02976246|Hemostatics|hemostatics|mesh-ancestor
111481787|NCT02976246|Coagulants|coagulants|mesh-ancestor
111481788|NCT02976012|Aflibercept|aflibercept|mesh-list
111481789|NCT02976012|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111481790|NCT02976012|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111481791|NCT02976012|Growth Substances|growth substances|mesh-ancestor
111481792|NCT02976012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111481793|NCT02976012|Growth Inhibitors|growth inhibitors|mesh-ancestor
111481794|NCT02976012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111481795|NCT02975076|Aspirin|aspirin|mesh-list
111481796|NCT02975076|Clopidogrel|clopidogrel|mesh-list
111481797|NCT02975076|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111481798|NCT02975076|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111481799|NCT02975076|Analgesics|analgesics|mesh-ancestor
111481800|NCT02975076|Sensory System Agents|sensory system agents|mesh-ancestor
111481801|NCT02975076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111481802|NCT02975076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111481803|NCT02975076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111481804|NCT02975076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111481805|NCT02975076|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111481806|NCT02975076|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111481807|NCT02975076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111481808|NCT02975076|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111481809|NCT02975076|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110689846|NCT02908269|Vaccines|vaccines|mesh-list
111481810|NCT02975076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111481811|NCT02975076|Antipyretics|antipyretics|mesh-ancestor
111481812|NCT02975076|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111481813|NCT02975076|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111481814|NCT02975076|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111481815|NCT02975076|Purinergic Agents|purinergic agents|mesh-ancestor
111481816|NCT02975076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111481817|NCT02974920|Aspirin|aspirin|mesh-list
111481818|NCT02974920|Rivaroxaban|rivaroxaban|mesh-list
111481819|NCT02974920|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111481820|NCT02974920|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111481821|NCT02974920|Analgesics|analgesics|mesh-ancestor
111481822|NCT02974920|Sensory System Agents|sensory system agents|mesh-ancestor
111481823|NCT02974920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111481824|NCT02974920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111481825|NCT02974920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111481826|NCT02974920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111481827|NCT02974920|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111481828|NCT02974920|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111481829|NCT02974920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111481830|NCT02974920|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111481831|NCT02974920|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111481832|NCT02974920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111481833|NCT02974920|Antipyretics|antipyretics|mesh-ancestor
111481834|NCT02974920|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111481835|NCT02974920|Antithrombins|antithrombins|mesh-ancestor
111481836|NCT02974920|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111481837|NCT02974920|Protease Inhibitors|protease inhibitors|mesh-ancestor
111481838|NCT02974920|Anticoagulants|anticoagulants|mesh-ancestor
111481839|NCT02973204|Everolimus|everolimus|mesh-list
111481840|NCT02973204|Sorafenib|sorafenib|mesh-list
111481841|NCT02973204|Octreotide|octreotide|mesh-list
111481842|NCT02973204|Lanreotide|lanreotide|mesh-list
111481843|NCT02973204|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111481844|NCT02973204|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111481845|NCT02973204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111481846|NCT02973204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111481847|NCT02973204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111481848|NCT02973204|Immunologic Factors|immunologic factors|mesh-ancestor
111481849|NCT02973204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111481850|NCT02973204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111481851|NCT02973204|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111481852|NCT02973204|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111481853|NCT02959476|Ropivacaine|ropivacaine|mesh-list
111481854|NCT02959476|Anesthetics, Local|anesthetics, local|mesh-ancestor
111481855|NCT02959476|Anesthetics|anesthetics|mesh-ancestor
111102619|NCT03168035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111481856|NCT02959476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111481857|NCT02959476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111481858|NCT02959476|Sensory System Agents|sensory system agents|mesh-ancestor
111481859|NCT02959476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111481860|NCT02958852|Letrozole|letrozole|mesh-list
111481861|NCT02958852|Fulvestrant|fulvestrant|mesh-list
111481862|NCT02958852|Atorvastatin|atorvastatin|mesh-list
111481863|NCT02958852|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111481864|NCT02958852|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111481865|NCT02958852|Antimetabolites|antimetabolites|mesh-ancestor
111481866|NCT02958852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111481867|NCT02958852|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111481868|NCT02958852|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110645368|NCT05317858|Pembrolizumab|pembrolizumab|mesh-list
111481869|NCT02958852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111481870|NCT02958852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111481871|NCT02958852|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111481872|NCT02958852|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111481873|NCT02958852|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111481874|NCT02958852|Hormone Antagonists|hormone antagonists|mesh-ancestor
111481875|NCT02958852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111481876|NCT02958852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111481877|NCT02958852|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111481878|NCT02958852|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
111481879|NCT02641782|Aldesleukin|aldesleukin|mesh-list
111481880|NCT02641782|Interleukin-2|interleukin-2|mesh-list
111102620|NCT02397395|Simeprevir|simeprevir|mesh-list
111102621|NCT02397395|Antiviral Agents|antiviral agents|mesh-ancestor
111102622|NCT02397395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111481881|NCT02641782|Tretinoin|tretinoin|mesh-list
111481882|NCT02641782|Dinutuximab|dinutuximab|mesh-list
111481883|NCT02641782|Isotretinoin|isotretinoin|mesh-list
111481884|NCT02641782|Antibodies|antibodies|mesh-list
111481885|NCT02641782|Sargramostim|sargramostim|mesh-list
111481886|NCT02641782|Immunologic Factors|immunologic factors|mesh-ancestor
111481887|NCT02641782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111481888|NCT02641782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111481889|NCT02641782|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111481890|NCT02641782|Analgesics|analgesics|mesh-ancestor
111481891|NCT02641782|Sensory System Agents|sensory system agents|mesh-ancestor
111481892|NCT02641782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111481893|NCT02641782|Keratolytic Agents|keratolytic agents|mesh-ancestor
111481894|NCT02641782|Dermatologic Agents|dermatologic agents|mesh-ancestor
111481895|NCT02641782|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111481896|NCT02641782|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111481897|NCT02641782|Antiviral Agents|antiviral agents|mesh-ancestor
111481898|NCT02641782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111481899|NCT02641314|Celecoxib|celecoxib|mesh-list
111481900|NCT02641314|Propranolol|propranolol|mesh-list
111481901|NCT02641314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111481902|NCT02641314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111481903|NCT02641314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111481904|NCT02641314|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111481905|NCT02641314|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111481906|NCT02641314|Analgesics|analgesics|mesh-ancestor
111481907|NCT02641314|Sensory System Agents|sensory system agents|mesh-ancestor
111481908|NCT02641314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111481909|NCT02641314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111481910|NCT02641314|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111481911|NCT02641314|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111481912|NCT02641314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111481913|NCT02641314|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111481914|NCT02641314|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111481915|NCT02641314|Adrenergic Agents|adrenergic agents|mesh-ancestor
111481916|NCT02641314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111481917|NCT02641314|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111481918|NCT02641314|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111481919|NCT02641314|Vasodilator Agents|vasodilator agents|mesh-ancestor
111481920|NCT04769778|Valsartan|valsartan|mesh-list
111481921|NCT04769778|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111481922|NCT04769778|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111481923|NCT04769778|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111481924|NCT04769778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111481925|NCT04769076|Paclitaxel|paclitaxel|mesh-list
111481926|NCT04769076|Cisplatin|cisplatin|mesh-list
111481927|NCT04769076|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
110645373|NCT05283980|Bupivacaine|bupivacaine|mesh-list
111481928|NCT04769076|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111481929|NCT04769076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111481930|NCT04769076|Tubulin Modulators|tubulin modulators|mesh-ancestor
111481931|NCT04769076|Antimitotic Agents|antimitotic agents|mesh-ancestor
111481932|NCT04769076|Mitosis Modulators|mitosis modulators|mesh-ancestor
111481933|NCT04769076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111481934|NCT04769076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111481935|NCT04768764|Bupivacaine|bupivacaine|mesh-list
111481936|NCT04768764|Anesthetics|anesthetics|mesh-list
111481937|NCT04768764|Anesthetics, Local|anesthetics, local|mesh-ancestor
111481938|NCT04768764|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111481939|NCT04768764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111481940|NCT04768764|Sensory System Agents|sensory system agents|mesh-ancestor
111481941|NCT04768764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111481942|NCT04768530|Nitazoxanide|nitazoxanide|mesh-list
111481943|NCT04768530|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111481944|NCT04768530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111481945|NCT04748562|Progesterone|progesterone|mesh-list
111481946|NCT04748562|Progestins|progestins|mesh-ancestor
111481947|NCT04748562|Hormones|hormones|mesh-ancestor
111481948|NCT04748562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111481949|NCT04748562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111481950|NCT04745286|Ketamine|ketamine|mesh-list
111481951|NCT04745286|Esketamine|esketamine|mesh-list
111481952|NCT04745286|Analgesics|analgesics|mesh-ancestor
111481953|NCT04745286|Sensory System Agents|sensory system agents|mesh-ancestor
111481954|NCT04745286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111481955|NCT04745286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111481956|NCT04745286|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110689988|NCT00979589|Analgesics|analgesics|mesh-ancestor
111481957|NCT04745286|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111481958|NCT04745286|Anesthetics, General|anesthetics, general|mesh-ancestor
111102623|NCT02397395|Protease Inhibitors|protease inhibitors|mesh-ancestor
111481959|NCT04745286|Anesthetics|anesthetics|mesh-ancestor
111481960|NCT04745286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111481961|NCT04745286|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111481962|NCT04745286|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111481963|NCT04745286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111481964|NCT04745286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111481965|NCT04745286|Antidepressive Agents|antidepressive agents|mesh-ancestor
111481966|NCT04745286|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111481967|NCT04745442|Antithrombins|antithrombins|mesh-list
111481968|NCT04745442|Antithrombin III|antithrombin iii|mesh-list
111481969|NCT04745442|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111481970|NCT04745442|Protease Inhibitors|protease inhibitors|mesh-ancestor
111481971|NCT04745442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111481972|NCT04745442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111481973|NCT04745442|Anticoagulants|anticoagulants|mesh-ancestor
111481974|NCT04743180|Paclitaxel|paclitaxel|mesh-list
111481975|NCT04743180|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111481976|NCT04743180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111481977|NCT04743180|Tubulin Modulators|tubulin modulators|mesh-ancestor
111481978|NCT04743180|Antimitotic Agents|antimitotic agents|mesh-ancestor
111481979|NCT04743180|Mitosis Modulators|mitosis modulators|mesh-ancestor
111481980|NCT04743180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111481981|NCT04740840|Amlodipine|amlodipine|mesh-list
111481982|NCT04740840|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111481983|NCT04740840|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111481984|NCT04740840|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111481985|NCT04740840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111481986|NCT04740840|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111481987|NCT04740840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111481988|NCT04740840|Vasodilator Agents|vasodilator agents|mesh-ancestor
111481989|NCT04739826|Flumatinib|flumatinib|mesh-list
111481990|NCT04739826|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111481991|NCT04739826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111481992|NCT04739826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111481993|NCT04739202|Bevacizumab|bevacizumab|mesh-list
111481994|NCT04739202|Atezolizumab|atezolizumab|mesh-list
111481995|NCT04739202|Ipatasertib|ipatasertib|mesh-list
111481996|NCT04739202|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111481997|NCT04739202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111481998|NCT04739202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111481999|NCT04739202|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111482000|NCT04739202|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111482001|NCT04739202|Growth Substances|growth substances|mesh-ancestor
111482002|NCT04739202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111482003|NCT04739202|Growth Inhibitors|growth inhibitors|mesh-ancestor
111482004|NCT04739202|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111482005|NCT04739202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111482006|NCT04739202|Immunologic Factors|immunologic factors|mesh-ancestor
111482007|NCT04739202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111482008|NCT04739202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111482009|NCT04738188|Epirubicin|epirubicin|mesh-list
111482010|NCT04738188|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111482011|NCT04738188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111482012|NCT04738188|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111482013|NCT04738188|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111482014|NCT04738188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111482015|NCT04738188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111482016|NCT04737408|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111482017|NCT04737408|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111482018|NCT04737408|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111482019|NCT04737408|Antimetabolites|antimetabolites|mesh-ancestor
111482020|NCT04737408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111482021|NCT04737408|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111482022|NCT04737408|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111482023|NCT04737408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111482024|NCT05314140|Calcium|calcium|mesh-list
111482025|NCT05314140|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111482026|NCT05314140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111482027|NCT05313906|Cisplatin|cisplatin|mesh-list
111482028|NCT05313906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111482029|NCT05313828|Fluorometholone|fluorometholone|mesh-list
111482030|NCT05313828|Tobramycin|tobramycin|mesh-list
111102624|NCT02397395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111482032|NCT05313828|Hyaluronic Acid|hyaluronic acid|mesh-list
111482033|NCT05313828|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111482034|NCT05313828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111482035|NCT05313828|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111482036|NCT05313828|Immunologic Factors|immunologic factors|mesh-ancestor
111482037|NCT05313828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111482038|NCT05313828|Viscosupplements|viscosupplements|mesh-ancestor
111482039|NCT05313828|Protective Agents|protective agents|mesh-ancestor
111482040|NCT05313828|Antiviral Agents|antiviral agents|mesh-ancestor
111482041|NCT05313828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111482042|NCT05313828|Glucocorticoids|glucocorticoids|mesh-ancestor
111482043|NCT05313828|Hormones|hormones|mesh-ancestor
111482044|NCT05313828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111482045|NCT05313828|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111482046|NCT05313750|Levofloxacin|levofloxacin|mesh-list
111482047|NCT05313750|Sitafloxacin|sitafloxacin|mesh-list
111482048|NCT05313750|Anti-Infective Agents|anti-infective agents|mesh-list
111482049|NCT05313750|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111482050|NCT05313750|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111482051|NCT05313750|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111482052|NCT05313750|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111482053|NCT05313750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111482054|NCT05313750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111482055|NCT05313750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111482056|NCT05313750|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111482057|NCT05313750|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111482058|NCT04662684|Rivaroxaban|rivaroxaban|mesh-list
111482059|NCT04662684|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111482060|NCT04662684|Antithrombins|antithrombins|mesh-ancestor
111482061|NCT04662684|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111482062|NCT04662684|Protease Inhibitors|protease inhibitors|mesh-ancestor
111482063|NCT04662684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111482064|NCT04662684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111482065|NCT04662684|Anticoagulants|anticoagulants|mesh-ancestor
111482066|NCT05139966|Fluorides|fluorides|mesh-list
111482067|NCT05139966|Cariostatic Agents|cariostatic agents|mesh-ancestor
111482068|NCT05139966|Protective Agents|protective agents|mesh-ancestor
111482069|NCT05139966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111482070|NCT05138718|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
111482071|NCT05138718|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111482072|NCT05138718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111482073|NCT00575016|Botulinum Toxins|botulinum toxins|mesh-list
111482074|NCT00575016|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111482075|NCT00575016|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111482076|NCT00575016|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111482077|NCT00575016|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111482078|NCT00575016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111482079|NCT00575016|Cholinergic Agents|cholinergic agents|mesh-ancestor
111482080|NCT00575016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111482081|NCT00575016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111482082|NCT00575016|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111482083|NCT00575016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111482084|NCT00577590|Metformin|metformin|mesh-list
111482085|NCT00577590|Rosiglitazone|rosiglitazone|mesh-list
111482086|NCT00577590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111482087|NCT00577590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111482088|NCT00578214|Midazolam|midazolam|mesh-list
111482089|NCT00578214|Anesthetics|anesthetics|mesh-ancestor
111482090|NCT00578214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111482091|NCT00578214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111482092|NCT00578214|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111482093|NCT00578214|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111482094|NCT00578214|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111482095|NCT00578214|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111482096|NCT00578214|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111482097|NCT00578214|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111482098|NCT00578214|Anesthetics, General|anesthetics, general|mesh-ancestor
111482099|NCT00578214|GABA Modulators|gaba modulators|mesh-ancestor
111482100|NCT00578214|GABA Agents|gaba agents|mesh-ancestor
111482101|NCT00578214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110690137|NCT00290290|Povidone|povidone|mesh-list
111482102|NCT00578214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111482103|NCT00580398|Varenicline|varenicline|mesh-list
111482104|NCT00580398|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111482105|NCT00580398|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111482106|NCT00580398|Cholinergic Agents|cholinergic agents|mesh-ancestor
111482107|NCT00580398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111482108|NCT00580398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111482109|NCT00580398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111482110|NCT00582660|Celecoxib|celecoxib|mesh-list
111482111|NCT00582660|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111482112|NCT00582660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111482113|NCT00582660|Analgesics|analgesics|mesh-ancestor
111482114|NCT00582660|Sensory System Agents|sensory system agents|mesh-ancestor
111482115|NCT00582660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111482116|NCT00582660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111482117|NCT00582660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111482118|NCT00582660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111482119|NCT00582660|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111482120|NCT00582660|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111482121|NCT00582660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111482122|NCT00582660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111482123|NCT00582894|Fludarabine|fludarabine|mesh-list
111482124|NCT00582894|Alemtuzumab|alemtuzumab|mesh-list
111482125|NCT00582894|Busulfan|busulfan|mesh-list
111482126|NCT00582894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111482127|NCT00582894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111482128|NCT00582894|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111482129|NCT00582894|Immunologic Factors|immunologic factors|mesh-ancestor
111482130|NCT00582894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111482131|NCT00582894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111482132|NCT00582894|Alkylating Agents|alkylating agents|mesh-ancestor
111482133|NCT00582894|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111482134|NCT00582894|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111482135|NCT00585780|Prazosin|prazosin|mesh-list
111482136|NCT00585780|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111482137|NCT00585780|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111482138|NCT00585780|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111482139|NCT00585780|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111482140|NCT00585780|Adrenergic Agents|adrenergic agents|mesh-ancestor
111482141|NCT00585780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111482142|NCT00585780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111482143|NCT00585780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111482144|NCT00586482|Nicotine|nicotine|mesh-list
111482145|NCT00586482|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111482146|NCT00586482|Autonomic Agents|autonomic agents|mesh-ancestor
111482147|NCT00586482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111482148|NCT00586482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111482149|NCT00586482|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111482150|NCT00586482|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111482151|NCT00586482|Cholinergic Agents|cholinergic agents|mesh-ancestor
111482152|NCT00586482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111482153|NCT00586482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111482154|NCT03708354|Tocotrienols|tocotrienols|mesh-list
111482155|NCT03708354|Vitamin E|vitamin e|mesh-list
111482156|NCT03708354|Tocopherols|tocopherols|mesh-list
111482157|NCT03708354|Antioxidants|antioxidants|mesh-ancestor
111482158|NCT03708354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111482159|NCT03708354|Protective Agents|protective agents|mesh-ancestor
111482160|NCT03708354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111482161|NCT03708354|Vitamins|vitamins|mesh-ancestor
111482162|NCT03708354|Micronutrients|micronutrients|mesh-ancestor
111482163|NCT03297684|Aflibercept|aflibercept|mesh-list
111482164|NCT03297684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111482165|NCT03297684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111482166|NCT03297684|Growth Substances|growth substances|mesh-ancestor
111482167|NCT03297684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111482168|NCT03297684|Growth Inhibitors|growth inhibitors|mesh-ancestor
111482169|NCT03297684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111482170|NCT01685424|Etoricoxib|etoricoxib|mesh-list
111482171|NCT01685424|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111482172|NCT01685424|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111482173|NCT01685424|Analgesics|analgesics|mesh-ancestor
111482174|NCT01685424|Sensory System Agents|sensory system agents|mesh-ancestor
111482175|NCT01685424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111482176|NCT01685424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111102625|NCT02397395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111102626|NCT02397551|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
111102627|NCT02397551|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111482177|NCT01685424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111482178|NCT01685424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111482179|NCT01685424|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111482180|NCT01685424|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111482181|NCT01685424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111482182|NCT01685424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111482184|NCT01327638|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
111482185|NCT01327638|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111482186|NCT01327638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111482187|NCT01327638|Analgesics|analgesics|mesh-ancestor
111482188|NCT01327638|Sensory System Agents|sensory system agents|mesh-ancestor
111482189|NCT01327638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111482190|NCT01327638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111482191|NCT01327638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111482192|NCT01327638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111482193|NCT01327638|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111482194|NCT01327638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111482195|NCT01327638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111482196|NCT00393354|Etoricoxib|etoricoxib|mesh-list
111482197|NCT00393354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111482198|NCT00393354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111482199|NCT00393354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111482200|NCT00393354|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111482201|NCT00393354|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111482202|NCT00393354|Analgesics|analgesics|mesh-ancestor
111482203|NCT00393354|Sensory System Agents|sensory system agents|mesh-ancestor
111482204|NCT00393354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111482205|NCT00393354|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111482206|NCT00393354|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111482207|NCT00393354|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111482208|NCT00393354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111482209|NCT00166530|Atorvastatin|atorvastatin|mesh-list
111482210|NCT00166530|Simvastatin|simvastatin|mesh-list
111482211|NCT00166530|Ezetimibe|ezetimibe|mesh-list
111482212|NCT00166530|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111482213|NCT00166530|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111482214|NCT00166530|Antimetabolites|antimetabolites|mesh-ancestor
111482215|NCT00166530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111482216|NCT00166530|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111482217|NCT00166530|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111482218|NCT00166530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111482219|NCT00588900|Irinotecan|irinotecan|mesh-list
111482220|NCT00588900|Cediranib|cediranib|mesh-list
111482221|NCT00588900|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111482222|NCT00588900|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111482223|NCT00588900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111482224|NCT00588900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111482225|NCT00588900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111482226|NCT00588900|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111482227|NCT00589056|Nelfinavir|nelfinavir|mesh-list
111482228|NCT00589056|Etoposide|etoposide|mesh-list
111482229|NCT00589056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111482230|NCT00589056|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111482231|NCT00589056|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111482232|NCT00589056|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111482233|NCT00589056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111482234|NCT00589056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111482235|NCT00589056|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111102628|NCT02397551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111102629|NCT03168191|Menthol|menthol|mesh-list
111102630|NCT03168191|Nicotine|nicotine|mesh-list
111102631|NCT03168191|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111102632|NCT03168191|Autonomic Agents|autonomic agents|mesh-ancestor
111102633|NCT03168191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111102634|NCT03168191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111102635|NCT03168191|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111102636|NCT03168191|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111102637|NCT03168191|Cholinergic Agents|cholinergic agents|mesh-ancestor
111102638|NCT03168191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111102639|NCT03168191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111102640|NCT03168191|Antipruritics|antipruritics|mesh-ancestor
111102641|NCT03168191|Dermatologic Agents|dermatologic agents|mesh-ancestor
111102642|NCT05496075|Orlistat|orlistat|mesh-list
111482236|NCT00589056|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111482237|NCT00589056|Protease Inhibitors|protease inhibitors|mesh-ancestor
111482239|NCT00589056|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111482240|NCT00589056|Antiviral Agents|antiviral agents|mesh-ancestor
111482241|NCT00589056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111482242|NCT00590226|Insulin|insulin|mesh-list
111482243|NCT00590226|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111482244|NCT00590226|Insulin Aspart|insulin aspart|mesh-list
111482245|NCT00590226|Insulin, Isophane|insulin, isophane|mesh-list
111482246|NCT00590226|Isophane Insulin, Human|isophane insulin, human|mesh-list
111482247|NCT00590226|Isophane insulin, beef|isophane insulin, beef|mesh-list
111482248|NCT00590226|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111482249|NCT00590226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111482250|NCT00590460|Fludarabine|fludarabine|mesh-list
111482251|NCT00590460|Alemtuzumab|alemtuzumab|mesh-list
111482252|NCT00590460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111482253|NCT00590460|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111482254|NCT00590772|Montelukast|montelukast|mesh-list
111482255|NCT00590772|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111482256|NCT00590772|Respiratory System Agents|respiratory system agents|mesh-ancestor
111482257|NCT00590772|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
111482258|NCT00590772|Hormone Antagonists|hormone antagonists|mesh-ancestor
111482259|NCT00590772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110645405|NCT05264896|Vitamin B Complex|vitamin b complex|mesh-ancestor
111482260|NCT00590772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111482261|NCT00590772|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
111482262|NCT00590772|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111482263|NCT00590772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111482264|NCT00592176|Bevacizumab|bevacizumab|mesh-list
111482265|NCT00592176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111482266|NCT00592176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111482267|NCT00592176|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111482268|NCT00592176|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111482269|NCT00592176|Growth Substances|growth substances|mesh-ancestor
111482270|NCT00592176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111482271|NCT00592176|Growth Inhibitors|growth inhibitors|mesh-ancestor
111482272|NCT00592488|Acetylcarnitine|acetylcarnitine|mesh-list
111482273|NCT00592488|Vitamin B Complex|vitamin b complex|mesh-ancestor
111482274|NCT00592488|Vitamins|vitamins|mesh-ancestor
111482275|NCT00592488|Micronutrients|micronutrients|mesh-ancestor
111482276|NCT00592488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111482277|NCT00592488|Nootropic Agents|nootropic agents|mesh-ancestor
111482278|NCT00595530|Ketamine|ketamine|mesh-list
111482279|NCT00595530|Analgesics|analgesics|mesh-ancestor
111482280|NCT00595530|Sensory System Agents|sensory system agents|mesh-ancestor
111482281|NCT00595530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111482282|NCT00595530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111482283|NCT00595530|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111482284|NCT00595530|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111482285|NCT00595530|Anesthetics, General|anesthetics, general|mesh-ancestor
111482286|NCT00595530|Anesthetics|anesthetics|mesh-ancestor
111482287|NCT00595530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111482288|NCT00595530|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111482289|NCT00595530|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111482290|NCT00595530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111482291|NCT00595530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111482292|NCT00596622|Lithium Carbonate|lithium carbonate|mesh-list
111482293|NCT00596622|Antidepressive Agents|antidepressive agents|mesh-ancestor
111482294|NCT00596622|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111482295|NCT00596622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111482296|NCT00596622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111482297|NCT00596622|Antimanic Agents|antimanic agents|mesh-ancestor
111482298|NCT00596622|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111482299|NCT00596622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111482300|NCT00596622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111482301|NCT00597402|Bevacizumab|bevacizumab|mesh-list
111482302|NCT00597402|Irinotecan|irinotecan|mesh-list
111482303|NCT00597402|Temozolomide|temozolomide|mesh-list
111482304|NCT00597402|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111482305|NCT00597402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111482306|NCT00597402|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111482307|NCT00597402|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111482308|NCT00597402|Growth Substances|growth substances|mesh-ancestor
111482309|NCT00597402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110690349|NCT00364689|Rifaximin|rifaximin|mesh-list
111482310|NCT00597402|Growth Inhibitors|growth inhibitors|mesh-ancestor
111482311|NCT00597402|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111482312|NCT00597402|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111482313|NCT00597402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111482314|NCT00597402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111482315|NCT00597402|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111482316|NCT00597402|Alkylating Agents|alkylating agents|mesh-ancestor
111482317|NCT00598806|Apaziquone|apaziquone|mesh-list
111482318|NCT00598806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111482319|NCT00601926|Bevacizumab|bevacizumab|mesh-list
111482320|NCT00601926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111482321|NCT00601926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111482322|NCT00601926|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111482323|NCT00601926|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111482324|NCT00601926|Growth Substances|growth substances|mesh-ancestor
111482325|NCT00601926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111482326|NCT00601926|Growth Inhibitors|growth inhibitors|mesh-ancestor
111482327|NCT00603018|Fluoxetine|fluoxetine|mesh-list
110645412|NCT05256745|Paclitaxel|paclitaxel|mesh-list
111482328|NCT00603018|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111482329|NCT00603018|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111482330|NCT00603018|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111482331|NCT00603018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111482332|NCT00603018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111482333|NCT00603018|Serotonin Agents|serotonin agents|mesh-ancestor
111482334|NCT00603018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111482335|NCT00603018|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111482336|NCT00603018|Antidepressive Agents|antidepressive agents|mesh-ancestor
111482337|NCT00603018|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111482338|NCT00603018|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111482339|NCT00603018|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111482340|NCT00603018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111482341|NCT00603408|Cisplatin|cisplatin|mesh-list
111482342|NCT00603408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111482343|NCT00603720|Phenylephrine|phenylephrine|mesh-list
111482344|NCT00603720|Oxymetazoline|oxymetazoline|mesh-list
111482345|NCT00603720|NG-Nitroarginine Methyl Ester|ng-nitroarginine methyl ester|mesh-list
111482346|NCT00603720|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111482347|NCT00603720|Mydriatics|mydriatics|mesh-ancestor
111482348|NCT00603720|Autonomic Agents|autonomic agents|mesh-ancestor
111482349|NCT00603720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111482350|NCT00603720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111482351|NCT00603720|Sympathomimetics|sympathomimetics|mesh-ancestor
111482352|NCT00603720|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111482353|NCT00603720|Nasal Decongestants|nasal decongestants|mesh-ancestor
111482354|NCT00603720|Respiratory System Agents|respiratory system agents|mesh-ancestor
111482355|NCT00603720|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111482356|NCT00603720|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111482357|NCT00603720|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111482358|NCT00603720|Adrenergic Agents|adrenergic agents|mesh-ancestor
111482359|NCT00603720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111482360|NCT00603720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111482361|NCT00603720|Protective Agents|protective agents|mesh-ancestor
111482362|NCT00603720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111482363|NCT00625404|Tenofovir|tenofovir|mesh-list
111482364|NCT00625404|Emtricitabine|emtricitabine|mesh-list
111482365|NCT00625404|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
111482366|NCT00625404|Antiviral Agents|antiviral agents|mesh-ancestor
111482367|NCT00625404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111482368|NCT00625404|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111482369|NCT00625404|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111482370|NCT00625404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111482371|NCT00625404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111482372|NCT00625404|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111482373|NCT00625404|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111482374|NCT00626340|Fluoxetine|fluoxetine|mesh-list
111482375|NCT00626340|Estrogens|estrogens|mesh-list
111482376|NCT00626340|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111482377|NCT00626340|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111482378|NCT00626340|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111482379|NCT00626340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111102643|NCT05496075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111102644|NCT05496075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110690423|NCT00364533|Oxycodone|oxycodone|mesh-list
111102645|NCT05496075|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111482380|NCT00626340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111482381|NCT00626340|Serotonin Agents|serotonin agents|mesh-ancestor
111482382|NCT00626340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111482383|NCT00626340|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111482384|NCT00626340|Antidepressive Agents|antidepressive agents|mesh-ancestor
111482385|NCT00626340|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111482386|NCT00626340|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111482387|NCT00626340|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111482388|NCT00626340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111482389|NCT00626340|Hormones|hormones|mesh-ancestor
111482390|NCT00626340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111482391|NCT00626574|Epoetin Alfa|epoetin alfa|mesh-list
111482392|NCT00626574|Hematinics|hematinics|mesh-ancestor
111482393|NCT00626886|Bupivacaine|bupivacaine|mesh-list
111482394|NCT00626886|Anesthetics, Local|anesthetics, local|mesh-ancestor
111482395|NCT00626886|Anesthetics|anesthetics|mesh-ancestor
111482396|NCT00626886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111482397|NCT00626886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111482398|NCT00626886|Sensory System Agents|sensory system agents|mesh-ancestor
111482399|NCT00626886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111482400|NCT00628134|Calfactant|calfactant|mesh-list
111482401|NCT00628134|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
111482402|NCT00628134|Respiratory System Agents|respiratory system agents|mesh-ancestor
111482403|NCT00632814|Factor VIII|factor viii|mesh-list
111482404|NCT00632814|Coagulants|coagulants|mesh-ancestor
111482405|NCT00632970|Ritonavir|ritonavir|mesh-list
111482406|NCT00632970|Lopinavir|lopinavir|mesh-list
111482407|NCT00632970|Tenofovir|tenofovir|mesh-list
111482408|NCT00632970|Emtricitabine|emtricitabine|mesh-list
111482409|NCT00632970|Raltegravir Potassium|raltegravir potassium|mesh-list
111482410|NCT00632970|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
111482411|NCT00632970|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111482412|NCT00632970|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111482413|NCT00632970|Protease Inhibitors|protease inhibitors|mesh-ancestor
111482414|NCT00632970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111482415|NCT00632970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111482416|NCT00632970|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111482417|NCT00632970|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111482418|NCT00632970|Antiviral Agents|antiviral agents|mesh-ancestor
111482419|NCT00632970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111482420|NCT00632970|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111482421|NCT00632970|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111482422|NCT00632970|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111482423|NCT00632970|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111482424|NCT00632970|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111482425|NCT00632970|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111482426|NCT00635232|Irbesartan|irbesartan|mesh-list
111482427|NCT00635232|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111482428|NCT00635232|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111482429|NCT00635232|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111482430|NCT00635232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111482431|NCT00637494|Mifepristone|mifepristone|mesh-list
111482432|NCT00637494|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
111482433|NCT00637494|Abortifacient Agents|abortifacient agents|mesh-ancestor
111482434|NCT00637494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111482435|NCT00637494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111482436|NCT00637494|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111482437|NCT00637494|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111482438|NCT00637494|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111482439|NCT00637494|Contraceptive Agents|contraceptive agents|mesh-ancestor
111482440|NCT00637494|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
111482441|NCT00637494|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
111482442|NCT00637494|Hormone Antagonists|hormone antagonists|mesh-ancestor
111482443|NCT00637494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111482444|NCT00637494|Luteolytic Agents|luteolytic agents|mesh-ancestor
111482445|NCT00637494|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111482446|NCT00637494|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
111482447|NCT00638820|Busulfan|busulfan|mesh-list
111482448|NCT00638820|Alemtuzumab|alemtuzumab|mesh-list
111482449|NCT00638820|Clofarabine|clofarabine|mesh-list
111482450|NCT00638820|Alkylating Agents|alkylating agents|mesh-ancestor
111482451|NCT00638820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110690501|NCT00983177|Colchicine|colchicine|mesh-list
111482452|NCT00638820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111482453|NCT00638820|Immunologic Factors|immunologic factors|mesh-ancestor
111482454|NCT00638820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111482455|NCT00638820|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111482456|NCT00638820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111482457|NCT00638820|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111482458|NCT00638820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111482459|NCT00638820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111482460|NCT00638820|Antimetabolites|antimetabolites|mesh-ancestor
111482461|NCT00641862|Vitamin B 12|vitamin b 12|mesh-list
111482462|NCT00641862|Hydroxocobalamin|hydroxocobalamin|mesh-list
111482463|NCT00641862|Vitamins|vitamins|mesh-ancestor
111482464|NCT00641862|Micronutrients|micronutrients|mesh-ancestor
111482465|NCT00641862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111482466|NCT00641862|Vitamin B Complex|vitamin b complex|mesh-ancestor
111482467|NCT00641862|Hematinics|hematinics|mesh-ancestor
111482468|NCT00643578|Formoterol Fumarate|formoterol fumarate|mesh-list
111482469|NCT00643578|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111482470|NCT00643578|Autonomic Agents|autonomic agents|mesh-ancestor
111482471|NCT00643578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111482472|NCT00643578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111482473|NCT00643578|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111482474|NCT00643578|Respiratory System Agents|respiratory system agents|mesh-ancestor
111482475|NCT00643578|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111482476|NCT00643578|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111482477|NCT00643578|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111482478|NCT00643578|Adrenergic Agents|adrenergic agents|mesh-ancestor
111482479|NCT00643578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111482480|NCT00643578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111482481|NCT00644592|Fenofibrate|fenofibrate|mesh-list
111482482|NCT00644592|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111482483|NCT00644592|Antimetabolites|antimetabolites|mesh-ancestor
111482484|NCT00644592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111482485|NCT00644592|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111482486|NCT00645450|Propranolol|propranolol|mesh-list
111482487|NCT00645450|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111482488|NCT00645450|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111482489|NCT00645450|Adrenergic Agents|adrenergic agents|mesh-ancestor
111482490|NCT00645450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111482491|NCT00645450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111482492|NCT00645450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111482493|NCT00645450|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111482494|NCT00645450|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111482495|NCT00645450|Vasodilator Agents|vasodilator agents|mesh-ancestor
111482496|NCT00647400|Adalimumab|adalimumab|mesh-list
111482497|NCT00647400|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111482498|NCT00647400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111482499|NCT00647400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111482500|NCT00652314|Thrombin|thrombin|mesh-list
111482501|NCT00652314|Hemostatics|hemostatics|mesh-ancestor
111482502|NCT00652314|Coagulants|coagulants|mesh-ancestor
111482503|NCT00654030|Vaccines|vaccines|mesh-list
111482504|NCT00654030|Immunologic Factors|immunologic factors|mesh-ancestor
111482505|NCT00654030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111482506|NCT00656448|Epoetin Alfa|epoetin alfa|mesh-list
111482507|NCT00656448|Hematinics|hematinics|mesh-ancestor
111482508|NCT00660504|Etoposide|etoposide|mesh-list
111482509|NCT00660504|Amrubicin|amrubicin|mesh-list
111482510|NCT00660504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111482511|NCT00660504|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111482512|NCT00660504|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111482513|NCT00660504|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111482514|NCT00660504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111482515|NCT00660504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111482516|NCT00661674|Palonosetron|palonosetron|mesh-list
111482517|NCT00661674|Hydroxyzine|hydroxyzine|mesh-list
111482518|NCT00661674|Antiemetics|antiemetics|mesh-ancestor
111482519|NCT00661674|Autonomic Agents|autonomic agents|mesh-ancestor
111482520|NCT00661674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111482521|NCT00661674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111482522|NCT00661674|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111482523|NCT00661674|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111482524|NCT00661674|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111102646|NCT05496075|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111102647|NCT04280055|Psilocybin|psilocybin|mesh-list
111482525|NCT00661674|Serotonin Agents|serotonin agents|mesh-ancestor
111482526|NCT00661674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111482527|NCT00661674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111482528|NCT00661674|Antipruritics|antipruritics|mesh-ancestor
111482529|NCT00661674|Dermatologic Agents|dermatologic agents|mesh-ancestor
111482530|NCT00661674|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111482531|NCT00661674|Histamine Antagonists|histamine antagonists|mesh-ancestor
111482532|NCT00661674|Histamine Agents|histamine agents|mesh-ancestor
111482533|NCT00662298|Prednisolone|prednisolone|mesh-list
111482534|NCT00662298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111482535|NCT00662298|Glucocorticoids|glucocorticoids|mesh-ancestor
111482536|NCT00662298|Hormones|hormones|mesh-ancestor
111482537|NCT00662298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111482538|NCT00662298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111482539|NCT00662298|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111482540|NCT00662298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111482541|NCT00666666|Acetic Acid|acetic acid|mesh-list
111482542|NCT00666666|Bicalutamide|bicalutamide|mesh-list
111482543|NCT00666666|Gossypol acetic acid|gossypol acetic acid|mesh-list
111482544|NCT00666666|Gossypol|gossypol|mesh-list
111482545|NCT00666666|Hormones|hormones|mesh-list
111482546|NCT00666666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111482547|NCT00666666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111482548|NCT00666666|Androgen Antagonists|androgen antagonists|mesh-ancestor
111482549|NCT00666666|Hormone Antagonists|hormone antagonists|mesh-ancestor
111482550|NCT00666666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111482551|NCT00666666|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111482552|NCT00666666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111482553|NCT00666666|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111482554|NCT00666666|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111482555|NCT00666666|Contraceptive Agents|contraceptive agents|mesh-ancestor
111482556|NCT00666666|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111482557|NCT00666666|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
111482558|NCT00666666|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
111482559|NCT00666666|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
111482560|NCT00666978|Bupropion|bupropion|mesh-list
111482561|NCT00666978|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111482562|NCT00666978|Antidepressive Agents|antidepressive agents|mesh-ancestor
111482563|NCT00666978|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111482564|NCT00666978|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110645455|NCT05194124|alpha-MSH|alpha-msh|mesh-list
111482565|NCT00666978|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111482566|NCT00666978|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111482567|NCT00666978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111482568|NCT00666978|Dopamine Agents|dopamine agents|mesh-ancestor
111482569|NCT00666978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111482570|NCT00666978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111482571|NCT00666978|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111482572|NCT00666978|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111482573|NCT00666978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111482574|NCT00670956|Betamethasone|betamethasone|mesh-list
111482575|NCT00670956|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111482576|NCT00670956|Glucocorticoids|glucocorticoids|mesh-ancestor
111482577|NCT00670956|Hormones|hormones|mesh-ancestor
111482578|NCT00670956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111482579|NCT00670956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111482580|NCT00670956|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111482581|NCT00670956|Respiratory System Agents|respiratory system agents|mesh-ancestor
111482582|NCT00671502|Carisoprodol|carisoprodol|mesh-list
111482583|NCT00671502|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
111482584|NCT00671502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111482585|NCT00671502|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111482586|NCT00671502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111482587|NCT00671970|Bevacizumab|bevacizumab|mesh-list
111482588|NCT00671970|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111482589|NCT00671970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111482590|NCT00671970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111482591|NCT00671970|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111482592|NCT00671970|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111482593|NCT00671970|Growth Substances|growth substances|mesh-ancestor
111482594|NCT00671970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111482595|NCT00671970|Growth Inhibitors|growth inhibitors|mesh-ancestor
111482596|NCT00671970|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111482597|NCT00671970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111482598|NCT00671970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111482599|NCT00672204|Sirolimus|sirolimus|mesh-list
111482600|NCT00672204|Thymoglobulin|thymoglobulin|mesh-list
111102648|NCT04280055|Hallucinogens|hallucinogens|mesh-ancestor
111482601|NCT00672204|Antilymphocyte Serum|antilymphocyte serum|mesh-list
111482602|NCT00672204|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111482603|NCT00672204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111482604|NCT00672204|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111482605|NCT00672204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111482606|NCT00672204|Antifungal Agents|antifungal agents|mesh-ancestor
111482607|NCT00672204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111482608|NCT00672204|Immunologic Factors|immunologic factors|mesh-ancestor
111482609|NCT00672204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111482610|NCT00672438|Alfentanil|alfentanil|mesh-list
111482611|NCT00672438|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111482612|NCT00672438|Narcotics|narcotics|mesh-ancestor
111482613|NCT00672438|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111482614|NCT00672438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111482615|NCT00672438|Analgesics|analgesics|mesh-ancestor
111482616|NCT00672438|Sensory System Agents|sensory system agents|mesh-ancestor
111482617|NCT00672438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111482618|NCT00672438|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111482619|NCT00672438|Anesthetics, General|anesthetics, general|mesh-ancestor
111482620|NCT00672438|Anesthetics|anesthetics|mesh-ancestor
111482621|NCT00672594|Sunitinib|sunitinib|mesh-list
111482622|NCT00672594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111482623|NCT00672594|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111482624|NCT00672594|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111482625|NCT00672594|Growth Substances|growth substances|mesh-ancestor
111482626|NCT00672594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111482627|NCT00672594|Growth Inhibitors|growth inhibitors|mesh-ancestor
111482628|NCT00672594|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111482629|NCT00672594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110645471|NCT05176288|Palbociclib|palbociclib|mesh-list
111482630|NCT00672594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111482631|NCT00673764|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111482632|NCT00673764|Lubricant Eye Drops|lubricant eye drops|mesh-list
111482633|NCT00673764|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111482634|NCT00675792|Bromides|bromides|mesh-list
111482635|NCT00675792|Rocuronium|rocuronium|mesh-list
111482636|NCT00675792|Neostigmine|neostigmine|mesh-list
111482637|NCT00675792|Anticonvulsants|anticonvulsants|mesh-ancestor
111482638|NCT00675792|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
111482639|NCT00675792|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
111482640|NCT00675792|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111482641|NCT00675792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111482642|NCT00675792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111482643|NCT00675792|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111482644|NCT00675792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111482645|NCT00675792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111482646|NCT00675792|Cholinergic Agents|cholinergic agents|mesh-ancestor
111482647|NCT00675792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111482648|NCT00675792|Parasympathomimetics|parasympathomimetics|mesh-ancestor
111482649|NCT00675792|Autonomic Agents|autonomic agents|mesh-ancestor
111482650|NCT00676806|Cyclophosphamide|cyclophosphamide|mesh-list
111482651|NCT00676806|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111482652|NCT00676806|Immunologic Factors|immunologic factors|mesh-ancestor
111482653|NCT00676806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111482654|NCT00676806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111482655|NCT00676806|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111482656|NCT00676806|Alkylating Agents|alkylating agents|mesh-ancestor
111482657|NCT00676806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111482658|NCT00676806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111482659|NCT00676806|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111482660|NCT00678834|Tocopherols|tocopherols|mesh-list
111482661|NCT00678834|Vitamin E|vitamin e|mesh-list
111482662|NCT00678834|Tocotrienols|tocotrienols|mesh-list
111482663|NCT00678834|alpha-Tocopherol|alpha-tocopherol|mesh-list
111482664|NCT00678834|Antioxidants|antioxidants|mesh-ancestor
111482665|NCT00678834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111482666|NCT00678834|Protective Agents|protective agents|mesh-ancestor
111482667|NCT00678834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111482668|NCT00678834|Vitamins|vitamins|mesh-ancestor
111482669|NCT00678834|Micronutrients|micronutrients|mesh-ancestor
111482670|NCT00679380|Budesonide|budesonide|mesh-list
111482671|NCT00679380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111482672|NCT00679380|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111482673|NCT00679380|Autonomic Agents|autonomic agents|mesh-ancestor
111482674|NCT00679380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111482675|NCT00679380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111482676|NCT00679380|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111482677|NCT00679380|Respiratory System Agents|respiratory system agents|mesh-ancestor
111482678|NCT00679380|Glucocorticoids|glucocorticoids|mesh-ancestor
111482679|NCT00679380|Hormones|hormones|mesh-ancestor
111482680|NCT00679380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111482681|NCT00680706|Thiamine|thiamine|mesh-list
111482682|NCT00680706|Vitamins|vitamins|mesh-ancestor
111482683|NCT00680706|Micronutrients|micronutrients|mesh-ancestor
111482684|NCT00680706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111482685|NCT00680706|Vitamin B Complex|vitamin b complex|mesh-ancestor
111482686|NCT00682734|Diphenhydramine|diphenhydramine|mesh-list
111482687|NCT00682734|Promethazine|promethazine|mesh-list
111482688|NCT00682734|Metoclopramide|metoclopramide|mesh-list
111482689|NCT00682734|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111482690|NCT00682734|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111482691|NCT00682734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111482692|NCT00682734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111482693|NCT00682734|Anesthetics, Local|anesthetics, local|mesh-ancestor
111482694|NCT00682734|Anesthetics|anesthetics|mesh-ancestor
111482695|NCT00682734|Sensory System Agents|sensory system agents|mesh-ancestor
110645479|NCT05159934|Nicotine|nicotine|mesh-list
111482696|NCT00682734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111482697|NCT00682734|Antiemetics|antiemetics|mesh-ancestor
111482698|NCT00682734|Autonomic Agents|autonomic agents|mesh-ancestor
111482699|NCT00682734|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111482700|NCT00682734|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111482701|NCT00682734|Histamine Antagonists|histamine antagonists|mesh-ancestor
111482702|NCT00682734|Histamine Agents|histamine agents|mesh-ancestor
111482703|NCT00682734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111482704|NCT00682734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111482705|NCT00682734|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111482706|NCT00682734|Antipruritics|antipruritics|mesh-ancestor
111482707|NCT00682734|Dermatologic Agents|dermatologic agents|mesh-ancestor
111482708|NCT00682734|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111482709|NCT00682734|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111482710|NCT00682734|Dopamine Agents|dopamine agents|mesh-ancestor
111482711|NCT00683046|Fludarabine|fludarabine|mesh-list
111482712|NCT00683046|Melphalan|melphalan|mesh-list
111482713|NCT00683046|Alemtuzumab|alemtuzumab|mesh-list
111482714|NCT00683046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111482715|NCT00683046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111482716|NCT00683046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111482717|NCT00683046|Immunologic Factors|immunologic factors|mesh-ancestor
111482718|NCT00683046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111482719|NCT00683046|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111482720|NCT00683046|Alkylating Agents|alkylating agents|mesh-ancestor
111482721|NCT00683046|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111482722|NCT00683046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111482723|NCT00687102|Tamoxifen|tamoxifen|mesh-list
111482724|NCT00687102|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
111482725|NCT00687102|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111482726|NCT00687102|Hormone Antagonists|hormone antagonists|mesh-ancestor
111482727|NCT00687102|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111482728|NCT00687102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111482729|NCT00687102|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111482730|NCT00687102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111482731|NCT00687102|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111482732|NCT00687102|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111482733|NCT00687102|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111482734|NCT00690924|Calcitriol|calcitriol|mesh-list
111482735|NCT00690924|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111482736|NCT00690924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111482737|NCT00690924|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
111482738|NCT00690924|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111482739|NCT00690924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111482740|NCT00690924|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111482741|NCT00690924|Vitamins|vitamins|mesh-ancestor
111482742|NCT00690924|Micronutrients|micronutrients|mesh-ancestor
110645487|NCT05159934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111482743|NCT00690924|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111482744|NCT00691002|Calcitriol|calcitriol|mesh-list
111482745|NCT00691002|Hydrocortisone|hydrocortisone|mesh-list
111482746|NCT00691002|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
111482747|NCT00691002|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
111102649|NCT04280055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111482748|NCT00691002|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
111482749|NCT00691002|Calcipotriene|calcipotriene|mesh-list
111482750|NCT00691002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111102650|NCT04280055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111482751|NCT00691002|Dermatologic Agents|dermatologic agents|mesh-ancestor
111482752|NCT00691002|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111482753|NCT00691002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111482754|NCT00691002|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
111482755|NCT00691002|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111482756|NCT00691002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111482757|NCT00691002|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111482758|NCT00691002|Vitamins|vitamins|mesh-ancestor
111482759|NCT00691002|Micronutrients|micronutrients|mesh-ancestor
111482760|NCT00691002|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111482761|NCT00695292|Carboplatin|carboplatin|mesh-list
111482762|NCT00695292|Irinotecan|irinotecan|mesh-list
111482763|NCT00695292|Sunitinib|sunitinib|mesh-list
111482764|NCT00695292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111482765|NCT00695292|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111482766|NCT00695292|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111482767|NCT00695292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111482768|NCT00695292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111482769|NCT00695292|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111482770|NCT00695292|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111482771|NCT00695292|Growth Substances|growth substances|mesh-ancestor
111482772|NCT00695292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111482773|NCT00695292|Growth Inhibitors|growth inhibitors|mesh-ancestor
111482774|NCT00695292|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111482775|NCT00696618|Plasma-lyte 148|plasma-lyte 148|mesh-list
111482776|NCT00696618|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
111482777|NCT00696618|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111482778|NCT00700440|Cetuximab|cetuximab|mesh-list
111482779|NCT00700440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111482780|NCT00700440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111482781|NCT00701376|Liver Extracts|liver extracts|mesh-list
111482782|NCT00701376|Hematinics|hematinics|mesh-ancestor
111482783|NCT00702780|Escitalopram|escitalopram|mesh-list
111482784|NCT00702780|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111482785|NCT00702780|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111482786|NCT00702780|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111482787|NCT00702780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111482788|NCT00702780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111482789|NCT00702780|Serotonin Agents|serotonin agents|mesh-ancestor
111482790|NCT00702780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111482791|NCT00704028|Dextrans|dextrans|mesh-list
111482792|NCT00704028|Iron-Dextran Complex|iron-dextran complex|mesh-list
111482793|NCT00704028|Anticoagulants|anticoagulants|mesh-ancestor
111482794|NCT00704028|Plasma Substitutes|plasma substitutes|mesh-ancestor
111482795|NCT00704028|Blood Substitutes|blood substitutes|mesh-ancestor
111482796|NCT00704028|Hematinics|hematinics|mesh-ancestor
111482797|NCT00704262|Hydrocortisone|hydrocortisone|mesh-list
111482798|NCT00704262|Calcipotriene|calcipotriene|mesh-list
111482799|NCT00704262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111482800|NCT00704262|Dermatologic Agents|dermatologic agents|mesh-ancestor
111482801|NCT00706446|Fluticasone|fluticasone|mesh-list
111482802|NCT00706446|Xhance|xhance|mesh-list
111482803|NCT00706446|Budesonide|budesonide|mesh-list
111482804|NCT00706446|Bromides|bromides|mesh-list
111482805|NCT00706446|Formoterol Fumarate|formoterol fumarate|mesh-list
111482806|NCT00706446|Tiotropium Bromide|tiotropium bromide|mesh-list
111482807|NCT00706446|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
111482808|NCT00706446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111482809|NCT00706446|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111482810|NCT00706446|Autonomic Agents|autonomic agents|mesh-ancestor
111482811|NCT00706446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111482812|NCT00706446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111482813|NCT00706446|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111482814|NCT00706446|Respiratory System Agents|respiratory system agents|mesh-ancestor
111482815|NCT00706446|Dermatologic Agents|dermatologic agents|mesh-ancestor
111482816|NCT00706446|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111482817|NCT00706446|Glucocorticoids|glucocorticoids|mesh-ancestor
111482818|NCT00706446|Hormones|hormones|mesh-ancestor
111482819|NCT00706446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111482820|NCT00706446|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111482821|NCT00706446|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111482822|NCT00706446|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111482823|NCT00706446|Adrenergic Agents|adrenergic agents|mesh-ancestor
111102651|NCT05499117|Fluoxetine|fluoxetine|mesh-list
110690873|NCT00267202|Omalizumab|omalizumab|mesh-list
111482824|NCT00706446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111482825|NCT00706446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111482826|NCT00706446|Parasympatholytics|parasympatholytics|mesh-ancestor
111482827|NCT00706446|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111482828|NCT00706446|Cholinergic Agents|cholinergic agents|mesh-ancestor
111482829|NCT00706446|Anticonvulsants|anticonvulsants|mesh-ancestor
111482830|NCT00706836|Pregabalin|pregabalin|mesh-list
111482831|NCT00706836|Analgesics|analgesics|mesh-ancestor
111482832|NCT00706836|Sensory System Agents|sensory system agents|mesh-ancestor
111482833|NCT00706836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111482834|NCT00706836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111482835|NCT00706836|Anticonvulsants|anticonvulsants|mesh-ancestor
111482836|NCT00706836|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111482837|NCT00706836|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111482838|NCT00706836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111482839|NCT00706836|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111482840|NCT00706836|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111482841|NCT00706836|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111482842|NCT00706836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111482843|NCT00706836|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111482844|NCT00708942|Aminolevulinic Acid|aminolevulinic acid|mesh-list
111482845|NCT00708942|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111482846|NCT00708942|Dermatologic Agents|dermatologic agents|mesh-ancestor
111482847|NCT00711828|Dexamethasone|dexamethasone|mesh-list
111482848|NCT00711828|Cyclophosphamide|cyclophosphamide|mesh-list
111482849|NCT00711828|Rituximab|rituximab|mesh-list
111482850|NCT00711828|Bortezomib|bortezomib|mesh-list
111482851|NCT00711828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111482852|NCT00711828|Immunologic Factors|immunologic factors|mesh-ancestor
111482853|NCT00711828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111482854|NCT00711828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111482855|NCT00711828|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111482856|NCT00711828|Alkylating Agents|alkylating agents|mesh-ancestor
111482857|NCT00711828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111482858|NCT00711828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111482859|NCT00711828|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111482860|NCT00711828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111482861|NCT00711828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111482862|NCT00711828|Antiemetics|antiemetics|mesh-ancestor
111482863|NCT00711828|Autonomic Agents|autonomic agents|mesh-ancestor
111482864|NCT00711828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111482865|NCT00711828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111482866|NCT00711828|Glucocorticoids|glucocorticoids|mesh-ancestor
111482867|NCT00711828|Hormones|hormones|mesh-ancestor
111482868|NCT00711828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111482869|NCT00711828|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111482870|NCT00712530|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
111482871|NCT00712530|Antiviral Agents|antiviral agents|mesh-ancestor
111482872|NCT00712530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111482873|NCT00715884|Sirolimus|sirolimus|mesh-list
111482874|NCT00715884|Temsirolimus|temsirolimus|mesh-list
111482875|NCT00715884|MTOR Inhibitors|mtor inhibitors|mesh-list
111482876|NCT00715884|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111482877|NCT00715884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111482878|NCT00715884|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111482879|NCT00715884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111482880|NCT00715884|Antifungal Agents|antifungal agents|mesh-ancestor
111482881|NCT00715884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111482882|NCT00715884|Immunologic Factors|immunologic factors|mesh-ancestor
111482883|NCT00715884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111482884|NCT00715884|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111482885|NCT00715884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111482886|NCT00715884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111482887|NCT00716586|Dorzolamide|dorzolamide|mesh-list
111482888|NCT00716586|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111482889|NCT00716586|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
111482890|NCT00716586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111482891|NCT00716586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111482892|NCT00716742|Bimatoprost|bimatoprost|mesh-list
111482893|NCT00716742|Travoprost|travoprost|mesh-list
111482894|NCT00716742|Latanoprost|latanoprost|mesh-list
111482895|NCT00716742|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
111482896|NCT00716742|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111102652|NCT05499117|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111102653|NCT05499117|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111482897|NCT00716742|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111102654|NCT05499117|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111482898|NCT00716820|Sunitinib|sunitinib|mesh-list
111482899|NCT00716820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111482900|NCT00716820|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111482901|NCT00716820|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111482902|NCT00716820|Growth Substances|growth substances|mesh-ancestor
111482903|NCT00716820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111482904|NCT00716820|Growth Inhibitors|growth inhibitors|mesh-ancestor
111482905|NCT00716820|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111482906|NCT00716820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111482907|NCT00716820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111482908|NCT00717054|Scopolamine|scopolamine|mesh-list
111482909|NCT00717054|Aprepitant|aprepitant|mesh-list
111482910|NCT00717054|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
111482911|NCT00717054|Antiemetics|antiemetics|mesh-ancestor
111482912|NCT00717054|Autonomic Agents|autonomic agents|mesh-ancestor
111482913|NCT00717054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111482914|NCT00717054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111482915|NCT00717054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111482916|NCT00717054|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
111482917|NCT00717054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111482918|NCT00717054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111482919|NCT00717054|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111482920|NCT00717054|Mydriatics|mydriatics|mesh-ancestor
111482921|NCT00717054|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111482922|NCT00717054|Cholinergic Agents|cholinergic agents|mesh-ancestor
111482923|NCT00717054|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111482924|NCT00717054|Parasympatholytics|parasympatholytics|mesh-ancestor
111482925|NCT00717288|Insulin Detemir|insulin detemir|mesh-list
111482926|NCT00717288|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111482927|NCT00717288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111482928|NCT00719160|Esomeprazole|esomeprazole|mesh-list
111482929|NCT00719160|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111482930|NCT00719160|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111482931|NCT00719160|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111482932|NCT00719160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111482933|NCT00719160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111482934|NCT00720330|Lidocaine|lidocaine|mesh-list
111482935|NCT00720330|Ketamine|ketamine|mesh-list
111482936|NCT00720330|Ropivacaine|ropivacaine|mesh-list
111482937|NCT00720330|Anesthetics, Local|anesthetics, local|mesh-ancestor
111482938|NCT00720330|Anesthetics|anesthetics|mesh-ancestor
111482939|NCT00720330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111482940|NCT00720330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111482941|NCT00720330|Sensory System Agents|sensory system agents|mesh-ancestor
111482942|NCT00720330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111482943|NCT00720330|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111482944|NCT00720330|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111482945|NCT00720330|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111482946|NCT00720330|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111482947|NCT00720330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111482948|NCT00720330|Analgesics|analgesics|mesh-ancestor
111482949|NCT00720330|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111482950|NCT00720330|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111482951|NCT00720330|Anesthetics, General|anesthetics, general|mesh-ancestor
111482952|NCT00720330|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111482953|NCT00720330|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111482954|NCT00720330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111482955|NCT00721188|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
111482956|NCT00721188|Hematinics|hematinics|mesh-ancestor
111482957|NCT00722436|Tranexamic Acid|tranexamic acid|mesh-list
111482958|NCT00722436|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111482959|NCT00722436|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111482960|NCT00722436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111482961|NCT00722436|Hemostatics|hemostatics|mesh-ancestor
111482962|NCT00722436|Coagulants|coagulants|mesh-ancestor
111482963|NCT00724464|Interferons|interferons|mesh-list
111482964|NCT00724464|Ribavirin|ribavirin|mesh-list
111482965|NCT00724464|Interferon-alpha|interferon-alpha|mesh-list
111482966|NCT00724464|Interferon alpha-2|interferon alpha-2|mesh-list
111482967|NCT00724464|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
111482968|NCT00724464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111482969|NCT00724464|Antiviral Agents|antiviral agents|mesh-ancestor
111482970|NCT00724464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111482971|NCT00724464|Antimetabolites|antimetabolites|mesh-ancestor
111482972|NCT00724464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111119166|NCT05306873|Dermatologic Agents|dermatologic agents|mesh-ancestor
111482973|NCT00724464|Immunologic Factors|immunologic factors|mesh-ancestor
111482974|NCT00724464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111482975|NCT00726414|Quinine|quinine|mesh-list
111482976|NCT00726414|Antimalarials|antimalarials|mesh-ancestor
111482977|NCT00726414|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111482978|NCT00726414|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111482979|NCT00726414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111482980|NCT00726414|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
111482981|NCT00726414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111482982|NCT00726414|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111482983|NCT00726414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111482984|NCT00726414|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111482985|NCT00726414|Analgesics|analgesics|mesh-ancestor
111482986|NCT00726414|Sensory System Agents|sensory system agents|mesh-ancestor
111482987|NCT00727740|Indomethacin|indomethacin|mesh-list
111482988|NCT00727740|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111482989|NCT00727740|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111482990|NCT00727740|Analgesics|analgesics|mesh-ancestor
111482991|NCT00727740|Sensory System Agents|sensory system agents|mesh-ancestor
111482992|NCT00727740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111482993|NCT00727740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111482994|NCT00727740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111482995|NCT00727740|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111482996|NCT00727740|Gout Suppressants|gout suppressants|mesh-ancestor
111482997|NCT00727740|Tocolytic Agents|tocolytic agents|mesh-ancestor
111482998|NCT00727740|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111482999|NCT00727740|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111483000|NCT00727740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111483001|NCT00727740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111483003|NCT00728910|Atorvastatin|atorvastatin|mesh-list
111483004|NCT00728910|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111483005|NCT00728910|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111483006|NCT00728910|Antimetabolites|antimetabolites|mesh-ancestor
111483007|NCT00728910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111483008|NCT00728910|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111483009|NCT00728910|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111483010|NCT00728910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111483011|NCT00728910|Vasodilator Agents|vasodilator agents|mesh-ancestor
111483012|NCT00728910|Vitamin B Complex|vitamin b complex|mesh-ancestor
111483013|NCT00728910|Vitamins|vitamins|mesh-ancestor
111483014|NCT00728910|Micronutrients|micronutrients|mesh-ancestor
111483015|NCT00728910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111483016|NCT00729846|Bevacizumab|bevacizumab|mesh-list
111483017|NCT00729846|Verteporfin|verteporfin|mesh-list
111483018|NCT00729846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111483019|NCT00729846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111483020|NCT00729846|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111483021|NCT00729846|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111483022|NCT00729846|Growth Substances|growth substances|mesh-ancestor
111483023|NCT00729846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111483024|NCT00729846|Growth Inhibitors|growth inhibitors|mesh-ancestor
111483025|NCT00729846|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111483026|NCT00729846|Dermatologic Agents|dermatologic agents|mesh-ancestor
111483027|NCT00729924|Raltegravir Potassium|raltegravir potassium|mesh-list
111483028|NCT00729924|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111483029|NCT00729924|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111483030|NCT00729924|Antiviral Agents|antiviral agents|mesh-ancestor
111483031|NCT00729924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111483032|NCT00729924|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111483033|NCT00729924|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111483034|NCT00729924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111483035|NCT00729924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111483036|NCT00731874|Tacrolimus|tacrolimus|mesh-list
111483037|NCT00731874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111483038|NCT00731874|Immunologic Factors|immunologic factors|mesh-ancestor
111483039|NCT00731874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111483040|NCT00731874|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111483041|NCT00731874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111483042|NCT00731874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111483043|NCT00732654|Immunomodulating Agents|immunomodulating agents|mesh-list
111483044|NCT00732654|Immunologic Factors|immunologic factors|mesh-list
111483045|NCT00732654|Caseins|caseins|mesh-list
111483046|NCT00732654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111483047|NCT00732654|Chelating Agents|chelating agents|mesh-ancestor
111102655|NCT05499117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111483048|NCT00732654|Sequestering Agents|sequestering agents|mesh-ancestor
111483049|NCT00732654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111483051|NCT00733278|Contraceptive Agents|contraceptive agents|mesh-list
111483052|NCT00733278|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111483053|NCT00733278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111483054|NCT00733278|Trace Elements|trace elements|mesh-ancestor
111483055|NCT00733278|Micronutrients|micronutrients|mesh-ancestor
111483056|NCT00733356|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
111483057|NCT00733356|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111483058|NCT00733356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111483059|NCT00733356|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111483060|NCT00733356|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111483061|NCT00733356|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111483062|NCT00733356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111483063|NCT00733356|Dopamine Agents|dopamine agents|mesh-ancestor
111483064|NCT00733356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111483065|NCT00735306|Bevacizumab|bevacizumab|mesh-list
111483066|NCT00735306|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111483067|NCT00735306|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111483068|NCT00735306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111483069|NCT00735306|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111483070|NCT00735306|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111483071|NCT00735306|Growth Substances|growth substances|mesh-ancestor
111483072|NCT00735306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111483073|NCT00735306|Growth Inhibitors|growth inhibitors|mesh-ancestor
111483074|NCT00735306|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111483075|NCT00735306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111483076|NCT00735306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111483077|NCT00735462|Imiquimod|imiquimod|mesh-list
111483078|NCT00735462|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111483079|NCT00735462|Immunologic Factors|immunologic factors|mesh-ancestor
111483080|NCT00735462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111483081|NCT00735462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111483082|NCT00735462|Interferon Inducers|interferon inducers|mesh-ancestor
111483083|NCT00736242|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
111483084|NCT00736242|Interferon alpha-2|interferon alpha-2|mesh-list
111483085|NCT00736242|Antiviral Agents|antiviral agents|mesh-ancestor
111483086|NCT00736242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111483087|NCT00736242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111483088|NCT00736632|Vitamin D|vitamin d|mesh-list
111483089|NCT00736632|Ergocalciferols|ergocalciferols|mesh-list
111483090|NCT00736632|Cholecalciferol|cholecalciferol|mesh-list
111483091|NCT00736632|Vitamins|vitamins|mesh-list
111483092|NCT00736632|Micronutrients|micronutrients|mesh-ancestor
111483093|NCT00736632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111483094|NCT00736632|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111483095|NCT00736632|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111483096|NCT00737178|Copper|copper|mesh-list
111483097|NCT00737178|Trace Elements|trace elements|mesh-ancestor
111483098|NCT00737178|Micronutrients|micronutrients|mesh-ancestor
111483099|NCT00737178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111483100|NCT00741156|Enalaprilat|enalaprilat|mesh-list
111483101|NCT00741156|Enalapril|enalapril|mesh-list
111483102|NCT00741156|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
111483103|NCT00741156|Protease Inhibitors|protease inhibitors|mesh-ancestor
111483104|NCT00741156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111483105|NCT00741156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111483106|NCT00741156|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111483107|NCT00741468|Tolbutamide|tolbutamide|mesh-list
111483108|NCT00741468|Midazolam|midazolam|mesh-list
111483109|NCT00741468|Dextromethorphan|dextromethorphan|mesh-list
111483110|NCT00741468|Caffeine|caffeine|mesh-list
111483111|NCT00741468|Omeprazole|omeprazole|mesh-list
111483112|NCT00741468|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111483113|NCT00741468|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111483114|NCT00741468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111483115|NCT00741468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111483116|NCT00741468|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111483117|NCT00741468|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111483118|NCT00741468|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111483119|NCT00741468|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111483120|NCT00741468|Anesthetics, General|anesthetics, general|mesh-ancestor
111483121|NCT00741468|Anesthetics|anesthetics|mesh-ancestor
111483122|NCT00741468|GABA Modulators|gaba modulators|mesh-ancestor
111483123|NCT00741468|GABA Agents|gaba agents|mesh-ancestor
111483124|NCT00741468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111483125|NCT00741468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111483126|NCT00741468|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111483127|NCT00741468|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111483128|NCT00741468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111483129|NCT00741468|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
111483130|NCT00741468|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111483131|NCT00741468|Purinergic Agents|purinergic agents|mesh-ancestor
111483132|NCT00741468|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111483133|NCT00741468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111483134|NCT00741468|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111483135|NCT00741468|Antitussive Agents|antitussive agents|mesh-ancestor
111483136|NCT00741468|Respiratory System Agents|respiratory system agents|mesh-ancestor
111483137|NCT00741468|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111483138|NCT00741468|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111483139|NCT00741468|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111483140|NCT00741858|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
111483141|NCT00741858|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
111483142|NCT00741858|Estradiol|estradiol|mesh-list
111483143|NCT00741858|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
111483144|NCT00741858|Estrogens|estrogens|mesh-ancestor
111483145|NCT00741858|Hormones|hormones|mesh-ancestor
111483146|NCT00741858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111483147|NCT00741858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111483148|NCT00741858|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111483149|NCT00741858|Contraceptive Agents|contraceptive agents|mesh-ancestor
111483150|NCT00741858|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111483151|NCT00741858|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111483152|NCT00742872|Mosapride|mosapride|mesh-list
111483153|NCT00742872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111483154|NCT00742872|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111483155|NCT00742872|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111483156|NCT00742872|Serotonin Agents|serotonin agents|mesh-ancestor
111483157|NCT00742872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111483158|NCT00742872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111483159|NCT00743574|Vitamin D|vitamin d|mesh-list
111483160|NCT00743574|Ergocalciferols|ergocalciferols|mesh-list
111483161|NCT00743574|Cholecalciferol|cholecalciferol|mesh-list
111483162|NCT00743574|Vitamins|vitamins|mesh-list
111483163|NCT00743574|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
111483164|NCT00743574|Medroxyprogesterone|medroxyprogesterone|mesh-list
111483165|NCT00743574|Calcium|calcium|mesh-list
111483166|NCT00743574|Micronutrients|micronutrients|mesh-ancestor
111483167|NCT00743574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111483168|NCT00743574|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111483169|NCT00743574|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111483170|NCT00743574|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111483171|NCT00743574|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111483172|NCT00743574|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111483173|NCT00743574|Contraceptive Agents|contraceptive agents|mesh-ancestor
111483174|NCT00743574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111483175|NCT00743574|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111483176|NCT00743574|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111483177|NCT00743574|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
111483178|NCT00743574|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111483179|NCT00743574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111483180|NCT00743730|Morphine|morphine|mesh-list
111483181|NCT00743730|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111483182|NCT00743730|Narcotics|narcotics|mesh-ancestor
111483183|NCT00743730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111483184|NCT00743730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111483185|NCT00743730|Analgesics|analgesics|mesh-ancestor
111483186|NCT00743730|Sensory System Agents|sensory system agents|mesh-ancestor
111483187|NCT00743730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111483188|NCT00745290|Bupivacaine|bupivacaine|mesh-list
111483189|NCT00745290|Anesthetics, Local|anesthetics, local|mesh-ancestor
111483190|NCT00745290|Anesthetics|anesthetics|mesh-ancestor
111483191|NCT00745290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111483192|NCT00745290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111483193|NCT00745290|Sensory System Agents|sensory system agents|mesh-ancestor
111483194|NCT00745290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110691236|NCT04249544|Dopamine Agonists|dopamine agonists|mesh-ancestor
111483195|NCT00751530|Raltegravir Potassium|raltegravir potassium|mesh-list
111483196|NCT00751530|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111102656|NCT05499117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111483197|NCT00751530|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111483198|NCT00751530|Antiviral Agents|antiviral agents|mesh-ancestor
111483199|NCT00751530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111483200|NCT00751530|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111483201|NCT00751530|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111483202|NCT00751530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111483203|NCT00751530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111483204|NCT00753636|Isradipine|isradipine|mesh-list
111483205|NCT00753636|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111483206|NCT00753636|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111483207|NCT00753636|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111483208|NCT00753636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111483209|NCT00753636|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111483210|NCT00753636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111483211|NCT00753636|Vasodilator Agents|vasodilator agents|mesh-ancestor
111483212|NCT00754494|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111483213|NCT00754494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111483214|NCT00754494|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111483215|NCT00754494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111483216|NCT00754494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111483217|NCT00755040|Cyclosporine|cyclosporine|mesh-list
111483218|NCT00755040|Cyclosporins|cyclosporins|mesh-list
111483219|NCT00755040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111483220|NCT00755040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111483221|NCT00755040|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111483222|NCT00755040|Immunologic Factors|immunologic factors|mesh-ancestor
111483223|NCT00755040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111483224|NCT00755040|Antifungal Agents|antifungal agents|mesh-ancestor
111483225|NCT00755040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111483226|NCT00755040|Dermatologic Agents|dermatologic agents|mesh-ancestor
111483227|NCT00755040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111483228|NCT00755040|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111483229|NCT00755274|Vaccines|vaccines|mesh-list
111483230|NCT00755274|Immunologic Factors|immunologic factors|mesh-ancestor
111483231|NCT00755274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111483232|NCT00756600|Anesthetics|anesthetics|mesh-list
111483233|NCT00756600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111483234|NCT00756600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111483235|NCT00756678|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111483236|NCT00756678|Lubricant Eye Drops|lubricant eye drops|mesh-list
111483237|NCT00756678|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111483238|NCT00758784|Bromfenac|bromfenac|mesh-list
111483239|NCT00758784|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111483240|NCT00758784|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111483241|NCT00758784|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111483242|NCT00758784|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111483243|NCT00758784|Analgesics|analgesics|mesh-ancestor
111483244|NCT00758784|Sensory System Agents|sensory system agents|mesh-ancestor
111483245|NCT00758784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111483246|NCT00758784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111483247|NCT00758784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111483248|NCT00758784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111483249|NCT00759330|Flurbiprofen|flurbiprofen|mesh-list
111483250|NCT00759330|Analgesics|analgesics|mesh-ancestor
111483251|NCT00759330|Sensory System Agents|sensory system agents|mesh-ancestor
111483252|NCT00759330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111483253|NCT00759330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111483254|NCT00759330|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111483255|NCT00759330|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111483256|NCT00759330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111483257|NCT00759330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111483258|NCT00759330|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111483259|NCT00759330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110645620|NCT04990323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111483260|NCT00759330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111483261|NCT00759408|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
111483262|NCT00759408|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111483263|NCT00759408|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
111483264|NCT00759408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111483265|NCT00759642|Lapatinib|lapatinib|mesh-list
111483266|NCT00759642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111483267|NCT00759642|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111483268|NCT00759642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111483269|NCT00759642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111483270|NCT00759798|Cyclophosphamide|cyclophosphamide|mesh-list
111483271|NCT00759798|Rituximab|rituximab|mesh-list
111483272|NCT00759798|Fludarabine|fludarabine|mesh-list
111483273|NCT00759798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111483274|NCT00759798|Immunologic Factors|immunologic factors|mesh-ancestor
111483275|NCT00759798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111483276|NCT00759798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111483277|NCT00759798|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111483278|NCT00759798|Alkylating Agents|alkylating agents|mesh-ancestor
111483279|NCT00759798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111483280|NCT00759798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111483281|NCT00759798|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111483282|NCT00759798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111483283|NCT00760578|Pioglitazone|pioglitazone|mesh-list
111483284|NCT00760578|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111483285|NCT00760578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111483286|NCT00761202|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
111483287|NCT00761202|Hyaluronic Acid|hyaluronic acid|mesh-list
111483288|NCT00761202|Glycerol|glycerol|mesh-list
111483289|NCT00761202|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111483290|NCT00761202|Immunologic Factors|immunologic factors|mesh-ancestor
111483291|NCT00761202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111483292|NCT00761202|Viscosupplements|viscosupplements|mesh-ancestor
111483293|NCT00761202|Protective Agents|protective agents|mesh-ancestor
111483294|NCT00761202|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
111483295|NCT00761202|Laxatives|laxatives|mesh-ancestor
111483296|NCT00761202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111483297|NCT00761592|Botulinum Toxins|botulinum toxins|mesh-list
111483298|NCT00761592|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111483299|NCT00761592|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111483300|NCT00761592|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111483301|NCT00761592|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111483302|NCT00761592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111483303|NCT00761592|Cholinergic Agents|cholinergic agents|mesh-ancestor
111483304|NCT00761592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111483305|NCT00761592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111483306|NCT00761592|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111483307|NCT00761592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111483308|NCT00762450|Triclosan|triclosan|mesh-list
111483309|NCT00762450|Fluorides|fluorides|mesh-list
111483310|NCT00762450|Cariostatic Agents|cariostatic agents|mesh-ancestor
111483311|NCT00762450|Protective Agents|protective agents|mesh-ancestor
111483312|NCT00762450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111483313|NCT00762450|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111483314|NCT00762450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111483315|NCT00762450|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
111483316|NCT00762450|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111483317|NCT00762450|Antimetabolites|antimetabolites|mesh-ancestor
111483318|NCT00762450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111483319|NCT00762450|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111483320|NCT00762528|Triclosan|triclosan|mesh-list
111483321|NCT00762528|Fluorides|fluorides|mesh-list
111483322|NCT00762528|Fluorophosphate|fluorophosphate|mesh-list
111483323|NCT00762528|Cariostatic Agents|cariostatic agents|mesh-ancestor
111483324|NCT00762528|Protective Agents|protective agents|mesh-ancestor
111483325|NCT00762528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111483326|NCT00762528|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111483327|NCT00762528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111483328|NCT00762528|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
111483329|NCT00762528|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111483330|NCT00762528|Antimetabolites|antimetabolites|mesh-ancestor
111483331|NCT00762528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111483332|NCT00762528|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111483333|NCT00765648|Labetalol|labetalol|mesh-list
111483334|NCT00765648|Nicardipine|nicardipine|mesh-list
111483335|NCT00765648|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111483336|NCT00765648|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111483337|NCT00765648|Adrenergic Agents|adrenergic agents|mesh-ancestor
111483338|NCT00765648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111483339|NCT00765648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111483340|NCT00765648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111483341|NCT00765648|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111483342|NCT00765648|Sympathomimetics|sympathomimetics|mesh-ancestor
111483343|NCT00765648|Autonomic Agents|autonomic agents|mesh-ancestor
110409235|NCT02213328|Tenofovir|tenofovir|mesh-list
111483344|NCT00765648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111483345|NCT00765648|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111483346|NCT00765648|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111483347|NCT00765648|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111483348|NCT00765648|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111483349|NCT00765648|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111483350|NCT00765648|Vasodilator Agents|vasodilator agents|mesh-ancestor
111483351|NCT00766116|Azacitidine|azacitidine|mesh-list
111483353|NCT00766116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111483354|NCT00766116|Antimetabolites|antimetabolites|mesh-ancestor
111483355|NCT00766116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111483356|NCT00766116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111483357|NCT00766116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111483358|NCT00766116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111483359|NCT00766116|Immunotoxins|immunotoxins|mesh-ancestor
111483360|NCT00766116|Immunoconjugates|immunoconjugates|mesh-ancestor
111483361|NCT00766116|Immunologic Factors|immunologic factors|mesh-ancestor
111483362|NCT00766116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111483363|NCT00767364|Vaccines|vaccines|mesh-list
111483364|NCT00767364|Immunologic Factors|immunologic factors|mesh-ancestor
111483365|NCT00767364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111483366|NCT00769314|Acyclovir|acyclovir|mesh-list
111483367|NCT00769314|Antiviral Agents|antiviral agents|mesh-ancestor
111483368|NCT00769314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111483369|NCT00769392|Lidocaine|lidocaine|mesh-list
111483370|NCT00769392|Tetracaine|tetracaine|mesh-list
111483371|NCT00769392|Proxymetacaine|proxymetacaine|mesh-list
111483372|NCT00769392|Anesthetics, Local|anesthetics, local|mesh-ancestor
111483373|NCT00769392|Anesthetics|anesthetics|mesh-ancestor
111483374|NCT00769392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111483375|NCT00769392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111483376|NCT00769392|Sensory System Agents|sensory system agents|mesh-ancestor
111483377|NCT00769392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111483378|NCT00769392|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111483379|NCT00769392|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111483380|NCT00769392|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111483381|NCT00769392|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111483382|NCT00769392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111483383|NCT00770874|Cisplatin|cisplatin|mesh-list
111483384|NCT00770874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111483385|NCT00772590|Raltegravir Potassium|raltegravir potassium|mesh-list
111483386|NCT00772590|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111483387|NCT00772590|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111483388|NCT00772590|Antiviral Agents|antiviral agents|mesh-ancestor
111483389|NCT00772590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111483390|NCT00772590|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111483391|NCT00772590|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111483392|NCT00772590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111483393|NCT00772590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111483394|NCT00775944|Nicotine|nicotine|mesh-list
111483395|NCT00775944|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111483396|NCT00775944|Autonomic Agents|autonomic agents|mesh-ancestor
111483397|NCT00775944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111483398|NCT00775944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111483399|NCT00775944|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111483400|NCT00775944|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111483401|NCT00775944|Cholinergic Agents|cholinergic agents|mesh-ancestor
111483402|NCT00775944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111483403|NCT00775944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111483404|NCT00780234|Pioglitazone|pioglitazone|mesh-list
111483405|NCT00780234|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111483406|NCT00780234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111483407|NCT00784524|Aldesleukin|aldesleukin|mesh-list
111483408|NCT00784524|Interleukin-2|interleukin-2|mesh-list
111483409|NCT00784524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111483410|NCT00784524|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111483411|NCT00784524|Analgesics|analgesics|mesh-ancestor
111483412|NCT00784524|Sensory System Agents|sensory system agents|mesh-ancestor
111483413|NCT00784524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111483414|NCT00784524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111483415|NCT00784524|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111483416|NCT00784524|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111483417|NCT00784524|Antiviral Agents|antiviral agents|mesh-ancestor
111102657|NCT05499117|Serotonin Agents|serotonin agents|mesh-ancestor
110691462|NCT00265330|Ziprasidone|ziprasidone|mesh-list
111102658|NCT05499117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111483418|NCT00784524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111483420|NCT00785772|Analgesics|analgesics|mesh-ancestor
111483421|NCT00785772|Sensory System Agents|sensory system agents|mesh-ancestor
111483422|NCT00785772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111483423|NCT00785772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111483424|NCT00785772|Anticonvulsants|anticonvulsants|mesh-ancestor
111483425|NCT00785772|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111483426|NCT00785772|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111483427|NCT00785772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111483428|NCT00785772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111483429|NCT00785772|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111483430|NCT00785772|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111483431|NCT00785772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111483432|NCT00785772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111483433|NCT00785772|Antimanic Agents|antimanic agents|mesh-ancestor
111483434|NCT00787332|Desirudin|desirudin|mesh-list
111483435|NCT00787332|Argatroban|argatroban|mesh-list
111483436|NCT00787332|Antithrombins|antithrombins|mesh-ancestor
111483437|NCT00787332|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111483438|NCT00787332|Protease Inhibitors|protease inhibitors|mesh-ancestor
111483439|NCT00787332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111483440|NCT00787332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111483441|NCT00787332|Anticoagulants|anticoagulants|mesh-ancestor
111483442|NCT00787332|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111483443|NCT00787332|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111483444|NCT00787332|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111483445|NCT00787722|Methylprednisolone|methylprednisolone|mesh-list
111483446|NCT00787722|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111483447|NCT00787722|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111483448|NCT00787722|Prednisolone|prednisolone|mesh-list
111483449|NCT00787722|Prednisolone acetate|prednisolone acetate|mesh-list
111483450|NCT00787722|Cyclophosphamide|cyclophosphamide|mesh-list
111483451|NCT00787722|Rituximab|rituximab|mesh-list
111483452|NCT00787722|Thymoglobulin|thymoglobulin|mesh-list
111483453|NCT00787722|Antilymphocyte Serum|antilymphocyte serum|mesh-list
111483454|NCT00787722|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111483455|NCT00787722|Prednisolone phosphate|prednisolone phosphate|mesh-list
111483456|NCT00787722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111483457|NCT00787722|Immunologic Factors|immunologic factors|mesh-ancestor
111483458|NCT00787722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111483459|NCT00787722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111483460|NCT00787722|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111483461|NCT00787722|Alkylating Agents|alkylating agents|mesh-ancestor
111483462|NCT00787722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111483463|NCT00787722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111483464|NCT00787722|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111483465|NCT00787722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111483466|NCT00787722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111483467|NCT00787722|Antiemetics|antiemetics|mesh-ancestor
111483468|NCT00787722|Autonomic Agents|autonomic agents|mesh-ancestor
111483469|NCT00787722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111483470|NCT00787722|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111483471|NCT00787722|Glucocorticoids|glucocorticoids|mesh-ancestor
111483472|NCT00787722|Hormones|hormones|mesh-ancestor
111483473|NCT00787722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111483474|NCT00787722|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111483475|NCT00787722|Protective Agents|protective agents|mesh-ancestor
111483476|NCT00787722|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111483477|NCT00788892|Cytarabine|cytarabine|mesh-list
111483478|NCT00788892|Daunorubicin|daunorubicin|mesh-list
111483479|NCT00788892|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111483480|NCT00788892|Antimetabolites|antimetabolites|mesh-ancestor
111483481|NCT00788892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111483482|NCT00788892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111483483|NCT00788892|Antiviral Agents|antiviral agents|mesh-ancestor
111483484|NCT00788892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111483485|NCT00788892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111483486|NCT00788892|Immunologic Factors|immunologic factors|mesh-ancestor
111483487|NCT00788892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111483488|NCT00788892|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111483489|NCT00788892|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111102659|NCT05499117|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110691539|NCT00541385|Schistosomicides|schistosomicides|mesh-ancestor
111102660|NCT05499117|Antidepressive Agents|antidepressive agents|mesh-ancestor
111102661|NCT05499117|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111483490|NCT00788892|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111483491|NCT00788892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111483492|NCT00789672|Levodopa|levodopa|mesh-list
111483493|NCT00789672|Carbidopa|carbidopa|mesh-list
111483494|NCT00789672|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111483495|NCT00789672|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111483496|NCT00789672|Dopamine Agents|dopamine agents|mesh-ancestor
111483497|NCT00789672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111483498|NCT00789672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111483499|NCT00789672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111483500|NCT00789672|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
111483501|NCT00789672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111483502|NCT00789750|Pioglitazone|pioglitazone|mesh-list
111483503|NCT00789750|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
111483504|NCT00789750|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111483505|NCT00789750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111483506|NCT00789750|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111483507|NCT00789750|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111483508|NCT00789750|Antimetabolites|antimetabolites|mesh-ancestor
111483509|NCT00789750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111483510|NCT00789750|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111483511|NCT00790062|Oxytocin|oxytocin|mesh-list
111483512|NCT00790062|Oxytocics|oxytocics|mesh-ancestor
111483513|NCT00790062|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111483514|NCT00790062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111483515|NCT00793572|Cyclosporine|cyclosporine|mesh-list
111483516|NCT00793572|Mycophenolic Acid|mycophenolic acid|mesh-list
111483517|NCT00793572|Fludarabine|fludarabine|mesh-list
111483518|NCT00793572|Fludarabine phosphate|fludarabine phosphate|mesh-list
111483519|NCT00793572|Bortezomib|bortezomib|mesh-list
111483520|NCT00793572|Melphalan|melphalan|mesh-list
111483521|NCT00793572|Mechlorethamine|mechlorethamine|mesh-list
111483522|NCT00793572|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
111483523|NCT00793572|Cyclosporins|cyclosporins|mesh-list
111483524|NCT00793572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111483525|NCT00793572|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111483526|NCT00793572|Antimetabolites|antimetabolites|mesh-ancestor
111483527|NCT00793572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111483528|NCT00793572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111483529|NCT00793572|Immunologic Factors|immunologic factors|mesh-ancestor
111483530|NCT00793572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111483531|NCT00793572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111483532|NCT00793572|Antifungal Agents|antifungal agents|mesh-ancestor
111483533|NCT00793572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111483534|NCT00793572|Dermatologic Agents|dermatologic agents|mesh-ancestor
111483535|NCT00793572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111483536|NCT00793572|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111483537|NCT00793572|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111483538|NCT00793572|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111483539|NCT00793572|Antitubercular Agents|antitubercular agents|mesh-ancestor
111483540|NCT00793572|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111483541|NCT00793572|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111483542|NCT00793572|Alkylating Agents|alkylating agents|mesh-ancestor
111483543|NCT00793572|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111483544|NCT00793650|Bortezomib|bortezomib|mesh-list
111483545|NCT00793650|Melphalan|melphalan|mesh-list
111483546|NCT00793650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111483547|NCT00793650|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111483548|NCT00793650|Alkylating Agents|alkylating agents|mesh-ancestor
111483549|NCT00793650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111483550|NCT00793650|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111483551|NCT00793650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111483552|NCT00793650|Immunologic Factors|immunologic factors|mesh-ancestor
111483553|NCT00793650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111483554|NCT00795210|Hormones|hormones|mesh-list
111483555|NCT00795210|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
111483556|NCT00795210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111483557|NCT00795210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111483558|NCT00795288|Simvastatin|simvastatin|mesh-list
111102662|NCT05499117|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111483559|NCT00795288|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111483560|NCT00795288|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111483561|NCT00795288|Antimetabolites|antimetabolites|mesh-ancestor
111483562|NCT00795288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111102663|NCT05499117|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111483563|NCT00795288|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111483564|NCT00795288|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111483565|NCT00795288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111483566|NCT00795366|Vasopressins|vasopressins|mesh-list
111483567|NCT00795366|Arginine Vasopressin|arginine vasopressin|mesh-list
111483568|NCT00795366|Hemostatics|hemostatics|mesh-ancestor
111483569|NCT00795366|Coagulants|coagulants|mesh-ancestor
111483570|NCT00795366|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111483571|NCT00795366|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
111483572|NCT00795366|Natriuretic Agents|natriuretic agents|mesh-ancestor
111483573|NCT00795366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111483574|NCT00796302|Risperidone|risperidone|mesh-list
111483575|NCT00796302|Methylphenidate|methylphenidate|mesh-list
111483576|NCT00796302|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111483577|NCT00796302|Serotonin Agents|serotonin agents|mesh-ancestor
111483578|NCT00796302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111483579|NCT00796302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111483580|NCT00796302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111483581|NCT00796302|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111483582|NCT00796302|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111483583|NCT00796302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111483584|NCT00796302|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111483585|NCT00796302|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111483586|NCT00796302|Dopamine Agents|dopamine agents|mesh-ancestor
111483587|NCT00796302|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111483588|NCT00796302|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111483589|NCT00796302|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111483590|NCT00796302|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111483591|NCT00796926|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111483592|NCT00796926|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111483593|NCT00798018|Lidocaine|lidocaine|mesh-list
111483594|NCT00798018|Tetracaine|tetracaine|mesh-list
111483595|NCT00798018|Anesthetics, Local|anesthetics, local|mesh-ancestor
111483596|NCT00798018|Anesthetics|anesthetics|mesh-ancestor
111483597|NCT00798018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111483598|NCT00798018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111483599|NCT00798018|Sensory System Agents|sensory system agents|mesh-ancestor
111483600|NCT00798018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111483601|NCT00798018|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111483602|NCT00798018|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111483603|NCT00798018|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111483604|NCT00798018|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111483605|NCT00798018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111483606|NCT00798720|Bortezomib|bortezomib|mesh-list
111483607|NCT00798720|Vorinostat|vorinostat|mesh-list
111483608|NCT00798720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111483609|NCT00798720|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111483610|NCT00798720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111483611|NCT00798720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111483612|NCT00799578|Cysteamine|cysteamine|mesh-list
111483613|NCT00799578|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
111483614|NCT00799578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111483615|NCT00799812|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
111483616|NCT00799812|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111483617|NCT00799812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111483618|NCT00799812|Dermatologic Agents|dermatologic agents|mesh-ancestor
111483619|NCT00801138|Dexamethasone|dexamethasone|mesh-list
111483620|NCT00801138|Bupivacaine|bupivacaine|mesh-list
111483621|NCT00801138|Ropivacaine|ropivacaine|mesh-list
111483622|NCT00801138|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111483623|NCT00801138|Antiemetics|antiemetics|mesh-ancestor
111483624|NCT00801138|Autonomic Agents|autonomic agents|mesh-ancestor
111483625|NCT00801138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111483626|NCT00801138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111483627|NCT00801138|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111483628|NCT00801138|Glucocorticoids|glucocorticoids|mesh-ancestor
111483629|NCT00801138|Hormones|hormones|mesh-ancestor
111483630|NCT00801138|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111483631|NCT00801138|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111483632|NCT00801138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111483633|NCT00801138|Anesthetics, Local|anesthetics, local|mesh-ancestor
111483634|NCT00801138|Anesthetics|anesthetics|mesh-ancestor
111483635|NCT00801138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111483636|NCT00801138|Sensory System Agents|sensory system agents|mesh-ancestor
111483637|NCT00801684|Triptorelin Pamoate|triptorelin pamoate|mesh-list
111483638|NCT00801684|Formoterol Fumarate|formoterol fumarate|mesh-list
111483639|NCT00801684|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111483640|NCT00801684|Autonomic Agents|autonomic agents|mesh-ancestor
111483641|NCT00801684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111483642|NCT00801684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111483643|NCT00801684|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111483644|NCT00801684|Respiratory System Agents|respiratory system agents|mesh-ancestor
111483645|NCT00801684|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111483646|NCT00801684|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111483647|NCT00801684|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111483648|NCT00801684|Adrenergic Agents|adrenergic agents|mesh-ancestor
111483649|NCT00801684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111483650|NCT00801684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111483651|NCT00801684|Luteolytic Agents|luteolytic agents|mesh-ancestor
111483652|NCT00801684|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111483653|NCT00801684|Contraceptive Agents|contraceptive agents|mesh-ancestor
111483654|NCT00801684|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111483655|NCT00801684|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111483656|NCT00801684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111483657|NCT00801684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111483658|NCT00803010|Sirolimus|sirolimus|mesh-list
111483659|NCT00803010|Methotrexate|methotrexate|mesh-list
111483660|NCT00803010|Tacrolimus|tacrolimus|mesh-list
111483661|NCT00803010|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111483662|NCT00803010|Abortifacient Agents|abortifacient agents|mesh-ancestor
111483663|NCT00803010|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111483664|NCT00803010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111483665|NCT00803010|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111483666|NCT00803010|Antimetabolites|antimetabolites|mesh-ancestor
111483667|NCT00803010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111483668|NCT00803010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111483669|NCT00803010|Dermatologic Agents|dermatologic agents|mesh-ancestor
111483670|NCT00803010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111483671|NCT00803010|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111483672|NCT00803010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111483673|NCT00803010|Immunologic Factors|immunologic factors|mesh-ancestor
111483674|NCT00803010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111483675|NCT00803010|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111483676|NCT00803010|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111483677|NCT00803010|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111483678|NCT00803010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111483679|NCT00803010|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111483680|NCT00803010|Antifungal Agents|antifungal agents|mesh-ancestor
111483681|NCT00803400|Alprazolam|alprazolam|mesh-list
111483682|NCT00803400|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111483683|NCT00803400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111483684|NCT00803400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111483685|NCT00803400|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111483686|NCT00803400|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111483687|NCT00803400|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111483688|NCT00803400|GABA Modulators|gaba modulators|mesh-ancestor
111483689|NCT00803400|GABA Agents|gaba agents|mesh-ancestor
111483690|NCT00803400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111483691|NCT00803400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111483692|NCT00804648|Timolol|timolol|mesh-list
111483693|NCT00804648|Maleic acid|maleic acid|mesh-list
111483694|NCT00804648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111483695|NCT00804648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111483696|NCT00804648|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111483697|NCT00804648|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111483698|NCT00804648|Adrenergic Agents|adrenergic agents|mesh-ancestor
111483699|NCT00804648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111483700|NCT00804648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111483701|NCT00804648|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111483702|NCT00804648|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111483703|NCT00806598|Cyclosporine|cyclosporine|mesh-list
111483704|NCT00806598|Methylprednisolone|methylprednisolone|mesh-list
111483705|NCT00806598|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111483706|NCT00806598|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111483707|NCT00806598|Prednisolone|prednisolone|mesh-list
111483708|NCT00806598|Prednisolone acetate|prednisolone acetate|mesh-list
111483709|NCT00806598|Cyclosporins|cyclosporins|mesh-list
111483710|NCT00806598|Thymoglobulin|thymoglobulin|mesh-list
111483711|NCT00806598|Antilymphocyte Serum|antilymphocyte serum|mesh-list
111102664|NCT05499117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111102665|NCT05498337|Calcium|calcium|mesh-list
111483712|NCT00806598|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111483713|NCT00806598|Prednisolone phosphate|prednisolone phosphate|mesh-list
111483714|NCT00806598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111483715|NCT00806598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111483716|NCT00806598|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111483717|NCT00806598|Immunologic Factors|immunologic factors|mesh-ancestor
111483718|NCT00806598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111483719|NCT00806598|Antifungal Agents|antifungal agents|mesh-ancestor
111483720|NCT00806598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111483721|NCT00806598|Dermatologic Agents|dermatologic agents|mesh-ancestor
111483722|NCT00806598|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111483723|NCT00806598|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111483724|NCT00806598|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111483725|NCT00806598|Antiemetics|antiemetics|mesh-ancestor
111483726|NCT00806598|Autonomic Agents|autonomic agents|mesh-ancestor
111483727|NCT00806598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111483728|NCT00806598|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111483729|NCT00806598|Glucocorticoids|glucocorticoids|mesh-ancestor
111483730|NCT00806598|Hormones|hormones|mesh-ancestor
111483731|NCT00806598|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111483732|NCT00806598|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111483733|NCT00806598|Protective Agents|protective agents|mesh-ancestor
111483734|NCT00806598|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111483735|NCT00806598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111483736|NCT00807768|Paclitaxel|paclitaxel|mesh-list
111483737|NCT00807768|Carboplatin|carboplatin|mesh-list
111483738|NCT00807768|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111483739|NCT00807768|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111483740|NCT00807768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111483741|NCT00807768|Tubulin Modulators|tubulin modulators|mesh-ancestor
111483742|NCT00807768|Antimitotic Agents|antimitotic agents|mesh-ancestor
111483743|NCT00807768|Mitosis Modulators|mitosis modulators|mesh-ancestor
111483744|NCT00807768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111483745|NCT00808470|Beta Carotene|beta carotene|mesh-list
111483746|NCT00808470|Carotenoids|carotenoids|mesh-list
111483747|NCT00808470|Vitamins|vitamins|mesh-ancestor
111483748|NCT00808470|Micronutrients|micronutrients|mesh-ancestor
111483749|NCT00808470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111483750|NCT00808470|Antioxidants|antioxidants|mesh-ancestor
111483751|NCT00808470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111483752|NCT00808470|Protective Agents|protective agents|mesh-ancestor
111483753|NCT00808470|Provitamins|provitamins|mesh-ancestor
111483754|NCT00810576|Bortezomib|bortezomib|mesh-list
111483755|NCT00810576|Vorinostat|vorinostat|mesh-list
111483756|NCT00810576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111483757|NCT00810576|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111483758|NCT00810576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111483759|NCT00810576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111483760|NCT00811434|Lactulose|lactulose|mesh-list
111483761|NCT00811434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111483762|NCT00812604|Analgesics|analgesics|mesh-list
111483763|NCT00812604|Petrolatum|petrolatum|mesh-list
111483764|NCT00812604|Sensory System Agents|sensory system agents|mesh-ancestor
111483765|NCT00812604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111483766|NCT00812604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111483767|NCT00812604|Emollients|emollients|mesh-ancestor
111483768|NCT00812604|Dermatologic Agents|dermatologic agents|mesh-ancestor
111483769|NCT00812838|Botulinum Toxins|botulinum toxins|mesh-list
111483770|NCT00812838|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111483771|NCT00812838|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111483772|NCT00812838|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111483773|NCT00812838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110321281|NCT00338312|Hormones|hormones|mesh-ancestor
111483774|NCT00812838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111483775|NCT00812838|Cholinergic Agents|cholinergic agents|mesh-ancestor
111483776|NCT00812838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111483777|NCT00812838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111483778|NCT00812838|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111483779|NCT00812838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111483780|NCT00814788|Everolimus|everolimus|mesh-list
111483781|NCT00814788|Bicalutamide|bicalutamide|mesh-list
111483782|NCT00814788|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111483783|NCT00814788|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111483784|NCT00814788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111483785|NCT00814788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111483786|NCT00814788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111119167|NCT05306873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111483787|NCT00814788|Immunologic Factors|immunologic factors|mesh-ancestor
111483788|NCT00814788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111483789|NCT00814788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111483790|NCT00814788|Androgen Antagonists|androgen antagonists|mesh-ancestor
111483791|NCT00814788|Hormone Antagonists|hormone antagonists|mesh-ancestor
111483792|NCT00814788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111483794|NCT00820872|Docetaxel|docetaxel|mesh-list
111483795|NCT00820872|Trastuzumab|trastuzumab|mesh-list
111483796|NCT00820872|Lapatinib|lapatinib|mesh-list
111483797|NCT00820872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111483798|NCT00820872|Tubulin Modulators|tubulin modulators|mesh-ancestor
111483799|NCT00820872|Antimitotic Agents|antimitotic agents|mesh-ancestor
111483800|NCT00820872|Mitosis Modulators|mitosis modulators|mesh-ancestor
111483801|NCT00820872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111483802|NCT00820872|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111483803|NCT00820872|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111483804|NCT00820872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111483805|NCT00821184|Solifenacin Succinate|solifenacin succinate|mesh-list
111483806|NCT00821184|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111483807|NCT00821184|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111483808|NCT00821184|Cholinergic Agents|cholinergic agents|mesh-ancestor
111483809|NCT00821184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111483810|NCT00821184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111483811|NCT00821184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111483812|NCT00821184|Urological Agents|urological agents|mesh-ancestor
111483813|NCT05206812|Durvalumab|durvalumab|mesh-list
111483814|NCT05206812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111483815|NCT05206812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111483816|NCT05131152|Cyclosporine|cyclosporine|mesh-list
111483817|NCT05131152|Cyclosporins|cyclosporins|mesh-list
111483818|NCT05131152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111483819|NCT05131152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111483820|NCT05131152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111483821|NCT05131152|Immunologic Factors|immunologic factors|mesh-ancestor
111483822|NCT05131152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111483823|NCT05131152|Antifungal Agents|antifungal agents|mesh-ancestor
111483824|NCT05131152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111483825|NCT05131152|Dermatologic Agents|dermatologic agents|mesh-ancestor
111483826|NCT05131152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111483827|NCT05131152|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111483828|NCT04900116|Bupivacaine|bupivacaine|mesh-list
111483829|NCT04900116|Anesthetics, Local|anesthetics, local|mesh-ancestor
111483830|NCT04900116|Anesthetics|anesthetics|mesh-ancestor
111483831|NCT04900116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111483832|NCT04900116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111483833|NCT04900116|Sensory System Agents|sensory system agents|mesh-ancestor
111483834|NCT04900116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111483835|NCT04603248|Nivolumab|nivolumab|mesh-list
111483836|NCT04603248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111483837|NCT04603248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111483838|NCT04603248|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111483839|NCT04603248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111483840|NCT03936270|Letrozole|letrozole|mesh-list
111483841|NCT03936270|Palbociclib|palbociclib|mesh-list
111483842|NCT03936270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111483843|NCT03936270|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111483844|NCT03936270|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111483845|NCT03936270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111483846|NCT03936270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111483847|NCT03936270|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111483848|NCT03936270|Hormone Antagonists|hormone antagonists|mesh-ancestor
111483849|NCT03936270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111483850|NCT03936270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111483851|NCT03936270|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111483852|NCT03763656|Hydroxyurea|hydroxyurea|mesh-list
111483853|NCT03763656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111483854|NCT03763656|Antisickling Agents|antisickling agents|mesh-ancestor
111483855|NCT03763656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111483856|NCT03763656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111483857|NCT03763656|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111483858|NCT02682888|Oxytocin|oxytocin|mesh-list
111483859|NCT02682888|Oxytocics|oxytocics|mesh-ancestor
111483860|NCT02682888|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111483861|NCT02682888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111483863|NCT02641236|Polymyxins|polymyxins|mesh-list
111483864|NCT02641236|Polymyxin B|polymyxin b|mesh-list
111483865|NCT02641236|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111483866|NCT02641236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111483867|NCT00142272|Ciprofloxacin|ciprofloxacin|mesh-list
111483868|NCT00142272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111483869|NCT00142272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111483870|NCT00142272|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111483871|NCT00142272|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111483872|NCT00142272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111483873|NCT00142272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111483874|NCT00142272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111483875|NCT00142272|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111483876|NCT00142272|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111483877|NCT00821886|Carboplatin|carboplatin|mesh-list
111483878|NCT00821886|Trastuzumab|trastuzumab|mesh-list
111483879|NCT00821886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111483880|NCT00821886|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111483881|NCT00821964|Paclitaxel|paclitaxel|mesh-list
111483882|NCT00821964|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111483883|NCT00821964|Imiquimod|imiquimod|mesh-list
111483884|NCT00821964|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111483885|NCT00821964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111483886|NCT00821964|Tubulin Modulators|tubulin modulators|mesh-ancestor
111483887|NCT00821964|Antimitotic Agents|antimitotic agents|mesh-ancestor
111483888|NCT00821964|Mitosis Modulators|mitosis modulators|mesh-ancestor
111483889|NCT00821964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111483890|NCT00821964|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111483891|NCT00821964|Immunologic Factors|immunologic factors|mesh-ancestor
111483892|NCT00821964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111483893|NCT00821964|Interferon Inducers|interferon inducers|mesh-ancestor
111483894|NCT00822354|Tadalafil|tadalafil|mesh-list
111483895|NCT00822354|Vasodilator Agents|vasodilator agents|mesh-ancestor
111483896|NCT00822354|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111483897|NCT00822354|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111483898|NCT00822354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111483899|NCT00822354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111483900|NCT00822354|Urological Agents|urological agents|mesh-ancestor
111483901|NCT00824070|Moxifloxacin|moxifloxacin|mesh-list
111483902|NCT00824070|Gatifloxacin|gatifloxacin|mesh-list
111483903|NCT00824070|Besifloxacin|besifloxacin|mesh-list
111483904|NCT00824070|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
110645729|NCT04835441|ALPN-101|alpn-101|mesh-list
111483905|NCT00824070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111483906|NCT00824070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111483907|NCT00824070|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111483908|NCT00824070|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111483909|NCT00824070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111483910|NCT00824070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111483911|NCT00824070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111483912|NCT00824070|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111483913|NCT00824070|Contraceptive Agents|contraceptive agents|mesh-ancestor
111483914|NCT00824070|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111483915|NCT00824070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111483916|NCT00824070|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
111483917|NCT00824070|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111483918|NCT00824070|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111483919|NCT00824070|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
111483920|NCT00824070|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111483921|NCT00824460|Iron|iron|mesh-list
111483922|NCT00824460|Sevelamer|sevelamer|mesh-list
111483923|NCT00824460|Trace Elements|trace elements|mesh-ancestor
111483924|NCT00824460|Micronutrients|micronutrients|mesh-ancestor
111483925|NCT00824460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111483926|NCT00824460|Chelating Agents|chelating agents|mesh-ancestor
111483927|NCT00824460|Sequestering Agents|sequestering agents|mesh-ancestor
111483928|NCT00824460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111483929|NCT00824538|Sunitinib|sunitinib|mesh-list
111102666|NCT05498337|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111119168|NCT05306873|Immunologic Factors|immunologic factors|mesh-ancestor
111483930|NCT00824538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111483931|NCT00824538|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111483932|NCT00824538|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111102667|NCT05498337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111483933|NCT00824538|Growth Substances|growth substances|mesh-ancestor
111483934|NCT00824538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111483935|NCT00824538|Growth Inhibitors|growth inhibitors|mesh-ancestor
111483936|NCT00824538|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111483937|NCT00824538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111483938|NCT00824538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111483939|NCT00825786|Ropivacaine|ropivacaine|mesh-list
111483940|NCT00825786|Mepivacaine|mepivacaine|mesh-list
111483941|NCT00825786|Anesthetics, Local|anesthetics, local|mesh-ancestor
111483942|NCT00825786|Anesthetics|anesthetics|mesh-ancestor
111483943|NCT00825786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111483944|NCT00825786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111483945|NCT00825786|Sensory System Agents|sensory system agents|mesh-ancestor
111483946|NCT00825786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111483947|NCT00826800|Bevacizumab|bevacizumab|mesh-list
111483948|NCT00826800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111483949|NCT00826800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111483950|NCT00826800|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111483951|NCT00826800|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111483952|NCT00826800|Growth Substances|growth substances|mesh-ancestor
111483953|NCT00826800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111483954|NCT00826800|Growth Inhibitors|growth inhibitors|mesh-ancestor
111483955|NCT00830076|Metformin|metformin|mesh-list
111483956|NCT00830076|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111483957|NCT00830076|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111483958|NCT00830076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111483959|NCT00830076|Incretins|incretins|mesh-ancestor
111483960|NCT00830076|Hormones|hormones|mesh-ancestor
111483961|NCT00830076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111483962|NCT00830076|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111483963|NCT00830076|Protease Inhibitors|protease inhibitors|mesh-ancestor
111483964|NCT00830076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111483965|NCT00830076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111483966|NCT00830388|Ketoconazole|ketoconazole|mesh-list
111483967|NCT00830388|Antifungal Agents|antifungal agents|mesh-ancestor
111483968|NCT00830388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111483969|NCT00830388|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111483970|NCT00830388|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111483971|NCT00830388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111483972|NCT00830388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111483973|NCT00830388|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111483974|NCT00830388|Hormone Antagonists|hormone antagonists|mesh-ancestor
111483975|NCT00830388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111483976|NCT00830388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111483977|NCT00830388|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111483978|NCT00831480|Everolimus|everolimus|mesh-list
111483979|NCT00831480|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111483980|NCT00831480|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111483981|NCT00831480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111483982|NCT00831480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111483983|NCT00831480|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111483984|NCT00831480|Immunologic Factors|immunologic factors|mesh-ancestor
111483985|NCT00831480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111483986|NCT00831480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111483987|NCT00832338|Dexamethasone|dexamethasone|mesh-list
111483988|NCT00832338|Docetaxel|docetaxel|mesh-list
111483989|NCT00832338|Cyclophosphamide|cyclophosphamide|mesh-list
111483990|NCT00832338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111483991|NCT00832338|Antiemetics|antiemetics|mesh-ancestor
111483992|NCT00832338|Autonomic Agents|autonomic agents|mesh-ancestor
111483993|NCT00832338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111483994|NCT00832338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111483995|NCT00832338|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111483996|NCT00832338|Glucocorticoids|glucocorticoids|mesh-ancestor
111483997|NCT00832338|Hormones|hormones|mesh-ancestor
111483998|NCT00832338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111483999|NCT00832338|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111484000|NCT00832338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111484001|NCT00832338|Tubulin Modulators|tubulin modulators|mesh-ancestor
111484002|NCT00832338|Antimitotic Agents|antimitotic agents|mesh-ancestor
111484003|NCT00832338|Mitosis Modulators|mitosis modulators|mesh-ancestor
111102668|NCT01663233|Amlodipine|amlodipine|mesh-list
110692055|NCT04573673|Emodin|emodin|mesh-list
111484004|NCT00832338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111484005|NCT00832338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111484006|NCT00832338|Immunologic Factors|immunologic factors|mesh-ancestor
111484007|NCT00832338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111484008|NCT00832338|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111484009|NCT00832338|Alkylating Agents|alkylating agents|mesh-ancestor
111484010|NCT00832338|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111484011|NCT00834210|Nicotinic Acids|nicotinic acids|mesh-list
111484012|NCT00834210|Dapsone|dapsone|mesh-list
111484013|NCT00834210|Tazarotene|tazarotene|mesh-list
111484014|NCT00834210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111484015|NCT00834210|Antimalarials|antimalarials|mesh-ancestor
111484016|NCT00834210|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111484017|NCT00834210|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111484018|NCT00834210|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111484019|NCT00834210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111484020|NCT00834210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111484021|NCT00834210|Leprostatic Agents|leprostatic agents|mesh-ancestor
111484022|NCT00834210|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111484023|NCT00834210|Dermatologic Agents|dermatologic agents|mesh-ancestor
111484024|NCT00834210|Keratolytic Agents|keratolytic agents|mesh-ancestor
111484025|NCT00834210|Vitamin B Complex|vitamin b complex|mesh-ancestor
111484026|NCT00834210|Vitamins|vitamins|mesh-ancestor
111484027|NCT00834210|Micronutrients|micronutrients|mesh-ancestor
111484028|NCT00834210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111484029|NCT00834288|Tramadol|tramadol|mesh-list
111484030|NCT00834288|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111484031|NCT00834288|Narcotics|narcotics|mesh-ancestor
111484032|NCT00834288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111484033|NCT00834288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111484034|NCT00834288|Analgesics|analgesics|mesh-ancestor
111484035|NCT00834288|Sensory System Agents|sensory system agents|mesh-ancestor
111484036|NCT00834288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111484037|NCT00834678|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111484038|NCT00834678|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
111484039|NCT00834678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111484040|NCT00834678|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111484041|NCT00834678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111484042|NCT00834678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111484043|NCT00834678|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111484044|NCT00834678|Alkylating Agents|alkylating agents|mesh-ancestor
111484045|NCT00835224|Midodrine|midodrine|mesh-list
111484046|NCT00835224|Sympathomimetics|sympathomimetics|mesh-ancestor
111484047|NCT00835224|Autonomic Agents|autonomic agents|mesh-ancestor
111484048|NCT00835224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111484049|NCT00835224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111484050|NCT00835224|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111484051|NCT00835224|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111484052|NCT00835224|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111484053|NCT00835224|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111484054|NCT00835224|Adrenergic Agents|adrenergic agents|mesh-ancestor
111484055|NCT00835224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111484056|NCT00835224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111484057|NCT00835926|Vaccines|vaccines|mesh-list
111484058|NCT00835926|Immunologic Factors|immunologic factors|mesh-ancestor
111484059|NCT00835926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111484060|NCT00837252|Finasteride|finasteride|mesh-list
111484061|NCT00837252|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
111484062|NCT00837252|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111484063|NCT00837252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111484064|NCT00837252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111484065|NCT00837252|Hormone Antagonists|hormone antagonists|mesh-ancestor
111484066|NCT00837252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110645768|NCT04770779|Mitapivat|mitapivat|mesh-list
111484067|NCT00837252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111484068|NCT00837252|Urological Agents|urological agents|mesh-ancestor
111484069|NCT00839982|Cytarabine|cytarabine|mesh-list
111484070|NCT00839982|Clofarabine|clofarabine|mesh-list
111484071|NCT00839982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111484072|NCT00839982|Antimetabolites|antimetabolites|mesh-ancestor
111484073|NCT00839982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111484074|NCT00839982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111484075|NCT00839982|Antiviral Agents|antiviral agents|mesh-ancestor
111484076|NCT00839982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111484077|NCT00839982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110692129|NCT00358917|Protease Inhibitors|protease inhibitors|mesh-ancestor
111484078|NCT00839982|Immunologic Factors|immunologic factors|mesh-ancestor
111484079|NCT00839982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111484081|NCT00845130|Ascorbic Acid|ascorbic acid|mesh-list
111484082|NCT00845130|Micronutrients|micronutrients|mesh-ancestor
111484083|NCT00845130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111484084|NCT00845130|Antioxidants|antioxidants|mesh-ancestor
111484085|NCT00845130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111484086|NCT00845130|Protective Agents|protective agents|mesh-ancestor
111484087|NCT00848016|Acetic Acid|acetic acid|mesh-list
111484088|NCT00848016|Retinol acetate|retinol acetate|mesh-list
111484089|NCT00848016|Gossypol acetic acid|gossypol acetic acid|mesh-list
111484090|NCT00848016|Gossypol|gossypol|mesh-list
111484091|NCT00848016|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111484092|NCT00848016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111484093|NCT00848016|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111484094|NCT00848016|Immunologic Factors|immunologic factors|mesh-ancestor
111484095|NCT00848016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111484096|NCT00848016|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
111484097|NCT00848016|Protective Agents|protective agents|mesh-ancestor
111484098|NCT00848016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111484099|NCT00848016|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
111484100|NCT00848016|Contraceptive Agents|contraceptive agents|mesh-ancestor
111484101|NCT00848016|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111484102|NCT00848016|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111484103|NCT00848016|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111484104|NCT00848016|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
111484105|NCT00848016|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
111484106|NCT00849810|Metoprolol|metoprolol|mesh-list
111484107|NCT00849810|Nebivolol|nebivolol|mesh-list
111484108|NCT00849810|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111484109|NCT00849810|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111484110|NCT00849810|Sympatholytics|sympatholytics|mesh-ancestor
111484111|NCT00849810|Autonomic Agents|autonomic agents|mesh-ancestor
111484112|NCT00849810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111484113|NCT00849810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111484114|NCT00849810|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
111484115|NCT00849810|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111484116|NCT00849810|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111484117|NCT00849810|Adrenergic Agents|adrenergic agents|mesh-ancestor
111484118|NCT00849810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111484119|NCT00849810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111484120|NCT00849810|Vasodilator Agents|vasodilator agents|mesh-ancestor
111484121|NCT00849810|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
111484122|NCT00849810|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111484123|NCT00849810|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111484124|NCT00856050|Letrozole|letrozole|mesh-list
111484125|NCT00856050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111484126|NCT00856050|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111484127|NCT00856050|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111484128|NCT00856050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111484129|NCT00856050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111484130|NCT00856050|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111484131|NCT00856050|Hormone Antagonists|hormone antagonists|mesh-ancestor
111484132|NCT00856050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111484133|NCT00856050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111484134|NCT00858468|Vaccines|vaccines|mesh-list
111484135|NCT00858468|Immunologic Factors|immunologic factors|mesh-ancestor
111484136|NCT00858468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111484137|NCT00858858|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
111484138|NCT00858858|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
111484139|NCT00858858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111484140|NCT00866034|Cetrorelix|cetrorelix|mesh-list
111484141|NCT00866034|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111484142|NCT00866034|Fertility Agents|fertility agents|mesh-ancestor
111484143|NCT00866034|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111484144|NCT00866034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111484145|NCT00866034|Hormone Antagonists|hormone antagonists|mesh-ancestor
111484146|NCT00866034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111484147|NCT00868140|Pioglitazone|pioglitazone|mesh-list
111484148|NCT00868140|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111484149|NCT00868140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111484150|NCT00868374|Quetiapine Fumarate|quetiapine fumarate|mesh-list
111484151|NCT00868374|Antidepressive Agents|antidepressive agents|mesh-ancestor
110692207|NCT00445146|Elvitegravir|elvitegravir|mesh-list
111484152|NCT00868374|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111484153|NCT00868374|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111484154|NCT00868374|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111484155|NCT00868374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111484156|NCT00868374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111484157|NCT00868452|Valproic Acid|valproic acid|mesh-list
111484158|NCT00868452|Lithium Carbonate|lithium carbonate|mesh-list
111484159|NCT00868452|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
111484160|NCT00868452|Antidepressive Agents|antidepressive agents|mesh-ancestor
111484161|NCT00868452|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111484162|NCT00868452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111484163|NCT00868452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111484164|NCT00868452|Antimanic Agents|antimanic agents|mesh-ancestor
111484165|NCT00868452|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111484166|NCT00868452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111484167|NCT00868452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111484168|NCT00868452|Anticonvulsants|anticonvulsants|mesh-ancestor
111484169|NCT00868452|GABA Agents|gaba agents|mesh-ancestor
111484170|NCT00868452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111484171|NCT00868452|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111484172|NCT00868452|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
111484173|NCT00868452|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111484174|NCT00868452|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111484175|NCT00868452|Adrenergic Agents|adrenergic agents|mesh-ancestor
111484176|NCT00868452|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111484177|NCT00868452|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111484178|NCT00868452|Serotonin Agents|serotonin agents|mesh-ancestor
111484179|NCT00868452|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111484180|NCT00868452|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111484181|NCT00868452|Dopamine Agents|dopamine agents|mesh-ancestor
111484182|NCT00869622|Vitamin D|vitamin d|mesh-list
111484183|NCT00869622|Risedronic Acid|risedronic acid|mesh-list
111484184|NCT00869622|Calcium|calcium|mesh-list
111484185|NCT00869622|Vitamins|vitamins|mesh-ancestor
111484186|NCT00869622|Micronutrients|micronutrients|mesh-ancestor
111484187|NCT00869622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111484188|NCT00869622|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111484189|NCT00869622|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111484190|NCT00869622|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111484191|NCT00869622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111484192|NCT00869622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111484193|NCT00871260|Regadenoson|regadenoson|mesh-list
111484194|NCT00871260|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
111484195|NCT00871260|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
111484196|NCT00871260|Purinergic Agonists|purinergic agonists|mesh-ancestor
111484197|NCT00871260|Purinergic Agents|purinergic agents|mesh-ancestor
111484198|NCT00871260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111484199|NCT00871260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111484200|NCT00871260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111484201|NCT00874614|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
111484202|NCT00874614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111484203|NCT00874614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111484204|NCT00874614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111484205|NCT00874614|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111484206|NCT00875550|Fentanyl|fentanyl|mesh-list
111484207|NCT00875550|Midazolam|midazolam|mesh-list
111484208|NCT00875550|Dexmedetomidine|dexmedetomidine|mesh-list
111484209|NCT00875550|Morphine|morphine|mesh-list
111484210|NCT00875550|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111484211|NCT00875550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111484212|NCT00875550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111484213|NCT00875550|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111484214|NCT00875550|Analgesics|analgesics|mesh-ancestor
111484215|NCT00875550|Sensory System Agents|sensory system agents|mesh-ancestor
111484216|NCT00875550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111484217|NCT00875550|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111484218|NCT00875550|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111484219|NCT00875550|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111484220|NCT00875550|Adrenergic Agents|adrenergic agents|mesh-ancestor
111484221|NCT00875550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111484222|NCT00875550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111484223|NCT00875550|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111484224|NCT00875550|Narcotics|narcotics|mesh-ancestor
110692277|NCT02534337|Immunologic Factors|immunologic factors|mesh-ancestor
111484225|NCT00875550|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111484226|NCT00875550|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111484227|NCT00875550|Anesthetics, General|anesthetics, general|mesh-ancestor
111484228|NCT00875550|Anesthetics|anesthetics|mesh-ancestor
111484229|NCT00875550|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111484230|NCT00875550|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111484231|NCT00875550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111484232|NCT00875550|GABA Modulators|gaba modulators|mesh-ancestor
111484233|NCT00875550|GABA Agents|gaba agents|mesh-ancestor
111484234|NCT00878436|Bicalutamide|bicalutamide|mesh-list
111484235|NCT00878436|Panobinostat|panobinostat|mesh-list
111484236|NCT00878436|Androgen Antagonists|androgen antagonists|mesh-ancestor
111484237|NCT00878436|Hormone Antagonists|hormone antagonists|mesh-ancestor
111484238|NCT00878436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111484239|NCT00878436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111484240|NCT00878436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111484241|NCT00878436|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111484242|NCT00878436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111484243|NCT00878436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111484244|NCT00878826|Enoxaparin|enoxaparin|mesh-list
111484245|NCT00878826|Anticoagulants|anticoagulants|mesh-ancestor
111484246|NCT00878826|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111484247|NCT00878826|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111484248|NCT00878826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111484249|NCT00879060|Spironolactone|spironolactone|mesh-list
111484250|NCT00879060|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
111484251|NCT00879060|Hormone Antagonists|hormone antagonists|mesh-ancestor
111484252|NCT00879060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111484253|NCT00879060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111484254|NCT00879060|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
111484255|NCT00879060|Diuretics|diuretics|mesh-ancestor
111484256|NCT00879060|Natriuretic Agents|natriuretic agents|mesh-ancestor
111484257|NCT00882102|Decitabine|decitabine|mesh-list
111484258|NCT00882102|Gemtuzumab|gemtuzumab|mesh-list
111484259|NCT00882102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111484260|NCT00882102|Antimetabolites|antimetabolites|mesh-ancestor
111484261|NCT00882102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111484262|NCT00882102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111484263|NCT00882102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111484264|NCT00882102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111484265|NCT00882102|Immunotoxins|immunotoxins|mesh-ancestor
111484266|NCT00882102|Immunoconjugates|immunoconjugates|mesh-ancestor
111484267|NCT00882102|Immunologic Factors|immunologic factors|mesh-ancestor
111484268|NCT00882102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111484269|NCT00884052|Levetiracetam|levetiracetam|mesh-list
111484270|NCT00884052|Anticonvulsants|anticonvulsants|mesh-ancestor
111484271|NCT00884052|Nootropic Agents|nootropic agents|mesh-ancestor
111484272|NCT00886236|Gabapentin|gabapentin|mesh-list
111484273|NCT00886236|Analgesics|analgesics|mesh-ancestor
111102669|NCT01663233|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
111484274|NCT00886236|Sensory System Agents|sensory system agents|mesh-ancestor
111484275|NCT00886236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111484276|NCT00886236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111484277|NCT00886236|Anticonvulsants|anticonvulsants|mesh-ancestor
111484278|NCT00886236|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111484279|NCT00886236|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111484280|NCT00886236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111484281|NCT00886236|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111484282|NCT00886236|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111484283|NCT00886236|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111484284|NCT00886236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111484285|NCT00886236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111484286|NCT00886236|Antimanic Agents|antimanic agents|mesh-ancestor
111484287|NCT00886626|Exenatide|exenatide|mesh-list
111484288|NCT00886626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111484289|NCT00886626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111484290|NCT00886626|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111484291|NCT00886626|Incretins|incretins|mesh-ancestor
111484292|NCT00886626|Hormones|hormones|mesh-ancestor
111484293|NCT00886626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111484294|NCT00887562|Ubiquinone|ubiquinone|mesh-list
111484295|NCT00887562|Idebenone|idebenone|mesh-list
111102670|NCT01663233|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111102671|NCT01663233|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111484296|NCT00887562|Antioxidants|antioxidants|mesh-ancestor
111484297|NCT00887562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111484298|NCT00887562|Protective Agents|protective agents|mesh-ancestor
111102672|NCT01663233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111484299|NCT00887562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111484300|NCT00887562|Micronutrients|micronutrients|mesh-ancestor
111484301|NCT00887640|Diphenhydramine|diphenhydramine|mesh-list
111484302|NCT00887640|Promethazine|promethazine|mesh-list
111484303|NCT00887640|Sirolimus|sirolimus|mesh-list
111484304|NCT00887640|Temsirolimus|temsirolimus|mesh-list
111484305|NCT00887640|MTOR Inhibitors|mtor inhibitors|mesh-list
111484306|NCT00887640|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111484307|NCT00887640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111484308|NCT00887640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111484309|NCT00887640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111484310|NCT00887640|Immunologic Factors|immunologic factors|mesh-ancestor
111484311|NCT00887640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111484312|NCT00887640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111484313|NCT00887640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111484314|NCT00887640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111484315|NCT00887640|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111484316|NCT00887640|Antifungal Agents|antifungal agents|mesh-ancestor
111484317|NCT00887640|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111484318|NCT00887640|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111484319|NCT00887640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111484320|NCT00887640|Anesthetics, Local|anesthetics, local|mesh-ancestor
111484321|NCT00887640|Anesthetics|anesthetics|mesh-ancestor
111484322|NCT00887640|Sensory System Agents|sensory system agents|mesh-ancestor
111484323|NCT00887640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111484324|NCT00887640|Antiemetics|antiemetics|mesh-ancestor
111484325|NCT00887640|Autonomic Agents|autonomic agents|mesh-ancestor
111484326|NCT00887640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111484327|NCT00887640|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111484328|NCT00887640|Histamine Antagonists|histamine antagonists|mesh-ancestor
111484329|NCT00887640|Histamine Agents|histamine agents|mesh-ancestor
111484330|NCT00887640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111484331|NCT00887640|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111484332|NCT00887640|Antipruritics|antipruritics|mesh-ancestor
111484333|NCT00887640|Dermatologic Agents|dermatologic agents|mesh-ancestor
111484334|NCT00889200|Eszopiclone|eszopiclone|mesh-list
111484335|NCT00889200|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111484336|NCT00889200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111484337|NCT00889200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111484338|NCT00892710|Bevacizumab|bevacizumab|mesh-list
111484339|NCT00892710|Carboplatin|carboplatin|mesh-list
111484340|NCT00892710|Pemetrexed|pemetrexed|mesh-list
111484341|NCT00892710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111484342|NCT00892710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111484343|NCT00892710|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111484344|NCT00892710|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111484345|NCT00892710|Growth Substances|growth substances|mesh-ancestor
111484346|NCT00892710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111484347|NCT00892710|Growth Inhibitors|growth inhibitors|mesh-ancestor
111484348|NCT00892710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111484349|NCT00892710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111484350|NCT00892710|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111484351|NCT00892710|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111484352|NCT00894504|Carboplatin|carboplatin|mesh-list
111484353|NCT00894504|Gemcitabine|gemcitabine|mesh-list
111484354|NCT00894504|Panitumumab|panitumumab|mesh-list
111484355|NCT00894504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111484356|NCT00894504|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111484357|NCT00894504|Antimetabolites|antimetabolites|mesh-ancestor
111484358|NCT00894504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111484359|NCT00894504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111484360|NCT00895752|Riluzole|riluzole|mesh-list
111484361|NCT00895752|Anticonvulsants|anticonvulsants|mesh-ancestor
111484362|NCT00895752|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111484363|NCT00895752|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111484364|NCT00895752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111484365|NCT00895752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111484366|NCT00895752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111484367|NCT00895752|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111484368|NCT00895752|Protective Agents|protective agents|mesh-ancestor
111484369|NCT00896064|Vaccines|vaccines|mesh-list
111102673|NCT01663233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110692429|NCT00444912|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111484370|NCT00896064|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
111484372|NCT00896064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111484373|NCT00898560|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
111484374|NCT00898560|Anticonvulsants|anticonvulsants|mesh-ancestor
111484375|NCT00898560|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111484376|NCT00898560|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110645838|NCT04704934|Tubulin Modulators|tubulin modulators|mesh-ancestor
111484377|NCT00898560|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111484378|NCT00898560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111484379|NCT00899574|Imiquimod|imiquimod|mesh-list
111484380|NCT00899574|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111484381|NCT00899574|Immunologic Factors|immunologic factors|mesh-ancestor
111484382|NCT00899574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111484383|NCT00899574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111484384|NCT00899574|Interferon Inducers|interferon inducers|mesh-ancestor
111484385|NCT00900666|Botulinum Toxins|botulinum toxins|mesh-list
111484386|NCT00900666|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111484387|NCT00900666|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111484388|NCT00900666|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111484389|NCT00900666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111484390|NCT00900666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111484391|NCT00900666|Cholinergic Agents|cholinergic agents|mesh-ancestor
111484392|NCT00900666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111484393|NCT00900666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111484394|NCT00900666|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111484395|NCT00900666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111484396|NCT00902226|Escitalopram|escitalopram|mesh-list
111484397|NCT00902226|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111484398|NCT00902226|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111484399|NCT00902226|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111484400|NCT00902226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111484401|NCT00902226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111484402|NCT00902226|Serotonin Agents|serotonin agents|mesh-ancestor
111484403|NCT00902226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111484404|NCT00903162|Zoledronic Acid|zoledronic acid|mesh-list
111484405|NCT00903162|Letrozole|letrozole|mesh-list
111484406|NCT00903162|Leuprolide|leuprolide|mesh-list
111484407|NCT00903162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111484408|NCT00903162|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111484409|NCT00903162|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111484410|NCT00903162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111484411|NCT00903162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111484412|NCT00903162|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111484413|NCT00903162|Hormone Antagonists|hormone antagonists|mesh-ancestor
111484414|NCT00903162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111484415|NCT00903162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111484416|NCT00903162|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111484417|NCT00903162|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111484418|NCT00903162|Fertility Agents|fertility agents|mesh-ancestor
111484419|NCT00903162|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111484420|NCT00903162|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111484421|NCT00904488|Metolazone|metolazone|mesh-list
111484422|NCT00904488|Furosemide|furosemide|mesh-list
111484423|NCT00904488|Diuretics|diuretics|mesh-ancestor
111484424|NCT00904488|Natriuretic Agents|natriuretic agents|mesh-ancestor
111484425|NCT00904488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111484426|NCT00904488|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
111484427|NCT00904488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111484428|NCT00904488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111484429|NCT00904488|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111484430|NCT00904488|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
111484431|NCT00905580|Pregabalin|pregabalin|mesh-list
111484432|NCT00905580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111484433|NCT00905580|Analgesics|analgesics|mesh-ancestor
111484434|NCT00905580|Sensory System Agents|sensory system agents|mesh-ancestor
111484435|NCT00905580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111484436|NCT00905580|Anticonvulsants|anticonvulsants|mesh-ancestor
111484437|NCT00905580|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111484438|NCT00905580|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111484439|NCT00905580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111102674|NCT01663233|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111102675|NCT01663233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111102676|NCT01663233|Vasodilator Agents|vasodilator agents|mesh-ancestor
111484440|NCT00905580|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111484441|NCT00905580|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111484442|NCT00905580|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111484443|NCT00905580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111484444|NCT00905580|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111484445|NCT00908466|Sirolimus|sirolimus|mesh-list
111484446|NCT00908466|Temsirolimus|temsirolimus|mesh-list
111484447|NCT00908466|MTOR Inhibitors|mtor inhibitors|mesh-list
111484448|NCT00908466|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111484449|NCT00908466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111484450|NCT00908466|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111484451|NCT00908466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111484452|NCT00908466|Antifungal Agents|antifungal agents|mesh-ancestor
111484453|NCT00908466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111484454|NCT00908466|Immunologic Factors|immunologic factors|mesh-ancestor
111484455|NCT00908466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111484456|NCT00908466|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111484457|NCT00908466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111484458|NCT00908466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111484459|NCT00911586|Methyltestosterone|methyltestosterone|mesh-list
111484460|NCT00911586|Testosterone|testosterone|mesh-list
111484461|NCT00911586|Testosterone undecanoate|testosterone undecanoate|mesh-list
111484462|NCT00911586|Testosterone enanthate|testosterone enanthate|mesh-list
111484463|NCT00911586|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
111484464|NCT00911586|Androgens|androgens|mesh-ancestor
111484465|NCT00911586|Hormones|hormones|mesh-ancestor
111484466|NCT00911586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111484467|NCT00911586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111484468|NCT00911586|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111484469|NCT00911586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111484470|NCT00911586|Anabolic Agents|anabolic agents|mesh-ancestor
111484471|NCT00911742|Tramadol|tramadol|mesh-list
111484472|NCT00911742|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111484473|NCT00911742|Narcotics|narcotics|mesh-ancestor
111484474|NCT00911742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111484475|NCT00911742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111484476|NCT00911742|Analgesics|analgesics|mesh-ancestor
111484477|NCT00911742|Sensory System Agents|sensory system agents|mesh-ancestor
111484478|NCT00911742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111484479|NCT00912990|Cisatracurium|cisatracurium|mesh-list
111484480|NCT00912990|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
111484481|NCT00912990|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111484482|NCT00912990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111484483|NCT00912990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111484484|NCT00913068|Lidocaine|lidocaine|mesh-list
111484485|NCT00913068|Ropivacaine|ropivacaine|mesh-list
111484486|NCT00913068|Anesthetics, Local|anesthetics, local|mesh-ancestor
111484487|NCT00913068|Anesthetics|anesthetics|mesh-ancestor
111484488|NCT00913068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111484489|NCT00913068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111484490|NCT00913068|Sensory System Agents|sensory system agents|mesh-ancestor
111484491|NCT00913068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111484492|NCT00913068|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111484493|NCT00913068|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111484494|NCT00913068|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111484495|NCT00913068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111484496|NCT00913068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111484497|NCT00916032|Factor VIII|factor viii|mesh-list
111484498|NCT00916032|Coagulants|coagulants|mesh-ancestor
111484499|NCT00922194|Metformin|metformin|mesh-list
111484500|NCT00922194|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111484501|NCT00922194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111484502|NCT00923910|Acetaminophen|acetaminophen|mesh-list
111484503|NCT00923910|Diphenhydramine|diphenhydramine|mesh-list
111484504|NCT00923910|Promethazine|promethazine|mesh-list
111484505|NCT00923910|Interleukin-4|interleukin-4|mesh-list
111484506|NCT00923910|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
111484507|NCT00923910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111484508|NCT00923910|Analgesics|analgesics|mesh-ancestor
111484509|NCT00923910|Sensory System Agents|sensory system agents|mesh-ancestor
111484510|NCT00923910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111484511|NCT00923910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111484512|NCT00923910|Antipyretics|antipyretics|mesh-ancestor
111102677|NCT01663233|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111484513|NCT00923910|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111102678|NCT05494281|Anesthetics|anesthetics|mesh-list
111102679|NCT05494281|Anesthetics, Local|anesthetics, local|mesh-list
111484514|NCT00923910|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111484515|NCT00923910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111484516|NCT00923910|Anesthetics, Local|anesthetics, local|mesh-ancestor
111484517|NCT00923910|Anesthetics|anesthetics|mesh-ancestor
111484518|NCT00923910|Antiemetics|antiemetics|mesh-ancestor
111484519|NCT00923910|Autonomic Agents|autonomic agents|mesh-ancestor
111484520|NCT00923910|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111484521|NCT00923910|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111484522|NCT00923910|Histamine Antagonists|histamine antagonists|mesh-ancestor
111484523|NCT00923910|Histamine Agents|histamine agents|mesh-ancestor
111484524|NCT00923910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111484525|NCT00923910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111484526|NCT00923910|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111484527|NCT00923910|Antipruritics|antipruritics|mesh-ancestor
111484528|NCT00923910|Dermatologic Agents|dermatologic agents|mesh-ancestor
111484529|NCT00923910|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111484530|NCT00923910|Immunologic Factors|immunologic factors|mesh-ancestor
111484531|NCT00923910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111484532|NCT00923910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111484533|NCT00924066|Epothilones|epothilones|mesh-list
111484534|NCT00924066|Tubulin Modulators|tubulin modulators|mesh-ancestor
111484535|NCT00924066|Antimitotic Agents|antimitotic agents|mesh-ancestor
110645889|NCT04663308|Volixibat|volixibat|mesh-list
111484536|NCT00924066|Mitosis Modulators|mitosis modulators|mesh-ancestor
111484537|NCT00924066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111484538|NCT00924066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111484539|NCT00924612|Methyltestosterone|methyltestosterone|mesh-list
111484540|NCT00924612|Testosterone|testosterone|mesh-list
111484541|NCT00924612|Testosterone undecanoate|testosterone undecanoate|mesh-list
111484542|NCT00924612|Testosterone enanthate|testosterone enanthate|mesh-list
111484543|NCT00924612|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
111484544|NCT00924612|Androgens|androgens|mesh-ancestor
111484545|NCT00924612|Hormones|hormones|mesh-ancestor
111484546|NCT00924612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111484547|NCT00924612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111484548|NCT00924612|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111484549|NCT00924612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111484550|NCT00924612|Anabolic Agents|anabolic agents|mesh-ancestor
111484551|NCT00925782|Melphalan|melphalan|mesh-list
111484552|NCT00925782|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111484553|NCT00925782|Alkylating Agents|alkylating agents|mesh-ancestor
111484554|NCT00925782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111484555|NCT00925782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111484556|NCT00925782|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111484557|NCT00925782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111484558|NCT00925782|Immunologic Factors|immunologic factors|mesh-ancestor
111484559|NCT00925782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111484560|NCT00925938|Misoprostol|misoprostol|mesh-list
111484561|NCT00925938|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111484562|NCT00925938|Abortifacient Agents|abortifacient agents|mesh-ancestor
111484563|NCT00925938|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111484564|NCT00925938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111484565|NCT00925938|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111484566|NCT00925938|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111484567|NCT00925938|Oxytocics|oxytocics|mesh-ancestor
111484568|NCT00926952|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
111484569|NCT00926952|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111484570|NCT00926952|Dermatologic Agents|dermatologic agents|mesh-ancestor
111484571|NCT00927888|Bupivacaine|bupivacaine|mesh-list
111484572|NCT00927888|Anesthetics, Local|anesthetics, local|mesh-ancestor
111484573|NCT00927888|Anesthetics|anesthetics|mesh-ancestor
111484574|NCT00927888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111484575|NCT00927888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111484576|NCT00927888|Sensory System Agents|sensory system agents|mesh-ancestor
111484577|NCT00927888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111484578|NCT00928200|Cytarabine|cytarabine|mesh-list
111484579|NCT00928200|Dexamethasone|dexamethasone|mesh-list
111484580|NCT00928200|Dexamethasone acetate|dexamethasone acetate|mesh-list
111484581|NCT00928200|Doxorubicin|doxorubicin|mesh-list
111484582|NCT00928200|Methotrexate|methotrexate|mesh-list
111484583|NCT00928200|Vincristine|vincristine|mesh-list
111484584|NCT00928200|Asparaginase|asparaginase|mesh-list
111484585|NCT00928200|Dexrazoxane|dexrazoxane|mesh-list
111484586|NCT00928200|Razoxane|razoxane|mesh-list
111484587|NCT00928200|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
110692646|NCT05590559|Analgesics|analgesics|mesh-ancestor
111484588|NCT00928200|BB 1101|bb 1101|mesh-list
111484589|NCT00928200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111484590|NCT00928200|Antiemetics|antiemetics|mesh-ancestor
111102680|NCT05494281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111484591|NCT00928200|Autonomic Agents|autonomic agents|mesh-ancestor
111484592|NCT00928200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111484593|NCT00928200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111484594|NCT00928200|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111484595|NCT00928200|Glucocorticoids|glucocorticoids|mesh-ancestor
111484596|NCT00928200|Hormones|hormones|mesh-ancestor
111484597|NCT00928200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111484598|NCT00928200|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111484599|NCT00928200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111484600|NCT00928200|Protease Inhibitors|protease inhibitors|mesh-ancestor
111484601|NCT00928200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111484602|NCT00928200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111484603|NCT00928200|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111484604|NCT00928200|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111484605|NCT00928200|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111484606|NCT00928200|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111484607|NCT00928200|Abortifacient Agents|abortifacient agents|mesh-ancestor
111484608|NCT00928200|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111484609|NCT00928200|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111484610|NCT00928200|Antimetabolites|antimetabolites|mesh-ancestor
111484611|NCT00928200|Dermatologic Agents|dermatologic agents|mesh-ancestor
111484612|NCT00928200|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111484613|NCT00928200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111484614|NCT00928200|Immunologic Factors|immunologic factors|mesh-ancestor
111484615|NCT00928200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111484616|NCT00928200|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111484617|NCT00928200|Antiviral Agents|antiviral agents|mesh-ancestor
111484618|NCT00928200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111484619|NCT00928200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111484620|NCT00928200|Tubulin Modulators|tubulin modulators|mesh-ancestor
111484621|NCT00928200|Antimitotic Agents|antimitotic agents|mesh-ancestor
111484622|NCT00928200|Mitosis Modulators|mitosis modulators|mesh-ancestor
111484623|NCT00928200|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111484624|NCT00928200|Protective Agents|protective agents|mesh-ancestor
111484625|NCT00931164|Sodium Oxybate|sodium oxybate|mesh-list
111484626|NCT00931164|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111484627|NCT00931164|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111484628|NCT00931164|Anesthetics, General|anesthetics, general|mesh-ancestor
111484629|NCT00931164|Anesthetics|anesthetics|mesh-ancestor
111484630|NCT00931164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111484631|NCT00931164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111484632|NCT00931242|Thalidomide|thalidomide|mesh-list
111484633|NCT00931242|Apremilast|apremilast|mesh-list
111484634|NCT00931242|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111484635|NCT00931242|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111484636|NCT00931242|Analgesics|analgesics|mesh-ancestor
111484637|NCT00931242|Sensory System Agents|sensory system agents|mesh-ancestor
111484638|NCT00931242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111484639|NCT00931242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111484640|NCT00931242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111484641|NCT00931242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111484642|NCT00931242|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
111484643|NCT00931242|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111484644|NCT00931242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111484645|NCT00931242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111484646|NCT00931242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111484647|NCT00931242|Immunologic Factors|immunologic factors|mesh-ancestor
111484648|NCT00931242|Leprostatic Agents|leprostatic agents|mesh-ancestor
111484649|NCT00931242|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111484650|NCT00931242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111484651|NCT00931242|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111484652|NCT00931242|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111484653|NCT00931242|Growth Substances|growth substances|mesh-ancestor
111484654|NCT00931242|Growth Inhibitors|growth inhibitors|mesh-ancestor
111484655|NCT00931242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111484656|NCT00932022|Trospium chloride|trospium chloride|mesh-list
111484657|NCT00932022|Parasympatholytics|parasympatholytics|mesh-ancestor
111484658|NCT00932022|Autonomic Agents|autonomic agents|mesh-ancestor
111484659|NCT00932022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111484660|NCT00932022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111484661|NCT00932022|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111102681|NCT05494281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111484662|NCT00932022|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111484664|NCT00932022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111484665|NCT00932022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111484666|NCT00932022|Urological Agents|urological agents|mesh-ancestor
111484667|NCT00939120|Tolterodine Tartrate|tolterodine tartrate|mesh-list
111484668|NCT00939120|Dutasteride|dutasteride|mesh-list
111484669|NCT00939120|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
111484670|NCT00939120|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111484671|NCT00939120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111484672|NCT00939120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111484673|NCT00939120|Hormone Antagonists|hormone antagonists|mesh-ancestor
111484674|NCT00939120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111484675|NCT00939120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111484676|NCT00939120|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111484677|NCT00939120|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111484678|NCT00939120|Cholinergic Agents|cholinergic agents|mesh-ancestor
111484679|NCT00939120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111484680|NCT00939120|Urological Agents|urological agents|mesh-ancestor
111484681|NCT00939900|Zoledronic Acid|zoledronic acid|mesh-list
111484682|NCT00939900|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111484683|NCT00939900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111484684|NCT00943098|Diclofenac|diclofenac|mesh-list
111484685|NCT00943098|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111484686|NCT00943098|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111484687|NCT00943098|Analgesics|analgesics|mesh-ancestor
111484688|NCT00943098|Sensory System Agents|sensory system agents|mesh-ancestor
111484689|NCT00943098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111484690|NCT00943098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111484691|NCT00943098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111484692|NCT00943098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111484693|NCT00943098|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111484694|NCT00943098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111484695|NCT00943098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111484696|NCT00943800|Vidarabine|vidarabine|mesh-list
111484697|NCT00943800|Fludarabine|fludarabine|mesh-list
111484698|NCT00943800|Fludarabine phosphate|fludarabine phosphate|mesh-list
111484699|NCT00943800|Melphalan|melphalan|mesh-list
111484700|NCT00943800|Busulfan|busulfan|mesh-list
111484701|NCT00943800|Thiotepa|thiotepa|mesh-list
111484702|NCT00943800|Antilymphocyte Serum|antilymphocyte serum|mesh-list
111484703|NCT00943800|Thymoglobulin|thymoglobulin|mesh-list
111484704|NCT00943800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111484705|NCT00943800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111484706|NCT00943800|Antimetabolites|antimetabolites|mesh-ancestor
111484707|NCT00943800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111484708|NCT00943800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111484709|NCT00943800|Immunologic Factors|immunologic factors|mesh-ancestor
111484710|NCT00943800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111484711|NCT00943800|Antiviral Agents|antiviral agents|mesh-ancestor
111484712|NCT00943800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111484713|NCT00943800|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111484714|NCT00943800|Alkylating Agents|alkylating agents|mesh-ancestor
111484715|NCT00943800|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111484716|NCT00943878|Vaccines|vaccines|mesh-list
111484717|NCT00943878|Immunologic Factors|immunologic factors|mesh-ancestor
111484718|NCT00943878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111484719|NCT00945282|Ritonavir|ritonavir|mesh-list
111484720|NCT00945282|Lopinavir|lopinavir|mesh-list
111484721|NCT00945282|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111484722|NCT00945282|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111484723|NCT00945282|Protease Inhibitors|protease inhibitors|mesh-ancestor
111484724|NCT00945282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111484725|NCT00945282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111484726|NCT00945282|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111484727|NCT00945282|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111484728|NCT00945282|Antiviral Agents|antiviral agents|mesh-ancestor
111484729|NCT00945282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111484730|NCT00945282|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111484731|NCT00945282|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111484732|NCT00945750|Famotidine|famotidine|mesh-list
111484733|NCT00945750|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111484734|NCT00945750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111102682|NCT05494281|Sensory System Agents|sensory system agents|mesh-ancestor
110692794|NCT05357027|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111102683|NCT05494281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111484735|NCT00945750|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
111484736|NCT00945750|Histamine Antagonists|histamine antagonists|mesh-ancestor
111484738|NCT00945750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111484739|NCT00945750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111484740|NCT00945750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111484741|NCT00948090|Cyclophosphamide|cyclophosphamide|mesh-list
111484742|NCT00948090|Busulfan|busulfan|mesh-list
111484743|NCT00948090|Etoposide|etoposide|mesh-list
111484744|NCT00948090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111484745|NCT00948090|Immunologic Factors|immunologic factors|mesh-ancestor
111484746|NCT00948090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111484747|NCT00948090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111484748|NCT00948090|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111484749|NCT00948090|Alkylating Agents|alkylating agents|mesh-ancestor
111484750|NCT00948090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111484751|NCT00948090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111484752|NCT00948090|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111484753|NCT00948090|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111484754|NCT00948090|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111484755|NCT00948090|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111484756|NCT00948090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111484757|NCT00950352|Choline|choline|mesh-list
111484758|NCT00950352|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
111484759|NCT00950352|Lipotropic Agents|lipotropic agents|mesh-ancestor
111484760|NCT00950352|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111484761|NCT00950352|Antimetabolites|antimetabolites|mesh-ancestor
111484762|NCT00950352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111484763|NCT00950352|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111484764|NCT00950352|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111484765|NCT00950352|Nootropic Agents|nootropic agents|mesh-ancestor
111484766|NCT00953862|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
111484767|NCT00953862|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111484768|NCT00953862|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111484769|NCT00953862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111484770|NCT00953862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111484771|NCT00953862|Adrenergic Agents|adrenergic agents|mesh-ancestor
111484772|NCT00953862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111484773|NCT00953862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111484774|NCT00955266|Calcium|calcium|mesh-list
111484775|NCT00955266|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111484776|NCT00955266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111484777|NCT00957684|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
111484778|NCT00957684|Anticonvulsants|anticonvulsants|mesh-ancestor
111484779|NCT00957684|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111484780|NCT00957684|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111484781|NCT00957684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111484782|NCT00957684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111484783|NCT00961662|Tagatose|tagatose|mesh-list
111484784|NCT00961662|Iron Chelating Agents|iron chelating agents|mesh-ancestor
111484785|NCT00961662|Chelating Agents|chelating agents|mesh-ancestor
111484786|NCT00961662|Sequestering Agents|sequestering agents|mesh-ancestor
111484787|NCT00961662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111484788|NCT00964548|Dantrolene|dantrolene|mesh-list
111484789|NCT00964548|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
111484790|NCT00964548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111484791|NCT00964548|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111484792|NCT00964548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111484793|NCT00905268|Idebenone|idebenone|mesh-list
111484794|NCT00905268|Antioxidants|antioxidants|mesh-ancestor
111484795|NCT00905268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111484796|NCT00905268|Protective Agents|protective agents|mesh-ancestor
111484797|NCT00905268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111484798|NCT00967044|Everolimus|everolimus|mesh-list
111484799|NCT00967044|Panobinostat|panobinostat|mesh-list
111484800|NCT00967044|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111484801|NCT00967044|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111484802|NCT00967044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111484803|NCT00967044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111102684|NCT05494047|Vaccines|vaccines|mesh-list
111102685|NCT05494047|Immunologic Factors|immunologic factors|mesh-ancestor
110692867|NCT01564199|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111484804|NCT00967044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111484805|NCT00967044|Immunologic Factors|immunologic factors|mesh-ancestor
111484806|NCT00967044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111484807|NCT00967044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111484808|NCT00967044|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111484809|NCT00973752|Cytarabine|cytarabine|mesh-list
111484810|NCT00973752|Prednisone|prednisone|mesh-list
111484811|NCT00973752|Doxorubicin|doxorubicin|mesh-list
111484812|NCT00973752|Methotrexate|methotrexate|mesh-list
111484813|NCT00973752|Vincristine|vincristine|mesh-list
111484814|NCT00973752|Asparaginase|asparaginase|mesh-list
111484815|NCT00973752|Mercaptopurine|mercaptopurine|mesh-list
111484816|NCT00973752|Clofarabine|clofarabine|mesh-list
111484817|NCT00973752|Pegaspargase|pegaspargase|mesh-list
111484818|NCT00973752|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111484819|NCT00973752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111484820|NCT00973752|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111484821|NCT00973752|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111484822|NCT00973752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111484823|NCT00973752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111484824|NCT00973752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111484825|NCT00973752|Glucocorticoids|glucocorticoids|mesh-ancestor
111484826|NCT00973752|Hormones|hormones|mesh-ancestor
111484827|NCT00973752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111484828|NCT00973752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111484829|NCT00973752|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111484830|NCT00973752|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111484831|NCT00973752|Abortifacient Agents|abortifacient agents|mesh-ancestor
111484832|NCT00973752|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111484833|NCT00973752|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111484834|NCT00973752|Antimetabolites|antimetabolites|mesh-ancestor
111484835|NCT00973752|Dermatologic Agents|dermatologic agents|mesh-ancestor
111484836|NCT00973752|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111484837|NCT00973752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111484838|NCT00973752|Immunologic Factors|immunologic factors|mesh-ancestor
111484839|NCT00973752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111484840|NCT00973752|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111484841|NCT00973752|Antiviral Agents|antiviral agents|mesh-ancestor
111484842|NCT00973752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111484843|NCT00973752|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111484844|NCT00973752|Tubulin Modulators|tubulin modulators|mesh-ancestor
111484845|NCT00973752|Antimitotic Agents|antimitotic agents|mesh-ancestor
111484846|NCT00973752|Mitosis Modulators|mitosis modulators|mesh-ancestor
111484847|NCT00974142|Cyclosporine|cyclosporine|mesh-list
111484848|NCT00974142|Cyclosporins|cyclosporins|mesh-list
111484849|NCT00974142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111484850|NCT00974142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111484851|NCT00974142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111484852|NCT00974142|Immunologic Factors|immunologic factors|mesh-ancestor
111484853|NCT00974142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111484854|NCT00974142|Antifungal Agents|antifungal agents|mesh-ancestor
111484855|NCT00974142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111484856|NCT00974142|Dermatologic Agents|dermatologic agents|mesh-ancestor
111484857|NCT00974142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111484858|NCT00974142|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111484859|NCT00974376|Gabapentin|gabapentin|mesh-list
111484860|NCT00974376|Analgesics|analgesics|mesh-ancestor
111484861|NCT00974376|Sensory System Agents|sensory system agents|mesh-ancestor
111484862|NCT00974376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111484863|NCT00974376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111484864|NCT00974376|Anticonvulsants|anticonvulsants|mesh-ancestor
111484865|NCT00974376|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111484866|NCT00974376|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111484867|NCT00974376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111484868|NCT00974376|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111484869|NCT00974376|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111484870|NCT00974376|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111484871|NCT00974376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111484872|NCT00974376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111484873|NCT00974376|Antimanic Agents|antimanic agents|mesh-ancestor
111484874|NCT00976248|Everolimus|everolimus|mesh-list
111484875|NCT00976248|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111484876|NCT00976248|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110323081|NCT00351143|Xhance|xhance|mesh-list
111484877|NCT00976248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111102687|NCT05493969|Lamivudine|lamivudine|mesh-list
111484878|NCT00976248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111484879|NCT00976248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111484880|NCT00976248|Immunologic Factors|immunologic factors|mesh-ancestor
111484881|NCT00976248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111484882|NCT00976248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111484883|NCT00976404|Raltegravir Potassium|raltegravir potassium|mesh-list
111484884|NCT00976404|Maraviroc|maraviroc|mesh-list
111484885|NCT00976404|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111484886|NCT00976404|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111484887|NCT00976404|Antiviral Agents|antiviral agents|mesh-ancestor
111484888|NCT00976404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111484889|NCT00976404|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111484890|NCT00976404|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111484891|NCT00976404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111484892|NCT00976404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111484893|NCT00976404|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
111484894|NCT00976404|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
111484895|NCT00976404|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
111484896|NCT00983346|Bortezomib|bortezomib|mesh-list
111484897|NCT00983346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111484898|NCT00986856|Fusidic Acid|fusidic acid|mesh-list
111484899|NCT00986856|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111484900|NCT00986856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111484901|NCT00986856|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111484902|NCT00986856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111484903|NCT00986856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111484904|NCT00987480|Cyclosporine|cyclosporine|mesh-list
111484905|NCT00987480|Cyclophosphamide|cyclophosphamide|mesh-list
111484906|NCT00987480|Busulfan|busulfan|mesh-list
111484907|NCT00987480|Fludarabine|fludarabine|mesh-list
111484908|NCT00987480|Cyclosporins|cyclosporins|mesh-list
111484909|NCT00987480|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111484910|NCT00987480|Immunologic Factors|immunologic factors|mesh-ancestor
111484911|NCT00987480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111484912|NCT00987480|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111484913|NCT00987480|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111484914|NCT00987480|Alkylating Agents|alkylating agents|mesh-ancestor
111484915|NCT00987480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111484916|NCT00987480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111484917|NCT00987480|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111484918|NCT00987480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111484919|NCT00987480|Antifungal Agents|antifungal agents|mesh-ancestor
111484920|NCT00987480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111484921|NCT00987480|Dermatologic Agents|dermatologic agents|mesh-ancestor
111484922|NCT00987480|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111484923|NCT00987558|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
111484924|NCT00987558|Simvastatin|simvastatin|mesh-list
111484925|NCT00987558|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111484926|NCT00987558|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111484927|NCT00987558|Antimetabolites|antimetabolites|mesh-ancestor
111484928|NCT00987558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111484929|NCT00987558|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111484930|NCT00987558|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111484931|NCT00987558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111484932|NCT00987558|Anticonvulsants|anticonvulsants|mesh-ancestor
111484933|NCT00987558|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111484934|NCT00987558|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111484935|NCT00987558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111484936|NCT00987948|Maraviroc|maraviroc|mesh-list
111484937|NCT00987948|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
111484938|NCT00987948|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
111484939|NCT00987948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111484940|NCT00987948|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111484941|NCT00987948|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111484942|NCT00987948|Antiviral Agents|antiviral agents|mesh-ancestor
111484943|NCT00987948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111484944|NCT00987948|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
111484945|NCT00989586|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111484946|NCT00989586|Veltuzumab|veltuzumab|mesh-list
111484947|NCT00989586|Antibodies|antibodies|mesh-list
111484948|NCT00989586|Immunoglobulins|immunoglobulins|mesh-list
111484949|NCT00989586|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111484950|NCT00989586|Immunologic Factors|immunologic factors|mesh-ancestor
111484951|NCT00989586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111102688|NCT05493969|Dolutegravir|dolutegravir|mesh-list
111102689|NCT05493969|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111484952|NCT00989586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111484953|NCT00990288|Thrombin|thrombin|mesh-list
111484954|NCT00990288|Hemostatics|hemostatics|mesh-list
111484955|NCT00990288|Coagulants|coagulants|mesh-ancestor
111484956|NCT00991458|Cyclosporine|cyclosporine|mesh-list
111484957|NCT00991458|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111484958|NCT00991458|Cyclosporins|cyclosporins|mesh-list
111484959|NCT00991458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111484960|NCT00991458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111484961|NCT00991458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111484962|NCT00991458|Immunologic Factors|immunologic factors|mesh-ancestor
111484963|NCT00991458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111484964|NCT00991458|Antifungal Agents|antifungal agents|mesh-ancestor
111484965|NCT00991458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110646031|NCT04369937|Pembrolizumab|pembrolizumab|mesh-list
111484966|NCT00991458|Dermatologic Agents|dermatologic agents|mesh-ancestor
111484967|NCT00991458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111484968|NCT00991458|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111484969|NCT00991458|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111484970|NCT00993798|Bupivacaine|bupivacaine|mesh-list
111484971|NCT00993798|Anesthetics, Local|anesthetics, local|mesh-ancestor
111484972|NCT00993798|Anesthetics|anesthetics|mesh-ancestor
111484973|NCT00993798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111484974|NCT00993798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111484975|NCT00993798|Sensory System Agents|sensory system agents|mesh-ancestor
111484976|NCT00993798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111484977|NCT00997620|Fluticasone|fluticasone|mesh-list
111484979|NCT00997620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111484980|NCT00997620|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111484981|NCT00997620|Autonomic Agents|autonomic agents|mesh-ancestor
111484982|NCT00997620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111484983|NCT00997620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111484984|NCT00997620|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111484985|NCT00997620|Respiratory System Agents|respiratory system agents|mesh-ancestor
111484986|NCT00997620|Dermatologic Agents|dermatologic agents|mesh-ancestor
111484987|NCT00997620|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111484988|NCT00997932|Contraceptive Agents|contraceptive agents|mesh-list
111484989|NCT00997932|Levonorgestrel|levonorgestrel|mesh-list
111484990|NCT00997932|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111484991|NCT00997932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111484992|NCT00997932|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111484993|NCT00997932|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111484994|NCT00997932|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111484995|NCT00997932|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111484996|NCT00998010|Temozolomide|temozolomide|mesh-list
111484997|NCT00998010|Bortezomib|bortezomib|mesh-list
111484998|NCT00998010|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111484999|NCT00998010|Alkylating Agents|alkylating agents|mesh-ancestor
111485000|NCT00998010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111485001|NCT00998010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111485002|NCT00999102|Metoprolol|metoprolol|mesh-list
111485003|NCT00999102|Nebivolol|nebivolol|mesh-list
111485004|NCT00999102|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111485005|NCT00999102|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111485006|NCT00999102|Sympatholytics|sympatholytics|mesh-ancestor
111485007|NCT00999102|Autonomic Agents|autonomic agents|mesh-ancestor
111485008|NCT00999102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111485009|NCT00999102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111485010|NCT00999102|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
111485011|NCT00999102|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111485012|NCT00999102|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111485013|NCT00999102|Adrenergic Agents|adrenergic agents|mesh-ancestor
111485014|NCT00999102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111485015|NCT00999102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111485016|NCT00999102|Vasodilator Agents|vasodilator agents|mesh-ancestor
111485017|NCT00999102|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
111485018|NCT00999102|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111485019|NCT00999102|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111485020|NCT01000818|Raltegravir Potassium|raltegravir potassium|mesh-list
111485021|NCT01000818|Omeprazole|omeprazole|mesh-list
111485022|NCT01000818|Famotidine|famotidine|mesh-list
110693101|NCT01052025|Curcumin|curcumin|mesh-list
111485023|NCT01000818|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111485024|NCT01000818|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111485025|NCT01000818|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111485026|NCT01000818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111485027|NCT01000818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111102690|NCT05493969|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111485029|NCT01000818|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111485030|NCT01000818|Antiviral Agents|antiviral agents|mesh-ancestor
111485031|NCT01000818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111485032|NCT01000818|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111485033|NCT01000818|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111485034|NCT01000818|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
111485035|NCT01000818|Histamine Antagonists|histamine antagonists|mesh-ancestor
111485036|NCT01000818|Histamine Agents|histamine agents|mesh-ancestor
111485037|NCT01000818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111485038|NCT01000818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111485039|NCT01001052|Colchicine|colchicine|mesh-list
111485040|NCT01001052|Gout Suppressants|gout suppressants|mesh-ancestor
111485041|NCT01001052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111485042|NCT01001052|Tubulin Modulators|tubulin modulators|mesh-ancestor
111485043|NCT01001052|Antimitotic Agents|antimitotic agents|mesh-ancestor
111485044|NCT01001052|Mitosis Modulators|mitosis modulators|mesh-ancestor
111485045|NCT01001052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111485046|NCT01001052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111485047|NCT01001442|Indatuximab ravtansine|indatuximab ravtansine|mesh-list
111485048|NCT01001442|Immunoconjugates|immunoconjugates|mesh-ancestor
111485049|NCT01001442|Immunologic Factors|immunologic factors|mesh-ancestor
111485050|NCT01001442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111485051|NCT01003080|Hemostatics|hemostatics|mesh-list
111485052|NCT01003080|Coagulants|coagulants|mesh-ancestor
111485053|NCT01003938|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111485054|NCT01003938|Topotecan|topotecan|mesh-list
111485055|NCT01003938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111485056|NCT01003938|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111485057|NCT01003938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111485058|NCT01003938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111485059|NCT01003938|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111485060|NCT01003938|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111485061|NCT01004718|Deoxyglucose|deoxyglucose|mesh-list
111485062|NCT01004718|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
111485063|NCT01004718|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111485064|NCT01004718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111485065|NCT01004718|Antimetabolites|antimetabolites|mesh-ancestor
111485066|NCT01004718|Antiviral Agents|antiviral agents|mesh-ancestor
111485067|NCT01004718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111485068|NCT01005576|Fludarabine|fludarabine|mesh-list
111485069|NCT01005576|Melphalan|melphalan|mesh-list
111485070|NCT01005576|Alemtuzumab|alemtuzumab|mesh-list
111485071|NCT01005576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111485072|NCT01005576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111485073|NCT01005576|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111485074|NCT01005576|Immunologic Factors|immunologic factors|mesh-ancestor
111485075|NCT01005576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111485076|NCT01005576|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111485077|NCT01005576|Alkylating Agents|alkylating agents|mesh-ancestor
111485078|NCT01005576|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111485079|NCT01005576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111485080|NCT01005810|Acetylcysteine|acetylcysteine|mesh-list
111485081|NCT01005810|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111485082|NCT01005810|Antiviral Agents|antiviral agents|mesh-ancestor
111485083|NCT01005810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111485084|NCT01005810|Expectorants|expectorants|mesh-ancestor
111485085|NCT01005810|Respiratory System Agents|respiratory system agents|mesh-ancestor
111485086|NCT01005810|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111485087|NCT01005810|Antioxidants|antioxidants|mesh-ancestor
111485088|NCT01005810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111485089|NCT01005810|Protective Agents|protective agents|mesh-ancestor
111485090|NCT01005810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111485091|NCT01005810|Antidotes|antidotes|mesh-ancestor
111485092|NCT01005888|Complement C1s|complement c1s|mesh-list
111485093|NCT01005888|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
111485094|NCT01005888|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
111485095|NCT01005888|Immunologic Factors|immunologic factors|mesh-ancestor
111485096|NCT01005888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111485097|NCT01005888|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
111485098|NCT01005888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111485099|NCT01007994|Propranolol|propranolol|mesh-list
111485100|NCT01007994|Enalapril|enalapril|mesh-list
111485101|NCT01007994|Isradipine|isradipine|mesh-list
111485102|NCT01007994|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111485103|NCT01007994|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111485105|NCT01007994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111485106|NCT01007994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111485107|NCT01007994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111485108|NCT01007994|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111485109|NCT01007994|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111485110|NCT01007994|Vasodilator Agents|vasodilator agents|mesh-ancestor
111485111|NCT01007994|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
111485112|NCT01007994|Protease Inhibitors|protease inhibitors|mesh-ancestor
111485113|NCT01007994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111485114|NCT01007994|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111485115|NCT01007994|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111485116|NCT01007994|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111485117|NCT01008462|Cytarabine|cytarabine|mesh-list
111485118|NCT01008462|Mycophenolic Acid|mycophenolic acid|mesh-list
111485119|NCT01008462|Cyclophosphamide|cyclophosphamide|mesh-list
111485120|NCT01008462|Melphalan|melphalan|mesh-list
111485121|NCT01008462|Mechlorethamine|mechlorethamine|mesh-list
111485122|NCT01008462|Carmustine|carmustine|mesh-list
111485123|NCT01008462|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
111485124|NCT01008462|Fludarabine|fludarabine|mesh-list
111485125|NCT01008462|Fludarabine phosphate|fludarabine phosphate|mesh-list
111485126|NCT01008462|Etoposide|etoposide|mesh-list
111485127|NCT01008462|Etoposide phosphate|etoposide phosphate|mesh-list
111485128|NCT01008462|Podophyllotoxin|podophyllotoxin|mesh-list
111485129|NCT01008462|Tacrolimus|tacrolimus|mesh-list
111485130|NCT01008462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111485131|NCT01008462|Immunologic Factors|immunologic factors|mesh-ancestor
111485132|NCT01008462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111485133|NCT01008462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111485134|NCT01008462|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111485135|NCT01008462|Alkylating Agents|alkylating agents|mesh-ancestor
111485136|NCT01008462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111485137|NCT01008462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111485138|NCT01008462|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111485139|NCT01008462|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111485140|NCT01008462|Antimetabolites|antimetabolites|mesh-ancestor
111485141|NCT01008462|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111485142|NCT01008462|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111485143|NCT01008462|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111485144|NCT01008462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111485145|NCT01008462|Antiviral Agents|antiviral agents|mesh-ancestor
111485146|NCT01008462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111485147|NCT01008462|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111485148|NCT01008462|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111485149|NCT01008462|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111485150|NCT01008462|Antitubercular Agents|antitubercular agents|mesh-ancestor
111485151|NCT01008462|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111485152|NCT01008462|Keratolytic Agents|keratolytic agents|mesh-ancestor
111485153|NCT01008462|Dermatologic Agents|dermatologic agents|mesh-ancestor
111485154|NCT01008462|Tubulin Modulators|tubulin modulators|mesh-ancestor
111485155|NCT01008462|Antimitotic Agents|antimitotic agents|mesh-ancestor
111485156|NCT01008462|Mitosis Modulators|mitosis modulators|mesh-ancestor
111485157|NCT01010568|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
111485158|NCT01010568|Ofatumumab|ofatumumab|mesh-list
111485159|NCT01010568|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111485160|NCT01010568|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111485161|NCT01010568|Alkylating Agents|alkylating agents|mesh-ancestor
111485162|NCT01010568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111485163|NCT01010568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111485164|NCT01010568|Immunologic Factors|immunologic factors|mesh-ancestor
111485165|NCT01010568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111485166|NCT01011816|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
111485167|NCT01011816|Hemostatics|hemostatics|mesh-ancestor
111485168|NCT01011816|Coagulants|coagulants|mesh-ancestor
111485169|NCT01011894|Lenalidomide|lenalidomide|mesh-list
111485170|NCT01011894|Immunologic Factors|immunologic factors|mesh-ancestor
111485171|NCT01011894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111485172|NCT01011894|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111485173|NCT01011894|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111485174|NCT01011894|Growth Substances|growth substances|mesh-ancestor
111485175|NCT01011894|Growth Inhibitors|growth inhibitors|mesh-ancestor
111102691|NCT05493969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111485176|NCT01011894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111102692|NCT05493969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111102693|NCT05493969|Antiviral Agents|antiviral agents|mesh-ancestor
111485177|NCT01012674|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
111485178|NCT01012674|Chelating Agents|chelating agents|mesh-ancestor
111485179|NCT01012674|Sequestering Agents|sequestering agents|mesh-ancestor
111485180|NCT01012674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111485181|NCT01015170|Bupropion|bupropion|mesh-list
111485182|NCT01015170|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111485183|NCT01015170|Antidepressive Agents|antidepressive agents|mesh-ancestor
111485184|NCT01015170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111485185|NCT01015170|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111485186|NCT01015170|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111485187|NCT01015170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111485188|NCT01015170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111485189|NCT01015170|Dopamine Agents|dopamine agents|mesh-ancestor
111485190|NCT01015170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111485191|NCT01015170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111485192|NCT01015170|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111485193|NCT01015170|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111485194|NCT01015170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111485195|NCT01017042|Colchicine|colchicine|mesh-list
111485196|NCT01017042|Gout Suppressants|gout suppressants|mesh-ancestor
111485197|NCT01017042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111485198|NCT01017042|Tubulin Modulators|tubulin modulators|mesh-ancestor
111485199|NCT01017042|Antimitotic Agents|antimitotic agents|mesh-ancestor
111485200|NCT01017042|Mitosis Modulators|mitosis modulators|mesh-ancestor
111485201|NCT01017042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111485202|NCT01017042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111485203|NCT01018056|Riluzole|riluzole|mesh-list
111485204|NCT01018056|Anticonvulsants|anticonvulsants|mesh-ancestor
111485205|NCT01018056|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111485206|NCT01018056|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111485207|NCT01018056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111485208|NCT01018056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111485209|NCT01018056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111485210|NCT01018056|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111485211|NCT01018056|Protective Agents|protective agents|mesh-ancestor
111485212|NCT01018134|Desoximetasone|desoximetasone|mesh-list
111485213|NCT01018134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111485214|NCT01018134|Glucocorticoids|glucocorticoids|mesh-ancestor
111485215|NCT01018134|Hormones|hormones|mesh-ancestor
111485216|NCT01018134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111485217|NCT01018134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111485218|NCT01020006|Gemcitabine|gemcitabine|mesh-list
111485219|NCT01020006|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111485220|NCT01020006|Antimetabolites|antimetabolites|mesh-ancestor
111485221|NCT01020006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111485222|NCT01020006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111485223|NCT05395962|Carboplatin|carboplatin|mesh-list
111485224|NCT05395962|Bleomycin|bleomycin|mesh-list
111485225|NCT05395962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111485226|NCT05395962|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111485227|NCT05394480|Hydrocortisone|hydrocortisone|mesh-list
111485228|NCT05394480|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111485229|NCT05017584|Bupivacaine|bupivacaine|mesh-list
111485230|NCT05017584|Anesthetics, Local|anesthetics, local|mesh-ancestor
111485231|NCT05017584|Anesthetics|anesthetics|mesh-ancestor
111485232|NCT05017584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111485233|NCT05017584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111485234|NCT05017584|Sensory System Agents|sensory system agents|mesh-ancestor
111485235|NCT05017584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111485236|NCT04999332|Leucovorin|leucovorin|mesh-list
111485237|NCT04999332|Docetaxel|docetaxel|mesh-list
111485238|NCT04999332|Oxaliplatin|oxaliplatin|mesh-list
111485239|NCT04999332|Levoleucovorin|levoleucovorin|mesh-list
111485240|NCT04999332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111485241|NCT04999332|Tubulin Modulators|tubulin modulators|mesh-ancestor
111485242|NCT04999332|Antimitotic Agents|antimitotic agents|mesh-ancestor
111485243|NCT04999332|Mitosis Modulators|mitosis modulators|mesh-ancestor
111485244|NCT04999332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111485245|NCT04999332|Antidotes|antidotes|mesh-ancestor
111485246|NCT04999332|Protective Agents|protective agents|mesh-ancestor
111485247|NCT04999332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111485248|NCT04999332|Vitamin B Complex|vitamin b complex|mesh-ancestor
111102694|NCT05493969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111102695|NCT05493969|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111102696|NCT05493969|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111102697|NCT05493969|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111102698|NCT05493969|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111102699|NCT05493657|Aspirin|aspirin|mesh-list
111102700|NCT05493657|Clopidogrel|clopidogrel|mesh-list
111102701|NCT05493657|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111102702|NCT05493657|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111102703|NCT05493657|Analgesics|analgesics|mesh-ancestor
111485249|NCT04999332|Vitamins|vitamins|mesh-ancestor
111485250|NCT04999332|Micronutrients|micronutrients|mesh-ancestor
111485251|NCT04147416|Propofol|propofol|mesh-list
111485252|NCT04147416|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111485253|NCT04147416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111485254|NCT04147416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111485255|NCT04147416|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111485256|NCT04147416|Anesthetics, General|anesthetics, general|mesh-ancestor
111485257|NCT04147416|Anesthetics|anesthetics|mesh-ancestor
111485258|NCT02662062|Pembrolizumab|pembrolizumab|mesh-list
111485259|NCT02662062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111485260|NCT02662062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111485261|NCT02662062|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111485262|NCT02662062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111485263|NCT02406222|Dexamethasone|dexamethasone|mesh-list
111485264|NCT02406222|Cyclophosphamide|cyclophosphamide|mesh-list
111485265|NCT02406222|Pomalidomide|pomalidomide|mesh-list
111485266|NCT02406222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111485267|NCT02406222|Immunologic Factors|immunologic factors|mesh-ancestor
111485268|NCT02406222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111485269|NCT02406222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111485270|NCT02406222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111485271|NCT02406222|Alkylating Agents|alkylating agents|mesh-ancestor
111485272|NCT02406222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111485273|NCT02406222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111485274|NCT02406222|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111485275|NCT02406222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111485276|NCT02406222|Antiemetics|antiemetics|mesh-ancestor
111485277|NCT02406222|Autonomic Agents|autonomic agents|mesh-ancestor
111485278|NCT02406222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111485279|NCT02406222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111485280|NCT02406222|Glucocorticoids|glucocorticoids|mesh-ancestor
111485281|NCT02406222|Hormones|hormones|mesh-ancestor
111485282|NCT02406222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111485283|NCT02406222|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111485284|NCT02406222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111485285|NCT02406222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111485286|NCT02406222|Growth Substances|growth substances|mesh-ancestor
111485287|NCT02406222|Growth Inhibitors|growth inhibitors|mesh-ancestor
111485288|NCT00458796|Zoledronic Acid|zoledronic acid|mesh-list
111485289|NCT00458796|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111485290|NCT00458796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111485291|NCT01022190|Etoricoxib|etoricoxib|mesh-list
111485292|NCT01022190|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111485293|NCT01022190|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111485294|NCT01022190|Analgesics|analgesics|mesh-ancestor
111485295|NCT01022190|Sensory System Agents|sensory system agents|mesh-ancestor
111485296|NCT01022190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111485297|NCT01022190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111485298|NCT01022190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111485299|NCT01022190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111485300|NCT01022190|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111485301|NCT01022190|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111485302|NCT01022190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111485303|NCT01022190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111485304|NCT01024686|Vaccines|vaccines|mesh-list
111485305|NCT01024686|Immunologic Factors|immunologic factors|mesh-ancestor
111485306|NCT01024686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111485307|NCT01027806|Montelukast|montelukast|mesh-list
111485308|NCT01027806|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111485309|NCT01027806|Respiratory System Agents|respiratory system agents|mesh-ancestor
111485310|NCT01027806|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
111485311|NCT01027806|Hormone Antagonists|hormone antagonists|mesh-ancestor
111102704|NCT05493657|Sensory System Agents|sensory system agents|mesh-ancestor
111485312|NCT01027806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111102705|NCT05493657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111102706|NCT05493657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111485313|NCT01027806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111485314|NCT01027806|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
111485315|NCT01027806|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111485316|NCT01027806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111485317|NCT01029054|Dexamethasone|dexamethasone|mesh-list
111485318|NCT01029054|Dexamethasone acetate|dexamethasone acetate|mesh-list
111485319|NCT01029054|Lenalidomide|lenalidomide|mesh-list
111485320|NCT01029054|BB 1101|bb 1101|mesh-list
111485321|NCT01029054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111485322|NCT01029054|Antiemetics|antiemetics|mesh-ancestor
111485323|NCT01029054|Autonomic Agents|autonomic agents|mesh-ancestor
111485324|NCT01029054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111485325|NCT01029054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111485326|NCT01029054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111485327|NCT01029054|Glucocorticoids|glucocorticoids|mesh-ancestor
111485328|NCT01029054|Hormones|hormones|mesh-ancestor
111485329|NCT01029054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111485330|NCT01029054|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111485331|NCT01029054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111485332|NCT01029054|Protease Inhibitors|protease inhibitors|mesh-ancestor
111485333|NCT01029054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111485334|NCT01029054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111485335|NCT01029054|Immunologic Factors|immunologic factors|mesh-ancestor
111485336|NCT01029054|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111485337|NCT01029054|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111485338|NCT01029054|Growth Substances|growth substances|mesh-ancestor
110322883|NCT03274167|Gabapentin|gabapentin|mesh-list
111485339|NCT01029054|Growth Inhibitors|growth inhibitors|mesh-ancestor
111485340|NCT01032954|Botulinum Toxins|botulinum toxins|mesh-list
111485341|NCT01032954|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111485342|NCT01032954|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111485343|NCT01032954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111485344|NCT01032954|Cholinergic Agents|cholinergic agents|mesh-ancestor
111485345|NCT01032954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111485346|NCT01032954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111485347|NCT05592678|Donepezil|donepezil|mesh-list
111485348|NCT05592678|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111485349|NCT05592678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111485350|NCT05592678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111485351|NCT05592678|Cholinergic Agents|cholinergic agents|mesh-ancestor
111485352|NCT05592678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111485353|NCT05592678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111485354|NCT05592678|Nootropic Agents|nootropic agents|mesh-ancestor
111485355|NCT05402826|Vitamin E|vitamin e|mesh-list
111485356|NCT05402826|Vitamins|vitamins|mesh-ancestor
111485357|NCT05402826|Micronutrients|micronutrients|mesh-ancestor
111485358|NCT05402826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111485359|NCT05402826|Antioxidants|antioxidants|mesh-ancestor
111485360|NCT05402826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111485361|NCT05402826|Protective Agents|protective agents|mesh-ancestor
111485362|NCT05385042|Vitamin B 12|vitamin b 12|mesh-list
111485363|NCT05385042|Thiamine|thiamine|mesh-list
111485364|NCT05385042|Vitamins|vitamins|mesh-ancestor
111485365|NCT05385042|Micronutrients|micronutrients|mesh-ancestor
111485366|NCT05385042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111485367|NCT05385042|Vitamin B Complex|vitamin b complex|mesh-ancestor
111485368|NCT05306028|Metformin|metformin|mesh-list
111485369|NCT05306028|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111485370|NCT05306028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111485371|NCT05179668|Dapagliflozin|dapagliflozin|mesh-list
111485372|NCT05179668|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111485373|NCT05179668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111485374|NCT05179668|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111485375|NCT05179668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111485376|NCT04780932|Macitentan|macitentan|mesh-list
111485377|NCT04780932|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
111485378|NCT04780932|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
111485379|NCT04780932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111485380|NCT04780932|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
111485381|NCT04316910|Anesthetics|anesthetics|mesh-list
111485382|NCT04316910|Anesthetics, General|anesthetics, general|mesh-list
111485383|NCT04316910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111485384|NCT04316910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111485385|NCT04308330|Vorinostat|vorinostat|mesh-list
111485386|NCT04308330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111485387|NCT04308330|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111485388|NCT04308330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111485389|NCT04308330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111485390|NCT03680508|Dostarlimab|dostarlimab|mesh-list
111485391|NCT03680508|Antibodies|antibodies|mesh-list
111485392|NCT03680508|Immunoglobulins|immunoglobulins|mesh-list
111485393|NCT03680508|Immunologic Factors|immunologic factors|mesh-ancestor
111485394|NCT03680508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111485395|NCT03680508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111485396|NCT01842672|Mitoxantrone|mitoxantrone|mesh-list
111485397|NCT01842672|Clofarabine|clofarabine|mesh-list
111485398|NCT01842672|Analgesics|analgesics|mesh-ancestor
111485399|NCT01842672|Sensory System Agents|sensory system agents|mesh-ancestor
111485400|NCT01842672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111485401|NCT01842672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111485402|NCT01842672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111485403|NCT01842672|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111485404|NCT01842672|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111485405|NCT01842672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111485406|NCT01842672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111485407|NCT01842672|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111485408|NCT01842672|Antimetabolites|antimetabolites|mesh-ancestor
111485409|NCT01034592|Lenalidomide|lenalidomide|mesh-list
111485410|NCT01034592|Immunologic Factors|immunologic factors|mesh-ancestor
111485411|NCT01034592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111485412|NCT01034592|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111485413|NCT01034592|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111485414|NCT01034592|Growth Substances|growth substances|mesh-ancestor
111485415|NCT01034592|Growth Inhibitors|growth inhibitors|mesh-ancestor
111485416|NCT01034592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111485417|NCT01037790|Palbociclib|palbociclib|mesh-list
111485418|NCT01037790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111485419|NCT01037790|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111485420|NCT01037790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111485421|NCT01037790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111485422|NCT01043094|Pitavastatin|pitavastatin|mesh-list
111485423|NCT01043094|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111485424|NCT01043094|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111485425|NCT01043094|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111485426|NCT01043094|Antimetabolites|antimetabolites|mesh-ancestor
111485427|NCT01043094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111485428|NCT01043094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111485429|NCT01043094|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111485430|NCT01043640|Cyclosporine|cyclosporine|mesh-list
111485431|NCT01043640|Mycophenolic Acid|mycophenolic acid|mesh-list
111485432|NCT01043640|Cyclophosphamide|cyclophosphamide|mesh-list
111485433|NCT01043640|Busulfan|busulfan|mesh-list
111485434|NCT01043640|Alemtuzumab|alemtuzumab|mesh-list
111485435|NCT01043640|Cyclosporins|cyclosporins|mesh-list
111485436|NCT01043640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111485437|NCT01043640|Immunologic Factors|immunologic factors|mesh-ancestor
111485438|NCT01043640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111485439|NCT01043640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111485440|NCT01043640|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111485441|NCT01043640|Alkylating Agents|alkylating agents|mesh-ancestor
111485442|NCT01043640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111485443|NCT01043640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111485444|NCT01043640|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111485445|NCT01043640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111485446|NCT01043640|Antifungal Agents|antifungal agents|mesh-ancestor
111485447|NCT01043640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111485448|NCT01043640|Dermatologic Agents|dermatologic agents|mesh-ancestor
110646117|NCT04175613|Apremilast|apremilast|mesh-list
111485449|NCT01043640|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111485450|NCT01043640|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111485451|NCT01043640|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111485452|NCT01043640|Antitubercular Agents|antitubercular agents|mesh-ancestor
111485453|NCT01043640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111485454|NCT01043640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111485455|NCT01044966|Temozolomide|temozolomide|mesh-list
111102707|NCT05493657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111485456|NCT01044966|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111102708|NCT05493657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111485457|NCT01044966|Alkylating Agents|alkylating agents|mesh-ancestor
111485458|NCT01044966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111485459|NCT01044966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111485460|NCT01045122|Dexmedetomidine|dexmedetomidine|mesh-list
111485462|NCT01045122|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111485463|NCT01045122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111485464|NCT01045122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111485465|NCT01045122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111485466|NCT01045122|Analgesics|analgesics|mesh-ancestor
111485467|NCT01045122|Sensory System Agents|sensory system agents|mesh-ancestor
111485468|NCT01045122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111485469|NCT01045122|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111485470|NCT01045122|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111485471|NCT01045122|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111485472|NCT01045122|Adrenergic Agents|adrenergic agents|mesh-ancestor
111485473|NCT01045122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111485474|NCT01045122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111485475|NCT01045122|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111485476|NCT01045122|Anesthetics, General|anesthetics, general|mesh-ancestor
111485477|NCT01045122|Anesthetics|anesthetics|mesh-ancestor
111485478|NCT01050582|Risperidone|risperidone|mesh-list
111485479|NCT01050582|Antipsychotic Agents|antipsychotic agents|mesh-list
111485480|NCT01050582|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111485481|NCT01050582|Serotonin Agents|serotonin agents|mesh-ancestor
111485482|NCT01050582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111485483|NCT01050582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111485484|NCT01050582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111485485|NCT01050582|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111485486|NCT01050582|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111485487|NCT01050582|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111485488|NCT01050582|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111485489|NCT01050582|Dopamine Agents|dopamine agents|mesh-ancestor
111485490|NCT01050660|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
111485491|NCT01050660|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
111485492|NCT01050660|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
111485493|NCT01050660|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111485494|NCT01051440|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
111485495|NCT01051440|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111485496|NCT01051440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111485497|NCT01051440|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111485498|NCT01051440|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111485499|NCT01051440|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111485500|NCT01051440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111485501|NCT01051440|Dopamine Agents|dopamine agents|mesh-ancestor
111485502|NCT01051440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111485503|NCT01051596|Temozolomide|temozolomide|mesh-list
111485504|NCT01051596|Veliparib|veliparib|mesh-list
111485505|NCT01051596|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111485506|NCT01051596|Alkylating Agents|alkylating agents|mesh-ancestor
111485507|NCT01051596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111485508|NCT01051596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110646144|NCT04112823|BB 1101|bb 1101|mesh-list
111485509|NCT01051596|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111485510|NCT01051596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111485511|NCT01053000|Tazarotene|tazarotene|mesh-list
111485512|NCT01053000|Dermatologic Agents|dermatologic agents|mesh-ancestor
111485513|NCT01053000|Keratolytic Agents|keratolytic agents|mesh-ancestor
111485514|NCT05822453|Gemcitabine|gemcitabine|mesh-list
111485515|NCT05822453|Tislelizumab|tislelizumab|mesh-list
111485516|NCT05822453|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111485517|NCT05822453|Antimetabolites|antimetabolites|mesh-ancestor
111485518|NCT05822453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111485519|NCT05822453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111485520|NCT05822453|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111485521|NCT01028820|Aripiprazole|aripiprazole|mesh-list
111485522|NCT01028820|Antidepressive Agents|antidepressive agents|mesh-ancestor
111485523|NCT01028820|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111485524|NCT01028820|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111485525|NCT01028820|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111485526|NCT01028820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111485527|NCT01028820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111485528|NCT01028820|Dopamine Agonists|dopamine agonists|mesh-ancestor
111485529|NCT01028820|Dopamine Agents|dopamine agents|mesh-ancestor
111485530|NCT01028820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111485531|NCT01028820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111485532|NCT01028820|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111485533|NCT01028820|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111485534|NCT01028820|Serotonin Agents|serotonin agents|mesh-ancestor
111485535|NCT01028820|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111485536|NCT01028820|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111485537|NCT01028820|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111485538|NCT01028820|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111485539|NCT05822362|Cannabidiol|cannabidiol|mesh-list
111485540|NCT05822362|Anticonvulsants|anticonvulsants|mesh-ancestor
111485541|NCT05822323|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111485542|NCT05822323|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111485543|NCT05822323|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111485544|NCT05822323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111485545|NCT05822323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111485546|NCT05822323|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111485547|NCT05822323|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111485548|NCT05822323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111485549|NCT05822323|Cholinergic Agents|cholinergic agents|mesh-ancestor
111485550|NCT05822323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111485551|NCT05821933|Aflutinib|aflutinib|mesh-list
111485552|NCT05821933|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111485553|NCT05821933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111485554|NCT05821933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111485555|NCT05821751|Pembrolizumab|pembrolizumab|mesh-list
111485556|NCT05821751|Nivolumab|nivolumab|mesh-list
111485557|NCT05821751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111485558|NCT05821751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111485559|NCT05821751|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110646151|NCT04112823|Glucocorticoids|glucocorticoids|mesh-ancestor
111485560|NCT05821751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111485561|NCT05821712|Listerine|listerine|mesh-list
111485562|NCT05821712|Fluorides|fluorides|mesh-list
111485563|NCT05821712|Sodium Fluoride|sodium fluoride|mesh-list
111485564|NCT05821712|Cariostatic Agents|cariostatic agents|mesh-ancestor
111485565|NCT05821712|Protective Agents|protective agents|mesh-ancestor
111485566|NCT05821712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111485567|NCT05821712|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111485568|NCT05821712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111485569|NCT05821478|Metronidazole|metronidazole|mesh-list
111485570|NCT05821478|Rifampin|rifampin|mesh-list
111485571|NCT05821478|Ceftriaxone|ceftriaxone|mesh-list
111485572|NCT05821478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111485573|NCT05821478|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111485574|NCT05821478|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111485575|NCT05821478|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111485576|NCT05821478|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111485577|NCT05821478|Antitubercular Agents|antitubercular agents|mesh-ancestor
111485578|NCT05821478|Leprostatic Agents|leprostatic agents|mesh-ancestor
111485579|NCT05821478|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111485580|NCT05821478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111485581|NCT05821478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111485582|NCT05821478|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111485583|NCT05821478|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111485584|NCT05821478|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
111485585|NCT05821478|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
111485586|NCT05821478|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
111485587|NCT05821478|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111485588|NCT05821452|Paclitaxel|paclitaxel|mesh-list
111485589|NCT05821452|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111485590|NCT05821452|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111485591|NCT05821452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111485592|NCT05821452|Tubulin Modulators|tubulin modulators|mesh-ancestor
111485593|NCT05821452|Antimitotic Agents|antimitotic agents|mesh-ancestor
111485594|NCT05821452|Mitosis Modulators|mitosis modulators|mesh-ancestor
111485595|NCT05821452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111485596|NCT05821361|Bevacizumab|bevacizumab|mesh-list
111485597|NCT05821361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111485598|NCT05821361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111102709|NCT05493657|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111485599|NCT05821361|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111485600|NCT05821361|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111102710|NCT05493657|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111102711|NCT05493657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111102712|NCT05493657|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111485601|NCT05821361|Growth Substances|growth substances|mesh-ancestor
111485602|NCT05821361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111485603|NCT05821361|Growth Inhibitors|growth inhibitors|mesh-ancestor
111485604|NCT05821192|Dexamethasone|dexamethasone|mesh-list
111485606|NCT05821192|Gemcitabine|gemcitabine|mesh-list
111485607|NCT05821192|Antibodies|antibodies|mesh-list
111485608|NCT05821192|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111485609|NCT05821192|Immunologic Factors|immunologic factors|mesh-ancestor
111485610|NCT05821192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111485611|NCT05821192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111485612|NCT05821192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111485613|NCT05821192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111485614|NCT05821192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111485615|NCT05821192|Antiemetics|antiemetics|mesh-ancestor
111485616|NCT05821192|Autonomic Agents|autonomic agents|mesh-ancestor
111485617|NCT05821192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111485618|NCT05821192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111485619|NCT05821192|Glucocorticoids|glucocorticoids|mesh-ancestor
111485620|NCT05821192|Hormones|hormones|mesh-ancestor
111485621|NCT05821192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111485622|NCT05821192|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111485623|NCT05821192|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111485624|NCT05821192|Antimetabolites|antimetabolites|mesh-ancestor
111485625|NCT05821192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111485626|NCT05821153|Aldesleukin|aldesleukin|mesh-list
111485627|NCT05821153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111485628|NCT05821153|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111485629|NCT05821153|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111485630|NCT05821153|Antiviral Agents|antiviral agents|mesh-ancestor
111485631|NCT05821153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111485632|NCT05821062|Aspirin|aspirin|mesh-list
111485633|NCT05821062|Clopidogrel|clopidogrel|mesh-list
111485634|NCT05821062|Ticagrelor|ticagrelor|mesh-list
111485635|NCT05821062|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
111485636|NCT05821062|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111485637|NCT05821062|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111485638|NCT05821062|Analgesics|analgesics|mesh-ancestor
111485639|NCT05821062|Sensory System Agents|sensory system agents|mesh-ancestor
111485640|NCT05821062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111485641|NCT05821062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111485642|NCT05821062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111485643|NCT05821062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111485644|NCT05821062|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111485645|NCT05821062|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111485646|NCT05821062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111485647|NCT05821062|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111485648|NCT05821062|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111485649|NCT05821062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111485650|NCT05821062|Antipyretics|antipyretics|mesh-ancestor
111485651|NCT05821062|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111485652|NCT05821062|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111485653|NCT05821062|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111485654|NCT05821062|Purinergic Agents|purinergic agents|mesh-ancestor
111485655|NCT05821062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111485656|NCT05818553|Pramoxine|pramoxine|mesh-list
111485657|NCT05818553|Anesthetics, Local|anesthetics, local|mesh-ancestor
111485658|NCT05818553|Anesthetics|anesthetics|mesh-ancestor
111485659|NCT05818553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111485660|NCT05818553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111485661|NCT05818553|Sensory System Agents|sensory system agents|mesh-ancestor
111485662|NCT05818553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111485663|NCT05817162|Ropivacaine|ropivacaine|mesh-list
111485664|NCT05817162|Anesthetics, Local|anesthetics, local|mesh-ancestor
111485665|NCT05817162|Anesthetics|anesthetics|mesh-ancestor
111485666|NCT05817162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111485667|NCT05817162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111485668|NCT05817162|Sensory System Agents|sensory system agents|mesh-ancestor
111485669|NCT05817162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111485670|NCT05809180|Rituximab|rituximab|mesh-list
111485671|NCT05809180|Pomalidomide|pomalidomide|mesh-list
111485672|NCT05809180|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110693740|NCT03892889|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111485673|NCT05809180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111485674|NCT05809180|Immunologic Factors|immunologic factors|mesh-ancestor
111102713|NCT05493657|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111485675|NCT05809180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111485676|NCT05809180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111485677|NCT05809180|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111485678|NCT05809180|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111485679|NCT05809180|Growth Substances|growth substances|mesh-ancestor
111485680|NCT05809180|Growth Inhibitors|growth inhibitors|mesh-ancestor
111485681|NCT05802238|Tranexamic Acid|tranexamic acid|mesh-list
111485682|NCT05802238|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111485683|NCT05802238|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111485684|NCT05802238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111485685|NCT05802238|Hemostatics|hemostatics|mesh-ancestor
111485686|NCT05802238|Coagulants|coagulants|mesh-ancestor
111485687|NCT05796570|Decitabine|decitabine|mesh-list
111485688|NCT05796570|Lenograstim|lenograstim|mesh-list
111485689|NCT05796570|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111485690|NCT05796570|Immunologic Factors|immunologic factors|mesh-ancestor
111485691|NCT05796570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111485692|NCT05796570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111485693|NCT05796570|Antimetabolites|antimetabolites|mesh-ancestor
111485694|NCT05796570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111485695|NCT05796570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111485696|NCT05796570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111485697|NCT05791617|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
111485698|NCT05791617|Natriuretic Agents|natriuretic agents|mesh-ancestor
111485699|NCT05791617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111485700|NCT05738057|Cisplatin|cisplatin|mesh-list
111485701|NCT05738057|Gemcitabine|gemcitabine|mesh-list
111485702|NCT05738057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111485703|NCT05738057|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111485704|NCT05738057|Antimetabolites|antimetabolites|mesh-ancestor
111485705|NCT05738057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111485706|NCT05699408|Insulin Glargine|insulin glargine|mesh-list
111485707|NCT05699408|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111485708|NCT05699408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111485709|NCT05668286|Triamcinolone|triamcinolone|mesh-list
111485710|NCT05668286|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
111485711|NCT05668286|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
111485712|NCT05668286|Prilocaine|prilocaine|mesh-list
111485713|NCT05668286|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
111485714|NCT05668286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111485715|NCT05668286|Glucocorticoids|glucocorticoids|mesh-ancestor
111485716|NCT05668286|Hormones|hormones|mesh-ancestor
111485717|NCT05668286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111485718|NCT05668286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111485719|NCT05668286|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111485720|NCT05668286|Immunologic Factors|immunologic factors|mesh-ancestor
111485721|NCT05668286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111485722|NCT05668286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111485723|NCT05668286|Anesthetics, Local|anesthetics, local|mesh-ancestor
111485724|NCT05668286|Anesthetics|anesthetics|mesh-ancestor
111485725|NCT05668286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111485726|NCT05668286|Sensory System Agents|sensory system agents|mesh-ancestor
111485727|NCT05668286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111485728|NCT06024031|Acetylcysteine|acetylcysteine|mesh-list
111485729|NCT06024031|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111485730|NCT06024031|Antiviral Agents|antiviral agents|mesh-ancestor
111485731|NCT06024031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111485732|NCT06024031|Expectorants|expectorants|mesh-ancestor
111485733|NCT06024031|Respiratory System Agents|respiratory system agents|mesh-ancestor
111485734|NCT06024031|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111485735|NCT06024031|Antioxidants|antioxidants|mesh-ancestor
111485736|NCT06024031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111485737|NCT06024031|Protective Agents|protective agents|mesh-ancestor
111485738|NCT06024031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111485739|NCT06024031|Antidotes|antidotes|mesh-ancestor
111485740|NCT06024005|Solifenacin Succinate|solifenacin succinate|mesh-list
111485741|NCT06024005|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111485742|NCT06024005|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111485743|NCT06024005|Cholinergic Agents|cholinergic agents|mesh-ancestor
111485744|NCT06024005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111485745|NCT06024005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111485746|NCT06024005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111485747|NCT06024005|Urological Agents|urological agents|mesh-ancestor
111102714|NCT05493657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111485748|NCT06023875|Docetaxel|docetaxel|mesh-list
111485749|NCT06023875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111485750|NCT06023875|Tubulin Modulators|tubulin modulators|mesh-ancestor
111485751|NCT06023875|Antimitotic Agents|antimitotic agents|mesh-ancestor
111485752|NCT06023875|Mitosis Modulators|mitosis modulators|mesh-ancestor
111485753|NCT06023875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111485755|NCT06023862|Bevacizumab|bevacizumab|mesh-list
111485756|NCT06023862|Gemcitabine|gemcitabine|mesh-list
111485757|NCT06023862|Doxorubicin|doxorubicin|mesh-list
111485758|NCT06023862|Dostarlimab|dostarlimab|mesh-list
111485759|NCT06023862|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111485760|NCT06023862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111485761|NCT06023862|Tubulin Modulators|tubulin modulators|mesh-ancestor
111485762|NCT06023862|Antimitotic Agents|antimitotic agents|mesh-ancestor
111485763|NCT06023862|Mitosis Modulators|mitosis modulators|mesh-ancestor
111485764|NCT06023862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111485765|NCT06023862|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111485766|NCT06023862|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111485767|NCT06023862|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111485768|NCT06023862|Growth Substances|growth substances|mesh-ancestor
111485769|NCT06023862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111485770|NCT06023862|Growth Inhibitors|growth inhibitors|mesh-ancestor
111485771|NCT06023862|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111485772|NCT06023862|Antimetabolites|antimetabolites|mesh-ancestor
111485773|NCT06023862|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111485774|NCT06023862|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111485775|NCT06023862|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111485776|NCT06023862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111485777|NCT05814042|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111485778|NCT05614739|Pembrolizumab|pembrolizumab|mesh-list
111485779|NCT05614739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111485780|NCT05614739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111485781|NCT05614739|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111485782|NCT05614739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111485783|NCT05557877|Aspirin|aspirin|mesh-list
111485784|NCT05557877|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111485785|NCT05557877|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111485786|NCT05557877|Analgesics|analgesics|mesh-ancestor
111485787|NCT05557877|Sensory System Agents|sensory system agents|mesh-ancestor
111485788|NCT05557877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111485789|NCT05557877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111485790|NCT05557877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111485791|NCT05557877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111485792|NCT05557877|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111485793|NCT05557877|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111485794|NCT05557877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111485795|NCT05557877|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111485796|NCT05557877|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111485797|NCT05557877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111485798|NCT05557877|Antipyretics|antipyretics|mesh-ancestor
111485799|NCT05549661|Onvansertib|onvansertib|mesh-list
111485800|NCT05549661|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111485801|NCT05549661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111485802|NCT05549661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111485803|NCT05393713|Antibodies|antibodies|mesh-list
111485804|NCT05393713|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111485805|NCT05393713|Immunologic Factors|immunologic factors|mesh-ancestor
111485806|NCT05393713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111485807|NCT05297396|Analgesics, Opioid|analgesics, opioid|mesh-list
111485808|NCT05297396|Narcotics|narcotics|mesh-ancestor
111485809|NCT05297396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111485810|NCT05297396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111485811|NCT05297396|Analgesics|analgesics|mesh-ancestor
111485812|NCT05297396|Sensory System Agents|sensory system agents|mesh-ancestor
111485813|NCT05297396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111485814|NCT03695471|Pembrolizumab|pembrolizumab|mesh-list
111485815|NCT03695471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110646203|NCT03896737|Thalidomide|thalidomide|mesh-list
111485816|NCT03695471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111485817|NCT03695471|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111485818|NCT03695471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111485819|NCT02464696|Methylprednisolone|methylprednisolone|mesh-list
111485820|NCT02464696|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111485821|NCT02464696|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111102715|NCT05493657|Antipyretics|antipyretics|mesh-ancestor
111102716|NCT05493657|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111485823|NCT02464696|Prednisolone acetate|prednisolone acetate|mesh-list
111485824|NCT02464696|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111485825|NCT02464696|Prednisolone phosphate|prednisolone phosphate|mesh-list
111485826|NCT02464696|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111485827|NCT02464696|Antiemetics|antiemetics|mesh-ancestor
111485828|NCT02464696|Autonomic Agents|autonomic agents|mesh-ancestor
111485829|NCT02464696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111485830|NCT02464696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111485831|NCT02464696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111485832|NCT02464696|Glucocorticoids|glucocorticoids|mesh-ancestor
111485833|NCT02464696|Hormones|hormones|mesh-ancestor
111485834|NCT02464696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111485835|NCT02464696|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111485836|NCT02464696|Protective Agents|protective agents|mesh-ancestor
111485837|NCT02464696|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111485838|NCT02464696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111485839|NCT02389309|Sirolimus|sirolimus|mesh-list
111485840|NCT02389309|Cyclophosphamide|cyclophosphamide|mesh-list
111485841|NCT02389309|Temsirolimus|temsirolimus|mesh-list
111485842|NCT02389309|Dasatinib|dasatinib|mesh-list
111485843|NCT02389309|MTOR Inhibitors|mtor inhibitors|mesh-list
111485844|NCT02389309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111485845|NCT02389309|Immunologic Factors|immunologic factors|mesh-ancestor
111485846|NCT02389309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111485847|NCT02389309|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111485848|NCT02389309|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111485849|NCT02389309|Alkylating Agents|alkylating agents|mesh-ancestor
110646225|NCT03896737|Hormones|hormones|mesh-ancestor
111485850|NCT02389309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111485851|NCT02389309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111485852|NCT02389309|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111485853|NCT02389309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111485854|NCT02389309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111485855|NCT02389309|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111485856|NCT02389309|Antifungal Agents|antifungal agents|mesh-ancestor
111485857|NCT02389309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111485858|NCT02389309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111485859|NCT02231775|Trametinib|trametinib|mesh-list
111485860|NCT02231775|Dabrafenib|dabrafenib|mesh-list
111485861|NCT02231775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111485862|NCT02231775|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111485863|NCT02231775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111485864|NCT02231775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111485865|NCT02135874|Cytarabine|cytarabine|mesh-list
111485866|NCT02135874|Dexamethasone|dexamethasone|mesh-list
111485867|NCT02135874|Dexamethasone acetate|dexamethasone acetate|mesh-list
111485868|NCT02135874|Rituximab|rituximab|mesh-list
111485869|NCT02135874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111485870|NCT02135874|Vincristine|vincristine|mesh-list
111485871|NCT02135874|Sorafenib|sorafenib|mesh-list
111485872|NCT02135874|Idarubicin|idarubicin|mesh-list
111485873|NCT02135874|Clofarabine|clofarabine|mesh-list
111485874|NCT02135874|Antibodies|antibodies|mesh-list
111485875|NCT02135874|Immunoglobulins|immunoglobulins|mesh-list
111485876|NCT02135874|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111485877|NCT02135874|BB 1101|bb 1101|mesh-list
111485878|NCT02135874|Immunologic Factors|immunologic factors|mesh-ancestor
111485879|NCT02135874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111485880|NCT02135874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111485881|NCT02135874|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111485882|NCT02135874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111485883|NCT02135874|Antiemetics|antiemetics|mesh-ancestor
111485884|NCT02135874|Autonomic Agents|autonomic agents|mesh-ancestor
111102717|NCT05493657|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111102718|NCT05493657|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111102719|NCT05493657|Purinergic Agents|purinergic agents|mesh-ancestor
111102720|NCT05493657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111102721|NCT05493267|Zoledronic Acid|zoledronic acid|mesh-list
111102722|NCT05493267|Interleukin-2|interleukin-2|mesh-list
111102723|NCT05493267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111102724|NCT05493267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111102725|NCT05493267|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111485885|NCT02135874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111485886|NCT02135874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111485887|NCT02135874|Glucocorticoids|glucocorticoids|mesh-ancestor
111485888|NCT02135874|Hormones|hormones|mesh-ancestor
111485889|NCT02135874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111102726|NCT05493267|Analgesics|analgesics|mesh-ancestor
111485890|NCT02135874|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111485891|NCT02135874|Protease Inhibitors|protease inhibitors|mesh-ancestor
111485892|NCT02135874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111485893|NCT02135874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111485894|NCT02135874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111485895|NCT02135874|Antimetabolites|antimetabolites|mesh-ancestor
111485896|NCT02135874|Antiviral Agents|antiviral agents|mesh-ancestor
111485897|NCT02135874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111485898|NCT02135874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111485899|NCT02135874|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111485900|NCT02135874|Tubulin Modulators|tubulin modulators|mesh-ancestor
111485901|NCT02135874|Antimitotic Agents|antimitotic agents|mesh-ancestor
111485902|NCT02135874|Mitosis Modulators|mitosis modulators|mesh-ancestor
111485903|NCT02135874|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111485904|NCT02135874|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111485905|NCT02135874|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111485906|NCT02135874|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111485908|NCT01738139|Imatinib Mesylate|imatinib mesylate|mesh-list
111485909|NCT01738139|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111485910|NCT01738139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111485911|NCT01738139|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111485912|NCT01738139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111485913|NCT01738139|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111485914|NCT01738139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111485915|NCT00501826|Cytarabine|cytarabine|mesh-list
111485916|NCT00501826|6-methoxypurine arabinoside|6-methoxypurine arabinoside|mesh-list
111485917|NCT00501826|Dexamethasone|dexamethasone|mesh-list
111485918|NCT00501826|Dexamethasone acetate|dexamethasone acetate|mesh-list
111485919|NCT00501826|Prednisone|prednisone|mesh-list
111485920|NCT00501826|Cortisone|cortisone|mesh-list
111485921|NCT00501826|Cyclophosphamide|cyclophosphamide|mesh-list
111485922|NCT00501826|Doxorubicin|doxorubicin|mesh-list
111485923|NCT00501826|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111485924|NCT00501826|Methotrexate|methotrexate|mesh-list
111485925|NCT00501826|Vincristine|vincristine|mesh-list
111485926|NCT00501826|Venetoclax|venetoclax|mesh-list
111485927|NCT00501826|Asparaginase|asparaginase|mesh-list
111485928|NCT00501826|Mercaptopurine|mercaptopurine|mesh-list
111485929|NCT00501826|Pegaspargase|pegaspargase|mesh-list
111485930|NCT00501826|BB 1101|bb 1101|mesh-list
111485931|NCT00501826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111485932|NCT00501826|Immunologic Factors|immunologic factors|mesh-ancestor
111485933|NCT00501826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111485934|NCT00501826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111485935|NCT00501826|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111485936|NCT00501826|Alkylating Agents|alkylating agents|mesh-ancestor
111485937|NCT00501826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111485938|NCT00501826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111485939|NCT00501826|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111485940|NCT00501826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111485941|NCT00501826|Antiemetics|antiemetics|mesh-ancestor
111485942|NCT00501826|Autonomic Agents|autonomic agents|mesh-ancestor
111485943|NCT00501826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111485944|NCT00501826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111485945|NCT00501826|Glucocorticoids|glucocorticoids|mesh-ancestor
111485946|NCT00501826|Hormones|hormones|mesh-ancestor
111485947|NCT00501826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111485948|NCT00501826|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111485949|NCT00501826|Protease Inhibitors|protease inhibitors|mesh-ancestor
111485950|NCT00501826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111485951|NCT00501826|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111485952|NCT00501826|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111485953|NCT00501826|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111485954|NCT00501826|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111485955|NCT00501826|Abortifacient Agents|abortifacient agents|mesh-ancestor
111485956|NCT00501826|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111485957|NCT00501826|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111485958|NCT00501826|Antimetabolites|antimetabolites|mesh-ancestor
111485959|NCT00501826|Dermatologic Agents|dermatologic agents|mesh-ancestor
111485960|NCT00501826|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111102727|NCT05493267|Sensory System Agents|sensory system agents|mesh-ancestor
111485961|NCT00501826|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110694031|NCT00329901|Vaccines|vaccines|mesh-list
111485962|NCT00501826|Antiviral Agents|antiviral agents|mesh-ancestor
111485963|NCT00501826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111102728|NCT05493267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111485964|NCT00501826|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111485965|NCT00501826|Tubulin Modulators|tubulin modulators|mesh-ancestor
111485966|NCT00501826|Antimitotic Agents|antimitotic agents|mesh-ancestor
111485967|NCT00501826|Mitosis Modulators|mitosis modulators|mesh-ancestor
111485968|NCT05664958|Bupivacaine|bupivacaine|mesh-list
110159336|NCT00091117|Bortezomib|bortezomib|mesh-list
111485969|NCT05664958|Anesthetics, Local|anesthetics, local|mesh-ancestor
111485970|NCT05664958|Anesthetics|anesthetics|mesh-ancestor
111485971|NCT05664958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111485972|NCT05664958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111485973|NCT05664958|Sensory System Agents|sensory system agents|mesh-ancestor
111485974|NCT05664958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111485975|NCT05581823|Carbamazepine|carbamazepine|mesh-list
111485976|NCT05581823|Anticonvulsants|anticonvulsants|mesh-ancestor
111485977|NCT05581823|Antimanic Agents|antimanic agents|mesh-ancestor
111485978|NCT05581823|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111485979|NCT05581823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111485980|NCT05581823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111485981|NCT05581823|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111485982|NCT05581823|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111485983|NCT05581823|Analgesics|analgesics|mesh-ancestor
111485984|NCT05581823|Sensory System Agents|sensory system agents|mesh-ancestor
111485985|NCT05581823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111485986|NCT05581823|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111485987|NCT05581823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111485988|NCT05581823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111485989|NCT05581823|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111485990|NCT05581823|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111485991|NCT05500599|Fentanyl|fentanyl|mesh-list
111485992|NCT05500599|Midazolam|midazolam|mesh-list
111485993|NCT05500599|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111485994|NCT05500599|Narcotics|narcotics|mesh-ancestor
111485995|NCT05500599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111485996|NCT05500599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111485997|NCT05500599|Analgesics|analgesics|mesh-ancestor
111485998|NCT05500599|Sensory System Agents|sensory system agents|mesh-ancestor
111485999|NCT05500599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111486000|NCT05500599|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111486001|NCT05500599|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111486002|NCT05500599|Anesthetics, General|anesthetics, general|mesh-ancestor
111486003|NCT05500599|Anesthetics|anesthetics|mesh-ancestor
111486004|NCT05500599|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111486005|NCT05500599|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111486006|NCT05500599|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111486007|NCT05500599|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111486008|NCT05500599|GABA Modulators|gaba modulators|mesh-ancestor
111486009|NCT05500599|GABA Agents|gaba agents|mesh-ancestor
111486010|NCT05500599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111486011|NCT05500599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111486012|NCT05498116|Montelukast|montelukast|mesh-list
111486013|NCT05498116|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111486014|NCT05498116|Respiratory System Agents|respiratory system agents|mesh-ancestor
111486015|NCT05498116|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
111486016|NCT05498116|Hormone Antagonists|hormone antagonists|mesh-ancestor
111486017|NCT05498116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111486018|NCT05498116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111486019|NCT05498116|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
111486020|NCT05498116|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111486021|NCT05498116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111486022|NCT05471076|Complement C4b|complement c4b|mesh-list
111486023|NCT05471076|Immunologic Factors|immunologic factors|mesh-ancestor
111486024|NCT05471076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111486025|NCT05469178|Carboplatin|carboplatin|mesh-list
111486026|NCT05469178|Pembrolizumab|pembrolizumab|mesh-list
111486027|NCT05469178|Pemetrexed|pemetrexed|mesh-list
111486028|NCT05469178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111486029|NCT05469178|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111486030|NCT05469178|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111486031|NCT05469178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111486032|NCT05469178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111486033|NCT05469178|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111102729|NCT05493267|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111102730|NCT05492487|Megestrol Acetate|megestrol acetate|mesh-list
111486034|NCT05469178|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111486035|NCT05450484|Durvalumab|durvalumab|mesh-list
111486036|NCT05450484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111486037|NCT05450484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111486038|NCT05398484|Niacin|niacin|mesh-list
111486039|NCT05398484|Psilocybin|psilocybin|mesh-list
111486040|NCT05398484|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111486041|NCT05398484|Antimetabolites|antimetabolites|mesh-ancestor
111486042|NCT05398484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111486043|NCT05398484|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111486044|NCT05398484|Vasodilator Agents|vasodilator agents|mesh-ancestor
111486045|NCT05398484|Vitamin B Complex|vitamin b complex|mesh-ancestor
111486046|NCT05398484|Vitamins|vitamins|mesh-ancestor
111486047|NCT05398484|Micronutrients|micronutrients|mesh-ancestor
111486048|NCT05398484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111486049|NCT05398484|Hallucinogens|hallucinogens|mesh-ancestor
111486050|NCT05398484|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111486051|NCT05351502|Nitric Oxide|nitric oxide|mesh-list
111486052|NCT05351502|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111486053|NCT05351502|Autonomic Agents|autonomic agents|mesh-ancestor
111486054|NCT05351502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111486055|NCT05351502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111486056|NCT05351502|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111486057|NCT05351502|Respiratory System Agents|respiratory system agents|mesh-ancestor
111486058|NCT05351502|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111486059|NCT05351502|Antioxidants|antioxidants|mesh-ancestor
111486060|NCT05351502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111486061|NCT05351502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111486062|NCT05351502|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
111486063|NCT05351502|Vasodilator Agents|vasodilator agents|mesh-ancestor
111486064|NCT05351502|Gasotransmitters|gasotransmitters|mesh-ancestor
111486065|NCT05351502|Protective Agents|protective agents|mesh-ancestor
111486066|NCT05327296|Propofol|propofol|mesh-list
111486067|NCT05327296|Isoflurane|isoflurane|mesh-list
111486068|NCT05327296|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111486069|NCT05327296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111486070|NCT05327296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111486071|NCT05327296|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111486072|NCT05327296|Anesthetics, General|anesthetics, general|mesh-ancestor
111486073|NCT05327296|Anesthetics|anesthetics|mesh-ancestor
111486074|NCT05327296|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111486075|NCT05317000|Nivolumab|nivolumab|mesh-list
111486076|NCT05317000|Azacitidine|azacitidine|mesh-list
111486077|NCT05317000|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111486078|NCT05317000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111486079|NCT05317000|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111486080|NCT05317000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111486081|NCT05317000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111486082|NCT05317000|Antimetabolites|antimetabolites|mesh-ancestor
111486083|NCT05317000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111486084|NCT05292755|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
111486085|NCT05292755|Lubricant Eye Drops|lubricant eye drops|mesh-list
111486086|NCT05292755|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
111486087|NCT05292755|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111486088|NCT05292755|Laxatives|laxatives|mesh-ancestor
111486089|NCT05292755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111486090|NCT05283395|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111486091|NCT05283395|Latanoprost|latanoprost|mesh-list
111486092|NCT05283395|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111486093|NCT05275205|Aflibercept|aflibercept|mesh-list
111486094|NCT05275205|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111486095|NCT05275205|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111486096|NCT05275205|Growth Substances|growth substances|mesh-ancestor
111486097|NCT05275205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111486098|NCT05275205|Growth Inhibitors|growth inhibitors|mesh-ancestor
111486099|NCT05275205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111486100|NCT05270863|Brimonidine Tartrate|brimonidine tartrate|mesh-list
111486101|NCT05270863|Carbachol|carbachol|mesh-list
111486102|NCT05270863|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111486103|NCT05270863|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111486104|NCT05270863|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111486105|NCT05270863|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111486106|NCT05270863|Adrenergic Agents|adrenergic agents|mesh-ancestor
110646354|NCT03743766|Relatlimab|relatlimab|mesh-list
111486107|NCT05270863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111486108|NCT05270863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111486109|NCT05270863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111486110|NCT05270863|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110694175|NCT00352365|Lenalidomide|lenalidomide|mesh-list
111486111|NCT05270863|Miotics|miotics|mesh-ancestor
111102731|NCT05492487|Levonorgestrel|levonorgestrel|mesh-list
111486113|NCT05270863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111486114|NCT05270863|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111486115|NCT05270863|Cholinergic Agents|cholinergic agents|mesh-ancestor
111486116|NCT05270863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111486117|NCT05270863|Analgesics|analgesics|mesh-ancestor
111486118|NCT05270863|Sensory System Agents|sensory system agents|mesh-ancestor
111486119|NCT05270863|Protective Agents|protective agents|mesh-ancestor
111486120|NCT05237141|Etonogestrel|etonogestrel|mesh-list
111486121|NCT05237141|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111486122|NCT05237141|Contraceptive Agents|contraceptive agents|mesh-ancestor
111486123|NCT05237141|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111486124|NCT05237141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111486125|NCT05237141|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111486126|NCT05232409|Pembrolizumab|pembrolizumab|mesh-list
111486127|NCT05232409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111486128|NCT05232409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111486129|NCT05232409|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111486130|NCT05232409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111486131|NCT05137262|Cisplatin|cisplatin|mesh-list
111486132|NCT05137262|Doxorubicin|doxorubicin|mesh-list
111486133|NCT05137262|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111486134|NCT05137262|Methotrexate|methotrexate|mesh-list
111486135|NCT05137262|Durvalumab|durvalumab|mesh-list
111486136|NCT05137262|Abiraterone Acetate|abiraterone acetate|mesh-list
111486137|NCT05137262|Vinblastine|vinblastine|mesh-list
111486138|NCT05137262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111486139|NCT05137262|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111486140|NCT05137262|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111486141|NCT05137262|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111486142|NCT05137262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111486143|NCT05137262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111486144|NCT05137262|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111486145|NCT05137262|Abortifacient Agents|abortifacient agents|mesh-ancestor
111486146|NCT05137262|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111486147|NCT05137262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111486148|NCT05137262|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111486149|NCT05137262|Antimetabolites|antimetabolites|mesh-ancestor
111486150|NCT05137262|Dermatologic Agents|dermatologic agents|mesh-ancestor
111486151|NCT05137262|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111486152|NCT05137262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111486153|NCT05137262|Immunologic Factors|immunologic factors|mesh-ancestor
111486154|NCT05137262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111486155|NCT05137262|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111486156|NCT05137262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111486157|NCT05137262|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111486158|NCT05137262|Hormone Antagonists|hormone antagonists|mesh-ancestor
111486159|NCT05137262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111486160|NCT05137262|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111486161|NCT05137262|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111486162|NCT05137262|Tubulin Modulators|tubulin modulators|mesh-ancestor
111486163|NCT05137262|Antimitotic Agents|antimitotic agents|mesh-ancestor
111486164|NCT05137262|Mitosis Modulators|mitosis modulators|mesh-ancestor
111486165|NCT05124691|Ivermectin|ivermectin|mesh-list
111486166|NCT05124691|Albendazole|albendazole|mesh-list
111486167|NCT05124691|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111486168|NCT05124691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111486169|NCT05124691|Anthelmintics|anthelmintics|mesh-ancestor
111486170|NCT05124691|Anticestodal Agents|anticestodal agents|mesh-ancestor
111486171|NCT05124691|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
111486172|NCT05124691|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111486173|NCT05124691|Tubulin Modulators|tubulin modulators|mesh-ancestor
111486174|NCT05124691|Antimitotic Agents|antimitotic agents|mesh-ancestor
110646360|NCT03716180|Trastuzumab|trastuzumab|mesh-list
111486175|NCT05124691|Mitosis Modulators|mitosis modulators|mesh-ancestor
111486176|NCT05124691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111486177|NCT05124691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111486178|NCT05114837|Cyclophosphamide|cyclophosphamide|mesh-list
111486179|NCT05114837|Fludarabine|fludarabine|mesh-list
111486180|NCT05114837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111486181|NCT05114837|Immunologic Factors|immunologic factors|mesh-ancestor
111486182|NCT05114837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111102732|NCT05492487|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111102733|NCT05492487|Contraceptive Agents|contraceptive agents|mesh-ancestor
111486183|NCT05114837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111102734|NCT05492487|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111486184|NCT05114837|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111486186|NCT05114837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111486187|NCT05114837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111486188|NCT05114837|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111486189|NCT05014087|Digoxin|digoxin|mesh-list
111486190|NCT05014087|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111486191|NCT05014087|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111486192|NCT05014087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111486193|NCT05014087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111486194|NCT05014087|Protective Agents|protective agents|mesh-ancestor
111486195|NCT05014087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111486196|NCT04955678|Sorbitol|sorbitol|mesh-list
111486197|NCT04955678|Calcium|calcium|mesh-list
111486198|NCT04955678|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111486199|NCT04955678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111486200|NCT04955678|Cathartics|cathartics|mesh-ancestor
111486201|NCT04955678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111486202|NCT05175547|Clevidipine|clevidipine|mesh-list
111486203|NCT05175547|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111486204|NCT05175547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111486205|NCT05175547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111486206|NCT05175547|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111486207|NCT05175547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111486208|NCT04924166|Hydrocortisone|hydrocortisone|mesh-list
111486209|NCT04924166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111486210|NCT04908371|Lidocaine|lidocaine|mesh-list
111486211|NCT04908371|Epinephrine|epinephrine|mesh-list
111486212|NCT04908371|Racepinephrine|racepinephrine|mesh-list
111486213|NCT04908371|Levobupivacaine|levobupivacaine|mesh-list
111486214|NCT04908371|Epinephryl borate|epinephryl borate|mesh-list
111486215|NCT04908371|Anesthetics, Local|anesthetics, local|mesh-ancestor
111486216|NCT04908371|Anesthetics|anesthetics|mesh-ancestor
111486217|NCT04908371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111486218|NCT04908371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111486219|NCT04908371|Sensory System Agents|sensory system agents|mesh-ancestor
111486220|NCT04908371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111486221|NCT04908371|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111486222|NCT04908371|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111486223|NCT04908371|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111486224|NCT04908371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111486225|NCT04908371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111486226|NCT04908371|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111486227|NCT04908371|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111486228|NCT04908371|Adrenergic Agents|adrenergic agents|mesh-ancestor
111486229|NCT04908371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111486230|NCT04908371|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111486231|NCT04908371|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111486232|NCT04908371|Autonomic Agents|autonomic agents|mesh-ancestor
111486233|NCT04908371|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111486234|NCT04908371|Respiratory System Agents|respiratory system agents|mesh-ancestor
111486235|NCT04908371|Mydriatics|mydriatics|mesh-ancestor
111486236|NCT04908371|Sympathomimetics|sympathomimetics|mesh-ancestor
111486237|NCT04908371|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111486238|NCT04838379|Dexamethasone|dexamethasone|mesh-list
111486239|NCT04838379|Dexmedetomidine|dexmedetomidine|mesh-list
111486240|NCT04838379|Bupivacaine|bupivacaine|mesh-list
111486241|NCT04838379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111486242|NCT04838379|Antiemetics|antiemetics|mesh-ancestor
111486243|NCT04838379|Autonomic Agents|autonomic agents|mesh-ancestor
111486244|NCT04838379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111486245|NCT04838379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111486246|NCT04838379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111486247|NCT04838379|Glucocorticoids|glucocorticoids|mesh-ancestor
111486248|NCT04838379|Hormones|hormones|mesh-ancestor
111486249|NCT04838379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111486250|NCT04838379|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111486251|NCT04838379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111486252|NCT04838379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111486253|NCT04838379|Anesthetics, Local|anesthetics, local|mesh-ancestor
111486254|NCT04838379|Anesthetics|anesthetics|mesh-ancestor
111486255|NCT04838379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111102735|NCT05492487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111486256|NCT04838379|Sensory System Agents|sensory system agents|mesh-ancestor
111486257|NCT04838379|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111486258|NCT04838379|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111486259|NCT04838379|Analgesics|analgesics|mesh-ancestor
111486260|NCT04838379|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111486261|NCT04838379|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111486262|NCT04838379|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111486263|NCT04838379|Adrenergic Agents|adrenergic agents|mesh-ancestor
111486264|NCT04838379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111486265|NCT04830878|Methotrexate|methotrexate|mesh-list
111486266|NCT04830878|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111486267|NCT04830878|Abortifacient Agents|abortifacient agents|mesh-ancestor
111486268|NCT04830878|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111486269|NCT04830878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111486270|NCT04830878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111486271|NCT04830878|Antimetabolites|antimetabolites|mesh-ancestor
111486272|NCT04830878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111486273|NCT04830878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111486274|NCT04830878|Dermatologic Agents|dermatologic agents|mesh-ancestor
111486275|NCT04830878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111486276|NCT04830878|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111486277|NCT04830878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111486278|NCT04830878|Immunologic Factors|immunologic factors|mesh-ancestor
111486279|NCT04830878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111486280|NCT04830878|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111486281|NCT04812366|Prednisone|prednisone|mesh-list
111486282|NCT04812366|Docetaxel|docetaxel|mesh-list
111486283|NCT04812366|Atezolizumab|atezolizumab|mesh-list
111486284|NCT04812366|Abiraterone Acetate|abiraterone acetate|mesh-list
111486285|NCT04812366|Niraparib|niraparib|mesh-list
111486286|NCT04812366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111486287|NCT04812366|Tubulin Modulators|tubulin modulators|mesh-ancestor
111486288|NCT04812366|Antimitotic Agents|antimitotic agents|mesh-ancestor
111486289|NCT04812366|Mitosis Modulators|mitosis modulators|mesh-ancestor
111486290|NCT04812366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111486291|NCT04812366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111486292|NCT04812366|Glucocorticoids|glucocorticoids|mesh-ancestor
111486293|NCT04812366|Hormones|hormones|mesh-ancestor
111486294|NCT04812366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111486295|NCT04812366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111486296|NCT04812366|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111486297|NCT04812366|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111486298|NCT04812366|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111486299|NCT04812366|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111486300|NCT04812366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111486301|NCT04812366|Hormone Antagonists|hormone antagonists|mesh-ancestor
111486302|NCT04812366|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111486303|NCT04812366|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111486304|NCT04800107|Curcumin|curcumin|mesh-list
111486305|NCT04800107|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111486306|NCT04800107|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111486307|NCT04800107|Analgesics|analgesics|mesh-ancestor
111486308|NCT04800107|Sensory System Agents|sensory system agents|mesh-ancestor
111486309|NCT04800107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111486310|NCT04800107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111486311|NCT04800107|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111486312|NCT04800107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111486313|NCT04800107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111486314|NCT04800107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111486315|NCT04800107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111486316|NCT04786574|Tolvaptan|tolvaptan|mesh-list
111486317|NCT04786574|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
111486318|NCT04786574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111486319|NCT04786574|Natriuretic Agents|natriuretic agents|mesh-ancestor
111486320|NCT04786574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111486321|NCT04783857|Progesterone|progesterone|mesh-list
111486322|NCT04783857|Progestins|progestins|mesh-ancestor
111486323|NCT04783857|Hormones|hormones|mesh-ancestor
111486324|NCT04783857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111486325|NCT04783857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111102736|NCT05492487|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111486326|NCT04761159|Ketamine|ketamine|mesh-list
111486327|NCT04761159|Analgesics|analgesics|mesh-ancestor
111486328|NCT04761159|Sensory System Agents|sensory system agents|mesh-ancestor
111102737|NCT05492487|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111486329|NCT04761159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111486330|NCT04761159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111486331|NCT04761159|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111486332|NCT04761159|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111486333|NCT04761159|Anesthetics, General|anesthetics, general|mesh-ancestor
111486334|NCT04761159|Anesthetics|anesthetics|mesh-ancestor
111486335|NCT04761159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111486336|NCT04761159|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111486337|NCT04761159|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111486338|NCT04761159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111486339|NCT04761159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111486340|NCT04716296|Ketamine|ketamine|mesh-list
111486341|NCT04716296|Analgesics|analgesics|mesh-ancestor
111486342|NCT04716296|Sensory System Agents|sensory system agents|mesh-ancestor
111486343|NCT04716296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111486344|NCT04716296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111486345|NCT04716296|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111486346|NCT04716296|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111486347|NCT04716296|Anesthetics, General|anesthetics, general|mesh-ancestor
111486348|NCT04716296|Anesthetics|anesthetics|mesh-ancestor
111486349|NCT04716296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111486350|NCT04716296|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111486351|NCT04716296|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111486352|NCT04716296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111486353|NCT04716296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111486354|NCT04704141|Hormones|hormones|mesh-list
111486355|NCT04704141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111486356|NCT04704141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111486357|NCT04682041|Immunoglobulins|immunoglobulins|mesh-list
111486358|NCT04682041|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111486359|NCT04682041|Antibodies|antibodies|mesh-list
111486360|NCT04682041|Immunologic Factors|immunologic factors|mesh-ancestor
111486361|NCT04682041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111486362|NCT04675931|Artesunate|artesunate|mesh-list
111486363|NCT04675931|Lumefantrine|lumefantrine|mesh-list
111486364|NCT04675931|Artemether|artemether|mesh-list
111486365|NCT04675931|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
111486366|NCT04675931|Antimalarials|antimalarials|mesh-ancestor
111486367|NCT04675931|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111486368|NCT04675931|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111486369|NCT04675931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111486370|NCT04675931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111486371|NCT04675931|Antiviral Agents|antiviral agents|mesh-ancestor
111486372|NCT04675931|Schistosomicides|schistosomicides|mesh-ancestor
111486373|NCT04675931|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
111486374|NCT04675931|Anthelmintics|anthelmintics|mesh-ancestor
111486375|NCT04669678|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
111486376|NCT04669678|Medroxyprogesterone|medroxyprogesterone|mesh-list
111486377|NCT04669678|Etonogestrel|etonogestrel|mesh-list
111486378|NCT04669678|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111486379|NCT04669678|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111486380|NCT04669678|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111486381|NCT04669678|Contraceptive Agents|contraceptive agents|mesh-ancestor
111486382|NCT04669678|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111486383|NCT04669678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111486384|NCT04669678|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111486385|NCT04669678|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111486386|NCT04669678|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
111486387|NCT04669678|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111486388|NCT04669678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111486389|NCT04652661|Midazolam|midazolam|mesh-list
111486390|NCT04652661|Dexmedetomidine|dexmedetomidine|mesh-list
111486391|NCT04652661|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111486392|NCT04652661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111486393|NCT04652661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111486394|NCT04652661|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111486395|NCT04652661|Analgesics|analgesics|mesh-ancestor
111486396|NCT04652661|Sensory System Agents|sensory system agents|mesh-ancestor
111486397|NCT04652661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111486398|NCT04652661|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111486399|NCT04652661|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111486400|NCT04652661|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111486401|NCT04652661|Adrenergic Agents|adrenergic agents|mesh-ancestor
111486402|NCT04652661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111486403|NCT04652661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111486404|NCT04652661|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111486405|NCT04652661|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111486406|NCT04652661|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111486407|NCT04652661|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111486408|NCT04652661|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111486409|NCT04652661|Anesthetics, General|anesthetics, general|mesh-ancestor
111486410|NCT04652661|Anesthetics|anesthetics|mesh-ancestor
111486411|NCT04652661|GABA Modulators|gaba modulators|mesh-ancestor
111486412|NCT04652661|GABA Agents|gaba agents|mesh-ancestor
111486413|NCT04623931|Temozolomide|temozolomide|mesh-list
111486414|NCT04623931|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111486415|NCT04623931|Alkylating Agents|alkylating agents|mesh-ancestor
111486416|NCT04623931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111486417|NCT04623931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111486418|NCT04590781|Pembrolizumab|pembrolizumab|mesh-list
111486419|NCT04590781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111486420|NCT04590781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111486421|NCT04590781|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111486422|NCT04590781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111486423|NCT04573751|Verapamil|verapamil|mesh-list
111486424|NCT04573751|Epinephrine|epinephrine|mesh-list
111486425|NCT04573751|Racepinephrine|racepinephrine|mesh-list
111486426|NCT04573751|Epinephryl borate|epinephryl borate|mesh-list
111486427|NCT04573751|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111486428|NCT04573751|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111486429|NCT04573751|Adrenergic Agents|adrenergic agents|mesh-ancestor
111486430|NCT04573751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111486431|NCT04573751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111486432|NCT04573751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111486433|NCT04573751|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111486434|NCT04573751|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111486435|NCT04573751|Autonomic Agents|autonomic agents|mesh-ancestor
111486436|NCT04573751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111486437|NCT04573751|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111486438|NCT04573751|Respiratory System Agents|respiratory system agents|mesh-ancestor
111486439|NCT04573751|Mydriatics|mydriatics|mesh-ancestor
111486440|NCT04573751|Sympathomimetics|sympathomimetics|mesh-ancestor
111486441|NCT04573751|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111486442|NCT04573751|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111486443|NCT04573751|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111486444|NCT04573751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111486445|NCT04573751|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111486446|NCT04573751|Vasodilator Agents|vasodilator agents|mesh-ancestor
111486447|NCT04522622|Teriparatide|teriparatide|mesh-list
111486448|NCT04522622|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111486449|NCT04522622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111486450|NCT04522622|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111486451|NCT04483102|Liver Extracts|liver extracts|mesh-list
111486452|NCT04483102|Hematinics|hematinics|mesh-ancestor
111486453|NCT04474483|Melatonin|melatonin|mesh-list
111486454|NCT04474483|Antioxidants|antioxidants|mesh-ancestor
111486455|NCT04474483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111486456|NCT04474483|Protective Agents|protective agents|mesh-ancestor
111486457|NCT04474483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111486458|NCT04474483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111486459|NCT04432207|Atezolizumab|atezolizumab|mesh-list
111486460|NCT04432207|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111486461|NCT04432207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111486462|NCT04432207|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111486463|NCT04432207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111486464|NCT04425447|Anesthetics|anesthetics|mesh-list
111486465|NCT04425447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111486466|NCT04425447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111486467|NCT04345718|Buprenorphine|buprenorphine|mesh-list
111486468|NCT04345718|Analgesics, Opioid|analgesics, opioid|mesh-list
111486469|NCT04345718|Narcotics|narcotics|mesh-ancestor
111486470|NCT04345718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111486471|NCT04345718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111486472|NCT04345718|Analgesics|analgesics|mesh-ancestor
111486473|NCT04345718|Sensory System Agents|sensory system agents|mesh-ancestor
111486474|NCT04345718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111486475|NCT04345718|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110694548|NCT00999869|Hormones|hormones|mesh-ancestor
111486476|NCT04298541|Edotreotide|edotreotide|mesh-list
111486477|NCT04298541|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111486478|NCT04298541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111486479|NCT04249037|Tenofovir|tenofovir|mesh-list
111486480|NCT04249037|Emtricitabine|emtricitabine|mesh-list
111486481|NCT04249037|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
111486482|NCT04249037|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
111486483|NCT04249037|Antiviral Agents|antiviral agents|mesh-ancestor
111486484|NCT04249037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111486485|NCT04249037|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111486486|NCT04249037|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111486487|NCT04249037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111486488|NCT04249037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111486489|NCT04249037|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111486490|NCT04190550|Cytarabine|cytarabine|mesh-list
111486491|NCT04190550|Idarubicin|idarubicin|mesh-list
111486492|NCT04190550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111486493|NCT04190550|Antimetabolites|antimetabolites|mesh-ancestor
111486494|NCT04190550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111486495|NCT04190550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111486496|NCT04190550|Antiviral Agents|antiviral agents|mesh-ancestor
111486497|NCT04190550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111486498|NCT04190550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111486499|NCT04190550|Immunologic Factors|immunologic factors|mesh-ancestor
111486500|NCT04190550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111486501|NCT04190550|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111486502|NCT04190550|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111486503|NCT04190550|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111486504|NCT04190550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111486505|NCT04158739|Cytarabine|cytarabine|mesh-list
111486506|NCT04158739|Antibodies|antibodies|mesh-list
111486507|NCT04158739|Immunoglobulins|immunoglobulins|mesh-list
111486508|NCT04158739|Antibodies, Bispecific|antibodies, bispecific|mesh-list
111486509|NCT04158739|Immunologic Factors|immunologic factors|mesh-ancestor
111486510|NCT04158739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111486511|NCT04158739|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111486512|NCT04158739|Antimetabolites|antimetabolites|mesh-ancestor
111486513|NCT04158739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111486514|NCT04158739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111486515|NCT04158739|Antiviral Agents|antiviral agents|mesh-ancestor
111486516|NCT04158739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111486517|NCT04158739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111486518|NCT04148105|Cilostazol|cilostazol|mesh-list
111486519|NCT04148105|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111486520|NCT04148105|Autonomic Agents|autonomic agents|mesh-ancestor
111486521|NCT04148105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111486522|NCT04148105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111486523|NCT04148105|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111486524|NCT04148105|Respiratory System Agents|respiratory system agents|mesh-ancestor
111486525|NCT04148105|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111486526|NCT04148105|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111486527|NCT04148105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111486528|NCT04148105|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111486529|NCT04148105|Vasodilator Agents|vasodilator agents|mesh-ancestor
111486530|NCT04148105|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111486531|NCT04148105|Protective Agents|protective agents|mesh-ancestor
111486532|NCT04148105|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
111486533|NCT04148105|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111486534|NCT04148105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111486535|NCT04067518|Pegaspargase|pegaspargase|mesh-list
111486536|NCT04067518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111486537|NCT04033419|Memantine|memantine|mesh-list
111486538|NCT04033419|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111486539|NCT04033419|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111486540|NCT04033419|Dopamine Agents|dopamine agents|mesh-ancestor
111486541|NCT04033419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111486542|NCT04033419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111486543|NCT04033419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111486544|NCT04033419|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111486545|NCT04033419|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111486546|NCT04014283|Selenium|selenium|mesh-list
111102738|NCT05492487|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111102739|NCT05492487|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111486547|NCT04014283|Antioxidants|antioxidants|mesh-ancestor
111486548|NCT04014283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111486549|NCT04014283|Protective Agents|protective agents|mesh-ancestor
111486550|NCT04014283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111486551|NCT04014283|Trace Elements|trace elements|mesh-ancestor
111486552|NCT04014283|Micronutrients|micronutrients|mesh-ancestor
111486553|NCT04257578|Acalabrutinib|acalabrutinib|mesh-list
111486554|NCT04257578|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
111486555|NCT04257578|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
111486556|NCT04257578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111486557|NCT04257578|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111486558|NCT04257578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111486559|NCT04257578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111486560|NCT04257578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111486561|NCT03912233|Ivacaftor|ivacaftor|mesh-list
111486562|NCT03912233|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
111486563|NCT03912233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111486564|NCT03912233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111486565|NCT03842865|Immunomodulating Agents|immunomodulating agents|mesh-list
111486566|NCT03842865|Immunologic Factors|immunologic factors|mesh-ancestor
111486567|NCT03842865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111486568|NCT03834519|Prednisone|prednisone|mesh-list
111486569|NCT03834519|Prednisolone|prednisolone|mesh-list
111486570|NCT03834519|Pembrolizumab|pembrolizumab|mesh-list
111486571|NCT03834519|Olaparib|olaparib|mesh-list
111486572|NCT03834519|Abiraterone Acetate|abiraterone acetate|mesh-list
111486573|NCT03834519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111486574|NCT03834519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111486575|NCT03834519|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111486576|NCT03834519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111486577|NCT03834519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111486578|NCT03834519|Glucocorticoids|glucocorticoids|mesh-ancestor
111486579|NCT03834519|Hormones|hormones|mesh-ancestor
111486580|NCT03834519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111486581|NCT03834519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111486582|NCT03834519|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111486583|NCT03834519|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111486584|NCT03834519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111486585|NCT03834519|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111486586|NCT03834519|Hormone Antagonists|hormone antagonists|mesh-ancestor
111486587|NCT03834519|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111486588|NCT03781817|Ketamine|ketamine|mesh-list
111486589|NCT03781817|Analgesics|analgesics|mesh-ancestor
111486590|NCT03781817|Sensory System Agents|sensory system agents|mesh-ancestor
111486591|NCT03781817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111486592|NCT03781817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111486593|NCT03781817|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111486594|NCT03781817|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111486595|NCT03781817|Anesthetics, General|anesthetics, general|mesh-ancestor
111486596|NCT03781817|Anesthetics|anesthetics|mesh-ancestor
111486597|NCT03781817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111486598|NCT03781817|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111486599|NCT03781817|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111486600|NCT03781817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111486601|NCT03781817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111486602|NCT03732352|Deoxyglucose|deoxyglucose|mesh-list
111486603|NCT03732352|Osimertinib|osimertinib|mesh-list
111486604|NCT03732352|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
111486605|NCT03732352|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111486606|NCT03732352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111486607|NCT03732352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111486608|NCT03732352|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111486609|NCT03732352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111486610|NCT03732352|Antimetabolites|antimetabolites|mesh-ancestor
111486611|NCT03732352|Antiviral Agents|antiviral agents|mesh-ancestor
111486612|NCT03732352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111486613|NCT03636451|Lidocaine|lidocaine|mesh-list
111486614|NCT03636451|Vasopressins|vasopressins|mesh-list
111486615|NCT03636451|Arginine Vasopressin|arginine vasopressin|mesh-list
111486616|NCT03636451|Anesthetics, Local|anesthetics, local|mesh-ancestor
111486617|NCT03636451|Anesthetics|anesthetics|mesh-ancestor
111486618|NCT03636451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111486619|NCT03636451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111486620|NCT03636451|Sensory System Agents|sensory system agents|mesh-ancestor
110694688|NCT01021358|Antifungal Agents|antifungal agents|mesh-ancestor
111486621|NCT03636451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111486623|NCT03636451|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111486624|NCT03636451|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111486625|NCT03636451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111486626|NCT03636451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111486627|NCT03636451|Hemostatics|hemostatics|mesh-ancestor
111486628|NCT03636451|Coagulants|coagulants|mesh-ancestor
111486629|NCT03636451|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111486630|NCT03636451|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
111486631|NCT03636451|Natriuretic Agents|natriuretic agents|mesh-ancestor
111486632|NCT03576989|Mineral Oil|mineral oil|mesh-list
111486633|NCT03576989|Emollients|emollients|mesh-ancestor
111486634|NCT03576989|Dermatologic Agents|dermatologic agents|mesh-ancestor
111486635|NCT03539952|Penicillamine|penicillamine|mesh-list
111486636|NCT03539952|Trientine|trientine|mesh-list
111486637|NCT03539952|Chelating Agents|chelating agents|mesh-ancestor
111486638|NCT03539952|Sequestering Agents|sequestering agents|mesh-ancestor
111486639|NCT03539952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111486640|NCT03539952|Antidotes|antidotes|mesh-ancestor
111486641|NCT03539952|Protective Agents|protective agents|mesh-ancestor
111486642|NCT03539952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111486643|NCT03539952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111486644|NCT03454035|Palbociclib|palbociclib|mesh-list
111486645|NCT03454035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111486646|NCT03454035|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111486647|NCT03454035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111486648|NCT03454035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111486649|NCT03278691|Ketorolac|ketorolac|mesh-list
111486650|NCT03278691|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111486651|NCT03278691|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111486652|NCT03278691|Analgesics|analgesics|mesh-ancestor
111486653|NCT03278691|Sensory System Agents|sensory system agents|mesh-ancestor
111486654|NCT03278691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111486655|NCT03278691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111486656|NCT03278691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111486657|NCT03278691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111486658|NCT03278691|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111486659|NCT03278691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111486660|NCT03278691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111486661|NCT03093909|Gemcitabine|gemcitabine|mesh-list
111486662|NCT03093909|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111486663|NCT03093909|Antimetabolites|antimetabolites|mesh-ancestor
111486664|NCT03093909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111486665|NCT03093909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111486666|NCT02621489|Metformin|metformin|mesh-list
111486667|NCT02621489|Insulin Aspart|insulin aspart|mesh-list
111486668|NCT02621489|Exenatide|exenatide|mesh-list
111486669|NCT02621489|Biguanides|biguanides|mesh-list
111486670|NCT02621489|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111486671|NCT02621489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111486672|NCT02621489|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111486673|NCT02621489|Incretins|incretins|mesh-ancestor
111486674|NCT02621489|Hormones|hormones|mesh-ancestor
111486675|NCT02621489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111486676|NCT02596880|Ribavirin|ribavirin|mesh-list
111486677|NCT02596880|Sofosbuvir|sofosbuvir|mesh-list
111486678|NCT02596880|Antimetabolites|antimetabolites|mesh-ancestor
111486679|NCT02596880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111486680|NCT02596880|Antiviral Agents|antiviral agents|mesh-ancestor
111486681|NCT02596880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111486682|NCT02527434|Durvalumab|durvalumab|mesh-list
111486683|NCT02527434|Tremelimumab|tremelimumab|mesh-list
111486684|NCT02527434|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111486685|NCT02527434|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111486686|NCT02527434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111486687|NCT02527434|Immunologic Factors|immunologic factors|mesh-ancestor
111486688|NCT02527434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111486689|NCT02474368|Cisplatin|cisplatin|mesh-list
111486690|NCT02474368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111486691|NCT01995344|Cyclophosphamide|cyclophosphamide|mesh-list
111486692|NCT01995344|Fludarabine|fludarabine|mesh-list
111486693|NCT01995344|Interleukin-2|interleukin-2|mesh-list
111486694|NCT01995344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111102740|NCT05492487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111486695|NCT01995344|Immunologic Factors|immunologic factors|mesh-ancestor
111486696|NCT01995344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111486697|NCT01995344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111102741|NCT05492487|Appetite Stimulants|appetite stimulants|mesh-ancestor
111102742|NCT05492487|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111486698|NCT01995344|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111486699|NCT01995344|Alkylating Agents|alkylating agents|mesh-ancestor
111486700|NCT01995344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111486701|NCT01995344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111486702|NCT01995344|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111486703|NCT01995344|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111486704|NCT01995344|Analgesics|analgesics|mesh-ancestor
111486705|NCT01995344|Sensory System Agents|sensory system agents|mesh-ancestor
110397503|NCT00626509|Sunitinib|sunitinib|mesh-list
111486706|NCT01995344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111486707|NCT01845688|Losartan|losartan|mesh-list
111486708|NCT01845688|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111486709|NCT01845688|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111486710|NCT01845688|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111486711|NCT01845688|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111486712|NCT01845688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111486713|NCT01591291|Ondansetron|ondansetron|mesh-list
111486714|NCT01591291|Antiemetics|antiemetics|mesh-ancestor
111486715|NCT01591291|Autonomic Agents|autonomic agents|mesh-ancestor
111486716|NCT01591291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111486717|NCT01591291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111486718|NCT01591291|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111486719|NCT01591291|Antipruritics|antipruritics|mesh-ancestor
111486720|NCT01591291|Dermatologic Agents|dermatologic agents|mesh-ancestor
111486721|NCT01591291|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111486722|NCT01591291|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111486723|NCT01591291|Serotonin Agents|serotonin agents|mesh-ancestor
111486724|NCT01591291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111486725|NCT01591291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111486726|NCT01093300|Paclitaxel|paclitaxel|mesh-list
111486727|NCT01093300|Everolimus|everolimus|mesh-list
111486728|NCT01093300|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111486729|NCT01093300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111486730|NCT01093300|Tubulin Modulators|tubulin modulators|mesh-ancestor
111486731|NCT01093300|Antimitotic Agents|antimitotic agents|mesh-ancestor
111486732|NCT01093300|Mitosis Modulators|mitosis modulators|mesh-ancestor
111486733|NCT01093300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111486734|NCT01093300|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111486735|NCT01093300|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111486736|NCT01093300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111486737|NCT01093300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111486738|NCT01093300|Immunologic Factors|immunologic factors|mesh-ancestor
111486739|NCT01093300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111486740|NCT01053078|Naltrexone|naltrexone|mesh-list
111486741|NCT01053078|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111486742|NCT01053078|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111486743|NCT01053078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111486744|NCT01053078|Sensory System Agents|sensory system agents|mesh-ancestor
111486745|NCT01053078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111486746|NCT01053156|Minocycline|minocycline|mesh-list
111486747|NCT01053156|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111486748|NCT01053156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111486749|NCT01053312|Flutemetamol|flutemetamol|mesh-list
111486750|NCT01053312|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111486751|NCT01053312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111486752|NCT01054404|Furosemide|furosemide|mesh-list
111486753|NCT01054404|Diuretics|diuretics|mesh-ancestor
111486754|NCT01054404|Natriuretic Agents|natriuretic agents|mesh-ancestor
111486755|NCT01054404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110646428|NCT03566667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111486756|NCT01054404|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
111486757|NCT01054404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111486758|NCT01054404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111486759|NCT01055184|Vaccines|vaccines|mesh-list
111486760|NCT01055184|Immunologic Factors|immunologic factors|mesh-ancestor
111486761|NCT01055184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111486762|NCT01060020|Sildenafil Citrate|sildenafil citrate|mesh-list
111486763|NCT01060020|Vasodilator Agents|vasodilator agents|mesh-ancestor
111486764|NCT01060020|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111486765|NCT01060020|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111486766|NCT01060020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111486767|NCT01060020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111102743|NCT05492019|Doxycycline|doxycycline|mesh-list
111102744|NCT05492019|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111486768|NCT01060020|Urological Agents|urological agents|mesh-ancestor
111486770|NCT01060098|Etanercept|etanercept|mesh-list
111486771|NCT01060098|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111486772|NCT01060098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111486773|NCT01060098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111486774|NCT01060098|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111486775|NCT01060098|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111486776|NCT01060098|Analgesics|analgesics|mesh-ancestor
111486777|NCT01060098|Sensory System Agents|sensory system agents|mesh-ancestor
111486778|NCT01060098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111486779|NCT01060098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111486780|NCT01060098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111486781|NCT01060098|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111486782|NCT01060098|Immunologic Factors|immunologic factors|mesh-ancestor
111486783|NCT01061034|Aspirin|aspirin|mesh-list
111486784|NCT01061034|Omeprazole|omeprazole|mesh-list
111486785|NCT01061034|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111486786|NCT01061034|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111486787|NCT01061034|Analgesics|analgesics|mesh-ancestor
111486788|NCT01061034|Sensory System Agents|sensory system agents|mesh-ancestor
111486789|NCT01061034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111486790|NCT01061034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111486791|NCT01061034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111486792|NCT01061034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111486793|NCT01061034|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111486794|NCT01061034|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111486795|NCT01061034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111486796|NCT01061034|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111486797|NCT01061034|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111486798|NCT01061034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111486799|NCT01061034|Antipyretics|antipyretics|mesh-ancestor
111486800|NCT01061034|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111486801|NCT01061034|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111486802|NCT01061034|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111486803|NCT01065558|Ecopipam|ecopipam|mesh-list
111486804|NCT01065558|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111486805|NCT01065558|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111486806|NCT01065558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111486807|NCT01065558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111486808|NCT01065558|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111486809|NCT01065558|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111486810|NCT01065558|Dopamine Agents|dopamine agents|mesh-ancestor
111486811|NCT01065558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111486812|NCT01065558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111486813|NCT01066026|Hyaluronic Acid|hyaluronic acid|mesh-list
111486814|NCT01066026|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111486815|NCT01066026|Immunologic Factors|immunologic factors|mesh-ancestor
110646461|NCT03517137|Immunologic Factors|immunologic factors|mesh-ancestor
111486816|NCT01066026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111486817|NCT01066026|Viscosupplements|viscosupplements|mesh-ancestor
111486818|NCT01066026|Protective Agents|protective agents|mesh-ancestor
111486819|NCT01072188|Calcium Carbonate|calcium carbonate|mesh-list
111486820|NCT01072188|Calcium|calcium|mesh-list
111486821|NCT01072188|Fluorides|fluorides|mesh-list
111486822|NCT01072188|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111486823|NCT01072188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111486824|NCT01072188|Cariostatic Agents|cariostatic agents|mesh-ancestor
111486825|NCT01072188|Protective Agents|protective agents|mesh-ancestor
111486826|NCT01072188|Antacids|antacids|mesh-ancestor
111486827|NCT01072188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111486828|NCT01072188|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111486829|NCT01083732|Dabigatran|dabigatran|mesh-list
111486830|NCT01083732|Antithrombins|antithrombins|mesh-ancestor
111486831|NCT01083732|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111486832|NCT01083732|Protease Inhibitors|protease inhibitors|mesh-ancestor
111486833|NCT01083732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111486834|NCT01083732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111486835|NCT01083732|Anticoagulants|anticoagulants|mesh-ancestor
111486836|NCT01084278|Colchicine|colchicine|mesh-list
111486837|NCT01084278|Gout Suppressants|gout suppressants|mesh-ancestor
111486838|NCT01084278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111486839|NCT01084278|Tubulin Modulators|tubulin modulators|mesh-ancestor
111102745|NCT05492019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111102746|NCT05492019|Antimalarials|antimalarials|mesh-ancestor
110694907|NCT00461786|Pemetrexed|pemetrexed|mesh-list
111486840|NCT01084278|Antimitotic Agents|antimitotic agents|mesh-ancestor
111486841|NCT01084278|Mitosis Modulators|mitosis modulators|mesh-ancestor
110694987|NCT00424008|Hormones|hormones|mesh-ancestor
111486842|NCT01084278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111486843|NCT01084278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111486844|NCT01085760|Metronidazole|metronidazole|mesh-list
111486845|NCT01085760|Vancomycin|vancomycin|mesh-list
111486846|NCT01085760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111486847|NCT01085760|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111486848|NCT01085760|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111486849|NCT01085760|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111486850|NCT01090752|Metformin|metformin|mesh-list
111486851|NCT01090752|Pioglitazone|pioglitazone|mesh-list
111486852|NCT01090752|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111486853|NCT01090752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111486854|NCT01093794|Metformin|metformin|mesh-list
111486855|NCT01093794|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111486856|NCT01093794|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111486857|NCT01093794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111486858|NCT01093794|Incretins|incretins|mesh-ancestor
111486859|NCT01093794|Hormones|hormones|mesh-ancestor
111486860|NCT01093794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111486861|NCT01093794|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111486862|NCT01093794|Protease Inhibitors|protease inhibitors|mesh-ancestor
111486863|NCT01093794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111486864|NCT01093794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111486865|NCT01094106|Ropivacaine|ropivacaine|mesh-list
111486866|NCT01094106|Anesthetics, Local|anesthetics, local|mesh-ancestor
111486867|NCT01094106|Anesthetics|anesthetics|mesh-ancestor
111486868|NCT01094106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111486869|NCT01094106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111486870|NCT01094106|Sensory System Agents|sensory system agents|mesh-ancestor
111486871|NCT01094106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111486872|NCT01094574|Propranolol|propranolol|mesh-list
111486873|NCT01094574|Alfentanil|alfentanil|mesh-list
111486874|NCT01094574|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111486875|NCT01094574|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111486876|NCT01094574|Adrenergic Agents|adrenergic agents|mesh-ancestor
111486877|NCT01094574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111486878|NCT01094574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111486879|NCT01094574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111486880|NCT01094574|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110646481|NCT03514589|Hormones|hormones|mesh-ancestor
111486881|NCT01094574|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111486882|NCT01094574|Vasodilator Agents|vasodilator agents|mesh-ancestor
111486883|NCT01094574|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111486884|NCT01094574|Narcotics|narcotics|mesh-ancestor
111486885|NCT01094574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111486886|NCT01094574|Analgesics|analgesics|mesh-ancestor
111486887|NCT01094574|Sensory System Agents|sensory system agents|mesh-ancestor
111486888|NCT01094574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111486889|NCT01094574|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111486890|NCT01094574|Anesthetics, General|anesthetics, general|mesh-ancestor
111486891|NCT01094574|Anesthetics|anesthetics|mesh-ancestor
111486892|NCT01095510|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
111486893|NCT01095510|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
111486894|NCT01095510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111486895|NCT01095510|Immunologic Factors|immunologic factors|mesh-ancestor
111486896|NCT01095510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111486897|NCT01096290|Lubiprostone|lubiprostone|mesh-list
111486898|NCT01096290|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
111486899|NCT01096290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111486900|NCT01096290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111486901|NCT01096680|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
111486902|NCT01096680|Modafinil|modafinil|mesh-list
111486903|NCT01096680|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111486904|NCT01096680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111486905|NCT01096680|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111486906|NCT01096680|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111486907|NCT01096680|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111486908|NCT01096680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111486909|NCT01096680|Dopamine Agents|dopamine agents|mesh-ancestor
111486910|NCT01096680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111486911|NCT01096680|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
111486912|NCT01096680|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111486913|NCT01096680|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111486914|NCT01096992|Rituximab|rituximab|mesh-list
111486915|NCT01096992|Fludarabine|fludarabine|mesh-list
111102747|NCT05492019|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111102748|NCT05492019|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111102749|NCT05491785|Oxycodone|oxycodone|mesh-list
111102750|NCT05491785|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111102751|NCT05491785|Narcotics|narcotics|mesh-ancestor
111102752|NCT05491785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111102753|NCT05491785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111102754|NCT05491785|Analgesics|analgesics|mesh-ancestor
111102755|NCT05491785|Sensory System Agents|sensory system agents|mesh-ancestor
111102756|NCT05491785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111102757|NCT05484375|Capecitabine|capecitabine|mesh-list
111102758|NCT05484375|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111102759|NCT05484375|Antimetabolites|antimetabolites|mesh-ancestor
111102760|NCT05484375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111102761|NCT05484375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111102762|NCT05480007|Metformin|metformin|mesh-list
111102763|NCT05480007|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111102764|NCT05480007|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111102765|NCT05480007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111102766|NCT05480007|Incretins|incretins|mesh-ancestor
111102767|NCT05480007|Hormones|hormones|mesh-ancestor
111102768|NCT05480007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111102769|NCT05480007|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111102770|NCT05480007|Protease Inhibitors|protease inhibitors|mesh-ancestor
111102771|NCT05480007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111102772|NCT05480007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111102773|NCT05489601|Oxycodone|oxycodone|mesh-list
111102774|NCT05489601|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111102775|NCT05489601|Narcotics|narcotics|mesh-ancestor
111486916|NCT01096992|Fludarabine phosphate|fludarabine phosphate|mesh-list
111486917|NCT01096992|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
111486918|NCT01096992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111486919|NCT01096992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111486920|NCT01096992|Immunologic Factors|immunologic factors|mesh-ancestor
111486921|NCT01096992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111486922|NCT01096992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111486923|NCT01096992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111486924|NCT01096992|Antimetabolites|antimetabolites|mesh-ancestor
111486925|NCT01096992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111486926|NCT01096992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111486927|NCT01096992|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111486928|NCT01096992|Alkylating Agents|alkylating agents|mesh-ancestor
111486929|NCT01097304|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
111486930|NCT01097304|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
111486931|NCT01097304|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111486932|NCT01097460|Trastuzumab|trastuzumab|mesh-list
111486933|NCT01097460|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111486934|NCT01097460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111486935|NCT01098318|Sertraline|sertraline|mesh-list
111486936|NCT01098318|Antidepressive Agents|antidepressive agents|mesh-ancestor
111486937|NCT01098318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111486938|NCT01098318|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111486939|NCT01098318|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111486940|NCT01098318|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111486941|NCT01098318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111486942|NCT01098318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111486943|NCT01098318|Serotonin Agents|serotonin agents|mesh-ancestor
111486944|NCT01098318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111486945|NCT01100112|Budesonide|budesonide|mesh-list
111486946|NCT01100112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111486947|NCT01100112|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111486948|NCT01100112|Autonomic Agents|autonomic agents|mesh-ancestor
111486949|NCT01100112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111486950|NCT01100112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111486951|NCT01100112|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111486952|NCT01100112|Respiratory System Agents|respiratory system agents|mesh-ancestor
111486953|NCT01100112|Glucocorticoids|glucocorticoids|mesh-ancestor
111486954|NCT01100112|Hormones|hormones|mesh-ancestor
111486955|NCT01100112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111486956|NCT01100268|Methylphenidate|methylphenidate|mesh-list
111486957|NCT01100268|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111486958|NCT01100268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111486959|NCT01100268|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111102776|NCT05489601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110695097|NCT03983876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111486960|NCT01100268|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111486961|NCT01100268|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111486962|NCT01100268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111486963|NCT01100268|Dopamine Agents|dopamine agents|mesh-ancestor
111486964|NCT01100268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111486965|NCT01101750|Vaccines|vaccines|mesh-list
111486966|NCT01101750|Immunologic Factors|immunologic factors|mesh-ancestor
111486967|NCT01101750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111486968|NCT01102218|Pentoxifylline|pentoxifylline|mesh-list
111486969|NCT01102218|Epoetin Alfa|epoetin alfa|mesh-list
111486970|NCT01102218|Hematinics|hematinics|mesh-ancestor
111486971|NCT01102218|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111486972|NCT01102218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111486973|NCT01102218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111486974|NCT01102218|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111486975|NCT01102218|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111486976|NCT01102218|Protective Agents|protective agents|mesh-ancestor
111486977|NCT01102218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111486978|NCT01102218|Vasodilator Agents|vasodilator agents|mesh-ancestor
111486979|NCT01102218|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111486980|NCT01102218|Antioxidants|antioxidants|mesh-ancestor
111486981|NCT01103934|Vitamin D|vitamin d|mesh-list
111486982|NCT01103934|Cholecalciferol|cholecalciferol|mesh-list
111486983|NCT01103934|Fluticasone|fluticasone|mesh-list
111486984|NCT01103934|Xhance|xhance|mesh-list
111486985|NCT01103934|Vitamins|vitamins|mesh-ancestor
111486986|NCT01103934|Micronutrients|micronutrients|mesh-ancestor
111486987|NCT01103934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111486988|NCT01103934|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111486989|NCT01103934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111486990|NCT01103934|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111486991|NCT01103934|Autonomic Agents|autonomic agents|mesh-ancestor
111486992|NCT01103934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111486993|NCT01103934|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111486994|NCT01103934|Respiratory System Agents|respiratory system agents|mesh-ancestor
111486995|NCT01103934|Dermatologic Agents|dermatologic agents|mesh-ancestor
111486996|NCT01103934|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111486997|NCT01103934|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111486998|NCT01105650|Cyclosporine|cyclosporine|mesh-list
111486999|NCT01105650|Methylprednisolone|methylprednisolone|mesh-list
111487000|NCT01105650|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111487001|NCT01105650|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111487002|NCT01105650|Prednisolone|prednisolone|mesh-list
111487003|NCT01105650|Prednisolone acetate|prednisolone acetate|mesh-list
111487004|NCT01105650|Cyclophosphamide|cyclophosphamide|mesh-list
111487005|NCT01105650|Fludarabine|fludarabine|mesh-list
111487006|NCT01105650|Interleukin-2|interleukin-2|mesh-list
111487007|NCT01105650|Cyclosporins|cyclosporins|mesh-list
111487008|NCT01105650|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111487009|NCT01105650|Prednisolone phosphate|prednisolone phosphate|mesh-list
111487010|NCT01105650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111487011|NCT01105650|Immunologic Factors|immunologic factors|mesh-ancestor
111487012|NCT01105650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111487013|NCT01105650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111487014|NCT01105650|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111487015|NCT01105650|Alkylating Agents|alkylating agents|mesh-ancestor
111487016|NCT01105650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111487017|NCT01105650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111487018|NCT01105650|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111487019|NCT01105650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111487020|NCT01105650|Antifungal Agents|antifungal agents|mesh-ancestor
111487021|NCT01105650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111487022|NCT01105650|Dermatologic Agents|dermatologic agents|mesh-ancestor
111487023|NCT01105650|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111487024|NCT01105650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111487025|NCT01105650|Antiemetics|antiemetics|mesh-ancestor
111487026|NCT01105650|Autonomic Agents|autonomic agents|mesh-ancestor
111487027|NCT01105650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111487028|NCT01105650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111487029|NCT01105650|Glucocorticoids|glucocorticoids|mesh-ancestor
111487030|NCT01105650|Hormones|hormones|mesh-ancestor
111487031|NCT01105650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111487032|NCT01105650|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111487033|NCT01105650|Protective Agents|protective agents|mesh-ancestor
111487034|NCT01105650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111487035|NCT01105650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111102777|NCT05489601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111487037|NCT01105650|Sensory System Agents|sensory system agents|mesh-ancestor
111487038|NCT01110876|Temozolomide|temozolomide|mesh-list
111487039|NCT01110876|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111487040|NCT01110876|Vorinostat|vorinostat|mesh-list
111487041|NCT01110876|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111487042|NCT01110876|Alkylating Agents|alkylating agents|mesh-ancestor
111487043|NCT01110876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111487044|NCT01110876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111487045|NCT01110876|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111487046|NCT01110876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111487047|NCT01110876|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111487048|NCT01112358|Cetrorelix|cetrorelix|mesh-list
111487049|NCT01112358|Progesterone|progesterone|mesh-list
111487050|NCT01112358|Progestins|progestins|mesh-ancestor
111487051|NCT01112358|Hormones|hormones|mesh-ancestor
111487052|NCT01112358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111487053|NCT01112358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111487054|NCT01112358|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111487055|NCT01112358|Fertility Agents|fertility agents|mesh-ancestor
111487056|NCT01112358|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111487057|NCT01112358|Hormone Antagonists|hormone antagonists|mesh-ancestor
111487058|NCT01112670|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111487059|NCT01112670|Atorvastatin|atorvastatin|mesh-list
111487060|NCT01112670|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111487061|NCT01112670|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111487062|NCT01112670|Antimetabolites|antimetabolites|mesh-ancestor
111487063|NCT01112670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111487064|NCT01112670|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111487065|NCT01112670|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111487066|NCT01112670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111487067|NCT01112670|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111487068|NCT01112670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111487069|NCT01112670|Incretins|incretins|mesh-ancestor
111487070|NCT01112670|Hormones|hormones|mesh-ancestor
111487071|NCT01112670|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111487072|NCT01112670|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111487073|NCT01112670|Protease Inhibitors|protease inhibitors|mesh-ancestor
111487074|NCT01115556|Ranibizumab|ranibizumab|mesh-list
111487075|NCT01115556|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111487076|NCT01115556|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111487077|NCT01115556|Growth Substances|growth substances|mesh-ancestor
111487078|NCT01115556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111487079|NCT01115556|Growth Inhibitors|growth inhibitors|mesh-ancestor
111487080|NCT01115556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111487081|NCT01116102|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111487082|NCT01119222|Diphenhydramine|diphenhydramine|mesh-list
111487083|NCT01119222|Promethazine|promethazine|mesh-list
111487084|NCT01119222|Morphine|morphine|mesh-list
111487085|NCT01119222|Gabapentin|gabapentin|mesh-list
111487086|NCT01119222|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111487087|NCT01119222|Narcotics|narcotics|mesh-ancestor
111487088|NCT01119222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111487089|NCT01119222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111487090|NCT01119222|Analgesics|analgesics|mesh-ancestor
111487091|NCT01119222|Sensory System Agents|sensory system agents|mesh-ancestor
111487092|NCT01119222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111487093|NCT01119222|Anticonvulsants|anticonvulsants|mesh-ancestor
111487094|NCT01119222|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111487095|NCT01119222|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111487096|NCT01119222|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111487097|NCT01119222|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111487098|NCT01119222|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111487099|NCT01119222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111487100|NCT01119222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111487101|NCT01119222|Antimanic Agents|antimanic agents|mesh-ancestor
111487102|NCT01119222|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111487103|NCT01119222|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111487104|NCT01119222|Anesthetics, Local|anesthetics, local|mesh-ancestor
111487105|NCT01119222|Anesthetics|anesthetics|mesh-ancestor
111487106|NCT01119222|Antiemetics|antiemetics|mesh-ancestor
111102778|NCT05489601|Analgesics|analgesics|mesh-ancestor
111487107|NCT01119222|Autonomic Agents|autonomic agents|mesh-ancestor
111487108|NCT01119222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111487109|NCT01119222|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111102779|NCT05489601|Sensory System Agents|sensory system agents|mesh-ancestor
110646498|NCT03475810|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111102780|NCT05489601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111487110|NCT01119222|Histamine Antagonists|histamine antagonists|mesh-ancestor
111487111|NCT01119222|Histamine Agents|histamine agents|mesh-ancestor
111487112|NCT01119222|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111487113|NCT01119222|Antipruritics|antipruritics|mesh-ancestor
111487114|NCT01119222|Dermatologic Agents|dermatologic agents|mesh-ancestor
111487115|NCT01120236|Leuprolide|leuprolide|mesh-list
111487116|NCT01120236|Goserelin|goserelin|mesh-list
111487117|NCT01120236|Bicalutamide|bicalutamide|mesh-list
111487118|NCT01120236|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111487119|NCT01120236|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111487120|NCT01120236|Fertility Agents|fertility agents|mesh-ancestor
111487121|NCT01120236|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111487122|NCT01120236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111487123|NCT01120236|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111487124|NCT01120236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111487125|NCT01120236|Androgen Antagonists|androgen antagonists|mesh-ancestor
111487126|NCT01120236|Hormone Antagonists|hormone antagonists|mesh-ancestor
111487127|NCT01120236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111487128|NCT01120236|Immunologic Factors|immunologic factors|mesh-ancestor
111487129|NCT01120704|Nicotine|nicotine|mesh-list
111487130|NCT01120704|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111487131|NCT01120704|Autonomic Agents|autonomic agents|mesh-ancestor
111487132|NCT01120704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111487133|NCT01120704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111487134|NCT01120704|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111487135|NCT01120704|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111487136|NCT01120704|Cholinergic Agents|cholinergic agents|mesh-ancestor
111487137|NCT01120704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111487138|NCT01120704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111487139|NCT01122108|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
111487140|NCT01122108|Cholestyramine Resin|cholestyramine resin|mesh-list
111487141|NCT01122108|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111487142|NCT01122108|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111487143|NCT01122108|Antimetabolites|antimetabolites|mesh-ancestor
111487144|NCT01122108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111487145|NCT01122108|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111487146|NCT05307042|Vasopressins|vasopressins|mesh-list
111487147|NCT05307042|Arginine Vasopressin|arginine vasopressin|mesh-list
111487148|NCT05307042|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
111487149|NCT05307042|Hemostatics|hemostatics|mesh-ancestor
111487150|NCT05307042|Coagulants|coagulants|mesh-ancestor
111487151|NCT05307042|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111487152|NCT05307042|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
111487153|NCT05307042|Natriuretic Agents|natriuretic agents|mesh-ancestor
111487154|NCT05307042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111487155|NCT04974138|Folic Acid|folic acid|mesh-list
111487156|NCT04974138|Amlodipine|amlodipine|mesh-list
111487157|NCT04974138|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111487158|NCT04974138|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111487159|NCT04974138|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111487160|NCT04974138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111487161|NCT04974138|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111487162|NCT04974138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111487163|NCT04974138|Vasodilator Agents|vasodilator agents|mesh-ancestor
111487164|NCT04974138|Hematinics|hematinics|mesh-ancestor
111487165|NCT04974138|Vitamin B Complex|vitamin b complex|mesh-ancestor
111487166|NCT04974138|Vitamins|vitamins|mesh-ancestor
111487167|NCT04974138|Micronutrients|micronutrients|mesh-ancestor
111487168|NCT04973982|Tacrolimus|tacrolimus|mesh-list
111487169|NCT04973982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111487170|NCT04973982|Immunologic Factors|immunologic factors|mesh-ancestor
111487171|NCT04973982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111487172|NCT04973982|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111487173|NCT04973982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111487174|NCT04973982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111487175|NCT04187352|Cisplatin|cisplatin|mesh-list
111487176|NCT04187352|Fluorouracil|fluorouracil|mesh-list
111487177|NCT04187352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111487178|NCT04187352|Antimetabolites|antimetabolites|mesh-ancestor
111487179|NCT04187352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111487180|NCT04187352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111487181|NCT04187352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111487182|NCT04187352|Immunologic Factors|immunologic factors|mesh-ancestor
111487183|NCT04187352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111487184|NCT04142892|Onapristone|onapristone|mesh-list
111102781|NCT04276155|Anticoagulants|anticoagulants|mesh-list
111487185|NCT04142892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111487186|NCT04142892|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111487187|NCT04142892|Fertility Agents|fertility agents|mesh-ancestor
111487188|NCT04142892|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111487189|NCT04142892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111487190|NCT04142892|Hormone Antagonists|hormone antagonists|mesh-ancestor
111487191|NCT04142892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111487192|NCT03697356|Dexamethasone|dexamethasone|mesh-list
111487193|NCT03697356|Rituximab|rituximab|mesh-list
111487194|NCT03697356|Lenalidomide|lenalidomide|mesh-list
111487195|NCT03697356|Bortezomib|bortezomib|mesh-list
111487196|NCT03697356|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111487197|NCT03697356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111487198|NCT03697356|Immunologic Factors|immunologic factors|mesh-ancestor
111487199|NCT03697356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111487200|NCT03697356|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111487201|NCT03697356|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111487202|NCT03697356|Antiemetics|antiemetics|mesh-ancestor
111487203|NCT03697356|Autonomic Agents|autonomic agents|mesh-ancestor
111487204|NCT03697356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111487205|NCT03697356|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111487206|NCT03697356|Glucocorticoids|glucocorticoids|mesh-ancestor
111487207|NCT03697356|Hormones|hormones|mesh-ancestor
111487208|NCT03697356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111487209|NCT03697356|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111487210|NCT03697356|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111487211|NCT03697356|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111487212|NCT03697356|Growth Substances|growth substances|mesh-ancestor
111487213|NCT03697356|Growth Inhibitors|growth inhibitors|mesh-ancestor
111487214|NCT03616782|Ixazomib|ixazomib|mesh-list
111487215|NCT03616782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111487216|NCT03616782|Protease Inhibitors|protease inhibitors|mesh-ancestor
111487217|NCT03616782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111487218|NCT03616782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111487219|NCT02410512|Atezolizumab|atezolizumab|mesh-list
111487220|NCT02410512|Antibodies|antibodies|mesh-list
111487221|NCT02410512|Immunoglobulins|immunoglobulins|mesh-list
111487222|NCT02410512|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111487223|NCT02410512|Immunologic Factors|immunologic factors|mesh-ancestor
111487224|NCT02410512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111487225|NCT02410512|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111487226|NCT02410512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111487227|NCT02410512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111487228|NCT02410512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111487229|NCT00255138|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
111487230|NCT00255138|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111487231|NCT00255138|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111487232|NCT00255138|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111487233|NCT00255138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111487234|NCT00255138|Adrenergic Agents|adrenergic agents|mesh-ancestor
111487235|NCT00255138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111487236|NCT00255138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111487237|NCT01128192|Pasireotide|pasireotide|mesh-list
111487238|NCT01128192|Hormones|hormones|mesh-ancestor
111487239|NCT01128192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111487240|NCT01128192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111487241|NCT01128270|Chloral Hydrate|chloral hydrate|mesh-list
111487242|NCT01128270|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111487243|NCT01128270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111487244|NCT01128270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111487245|NCT01128972|Listerine|listerine|mesh-list
111487246|NCT01128972|Fluorides|fluorides|mesh-list
111487247|NCT01128972|Sodium Fluoride|sodium fluoride|mesh-list
111487248|NCT01128972|Cariostatic Agents|cariostatic agents|mesh-ancestor
111487249|NCT01128972|Protective Agents|protective agents|mesh-ancestor
111487250|NCT01128972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111487251|NCT01128972|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111487252|NCT01128972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111487253|NCT01129206|Deoxyglucose|deoxyglucose|mesh-list
111487254|NCT01129206|Docetaxel|docetaxel|mesh-list
111487255|NCT01129206|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
111487256|NCT01129206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111102782|NCT05488899|Iodine|iodine|mesh-list
111487257|NCT01129206|Tubulin Modulators|tubulin modulators|mesh-ancestor
111102783|NCT05488899|Cadexomer iodine|cadexomer iodine|mesh-list
111102784|NCT05488899|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111102785|NCT05488899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111487258|NCT01129206|Antimitotic Agents|antimitotic agents|mesh-ancestor
111487259|NCT01129206|Mitosis Modulators|mitosis modulators|mesh-ancestor
111487260|NCT01129206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111487261|NCT01129206|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111487262|NCT01129206|Antimetabolites|antimetabolites|mesh-ancestor
111487263|NCT01129206|Antiviral Agents|antiviral agents|mesh-ancestor
111487264|NCT01129206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111487266|NCT01129440|Fluorides, Topical|fluorides, topical|mesh-list
111487267|NCT01129440|Cariostatic Agents|cariostatic agents|mesh-ancestor
111487268|NCT01129440|Protective Agents|protective agents|mesh-ancestor
111487269|NCT01129440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111487270|NCT01130844|Mesalamine|mesalamine|mesh-list
111487271|NCT01130844|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111487272|NCT01130844|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111487273|NCT01130844|Analgesics|analgesics|mesh-ancestor
111487274|NCT01130844|Sensory System Agents|sensory system agents|mesh-ancestor
111487275|NCT01130844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111487276|NCT01130844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111487277|NCT01130844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111487278|NCT01130844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111487279|NCT01134198|Mifepristone|mifepristone|mesh-list
111487280|NCT01134198|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
111487281|NCT01134198|Abortifacient Agents|abortifacient agents|mesh-ancestor
111487282|NCT01134198|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111487283|NCT01134198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111487284|NCT01134198|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111487285|NCT01134198|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111487286|NCT01134198|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111487287|NCT01134198|Contraceptive Agents|contraceptive agents|mesh-ancestor
111487288|NCT01134198|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
111487289|NCT01134198|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
111487290|NCT01134198|Hormone Antagonists|hormone antagonists|mesh-ancestor
111487291|NCT01134198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111487292|NCT01134198|Luteolytic Agents|luteolytic agents|mesh-ancestor
111487293|NCT01134198|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111487294|NCT01134198|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
111487295|NCT01135368|Lansoprazole|lansoprazole|mesh-list
111487296|NCT01135368|Dexlansoprazole|dexlansoprazole|mesh-list
111487297|NCT01135368|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111487298|NCT01135368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111487299|NCT01135368|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111487300|NCT01135368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111487301|NCT01135368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111487302|NCT01136226|Leuprolide|leuprolide|mesh-list
111487303|NCT01136226|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111487304|NCT01136226|Fertility Agents|fertility agents|mesh-ancestor
111487305|NCT01136226|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111487306|NCT01136226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111487307|NCT01136226|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111487308|NCT01136226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111487309|NCT01137396|Modafinil|modafinil|mesh-list
111487310|NCT01137396|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111487311|NCT01137396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111487312|NCT01137396|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
111487313|NCT01137396|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111487314|NCT01137396|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111487315|NCT01137396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111487316|NCT01139190|Naproxen|naproxen|mesh-list
111487317|NCT01139190|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111487318|NCT01139190|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111487319|NCT01139190|Analgesics|analgesics|mesh-ancestor
111487320|NCT01139190|Sensory System Agents|sensory system agents|mesh-ancestor
111487321|NCT01139190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111487322|NCT01139190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111487323|NCT01139190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111487324|NCT01139190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111487325|NCT01139190|Gout Suppressants|gout suppressants|mesh-ancestor
111487326|NCT01139190|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111487327|NCT01139190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111487328|NCT01139190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111102786|NCT05488899|Trace Elements|trace elements|mesh-ancestor
111487329|NCT01140360|Imatinib Mesylate|imatinib mesylate|mesh-list
111487330|NCT01140360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111487331|NCT01140360|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111487332|NCT01140360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111487333|NCT01140360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111487334|NCT01142310|Lamotrigine|lamotrigine|mesh-list
111487335|NCT01142310|Anticonvulsants|anticonvulsants|mesh-ancestor
111487336|NCT01142310|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111487337|NCT01142310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111487338|NCT01142310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111487339|NCT01142310|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111487340|NCT01142310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111487341|NCT01142310|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111487342|NCT01142310|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111487343|NCT01142310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111487344|NCT01142310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111487345|NCT01142310|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111487347|NCT01144338|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111487348|NCT01144338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111487349|NCT01144338|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111487350|NCT01144338|Incretins|incretins|mesh-ancestor
111487351|NCT01144338|Hormones|hormones|mesh-ancestor
111487352|NCT01144338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111487353|NCT01144494|Brimonidine Tartrate|brimonidine tartrate|mesh-list
111487354|NCT01144494|Lubricant Eye Drops|lubricant eye drops|mesh-list
111487355|NCT01144494|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111487356|NCT01144494|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111487357|NCT01144494|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111487358|NCT01144494|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111487359|NCT01144494|Adrenergic Agents|adrenergic agents|mesh-ancestor
111487360|NCT01144494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111487361|NCT01144494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111487362|NCT01144494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111487363|NCT01144494|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
111487364|NCT01144494|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111487365|NCT01146600|Clarithromycin|clarithromycin|mesh-list
111487366|NCT01146600|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111487367|NCT01146600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111487368|NCT01146600|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111487369|NCT01146600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111487370|NCT01146600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111487371|NCT01146600|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111487372|NCT01146600|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111487373|NCT01146834|Plerixafor|plerixafor|mesh-list
111487374|NCT01146834|Cyclophosphamide|cyclophosphamide|mesh-list
111487375|NCT01146834|Bortezomib|bortezomib|mesh-list
111487376|NCT01146834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111487377|NCT01146834|Immunologic Factors|immunologic factors|mesh-ancestor
111487378|NCT01146834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111487379|NCT01146834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111487380|NCT01146834|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111487381|NCT01146834|Alkylating Agents|alkylating agents|mesh-ancestor
111487382|NCT01146834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111487383|NCT01146834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111487384|NCT01146834|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111487385|NCT01146834|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111487386|NCT01146834|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111487387|NCT01146834|Antiviral Agents|antiviral agents|mesh-ancestor
111487388|NCT01146834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111487389|NCT01147302|Complement C1s|complement c1s|mesh-list
111487390|NCT01147302|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
111487391|NCT01147302|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
111487392|NCT01147302|Immunologic Factors|immunologic factors|mesh-ancestor
111487393|NCT01147302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111487394|NCT01147302|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
111487395|NCT01147302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111487396|NCT01149876|Tretinoin|tretinoin|mesh-list
111487397|NCT01149876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111487398|NCT01149876|Keratolytic Agents|keratolytic agents|mesh-ancestor
111487399|NCT01149876|Dermatologic Agents|dermatologic agents|mesh-ancestor
111487400|NCT01150500|Sirolimus|sirolimus|mesh-list
111487401|NCT01150500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111102787|NCT05488899|Micronutrients|micronutrients|mesh-ancestor
111487402|NCT01150500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111487403|NCT01150500|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111487404|NCT01150500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111487405|NCT01150500|Antifungal Agents|antifungal agents|mesh-ancestor
111487406|NCT01150500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111487407|NCT01150500|Immunologic Factors|immunologic factors|mesh-ancestor
111487408|NCT01150500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111487409|NCT01151046|Exemestane|exemestane|mesh-list
111487410|NCT01151046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111487411|NCT01151046|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111487412|NCT01151046|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111487413|NCT01151046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111487414|NCT01151046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111487415|NCT01151046|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111487416|NCT01151046|Hormone Antagonists|hormone antagonists|mesh-ancestor
111487417|NCT01151046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111487418|NCT01151046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111487419|NCT01151436|Hyaluronic Acid|hyaluronic acid|mesh-list
111487420|NCT01151436|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111487421|NCT01151436|Immunologic Factors|immunologic factors|mesh-ancestor
111487422|NCT01151436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111487423|NCT01151436|Viscosupplements|viscosupplements|mesh-ancestor
111487424|NCT01151436|Protective Agents|protective agents|mesh-ancestor
111487425|NCT01153620|Polihexanide|polihexanide|mesh-list
111487426|NCT01153620|Disinfectants|disinfectants|mesh-ancestor
111487427|NCT01153620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111487428|NCT01163214|Ropivacaine|ropivacaine|mesh-list
111487429|NCT01163214|Anesthetics, Local|anesthetics, local|mesh-ancestor
111487430|NCT01163214|Anesthetics|anesthetics|mesh-ancestor
111487431|NCT01163214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111487432|NCT01163214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111487433|NCT01163214|Sensory System Agents|sensory system agents|mesh-ancestor
111487434|NCT01163214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111487435|NCT01163604|Argatroban|argatroban|mesh-list
111487436|NCT01163604|Clopidogrel|clopidogrel|mesh-list
111487437|NCT01163604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111487438|NCT01163604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111487439|NCT01163604|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111487440|NCT01163604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111487441|NCT01163604|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111487442|NCT01163604|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111487443|NCT01163604|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111487444|NCT01163604|Purinergic Agents|purinergic agents|mesh-ancestor
111487445|NCT01163604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111487446|NCT01163604|Antithrombins|antithrombins|mesh-ancestor
111487447|NCT01163604|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111487448|NCT01163604|Protease Inhibitors|protease inhibitors|mesh-ancestor
111487449|NCT01163604|Anticoagulants|anticoagulants|mesh-ancestor
111487450|NCT01168674|Ziprasidone|ziprasidone|mesh-list
111487451|NCT01168674|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111487452|NCT01168674|Serotonin Agents|serotonin agents|mesh-ancestor
111487453|NCT01168674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111487454|NCT01168674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111487455|NCT01168674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111487456|NCT01168674|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111487457|NCT01168674|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111487458|NCT01168674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111487459|NCT01168674|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111487460|NCT01168674|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111487461|NCT01168674|Dopamine Agents|dopamine agents|mesh-ancestor
111487462|NCT01168908|Sildenafil Citrate|sildenafil citrate|mesh-list
111487463|NCT01168908|Vasodilator Agents|vasodilator agents|mesh-ancestor
111487464|NCT01168908|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111487465|NCT01168908|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111487466|NCT01168908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111487467|NCT01168908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111487468|NCT01168908|Urological Agents|urological agents|mesh-ancestor
111487469|NCT01170390|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
111487470|NCT01170390|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
111102788|NCT05488899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111102789|NCT05483439|Cyclophosphamide|cyclophosphamide|mesh-list
111487471|NCT01170390|Levonorgestrel|levonorgestrel|mesh-list
111487472|NCT01170390|Ethinyl Estradiol|ethinyl estradiol|mesh-list
111487473|NCT01170390|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
111102790|NCT05483439|Carboplatin|carboplatin|mesh-list
111487474|NCT01170390|Estradiol|estradiol|mesh-list
111487475|NCT01170390|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
111487476|NCT01170390|Estrogens|estrogens|mesh-ancestor
111487477|NCT01170390|Hormones|hormones|mesh-ancestor
111487478|NCT01170390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111487479|NCT01170390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111487480|NCT01170390|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111487481|NCT01170390|Contraceptive Agents|contraceptive agents|mesh-ancestor
111487482|NCT01170390|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111487483|NCT01170390|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111487484|NCT01170390|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111487485|NCT01170390|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111487486|NCT01170390|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111487487|NCT01170390|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
111487488|NCT01134510|Complement C1s|complement c1s|mesh-list
111487489|NCT01134510|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
111487490|NCT01134510|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
111487491|NCT01134510|Immunologic Factors|immunologic factors|mesh-ancestor
111487492|NCT01134510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111487493|NCT01134510|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
111487494|NCT01134510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111487495|NCT01171794|Ibuprofen|ibuprofen|mesh-list
111487496|NCT01171794|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111487497|NCT01171794|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111487498|NCT01171794|Analgesics|analgesics|mesh-ancestor
111487499|NCT01171794|Sensory System Agents|sensory system agents|mesh-ancestor
111487500|NCT01171794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111487501|NCT01171794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111487502|NCT01171794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111487503|NCT01171794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111487504|NCT01171794|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111487505|NCT01171794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111487506|NCT01171794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111487507|NCT01175148|Atorvastatin|atorvastatin|mesh-list
111487508|NCT01175148|Calcium|calcium|mesh-list
111487509|NCT01175148|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111487510|NCT01175148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111487511|NCT01175148|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111487512|NCT01175148|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111487513|NCT01175148|Antimetabolites|antimetabolites|mesh-ancestor
111487514|NCT01175148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111487515|NCT01175148|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110646565|NCT03156036|Alkylating Agents|alkylating agents|mesh-ancestor
111487516|NCT01175148|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111487517|NCT01175148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111487518|NCT01177098|Timolol|timolol|mesh-list
111487519|NCT01177098|Bimatoprost|bimatoprost|mesh-list
111487520|NCT01177098|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111487521|NCT01177098|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111487522|NCT01177098|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111487523|NCT01177098|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111487524|NCT01177098|Adrenergic Agents|adrenergic agents|mesh-ancestor
111487525|NCT01177098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111487526|NCT01177098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111487527|NCT01177098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111487528|NCT01177098|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111487529|NCT01177098|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111487530|NCT01177956|Fluorouracil|fluorouracil|mesh-list
111487531|NCT01177956|Cetuximab|cetuximab|mesh-list
111487532|NCT01177956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111487533|NCT01177956|Antimetabolites|antimetabolites|mesh-ancestor
111487534|NCT01177956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111487535|NCT01177956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111487536|NCT01177956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111487537|NCT01177956|Immunologic Factors|immunologic factors|mesh-ancestor
111487538|NCT01177956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111487539|NCT01177956|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111487540|NCT01183650|Tadalafil|tadalafil|mesh-list
111487541|NCT01183650|Vasodilator Agents|vasodilator agents|mesh-ancestor
111487542|NCT01183650|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111487543|NCT01183650|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111487544|NCT01183650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111102791|NCT05483439|Docetaxel|docetaxel|mesh-list
111487545|NCT01183650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111487546|NCT01183650|Urological Agents|urological agents|mesh-ancestor
111487547|NCT01184898|Cytarabine|cytarabine|mesh-list
111487548|NCT01184898|Sirolimus|sirolimus|mesh-list
111487549|NCT01184898|Etoposide|etoposide|mesh-list
111487550|NCT01184898|Mitoxantrone|mitoxantrone|mesh-list
111487551|NCT01184898|Etoposide phosphate|etoposide phosphate|mesh-list
111487552|NCT01184898|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111487553|NCT01184898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111487554|NCT01184898|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111487555|NCT01184898|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111487556|NCT01184898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111487557|NCT01184898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111487558|NCT01184898|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111487559|NCT01184898|Antimetabolites|antimetabolites|mesh-ancestor
111487560|NCT01184898|Antiviral Agents|antiviral agents|mesh-ancestor
111487561|NCT01184898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111487562|NCT01184898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111487563|NCT01184898|Immunologic Factors|immunologic factors|mesh-ancestor
111487564|NCT01184898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111487565|NCT01184898|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111487566|NCT01184898|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111487567|NCT01184898|Antifungal Agents|antifungal agents|mesh-ancestor
111487568|NCT01184898|Analgesics|analgesics|mesh-ancestor
111487569|NCT01184898|Sensory System Agents|sensory system agents|mesh-ancestor
111487570|NCT01184898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111487571|NCT01188876|Folic Acid|folic acid|mesh-list
111487572|NCT01188876|Vitamin B 12|vitamin b 12|mesh-list
111487573|NCT01188876|Hydroxocobalamin|hydroxocobalamin|mesh-list
111487574|NCT01188876|Carboplatin|carboplatin|mesh-list
111487575|NCT01188876|Vitamins|vitamins|mesh-ancestor
111487576|NCT01188876|Micronutrients|micronutrients|mesh-ancestor
111487577|NCT01188876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111487578|NCT01188876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111487579|NCT01188876|Hematinics|hematinics|mesh-ancestor
111487580|NCT01188876|Vitamin B Complex|vitamin b complex|mesh-ancestor
111487581|NCT01193868|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
111487582|NCT01193868|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
111487583|NCT01193868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111487584|NCT01193868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111487585|NCT01195116|Dexmedetomidine|dexmedetomidine|mesh-list
111487586|NCT01195116|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111487587|NCT01195116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111487588|NCT01195116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111487589|NCT01195116|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111487590|NCT01195116|Analgesics|analgesics|mesh-ancestor
111487591|NCT01195116|Sensory System Agents|sensory system agents|mesh-ancestor
111487592|NCT01195116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111487593|NCT01195116|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111487594|NCT01195116|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111487595|NCT01195116|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111487596|NCT01195116|Adrenergic Agents|adrenergic agents|mesh-ancestor
111487597|NCT01195116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111487598|NCT01195116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111487599|NCT01197612|Budesonide|budesonide|mesh-list
111487600|NCT01197612|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111487601|NCT01197612|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111487602|NCT01197612|Autonomic Agents|autonomic agents|mesh-ancestor
111487603|NCT01197612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111487604|NCT01197612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111487605|NCT01197612|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111487606|NCT01197612|Respiratory System Agents|respiratory system agents|mesh-ancestor
111487607|NCT01197612|Glucocorticoids|glucocorticoids|mesh-ancestor
111487608|NCT01197612|Hormones|hormones|mesh-ancestor
111487609|NCT01197612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111487610|NCT01198158|Bevacizumab|bevacizumab|mesh-list
111487611|NCT01198158|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111487612|NCT01198158|Everolimus|everolimus|mesh-list
111487613|NCT01198158|Endothelial Growth Factors|endothelial growth factors|mesh-list
111487614|NCT01198158|Antibodies|antibodies|mesh-list
111487615|NCT01198158|Immunoglobulins|immunoglobulins|mesh-list
111487616|NCT01198158|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111487617|NCT01198158|Immunoglobulin G|immunoglobulin g|mesh-list
111102793|NCT05483439|Epirubicin|epirubicin|mesh-list
111487618|NCT01198158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111487619|NCT01198158|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111487620|NCT01198158|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111487621|NCT01198158|Growth Substances|growth substances|mesh-ancestor
111487622|NCT01198158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111487623|NCT01198158|Growth Inhibitors|growth inhibitors|mesh-ancestor
111487624|NCT01198158|Immunologic Factors|immunologic factors|mesh-ancestor
111487625|NCT01198158|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111487626|NCT01198158|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111487627|NCT01198158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111487628|NCT01198158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111487629|NCT01198158|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111487630|NCT01203774|Insulin Glargine|insulin glargine|mesh-list
111487631|NCT01203774|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111487632|NCT01203774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111487633|NCT01205646|Zoledronic Acid|zoledronic acid|mesh-list
111487634|NCT01205646|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111487635|NCT01205646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111487636|NCT01206660|Desoximetasone|desoximetasone|mesh-list
111487637|NCT01206660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111487638|NCT01206660|Glucocorticoids|glucocorticoids|mesh-ancestor
111487639|NCT01206660|Hormones|hormones|mesh-ancestor
111487640|NCT01206660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111487641|NCT01206660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111487642|NCT01207752|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111487643|NCT01207752|Lubricant Eye Drops|lubricant eye drops|mesh-list
111487644|NCT01207752|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111487645|NCT01207908|Mecasermin|mecasermin|mesh-list
111487646|NCT01207908|Growth Substances|growth substances|mesh-ancestor
111487647|NCT01207908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111487648|NCT01208922|Ciprofloxacin|ciprofloxacin|mesh-list
111487649|NCT01208922|Rifamycins|rifamycins|mesh-list
111487650|NCT01208922|Rifamycin SV|rifamycin sv|mesh-list
111487651|NCT01208922|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111487652|NCT01208922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111487653|NCT01208922|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111487654|NCT01208922|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111487655|NCT01208922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111487656|NCT01208922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111487657|NCT01208922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111487658|NCT01208922|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111487659|NCT01208922|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111487660|NCT01208922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111487661|NCT01210170|Mometasone Furoate|mometasone furoate|mesh-list
111487662|NCT01210170|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111487663|NCT01210170|Dermatologic Agents|dermatologic agents|mesh-ancestor
111487664|NCT01210170|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111487665|NCT01210560|Tolvaptan|tolvaptan|mesh-list
111487666|NCT01210560|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
111487667|NCT01210560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111487668|NCT01210560|Natriuretic Agents|natriuretic agents|mesh-ancestor
111487669|NCT01210560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111487670|NCT01211730|Insulin|insulin|mesh-list
111487671|NCT01211730|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111487672|NCT01211730|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111487673|NCT01211730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111487674|NCT01212900|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
111487675|NCT01212900|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111487676|NCT01212900|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111487677|NCT01212900|Antimetabolites|antimetabolites|mesh-ancestor
111487678|NCT01212900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111487679|NCT01212900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111487680|NCT01212900|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111487681|NCT01215318|Silicon|silicon|mesh-list
111487682|NCT01215318|Trace Elements|trace elements|mesh-ancestor
111487683|NCT01215318|Micronutrients|micronutrients|mesh-ancestor
111487684|NCT01215318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111487685|NCT01215786|Timolol|timolol|mesh-list
111487686|NCT01215786|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111487687|NCT01215786|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111487688|NCT01215786|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111487689|NCT01215786|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111487690|NCT01215786|Adrenergic Agents|adrenergic agents|mesh-ancestor
111487691|NCT01215786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111102794|NCT05483439|Pertuzumab|pertuzumab|mesh-list
111102795|NCT05483439|Antibodies|antibodies|mesh-list
111102796|NCT05483439|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111487692|NCT01215786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111487693|NCT01215786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111487694|NCT01215786|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111487695|NCT01215786|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111487696|NCT01216410|Phenylephrine|phenylephrine|mesh-list
111487697|NCT01216410|Oxymetazoline|oxymetazoline|mesh-list
111487698|NCT01216410|Ondansetron|ondansetron|mesh-list
111487699|NCT01216410|Metoclopramide|metoclopramide|mesh-list
111487700|NCT01216410|Antiemetics|antiemetics|mesh-ancestor
111487701|NCT01216410|Autonomic Agents|autonomic agents|mesh-ancestor
111487702|NCT01216410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111487703|NCT01216410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111487704|NCT01216410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111487705|NCT01216410|Antipruritics|antipruritics|mesh-ancestor
111487706|NCT01216410|Dermatologic Agents|dermatologic agents|mesh-ancestor
111487707|NCT01216410|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111487708|NCT01216410|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111487709|NCT01216410|Serotonin Agents|serotonin agents|mesh-ancestor
111487710|NCT01216410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111487711|NCT01216410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111487712|NCT01216410|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111487713|NCT01216410|Mydriatics|mydriatics|mesh-ancestor
111487714|NCT01216410|Sympathomimetics|sympathomimetics|mesh-ancestor
111487715|NCT01216410|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111487716|NCT01216410|Nasal Decongestants|nasal decongestants|mesh-ancestor
111487717|NCT01216410|Respiratory System Agents|respiratory system agents|mesh-ancestor
111487718|NCT01216410|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111487719|NCT01216410|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111487720|NCT01216410|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111487721|NCT01216410|Adrenergic Agents|adrenergic agents|mesh-ancestor
111487722|NCT01216410|Protective Agents|protective agents|mesh-ancestor
111487723|NCT01216410|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111487724|NCT01216410|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111487725|NCT01216410|Dopamine Agents|dopamine agents|mesh-ancestor
111487726|NCT01218048|Carboplatin|carboplatin|mesh-list
111487727|NCT01218048|Cetuximab|cetuximab|mesh-list
111487728|NCT01218048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111487729|NCT01218048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111487730|NCT01218984|Naltrexone|naltrexone|mesh-list
111487731|NCT01218984|Hydromorphone|hydromorphone|mesh-list
111487732|NCT01218984|Naloxone|naloxone|mesh-list
111487733|NCT01218984|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111487734|NCT01218984|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111487735|NCT01218984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111487736|NCT01218984|Sensory System Agents|sensory system agents|mesh-ancestor
111487737|NCT01218984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111487738|NCT01218984|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111487739|NCT01218984|Narcotics|narcotics|mesh-ancestor
111487740|NCT01218984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111487741|NCT01218984|Analgesics|analgesics|mesh-ancestor
111487742|NCT01222260|Dexamethasone|dexamethasone|mesh-list
111487743|NCT01222260|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
111487744|NCT01222260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111487745|NCT01222260|Antiemetics|antiemetics|mesh-ancestor
111487746|NCT01222260|Autonomic Agents|autonomic agents|mesh-ancestor
111487747|NCT01222260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111487748|NCT01222260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111487749|NCT01222260|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111487750|NCT01222260|Glucocorticoids|glucocorticoids|mesh-ancestor
111487751|NCT01222260|Hormones|hormones|mesh-ancestor
111487752|NCT01222260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111487753|NCT01222260|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111487754|NCT01222260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111487755|NCT01222260|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111487756|NCT01222260|Alkylating Agents|alkylating agents|mesh-ancestor
111487757|NCT01222260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111487758|NCT01222572|Etoposide|etoposide|mesh-list
111487759|NCT01222572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111487760|NCT01222572|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111487761|NCT01222572|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111487762|NCT01222572|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111487763|NCT01222572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111487764|NCT01222572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111102797|NCT05483439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111487765|NCT01222884|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
111102798|NCT05483439|Immunologic Factors|immunologic factors|mesh-ancestor
111487766|NCT01222884|Hematinics|hematinics|mesh-ancestor
111487767|NCT01223352|Bosentan|bosentan|mesh-list
111487768|NCT01223352|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111487769|NCT01223352|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
111487770|NCT01223352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111487771|NCT01224210|Ambrisentan|ambrisentan|mesh-list
111487772|NCT01224210|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111487773|NCT01224678|Vitamin D|vitamin d|mesh-list
111487774|NCT01224678|Vitamins|vitamins|mesh-ancestor
111487775|NCT01224678|Micronutrients|micronutrients|mesh-ancestor
111487776|NCT01224678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111487777|NCT01224678|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111487778|NCT01225068|Milnacipran|milnacipran|mesh-list
111487779|NCT01225068|Levomilnacipran|levomilnacipran|mesh-list
111487780|NCT01225068|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111487781|NCT01225068|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111487782|NCT01225068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111487783|NCT01225068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111487784|NCT01225068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111487785|NCT01225068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111487786|NCT01225068|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111487787|NCT01225068|Analgesics|analgesics|mesh-ancestor
111487788|NCT01225068|Sensory System Agents|sensory system agents|mesh-ancestor
111487789|NCT01225068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111487790|NCT01225068|Antidepressive Agents|antidepressive agents|mesh-ancestor
111487791|NCT01225068|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111487792|NCT01226706|Botulinum Toxins|botulinum toxins|mesh-list
111487793|NCT01226706|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111487794|NCT01226706|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111487795|NCT01226706|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111487796|NCT01226706|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111487797|NCT01226706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111487798|NCT01226706|Cholinergic Agents|cholinergic agents|mesh-ancestor
111487799|NCT01226706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111487800|NCT01226706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111487801|NCT01226706|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111487802|NCT01226706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111487803|NCT01231230|Fluticasone|fluticasone|mesh-list
111487804|NCT01231230|Xhance|xhance|mesh-list
111487805|NCT01231230|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
111487806|NCT01231230|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
111487807|NCT01231230|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111487808|NCT01231230|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111487809|NCT01231230|Autonomic Agents|autonomic agents|mesh-ancestor
111487810|NCT01231230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111487811|NCT01231230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111487812|NCT01231230|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111487813|NCT01231230|Respiratory System Agents|respiratory system agents|mesh-ancestor
111487814|NCT01231230|Dermatologic Agents|dermatologic agents|mesh-ancestor
111487815|NCT01231230|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111487816|NCT01231230|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111487817|NCT01231230|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111487818|NCT01231230|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111487819|NCT01231230|Adrenergic Agents|adrenergic agents|mesh-ancestor
111487820|NCT01231230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111487821|NCT01231230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111487822|NCT01231230|Glucocorticoids|glucocorticoids|mesh-ancestor
111487823|NCT01231230|Hormones|hormones|mesh-ancestor
111487824|NCT01231230|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111487825|NCT01231230|Sympathomimetics|sympathomimetics|mesh-ancestor
111487826|NCT01232946|Insulin|insulin|mesh-list
111487827|NCT01232946|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111487828|NCT01232946|Liraglutide|liraglutide|mesh-list
111487829|NCT01232946|Insulin Detemir|insulin detemir|mesh-list
111487830|NCT01232946|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111487831|NCT01232946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111487832|NCT01232946|Incretins|incretins|mesh-ancestor
111487833|NCT01232946|Hormones|hormones|mesh-ancestor
111487834|NCT01232946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111487835|NCT01235910|Cyclosporine|cyclosporine|mesh-list
111487836|NCT01235910|Cyclosporins|cyclosporins|mesh-list
111487837|NCT01235910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111487838|NCT01235910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111487839|NCT01235910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111102799|NCT05483439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111102801|NCT05483439|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111487840|NCT01235910|Immunologic Factors|immunologic factors|mesh-ancestor
111487841|NCT01235910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111487842|NCT01235910|Antifungal Agents|antifungal agents|mesh-ancestor
111102802|NCT05483439|Alkylating Agents|alkylating agents|mesh-ancestor
111102803|NCT05483439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110819897|NCT02589860|Melphalan|melphalan|mesh-list
111102804|NCT05483439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111487843|NCT01235910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111487844|NCT01235910|Dermatologic Agents|dermatologic agents|mesh-ancestor
111487845|NCT01235910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111487846|NCT01235910|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111487847|NCT01236378|Sirolimus|sirolimus|mesh-list
111487848|NCT01236378|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111487849|NCT01236378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111487850|NCT01236378|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111487851|NCT01236378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111487852|NCT01236378|Antifungal Agents|antifungal agents|mesh-ancestor
111487853|NCT01236378|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111487854|NCT01236378|Immunologic Factors|immunologic factors|mesh-ancestor
111487855|NCT01236378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111487856|NCT01236768|Contraceptive Agents|contraceptive agents|mesh-list
111487857|NCT01236768|Contraceptives, Oral|contraceptives, oral|mesh-list
111487858|NCT01236768|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-list
111487859|NCT01236768|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111487860|NCT01236768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111487861|NCT01236768|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111487862|NCT01236768|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111487863|NCT01238640|Nicotine|nicotine|mesh-list
111487864|NCT01238640|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111487865|NCT01238640|Autonomic Agents|autonomic agents|mesh-ancestor
111487866|NCT01238640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111487867|NCT01238640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111487868|NCT01238640|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111487869|NCT01238640|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111487870|NCT01238640|Cholinergic Agents|cholinergic agents|mesh-ancestor
111102805|NCT05483439|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111102806|NCT05483439|Tubulin Modulators|tubulin modulators|mesh-ancestor
111102807|NCT05483439|Antimitotic Agents|antimitotic agents|mesh-ancestor
111102808|NCT05483439|Mitosis Modulators|mitosis modulators|mesh-ancestor
111102809|NCT05483439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111102810|NCT05483439|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111102811|NCT05483439|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111102812|NCT05483439|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111102813|NCT05483439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111102815|NCT03748095|Piperacillin|piperacillin|mesh-list
111102816|NCT03748095|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111102817|NCT03748095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111102818|NCT03748095|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
111102819|NCT03748095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111102820|NCT03748095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111102821|NCT04275375|Anesthetics|anesthetics|mesh-list
111102822|NCT04275375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111102823|NCT04275375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111102824|NCT05488353|Disitamab vedotin|disitamab vedotin|mesh-list
111102825|NCT05488353|Immunoconjugates|immunoconjugates|mesh-ancestor
111487871|NCT01238640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111487872|NCT01238640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111487873|NCT01247064|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111487874|NCT01247220|Ranibizumab|ranibizumab|mesh-list
111487875|NCT01247220|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111487876|NCT01247220|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111487877|NCT01247220|Growth Substances|growth substances|mesh-ancestor
111487878|NCT01247220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111487879|NCT01247220|Growth Inhibitors|growth inhibitors|mesh-ancestor
111487880|NCT01247220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111487881|NCT01249872|Morphine|morphine|mesh-list
111487882|NCT01249872|Levobupivacaine|levobupivacaine|mesh-list
111487883|NCT01249872|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111102826|NCT05488353|Immunologic Factors|immunologic factors|mesh-ancestor
111102827|NCT05488353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111487884|NCT01249872|Narcotics|narcotics|mesh-ancestor
111102828|NCT04543071|Paclitaxel|paclitaxel|mesh-list
111487885|NCT01249872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111487886|NCT01249872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111487887|NCT01249872|Analgesics|analgesics|mesh-ancestor
111487888|NCT01249872|Sensory System Agents|sensory system agents|mesh-ancestor
111487889|NCT01249872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111487890|NCT01249872|Anesthetics, Local|anesthetics, local|mesh-ancestor
111487891|NCT01249872|Anesthetics|anesthetics|mesh-ancestor
111487892|NCT01250184|Lidocaine|lidocaine|mesh-list
111487893|NCT01250184|Anesthetics, Local|anesthetics, local|mesh-ancestor
111487894|NCT01250184|Anesthetics|anesthetics|mesh-ancestor
111487895|NCT01250184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111487896|NCT01250184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111487897|NCT01250184|Sensory System Agents|sensory system agents|mesh-ancestor
111487898|NCT01250184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111487899|NCT01250184|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111487900|NCT01250184|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111487901|NCT01250184|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111487902|NCT01250184|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111487903|NCT01250184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111487904|NCT01250730|Crizotinib|crizotinib|mesh-list
111487905|NCT01250730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111487906|NCT01250730|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111487907|NCT01250730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111487908|NCT01250730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111487909|NCT01251978|Ranibizumab|ranibizumab|mesh-list
111487910|NCT01251978|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111487911|NCT01251978|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111487912|NCT01251978|Growth Substances|growth substances|mesh-ancestor
111487913|NCT01251978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111487914|NCT01251978|Growth Inhibitors|growth inhibitors|mesh-ancestor
111487915|NCT01251978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111487916|NCT01253460|Cyclophosphamide|cyclophosphamide|mesh-list
111487917|NCT01253460|Rituximab|rituximab|mesh-list
111487918|NCT01253460|Sapacitabine|sapacitabine|mesh-list
111487919|NCT01253460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111487920|NCT01253460|Immunologic Factors|immunologic factors|mesh-ancestor
111487921|NCT01253460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111487922|NCT01253460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111487923|NCT01253460|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111487924|NCT01253460|Alkylating Agents|alkylating agents|mesh-ancestor
111487925|NCT01253460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111487926|NCT01253460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111487927|NCT01253460|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111487928|NCT01253460|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111487929|NCT01254396|Sildenafil Citrate|sildenafil citrate|mesh-list
111487930|NCT01254396|Vasodilator Agents|vasodilator agents|mesh-ancestor
111487931|NCT01254396|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111487932|NCT01254396|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111487933|NCT01254396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111487934|NCT01254396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111487935|NCT01254396|Urological Agents|urological agents|mesh-ancestor
111487936|NCT01254552|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
111487937|NCT01254552|Chelating Agents|chelating agents|mesh-ancestor
111487938|NCT01254552|Sequestering Agents|sequestering agents|mesh-ancestor
111487939|NCT01254552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111487940|NCT01244724|Escitalopram|escitalopram|mesh-list
111487941|NCT01244724|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111487942|NCT01244724|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111487943|NCT01244724|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111487944|NCT01244724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111487945|NCT01244724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111487946|NCT01244724|Serotonin Agents|serotonin agents|mesh-ancestor
111487947|NCT01244724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111102829|NCT04543071|Gemcitabine|gemcitabine|mesh-list
111102830|NCT04543071|Cemiplimab|cemiplimab|mesh-list
111102831|NCT04543071|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111102832|NCT04543071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111102833|NCT04543071|Tubulin Modulators|tubulin modulators|mesh-ancestor
111102834|NCT04543071|Antimitotic Agents|antimitotic agents|mesh-ancestor
111102835|NCT04543071|Mitosis Modulators|mitosis modulators|mesh-ancestor
111102836|NCT04543071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110696025|NCT00418938|Antidotes|antidotes|mesh-ancestor
111102837|NCT04543071|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111487948|NCT01258374|Raltegravir Potassium|raltegravir potassium|mesh-list
111487949|NCT01258374|Darunavir|darunavir|mesh-list
111487950|NCT01258374|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111487951|NCT01258374|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111487952|NCT01258374|Antiviral Agents|antiviral agents|mesh-ancestor
111487953|NCT01258374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111487954|NCT01258374|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111487955|NCT01258374|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111487956|NCT01258374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111487957|NCT01258374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111487958|NCT01258374|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111487959|NCT01258374|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111487960|NCT01258374|Protease Inhibitors|protease inhibitors|mesh-ancestor
111487961|NCT01262118|Tofacitinib|tofacitinib|mesh-list
111487962|NCT01262118|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
111487963|NCT01262118|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111487964|NCT01262118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111487965|NCT01262118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111487966|NCT01263132|Thiamine|thiamine|mesh-list
111487967|NCT01263132|Vitamin B 12|vitamin b 12|mesh-list
111487968|NCT01263132|Gabapentin|gabapentin|mesh-list
111487969|NCT01263132|Analgesics|analgesics|mesh-ancestor
111487970|NCT01263132|Sensory System Agents|sensory system agents|mesh-ancestor
111487971|NCT01263132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111487972|NCT01263132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111487973|NCT01263132|Anticonvulsants|anticonvulsants|mesh-ancestor
111487974|NCT01263132|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111487975|NCT01263132|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111487976|NCT01263132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111487977|NCT01263132|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111487978|NCT01263132|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111487979|NCT01263132|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111487980|NCT01263132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111487981|NCT01263132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111487982|NCT01263132|Antimanic Agents|antimanic agents|mesh-ancestor
111487983|NCT01263132|Vitamin B Complex|vitamin b complex|mesh-ancestor
111487984|NCT01263132|Vitamins|vitamins|mesh-ancestor
111487985|NCT01263132|Micronutrients|micronutrients|mesh-ancestor
111487986|NCT01267656|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111487987|NCT01267656|Lubricant Eye Drops|lubricant eye drops|mesh-list
111487988|NCT01267656|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111487989|NCT01270542|Bevacizumab|bevacizumab|mesh-list
111487990|NCT01270542|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111487991|NCT01270542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111487992|NCT01270542|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111487993|NCT01270542|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111487994|NCT01270542|Growth Substances|growth substances|mesh-ancestor
111487995|NCT01270542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111487996|NCT01270542|Growth Inhibitors|growth inhibitors|mesh-ancestor
111487997|NCT01271244|Escitalopram|escitalopram|mesh-list
111487998|NCT01271244|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111487999|NCT01271244|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111488000|NCT01271244|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111488001|NCT01271244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111488002|NCT01271244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111488003|NCT01271244|Serotonin Agents|serotonin agents|mesh-ancestor
110646662|NCT02864147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111488004|NCT01271244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111488005|NCT01272960|Levonorgestrel|levonorgestrel|mesh-list
111488006|NCT01272960|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111488007|NCT01272960|Contraceptive Agents|contraceptive agents|mesh-ancestor
111488008|NCT01272960|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111488009|NCT01272960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111488010|NCT01272960|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111488011|NCT01272960|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111488012|NCT01272960|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111488013|NCT01275300|Aspirin|aspirin|mesh-list
111488014|NCT01275300|Niacin|niacin|mesh-list
111488015|NCT01275300|Niacinamide|niacinamide|mesh-list
111488016|NCT01275300|Nicotinic Acids|nicotinic acids|mesh-list
111488017|NCT01275300|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111488018|NCT01275300|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111488019|NCT01275300|Analgesics|analgesics|mesh-ancestor
111488020|NCT01275300|Sensory System Agents|sensory system agents|mesh-ancestor
111488021|NCT01275300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111488022|NCT01275300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111102839|NCT04543071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111102840|NCT05487963|Tofacitinib|tofacitinib|mesh-list
111488023|NCT01275300|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111488024|NCT01275300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111488025|NCT01275300|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111488026|NCT01275300|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111488027|NCT01275300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111488028|NCT01275300|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111488029|NCT01275300|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111488030|NCT01275300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111488031|NCT01275300|Antipyretics|antipyretics|mesh-ancestor
111488032|NCT01275300|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111488033|NCT01275300|Antimetabolites|antimetabolites|mesh-ancestor
111488034|NCT01275300|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111488035|NCT01275300|Vasodilator Agents|vasodilator agents|mesh-ancestor
111488036|NCT01275300|Vitamin B Complex|vitamin b complex|mesh-ancestor
111488037|NCT01275300|Vitamins|vitamins|mesh-ancestor
111488038|NCT01275300|Micronutrients|micronutrients|mesh-ancestor
111488039|NCT01276314|Prednisolone|prednisolone|mesh-list
111488040|NCT01276314|Etanercept|etanercept|mesh-list
111488041|NCT01276314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111488042|NCT01276314|Glucocorticoids|glucocorticoids|mesh-ancestor
111488043|NCT01276314|Hormones|hormones|mesh-ancestor
111488044|NCT01276314|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111488045|NCT01276314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111488046|NCT01276314|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111488047|NCT01276314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111488048|NCT01276314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111488049|NCT01276314|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111488050|NCT01276314|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111488051|NCT01276314|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111488052|NCT01276314|Analgesics|analgesics|mesh-ancestor
111488053|NCT01276314|Sensory System Agents|sensory system agents|mesh-ancestor
111488054|NCT01276314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111488055|NCT01276314|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111488056|NCT01276314|Immunologic Factors|immunologic factors|mesh-ancestor
111488057|NCT01280058|Paclitaxel|paclitaxel|mesh-list
111488058|NCT01280058|Carboplatin|carboplatin|mesh-list
111488059|NCT01280058|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111488060|NCT01280058|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111488061|NCT01280058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111488062|NCT01280058|Tubulin Modulators|tubulin modulators|mesh-ancestor
111488063|NCT01280058|Antimitotic Agents|antimitotic agents|mesh-ancestor
111488064|NCT01280058|Mitosis Modulators|mitosis modulators|mesh-ancestor
111488065|NCT01280058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111488066|NCT01280604|Fenofibrate|fenofibrate|mesh-list
111488067|NCT01280604|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111488068|NCT01280604|Antimetabolites|antimetabolites|mesh-ancestor
111488069|NCT01280604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111488070|NCT01280604|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111488071|NCT01282242|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
111488072|NCT01282242|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111488073|NCT01282242|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111488074|NCT01282242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111488075|NCT01285050|Tenofovir|tenofovir|mesh-list
111488076|NCT01285050|Emtricitabine|emtricitabine|mesh-list
111488077|NCT01285050|Raltegravir Potassium|raltegravir potassium|mesh-list
111488078|NCT01285050|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
111488079|NCT01285050|Antiviral Agents|antiviral agents|mesh-ancestor
111488080|NCT01285050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111488081|NCT01285050|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111488082|NCT01285050|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111488083|NCT01285050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111488084|NCT01285050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111488085|NCT01285050|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111488086|NCT01285050|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111488087|NCT01285050|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111488088|NCT01286454|Fesoterodine|fesoterodine|mesh-list
111488089|NCT01286454|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111488090|NCT01286454|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111488091|NCT01286454|Cholinergic Agents|cholinergic agents|mesh-ancestor
111488092|NCT01286454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111119169|NCT05306873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111488093|NCT01286454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111488094|NCT01286454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111488096|NCT01287078|Cyclosporine|cyclosporine|mesh-list
111488097|NCT01287078|Cyclosporins|cyclosporins|mesh-list
111488098|NCT01287078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111488099|NCT01287078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111488100|NCT01287078|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111488101|NCT01287078|Immunologic Factors|immunologic factors|mesh-ancestor
111488102|NCT01287078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111488103|NCT01287078|Antifungal Agents|antifungal agents|mesh-ancestor
111488104|NCT01287078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111488105|NCT01287078|Dermatologic Agents|dermatologic agents|mesh-ancestor
111488106|NCT01287078|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111488107|NCT01287078|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111488108|NCT01291056|Clomiphene|clomiphene|mesh-list
111488109|NCT01291056|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111488110|NCT01291056|Hormone Antagonists|hormone antagonists|mesh-ancestor
111488111|NCT01291056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111488112|NCT01291056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111488113|NCT01291056|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111488114|NCT01291056|Fertility Agents|fertility agents|mesh-ancestor
111488115|NCT01291056|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111488116|NCT01291056|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111488117|NCT01291056|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111488118|NCT01292304|Tolvaptan|tolvaptan|mesh-list
111488119|NCT01292304|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
111488120|NCT01292304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111488121|NCT01292304|Natriuretic Agents|natriuretic agents|mesh-ancestor
111488122|NCT01292304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111488123|NCT01293396|Insulin|insulin|mesh-list
111488124|NCT01293396|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111488125|NCT01293396|Insulin Aspart|insulin aspart|mesh-list
111488126|NCT01293396|Insulin, Long-Acting|insulin, long-acting|mesh-list
111488127|NCT01293396|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
111488128|NCT01293396|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
111488129|NCT01293396|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111488130|NCT01293396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111488131|NCT01294098|Bupivacaine|bupivacaine|mesh-list
111488132|NCT01294098|Anesthetics, Local|anesthetics, local|mesh-ancestor
111488133|NCT01294098|Anesthetics|anesthetics|mesh-ancestor
111488134|NCT01294098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111488135|NCT01294098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111488136|NCT01294098|Sensory System Agents|sensory system agents|mesh-ancestor
111488137|NCT01294098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111488138|NCT01295112|Dexamethasone|dexamethasone|mesh-list
111488139|NCT01295112|Dexamethasone acetate|dexamethasone acetate|mesh-list
111488140|NCT01295112|Bevacizumab|bevacizumab|mesh-list
111488141|NCT01295112|BB 1101|bb 1101|mesh-list
111488142|NCT01295112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111488143|NCT01295112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111488144|NCT01295112|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111488145|NCT01295112|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111488146|NCT01295112|Growth Substances|growth substances|mesh-ancestor
111488147|NCT01295112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111488148|NCT01295112|Growth Inhibitors|growth inhibitors|mesh-ancestor
111488149|NCT01295112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111488150|NCT01295112|Antiemetics|antiemetics|mesh-ancestor
111488151|NCT01295112|Autonomic Agents|autonomic agents|mesh-ancestor
111488152|NCT01295112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111488153|NCT01295112|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111488154|NCT01295112|Glucocorticoids|glucocorticoids|mesh-ancestor
111488155|NCT01295112|Hormones|hormones|mesh-ancestor
111488156|NCT01295112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111488157|NCT01295112|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111488158|NCT01295112|Protease Inhibitors|protease inhibitors|mesh-ancestor
111488159|NCT01295112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111488160|NCT01295112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111488161|NCT01301742|Empagliflozin|empagliflozin|mesh-list
111488162|NCT01301742|Gemfibrozil|gemfibrozil|mesh-list
111488163|NCT01301742|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111488164|NCT01301742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111488165|NCT01301742|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110696234|NCT01565798|Copper|copper|mesh-list
111488166|NCT01301742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111488167|NCT01301742|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111488168|NCT01301742|Antimetabolites|antimetabolites|mesh-ancestor
111488169|NCT01301742|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111488170|NCT01301742|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
111488171|NCT01301742|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111488172|NCT01301742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111488174|NCT01304082|Anesthetics, Local|anesthetics, local|mesh-ancestor
111488175|NCT01304082|Anesthetics|anesthetics|mesh-ancestor
111488176|NCT01304082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111488177|NCT01304082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111488178|NCT01304082|Sensory System Agents|sensory system agents|mesh-ancestor
111488179|NCT01304082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111488180|NCT01304082|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111488181|NCT01304082|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111488182|NCT01304082|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111488183|NCT01304082|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111488184|NCT01304082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111488185|NCT01304238|PENTA|penta|mesh-list
111488186|NCT01304238|Lepirudin|lepirudin|mesh-list
111488187|NCT01304238|Danaparoid|danaparoid|mesh-list
111488188|NCT01304238|Fondaparinux|fondaparinux|mesh-list
111488189|NCT01304238|Argatroban|argatroban|mesh-list
111488190|NCT01304238|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111488191|NCT01304238|Antithrombins|antithrombins|mesh-ancestor
111488192|NCT01304238|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111488193|NCT01304238|Protease Inhibitors|protease inhibitors|mesh-ancestor
111488194|NCT01304238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111488195|NCT01304238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111488196|NCT01304238|Anticoagulants|anticoagulants|mesh-ancestor
111488197|NCT01304238|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111488198|NCT01304238|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111488199|NCT01304238|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111488200|NCT01305252|Treprostinil|treprostinil|mesh-list
111488201|NCT01305252|Tadalafil|tadalafil|mesh-list
111488202|NCT01305252|Vasodilator Agents|vasodilator agents|mesh-ancestor
111488203|NCT01305252|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111488204|NCT01305252|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111488205|NCT01305252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111488206|NCT01305252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111488207|NCT01305252|Urological Agents|urological agents|mesh-ancestor
111488208|NCT01305252|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111488209|NCT01308060|Botulinum Toxins|botulinum toxins|mesh-list
111488210|NCT01308060|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111488211|NCT01308060|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111488212|NCT01308060|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111488213|NCT01308060|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111488214|NCT01308060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111488215|NCT01308060|Cholinergic Agents|cholinergic agents|mesh-ancestor
111488216|NCT01308060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111488217|NCT01308060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111488218|NCT01308060|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111488219|NCT01308060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111488220|NCT01308294|Vaccines|vaccines|mesh-list
111488221|NCT01308294|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
111488222|NCT01308294|Immunologic Factors|immunologic factors|mesh-ancestor
111488223|NCT01308294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111488224|NCT01308294|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111488225|NCT01308840|Gemcitabine|gemcitabine|mesh-list
111488226|NCT01308840|Oxaliplatin|oxaliplatin|mesh-list
111488227|NCT01308840|Panitumumab|panitumumab|mesh-list
111488228|NCT01308840|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111488229|NCT01308840|Antimetabolites|antimetabolites|mesh-ancestor
111488230|NCT01308840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111488231|NCT01308840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111488232|NCT01308840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111488233|NCT01311102|Lidocaine|lidocaine|mesh-list
111488234|NCT01311102|Anesthetics, Local|anesthetics, local|mesh-ancestor
111488235|NCT01311102|Anesthetics|anesthetics|mesh-ancestor
111488236|NCT01311102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111488237|NCT01311102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111488238|NCT01311102|Sensory System Agents|sensory system agents|mesh-ancestor
111488239|NCT01311102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111488240|NCT01311102|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111488241|NCT01311102|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111488242|NCT01311102|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111488243|NCT01311102|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111488244|NCT01311102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111488245|NCT01312038|Simethicone|simethicone|mesh-list
111488246|NCT01312038|Antifoaming Agents|antifoaming agents|mesh-ancestor
111488247|NCT01312038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111488248|NCT01312038|Emollients|emollients|mesh-ancestor
111488249|NCT01312038|Dermatologic Agents|dermatologic agents|mesh-ancestor
111488250|NCT01312272|Oxytocin|oxytocin|mesh-list
111488251|NCT01312272|Oxytocics|oxytocics|mesh-ancestor
111488252|NCT01312272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111488253|NCT01312272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111488254|NCT01312818|Dexamethasone|dexamethasone|mesh-list
111488255|NCT01312818|Methotrexate|methotrexate|mesh-list
111488256|NCT01312818|Bortezomib|bortezomib|mesh-list
111488257|NCT01312818|Imatinib Mesylate|imatinib mesylate|mesh-list
111488258|NCT01312818|Vorinostat|vorinostat|mesh-list
111488259|NCT01312818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111488260|NCT01312818|Antiemetics|antiemetics|mesh-ancestor
111488261|NCT01312818|Autonomic Agents|autonomic agents|mesh-ancestor
111488262|NCT01312818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111488263|NCT01312818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111488264|NCT01312818|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111488265|NCT01312818|Glucocorticoids|glucocorticoids|mesh-ancestor
111488266|NCT01312818|Hormones|hormones|mesh-ancestor
111488267|NCT01312818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111488268|NCT01312818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111488269|NCT01312818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111488270|NCT01312818|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111488271|NCT01312818|Abortifacient Agents|abortifacient agents|mesh-ancestor
111488272|NCT01312818|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111488273|NCT01312818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111488274|NCT01312818|Antimetabolites|antimetabolites|mesh-ancestor
111488275|NCT01312818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111488276|NCT01312818|Dermatologic Agents|dermatologic agents|mesh-ancestor
111488277|NCT01312818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111488278|NCT01312818|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111488279|NCT01312818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111488280|NCT01312818|Immunologic Factors|immunologic factors|mesh-ancestor
111488281|NCT01312818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111488282|NCT01312818|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111488283|NCT01312818|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111488284|NCT01312818|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111488285|NCT01313520|Infliximab|infliximab|mesh-list
111488286|NCT01313520|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111488287|NCT01313520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111488288|NCT01313520|Dermatologic Agents|dermatologic agents|mesh-ancestor
111488289|NCT01313520|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111488290|NCT01313520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111488291|NCT01315002|Nicotine|nicotine|mesh-list
111488292|NCT01315002|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111488293|NCT01315002|Autonomic Agents|autonomic agents|mesh-ancestor
111488294|NCT01315002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111488295|NCT01315002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111488296|NCT01315002|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111488297|NCT01315002|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111488298|NCT01315002|Cholinergic Agents|cholinergic agents|mesh-ancestor
111488299|NCT01315002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111488300|NCT01315002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111488301|NCT01315158|Fentanyl|fentanyl|mesh-list
111488302|NCT01315158|Midazolam|midazolam|mesh-list
111488303|NCT01315158|Analgesics, Opioid|analgesics, opioid|mesh-list
111488304|NCT01315158|Propofol|propofol|mesh-list
111488305|NCT01315158|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111488306|NCT01315158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111488307|NCT01315158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111488308|NCT01315158|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111488309|NCT01315158|Anesthetics, General|anesthetics, general|mesh-ancestor
111488310|NCT01315158|Anesthetics|anesthetics|mesh-ancestor
111488311|NCT01315158|Narcotics|narcotics|mesh-ancestor
111488312|NCT01315158|Analgesics|analgesics|mesh-ancestor
111488313|NCT01315158|Sensory System Agents|sensory system agents|mesh-ancestor
111102841|NCT05487963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111488314|NCT01315158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111488315|NCT01315158|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111488316|NCT01315158|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111488317|NCT01315158|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111488318|NCT01315158|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111488319|NCT01315158|GABA Modulators|gaba modulators|mesh-ancestor
111488320|NCT01315158|GABA Agents|gaba agents|mesh-ancestor
111488321|NCT01315158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111488322|NCT01315158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111488323|NCT01318278|Dopamine|dopamine|mesh-list
111488324|NCT01318278|Vasopressins|vasopressins|mesh-list
111488325|NCT01318278|Arginine Vasopressin|arginine vasopressin|mesh-list
111488326|NCT01318278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111488327|NCT01318278|Hemostatics|hemostatics|mesh-ancestor
111488328|NCT01318278|Coagulants|coagulants|mesh-ancestor
111488329|NCT01318278|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111488330|NCT01318278|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
111488331|NCT01318278|Natriuretic Agents|natriuretic agents|mesh-ancestor
111488332|NCT01318278|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111488333|NCT01318278|Sympathomimetics|sympathomimetics|mesh-ancestor
111488334|NCT01318278|Autonomic Agents|autonomic agents|mesh-ancestor
111488335|NCT01318278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111488336|NCT01318278|Dopamine Agents|dopamine agents|mesh-ancestor
111488337|NCT01318278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111488338|NCT01318278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111488339|NCT01318278|Protective Agents|protective agents|mesh-ancestor
111488340|NCT01318356|Doxycycline|doxycycline|mesh-list
111488341|NCT01318356|Tetracycline|tetracycline|mesh-list
111488342|NCT01318356|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111488343|NCT01318356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111488344|NCT01318356|Antimalarials|antimalarials|mesh-ancestor
111488345|NCT01318356|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111488346|NCT01318356|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111488347|NCT01318356|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111488348|NCT01318356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111488349|NCT01318356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111488350|NCT01324128|Iron|iron|mesh-list
111488351|NCT01324128|Sevelamer|sevelamer|mesh-list
111488352|NCT01324128|Trace Elements|trace elements|mesh-ancestor
111488353|NCT01324128|Micronutrients|micronutrients|mesh-ancestor
111488354|NCT01324128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111488355|NCT01324128|Chelating Agents|chelating agents|mesh-ancestor
111488356|NCT01324128|Sequestering Agents|sequestering agents|mesh-ancestor
111488357|NCT01324128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111488358|NCT01328184|Empagliflozin|empagliflozin|mesh-list
111488359|NCT01328184|Levonorgestrel|levonorgestrel|mesh-list
111488360|NCT01328184|Ethinyl Estradiol|ethinyl estradiol|mesh-list
111488361|NCT01328184|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
111488362|NCT01328184|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
111488363|NCT01328184|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111488364|NCT01328184|Contraceptive Agents|contraceptive agents|mesh-ancestor
111488365|NCT01328184|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111488366|NCT01328184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111488367|NCT01328184|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111488368|NCT01328184|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111488369|NCT01328184|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111488370|NCT01328184|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111488371|NCT01328184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111488372|NCT01328184|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111488373|NCT01328184|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111488374|NCT01328184|Estrogens|estrogens|mesh-ancestor
111488375|NCT01328184|Hormones|hormones|mesh-ancestor
111488376|NCT01328184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111488377|NCT01328184|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
111488378|NCT01328184|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
111488379|NCT01328184|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
111488380|NCT01328184|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
111488381|NCT01328964|Fluticasone|fluticasone|mesh-list
111488382|NCT01328964|Xhance|xhance|mesh-list
111488383|NCT01328964|Budesonide|budesonide|mesh-list
111488384|NCT01328964|Montelukast|montelukast|mesh-list
111488385|NCT01328964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111488386|NCT01328964|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111488387|NCT01328964|Autonomic Agents|autonomic agents|mesh-ancestor
111488388|NCT01328964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111488389|NCT01328964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111102842|NCT05487963|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
111488390|NCT01328964|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111488391|NCT01328964|Respiratory System Agents|respiratory system agents|mesh-ancestor
111488392|NCT01328964|Dermatologic Agents|dermatologic agents|mesh-ancestor
111488393|NCT01328964|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111488395|NCT01328964|Hormones|hormones|mesh-ancestor
111488396|NCT01328964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111488397|NCT01328964|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
111488398|NCT01328964|Hormone Antagonists|hormone antagonists|mesh-ancestor
111488399|NCT01328964|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
111488400|NCT01328964|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111488401|NCT01328964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111488402|NCT01330134|Lidocaine|lidocaine|mesh-list
111488403|NCT01330134|Anesthetics, Local|anesthetics, local|mesh-ancestor
111488404|NCT01330134|Anesthetics|anesthetics|mesh-ancestor
111488405|NCT01330134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111488406|NCT01330134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111488407|NCT01330134|Sensory System Agents|sensory system agents|mesh-ancestor
111488408|NCT01330134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111488409|NCT01330134|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111488410|NCT01330134|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111488411|NCT01330134|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111488412|NCT01330134|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111488413|NCT01330134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111488414|NCT01330290|Rotigotine|rotigotine|mesh-list
111488415|NCT01330290|Dopamine Agonists|dopamine agonists|mesh-ancestor
111488416|NCT01330290|Dopamine Agents|dopamine agents|mesh-ancestor
111488417|NCT01330290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111488418|NCT01330290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111488419|NCT01330290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111488420|NCT01331304|Quetiapine Fumarate|quetiapine fumarate|mesh-list
111488421|NCT01331304|Antidepressive Agents|antidepressive agents|mesh-ancestor
111488422|NCT01331304|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111488423|NCT01331304|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111488424|NCT01331304|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111488425|NCT01331304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111488426|NCT01331304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111488427|NCT01331694|Fluticasone|fluticasone|mesh-list
111488428|NCT01331694|Bromides|bromides|mesh-list
111488429|NCT01331694|Albuterol|albuterol|mesh-list
111488430|NCT01331694|Tiotropium Bromide|tiotropium bromide|mesh-list
111488431|NCT01331694|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
111488432|NCT01331694|Ipratropium|ipratropium|mesh-list
111488433|NCT01331694|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
111488434|NCT01331694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111488435|NCT01331694|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111488436|NCT01331694|Autonomic Agents|autonomic agents|mesh-ancestor
111488437|NCT01331694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111488438|NCT01331694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111488439|NCT01331694|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111488440|NCT01331694|Respiratory System Agents|respiratory system agents|mesh-ancestor
111488441|NCT01331694|Dermatologic Agents|dermatologic agents|mesh-ancestor
111488442|NCT01331694|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111488443|NCT01331694|Parasympatholytics|parasympatholytics|mesh-ancestor
111488444|NCT01331694|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111488445|NCT01331694|Cholinergic Agents|cholinergic agents|mesh-ancestor
111488446|NCT01331694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111488447|NCT01331694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111488448|NCT01331694|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111488449|NCT01331694|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111488450|NCT01331694|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111488451|NCT01331694|Adrenergic Agents|adrenergic agents|mesh-ancestor
111488452|NCT01331694|Anticonvulsants|anticonvulsants|mesh-ancestor
111488453|NCT01331694|Tocolytic Agents|tocolytic agents|mesh-ancestor
111488454|NCT01331694|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111488455|NCT01331694|Glucocorticoids|glucocorticoids|mesh-ancestor
111488456|NCT01331694|Hormones|hormones|mesh-ancestor
111488457|NCT01331694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111488458|NCT01331694|Sympathomimetics|sympathomimetics|mesh-ancestor
111488459|NCT01333098|Mifepristone|mifepristone|mesh-list
111488460|NCT01333098|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
111488461|NCT01333098|Abortifacient Agents|abortifacient agents|mesh-ancestor
111488462|NCT01333098|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111102843|NCT05487963|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110696544|NCT03795194|Ampicillin|ampicillin|mesh-list
111488463|NCT01333098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111488464|NCT01333098|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111488465|NCT01333098|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111488466|NCT01333098|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111488467|NCT01333098|Contraceptive Agents|contraceptive agents|mesh-ancestor
111488468|NCT01333098|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
111488469|NCT01333098|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
111488470|NCT01333098|Hormone Antagonists|hormone antagonists|mesh-ancestor
111488471|NCT01333098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111488472|NCT01333098|Luteolytic Agents|luteolytic agents|mesh-ancestor
111488473|NCT01333098|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111488474|NCT01333098|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
111488475|NCT01333488|Magnesium Sulfate|magnesium sulfate|mesh-list
111488476|NCT01333488|Analgesics|analgesics|mesh-ancestor
111488477|NCT01333488|Sensory System Agents|sensory system agents|mesh-ancestor
111488478|NCT01333488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111488479|NCT01333488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111488480|NCT01333488|Anesthetics|anesthetics|mesh-ancestor
111488481|NCT01333488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111488482|NCT01333488|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111488483|NCT01333488|Anticonvulsants|anticonvulsants|mesh-ancestor
111488484|NCT01333488|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111488485|NCT01333488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111488486|NCT01333488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111488487|NCT01333488|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111488488|NCT01333488|Tocolytic Agents|tocolytic agents|mesh-ancestor
111488489|NCT01333488|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111488490|NCT01335204|Bavituximab|bavituximab|mesh-list
111488491|NCT01335204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111488492|NCT01335204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111488493|NCT01335750|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111488494|NCT01336296|Mycophenolic Acid|mycophenolic acid|mesh-list
111488495|NCT01336296|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111488496|NCT01336296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111488497|NCT01336296|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111488498|NCT01336296|Antitubercular Agents|antitubercular agents|mesh-ancestor
111488499|NCT01336296|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111488500|NCT01336296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111488501|NCT01336296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111488502|NCT01336296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111488503|NCT01337700|Milnacipran|milnacipran|mesh-list
111488504|NCT01337700|Levomilnacipran|levomilnacipran|mesh-list
111488505|NCT01337700|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111488506|NCT01337700|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111488507|NCT01337700|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111488508|NCT01337700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111488509|NCT01337700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111488510|NCT01337700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111488511|NCT01337700|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111488512|NCT01337700|Analgesics|analgesics|mesh-ancestor
111488513|NCT01337700|Sensory System Agents|sensory system agents|mesh-ancestor
111488514|NCT01337700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111488515|NCT01337700|Antidepressive Agents|antidepressive agents|mesh-ancestor
111488516|NCT01337700|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111488517|NCT01339260|Dexamethasone|dexamethasone|mesh-list
111488518|NCT01339260|Palonosetron|palonosetron|mesh-list
111488519|NCT01339260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111488520|NCT01339260|Antiemetics|antiemetics|mesh-ancestor
111488521|NCT01339260|Autonomic Agents|autonomic agents|mesh-ancestor
111488522|NCT01339260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111488523|NCT01339260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111488524|NCT01339260|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111488525|NCT01339260|Glucocorticoids|glucocorticoids|mesh-ancestor
111488527|NCT01339260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111488528|NCT01339260|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111488529|NCT01339260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111488530|NCT01339260|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111488531|NCT01339260|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111488532|NCT01339260|Serotonin Agents|serotonin agents|mesh-ancestor
111488533|NCT01339260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111102844|NCT05487963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111488534|NCT01339260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111488535|NCT01340586|Apixaban|apixaban|mesh-list
111488536|NCT01340586|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111488537|NCT01340586|Antithrombins|antithrombins|mesh-ancestor
111488538|NCT01340586|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111488539|NCT01340586|Protease Inhibitors|protease inhibitors|mesh-ancestor
111488540|NCT01340586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111488541|NCT01340586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111488542|NCT01340586|Anticoagulants|anticoagulants|mesh-ancestor
111488543|NCT01342770|Pioglitazone|pioglitazone|mesh-list
111488544|NCT01342770|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111488545|NCT01342770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111488546|NCT01343004|Teriparatide|teriparatide|mesh-list
111488547|NCT01343004|Abaloparatide|abaloparatide|mesh-list
111488548|NCT01343004|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111488549|NCT01343004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111488550|NCT01343004|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111488551|NCT01347060|Fluticasone|fluticasone|mesh-list
111488552|NCT01347060|Xhance|xhance|mesh-list
111488553|NCT01347060|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
111488554|NCT01347060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111488555|NCT01347060|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111488556|NCT01347060|Autonomic Agents|autonomic agents|mesh-ancestor
111488557|NCT01347060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111488558|NCT01347060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111488559|NCT01347060|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111488560|NCT01347060|Respiratory System Agents|respiratory system agents|mesh-ancestor
111488561|NCT01347060|Dermatologic Agents|dermatologic agents|mesh-ancestor
111488562|NCT01347060|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111488563|NCT01347060|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111488564|NCT01347060|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111488565|NCT01347060|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111488566|NCT01347060|Adrenergic Agents|adrenergic agents|mesh-ancestor
111488567|NCT01347060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111488568|NCT01347060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111488569|NCT01351740|Ritonavir|ritonavir|mesh-list
111488570|NCT01351740|Atazanavir Sulfate|atazanavir sulfate|mesh-list
111488571|NCT01351740|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111488572|NCT01351740|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111488573|NCT01351740|Protease Inhibitors|protease inhibitors|mesh-ancestor
111488574|NCT01351740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111488575|NCT01351740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111488576|NCT01351740|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111488577|NCT01351740|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111488578|NCT01351740|Antiviral Agents|antiviral agents|mesh-ancestor
111488579|NCT01351740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111488580|NCT01351740|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111488581|NCT01351740|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111488582|NCT01353144|Aspirin|aspirin|mesh-list
111488583|NCT01353144|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111488584|NCT01353144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111488585|NCT01353144|Analgesics|analgesics|mesh-ancestor
111488586|NCT01353144|Sensory System Agents|sensory system agents|mesh-ancestor
111488587|NCT01353144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111488588|NCT01353144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111488589|NCT01353144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111488590|NCT01353144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111488591|NCT01353144|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111488592|NCT01353144|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111488593|NCT01353144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111488594|NCT01353144|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111488595|NCT01353144|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111488596|NCT01353144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111488597|NCT01353144|Antipyretics|antipyretics|mesh-ancestor
111488598|NCT01362192|Chlorhexidine|chlorhexidine|mesh-list
111488599|NCT01362192|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
111488600|NCT01362192|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111488601|NCT01362192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111488602|NCT01362192|Disinfectants|disinfectants|mesh-ancestor
111488603|NCT01362192|Dermatologic Agents|dermatologic agents|mesh-ancestor
111488604|NCT01363050|Ketorolac|ketorolac|mesh-list
111488605|NCT01363050|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
111488606|NCT01363050|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111102846|NCT05487807|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111488607|NCT01363050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111488608|NCT01363050|Analgesics|analgesics|mesh-ancestor
111488609|NCT01363050|Sensory System Agents|sensory system agents|mesh-ancestor
111488610|NCT01363050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111488611|NCT01363050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111488612|NCT01363050|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111488613|NCT01363050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111488614|NCT01363050|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111488615|NCT01363050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111488616|NCT01363050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111488617|NCT01363128|Cytarabine|cytarabine|mesh-list
111488618|NCT01363128|Dexamethasone|dexamethasone|mesh-list
111488619|NCT01363128|Dexamethasone acetate|dexamethasone acetate|mesh-list
111488620|NCT01363128|Cyclophosphamide|cyclophosphamide|mesh-list
111488621|NCT01363128|Doxorubicin|doxorubicin|mesh-list
111488622|NCT01363128|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111488623|NCT01363128|Methotrexate|methotrexate|mesh-list
111488624|NCT01363128|Vincristine|vincristine|mesh-list
111488625|NCT01363128|Ofatumumab|ofatumumab|mesh-list
111488626|NCT01363128|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111488627|NCT01363128|BB 1101|bb 1101|mesh-list
111488628|NCT01363128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111488629|NCT01363128|Immunologic Factors|immunologic factors|mesh-ancestor
111488630|NCT01363128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111488631|NCT01363128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111488632|NCT01363128|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111488633|NCT01363128|Alkylating Agents|alkylating agents|mesh-ancestor
111488634|NCT01363128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111488635|NCT01363128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111488636|NCT01363128|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111488637|NCT01363128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111488638|NCT01363128|Antiemetics|antiemetics|mesh-ancestor
111488639|NCT01363128|Autonomic Agents|autonomic agents|mesh-ancestor
111488640|NCT01363128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111488641|NCT01363128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111488642|NCT01363128|Glucocorticoids|glucocorticoids|mesh-ancestor
111488643|NCT01363128|Hormones|hormones|mesh-ancestor
111488644|NCT01363128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111488645|NCT01363128|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111488646|NCT01363128|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111488647|NCT01363128|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111488648|NCT01363128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111488649|NCT01363128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111488650|NCT01363128|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111488651|NCT01363128|Abortifacient Agents|abortifacient agents|mesh-ancestor
111488652|NCT01363128|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111488653|NCT01363128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111488654|NCT01363128|Antimetabolites|antimetabolites|mesh-ancestor
111488655|NCT01363128|Dermatologic Agents|dermatologic agents|mesh-ancestor
111488656|NCT01363128|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111488657|NCT01363128|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111488658|NCT01363128|Antiviral Agents|antiviral agents|mesh-ancestor
111488659|NCT01363128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111488660|NCT01363128|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111488661|NCT01363128|Tubulin Modulators|tubulin modulators|mesh-ancestor
111488662|NCT01363128|Antimitotic Agents|antimitotic agents|mesh-ancestor
111488663|NCT01363128|Mitosis Modulators|mitosis modulators|mesh-ancestor
111488664|NCT01363128|Protease Inhibitors|protease inhibitors|mesh-ancestor
111488665|NCT01365624|Ketorolac|ketorolac|mesh-list
111488666|NCT01365624|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
111488667|NCT01365624|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111488668|NCT01365624|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111488669|NCT01365624|Analgesics|analgesics|mesh-ancestor
111488670|NCT01365624|Sensory System Agents|sensory system agents|mesh-ancestor
111488671|NCT01365624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111488672|NCT01365624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111488673|NCT01365624|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111488674|NCT01365624|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111488675|NCT01365624|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111488676|NCT01365624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111488677|NCT01365624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111488678|NCT01371786|Mometasone Furoate|mometasone furoate|mesh-list
111488679|NCT01371786|Ciclesonide|ciclesonide|mesh-list
111488680|NCT01371786|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111488681|NCT01371786|Dermatologic Agents|dermatologic agents|mesh-ancestor
111488682|NCT01371786|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111488683|NCT01371786|Glucocorticoids|glucocorticoids|mesh-ancestor
111488684|NCT01371786|Hormones|hormones|mesh-ancestor
111488685|NCT01371786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111488686|NCT01371786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111488687|NCT01377636|Isoproterenol|isoproterenol|mesh-list
111488688|NCT01377636|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111488689|NCT01377636|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111488690|NCT01377636|Adrenergic Agents|adrenergic agents|mesh-ancestor
111488691|NCT01377636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111488692|NCT01377636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111488693|NCT01377636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111488694|NCT01377636|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111488695|NCT01377636|Autonomic Agents|autonomic agents|mesh-ancestor
111488696|NCT01377636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111488697|NCT01377636|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111488698|NCT01377636|Respiratory System Agents|respiratory system agents|mesh-ancestor
111488699|NCT01377636|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111488700|NCT01377636|Sympathomimetics|sympathomimetics|mesh-ancestor
111488701|NCT01377636|Protective Agents|protective agents|mesh-ancestor
111488702|NCT01378416|Decitabine|decitabine|mesh-list
111488703|NCT01378416|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111488704|NCT01378416|Antimetabolites|antimetabolites|mesh-ancestor
111488705|NCT01378416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111488706|NCT01378416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111488707|NCT01378416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111488708|NCT01379664|Sevoflurane|sevoflurane|mesh-list
111488709|NCT01379664|Isoflurane|isoflurane|mesh-list
111488710|NCT01379664|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111488711|NCT01379664|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111488712|NCT01379664|Anesthetics, General|anesthetics, general|mesh-ancestor
111488713|NCT01379664|Anesthetics|anesthetics|mesh-ancestor
111488714|NCT01379664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111488715|NCT01379664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111488716|NCT01380366|Hormones|hormones|mesh-list
111488717|NCT01380366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111488718|NCT01380366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111488719|NCT01387464|Bromfenac|bromfenac|mesh-list
111488720|NCT01387464|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111488721|NCT01387464|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111488722|NCT01387464|Analgesics|analgesics|mesh-ancestor
111488723|NCT01387464|Sensory System Agents|sensory system agents|mesh-ancestor
111488724|NCT01387464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111488725|NCT01387464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111488726|NCT01387464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111488727|NCT01387464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111488728|NCT01388946|Ropivacaine|ropivacaine|mesh-list
111488729|NCT01388946|Anesthetics, Local|anesthetics, local|mesh-ancestor
111488730|NCT01388946|Anesthetics|anesthetics|mesh-ancestor
111488731|NCT01388946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111488732|NCT01388946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111488733|NCT01388946|Sensory System Agents|sensory system agents|mesh-ancestor
111488734|NCT01388946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111488735|NCT01390818|Niacinamide|niacinamide|mesh-list
111488736|NCT01390818|Sirolimus|sirolimus|mesh-list
111488737|NCT01390818|MTOR Inhibitors|mtor inhibitors|mesh-list
111488738|NCT01390818|Temsirolimus|temsirolimus|mesh-list
111488739|NCT01390818|Elafin|elafin|mesh-list
111488740|NCT01390818|Protease Inhibitors|protease inhibitors|mesh-ancestor
111488741|NCT01390818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111488742|NCT01390818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111488743|NCT01390818|Vitamin B Complex|vitamin b complex|mesh-ancestor
111488744|NCT01390818|Vitamins|vitamins|mesh-ancestor
111488745|NCT01390818|Micronutrients|micronutrients|mesh-ancestor
111488746|NCT01390818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111488747|NCT01390818|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111488748|NCT01390818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111488749|NCT01390818|Immunologic Factors|immunologic factors|mesh-ancestor
111488750|NCT01390818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111488751|NCT01390818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111488752|NCT01390818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111488753|NCT01390818|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111488754|NCT01390818|Antifungal Agents|antifungal agents|mesh-ancestor
111119170|NCT05306873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111488755|NCT01391286|Bimatoprost|bimatoprost|mesh-list
111488756|NCT01391286|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111488757|NCT01391286|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111488758|NCT01391364|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111488759|NCT01393392|Methadone|methadone|mesh-list
111488760|NCT01393392|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111488761|NCT01393392|Narcotics|narcotics|mesh-ancestor
111488762|NCT01393392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111488763|NCT01393392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111488764|NCT01393392|Analgesics|analgesics|mesh-ancestor
111488765|NCT01393392|Sensory System Agents|sensory system agents|mesh-ancestor
111488766|NCT01393392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111488767|NCT01393392|Antitussive Agents|antitussive agents|mesh-ancestor
111488768|NCT01393392|Respiratory System Agents|respiratory system agents|mesh-ancestor
111488769|NCT01393704|Vasopressins|vasopressins|mesh-list
111488770|NCT01393704|Arginine Vasopressin|arginine vasopressin|mesh-list
111488771|NCT01393704|Hemostatics|hemostatics|mesh-ancestor
111488772|NCT01393704|Coagulants|coagulants|mesh-ancestor
111488773|NCT01393704|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111488774|NCT01393704|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
111488775|NCT01393704|Natriuretic Agents|natriuretic agents|mesh-ancestor
111488776|NCT01393704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111488777|NCT01399008|Colchicine|colchicine|mesh-list
111488778|NCT01399008|Allopurinol|allopurinol|mesh-list
111488779|NCT01399008|Gout Suppressants|gout suppressants|mesh-ancestor
111488780|NCT01399008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111488781|NCT01399008|Tubulin Modulators|tubulin modulators|mesh-ancestor
111488782|NCT01399008|Antimitotic Agents|antimitotic agents|mesh-ancestor
111488783|NCT01399008|Mitosis Modulators|mitosis modulators|mesh-ancestor
111488784|NCT01399008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111488785|NCT01399008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111488786|NCT01399008|Antimetabolites|antimetabolites|mesh-ancestor
111488787|NCT01399008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111488788|NCT01399008|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111488789|NCT01399008|Antioxidants|antioxidants|mesh-ancestor
111488790|NCT01399008|Protective Agents|protective agents|mesh-ancestor
111488791|NCT01399008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111488792|NCT01399866|Cycloserine|cycloserine|mesh-list
111488793|NCT01399866|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111488794|NCT01399866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111488795|NCT01399866|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111488796|NCT01399866|Antitubercular Agents|antitubercular agents|mesh-ancestor
111488797|NCT01399866|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111488798|NCT01399866|Antimetabolites|antimetabolites|mesh-ancestor
111488799|NCT01399866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111488800|NCT01402050|Dinoprostone|dinoprostone|mesh-list
111488801|NCT01402050|Oxytocics|oxytocics|mesh-ancestor
111488802|NCT01402050|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111488803|NCT01402050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111488804|NCT01403376|Interferons|interferons|mesh-list
111488805|NCT01403376|Interferon-beta|interferon-beta|mesh-list
111488806|NCT01403376|Teriflunomide|teriflunomide|mesh-list
111488807|NCT01403376|Interferon beta-1b|interferon beta-1b|mesh-list
111488808|NCT01403376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111488809|NCT01403376|Antiviral Agents|antiviral agents|mesh-ancestor
111488810|NCT01403376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111488811|NCT01403376|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111488812|NCT01403376|Immunologic Factors|immunologic factors|mesh-ancestor
111488813|NCT01403376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111488814|NCT01403376|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111488815|NCT01403376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111488816|NCT01403376|Analgesics|analgesics|mesh-ancestor
111488817|NCT01403376|Sensory System Agents|sensory system agents|mesh-ancestor
111488818|NCT01403376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111488819|NCT01403376|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111488820|NCT01403376|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111488821|NCT01403376|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111488822|NCT01404936|Interferons|interferons|mesh-list
111488823|NCT01404936|Interferon-alpha|interferon-alpha|mesh-list
111488824|NCT01404936|Interferon alpha-2|interferon alpha-2|mesh-list
111488825|NCT01404936|Doxorubicin|doxorubicin|mesh-list
111488826|NCT01404936|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111488827|NCT01404936|Bleomycin|bleomycin|mesh-list
111488828|NCT01404936|Dacarbazine|dacarbazine|mesh-list
111102848|NCT05487807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111102849|NCT05487807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111488829|NCT01404936|Vinblastine|vinblastine|mesh-list
111488830|NCT01404936|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111488831|NCT01404936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111488832|NCT01404936|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111488833|NCT01404936|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111488834|NCT01404936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111488835|NCT01404936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111488836|NCT01404936|Antiviral Agents|antiviral agents|mesh-ancestor
111488837|NCT01404936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111488838|NCT01404936|Immunologic Factors|immunologic factors|mesh-ancestor
111488839|NCT01404936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111488840|NCT01404936|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111488841|NCT01404936|Alkylating Agents|alkylating agents|mesh-ancestor
111488842|NCT01404936|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111488843|NCT01404936|Tubulin Modulators|tubulin modulators|mesh-ancestor
111488844|NCT01404936|Antimitotic Agents|antimitotic agents|mesh-ancestor
111488845|NCT01404936|Mitosis Modulators|mitosis modulators|mesh-ancestor
111488846|NCT01410084|Vitamin D|vitamin d|mesh-list
111488847|NCT01410084|Cholecalciferol|cholecalciferol|mesh-list
111488848|NCT01410084|Vitamins|vitamins|mesh-list
111488849|NCT01410084|Vitamin E|vitamin e|mesh-list
111488850|NCT01410084|Micronutrients|micronutrients|mesh-ancestor
111488851|NCT01410084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111488852|NCT01410084|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111488853|NCT01410084|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111488854|NCT01410084|Antioxidants|antioxidants|mesh-ancestor
111488855|NCT01410084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111488856|NCT01410084|Protective Agents|protective agents|mesh-ancestor
111488857|NCT01413516|Varenicline|varenicline|mesh-list
111488858|NCT01413516|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111488859|NCT01413516|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111488860|NCT01413516|Cholinergic Agents|cholinergic agents|mesh-ancestor
111488861|NCT01413516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111488862|NCT01413516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111488863|NCT01413516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111488864|NCT01413750|Paclitaxel|paclitaxel|mesh-list
111488865|NCT01413750|Carboplatin|carboplatin|mesh-list
111488866|NCT01413750|Vorinostat|vorinostat|mesh-list
111488867|NCT01413750|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111488868|NCT01413750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111488869|NCT01413750|Tubulin Modulators|tubulin modulators|mesh-ancestor
111488870|NCT01413750|Antimitotic Agents|antimitotic agents|mesh-ancestor
111488871|NCT01413750|Mitosis Modulators|mitosis modulators|mesh-ancestor
111488872|NCT01413750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111488873|NCT01413750|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111488874|NCT01413750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111488875|NCT01417026|Oxytocin|oxytocin|mesh-list
111488876|NCT01417026|Oxytocics|oxytocics|mesh-ancestor
111488877|NCT01417026|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111488878|NCT01417026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111488879|NCT01420146|Trastuzumab|trastuzumab|mesh-list
111488880|NCT01420146|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111488881|NCT01420146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111488882|NCT01421472|Paclitaxel|paclitaxel|mesh-list
111488883|NCT01421472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111488884|NCT01421472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111488885|NCT01421472|Tubulin Modulators|tubulin modulators|mesh-ancestor
111488886|NCT01421472|Antimitotic Agents|antimitotic agents|mesh-ancestor
111488887|NCT01421472|Mitosis Modulators|mitosis modulators|mesh-ancestor
111488888|NCT01421472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111488889|NCT01428336|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
111488890|NCT01428336|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
111488891|NCT01428336|Cosyntropin|cosyntropin|mesh-list
111488892|NCT01428336|beta-Endorphin|beta-endorphin|mesh-list
111488893|NCT01428336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111488894|NCT01428336|Hormones|hormones|mesh-ancestor
111488895|NCT01428336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111488896|NCT01428336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111488897|NCT01428336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111488898|NCT01429272|Aspirin|aspirin|mesh-list
111488899|NCT01429272|Minocycline|minocycline|mesh-list
111488900|NCT01429272|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111488901|NCT01429272|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111488902|NCT01429272|Analgesics|analgesics|mesh-ancestor
111488903|NCT01429272|Sensory System Agents|sensory system agents|mesh-ancestor
111488904|NCT01429272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111488905|NCT01429272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111488906|NCT01429272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111488907|NCT01429272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111488908|NCT01429272|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111102850|NCT05487807|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111102851|NCT05487807|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111102852|NCT05487807|Cholinergic Agents|cholinergic agents|mesh-ancestor
111488909|NCT01429272|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111488910|NCT01429272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111488911|NCT01429272|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111488912|NCT01429272|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111488913|NCT01429272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111488914|NCT01429272|Antipyretics|antipyretics|mesh-ancestor
111488915|NCT01429272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111488916|NCT01429272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111488917|NCT01429350|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
111488918|NCT01429350|Plasminogen|plasminogen|mesh-list
111488919|NCT01429350|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111488920|NCT01429350|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111488921|NCT01429350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111488922|NCT01432236|Pregabalin|pregabalin|mesh-list
111488923|NCT01432236|Analgesics|analgesics|mesh-ancestor
111488924|NCT01432236|Sensory System Agents|sensory system agents|mesh-ancestor
111488925|NCT01432236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111488926|NCT01432236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111488927|NCT01432236|Anticonvulsants|anticonvulsants|mesh-ancestor
111488928|NCT01432236|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111488929|NCT01432236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111488930|NCT01432236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111488931|NCT01432236|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111488932|NCT01432236|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111488933|NCT01432236|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111488934|NCT01432236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111488935|NCT01432236|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111488936|NCT01434186|Metformin|metformin|mesh-list
111488937|NCT01434186|Saxagliptin|saxagliptin|mesh-list
111488938|NCT01434186|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111488939|NCT01434186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111488940|NCT01434186|Incretins|incretins|mesh-ancestor
111488941|NCT01434186|Hormones|hormones|mesh-ancestor
111488942|NCT01434186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111488943|NCT01434186|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111488944|NCT01434186|Protease Inhibitors|protease inhibitors|mesh-ancestor
111488945|NCT01434186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111488946|NCT01434186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111488947|NCT01434342|Nicotine|nicotine|mesh-list
111488948|NCT01434342|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111488949|NCT01434342|Autonomic Agents|autonomic agents|mesh-ancestor
111488950|NCT01434342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110326633|NCT00441662|Triamcinolone|triamcinolone|mesh-list
111488951|NCT01434342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111488952|NCT01434342|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111488953|NCT01434342|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111488954|NCT01434342|Cholinergic Agents|cholinergic agents|mesh-ancestor
111488955|NCT01434342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111488956|NCT01434342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111488957|NCT01435824|Amoxicillin|amoxicillin|mesh-list
111488958|NCT01435824|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111488959|NCT01435824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111488960|NCT01436526|Rivaroxaban|rivaroxaban|mesh-list
111488961|NCT01436526|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111488962|NCT01436526|Antithrombins|antithrombins|mesh-ancestor
111488963|NCT01436526|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111488964|NCT01436526|Protease Inhibitors|protease inhibitors|mesh-ancestor
111488965|NCT01436526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111488966|NCT01436526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111488967|NCT01436526|Anticoagulants|anticoagulants|mesh-ancestor
111488968|NCT01438710|Tacrolimus|tacrolimus|mesh-list
111488969|NCT01438710|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111488970|NCT01438710|Immunologic Factors|immunologic factors|mesh-ancestor
111488971|NCT01438710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111488972|NCT01438710|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111488973|NCT01438710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111488974|NCT01438710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111488975|NCT01443546|Leuprolide|leuprolide|mesh-list
111488976|NCT01443546|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111488977|NCT01443546|Fertility Agents|fertility agents|mesh-ancestor
111488978|NCT01443546|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111488979|NCT01443546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110697063|NCT01070836|Natalizumab|natalizumab|mesh-list
111102853|NCT05487807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111488980|NCT01443546|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111488981|NCT01443546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111488982|NCT01444716|Ofatumumab|ofatumumab|mesh-list
111488983|NCT01444716|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111488984|NCT01444716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111488985|NCT01444716|Immunologic Factors|immunologic factors|mesh-ancestor
111488986|NCT01444716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111488987|NCT01445028|Isotretinoin|isotretinoin|mesh-list
111488988|NCT01445028|Dermatologic Agents|dermatologic agents|mesh-ancestor
111488989|NCT01452126|Ropivacaine|ropivacaine|mesh-list
111488990|NCT01452126|Anesthetics, Local|anesthetics, local|mesh-ancestor
111488991|NCT01452126|Anesthetics|anesthetics|mesh-ancestor
111488992|NCT01452126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111488993|NCT01452126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111488994|NCT01452126|Sensory System Agents|sensory system agents|mesh-ancestor
111488995|NCT01452126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111488996|NCT01457430|Icatibant|icatibant|mesh-list
111488997|NCT01457430|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111488998|NCT01457430|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111488999|NCT01457430|Analgesics|analgesics|mesh-ancestor
111489000|NCT01457430|Sensory System Agents|sensory system agents|mesh-ancestor
111489001|NCT01457430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111489002|NCT01457430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111489003|NCT01457430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111489004|NCT01457430|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111489005|NCT01457430|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
111489006|NCT01457430|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
111489007|NCT01457430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111489008|NCT01457430|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
111489009|NCT01457430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111489010|NCT01457430|Immunologic Factors|immunologic factors|mesh-ancestor
111489011|NCT01458990|Omeprazole|omeprazole|mesh-list
111489012|NCT01458990|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111489013|NCT01458990|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111489014|NCT01458990|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111489015|NCT01458990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111489016|NCT01458990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111489017|NCT01460940|Lenalidomide|lenalidomide|mesh-list
111489018|NCT01460940|Panobinostat|panobinostat|mesh-list
110646772|NCT02517684|Immunologic Factors|immunologic factors|mesh-ancestor
111489019|NCT01460940|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
111489020|NCT01460940|Immunologic Factors|immunologic factors|mesh-ancestor
111489021|NCT01460940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111489022|NCT01460940|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111489023|NCT01460940|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111489024|NCT01460940|Growth Substances|growth substances|mesh-ancestor
111489025|NCT01460940|Growth Inhibitors|growth inhibitors|mesh-ancestor
111489026|NCT01460940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111489027|NCT01460940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111489028|NCT01460940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111489029|NCT01462812|Sumatriptan|sumatriptan|mesh-list
111489030|NCT01462812|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111489031|NCT01462812|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111489032|NCT01462812|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111489033|NCT01462812|Serotonin Agents|serotonin agents|mesh-ancestor
111489034|NCT01462812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111489035|NCT01462812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111489036|NCT01462812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111489037|NCT01463202|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
111489038|NCT01463202|Medroxyprogesterone|medroxyprogesterone|mesh-list
111489039|NCT01463202|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111489040|NCT01463202|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111489041|NCT01463202|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111489042|NCT01463202|Contraceptive Agents|contraceptive agents|mesh-ancestor
111489043|NCT01463202|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111489044|NCT01463202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111489045|NCT01463202|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111489046|NCT01463202|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111489047|NCT01463202|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
111489048|NCT01463202|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111489049|NCT01463202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111102854|NCT05487807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111102855|NCT04274595|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
111489050|NCT01467882|Triptorelin Pamoate|triptorelin pamoate|mesh-list
111102856|NCT04274595|Antiviral Agents|antiviral agents|mesh-ancestor
111489051|NCT01467882|Luteolytic Agents|luteolytic agents|mesh-ancestor
111489052|NCT01467882|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111489053|NCT01467882|Contraceptive Agents|contraceptive agents|mesh-ancestor
111489054|NCT01467882|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111489055|NCT01467882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111489056|NCT01467882|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111489057|NCT01467882|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111489058|NCT01467882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111489059|NCT01468350|4-Aminopyridine|4-aminopyridine|mesh-list
111489060|NCT01468350|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
111489061|NCT01468350|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111489062|NCT01468350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111489063|NCT01468584|Ribavirin|ribavirin|mesh-list
111489064|NCT01468584|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
111489065|NCT01468584|Antimetabolites|antimetabolites|mesh-ancestor
111489066|NCT01468584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111489067|NCT01468584|Antiviral Agents|antiviral agents|mesh-ancestor
111489068|NCT01468584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111489069|NCT01472874|Trientine|trientine|mesh-list
111489070|NCT01472874|Chelating Agents|chelating agents|mesh-ancestor
111489071|NCT01472874|Sequestering Agents|sequestering agents|mesh-ancestor
111489072|NCT01472874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111489073|NCT01474122|Macitentan|macitentan|mesh-list
111489074|NCT01474122|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
111489075|NCT01474122|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
111489076|NCT01474122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111489077|NCT01474122|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
111489078|NCT01474590|Doxycycline|doxycycline|mesh-list
111489079|NCT01474590|Isotretinoin|isotretinoin|mesh-list
111489080|NCT01474590|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111489081|NCT01474590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111489082|NCT01474590|Antimalarials|antimalarials|mesh-ancestor
111489083|NCT01474590|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111489084|NCT01474590|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111489085|NCT01474590|Dermatologic Agents|dermatologic agents|mesh-ancestor
111489086|NCT01477320|Pantoprazole|pantoprazole|mesh-list
111489087|NCT01477320|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111489088|NCT01477320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111489089|NCT01477320|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111489090|NCT01477320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111489091|NCT01477320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111489092|NCT01478256|Erythromycin|erythromycin|mesh-list
111489093|NCT01478256|Erythromycin Estolate|erythromycin estolate|mesh-list
111489094|NCT01478256|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
111489095|NCT01478256|Erythromycin stearate|erythromycin stearate|mesh-list
111489096|NCT01478256|Besifloxacin|besifloxacin|mesh-list
111489097|NCT01478256|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111489098|NCT01478256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111489099|NCT01478256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111489100|NCT01478256|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111489101|NCT01478256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111489102|NCT01478256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111489103|NCT01478256|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111489104|NCT01478256|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111489105|NCT01478256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111489106|NCT01479270|Epinephrine|epinephrine|mesh-list
111489107|NCT01479270|Ropivacaine|ropivacaine|mesh-list
111489108|NCT01479270|Anesthetics, Local|anesthetics, local|mesh-ancestor
111489109|NCT01479270|Anesthetics|anesthetics|mesh-ancestor
111489110|NCT01479270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111489111|NCT01479270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111489112|NCT01479270|Sensory System Agents|sensory system agents|mesh-ancestor
111489113|NCT01479270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111489114|NCT01479270|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111489115|NCT01479270|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111489116|NCT01479270|Adrenergic Agents|adrenergic agents|mesh-ancestor
111489117|NCT01479270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111489118|NCT01479270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111489119|NCT01479270|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111489120|NCT01479270|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111489121|NCT01479270|Autonomic Agents|autonomic agents|mesh-ancestor
111489122|NCT01479270|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110697194|NCT01040286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110697270|NCT03970798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111489123|NCT01479270|Respiratory System Agents|respiratory system agents|mesh-ancestor
111489124|NCT01479270|Mydriatics|mydriatics|mesh-ancestor
111489125|NCT01479270|Sympathomimetics|sympathomimetics|mesh-ancestor
111489126|NCT01479270|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111489127|NCT01479348|Tetrahydrouridine|tetrahydrouridine|mesh-list
111489128|NCT01479348|Antimetabolites|antimetabolites|mesh-ancestor
111489129|NCT01479348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111489130|NCT01483560|Metformin|metformin|mesh-list
111489131|NCT01483560|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111489132|NCT01483560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111489133|NCT01484340|Nicotine|nicotine|mesh-list
111489134|NCT01484340|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111489135|NCT01484340|Autonomic Agents|autonomic agents|mesh-ancestor
111489136|NCT01484340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111489137|NCT01484340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111489138|NCT01484340|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111489139|NCT01484340|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111489140|NCT01484340|Cholinergic Agents|cholinergic agents|mesh-ancestor
111489141|NCT01484340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111489142|NCT01484340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111489143|NCT01485588|hI-con1|hi-con1|mesh-list
111489144|NCT01485588|Immunoconjugates|immunoconjugates|mesh-ancestor
111489145|NCT01485588|Immunologic Factors|immunologic factors|mesh-ancestor
111489146|NCT01485588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111489147|NCT01488318|Cetuximab|cetuximab|mesh-list
111489148|NCT01488318|Dasatinib|dasatinib|mesh-list
111489149|NCT01488318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111489150|NCT01488318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111489151|NCT01488318|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111489152|NCT01488318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111489153|NCT01488318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111489154|NCT01495572|Aldesleukin|aldesleukin|mesh-list
111489155|NCT01495572|Cyclophosphamide|cyclophosphamide|mesh-list
111489156|NCT01495572|Fludarabine|fludarabine|mesh-list
111489157|NCT01495572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111489158|NCT01495572|Immunologic Factors|immunologic factors|mesh-ancestor
111489159|NCT01495572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111489160|NCT01495572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111489161|NCT01495572|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111489162|NCT01495572|Alkylating Agents|alkylating agents|mesh-ancestor
111489163|NCT01495572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111489164|NCT01495572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111489165|NCT01495572|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111489166|NCT01495572|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111489167|NCT01495572|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111489168|NCT01495572|Antiviral Agents|antiviral agents|mesh-ancestor
111489169|NCT01495572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111489170|NCT01504854|Resveratrol|resveratrol|mesh-list
111489171|NCT01504854|Antioxidants|antioxidants|mesh-ancestor
111489172|NCT01504854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111489173|NCT01504854|Protective Agents|protective agents|mesh-ancestor
111489174|NCT01504854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111489175|NCT01504854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111489176|NCT01504854|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111489177|NCT01508832|Lidocaine|lidocaine|mesh-list
111489178|NCT01508832|Bupivacaine|bupivacaine|mesh-list
111489179|NCT01508832|Anesthetics, Local|anesthetics, local|mesh-ancestor
111489180|NCT01508832|Anesthetics|anesthetics|mesh-ancestor
111489181|NCT01508832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111489182|NCT01508832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111489183|NCT01508832|Sensory System Agents|sensory system agents|mesh-ancestor
111489184|NCT01508832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111489185|NCT01508832|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111489186|NCT01508832|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111489187|NCT01508832|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111489188|NCT01508832|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111489189|NCT01508832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111489190|NCT01511640|Pregabalin|pregabalin|mesh-list
111489191|NCT01511640|Analgesics|analgesics|mesh-ancestor
111489192|NCT01511640|Sensory System Agents|sensory system agents|mesh-ancestor
111489193|NCT01511640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111489194|NCT01511640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111489195|NCT01511640|Anticonvulsants|anticonvulsants|mesh-ancestor
111489196|NCT01511640|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111489197|NCT01511640|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111102857|NCT04274595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111489198|NCT01511640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111489199|NCT01511640|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111489200|NCT01511640|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111489201|NCT01511640|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111489202|NCT01511640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111489203|NCT01511640|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111489204|NCT01513122|Ritonavir|ritonavir|mesh-list
111489205|NCT01513122|Lopinavir|lopinavir|mesh-list
111489206|NCT01513122|Raltegravir Potassium|raltegravir potassium|mesh-list
111489207|NCT01513122|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111489208|NCT01513122|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111489209|NCT01513122|Protease Inhibitors|protease inhibitors|mesh-ancestor
110646811|NCT02209545|Oxytocics|oxytocics|mesh-ancestor
111489210|NCT01513122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111489211|NCT01513122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111489212|NCT01513122|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111489213|NCT01513122|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111489214|NCT01513122|Antiviral Agents|antiviral agents|mesh-ancestor
111489215|NCT01513122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111489216|NCT01513122|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111489217|NCT01513122|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111489218|NCT01513122|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111489219|NCT01513122|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111489220|NCT01513902|Tofacitinib|tofacitinib|mesh-list
111489221|NCT01513902|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
111489222|NCT01513902|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111489223|NCT01513902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111489224|NCT01513902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111489225|NCT01515540|Lidocaine|lidocaine|mesh-list
111489226|NCT01515540|Anesthetics, Local|anesthetics, local|mesh-ancestor
111489227|NCT01515540|Anesthetics|anesthetics|mesh-ancestor
111489228|NCT01515540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111489229|NCT01515540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111489230|NCT01515540|Sensory System Agents|sensory system agents|mesh-ancestor
111489231|NCT01515540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111489232|NCT01515540|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111489233|NCT01515540|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111489234|NCT01515540|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111489235|NCT01515540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111489236|NCT01515540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111489237|NCT01519284|Levodopa|levodopa|mesh-list
111489238|NCT01519284|Carbidopa|carbidopa|mesh-list
111489239|NCT01519284|Opicapone|opicapone|mesh-list
111489240|NCT01519284|Entacapone|entacapone|mesh-list
111489241|NCT01519284|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111489242|NCT01519284|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111489243|NCT01519284|Dopamine Agents|dopamine agents|mesh-ancestor
111489244|NCT01519284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111489245|NCT01519284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111489246|NCT01519284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111489247|NCT01519284|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
111489248|NCT01519284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111489249|NCT01519284|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
111489250|NCT01520454|Heparin|heparin|mesh-list
111489251|NCT01520454|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
111489252|NCT01520454|Anticoagulants|anticoagulants|mesh-ancestor
111489253|NCT01520454|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111489254|NCT01520454|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111489255|NCT01520454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111489256|NCT01520454|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
111489257|NCT01520454|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
111489258|NCT01520454|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111489259|NCT01520688|Fluticasone|fluticasone|mesh-list
111489260|NCT01520688|Xhance|xhance|mesh-list
111489261|NCT01520688|Budesonide|budesonide|mesh-list
111489262|NCT01520688|Beclomethasone|beclomethasone|mesh-list
111489263|NCT01520688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111489264|NCT01520688|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111489265|NCT01520688|Autonomic Agents|autonomic agents|mesh-ancestor
111489266|NCT01520688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111489267|NCT01520688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111489268|NCT01520688|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111489269|NCT01520688|Respiratory System Agents|respiratory system agents|mesh-ancestor
111489270|NCT01520688|Dermatologic Agents|dermatologic agents|mesh-ancestor
111489271|NCT01520688|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111489272|NCT01520688|Glucocorticoids|glucocorticoids|mesh-ancestor
111489273|NCT01520688|Hormones|hormones|mesh-ancestor
111489274|NCT01520688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111489275|NCT01521546|Eplerenone|eplerenone|mesh-list
111489276|NCT01521546|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
111489277|NCT01521546|Hormone Antagonists|hormone antagonists|mesh-ancestor
110646813|NCT02108964|Nazartinib|nazartinib|mesh-list
111489278|NCT01521546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111489279|NCT01521546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111489280|NCT01521546|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
111489281|NCT01521546|Diuretics|diuretics|mesh-ancestor
111489282|NCT01521546|Natriuretic Agents|natriuretic agents|mesh-ancestor
111489283|NCT01521546|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111489284|NCT01523496|Vitamin D|vitamin d|mesh-list
111489285|NCT01523496|Ergocalciferols|ergocalciferols|mesh-list
111489286|NCT01523496|Cholecalciferol|cholecalciferol|mesh-list
111489287|NCT01523496|Calcifediol|calcifediol|mesh-list
111489288|NCT01523496|Vitamins|vitamins|mesh-list
111489289|NCT01523496|Micronutrients|micronutrients|mesh-ancestor
111489290|NCT01523496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111489291|NCT01523496|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111489292|NCT01523496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111489293|NCT01526538|Cycloserine|cycloserine|mesh-list
111489294|NCT01526538|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111489295|NCT01526538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111489296|NCT01526538|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111489297|NCT01526538|Antitubercular Agents|antitubercular agents|mesh-ancestor
111489298|NCT01526538|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111489299|NCT01526538|Antimetabolites|antimetabolites|mesh-ancestor
111489300|NCT01526538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111489301|NCT01529502|Nitric Oxide|nitric oxide|mesh-list
111489302|NCT01529502|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111489303|NCT01529502|Autonomic Agents|autonomic agents|mesh-ancestor
111489304|NCT01529502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111489305|NCT01529502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111489306|NCT01529502|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111489307|NCT01529502|Respiratory System Agents|respiratory system agents|mesh-ancestor
111489308|NCT01529502|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111489309|NCT01529502|Antioxidants|antioxidants|mesh-ancestor
111489310|NCT01529502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111489311|NCT01529502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111489312|NCT01529502|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
111489313|NCT01529502|Vasodilator Agents|vasodilator agents|mesh-ancestor
111489314|NCT01529502|Gasotransmitters|gasotransmitters|mesh-ancestor
111489315|NCT01529502|Protective Agents|protective agents|mesh-ancestor
111489316|NCT01532700|Ofatumumab|ofatumumab|mesh-list
111489317|NCT01532700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111489318|NCT01533948|Axitinib|axitinib|mesh-list
111489319|NCT01533948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111489320|NCT01533948|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111489321|NCT01533948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111489322|NCT01533948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111489323|NCT01534416|Bupivacaine|bupivacaine|mesh-list
111489324|NCT01534416|Anesthetics, Local|anesthetics, local|mesh-ancestor
111489325|NCT01534416|Anesthetics|anesthetics|mesh-ancestor
111489326|NCT01534416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111489327|NCT01534416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111489328|NCT01534416|Sensory System Agents|sensory system agents|mesh-ancestor
111489329|NCT01534416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111489330|NCT01535664|4-Aminopyridine|4-aminopyridine|mesh-list
111489331|NCT01535664|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
111489332|NCT01535664|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111489333|NCT01535664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111489334|NCT01535976|Ketamine|ketamine|mesh-list
111489335|NCT01535976|Analgesics|analgesics|mesh-ancestor
111489336|NCT01535976|Sensory System Agents|sensory system agents|mesh-ancestor
111489337|NCT01535976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111489338|NCT01535976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111489339|NCT01535976|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111489340|NCT01535976|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111489341|NCT01535976|Anesthetics, General|anesthetics, general|mesh-ancestor
111489342|NCT01535976|Anesthetics|anesthetics|mesh-ancestor
111489343|NCT01535976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111489344|NCT01535976|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111102859|NCT05476731|Clotrimazole|clotrimazole|mesh-list
111489346|NCT01535976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111489347|NCT01535976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111489348|NCT01536366|Repaglinide|repaglinide|mesh-list
111489349|NCT01536366|Opicapone|opicapone|mesh-list
111489350|NCT01536366|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111489351|NCT01536366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111489352|NCT01536366|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
111489353|NCT01536366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111489354|NCT01536366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111489355|NCT01536366|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111489356|NCT01536366|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111489357|NCT01537926|Acetylcysteine|acetylcysteine|mesh-list
111489358|NCT01537926|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111489359|NCT01537926|Antiviral Agents|antiviral agents|mesh-ancestor
111489360|NCT01537926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111489361|NCT01537926|Expectorants|expectorants|mesh-ancestor
111489362|NCT01537926|Respiratory System Agents|respiratory system agents|mesh-ancestor
111489363|NCT01537926|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111489364|NCT01537926|Antioxidants|antioxidants|mesh-ancestor
111489365|NCT01537926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111489366|NCT01537926|Protective Agents|protective agents|mesh-ancestor
111489367|NCT01537926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111489368|NCT01537926|Antidotes|antidotes|mesh-ancestor
111489369|NCT01538862|Lenograstim|lenograstim|mesh-list
111489370|NCT01538862|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111489371|NCT01538862|Immunologic Factors|immunologic factors|mesh-ancestor
111489372|NCT01538862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111489373|NCT01541358|Listerine|listerine|mesh-list
111489374|NCT01541358|Fluorides|fluorides|mesh-list
111489375|NCT01541358|Sodium Fluoride|sodium fluoride|mesh-list
111489376|NCT01541358|Cariostatic Agents|cariostatic agents|mesh-ancestor
111489377|NCT01541358|Protective Agents|protective agents|mesh-ancestor
111489378|NCT01541358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111489379|NCT01541358|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111489380|NCT01541358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111489381|NCT01542372|Prazosin|prazosin|mesh-list
111489382|NCT01542372|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111489383|NCT01542372|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111489384|NCT01542372|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111489385|NCT01542372|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111489386|NCT01542372|Adrenergic Agents|adrenergic agents|mesh-ancestor
111489387|NCT01542372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111489388|NCT01542372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111489389|NCT01542372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111489390|NCT01542684|Azacitidine|azacitidine|mesh-list
111489391|NCT01542684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111489392|NCT01542684|Antimetabolites|antimetabolites|mesh-ancestor
111489393|NCT01542684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111489394|NCT01542684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111489395|NCT01542684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111489396|NCT01543074|Allyl sulfide|allyl sulfide|mesh-list
111489397|NCT01543074|Antioxidants|antioxidants|mesh-ancestor
111489398|NCT01543074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111489399|NCT01543074|Protective Agents|protective agents|mesh-ancestor
111489400|NCT01543074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111489401|NCT01543074|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
111489402|NCT01543074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111489403|NCT01543074|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111489404|NCT01543074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111489405|NCT01545336|Anastrozole|anastrozole|mesh-list
111489406|NCT01545336|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111489407|NCT01545336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111489408|NCT01545336|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111489409|NCT01545336|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111489410|NCT01545336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110646840|NCT01928394|Ipilimumab|ipilimumab|mesh-list
111489411|NCT01545336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111489412|NCT01545336|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111489413|NCT01545336|Hormone Antagonists|hormone antagonists|mesh-ancestor
111489414|NCT01545336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111489415|NCT01545336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111489416|NCT01548690|Phenylacetic acid|phenylacetic acid|mesh-list
111102860|NCT05476731|Miconazole|miconazole|mesh-list
111489417|NCT01548690|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111489419|NCT01548690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111489420|NCT01548690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111489421|NCT01551888|Formoterol Fumarate|formoterol fumarate|mesh-list
111489422|NCT01551888|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111489423|NCT01551888|Autonomic Agents|autonomic agents|mesh-ancestor
111489424|NCT01551888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111489425|NCT01551888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111489426|NCT01551888|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111489427|NCT01551888|Respiratory System Agents|respiratory system agents|mesh-ancestor
111489428|NCT01551888|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111489429|NCT01551888|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111489430|NCT01551888|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111489431|NCT01551888|Adrenergic Agents|adrenergic agents|mesh-ancestor
111489432|NCT01551888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111489433|NCT01551888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111489434|NCT01553058|Adalimumab|adalimumab|mesh-list
111489435|NCT01553058|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111489436|NCT01553058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111489437|NCT01553058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111489438|NCT01553292|Pulmonary Surfactants|pulmonary surfactants|mesh-list
111489439|NCT01553292|Respiratory System Agents|respiratory system agents|mesh-ancestor
111489440|NCT01556724|Ropivacaine|ropivacaine|mesh-list
111489441|NCT01556724|Anesthetics, Local|anesthetics, local|mesh-ancestor
111489442|NCT01556724|Anesthetics|anesthetics|mesh-ancestor
111489443|NCT01556724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111489444|NCT01556724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111489445|NCT01556724|Sensory System Agents|sensory system agents|mesh-ancestor
111489446|NCT01556724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111489447|NCT01558128|Amiodarone|amiodarone|mesh-list
111489448|NCT01558128|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111489449|NCT01558128|Vasodilator Agents|vasodilator agents|mesh-ancestor
111489450|NCT01558128|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
111489451|NCT01558128|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111489452|NCT01558128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111489453|NCT01558128|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111489454|NCT01558128|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111489455|NCT01558128|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111489456|NCT01558128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111489457|NCT01558128|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111489458|NCT01558128|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111489459|NCT01558128|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111489460|NCT01559064|Lidocaine|lidocaine|mesh-list
111489461|NCT01559064|Hyaluronic Acid|hyaluronic acid|mesh-list
111489462|NCT01559064|Anesthetics, Local|anesthetics, local|mesh-ancestor
111489463|NCT01559064|Anesthetics|anesthetics|mesh-ancestor
111489464|NCT01559064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111489465|NCT01559064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111489466|NCT01559064|Sensory System Agents|sensory system agents|mesh-ancestor
111489467|NCT01559064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111489468|NCT01559064|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111489469|NCT01559064|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111489470|NCT01559064|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111489471|NCT01559064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111489472|NCT01559064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111489473|NCT01559064|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111489474|NCT01559064|Immunologic Factors|immunologic factors|mesh-ancestor
111489475|NCT01559064|Viscosupplements|viscosupplements|mesh-ancestor
111489476|NCT01559064|Protective Agents|protective agents|mesh-ancestor
111489477|NCT01559922|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
111489478|NCT01559922|Vasodilator Agents|vasodilator agents|mesh-ancestor
111489479|NCT01559922|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
111489480|NCT01559922|Protective Agents|protective agents|mesh-ancestor
111489481|NCT01559922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111489482|NCT01560624|Treprostinil|treprostinil|mesh-list
111489483|NCT01560624|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111489484|NCT01562886|Rilpivirine|rilpivirine|mesh-list
111489485|NCT01562886|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111489486|NCT01562886|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111489487|NCT01562886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111102861|NCT05476731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111102862|NCT05476731|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111489488|NCT01562886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111489489|NCT01562886|Antiviral Agents|antiviral agents|mesh-ancestor
111489490|NCT01562886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111489491|NCT01562886|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111489492|NCT01562886|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111489493|NCT01563198|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
111489494|NCT01563198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111489495|NCT01563198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111489496|NCT01564914|Bevacizumab|bevacizumab|mesh-list
111489497|NCT01564914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111489498|NCT01564914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111489499|NCT01564914|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111489500|NCT01564914|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111489501|NCT01564914|Growth Substances|growth substances|mesh-ancestor
111489502|NCT01564914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111489503|NCT01564914|Growth Inhibitors|growth inhibitors|mesh-ancestor
111489504|NCT01565538|Pemetrexed|pemetrexed|mesh-list
111489505|NCT01565538|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111489506|NCT01565538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111489507|NCT01565538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111489508|NCT01565538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111489509|NCT01565538|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111489510|NCT01565538|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111489511|NCT01565538|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111489512|NCT01565616|Fludarabine|fludarabine|mesh-list
111489513|NCT01565616|Busulfan|busulfan|mesh-list
111489514|NCT01565616|Thymoglobulin|thymoglobulin|mesh-list
111489515|NCT01565616|Antilymphocyte Serum|antilymphocyte serum|mesh-list
111489516|NCT01565616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111489517|NCT01565616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111489518|NCT01565616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111489519|NCT01565616|Immunologic Factors|immunologic factors|mesh-ancestor
111489520|NCT01565616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111489521|NCT01565616|Alkylating Agents|alkylating agents|mesh-ancestor
111489522|NCT01565616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111489523|NCT01565616|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111489524|NCT01566162|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
111489525|NCT01566162|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111489526|NCT01566162|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111489527|NCT01566162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111489528|NCT01566162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111489529|NCT01566162|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111489530|NCT01566162|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
111489531|NCT01566162|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111489532|NCT01566162|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110646863|NCT01844986|Olaparib|olaparib|mesh-list
111489533|NCT01566162|Adrenergic Agents|adrenergic agents|mesh-ancestor
111489534|NCT01566162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111489535|NCT01566162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111489536|NCT01566162|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111489537|NCT01566162|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111489538|NCT01566162|Serotonin Agents|serotonin agents|mesh-ancestor
111489539|NCT01566162|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111489540|NCT01566162|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111489541|NCT01566162|Dopamine Agents|dopamine agents|mesh-ancestor
111489542|NCT01569126|Fluoxetine|fluoxetine|mesh-list
111489543|NCT01569126|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111489544|NCT01569126|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111489545|NCT01569126|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111489546|NCT01569126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111489547|NCT01569126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111489548|NCT01569126|Serotonin Agents|serotonin agents|mesh-ancestor
111489549|NCT01569126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111489550|NCT01569126|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111489551|NCT01569126|Antidepressive Agents|antidepressive agents|mesh-ancestor
111489552|NCT01569126|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111489553|NCT01569126|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111489554|NCT01569126|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111489555|NCT01569126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111489556|NCT01569828|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
111489557|NCT01569828|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111102863|NCT05476731|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111489558|NCT01569828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111489560|NCT01577706|Dextroamphetamine|dextroamphetamine|mesh-list
111489561|NCT01577706|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111489562|NCT01577706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111489563|NCT01577706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111489564|NCT01577706|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111489565|NCT01577706|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111489566|NCT01577706|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111489567|NCT01577706|GABA Modulators|gaba modulators|mesh-ancestor
111489568|NCT01577706|GABA Agents|gaba agents|mesh-ancestor
111489569|NCT01577706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111489570|NCT01577706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111489571|NCT01577706|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111489572|NCT01577706|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111489573|NCT01577706|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111489574|NCT01577706|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111489575|NCT01577706|Dopamine Agents|dopamine agents|mesh-ancestor
111489576|NCT01580592|Omalizumab|omalizumab|mesh-list
111489577|NCT01580592|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111489578|NCT01580592|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111489579|NCT01580592|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111489580|NCT01580592|Respiratory System Agents|respiratory system agents|mesh-ancestor
111489581|NCT01580592|Immunologic Factors|immunologic factors|mesh-ancestor
111489582|NCT01580592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111489583|NCT01588158|Acetaminophen|acetaminophen|mesh-list
111489584|NCT01588158|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
111489585|NCT01588158|Hydrocodone|hydrocodone|mesh-list
111489586|NCT01588158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111489587|NCT01588158|Analgesics|analgesics|mesh-ancestor
111489588|NCT01588158|Sensory System Agents|sensory system agents|mesh-ancestor
111489589|NCT01588158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111489590|NCT01588158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111489591|NCT01588158|Antipyretics|antipyretics|mesh-ancestor
111489592|NCT01588158|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111489593|NCT01588158|Narcotics|narcotics|mesh-ancestor
111489594|NCT01588158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111489595|NCT01588158|Antitussive Agents|antitussive agents|mesh-ancestor
111489596|NCT01588158|Respiratory System Agents|respiratory system agents|mesh-ancestor
111489597|NCT01588158|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111489598|NCT01588158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111489599|NCT01588158|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111489600|NCT01588470|Pioglitazone|pioglitazone|mesh-list
111489601|NCT01588470|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111489602|NCT01588470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111489603|NCT01591746|Botulinum Toxins|botulinum toxins|mesh-list
111489604|NCT01591746|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111489605|NCT01591746|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111489606|NCT01591746|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111489607|NCT01591746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111489608|NCT01591746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111489609|NCT01591746|Cholinergic Agents|cholinergic agents|mesh-ancestor
111489610|NCT01591746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111489611|NCT01591746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111489612|NCT01591746|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111489613|NCT01591746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111489614|NCT05565924|Biguanides|biguanides|mesh-list
111489615|NCT05565924|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111489616|NCT05565924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111489617|NCT05564832|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111489618|NCT05564832|Pilocarpine|pilocarpine|mesh-list
111489619|NCT05564832|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111489620|NCT05564832|Miotics|miotics|mesh-ancestor
111489621|NCT05564832|Autonomic Agents|autonomic agents|mesh-ancestor
111489622|NCT05564832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111489623|NCT05564832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111489624|NCT05564832|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
111489625|NCT05564832|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111489626|NCT05564832|Cholinergic Agents|cholinergic agents|mesh-ancestor
111489627|NCT05564832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111489628|NCT05564832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111489629|NCT05564442|Benzocaine|benzocaine|mesh-list
111489630|NCT05564442|Anesthetics, Local|anesthetics, local|mesh-ancestor
111489631|NCT05564442|Anesthetics|anesthetics|mesh-ancestor
111489632|NCT05564442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111489633|NCT05564442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111489635|NCT05564442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111489636|NCT05493540|Ibuprofen|ibuprofen|mesh-list
111489637|NCT05493540|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111489638|NCT05493540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111489639|NCT05493540|Analgesics|analgesics|mesh-ancestor
111489640|NCT05493540|Sensory System Agents|sensory system agents|mesh-ancestor
111489641|NCT05493540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111489642|NCT05493540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111489643|NCT05493540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111489644|NCT05493540|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111489645|NCT05493540|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111489646|NCT05493540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111489647|NCT05493540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111489648|NCT05672472|Sivelestat|sivelestat|mesh-list
111489649|NCT05672472|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111489650|NCT05672472|Protease Inhibitors|protease inhibitors|mesh-ancestor
111102864|NCT05476731|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111102865|NCT05476731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111102866|NCT05476731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111102867|NCT05476731|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111102868|NCT05476731|Hormone Antagonists|hormone antagonists|mesh-ancestor
111102869|NCT05476731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111102870|NCT05476731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111102871|NCT05476731|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111102872|NCT05476731|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111102873|NCT05482113|Bupivacaine|bupivacaine|mesh-list
111102874|NCT05482113|Anesthetics, Local|anesthetics, local|mesh-ancestor
111102875|NCT05482113|Anesthetics|anesthetics|mesh-ancestor
111102876|NCT05482113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110819958|NCT01225705|Antiviral Agents|antiviral agents|mesh-ancestor
111102877|NCT05482113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111102878|NCT05482113|Sensory System Agents|sensory system agents|mesh-ancestor
111102879|NCT05482113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111102881|NCT05481957|Antidepressive Agents|antidepressive agents|mesh-ancestor
111102882|NCT05481957|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111102883|NCT05481957|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111102884|NCT05481957|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111102885|NCT05481957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111102886|NCT05481957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111102887|NCT05481957|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111102888|NCT05481957|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111102889|NCT05481957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111102890|NCT05481957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111102891|NCT05481957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111102892|NCT05481957|Serotonin Agents|serotonin agents|mesh-ancestor
111102893|NCT05481957|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111102894|NCT05481957|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111102895|NCT05481957|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111102896|NCT05481957|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111102897|NCT05475561|Bupivacaine|bupivacaine|mesh-list
111102898|NCT05475561|Anesthetics, Local|anesthetics, local|mesh-ancestor
111102899|NCT05475561|Anesthetics|anesthetics|mesh-ancestor
111102900|NCT05475561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111102901|NCT05475561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111102902|NCT05475561|Sensory System Agents|sensory system agents|mesh-ancestor
111102903|NCT05475561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111102904|NCT05476341|Bevacizumab|bevacizumab|mesh-list
111102905|NCT05476341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111102906|NCT05476341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111102907|NCT05476341|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111102908|NCT05476341|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111102909|NCT05476341|Growth Substances|growth substances|mesh-ancestor
111102910|NCT05476341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111102911|NCT05476341|Growth Inhibitors|growth inhibitors|mesh-ancestor
111102912|NCT05481723|Norepinephrine|norepinephrine|mesh-list
111102913|NCT05481723|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110697791|NCT03980379|Rituximab|rituximab|mesh-list
111489651|NCT05672472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111102914|NCT05481723|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111489652|NCT05672472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111102915|NCT05481723|Adrenergic Agents|adrenergic agents|mesh-ancestor
111102916|NCT05481723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111102917|NCT05481723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111102918|NCT05481723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111102919|NCT05481723|Sympathomimetics|sympathomimetics|mesh-ancestor
111102920|NCT05481723|Autonomic Agents|autonomic agents|mesh-ancestor
111102921|NCT05481723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111102922|NCT05481723|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111102923|NCT04272021|Methylphenidate|methylphenidate|mesh-list
111102924|NCT04272021|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111102925|NCT04272021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111102926|NCT04272021|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111102927|NCT04272021|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111102928|NCT04272021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111102929|NCT04272021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111102930|NCT04272021|Dopamine Agents|dopamine agents|mesh-ancestor
111102931|NCT04272021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111102932|NCT02697773|Tanezumab|tanezumab|mesh-list
111102933|NCT02697773|Analgesics|analgesics|mesh-ancestor
111102934|NCT02697773|Sensory System Agents|sensory system agents|mesh-ancestor
111102935|NCT02697773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111102936|NCT02697773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111102937|NCT02394821|Metronidazole|metronidazole|mesh-list
111102938|NCT02394821|Polihexanide|polihexanide|mesh-list
111102939|NCT02394821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111102940|NCT02394821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111102941|NCT02394821|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111102942|NCT02394821|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111102943|NCT02394821|Disinfectants|disinfectants|mesh-ancestor
111102944|NCT02394743|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
111102945|NCT02394743|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111102946|NCT02394743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111102947|NCT05745857|Bevacizumab|bevacizumab|mesh-list
111102948|NCT05745857|Cetuximab|cetuximab|mesh-list
111102949|NCT05745857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111102950|NCT05745857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111102951|NCT05745857|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111102952|NCT05745857|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111102953|NCT05745857|Growth Substances|growth substances|mesh-ancestor
111102954|NCT05745857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111102955|NCT05745857|Growth Inhibitors|growth inhibitors|mesh-ancestor
111102956|NCT05745779|Vitamin D|vitamin d|mesh-list
111102957|NCT05745779|Vitamins|vitamins|mesh-list
111102958|NCT05745779|Vitamin B 12|vitamin b 12|mesh-list
111102959|NCT05745779|Hydroxocobalamin|hydroxocobalamin|mesh-list
111102960|NCT05745779|Micronutrients|micronutrients|mesh-ancestor
111102961|NCT05745779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111102962|NCT05745779|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111102963|NCT05745779|Vitamin B Complex|vitamin b complex|mesh-ancestor
111102964|NCT05745779|Hematinics|hematinics|mesh-ancestor
111102965|NCT02394197|Chloroquine|chloroquine|mesh-list
111102966|NCT02394197|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
111102967|NCT02394197|Primaquine|primaquine|mesh-list
111102968|NCT02394197|Amebicides|amebicides|mesh-ancestor
111102969|NCT02394197|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111102970|NCT02394197|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111102971|NCT02394197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111102972|NCT02394197|Antimalarials|antimalarials|mesh-ancestor
111102973|NCT02394197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111102974|NCT02394197|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111102975|NCT02394197|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111102976|NCT02394197|Analgesics|analgesics|mesh-ancestor
111102977|NCT02394197|Sensory System Agents|sensory system agents|mesh-ancestor
111102978|NCT02394197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111102979|NCT02394197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111102980|NCT02394197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111102981|NCT02394197|Filaricides|filaricides|mesh-ancestor
111102982|NCT02394197|Antinematodal Agents|antinematodal agents|mesh-ancestor
111102983|NCT02394197|Anthelmintics|anthelmintics|mesh-ancestor
111102984|NCT02394119|Rituximab|rituximab|mesh-list
111102985|NCT02394119|Ofatumumab|ofatumumab|mesh-list
111102986|NCT02394119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111102987|NCT02394119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111102988|NCT02394119|Immunologic Factors|immunologic factors|mesh-ancestor
111102989|NCT02394119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111102990|NCT02394119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111102991|NCT03167333|Hyaluronic Acid|hyaluronic acid|mesh-list
111102992|NCT03167333|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111102993|NCT03167333|Immunologic Factors|immunologic factors|mesh-ancestor
111102994|NCT03167333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111102995|NCT03167333|Viscosupplements|viscosupplements|mesh-ancestor
111102996|NCT03167333|Protective Agents|protective agents|mesh-ancestor
111102997|NCT02393963|Tranexamic Acid|tranexamic acid|mesh-list
111102998|NCT02393963|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111102999|NCT02393963|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111103000|NCT02393963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111103001|NCT02393963|Hemostatics|hemostatics|mesh-ancestor
111103002|NCT02393963|Coagulants|coagulants|mesh-ancestor
111103003|NCT03115619|Pirfenidone|pirfenidone|mesh-list
111103004|NCT03115619|Analgesics|analgesics|mesh-ancestor
111103005|NCT03115619|Sensory System Agents|sensory system agents|mesh-ancestor
111103006|NCT03115619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111103007|NCT03115619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111103008|NCT03115619|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111103009|NCT03115619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111103010|NCT03115619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111103011|NCT03115619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111103012|NCT03115619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111103013|NCT02393573|Metformin|metformin|mesh-list
111103014|NCT02393573|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111103015|NCT02393573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111103016|NCT05745467|Povidone-Iodine|povidone-iodine|mesh-list
111103017|NCT05745467|Povidone|povidone|mesh-list
111103018|NCT05745467|Plasma Substitutes|plasma substitutes|mesh-ancestor
111103019|NCT05745467|Blood Substitutes|blood substitutes|mesh-ancestor
111103020|NCT05745467|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111103021|NCT05745467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111103022|NCT02393261|Dialysis Solutions|dialysis solutions|mesh-list
111103023|NCT02393261|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111103024|NCT02693171|Dinutuximab|dinutuximab|mesh-list
111103025|NCT02693171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111103026|NCT02392793|Irinotecan|irinotecan|mesh-list
111103027|NCT02392793|Temozolomide|temozolomide|mesh-list
111103028|NCT02392793|Talazoparib|talazoparib|mesh-list
111103029|NCT02392793|Lenograstim|lenograstim|mesh-list
111103030|NCT02392793|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111103031|NCT02392793|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111103032|NCT02392793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111103033|NCT02392793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111103034|NCT02392793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111103035|NCT02392793|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111103036|NCT02392793|Immunologic Factors|immunologic factors|mesh-ancestor
111103037|NCT02392793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111103038|NCT02392793|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111103039|NCT02392793|Alkylating Agents|alkylating agents|mesh-ancestor
111103040|NCT02392793|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111103041|NCT03167177|Leucovorin|leucovorin|mesh-list
111103042|NCT03167177|Paclitaxel|paclitaxel|mesh-list
111103043|NCT03167177|Cyclophosphamide|cyclophosphamide|mesh-list
111103044|NCT03167177|Bevacizumab|bevacizumab|mesh-list
111103045|NCT03167177|Fluorouracil|fluorouracil|mesh-list
111103046|NCT03167177|Capecitabine|capecitabine|mesh-list
111103047|NCT03167177|Nivolumab|nivolumab|mesh-list
111103048|NCT03167177|Avelumab|avelumab|mesh-list
111103049|NCT03167177|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111103050|NCT03167177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111103051|NCT03167177|Tubulin Modulators|tubulin modulators|mesh-ancestor
111103052|NCT03167177|Antimitotic Agents|antimitotic agents|mesh-ancestor
111103053|NCT03167177|Mitosis Modulators|mitosis modulators|mesh-ancestor
111103054|NCT03167177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111103055|NCT03167177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111103056|NCT03167177|Immunologic Factors|immunologic factors|mesh-ancestor
111103057|NCT03167177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111103058|NCT03167177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111103059|NCT03167177|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111103060|NCT03167177|Alkylating Agents|alkylating agents|mesh-ancestor
111103061|NCT03167177|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111489654|NCT05672394|Epinephrine|epinephrine|mesh-list
111103062|NCT03167177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111103063|NCT03167177|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111103064|NCT03167177|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111103065|NCT03167177|Growth Substances|growth substances|mesh-ancestor
111103066|NCT03167177|Growth Inhibitors|growth inhibitors|mesh-ancestor
111103067|NCT03167177|Antimetabolites|antimetabolites|mesh-ancestor
111103068|NCT03167177|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111103069|NCT03167177|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111103070|NCT03167177|Antidotes|antidotes|mesh-ancestor
111103071|NCT03167177|Protective Agents|protective agents|mesh-ancestor
111103072|NCT03167177|Vitamin B Complex|vitamin b complex|mesh-ancestor
111103073|NCT03167177|Vitamins|vitamins|mesh-ancestor
111103074|NCT03167177|Micronutrients|micronutrients|mesh-ancestor
111103075|NCT02392169|Methylphenidate|methylphenidate|mesh-list
111103076|NCT02392169|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111103077|NCT02392169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111103078|NCT02392169|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111103079|NCT02392169|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111103080|NCT02392169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111103081|NCT02392169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111103082|NCT02392169|Dopamine Agents|dopamine agents|mesh-ancestor
111103083|NCT02392169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111103084|NCT03166865|Hyaluronic Acid|hyaluronic acid|mesh-list
111103085|NCT03166865|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111103086|NCT03166865|Immunologic Factors|immunologic factors|mesh-ancestor
111103087|NCT03166865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111103088|NCT03166865|Viscosupplements|viscosupplements|mesh-ancestor
111103089|NCT03166865|Protective Agents|protective agents|mesh-ancestor
111103090|NCT03166787|Tadalafil|tadalafil|mesh-list
111103091|NCT03166787|Charcoal|charcoal|mesh-list
111103092|NCT03166787|Carbon Monoxide|carbon monoxide|mesh-list
111103093|NCT03166787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111103094|NCT03166787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111103095|NCT03166787|Protective Agents|protective agents|mesh-ancestor
111103096|NCT03166787|Vasodilator Agents|vasodilator agents|mesh-ancestor
111103097|NCT03166787|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111103098|NCT03166787|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111103099|NCT03166787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111103100|NCT03166787|Urological Agents|urological agents|mesh-ancestor
111103101|NCT03166787|Antidotes|antidotes|mesh-ancestor
111103102|NCT03166787|Antimetabolites|antimetabolites|mesh-ancestor
111103103|NCT03166787|Gasotransmitters|gasotransmitters|mesh-ancestor
111103104|NCT03166787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111103105|NCT03166553|Oxaliplatin|oxaliplatin|mesh-list
111103106|NCT03166553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111103107|NCT03167957|Amphotericin B|amphotericin b|mesh-list
111103108|NCT03167957|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
111103109|NCT03167957|Amebicides|amebicides|mesh-ancestor
111103110|NCT03167957|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111103111|NCT03167957|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111103112|NCT03167957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111103113|NCT03167957|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111103114|NCT03167957|Antifungal Agents|antifungal agents|mesh-ancestor
111103115|NCT03166397|Cyclophosphamide|cyclophosphamide|mesh-list
111103116|NCT03166397|Nivolumab|nivolumab|mesh-list
111103117|NCT03166397|Fludarabine|fludarabine|mesh-list
111103118|NCT03166397|Ipilimumab|ipilimumab|mesh-list
111103119|NCT03166397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111103120|NCT03166397|Immunologic Factors|immunologic factors|mesh-ancestor
111103121|NCT03166397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111103122|NCT03166397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111103123|NCT03166397|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111103124|NCT03166397|Alkylating Agents|alkylating agents|mesh-ancestor
111103125|NCT03166397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111103126|NCT03166397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111103127|NCT03166397|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111103128|NCT03166397|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111103129|NCT03166397|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111103130|NCT05745935|Oxytocin|oxytocin|mesh-list
111103131|NCT05745935|Oxytocics|oxytocics|mesh-ancestor
111103132|NCT05745935|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111103133|NCT05745935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111103134|NCT02552121|Tisotumab vedotin|tisotumab vedotin|mesh-list
111489655|NCT05672394|Bupivacaine|bupivacaine|mesh-list
111489656|NCT05672394|Anesthetics, Local|anesthetics, local|mesh-ancestor
111489657|NCT05672394|Anesthetics|anesthetics|mesh-ancestor
111489658|NCT05672394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111103135|NCT02552121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111103136|NCT02552121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111103137|NCT02552355|Metformin|metformin|mesh-list
111103138|NCT02552355|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111489659|NCT05672394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111103139|NCT02552355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111103140|NCT02551731|Cannabidiol|cannabidiol|mesh-list
111103141|NCT02551731|Anticonvulsants|anticonvulsants|mesh-ancestor
111103142|NCT04479657|Cefuroxime|cefuroxime|mesh-list
111103143|NCT04479657|Cefuroxime axetil|cefuroxime axetil|mesh-list
111103144|NCT04479657|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111103145|NCT04479657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111103146|NCT05475873|Ondansetron|ondansetron|mesh-list
111103147|NCT05475873|Antiemetics|antiemetics|mesh-ancestor
111103148|NCT05475873|Autonomic Agents|autonomic agents|mesh-ancestor
111103149|NCT05475873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111103150|NCT05475873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111103151|NCT05475873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111103152|NCT05475873|Antipruritics|antipruritics|mesh-ancestor
111103153|NCT05475873|Dermatologic Agents|dermatologic agents|mesh-ancestor
111103154|NCT05475873|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111103155|NCT05475873|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111103156|NCT05475873|Serotonin Agents|serotonin agents|mesh-ancestor
111103157|NCT05475873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111103158|NCT05475873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111103159|NCT05471661|PENTA|penta|mesh-list
111103160|NCT05471661|Anticoagulants|anticoagulants|mesh-ancestor
111103161|NCT05471661|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111103162|NCT05471661|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111103163|NCT05471661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111103164|NCT05480631|Mitogens|mitogens|mesh-list
111103165|NCT05480631|Mitosis Modulators|mitosis modulators|mesh-ancestor
111103166|NCT05480631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111103167|NCT02542605|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
111103168|NCT02542605|Erenumab|erenumab|mesh-list
111103169|NCT02542605|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
111103170|NCT02542605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111103171|NCT02542605|Analgesics|analgesics|mesh-ancestor
111103172|NCT02542605|Sensory System Agents|sensory system agents|mesh-ancestor
111103173|NCT02542605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111103174|NCT02542605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111103175|NCT02542605|Growth Substances|growth substances|mesh-ancestor
111103176|NCT02542605|Vasodilator Agents|vasodilator agents|mesh-ancestor
111103177|NCT02542605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111103178|NCT02550795|Dexamethasone|dexamethasone|mesh-list
111103179|NCT02550795|Dexmedetomidine|dexmedetomidine|mesh-list
111103180|NCT02550795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111103181|NCT02550795|Antiemetics|antiemetics|mesh-ancestor
111103182|NCT02550795|Autonomic Agents|autonomic agents|mesh-ancestor
111103183|NCT02550795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110820260|NCT02302768|Selenium|selenium|mesh-list
111103184|NCT02550795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111103185|NCT02550795|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111103186|NCT02550795|Glucocorticoids|glucocorticoids|mesh-ancestor
111103187|NCT02550795|Hormones|hormones|mesh-ancestor
111103188|NCT02550795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111103189|NCT02550795|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111103190|NCT02550795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111103191|NCT02550795|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111103192|NCT02550795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111103193|NCT02550795|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111103194|NCT02550795|Analgesics|analgesics|mesh-ancestor
111103195|NCT02550795|Sensory System Agents|sensory system agents|mesh-ancestor
111103196|NCT02550795|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111103197|NCT02550795|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111103198|NCT02550795|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111103199|NCT02550795|Adrenergic Agents|adrenergic agents|mesh-ancestor
111103200|NCT02550795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111103201|NCT02550795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111103202|NCT02541903|Afatinib|afatinib|mesh-list
111103203|NCT02541903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111103204|NCT02541903|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111103205|NCT02541903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111103206|NCT02541903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111103207|NCT02541669|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
111103208|NCT02541669|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111103209|NCT02541669|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111103210|NCT02541669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111489660|NCT05672394|Sensory System Agents|sensory system agents|mesh-ancestor
111103211|NCT05455047|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
111103212|NCT05455047|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111103213|NCT05455047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111103214|NCT02688647|Belumosudil|belumosudil|mesh-list
111103215|NCT02688647|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111103216|NCT02688647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111103217|NCT02688647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111103218|NCT05453799|Antibodies|antibodies|mesh-list
111103219|NCT05453799|Immunoglobulins|immunoglobulins|mesh-list
111103220|NCT05453799|Antibodies, Bispecific|antibodies, bispecific|mesh-list
111103221|NCT05453799|Immunologic Factors|immunologic factors|mesh-ancestor
111103222|NCT05453799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111103223|NCT05453487|Vaccines|vaccines|mesh-list
111103224|NCT05453487|Immunologic Factors|immunologic factors|mesh-ancestor
111103225|NCT05453487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111103226|NCT05431725|Vaccines|vaccines|mesh-list
111103227|NCT05431725|Immunologic Factors|immunologic factors|mesh-ancestor
111103228|NCT05431725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111103229|NCT02548455|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
111103230|NCT02548455|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111103231|NCT02548455|Contraceptive Agents|contraceptive agents|mesh-ancestor
111103232|NCT02548455|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111103233|NCT02548455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111103234|NCT02548455|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
111103235|NCT02548455|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111103236|NCT02548455|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111103237|NCT05451615|Abatacept|abatacept|mesh-list
111103238|NCT05451615|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
111103239|NCT05451615|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111103240|NCT05451615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111103241|NCT05451615|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111103242|NCT05451615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111103243|NCT05451615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111103244|NCT05451615|Immunologic Factors|immunologic factors|mesh-ancestor
111103245|NCT05451615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111103246|NCT05451615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111103247|NCT05451615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111103248|NCT05451615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111103249|NCT05727527|Anesthetics|anesthetics|mesh-list
111103250|NCT05727527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111103251|NCT05727527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111103252|NCT02534883|Misoprostol|misoprostol|mesh-list
111103253|NCT02534883|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111103254|NCT02534883|Abortifacient Agents|abortifacient agents|mesh-ancestor
110646916|NCT01669824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111103255|NCT02534883|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111103256|NCT02534883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111103257|NCT02534883|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111103258|NCT02534883|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111103259|NCT02534883|Oxytocics|oxytocics|mesh-ancestor
111103260|NCT05626439|Alprazolam|alprazolam|mesh-list
111103261|NCT05626439|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111103262|NCT05626439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111103263|NCT05626439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111103264|NCT05626439|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111103265|NCT05626439|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111103266|NCT05626439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111103267|NCT05626439|GABA Modulators|gaba modulators|mesh-ancestor
111103268|NCT05626439|GABA Agents|gaba agents|mesh-ancestor
111103269|NCT05626439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111103270|NCT05626439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111103271|NCT05430009|Pembrolizumab|pembrolizumab|mesh-list
111103272|NCT05430009|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111103273|NCT05430009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111103274|NCT05430009|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111103275|NCT05430009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111103276|NCT05429697|Pembrolizumab|pembrolizumab|mesh-list
111103277|NCT05429697|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111103278|NCT05429697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111103279|NCT05429697|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111103280|NCT05429697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111489661|NCT05672394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111489662|NCT05672394|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111489663|NCT05672394|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111103282|NCT02540265|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111103283|NCT02540265|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111103284|NCT02540265|Analgesics|analgesics|mesh-ancestor
111103285|NCT02540265|Sensory System Agents|sensory system agents|mesh-ancestor
111103286|NCT02540265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111103287|NCT02540265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111103288|NCT02540265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111103289|NCT02540265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111103290|NCT02540265|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111103291|NCT02540265|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111103292|NCT02540265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111103293|NCT02540265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111103294|NCT02684357|Ustekinumab|ustekinumab|mesh-list
111103295|NCT02684357|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111103296|NCT02684357|Dermatologic Agents|dermatologic agents|mesh-ancestor
111103297|NCT02684357|Immunologic Factors|immunologic factors|mesh-ancestor
111103298|NCT02684357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111103299|NCT03115073|Clotrimazole|clotrimazole|mesh-list
111103300|NCT03115073|Miconazole|miconazole|mesh-list
111103301|NCT03115073|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111103302|NCT03115073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111103303|NCT03115073|Antifungal Agents|antifungal agents|mesh-ancestor
111103304|NCT03115073|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111103305|NCT03115073|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111103306|NCT03115073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111103307|NCT03115073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111103308|NCT03115073|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111103309|NCT03115073|Hormone Antagonists|hormone antagonists|mesh-ancestor
111103310|NCT03115073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111103311|NCT03115073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111103312|NCT03115073|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111103313|NCT03115073|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111103314|NCT03166163|Chlorhexidine|chlorhexidine|mesh-list
111103315|NCT03166163|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111103316|NCT03166163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111103317|NCT03166163|Disinfectants|disinfectants|mesh-ancestor
111103318|NCT03165929|Flurbiprofen|flurbiprofen|mesh-list
111103319|NCT03165929|Analgesics|analgesics|mesh-ancestor
111103320|NCT03165929|Sensory System Agents|sensory system agents|mesh-ancestor
111103321|NCT03165929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111103322|NCT03165929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111103323|NCT03165929|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111103324|NCT03165929|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111103325|NCT03165929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111103326|NCT03165929|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111103327|NCT03165929|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111103328|NCT03165929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111103329|NCT03165929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111103331|NCT03206073|Tremelimumab|tremelimumab|mesh-list
111103332|NCT03206073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111103333|NCT03206073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111103334|NCT03142893|Ketoconazole|ketoconazole|mesh-list
111103335|NCT03142893|Dexamethasone|dexamethasone|mesh-list
111103336|NCT03142893|Dexamethasone acetate|dexamethasone acetate|mesh-list
111103337|NCT03142893|Hydrocortisone|hydrocortisone|mesh-list
111103338|NCT03142893|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
111103339|NCT03142893|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111103340|NCT03142893|Hormones|hormones|mesh-list
111103341|NCT03142893|Cosyntropin|cosyntropin|mesh-list
111103342|NCT03142893|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
111103343|NCT03142893|BB 1101|bb 1101|mesh-list
111103344|NCT03142893|Ganirelix|ganirelix|mesh-list
111103345|NCT03142893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111103346|NCT03142893|Antiemetics|antiemetics|mesh-ancestor
111103347|NCT03142893|Autonomic Agents|autonomic agents|mesh-ancestor
111103348|NCT03142893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111103349|NCT03142893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111103350|NCT03142893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111103351|NCT03142893|Glucocorticoids|glucocorticoids|mesh-ancestor
111103352|NCT03142893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111103353|NCT03142893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111103354|NCT03142893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111103355|NCT03142893|Protease Inhibitors|protease inhibitors|mesh-ancestor
111103357|NCT03142893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111103358|NCT03142893|Antifungal Agents|antifungal agents|mesh-ancestor
111103359|NCT03142893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111103360|NCT03142893|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111103361|NCT03142893|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111103362|NCT03142893|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111103363|NCT03142893|Hormone Antagonists|hormone antagonists|mesh-ancestor
111103364|NCT03142893|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111103365|NCT02547129|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111103366|NCT02547129|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
111103367|NCT02547129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111103368|NCT02547129|Antitubercular Agents|antitubercular agents|mesh-ancestor
111103369|NCT02546193|Misoprostol|misoprostol|mesh-list
111103370|NCT02546193|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111103371|NCT02546193|Abortifacient Agents|abortifacient agents|mesh-ancestor
111103372|NCT02546193|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111103373|NCT02546193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111103374|NCT02546193|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111103375|NCT02546193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111103376|NCT02546193|Oxytocics|oxytocics|mesh-ancestor
111103377|NCT01661595|Sildenafil Citrate|sildenafil citrate|mesh-list
111103378|NCT01661595|Tadalafil|tadalafil|mesh-list
111103379|NCT01661595|Vasodilator Agents|vasodilator agents|mesh-ancestor
111103380|NCT01661595|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111103381|NCT01661595|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111103382|NCT01661595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111103383|NCT01661595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111103384|NCT01661595|Urological Agents|urological agents|mesh-ancestor
111103385|NCT04262661|Insulin Glargine|insulin glargine|mesh-list
111103386|NCT04262661|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111103387|NCT04262661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111103388|NCT02957097|Gabapentin|gabapentin|mesh-list
111103389|NCT02957097|Analgesics|analgesics|mesh-ancestor
111103390|NCT02957097|Sensory System Agents|sensory system agents|mesh-ancestor
110646950|NCT01307956|Antidotes|antidotes|mesh-ancestor
111103391|NCT02957097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111103392|NCT02957097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111103393|NCT02957097|Anticonvulsants|anticonvulsants|mesh-ancestor
111103394|NCT02957097|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111103395|NCT02957097|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111103396|NCT02957097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111103397|NCT02957097|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111103398|NCT02957097|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111103399|NCT02957097|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111103400|NCT02957097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111103401|NCT02957097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111103402|NCT02957097|Antimanic Agents|antimanic agents|mesh-ancestor
111103403|NCT03165383|Morphine|morphine|mesh-list
111103404|NCT03165383|Bupivacaine|bupivacaine|mesh-list
111103405|NCT03165383|Anesthetics, Local|anesthetics, local|mesh-ancestor
111103406|NCT03165383|Anesthetics|anesthetics|mesh-ancestor
111103407|NCT03165383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111103408|NCT03165383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111103409|NCT03165383|Sensory System Agents|sensory system agents|mesh-ancestor
111103410|NCT03165383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111103411|NCT03165383|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111103412|NCT03165383|Narcotics|narcotics|mesh-ancestor
111103413|NCT03165383|Analgesics|analgesics|mesh-ancestor
111103414|NCT03162185|Escitalopram|escitalopram|mesh-list
111103415|NCT03162185|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111103416|NCT03162185|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111103417|NCT03162185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111103418|NCT03162185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111103419|NCT03162185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111103420|NCT03162185|Serotonin Agents|serotonin agents|mesh-ancestor
111103421|NCT03162185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111103422|NCT02678351|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
111103423|NCT02678351|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111103424|NCT02678351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111103425|NCT05286437|Pembrolizumab|pembrolizumab|mesh-list
111103426|NCT05286437|Letrozole|letrozole|mesh-list
111103427|NCT05286437|Lenvatinib|lenvatinib|mesh-list
111489664|NCT05672394|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111489665|NCT05672394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111103428|NCT05286437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111103429|NCT05286437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111103430|NCT05286437|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111103431|NCT05286437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111103432|NCT05286437|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111103433|NCT05286437|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111103434|NCT05286437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111103435|NCT05286437|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111103436|NCT05286437|Hormone Antagonists|hormone antagonists|mesh-ancestor
111103437|NCT05286437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111103438|NCT05286437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111103439|NCT05286437|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111103440|NCT05464173|Fulvestrant|fulvestrant|mesh-list
111103441|NCT05464173|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111103442|NCT05464173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111103443|NCT05464173|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
111103444|NCT05464173|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111103445|NCT05464173|Hormone Antagonists|hormone antagonists|mesh-ancestor
111103446|NCT05464173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111103447|NCT05464173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111103448|NCT02683187|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111103449|NCT02683187|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111103450|NCT02683187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111103451|NCT02683187|Incretins|incretins|mesh-ancestor
111103452|NCT02683187|Hormones|hormones|mesh-ancestor
111103453|NCT02683187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111103454|NCT02683187|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111103455|NCT02683187|Protease Inhibitors|protease inhibitors|mesh-ancestor
111103456|NCT02683187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110646957|NCT01196390|Carboplatin|carboplatin|mesh-list
111103457|NCT02683187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111103458|NCT05515601|Mirikizumab|mirikizumab|mesh-list
111103459|NCT05515601|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111103460|NCT05515601|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111103461|NCT05515601|Analgesics|analgesics|mesh-ancestor
111103462|NCT05515601|Sensory System Agents|sensory system agents|mesh-ancestor
111103463|NCT05515601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111103464|NCT05515601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111103465|NCT05515601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111103466|NCT05515601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111103467|NCT05515601|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111103468|NCT05515601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111103469|NCT02683109|Tiotropium Bromide|tiotropium bromide|mesh-list
111103470|NCT02683109|Olodaterol|olodaterol|mesh-list
111103471|NCT02683109|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111103472|NCT02683109|Autonomic Agents|autonomic agents|mesh-ancestor
111103473|NCT02683109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111103474|NCT02683109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111103475|NCT02683109|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111103476|NCT02683109|Respiratory System Agents|respiratory system agents|mesh-ancestor
111103477|NCT02683109|Parasympatholytics|parasympatholytics|mesh-ancestor
110820559|NCT01133119|Sensory System Agents|sensory system agents|mesh-ancestor
111103478|NCT02683109|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111103479|NCT02683109|Cholinergic Agents|cholinergic agents|mesh-ancestor
111103480|NCT02683109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111103481|NCT02683109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111103483|NCT02544321|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111103484|NCT02544321|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111103485|NCT02544321|Hormone Antagonists|hormone antagonists|mesh-ancestor
111103486|NCT02544321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111103487|NCT02544321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111103488|NCT02544321|Dopamine Agonists|dopamine agonists|mesh-ancestor
111103489|NCT02544321|Dopamine Agents|dopamine agents|mesh-ancestor
111103490|NCT02544321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111103491|NCT02544321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111103492|NCT02533401|Cyclophosphamide|cyclophosphamide|mesh-list
111103493|NCT02533401|Rituximab|rituximab|mesh-list
111103494|NCT02533401|Fludarabine|fludarabine|mesh-list
111103495|NCT02533401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111103496|NCT02533401|Immunologic Factors|immunologic factors|mesh-ancestor
111103497|NCT02533401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111489666|NCT05672394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111489667|NCT05672394|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111103498|NCT02533401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111103499|NCT02533401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111103500|NCT02533401|Alkylating Agents|alkylating agents|mesh-ancestor
111103501|NCT02533401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111103502|NCT02533401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111103503|NCT02533401|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111103504|NCT02533401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111103505|NCT03164837|68Ga-NOTA-RM26|68ga-nota-rm26|mesh-list
111103506|NCT03164837|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111103507|NCT03164837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111103508|NCT02536833|Lorecivivint|lorecivivint|mesh-list
111103509|NCT02536833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111103510|NCT02680847|Naltrexone|naltrexone|mesh-list
111103511|NCT02680847|Oxycodone|oxycodone|mesh-list
111103512|NCT02680847|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111103513|NCT02680847|Narcotics|narcotics|mesh-ancestor
111103514|NCT02680847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111103515|NCT02680847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111103516|NCT02680847|Analgesics|analgesics|mesh-ancestor
111103517|NCT02680847|Sensory System Agents|sensory system agents|mesh-ancestor
111103518|NCT02680847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111103519|NCT02680847|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110294183|NCT00236574|Galantamine|galantamine|mesh-list
111103520|NCT02680847|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111103521|NCT03959241|Mycophenolic Acid|mycophenolic acid|mesh-list
111103522|NCT03959241|Cyclophosphamide|cyclophosphamide|mesh-list
111103523|NCT03959241|Methotrexate|methotrexate|mesh-list
111103524|NCT03959241|Tacrolimus|tacrolimus|mesh-list
111103525|NCT03959241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111103526|NCT03959241|Immunologic Factors|immunologic factors|mesh-ancestor
111103527|NCT03959241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111103528|NCT03959241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111103529|NCT03959241|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111103530|NCT03959241|Alkylating Agents|alkylating agents|mesh-ancestor
111103531|NCT03959241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111103532|NCT03959241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111103533|NCT03959241|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111103534|NCT03959241|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111103535|NCT03959241|Abortifacient Agents|abortifacient agents|mesh-ancestor
111103536|NCT03959241|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111103537|NCT03959241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111103538|NCT03959241|Antimetabolites|antimetabolites|mesh-ancestor
111103539|NCT03959241|Dermatologic Agents|dermatologic agents|mesh-ancestor
111103540|NCT03959241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111103541|NCT03959241|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111103542|NCT03959241|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111103543|NCT03959241|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111103544|NCT03959241|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111103545|NCT03959241|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111103546|NCT03959241|Antitubercular Agents|antitubercular agents|mesh-ancestor
111103547|NCT03959241|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111103548|NCT03959241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111103549|NCT02532855|Metformin|metformin|mesh-list
111103550|NCT02532855|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111103551|NCT02532855|Dapagliflozin|dapagliflozin|mesh-list
111103552|NCT02532855|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111103553|NCT02532855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111103555|NCT02532855|Hormones|hormones|mesh-ancestor
111103556|NCT02532855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111103557|NCT02532855|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111103558|NCT02532855|Protease Inhibitors|protease inhibitors|mesh-ancestor
111103559|NCT02532855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111103560|NCT02532855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111103561|NCT02532855|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111103562|NCT04262427|Cyclophosphamide|cyclophosphamide|mesh-list
111103563|NCT04262427|Pembrolizumab|pembrolizumab|mesh-list
111103564|NCT04262427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111103565|NCT04262427|Immunologic Factors|immunologic factors|mesh-ancestor
111103566|NCT04262427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111103567|NCT04262427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111489668|NCT05672394|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111489669|NCT05672394|Adrenergic Agents|adrenergic agents|mesh-ancestor
111489670|NCT05672394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111489671|NCT05672394|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111103568|NCT04262427|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111103569|NCT04262427|Alkylating Agents|alkylating agents|mesh-ancestor
111489672|NCT05672394|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111103570|NCT04262427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111103571|NCT04262427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111103572|NCT04262427|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111103573|NCT04262427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111103574|NCT04262427|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111103576|NCT02530125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111103577|NCT02530125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111103578|NCT05422521|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
111103579|NCT05422521|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111103580|NCT05422521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111103581|NCT05421819|Calcium, Dietary|calcium, dietary|mesh-list
111103582|NCT05421819|Vitamin D|vitamin d|mesh-list
111103583|NCT05421819|Ergocalciferols|ergocalciferols|mesh-list
111103584|NCT05421819|Cholecalciferol|cholecalciferol|mesh-list
111103585|NCT05421819|Vitamins|vitamins|mesh-list
111103586|NCT05421819|Calcium|calcium|mesh-list
111103587|NCT05421819|Micronutrients|micronutrients|mesh-ancestor
111103588|NCT05421819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111103589|NCT05421819|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111103590|NCT05421819|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111103591|NCT02055820|Prednisone|prednisone|mesh-list
111103592|NCT02055820|Cyclophosphamide|cyclophosphamide|mesh-list
111103593|NCT02055820|Rituximab|rituximab|mesh-list
111103594|NCT02055820|Doxorubicin|doxorubicin|mesh-list
111103595|NCT02055820|Vincristine|vincristine|mesh-list
111103596|NCT02055820|Venetoclax|venetoclax|mesh-list
111103597|NCT02055820|Obinutuzumab|obinutuzumab|mesh-list
111103598|NCT02055820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111103599|NCT02055820|Immunologic Factors|immunologic factors|mesh-ancestor
111103600|NCT02055820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111103601|NCT02055820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111103602|NCT02055820|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111103603|NCT02055820|Alkylating Agents|alkylating agents|mesh-ancestor
111103604|NCT02055820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111103605|NCT02055820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111103606|NCT02055820|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111103607|NCT02055820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111103608|NCT02055820|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111103609|NCT02055820|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111103610|NCT02055820|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111103611|NCT02055820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111103612|NCT02055820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111103613|NCT02055820|Glucocorticoids|glucocorticoids|mesh-ancestor
111103614|NCT02055820|Hormones|hormones|mesh-ancestor
111103615|NCT02055820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111103616|NCT02055820|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111103617|NCT02055820|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111103618|NCT02055820|Tubulin Modulators|tubulin modulators|mesh-ancestor
111103619|NCT02055820|Antimitotic Agents|antimitotic agents|mesh-ancestor
111103620|NCT02055820|Mitosis Modulators|mitosis modulators|mesh-ancestor
111103621|NCT02055352|Fluticasone|fluticasone|mesh-list
111103622|NCT02055352|Budesonide|budesonide|mesh-list
111103623|NCT02055352|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
111103624|NCT02055352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111103625|NCT02055352|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111103626|NCT02055352|Autonomic Agents|autonomic agents|mesh-ancestor
111103627|NCT02055352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111103628|NCT02055352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111103629|NCT02055352|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111103630|NCT02055352|Respiratory System Agents|respiratory system agents|mesh-ancestor
111103631|NCT02055352|Dermatologic Agents|dermatologic agents|mesh-ancestor
111103632|NCT02055352|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111103633|NCT02055352|Glucocorticoids|glucocorticoids|mesh-ancestor
111103634|NCT02055352|Hormones|hormones|mesh-ancestor
111103635|NCT02055352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111103636|NCT02055352|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111103637|NCT02055352|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111103638|NCT02055352|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111103639|NCT02055352|Adrenergic Agents|adrenergic agents|mesh-ancestor
111103640|NCT02055352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111103641|NCT02055352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111103642|NCT02034916|Talazoparib|talazoparib|mesh-list
111103643|NCT02034916|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111489674|NCT05672394|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111103644|NCT02034916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111103645|NCT02034916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111103646|NCT02034916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111103647|NCT01374425|Leucovorin|leucovorin|mesh-list
111103648|NCT01374425|Bevacizumab|bevacizumab|mesh-list
111103649|NCT01374425|Fluorouracil|fluorouracil|mesh-list
111103650|NCT01374425|Capecitabine|capecitabine|mesh-list
111103651|NCT01374425|Oxaliplatin|oxaliplatin|mesh-list
111103652|NCT01374425|Irinotecan|irinotecan|mesh-list
111103653|NCT01374425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111103654|NCT01374425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111103655|NCT01374425|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111103656|NCT01374425|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111103657|NCT01374425|Growth Substances|growth substances|mesh-ancestor
111103658|NCT01374425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111103659|NCT01374425|Growth Inhibitors|growth inhibitors|mesh-ancestor
111103660|NCT01374425|Antimetabolites|antimetabolites|mesh-ancestor
111103661|NCT01374425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111103662|NCT01374425|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111103663|NCT01374425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111103664|NCT01374425|Immunologic Factors|immunologic factors|mesh-ancestor
111103665|NCT01374425|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111103666|NCT01374425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111103667|NCT01374425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111103668|NCT01374425|Antidotes|antidotes|mesh-ancestor
111103669|NCT01374425|Protective Agents|protective agents|mesh-ancestor
111103670|NCT01374425|Vitamin B Complex|vitamin b complex|mesh-ancestor
111103671|NCT01374425|Vitamins|vitamins|mesh-ancestor
111103672|NCT01374425|Micronutrients|micronutrients|mesh-ancestor
111103673|NCT02085460|Rebamipide|rebamipide|mesh-list
111103674|NCT02085460|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111103675|NCT02085460|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111103676|NCT02085460|Antioxidants|antioxidants|mesh-ancestor
111103677|NCT02085460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111103678|NCT02085460|Protective Agents|protective agents|mesh-ancestor
111103679|NCT02085460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111103680|NCT02085460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111103681|NCT03164291|Rifabutin|rifabutin|mesh-list
111103682|NCT03164291|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111103683|NCT03164291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111103684|NCT03164291|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111103685|NCT03164291|Antitubercular Agents|antitubercular agents|mesh-ancestor
111103686|NCT02084134|Dexamethasone|dexamethasone|mesh-list
111103687|NCT02084134|Dexamethasone acetate|dexamethasone acetate|mesh-list
111103688|NCT02084134|Hydrocortisone|hydrocortisone|mesh-list
111103689|NCT02084134|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
111103690|NCT02084134|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
111103691|NCT02084134|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
111103692|NCT02084134|BB 1101|bb 1101|mesh-list
111103693|NCT02084134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111103694|NCT02084134|Antiemetics|antiemetics|mesh-ancestor
111103695|NCT02084134|Autonomic Agents|autonomic agents|mesh-ancestor
111103696|NCT02084134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111103697|NCT02084134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111103698|NCT02084134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111103699|NCT02084134|Glucocorticoids|glucocorticoids|mesh-ancestor
111103700|NCT02084134|Hormones|hormones|mesh-ancestor
111103701|NCT02084134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111103702|NCT02084134|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111103703|NCT02084134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111103704|NCT02084134|Protease Inhibitors|protease inhibitors|mesh-ancestor
111103705|NCT02084134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111103706|NCT02084134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111103707|NCT01374269|Acetaminophen|acetaminophen|mesh-list
111103708|NCT01374269|Celecoxib|celecoxib|mesh-list
111103709|NCT01374269|Naproxen|naproxen|mesh-list
111103710|NCT01374269|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
111103711|NCT01374269|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
111103712|NCT01374269|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111103713|NCT01374269|Analgesics|analgesics|mesh-ancestor
111103714|NCT01374269|Sensory System Agents|sensory system agents|mesh-ancestor
111103715|NCT01374269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111103716|NCT01374269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111103717|NCT01374269|Antipyretics|antipyretics|mesh-ancestor
111103718|NCT01374269|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111103719|NCT01374269|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111103720|NCT01374269|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111103721|NCT01374269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111103722|NCT01374269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111103723|NCT01374269|Gout Suppressants|gout suppressants|mesh-ancestor
111103724|NCT03163979|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
111103725|NCT03163979|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111103726|NCT03163979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111103728|NCT03163589|Hematinics|hematinics|mesh-ancestor
111103729|NCT03163277|Emtricitabine|emtricitabine|mesh-list
111103730|NCT03163277|Maraviroc|maraviroc|mesh-list
111103731|NCT03163277|Darunavir|darunavir|mesh-list
111103732|NCT03163277|Cobicistat|cobicistat|mesh-list
111103733|NCT03163277|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
111103734|NCT03163277|Antiviral Agents|antiviral agents|mesh-ancestor
111103735|NCT03163277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111103736|NCT03163277|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111103737|NCT03163277|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111103738|NCT03163277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111103739|NCT03163277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111103740|NCT03163277|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111103741|NCT03163277|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111103742|NCT03163277|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
111103743|NCT03163277|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
111103744|NCT03163277|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
111103745|NCT03163277|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111103746|NCT03163277|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111103747|NCT03163277|Protease Inhibitors|protease inhibitors|mesh-ancestor
111103748|NCT03163277|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111103749|NCT03163277|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111103750|NCT05419817|Pembrolizumab|pembrolizumab|mesh-list
111103751|NCT05419817|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111103752|NCT05419817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111103753|NCT05419817|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111103754|NCT05419817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111103755|NCT05392205|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
111103756|NCT05392205|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111103757|NCT05392205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111103758|NCT02679755|Letrozole|letrozole|mesh-list
111103759|NCT02679755|Palbociclib|palbociclib|mesh-list
111103760|NCT02679755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111103761|NCT02679755|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111103762|NCT02679755|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111103763|NCT02679755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111103764|NCT02679755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111103765|NCT02679755|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111103766|NCT02679755|Hormone Antagonists|hormone antagonists|mesh-ancestor
111103767|NCT02679755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111103768|NCT02679755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111103769|NCT02679755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111103770|NCT03163121|Vaccines|vaccines|mesh-list
111103771|NCT03163121|Immunologic Factors|immunologic factors|mesh-ancestor
111103772|NCT03163121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111103773|NCT03114371|Oxytocin|oxytocin|mesh-list
111103774|NCT03114371|Oxytocics|oxytocics|mesh-ancestor
111103775|NCT03114371|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111103776|NCT03114371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111103777|NCT04905407|Azacitidine|azacitidine|mesh-list
111103778|NCT04905407|Venetoclax|venetoclax|mesh-list
111103779|NCT04905407|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111103780|NCT04905407|Antimetabolites|antimetabolites|mesh-ancestor
110646991|NCT00905515|Antifungal Agents|antifungal agents|mesh-ancestor
111103781|NCT04905407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111103782|NCT04905407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111103783|NCT04905407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111103784|NCT03114215|Biotin|biotin|mesh-list
111103785|NCT03114215|Vitamin B Complex|vitamin b complex|mesh-ancestor
111103786|NCT03114215|Vitamins|vitamins|mesh-ancestor
111103787|NCT03114215|Micronutrients|micronutrients|mesh-ancestor
111103788|NCT03114215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111103789|NCT05675813|Azacitidine|azacitidine|mesh-list
111103790|NCT05675813|Tislelizumab|tislelizumab|mesh-list
111103791|NCT05675813|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111103792|NCT05675813|Antimetabolites|antimetabolites|mesh-ancestor
110697830|NCT01069263|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
111489675|NCT05672394|Respiratory System Agents|respiratory system agents|mesh-ancestor
111489676|NCT05672394|Mydriatics|mydriatics|mesh-ancestor
111489677|NCT05672394|Sympathomimetics|sympathomimetics|mesh-ancestor
111489678|NCT05672394|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111489679|NCT05607342|SR 142801|sr 142801|mesh-list
111489680|NCT05607342|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111103793|NCT05675813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111103794|NCT05675813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111103795|NCT05675813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111103796|NCT05675813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111103797|NCT02397083|Everolimus|everolimus|mesh-list
111103798|NCT02397083|Levonorgestrel|levonorgestrel|mesh-list
111103799|NCT02397083|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111103800|NCT02397083|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111489681|NCT05607342|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111103801|NCT02397083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111103802|NCT02397083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111103803|NCT02397083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111103804|NCT02397083|Immunologic Factors|immunologic factors|mesh-ancestor
111103805|NCT02397083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111103806|NCT02397083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111103807|NCT02397083|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111103808|NCT02397083|Contraceptive Agents|contraceptive agents|mesh-ancestor
111103809|NCT02397083|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111103810|NCT02397083|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111103811|NCT02397083|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111103812|NCT02397083|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111103813|NCT02667275|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111103814|NCT01729091|Lenalidomide|lenalidomide|mesh-list
111103815|NCT01729091|Melphalan|melphalan|mesh-list
111103816|NCT01729091|Mechlorethamine|mechlorethamine|mesh-list
111103817|NCT01729091|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
111103818|NCT01729091|Elotuzumab|elotuzumab|mesh-list
111103819|NCT01729091|Immunologic Factors|immunologic factors|mesh-ancestor
111103820|NCT01729091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111103821|NCT01729091|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111103822|NCT01729091|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111103823|NCT01729091|Growth Substances|growth substances|mesh-ancestor
111103824|NCT01729091|Growth Inhibitors|growth inhibitors|mesh-ancestor
111103825|NCT01729091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111103826|NCT01729091|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111103827|NCT01729091|Alkylating Agents|alkylating agents|mesh-ancestor
111103828|NCT01729091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111103829|NCT01729091|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111103830|NCT01729091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111103831|NCT04205903|Paclitaxel|paclitaxel|mesh-list
111103832|NCT04205903|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111103833|NCT04205903|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111103834|NCT04205903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111103835|NCT04205903|Tubulin Modulators|tubulin modulators|mesh-ancestor
111103836|NCT04205903|Antimitotic Agents|antimitotic agents|mesh-ancestor
111103837|NCT04205903|Mitosis Modulators|mitosis modulators|mesh-ancestor
111103838|NCT04205903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111103839|NCT02670551|Cariprazine|cariprazine|mesh-list
111103840|NCT02670551|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111103841|NCT02670551|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111103842|NCT02670551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110647005|NCT00659126|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111103843|NCT02670551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111103844|NCT02670551|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111103845|NCT01430351|Metformin|metformin|mesh-list
111103846|NCT01430351|Mefloquine|mefloquine|mesh-list
111103847|NCT01430351|Temozolomide|temozolomide|mesh-list
111103848|NCT01430351|Memantine|memantine|mesh-list
111103849|NCT01430351|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111103850|NCT01430351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111103851|NCT01430351|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111103852|NCT01430351|Alkylating Agents|alkylating agents|mesh-ancestor
111103853|NCT01430351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110820931|NCT02304250|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111489682|NCT05607342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111103854|NCT01430351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111103855|NCT01430351|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111103856|NCT01430351|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111103857|NCT01430351|Dopamine Agents|dopamine agents|mesh-ancestor
111103858|NCT01430351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110697837|NCT01067235|Modafinil|modafinil|mesh-list
111489683|NCT05607342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111103859|NCT01430351|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111103860|NCT01430351|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111103861|NCT01430351|Antimalarials|antimalarials|mesh-ancestor
111103862|NCT01430351|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111103863|NCT01430351|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111103864|NCT01430351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111103865|NCT00893399|Gemtuzumab|gemtuzumab|mesh-list
111103866|NCT00893399|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111103867|NCT00893399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111103868|NCT00893399|Immunotoxins|immunotoxins|mesh-ancestor
111103869|NCT00893399|Immunoconjugates|immunoconjugates|mesh-ancestor
111103870|NCT00893399|Immunologic Factors|immunologic factors|mesh-ancestor
111103871|NCT00893399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111103872|NCT05675033|Bevacizumab|bevacizumab|mesh-list
111103873|NCT05675033|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111103874|NCT05675033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111103875|NCT05675033|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111103876|NCT05675033|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111103877|NCT05675033|Growth Substances|growth substances|mesh-ancestor
111103878|NCT05675033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111103879|NCT05675033|Growth Inhibitors|growth inhibitors|mesh-ancestor
111103880|NCT04103489|Eculizumab|eculizumab|mesh-list
111103881|NCT04103489|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
111103882|NCT04103489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111103883|NCT04103489|Immunologic Factors|immunologic factors|mesh-ancestor
111103884|NCT04103489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111103885|NCT04479527|Apatinib|apatinib|mesh-list
111103886|NCT04479527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111103887|NCT04479527|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111103888|NCT04479527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111103889|NCT04479527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111103890|NCT02391077|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111103891|NCT02391077|Chlorhexidine|chlorhexidine|mesh-list
111103892|NCT02391077|Povidone-Iodine|povidone-iodine|mesh-list
111103893|NCT02391077|Povidone|povidone|mesh-list
111103894|NCT02391077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111103895|NCT02391077|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111103896|NCT02391077|Disinfectants|disinfectants|mesh-ancestor
111103897|NCT02391077|Plasma Substitutes|plasma substitutes|mesh-ancestor
111103898|NCT02391077|Blood Substitutes|blood substitutes|mesh-ancestor
111103899|NCT02390921|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
111103900|NCT02390921|Hematinics|hematinics|mesh-ancestor
111103901|NCT02390843|Cyclophosphamide|cyclophosphamide|mesh-list
111103902|NCT02390843|Topotecan|topotecan|mesh-list
111103903|NCT02390843|Simvastatin|simvastatin|mesh-list
111103904|NCT02390843|Lenograstim|lenograstim|mesh-list
111103905|NCT02390843|Mitogens|mitogens|mesh-list
111103906|NCT02390843|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111103907|NCT02390843|Immunologic Factors|immunologic factors|mesh-ancestor
111103908|NCT02390843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111103909|NCT02390843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111103910|NCT02390843|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111103911|NCT02390843|Alkylating Agents|alkylating agents|mesh-ancestor
111103912|NCT02390843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111103913|NCT02390843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111103914|NCT02390843|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111103915|NCT02390843|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111103916|NCT02390843|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111103917|NCT02390843|Antimetabolites|antimetabolites|mesh-ancestor
111103918|NCT02390843|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111103919|NCT02390843|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111103920|NCT02390843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111103921|NCT02390843|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111103922|NCT02390843|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111103923|NCT02390843|Mitosis Modulators|mitosis modulators|mesh-ancestor
111103924|NCT02390843|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111103925|NCT02390375|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111103926|NCT02390375|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111103927|NCT02390375|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111489685|NCT05326464|Tofacitinib|tofacitinib|mesh-list
111103928|NCT02390375|Antimetabolites|antimetabolites|mesh-ancestor
111103929|NCT02390375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111103930|NCT02390375|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111103931|NCT02390375|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111489686|NCT05326464|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
111489687|NCT05326464|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111103932|NCT02390375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111103933|NCT03806309|Leucovorin|leucovorin|mesh-list
111103934|NCT03806309|Fluorouracil|fluorouracil|mesh-list
111103935|NCT03806309|Irinotecan|irinotecan|mesh-list
111103936|NCT03806309|Antimetabolites|antimetabolites|mesh-ancestor
111103937|NCT03806309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111103938|NCT03806309|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111103939|NCT03806309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111103940|NCT03806309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111103941|NCT03806309|Immunologic Factors|immunologic factors|mesh-ancestor
111103942|NCT03806309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111103943|NCT03806309|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111103944|NCT03806309|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111103945|NCT03806309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111103946|NCT03806309|Antidotes|antidotes|mesh-ancestor
111103947|NCT03806309|Protective Agents|protective agents|mesh-ancestor
111103948|NCT03806309|Vitamin B Complex|vitamin b complex|mesh-ancestor
111103949|NCT03806309|Vitamins|vitamins|mesh-ancestor
111103950|NCT03806309|Micronutrients|micronutrients|mesh-ancestor
111103951|NCT03489629|Chlorhexidine|chlorhexidine|mesh-list
111103952|NCT03489629|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
111103953|NCT03489629|Minocycline|minocycline|mesh-list
111103954|NCT03489629|Trimethoprim|trimethoprim|mesh-list
111103955|NCT03489629|Sulfamethoxazole|sulfamethoxazole|mesh-list
111103956|NCT03489629|Mupirocin|mupirocin|mesh-list
111103957|NCT03489629|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
111103958|NCT03489629|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111103959|NCT03489629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111103960|NCT03489629|Disinfectants|disinfectants|mesh-ancestor
111103961|NCT03489629|Dermatologic Agents|dermatologic agents|mesh-ancestor
111103962|NCT03489629|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111103963|NCT03489629|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111103964|NCT03489629|Antimalarials|antimalarials|mesh-ancestor
111103965|NCT03489629|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111103966|NCT03489629|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111103967|NCT03489629|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111103968|NCT03489629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111103969|NCT03489629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111103970|NCT03489629|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111103971|NCT03489629|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
111103972|NCT03489629|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111103973|NCT03489629|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111103974|NCT02389751|Paclitaxel|paclitaxel|mesh-list
111103975|NCT02389751|Carboplatin|carboplatin|mesh-list
111103976|NCT02389751|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111103977|NCT02389751|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111103978|NCT02389751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111103979|NCT02389751|Tubulin Modulators|tubulin modulators|mesh-ancestor
111103980|NCT02389751|Antimitotic Agents|antimitotic agents|mesh-ancestor
111103981|NCT02389751|Mitosis Modulators|mitosis modulators|mesh-ancestor
111103982|NCT02389751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111103983|NCT02390063|Cyclophosphamide|cyclophosphamide|mesh-list
111103984|NCT02390063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111103985|NCT02390063|Immunologic Factors|immunologic factors|mesh-ancestor
111103986|NCT02390063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111103987|NCT02390063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111103988|NCT02390063|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111103989|NCT02390063|Alkylating Agents|alkylating agents|mesh-ancestor
111103990|NCT02390063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111103991|NCT02390063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111103992|NCT02390063|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111103993|NCT02388035|Cefotaxime|cefotaxime|mesh-list
111103994|NCT02388035|Cefoxitin|cefoxitin|mesh-list
111103995|NCT02388035|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111103996|NCT02388035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111103997|NCT02389439|Artesunate|artesunate|mesh-list
111103998|NCT02389439|Pyronaridine|pyronaridine|mesh-list
111103999|NCT02389439|Pyronaridine tetraphosphate, artesunate drug combination|pyronaridine tetraphosphate, artesunate drug combination|mesh-list
111104000|NCT02389439|Antimalarials|antimalarials|mesh-ancestor
111104001|NCT02389439|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111104002|NCT02389439|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111489688|NCT05326464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111104003|NCT02389439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110821092|NCT02312440|Hemostatics|hemostatics|mesh-ancestor
111489689|NCT05326464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111489690|NCT04887792|Acetazolamide|acetazolamide|mesh-list
111489691|NCT04887792|Anticonvulsants|anticonvulsants|mesh-ancestor
111104004|NCT02389439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111104005|NCT02389439|Antiviral Agents|antiviral agents|mesh-ancestor
111104006|NCT02389439|Schistosomicides|schistosomicides|mesh-ancestor
111104007|NCT02389439|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
111104008|NCT02389439|Anthelmintics|anthelmintics|mesh-ancestor
111104009|NCT02663687|Complement C1s|complement c1s|mesh-list
111104010|NCT02663687|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
111104011|NCT02663687|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
111104012|NCT02663687|Immunologic Factors|immunologic factors|mesh-ancestor
111104013|NCT02663687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111104014|NCT02663687|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
111104015|NCT02663687|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111104016|NCT02663453|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
111104017|NCT02663453|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
111104018|NCT02663453|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
111104019|NCT02663453|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111104020|NCT04439825|Botulinum Toxins|botulinum toxins|mesh-list
111104021|NCT04439825|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111104022|NCT04439825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111104023|NCT04439825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111104024|NCT04439825|Cholinergic Agents|cholinergic agents|mesh-ancestor
111104025|NCT04439825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111104026|NCT04439825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111104027|NCT02388581|Amoxicillin|amoxicillin|mesh-list
111104028|NCT02388581|Metronidazole|metronidazole|mesh-list
111104029|NCT02388581|Clarithromycin|clarithromycin|mesh-list
111104030|NCT02388581|Lansoprazole|lansoprazole|mesh-list
111104031|NCT02388581|Dexlansoprazole|dexlansoprazole|mesh-list
111104032|NCT02388581|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111104033|NCT02388581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111104034|NCT02388581|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111104035|NCT02388581|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111104036|NCT02388581|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111104037|NCT02388581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111104038|NCT02388581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111104039|NCT02388581|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111104040|NCT02388581|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111104041|NCT02388581|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111104042|NCT02388581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111104043|NCT02388581|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111104044|NCT02387567|Lidocaine|lidocaine|mesh-list
111104045|NCT02387567|Anesthetics, Local|anesthetics, local|mesh-ancestor
111104046|NCT02387567|Anesthetics|anesthetics|mesh-ancestor
111104047|NCT02387567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111104048|NCT02387567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110647017|NCT00581139|GABA Modulators|gaba modulators|mesh-ancestor
111104049|NCT02387567|Sensory System Agents|sensory system agents|mesh-ancestor
111104050|NCT02387567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111104051|NCT02387567|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111104052|NCT02387567|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111104053|NCT02387567|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111104054|NCT02387567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111104055|NCT02387567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111104056|NCT02383121|Midodrine|midodrine|mesh-list
111104057|NCT02383121|Sympathomimetics|sympathomimetics|mesh-ancestor
111104058|NCT02383121|Autonomic Agents|autonomic agents|mesh-ancestor
111104059|NCT02383121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111104060|NCT02383121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111104061|NCT02383121|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111104062|NCT02383121|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111104063|NCT02383121|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111104064|NCT02383121|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111104065|NCT02383121|Adrenergic Agents|adrenergic agents|mesh-ancestor
111104066|NCT02383121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111104067|NCT02383121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111104068|NCT02387021|Ropivacaine|ropivacaine|mesh-list
111104069|NCT02387021|Anesthetics, Local|anesthetics, local|mesh-ancestor
111104070|NCT02387021|Anesthetics|anesthetics|mesh-ancestor
111104071|NCT02387021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111104072|NCT02387021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111104073|NCT02387021|Sensory System Agents|sensory system agents|mesh-ancestor
111104074|NCT02387021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111489692|NCT04887792|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
111104075|NCT02386943|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111104076|NCT02386943|Saxagliptin|saxagliptin|mesh-list
111104077|NCT02386943|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111104078|NCT02386943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111104079|NCT02386943|Incretins|incretins|mesh-ancestor
111104080|NCT02386943|Hormones|hormones|mesh-ancestor
111104081|NCT02386943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111104082|NCT02386943|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111104083|NCT02386943|Protease Inhibitors|protease inhibitors|mesh-ancestor
111104084|NCT02386943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111104085|NCT02386943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111104087|NCT02084056|Linagliptin|linagliptin|mesh-list
111104088|NCT02084056|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111104089|NCT02084056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111104090|NCT02084056|Incretins|incretins|mesh-ancestor
111104091|NCT02084056|Hormones|hormones|mesh-ancestor
111104092|NCT02084056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111104093|NCT02084056|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111104094|NCT02084056|Protease Inhibitors|protease inhibitors|mesh-ancestor
111104095|NCT02084056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111104096|NCT02084056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111104097|NCT04714372|Cyclophosphamide|cyclophosphamide|mesh-list
111104098|NCT04714372|Fludarabine|fludarabine|mesh-list
111104099|NCT04714372|Daratumumab|daratumumab|mesh-list
111104100|NCT04714372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111104101|NCT04714372|Immunologic Factors|immunologic factors|mesh-ancestor
111104102|NCT04714372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111104103|NCT04714372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111104104|NCT04714372|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111104105|NCT04714372|Alkylating Agents|alkylating agents|mesh-ancestor
111104106|NCT04714372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111104107|NCT04714372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111104108|NCT04714372|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111104109|NCT04787471|Riboflavin|riboflavin|mesh-list
111104110|NCT04787471|Vitamin B Complex|vitamin b complex|mesh-ancestor
111104111|NCT04787471|Vitamins|vitamins|mesh-ancestor
111104112|NCT04787471|Micronutrients|micronutrients|mesh-ancestor
111104113|NCT04787471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111104114|NCT04787471|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111104115|NCT04787471|Dermatologic Agents|dermatologic agents|mesh-ancestor
111104116|NCT02386397|Gemcitabine|gemcitabine|mesh-list
111104117|NCT02386397|Oxaliplatin|oxaliplatin|mesh-list
111104118|NCT02386397|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111104119|NCT02386397|Antimetabolites|antimetabolites|mesh-ancestor
111104120|NCT02386397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111104121|NCT02386397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111104122|NCT02386475|Dexetimide|dexetimide|mesh-list
111104123|NCT02386475|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
111104124|NCT02386475|Citalopram|citalopram|mesh-list
111104125|NCT02386475|Escitalopram|escitalopram|mesh-list
111104126|NCT02386475|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111104127|NCT02386475|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111104128|NCT02386475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111104129|NCT02386475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111104130|NCT02386475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111104131|NCT02386475|Serotonin Agents|serotonin agents|mesh-ancestor
111104132|NCT02386475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111104133|NCT02386475|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111104134|NCT02386475|Antidepressive Agents|antidepressive agents|mesh-ancestor
111104135|NCT02386475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111104136|NCT02386475|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111104137|NCT02386475|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111104138|NCT02386475|Parasympatholytics|parasympatholytics|mesh-ancestor
111104139|NCT02386475|Autonomic Agents|autonomic agents|mesh-ancestor
111104140|NCT02386475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111104141|NCT02386475|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111104142|NCT02386475|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111104143|NCT02386475|Cholinergic Agents|cholinergic agents|mesh-ancestor
111104144|NCT02386475|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111104145|NCT02386475|Immunologic Factors|immunologic factors|mesh-ancestor
111104146|NCT02386475|Dopamine Agonists|dopamine agonists|mesh-ancestor
111489693|NCT04887792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111489694|NCT04887792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111104147|NCT02386475|Dopamine Agents|dopamine agents|mesh-ancestor
111104148|NCT02382653|Piroxicam|piroxicam|mesh-list
111104149|NCT02382653|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111489695|NCT04887792|Diuretics|diuretics|mesh-ancestor
111104150|NCT02382653|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111104151|NCT02382653|Analgesics|analgesics|mesh-ancestor
111104152|NCT02382653|Sensory System Agents|sensory system agents|mesh-ancestor
111104153|NCT02382653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111104154|NCT02382653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111104155|NCT02382653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111104156|NCT02382653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111104157|NCT02382653|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111104158|NCT02382653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111104159|NCT02382653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111104160|NCT02382263|Paclitaxel|paclitaxel|mesh-list
111104161|NCT02382263|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111104162|NCT02382263|Gemcitabine|gemcitabine|mesh-list
111104163|NCT02382263|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111104164|NCT02382263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111104165|NCT02382263|Tubulin Modulators|tubulin modulators|mesh-ancestor
111104166|NCT02382263|Antimitotic Agents|antimitotic agents|mesh-ancestor
111104167|NCT02382263|Mitosis Modulators|mitosis modulators|mesh-ancestor
111104168|NCT02382263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111104169|NCT02382263|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111104170|NCT02382263|Antimetabolites|antimetabolites|mesh-ancestor
111104171|NCT02382029|Clonazepam|clonazepam|mesh-list
111104172|NCT02382029|Anticonvulsants|anticonvulsants|mesh-ancestor
111104173|NCT02382029|GABA Modulators|gaba modulators|mesh-ancestor
111104174|NCT02382029|GABA Agents|gaba agents|mesh-ancestor
111104175|NCT02382029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111104176|NCT02382029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111104177|NCT02382029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111104178|NCT02385617|Octreotide|octreotide|mesh-list
111104179|NCT02385617|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111104180|NCT02385617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111104181|NCT02385617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111104182|NCT02385539|Levobupivacaine|levobupivacaine|mesh-list
111104183|NCT02385539|Anesthetics, Local|anesthetics, local|mesh-ancestor
111104184|NCT02385539|Anesthetics|anesthetics|mesh-ancestor
111104185|NCT02385539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111104186|NCT02385539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111104187|NCT02385539|Sensory System Agents|sensory system agents|mesh-ancestor
111104188|NCT02385539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111104189|NCT02385461|Heparin|heparin|mesh-list
111104190|NCT02385461|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
111104191|NCT02385461|Tinzaparin|tinzaparin|mesh-list
111104192|NCT02385461|Dalteparin|dalteparin|mesh-list
111104193|NCT02385461|Anticoagulants|anticoagulants|mesh-ancestor
111104194|NCT02385461|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111104195|NCT02385461|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111104196|NCT02385461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111104197|NCT02381717|Morphine|morphine|mesh-list
111104198|NCT02381717|Bupivacaine|bupivacaine|mesh-list
111104199|NCT02381717|Anesthetics, Local|anesthetics, local|mesh-ancestor
111104200|NCT02381717|Anesthetics|anesthetics|mesh-ancestor
111104201|NCT02381717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111104202|NCT02381717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111104203|NCT02381717|Sensory System Agents|sensory system agents|mesh-ancestor
111104204|NCT02381717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111104205|NCT02381717|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111104206|NCT02381717|Narcotics|narcotics|mesh-ancestor
111104207|NCT02381717|Analgesics|analgesics|mesh-ancestor
111104208|NCT02385305|Anesthetics|anesthetics|mesh-list
111104209|NCT02385305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111104210|NCT02385305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111104211|NCT02385227|Nicotine|nicotine|mesh-list
111104212|NCT02385227|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111104213|NCT02385227|Autonomic Agents|autonomic agents|mesh-ancestor
111104214|NCT02385227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111104215|NCT02385227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111104216|NCT02385227|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111104217|NCT02385227|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111104218|NCT02385227|Cholinergic Agents|cholinergic agents|mesh-ancestor
111104219|NCT02385227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111489696|NCT04887792|Natriuretic Agents|natriuretic agents|mesh-ancestor
111489697|NCT04887792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111104220|NCT02385227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111104221|NCT02381249|Octreotide|octreotide|mesh-list
111489698|NCT04518228|Ritonavir|ritonavir|mesh-list
111489699|NCT04518228|Lopinavir|lopinavir|mesh-list
111489700|NCT04518228|Atazanavir Sulfate|atazanavir sulfate|mesh-list
111104222|NCT02381249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111104223|NCT02381249|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111104224|NCT02381249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111104225|NCT02385071|Simeprevir|simeprevir|mesh-list
111104226|NCT02385071|Antiviral Agents|antiviral agents|mesh-ancestor
111104227|NCT02385071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111104228|NCT02385071|Protease Inhibitors|protease inhibitors|mesh-ancestor
111104229|NCT02385071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111104230|NCT02385071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111104231|NCT02384915|Prilocaine|prilocaine|mesh-list
111104232|NCT02384915|Mepivacaine|mepivacaine|mesh-list
111104233|NCT02384915|Anesthetics|anesthetics|mesh-ancestor
111104234|NCT02384915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111104235|NCT02384915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111104236|NCT02384915|Anesthetics, Local|anesthetics, local|mesh-ancestor
111104237|NCT02384915|Sensory System Agents|sensory system agents|mesh-ancestor
111104238|NCT02384915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111104239|NCT04895735|Pembrolizumab|pembrolizumab|mesh-list
111104240|NCT04895735|Pemetrexed|pemetrexed|mesh-list
111104241|NCT04895735|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111104242|NCT04895735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111104243|NCT04895735|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111104244|NCT04895735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111104245|NCT04895735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111104246|NCT04895735|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111104247|NCT04895735|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111104248|NCT02384837|Sirolimus|sirolimus|mesh-list
111104249|NCT02384837|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111104250|NCT02384837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111104251|NCT02384837|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111104252|NCT02384837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111104253|NCT02384837|Antifungal Agents|antifungal agents|mesh-ancestor
111104254|NCT02384837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111104255|NCT02384837|Immunologic Factors|immunologic factors|mesh-ancestor
111104256|NCT02384837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111104257|NCT03105791|Analgesics, Opioid|analgesics, opioid|mesh-list
111104258|NCT03105791|Narcotics|narcotics|mesh-ancestor
111104259|NCT03105791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111104260|NCT03105791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111104261|NCT03105791|Analgesics|analgesics|mesh-ancestor
111104262|NCT03105791|Sensory System Agents|sensory system agents|mesh-ancestor
111104263|NCT03105791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111104264|NCT02384135|Fibrin fragment D|fibrin fragment d|mesh-list
111104265|NCT02384135|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111104266|NCT02384135|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111104267|NCT02384135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111104268|NCT02384135|Hemostatics|hemostatics|mesh-ancestor
111104269|NCT02384135|Coagulants|coagulants|mesh-ancestor
111104270|NCT02380625|Azithromycin|azithromycin|mesh-list
111104271|NCT02380625|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111104272|NCT02380625|Sunitinib|sunitinib|mesh-list
111104273|NCT02380625|Irbesartan|irbesartan|mesh-list
111104274|NCT02380625|Atorvastatin|atorvastatin|mesh-list
111104275|NCT02380625|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111104276|NCT02380625|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111104277|NCT02380625|Antimetabolites|antimetabolites|mesh-ancestor
111104278|NCT02380625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111104279|NCT02380625|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111104280|NCT02380625|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111104281|NCT02380625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111104282|NCT02380625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111104283|NCT02380625|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111104284|NCT02380625|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111104285|NCT02380625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111104286|NCT02380625|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111104287|NCT02380625|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111104288|NCT02380625|Growth Substances|growth substances|mesh-ancestor
111104289|NCT02380625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111489701|NCT04518228|Darunavir|darunavir|mesh-list
111104290|NCT02380625|Growth Inhibitors|growth inhibitors|mesh-ancestor
111104291|NCT02380625|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111104292|NCT02380625|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111104293|NCT02380625|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111489702|NCT04518228|Tenofovir|tenofovir|mesh-list
111489703|NCT04518228|Dolutegravir|dolutegravir|mesh-list
111489704|NCT04518228|Cobicistat|cobicistat|mesh-list
111104294|NCT02380313|Prednisone|prednisone|mesh-list
111104295|NCT02380313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111104296|NCT02380313|Glucocorticoids|glucocorticoids|mesh-ancestor
111104297|NCT02380313|Hormones|hormones|mesh-ancestor
111104298|NCT02380313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111104299|NCT02380313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111104300|NCT02380313|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111104301|NCT02380313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111104302|NCT01625182|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
111104303|NCT01625182|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
111104304|NCT01625182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110821386|NCT02306278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111104305|NCT01625182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111104306|NCT01625182|Immunologic Factors|immunologic factors|mesh-ancestor
111104307|NCT01625182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111104308|NCT02383901|Methotrexate|methotrexate|mesh-list
111104309|NCT02383901|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111104310|NCT02383901|Abortifacient Agents|abortifacient agents|mesh-ancestor
111104311|NCT02383901|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111104312|NCT02383901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111104313|NCT02383901|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111104314|NCT02383901|Antimetabolites|antimetabolites|mesh-ancestor
111104315|NCT02383901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110647037|NCT00482690|Nicotine|nicotine|mesh-list
111104316|NCT02383901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111104317|NCT02383901|Dermatologic Agents|dermatologic agents|mesh-ancestor
111104318|NCT02383901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111104319|NCT02383901|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111104320|NCT02383901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111104321|NCT02383901|Immunologic Factors|immunologic factors|mesh-ancestor
111104322|NCT02383901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111104323|NCT02383901|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111104324|NCT02383823|Estradiol|estradiol|mesh-list
111104325|NCT02383823|Estrogens|estrogens|mesh-list
111104326|NCT02383823|Hormones|hormones|mesh-ancestor
111104327|NCT02383823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111104328|NCT02383823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111104329|NCT02380001|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
111104330|NCT02380001|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111104331|NCT02380001|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111104332|NCT02380001|Analgesics|analgesics|mesh-ancestor
111104333|NCT02380001|Sensory System Agents|sensory system agents|mesh-ancestor
111104334|NCT02380001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111104335|NCT02380001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111104336|NCT02380001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111104337|NCT02380001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111104338|NCT02379767|Harmine|harmine|mesh-list
111104339|NCT02379767|Hallucinogens|hallucinogens|mesh-ancestor
111104340|NCT02379767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111104341|NCT02379767|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111104342|NCT02379767|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
111104343|NCT02379767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111104344|NCT02379767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111104345|NCT02661815|Paclitaxel|paclitaxel|mesh-list
111104346|NCT02661815|Bevacizumab|bevacizumab|mesh-list
111104347|NCT02661815|Ricolinostat|ricolinostat|mesh-list
111104348|NCT02661815|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111104349|NCT02661815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111104350|NCT02661815|Tubulin Modulators|tubulin modulators|mesh-ancestor
111104351|NCT02661815|Antimitotic Agents|antimitotic agents|mesh-ancestor
111104352|NCT02661815|Mitosis Modulators|mitosis modulators|mesh-ancestor
111104353|NCT02661815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111104354|NCT02661815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111104355|NCT02661815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111104356|NCT02661815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111104357|NCT02661815|Growth Substances|growth substances|mesh-ancestor
111104358|NCT02661815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111104359|NCT02661815|Growth Inhibitors|growth inhibitors|mesh-ancestor
111104360|NCT02661815|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111104361|NCT02661815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111104362|NCT02377193|Mycophenolic Acid|mycophenolic acid|mesh-list
111104363|NCT02377193|Tacrolimus|tacrolimus|mesh-list
111104364|NCT02377193|Basiliximab|basiliximab|mesh-list
110828157|NCT01178047|Rasagiline|rasagiline|mesh-list
111489705|NCT04518228|Cabotegravir|cabotegravir|mesh-list
111489706|NCT04518228|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111104365|NCT02377193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111104366|NCT02377193|Immunologic Factors|immunologic factors|mesh-ancestor
111104367|NCT02377193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111104368|NCT02377193|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111104369|NCT02377193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111104370|NCT02377193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111104371|NCT02377193|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111104372|NCT02377193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111104373|NCT02377193|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111104374|NCT02377193|Antitubercular Agents|antitubercular agents|mesh-ancestor
111104375|NCT02377193|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111104376|NCT02377193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111104377|NCT04688021|Cytarabine|cytarabine|mesh-list
111104378|NCT04688021|Cyclosporine|cyclosporine|mesh-list
111104379|NCT04688021|Mycophenolic Acid|mycophenolic acid|mesh-list
111104380|NCT04688021|Cyclophosphamide|cyclophosphamide|mesh-list
111104381|NCT04688021|Busulfan|busulfan|mesh-list
111104382|NCT04688021|Cyclosporins|cyclosporins|mesh-list
111104383|NCT04688021|Antilymphocyte Serum|antilymphocyte serum|mesh-list
111104384|NCT04688021|Thymoglobulin|thymoglobulin|mesh-list
111104385|NCT04688021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111104386|NCT04688021|Immunologic Factors|immunologic factors|mesh-ancestor
111104387|NCT04688021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111104388|NCT04688021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111104389|NCT04688021|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111104390|NCT04688021|Alkylating Agents|alkylating agents|mesh-ancestor
111104391|NCT04688021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111104392|NCT04688021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111104393|NCT04688021|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111104394|NCT04688021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111104395|NCT04688021|Antimetabolites|antimetabolites|mesh-ancestor
111104396|NCT04688021|Antiviral Agents|antiviral agents|mesh-ancestor
111104397|NCT04688021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111104398|NCT04688021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111104399|NCT04688021|Antifungal Agents|antifungal agents|mesh-ancestor
111104400|NCT04688021|Dermatologic Agents|dermatologic agents|mesh-ancestor
111104401|NCT04688021|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111104402|NCT04688021|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111104403|NCT04688021|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111104404|NCT04688021|Antitubercular Agents|antitubercular agents|mesh-ancestor
111104405|NCT04688021|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111104406|NCT02053246|Nebivolol|nebivolol|mesh-list
111104407|NCT02053246|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111104408|NCT02053246|Vasodilator Agents|vasodilator agents|mesh-ancestor
111104409|NCT02053246|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
111104410|NCT02053246|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111104411|NCT02053246|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111104412|NCT02053246|Adrenergic Agents|adrenergic agents|mesh-ancestor
111104413|NCT02053246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111104414|NCT02053246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111104415|NCT02053246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111104416|NCT04678661|Insulin|insulin|mesh-list
111104417|NCT04678661|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111104418|NCT04678661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111104419|NCT02379299|Hormones|hormones|mesh-list
111104420|NCT02379299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111104421|NCT02379299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111104422|NCT02376881|Epoetin Alfa|epoetin alfa|mesh-list
111104423|NCT02376881|Hematinics|hematinics|mesh-ancestor
111104424|NCT02032888|Sofosbuvir|sofosbuvir|mesh-list
111104425|NCT02032888|Antiviral Agents|antiviral agents|mesh-ancestor
111104426|NCT02032888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111104427|NCT02376803|Warfarin|warfarin|mesh-list
111104428|NCT02376803|Anticoagulants|anticoagulants|mesh-ancestor
111104429|NCT04132427|Vancomycin|vancomycin|mesh-list
111104430|NCT04132427|Magnesium citrate|magnesium citrate|mesh-list
111104431|NCT04132427|Citric Acid|citric acid|mesh-list
111104432|NCT04132427|Sodium Citrate|sodium citrate|mesh-list
111104433|NCT04132427|Anticoagulants|anticoagulants|mesh-ancestor
111104434|NCT04132427|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
111104435|NCT04132427|Chelating Agents|chelating agents|mesh-ancestor
111104436|NCT04132427|Sequestering Agents|sequestering agents|mesh-ancestor
111104437|NCT04132427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111104438|NCT04132427|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111104439|NCT04132427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111104440|NCT04132427|Cathartics|cathartics|mesh-ancestor
111489707|NCT04518228|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111104442|NCT02031640|Beclomethasone|beclomethasone|mesh-list
111104443|NCT02031640|Albuterol|albuterol|mesh-list
111104444|NCT02031640|Bronchodilator Agents|bronchodilator agents|mesh-list
111104445|NCT02031640|Autonomic Agents|autonomic agents|mesh-ancestor
111104446|NCT02031640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111104447|NCT02031640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111104448|NCT02031640|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111104449|NCT02031640|Respiratory System Agents|respiratory system agents|mesh-ancestor
111104450|NCT02031640|Tocolytic Agents|tocolytic agents|mesh-ancestor
111104451|NCT02031640|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111104452|NCT02031640|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111104453|NCT02031640|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111104454|NCT02031640|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111104455|NCT02031640|Adrenergic Agents|adrenergic agents|mesh-ancestor
110821541|NCT01141153|Antipyretics|antipyretics|mesh-ancestor
111104456|NCT02031640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111104457|NCT02031640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111104458|NCT02031640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111104459|NCT02031640|Glucocorticoids|glucocorticoids|mesh-ancestor
111104460|NCT02031640|Hormones|hormones|mesh-ancestor
111104461|NCT02031640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111104462|NCT02376413|Trastuzumab|trastuzumab|mesh-list
111104463|NCT02376413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111104464|NCT02376413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111104465|NCT02378441|Metformin|metformin|mesh-list
111104466|NCT02378441|Atorvastatin|atorvastatin|mesh-list
111104467|NCT02378441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111104468|NCT02378441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111104469|NCT02378441|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111104470|NCT02378441|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111104471|NCT02378441|Antimetabolites|antimetabolites|mesh-ancestor
111104472|NCT02378441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111104473|NCT02378441|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111104474|NCT02378441|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111104475|NCT02378441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111104476|NCT04600427|Anesthetics|anesthetics|mesh-list
111104477|NCT04600427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111104478|NCT04600427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111104479|NCT02378129|Methamphetamine|methamphetamine|mesh-list
111104480|NCT02378129|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111104481|NCT02378129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111104482|NCT02378129|Sympathomimetics|sympathomimetics|mesh-ancestor
111104483|NCT02378129|Autonomic Agents|autonomic agents|mesh-ancestor
111104484|NCT02378129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111104485|NCT02378129|Dopamine Agents|dopamine agents|mesh-ancestor
111104486|NCT02378129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111104487|NCT02378129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111104488|NCT02378129|Adrenergic Agents|adrenergic agents|mesh-ancestor
111104489|NCT02378129|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111104490|NCT02378129|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111104491|NCT02378129|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111104492|NCT02378129|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111104493|NCT02376335|Rituximab|rituximab|mesh-list
111104494|NCT02376335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111104495|NCT02376335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111104496|NCT02376335|Immunologic Factors|immunologic factors|mesh-ancestor
111104497|NCT02376335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111104498|NCT02376335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111104499|NCT02375867|Methylprednisolone|methylprednisolone|mesh-list
111104500|NCT02375867|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111104501|NCT02375867|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111104502|NCT02375867|Prednisolone|prednisolone|mesh-list
111104503|NCT02375867|Prednisolone acetate|prednisolone acetate|mesh-list
111104504|NCT02375867|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111104505|NCT02375867|Prednisolone phosphate|prednisolone phosphate|mesh-list
111104506|NCT02375867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111104507|NCT02375867|Antiemetics|antiemetics|mesh-ancestor
111104508|NCT02375867|Autonomic Agents|autonomic agents|mesh-ancestor
111104509|NCT02375867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111104510|NCT02375867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111489708|NCT04518228|Protease Inhibitors|protease inhibitors|mesh-ancestor
111489709|NCT04518228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111104511|NCT02375867|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111104512|NCT02375867|Glucocorticoids|glucocorticoids|mesh-ancestor
111104513|NCT02375867|Hormones|hormones|mesh-ancestor
111104514|NCT02375867|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111104515|NCT02375867|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111104516|NCT02375867|Protective Agents|protective agents|mesh-ancestor
111104517|NCT02375867|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111104518|NCT02375867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111104519|NCT04540133|Dexamethasone|dexamethasone|mesh-list
111104520|NCT04540133|Dexamethasone acetate|dexamethasone acetate|mesh-list
111104521|NCT04540133|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111104522|NCT04540133|BB 1101|bb 1101|mesh-list
111104523|NCT04540133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111104524|NCT04540133|Antiemetics|antiemetics|mesh-ancestor
111104525|NCT04540133|Autonomic Agents|autonomic agents|mesh-ancestor
111104526|NCT04540133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111104527|NCT04540133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111104528|NCT04540133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111104529|NCT04540133|Glucocorticoids|glucocorticoids|mesh-ancestor
111104530|NCT04540133|Hormones|hormones|mesh-ancestor
111104531|NCT04540133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111104532|NCT04540133|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111104533|NCT04540133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111104535|NCT04540133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111104536|NCT04540133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111104537|NCT02375243|Dexmedetomidine|dexmedetomidine|mesh-list
111104538|NCT02375243|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111104539|NCT02375243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111104540|NCT02375243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111104541|NCT02375243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111104542|NCT02375243|Analgesics|analgesics|mesh-ancestor
111104543|NCT02375243|Sensory System Agents|sensory system agents|mesh-ancestor
111104544|NCT02375243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111104545|NCT02375243|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111104546|NCT02375243|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111104547|NCT02375243|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111104548|NCT02375243|Adrenergic Agents|adrenergic agents|mesh-ancestor
111104549|NCT02375243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111104550|NCT02375243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111104551|NCT02374931|Estradiol|estradiol|mesh-list
111104552|NCT02374931|Estrogens|estrogens|mesh-ancestor
111104553|NCT02374931|Hormones|hormones|mesh-ancestor
111104554|NCT02374931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111104555|NCT02374931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111104556|NCT02377661|Amlodipine|amlodipine|mesh-list
111104557|NCT02377661|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
111104558|NCT02377661|Olmesartan|olmesartan|mesh-list
111104559|NCT02377661|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
111104560|NCT02377661|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111104561|NCT02377661|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111104562|NCT02377661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111104563|NCT02377661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111104564|NCT02377661|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111104565|NCT02377661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111104566|NCT02377661|Vasodilator Agents|vasodilator agents|mesh-ancestor
111104567|NCT02377661|Diuretics|diuretics|mesh-ancestor
111104568|NCT02377661|Natriuretic Agents|natriuretic agents|mesh-ancestor
111104569|NCT02377661|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
111104570|NCT02377661|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111104571|NCT02377661|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111104572|NCT02372357|Posaconazole|posaconazole|mesh-list
111104573|NCT02372357|Antifungal Agents|antifungal agents|mesh-ancestor
111104574|NCT02372357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111104575|NCT02372357|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
111104576|NCT02372357|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111104577|NCT02372357|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111104578|NCT02372357|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111104579|NCT02372357|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111104580|NCT02372357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111104581|NCT02372357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111104582|NCT02372357|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111104583|NCT02372357|Hormone Antagonists|hormone antagonists|mesh-ancestor
111104584|NCT02372357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111489710|NCT04518228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111104585|NCT02372357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111104586|NCT03672773|Temozolomide|temozolomide|mesh-list
111104587|NCT03672773|Talazoparib|talazoparib|mesh-list
111104588|NCT03672773|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111104589|NCT03672773|Alkylating Agents|alkylating agents|mesh-ancestor
111104590|NCT03672773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111104591|NCT03672773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111104592|NCT03672773|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111104593|NCT03672773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111104594|NCT03625349|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
111104595|NCT03625349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111104596|NCT03625349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111104597|NCT02371577|Lenalidomide|lenalidomide|mesh-list
111104598|NCT02371577|Immunologic Factors|immunologic factors|mesh-ancestor
111104599|NCT02371577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111104600|NCT02371577|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110821685|NCT04462666|Etoricoxib|etoricoxib|mesh-list
111104601|NCT02371577|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111104602|NCT02371577|Growth Substances|growth substances|mesh-ancestor
111104603|NCT02371577|Growth Inhibitors|growth inhibitors|mesh-ancestor
111104604|NCT02371577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111104605|NCT02373449|Ketamine|ketamine|mesh-list
111104606|NCT02373449|Analgesics|analgesics|mesh-ancestor
111104607|NCT02373449|Sensory System Agents|sensory system agents|mesh-ancestor
111104608|NCT02373449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111104609|NCT02373449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111104610|NCT02373449|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111104611|NCT02373449|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111104612|NCT02373449|Anesthetics, General|anesthetics, general|mesh-ancestor
111104613|NCT02373449|Anesthetics|anesthetics|mesh-ancestor
111104614|NCT02373449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111104615|NCT02373449|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111104616|NCT02373449|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111104617|NCT02373449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111104618|NCT02373449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111104619|NCT02371421|Allopurinol|allopurinol|mesh-list
111104620|NCT02371421|Antimetabolites|antimetabolites|mesh-ancestor
111104621|NCT02371421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111104622|NCT02371421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111104623|NCT02371421|Gout Suppressants|gout suppressants|mesh-ancestor
111104624|NCT02371421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111104625|NCT02371421|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111104626|NCT02371421|Antioxidants|antioxidants|mesh-ancestor
111104627|NCT02371421|Protective Agents|protective agents|mesh-ancestor
111104628|NCT02371421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111104629|NCT02371031|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
111104630|NCT02371031|Dopamine Agents|dopamine agents|mesh-ancestor
111104631|NCT02371031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111104632|NCT02371031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111104633|NCT02371031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111104634|NCT03959891|Letrozole|letrozole|mesh-list
111104635|NCT03959891|Fulvestrant|fulvestrant|mesh-list
111104636|NCT03959891|Palbociclib|palbociclib|mesh-list
111104637|NCT03959891|Ipatasertib|ipatasertib|mesh-list
111104638|NCT03959891|Aromatase Inhibitors|aromatase inhibitors|mesh-list
111104639|NCT03959891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111104640|NCT03959891|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111104641|NCT03959891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111104642|NCT03959891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110647071|NCT00004197|Hormones|hormones|mesh-ancestor
111104643|NCT03959891|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111104644|NCT03959891|Hormone Antagonists|hormone antagonists|mesh-ancestor
111104645|NCT03959891|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111104646|NCT03959891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111104647|NCT03959891|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111104648|NCT03959891|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
111104649|NCT03959891|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111104650|NCT02373215|Nalbuphine|nalbuphine|mesh-list
111104651|NCT02373215|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111104652|NCT02373215|Narcotics|narcotics|mesh-ancestor
111104653|NCT02373215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111104654|NCT02373215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111489711|NCT04518228|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111489712|NCT04518228|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111489713|NCT04518228|Antiviral Agents|antiviral agents|mesh-ancestor
111104655|NCT02373215|Analgesics|analgesics|mesh-ancestor
111104656|NCT02373215|Sensory System Agents|sensory system agents|mesh-ancestor
111104657|NCT02373215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111104658|NCT03785249|Pembrolizumab|pembrolizumab|mesh-list
111104659|NCT03785249|Cetuximab|cetuximab|mesh-list
111104660|NCT03785249|Afatinib|afatinib|mesh-list
111104661|NCT03785249|Adagrasib|adagrasib|mesh-list
111104662|NCT03785249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111104663|NCT03785249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111104664|NCT03785249|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111104665|NCT03785249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111104666|NCT03785249|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111104667|NCT03785249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111104668|NCT02372903|Palmidrol|palmidrol|mesh-list
111104669|NCT02372903|Analgesics|analgesics|mesh-ancestor
111104670|NCT02372903|Sensory System Agents|sensory system agents|mesh-ancestor
111104671|NCT02372903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111104672|NCT02372903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111104673|NCT02372903|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111104674|NCT02372903|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111104675|NCT02372903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111104676|NCT02372903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111104677|NCT02372903|Antiviral Agents|antiviral agents|mesh-ancestor
111104678|NCT02372903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111104679|NCT02372903|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
111104680|NCT02372903|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
111104681|NCT02372903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111104682|NCT02372903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111104683|NCT02372903|Hormones|hormones|mesh-ancestor
111104684|NCT02372903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111104685|NCT02372591|Buprenorphine|buprenorphine|mesh-list
111104686|NCT02372591|Hydromorphone|hydromorphone|mesh-list
111104687|NCT02372591|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111104688|NCT02372591|Narcotics|narcotics|mesh-ancestor
111104689|NCT02372591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111104690|NCT02372591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111104691|NCT02372591|Analgesics|analgesics|mesh-ancestor
111104692|NCT02372591|Sensory System Agents|sensory system agents|mesh-ancestor
111104693|NCT02372591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111104694|NCT02372591|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111104695|NCT02372669|Chitosan|chitosan|mesh-list
111104696|NCT02372669|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111104697|NCT02372669|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111104698|NCT02372669|Antimetabolites|antimetabolites|mesh-ancestor
111104699|NCT02372669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111104700|NCT02372669|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111104701|NCT02372669|Chelating Agents|chelating agents|mesh-ancestor
111104702|NCT02372669|Sequestering Agents|sequestering agents|mesh-ancestor
111104703|NCT02372669|Hemostatics|hemostatics|mesh-ancestor
111104704|NCT02372669|Coagulants|coagulants|mesh-ancestor
111104705|NCT02369861|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111104706|NCT02369861|Lubricant Eye Drops|lubricant eye drops|mesh-list
111104707|NCT02369861|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111104708|NCT02369939|Fluorouracil|fluorouracil|mesh-list
111104709|NCT02369939|Mitomycins|mitomycins|mesh-list
111104710|NCT02369939|Mitomycin|mitomycin|mesh-list
111104711|NCT02369939|Antimetabolites|antimetabolites|mesh-ancestor
111104712|NCT02369939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111104713|NCT02369939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111104714|NCT02369939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111104715|NCT02369939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111104716|NCT02369939|Immunologic Factors|immunologic factors|mesh-ancestor
111104717|NCT02369939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111104718|NCT02369939|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111104719|NCT02369939|Alkylating Agents|alkylating agents|mesh-ancestor
111104720|NCT02369939|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111104721|NCT02369939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111104722|NCT02369549|Curcumin|curcumin|mesh-list
111104723|NCT02369549|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111104724|NCT02369549|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111489714|NCT04518228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111489715|NCT04518228|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111104725|NCT02369549|Analgesics|analgesics|mesh-ancestor
111104726|NCT02369549|Sensory System Agents|sensory system agents|mesh-ancestor
110697859|NCT03980223|Doxycycline|doxycycline|mesh-list
111104727|NCT02369549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111104728|NCT02369549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111104729|NCT02369549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111104730|NCT02369549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111104731|NCT02369549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111104732|NCT02369549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111104733|NCT02369549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111104734|NCT02365415|Sirolimus|sirolimus|mesh-list
111104735|NCT02365415|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111104736|NCT02365415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111104737|NCT02365415|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111104738|NCT02365415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111104739|NCT02365415|Antifungal Agents|antifungal agents|mesh-ancestor
111104740|NCT02365415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111104741|NCT02365415|Immunologic Factors|immunologic factors|mesh-ancestor
111104742|NCT02365415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111104743|NCT02369081|Bisoprolol|bisoprolol|mesh-list
111104744|NCT02369081|Doxazosin|doxazosin|mesh-list
111104745|NCT02369081|Spironolactone|spironolactone|mesh-list
111104746|NCT02369081|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
111104747|NCT02369081|Hormone Antagonists|hormone antagonists|mesh-ancestor
111104748|NCT02369081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111104749|NCT02369081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111104750|NCT02369081|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
111104751|NCT02369081|Diuretics|diuretics|mesh-ancestor
111104752|NCT02369081|Natriuretic Agents|natriuretic agents|mesh-ancestor
111104753|NCT02369081|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111104754|NCT02369081|Sympatholytics|sympatholytics|mesh-ancestor
111104755|NCT02369081|Autonomic Agents|autonomic agents|mesh-ancestor
111104756|NCT02369081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111104757|NCT02369081|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
111104758|NCT02369081|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111104759|NCT02369081|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111104760|NCT02369081|Adrenergic Agents|adrenergic agents|mesh-ancestor
111104761|NCT02369081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111104762|NCT02369081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111104763|NCT02369081|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111104764|NCT02369081|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111104765|NCT02365493|Cefazolin|cefazolin|mesh-list
111104766|NCT02365493|Lactams|lactams|mesh-list
111104767|NCT02365493|beta-Lactams|beta-lactams|mesh-list
111104768|NCT02365493|Floxacillin|floxacillin|mesh-list
111104769|NCT02365493|Cloxacillin|cloxacillin|mesh-list
111104770|NCT02365493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111104771|NCT02365493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111104772|NCT02365181|Ropivacaine|ropivacaine|mesh-list
111104773|NCT02365181|Anesthetics, Local|anesthetics, local|mesh-list
111104774|NCT02365181|Anesthetics|anesthetics|mesh-list
111104775|NCT02365181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111104776|NCT02365181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111104777|NCT02365181|Sensory System Agents|sensory system agents|mesh-ancestor
111104778|NCT02365181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111104779|NCT05653895|Metformin|metformin|mesh-list
111104780|NCT05653895|Resveratrol|resveratrol|mesh-list
111104781|NCT05653895|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111104782|NCT05653895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111104783|NCT05653895|Antioxidants|antioxidants|mesh-ancestor
111104784|NCT05653895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111104785|NCT05653895|Protective Agents|protective agents|mesh-ancestor
111104786|NCT05653895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111104787|NCT05653895|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111104788|NCT02364479|Etanercept|etanercept|mesh-list
111104789|NCT02364479|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111104790|NCT02364479|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111104791|NCT02364479|Analgesics|analgesics|mesh-ancestor
111104792|NCT02364479|Sensory System Agents|sensory system agents|mesh-ancestor
111104793|NCT02364479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111104794|NCT02364479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111104795|NCT02364479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111104796|NCT02364479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111489716|NCT04518228|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111489717|NCT04518228|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111489718|NCT04518228|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111489719|NCT04518228|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110697862|NCT03980223|Antimalarials|antimalarials|mesh-ancestor
111104797|NCT02364479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111104798|NCT02364479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111104799|NCT02364479|Immunologic Factors|immunologic factors|mesh-ancestor
111104800|NCT05653817|Paclitaxel|paclitaxel|mesh-list
111104801|NCT05653817|Apatinib|apatinib|mesh-list
111104802|NCT05653817|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111104803|NCT05653817|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111104804|NCT05653817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111104805|NCT05653817|Tubulin Modulators|tubulin modulators|mesh-ancestor
111104806|NCT05653817|Antimitotic Agents|antimitotic agents|mesh-ancestor
111104807|NCT05653817|Mitosis Modulators|mitosis modulators|mesh-ancestor
111104808|NCT05653817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111104809|NCT05653817|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111104810|NCT05653817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111104811|NCT02052310|Epoetin Alfa|epoetin alfa|mesh-list
111104812|NCT02052310|Hematinics|hematinics|mesh-ancestor
111104813|NCT02368379|Metyrapone|metyrapone|mesh-list
111104814|NCT02368379|Antimetabolites|antimetabolites|mesh-ancestor
111104815|NCT02368379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111104816|NCT02368379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111104817|NCT02051296|Minocycline|minocycline|mesh-list
111104818|NCT02051296|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111104819|NCT02051296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111104820|NCT02367755|Lorazepam|lorazepam|mesh-list
111104821|NCT02367755|Propofol|propofol|mesh-list
111104822|NCT02367755|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111104823|NCT02367755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110821914|NCT01351298|Nasal Decongestants|nasal decongestants|mesh-ancestor
111104824|NCT02367755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111104825|NCT02367755|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111104826|NCT02367755|Anesthetics, General|anesthetics, general|mesh-ancestor
111104827|NCT02367755|Anesthetics|anesthetics|mesh-ancestor
111104828|NCT02367755|Anticonvulsants|anticonvulsants|mesh-ancestor
111104830|NCT02367755|Autonomic Agents|autonomic agents|mesh-ancestor
111104831|NCT02367755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111104832|NCT02367755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111104833|NCT02367755|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111104834|NCT02367755|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111104835|NCT02367755|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111104836|NCT02367755|GABA Modulators|gaba modulators|mesh-ancestor
111104837|NCT02367755|GABA Agents|gaba agents|mesh-ancestor
111104838|NCT02367755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111104839|NCT02367755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111104840|NCT02363699|Lidocaine|lidocaine|mesh-list
111104841|NCT02363699|Anesthetics, Local|anesthetics, local|mesh-ancestor
111104842|NCT02363699|Anesthetics|anesthetics|mesh-ancestor
111104843|NCT02363699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111104844|NCT02363699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111104845|NCT02363699|Sensory System Agents|sensory system agents|mesh-ancestor
111104846|NCT02363699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111104847|NCT02363699|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111104848|NCT02363699|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111104849|NCT02363699|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111104850|NCT02363699|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111104851|NCT02363699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111104852|NCT02049814|Metformin|metformin|mesh-list
111104853|NCT02049814|Acarbose|acarbose|mesh-list
111104854|NCT02049814|Voglibose|voglibose|mesh-list
111104855|NCT02049814|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111104856|NCT02049814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111104857|NCT02049814|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
111104858|NCT02049814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111104859|NCT02049814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111489720|NCT04518228|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111489721|NCT03729258|Amantadine|amantadine|mesh-list
111489722|NCT03729258|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111489723|NCT03729258|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111489724|NCT03729258|Antiviral Agents|antiviral agents|mesh-ancestor
111489725|NCT03729258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111489726|NCT03729258|Dopamine Agents|dopamine agents|mesh-ancestor
111489727|NCT03729258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111489728|NCT03729258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111489729|NCT03729258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111104860|NCT03344159|Spironolactone|spironolactone|mesh-list
111104861|NCT03344159|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
111104862|NCT03344159|Hormone Antagonists|hormone antagonists|mesh-ancestor
110697872|NCT00402168|Cyclosporine|cyclosporine|mesh-list
111489730|NCT03729258|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111104863|NCT03344159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111104864|NCT03344159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111104865|NCT03344159|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
111104866|NCT03344159|Diuretics|diuretics|mesh-ancestor
111104867|NCT03344159|Natriuretic Agents|natriuretic agents|mesh-ancestor
111104868|NCT03324113|Diphenhydramine|diphenhydramine|mesh-list
111104869|NCT03324113|Promethazine|promethazine|mesh-list
111104870|NCT03324113|Dexamethasone|dexamethasone|mesh-list
111104871|NCT03324113|Naphazoline|naphazoline|mesh-list
111104872|NCT03324113|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111104873|NCT03324113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111104874|NCT03324113|Antiemetics|antiemetics|mesh-ancestor
111104875|NCT03324113|Autonomic Agents|autonomic agents|mesh-ancestor
111104876|NCT03324113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111104877|NCT03324113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111104878|NCT03324113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111104879|NCT03324113|Glucocorticoids|glucocorticoids|mesh-ancestor
111104880|NCT03324113|Hormones|hormones|mesh-ancestor
111104881|NCT03324113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111104882|NCT03324113|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111104883|NCT03324113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111104884|NCT03324113|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111104885|NCT03324113|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111104886|NCT03324113|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111104887|NCT03324113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111104888|NCT03324113|Anesthetics, Local|anesthetics, local|mesh-ancestor
111104889|NCT03324113|Anesthetics|anesthetics|mesh-ancestor
111104890|NCT03324113|Sensory System Agents|sensory system agents|mesh-ancestor
111104891|NCT03324113|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111104892|NCT03324113|Histamine Antagonists|histamine antagonists|mesh-ancestor
111104893|NCT03324113|Histamine Agents|histamine agents|mesh-ancestor
111104894|NCT03324113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111104895|NCT03324113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111104896|NCT03324113|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111104897|NCT03324113|Antipruritics|antipruritics|mesh-ancestor
111104898|NCT03324113|Dermatologic Agents|dermatologic agents|mesh-ancestor
111104899|NCT03324113|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111104900|NCT03324113|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111104901|NCT03324113|Adrenergic Agents|adrenergic agents|mesh-ancestor
111104902|NCT03324113|Nasal Decongestants|nasal decongestants|mesh-ancestor
111104903|NCT03324113|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111104904|NCT03324113|Respiratory System Agents|respiratory system agents|mesh-ancestor
111104905|NCT02079844|Antipsychotic Agents|antipsychotic agents|mesh-list
111104906|NCT02079844|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111104907|NCT02079844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111104908|NCT02079844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111104909|NCT02079844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111104910|NCT02363075|Dextroamphetamine|dextroamphetamine|mesh-list
111104911|NCT02363075|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111104912|NCT02363075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111104913|NCT02363075|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111104914|NCT02363075|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111104915|NCT02363075|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111104916|NCT02363075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111104917|NCT02363075|Dopamine Agents|dopamine agents|mesh-ancestor
111104918|NCT02363075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111104919|NCT02367053|Glucagon|glucagon|mesh-list
111104920|NCT02367053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111104921|NCT02367053|Hormones|hormones|mesh-ancestor
111104922|NCT02367053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111104923|NCT02367053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111104924|NCT04417114|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111104925|NCT04417114|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111104926|NCT04417114|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111104927|NCT04417114|Antimetabolites|antimetabolites|mesh-ancestor
111104928|NCT04417114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111104929|NCT04417114|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111104930|NCT04417114|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111104931|NCT04417114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111104932|NCT02366975|Testosterone|testosterone|mesh-list
111104933|NCT02366975|Androgens|androgens|mesh-ancestor
111489731|NCT03729258|Analgesics|analgesics|mesh-ancestor
111104934|NCT02366975|Hormones|hormones|mesh-ancestor
111489732|NCT03729258|Sensory System Agents|sensory system agents|mesh-ancestor
111104935|NCT02366975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111104936|NCT02366975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111104937|NCT04479371|Bupivacaine|bupivacaine|mesh-list
111104938|NCT04479371|Anesthetics, Local|anesthetics, local|mesh-ancestor
111104939|NCT04479371|Anesthetics|anesthetics|mesh-ancestor
111104940|NCT04479371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111104941|NCT04479371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111104942|NCT04479371|Sensory System Agents|sensory system agents|mesh-ancestor
111104943|NCT04479371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111104944|NCT03112655|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
111104945|NCT03112655|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111104946|NCT03112655|Antidepressive Agents|antidepressive agents|mesh-ancestor
111104947|NCT03112655|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111104948|NCT02366585|Cyclosporine|cyclosporine|mesh-list
111104949|NCT02366585|Cyclosporins|cyclosporins|mesh-list
111104950|NCT02366585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111104951|NCT02366585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111104952|NCT02366585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111104953|NCT02366585|Immunologic Factors|immunologic factors|mesh-ancestor
111104954|NCT02366585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111104955|NCT02366585|Antifungal Agents|antifungal agents|mesh-ancestor
111104956|NCT02366585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111104957|NCT02366585|Dermatologic Agents|dermatologic agents|mesh-ancestor
111104958|NCT02366585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111104959|NCT02366585|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111104960|NCT02079532|Rituximab|rituximab|mesh-list
111104961|NCT02079532|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111104962|NCT02079532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111104963|NCT02079532|Immunologic Factors|immunologic factors|mesh-ancestor
111104964|NCT02079532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111104965|NCT02079532|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111104966|NCT02958917|Pirfenidone|pirfenidone|mesh-list
111104967|NCT02958917|Analgesics|analgesics|mesh-ancestor
111104968|NCT02958917|Sensory System Agents|sensory system agents|mesh-ancestor
111104969|NCT02958917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111104970|NCT02958917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111104971|NCT02958917|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111104972|NCT02958917|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111104973|NCT02958917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111104974|NCT02958917|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111104975|NCT02958917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111104976|NCT02362529|Minocycline|minocycline|mesh-list
111104977|NCT02362529|Celecoxib|celecoxib|mesh-list
111104978|NCT02362529|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111104979|NCT02362529|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111104980|NCT02362529|Analgesics|analgesics|mesh-ancestor
111104981|NCT02362529|Sensory System Agents|sensory system agents|mesh-ancestor
111104982|NCT02362529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111104983|NCT02362529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111104984|NCT02362529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111104985|NCT02362529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111104986|NCT02362529|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111104987|NCT02362529|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111104988|NCT02362529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111104989|NCT02362529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111104990|NCT02362529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111104991|NCT02362529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111104992|NCT02769689|Methylprednisolone|methylprednisolone|mesh-list
111104993|NCT02769689|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111104994|NCT02769689|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111104995|NCT02769689|Prednisolone|prednisolone|mesh-list
111104996|NCT02769689|Prednisolone acetate|prednisolone acetate|mesh-list
111104997|NCT02769689|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111104998|NCT02769689|Prednisolone phosphate|prednisolone phosphate|mesh-list
111104999|NCT02769689|Natalizumab|natalizumab|mesh-list
111105000|NCT02769689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111105001|NCT02769689|Antiemetics|antiemetics|mesh-ancestor
111105002|NCT02769689|Autonomic Agents|autonomic agents|mesh-ancestor
111105003|NCT02769689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111105004|NCT02769689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111105005|NCT02769689|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111105006|NCT02769689|Glucocorticoids|glucocorticoids|mesh-ancestor
111105007|NCT02769689|Hormones|hormones|mesh-ancestor
111489733|NCT03729258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111489734|NCT03355170|Domperidone|domperidone|mesh-list
111489735|NCT03355170|Lansoprazole|lansoprazole|mesh-list
111489736|NCT03355170|Dexlansoprazole|dexlansoprazole|mesh-list
111105008|NCT02769689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111105009|NCT02769689|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111105010|NCT02769689|Protective Agents|protective agents|mesh-ancestor
111105011|NCT02769689|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111105012|NCT02769689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111105013|NCT02769689|Immunologic Factors|immunologic factors|mesh-ancestor
111105014|NCT02365571|Itraconazole|itraconazole|mesh-list
111105015|NCT02365571|Antifungal Agents|antifungal agents|mesh-ancestor
111105016|NCT02365571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111105017|NCT02365571|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111105018|NCT02365571|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111105019|NCT02365571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111105020|NCT02365571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111105021|NCT02365571|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111105022|NCT02365571|Hormone Antagonists|hormone antagonists|mesh-ancestor
111105023|NCT02365571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111105024|NCT02365571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111105025|NCT02365571|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111105026|NCT02365727|Clonidine|clonidine|mesh-list
111105027|NCT02365727|Epinephrine|epinephrine|mesh-list
111105028|NCT02365727|Bupivacaine|bupivacaine|mesh-list
111105029|NCT02365727|Ropivacaine|ropivacaine|mesh-list
111105030|NCT02365727|Anesthetics, Local|anesthetics, local|mesh-ancestor
110647112|NCT00519831|Cetuximab|cetuximab|mesh-list
111105031|NCT02365727|Anesthetics|anesthetics|mesh-ancestor
111105032|NCT02365727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111105033|NCT02365727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111105034|NCT02365727|Sensory System Agents|sensory system agents|mesh-ancestor
111105035|NCT02365727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111105036|NCT02365727|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111105037|NCT02365727|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111105038|NCT02365727|Adrenergic Agents|adrenergic agents|mesh-ancestor
111105039|NCT02365727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111105040|NCT02365727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111105041|NCT02365727|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111105042|NCT02365727|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111105043|NCT02365727|Autonomic Agents|autonomic agents|mesh-ancestor
111105044|NCT02365727|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111105045|NCT02365727|Respiratory System Agents|respiratory system agents|mesh-ancestor
111105046|NCT02365727|Mydriatics|mydriatics|mesh-ancestor
111105047|NCT02365727|Sympathomimetics|sympathomimetics|mesh-ancestor
111105048|NCT02365727|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111105049|NCT02365727|Analgesics|analgesics|mesh-ancestor
111105050|NCT02365727|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110822133|NCT02441686|Dexamethasone|dexamethasone|mesh-list
111105051|NCT02365727|Sympatholytics|sympatholytics|mesh-ancestor
111105052|NCT02365727|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111105053|NCT02365805|Paclitaxel|paclitaxel|mesh-list
111105054|NCT02365805|Docetaxel|docetaxel|mesh-list
111105055|NCT02365805|Fluorouracil|fluorouracil|mesh-list
111105056|NCT02365805|Epirubicin|epirubicin|mesh-list
111105057|NCT02365805|Cyclophosphamide|cyclophosphamide|mesh-list
111105058|NCT02365805|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111105059|NCT02365805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111105060|NCT02365805|Tubulin Modulators|tubulin modulators|mesh-ancestor
111105061|NCT02365805|Antimitotic Agents|antimitotic agents|mesh-ancestor
111105062|NCT02365805|Mitosis Modulators|mitosis modulators|mesh-ancestor
111105063|NCT02365805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111105064|NCT02365805|Antimetabolites|antimetabolites|mesh-ancestor
111105065|NCT02365805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111105066|NCT02365805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111105067|NCT02365805|Immunologic Factors|immunologic factors|mesh-ancestor
111105068|NCT02365805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111105069|NCT02365805|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111105070|NCT02365805|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111105071|NCT02365805|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111105072|NCT02365805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111105073|NCT02365805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111105074|NCT02365805|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111105075|NCT02365805|Alkylating Agents|alkylating agents|mesh-ancestor
111105076|NCT02365805|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111105077|NCT03112889|Valproic Acid|valproic acid|mesh-list
111105078|NCT03112889|Anticonvulsants|anticonvulsants|mesh-ancestor
111105079|NCT03112889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111105080|NCT03112889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111489737|NCT03355170|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111105081|NCT03112889|GABA Agents|gaba agents|mesh-ancestor
111105082|NCT03112889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111105083|NCT03112889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111105084|NCT03112889|Antimanic Agents|antimanic agents|mesh-ancestor
111105085|NCT03112889|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111105086|NCT03112889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111105087|NCT03112889|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111105088|NCT03112577|Fluticasone|fluticasone|mesh-list
111105090|NCT03112577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111105091|NCT03112577|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111105092|NCT03112577|Autonomic Agents|autonomic agents|mesh-ancestor
110647115|NCT04303845|Erenumab|erenumab|mesh-list
111105093|NCT03112577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111105094|NCT03112577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111105095|NCT03112577|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111105096|NCT03112577|Respiratory System Agents|respiratory system agents|mesh-ancestor
111105097|NCT03112577|Dermatologic Agents|dermatologic agents|mesh-ancestor
111105098|NCT03112577|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111105099|NCT02361905|Leuprolide|leuprolide|mesh-list
111105100|NCT02361905|Ulipristal acetate|ulipristal acetate|mesh-list
111105101|NCT02361905|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111105102|NCT02361905|Fertility Agents|fertility agents|mesh-ancestor
111105103|NCT02361905|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111105104|NCT02361905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111105105|NCT02361905|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111105106|NCT02361905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111105107|NCT02361905|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111105108|NCT02361905|Contraceptive Agents|contraceptive agents|mesh-ancestor
111105109|NCT02361905|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111105110|NCT02361749|Botulinum Toxins|botulinum toxins|mesh-list
111105111|NCT02361749|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111105112|NCT02361749|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111105113|NCT02361749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111105114|NCT02361749|Cholinergic Agents|cholinergic agents|mesh-ancestor
111105115|NCT02361749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111105116|NCT02361749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111105117|NCT04372433|Azacitidine|azacitidine|mesh-list
111105118|NCT04372433|Venetoclax|venetoclax|mesh-list
111105119|NCT04372433|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111105120|NCT04372433|Antimetabolites|antimetabolites|mesh-ancestor
111105121|NCT04372433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111105122|NCT04372433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111105123|NCT04372433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111105124|NCT02358707|Ibuprofen|ibuprofen|mesh-list
111105125|NCT02358707|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111105126|NCT02358707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111105127|NCT02358707|Analgesics|analgesics|mesh-ancestor
111105128|NCT02358707|Sensory System Agents|sensory system agents|mesh-ancestor
111105129|NCT02358707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111105130|NCT02358707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111105131|NCT02358707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111105133|NCT02358707|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111105134|NCT02358707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111105135|NCT02358707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111105136|NCT02360501|Docetaxel|docetaxel|mesh-list
111105137|NCT02360501|Capecitabine|capecitabine|mesh-list
111105138|NCT02360501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111105139|NCT02360501|Tubulin Modulators|tubulin modulators|mesh-ancestor
111105140|NCT02360501|Antimitotic Agents|antimitotic agents|mesh-ancestor
111105141|NCT02360501|Mitosis Modulators|mitosis modulators|mesh-ancestor
111105142|NCT02360501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111105143|NCT02360501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111105144|NCT02360501|Antimetabolites|antimetabolites|mesh-ancestor
111105145|NCT02360423|Sirolimus|sirolimus|mesh-list
111105146|NCT02360423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111105147|NCT02360423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111105148|NCT02360423|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111105149|NCT02360423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111105150|NCT02360423|Antifungal Agents|antifungal agents|mesh-ancestor
111489738|NCT03355170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111489739|NCT03355170|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111489740|NCT03355170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111489741|NCT03355170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111105151|NCT02360423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111105152|NCT02360423|Immunologic Factors|immunologic factors|mesh-ancestor
111105153|NCT02360423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111489742|NCT03355170|Antiemetics|antiemetics|mesh-ancestor
111489743|NCT03355170|Autonomic Agents|autonomic agents|mesh-ancestor
111489744|NCT03355170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111489745|NCT03355170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111489746|NCT03355170|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111105154|NCT02358161|Paclitaxel|paclitaxel|mesh-list
111105155|NCT02358161|Gemcitabine|gemcitabine|mesh-list
111105156|NCT02358161|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111105157|NCT02358161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111105158|NCT02358161|Tubulin Modulators|tubulin modulators|mesh-ancestor
111105159|NCT02358161|Antimitotic Agents|antimitotic agents|mesh-ancestor
111105160|NCT02358161|Mitosis Modulators|mitosis modulators|mesh-ancestor
111105161|NCT02358161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111105162|NCT02358161|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111105163|NCT02358161|Antimetabolites|antimetabolites|mesh-ancestor
111105164|NCT02357849|Aripiprazole|aripiprazole|mesh-list
111105165|NCT02357849|Fluoxetine|fluoxetine|mesh-list
111105166|NCT02357849|Antidepressive Agents|antidepressive agents|mesh-ancestor
111105167|NCT02357849|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111105168|NCT02357849|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111105169|NCT02357849|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111105170|NCT02357849|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111105171|NCT02357849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111105172|NCT02357849|Dopamine Agonists|dopamine agonists|mesh-ancestor
111105173|NCT02357849|Dopamine Agents|dopamine agents|mesh-ancestor
111105174|NCT02357849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111105175|NCT02357849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111105176|NCT02357849|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111105177|NCT02357849|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111105178|NCT02357849|Serotonin Agents|serotonin agents|mesh-ancestor
111105179|NCT02357849|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111105180|NCT02357849|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111105181|NCT02357849|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111105182|NCT02357849|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111105183|NCT02357849|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111105184|NCT02357849|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111105185|NCT02357849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111105186|NCT02357849|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111105187|NCT02357849|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111105188|NCT02357849|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111105189|NCT02357849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111105190|NCT02357693|Aprepitant|aprepitant|mesh-list
111105191|NCT02357693|Antiemetics|antiemetics|mesh-ancestor
111105192|NCT02357693|Autonomic Agents|autonomic agents|mesh-ancestor
111105193|NCT02357693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111105194|NCT02357693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111105195|NCT02357693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111105196|NCT02357693|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
111105197|NCT02357693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111105198|NCT02357693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111105199|NCT02357537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
111105200|NCT02357615|Nifedipine|nifedipine|mesh-list
111105201|NCT02357615|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111105202|NCT02357615|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111105203|NCT02357615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111105204|NCT02357615|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111105205|NCT02357615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111105206|NCT02357615|Vasodilator Agents|vasodilator agents|mesh-ancestor
111105207|NCT02357615|Tocolytic Agents|tocolytic agents|mesh-ancestor
111105208|NCT02357615|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111105209|NCT03160001|Niclosamide|niclosamide|mesh-list
111105210|NCT03160001|Etanercept|etanercept|mesh-list
111105211|NCT03160001|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111105212|NCT03160001|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111105213|NCT03160001|Analgesics|analgesics|mesh-ancestor
111105214|NCT03160001|Sensory System Agents|sensory system agents|mesh-ancestor
111105215|NCT03160001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111105216|NCT03160001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111105217|NCT03160001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111489747|NCT03355170|Dopamine Agents|dopamine agents|mesh-ancestor
111489748|NCT03355170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111489749|NCT02760498|Cemiplimab|cemiplimab|mesh-list
111489750|NCT02760498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111105218|NCT03160001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111105219|NCT03160001|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111105220|NCT03160001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111105221|NCT03160001|Immunologic Factors|immunologic factors|mesh-ancestor
111105222|NCT03160001|Anticestodal Agents|anticestodal agents|mesh-ancestor
111105223|NCT03160001|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
111105224|NCT03160001|Anthelmintics|anthelmintics|mesh-ancestor
111105225|NCT03160001|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111105226|NCT03160001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111105227|NCT03160001|Antinematodal Agents|antinematodal agents|mesh-ancestor
111105228|NCT02359643|Aspirin|aspirin|mesh-list
111105229|NCT02359643|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111105230|NCT02359643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111105231|NCT02359643|Analgesics|analgesics|mesh-ancestor
111105232|NCT02359643|Sensory System Agents|sensory system agents|mesh-ancestor
111105233|NCT02359643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111105234|NCT02359643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111105235|NCT02359643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111105236|NCT02359643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111105237|NCT02359643|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111105238|NCT02359643|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111105239|NCT02359643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111105240|NCT02359643|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111105241|NCT02359643|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111105242|NCT02359643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111105243|NCT02359643|Antipyretics|antipyretics|mesh-ancestor
111105244|NCT02359721|Clarithromycin|clarithromycin|mesh-list
111105245|NCT02359721|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111105246|NCT02359721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111105247|NCT02359721|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111105248|NCT02359721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111105249|NCT02359721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111105250|NCT02359721|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111105251|NCT02359721|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111105252|NCT02357303|Acetylcysteine|acetylcysteine|mesh-list
111105253|NCT02357303|Simethicone|simethicone|mesh-list
111105254|NCT02357303|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111105255|NCT02357303|Antiviral Agents|antiviral agents|mesh-ancestor
111105256|NCT02357303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111105257|NCT02357303|Expectorants|expectorants|mesh-ancestor
111105258|NCT02357303|Respiratory System Agents|respiratory system agents|mesh-ancestor
111105259|NCT02357303|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111105260|NCT02357303|Antioxidants|antioxidants|mesh-ancestor
111105261|NCT02357303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111105262|NCT02357303|Protective Agents|protective agents|mesh-ancestor
111105263|NCT02357303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111105264|NCT02357303|Antidotes|antidotes|mesh-ancestor
111105265|NCT02357303|Antifoaming Agents|antifoaming agents|mesh-ancestor
111105266|NCT02357303|Emollients|emollients|mesh-ancestor
111105267|NCT02357303|Dermatologic Agents|dermatologic agents|mesh-ancestor
111105268|NCT02357225|Bromides|bromides|mesh-list
111105269|NCT02357225|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
111105270|NCT02357225|Anticonvulsants|anticonvulsants|mesh-ancestor
111105271|NCT02357225|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111105272|NCT02357225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111105273|NCT02357225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111105274|NCT02357225|Cholinergic Agents|cholinergic agents|mesh-ancestor
111105275|NCT02357225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111105276|NCT02357225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111105277|NCT02357069|Etanercept|etanercept|mesh-list
111105278|NCT02357069|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111105279|NCT02357069|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111105280|NCT02357069|Analgesics|analgesics|mesh-ancestor
111105281|NCT02357069|Sensory System Agents|sensory system agents|mesh-ancestor
111105282|NCT02357069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111105283|NCT02357069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111105284|NCT02357069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111105285|NCT02357069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111105286|NCT02357069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111105287|NCT02357069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111489751|NCT02760498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111105288|NCT02357069|Immunologic Factors|immunologic factors|mesh-ancestor
111105289|NCT02356913|Nicotine|nicotine|mesh-list
111105290|NCT02356913|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111489753|NCT02538666|Ipilimumab|ipilimumab|mesh-list
111105291|NCT02356913|Autonomic Agents|autonomic agents|mesh-ancestor
111105292|NCT02356913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111105293|NCT02356913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111105294|NCT02356913|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111105295|NCT02356913|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111105296|NCT02356913|Cholinergic Agents|cholinergic agents|mesh-ancestor
111105297|NCT02356913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111105298|NCT02356913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111105299|NCT02352545|Montelukast|montelukast|mesh-list
111105300|NCT02352545|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111105301|NCT02352545|Respiratory System Agents|respiratory system agents|mesh-ancestor
111105302|NCT02352545|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
111105303|NCT02352545|Hormone Antagonists|hormone antagonists|mesh-ancestor
111105304|NCT02352545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111105305|NCT02352545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111105306|NCT02352545|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
111105307|NCT02352545|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111105308|NCT02352545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111105309|NCT02356835|Nitric Oxide|nitric oxide|mesh-list
111105310|NCT02356835|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111105311|NCT02356835|Autonomic Agents|autonomic agents|mesh-ancestor
111105312|NCT02356835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111105313|NCT02356835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111105314|NCT02356835|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111105315|NCT02356835|Respiratory System Agents|respiratory system agents|mesh-ancestor
111105316|NCT02356835|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111105317|NCT02356835|Antioxidants|antioxidants|mesh-ancestor
111105318|NCT02356835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111105319|NCT02356835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111105320|NCT02356835|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
111105321|NCT02356835|Vasodilator Agents|vasodilator agents|mesh-ancestor
111105322|NCT02356835|Gasotransmitters|gasotransmitters|mesh-ancestor
111105323|NCT02356835|Protective Agents|protective agents|mesh-ancestor
111105324|NCT02352701|Amoxicillin|amoxicillin|mesh-list
111105325|NCT02352701|Levofloxacin|levofloxacin|mesh-list
111105326|NCT02352701|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111105327|NCT02352701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111105328|NCT02352701|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111105329|NCT02352701|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111105330|NCT02352701|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111105331|NCT02352701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111105332|NCT02352701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111105333|NCT02352701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111105334|NCT02352701|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111105335|NCT02352701|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111105336|NCT02356445|Infliximab|infliximab|mesh-list
111105337|NCT02356445|Methotrexate|methotrexate|mesh-list
111105338|NCT02356445|Azathioprine|azathioprine|mesh-list
111105339|NCT02356445|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111105340|NCT02356445|Abortifacient Agents|abortifacient agents|mesh-ancestor
111105341|NCT02356445|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111105342|NCT02356445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111105343|NCT02356445|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111105344|NCT02356445|Antimetabolites|antimetabolites|mesh-ancestor
111105345|NCT02356445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111105346|NCT02356445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111105347|NCT02356445|Dermatologic Agents|dermatologic agents|mesh-ancestor
110822430|NCT01238965|Antidotes|antidotes|mesh-ancestor
111105348|NCT02356445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111105349|NCT02356445|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111105350|NCT02356445|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111105351|NCT02356445|Immunologic Factors|immunologic factors|mesh-ancestor
111105352|NCT02356445|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111105353|NCT02356445|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111105354|NCT02356445|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111105355|NCT02356445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111105356|NCT02356445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111105357|NCT02356679|Ethanol|ethanol|mesh-list
111105358|NCT02356679|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111489754|NCT02538666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111489755|NCT02538666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111105359|NCT02356679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111105360|NCT02356679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111105361|NCT02356679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111105362|NCT02352155|Epinephrine|epinephrine|mesh-list
111105363|NCT02352155|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111105364|NCT02352155|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111105365|NCT02352155|Adrenergic Agents|adrenergic agents|mesh-ancestor
111105366|NCT02352155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111105367|NCT02352155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111105368|NCT02352155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111105369|NCT02352155|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111105370|NCT02352155|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111105371|NCT02352155|Autonomic Agents|autonomic agents|mesh-ancestor
111105372|NCT02352155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111105373|NCT02352155|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111105374|NCT02352155|Respiratory System Agents|respiratory system agents|mesh-ancestor
111105375|NCT02352155|Mydriatics|mydriatics|mesh-ancestor
111105376|NCT02352155|Sympathomimetics|sympathomimetics|mesh-ancestor
111105377|NCT02352155|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111105378|NCT02352311|Tadalafil|tadalafil|mesh-list
111105379|NCT02352311|Dutasteride|dutasteride|mesh-list
111105380|NCT02352311|Vasodilator Agents|vasodilator agents|mesh-ancestor
111105381|NCT02352311|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111105382|NCT02352311|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111105383|NCT02352311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111105384|NCT02352311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111105385|NCT02352311|Urological Agents|urological agents|mesh-ancestor
111105386|NCT02352311|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
111105387|NCT02352311|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111105388|NCT02352311|Hormone Antagonists|hormone antagonists|mesh-ancestor
111105389|NCT02352311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111105390|NCT02352311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111105391|NCT02355431|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111105392|NCT02355431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111105393|NCT02355431|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111105394|NCT02355431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111105395|NCT02355431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111105396|NCT02351687|Pyrimethamine|pyrimethamine|mesh-list
111105397|NCT02351687|Sulfadoxine|sulfadoxine|mesh-list
111105398|NCT02351687|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
111105399|NCT02351687|Albendazole|albendazole|mesh-list
111105400|NCT02351687|Antimalarials|antimalarials|mesh-ancestor
111105401|NCT02351687|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111105402|NCT02351687|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111105403|NCT02351687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111105404|NCT02351687|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111105405|NCT02351687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111105406|NCT02351687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111105407|NCT02351687|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111105408|NCT02351687|Anthelmintics|anthelmintics|mesh-ancestor
111105409|NCT02351687|Anticestodal Agents|anticestodal agents|mesh-ancestor
111105410|NCT02351687|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
111105411|NCT02351687|Tubulin Modulators|tubulin modulators|mesh-ancestor
111105412|NCT02351687|Antimitotic Agents|antimitotic agents|mesh-ancestor
111105413|NCT02351687|Mitosis Modulators|mitosis modulators|mesh-ancestor
111105414|NCT02351687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111105415|NCT02355509|Acarbose|acarbose|mesh-list
111105416|NCT02355509|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
111105417|NCT02355509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111105418|NCT02355509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111105419|NCT02355509|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111105420|NCT02355509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111105421|NCT02355197|Ascorbic Acid|ascorbic acid|mesh-list
111105422|NCT02355197|Vitamins|vitamins|mesh-ancestor
111105423|NCT02355197|Micronutrients|micronutrients|mesh-ancestor
111105424|NCT02355197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111105425|NCT02355197|Antioxidants|antioxidants|mesh-ancestor
111105426|NCT02355197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111105427|NCT02355197|Protective Agents|protective agents|mesh-ancestor
111105428|NCT02351297|Caseins|caseins|mesh-list
111105429|NCT02351297|Chelating Agents|chelating agents|mesh-ancestor
111105430|NCT02351297|Sequestering Agents|sequestering agents|mesh-ancestor
110024194|NCT00004368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111489756|NCT02538666|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111105431|NCT02351297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111105432|NCT02355119|Gemcitabine|gemcitabine|mesh-list
111105433|NCT02355119|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111105434|NCT02355119|Antimetabolites|antimetabolites|mesh-ancestor
111105435|NCT02355119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111105436|NCT02355119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111105437|NCT03149939|Febuxostat|febuxostat|mesh-list
111105438|NCT03149939|Gout Suppressants|gout suppressants|mesh-ancestor
111105439|NCT03149939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111105440|NCT03149783|Ropivacaine|ropivacaine|mesh-list
111105441|NCT03149783|Anesthetics, Local|anesthetics, local|mesh-ancestor
111105442|NCT03149783|Anesthetics|anesthetics|mesh-ancestor
111105443|NCT03149783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111105444|NCT03149783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111105445|NCT03149783|Sensory System Agents|sensory system agents|mesh-ancestor
111105446|NCT03149783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111105447|NCT02354885|Tranexamic Acid|tranexamic acid|mesh-list
111105448|NCT02354885|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111105449|NCT02354885|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111105450|NCT02354885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111105451|NCT02354885|Hemostatics|hemostatics|mesh-ancestor
111105452|NCT02354885|Coagulants|coagulants|mesh-ancestor
111105453|NCT02354807|Mirabegron|mirabegron|mesh-list
111105454|NCT02354807|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
111105455|NCT02354807|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111105456|NCT02354807|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111105457|NCT02354807|Adrenergic Agents|adrenergic agents|mesh-ancestor
111105458|NCT02354807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111105459|NCT02354807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111105460|NCT02354807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111105461|NCT02354807|Urological Agents|urological agents|mesh-ancestor
111105462|NCT03159845|Levofloxacin|levofloxacin|mesh-list
111105463|NCT03159845|Fluconazole|fluconazole|mesh-list
111105464|NCT03159845|Acyclovir|acyclovir|mesh-list
111105465|NCT03159845|Zinc Sulfate|zinc sulfate|mesh-list
111105466|NCT03159845|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111105467|NCT03159845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111105468|NCT03159845|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111105469|NCT03159845|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111105470|NCT03159845|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111105471|NCT03159845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111105472|NCT03159845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111105473|NCT03159845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111105474|NCT03159845|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111105475|NCT03159845|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111105476|NCT03159845|Antifungal Agents|antifungal agents|mesh-ancestor
111105477|NCT03159845|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111105478|NCT03159845|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111105479|NCT03159845|Hormone Antagonists|hormone antagonists|mesh-ancestor
111105480|NCT03159845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111105481|NCT03159845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111105482|NCT03159845|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111105483|NCT03159845|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111105484|NCT03159845|Antiviral Agents|antiviral agents|mesh-ancestor
111105485|NCT03159845|Astringents|astringents|mesh-ancestor
111105486|NCT03159845|Dermatologic Agents|dermatologic agents|mesh-ancestor
111105487|NCT02350751|MEDI8852|medi8852|mesh-list
111105488|NCT02350751|Antiviral Agents|antiviral agents|mesh-ancestor
111105489|NCT02350751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111105490|NCT02350985|Propranolol|propranolol|mesh-list
111105491|NCT02350985|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
111105492|NCT02350985|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111105493|NCT02350985|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111105494|NCT02350985|Adrenergic Agents|adrenergic agents|mesh-ancestor
111105495|NCT02350985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111105496|NCT02350985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111105497|NCT02350985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111105498|NCT02350985|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111105499|NCT02350985|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111105500|NCT02350985|Vasodilator Agents|vasodilator agents|mesh-ancestor
111119171|NCT05306873|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111489757|NCT02538666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111489758|NCT02407236|Ustekinumab|ustekinumab|mesh-list
111489759|NCT02407236|Dermatologic Agents|dermatologic agents|mesh-ancestor
111489760|NCT00221598|Dialysis Solutions|dialysis solutions|mesh-list
111489761|NCT00221598|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111105501|NCT02350985|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111105502|NCT02350985|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111105503|NCT02350985|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111105504|NCT02350985|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111105505|NCT02350985|Antidepressive Agents|antidepressive agents|mesh-ancestor
111105506|NCT02350985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111105507|NCT02354261|Itraconazole|itraconazole|mesh-list
111105508|NCT02354261|Antifungal Agents|antifungal agents|mesh-ancestor
111105509|NCT02354261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111105510|NCT02354261|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111105511|NCT02354261|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111105512|NCT02354261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111105513|NCT02354261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111105514|NCT02354261|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111105515|NCT02354261|Hormone Antagonists|hormone antagonists|mesh-ancestor
111105516|NCT02354261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111105517|NCT02354261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111105518|NCT02354261|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111105519|NCT02350439|Adenosine|adenosine|mesh-list
111105520|NCT02350439|Analgesics|analgesics|mesh-ancestor
111105521|NCT02350439|Sensory System Agents|sensory system agents|mesh-ancestor
111105522|NCT02350439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111105523|NCT02350439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111105524|NCT02350439|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111105525|NCT02350439|Vasodilator Agents|vasodilator agents|mesh-ancestor
111105526|NCT02350439|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
111105527|NCT02350439|Purinergic Agonists|purinergic agonists|mesh-ancestor
111105528|NCT02350439|Purinergic Agents|purinergic agents|mesh-ancestor
111105529|NCT02350439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111105530|NCT02350439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111105531|NCT02350673|Atezolizumab|atezolizumab|mesh-list
111105532|NCT02350673|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111105533|NCT02350673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111105534|NCT02350673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111105535|NCT02350673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111105536|NCT02350361|Endostatins|endostatins|mesh-list
111105537|NCT02350361|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111105538|NCT02350361|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111105539|NCT02350361|Growth Substances|growth substances|mesh-ancestor
111105540|NCT02350361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111105541|NCT02350361|Growth Inhibitors|growth inhibitors|mesh-ancestor
111105542|NCT02350361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111105543|NCT02353949|Flutemetamol|flutemetamol|mesh-list
111105544|NCT02353949|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111105545|NCT02353949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111105546|NCT02354027|Metformin|metformin|mesh-list
111105547|NCT02354027|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111105548|NCT02354027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111105549|NCT03149393|Mosapride|mosapride|mesh-list
111105550|NCT03149393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111105551|NCT03149393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111105552|NCT03149393|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111105553|NCT03149393|Serotonin Agents|serotonin agents|mesh-ancestor
111105554|NCT03149393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111105555|NCT03149393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111105556|NCT02353715|Abiraterone Acetate|abiraterone acetate|mesh-list
111105557|NCT02353715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111105558|NCT02353715|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111105559|NCT02353715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111105560|NCT02353715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111105561|NCT02353715|Hormone Antagonists|hormone antagonists|mesh-ancestor
111105562|NCT02353715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111105563|NCT02353715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111105564|NCT02353715|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111105565|NCT02353325|Ascorbic Acid|ascorbic acid|mesh-list
111105566|NCT02353325|Fesoterodine|fesoterodine|mesh-list
110822659|NCT01375777|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111489762|NCT05120076|Dexamethasone|dexamethasone|mesh-list
111489763|NCT05120076|Dexamethasone acetate|dexamethasone acetate|mesh-list
111489764|NCT05120076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111105567|NCT02353325|Antioxidants|antioxidants|mesh-ancestor
111105568|NCT02353325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111105569|NCT02353325|Protective Agents|protective agents|mesh-ancestor
111105570|NCT02353325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111105572|NCT02353325|Micronutrients|micronutrients|mesh-ancestor
111105573|NCT02353325|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111105574|NCT02353325|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111105575|NCT02353325|Cholinergic Agents|cholinergic agents|mesh-ancestor
111105576|NCT02353325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111105577|NCT02353325|Urological Agents|urological agents|mesh-ancestor
111105578|NCT03157505|Immunomodulating Agents|immunomodulating agents|mesh-list
111105579|NCT03157505|Immunologic Factors|immunologic factors|mesh-list
111105580|NCT03157505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111105581|NCT03157193|Hyaluronic Acid|hyaluronic acid|mesh-list
111105582|NCT03157193|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111105583|NCT03157193|Immunologic Factors|immunologic factors|mesh-ancestor
111105584|NCT03157193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111105585|NCT03157193|Viscosupplements|viscosupplements|mesh-ancestor
111105586|NCT03157193|Protective Agents|protective agents|mesh-ancestor
111105587|NCT03149159|Nivolumab|nivolumab|mesh-list
111105588|NCT03149159|Ipilimumab|ipilimumab|mesh-list
111105589|NCT03149159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111105590|NCT03149159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111105591|NCT03149159|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111105592|NCT03149159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111105593|NCT03155477|Cholecalciferol|cholecalciferol|mesh-list
111105594|NCT03155477|Vitamin D|vitamin d|mesh-list
111105595|NCT03155477|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111105596|NCT03155477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111105597|NCT03155477|Vitamins|vitamins|mesh-ancestor
111105598|NCT03155477|Micronutrients|micronutrients|mesh-ancestor
111105599|NCT03155477|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111105600|NCT02349581|Bupivacaine|bupivacaine|mesh-list
111105601|NCT02349581|Anesthetics, Local|anesthetics, local|mesh-ancestor
111105602|NCT02349581|Anesthetics|anesthetics|mesh-ancestor
111105603|NCT02349581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111105604|NCT02349581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111105605|NCT02349581|Sensory System Agents|sensory system agents|mesh-ancestor
111105606|NCT02349581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111105607|NCT03154385|Rituximab|rituximab|mesh-list
111105608|NCT03154385|Belimumab|belimumab|mesh-list
111105609|NCT03154385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111105610|NCT03154385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111105611|NCT03154385|Immunologic Factors|immunologic factors|mesh-ancestor
111105612|NCT03154385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110647168|NCT00511875|Doxycycline|doxycycline|mesh-list
111105613|NCT03154385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111105614|NCT03154385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111105615|NCT03112187|Iron|iron|mesh-list
111105616|NCT03112187|Trace Elements|trace elements|mesh-ancestor
111105617|NCT03112187|Micronutrients|micronutrients|mesh-ancestor
111105618|NCT03112187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111105619|NCT03147677|Alfacalcidol|alfacalcidol|mesh-list
111105620|NCT03147677|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
111105621|NCT03147677|Irbesartan|irbesartan|mesh-list
111105622|NCT03147677|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111105623|NCT03147677|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111105624|NCT03147677|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111105625|NCT03147677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111105626|NCT03147677|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111105627|NCT03147677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111105628|NCT03147677|Vitamins|vitamins|mesh-ancestor
111105629|NCT03147677|Micronutrients|micronutrients|mesh-ancestor
111105630|NCT03148535|Lithium Carbonate|lithium carbonate|mesh-list
111105631|NCT03148535|Antidepressive Agents|antidepressive agents|mesh-list
111105632|NCT03148535|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111105633|NCT03148535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111105634|NCT03148535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111489766|NCT05120076|Autonomic Agents|autonomic agents|mesh-ancestor
111489767|NCT05120076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111105635|NCT03148535|Antimanic Agents|antimanic agents|mesh-ancestor
111105636|NCT03148535|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111489768|NCT05120076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111105637|NCT03148535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111105638|NCT03148535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111105639|NCT03147599|Mebeverine|mebeverine|mesh-list
111105640|NCT03147599|Anticonvulsants|anticonvulsants|mesh-ancestor
110822736|NCT03491410|Aspirin|aspirin|mesh-list
111105641|NCT03147599|Parasympatholytics|parasympatholytics|mesh-ancestor
111105642|NCT03147599|Autonomic Agents|autonomic agents|mesh-ancestor
111105643|NCT03147599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111105644|NCT03147599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111105645|NCT02349113|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
111105646|NCT02349113|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
111105647|NCT02349113|Estrogens|estrogens|mesh-list
111105648|NCT02349113|Estradiol|estradiol|mesh-list
111105649|NCT02349113|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
111105650|NCT02349113|Hormones|hormones|mesh-ancestor
111105651|NCT02349113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111105652|NCT02349113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111105653|NCT02349113|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111105654|NCT02349113|Contraceptive Agents|contraceptive agents|mesh-ancestor
111105655|NCT02349113|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111105656|NCT02349113|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111105657|NCT04183205|Sertraline|sertraline|mesh-list
111105658|NCT04183205|Antidepressive Agents|antidepressive agents|mesh-ancestor
111105659|NCT04183205|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111105660|NCT04183205|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111105661|NCT04183205|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111105662|NCT04183205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111105663|NCT04183205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111105664|NCT04183205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111105665|NCT04183205|Serotonin Agents|serotonin agents|mesh-ancestor
111105666|NCT04183205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111105667|NCT04151849|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
111105668|NCT04151849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111105669|NCT04151849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111105670|NCT04151849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111105671|NCT02348177|Ritonavir|ritonavir|mesh-list
111105672|NCT02348177|Lopinavir|lopinavir|mesh-list
111105673|NCT02348177|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111105674|NCT02348177|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111105675|NCT02348177|Protease Inhibitors|protease inhibitors|mesh-ancestor
111105676|NCT02348177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111105677|NCT02348177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111105678|NCT02348177|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111105679|NCT02348177|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111105680|NCT02348177|Antiviral Agents|antiviral agents|mesh-ancestor
111105681|NCT02348177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111105682|NCT02348177|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111105683|NCT02348177|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111105684|NCT02348255|Bevacizumab|bevacizumab|mesh-list
111105685|NCT02348255|Carmustine|carmustine|mesh-list
111105686|NCT02348255|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111105687|NCT02348255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111105688|NCT02348255|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111105689|NCT02348255|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111105690|NCT02348255|Growth Substances|growth substances|mesh-ancestor
111105691|NCT02348255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111105692|NCT02348255|Growth Inhibitors|growth inhibitors|mesh-ancestor
111105693|NCT02348255|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111105694|NCT02348255|Alkylating Agents|alkylating agents|mesh-ancestor
111105695|NCT02348255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111105696|NCT02348333|Dotinurad|dotinurad|mesh-list
111105697|NCT02348333|Uricosuric Agents|uricosuric agents|mesh-ancestor
111105698|NCT02348333|Gout Suppressants|gout suppressants|mesh-ancestor
111105699|NCT02348333|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111105700|NCT02343419|Methacholine Chloride|methacholine chloride|mesh-list
111105701|NCT02343419|Miotics|miotics|mesh-ancestor
111105702|NCT02343419|Autonomic Agents|autonomic agents|mesh-ancestor
111105703|NCT02343419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111105704|NCT02343419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111105705|NCT02343419|Parasympathomimetics|parasympathomimetics|mesh-ancestor
111105706|NCT02343419|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
111105707|NCT02343419|Respiratory System Agents|respiratory system agents|mesh-ancestor
111105708|NCT02343419|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
111105709|NCT02343419|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111489769|NCT05120076|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111489770|NCT05120076|Glucocorticoids|glucocorticoids|mesh-ancestor
111489771|NCT05120076|Hormones|hormones|mesh-ancestor
111105710|NCT02343419|Cholinergic Agents|cholinergic agents|mesh-ancestor
111105711|NCT02343419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111489772|NCT05120076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111489773|NCT05120076|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111489774|NCT05120076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111105712|NCT02343419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111105713|NCT02342717|Itraconazole|itraconazole|mesh-list
111105714|NCT02342717|BI 425809|bi 425809|mesh-list
111105715|NCT02342717|Antifungal Agents|antifungal agents|mesh-ancestor
111105716|NCT02342717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111105717|NCT02342717|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111105718|NCT02342717|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111105720|NCT02342717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111105721|NCT02342717|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111105722|NCT02342717|Hormone Antagonists|hormone antagonists|mesh-ancestor
111105723|NCT02342717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111105724|NCT02342717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111105725|NCT02342717|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111105726|NCT02342717|Nootropic Agents|nootropic agents|mesh-ancestor
111105727|NCT04478357|Fesoterodine|fesoterodine|mesh-list
111105728|NCT04478357|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111105729|NCT04478357|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111105730|NCT04478357|Cholinergic Agents|cholinergic agents|mesh-ancestor
111105731|NCT04478357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111105732|NCT04478357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111105733|NCT04478357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111105734|NCT04478357|Urological Agents|urological agents|mesh-ancestor
111105735|NCT04478513|Fluvoxamine|fluvoxamine|mesh-list
111105736|NCT04478513|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111105737|NCT04478513|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111105738|NCT04478513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111105739|NCT04478513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111105740|NCT04478513|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111105741|NCT04478513|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111105742|NCT04478513|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111105743|NCT04478513|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111105744|NCT04478513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111105745|NCT04478513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111105746|NCT04478513|Serotonin Agents|serotonin agents|mesh-ancestor
111105747|NCT04478513|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111105748|NCT04478513|Antidepressive Agents|antidepressive agents|mesh-ancestor
111105749|NCT04478513|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111105750|NCT04478513|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111105751|NCT04478513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111105752|NCT04478513|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111105753|NCT02342093|Drospirenone|drospirenone|mesh-list
111105754|NCT02342093|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
111105755|NCT02342093|Hormone Antagonists|hormone antagonists|mesh-ancestor
111105756|NCT02342093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111105757|NCT02342093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111105758|NCT02342093|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
111105759|NCT02342093|Diuretics|diuretics|mesh-ancestor
111105760|NCT02342093|Natriuretic Agents|natriuretic agents|mesh-ancestor
111105761|NCT02347319|Silymarin|silymarin|mesh-list
111105762|NCT02347319|Antioxidants|antioxidants|mesh-ancestor
111105763|NCT02347319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111105764|NCT02347319|Protective Agents|protective agents|mesh-ancestor
111105765|NCT02347319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111105766|NCT02347163|Zoledronic Acid|zoledronic acid|mesh-list
111105767|NCT02347163|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111105768|NCT02347163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111105769|NCT02341703|Metformin|metformin|mesh-list
111105770|NCT02341703|Pioglitazone|pioglitazone|mesh-list
111105771|NCT02341703|Letrozole|letrozole|mesh-list
111105772|NCT02341703|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111105773|NCT02341703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111105774|NCT02341703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111105775|NCT02341703|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111105776|NCT02341703|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111105777|NCT02341703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111105778|NCT02341703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110697919|NCT00290511|Mitoxantrone|mitoxantrone|mesh-list
111489775|NCT05094804|Docetaxel|docetaxel|mesh-list
111105779|NCT02341703|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111105780|NCT02341703|Hormone Antagonists|hormone antagonists|mesh-ancestor
111105781|NCT02341703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111105782|NCT02341547|Epoetin Alfa|epoetin alfa|mesh-list
111105783|NCT02341547|Hematinics|hematinics|mesh-ancestor
111105784|NCT02341079|Bupivacaine|bupivacaine|mesh-list
111105785|NCT02341079|Anesthetics, Local|anesthetics, local|mesh-ancestor
111105786|NCT02341079|Anesthetics|anesthetics|mesh-ancestor
111105787|NCT02341079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111105788|NCT02341079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111105789|NCT02341079|Sensory System Agents|sensory system agents|mesh-ancestor
111105790|NCT02341079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111105791|NCT02346539|Nicotine|nicotine|mesh-list
111105792|NCT02346539|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111105793|NCT02346539|Autonomic Agents|autonomic agents|mesh-ancestor
111105794|NCT02346539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111105795|NCT02346539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111105796|NCT02346539|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111105797|NCT02346539|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111105798|NCT02346539|Cholinergic Agents|cholinergic agents|mesh-ancestor
111105799|NCT02346539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111105800|NCT02346539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111105801|NCT05254223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
111105802|NCT02340455|Pregabalin|pregabalin|mesh-list
111105803|NCT02340455|Analgesics|analgesics|mesh-ancestor
111105804|NCT02340455|Sensory System Agents|sensory system agents|mesh-ancestor
110647182|NCT02576327|Autonomic Agents|autonomic agents|mesh-ancestor
111105805|NCT02340455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111105806|NCT02340455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111105807|NCT02340455|Anticonvulsants|anticonvulsants|mesh-ancestor
111105808|NCT02340455|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111105809|NCT02340455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111105810|NCT02340455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111105811|NCT02340455|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111105812|NCT02340455|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111105813|NCT02340455|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111105814|NCT02340455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111105815|NCT02340455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111105816|NCT02345837|Clomiphene|clomiphene|mesh-list
111105817|NCT02345837|Enclomiphene|enclomiphene|mesh-list
111105818|NCT02345837|Zuclomiphene|zuclomiphene|mesh-list
111105819|NCT02345837|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111105820|NCT02345837|Hormone Antagonists|hormone antagonists|mesh-ancestor
111105821|NCT02345837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111105822|NCT02345837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111105823|NCT02345837|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111105824|NCT02345837|Fertility Agents|fertility agents|mesh-ancestor
111105825|NCT02345837|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111105826|NCT02345837|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111105827|NCT02345837|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111105828|NCT02345993|Beclomethasone|beclomethasone|mesh-list
111105829|NCT02345993|Formoterol Fumarate|formoterol fumarate|mesh-list
111105830|NCT02345993|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111105831|NCT02345993|Autonomic Agents|autonomic agents|mesh-ancestor
111105832|NCT02345993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111105833|NCT02345993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111105834|NCT02345993|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111105835|NCT02345993|Respiratory System Agents|respiratory system agents|mesh-ancestor
111105836|NCT02345993|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111105837|NCT02345993|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111105838|NCT02345993|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111105839|NCT02345993|Adrenergic Agents|adrenergic agents|mesh-ancestor
111105840|NCT02345993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111105841|NCT02345993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111105842|NCT02345993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111105843|NCT02345993|Glucocorticoids|glucocorticoids|mesh-ancestor
111105844|NCT02345993|Hormones|hormones|mesh-ancestor
111105845|NCT02345993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111105846|NCT02345681|Furosemide|furosemide|mesh-list
111105847|NCT02345681|Diuretics|diuretics|mesh-ancestor
111489776|NCT05094804|Cemiplimab|cemiplimab|mesh-list
111489777|NCT05094804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111489778|NCT05094804|Tubulin Modulators|tubulin modulators|mesh-ancestor
111105848|NCT02345681|Natriuretic Agents|natriuretic agents|mesh-ancestor
111489779|NCT05094804|Antimitotic Agents|antimitotic agents|mesh-ancestor
111105849|NCT02345681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111489780|NCT05094804|Mitosis Modulators|mitosis modulators|mesh-ancestor
111489781|NCT05094804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111105850|NCT02345681|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
111105851|NCT02345681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111105852|NCT02345681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111105853|NCT02340611|Olaparib|olaparib|mesh-list
111105854|NCT02340611|Cediranib|cediranib|mesh-list
111105855|NCT02340611|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111105856|NCT02340611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111105857|NCT02340611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111105858|NCT02340611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111105859|NCT02340611|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111105860|NCT03145649|Insulin|insulin|mesh-list
111105861|NCT03145649|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111105862|NCT03145649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111105863|NCT02345213|Donepezil|donepezil|mesh-list
111105864|NCT02345213|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111105865|NCT02345213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111105866|NCT02345213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111105867|NCT02345213|Cholinergic Agents|cholinergic agents|mesh-ancestor
111105868|NCT02345213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111105869|NCT02345213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111105870|NCT02345213|Nootropic Agents|nootropic agents|mesh-ancestor
111105871|NCT02339753|Carboplatin|carboplatin|mesh-list
111105872|NCT02339753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111105873|NCT02339441|Mycophenolic Acid|mycophenolic acid|mesh-list
111105874|NCT02339441|Cyclophosphamide|cyclophosphamide|mesh-list
111105875|NCT02339441|Methotrexate|methotrexate|mesh-list
111105876|NCT02339441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111105877|NCT02339441|Immunologic Factors|immunologic factors|mesh-ancestor
111105878|NCT02339441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111105879|NCT02339441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111105880|NCT02339441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111105881|NCT02339441|Alkylating Agents|alkylating agents|mesh-ancestor
111105882|NCT02339441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111105883|NCT02339441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111105884|NCT02339441|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111105885|NCT02339441|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111105886|NCT02339441|Abortifacient Agents|abortifacient agents|mesh-ancestor
111105887|NCT02339441|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111105888|NCT02339441|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111105889|NCT02339441|Antimetabolites|antimetabolites|mesh-ancestor
111105890|NCT02339441|Dermatologic Agents|dermatologic agents|mesh-ancestor
111105891|NCT02339441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111105892|NCT02339441|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111105893|NCT02339441|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111105894|NCT02339441|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111105895|NCT02339441|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111105896|NCT02339441|Antitubercular Agents|antitubercular agents|mesh-ancestor
111105897|NCT02339441|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111105898|NCT02339441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111105899|NCT02344823|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
111105900|NCT02344823|Vasodilator Agents|vasodilator agents|mesh-ancestor
111105901|NCT02344823|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111105902|NCT02344823|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111105903|NCT02344823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111105904|NCT02344823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111105905|NCT02344823|Urological Agents|urological agents|mesh-ancestor
111105906|NCT03145961|Pembrolizumab|pembrolizumab|mesh-list
111105907|NCT03145961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111105908|NCT03145961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111105909|NCT03145961|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111105910|NCT03145961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111105911|NCT02339207|Adafosbuvir|adafosbuvir|mesh-list
111105912|NCT02339207|Antiviral Agents|antiviral agents|mesh-ancestor
111105913|NCT02339207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111105914|NCT02344511|Vancomycin|vancomycin|mesh-list
111105915|NCT02344511|Cefazolin|cefazolin|mesh-list
111105916|NCT02344511|Dalbavancin|dalbavancin|mesh-list
111105917|NCT02344511|Oxacillin|oxacillin|mesh-list
111105918|NCT02344511|Nafcillin|nafcillin|mesh-list
111105919|NCT02344511|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111489782|NCT05094804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111105920|NCT02344511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111105922|NCT02344589|Anesthetics, Local|anesthetics, local|mesh-ancestor
111105923|NCT02344589|Anesthetics|anesthetics|mesh-ancestor
111105924|NCT02344589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111105925|NCT02344589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111105926|NCT02344589|Sensory System Agents|sensory system agents|mesh-ancestor
111105927|NCT02344589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111105928|NCT02344589|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111105929|NCT02344589|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111105930|NCT02344589|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111105931|NCT02344589|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111105932|NCT02344589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111105933|NCT02338115|Paclitaxel|paclitaxel|mesh-list
111105934|NCT02338115|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111105935|NCT02338115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111105936|NCT02338115|Tubulin Modulators|tubulin modulators|mesh-ancestor
111105937|NCT02338115|Antimitotic Agents|antimitotic agents|mesh-ancestor
111105938|NCT02338115|Mitosis Modulators|mitosis modulators|mesh-ancestor
111105939|NCT02338115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111105940|NCT02337881|Sildenafil Citrate|sildenafil citrate|mesh-list
111105941|NCT02337881|Vasodilator Agents|vasodilator agents|mesh-ancestor
111105942|NCT02337881|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111105943|NCT02337881|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111105944|NCT02337881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111105945|NCT02337881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111105946|NCT02337881|Urological Agents|urological agents|mesh-ancestor
111105947|NCT02337257|Vitamin D|vitamin d|mesh-list
111105948|NCT02337257|Cholecalciferol|cholecalciferol|mesh-list
111105949|NCT02337257|Vitamins|vitamins|mesh-ancestor
111105950|NCT02337257|Micronutrients|micronutrients|mesh-ancestor
111105951|NCT02337257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111105952|NCT02337257|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111105953|NCT02337257|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111105954|NCT02337413|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
111105955|NCT02337413|Laxatives|laxatives|mesh-ancestor
111105956|NCT02337413|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111105957|NCT02337023|Technetium Tc 99m bicisate|technetium tc 99m bicisate|mesh-list
111105958|NCT02337023|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111105959|NCT02337023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111105960|NCT04477811|Vitamins|vitamins|mesh-list
111105961|NCT04477811|Vitamin K|vitamin k|mesh-list
111105962|NCT04477811|Vitamin K 2|vitamin k 2|mesh-list
111105963|NCT04477811|Vitamin K 1|vitamin k 1|mesh-list
111105964|NCT04477811|Micronutrients|micronutrients|mesh-ancestor
111105965|NCT04477811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111105966|NCT04477811|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111105967|NCT04477811|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111105968|NCT04477811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111105969|NCT04477811|Hemostatics|hemostatics|mesh-ancestor
111105970|NCT04477811|Coagulants|coagulants|mesh-ancestor
111105971|NCT02332031|Sorafenib|sorafenib|mesh-list
111105972|NCT02332031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111105973|NCT02332031|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111105974|NCT02332031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111105975|NCT02332031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111105976|NCT03112031|Tamoxifen|tamoxifen|mesh-list
111105977|NCT03112031|Fluconazole|fluconazole|mesh-list
111105978|NCT03112031|Amphotericin B|amphotericin b|mesh-list
111105979|NCT03112031|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
111105980|NCT03112031|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111105981|NCT03112031|Hormone Antagonists|hormone antagonists|mesh-ancestor
111105982|NCT03112031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111105983|NCT03112031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111105984|NCT03112031|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111105985|NCT03112031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111105986|NCT03112031|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111105987|NCT03112031|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111105988|NCT03112031|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111105989|NCT03112031|Antifungal Agents|antifungal agents|mesh-ancestor
111105990|NCT03112031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111105991|NCT03112031|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111105992|NCT03112031|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110411759|NCT00943735|Fesoterodine|fesoterodine|mesh-list
111105993|NCT03112031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111105994|NCT03112031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111105995|NCT03112031|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111105996|NCT03112031|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111105997|NCT03112031|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111105998|NCT03112031|Amebicides|amebicides|mesh-ancestor
111105999|NCT03112031|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111106000|NCT03112031|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111106001|NCT03112031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111106002|NCT03111797|Morphine|morphine|mesh-list
111106003|NCT03111797|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111106004|NCT03111797|Narcotics|narcotics|mesh-ancestor
111106005|NCT03111797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111106006|NCT03111797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111106007|NCT03111797|Analgesics|analgesics|mesh-ancestor
111106008|NCT03111797|Sensory System Agents|sensory system agents|mesh-ancestor
111106009|NCT03111797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111106010|NCT02938013|Sofosbuvir|sofosbuvir|mesh-list
111106012|NCT02938013|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
111106013|NCT02938013|Antiviral Agents|antiviral agents|mesh-ancestor
111106014|NCT02938013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111106015|NCT02820311|Moxifloxacin|moxifloxacin|mesh-list
111106016|NCT02820311|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111106017|NCT02820311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111106018|NCT02820311|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111106019|NCT02820311|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111106020|NCT02820311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111106021|NCT02820311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111106022|NCT02820311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111106023|NCT02336633|Resveratrol|resveratrol|mesh-list
111106024|NCT02336633|Antioxidants|antioxidants|mesh-ancestor
111106025|NCT02336633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111106026|NCT02336633|Protective Agents|protective agents|mesh-ancestor
111106027|NCT02336633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111106028|NCT02336633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111106029|NCT02336633|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111106030|NCT02336477|Mexiletine|mexiletine|mesh-list
111106031|NCT02336477|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111106032|NCT02336477|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111106033|NCT02336477|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111106034|NCT02336477|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111106035|NCT02336477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111106036|NCT04624451|Dalbavancin|dalbavancin|mesh-list
111106037|NCT04624451|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111106038|NCT04624451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111106039|NCT02642315|Gabapentin|gabapentin|mesh-list
111106040|NCT02642315|Analgesics|analgesics|mesh-ancestor
111106041|NCT02642315|Sensory System Agents|sensory system agents|mesh-ancestor
111106042|NCT02642315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111106043|NCT02642315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111106044|NCT02642315|Anticonvulsants|anticonvulsants|mesh-ancestor
111106045|NCT02642315|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111106046|NCT02642315|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111106047|NCT02642315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111106048|NCT02642315|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111106049|NCT02642315|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111106050|NCT02642315|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111106051|NCT02642315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111106052|NCT02642315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111106053|NCT02642315|Antimanic Agents|antimanic agents|mesh-ancestor
111106054|NCT02518139|Tiotropium Bromide|tiotropium bromide|mesh-list
111106055|NCT02518139|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111106056|NCT02518139|Autonomic Agents|autonomic agents|mesh-ancestor
111106057|NCT02518139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111106058|NCT02518139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111106059|NCT02518139|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111106060|NCT02518139|Respiratory System Agents|respiratory system agents|mesh-ancestor
111106061|NCT02518139|Parasympatholytics|parasympatholytics|mesh-ancestor
111106062|NCT02518139|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111106063|NCT02518139|Cholinergic Agents|cholinergic agents|mesh-ancestor
111106064|NCT02518139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111106065|NCT02518139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111489783|NCT04868760|Ipilimumab|ipilimumab|mesh-list
111489784|NCT04868760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111106066|NCT02709889|Dexamethasone|dexamethasone|mesh-list
110647210|NCT00183391|Adrenergic Agents|adrenergic agents|mesh-ancestor
111106067|NCT02709889|Rovalpituzumab tesirine|rovalpituzumab tesirine|mesh-list
111106068|NCT02709889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111106069|NCT02709889|Antiemetics|antiemetics|mesh-ancestor
111106070|NCT02709889|Autonomic Agents|autonomic agents|mesh-ancestor
111106071|NCT02709889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111106072|NCT02709889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111106073|NCT02709889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111106074|NCT02709889|Glucocorticoids|glucocorticoids|mesh-ancestor
111106076|NCT02709889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111106077|NCT02709889|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111106078|NCT02709889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111106079|NCT02709889|Immunoconjugates|immunoconjugates|mesh-ancestor
111106080|NCT02709889|Immunologic Factors|immunologic factors|mesh-ancestor
111106081|NCT03189901|Simendan|simendan|mesh-list
111106082|NCT03189901|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111106083|NCT03189901|Vasodilator Agents|vasodilator agents|mesh-ancestor
111106084|NCT03189901|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
111106085|NCT03189901|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111106087|NCT03189901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111106088|NCT03189901|Protective Agents|protective agents|mesh-ancestor
111106089|NCT03189901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111106090|NCT02711995|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
111106091|NCT02711995|Botulinum Toxins|botulinum toxins|mesh-list
111106092|NCT02711995|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111106093|NCT02711995|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111106094|NCT02711995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111106095|NCT02711995|Cholinergic Agents|cholinergic agents|mesh-ancestor
111106096|NCT02711995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111106097|NCT02711995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111106098|NCT02711995|Laxatives|laxatives|mesh-ancestor
111106099|NCT02711995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111106100|NCT03193723|Anesthetics|anesthetics|mesh-list
111106101|NCT03193723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111106102|NCT03193723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111106103|NCT02437825|Octreotide|octreotide|mesh-list
111106104|NCT02437825|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111106105|NCT02437825|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111106106|NCT02437825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111106107|NCT02442817|Linagliptin|linagliptin|mesh-list
111106108|NCT02442817|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111106109|NCT02442817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111106110|NCT02442817|Incretins|incretins|mesh-ancestor
111106111|NCT02442817|Hormones|hormones|mesh-ancestor
111106112|NCT02442817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111106113|NCT02442817|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111106114|NCT02442817|Protease Inhibitors|protease inhibitors|mesh-ancestor
111106115|NCT02442817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111106116|NCT02442817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111106117|NCT02437591|Fidaxomicin|fidaxomicin|mesh-list
111106118|NCT02437591|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111106119|NCT02437591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111106120|NCT02442739|Ketamine|ketamine|mesh-list
111106121|NCT02442739|Analgesics|analgesics|mesh-ancestor
111106122|NCT02442739|Sensory System Agents|sensory system agents|mesh-ancestor
111106123|NCT02442739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111106124|NCT02442739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111106125|NCT02442739|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111106126|NCT02442739|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111106127|NCT02442739|Anesthetics, General|anesthetics, general|mesh-ancestor
111106128|NCT02442739|Anesthetics|anesthetics|mesh-ancestor
111106129|NCT02442739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111106130|NCT02442739|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111106131|NCT02442739|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111106132|NCT02442739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111106133|NCT02442739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111106134|NCT03022903|Aminolevulinic Acid|aminolevulinic acid|mesh-list
111106135|NCT03022903|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111106136|NCT03022903|Dermatologic Agents|dermatologic agents|mesh-ancestor
111106137|NCT02442427|Palivizumab|palivizumab|mesh-list
111489785|NCT04868760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111489786|NCT04868760|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111106138|NCT02442427|Antiviral Agents|antiviral agents|mesh-ancestor
111489787|NCT04868760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111106139|NCT02442427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111106140|NCT03189043|Anti-Infective Agents|anti-infective agents|mesh-list
111106141|NCT03189043|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111106142|NCT05233735|Betamethasone|betamethasone|mesh-list
111106143|NCT05233735|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111106144|NCT05233735|Glucocorticoids|glucocorticoids|mesh-ancestor
111106145|NCT05233735|Hormones|hormones|mesh-ancestor
111106146|NCT05233735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111106147|NCT05233735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111106148|NCT05233735|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111106149|NCT05233735|Respiratory System Agents|respiratory system agents|mesh-ancestor
111106150|NCT02436499|Botulinum Toxins|botulinum toxins|mesh-list
111106151|NCT02436499|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111106152|NCT02436499|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111106153|NCT02436499|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111106154|NCT02436499|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111106155|NCT02436499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111106156|NCT02436499|Cholinergic Agents|cholinergic agents|mesh-ancestor
111106157|NCT02436499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111106158|NCT02436499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111106159|NCT02436499|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111106160|NCT02436499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111106161|NCT02331563|Dexmedetomidine|dexmedetomidine|mesh-list
111106162|NCT02331563|Bupivacaine|bupivacaine|mesh-list
111106163|NCT02331563|Anesthetics, Local|anesthetics, local|mesh-ancestor
111106164|NCT02331563|Anesthetics|anesthetics|mesh-ancestor
111106165|NCT02331563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111106166|NCT02331563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111106167|NCT02331563|Sensory System Agents|sensory system agents|mesh-ancestor
111106168|NCT02331563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111106169|NCT02331563|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111106170|NCT02331563|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111106171|NCT02331563|Analgesics|analgesics|mesh-ancestor
111106172|NCT02331563|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111106173|NCT02331563|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111106174|NCT02331563|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111106175|NCT02331563|Adrenergic Agents|adrenergic agents|mesh-ancestor
111106176|NCT02331563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111106177|NCT02331563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111106178|NCT02331173|Dorzolamide|dorzolamide|mesh-list
111106179|NCT02331173|Brinzolamide|brinzolamide|mesh-list
111106180|NCT02331173|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111106181|NCT02331173|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
111106182|NCT02331173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111106183|NCT02331173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111106184|NCT02709109|Ivacaftor|ivacaftor|mesh-list
111106185|NCT02709109|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
111106186|NCT02709109|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111106187|NCT02709109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111106188|NCT03117595|Fentanyl|fentanyl|mesh-list
111106189|NCT03117595|Morphine|morphine|mesh-list
111106190|NCT03117595|Bupivacaine|bupivacaine|mesh-list
111106191|NCT03117595|Anesthetics, Local|anesthetics, local|mesh-ancestor
111106192|NCT03117595|Anesthetics|anesthetics|mesh-ancestor
111106193|NCT03117595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111106194|NCT03117595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111106195|NCT03117595|Sensory System Agents|sensory system agents|mesh-ancestor
111106196|NCT03117595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111106197|NCT03117595|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111106198|NCT03117595|Narcotics|narcotics|mesh-ancestor
111106199|NCT03117595|Analgesics|analgesics|mesh-ancestor
111106200|NCT03117595|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111106201|NCT03117595|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111106202|NCT03117595|Anesthetics, General|anesthetics, general|mesh-ancestor
111106203|NCT02039531|Mitogens|mitogens|mesh-list
111106204|NCT02039531|Hyaluronic Acid|hyaluronic acid|mesh-list
111106205|NCT02039531|Mitosis Modulators|mitosis modulators|mesh-ancestor
111106206|NCT02039531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111106207|NCT02039531|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111489788|NCT04508166|Sodium Oxybate|sodium oxybate|mesh-list
111106208|NCT02039531|Immunologic Factors|immunologic factors|mesh-ancestor
111106209|NCT02039531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111106210|NCT02039531|Viscosupplements|viscosupplements|mesh-ancestor
111106211|NCT02039531|Protective Agents|protective agents|mesh-ancestor
111489789|NCT04508166|Dexmedetomidine|dexmedetomidine|mesh-list
111106212|NCT02331251|Paclitaxel|paclitaxel|mesh-list
111106213|NCT02331251|Vinorelbine|vinorelbine|mesh-list
111106214|NCT02331251|Docetaxel|docetaxel|mesh-list
111106215|NCT02331251|Gemcitabine|gemcitabine|mesh-list
111106216|NCT02331251|Doxorubicin|doxorubicin|mesh-list
111106217|NCT02331251|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111106218|NCT02331251|Pembrolizumab|pembrolizumab|mesh-list
111106219|NCT02331251|Irinotecan|irinotecan|mesh-list
111106220|NCT02331251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111106221|NCT02331251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111106222|NCT02331251|Tubulin Modulators|tubulin modulators|mesh-ancestor
111106223|NCT02331251|Antimitotic Agents|antimitotic agents|mesh-ancestor
111106224|NCT02331251|Mitosis Modulators|mitosis modulators|mesh-ancestor
111106225|NCT02331251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111106226|NCT02331251|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111106227|NCT02331251|Antimetabolites|antimetabolites|mesh-ancestor
111106228|NCT02331251|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111106229|NCT02331251|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111106230|NCT02331251|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111106231|NCT02331251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111106232|NCT02331251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111106233|NCT02331251|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111106234|NCT02331251|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111106235|NCT02435797|Nicorandil|nicorandil|mesh-list
111106236|NCT02435797|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111106237|NCT02435797|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111106238|NCT02435797|Vasodilator Agents|vasodilator agents|mesh-ancestor
111106239|NCT02435797|Vitamin B Complex|vitamin b complex|mesh-ancestor
111106240|NCT02435797|Vitamins|vitamins|mesh-ancestor
111106241|NCT02435797|Micronutrients|micronutrients|mesh-ancestor
111106242|NCT02435797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111106243|NCT02330705|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
111106244|NCT02330705|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111106245|NCT02330705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111106246|NCT02330783|Bevacizumab|bevacizumab|mesh-list
111106247|NCT02330783|Sorafenib|sorafenib|mesh-list
111106248|NCT02330783|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111106249|NCT02330783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111106250|NCT02330783|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111106251|NCT02330783|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111106252|NCT02330783|Growth Substances|growth substances|mesh-ancestor
111106253|NCT02330783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111106254|NCT02330783|Growth Inhibitors|growth inhibitors|mesh-ancestor
111106255|NCT02330783|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111106256|NCT02330783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111106257|NCT02330783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111106258|NCT02335151|Desflurane|desflurane|mesh-list
111106259|NCT02335151|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111106260|NCT02335151|Anesthetics, General|anesthetics, general|mesh-ancestor
111106261|NCT02335151|Anesthetics|anesthetics|mesh-ancestor
111106262|NCT02335151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111106263|NCT02335151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111106264|NCT02441803|Cytarabine|cytarabine|mesh-list
111106265|NCT02441803|Mycophenolic Acid|mycophenolic acid|mesh-list
111106266|NCT02441803|Cyclophosphamide|cyclophosphamide|mesh-list
111106267|NCT02441803|Busulfan|busulfan|mesh-list
111106268|NCT02441803|Fludarabine|fludarabine|mesh-list
111106269|NCT02441803|Fludarabine phosphate|fludarabine phosphate|mesh-list
111106270|NCT02441803|Decitabine|decitabine|mesh-list
111106271|NCT02441803|Idarubicin|idarubicin|mesh-list
111106272|NCT02441803|Clofarabine|clofarabine|mesh-list
111106273|NCT02441803|Tacrolimus|tacrolimus|mesh-list
111106274|NCT02441803|Thymoglobulin|thymoglobulin|mesh-list
111106275|NCT02441803|Antilymphocyte Serum|antilymphocyte serum|mesh-list
111106276|NCT02441803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111106277|NCT02441803|Immunologic Factors|immunologic factors|mesh-ancestor
111106278|NCT02441803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111106279|NCT02441803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111106280|NCT02441803|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111106281|NCT02441803|Alkylating Agents|alkylating agents|mesh-ancestor
111106282|NCT02441803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111489790|NCT04508166|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111106283|NCT02441803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111106284|NCT02441803|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111106285|NCT02441803|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111106286|NCT02441803|Antimetabolites|antimetabolites|mesh-ancestor
111106287|NCT02441803|Antiviral Agents|antiviral agents|mesh-ancestor
111106288|NCT02441803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111106289|NCT02441803|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111106290|NCT02441803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111106291|NCT02441803|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111106292|NCT02441803|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111106293|NCT02441803|Antitubercular Agents|antitubercular agents|mesh-ancestor
111106294|NCT02441803|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111106295|NCT02441803|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111106296|NCT02441803|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111106297|NCT02709655|Vortioxetine|vortioxetine|mesh-list
111106298|NCT02709655|Fluoxetine|fluoxetine|mesh-list
111106299|NCT02709655|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111106300|NCT02709655|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111106301|NCT02709655|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111106302|NCT02709655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111106303|NCT02709655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111106304|NCT02709655|Serotonin Agents|serotonin agents|mesh-ancestor
111106305|NCT02709655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111106306|NCT02709655|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111106307|NCT02709655|Antidepressive Agents|antidepressive agents|mesh-ancestor
111106308|NCT02709655|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110823412|NCT05154968|Mannitol|mannitol|mesh-list
111106309|NCT02709655|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111106310|NCT02709655|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111106311|NCT02709655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111106312|NCT02709655|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111106313|NCT02709655|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111106314|NCT02709655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111106315|NCT02709655|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111106316|NCT02709655|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111106317|NCT02709655|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111106318|NCT02709655|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111106319|NCT02334605|Capsaicin|capsaicin|mesh-list
111106320|NCT02334605|Antipruritics|antipruritics|mesh-ancestor
111106321|NCT02334605|Dermatologic Agents|dermatologic agents|mesh-ancestor
111106322|NCT02334605|Sensory System Agents|sensory system agents|mesh-ancestor
111106323|NCT02334605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111106324|NCT02334605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111106325|NCT02329535|Progesterone|progesterone|mesh-list
111106326|NCT02329535|Progestins|progestins|mesh-ancestor
111106327|NCT02329535|Hormones|hormones|mesh-ancestor
111106328|NCT02329535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111106329|NCT02329535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111106330|NCT03187795|Mirabegron|mirabegron|mesh-list
111106331|NCT03187795|Oxybutynin|oxybutynin|mesh-list
111106332|NCT03187795|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
111106333|NCT03187795|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111106334|NCT03187795|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111106335|NCT03187795|Adrenergic Agents|adrenergic agents|mesh-ancestor
111106336|NCT03187795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111106337|NCT03187795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111106338|NCT03187795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111106339|NCT03187795|Urological Agents|urological agents|mesh-ancestor
111106340|NCT03187795|Parasympatholytics|parasympatholytics|mesh-ancestor
111106341|NCT03187795|Autonomic Agents|autonomic agents|mesh-ancestor
111106342|NCT03187795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111106343|NCT03187795|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111106344|NCT03187795|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111106345|NCT03187795|Cholinergic Agents|cholinergic agents|mesh-ancestor
111106346|NCT02435563|Ritonavir|ritonavir|mesh-list
111106347|NCT02435563|Ticagrelor|ticagrelor|mesh-list
111106348|NCT02435563|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111106349|NCT02435563|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111106350|NCT02435563|Protease Inhibitors|protease inhibitors|mesh-ancestor
111106351|NCT02435563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111106352|NCT02435563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111106353|NCT02435563|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111106354|NCT02435563|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111106355|NCT02435563|Antiviral Agents|antiviral agents|mesh-ancestor
111106356|NCT02435563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111106357|NCT02435563|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111106358|NCT02435563|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111489791|NCT04508166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111489792|NCT04508166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111489793|NCT04508166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111489794|NCT04508166|Analgesics|analgesics|mesh-ancestor
111106359|NCT02435563|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111106360|NCT02435563|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111106361|NCT02435563|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111106362|NCT02435563|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111106363|NCT02435563|Purinergic Agents|purinergic agents|mesh-ancestor
111106364|NCT02435563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111106365|NCT02435563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111106366|NCT02433847|Mosapride|mosapride|mesh-list
111106367|NCT02433847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111106368|NCT02433847|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111106369|NCT02433847|Serotonin Agents|serotonin agents|mesh-ancestor
111106370|NCT02433847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111106371|NCT02433847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111106372|NCT02433847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111106373|NCT02435095|Antipsychotic Agents|antipsychotic agents|mesh-list
111106374|NCT02435095|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111106375|NCT02435095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111106376|NCT02435095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111106377|NCT02435095|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111106378|NCT02328521|Nicorandil|nicorandil|mesh-list
111106379|NCT02328521|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111106380|NCT02328521|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111106381|NCT02328521|Vasodilator Agents|vasodilator agents|mesh-ancestor
111106382|NCT02328521|Vitamin B Complex|vitamin b complex|mesh-ancestor
111106383|NCT02328521|Vitamins|vitamins|mesh-ancestor
111106384|NCT02328521|Micronutrients|micronutrients|mesh-ancestor
111106385|NCT02328521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111106386|NCT03831503|Antibodies|antibodies|mesh-list
111106387|NCT03831503|Immunologic Factors|immunologic factors|mesh-ancestor
111106388|NCT03831503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111106389|NCT03187093|Vortioxetine|vortioxetine|mesh-list
111106390|NCT03187093|Escitalopram|escitalopram|mesh-list
111106391|NCT03187093|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111106392|NCT03187093|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111106393|NCT03187093|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111106394|NCT03187093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111106395|NCT03187093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111106396|NCT03187093|Serotonin Agents|serotonin agents|mesh-ancestor
111106397|NCT03187093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111106398|NCT03187093|Antidepressive Agents|antidepressive agents|mesh-ancestor
111106399|NCT03187093|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111106400|NCT03187093|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111106401|NCT03187093|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111106402|NCT03187093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111106403|NCT03187093|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111106404|NCT03187093|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111106405|NCT03187093|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111106406|NCT03187093|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111106407|NCT02039999|Citric Acid|citric acid|mesh-list
111106408|NCT02039999|Sodium Citrate|sodium citrate|mesh-list
111106409|NCT02039999|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111106410|NCT02039999|Anticoagulants|anticoagulants|mesh-ancestor
111106411|NCT02039999|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
111106412|NCT02039999|Chelating Agents|chelating agents|mesh-ancestor
111106413|NCT02039999|Sequestering Agents|sequestering agents|mesh-ancestor
111106414|NCT02039999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111106415|NCT02434861|Sulfasalazine|sulfasalazine|mesh-list
111106416|NCT02434861|Digoxin|digoxin|mesh-list
111106417|NCT02434861|Rolapitant|rolapitant|mesh-list
111106418|NCT02434861|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111106419|NCT02434861|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111106420|NCT02434861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111106421|NCT02434861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111106422|NCT02434861|Protective Agents|protective agents|mesh-ancestor
111106423|NCT02434861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111106424|NCT02434861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111106425|NCT02434861|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111106426|NCT02434861|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111106427|NCT02434861|Analgesics|analgesics|mesh-ancestor
111106428|NCT02434861|Sensory System Agents|sensory system agents|mesh-ancestor
111106429|NCT02434861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111106430|NCT02434861|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111489795|NCT04508166|Sensory System Agents|sensory system agents|mesh-ancestor
111489796|NCT04508166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111106431|NCT02434861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111106432|NCT02434861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111106433|NCT02434861|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
111106434|NCT02434861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111106436|NCT03187015|Midazolam|midazolam|mesh-list
111106437|NCT03187015|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111106438|NCT03187015|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111106439|NCT03187015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111106440|NCT03187015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111106441|NCT03187015|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111106442|NCT03187015|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111106443|NCT03187015|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111106444|NCT03187015|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111106445|NCT03187015|Anesthetics, General|anesthetics, general|mesh-ancestor
111106446|NCT03187015|Anesthetics|anesthetics|mesh-ancestor
111106447|NCT03187015|GABA Modulators|gaba modulators|mesh-ancestor
111106448|NCT03187015|GABA Agents|gaba agents|mesh-ancestor
111106449|NCT03187015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111106450|NCT03187015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111106451|NCT03187015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111106452|NCT03187015|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111106453|NCT03187015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111106454|NCT02328053|Voriconazole|voriconazole|mesh-list
111106455|NCT02328053|Natamycin|natamycin|mesh-list
111106456|NCT02328053|Antifungal Agents|antifungal agents|mesh-list
111106457|NCT02328053|Clotrimazole|clotrimazole|mesh-list
111106458|NCT02328053|Miconazole|miconazole|mesh-list
111106459|NCT02328053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111106460|NCT02328053|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111106461|NCT02328053|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111106462|NCT02328053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111106463|NCT02328053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111106464|NCT02328053|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111106465|NCT02328053|Hormone Antagonists|hormone antagonists|mesh-ancestor
111106466|NCT02328053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111106467|NCT02328053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111106468|NCT02328053|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111106469|NCT02328053|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111106470|NCT02328053|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111106471|NCT02328053|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111106472|NCT02022748|Ticagrelor|ticagrelor|mesh-list
111106473|NCT02022748|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111106474|NCT02022748|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111106475|NCT02022748|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111106476|NCT02022748|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111106477|NCT02022748|Purinergic Agents|purinergic agents|mesh-ancestor
111106478|NCT02022748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111106479|NCT02022748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111106480|NCT02022748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111106481|NCT02333513|Vincristine|vincristine|mesh-list
111106482|NCT02333513|Lomustine|lomustine|mesh-list
111106483|NCT02333513|Procarbazine|procarbazine|mesh-list
111106484|NCT02333513|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111106485|NCT02333513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111106486|NCT02333513|Tubulin Modulators|tubulin modulators|mesh-ancestor
111106487|NCT02333513|Antimitotic Agents|antimitotic agents|mesh-ancestor
111106488|NCT02333513|Mitosis Modulators|mitosis modulators|mesh-ancestor
111106489|NCT02333513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111106490|NCT02333513|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111106491|NCT02333513|Alkylating Agents|alkylating agents|mesh-ancestor
111106492|NCT02434549|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111106493|NCT02434549|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111106494|NCT02434549|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111106495|NCT02434549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111106496|NCT02434549|Cholinergic Agents|cholinergic agents|mesh-ancestor
111106497|NCT02434549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111106498|NCT02434549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111106499|NCT02328209|Ranibizumab|ranibizumab|mesh-list
111106500|NCT02328209|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111106501|NCT02328209|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111489797|NCT04508166|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111489798|NCT04508166|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111489799|NCT04508166|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111106502|NCT02328209|Growth Substances|growth substances|mesh-ancestor
111106503|NCT02328209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111106504|NCT02328209|Growth Inhibitors|growth inhibitors|mesh-ancestor
111106505|NCT02328209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111106506|NCT02328443|Itraconazole|itraconazole|mesh-list
111106507|NCT02328443|Rifampin|rifampin|mesh-list
111106508|NCT02328443|Midazolam|midazolam|mesh-list
111106509|NCT02328443|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111106510|NCT02328443|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111106511|NCT02328443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111106512|NCT02328443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111106513|NCT02328443|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111106514|NCT02328443|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111106515|NCT02328443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111106516|NCT02328443|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111106517|NCT02328443|Anesthetics, General|anesthetics, general|mesh-ancestor
111106518|NCT02328443|Anesthetics|anesthetics|mesh-ancestor
111106519|NCT02328443|GABA Modulators|gaba modulators|mesh-ancestor
111106520|NCT02328443|GABA Agents|gaba agents|mesh-ancestor
111106521|NCT02328443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111106522|NCT02328443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111106523|NCT02328443|Antifungal Agents|antifungal agents|mesh-ancestor
111106524|NCT02328443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111106525|NCT02328443|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111106526|NCT02328443|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111106527|NCT02328443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111106528|NCT02328443|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111106529|NCT02328443|Hormone Antagonists|hormone antagonists|mesh-ancestor
111106530|NCT02328443|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111106531|NCT02328443|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111106532|NCT02328443|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111106533|NCT02328443|Antitubercular Agents|antitubercular agents|mesh-ancestor
111106534|NCT02328443|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111106535|NCT02328443|Leprostatic Agents|leprostatic agents|mesh-ancestor
111106536|NCT02328443|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111106537|NCT02328443|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111106538|NCT02328443|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111106539|NCT02328443|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
111106540|NCT02328443|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
111106541|NCT02328443|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
111106542|NCT02328443|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111106543|NCT02039765|Brimonidine Tartrate|brimonidine tartrate|mesh-list
111106544|NCT02039765|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111106545|NCT02039765|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111106546|NCT02039765|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111106547|NCT02039765|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111106548|NCT02039765|Adrenergic Agents|adrenergic agents|mesh-ancestor
111106549|NCT02039765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111106550|NCT02039765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111106551|NCT02039765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111106553|NCT03191539|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111106554|NCT03191539|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111106555|NCT03191539|Analgesics|analgesics|mesh-ancestor
111106556|NCT03191539|Sensory System Agents|sensory system agents|mesh-ancestor
111106557|NCT03191539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111106558|NCT03191539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111106559|NCT03191539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111106560|NCT03191539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111106561|NCT03191539|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
111106562|NCT03191539|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111106563|NCT03191539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111106564|NCT03191539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111106565|NCT02433925|Resveratrol|resveratrol|mesh-list
111106566|NCT02433925|Antioxidants|antioxidants|mesh-ancestor
111106567|NCT02433925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111106568|NCT02433925|Protective Agents|protective agents|mesh-ancestor
111106569|NCT02433925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111489800|NCT04508166|Adrenergic Agents|adrenergic agents|mesh-ancestor
111489801|NCT04508166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111489802|NCT04508166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111489803|NCT04508166|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111489804|NCT04508166|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111489805|NCT04508166|Anesthetics, General|anesthetics, general|mesh-ancestor
111106570|NCT02433925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111106571|NCT02433925|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111106572|NCT02332967|Palmitic Acid|palmitic acid|mesh-list
111106573|NCT02332967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111106574|NCT02332967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111106575|NCT02327663|Emtricitabine|emtricitabine|mesh-list
111106576|NCT02327663|Antiviral Agents|antiviral agents|mesh-ancestor
111106577|NCT02327663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111106578|NCT02327663|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111106579|NCT02327663|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111106580|NCT02327663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111106581|NCT02327663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111106582|NCT02327663|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111106583|NCT02327663|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111106584|NCT02333123|Aspirin|aspirin|mesh-list
111106585|NCT02333123|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111106586|NCT02333123|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111106587|NCT02333123|Analgesics|analgesics|mesh-ancestor
111106588|NCT02333123|Sensory System Agents|sensory system agents|mesh-ancestor
111106589|NCT02333123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111106590|NCT02333123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111106591|NCT02333123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111106592|NCT02333123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111106593|NCT02333123|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111106594|NCT02333123|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111106595|NCT02333123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111106596|NCT02333123|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111106597|NCT02333123|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111106598|NCT02333123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111106599|NCT02333123|Antipyretics|antipyretics|mesh-ancestor
111106600|NCT02332811|Sevelamer|sevelamer|mesh-list
111106601|NCT02332811|Chelating Agents|chelating agents|mesh-ancestor
111106602|NCT02332811|Sequestering Agents|sequestering agents|mesh-ancestor
111106603|NCT02332811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111106604|NCT02433457|Omeprazole|omeprazole|mesh-list
111106605|NCT02433457|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111106606|NCT02433457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111106607|NCT02433457|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111106608|NCT02433457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111106609|NCT02433457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111106610|NCT02021656|Sofosbuvir|sofosbuvir|mesh-list
111106611|NCT02021656|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
111106612|NCT02021656|Ledipasvir|ledipasvir|mesh-list
111106613|NCT02021656|Antiviral Agents|antiviral agents|mesh-ancestor
111106614|NCT02021656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111106615|NCT03145025|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
111106616|NCT03145025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111106617|NCT03145025|Glucocorticoids|glucocorticoids|mesh-ancestor
111106618|NCT03145025|Hormones|hormones|mesh-ancestor
111106619|NCT03145025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111106620|NCT03145025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111106621|NCT03144947|Docetaxel|docetaxel|mesh-list
111106622|NCT03144947|Trastuzumab|trastuzumab|mesh-list
111106623|NCT03144947|Pertuzumab|pertuzumab|mesh-list
111106624|NCT03144947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111106625|NCT03144947|Tubulin Modulators|tubulin modulators|mesh-ancestor
111106626|NCT03144947|Antimitotic Agents|antimitotic agents|mesh-ancestor
111106627|NCT03144947|Mitosis Modulators|mitosis modulators|mesh-ancestor
111106628|NCT03144947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111106629|NCT03144947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111106630|NCT02433535|Simvastatin|simvastatin|mesh-list
111106631|NCT02433535|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111106632|NCT02433535|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111106633|NCT02433535|Antimetabolites|antimetabolites|mesh-ancestor
111106634|NCT02433535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111106635|NCT02433535|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111106636|NCT02433535|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111106637|NCT02433535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111106638|NCT03144713|Terlipressin|terlipressin|mesh-list
111106639|NCT03144713|Midodrine|midodrine|mesh-list
111106640|NCT03144713|Sympathomimetics|sympathomimetics|mesh-ancestor
111489806|NCT04508166|Anesthetics|anesthetics|mesh-ancestor
111106641|NCT03144713|Autonomic Agents|autonomic agents|mesh-ancestor
111106642|NCT03144713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111106643|NCT03144713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111106644|NCT03144713|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111106645|NCT03144713|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111106646|NCT03144713|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111106647|NCT03144713|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111106648|NCT03144713|Adrenergic Agents|adrenergic agents|mesh-ancestor
111106649|NCT03144713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111106650|NCT03144713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111106651|NCT03144713|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111106653|NCT03191383|Immunologic Factors|immunologic factors|mesh-ancestor
111106654|NCT03191383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111106655|NCT02075632|Alclometasone dipropionate|alclometasone dipropionate|mesh-list
111106656|NCT02075632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111106657|NCT02075632|Glucocorticoids|glucocorticoids|mesh-ancestor
111106658|NCT02075632|Hormones|hormones|mesh-ancestor
111106659|NCT02075632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111106660|NCT02075632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111106661|NCT02430259|Isoniazid|isoniazid|mesh-list
111106662|NCT02430259|Rifapentine|rifapentine|mesh-list
111106663|NCT02430259|Antitubercular Agents|antitubercular agents|mesh-ancestor
111106664|NCT02430259|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111106665|NCT02430259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111106666|NCT02430259|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
111106667|NCT02430259|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111106668|NCT02430259|Antimetabolites|antimetabolites|mesh-ancestor
111106669|NCT02430259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111106670|NCT02430259|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111106671|NCT02430259|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111106672|NCT02430259|Leprostatic Agents|leprostatic agents|mesh-ancestor
111106673|NCT02327039|Dapagliflozin|dapagliflozin|mesh-list
111106674|NCT02327039|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111106675|NCT02327039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111106676|NCT02327039|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111106677|NCT02327039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111106678|NCT03142607|Chlorhexidine|chlorhexidine|mesh-list
111106679|NCT03142607|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110823796|NCT03382730|Chlorhexidine|chlorhexidine|mesh-list
111106681|NCT03142607|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111106682|NCT03142607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111106683|NCT03142607|Disinfectants|disinfectants|mesh-ancestor
111106684|NCT03142607|Dermatologic Agents|dermatologic agents|mesh-ancestor
111106685|NCT03142607|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111106686|NCT03142607|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111106687|NCT03142607|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111106688|NCT03186547|Botulinum Toxins|botulinum toxins|mesh-list
111106689|NCT03186547|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111106690|NCT03186547|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111106691|NCT03186547|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111106692|NCT03186547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111106693|NCT03186547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111106694|NCT03186547|Cholinergic Agents|cholinergic agents|mesh-ancestor
111106695|NCT03186547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111106696|NCT03186547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111106697|NCT03186547|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111106698|NCT03186547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111106699|NCT05077475|Cryptophycin 52|cryptophycin 52|mesh-list
111106700|NCT05077475|Antimitotic Agents|antimitotic agents|mesh-ancestor
111106701|NCT05077475|Mitosis Modulators|mitosis modulators|mesh-ancestor
111106702|NCT05077475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111106703|NCT05077475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111106704|NCT02326727|Fentanyl|fentanyl|mesh-list
111106705|NCT02326727|Nitrous Oxide|nitrous oxide|mesh-list
111106706|NCT02326727|Propofol|propofol|mesh-list
111106707|NCT02326727|Ropivacaine|ropivacaine|mesh-list
111106708|NCT02326727|Isoflurane|isoflurane|mesh-list
111106709|NCT02326727|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111119172|NCT05289687|Daratumumab|daratumumab|mesh-list
111489807|NCT04444440|Ciprofloxacin|ciprofloxacin|mesh-list
111489808|NCT04444440|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111489809|NCT04444440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111489810|NCT04444440|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111489811|NCT04444440|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111489812|NCT04444440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111489813|NCT04444440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111106710|NCT02326727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111106711|NCT02326727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111106712|NCT02326727|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111106713|NCT02326727|Anesthetics, General|anesthetics, general|mesh-ancestor
111106714|NCT02326727|Anesthetics|anesthetics|mesh-ancestor
111106715|NCT02326727|Anesthetics, Local|anesthetics, local|mesh-ancestor
111106716|NCT02326727|Sensory System Agents|sensory system agents|mesh-ancestor
111106717|NCT02326727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111106718|NCT02326727|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111106719|NCT02326727|Narcotics|narcotics|mesh-ancestor
111106720|NCT02326727|Analgesics|analgesics|mesh-ancestor
111106721|NCT02326727|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111106722|NCT02326727|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111106723|NCT02326727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111106724|NCT02432911|Cytarabine|cytarabine|mesh-list
111106725|NCT02432911|Aclacinomycins|aclacinomycins|mesh-list
111106726|NCT02432911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111106727|NCT02432911|Antimetabolites|antimetabolites|mesh-ancestor
111106728|NCT02432911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111106729|NCT02432911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111106730|NCT02432911|Antiviral Agents|antiviral agents|mesh-ancestor
111106731|NCT02432911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111106732|NCT02432911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111106733|NCT02432911|Immunologic Factors|immunologic factors|mesh-ancestor
111106734|NCT02432911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111106735|NCT02432911|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111106736|NCT02432911|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111106737|NCT03588767|Vitamin D|vitamin d|mesh-list
111106738|NCT03588767|Ergocalciferols|ergocalciferols|mesh-list
111106739|NCT03588767|Cholecalciferol|cholecalciferol|mesh-list
111106740|NCT03588767|Vitamins|vitamins|mesh-list
111106741|NCT03588767|Anabolic Androgenic Steroids|anabolic androgenic steroids|mesh-list
111106742|NCT03588767|Testosterone Congeners|testosterone congeners|mesh-list
111106743|NCT03588767|Micronutrients|micronutrients|mesh-ancestor
110647330|NCT02577809|Narcotics|narcotics|mesh-ancestor
111106744|NCT03588767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111106745|NCT03588767|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111106746|NCT03588767|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111106747|NCT03588767|Anabolic Agents|anabolic agents|mesh-ancestor
111106748|NCT03588767|Hormones|hormones|mesh-ancestor
111106749|NCT03588767|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111106750|NCT03588767|Performance-Enhancing Substances|performance-enhancing substances|mesh-ancestor
111106751|NCT02440399|Acetaminophen|acetaminophen|mesh-list
111106752|NCT02440399|Diclofenac|diclofenac|mesh-list
111106753|NCT02440399|Morphine|morphine|mesh-list
111106754|NCT02440399|Oxycodone|oxycodone|mesh-list
111106755|NCT02440399|Tramadol|tramadol|mesh-list
111106756|NCT02440399|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111106757|NCT02440399|Narcotics|narcotics|mesh-ancestor
111106758|NCT02440399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111106759|NCT02440399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111106760|NCT02440399|Analgesics|analgesics|mesh-ancestor
111106761|NCT02440399|Sensory System Agents|sensory system agents|mesh-ancestor
111106762|NCT02440399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111106763|NCT02440399|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111106764|NCT02440399|Antipyretics|antipyretics|mesh-ancestor
111106765|NCT02440399|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111106766|NCT02440399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111106767|NCT02440399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111106768|NCT02440399|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111106769|NCT02440399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111106770|NCT02440399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111106771|NCT02429713|Oxymetazoline|oxymetazoline|mesh-list
111106772|NCT02429713|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111106773|NCT02429713|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111106774|NCT02429713|Adrenergic Agents|adrenergic agents|mesh-ancestor
111106775|NCT02429713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111106776|NCT02429713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111106777|NCT02429713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111106778|NCT02429713|Sympathomimetics|sympathomimetics|mesh-ancestor
111106779|NCT02429713|Autonomic Agents|autonomic agents|mesh-ancestor
111106780|NCT02429713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111106781|NCT02429713|Nasal Decongestants|nasal decongestants|mesh-ancestor
111106782|NCT02429713|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111489814|NCT04444440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111489815|NCT04444440|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111106783|NCT02429713|Respiratory System Agents|respiratory system agents|mesh-ancestor
111106784|NCT03191305|Warfarin|warfarin|mesh-list
111489816|NCT04444440|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111106785|NCT03191305|Anticoagulants|anticoagulants|mesh-ancestor
111106786|NCT03144401|Misoprostol|misoprostol|mesh-list
111106787|NCT03144401|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111106788|NCT03144401|Abortifacient Agents|abortifacient agents|mesh-ancestor
111106789|NCT03144401|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111106790|NCT03144401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111106791|NCT03144401|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111106792|NCT03144401|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111106793|NCT03144401|Oxytocics|oxytocics|mesh-ancestor
111106794|NCT04483765|Anesthetics|anesthetics|mesh-list
111106795|NCT04483765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111106796|NCT04483765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111106797|NCT03186313|Ribavirin|ribavirin|mesh-list
111106798|NCT03186313|Sofosbuvir|sofosbuvir|mesh-list
111106799|NCT03186313|Antimetabolites|antimetabolites|mesh-ancestor
111106800|NCT03186313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111106801|NCT03186313|Antiviral Agents|antiviral agents|mesh-ancestor
111106802|NCT03186313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111106803|NCT03144245|Pembrolizumab|pembrolizumab|mesh-list
111106804|NCT03144245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111106805|NCT03144245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111106806|NCT03144245|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111106807|NCT03144245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111106808|NCT04996199|Zileuton|zileuton|mesh-list
111106809|NCT04996199|Carbamazepine|carbamazepine|mesh-list
111106810|NCT04996199|Oxcarbazepine|oxcarbazepine|mesh-list
111106811|NCT04996199|Anticonvulsants|anticonvulsants|mesh-ancestor
111106812|NCT04996199|Antimanic Agents|antimanic agents|mesh-ancestor
110331418|NCT00472355|Apomorphine|apomorphine|mesh-list
111106813|NCT04996199|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111106814|NCT04996199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111106815|NCT04996199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111106816|NCT04996199|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111106817|NCT04996199|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111106818|NCT04996199|Analgesics|analgesics|mesh-ancestor
111106819|NCT04996199|Sensory System Agents|sensory system agents|mesh-ancestor
111106820|NCT04996199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111106821|NCT04996199|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111106822|NCT04996199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111106823|NCT04996199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111106824|NCT04996199|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111106825|NCT04996199|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111106826|NCT04996199|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111106827|NCT04996199|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111106828|NCT04996199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111106829|NCT04996199|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111106830|NCT04996199|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
110823931|NCT01319864|Antiviral Agents|antiviral agents|mesh-ancestor
111106831|NCT04996199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111106832|NCT04996199|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
111106833|NCT04996199|Hormone Antagonists|hormone antagonists|mesh-ancestor
111106834|NCT04996199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111106836|NCT02432833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111106837|NCT02432833|Immunologic Factors|immunologic factors|mesh-ancestor
111106838|NCT02432833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111106839|NCT02432833|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111106840|NCT02432833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111106841|NCT02432833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111106842|NCT02429323|Sevoflurane|sevoflurane|mesh-list
111106843|NCT02429323|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111106844|NCT02429323|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111106845|NCT02429323|Anesthetics, General|anesthetics, general|mesh-ancestor
111106846|NCT02429323|Anesthetics|anesthetics|mesh-ancestor
111106847|NCT02429323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111106848|NCT02429323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111106849|NCT02326103|Ciprofloxacin|ciprofloxacin|mesh-list
111106850|NCT02326103|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111106851|NCT02326103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111106852|NCT02326103|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111106853|NCT02326103|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111106854|NCT02326103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111489817|NCT04175964|Metformin|metformin|mesh-list
111106855|NCT02326103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111106856|NCT02326103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111106857|NCT02326103|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111106858|NCT02326103|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111106859|NCT04984733|Nivolumab|nivolumab|mesh-list
111106860|NCT04984733|Temozolomide|temozolomide|mesh-list
111106861|NCT04984733|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111106862|NCT04984733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111106863|NCT04984733|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111106864|NCT04984733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111106865|NCT04984733|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111106866|NCT04984733|Alkylating Agents|alkylating agents|mesh-ancestor
111106867|NCT02707861|Ibalizumab|ibalizumab|mesh-list
111106868|NCT02707861|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111106869|NCT02707861|Antiviral Agents|antiviral agents|mesh-ancestor
111106870|NCT02707861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111106871|NCT02707861|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111106872|NCT02432599|Choline|choline|mesh-list
111106873|NCT02432599|Lipotropic Agents|lipotropic agents|mesh-ancestor
111106874|NCT02432599|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111106875|NCT02432599|Antimetabolites|antimetabolites|mesh-ancestor
111106876|NCT02432599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111106877|NCT02432599|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111106878|NCT02432599|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111106879|NCT02432599|Nootropic Agents|nootropic agents|mesh-ancestor
111106880|NCT03185143|Acetaminophen|acetaminophen|mesh-list
111106881|NCT03185143|Sumatriptan|sumatriptan|mesh-list
111106882|NCT03185143|Naltrexone|naltrexone|mesh-list
111106883|NCT03185143|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111106884|NCT03185143|Analgesics|analgesics|mesh-ancestor
111106885|NCT03185143|Sensory System Agents|sensory system agents|mesh-ancestor
111106886|NCT03185143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111106887|NCT03185143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111106888|NCT03185143|Antipyretics|antipyretics|mesh-ancestor
111106889|NCT03185143|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111106890|NCT03185143|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111106891|NCT03185143|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111106892|NCT03185143|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111106893|NCT03185143|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111106894|NCT03185143|Serotonin Agents|serotonin agents|mesh-ancestor
111106895|NCT03185143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111106896|NCT03185143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111106897|NCT05076773|Morphine|morphine|mesh-list
111106898|NCT05076773|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111106899|NCT05076773|Narcotics|narcotics|mesh-ancestor
111106900|NCT05076773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111106901|NCT05076773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111106902|NCT05076773|Analgesics|analgesics|mesh-ancestor
111106903|NCT05076773|Sensory System Agents|sensory system agents|mesh-ancestor
111106904|NCT05076773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111106905|NCT02432677|Remifentanil|remifentanil|mesh-list
111106906|NCT02432677|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111106907|NCT02432677|Narcotics|narcotics|mesh-ancestor
111106908|NCT02432677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111106909|NCT02432677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111106910|NCT02432677|Analgesics|analgesics|mesh-ancestor
111106911|NCT02432677|Sensory System Agents|sensory system agents|mesh-ancestor
111106912|NCT02432677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111106913|NCT03442673|Gemcitabine|gemcitabine|mesh-list
111106914|NCT03442673|Vinorelbine|vinorelbine|mesh-list
111106915|NCT03442673|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111106916|NCT03442673|Antimetabolites|antimetabolites|mesh-ancestor
111106917|NCT03442673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111106918|NCT03442673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111106919|NCT03442673|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111106920|NCT03442673|Tubulin Modulators|tubulin modulators|mesh-ancestor
111106921|NCT03442673|Antimitotic Agents|antimitotic agents|mesh-ancestor
111106922|NCT03442673|Mitosis Modulators|mitosis modulators|mesh-ancestor
111106923|NCT02432365|Paclitaxel|paclitaxel|mesh-list
111106924|NCT02432365|Cisplatin|cisplatin|mesh-list
111106925|NCT02432365|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111106926|NCT02432365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111106927|NCT02432365|Tubulin Modulators|tubulin modulators|mesh-ancestor
111489818|NCT04175964|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111489819|NCT04175964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111489820|NCT03624270|Ascorbic Acid|ascorbic acid|mesh-list
111106928|NCT02432365|Antimitotic Agents|antimitotic agents|mesh-ancestor
111106929|NCT02432365|Mitosis Modulators|mitosis modulators|mesh-ancestor
111119173|NCT05289687|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111489821|NCT03624270|Arsenic Trioxide|arsenic trioxide|mesh-list
111106930|NCT02432365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111106932|NCT05076695|Fulvestrant|fulvestrant|mesh-list
111106933|NCT05076695|Palbociclib|palbociclib|mesh-list
111106934|NCT05076695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111106935|NCT05076695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111106936|NCT05076695|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111106937|NCT05076695|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
111106938|NCT05076695|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111106939|NCT05076695|Hormone Antagonists|hormone antagonists|mesh-ancestor
111106940|NCT05076695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111106941|NCT05076695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111106942|NCT05076695|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111106943|NCT05076695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111106944|NCT05076695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111106945|NCT03143933|Fentanyl|fentanyl|mesh-list
111106946|NCT03143933|Propofol|propofol|mesh-list
111106947|NCT03143933|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111106948|NCT03143933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111106949|NCT03143933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111106950|NCT03143933|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111106951|NCT03143933|Anesthetics, General|anesthetics, general|mesh-ancestor
111106952|NCT03143933|Anesthetics|anesthetics|mesh-ancestor
111106953|NCT03143933|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111106954|NCT03143933|Narcotics|narcotics|mesh-ancestor
111106955|NCT03143933|Analgesics|analgesics|mesh-ancestor
111106956|NCT03143933|Sensory System Agents|sensory system agents|mesh-ancestor
111106957|NCT03143933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111106958|NCT03143933|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111106959|NCT02440243|Vaccines|vaccines|mesh-list
111106960|NCT02440243|Immunologic Factors|immunologic factors|mesh-ancestor
111106961|NCT02440243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111106962|NCT04705259|Anti-Infective Agents|anti-infective agents|mesh-list
111106963|NCT04705259|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111106964|NCT05076461|Ondansetron|ondansetron|mesh-list
111106965|NCT05076461|Antiemetics|antiemetics|mesh-ancestor
111106966|NCT05076461|Autonomic Agents|autonomic agents|mesh-ancestor
111106967|NCT05076461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111106968|NCT05076461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111106969|NCT05076461|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111106970|NCT05076461|Antipruritics|antipruritics|mesh-ancestor
111106971|NCT05076461|Dermatologic Agents|dermatologic agents|mesh-ancestor
111106972|NCT05076461|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111106973|NCT05076461|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111106974|NCT05076461|Serotonin Agents|serotonin agents|mesh-ancestor
111106975|NCT05076461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111106976|NCT05076461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111106977|NCT02428933|Bromocriptine|bromocriptine|mesh-list
111106978|NCT02428933|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111106979|NCT02428933|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111106980|NCT02428933|Hormone Antagonists|hormone antagonists|mesh-ancestor
111106981|NCT02428933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111106982|NCT02428933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111106983|NCT02428933|Dopamine Agonists|dopamine agonists|mesh-ancestor
111106984|NCT02428933|Dopamine Agents|dopamine agents|mesh-ancestor
111106985|NCT02428933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111106986|NCT02428933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111106987|NCT02428777|Diclofenac|diclofenac|mesh-list
111106988|NCT02428777|Tramadol|tramadol|mesh-list
111106989|NCT02428777|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111106990|NCT02428777|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111106991|NCT02428777|Analgesics|analgesics|mesh-ancestor
111106992|NCT02428777|Sensory System Agents|sensory system agents|mesh-ancestor
111106993|NCT02428777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111106994|NCT02428777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111106995|NCT02428777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111106996|NCT02428777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111106997|NCT02428777|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111106998|NCT02428777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111106999|NCT02428777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111489822|NCT03624270|Antioxidants|antioxidants|mesh-ancestor
111489823|NCT03624270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111489824|NCT03624270|Protective Agents|protective agents|mesh-ancestor
111107000|NCT02428777|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111489825|NCT03624270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111107002|NCT02428777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111107003|NCT02432053|Tacrolimus|tacrolimus|mesh-list
111107004|NCT02432053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111107005|NCT02432053|Immunologic Factors|immunologic factors|mesh-ancestor
111107006|NCT02432053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111107007|NCT02432053|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111107008|NCT02432053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111107009|NCT02432053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111107010|NCT03141827|Insulin|insulin|mesh-list
111107011|NCT03141827|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111107012|NCT03141827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111107013|NCT03190681|Methylphenidate|methylphenidate|mesh-list
111107014|NCT03190681|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111107015|NCT03190681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111107016|NCT03190681|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111107017|NCT03190681|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111107018|NCT03190681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111107019|NCT03190681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111107020|NCT03190681|Dopamine Agents|dopamine agents|mesh-ancestor
111107021|NCT03190681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111107022|NCT03186001|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111107023|NCT03186001|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111107024|NCT03186001|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111107025|NCT03186001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111107026|NCT03186001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111107027|NCT03186001|Cholinergic Agents|cholinergic agents|mesh-ancestor
111107028|NCT03186001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111107029|NCT03186001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111107030|NCT03186001|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111107031|NCT03186001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111107032|NCT04593563|Psilocybin|psilocybin|mesh-list
111107033|NCT04593563|Hallucinogens|hallucinogens|mesh-ancestor
111107034|NCT04593563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111107035|NCT04593563|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111107036|NCT04551911|Calcifediol|calcifediol|mesh-list
111107037|NCT04551911|Vitamins|vitamins|mesh-ancestor
111107038|NCT04551911|Micronutrients|micronutrients|mesh-ancestor
111107039|NCT04551911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111107040|NCT04551911|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111107041|NCT02431975|Ritonavir|ritonavir|mesh-list
111107042|NCT02431975|Lopinavir|lopinavir|mesh-list
111107043|NCT02431975|Lamivudine|lamivudine|mesh-list
111107044|NCT02431975|Zidovudine|zidovudine|mesh-list
111107045|NCT02431975|Nevirapine|nevirapine|mesh-list
111107046|NCT02431975|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111107047|NCT02431975|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111107048|NCT02431975|Protease Inhibitors|protease inhibitors|mesh-ancestor
111107049|NCT02431975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111107050|NCT02431975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111107051|NCT02431975|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111107052|NCT02431975|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111107053|NCT02431975|Antiviral Agents|antiviral agents|mesh-ancestor
111107054|NCT02431975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111107055|NCT02431975|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111107056|NCT02431975|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111107057|NCT02431975|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111107058|NCT02431975|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111107059|NCT02431975|Antimetabolites|antimetabolites|mesh-ancestor
111107060|NCT02431975|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111107061|NCT02431975|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111107062|NCT03143465|Calcitonin|calcitonin|mesh-list
111107063|NCT03143465|Salmon calcitonin|salmon calcitonin|mesh-list
111107064|NCT03143465|Sildenafil Citrate|sildenafil citrate|mesh-list
111107065|NCT03143465|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
111107066|NCT03143465|Katacalcin|katacalcin|mesh-list
111107067|NCT03143465|Vasodilator Agents|vasodilator agents|mesh-ancestor
111107068|NCT03143465|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111107069|NCT03143465|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111107070|NCT03143465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111489826|NCT03624270|Vitamins|vitamins|mesh-ancestor
111489827|NCT03624270|Micronutrients|micronutrients|mesh-ancestor
111107071|NCT03143465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111489828|NCT03624270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111107072|NCT03143465|Urological Agents|urological agents|mesh-ancestor
111107073|NCT03143465|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111107074|NCT03143465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111107075|NCT03143465|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111107076|NCT05034809|Melatonin|melatonin|mesh-list
111107077|NCT05034809|Antioxidants|antioxidants|mesh-ancestor
111107078|NCT05034809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111107079|NCT05034809|Protective Agents|protective agents|mesh-ancestor
111107080|NCT05034809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111107081|NCT05034809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111107082|NCT02428543|Cytarabine|cytarabine|mesh-list
111107083|NCT02428543|Ponatinib|ponatinib|mesh-list
111107084|NCT02428543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111107085|NCT02428543|Antimetabolites|antimetabolites|mesh-ancestor
111107086|NCT02428543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111107087|NCT02428543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111107088|NCT02428543|Antiviral Agents|antiviral agents|mesh-ancestor
111107089|NCT02428543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111107090|NCT02428543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111107091|NCT02428543|Immunologic Factors|immunologic factors|mesh-ancestor
111107092|NCT02428543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111107093|NCT02428543|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111107094|NCT02428543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111107095|NCT04428203|Cannabidiol|cannabidiol|mesh-list
111107096|NCT04428203|Anticonvulsants|anticonvulsants|mesh-ancestor
111107097|NCT02431663|Ketamine|ketamine|mesh-list
111107098|NCT02431663|Analgesics|analgesics|mesh-ancestor
111107099|NCT02431663|Sensory System Agents|sensory system agents|mesh-ancestor
111107100|NCT02431663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111107101|NCT02431663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111107102|NCT02431663|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111107103|NCT02431663|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111107104|NCT02431663|Anesthetics, General|anesthetics, general|mesh-ancestor
111107105|NCT02431663|Anesthetics|anesthetics|mesh-ancestor
111107106|NCT02431663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111107107|NCT02431663|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111107108|NCT02431663|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111107109|NCT02431663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111107110|NCT02431663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111107111|NCT03185845|Warfarin|warfarin|mesh-list
111107112|NCT03185845|Anticoagulants|anticoagulants|mesh-ancestor
111107113|NCT03182803|Antibodies|antibodies|mesh-list
111107114|NCT03182803|Immunologic Factors|immunologic factors|mesh-ancestor
111107115|NCT03182803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111107116|NCT04596917|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
111107117|NCT04596917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111107118|NCT04596917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111107119|NCT03185611|Rifaximin|rifaximin|mesh-list
111107120|NCT03185611|Azathioprine|azathioprine|mesh-list
111107121|NCT03185611|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111107122|NCT03185611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111107123|NCT03185611|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111107124|NCT03185611|Antimetabolites|antimetabolites|mesh-ancestor
111107125|NCT03185611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111107126|NCT03185611|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110676914|NCT03318900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111107127|NCT03185611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111107128|NCT03185611|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111107129|NCT03185611|Immunologic Factors|immunologic factors|mesh-ancestor
111107130|NCT03185611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110647366|NCT00487084|Anesthetics|anesthetics|mesh-ancestor
111107131|NCT03185611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111107132|NCT02431429|Miltefosine|miltefosine|mesh-list
111107133|NCT02431429|Antifungal Agents|antifungal agents|mesh-ancestor
111107134|NCT02431429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111107135|NCT02431429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111107136|NCT02431429|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111107137|NCT02431429|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111107138|NCT02027428|Paclitaxel|paclitaxel|mesh-list
111107139|NCT02027428|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111107140|NCT02027428|Carboplatin|carboplatin|mesh-list
111489829|NCT03498066|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
111489830|NCT03498066|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111107141|NCT02027428|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111489831|NCT03498066|Adrenergic Agents|adrenergic agents|mesh-ancestor
111489832|NCT03498066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111489833|NCT03498066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111489834|NCT03498066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111489835|NCT03455088|Fluoxetine|fluoxetine|mesh-list
111489836|NCT03455088|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111489837|NCT03455088|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111489838|NCT03455088|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111489839|NCT03455088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111489840|NCT03455088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111489841|NCT03455088|Serotonin Agents|serotonin agents|mesh-ancestor
111489842|NCT03455088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111489843|NCT03455088|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111489844|NCT03455088|Antidepressive Agents|antidepressive agents|mesh-ancestor
111489845|NCT03455088|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111107142|NCT02027428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111107143|NCT02027428|Tubulin Modulators|tubulin modulators|mesh-ancestor
111107144|NCT02027428|Antimitotic Agents|antimitotic agents|mesh-ancestor
111107145|NCT02027428|Mitosis Modulators|mitosis modulators|mesh-ancestor
111107146|NCT02027428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111107147|NCT03184363|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111107148|NCT03184363|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111107149|NCT03184363|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111107150|NCT03184363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111107151|NCT03184363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111107152|NCT03184363|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111107153|NCT03184363|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111107154|NCT03184363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111107155|NCT03184363|Cholinergic Agents|cholinergic agents|mesh-ancestor
111107156|NCT03184363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111107157|NCT02431039|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111107158|NCT02431039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111107159|NCT01995136|Travoprost|travoprost|mesh-list
111107160|NCT01995136|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111107161|NCT01995136|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111107162|NCT01995136|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111107163|NCT03141593|Vitamin D|vitamin d|mesh-list
111107164|NCT03141593|Ergocalciferols|ergocalciferols|mesh-list
111107165|NCT03141593|Cholecalciferol|cholecalciferol|mesh-list
111107166|NCT03141593|Vitamins|vitamins|mesh-list
111107167|NCT03141593|Micronutrients|micronutrients|mesh-ancestor
111107168|NCT03141593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111107169|NCT03141593|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111107170|NCT03141593|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111107171|NCT04102241|Hemay005|hemay005|mesh-list
111107172|NCT04102241|Dermatologic Agents|dermatologic agents|mesh-ancestor
111107173|NCT04102241|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
111107174|NCT04102241|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111107175|NCT04102241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111107176|NCT04102241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111107177|NCT03576443|Idelalisib|idelalisib|mesh-list
111107178|NCT03576443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111107179|NCT03576443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111107180|NCT03576443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111107181|NCT02427529|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
110647377|NCT00487084|Narcotics|narcotics|mesh-ancestor
111107182|NCT02427529|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111107183|NCT02427529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111107184|NCT04438733|Anastrozole|anastrozole|mesh-list
111107185|NCT04438733|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111107186|NCT04438733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111107187|NCT04438733|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111107188|NCT04438733|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111107189|NCT04438733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111107190|NCT04438733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111107191|NCT04438733|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111107192|NCT04438733|Hormone Antagonists|hormone antagonists|mesh-ancestor
111107193|NCT04438733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111107194|NCT04438733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111107195|NCT04438811|Anesthetics|anesthetics|mesh-list
111107196|NCT04438811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111107197|NCT04438811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111107198|NCT02427295|Octreotide|octreotide|mesh-list
111107199|NCT02427295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111107200|NCT02427295|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111107201|NCT02427295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111107202|NCT01994590|Prednisone|prednisone|mesh-list
111107203|NCT01994590|Abiraterone Acetate|abiraterone acetate|mesh-list
111107204|NCT01994590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111107205|NCT01994590|Glucocorticoids|glucocorticoids|mesh-ancestor
111107206|NCT01994590|Hormones|hormones|mesh-ancestor
111107207|NCT01994590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111107208|NCT01994590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111107209|NCT01994590|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111107210|NCT01994590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111107211|NCT01994590|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111107212|NCT01994590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111107213|NCT01994590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111107214|NCT01994590|Hormone Antagonists|hormone antagonists|mesh-ancestor
111107215|NCT01994590|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111107216|NCT05387603|Capecitabine|capecitabine|mesh-list
111107217|NCT05387603|Edotreotide lutetium LU-177|edotreotide lutetium lu-177|mesh-list
111107218|NCT05387603|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111107219|NCT05387603|Antimetabolites|antimetabolites|mesh-ancestor
111107220|NCT05387603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111107221|NCT05387603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111107222|NCT05387603|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111107223|NCT03182413|Modafinil|modafinil|mesh-list
111107224|NCT03182413|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111107225|NCT03182413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111107226|NCT03182413|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
111107227|NCT03182413|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111107228|NCT03182413|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111107229|NCT03182413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111107230|NCT03182257|ONO-7579|ono-7579|mesh-list
111107231|NCT03182257|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111107232|NCT03182257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111107233|NCT03182257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111107234|NCT03183739|ASP8062|asp8062|mesh-list
111107235|NCT03183739|Analgesics|analgesics|mesh-ancestor
111107236|NCT03183739|Sensory System Agents|sensory system agents|mesh-ancestor
111107237|NCT03183739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111107238|NCT03183739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111107239|NCT03183739|GABA Modulators|gaba modulators|mesh-ancestor
111107240|NCT03183739|GABA Agents|gaba agents|mesh-ancestor
111107241|NCT03183739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111107242|NCT03183739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111107243|NCT03117439|Antifungal Agents|antifungal agents|mesh-list
111107244|NCT03117439|Clotrimazole|clotrimazole|mesh-list
111107245|NCT03117439|Miconazole|miconazole|mesh-list
111107246|NCT03117439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111107247|NCT03117439|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111107248|NCT03117439|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111107249|NCT03117439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111107250|NCT03117439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111107251|NCT03117439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111107252|NCT03117439|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111107253|NCT03117439|Hormone Antagonists|hormone antagonists|mesh-ancestor
111107254|NCT03117439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111107255|NCT03117439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111107256|NCT03117439|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111107257|NCT03117439|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111107258|NCT02426905|Trientine|trientine|mesh-list
111107259|NCT02426905|Chelating Agents|chelating agents|mesh-ancestor
111107260|NCT02426905|Sequestering Agents|sequestering agents|mesh-ancestor
111107261|NCT02426905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111107262|NCT02421289|Efavirenz|efavirenz|mesh-list
111107263|NCT02421289|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111107264|NCT02421289|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111107265|NCT02421289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111107266|NCT02421289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111107267|NCT02421289|Antiviral Agents|antiviral agents|mesh-ancestor
111107268|NCT02421289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111107269|NCT02421289|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111489846|NCT03455088|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111107270|NCT02421289|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111107271|NCT02421289|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111107272|NCT02421289|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111107273|NCT02421289|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111107274|NCT02421289|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111107275|NCT03141125|Ethanol|ethanol|mesh-list
111107276|NCT03141125|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111107277|NCT03141125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111107278|NCT03141125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111107279|NCT03141125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111107280|NCT02426983|Dextromethorphan|dextromethorphan|mesh-list
111107281|NCT02426983|Antitussive Agents|antitussive agents|mesh-ancestor
111107282|NCT02426983|Respiratory System Agents|respiratory system agents|mesh-ancestor
111107283|NCT02426983|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111107284|NCT02426983|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111107285|NCT02426983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111107286|NCT02426983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111107287|NCT02426983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111107288|NCT03142763|Choline|choline|mesh-list
111107289|NCT03142763|Lipotropic Agents|lipotropic agents|mesh-ancestor
111107290|NCT03142763|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111107291|NCT03142763|Antimetabolites|antimetabolites|mesh-ancestor
111107292|NCT03142763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111107293|NCT03142763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111107294|NCT03142763|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111107295|NCT03142763|Nootropic Agents|nootropic agents|mesh-ancestor
111107296|NCT03511391|Pembrolizumab|pembrolizumab|mesh-list
111107297|NCT03511391|Nivolumab|nivolumab|mesh-list
111107298|NCT03511391|Atezolizumab|atezolizumab|mesh-list
111107299|NCT03511391|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
111107300|NCT03511391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111107301|NCT03511391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111107302|NCT03511391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111107303|NCT05081765|Olaparib|olaparib|mesh-list
111107304|NCT05081765|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111107305|NCT05081765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111107306|NCT05081765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111107307|NCT05081765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111107308|NCT05078177|Rituximab|rituximab|mesh-list
111107309|NCT05078177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111107310|NCT05078177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111107311|NCT05078177|Immunologic Factors|immunologic factors|mesh-ancestor
111107312|NCT05078177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111107313|NCT05078177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111107314|NCT05081687|Oxaliplatin|oxaliplatin|mesh-list
111107315|NCT05081687|Irinotecan|irinotecan|mesh-list
111107316|NCT05081687|Folfirinox|folfirinox|mesh-list
111107317|NCT05081687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111107318|NCT05081687|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111107319|NCT05081687|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111107320|NCT05081687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111107321|NCT05081687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111107322|NCT05387369|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
111107323|NCT05387369|Antiviral Agents|antiviral agents|mesh-ancestor
111107324|NCT05387369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111107325|NCT05080985|Bupivacaine|bupivacaine|mesh-list
111107326|NCT05080985|Anesthetics, Local|anesthetics, local|mesh-ancestor
111107327|NCT05080985|Anesthetics|anesthetics|mesh-ancestor
111107328|NCT05080985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111107329|NCT05080985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111107330|NCT05080985|Sensory System Agents|sensory system agents|mesh-ancestor
111107331|NCT05080985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111107332|NCT03139487|Dalteparin|dalteparin|mesh-list
111107333|NCT03139487|Tinzaparin|tinzaparin|mesh-list
111107334|NCT03139487|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
111107335|NCT03139487|Rivaroxaban|rivaroxaban|mesh-list
111107336|NCT03139487|Apixaban|apixaban|mesh-list
111107337|NCT03139487|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111489847|NCT03455088|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111489848|NCT03455088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111107338|NCT03139487|Antithrombins|antithrombins|mesh-ancestor
111107339|NCT03139487|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110413111|NCT04410042|Hemostatics|hemostatics|mesh-ancestor
111489849|NCT03355560|Nivolumab|nivolumab|mesh-list
111107341|NCT03139487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111107342|NCT03139487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111107343|NCT03139487|Anticoagulants|anticoagulants|mesh-ancestor
111107344|NCT03139487|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111107345|NCT03139487|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111107346|NCT03139253|Amoxicillin|amoxicillin|mesh-list
111107347|NCT03139253|Clarithromycin|clarithromycin|mesh-list
111107348|NCT03139253|Levofloxacin|levofloxacin|mesh-list
111107349|NCT03139253|Tetracycline|tetracycline|mesh-list
111107350|NCT03139253|Tinidazole|tinidazole|mesh-list
111107351|NCT03139253|Furazolidone|furazolidone|mesh-list
111107352|NCT03139253|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111107353|NCT03139253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111107354|NCT03139253|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111107355|NCT03139253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111107356|NCT03139253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111107357|NCT03139253|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111107358|NCT03139253|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111107359|NCT03139253|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111107360|NCT03139253|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111107361|NCT03139253|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111107362|NCT03139253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111107363|NCT03139253|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111107364|NCT03139253|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111107365|NCT03139253|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
111107366|NCT03139253|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111107367|NCT03139253|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111107368|NCT03139253|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
111107369|NCT03139253|Alkylating Agents|alkylating agents|mesh-ancestor
111107370|NCT03139409|Chlorhexidine|chlorhexidine|mesh-list
111107371|NCT03139409|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111107372|NCT03139409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111107373|NCT03139409|Disinfectants|disinfectants|mesh-ancestor
111107374|NCT02019472|Adalimumab|adalimumab|mesh-list
111107375|NCT02019472|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111107376|NCT02019472|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111107377|NCT02019472|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111107378|NCT02019472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111107379|NCT02019472|Immunologic Factors|immunologic factors|mesh-ancestor
111107380|NCT02019472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111107381|NCT00157937|Theophylline|theophylline|mesh-list
111107382|NCT00157937|Montelukast|montelukast|mesh-list
111107383|NCT00157937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111107384|NCT00157937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111107385|NCT00157937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111107386|NCT00157937|Autonomic Agents|autonomic agents|mesh-ancestor
111107387|NCT00157937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111107388|NCT00157937|Respiratory System Agents|respiratory system agents|mesh-ancestor
111107389|NCT00157937|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111107390|NCT00157937|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
111107391|NCT00157937|Hormone Antagonists|hormone antagonists|mesh-ancestor
111107392|NCT00157937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111107393|NCT00157937|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
111107394|NCT00157937|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111107395|NCT00157937|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111107396|NCT00157937|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111107397|NCT00157937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111107398|NCT00157937|Vasodilator Agents|vasodilator agents|mesh-ancestor
111107399|NCT00157937|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
111107400|NCT00157937|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111107401|NCT00157937|Purinergic Agents|purinergic agents|mesh-ancestor
111107402|NCT03139565|Vaccines|vaccines|mesh-list
111107403|NCT03139565|Immunologic Factors|immunologic factors|mesh-ancestor
111107404|NCT03139565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111107405|NCT03139331|Irinotecan|irinotecan|mesh-list
111107406|NCT03139331|Temozolomide|temozolomide|mesh-list
111107407|NCT03139331|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111107408|NCT03139331|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111107409|NCT03139331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111489850|NCT03355560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111489851|NCT03355560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111489852|NCT03355560|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111107410|NCT03139331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111107411|NCT03139331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111107412|NCT03139331|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111107413|NCT03139331|Alkylating Agents|alkylating agents|mesh-ancestor
111107414|NCT04423601|Itraconazole|itraconazole|mesh-list
111107415|NCT04423601|Antifungal Agents|antifungal agents|mesh-ancestor
111107416|NCT04423601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111107417|NCT04423601|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111107418|NCT04423601|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111107419|NCT04423601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111107420|NCT04423601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111107421|NCT04423601|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111107422|NCT04423601|Hormone Antagonists|hormone antagonists|mesh-ancestor
111107423|NCT04423601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111107424|NCT04423601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111107425|NCT04423601|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111107426|NCT04983095|Hormones|hormones|mesh-list
111107427|NCT04983095|Androgens|androgens|mesh-list
111107428|NCT04983095|Hormone Antagonists|hormone antagonists|mesh-list
111107429|NCT04983095|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111107430|NCT04983095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111107431|NCT02936687|Ambrisentan|ambrisentan|mesh-list
111107432|NCT02936687|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111107433|NCT04722809|Botulinum Toxins|botulinum toxins|mesh-list
111107434|NCT04722809|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111107435|NCT04722809|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111107436|NCT04722809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111107437|NCT04722809|Cholinergic Agents|cholinergic agents|mesh-ancestor
111107438|NCT04722809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111107439|NCT04722809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111107440|NCT05083793|Pregabalin|pregabalin|mesh-list
111107441|NCT05083793|Analgesics|analgesics|mesh-ancestor
111107442|NCT05083793|Sensory System Agents|sensory system agents|mesh-ancestor
111107443|NCT05083793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111107444|NCT05083793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111107445|NCT05083793|Anticonvulsants|anticonvulsants|mesh-ancestor
111107446|NCT05083793|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111107447|NCT05083793|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111107448|NCT05083793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111107449|NCT05083793|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111107450|NCT05083793|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111107451|NCT05083793|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111107452|NCT05083793|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111107453|NCT05083793|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111107454|NCT05083013|Chrysarobin|chrysarobin|mesh-list
111107455|NCT05083013|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111107456|NCT05083013|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111107457|NCT05083013|Analgesics|analgesics|mesh-ancestor
111107458|NCT05083013|Sensory System Agents|sensory system agents|mesh-ancestor
111107459|NCT05083013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111107460|NCT05083013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111107461|NCT05083013|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111107462|NCT05083013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111107463|NCT05073653|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
111107464|NCT05073653|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111107465|NCT05073653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111107466|NCT03223883|Curcumin|curcumin|mesh-list
111107467|NCT03223883|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111107468|NCT03223883|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111107469|NCT03223883|Analgesics|analgesics|mesh-ancestor
111107470|NCT03223883|Sensory System Agents|sensory system agents|mesh-ancestor
111107471|NCT03223883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111107472|NCT03223883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111107473|NCT03223883|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111107474|NCT03223883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111107475|NCT03223883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111107476|NCT03223883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111107477|NCT03223883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111107478|NCT02420899|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111107479|NCT02420899|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111489853|NCT03355560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111489854|NCT01600170|Atorvastatin|atorvastatin|mesh-list
111489855|NCT01600170|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111107480|NCT02420899|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111107481|NCT02420899|Antimetabolites|antimetabolites|mesh-ancestor
111107482|NCT02420899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111107483|NCT02420899|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111107484|NCT02420899|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111107485|NCT02420899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111107486|NCT03194165|Ritonavir|ritonavir|mesh-list
111107487|NCT03194165|Atazanavir Sulfate|atazanavir sulfate|mesh-list
111107488|NCT03194165|Darunavir|darunavir|mesh-list
111107489|NCT03194165|Raltegravir Potassium|raltegravir potassium|mesh-list
111107490|NCT03194165|Nevirapine|nevirapine|mesh-list
111107491|NCT03194165|Dolutegravir|dolutegravir|mesh-list
111107492|NCT03194165|Rilpivirine|rilpivirine|mesh-list
111107493|NCT03194165|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111107494|NCT03194165|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111107495|NCT03194165|Protease Inhibitors|protease inhibitors|mesh-ancestor
111107496|NCT03194165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111107497|NCT03194165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111107498|NCT03194165|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111107499|NCT03194165|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111107500|NCT03194165|Antiviral Agents|antiviral agents|mesh-ancestor
111107501|NCT03194165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111107502|NCT03194165|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111107503|NCT03194165|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111107504|NCT03194165|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111107505|NCT03194165|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111107506|NCT03194165|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111107507|NCT03194165|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111107508|NCT03194165|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111107509|NCT03194165|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111107510|NCT04065113|Ethanol|ethanol|mesh-list
111107511|NCT04065113|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111107512|NCT04065113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111107513|NCT04065113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111107514|NCT04065113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111107515|NCT03116737|Benzocaine|benzocaine|mesh-list
111107516|NCT03116737|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111107517|NCT03116737|Anesthetics, Local|anesthetics, local|mesh-ancestor
111107518|NCT03116737|Anesthetics|anesthetics|mesh-ancestor
111107519|NCT03116737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111107520|NCT03116737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111107521|NCT03116737|Sensory System Agents|sensory system agents|mesh-ancestor
111107522|NCT03116737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111107523|NCT03116659|Doxycycline|doxycycline|mesh-list
111107524|NCT03116659|Imiquimod|imiquimod|mesh-list
111107525|NCT03116659|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111107526|NCT03116659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111107527|NCT03116659|Antimalarials|antimalarials|mesh-ancestor
111107528|NCT03116659|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111107529|NCT03116659|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111107530|NCT03116659|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111107531|NCT03116659|Immunologic Factors|immunologic factors|mesh-ancestor
111107532|NCT03116659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111107533|NCT03116659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111107534|NCT03116659|Interferon Inducers|interferon inducers|mesh-ancestor
111107535|NCT01993888|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
111107536|NCT01993888|Hemostatics|hemostatics|mesh-ancestor
111107537|NCT01993888|Coagulants|coagulants|mesh-ancestor
111107538|NCT02425813|Methylprednisolone|methylprednisolone|mesh-list
110698003|NCT00391092|Trastuzumab|trastuzumab|mesh-list
111489856|NCT01600170|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111489857|NCT01600170|Antimetabolites|antimetabolites|mesh-ancestor
111489858|NCT01600170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111489859|NCT01600170|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111489860|NCT01600170|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111489861|NCT01600170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111489862|NCT01600950|Insulin Glargine|insulin glargine|mesh-list
111489863|NCT01600950|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111489864|NCT01600950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111489865|NCT01605942|Dexamethasone|dexamethasone|mesh-list
111489866|NCT01605942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111489867|NCT01605942|Antiemetics|antiemetics|mesh-ancestor
111489868|NCT01605942|Autonomic Agents|autonomic agents|mesh-ancestor
111489869|NCT01605942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111489870|NCT01605942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111489871|NCT01605942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111489872|NCT01605942|Glucocorticoids|glucocorticoids|mesh-ancestor
111107539|NCT02425813|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111107540|NCT02425813|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111107541|NCT02425813|Prednisolone|prednisolone|mesh-list
111107542|NCT02425813|Prednisolone acetate|prednisolone acetate|mesh-list
111107543|NCT02425813|Budesonide|budesonide|mesh-list
111107544|NCT02425813|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111107545|NCT02425813|Prednisolone phosphate|prednisolone phosphate|mesh-list
111107546|NCT02425813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111107547|NCT02425813|Antiemetics|antiemetics|mesh-ancestor
111107548|NCT02425813|Autonomic Agents|autonomic agents|mesh-ancestor
111107549|NCT02425813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111107550|NCT02425813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111107551|NCT02425813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111107552|NCT02425813|Glucocorticoids|glucocorticoids|mesh-ancestor
111107553|NCT02425813|Hormones|hormones|mesh-ancestor
111107554|NCT02425813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111107555|NCT02425813|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111107556|NCT02425813|Protective Agents|protective agents|mesh-ancestor
111107557|NCT02425813|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111107558|NCT02425813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111107559|NCT02425813|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111107560|NCT02425813|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111107561|NCT02425813|Respiratory System Agents|respiratory system agents|mesh-ancestor
111107562|NCT03106831|Norepinephrine|norepinephrine|mesh-list
111107563|NCT03106831|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111107564|NCT03106831|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111107565|NCT03106831|Adrenergic Agents|adrenergic agents|mesh-ancestor
111107566|NCT03106831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111107567|NCT03106831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110824674|NCT03480100|Xylometazoline|xylometazoline|mesh-list
111107568|NCT03106831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111107569|NCT03106831|Sympathomimetics|sympathomimetics|mesh-ancestor
111107570|NCT03106831|Autonomic Agents|autonomic agents|mesh-ancestor
111107571|NCT03106831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111107572|NCT03106831|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111107573|NCT03138785|Itraconazole|itraconazole|mesh-list
111107574|NCT03138785|Voriconazole|voriconazole|mesh-list
111107575|NCT03138785|Levofloxacin|levofloxacin|mesh-list
111107576|NCT03138785|Antifungal Agents|antifungal agents|mesh-ancestor
111107577|NCT03138785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111107578|NCT03138785|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111107579|NCT03138785|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111107580|NCT03138785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111107581|NCT03138785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111107582|NCT03138785|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111107583|NCT03138785|Hormone Antagonists|hormone antagonists|mesh-ancestor
111107584|NCT03138785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111107585|NCT03138785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111107586|NCT03138785|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111107587|NCT03138785|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111107588|NCT03138785|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111107589|NCT03138785|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111107590|NCT03138785|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111107591|NCT03138785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111107592|NCT03138785|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111107594|NCT03106597|Manidipine|manidipine|mesh-list
111107595|NCT03106597|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111107596|NCT03106597|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111107597|NCT03106597|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111107598|NCT03106597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111107599|NCT03106597|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111107600|NCT03106597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111107601|NCT03106597|Vasodilator Agents|vasodilator agents|mesh-ancestor
111107602|NCT02018458|Paclitaxel|paclitaxel|mesh-list
111107603|NCT02018458|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111107604|NCT02018458|Cyclophosphamide|cyclophosphamide|mesh-list
111107605|NCT02018458|Carboplatin|carboplatin|mesh-list
111107606|NCT02018458|Doxorubicin|doxorubicin|mesh-list
111107607|NCT02018458|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111107608|NCT02018458|Vaccines|vaccines|mesh-list
111107609|NCT02018458|Immunologic Factors|immunologic factors|mesh-ancestor
111107610|NCT02018458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111107611|NCT02018458|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111489874|NCT01605942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111107613|NCT02018458|Tubulin Modulators|tubulin modulators|mesh-ancestor
111107614|NCT02018458|Antimitotic Agents|antimitotic agents|mesh-ancestor
111107615|NCT02018458|Mitosis Modulators|mitosis modulators|mesh-ancestor
111107616|NCT02018458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111107617|NCT02018458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111107618|NCT02018458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111107619|NCT02018458|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111107620|NCT02018458|Alkylating Agents|alkylating agents|mesh-ancestor
111107621|NCT02018458|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111107622|NCT02018458|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111107623|NCT02018458|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111107624|NCT02018458|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111107625|NCT02018458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111107626|NCT02423083|Guanabenz|guanabenz|mesh-list
111107627|NCT02423083|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111107628|NCT02423083|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111107629|NCT02423083|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111107630|NCT02423083|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111107631|NCT02423083|Adrenergic Agents|adrenergic agents|mesh-ancestor
111107632|NCT02423083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111107633|NCT02423083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111107634|NCT02423083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111107635|NCT02423863|Pembrolizumab|pembrolizumab|mesh-list
111107636|NCT02423863|Nivolumab|nivolumab|mesh-list
111107637|NCT02423863|Atezolizumab|atezolizumab|mesh-list
111107638|NCT02423863|Durvalumab|durvalumab|mesh-list
111107639|NCT02423863|Cemiplimab|cemiplimab|mesh-list
111107640|NCT02423863|Poly ICLC|poly iclc|mesh-list
111107641|NCT02423863|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111107642|NCT02423863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111107643|NCT02423863|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111107644|NCT02423863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111107645|NCT02423863|Interferon Inducers|interferon inducers|mesh-ancestor
111107646|NCT02423863|Immunologic Factors|immunologic factors|mesh-ancestor
111107647|NCT02423863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111107648|NCT03178747|Methylene Blue|methylene blue|mesh-list
111107649|NCT03178747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111107650|NCT03178747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111107651|NCT05392673|Bilirubin|bilirubin|mesh-list
111107652|NCT05392673|Antioxidants|antioxidants|mesh-ancestor
111107653|NCT05392673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111107654|NCT05392673|Protective Agents|protective agents|mesh-ancestor
111107655|NCT05392673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111107656|NCT02425579|Carbon Monoxide|carbon monoxide|mesh-list
111107657|NCT02425579|Antimetabolites|antimetabolites|mesh-ancestor
111107658|NCT02425579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111107659|NCT02425579|Gasotransmitters|gasotransmitters|mesh-ancestor
111107660|NCT02425579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111107661|NCT02425579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111107662|NCT03178591|Dapagliflozin|dapagliflozin|mesh-list
111107663|NCT03178591|Vildagliptin|vildagliptin|mesh-list
111107664|NCT03178591|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111107665|NCT03178591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111107666|NCT03178591|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111107667|NCT03178591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111107668|NCT03178591|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111107669|NCT03178591|Protease Inhibitors|protease inhibitors|mesh-ancestor
110647447|NCT02577575|Oxytocin|oxytocin|mesh-list
111107670|NCT03178591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111107671|NCT01993186|Glycerol|glycerol|mesh-list
111107672|NCT01993186|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
111107673|NCT01993186|Protective Agents|protective agents|mesh-ancestor
111107674|NCT01993186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111107675|NCT03181243|Anesthetics|anesthetics|mesh-list
111107676|NCT03181243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111107677|NCT03181243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111107678|NCT02420665|Acetic Acid|acetic acid|mesh-list
111107679|NCT02420665|Proflavine|proflavine|mesh-list
111107680|NCT02420665|Retinol acetate|retinol acetate|mesh-list
111107681|NCT02420665|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111107682|NCT02420665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111107683|NCT02420665|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111107684|NCT02420665|Immunologic Factors|immunologic factors|mesh-ancestor
111489875|NCT01605942|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111107685|NCT02420665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111107686|NCT02420665|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
111107687|NCT02420665|Protective Agents|protective agents|mesh-ancestor
111107688|NCT02420665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111107689|NCT02420665|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111107690|NCT02016898|Mitomycins|mitomycins|mesh-list
111107691|NCT02016898|Mitomycin|mitomycin|mesh-list
111107692|NCT02016898|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111107693|NCT02016898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111107694|NCT02016898|Alkylating Agents|alkylating agents|mesh-ancestor
111107695|NCT02016898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111107696|NCT02016898|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111107697|NCT02016898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111107698|NCT04482907|Hormones|hormones|mesh-list
111107699|NCT04482907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111107700|NCT04482907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111107701|NCT02420509|Leucovorin|leucovorin|mesh-list
111107702|NCT02420509|Capecitabine|capecitabine|mesh-list
111107703|NCT02420509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111107704|NCT02420509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111107705|NCT02420509|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111107706|NCT02420509|Antimetabolites|antimetabolites|mesh-ancestor
111107707|NCT02420509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111107708|NCT02420509|Antidotes|antidotes|mesh-ancestor
111107709|NCT02420509|Protective Agents|protective agents|mesh-ancestor
111107710|NCT02420509|Vitamin B Complex|vitamin b complex|mesh-ancestor
111107711|NCT02420509|Vitamins|vitamins|mesh-ancestor
111107712|NCT02420509|Micronutrients|micronutrients|mesh-ancestor
111107713|NCT02416531|Clobetasol|clobetasol|mesh-list
111107714|NCT02416531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111107715|NCT02416531|Glucocorticoids|glucocorticoids|mesh-ancestor
111107716|NCT02416531|Hormones|hormones|mesh-ancestor
111107717|NCT02416531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111107718|NCT02416531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111107719|NCT04483063|Chlorhexidine|chlorhexidine|mesh-list
111107720|NCT04483063|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
111107721|NCT04483063|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111107722|NCT04483063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111107723|NCT04483063|Disinfectants|disinfectants|mesh-ancestor
111107724|NCT04483063|Dermatologic Agents|dermatologic agents|mesh-ancestor
111107725|NCT02416141|Tramadol|tramadol|mesh-list
111107726|NCT02416141|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111107727|NCT02416141|Narcotics|narcotics|mesh-ancestor
111107728|NCT02416141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111107729|NCT02416141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111107730|NCT02416141|Analgesics|analgesics|mesh-ancestor
111107731|NCT02416141|Sensory System Agents|sensory system agents|mesh-ancestor
111107732|NCT02416141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111107733|NCT03138239|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
111107734|NCT03138239|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111107735|NCT03138239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111107736|NCT02416063|Dexmedetomidine|dexmedetomidine|mesh-list
111107737|NCT02416063|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111107738|NCT02416063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111107739|NCT02416063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111107740|NCT02416063|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111107741|NCT02416063|Analgesics|analgesics|mesh-ancestor
111107742|NCT02416063|Sensory System Agents|sensory system agents|mesh-ancestor
111107743|NCT02416063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111107744|NCT02416063|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111107745|NCT02416063|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111107746|NCT02416063|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111107747|NCT02416063|Adrenergic Agents|adrenergic agents|mesh-ancestor
111107748|NCT02416063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111107749|NCT02416063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111107750|NCT01828697|Enoxaparin|enoxaparin|mesh-list
111107751|NCT01828697|Dalteparin|dalteparin|mesh-list
111107752|NCT01828697|Tinzaparin|tinzaparin|mesh-list
111107753|NCT01828697|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
111489876|NCT01605942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111489877|NCT01608672|Botulinum Toxins|botulinum toxins|mesh-list
111489878|NCT01608672|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111107754|NCT01828697|Nadroparin|nadroparin|mesh-list
111107755|NCT01828697|Enoxaparin sodium|enoxaparin sodium|mesh-list
111107756|NCT01828697|Anticoagulants|anticoagulants|mesh-ancestor
110698022|NCT01044342|Donepezil|donepezil|mesh-list
111489879|NCT01608672|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111107757|NCT01828697|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111107758|NCT01828697|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111107759|NCT01828697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111107761|NCT02415985|Rifabutin|rifabutin|mesh-list
111107762|NCT02415985|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111107763|NCT02415985|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111107764|NCT02415985|Protease Inhibitors|protease inhibitors|mesh-ancestor
111107765|NCT02415985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111107766|NCT02415985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111107767|NCT02415985|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111107768|NCT02415985|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111107769|NCT02415985|Antiviral Agents|antiviral agents|mesh-ancestor
111107770|NCT02415985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111107771|NCT02415985|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111107772|NCT02415985|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111107773|NCT02415985|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111107774|NCT02415985|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111107775|NCT02415985|Antitubercular Agents|antitubercular agents|mesh-ancestor
111107776|NCT02415907|(2-(6-fluoro-1H-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|(2-(6-fluoro-1h-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|mesh-list
111107777|NCT02415907|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111107778|NCT02415907|Serotonin Agents|serotonin agents|mesh-ancestor
111107779|NCT02415907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111107780|NCT02415907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111107781|NCT02415907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111107782|NCT02415829|Capecitabine|capecitabine|mesh-list
111107783|NCT02415829|Oxaliplatin|oxaliplatin|mesh-list
111107784|NCT02415829|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111107785|NCT02415829|Antimetabolites|antimetabolites|mesh-ancestor
111107786|NCT02415829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111107787|NCT02415829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111107788|NCT04631393|Alfentanil|alfentanil|mesh-list
111107789|NCT04631393|Propofol|propofol|mesh-list
111107790|NCT04631393|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111107791|NCT04631393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111107792|NCT04631393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111107793|NCT04631393|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111107794|NCT04631393|Anesthetics, General|anesthetics, general|mesh-ancestor
111107795|NCT04631393|Anesthetics|anesthetics|mesh-ancestor
111107796|NCT04631393|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111107797|NCT04631393|Narcotics|narcotics|mesh-ancestor
111107798|NCT04631393|Analgesics|analgesics|mesh-ancestor
111107799|NCT04631393|Sensory System Agents|sensory system agents|mesh-ancestor
111107800|NCT04631393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111107801|NCT03180775|Glycine|glycine|mesh-list
111107802|NCT03180775|Glycine Agents|glycine agents|mesh-ancestor
111107803|NCT03180775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111107804|NCT03180775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111107805|NCT03180775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111107806|NCT03137927|Vaccines|vaccines|mesh-list
111107807|NCT03137927|Immunologic Factors|immunologic factors|mesh-ancestor
111107808|NCT03137927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111107809|NCT04482985|Meclizine|meclizine|mesh-list
111107810|NCT04482985|Antiemetics|antiemetics|mesh-ancestor
111107811|NCT04482985|Autonomic Agents|autonomic agents|mesh-ancestor
111107812|NCT04482985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111107813|NCT04482985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111107814|NCT04482985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111107815|NCT04482985|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111107816|NCT04482985|Histamine Antagonists|histamine antagonists|mesh-ancestor
111107817|NCT04482985|Histamine Agents|histamine agents|mesh-ancestor
111107818|NCT04482985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111107819|NCT04482985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111107820|NCT04482985|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111107821|NCT04482985|Cholinergic Agents|cholinergic agents|mesh-ancestor
111107822|NCT04482985|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111107823|NCT05385263|Nivolumab|nivolumab|mesh-list
111107824|NCT05385263|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111107825|NCT05385263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111107826|NCT05385263|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111107827|NCT05385263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111107828|NCT03180229|Granisetron|granisetron|mesh-list
111489880|NCT01608672|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111107830|NCT03180229|Autonomic Agents|autonomic agents|mesh-ancestor
111107831|NCT03180229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111107832|NCT03180229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111107833|NCT03180229|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111107834|NCT03180229|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111107835|NCT03180229|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111107836|NCT03180229|Serotonin Agents|serotonin agents|mesh-ancestor
111107837|NCT03180229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111107838|NCT03180229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111107839|NCT03178123|Interferons|interferons|mesh-list
111107840|NCT03178123|Antibodies|antibodies|mesh-list
111107841|NCT03178123|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111107842|NCT03178123|Immunologic Factors|immunologic factors|mesh-ancestor
111107843|NCT03178123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111107844|NCT03178123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111107845|NCT03178123|Antiviral Agents|antiviral agents|mesh-ancestor
111107846|NCT03178123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111107847|NCT03820817|Rifaximin|rifaximin|mesh-list
111107848|NCT03820817|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111107849|NCT03820817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111107850|NCT03820817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111107851|NCT05111197|Immunomodulating Agents|immunomodulating agents|mesh-list
111107852|NCT05111197|Immunologic Factors|immunologic factors|mesh-ancestor
111107853|NCT05111197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111107854|NCT05106517|Zoledronic Acid|zoledronic acid|mesh-list
111107855|NCT05106517|Denosumab|denosumab|mesh-list
111107856|NCT05106517|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111107857|NCT05106517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111107858|NCT03140033|Misoprostol|misoprostol|mesh-list
111107859|NCT03140033|Ranitidine|ranitidine|mesh-list
111107860|NCT03140033|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
111107861|NCT03140033|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111107862|NCT03140033|Abortifacient Agents|abortifacient agents|mesh-ancestor
111107863|NCT03140033|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111107864|NCT03140033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111107865|NCT03140033|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111107866|NCT03140033|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111107867|NCT03140033|Oxytocics|oxytocics|mesh-ancestor
111107868|NCT03140033|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
111107869|NCT03140033|Histamine Antagonists|histamine antagonists|mesh-ancestor
111107870|NCT03140033|Histamine Agents|histamine agents|mesh-ancestor
111107871|NCT03140033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111107872|NCT03140033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111107873|NCT05338931|Gossypol acetic acid|gossypol acetic acid|mesh-list
111107874|NCT05338931|Gossypol|gossypol|mesh-list
111107875|NCT05338931|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111107876|NCT05338931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111107877|NCT05338931|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111107878|NCT05338931|Contraceptive Agents|contraceptive agents|mesh-ancestor
111107879|NCT05338931|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111107880|NCT05338931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111107881|NCT05338931|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
111107882|NCT05338931|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
111107883|NCT05338931|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
111107884|NCT02706691|Infigratinib|infigratinib|mesh-list
111107885|NCT02706691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111107886|NCT02419729|Estrogens|estrogens|mesh-list
111107887|NCT02419729|Hormones|hormones|mesh-ancestor
111107888|NCT02419729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111107889|NCT02419729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111107890|NCT03697031|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
111107891|NCT03697031|Hormones|hormones|mesh-ancestor
111107892|NCT03697031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111107893|NCT03697031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111107894|NCT02419651|Diclofenac|diclofenac|mesh-list
111107895|NCT02419651|Tramadol|tramadol|mesh-list
111107896|NCT02419651|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111107897|NCT02419651|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111107898|NCT02419651|Analgesics|analgesics|mesh-ancestor
111107899|NCT02419651|Sensory System Agents|sensory system agents|mesh-ancestor
111489881|NCT01608672|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111107900|NCT02419651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111107901|NCT02419651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110024195|NCT00004368|Tubulin Modulators|tubulin modulators|mesh-ancestor
111107902|NCT02419651|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111107903|NCT02419651|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111489882|NCT01608672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111107904|NCT02419651|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111107905|NCT02419651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111107906|NCT02419651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111107907|NCT02419651|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111107908|NCT02419651|Narcotics|narcotics|mesh-ancestor
111107909|NCT02419651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111107910|NCT05088239|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111107911|NCT05088239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111107912|NCT02419261|Analgesics|analgesics|mesh-list
111107913|NCT02419261|Ropivacaine|ropivacaine|mesh-list
111107914|NCT02419261|Anesthetics, Local|anesthetics, local|mesh-ancestor
111107915|NCT02419261|Anesthetics|anesthetics|mesh-ancestor
111107916|NCT02419261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111107917|NCT02419261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111107918|NCT02419261|Sensory System Agents|sensory system agents|mesh-ancestor
111107919|NCT02419261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111107920|NCT02414503|Oxytocin|oxytocin|mesh-list
111107921|NCT02414503|Oxytocics|oxytocics|mesh-ancestor
111107922|NCT02414503|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111107923|NCT02414503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111107924|NCT03137615|Anesthetics|anesthetics|mesh-list
111107925|NCT03137615|Anesthetics, Local|anesthetics, local|mesh-list
111107926|NCT03137615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111107927|NCT03137615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111107928|NCT03137615|Sensory System Agents|sensory system agents|mesh-ancestor
111107929|NCT03137615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111107930|NCT03415061|Insulin|insulin|mesh-list
111107931|NCT03415061|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111107932|NCT03415061|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111107933|NCT03415061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111107934|NCT05088083|Paclitaxel|paclitaxel|mesh-list
111107935|NCT05088083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111107936|NCT05088083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111107937|NCT05088083|Tubulin Modulators|tubulin modulators|mesh-ancestor
111107938|NCT05088083|Antimitotic Agents|antimitotic agents|mesh-ancestor
111107939|NCT05088083|Mitosis Modulators|mitosis modulators|mesh-ancestor
111107940|NCT05088083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111107941|NCT03110159|Aminolevulinic Acid|aminolevulinic acid|mesh-list
111107942|NCT03110159|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111107943|NCT03110159|Dermatologic Agents|dermatologic agents|mesh-ancestor
111107944|NCT01990768|Tranexamic Acid|tranexamic acid|mesh-list
111107945|NCT01990768|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111107946|NCT01990768|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111107947|NCT01990768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111107948|NCT01990768|Hemostatics|hemostatics|mesh-ancestor
111107949|NCT01990768|Coagulants|coagulants|mesh-ancestor
111107950|NCT05228327|Salicylic Acid|salicylic acid|mesh-list
111107951|NCT05228327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111107952|NCT05228327|Antifungal Agents|antifungal agents|mesh-ancestor
111107953|NCT05228327|Keratolytic Agents|keratolytic agents|mesh-ancestor
111107954|NCT05228327|Dermatologic Agents|dermatologic agents|mesh-ancestor
111107955|NCT02624765|Digoxin|digoxin|mesh-list
111107956|NCT02624765|Sotalol|sotalol|mesh-list
111107957|NCT02624765|Flecainide|flecainide|mesh-list
111107958|NCT02624765|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111107959|NCT02624765|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111107960|NCT02624765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111107961|NCT02624765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111107962|NCT02624765|Protective Agents|protective agents|mesh-ancestor
111107963|NCT02624765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111107964|NCT02624765|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111107965|NCT02624765|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111107966|NCT02624765|Adrenergic Agents|adrenergic agents|mesh-ancestor
111107967|NCT02624765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111489883|NCT01608672|Cholinergic Agents|cholinergic agents|mesh-ancestor
111489884|NCT01608672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111489885|NCT01608672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111489886|NCT01608672|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111489887|NCT01608672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111489888|NCT01610154|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111489889|NCT01610154|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111489890|NCT01610154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111489891|NCT01610154|Incretins|incretins|mesh-ancestor
111489892|NCT01610154|Hormones|hormones|mesh-ancestor
111489893|NCT01610154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111107968|NCT02624765|Sympatholytics|sympatholytics|mesh-ancestor
111107969|NCT02624765|Autonomic Agents|autonomic agents|mesh-ancestor
111107970|NCT02624765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111107971|NCT02624765|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111107972|NCT02624765|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111107973|NCT02624765|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111107974|NCT05085587|Fluticasone|fluticasone|mesh-list
111107975|NCT05085587|Xhance|xhance|mesh-list
111107976|NCT05085587|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
111107977|NCT05085587|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
111107978|NCT05085587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111107979|NCT05085587|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111107980|NCT05085587|Autonomic Agents|autonomic agents|mesh-ancestor
111107981|NCT05085587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111107982|NCT05085587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111107983|NCT05085587|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111107984|NCT05085587|Respiratory System Agents|respiratory system agents|mesh-ancestor
111107985|NCT05085587|Dermatologic Agents|dermatologic agents|mesh-ancestor
111107986|NCT05085587|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111107987|NCT05085587|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111107988|NCT05085587|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111107989|NCT05085587|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111107990|NCT05085587|Adrenergic Agents|adrenergic agents|mesh-ancestor
111107991|NCT05085587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111107992|NCT05085587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111107993|NCT05085587|Glucocorticoids|glucocorticoids|mesh-ancestor
111107994|NCT05085587|Hormones|hormones|mesh-ancestor
111107995|NCT05085587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111107996|NCT05085587|Sympathomimetics|sympathomimetics|mesh-ancestor
111107997|NCT01990534|Brentuximab Vedotin|brentuximab vedotin|mesh-list
111107998|NCT01990534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111107999|NCT01990534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111108000|NCT01990534|Immunotoxins|immunotoxins|mesh-ancestor
111108001|NCT01990534|Immunoconjugates|immunoconjugates|mesh-ancestor
111108002|NCT01990534|Immunologic Factors|immunologic factors|mesh-ancestor
111108003|NCT01990534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111108004|NCT05084573|Bupivacaine|bupivacaine|mesh-list
111108005|NCT05084573|Anesthetics, Local|anesthetics, local|mesh-ancestor
111108006|NCT05084573|Anesthetics|anesthetics|mesh-ancestor
111108007|NCT05084573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111108008|NCT05084573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111108009|NCT05084573|Sensory System Agents|sensory system agents|mesh-ancestor
111108010|NCT05084573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111108011|NCT05088707|Misoprostol|misoprostol|mesh-list
111108012|NCT05088707|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111108013|NCT05088707|Abortifacient Agents|abortifacient agents|mesh-ancestor
111108014|NCT05088707|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111108015|NCT05088707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111108016|NCT05088707|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111108017|NCT05088707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111108018|NCT05088707|Oxytocics|oxytocics|mesh-ancestor
111108019|NCT05028257|Vaccines|vaccines|mesh-list
111108020|NCT05028257|Immunologic Factors|immunologic factors|mesh-ancestor
111108021|NCT05028257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111108022|NCT03135977|Etoposide|etoposide|mesh-list
111108023|NCT03135977|Apatinib|apatinib|mesh-list
111108024|NCT03135977|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111108025|NCT03135977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111108026|NCT03135977|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111108027|NCT03135977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111108028|NCT03135977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111108029|NCT03135977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111108030|NCT03135977|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111108031|NCT04850651|Fluconazole|fluconazole|mesh-list
111108032|NCT04850651|Antifungal Agents|antifungal agents|mesh-ancestor
111108033|NCT04850651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111108034|NCT04850651|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111108035|NCT04850651|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111108036|NCT04850651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110647511|NCT00581555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111108037|NCT04850651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111108038|NCT04850651|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111108039|NCT04850651|Hormone Antagonists|hormone antagonists|mesh-ancestor
111489894|NCT01610154|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111489895|NCT01610154|Protease Inhibitors|protease inhibitors|mesh-ancestor
111489896|NCT01610154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111489897|NCT01610154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111108040|NCT04850651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111108041|NCT04850651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111108042|NCT04850651|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111108043|NCT04850651|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111108045|NCT04837235|Dermatologic Agents|dermatologic agents|mesh-ancestor
111108046|NCT04837235|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
111108047|NCT04837235|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111108048|NCT04837235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111108049|NCT04837235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111108050|NCT02702401|Pembrolizumab|pembrolizumab|mesh-list
111108051|NCT02702401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111108052|NCT02702401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111108053|NCT02702401|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111108054|NCT02702401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111108055|NCT03116971|Etoposide|etoposide|mesh-list
111108056|NCT03116971|Peposertib|peposertib|mesh-list
111108057|NCT03116971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111108058|NCT03116971|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111108059|NCT03116971|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111108060|NCT03116971|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111108061|NCT03116971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111108062|NCT03116971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111108063|NCT03116971|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111108064|NCT02414581|Ethanol|ethanol|mesh-list
111108065|NCT02414581|Chlorhexidine|chlorhexidine|mesh-list
111108066|NCT02414581|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
111108067|NCT02414581|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111108068|NCT02414581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111108069|NCT02414581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111108070|NCT02414581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111108071|NCT02414581|Disinfectants|disinfectants|mesh-ancestor
111108072|NCT02414581|Dermatologic Agents|dermatologic agents|mesh-ancestor
111108073|NCT02419105|Vitamin D|vitamin d|mesh-list
111108074|NCT02419105|Cholecalciferol|cholecalciferol|mesh-list
111108075|NCT02419105|Testosterone|testosterone|mesh-list
111108076|NCT02419105|Vitamins|vitamins|mesh-ancestor
111108077|NCT02419105|Micronutrients|micronutrients|mesh-ancestor
111108078|NCT02419105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111108079|NCT02419105|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111108080|NCT02419105|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111108081|NCT02419105|Androgens|androgens|mesh-ancestor
111108082|NCT02419105|Hormones|hormones|mesh-ancestor
111108083|NCT02419105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111108084|NCT04643249|Repaglinide|repaglinide|mesh-list
111108085|NCT04643249|Flurbiprofen|flurbiprofen|mesh-list
111108086|NCT04643249|Midazolam|midazolam|mesh-list
111108087|NCT04643249|Dextromethorphan|dextromethorphan|mesh-list
111108088|NCT04643249|Caffeine|caffeine|mesh-list
111108089|NCT04643249|Bupropion|bupropion|mesh-list
111108090|NCT04643249|Omeprazole|omeprazole|mesh-list
111108091|NCT04643249|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111108092|NCT04643249|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111108093|NCT04643249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111108094|NCT04643249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111108095|NCT04643249|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111108096|NCT04643249|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111108097|NCT04643249|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111108098|NCT04643249|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111108099|NCT04643249|Anesthetics, General|anesthetics, general|mesh-ancestor
111108100|NCT04643249|Anesthetics|anesthetics|mesh-ancestor
111108101|NCT04643249|GABA Modulators|gaba modulators|mesh-ancestor
111108102|NCT04643249|GABA Agents|gaba agents|mesh-ancestor
111108103|NCT04643249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110647521|NCT00469144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111108104|NCT04643249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111108105|NCT04643249|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111108106|NCT04643249|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111108107|NCT04643249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111108108|NCT04643249|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
111108109|NCT04643249|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111108110|NCT04643249|Purinergic Agents|purinergic agents|mesh-ancestor
111108111|NCT04643249|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111108112|NCT04643249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111108113|NCT04643249|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111108114|NCT04643249|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111108115|NCT04643249|Antidepressive Agents|antidepressive agents|mesh-ancestor
111108116|NCT04643249|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111108117|NCT04643249|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111108118|NCT04643249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111108119|NCT04643249|Dopamine Agents|dopamine agents|mesh-ancestor
111108120|NCT04643249|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111108121|NCT04643249|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111108122|NCT04643249|Antitussive Agents|antitussive agents|mesh-ancestor
111108123|NCT04643249|Respiratory System Agents|respiratory system agents|mesh-ancestor
111108124|NCT04643249|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111108125|NCT04643249|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111108126|NCT04643249|Analgesics|analgesics|mesh-ancestor
111108127|NCT04643249|Sensory System Agents|sensory system agents|mesh-ancestor
111108128|NCT04643249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111108129|NCT04643249|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111108130|NCT04643249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111108131|NCT04643249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111108132|NCT04643249|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111108133|NCT04643249|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111108134|NCT04643249|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111108135|NCT02414425|Botulinum Toxins|botulinum toxins|mesh-list
111108136|NCT02414425|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111108137|NCT02414425|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111108138|NCT02414425|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111108139|NCT02414425|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111108140|NCT02414425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111108141|NCT02414425|Cholinergic Agents|cholinergic agents|mesh-ancestor
111108142|NCT02414425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110647525|NCT03987022|Acetaminophen|acetaminophen|mesh-list
111108143|NCT02414425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111108144|NCT02414425|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111108145|NCT02414425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111108146|NCT03116893|Itraconazole|itraconazole|mesh-list
111108147|NCT03116893|Rifampin|rifampin|mesh-list
111108148|NCT03116893|Antifungal Agents|antifungal agents|mesh-ancestor
111108149|NCT03116893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111108150|NCT03116893|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111108151|NCT03116893|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111108152|NCT03116893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111108153|NCT03116893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111108154|NCT03116893|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111108155|NCT03116893|Hormone Antagonists|hormone antagonists|mesh-ancestor
111108156|NCT03116893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111108157|NCT03116893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111108158|NCT03116893|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111108159|NCT03116893|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111108160|NCT03116893|Antitubercular Agents|antitubercular agents|mesh-ancestor
111108161|NCT03116893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111108162|NCT03116893|Leprostatic Agents|leprostatic agents|mesh-ancestor
111108163|NCT03116893|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111108164|NCT03116893|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111108165|NCT03116893|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111108166|NCT03116893|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
111108167|NCT03116893|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
111108168|NCT03116893|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
111108169|NCT03116893|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111108171|NCT05737511|Gabapentin|gabapentin|mesh-list
111108172|NCT05737511|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
111108173|NCT05737511|Milnacipran|milnacipran|mesh-list
111108174|NCT05737511|Levetiracetam|levetiracetam|mesh-list
111108175|NCT05737511|Lorazepam|lorazepam|mesh-list
111108176|NCT05737511|Clonazepam|clonazepam|mesh-list
111108177|NCT05737511|Dexetimide|dexetimide|mesh-list
111108178|NCT05737511|Olanzapine|olanzapine|mesh-list
111108179|NCT05737511|Alprazolam|alprazolam|mesh-list
111108180|NCT05737511|Mirtazapine|mirtazapine|mesh-list
111108181|NCT05737511|Fluvoxamine|fluvoxamine|mesh-list
111108182|NCT05737511|Tranylcypromine|tranylcypromine|mesh-list
111108183|NCT05737511|Risperidone|risperidone|mesh-list
111489899|NCT01611948|Antiemetics|antiemetics|mesh-ancestor
111108184|NCT05737511|Quetiapine Fumarate|quetiapine fumarate|mesh-list
111489900|NCT01611948|Autonomic Agents|autonomic agents|mesh-ancestor
111489901|NCT01611948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111108186|NCT05737511|Bupropion|bupropion|mesh-list
111108187|NCT05737511|Sertraline|sertraline|mesh-list
111108188|NCT05737511|Fluoxetine|fluoxetine|mesh-list
111108189|NCT05737511|Paroxetine|paroxetine|mesh-list
111108190|NCT05737511|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
111108191|NCT05737511|Reboxetine|reboxetine|mesh-list
111108192|NCT05737511|Imipramine|imipramine|mesh-list
111108193|NCT05737511|Clomipramine|clomipramine|mesh-list
111108194|NCT05737511|Phenelzine|phenelzine|mesh-list
111108195|NCT05737511|Moclobemide|moclobemide|mesh-list
111108196|NCT05737511|Hydroxyzine|hydroxyzine|mesh-list
111108197|NCT05737511|Escitalopram|escitalopram|mesh-list
111108198|NCT05737511|Analgesics|analgesics|mesh-ancestor
111108199|NCT05737511|Sensory System Agents|sensory system agents|mesh-ancestor
111108200|NCT05737511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111108201|NCT05737511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111108202|NCT05737511|Anticonvulsants|anticonvulsants|mesh-ancestor
111108203|NCT05737511|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111108204|NCT05737511|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111108205|NCT05737511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111108206|NCT05737511|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111108207|NCT05737511|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111108208|NCT05737511|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111108209|NCT05737511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111108210|NCT05737511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111108211|NCT05737511|Antimanic Agents|antimanic agents|mesh-ancestor
111108212|NCT05737511|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111108213|NCT05737511|Serotonin Agents|serotonin agents|mesh-ancestor
111108214|NCT05737511|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111108215|NCT05737511|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111108216|NCT05737511|Dopamine Agents|dopamine agents|mesh-ancestor
111108217|NCT05737511|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111108218|NCT05737511|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111108219|NCT05737511|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111108220|NCT05737511|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111108221|NCT05737511|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111108222|NCT05737511|Parasympatholytics|parasympatholytics|mesh-ancestor
111108223|NCT05737511|Autonomic Agents|autonomic agents|mesh-ancestor
111108224|NCT05737511|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111108225|NCT05737511|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111108226|NCT05737511|Cholinergic Agents|cholinergic agents|mesh-ancestor
111108227|NCT05737511|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111108228|NCT05737511|Antidepressive Agents|antidepressive agents|mesh-ancestor
111108229|NCT05737511|Antiemetics|antiemetics|mesh-ancestor
111108230|NCT05737511|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111108231|NCT05737511|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111108232|NCT05737511|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111108233|NCT05737511|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111108234|NCT05737511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111108235|NCT05737511|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111108236|NCT05737511|Nootropic Agents|nootropic agents|mesh-ancestor
111108237|NCT05737511|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111108238|NCT05737511|GABA Modulators|gaba modulators|mesh-ancestor
111108239|NCT05737511|GABA Agents|gaba agents|mesh-ancestor
111108240|NCT05737511|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111108241|NCT05737511|Histamine Antagonists|histamine antagonists|mesh-ancestor
111108242|NCT05737511|Histamine Agents|histamine agents|mesh-ancestor
111108243|NCT05737511|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
111108244|NCT05737511|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111108245|NCT05737511|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111108246|NCT05737511|Adrenergic Agents|adrenergic agents|mesh-ancestor
111108247|NCT05737511|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111108248|NCT05737511|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111108249|NCT05737511|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111108250|NCT05737511|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
111108251|NCT05737511|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111108252|NCT05737511|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111108253|NCT05737511|Anesthetics, General|anesthetics, general|mesh-ancestor
111108254|NCT05737511|Anesthetics|anesthetics|mesh-ancestor
111108255|NCT05737511|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111108256|NCT05737511|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111108257|NCT05737511|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111108258|NCT05737511|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111108259|NCT05737511|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
111108260|NCT05737511|Antipruritics|antipruritics|mesh-ancestor
111108261|NCT05737511|Dermatologic Agents|dermatologic agents|mesh-ancestor
111108262|NCT05737511|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
111108263|NCT03179839|Fluvoxamine|fluvoxamine|mesh-list
111108264|NCT03179839|Sertraline|sertraline|mesh-list
111108265|NCT03179839|Antidepressive Agents|antidepressive agents|mesh-ancestor
111108266|NCT03179839|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111108267|NCT03179839|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111108268|NCT03179839|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111108269|NCT03179839|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111108270|NCT03179839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111108271|NCT03179839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111108272|NCT03179839|Serotonin Agents|serotonin agents|mesh-ancestor
111108273|NCT03179839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111108274|NCT03179839|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111108275|NCT03179839|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111108276|NCT03179839|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111108277|NCT03179839|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111108278|NCT03179839|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111108279|NCT03179839|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111108280|NCT03179839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111108281|NCT03179839|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111108282|NCT05736887|Acetylcysteine|acetylcysteine|mesh-list
111108283|NCT05736887|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111108284|NCT05736887|Antiviral Agents|antiviral agents|mesh-ancestor
111108285|NCT05736887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111108286|NCT05736887|Expectorants|expectorants|mesh-ancestor
111108287|NCT05736887|Respiratory System Agents|respiratory system agents|mesh-ancestor
111108288|NCT05736887|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111108289|NCT05736887|Antioxidants|antioxidants|mesh-ancestor
111108290|NCT05736887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111108291|NCT05736887|Protective Agents|protective agents|mesh-ancestor
111108292|NCT05736887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111108293|NCT05736887|Antidotes|antidotes|mesh-ancestor
111108294|NCT02703337|Insulin Lispro|insulin lispro|mesh-list
111108295|NCT02703337|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111108296|NCT02703337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111108297|NCT04483219|Antibodies|antibodies|mesh-list
111108298|NCT04483219|Immunologic Factors|immunologic factors|mesh-ancestor
111108299|NCT04483219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111108300|NCT03176563|Fosfomycin|fosfomycin|mesh-list
111108301|NCT03176563|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111108302|NCT03176563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111108303|NCT03827447|Vancomycin|vancomycin|mesh-list
111108304|NCT03827447|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111108305|NCT03827447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111108306|NCT01680497|Hyaluronic Acid|hyaluronic acid|mesh-list
111108307|NCT01680497|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111108308|NCT01680497|Immunologic Factors|immunologic factors|mesh-ancestor
111108309|NCT01680497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111108310|NCT01680497|Viscosupplements|viscosupplements|mesh-ancestor
111108311|NCT01680497|Protective Agents|protective agents|mesh-ancestor
111108312|NCT02423395|Orphenadrine|orphenadrine|mesh-list
111108313|NCT02423395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111108314|NCT02423395|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111108315|NCT02423395|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111108316|NCT02423395|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
111108317|NCT02423395|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111108318|NCT02423395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111108319|NCT02423395|Parasympatholytics|parasympatholytics|mesh-ancestor
111108320|NCT02423395|Autonomic Agents|autonomic agents|mesh-ancestor
111108321|NCT02423395|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111108322|NCT02423395|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111108323|NCT02423395|Cholinergic Agents|cholinergic agents|mesh-ancestor
111108324|NCT02423395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111108325|NCT02423395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111108326|NCT02423395|Cytochrome P-450 CYP2B6 Inhibitors|cytochrome p-450 cyp2b6 inhibitors|mesh-ancestor
111108327|NCT02423395|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111108328|NCT02423395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111108330|NCT05694689|Cholecalciferol|cholecalciferol|mesh-list
111108331|NCT05694689|Vitamins|vitamins|mesh-ancestor
111108332|NCT05694689|Micronutrients|micronutrients|mesh-ancestor
111489902|NCT01611948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111108333|NCT05694689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111108334|NCT05694689|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111489903|NCT01611948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111108335|NCT05694689|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111108336|NCT02423239|Paclitaxel|paclitaxel|mesh-list
111108337|NCT02423239|Gemcitabine|gemcitabine|mesh-list
111108338|NCT02423239|Sorafenib|sorafenib|mesh-list
111108339|NCT02423239|HU 211|hu 211|mesh-list
111108340|NCT02423239|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111108341|NCT02423239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111108342|NCT02423239|Tubulin Modulators|tubulin modulators|mesh-ancestor
111108343|NCT02423239|Antimitotic Agents|antimitotic agents|mesh-ancestor
111108344|NCT02423239|Mitosis Modulators|mitosis modulators|mesh-ancestor
111108345|NCT02423239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111108346|NCT02423239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111108347|NCT02423239|Antimetabolites|antimetabolites|mesh-ancestor
111108348|NCT02423239|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111108349|NCT02423239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111108350|NCT02423239|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111108351|NCT02423239|Antiemetics|antiemetics|mesh-ancestor
111108352|NCT02423239|Autonomic Agents|autonomic agents|mesh-ancestor
111108353|NCT02423239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111108354|NCT02423239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111108355|NCT02423239|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111108356|NCT02423239|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111108357|NCT02423239|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111108358|NCT02423239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111108359|NCT02423239|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111108360|NCT02423239|Protective Agents|protective agents|mesh-ancestor
111108361|NCT02449733|Tenofovir|tenofovir|mesh-list
111108362|NCT02449733|Emtricitabine|emtricitabine|mesh-list
111108363|NCT02449733|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
111108364|NCT02449733|Antiviral Agents|antiviral agents|mesh-ancestor
111108365|NCT02449733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111108366|NCT02449733|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111108367|NCT02449733|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111108368|NCT02449733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111108369|NCT02449733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111108370|NCT02449733|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111108371|NCT02449733|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111108372|NCT02417467|Nicotine|nicotine|mesh-list
111108373|NCT02417467|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111108374|NCT02417467|Autonomic Agents|autonomic agents|mesh-ancestor
111108375|NCT02417467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111108376|NCT02417467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111108377|NCT02417467|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111108378|NCT02417467|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111108379|NCT02417467|Cholinergic Agents|cholinergic agents|mesh-ancestor
111108380|NCT02417467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111108381|NCT02417467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111108382|NCT02417389|Alendronate|alendronate|mesh-list
111108383|NCT02417389|Cinacalcet|cinacalcet|mesh-list
111108384|NCT02417389|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111108385|NCT02417389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111108386|NCT02417389|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111108387|NCT02417389|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
111108388|NCT02417389|Hormone Antagonists|hormone antagonists|mesh-ancestor
111108389|NCT02417389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111108390|NCT02413021|Cytarabine|cytarabine|mesh-list
111108391|NCT02413021|Deferasirox|deferasirox|mesh-list
111108392|NCT02413021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111108393|NCT02413021|Antimetabolites|antimetabolites|mesh-ancestor
111108394|NCT02413021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111489904|NCT01611948|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
111489905|NCT01611948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111489906|NCT01611948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111489907|NCT01612884|Clopidogrel|clopidogrel|mesh-list
111489908|NCT01612884|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
111489909|NCT01612884|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111489910|NCT01612884|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111489911|NCT01612884|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111489912|NCT01612884|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111489913|NCT01612884|Purinergic Agents|purinergic agents|mesh-ancestor
111489914|NCT01612884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111489915|NCT01612884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111108395|NCT02413021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111489916|NCT01612884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111108397|NCT02413021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111108398|NCT02413021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111108399|NCT02413021|Immunologic Factors|immunologic factors|mesh-ancestor
111108400|NCT02413021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111108401|NCT02413021|Iron Chelating Agents|iron chelating agents|mesh-ancestor
111108402|NCT02413021|Chelating Agents|chelating agents|mesh-ancestor
111108403|NCT02413021|Sequestering Agents|sequestering agents|mesh-ancestor
111108404|NCT01680341|Insulin|insulin|mesh-list
111108405|NCT01680341|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111108406|NCT01680341|Insulin Aspart|insulin aspart|mesh-list
111108407|NCT01680341|Insulin, Long-Acting|insulin, long-acting|mesh-list
111108408|NCT01680341|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
111108409|NCT01680341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111108410|NCT01680341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111108411|NCT03177811|Acetazolamide|acetazolamide|mesh-list
111108412|NCT03177811|Anticonvulsants|anticonvulsants|mesh-ancestor
111108413|NCT03177811|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
111108414|NCT03177811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111108415|NCT03177811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111108416|NCT03177811|Diuretics|diuretics|mesh-ancestor
111108417|NCT03177811|Natriuretic Agents|natriuretic agents|mesh-ancestor
111108418|NCT03177811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111108419|NCT03175939|Fluorouracil|fluorouracil|mesh-list
111108420|NCT03175939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111108421|NCT03175939|Antimetabolites|antimetabolites|mesh-ancestor
111108422|NCT03175939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111108423|NCT03175939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111108424|NCT03175939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111108425|NCT03175939|Immunologic Factors|immunologic factors|mesh-ancestor
111108426|NCT03175939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111108427|NCT03199625|Antidepressive Agents|antidepressive agents|mesh-list
111108428|NCT03199625|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111108429|NCT02417077|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111108430|NCT02417077|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111108431|NCT02417077|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111108432|NCT02417077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111108433|NCT02417077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111108434|NCT02417077|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111108435|NCT02417077|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111108436|NCT02417077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111108437|NCT02417077|Cholinergic Agents|cholinergic agents|mesh-ancestor
111108438|NCT02417077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111108439|NCT03179527|Vasodilator Agents|vasodilator agents|mesh-list
111108440|NCT03179527|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
111108441|NCT03179527|Lipid Regulating Agents|lipid regulating agents|mesh-list
111108442|NCT02412475|Cytarabine|cytarabine|mesh-list
111108443|NCT02412475|Fludarabine|fludarabine|mesh-list
111108444|NCT02412475|Sorafenib|sorafenib|mesh-list
111108445|NCT02412475|Decitabine|decitabine|mesh-list
111108446|NCT02412475|Vorinostat|vorinostat|mesh-list
111108447|NCT02412475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111108448|NCT02412475|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111108449|NCT02412475|Antimetabolites|antimetabolites|mesh-ancestor
111108450|NCT02412475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111108451|NCT02412475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111108452|NCT02412475|Immunologic Factors|immunologic factors|mesh-ancestor
111108453|NCT02412475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111489917|NCT01614210|Tamoxifen|tamoxifen|mesh-list
111489918|NCT01614210|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111489919|NCT01614210|Hormone Antagonists|hormone antagonists|mesh-ancestor
111489920|NCT01614210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111489921|NCT01614210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111489922|NCT01614210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111489923|NCT01614210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111489924|NCT01614210|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111489925|NCT01614210|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111489926|NCT01614210|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111489927|NCT01616082|Phentermine|phentermine|mesh-list
111489928|NCT01616082|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110647588|NCT00519285|Docetaxel|docetaxel|mesh-list
111489929|NCT01616082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111489930|NCT01616082|Appetite Depressants|appetite depressants|mesh-ancestor
111108454|NCT02412475|Antiviral Agents|antiviral agents|mesh-ancestor
111108455|NCT02412475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111108456|NCT02412475|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111108457|NCT02412475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111108458|NCT02412475|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111108459|NCT04543643|Carvedilol|carvedilol|mesh-list
111108460|NCT04543643|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111108461|NCT04543643|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111108462|NCT04543643|Adrenergic Agents|adrenergic agents|mesh-ancestor
111108463|NCT04543643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111108464|NCT04543643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111108465|NCT04543643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111108466|NCT04543643|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111108467|NCT04543643|Antioxidants|antioxidants|mesh-ancestor
111108468|NCT04543643|Protective Agents|protective agents|mesh-ancestor
111108469|NCT04543643|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111108470|NCT04543643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111108471|NCT04543643|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111108472|NCT04543643|Vasodilator Agents|vasodilator agents|mesh-ancestor
111108473|NCT04543643|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111108474|NCT04543643|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111108476|NCT05377619|Prucalopride|prucalopride|mesh-list
111108477|NCT05377619|Laxatives|laxatives|mesh-ancestor
111108478|NCT05377619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111108479|NCT05377619|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
111108480|NCT05377619|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111108481|NCT05377619|Serotonin Agents|serotonin agents|mesh-ancestor
111108482|NCT05377619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111108483|NCT05377619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111108484|NCT05377619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111108485|NCT05377619|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111108486|NCT05377619|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111108487|NCT05377619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111108488|NCT05377619|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111108489|NCT03199157|Fentanyl|fentanyl|mesh-list
111108490|NCT03199157|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111108491|NCT03199157|Narcotics|narcotics|mesh-ancestor
111108492|NCT03199157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111108493|NCT03199157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111108494|NCT03199157|Analgesics|analgesics|mesh-ancestor
111108495|NCT03199157|Sensory System Agents|sensory system agents|mesh-ancestor
111108496|NCT03199157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111108497|NCT03199157|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111108498|NCT03199157|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111108499|NCT03199157|Anesthetics, General|anesthetics, general|mesh-ancestor
111108500|NCT03199157|Anesthetics|anesthetics|mesh-ancestor
111108501|NCT00641381|Cyclophosphamide|cyclophosphamide|mesh-list
111108502|NCT00641381|Carmustine|carmustine|mesh-list
111108503|NCT00641381|Etoposide|etoposide|mesh-list
111108504|NCT00641381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111489931|NCT01616082|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111489932|NCT01616082|Sympathomimetics|sympathomimetics|mesh-ancestor
111489933|NCT01616082|Autonomic Agents|autonomic agents|mesh-ancestor
111489934|NCT01616082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111489935|NCT01616082|Adrenergic Agents|adrenergic agents|mesh-ancestor
110647597|NCT00519285|Hormones|hormones|mesh-ancestor
111489936|NCT01616082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111489937|NCT01616082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111489938|NCT01616160|Mometasone Furoate|mometasone furoate|mesh-list
111489939|NCT01616160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111489940|NCT01616160|Dermatologic Agents|dermatologic agents|mesh-ancestor
111489941|NCT01616160|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111489942|NCT01619982|Vancomycin|vancomycin|mesh-list
111489943|NCT01619982|Cefazolin|cefazolin|mesh-list
111489944|NCT01619982|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111489945|NCT01619982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111489946|NCT01620216|Sorafenib|sorafenib|mesh-list
111489947|NCT01620216|Sunitinib|sunitinib|mesh-list
111489948|NCT01620216|Dasatinib|dasatinib|mesh-list
111489949|NCT01620216|Ponatinib|ponatinib|mesh-list
111489950|NCT01620216|Idelalisib|idelalisib|mesh-list
111489951|NCT01620216|Antineoplastic Agents|antineoplastic agents|mesh-list
111489952|NCT01620216|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
111489953|NCT01620216|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111108505|NCT00641381|Immunologic Factors|immunologic factors|mesh-ancestor
111108506|NCT00641381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110698085|NCT00288639|Pregabalin|pregabalin|mesh-list
111489954|NCT01620216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111489955|NCT01620216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111489956|NCT01620216|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111489957|NCT01620216|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111108507|NCT00641381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111108508|NCT00641381|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111108509|NCT00641381|Alkylating Agents|alkylating agents|mesh-ancestor
111108510|NCT00641381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111108511|NCT00641381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111108512|NCT00641381|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111108513|NCT00641381|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111108514|NCT00641381|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111108515|NCT00641381|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111108516|NCT00641381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111108517|NCT02416999|Bevacizumab|bevacizumab|mesh-list
111108518|NCT02416999|Temozolomide|temozolomide|mesh-list
111108519|NCT02416999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111108520|NCT02416999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111108521|NCT02416999|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111108522|NCT02416999|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111108523|NCT02416999|Growth Substances|growth substances|mesh-ancestor
111108524|NCT02416999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111108525|NCT02416999|Growth Inhibitors|growth inhibitors|mesh-ancestor
111108526|NCT02416999|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111108527|NCT02416999|Alkylating Agents|alkylating agents|mesh-ancestor
111108528|NCT02416999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111108529|NCT02412085|Golimumab|golimumab|mesh-list
111108530|NCT02412085|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111108531|NCT02412085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111108532|NCT02412085|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111108533|NCT02412085|Immunologic Factors|immunologic factors|mesh-ancestor
111108534|NCT02412085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111108535|NCT01679405|Cisplatin|cisplatin|mesh-list
111108536|NCT01679405|Gemcitabine|gemcitabine|mesh-list
111108537|NCT01679405|Afatinib|afatinib|mesh-list
111108538|NCT01679405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111108539|NCT01679405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111108540|NCT01679405|Antimetabolites|antimetabolites|mesh-ancestor
111108541|NCT01679405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111108542|NCT01679405|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111108543|NCT01679405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111108544|NCT03175705|Interleukin-2|interleukin-2|mesh-list
111108545|NCT03175705|Tegafur|tegafur|mesh-list
111108546|NCT03175705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111108547|NCT03175705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111108548|NCT03175705|Analgesics|analgesics|mesh-ancestor
111108549|NCT03175705|Sensory System Agents|sensory system agents|mesh-ancestor
111108550|NCT03175705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111108551|NCT03175705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111108552|NCT03175705|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111108553|NCT03175705|Antimetabolites|antimetabolites|mesh-ancestor
111108554|NCT03175705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111108555|NCT00301457|Anastrozole|anastrozole|mesh-list
111108556|NCT00301457|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111108557|NCT00301457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111108558|NCT00301457|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111108559|NCT00301457|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111108560|NCT00301457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111108561|NCT00301457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111108562|NCT00301457|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111108563|NCT00301457|Hormone Antagonists|hormone antagonists|mesh-ancestor
111108564|NCT00301457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111108565|NCT00301457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111108567|NCT03177109|Fluorides, Topical|fluorides, topical|mesh-list
111108568|NCT03177109|Cariostatic Agents|cariostatic agents|mesh-ancestor
111108569|NCT03177109|Protective Agents|protective agents|mesh-ancestor
111108570|NCT03177109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111108571|NCT05094947|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
111108572|NCT05094947|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111108573|NCT05094947|Adrenergic Agents|adrenergic agents|mesh-ancestor
111108574|NCT05094947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111108575|NCT05094947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111108576|NCT05094947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111108577|NCT02421913|Ketamine|ketamine|mesh-list
111108578|NCT02421913|Analgesics|analgesics|mesh-ancestor
110414399|NCT05402293|Lidocaine|lidocaine|mesh-list
111108579|NCT02421913|Sensory System Agents|sensory system agents|mesh-ancestor
111108580|NCT02421913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111108581|NCT02421913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111108582|NCT02421913|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111108583|NCT02421913|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111108584|NCT02421913|Anesthetics, General|anesthetics, general|mesh-ancestor
111108585|NCT02421913|Anesthetics|anesthetics|mesh-ancestor
111108586|NCT02421913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111108587|NCT02421913|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111108588|NCT02421913|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111108589|NCT02421913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111108590|NCT02421913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111108591|NCT03179293|Propofol|propofol|mesh-list
111108592|NCT03179293|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111108593|NCT03179293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111108594|NCT03179293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111108595|NCT03179293|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111108596|NCT03179293|Anesthetics, General|anesthetics, general|mesh-ancestor
111108597|NCT03179293|Anesthetics|anesthetics|mesh-ancestor
111108598|NCT02416765|Glucagon|glucagon|mesh-list
111108599|NCT02416765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111108600|NCT02416765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111108601|NCT02416765|Hormones|hormones|mesh-ancestor
111108602|NCT02416765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111108603|NCT02703259|Acetaminophen|acetaminophen|mesh-list
111108604|NCT02703259|Celecoxib|celecoxib|mesh-list
111108605|NCT02703259|Gabapentin|gabapentin|mesh-list
111108606|NCT02703259|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111108607|NCT02703259|Analgesics|analgesics|mesh-ancestor
110647630|NCT02099123|Atorvastatin|atorvastatin|mesh-list
111108608|NCT02703259|Sensory System Agents|sensory system agents|mesh-ancestor
111108609|NCT02703259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111108610|NCT02703259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111108611|NCT02703259|Antipyretics|antipyretics|mesh-ancestor
111108612|NCT02703259|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111108613|NCT02703259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111108614|NCT02703259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111108615|NCT02703259|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111108616|NCT02703259|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111108617|NCT02703259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111108618|NCT02703259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111108619|NCT02703259|Anticonvulsants|anticonvulsants|mesh-ancestor
111108620|NCT02703259|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111108621|NCT02703259|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111108622|NCT02703259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111108623|NCT02703259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111108624|NCT02703259|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111108625|NCT02703259|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111108626|NCT02703259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111108627|NCT02703259|Antimanic Agents|antimanic agents|mesh-ancestor
111108628|NCT02416687|Etonogestrel|etonogestrel|mesh-list
111108629|NCT02416687|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111108630|NCT02416687|Contraceptive Agents|contraceptive agents|mesh-ancestor
111108631|NCT02416687|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111108632|NCT02416687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111108633|NCT02416687|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111108634|NCT02411695|Brexpiprazole|brexpiprazole|mesh-list
111108635|NCT02411695|Serotonin Agents|serotonin agents|mesh-ancestor
111108636|NCT02411695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111108637|NCT02411695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111108638|NCT02411695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111108639|NCT02411695|Dopamine Agonists|dopamine agonists|mesh-ancestor
111108640|NCT02411695|Dopamine Agents|dopamine agents|mesh-ancestor
111108641|NCT05093231|Pembrolizumab|pembrolizumab|mesh-list
111108642|NCT05093231|Olaparib|olaparib|mesh-list
111108643|NCT05093231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111108644|NCT05093231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111108645|NCT05093231|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111108646|NCT05093231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111108647|NCT05093231|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111108648|NCT05093231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111108649|NCT02411149|Epinephrine|epinephrine|mesh-list
111108650|NCT02411149|Racepinephrine|racepinephrine|mesh-list
111489958|NCT01620216|Growth Substances|growth substances|mesh-ancestor
111489959|NCT01620216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111108651|NCT02411149|Morphine|morphine|mesh-list
111108652|NCT02411149|Ropivacaine|ropivacaine|mesh-list
111108653|NCT02411149|Epinephryl borate|epinephryl borate|mesh-list
111108654|NCT02411149|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111108655|NCT02411149|Narcotics|narcotics|mesh-ancestor
111108656|NCT02411149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111108657|NCT02411149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111108658|NCT02411149|Analgesics|analgesics|mesh-ancestor
111108659|NCT02411149|Sensory System Agents|sensory system agents|mesh-ancestor
111108660|NCT02411149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111108661|NCT02411149|Anesthetics, Local|anesthetics, local|mesh-ancestor
111108662|NCT02411149|Anesthetics|anesthetics|mesh-ancestor
111108663|NCT02411149|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111108664|NCT02411149|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111108665|NCT02411149|Adrenergic Agents|adrenergic agents|mesh-ancestor
111108666|NCT02411149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111108667|NCT02411149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111108668|NCT02411149|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111108669|NCT02411149|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111108670|NCT02411149|Autonomic Agents|autonomic agents|mesh-ancestor
111108671|NCT02411149|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111108672|NCT02411149|Respiratory System Agents|respiratory system agents|mesh-ancestor
111108673|NCT02411149|Mydriatics|mydriatics|mesh-ancestor
111108674|NCT02411149|Sympathomimetics|sympathomimetics|mesh-ancestor
111108675|NCT02411149|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111108676|NCT04413227|Docetaxel|docetaxel|mesh-list
111108677|NCT04413227|Endostatins|endostatins|mesh-list
111108678|NCT04413227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111108679|NCT04413227|Tubulin Modulators|tubulin modulators|mesh-ancestor
111108680|NCT04413227|Antimitotic Agents|antimitotic agents|mesh-ancestor
111108681|NCT04413227|Mitosis Modulators|mitosis modulators|mesh-ancestor
111108682|NCT04413227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111108683|NCT04413227|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111108684|NCT04413227|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111108685|NCT04413227|Growth Substances|growth substances|mesh-ancestor
111108686|NCT04413227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111108687|NCT04413227|Growth Inhibitors|growth inhibitors|mesh-ancestor
111108688|NCT02410135|Mirabegron|mirabegron|mesh-list
111108689|NCT02410135|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
111108690|NCT02410135|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111108691|NCT02410135|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111108692|NCT02410135|Adrenergic Agents|adrenergic agents|mesh-ancestor
111108693|NCT02410135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111108694|NCT02410135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111108695|NCT02410135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111108696|NCT02410135|Urological Agents|urological agents|mesh-ancestor
111108697|NCT02410759|Carbetocin|carbetocin|mesh-list
111108698|NCT02410759|Ergonovine|ergonovine|mesh-list
111108699|NCT02410759|Oxytocics|oxytocics|mesh-ancestor
111108700|NCT02410759|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111108701|NCT02410759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111108702|NCT03175081|Ropivacaine|ropivacaine|mesh-list
111108703|NCT03175081|Anesthetics, Local|anesthetics, local|mesh-ancestor
111108704|NCT03175081|Anesthetics|anesthetics|mesh-ancestor
111108705|NCT03175081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111108706|NCT03175081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111108707|NCT03175081|Sensory System Agents|sensory system agents|mesh-ancestor
111108708|NCT03175081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111108709|NCT02409823|Antipsychotic Agents|antipsychotic agents|mesh-list
111108710|NCT02409823|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111108711|NCT02409823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111108712|NCT02409823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111108713|NCT02409823|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111108714|NCT02401477|Amoxicillin|amoxicillin|mesh-list
111108715|NCT02401477|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111108716|NCT02401477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111108717|NCT03174457|Micafungin|micafungin|mesh-list
111108718|NCT03174457|Antifungal Agents|antifungal agents|mesh-ancestor
111108719|NCT03174457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111108720|NCT02401243|Insulin Glargine|insulin glargine|mesh-list
111108721|NCT02401243|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111108722|NCT02401243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111489960|NCT01620216|Growth Inhibitors|growth inhibitors|mesh-ancestor
111489961|NCT01621230|Fentanyl|fentanyl|mesh-list
111489962|NCT01621230|Bupivacaine|bupivacaine|mesh-list
111108723|NCT02409433|Lacosamide|lacosamide|mesh-list
111108724|NCT02409433|Phenytoin|phenytoin|mesh-list
111108725|NCT02409433|Anticonvulsants|anticonvulsants|mesh-ancestor
111489963|NCT01621230|Anesthetics, Local|anesthetics, local|mesh-ancestor
111108726|NCT02409433|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111108727|NCT02409433|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111108728|NCT02409433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111108729|NCT02409433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111108730|NCT02409433|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
111108731|NCT02409433|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111108732|NCT01989754|Canagliflozin|canagliflozin|mesh-list
111108733|NCT01989754|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111108734|NCT01989754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111108735|NCT01989754|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111108736|NCT01989754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111108737|NCT01619878|Lumefantrine|lumefantrine|mesh-list
111108738|NCT01619878|Artemether|artemether|mesh-list
111108739|NCT01619878|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
111108740|NCT01619878|Antimalarials|antimalarials|mesh-ancestor
111108741|NCT01619878|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111108742|NCT01619878|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111108743|NCT01619878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111108744|NCT02015104|BCG Vaccine|bcg vaccine|mesh-list
111108745|NCT02015104|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111108746|NCT02015104|Immunologic Factors|immunologic factors|mesh-ancestor
111108747|NCT02015104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111108748|NCT01989208|Sodium sulfate|sodium sulfate|mesh-list
111108749|NCT01989208|Cathartics|cathartics|mesh-ancestor
111108750|NCT01989208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111108751|NCT01619410|Clindamycin|clindamycin|mesh-list
111108752|NCT01619410|Clindamycin palmitate|clindamycin palmitate|mesh-list
111108753|NCT01619410|Clindamycin phosphate|clindamycin phosphate|mesh-list
111108754|NCT01619410|Linezolid|linezolid|mesh-list
111108755|NCT01619410|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111108756|NCT01619410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111108757|NCT01619410|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111108758|NCT01619410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111108759|NCT01619410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111108760|NCT04666714|Pregabalin|pregabalin|mesh-list
111108761|NCT04666714|Analgesics|analgesics|mesh-ancestor
111108762|NCT04666714|Sensory System Agents|sensory system agents|mesh-ancestor
111108763|NCT04666714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111108764|NCT04666714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111108765|NCT04666714|Anticonvulsants|anticonvulsants|mesh-ancestor
111108766|NCT04666714|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111108767|NCT04666714|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111108768|NCT04666714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111108769|NCT04666714|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111108770|NCT04666714|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111108771|NCT04666714|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111108772|NCT04666714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111108773|NCT04666714|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111108774|NCT01261247|Panobinostat|panobinostat|mesh-list
111108775|NCT01261247|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
111108776|NCT01261247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111108777|NCT01261247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111108778|NCT01261247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111108779|NCT03233243|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111108780|NCT03233243|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111108781|NCT03233243|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111108782|NCT03233243|Antimetabolites|antimetabolites|mesh-ancestor
111108783|NCT03233243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111108784|NCT03233243|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111108785|NCT03233243|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111108786|NCT03233243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111108787|NCT02449655|Paclitaxel|paclitaxel|mesh-list
111108788|NCT02449655|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111108789|NCT02449655|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111108790|NCT02449655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111108791|NCT02449655|Tubulin Modulators|tubulin modulators|mesh-ancestor
111108792|NCT02449655|Antimitotic Agents|antimitotic agents|mesh-ancestor
111108793|NCT02449655|Mitosis Modulators|mitosis modulators|mesh-ancestor
111108794|NCT02449655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111108795|NCT04254731|Methadone|methadone|mesh-list
111108796|NCT04254731|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111108797|NCT04254731|Narcotics|narcotics|mesh-ancestor
111489964|NCT01621230|Anesthetics|anesthetics|mesh-ancestor
111489965|NCT01621230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111489966|NCT01621230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111489967|NCT01621230|Sensory System Agents|sensory system agents|mesh-ancestor
111108798|NCT04254731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111108799|NCT04254731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111108800|NCT04254731|Analgesics|analgesics|mesh-ancestor
111108801|NCT04254731|Sensory System Agents|sensory system agents|mesh-ancestor
111108802|NCT04254731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111108803|NCT04254731|Antitussive Agents|antitussive agents|mesh-ancestor
111108804|NCT04254731|Respiratory System Agents|respiratory system agents|mesh-ancestor
111108805|NCT01603277|Antibodies|antibodies|mesh-list
111108806|NCT01603277|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111108807|NCT01603277|Immunologic Factors|immunologic factors|mesh-ancestor
111108808|NCT01603277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111108809|NCT01678313|Celecoxib|celecoxib|mesh-list
111108810|NCT01678313|Doxazosin|doxazosin|mesh-list
111108811|NCT01678313|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111108812|NCT01678313|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111108813|NCT01678313|Analgesics|analgesics|mesh-ancestor
111108814|NCT01678313|Sensory System Agents|sensory system agents|mesh-ancestor
111108815|NCT01678313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111108816|NCT01678313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111108817|NCT01678313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111108818|NCT01678313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111108819|NCT01678313|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111108820|NCT01678313|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111108821|NCT01678313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111108822|NCT01678313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111108823|NCT01678313|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111108824|NCT01678313|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111108825|NCT01678313|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110647691|NCT00468052|Fentanyl|fentanyl|mesh-list
111108826|NCT01678313|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111108827|NCT01678313|Adrenergic Agents|adrenergic agents|mesh-ancestor
111108828|NCT01678313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111108829|NCT03197207|Camphor|camphor|mesh-list
111108830|NCT03197207|Salicylates|salicylates|mesh-list
111108831|NCT03197207|Methyl salicylate|methyl salicylate|mesh-list
111108832|NCT03197207|Menthol|menthol|mesh-list
111108833|NCT03197207|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111108834|NCT03197207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111108835|NCT03197207|Antipruritics|antipruritics|mesh-ancestor
111108836|NCT03197207|Dermatologic Agents|dermatologic agents|mesh-ancestor
111108837|NCT03197207|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111108838|NCT03197207|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111108839|NCT03197207|Analgesics|analgesics|mesh-ancestor
111108840|NCT03197207|Sensory System Agents|sensory system agents|mesh-ancestor
111108841|NCT03197207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111108842|NCT03197207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111108843|NCT03197207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111108844|NCT03197207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111108845|NCT03197207|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111108846|NCT03197207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111108847|NCT03197207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111108848|NCT01603121|Lisofylline|lisofylline|mesh-list
111108849|NCT01603121|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111108850|NCT01603121|Immunologic Factors|immunologic factors|mesh-ancestor
111108851|NCT01603121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111108852|NCT01603121|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111108853|NCT01603121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111108854|NCT01603121|Analgesics|analgesics|mesh-ancestor
111108855|NCT01603121|Sensory System Agents|sensory system agents|mesh-ancestor
111108856|NCT01603121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111108857|NCT01603121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111108858|NCT01603121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111108859|NCT01603121|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111108860|NCT02449265|Prednisone|prednisone|mesh-list
111108861|NCT02449265|Cyclophosphamide|cyclophosphamide|mesh-list
111108862|NCT02449265|Doxorubicin|doxorubicin|mesh-list
111108863|NCT02449265|Vincristine|vincristine|mesh-list
111108864|NCT02449265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111108865|NCT02449265|Immunologic Factors|immunologic factors|mesh-ancestor
111108866|NCT02449265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111108867|NCT02449265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110647706|NCT00468052|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111108868|NCT02449265|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111489968|NCT01621230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111108869|NCT02449265|Alkylating Agents|alkylating agents|mesh-ancestor
110414680|NCT04540211|Atezolizumab|atezolizumab|mesh-list
111108870|NCT02449265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111108871|NCT02449265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111108872|NCT02449265|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111108873|NCT02449265|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111108874|NCT02449265|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111108875|NCT02449265|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111108876|NCT02449265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111108877|NCT02449265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111108878|NCT02449265|Glucocorticoids|glucocorticoids|mesh-ancestor
111108879|NCT02449265|Hormones|hormones|mesh-ancestor
111108880|NCT02449265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111108881|NCT02449265|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111108882|NCT02449265|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111108883|NCT02449265|Tubulin Modulators|tubulin modulators|mesh-ancestor
111108884|NCT02449265|Antimitotic Agents|antimitotic agents|mesh-ancestor
111108885|NCT02449265|Mitosis Modulators|mitosis modulators|mesh-ancestor
111108886|NCT03196817|Betamethasone|betamethasone|mesh-list
111108887|NCT03196817|Betamethasone Valerate|betamethasone valerate|mesh-list
111108888|NCT03196817|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
111108889|NCT03196817|Betamethasone benzoate|betamethasone benzoate|mesh-list
111108890|NCT03196817|Lidocaine|lidocaine|mesh-list
111108891|NCT03196817|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
111108892|NCT03196817|Anesthetics, Local|anesthetics, local|mesh-ancestor
111108893|NCT03196817|Anesthetics|anesthetics|mesh-ancestor
111108894|NCT03196817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111108895|NCT03196817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111108896|NCT03196817|Sensory System Agents|sensory system agents|mesh-ancestor
111108897|NCT03196817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111108898|NCT03196817|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111108899|NCT03196817|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111108900|NCT03196817|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111108901|NCT03196817|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111108902|NCT03196817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111108903|NCT03196817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111108904|NCT03196817|Glucocorticoids|glucocorticoids|mesh-ancestor
111108905|NCT03196817|Hormones|hormones|mesh-ancestor
111108906|NCT03196817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111108907|NCT03196817|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111108908|NCT03196817|Respiratory System Agents|respiratory system agents|mesh-ancestor
111108909|NCT05091359|Calcium|calcium|mesh-list
111108910|NCT05091359|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111108911|NCT05091359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111108912|NCT03564821|Ivosidenib|ivosidenib|mesh-list
111108913|NCT03564821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111108914|NCT03564821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111108915|NCT03564821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111108916|NCT02014402|Thrombin|thrombin|mesh-list
111108917|NCT02014402|Hemostatics|hemostatics|mesh-ancestor
111108918|NCT02014402|Coagulants|coagulants|mesh-ancestor
111108919|NCT01988662|Ranibizumab|ranibizumab|mesh-list
111108920|NCT01988662|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111108921|NCT01988662|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111108922|NCT01988662|Growth Substances|growth substances|mesh-ancestor
111108923|NCT01988662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111108924|NCT01988662|Growth Inhibitors|growth inhibitors|mesh-ancestor
111108925|NCT01988662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111108926|NCT00127673|Sertraline|sertraline|mesh-list
111108927|NCT00127673|Antidepressive Agents|antidepressive agents|mesh-ancestor
111108928|NCT00127673|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111108929|NCT00127673|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111108930|NCT00127673|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111108931|NCT00127673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111108932|NCT00127673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111108933|NCT00127673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111108934|NCT00127673|Serotonin Agents|serotonin agents|mesh-ancestor
111108935|NCT00127673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111108936|NCT02449187|Calcium, Dietary|calcium, dietary|mesh-list
111108937|NCT02449187|Metformin|metformin|mesh-list
111108938|NCT02449187|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111108939|NCT02449187|Calcium|calcium|mesh-list
111489969|NCT01621230|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111489970|NCT01621230|Narcotics|narcotics|mesh-ancestor
111489971|NCT01621230|Analgesics|analgesics|mesh-ancestor
111489972|NCT01621230|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111489973|NCT01621230|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111108940|NCT02449187|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111108941|NCT02449187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111108942|NCT02449187|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111108943|NCT02449187|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111108944|NCT02449187|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111108945|NCT02449187|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111108946|NCT02449187|Antimetabolites|antimetabolites|mesh-ancestor
111108947|NCT02449187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111108948|NCT02449187|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111108949|NCT02449187|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111108950|NCT02449187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111108951|NCT02677181|Mycophenolic Acid|mycophenolic acid|mesh-list
111108952|NCT02677181|Methotrexate|methotrexate|mesh-list
111108953|NCT02677181|Thymoglobulin|thymoglobulin|mesh-list
111108954|NCT02677181|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111108955|NCT02677181|Abortifacient Agents|abortifacient agents|mesh-ancestor
111108956|NCT02677181|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111108957|NCT02677181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111108958|NCT02677181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111108959|NCT02677181|Antimetabolites|antimetabolites|mesh-ancestor
111108960|NCT02677181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111108961|NCT02677181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111108962|NCT02677181|Dermatologic Agents|dermatologic agents|mesh-ancestor
111108963|NCT02677181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111108964|NCT02677181|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111108965|NCT02677181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111108966|NCT02677181|Immunologic Factors|immunologic factors|mesh-ancestor
111108967|NCT02677181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111108968|NCT02677181|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111108969|NCT02677181|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111108970|NCT02677181|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111108971|NCT02677181|Antitubercular Agents|antitubercular agents|mesh-ancestor
111108972|NCT02677181|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111108973|NCT02677181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111108974|NCT05095025|Bupivacaine|bupivacaine|mesh-list
111108975|NCT05095025|Anesthetics, Local|anesthetics, local|mesh-ancestor
111108976|NCT05095025|Anesthetics|anesthetics|mesh-ancestor
111108977|NCT05095025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111108978|NCT05095025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111108979|NCT05095025|Sensory System Agents|sensory system agents|mesh-ancestor
111108980|NCT05095025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111108981|NCT05056259|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
111108982|NCT05056259|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111108983|NCT05056259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111108984|NCT01987960|Brexpiprazole|brexpiprazole|mesh-list
111108985|NCT01987960|Serotonin Agents|serotonin agents|mesh-ancestor
111108986|NCT01987960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111108987|NCT01987960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111108988|NCT01987960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111108989|NCT01987960|Dopamine Agonists|dopamine agonists|mesh-ancestor
111108990|NCT01987960|Dopamine Agents|dopamine agents|mesh-ancestor
111108991|NCT05084027|Fludarabine|fludarabine|mesh-list
111108992|NCT05084027|Melphalan|melphalan|mesh-list
111108993|NCT05084027|Venetoclax|venetoclax|mesh-list
111108994|NCT05084027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111108995|NCT05084027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111108996|NCT05084027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111108997|NCT05084027|Immunologic Factors|immunologic factors|mesh-ancestor
111108998|NCT05084027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111108999|NCT05084027|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111109000|NCT05084027|Alkylating Agents|alkylating agents|mesh-ancestor
111109001|NCT05084027|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111109002|NCT02013622|Brexpiprazole|brexpiprazole|mesh-list
111109003|NCT02013622|Serotonin Agents|serotonin agents|mesh-ancestor
111109004|NCT02013622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111109005|NCT02013622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111109006|NCT02013622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111109007|NCT02013622|Dopamine Agonists|dopamine agonists|mesh-ancestor
111109008|NCT02013622|Dopamine Agents|dopamine agents|mesh-ancestor
111489974|NCT01621230|Anesthetics, General|anesthetics, general|mesh-ancestor
111489975|NCT01621776|Insulin|insulin|mesh-list
111489976|NCT01621776|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111489977|NCT01621776|Insulin Aspart|insulin aspart|mesh-list
111489978|NCT01621776|Insulin Lispro|insulin lispro|mesh-list
111489979|NCT01621776|Insulin glulisine|insulin glulisine|mesh-list
111489980|NCT01621776|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111489981|NCT01621776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111109009|NCT02448797|Vinorelbine|vinorelbine|mesh-list
111109010|NCT02448797|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111109011|NCT02448797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111109012|NCT02448797|Tubulin Modulators|tubulin modulators|mesh-ancestor
111109013|NCT02448797|Antimitotic Agents|antimitotic agents|mesh-ancestor
111109014|NCT02448797|Mitosis Modulators|mitosis modulators|mesh-ancestor
111109015|NCT02448797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111109016|NCT04438421|Chlorhexidine|chlorhexidine|mesh-list
111109017|NCT04438421|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
111109018|NCT04438421|Hydrogen Peroxide|hydrogen peroxide|mesh-list
111109019|NCT04438421|Hyaluronic Acid|hyaluronic acid|mesh-list
111109020|NCT04438421|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111109021|NCT04438421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111109022|NCT04438421|Disinfectants|disinfectants|mesh-ancestor
111109023|NCT04438421|Dermatologic Agents|dermatologic agents|mesh-ancestor
111109024|NCT04438421|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111109025|NCT04438421|Immunologic Factors|immunologic factors|mesh-ancestor
111109026|NCT04438421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111109027|NCT04438421|Viscosupplements|viscosupplements|mesh-ancestor
111109028|NCT04438421|Protective Agents|protective agents|mesh-ancestor
111109029|NCT05099081|Ethanolamine oleate|ethanolamine oleate|mesh-list
111109030|NCT05099081|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
111109031|NCT05099081|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111109032|NCT04438577|Lidocaine|lidocaine|mesh-list
111109033|NCT04438577|Anesthetics, Local|anesthetics, local|mesh-ancestor
111109034|NCT04438577|Anesthetics|anesthetics|mesh-ancestor
111109035|NCT04438577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111109036|NCT04438577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111109037|NCT04438577|Sensory System Agents|sensory system agents|mesh-ancestor
111109038|NCT04438577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111109039|NCT04438577|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111109040|NCT04438577|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111109041|NCT04438577|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111109042|NCT04438577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111109043|NCT04438577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111109044|NCT05087615|Ondansetron|ondansetron|mesh-list
111109045|NCT05087615|Metoclopramide|metoclopramide|mesh-list
111109046|NCT05087615|Granisetron|granisetron|mesh-list
111109047|NCT05087615|Antiemetics|antiemetics|mesh-ancestor
111109048|NCT05087615|Autonomic Agents|autonomic agents|mesh-ancestor
111109049|NCT05087615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111109050|NCT05087615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111109051|NCT05087615|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111109052|NCT05087615|Antipruritics|antipruritics|mesh-ancestor
111109053|NCT05087615|Dermatologic Agents|dermatologic agents|mesh-ancestor
111109054|NCT05087615|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111109055|NCT05087615|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111109056|NCT05087615|Serotonin Agents|serotonin agents|mesh-ancestor
111109057|NCT05087615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111109058|NCT05087615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111109059|NCT05087615|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111109060|NCT05087615|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111109061|NCT05087615|Dopamine Agents|dopamine agents|mesh-ancestor
111109062|NCT01987102|Leucovorin|leucovorin|mesh-list
111109063|NCT01987102|Calcium|calcium|mesh-list
111109064|NCT01987102|Levoleucovorin|levoleucovorin|mesh-list
111109065|NCT01987102|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111109066|NCT01987102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111109067|NCT01987102|Antidotes|antidotes|mesh-ancestor
111109068|NCT01987102|Protective Agents|protective agents|mesh-ancestor
111109069|NCT01987102|Vitamin B Complex|vitamin b complex|mesh-ancestor
111109070|NCT01987102|Vitamins|vitamins|mesh-ancestor
111109071|NCT01987102|Micronutrients|micronutrients|mesh-ancestor
111109072|NCT02013544|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
111109073|NCT02013544|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111109074|NCT02013544|Immunologic Factors|immunologic factors|mesh-ancestor
111109075|NCT02013544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111489982|NCT01631682|Propranolol|propranolol|mesh-list
111489983|NCT01631682|Oxytocin|oxytocin|mesh-list
111489984|NCT01631682|Mifepristone|mifepristone|mesh-list
111109076|NCT03968939|Diphenhydramine|diphenhydramine|mesh-list
111109077|NCT03968939|Promethazine|promethazine|mesh-list
111109078|NCT03968939|Melatonin|melatonin|mesh-list
111109079|NCT03968939|Antioxidants|antioxidants|mesh-ancestor
111109080|NCT03968939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111109081|NCT03968939|Protective Agents|protective agents|mesh-ancestor
111109082|NCT03968939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111109083|NCT03968939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111109084|NCT03968939|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111109085|NCT03968939|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111109086|NCT03968939|Anesthetics, Local|anesthetics, local|mesh-ancestor
111109087|NCT03968939|Anesthetics|anesthetics|mesh-ancestor
111109088|NCT03968939|Sensory System Agents|sensory system agents|mesh-ancestor
111109089|NCT03968939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111109090|NCT03968939|Antiemetics|antiemetics|mesh-ancestor
111109091|NCT03968939|Autonomic Agents|autonomic agents|mesh-ancestor
111109092|NCT03968939|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111109093|NCT03968939|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111109094|NCT03968939|Histamine Antagonists|histamine antagonists|mesh-ancestor
111109095|NCT03968939|Histamine Agents|histamine agents|mesh-ancestor
111109096|NCT03968939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111109097|NCT03968939|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111109098|NCT03968939|Antipruritics|antipruritics|mesh-ancestor
111109099|NCT03968939|Dermatologic Agents|dermatologic agents|mesh-ancestor
111109100|NCT03856619|Teriflunomide|teriflunomide|mesh-list
111109101|NCT03856619|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111109102|NCT03856619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111109103|NCT03856619|Analgesics|analgesics|mesh-ancestor
111109104|NCT03856619|Sensory System Agents|sensory system agents|mesh-ancestor
111109105|NCT03856619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111109106|NCT03856619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111109107|NCT03856619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111109108|NCT03856619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111109109|NCT03856619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111109110|NCT03856619|Immunologic Factors|immunologic factors|mesh-ancestor
111109111|NCT02448407|Hyaluronic Acid|hyaluronic acid|mesh-list
111109112|NCT02448407|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111109113|NCT02448407|Immunologic Factors|immunologic factors|mesh-ancestor
111109114|NCT02448407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111109115|NCT02448407|Viscosupplements|viscosupplements|mesh-ancestor
111109116|NCT02448407|Protective Agents|protective agents|mesh-ancestor
111109117|NCT05098847|Lenvatinib|lenvatinib|mesh-list
111109118|NCT05098847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111109119|NCT05098847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111109120|NCT05098847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111109121|NCT05098847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111109122|NCT04517357|Apatinib|apatinib|mesh-list
111109123|NCT04517357|Fluzoparib|fluzoparib|mesh-list
111109124|NCT04517357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111109125|NCT04517357|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111109126|NCT04517357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111109127|NCT04517357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111109128|NCT04517357|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111109129|NCT02012296|Mifepristone|mifepristone|mesh-list
111109130|NCT02012296|Androgens|androgens|mesh-list
111109131|NCT02012296|Hormones|hormones|mesh-ancestor
111109132|NCT02012296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111109133|NCT02012296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111109134|NCT02012296|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
111109135|NCT02012296|Abortifacient Agents|abortifacient agents|mesh-ancestor
111109136|NCT02012296|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111109137|NCT02012296|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111109138|NCT02012296|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111109139|NCT02012296|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111109140|NCT02012296|Contraceptive Agents|contraceptive agents|mesh-ancestor
111109141|NCT02012296|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
111109142|NCT02012296|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
111109143|NCT02012296|Hormone Antagonists|hormone antagonists|mesh-ancestor
111109144|NCT02012296|Luteolytic Agents|luteolytic agents|mesh-ancestor
111109145|NCT02012296|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111109146|NCT02012296|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
111109147|NCT02012218|Brexpiprazole|brexpiprazole|mesh-list
111109148|NCT02012218|Serotonin Agents|serotonin agents|mesh-ancestor
110826246|NCT03881293|Lidocaine|lidocaine|mesh-list
111109149|NCT02012218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111109150|NCT02012218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111109151|NCT02012218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111109152|NCT02012218|Dopamine Agonists|dopamine agonists|mesh-ancestor
111489986|NCT01631682|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111109153|NCT02012218|Dopamine Agents|dopamine agents|mesh-ancestor
111489987|NCT01631682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111109155|NCT04177498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111109156|NCT04177498|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111109157|NCT04177498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111109158|NCT04177498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111109159|NCT04658836|Triamcinolone|triamcinolone|mesh-list
111109160|NCT04658836|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
111109161|NCT04658836|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
111109162|NCT04658836|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
111109163|NCT04658836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111109164|NCT04658836|Glucocorticoids|glucocorticoids|mesh-ancestor
111109165|NCT04658836|Hormones|hormones|mesh-ancestor
111109166|NCT04658836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111109167|NCT04658836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111109168|NCT04658836|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111109169|NCT04658836|Immunologic Factors|immunologic factors|mesh-ancestor
111109170|NCT04658836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111109171|NCT04658836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111109172|NCT01677377|Risperidone|risperidone|mesh-list
111109173|NCT01677377|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111109174|NCT01677377|Serotonin Agents|serotonin agents|mesh-ancestor
111109175|NCT01677377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111109176|NCT01677377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111109177|NCT01677377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111109178|NCT01677377|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111109179|NCT01677377|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111109180|NCT01677377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111109181|NCT01677377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111109182|NCT01677377|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111109183|NCT01677377|Dopamine Agents|dopamine agents|mesh-ancestor
111109184|NCT05097911|Bevacizumab|bevacizumab|mesh-list
111109185|NCT05097911|Atezolizumab|atezolizumab|mesh-list
111109186|NCT05097911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111109187|NCT05097911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111109188|NCT05097911|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111109189|NCT05097911|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111109190|NCT05097911|Growth Substances|growth substances|mesh-ancestor
111109191|NCT05097911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111109192|NCT05097911|Growth Inhibitors|growth inhibitors|mesh-ancestor
111109193|NCT05097911|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111109194|NCT05097911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111109195|NCT05097365|Folic Acid|folic acid|mesh-list
111109196|NCT05097365|Vitamin B 12|vitamin b 12|mesh-list
111109197|NCT05097365|Hydroxocobalamin|hydroxocobalamin|mesh-list
111109198|NCT05097365|Vitamins|vitamins|mesh-ancestor
111109199|NCT05097365|Micronutrients|micronutrients|mesh-ancestor
111109200|NCT05097365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111109201|NCT05097365|Hematinics|hematinics|mesh-ancestor
111109202|NCT05097365|Vitamin B Complex|vitamin b complex|mesh-ancestor
111109203|NCT01964716|Vaccines|vaccines|mesh-list
111109204|NCT01964716|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
111109205|NCT01964716|Immunologic Factors|immunologic factors|mesh-ancestor
111109206|NCT01964716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111109207|NCT01964560|Lacosamide|lacosamide|mesh-list
111109208|NCT01964560|Anticonvulsants|anticonvulsants|mesh-ancestor
111109209|NCT01964560|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111109210|NCT01964560|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111109211|NCT01964560|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111109212|NCT01964560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111109213|NCT02659943|Cyclophosphamide|cyclophosphamide|mesh-list
111109214|NCT02659943|Fludarabine|fludarabine|mesh-list
111109215|NCT02659943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111109216|NCT02659943|Immunologic Factors|immunologic factors|mesh-ancestor
111109217|NCT02659943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111109218|NCT02659943|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111109219|NCT02659943|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111109220|NCT02659943|Alkylating Agents|alkylating agents|mesh-ancestor
111109221|NCT02659943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110826346|NCT03880981|Ibuprofen|ibuprofen|mesh-list
111109222|NCT02659943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111109223|NCT02659943|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111109224|NCT05083325|Oseltamivir|oseltamivir|mesh-list
111489988|NCT01631682|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111109225|NCT05083325|Antiviral Agents|antiviral agents|mesh-ancestor
111489989|NCT01631682|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111109226|NCT05083325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111489991|NCT01631682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111489992|NCT01631682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111489993|NCT01631682|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111489994|NCT01631682|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111109227|NCT05083325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111109228|NCT05083325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111109229|NCT01677299|Metformin|metformin|mesh-list
111109230|NCT01677299|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111109231|NCT01677299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111109232|NCT04999631|Ethanol|ethanol|mesh-list
111109233|NCT04999631|Squaric acid dibutyl ester|squaric acid dibutyl ester|mesh-list
111109234|NCT04999631|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111109235|NCT04999631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111109236|NCT04999631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111109237|NCT04999631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111109238|NCT04999631|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111109239|NCT04999631|Immunologic Factors|immunologic factors|mesh-ancestor
111109240|NCT02718833|Dexamethasone|dexamethasone|mesh-list
111109241|NCT02718833|Bortezomib|bortezomib|mesh-list
111109242|NCT02718833|Pomalidomide|pomalidomide|mesh-list
111109243|NCT02718833|Elotuzumab|elotuzumab|mesh-list
111109244|NCT02718833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111109245|NCT02718833|Antiemetics|antiemetics|mesh-ancestor
111109246|NCT02718833|Autonomic Agents|autonomic agents|mesh-ancestor
111109247|NCT02718833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111109248|NCT02718833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111109249|NCT02718833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111109250|NCT02718833|Glucocorticoids|glucocorticoids|mesh-ancestor
111109251|NCT02718833|Hormones|hormones|mesh-ancestor
111109252|NCT02718833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111109253|NCT02718833|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111109254|NCT02718833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111109255|NCT02718833|Immunologic Factors|immunologic factors|mesh-ancestor
111109256|NCT02718833|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111109257|NCT02718833|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111109258|NCT02718833|Growth Substances|growth substances|mesh-ancestor
111109259|NCT02718833|Growth Inhibitors|growth inhibitors|mesh-ancestor
111109260|NCT04908293|Listerine|listerine|mesh-list
111109261|NCT04908293|Sodium Fluoride|sodium fluoride|mesh-list
111109262|NCT04908293|Cariostatic Agents|cariostatic agents|mesh-ancestor
111109263|NCT04908293|Protective Agents|protective agents|mesh-ancestor
111109264|NCT04908293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111109265|NCT04908293|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111109266|NCT04908293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111109267|NCT01964326|Atorvastatin|atorvastatin|mesh-list
111109268|NCT01964326|Calcium|calcium|mesh-list
111109269|NCT01964326|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111109270|NCT01964326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111109271|NCT01964326|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111109272|NCT01964326|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111109273|NCT01964326|Antimetabolites|antimetabolites|mesh-ancestor
111109274|NCT01964326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111109275|NCT01964326|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111109276|NCT01964326|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111109277|NCT01964326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111109278|NCT05102045|Memantine|memantine|mesh-list
111109279|NCT05102045|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
111109280|NCT05102045|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111109281|NCT05102045|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111109282|NCT05102045|Dopamine Agents|dopamine agents|mesh-ancestor
111109283|NCT05102045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111109284|NCT05102045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111489995|NCT01631682|Vasodilator Agents|vasodilator agents|mesh-ancestor
111489996|NCT01631682|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
111489997|NCT01631682|Abortifacient Agents|abortifacient agents|mesh-ancestor
111489998|NCT01631682|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111489999|NCT01631682|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111490000|NCT01631682|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111490001|NCT01631682|Contraceptive Agents|contraceptive agents|mesh-ancestor
111490002|NCT01631682|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
111109285|NCT05102045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111109286|NCT05102045|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111109288|NCT05102045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111109289|NCT05102045|Cholinergic Agents|cholinergic agents|mesh-ancestor
111109290|NCT04414241|Hydroxychloroquine|hydroxychloroquine|mesh-list
111109291|NCT04414241|Antimalarials|antimalarials|mesh-ancestor
111109292|NCT04414241|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111109293|NCT04414241|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111109294|NCT04414241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111109295|NCT04414241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111109296|NCT04414241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111109297|NCT04414241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111109298|NCT04531553|Levobupivacaine|levobupivacaine|mesh-list
111109299|NCT04531553|Anesthetics, Local|anesthetics, local|mesh-ancestor
111109300|NCT04531553|Anesthetics|anesthetics|mesh-ancestor
111109301|NCT04531553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111109302|NCT04531553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111109303|NCT04531553|Sensory System Agents|sensory system agents|mesh-ancestor
111109304|NCT04531553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111109305|NCT05101811|Vitamin D|vitamin d|mesh-list
111109306|NCT05101811|Ergocalciferols|ergocalciferols|mesh-list
111109307|NCT05101811|Cholecalciferol|cholecalciferol|mesh-list
111109308|NCT05101811|Vitamins|vitamins|mesh-list
111109309|NCT05101811|Micronutrients|micronutrients|mesh-ancestor
111109310|NCT05101811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111109311|NCT05101811|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111109312|NCT05101811|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111109313|NCT04088123|Ticagrelor|ticagrelor|mesh-list
111109314|NCT04088123|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111109315|NCT04088123|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111109316|NCT04088123|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111109317|NCT04088123|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111109318|NCT04088123|Purinergic Agents|purinergic agents|mesh-ancestor
111109319|NCT04088123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111109320|NCT04088123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111109321|NCT04088123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111109322|NCT05164367|Atropine|atropine|mesh-list
111109323|NCT05164367|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111109324|NCT05164367|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111109325|NCT05164367|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111109326|NCT05164367|Autonomic Agents|autonomic agents|mesh-ancestor
111109327|NCT05164367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111109328|NCT05164367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111109329|NCT05164367|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111109330|NCT05164367|Respiratory System Agents|respiratory system agents|mesh-ancestor
111109331|NCT05164367|Mydriatics|mydriatics|mesh-ancestor
111109332|NCT05164367|Parasympatholytics|parasympatholytics|mesh-ancestor
111109333|NCT05164367|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111109334|NCT05164367|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111109335|NCT05164367|Cholinergic Agents|cholinergic agents|mesh-ancestor
111109336|NCT05164367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111109337|NCT05164367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111109338|NCT03847181|Vitamin K|vitamin k|mesh-list
111109339|NCT03847181|Warfarin|warfarin|mesh-list
111109340|NCT03847181|Rivaroxaban|rivaroxaban|mesh-list
111109341|NCT03847181|Apixaban|apixaban|mesh-list
111109342|NCT03847181|Anticoagulants|anticoagulants|mesh-list
111109343|NCT03847181|Vitamins|vitamins|mesh-ancestor
111109344|NCT03847181|Micronutrients|micronutrients|mesh-ancestor
111109345|NCT03847181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111109346|NCT03847181|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111109347|NCT03847181|Antithrombins|antithrombins|mesh-ancestor
111109348|NCT03847181|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111109349|NCT03847181|Protease Inhibitors|protease inhibitors|mesh-ancestor
111109350|NCT03847181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111109351|NCT03847181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111109352|NCT03847181|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111109353|NCT03847181|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111109354|NCT03847181|Hemostatics|hemostatics|mesh-ancestor
111109355|NCT03847181|Coagulants|coagulants|mesh-ancestor
111109356|NCT03477851|Tramadol|tramadol|mesh-list
111109357|NCT03477851|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111109358|NCT03477851|Narcotics|narcotics|mesh-ancestor
111490003|NCT01631682|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
111490004|NCT01631682|Hormone Antagonists|hormone antagonists|mesh-ancestor
111109359|NCT03477851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111109360|NCT03477851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111109362|NCT03477851|Sensory System Agents|sensory system agents|mesh-ancestor
111109363|NCT03477851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111109365|NCT02409199|Apatinib|apatinib|mesh-list
111109366|NCT02409199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111109367|NCT02409199|Tubulin Modulators|tubulin modulators|mesh-ancestor
111109368|NCT02409199|Antimitotic Agents|antimitotic agents|mesh-ancestor
111109369|NCT02409199|Mitosis Modulators|mitosis modulators|mesh-ancestor
111109370|NCT02409199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111109371|NCT02409199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111109372|NCT02409199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111109373|NCT03115489|Ketamine|ketamine|mesh-list
111109374|NCT03115489|Propofol|propofol|mesh-list
111109375|NCT03115489|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111109376|NCT03115489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111109377|NCT03115489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111109378|NCT03115489|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111109379|NCT03115489|Anesthetics, General|anesthetics, general|mesh-ancestor
111109380|NCT03115489|Anesthetics|anesthetics|mesh-ancestor
111109381|NCT03115489|Analgesics|analgesics|mesh-ancestor
111109382|NCT03115489|Sensory System Agents|sensory system agents|mesh-ancestor
111109383|NCT03115489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111109384|NCT03115489|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111109385|NCT03115489|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111109386|NCT03115489|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111109387|NCT03115489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111109388|NCT03115489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111109390|NCT03168997|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111109391|NCT03168997|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111109392|NCT03168997|Dopamine Agents|dopamine agents|mesh-ancestor
111109393|NCT03168997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111109394|NCT03168997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111109395|NCT03168997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111109396|NCT03168997|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111109397|NCT03168997|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111109398|NCT03171727|Heparin|heparin|mesh-list
111109399|NCT03171727|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
111109400|NCT03171727|Tinzaparin|tinzaparin|mesh-list
111109401|NCT03171727|Dalteparin|dalteparin|mesh-list
111109402|NCT03171727|Anticoagulants|anticoagulants|mesh-ancestor
111109403|NCT03171727|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111109404|NCT03171727|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111109405|NCT03171727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111109406|NCT02400931|Rocuronium|rocuronium|mesh-list
111109407|NCT02400931|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
111109408|NCT02400931|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
111109409|NCT02400931|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111109410|NCT02400931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111109411|NCT02400931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111109412|NCT03116269|Aspirin|aspirin|mesh-list
111109413|NCT03116269|Cilostazol|cilostazol|mesh-list
111109414|NCT03116269|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111109415|NCT03116269|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111109416|NCT03116269|Analgesics|analgesics|mesh-ancestor
111109417|NCT03116269|Sensory System Agents|sensory system agents|mesh-ancestor
111109418|NCT03116269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111109419|NCT03116269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111109420|NCT03116269|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111109421|NCT03116269|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111109422|NCT03116269|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111109423|NCT03116269|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111109424|NCT03116269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111109425|NCT03116269|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111109426|NCT03116269|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111109427|NCT03116269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111109428|NCT03116269|Antipyretics|antipyretics|mesh-ancestor
111109429|NCT03116269|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111109430|NCT03116269|Autonomic Agents|autonomic agents|mesh-ancestor
111109431|NCT03116269|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111109432|NCT03116269|Respiratory System Agents|respiratory system agents|mesh-ancestor
111109433|NCT03116269|Vasodilator Agents|vasodilator agents|mesh-ancestor
111109434|NCT03116269|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111109435|NCT03116269|Protective Agents|protective agents|mesh-ancestor
111109436|NCT03116269|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
111490005|NCT01631682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111490006|NCT01631682|Luteolytic Agents|luteolytic agents|mesh-ancestor
111490007|NCT01631682|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111490008|NCT01631682|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
111109437|NCT03116269|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111109439|NCT03174067|Buprenorphine|buprenorphine|mesh-list
111109440|NCT03174067|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111109441|NCT03174067|Narcotics|narcotics|mesh-ancestor
111109442|NCT03174067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111109443|NCT03174067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111109444|NCT03174067|Analgesics|analgesics|mesh-ancestor
111109445|NCT03174067|Sensory System Agents|sensory system agents|mesh-ancestor
111109446|NCT03174067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111109447|NCT03174067|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111109448|NCT03174067|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111109449|NCT03174067|Sympatholytics|sympatholytics|mesh-ancestor
111109450|NCT03174067|Autonomic Agents|autonomic agents|mesh-ancestor
111109451|NCT03174067|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111109452|NCT03174067|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111109453|NCT03174067|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111109454|NCT03174067|Adrenergic Agents|adrenergic agents|mesh-ancestor
111109455|NCT03174067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111109456|NCT03174067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111109457|NCT02408185|Colistin|colistin|mesh-list
111109458|NCT02408185|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111109459|NCT02408185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111109460|NCT02408419|Bupivacaine|bupivacaine|mesh-list
111109461|NCT02408419|Anesthetics, Local|anesthetics, local|mesh-ancestor
111109462|NCT02408419|Anesthetics|anesthetics|mesh-ancestor
111109463|NCT02408419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111109464|NCT02408419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111109465|NCT02408419|Sensory System Agents|sensory system agents|mesh-ancestor
111109466|NCT02408419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111109467|NCT00708097|Fluorides|fluorides|mesh-list
111109468|NCT00708097|Cariostatic Agents|cariostatic agents|mesh-ancestor
111109469|NCT00708097|Protective Agents|protective agents|mesh-ancestor
111109470|NCT00708097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111109471|NCT02400775|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
111109472|NCT02400775|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111109473|NCT02400775|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111109474|NCT02400775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111109475|NCT02405689|Dexmedetomidine|dexmedetomidine|mesh-list
111109476|NCT02405689|Remifentanil|remifentanil|mesh-list
111109477|NCT02405689|Sevoflurane|sevoflurane|mesh-list
111109478|NCT02405689|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111109479|NCT02405689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111109480|NCT02405689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111109481|NCT02405689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111109482|NCT02405689|Analgesics|analgesics|mesh-ancestor
111109483|NCT02405689|Sensory System Agents|sensory system agents|mesh-ancestor
111109484|NCT02405689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111109485|NCT02405689|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111109486|NCT02405689|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111109487|NCT02405689|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111109488|NCT02405689|Adrenergic Agents|adrenergic agents|mesh-ancestor
111109489|NCT02405689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111109490|NCT02405689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111109491|NCT02405689|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111109492|NCT02405689|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111109493|NCT02405689|Anesthetics, General|anesthetics, general|mesh-ancestor
111109494|NCT02405689|Anesthetics|anesthetics|mesh-ancestor
111109495|NCT02405689|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111109496|NCT02405689|Narcotics|narcotics|mesh-ancestor
111109497|NCT02400619|Botulinum Toxins|botulinum toxins|mesh-list
111109498|NCT02400619|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111109499|NCT02400619|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111109500|NCT02400619|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111109501|NCT02400619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111109502|NCT02400619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111490009|NCT01635504|Botulinum Toxins|botulinum toxins|mesh-list
111490010|NCT01635504|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111490011|NCT01635504|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111109503|NCT02400619|Cholinergic Agents|cholinergic agents|mesh-ancestor
111490012|NCT01635504|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111490013|NCT01635504|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111109504|NCT02400619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111109505|NCT02400619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111109506|NCT02400619|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111109507|NCT02400619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111109508|NCT02699125|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
111109510|NCT02699125|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111109511|NCT02699125|Diuretics|diuretics|mesh-ancestor
111109512|NCT02699125|Natriuretic Agents|natriuretic agents|mesh-ancestor
111109513|NCT02699125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111109514|NCT02699125|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
111109515|NCT02699125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111109516|NCT02699125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111109517|NCT02699125|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111109518|NCT02699125|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111109519|NCT02699125|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111109520|NCT02699125|Adrenergic Agents|adrenergic agents|mesh-ancestor
111109521|NCT02699125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111109522|NCT04279535|Ascorbic Acid|ascorbic acid|mesh-list
111109523|NCT04279535|Antioxidants|antioxidants|mesh-ancestor
111109524|NCT04279535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111109525|NCT04279535|Protective Agents|protective agents|mesh-ancestor
110826635|NCT01100801|Cisplatin|cisplatin|mesh-list
111109526|NCT04279535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111109527|NCT04279535|Vitamins|vitamins|mesh-ancestor
111109528|NCT04279535|Micronutrients|micronutrients|mesh-ancestor
111109529|NCT02400151|Vitamin D|vitamin d|mesh-list
111109530|NCT02400151|Vitamins|vitamins|mesh-ancestor
111109531|NCT02400151|Micronutrients|micronutrients|mesh-ancestor
111109532|NCT02400151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111109533|NCT02400151|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111109534|NCT02400385|Nivolumab|nivolumab|mesh-list
111109535|NCT02400385|Sunitinib|sunitinib|mesh-list
111109536|NCT02400385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111109537|NCT02400385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111109538|NCT02400385|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111109539|NCT02400385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111109540|NCT02400385|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111109541|NCT02400385|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111109542|NCT02400385|Growth Substances|growth substances|mesh-ancestor
111109543|NCT02400385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111109544|NCT02400385|Growth Inhibitors|growth inhibitors|mesh-ancestor
111109545|NCT02400385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111109546|NCT02400385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111109547|NCT03173365|Brimonidine Tartrate|brimonidine tartrate|mesh-list
111109548|NCT03173365|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111109549|NCT03173365|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111109550|NCT03173365|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111109551|NCT03173365|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111109552|NCT03173365|Adrenergic Agents|adrenergic agents|mesh-ancestor
111109553|NCT03173365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111109554|NCT03173365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111109555|NCT03173365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111109556|NCT05100719|Mebeverine|mebeverine|mesh-list
111109557|NCT05100719|Simethicone|simethicone|mesh-list
111109558|NCT05100719|Citric Acid|citric acid|mesh-list
111109559|NCT05100719|Sodium Citrate|sodium citrate|mesh-list
111109560|NCT05100719|Alverine|alverine|mesh-list
111109561|NCT05100719|Anticoagulants|anticoagulants|mesh-ancestor
111109562|NCT05100719|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
111109563|NCT05100719|Chelating Agents|chelating agents|mesh-ancestor
111109564|NCT05100719|Sequestering Agents|sequestering agents|mesh-ancestor
111109565|NCT05100719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111109566|NCT05100719|Antifoaming Agents|antifoaming agents|mesh-ancestor
111109567|NCT05100719|Emollients|emollients|mesh-ancestor
111109568|NCT05100719|Dermatologic Agents|dermatologic agents|mesh-ancestor
111109569|NCT05100719|Parasympatholytics|parasympatholytics|mesh-ancestor
111109570|NCT05100719|Autonomic Agents|autonomic agents|mesh-ancestor
111109571|NCT05100719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111109572|NCT05100719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111109573|NCT05100719|Anticonvulsants|anticonvulsants|mesh-ancestor
111109574|NCT05100563|Naltrexone|naltrexone|mesh-list
111109575|NCT05100563|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111109576|NCT05100563|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111109577|NCT05100563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111109578|NCT05100563|Sensory System Agents|sensory system agents|mesh-ancestor
111109579|NCT05100563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111109580|NCT05100329|Mitoxantrone|mitoxantrone|mesh-list
111109581|NCT05100329|Analgesics|analgesics|mesh-ancestor
111109582|NCT05100329|Sensory System Agents|sensory system agents|mesh-ancestor
111109583|NCT05100329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111109584|NCT05100329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111109585|NCT05100329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111109586|NCT05100329|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111109587|NCT05100329|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111109588|NCT05100329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111109589|NCT05100329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111109590|NCT04530539|Ascorbic Acid|ascorbic acid|mesh-list
111109591|NCT04530539|Melatonin|melatonin|mesh-list
111109592|NCT04530539|Vitamins|vitamins|mesh-ancestor
111109593|NCT04530539|Micronutrients|micronutrients|mesh-ancestor
111109594|NCT04530539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111109595|NCT04530539|Antioxidants|antioxidants|mesh-ancestor
111109596|NCT04530539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111109597|NCT04530539|Protective Agents|protective agents|mesh-ancestor
111109598|NCT04530539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111109599|NCT02698891|Paclitaxel|paclitaxel|mesh-list
111109600|NCT02698891|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111109601|NCT02698891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111109602|NCT02698891|Tubulin Modulators|tubulin modulators|mesh-ancestor
111109603|NCT02698891|Antimitotic Agents|antimitotic agents|mesh-ancestor
111109604|NCT02698891|Mitosis Modulators|mitosis modulators|mesh-ancestor
110648003|NCT01021930|Mitosis Modulators|mitosis modulators|mesh-ancestor
111109605|NCT02698891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111109607|NCT04719065|Analgesics|analgesics|mesh-ancestor
111109608|NCT04719065|Sensory System Agents|sensory system agents|mesh-ancestor
111109609|NCT04719065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111109610|NCT04719065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111109611|NCT04719065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111109612|NCT04719065|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111109613|NCT04719065|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111109614|NCT04719065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111109615|NCT04719065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111109616|NCT02399059|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111109617|NCT02399059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111109618|NCT05108051|Oseltamivir|oseltamivir|mesh-list
111109619|NCT05108051|Antiviral Agents|antiviral agents|mesh-ancestor
111109620|NCT05108051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111109621|NCT05108051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111109622|NCT05108051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111109623|NCT03765359|Metformin|metformin|mesh-list
111109624|NCT03765359|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111109625|NCT03765359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111109626|NCT04351295|Chloroquine|chloroquine|mesh-list
111109627|NCT04351295|Favipiravir|favipiravir|mesh-list
111109628|NCT04351295|Amebicides|amebicides|mesh-ancestor
111109629|NCT04351295|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111109630|NCT04351295|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111109631|NCT04351295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111109632|NCT04351295|Antimalarials|antimalarials|mesh-ancestor
111109633|NCT04351295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111109634|NCT04351295|Antiviral Agents|antiviral agents|mesh-ancestor
111109635|NCT02399137|Paclitaxel|paclitaxel|mesh-list
111109636|NCT02399137|Gemcitabine|gemcitabine|mesh-list
111109637|NCT02399137|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111109638|NCT02399137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111109639|NCT02399137|Tubulin Modulators|tubulin modulators|mesh-ancestor
111109640|NCT02399137|Antimitotic Agents|antimitotic agents|mesh-ancestor
111109641|NCT02399137|Mitosis Modulators|mitosis modulators|mesh-ancestor
111109642|NCT02399137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111109643|NCT02399137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111109644|NCT02399137|Antimetabolites|antimetabolites|mesh-ancestor
111109645|NCT05093387|Carboplatin|carboplatin|mesh-list
111109646|NCT05093387|Pembrolizumab|pembrolizumab|mesh-list
111109647|NCT05093387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111490014|NCT01635504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111490015|NCT01635504|Cholinergic Agents|cholinergic agents|mesh-ancestor
111109648|NCT05093387|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111109649|NCT05093387|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110698161|NCT01045902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111109650|NCT05093387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111109652|NCT02407171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111109653|NCT02407171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111109654|NCT02407171|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111109655|NCT02407171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111109656|NCT02850263|Aflibercept|aflibercept|mesh-list
111109657|NCT02850263|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111109658|NCT02850263|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111109659|NCT02850263|Growth Substances|growth substances|mesh-ancestor
111109660|NCT02850263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111109661|NCT02850263|Growth Inhibitors|growth inhibitors|mesh-ancestor
111109662|NCT02850263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111109663|NCT04481815|Rituximab|rituximab|mesh-list
111109664|NCT04481815|Methotrexate|methotrexate|mesh-list
111109665|NCT04481815|Lenalidomide|lenalidomide|mesh-list
111109666|NCT04481815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111109667|NCT04481815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111109668|NCT04481815|Immunologic Factors|immunologic factors|mesh-ancestor
111109669|NCT04481815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111109670|NCT04481815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111109671|NCT04481815|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111109672|NCT04481815|Abortifacient Agents|abortifacient agents|mesh-ancestor
111109673|NCT04481815|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111109674|NCT04481815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111109675|NCT04481815|Antimetabolites|antimetabolites|mesh-ancestor
111109676|NCT04481815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111109677|NCT04481815|Dermatologic Agents|dermatologic agents|mesh-ancestor
111109678|NCT04481815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111109679|NCT04481815|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111109680|NCT04481815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111109681|NCT04481815|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111109682|NCT04481815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111109683|NCT04481815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111109684|NCT04481815|Growth Substances|growth substances|mesh-ancestor
111109685|NCT04481815|Growth Inhibitors|growth inhibitors|mesh-ancestor
111109686|NCT05106803|Amoxicillin|amoxicillin|mesh-list
111109687|NCT05106803|Vancomycin|vancomycin|mesh-list
111109688|NCT05106803|Ciprofloxacin|ciprofloxacin|mesh-list
111109689|NCT05106803|Clindamycin|clindamycin|mesh-list
111109690|NCT05106803|Gentamicins|gentamicins|mesh-list
111109691|NCT05106803|Tetracycline|tetracycline|mesh-list
111109692|NCT05106803|Penicillins|penicillins|mesh-list
111109693|NCT05106803|Erythromycin|erythromycin|mesh-list
111109694|NCT05106803|Ampicillin|ampicillin|mesh-list
111109695|NCT05106803|Clavulanic Acids|clavulanic acids|mesh-list
111109696|NCT05106803|Clavulanic Acid|clavulanic acid|mesh-list
111109697|NCT05106803|Cefepime|cefepime|mesh-list
111109698|NCT05106803|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
111109699|NCT05106803|Norfloxacin|norfloxacin|mesh-list
111109700|NCT05106803|Oxacillin|oxacillin|mesh-list
111109701|NCT05106803|Chloramphenicol|chloramphenicol|mesh-list
111109702|NCT05106803|Trimethoprim|trimethoprim|mesh-list
111109703|NCT05106803|Sulfamethoxazole|sulfamethoxazole|mesh-list
111109704|NCT05106803|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111109705|NCT05106803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111109706|NCT05106803|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111109707|NCT05106803|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111109708|NCT05106803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111109709|NCT05106803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111109710|NCT05106803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111109711|NCT05106803|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111109712|NCT05106803|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111109713|NCT05106803|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111109714|NCT05106803|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111109715|NCT05106803|Antimalarials|antimalarials|mesh-ancestor
111109716|NCT05106803|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111109717|NCT05106803|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111490016|NCT01635504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111490017|NCT01635504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111490018|NCT01635504|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111490019|NCT01635504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111490020|NCT01636206|Lifitegrast|lifitegrast|mesh-list
111109718|NCT05106803|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111109719|NCT05106803|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111109720|NCT05106803|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
111490021|NCT01636206|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
111490022|NCT01636206|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111109721|NCT05106803|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111109722|NCT05106803|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
111109723|NCT02398357|Nadroparin|nadroparin|mesh-list
111109724|NCT02398357|Warfarin|warfarin|mesh-list
111109725|NCT02398357|Calcium|calcium|mesh-list
111109726|NCT02398357|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111109727|NCT02398357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111109728|NCT02398357|Anticoagulants|anticoagulants|mesh-ancestor
111109729|NCT02398357|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111109730|NCT02398357|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111109731|NCT02398357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111109732|NCT02398201|Bezafibrate|bezafibrate|mesh-list
111109733|NCT02398201|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111109734|NCT02398201|Antimetabolites|antimetabolites|mesh-ancestor
111109735|NCT02398201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111109736|NCT02398201|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111109737|NCT05106179|Propranolol|propranolol|mesh-list
111109738|NCT05106179|Atenolol|atenolol|mesh-list
111109739|NCT05106179|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111109740|NCT05106179|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111109741|NCT05106179|Adrenergic Agents|adrenergic agents|mesh-ancestor
111109742|NCT05106179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111109743|NCT05106179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111109744|NCT05106179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111109745|NCT05106179|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111109746|NCT05106179|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111109747|NCT05106179|Vasodilator Agents|vasodilator agents|mesh-ancestor
111109748|NCT05106179|Sympatholytics|sympatholytics|mesh-ancestor
111109749|NCT05106179|Autonomic Agents|autonomic agents|mesh-ancestor
111109750|NCT05106179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111109751|NCT05106179|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
111109752|NCT02406781|Pembrolizumab|pembrolizumab|mesh-list
111109753|NCT02406781|Cyclophosphamide|cyclophosphamide|mesh-list
110826850|NCT03882775|Bivalirudin|bivalirudin|mesh-list
111109754|NCT02406781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111109755|NCT02406781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111109756|NCT02406781|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111109757|NCT02406781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111109758|NCT02406781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111109759|NCT02406781|Immunologic Factors|immunologic factors|mesh-ancestor
111109760|NCT02406781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111109761|NCT02406781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111109762|NCT02406781|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111109763|NCT02406781|Alkylating Agents|alkylating agents|mesh-ancestor
111109764|NCT02406781|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111109765|NCT05106023|Temozolomide|temozolomide|mesh-list
111109766|NCT05106023|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111109767|NCT05106023|Alkylating Agents|alkylating agents|mesh-ancestor
111109768|NCT05106023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111109769|NCT05106023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111109770|NCT02398123|Bupivacaine|bupivacaine|mesh-list
111109771|NCT02398123|Anesthetics, Local|anesthetics, local|mesh-ancestor
111109772|NCT02398123|Anesthetics|anesthetics|mesh-ancestor
111109773|NCT02398123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111109774|NCT02398123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111109775|NCT02398123|Sensory System Agents|sensory system agents|mesh-ancestor
111109776|NCT02398123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111109777|NCT02404363|Clopidogrel|clopidogrel|mesh-list
111109778|NCT02404363|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111109779|NCT02404363|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111109780|NCT02404363|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111109781|NCT02404363|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111109782|NCT02404363|Purinergic Agents|purinergic agents|mesh-ancestor
111109783|NCT02404363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111109784|NCT02404363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111109785|NCT02404363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111109786|NCT02404519|Vitamin K 2|vitamin k 2|mesh-list
111109787|NCT02404519|Vitamin K|vitamin k|mesh-list
111109788|NCT02404519|Menaquinone 7|menaquinone 7|mesh-list
111109789|NCT02404519|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111109790|NCT02404519|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111109791|NCT02404519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111109792|NCT02404519|Hemostatics|hemostatics|mesh-ancestor
111490023|NCT01639872|Risperidone|risperidone|mesh-list
111109793|NCT02404519|Coagulants|coagulants|mesh-ancestor
111109794|NCT02404519|Vitamins|vitamins|mesh-ancestor
111109795|NCT02404519|Micronutrients|micronutrients|mesh-ancestor
111109796|NCT02404519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111109797|NCT03173131|Analgesics, Opioid|analgesics, opioid|mesh-list
111109798|NCT03173131|Narcotics|narcotics|mesh-ancestor
111109799|NCT03173131|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111109800|NCT03173131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111109801|NCT03173131|Analgesics|analgesics|mesh-ancestor
111109802|NCT03173131|Sensory System Agents|sensory system agents|mesh-ancestor
111109803|NCT03173131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111109804|NCT02658149|Ketorolac|ketorolac|mesh-list
111109805|NCT02658149|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
111109806|NCT02658149|Epinephrine|epinephrine|mesh-list
111109807|NCT02658149|Morphine|morphine|mesh-list
111109808|NCT02658149|Ropivacaine|ropivacaine|mesh-list
111109809|NCT02658149|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111109810|NCT02658149|Narcotics|narcotics|mesh-ancestor
111109811|NCT02658149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111109812|NCT02658149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111109813|NCT02658149|Analgesics|analgesics|mesh-ancestor
111109814|NCT02658149|Sensory System Agents|sensory system agents|mesh-ancestor
111109815|NCT02658149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111109816|NCT02658149|Anesthetics, Local|anesthetics, local|mesh-ancestor
111109817|NCT02658149|Anesthetics|anesthetics|mesh-ancestor
111109818|NCT02658149|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111109819|NCT02658149|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111109820|NCT02658149|Adrenergic Agents|adrenergic agents|mesh-ancestor
111109821|NCT02658149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111109822|NCT02658149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111109823|NCT02658149|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111109824|NCT02658149|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111109825|NCT02658149|Autonomic Agents|autonomic agents|mesh-ancestor
111109826|NCT02658149|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111109827|NCT02658149|Respiratory System Agents|respiratory system agents|mesh-ancestor
111109828|NCT02658149|Mydriatics|mydriatics|mesh-ancestor
111109829|NCT02658149|Sympathomimetics|sympathomimetics|mesh-ancestor
110826935|NCT03882541|Anesthetics|anesthetics|mesh-ancestor
111109830|NCT02658149|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111109831|NCT02658149|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111109832|NCT02658149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111109833|NCT02658149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111109834|NCT02658149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111109835|NCT02658149|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111109836|NCT02658149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111109838|NCT04481971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111109839|NCT04481971|Glucocorticoids|glucocorticoids|mesh-ancestor
111109840|NCT04481971|Hormones|hormones|mesh-ancestor
111109841|NCT04481971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111109842|NCT04481971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111109843|NCT04481971|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111109844|NCT04481971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111109845|NCT03172741|Dronabinol|dronabinol|mesh-list
111109846|NCT03172741|Cannabidiol|cannabidiol|mesh-list
111109847|NCT03172741|Anticonvulsants|anticonvulsants|mesh-ancestor
111109848|NCT03172741|Hallucinogens|hallucinogens|mesh-ancestor
111109849|NCT03172741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111109850|NCT03172741|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111109851|NCT03172741|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111109852|NCT03172741|Analgesics|analgesics|mesh-ancestor
111109853|NCT03172741|Sensory System Agents|sensory system agents|mesh-ancestor
111109854|NCT03172741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111109855|NCT03172741|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
111109856|NCT03172741|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
111109857|NCT03172741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111109858|NCT03172741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111109859|NCT03172741|Hormones|hormones|mesh-ancestor
111109860|NCT03172741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111109861|NCT02702011|Empagliflozin|empagliflozin|mesh-list
111109862|NCT02702011|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111109863|NCT02702011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111109864|NCT02702011|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111109865|NCT02702011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111109866|NCT03170713|Ibuprofen|ibuprofen|mesh-list
111490024|NCT01639872|Clozapine|clozapine|mesh-list
111109867|NCT03170713|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
111109868|NCT03170713|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111109869|NCT03170713|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111109870|NCT03170713|Analgesics|analgesics|mesh-ancestor
111109871|NCT03170713|Sensory System Agents|sensory system agents|mesh-ancestor
111109872|NCT03170713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111109873|NCT03170713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111109874|NCT03170713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111109875|NCT03170713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111109876|NCT03170713|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111109877|NCT03170713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111109878|NCT03170713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111109879|NCT02657369|Lenvatinib|lenvatinib|mesh-list
111109880|NCT02657369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111109881|NCT02657369|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111109882|NCT02657369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111109883|NCT02657369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111109884|NCT02397421|Dapagliflozin|dapagliflozin|mesh-list
111109885|NCT02397421|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111109886|NCT02397421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111109887|NCT02397421|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111109888|NCT02397421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111109889|NCT04832009|Ascorbic Acid|ascorbic acid|mesh-list
111109890|NCT04832009|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
111109891|NCT04832009|Antioxidants|antioxidants|mesh-ancestor
111109892|NCT04832009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111109893|NCT04832009|Protective Agents|protective agents|mesh-ancestor
111109894|NCT04832009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111109895|NCT04832009|Vitamins|vitamins|mesh-ancestor
111109896|NCT04832009|Micronutrients|micronutrients|mesh-ancestor
111109897|NCT04832009|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
111109898|NCT04832009|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
111109899|NCT04832009|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111109900|NCT03129113|Metformin|metformin|mesh-list
111109901|NCT03129113|Maraviroc|maraviroc|mesh-list
111109902|NCT03129113|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111109903|NCT03129113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111109904|NCT03129113|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
111109905|NCT03129113|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
111109906|NCT03129113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111109907|NCT03129113|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111109908|NCT03129113|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111109909|NCT03129113|Antiviral Agents|antiviral agents|mesh-ancestor
111109910|NCT03129113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111109911|NCT03129113|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
111109913|NCT05105009|Diuretics|diuretics|mesh-ancestor
111109914|NCT05105009|Natriuretic Agents|natriuretic agents|mesh-ancestor
111109915|NCT05105009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111109916|NCT05105009|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
111109917|NCT05105009|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111109918|NCT05105009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111109919|NCT05104931|Piroxicam|piroxicam|mesh-list
111109920|NCT05104931|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111109921|NCT05104931|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111109922|NCT05104931|Analgesics|analgesics|mesh-ancestor
111109923|NCT05104931|Sensory System Agents|sensory system agents|mesh-ancestor
111109924|NCT05104931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111109925|NCT05104931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111109926|NCT05104931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111109927|NCT05104931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111109928|NCT05104931|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111109929|NCT05104931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111109930|NCT05104931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111109931|NCT02397499|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
111109932|NCT02397499|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111109933|NCT02397499|Autonomic Agents|autonomic agents|mesh-ancestor
111109934|NCT02397499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111109935|NCT02397499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111109936|NCT02397499|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111109937|NCT02397499|Respiratory System Agents|respiratory system agents|mesh-ancestor
110698170|NCT01041690|Bevacizumab|bevacizumab|mesh-list
111490025|NCT01639872|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111490026|NCT01639872|Serotonin Agents|serotonin agents|mesh-ancestor
111490027|NCT01639872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111490028|NCT01639872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111109938|NCT02397499|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111109939|NCT02397499|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111109940|NCT02397499|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111109941|NCT02397499|Adrenergic Agents|adrenergic agents|mesh-ancestor
111109942|NCT02397499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111109943|NCT02397499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111109945|NCT02406703|Chloroprocaine|chloroprocaine|mesh-list
111109946|NCT02406703|Anesthetics, Local|anesthetics, local|mesh-ancestor
111109947|NCT02406703|Anesthetics|anesthetics|mesh-ancestor
111109948|NCT02406703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111109949|NCT02406703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111109950|NCT02406703|Sensory System Agents|sensory system agents|mesh-ancestor
111109951|NCT02406703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111109952|NCT02682641|Rituximab|rituximab|mesh-list
111109953|NCT02682641|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111109954|NCT02682641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111109955|NCT02682641|Immunologic Factors|immunologic factors|mesh-ancestor
111109956|NCT02682641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111109957|NCT02682641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111109958|NCT05110469|Magnesium Sulfate|magnesium sulfate|mesh-list
111109959|NCT05110469|Meperidine|meperidine|mesh-list
111109960|NCT05110469|Analgesics|analgesics|mesh-ancestor
111109961|NCT05110469|Sensory System Agents|sensory system agents|mesh-ancestor
111109962|NCT05110469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111109963|NCT05110469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111109964|NCT05110469|Anesthetics|anesthetics|mesh-ancestor
111109965|NCT05110469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111109966|NCT05110469|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111109967|NCT05110469|Anticonvulsants|anticonvulsants|mesh-ancestor
111109968|NCT05110469|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110648068|NCT02574611|Neostigmine|neostigmine|mesh-list
111109969|NCT05110469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111109970|NCT05110469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111109971|NCT05110469|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111109972|NCT05110469|Tocolytic Agents|tocolytic agents|mesh-ancestor
111109973|NCT05110469|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111109974|NCT05110469|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111109975|NCT05110469|Narcotics|narcotics|mesh-ancestor
111109976|NCT05110469|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111109977|NCT02404051|Everolimus|everolimus|mesh-list
111109978|NCT02404051|Fulvestrant|fulvestrant|mesh-list
111109979|NCT02404051|Exemestane|exemestane|mesh-list
111109980|NCT02404051|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111109981|NCT02404051|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111109982|NCT02404051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111109983|NCT02404051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111109984|NCT02404051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111109985|NCT02404051|Immunologic Factors|immunologic factors|mesh-ancestor
111109986|NCT02404051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111109987|NCT02404051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111109988|NCT02404051|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111109989|NCT02404051|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
111109990|NCT02404051|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111109991|NCT02404051|Hormone Antagonists|hormone antagonists|mesh-ancestor
111109992|NCT02404051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111109993|NCT02404051|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111109994|NCT02404051|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111109995|NCT05094323|Bupivacaine|bupivacaine|mesh-list
111109996|NCT05094323|Anesthetics, Local|anesthetics, local|mesh-ancestor
111109997|NCT05094323|Anesthetics|anesthetics|mesh-ancestor
111109998|NCT05094323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111109999|NCT05094323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111110000|NCT05094323|Sensory System Agents|sensory system agents|mesh-ancestor
111110001|NCT05094323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111110002|NCT03170323|Cyclosporine|cyclosporine|mesh-list
111110003|NCT03170323|Mycophenolic Acid|mycophenolic acid|mesh-list
111110004|NCT03170323|Cyclosporins|cyclosporins|mesh-list
111110005|NCT03170323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111110006|NCT03170323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111490029|NCT01639872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111110007|NCT03170323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111110008|NCT03170323|Immunologic Factors|immunologic factors|mesh-ancestor
111110009|NCT03170323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111490030|NCT01639872|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111490031|NCT01639872|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111110010|NCT03170323|Antifungal Agents|antifungal agents|mesh-ancestor
111110011|NCT03170323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111110012|NCT03170323|Dermatologic Agents|dermatologic agents|mesh-ancestor
111110013|NCT03170323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111110014|NCT03170323|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111110015|NCT03170323|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111110016|NCT03170323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111110017|NCT03170323|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111110018|NCT03170323|Antitubercular Agents|antitubercular agents|mesh-ancestor
111110019|NCT03170323|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111110020|NCT02396563|Ropivacaine|ropivacaine|mesh-list
111110021|NCT02396563|Anesthetics, Local|anesthetics, local|mesh-ancestor
111110022|NCT02396563|Anesthetics|anesthetics|mesh-ancestor
111110023|NCT02396563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111110024|NCT02396563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111110025|NCT02396563|Sensory System Agents|sensory system agents|mesh-ancestor
111110026|NCT02396563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111110027|NCT05109377|Tadalafil|tadalafil|mesh-list
111110028|NCT05109377|Vasodilator Agents|vasodilator agents|mesh-ancestor
111110029|NCT05109377|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111110030|NCT05109377|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111110031|NCT05109377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111110032|NCT05109377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111110033|NCT05109377|Urological Agents|urological agents|mesh-ancestor
111110034|NCT05109299|Fluorides|fluorides|mesh-list
111110035|NCT05109299|Cariostatic Agents|cariostatic agents|mesh-ancestor
111110036|NCT05109299|Protective Agents|protective agents|mesh-ancestor
111110037|NCT05109299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111110038|NCT05108597|Misoprostol|misoprostol|mesh-list
111110039|NCT05108597|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111110040|NCT05108597|Abortifacient Agents|abortifacient agents|mesh-ancestor
111110041|NCT05108597|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111110042|NCT05108597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111110043|NCT05108597|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111110044|NCT05108597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111110045|NCT05108597|Oxytocics|oxytocics|mesh-ancestor
111110046|NCT02396329|Chlorhexidine|chlorhexidine|mesh-list
111110047|NCT02396329|Povidone-Iodine|povidone-iodine|mesh-list
111110048|NCT02396329|Povidone|povidone|mesh-list
111110049|NCT02396329|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111110050|NCT02396329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111110051|NCT02396329|Disinfectants|disinfectants|mesh-ancestor
111110052|NCT02396329|Plasma Substitutes|plasma substitutes|mesh-ancestor
111110053|NCT02396329|Blood Substitutes|blood substitutes|mesh-ancestor
111110054|NCT03168139|Pembrolizumab|pembrolizumab|mesh-list
111110055|NCT03168139|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111110056|NCT03168139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111110057|NCT03168139|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111110058|NCT03168139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111110059|NCT02395783|Melatonin|melatonin|mesh-list
111110060|NCT02395783|Antioxidants|antioxidants|mesh-ancestor
111110061|NCT02395783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111110062|NCT02395783|Protective Agents|protective agents|mesh-ancestor
111110063|NCT02395783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111110064|NCT02395783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111110065|NCT04555343|Tranexamic Acid|tranexamic acid|mesh-list
111110066|NCT04555343|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111110067|NCT04555343|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111110068|NCT04555343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111110069|NCT04555343|Hemostatics|hemostatics|mesh-ancestor
111110070|NCT04555343|Coagulants|coagulants|mesh-ancestor
111110071|NCT04528667|Abivertinib|abivertinib|mesh-list
111110072|NCT04528667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111110073|NCT04528667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111110074|NCT04528667|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111110075|NCT04309877|Theophylline|theophylline|mesh-list
111110076|NCT04309877|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111490032|NCT01639872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111110077|NCT04309877|Autonomic Agents|autonomic agents|mesh-ancestor
111490033|NCT01639872|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111110078|NCT04309877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111110079|NCT04309877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111490034|NCT01639872|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111110080|NCT04309877|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111110081|NCT04309877|Respiratory System Agents|respiratory system agents|mesh-ancestor
111110082|NCT04309877|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111110083|NCT04309877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111110084|NCT04309877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111110085|NCT04309877|Vasodilator Agents|vasodilator agents|mesh-ancestor
111110086|NCT04309877|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
111110087|NCT04309877|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111110088|NCT04309877|Purinergic Agents|purinergic agents|mesh-ancestor
111110089|NCT04309877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111110090|NCT04367909|Carboplatin|carboplatin|mesh-list
111110091|NCT04367909|Docetaxel|docetaxel|mesh-list
111110092|NCT04367909|Nimotuzumab|nimotuzumab|mesh-list
111110093|NCT04367909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111110094|NCT04367909|Tubulin Modulators|tubulin modulators|mesh-ancestor
111110095|NCT04367909|Antimitotic Agents|antimitotic agents|mesh-ancestor
111110096|NCT04367909|Mitosis Modulators|mitosis modulators|mesh-ancestor
111110097|NCT04367909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111110098|NCT04367909|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111110099|NCT04058873|Levonorgestrel|levonorgestrel|mesh-list
111110100|NCT04058873|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111110101|NCT04058873|Contraceptive Agents|contraceptive agents|mesh-ancestor
111110102|NCT04058873|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110648136|NCT00956748|Antiviral Agents|antiviral agents|mesh-ancestor
111110103|NCT04058873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111110104|NCT04058873|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111110105|NCT04058873|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111110106|NCT04058873|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111110107|NCT04196075|Andrographolide|andrographolide|mesh-list
111110108|NCT04196075|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111110109|NCT04196075|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111110110|NCT04196075|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111110111|NCT04196075|Analgesics|analgesics|mesh-ancestor
111110112|NCT04196075|Sensory System Agents|sensory system agents|mesh-ancestor
111110113|NCT04196075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111110114|NCT04196075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111110115|NCT04196075|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111110116|NCT04196075|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111110117|NCT04196075|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111110118|NCT04196075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111110119|NCT04196075|Antiviral Agents|antiviral agents|mesh-ancestor
111110120|NCT04196075|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111110121|NCT03863483|Docetaxel|docetaxel|mesh-list
111110122|NCT03863483|Pemetrexed|pemetrexed|mesh-list
111110123|NCT03863483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111110124|NCT03863483|Tubulin Modulators|tubulin modulators|mesh-ancestor
111110125|NCT03863483|Antimitotic Agents|antimitotic agents|mesh-ancestor
110827230|NCT01270789|Liraglutide|liraglutide|mesh-list
111110126|NCT03863483|Mitosis Modulators|mitosis modulators|mesh-ancestor
111110127|NCT03863483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111110128|NCT03863483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111110129|NCT03863483|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111110130|NCT03863483|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111110132|NCT03830411|Pemetrexed|pemetrexed|mesh-list
111110133|NCT03830411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111110134|NCT03830411|Tubulin Modulators|tubulin modulators|mesh-ancestor
111110135|NCT03830411|Antimitotic Agents|antimitotic agents|mesh-ancestor
111110136|NCT03830411|Mitosis Modulators|mitosis modulators|mesh-ancestor
111110137|NCT03830411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111110138|NCT03830411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111110139|NCT03830411|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111110140|NCT03830411|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111110141|NCT03300479|Urapidil|urapidil|mesh-list
111110142|NCT03300479|Clevidipine|clevidipine|mesh-list
111110143|NCT03300479|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111110144|NCT03300479|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111110145|NCT03300479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111110146|NCT03300479|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111110147|NCT03300479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111110148|NCT03300479|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111110149|NCT03300479|Vasodilator Agents|vasodilator agents|mesh-ancestor
111110150|NCT03300479|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111490035|NCT01639872|Dopamine Agents|dopamine agents|mesh-ancestor
111110151|NCT03300479|Serotonin Agents|serotonin agents|mesh-ancestor
111110152|NCT03300479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111490036|NCT01639872|GABA Antagonists|gaba antagonists|mesh-ancestor
111110153|NCT03300479|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111110154|NCT03300479|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111110155|NCT03300479|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111110156|NCT03300479|Adrenergic Agents|adrenergic agents|mesh-ancestor
111110157|NCT03012425|Hydrocortisone|hydrocortisone|mesh-list
111110158|NCT03012425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111110159|NCT03540875|Remifentanil|remifentanil|mesh-list
111110161|NCT03540875|Anesthetics|anesthetics|mesh-ancestor
111110162|NCT03540875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111110163|NCT03540875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111110164|NCT03540875|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111110165|NCT03540875|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111110166|NCT03540875|Anesthetics, General|anesthetics, general|mesh-ancestor
110648170|NCT00462982|Sunitinib|sunitinib|mesh-list
111110167|NCT03540875|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111110168|NCT03540875|Narcotics|narcotics|mesh-ancestor
111110169|NCT03540875|Analgesics|analgesics|mesh-ancestor
111110170|NCT03540875|Sensory System Agents|sensory system agents|mesh-ancestor
111110171|NCT03540875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111110172|NCT03536507|Acetazolamide|acetazolamide|mesh-list
111110173|NCT03536507|Anticonvulsants|anticonvulsants|mesh-ancestor
111110174|NCT03536507|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
111110175|NCT03536507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111110176|NCT03536507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111110177|NCT03536507|Diuretics|diuretics|mesh-ancestor
111110178|NCT03536507|Natriuretic Agents|natriuretic agents|mesh-ancestor
111110179|NCT03536507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111110180|NCT04765787|Acetaminophen|acetaminophen|mesh-list
111110181|NCT04765787|Orphenadrine|orphenadrine|mesh-list
111110182|NCT04765787|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111110183|NCT04765787|Analgesics|analgesics|mesh-ancestor
111110184|NCT04765787|Sensory System Agents|sensory system agents|mesh-ancestor
111110185|NCT04765787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111110186|NCT04765787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111110187|NCT04765787|Antipyretics|antipyretics|mesh-ancestor
111110188|NCT04765787|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111110189|NCT04765787|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111110190|NCT04765787|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
111110191|NCT04765787|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111110192|NCT04765787|Parasympatholytics|parasympatholytics|mesh-ancestor
111110193|NCT04765787|Autonomic Agents|autonomic agents|mesh-ancestor
111110194|NCT04765787|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111110195|NCT04765787|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111110196|NCT04765787|Cholinergic Agents|cholinergic agents|mesh-ancestor
111110197|NCT04765787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111110198|NCT04765787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111110199|NCT04765787|Cytochrome P-450 CYP2B6 Inhibitors|cytochrome p-450 cyp2b6 inhibitors|mesh-ancestor
111110200|NCT04765787|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111110201|NCT04765787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111110202|NCT02944799|Vitamin D|vitamin d|mesh-list
111110203|NCT02944799|Alendronate|alendronate|mesh-list
111110204|NCT02944799|Calcium|calcium|mesh-list
111110205|NCT02944799|Vitamins|vitamins|mesh-ancestor
111110206|NCT02944799|Micronutrients|micronutrients|mesh-ancestor
111110207|NCT02944799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111110208|NCT02944799|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111110209|NCT02944799|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111110210|NCT05115149|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
111110211|NCT05115149|Antioxidants|antioxidants|mesh-ancestor
111110212|NCT05115149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111110213|NCT05115149|Protective Agents|protective agents|mesh-ancestor
111110214|NCT05115149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111110215|NCT05115149|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
111110216|NCT05115149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111110217|NCT04638803|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
111110218|NCT04638803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111110219|NCT04592783|Antihypertensive Agents|antihypertensive agents|mesh-list
111110220|NCT04521881|Tranexamic Acid|tranexamic acid|mesh-list
111110221|NCT04521881|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111110222|NCT04521881|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111110223|NCT04521881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111490037|NCT01639872|GABA Agents|gaba agents|mesh-ancestor
111490038|NCT01640340|Dexamethasone|dexamethasone|mesh-list
111490039|NCT01640340|Ondansetron|ondansetron|mesh-list
111490040|NCT01640340|Aprepitant|aprepitant|mesh-list
111110224|NCT04521881|Hemostatics|hemostatics|mesh-ancestor
111490041|NCT01640340|Palonosetron|palonosetron|mesh-list
111490042|NCT01640340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111110225|NCT04521881|Coagulants|coagulants|mesh-ancestor
111110226|NCT04305899|Deucravacitinib|deucravacitinib|mesh-list
111110227|NCT04305899|Dermatologic Agents|dermatologic agents|mesh-ancestor
111110228|NCT04305899|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111110229|NCT04305899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111110230|NCT04305899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111110231|NCT01675661|Acetylcysteine|acetylcysteine|mesh-list
111110232|NCT01675661|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111110233|NCT01675661|Antiviral Agents|antiviral agents|mesh-ancestor
111110234|NCT01675661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111110235|NCT01675661|Expectorants|expectorants|mesh-ancestor
111110236|NCT01675661|Respiratory System Agents|respiratory system agents|mesh-ancestor
111110237|NCT01675661|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111110238|NCT01675661|Antioxidants|antioxidants|mesh-ancestor
111110239|NCT01675661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111110240|NCT01675661|Protective Agents|protective agents|mesh-ancestor
111110241|NCT01675661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111110242|NCT01675661|Antidotes|antidotes|mesh-ancestor
111110243|NCT05113511|Bevacizumab|bevacizumab|mesh-list
111110244|NCT05113511|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111110245|NCT05113511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111110246|NCT05113511|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111110247|NCT05113511|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111110248|NCT05113511|Growth Substances|growth substances|mesh-ancestor
111110249|NCT05113511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111110250|NCT05113511|Growth Inhibitors|growth inhibitors|mesh-ancestor
111110251|NCT03169985|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111110252|NCT03169985|Ezetimibe|ezetimibe|mesh-list
111110253|NCT03169985|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111110254|NCT03169985|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111110255|NCT03169985|Antimetabolites|antimetabolites|mesh-ancestor
111110256|NCT03169985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111110257|NCT03169985|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111110258|NCT03169985|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111110259|NCT03169985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111110260|NCT04161989|Progesterone|progesterone|mesh-list
111110261|NCT04161989|Progestins|progestins|mesh-ancestor
111110262|NCT04161989|Hormones|hormones|mesh-ancestor
111110263|NCT04161989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111110264|NCT04161989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111110265|NCT01986010|Aluminum phosphate|aluminum phosphate|mesh-list
111110266|NCT01986010|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111110267|NCT01986010|Immunologic Factors|immunologic factors|mesh-ancestor
111110268|NCT01986010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111110269|NCT01986010|Antacids|antacids|mesh-ancestor
111110270|NCT01986010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111110271|NCT01986010|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111110272|NCT04160117|Colchicine|colchicine|mesh-list
111110273|NCT04160117|Gout Suppressants|gout suppressants|mesh-ancestor
111110274|NCT04160117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111110275|NCT04160117|Tubulin Modulators|tubulin modulators|mesh-ancestor
111110276|NCT04160117|Antimitotic Agents|antimitotic agents|mesh-ancestor
111110277|NCT04160117|Mitosis Modulators|mitosis modulators|mesh-ancestor
111110278|NCT04160117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111110279|NCT04160117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111110280|NCT04414631|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
111110281|NCT04414631|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
111110282|NCT04414631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111110283|NCT04414631|Immunologic Factors|immunologic factors|mesh-ancestor
111110284|NCT04414631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111110285|NCT03115255|Ranibizumab|ranibizumab|mesh-list
111110286|NCT03115255|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111110287|NCT03115255|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111110288|NCT03115255|Growth Substances|growth substances|mesh-ancestor
111110289|NCT03115255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111110290|NCT03115255|Growth Inhibitors|growth inhibitors|mesh-ancestor
111110291|NCT03115255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111110292|NCT02009878|Tolvaptan|tolvaptan|mesh-list
111110293|NCT02009878|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
111490043|NCT01640340|Antiemetics|antiemetics|mesh-ancestor
111490044|NCT01640340|Autonomic Agents|autonomic agents|mesh-ancestor
111490045|NCT01640340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111110294|NCT02009878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111110295|NCT02009878|Natriuretic Agents|natriuretic agents|mesh-ancestor
111490046|NCT01640340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111490047|NCT01640340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111490048|NCT01640340|Glucocorticoids|glucocorticoids|mesh-ancestor
111110296|NCT02009878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111110297|NCT02009722|Morphine|morphine|mesh-list
111110298|NCT02009722|Hydromorphone|hydromorphone|mesh-list
111110299|NCT02009722|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111110300|NCT02009722|Narcotics|narcotics|mesh-ancestor
111110301|NCT02009722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111110302|NCT02009722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111110303|NCT02009722|Analgesics|analgesics|mesh-ancestor
111110304|NCT02009722|Sensory System Agents|sensory system agents|mesh-ancestor
111110305|NCT02009722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111110306|NCT02655419|Metronidazole|metronidazole|mesh-list
111110307|NCT02655419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111110308|NCT02655419|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111110309|NCT02655419|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111110310|NCT02655419|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111110311|NCT01962922|Tacrolimus|tacrolimus|mesh-list
111110312|NCT01962922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111110313|NCT01962922|Immunologic Factors|immunologic factors|mesh-ancestor
111110314|NCT01962922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111110315|NCT01962922|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111110316|NCT01962922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111110317|NCT01962922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111110318|NCT04198961|Analgesics, Opioid|analgesics, opioid|mesh-list
111110319|NCT04198961|Narcotics|narcotics|mesh-ancestor
111110320|NCT04198961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111110321|NCT04198961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111110322|NCT04198961|Analgesics|analgesics|mesh-ancestor
111110323|NCT04198961|Sensory System Agents|sensory system agents|mesh-ancestor
111110324|NCT04198961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111110325|NCT01984684|Vancomycin|vancomycin|mesh-list
111110326|NCT01984684|Aztreonam|aztreonam|mesh-list
111110327|NCT01984684|Delafloxacin|delafloxacin|mesh-list
111110328|NCT01984684|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111110329|NCT01984684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111110330|NCT02694523|Adalimumab|adalimumab|mesh-list
111110331|NCT02694523|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111110332|NCT02694523|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111110333|NCT02694523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111110334|NCT02694523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111110335|NCT02694523|Immunologic Factors|immunologic factors|mesh-ancestor
111110336|NCT02694523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111110337|NCT05038475|Antibodies|antibodies|mesh-list
111110338|NCT05038475|Immunologic Factors|immunologic factors|mesh-ancestor
111110339|NCT05038475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111110340|NCT02009332|Sirolimus|sirolimus|mesh-list
111110341|NCT02009332|Gemcitabine|gemcitabine|mesh-list
111110342|NCT02009332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111110343|NCT02009332|Antimetabolites|antimetabolites|mesh-ancestor
111110344|NCT02009332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111110345|NCT02009332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111110346|NCT02009332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111110347|NCT02009332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111110348|NCT02009332|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111110349|NCT02009332|Antifungal Agents|antifungal agents|mesh-ancestor
111110350|NCT02009332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111110351|NCT02009332|Immunologic Factors|immunologic factors|mesh-ancestor
111110352|NCT02009332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111110353|NCT04518293|Amlodipine|amlodipine|mesh-list
111110354|NCT04518293|Telmisartan|telmisartan|mesh-list
111110355|NCT04518293|Indapamide|indapamide|mesh-list
111110356|NCT04518293|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111110357|NCT04518293|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111110358|NCT04518293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111110359|NCT04518293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111110360|NCT04518293|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111110361|NCT04518293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111110362|NCT04518293|Vasodilator Agents|vasodilator agents|mesh-ancestor
111110363|NCT04518293|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111110364|NCT04518293|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111110365|NCT04518293|Diuretics|diuretics|mesh-ancestor
111110366|NCT04518293|Natriuretic Agents|natriuretic agents|mesh-ancestor
111110367|NCT04518293|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
111110368|NCT01984294|Ribavirin|ribavirin|mesh-list
110416174|NCT00637819|Leflunomide|leflunomide|mesh-list
111490049|NCT01640340|Hormones|hormones|mesh-ancestor
111490050|NCT01640340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111490051|NCT01640340|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111110369|NCT01984294|Antiviral Agents|antiviral agents|mesh-ancestor
111110370|NCT01984294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111110371|NCT01984294|Antimetabolites|antimetabolites|mesh-ancestor
111110372|NCT01984294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111110373|NCT03170479|Vitamin D|vitamin d|mesh-list
111110374|NCT03170479|Vitamins|vitamins|mesh-ancestor
111110375|NCT03170479|Micronutrients|micronutrients|mesh-ancestor
111110376|NCT03170479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111110377|NCT03170479|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111110378|NCT01962298|Rocuronium|rocuronium|mesh-list
111110379|NCT01962298|Neostigmine|neostigmine|mesh-list
111110380|NCT01962298|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
111110381|NCT01962298|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
111110382|NCT01962298|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111110383|NCT01962298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111110384|NCT01962298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111110385|NCT01962298|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111110386|NCT01962298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111110387|NCT01962298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111110388|NCT01962298|Cholinergic Agents|cholinergic agents|mesh-ancestor
111110389|NCT01962298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111110390|NCT01962298|Parasympathomimetics|parasympathomimetics|mesh-ancestor
111110391|NCT01962298|Autonomic Agents|autonomic agents|mesh-ancestor
111110392|NCT03169933|Androgens|androgens|mesh-list
111110393|NCT03169933|Hormones|hormones|mesh-ancestor
111110394|NCT03169933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111110395|NCT03169933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111110396|NCT04416334|Acetaminophen|acetaminophen|mesh-list
111110397|NCT04416334|Colchicine|colchicine|mesh-list
111110398|NCT04416334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111110399|NCT04416334|Analgesics|analgesics|mesh-ancestor
111110400|NCT04416334|Sensory System Agents|sensory system agents|mesh-ancestor
111110401|NCT04416334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111110402|NCT04416334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111110403|NCT04416334|Antipyretics|antipyretics|mesh-ancestor
111110404|NCT04416334|Gout Suppressants|gout suppressants|mesh-ancestor
111110405|NCT04416334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111110406|NCT04416334|Tubulin Modulators|tubulin modulators|mesh-ancestor
111110407|NCT04416334|Antimitotic Agents|antimitotic agents|mesh-ancestor
111110408|NCT04416334|Mitosis Modulators|mitosis modulators|mesh-ancestor
111110409|NCT04416334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111110410|NCT04416334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111110411|NCT02403349|Atenolol|atenolol|mesh-list
111110412|NCT02403349|Valsartan|valsartan|mesh-list
111110413|NCT02403349|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111110414|NCT02403349|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111110415|NCT02403349|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111110416|NCT02403349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111110417|NCT02403349|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111110418|NCT02403349|Sympatholytics|sympatholytics|mesh-ancestor
111110419|NCT02403349|Autonomic Agents|autonomic agents|mesh-ancestor
111110420|NCT02403349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111110421|NCT02403349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111110422|NCT02403349|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
111110423|NCT02403349|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111110424|NCT02403349|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111110425|NCT02403349|Adrenergic Agents|adrenergic agents|mesh-ancestor
111110426|NCT02403349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111110427|NCT04735822|Belumosudil|belumosudil|mesh-list
111110428|NCT04735822|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111110429|NCT04735822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111110430|NCT04735822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111110432|NCT01984138|Estrogens|estrogens|mesh-ancestor
111110433|NCT01984138|Hormones|hormones|mesh-ancestor
111110434|NCT01984138|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111110435|NCT01984138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111110436|NCT01982812|Levetiracetam|levetiracetam|mesh-list
111110437|NCT01982812|Anticonvulsants|anticonvulsants|mesh-ancestor
111110438|NCT01982812|Nootropic Agents|nootropic agents|mesh-ancestor
111110439|NCT02007070|Pembrolizumab|pembrolizumab|mesh-list
111110440|NCT02007070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110698193|NCT01068327|Leucovorin|leucovorin|mesh-list
111110441|NCT02007070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111110442|NCT02007070|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111110443|NCT02007070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111110444|NCT03906617|Dexamethasone|dexamethasone|mesh-list
111110445|NCT03906617|Epinephrine|epinephrine|mesh-list
111110446|NCT03906617|Bupivacaine|bupivacaine|mesh-list
111110447|NCT03906617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111110448|NCT03906617|Antiemetics|antiemetics|mesh-ancestor
111110449|NCT03906617|Autonomic Agents|autonomic agents|mesh-ancestor
111110450|NCT03906617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111110451|NCT03906617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111110452|NCT03906617|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111110453|NCT03906617|Glucocorticoids|glucocorticoids|mesh-ancestor
111110454|NCT03906617|Hormones|hormones|mesh-ancestor
111110455|NCT03906617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111110456|NCT03906617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111110457|NCT03906617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111110458|NCT03906617|Anesthetics, Local|anesthetics, local|mesh-ancestor
111110459|NCT03906617|Anesthetics|anesthetics|mesh-ancestor
111110460|NCT03906617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111110461|NCT03906617|Sensory System Agents|sensory system agents|mesh-ancestor
111110462|NCT03906617|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111110463|NCT03906617|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111110464|NCT03906617|Adrenergic Agents|adrenergic agents|mesh-ancestor
111110465|NCT03906617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111110466|NCT03906617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111110467|NCT03906617|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111110468|NCT03906617|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111110469|NCT03906617|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111110470|NCT03906617|Respiratory System Agents|respiratory system agents|mesh-ancestor
111110471|NCT03906617|Mydriatics|mydriatics|mesh-ancestor
111110472|NCT03906617|Sympathomimetics|sympathomimetics|mesh-ancestor
111110473|NCT03906617|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111110474|NCT04655482|Aflibercept|aflibercept|mesh-list
111110475|NCT04655482|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111110476|NCT04655482|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111110477|NCT04655482|Growth Substances|growth substances|mesh-ancestor
111110478|NCT04655482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111110479|NCT04655482|Growth Inhibitors|growth inhibitors|mesh-ancestor
111110480|NCT04655482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111110481|NCT04515797|Antiviral Agents|antiviral agents|mesh-list
111110482|NCT04515797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111110483|NCT02184767|Loxapine|loxapine|mesh-list
111110484|NCT02184767|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111110485|NCT02184767|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111110486|NCT02184767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111110487|NCT02184767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111110488|NCT02184767|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111110489|NCT02184767|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111110490|NCT02184767|Dopamine Agents|dopamine agents|mesh-ancestor
111110491|NCT02184767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111110492|NCT02184767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111110493|NCT01981954|Solifenacin Succinate|solifenacin succinate|mesh-list
111110494|NCT01981954|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111110495|NCT01981954|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111110496|NCT01981954|Cholinergic Agents|cholinergic agents|mesh-ancestor
111110497|NCT01981954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111110498|NCT01981954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111110499|NCT01981954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111110500|NCT01981954|Urological Agents|urological agents|mesh-ancestor
111110501|NCT03727139|Rasagiline|rasagiline|mesh-list
111110502|NCT03727139|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
111110503|NCT03727139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111110504|NCT03727139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111490052|NCT01640340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111490053|NCT01640340|Antipruritics|antipruritics|mesh-ancestor
111490054|NCT01640340|Dermatologic Agents|dermatologic agents|mesh-ancestor
111490055|NCT01640340|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111490056|NCT01640340|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111490057|NCT01640340|Serotonin Agents|serotonin agents|mesh-ancestor
111490058|NCT01640340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111490059|NCT01640340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111490060|NCT01640340|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
111110505|NCT03727139|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111110506|NCT03727139|Protective Agents|protective agents|mesh-ancestor
111110507|NCT03727139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111110508|NCT05120687|Cyclosporine|cyclosporine|mesh-list
111110509|NCT05120687|Mycophenolic Acid|mycophenolic acid|mesh-list
111110510|NCT05120687|Adalimumab|adalimumab|mesh-list
111110511|NCT05120687|Cyclophosphamide|cyclophosphamide|mesh-list
111110512|NCT05120687|Methotrexate|methotrexate|mesh-list
111110513|NCT05120687|Cyclosporins|cyclosporins|mesh-list
111110514|NCT05120687|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111110515|NCT05120687|Immunologic Factors|immunologic factors|mesh-ancestor
111110516|NCT05120687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111110517|NCT05120687|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111110518|NCT05120687|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111110519|NCT05120687|Alkylating Agents|alkylating agents|mesh-ancestor
111110520|NCT05120687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111110521|NCT05120687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111110522|NCT05120687|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111110523|NCT05120687|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111110524|NCT05120687|Abortifacient Agents|abortifacient agents|mesh-ancestor
111110525|NCT05120687|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111110526|NCT05120687|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111110527|NCT05120687|Antimetabolites|antimetabolites|mesh-ancestor
111110528|NCT05120687|Dermatologic Agents|dermatologic agents|mesh-ancestor
111110529|NCT05120687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111110530|NCT05120687|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111110531|NCT05120687|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111110532|NCT05120687|Antifungal Agents|antifungal agents|mesh-ancestor
111110533|NCT05120687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111110534|NCT05120687|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111110535|NCT05120687|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111110536|NCT05120687|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111110537|NCT05120687|Antitubercular Agents|antitubercular agents|mesh-ancestor
111110538|NCT05120687|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111110539|NCT05120687|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111110540|NCT05120687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111110541|NCT03416855|Insulin|insulin|mesh-list
111110542|NCT03416855|Insulin Aspart|insulin aspart|mesh-list
111110543|NCT03416855|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111110544|NCT03416855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111110545|NCT05121779|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
111110546|NCT05121779|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111110547|NCT05121779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111110548|NCT02693119|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111110549|NCT02693119|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111110550|NCT04224545|Colchicine|colchicine|mesh-list
111110551|NCT04224545|Gout Suppressants|gout suppressants|mesh-ancestor
111110552|NCT04224545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111110553|NCT04224545|Tubulin Modulators|tubulin modulators|mesh-ancestor
111110554|NCT04224545|Antimitotic Agents|antimitotic agents|mesh-ancestor
111110555|NCT04224545|Mitosis Modulators|mitosis modulators|mesh-ancestor
111110556|NCT04224545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111110557|NCT04224545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111110558|NCT05121233|Diclofenac|diclofenac|mesh-list
111110559|NCT05121233|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111110560|NCT05121233|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111110561|NCT05121233|Analgesics|analgesics|mesh-ancestor
111110562|NCT05121233|Sensory System Agents|sensory system agents|mesh-ancestor
111110563|NCT05121233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111110564|NCT05121233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111110565|NCT05121233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111110566|NCT05121233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111110567|NCT05121233|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111110568|NCT05121233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111110569|NCT05121233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111110570|NCT05745259|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
111110571|NCT05745259|Tenecteplase|tenecteplase|mesh-list
111110572|NCT05745259|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111110573|NCT05745259|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111110574|NCT05745259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111110575|NCT02893241|Cafedrine|cafedrine|mesh-list
111110576|NCT02893241|Theodrenaline|theodrenaline|mesh-list
111110577|NCT02893241|Ephedrine|ephedrine|mesh-list
111110578|NCT02893241|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111110579|NCT02893241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111490061|NCT01641120|Interferons|interferons|mesh-list
111490062|NCT01641120|Interferon-beta|interferon-beta|mesh-list
111110580|NCT02893241|Sympathomimetics|sympathomimetics|mesh-ancestor
111110581|NCT02893241|Autonomic Agents|autonomic agents|mesh-ancestor
111110582|NCT02893241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111110583|NCT02893241|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111110584|NCT02893241|Adrenergic Agents|adrenergic agents|mesh-ancestor
111110585|NCT02893241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111110586|NCT02893241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111110587|NCT02893241|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111110588|NCT02893241|Vasodilator Agents|vasodilator agents|mesh-ancestor
111110589|NCT02395237|Glimepiride|glimepiride|mesh-list
111110590|NCT02395237|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111110591|NCT02395237|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111110592|NCT02395237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111110593|NCT02395237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111110594|NCT02395237|Immunologic Factors|immunologic factors|mesh-ancestor
111110595|NCT02394847|Propofol|propofol|mesh-list
111110596|NCT02394847|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111110597|NCT02394847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111110598|NCT02394847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111110599|NCT02394847|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111110600|NCT02394847|Anesthetics, General|anesthetics, general|mesh-ancestor
111110601|NCT02394847|Anesthetics|anesthetics|mesh-ancestor
111110602|NCT05021861|Cyproterone Acetate|cyproterone acetate|mesh-list
111110603|NCT05021861|Ethinyl Estradiol|ethinyl estradiol|mesh-list
111110604|NCT05021861|Estradiol|estradiol|mesh-list
111110605|NCT05021861|Cyproterone|cyproterone|mesh-list
111110606|NCT05021861|Cyproterone acetate, ethinyl estradiol drug combination|cyproterone acetate, ethinyl estradiol drug combination|mesh-list
111110607|NCT05021861|Estrogens|estrogens|mesh-ancestor
111110608|NCT05021861|Hormones|hormones|mesh-ancestor
111110609|NCT05021861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111110610|NCT05021861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111110611|NCT05021861|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111110612|NCT05021861|Contraceptive Agents|contraceptive agents|mesh-ancestor
111110613|NCT05021861|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111110614|NCT05021861|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111110615|NCT05021861|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111110616|NCT05021861|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111110617|NCT05021861|Androgen Antagonists|androgen antagonists|mesh-ancestor
111110618|NCT05021861|Hormone Antagonists|hormone antagonists|mesh-ancestor
111110619|NCT05021861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111110620|NCT05021861|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
111110621|NCT02403037|Dexamethasone|dexamethasone|mesh-list
111110622|NCT02403037|Dexamethasone acetate|dexamethasone acetate|mesh-list
111110623|NCT02403037|Antiemetics|antiemetics|mesh-list
111110624|NCT02403037|Emetics|emetics|mesh-list
111110625|NCT02403037|BB 1101|bb 1101|mesh-list
111110626|NCT02403037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111110627|NCT02403037|Autonomic Agents|autonomic agents|mesh-ancestor
111110628|NCT02403037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111110629|NCT02403037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111110630|NCT02403037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111110631|NCT02403037|Glucocorticoids|glucocorticoids|mesh-ancestor
111110632|NCT02403037|Hormones|hormones|mesh-ancestor
111110633|NCT02403037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111110634|NCT02403037|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111110635|NCT02403037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111110636|NCT02403037|Protease Inhibitors|protease inhibitors|mesh-ancestor
111110637|NCT02403037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111110638|NCT02403037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111110639|NCT02653625|Cenicriviroc|cenicriviroc|mesh-list
111110640|NCT02653625|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
111110641|NCT02653625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111110642|NCT02653625|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111110643|NCT02653625|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111110644|NCT02653625|Antiviral Agents|antiviral agents|mesh-ancestor
111110645|NCT02653625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111110646|NCT04480333|Antiviral Agents|antiviral agents|mesh-list
111110647|NCT04480333|Remdesivir|remdesivir|mesh-list
111110648|NCT04480333|Neuroprotective Agents|neuroprotective agents|mesh-list
111110649|NCT04480333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111110650|NCT04480333|Antimetabolites|antimetabolites|mesh-ancestor
111490063|NCT01641120|Interferon beta-1a|interferon beta-1a|mesh-list
111490064|NCT01641120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111110651|NCT04480333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111110652|NCT04480333|Protective Agents|protective agents|mesh-ancestor
111490065|NCT01641120|Antiviral Agents|antiviral agents|mesh-ancestor
110827756|NCT01170325|Valproic Acid|valproic acid|mesh-list
111490066|NCT01641120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111110653|NCT04480333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111110655|NCT03166891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111110656|NCT03166891|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111110657|NCT03166891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111110658|NCT03166891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111110659|NCT01980940|Etoricoxib|etoricoxib|mesh-list
111110660|NCT01980940|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
111110661|NCT01980940|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111110662|NCT01980940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111110663|NCT01980940|Analgesics|analgesics|mesh-ancestor
111110664|NCT01980940|Sensory System Agents|sensory system agents|mesh-ancestor
111110665|NCT01980940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111110666|NCT01980940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111110667|NCT01980940|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111110668|NCT01980940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111110669|NCT01980940|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111110670|NCT01980940|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111110671|NCT01980940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111110672|NCT01980940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111110673|NCT01980940|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
111110674|NCT01980940|Protective Agents|protective agents|mesh-ancestor
111110675|NCT01980940|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111110676|NCT01980940|Antioxidants|antioxidants|mesh-ancestor
111110677|NCT01960114|Acetaminophen|acetaminophen|mesh-list
111110678|NCT01960114|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111110679|NCT01960114|Analgesics|analgesics|mesh-ancestor
111110680|NCT01960114|Sensory System Agents|sensory system agents|mesh-ancestor
111110681|NCT01960114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111110682|NCT01960114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111110683|NCT01960114|Antipyretics|antipyretics|mesh-ancestor
111110684|NCT04752527|Sorafenib|sorafenib|mesh-list
111110685|NCT04752527|Decitabine|decitabine|mesh-list
111110686|NCT04752527|Venetoclax|venetoclax|mesh-list
111110687|NCT04752527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111110688|NCT04752527|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111110689|NCT04752527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111110690|NCT04752527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111110691|NCT04752527|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111110692|NCT04752527|Antimetabolites|antimetabolites|mesh-ancestor
111110693|NCT05229497|Carboplatin|carboplatin|mesh-list
111110694|NCT05229497|Fluorouracil|fluorouracil|mesh-list
111110695|NCT05229497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111110696|NCT05229497|Antimetabolites|antimetabolites|mesh-ancestor
111110697|NCT05229497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111110698|NCT05229497|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111110699|NCT05229497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111110700|NCT05229497|Immunologic Factors|immunologic factors|mesh-ancestor
111110701|NCT05229497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111110702|NCT03169777|Leucovorin|leucovorin|mesh-list
111110703|NCT03169777|Cyclophosphamide|cyclophosphamide|mesh-list
111110704|NCT03169777|Bevacizumab|bevacizumab|mesh-list
111110705|NCT03169777|Fluorouracil|fluorouracil|mesh-list
111110706|NCT03169777|Capecitabine|capecitabine|mesh-list
111110707|NCT03169777|Oxaliplatin|oxaliplatin|mesh-list
111110708|NCT03169777|Nivolumab|nivolumab|mesh-list
111110709|NCT03169777|Cetuximab|cetuximab|mesh-list
111110710|NCT03169777|Fulvestrant|fulvestrant|mesh-list
111110711|NCT03169777|Avelumab|avelumab|mesh-list
111110712|NCT03169777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111110713|NCT03169777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111110714|NCT03169777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111110715|NCT03169777|Immunologic Factors|immunologic factors|mesh-ancestor
111110716|NCT03169777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111110717|NCT03169777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111110718|NCT03169777|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111110719|NCT03169777|Alkylating Agents|alkylating agents|mesh-ancestor
111110720|NCT03169777|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111110721|NCT03169777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111110722|NCT03169777|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111110723|NCT03169777|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111110724|NCT03169777|Growth Substances|growth substances|mesh-ancestor
111490067|NCT01641120|Immunologic Factors|immunologic factors|mesh-ancestor
111110725|NCT03169777|Growth Inhibitors|growth inhibitors|mesh-ancestor
111110726|NCT03169777|Antimetabolites|antimetabolites|mesh-ancestor
111110727|NCT03169777|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111490068|NCT01641120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111110728|NCT03169777|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111110729|NCT03169777|Antidotes|antidotes|mesh-ancestor
111110730|NCT03169777|Protective Agents|protective agents|mesh-ancestor
111110731|NCT03169777|Vitamin B Complex|vitamin b complex|mesh-ancestor
111110733|NCT03169777|Micronutrients|micronutrients|mesh-ancestor
111110734|NCT03169777|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111110735|NCT03169777|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
111110736|NCT03169777|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111110737|NCT03169777|Hormone Antagonists|hormone antagonists|mesh-ancestor
111110738|NCT03169777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111110739|NCT01980706|Baclofen|baclofen|mesh-list
111110740|NCT01980706|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
111110741|NCT01980706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111110742|NCT01980706|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111110743|NCT01980706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111110744|NCT01980706|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
111110745|NCT01980706|GABA Agonists|gaba agonists|mesh-ancestor
111110746|NCT01980706|GABA Agents|gaba agents|mesh-ancestor
111110747|NCT01980706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111110748|NCT01980706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111110749|NCT02092571|Progesterone|progesterone|mesh-list
111110750|NCT02092571|Progestins|progestins|mesh-ancestor
111110751|NCT02092571|Hormones|hormones|mesh-ancestor
111110752|NCT02092571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111110753|NCT02092571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111110754|NCT02402725|Dexamethasone|dexamethasone|mesh-list
111110755|NCT02402725|Dexamethasone acetate|dexamethasone acetate|mesh-list
111110756|NCT02402725|BB 1101|bb 1101|mesh-list
111110757|NCT02402725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111110758|NCT02402725|Antiemetics|antiemetics|mesh-ancestor
111110759|NCT02402725|Autonomic Agents|autonomic agents|mesh-ancestor
111110760|NCT02402725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111110761|NCT02402725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111110762|NCT02402725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111110763|NCT02402725|Glucocorticoids|glucocorticoids|mesh-ancestor
111110764|NCT02402725|Hormones|hormones|mesh-ancestor
111110765|NCT02402725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111110766|NCT02402725|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111110767|NCT02402725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111110768|NCT02402725|Protease Inhibitors|protease inhibitors|mesh-ancestor
111110769|NCT02402725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111110770|NCT02402725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111110771|NCT02394145|Clopidogrel|clopidogrel|mesh-list
111110772|NCT02394145|Ticagrelor|ticagrelor|mesh-list
111110773|NCT02394145|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111110774|NCT02394145|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111110775|NCT02394145|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111110776|NCT02394145|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111110777|NCT02394145|Purinergic Agents|purinergic agents|mesh-ancestor
111110778|NCT02394145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111110779|NCT02394145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111110780|NCT02394145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111110781|NCT02004886|Metformin|metformin|mesh-list
111110782|NCT02004886|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111110783|NCT02004886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111110784|NCT05228483|Mometasone Furoate|mometasone furoate|mesh-list
111110785|NCT05228483|Aminolevulinic Acid|aminolevulinic acid|mesh-list
111110786|NCT05228483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111110787|NCT05228483|Dermatologic Agents|dermatologic agents|mesh-ancestor
111110788|NCT05228483|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111110789|NCT05228483|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111110790|NCT04255277|Moxifloxacin|moxifloxacin|mesh-list
111110791|NCT04255277|Levonorgestrel|levonorgestrel|mesh-list
111110792|NCT04255277|Ethinyl Estradiol|ethinyl estradiol|mesh-list
111110793|NCT04255277|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
111110794|NCT04255277|Contraceptive Agents|contraceptive agents|mesh-list
111110795|NCT04255277|Contraceptives, Oral|contraceptives, oral|mesh-list
111110796|NCT04255277|Charcoal|charcoal|mesh-list
111110797|NCT04255277|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111490069|NCT01641120|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111110798|NCT04255277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111110799|NCT04255277|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111110800|NCT04255277|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111110801|NCT04255277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111119174|NCT05289687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111110802|NCT04255277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111490070|NCT01643382|Insulin|insulin|mesh-list
111490071|NCT01643382|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111490072|NCT01643382|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111490073|NCT01643382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111110803|NCT04255277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111110804|NCT04255277|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111110805|NCT04255277|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111110806|NCT04255277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111110807|NCT04255277|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111110808|NCT04255277|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111110809|NCT04255277|Antidotes|antidotes|mesh-ancestor
111110810|NCT04255277|Protective Agents|protective agents|mesh-ancestor
111110811|NCT04255277|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111110812|NCT04255277|Estrogens|estrogens|mesh-ancestor
111110813|NCT04255277|Hormones|hormones|mesh-ancestor
111110814|NCT04255277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111110815|NCT04007705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
111110816|NCT04435925|Fentanyl|fentanyl|mesh-list
111110817|NCT04435925|Remifentanil|remifentanil|mesh-list
111110818|NCT04435925|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111110819|NCT04435925|Narcotics|narcotics|mesh-ancestor
111110820|NCT04435925|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111110821|NCT04435925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111110822|NCT04435925|Analgesics|analgesics|mesh-ancestor
111110823|NCT04435925|Sensory System Agents|sensory system agents|mesh-ancestor
111110824|NCT04435925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111110825|NCT04435925|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111110826|NCT04435925|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111110827|NCT04435925|Anesthetics, General|anesthetics, general|mesh-ancestor
111110828|NCT04435925|Anesthetics|anesthetics|mesh-ancestor
111110829|NCT04649476|Cisplatin|cisplatin|mesh-list
111110830|NCT04649476|Docetaxel|docetaxel|mesh-list
111110831|NCT04649476|Fluorouracil|fluorouracil|mesh-list
111110832|NCT04649476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111110833|NCT04649476|Tubulin Modulators|tubulin modulators|mesh-ancestor
111110834|NCT04649476|Antimitotic Agents|antimitotic agents|mesh-ancestor
111110835|NCT04649476|Mitosis Modulators|mitosis modulators|mesh-ancestor
111110836|NCT04649476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111110837|NCT04649476|Antimetabolites|antimetabolites|mesh-ancestor
111110838|NCT04649476|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111110839|NCT04649476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111110840|NCT04649476|Immunologic Factors|immunologic factors|mesh-ancestor
111110841|NCT04649476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111110842|NCT05117957|Sorafenib|sorafenib|mesh-list
111110843|NCT05117957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111110844|NCT05117957|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111110845|NCT05117957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111110846|NCT05117957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111110847|NCT03343301|Bemarituzumab|bemarituzumab|mesh-list
111110848|NCT03343301|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111110849|NCT03343301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111110850|NCT03251729|Progesterone|progesterone|mesh-list
111110851|NCT03251729|Progestins|progestins|mesh-ancestor
111110852|NCT03251729|Hormones|hormones|mesh-ancestor
111110853|NCT03251729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111110854|NCT03251729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111110855|NCT02696785|Adalimumab|adalimumab|mesh-list
111110856|NCT02696785|Ixekizumab|ixekizumab|mesh-list
111110857|NCT02696785|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111110858|NCT02696785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111110859|NCT02696785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111110860|NCT02696785|Dermatologic Agents|dermatologic agents|mesh-ancestor
111110861|NCT02004262|Cyclophosphamide|cyclophosphamide|mesh-list
111110862|NCT02004262|Pancrelipase|pancrelipase|mesh-list
111110863|NCT02004262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111110864|NCT02004262|Immunologic Factors|immunologic factors|mesh-ancestor
111110865|NCT02004262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111110866|NCT02004262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111110867|NCT02004262|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111110868|NCT02004262|Alkylating Agents|alkylating agents|mesh-ancestor
111110869|NCT02004262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111110870|NCT02004262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111110871|NCT02004262|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111110872|NCT02004262|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111490074|NCT01643616|Midazolam|midazolam|mesh-list
111490075|NCT01643616|Ropivacaine|ropivacaine|mesh-list
111110873|NCT02393599|Cocaine|cocaine|mesh-list
111110874|NCT02393599|Anesthetics, Local|anesthetics, local|mesh-ancestor
111110875|NCT02393599|Anesthetics|anesthetics|mesh-ancestor
110648330|NCT00718757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111110876|NCT02393599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111110877|NCT02393599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111110878|NCT02393599|Sensory System Agents|sensory system agents|mesh-ancestor
111110879|NCT02393599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111110880|NCT02393599|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110827986|NCT03863977|Hormones|hormones|mesh-ancestor
111110881|NCT02393599|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111110882|NCT02393599|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111110883|NCT02393599|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111110884|NCT02393599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111110886|NCT02393599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111110887|NCT02402491|Aspirin|aspirin|mesh-list
111110888|NCT02402491|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-list
111110889|NCT02402491|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111110890|NCT02402491|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111110891|NCT02402491|Analgesics|analgesics|mesh-ancestor
111110892|NCT02402491|Sensory System Agents|sensory system agents|mesh-ancestor
111110893|NCT02402491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111110894|NCT02402491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111110895|NCT02402491|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111110896|NCT02402491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111110897|NCT02402491|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111110898|NCT02402491|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111110899|NCT02402491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111110900|NCT02402491|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111110901|NCT02402491|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111110902|NCT02402491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111110903|NCT02402491|Antipyretics|antipyretics|mesh-ancestor
111110904|NCT02402491|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111110905|NCT02402491|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111110906|NCT02402491|Purinergic Agents|purinergic agents|mesh-ancestor
111110907|NCT02402491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111110908|NCT02402413|Androgens|androgens|mesh-list
111110909|NCT02402413|Hormones|hormones|mesh-ancestor
111110910|NCT02402413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111110911|NCT02402413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111110912|NCT02393443|Oxytocin|oxytocin|mesh-list
111110913|NCT02393443|Oxytocics|oxytocics|mesh-ancestor
111110914|NCT02393443|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111110915|NCT02393443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111110916|NCT01977898|Morphine|morphine|mesh-list
111110917|NCT01977898|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111110918|NCT01977898|Narcotics|narcotics|mesh-ancestor
111110919|NCT01977898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111110920|NCT01977898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111110921|NCT01977898|Analgesics|analgesics|mesh-ancestor
111110922|NCT01977898|Sensory System Agents|sensory system agents|mesh-ancestor
111110923|NCT01977898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111110924|NCT05744479|Metformin|metformin|mesh-list
111110925|NCT05744479|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111110926|NCT05744479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111110927|NCT02003638|Niacin|niacin|mesh-list
111110928|NCT02003638|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111110929|NCT02003638|Antimetabolites|antimetabolites|mesh-ancestor
111110930|NCT02003638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111110931|NCT02003638|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111110932|NCT02003638|Vasodilator Agents|vasodilator agents|mesh-ancestor
111110933|NCT02003638|Vitamin B Complex|vitamin b complex|mesh-ancestor
111110934|NCT02003638|Vitamins|vitamins|mesh-ancestor
111110935|NCT02003638|Micronutrients|micronutrients|mesh-ancestor
111110936|NCT02003638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111110937|NCT04649398|Nimodipine|nimodipine|mesh-list
111110938|NCT04649398|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111110939|NCT04649398|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111110940|NCT04649398|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111110941|NCT04649398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111490077|NCT01643616|Anesthetics, Local|anesthetics, local|mesh-ancestor
111490078|NCT01643616|Anesthetics|anesthetics|mesh-ancestor
111490079|NCT01643616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111110942|NCT04649398|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110698223|NCT01045980|Vitamins|vitamins|mesh-list
111110943|NCT04649398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111110945|NCT02402179|Tryptophan|tryptophan|mesh-list
111110946|NCT02402179|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111110947|NCT02402179|Antidepressive Agents|antidepressive agents|mesh-ancestor
111110948|NCT02402179|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111110949|NCT02401945|Aflibercept|aflibercept|mesh-list
111110950|NCT02401945|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111110951|NCT02401945|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111110952|NCT02401945|Growth Substances|growth substances|mesh-ancestor
111110953|NCT02401945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111110954|NCT02401945|Growth Inhibitors|growth inhibitors|mesh-ancestor
111110955|NCT02401945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111110956|NCT02003014|Pioglitazone|pioglitazone|mesh-list
111110957|NCT02003014|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111110958|NCT02003014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111110959|NCT01977352|Bupivacaine|bupivacaine|mesh-list
111110960|NCT01977352|Anesthetics, Local|anesthetics, local|mesh-ancestor
111110961|NCT01977352|Anesthetics|anesthetics|mesh-ancestor
111110962|NCT01977352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111110963|NCT01977352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111110964|NCT01977352|Sensory System Agents|sensory system agents|mesh-ancestor
111110965|NCT01977352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111110966|NCT03166111|Lidocaine|lidocaine|mesh-list
111110967|NCT03166111|Anesthetics, Local|anesthetics, local|mesh-ancestor
111110968|NCT03166111|Anesthetics|anesthetics|mesh-ancestor
111110969|NCT03166111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111110970|NCT03166111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111110971|NCT03166111|Sensory System Agents|sensory system agents|mesh-ancestor
111110972|NCT03166111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111110973|NCT03166111|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111110974|NCT03166111|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111110975|NCT03166111|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111110976|NCT03166111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111110977|NCT03166111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111110978|NCT05117021|Bupivacaine|bupivacaine|mesh-list
111110979|NCT05117021|Anesthetics, Local|anesthetics, local|mesh-ancestor
111110980|NCT05117021|Anesthetics|anesthetics|mesh-ancestor
111110981|NCT05117021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111110982|NCT05117021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111110983|NCT05117021|Sensory System Agents|sensory system agents|mesh-ancestor
111110984|NCT05117021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111110985|NCT02392663|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111110986|NCT02392117|Insulin|insulin|mesh-list
111110987|NCT02392117|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111110988|NCT02392117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111110989|NCT02812433|Sildenafil Citrate|sildenafil citrate|mesh-list
111110990|NCT02812433|Vasodilator Agents|vasodilator agents|mesh-ancestor
111110991|NCT02812433|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111110992|NCT02812433|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111110993|NCT02812433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111110994|NCT02812433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111110995|NCT02812433|Urological Agents|urological agents|mesh-ancestor
111110996|NCT02392039|Loratadine|loratadine|mesh-list
111110997|NCT02392039|Antipruritics|antipruritics|mesh-ancestor
111110998|NCT02392039|Dermatologic Agents|dermatologic agents|mesh-ancestor
111110999|NCT02392039|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111111000|NCT02392039|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
111111001|NCT02392039|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111111002|NCT02392039|Histamine Antagonists|histamine antagonists|mesh-ancestor
111111003|NCT02392039|Histamine Agents|histamine agents|mesh-ancestor
111111004|NCT02392039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111111005|NCT02392039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111111006|NCT02392039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111111007|NCT03106363|Ethanol|ethanol|mesh-list
111111008|NCT03106363|Dronabinol|dronabinol|mesh-list
111111009|NCT03106363|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111111010|NCT03106363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111111011|NCT03106363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111111012|NCT03106363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111111013|NCT03106363|Hallucinogens|hallucinogens|mesh-ancestor
111490080|NCT01643616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111111014|NCT03106363|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111490081|NCT01643616|Sensory System Agents|sensory system agents|mesh-ancestor
111490082|NCT01643616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111111015|NCT03106363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111111017|NCT03106363|Sensory System Agents|sensory system agents|mesh-ancestor
111111018|NCT03106363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111111019|NCT03106363|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
111111020|NCT03106363|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
111111021|NCT03106363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111111022|NCT03106363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111111023|NCT03106363|Hormones|hormones|mesh-ancestor
111111024|NCT03106363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111111025|NCT03106519|Bupivacaine|bupivacaine|mesh-list
111111026|NCT03106519|Anesthetics, Local|anesthetics, local|mesh-ancestor
111111027|NCT03106519|Anesthetics|anesthetics|mesh-ancestor
111111028|NCT03106519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111111029|NCT03106519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111111030|NCT03106519|Sensory System Agents|sensory system agents|mesh-ancestor
111111031|NCT03106519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111111032|NCT02687815|Vitamin D|vitamin d|mesh-list
111111033|NCT02687815|Cholecalciferol|cholecalciferol|mesh-list
111111034|NCT02687815|Vitamins|vitamins|mesh-ancestor
111111035|NCT02687815|Micronutrients|micronutrients|mesh-ancestor
111111036|NCT02687815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111111037|NCT02687815|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111111038|NCT02687815|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111111039|NCT03915665|Chlorhexidine|chlorhexidine|mesh-list
111111040|NCT03915665|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111111041|NCT03915665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111111042|NCT03915665|Disinfectants|disinfectants|mesh-ancestor
111111043|NCT01959334|Glucagon|glucagon|mesh-list
111111044|NCT01959334|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
111111045|NCT01959334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111111046|NCT01959334|Hormones|hormones|mesh-ancestor
111111047|NCT01959334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111111048|NCT01959334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111111049|NCT01959334|Incretins|incretins|mesh-ancestor
111111050|NCT01958476|Morphine|morphine|mesh-list
111111051|NCT01958476|Methadone|methadone|mesh-list
111111052|NCT01958476|Phenobarbital|phenobarbital|mesh-list
111111053|NCT01958476|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111111054|NCT01958476|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111111055|NCT01958476|Narcotics|narcotics|mesh-ancestor
111111056|NCT01958476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111111057|NCT01958476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111111058|NCT01958476|Analgesics|analgesics|mesh-ancestor
111111059|NCT01958476|Sensory System Agents|sensory system agents|mesh-ancestor
111111060|NCT01958476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111111061|NCT01958476|Antitussive Agents|antitussive agents|mesh-ancestor
111111062|NCT01958476|Respiratory System Agents|respiratory system agents|mesh-ancestor
111111063|NCT01958476|Anticonvulsants|anticonvulsants|mesh-ancestor
111111064|NCT01958476|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111111065|NCT01958476|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111111066|NCT01958476|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111111067|NCT01958476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111111068|NCT01958476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111111069|NCT01958476|GABA Modulators|gaba modulators|mesh-ancestor
111111070|NCT01958476|GABA Agents|gaba agents|mesh-ancestor
111111071|NCT01958476|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111111072|NCT01958476|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111111073|NCT01958476|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111111074|NCT04809181|Azacitidine|azacitidine|mesh-list
111111075|NCT04809181|Venetoclax|venetoclax|mesh-list
111111076|NCT04809181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111111077|NCT04809181|Antimetabolites|antimetabolites|mesh-ancestor
111111078|NCT04809181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111111079|NCT04809181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111111080|NCT04809181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111111081|NCT01057121|Lenalidomide|lenalidomide|mesh-list
111111082|NCT01057121|Immunologic Factors|immunologic factors|mesh-ancestor
111111083|NCT01057121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111111084|NCT01057121|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111111085|NCT01057121|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111111086|NCT01057121|Growth Substances|growth substances|mesh-ancestor
111111087|NCT01057121|Growth Inhibitors|growth inhibitors|mesh-ancestor
110698228|NCT00388674|Entecavir|entecavir|mesh-list
111111088|NCT01057121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111111090|NCT02695537|Anticonvulsants|anticonvulsants|mesh-ancestor
111111091|NCT04620941|Chrysarobin|chrysarobin|mesh-list
111111092|NCT04620941|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111111093|NCT04620941|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111111094|NCT04620941|Analgesics|analgesics|mesh-ancestor
111111095|NCT04620941|Sensory System Agents|sensory system agents|mesh-ancestor
111111096|NCT04620941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111111097|NCT04620941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111111098|NCT04620941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111111099|NCT04620941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111111100|NCT04210349|Vaccines|vaccines|mesh-list
111111101|NCT04210349|Immunologic Factors|immunologic factors|mesh-ancestor
111111102|NCT04210349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111111103|NCT01353313|Hydrocortisone|hydrocortisone|mesh-list
111111104|NCT01353313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111111105|NCT04746989|Allopurinol|allopurinol|mesh-list
111111106|NCT04746989|Probenecid|probenecid|mesh-list
111111107|NCT04746989|Antimetabolites|antimetabolites|mesh-ancestor
111111108|NCT04746989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111111109|NCT04746989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111111110|NCT04746989|Gout Suppressants|gout suppressants|mesh-ancestor
111111111|NCT04746989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111111112|NCT04746989|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111111113|NCT04746989|Antioxidants|antioxidants|mesh-ancestor
111111114|NCT04746989|Protective Agents|protective agents|mesh-ancestor
111111115|NCT04746989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111111116|NCT04746989|Uricosuric Agents|uricosuric agents|mesh-ancestor
111111117|NCT04671953|Metformin|metformin|mesh-list
111111118|NCT04671953|Deucravacitinib|deucravacitinib|mesh-list
111111119|NCT04671953|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111111120|NCT04671953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111111121|NCT04671953|Dermatologic Agents|dermatologic agents|mesh-ancestor
111111122|NCT04671953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111111123|NCT04671953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111111124|NCT04671953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111111125|NCT04585061|Lidocaine|lidocaine|mesh-list
111111126|NCT04585061|Anesthetics, Local|anesthetics, local|mesh-ancestor
111111127|NCT04585061|Anesthetics|anesthetics|mesh-ancestor
111111128|NCT04585061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111111129|NCT04585061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111111130|NCT04585061|Sensory System Agents|sensory system agents|mesh-ancestor
111111131|NCT04585061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111111132|NCT04585061|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111111133|NCT04585061|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111111134|NCT04585061|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111111135|NCT04585061|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111111136|NCT04585061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111111137|NCT03874091|Epinephrine|epinephrine|mesh-list
111111138|NCT03874091|Racepinephrine|racepinephrine|mesh-list
111111139|NCT03874091|Morphine|morphine|mesh-list
111111140|NCT03874091|Bupivacaine|bupivacaine|mesh-list
111111141|NCT03874091|Epinephryl borate|epinephryl borate|mesh-list
111111142|NCT03874091|Anesthetics, Local|anesthetics, local|mesh-ancestor
111111143|NCT03874091|Anesthetics|anesthetics|mesh-ancestor
111111144|NCT03874091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111111145|NCT03874091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111111146|NCT03874091|Sensory System Agents|sensory system agents|mesh-ancestor
111111147|NCT03874091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111111148|NCT03874091|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111111149|NCT03874091|Narcotics|narcotics|mesh-ancestor
111111150|NCT03874091|Analgesics|analgesics|mesh-ancestor
111111151|NCT03874091|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111111152|NCT03874091|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111111153|NCT03874091|Adrenergic Agents|adrenergic agents|mesh-ancestor
111111154|NCT03874091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111111155|NCT03874091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111111156|NCT03874091|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111111157|NCT03874091|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111490083|NCT01643616|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111111158|NCT03874091|Autonomic Agents|autonomic agents|mesh-ancestor
111111159|NCT03874091|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111111160|NCT03874091|Respiratory System Agents|respiratory system agents|mesh-ancestor
111111161|NCT03874091|Mydriatics|mydriatics|mesh-ancestor
111111162|NCT03874091|Sympathomimetics|sympathomimetics|mesh-ancestor
110698229|NCT00388674|Antiviral Agents|antiviral agents|mesh-ancestor
111490084|NCT01643616|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111111163|NCT03874091|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111111164|NCT01362491|Ibuprofen|ibuprofen|mesh-list
111111165|NCT01362491|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111111166|NCT01362491|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111111167|NCT01362491|Analgesics|analgesics|mesh-ancestor
111111168|NCT01362491|Sensory System Agents|sensory system agents|mesh-ancestor
111111169|NCT01362491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111111170|NCT01362491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111111171|NCT01362491|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111111172|NCT01362491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111111173|NCT01362491|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111111174|NCT01362491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111111175|NCT01362491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111111176|NCT03560297|Nitrazepam|nitrazepam|mesh-list
111111177|NCT03560297|Anticonvulsants|anticonvulsants|mesh-ancestor
111111178|NCT03560297|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111111179|NCT03560297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111111180|NCT03560297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111111181|NCT03560297|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111111182|NCT03560297|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111111183|NCT03560297|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111111184|NCT03560297|GABA Modulators|gaba modulators|mesh-ancestor
111111185|NCT03560297|GABA Agents|gaba agents|mesh-ancestor
111111186|NCT03560297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111111187|NCT03560297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111111188|NCT04122287|Levofloxacin|levofloxacin|mesh-list
111111189|NCT04122287|Tinidazole|tinidazole|mesh-list
111111190|NCT04122287|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111111191|NCT04122287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111111192|NCT04122287|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111111193|NCT04122287|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111111194|NCT04122287|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111111195|NCT04122287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111111196|NCT04122287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111111197|NCT04122287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111111198|NCT04122287|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111111199|NCT04122287|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111111200|NCT04122287|Alkylating Agents|alkylating agents|mesh-ancestor
111111201|NCT04122287|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
111111202|NCT04122287|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111111203|NCT04122287|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111111204|NCT05746351|Fentanyl|fentanyl|mesh-list
111111205|NCT05746351|Dexmedetomidine|dexmedetomidine|mesh-list
111111206|NCT05746351|Nalbuphine|nalbuphine|mesh-list
111111207|NCT05746351|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111111208|NCT05746351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111111209|NCT05746351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111111210|NCT05746351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111111211|NCT05746351|Analgesics|analgesics|mesh-ancestor
111111212|NCT05746351|Sensory System Agents|sensory system agents|mesh-ancestor
111111213|NCT05746351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111111214|NCT05746351|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111111215|NCT05746351|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111111216|NCT05746351|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111111217|NCT05746351|Adrenergic Agents|adrenergic agents|mesh-ancestor
111111218|NCT05746351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111111219|NCT05746351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111111220|NCT05746351|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111111221|NCT05746351|Narcotics|narcotics|mesh-ancestor
111111222|NCT05746351|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111111223|NCT05746351|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111111224|NCT05746351|Anesthetics, General|anesthetics, general|mesh-ancestor
111111225|NCT05746351|Anesthetics|anesthetics|mesh-ancestor
111111226|NCT05403281|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111111227|NCT05403281|Dapagliflozin|dapagliflozin|mesh-list
111111228|NCT05403281|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111111229|NCT05403281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111111230|NCT05403281|Incretins|incretins|mesh-ancestor
111111231|NCT05403281|Hormones|hormones|mesh-ancestor
111111232|NCT05403281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111111233|NCT05403281|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111490085|NCT01643616|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111111234|NCT05403281|Protease Inhibitors|protease inhibitors|mesh-ancestor
111111235|NCT05403281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111490086|NCT01643616|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111111236|NCT05403281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111111237|NCT05403281|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111111238|NCT03115099|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111111239|NCT03115099|Liraglutide|liraglutide|mesh-list
111111240|NCT03115099|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111111241|NCT03115099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111111242|NCT03115099|Incretins|incretins|mesh-ancestor
111111243|NCT03115099|Hormones|hormones|mesh-ancestor
111111244|NCT03115099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111111245|NCT03115099|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111111246|NCT03115099|Protease Inhibitors|protease inhibitors|mesh-ancestor
111111247|NCT03115099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111111248|NCT03115099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111111249|NCT03165097|ACT-709478|act-709478|mesh-list
111111250|NCT03165097|Midazolam|midazolam|mesh-list
111111251|NCT03165097|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111111252|NCT03165097|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111111253|NCT03165097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111111254|NCT03165097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111111255|NCT03165097|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111111256|NCT03165097|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111111257|NCT03165097|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111111258|NCT03165097|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111111259|NCT03165097|Anesthetics, General|anesthetics, general|mesh-ancestor
111111260|NCT03165097|Anesthetics|anesthetics|mesh-ancestor
111111261|NCT03165097|GABA Modulators|gaba modulators|mesh-ancestor
111111262|NCT03165097|GABA Agents|gaba agents|mesh-ancestor
111111263|NCT03165097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111111264|NCT03165097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111111265|NCT03165097|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111111266|NCT03165097|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111111267|NCT03165097|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111111268|NCT03165409|Nivolumab|nivolumab|mesh-list
111111269|NCT03165409|Ipilimumab|ipilimumab|mesh-list
111111270|NCT03165409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111111271|NCT03165409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111111272|NCT03165409|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111111273|NCT03165409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111111274|NCT05403125|Listerine|listerine|mesh-list
111111275|NCT05403125|Fluorides|fluorides|mesh-list
111111276|NCT05403125|Sodium Fluoride|sodium fluoride|mesh-list
111111277|NCT05403125|Cariostatic Agents|cariostatic agents|mesh-ancestor
111111278|NCT05403125|Protective Agents|protective agents|mesh-ancestor
111111279|NCT05403125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111111280|NCT05403125|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111111281|NCT05403125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111111282|NCT05701423|Natalizumab|natalizumab|mesh-list
111111283|NCT05701423|Immunologic Factors|immunologic factors|mesh-ancestor
111111284|NCT05701423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111111285|NCT02795351|Sildenafil Citrate|sildenafil citrate|mesh-list
111111286|NCT02795351|Vasodilator Agents|vasodilator agents|mesh-ancestor
111111287|NCT02795351|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111111288|NCT02795351|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111111289|NCT02795351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111111290|NCT02795351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111111291|NCT02795351|Urological Agents|urological agents|mesh-ancestor
111111292|NCT05403047|Tenofovir|tenofovir|mesh-list
111111293|NCT05403047|Antiviral Agents|antiviral agents|mesh-ancestor
111111294|NCT05403047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111111295|NCT05403047|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111111296|NCT05403047|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111111297|NCT05403047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111111298|NCT05403047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111111299|NCT05403047|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111111300|NCT05403047|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111111301|NCT04563845|Moxifloxacin|moxifloxacin|mesh-list
111111302|NCT04563845|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111111303|NCT04563845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111111304|NCT04563845|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111111305|NCT04563845|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111111306|NCT04563845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111111307|NCT04563845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110698234|NCT00388362|Glucocorticoids|glucocorticoids|mesh-ancestor
111490087|NCT01643616|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111111308|NCT04563845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111111309|NCT03927443|Bimatoprost|bimatoprost|mesh-list
111111310|NCT03927443|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111111311|NCT05124353|Cerebrolysin|cerebrolysin|mesh-list
111111312|NCT05124353|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111111313|NCT05124353|Protective Agents|protective agents|mesh-ancestor
111111314|NCT05124353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111111315|NCT05124353|Nootropic Agents|nootropic agents|mesh-ancestor
111111316|NCT03805841|Bromides|bromides|mesh-list
111111317|NCT03805841|Anticonvulsants|anticonvulsants|mesh-ancestor
111111318|NCT02684617|Pembrolizumab|pembrolizumab|mesh-list
111111319|NCT02684617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111111320|NCT02684617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111111321|NCT02684617|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111111322|NCT02684617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111111323|NCT01999972|Axitinib|axitinib|mesh-list
111111324|NCT01999972|Crizotinib|crizotinib|mesh-list
111111325|NCT01999972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111111326|NCT01999972|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111111327|NCT01999972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111111328|NCT01999972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111111329|NCT04055389|Antithrombins|antithrombins|mesh-list
111111330|NCT04055389|Antithrombin III|antithrombin iii|mesh-list
111111331|NCT04055389|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111111332|NCT04055389|Protease Inhibitors|protease inhibitors|mesh-ancestor
111111333|NCT04055389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111111334|NCT04055389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111111335|NCT04055389|Anticoagulants|anticoagulants|mesh-ancestor
111111336|NCT05697055|Ritonavir|ritonavir|mesh-list
111111337|NCT05697055|Nirmatrelvir|nirmatrelvir|mesh-list
111111338|NCT05697055|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
111111339|NCT05697055|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111111340|NCT05697055|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111111341|NCT05697055|Protease Inhibitors|protease inhibitors|mesh-ancestor
111111342|NCT05697055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111111343|NCT05697055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111111344|NCT05697055|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111111345|NCT05697055|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111111346|NCT05697055|Antiviral Agents|antiviral agents|mesh-ancestor
111111347|NCT05697055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111111348|NCT05697055|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111111349|NCT05697055|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111111350|NCT03162367|Sulfadiazine|sulfadiazine|mesh-list
111111351|NCT03162367|Silver Sulfadiazine|silver sulfadiazine|mesh-list
111111352|NCT03162367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111111353|NCT03162367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111111354|NCT03162367|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111111355|NCT03162367|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111111356|NCT03162367|Coccidiostats|coccidiostats|mesh-ancestor
111111357|NCT03162367|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111111358|NCT01999894|Memantine|memantine|mesh-list
111111359|NCT01999894|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111111360|NCT01999894|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111111361|NCT01999894|Dopamine Agents|dopamine agents|mesh-ancestor
111111362|NCT01999894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111111363|NCT01999894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111111364|NCT01999894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111111365|NCT01999894|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111111366|NCT01999894|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111111367|NCT01976806|Aspirin|aspirin|mesh-list
111111368|NCT01976806|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111111369|NCT01976806|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111111370|NCT01976806|Analgesics|analgesics|mesh-ancestor
111111371|NCT01976806|Sensory System Agents|sensory system agents|mesh-ancestor
111111372|NCT01976806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111111373|NCT01976806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111111374|NCT01976806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111111375|NCT01976806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111111376|NCT01976806|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111111377|NCT01976806|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111111378|NCT01976806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111490088|NCT01643616|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111490089|NCT01643616|Anesthetics, General|anesthetics, general|mesh-ancestor
111111379|NCT01976806|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111111380|NCT01976806|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111111381|NCT01976806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111111382|NCT01976806|Antipyretics|antipyretics|mesh-ancestor
111111383|NCT01976728|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
111111384|NCT01976728|Hormones|hormones|mesh-ancestor
111111385|NCT01976728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111111386|NCT01976728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111111387|NCT02689219|Brentuximab Vedotin|brentuximab vedotin|mesh-list
111111388|NCT02689219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111111389|NCT02689219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111111390|NCT02689219|Immunotoxins|immunotoxins|mesh-ancestor
111111391|NCT02689219|Immunoconjugates|immunoconjugates|mesh-ancestor
111111392|NCT02689219|Immunologic Factors|immunologic factors|mesh-ancestor
111111393|NCT02689219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111111394|NCT03165253|Amoxicillin|amoxicillin|mesh-list
111111395|NCT03165253|Clarithromycin|clarithromycin|mesh-list
111111396|NCT03165253|Omeprazole|omeprazole|mesh-list
111111397|NCT03165253|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111111398|NCT03165253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111111399|NCT03165253|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111111400|NCT03165253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111111401|NCT03165253|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111111402|NCT03165253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111111403|NCT03165253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111111404|NCT03165253|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111111405|NCT03165253|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111111406|NCT03165253|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111111407|NCT05543317|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
111111408|NCT05543317|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111111409|NCT05543317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111111411|NCT04718389|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111111412|NCT04718389|Respiratory System Agents|respiratory system agents|mesh-ancestor
111111413|NCT03161977|Mannitol|mannitol|mesh-list
111111414|NCT03161977|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
111111415|NCT03161977|Diuretics|diuretics|mesh-ancestor
111111416|NCT03161977|Natriuretic Agents|natriuretic agents|mesh-ancestor
111111417|NCT03161977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111111418|NCT02683525|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111111419|NCT02683525|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111111420|NCT02683525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111111421|NCT02683525|Incretins|incretins|mesh-ancestor
111111422|NCT02683525|Hormones|hormones|mesh-ancestor
111111423|NCT02683525|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111111424|NCT02683525|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111111425|NCT02683525|Protease Inhibitors|protease inhibitors|mesh-ancestor
111111426|NCT02683525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111111427|NCT02683525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111111428|NCT01976338|Ranibizumab|ranibizumab|mesh-list
111111429|NCT01976338|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111111430|NCT01976338|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111111431|NCT01976338|Growth Substances|growth substances|mesh-ancestor
111111432|NCT01976338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111111433|NCT01976338|Growth Inhibitors|growth inhibitors|mesh-ancestor
111111434|NCT01976338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111111435|NCT02651987|Lanreotide|lanreotide|mesh-list
111111436|NCT02651987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111111437|NCT05115773|Anesthetics|anesthetics|mesh-list
111111438|NCT05115773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111111439|NCT05115773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111111440|NCT04657939|Pioglitazone|pioglitazone|mesh-list
111111441|NCT04657939|Liraglutide|liraglutide|mesh-list
111111442|NCT04657939|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111111443|NCT04657939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111111444|NCT04657939|Incretins|incretins|mesh-ancestor
111111445|NCT04657939|Hormones|hormones|mesh-ancestor
111111446|NCT04657939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111111447|NCT01999114|Moxifloxacin|moxifloxacin|mesh-list
111111448|NCT01999114|Naltrexone|naltrexone|mesh-list
111111449|NCT01999114|Buprenorphine|buprenorphine|mesh-list
111111450|NCT01999114|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
111111451|NCT01999114|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111111452|NCT01999114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111490090|NCT01643616|GABA Modulators|gaba modulators|mesh-ancestor
111490091|NCT01643616|GABA Agents|gaba agents|mesh-ancestor
111490092|NCT01643616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111490093|NCT01643616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111490095|NCT01644396|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111111453|NCT01999114|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111111454|NCT01999114|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111111455|NCT01999114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111111456|NCT01999114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111111457|NCT01999114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111111458|NCT01999114|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111111459|NCT01999114|Contraceptive Agents|contraceptive agents|mesh-ancestor
111111460|NCT01999114|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111111461|NCT01999114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111111462|NCT01999114|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
111111463|NCT01999114|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111111464|NCT01999114|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111111465|NCT01999114|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111111466|NCT01999114|Narcotics|narcotics|mesh-ancestor
111111467|NCT01999114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111111468|NCT01999114|Analgesics|analgesics|mesh-ancestor
111111469|NCT01999114|Sensory System Agents|sensory system agents|mesh-ancestor
111111470|NCT01999114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111111471|NCT01999114|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111111472|NCT01999114|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111111473|NCT04500275|Vancomycin|vancomycin|mesh-list
111111474|NCT04500275|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111111475|NCT04500275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111111476|NCT04503161|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
111111477|NCT04503161|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
111111478|NCT04503161|Estradiol|estradiol|mesh-list
111111479|NCT04503161|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
111111480|NCT04503161|Estrogens|estrogens|mesh-ancestor
111111481|NCT04503161|Hormones|hormones|mesh-ancestor
110828585|NCT03480009|Antitussive Agents|antitussive agents|mesh-ancestor
111111482|NCT04503161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111111483|NCT04503161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111111484|NCT04503161|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111111485|NCT04503161|Contraceptive Agents|contraceptive agents|mesh-ancestor
111111486|NCT04503161|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111111487|NCT04503161|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111111488|NCT02214407|Decitabine|decitabine|mesh-list
111111489|NCT02214407|Hydroxyurea|hydroxyurea|mesh-list
111111490|NCT02214407|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111111491|NCT02214407|Antimetabolites|antimetabolites|mesh-ancestor
111111492|NCT02214407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111111493|NCT02214407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111111494|NCT02214407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111111495|NCT02214407|Antisickling Agents|antisickling agents|mesh-ancestor
111111496|NCT02214407|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111111497|NCT02261285|Nivolumab|nivolumab|mesh-list
111111498|NCT02261285|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111111499|NCT02261285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111111500|NCT02261285|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111111501|NCT02261285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111111502|NCT01288625|Amifostine|amifostine|mesh-list
111111503|NCT01288625|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111111504|NCT01288625|Protective Agents|protective agents|mesh-ancestor
111111505|NCT01288625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111111506|NCT01374451|Everolimus|everolimus|mesh-list
111111507|NCT01374451|Pasireotide|pasireotide|mesh-list
111111508|NCT01374451|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111111509|NCT01374451|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111111510|NCT01374451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111111511|NCT01374451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111111512|NCT01374451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111111513|NCT01374451|Immunologic Factors|immunologic factors|mesh-ancestor
111111514|NCT01374451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111111515|NCT01374451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111111516|NCT01374451|Hormones|hormones|mesh-ancestor
111111517|NCT01374451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111111518|NCT02674399|Hylan|hylan|mesh-list
111111519|NCT02674399|Viscosupplements|viscosupplements|mesh-ancestor
111111520|NCT02674399|Protective Agents|protective agents|mesh-ancestor
111111521|NCT02674399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111490096|NCT01644396|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111111522|NCT03161509|Acetaminophen|acetaminophen|mesh-list
111111523|NCT03161509|Lamotrigine|lamotrigine|mesh-list
111111524|NCT03161509|Carbamazepine|carbamazepine|mesh-list
111111525|NCT03161509|Phenytoin|phenytoin|mesh-list
111111526|NCT03161509|Valproic Acid|valproic acid|mesh-list
111111527|NCT03161509|Anticonvulsants|anticonvulsants|mesh-list
111111528|NCT03161509|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111111529|NCT03161509|Analgesics|analgesics|mesh-ancestor
111111530|NCT03161509|Sensory System Agents|sensory system agents|mesh-ancestor
111111531|NCT03161509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111111532|NCT03161509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111111533|NCT03161509|Antipyretics|antipyretics|mesh-ancestor
111111534|NCT03161509|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111111535|NCT03161509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111111536|NCT03161509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111111537|NCT03161509|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111111538|NCT03161509|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111111539|NCT03161509|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111111540|NCT03161509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111111541|NCT03161509|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111111542|NCT03161509|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111111543|NCT03161509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111111544|NCT03161509|GABA Agents|gaba agents|mesh-ancestor
111111545|NCT03161509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111111546|NCT03161509|Antimanic Agents|antimanic agents|mesh-ancestor
111111547|NCT03161509|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111111548|NCT03161509|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111111549|NCT03161509|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111111550|NCT03161509|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
111111551|NCT02676895|Vaccines|vaccines|mesh-list
111111552|NCT02676895|Immunologic Factors|immunologic factors|mesh-ancestor
111111553|NCT02676895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110828663|NCT03500211|Lidocaine|lidocaine|mesh-list
111111554|NCT04440085|Midodrine|midodrine|mesh-list
111111555|NCT04440085|Sympathomimetics|sympathomimetics|mesh-ancestor
111111556|NCT04440085|Autonomic Agents|autonomic agents|mesh-ancestor
111111557|NCT04440085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111111558|NCT04440085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111111559|NCT04440085|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111111560|NCT04440085|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111111561|NCT04440085|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111111562|NCT04440085|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111111563|NCT04440085|Adrenergic Agents|adrenergic agents|mesh-ancestor
111111564|NCT04440085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111111565|NCT04440085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111111567|NCT05129033|Itraconazole|itraconazole|mesh-list
111111568|NCT05129033|Prednisone|prednisone|mesh-list
111111569|NCT05129033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111111570|NCT05129033|Glucocorticoids|glucocorticoids|mesh-ancestor
111111571|NCT05129033|Hormones|hormones|mesh-ancestor
111111572|NCT05129033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111111573|NCT05129033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111111574|NCT05129033|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111111575|NCT05129033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111111576|NCT05129033|Antifungal Agents|antifungal agents|mesh-ancestor
111111577|NCT05129033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111111578|NCT05129033|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111111579|NCT05129033|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111111580|NCT05129033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111111581|NCT05129033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111111582|NCT05129033|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111111583|NCT05129033|Hormone Antagonists|hormone antagonists|mesh-ancestor
111111584|NCT05129033|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111111585|NCT05129033|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111111586|NCT05129033|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111111587|NCT05129033|Respiratory System Agents|respiratory system agents|mesh-ancestor
111111588|NCT05128721|Vaccines|vaccines|mesh-list
111111589|NCT05128721|Immunologic Factors|immunologic factors|mesh-ancestor
111111590|NCT05128721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111111591|NCT05128175|Levodopa|levodopa|mesh-list
111111592|NCT05128175|Carbidopa|carbidopa|mesh-list
111111593|NCT05128175|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
111111594|NCT05128175|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111111595|NCT05128175|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111490097|NCT01644396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111490098|NCT01645098|Dexmedetomidine|dexmedetomidine|mesh-list
111490099|NCT01645098|Ketamine|ketamine|mesh-list
111111596|NCT05128175|Dopamine Agents|dopamine agents|mesh-ancestor
111111597|NCT05128175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111111598|NCT05128175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111111599|NCT05128175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111111600|NCT05128175|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
111111601|NCT05128175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111111602|NCT05128175|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111111603|NCT05128175|Immunologic Factors|immunologic factors|mesh-ancestor
111111604|NCT05128175|Dopamine Agonists|dopamine agonists|mesh-ancestor
111111606|NCT04184453|Iron Chelating Agents|iron chelating agents|mesh-ancestor
111111607|NCT04184453|Chelating Agents|chelating agents|mesh-ancestor
111111608|NCT04184453|Sequestering Agents|sequestering agents|mesh-ancestor
111111609|NCT04184453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111111610|NCT05127707|Analgesics, Opioid|analgesics, opioid|mesh-list
111111611|NCT05127707|Narcotics|narcotics|mesh-ancestor
111111612|NCT05127707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111111613|NCT05127707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111111614|NCT05127707|Analgesics|analgesics|mesh-ancestor
111111615|NCT05127707|Sensory System Agents|sensory system agents|mesh-ancestor
111111616|NCT05127707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111111617|NCT02207465|Paclitaxel|paclitaxel|mesh-list
111111618|NCT02207465|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111111619|NCT02207465|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111111620|NCT02207465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111111621|NCT02207465|Tubulin Modulators|tubulin modulators|mesh-ancestor
111111622|NCT02207465|Antimitotic Agents|antimitotic agents|mesh-ancestor
111111623|NCT02207465|Mitosis Modulators|mitosis modulators|mesh-ancestor
111111624|NCT02207465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111111625|NCT00719225|Abatacept|abatacept|mesh-list
111111626|NCT00719225|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111111627|NCT00719225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111111628|NCT00719225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111111629|NCT00719225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111111630|NCT00719225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111111631|NCT00719225|Immunologic Factors|immunologic factors|mesh-ancestor
111111632|NCT00719225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111111633|NCT00719225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111111634|NCT05134337|Itraconazole|itraconazole|mesh-list
111111635|NCT05134337|Rifampin|rifampin|mesh-list
111111636|NCT05134337|Antifungal Agents|antifungal agents|mesh-ancestor
111111637|NCT05134337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111111638|NCT05134337|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111111639|NCT05134337|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111111640|NCT05134337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111111641|NCT05134337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111111642|NCT05134337|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111111643|NCT05134337|Hormone Antagonists|hormone antagonists|mesh-ancestor
111111644|NCT05134337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111111645|NCT05134337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111111646|NCT05134337|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111111647|NCT05134337|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111111648|NCT05134337|Antitubercular Agents|antitubercular agents|mesh-ancestor
111111649|NCT05134337|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111111650|NCT05134337|Leprostatic Agents|leprostatic agents|mesh-ancestor
111111651|NCT05134337|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111111652|NCT05134337|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111111653|NCT05134337|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111111654|NCT05134337|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
111111655|NCT05134337|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
111111656|NCT05134337|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
111111657|NCT05134337|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111111658|NCT04499495|Aminosalicylic Acid|aminosalicylic acid|mesh-list
111111659|NCT04499495|Mesalamine|mesalamine|mesh-list
111111660|NCT04499495|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111111661|NCT04499495|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111111662|NCT04499495|Analgesics|analgesics|mesh-ancestor
111111663|NCT04499495|Sensory System Agents|sensory system agents|mesh-ancestor
111111664|NCT04499495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111490100|NCT01645098|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111490101|NCT01645098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111490102|NCT01645098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111490103|NCT01645098|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111490104|NCT01645098|Analgesics|analgesics|mesh-ancestor
111111665|NCT04499495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111111666|NCT04499495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111111667|NCT04499495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111111668|NCT04499495|Antitubercular Agents|antitubercular agents|mesh-ancestor
111111669|NCT04499495|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111111670|NCT04499495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111111671|NCT05323175|Ropivacaine|ropivacaine|mesh-list
111111672|NCT05323175|Anesthetics, Local|anesthetics, local|mesh-ancestor
111111673|NCT05323175|Anesthetics|anesthetics|mesh-ancestor
111111674|NCT05323175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111111675|NCT05323175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111111676|NCT05323175|Sensory System Agents|sensory system agents|mesh-ancestor
111111677|NCT05323175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111111678|NCT05279963|Amitriptyline|amitriptyline|mesh-list
111111679|NCT05279963|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
111111680|NCT05279963|Antidepressive Agents|antidepressive agents|mesh-ancestor
111111681|NCT05279963|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111111682|NCT05279963|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111111683|NCT05279963|Analgesics|analgesics|mesh-ancestor
111111684|NCT05279963|Sensory System Agents|sensory system agents|mesh-ancestor
111111685|NCT05279963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111111686|NCT05279963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111111687|NCT05279963|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111111688|NCT05279963|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111111689|NCT05279963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111111690|NCT05279963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111111691|NCT05279963|Adrenergic Agents|adrenergic agents|mesh-ancestor
111111692|NCT05279963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111111693|NCT05126693|Botulinum Toxins|botulinum toxins|mesh-list
111111694|NCT05126693|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111111695|NCT05126693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111111696|NCT05126693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111111697|NCT05126693|Cholinergic Agents|cholinergic agents|mesh-ancestor
111111698|NCT05126693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111111699|NCT05126693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111111700|NCT05133635|Methylprednisolone|methylprednisolone|mesh-list
110828809|NCT03393000|Antioxidants|antioxidants|mesh-ancestor
111111701|NCT05133635|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111111702|NCT05133635|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111111703|NCT05133635|Prednisolone|prednisolone|mesh-list
111111704|NCT05133635|Prednisolone acetate|prednisolone acetate|mesh-list
111111705|NCT05133635|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111111706|NCT05133635|Prednisolone phosphate|prednisolone phosphate|mesh-list
111111707|NCT05133635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111111708|NCT05133635|Antiemetics|antiemetics|mesh-ancestor
111111709|NCT05133635|Autonomic Agents|autonomic agents|mesh-ancestor
111111710|NCT05133635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111111711|NCT05133635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111111712|NCT05133635|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111111713|NCT05133635|Glucocorticoids|glucocorticoids|mesh-ancestor
111111715|NCT05133635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111111716|NCT05133635|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111111717|NCT05133635|Protective Agents|protective agents|mesh-ancestor
111111718|NCT05133635|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111111719|NCT05133635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111111720|NCT04219969|Deoxyglucose|deoxyglucose|mesh-list
111111721|NCT04219969|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
111111722|NCT04219969|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111111723|NCT04219969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111111724|NCT04219969|Antimetabolites|antimetabolites|mesh-ancestor
111111725|NCT04219969|Antiviral Agents|antiviral agents|mesh-ancestor
111111726|NCT04219969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111111727|NCT05132777|Osimertinib|osimertinib|mesh-list
111111728|NCT05132777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111111729|NCT05132777|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111111730|NCT05132777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111111731|NCT05132777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111111732|NCT05422027|Dexamethasone|dexamethasone|mesh-list
111111733|NCT05422027|Dexamethasone acetate|dexamethasone acetate|mesh-list
111111734|NCT05422027|Lenalidomide|lenalidomide|mesh-list
111111735|NCT05422027|Bortezomib|bortezomib|mesh-list
111111736|NCT05422027|BB 1101|bb 1101|mesh-list
111111737|NCT05422027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111490105|NCT01645098|Sensory System Agents|sensory system agents|mesh-ancestor
111490106|NCT01645098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111490107|NCT01645098|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111111738|NCT05422027|Antiemetics|antiemetics|mesh-ancestor
111111739|NCT05422027|Autonomic Agents|autonomic agents|mesh-ancestor
111111740|NCT05422027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111111741|NCT05422027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111111742|NCT05422027|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111111743|NCT05422027|Glucocorticoids|glucocorticoids|mesh-ancestor
111111744|NCT05422027|Hormones|hormones|mesh-ancestor
111111745|NCT05422027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111111746|NCT05422027|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111111747|NCT05422027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111111748|NCT05422027|Protease Inhibitors|protease inhibitors|mesh-ancestor
111111749|NCT05422027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111111750|NCT05422027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111111751|NCT05422027|Immunologic Factors|immunologic factors|mesh-ancestor
111111752|NCT05422027|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111111753|NCT05422027|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111111754|NCT05422027|Growth Substances|growth substances|mesh-ancestor
111111755|NCT05422027|Growth Inhibitors|growth inhibitors|mesh-ancestor
111111756|NCT05072821|Botulinum Toxins|botulinum toxins|mesh-list
111111757|NCT05072821|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111111758|NCT05072821|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111111759|NCT05072821|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111111760|NCT05072821|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111111761|NCT05072821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111111762|NCT05072821|Cholinergic Agents|cholinergic agents|mesh-ancestor
111111763|NCT05072821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111111764|NCT05072821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111111765|NCT05072821|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111111766|NCT05072821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111111767|NCT01674725|Ribavirin|ribavirin|mesh-list
111111768|NCT01674725|Antimetabolites|antimetabolites|mesh-ancestor
111111769|NCT01674725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111111770|NCT01674725|Antiviral Agents|antiviral agents|mesh-ancestor
111111771|NCT01674725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111111772|NCT05404061|Hormones|hormones|mesh-list
111111773|NCT05404061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111111774|NCT05404061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110828888|NCT03719625|Ephedrine|ephedrine|mesh-list
111111775|NCT05051293|Testosterone|testosterone|mesh-list
111111776|NCT05051293|Estrogens|estrogens|mesh-list
111111777|NCT05051293|Androgens|androgens|mesh-ancestor
111111778|NCT05051293|Hormones|hormones|mesh-ancestor
111111779|NCT05051293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111111780|NCT05051293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111111781|NCT03161041|Bevacizumab|bevacizumab|mesh-list
111111782|NCT03161041|Oxaliplatin|oxaliplatin|mesh-list
111111783|NCT03161041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111111784|NCT03161041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111111785|NCT03161041|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111111786|NCT03161041|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111111787|NCT03161041|Growth Substances|growth substances|mesh-ancestor
111111788|NCT03161041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111111789|NCT03161041|Growth Inhibitors|growth inhibitors|mesh-ancestor
111111790|NCT04139317|Pembrolizumab|pembrolizumab|mesh-list
111111791|NCT04139317|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111111792|NCT04139317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111111793|NCT04139317|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111111794|NCT04139317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111111795|NCT03163693|Dexmedetomidine|dexmedetomidine|mesh-list
111111796|NCT03163693|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111111797|NCT03163693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111111798|NCT03163693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111111799|NCT03163693|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111111800|NCT03163693|Analgesics|analgesics|mesh-ancestor
111111801|NCT03163693|Sensory System Agents|sensory system agents|mesh-ancestor
111111802|NCT03163693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111111803|NCT03163693|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111111804|NCT03163693|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111490108|NCT01645098|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111111805|NCT03163693|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111490109|NCT01645098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111111806|NCT03163693|Adrenergic Agents|adrenergic agents|mesh-ancestor
111111807|NCT03163693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111111808|NCT03163693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111111809|NCT05030545|Eplerenone|eplerenone|mesh-list
111111810|NCT05030545|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
111111811|NCT05030545|Mineralocorticoids|mineralocorticoids|mesh-list
111111812|NCT05030545|Hormone Antagonists|hormone antagonists|mesh-ancestor
111111813|NCT05030545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111111814|NCT05030545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111111815|NCT05030545|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
111111816|NCT05030545|Diuretics|diuretics|mesh-ancestor
111111817|NCT05030545|Natriuretic Agents|natriuretic agents|mesh-ancestor
111111818|NCT05030545|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111111819|NCT05030545|Hormones|hormones|mesh-ancestor
111111820|NCT03164161|Endorphins|endorphins|mesh-list
111111821|NCT03164161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111111822|NCT03164161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111111823|NCT03164161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111111824|NCT00754949|Azithromycin|azithromycin|mesh-list
111111825|NCT00754949|Dexamethasone|dexamethasone|mesh-list
111111826|NCT00754949|Dexamethasone acetate|dexamethasone acetate|mesh-list
111111827|NCT00754949|BB 1101|bb 1101|mesh-list
111111828|NCT00754949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111111829|NCT00754949|Antiemetics|antiemetics|mesh-ancestor
111111830|NCT00754949|Autonomic Agents|autonomic agents|mesh-ancestor
111111831|NCT00754949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111111832|NCT00754949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111111833|NCT00754949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111111834|NCT00754949|Glucocorticoids|glucocorticoids|mesh-ancestor
111111835|NCT00754949|Hormones|hormones|mesh-ancestor
110648455|NCT01009437|Ritonavir|ritonavir|mesh-list
111111836|NCT00754949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111111837|NCT00754949|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111111838|NCT00754949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111111839|NCT00754949|Protease Inhibitors|protease inhibitors|mesh-ancestor
111111840|NCT00754949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111111841|NCT00754949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111111842|NCT00754949|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111111843|NCT00754949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111111844|NCT03160807|Levofloxacin|levofloxacin|mesh-list
111111845|NCT03160807|Ofloxacin|ofloxacin|mesh-list
111111846|NCT03160807|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111111847|NCT03160807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111111848|NCT03160807|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110828959|NCT00004259|Carmustine|carmustine|mesh-list
111111849|NCT03160807|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111111850|NCT03160807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111111851|NCT03160807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111111852|NCT03160807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111111853|NCT03160807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111111854|NCT03160807|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111111855|NCT03160807|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111111856|NCT01674569|Ranibizumab|ranibizumab|mesh-list
111111857|NCT01674569|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111111858|NCT01674569|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111111859|NCT01674569|Growth Substances|growth substances|mesh-ancestor
111111860|NCT01674569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111111861|NCT01674569|Growth Inhibitors|growth inhibitors|mesh-ancestor
111111862|NCT01674569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111111863|NCT03160729|Dexamethasone|dexamethasone|mesh-list
111111864|NCT03160729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111111865|NCT03160729|Antiemetics|antiemetics|mesh-ancestor
111111866|NCT03160729|Autonomic Agents|autonomic agents|mesh-ancestor
111111867|NCT03160729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111111868|NCT03160729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111111869|NCT03160729|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111111870|NCT03160729|Glucocorticoids|glucocorticoids|mesh-ancestor
111111871|NCT03160729|Hormones|hormones|mesh-ancestor
111111872|NCT03160729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111111873|NCT03160729|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111111874|NCT03160729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111111875|NCT04439929|Adalimumab|adalimumab|mesh-list
111111876|NCT04439929|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111111877|NCT04439929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111111878|NCT04439929|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111490110|NCT01645098|Adrenergic Agents|adrenergic agents|mesh-ancestor
111111879|NCT05131841|Vinorelbine|vinorelbine|mesh-list
111111880|NCT05131841|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111111881|NCT05131841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111111882|NCT05131841|Tubulin Modulators|tubulin modulators|mesh-ancestor
111111883|NCT05131841|Antimitotic Agents|antimitotic agents|mesh-ancestor
111111884|NCT05131841|Mitosis Modulators|mitosis modulators|mesh-ancestor
111111885|NCT05131841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111111886|NCT03163849|Sofosbuvir|sofosbuvir|mesh-list
111111887|NCT03163849|Antiviral Agents|antiviral agents|mesh-ancestor
111111888|NCT03163849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111111889|NCT03163381|Apatinib|apatinib|mesh-list
111111890|NCT03163381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111111891|NCT03163381|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111111892|NCT03163381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110648461|NCT01009437|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111111893|NCT03163381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111111894|NCT05131295|Dapsone|dapsone|mesh-list
111111895|NCT05131295|Aluminum Hydroxide|aluminum hydroxide|mesh-list
111111896|NCT05131295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111111897|NCT05131295|Antimalarials|antimalarials|mesh-ancestor
111111898|NCT05131295|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111111899|NCT05131295|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111111900|NCT05131295|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111111901|NCT05131295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111111902|NCT05131295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111111903|NCT05131295|Leprostatic Agents|leprostatic agents|mesh-ancestor
111111904|NCT05131295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111111905|NCT05131295|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111111906|NCT05131295|Immunologic Factors|immunologic factors|mesh-ancestor
111111907|NCT05131295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111111908|NCT05131295|Antacids|antacids|mesh-ancestor
111111909|NCT05131295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111111910|NCT01374217|Clarithromycin|clarithromycin|mesh-list
111111911|NCT01374217|Dexamethasone|dexamethasone|mesh-list
111111912|NCT01374217|Lenalidomide|lenalidomide|mesh-list
111111913|NCT01374217|Tadalafil|tadalafil|mesh-list
111111914|NCT01374217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111111915|NCT01374217|Antiemetics|antiemetics|mesh-ancestor
111111916|NCT01374217|Autonomic Agents|autonomic agents|mesh-ancestor
111111917|NCT01374217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111111918|NCT01374217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111111919|NCT01374217|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111111920|NCT01374217|Glucocorticoids|glucocorticoids|mesh-ancestor
111111921|NCT01374217|Hormones|hormones|mesh-ancestor
111111922|NCT01374217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111111923|NCT01374217|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111111924|NCT01374217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111111925|NCT01374217|Immunologic Factors|immunologic factors|mesh-ancestor
111111926|NCT01374217|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111111927|NCT01374217|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111111928|NCT01374217|Growth Substances|growth substances|mesh-ancestor
111111929|NCT01374217|Growth Inhibitors|growth inhibitors|mesh-ancestor
111111930|NCT01374217|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111111931|NCT01374217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111111932|NCT01374217|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111111933|NCT01374217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111111934|NCT01374217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111111935|NCT01374217|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111111936|NCT01374217|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111111937|NCT01374217|Vasodilator Agents|vasodilator agents|mesh-ancestor
111111938|NCT01374217|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111111939|NCT01374217|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111111940|NCT01374217|Urological Agents|urological agents|mesh-ancestor
111111941|NCT04941937|Thalidomide|thalidomide|mesh-list
111111942|NCT04941937|Dexamethasone|dexamethasone|mesh-list
111111943|NCT04941937|Lenalidomide|lenalidomide|mesh-list
111111944|NCT04941937|Pomalidomide|pomalidomide|mesh-list
111111945|NCT04941937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111111946|NCT04941937|Antiemetics|antiemetics|mesh-ancestor
111111947|NCT04941937|Autonomic Agents|autonomic agents|mesh-ancestor
111111948|NCT04941937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111111949|NCT04941937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111111950|NCT04941937|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111111951|NCT04941937|Glucocorticoids|glucocorticoids|mesh-ancestor
111111952|NCT04941937|Hormones|hormones|mesh-ancestor
111111953|NCT04941937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111119175|NCT05289687|Immunologic Factors|immunologic factors|mesh-ancestor
111111954|NCT04941937|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111111955|NCT04941937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111490111|NCT01645098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111490112|NCT01645098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111490113|NCT01645098|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111111956|NCT04941937|Immunologic Factors|immunologic factors|mesh-ancestor
111111957|NCT04941937|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111111958|NCT04941937|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111111959|NCT04941937|Growth Substances|growth substances|mesh-ancestor
111111960|NCT04941937|Growth Inhibitors|growth inhibitors|mesh-ancestor
111111961|NCT04941937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111111962|NCT04941937|Leprostatic Agents|leprostatic agents|mesh-ancestor
111111963|NCT04941937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111111964|NCT04941937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111111966|NCT05124431|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111111967|NCT05124431|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111111968|NCT05124431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111111969|NCT05124431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111111970|NCT05124431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111111971|NCT05124431|Immunologic Factors|immunologic factors|mesh-ancestor
111111972|NCT05124431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111111973|NCT05124431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111111974|NCT04877275|Dexamethasone|dexamethasone|mesh-list
111111975|NCT04877275|Cyclophosphamide|cyclophosphamide|mesh-list
111111976|NCT04877275|Doxorubicin|doxorubicin|mesh-list
111111977|NCT04877275|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111111978|NCT04877275|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111111979|NCT04877275|Immunologic Factors|immunologic factors|mesh-ancestor
111111980|NCT04877275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111111981|NCT04877275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111111982|NCT04877275|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111111983|NCT04877275|Alkylating Agents|alkylating agents|mesh-ancestor
111111984|NCT04877275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111111985|NCT04877275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111111986|NCT04877275|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111111987|NCT04877275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111111988|NCT04877275|Antiemetics|antiemetics|mesh-ancestor
111111989|NCT04877275|Autonomic Agents|autonomic agents|mesh-ancestor
111111990|NCT04877275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111111991|NCT04877275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111111992|NCT04877275|Glucocorticoids|glucocorticoids|mesh-ancestor
111111993|NCT04877275|Hormones|hormones|mesh-ancestor
111111994|NCT04877275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111111995|NCT04877275|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111111996|NCT04877275|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111111997|NCT04877275|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111111998|NCT04877275|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111111999|NCT04877275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111112000|NCT04955249|Dexmedetomidine|dexmedetomidine|mesh-list
111112001|NCT04955249|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111112002|NCT04955249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111112003|NCT04955249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111112004|NCT04955249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111112005|NCT04955249|Analgesics|analgesics|mesh-ancestor
111112006|NCT04955249|Sensory System Agents|sensory system agents|mesh-ancestor
111112007|NCT04955249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111112008|NCT04955249|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111112009|NCT04955249|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111112010|NCT04955249|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111112011|NCT04955249|Adrenergic Agents|adrenergic agents|mesh-ancestor
111112012|NCT04955249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111112013|NCT04955249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111112014|NCT05676463|Ascorbic Acid|ascorbic acid|mesh-list
111112015|NCT05676463|Methyltestosterone|methyltestosterone|mesh-list
111112016|NCT05676463|Hormones|hormones|mesh-list
111112017|NCT05676463|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
111112018|NCT05676463|Androgens|androgens|mesh-list
111112019|NCT05676463|Androgen Antagonists|androgen antagonists|mesh-list
111112020|NCT05676463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111490114|NCT01645098|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111490115|NCT01645098|Anesthetics, General|anesthetics, general|mesh-ancestor
111490116|NCT01645098|Anesthetics|anesthetics|mesh-ancestor
111112021|NCT05676463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111490117|NCT01645098|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110648483|NCT00952302|Trace Elements|trace elements|mesh-ancestor
111112023|NCT05676463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111112024|NCT05676463|Protective Agents|protective agents|mesh-ancestor
111112025|NCT05676463|Vitamins|vitamins|mesh-ancestor
111112026|NCT05676463|Micronutrients|micronutrients|mesh-ancestor
111112027|NCT05676463|Estrogens|estrogens|mesh-ancestor
111112028|NCT05676463|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111112029|NCT05676463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111112030|NCT05676463|Anabolic Agents|anabolic agents|mesh-ancestor
111112031|NCT05676463|Hormone Antagonists|hormone antagonists|mesh-ancestor
111112032|NCT03114085|Capecitabine|capecitabine|mesh-list
111112033|NCT03114085|Apatinib|apatinib|mesh-list
111112034|NCT03114085|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111112035|NCT03114085|Antimetabolites|antimetabolites|mesh-ancestor
111112036|NCT03114085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111112037|NCT03114085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111112038|NCT03114085|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111112039|NCT03114085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111112040|NCT04886453|Morphine|morphine|mesh-list
111112041|NCT04886453|Anesthetics|anesthetics|mesh-list
111112042|NCT04886453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111112043|NCT04886453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111112044|NCT04886453|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111112045|NCT04886453|Narcotics|narcotics|mesh-ancestor
111112046|NCT04886453|Analgesics|analgesics|mesh-ancestor
111112047|NCT04886453|Sensory System Agents|sensory system agents|mesh-ancestor
111112048|NCT04886453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111112049|NCT05136521|Trazodone|trazodone|mesh-list
111112050|NCT05136521|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111112051|NCT05136521|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111112052|NCT05136521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111112053|NCT05136521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111112054|NCT05136521|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111112055|NCT05136521|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111112056|NCT05136521|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111112057|NCT05136521|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111112058|NCT05136521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111112059|NCT05136521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111112060|NCT05136521|Serotonin Agents|serotonin agents|mesh-ancestor
111112061|NCT05136521|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111112062|NCT05136521|Antidepressive Agents|antidepressive agents|mesh-ancestor
111112063|NCT05343013|Trifluridine|trifluridine|mesh-list
111112064|NCT05343013|Antimetabolites|antimetabolites|mesh-ancestor
111112065|NCT05343013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111112066|NCT05343013|Antiviral Agents|antiviral agents|mesh-ancestor
111112067|NCT05343013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111112068|NCT02388373|Fluticasone|fluticasone|mesh-list
111112069|NCT02388373|Xhance|xhance|mesh-list
111112070|NCT02388373|Formoterol Fumarate|formoterol fumarate|mesh-list
111112071|NCT02388373|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
111112072|NCT02388373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111112073|NCT02388373|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111112074|NCT02388373|Autonomic Agents|autonomic agents|mesh-ancestor
111112075|NCT02388373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111112076|NCT02388373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111112077|NCT02388373|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111112078|NCT02388373|Respiratory System Agents|respiratory system agents|mesh-ancestor
111112079|NCT02388373|Dermatologic Agents|dermatologic agents|mesh-ancestor
111112080|NCT02388373|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111112081|NCT02388373|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111112082|NCT02388373|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111112083|NCT02388373|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111112084|NCT02388373|Adrenergic Agents|adrenergic agents|mesh-ancestor
111112085|NCT02388373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111112086|NCT02388373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111112087|NCT01674647|Vitamin K|vitamin k|mesh-list
111112088|NCT01674647|Rivaroxaban|rivaroxaban|mesh-list
111112089|NCT01674647|Vitamins|vitamins|mesh-ancestor
111112090|NCT01674647|Micronutrients|micronutrients|mesh-ancestor
110648488|NCT00518973|Antidepressive Agents|antidepressive agents|mesh-ancestor
111112091|NCT01674647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111112092|NCT01674647|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111112093|NCT01674647|Antithrombins|antithrombins|mesh-ancestor
111112094|NCT01674647|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111112095|NCT01674647|Protease Inhibitors|protease inhibitors|mesh-ancestor
111112096|NCT01674647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111490118|NCT01645098|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111490119|NCT01650402|Antihypertensive Agents|antihypertensive agents|mesh-list
111490120|NCT01651806|Tranexamic Acid|tranexamic acid|mesh-list
111112097|NCT01674647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111112098|NCT01674647|Anticoagulants|anticoagulants|mesh-ancestor
111112099|NCT01674647|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111112100|NCT01674647|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111112101|NCT01674647|Hemostatics|hemostatics|mesh-ancestor
111112102|NCT01674647|Coagulants|coagulants|mesh-ancestor
111112103|NCT02669407|Lidocaine|lidocaine|mesh-list
111112104|NCT02669407|Anesthetics, Local|anesthetics, local|mesh-list
111112105|NCT02669407|Anesthetics|anesthetics|mesh-list
111112106|NCT02669407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111112107|NCT02669407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111112108|NCT02669407|Sensory System Agents|sensory system agents|mesh-ancestor
111112109|NCT02669407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111112110|NCT02669407|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111112111|NCT02669407|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111112112|NCT02669407|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111112113|NCT02669407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111112114|NCT02669407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111112115|NCT04637555|Valsartan|valsartan|mesh-list
111112116|NCT04637555|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
111112117|NCT04637555|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111112118|NCT04637555|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111112119|NCT04637555|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111112120|NCT04637555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111112121|NCT02388061|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
111112122|NCT02388061|Plasminogen|plasminogen|mesh-list
111112123|NCT02388061|Tenecteplase|tenecteplase|mesh-list
111112124|NCT02388061|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111112125|NCT02388061|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111112126|NCT02388061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111112127|NCT04556357|Phenylephrine|phenylephrine|mesh-list
111112128|NCT04556357|Oxymetazoline|oxymetazoline|mesh-list
111112129|NCT04556357|Norepinephrine|norepinephrine|mesh-list
111112130|NCT04556357|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
111112131|NCT04556357|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111112132|NCT04556357|Mydriatics|mydriatics|mesh-ancestor
111112133|NCT04556357|Autonomic Agents|autonomic agents|mesh-ancestor
111112134|NCT04556357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111112135|NCT04556357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111112136|NCT04556357|Sympathomimetics|sympathomimetics|mesh-ancestor
111112137|NCT04556357|Nasal Decongestants|nasal decongestants|mesh-ancestor
111112138|NCT04556357|Respiratory System Agents|respiratory system agents|mesh-ancestor
111112139|NCT04556357|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111112140|NCT04556357|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111112141|NCT04556357|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111112142|NCT04556357|Adrenergic Agents|adrenergic agents|mesh-ancestor
111112143|NCT04556357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111112144|NCT04556357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111112145|NCT04556357|Protective Agents|protective agents|mesh-ancestor
111112146|NCT04553939|Gemcitabine|gemcitabine|mesh-list
111112147|NCT04553939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111112148|NCT04553939|Antimetabolites|antimetabolites|mesh-ancestor
111112149|NCT04553939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111112150|NCT04553939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111112151|NCT03113773|Aldesleukin|aldesleukin|mesh-list
111112152|NCT03113773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111112153|NCT03113773|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111112154|NCT03113773|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111112155|NCT03113773|Antiviral Agents|antiviral agents|mesh-ancestor
111112156|NCT03113773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111112157|NCT05306041|Inavolisib|inavolisib|mesh-list
110648496|NCT05300334|Sensory System Agents|sensory system agents|mesh-ancestor
111112158|NCT05306041|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
111112159|NCT05306041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111112160|NCT05306041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111112161|NCT04874831|Avelumab|avelumab|mesh-list
111112162|NCT04874831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111112163|NCT04874831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111112164|NCT05122169|Iodine|iodine|mesh-list
111112165|NCT05122169|Chlorhexidine|chlorhexidine|mesh-list
111112166|NCT05122169|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
111112167|NCT05122169|Povidone-Iodine|povidone-iodine|mesh-list
111112168|NCT05122169|Povidone|povidone|mesh-list
111112169|NCT05122169|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111112170|NCT05122169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111112171|NCT05122169|Disinfectants|disinfectants|mesh-ancestor
111112172|NCT05122169|Dermatologic Agents|dermatologic agents|mesh-ancestor
111112173|NCT05122169|Trace Elements|trace elements|mesh-ancestor
111112174|NCT05122169|Micronutrients|micronutrients|mesh-ancestor
111112175|NCT05122169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111112176|NCT05122169|Plasma Substitutes|plasma substitutes|mesh-ancestor
111112177|NCT05122169|Blood Substitutes|blood substitutes|mesh-ancestor
111112178|NCT04359329|Estradiol|estradiol|mesh-list
111112179|NCT04359329|Estrogens|estrogens|mesh-ancestor
111112180|NCT04359329|Hormones|hormones|mesh-ancestor
111112181|NCT04359329|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111112182|NCT04359329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111112183|NCT05403749|Aflibercept|aflibercept|mesh-list
111112184|NCT05403749|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111112185|NCT05403749|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111112186|NCT05403749|Growth Substances|growth substances|mesh-ancestor
111112187|NCT05403749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111112188|NCT05403749|Growth Inhibitors|growth inhibitors|mesh-ancestor
111112189|NCT05403749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111112190|NCT04203875|Abatacept|abatacept|mesh-list
111112191|NCT04203875|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111112192|NCT04203875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111112193|NCT04203875|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111112194|NCT04203875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111112195|NCT04203875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111112196|NCT04203875|Immunologic Factors|immunologic factors|mesh-ancestor
111112197|NCT04203875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111112198|NCT04203875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111112199|NCT04491383|Tocovid|tocovid|mesh-list
111112200|NCT04491383|Vitamins|vitamins|mesh-ancestor
111112201|NCT04491383|Micronutrients|micronutrients|mesh-ancestor
111112202|NCT04491383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111112203|NCT05900674|Reteplase|reteplase|mesh-list
111112204|NCT05900674|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111112205|NCT05900674|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111112206|NCT05900674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111112207|NCT05900661|Inositol|inositol|mesh-list
111112208|NCT05900661|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
111112209|NCT05900661|Vitamin B Complex|vitamin b complex|mesh-ancestor
111112210|NCT05900661|Vitamins|vitamins|mesh-ancestor
111112211|NCT05900661|Micronutrients|micronutrients|mesh-ancestor
111112212|NCT05900661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111112213|NCT05900661|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111112214|NCT05900661|Immunologic Factors|immunologic factors|mesh-ancestor
111112215|NCT05900635|Lactoferrin|lactoferrin|mesh-list
111112216|NCT05900635|Glycine|glycine|mesh-list
111112217|NCT05900635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111112218|NCT05900635|Glycine Agents|glycine agents|mesh-ancestor
111112219|NCT05900635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111112220|NCT05900635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111112221|NCT05900635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111112222|NCT05900531|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111112223|NCT05900531|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111112224|NCT05900531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111112225|NCT05900531|Incretins|incretins|mesh-ancestor
111112226|NCT05900531|Hormones|hormones|mesh-ancestor
111112227|NCT05900531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110337131|NCT00514410|Hematinics|hematinics|mesh-ancestor
111112228|NCT05900531|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111112229|NCT05900531|Protease Inhibitors|protease inhibitors|mesh-ancestor
111112230|NCT05900531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111112231|NCT05900531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111112232|NCT05900401|Cyclophosphamide|cyclophosphamide|mesh-list
111112234|NCT05900401|Fludarabine|fludarabine|mesh-list
111112235|NCT05900401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111112236|NCT05900401|Immunologic Factors|immunologic factors|mesh-ancestor
111112237|NCT05900401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111112238|NCT05900401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111112239|NCT05900401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111490122|NCT01651806|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111112240|NCT05900401|Alkylating Agents|alkylating agents|mesh-ancestor
111112241|NCT05900401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111112242|NCT05900401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111112243|NCT05900401|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111112244|NCT05900401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111112245|NCT05900349|Caffeine|caffeine|mesh-list
111112246|NCT05900349|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111112247|NCT05900349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111112248|NCT05900349|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111112249|NCT05900349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111112250|NCT05900349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111112251|NCT05900349|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
111112252|NCT05900349|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111112253|NCT05900349|Purinergic Agents|purinergic agents|mesh-ancestor
111112254|NCT05900349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111112255|NCT05900336|Naproxen|naproxen|mesh-list
111112256|NCT05900336|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111112257|NCT05900336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111112258|NCT05900336|Analgesics|analgesics|mesh-ancestor
111112259|NCT05900336|Sensory System Agents|sensory system agents|mesh-ancestor
111112260|NCT05900336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111112261|NCT05900336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111112262|NCT05900336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111112263|NCT05900336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111112264|NCT05900336|Gout Suppressants|gout suppressants|mesh-ancestor
111112265|NCT05900336|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111112266|NCT05900336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111112267|NCT05900336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111112268|NCT05900258|Tirbanibulin|tirbanibulin|mesh-list
111112269|NCT05900258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111112270|NCT05900258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111112271|NCT05900245|Propofol|propofol|mesh-list
111112272|NCT05900245|Anesthetics|anesthetics|mesh-list
111112273|NCT05900245|Succinylcholine|succinylcholine|mesh-list
111112274|NCT05900245|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111112275|NCT05900245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111112276|NCT05900245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111112277|NCT05900245|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111112278|NCT05900245|Anesthetics, General|anesthetics, general|mesh-ancestor
111112279|NCT05900245|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
111112280|NCT05900245|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
111112281|NCT05900245|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111112282|NCT05900245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111112283|NCT05900232|Antibodies|antibodies|mesh-list
111112284|NCT05900232|Immunologic Factors|immunologic factors|mesh-ancestor
111112285|NCT05900232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111112286|NCT05900219|Vemurafenib|vemurafenib|mesh-list
111112287|NCT05900219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111112288|NCT05900219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111112289|NCT05900219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111112290|NCT05900219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111112291|NCT05900206|Paclitaxel|paclitaxel|mesh-list
111112292|NCT05900206|Docetaxel|docetaxel|mesh-list
111112293|NCT05900206|Cyclophosphamide|cyclophosphamide|mesh-list
111112294|NCT05900206|Carboplatin|carboplatin|mesh-list
111112295|NCT05900206|Trastuzumab|trastuzumab|mesh-list
111112296|NCT05900206|Letrozole|letrozole|mesh-list
111112297|NCT05900206|Epirubicin|epirubicin|mesh-list
111112298|NCT05900206|Pertuzumab|pertuzumab|mesh-list
111112299|NCT05900206|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
111112300|NCT05900206|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111112301|NCT05900206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111112302|NCT05900206|Tubulin Modulators|tubulin modulators|mesh-ancestor
111112303|NCT05900206|Antimitotic Agents|antimitotic agents|mesh-ancestor
111112304|NCT05900206|Mitosis Modulators|mitosis modulators|mesh-ancestor
111112305|NCT05900206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111112306|NCT05900206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111112307|NCT05900206|Immunologic Factors|immunologic factors|mesh-ancestor
111112308|NCT05900206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111112309|NCT05900206|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111112310|NCT05900206|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111112311|NCT05900206|Alkylating Agents|alkylating agents|mesh-ancestor
111112312|NCT05900206|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111112313|NCT05900206|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111490123|NCT01651806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111490124|NCT01651806|Hemostatics|hemostatics|mesh-ancestor
111112314|NCT05900206|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111112315|NCT05900206|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111490125|NCT01651806|Coagulants|coagulants|mesh-ancestor
111112316|NCT05900206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111112317|NCT05900206|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111112318|NCT05900206|Hormone Antagonists|hormone antagonists|mesh-ancestor
111112319|NCT05900206|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111112320|NCT05900206|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111112321|NCT05900206|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111112322|NCT05900206|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111112323|NCT05900206|Immunoconjugates|immunoconjugates|mesh-ancestor
111112324|NCT05899829|Rifampin|rifampin|mesh-list
111112325|NCT05899829|Rabeprazole|rabeprazole|mesh-list
111112326|NCT05899829|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111112327|NCT05899829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111112328|NCT05899829|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111112329|NCT05899829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111112330|NCT05899829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111112331|NCT05899829|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111112332|NCT05899829|Antitubercular Agents|antitubercular agents|mesh-ancestor
111112333|NCT05899829|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111112334|NCT05899829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111112335|NCT05899829|Leprostatic Agents|leprostatic agents|mesh-ancestor
111112336|NCT05899829|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111112337|NCT05899829|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111112338|NCT05899829|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111112339|NCT05899829|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
111112340|NCT05899829|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
111112341|NCT05899829|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
111112342|NCT05899829|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111112343|NCT05899764|Brivaracetam|brivaracetam|mesh-list
111112344|NCT05899764|Anticonvulsants|anticonvulsants|mesh-ancestor
111112345|NCT05899751|Methotrexate|methotrexate|mesh-list
111112346|NCT05899751|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111112347|NCT05899751|Abortifacient Agents|abortifacient agents|mesh-ancestor
111112348|NCT05899751|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111112349|NCT05899751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111112350|NCT05899751|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111112351|NCT05899751|Antimetabolites|antimetabolites|mesh-ancestor
111112352|NCT05899751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111112353|NCT05899751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111112354|NCT05899751|Dermatologic Agents|dermatologic agents|mesh-ancestor
111112355|NCT05899751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111112356|NCT05899751|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111112357|NCT05899751|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111112358|NCT05899751|Immunologic Factors|immunologic factors|mesh-ancestor
111112359|NCT05899751|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111112360|NCT05899751|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111112361|NCT05899621|Prednisone|prednisone|mesh-list
111112362|NCT05899621|Cyclophosphamide|cyclophosphamide|mesh-list
111112363|NCT05899621|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
111112364|NCT05899621|Doxorubicin|doxorubicin|mesh-list
111112365|NCT05899621|Vincristine|vincristine|mesh-list
111112366|NCT05899621|Lenalidomide|lenalidomide|mesh-list
111112367|NCT05899621|Obinutuzumab|obinutuzumab|mesh-list
111112368|NCT05899621|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111112369|NCT05899621|Immunologic Factors|immunologic factors|mesh-ancestor
111112370|NCT05899621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111112371|NCT05899621|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111112372|NCT05899621|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111112373|NCT05899621|Alkylating Agents|alkylating agents|mesh-ancestor
111112374|NCT05899621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111112375|NCT05899621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111112376|NCT05899621|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111112377|NCT05899621|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111112378|NCT05899621|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111112379|NCT05899621|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111112380|NCT05899621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111112381|NCT05899621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111112382|NCT05899621|Glucocorticoids|glucocorticoids|mesh-ancestor
111112383|NCT05899621|Hormones|hormones|mesh-ancestor
111112384|NCT05899621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111112385|NCT05899621|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111112386|NCT05899621|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111112387|NCT05899621|Tubulin Modulators|tubulin modulators|mesh-ancestor
111112388|NCT05899621|Antimitotic Agents|antimitotic agents|mesh-ancestor
111490126|NCT01652040|Methyltestosterone|methyltestosterone|mesh-list
111490127|NCT01652040|Testosterone|testosterone|mesh-list
111490128|NCT01652040|Testosterone undecanoate|testosterone undecanoate|mesh-list
111112389|NCT05899621|Mitosis Modulators|mitosis modulators|mesh-ancestor
111112390|NCT05899621|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111112391|NCT05899621|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111112392|NCT05899621|Growth Substances|growth substances|mesh-ancestor
111112393|NCT05899621|Growth Inhibitors|growth inhibitors|mesh-ancestor
111112394|NCT05899621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111112395|NCT05899517|Oxytocin|oxytocin|mesh-list
111112396|NCT05899517|Oxytocics|oxytocics|mesh-ancestor
111112397|NCT05899517|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111112398|NCT05899517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111112399|NCT05899465|Tranexamic Acid|tranexamic acid|mesh-list
111112400|NCT05899465|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111112401|NCT05899465|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111112402|NCT05899465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111112403|NCT05899465|Hemostatics|hemostatics|mesh-ancestor
111112404|NCT05899465|Coagulants|coagulants|mesh-ancestor
111112405|NCT05899127|Lidocaine|lidocaine|mesh-list
111112406|NCT05899127|Sufentanil|sufentanil|mesh-list
111112407|NCT05899127|Remifentanil|remifentanil|mesh-list
111112408|NCT05899127|Dsuvia|dsuvia|mesh-list
111112409|NCT05899127|Propofol|propofol|mesh-list
111112410|NCT05899127|Etomidate|etomidate|mesh-list
111112411|NCT05899127|Rocuronium|rocuronium|mesh-list
111112412|NCT05899127|Anesthetics, Local|anesthetics, local|mesh-ancestor
111112413|NCT05899127|Anesthetics|anesthetics|mesh-ancestor
111112414|NCT05899127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111112415|NCT05899127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111112416|NCT05899127|Sensory System Agents|sensory system agents|mesh-ancestor
111112417|NCT05899127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111112418|NCT05899127|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111112419|NCT05899127|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111112420|NCT05899127|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111112421|NCT05899127|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111112422|NCT05899127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111112423|NCT05899127|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111112424|NCT05899127|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111112425|NCT05899127|Anesthetics, General|anesthetics, general|mesh-ancestor
111112426|NCT05899127|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111112427|NCT05899127|Narcotics|narcotics|mesh-ancestor
111112428|NCT05899127|Analgesics|analgesics|mesh-ancestor
111112429|NCT05899127|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
111112430|NCT05899127|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
111112431|NCT05899127|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111112432|NCT05899127|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111112433|NCT05899049|Pembrolizumab|pembrolizumab|mesh-list
111112434|NCT05899049|Lenvatinib|lenvatinib|mesh-list
111112435|NCT05899049|Belzutifan|belzutifan|mesh-list
111112436|NCT05899049|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111112437|NCT05899049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111112438|NCT05899049|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111112439|NCT05899049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111112440|NCT05899049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111112441|NCT05899049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111112442|NCT05898984|Beclomethasone|beclomethasone|mesh-list
111112443|NCT05898984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111112444|NCT05898984|Glucocorticoids|glucocorticoids|mesh-ancestor
111112445|NCT05898984|Hormones|hormones|mesh-ancestor
111112446|NCT05898984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111112447|NCT05898984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111112448|NCT05898984|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111112449|NCT05898984|Respiratory System Agents|respiratory system agents|mesh-ancestor
110829557|NCT03363906|Immunologic Factors|immunologic factors|mesh-ancestor
111112450|NCT05898633|Pulmonary Surfactants|pulmonary surfactants|mesh-list
111112451|NCT05898633|Pulmonary Surfactant-Associated Protein D|pulmonary surfactant-associated protein d|mesh-list
111112452|NCT05898633|Respiratory System Agents|respiratory system agents|mesh-ancestor
111112453|NCT05898451|Cisplatin|cisplatin|mesh-list
111490129|NCT01652040|Testosterone enanthate|testosterone enanthate|mesh-list
111490130|NCT01652040|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
111112454|NCT05898451|Dacarbazine|dacarbazine|mesh-list
111112455|NCT05898451|Lomustine|lomustine|mesh-list
111112456|NCT05898451|Thymalfasin|thymalfasin|mesh-list
111112457|NCT05898451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111112458|NCT05898451|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111112459|NCT05898451|Alkylating Agents|alkylating agents|mesh-ancestor
111490131|NCT01652040|Androgens|androgens|mesh-ancestor
111490132|NCT01652040|Hormones|hormones|mesh-ancestor
111490133|NCT01652040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111112460|NCT05898451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111112461|NCT05898451|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111112462|NCT05898451|Immunologic Factors|immunologic factors|mesh-ancestor
111112463|NCT05898451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111112464|NCT05898373|Antineoplastic Agents|antineoplastic agents|mesh-list
111112465|NCT05898321|Goserelin|goserelin|mesh-list
111112466|NCT05898321|Mifepristone|mifepristone|mesh-list
111112467|NCT05898321|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
111112468|NCT05898321|Abortifacient Agents|abortifacient agents|mesh-ancestor
111112469|NCT05898321|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111112470|NCT05898321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111112471|NCT05898321|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111112472|NCT05898321|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111112473|NCT05898321|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111112474|NCT05898321|Contraceptive Agents|contraceptive agents|mesh-ancestor
111112475|NCT05898321|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
111112476|NCT05898321|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
111112477|NCT05898321|Hormone Antagonists|hormone antagonists|mesh-ancestor
111112478|NCT05898321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111112479|NCT05898321|Luteolytic Agents|luteolytic agents|mesh-ancestor
111112480|NCT05898321|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111112481|NCT05898321|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
111112482|NCT05898321|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111112483|NCT05898321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111112484|NCT05898308|Rituximab|rituximab|mesh-list
111112485|NCT05898308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111112486|NCT05898308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111112487|NCT05898308|Immunologic Factors|immunologic factors|mesh-ancestor
111112488|NCT05898308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111112489|NCT05898308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111112490|NCT05898256|Gemcitabine|gemcitabine|mesh-list
111112491|NCT05898256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111112492|NCT05898256|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111112493|NCT05898256|Antimetabolites|antimetabolites|mesh-ancestor
111112494|NCT05898256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111112495|NCT05898087|Bupivacaine|bupivacaine|mesh-list
111112496|NCT05898087|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111112497|NCT05898087|Anesthetics, Local|anesthetics, local|mesh-ancestor
111112498|NCT05898087|Anesthetics|anesthetics|mesh-ancestor
111112499|NCT05898087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111112500|NCT05898087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111112501|NCT05898087|Sensory System Agents|sensory system agents|mesh-ancestor
111112502|NCT05898087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111112503|NCT05897918|Tranexamic Acid|tranexamic acid|mesh-list
111112504|NCT05897918|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111112505|NCT05897918|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111112506|NCT05897918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111112507|NCT05897918|Hemostatics|hemostatics|mesh-ancestor
111112508|NCT05897918|Coagulants|coagulants|mesh-ancestor
111112509|NCT05897034|Doxycycline|doxycycline|mesh-list
111112510|NCT05897034|Nitazoxanide|nitazoxanide|mesh-list
111112511|NCT05897034|Pentoxifylline|pentoxifylline|mesh-list
111112512|NCT05897034|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111112513|NCT05897034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111112514|NCT05897034|Antimalarials|antimalarials|mesh-ancestor
111112515|NCT05897034|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111112516|NCT05897034|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111112517|NCT05897034|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111112518|NCT05897034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111112519|NCT05897034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111112520|NCT05897034|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110648545|NCT00719459|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
111112521|NCT05897034|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111112522|NCT05897034|Protective Agents|protective agents|mesh-ancestor
111112523|NCT05897034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111112524|NCT05897034|Vasodilator Agents|vasodilator agents|mesh-ancestor
111112525|NCT05897034|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111112526|NCT05897034|Antioxidants|antioxidants|mesh-ancestor
111112527|NCT05897008|Omalizumab|omalizumab|mesh-list
111112528|NCT05897008|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111112529|NCT05897008|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111112530|NCT05897008|Respiratory System Agents|respiratory system agents|mesh-ancestor
111112531|NCT05892939|Oxytocin|oxytocin|mesh-list
111112532|NCT05892939|Oxytocics|oxytocics|mesh-ancestor
111112533|NCT05892939|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111112534|NCT05892939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111112536|NCT05890534|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111112537|NCT05890534|Immunologic Factors|immunologic factors|mesh-ancestor
111112538|NCT05890534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111112539|NCT05890534|Antioxidants|antioxidants|mesh-ancestor
111112540|NCT05890534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111112541|NCT05890534|Protective Agents|protective agents|mesh-ancestor
111112542|NCT05890534|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111112543|NCT05886049|Cytarabine|cytarabine|mesh-list
111112544|NCT05886049|Daunorubicin|daunorubicin|mesh-list
111112545|NCT05886049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111112546|NCT05886049|Antimetabolites|antimetabolites|mesh-ancestor
111112547|NCT05886049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111112548|NCT05886049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111112549|NCT05886049|Antiviral Agents|antiviral agents|mesh-ancestor
111112550|NCT05886049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111112551|NCT05886049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111112552|NCT05886049|Immunologic Factors|immunologic factors|mesh-ancestor
111112553|NCT05886049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111112554|NCT05886049|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111112555|NCT05886049|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111112556|NCT05886049|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111112557|NCT05886049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111112558|NCT05861765|Papaverine|papaverine|mesh-list
111112559|NCT05861765|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111112560|NCT05861765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111112561|NCT05861765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111112562|NCT05861765|Vasodilator Agents|vasodilator agents|mesh-ancestor
111112563|NCT05861765|Urological Agents|urological agents|mesh-ancestor
111112564|NCT05849207|Cyclophosphamide|cyclophosphamide|mesh-list
111112565|NCT05849207|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111112566|NCT05849207|Immunologic Factors|immunologic factors|mesh-ancestor
111112567|NCT05849207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111112568|NCT05849207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111112569|NCT05849207|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111112570|NCT05849207|Alkylating Agents|alkylating agents|mesh-ancestor
111112571|NCT05849207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111112572|NCT05849207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111112573|NCT05849207|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111112574|NCT05818618|Clobetasol|clobetasol|mesh-list
111112575|NCT05818618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111112576|NCT05818618|Glucocorticoids|glucocorticoids|mesh-ancestor
111112577|NCT05818618|Hormones|hormones|mesh-ancestor
111112578|NCT05818618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111112579|NCT05818618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111112580|NCT05809921|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
111112581|NCT05809921|Tenecteplase|tenecteplase|mesh-list
111112582|NCT05809921|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111112583|NCT05809921|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111112584|NCT05809921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111112585|NCT05804513|Lixisenatide|lixisenatide|mesh-list
111112586|NCT05804513|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111112587|NCT05804513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111112588|NCT05783219|Lidocaine|lidocaine|mesh-list
111112589|NCT05783219|Anesthetics, Local|anesthetics, local|mesh-ancestor
111112590|NCT05783219|Anesthetics|anesthetics|mesh-ancestor
111112591|NCT05783219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111112592|NCT05783219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111112593|NCT05783219|Sensory System Agents|sensory system agents|mesh-ancestor
111112594|NCT05783219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111112595|NCT05783219|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111112596|NCT05783219|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111112597|NCT05783219|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111112598|NCT05783219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111112599|NCT05783219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111112600|NCT05747352|Insulin|insulin|mesh-list
111112601|NCT05747352|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111112602|NCT05747352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111112603|NCT05733507|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
111112604|NCT05733507|Tenecteplase|tenecteplase|mesh-list
111112605|NCT05733507|Tirofiban|tirofiban|mesh-list
110418402|NCT01101165|Oxycodone|oxycodone|mesh-list
111490134|NCT01652040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111112606|NCT05733507|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111112607|NCT05733507|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111112608|NCT05733507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111112609|NCT05733507|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111112610|NCT05709444|Angiotensin II|angiotensin ii|mesh-list
111112611|NCT05709444|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
111112612|NCT05709444|alpha-MSH|alpha-msh|mesh-list
111112613|NCT05709444|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
111112614|NCT05709444|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111112615|NCT05709444|Protease Inhibitors|protease inhibitors|mesh-ancestor
111112616|NCT05709444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111112617|NCT05709444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111112618|NCT05709444|Hormones|hormones|mesh-ancestor
111112619|NCT05709444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111112620|NCT05709444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111112621|NCT05704036|Estradiol|estradiol|mesh-list
111112622|NCT05704036|Estrogens|estrogens|mesh-list
111112623|NCT05704036|Progesterone|progesterone|mesh-list
111112624|NCT05704036|Hormones|hormones|mesh-ancestor
111112625|NCT05704036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111112626|NCT05704036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111112627|NCT05704036|Progestins|progestins|mesh-ancestor
111112628|NCT05583110|Trastuzumab|trastuzumab|mesh-list
111112629|NCT05583110|Vinorelbine|vinorelbine|mesh-list
111112630|NCT05583110|Tucatinib|tucatinib|mesh-list
111112631|NCT05583110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111112632|NCT05583110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111112633|NCT05583110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111112634|NCT05583110|Tubulin Modulators|tubulin modulators|mesh-ancestor
111112635|NCT05583110|Antimitotic Agents|antimitotic agents|mesh-ancestor
111112636|NCT05583110|Mitosis Modulators|mitosis modulators|mesh-ancestor
111112637|NCT05583110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111112638|NCT05583110|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111112639|NCT05583110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111112640|NCT05565937|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111112641|NCT05537935|Naltrexone|naltrexone|mesh-list
111112642|NCT05537935|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111112643|NCT05537935|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111112644|NCT05537935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111112645|NCT05537935|Sensory System Agents|sensory system agents|mesh-ancestor
111112646|NCT05537935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111112647|NCT05455697|Prednisone|prednisone|mesh-list
111112648|NCT05455697|Cyclophosphamide|cyclophosphamide|mesh-list
111112649|NCT05455697|Rituximab|rituximab|mesh-list
111112650|NCT05455697|Doxorubicin|doxorubicin|mesh-list
111112651|NCT05455697|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111112652|NCT05455697|Vincristine|vincristine|mesh-list
111112653|NCT05455697|Daunorubicin|daunorubicin|mesh-list
111112654|NCT05455697|Immunoglobulins|immunoglobulins|mesh-list
111112655|NCT05455697|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
111112656|NCT05455697|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111112657|NCT05455697|Immunologic Factors|immunologic factors|mesh-ancestor
110648577|NCT00719693|Antimetabolites|antimetabolites|mesh-ancestor
111112658|NCT05455697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111112659|NCT05455697|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111112660|NCT05455697|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111112661|NCT05455697|Alkylating Agents|alkylating agents|mesh-ancestor
111112662|NCT05455697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111112663|NCT05455697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111112664|NCT05455697|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111112665|NCT05455697|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111112666|NCT05455697|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111112667|NCT05455697|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111112668|NCT05455697|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111112669|NCT05455697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111112670|NCT05455697|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111112671|NCT05455697|Glucocorticoids|glucocorticoids|mesh-ancestor
111112672|NCT05455697|Hormones|hormones|mesh-ancestor
111112673|NCT05455697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111112674|NCT05455697|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111112675|NCT05455697|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111112676|NCT05455697|Tubulin Modulators|tubulin modulators|mesh-ancestor
111112677|NCT05455697|Antimitotic Agents|antimitotic agents|mesh-ancestor
111112678|NCT05455697|Mitosis Modulators|mitosis modulators|mesh-ancestor
111112679|NCT05455697|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111490135|NCT01652040|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111490136|NCT01652040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111112680|NCT05411679|Olaparib|olaparib|mesh-list
111112681|NCT05411679|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111112682|NCT05411679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111112683|NCT05411679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111112684|NCT05411679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111112685|NCT05406479|Bedaquiline|bedaquiline|mesh-list
111112686|NCT05406479|Antitubercular Agents|antitubercular agents|mesh-ancestor
111112687|NCT05406479|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111112688|NCT05406479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111112689|NCT05384665|Sufentanil|sufentanil|mesh-list
111112690|NCT05384665|Remifentanil|remifentanil|mesh-list
111112691|NCT05384665|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111112692|NCT05384665|Narcotics|narcotics|mesh-ancestor
111112693|NCT05384665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111112694|NCT05384665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111112695|NCT05384665|Analgesics|analgesics|mesh-ancestor
111112696|NCT05384665|Sensory System Agents|sensory system agents|mesh-ancestor
111112697|NCT05384665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111112698|NCT05384665|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111112699|NCT05384665|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111112700|NCT05384665|Anesthetics, General|anesthetics, general|mesh-ancestor
111112701|NCT05384665|Anesthetics|anesthetics|mesh-ancestor
111112702|NCT05325281|Thioctic Acid|thioctic acid|mesh-list
111112703|NCT05325281|Gemcitabine|gemcitabine|mesh-list
111112704|NCT05325281|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111112705|NCT05325281|Antimetabolites|antimetabolites|mesh-ancestor
111112706|NCT05325281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111112707|NCT05325281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111112708|NCT05325281|Antioxidants|antioxidants|mesh-ancestor
111112709|NCT05325281|Protective Agents|protective agents|mesh-ancestor
111112710|NCT05325281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111112711|NCT05325281|Vitamin B Complex|vitamin b complex|mesh-ancestor
111112712|NCT05325281|Vitamins|vitamins|mesh-ancestor
111112713|NCT05325281|Micronutrients|micronutrients|mesh-ancestor
111112714|NCT05254275|Chlorhexidine|chlorhexidine|mesh-list
111112715|NCT05254275|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111112716|NCT05254275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111112717|NCT05254275|Disinfectants|disinfectants|mesh-ancestor
111112718|NCT05193994|Lamivudine|lamivudine|mesh-list
111112719|NCT05193994|Abacavir|abacavir|mesh-list
111112720|NCT05193994|Dolutegravir|dolutegravir|mesh-list
111112721|NCT05193994|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111112722|NCT05193994|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111112723|NCT05193994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111112724|NCT05193994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111112725|NCT05193994|Antiviral Agents|antiviral agents|mesh-ancestor
111112726|NCT05193994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111112727|NCT05193994|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111112728|NCT05193994|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111112729|NCT05193994|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111112730|NCT05193994|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111112731|NCT05191784|Bevacizumab|bevacizumab|mesh-list
111112732|NCT05191784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111112733|NCT05191784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111112734|NCT05191784|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111112735|NCT05191784|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111112736|NCT05191784|Growth Substances|growth substances|mesh-ancestor
111112737|NCT05191784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111112738|NCT05191784|Growth Inhibitors|growth inhibitors|mesh-ancestor
111112739|NCT05137717|Maribavir|maribavir|mesh-list
111112740|NCT05137717|Antiviral Agents|antiviral agents|mesh-ancestor
111112741|NCT05137717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111112742|NCT05077709|Pembrolizumab|pembrolizumab|mesh-list
111112743|NCT05077709|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111112744|NCT05077709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111112745|NCT05077709|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111112746|NCT05077709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111112747|NCT05020821|Dexmedetomidine|dexmedetomidine|mesh-list
111112748|NCT05020821|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111112749|NCT05020821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111112750|NCT05020821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111112751|NCT05020821|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111112752|NCT05020821|Analgesics|analgesics|mesh-ancestor
111112753|NCT05020821|Sensory System Agents|sensory system agents|mesh-ancestor
111112754|NCT05020821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111112755|NCT05020821|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111112756|NCT05020821|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111112757|NCT05020821|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111112758|NCT05020821|Adrenergic Agents|adrenergic agents|mesh-ancestor
111112759|NCT05020821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111112760|NCT05020821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111112761|NCT05020665|Cytarabine|cytarabine|mesh-list
111112762|NCT05020665|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111112763|NCT05020665|Antimetabolites|antimetabolites|mesh-ancestor
111112764|NCT05020665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111112765|NCT05020665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111112766|NCT05020665|Antiviral Agents|antiviral agents|mesh-ancestor
111112767|NCT05020665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111112768|NCT05020665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111112769|NCT05020665|Immunologic Factors|immunologic factors|mesh-ancestor
111112770|NCT05020665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111112771|NCT04996264|Varespladib methyl|varespladib methyl|mesh-list
111112772|NCT04996264|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
111112773|NCT04996264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111112774|NCT04996264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111112775|NCT04941716|Venetoclax|venetoclax|mesh-list
111112776|NCT04941716|Acalabrutinib|acalabrutinib|mesh-list
111112777|NCT04941716|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
111112778|NCT04941716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111112779|NCT04941716|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111112780|NCT04941716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111112781|NCT04941716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111112782|NCT04911062|Epinephrine|epinephrine|mesh-list
111112783|NCT04911062|Bupivacaine|bupivacaine|mesh-list
111112784|NCT04911062|Anesthetics, Local|anesthetics, local|mesh-ancestor
111112785|NCT04911062|Anesthetics|anesthetics|mesh-ancestor
111112786|NCT04911062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111112787|NCT04911062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111112788|NCT04911062|Sensory System Agents|sensory system agents|mesh-ancestor
111112789|NCT04911062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111112790|NCT04911062|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111112791|NCT04911062|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111112792|NCT04911062|Adrenergic Agents|adrenergic agents|mesh-ancestor
111112793|NCT04911062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111112794|NCT04911062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111112795|NCT04911062|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111112796|NCT04911062|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111112797|NCT04911062|Autonomic Agents|autonomic agents|mesh-ancestor
111112798|NCT04911062|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111112799|NCT04911062|Respiratory System Agents|respiratory system agents|mesh-ancestor
111112800|NCT04911062|Mydriatics|mydriatics|mesh-ancestor
111112801|NCT04911062|Sympathomimetics|sympathomimetics|mesh-ancestor
111112802|NCT04911062|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111112803|NCT04892472|Pembrolizumab|pembrolizumab|mesh-list
111112804|NCT04892472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111112805|NCT04892472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111112806|NCT04892472|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111112807|NCT04892472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111112808|NCT04818749|Dexamethasone|dexamethasone|mesh-list
111112809|NCT04818749|Dexamethasone acetate|dexamethasone acetate|mesh-list
111112810|NCT04818749|Dexmedetomidine|dexmedetomidine|mesh-list
111112811|NCT04818749|BB 1101|bb 1101|mesh-list
111112812|NCT04818749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111112813|NCT04818749|Antiemetics|antiemetics|mesh-ancestor
111112814|NCT04818749|Autonomic Agents|autonomic agents|mesh-ancestor
111112815|NCT04818749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111112816|NCT04818749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111112817|NCT04818749|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111112818|NCT04818749|Glucocorticoids|glucocorticoids|mesh-ancestor
111112819|NCT04818749|Hormones|hormones|mesh-ancestor
111112820|NCT04818749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111112821|NCT04818749|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111112822|NCT04818749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111112823|NCT04818749|Protease Inhibitors|protease inhibitors|mesh-ancestor
111112824|NCT04818749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111112825|NCT04818749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111490137|NCT01652040|Anabolic Agents|anabolic agents|mesh-ancestor
111490138|NCT01652976|Leucovorin|leucovorin|mesh-list
111490139|NCT01652976|Fluorouracil|fluorouracil|mesh-list
111490140|NCT01652976|Oxaliplatin|oxaliplatin|mesh-list
111112826|NCT04818749|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111112827|NCT04818749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111490141|NCT01652976|Dasatinib|dasatinib|mesh-list
111490142|NCT01652976|Antimetabolites|antimetabolites|mesh-ancestor
111490143|NCT01652976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111490144|NCT01652976|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110829928|NCT03477448|Bleomycin|bleomycin|mesh-list
111112828|NCT04818749|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111112829|NCT04818749|Analgesics|analgesics|mesh-ancestor
111112830|NCT04818749|Sensory System Agents|sensory system agents|mesh-ancestor
111112831|NCT04818749|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111112832|NCT04818749|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111112833|NCT04818749|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111112834|NCT04818749|Adrenergic Agents|adrenergic agents|mesh-ancestor
111112835|NCT04818749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111112836|NCT04776395|Dexamethasone|dexamethasone|mesh-list
111112837|NCT04776395|Dexamethasone acetate|dexamethasone acetate|mesh-list
111490145|NCT01652976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111490146|NCT01652976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111490147|NCT01652976|Immunologic Factors|immunologic factors|mesh-ancestor
111490148|NCT01652976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111112838|NCT04776395|Ichthammol|ichthammol|mesh-list
111112839|NCT04776395|BB 1101|bb 1101|mesh-list
111112840|NCT04776395|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111112841|NCT04776395|Antiemetics|antiemetics|mesh-ancestor
111112842|NCT04776395|Autonomic Agents|autonomic agents|mesh-ancestor
111112843|NCT04776395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111112844|NCT04776395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111112845|NCT04776395|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111112846|NCT04776395|Glucocorticoids|glucocorticoids|mesh-ancestor
111112847|NCT04776395|Hormones|hormones|mesh-ancestor
111112848|NCT04776395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111112849|NCT04776395|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111112850|NCT04776395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111112851|NCT04776395|Protease Inhibitors|protease inhibitors|mesh-ancestor
111112852|NCT04776395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111112853|NCT04776395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111112854|NCT04776395|Dermatologic Agents|dermatologic agents|mesh-ancestor
111112855|NCT04738643|Varenicline|varenicline|mesh-list
111112856|NCT04738643|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111112857|NCT04738643|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111112858|NCT04738643|Cholinergic Agents|cholinergic agents|mesh-ancestor
111112859|NCT04738643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111112860|NCT04738643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111112861|NCT04738643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111112862|NCT04588688|Mifepristone|mifepristone|mesh-list
111112863|NCT04588688|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
111112864|NCT04588688|Abortifacient Agents|abortifacient agents|mesh-ancestor
111112865|NCT04588688|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111112866|NCT04588688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111112867|NCT04588688|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111112868|NCT04588688|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111112869|NCT04588688|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111112870|NCT04588688|Contraceptive Agents|contraceptive agents|mesh-ancestor
111112871|NCT04588688|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
111112872|NCT04588688|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
111112873|NCT04588688|Hormone Antagonists|hormone antagonists|mesh-ancestor
111112874|NCT04588688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111112875|NCT04588688|Luteolytic Agents|luteolytic agents|mesh-ancestor
111112876|NCT04588688|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111112877|NCT04588688|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
111112878|NCT04587830|Temozolomide|temozolomide|mesh-list
111112879|NCT04587830|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111112880|NCT04587830|Alkylating Agents|alkylating agents|mesh-ancestor
111112881|NCT04587830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111112882|NCT04587830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111112883|NCT04558281|Ropivacaine|ropivacaine|mesh-list
111112884|NCT04558281|Anesthetics, Local|anesthetics, local|mesh-ancestor
111112885|NCT04558281|Anesthetics|anesthetics|mesh-ancestor
111490149|NCT01652976|Antidotes|antidotes|mesh-ancestor
111490150|NCT01652976|Protective Agents|protective agents|mesh-ancestor
111490151|NCT01652976|Vitamin B Complex|vitamin b complex|mesh-ancestor
111490152|NCT01652976|Vitamins|vitamins|mesh-ancestor
111112886|NCT04558281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111490153|NCT01652976|Micronutrients|micronutrients|mesh-ancestor
111490154|NCT01652976|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111112887|NCT04558281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111112888|NCT04558281|Sensory System Agents|sensory system agents|mesh-ancestor
111112889|NCT04558281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111112890|NCT04498468|Dexamethasone|dexamethasone|mesh-list
111112891|NCT04498468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111112892|NCT04498468|Antiemetics|antiemetics|mesh-ancestor
111112893|NCT04498468|Autonomic Agents|autonomic agents|mesh-ancestor
111112894|NCT04498468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111112895|NCT04498468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111112896|NCT04498468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111112897|NCT04498468|Glucocorticoids|glucocorticoids|mesh-ancestor
111112898|NCT04498468|Hormones|hormones|mesh-ancestor
111112899|NCT04498468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111112900|NCT04498468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111112901|NCT04498468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111112903|NCT04343222|Bromfenac|bromfenac|mesh-list
111112904|NCT04343222|Lubricant Eye Drops|lubricant eye drops|mesh-list
111112905|NCT04343222|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
111112906|NCT04343222|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111112907|NCT04343222|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111112908|NCT04343222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111112909|NCT04343222|Analgesics|analgesics|mesh-ancestor
111112910|NCT04343222|Sensory System Agents|sensory system agents|mesh-ancestor
111112911|NCT04343222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111112912|NCT04343222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111112913|NCT04343222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111112914|NCT04343222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111112915|NCT04342039|Budesonide|budesonide|mesh-list
111112916|NCT04342039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111112917|NCT04342039|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111112918|NCT04342039|Autonomic Agents|autonomic agents|mesh-ancestor
111112919|NCT04342039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111112920|NCT04342039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111112921|NCT04342039|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111112922|NCT04342039|Respiratory System Agents|respiratory system agents|mesh-ancestor
111112923|NCT04342039|Glucocorticoids|glucocorticoids|mesh-ancestor
111112924|NCT04342039|Hormones|hormones|mesh-ancestor
111112925|NCT04342039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111112926|NCT04311671|Ivermectin|ivermectin|mesh-list
111112927|NCT04311671|Albendazole|albendazole|mesh-list
111112928|NCT04311671|Moxidectin|moxidectin|mesh-list
111112929|NCT04311671|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111112930|NCT04311671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111112931|NCT04311671|Anthelmintics|anthelmintics|mesh-ancestor
111112932|NCT04311671|Anticestodal Agents|anticestodal agents|mesh-ancestor
111112933|NCT04311671|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
111112934|NCT04311671|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111112935|NCT04311671|Tubulin Modulators|tubulin modulators|mesh-ancestor
111112936|NCT04311671|Antimitotic Agents|antimitotic agents|mesh-ancestor
111112937|NCT04311671|Mitosis Modulators|mitosis modulators|mesh-ancestor
111112938|NCT04311671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111112939|NCT04311671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111112940|NCT04311671|Antinematodal Agents|antinematodal agents|mesh-ancestor
111112941|NCT04281108|Fluticasone|fluticasone|mesh-list
111112942|NCT04281108|Xhance|xhance|mesh-list
111112943|NCT04281108|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111112944|NCT04281108|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111112945|NCT04281108|Autonomic Agents|autonomic agents|mesh-ancestor
111112946|NCT04281108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111112947|NCT04281108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111112948|NCT04281108|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111112949|NCT04281108|Respiratory System Agents|respiratory system agents|mesh-ancestor
111112950|NCT04281108|Dermatologic Agents|dermatologic agents|mesh-ancestor
111112951|NCT04281108|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111112952|NCT04268849|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
111112953|NCT04268849|Hematinics|hematinics|mesh-ancestor
111112954|NCT04268849|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
111112955|NCT04268849|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111112956|NCT04258046|Trametinib|trametinib|mesh-list
111112957|NCT04258046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111112958|NCT04258046|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111112959|NCT04258046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111112960|NCT04258046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111112961|NCT04189055|Irinotecan|irinotecan|mesh-list
111112962|NCT04189055|Cetuximab|cetuximab|mesh-list
111112963|NCT04189055|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111112964|NCT04189055|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111490155|NCT01652976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111490156|NCT01656252|Cytarabine|cytarabine|mesh-list
111112965|NCT04189055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111112966|NCT04189055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111112967|NCT04189055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111112968|NCT04189055|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111112969|NCT04147806|Dexamethasone|dexamethasone|mesh-list
111112970|NCT04147806|Tamsulosin|tamsulosin|mesh-list
111112971|NCT04147806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111112972|NCT04147806|Antiemetics|antiemetics|mesh-ancestor
111112973|NCT04147806|Autonomic Agents|autonomic agents|mesh-ancestor
111112974|NCT04147806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111112975|NCT04147806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111112976|NCT04147806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111112977|NCT04147806|Glucocorticoids|glucocorticoids|mesh-ancestor
111112978|NCT04147806|Hormones|hormones|mesh-ancestor
111112979|NCT04147806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111112980|NCT04147806|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111112981|NCT04147806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111112982|NCT04147806|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111112983|NCT04147806|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111112984|NCT04147806|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111112985|NCT04147806|Adrenergic Agents|adrenergic agents|mesh-ancestor
111112986|NCT04147806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111112987|NCT04147806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111112988|NCT04147806|Urological Agents|urological agents|mesh-ancestor
111112990|NCT04122625|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111112991|NCT04122625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111112992|NCT04122625|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111112993|NCT04122625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111112994|NCT04077346|Glycoprotein, Klebsiella pneumoniae|glycoprotein, klebsiella pneumoniae|mesh-list
111112995|NCT04077346|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111112996|NCT04077346|Immunologic Factors|immunologic factors|mesh-ancestor
111112997|NCT04077346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111112998|NCT04076462|Octreotide|octreotide|mesh-list
111112999|NCT04076462|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111113000|NCT04076462|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111113001|NCT04076462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111113002|NCT04057898|Ibudilast|ibudilast|mesh-list
111113003|NCT04057898|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111113004|NCT04057898|Autonomic Agents|autonomic agents|mesh-ancestor
111113005|NCT04057898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111113006|NCT04057898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111113007|NCT04057898|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111113008|NCT04057898|Respiratory System Agents|respiratory system agents|mesh-ancestor
111113009|NCT04057898|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111113010|NCT04057898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111113011|NCT04057898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111113012|NCT04057898|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111113013|NCT04057898|Vasodilator Agents|vasodilator agents|mesh-ancestor
111113014|NCT04044313|Lenvatinib|lenvatinib|mesh-list
111113015|NCT04044313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111113016|NCT04044313|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111113017|NCT04044313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111113018|NCT04044313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111113019|NCT04032990|Glycoprotein, Klebsiella pneumoniae|glycoprotein, klebsiella pneumoniae|mesh-list
111113020|NCT04032990|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111113021|NCT04032990|Immunologic Factors|immunologic factors|mesh-ancestor
111113022|NCT04032990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111113023|NCT03828201|Levofloxacin|levofloxacin|mesh-list
111113024|NCT03828201|Linezolid|linezolid|mesh-list
111113025|NCT03828201|Bedaquiline|bedaquiline|mesh-list
111113026|NCT03828201|Clofazimine|clofazimine|mesh-list
111113027|NCT03828201|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111113028|NCT03828201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111113029|NCT03828201|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111113030|NCT03828201|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111113031|NCT03828201|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111113032|NCT03828201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111113033|NCT03828201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111113034|NCT03828201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111490157|NCT01656252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111490158|NCT01656252|Antimetabolites|antimetabolites|mesh-ancestor
111490159|NCT01656252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111113035|NCT03828201|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111113036|NCT03828201|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111113037|NCT03828201|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111113038|NCT03828201|Antitubercular Agents|antitubercular agents|mesh-ancestor
111113039|NCT03828201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111113040|NCT03828201|Leprostatic Agents|leprostatic agents|mesh-ancestor
111113042|NCT03824704|Rucaparib|rucaparib|mesh-list
111113043|NCT03824704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111113044|NCT03824704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111113045|NCT03824704|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111113046|NCT03824704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111113047|NCT03824704|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111113048|NCT03824704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111113049|NCT03798106|Durvalumab|durvalumab|mesh-list
110830153|NCT01108601|Ciprofloxacin|ciprofloxacin|mesh-list
111113050|NCT03798106|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111113051|NCT03798106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111113053|NCT03767075|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
111113054|NCT03767075|Futibatinib|futibatinib|mesh-list
111113055|NCT03767075|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111113056|NCT03767075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111113057|NCT03767075|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111113058|NCT03767075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111113059|NCT03766581|Aspirin|aspirin|mesh-list
111113060|NCT03766581|Clopidogrel|clopidogrel|mesh-list
111113061|NCT03766581|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111113062|NCT03766581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111113063|NCT03766581|Analgesics|analgesics|mesh-ancestor
111113064|NCT03766581|Sensory System Agents|sensory system agents|mesh-ancestor
111113065|NCT03766581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111113066|NCT03766581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111113067|NCT03766581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111113068|NCT03766581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111113069|NCT03766581|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111113070|NCT03766581|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111113071|NCT03766581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111113072|NCT03766581|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111113073|NCT03766581|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111113074|NCT03766581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111113075|NCT03766581|Antipyretics|antipyretics|mesh-ancestor
111113076|NCT03766581|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111113077|NCT03766581|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111113078|NCT03766581|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111113079|NCT03766581|Purinergic Agents|purinergic agents|mesh-ancestor
111113080|NCT03766581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111113081|NCT03702725|Dexamethasone|dexamethasone|mesh-list
111113082|NCT03702725|Lenalidomide|lenalidomide|mesh-list
111113083|NCT03702725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111113084|NCT03702725|Antiemetics|antiemetics|mesh-ancestor
111113085|NCT03702725|Autonomic Agents|autonomic agents|mesh-ancestor
111113086|NCT03702725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111113087|NCT03702725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111113088|NCT03702725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111113089|NCT03702725|Glucocorticoids|glucocorticoids|mesh-ancestor
111113090|NCT03702725|Hormones|hormones|mesh-ancestor
111113091|NCT03702725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111113092|NCT03702725|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111113093|NCT03702725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111113094|NCT03702725|Immunologic Factors|immunologic factors|mesh-ancestor
111113095|NCT03702725|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111113096|NCT03702725|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111113097|NCT03702725|Growth Substances|growth substances|mesh-ancestor
111113098|NCT03702725|Growth Inhibitors|growth inhibitors|mesh-ancestor
111113099|NCT03670966|Mycophenolic Acid|mycophenolic acid|mesh-list
111113100|NCT03670966|Cyclophosphamide|cyclophosphamide|mesh-list
111113101|NCT03670966|Fludarabine|fludarabine|mesh-list
111113102|NCT03670966|Fludarabine phosphate|fludarabine phosphate|mesh-list
111113103|NCT03670966|Tacrolimus|tacrolimus|mesh-list
111113104|NCT03670966|Antibodies|antibodies|mesh-list
111113105|NCT03670966|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111113106|NCT03670966|Lenograstim|lenograstim|mesh-list
111113107|NCT03670966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111113108|NCT03670966|Immunologic Factors|immunologic factors|mesh-ancestor
111113109|NCT03670966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111113110|NCT03670966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111113111|NCT03670966|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111113112|NCT03670966|Alkylating Agents|alkylating agents|mesh-ancestor
110648626|NCT02573363|Mitoxantrone|mitoxantrone|mesh-list
111113113|NCT03670966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111113114|NCT03670966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111113115|NCT03670966|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111113116|NCT03670966|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111113117|NCT03670966|Antimetabolites|antimetabolites|mesh-ancestor
111113118|NCT03670966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111113119|NCT03670966|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111113120|NCT03670966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111113121|NCT03670966|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111113122|NCT03670966|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111113123|NCT03670966|Antitubercular Agents|antitubercular agents|mesh-ancestor
111113124|NCT03670966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111113125|NCT03670966|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111113126|NCT03653247|Plerixafor|plerixafor|mesh-list
111113127|NCT03653247|Busulfan|busulfan|mesh-list
111113128|NCT03653247|Alkylating Agents|alkylating agents|mesh-ancestor
111113129|NCT03653247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111113130|NCT03653247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111113131|NCT03653247|Immunologic Factors|immunologic factors|mesh-ancestor
111113132|NCT03653247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111113133|NCT03653247|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111113134|NCT03653247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111113135|NCT03653247|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111113136|NCT03653247|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111113137|NCT03653247|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111113138|NCT03653247|Antiviral Agents|antiviral agents|mesh-ancestor
111113139|NCT03653247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111113140|NCT03527745|Albendazole|albendazole|mesh-list
111113141|NCT03527745|Anthelmintics|anthelmintics|mesh-ancestor
111113142|NCT03527745|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111113143|NCT03527745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111113144|NCT03527745|Anticestodal Agents|anticestodal agents|mesh-ancestor
111113145|NCT03527745|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
111113146|NCT03527745|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111113147|NCT03527745|Tubulin Modulators|tubulin modulators|mesh-ancestor
111113148|NCT03527745|Antimitotic Agents|antimitotic agents|mesh-ancestor
111113149|NCT03527745|Mitosis Modulators|mitosis modulators|mesh-ancestor
111113150|NCT03527745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111113151|NCT03527745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111113152|NCT03522584|Durvalumab|durvalumab|mesh-list
111113153|NCT03522584|Ipilimumab|ipilimumab|mesh-list
111113154|NCT03522584|Tremelimumab|tremelimumab|mesh-list
111113155|NCT03522584|Immunoglobulins|immunoglobulins|mesh-list
111113156|NCT03522584|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111113157|NCT03522584|Immunoglobulin G|immunoglobulin g|mesh-list
111113158|NCT03522584|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111113159|NCT03522584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111113160|NCT03522584|Immunologic Factors|immunologic factors|mesh-ancestor
111113161|NCT03522584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111113162|NCT03522584|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111113163|NCT03522584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111113164|NCT03330405|Avelumab|avelumab|mesh-list
111113165|NCT03330405|Talazoparib|talazoparib|mesh-list
111113166|NCT03330405|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111113167|NCT03330405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111113168|NCT03330405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111113169|NCT03330405|Immunologic Factors|immunologic factors|mesh-ancestor
111113170|NCT03330405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111113171|NCT03330405|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111113172|NCT03330405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111113173|NCT03330405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111113174|NCT03284463|Glyburide|glyburide|mesh-list
111113175|NCT03284463|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111113176|NCT03284463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111113177|NCT03223103|Poly ICLC|poly iclc|mesh-list
111113178|NCT03223103|Interferon Inducers|interferon inducers|mesh-ancestor
111113179|NCT03223103|Immunologic Factors|immunologic factors|mesh-ancestor
111490160|NCT01656252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111113180|NCT03223103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111113181|NCT03174782|Bupivacaine|bupivacaine|mesh-list
111113182|NCT03174782|Anesthetics, Local|anesthetics, local|mesh-ancestor
111490161|NCT01656252|Antiviral Agents|antiviral agents|mesh-ancestor
111113183|NCT03174782|Anesthetics|anesthetics|mesh-ancestor
111113184|NCT03174782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111113185|NCT03174782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111113186|NCT03174782|Sensory System Agents|sensory system agents|mesh-ancestor
111113187|NCT03174782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111113188|NCT03128034|Cyclosporine|cyclosporine|mesh-list
111113189|NCT03128034|Mycophenolic Acid|mycophenolic acid|mesh-list
111113190|NCT03128034|Fludarabine|fludarabine|mesh-list
111113191|NCT03128034|Fludarabine phosphate|fludarabine phosphate|mesh-list
111113192|NCT03128034|Cyclosporins|cyclosporins|mesh-list
111113193|NCT03128034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111113194|NCT03128034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111113195|NCT03128034|Antimetabolites|antimetabolites|mesh-ancestor
111113196|NCT03128034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111113197|NCT03128034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111113198|NCT03128034|Immunologic Factors|immunologic factors|mesh-ancestor
110830300|NCT01147822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111113199|NCT03128034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111113200|NCT03128034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111113201|NCT03128034|Antifungal Agents|antifungal agents|mesh-ancestor
111113202|NCT03128034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111113203|NCT03128034|Dermatologic Agents|dermatologic agents|mesh-ancestor
111113204|NCT03128034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111113205|NCT03128034|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111113206|NCT03128034|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111113207|NCT03128034|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111113208|NCT03128034|Antitubercular Agents|antitubercular agents|mesh-ancestor
111113209|NCT03128034|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111113210|NCT02919969|Pembrolizumab|pembrolizumab|mesh-list
111113211|NCT02919969|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111113212|NCT02919969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111113213|NCT02919969|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111113214|NCT02919969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111113215|NCT02837263|Pembrolizumab|pembrolizumab|mesh-list
111113216|NCT02837263|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111113217|NCT02837263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111113218|NCT02837263|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111113219|NCT02837263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111113220|NCT02616640|Dexamethasone|dexamethasone|mesh-list
111113221|NCT02616640|Durvalumab|durvalumab|mesh-list
111113222|NCT02616640|Pomalidomide|pomalidomide|mesh-list
111113223|NCT02616640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111113224|NCT02616640|Antiemetics|antiemetics|mesh-ancestor
111113225|NCT02616640|Autonomic Agents|autonomic agents|mesh-ancestor
111113226|NCT02616640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111113227|NCT02616640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111113228|NCT02616640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111113229|NCT02616640|Glucocorticoids|glucocorticoids|mesh-ancestor
111113230|NCT02616640|Hormones|hormones|mesh-ancestor
111113231|NCT02616640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111113232|NCT02616640|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111113233|NCT02616640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111113234|NCT02616640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111113235|NCT02616640|Immunologic Factors|immunologic factors|mesh-ancestor
111113236|NCT02616640|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111113237|NCT02616640|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111113238|NCT02616640|Growth Substances|growth substances|mesh-ancestor
111113239|NCT02616640|Growth Inhibitors|growth inhibitors|mesh-ancestor
111113240|NCT02352883|Hormones|hormones|mesh-list
111113241|NCT02352883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111113242|NCT02352883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111113243|NCT02270632|Methotrexate|methotrexate|mesh-list
111113244|NCT02270632|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111113245|NCT02270632|Abortifacient Agents|abortifacient agents|mesh-ancestor
111113246|NCT02270632|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111113247|NCT02270632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111113248|NCT02270632|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111113249|NCT02270632|Antimetabolites|antimetabolites|mesh-ancestor
111113250|NCT02270632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111490162|NCT01656252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111113251|NCT02270632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111490163|NCT01656252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111490164|NCT01656252|Immunologic Factors|immunologic factors|mesh-ancestor
111490165|NCT01656252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111113252|NCT02270632|Dermatologic Agents|dermatologic agents|mesh-ancestor
111113253|NCT02270632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111113254|NCT02270632|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111113255|NCT02270632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111113256|NCT02270632|Immunologic Factors|immunologic factors|mesh-ancestor
111113257|NCT02270632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111113258|NCT02270632|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111113259|NCT01891344|Rucaparib|rucaparib|mesh-list
111113260|NCT01891344|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111113261|NCT01891344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111113262|NCT01891344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111113263|NCT01891344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111113264|NCT01188096|Poly ICLC|poly iclc|mesh-list
111113265|NCT01188096|Interferon Inducers|interferon inducers|mesh-ancestor
111113266|NCT01188096|Immunologic Factors|immunologic factors|mesh-ancestor
111113267|NCT01188096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111113268|NCT00632853|Carboplatin|carboplatin|mesh-list
111113269|NCT00632853|Etoposide|etoposide|mesh-list
111113270|NCT00632853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111113271|NCT00632853|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111113272|NCT00632853|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110830375|NCT05158348|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111113273|NCT00632853|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111113274|NCT00632853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111113275|NCT00632853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111113277|NCT00579826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111113278|NCT00579826|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111113279|NCT00579826|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111113280|NCT00579826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111113281|NCT00579826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111113282|NCT00579826|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111113283|NCT00579826|Hormone Antagonists|hormone antagonists|mesh-ancestor
111113284|NCT00579826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111113285|NCT00579826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111113286|NCT00106691|Toremifene|toremifene|mesh-list
111113287|NCT00106691|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111113288|NCT00106691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111113289|NCT00106691|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111113290|NCT00106691|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111113291|NCT00106691|Hormone Antagonists|hormone antagonists|mesh-ancestor
111113292|NCT00106691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111113293|NCT00106691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111113294|NCT00106691|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111113295|NCT04576325|Voriconazole|voriconazole|mesh-list
111113296|NCT04576325|Antifungal Agents|antifungal agents|mesh-ancestor
111113297|NCT04576325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111113298|NCT04576325|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111113299|NCT04576325|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111113300|NCT04576325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111113301|NCT04576325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111113302|NCT04576325|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111113303|NCT04576325|Hormone Antagonists|hormone antagonists|mesh-ancestor
111113304|NCT04576325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111113305|NCT04576325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110648648|NCT00715637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111113306|NCT04576325|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111113307|NCT03126617|Elotuzumab|elotuzumab|mesh-list
111113308|NCT03126617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111113309|NCT04422743|Tramiprosate|tramiprosate|mesh-list
111113310|NCT04422743|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
111113311|NCT04422743|Nootropic Agents|nootropic agents|mesh-ancestor
111113312|NCT04422743|Anticonvulsants|anticonvulsants|mesh-ancestor
111113313|NCT04422743|GABA Agonists|gaba agonists|mesh-ancestor
111113314|NCT04422743|GABA Agents|gaba agents|mesh-ancestor
111113315|NCT04422743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111113316|NCT04422743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111113317|NCT04422743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111113318|NCT02535221|Epirubicin|epirubicin|mesh-list
111113319|NCT02535221|Goserelin|goserelin|mesh-list
111113320|NCT02535221|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111490166|NCT01661088|Folfirinox|folfirinox|mesh-list
111490167|NCT01661088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111490168|NCT01661946|Bevacizumab|bevacizumab|mesh-list
111490169|NCT01661946|Ranibizumab|ranibizumab|mesh-list
111113321|NCT02535221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111113322|NCT02535221|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111113323|NCT02535221|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111113324|NCT02535221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111113325|NCT02535221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111113326|NCT02535221|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111113327|NCT00000587|Epoetin Alfa|epoetin alfa|mesh-list
111113328|NCT00000587|Hematinics|hematinics|mesh-ancestor
111113329|NCT04592159|Nabiximols|nabiximols|mesh-list
111113330|NCT04592159|Analgesics|analgesics|mesh-ancestor
111113331|NCT04592159|Sensory System Agents|sensory system agents|mesh-ancestor
111113332|NCT04592159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111113333|NCT04592159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111113334|NCT05137145|Linaclotide|linaclotide|mesh-list
111113335|NCT05137145|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
111113336|NCT05137145|Enzyme Activators|enzyme activators|mesh-ancestor
111113337|NCT05137145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111113338|NCT05137145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111113339|NCT05304845|Aspirin|aspirin|mesh-list
111113340|NCT05304845|Fexuprazan|fexuprazan|mesh-list
111113341|NCT05304845|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111113342|NCT05304845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111113343|NCT05304845|Analgesics|analgesics|mesh-ancestor
110830467|NCT03481725|Coal Tar|coal tar|mesh-list
111113344|NCT05304845|Sensory System Agents|sensory system agents|mesh-ancestor
111113345|NCT05304845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111113346|NCT05304845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111113347|NCT05304845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111113348|NCT05304845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111113349|NCT05304845|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111113350|NCT05304845|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111113351|NCT05304845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111113352|NCT05304845|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111113353|NCT05304845|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111113354|NCT05304845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111113355|NCT05304845|Antipyretics|antipyretics|mesh-ancestor
111113356|NCT05304845|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111113357|NCT05303597|Lidocaine|lidocaine|mesh-list
111113358|NCT05303597|Anesthetics, Local|anesthetics, local|mesh-ancestor
111113359|NCT05303597|Anesthetics|anesthetics|mesh-ancestor
111113360|NCT05303597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111113361|NCT05303597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111113362|NCT05303597|Sensory System Agents|sensory system agents|mesh-ancestor
111113363|NCT05303597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111113364|NCT05303597|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111113365|NCT05303597|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111113366|NCT05303597|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111113367|NCT05303597|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111113368|NCT05303597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111113369|NCT04892459|Vaccines|vaccines|mesh-list
111113370|NCT04892459|Immunologic Factors|immunologic factors|mesh-ancestor
110648656|NCT00715637|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111113371|NCT04892459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111113372|NCT04881539|Cannabidiol|cannabidiol|mesh-list
111113373|NCT04881539|Anticonvulsants|anticonvulsants|mesh-ancestor
111113374|NCT05303285|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111113375|NCT05303285|Immunologic Factors|immunologic factors|mesh-ancestor
111113376|NCT05303285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111113377|NCT04280939|Anesthetics|anesthetics|mesh-list
111113378|NCT04280939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111113379|NCT04280939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111113380|NCT04489589|Midodrine|midodrine|mesh-list
111113381|NCT04489589|Sympathomimetics|sympathomimetics|mesh-ancestor
111113382|NCT04489589|Autonomic Agents|autonomic agents|mesh-ancestor
111113383|NCT04489589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111113384|NCT04489589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111113385|NCT04489589|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111113386|NCT04489589|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111113387|NCT04489589|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111113388|NCT04489589|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111113389|NCT04489589|Adrenergic Agents|adrenergic agents|mesh-ancestor
111490170|NCT01661946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111490171|NCT01661946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111113390|NCT04489589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111113391|NCT04489589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111490172|NCT01661946|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111490173|NCT01661946|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111113392|NCT04328441|BCG Vaccine|bcg vaccine|mesh-list
111113393|NCT04328441|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111113394|NCT04328441|Immunologic Factors|immunologic factors|mesh-ancestor
111113395|NCT04328441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111113396|NCT04314713|Scopolamine|scopolamine|mesh-list
111113397|NCT04314713|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
111113398|NCT04314713|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111113399|NCT04314713|Antiemetics|antiemetics|mesh-ancestor
111113400|NCT04314713|Autonomic Agents|autonomic agents|mesh-ancestor
111113401|NCT04314713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111113402|NCT04314713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111113403|NCT04314713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111113404|NCT04314713|Mydriatics|mydriatics|mesh-ancestor
111113405|NCT04314713|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111113406|NCT04314713|Cholinergic Agents|cholinergic agents|mesh-ancestor
111113407|NCT04314713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111113408|NCT04314713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111113409|NCT04314713|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111113410|NCT04314713|Parasympatholytics|parasympatholytics|mesh-ancestor
111113411|NCT04121507|Cyclophosphamide|cyclophosphamide|mesh-list
111113412|NCT04121507|Thiotepa|thiotepa|mesh-list
111113413|NCT04121507|Fludarabine|fludarabine|mesh-list
111113414|NCT04121507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111113415|NCT04121507|Immunologic Factors|immunologic factors|mesh-ancestor
111113416|NCT04121507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111113417|NCT04121507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111113418|NCT04121507|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111113419|NCT04121507|Alkylating Agents|alkylating agents|mesh-ancestor
111113420|NCT04121507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111113421|NCT04121507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111113422|NCT04121507|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111113424|NCT04719221|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
111113425|NCT04719221|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111113426|NCT04719221|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111113427|NCT04719221|Antimetabolites|antimetabolites|mesh-ancestor
111113428|NCT04719221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111113429|NCT04719221|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111113430|NCT04719221|Protease Inhibitors|protease inhibitors|mesh-ancestor
111113431|NCT04719221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111113432|NCT04719221|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111113433|NCT03790397|Osimertinib|osimertinib|mesh-list
111113434|NCT03790397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111113435|NCT03790397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111113436|NCT03790397|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111113437|NCT03790397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111113438|NCT03718559|Edoxaban|edoxaban|mesh-list
111113439|NCT03718559|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
111113440|NCT03718559|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111113441|NCT03718559|Antithrombins|antithrombins|mesh-ancestor
111113442|NCT03718559|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111113443|NCT03718559|Protease Inhibitors|protease inhibitors|mesh-ancestor
111113444|NCT03718559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111113445|NCT03718559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111113446|NCT03718559|Anticoagulants|anticoagulants|mesh-ancestor
111113447|NCT01228331|Cytarabine|cytarabine|mesh-list
111113448|NCT01228331|Dexamethasone|dexamethasone|mesh-list
111113449|NCT01228331|Methylprednisolone|methylprednisolone|mesh-list
111113450|NCT01228331|Cyclophosphamide|cyclophosphamide|mesh-list
111113451|NCT01228331|Doxorubicin|doxorubicin|mesh-list
111113452|NCT01228331|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111113453|NCT01228331|Methotrexate|methotrexate|mesh-list
111113454|NCT01228331|Etoposide|etoposide|mesh-list
111113455|NCT01228331|Vincristine|vincristine|mesh-list
111113456|NCT01228331|Daunorubicin|daunorubicin|mesh-list
111113457|NCT01228331|Mercaptopurine|mercaptopurine|mesh-list
111113458|NCT01228331|Clofarabine|clofarabine|mesh-list
111113459|NCT01228331|Pegaspargase|pegaspargase|mesh-list
111113460|NCT01228331|Thioguanine|thioguanine|mesh-list
111113461|NCT01228331|Etoposide phosphate|etoposide phosphate|mesh-list
111113462|NCT01228331|Amsacrine|amsacrine|mesh-list
111113463|NCT01228331|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111113464|NCT01228331|Immunologic Factors|immunologic factors|mesh-ancestor
111113465|NCT01228331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111113466|NCT01228331|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111113467|NCT01228331|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111113468|NCT01228331|Alkylating Agents|alkylating agents|mesh-ancestor
111490175|NCT01661946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111113469|NCT01228331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111113470|NCT01228331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111113471|NCT01228331|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111113472|NCT01228331|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111113473|NCT01228331|Antiemetics|antiemetics|mesh-ancestor
111113474|NCT01228331|Autonomic Agents|autonomic agents|mesh-ancestor
111113475|NCT01228331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111113476|NCT01228331|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111113477|NCT01228331|Glucocorticoids|glucocorticoids|mesh-ancestor
111113478|NCT01228331|Hormones|hormones|mesh-ancestor
111113479|NCT01228331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111113480|NCT01228331|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111113481|NCT01228331|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111113482|NCT01228331|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111113483|NCT01228331|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111113484|NCT01228331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111113485|NCT01228331|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111113486|NCT01228331|Abortifacient Agents|abortifacient agents|mesh-ancestor
111113487|NCT01228331|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111113488|NCT01228331|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111113489|NCT01228331|Antimetabolites|antimetabolites|mesh-ancestor
111113490|NCT01228331|Dermatologic Agents|dermatologic agents|mesh-ancestor
111113491|NCT01228331|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110830606|NCT03847207|Hormones|hormones|mesh-ancestor
111113492|NCT01228331|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111113493|NCT01228331|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111113494|NCT01228331|Antiviral Agents|antiviral agents|mesh-ancestor
111113495|NCT01228331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111113496|NCT01228331|Tubulin Modulators|tubulin modulators|mesh-ancestor
111113497|NCT01228331|Antimitotic Agents|antimitotic agents|mesh-ancestor
111113498|NCT01228331|Mitosis Modulators|mitosis modulators|mesh-ancestor
111113499|NCT01228331|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111113500|NCT01228331|Protective Agents|protective agents|mesh-ancestor
111113501|NCT01171937|Risperidone|risperidone|mesh-list
111113502|NCT01171937|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111113503|NCT01171937|Serotonin Agents|serotonin agents|mesh-ancestor
111113504|NCT01171937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111113505|NCT01171937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111113506|NCT01171937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111113507|NCT01171937|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111113508|NCT01171937|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111113509|NCT01171937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111113510|NCT01171937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111113511|NCT01171937|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111113512|NCT01171937|Dopamine Agents|dopamine agents|mesh-ancestor
111113513|NCT03136445|Tranexamic Acid|tranexamic acid|mesh-list
111113514|NCT03136445|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111113515|NCT03136445|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111113516|NCT03136445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111113517|NCT03136445|Hemostatics|hemostatics|mesh-ancestor
111113518|NCT03136445|Coagulants|coagulants|mesh-ancestor
111113519|NCT00887783|Vinorelbine|vinorelbine|mesh-list
111113520|NCT00887783|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111113521|NCT00887783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111113522|NCT00887783|Tubulin Modulators|tubulin modulators|mesh-ancestor
111113523|NCT00887783|Antimitotic Agents|antimitotic agents|mesh-ancestor
111113524|NCT00887783|Mitosis Modulators|mitosis modulators|mesh-ancestor
111113525|NCT00887783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111113526|NCT02047097|Dimethyl Fumarate|dimethyl fumarate|mesh-list
111113527|NCT02047097|Dermatologic Agents|dermatologic agents|mesh-ancestor
111113528|NCT02047097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111113529|NCT02047097|Immunologic Factors|immunologic factors|mesh-ancestor
111113530|NCT02047097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111113531|NCT01125371|Ethanol|ethanol|mesh-list
111113532|NCT01125371|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111113533|NCT01125371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111113534|NCT01125371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111113535|NCT01125371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111113536|NCT03199547|Azithromycin|azithromycin|mesh-list
111113537|NCT03199547|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111113538|NCT03199547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111113539|NCT00416351|Clofarabine|clofarabine|mesh-list
111113540|NCT00416351|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111490176|NCT01661946|Growth Inhibitors|growth inhibitors|mesh-ancestor
111113541|NCT00416351|Antimetabolites|antimetabolites|mesh-ancestor
111113542|NCT00416351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111113543|NCT00416351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111113544|NCT03938831|Fentanyl|fentanyl|mesh-list
111113545|NCT03938831|Dexmedetomidine|dexmedetomidine|mesh-list
111113546|NCT03938831|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111113547|NCT03938831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111113548|NCT03938831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111113549|NCT03938831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111113550|NCT03938831|Analgesics|analgesics|mesh-ancestor
111113551|NCT03938831|Sensory System Agents|sensory system agents|mesh-ancestor
111113552|NCT03938831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111113553|NCT03938831|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111113554|NCT03938831|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111113555|NCT03938831|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111113556|NCT03938831|Adrenergic Agents|adrenergic agents|mesh-ancestor
111113557|NCT03938831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111113558|NCT03938831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111113559|NCT03938831|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111113560|NCT03938831|Narcotics|narcotics|mesh-ancestor
111113561|NCT03938831|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111113562|NCT03938831|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111113563|NCT03938831|Anesthetics, General|anesthetics, general|mesh-ancestor
111113564|NCT03938831|Anesthetics|anesthetics|mesh-ancestor
111113565|NCT03855917|Sofosbuvir|sofosbuvir|mesh-list
111113566|NCT03855917|Antiviral Agents|antiviral agents|mesh-ancestor
111113567|NCT03855917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111113568|NCT03104855|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
111113569|NCT03104855|Calcifediol|calcifediol|mesh-list
111113570|NCT03104855|Vitamins|vitamins|mesh-ancestor
111113571|NCT03104855|Micronutrients|micronutrients|mesh-ancestor
111113572|NCT03104855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111113573|NCT03104855|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111113574|NCT03104621|Benzalkonium Compounds|benzalkonium compounds|mesh-list
111113575|NCT03104621|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111113576|NCT03104621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111113577|NCT03102359|Dexmedetomidine|dexmedetomidine|mesh-list
111113578|NCT03102359|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111113579|NCT03102359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111113580|NCT03102359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111113581|NCT03102359|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111113582|NCT03102359|Analgesics|analgesics|mesh-ancestor
111113583|NCT03102359|Sensory System Agents|sensory system agents|mesh-ancestor
111113584|NCT03102359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111113585|NCT03102359|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111113586|NCT03102359|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111113587|NCT03102359|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111113588|NCT03102359|Adrenergic Agents|adrenergic agents|mesh-ancestor
111113589|NCT03102359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111113590|NCT03102359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111113591|NCT03104309|Levonorgestrel|levonorgestrel|mesh-list
111113592|NCT03104309|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111113593|NCT03104309|Contraceptive Agents|contraceptive agents|mesh-ancestor
111113594|NCT03104309|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111113595|NCT03104309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111113596|NCT03104309|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111113597|NCT03104309|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111490178|NCT01663272|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111490179|NCT01663272|Antimetabolites|antimetabolites|mesh-ancestor
111490180|NCT01663272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111490181|NCT01663272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111490182|NCT01667796|Vitamin D|vitamin d|mesh-list
111490183|NCT01667796|Cholecalciferol|cholecalciferol|mesh-list
111490184|NCT01667796|Vitamins|vitamins|mesh-ancestor
111490185|NCT01667796|Micronutrients|micronutrients|mesh-ancestor
111490186|NCT01667796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111490187|NCT01667796|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111490188|NCT01667796|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111490189|NCT01668030|Bacitracin|bacitracin|mesh-list
111490190|NCT01668030|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111490191|NCT01668030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111113598|NCT03104309|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111113600|NCT03832049|Immunologic Factors|immunologic factors|mesh-ancestor
111113601|NCT03832049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111113602|NCT02102477|Androgens|androgens|mesh-list
111113603|NCT02102477|Hormones|hormones|mesh-ancestor
111113604|NCT02102477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111113605|NCT02102477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111113606|NCT03103685|Clopidogrel|clopidogrel|mesh-list
111113607|NCT03103685|Ticagrelor|ticagrelor|mesh-list
111113608|NCT03103685|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
111113609|NCT03103685|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111113610|NCT03103685|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111113611|NCT03103685|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111113612|NCT03103685|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111113613|NCT03103685|Purinergic Agents|purinergic agents|mesh-ancestor
111113614|NCT03103685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111113615|NCT03103685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111113616|NCT03103685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111113617|NCT03748433|Insulin|insulin|mesh-list
111113618|NCT03748433|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111113619|NCT03748433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111113620|NCT00540995|Etoposide|etoposide|mesh-list
111113621|NCT00540995|Podophyllotoxin|podophyllotoxin|mesh-list
111113622|NCT00540995|Etoposide phosphate|etoposide phosphate|mesh-list
111113623|NCT00540995|Busulfan|busulfan|mesh-list
111113624|NCT00540995|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111113625|NCT00540995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110648680|NCT00893594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111113626|NCT00540995|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111113627|NCT00540995|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111113628|NCT00540995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111113629|NCT00540995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111113630|NCT00540995|Alkylating Agents|alkylating agents|mesh-ancestor
111113631|NCT00540995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111113632|NCT00540995|Immunologic Factors|immunologic factors|mesh-ancestor
111113633|NCT00540995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111113634|NCT00540995|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111113635|NCT00540995|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111113636|NCT00540995|Keratolytic Agents|keratolytic agents|mesh-ancestor
111113637|NCT00540995|Dermatologic Agents|dermatologic agents|mesh-ancestor
111113638|NCT00540995|Tubulin Modulators|tubulin modulators|mesh-ancestor
111113639|NCT00540995|Antimitotic Agents|antimitotic agents|mesh-ancestor
111113640|NCT00540995|Mitosis Modulators|mitosis modulators|mesh-ancestor
111113641|NCT03103451|Antibodies, Bispecific|antibodies, bispecific|mesh-list
111113642|NCT03103451|Immunologic Factors|immunologic factors|mesh-ancestor
111113643|NCT03103451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111113644|NCT05103215|Lidocaine|lidocaine|mesh-list
111113645|NCT05103215|Anesthetics, Local|anesthetics, local|mesh-ancestor
111113646|NCT05103215|Anesthetics|anesthetics|mesh-ancestor
111113647|NCT05103215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111113648|NCT05103215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111113649|NCT05103215|Sensory System Agents|sensory system agents|mesh-ancestor
111113650|NCT05103215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111113651|NCT05103215|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111113652|NCT05103215|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111113653|NCT05103215|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111113654|NCT05103215|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111113655|NCT05103215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111113656|NCT05001815|Insulin|insulin|mesh-list
111113657|NCT05001815|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111113658|NCT05001815|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111113659|NCT05001815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111113660|NCT02644967|Ipilimumab|ipilimumab|mesh-list
111113661|NCT02644967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111113662|NCT02644967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111113663|NCT02644967|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111113664|NCT02644967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111113665|NCT04771637|Dexmedetomidine|dexmedetomidine|mesh-list
111113666|NCT04771637|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111113667|NCT04771637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111113668|NCT04771637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111113669|NCT04771637|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111113670|NCT04771637|Analgesics|analgesics|mesh-ancestor
111113671|NCT04771637|Sensory System Agents|sensory system agents|mesh-ancestor
111113672|NCT04771637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111490192|NCT01668030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111490193|NCT01669434|Ramipril|ramipril|mesh-list
111490194|NCT01669434|Enalapril|enalapril|mesh-list
111113673|NCT04771637|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111113674|NCT04771637|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111113675|NCT04771637|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111113676|NCT04771637|Adrenergic Agents|adrenergic agents|mesh-ancestor
111113677|NCT04771637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111113678|NCT04771637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111113679|NCT03101735|Dimethyl Fumarate|dimethyl fumarate|mesh-list
111113680|NCT03101735|Dermatologic Agents|dermatologic agents|mesh-ancestor
111113681|NCT03101735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111113682|NCT03101735|Immunologic Factors|immunologic factors|mesh-ancestor
111113683|NCT03101735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111113684|NCT04701593|Triamcinolone|triamcinolone|mesh-list
111113685|NCT04701593|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
111113686|NCT04701593|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
111113687|NCT04701593|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
111113688|NCT04701593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111113689|NCT04701593|Glucocorticoids|glucocorticoids|mesh-ancestor
111113690|NCT04701593|Hormones|hormones|mesh-ancestor
111113691|NCT04701593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111113692|NCT04701593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111113693|NCT04701593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111113694|NCT04701593|Immunologic Factors|immunologic factors|mesh-ancestor
111113695|NCT04701593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111113696|NCT04701593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111113697|NCT05243693|Brentuximab Vedotin|brentuximab vedotin|mesh-list
111113698|NCT05243693|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111113699|NCT05243693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111113700|NCT05243693|Immunotoxins|immunotoxins|mesh-ancestor
111113701|NCT05243693|Immunoconjugates|immunoconjugates|mesh-ancestor
111113702|NCT05243693|Immunologic Factors|immunologic factors|mesh-ancestor
111113703|NCT05243693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111113704|NCT04552847|Octreotide|octreotide|mesh-list
111113705|NCT04552847|Al18F-NOTA-octreotide|al18f-nota-octreotide|mesh-list
111113706|NCT04552847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111113707|NCT04552847|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111113708|NCT04552847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111113709|NCT04552847|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111113710|NCT04552847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111113711|NCT05167331|Nitrous Oxide|nitrous oxide|mesh-list
111113712|NCT05167331|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111113713|NCT05167331|Anesthetics, General|anesthetics, general|mesh-ancestor
111113714|NCT05167331|Anesthetics|anesthetics|mesh-ancestor
111113715|NCT05167331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111113716|NCT05167331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111113717|NCT05167331|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110676915|NCT03318900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111113718|NCT05167331|Analgesics|analgesics|mesh-ancestor
111113719|NCT05167331|Sensory System Agents|sensory system agents|mesh-ancestor
111113720|NCT05167331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111113721|NCT04509401|Vitamins|vitamins|mesh-list
111113722|NCT04509401|Vitamin B 6|vitamin b 6|mesh-list
111113723|NCT04509401|Pyridoxal|pyridoxal|mesh-list
111113724|NCT04509401|Pyridoxine|pyridoxine|mesh-list
111113725|NCT04509401|Vitamin B Complex|vitamin b complex|mesh-list
111113726|NCT04509401|Micronutrients|micronutrients|mesh-ancestor
111113727|NCT04509401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111113728|NCT05155007|Cyclosporine|cyclosporine|mesh-list
111113729|NCT05155007|Cyclosporins|cyclosporins|mesh-list
111113730|NCT05155007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111113731|NCT05155007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111113732|NCT05155007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111113733|NCT05155007|Immunologic Factors|immunologic factors|mesh-ancestor
111113734|NCT05155007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111113735|NCT05155007|Antifungal Agents|antifungal agents|mesh-ancestor
111113736|NCT05155007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111113737|NCT05155007|Dermatologic Agents|dermatologic agents|mesh-ancestor
111113738|NCT05155007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111113739|NCT05155007|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111113740|NCT01641107|Ponatinib|ponatinib|mesh-list
111113741|NCT01641107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111113742|NCT01641107|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111113743|NCT01641107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111113744|NCT01641107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111113745|NCT03101423|Interleukin-2|interleukin-2|mesh-list
111113746|NCT03101423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111490195|NCT01669434|Enalaprilat|enalaprilat|mesh-list
111490196|NCT01669434|Lisinopril|lisinopril|mesh-list
111490197|NCT01669434|Perindopril|perindopril|mesh-list
111113747|NCT03101423|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111113748|NCT03101423|Analgesics|analgesics|mesh-ancestor
111113749|NCT03101423|Sensory System Agents|sensory system agents|mesh-ancestor
111113750|NCT03101423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111113751|NCT03101423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111113752|NCT05073029|Vitamin D|vitamin d|mesh-list
111113753|NCT05073029|Cholecalciferol|cholecalciferol|mesh-list
111113754|NCT05073029|Vitamins|vitamins|mesh-ancestor
111113755|NCT05073029|Micronutrients|micronutrients|mesh-ancestor
111113756|NCT05073029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111113757|NCT05073029|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110648693|NCT00953394|Octreotide|octreotide|mesh-list
111113758|NCT05073029|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111113759|NCT02642159|Nicotinic Acids|nicotinic acids|mesh-list
111113760|NCT02642159|Niacin|niacin|mesh-list
111113761|NCT02642159|Niacinamide|niacinamide|mesh-list
111113762|NCT02642159|Hypoglycemic Agents|hypoglycemic agents|mesh-list
111113763|NCT02642159|Ezetimibe|ezetimibe|mesh-list
111113764|NCT02642159|Alirocumab|alirocumab|mesh-list
111113765|NCT02642159|Fenofibrate|fenofibrate|mesh-list
111113766|NCT02642159|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111113767|NCT02642159|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111113768|NCT02642159|Antimetabolites|antimetabolites|mesh-ancestor
111113769|NCT02642159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111113770|NCT02642159|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111113771|NCT02642159|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
111113772|NCT02642159|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111113773|NCT02642159|Protease Inhibitors|protease inhibitors|mesh-ancestor
111113774|NCT02642159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111113775|NCT02642159|Vitamin B Complex|vitamin b complex|mesh-ancestor
111113776|NCT02642159|Vitamins|vitamins|mesh-ancestor
111113777|NCT02642159|Micronutrients|micronutrients|mesh-ancestor
111113778|NCT02642159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111113779|NCT02642159|Vasodilator Agents|vasodilator agents|mesh-ancestor
111113780|NCT05072873|Tranexamic Acid|tranexamic acid|mesh-list
111113781|NCT05072873|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111113782|NCT05072873|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111113783|NCT05072873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111113784|NCT05072873|Hemostatics|hemostatics|mesh-ancestor
111113785|NCT05072873|Coagulants|coagulants|mesh-ancestor
111113786|NCT05072405|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111113787|NCT05072405|Simvastatin|simvastatin|mesh-list
111113788|NCT05072405|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111113789|NCT05072405|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111113790|NCT05072405|Antimetabolites|antimetabolites|mesh-ancestor
111113791|NCT05072405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110830906|NCT05601895|Sorafenib|sorafenib|mesh-list
111113792|NCT05072405|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111113793|NCT05072405|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111113794|NCT05072405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111113795|NCT03101579|Folic Acid|folic acid|mesh-list
111113796|NCT03101579|Vitamin B 12|vitamin b 12|mesh-list
111113797|NCT03101579|Dexamethasone|dexamethasone|mesh-list
111113798|NCT03101579|Pemetrexed|pemetrexed|mesh-list
111113799|NCT03101579|Vitamins|vitamins|mesh-ancestor
111113800|NCT03101579|Micronutrients|micronutrients|mesh-ancestor
111113801|NCT03101579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111113802|NCT03101579|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111113803|NCT03101579|Antiemetics|antiemetics|mesh-ancestor
111113804|NCT03101579|Autonomic Agents|autonomic agents|mesh-ancestor
111113805|NCT03101579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111113806|NCT03101579|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111113807|NCT03101579|Glucocorticoids|glucocorticoids|mesh-ancestor
111113808|NCT03101579|Hormones|hormones|mesh-ancestor
111113809|NCT03101579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111113810|NCT03101579|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111113811|NCT03101579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111113812|NCT03101579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111113813|NCT03101579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111113814|NCT03101579|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111490198|NCT01669434|Benazepril|benazepril|mesh-list
111113815|NCT03101579|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111113816|NCT03101579|Hematinics|hematinics|mesh-ancestor
111113817|NCT03101579|Vitamin B Complex|vitamin b complex|mesh-ancestor
111113818|NCT05071781|Hormones|hormones|mesh-list
111113819|NCT05071781|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
111113820|NCT05071781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111113821|NCT05071781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111490199|NCT01669434|Captopril|captopril|mesh-list
111490200|NCT01669434|Quinapril|quinapril|mesh-list
111113822|NCT03882905|Ezetimibe|ezetimibe|mesh-list
111113823|NCT03882905|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111113824|NCT03882905|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111113825|NCT03882905|Antimetabolites|antimetabolites|mesh-ancestor
111113826|NCT03882905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111113827|NCT03882905|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111113828|NCT02669017|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
111113829|NCT02669017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111113830|NCT02669017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111113831|NCT04479865|Donepezil|donepezil|mesh-list
111113832|NCT04479865|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111113833|NCT04479865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111113834|NCT04479865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111113835|NCT04479865|Cholinergic Agents|cholinergic agents|mesh-ancestor
111113836|NCT04479865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111113837|NCT04479865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111113838|NCT04479865|Nootropic Agents|nootropic agents|mesh-ancestor
111113839|NCT02668393|Docetaxel|docetaxel|mesh-list
111113840|NCT02668393|Nintedanib|nintedanib|mesh-list
111113841|NCT02668393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111113842|NCT02668393|Tubulin Modulators|tubulin modulators|mesh-ancestor
111113843|NCT02668393|Antimitotic Agents|antimitotic agents|mesh-ancestor
111113844|NCT02668393|Mitosis Modulators|mitosis modulators|mesh-ancestor
111113845|NCT02668393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111113846|NCT02668393|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111113847|NCT02668393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111113848|NCT05251129|Atorvastatin|atorvastatin|mesh-list
111113849|NCT05251129|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111113850|NCT05251129|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111113851|NCT05251129|Antimetabolites|antimetabolites|mesh-ancestor
111113852|NCT05251129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111113853|NCT05251129|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111113854|NCT05251129|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111113855|NCT05251129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111113856|NCT03412591|Suvorexant|suvorexant|mesh-list
111113857|NCT03412591|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111113858|NCT03412591|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111113859|NCT03412591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111113860|NCT03412591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111113861|NCT03412591|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
111113862|NCT03412591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111113863|NCT03412591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111113864|NCT01226563|Calcium|calcium|mesh-list
111113865|NCT01226563|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111113866|NCT01226563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111113867|NCT02382757|Insulin|insulin|mesh-list
111113868|NCT02382757|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111113869|NCT02382757|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111113870|NCT02382757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111113871|NCT02382679|Vitamins|vitamins|mesh-list
111113872|NCT02382679|Micronutrients|micronutrients|mesh-ancestor
111113873|NCT02382679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111113874|NCT00916747|Zoledronic Acid|zoledronic acid|mesh-list
111113875|NCT00916747|Pravastatin|pravastatin|mesh-list
111113876|NCT00916747|Lonafarnib|lonafarnib|mesh-list
111113877|NCT00916747|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111113878|NCT00916747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111113879|NCT00916747|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111113880|NCT00916747|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111113881|NCT00916747|Antimetabolites|antimetabolites|mesh-ancestor
111113882|NCT00916747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111113883|NCT00916747|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111113884|NCT00916747|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111113885|NCT00916747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111113886|NCT02391883|Clopidogrel|clopidogrel|mesh-list
111113887|NCT02391883|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111113888|NCT02391883|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111113889|NCT02391883|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111490201|NCT01669434|Trandolapril|trandolapril|mesh-list
111490202|NCT01669434|Fosinopril|fosinopril|mesh-list
111113890|NCT02391883|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111113891|NCT02391883|Purinergic Agents|purinergic agents|mesh-ancestor
111490203|NCT01669434|Moexipril|moexipril|mesh-list
110698332|NCT00431444|Zoledronic Acid|zoledronic acid|mesh-list
111490204|NCT01669434|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
111113892|NCT02391883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111113893|NCT02391883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111113894|NCT02391883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111113895|NCT02382523|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
111113897|NCT02382523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111113898|NCT02382523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111113899|NCT02391805|Tenofovir|tenofovir|mesh-list
111113900|NCT02391805|Entecavir|entecavir|mesh-list
111113901|NCT02391805|Antiviral Agents|antiviral agents|mesh-ancestor
111113902|NCT02391805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111113903|NCT02391805|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111113904|NCT02391805|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111113905|NCT02391805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111113906|NCT02391805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111113907|NCT02391805|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111113908|NCT02391805|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111113909|NCT02391181|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
111113910|NCT02391181|Hematinics|hematinics|mesh-ancestor
111113911|NCT02381899|Rituximab|rituximab|mesh-list
111113912|NCT02381899|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
111113913|NCT02381899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111113914|NCT02381899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111113915|NCT02381899|Immunologic Factors|immunologic factors|mesh-ancestor
111113916|NCT02381899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111113917|NCT02381899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111113918|NCT02381899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111113919|NCT02381899|Alkylating Agents|alkylating agents|mesh-ancestor
111113920|NCT02381899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111113921|NCT01998958|Esketamine|esketamine|mesh-list
111113922|NCT01998958|Antidepressive Agents|antidepressive agents|mesh-ancestor
111113923|NCT01998958|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111113924|NCT02386111|Sunitinib|sunitinib|mesh-list
111113925|NCT02386111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111113926|NCT02386111|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111113927|NCT02386111|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111113928|NCT02386111|Growth Substances|growth substances|mesh-ancestor
111113929|NCT02386111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111113930|NCT02386111|Growth Inhibitors|growth inhibitors|mesh-ancestor
111113931|NCT02386111|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111113932|NCT02386111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111113933|NCT02386111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111113934|NCT02386033|Atorvastatin|atorvastatin|mesh-list
111113935|NCT02386033|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111113936|NCT02386033|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111113937|NCT02386033|Antimetabolites|antimetabolites|mesh-ancestor
111113938|NCT02386033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111113939|NCT02386033|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111113940|NCT02386033|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111113941|NCT02386033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111113942|NCT01958164|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
111113943|NCT01958164|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111113944|NCT01958164|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110648718|NCT00715871|Nicotine|nicotine|mesh-list
111113945|NCT01958164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111113946|NCT02381275|Tenofovir|tenofovir|mesh-list
111113947|NCT02381275|Antiviral Agents|antiviral agents|mesh-ancestor
111113948|NCT02381275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111113949|NCT02381275|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111113950|NCT02381275|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111113951|NCT02381275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111113952|NCT02381275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111113953|NCT02381275|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111113954|NCT02381275|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111113955|NCT04693507|Antarelix|antarelix|mesh-list
111113956|NCT04693507|Hormone Antagonists|hormone antagonists|mesh-ancestor
111113957|NCT04693507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111113958|NCT04693507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111490205|NCT01669434|Protease Inhibitors|protease inhibitors|mesh-ancestor
111490206|NCT01669434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111113959|NCT03105661|Atenolol|atenolol|mesh-list
111113960|NCT03105661|Labetalol|labetalol|mesh-list
111113961|NCT03105661|Nifedipine|nifedipine|mesh-list
111113962|NCT03105661|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111113963|NCT03105661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111113964|NCT03105661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111113965|NCT03105661|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111113966|NCT03105661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111113967|NCT03105661|Vasodilator Agents|vasodilator agents|mesh-ancestor
111113968|NCT03105661|Tocolytic Agents|tocolytic agents|mesh-ancestor
111113969|NCT03105661|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111113970|NCT03105661|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111113971|NCT03105661|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111113972|NCT03105661|Sympatholytics|sympatholytics|mesh-ancestor
111113973|NCT03105661|Autonomic Agents|autonomic agents|mesh-ancestor
111113974|NCT03105661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111113975|NCT03105661|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
111113976|NCT03105661|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111113977|NCT03105661|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111113978|NCT03105661|Adrenergic Agents|adrenergic agents|mesh-ancestor
111113979|NCT03105661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111113980|NCT03105661|Sympathomimetics|sympathomimetics|mesh-ancestor
111113981|NCT03105661|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111113982|NCT03105661|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111113983|NCT01998880|Rituximab|rituximab|mesh-list
111113984|NCT01998880|Obinutuzumab|obinutuzumab|mesh-list
111113985|NCT01998880|Chlorambucil|chlorambucil|mesh-list
111113986|NCT01998880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111113987|NCT01998880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111113988|NCT01998880|Immunologic Factors|immunologic factors|mesh-ancestor
111113989|NCT01998880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111113990|NCT01998880|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111113991|NCT01998880|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111113992|NCT01998880|Alkylating Agents|alkylating agents|mesh-ancestor
111113993|NCT01998880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111113994|NCT04747561|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
111113995|NCT04747561|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111113996|NCT04747561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111113997|NCT02385019|Immunomodulating Agents|immunomodulating agents|mesh-list
111113998|NCT02385019|Immunologic Factors|immunologic factors|mesh-ancestor
111113999|NCT02385019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111114000|NCT02380417|Ropivacaine|ropivacaine|mesh-list
111114001|NCT02380417|Anesthetics, Local|anesthetics, local|mesh-ancestor
111114002|NCT02380417|Anesthetics|anesthetics|mesh-ancestor
111114003|NCT02380417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111114004|NCT02380417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111114005|NCT02380417|Sensory System Agents|sensory system agents|mesh-ancestor
111114006|NCT02380417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111114007|NCT02390089|Capsaicin|capsaicin|mesh-list
111114008|NCT02390089|Antipruritics|antipruritics|mesh-ancestor
111114009|NCT02390089|Dermatologic Agents|dermatologic agents|mesh-ancestor
111114010|NCT02390089|Sensory System Agents|sensory system agents|mesh-ancestor
111114011|NCT02390089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111114012|NCT02390089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111114013|NCT02379793|Mineral Oil|mineral oil|mesh-list
111114014|NCT02379793|Emollients|emollients|mesh-ancestor
111114015|NCT02379793|Dermatologic Agents|dermatologic agents|mesh-ancestor
111114016|NCT01975246|Amlodipine|amlodipine|mesh-list
111114017|NCT01975246|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
111114018|NCT01975246|Telmisartan|telmisartan|mesh-list
111114019|NCT01975246|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
111114020|NCT01975246|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111114021|NCT01975246|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111114022|NCT01975246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111114023|NCT01975246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111114024|NCT01975246|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111114025|NCT01975246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111114026|NCT01975246|Vasodilator Agents|vasodilator agents|mesh-ancestor
111114027|NCT01975246|Diuretics|diuretics|mesh-ancestor
111114028|NCT01975246|Natriuretic Agents|natriuretic agents|mesh-ancestor
111114029|NCT01975246|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
111114030|NCT01975246|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111114031|NCT01975246|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111490207|NCT01669434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111490208|NCT01669434|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111490209|NCT01669434|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111490210|NCT01669434|Protective Agents|protective agents|mesh-ancestor
111114032|NCT02389933|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
111114033|NCT02389933|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111114034|NCT02389933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111114035|NCT02379715|Remifentanil|remifentanil|mesh-list
111114037|NCT02379715|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111114038|NCT02379715|Narcotics|narcotics|mesh-ancestor
111114039|NCT02379715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111114040|NCT02379715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111114041|NCT02379715|Analgesics|analgesics|mesh-ancestor
111114042|NCT02379715|Sensory System Agents|sensory system agents|mesh-ancestor
111114043|NCT02379715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111114044|NCT02379715|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111114045|NCT02379715|Anesthetics, General|anesthetics, general|mesh-ancestor
111114046|NCT02379715|Anesthetics|anesthetics|mesh-ancestor
111114047|NCT04439773|Lidocaine|lidocaine|mesh-list
111114048|NCT04439773|Anesthetics, Local|anesthetics, local|mesh-ancestor
111114049|NCT04439773|Anesthetics|anesthetics|mesh-ancestor
111114050|NCT04439773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111114051|NCT04439773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111114052|NCT04439773|Sensory System Agents|sensory system agents|mesh-ancestor
111114053|NCT04439773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111114054|NCT04439773|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111114055|NCT04439773|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111114056|NCT04439773|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111114057|NCT04439773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111114058|NCT04439773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111114059|NCT02389231|Interleukin-2|interleukin-2|mesh-list
111114060|NCT02389231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111114061|NCT02389231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111114062|NCT02389231|Analgesics|analgesics|mesh-ancestor
111114063|NCT02389231|Sensory System Agents|sensory system agents|mesh-ancestor
111114064|NCT02389231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111114065|NCT02389231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111114066|NCT02383927|Tipifarnib|tipifarnib|mesh-list
111114067|NCT02383927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111114068|NCT02383771|Aspirin|aspirin|mesh-list
111114069|NCT02383771|Ticagrelor|ticagrelor|mesh-list
111114070|NCT02383771|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111114071|NCT02383771|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111114072|NCT02383771|Analgesics|analgesics|mesh-ancestor
111114073|NCT02383771|Sensory System Agents|sensory system agents|mesh-ancestor
111114074|NCT02383771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111114075|NCT02383771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111114076|NCT02383771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111114077|NCT02383771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111114078|NCT02383771|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111114079|NCT02383771|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111114080|NCT02383771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111114081|NCT02383771|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111114082|NCT02383771|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111114083|NCT02383771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111114084|NCT02383771|Antipyretics|antipyretics|mesh-ancestor
111114085|NCT02383771|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111114086|NCT02383771|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111114087|NCT02383771|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111114088|NCT02383771|Purinergic Agents|purinergic agents|mesh-ancestor
111114089|NCT02383771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111114090|NCT02378623|Apixaban|apixaban|mesh-list
111114091|NCT02378623|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111114092|NCT02378623|Antithrombins|antithrombins|mesh-ancestor
111114094|NCT02378623|Protease Inhibitors|protease inhibitors|mesh-ancestor
111114095|NCT02378623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111114096|NCT02378623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111114097|NCT02378623|Anticoagulants|anticoagulants|mesh-ancestor
111114098|NCT02372149|Immunoglobulins|immunoglobulins|mesh-list
111114099|NCT02372149|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111114100|NCT02372149|Antibodies|antibodies|mesh-list
111114101|NCT02372149|gamma-Globulins|gamma-globulins|mesh-list
111114102|NCT02372149|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
111114103|NCT02372149|Immunologic Factors|immunologic factors|mesh-ancestor
111490211|NCT01669434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111490212|NCT01678794|Candesartan|candesartan|mesh-list
111490213|NCT01678794|Candesartan cilexetil|candesartan cilexetil|mesh-list
111114104|NCT02372149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111490214|NCT01678794|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111490215|NCT01678794|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111114105|NCT02661061|Midazolam|midazolam|mesh-list
111114106|NCT02661061|Ketamine|ketamine|mesh-list
111114107|NCT02661061|Analgesics|analgesics|mesh-ancestor
111114108|NCT02661061|Sensory System Agents|sensory system agents|mesh-ancestor
111114109|NCT02661061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111114110|NCT02661061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111114111|NCT02661061|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111114112|NCT02661061|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111114113|NCT02661061|Anesthetics, General|anesthetics, general|mesh-ancestor
111114114|NCT02661061|Anesthetics|anesthetics|mesh-ancestor
111114115|NCT02661061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111114116|NCT02661061|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111114117|NCT02661061|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111114118|NCT02661061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111114119|NCT02661061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111114120|NCT02661061|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111114121|NCT02661061|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111114122|NCT02661061|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111114123|NCT02661061|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111114124|NCT02661061|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111114125|NCT02661061|GABA Modulators|gaba modulators|mesh-ancestor
111114126|NCT02661061|GABA Agents|gaba agents|mesh-ancestor
111114127|NCT02376985|Everolimus|everolimus|mesh-list
111114128|NCT02376985|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111114129|NCT02376985|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111114130|NCT02376985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111114131|NCT02376985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111114132|NCT02376985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111114133|NCT02376985|Immunologic Factors|immunologic factors|mesh-ancestor
111114134|NCT02376985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111114135|NCT02376985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111114136|NCT02371993|Choline|choline|mesh-list
111114137|NCT02371993|Lipotropic Agents|lipotropic agents|mesh-ancestor
111114138|NCT02371993|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111114139|NCT02371993|Antimetabolites|antimetabolites|mesh-ancestor
111114140|NCT02371993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111114141|NCT02371993|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111114142|NCT02371993|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111114143|NCT02371993|Nootropic Agents|nootropic agents|mesh-ancestor
111114144|NCT02371603|Pioglitazone|pioglitazone|mesh-list
111114145|NCT02371603|Trimethoprim|trimethoprim|mesh-list
111114146|NCT02371603|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111114147|NCT02371603|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111114148|NCT02371603|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111114149|NCT02371603|Antimetabolites|antimetabolites|mesh-ancestor
111114150|NCT02371603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111114151|NCT02371603|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111114152|NCT02371603|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111114153|NCT02371603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111114154|NCT02371603|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111114155|NCT02371603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111114156|NCT02371603|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111114157|NCT02371603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111114158|NCT02371603|Antimalarials|antimalarials|mesh-ancestor
111114159|NCT02371603|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111114160|NCT02371603|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111114161|NCT02371603|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111114162|NCT02371603|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111114163|NCT02371603|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
111114164|NCT02371603|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111114165|NCT04149145|Niraparib|niraparib|mesh-list
111114166|NCT04149145|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111114167|NCT04149145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111114168|NCT04149145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111114169|NCT04149145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111114170|NCT02378389|Docetaxel|docetaxel|mesh-list
111114171|NCT02378389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111114172|NCT02378389|Tubulin Modulators|tubulin modulators|mesh-ancestor
111114173|NCT02378389|Antimitotic Agents|antimitotic agents|mesh-ancestor
111114174|NCT02378389|Mitosis Modulators|mitosis modulators|mesh-ancestor
111114175|NCT02378389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111490216|NCT01678794|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111114176|NCT02376595|Bromides|bromides|mesh-list
111114177|NCT02376595|Rocuronium|rocuronium|mesh-list
111114178|NCT02376595|Anticonvulsants|anticonvulsants|mesh-ancestor
111114179|NCT02376595|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
111114180|NCT02376595|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
111114181|NCT02376595|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111114182|NCT02376595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111114183|NCT02376595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111114184|NCT02370745|Insulin|insulin|mesh-list
111114185|NCT02370745|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111114186|NCT02370745|Incretins|incretins|mesh-list
111114187|NCT02370745|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111114188|NCT02370745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111114189|NCT02370745|Hormones|hormones|mesh-ancestor
111114190|NCT02370745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111114191|NCT02376049|Betamethasone|betamethasone|mesh-list
111114192|NCT02376049|Betamethasone Valerate|betamethasone valerate|mesh-list
111114193|NCT02376049|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
111114194|NCT02376049|Betamethasone benzoate|betamethasone benzoate|mesh-list
111114195|NCT02376049|Clobetasol|clobetasol|mesh-list
111114196|NCT02376049|Pimecrolimus|pimecrolimus|mesh-list
111114197|NCT02376049|Emollients|emollients|mesh-list
111114198|NCT02376049|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
111114199|NCT02376049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111114200|NCT02376049|Glucocorticoids|glucocorticoids|mesh-ancestor
111114201|NCT02376049|Hormones|hormones|mesh-ancestor
111114202|NCT02376049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111114203|NCT02376049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111114204|NCT02376049|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111114205|NCT02376049|Respiratory System Agents|respiratory system agents|mesh-ancestor
111114206|NCT02376049|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111114207|NCT02376049|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111114208|NCT02376049|Analgesics|analgesics|mesh-ancestor
111114209|NCT02376049|Sensory System Agents|sensory system agents|mesh-ancestor
111114210|NCT02376049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111114211|NCT02376049|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111114212|NCT02376049|Dermatologic Agents|dermatologic agents|mesh-ancestor
111114213|NCT02376049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111114214|NCT02376049|Immunologic Factors|immunologic factors|mesh-ancestor
111114215|NCT02376049|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111114216|NCT02376049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111114217|NCT02376049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111114218|NCT02376205|Bupivacaine|bupivacaine|mesh-list
111114219|NCT02376205|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111114220|NCT02376205|Anesthetics, Local|anesthetics, local|mesh-ancestor
111114221|NCT02376205|Anesthetics|anesthetics|mesh-ancestor
111114222|NCT02376205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111114223|NCT02376205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111114224|NCT02376205|Sensory System Agents|sensory system agents|mesh-ancestor
111114225|NCT02376205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111114226|NCT02370433|Glycopyrrolate|glycopyrrolate|mesh-list
111114227|NCT02370433|Neostigmine|neostigmine|mesh-list
111114228|NCT02370433|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111114229|NCT02370433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111114230|NCT02370433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111114231|NCT02370433|Cholinergic Agents|cholinergic agents|mesh-ancestor
111114232|NCT02370433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111114233|NCT02370433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111114234|NCT02370433|Parasympathomimetics|parasympathomimetics|mesh-ancestor
111114235|NCT02370433|Autonomic Agents|autonomic agents|mesh-ancestor
111114236|NCT02370433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111114237|NCT02370433|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111114238|NCT02370433|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111114239|NCT02370433|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111114240|NCT01957150|Fluticasone|fluticasone|mesh-list
111114241|NCT01957150|Xhance|xhance|mesh-list
111114242|NCT01957150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111114243|NCT01957150|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111114244|NCT01957150|Autonomic Agents|autonomic agents|mesh-ancestor
111114245|NCT01957150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111114246|NCT01957150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111114247|NCT01957150|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111114248|NCT01957150|Respiratory System Agents|respiratory system agents|mesh-ancestor
111114249|NCT01957150|Dermatologic Agents|dermatologic agents|mesh-ancestor
111114250|NCT01957150|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111490217|NCT01678794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111490218|NCT01680900|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
111114252|NCT01995526|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111114253|NCT01995526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111114254|NCT01973218|Vaccines|vaccines|mesh-list
111114255|NCT01973218|Immunologic Factors|immunologic factors|mesh-ancestor
111114256|NCT01973218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111114257|NCT01946152|Dexamethasone|dexamethasone|mesh-list
111114258|NCT01946152|Dexamethasone acetate|dexamethasone acetate|mesh-list
111114259|NCT01946152|Pomalidomide|pomalidomide|mesh-list
111114260|NCT01946152|Ichthammol|ichthammol|mesh-list
111114261|NCT01946152|Lenograstim|lenograstim|mesh-list
111114262|NCT01946152|BB 1101|bb 1101|mesh-list
111114263|NCT01946152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111114264|NCT01946152|Antiemetics|antiemetics|mesh-ancestor
111114265|NCT01946152|Autonomic Agents|autonomic agents|mesh-ancestor
111114266|NCT01946152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111114267|NCT01946152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111114268|NCT01946152|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111114269|NCT01946152|Glucocorticoids|glucocorticoids|mesh-ancestor
111114270|NCT01946152|Hormones|hormones|mesh-ancestor
111114271|NCT01946152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111114272|NCT01946152|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111114273|NCT01946152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111114274|NCT01946152|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111114275|NCT01946152|Immunologic Factors|immunologic factors|mesh-ancestor
111114276|NCT01946152|Protease Inhibitors|protease inhibitors|mesh-ancestor
111114277|NCT01946152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111114278|NCT01946152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111114279|NCT01946152|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111114280|NCT01946152|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111114281|NCT01946152|Growth Substances|growth substances|mesh-ancestor
111114282|NCT01946152|Growth Inhibitors|growth inhibitors|mesh-ancestor
111114283|NCT01946152|Dermatologic Agents|dermatologic agents|mesh-ancestor
111114284|NCT01971346|Etanercept|etanercept|mesh-list
111114285|NCT01971346|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111114286|NCT01971346|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111114287|NCT01971346|Analgesics|analgesics|mesh-ancestor
111114288|NCT01971346|Sensory System Agents|sensory system agents|mesh-ancestor
111114289|NCT01971346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111114290|NCT01971346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111114291|NCT01971346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111114292|NCT01971346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111114293|NCT01971346|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111114294|NCT01971346|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111114295|NCT01971346|Immunologic Factors|immunologic factors|mesh-ancestor
111114296|NCT01945216|Alogliptin|alogliptin|mesh-list
111114297|NCT01945216|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111114298|NCT01945216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111114299|NCT01945216|Incretins|incretins|mesh-ancestor
111114300|NCT01945216|Hormones|hormones|mesh-ancestor
111114301|NCT01945216|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111114302|NCT01945216|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111114303|NCT01945216|Protease Inhibitors|protease inhibitors|mesh-ancestor
111114304|NCT01945216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111114305|NCT01945216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111114306|NCT02641379|Ribavirin|ribavirin|mesh-list
111114307|NCT02641379|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
111114308|NCT02641379|Antimetabolites|antimetabolites|mesh-ancestor
111114309|NCT02641379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111114310|NCT02641379|Antiviral Agents|antiviral agents|mesh-ancestor
111114311|NCT02641379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111114312|NCT02660983|Donepezil|donepezil|mesh-list
111114313|NCT02660983|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111114314|NCT02660983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111114315|NCT02660983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111114316|NCT02660983|Cholinergic Agents|cholinergic agents|mesh-ancestor
111114317|NCT02660983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111114318|NCT02660983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111114319|NCT02660983|Nootropic Agents|nootropic agents|mesh-ancestor
110831426|NCT03715725|Warfarin|warfarin|mesh-list
111114320|NCT05070221|Axitinib|axitinib|mesh-list
111114321|NCT05070221|Antibodies|antibodies|mesh-list
111490219|NCT01680900|Antidepressive Agents|antidepressive agents|mesh-ancestor
111114322|NCT05070221|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111490220|NCT01680900|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111114323|NCT05070221|Immunologic Factors|immunologic factors|mesh-ancestor
110698347|NCT01068405|Methotrexate|methotrexate|mesh-list
111114324|NCT05070221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111114325|NCT05070221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111114326|NCT05070221|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111114328|NCT05070221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111114329|NCT04404439|Topiramate|topiramate|mesh-list
111114330|NCT04404439|Verapamil|verapamil|mesh-list
111114331|NCT04404439|Paroxetine|paroxetine|mesh-list
111114332|NCT04404439|Nortriptyline|nortriptyline|mesh-list
111114333|NCT04404439|Anticonvulsants|anticonvulsants|mesh-ancestor
111114334|NCT04404439|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111114335|NCT04404439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111114336|NCT04404439|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111114337|NCT04404439|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111114338|NCT04404439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111114339|NCT04404439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111114340|NCT04404439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111114341|NCT04404439|Serotonin Agents|serotonin agents|mesh-ancestor
111114342|NCT04404439|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111114343|NCT04404439|Antidepressive Agents|antidepressive agents|mesh-ancestor
111114344|NCT04404439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111114345|NCT04404439|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111114346|NCT04404439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111114347|NCT04404439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111114348|NCT04404439|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111114349|NCT04404439|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111114350|NCT04404439|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111114351|NCT04404439|Vasodilator Agents|vasodilator agents|mesh-ancestor
111114352|NCT04404439|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
111114353|NCT04404439|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111114354|NCT04404439|Adrenergic Agents|adrenergic agents|mesh-ancestor
111114355|NCT01953328|Atorvastatin|atorvastatin|mesh-list
111114356|NCT01953328|Evolocumab|evolocumab|mesh-list
111114357|NCT01953328|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111114358|NCT01953328|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111114359|NCT01953328|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111114360|NCT01953328|Antimetabolites|antimetabolites|mesh-ancestor
111114361|NCT01953328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111114362|NCT01953328|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111114363|NCT01953328|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111114364|NCT01953328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111114365|NCT01953328|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
111114366|NCT01953328|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111114367|NCT01953328|Protease Inhibitors|protease inhibitors|mesh-ancestor
111114368|NCT01953328|Immunologic Factors|immunologic factors|mesh-ancestor
111114369|NCT01953328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111114370|NCT03100955|Cisplatin|cisplatin|mesh-list
111114371|NCT03100955|Etoposide|etoposide|mesh-list
111114372|NCT03100955|Etoposide phosphate|etoposide phosphate|mesh-list
111114373|NCT03100955|Apatinib|apatinib|mesh-list
111114374|NCT03100955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111114375|NCT03100955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111114376|NCT03100955|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111114377|NCT03100955|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111114378|NCT03100955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111114379|NCT03100955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111114380|NCT03100955|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111114381|NCT02377609|Tacrolimus|tacrolimus|mesh-list
111114382|NCT02377609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111114383|NCT02377609|Immunologic Factors|immunologic factors|mesh-ancestor
111114384|NCT02377609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111114385|NCT02377609|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111114386|NCT02377609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111114387|NCT02377609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111114388|NCT02369965|Ritonavir|ritonavir|mesh-list
111114389|NCT02369965|Lopinavir|lopinavir|mesh-list
111114390|NCT02369965|Tenofovir|tenofovir|mesh-list
111114391|NCT02369965|Lamivudine|lamivudine|mesh-list
111114392|NCT02369965|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111114393|NCT02369965|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111490221|NCT01680900|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111490222|NCT01680900|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111490223|NCT01680900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111114394|NCT02369965|Protease Inhibitors|protease inhibitors|mesh-ancestor
111114395|NCT02369965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111114396|NCT02369965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111114397|NCT02369965|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111114398|NCT02369965|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111114399|NCT02369965|Antiviral Agents|antiviral agents|mesh-ancestor
111114400|NCT02369965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111114401|NCT02369965|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111114402|NCT02369965|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111114403|NCT02369965|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111114404|NCT02369965|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111114405|NCT02640755|Paclitaxel|paclitaxel|mesh-list
111114406|NCT02640755|Fulvestrant|fulvestrant|mesh-list
111114407|NCT02640755|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111114408|NCT02640755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111114409|NCT02640755|Tubulin Modulators|tubulin modulators|mesh-ancestor
111114410|NCT02640755|Antimitotic Agents|antimitotic agents|mesh-ancestor
111114411|NCT02640755|Mitosis Modulators|mitosis modulators|mesh-ancestor
111114412|NCT02640755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111114413|NCT02640755|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111114414|NCT02640755|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
111114415|NCT02640755|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111114416|NCT02640755|Hormone Antagonists|hormone antagonists|mesh-ancestor
111114417|NCT02640755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111114418|NCT02640755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111114419|NCT04400539|Nivolumab|nivolumab|mesh-list
111114420|NCT04400539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111114421|NCT04400539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111114422|NCT04400539|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111114423|NCT04400539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111114424|NCT03099785|Rifamycins|rifamycins|mesh-list
111114425|NCT03099785|Rifamycin SV|rifamycin sv|mesh-list
111114426|NCT03099785|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111114427|NCT03099785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111114428|NCT03099785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111114429|NCT02375503|Vitamin D|vitamin d|mesh-list
111114430|NCT02375503|Calcium|calcium|mesh-list
111114431|NCT02375503|Vitamins|vitamins|mesh-ancestor
111114432|NCT02375503|Micronutrients|micronutrients|mesh-ancestor
111114433|NCT02375503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111114434|NCT02375503|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111114435|NCT02375503|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111114436|NCT00867191|Desloratadine|desloratadine|mesh-list
111114437|NCT00867191|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111114438|NCT00867191|Cholinergic Agents|cholinergic agents|mesh-ancestor
111114439|NCT00867191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111114440|NCT00867191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111114441|NCT00867191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111114442|NCT00867191|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
111114443|NCT00867191|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111114444|NCT00867191|Histamine Antagonists|histamine antagonists|mesh-ancestor
111114445|NCT00867191|Histamine Agents|histamine agents|mesh-ancestor
111114446|NCT00834119|Mometasone Furoate|mometasone furoate|mesh-list
111114447|NCT00834119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111114448|NCT00834119|Dermatologic Agents|dermatologic agents|mesh-ancestor
111114449|NCT00834119|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111114450|NCT02299141|Nintedanib|nintedanib|mesh-list
111114451|NCT02299141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111114452|NCT02299141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111114453|NCT02299141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111114454|NCT02299141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111114455|NCT02643251|Clonidine|clonidine|mesh-list
111114456|NCT02643251|Analgesics|analgesics|mesh-ancestor
111114457|NCT02643251|Sensory System Agents|sensory system agents|mesh-ancestor
111114458|NCT02643251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111114459|NCT02643251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111114460|NCT02643251|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111114461|NCT02643251|Sympatholytics|sympatholytics|mesh-ancestor
111114462|NCT02643251|Autonomic Agents|autonomic agents|mesh-ancestor
110648786|NCT00712439|Anticonvulsants|anticonvulsants|mesh-ancestor
111114463|NCT02643251|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111114464|NCT02643251|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111490224|NCT01680900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111490225|NCT01680900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111490226|NCT01680900|Serotonin Agents|serotonin agents|mesh-ancestor
111490227|NCT01680900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111490228|NCT01680900|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111114465|NCT02643251|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111114466|NCT02643251|Adrenergic Agents|adrenergic agents|mesh-ancestor
111114467|NCT02643251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111114468|NCT02643251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111114469|NCT02375191|Fentanyl|fentanyl|mesh-list
111114470|NCT02375191|Dexmedetomidine|dexmedetomidine|mesh-list
111114471|NCT02375191|Ropivacaine|ropivacaine|mesh-list
111114472|NCT02375191|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111114473|NCT02375191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111114474|NCT02375191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111114475|NCT02375191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111114476|NCT02375191|Analgesics|analgesics|mesh-ancestor
111114477|NCT02375191|Sensory System Agents|sensory system agents|mesh-ancestor
111114478|NCT02375191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111114479|NCT02375191|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111114480|NCT02375191|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111114481|NCT02375191|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111114482|NCT02375191|Adrenergic Agents|adrenergic agents|mesh-ancestor
111114483|NCT02375191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111114484|NCT02375191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111114485|NCT02375191|Anesthetics, Local|anesthetics, local|mesh-ancestor
111114486|NCT02375191|Anesthetics|anesthetics|mesh-ancestor
111114487|NCT02375191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111114488|NCT02375191|Narcotics|narcotics|mesh-ancestor
111114489|NCT02375191|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111114490|NCT02375191|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111114491|NCT02375191|Anesthetics, General|anesthetics, general|mesh-ancestor
111114492|NCT03100877|Cyclophosphamide|cyclophosphamide|mesh-list
111114493|NCT03100877|Melphalan|melphalan|mesh-list
111114494|NCT03100877|Mechlorethamine|mechlorethamine|mesh-list
111114495|NCT03100877|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
111114496|NCT03100877|Lenalidomide|lenalidomide|mesh-list
111114497|NCT03100877|Lenograstim|lenograstim|mesh-list
111114498|NCT03100877|Mitogens|mitogens|mesh-list
111114499|NCT03100877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111114500|NCT03100877|Immunologic Factors|immunologic factors|mesh-ancestor
111114501|NCT03100877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111114502|NCT03100877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111114503|NCT03100877|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111114504|NCT03100877|Alkylating Agents|alkylating agents|mesh-ancestor
111114505|NCT03100877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111114506|NCT03100877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111114507|NCT03100877|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111114508|NCT03100877|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111114509|NCT03100877|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111114510|NCT03100877|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111114511|NCT03100877|Growth Substances|growth substances|mesh-ancestor
111114512|NCT03100877|Growth Inhibitors|growth inhibitors|mesh-ancestor
111114513|NCT03100877|Mitosis Modulators|mitosis modulators|mesh-ancestor
111114514|NCT00794495|Cetirizine|cetirizine|mesh-list
111114515|NCT00794495|Desloratadine|desloratadine|mesh-list
111114516|NCT00794495|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111114517|NCT00794495|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
111114518|NCT00794495|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111114519|NCT00794495|Histamine Antagonists|histamine antagonists|mesh-ancestor
111114520|NCT00794495|Histamine Agents|histamine agents|mesh-ancestor
111114521|NCT00794495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111114522|NCT00794495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111114523|NCT00794495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111114524|NCT00794495|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111114525|NCT00794495|Cholinergic Agents|cholinergic agents|mesh-ancestor
111114526|NCT04157075|Bupivacaine|bupivacaine|mesh-list
111114527|NCT04157075|Anesthetics, Local|anesthetics, local|mesh-ancestor
111114528|NCT04157075|Anesthetics|anesthetics|mesh-ancestor
111114529|NCT04157075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111490229|NCT01680900|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111490230|NCT01682538|Nitisinone|nitisinone|mesh-list
111490231|NCT01682538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111490232|NCT01682538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111490233|NCT01684020|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
111490234|NCT01684020|Hemostatics|hemostatics|mesh-ancestor
111490235|NCT01684020|Coagulants|coagulants|mesh-ancestor
111114530|NCT04157075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111114531|NCT04157075|Sensory System Agents|sensory system agents|mesh-ancestor
111114532|NCT04157075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111114533|NCT00763529|Fluticasone|fluticasone|mesh-list
111114534|NCT00763529|Mometasone Furoate|mometasone furoate|mesh-list
111114535|NCT00763529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111114536|NCT00763529|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111114537|NCT00763529|Autonomic Agents|autonomic agents|mesh-ancestor
111114538|NCT00763529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111114539|NCT00763529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111114540|NCT00763529|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111114541|NCT00763529|Respiratory System Agents|respiratory system agents|mesh-ancestor
111114542|NCT00763529|Dermatologic Agents|dermatologic agents|mesh-ancestor
111114543|NCT00763529|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111114544|NCT03105505|Fusidic Acid|fusidic acid|mesh-list
111114545|NCT03105505|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111114546|NCT03105505|Permethrin|permethrin|mesh-list
111114547|NCT03105505|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111114548|NCT03105505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111114549|NCT03105505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111114550|NCT03105505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111114551|NCT03105505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111114552|NCT03105505|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111114553|NCT03105193|Lidocaine|lidocaine|mesh-list
111114554|NCT03105193|Anesthetics, Local|anesthetics, local|mesh-ancestor
111114555|NCT03105193|Anesthetics|anesthetics|mesh-ancestor
111114556|NCT03105193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111114557|NCT03105193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111114558|NCT03105193|Sensory System Agents|sensory system agents|mesh-ancestor
111114559|NCT03105193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111114560|NCT03105193|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111114561|NCT03105193|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111114562|NCT03105193|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111114563|NCT03105193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111114564|NCT03105193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111114565|NCT05066633|Metoprolol|metoprolol|mesh-list
111114566|NCT05066633|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111114567|NCT05066633|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111114568|NCT05066633|Sympatholytics|sympatholytics|mesh-ancestor
111114569|NCT05066633|Autonomic Agents|autonomic agents|mesh-ancestor
111114570|NCT05066633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111114571|NCT05066633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111114572|NCT05066633|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
111114573|NCT05066633|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111114574|NCT05066633|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111114575|NCT05066633|Adrenergic Agents|adrenergic agents|mesh-ancestor
111114576|NCT05066633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111114577|NCT05066633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111114578|NCT04439305|Dasatinib|dasatinib|mesh-list
111114579|NCT04439305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111114580|NCT04439305|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111114581|NCT04439305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111114582|NCT04439305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111114583|NCT02368951|Aprutumab ixadotin|aprutumab ixadotin|mesh-list
111114584|NCT02368951|Immunoconjugates|immunoconjugates|mesh-ancestor
111114585|NCT02368951|Immunologic Factors|immunologic factors|mesh-ancestor
111114586|NCT02368951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111114587|NCT02368795|Indomethacin|indomethacin|mesh-list
111114588|NCT02368795|Isosorbide|isosorbide|mesh-list
111114589|NCT02368795|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
111114590|NCT02368795|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
111114591|NCT02368795|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111114592|NCT02368795|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111114593|NCT02368795|Analgesics|analgesics|mesh-ancestor
111114594|NCT02368795|Sensory System Agents|sensory system agents|mesh-ancestor
111114595|NCT02368795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111114596|NCT02368795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111114597|NCT02368795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111114598|NCT02368795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111114599|NCT02368795|Gout Suppressants|gout suppressants|mesh-ancestor
111114600|NCT02368795|Tocolytic Agents|tocolytic agents|mesh-ancestor
111114601|NCT02368795|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111114602|NCT02368795|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111114603|NCT02368795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111114604|NCT02368795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111114605|NCT02368795|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
111490236|NCT01684410|Protease Inhibitors|protease inhibitors|mesh-list
111114606|NCT02368795|Diuretics|diuretics|mesh-ancestor
111490237|NCT01684410|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
111114607|NCT02368795|Natriuretic Agents|natriuretic agents|mesh-ancestor
111114608|NCT02368795|Vasodilator Agents|vasodilator agents|mesh-ancestor
111114609|NCT02368795|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
111114610|NCT00650663|Simvastatin|simvastatin|mesh-list
111114611|NCT00650663|Ezetimibe|ezetimibe|mesh-list
111114612|NCT00650663|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111114613|NCT00650663|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111114614|NCT00650663|Antimetabolites|antimetabolites|mesh-ancestor
111114615|NCT00650663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111114616|NCT00650663|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111114617|NCT00650663|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111114618|NCT00650663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111114619|NCT02368717|Mesalamine|mesalamine|mesh-list
111114620|NCT02368717|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111114621|NCT02368717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111114622|NCT02368717|Analgesics|analgesics|mesh-ancestor
111114623|NCT02368717|Sensory System Agents|sensory system agents|mesh-ancestor
111114624|NCT02368717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111114625|NCT02368717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111114626|NCT02368717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111114627|NCT02368717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111114628|NCT04231565|Tenofovir|tenofovir|mesh-list
111114629|NCT04231565|Antiviral Agents|antiviral agents|mesh-ancestor
111114630|NCT04231565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111114631|NCT04231565|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111114632|NCT04231565|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111114633|NCT04231565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111114634|NCT04231565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111114635|NCT04231565|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111114636|NCT04231565|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111114637|NCT03100565|Lidocaine|lidocaine|mesh-list
111114638|NCT03100565|Anesthetics, Local|anesthetics, local|mesh-ancestor
111114639|NCT03100565|Anesthetics|anesthetics|mesh-ancestor
111114640|NCT03100565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111114641|NCT03100565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111114642|NCT03100565|Sensory System Agents|sensory system agents|mesh-ancestor
111114643|NCT03100565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111114644|NCT03100565|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111114645|NCT03100565|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111114646|NCT03100565|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111114647|NCT03100565|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111114648|NCT03100565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111114649|NCT05035277|Aspirin|aspirin|mesh-list
111114650|NCT05035277|Rivaroxaban|rivaroxaban|mesh-list
111114651|NCT05035277|Apixaban|apixaban|mesh-list
111114652|NCT05035277|Edoxaban|edoxaban|mesh-list
111114653|NCT05035277|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111114654|NCT05035277|Antithrombins|antithrombins|mesh-ancestor
111114655|NCT05035277|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111114656|NCT05035277|Protease Inhibitors|protease inhibitors|mesh-ancestor
111114657|NCT05035277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111114658|NCT05035277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111114659|NCT05035277|Anticoagulants|anticoagulants|mesh-ancestor
111114660|NCT05035277|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111114661|NCT05035277|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111114662|NCT05035277|Analgesics|analgesics|mesh-ancestor
111114663|NCT05035277|Sensory System Agents|sensory system agents|mesh-ancestor
111114664|NCT05035277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111114665|NCT05035277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111114666|NCT05035277|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111114667|NCT05035277|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111114668|NCT05035277|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111114669|NCT05035277|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111114670|NCT05035277|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111114671|NCT05035277|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111114672|NCT05035277|Antipyretics|antipyretics|mesh-ancestor
111114673|NCT02374645|Gefitinib|gefitinib|mesh-list
111114674|NCT02374645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111114675|NCT02374645|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111114676|NCT02374645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111114677|NCT02374645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111114678|NCT02368561|Hyaluronic Acid|hyaluronic acid|mesh-list
111114679|NCT02368561|Hylan|hylan|mesh-list
111114680|NCT02368561|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111490238|NCT01684410|Protein C Inhibitor|protein c inhibitor|mesh-list
111114681|NCT02368561|Immunologic Factors|immunologic factors|mesh-ancestor
111114682|NCT02368561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111114683|NCT02368561|Viscosupplements|viscosupplements|mesh-ancestor
111114684|NCT02368561|Protective Agents|protective agents|mesh-ancestor
111114685|NCT04095845|Tacrine|tacrine|mesh-list
111114686|NCT04095845|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111114687|NCT04095845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111114688|NCT04095845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111114689|NCT04095845|Cholinergic Agents|cholinergic agents|mesh-ancestor
111114690|NCT04095845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111114691|NCT04095845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111114692|NCT04095845|Parasympathomimetics|parasympathomimetics|mesh-ancestor
111114693|NCT04095845|Autonomic Agents|autonomic agents|mesh-ancestor
111114694|NCT04095845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111114695|NCT04095845|Nootropic Agents|nootropic agents|mesh-ancestor
111114696|NCT02374489|Ceritinib|ceritinib|mesh-list
111114697|NCT02374489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111114698|NCT02374489|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111114699|NCT02374489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111114700|NCT02374489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111114701|NCT02374567|Topiramate|topiramate|mesh-list
111114702|NCT02374567|Diphenhydramine|diphenhydramine|mesh-list
111114703|NCT02374567|Promethazine|promethazine|mesh-list
111114704|NCT02374567|Pregabalin|pregabalin|mesh-list
111114705|NCT02374567|Lamotrigine|lamotrigine|mesh-list
111114706|NCT02374567|Lacosamide|lacosamide|mesh-list
111114707|NCT02374567|Carbamazepine|carbamazepine|mesh-list
111114708|NCT02374567|Phenytoin|phenytoin|mesh-list
111114709|NCT02374567|Oxcarbazepine|oxcarbazepine|mesh-list
111114710|NCT02374567|Nicergoline|nicergoline|mesh-list
111114711|NCT02374567|Midazolam|midazolam|mesh-list
111114712|NCT02374567|Diazepam|diazepam|mesh-list
111114713|NCT02374567|Triazolam|triazolam|mesh-list
111114714|NCT02374567|Acamprosate|acamprosate|mesh-list
111114715|NCT02374567|Gabapentin|gabapentin|mesh-list
111114716|NCT02374567|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
111114717|NCT02374567|Amitriptyline|amitriptyline|mesh-list
111114718|NCT02374567|Methotrimeprazine|methotrimeprazine|mesh-list
111114719|NCT02374567|Levetiracetam|levetiracetam|mesh-list
111114720|NCT02374567|Valproic Acid|valproic acid|mesh-list
111114721|NCT02374567|Lorazepam|lorazepam|mesh-list
111114722|NCT02374567|Clonazepam|clonazepam|mesh-list
111114723|NCT02374567|Phenobarbital|phenobarbital|mesh-list
111114724|NCT02374567|Clobazam|clobazam|mesh-list
111114725|NCT02374567|Zaleplon|zaleplon|mesh-list
111114726|NCT02374567|Nitrazepam|nitrazepam|mesh-list
111114727|NCT02374567|Chlormethiazole|chlormethiazole|mesh-list
111114728|NCT02374567|Memantine|memantine|mesh-list
111114729|NCT02374567|Biperiden|biperiden|mesh-list
111114730|NCT02374567|Haloperidol|haloperidol|mesh-list
111114731|NCT02374567|Pimozide|pimozide|mesh-list
111114732|NCT02374567|Olanzapine|olanzapine|mesh-list
111114733|NCT02374567|Zolpidem|zolpidem|mesh-list
111114734|NCT02374567|Alprazolam|alprazolam|mesh-list
111114735|NCT02374567|Zopiclone|zopiclone|mesh-list
111114736|NCT02374567|Agomelatine|agomelatine|mesh-list
111114737|NCT02374567|Chloral Hydrate|chloral hydrate|mesh-list
111114738|NCT02374567|Doxepin|doxepin|mesh-list
111114739|NCT02374567|Oxazepam|oxazepam|mesh-list
111114740|NCT02374567|Temazepam|temazepam|mesh-list
111114741|NCT02374567|Brotizolam|brotizolam|mesh-list
111114742|NCT02374567|Lormetazepam|lormetazepam|mesh-list
111114743|NCT02374567|Flurazepam|flurazepam|mesh-list
111114744|NCT02374567|Mirtazapine|mirtazapine|mesh-list
111114745|NCT02374567|Fluvoxamine|fluvoxamine|mesh-list
111114746|NCT02374567|Buspirone|buspirone|mesh-list
111114747|NCT02374567|Trazodone|trazodone|mesh-list
111114748|NCT02374567|Tranylcypromine|tranylcypromine|mesh-list
111114749|NCT02374567|Bromazepam|bromazepam|mesh-list
111114750|NCT02374567|Risperidone|risperidone|mesh-list
111490239|NCT01684410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111490240|NCT01684410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111114751|NCT02374567|Melatonin|melatonin|mesh-list
111114752|NCT02374567|Aripiprazole|aripiprazole|mesh-list
111114753|NCT02374567|Quetiapine Fumarate|quetiapine fumarate|mesh-list
111114754|NCT02374567|Paliperidone Palmitate|paliperidone palmitate|mesh-list
111490241|NCT01684410|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
111114755|NCT02374567|Ziprasidone|ziprasidone|mesh-list
111114756|NCT02374567|Clozapine|clozapine|mesh-list
111114757|NCT02374567|Amisulpride|amisulpride|mesh-list
111114758|NCT02374567|Flupenthixol|flupenthixol|mesh-list
111114759|NCT02374567|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
111114760|NCT02374567|Perphenazine|perphenazine|mesh-list
111114761|NCT02374567|Sertindole|sertindole|mesh-list
111114762|NCT02374567|Sulpiride|sulpiride|mesh-list
111114763|NCT02374567|Fluphenazine|fluphenazine|mesh-list
111114764|NCT02374567|Fluphenazine depot|fluphenazine depot|mesh-list
111114765|NCT02374567|Fluphenazine enanthate|fluphenazine enanthate|mesh-list
111114766|NCT02374567|Thioridazine|thioridazine|mesh-list
111114767|NCT02374567|Pipamperone|pipamperone|mesh-list
111114768|NCT02374567|Clopenthixol|clopenthixol|mesh-list
111490242|NCT01684410|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111114769|NCT02374567|Chlorprothixene|chlorprothixene|mesh-list
111114770|NCT02374567|Tiapride Hydrochloride|tiapride hydrochloride|mesh-list
110831880|NCT03780959|Etanercept|etanercept|mesh-list
111114771|NCT02374567|Fluspirilene|fluspirilene|mesh-list
111114772|NCT02374567|Perazine|perazine|mesh-list
111114773|NCT02374567|Bromperidol|bromperidol|mesh-list
111114774|NCT02374567|Benperidol|benperidol|mesh-list
111114775|NCT02374567|Rivastigmine|rivastigmine|mesh-list
111114776|NCT02374567|Piracetam|piracetam|mesh-list
111114777|NCT02374567|Donepezil|donepezil|mesh-list
111114778|NCT02374567|Galantamine|galantamine|mesh-list
111114779|NCT02374567|Citalopram|citalopram|mesh-list
111114780|NCT02374567|Bupropion|bupropion|mesh-list
111114781|NCT02374567|Sertraline|sertraline|mesh-list
111114782|NCT02374567|Fluoxetine|fluoxetine|mesh-list
111114783|NCT02374567|Paroxetine|paroxetine|mesh-list
111114784|NCT02374567|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
111114785|NCT02374567|Nortriptyline|nortriptyline|mesh-list
111114786|NCT02374567|Reboxetine|reboxetine|mesh-list
111114787|NCT02374567|Imipramine|imipramine|mesh-list
111114788|NCT02374567|Clomipramine|clomipramine|mesh-list
111114789|NCT02374567|Moclobemide|moclobemide|mesh-list
111114790|NCT02374567|Mianserin|mianserin|mesh-list
111114791|NCT02374567|Opipramol|opipramol|mesh-list
111114792|NCT02374567|Maprotiline|maprotiline|mesh-list
111114793|NCT02374567|Trimipramine|trimipramine|mesh-list
111114794|NCT02374567|Hydroxyzine|hydroxyzine|mesh-list
111114795|NCT02374567|Escitalopram|escitalopram|mesh-list
111114796|NCT02374567|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111114797|NCT02374567|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111114798|NCT02374567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111114799|NCT02374567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111114800|NCT02374567|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111114801|NCT02374567|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111114802|NCT02374567|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111114803|NCT02374567|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111114804|NCT02374567|Anesthetics, General|anesthetics, general|mesh-ancestor
111114805|NCT02374567|Anesthetics|anesthetics|mesh-ancestor
111114806|NCT02374567|GABA Modulators|gaba modulators|mesh-ancestor
111114807|NCT02374567|GABA Agents|gaba agents|mesh-ancestor
111114808|NCT02374567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111114809|NCT02374567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111114810|NCT02374567|Analgesics|analgesics|mesh-ancestor
111114811|NCT02374567|Sensory System Agents|sensory system agents|mesh-ancestor
111114812|NCT02374567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111114813|NCT02374567|Anticonvulsants|anticonvulsants|mesh-ancestor
111114814|NCT02374567|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111114815|NCT02374567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110648807|NCT00712517|Propofol|propofol|mesh-list
111114816|NCT02374567|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111114817|NCT02374567|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111114818|NCT02374567|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111114819|NCT02374567|Antimanic Agents|antimanic agents|mesh-ancestor
111114820|NCT02374567|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111114821|NCT02374567|Serotonin Agents|serotonin agents|mesh-ancestor
111114822|NCT02374567|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111114823|NCT02374567|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111114824|NCT02374567|Dopamine Agents|dopamine agents|mesh-ancestor
111114825|NCT02374567|Antioxidants|antioxidants|mesh-ancestor
111114826|NCT02374567|Protective Agents|protective agents|mesh-ancestor
111114827|NCT02374567|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111114828|NCT02374567|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111114829|NCT02374567|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111114830|NCT02374567|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111114831|NCT02374567|Parasympatholytics|parasympatholytics|mesh-ancestor
111114832|NCT02374567|Autonomic Agents|autonomic agents|mesh-ancestor
111114833|NCT02374567|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111114834|NCT02374567|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111114835|NCT02374567|Cholinergic Agents|cholinergic agents|mesh-ancestor
111114836|NCT02374567|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111490243|NCT01689324|Vaccines|vaccines|mesh-list
111490244|NCT01689324|Immunologic Factors|immunologic factors|mesh-ancestor
111114837|NCT02374567|Antidepressive Agents|antidepressive agents|mesh-ancestor
111114838|NCT02374567|Antiemetics|antiemetics|mesh-ancestor
111114839|NCT02374567|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111114840|NCT02374567|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111114841|NCT02374567|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111490245|NCT01689324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111114842|NCT02374567|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111114843|NCT02374567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111114844|NCT02374567|Dopamine Agonists|dopamine agonists|mesh-ancestor
111114845|NCT02374567|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111114846|NCT02374567|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111114847|NCT02374567|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111114848|NCT02374567|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111114849|NCT02374567|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111114850|NCT02374567|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111114851|NCT02374567|Nootropic Agents|nootropic agents|mesh-ancestor
111114852|NCT02374567|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111114853|NCT02374567|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111114854|NCT02374567|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111114855|NCT02374567|Anesthetics, Local|anesthetics, local|mesh-ancestor
111114856|NCT02374567|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111114857|NCT02374567|Histamine Antagonists|histamine antagonists|mesh-ancestor
111114858|NCT02374567|Histamine Agents|histamine agents|mesh-ancestor
111114859|NCT02374567|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111114860|NCT02374567|Antipruritics|antipruritics|mesh-ancestor
111114861|NCT02374567|Dermatologic Agents|dermatologic agents|mesh-ancestor
111114862|NCT02374567|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
111114863|NCT02374567|GABA Agonists|gaba agonists|mesh-ancestor
111114864|NCT02374567|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111114865|NCT02374567|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
111114866|NCT02374567|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111114867|NCT02374567|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111114868|NCT02374567|Adrenergic Agents|adrenergic agents|mesh-ancestor
111114869|NCT02374567|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111114870|NCT02374567|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111114871|NCT02374567|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111114872|NCT02374567|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111114873|NCT02374567|Parasympathomimetics|parasympathomimetics|mesh-ancestor
111114874|NCT02374567|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
111114875|NCT02374567|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111114876|NCT02374567|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111114877|NCT02374567|GABA Antagonists|gaba antagonists|mesh-ancestor
111114878|NCT02374567|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
111114879|NCT02374567|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111114880|NCT02374567|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111114881|NCT02374567|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110648812|NCT00712517|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111114882|NCT02374567|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
111114883|NCT02374567|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111114884|NCT02374567|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111114885|NCT02374567|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
111114886|NCT02374567|Vasodilator Agents|vasodilator agents|mesh-ancestor
111114887|NCT03965741|Rivaroxaban|rivaroxaban|mesh-list
111114888|NCT03965741|Apixaban|apixaban|mesh-list
111114889|NCT03965741|Dabigatran|dabigatran|mesh-list
111114890|NCT03965741|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111114891|NCT03965741|Antithrombins|antithrombins|mesh-ancestor
111114892|NCT03965741|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111114893|NCT03965741|Protease Inhibitors|protease inhibitors|mesh-ancestor
111114894|NCT03965741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111114895|NCT03965741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111114896|NCT03965741|Anticoagulants|anticoagulants|mesh-ancestor
111114897|NCT02368171|Nitric Oxide|nitric oxide|mesh-list
111114898|NCT02368171|Carbon Monoxide|carbon monoxide|mesh-list
111114899|NCT02368171|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111114900|NCT02368171|Autonomic Agents|autonomic agents|mesh-ancestor
111114901|NCT02368171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111114902|NCT02368171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111114903|NCT02368171|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111114904|NCT02368171|Respiratory System Agents|respiratory system agents|mesh-ancestor
111114905|NCT02368171|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111114906|NCT02368171|Antioxidants|antioxidants|mesh-ancestor
111114907|NCT02368171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111114908|NCT02368171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111114909|NCT02368171|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
111114910|NCT02368171|Vasodilator Agents|vasodilator agents|mesh-ancestor
111114911|NCT02368171|Gasotransmitters|gasotransmitters|mesh-ancestor
111114912|NCT02368171|Protective Agents|protective agents|mesh-ancestor
111114913|NCT02368171|Antimetabolites|antimetabolites|mesh-ancestor
111114914|NCT02364583|Primaquine|primaquine|mesh-list
111490246|NCT01692756|Triamcinolone|triamcinolone|mesh-list
111490247|NCT01692756|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
111490248|NCT01692756|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
111490249|NCT01692756|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111114915|NCT02364583|Antimalarials|antimalarials|mesh-ancestor
111114916|NCT02364583|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111114917|NCT02364583|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111490250|NCT01692756|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
111490251|NCT01692756|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111114918|NCT02364583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111114919|NCT02368015|Cefazolin|cefazolin|mesh-list
111114920|NCT02368015|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111114921|NCT02368015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111114922|NCT02373943|Carotenoids|carotenoids|mesh-list
111114923|NCT02373943|Antioxidants|antioxidants|mesh-ancestor
111114924|NCT02373943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111114925|NCT02373943|Protective Agents|protective agents|mesh-ancestor
111114926|NCT02373943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111114927|NCT04632433|Cemiplimab|cemiplimab|mesh-list
111114928|NCT04632433|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111114929|NCT04632433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111114930|NCT02368249|Terlipressin|terlipressin|mesh-list
111114931|NCT02368249|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111114932|NCT02368249|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111114933|NCT02367937|Flurbiprofen|flurbiprofen|mesh-list
111114934|NCT02367937|Midazolam|midazolam|mesh-list
111114935|NCT02367937|Omeprazole|omeprazole|mesh-list
111114936|NCT02367937|Simvastatin|simvastatin|mesh-list
111114937|NCT02367937|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111114938|NCT02367937|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111114939|NCT02367937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111114940|NCT02367937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111114941|NCT02367937|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111114942|NCT02367937|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111114943|NCT02367937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111114944|NCT02367937|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111114945|NCT02367937|Anesthetics, General|anesthetics, general|mesh-ancestor
111114946|NCT02367937|Anesthetics|anesthetics|mesh-ancestor
111114947|NCT02367937|GABA Modulators|gaba modulators|mesh-ancestor
111114948|NCT02367937|GABA Agents|gaba agents|mesh-ancestor
111114949|NCT02367937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111114950|NCT02367937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111114951|NCT02367937|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111114952|NCT02367937|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111114953|NCT02367937|Antimetabolites|antimetabolites|mesh-ancestor
111114954|NCT02367937|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111114955|NCT02367937|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111114956|NCT02367937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111114957|NCT02367937|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111114958|NCT02367937|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111114959|NCT02367937|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111114960|NCT02367937|Analgesics|analgesics|mesh-ancestor
111114961|NCT02367937|Sensory System Agents|sensory system agents|mesh-ancestor
111114962|NCT02367937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111114963|NCT02367937|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111114964|NCT02367937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111114965|NCT02367937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111114966|NCT02367937|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111114967|NCT02367937|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111114968|NCT05011487|Pemetrexed|pemetrexed|mesh-list
111114969|NCT05011487|Osimertinib|osimertinib|mesh-list
111114970|NCT05011487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111114971|NCT05011487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111114972|NCT05011487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111114973|NCT05011487|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111114974|NCT05011487|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111114975|NCT05011487|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111114976|NCT02367547|Aminolevulinic Acid|aminolevulinic acid|mesh-list
111114977|NCT02367547|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
111114978|NCT02367547|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111114979|NCT02367547|Dermatologic Agents|dermatologic agents|mesh-ancestor
111114980|NCT05061641|Progesterone|progesterone|mesh-list
111114981|NCT05061641|Progestins|progestins|mesh-ancestor
111114982|NCT05061641|Hormones|hormones|mesh-ancestor
111114983|NCT05061641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111114984|NCT05061641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111114985|NCT03100019|Resveratrol|resveratrol|mesh-list
111114986|NCT03100019|Antioxidants|antioxidants|mesh-ancestor
111114987|NCT03100019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111114988|NCT03100019|Protective Agents|protective agents|mesh-ancestor
111490252|NCT01692756|Glucocorticoids|glucocorticoids|mesh-ancestor
111490253|NCT01692756|Hormones|hormones|mesh-ancestor
111114989|NCT03100019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111114991|NCT03100019|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111114992|NCT05047055|Moxifloxacin|moxifloxacin|mesh-list
111114993|NCT05047055|Rifampin|rifampin|mesh-list
111114994|NCT05047055|Isoniazid|isoniazid|mesh-list
111114995|NCT05047055|Pyrazinamide|pyrazinamide|mesh-list
111114996|NCT05047055|Ethambutol|ethambutol|mesh-list
111114997|NCT05047055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111114998|NCT05047055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111114999|NCT05047055|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111115000|NCT05047055|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111115001|NCT05047055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111115002|NCT05047055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111115003|NCT05047055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111115004|NCT05047055|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111115005|NCT05047055|Antitubercular Agents|antitubercular agents|mesh-ancestor
111115006|NCT05047055|Leprostatic Agents|leprostatic agents|mesh-ancestor
111115007|NCT05047055|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111115008|NCT05047055|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111115009|NCT05047055|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111115010|NCT05047055|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110648820|NCT00712595|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111115011|NCT05047055|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
111115012|NCT05047055|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
111115013|NCT05047055|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111115014|NCT05047055|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
111115015|NCT05047055|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111115016|NCT05047055|Antimetabolites|antimetabolites|mesh-ancestor
111115017|NCT05047055|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111115018|NCT03098537|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
111115019|NCT03098537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111115020|NCT03098537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111115022|NCT05046041|Mifepristone|mifepristone|mesh-list
111115023|NCT05046041|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111115024|NCT05046041|Abortifacient Agents|abortifacient agents|mesh-ancestor
111115025|NCT05046041|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111115026|NCT05046041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111115027|NCT05046041|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111115028|NCT05046041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111115029|NCT05046041|Oxytocics|oxytocics|mesh-ancestor
111115030|NCT05046041|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
111115031|NCT05046041|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111115032|NCT05046041|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111115033|NCT05046041|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111115034|NCT05046041|Contraceptive Agents|contraceptive agents|mesh-ancestor
111115035|NCT05046041|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
111115036|NCT05046041|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
111115037|NCT05046041|Hormone Antagonists|hormone antagonists|mesh-ancestor
111115038|NCT05046041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111115039|NCT05046041|Luteolytic Agents|luteolytic agents|mesh-ancestor
111115040|NCT05046041|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111115041|NCT05046041|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
111115042|NCT01970878|Bromides|bromides|mesh-list
111115043|NCT01970878|Tiotropium Bromide|tiotropium bromide|mesh-list
111115044|NCT01970878|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111115045|NCT01970878|Autonomic Agents|autonomic agents|mesh-ancestor
111115046|NCT01970878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111115047|NCT01970878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111115048|NCT01970878|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111115049|NCT01970878|Respiratory System Agents|respiratory system agents|mesh-ancestor
111115050|NCT01970878|Parasympatholytics|parasympatholytics|mesh-ancestor
111115051|NCT01970878|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111115052|NCT01970878|Cholinergic Agents|cholinergic agents|mesh-ancestor
111115053|NCT01970878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111115054|NCT01970878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111115055|NCT01970878|Anticonvulsants|anticonvulsants|mesh-ancestor
111115056|NCT05045651|Cimetidine|cimetidine|mesh-list
111115057|NCT05045651|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111115058|NCT05045651|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111115059|NCT05045651|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
111115060|NCT05045651|Histamine Antagonists|histamine antagonists|mesh-ancestor
111115061|NCT05045651|Histamine Agents|histamine agents|mesh-ancestor
110698381|NCT00429416|Cyclophosphamide|cyclophosphamide|mesh-list
111490254|NCT01692756|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111115062|NCT05045651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111115063|NCT05045651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111115064|NCT05045651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111115065|NCT05045651|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111115066|NCT05045651|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111115067|NCT05045651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111115068|NCT05059145|Chlorhexidine|chlorhexidine|mesh-list
111115069|NCT05059145|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
111115070|NCT05059145|Fluconazole|fluconazole|mesh-list
111115071|NCT05059145|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111115072|NCT05059145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111115073|NCT05059145|Disinfectants|disinfectants|mesh-ancestor
111115074|NCT05059145|Dermatologic Agents|dermatologic agents|mesh-ancestor
111115075|NCT05059145|Antifungal Agents|antifungal agents|mesh-ancestor
111115076|NCT05059145|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111115077|NCT05059145|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111115078|NCT05059145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111115079|NCT05059145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111115080|NCT05059145|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111115081|NCT05059145|Hormone Antagonists|hormone antagonists|mesh-ancestor
111115082|NCT05059145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111115083|NCT05059145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111115084|NCT05059145|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111115085|NCT05059145|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111115086|NCT05058677|Lidocaine|lidocaine|mesh-list
111115087|NCT05058677|Anesthetics, Local|anesthetics, local|mesh-ancestor
111115088|NCT05058677|Anesthetics|anesthetics|mesh-ancestor
111115089|NCT05058677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111115090|NCT05058677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110832166|NCT05282407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111115091|NCT05058677|Sensory System Agents|sensory system agents|mesh-ancestor
111115092|NCT05058677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111115093|NCT05058677|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111115094|NCT05058677|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111115095|NCT05058677|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111115096|NCT05058677|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111115097|NCT05058677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111115099|NCT01970488|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111115100|NCT01970488|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111115101|NCT01970488|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111115102|NCT03097835|Anesthetics|anesthetics|mesh-list
111115103|NCT03097835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111115104|NCT03097835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111115105|NCT03097601|Sunitinib|sunitinib|mesh-list
111115106|NCT03097601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111115107|NCT03097601|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111115108|NCT03097601|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111115109|NCT03097601|Growth Substances|growth substances|mesh-ancestor
111115110|NCT03097601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111115111|NCT03097601|Growth Inhibitors|growth inhibitors|mesh-ancestor
111115112|NCT03097601|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111115113|NCT03097601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111115114|NCT03097601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111115115|NCT05058755|Etoposide|etoposide|mesh-list
111115116|NCT05058755|Lenalidomide|lenalidomide|mesh-list
111115117|NCT05058755|Azacitidine|azacitidine|mesh-list
111115118|NCT05058755|Tislelizumab|tislelizumab|mesh-list
111115119|NCT05058755|Pegaspargase|pegaspargase|mesh-list
111115120|NCT05058755|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111115121|NCT05058755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111115122|NCT05058755|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111115123|NCT05058755|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111115124|NCT05058755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111115125|NCT05058755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111115126|NCT05058755|Immunologic Factors|immunologic factors|mesh-ancestor
111115127|NCT05058755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111115128|NCT05058755|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111115129|NCT05058755|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111115130|NCT05058755|Growth Substances|growth substances|mesh-ancestor
111115131|NCT05058755|Growth Inhibitors|growth inhibitors|mesh-ancestor
111490255|NCT01692756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111490256|NCT01692756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111115132|NCT05058755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111115134|NCT05058755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111115135|NCT05044169|Broncho-Vaxom|broncho-vaxom|mesh-list
111115136|NCT05044169|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111115137|NCT05044169|Immunologic Factors|immunologic factors|mesh-ancestor
111115138|NCT05044169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111115139|NCT05058209|Triamcinolone|triamcinolone|mesh-list
111115140|NCT05058209|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
111115141|NCT05058209|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
111115142|NCT05058209|Betamethasone|betamethasone|mesh-list
111115143|NCT05058209|Betamethasone Valerate|betamethasone valerate|mesh-list
111115144|NCT05058209|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
111115145|NCT05058209|Betamethasone benzoate|betamethasone benzoate|mesh-list
111115146|NCT05058209|Betamethasone acetate|betamethasone acetate|mesh-list
111115147|NCT05058209|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
111115148|NCT05058209|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
111115149|NCT05058209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111115150|NCT05058209|Glucocorticoids|glucocorticoids|mesh-ancestor
111115151|NCT05058209|Hormones|hormones|mesh-ancestor
111115152|NCT05058209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111115153|NCT05058209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111115154|NCT05058209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111115155|NCT05058209|Immunologic Factors|immunologic factors|mesh-ancestor
111115156|NCT05058209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111115157|NCT05058209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111115158|NCT05058209|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111115159|NCT05058209|Respiratory System Agents|respiratory system agents|mesh-ancestor
111115160|NCT05057663|Fluorouracil|fluorouracil|mesh-list
111115161|NCT05057663|Bleomycin|bleomycin|mesh-list
111115162|NCT05057663|Antimetabolites|antimetabolites|mesh-ancestor
111115163|NCT05057663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110832251|NCT03714555|Copper|copper|mesh-list
111115164|NCT05057663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111115165|NCT05057663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111115166|NCT05057663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111115167|NCT05057663|Immunologic Factors|immunologic factors|mesh-ancestor
111115168|NCT05057663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111115169|NCT05057663|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111115170|NCT03097445|Nicotine|nicotine|mesh-list
111115171|NCT03097445|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111115172|NCT03097445|Autonomic Agents|autonomic agents|mesh-ancestor
111115173|NCT03097445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111115174|NCT03097445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111115175|NCT03097445|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111115176|NCT03097445|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111115177|NCT03097445|Cholinergic Agents|cholinergic agents|mesh-ancestor
111115178|NCT03097445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111115179|NCT03097445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111115180|NCT05057351|Glycerol|glycerol|mesh-list
111115181|NCT05057351|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
111115182|NCT05057351|Protective Agents|protective agents|mesh-ancestor
111115183|NCT05057351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111115184|NCT03097211|Levodopa|levodopa|mesh-list
111115185|NCT03097211|Benserazide|benserazide|mesh-list
111115186|NCT03097211|Resveratrol|resveratrol|mesh-list
111115187|NCT03097211|Benserazide, levodopa drug combination|benserazide, levodopa drug combination|mesh-list
111115188|NCT03097211|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111115189|NCT03097211|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111115190|NCT03097211|Dopamine Agents|dopamine agents|mesh-ancestor
111115191|NCT03097211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111115192|NCT03097211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111115193|NCT03097211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111115194|NCT03097211|Antioxidants|antioxidants|mesh-ancestor
111115195|NCT03097211|Protective Agents|protective agents|mesh-ancestor
111115196|NCT03097211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111115197|NCT03097211|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111115198|NCT05043935|Anti-Infective Agents|anti-infective agents|mesh-list
111115199|NCT05043935|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111115200|NCT05056337|Lenvatinib|lenvatinib|mesh-list
111115201|NCT05056337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111115202|NCT05056337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111490257|NCT01692756|Immunologic Factors|immunologic factors|mesh-ancestor
111115203|NCT05056337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111490258|NCT01692756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110698386|NCT00429416|Sargramostim|sargramostim|mesh-list
111115204|NCT05056337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111115205|NCT05056025|Vitamins|vitamins|mesh-list
111115206|NCT05056025|Micronutrients|micronutrients|mesh-ancestor
111115207|NCT05056025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111115208|NCT02661217|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
111115209|NCT02661217|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111115210|NCT02661217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111115211|NCT05044091|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
111115212|NCT05044091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111115213|NCT05044091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111115214|NCT05044091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111115215|NCT01952080|Teduglutide|teduglutide|mesh-list
111115216|NCT01952080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111115217|NCT01952080|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111115218|NCT01952080|Protective Agents|protective agents|mesh-ancestor
111115219|NCT01952080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111115220|NCT01951378|Albuterol|albuterol|mesh-list
111115221|NCT01951378|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111115222|NCT01951378|Autonomic Agents|autonomic agents|mesh-ancestor
111115223|NCT01951378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111115224|NCT01951378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111115225|NCT01951378|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111115226|NCT01951378|Respiratory System Agents|respiratory system agents|mesh-ancestor
111115227|NCT01951378|Tocolytic Agents|tocolytic agents|mesh-ancestor
111115228|NCT01951378|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111115229|NCT01951378|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111115230|NCT01951378|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111115231|NCT01951378|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111115232|NCT01951378|Adrenergic Agents|adrenergic agents|mesh-ancestor
111115233|NCT01951378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111115234|NCT01951378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111115235|NCT05043233|Methimazole|methimazole|mesh-list
111115236|NCT05043233|Antithyroid Agents|antithyroid agents|mesh-ancestor
111115237|NCT05043233|Hormone Antagonists|hormone antagonists|mesh-ancestor
111115238|NCT05043233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111115239|NCT05043233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111115240|NCT05054465|Venetoclax|venetoclax|mesh-list
111115241|NCT05054465|Navitoclax|navitoclax|mesh-list
111115242|NCT05054465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111115243|NCT03860233|Oxytocin|oxytocin|mesh-list
111115244|NCT03860233|Oxytocics|oxytocics|mesh-ancestor
111115245|NCT03860233|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111115246|NCT03860233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111115247|NCT02373085|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111115248|NCT02373085|Anti-Infective Agents|anti-infective agents|mesh-list
111115249|NCT01361009|Pramipexole|pramipexole|mesh-list
111115250|NCT01361009|Antioxidants|antioxidants|mesh-ancestor
111115251|NCT01361009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111115252|NCT01361009|Protective Agents|protective agents|mesh-ancestor
111115253|NCT01361009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111115254|NCT01361009|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111115255|NCT01361009|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111115256|NCT01361009|Dopamine Agonists|dopamine agonists|mesh-ancestor
111115257|NCT01361009|Dopamine Agents|dopamine agents|mesh-ancestor
111115258|NCT01361009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111115259|NCT02373163|Amlodipine|amlodipine|mesh-list
111115260|NCT02373163|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
111115261|NCT02373163|Telmisartan|telmisartan|mesh-list
111115262|NCT02373163|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111115263|NCT02373163|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111115264|NCT02373163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111115265|NCT02373163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111115266|NCT02373163|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111115267|NCT02373163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111115268|NCT02373163|Vasodilator Agents|vasodilator agents|mesh-ancestor
111115269|NCT02373163|Diuretics|diuretics|mesh-ancestor
111115270|NCT02373163|Natriuretic Agents|natriuretic agents|mesh-ancestor
111115271|NCT02373163|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
111115272|NCT02373163|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111115273|NCT02373163|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111490259|NCT01692756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111490260|NCT01695330|Bortezomib|bortezomib|mesh-list
111490261|NCT01695330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111490262|NCT01701102|Fentanyl|fentanyl|mesh-list
111490263|NCT01701102|Mepivacaine|mepivacaine|mesh-list
111490264|NCT01701102|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111490265|NCT01701102|Narcotics|narcotics|mesh-ancestor
111490266|NCT01701102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111490267|NCT01701102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111490268|NCT01701102|Analgesics|analgesics|mesh-ancestor
111115274|NCT02366377|Metformin|metformin|mesh-list
111115275|NCT02366377|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111115276|NCT02366377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111115277|NCT02366299|Dexmedetomidine|dexmedetomidine|mesh-list
111115278|NCT02366299|Propofol|propofol|mesh-list
111115279|NCT02366299|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111115280|NCT02366299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111115281|NCT02366299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111115282|NCT02366299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111115283|NCT02366299|Analgesics|analgesics|mesh-ancestor
111115284|NCT02366299|Sensory System Agents|sensory system agents|mesh-ancestor
111115285|NCT02366299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111115286|NCT02366299|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111115287|NCT02366299|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111115288|NCT02366299|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111115289|NCT02366299|Adrenergic Agents|adrenergic agents|mesh-ancestor
111115290|NCT02366299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111115291|NCT02366299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111115292|NCT02366299|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111115293|NCT02366299|Anesthetics, General|anesthetics, general|mesh-ancestor
111115294|NCT02366299|Anesthetics|anesthetics|mesh-ancestor
111115295|NCT05041985|Diazepam|diazepam|mesh-list
111115296|NCT05041985|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111115297|NCT05041985|Anticonvulsants|anticonvulsants|mesh-ancestor
111115298|NCT05041985|Antiemetics|antiemetics|mesh-ancestor
111115299|NCT05041985|Autonomic Agents|autonomic agents|mesh-ancestor
111115300|NCT05041985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111115301|NCT05041985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111115302|NCT05041985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111115303|NCT05041985|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111115304|NCT05041985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111115305|NCT05041985|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
111115306|NCT05041985|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111115307|NCT05041985|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111115308|NCT05041985|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111115309|NCT05041985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111115310|NCT05041985|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111115311|NCT05041985|Anesthetics, General|anesthetics, general|mesh-ancestor
111115312|NCT05041985|Anesthetics|anesthetics|mesh-ancestor
111115313|NCT05041985|GABA Modulators|gaba modulators|mesh-ancestor
111115314|NCT05041985|GABA Agents|gaba agents|mesh-ancestor
111115315|NCT05041985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111115316|NCT05041985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111115317|NCT05053841|Metformin|metformin|mesh-list
111115318|NCT05053841|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111115319|NCT05053841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111115320|NCT02372461|Amoxicillin|amoxicillin|mesh-list
111115321|NCT02372461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111115322|NCT02372461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111115323|NCT04499131|Progesterone|progesterone|mesh-list
111115324|NCT04499131|Progestins|progestins|mesh-ancestor
111115325|NCT04499131|Hormones|hormones|mesh-ancestor
111115326|NCT04499131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111115327|NCT04499131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111490269|NCT01701102|Sensory System Agents|sensory system agents|mesh-ancestor
111490270|NCT01701102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111490271|NCT01701102|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111490272|NCT01701102|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111490273|NCT01701102|Anesthetics, General|anesthetics, general|mesh-ancestor
111490274|NCT01701102|Anesthetics|anesthetics|mesh-ancestor
111490275|NCT01701102|Anesthetics, Local|anesthetics, local|mesh-ancestor
111490276|NCT01701414|Bupivacaine|bupivacaine|mesh-list
111490277|NCT01701414|Anesthetics, Local|anesthetics, local|mesh-ancestor
111490278|NCT01701414|Anesthetics|anesthetics|mesh-ancestor
111115328|NCT02366065|Acetaminophen|acetaminophen|mesh-list
111115329|NCT02366065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111115330|NCT02366065|Analgesics|analgesics|mesh-ancestor
111490279|NCT01701414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111490280|NCT01701414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111115331|NCT02366065|Sensory System Agents|sensory system agents|mesh-ancestor
111115332|NCT02366065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111115333|NCT02366065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111115334|NCT02366065|Antipyretics|antipyretics|mesh-ancestor
111115335|NCT02362945|Oxytocin|oxytocin|mesh-list
111115336|NCT02362945|Oxytocics|oxytocics|mesh-ancestor
111115337|NCT02362945|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111115338|NCT02362945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111115339|NCT02365909|Bupivacaine|bupivacaine|mesh-list
111115340|NCT02365909|Anesthetics, Local|anesthetics, local|mesh-ancestor
111115341|NCT02365909|Anesthetics|anesthetics|mesh-ancestor
111115342|NCT02365909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111115343|NCT02365909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111115344|NCT02365909|Sensory System Agents|sensory system agents|mesh-ancestor
111115345|NCT02365909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111115346|NCT05052515|Choline|choline|mesh-list
111115347|NCT05052515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111115348|NCT05052515|Lipotropic Agents|lipotropic agents|mesh-ancestor
111115349|NCT05052515|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111115350|NCT05052515|Antimetabolites|antimetabolites|mesh-ancestor
111115351|NCT05052515|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111115352|NCT05052515|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111115353|NCT05052515|Nootropic Agents|nootropic agents|mesh-ancestor
111115354|NCT02365675|Petrolatum|petrolatum|mesh-list
111115355|NCT02365675|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
111115356|NCT02365675|Laxatives|laxatives|mesh-ancestor
111115357|NCT02365675|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111115358|NCT02365675|Emollients|emollients|mesh-ancestor
111115359|NCT02365675|Dermatologic Agents|dermatologic agents|mesh-ancestor
111115360|NCT05052437|Capecitabine|capecitabine|mesh-list
111115361|NCT05052437|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111115362|NCT05052437|Antimetabolites|antimetabolites|mesh-ancestor
111115363|NCT05052437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111115364|NCT05052437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111115365|NCT05052359|Lectins|lectins|mesh-list
111115366|NCT05052359|Agglutinins|agglutinins|mesh-ancestor
111115367|NCT05052359|Immunologic Factors|immunologic factors|mesh-ancestor
111115368|NCT05052359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111115369|NCT05052359|Coagulants|coagulants|mesh-ancestor
111115370|NCT02362711|Levonorgestrel|levonorgestrel|mesh-list
111115371|NCT02362711|Ethinyl Estradiol|ethinyl estradiol|mesh-list
111115372|NCT02362711|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111115373|NCT02362711|Contraceptive Agents|contraceptive agents|mesh-ancestor
111115374|NCT02362711|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111115375|NCT02362711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111115376|NCT02362711|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111115377|NCT02362711|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111115378|NCT02362711|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111115379|NCT02362711|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111115380|NCT02362711|Estrogens|estrogens|mesh-ancestor
111115381|NCT02362711|Hormones|hormones|mesh-ancestor
111115382|NCT02362711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111115383|NCT01944046|Oxytocin|oxytocin|mesh-list
111115384|NCT01944046|Oxytocics|oxytocics|mesh-ancestor
111115385|NCT01944046|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111115386|NCT01944046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111115387|NCT00773695|Paclitaxel|paclitaxel|mesh-list
111115388|NCT00773695|Docetaxel|docetaxel|mesh-list
111115389|NCT00773695|Cyclophosphamide|cyclophosphamide|mesh-list
111115390|NCT00773695|Bevacizumab|bevacizumab|mesh-list
111115391|NCT00773695|Fluorouracil|fluorouracil|mesh-list
111115392|NCT00773695|Epirubicin|epirubicin|mesh-list
111115393|NCT00773695|Aromatase Inhibitors|aromatase inhibitors|mesh-list
111115394|NCT00773695|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111115395|NCT00773695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111115396|NCT00773695|Tubulin Modulators|tubulin modulators|mesh-ancestor
111115397|NCT00773695|Antimitotic Agents|antimitotic agents|mesh-ancestor
111115398|NCT00773695|Mitosis Modulators|mitosis modulators|mesh-ancestor
110648863|NCT00721331|Loratadine|loratadine|mesh-list
111115399|NCT00773695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111115400|NCT00773695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111115401|NCT00773695|Immunologic Factors|immunologic factors|mesh-ancestor
111115402|NCT00773695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111115403|NCT00773695|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111115404|NCT00773695|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111490281|NCT01701414|Sensory System Agents|sensory system agents|mesh-ancestor
111115405|NCT00773695|Alkylating Agents|alkylating agents|mesh-ancestor
111115406|NCT00773695|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111115407|NCT00773695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111115408|NCT00773695|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110024196|NCT00004368|Antimitotic Agents|antimitotic agents|mesh-ancestor
111115409|NCT00773695|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111115410|NCT00773695|Growth Substances|growth substances|mesh-ancestor
111115411|NCT00773695|Growth Inhibitors|growth inhibitors|mesh-ancestor
111115412|NCT00773695|Antimetabolites|antimetabolites|mesh-ancestor
111115413|NCT00773695|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111115414|NCT00773695|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111115415|NCT00773695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111115416|NCT00773695|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111115417|NCT00773695|Hormone Antagonists|hormone antagonists|mesh-ancestor
111115418|NCT00773695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111115419|NCT00773695|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111115420|NCT00773695|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111115421|NCT00773695|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111115423|NCT01969084|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111115424|NCT01969084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111115425|NCT01969084|Incretins|incretins|mesh-ancestor
111115426|NCT01969084|Hormones|hormones|mesh-ancestor
111115427|NCT01969084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111115428|NCT01969084|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111115429|NCT01969084|Protease Inhibitors|protease inhibitors|mesh-ancestor
111115430|NCT01969084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111115431|NCT01969084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111115432|NCT02362399|Sildenafil Citrate|sildenafil citrate|mesh-list
111115433|NCT02362399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111115434|NCT02362399|Vasodilator Agents|vasodilator agents|mesh-ancestor
111115435|NCT02362399|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111115436|NCT02362399|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111115437|NCT02362399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111115438|NCT02362399|Urological Agents|urological agents|mesh-ancestor
111115439|NCT04410887|Olaparib|olaparib|mesh-list
111115440|NCT04410887|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111115441|NCT04410887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111115442|NCT04410887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111115443|NCT04410887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111115444|NCT02358499|Posaconazole|posaconazole|mesh-list
111115445|NCT02358499|Antifungal Agents|antifungal agents|mesh-ancestor
111115446|NCT02358499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111115447|NCT02358499|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
111115448|NCT02358499|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111115449|NCT02358499|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111115450|NCT02358499|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111115451|NCT02358499|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111115452|NCT02358499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111115453|NCT02358499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111115454|NCT02358499|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111115455|NCT02358499|Hormone Antagonists|hormone antagonists|mesh-ancestor
111115456|NCT02358499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111115457|NCT02358499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111115458|NCT02358265|Cyproheptadine|cyproheptadine|mesh-list
111115459|NCT02358265|Antipruritics|antipruritics|mesh-ancestor
111115460|NCT02358265|Dermatologic Agents|dermatologic agents|mesh-ancestor
111115461|NCT02358265|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111115462|NCT02358265|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111115463|NCT02358265|Histamine Antagonists|histamine antagonists|mesh-ancestor
111115464|NCT02358265|Histamine Agents|histamine agents|mesh-ancestor
110832543|NCT01220219|Pregabalin|pregabalin|mesh-list
111115465|NCT02358265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111115466|NCT02358265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111115467|NCT02358265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111115468|NCT02358265|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111115469|NCT02358265|Serotonin Agents|serotonin agents|mesh-ancestor
111115470|NCT02358265|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111115471|NCT01968694|Diphenhydramine|diphenhydramine|mesh-list
111115472|NCT01968694|Promethazine|promethazine|mesh-list
111115473|NCT01968694|Lidocaine|lidocaine|mesh-list
111115474|NCT01968694|Anesthetics, Local|anesthetics, local|mesh-ancestor
111115475|NCT01968694|Anesthetics|anesthetics|mesh-ancestor
111115476|NCT01968694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111490282|NCT01701414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111490283|NCT01706952|Epinephrine|epinephrine|mesh-list
111490284|NCT01706952|Racepinephrine|racepinephrine|mesh-list
111490285|NCT01706952|Cocaine|cocaine|mesh-list
111490286|NCT01706952|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111490287|NCT01706952|Epinephryl borate|epinephryl borate|mesh-list
111490288|NCT01706952|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111115477|NCT01968694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111115478|NCT01968694|Sensory System Agents|sensory system agents|mesh-ancestor
111115479|NCT01968694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111115480|NCT01968694|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111115481|NCT01968694|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111115482|NCT01968694|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111115483|NCT01968694|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111115484|NCT01968694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111115485|NCT01968694|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111115486|NCT01968694|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111115487|NCT01968694|Antiemetics|antiemetics|mesh-ancestor
111115488|NCT01968694|Autonomic Agents|autonomic agents|mesh-ancestor
111115489|NCT01968694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111115490|NCT01968694|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111115491|NCT01968694|Histamine Antagonists|histamine antagonists|mesh-ancestor
111115492|NCT01968694|Histamine Agents|histamine agents|mesh-ancestor
111115493|NCT01968694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111115494|NCT01968694|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111115495|NCT01968694|Antipruritics|antipruritics|mesh-ancestor
111115496|NCT01968694|Dermatologic Agents|dermatologic agents|mesh-ancestor
111115497|NCT05038007|Bupivacaine|bupivacaine|mesh-list
111115498|NCT05038007|Anesthetics, Local|anesthetics, local|mesh-ancestor
111115499|NCT05038007|Anesthetics|anesthetics|mesh-ancestor
111115500|NCT05038007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111115501|NCT05038007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111115502|NCT05038007|Sensory System Agents|sensory system agents|mesh-ancestor
111115503|NCT05038007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111115504|NCT02362165|Dexamethasone|dexamethasone|mesh-list
111115505|NCT02362165|Cyclophosphamide|cyclophosphamide|mesh-list
111115506|NCT02362165|Doxorubicin|doxorubicin|mesh-list
111115508|NCT02362165|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111115509|NCT02362165|Immunologic Factors|immunologic factors|mesh-ancestor
111115510|NCT02362165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111115511|NCT02362165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111115512|NCT02362165|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111115513|NCT02362165|Alkylating Agents|alkylating agents|mesh-ancestor
111115514|NCT02362165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111115515|NCT02362165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111115516|NCT02362165|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111115517|NCT02362165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111115518|NCT02362165|Antiemetics|antiemetics|mesh-ancestor
111115519|NCT02362165|Autonomic Agents|autonomic agents|mesh-ancestor
111115520|NCT02362165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111115521|NCT02362165|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111115522|NCT02362165|Glucocorticoids|glucocorticoids|mesh-ancestor
111115523|NCT02362165|Hormones|hormones|mesh-ancestor
111115524|NCT02362165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111115525|NCT02362165|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110648872|NCT00721331|Histamine Agents|histamine agents|mesh-ancestor
111115526|NCT02362165|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111115527|NCT02362165|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111115528|NCT02362165|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111115529|NCT02362165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111115530|NCT05049473|Cytarabine|cytarabine|mesh-list
111115531|NCT05049473|Dexamethasone|dexamethasone|mesh-list
111115532|NCT05049473|Prednisone|prednisone|mesh-list
111115533|NCT05049473|Hydrocortisone|hydrocortisone|mesh-list
111115534|NCT05049473|Cyclophosphamide|cyclophosphamide|mesh-list
111115535|NCT05049473|Rituximab|rituximab|mesh-list
111115536|NCT05049473|Doxorubicin|doxorubicin|mesh-list
111115537|NCT05049473|Methotrexate|methotrexate|mesh-list
111115538|NCT05049473|Etoposide|etoposide|mesh-list
110832613|NCT01204723|Autonomic Agents|autonomic agents|mesh-ancestor
111115539|NCT05049473|Vincristine|vincristine|mesh-list
111115540|NCT05049473|Vindesine|vindesine|mesh-list
111115541|NCT05049473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111115543|NCT05049473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111115544|NCT05049473|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111115545|NCT05049473|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111115546|NCT05049473|Alkylating Agents|alkylating agents|mesh-ancestor
111115547|NCT05049473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111490289|NCT01706952|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111115548|NCT05049473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111115549|NCT05049473|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110698414|NCT00429182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111115550|NCT05049473|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111115551|NCT05049473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111115552|NCT05049473|Antiemetics|antiemetics|mesh-ancestor
111115553|NCT05049473|Autonomic Agents|autonomic agents|mesh-ancestor
111115554|NCT05049473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111115555|NCT05049473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111115556|NCT05049473|Glucocorticoids|glucocorticoids|mesh-ancestor
111115557|NCT05049473|Hormones|hormones|mesh-ancestor
111115558|NCT05049473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111115559|NCT05049473|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111115560|NCT05049473|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111115561|NCT05049473|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111115562|NCT05049473|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111115563|NCT05049473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111115564|NCT05049473|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111115565|NCT05049473|Abortifacient Agents|abortifacient agents|mesh-ancestor
111115566|NCT05049473|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111115567|NCT05049473|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111115568|NCT05049473|Antimetabolites|antimetabolites|mesh-ancestor
111115569|NCT05049473|Dermatologic Agents|dermatologic agents|mesh-ancestor
111115570|NCT05049473|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111115571|NCT05049473|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111115572|NCT05049473|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111115573|NCT05049473|Antiviral Agents|antiviral agents|mesh-ancestor
111115574|NCT05049473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111115575|NCT05049473|Tubulin Modulators|tubulin modulators|mesh-ancestor
111115576|NCT05049473|Antimitotic Agents|antimitotic agents|mesh-ancestor
111115577|NCT05049473|Mitosis Modulators|mitosis modulators|mesh-ancestor
111115578|NCT02361931|Epoetin Alfa|epoetin alfa|mesh-list
111115579|NCT02361931|Hematinics|hematinics|mesh-ancestor
111115580|NCT05037695|Empagliflozin|empagliflozin|mesh-list
111115581|NCT05037695|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111115582|NCT05037695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111115583|NCT05037695|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111115584|NCT05037695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111115585|NCT02357563|Leuprolide|leuprolide|mesh-list
111115586|NCT02357563|Ulipristal acetate|ulipristal acetate|mesh-list
111115587|NCT02357563|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110648883|NCT00123955|Spironolactone|spironolactone|mesh-list
111115588|NCT02357563|Fertility Agents|fertility agents|mesh-ancestor
111115589|NCT02357563|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111115590|NCT02357563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111115591|NCT02357563|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111115592|NCT02357563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111115593|NCT02357563|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111115594|NCT02357563|Contraceptive Agents|contraceptive agents|mesh-ancestor
111115595|NCT02357563|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111115596|NCT02640053|Paclitaxel|paclitaxel|mesh-list
111115597|NCT02640053|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111115598|NCT02640053|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111115599|NCT02640053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111115600|NCT02640053|Tubulin Modulators|tubulin modulators|mesh-ancestor
111115601|NCT02640053|Antimitotic Agents|antimitotic agents|mesh-ancestor
111115602|NCT02640053|Mitosis Modulators|mitosis modulators|mesh-ancestor
111115603|NCT02640053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111115604|NCT03160261|Exenatide|exenatide|mesh-list
111115605|NCT03160261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111115606|NCT03160261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111115607|NCT03160261|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111115608|NCT03160261|Incretins|incretins|mesh-ancestor
111115609|NCT03160261|Hormones|hormones|mesh-ancestor
111115610|NCT03160261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111115611|NCT02361775|Ropivacaine|ropivacaine|mesh-list
111115612|NCT02361775|Anesthetics, Local|anesthetics, local|mesh-ancestor
111115613|NCT02361775|Anesthetics|anesthetics|mesh-ancestor
111115614|NCT02361775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110832706|NCT03130504|Hormones|hormones|mesh-ancestor
111115615|NCT02361775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111115616|NCT02361775|Sensory System Agents|sensory system agents|mesh-ancestor
111115617|NCT02361775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111490290|NCT01706952|Adrenergic Agents|adrenergic agents|mesh-ancestor
111490291|NCT01706952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111490292|NCT01706952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111490293|NCT01706952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111115618|NCT02361619|Clarithromycin|clarithromycin|mesh-list
111115620|NCT02361619|Metoprolol|metoprolol|mesh-list
111115622|NCT02361619|Caffeine|caffeine|mesh-list
111115623|NCT02361619|Esomeprazole|esomeprazole|mesh-list
111115624|NCT02361619|Dabigatran|dabigatran|mesh-list
111115625|NCT02361619|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111115626|NCT02361619|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111115627|NCT02361619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111115628|NCT02361619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111115629|NCT02361619|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111115630|NCT02361619|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111115631|NCT02361619|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111115632|NCT02361619|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111115633|NCT02361619|Anesthetics, General|anesthetics, general|mesh-ancestor
111115634|NCT02361619|Anesthetics|anesthetics|mesh-ancestor
111115635|NCT02361619|GABA Modulators|gaba modulators|mesh-ancestor
111115636|NCT02361619|GABA Agents|gaba agents|mesh-ancestor
111115637|NCT02361619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111115638|NCT02361619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111115639|NCT02361619|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111115640|NCT02361619|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111115641|NCT02361619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111115642|NCT02361619|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
111115643|NCT02361619|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111115644|NCT02361619|Purinergic Agents|purinergic agents|mesh-ancestor
111115645|NCT02361619|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111115646|NCT02361619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111115647|NCT02361619|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111115648|NCT02361619|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111115649|NCT02361619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111115650|NCT02361619|Analgesics|analgesics|mesh-ancestor
111115651|NCT02361619|Sensory System Agents|sensory system agents|mesh-ancestor
111115652|NCT02361619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111115653|NCT02361619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111115654|NCT02361619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111115655|NCT02361619|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111115656|NCT02361619|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111115657|NCT02361619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111115658|NCT02361619|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111115659|NCT02361619|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111115660|NCT02361619|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111115661|NCT02361619|Antithrombins|antithrombins|mesh-ancestor
111115662|NCT02361619|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111115663|NCT02361619|Protease Inhibitors|protease inhibitors|mesh-ancestor
111115664|NCT02361619|Anticoagulants|anticoagulants|mesh-ancestor
111115665|NCT02361619|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111115666|NCT02361619|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111115667|NCT02361619|Sympatholytics|sympatholytics|mesh-ancestor
111115668|NCT02361619|Autonomic Agents|autonomic agents|mesh-ancestor
111115669|NCT02361619|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
111115670|NCT02361619|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111115671|NCT02361619|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111115672|NCT02361619|Adrenergic Agents|adrenergic agents|mesh-ancestor
111115673|NCT02352025|Equol|equol|mesh-list
111115674|NCT02352025|Phytoestrogens|phytoestrogens|mesh-ancestor
111115675|NCT02352025|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
111115676|NCT02352025|Estrogens|estrogens|mesh-ancestor
111115677|NCT02352025|Hormones|hormones|mesh-ancestor
111115678|NCT02352025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111115679|NCT02352025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111115680|NCT01950364|Rifampin|rifampin|mesh-list
111115681|NCT01950364|Brentuximab Vedotin|brentuximab vedotin|mesh-list
111115682|NCT01950364|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111115683|NCT01950364|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111115684|NCT01950364|Antitubercular Agents|antitubercular agents|mesh-ancestor
111115685|NCT01950364|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111490294|NCT01706952|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111490295|NCT01706952|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111490296|NCT01706952|Autonomic Agents|autonomic agents|mesh-ancestor
111490297|NCT01706952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111490298|NCT01706952|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111490299|NCT01706952|Respiratory System Agents|respiratory system agents|mesh-ancestor
111490300|NCT01706952|Mydriatics|mydriatics|mesh-ancestor
111490301|NCT01706952|Sympathomimetics|sympathomimetics|mesh-ancestor
111115686|NCT01950364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111115687|NCT01950364|Leprostatic Agents|leprostatic agents|mesh-ancestor
111115688|NCT01950364|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111490302|NCT01706952|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111115689|NCT01950364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111115690|NCT01950364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111115691|NCT01950364|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111115692|NCT01950364|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111115693|NCT01950364|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
111115694|NCT01950364|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
111115695|NCT01950364|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
111115696|NCT01950364|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111115697|NCT01950364|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111115698|NCT01950364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111115700|NCT01950364|Immunoconjugates|immunoconjugates|mesh-ancestor
111115701|NCT01950364|Immunologic Factors|immunologic factors|mesh-ancestor
111115702|NCT01950364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111115703|NCT05047991|Leucovorin|leucovorin|mesh-list
111115704|NCT05047991|Paclitaxel|paclitaxel|mesh-list
111115705|NCT05047991|Gemcitabine|gemcitabine|mesh-list
111115706|NCT05047991|Fluorouracil|fluorouracil|mesh-list
111115707|NCT05047991|Oxaliplatin|oxaliplatin|mesh-list
111115708|NCT05047991|Irinotecan|irinotecan|mesh-list
111115709|NCT05047991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111115710|NCT05047991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111115711|NCT05047991|Tubulin Modulators|tubulin modulators|mesh-ancestor
111115712|NCT05047991|Antimitotic Agents|antimitotic agents|mesh-ancestor
111115713|NCT05047991|Mitosis Modulators|mitosis modulators|mesh-ancestor
111115714|NCT05047991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111115715|NCT05047991|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111115716|NCT05047991|Antimetabolites|antimetabolites|mesh-ancestor
111115717|NCT05047991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111115718|NCT05047991|Immunologic Factors|immunologic factors|mesh-ancestor
111115719|NCT05047991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111115720|NCT05047991|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111115721|NCT05047991|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111115722|NCT05047991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111115723|NCT05047991|Antidotes|antidotes|mesh-ancestor
111115724|NCT05047991|Protective Agents|protective agents|mesh-ancestor
111115725|NCT05047991|Vitamin B Complex|vitamin b complex|mesh-ancestor
111115726|NCT05047991|Vitamins|vitamins|mesh-ancestor
111115727|NCT05047991|Micronutrients|micronutrients|mesh-ancestor
111115728|NCT00014443|Thalidomide|thalidomide|mesh-list
111115729|NCT00014443|Topotecan|topotecan|mesh-list
111115730|NCT00014443|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111115731|NCT00014443|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111115732|NCT00014443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111115733|NCT00014443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111115734|NCT00014443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111115735|NCT00014443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111115736|NCT00014443|Immunologic Factors|immunologic factors|mesh-ancestor
111115737|NCT00014443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111115738|NCT00014443|Leprostatic Agents|leprostatic agents|mesh-ancestor
111115739|NCT00014443|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111115740|NCT00014443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111115741|NCT00014443|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111115742|NCT00014443|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111115743|NCT00014443|Growth Substances|growth substances|mesh-ancestor
111115744|NCT00014443|Growth Inhibitors|growth inhibitors|mesh-ancestor
111115745|NCT05047133|Tranexamic Acid|tranexamic acid|mesh-list
111115746|NCT05047133|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111115747|NCT05047133|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111115748|NCT05047133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111115749|NCT05047133|Hemostatics|hemostatics|mesh-ancestor
111115750|NCT05047133|Coagulants|coagulants|mesh-ancestor
111115751|NCT04334863|Tyrphostins|tyrphostins|mesh-list
111115752|NCT04334863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111115753|NCT04334863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111115754|NCT04334863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111115755|NCT02357407|Ciprofloxacin|ciprofloxacin|mesh-list
111115756|NCT02357407|Ofloxacin|ofloxacin|mesh-list
111115757|NCT02357407|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111115758|NCT02357407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111490303|NCT01706952|Anesthetics, Local|anesthetics, local|mesh-ancestor
111490304|NCT01706952|Anesthetics|anesthetics|mesh-ancestor
111490305|NCT01706952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111115759|NCT02357407|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111115760|NCT02357407|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111115762|NCT02357407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111115763|NCT02357407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111115764|NCT02357407|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111115765|NCT02357407|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111115766|NCT02357407|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111115767|NCT02038699|TIC10 compound|tic10 compound|mesh-list
111115768|NCT02038699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111115769|NCT03160651|Methylprednisolone|methylprednisolone|mesh-list
111115770|NCT03160651|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111115771|NCT03160651|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111115772|NCT03160651|Prednisolone|prednisolone|mesh-list
111115773|NCT03160651|Prednisolone acetate|prednisolone acetate|mesh-list
111115774|NCT03160651|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111115775|NCT03160651|Prednisolone phosphate|prednisolone phosphate|mesh-list
111115776|NCT03160651|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111115777|NCT03160651|Antiemetics|antiemetics|mesh-ancestor
111115778|NCT03160651|Autonomic Agents|autonomic agents|mesh-ancestor
111115779|NCT03160651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111115780|NCT03160651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111115781|NCT03160651|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111115782|NCT03160651|Glucocorticoids|glucocorticoids|mesh-ancestor
111115783|NCT03160651|Hormones|hormones|mesh-ancestor
111115784|NCT03160651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111115785|NCT03160651|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111115786|NCT03160651|Protective Agents|protective agents|mesh-ancestor
111115787|NCT03160651|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111115788|NCT03160651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111115789|NCT05034965|Hyaluronic Acid|hyaluronic acid|mesh-list
111115790|NCT05034965|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111115791|NCT05034965|Immunologic Factors|immunologic factors|mesh-ancestor
111115792|NCT05034965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111115793|NCT05034965|Viscosupplements|viscosupplements|mesh-ancestor
111115794|NCT05034965|Protective Agents|protective agents|mesh-ancestor
111115795|NCT03160339|Vaccines|vaccines|mesh-list
111115796|NCT03160339|Immunologic Factors|immunologic factors|mesh-ancestor
111115797|NCT03160339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111115798|NCT05034887|Trastuzumab|trastuzumab|mesh-list
111115799|NCT05034887|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
111115800|NCT05034887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111115801|NCT05034887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111115802|NCT05034887|Immunoconjugates|immunoconjugates|mesh-ancestor
111115803|NCT05034887|Immunologic Factors|immunologic factors|mesh-ancestor
111115804|NCT05034887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111115805|NCT02039011|Tiotropium Bromide|tiotropium bromide|mesh-list
111115806|NCT02039011|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111115807|NCT02039011|Autonomic Agents|autonomic agents|mesh-ancestor
111115808|NCT02039011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111115809|NCT02039011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111115810|NCT02039011|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111115811|NCT02039011|Respiratory System Agents|respiratory system agents|mesh-ancestor
111115812|NCT02039011|Parasympatholytics|parasympatholytics|mesh-ancestor
111115813|NCT02039011|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111115814|NCT02039011|Cholinergic Agents|cholinergic agents|mesh-ancestor
111115815|NCT02039011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111115816|NCT02039011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111115817|NCT05024825|Acetaminophen|acetaminophen|mesh-list
111115818|NCT05024825|Ibuprofen|ibuprofen|mesh-list
111115819|NCT05024825|Gabapentin|gabapentin|mesh-list
111115820|NCT05024825|Hydrocodone|hydrocodone|mesh-list
111115821|NCT05024825|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111115822|NCT05024825|Analgesics|analgesics|mesh-ancestor
111115823|NCT05024825|Sensory System Agents|sensory system agents|mesh-ancestor
111115824|NCT05024825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111115825|NCT05024825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111115826|NCT05024825|Antipyretics|antipyretics|mesh-ancestor
111115827|NCT05024825|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111115828|NCT05024825|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111115829|NCT05024825|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111115830|NCT05024825|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111115831|NCT05024825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111490306|NCT01706952|Sensory System Agents|sensory system agents|mesh-ancestor
111490307|NCT01706952|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111119176|NCT05289687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111490308|NCT01706952|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111490309|NCT01706952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111490310|NCT01706952|Dopamine Agents|dopamine agents|mesh-ancestor
111490311|NCT01707420|Gabapentin|gabapentin|mesh-list
111490312|NCT01707420|Analgesics|analgesics|mesh-ancestor
111115832|NCT05024825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111115833|NCT05024825|Anticonvulsants|anticonvulsants|mesh-ancestor
111115834|NCT05024825|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111115835|NCT05024825|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111115836|NCT05024825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111115837|NCT05024825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111115838|NCT05024825|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111115839|NCT05024825|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111115840|NCT05024825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111115841|NCT05024825|Antimanic Agents|antimanic agents|mesh-ancestor
111115842|NCT05024825|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111115844|NCT05024825|Antitussive Agents|antitussive agents|mesh-ancestor
111115845|NCT05024825|Respiratory System Agents|respiratory system agents|mesh-ancestor
111115846|NCT05024435|Pulmonary Surfactants|pulmonary surfactants|mesh-list
111115847|NCT05024435|Respiratory System Agents|respiratory system agents|mesh-ancestor
111115848|NCT03093467|Anti-Anxiety Agents|anti-anxiety agents|mesh-list
111115849|NCT03093467|Antipsychotic Agents|antipsychotic agents|mesh-list
111115850|NCT03093467|Antidepressive Agents|antidepressive agents|mesh-list
111115851|NCT03093467|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111115852|NCT03093467|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111115853|NCT03093467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111115854|NCT03093467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111115855|NCT03149653|SMOFlipid|smoflipid|mesh-list
111115856|NCT03149653|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
111115857|NCT03149653|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
111115858|NCT03149653|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111115859|NCT03093545|Immunoglobulins|immunoglobulins|mesh-list
111115860|NCT03093545|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111115861|NCT03093545|Antibodies|antibodies|mesh-list
111115862|NCT03093545|Immunologic Factors|immunologic factors|mesh-ancestor
111115863|NCT03093545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111115864|NCT05024357|Dasatinib|dasatinib|mesh-list
111115865|NCT05024357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111115866|NCT05024357|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111115867|NCT05024357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111115868|NCT05024357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111115869|NCT03095105|Resveratrol|resveratrol|mesh-list
111115870|NCT03095105|Antioxidants|antioxidants|mesh-ancestor
111115871|NCT03095105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111115872|NCT03095105|Protective Agents|protective agents|mesh-ancestor
111115873|NCT03095105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111115874|NCT03095105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111115875|NCT03095105|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111115876|NCT01968070|Celecoxib|celecoxib|mesh-list
111115877|NCT01968070|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111115878|NCT01968070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111115879|NCT01968070|Analgesics|analgesics|mesh-ancestor
111115880|NCT01968070|Sensory System Agents|sensory system agents|mesh-ancestor
111115881|NCT01968070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111115882|NCT01968070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111115883|NCT01968070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111115884|NCT01968070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111115885|NCT01968070|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111115886|NCT01968070|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111115887|NCT01968070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111115888|NCT01968070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111115889|NCT03093389|Resveratrol|resveratrol|mesh-list
111115890|NCT03093389|Antioxidants|antioxidants|mesh-ancestor
111115891|NCT03093389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111115892|NCT03093389|Protective Agents|protective agents|mesh-ancestor
111115893|NCT03093389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111115894|NCT03093389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111115895|NCT03093389|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111115896|NCT01949116|Folic Acid|folic acid|mesh-list
111115897|NCT01949116|Methotrexate|methotrexate|mesh-list
111115898|NCT01949116|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111115899|NCT01949116|Abortifacient Agents|abortifacient agents|mesh-ancestor
111115900|NCT01949116|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111490313|NCT01707420|Sensory System Agents|sensory system agents|mesh-ancestor
111115901|NCT01949116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111115902|NCT01949116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111115904|NCT01949116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111115905|NCT01949116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111115906|NCT01949116|Dermatologic Agents|dermatologic agents|mesh-ancestor
111115907|NCT01949116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111115908|NCT01949116|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111115909|NCT01949116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111115910|NCT01949116|Immunologic Factors|immunologic factors|mesh-ancestor
111115911|NCT01949116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111115912|NCT01949116|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111115913|NCT01949116|Hematinics|hematinics|mesh-ancestor
111115914|NCT01949116|Vitamin B Complex|vitamin b complex|mesh-ancestor
111115915|NCT01949116|Vitamins|vitamins|mesh-ancestor
111115916|NCT01949116|Micronutrients|micronutrients|mesh-ancestor
110676916|NCT03318900|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111115917|NCT01673009|Imatinib Mesylate|imatinib mesylate|mesh-list
111115918|NCT01673009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111115919|NCT01673009|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111115920|NCT01673009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111115921|NCT01673009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111115922|NCT02350387|Oxymetazoline|oxymetazoline|mesh-list
111115923|NCT02350387|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111115924|NCT02350387|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111115925|NCT02350387|Adrenergic Agents|adrenergic agents|mesh-ancestor
111115926|NCT02350387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111115927|NCT02350387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111115928|NCT02350387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111115929|NCT02350387|Sympathomimetics|sympathomimetics|mesh-ancestor
111115930|NCT02350387|Autonomic Agents|autonomic agents|mesh-ancestor
111115931|NCT02350387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111115932|NCT02350387|Nasal Decongestants|nasal decongestants|mesh-ancestor
111115933|NCT02350387|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111115934|NCT02350387|Respiratory System Agents|respiratory system agents|mesh-ancestor
111115935|NCT02350543|Aspirin|aspirin|mesh-list
111115936|NCT02350543|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111115937|NCT02350543|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111115938|NCT02350543|Analgesics|analgesics|mesh-ancestor
111115939|NCT02350543|Sensory System Agents|sensory system agents|mesh-ancestor
111115940|NCT02350543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111115941|NCT02350543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111115942|NCT02350543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111115943|NCT02350543|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111115944|NCT02350543|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111115945|NCT02350543|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111115946|NCT02350543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111115947|NCT02350543|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111115948|NCT02350543|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111115949|NCT02350543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111115950|NCT02350543|Antipyretics|antipyretics|mesh-ancestor
111115951|NCT05023577|Metronidazole|metronidazole|mesh-list
111115952|NCT05023577|Clarithromycin|clarithromycin|mesh-list
111115953|NCT05023577|Levofloxacin|levofloxacin|mesh-list
111115954|NCT05023577|Potassium Citrate|potassium citrate|mesh-list
111115955|NCT05023577|Rabeprazole|rabeprazole|mesh-list
111115956|NCT05023577|Bismuth|bismuth|mesh-list
111115957|NCT05023577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111115958|NCT05023577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111115959|NCT05023577|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111115960|NCT05023577|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111115961|NCT05023577|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111115962|NCT05023577|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111115963|NCT05023577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111115964|NCT05023577|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111115965|NCT05023577|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111115966|NCT05023577|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111115967|NCT05023577|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111115968|NCT05023577|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111115969|NCT05023577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111115970|NCT05023577|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111115971|NCT05023577|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111115972|NCT05023577|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111115973|NCT05023577|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111115974|NCT05023577|Antacids|antacids|mesh-ancestor
111115975|NCT05023577|Diuretics|diuretics|mesh-ancestor
111115976|NCT05023577|Natriuretic Agents|natriuretic agents|mesh-ancestor
111115977|NCT05023577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111115978|NCT05023577|Expectorants|expectorants|mesh-ancestor
111115979|NCT05023577|Respiratory System Agents|respiratory system agents|mesh-ancestor
111115980|NCT03149419|Paroxetine|paroxetine|mesh-list
111115981|NCT03149419|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111115982|NCT03149419|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111115983|NCT03149419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111115984|NCT03149419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111115985|NCT03149419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111115986|NCT03149419|Serotonin Agents|serotonin agents|mesh-ancestor
111115987|NCT03149419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111115988|NCT03149419|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111115989|NCT03149419|Antidepressive Agents|antidepressive agents|mesh-ancestor
111115990|NCT03149419|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111115991|NCT03149419|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111115992|NCT03149419|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111115993|NCT03149419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111115994|NCT03092765|Quetmolimab|quetmolimab|mesh-list
111115995|NCT03092765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111115996|NCT01939366|Pregabalin|pregabalin|mesh-list
111115997|NCT01939366|Analgesics|analgesics|mesh-ancestor
111115998|NCT01939366|Sensory System Agents|sensory system agents|mesh-ancestor
111115999|NCT01939366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111116000|NCT01939366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111116001|NCT01939366|Anticonvulsants|anticonvulsants|mesh-ancestor
111116002|NCT01939366|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111116003|NCT01939366|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111116004|NCT01939366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111116005|NCT01939366|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111116006|NCT01939366|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111116007|NCT01939366|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111116008|NCT01939366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111116009|NCT01939366|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111116010|NCT04434365|Aspirin|aspirin|mesh-list
111116011|NCT04434365|Clopidogrel|clopidogrel|mesh-list
111116012|NCT04434365|Atorvastatin|atorvastatin|mesh-list
111116013|NCT04434365|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111116014|NCT04434365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111116015|NCT04434365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111116016|NCT04434365|Analgesics|analgesics|mesh-ancestor
111116017|NCT04434365|Sensory System Agents|sensory system agents|mesh-ancestor
111116018|NCT04434365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111116019|NCT04434365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111116020|NCT04434365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111116021|NCT04434365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111116022|NCT04434365|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111116023|NCT04434365|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111116024|NCT04434365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111116025|NCT04434365|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111116026|NCT04434365|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111116027|NCT04434365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111116028|NCT04434365|Antipyretics|antipyretics|mesh-ancestor
111116029|NCT04434365|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111116030|NCT04434365|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111116031|NCT04434365|Antimetabolites|antimetabolites|mesh-ancestor
111116032|NCT04434365|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111116033|NCT04434365|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111116034|NCT04434365|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111116035|NCT04434365|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111116036|NCT04434365|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111116037|NCT04434365|Purinergic Agents|purinergic agents|mesh-ancestor
111116038|NCT04434365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111116039|NCT05032235|Fluzoparib|fluzoparib|mesh-list
111116040|NCT05032235|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111116041|NCT05032235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111116042|NCT05032235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111116043|NCT05032235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111116044|NCT05031923|Anti-Infective Agents|anti-infective agents|mesh-list
111116045|NCT05031923|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111116046|NCT03149575|Carboplatin|carboplatin|mesh-list
111116047|NCT03149575|Temozolomide|temozolomide|mesh-list
111116048|NCT03149575|Lomustine|lomustine|mesh-list
111490314|NCT01707420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111116049|NCT03149575|Dianhydrogalactitol|dianhydrogalactitol|mesh-list
111116050|NCT03149575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111116051|NCT03149575|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111116052|NCT03149575|Alkylating Agents|alkylating agents|mesh-ancestor
111116053|NCT03149575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111116054|NCT05032001|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
111116055|NCT05032001|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
111116057|NCT05032001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111116058|NCT05032001|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111116059|NCT05032001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111116060|NCT05032001|Protease Inhibitors|protease inhibitors|mesh-ancestor
111116061|NCT05032001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111116062|NCT05031689|Sunscreening Agents|sunscreening agents|mesh-list
111116063|NCT05031689|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111116064|NCT05031689|Protective Agents|protective agents|mesh-ancestor
111116065|NCT05031689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111116066|NCT05031689|Dermatologic Agents|dermatologic agents|mesh-ancestor
111116067|NCT02350231|Progesterone|progesterone|mesh-list
111116068|NCT02350231|Progestins|progestins|mesh-ancestor
111116069|NCT02350231|Hormones|hormones|mesh-ancestor
111116070|NCT02350231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111116071|NCT02350231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111116072|NCT01918306|Cisplatin|cisplatin|mesh-list
111116073|NCT01918306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111116074|NCT05031143|Triamcinolone|triamcinolone|mesh-list
111116075|NCT05031143|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
111116076|NCT05031143|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
111116077|NCT05031143|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
111116078|NCT05031143|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111116079|NCT05031143|Glucocorticoids|glucocorticoids|mesh-ancestor
111116080|NCT05031143|Hormones|hormones|mesh-ancestor
111116081|NCT05031143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111116082|NCT05031143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111116083|NCT05031143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111116084|NCT05031143|Immunologic Factors|immunologic factors|mesh-ancestor
111116085|NCT05031143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111116086|NCT05031143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111116087|NCT01916980|Desloratadine|desloratadine|mesh-list
111116088|NCT01916980|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111116089|NCT01916980|Cholinergic Agents|cholinergic agents|mesh-ancestor
111116090|NCT01916980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111116091|NCT01916980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111116092|NCT01916980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111116093|NCT01916980|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
111116094|NCT01916980|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111116095|NCT01916980|Histamine Antagonists|histamine antagonists|mesh-ancestor
111116096|NCT01916980|Histamine Agents|histamine agents|mesh-ancestor
111116097|NCT02348281|Bicalutamide|bicalutamide|mesh-list
111116098|NCT02348281|Androgen Antagonists|androgen antagonists|mesh-ancestor
111116099|NCT02348281|Hormone Antagonists|hormone antagonists|mesh-ancestor
111116100|NCT02348281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111116101|NCT02348281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111116102|NCT02348281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111116103|NCT04638400|Simvastatin|simvastatin|mesh-list
111116104|NCT04638400|Ezetimibe|ezetimibe|mesh-list
111116105|NCT04638400|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111116106|NCT04638400|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111116107|NCT04638400|Antimetabolites|antimetabolites|mesh-ancestor
111116108|NCT04638400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111116109|NCT04638400|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111116110|NCT04638400|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111116111|NCT04638400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111116112|NCT02349919|Procaterol|procaterol|mesh-list
111116113|NCT02349919|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111116114|NCT02349919|Autonomic Agents|autonomic agents|mesh-ancestor
110648939|NCT00893906|Vaccines|vaccines|mesh-list
111116115|NCT02349919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111116116|NCT02349919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111116117|NCT02349919|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111116118|NCT02349919|Respiratory System Agents|respiratory system agents|mesh-ancestor
111490315|NCT01707420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111490316|NCT01707420|Anticonvulsants|anticonvulsants|mesh-ancestor
111490317|NCT01707420|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111116119|NCT02349919|Sympathomimetics|sympathomimetics|mesh-ancestor
111490318|NCT01707420|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111116120|NCT02349919|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111116121|NCT02349919|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111116122|NCT02349919|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111116123|NCT02349919|Adrenergic Agents|adrenergic agents|mesh-ancestor
111116124|NCT02349919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111116125|NCT02349919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111116127|NCT02349763|Dexamethasone acetate|dexamethasone acetate|mesh-list
111116128|NCT02349763|BB 1101|bb 1101|mesh-list
111116129|NCT02349763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111116130|NCT02349763|Antiemetics|antiemetics|mesh-ancestor
111116131|NCT02349763|Autonomic Agents|autonomic agents|mesh-ancestor
111116132|NCT02349763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111116133|NCT02349763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111116134|NCT02349763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111116135|NCT02349763|Glucocorticoids|glucocorticoids|mesh-ancestor
111116136|NCT02349763|Hormones|hormones|mesh-ancestor
111116137|NCT02349763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111116138|NCT02349763|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111116139|NCT02349763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111116140|NCT02349763|Protease Inhibitors|protease inhibitors|mesh-ancestor
111116141|NCT02349763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111116142|NCT02349763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111116143|NCT02349841|Amoxicillin|amoxicillin|mesh-list
111116144|NCT02349841|Meropenem|meropenem|mesh-list
111116145|NCT02349841|Clavulanic Acids|clavulanic acids|mesh-list
111116146|NCT02349841|Clavulanic Acid|clavulanic acid|mesh-list
111116147|NCT02349841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111116148|NCT02349841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111116149|NCT02349841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111116150|NCT02349841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111116151|NCT02349841|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
111116152|NCT02354053|Abacavir, dolutegravir, and lamivudine drug combination|abacavir, dolutegravir, and lamivudine drug combination|mesh-list
111116153|NCT02354053|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111116154|NCT02354053|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111116155|NCT02354053|Antiviral Agents|antiviral agents|mesh-ancestor
111116156|NCT02354053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111116157|NCT05028803|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
111116158|NCT05028803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111116159|NCT03094481|Epinephrine|epinephrine|mesh-list
111116160|NCT03094481|Bupivacaine|bupivacaine|mesh-list
111116161|NCT03094481|Anesthetics, Local|anesthetics, local|mesh-ancestor
111116162|NCT03094481|Anesthetics|anesthetics|mesh-ancestor
111116163|NCT03094481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111116164|NCT03094481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111116165|NCT03094481|Sensory System Agents|sensory system agents|mesh-ancestor
111116166|NCT03094481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111116167|NCT03094481|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111116168|NCT03094481|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111116169|NCT03094481|Adrenergic Agents|adrenergic agents|mesh-ancestor
111116170|NCT03094481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111116171|NCT03094481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111116172|NCT03094481|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111116173|NCT03094481|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111116174|NCT03094481|Autonomic Agents|autonomic agents|mesh-ancestor
111116175|NCT03094481|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111116176|NCT03094481|Respiratory System Agents|respiratory system agents|mesh-ancestor
111116177|NCT03094481|Mydriatics|mydriatics|mesh-ancestor
111116178|NCT03094481|Sympathomimetics|sympathomimetics|mesh-ancestor
111116179|NCT03094481|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111116180|NCT04438837|Hydroxychloroquine|hydroxychloroquine|mesh-list
111116181|NCT04438837|Antimalarials|antimalarials|mesh-ancestor
111116182|NCT04438837|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110648942|NCT00721487|Fluconazole|fluconazole|mesh-list
111116183|NCT04438837|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111116184|NCT04438837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111116185|NCT04438837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111116186|NCT04438837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111116187|NCT04438837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111116188|NCT02348125|Thioctic Acid|thioctic acid|mesh-list
111116189|NCT02348125|Antioxidants|antioxidants|mesh-ancestor
111490319|NCT01707420|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111116190|NCT02348125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111116191|NCT02348125|Protective Agents|protective agents|mesh-ancestor
111490321|NCT01707420|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111116192|NCT02348125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111116193|NCT02348125|Vitamin B Complex|vitamin b complex|mesh-ancestor
111116194|NCT02348125|Vitamins|vitamins|mesh-ancestor
111116195|NCT02348125|Micronutrients|micronutrients|mesh-ancestor
111116196|NCT05028335|Carbamide Peroxide|carbamide peroxide|mesh-list
111116197|NCT05028335|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111116198|NCT05028335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111116199|NCT03094403|Azelaic acid|azelaic acid|mesh-list
111116200|NCT03094403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111116201|NCT03094403|Dermatologic Agents|dermatologic agents|mesh-ancestor
111116202|NCT02347891|Belimumab|belimumab|mesh-list
111116203|NCT02347891|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111116204|NCT02347891|Immunologic Factors|immunologic factors|mesh-ancestor
111116205|NCT02347891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111116206|NCT03147157|Tacrolimus|tacrolimus|mesh-list
111116207|NCT03147157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111116208|NCT03147157|Immunologic Factors|immunologic factors|mesh-ancestor
111116209|NCT03147157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111116210|NCT03147157|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111116211|NCT03147157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111116212|NCT03147157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110833281|NCT03821623|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111116213|NCT02347501|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111116214|NCT02347501|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111116215|NCT02347501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111116216|NCT02347501|Incretins|incretins|mesh-ancestor
111116217|NCT02347501|Hormones|hormones|mesh-ancestor
111116218|NCT02347501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111116219|NCT02347501|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111116220|NCT02347501|Protease Inhibitors|protease inhibitors|mesh-ancestor
111116221|NCT02347501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111116222|NCT02347501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111116223|NCT03148717|Misoprostol|misoprostol|mesh-list
111116224|NCT03148717|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111116225|NCT03148717|Abortifacient Agents|abortifacient agents|mesh-ancestor
111116226|NCT03148717|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111116227|NCT03148717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111116228|NCT03148717|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111116229|NCT03148717|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111116230|NCT03148717|Oxytocics|oxytocics|mesh-ancestor
111116231|NCT02349607|Ibuprofen|ibuprofen|mesh-list
111116232|NCT02349607|Pregabalin|pregabalin|mesh-list
111116233|NCT02349607|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111116234|NCT02349607|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111116235|NCT02349607|Analgesics|analgesics|mesh-ancestor
111116236|NCT02349607|Sensory System Agents|sensory system agents|mesh-ancestor
111116237|NCT02349607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111116238|NCT02349607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111116239|NCT02349607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111116240|NCT02349607|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111116241|NCT02349607|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111116242|NCT02349607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111116243|NCT02349607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111116244|NCT02349607|Anticonvulsants|anticonvulsants|mesh-ancestor
111116245|NCT02349607|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111116246|NCT02349607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111116247|NCT02349607|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111116248|NCT02349607|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111116249|NCT02349607|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111116250|NCT02349607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111116251|NCT02349607|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111116252|NCT05019755|Varespladib methyl|varespladib methyl|mesh-list
111116253|NCT05019755|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
111116254|NCT05019755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111116255|NCT05019755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111116256|NCT04478461|Antibodies|antibodies|mesh-list
111116257|NCT04478461|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111116258|NCT04478461|Immunologic Factors|immunologic factors|mesh-ancestor
111490322|NCT01707420|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111116259|NCT04478461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111116260|NCT04108481|Durvalumab|durvalumab|mesh-list
111116261|NCT04108481|Methamphetamine|methamphetamine|mesh-list
111116262|NCT04108481|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111116263|NCT04108481|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111116264|NCT04108481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111116265|NCT04108481|Immunologic Factors|immunologic factors|mesh-ancestor
111116266|NCT04108481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111116267|NCT04108481|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111116268|NCT04108481|Sympathomimetics|sympathomimetics|mesh-ancestor
111116269|NCT04108481|Autonomic Agents|autonomic agents|mesh-ancestor
111116270|NCT04108481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111116271|NCT04108481|Dopamine Agents|dopamine agents|mesh-ancestor
111116272|NCT04108481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111116273|NCT04108481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111116274|NCT04108481|Adrenergic Agents|adrenergic agents|mesh-ancestor
111116275|NCT04108481|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111116276|NCT04108481|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111116277|NCT04108481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111116278|NCT04108481|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111116279|NCT02353507|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
111116280|NCT02353507|Laxatives|laxatives|mesh-ancestor
111116281|NCT02353507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111116282|NCT03148561|Misoprostol|misoprostol|mesh-list
111116283|NCT03148561|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111116284|NCT03148561|Abortifacient Agents|abortifacient agents|mesh-ancestor
111116285|NCT03148561|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111116286|NCT03148561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111116287|NCT03148561|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111116288|NCT03148561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111116290|NCT02353429|Toremifene|toremifene|mesh-list
111116291|NCT02353429|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111116292|NCT02353429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111116293|NCT02353429|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111116294|NCT02353429|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111116295|NCT02353429|Hormone Antagonists|hormone antagonists|mesh-ancestor
111116296|NCT02353429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111116297|NCT02353429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111116298|NCT02353429|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111116299|NCT05027243|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
111116300|NCT05027243|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111116301|NCT05027243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111116302|NCT05027243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111116303|NCT05027243|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111116304|NCT05027243|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111116305|NCT05027243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111116306|NCT05027243|Cholinergic Agents|cholinergic agents|mesh-ancestor
111116307|NCT05027243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111116308|NCT03112135|Epinephrine|epinephrine|mesh-list
111116309|NCT03112135|Tranexamic Acid|tranexamic acid|mesh-list
111116310|NCT03112135|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111116311|NCT03112135|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111116312|NCT03112135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111116313|NCT03112135|Hemostatics|hemostatics|mesh-ancestor
111116314|NCT03112135|Coagulants|coagulants|mesh-ancestor
111116315|NCT03112135|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111116316|NCT03112135|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111116317|NCT03112135|Adrenergic Agents|adrenergic agents|mesh-ancestor
111116318|NCT03112135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111116319|NCT03112135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111116320|NCT03112135|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111116321|NCT03112135|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111116322|NCT03112135|Autonomic Agents|autonomic agents|mesh-ancestor
111116323|NCT03112135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111116324|NCT03112135|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111116325|NCT03112135|Respiratory System Agents|respiratory system agents|mesh-ancestor
111116326|NCT03112135|Mydriatics|mydriatics|mesh-ancestor
111116327|NCT03112135|Sympathomimetics|sympathomimetics|mesh-ancestor
111116328|NCT03112135|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111116329|NCT04477993|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
111116330|NCT04477993|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111116331|NCT04477993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111116332|NCT04477993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111116333|NCT03146533|Cyclophosphamide|cyclophosphamide|mesh-list
111116334|NCT03146533|Fludarabine|fludarabine|mesh-list
111116335|NCT03146533|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111116336|NCT03146533|Immunologic Factors|immunologic factors|mesh-ancestor
111116337|NCT03146533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111116338|NCT03146533|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111116339|NCT03146533|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111116340|NCT03146533|Alkylating Agents|alkylating agents|mesh-ancestor
111116341|NCT03146533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111116342|NCT03146533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111116343|NCT03146533|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111116344|NCT03090971|Diclofenac|diclofenac|mesh-list
111116345|NCT03090971|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111116346|NCT03090971|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111116347|NCT03090971|Analgesics|analgesics|mesh-ancestor
111116348|NCT03090971|Sensory System Agents|sensory system agents|mesh-ancestor
111116349|NCT03090971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111116350|NCT03090971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111116351|NCT03090971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111116352|NCT03090971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111116353|NCT03090971|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111116354|NCT03090971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111116355|NCT03090971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111116356|NCT03146689|Ibuprofen|ibuprofen|mesh-list
111116357|NCT03146689|Capsaicin|capsaicin|mesh-list
111116358|NCT03146689|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111116359|NCT03146689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111116360|NCT03146689|Analgesics|analgesics|mesh-ancestor
111116361|NCT03146689|Sensory System Agents|sensory system agents|mesh-ancestor
111116362|NCT03146689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111116363|NCT03146689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111116365|NCT03146689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111116366|NCT03146689|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111116367|NCT03146689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111116368|NCT03146689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111116369|NCT03146689|Antipruritics|antipruritics|mesh-ancestor
111116370|NCT03146689|Dermatologic Agents|dermatologic agents|mesh-ancestor
111116371|NCT05255575|Ertapenem|ertapenem|mesh-list
111116372|NCT05255575|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111116373|NCT05255575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111116374|NCT05026229|Cytarabine|cytarabine|mesh-list
111116375|NCT05026229|Prednisone|prednisone|mesh-list
111116376|NCT05026229|Methotrexate|methotrexate|mesh-list
111116377|NCT05026229|Vincristine|vincristine|mesh-list
111116378|NCT05026229|Dasatinib|dasatinib|mesh-list
111116379|NCT05026229|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111116380|NCT05026229|Glucocorticoids|glucocorticoids|mesh-ancestor
111116381|NCT05026229|Hormones|hormones|mesh-ancestor
111116382|NCT05026229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111116383|NCT05026229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111116384|NCT05026229|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111116385|NCT05026229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111116386|NCT05026229|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111116387|NCT05026229|Abortifacient Agents|abortifacient agents|mesh-ancestor
111116388|NCT05026229|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111116389|NCT05026229|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111116390|NCT05026229|Antimetabolites|antimetabolites|mesh-ancestor
111116391|NCT05026229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111116392|NCT05026229|Dermatologic Agents|dermatologic agents|mesh-ancestor
111116393|NCT05026229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111116394|NCT05026229|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111116395|NCT05026229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111116396|NCT05026229|Immunologic Factors|immunologic factors|mesh-ancestor
111116397|NCT05026229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111116398|NCT05026229|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111116399|NCT05026229|Antiviral Agents|antiviral agents|mesh-ancestor
111116400|NCT05026229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111116401|NCT05026229|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111116402|NCT05026229|Tubulin Modulators|tubulin modulators|mesh-ancestor
111116403|NCT05026229|Antimitotic Agents|antimitotic agents|mesh-ancestor
111116404|NCT05026229|Mitosis Modulators|mitosis modulators|mesh-ancestor
111116405|NCT05026229|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111116406|NCT02343679|Ceritinib|ceritinib|mesh-list
111116407|NCT02343679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111116408|NCT02343679|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111490324|NCT01707420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111490325|NCT01707420|Antimanic Agents|antimanic agents|mesh-ancestor
111490326|NCT01708122|Fentanyl|fentanyl|mesh-list
111116410|NCT02343679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111116411|NCT02348905|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
111116412|NCT02348905|Hormones|hormones|mesh-ancestor
111116413|NCT02348905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111116414|NCT02348905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111116415|NCT02347033|Sertraline|sertraline|mesh-list
111116416|NCT02347033|Antidepressive Agents|antidepressive agents|mesh-ancestor
111116417|NCT02347033|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111116418|NCT02347033|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111116419|NCT02347033|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111116420|NCT02347033|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111116421|NCT02347033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111116422|NCT02347033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111116423|NCT02347033|Serotonin Agents|serotonin agents|mesh-ancestor
111116424|NCT02347033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111116425|NCT04949633|Oxytocin|oxytocin|mesh-list
111116426|NCT04949633|Oxytocics|oxytocics|mesh-ancestor
111116427|NCT04949633|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111116428|NCT04949633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111116429|NCT03146377|Capecitabine|capecitabine|mesh-list
111116430|NCT03146377|Oxaliplatin|oxaliplatin|mesh-list
111116431|NCT03146377|Irinotecan|irinotecan|mesh-list
111116432|NCT03146377|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111116433|NCT03146377|Antimetabolites|antimetabolites|mesh-ancestor
111116434|NCT03146377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111116435|NCT03146377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111116436|NCT03146377|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111116437|NCT03146377|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111116438|NCT03146377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111116439|NCT02346955|Pembrolizumab|pembrolizumab|mesh-list
111116440|NCT02346955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111116441|NCT02346955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111116442|NCT02346955|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111116443|NCT02346955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111116444|NCT03079505|Dasatinib|dasatinib|mesh-list
111116445|NCT03079505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111116446|NCT03079505|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111116447|NCT03079505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111116448|NCT03079505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111116449|NCT02343211|Immunoglobulins|immunoglobulins|mesh-list
111116450|NCT02343211|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111116451|NCT02343211|Antibodies|antibodies|mesh-list
111116452|NCT02343211|Immunologic Factors|immunologic factors|mesh-ancestor
111116453|NCT02343211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111116454|NCT03090503|Risperidone|risperidone|mesh-list
111116455|NCT03090503|Aripiprazole|aripiprazole|mesh-list
111116456|NCT03090503|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111116457|NCT03090503|Serotonin Agents|serotonin agents|mesh-ancestor
111116458|NCT03090503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111116459|NCT03090503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111116460|NCT03090503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111116461|NCT03090503|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111116462|NCT03090503|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111116463|NCT03090503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111116464|NCT03090503|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111116465|NCT03090503|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111116466|NCT03090503|Dopamine Agents|dopamine agents|mesh-ancestor
111116467|NCT03090503|Antidepressive Agents|antidepressive agents|mesh-ancestor
111116468|NCT03090503|Dopamine Agonists|dopamine agonists|mesh-ancestor
111116469|NCT03090503|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111116470|NCT03090503|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111116471|NCT03090503|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111116472|NCT03090503|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111116473|NCT02343289|Clarithromycin|clarithromycin|mesh-list
111116474|NCT02343289|Esketamine|esketamine|mesh-list
111116475|NCT02343289|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111116476|NCT02343289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111116477|NCT02343289|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110698457|NCT00301821|Hormones|hormones|mesh-ancestor
111490327|NCT01708122|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111490328|NCT01708122|Narcotics|narcotics|mesh-ancestor
111490329|NCT01708122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111116479|NCT02343289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111116480|NCT02343289|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111116481|NCT02343289|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111116482|NCT02343289|Antidepressive Agents|antidepressive agents|mesh-ancestor
111116483|NCT02343289|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111116484|NCT05008523|Analgesics, Opioid|analgesics, opioid|mesh-list
111116485|NCT05008523|Narcotics|narcotics|mesh-ancestor
111116486|NCT05008523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111116487|NCT05008523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111116488|NCT05008523|Analgesics|analgesics|mesh-ancestor
111116489|NCT05008523|Sensory System Agents|sensory system agents|mesh-ancestor
111116490|NCT05008523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111116491|NCT03090269|Methylphenidate|methylphenidate|mesh-list
111116492|NCT03090269|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111116493|NCT03090269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111116494|NCT03090269|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111116495|NCT03090269|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111116496|NCT03090269|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111116497|NCT03090269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111116498|NCT03090269|Dopamine Agents|dopamine agents|mesh-ancestor
111116499|NCT03090269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111116500|NCT05008679|Oseltamivir|oseltamivir|mesh-list
111116501|NCT05008679|Antiviral Agents|antiviral agents|mesh-ancestor
111116502|NCT05008679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111116503|NCT05008679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111116504|NCT05008679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111116505|NCT03090035|Interferons|interferons|mesh-list
111116506|NCT03090035|Ribavirin|ribavirin|mesh-list
111116507|NCT03090035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111116508|NCT03090035|Antiviral Agents|antiviral agents|mesh-ancestor
111116509|NCT03090035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111116510|NCT03090035|Antimetabolites|antimetabolites|mesh-ancestor
111116511|NCT03090035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111116512|NCT05008367|Dexamethasone|dexamethasone|mesh-list
111116513|NCT05008367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111116514|NCT05008367|Antiemetics|antiemetics|mesh-ancestor
111116515|NCT05008367|Autonomic Agents|autonomic agents|mesh-ancestor
111116516|NCT05008367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111116517|NCT05008367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111116518|NCT05008367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111116519|NCT05008367|Glucocorticoids|glucocorticoids|mesh-ancestor
111116520|NCT05008367|Hormones|hormones|mesh-ancestor
111116521|NCT05008367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111116522|NCT05008367|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111116523|NCT05008367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111116524|NCT02342587|Lapatinib|lapatinib|mesh-list
111116525|NCT02342587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111116526|NCT02342587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111116527|NCT02342587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111116528|NCT02342587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111116529|NCT02346331|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111116530|NCT02346331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111116531|NCT02342509|Sevoflurane|sevoflurane|mesh-list
111116532|NCT02342509|Desflurane|desflurane|mesh-list
111116533|NCT02342509|Isoflurane|isoflurane|mesh-list
111116534|NCT02342509|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111116535|NCT02342509|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111116536|NCT02342509|Anesthetics, General|anesthetics, general|mesh-ancestor
111116537|NCT02342509|Anesthetics|anesthetics|mesh-ancestor
111116538|NCT02342509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111116539|NCT02342509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111116540|NCT03079271|Benzocaine|benzocaine|mesh-list
111116541|NCT03079271|Anesthetics, Local|anesthetics, local|mesh-ancestor
111116542|NCT03079271|Anesthetics|anesthetics|mesh-ancestor
111116543|NCT03079271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111116544|NCT03079271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111116545|NCT03079271|Sensory System Agents|sensory system agents|mesh-ancestor
111116546|NCT03079271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111116547|NCT02342353|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111116548|NCT02342353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111490330|NCT01708122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111490331|NCT01708122|Analgesics|analgesics|mesh-ancestor
111116549|NCT02342353|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111116550|NCT02342353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111116551|NCT02342353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111116552|NCT02337127|Lamivudine|lamivudine|mesh-list
111116553|NCT02337127|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111116554|NCT02337127|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111116555|NCT02337127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111116556|NCT02337127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111116557|NCT02337127|Antiviral Agents|antiviral agents|mesh-ancestor
111116558|NCT02337127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111116559|NCT02337127|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111116560|NCT02337127|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111116561|NCT02337205|Tirbanibulin|tirbanibulin|mesh-list
111116562|NCT02337205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111116563|NCT02337205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111116564|NCT05007587|Leucovorin|leucovorin|mesh-list
111116565|NCT05007587|Fluorouracil|fluorouracil|mesh-list
111116566|NCT05007587|Raltitrexed|raltitrexed|mesh-list
111116567|NCT05007587|Oxaliplatin|oxaliplatin|mesh-list
111116568|NCT05007587|Lenvatinib|lenvatinib|mesh-list
111116569|NCT05007587|Antimetabolites|antimetabolites|mesh-ancestor
111116570|NCT05007587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111116571|NCT05007587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111116572|NCT05007587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111116573|NCT05007587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111116574|NCT05007587|Immunologic Factors|immunologic factors|mesh-ancestor
111116575|NCT05007587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111116576|NCT05007587|Antidotes|antidotes|mesh-ancestor
111116577|NCT05007587|Protective Agents|protective agents|mesh-ancestor
111116578|NCT05007587|Vitamin B Complex|vitamin b complex|mesh-ancestor
111116579|NCT05007587|Vitamins|vitamins|mesh-ancestor
111116580|NCT05007587|Micronutrients|micronutrients|mesh-ancestor
111116581|NCT05007587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111116582|NCT05007587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111116583|NCT05007587|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111116584|NCT02039323|Tenofovir|tenofovir|mesh-list
111116585|NCT02039323|Maraviroc|maraviroc|mesh-list
111116586|NCT02039323|Antiviral Agents|antiviral agents|mesh-ancestor
111116587|NCT02039323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111116588|NCT02039323|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111116589|NCT02039323|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111116590|NCT02039323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111116591|NCT02039323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111116592|NCT02039323|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111116593|NCT02039323|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111116594|NCT02039323|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
111116595|NCT02039323|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
111116596|NCT02039323|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
111116597|NCT03079115|Atorvastatin|atorvastatin|mesh-list
111116598|NCT03079115|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111116599|NCT03079115|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111116600|NCT03079115|Antimetabolites|antimetabolites|mesh-ancestor
111116601|NCT03079115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111116602|NCT03079115|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111116603|NCT03079115|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111116604|NCT03079115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111116605|NCT05917431|Tislelizumab|tislelizumab|mesh-list
111116606|NCT05917431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111116607|NCT05917431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111116608|NCT05917405|Fludarabine|fludarabine|mesh-list
111116609|NCT05917405|Busulfan|busulfan|mesh-list
111116610|NCT05917405|Clofarabine|clofarabine|mesh-list
111116611|NCT05917405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111116612|NCT05917405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111116613|NCT05917405|Antimetabolites|antimetabolites|mesh-ancestor
111116614|NCT05917405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111116615|NCT05917405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111116616|NCT05917405|Immunologic Factors|immunologic factors|mesh-ancestor
111116617|NCT05917405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111116618|NCT05917405|Alkylating Agents|alkylating agents|mesh-ancestor
111116619|NCT05917405|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111116620|NCT05917405|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111490332|NCT01708122|Sensory System Agents|sensory system agents|mesh-ancestor
111490333|NCT01708122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111116621|NCT05917288|Belimumab|belimumab|mesh-list
111116622|NCT05917288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111116623|NCT05917288|Immunologic Factors|immunologic factors|mesh-ancestor
111490334|NCT01708122|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111490335|NCT01708122|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111490336|NCT01708122|Anesthetics, General|anesthetics, general|mesh-ancestor
111116624|NCT05917288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111116625|NCT05917223|Caseins|caseins|mesh-list
111116626|NCT05917223|Chelating Agents|chelating agents|mesh-ancestor
111116627|NCT05917223|Sequestering Agents|sequestering agents|mesh-ancestor
111116628|NCT05917223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111116629|NCT05991622|Rilpivirine|rilpivirine|mesh-list
111116630|NCT05991622|Cabotegravir, rilpivirine drug combination|cabotegravir, rilpivirine drug combination|mesh-list
111116631|NCT05991622|Buprenorphine|buprenorphine|mesh-list
111116632|NCT05991622|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111116633|NCT05991622|Narcotics|narcotics|mesh-ancestor
111116634|NCT05991622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111116635|NCT05991622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111116636|NCT05991622|Analgesics|analgesics|mesh-ancestor
111116637|NCT05991622|Sensory System Agents|sensory system agents|mesh-ancestor
111116638|NCT05991622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111116639|NCT05991622|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111116640|NCT05991622|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111116641|NCT05991622|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111116642|NCT05991622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111116643|NCT05991622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111116644|NCT05991622|Antiviral Agents|antiviral agents|mesh-ancestor
111116645|NCT05991622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111116646|NCT05991622|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111116647|NCT05991622|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111116648|NCT05991518|Cisplatin|cisplatin|mesh-list
111116649|NCT05991518|Gemcitabine|gemcitabine|mesh-list
111116650|NCT05991518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111116651|NCT05991518|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111116652|NCT05991518|Antimetabolites|antimetabolites|mesh-ancestor
111116653|NCT05991518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111116654|NCT05991466|Dexmedetomidine|dexmedetomidine|mesh-list
111116655|NCT05991466|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111116656|NCT05991466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111116657|NCT05991466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111116658|NCT05991466|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111116659|NCT05991466|Analgesics|analgesics|mesh-ancestor
111116660|NCT05991466|Sensory System Agents|sensory system agents|mesh-ancestor
111116661|NCT05991466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111116662|NCT05991466|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111116663|NCT05991466|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111116664|NCT05991466|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111116665|NCT05991466|Adrenergic Agents|adrenergic agents|mesh-ancestor
111116666|NCT05991466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111116667|NCT05991466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111116668|NCT05991453|Propofol|propofol|mesh-list
111116669|NCT05991453|Anesthetics|anesthetics|mesh-list
111116670|NCT05991453|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111116671|NCT05991453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111116672|NCT05991453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111116673|NCT05991453|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111116674|NCT05991453|Anesthetics, General|anesthetics, general|mesh-ancestor
111116675|NCT05991427|Vaccines|vaccines|mesh-list
111116676|NCT05991427|Immunologic Factors|immunologic factors|mesh-ancestor
111116677|NCT05991427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111116678|NCT05991388|Dexamethasone|dexamethasone|mesh-list
111116679|NCT05991388|Rituximab|rituximab|mesh-list
111116680|NCT05991388|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
111116681|NCT05991388|Carboplatin|carboplatin|mesh-list
111116682|NCT05991388|Etoposide|etoposide|mesh-list
111116683|NCT05991388|Etoposide phosphate|etoposide phosphate|mesh-list
111116684|NCT05991388|Ifosfamide|ifosfamide|mesh-list
111116685|NCT05991388|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111116686|NCT05991388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111116687|NCT05991388|Immunologic Factors|immunologic factors|mesh-ancestor
111116688|NCT05991388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111116689|NCT05991388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111116690|NCT05991388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111116691|NCT05991388|Antiemetics|antiemetics|mesh-ancestor
111490337|NCT01708122|Anesthetics|anesthetics|mesh-ancestor
111116692|NCT05991388|Autonomic Agents|autonomic agents|mesh-ancestor
111116693|NCT05991388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111116694|NCT05991388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111116695|NCT05991388|Glucocorticoids|glucocorticoids|mesh-ancestor
111490338|NCT01708278|Folic Acid|folic acid|mesh-list
111490339|NCT01708278|Quercetin|quercetin|mesh-list
111490340|NCT01708278|Hematinics|hematinics|mesh-ancestor
111116696|NCT05991388|Hormones|hormones|mesh-ancestor
111116697|NCT05991388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111116698|NCT05991388|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111116699|NCT05991388|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111116700|NCT05991388|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111116701|NCT05991388|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111116702|NCT05991388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111116703|NCT05991388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111116704|NCT05991388|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111116705|NCT05991388|Alkylating Agents|alkylating agents|mesh-ancestor
111116706|NCT05991375|Dexmedetomidine|dexmedetomidine|mesh-list
111116707|NCT05991375|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111116708|NCT05991375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111116709|NCT05991375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111116710|NCT05991375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111116711|NCT05991375|Analgesics|analgesics|mesh-ancestor
111116712|NCT05991375|Sensory System Agents|sensory system agents|mesh-ancestor
111116713|NCT05991375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111116714|NCT05991375|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111116715|NCT05991375|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111116716|NCT05991375|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111116717|NCT05991375|Adrenergic Agents|adrenergic agents|mesh-ancestor
111116718|NCT05991375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111116719|NCT05991375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111116720|NCT05991284|Valsartan|valsartan|mesh-list
111116721|NCT05991284|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
111116722|NCT05991284|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111116723|NCT05991284|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111116724|NCT05991284|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111116725|NCT05991284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111116726|NCT05991232|Ketamine|ketamine|mesh-list
111116727|NCT05991232|Analgesics|analgesics|mesh-ancestor
111116728|NCT05991232|Sensory System Agents|sensory system agents|mesh-ancestor
111116729|NCT05991232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111116730|NCT05991232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111116731|NCT05991232|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111116732|NCT05991232|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111116733|NCT05991232|Anesthetics, General|anesthetics, general|mesh-ancestor
111116734|NCT05991232|Anesthetics|anesthetics|mesh-ancestor
111116735|NCT05991232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111116736|NCT05991232|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111116737|NCT05991232|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111116738|NCT05991232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111116739|NCT05991232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111116740|NCT05991037|Psychotropic Drugs|psychotropic drugs|mesh-list
111116741|NCT05990933|Epinephrine|epinephrine|mesh-list
111116742|NCT05990933|Racepinephrine|racepinephrine|mesh-list
111116743|NCT05990933|Epinephryl borate|epinephryl borate|mesh-list
111116744|NCT05990933|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111116745|NCT05990933|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111116746|NCT05990933|Adrenergic Agents|adrenergic agents|mesh-ancestor
111116747|NCT05990933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111116748|NCT05990933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111116749|NCT05990933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111116750|NCT05990933|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111116751|NCT05990933|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111116752|NCT05990933|Autonomic Agents|autonomic agents|mesh-ancestor
111116753|NCT05990933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111116754|NCT05990933|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111116755|NCT05990933|Respiratory System Agents|respiratory system agents|mesh-ancestor
111116756|NCT05990933|Mydriatics|mydriatics|mesh-ancestor
111116757|NCT05990933|Sympathomimetics|sympathomimetics|mesh-ancestor
111116758|NCT05990933|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111116759|NCT05990881|Botulinum Toxins|botulinum toxins|mesh-list
111116760|NCT05990881|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111116761|NCT05990881|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111119177|NCT05272384|Nivolumab|nivolumab|mesh-list
111490341|NCT01708278|Vitamin B Complex|vitamin b complex|mesh-ancestor
111490342|NCT01708278|Vitamins|vitamins|mesh-ancestor
111490343|NCT01708278|Micronutrients|micronutrients|mesh-ancestor
111490344|NCT01708278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111490345|NCT01708278|Antioxidants|antioxidants|mesh-ancestor
111490346|NCT01708278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111116762|NCT05990881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111116763|NCT05990881|Cholinergic Agents|cholinergic agents|mesh-ancestor
111116764|NCT05990881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111116765|NCT05990881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111116766|NCT05990868|Acetaminophen|acetaminophen|mesh-list
111116767|NCT05990868|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111116768|NCT05990868|Analgesics|analgesics|mesh-ancestor
111116769|NCT05990868|Sensory System Agents|sensory system agents|mesh-ancestor
111116770|NCT05990868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111116771|NCT05990868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111116772|NCT05990868|Antipyretics|antipyretics|mesh-ancestor
111116773|NCT05990842|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111116774|NCT05990842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111116775|NCT05990829|Aflibercept|aflibercept|mesh-list
111116776|NCT05990829|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111116777|NCT05990829|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111116778|NCT05990829|Growth Substances|growth substances|mesh-ancestor
111116779|NCT05990829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111116780|NCT05990829|Growth Inhibitors|growth inhibitors|mesh-ancestor
111116781|NCT05990829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111116783|NCT05990686|Tramadol|tramadol|mesh-list
111116784|NCT05990686|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111116785|NCT05990686|Narcotics|narcotics|mesh-ancestor
111116786|NCT05990686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111116787|NCT05990686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111116788|NCT05990686|Analgesics|analgesics|mesh-ancestor
111116789|NCT05990686|Sensory System Agents|sensory system agents|mesh-ancestor
111116790|NCT05990686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111116791|NCT05990686|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111116792|NCT05990686|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111116793|NCT05990686|Anesthetics, General|anesthetics, general|mesh-ancestor
111116794|NCT05990686|Anesthetics|anesthetics|mesh-ancestor
111116795|NCT05990543|Capecitabine|capecitabine|mesh-list
111116796|NCT05990543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111116797|NCT05990543|Antimetabolites|antimetabolites|mesh-ancestor
111116798|NCT05990543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111116799|NCT05990543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111116800|NCT05990465|Pirtobrutinib|pirtobrutinib|mesh-list
111116801|NCT05990465|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111116802|NCT05990465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111116803|NCT05990465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111116804|NCT05990387|Mirabegron|mirabegron|mesh-list
111116805|NCT05990387|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
111116806|NCT05990387|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111116807|NCT05990387|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111116808|NCT05990387|Adrenergic Agents|adrenergic agents|mesh-ancestor
111116809|NCT05990387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111116810|NCT05990387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111116811|NCT05990387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111116812|NCT05990387|Urological Agents|urological agents|mesh-ancestor
111116814|NCT05990374|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111116815|NCT05990374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111116816|NCT05990374|Incretins|incretins|mesh-ancestor
111116817|NCT05990374|Hormones|hormones|mesh-ancestor
111116818|NCT05990374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111116819|NCT05990205|Metformin|metformin|mesh-list
111116820|NCT05990205|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111116821|NCT05990205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111116822|NCT05990192|Niraparib|niraparib|mesh-list
111116823|NCT05990192|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111116824|NCT05990192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111116825|NCT05990192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111116826|NCT05990192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111116827|NCT05990127|Paclitaxel|paclitaxel|mesh-list
111116828|NCT05990127|Carboplatin|carboplatin|mesh-list
111116829|NCT05990127|Pemetrexed|pemetrexed|mesh-list
111116830|NCT05990127|Tislelizumab|tislelizumab|mesh-list
111116831|NCT05990127|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111116832|NCT05990127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111116833|NCT05990127|Tubulin Modulators|tubulin modulators|mesh-ancestor
111116834|NCT05990127|Antimitotic Agents|antimitotic agents|mesh-ancestor
111116835|NCT05990127|Mitosis Modulators|mitosis modulators|mesh-ancestor
111116836|NCT05990127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111116837|NCT05990127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111490347|NCT01708278|Protective Agents|protective agents|mesh-ancestor
111490348|NCT01708590|Brodalumab|brodalumab|mesh-list
111490349|NCT01708590|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111490350|NCT01708590|Dermatologic Agents|dermatologic agents|mesh-ancestor
111490351|NCT01708590|Immunologic Factors|immunologic factors|mesh-ancestor
111490352|NCT01708590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111490353|NCT05710146|Tranexamic Acid|tranexamic acid|mesh-list
111490354|NCT05710146|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111490355|NCT05710146|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111490356|NCT05710146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111490357|NCT05710146|Hemostatics|hemostatics|mesh-ancestor
111116838|NCT05990127|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111116839|NCT05990127|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111116840|NCT05990127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111116841|NCT05989984|Iron|iron|mesh-list
111116842|NCT05989984|Trace Elements|trace elements|mesh-ancestor
111116843|NCT05989984|Micronutrients|micronutrients|mesh-ancestor
111116844|NCT05989984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111116845|NCT05989932|Upadacitinib|upadacitinib|mesh-list
111116846|NCT05989932|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
111116847|NCT05989932|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111116848|NCT05989932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111116849|NCT05989932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111116850|NCT05989932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111116851|NCT05989633|Selenium|selenium|mesh-list
111116852|NCT05989633|Antioxidants|antioxidants|mesh-ancestor
111116853|NCT05989633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111116854|NCT05989633|Protective Agents|protective agents|mesh-ancestor
111116855|NCT05989633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111116856|NCT05989633|Trace Elements|trace elements|mesh-ancestor
111116857|NCT05989633|Micronutrients|micronutrients|mesh-ancestor
111116858|NCT05988879|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
111116859|NCT05988879|Antiviral Agents|antiviral agents|mesh-ancestor
111116860|NCT05988879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111116861|NCT05988372|Paclitaxel|paclitaxel|mesh-list
111116862|NCT05988372|Gemcitabine|gemcitabine|mesh-list
111116863|NCT05988372|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111116864|NCT05988372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111490358|NCT05710146|Coagulants|coagulants|mesh-ancestor
111490359|NCT05683548|Interferons|interferons|mesh-list
111490360|NCT05683548|Tenofovir|tenofovir|mesh-list
111490361|NCT05683548|Interferon-alpha|interferon-alpha|mesh-list
111490362|NCT05683548|Interferon alpha-2|interferon alpha-2|mesh-list
111490363|NCT05683548|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
111490364|NCT05683548|REP 2139|rep 2139|mesh-list
111490365|NCT05683548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111490366|NCT05683548|Antiviral Agents|antiviral agents|mesh-ancestor
111490367|NCT05683548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111490368|NCT05683548|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111490369|NCT05683548|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111490370|NCT05683548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111116865|NCT05988372|Tubulin Modulators|tubulin modulators|mesh-ancestor
111116866|NCT05988372|Antimitotic Agents|antimitotic agents|mesh-ancestor
111116867|NCT05988372|Mitosis Modulators|mitosis modulators|mesh-ancestor
111116868|NCT05988372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111116869|NCT05988372|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111116870|NCT05988372|Antimetabolites|antimetabolites|mesh-ancestor
111116871|NCT05987826|Aflutinib|aflutinib|mesh-list
111116872|NCT05987826|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111116873|NCT05987826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111116874|NCT05987826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111116875|NCT05973006|Vaccines|vaccines|mesh-list
111116876|NCT05973006|Immunologic Factors|immunologic factors|mesh-ancestor
111116877|NCT05973006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111116878|NCT05965570|Clarithromycin|clarithromycin|mesh-list
111116879|NCT05965570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111116880|NCT05965570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111116881|NCT05965570|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111116882|NCT05965570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111490371|NCT05683548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111490372|NCT05683548|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111116883|NCT05965570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111116884|NCT05965570|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110698479|NCT00372996|Exemestane|exemestane|mesh-list
111490373|NCT05683548|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111490374|NCT05683548|Immunologic Factors|immunologic factors|mesh-ancestor
111116885|NCT05965570|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111490375|NCT05683548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111490377|NCT05661942|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111490378|NCT05661942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111490379|NCT05636436|Vaccines|vaccines|mesh-list
111490380|NCT05636436|Immunologic Factors|immunologic factors|mesh-ancestor
111490381|NCT05636436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111490382|NCT05463354|Vaccines|vaccines|mesh-list
111490383|NCT05463354|Immunologic Factors|immunologic factors|mesh-ancestor
111490384|NCT05463354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111490385|NCT05293548|Vaccines|vaccines|mesh-list
111490386|NCT05293548|Immunologic Factors|immunologic factors|mesh-ancestor
111490387|NCT05293548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111490388|NCT05157360|Vitamins|vitamins|mesh-list
111116887|NCT05964647|Lorazepam|lorazepam|mesh-list
111116888|NCT05964647|Olanzapine|olanzapine|mesh-list
111116889|NCT05964647|Antiemetics|antiemetics|mesh-ancestor
111116890|NCT05964647|Autonomic Agents|autonomic agents|mesh-ancestor
111116891|NCT05964647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111116892|NCT05964647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111116893|NCT05964647|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111116894|NCT05964647|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111116895|NCT05964647|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111116896|NCT05964647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111116897|NCT05964647|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111116898|NCT05964647|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111116899|NCT05964647|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111116900|NCT05964647|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111116901|NCT05964647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111116902|NCT05964647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111116903|NCT05964647|Serotonin Agents|serotonin agents|mesh-ancestor
111116904|NCT05964647|Anticonvulsants|anticonvulsants|mesh-ancestor
111116905|NCT05964647|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111116906|NCT05964647|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111116907|NCT05964647|GABA Modulators|gaba modulators|mesh-ancestor
111116908|NCT05964647|GABA Agents|gaba agents|mesh-ancestor
111116909|NCT05964647|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111116910|NCT05964647|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111116911|NCT05964647|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111116912|NCT05952804|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111116913|NCT05952804|Immunoglobulins|immunoglobulins|mesh-list
111116914|NCT05952804|Antibodies|antibodies|mesh-list
111116915|NCT05952804|gamma-Globulins|gamma-globulins|mesh-list
111116916|NCT05952804|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111116917|NCT05952804|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
111116918|NCT05952804|Immunologic Factors|immunologic factors|mesh-ancestor
111116919|NCT05952804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111116920|NCT05949190|Azithromycin|azithromycin|mesh-list
111116921|NCT05949190|Pyrimethamine|pyrimethamine|mesh-list
111116922|NCT05949190|Sulfadoxine|sulfadoxine|mesh-list
111116923|NCT05949190|Albendazole|albendazole|mesh-list
111116924|NCT05949190|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
111116925|NCT05949190|Choline|choline|mesh-list
111116926|NCT05949190|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111116927|NCT05949190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111116928|NCT05949190|Lipotropic Agents|lipotropic agents|mesh-ancestor
111116929|NCT05949190|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111116930|NCT05949190|Antimetabolites|antimetabolites|mesh-ancestor
111116931|NCT05949190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111116932|NCT05949190|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111116933|NCT05949190|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111116934|NCT05949190|Nootropic Agents|nootropic agents|mesh-ancestor
111116935|NCT05949190|Antimalarials|antimalarials|mesh-ancestor
111116936|NCT05949190|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111116937|NCT05949190|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111116938|NCT05949190|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111116939|NCT05949190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111116940|NCT05949190|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111116941|NCT05949190|Anthelmintics|anthelmintics|mesh-ancestor
111116942|NCT05949190|Anticestodal Agents|anticestodal agents|mesh-ancestor
111116943|NCT05949190|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
111116944|NCT05949190|Tubulin Modulators|tubulin modulators|mesh-ancestor
111116945|NCT05949190|Antimitotic Agents|antimitotic agents|mesh-ancestor
111116946|NCT05949190|Mitosis Modulators|mitosis modulators|mesh-ancestor
111116947|NCT05949190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111116948|NCT05915949|Dapagliflozin|dapagliflozin|mesh-list
110698508|NCT00300885|Paclitaxel|paclitaxel|mesh-list
111490389|NCT05157360|Hydrocortisone|hydrocortisone|mesh-list
111116949|NCT05915949|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111116950|NCT05915949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111116951|NCT05915949|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111116952|NCT05915949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111116953|NCT05890352|Lenalidomide|lenalidomide|mesh-list
111116954|NCT05890352|Zanubrutinib|zanubrutinib|mesh-list
111116955|NCT05890352|Immunoglobulins|immunoglobulins|mesh-list
111116956|NCT05890352|Immunologic Factors|immunologic factors|mesh-ancestor
111116957|NCT05890352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111116958|NCT05890352|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111116959|NCT05890352|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111116960|NCT05890352|Growth Substances|growth substances|mesh-ancestor
111116961|NCT05890352|Growth Inhibitors|growth inhibitors|mesh-ancestor
111116962|NCT05890352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111116963|NCT05890352|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111116964|NCT05890352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111116965|NCT05890352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111116967|NCT05881265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111116968|NCT05874037|Fluvoxamine|fluvoxamine|mesh-list
111116969|NCT05874037|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111116970|NCT05874037|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111116971|NCT05874037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111116972|NCT05874037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111116973|NCT05874037|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111116974|NCT05874037|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111116975|NCT05874037|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111116976|NCT05874037|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111116977|NCT05874037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111116978|NCT05874037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111116979|NCT05874037|Serotonin Agents|serotonin agents|mesh-ancestor
111116980|NCT05874037|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111116981|NCT05874037|Antidepressive Agents|antidepressive agents|mesh-ancestor
111116982|NCT05874037|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111116983|NCT05874037|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111116984|NCT05874037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111116985|NCT05874037|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111116986|NCT05858710|Doxorubicin|doxorubicin|mesh-list
111116987|NCT05858710|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111116988|NCT05858710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111116989|NCT05858710|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111116990|NCT05858710|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111116991|NCT05858710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111116992|NCT05858710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111116993|NCT05832229|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111116994|NCT05832229|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111116995|NCT05832229|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111116996|NCT05832229|Antimetabolites|antimetabolites|mesh-ancestor
111116997|NCT05832229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111116998|NCT05832229|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111116999|NCT05832229|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111117000|NCT05832229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111117001|NCT05814939|Tofacitinib|tofacitinib|mesh-list
111117002|NCT05814939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111117003|NCT05814939|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
111117004|NCT05814939|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111117005|NCT05814939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111117006|NCT05800860|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
111117007|NCT05800860|Hallucinogens|hallucinogens|mesh-ancestor
111117008|NCT05800860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111117009|NCT05800860|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111117010|NCT05800860|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111117011|NCT05800860|Serotonin Agents|serotonin agents|mesh-ancestor
111117012|NCT05800860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111117013|NCT05800860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111117014|NCT05800860|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111117015|NCT05753956|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
111117016|NCT05753956|Hallucinogens|hallucinogens|mesh-ancestor
111117017|NCT05753956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111117018|NCT05753956|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111117019|NCT05753956|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111117020|NCT05753956|Serotonin Agents|serotonin agents|mesh-ancestor
111117021|NCT05753956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111117022|NCT05753956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111117023|NCT05753956|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111117024|NCT05732389|Nivolumab|nivolumab|mesh-list
111117025|NCT05732389|Ipilimumab|ipilimumab|mesh-list
111117026|NCT05732389|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111117027|NCT05732389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111117028|NCT05732389|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111117029|NCT05732389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111117030|NCT05729282|Diazoxide|diazoxide|mesh-list
111117031|NCT05729282|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111117032|NCT05729282|Vasodilator Agents|vasodilator agents|mesh-ancestor
111117033|NCT05698511|Psilocybin|psilocybin|mesh-list
111117034|NCT05698511|Hallucinogens|hallucinogens|mesh-ancestor
111117035|NCT05698511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111117036|NCT05698511|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111117037|NCT05686044|Phenserine|phenserine|mesh-list
111117038|NCT05686044|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111117039|NCT05686044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111117040|NCT05686044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111117041|NCT05686044|Cholinergic Agents|cholinergic agents|mesh-ancestor
111117042|NCT05686044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111117043|NCT05686044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111117044|NCT05671029|Moxifloxacin|moxifloxacin|mesh-list
111117045|NCT05671029|Pritelivir|pritelivir|mesh-list
111117046|NCT05671029|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
111117047|NCT05671029|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111117048|NCT05671029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111117049|NCT05671029|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111117050|NCT05671029|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111117051|NCT05671029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111117052|NCT05671029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111117053|NCT05671029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111117054|NCT05671029|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111117055|NCT05671029|Contraceptive Agents|contraceptive agents|mesh-ancestor
111117056|NCT05671029|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111117057|NCT05671029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111117058|NCT05671029|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
111117059|NCT05671029|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111117060|NCT05671029|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111117061|NCT05671029|Antiviral Agents|antiviral agents|mesh-ancestor
111117062|NCT05659537|Dulaglutide|dulaglutide|mesh-list
111117063|NCT05659537|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111117064|NCT05659537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111117065|NCT05640245|Adalimumab|adalimumab|mesh-list
111117066|NCT05640245|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111117067|NCT05640245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111117068|NCT05640245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111117069|NCT05633615|Cyclophosphamide|cyclophosphamide|mesh-list
111117070|NCT05633615|Fludarabine|fludarabine|mesh-list
111117071|NCT05633615|Tisagenlecleucel|tisagenlecleucel|mesh-list
111117072|NCT05633615|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
111117073|NCT05633615|Antibodies|antibodies|mesh-list
111117074|NCT05633615|Immunoglobulins|immunoglobulins|mesh-list
111117075|NCT05633615|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111117076|NCT05633615|Antibodies, Bispecific|antibodies, bispecific|mesh-list
111117077|NCT05633615|Immunoconjugates|immunoconjugates|mesh-list
111117078|NCT05633615|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
111117079|NCT05633615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111117080|NCT05633615|Immunologic Factors|immunologic factors|mesh-ancestor
111117081|NCT05633615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111117082|NCT05633615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111117083|NCT05633615|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111117084|NCT05633615|Alkylating Agents|alkylating agents|mesh-ancestor
111117085|NCT05633615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111117086|NCT05633615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111117087|NCT05633615|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111117088|NCT05633615|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111117089|NCT05632211|Golimumab|golimumab|mesh-list
111117090|NCT05632211|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111117091|NCT05632211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111117092|NCT05632211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111117093|NCT05632211|Immunologic Factors|immunologic factors|mesh-ancestor
111117094|NCT05632211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111490391|NCT05157360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111490392|NCT05157360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111490393|NCT05136066|Peppermint oil|peppermint oil|mesh-list
111490394|NCT05136066|Antiemetics|antiemetics|mesh-ancestor
111117095|NCT05608070|Oxytocin|oxytocin|mesh-list
111117096|NCT05608070|Oxytocics|oxytocics|mesh-ancestor
111117097|NCT05608070|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111117098|NCT05608070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111117099|NCT05577702|Tislelizumab|tislelizumab|mesh-list
111117100|NCT05577702|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111117101|NCT05577702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111117102|NCT05561387|Dexamethasone|dexamethasone|mesh-list
111117103|NCT05561387|Dexamethasone acetate|dexamethasone acetate|mesh-list
111117104|NCT05561387|Lenalidomide|lenalidomide|mesh-list
111117105|NCT05561387|Bortezomib|bortezomib|mesh-list
111117106|NCT05561387|Daratumumab|daratumumab|mesh-list
111117107|NCT05561387|Ichthammol|ichthammol|mesh-list
111117108|NCT05561387|BB 1101|bb 1101|mesh-list
111117109|NCT05561387|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111117110|NCT05561387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111117111|NCT05561387|Antiemetics|antiemetics|mesh-ancestor
111117112|NCT05561387|Autonomic Agents|autonomic agents|mesh-ancestor
111117113|NCT05561387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111117114|NCT05561387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111117115|NCT05561387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111117116|NCT05561387|Glucocorticoids|glucocorticoids|mesh-ancestor
111117117|NCT05561387|Hormones|hormones|mesh-ancestor
111117118|NCT05561387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111117119|NCT05561387|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111117120|NCT05561387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111117121|NCT05561387|Protease Inhibitors|protease inhibitors|mesh-ancestor
111117122|NCT05561387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111117123|NCT05561387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111117124|NCT05561387|Immunologic Factors|immunologic factors|mesh-ancestor
111117125|NCT05561387|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111117126|NCT05561387|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111117127|NCT05561387|Growth Substances|growth substances|mesh-ancestor
111117128|NCT05561387|Growth Inhibitors|growth inhibitors|mesh-ancestor
111117129|NCT05561387|Dermatologic Agents|dermatologic agents|mesh-ancestor
111117130|NCT05553691|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
111117131|NCT05553691|Hallucinogens|hallucinogens|mesh-ancestor
111117132|NCT05553691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111117133|NCT05553691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111117134|NCT05553691|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111117135|NCT05553691|Serotonin Agents|serotonin agents|mesh-ancestor
111117136|NCT05553691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111117137|NCT05553691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111117138|NCT05553691|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111117139|NCT05530655|Lisinopril|lisinopril|mesh-list
111117140|NCT05530655|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
111117141|NCT05530655|Protease Inhibitors|protease inhibitors|mesh-ancestor
111117142|NCT05530655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111117143|NCT05530655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111117144|NCT05530655|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111117145|NCT05530655|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111117146|NCT05530655|Protective Agents|protective agents|mesh-ancestor
111117147|NCT05530655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111117148|NCT05405166|Dexamethasone|dexamethasone|mesh-list
111117149|NCT05405166|Pomalidomide|pomalidomide|mesh-list
111117150|NCT05405166|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111117151|NCT05405166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111117152|NCT05405166|Antiemetics|antiemetics|mesh-ancestor
111117153|NCT05405166|Autonomic Agents|autonomic agents|mesh-ancestor
111117154|NCT05405166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111117155|NCT05405166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111117156|NCT05405166|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111117157|NCT05405166|Glucocorticoids|glucocorticoids|mesh-ancestor
111117158|NCT05405166|Hormones|hormones|mesh-ancestor
111117159|NCT05405166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111117160|NCT05405166|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111117161|NCT05405166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111117162|NCT05405166|Immunologic Factors|immunologic factors|mesh-ancestor
111117163|NCT05405166|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111117164|NCT05405166|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111490395|NCT05136066|Autonomic Agents|autonomic agents|mesh-ancestor
111117165|NCT05405166|Growth Substances|growth substances|mesh-ancestor
111117166|NCT05405166|Growth Inhibitors|growth inhibitors|mesh-ancestor
111490396|NCT05136066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111117167|NCT05374564|Flutemetamol|flutemetamol|mesh-list
111117168|NCT05374564|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111117169|NCT05374564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111117170|NCT05370599|Losartan|losartan|mesh-list
111117171|NCT05370599|Amlodipine|amlodipine|mesh-list
111117172|NCT05370599|Chlorthalidone|chlorthalidone|mesh-list
111117173|NCT05370599|Antihypertensive Agents|antihypertensive agents|mesh-list
111117174|NCT05370599|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111117175|NCT05370599|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111117176|NCT05370599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111117177|NCT05370599|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111117178|NCT05370599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111117179|NCT05370599|Vasodilator Agents|vasodilator agents|mesh-ancestor
111117180|NCT05370599|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111117181|NCT05370599|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111117182|NCT05370599|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111117183|NCT05370599|Diuretics|diuretics|mesh-ancestor
111117184|NCT05370599|Natriuretic Agents|natriuretic agents|mesh-ancestor
110834258|NCT03921593|Pancrelipase|pancrelipase|mesh-list
111117185|NCT05370599|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
111117186|NCT05301712|Naloxone|naloxone|mesh-list
111117187|NCT05301712|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111117188|NCT05301712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111117189|NCT05301712|Sensory System Agents|sensory system agents|mesh-ancestor
111117190|NCT05301712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111117191|NCT05266612|Nivolumab|nivolumab|mesh-list
111117192|NCT05266612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111117193|NCT05266612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111117194|NCT05266612|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111117195|NCT05266612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111117196|NCT05222191|Chlorthalidone|chlorthalidone|mesh-list
111117197|NCT05222191|Spironolactone|spironolactone|mesh-list
111117198|NCT05222191|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
111117199|NCT05222191|Hormone Antagonists|hormone antagonists|mesh-ancestor
111117200|NCT05222191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111117201|NCT05222191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111117202|NCT05222191|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
111117203|NCT05222191|Diuretics|diuretics|mesh-ancestor
111117204|NCT05222191|Natriuretic Agents|natriuretic agents|mesh-ancestor
111117205|NCT05222191|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111117206|NCT05222191|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
111117207|NCT05222191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111117208|NCT05222191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111117209|NCT05189015|Olmesartan|olmesartan|mesh-list
111117210|NCT05189015|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
111117211|NCT05189015|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111117212|NCT05189015|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111117213|NCT05189015|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111117214|NCT05189015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111117215|NCT05153070|Cyclosporine|cyclosporine|mesh-list
111117216|NCT05153070|Cyclosporins|cyclosporins|mesh-list
111117217|NCT05153070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111117218|NCT05153070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111117219|NCT05153070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111117220|NCT05153070|Immunologic Factors|immunologic factors|mesh-ancestor
111117221|NCT05153070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111117222|NCT05153070|Antifungal Agents|antifungal agents|mesh-ancestor
111117223|NCT05153070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111117224|NCT05153070|Dermatologic Agents|dermatologic agents|mesh-ancestor
111117225|NCT05153070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111117226|NCT05153070|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111117227|NCT05132075|Docetaxel|docetaxel|mesh-list
111117228|NCT05132075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111117229|NCT05132075|Tubulin Modulators|tubulin modulators|mesh-ancestor
111117230|NCT05132075|Antimitotic Agents|antimitotic agents|mesh-ancestor
111117231|NCT05132075|Mitosis Modulators|mitosis modulators|mesh-ancestor
111117232|NCT05132075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111117233|NCT05084196|Melatonin|melatonin|mesh-list
111490397|NCT05136066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111490398|NCT05136066|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111117234|NCT05084196|Antioxidants|antioxidants|mesh-ancestor
111117235|NCT05084196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111490399|NCT05136066|Parasympatholytics|parasympatholytics|mesh-ancestor
111490400|NCT04676802|Analgesics, Opioid|analgesics, opioid|mesh-list
111117236|NCT05084196|Protective Agents|protective agents|mesh-ancestor
111117237|NCT05084196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111117238|NCT05084196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111117239|NCT05065671|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
111117240|NCT05065671|Tolcapone|tolcapone|mesh-list
111117241|NCT05065671|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111117242|NCT05065671|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111117243|NCT05065671|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111117244|NCT05065671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111117245|NCT05065671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111117246|NCT05065671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111117247|NCT05065671|Analgesics|analgesics|mesh-ancestor
111117248|NCT05065671|Sensory System Agents|sensory system agents|mesh-ancestor
111117249|NCT05065671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111117250|NCT05065671|Antidepressive Agents|antidepressive agents|mesh-ancestor
111117251|NCT05065671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111117252|NCT05065671|Dopamine Agents|dopamine agents|mesh-ancestor
111117253|NCT05065671|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111117254|NCT05065671|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111117255|NCT05065671|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
111117256|NCT05065671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111117257|NCT05045638|Sotorasib|sotorasib|mesh-list
111117258|NCT05045638|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111117259|NCT05045638|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111117260|NCT05045638|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111117261|NCT05045638|Antimetabolites|antimetabolites|mesh-ancestor
111117262|NCT05045638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111117263|NCT05045638|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111117264|NCT05045638|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111117265|NCT05045638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111117266|NCT05045638|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111117267|NCT05045638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111117268|NCT05045638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111117269|NCT05044819|Cannabidiol|cannabidiol|mesh-list
111117270|NCT05044819|Anticonvulsants|anticonvulsants|mesh-ancestor
111117271|NCT05040360|Capecitabine|capecitabine|mesh-list
111117272|NCT05040360|Temozolomide|temozolomide|mesh-list
111117273|NCT05040360|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111117274|NCT05040360|Antimetabolites|antimetabolites|mesh-ancestor
111117275|NCT05040360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111117276|NCT05040360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111117277|NCT05040360|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111117278|NCT05040360|Alkylating Agents|alkylating agents|mesh-ancestor
111117279|NCT05011513|Ritonavir|ritonavir|mesh-list
111117280|NCT05011513|Nirmatrelvir|nirmatrelvir|mesh-list
111117281|NCT05011513|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111117282|NCT05011513|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111117283|NCT05011513|Protease Inhibitors|protease inhibitors|mesh-ancestor
111117284|NCT05011513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111117285|NCT05011513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111117286|NCT05011513|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111117287|NCT05011513|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111117288|NCT05011513|Antiviral Agents|antiviral agents|mesh-ancestor
111117289|NCT05011513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111117290|NCT05011513|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111117291|NCT05011513|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111117292|NCT05006573|Benralizumab|benralizumab|mesh-list
111117293|NCT05006573|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111117294|NCT05006573|Respiratory System Agents|respiratory system agents|mesh-ancestor
111117295|NCT04970901|Obinutuzumab|obinutuzumab|mesh-list
111117296|NCT04970901|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
111117297|NCT04970901|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
111117298|NCT04970901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111117299|NCT04970901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111117300|NCT04970901|Immunoconjugates|immunoconjugates|mesh-ancestor
111117301|NCT04970901|Immunologic Factors|immunologic factors|mesh-ancestor
111117302|NCT04970901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111117303|NCT04936542|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111117304|NCT04936542|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111117305|NCT04936542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111117306|NCT04936542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111490401|NCT04676802|Narcotics|narcotics|mesh-ancestor
111117307|NCT04936542|Cholinergic Agents|cholinergic agents|mesh-ancestor
111117308|NCT04936542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111117309|NCT04936542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111117310|NCT04849416|Pirtobrutinib|pirtobrutinib|mesh-list
111117311|NCT04849416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111117312|NCT04849416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111117313|NCT04849416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111117314|NCT04818034|Dapagliflozin|dapagliflozin|mesh-list
111117315|NCT04818034|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111117316|NCT04818034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111117317|NCT04818034|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111117318|NCT04818034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111117319|NCT04812028|Magnesium Sulfate|magnesium sulfate|mesh-list
111117320|NCT04812028|Analgesics|analgesics|mesh-ancestor
111117321|NCT04812028|Sensory System Agents|sensory system agents|mesh-ancestor
111117322|NCT04812028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111117323|NCT04812028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111117324|NCT04812028|Anesthetics|anesthetics|mesh-ancestor
111117325|NCT04812028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111117326|NCT04812028|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111117327|NCT04812028|Anticonvulsants|anticonvulsants|mesh-ancestor
111117328|NCT04812028|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111117329|NCT04812028|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110834411|NCT03810547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111117330|NCT04812028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111117331|NCT04812028|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111117332|NCT04812028|Tocolytic Agents|tocolytic agents|mesh-ancestor
111117333|NCT04812028|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111117334|NCT04807972|Folfirinox|folfirinox|mesh-list
111117335|NCT04807972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111117336|NCT04792190|Dapagliflozin|dapagliflozin|mesh-list
111117337|NCT04792190|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111117338|NCT04792190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111117339|NCT04792190|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111117340|NCT04792190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111117341|NCT04770012|Aspirin|aspirin|mesh-list
111117342|NCT04770012|Clopidogrel|clopidogrel|mesh-list
111117343|NCT04770012|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111117344|NCT04770012|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111117345|NCT04770012|Analgesics|analgesics|mesh-ancestor
111117346|NCT04770012|Sensory System Agents|sensory system agents|mesh-ancestor
111117347|NCT04770012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111117348|NCT04770012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111117349|NCT04770012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111117350|NCT04770012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111117351|NCT04770012|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111117352|NCT04770012|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111117353|NCT04770012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111117354|NCT04770012|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111117355|NCT04770012|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111117356|NCT04770012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111117357|NCT04770012|Antipyretics|antipyretics|mesh-ancestor
111117358|NCT04770012|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111117359|NCT04770012|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111117360|NCT04770012|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111117361|NCT04770012|Purinergic Agents|purinergic agents|mesh-ancestor
111117362|NCT04770012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111117363|NCT04755244|Azacitidine|azacitidine|mesh-list
111117364|NCT04755244|Venetoclax|venetoclax|mesh-list
111117365|NCT04755244|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111117366|NCT04755244|Antimetabolites|antimetabolites|mesh-ancestor
111117367|NCT04755244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111117368|NCT04755244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111117369|NCT04755244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111117370|NCT04718740|Vitamin K|vitamin k|mesh-list
111117371|NCT04718740|Repaglinide|repaglinide|mesh-list
111117372|NCT04718740|Fluzoparib|fluzoparib|mesh-list
111117373|NCT04718740|Midazolam|midazolam|mesh-list
111117374|NCT04718740|Caffeine|caffeine|mesh-list
111117375|NCT04718740|Bupropion|bupropion|mesh-list
111490402|NCT04676802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111490403|NCT04676802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111490404|NCT04676802|Analgesics|analgesics|mesh-ancestor
111117376|NCT04718740|Omeprazole|omeprazole|mesh-list
111117377|NCT04718740|Warfarin|warfarin|mesh-list
111117378|NCT04718740|Vitamins|vitamins|mesh-ancestor
111117379|NCT04718740|Micronutrients|micronutrients|mesh-ancestor
111117380|NCT04718740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111117381|NCT04718740|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111117382|NCT04718740|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111117383|NCT04718740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111117384|NCT04718740|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111117385|NCT04718740|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111117386|NCT04718740|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111117387|NCT04718740|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111117388|NCT04718740|Anesthetics, General|anesthetics, general|mesh-ancestor
111117389|NCT04718740|Anesthetics|anesthetics|mesh-ancestor
111117390|NCT04718740|GABA Modulators|gaba modulators|mesh-ancestor
111117391|NCT04718740|GABA Agents|gaba agents|mesh-ancestor
111117392|NCT04718740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111117393|NCT04718740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111117394|NCT04718740|Anticoagulants|anticoagulants|mesh-ancestor
111117395|NCT04718740|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111117396|NCT04718740|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111117397|NCT04718740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111117398|NCT04718740|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
111117399|NCT04718740|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111117400|NCT04718740|Purinergic Agents|purinergic agents|mesh-ancestor
111117401|NCT04718740|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111117402|NCT04718740|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111117403|NCT04718740|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111117404|NCT04718740|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110834504|NCT03711422|Afatinib|afatinib|mesh-list
111117405|NCT04718740|Antidepressive Agents|antidepressive agents|mesh-ancestor
111117406|NCT04718740|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111117407|NCT04718740|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111117408|NCT04718740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111117409|NCT04718740|Dopamine Agents|dopamine agents|mesh-ancestor
111117410|NCT04718740|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111117411|NCT04718740|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111117412|NCT04718740|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111117413|NCT04718740|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111117414|NCT04718740|Hemostatics|hemostatics|mesh-ancestor
111117415|NCT04718740|Coagulants|coagulants|mesh-ancestor
111117416|NCT04718740|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111117417|NCT04718740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111117418|NCT04718740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111117419|NCT04647916|Camptothecin|camptothecin|mesh-list
111117420|NCT04647916|Irinotecan|irinotecan|mesh-list
111117421|NCT04647916|Immunoconjugates|immunoconjugates|mesh-list
111117422|NCT04647916|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
111117423|NCT04647916|Immunologic Factors|immunologic factors|mesh-ancestor
111117424|NCT04647916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111117425|NCT04647916|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111117426|NCT04647916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111117427|NCT04647916|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111117428|NCT04647916|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111117429|NCT04647916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111117430|NCT04647916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111117431|NCT04590248|Adavosertib|adavosertib|mesh-list
111117432|NCT04590248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111117433|NCT04590248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111117434|NCT04586231|Lenvatinib|lenvatinib|mesh-list
111117435|NCT04586231|Belzutifan|belzutifan|mesh-list
111117436|NCT04586231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111117437|NCT04586231|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111117438|NCT04586231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111490405|NCT04676802|Sensory System Agents|sensory system agents|mesh-ancestor
111490406|NCT04676802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111490407|NCT04068948|Midazolam|midazolam|mesh-list
111490408|NCT04068948|Meperidine|meperidine|mesh-list
111490409|NCT04068948|Hydroxyzine|hydroxyzine|mesh-list
111490410|NCT04068948|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111490411|NCT04068948|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111490412|NCT04068948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111490413|NCT04068948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111490414|NCT04068948|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111490415|NCT04068948|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110698527|NCT00292227|Moxifloxacin|moxifloxacin|mesh-list
111490416|NCT04068948|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111490417|NCT04068948|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111490418|NCT04068948|Anesthetics, General|anesthetics, general|mesh-ancestor
111117439|NCT04586231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111117440|NCT04560816|Moxifloxacin|moxifloxacin|mesh-list
111117441|NCT04560816|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
111117442|NCT04560816|Choline|choline|mesh-list
111117443|NCT04560816|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111117444|NCT04560816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111117445|NCT04560816|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111117446|NCT04560816|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111117447|NCT04560816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111117448|NCT04560816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111117449|NCT04560816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111117450|NCT04560816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111117451|NCT04560816|Lipotropic Agents|lipotropic agents|mesh-ancestor
111117452|NCT04560816|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111117453|NCT04560816|Antimetabolites|antimetabolites|mesh-ancestor
111117454|NCT04560816|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111117455|NCT04560816|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111117456|NCT04560816|Nootropic Agents|nootropic agents|mesh-ancestor
111117457|NCT04560816|Chelating Agents|chelating agents|mesh-ancestor
111117458|NCT04560816|Sequestering Agents|sequestering agents|mesh-ancestor
111117459|NCT04560816|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111117460|NCT04560816|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111117461|NCT04560816|Growth Substances|growth substances|mesh-ancestor
111117462|NCT04560816|Growth Inhibitors|growth inhibitors|mesh-ancestor
111117463|NCT04511013|Nivolumab|nivolumab|mesh-list
111117464|NCT04511013|Ipilimumab|ipilimumab|mesh-list
111117465|NCT04511013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111117466|NCT04511013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111117467|NCT04511013|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111117468|NCT04511013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111117469|NCT04508725|Mitogens|mitogens|mesh-list
111117470|NCT04508725|Endothelial Growth Factors|endothelial growth factors|mesh-list
111117471|NCT04508725|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
111117472|NCT04508725|Mitosis Modulators|mitosis modulators|mesh-ancestor
111117473|NCT04508725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111117474|NCT04508725|Growth Substances|growth substances|mesh-ancestor
111117475|NCT04508725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111117476|NCT04508725|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111117477|NCT04508725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111117478|NCT04504318|Enoxaparin|enoxaparin|mesh-list
111117479|NCT04504318|Apixaban|apixaban|mesh-list
111117480|NCT04504318|Anticoagulants|anticoagulants|mesh-ancestor
111117481|NCT04504318|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111117482|NCT04504318|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111117483|NCT04504318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111117484|NCT04504318|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111117485|NCT04504318|Antithrombins|antithrombins|mesh-ancestor
111117486|NCT04504318|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111117487|NCT04504318|Protease Inhibitors|protease inhibitors|mesh-ancestor
111117488|NCT04504318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111117489|NCT04468061|Pembrolizumab|pembrolizumab|mesh-list
111117490|NCT04468061|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
111117491|NCT04468061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111117492|NCT04468061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111117493|NCT04468061|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111117494|NCT04468061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111117495|NCT04468061|Immunoconjugates|immunoconjugates|mesh-ancestor
111117496|NCT04468061|Immunologic Factors|immunologic factors|mesh-ancestor
111117497|NCT04468061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111117498|NCT04417517|Azacitidine|azacitidine|mesh-list
111117499|NCT04417517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111117500|NCT04417517|Antimetabolites|antimetabolites|mesh-ancestor
111117501|NCT04417517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111117502|NCT04417517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111117503|NCT04417517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111117504|NCT04417257|Fenretinide|fenretinide|mesh-list
111490419|NCT04068948|Anesthetics|anesthetics|mesh-ancestor
111490420|NCT04068948|GABA Modulators|gaba modulators|mesh-ancestor
111490421|NCT04068948|GABA Agents|gaba agents|mesh-ancestor
111490422|NCT04068948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111490423|NCT04068948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111490424|NCT04068948|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111117505|NCT04417257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111117506|NCT04417257|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
111117507|NCT04417257|Protective Agents|protective agents|mesh-ancestor
111490425|NCT04068948|Narcotics|narcotics|mesh-ancestor
111490426|NCT04068948|Analgesics|analgesics|mesh-ancestor
111490427|NCT04068948|Sensory System Agents|sensory system agents|mesh-ancestor
111117508|NCT04417257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111117509|NCT04402073|Vincristine|vincristine|mesh-list
111117510|NCT04402073|Lomustine|lomustine|mesh-list
111117511|NCT04402073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111117512|NCT04402073|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111117513|NCT04402073|Tubulin Modulators|tubulin modulators|mesh-ancestor
111117514|NCT04402073|Antimitotic Agents|antimitotic agents|mesh-ancestor
111117515|NCT04402073|Mitosis Modulators|mitosis modulators|mesh-ancestor
111117516|NCT04402073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111117517|NCT04402073|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111117518|NCT04402073|Alkylating Agents|alkylating agents|mesh-ancestor
111117519|NCT04337177|Temozolomide|temozolomide|mesh-list
111117520|NCT04337177|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111117521|NCT04337177|Alkylating Agents|alkylating agents|mesh-ancestor
111117522|NCT04337177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111117523|NCT04337177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111117524|NCT04205968|Calcium, Dietary|calcium, dietary|mesh-list
111117525|NCT04205968|Leucovorin|leucovorin|mesh-list
111117526|NCT04205968|Folic Acid|folic acid|mesh-list
111117527|NCT04205968|Paclitaxel|paclitaxel|mesh-list
111117528|NCT04205968|Camptothecin|camptothecin|mesh-list
111117529|NCT04205968|Fluorouracil|fluorouracil|mesh-list
111117530|NCT04205968|Irinotecan|irinotecan|mesh-list
111117531|NCT04205968|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111117532|NCT04205968|Ramucirumab|ramucirumab|mesh-list
111117533|NCT04205968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111117534|NCT04205968|Antibodies|antibodies|mesh-list
111117535|NCT04205968|Immunoglobulins|immunoglobulins|mesh-list
111117536|NCT04205968|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111117537|NCT04205968|Lexatumumab|lexatumumab|mesh-list
111117538|NCT04205968|Calcium|calcium|mesh-list
111117539|NCT04205968|Levoleucovorin|levoleucovorin|mesh-list
111117540|NCT04205968|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111117541|NCT04205968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111117542|NCT04205968|Tubulin Modulators|tubulin modulators|mesh-ancestor
111117543|NCT04205968|Antimitotic Agents|antimitotic agents|mesh-ancestor
111117544|NCT04205968|Mitosis Modulators|mitosis modulators|mesh-ancestor
111117545|NCT04205968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111117546|NCT04205968|Immunologic Factors|immunologic factors|mesh-ancestor
111117547|NCT04205968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111117548|NCT04205968|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111117549|NCT04205968|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111117550|NCT04205968|Antimetabolites|antimetabolites|mesh-ancestor
111117551|NCT04205968|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111117552|NCT04205968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111117553|NCT04205968|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111117554|NCT04205968|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111117555|NCT04205968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111117556|NCT04205968|Antidotes|antidotes|mesh-ancestor
111117557|NCT04205968|Protective Agents|protective agents|mesh-ancestor
111117558|NCT04205968|Vitamin B Complex|vitamin b complex|mesh-ancestor
111117559|NCT04205968|Vitamins|vitamins|mesh-ancestor
111117560|NCT04205968|Micronutrients|micronutrients|mesh-ancestor
111117561|NCT04205968|Hematinics|hematinics|mesh-ancestor
111117562|NCT04204941|Doxorubicin|doxorubicin|mesh-list
111117563|NCT04204941|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111117564|NCT04204941|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111117565|NCT04204941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111117566|NCT04204941|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111117567|NCT04204941|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111117568|NCT04204941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111117569|NCT04204941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111117570|NCT04146922|Anti-Infective Agents|anti-infective agents|mesh-list
111117571|NCT04146922|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111117572|NCT04143061|Vaccines|vaccines|mesh-list
111117573|NCT04143061|Immunologic Factors|immunologic factors|mesh-ancestor
111117574|NCT04143061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111117575|NCT04141020|Sirolimus|sirolimus|mesh-list
111490428|NCT04068948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111490429|NCT04068948|Antipruritics|antipruritics|mesh-ancestor
111490430|NCT04068948|Dermatologic Agents|dermatologic agents|mesh-ancestor
111117576|NCT04141020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111117577|NCT04141020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111117578|NCT04141020|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111117579|NCT04141020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111117580|NCT04141020|Antifungal Agents|antifungal agents|mesh-ancestor
111490431|NCT04068948|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111117581|NCT04141020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111117582|NCT04141020|Immunologic Factors|immunologic factors|mesh-ancestor
111117583|NCT04141020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111117584|NCT04083235|Leucovorin|leucovorin|mesh-list
111117585|NCT04083235|Paclitaxel|paclitaxel|mesh-list
111117586|NCT04083235|Gemcitabine|gemcitabine|mesh-list
111117587|NCT04083235|Fluorouracil|fluorouracil|mesh-list
111117588|NCT04083235|Oxaliplatin|oxaliplatin|mesh-list
111117589|NCT04083235|Irinotecan|irinotecan|mesh-list
111117590|NCT04083235|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111117591|NCT04083235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111117592|NCT04083235|Tubulin Modulators|tubulin modulators|mesh-ancestor
111117593|NCT04083235|Antimitotic Agents|antimitotic agents|mesh-ancestor
111117594|NCT04083235|Mitosis Modulators|mitosis modulators|mesh-ancestor
111117595|NCT04083235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111117596|NCT04083235|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111117597|NCT04083235|Antimetabolites|antimetabolites|mesh-ancestor
111117598|NCT04083235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111117599|NCT04083235|Immunologic Factors|immunologic factors|mesh-ancestor
111117600|NCT04083235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111117601|NCT04083235|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111117602|NCT04083235|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111117603|NCT04083235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111117604|NCT04083235|Antidotes|antidotes|mesh-ancestor
111117605|NCT04083235|Protective Agents|protective agents|mesh-ancestor
111117606|NCT04083235|Vitamin B Complex|vitamin b complex|mesh-ancestor
111117607|NCT04083235|Vitamins|vitamins|mesh-ancestor
111117608|NCT04083235|Micronutrients|micronutrients|mesh-ancestor
111117609|NCT04071457|Lenalidomide|lenalidomide|mesh-list
111117610|NCT04071457|Daratumumab|daratumumab|mesh-list
111117611|NCT04071457|Immunologic Factors|immunologic factors|mesh-ancestor
111117612|NCT04071457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111117613|NCT04071457|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111117614|NCT04071457|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111117615|NCT04071457|Growth Substances|growth substances|mesh-ancestor
111117616|NCT04071457|Growth Inhibitors|growth inhibitors|mesh-ancestor
111117617|NCT04071457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111117618|NCT04060719|Rifampin|rifampin|mesh-list
111117619|NCT04060719|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111117620|NCT04060719|Antitubercular Agents|antitubercular agents|mesh-ancestor
111117621|NCT04060719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111117622|NCT04060719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111117623|NCT04060719|Leprostatic Agents|leprostatic agents|mesh-ancestor
111117624|NCT04060719|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111117625|NCT04060719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111117626|NCT04060719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111117627|NCT04060719|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111117628|NCT04060719|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111117629|NCT04060719|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
111117630|NCT04060719|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
111117631|NCT04060719|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
111117632|NCT04060719|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111117633|NCT04047862|Paclitaxel|paclitaxel|mesh-list
110834713|NCT01304095|Ranolazine|ranolazine|mesh-list
111117634|NCT04047862|Etoposide|etoposide|mesh-list
111117635|NCT04047862|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111117636|NCT04047862|Carboplatin|carboplatin|mesh-list
111117637|NCT04047862|Fluorouracil|fluorouracil|mesh-list
111117638|NCT04047862|Capecitabine|capecitabine|mesh-list
111117639|NCT04047862|Oxaliplatin|oxaliplatin|mesh-list
111117640|NCT04047862|Pemetrexed|pemetrexed|mesh-list
111117641|NCT04047862|Tislelizumab|tislelizumab|mesh-list
111117642|NCT04047862|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111117643|NCT04047862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111117644|NCT04047862|Tubulin Modulators|tubulin modulators|mesh-ancestor
111117645|NCT04047862|Antimitotic Agents|antimitotic agents|mesh-ancestor
111117646|NCT04047862|Mitosis Modulators|mitosis modulators|mesh-ancestor
111117647|NCT04047862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111117648|NCT04047862|Antimetabolites|antimetabolites|mesh-ancestor
111490432|NCT04068948|Histamine Antagonists|histamine antagonists|mesh-ancestor
111490433|NCT04068948|Histamine Agents|histamine agents|mesh-ancestor
111490434|NCT03517722|Ustekinumab|ustekinumab|mesh-list
111117649|NCT04047862|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111117650|NCT04047862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111117651|NCT04047862|Immunologic Factors|immunologic factors|mesh-ancestor
111117652|NCT04047862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111119178|NCT05272384|Decitabine|decitabine|mesh-list
111490435|NCT03517722|Dermatologic Agents|dermatologic agents|mesh-ancestor
111117653|NCT04047862|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111117654|NCT04047862|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111117655|NCT04047862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111117656|NCT04047862|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111117657|NCT04047862|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111117658|NCT04047862|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111117659|NCT04039204|Contraceptive Agents|contraceptive agents|mesh-list
111117660|NCT04039204|Contraceptives, Oral|contraceptives, oral|mesh-list
111117661|NCT04039204|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111117662|NCT04039204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111117663|NCT04039204|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111117664|NCT03877406|Empagliflozin|empagliflozin|mesh-list
111117665|NCT03877406|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
111117666|NCT03877406|Hypoglycemic Agents|hypoglycemic agents|mesh-list
111117667|NCT03877406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111117668|NCT03877406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111117669|NCT03746106|Thiamine|thiamine|mesh-list
111117670|NCT03746106|Metformin|metformin|mesh-list
111117671|NCT03746106|Trimethoprim|trimethoprim|mesh-list
111117672|NCT03746106|Vitamins|vitamins|mesh-ancestor
111117673|NCT03746106|Micronutrients|micronutrients|mesh-ancestor
111117674|NCT03746106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111117675|NCT03746106|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111117676|NCT03746106|Vitamin B Complex|vitamin b complex|mesh-ancestor
111117677|NCT03746106|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111117678|NCT03746106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111117679|NCT03746106|Antimalarials|antimalarials|mesh-ancestor
111117680|NCT03746106|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111117681|NCT03746106|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111117682|NCT03746106|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111117683|NCT03746106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111117684|NCT03746106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111117685|NCT03746106|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111117686|NCT03746106|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
111117687|NCT03746106|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111117688|NCT03737461|Lidocaine|lidocaine|mesh-list
111117689|NCT03737461|Anesthetics, Local|anesthetics, local|mesh-ancestor
111117690|NCT03737461|Anesthetics|anesthetics|mesh-ancestor
111117691|NCT03737461|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111117692|NCT03737461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111117693|NCT03737461|Sensory System Agents|sensory system agents|mesh-ancestor
111117694|NCT03737461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111117695|NCT03737461|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111117696|NCT03737461|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111117697|NCT03737461|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111117698|NCT03737461|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111117699|NCT03737461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111117700|NCT03722173|Itraconazole|itraconazole|mesh-list
111117701|NCT03722173|Antifungal Agents|antifungal agents|mesh-ancestor
111117702|NCT03722173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111117703|NCT03722173|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111117704|NCT03722173|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111117705|NCT03722173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111117706|NCT03722173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111117707|NCT03722173|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111117708|NCT03722173|Hormone Antagonists|hormone antagonists|mesh-ancestor
111117709|NCT03722173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111117710|NCT03722173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111117711|NCT03722173|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111117713|NCT03717194|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111117714|NCT03717194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111117715|NCT03717194|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111117716|NCT03717194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111117717|NCT03695380|Atezolizumab|atezolizumab|mesh-list
111117718|NCT03695380|Niraparib|niraparib|mesh-list
111117719|NCT03695380|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111117720|NCT03695380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111117721|NCT03695380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111117722|NCT03695380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111490437|NCT02130492|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111117723|NCT03695380|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111117724|NCT03695380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111117725|NCT03691610|Vaccines|vaccines|mesh-list
111117726|NCT03691610|Immunologic Factors|immunologic factors|mesh-ancestor
111117727|NCT03691610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111117728|NCT03678025|Prednisone|prednisone|mesh-list
111117729|NCT03678025|Cortisone|cortisone|mesh-list
111117730|NCT03678025|Docetaxel|docetaxel|mesh-list
111117731|NCT03678025|Leuprolide|leuprolide|mesh-list
111117732|NCT03678025|Goserelin|goserelin|mesh-list
111117733|NCT03678025|Bicalutamide|bicalutamide|mesh-list
111117734|NCT03678025|Triptorelin Pamoate|triptorelin pamoate|mesh-list
111117735|NCT03678025|Flutamide|flutamide|mesh-list
111117736|NCT03678025|Nilutamide|nilutamide|mesh-list
111117737|NCT03678025|Tryptophan|tryptophan|mesh-list
111117738|NCT03678025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111117739|NCT03678025|Tubulin Modulators|tubulin modulators|mesh-ancestor
111117740|NCT03678025|Antimitotic Agents|antimitotic agents|mesh-ancestor
111117741|NCT03678025|Mitosis Modulators|mitosis modulators|mesh-ancestor
111117742|NCT03678025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111117743|NCT03678025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111117744|NCT03678025|Glucocorticoids|glucocorticoids|mesh-ancestor
111117745|NCT03678025|Hormones|hormones|mesh-ancestor
111117746|NCT03678025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111117747|NCT03678025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111117748|NCT03678025|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111117749|NCT03678025|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111117750|NCT03678025|Fertility Agents|fertility agents|mesh-ancestor
111117751|NCT03678025|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111117752|NCT03678025|Androgen Antagonists|androgen antagonists|mesh-ancestor
111117753|NCT03678025|Hormone Antagonists|hormone antagonists|mesh-ancestor
111117754|NCT03678025|Luteolytic Agents|luteolytic agents|mesh-ancestor
111117755|NCT03678025|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111117756|NCT03678025|Contraceptive Agents|contraceptive agents|mesh-ancestor
111117757|NCT03678025|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111117758|NCT03678025|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111117759|NCT03678025|Antidepressive Agents|antidepressive agents|mesh-ancestor
111117760|NCT03678025|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111117761|NCT03644485|Mycophenolic Acid|mycophenolic acid|mesh-list
111117762|NCT03644485|Tacrolimus|tacrolimus|mesh-list
111117763|NCT03644485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111117764|NCT03644485|Immunologic Factors|immunologic factors|mesh-ancestor
111117765|NCT03644485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111117766|NCT03644485|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111117767|NCT03644485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111117768|NCT03644485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111117769|NCT03644485|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111117770|NCT03644485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111117771|NCT03644485|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111117772|NCT03644485|Antitubercular Agents|antitubercular agents|mesh-ancestor
111117773|NCT03644485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111117774|NCT03644485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111117775|NCT03636256|Docetaxel|docetaxel|mesh-list
111117776|NCT03636256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111117777|NCT03636256|Tubulin Modulators|tubulin modulators|mesh-ancestor
111117778|NCT03636256|Antimitotic Agents|antimitotic agents|mesh-ancestor
111117779|NCT03636256|Mitosis Modulators|mitosis modulators|mesh-ancestor
111117780|NCT03636256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111117781|NCT03555149|Bevacizumab|bevacizumab|mesh-list
111117782|NCT03555149|Atezolizumab|atezolizumab|mesh-list
111117783|NCT03555149|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111117784|NCT03555149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110834928|NCT03792217|Eusol|eusol|mesh-list
111117785|NCT03555149|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111117786|NCT03555149|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111117787|NCT03555149|Growth Substances|growth substances|mesh-ancestor
111117788|NCT03555149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111117789|NCT03555149|Growth Inhibitors|growth inhibitors|mesh-ancestor
111117790|NCT03555149|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111117791|NCT03555149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111117792|NCT03451331|Carboplatin|carboplatin|mesh-list
111490438|NCT02130492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111490439|NCT01309074|Pregabalin|pregabalin|mesh-list
111490440|NCT01309074|Sertraline|sertraline|mesh-list
111117793|NCT03451331|Gemcitabine|gemcitabine|mesh-list
111117794|NCT03451331|Oxaliplatin|oxaliplatin|mesh-list
110676917|NCT03318900|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110676918|NCT03318900|Analgesics|analgesics|mesh-ancestor
111490441|NCT01309074|Analgesics|analgesics|mesh-ancestor
110676919|NCT03318900|Sensory System Agents|sensory system agents|mesh-ancestor
110676920|NCT03318900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110676921|NCT03318900|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110676922|NCT03318900|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110676923|NCT03318900|Antiviral Agents|antiviral agents|mesh-ancestor
110676924|NCT03318900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110676925|NCT03306446|Adalimumab|adalimumab|mesh-list
110676926|NCT03306446|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110676927|NCT03306446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110676928|NCT03306446|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110676929|NCT03292133|Gefitinib|gefitinib|mesh-list
110676930|NCT03292133|Nazartinib|nazartinib|mesh-list
110676931|NCT03292133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110676932|NCT03292133|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110676933|NCT03292133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110676934|NCT03292133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110676935|NCT03289728|Dobutamine|dobutamine|mesh-list
110676936|NCT03289728|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110676937|NCT03289728|Sympathomimetics|sympathomimetics|mesh-ancestor
110676938|NCT03289728|Autonomic Agents|autonomic agents|mesh-ancestor
110676939|NCT03289728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110676940|NCT03289728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110676941|NCT03289728|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
110676942|NCT03289728|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110676943|NCT03289728|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110676944|NCT03289728|Adrenergic Agents|adrenergic agents|mesh-ancestor
110676945|NCT03289728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110676946|NCT03289728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110676947|NCT03289728|Protective Agents|protective agents|mesh-ancestor
110676948|NCT03283917|Dexamethasone|dexamethasone|mesh-list
110676950|NCT03283917|Daratumumab|daratumumab|mesh-list
110676951|NCT03283917|Ixazomib|ixazomib|mesh-list
110676952|NCT03283917|Ichthammol|ichthammol|mesh-list
110676953|NCT03283917|BB 1101|bb 1101|mesh-list
110676954|NCT03283917|Glycine|glycine|mesh-list
110676955|NCT03283917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110676956|NCT03283917|Antiemetics|antiemetics|mesh-ancestor
110676957|NCT03283917|Autonomic Agents|autonomic agents|mesh-ancestor
110676958|NCT03283917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110676959|NCT03283917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110676960|NCT03283917|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110676961|NCT03283917|Glucocorticoids|glucocorticoids|mesh-ancestor
110676962|NCT03283917|Hormones|hormones|mesh-ancestor
110676963|NCT03283917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110676964|NCT03283917|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110676965|NCT03283917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110676966|NCT03283917|Protease Inhibitors|protease inhibitors|mesh-ancestor
110676967|NCT03283917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110676968|NCT03283917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110676969|NCT03283917|Dermatologic Agents|dermatologic agents|mesh-ancestor
110676970|NCT03283917|Glycine Agents|glycine agents|mesh-ancestor
110676971|NCT03283917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110676972|NCT03275415|Budesonide|budesonide|mesh-list
110676973|NCT03275415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110676974|NCT03275415|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110676975|NCT03275415|Autonomic Agents|autonomic agents|mesh-ancestor
110676976|NCT03275415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110676977|NCT03275415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110676978|NCT03275415|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110676979|NCT03275415|Respiratory System Agents|respiratory system agents|mesh-ancestor
110676980|NCT03275415|Glucocorticoids|glucocorticoids|mesh-ancestor
110676981|NCT03275415|Hormones|hormones|mesh-ancestor
110676982|NCT03275415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110676983|NCT03233724|Pembrolizumab|pembrolizumab|mesh-list
110676984|NCT03233724|Decitabine|decitabine|mesh-list
110676985|NCT03233724|Tetrahydrouridine|tetrahydrouridine|mesh-list
111117795|NCT03451331|Nivolumab|nivolumab|mesh-list
111117796|NCT03451331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111117797|NCT03451331|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111117798|NCT03451331|Antimetabolites|antimetabolites|mesh-ancestor
111117799|NCT03451331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111117800|NCT03451331|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111117801|NCT03451331|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111117802|NCT03418961|Carvedilol|carvedilol|mesh-list
111117803|NCT03418961|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111117804|NCT03418961|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111490442|NCT01309074|Sensory System Agents|sensory system agents|mesh-ancestor
111490443|NCT01309074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111490444|NCT01309074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111490445|NCT01309074|Anticonvulsants|anticonvulsants|mesh-ancestor
111117805|NCT03418961|Adrenergic Agents|adrenergic agents|mesh-ancestor
111117806|NCT03418961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111117807|NCT03418961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111117808|NCT03418961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111117809|NCT03418961|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111117810|NCT03418961|Antioxidants|antioxidants|mesh-ancestor
111117811|NCT03418961|Protective Agents|protective agents|mesh-ancestor
111117812|NCT03418961|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111117813|NCT03418961|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111117814|NCT03418961|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111117815|NCT03418961|Vasodilator Agents|vasodilator agents|mesh-ancestor
111117816|NCT03418961|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111117817|NCT03418961|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111117818|NCT03388632|Nivolumab|nivolumab|mesh-list
111117819|NCT03388632|Ipilimumab|ipilimumab|mesh-list
111117820|NCT03388632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111117821|NCT03388632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111117822|NCT03388632|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111117823|NCT03388632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111117824|NCT03386357|Pembrolizumab|pembrolizumab|mesh-list
111117825|NCT03386357|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111117826|NCT03386357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111117827|NCT03386357|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111117828|NCT03386357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111117829|NCT03293784|Infliximab|infliximab|mesh-list
111117830|NCT03293784|Certolizumab Pegol|certolizumab pegol|mesh-list
111117831|NCT03293784|Nivolumab|nivolumab|mesh-list
111117832|NCT03293784|Ipilimumab|ipilimumab|mesh-list
111117833|NCT03293784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111117834|NCT03293784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111117835|NCT03293784|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111117836|NCT03293784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111117837|NCT03293784|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111117838|NCT03293784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111117839|NCT03293784|Dermatologic Agents|dermatologic agents|mesh-ancestor
111117840|NCT03293784|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111117841|NCT03293784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111117842|NCT03293784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111117843|NCT03293784|Immunologic Factors|immunologic factors|mesh-ancestor
111117844|NCT03293784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111117845|NCT03109288|Pioglitazone|pioglitazone|mesh-list
111117846|NCT03109288|Clemastine|clemastine|mesh-list
111117847|NCT03109288|Pirfenidone|pirfenidone|mesh-list
111117848|NCT03109288|Dantrolene|dantrolene|mesh-list
111117849|NCT03109288|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111117850|NCT03109288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111117851|NCT03109288|Analgesics|analgesics|mesh-ancestor
111117852|NCT03109288|Sensory System Agents|sensory system agents|mesh-ancestor
111117853|NCT03109288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111117854|NCT03109288|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111117855|NCT03109288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111117856|NCT03109288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111117857|NCT03109288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111117858|NCT03109288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111117859|NCT03109288|Antipruritics|antipruritics|mesh-ancestor
111117860|NCT03109288|Dermatologic Agents|dermatologic agents|mesh-ancestor
111117861|NCT03109288|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111117862|NCT03109288|Histamine Antagonists|histamine antagonists|mesh-ancestor
111117863|NCT03109288|Histamine Agents|histamine agents|mesh-ancestor
111117864|NCT03109288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111117865|NCT03109288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111117866|NCT03109288|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111117867|NCT03109288|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
111117868|NCT03109288|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110834960|NCT03792295|Ibuprofen|ibuprofen|mesh-list
111117869|NCT03013218|Paclitaxel|paclitaxel|mesh-list
111117870|NCT03013218|Rituximab|rituximab|mesh-list
111117871|NCT03013218|Pembrolizumab|pembrolizumab|mesh-list
111117872|NCT03013218|Trastuzumab|trastuzumab|mesh-list
111117873|NCT03013218|Ramucirumab|ramucirumab|mesh-list
111117874|NCT03013218|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111117875|NCT03013218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110423717|NCT02268175|Hormones|hormones|mesh-ancestor
111490447|NCT01309074|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111490448|NCT01309074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111117876|NCT03013218|Tubulin Modulators|tubulin modulators|mesh-ancestor
111117877|NCT03013218|Antimitotic Agents|antimitotic agents|mesh-ancestor
111117878|NCT03013218|Mitosis Modulators|mitosis modulators|mesh-ancestor
111117879|NCT03013218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111117880|NCT03013218|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111117881|NCT03013218|Immunologic Factors|immunologic factors|mesh-ancestor
111117882|NCT03013218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111117883|NCT03013218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111117884|NCT03013218|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111117885|NCT02996487|Vancomycin|vancomycin|mesh-list
111117886|NCT02996487|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111117887|NCT02996487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111117888|NCT02980276|Metformin|metformin|mesh-list
111117889|NCT02980276|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111117890|NCT02980276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111117891|NCT02937818|Carboplatin|carboplatin|mesh-list
111117892|NCT02937818|Durvalumab|durvalumab|mesh-list
111117893|NCT02937818|Olaparib|olaparib|mesh-list
111117894|NCT02937818|Tremelimumab|tremelimumab|mesh-list
111117895|NCT02937818|Adavosertib|adavosertib|mesh-list
111117896|NCT02937818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111117897|NCT02937818|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111117898|NCT02937818|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111117899|NCT02937818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111117900|NCT02937818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111117901|NCT02614794|Capecitabine|capecitabine|mesh-list
111117902|NCT02614794|Trastuzumab|trastuzumab|mesh-list
111117903|NCT02614794|Tucatinib|tucatinib|mesh-list
111117904|NCT02614794|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111117905|NCT02614794|Antimetabolites|antimetabolites|mesh-ancestor
111117906|NCT02614794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111117907|NCT02614794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111117908|NCT02614794|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111117909|NCT02614794|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111117910|NCT02614794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111117911|NCT02495896|Paclitaxel|paclitaxel|mesh-list
111117912|NCT02495896|Docetaxel|docetaxel|mesh-list
111117913|NCT02495896|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111117914|NCT02495896|Cisplatin|cisplatin|mesh-list
111117915|NCT02495896|Gemcitabine|gemcitabine|mesh-list
111117916|NCT02495896|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111117917|NCT02495896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111117918|NCT02495896|Tubulin Modulators|tubulin modulators|mesh-ancestor
111117919|NCT02495896|Antimitotic Agents|antimitotic agents|mesh-ancestor
111117920|NCT02495896|Mitosis Modulators|mitosis modulators|mesh-ancestor
111117921|NCT02495896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111117922|NCT02495896|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111117923|NCT02495896|Antimetabolites|antimetabolites|mesh-ancestor
111117924|NCT02125968|Oxymetazoline|oxymetazoline|mesh-list
111117925|NCT02125968|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111117926|NCT02125968|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111117927|NCT02125968|Adrenergic Agents|adrenergic agents|mesh-ancestor
111117928|NCT02125968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111117929|NCT02125968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111117930|NCT02125968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111117931|NCT02125968|Sympathomimetics|sympathomimetics|mesh-ancestor
111117932|NCT02125968|Autonomic Agents|autonomic agents|mesh-ancestor
111117933|NCT02125968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111117934|NCT02125968|Nasal Decongestants|nasal decongestants|mesh-ancestor
111117935|NCT02125968|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111117936|NCT02125968|Respiratory System Agents|respiratory system agents|mesh-ancestor
111117937|NCT01782443|Aflibercept|aflibercept|mesh-list
111117938|NCT01782443|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111117939|NCT01782443|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111117940|NCT01782443|Growth Substances|growth substances|mesh-ancestor
111117941|NCT01782443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111117942|NCT01782443|Growth Inhibitors|growth inhibitors|mesh-ancestor
111117943|NCT01782443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111117944|NCT01712815|Clevudine|clevudine|mesh-list
111117945|NCT01712815|Antiviral Agents|antiviral agents|mesh-ancestor
111117946|NCT01712815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111117947|NCT01555632|Atorvastatin|atorvastatin|mesh-list
111117948|NCT01555632|Calcium|calcium|mesh-list
111117949|NCT01555632|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111117950|NCT01555632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111490449|NCT01309074|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111117951|NCT01555632|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111117952|NCT01555632|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111117953|NCT01555632|Antimetabolites|antimetabolites|mesh-ancestor
111117954|NCT01555632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111117955|NCT01555632|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111117956|NCT01555632|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111117957|NCT01555632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111117958|NCT01274026|Verapamil|verapamil|mesh-list
111117959|NCT01274026|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111117960|NCT01274026|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111117961|NCT01274026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111117962|NCT01274026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111117963|NCT01274026|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111117964|NCT01274026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111117965|NCT01274026|Vasodilator Agents|vasodilator agents|mesh-ancestor
111117966|NCT01186029|Aprepitant|aprepitant|mesh-list
111117967|NCT01186029|Antiemetics|antiemetics|mesh-ancestor
111117968|NCT01186029|Autonomic Agents|autonomic agents|mesh-ancestor
111117969|NCT01186029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111117970|NCT01186029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111117971|NCT01186029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111117972|NCT01186029|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
111117973|NCT01186029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111117974|NCT01186029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111117975|NCT00955968|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
111117976|NCT00955968|Antiviral Agents|antiviral agents|mesh-ancestor
111117977|NCT00955968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111117978|NCT00903110|Mecasermin|mecasermin|mesh-list
111117979|NCT00903110|Growth Substances|growth substances|mesh-ancestor
111117980|NCT00903110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111117981|NCT00896012|Sirolimus|sirolimus|mesh-list
111117982|NCT00896012|Tacrolimus|tacrolimus|mesh-list
111117983|NCT00896012|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111117984|NCT00896012|Immunologic Factors|immunologic factors|mesh-ancestor
111117985|NCT00896012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111117986|NCT00896012|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111117987|NCT00896012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111117988|NCT00896012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111117989|NCT00896012|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111117990|NCT00896012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111117991|NCT00896012|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111117992|NCT00896012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111117993|NCT00896012|Antifungal Agents|antifungal agents|mesh-ancestor
111117994|NCT00876226|Citalopram|citalopram|mesh-list
111117995|NCT00876226|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111117996|NCT00876226|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111117997|NCT00876226|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111117998|NCT00876226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111117999|NCT00876226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111118000|NCT00876226|Serotonin Agents|serotonin agents|mesh-ancestor
111118001|NCT00876226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111118002|NCT00876226|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111118003|NCT00876226|Antidepressive Agents|antidepressive agents|mesh-ancestor
111118004|NCT00876226|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111118005|NCT00816413|Cyclosporine|cyclosporine|mesh-list
111118006|NCT00816413|Mycophenolic Acid|mycophenolic acid|mesh-list
111118007|NCT00816413|Pentostatin|pentostatin|mesh-list
111118008|NCT00816413|Cyclosporins|cyclosporins|mesh-list
111118009|NCT00816413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111118010|NCT00816413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111118011|NCT00816413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111118012|NCT00816413|Immunologic Factors|immunologic factors|mesh-ancestor
111118013|NCT00816413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111118014|NCT00816413|Antifungal Agents|antifungal agents|mesh-ancestor
111118015|NCT00816413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111118016|NCT00816413|Dermatologic Agents|dermatologic agents|mesh-ancestor
111118017|NCT00816413|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111118018|NCT00816413|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111118019|NCT00816413|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111490450|NCT01309074|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111490451|NCT01309074|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111490452|NCT01309074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111118020|NCT00816413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111118021|NCT00816413|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111118022|NCT00816413|Antitubercular Agents|antitubercular agents|mesh-ancestor
111118023|NCT00816413|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111118024|NCT00816413|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
111118025|NCT00254384|Cisplatin|cisplatin|mesh-list
111118026|NCT00254384|Docetaxel|docetaxel|mesh-list
111118027|NCT00254384|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111118028|NCT00254384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111118029|NCT00254384|Tubulin Modulators|tubulin modulators|mesh-ancestor
111118030|NCT00254384|Antimitotic Agents|antimitotic agents|mesh-ancestor
111118031|NCT00254384|Mitosis Modulators|mitosis modulators|mesh-ancestor
111118032|NCT00254384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111118033|NCT00254384|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111118034|NCT00254384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111118035|NCT05916963|Furosemide|furosemide|mesh-list
111118036|NCT05916963|Diuretics|diuretics|mesh-ancestor
111118037|NCT05916963|Natriuretic Agents|natriuretic agents|mesh-ancestor
111118038|NCT05916963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111118039|NCT05916963|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
111118040|NCT05916963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111118041|NCT05916963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111118042|NCT05916937|Omalizumab|omalizumab|mesh-list
111118043|NCT05916937|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111118044|NCT05916937|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111118045|NCT05916937|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111118046|NCT05916937|Respiratory System Agents|respiratory system agents|mesh-ancestor
111118047|NCT05916937|Immunologic Factors|immunologic factors|mesh-ancestor
111118048|NCT05916937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111118049|NCT02342977|Lacosamide|lacosamide|mesh-list
111118050|NCT02342977|Anticonvulsants|anticonvulsants|mesh-ancestor
111118051|NCT02342977|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111118052|NCT02342977|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111118053|NCT02342977|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111118054|NCT02342977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111118055|NCT05916781|Mycophenolic Acid|mycophenolic acid|mesh-list
111118056|NCT05916781|Tacrolimus|tacrolimus|mesh-list
111118057|NCT05916781|Glucocorticoids|glucocorticoids|mesh-list
111118058|NCT05916781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111118059|NCT05916781|Immunologic Factors|immunologic factors|mesh-ancestor
111118060|NCT05916781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111118061|NCT05916781|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111118062|NCT05916781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111118063|NCT05916781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111118064|NCT05916781|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111118065|NCT05916781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111118066|NCT05916781|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111118067|NCT05916781|Antitubercular Agents|antitubercular agents|mesh-ancestor
111118068|NCT05916781|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111118069|NCT05916781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111118070|NCT05916781|Hormones|hormones|mesh-ancestor
111118071|NCT05916781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111118072|NCT05916755|Cyclophosphamide|cyclophosphamide|mesh-list
111118073|NCT05916755|Carboplatin|carboplatin|mesh-list
111118074|NCT05916755|Pembrolizumab|pembrolizumab|mesh-list
111118075|NCT05916755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111118076|NCT05916755|Immunologic Factors|immunologic factors|mesh-ancestor
111118077|NCT05916755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111118078|NCT05916755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111118079|NCT05916755|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111118080|NCT05916755|Alkylating Agents|alkylating agents|mesh-ancestor
111118081|NCT05916755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111118082|NCT05916755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111118083|NCT05916755|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111118084|NCT05916755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111118085|NCT05916755|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111118086|NCT05916742|Dipyrone|dipyrone|mesh-list
111118087|NCT05916742|Amoxicillin|amoxicillin|mesh-list
111118088|NCT05916742|Chlorhexidine|chlorhexidine|mesh-list
111118089|NCT05916742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111490453|NCT01309074|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111118090|NCT05916742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111118091|NCT05916742|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111490454|NCT01309074|Antidepressive Agents|antidepressive agents|mesh-ancestor
111118093|NCT05916742|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111118094|NCT05916742|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111118095|NCT05916742|Analgesics|analgesics|mesh-ancestor
111118096|NCT05916742|Sensory System Agents|sensory system agents|mesh-ancestor
111118097|NCT05916742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111118098|NCT05916742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111118099|NCT05916742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111118100|NCT05916742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111118101|NCT05916742|Antipyretics|antipyretics|mesh-ancestor
111118102|NCT05916729|Miconazole|miconazole|mesh-list
111118103|NCT05916729|Antifungal Agents|antifungal agents|mesh-ancestor
111118104|NCT05916729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111118105|NCT05916729|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111118106|NCT05916729|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111118107|NCT05916729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111118108|NCT05916729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111118109|NCT05916729|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111118110|NCT05916729|Hormone Antagonists|hormone antagonists|mesh-ancestor
111118111|NCT05916729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111118112|NCT05916729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111118113|NCT05916729|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111118114|NCT05916729|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111118115|NCT05916716|Dipyrone|dipyrone|mesh-list
111118116|NCT05916716|Amoxicillin|amoxicillin|mesh-list
111118117|NCT05916716|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111118118|NCT05916716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111118119|NCT05916716|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111118120|NCT05916716|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111118121|NCT05916716|Analgesics|analgesics|mesh-ancestor
111118122|NCT05916716|Sensory System Agents|sensory system agents|mesh-ancestor
111118123|NCT05916716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111118124|NCT05916716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111118125|NCT05916716|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111118126|NCT05916716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111118127|NCT05916716|Antipyretics|antipyretics|mesh-ancestor
111118128|NCT05916690|Bleomycin|bleomycin|mesh-list
111118129|NCT05916690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111118130|NCT05916690|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111118131|NCT05916586|Prednisone|prednisone|mesh-list
111118132|NCT05916586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111118133|NCT05916586|Glucocorticoids|glucocorticoids|mesh-ancestor
111118134|NCT05916586|Hormones|hormones|mesh-ancestor
111118135|NCT05916586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111118136|NCT05916586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111118137|NCT05916586|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111118138|NCT05916586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111118139|NCT05916521|Fluorides|fluorides|mesh-list
111118140|NCT05916521|Tin Fluorides|tin fluorides|mesh-list
111118141|NCT05916521|Fluorophosphate|fluorophosphate|mesh-list
111118142|NCT05916521|Cariostatic Agents|cariostatic agents|mesh-ancestor
111118143|NCT05916521|Protective Agents|protective agents|mesh-ancestor
111118144|NCT05916521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111118145|NCT05916508|Fluorides|fluorides|mesh-list
111118146|NCT05916508|Tin Fluorides|tin fluorides|mesh-list
111118147|NCT05916508|Fluorophosphate|fluorophosphate|mesh-list
111118148|NCT05916508|Cariostatic Agents|cariostatic agents|mesh-ancestor
111118149|NCT05916508|Protective Agents|protective agents|mesh-ancestor
111118150|NCT05916508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111118151|NCT05916469|Levonorgestrel|levonorgestrel|mesh-list
111118152|NCT05916469|Norethindrone|norethindrone|mesh-list
111118153|NCT05916469|Norethindrone Acetate|norethindrone acetate|mesh-list
111118154|NCT05916469|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111118155|NCT05916469|Contraceptive Agents|contraceptive agents|mesh-ancestor
111118156|NCT05916469|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111118157|NCT05916469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111118158|NCT05916469|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111118159|NCT05916469|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111118160|NCT05916469|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111118161|NCT05916469|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111118162|NCT05916339|Methylphenidate|methylphenidate|mesh-list
111490455|NCT01309074|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111118163|NCT05916339|Amphetamine|amphetamine|mesh-list
111118164|NCT05916339|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
111118165|NCT05916339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111118166|NCT05916339|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111118167|NCT05916339|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111118168|NCT05916339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111118169|NCT05916339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111118170|NCT05916339|Dopamine Agents|dopamine agents|mesh-ancestor
111118171|NCT05916339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111118172|NCT05916339|Sympathomimetics|sympathomimetics|mesh-ancestor
111118173|NCT05916339|Autonomic Agents|autonomic agents|mesh-ancestor
111118174|NCT05916339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111118175|NCT05916339|Adrenergic Agents|adrenergic agents|mesh-ancestor
111118176|NCT05916339|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111118177|NCT05916105|Ciprofloxacin|ciprofloxacin|mesh-list
111118178|NCT05916105|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111118179|NCT05916105|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111118180|NCT05916105|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111118181|NCT05916105|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111118182|NCT05916105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111118183|NCT05916105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111118184|NCT05916105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111118185|NCT05916105|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111118186|NCT05916105|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111118187|NCT05916066|Niacinamide|niacinamide|mesh-list
111118189|NCT05916066|Nicotinic Acids|nicotinic acids|mesh-list
111118190|NCT05916066|Vitamin B Complex|vitamin b complex|mesh-ancestor
111118191|NCT05916066|Vitamins|vitamins|mesh-ancestor
111118192|NCT05916066|Micronutrients|micronutrients|mesh-ancestor
111118193|NCT05916066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111118194|NCT05916066|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111118195|NCT05916066|Antimetabolites|antimetabolites|mesh-ancestor
111118196|NCT05916066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111118197|NCT05916066|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111118198|NCT05916066|Vasodilator Agents|vasodilator agents|mesh-ancestor
111118199|NCT05915884|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
111118200|NCT05915884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111118201|NCT05915884|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111118202|NCT05915884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111118203|NCT05915871|Clarithromycin|clarithromycin|mesh-list
111118204|NCT05915871|Bismuth|bismuth|mesh-list
111118205|NCT05915871|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111118206|NCT05915871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111118207|NCT05915871|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111118208|NCT05915871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111118209|NCT05915871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111118210|NCT05915871|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111118211|NCT05915871|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111118212|NCT05915871|Antacids|antacids|mesh-ancestor
111118213|NCT05915871|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111118214|NCT05915676|Immunoglobulins|immunoglobulins|mesh-list
111118215|NCT05915676|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111118216|NCT05915676|Antibodies|antibodies|mesh-list
111118217|NCT05915676|Immunologic Factors|immunologic factors|mesh-ancestor
111118218|NCT05915676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111118219|NCT05915520|Pantoprazole|pantoprazole|mesh-list
111118220|NCT05915520|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111118221|NCT05915520|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111118222|NCT05915520|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111118223|NCT05915520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111118224|NCT05915520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111118225|NCT05915481|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
111118226|NCT05915481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111118227|NCT05915481|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111118228|NCT05915481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111118229|NCT05915286|Chlorthalidone|chlorthalidone|mesh-list
111118230|NCT05915286|Furosemide|furosemide|mesh-list
111118231|NCT05915286|Diuretics|diuretics|mesh-ancestor
111118232|NCT05915286|Natriuretic Agents|natriuretic agents|mesh-ancestor
111118233|NCT05915286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111118234|NCT05915286|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
111118235|NCT05915286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111490456|NCT01309074|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111490457|NCT01309074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111118236|NCT05915286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111118237|NCT05915286|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111118238|NCT05915286|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
111118239|NCT05915260|Adenosine|adenosine|mesh-list
111118240|NCT05915260|Analgesics|analgesics|mesh-ancestor
111118241|NCT05915260|Sensory System Agents|sensory system agents|mesh-ancestor
111118242|NCT05915260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111118243|NCT05915260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111118244|NCT05915260|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111118245|NCT05915260|Vasodilator Agents|vasodilator agents|mesh-ancestor
111118246|NCT05915260|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
111118247|NCT05915260|Purinergic Agonists|purinergic agonists|mesh-ancestor
111118248|NCT05915260|Purinergic Agents|purinergic agents|mesh-ancestor
111118249|NCT05915260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111118250|NCT05915260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111118251|NCT05915169|Chrysarobin|chrysarobin|mesh-list
111118252|NCT05915169|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111118253|NCT05915169|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111118254|NCT05915169|Analgesics|analgesics|mesh-ancestor
111118255|NCT05915169|Sensory System Agents|sensory system agents|mesh-ancestor
111118256|NCT05915169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111118257|NCT05915169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111118258|NCT05915169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111118259|NCT05915169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111118261|NCT05915104|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111118262|NCT05915104|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111118263|NCT05915104|Autonomic Agents|autonomic agents|mesh-ancestor
111118264|NCT05915104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111118265|NCT05915104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111118266|NCT05915104|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111118267|NCT05915104|Respiratory System Agents|respiratory system agents|mesh-ancestor
111118268|NCT05915104|Glucocorticoids|glucocorticoids|mesh-ancestor
111118269|NCT05915104|Hormones|hormones|mesh-ancestor
111118270|NCT05915104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111118271|NCT05915013|Ketamine|ketamine|mesh-list
111118272|NCT05915013|Analgesics|analgesics|mesh-ancestor
111118273|NCT05915013|Sensory System Agents|sensory system agents|mesh-ancestor
111118274|NCT05915013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111118275|NCT05915013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111118276|NCT05915013|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111118277|NCT05915013|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111118278|NCT05915013|Anesthetics, General|anesthetics, general|mesh-ancestor
111118279|NCT05915013|Anesthetics|anesthetics|mesh-ancestor
111118280|NCT05915013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111118281|NCT05915013|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111118282|NCT05915013|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111118283|NCT05915013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111118284|NCT05915013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111118285|NCT05914805|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111118286|NCT05914779|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111118287|NCT05914779|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
111118288|NCT05914779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111118289|NCT05914779|Antitubercular Agents|antitubercular agents|mesh-ancestor
111118290|NCT05914753|Cyclophosphamide|cyclophosphamide|mesh-list
111118291|NCT05914753|Docetaxel|docetaxel|mesh-list
111118292|NCT05914753|Epirubicin|epirubicin|mesh-list
111118293|NCT05914753|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111118294|NCT05914753|Immunologic Factors|immunologic factors|mesh-ancestor
111118295|NCT05914753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111118296|NCT05914753|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111118297|NCT05914753|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111118298|NCT05914753|Alkylating Agents|alkylating agents|mesh-ancestor
111118299|NCT05914753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111118300|NCT05914753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111118301|NCT05914753|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111118302|NCT05914753|Tubulin Modulators|tubulin modulators|mesh-ancestor
111118303|NCT05914753|Antimitotic Agents|antimitotic agents|mesh-ancestor
111118304|NCT05914753|Mitosis Modulators|mitosis modulators|mesh-ancestor
111118305|NCT05914753|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111118306|NCT05914753|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111490458|NCT01309074|Serotonin Agents|serotonin agents|mesh-ancestor
111490459|NCT01074294|Brexpiprazole|brexpiprazole|mesh-list
111490460|NCT01074294|Serotonin Agents|serotonin agents|mesh-ancestor
111490461|NCT01074294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111118307|NCT05914753|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111118308|NCT05914753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111118309|NCT05914701|Letermovir|letermovir|mesh-list
111118310|NCT05914701|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111118311|NCT05914701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111118312|NCT05914701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111118313|NCT05914701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111118314|NCT05914701|Antiviral Agents|antiviral agents|mesh-ancestor
111118315|NCT05914701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111118316|NCT05914675|Letermovir|letermovir|mesh-list
111118317|NCT05914675|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111118318|NCT05914675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111118319|NCT05914675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111118320|NCT05914675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111118321|NCT05914675|Antiviral Agents|antiviral agents|mesh-ancestor
111118322|NCT05914675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111118323|NCT05914662|Rituximab|rituximab|mesh-list
111118324|NCT05914662|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
111118325|NCT05914662|Zanubrutinib|zanubrutinib|mesh-list
111118326|NCT05914662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111118327|NCT05914662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111118328|NCT05914662|Immunologic Factors|immunologic factors|mesh-ancestor
111118329|NCT05914662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111118330|NCT05914662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111118331|NCT05914662|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111118332|NCT05914662|Alkylating Agents|alkylating agents|mesh-ancestor
111118333|NCT05914662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111118334|NCT05914662|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111118335|NCT05914662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111118336|NCT05914610|Oxaliplatin|oxaliplatin|mesh-list
111118337|NCT05914610|Tegafur|tegafur|mesh-list
111118338|NCT05914610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111118339|NCT05914610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111118340|NCT05914610|Antimetabolites|antimetabolites|mesh-ancestor
111118341|NCT05914610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111118342|NCT05914545|Immunoconjugates|immunoconjugates|mesh-list
111118343|NCT05914545|Immunologic Factors|immunologic factors|mesh-ancestor
111118344|NCT05914545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111118345|NCT05914454|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
111118346|NCT05914454|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111118347|NCT05914350|Methylprednisolone|methylprednisolone|mesh-list
111118348|NCT05914350|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111118349|NCT05914350|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111118350|NCT05914350|Prednisolone|prednisolone|mesh-list
111118351|NCT05914350|Prednisolone acetate|prednisolone acetate|mesh-list
111118352|NCT05914350|Lidocaine|lidocaine|mesh-list
111118353|NCT05914350|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111118354|NCT05914350|Prednisolone phosphate|prednisolone phosphate|mesh-list
111118355|NCT05914350|Anesthetics, Local|anesthetics, local|mesh-ancestor
111118356|NCT05914350|Anesthetics|anesthetics|mesh-ancestor
111118357|NCT05914350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111118358|NCT05914350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111118359|NCT05914350|Sensory System Agents|sensory system agents|mesh-ancestor
111118360|NCT05914350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111118361|NCT05914350|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111118362|NCT05914350|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111118363|NCT05914350|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111118364|NCT05914350|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111118365|NCT05914350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111118366|NCT05914350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111118367|NCT05914350|Antiemetics|antiemetics|mesh-ancestor
111118368|NCT05914350|Autonomic Agents|autonomic agents|mesh-ancestor
111118369|NCT05914350|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111118370|NCT05914350|Glucocorticoids|glucocorticoids|mesh-ancestor
111118371|NCT05914350|Hormones|hormones|mesh-ancestor
111118372|NCT05914350|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111118373|NCT05914350|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111118374|NCT05914350|Protective Agents|protective agents|mesh-ancestor
111118375|NCT05914350|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111118376|NCT05914350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111118377|NCT05914285|Albuterol|albuterol|mesh-list
111490462|NCT01074294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111490463|NCT01074294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111490464|NCT01074294|Dopamine Agonists|dopamine agonists|mesh-ancestor
111490465|NCT01074294|Dopamine Agents|dopamine agents|mesh-ancestor
111490466|NCT01074138|Tirbanibulin|tirbanibulin|mesh-list
111490467|NCT01074138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111490468|NCT01074138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111118378|NCT05914285|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111118379|NCT05914285|Autonomic Agents|autonomic agents|mesh-ancestor
111118380|NCT05914285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111118381|NCT05914285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111118382|NCT05914285|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110649298|NCT00894998|Heparin|heparin|mesh-list
111118383|NCT05914285|Respiratory System Agents|respiratory system agents|mesh-ancestor
111118384|NCT05914285|Tocolytic Agents|tocolytic agents|mesh-ancestor
111118385|NCT05914285|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111118386|NCT05914285|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111118387|NCT05914285|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111118388|NCT05914285|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111118389|NCT05914285|Adrenergic Agents|adrenergic agents|mesh-ancestor
111118390|NCT05914285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111118391|NCT05914285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110835477|NCT03444142|Exenatide|exenatide|mesh-list
111118393|NCT05914194|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111118394|NCT05914194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111118395|NCT05914194|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111118396|NCT05914194|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111118397|NCT05914194|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111118398|NCT05914194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111118399|NCT05914194|Adrenergic Agents|adrenergic agents|mesh-ancestor
111118400|NCT05914194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111118401|NCT05914194|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111118402|NCT05914194|Dopamine Agents|dopamine agents|mesh-ancestor
111118403|NCT05914129|Liver Extracts|liver extracts|mesh-list
111118404|NCT05914129|Hematinics|hematinics|mesh-ancestor
111118405|NCT05913947|Cariprazine|cariprazine|mesh-list
111118406|NCT05913947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111118407|NCT05913947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111118408|NCT05913947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111118409|NCT05913947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111118410|NCT05913947|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111118411|NCT05913856|Chlorhexidine|chlorhexidine|mesh-list
111118412|NCT05913856|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111118413|NCT05913856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111118414|NCT05913856|Disinfectants|disinfectants|mesh-ancestor
111118415|NCT05913661|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
111118416|NCT05913661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111118417|NCT05913661|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111118418|NCT05913661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111118419|NCT05913596|Daratumumab|daratumumab|mesh-list
111118420|NCT05913596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111118421|NCT05913583|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
111118422|NCT05913583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111118423|NCT05913583|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111118424|NCT05913583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111118425|NCT05913570|Antibodies|antibodies|mesh-list
111118426|NCT05913570|Antibodies, Bispecific|antibodies, bispecific|mesh-list
111118427|NCT05913570|Immunologic Factors|immunologic factors|mesh-ancestor
111118428|NCT05913570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111118429|NCT05913466|Tranexamic Acid|tranexamic acid|mesh-list
111118430|NCT05913466|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111118431|NCT05913466|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111118432|NCT05913466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111118433|NCT05913466|Hemostatics|hemostatics|mesh-ancestor
111118434|NCT05913466|Coagulants|coagulants|mesh-ancestor
111118435|NCT05913427|Cisplatin|cisplatin|mesh-list
111118436|NCT05913427|Doxorubicin|doxorubicin|mesh-list
111118437|NCT05913427|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111118438|NCT05913427|Etoposide|etoposide|mesh-list
111118439|NCT05913427|Etoposide phosphate|etoposide phosphate|mesh-list
111118440|NCT05913427|Megestrol|megestrol|mesh-list
111118441|NCT05913427|Megestrol Acetate|megestrol acetate|mesh-list
111118442|NCT05913427|Mitotane|mitotane|mesh-list
111118443|NCT05913427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111118444|NCT05913427|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111118445|NCT05913427|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111118446|NCT05913427|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111118447|NCT05913427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111118448|NCT05913427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110649304|NCT00713921|Fesoterodine|fesoterodine|mesh-list
111118449|NCT05913427|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111118450|NCT05913427|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111118451|NCT05913427|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111118452|NCT05913427|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111118453|NCT05913427|Contraceptive Agents|contraceptive agents|mesh-ancestor
111118454|NCT05913427|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111118455|NCT05913427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111118456|NCT05913427|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111118457|NCT05913427|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111118458|NCT05913427|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111118459|NCT05913427|Appetite Stimulants|appetite stimulants|mesh-ancestor
111118460|NCT05913427|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111118461|NCT05913414|Iron|iron|mesh-list
111118462|NCT05913414|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
111118463|NCT05913414|Ferric Compounds|ferric compounds|mesh-list
111118464|NCT05913414|Trace Elements|trace elements|mesh-ancestor
111118465|NCT05913414|Micronutrients|micronutrients|mesh-ancestor
110835548|NCT01136213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111118466|NCT05913414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111118467|NCT05913414|Hematinics|hematinics|mesh-ancestor
111118468|NCT05913180|Ascorbic Acid|ascorbic acid|mesh-list
111118469|NCT05913180|Vitamins|vitamins|mesh-ancestor
111118470|NCT05913180|Micronutrients|micronutrients|mesh-ancestor
111118471|NCT05913180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111118472|NCT05913180|Antioxidants|antioxidants|mesh-ancestor
111118473|NCT05913180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111118474|NCT05913180|Protective Agents|protective agents|mesh-ancestor
111118475|NCT05913115|Bemarituzumab|bemarituzumab|mesh-list
111118476|NCT05913115|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111118477|NCT05913115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111118478|NCT05912816|Tislelizumab|tislelizumab|mesh-list
111118479|NCT05912816|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111118480|NCT05912816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111118481|NCT05912712|Infliximab|infliximab|mesh-list
111118482|NCT05912712|Mesalamine|mesalamine|mesh-list
111118483|NCT05912712|Thrombin|thrombin|mesh-list
111118484|NCT05912712|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111118485|NCT05912712|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111118486|NCT05912712|Dermatologic Agents|dermatologic agents|mesh-ancestor
111118487|NCT05912712|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111118488|NCT05912712|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111118489|NCT05912712|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111118490|NCT05912712|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111118491|NCT05912712|Analgesics|analgesics|mesh-ancestor
111118492|NCT05912712|Sensory System Agents|sensory system agents|mesh-ancestor
111118493|NCT05912712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111118494|NCT05912712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111118495|NCT05912712|Hemostatics|hemostatics|mesh-ancestor
111118496|NCT05912712|Coagulants|coagulants|mesh-ancestor
111118497|NCT05912686|Atorvastatin|atorvastatin|mesh-list
111118498|NCT05912686|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111118499|NCT05912686|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111118500|NCT05912686|Antimetabolites|antimetabolites|mesh-ancestor
111118501|NCT05912686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111118502|NCT05912686|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111118503|NCT05912686|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111118504|NCT05912686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111118505|NCT05912621|Tirzepatide|tirzepatide|mesh-list
111118506|NCT05912621|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111118507|NCT05912621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111118508|NCT05912621|Incretins|incretins|mesh-ancestor
111118509|NCT05912621|Hormones|hormones|mesh-ancestor
111118510|NCT05912621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111118511|NCT05912387|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111118512|NCT05912387|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111118513|NCT05912387|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111118514|NCT05912387|Antimetabolites|antimetabolites|mesh-ancestor
111118515|NCT05912387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111118516|NCT05912387|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111118517|NCT05912387|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111118518|NCT05912387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111118519|NCT05912335|Anesthetics|anesthetics|mesh-list
111118520|NCT05912335|Anesthetics, Local|anesthetics, local|mesh-list
111118521|NCT05912335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111490469|NCT00951132|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110024197|NCT00004368|Mitosis Modulators|mitosis modulators|mesh-ancestor
111118523|NCT05912335|Sensory System Agents|sensory system agents|mesh-ancestor
111118524|NCT05912335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111118525|NCT05912205|Disitamab vedotin|disitamab vedotin|mesh-list
111118526|NCT05912205|Immunoconjugates|immunoconjugates|mesh-ancestor
111118527|NCT05912205|Immunologic Factors|immunologic factors|mesh-ancestor
111118528|NCT05912205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111118529|NCT05912192|Mometasone Furoate|mometasone furoate|mesh-list
111118530|NCT05912192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111118531|NCT05912192|Dermatologic Agents|dermatologic agents|mesh-ancestor
111118532|NCT05912192|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111118533|NCT05912179|Liver Extracts|liver extracts|mesh-list
111118534|NCT05912179|Hematinics|hematinics|mesh-ancestor
111118535|NCT05912114|Mannitol|mannitol|mesh-list
111118536|NCT05912114|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
111118537|NCT05912114|Diuretics|diuretics|mesh-ancestor
111118538|NCT05912114|Natriuretic Agents|natriuretic agents|mesh-ancestor
111118539|NCT05912114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111118540|NCT05912075|Capecitabine|capecitabine|mesh-list
111118541|NCT05912075|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110835626|NCT03437980|Propofol|propofol|mesh-list
111118542|NCT05912075|Antimetabolites|antimetabolites|mesh-ancestor
111118543|NCT05912075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111118544|NCT05912075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111118545|NCT05911828|Ferroquine|ferroquine|mesh-list
111118546|NCT05911828|Antimalarials|antimalarials|mesh-ancestor
111118547|NCT05911828|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111118548|NCT05911828|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111118549|NCT05911828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111118550|NCT05911659|Ticagrelor|ticagrelor|mesh-list
111118551|NCT05911659|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111118552|NCT05911659|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111118553|NCT05911659|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111118554|NCT05911659|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111118555|NCT05911659|Purinergic Agents|purinergic agents|mesh-ancestor
111118556|NCT05911659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111118557|NCT05911659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111118558|NCT05911659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111118559|NCT05911503|Ganciclovir|ganciclovir|mesh-list
111118560|NCT05911503|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
111118561|NCT05911503|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111118562|NCT05911503|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111118563|NCT05911503|Antiviral Agents|antiviral agents|mesh-ancestor
111118564|NCT05911503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111118565|NCT05911503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111118566|NCT05911503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111118567|NCT05911503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111118568|NCT05911438|Epoetin Alfa|epoetin alfa|mesh-list
111118569|NCT05911438|Hematinics|hematinics|mesh-ancestor
111118570|NCT05911347|Psyllium|psyllium|mesh-list
111118571|NCT05911347|Cathartics|cathartics|mesh-ancestor
111118572|NCT05911347|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111118573|NCT05911308|Paclitaxel|paclitaxel|mesh-list
111118574|NCT05911308|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111118575|NCT05911308|Carboplatin|carboplatin|mesh-list
111118576|NCT05911308|Pemetrexed|pemetrexed|mesh-list
111118577|NCT05911308|Durvalumab|durvalumab|mesh-list
111118578|NCT05911308|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111118579|NCT05911308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111118580|NCT05911308|Tubulin Modulators|tubulin modulators|mesh-ancestor
111118581|NCT05911308|Antimitotic Agents|antimitotic agents|mesh-ancestor
111118582|NCT05911308|Mitosis Modulators|mitosis modulators|mesh-ancestor
111118583|NCT05911308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111118584|NCT05911308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111118585|NCT05911308|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111118586|NCT05911308|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111118587|NCT05911308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111118588|NCT05911282|Acetylcysteine|acetylcysteine|mesh-list
111118589|NCT05911282|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111118590|NCT05911282|Antiviral Agents|antiviral agents|mesh-ancestor
111118591|NCT05911282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111118592|NCT05911282|Expectorants|expectorants|mesh-ancestor
111118593|NCT05911282|Respiratory System Agents|respiratory system agents|mesh-ancestor
111118594|NCT05911282|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111118595|NCT05911282|Antioxidants|antioxidants|mesh-ancestor
111118596|NCT05911282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111118597|NCT05911282|Protective Agents|protective agents|mesh-ancestor
111118598|NCT05911282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111118599|NCT05911282|Antidotes|antidotes|mesh-ancestor
111118600|NCT05911022|Colchicine|colchicine|mesh-list
111118601|NCT05911022|Gout Suppressants|gout suppressants|mesh-ancestor
111118602|NCT05911022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111118603|NCT05911022|Tubulin Modulators|tubulin modulators|mesh-ancestor
111118604|NCT05911022|Antimitotic Agents|antimitotic agents|mesh-ancestor
111118605|NCT05911022|Mitosis Modulators|mitosis modulators|mesh-ancestor
111118606|NCT05911022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111118607|NCT05911022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111118608|NCT05909150|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111118609|NCT05907655|Nitroglycerin|nitroglycerin|mesh-list
111118610|NCT05907655|Vasodilator Agents|vasodilator agents|mesh-ancestor
111118611|NCT05907512|Endostar protein|endostar protein|mesh-list
111118612|NCT05907512|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111118613|NCT05907512|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111118614|NCT05907512|Growth Substances|growth substances|mesh-ancestor
111118615|NCT05907512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111118616|NCT05907512|Growth Inhibitors|growth inhibitors|mesh-ancestor
111118617|NCT05907512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110835697|NCT01306591|Bevacizumab|bevacizumab|mesh-list
111118618|NCT05906056|Zoledronic Acid|zoledronic acid|mesh-list
111118619|NCT05906056|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111118620|NCT05906056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111118621|NCT05905770|Alemtuzumab|alemtuzumab|mesh-list
111118622|NCT05905770|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111118623|NCT05905770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111118624|NCT05905510|Anesthetics|anesthetics|mesh-list
111118625|NCT05905510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111118626|NCT05905510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111118627|NCT05904964|Disitamab vedotin|disitamab vedotin|mesh-list
111118628|NCT05904964|Immunoconjugates|immunoconjugates|mesh-ancestor
111118629|NCT05904964|Immunologic Factors|immunologic factors|mesh-ancestor
111118630|NCT05904964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111118631|NCT05904353|Zoledronic Acid|zoledronic acid|mesh-list
111118632|NCT05904353|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111118633|NCT05904353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111118634|NCT05903014|Acetylcysteine|acetylcysteine|mesh-list
111118635|NCT05903014|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111118636|NCT05903014|Antiviral Agents|antiviral agents|mesh-ancestor
111118637|NCT05903014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111118638|NCT05903014|Expectorants|expectorants|mesh-ancestor
111118639|NCT05903014|Respiratory System Agents|respiratory system agents|mesh-ancestor
111118640|NCT05903014|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111118641|NCT05903014|Antioxidants|antioxidants|mesh-ancestor
111118642|NCT05903014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111118643|NCT05903014|Protective Agents|protective agents|mesh-ancestor
111118644|NCT05903014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111118645|NCT05903014|Antidotes|antidotes|mesh-ancestor
111118646|NCT05888870|Daratumumab|daratumumab|mesh-list
111118647|NCT05888870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111118648|NCT05888532|Copper|copper|mesh-list
111118649|NCT05888532|Trace Elements|trace elements|mesh-ancestor
111118650|NCT05888532|Micronutrients|micronutrients|mesh-ancestor
111118651|NCT05888532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111118652|NCT05874492|Dermatologic Agents|dermatologic agents|mesh-list
111118653|NCT05872854|Hypericin|hypericin|mesh-list
111118654|NCT05872854|Antidepressive Agents|antidepressive agents|mesh-ancestor
111118655|NCT05872854|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111118656|NCT05872854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111118657|NCT05872854|Antiviral Agents|antiviral agents|mesh-ancestor
111118658|NCT05872854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111118659|NCT05872854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111118660|NCT05872854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111118661|NCT05872854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111118662|NCT05872854|Immunologic Factors|immunologic factors|mesh-ancestor
111118663|NCT05872854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111118664|NCT05860881|Sirolimus|sirolimus|mesh-list
111118665|NCT05860881|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111118666|NCT05860881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111490470|NCT00951132|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111490471|NCT00951132|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111490472|NCT00951132|Antimetabolites|antimetabolites|mesh-ancestor
111118667|NCT05860881|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111118668|NCT05860881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111118669|NCT05860881|Antifungal Agents|antifungal agents|mesh-ancestor
110698585|NCT00386022|Hormones|hormones|mesh-ancestor
111490473|NCT00951132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111490474|NCT00951132|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111490475|NCT00951132|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111118670|NCT05860881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111118671|NCT05860881|Immunologic Factors|immunologic factors|mesh-ancestor
111118672|NCT05860881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111118673|NCT05856305|Copper|copper|mesh-list
111118674|NCT05856305|Chlorophyllin|chlorophyllin|mesh-list
111118675|NCT05856305|Trace Elements|trace elements|mesh-ancestor
111118676|NCT05856305|Micronutrients|micronutrients|mesh-ancestor
111118677|NCT05856305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111118678|NCT05856305|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
111118679|NCT05856305|Protective Agents|protective agents|mesh-ancestor
111118680|NCT05823896|Ritonavir|ritonavir|mesh-list
111118681|NCT05823896|Nirmatrelvir|nirmatrelvir|mesh-list
111118682|NCT05823896|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
111118683|NCT05823896|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111118684|NCT05823896|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111118685|NCT05823896|Protease Inhibitors|protease inhibitors|mesh-ancestor
111118686|NCT05823896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111118687|NCT05823896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111118688|NCT05823896|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111118689|NCT05823896|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111118690|NCT05823896|Antiviral Agents|antiviral agents|mesh-ancestor
111118691|NCT05823896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111118692|NCT05823896|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111118693|NCT05823896|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111118694|NCT05821088|Carboplatin|carboplatin|mesh-list
110835773|NCT04455958|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111118695|NCT05821088|Etoposide|etoposide|mesh-list
111118696|NCT05821088|Lenalidomide|lenalidomide|mesh-list
111118697|NCT05821088|Etoposide phosphate|etoposide phosphate|mesh-list
111118698|NCT05821088|Ifosfamide|ifosfamide|mesh-list
111118699|NCT05821088|Isophosphamide mustard|isophosphamide mustard|mesh-list
111118700|NCT05821088|Podophyllotoxin|podophyllotoxin|mesh-list
111118701|NCT05821088|Immunoglobulins|immunoglobulins|mesh-list
111118702|NCT05821088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111118703|NCT05821088|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111118704|NCT05821088|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111118705|NCT05821088|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111118706|NCT05821088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111118707|NCT05821088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111118708|NCT05821088|Immunologic Factors|immunologic factors|mesh-ancestor
111118709|NCT05821088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111118710|NCT05821088|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111118711|NCT05821088|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111118712|NCT05821088|Growth Substances|growth substances|mesh-ancestor
111118713|NCT05821088|Growth Inhibitors|growth inhibitors|mesh-ancestor
111118714|NCT05821088|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111118715|NCT05821088|Alkylating Agents|alkylating agents|mesh-ancestor
111118716|NCT05821088|Keratolytic Agents|keratolytic agents|mesh-ancestor
111118717|NCT05821088|Dermatologic Agents|dermatologic agents|mesh-ancestor
111118718|NCT05821088|Tubulin Modulators|tubulin modulators|mesh-ancestor
111118719|NCT05821088|Antimitotic Agents|antimitotic agents|mesh-ancestor
111118720|NCT05821088|Mitosis Modulators|mitosis modulators|mesh-ancestor
111118721|NCT05794581|Liraglutide|liraglutide|mesh-list
111118722|NCT05794581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111118723|NCT05794581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111118724|NCT05794581|Incretins|incretins|mesh-ancestor
111118725|NCT05794581|Hormones|hormones|mesh-ancestor
111118726|NCT05794581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111118727|NCT05776524|Paclitaxel|paclitaxel|mesh-list
111118728|NCT05776524|Gemcitabine|gemcitabine|mesh-list
111118729|NCT05776524|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111118730|NCT05776524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111118731|NCT05776524|Tubulin Modulators|tubulin modulators|mesh-ancestor
111118732|NCT05776524|Antimitotic Agents|antimitotic agents|mesh-ancestor
111118733|NCT05776524|Mitosis Modulators|mitosis modulators|mesh-ancestor
111118734|NCT05776524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111118735|NCT05776524|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111118736|NCT05776524|Antimetabolites|antimetabolites|mesh-ancestor
111118737|NCT05767944|Anesthetics|anesthetics|mesh-list
111118738|NCT05767944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111118739|NCT05767944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111118740|NCT05751265|Paclitaxel|paclitaxel|mesh-list
111118741|NCT05751265|Tislelizumab|tislelizumab|mesh-list
111118742|NCT05751265|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111118743|NCT05751265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111118744|NCT05751265|Tubulin Modulators|tubulin modulators|mesh-ancestor
111118745|NCT05751265|Antimitotic Agents|antimitotic agents|mesh-ancestor
111118746|NCT05751265|Mitosis Modulators|mitosis modulators|mesh-ancestor
111118747|NCT05751265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111118748|NCT05751265|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111118749|NCT05716854|Moxifloxacin|moxifloxacin|mesh-list
111118750|NCT05716854|Clarithromycin|clarithromycin|mesh-list
111118751|NCT05716854|Cobicistat|cobicistat|mesh-list
111118752|NCT05716854|Pimozide|pimozide|mesh-list
111118753|NCT05716854|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
111118754|NCT05716854|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111118755|NCT05716854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111118756|NCT05716854|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111118757|NCT05716854|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111118758|NCT05716854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111118759|NCT05716854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111118760|NCT05716854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111118761|NCT05716854|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111118762|NCT05716854|Contraceptive Agents|contraceptive agents|mesh-ancestor
111118763|NCT05716854|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111118764|NCT05716854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111118765|NCT05716854|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
111118766|NCT05716854|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111118767|NCT05716854|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111118768|NCT05716854|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111118769|NCT05716854|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111118770|NCT05716854|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111118771|NCT05716854|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111118772|NCT05716854|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111118773|NCT05716854|Antiviral Agents|antiviral agents|mesh-ancestor
111118774|NCT05716854|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111118775|NCT05716854|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111118776|NCT05716854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111118777|NCT05716854|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111118778|NCT05716854|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111118779|NCT05716854|Dopamine Agents|dopamine agents|mesh-ancestor
111118780|NCT05716854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111118781|NCT05716854|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111118782|NCT05714553|Leucovorin|leucovorin|mesh-list
111118783|NCT05714553|Docetaxel|docetaxel|mesh-list
111118784|NCT05714553|Pembrolizumab|pembrolizumab|mesh-list
111118785|NCT05714553|Levoleucovorin|levoleucovorin|mesh-list
111118786|NCT05714553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111118787|NCT05714553|Tubulin Modulators|tubulin modulators|mesh-ancestor
111118788|NCT05714553|Antimitotic Agents|antimitotic agents|mesh-ancestor
111118789|NCT05714553|Mitosis Modulators|mitosis modulators|mesh-ancestor
111118790|NCT05714553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111118791|NCT05714553|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111118792|NCT05714553|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111118793|NCT05714553|Antidotes|antidotes|mesh-ancestor
111118794|NCT05714553|Protective Agents|protective agents|mesh-ancestor
111118795|NCT05714553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111118796|NCT05714553|Vitamin B Complex|vitamin b complex|mesh-ancestor
111118797|NCT05714553|Vitamins|vitamins|mesh-ancestor
111118798|NCT05714553|Micronutrients|micronutrients|mesh-ancestor
111118799|NCT05713760|Tirbanibulin|tirbanibulin|mesh-list
111118800|NCT05713760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111118801|NCT05713760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111118802|NCT05713630|Tranexamic Acid|tranexamic acid|mesh-list
111118803|NCT05713630|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111118804|NCT05713630|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111118805|NCT05713630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111118806|NCT05713630|Hemostatics|hemostatics|mesh-ancestor
111118807|NCT05713630|Coagulants|coagulants|mesh-ancestor
111118808|NCT05702853|Cyclophosphamide|cyclophosphamide|mesh-list
111118809|NCT05702853|Fludarabine|fludarabine|mesh-list
111118810|NCT05702853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111490476|NCT00951132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111490477|NCT01717872|Pyrithione zinc|pyrithione zinc|mesh-list
111490478|NCT01717872|Keratolytic Agents|keratolytic agents|mesh-ancestor
111118811|NCT05702853|Immunologic Factors|immunologic factors|mesh-ancestor
110649388|NCT00723437|Keratolytic Agents|keratolytic agents|mesh-ancestor
111118812|NCT05702853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111490479|NCT01717872|Dermatologic Agents|dermatologic agents|mesh-ancestor
111118813|NCT05702853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111118814|NCT05702853|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110698589|NCT01068795|Enoxaparin|enoxaparin|mesh-list
111490480|NCT01721226|Opiate Alkaloids|opiate alkaloids|mesh-list
111118815|NCT05702853|Alkylating Agents|alkylating agents|mesh-ancestor
111118816|NCT05702853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111118817|NCT05702853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111118818|NCT05702853|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111118819|NCT05701488|Durvalumab|durvalumab|mesh-list
111118820|NCT05701488|Tremelimumab|tremelimumab|mesh-list
111118821|NCT05701488|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111118822|NCT05701488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111118823|NCT05695261|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111118824|NCT05695261|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
111118825|NCT05695261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111118826|NCT05695261|Antitubercular Agents|antitubercular agents|mesh-ancestor
111118827|NCT05685407|Caffeine|caffeine|mesh-list
111118828|NCT05685407|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111118829|NCT05685407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111118830|NCT05685407|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111118831|NCT05685407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111118832|NCT05685407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111118833|NCT05685407|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
111118834|NCT05685407|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111118835|NCT05685407|Purinergic Agents|purinergic agents|mesh-ancestor
111118836|NCT05685407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111118837|NCT05684276|Paclitaxel|paclitaxel|mesh-list
111118838|NCT05684276|Carboplatin|carboplatin|mesh-list
111118839|NCT05684276|Nivolumab|nivolumab|mesh-list
111118840|NCT05684276|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111118841|NCT05684276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111118842|NCT05684276|Tubulin Modulators|tubulin modulators|mesh-ancestor
111118843|NCT05684276|Antimitotic Agents|antimitotic agents|mesh-ancestor
111118844|NCT05684276|Mitosis Modulators|mitosis modulators|mesh-ancestor
111118845|NCT05684276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110835926|NCT03339453|Incretins|incretins|mesh-ancestor
111118846|NCT05684276|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111118847|NCT05684276|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111118849|NCT05672459|Fludarabine|fludarabine|mesh-list
111118850|NCT05672459|Fludarabine phosphate|fludarabine phosphate|mesh-list
111118851|NCT05672459|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111118852|NCT05672459|Immunologic Factors|immunologic factors|mesh-ancestor
111118853|NCT05672459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111118854|NCT05672459|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111118855|NCT05672459|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111118856|NCT05672459|Alkylating Agents|alkylating agents|mesh-ancestor
111118857|NCT05672459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111118858|NCT05672459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111118859|NCT05672459|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111118860|NCT05672459|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111118861|NCT05672459|Antimetabolites|antimetabolites|mesh-ancestor
111118862|NCT05672342|Dronabinol|dronabinol|mesh-list
111118863|NCT05672342|Cannabidiol|cannabidiol|mesh-list
111118864|NCT05672342|Anticonvulsants|anticonvulsants|mesh-ancestor
111118865|NCT05672342|Hallucinogens|hallucinogens|mesh-ancestor
111118866|NCT05672342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111118867|NCT05672342|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111118868|NCT05672342|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111118869|NCT05672342|Analgesics|analgesics|mesh-ancestor
111118870|NCT05672342|Sensory System Agents|sensory system agents|mesh-ancestor
111118871|NCT05672342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111118872|NCT05672342|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
111118873|NCT05672342|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
111118874|NCT05672342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111118875|NCT05672342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111118876|NCT05672342|Hormones|hormones|mesh-ancestor
110799548|NCT03752931|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111118877|NCT05672342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111118878|NCT05669820|Antisecretory factor|antisecretory factor|mesh-list
111118879|NCT05669820|Antidiarrheals|antidiarrheals|mesh-ancestor
111118880|NCT05669820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111118881|NCT05667116|Cilgavimab and tixagevimab drug combination|cilgavimab and tixagevimab drug combination|mesh-list
111118882|NCT05667116|Antiviral Agents|antiviral agents|mesh-ancestor
111118883|NCT05667116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111118884|NCT05655182|Vaccines|vaccines|mesh-list
111118885|NCT05655182|Immunologic Factors|immunologic factors|mesh-ancestor
111118886|NCT05655182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111490481|NCT01721226|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111490482|NCT01721226|Narcotics|narcotics|mesh-ancestor
110698594|NCT00286455|Alogliptin|alogliptin|mesh-list
111118887|NCT05641051|Metoclopramide|metoclopramide|mesh-list
111118888|NCT05641051|Antiemetics|antiemetics|mesh-ancestor
111118889|NCT05641051|Autonomic Agents|autonomic agents|mesh-ancestor
111118890|NCT05641051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111118891|NCT05641051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111118892|NCT05641051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111118893|NCT05641051|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111118894|NCT05641051|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111118895|NCT05641051|Dopamine Agents|dopamine agents|mesh-ancestor
111118896|NCT05641051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111118897|NCT05641051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111118898|NCT05631626|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
111118899|NCT05631626|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111118900|NCT05631626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111118901|NCT05631626|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111118902|NCT05631626|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111118903|NCT05631626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111118904|NCT05631626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111118905|NCT05631626|Dopamine Agents|dopamine agents|mesh-ancestor
111118906|NCT05631626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111118907|NCT05618366|Venetoclax|venetoclax|mesh-list
111118908|NCT05618366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111118909|NCT05587998|Morphine|morphine|mesh-list
111118910|NCT05587998|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111118911|NCT05587998|Narcotics|narcotics|mesh-ancestor
111118912|NCT05587998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111118913|NCT05587998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111118914|NCT05587998|Analgesics|analgesics|mesh-ancestor
111118915|NCT05587998|Sensory System Agents|sensory system agents|mesh-ancestor
111118916|NCT05587998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111118917|NCT05585398|Botulinum Toxins|botulinum toxins|mesh-list
111118918|NCT05585398|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111118919|NCT05585398|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111118920|NCT05585398|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
111118921|NCT05585398|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111118922|NCT05585398|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111118923|NCT05585398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111118924|NCT05585398|Cholinergic Agents|cholinergic agents|mesh-ancestor
111118925|NCT05585398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111118926|NCT05585398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111118927|NCT05585398|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111118928|NCT05585398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111118929|NCT05571735|Vaccines|vaccines|mesh-list
111118930|NCT05571735|Immunologic Factors|immunologic factors|mesh-ancestor
111118931|NCT05571735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111118932|NCT05554237|Ceftibuten|ceftibuten|mesh-list
111118933|NCT05554237|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111118934|NCT05554237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111118935|NCT05550870|Fenugreek seed meal|fenugreek seed meal|mesh-list
111118936|NCT05550870|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111118937|NCT05550870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111118938|NCT05544695|Hyaluronic Acid|hyaluronic acid|mesh-list
111118939|NCT05544695|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111118940|NCT05544695|Immunologic Factors|immunologic factors|mesh-ancestor
111118941|NCT05544695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111118942|NCT05544695|Viscosupplements|viscosupplements|mesh-ancestor
111118943|NCT05544695|Protective Agents|protective agents|mesh-ancestor
111118944|NCT05543278|Amiodarone|amiodarone|mesh-list
111118945|NCT05543278|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110649401|NCT01028170|Diuretics|diuretics|mesh-ancestor
111118946|NCT05543278|Vasodilator Agents|vasodilator agents|mesh-ancestor
111118947|NCT05543278|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
111118948|NCT05543278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111118949|NCT05543278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111118950|NCT05543278|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111118951|NCT05543278|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111118952|NCT05543278|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111490483|NCT01721226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111490484|NCT01721226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111490485|NCT01721226|Analgesics|analgesics|mesh-ancestor
111490486|NCT01721226|Sensory System Agents|sensory system agents|mesh-ancestor
111490487|NCT01721226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111490488|NCT01721460|Dexmedetomidine|dexmedetomidine|mesh-list
111490489|NCT01721460|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111490490|NCT01721460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111490491|NCT01721460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111490492|NCT01721460|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111118953|NCT05543278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111118954|NCT05543278|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111118955|NCT05543278|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111118956|NCT05543278|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111118957|NCT05538312|Itraconazole|itraconazole|mesh-list
111118958|NCT05538312|Antifungal Agents|antifungal agents|mesh-ancestor
111118959|NCT05538312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111118960|NCT05538312|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111118961|NCT05538312|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111118962|NCT05538312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111118963|NCT05538312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111118964|NCT05538312|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111118965|NCT05538312|Hormone Antagonists|hormone antagonists|mesh-ancestor
111118966|NCT05538312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111118967|NCT05538312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111118968|NCT05538312|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111118969|NCT05507476|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
111118970|NCT05507476|Epinephrine|epinephrine|mesh-list
111118971|NCT05507476|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111118972|NCT05507476|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111118973|NCT05507476|Adrenergic Agents|adrenergic agents|mesh-ancestor
111118974|NCT05507476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111118975|NCT05507476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111118976|NCT05507476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111118977|NCT05507476|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111118978|NCT05507476|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111118979|NCT05507476|Autonomic Agents|autonomic agents|mesh-ancestor
111118980|NCT05507476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111118981|NCT05507476|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111118982|NCT05507476|Respiratory System Agents|respiratory system agents|mesh-ancestor
111118983|NCT05507476|Mydriatics|mydriatics|mesh-ancestor
111118984|NCT05507476|Sympathomimetics|sympathomimetics|mesh-ancestor
111118985|NCT05507476|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111118986|NCT05507476|Hemostatics|hemostatics|mesh-ancestor
111118987|NCT05507476|Coagulants|coagulants|mesh-ancestor
111118988|NCT05507476|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
111118989|NCT05507476|Natriuretic Agents|natriuretic agents|mesh-ancestor
111118990|NCT05501756|Alemtuzumab|alemtuzumab|mesh-list
111118991|NCT05501756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111118992|NCT05501756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110836075|NCT03787927|Antipyretics|antipyretics|mesh-ancestor
111118993|NCT05500326|Ivermectin|ivermectin|mesh-list
111118994|NCT05500326|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111118995|NCT05500326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111118996|NCT05494125|Ropivacaine|ropivacaine|mesh-list
111118997|NCT05494125|Anesthetics, Local|anesthetics, local|mesh-ancestor
111118998|NCT05494125|Anesthetics|anesthetics|mesh-ancestor
111118999|NCT05494125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110649407|NCT00518115|Exenatide|exenatide|mesh-list
111119000|NCT05494125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111119001|NCT05494125|Sensory System Agents|sensory system agents|mesh-ancestor
111119002|NCT05494125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111119003|NCT05484401|Ibuprofen|ibuprofen|mesh-list
111119004|NCT05484401|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111119005|NCT05484401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111119006|NCT05484401|Analgesics|analgesics|mesh-ancestor
111119007|NCT05484401|Sensory System Agents|sensory system agents|mesh-ancestor
111119008|NCT05484401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111119009|NCT05484401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111119010|NCT05484401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111119011|NCT05484401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111119012|NCT05484401|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111119013|NCT05484401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111119014|NCT05484401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111119015|NCT05447676|4-Aminopyridine|4-aminopyridine|mesh-list
111119016|NCT05447676|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
111119017|NCT05447676|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111119018|NCT05447676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111119019|NCT05442580|Cyclophosphamide|cyclophosphamide|mesh-list
111119020|NCT05442580|Fludarabine|fludarabine|mesh-list
111490493|NCT01721460|Analgesics|analgesics|mesh-ancestor
111119021|NCT05442580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111119022|NCT05442580|Immunologic Factors|immunologic factors|mesh-ancestor
111490494|NCT01721460|Sensory System Agents|sensory system agents|mesh-ancestor
111490495|NCT01721460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111119023|NCT05442580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111119024|NCT05442580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111119025|NCT05442580|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111119026|NCT05442580|Alkylating Agents|alkylating agents|mesh-ancestor
111119027|NCT05442580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111119028|NCT05442580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111119029|NCT05442580|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111119030|NCT05435573|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
111119031|NCT05435573|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111119032|NCT05435573|Plasma Substitutes|plasma substitutes|mesh-ancestor
111119033|NCT05435573|Blood Substitutes|blood substitutes|mesh-ancestor
111119034|NCT05428969|Azacitidine|azacitidine|mesh-list
111119035|NCT05428969|Venetoclax|venetoclax|mesh-list
111119036|NCT05428969|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111119037|NCT05428969|Antimetabolites|antimetabolites|mesh-ancestor
111119038|NCT05428969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111119039|NCT05428969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111119040|NCT05428969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111119041|NCT05423340|Nicotine|nicotine|mesh-list
111119042|NCT05423340|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111119043|NCT05423340|Autonomic Agents|autonomic agents|mesh-ancestor
111119044|NCT05423340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111119045|NCT05423340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111119046|NCT05423340|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111119047|NCT05423340|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111119048|NCT05423340|Cholinergic Agents|cholinergic agents|mesh-ancestor
111119049|NCT05423340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111119050|NCT05423340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111119051|NCT05418582|Carbamazepine|carbamazepine|mesh-list
111119052|NCT05418582|Anticonvulsants|anticonvulsants|mesh-ancestor
111119053|NCT05418582|Antimanic Agents|antimanic agents|mesh-ancestor
111119054|NCT05418582|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111119055|NCT05418582|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111119056|NCT05418582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111119057|NCT05418582|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111119058|NCT05418582|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111119059|NCT05418582|Analgesics|analgesics|mesh-ancestor
111119060|NCT05418582|Sensory System Agents|sensory system agents|mesh-ancestor
111119061|NCT05418582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110649413|NCT00518115|Hormones|hormones|mesh-ancestor
111119062|NCT05418582|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111119063|NCT05418582|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111119064|NCT05418582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111119065|NCT05418582|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111119066|NCT05418582|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111119067|NCT05417425|Lidocaine|lidocaine|mesh-list
111119068|NCT05417425|Protective Agents|protective agents|mesh-list
111119069|NCT05417425|Anesthetics, Local|anesthetics, local|mesh-ancestor
111119070|NCT05417425|Anesthetics|anesthetics|mesh-ancestor
111119071|NCT05417425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111119072|NCT05417425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111119073|NCT05417425|Sensory System Agents|sensory system agents|mesh-ancestor
111119074|NCT05417425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111119075|NCT05417425|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111119076|NCT05417425|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111119077|NCT05417425|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111119078|NCT05417425|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111119079|NCT05417425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111119080|NCT05413915|Imatinib Mesylate|imatinib mesylate|mesh-list
111119081|NCT05413915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111119082|NCT05413915|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111119083|NCT05413915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111119084|NCT05413915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111119085|NCT05394103|Pembrolizumab|pembrolizumab|mesh-list
111119086|NCT05394103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111119087|NCT05394103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111119088|NCT05394103|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111119089|NCT05394103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111119090|NCT05388474|Ibalizumab|ibalizumab|mesh-list
111119091|NCT05388474|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111119092|NCT05388474|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111119093|NCT05388474|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110959324|NCT03388970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110959325|NCT03388970|Hemostatics|hemostatics|mesh-ancestor
110959326|NCT03388970|Coagulants|coagulants|mesh-ancestor
110959327|NCT00616941|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
110959328|NCT00616941|Poly ICLC|poly iclc|mesh-list
110959329|NCT00616941|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110959330|NCT00616941|Immunologic Factors|immunologic factors|mesh-ancestor
110959331|NCT00616941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110959332|NCT00616941|Interferon Inducers|interferon inducers|mesh-ancestor
110959333|NCT03388892|Paclitaxel|paclitaxel|mesh-list
110959334|NCT03388892|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110959335|NCT03388892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110959336|NCT03388892|Tubulin Modulators|tubulin modulators|mesh-ancestor
110959337|NCT03388892|Antimitotic Agents|antimitotic agents|mesh-ancestor
110959338|NCT03388892|Mitosis Modulators|mitosis modulators|mesh-ancestor
110959339|NCT03388892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110959340|NCT02577718|Ethanol|ethanol|mesh-list
110959341|NCT02577718|Nitroglycerin|nitroglycerin|mesh-list
110959342|NCT02577718|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110959343|NCT02577718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110959344|NCT02577718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110959345|NCT02577718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110959346|NCT02577718|Vasodilator Agents|vasodilator agents|mesh-ancestor
110959347|NCT00520533|Sunitinib|sunitinib|mesh-list
110959348|NCT00520533|Antibodies|antibodies|mesh-list
110959349|NCT00520533|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110959350|NCT00520533|Immunologic Factors|immunologic factors|mesh-ancestor
110959351|NCT00520533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110959352|NCT00520533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110959353|NCT00520533|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110959354|NCT00520533|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110959355|NCT00520533|Growth Substances|growth substances|mesh-ancestor
110959356|NCT00520533|Growth Inhibitors|growth inhibitors|mesh-ancestor
110959357|NCT00520533|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110959358|NCT00520533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110959359|NCT00520533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110959360|NCT03388814|Bupivacaine|bupivacaine|mesh-list
110959361|NCT03388814|Anesthetics, Local|anesthetics, local|mesh-ancestor
110959362|NCT03388814|Anesthetics|anesthetics|mesh-ancestor
110959363|NCT03388814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110959364|NCT03388814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110959365|NCT03388814|Sensory System Agents|sensory system agents|mesh-ancestor
110959366|NCT03388814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110959367|NCT04680988|Paclitaxel|paclitaxel|mesh-list
110959368|NCT04680988|Gemcitabine|gemcitabine|mesh-list
110959369|NCT04680988|Pemetrexed|pemetrexed|mesh-list
110959370|NCT04680988|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110959371|NCT04680988|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110959372|NCT04680988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110959373|NCT04680988|Tubulin Modulators|tubulin modulators|mesh-ancestor
110959374|NCT04680988|Antimitotic Agents|antimitotic agents|mesh-ancestor
110959375|NCT04680988|Mitosis Modulators|mitosis modulators|mesh-ancestor
110959376|NCT04680988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110959377|NCT04680988|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110959378|NCT04680988|Antimetabolites|antimetabolites|mesh-ancestor
110959379|NCT04680988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110959380|NCT04680988|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110959381|NCT04680988|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110959382|NCT02289144|Ceritinib|ceritinib|mesh-list
110959383|NCT02289144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110959384|NCT02289144|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110959385|NCT02289144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110959386|NCT02289144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110959387|NCT03393026|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
110959388|NCT03393026|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110959389|NCT03393026|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110959390|NCT03393026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110959391|NCT03393026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110959392|NCT03393026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111490496|NCT01721460|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111490497|NCT01721460|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110959393|NCT03393026|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
110959394|NCT03393026|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110959395|NCT03393026|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111490498|NCT01721460|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111490499|NCT01721460|Adrenergic Agents|adrenergic agents|mesh-ancestor
111490500|NCT01721460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111490501|NCT01721460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110959396|NCT03393026|Adrenergic Agents|adrenergic agents|mesh-ancestor
110959397|NCT03393026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110959398|NCT03393026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110959399|NCT03393026|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110959400|NCT03393026|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110959401|NCT03393026|Serotonin Agents|serotonin agents|mesh-ancestor
110959402|NCT03393026|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110959403|NCT03393026|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110959404|NCT03393026|Dopamine Agents|dopamine agents|mesh-ancestor
110959405|NCT02144415|Amphetamine|amphetamine|mesh-list
110959406|NCT02144415|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
110959407|NCT02144415|Dextroamphetamine|dextroamphetamine|mesh-list
110959408|NCT02144415|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110959409|NCT02144415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110959410|NCT02144415|Sympathomimetics|sympathomimetics|mesh-ancestor
110959411|NCT02144415|Autonomic Agents|autonomic agents|mesh-ancestor
110959412|NCT02144415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110959413|NCT02144415|Dopamine Agents|dopamine agents|mesh-ancestor
110959414|NCT02144415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110959415|NCT02144415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110959416|NCT02144415|Adrenergic Agents|adrenergic agents|mesh-ancestor
110959417|NCT02144415|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110959418|NCT02144415|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110959419|NCT02144415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110959420|NCT02144415|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110959422|NCT02739984|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110959423|NCT02739984|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
110959424|NCT02739984|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110959425|NCT02739984|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110959426|NCT02739984|Antimetabolites|antimetabolites|mesh-ancestor
110959427|NCT02739984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110959428|NCT02739984|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110959429|NCT02739984|Protease Inhibitors|protease inhibitors|mesh-ancestor
110959430|NCT02739984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110959431|NCT02739984|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110959432|NCT02739984|Immunologic Factors|immunologic factors|mesh-ancestor
110959433|NCT02739984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110959434|NCT00496730|Atorvastatin|atorvastatin|mesh-list
110959435|NCT00496730|Simvastatin|simvastatin|mesh-list
110959436|NCT00496730|Ezetimibe|ezetimibe|mesh-list
110959437|NCT00496730|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110959438|NCT00496730|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110959439|NCT00496730|Antimetabolites|antimetabolites|mesh-ancestor
110959440|NCT00496730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110959441|NCT00496730|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110959442|NCT00496730|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110959443|NCT00496730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110959444|NCT00446186|Montelukast|montelukast|mesh-list
110959445|NCT00446186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110959446|NCT00446186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110959447|NCT00446186|Respiratory System Agents|respiratory system agents|mesh-ancestor
110959448|NCT00446186|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110959449|NCT00446186|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110959450|NCT00446186|Hormone Antagonists|hormone antagonists|mesh-ancestor
110959451|NCT00446186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110959452|NCT00446186|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110959453|NCT00446186|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110959454|NCT02140983|Liraglutide|liraglutide|mesh-list
110959455|NCT02140983|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110959456|NCT02140983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110959457|NCT02140983|Incretins|incretins|mesh-ancestor
110959459|NCT02140983|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110959460|NCT00394160|Montelukast|montelukast|mesh-list
110959461|NCT00394160|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110959462|NCT00394160|Respiratory System Agents|respiratory system agents|mesh-ancestor
110959463|NCT00394160|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110959464|NCT00394160|Hormone Antagonists|hormone antagonists|mesh-ancestor
110959465|NCT00394160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110959466|NCT00394160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110959467|NCT00394160|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110959468|NCT00394160|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110959469|NCT00394160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110959470|NCT03392792|Plasminogen|plasminogen|mesh-list
110959471|NCT03392792|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
110959472|NCT03392792|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110959473|NCT03392792|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110959474|NCT03392792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110959475|NCT02739828|Adalimumab|adalimumab|mesh-list
110959476|NCT02739828|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110959477|NCT02739828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110959478|NCT02739828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110959479|NCT02141139|Ibuprofen|ibuprofen|mesh-list
110959480|NCT02141139|Ketorolac|ketorolac|mesh-list
110959481|NCT02141139|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110959482|NCT02141139|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110959483|NCT02141139|Analgesics|analgesics|mesh-ancestor
110959484|NCT02141139|Sensory System Agents|sensory system agents|mesh-ancestor
110959485|NCT02141139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110959486|NCT02141139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110959487|NCT02141139|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110959488|NCT02141139|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110959489|NCT02141139|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110959490|NCT02141139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110959491|NCT02141139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110959492|NCT03108495|Pembrolizumab|pembrolizumab|mesh-list
110959493|NCT03108495|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110959494|NCT03108495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110959495|NCT03108495|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110959496|NCT03108495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110959497|NCT05297032|Quercetin|quercetin|mesh-list
110959498|NCT05297032|Antioxidants|antioxidants|mesh-ancestor
110959499|NCT05297032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110959500|NCT05297032|Protective Agents|protective agents|mesh-ancestor
110959501|NCT05297032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110959502|NCT03388580|Dimercaprol|dimercaprol|mesh-list
110959503|NCT03388580|Chelating Agents|chelating agents|mesh-ancestor
110959504|NCT03388580|Sequestering Agents|sequestering agents|mesh-ancestor
110959505|NCT03388580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110959506|NCT03525912|Ketamine|ketamine|mesh-list
110959507|NCT03525912|Analgesics|analgesics|mesh-list
110959508|NCT03525912|Sensory System Agents|sensory system agents|mesh-ancestor
110959509|NCT03525912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110959510|NCT03525912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110959511|NCT03525912|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110959512|NCT03525912|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110959513|NCT03525912|Anesthetics, General|anesthetics, general|mesh-ancestor
110959514|NCT03525912|Anesthetics|anesthetics|mesh-ancestor
110959515|NCT03525912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110959516|NCT03525912|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110959517|NCT03525912|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110959518|NCT03525912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110959519|NCT03525912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110959520|NCT02289378|Docetaxel|docetaxel|mesh-list
110959521|NCT02289378|Oxaliplatin|oxaliplatin|mesh-list
110959522|NCT02289378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110959523|NCT02289378|Tubulin Modulators|tubulin modulators|mesh-ancestor
110959524|NCT02289378|Antimitotic Agents|antimitotic agents|mesh-ancestor
110959525|NCT02289378|Mitosis Modulators|mitosis modulators|mesh-ancestor
110959526|NCT02289378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110959527|NCT03851614|Durvalumab|durvalumab|mesh-list
110959528|NCT03851614|Olaparib|olaparib|mesh-list
110959529|NCT03851614|Cediranib|cediranib|mesh-list
110959530|NCT03851614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110959531|NCT03851614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110959532|NCT03851614|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110959533|NCT03851614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110959534|NCT03851614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110959535|NCT03851614|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110959536|NCT04565600|Etoricoxib|etoricoxib|mesh-list
110959537|NCT04565600|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111490502|NCT01722318|Plecanatide|plecanatide|mesh-list
111490503|NCT01722318|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
110959538|NCT04565600|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111490504|NCT01722318|Enzyme Activators|enzyme activators|mesh-ancestor
110959539|NCT04565600|Analgesics|analgesics|mesh-ancestor
110959540|NCT04565600|Sensory System Agents|sensory system agents|mesh-ancestor
110959541|NCT04565600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110959542|NCT04565600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110959543|NCT04565600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110959544|NCT04565600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110959545|NCT04565600|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110959546|NCT04565600|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110959547|NCT04565600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110959548|NCT04565600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110959549|NCT04435808|Hydroxychloroquine|hydroxychloroquine|mesh-list
110959550|NCT04435808|Antimalarials|antimalarials|mesh-ancestor
110959551|NCT04435808|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110959552|NCT04435808|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110959553|NCT04435808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110959554|NCT04435808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110959555|NCT04435808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110959556|NCT04435808|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110959557|NCT03388346|Edetic Acid|edetic acid|mesh-list
110959558|NCT03388346|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
110959559|NCT03388346|Chelating Agents|chelating agents|mesh-ancestor
110959560|NCT03388346|Sequestering Agents|sequestering agents|mesh-ancestor
110959561|NCT03388346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110959562|NCT03388346|Anticoagulants|anticoagulants|mesh-ancestor
110959563|NCT03388346|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110959564|NCT03388346|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110959566|NCT05631730|Flecainide|flecainide|mesh-list
110959567|NCT05631730|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110959568|NCT05631730|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110959569|NCT05631730|Sympatholytics|sympatholytics|mesh-ancestor
110959570|NCT05631730|Autonomic Agents|autonomic agents|mesh-ancestor
110959571|NCT05631730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110959572|NCT05631730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110959573|NCT05631730|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110959574|NCT05631730|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110959575|NCT05631730|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110959576|NCT05631730|Adrenergic Agents|adrenergic agents|mesh-ancestor
110959577|NCT05631730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110959578|NCT05631730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110959579|NCT05631730|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110959580|NCT05631730|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110959581|NCT05631730|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110959582|NCT00092144|Montelukast|montelukast|mesh-list
110959583|NCT00092144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110959584|NCT00092144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110959585|NCT00092144|Respiratory System Agents|respiratory system agents|mesh-ancestor
110959586|NCT00092144|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110959587|NCT00092144|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110959588|NCT00092144|Hormone Antagonists|hormone antagonists|mesh-ancestor
110959589|NCT00092144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110959590|NCT00092144|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110959591|NCT00092144|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110959592|NCT02289768|Salicylic Acid|salicylic acid|mesh-list
110959593|NCT02289768|Salicylates|salicylates|mesh-list
110959594|NCT02289768|Fluorouracil|fluorouracil|mesh-list
110959595|NCT02289768|Antimetabolites|antimetabolites|mesh-ancestor
110959596|NCT02289768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110959597|NCT02289768|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110959598|NCT02289768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110959599|NCT02289768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110959600|NCT02289768|Immunologic Factors|immunologic factors|mesh-ancestor
110959601|NCT02289768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110959602|NCT02289768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110959603|NCT02289768|Antifungal Agents|antifungal agents|mesh-ancestor
110959604|NCT02289768|Keratolytic Agents|keratolytic agents|mesh-ancestor
110959605|NCT02289768|Dermatologic Agents|dermatologic agents|mesh-ancestor
110959606|NCT02289768|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110959607|NCT02289768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110959608|NCT02289768|Analgesics|analgesics|mesh-ancestor
111490505|NCT01722318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111490506|NCT01722318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111490507|NCT01723722|Methadone|methadone|mesh-list
111490508|NCT01723722|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111490509|NCT01723722|Narcotics|narcotics|mesh-ancestor
111490510|NCT01723722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110959609|NCT02289768|Sensory System Agents|sensory system agents|mesh-ancestor
110959610|NCT02289768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110959611|NCT02289768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110959612|NCT02289768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110959613|NCT02289768|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110959614|NCT02289768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110959615|NCT04330430|Nivolumab|nivolumab|mesh-list
110959616|NCT04330430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110959617|NCT04330430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111490511|NCT01723722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111490512|NCT01723722|Analgesics|analgesics|mesh-ancestor
111490513|NCT01723722|Sensory System Agents|sensory system agents|mesh-ancestor
111490514|NCT01723722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111490515|NCT01723722|Antitussive Agents|antitussive agents|mesh-ancestor
110959618|NCT04330430|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110959619|NCT04330430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110959620|NCT03387956|Dexamethasone|dexamethasone|mesh-list
110959621|NCT03387956|Atropine|atropine|mesh-list
110959622|NCT03387956|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110959623|NCT03387956|Antiemetics|antiemetics|mesh-ancestor
110959624|NCT03387956|Autonomic Agents|autonomic agents|mesh-ancestor
110959625|NCT03387956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110959626|NCT03387956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110959627|NCT03387956|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110959628|NCT03387956|Glucocorticoids|glucocorticoids|mesh-ancestor
110959629|NCT03387956|Hormones|hormones|mesh-ancestor
110959630|NCT03387956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110649528|NCT00450580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110959631|NCT03387956|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110959632|NCT03387956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110959633|NCT03387956|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110959634|NCT03387956|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110959635|NCT03387956|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110959636|NCT03387956|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110959637|NCT03387956|Respiratory System Agents|respiratory system agents|mesh-ancestor
110959638|NCT03387956|Mydriatics|mydriatics|mesh-ancestor
110959639|NCT03387956|Parasympatholytics|parasympatholytics|mesh-ancestor
110959640|NCT03387956|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110959641|NCT03387956|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110959642|NCT03387956|Cholinergic Agents|cholinergic agents|mesh-ancestor
110959643|NCT03387956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110959644|NCT03387956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110959645|NCT03384524|Metoprolol|metoprolol|mesh-list
110959646|NCT03384524|Bromocriptine|bromocriptine|mesh-list
110959647|NCT03384524|Tamsulosin|tamsulosin|mesh-list
110959648|NCT03384524|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110959649|NCT03384524|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110959650|NCT03384524|Sympatholytics|sympatholytics|mesh-ancestor
110959651|NCT03384524|Autonomic Agents|autonomic agents|mesh-ancestor
110959652|NCT03384524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110959653|NCT03384524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110959654|NCT03384524|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110959655|NCT03384524|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110959656|NCT03384524|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110959657|NCT03384524|Adrenergic Agents|adrenergic agents|mesh-ancestor
110959658|NCT03384524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110959659|NCT03384524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110959660|NCT03384524|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110959661|NCT03384524|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110959662|NCT03384524|Urological Agents|urological agents|mesh-ancestor
110959663|NCT03384524|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110959664|NCT03384524|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110959665|NCT03384524|Hormone Antagonists|hormone antagonists|mesh-ancestor
110959666|NCT03384524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110959667|NCT03384524|Dopamine Agonists|dopamine agonists|mesh-ancestor
110959668|NCT03384524|Dopamine Agents|dopamine agents|mesh-ancestor
110959669|NCT02289924|Aflibercept|aflibercept|mesh-list
110959670|NCT02289924|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110959671|NCT02289924|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110959672|NCT02289924|Growth Substances|growth substances|mesh-ancestor
111119094|NCT05388474|Antiviral Agents|antiviral agents|mesh-ancestor
111490516|NCT01723722|Respiratory System Agents|respiratory system agents|mesh-ancestor
111490517|NCT01728636|Tranexamic Acid|tranexamic acid|mesh-list
111490518|NCT01728636|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111490519|NCT01728636|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111490520|NCT01728636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111490521|NCT01728636|Hemostatics|hemostatics|mesh-ancestor
110959673|NCT02289924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110959674|NCT02289924|Growth Inhibitors|growth inhibitors|mesh-ancestor
110959675|NCT02289924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110959676|NCT03387644|Pregabalin|pregabalin|mesh-list
110959677|NCT03387644|Analgesics|analgesics|mesh-ancestor
110959678|NCT03387644|Sensory System Agents|sensory system agents|mesh-ancestor
110959679|NCT03387644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110959680|NCT03387644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110959681|NCT03387644|Anticonvulsants|anticonvulsants|mesh-ancestor
110959682|NCT03387644|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110959683|NCT03387644|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110959684|NCT03387644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110959685|NCT03387644|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110959686|NCT03387644|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110959687|NCT03387644|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110959688|NCT03387644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110959689|NCT03387644|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110959690|NCT02290002|Calcium Dobesilate|calcium dobesilate|mesh-list
110959691|NCT02290002|Calcium|calcium|mesh-list
110959692|NCT02290002|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110959693|NCT02290002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110959694|NCT02290002|Hemostatics|hemostatics|mesh-ancestor
110959695|NCT02290002|Coagulants|coagulants|mesh-ancestor
110959696|NCT02294292|Carvedilol|carvedilol|mesh-list
110959697|NCT02294292|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110959698|NCT02294292|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110959699|NCT02294292|Adrenergic Agents|adrenergic agents|mesh-ancestor
110959700|NCT02294292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110959701|NCT02294292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110959702|NCT02294292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110959703|NCT02294292|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110959704|NCT02294292|Antioxidants|antioxidants|mesh-ancestor
110959705|NCT02294292|Protective Agents|protective agents|mesh-ancestor
110959706|NCT02294292|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110959707|NCT02294292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110959708|NCT02294292|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110959709|NCT02294292|Vasodilator Agents|vasodilator agents|mesh-ancestor
110959710|NCT02294292|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110959711|NCT02294292|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110959712|NCT03387566|Immunoglobulins|immunoglobulins|mesh-list
110959713|NCT03387566|Endothelial Growth Factors|endothelial growth factors|mesh-list
110959714|NCT03387566|Immunologic Factors|immunologic factors|mesh-ancestor
110959715|NCT03387566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110959716|NCT03387566|Growth Substances|growth substances|mesh-ancestor
110959717|NCT03391856|Acetylcysteine|acetylcysteine|mesh-list
110959718|NCT03391856|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110959719|NCT03391856|Antiviral Agents|antiviral agents|mesh-ancestor
110959720|NCT03391856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110959721|NCT03391856|Expectorants|expectorants|mesh-ancestor
110959722|NCT03391856|Respiratory System Agents|respiratory system agents|mesh-ancestor
110959723|NCT03391856|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110959724|NCT03391856|Antioxidants|antioxidants|mesh-ancestor
110959725|NCT03391856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110959726|NCT03391856|Protective Agents|protective agents|mesh-ancestor
110959727|NCT03391856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110959728|NCT03391856|Antidotes|antidotes|mesh-ancestor
110959729|NCT01664494|Capecitabine|capecitabine|mesh-list
110959730|NCT01664494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110959731|NCT01664494|Antimetabolites|antimetabolites|mesh-ancestor
110959732|NCT01664494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110959733|NCT01664494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110959734|NCT02290470|Dexamethasone|dexamethasone|mesh-list
110959735|NCT02290470|Dexamethasone acetate|dexamethasone acetate|mesh-list
110959736|NCT02290470|Paclitaxel|paclitaxel|mesh-list
110959737|NCT02290470|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110959738|NCT02290470|Carboplatin|carboplatin|mesh-list
110959739|NCT02290470|Olanzapine|olanzapine|mesh-list
110959740|NCT02290470|Palonosetron|palonosetron|mesh-list
110959741|NCT02290470|BB 1101|bb 1101|mesh-list
110698625|NCT00286221|Anesthetics|anesthetics|mesh-ancestor
111490522|NCT01728636|Coagulants|coagulants|mesh-ancestor
110959742|NCT02290470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110959743|NCT02290470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110959745|NCT02290470|Antimitotic Agents|antimitotic agents|mesh-ancestor
110959746|NCT02290470|Mitosis Modulators|mitosis modulators|mesh-ancestor
110959747|NCT02290470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110959748|NCT02290470|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110959749|NCT02290470|Antiemetics|antiemetics|mesh-ancestor
110959750|NCT02290470|Autonomic Agents|autonomic agents|mesh-ancestor
110959751|NCT02290470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110959752|NCT02290470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110959753|NCT02290470|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110671780|NCT04042805|Lenvatinib|lenvatinib|mesh-list
110959754|NCT02290470|Glucocorticoids|glucocorticoids|mesh-ancestor
110959755|NCT02290470|Hormones|hormones|mesh-ancestor
110959756|NCT02290470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110959757|NCT02290470|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110959758|NCT02290470|Protease Inhibitors|protease inhibitors|mesh-ancestor
110959759|NCT02290470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110959760|NCT02290470|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110959761|NCT02290470|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110959762|NCT02290470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110959763|NCT02290470|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110959764|NCT02290470|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110959765|NCT02290470|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110959766|NCT02290470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110959767|NCT02290470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110959768|NCT02290470|Serotonin Agents|serotonin agents|mesh-ancestor
110959769|NCT02290470|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110959770|NCT02290470|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110959771|NCT05172518|Capecitabine|capecitabine|mesh-list
110959773|NCT05172518|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110959774|NCT05172518|Antimetabolites|antimetabolites|mesh-ancestor
110959775|NCT05172518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110959776|NCT05172518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110959777|NCT03724084|Cytarabine|cytarabine|mesh-list
110959778|NCT03724084|Daunorubicin|daunorubicin|mesh-list
110959779|NCT03724084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110959780|NCT03724084|Antimetabolites|antimetabolites|mesh-ancestor
110959781|NCT03724084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110959782|NCT03724084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110959783|NCT03724084|Antiviral Agents|antiviral agents|mesh-ancestor
110959784|NCT03724084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110959785|NCT03724084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110959786|NCT03724084|Immunologic Factors|immunologic factors|mesh-ancestor
110959787|NCT03724084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110959788|NCT03724084|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110959789|NCT03724084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110959790|NCT03724084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110959791|NCT03724084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110959792|NCT05172440|Tislelizumab|tislelizumab|mesh-list
110959793|NCT05172440|Axitinib|axitinib|mesh-list
110959794|NCT05172440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110959795|NCT05172440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110959796|NCT05172440|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110959797|NCT05172440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110959798|NCT05172440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110959799|NCT02298582|Fentanyl|fentanyl|mesh-list
110959800|NCT02298582|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110959801|NCT02298582|Narcotics|narcotics|mesh-ancestor
110959802|NCT02298582|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110959803|NCT02298582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110959804|NCT02298582|Analgesics|analgesics|mesh-ancestor
110959805|NCT02298582|Sensory System Agents|sensory system agents|mesh-ancestor
110959806|NCT02298582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110959807|NCT02298582|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110959808|NCT02298582|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110959809|NCT02298582|Anesthetics, General|anesthetics, general|mesh-ancestor
110959810|NCT02298582|Anesthetics|anesthetics|mesh-ancestor
110959811|NCT02298660|Botulinum Toxins|botulinum toxins|mesh-list
110959812|NCT02298660|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111490523|NCT01729338|Cyclophosphamide|cyclophosphamide|mesh-list
111490524|NCT01729338|Lenalidomide|lenalidomide|mesh-list
111490525|NCT01729338|Bortezomib|bortezomib|mesh-list
110959813|NCT02298660|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111490526|NCT01729338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110959814|NCT02298660|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110959815|NCT02298660|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110959816|NCT02298660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110959817|NCT02298660|Cholinergic Agents|cholinergic agents|mesh-ancestor
110959818|NCT02298660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110959819|NCT02298660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110959820|NCT02298660|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110959821|NCT02298660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110959822|NCT01396408|Sirolimus|sirolimus|mesh-list
110959823|NCT01396408|Sunitinib|sunitinib|mesh-list
110959824|NCT01396408|Temsirolimus|temsirolimus|mesh-list
110959825|NCT01396408|MTOR Inhibitors|mtor inhibitors|mesh-list
110959826|NCT01396408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110959827|NCT01396408|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110959828|NCT01396408|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110959829|NCT01396408|Growth Substances|growth substances|mesh-ancestor
110959830|NCT01396408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110959831|NCT01396408|Growth Inhibitors|growth inhibitors|mesh-ancestor
110959832|NCT01396408|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110959833|NCT01396408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110959834|NCT01396408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110959835|NCT01396408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110959836|NCT01396408|Immunologic Factors|immunologic factors|mesh-ancestor
110959837|NCT01396408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110959838|NCT01396408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110959839|NCT01396408|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110959840|NCT01396408|Antifungal Agents|antifungal agents|mesh-ancestor
110959841|NCT03571334|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
110959842|NCT03571334|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110959843|NCT03571334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110959844|NCT03571334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110959845|NCT03571334|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110959846|NCT03571334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110959847|NCT03571334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110959848|NCT03571334|Cholinergic Agents|cholinergic agents|mesh-ancestor
110959849|NCT03571334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110959850|NCT05440942|Trametinib|trametinib|mesh-list
110959851|NCT05440942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110959852|NCT05440942|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110959853|NCT05440942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110959854|NCT05440942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110959855|NCT02291094|Lidocaine|lidocaine|mesh-list
110959856|NCT02291094|Remifentanil|remifentanil|mesh-list
110959857|NCT02291094|Anesthetics, Local|anesthetics, local|mesh-ancestor
110959858|NCT02291094|Anesthetics|anesthetics|mesh-ancestor
110959859|NCT02291094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110649629|NCT00509769|Tubulin Modulators|tubulin modulators|mesh-ancestor
110959860|NCT02291094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110959861|NCT02291094|Sensory System Agents|sensory system agents|mesh-ancestor
110959862|NCT02291094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110959863|NCT02291094|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110959864|NCT02291094|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110959865|NCT02291094|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110959866|NCT02291094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110959867|NCT02291094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110959868|NCT02291094|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110959869|NCT02291094|Narcotics|narcotics|mesh-ancestor
110959870|NCT02291094|Analgesics|analgesics|mesh-ancestor
110959871|NCT03387098|Leucovorin|leucovorin|mesh-list
110959872|NCT03387098|Paclitaxel|paclitaxel|mesh-list
110959873|NCT03387098|Cyclophosphamide|cyclophosphamide|mesh-list
110959874|NCT03387098|Bevacizumab|bevacizumab|mesh-list
110959875|NCT03387098|Fluorouracil|fluorouracil|mesh-list
110959876|NCT03387098|Capecitabine|capecitabine|mesh-list
110959877|NCT03387098|Oxaliplatin|oxaliplatin|mesh-list
110959878|NCT03387098|Avelumab|avelumab|mesh-list
110959879|NCT03387098|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110959880|NCT03387098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110959881|NCT03387098|Tubulin Modulators|tubulin modulators|mesh-ancestor
110959882|NCT03387098|Antimitotic Agents|antimitotic agents|mesh-ancestor
110959883|NCT03387098|Mitosis Modulators|mitosis modulators|mesh-ancestor
110959884|NCT03387098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110959885|NCT03387098|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110959886|NCT03387098|Immunologic Factors|immunologic factors|mesh-ancestor
110959887|NCT03387098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110959888|NCT03387098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110959889|NCT03387098|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110959890|NCT03387098|Alkylating Agents|alkylating agents|mesh-ancestor
110959891|NCT03387098|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110959892|NCT03387098|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110959893|NCT03387098|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110959894|NCT03387098|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110959895|NCT03387098|Growth Substances|growth substances|mesh-ancestor
110959896|NCT03387098|Growth Inhibitors|growth inhibitors|mesh-ancestor
110959898|NCT03387098|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110959899|NCT03387098|Antidotes|antidotes|mesh-ancestor
110959900|NCT03387098|Protective Agents|protective agents|mesh-ancestor
110959901|NCT03387098|Vitamin B Complex|vitamin b complex|mesh-ancestor
110959902|NCT03387098|Vitamins|vitamins|mesh-ancestor
110959903|NCT03387098|Micronutrients|micronutrients|mesh-ancestor
110959904|NCT02577016|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110959905|NCT02577016|Ipragliflozin|ipragliflozin|mesh-list
110959906|NCT02577016|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110959907|NCT02577016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110959908|NCT02577016|Incretins|incretins|mesh-ancestor
110959909|NCT02577016|Hormones|hormones|mesh-ancestor
110959910|NCT02577016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110959911|NCT02577016|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110959912|NCT02577016|Protease Inhibitors|protease inhibitors|mesh-ancestor
110959913|NCT02577016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110959914|NCT02577016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110959915|NCT02577016|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110959916|NCT04465110|Grape Seed Extract|grape seed extract|mesh-list
110959917|NCT04465110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110959918|NCT04465110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110959919|NCT04465110|Antioxidants|antioxidants|mesh-ancestor
110959920|NCT04465110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110959921|NCT04465110|Protective Agents|protective agents|mesh-ancestor
110959922|NCT04465110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110959923|NCT03391700|Rocuronium|rocuronium|mesh-list
110959924|NCT03391700|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110959925|NCT03391700|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110959926|NCT03391700|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110959927|NCT03391700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110959928|NCT03391700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110959929|NCT02294838|Citric Acid|citric acid|mesh-list
110959930|NCT02294838|Sodium Citrate|sodium citrate|mesh-list
110959931|NCT02294838|Anticoagulants|anticoagulants|mesh-ancestor
110959932|NCT02294838|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110959933|NCT02294838|Chelating Agents|chelating agents|mesh-ancestor
110959934|NCT02294838|Sequestering Agents|sequestering agents|mesh-ancestor
110959935|NCT02294838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110959936|NCT03383822|Insulin|insulin|mesh-list
110959937|NCT03383822|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110959938|NCT03383822|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110959939|NCT03383822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110959940|NCT03514446|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110959941|NCT03514446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110959942|NCT03383744|Vitamin A|vitamin a|mesh-list
110959943|NCT03383744|Vitamins|vitamins|mesh-ancestor
110959944|NCT03383744|Micronutrients|micronutrients|mesh-ancestor
110959945|NCT03383744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110959946|NCT05662358|Denosumab|denosumab|mesh-list
110959947|NCT05662358|Alendronate|alendronate|mesh-list
110959948|NCT05662358|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110959949|NCT05662358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110959950|NCT02294994|Tirofiban|tirofiban|mesh-list
110959951|NCT02294994|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110959952|NCT02294994|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110959953|NCT02294994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110959954|NCT02294994|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110959955|NCT03386630|Sufentanil|sufentanil|mesh-list
110959956|NCT03386630|Morphine|morphine|mesh-list
111490527|NCT01729338|Immunologic Factors|immunologic factors|mesh-ancestor
110959957|NCT03386630|Dsuvia|dsuvia|mesh-list
111490528|NCT01729338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110959958|NCT03386630|Bupivacaine|bupivacaine|mesh-list
110959959|NCT03386630|Anesthetics, Local|anesthetics, local|mesh-ancestor
110959960|NCT03386630|Anesthetics|anesthetics|mesh-ancestor
111490529|NCT01729338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110698636|NCT01065129|Plerixafor|plerixafor|mesh-list
110959961|NCT03386630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110959963|NCT03386630|Sensory System Agents|sensory system agents|mesh-ancestor
110959964|NCT03386630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110959965|NCT03386630|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110959966|NCT03386630|Narcotics|narcotics|mesh-ancestor
110959967|NCT03386630|Analgesics|analgesics|mesh-ancestor
110959968|NCT03386630|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110959969|NCT03386630|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110959970|NCT03386630|Anesthetics, General|anesthetics, general|mesh-ancestor
110959971|NCT03132714|Amoxicillin|amoxicillin|mesh-list
110959972|NCT03132714|Metronidazole|metronidazole|mesh-list
110959973|NCT03132714|Clarithromycin|clarithromycin|mesh-list
110959974|NCT03132714|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110959975|NCT03132714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110959976|NCT03132714|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110959977|NCT03132714|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110959978|NCT03132714|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110959979|NCT03132714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110959980|NCT03132714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110959981|NCT03132714|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110959982|NCT03132714|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110959983|NCT03386318|Oxycodone|oxycodone|mesh-list
110959984|NCT03386318|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110959985|NCT03386318|Narcotics|narcotics|mesh-ancestor
110959986|NCT03386318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110959987|NCT03386318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110959988|NCT03386318|Analgesics|analgesics|mesh-ancestor
110959989|NCT03386318|Sensory System Agents|sensory system agents|mesh-ancestor
110959990|NCT03386318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110959991|NCT03339284|Dexamethasone|dexamethasone|mesh-list
110959992|NCT03339284|Dexamethasone acetate|dexamethasone acetate|mesh-list
110959993|NCT03339284|Ropivacaine|ropivacaine|mesh-list
110959994|NCT03339284|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
110959995|NCT03339284|BB 1101|bb 1101|mesh-list
110959996|NCT03339284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110959997|NCT03339284|Antiemetics|antiemetics|mesh-ancestor
110959998|NCT03339284|Autonomic Agents|autonomic agents|mesh-ancestor
110959999|NCT03339284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110960000|NCT03339284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110960001|NCT03339284|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110960002|NCT03339284|Glucocorticoids|glucocorticoids|mesh-ancestor
110960003|NCT03339284|Hormones|hormones|mesh-ancestor
110960004|NCT03339284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110960005|NCT03339284|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110960006|NCT03339284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110960007|NCT03339284|Anesthetics, Local|anesthetics, local|mesh-ancestor
110960008|NCT03339284|Anesthetics|anesthetics|mesh-ancestor
110960009|NCT03339284|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110960010|NCT03339284|Sensory System Agents|sensory system agents|mesh-ancestor
110960011|NCT03339284|Protease Inhibitors|protease inhibitors|mesh-ancestor
110960012|NCT03339284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110960013|NCT03339284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110960014|NCT02291562|Dronabinol|dronabinol|mesh-list
110960015|NCT02291562|Cannabidiol|cannabidiol|mesh-list
110960016|NCT02291562|Anticonvulsants|anticonvulsants|mesh-ancestor
110960017|NCT02291562|Hallucinogens|hallucinogens|mesh-ancestor
110960018|NCT02291562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110960019|NCT02291562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110960020|NCT02291562|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110960021|NCT02291562|Analgesics|analgesics|mesh-ancestor
110960022|NCT02291562|Sensory System Agents|sensory system agents|mesh-ancestor
110960023|NCT02291562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110960024|NCT02291562|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
110960025|NCT02291562|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110960026|NCT02291562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110960027|NCT02291562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110960028|NCT02291562|Hormones|hormones|mesh-ancestor
110960029|NCT02291562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110960030|NCT03316586|Nivolumab|nivolumab|mesh-list
110960031|NCT03316586|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110960032|NCT03316586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111490530|NCT01729338|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111490531|NCT01729338|Alkylating Agents|alkylating agents|mesh-ancestor
110425666|NCT01032291|Lenalidomide|lenalidomide|mesh-list
111490532|NCT01729338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111490533|NCT01729338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111490534|NCT01729338|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111490535|NCT01729338|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111490536|NCT01729338|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110960033|NCT03316586|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110960034|NCT03316586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110960035|NCT03383276|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
110960036|NCT03383276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110960037|NCT02295150|Nadroparin|nadroparin|mesh-list
110960038|NCT02295150|Anticoagulants|anticoagulants|mesh-ancestor
110960039|NCT02295150|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110960040|NCT02295150|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110960041|NCT02295150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110960042|NCT03390608|Trastuzumab|trastuzumab|mesh-list
110960043|NCT03390608|Estrogens|estrogens|mesh-list
110960044|NCT03390608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110960045|NCT03390608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110960046|NCT03390608|Hormones|hormones|mesh-ancestor
110960047|NCT03390608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110960048|NCT03390608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110960049|NCT03513822|Midazolam|midazolam|mesh-list
110960050|NCT03513822|Ketamine|ketamine|mesh-list
110960051|NCT03513822|Analgesics|analgesics|mesh-ancestor
110960052|NCT03513822|Sensory System Agents|sensory system agents|mesh-ancestor
110960053|NCT03513822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110960054|NCT03513822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110960055|NCT03513822|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110960056|NCT03513822|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110960057|NCT03513822|Anesthetics, General|anesthetics, general|mesh-ancestor
110960058|NCT03513822|Anesthetics|anesthetics|mesh-ancestor
110960059|NCT03513822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110960060|NCT03513822|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110960061|NCT03513822|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110960062|NCT03513822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110960063|NCT03513822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110960064|NCT03513822|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110960065|NCT03513822|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110960066|NCT03513822|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110960067|NCT03513822|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110960068|NCT03513822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110960069|NCT03513822|GABA Modulators|gaba modulators|mesh-ancestor
110960070|NCT03513822|GABA Agents|gaba agents|mesh-ancestor
110960071|NCT03383120|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110960072|NCT03383120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110960073|NCT03513432|Ethanol|ethanol|mesh-list
110960074|NCT03513432|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110960075|NCT03513432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110960076|NCT03513432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110960077|NCT03513432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110960078|NCT02299440|Ketamine|ketamine|mesh-list
110960079|NCT02299440|Analgesics|analgesics|mesh-ancestor
110960080|NCT02299440|Sensory System Agents|sensory system agents|mesh-ancestor
110960081|NCT02299440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110960082|NCT02299440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110960083|NCT02299440|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110960084|NCT02299440|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110960085|NCT02299440|Anesthetics, General|anesthetics, general|mesh-ancestor
110960086|NCT02299440|Anesthetics|anesthetics|mesh-ancestor
110960087|NCT02299440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110960088|NCT02299440|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110960089|NCT02299440|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110960090|NCT02299440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110960091|NCT02299440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110960092|NCT02145195|Vitamin D|vitamin d|mesh-list
110960093|NCT02145195|Cholecalciferol|cholecalciferol|mesh-list
110960094|NCT02145195|Vitamins|vitamins|mesh-ancestor
110960095|NCT02145195|Micronutrients|micronutrients|mesh-ancestor
111490537|NCT01729338|Growth Substances|growth substances|mesh-ancestor
111490538|NCT01729338|Growth Inhibitors|growth inhibitors|mesh-ancestor
111490539|NCT01729494|Mycophenolic Acid|mycophenolic acid|mesh-list
111490540|NCT01729494|Prednisone|prednisone|mesh-list
110960096|NCT02145195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110960097|NCT02145195|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110698642|NCT01065129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110960098|NCT02145195|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110960099|NCT03517020|Nebivolol|nebivolol|mesh-list
110649665|NCT01080079|Terbinafine|terbinafine|mesh-list
110960100|NCT03517020|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110960101|NCT03517020|Vasodilator Agents|vasodilator agents|mesh-ancestor
110960102|NCT03517020|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
110960103|NCT03517020|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110960104|NCT03517020|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110960105|NCT03517020|Adrenergic Agents|adrenergic agents|mesh-ancestor
110960106|NCT03517020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110960107|NCT03517020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110960108|NCT03517020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110960109|NCT02254629|Laxatives|laxatives|mesh-list
110960110|NCT02254629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110960111|NCT02145585|Anesthetics|anesthetics|mesh-list
110960112|NCT02145585|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110960113|NCT02145585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110960114|NCT02291796|Bezafibrate|bezafibrate|mesh-list
110960115|NCT02291796|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110960116|NCT02291796|Antimetabolites|antimetabolites|mesh-ancestor
110960117|NCT02291796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110960118|NCT02291796|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110960119|NCT03544827|Atropine|atropine|mesh-list
110960120|NCT03544827|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110960121|NCT03544827|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110960122|NCT03544827|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110960123|NCT03544827|Autonomic Agents|autonomic agents|mesh-ancestor
110960124|NCT03544827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110960125|NCT03544827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110960126|NCT03544827|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110960127|NCT03544827|Respiratory System Agents|respiratory system agents|mesh-ancestor
110960128|NCT03544827|Mydriatics|mydriatics|mesh-ancestor
110960129|NCT03544827|Parasympatholytics|parasympatholytics|mesh-ancestor
110960130|NCT03544827|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110960131|NCT03544827|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110960133|NCT03544827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110960134|NCT03544827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110960135|NCT00107991|Etanercept|etanercept|mesh-list
110960136|NCT00107991|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110960137|NCT00107991|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110960138|NCT00107991|Analgesics|analgesics|mesh-ancestor
110960139|NCT00107991|Sensory System Agents|sensory system agents|mesh-ancestor
110960140|NCT00107991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110960141|NCT00107991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110960142|NCT00107991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110960143|NCT00107991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110960144|NCT00107991|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110960145|NCT00107991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110960146|NCT00107991|Immunologic Factors|immunologic factors|mesh-ancestor
110960147|NCT03513276|Epinephrine|epinephrine|mesh-list
110960148|NCT03513276|Racepinephrine|racepinephrine|mesh-list
110960149|NCT03513276|Ropivacaine|ropivacaine|mesh-list
110960150|NCT03513276|Epinephryl borate|epinephryl borate|mesh-list
110960151|NCT03513276|Anesthetics, Local|anesthetics, local|mesh-ancestor
110960152|NCT03513276|Anesthetics|anesthetics|mesh-ancestor
110960153|NCT03513276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110960154|NCT03513276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110960155|NCT03513276|Sensory System Agents|sensory system agents|mesh-ancestor
110960156|NCT03513276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110960157|NCT03513276|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110960158|NCT03513276|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110960159|NCT03513276|Adrenergic Agents|adrenergic agents|mesh-ancestor
110960160|NCT03513276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110960161|NCT03513276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110960162|NCT03513276|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110960163|NCT03513276|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110960164|NCT03513276|Autonomic Agents|autonomic agents|mesh-ancestor
110960165|NCT03513276|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110960166|NCT03513276|Respiratory System Agents|respiratory system agents|mesh-ancestor
110960167|NCT03513276|Mydriatics|mydriatics|mesh-ancestor
110960168|NCT03513276|Sympathomimetics|sympathomimetics|mesh-ancestor
110960169|NCT03513276|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110960170|NCT02291874|Ipragliflozin|ipragliflozin|mesh-list
110960171|NCT02291874|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111490541|NCT01729494|Alemtuzumab|alemtuzumab|mesh-list
111490542|NCT01729494|Abatacept|abatacept|mesh-list
111490543|NCT01729494|Tacrolimus|tacrolimus|mesh-list
110960172|NCT02291874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110960173|NCT02291874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110960174|NCT02291874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110960176|NCT03516630|Trazodone|trazodone|mesh-list
110960177|NCT03516630|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110960178|NCT03516630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110960179|NCT03516630|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110960180|NCT03516630|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110960181|NCT03516630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110960182|NCT03516630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110960183|NCT03516630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110960184|NCT03516630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110960185|NCT03516630|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110960186|NCT03516630|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110960187|NCT03516630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110960188|NCT03516630|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110960189|NCT03516630|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110960190|NCT03516630|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110960191|NCT03516630|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110960192|NCT03516630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110960193|NCT03516630|Serotonin Agents|serotonin agents|mesh-ancestor
110960194|NCT03516630|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110960195|NCT03516630|Antidepressive Agents|antidepressive agents|mesh-ancestor
110960196|NCT02142075|Daptomycin|daptomycin|mesh-list
110960197|NCT02142075|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110960198|NCT02142075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110960199|NCT02145975|Fentanyl|fentanyl|mesh-list
110960200|NCT02145975|Morphine|morphine|mesh-list
110960201|NCT02145975|Analgesics, Opioid|analgesics, opioid|mesh-list
110960202|NCT02145975|Narcotics|narcotics|mesh-ancestor
110960203|NCT02145975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110672229|NCT00618995|Niacin|niacin|mesh-list
110960204|NCT02145975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110960205|NCT02145975|Analgesics|analgesics|mesh-ancestor
110960206|NCT02145975|Sensory System Agents|sensory system agents|mesh-ancestor
110960207|NCT02145975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110960208|NCT02145975|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110960209|NCT02145975|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110960210|NCT02145975|Anesthetics, General|anesthetics, general|mesh-ancestor
110960211|NCT02145975|Anesthetics|anesthetics|mesh-ancestor
110960212|NCT02295852|Calcium|calcium|mesh-list
110960213|NCT02295852|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110960214|NCT02295852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110960215|NCT02295930|Bevacizumab|bevacizumab|mesh-list
110960216|NCT02295930|Cetuximab|cetuximab|mesh-list
110960217|NCT02295930|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110960218|NCT02295930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110960219|NCT02295930|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110960220|NCT02295930|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110960221|NCT02295930|Growth Substances|growth substances|mesh-ancestor
110960222|NCT02295930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110960223|NCT02295930|Growth Inhibitors|growth inhibitors|mesh-ancestor
110960224|NCT02142309|Pioglitazone|pioglitazone|mesh-list
110960225|NCT02142309|Glimepiride|glimepiride|mesh-list
110960226|NCT02142309|Canagliflozin|canagliflozin|mesh-list
110960227|NCT02142309|Vildagliptin|vildagliptin|mesh-list
110960228|NCT02142309|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110960229|NCT02142309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110960230|NCT02142309|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110960231|NCT02142309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110960232|NCT02142309|Immunologic Factors|immunologic factors|mesh-ancestor
110960233|NCT02142309|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110960234|NCT02142309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110960235|NCT02142309|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110960236|NCT02142309|Protease Inhibitors|protease inhibitors|mesh-ancestor
110960237|NCT02142309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110960238|NCT02146209|Metronidazole|metronidazole|mesh-list
110960239|NCT02146209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110960240|NCT02146209|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111490544|NCT01729494|Thymoglobulin|thymoglobulin|mesh-list
111490545|NCT01729494|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110960241|NCT02146209|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111490546|NCT01729494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110960242|NCT02146209|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110960243|NCT02299908|Bupivacaine|bupivacaine|mesh-list
111490547|NCT01729494|Glucocorticoids|glucocorticoids|mesh-ancestor
111490548|NCT01729494|Hormones|hormones|mesh-ancestor
111490549|NCT01729494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110960244|NCT02299908|Anesthetics, Local|anesthetics, local|mesh-list
110960245|NCT02299908|Anesthetics|anesthetics|mesh-list
110960246|NCT02299908|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110960247|NCT02299908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110960248|NCT02299908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110960249|NCT02299908|Sensory System Agents|sensory system agents|mesh-ancestor
110960250|NCT02299908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110960251|NCT02142543|Zinc Oxide|zinc oxide|mesh-list
110960252|NCT02142543|Dermatologic Agents|dermatologic agents|mesh-ancestor
110960253|NCT02142543|Sunscreening Agents|sunscreening agents|mesh-ancestor
110960254|NCT02142543|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110960255|NCT02142543|Protective Agents|protective agents|mesh-ancestor
110960256|NCT02142543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110960257|NCT03390374|Nystatin|nystatin|mesh-list
110960258|NCT03390374|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110960259|NCT03390374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110960260|NCT03390374|Antifungal Agents|antifungal agents|mesh-ancestor
110960261|NCT03390374|Ionophores|ionophores|mesh-ancestor
110960262|NCT03390374|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110960263|NCT03390374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110960264|NCT03545373|Amoxicillin|amoxicillin|mesh-list
110960265|NCT03545373|Azithromycin|azithromycin|mesh-list
110960266|NCT03545373|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110960267|NCT03545373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110960268|NCT00492856|Methotrexate|methotrexate|mesh-list
110960269|NCT00492856|Mercaptopurine|mercaptopurine|mesh-list
110960270|NCT00492856|Tretinoin|tretinoin|mesh-list
110960271|NCT00492856|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110960272|NCT00492856|Abortifacient Agents|abortifacient agents|mesh-ancestor
110960273|NCT00492856|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110960274|NCT00492856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110960275|NCT00492856|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110960276|NCT00492856|Antimetabolites|antimetabolites|mesh-ancestor
110960277|NCT00492856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110960278|NCT00492856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110960279|NCT00492856|Dermatologic Agents|dermatologic agents|mesh-ancestor
110960280|NCT00492856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110960281|NCT00492856|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110960282|NCT00492856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110960283|NCT00492856|Immunologic Factors|immunologic factors|mesh-ancestor
110960284|NCT00492856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110960285|NCT00492856|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110960286|NCT00492856|Keratolytic Agents|keratolytic agents|mesh-ancestor
110960287|NCT02142777|Equol|equol|mesh-list
110960288|NCT02142777|Phytoestrogens|phytoestrogens|mesh-ancestor
110960289|NCT02142777|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
110960290|NCT02142777|Estrogens|estrogens|mesh-ancestor
110960291|NCT02142777|Hormones|hormones|mesh-ancestor
110960292|NCT02142777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110960293|NCT02142777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110960294|NCT02143167|4-Aminopyridine|4-aminopyridine|mesh-list
110960295|NCT02143167|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
110960296|NCT02143167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110960297|NCT02143167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110960298|NCT03544671|Vitamin D|vitamin d|mesh-list
110960299|NCT03544671|Vitamins|vitamins|mesh-ancestor
110960300|NCT03544671|Micronutrients|micronutrients|mesh-ancestor
110960301|NCT03544671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110960302|NCT03544671|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110960303|NCT03390062|Apatinib|apatinib|mesh-list
110960304|NCT03390062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110960305|NCT03390062|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110960306|NCT03390062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110960307|NCT03390062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110960308|NCT03382886|Bevacizumab|bevacizumab|mesh-list
110960309|NCT03382886|Nivolumab|nivolumab|mesh-list
111490550|NCT01729494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111490551|NCT01729494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111490552|NCT01729494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110960310|NCT03382886|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111490553|NCT01729494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110960311|NCT03382886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110960312|NCT03382886|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110960313|NCT03382886|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110960314|NCT03382886|Growth Substances|growth substances|mesh-ancestor
110960315|NCT03382886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110960316|NCT03382886|Growth Inhibitors|growth inhibitors|mesh-ancestor
110960317|NCT03382886|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110960318|NCT03382886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110960319|NCT03125486|Belimumab|belimumab|mesh-list
110960320|NCT03125486|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110960321|NCT03125486|Immunologic Factors|immunologic factors|mesh-ancestor
110960322|NCT03125486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110960323|NCT02147925|Metformin|metformin|mesh-list
110960324|NCT02147925|Insulin Glargine|insulin glargine|mesh-list
110960325|NCT02147925|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110960326|NCT02147925|Liraglutide|liraglutide|mesh-list
110960327|NCT02147925|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110960328|NCT02147925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110960329|NCT02147925|Incretins|incretins|mesh-ancestor
110960330|NCT02147925|Hormones|hormones|mesh-ancestor
110960331|NCT02147925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110960332|NCT02147925|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110960333|NCT02147925|Protease Inhibitors|protease inhibitors|mesh-ancestor
110960334|NCT02147925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110960335|NCT02147925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110960336|NCT03544047|Paclitaxel|paclitaxel|mesh-list
110960337|NCT03544047|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110960338|NCT03544047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110960339|NCT03544047|Tubulin Modulators|tubulin modulators|mesh-ancestor
110960340|NCT03544047|Antimitotic Agents|antimitotic agents|mesh-ancestor
110960341|NCT03544047|Mitosis Modulators|mitosis modulators|mesh-ancestor
110960342|NCT03544047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110960343|NCT03544125|Durvalumab|durvalumab|mesh-list
110960344|NCT03544125|Olaparib|olaparib|mesh-list
110960345|NCT03544125|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
110960346|NCT03544125|Immunoglobulins|immunoglobulins|mesh-list
110649723|NCT02540642|Vitamins|vitamins|mesh-ancestor
110960347|NCT03544125|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110960348|NCT03544125|Immunoglobulin G|immunoglobulin g|mesh-list
110960349|NCT03544125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110960350|NCT03544125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110960351|NCT03544125|Immunologic Factors|immunologic factors|mesh-ancestor
110960352|NCT03544125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110960353|NCT03544125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110960354|NCT03544125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110960355|NCT02146911|Bupropion|bupropion|mesh-list
110960356|NCT02146911|Varenicline|varenicline|mesh-list
110960357|NCT02146911|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110960358|NCT02146911|Antidepressive Agents|antidepressive agents|mesh-ancestor
110960359|NCT02146911|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110960360|NCT02146911|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110960361|NCT02146911|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110960362|NCT02146911|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110960363|NCT02146911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110960364|NCT02146911|Dopamine Agents|dopamine agents|mesh-ancestor
110960365|NCT02146911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110960366|NCT02146911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110960367|NCT02146911|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110960368|NCT02146911|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110960369|NCT02146911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110960370|NCT02146911|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110960371|NCT02146911|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110960372|NCT02146911|Cholinergic Agents|cholinergic agents|mesh-ancestor
110960373|NCT02776683|Bevacizumab|bevacizumab|mesh-list
110960374|NCT02776683|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110960375|NCT02776683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110960376|NCT02776683|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110960377|NCT02776683|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110960378|NCT02776683|Growth Substances|growth substances|mesh-ancestor
110960379|NCT02776683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110960380|NCT02776683|Growth Inhibitors|growth inhibitors|mesh-ancestor
110960381|NCT02963714|Vaccines|vaccines|mesh-list
110960382|NCT02963714|Immunologic Factors|immunologic factors|mesh-ancestor
111490554|NCT01729494|Immunologic Factors|immunologic factors|mesh-ancestor
111490555|NCT01729494|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110960383|NCT02963714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110960384|NCT02148393|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
110960385|NCT02148393|Estradiol|estradiol|mesh-list
110960386|NCT02148393|Progesterone|progesterone|mesh-list
110960387|NCT02148393|Estrogens|estrogens|mesh-ancestor
110960388|NCT02148393|Hormones|hormones|mesh-ancestor
110960389|NCT02148393|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110960390|NCT02148393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110960391|NCT02148393|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110960392|NCT02148393|Progestins|progestins|mesh-ancestor
110960393|NCT00104871|Bortezomib|bortezomib|mesh-list
110960394|NCT00104871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110960395|NCT03385538|Clopidogrel|clopidogrel|mesh-list
110960396|NCT03385538|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110960397|NCT03385538|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110960398|NCT03385538|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110960399|NCT03385538|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110960400|NCT03385538|Purinergic Agents|purinergic agents|mesh-ancestor
110960401|NCT03385538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110960402|NCT03385538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110960403|NCT03385538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110960404|NCT02147379|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
110960405|NCT02147379|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110960406|NCT02147379|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110960407|NCT02147379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110960408|NCT02147379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110960409|NCT02147379|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110960410|NCT02147379|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
110960411|NCT02147379|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110960412|NCT02147379|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110960413|NCT02147379|Adrenergic Agents|adrenergic agents|mesh-ancestor
110960414|NCT02147379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110960415|NCT02147379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110960416|NCT02147379|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110960417|NCT02147379|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110960418|NCT02147379|Serotonin Agents|serotonin agents|mesh-ancestor
110960419|NCT02147379|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110960420|NCT02147379|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110960421|NCT02147379|Dopamine Agents|dopamine agents|mesh-ancestor
110960422|NCT02148549|Oxaliplatin|oxaliplatin|mesh-list
110960423|NCT02148549|Irinotecan|irinotecan|mesh-list
110960424|NCT02148549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110960425|NCT02148549|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110960426|NCT02148549|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110960427|NCT02148549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110960428|NCT02148549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110960429|NCT03375398|PAZ320|paz320|mesh-list
110960430|NCT03375398|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110960431|NCT03375398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110960432|NCT02147535|Methylphenidate|methylphenidate|mesh-list
110960433|NCT02147535|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110960434|NCT02147535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110960435|NCT02147535|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110960436|NCT02147535|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110960437|NCT02147535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110960438|NCT02147535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110960439|NCT02147535|Dopamine Agents|dopamine agents|mesh-ancestor
110960440|NCT02147535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110960441|NCT03446612|Nitroprusside|nitroprusside|mesh-list
110960442|NCT03446612|Acetylcholine|acetylcholine|mesh-list
110960443|NCT03446612|Darbepoetin alfa|darbepoetin alfa|mesh-list
110960444|NCT03446612|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
110960445|NCT03446612|Hematinics|hematinics|mesh-ancestor
110960446|NCT03446612|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110960447|NCT03446612|Vasodilator Agents|vasodilator agents|mesh-ancestor
110960448|NCT03446612|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
110960449|NCT03446612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110960450|NCT03446612|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110960451|NCT03446612|Cholinergic Agents|cholinergic agents|mesh-ancestor
110960452|NCT03446612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110649755|NCT00725777|Lumefantrine|lumefantrine|mesh-list
110960453|NCT03446612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110960454|NCT03446612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111490556|NCT01729494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110960455|NCT02148783|Methylphenidate|methylphenidate|mesh-list
110960456|NCT02148783|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110960457|NCT02148783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111490557|NCT01729494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110960458|NCT02148783|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110960459|NCT02148783|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110960460|NCT02148783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110960461|NCT02148783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110960462|NCT02148783|Dopamine Agents|dopamine agents|mesh-ancestor
110960463|NCT02148783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110960464|NCT02155803|Hormones|hormones|mesh-list
110960465|NCT02155803|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
110960466|NCT02155803|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
110960467|NCT02155803|beta-Endorphin|beta-endorphin|mesh-list
110960468|NCT02155803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110960469|NCT02155803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110960470|NCT02155803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110960471|NCT02155803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110960472|NCT02148861|Insulin|insulin|mesh-list
110960473|NCT02148861|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110960474|NCT02148861|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110960475|NCT02148861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110960476|NCT02152059|Nintedanib|nintedanib|mesh-list
110960477|NCT02152059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110960478|NCT02152059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110960479|NCT02152059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110960480|NCT02152059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110960481|NCT02149095|Treprostinil|treprostinil|mesh-list
110960482|NCT02149095|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110960483|NCT02149329|Meropenem|meropenem|mesh-list
110960484|NCT02149329|Imipenem|imipenem|mesh-list
110960485|NCT02149329|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
110960486|NCT02149329|Cilastatin|cilastatin|mesh-list
110960487|NCT02149329|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110960488|NCT02149329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110960489|NCT02149329|Protease Inhibitors|protease inhibitors|mesh-ancestor
110960490|NCT02149329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110960491|NCT02149329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110960492|NCT03255512|Isosorbide|isosorbide|mesh-list
110960493|NCT03255512|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
110960494|NCT03255512|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
110960495|NCT03255512|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110960496|NCT03255512|Diuretics|diuretics|mesh-ancestor
110960497|NCT03255512|Natriuretic Agents|natriuretic agents|mesh-ancestor
110960498|NCT03255512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110960499|NCT03255512|Vasodilator Agents|vasodilator agents|mesh-ancestor
110960500|NCT03255512|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
110960501|NCT03255512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110960502|NCT02149407|Glycerol|glycerol|mesh-list
110960503|NCT02149407|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
110672539|NCT00858455|Dolutegravir|dolutegravir|mesh-list
110960504|NCT02149407|Protective Agents|protective agents|mesh-ancestor
110960505|NCT02149407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110960506|NCT03543657|Darbepoetin alfa|darbepoetin alfa|mesh-list
110960507|NCT03543657|Hematinics|hematinics|mesh-ancestor
110960508|NCT04925193|Dexamethasone|dexamethasone|mesh-list
110960509|NCT04925193|Daratumumab|daratumumab|mesh-list
110960510|NCT04925193|Pomalidomide|pomalidomide|mesh-list
110960511|NCT04925193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110960512|NCT04925193|Antiemetics|antiemetics|mesh-ancestor
110960513|NCT04925193|Autonomic Agents|autonomic agents|mesh-ancestor
110960514|NCT04925193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110960515|NCT04925193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110960516|NCT04925193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110960517|NCT04925193|Glucocorticoids|glucocorticoids|mesh-ancestor
110960518|NCT04925193|Hormones|hormones|mesh-ancestor
110960519|NCT04925193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110960520|NCT04925193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110960521|NCT04925193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110960522|NCT04925193|Immunologic Factors|immunologic factors|mesh-ancestor
110960523|NCT04925193|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110960524|NCT04925193|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110960525|NCT04925193|Growth Substances|growth substances|mesh-ancestor
110960526|NCT04925193|Growth Inhibitors|growth inhibitors|mesh-ancestor
110960527|NCT03542955|Etoricoxib|etoricoxib|mesh-list
110960528|NCT03542955|Analgesics|analgesics|mesh-list
111490558|NCT01729494|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111490559|NCT01729494|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110960529|NCT03542955|Sensory System Agents|sensory system agents|mesh-ancestor
111490560|NCT01729494|Antitubercular Agents|antitubercular agents|mesh-ancestor
110960530|NCT03542955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110960531|NCT03542955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110960532|NCT03542955|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110960533|NCT03542955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110960534|NCT03542955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110960535|NCT03542955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110960536|NCT03542955|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110960537|NCT03542955|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110960538|NCT03542955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110960539|NCT03542955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110960540|NCT03542331|Ethiodized Oil|ethiodized oil|mesh-list
110960541|NCT03542331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110960542|NCT04988074|Cemiplimab|cemiplimab|mesh-list
110960543|NCT04988074|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110960544|NCT04988074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110960545|NCT00104637|Sildenafil Citrate|sildenafil citrate|mesh-list
110960546|NCT00104637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110960547|NCT00104637|Vasodilator Agents|vasodilator agents|mesh-ancestor
110960548|NCT00104637|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110960549|NCT00104637|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110960550|NCT00104637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110960551|NCT00104637|Urological Agents|urological agents|mesh-ancestor
110960552|NCT04810208|Docetaxel|docetaxel|mesh-list
110960553|NCT04810208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110960554|NCT04810208|Tubulin Modulators|tubulin modulators|mesh-ancestor
110960555|NCT04810208|Antimitotic Agents|antimitotic agents|mesh-ancestor
110960556|NCT04810208|Mitosis Modulators|mitosis modulators|mesh-ancestor
110960557|NCT04810208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110960558|NCT04445636|Dexmedetomidine|dexmedetomidine|mesh-list
110960559|NCT04445636|Morphine|morphine|mesh-list
110960560|NCT04445636|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110960561|NCT04445636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110960562|NCT04445636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110960563|NCT04445636|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110960564|NCT04445636|Analgesics|analgesics|mesh-ancestor
110960565|NCT04445636|Sensory System Agents|sensory system agents|mesh-ancestor
110960566|NCT04445636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110960567|NCT04445636|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110960568|NCT04445636|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110960569|NCT04445636|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110960570|NCT04445636|Adrenergic Agents|adrenergic agents|mesh-ancestor
110960571|NCT04445636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110960572|NCT04445636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110960573|NCT04445636|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110960574|NCT04445636|Narcotics|narcotics|mesh-ancestor
110960575|NCT02152917|Tranexamic Acid|tranexamic acid|mesh-list
110960576|NCT02152917|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110960577|NCT02152917|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110960578|NCT02152917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110960580|NCT02152917|Coagulants|coagulants|mesh-ancestor
110960581|NCT03111212|Iloprost|iloprost|mesh-list
110960582|NCT03111212|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110649773|NCT00460798|Sunitinib|sunitinib|mesh-list
110960583|NCT03111212|Vasodilator Agents|vasodilator agents|mesh-ancestor
110960584|NCT03170206|Palbociclib|palbociclib|mesh-list
110960585|NCT03170206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110960586|NCT03170206|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110960587|NCT03170206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110960588|NCT03170206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110960589|NCT05424016|Propranolol|propranolol|mesh-list
110960590|NCT05424016|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110960591|NCT05424016|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110960592|NCT05424016|Adrenergic Agents|adrenergic agents|mesh-ancestor
110960593|NCT05424016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110960594|NCT05424016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110960595|NCT05424016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110960596|NCT05424016|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110960597|NCT05424016|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110960598|NCT05424016|Vasodilator Agents|vasodilator agents|mesh-ancestor
110960599|NCT02149953|Glycine|glycine|mesh-list
111490561|NCT01729494|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111490562|NCT01729494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111490563|NCT01729494|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110698672|NCT00283803|Hormones|hormones|mesh-list
111490564|NCT01729494|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111490565|NCT01729494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111490566|NCT05317260|Antiviral Agents|antiviral agents|mesh-list
111490567|NCT05317260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110960600|NCT02149953|Glycine Agents|glycine agents|mesh-ancestor
110960601|NCT02149953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110960602|NCT02149953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110960603|NCT02149953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110960604|NCT03380936|Tacrolimus|tacrolimus|mesh-list
110960605|NCT03380936|Immunoglobulins|immunoglobulins|mesh-list
110960606|NCT03380936|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110960607|NCT03380936|Antibodies|antibodies|mesh-list
110960608|NCT03380936|gamma-Globulins|gamma-globulins|mesh-list
110960609|NCT03380936|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110960610|NCT03380936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110960611|NCT03380936|Immunologic Factors|immunologic factors|mesh-ancestor
110960612|NCT03380936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110960613|NCT03380936|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110960614|NCT03380936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110960615|NCT03380936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110960616|NCT02150031|Chlorhexidine|chlorhexidine|mesh-list
110960617|NCT02150031|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110960618|NCT02150031|Lidocaine|lidocaine|mesh-list
110960619|NCT02150031|Epinephrine|epinephrine|mesh-list
110960620|NCT02150031|Racepinephrine|racepinephrine|mesh-list
110960621|NCT02150031|Epinephryl borate|epinephryl borate|mesh-list
110960622|NCT02150031|Anesthetics, Local|anesthetics, local|mesh-ancestor
110960623|NCT02150031|Anesthetics|anesthetics|mesh-ancestor
110960624|NCT02150031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110960625|NCT02150031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110960626|NCT02150031|Sensory System Agents|sensory system agents|mesh-ancestor
110960627|NCT02150031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110960628|NCT02150031|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110960629|NCT02150031|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110960630|NCT02150031|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110960631|NCT02150031|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110960632|NCT02150031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110960633|NCT02150031|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110960634|NCT02150031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110960635|NCT02150031|Disinfectants|disinfectants|mesh-ancestor
110960636|NCT02150031|Dermatologic Agents|dermatologic agents|mesh-ancestor
110649781|NCT00460798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110960637|NCT02150031|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110960638|NCT02150031|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110960639|NCT02150031|Adrenergic Agents|adrenergic agents|mesh-ancestor
110960640|NCT02150031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110960641|NCT02150031|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110960642|NCT02150031|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110960643|NCT02150031|Autonomic Agents|autonomic agents|mesh-ancestor
110960644|NCT02150031|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110960645|NCT02150031|Respiratory System Agents|respiratory system agents|mesh-ancestor
110960646|NCT02150031|Mydriatics|mydriatics|mesh-ancestor
110960647|NCT02150031|Sympathomimetics|sympathomimetics|mesh-ancestor
110960648|NCT02150031|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110960649|NCT04655170|Albuterol|albuterol|mesh-list
110960650|NCT04655170|Formoterol Fumarate|formoterol fumarate|mesh-list
110960651|NCT04655170|Ipratropium|ipratropium|mesh-list
110960652|NCT04655170|Cholinergic Antagonists|cholinergic antagonists|mesh-list
110960653|NCT04655170|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110672692|NCT00524316|Sunitinib|sunitinib|mesh-list
110960654|NCT04655170|Autonomic Agents|autonomic agents|mesh-ancestor
110960655|NCT04655170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110960656|NCT04655170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110960657|NCT04655170|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110960658|NCT04655170|Respiratory System Agents|respiratory system agents|mesh-ancestor
110960659|NCT04655170|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110960660|NCT04655170|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110960661|NCT04655170|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110960662|NCT04655170|Adrenergic Agents|adrenergic agents|mesh-ancestor
110960663|NCT04655170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110960664|NCT04655170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110960665|NCT04655170|Tocolytic Agents|tocolytic agents|mesh-ancestor
110960666|NCT04655170|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110960667|NCT04655170|Cholinergic Agents|cholinergic agents|mesh-ancestor
111490568|NCT05316480|Nimotuzumab|nimotuzumab|mesh-list
110960668|NCT02156661|Oxytocin|oxytocin|mesh-list
110960669|NCT02156661|Oxytocics|oxytocics|mesh-ancestor
111490569|NCT05316480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111490570|NCT05316480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110960670|NCT02156661|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110960671|NCT02156661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110960672|NCT03065062|Palbociclib|palbociclib|mesh-list
110960673|NCT03065062|Gedatolisib|gedatolisib|mesh-list
110960674|NCT03065062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110960675|NCT03065062|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110960676|NCT03065062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110960677|NCT03065062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110960678|NCT03374774|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
110960679|NCT03374774|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110960680|NCT03374774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110960681|NCT04827862|Pembrolizumab|pembrolizumab|mesh-list
110960682|NCT04827862|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110960683|NCT04827862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110960684|NCT04827862|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110960685|NCT04827862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110960686|NCT03374540|Vitamin K|vitamin k|mesh-list
110960687|NCT03374540|Rivaroxaban|rivaroxaban|mesh-list
110960688|NCT03374540|Vitamins|vitamins|mesh-ancestor
110960689|NCT03374540|Micronutrients|micronutrients|mesh-ancestor
110960690|NCT03374540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110960691|NCT03374540|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110960692|NCT03374540|Antithrombins|antithrombins|mesh-ancestor
110960693|NCT03374540|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110960694|NCT03374540|Protease Inhibitors|protease inhibitors|mesh-ancestor
110960695|NCT03374540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110960696|NCT03374540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110960697|NCT03374540|Anticoagulants|anticoagulants|mesh-ancestor
110960698|NCT03374540|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110960699|NCT03374540|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110960700|NCT03374540|Hemostatics|hemostatics|mesh-ancestor
110960701|NCT03374540|Coagulants|coagulants|mesh-ancestor
110960702|NCT02780115|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110960703|NCT02780115|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110960704|NCT03378674|Remifentanil|remifentanil|mesh-list
110960705|NCT03378674|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110960706|NCT03378674|Narcotics|narcotics|mesh-ancestor
110960707|NCT03378674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110960708|NCT03378674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110960709|NCT03378674|Analgesics|analgesics|mesh-ancestor
110960710|NCT03378674|Sensory System Agents|sensory system agents|mesh-ancestor
110960711|NCT03378674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110960712|NCT02157207|Vitamins|vitamins|mesh-list
110960713|NCT02157207|Vitamin E|vitamin e|mesh-list
110960714|NCT02157207|Antioxidants|antioxidants|mesh-list
110960715|NCT02157207|Micronutrients|micronutrients|mesh-ancestor
110960716|NCT02157207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110960717|NCT02157207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110960718|NCT02157207|Protective Agents|protective agents|mesh-ancestor
110960719|NCT02261103|Pramipexole|pramipexole|mesh-list
110960720|NCT02261103|Antioxidants|antioxidants|mesh-ancestor
110960721|NCT02261103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110960722|NCT02261103|Protective Agents|protective agents|mesh-ancestor
110960723|NCT02261103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110960724|NCT02261103|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110960725|NCT02261103|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110960726|NCT02261103|Dopamine Agonists|dopamine agonists|mesh-ancestor
110960727|NCT02261103|Dopamine Agents|dopamine agents|mesh-ancestor
110960728|NCT02261103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110960729|NCT02766777|Lubiprostone|lubiprostone|mesh-list
110960730|NCT02766777|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
110960731|NCT02766777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110960732|NCT02766777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110960733|NCT03374306|Atropine|atropine|mesh-list
110960734|NCT03374306|Lubricant Eye Drops|lubricant eye drops|mesh-list
110960735|NCT03374306|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110960736|NCT03374306|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110960737|NCT03374306|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110960738|NCT03374306|Autonomic Agents|autonomic agents|mesh-ancestor
110960739|NCT03374306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110960740|NCT03374306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110960741|NCT03374306|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111490571|NCT05316246|Tislelizumab|tislelizumab|mesh-list
110960742|NCT03374306|Respiratory System Agents|respiratory system agents|mesh-ancestor
110960743|NCT03374306|Mydriatics|mydriatics|mesh-ancestor
110960744|NCT03374306|Parasympatholytics|parasympatholytics|mesh-ancestor
110960745|NCT03374306|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110960746|NCT03374306|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110960747|NCT03374306|Cholinergic Agents|cholinergic agents|mesh-ancestor
110960748|NCT03374306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110960749|NCT03374306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110960750|NCT03374306|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110960751|NCT03374306|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110960752|NCT05534230|Dexmedetomidine|dexmedetomidine|mesh-list
110960753|NCT05534230|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110960754|NCT05534230|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110960755|NCT05534230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110960756|NCT05534230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110960757|NCT05534230|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110960758|NCT05534230|Analgesics|analgesics|mesh-ancestor
110960759|NCT05534230|Sensory System Agents|sensory system agents|mesh-ancestor
110960760|NCT05534230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110960761|NCT05534230|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110960762|NCT05534230|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110960763|NCT05534230|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110960764|NCT05534230|Adrenergic Agents|adrenergic agents|mesh-ancestor
110960765|NCT05534230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110960766|NCT05534230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110960768|NCT03369782|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110960769|NCT03369782|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110960770|NCT03369782|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110960771|NCT03369782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110649813|NCT00726011|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110960772|NCT03369782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110960773|NCT00157014|Cyclosporine|cyclosporine|mesh-list
110960774|NCT00157014|Mycophenolic Acid|mycophenolic acid|mesh-list
110960775|NCT00157014|Prednisone|prednisone|mesh-list
110960776|NCT00157014|Methylprednisolone|methylprednisolone|mesh-list
110960777|NCT00157014|Tacrolimus|tacrolimus|mesh-list
110960778|NCT00157014|Cyclosporins|cyclosporins|mesh-list
110960779|NCT00157014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110960780|NCT00157014|Glucocorticoids|glucocorticoids|mesh-ancestor
110960781|NCT00157014|Hormones|hormones|mesh-ancestor
110960782|NCT00157014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110960783|NCT00157014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110960784|NCT00157014|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110960785|NCT00157014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110960786|NCT00157014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110960787|NCT00157014|Immunologic Factors|immunologic factors|mesh-ancestor
110960788|NCT00157014|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110960789|NCT00157014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110960790|NCT00157014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110960791|NCT00157014|Antifungal Agents|antifungal agents|mesh-ancestor
110960792|NCT00157014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110960793|NCT00157014|Dermatologic Agents|dermatologic agents|mesh-ancestor
110960794|NCT00157014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110960795|NCT00157014|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110960796|NCT00157014|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110960797|NCT00157014|Antitubercular Agents|antitubercular agents|mesh-ancestor
110960798|NCT00157014|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110960799|NCT00157014|Antiemetics|antiemetics|mesh-ancestor
110960800|NCT00157014|Autonomic Agents|autonomic agents|mesh-ancestor
110960801|NCT00157014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110960802|NCT00157014|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110960803|NCT00157014|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110960804|NCT00157014|Protective Agents|protective agents|mesh-ancestor
110960805|NCT03374228|Linrodostat|linrodostat|mesh-list
110960807|NCT03374228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110960808|NCT02778867|Fluticasone|fluticasone|mesh-list
110960809|NCT02778867|Xhance|xhance|mesh-list
110960810|NCT02778867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110960811|NCT02778867|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110960812|NCT02778867|Autonomic Agents|autonomic agents|mesh-ancestor
110960813|NCT02778867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110960814|NCT02778867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110960815|NCT02778867|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110960816|NCT02778867|Respiratory System Agents|respiratory system agents|mesh-ancestor
110960817|NCT02778867|Dermatologic Agents|dermatologic agents|mesh-ancestor
110960818|NCT02778867|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111490572|NCT05316246|Brentuximab Vedotin|brentuximab vedotin|mesh-list
111490573|NCT05316246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111490574|NCT05316246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110960819|NCT04232072|Ibuprofen|ibuprofen|mesh-list
110960820|NCT04232072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110960821|NCT04232072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110960822|NCT04232072|Analgesics|analgesics|mesh-ancestor
110960823|NCT04232072|Sensory System Agents|sensory system agents|mesh-ancestor
110960824|NCT04232072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110960825|NCT04232072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110960826|NCT04232072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110960827|NCT04232072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110960828|NCT04232072|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110960829|NCT04232072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110960830|NCT04232072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110960831|NCT02300064|Antioxidants|antioxidants|mesh-list
110960832|NCT02300064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110960833|NCT02300064|Protective Agents|protective agents|mesh-ancestor
110960834|NCT02300064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110960835|NCT02688712|Fluorouracil|fluorouracil|mesh-list
110960836|NCT02688712|Capecitabine|capecitabine|mesh-list
110960837|NCT02688712|Antimetabolites|antimetabolites|mesh-ancestor
110960838|NCT02688712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110960839|NCT02688712|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110960840|NCT02688712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110960841|NCT02688712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110960842|NCT02688712|Immunologic Factors|immunologic factors|mesh-ancestor
110960843|NCT02688712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110960844|NCT03373994|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110960845|NCT03373994|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110960846|NCT03373994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110960847|NCT02617550|Nitroglycerin|nitroglycerin|mesh-list
110960848|NCT02617550|Vasodilator Agents|vasodilator agents|mesh-ancestor
110960849|NCT03512808|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
110960850|NCT03512808|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
110960851|NCT03512808|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110960852|NCT02519582|Niclosamide|niclosamide|mesh-list
110960853|NCT02519582|Anticestodal Agents|anticestodal agents|mesh-ancestor
110960854|NCT02519582|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110960855|NCT02519582|Anthelmintics|anthelmintics|mesh-ancestor
110960856|NCT02519582|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110960857|NCT02519582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110960858|NCT02519582|Antinematodal Agents|antinematodal agents|mesh-ancestor
110960859|NCT02467582|Aspirin|aspirin|mesh-list
110960860|NCT02467582|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110960861|NCT02467582|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110960862|NCT02467582|Analgesics|analgesics|mesh-ancestor
110960863|NCT02467582|Sensory System Agents|sensory system agents|mesh-ancestor
110960864|NCT02467582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110960865|NCT02467582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110960866|NCT02467582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110960867|NCT02467582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110960868|NCT02467582|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110960869|NCT02467582|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110960870|NCT02467582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110960871|NCT02467582|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110960872|NCT02467582|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110960873|NCT02467582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110960874|NCT02467582|Antipyretics|antipyretics|mesh-ancestor
110960875|NCT05467462|Tranexamic Acid|tranexamic acid|mesh-list
110960876|NCT05467462|Oxytocin|oxytocin|mesh-list
110960877|NCT05467462|Carbetocin|carbetocin|mesh-list
110960878|NCT05467462|Oxytocics|oxytocics|mesh-ancestor
110960879|NCT05467462|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110960880|NCT05467462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110960882|NCT05467462|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110960883|NCT05467462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110960884|NCT05467462|Hemostatics|hemostatics|mesh-ancestor
110960885|NCT05467462|Coagulants|coagulants|mesh-ancestor
110960886|NCT03369002|Seladelpar|seladelpar|mesh-list
110960887|NCT03369002|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110960888|NCT03369002|Antimetabolites|antimetabolites|mesh-ancestor
111490575|NCT05316246|Immunotoxins|immunotoxins|mesh-ancestor
111490576|NCT05316246|Immunoconjugates|immunoconjugates|mesh-ancestor
110960889|NCT03369002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111490577|NCT05316246|Immunologic Factors|immunologic factors|mesh-ancestor
110960890|NCT03369002|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110960891|NCT05533606|Lactams|lactams|mesh-list
110960892|NCT05533606|beta-Lactams|beta-lactams|mesh-list
110960893|NCT05533606|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110960894|NCT05533606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110960895|NCT02300376|Edetic Acid|edetic acid|mesh-list
110960896|NCT02300376|Calcium|calcium|mesh-list
110960897|NCT02300376|Pentetic Acid|pentetic acid|mesh-list
110960898|NCT02300376|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110960899|NCT02300376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110960900|NCT02300376|Anticoagulants|anticoagulants|mesh-ancestor
110960901|NCT02300376|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110960902|NCT02300376|Chelating Agents|chelating agents|mesh-ancestor
110960903|NCT02300376|Sequestering Agents|sequestering agents|mesh-ancestor
110960904|NCT02300376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110960905|NCT02300376|Antidotes|antidotes|mesh-ancestor
110960906|NCT02300376|Protective Agents|protective agents|mesh-ancestor
110960907|NCT02300376|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110960908|NCT02296398|Romidepsin|romidepsin|mesh-list
110960909|NCT02296398|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110960910|NCT02296398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110960911|NCT02296398|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110960912|NCT02296398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110960913|NCT02296398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110960914|NCT03520062|Liraglutide|liraglutide|mesh-list
110960915|NCT03520062|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110960916|NCT03520062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110960917|NCT03520062|Incretins|incretins|mesh-ancestor
110960918|NCT03520062|Hormones|hormones|mesh-ancestor
110960919|NCT03520062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110960920|NCT02206984|Tamoxifen|tamoxifen|mesh-list
110960921|NCT02206984|Fulvestrant|fulvestrant|mesh-list
110960922|NCT02206984|Anastrozole|anastrozole|mesh-list
110960923|NCT02206984|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110960924|NCT02206984|Hormone Antagonists|hormone antagonists|mesh-ancestor
110960925|NCT02206984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110960926|NCT02206984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110960927|NCT02206984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110960928|NCT02206984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110960929|NCT02206984|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110960930|NCT02206984|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110960931|NCT02206984|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110960932|NCT02206984|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110960933|NCT02206984|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110960934|NCT02206984|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110960935|NCT02206984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110960936|NCT02206984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110960937|NCT03512574|Pregabalin|pregabalin|mesh-list
110960938|NCT03512574|Dexmedetomidine|dexmedetomidine|mesh-list
110960939|NCT03512574|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110960940|NCT03512574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110960941|NCT03512574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110960942|NCT03512574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110960943|NCT03512574|Analgesics|analgesics|mesh-ancestor
110960944|NCT03512574|Sensory System Agents|sensory system agents|mesh-ancestor
110960945|NCT03512574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110960946|NCT03512574|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110960947|NCT03512574|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110960948|NCT03512574|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110960949|NCT03512574|Adrenergic Agents|adrenergic agents|mesh-ancestor
110960950|NCT03512574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110960951|NCT03512574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110960952|NCT03512574|Anticonvulsants|anticonvulsants|mesh-ancestor
110960953|NCT03512574|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110960954|NCT03512574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110960955|NCT03512574|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110960956|NCT03512574|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110960957|NCT03512574|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110960958|NCT03512574|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110960959|NCT01994980|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110960960|NCT01994980|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
111490578|NCT05316246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111490579|NCT05315388|Vitamins|vitamins|mesh-list
110960961|NCT01994980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111490580|NCT05315388|Micronutrients|micronutrients|mesh-ancestor
110698686|NCT00283803|Analgesics|analgesics|mesh-ancestor
110960962|NCT01994980|Antitubercular Agents|antitubercular agents|mesh-ancestor
111490581|NCT05315388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111490582|NCT04894188|Goserelin|goserelin|mesh-list
111490583|NCT04894188|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111490584|NCT04894188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110960963|NCT03377348|Triamcinolone|triamcinolone|mesh-list
110960964|NCT03377348|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110960965|NCT03377348|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110960966|NCT03377348|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110960967|NCT03377348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110960968|NCT03377348|Glucocorticoids|glucocorticoids|mesh-ancestor
110960970|NCT03377348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110960971|NCT03377348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110960972|NCT03377348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110960973|NCT03377348|Immunologic Factors|immunologic factors|mesh-ancestor
110960974|NCT03377348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110960975|NCT03377348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110960976|NCT02255253|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110960977|NCT02255253|Telmisartan|telmisartan|mesh-list
110960978|NCT02255253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110960979|NCT02255253|Diuretics|diuretics|mesh-ancestor
110960980|NCT02255253|Natriuretic Agents|natriuretic agents|mesh-ancestor
110960981|NCT02255253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110960982|NCT02255253|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110960983|NCT02255253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110960984|NCT02255253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110960985|NCT02255253|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110960986|NCT02255253|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110960987|NCT02300688|Maleic acid|maleic acid|mesh-list
110960988|NCT02300688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110960989|NCT02300688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110960990|NCT03896984|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
110960991|NCT03896984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110960992|NCT02151279|Chitosan|chitosan|mesh-list
110960993|NCT02151279|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110960994|NCT02151279|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110960995|NCT02151279|Antimetabolites|antimetabolites|mesh-ancestor
110960996|NCT02151279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110960997|NCT02151279|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110960998|NCT02151279|Chelating Agents|chelating agents|mesh-ancestor
110960999|NCT02151279|Sequestering Agents|sequestering agents|mesh-ancestor
110961000|NCT02151279|Hemostatics|hemostatics|mesh-ancestor
110961001|NCT02151279|Coagulants|coagulants|mesh-ancestor
110961002|NCT02159313|Riociguat|riociguat|mesh-list
110961003|NCT02159313|Enzyme Activators|enzyme activators|mesh-ancestor
110961004|NCT02159313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110961005|NCT03515772|Darunavir|darunavir|mesh-list
110961006|NCT03515772|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110961007|NCT03515772|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110961008|NCT03515772|Protease Inhibitors|protease inhibitors|mesh-ancestor
110961009|NCT03515772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110961010|NCT03515772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110961011|NCT03515772|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110961012|NCT03515772|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110961013|NCT03515772|Antiviral Agents|antiviral agents|mesh-ancestor
110961014|NCT03515772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110961015|NCT03519750|Melatonin|melatonin|mesh-list
110961016|NCT03519750|Antioxidants|antioxidants|mesh-ancestor
110961017|NCT03519750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110961018|NCT03519750|Protective Agents|protective agents|mesh-ancestor
110961019|NCT03519750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110961020|NCT03519750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111490585|NCT04724772|Tranexamic Acid|tranexamic acid|mesh-list
111490586|NCT04724772|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111490587|NCT04724772|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111490588|NCT04724772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111490589|NCT04724772|Hemostatics|hemostatics|mesh-ancestor
111490590|NCT04724772|Coagulants|coagulants|mesh-ancestor
111490591|NCT04007874|Vitamin E|vitamin e|mesh-list
111490592|NCT04007874|Levonorgestrel|levonorgestrel|mesh-list
111490593|NCT04007874|Ethinyl Estradiol|ethinyl estradiol|mesh-list
111490594|NCT04007874|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
111490595|NCT04007874|Vitamins|vitamins|mesh-ancestor
111490596|NCT04007874|Micronutrients|micronutrients|mesh-ancestor
111490597|NCT04007874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110649838|NCT00727103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111490599|NCT04007874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111490600|NCT04007874|Protective Agents|protective agents|mesh-ancestor
110961021|NCT02158143|Vitamin D|vitamin d|mesh-list
110961022|NCT02158143|Cholecalciferol|cholecalciferol|mesh-list
110961023|NCT02158143|Vitamins|vitamins|mesh-ancestor
110961024|NCT02158143|Micronutrients|micronutrients|mesh-ancestor
110961025|NCT02158143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110961026|NCT02158143|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110961027|NCT02158143|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110961028|NCT02158221|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
110961029|NCT02158221|Growth Substances|growth substances|mesh-ancestor
110961030|NCT02158221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110961031|NCT02158221|Vasodilator Agents|vasodilator agents|mesh-ancestor
110961032|NCT02158221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110961033|NCT02158221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110961035|NCT02519816|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110961036|NCT02519816|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110961037|NCT02301000|Metronidazole|metronidazole|mesh-list
110961038|NCT02301000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110961039|NCT02301000|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110961040|NCT02301000|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110961041|NCT02301000|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110961042|NCT02292732|Trametinib|trametinib|mesh-list
110961043|NCT02292732|Norinyl|norinyl|mesh-list
110961044|NCT02292732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110961045|NCT02292732|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110961046|NCT02292732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110961047|NCT02292732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110961048|NCT02292732|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110961049|NCT02292732|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110961050|NCT02292732|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110961051|NCT02292732|Contraceptive Agents|contraceptive agents|mesh-ancestor
110961052|NCT02292732|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110961053|NCT02292732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110961054|NCT02292732|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110961055|NCT02292732|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110961056|NCT03376958|Apatinib|apatinib|mesh-list
110961057|NCT03376958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110961058|NCT03376958|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110961059|NCT03376958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110961060|NCT03376958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110961061|NCT03367676|Docetaxel|docetaxel|mesh-list
110961062|NCT03367676|Trastuzumab|trastuzumab|mesh-list
110961063|NCT03367676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110961064|NCT03367676|Tubulin Modulators|tubulin modulators|mesh-ancestor
110961065|NCT03367676|Antimitotic Agents|antimitotic agents|mesh-ancestor
110961066|NCT03367676|Mitosis Modulators|mitosis modulators|mesh-ancestor
110961067|NCT03367676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110961068|NCT03367676|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110961069|NCT03515538|Cisplatin|cisplatin|mesh-list
110961070|NCT03515538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110961071|NCT02158689|Letrozole|letrozole|mesh-list
110961072|NCT02158689|Menotropins|menotropins|mesh-list
110961073|NCT02158689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110961074|NCT02158689|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110961075|NCT02158689|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110961076|NCT02158689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110961077|NCT02158689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110961078|NCT02158689|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110961079|NCT02158689|Hormone Antagonists|hormone antagonists|mesh-ancestor
110961080|NCT02158689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110961081|NCT02158689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110961082|NCT02158689|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110961083|NCT02158689|Fertility Agents|fertility agents|mesh-ancestor
110961084|NCT02158689|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110961085|NCT03372200|Febuxostat|febuxostat|mesh-list
110961086|NCT03372200|Dotinurad|dotinurad|mesh-list
110961087|NCT03372200|Gout Suppressants|gout suppressants|mesh-ancestor
110961088|NCT03372200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110961089|NCT03372200|Uricosuric Agents|uricosuric agents|mesh-ancestor
110961090|NCT03372122|Chlorhexidine|chlorhexidine|mesh-list
110961091|NCT03372122|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110961092|NCT03372122|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110698704|NCT01033370|Clevidipine|clevidipine|mesh-list
110961093|NCT03372122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110961094|NCT03372122|Disinfectants|disinfectants|mesh-ancestor
110961095|NCT03372122|Dermatologic Agents|dermatologic agents|mesh-ancestor
110961096|NCT02158845|Leuprolide|leuprolide|mesh-list
110961097|NCT02158845|Levonorgestrel|levonorgestrel|mesh-list
110961098|NCT02158845|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110961099|NCT02158845|Fertility Agents|fertility agents|mesh-ancestor
110961100|NCT02158845|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110961101|NCT02158845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110673136|NCT00871247|Finasteride|finasteride|mesh-list
110961102|NCT02158845|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110961103|NCT02158845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110961104|NCT02158845|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110961105|NCT02158845|Contraceptive Agents|contraceptive agents|mesh-ancestor
110961106|NCT02158845|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110961107|NCT02158845|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110961108|NCT02158845|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110961110|NCT02292966|Protease Inhibitors|protease inhibitors|mesh-ancestor
110961111|NCT02292966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110961112|NCT02292966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110961113|NCT02519660|Lidocaine|lidocaine|mesh-list
110961114|NCT02519660|Tetracaine|tetracaine|mesh-list
110961115|NCT02519660|Prilocaine|prilocaine|mesh-list
110961116|NCT02519660|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
110961117|NCT02519660|Anesthetics, Local|anesthetics, local|mesh-ancestor
110961118|NCT02519660|Anesthetics|anesthetics|mesh-ancestor
110961119|NCT02519660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110961120|NCT02519660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110961121|NCT02519660|Sensory System Agents|sensory system agents|mesh-ancestor
110961122|NCT02519660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110961123|NCT02519660|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110961124|NCT02519660|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110961125|NCT02519660|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110961126|NCT02519660|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110961127|NCT02519660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110961128|NCT02519660|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
110961129|NCT02297490|Immunomodulating Agents|immunomodulating agents|mesh-list
110961130|NCT02297490|Immunologic Factors|immunologic factors|mesh-ancestor
110961131|NCT02297490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110961132|NCT02297568|Vitamin D|vitamin d|mesh-list
110961133|NCT02297568|Ergocalciferols|ergocalciferols|mesh-list
110961134|NCT02297568|Vitamins|vitamins|mesh-ancestor
110961135|NCT02297568|Micronutrients|micronutrients|mesh-ancestor
110961136|NCT02297568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110961137|NCT02297568|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110961138|NCT02297568|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110961139|NCT03515382|Itraconazole|itraconazole|mesh-list
110961140|NCT03515382|Voriconazole|voriconazole|mesh-list
110961141|NCT03515382|Antifungal Agents|antifungal agents|mesh-ancestor
110961142|NCT03515382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110961143|NCT03515382|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110961144|NCT03515382|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110961145|NCT03515382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110961146|NCT03515382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110961147|NCT03515382|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110961148|NCT03515382|Hormone Antagonists|hormone antagonists|mesh-ancestor
110961149|NCT03515382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110961150|NCT03515382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110961151|NCT03515382|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110961152|NCT03511560|Tacrolimus|tacrolimus|mesh-list
110961153|NCT03511560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110961154|NCT03511560|Immunologic Factors|immunologic factors|mesh-ancestor
110961155|NCT03511560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110961156|NCT03511560|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110961157|NCT03511560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110961158|NCT03511560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110961159|NCT03688802|Varenicline|varenicline|mesh-list
110961160|NCT03688802|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110961161|NCT03688802|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110961162|NCT03688802|Cholinergic Agents|cholinergic agents|mesh-ancestor
111490601|NCT04007874|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111490602|NCT04007874|Contraceptive Agents|contraceptive agents|mesh-ancestor
111490603|NCT04007874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111490604|NCT04007874|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111490605|NCT04007874|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110961163|NCT03688802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110961164|NCT03688802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110961165|NCT03688802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110961167|NCT02293356|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110961168|NCT02293356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110961169|NCT03616418|Antihypertensive Agents|antihypertensive agents|mesh-list
110961170|NCT03616418|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
110961171|NCT03371498|Methylprednisolone|methylprednisolone|mesh-list
110961172|NCT03371498|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110961173|NCT03371498|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110961174|NCT03371498|Prednisolone|prednisolone|mesh-list
110961175|NCT03371498|Prednisolone acetate|prednisolone acetate|mesh-list
110961176|NCT03371498|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110961177|NCT03371498|Prednisolone phosphate|prednisolone phosphate|mesh-list
110961178|NCT03371498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110961179|NCT03371498|Antiemetics|antiemetics|mesh-ancestor
110961180|NCT03371498|Autonomic Agents|autonomic agents|mesh-ancestor
110961181|NCT03371498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110961182|NCT03371498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110961183|NCT03371498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110961184|NCT03371498|Glucocorticoids|glucocorticoids|mesh-ancestor
110961185|NCT03371498|Hormones|hormones|mesh-ancestor
110961186|NCT03371498|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110961187|NCT03371498|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110961188|NCT03371498|Protective Agents|protective agents|mesh-ancestor
110961189|NCT03371498|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110961190|NCT03371498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110961191|NCT03376178|Lidocaine|lidocaine|mesh-list
110961192|NCT03376178|Ropivacaine|ropivacaine|mesh-list
110961193|NCT03376178|Anesthetics, Local|anesthetics, local|mesh-ancestor
110961194|NCT03376178|Anesthetics|anesthetics|mesh-ancestor
110961195|NCT03376178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110961196|NCT03376178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110961197|NCT03376178|Sensory System Agents|sensory system agents|mesh-ancestor
110649877|NCT00903188|Antiemetics|antiemetics|mesh-ancestor
110961198|NCT03376178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110961199|NCT03376178|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110961200|NCT03376178|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110961201|NCT03376178|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110961202|NCT03376178|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110961203|NCT03376178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110961204|NCT03514836|Cyclophosphamide|cyclophosphamide|mesh-list
110961205|NCT03514836|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110961206|NCT03514836|Immunologic Factors|immunologic factors|mesh-ancestor
110961207|NCT03514836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110961208|NCT03514836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110961209|NCT03514836|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110961210|NCT03514836|Alkylating Agents|alkylating agents|mesh-ancestor
110961211|NCT03514836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110961212|NCT03514836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110961213|NCT03514836|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110961214|NCT03371342|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110961215|NCT03371342|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110961216|NCT03371342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110961217|NCT03371342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110961218|NCT03371342|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110961219|NCT03371342|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110961220|NCT03371342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110961221|NCT03371342|Cholinergic Agents|cholinergic agents|mesh-ancestor
110961222|NCT03371342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110961223|NCT02302326|Folic Acid|folic acid|mesh-list
110961224|NCT02302326|Inositol|inositol|mesh-list
110961225|NCT02302326|Metformin|metformin|mesh-list
110961226|NCT02302326|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110961227|NCT02302326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110961228|NCT02302326|Hematinics|hematinics|mesh-ancestor
110961229|NCT02302326|Vitamin B Complex|vitamin b complex|mesh-ancestor
110961230|NCT02302326|Vitamins|vitamins|mesh-ancestor
110961231|NCT02302326|Micronutrients|micronutrients|mesh-ancestor
110961232|NCT02293590|Sulfasalazine|sulfasalazine|mesh-list
110961233|NCT02293590|Certolizumab Pegol|certolizumab pegol|mesh-list
110961234|NCT02293590|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110961235|NCT02293590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111490606|NCT04007874|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110961236|NCT02293590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110961237|NCT02293590|Immunologic Factors|immunologic factors|mesh-ancestor
110961238|NCT02293590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110961239|NCT02293590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110961240|NCT02293590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110961241|NCT02293590|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110961242|NCT02293590|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110961243|NCT02293590|Analgesics|analgesics|mesh-ancestor
110961244|NCT02293590|Sensory System Agents|sensory system agents|mesh-ancestor
110961245|NCT02293590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110961246|NCT02293590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110961247|NCT02302404|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110961248|NCT03124082|Lidocaine|lidocaine|mesh-list
110961249|NCT03124082|Clonidine|clonidine|mesh-list
110961250|NCT03124082|Ketamine|ketamine|mesh-list
110961251|NCT03124082|Remifentanil|remifentanil|mesh-list
110961252|NCT03124082|Anesthetics, Local|anesthetics, local|mesh-ancestor
110961253|NCT03124082|Anesthetics|anesthetics|mesh-ancestor
110961254|NCT03124082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110961255|NCT03124082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110961256|NCT03124082|Sensory System Agents|sensory system agents|mesh-ancestor
110961257|NCT03124082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110961258|NCT03124082|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110961259|NCT03124082|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110961260|NCT03124082|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110961261|NCT03124082|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110961262|NCT03124082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110961263|NCT03124082|Analgesics|analgesics|mesh-ancestor
110961264|NCT03124082|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110961265|NCT03124082|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110961266|NCT03124082|Anesthetics, General|anesthetics, general|mesh-ancestor
110961267|NCT03124082|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110961268|NCT03124082|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110961269|NCT03124082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110961270|NCT03124082|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110961271|NCT03124082|Narcotics|narcotics|mesh-ancestor
110961272|NCT03124082|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110961273|NCT03124082|Sympatholytics|sympatholytics|mesh-ancestor
110961274|NCT03124082|Autonomic Agents|autonomic agents|mesh-ancestor
110961275|NCT03124082|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110961276|NCT03124082|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110961277|NCT03124082|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110961278|NCT03124082|Adrenergic Agents|adrenergic agents|mesh-ancestor
110961279|NCT03518502|Sorafenib|sorafenib|mesh-list
110961280|NCT03518502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110961281|NCT03518502|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110961282|NCT03518502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110961283|NCT03518502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110961284|NCT02301780|Aspirin|aspirin|mesh-list
110961285|NCT02301780|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110961286|NCT02301780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110961287|NCT02301780|Analgesics|analgesics|mesh-ancestor
110961288|NCT02301780|Sensory System Agents|sensory system agents|mesh-ancestor
110961289|NCT02301780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110961290|NCT02301780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110961291|NCT02301780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110961292|NCT02301780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110961293|NCT02301780|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110961294|NCT02301780|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110961295|NCT02301780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110961296|NCT02301780|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110961297|NCT02301780|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110961298|NCT02301780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110961299|NCT02301780|Antipyretics|antipyretics|mesh-ancestor
110961300|NCT04527068|Bevacizumab|bevacizumab|mesh-list
110961301|NCT04527068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110961302|NCT04527068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110961303|NCT04527068|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110961304|NCT04527068|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110961305|NCT04527068|Growth Substances|growth substances|mesh-ancestor
110961306|NCT04527068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111490607|NCT04007874|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110961307|NCT04527068|Growth Inhibitors|growth inhibitors|mesh-ancestor
110961308|NCT02739360|Idelalisib|idelalisib|mesh-list
110961309|NCT02739360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111490608|NCT04007874|Estrogens|estrogens|mesh-ancestor
111490609|NCT04007874|Hormones|hormones|mesh-ancestor
110961310|NCT02739360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110961311|NCT02739360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110961312|NCT03123770|Cyclophosphamide|cyclophosphamide|mesh-list
110961313|NCT03123770|Docetaxel|docetaxel|mesh-list
110961314|NCT03123770|Doxorubicin|doxorubicin|mesh-list
110961315|NCT03123770|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110961316|NCT03123770|Epirubicin|epirubicin|mesh-list
110961317|NCT03123770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110961318|NCT03123770|Immunologic Factors|immunologic factors|mesh-ancestor
110961319|NCT03123770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110961320|NCT03123770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110961321|NCT03123770|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110961322|NCT03123770|Alkylating Agents|alkylating agents|mesh-ancestor
110961323|NCT03123770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110961324|NCT03123770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110961325|NCT03123770|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110961326|NCT03123770|Tubulin Modulators|tubulin modulators|mesh-ancestor
110961327|NCT03123770|Antimitotic Agents|antimitotic agents|mesh-ancestor
110961328|NCT03123770|Mitosis Modulators|mitosis modulators|mesh-ancestor
110961329|NCT03123770|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110961330|NCT03123770|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110961331|NCT03123770|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110961332|NCT03123770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110961333|NCT04464642|Methotrexate|methotrexate|mesh-list
110961334|NCT04464642|Tofacitinib|tofacitinib|mesh-list
110961335|NCT04464642|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110961336|NCT04464642|Abortifacient Agents|abortifacient agents|mesh-ancestor
110961337|NCT04464642|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110961338|NCT04464642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110961339|NCT04464642|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110961340|NCT04464642|Antimetabolites|antimetabolites|mesh-ancestor
110961341|NCT04464642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110961342|NCT04464642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110961343|NCT04464642|Dermatologic Agents|dermatologic agents|mesh-ancestor
110961344|NCT04464642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110961345|NCT04464642|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110961346|NCT04464642|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110961347|NCT04464642|Immunologic Factors|immunologic factors|mesh-ancestor
110961348|NCT04464642|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110961349|NCT04464642|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110961350|NCT04464642|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
110961351|NCT04464642|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110961352|NCT02293668|Letrozole|letrozole|mesh-list
110961353|NCT02293668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110961354|NCT02293668|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110961355|NCT02293668|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110961356|NCT02293668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110961357|NCT02293668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110961358|NCT02293668|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110961359|NCT02293668|Hormone Antagonists|hormone antagonists|mesh-ancestor
110961360|NCT02293668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110961361|NCT02293668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110961362|NCT03123692|N,N'-Bis(2-mercaptoethyl)isophthalamide|n,n'-bis(2-mercaptoethyl)isophthalamide|mesh-list
110961363|NCT03123692|Chelating Agents|chelating agents|mesh-ancestor
110961364|NCT03123692|Sequestering Agents|sequestering agents|mesh-ancestor
110961365|NCT03123692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110961366|NCT03375632|Dotinurad|dotinurad|mesh-list
110961367|NCT03375632|Uricosuric Agents|uricosuric agents|mesh-ancestor
110961368|NCT03375632|Gout Suppressants|gout suppressants|mesh-ancestor
110961369|NCT03375632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110961370|NCT02302170|Vaccines|vaccines|mesh-list
110961371|NCT02302170|Immunologic Factors|immunologic factors|mesh-ancestor
110961372|NCT02302170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110961373|NCT03371186|Contraceptive Agents|contraceptive agents|mesh-list
110961374|NCT03371186|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110961375|NCT03371186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110961376|NCT02302950|Raltegravir Potassium|raltegravir potassium|mesh-list
110961377|NCT02302950|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110961378|NCT02302950|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111490610|NCT04007874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110961379|NCT02302950|Antiviral Agents|antiviral agents|mesh-ancestor
110698715|NCT03742466|Methylprednisolone|methylprednisolone|mesh-list
110961380|NCT02302950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110961381|NCT02302950|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110961382|NCT02302950|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110961383|NCT02302950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110961384|NCT02302950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110961385|NCT02293824|Caffeine|caffeine|mesh-list
110961386|NCT02293824|Caffeine citrate|caffeine citrate|mesh-list
110961387|NCT02293824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110961388|NCT02293824|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110961389|NCT02293824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110961390|NCT02293824|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110961391|NCT02293824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110961392|NCT02293824|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110961393|NCT02293824|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110961394|NCT02293824|Purinergic Agents|purinergic agents|mesh-ancestor
110961395|NCT02293824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110961396|NCT03366584|Vitamin D|vitamin d|mesh-list
110961397|NCT03366584|Cholecalciferol|cholecalciferol|mesh-list
110961398|NCT03366584|Beta Carotene|beta carotene|mesh-list
110961399|NCT03366584|Zinc|zinc|mesh-list
110961400|NCT03366584|Dexamethasone|dexamethasone|mesh-list
110961401|NCT03366584|Carotenoids|carotenoids|mesh-list
110961402|NCT03366584|Picolinic acid|picolinic acid|mesh-list
110961403|NCT03366584|Vitamins|vitamins|mesh-ancestor
110961404|NCT03366584|Micronutrients|micronutrients|mesh-ancestor
110961405|NCT03366584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110961406|NCT03366584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110961407|NCT03366584|Antiemetics|antiemetics|mesh-ancestor
110961408|NCT03366584|Autonomic Agents|autonomic agents|mesh-ancestor
110961409|NCT03366584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110961410|NCT03366584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110961411|NCT03366584|Glucocorticoids|glucocorticoids|mesh-ancestor
110961412|NCT03366584|Hormones|hormones|mesh-ancestor
110961413|NCT03366584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110961414|NCT03366584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110961415|NCT03366584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110961416|NCT03366584|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110961417|NCT03366584|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110961418|NCT03366584|Trace Elements|trace elements|mesh-ancestor
110961419|NCT03366584|Antioxidants|antioxidants|mesh-ancestor
110961420|NCT03366584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110961421|NCT03366584|Protective Agents|protective agents|mesh-ancestor
110961422|NCT03366584|Provitamins|provitamins|mesh-ancestor
110961423|NCT03366584|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110961424|NCT03366584|Chelating Agents|chelating agents|mesh-ancestor
110961425|NCT03366584|Sequestering Agents|sequestering agents|mesh-ancestor
110961426|NCT03370562|Dexmedetomidine|dexmedetomidine|mesh-list
110961427|NCT03370562|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110961428|NCT03370562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110961429|NCT03370562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110961430|NCT03370562|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110961431|NCT03370562|Analgesics|analgesics|mesh-ancestor
110961432|NCT03370562|Sensory System Agents|sensory system agents|mesh-ancestor
110961433|NCT03370562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110961434|NCT03370562|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110961435|NCT03370562|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110961436|NCT03370562|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110961437|NCT03370562|Adrenergic Agents|adrenergic agents|mesh-ancestor
110961438|NCT03370562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110961439|NCT03370562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110961440|NCT03370328|Peppermint oil|peppermint oil|mesh-list
110961441|NCT03370328|Antiemetics|antiemetics|mesh-ancestor
110961442|NCT03370328|Autonomic Agents|autonomic agents|mesh-ancestor
110961443|NCT03370328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110961444|NCT03370328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110961445|NCT03370328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110961446|NCT03370328|Parasympatholytics|parasympatholytics|mesh-ancestor
110961447|NCT02303106|Lamotrigine|lamotrigine|mesh-list
110961448|NCT02303106|Anticonvulsants|anticonvulsants|mesh-ancestor
110961449|NCT02303106|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110961450|NCT02303106|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110961451|NCT02303106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110698716|NCT03742466|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111490611|NCT04007874|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
111490612|NCT03878472|Oxaliplatin|oxaliplatin|mesh-list
111490613|NCT03878472|Apatinib|apatinib|mesh-list
111490614|NCT03878472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111490615|NCT03878472|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111490616|NCT03878472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110961452|NCT02303106|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110961453|NCT02303106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110961454|NCT02303106|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110961455|NCT02303106|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110961456|NCT02303106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110961457|NCT02303106|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110961458|NCT02303106|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110961459|NCT04525664|Amoxicillin|amoxicillin|mesh-list
110961460|NCT04525664|Clarithromycin|clarithromycin|mesh-list
110961461|NCT04525664|Omeprazole|omeprazole|mesh-list
110961462|NCT04525664|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110961463|NCT04525664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110961464|NCT04525664|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110961465|NCT04525664|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110961466|NCT04525664|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110961467|NCT04525664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110961468|NCT04525664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110961469|NCT04525664|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110961470|NCT04525664|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110961471|NCT04525664|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110961472|NCT03510546|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
110961473|NCT03510546|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110961474|NCT03510546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110961475|NCT03510546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110673499|NCT00420303|Sensory System Agents|sensory system agents|mesh-ancestor
110961476|NCT03510546|Cholinergic Agents|cholinergic agents|mesh-ancestor
110961477|NCT03510546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110961478|NCT03510546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110961479|NCT03505008|Adalimumab|adalimumab|mesh-list
110961480|NCT03505008|Methotrexate|methotrexate|mesh-list
110961481|NCT03505008|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110961482|NCT03505008|Abortifacient Agents|abortifacient agents|mesh-ancestor
110961483|NCT03505008|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110961484|NCT03505008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110961485|NCT03505008|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110961486|NCT03505008|Antimetabolites|antimetabolites|mesh-ancestor
110961487|NCT03505008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110961488|NCT03505008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110961489|NCT03505008|Dermatologic Agents|dermatologic agents|mesh-ancestor
110961490|NCT03505008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110961491|NCT03505008|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110961492|NCT03505008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110961493|NCT03505008|Immunologic Factors|immunologic factors|mesh-ancestor
110961494|NCT03505008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110961495|NCT03505008|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110961496|NCT03505008|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110961497|NCT03505008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110961498|NCT03507426|Ketamine|ketamine|mesh-list
110961499|NCT03507426|Analgesics|analgesics|mesh-ancestor
110961500|NCT03507426|Sensory System Agents|sensory system agents|mesh-ancestor
110961501|NCT03507426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110961502|NCT03507426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110961503|NCT03507426|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110961504|NCT03507426|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110961505|NCT03507426|Anesthetics, General|anesthetics, general|mesh-ancestor
110961506|NCT03507426|Anesthetics|anesthetics|mesh-ancestor
110961507|NCT03507426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110961508|NCT03507426|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110961509|NCT03507426|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110961510|NCT03507426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110961511|NCT03507426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110961512|NCT02311530|Felodipine|felodipine|mesh-list
110961513|NCT02311530|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110961514|NCT02311530|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110961515|NCT02311530|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110961516|NCT02311530|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110961517|NCT02311530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110961518|NCT02311530|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110961519|NCT02311530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110961520|NCT02311530|Vasodilator Agents|vasodilator agents|mesh-ancestor
111490617|NCT03878472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110961521|NCT04522466|Hydroxychloroquine|hydroxychloroquine|mesh-list
111490618|NCT03162510|Paclitaxel|paclitaxel|mesh-list
110961522|NCT04522466|Antimalarials|antimalarials|mesh-ancestor
110961523|NCT04522466|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110961524|NCT04522466|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110961525|NCT04522466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110961526|NCT04522466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110961527|NCT04522466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110961528|NCT04522466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110961529|NCT02306772|Mesalamine|mesalamine|mesh-list
110961530|NCT02306772|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110961531|NCT02306772|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110961532|NCT02306772|Analgesics|analgesics|mesh-ancestor
110961533|NCT02306772|Sensory System Agents|sensory system agents|mesh-ancestor
110961534|NCT02306772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110961535|NCT02306772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110961536|NCT02306772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110961537|NCT02306772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110961538|NCT03507348|Rituximab|rituximab|mesh-list
110961539|NCT03507348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110961540|NCT03507348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110961541|NCT03507348|Immunologic Factors|immunologic factors|mesh-ancestor
110961542|NCT03507348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110961543|NCT03507348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110961544|NCT02518802|Pemetrexed|pemetrexed|mesh-list
110961545|NCT02518802|Gefitinib|gefitinib|mesh-list
110961546|NCT02518802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110961547|NCT02518802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110961548|NCT02518802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110673577|NCT01035021|Rocuronium|rocuronium|mesh-list
110961549|NCT02518802|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110961550|NCT02518802|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110961551|NCT02518802|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110961553|NCT04524026|Aromatase Inhibitors|aromatase inhibitors|mesh-list
110961554|NCT04524026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110961555|NCT04524026|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110961556|NCT04524026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110961557|NCT04524026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110961558|NCT04524026|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110961559|NCT04524026|Hormone Antagonists|hormone antagonists|mesh-ancestor
110961560|NCT04524026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110961561|NCT04524026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110961562|NCT02311608|Octreotide|octreotide|mesh-list
110961563|NCT02311608|Terlipressin|terlipressin|mesh-list
110961564|NCT02311608|Somatostatin|somatostatin|mesh-list
110961565|NCT02311608|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110961566|NCT02311608|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110961567|NCT02311608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110961568|NCT02311608|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110961569|NCT02311608|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110961570|NCT02311608|Hormones|hormones|mesh-ancestor
110961571|NCT02311608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110961572|NCT02311608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110961573|NCT02307006|Vancomycin|vancomycin|mesh-list
110961574|NCT02307006|Cefazolin|cefazolin|mesh-list
110961575|NCT02307006|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
110961576|NCT02307006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110961577|NCT02307006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110961578|NCT03362684|Cetuximab|cetuximab|mesh-list
110961579|NCT03362684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110961580|NCT03362684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110961581|NCT02311686|Ethanol|ethanol|mesh-list
110961582|NCT02311686|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110961583|NCT02311686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110961584|NCT02311686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110961585|NCT02311686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110961586|NCT02311764|Carboplatin|carboplatin|mesh-list
110961587|NCT02311764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110961588|NCT03365726|Dobutamine|dobutamine|mesh-list
110961589|NCT03365726|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110961590|NCT03365726|Sympathomimetics|sympathomimetics|mesh-ancestor
110961591|NCT03365726|Autonomic Agents|autonomic agents|mesh-ancestor
110961592|NCT03365726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110961593|NCT03365726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110961594|NCT03365726|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
111490619|NCT03162510|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110961595|NCT03365726|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110961596|NCT03365726|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110961597|NCT03365726|Adrenergic Agents|adrenergic agents|mesh-ancestor
110961598|NCT03365726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110961599|NCT03365726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110961600|NCT03365726|Protective Agents|protective agents|mesh-ancestor
110961602|NCT02303418|Carbetocin|carbetocin|mesh-list
110961603|NCT02303418|Oxytocics|oxytocics|mesh-ancestor
110961604|NCT02303418|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110961605|NCT02303418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110961606|NCT03510000|Empagliflozin|empagliflozin|mesh-list
110961607|NCT03510000|Pancrelipase|pancrelipase|mesh-list
110961608|NCT03510000|Hormones|hormones|mesh-list
110961609|NCT03510000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110961610|NCT03510000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110961611|NCT03510000|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110961612|NCT03510000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110961613|NCT03510000|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110961614|NCT03510000|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110961615|NCT03358082|Hydrocortisone|hydrocortisone|mesh-list
110961616|NCT03358082|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
110961617|NCT03358082|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
110961618|NCT03358082|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
110961619|NCT03358082|Tacrolimus|tacrolimus|mesh-list
110961620|NCT03358082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110961621|NCT03358082|Immunologic Factors|immunologic factors|mesh-ancestor
110961622|NCT03358082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110673658|NCT00875927|Zinc|zinc|mesh-list
110961623|NCT03358082|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110961624|NCT03358082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110961625|NCT03358082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110961626|NCT03358082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110961627|NCT03358004|Capecitabine|capecitabine|mesh-list
110961628|NCT03358004|Vinorelbine|vinorelbine|mesh-list
110961629|NCT03358004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110961630|NCT03358004|Antimetabolites|antimetabolites|mesh-ancestor
110961631|NCT03358004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110961632|NCT03358004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110961633|NCT03358004|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110961634|NCT03358004|Tubulin Modulators|tubulin modulators|mesh-ancestor
110961635|NCT03358004|Antimitotic Agents|antimitotic agents|mesh-ancestor
110961636|NCT03358004|Mitosis Modulators|mitosis modulators|mesh-ancestor
110961637|NCT03509922|Sarpogrelate|sarpogrelate|mesh-list
110961638|NCT03509922|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110961639|NCT03509922|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110961640|NCT03509922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110961641|NCT03509922|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110961642|NCT03509922|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110961643|NCT03509922|Serotonin Agents|serotonin agents|mesh-ancestor
110961644|NCT03509922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110961645|NCT03509922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110961646|NCT03365336|Oseltamivir|oseltamivir|mesh-list
110961647|NCT03365336|Antiviral Agents|antiviral agents|mesh-ancestor
110961648|NCT03365336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110961649|NCT03365336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110961650|NCT03365336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110961651|NCT03362216|Diclofenac|diclofenac|mesh-list
110961652|NCT03362216|Salicylates|salicylates|mesh-list
110961653|NCT03362216|Methyl salicylate|methyl salicylate|mesh-list
110961654|NCT03362216|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110961655|NCT03362216|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110961656|NCT03362216|Analgesics|analgesics|mesh-ancestor
110961657|NCT03362216|Sensory System Agents|sensory system agents|mesh-ancestor
110961658|NCT03362216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110961659|NCT03362216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110961660|NCT03362216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110961661|NCT03362216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110961662|NCT03362216|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110961663|NCT03362216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111490620|NCT03162510|Oxaliplatin|oxaliplatin|mesh-list
111490621|NCT03162510|Tegafur|tegafur|mesh-list
110961664|NCT03362216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110961665|NCT02312076|Triptorelin Pamoate|triptorelin pamoate|mesh-list
111490622|NCT03162510|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111490623|NCT03162510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111490624|NCT03162510|Tubulin Modulators|tubulin modulators|mesh-ancestor
110961666|NCT02312076|Luteolytic Agents|luteolytic agents|mesh-ancestor
110961667|NCT02312076|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110961668|NCT02312076|Contraceptive Agents|contraceptive agents|mesh-ancestor
110961669|NCT02312076|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110961670|NCT02312076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110961671|NCT02312076|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110961672|NCT02312076|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110961673|NCT02312076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110961674|NCT02307396|Haloperidol|haloperidol|mesh-list
110961675|NCT02307396|Pimozide|pimozide|mesh-list
110961676|NCT02307396|Olanzapine|olanzapine|mesh-list
110961677|NCT02307396|Risperidone|risperidone|mesh-list
110961678|NCT02307396|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110961679|NCT02307396|Paliperidone Palmitate|paliperidone palmitate|mesh-list
110961680|NCT02307396|Ziprasidone|ziprasidone|mesh-list
110961681|NCT02307396|Amisulpride|amisulpride|mesh-list
110961682|NCT02307396|Perphenazine|perphenazine|mesh-list
110961683|NCT02307396|Sertindole|sertindole|mesh-list
110961684|NCT02307396|Sulpiride|sulpiride|mesh-list
110961685|NCT02307396|Fluphenazine|fluphenazine|mesh-list
110961686|NCT02307396|Fluphenazine depot|fluphenazine depot|mesh-list
110961687|NCT02307396|Fluphenazine enanthate|fluphenazine enanthate|mesh-list
110961688|NCT02307396|Thioridazine|thioridazine|mesh-list
110961689|NCT02307396|Clopenthixol|clopenthixol|mesh-list
110961690|NCT02307396|Fluspirilene|fluspirilene|mesh-list
110961691|NCT02307396|Benperidol|benperidol|mesh-list
110961692|NCT02307396|Bromperidol|bromperidol|mesh-list
110961693|NCT02307396|Perazine|perazine|mesh-list
110961694|NCT02307396|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110961695|NCT02307396|Serotonin Agents|serotonin agents|mesh-ancestor
110961696|NCT02307396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110961697|NCT02307396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110961698|NCT02307396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110961699|NCT02307396|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110961700|NCT02307396|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110961701|NCT02307396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110961702|NCT02307396|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110961703|NCT02307396|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110961704|NCT02307396|Dopamine Agents|dopamine agents|mesh-ancestor
110961706|NCT02307396|Autonomic Agents|autonomic agents|mesh-ancestor
110961707|NCT02307396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110961708|NCT02307396|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110961709|NCT02307396|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110961710|NCT02307396|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110961711|NCT02307396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110961712|NCT02307396|Antidepressive Agents|antidepressive agents|mesh-ancestor
110961713|NCT02307396|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110961714|NCT02307396|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110961715|NCT02307396|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110961716|NCT02307396|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110961717|NCT03509688|Entecavir|entecavir|mesh-list
110961718|NCT03509688|Resveratrol|resveratrol|mesh-list
110961719|NCT03509688|Antiviral Agents|antiviral agents|mesh-ancestor
110961720|NCT03509688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110961721|NCT03509688|Antioxidants|antioxidants|mesh-ancestor
110961722|NCT03509688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110961723|NCT03509688|Protective Agents|protective agents|mesh-ancestor
110961724|NCT03509688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110961725|NCT03509688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110961726|NCT03509688|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110961727|NCT02303730|Insulin Glargine|insulin glargine|mesh-list
110961728|NCT02303730|Exenatide|exenatide|mesh-list
110961729|NCT02303730|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110961730|NCT02303730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110961731|NCT02303730|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110961732|NCT02303730|Incretins|incretins|mesh-ancestor
110961733|NCT02303730|Hormones|hormones|mesh-ancestor
110961734|NCT02303730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111490625|NCT03162510|Antimitotic Agents|antimitotic agents|mesh-ancestor
110961735|NCT04524728|Letrozole|letrozole|mesh-list
110961736|NCT04524728|Fulvestrant|fulvestrant|mesh-list
110961737|NCT04524728|Palbociclib|palbociclib|mesh-list
110961738|NCT04524728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110961739|NCT04524728|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110961740|NCT04524728|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110961741|NCT04524728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110961742|NCT04524728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111490626|NCT03162510|Mitosis Modulators|mitosis modulators|mesh-ancestor
111490627|NCT03162510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110961743|NCT04524728|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110961744|NCT04524728|Hormone Antagonists|hormone antagonists|mesh-ancestor
110961745|NCT04524728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110961746|NCT04524728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110961747|NCT04524728|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110961748|NCT04524728|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110961749|NCT04524728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110961750|NCT04523792|Buprenorphine|buprenorphine|mesh-list
110961751|NCT04523792|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110961752|NCT04523792|Narcotics|narcotics|mesh-ancestor
110961753|NCT04523792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110961754|NCT04523792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110961755|NCT04523792|Analgesics|analgesics|mesh-ancestor
110961756|NCT04523792|Sensory System Agents|sensory system agents|mesh-ancestor
110961757|NCT04523792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110961758|NCT04523792|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110961759|NCT02312232|Levodopa|levodopa|mesh-list
110961760|NCT02312232|Carbidopa|carbidopa|mesh-list
110961761|NCT02312232|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110961762|NCT02312232|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110961763|NCT02312232|Dopamine Agents|dopamine agents|mesh-ancestor
110961764|NCT02312232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110961765|NCT02312232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110961766|NCT02312232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110961767|NCT02312232|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
110961768|NCT02312232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110961769|NCT02303886|Methylene Blue|methylene blue|mesh-list
110961770|NCT02303886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110961771|NCT02303886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110961772|NCT02518958|Nivolumab|nivolumab|mesh-list
110961773|NCT02518958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110961774|NCT02518958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110961775|NCT02518958|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110961776|NCT02518958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110961778|NCT03506802|Plerixafor|plerixafor|mesh-list
110961779|NCT03506802|Lenalidomide|lenalidomide|mesh-list
110961780|NCT03506802|Melphalan|melphalan|mesh-list
110961781|NCT03506802|Interleukin-2|interleukin-2|mesh-list
110961782|NCT03506802|Mechlorethamine|mechlorethamine|mesh-list
110961783|NCT03506802|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
110961784|NCT03506802|Lenograstim|lenograstim|mesh-list
110961785|NCT03506802|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110961786|NCT03506802|Immunologic Factors|immunologic factors|mesh-ancestor
110961787|NCT03506802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110961788|NCT03506802|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110961789|NCT03506802|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110961790|NCT03506802|Growth Substances|growth substances|mesh-ancestor
110961791|NCT03506802|Growth Inhibitors|growth inhibitors|mesh-ancestor
110961792|NCT03506802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110961793|NCT03506802|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110961794|NCT03506802|Alkylating Agents|alkylating agents|mesh-ancestor
110961795|NCT03506802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110961796|NCT03506802|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110961797|NCT03506802|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110961798|NCT03506802|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110961799|NCT03506802|Analgesics|analgesics|mesh-ancestor
110961800|NCT03506802|Sensory System Agents|sensory system agents|mesh-ancestor
110961801|NCT03506802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110961802|NCT03506802|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110961803|NCT03506802|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110961804|NCT03506802|Antiviral Agents|antiviral agents|mesh-ancestor
110961805|NCT03506802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110961806|NCT02307864|Moxifloxacin|moxifloxacin|mesh-list
110961807|NCT02307864|Tramadol|tramadol|mesh-list
110961808|NCT02307864|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
110961809|NCT02307864|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110961810|NCT02307864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110961811|NCT02307864|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110961812|NCT02307864|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110961813|NCT02307864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110961814|NCT02307864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111490628|NCT03162510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110961815|NCT02307864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110961816|NCT02307864|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110961817|NCT02307864|Contraceptive Agents|contraceptive agents|mesh-ancestor
110961818|NCT02307864|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110961819|NCT02307864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110961820|NCT02307864|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110961821|NCT02307864|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110961822|NCT02307864|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110961823|NCT02307864|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110961824|NCT02307864|Narcotics|narcotics|mesh-ancestor
110961825|NCT02307864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110961826|NCT02307864|Analgesics|analgesics|mesh-ancestor
110961827|NCT02307864|Sensory System Agents|sensory system agents|mesh-ancestor
110961828|NCT02307864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110961829|NCT02304042|Oxytocin|oxytocin|mesh-list
110961830|NCT02304042|Carbetocin|carbetocin|mesh-list
110961831|NCT02304042|Oxytocics|oxytocics|mesh-ancestor
110961832|NCT02304042|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110961833|NCT02304042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110961834|NCT02308098|Budesonide|budesonide|mesh-list
110961835|NCT02308098|Formoterol Fumarate|formoterol fumarate|mesh-list
110961836|NCT02308098|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
110961837|NCT02308098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110961838|NCT02308098|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110961839|NCT02308098|Autonomic Agents|autonomic agents|mesh-ancestor
110961840|NCT02308098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110961841|NCT02308098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110961842|NCT02308098|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110961843|NCT02308098|Respiratory System Agents|respiratory system agents|mesh-ancestor
110961844|NCT02308098|Glucocorticoids|glucocorticoids|mesh-ancestor
110961845|NCT02308098|Hormones|hormones|mesh-ancestor
110961846|NCT02308098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110961847|NCT02308098|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110961848|NCT02308098|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110961849|NCT02308098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110961850|NCT02308098|Adrenergic Agents|adrenergic agents|mesh-ancestor
110961851|NCT02308098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110961852|NCT02308098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110961853|NCT03504072|Etanercept|etanercept|mesh-list
110961854|NCT03504072|Tofacitinib|tofacitinib|mesh-list
110961855|NCT03504072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110961856|NCT03504072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110961857|NCT03504072|Analgesics|analgesics|mesh-ancestor
110961858|NCT03504072|Sensory System Agents|sensory system agents|mesh-ancestor
110961859|NCT03504072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110961860|NCT03504072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110961861|NCT03504072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110961862|NCT03504072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110961863|NCT03504072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110961864|NCT03504072|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110961865|NCT03504072|Immunologic Factors|immunologic factors|mesh-ancestor
110961866|NCT03504072|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
110961867|NCT03504072|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110961868|NCT03504072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110961869|NCT03504072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110961870|NCT03361280|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
110961871|NCT03361280|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110961872|NCT03361280|Adrenergic Agents|adrenergic agents|mesh-ancestor
110961873|NCT03361280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110961874|NCT03361280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110961875|NCT03361280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110961876|NCT02308254|Lixisenatide|lixisenatide|mesh-list
110961877|NCT02308254|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110961878|NCT02308254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110961879|NCT03361124|Oxytocin|oxytocin|mesh-list
110961880|NCT03361124|Oxytocics|oxytocics|mesh-ancestor
110961881|NCT03361124|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110961882|NCT03361124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110961883|NCT03364088|Oxycodone|oxycodone|mesh-list
110961884|NCT03364088|Anesthetics|anesthetics|mesh-list
111490629|NCT03162510|Antimetabolites|antimetabolites|mesh-ancestor
111490630|NCT02996760|Mitogens|mitogens|mesh-list
111490631|NCT02996760|Mitosis Modulators|mitosis modulators|mesh-ancestor
111490632|NCT02996760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110961885|NCT03364088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111490634|NCT02987946|Anticoagulants|anticoagulants|mesh-ancestor
110961886|NCT03364088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110961887|NCT03364088|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110961888|NCT03364088|Narcotics|narcotics|mesh-ancestor
110961889|NCT03364088|Analgesics|analgesics|mesh-ancestor
110961890|NCT03364088|Sensory System Agents|sensory system agents|mesh-ancestor
110961891|NCT03364088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110961892|NCT02304198|Udenafil|udenafil|mesh-list
110961893|NCT02304198|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110961894|NCT02304198|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110961895|NCT02304198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110961896|NCT02304198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110961897|NCT02304276|Calcium|calcium|mesh-list
110961898|NCT02304276|Fluorides|fluorides|mesh-list
110961899|NCT02304276|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110961900|NCT02304276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110961901|NCT02304276|Cariostatic Agents|cariostatic agents|mesh-ancestor
110961902|NCT02304276|Protective Agents|protective agents|mesh-ancestor
110961903|NCT04524260|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110961904|NCT02308332|Tenofovir|tenofovir|mesh-list
110961905|NCT02308332|Emtricitabine|emtricitabine|mesh-list
110961906|NCT02308332|Rilpivirine|rilpivirine|mesh-list
110961907|NCT02308332|Antiviral Agents|antiviral agents|mesh-ancestor
110961908|NCT02308332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110961909|NCT02308332|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110961910|NCT02308332|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110961911|NCT02308332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110961912|NCT02308332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110961913|NCT02308332|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110961914|NCT02308332|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110961915|NCT03509298|Antibodies|antibodies|mesh-list
110961916|NCT03509298|Antibodies, Bispecific|antibodies, bispecific|mesh-list
110961917|NCT03509298|Immunologic Factors|immunologic factors|mesh-ancestor
110961918|NCT03509298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110961919|NCT03503994|Beclomethasone|beclomethasone|mesh-list
110961920|NCT03503994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110961921|NCT03503994|Glucocorticoids|glucocorticoids|mesh-ancestor
110961922|NCT03503994|Hormones|hormones|mesh-ancestor
110961923|NCT03503994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110961924|NCT03503994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110673949|NCT05883384|Caseins|caseins|mesh-list
110961925|NCT03503994|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110961926|NCT03503994|Respiratory System Agents|respiratory system agents|mesh-ancestor
110961927|NCT01796002|Romidepsin|romidepsin|mesh-list
110961928|NCT01796002|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110961929|NCT01796002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110961930|NCT01796002|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110961931|NCT01796002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110961932|NCT01796002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110961933|NCT03509142|Sirolimus|sirolimus|mesh-list
110961934|NCT03509142|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110961935|NCT03509142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110961936|NCT03509142|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110961937|NCT03509142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110961938|NCT03509142|Antifungal Agents|antifungal agents|mesh-ancestor
110961939|NCT03509142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110961940|NCT03509142|Immunologic Factors|immunologic factors|mesh-ancestor
110961941|NCT03509142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110961942|NCT03356912|Prednisone|prednisone|mesh-list
110961943|NCT03356912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110961944|NCT03356912|Glucocorticoids|glucocorticoids|mesh-ancestor
110961945|NCT03356912|Hormones|hormones|mesh-ancestor
110961946|NCT03356912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110961947|NCT03356912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110961948|NCT03356912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110961949|NCT03356912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110961950|NCT00102687|Azacitidine|azacitidine|mesh-list
110961951|NCT00102687|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110961952|NCT00102687|Antimetabolites|antimetabolites|mesh-ancestor
110961953|NCT00102687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110961954|NCT00102687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111490635|NCT02987946|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110961955|NCT00102687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110961956|NCT04509440|Triamcinolone|triamcinolone|mesh-list
110961958|NCT04509440|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110961959|NCT04509440|Anesthetics|anesthetics|mesh-list
110961960|NCT04509440|Mepivacaine|mepivacaine|mesh-list
110961961|NCT04509440|Anesthetics, Local|anesthetics, local|mesh-list
110961962|NCT04509440|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110961963|NCT04509440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110961964|NCT04509440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110961965|NCT04509440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110961966|NCT04509440|Glucocorticoids|glucocorticoids|mesh-ancestor
110961967|NCT04509440|Hormones|hormones|mesh-ancestor
110961968|NCT04509440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110961969|NCT04509440|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110961970|NCT04509440|Immunologic Factors|immunologic factors|mesh-ancestor
110961971|NCT04509440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110961972|NCT04509440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110961973|NCT04509440|Sensory System Agents|sensory system agents|mesh-ancestor
110961974|NCT04509440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110961975|NCT02312544|Timolol|timolol|mesh-list
110961976|NCT02312544|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110961977|NCT02312544|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110961978|NCT02312544|Adrenergic Agents|adrenergic agents|mesh-ancestor
110961979|NCT02312544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110961980|NCT02312544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110961981|NCT02312544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110961982|NCT02312544|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110961983|NCT02312544|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110961984|NCT03360734|Cetuximab|cetuximab|mesh-list
110961985|NCT03360734|Panitumumab|panitumumab|mesh-list
110961986|NCT03360734|Necitumumab|necitumumab|mesh-list
110961987|NCT03360734|Antibodies|antibodies|mesh-list
110961988|NCT03360734|Immunologic Factors|immunologic factors|mesh-ancestor
110961989|NCT03360734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110961990|NCT03360734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110961991|NCT03360734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110961992|NCT02308644|Bevacizumab|bevacizumab|mesh-list
110961993|NCT02308644|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110961994|NCT02308644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110961995|NCT02308644|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110961996|NCT02308644|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110961997|NCT02308644|Growth Substances|growth substances|mesh-ancestor
110961998|NCT02308644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110674025|NCT05882864|Triamcinolone|triamcinolone|mesh-list
110961999|NCT02308644|Growth Inhibitors|growth inhibitors|mesh-ancestor
110962000|NCT04510636|Pembrolizumab|pembrolizumab|mesh-list
110962001|NCT04510636|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110962002|NCT04510636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110962003|NCT04510636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110962004|NCT04510636|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110962005|NCT04510636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110962006|NCT04510636|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110962007|NCT04510636|Alkylating Agents|alkylating agents|mesh-ancestor
110962008|NCT03540849|Brentuximab Vedotin|brentuximab vedotin|mesh-list
110962009|NCT03540849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110962010|NCT03540849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110962011|NCT03540849|Immunotoxins|immunotoxins|mesh-ancestor
110962012|NCT03540849|Immunoconjugates|immunoconjugates|mesh-ancestor
110962013|NCT03540849|Immunologic Factors|immunologic factors|mesh-ancestor
110962014|NCT03540849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110962015|NCT04520126|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
110962016|NCT04520126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110962017|NCT04520126|Antioxidants|antioxidants|mesh-ancestor
110962018|NCT04520126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110962019|NCT04520126|Protective Agents|protective agents|mesh-ancestor
110962020|NCT04520126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110962021|NCT04520126|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110962022|NCT02304354|Rituximab|rituximab|mesh-list
110962023|NCT02304354|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110962024|NCT02304354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110962025|NCT02304354|Immunologic Factors|immunologic factors|mesh-ancestor
110962026|NCT02304354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111490636|NCT02987946|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110649992|NCT00509067|Olanzapine|olanzapine|mesh-list
110962027|NCT02304354|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110962028|NCT03356600|Apatinib|apatinib|mesh-list
110962029|NCT03356600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110962030|NCT03356600|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110962031|NCT03356600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110962032|NCT03356600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110962033|NCT00102531|Cisplatin|cisplatin|mesh-list
110962034|NCT00102531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110962035|NCT05347654|Sulfadiazine|sulfadiazine|mesh-list
110962036|NCT05347654|Silver Sulfadiazine|silver sulfadiazine|mesh-list
110962037|NCT05347654|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110962038|NCT05347654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110962039|NCT05347654|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110962040|NCT05347654|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110962041|NCT05347654|Coccidiostats|coccidiostats|mesh-ancestor
110962042|NCT05347654|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110962043|NCT03360266|Listerine|listerine|mesh-list
110962044|NCT03360266|Fluorides|fluorides|mesh-list
110962045|NCT03360266|Sodium Fluoride|sodium fluoride|mesh-list
110962046|NCT03360266|Fluorides, Topical|fluorides, topical|mesh-list
110962047|NCT03360266|Cariostatic Agents|cariostatic agents|mesh-ancestor
110962048|NCT03360266|Protective Agents|protective agents|mesh-ancestor
110962049|NCT03360266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110962050|NCT03360266|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110962051|NCT03360266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110962052|NCT02154789|Polidocanol|polidocanol|mesh-list
110962053|NCT02154789|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
110962054|NCT02154789|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110962055|NCT02771145|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110962056|NCT03506256|Norfloxacin|norfloxacin|mesh-list
110962057|NCT03506256|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110962058|NCT03506256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110962059|NCT03506256|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110962060|NCT03506256|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110962061|NCT03506256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110962062|NCT03506256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110962063|NCT03506256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110962064|NCT03506256|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110962065|NCT03506256|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110962066|NCT03356444|Docetaxel|docetaxel|mesh-list
110962067|NCT03356444|Abiraterone Acetate|abiraterone acetate|mesh-list
110962068|NCT03356444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110962069|NCT03356444|Tubulin Modulators|tubulin modulators|mesh-ancestor
110962070|NCT03356444|Antimitotic Agents|antimitotic agents|mesh-ancestor
110962071|NCT03356444|Mitosis Modulators|mitosis modulators|mesh-ancestor
110962072|NCT03356444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110962073|NCT03356444|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110962074|NCT03356444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110962075|NCT03356444|Hormone Antagonists|hormone antagonists|mesh-ancestor
110962076|NCT03356444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110962077|NCT03356444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110962078|NCT03356444|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110962080|NCT03503604|Paclitaxel|paclitaxel|mesh-list
110962081|NCT03503604|Carboplatin|carboplatin|mesh-list
110962082|NCT03503604|Gemcitabine|gemcitabine|mesh-list
110962083|NCT03503604|Fluorouracil|fluorouracil|mesh-list
110962084|NCT03503604|Oxaliplatin|oxaliplatin|mesh-list
110962085|NCT03503604|Irinotecan|irinotecan|mesh-list
110962086|NCT03503604|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110962087|NCT03503604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110962088|NCT03503604|Tubulin Modulators|tubulin modulators|mesh-ancestor
110962089|NCT03503604|Antimitotic Agents|antimitotic agents|mesh-ancestor
110962090|NCT03503604|Mitosis Modulators|mitosis modulators|mesh-ancestor
110962091|NCT03503604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110962092|NCT03503604|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110962093|NCT03503604|Antimetabolites|antimetabolites|mesh-ancestor
110962094|NCT03503604|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110962095|NCT03503604|Immunologic Factors|immunologic factors|mesh-ancestor
110962096|NCT03503604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110962097|NCT03503604|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110962098|NCT03503604|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110962099|NCT03503604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110962100|NCT03503604|Antidotes|antidotes|mesh-ancestor
110962101|NCT03503604|Protective Agents|protective agents|mesh-ancestor
110962102|NCT03503604|Vitamin B Complex|vitamin b complex|mesh-ancestor
110962103|NCT03503604|Vitamins|vitamins|mesh-ancestor
111490637|NCT02987946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110962104|NCT03503604|Micronutrients|micronutrients|mesh-ancestor
111490638|NCT02394132|Imiquimod|imiquimod|mesh-list
111490639|NCT02394132|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111490640|NCT02394132|Immunologic Factors|immunologic factors|mesh-ancestor
111490641|NCT02394132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110962106|NCT04508816|Nimotuzumab|nimotuzumab|mesh-list
110962107|NCT04508816|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110962108|NCT04508816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110962109|NCT03359876|Warfarin|warfarin|mesh-list
110962110|NCT03359876|Rivaroxaban|rivaroxaban|mesh-list
110962111|NCT03359876|Anticoagulants|anticoagulants|mesh-ancestor
110962112|NCT03359876|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110962113|NCT03359876|Antithrombins|antithrombins|mesh-ancestor
110962114|NCT03359876|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110962115|NCT03359876|Protease Inhibitors|protease inhibitors|mesh-ancestor
110962116|NCT03359876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110962117|NCT03359876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110962118|NCT05226832|Triamcinolone|triamcinolone|mesh-list
110962119|NCT05226832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110962120|NCT05226832|Glucocorticoids|glucocorticoids|mesh-ancestor
110962121|NCT05226832|Hormones|hormones|mesh-ancestor
110962122|NCT05226832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110962123|NCT05226832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110962124|NCT03354572|Acetylcysteine|acetylcysteine|mesh-list
110962125|NCT03354572|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110962126|NCT03354572|Antiviral Agents|antiviral agents|mesh-ancestor
110962127|NCT03354572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110962128|NCT03354572|Expectorants|expectorants|mesh-ancestor
110962129|NCT03354572|Respiratory System Agents|respiratory system agents|mesh-ancestor
110962130|NCT03354572|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110962131|NCT03354572|Antioxidants|antioxidants|mesh-ancestor
110962132|NCT03354572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110962133|NCT03354572|Protective Agents|protective agents|mesh-ancestor
110962134|NCT03354572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110962135|NCT03354572|Antidotes|antidotes|mesh-ancestor
110962136|NCT03359798|Narcotics|narcotics|mesh-list
110962137|NCT03359798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110962138|NCT03359798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110962139|NCT03359798|Analgesics|analgesics|mesh-ancestor
110962140|NCT03359798|Sensory System Agents|sensory system agents|mesh-ancestor
110962141|NCT03359798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110962142|NCT02309346|Clindamycin|clindamycin|mesh-list
110962143|NCT02309346|Clindamycin palmitate|clindamycin palmitate|mesh-list
110962144|NCT02309346|Clindamycin phosphate|clindamycin phosphate|mesh-list
110962145|NCT02309346|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110962146|NCT02309346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110962147|NCT02309346|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110962148|NCT02309346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110962149|NCT02309346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110962150|NCT03356054|Brentuximab Vedotin|brentuximab vedotin|mesh-list
110962151|NCT03356054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110962152|NCT03356054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110962153|NCT03356054|Immunotoxins|immunotoxins|mesh-ancestor
110962154|NCT03356054|Immunoconjugates|immunoconjugates|mesh-ancestor
110962155|NCT03356054|Immunologic Factors|immunologic factors|mesh-ancestor
110962156|NCT03356054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110962157|NCT03354494|Desogestrel|desogestrel|mesh-list
110962158|NCT03354494|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110962159|NCT03354494|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110962160|NCT03354494|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110962161|NCT03354494|Contraceptive Agents|contraceptive agents|mesh-ancestor
110962162|NCT03354494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110962163|NCT03354494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110650006|NCT00509067|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110962164|NCT03354494|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110962165|NCT03354494|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110962166|NCT03354494|Progestins|progestins|mesh-ancestor
110962167|NCT03354494|Hormones|hormones|mesh-ancestor
110962168|NCT03354494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110962169|NCT03354338|Amoxicillin|amoxicillin|mesh-list
110962170|NCT03354338|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110962171|NCT03354338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110962172|NCT02304822|Ciprofloxacin|ciprofloxacin|mesh-list
110962173|NCT02304822|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110962174|NCT02304822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110962175|NCT02304822|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110962176|NCT02304822|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110962177|NCT02304822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111490642|NCT02394132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110962178|NCT02304822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110962179|NCT02304822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111490643|NCT02394132|Interferon Inducers|interferon inducers|mesh-ancestor
111490644|NCT00700596|Salvinorin A|salvinorin a|mesh-list
110962180|NCT02304822|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110962181|NCT02304822|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110962182|NCT02309424|Acetic Acid|acetic acid|mesh-list
110962183|NCT02309424|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110962184|NCT02309424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110962185|NCT03506178|Phenylephrine|phenylephrine|mesh-list
110962186|NCT03506178|Oxymetazoline|oxymetazoline|mesh-list
110962187|NCT03506178|Menthol|menthol|mesh-list
110962188|NCT03506178|Antipruritics|antipruritics|mesh-ancestor
110962189|NCT03506178|Dermatologic Agents|dermatologic agents|mesh-ancestor
110962190|NCT03506178|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110962191|NCT03506178|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110962192|NCT03506178|Adrenergic Agents|adrenergic agents|mesh-ancestor
110962193|NCT03506178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110962194|NCT03506178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110962195|NCT03506178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110962196|NCT03506178|Sympathomimetics|sympathomimetics|mesh-ancestor
110962197|NCT03506178|Autonomic Agents|autonomic agents|mesh-ancestor
110962198|NCT03506178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110962199|NCT03506178|Nasal Decongestants|nasal decongestants|mesh-ancestor
110962200|NCT03506178|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110962201|NCT03506178|Respiratory System Agents|respiratory system agents|mesh-ancestor
110962202|NCT03506178|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110962203|NCT03506178|Mydriatics|mydriatics|mesh-ancestor
110962204|NCT03506178|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110962205|NCT03506178|Protective Agents|protective agents|mesh-ancestor
110962206|NCT05210374|Copper|copper|mesh-list
110962207|NCT05210374|Doxorubicin|doxorubicin|mesh-list
110962208|NCT05210374|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110962209|NCT05210374|Disulfiram|disulfiram|mesh-list
110962210|NCT05210374|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110962211|NCT05210374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110962212|NCT05210374|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110962213|NCT05210374|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110962214|NCT05210374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110962215|NCT05210374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110962216|NCT05210374|Trace Elements|trace elements|mesh-ancestor
110962217|NCT05210374|Micronutrients|micronutrients|mesh-ancestor
110962218|NCT05210374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110962219|NCT05210374|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110962220|NCT05210374|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
110962221|NCT02578186|Diphenhydramine|diphenhydramine|mesh-list
110962222|NCT02578186|Promethazine|promethazine|mesh-list
110962223|NCT02578186|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110962224|NCT02578186|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110962225|NCT02578186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110962226|NCT02578186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110962227|NCT02578186|Anesthetics, Local|anesthetics, local|mesh-ancestor
110962228|NCT02578186|Anesthetics|anesthetics|mesh-ancestor
110962229|NCT02578186|Sensory System Agents|sensory system agents|mesh-ancestor
110962230|NCT02578186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110962231|NCT02578186|Antiemetics|antiemetics|mesh-ancestor
110962232|NCT02578186|Autonomic Agents|autonomic agents|mesh-ancestor
110962233|NCT02578186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110962234|NCT02578186|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110962235|NCT02578186|Histamine Antagonists|histamine antagonists|mesh-ancestor
110962236|NCT02578186|Histamine Agents|histamine agents|mesh-ancestor
110962237|NCT02578186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110962238|NCT02578186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110962239|NCT02578186|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110962240|NCT02578186|Antipruritics|antipruritics|mesh-ancestor
110962241|NCT02578186|Dermatologic Agents|dermatologic agents|mesh-ancestor
110962242|NCT04128436|Progesterone|progesterone|mesh-list
110962243|NCT04128436|Progestins|progestins|mesh-ancestor
110962245|NCT04128436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111490645|NCT00700596|Hallucinogens|hallucinogens|mesh-ancestor
111490646|NCT00700596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111490647|NCT00700596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111490648|NCT01733472|Remifentanil|remifentanil|mesh-list
111490649|NCT01733472|Propofol|propofol|mesh-list
110962246|NCT04128436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111490650|NCT01733472|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111490651|NCT01733472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110962247|NCT02309658|Cisplatin|cisplatin|mesh-list
110962248|NCT02309658|Gemcitabine|gemcitabine|mesh-list
110962249|NCT02309658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110962250|NCT02309658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110962251|NCT02309658|Antimetabolites|antimetabolites|mesh-ancestor
110962252|NCT02309658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110962253|NCT05532280|Etoricoxib|etoricoxib|mesh-list
110962254|NCT05532280|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110962255|NCT05532280|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110962256|NCT05532280|Analgesics|analgesics|mesh-ancestor
110962257|NCT05532280|Sensory System Agents|sensory system agents|mesh-ancestor
110962258|NCT05532280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110962259|NCT05532280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110962260|NCT05532280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110962261|NCT05532280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110962262|NCT05532280|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110962263|NCT05532280|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110962264|NCT05532280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110962265|NCT05532280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110962266|NCT04517162|Povidone|povidone|mesh-list
110962267|NCT04517162|Plasma Substitutes|plasma substitutes|mesh-ancestor
110962268|NCT04517162|Blood Substitutes|blood substitutes|mesh-ancestor
110962269|NCT02155023|Insulin|insulin|mesh-list
110962270|NCT02155023|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110962271|NCT02155023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110962272|NCT02155023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110962273|NCT02163213|Immunoglobulins|immunoglobulins|mesh-list
110962274|NCT02163213|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110962275|NCT02163213|Antibodies|antibodies|mesh-list
110962276|NCT02163213|Immunologic Factors|immunologic factors|mesh-ancestor
110962277|NCT02163213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110962278|NCT04443920|Tranexamic Acid|tranexamic acid|mesh-list
110962279|NCT04443920|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110962280|NCT04443920|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110962281|NCT04443920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110962282|NCT04443920|Hemostatics|hemostatics|mesh-ancestor
110962283|NCT04443920|Coagulants|coagulants|mesh-ancestor
110962284|NCT03359018|Apatinib|apatinib|mesh-list
110962285|NCT03359018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110962286|NCT03359018|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110962287|NCT03359018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110962288|NCT03359018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110962289|NCT05530252|Minocycline|minocycline|mesh-list
110962290|NCT05530252|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110962291|NCT05530252|Anti-Infective Agents|anti-infective agents|mesh-list
110962292|NCT02163291|Paclitaxel|paclitaxel|mesh-list
110962293|NCT02163291|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110962294|NCT02163291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110962295|NCT02163291|Tubulin Modulators|tubulin modulators|mesh-ancestor
110962296|NCT02163291|Antimitotic Agents|antimitotic agents|mesh-ancestor
110962297|NCT02163291|Mitosis Modulators|mitosis modulators|mesh-ancestor
110962298|NCT02163291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110962299|NCT03505788|Acetazolamide|acetazolamide|mesh-list
110962300|NCT03505788|Anticonvulsants|anticonvulsants|mesh-ancestor
110962301|NCT03505788|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110962302|NCT03505788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110962303|NCT03505788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110962304|NCT03505788|Diuretics|diuretics|mesh-ancestor
110962305|NCT03505788|Natriuretic Agents|natriuretic agents|mesh-ancestor
110962306|NCT03505788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110962307|NCT02309970|Aspirin|aspirin|mesh-list
110962308|NCT02309970|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
110962309|NCT02309970|Warfarin|warfarin|mesh-list
110962310|NCT02309970|Rivaroxaban|rivaroxaban|mesh-list
110962311|NCT02309970|Dabigatran|dabigatran|mesh-list
110962312|NCT02309970|Apixaban|apixaban|mesh-list
110962313|NCT02309970|Clopidogrel|clopidogrel|mesh-list
110962314|NCT02309970|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110962315|NCT02309970|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111490652|NCT01733472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111490653|NCT01733472|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111490654|NCT01733472|Anesthetics, General|anesthetics, general|mesh-ancestor
110962316|NCT02309970|Analgesics|analgesics|mesh-ancestor
110962317|NCT02309970|Sensory System Agents|sensory system agents|mesh-ancestor
110962318|NCT02309970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110962319|NCT02309970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111490655|NCT01733472|Anesthetics|anesthetics|mesh-ancestor
111490656|NCT01733472|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110962320|NCT02309970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110962321|NCT02309970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110962322|NCT02309970|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110962323|NCT02309970|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110962324|NCT02309970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110962325|NCT02309970|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110962326|NCT02309970|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110962327|NCT02309970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110962328|NCT02309970|Antipyretics|antipyretics|mesh-ancestor
110962329|NCT02309970|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110962330|NCT02309970|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110962331|NCT02309970|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110962332|NCT02309970|Purinergic Agents|purinergic agents|mesh-ancestor
110962333|NCT02309970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110962334|NCT02309970|Anticoagulants|anticoagulants|mesh-ancestor
110962335|NCT02309970|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110962336|NCT02309970|Antithrombins|antithrombins|mesh-ancestor
110962337|NCT02309970|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110962338|NCT02309970|Protease Inhibitors|protease inhibitors|mesh-ancestor
110962339|NCT03353948|Metformin|metformin|mesh-list
110962340|NCT03353948|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110962341|NCT03353948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110962342|NCT02161653|Pyridoxine|pyridoxine|mesh-list
110962343|NCT02161653|Prednisone|prednisone|mesh-list
110962344|NCT02161653|Pentoxifylline|pentoxifylline|mesh-list
110962345|NCT02161653|Metadoxine|metadoxine|mesh-list
110962346|NCT02161653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110962347|NCT02161653|Glucocorticoids|glucocorticoids|mesh-ancestor
110962348|NCT02161653|Hormones|hormones|mesh-ancestor
110962349|NCT02161653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110962350|NCT02161653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110962351|NCT02161653|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110962352|NCT02161653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110962353|NCT02161653|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110962354|NCT02161653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110962355|NCT02161653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110962356|NCT02161653|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110962357|NCT02161653|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110962358|NCT02161653|Protective Agents|protective agents|mesh-ancestor
110962359|NCT02161653|Vasodilator Agents|vasodilator agents|mesh-ancestor
110962360|NCT02161653|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110962361|NCT02161653|Antioxidants|antioxidants|mesh-ancestor
110962362|NCT02161653|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110962363|NCT02161653|Vitamin B Complex|vitamin b complex|mesh-ancestor
110962364|NCT02161653|Vitamins|vitamins|mesh-ancestor
110962365|NCT02161653|Micronutrients|micronutrients|mesh-ancestor
110962366|NCT02576938|Triamcinolone|triamcinolone|mesh-list
110962367|NCT02576938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110962368|NCT02576938|Glucocorticoids|glucocorticoids|mesh-ancestor
110962369|NCT02576938|Hormones|hormones|mesh-ancestor
110962370|NCT02576938|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110962371|NCT02576938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110962372|NCT02305836|Donepezil|donepezil|mesh-list
110962373|NCT02305836|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110962374|NCT02305836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110962375|NCT02305836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110962376|NCT02305836|Cholinergic Agents|cholinergic agents|mesh-ancestor
110962377|NCT02305836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110962378|NCT02305836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110962379|NCT02305836|Nootropic Agents|nootropic agents|mesh-ancestor
110962380|NCT03503136|Cisplatin|cisplatin|mesh-list
110962381|NCT03503136|Docetaxel|docetaxel|mesh-list
110962382|NCT03503136|Fluorouracil|fluorouracil|mesh-list
110962383|NCT03503136|Capecitabine|capecitabine|mesh-list
110962384|NCT03503136|Nedaplatin|nedaplatin|mesh-list
110962385|NCT03503136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110962386|NCT03503136|Tubulin Modulators|tubulin modulators|mesh-ancestor
110962387|NCT03503136|Antimitotic Agents|antimitotic agents|mesh-ancestor
110962388|NCT03503136|Mitosis Modulators|mitosis modulators|mesh-ancestor
110962389|NCT03503136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110962390|NCT03503136|Antimetabolites|antimetabolites|mesh-ancestor
110962391|NCT03503136|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111490657|NCT01733472|Narcotics|narcotics|mesh-ancestor
110962392|NCT03503136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110962393|NCT03503136|Immunologic Factors|immunologic factors|mesh-ancestor
111490658|NCT01733472|Analgesics|analgesics|mesh-ancestor
110962394|NCT03503136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110962395|NCT02305992|Bupivacaine|bupivacaine|mesh-list
110962396|NCT02305992|Anesthetics, Local|anesthetics, local|mesh-list
110962397|NCT02305992|Anesthetics|anesthetics|mesh-list
110962398|NCT02305992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110962399|NCT02305992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110962400|NCT02305992|Sensory System Agents|sensory system agents|mesh-ancestor
110962401|NCT02305992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110962402|NCT03355352|Sufentanil|sufentanil|mesh-list
110962403|NCT03355352|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110962404|NCT03355352|Narcotics|narcotics|mesh-ancestor
110962405|NCT03355352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110962406|NCT03355352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110962407|NCT03355352|Analgesics|analgesics|mesh-ancestor
110962408|NCT03355352|Sensory System Agents|sensory system agents|mesh-ancestor
110962409|NCT03355352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110962410|NCT03355352|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110962411|NCT03355352|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110962412|NCT03355352|Anesthetics, General|anesthetics, general|mesh-ancestor
110962413|NCT03355352|Anesthetics|anesthetics|mesh-ancestor
110962414|NCT05529940|Folfirinox|folfirinox|mesh-list
110962415|NCT05529940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110962416|NCT04463784|Efavirenz|efavirenz|mesh-list
110962417|NCT04463784|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110962418|NCT04463784|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110962419|NCT04463784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110962420|NCT04463784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110962421|NCT04463784|Antiviral Agents|antiviral agents|mesh-ancestor
110962422|NCT04463784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110650033|NCT02538146|Acetylcarnitine|acetylcarnitine|mesh-list
110962423|NCT04463784|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110962424|NCT04463784|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110962425|NCT04463784|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110962426|NCT04463784|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110962427|NCT04463784|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110962428|NCT04463784|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110962429|NCT02310360|Fallypride|fallypride|mesh-list
110962430|NCT02310360|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110962431|NCT02310360|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110962432|NCT02310360|Dopamine Agents|dopamine agents|mesh-ancestor
110962433|NCT02310360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110962434|NCT02310360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110962435|NCT02310360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110962436|NCT03353480|Azithromycin|azithromycin|mesh-list
110962437|NCT03353480|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110962438|NCT03353480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110962439|NCT02306070|Metformin|metformin|mesh-list
110962440|NCT02306070|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110962441|NCT02306070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110962442|NCT03502824|Anti-Infective Agents|anti-infective agents|mesh-list
110962443|NCT03502824|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110962444|NCT03353324|Bevacizumab|bevacizumab|mesh-list
110962445|NCT03353324|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110962446|NCT03353324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110962447|NCT03353324|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110962448|NCT03353324|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110962449|NCT03353324|Growth Substances|growth substances|mesh-ancestor
110962450|NCT03353324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110962451|NCT03353324|Growth Inhibitors|growth inhibitors|mesh-ancestor
110962452|NCT03354962|Nivolumab|nivolumab|mesh-list
110962453|NCT03354962|Ipilimumab|ipilimumab|mesh-list
110962454|NCT03354962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110962455|NCT03354962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110674477|NCT05795647|Antioxidants|antioxidants|mesh-ancestor
110962456|NCT03354962|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110962457|NCT03354962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110962458|NCT04511468|Copper|copper|mesh-list
110962459|NCT04511468|Chromium|chromium|mesh-list
110962460|NCT04511468|Micronutrients|micronutrients|mesh-ancestor
111490659|NCT01733472|Sensory System Agents|sensory system agents|mesh-ancestor
111490660|NCT01733472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111490661|NCT01736358|Ketorolac|ketorolac|mesh-list
111490662|NCT01736358|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110962461|NCT04511468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110962462|NCT04511468|Trace Elements|trace elements|mesh-ancestor
110962463|NCT05531422|Fentanyl|fentanyl|mesh-list
110962464|NCT05531422|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110962465|NCT05531422|Narcotics|narcotics|mesh-ancestor
110962466|NCT05531422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110962467|NCT05531422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110962468|NCT05531422|Analgesics|analgesics|mesh-ancestor
110962469|NCT05531422|Sensory System Agents|sensory system agents|mesh-ancestor
110962470|NCT05531422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110962471|NCT05531422|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110962472|NCT05531422|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110962473|NCT05531422|Anesthetics, General|anesthetics, general|mesh-ancestor
110962474|NCT05531422|Anesthetics|anesthetics|mesh-ancestor
110962475|NCT03354806|Analgesics|analgesics|mesh-list
110962476|NCT03354806|Sensory System Agents|sensory system agents|mesh-ancestor
110962477|NCT03354806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110962478|NCT03354806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110962479|NCT05529082|Analgesics, Opioid|analgesics, opioid|mesh-list
110962480|NCT05529082|Narcotics|narcotics|mesh-ancestor
110962481|NCT05529082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110962482|NCT05529082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110962483|NCT05529082|Analgesics|analgesics|mesh-ancestor
110962484|NCT05529082|Sensory System Agents|sensory system agents|mesh-ancestor
110962485|NCT05529082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110962486|NCT05285878|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
110962487|NCT05285878|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
110650043|NCT00730223|Nevirapine|nevirapine|mesh-list
110962488|NCT05285878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110962489|NCT05285878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110962490|NCT05285878|Immunologic Factors|immunologic factors|mesh-ancestor
110962491|NCT05285878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110962492|NCT02314182|Bevacizumab|bevacizumab|mesh-list
110962493|NCT02314182|Capecitabine|capecitabine|mesh-list
110962494|NCT02314182|Oxaliplatin|oxaliplatin|mesh-list
110962495|NCT02314182|Irinotecan|irinotecan|mesh-list
110962496|NCT02314182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110962497|NCT02314182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110962498|NCT02314182|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110962499|NCT02314182|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110962500|NCT02314182|Growth Substances|growth substances|mesh-ancestor
110962501|NCT02314182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110962502|NCT02314182|Growth Inhibitors|growth inhibitors|mesh-ancestor
110962503|NCT02314182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110962504|NCT02314182|Antimetabolites|antimetabolites|mesh-ancestor
110962505|NCT02314182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110962506|NCT02314182|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110962507|NCT02314182|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110962508|NCT02314182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110962509|NCT05531344|Tamsulosin|tamsulosin|mesh-list
110962510|NCT05531344|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110962511|NCT05531344|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110962512|NCT05531344|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110962513|NCT05531344|Adrenergic Agents|adrenergic agents|mesh-ancestor
110962514|NCT05531344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110962515|NCT05531344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110962516|NCT05531344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110962517|NCT05531344|Urological Agents|urological agents|mesh-ancestor
110962518|NCT05531266|Glucocorticoids|glucocorticoids|mesh-list
110962519|NCT05531266|Hormones|hormones|mesh-ancestor
110962520|NCT05531266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110962521|NCT05531266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110962522|NCT03349658|Anesthetics|anesthetics|mesh-list
110962523|NCT03349658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110962524|NCT03349658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110962525|NCT03353012|Levonorgestrel|levonorgestrel|mesh-list
110962526|NCT03353012|Etonogestrel|etonogestrel|mesh-list
110962527|NCT03353012|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110962528|NCT03353012|Contraceptive Agents|contraceptive agents|mesh-ancestor
110962529|NCT03353012|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110962530|NCT03353012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110962531|NCT03353012|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110962532|NCT03353012|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110962533|NCT03353012|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111490663|NCT01736358|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111490664|NCT01736358|Analgesics|analgesics|mesh-ancestor
110962535|NCT04462614|Anticoagulants|anticoagulants|mesh-ancestor
110962536|NCT04462614|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111490665|NCT01736358|Sensory System Agents|sensory system agents|mesh-ancestor
110962537|NCT04462614|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110962538|NCT04462614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110962539|NCT03349424|Somatostatin|somatostatin|mesh-list
110962540|NCT03349424|Hormones|hormones|mesh-ancestor
110962541|NCT03349424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110962542|NCT03349424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110962543|NCT03349346|Rituximab|rituximab|mesh-list
110962544|NCT03349346|Carboplatin|carboplatin|mesh-list
110962545|NCT03349346|Etoposide|etoposide|mesh-list
110962546|NCT03349346|Ifosfamide|ifosfamide|mesh-list
110962547|NCT03349346|Idelalisib|idelalisib|mesh-list
110962548|NCT03349346|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110962549|NCT03349346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110962550|NCT03349346|Immunologic Factors|immunologic factors|mesh-ancestor
110962551|NCT03349346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110962552|NCT03349346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110962553|NCT03349346|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110962554|NCT03349346|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110962555|NCT03349346|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110962556|NCT03349346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110962557|NCT03349346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110962558|NCT03349346|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110962559|NCT03349346|Alkylating Agents|alkylating agents|mesh-ancestor
110962560|NCT03502434|Petrolatum|petrolatum|mesh-list
110962561|NCT03502434|Emollients|emollients|mesh-ancestor
110962562|NCT03502434|Dermatologic Agents|dermatologic agents|mesh-ancestor
110962563|NCT03352700|Dyclonine|dyclonine|mesh-list
110962564|NCT03352700|Anesthetics, Local|anesthetics, local|mesh-ancestor
110962565|NCT03352700|Anesthetics|anesthetics|mesh-ancestor
110962566|NCT03352700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110962567|NCT03352700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110962568|NCT03352700|Sensory System Agents|sensory system agents|mesh-ancestor
110962569|NCT03352700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110962570|NCT05522998|Propofol|propofol|mesh-list
110962571|NCT05522998|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110962572|NCT05522998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110962573|NCT05522998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110962574|NCT05522998|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110962575|NCT05522998|Anesthetics, General|anesthetics, general|mesh-ancestor
110962576|NCT05522998|Anesthetics|anesthetics|mesh-ancestor
110962577|NCT03349190|Ulipristal acetate|ulipristal acetate|mesh-list
110962578|NCT03349190|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110962579|NCT03349190|Contraceptive Agents|contraceptive agents|mesh-ancestor
110962580|NCT03349190|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110962581|NCT03349190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110962582|NCT03349190|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110962583|NCT03498534|Isoniazid|isoniazid|mesh-list
110962584|NCT03498534|Antitubercular Agents|antitubercular agents|mesh-ancestor
110962585|NCT03498534|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110962586|NCT03498534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110962587|NCT03498534|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
110962588|NCT03498534|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110962589|NCT03498534|Antimetabolites|antimetabolites|mesh-ancestor
110962590|NCT03498534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110962591|NCT03498534|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110962592|NCT03502356|Azithromycin|azithromycin|mesh-list
110962593|NCT03502356|Cefazolin|cefazolin|mesh-list
110962594|NCT03502356|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110962595|NCT03502356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110962596|NCT03498456|Amoxicillin|amoxicillin|mesh-list
110962597|NCT03498456|Clarithromycin|clarithromycin|mesh-list
110962598|NCT03498456|Lansoprazole|lansoprazole|mesh-list
110962599|NCT03498456|Dexlansoprazole|dexlansoprazole|mesh-list
110962600|NCT03498456|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110962601|NCT03498456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110962602|NCT03498456|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110962603|NCT03498456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110962604|NCT03498456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110962605|NCT03498456|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110962606|NCT03498456|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110962607|NCT03498456|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111490666|NCT01736358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111490667|NCT01736358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111490668|NCT01736358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110962608|NCT03498456|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110962609|NCT03498456|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111490669|NCT01736358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110962611|NCT02317146|Analgesics|analgesics|mesh-ancestor
110962612|NCT02317146|Sensory System Agents|sensory system agents|mesh-ancestor
110962613|NCT02317146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110962614|NCT02317146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110962615|NCT02317146|Anesthetics|anesthetics|mesh-ancestor
110962616|NCT02317146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110962617|NCT02317146|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110962618|NCT02317146|Anticonvulsants|anticonvulsants|mesh-ancestor
110962619|NCT02317146|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110962620|NCT02317146|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110962621|NCT02317146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110962622|NCT02317146|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110962623|NCT02317146|Tocolytic Agents|tocolytic agents|mesh-ancestor
110962624|NCT02317146|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110962625|NCT05528146|Psyllium|psyllium|mesh-list
110962626|NCT05528146|Cathartics|cathartics|mesh-ancestor
110962627|NCT05528146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110962628|NCT03349112|Lidocaine|lidocaine|mesh-list
110962629|NCT03349112|Anesthetics, Local|anesthetics, local|mesh-ancestor
110962630|NCT03349112|Anesthetics|anesthetics|mesh-ancestor
110962631|NCT03349112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110962632|NCT03349112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110962633|NCT03349112|Sensory System Agents|sensory system agents|mesh-ancestor
110962634|NCT03349112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110962635|NCT03349112|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110962636|NCT03349112|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110962637|NCT03349112|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110962638|NCT03349112|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110962639|NCT03349112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110962640|NCT03498222|Carboplatin|carboplatin|mesh-list
110962641|NCT03498222|Pemetrexed|pemetrexed|mesh-list
110962642|NCT03498222|Atezolizumab|atezolizumab|mesh-list
110962643|NCT03498222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110962644|NCT03498222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110962645|NCT03498222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110962646|NCT03498222|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110962647|NCT03498222|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110962648|NCT03498222|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110962649|NCT03498222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110962650|NCT02518022|Insulin|insulin|mesh-list
110962651|NCT02518022|Insulin Lispro|insulin lispro|mesh-list
110962652|NCT02518022|Insulin Aspart|insulin aspart|mesh-list
110962653|NCT02518022|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110962654|NCT02518022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110962655|NCT05504252|Fluorouracil|fluorouracil|mesh-list
110962656|NCT05504252|Oxaliplatin|oxaliplatin|mesh-list
110962657|NCT05504252|Nivolumab|nivolumab|mesh-list
110962658|NCT05504252|Antimetabolites|antimetabolites|mesh-ancestor
110962659|NCT05504252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110962660|NCT05504252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110962661|NCT05504252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110962662|NCT05504252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110962663|NCT05504252|Immunologic Factors|immunologic factors|mesh-ancestor
110962664|NCT05504252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110962665|NCT05504252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110962666|NCT05504252|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110962667|NCT03497988|Oxytocin|oxytocin|mesh-list
110962668|NCT03497988|Oxytocics|oxytocics|mesh-ancestor
110962669|NCT03497988|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110962670|NCT03497988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110962671|NCT04610476|Sulfasalazine|sulfasalazine|mesh-list
110962672|NCT04610476|Prednisolone|prednisolone|mesh-list
110962673|NCT04610476|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110962674|NCT04610476|Methylprednisolone|methylprednisolone|mesh-list
110962675|NCT04610476|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110962676|NCT04610476|Prednisolone acetate|prednisolone acetate|mesh-list
110962677|NCT04610476|Adalimumab|adalimumab|mesh-list
110962678|NCT04610476|Infliximab|infliximab|mesh-list
110962679|NCT04610476|Etanercept|etanercept|mesh-list
111490670|NCT01736358|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111490671|NCT01736358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110962680|NCT04610476|Apremilast|apremilast|mesh-list
110962681|NCT04610476|Golimumab|golimumab|mesh-list
110674704|NCT05541471|Midazolam|midazolam|mesh-list
110674705|NCT05541471|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110962682|NCT04610476|Certolizumab Pegol|certolizumab pegol|mesh-list
111490672|NCT01736358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110962683|NCT04610476|Methotrexate|methotrexate|mesh-list
110962685|NCT04610476|Ustekinumab|ustekinumab|mesh-list
110962687|NCT04610476|Tofacitinib|tofacitinib|mesh-list
110962688|NCT04610476|Leflunomide|leflunomide|mesh-list
110962689|NCT04610476|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110962690|NCT04610476|Prednisolone phosphate|prednisolone phosphate|mesh-list
110962691|NCT04610476|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110962692|NCT04610476|Abortifacient Agents|abortifacient agents|mesh-ancestor
110962693|NCT04610476|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110962694|NCT04610476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110962695|NCT04610476|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110962696|NCT04610476|Antimetabolites|antimetabolites|mesh-ancestor
110962697|NCT04610476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110962698|NCT04610476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110962699|NCT04610476|Dermatologic Agents|dermatologic agents|mesh-ancestor
110962700|NCT04610476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110962701|NCT04610476|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110962702|NCT04610476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110962703|NCT04610476|Immunologic Factors|immunologic factors|mesh-ancestor
110962704|NCT04610476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110962705|NCT04610476|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110962706|NCT04610476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110962707|NCT04610476|Glucocorticoids|glucocorticoids|mesh-ancestor
110962708|NCT04610476|Hormones|hormones|mesh-ancestor
110962709|NCT04610476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110962710|NCT04610476|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110962711|NCT04610476|Antiemetics|antiemetics|mesh-ancestor
110962712|NCT04610476|Autonomic Agents|autonomic agents|mesh-ancestor
110962713|NCT04610476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110962714|NCT04610476|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110962715|NCT04610476|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110962716|NCT04610476|Protective Agents|protective agents|mesh-ancestor
110962717|NCT04610476|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110962718|NCT04610476|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110962719|NCT04610476|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110962720|NCT04610476|Analgesics|analgesics|mesh-ancestor
110962721|NCT04610476|Sensory System Agents|sensory system agents|mesh-ancestor
110962722|NCT04610476|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110962723|NCT04610476|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110962724|NCT04610476|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
110962725|NCT04610476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110962726|NCT04610476|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
110962727|NCT04610476|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110962728|NCT04610476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110962729|NCT03348800|Anesthetics|anesthetics|mesh-list
110962730|NCT03348800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110962731|NCT03348800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110962732|NCT02314806|Clindamycin|clindamycin|mesh-list
110962733|NCT02314806|Clindamycin palmitate|clindamycin palmitate|mesh-list
110962734|NCT02314806|Clindamycin phosphate|clindamycin phosphate|mesh-list
110962735|NCT02314806|Gentamicins|gentamicins|mesh-list
110962736|NCT02314806|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110962737|NCT02314806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110962738|NCT02314806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110962739|NCT02314806|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110962740|NCT02314806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110799549|NCT03752931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110962741|NCT02314806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110962742|NCT00709202|Betahistine|betahistine|mesh-list
110962743|NCT00709202|Vasodilator Agents|vasodilator agents|mesh-ancestor
110962744|NCT00709202|Histamine Agonists|histamine agonists|mesh-ancestor
110962745|NCT00709202|Histamine Agents|histamine agents|mesh-ancestor
110962746|NCT00709202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110962747|NCT00709202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110962748|NCT00709202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110962749|NCT05517538|Botulinum Toxins|botulinum toxins|mesh-list
110962750|NCT05517538|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110962751|NCT05517538|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110962752|NCT05517538|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110962753|NCT05517538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110962754|NCT05517538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111490673|NCT01740258|Bevacizumab|bevacizumab|mesh-list
110962756|NCT05517538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110962757|NCT05517538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110962758|NCT05517538|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110962759|NCT05517538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110962760|NCT02321280|Denosumab|denosumab|mesh-list
110962761|NCT02321280|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110962762|NCT02321280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110962763|NCT05527444|Thalidomide|thalidomide|mesh-list
110962764|NCT05527444|Adalimumab|adalimumab|mesh-list
110962765|NCT05527444|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110962766|NCT05527444|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110962767|NCT05527444|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110962768|NCT05527444|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110962769|NCT05527444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110962770|NCT05527444|Immunologic Factors|immunologic factors|mesh-ancestor
110962771|NCT05527444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110962772|NCT05527444|Leprostatic Agents|leprostatic agents|mesh-ancestor
110962773|NCT05527444|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110962774|NCT05527444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110962775|NCT05527444|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110962776|NCT05527444|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110962777|NCT05527444|Growth Substances|growth substances|mesh-ancestor
110962778|NCT05527444|Growth Inhibitors|growth inhibitors|mesh-ancestor
110962779|NCT05527444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110962780|NCT05439902|Tamsulosin|tamsulosin|mesh-list
110962781|NCT05439902|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110962782|NCT05439902|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110962783|NCT05439902|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110962784|NCT05439902|Adrenergic Agents|adrenergic agents|mesh-ancestor
110962785|NCT05439902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110962786|NCT05439902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110962787|NCT05439902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110962788|NCT05439902|Urological Agents|urological agents|mesh-ancestor
110962789|NCT02315118|Rituximab|rituximab|mesh-list
110962790|NCT02315118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110962791|NCT02315118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110962792|NCT02315118|Immunologic Factors|immunologic factors|mesh-ancestor
110962793|NCT02315118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110962794|NCT02315118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110962795|NCT03122756|Dexamethasone|dexamethasone|mesh-list
110962796|NCT03122756|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110962797|NCT03122756|Antiemetics|antiemetics|mesh-ancestor
110962798|NCT03122756|Autonomic Agents|autonomic agents|mesh-ancestor
110962799|NCT03122756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110962800|NCT03122756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110962801|NCT03122756|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110962802|NCT03122756|Glucocorticoids|glucocorticoids|mesh-ancestor
110962803|NCT03122756|Hormones|hormones|mesh-ancestor
110962804|NCT03122756|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110962805|NCT03122756|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110962806|NCT03122756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110962807|NCT03122678|Thiamine|thiamine|mesh-list
110962808|NCT03122678|Vitamins|vitamins|mesh-ancestor
110962809|NCT03122678|Micronutrients|micronutrients|mesh-ancestor
110962810|NCT03122678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110962811|NCT03122678|Vitamin B Complex|vitamin b complex|mesh-ancestor
110962812|NCT02317770|Lidocaine|lidocaine|mesh-list
110962813|NCT02317770|Anesthetics, Local|anesthetics, local|mesh-ancestor
110962814|NCT02317770|Anesthetics|anesthetics|mesh-ancestor
110962815|NCT02317770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110962816|NCT02317770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110962817|NCT02317770|Sensory System Agents|sensory system agents|mesh-ancestor
110962818|NCT02317770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110962819|NCT02317770|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110962820|NCT02317770|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111490674|NCT01740258|Temozolomide|temozolomide|mesh-list
111490675|NCT01740258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111490676|NCT01740258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110962821|NCT02317770|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110962822|NCT02317770|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110962823|NCT02317770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110962824|NCT05527054|Diuretics|diuretics|mesh-list
110962825|NCT05527054|Natriuretic Agents|natriuretic agents|mesh-ancestor
110698778|NCT01324596|Prednisolone|prednisolone|mesh-list
110962826|NCT05527054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110962827|NCT04506242|Apatinib|apatinib|mesh-list
110962828|NCT04506242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110962829|NCT04506242|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110962830|NCT04506242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110962831|NCT04506242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110962832|NCT05526898|Triamcinolone|triamcinolone|mesh-list
110674869|NCT06014489|Cobicistat|cobicistat|mesh-list
110962833|NCT05526898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110962834|NCT05526898|Glucocorticoids|glucocorticoids|mesh-ancestor
110962835|NCT05526898|Hormones|hormones|mesh-ancestor
110962836|NCT05526898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110962837|NCT05526898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110962838|NCT05526820|Vaccines|vaccines|mesh-list
110962839|NCT05526820|Immunologic Factors|immunologic factors|mesh-ancestor
110962840|NCT05526820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110962841|NCT03352076|Danazol|danazol|mesh-list
110962842|NCT03352076|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110962843|NCT03352076|Hormone Antagonists|hormone antagonists|mesh-ancestor
110962844|NCT03352076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110962845|NCT03352076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110962846|NCT03497442|Brimonidine Tartrate|brimonidine tartrate|mesh-list
110962847|NCT03497442|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110962848|NCT03497442|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110962849|NCT03497442|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110962850|NCT03497442|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110962851|NCT03497442|Adrenergic Agents|adrenergic agents|mesh-ancestor
110962852|NCT03497442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110962853|NCT03497442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110962854|NCT03497442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110962855|NCT02738580|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
110962856|NCT02738580|Hormones|hormones|mesh-ancestor
110962857|NCT02738580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110962858|NCT02738580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110962859|NCT03497364|Bupivacaine|bupivacaine|mesh-list
110962860|NCT03497364|Ropivacaine|ropivacaine|mesh-list
110962861|NCT03497364|Anesthetics, Local|anesthetics, local|mesh-ancestor
110962862|NCT03497364|Anesthetics|anesthetics|mesh-ancestor
110962863|NCT03497364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110962864|NCT03497364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110962865|NCT03497364|Sensory System Agents|sensory system agents|mesh-ancestor
110962866|NCT03497364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110962867|NCT03348254|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110962868|NCT03348254|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
110962869|NCT03348254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110962870|NCT03348254|Antitubercular Agents|antitubercular agents|mesh-ancestor
110962871|NCT05516446|Chromium|chromium|mesh-list
110962872|NCT05516446|Paclitaxel|paclitaxel|mesh-list
110962873|NCT05516446|Everolimus|everolimus|mesh-list
110962874|NCT05516446|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110962875|NCT05516446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110962876|NCT05516446|Tubulin Modulators|tubulin modulators|mesh-ancestor
110962877|NCT05516446|Antimitotic Agents|antimitotic agents|mesh-ancestor
110962878|NCT05516446|Mitosis Modulators|mitosis modulators|mesh-ancestor
110962879|NCT05516446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110962880|NCT05516446|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110962881|NCT05516446|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110962882|NCT05516446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110962883|NCT05516446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110962884|NCT05516446|Immunologic Factors|immunologic factors|mesh-ancestor
110962885|NCT05516446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110962886|NCT05516446|Trace Elements|trace elements|mesh-ancestor
110962887|NCT05516446|Micronutrients|micronutrients|mesh-ancestor
110962888|NCT02318082|Aldesleukin|aldesleukin|mesh-list
110962889|NCT02318082|Interleukin-2|interleukin-2|mesh-list
110962890|NCT02318082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110962891|NCT02318082|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110962892|NCT02318082|Analgesics|analgesics|mesh-ancestor
111490677|NCT01740258|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111490678|NCT01740258|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111490679|NCT01740258|Growth Substances|growth substances|mesh-ancestor
111490680|NCT01740258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111490681|NCT01740258|Growth Inhibitors|growth inhibitors|mesh-ancestor
110962893|NCT02318082|Sensory System Agents|sensory system agents|mesh-ancestor
110962894|NCT02318082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110962895|NCT02318082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110962896|NCT02318082|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110962897|NCT02318082|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110962898|NCT02318082|Antiviral Agents|antiviral agents|mesh-ancestor
110962899|NCT02318082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110962901|NCT03348098|Apatinib|apatinib|mesh-list
110674933|NCT06013436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110674934|NCT06013436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110674935|NCT06013436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110674936|NCT06013436|Immunologic Factors|immunologic factors|mesh-ancestor
110674937|NCT06013436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110674938|NCT06013436|Antifungal Agents|antifungal agents|mesh-ancestor
110962902|NCT03348098|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110962903|NCT03348098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110962904|NCT03348098|Tubulin Modulators|tubulin modulators|mesh-ancestor
110962905|NCT03348098|Antimitotic Agents|antimitotic agents|mesh-ancestor
110962906|NCT03348098|Mitosis Modulators|mitosis modulators|mesh-ancestor
110962907|NCT03348098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110962908|NCT03348098|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110962909|NCT03348098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110962910|NCT03351842|Cisplatin|cisplatin|mesh-list
110962911|NCT03351842|Carboplatin|carboplatin|mesh-list
110962912|NCT03351842|Pemetrexed|pemetrexed|mesh-list
110962913|NCT03351842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110962914|NCT03351842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110962915|NCT03351842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110962916|NCT03351842|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110962917|NCT03351842|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110962918|NCT02447406|Docetaxel|docetaxel|mesh-list
110962919|NCT02447406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110962920|NCT02447406|Tubulin Modulators|tubulin modulators|mesh-ancestor
110962921|NCT02447406|Antimitotic Agents|antimitotic agents|mesh-ancestor
110962922|NCT02447406|Mitosis Modulators|mitosis modulators|mesh-ancestor
110962923|NCT02447406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110962924|NCT04505228|Atropine|atropine|mesh-list
110962925|NCT04505228|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110962926|NCT04505228|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110962927|NCT04505228|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110962928|NCT04505228|Autonomic Agents|autonomic agents|mesh-ancestor
110962929|NCT04505228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110962930|NCT04505228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110962931|NCT04505228|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110962932|NCT04505228|Respiratory System Agents|respiratory system agents|mesh-ancestor
110962933|NCT04505228|Mydriatics|mydriatics|mesh-ancestor
110962934|NCT04505228|Parasympatholytics|parasympatholytics|mesh-ancestor
110962935|NCT04505228|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110962936|NCT04505228|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110962937|NCT04505228|Cholinergic Agents|cholinergic agents|mesh-ancestor
110962938|NCT04505228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110962939|NCT04505228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110962940|NCT05584826|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
110962941|NCT05584826|Hallucinogens|hallucinogens|mesh-ancestor
110962942|NCT05584826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110962943|NCT05584826|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110962944|NCT05584826|Serotonin Agents|serotonin agents|mesh-ancestor
110962945|NCT05584826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110962946|NCT05584826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110962947|NCT05584826|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110962948|NCT05584826|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110962949|NCT05584826|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110962950|NCT05584826|Adrenergic Agents|adrenergic agents|mesh-ancestor
110962951|NCT03161028|Thioctic Acid|thioctic acid|mesh-list
110962952|NCT03161028|Antioxidants|antioxidants|mesh-ancestor
110962953|NCT03161028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110962954|NCT03161028|Protective Agents|protective agents|mesh-ancestor
110962955|NCT03161028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110962956|NCT03161028|Vitamin B Complex|vitamin b complex|mesh-ancestor
110962957|NCT03161028|Vitamins|vitamins|mesh-ancestor
110962958|NCT03161028|Micronutrients|micronutrients|mesh-ancestor
110962959|NCT02322372|Bupivacaine|bupivacaine|mesh-list
111490682|NCT01740258|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111490683|NCT01740258|Alkylating Agents|alkylating agents|mesh-ancestor
110962960|NCT02322372|Anesthetics|anesthetics|mesh-ancestor
110698789|NCT01324596|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111490684|NCT01740258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110962961|NCT02322372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110962962|NCT02322372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110962963|NCT02322372|Anesthetics, Local|anesthetics, local|mesh-ancestor
110962964|NCT02322372|Sensory System Agents|sensory system agents|mesh-ancestor
110962965|NCT02322372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110962966|NCT01376804|Valganciclovir|valganciclovir|mesh-list
110962967|NCT01376804|Antiviral Agents|antiviral agents|mesh-ancestor
110962968|NCT01376804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110962969|NCT05526118|Tenofovir|tenofovir|mesh-list
110962970|NCT05526118|Emtricitabine|emtricitabine|mesh-list
110962971|NCT05526118|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
110962972|NCT05526118|Antiviral Agents|antiviral agents|mesh-ancestor
110962973|NCT05526118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110962974|NCT05526118|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110962975|NCT05526118|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110962976|NCT05526118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110962977|NCT05526118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110962978|NCT05526118|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110962979|NCT05526118|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110962980|NCT03122132|Ritonavir|ritonavir|mesh-list
110962981|NCT03122132|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110962982|NCT03122132|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110962983|NCT03122132|Protease Inhibitors|protease inhibitors|mesh-ancestor
110962984|NCT03122132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110962985|NCT03122132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110962986|NCT03122132|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110962987|NCT03122132|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110962988|NCT03122132|Antiviral Agents|antiviral agents|mesh-ancestor
110962989|NCT03122132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110962990|NCT03122132|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110962991|NCT03122132|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110962992|NCT03351686|Tranexamic Acid|tranexamic acid|mesh-list
110962993|NCT03351686|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110962994|NCT03351686|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110962995|NCT03351686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110962996|NCT03351686|Hemostatics|hemostatics|mesh-ancestor
110962997|NCT03351686|Coagulants|coagulants|mesh-ancestor
110962998|NCT03347864|68Ga-NOTA-RM26|68ga-nota-rm26|mesh-list
110962999|NCT03347864|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110963000|NCT03347864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110963001|NCT02319018|Calcium, Dietary|calcium, dietary|mesh-list
110963002|NCT02319018|Leucovorin|leucovorin|mesh-list
110963003|NCT02319018|Folic Acid|folic acid|mesh-list
110963004|NCT02319018|Fluorouracil|fluorouracil|mesh-list
110963005|NCT02319018|Oxaliplatin|oxaliplatin|mesh-list
110963006|NCT02319018|Calcium|calcium|mesh-list
110963007|NCT02319018|Levoleucovorin|levoleucovorin|mesh-list
110963008|NCT02319018|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110963009|NCT02319018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110963010|NCT02319018|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110963011|NCT02319018|Antimetabolites|antimetabolites|mesh-ancestor
110963012|NCT02319018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110963013|NCT02319018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110963014|NCT02319018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110963015|NCT02319018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110963016|NCT02319018|Immunologic Factors|immunologic factors|mesh-ancestor
110963017|NCT02319018|Antidotes|antidotes|mesh-ancestor
110963018|NCT02319018|Protective Agents|protective agents|mesh-ancestor
110963019|NCT02319018|Vitamin B Complex|vitamin b complex|mesh-ancestor
110963020|NCT02319018|Vitamins|vitamins|mesh-ancestor
110963021|NCT02319018|Micronutrients|micronutrients|mesh-ancestor
110963022|NCT02319018|Hematinics|hematinics|mesh-ancestor
110963023|NCT02574520|Bupivacaine|bupivacaine|mesh-list
110963024|NCT02574520|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110963025|NCT02574520|Anesthetics, Local|anesthetics, local|mesh-ancestor
110963026|NCT02574520|Anesthetics|anesthetics|mesh-ancestor
110963027|NCT02574520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110963028|NCT02574520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110963029|NCT02574520|Sensory System Agents|sensory system agents|mesh-ancestor
111490685|NCT01740414|Ibudilast|ibudilast|mesh-list
111490686|NCT01740414|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111490687|NCT01740414|Autonomic Agents|autonomic agents|mesh-ancestor
110963030|NCT02574520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110963031|NCT04425226|Pembrolizumab|pembrolizumab|mesh-list
110963032|NCT04425226|Lenvatinib|lenvatinib|mesh-list
110963033|NCT04425226|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110963035|NCT04425226|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110963036|NCT04425226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110963037|NCT04425226|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110675086|NCT05981131|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110675087|NCT05981131|Immunologic Factors|immunologic factors|mesh-ancestor
110675088|NCT05981131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110675089|NCT05966090|Vaccines|vaccines|mesh-list
110675090|NCT05966090|Immunologic Factors|immunologic factors|mesh-ancestor
110675091|NCT05966090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110675092|NCT05926570|Cinacalcet|cinacalcet|mesh-list
110675093|NCT05926570|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110675094|NCT05926570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110675095|NCT05926570|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
110675096|NCT05926570|Hormone Antagonists|hormone antagonists|mesh-ancestor
110963038|NCT04425226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110963039|NCT05520658|Fluorouracil|fluorouracil|mesh-list
110963040|NCT05520658|Digoxin|digoxin|mesh-list
110963041|NCT05520658|Furosemide|furosemide|mesh-list
110963042|NCT05520658|Antimetabolites|antimetabolites|mesh-ancestor
110963043|NCT05520658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110963045|NCT05520658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110963046|NCT05520658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110963047|NCT05520658|Immunologic Factors|immunologic factors|mesh-ancestor
110963048|NCT05520658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110963049|NCT05520658|Diuretics|diuretics|mesh-ancestor
110963050|NCT05520658|Natriuretic Agents|natriuretic agents|mesh-ancestor
110963051|NCT05520658|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110963052|NCT05520658|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110963053|NCT05520658|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110963054|NCT05520658|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110963055|NCT05520658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110963056|NCT05520658|Protective Agents|protective agents|mesh-ancestor
110963057|NCT04462926|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
110963058|NCT04462926|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110963059|NCT04462926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110963060|NCT05140954|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
110963061|NCT05140954|Antiviral Agents|antiviral agents|mesh-ancestor
110963062|NCT05140954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110963063|NCT05140954|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110963064|NCT05140954|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110963065|NCT05140954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110963066|NCT05140954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110963067|NCT05140954|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110963068|NCT05140954|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110963069|NCT03351062|Tamoxifen|tamoxifen|mesh-list
110963070|NCT03351062|Toremifene|toremifene|mesh-list
110963071|NCT03351062|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110963072|NCT03351062|Hormone Antagonists|hormone antagonists|mesh-ancestor
110963073|NCT03351062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110963074|NCT03351062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110963075|NCT03351062|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110963076|NCT03351062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110963077|NCT03351062|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110963078|NCT03351062|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110963079|NCT03351062|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110963080|NCT03496740|Bupivacaine|bupivacaine|mesh-list
110963081|NCT03496740|Anesthetics, Local|anesthetics, local|mesh-ancestor
110963082|NCT03496740|Anesthetics|anesthetics|mesh-ancestor
110963083|NCT03496740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110963084|NCT03496740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110963085|NCT03496740|Sensory System Agents|sensory system agents|mesh-ancestor
110963086|NCT03496740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110963087|NCT05515822|Oxycodone|oxycodone|mesh-list
110963088|NCT05515822|Dezocine|dezocine|mesh-list
110963089|NCT05515822|Esketamine|esketamine|mesh-list
110963090|NCT05515822|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110963091|NCT05515822|Narcotics|narcotics|mesh-ancestor
110963092|NCT05515822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110963093|NCT05515822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110963094|NCT05515822|Analgesics|analgesics|mesh-ancestor
110963095|NCT05515822|Sensory System Agents|sensory system agents|mesh-ancestor
111490688|NCT01740414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110698796|NCT01324596|Alkylating Agents|alkylating agents|mesh-ancestor
110963096|NCT05515822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110963097|NCT05515822|Antidepressive Agents|antidepressive agents|mesh-ancestor
110963098|NCT05515822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110963100|NCT04294654|Antidepressive Agents|antidepressive agents|mesh-ancestor
110963101|NCT04294654|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110963102|NCT04294654|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110963103|NCT04294654|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110963104|NCT04294654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110963105|NCT04294654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110963106|NCT04294654|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110963107|NCT04294654|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110963108|NCT04294654|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110675158|NCT05784246|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110675159|NCT05784246|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110675160|NCT05784246|Analgesics|analgesics|mesh-ancestor
110675161|NCT05784246|Sensory System Agents|sensory system agents|mesh-ancestor
110675162|NCT05784246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110675165|NCT05784246|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110963109|NCT04294654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110963110|NCT04294654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110963111|NCT04294654|Serotonin Agents|serotonin agents|mesh-ancestor
110963112|NCT04294654|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110963113|NCT04294654|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110963114|NCT04294654|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110963115|NCT04294654|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110963116|NCT03496506|Selexipag|selexipag|mesh-list
110963117|NCT03496506|Clopidogrel|clopidogrel|mesh-list
110963118|NCT03496506|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110963119|NCT03496506|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110963120|NCT03496506|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110963121|NCT03496506|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110963122|NCT03496506|Purinergic Agents|purinergic agents|mesh-ancestor
110963123|NCT03496506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110963124|NCT03496506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110963125|NCT03496506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110963126|NCT03496506|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110963127|NCT04766684|Lidocaine|lidocaine|mesh-list
110963128|NCT04766684|Anesthetics, Local|anesthetics, local|mesh-ancestor
110963129|NCT04766684|Anesthetics|anesthetics|mesh-ancestor
110963130|NCT04766684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110963131|NCT04766684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110963132|NCT04766684|Sensory System Agents|sensory system agents|mesh-ancestor
110963133|NCT04766684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110963134|NCT04766684|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110963135|NCT04766684|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110963136|NCT04766684|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110963137|NCT04766684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110963138|NCT04766684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110963139|NCT02325024|Nabiximols|nabiximols|mesh-list
110963140|NCT02325024|Analgesics|analgesics|mesh-ancestor
110963141|NCT02325024|Sensory System Agents|sensory system agents|mesh-ancestor
110963142|NCT02325024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110963143|NCT02325024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110963144|NCT02319564|Beclomethasone|beclomethasone|mesh-list
110963145|NCT02319564|Albuterol|albuterol|mesh-list
110963146|NCT02319564|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110963147|NCT02319564|Autonomic Agents|autonomic agents|mesh-ancestor
110963148|NCT02319564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110963149|NCT02319564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110963150|NCT02319564|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110963151|NCT02319564|Respiratory System Agents|respiratory system agents|mesh-ancestor
110963152|NCT02319564|Tocolytic Agents|tocolytic agents|mesh-ancestor
110963153|NCT02319564|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110963154|NCT02319564|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110963155|NCT02319564|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110963156|NCT02319564|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110963157|NCT02319564|Adrenergic Agents|adrenergic agents|mesh-ancestor
110963158|NCT02319564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110963159|NCT02319564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110963160|NCT02319564|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110428813|NCT01007253|Fluticasone|fluticasone|mesh-list
111490689|NCT01740414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111490690|NCT01740414|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111490691|NCT01740414|Respiratory System Agents|respiratory system agents|mesh-ancestor
110963161|NCT02319564|Glucocorticoids|glucocorticoids|mesh-ancestor
110963163|NCT02319564|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110963164|NCT05056402|Vaccines|vaccines|mesh-list
110963165|NCT05056402|Immunologic Factors|immunologic factors|mesh-ancestor
110963166|NCT05056402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110963167|NCT02325180|Lumefantrine|lumefantrine|mesh-list
110963168|NCT02325180|Artemether|artemether|mesh-list
110963169|NCT02325180|Piperaquine|piperaquine|mesh-list
110963170|NCT02325180|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
110963171|NCT02325180|Artenimol|artenimol|mesh-list
110963172|NCT02325180|Antimalarials|antimalarials|mesh-ancestor
110963173|NCT02325180|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110963174|NCT02325180|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110963175|NCT02325180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110963176|NCT00709592|Mycophenolic Acid|mycophenolic acid|mesh-list
110675234|NCT05631886|Alkylating Agents|alkylating agents|mesh-ancestor
110675235|NCT05631886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110675236|NCT05631886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110675237|NCT05631886|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110675238|NCT05631886|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110675244|NCT05601752|Nivolumab|nivolumab|mesh-list
110963177|NCT00709592|Tacrolimus|tacrolimus|mesh-list
110963178|NCT00709592|Thymoglobulin|thymoglobulin|mesh-list
110963179|NCT00709592|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110963180|NCT00709592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110963181|NCT00709592|Immunologic Factors|immunologic factors|mesh-ancestor
110963182|NCT00709592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110963183|NCT00709592|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110963184|NCT00709592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110963185|NCT00709592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110963186|NCT00709592|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110963187|NCT00709592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110963188|NCT00709592|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110963189|NCT00709592|Antitubercular Agents|antitubercular agents|mesh-ancestor
110963190|NCT00709592|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110963191|NCT00709592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110963192|NCT05515354|Nicotine|nicotine|mesh-list
110963193|NCT05515354|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110963194|NCT05515354|Autonomic Agents|autonomic agents|mesh-ancestor
110963195|NCT05515354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110963196|NCT05515354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110963197|NCT05515354|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110963198|NCT05515354|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110963199|NCT05515354|Cholinergic Agents|cholinergic agents|mesh-ancestor
110963200|NCT05515354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110963201|NCT05515354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110963202|NCT02437370|Gemcitabine|gemcitabine|mesh-list
110963203|NCT02437370|Docetaxel|docetaxel|mesh-list
110963204|NCT02437370|Pembrolizumab|pembrolizumab|mesh-list
110963205|NCT02437370|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110963206|NCT02437370|Antimetabolites|antimetabolites|mesh-ancestor
110963207|NCT02437370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110963208|NCT02437370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110963209|NCT02437370|Tubulin Modulators|tubulin modulators|mesh-ancestor
110963210|NCT02437370|Antimitotic Agents|antimitotic agents|mesh-ancestor
110963211|NCT02437370|Mitosis Modulators|mitosis modulators|mesh-ancestor
110963212|NCT02437370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110963213|NCT02437370|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110963214|NCT05515120|Aspirin|aspirin|mesh-list
110963215|NCT05515120|Vitamin K|vitamin k|mesh-list
110963216|NCT05515120|Rivaroxaban|rivaroxaban|mesh-list
110963217|NCT05515120|Acenocoumarol|acenocoumarol|mesh-list
110963218|NCT05515120|Vitamins|vitamins|mesh-ancestor
110963219|NCT05515120|Micronutrients|micronutrients|mesh-ancestor
110963220|NCT05515120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110963221|NCT05515120|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110963222|NCT05515120|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110963223|NCT05515120|Analgesics|analgesics|mesh-ancestor
110963224|NCT05515120|Sensory System Agents|sensory system agents|mesh-ancestor
110963225|NCT05515120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110963226|NCT05515120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110963227|NCT05515120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110963228|NCT05515120|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110963229|NCT05515120|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111490692|NCT01740414|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110963230|NCT05515120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110963231|NCT05515120|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110963232|NCT05515120|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110963234|NCT05515120|Antipyretics|antipyretics|mesh-ancestor
110963235|NCT05515120|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110963236|NCT05515120|Antithrombins|antithrombins|mesh-ancestor
110963237|NCT05515120|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110963238|NCT05515120|Protease Inhibitors|protease inhibitors|mesh-ancestor
110963239|NCT05515120|Anticoagulants|anticoagulants|mesh-ancestor
110963240|NCT05515120|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110963241|NCT05515120|Hemostatics|hemostatics|mesh-ancestor
110963242|NCT05515120|Coagulants|coagulants|mesh-ancestor
110963243|NCT02323230|Cyclophosphamide|cyclophosphamide|mesh-list
110963244|NCT02323230|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110963245|NCT02323230|Immunologic Factors|immunologic factors|mesh-ancestor
110963246|NCT02323230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110963247|NCT02323230|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110963248|NCT02323230|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110963249|NCT02323230|Alkylating Agents|alkylating agents|mesh-ancestor
110963250|NCT02323230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110963251|NCT02323230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110963252|NCT02323230|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110963253|NCT05042128|Paclitaxel|paclitaxel|mesh-list
110963255|NCT05042128|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110963256|NCT05042128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110963257|NCT05042128|Tubulin Modulators|tubulin modulators|mesh-ancestor
110963258|NCT05042128|Antimitotic Agents|antimitotic agents|mesh-ancestor
110963259|NCT05042128|Mitosis Modulators|mitosis modulators|mesh-ancestor
110963260|NCT05042128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110963261|NCT05042128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110963262|NCT05042128|Antimetabolites|antimetabolites|mesh-ancestor
110963263|NCT03495804|Mannitol|mannitol|mesh-list
110963264|NCT03495804|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110963265|NCT03495804|Diuretics|diuretics|mesh-ancestor
110963266|NCT03495804|Natriuretic Agents|natriuretic agents|mesh-ancestor
110963267|NCT03495804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110963268|NCT05519410|Lenvatinib|lenvatinib|mesh-list
110963269|NCT05519410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110963270|NCT05519410|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110963271|NCT05519410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110650145|NCT00927524|Insulin|insulin|mesh-list
110963272|NCT05519410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110963273|NCT05578586|Meropenem|meropenem|mesh-list
110963274|NCT05578586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110963275|NCT05578586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110963276|NCT02570074|Fosfomycin|fosfomycin|mesh-list
110963277|NCT02570074|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110963278|NCT02570074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110963279|NCT02569996|Rituximab|rituximab|mesh-list
110963280|NCT02569996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110963281|NCT02569996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110963282|NCT02569996|Immunologic Factors|immunologic factors|mesh-ancestor
110963283|NCT02569996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110963284|NCT02569996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110963285|NCT02325882|Fentanyl|fentanyl|mesh-list
110963286|NCT02325882|Dexmedetomidine|dexmedetomidine|mesh-list
110963287|NCT02325882|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110963288|NCT02325882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110963289|NCT02325882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110963290|NCT02325882|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110963291|NCT02325882|Analgesics|analgesics|mesh-ancestor
110963292|NCT02325882|Sensory System Agents|sensory system agents|mesh-ancestor
110963293|NCT02325882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110963294|NCT02325882|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110963295|NCT02325882|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110963296|NCT02325882|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110963297|NCT02325882|Adrenergic Agents|adrenergic agents|mesh-ancestor
111490693|NCT01740414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111490694|NCT01740414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110963298|NCT02325882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110963299|NCT02325882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110963300|NCT02325882|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110963301|NCT02325882|Narcotics|narcotics|mesh-ancestor
111490695|NCT01740414|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111490696|NCT01740414|Vasodilator Agents|vasodilator agents|mesh-ancestor
111490697|NCT01740726|Fluoxetine|fluoxetine|mesh-list
111490698|NCT01740726|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110963302|NCT02325882|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110963303|NCT02325882|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110963304|NCT02325882|Anesthetics, General|anesthetics, general|mesh-ancestor
110963305|NCT02325882|Anesthetics|anesthetics|mesh-ancestor
110963306|NCT00708500|Interferons|interferons|mesh-list
110963307|NCT00708500|Ribavirin|ribavirin|mesh-list
110963308|NCT00708500|Interferon-alpha|interferon-alpha|mesh-list
110963309|NCT00708500|Interferon alpha-2|interferon alpha-2|mesh-list
110963310|NCT00708500|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110963311|NCT00708500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110963312|NCT00708500|Antiviral Agents|antiviral agents|mesh-ancestor
110963313|NCT00708500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110963314|NCT00708500|Antimetabolites|antimetabolites|mesh-ancestor
110963315|NCT00708500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110963316|NCT00708500|Immunologic Factors|immunologic factors|mesh-ancestor
110963317|NCT00708500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110963318|NCT05144100|Cisplatin|cisplatin|mesh-list
110963319|NCT05144100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110963320|NCT02320032|Aripiprazole|aripiprazole|mesh-list
110963321|NCT02320032|Aripiprazole lauroxil|aripiprazole lauroxil|mesh-list
110963322|NCT02320032|Antidepressive Agents|antidepressive agents|mesh-ancestor
110963323|NCT02320032|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110963324|NCT02320032|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110963325|NCT02320032|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110963326|NCT02320032|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110963327|NCT02320032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110963328|NCT02320032|Dopamine Agonists|dopamine agonists|mesh-ancestor
110963329|NCT02320032|Dopamine Agents|dopamine agents|mesh-ancestor
110963330|NCT02320032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110963331|NCT02320032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110963332|NCT02320032|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110963333|NCT02320032|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110963334|NCT02320032|Serotonin Agents|serotonin agents|mesh-ancestor
110963335|NCT02320032|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110963336|NCT02320032|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110963337|NCT02320032|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110963338|NCT02320032|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110963339|NCT05514652|Analgesics, Opioid|analgesics, opioid|mesh-list
110963340|NCT05514652|Anesthetics|anesthetics|mesh-list
110963341|NCT05514652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110963342|NCT05514652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110963343|NCT05514652|Narcotics|narcotics|mesh-ancestor
110963344|NCT05514652|Analgesics|analgesics|mesh-ancestor
110963345|NCT05514652|Sensory System Agents|sensory system agents|mesh-ancestor
110963346|NCT05514652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110963347|NCT00673244|Furosemide|furosemide|mesh-list
110963348|NCT00673244|Diuretics|diuretics|mesh-ancestor
110963349|NCT00673244|Natriuretic Agents|natriuretic agents|mesh-ancestor
110963350|NCT00673244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110963351|NCT00673244|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110963352|NCT00673244|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110963353|NCT00673244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110963354|NCT02517788|Interferons|interferons|mesh-list
110963355|NCT02517788|Interferon-beta|interferon-beta|mesh-list
110963356|NCT02517788|Interferon beta-1a|interferon beta-1a|mesh-list
110963357|NCT02517788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110963358|NCT02517788|Antiviral Agents|antiviral agents|mesh-ancestor
110963359|NCT02517788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110963360|NCT02517788|Immunologic Factors|immunologic factors|mesh-ancestor
110963361|NCT02517788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110963362|NCT02517788|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110963363|NCT04599790|Lenvatinib|lenvatinib|mesh-list
110963364|NCT04599790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110963365|NCT04599790|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110963366|NCT04599790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110963367|NCT04599790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110963368|NCT03132168|Anesthetics|anesthetics|mesh-list
110963369|NCT03132168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110963370|NCT03132168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110963371|NCT04937062|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
110963372|NCT04937062|Glycerol|glycerol|mesh-list
110963373|NCT04937062|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
110963374|NCT04937062|Protective Agents|protective agents|mesh-ancestor
110963375|NCT04937062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110963376|NCT04937062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110963377|NCT02324010|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110963378|NCT02324010|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110963379|NCT02324010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110963380|NCT02324010|Incretins|incretins|mesh-ancestor
110963381|NCT02324010|Hormones|hormones|mesh-ancestor
110963382|NCT02324010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110963383|NCT02324010|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110963384|NCT02324010|Protease Inhibitors|protease inhibitors|mesh-ancestor
110963385|NCT02324010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110963386|NCT02324010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110963387|NCT02320734|Rocuronium|rocuronium|mesh-list
110963388|NCT02320734|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110963389|NCT02320734|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110963390|NCT02320734|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110963391|NCT02320734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110963392|NCT02320734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110963393|NCT03346226|Dexmedetomidine|dexmedetomidine|mesh-list
110963394|NCT03346226|Propofol|propofol|mesh-list
110963395|NCT03346226|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110675454|NCT04865419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110675455|NCT04865419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110675456|NCT04865419|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110675457|NCT04808505|Miglustat|miglustat|mesh-list
110675458|NCT04808505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110675459|NCT04808505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110675460|NCT04808505|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110963396|NCT03346226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110963397|NCT03346226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110963398|NCT03346226|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110963399|NCT03346226|Analgesics|analgesics|mesh-ancestor
110963400|NCT03346226|Sensory System Agents|sensory system agents|mesh-ancestor
110963401|NCT03346226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110963402|NCT03346226|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110963403|NCT03346226|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110963404|NCT03346226|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110963405|NCT03346226|Adrenergic Agents|adrenergic agents|mesh-ancestor
110963406|NCT03346226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110963407|NCT03346226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110963408|NCT03346226|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110963409|NCT03346226|Anesthetics, General|anesthetics, general|mesh-ancestor
110963410|NCT03346226|Anesthetics|anesthetics|mesh-ancestor
110963411|NCT03347240|Baclofen|baclofen|mesh-list
110963412|NCT03347240|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110963413|NCT03347240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110963414|NCT03347240|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110963415|NCT03347240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110963416|NCT03347240|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
110963417|NCT03347240|GABA Agonists|gaba agonists|mesh-ancestor
110963418|NCT03347240|GABA Agents|gaba agents|mesh-ancestor
110963419|NCT03347240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110963420|NCT03347240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110963421|NCT02324088|Cyclophosphamide|cyclophosphamide|mesh-list
110963422|NCT02324088|Docetaxel|docetaxel|mesh-list
110963423|NCT02324088|Epirubicin|epirubicin|mesh-list
110963424|NCT02324088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110963425|NCT02324088|Immunologic Factors|immunologic factors|mesh-ancestor
110963426|NCT02324088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110963427|NCT02324088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110963428|NCT02324088|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110963429|NCT02324088|Alkylating Agents|alkylating agents|mesh-ancestor
110963430|NCT02324088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110963431|NCT02324088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110398010|NCT02875717|Analgesics|analgesics|mesh-ancestor
110963432|NCT02324088|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110963433|NCT02324088|Tubulin Modulators|tubulin modulators|mesh-ancestor
110963434|NCT02324088|Antimitotic Agents|antimitotic agents|mesh-ancestor
110963435|NCT02324088|Mitosis Modulators|mitosis modulators|mesh-ancestor
110963436|NCT02324088|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111490699|NCT01740726|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111490700|NCT01740726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111490701|NCT01740726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111490703|NCT01740726|Serotonin Agents|serotonin agents|mesh-ancestor
110963437|NCT02324088|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110963438|NCT02324088|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110963439|NCT02324088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110963440|NCT02324166|Cefazolin|cefazolin|mesh-list
110963441|NCT02324166|Lidocaine|lidocaine|mesh-list
110963442|NCT02324166|Anesthetics, Local|anesthetics, local|mesh-ancestor
110963443|NCT02324166|Anesthetics|anesthetics|mesh-ancestor
110963444|NCT02324166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110963445|NCT02324166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110963446|NCT02324166|Sensory System Agents|sensory system agents|mesh-ancestor
110963447|NCT02324166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110963448|NCT02324166|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110963449|NCT02324166|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110963450|NCT02324166|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110963451|NCT02324166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110963452|NCT02324166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110963453|NCT02324166|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110963454|NCT02324166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110963455|NCT03346538|Edaravone|edaravone|mesh-list
110963456|NCT03346538|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110963457|NCT03346538|Antioxidants|antioxidants|mesh-ancestor
110963458|NCT03346538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110675537|NCT04506567|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
110675538|NCT04506567|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110675539|NCT04506567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110675540|NCT04361708|Leucovorin|leucovorin|mesh-list
110675541|NCT04361708|Docetaxel|docetaxel|mesh-list
110675542|NCT04361708|Fluorouracil|fluorouracil|mesh-list
110675543|NCT04361708|Oxaliplatin|oxaliplatin|mesh-list
110675544|NCT04361708|Irinotecan|irinotecan|mesh-list
110675545|NCT04361708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110675546|NCT04361708|Tubulin Modulators|tubulin modulators|mesh-ancestor
110675547|NCT04361708|Antimitotic Agents|antimitotic agents|mesh-ancestor
110675548|NCT04361708|Mitosis Modulators|mitosis modulators|mesh-ancestor
110675549|NCT04361708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110963459|NCT03346538|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110963460|NCT03346538|Protective Agents|protective agents|mesh-ancestor
110963461|NCT03346538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110963462|NCT02513342|Docetaxel|docetaxel|mesh-list
110963463|NCT02513342|Endostar protein|endostar protein|mesh-list
110963464|NCT02513342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110963465|NCT02513342|Tubulin Modulators|tubulin modulators|mesh-ancestor
110963466|NCT02513342|Antimitotic Agents|antimitotic agents|mesh-ancestor
110963467|NCT02513342|Mitosis Modulators|mitosis modulators|mesh-ancestor
110963468|NCT02513342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110963469|NCT02513342|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110963470|NCT02513342|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110963471|NCT02513342|Growth Substances|growth substances|mesh-ancestor
110963472|NCT02513342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110963473|NCT02513342|Growth Inhibitors|growth inhibitors|mesh-ancestor
110963474|NCT03495024|Varenicline|varenicline|mesh-list
110963475|NCT03495024|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110963476|NCT03495024|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110963477|NCT03495024|Cholinergic Agents|cholinergic agents|mesh-ancestor
110963478|NCT03495024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110963479|NCT03495024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110963480|NCT03495024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110963481|NCT04188314|Desflurane|desflurane|mesh-list
110963482|NCT04188314|Isoflurane|isoflurane|mesh-list
110963483|NCT04188314|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110963484|NCT04188314|Anesthetics, General|anesthetics, general|mesh-ancestor
110963485|NCT04188314|Anesthetics|anesthetics|mesh-ancestor
110963486|NCT04188314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110963487|NCT04188314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110963488|NCT05512780|Letrozole|letrozole|mesh-list
110963489|NCT05512780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110963490|NCT05512780|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110963491|NCT05512780|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110963492|NCT05512780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110963493|NCT05512780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110963494|NCT05512780|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110963495|NCT05512780|Hormone Antagonists|hormone antagonists|mesh-ancestor
110963496|NCT05512780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110963497|NCT05512780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110963498|NCT02517164|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
110963499|NCT02517164|Calcifediol|calcifediol|mesh-list
110963500|NCT02517164|Vitamins|vitamins|mesh-ancestor
110963501|NCT02517164|Micronutrients|micronutrients|mesh-ancestor
110963502|NCT02517164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110963503|NCT02517164|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110963504|NCT04834362|Insulin|insulin|mesh-list
110963505|NCT04834362|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110963506|NCT04834362|Insulin Glargine|insulin glargine|mesh-list
110963507|NCT04834362|Insulin Aspart|insulin aspart|mesh-list
110963508|NCT04834362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110963509|NCT04834362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110963510|NCT05512702|Heparin|heparin|mesh-list
110963511|NCT05512702|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
110963512|NCT05512702|Plasminogen|plasminogen|mesh-list
110963513|NCT05512702|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
110963514|NCT05512702|Tinzaparin|tinzaparin|mesh-list
110963515|NCT05512702|Dalteparin|dalteparin|mesh-list
110963516|NCT05512702|Anticoagulants|anticoagulants|mesh-ancestor
110963517|NCT05512702|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110963518|NCT05512702|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110963519|NCT05512702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110963520|NCT05512546|Aspirin|aspirin|mesh-list
110963521|NCT05512546|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110963522|NCT05512546|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110963523|NCT05512546|Analgesics|analgesics|mesh-ancestor
110963524|NCT05512546|Sensory System Agents|sensory system agents|mesh-ancestor
110963525|NCT05512546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110963526|NCT05512546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110963527|NCT05512546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110963528|NCT05512546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110963529|NCT05512546|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110963530|NCT05512546|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110963531|NCT05512546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110963532|NCT05512546|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110963533|NCT05512546|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110963534|NCT05512546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110963536|NCT03345134|Pembrolizumab|pembrolizumab|mesh-list
110963537|NCT03345134|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110963538|NCT03345134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110963539|NCT03345134|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110963540|NCT03345134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110963541|NCT02512562|Simeprevir|simeprevir|mesh-list
110963542|NCT02512562|Odalasvir|odalasvir|mesh-list
110963543|NCT02512562|Antiviral Agents|antiviral agents|mesh-ancestor
110963544|NCT02512562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110963545|NCT02512562|Protease Inhibitors|protease inhibitors|mesh-ancestor
110963546|NCT02512562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110963547|NCT02512562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110963548|NCT02516774|Adalimumab|adalimumab|mesh-list
110963549|NCT02516774|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110963550|NCT02516774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110963551|NCT02516774|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110963552|NCT05510986|Fentanyl|fentanyl|mesh-list
110963553|NCT05510986|Oxycodone|oxycodone|mesh-list
110963554|NCT05510986|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110963555|NCT05510986|Narcotics|narcotics|mesh-ancestor
110963556|NCT05510986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110963557|NCT05510986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110963558|NCT05510986|Analgesics|analgesics|mesh-ancestor
110963559|NCT05510986|Sensory System Agents|sensory system agents|mesh-ancestor
110963560|NCT05510986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110963561|NCT05510986|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110963562|NCT05510986|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110963563|NCT05510986|Anesthetics, General|anesthetics, general|mesh-ancestor
110963564|NCT05510986|Anesthetics|anesthetics|mesh-ancestor
110963565|NCT04872400|Vancomycin|vancomycin|mesh-list
110963566|NCT04872400|Tobramycin|tobramycin|mesh-list
110963567|NCT04872400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110963568|NCT04872400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110963569|NCT00101907|Gemcitabine|gemcitabine|mesh-list
110963570|NCT00101907|Panitumumab|panitumumab|mesh-list
110963571|NCT00101907|Motesanib diphosphate|motesanib diphosphate|mesh-list
110963572|NCT00101907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110963573|NCT00101907|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110963574|NCT00101907|Antimetabolites|antimetabolites|mesh-ancestor
110963575|NCT00101907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110963576|NCT00101907|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110963578|NCT00101907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110963579|NCT03491748|Cefpodoxime|cefpodoxime|mesh-list
110963580|NCT03491748|Cefpodoxime proxetil|cefpodoxime proxetil|mesh-list
110963581|NCT03491748|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110963582|NCT03491748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110963583|NCT04769206|Galantamine|galantamine|mesh-list
110963584|NCT04769206|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110963585|NCT04769206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110963586|NCT04769206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110963587|NCT04769206|Cholinergic Agents|cholinergic agents|mesh-ancestor
110963588|NCT04769206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110963589|NCT04769206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110963590|NCT04769206|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110963591|NCT04769206|Autonomic Agents|autonomic agents|mesh-ancestor
110963592|NCT04769206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110963593|NCT04769206|Nootropic Agents|nootropic agents|mesh-ancestor
110963594|NCT03492996|Delpazolid|delpazolid|mesh-list
110963595|NCT03492996|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110963596|NCT03492996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110963597|NCT03492996|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110963598|NCT03492996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110963599|NCT03492996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110963600|NCT02161965|Warfarin|warfarin|mesh-list
110963601|NCT02161965|Rivaroxaban|rivaroxaban|mesh-list
110963602|NCT02161965|Fluindione|fluindione|mesh-list
110963603|NCT02161965|Phenindione|phenindione|mesh-list
110963604|NCT02161965|Anticoagulants|anticoagulants|mesh-ancestor
110963605|NCT02161965|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110963606|NCT02161965|Antithrombins|antithrombins|mesh-ancestor
110963607|NCT02161965|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110963608|NCT02161965|Protease Inhibitors|protease inhibitors|mesh-ancestor
110963609|NCT02161965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110963610|NCT02161965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110963611|NCT02050308|Nicotine|nicotine|mesh-list
110963612|NCT02050308|Varenicline|varenicline|mesh-list
110963613|NCT02050308|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110963614|NCT02050308|Autonomic Agents|autonomic agents|mesh-ancestor
110963615|NCT02050308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110963616|NCT02050308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110963617|NCT02050308|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110963618|NCT02050308|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110963619|NCT02050308|Cholinergic Agents|cholinergic agents|mesh-ancestor
110963620|NCT02050308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110963621|NCT02050308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110963622|NCT02516618|Fasinumab|fasinumab|mesh-list
110963623|NCT02516618|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110963624|NCT02516618|Analgesics|analgesics|mesh-ancestor
110963625|NCT02516618|Sensory System Agents|sensory system agents|mesh-ancestor
110963626|NCT02516618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110963627|NCT02516618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110963628|NCT05507554|Analgesics|analgesics|mesh-list
110963629|NCT05507554|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
110963630|NCT05507554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110963631|NCT05507554|Sensory System Agents|sensory system agents|mesh-ancestor
110963632|NCT05507554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110963633|NCT02516462|Hormones|hormones|mesh-list
110963634|NCT02516462|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
110963635|NCT02516462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110963636|NCT02516462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110963637|NCT04650204|Anticonvulsants|anticonvulsants|mesh-list
110963638|NCT04501250|Insulin|insulin|mesh-list
110963639|NCT04501250|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110963640|NCT04501250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110963641|NCT04501250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110963642|NCT02761629|Interferons|interferons|mesh-list
110963643|NCT02761629|Ribavirin|ribavirin|mesh-list
110963644|NCT02761629|Interferon-alpha|interferon-alpha|mesh-list
110963645|NCT02761629|Interferon alpha-2|interferon alpha-2|mesh-list
110963646|NCT02761629|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
111490704|NCT01740726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110963647|NCT02761629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110963648|NCT02761629|Antiviral Agents|antiviral agents|mesh-ancestor
110963649|NCT02761629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110963650|NCT02761629|Antimetabolites|antimetabolites|mesh-ancestor
110698811|NCT01324596|Hormones|hormones|mesh-ancestor
111490705|NCT01740726|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111490707|NCT01740726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110963651|NCT02761629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110963652|NCT02761629|Immunologic Factors|immunologic factors|mesh-ancestor
110963653|NCT02761629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110963654|NCT03345992|Clarithromycin|clarithromycin|mesh-list
110963655|NCT03345992|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110963656|NCT03345992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110963657|NCT03345992|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110963658|NCT03345992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110963659|NCT03345992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110963660|NCT03345992|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110963661|NCT03345992|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110963662|NCT02162121|Ketorolac|ketorolac|mesh-list
110963663|NCT02162121|Buprenorphine|buprenorphine|mesh-list
110963664|NCT02162121|Anesthetics|anesthetics|mesh-list
110963665|NCT02162121|Ropivacaine|ropivacaine|mesh-list
110963666|NCT02162121|Levobupivacaine|levobupivacaine|mesh-list
110963667|NCT02162121|Mepivacaine|mepivacaine|mesh-list
110963668|NCT02162121|Anesthetics, Local|anesthetics, local|mesh-list
110963669|NCT02162121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110963670|NCT02162121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110963671|NCT02162121|Sensory System Agents|sensory system agents|mesh-ancestor
110963672|NCT02162121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110963673|NCT02162121|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110963674|NCT02162121|Narcotics|narcotics|mesh-ancestor
110963675|NCT02162121|Analgesics|analgesics|mesh-ancestor
110963676|NCT02162121|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110963677|NCT02162121|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110963678|NCT02162121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110963679|NCT02162121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110963680|NCT02162121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110963681|NCT02162121|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110963682|NCT02162121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110963683|NCT02162121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110963684|NCT02511704|Nicotine|nicotine|mesh-list
110963685|NCT02511704|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110963686|NCT02511704|Autonomic Agents|autonomic agents|mesh-ancestor
110963687|NCT02511704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110675752|NCT03270059|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
110963688|NCT02511704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110963689|NCT02511704|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110963690|NCT02511704|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110963691|NCT02511704|Cholinergic Agents|cholinergic agents|mesh-ancestor
110963692|NCT02511704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110963693|NCT02511704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110963694|NCT04500704|Carboplatin|carboplatin|mesh-list
110963696|NCT04500704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110963697|NCT04500704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110963698|NCT04500704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110963699|NCT04500704|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110963700|NCT04500704|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110963701|NCT02164773|Magnesium Sulfate|magnesium sulfate|mesh-list
110963702|NCT02164773|Analgesics|analgesics|mesh-ancestor
110963703|NCT02164773|Sensory System Agents|sensory system agents|mesh-ancestor
110963704|NCT02164773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110963705|NCT02164773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110963706|NCT02164773|Anesthetics|anesthetics|mesh-ancestor
110963707|NCT02164773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110963708|NCT02164773|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110963709|NCT02164773|Anticonvulsants|anticonvulsants|mesh-ancestor
110963710|NCT02164773|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110963711|NCT02164773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110963712|NCT02164773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110963713|NCT02164773|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110963714|NCT02164773|Tocolytic Agents|tocolytic agents|mesh-ancestor
110963715|NCT02164773|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110963716|NCT00101439|Ezetimibe|ezetimibe|mesh-list
110963717|NCT00101439|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110963718|NCT00101439|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110963719|NCT00101439|Antimetabolites|antimetabolites|mesh-ancestor
110963720|NCT00101439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110963721|NCT00101439|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110963722|NCT03344822|Choline|choline|mesh-list
110963723|NCT03344822|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
110963724|NCT03344822|Lipotropic Agents|lipotropic agents|mesh-ancestor
110963725|NCT03344822|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110963726|NCT03344822|Antimetabolites|antimetabolites|mesh-ancestor
110963727|NCT03344822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110963728|NCT03344822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110963729|NCT03344822|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110963730|NCT03344822|Nootropic Agents|nootropic agents|mesh-ancestor
110963731|NCT03344822|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110963732|NCT02162745|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110963733|NCT02506790|Toremifene|toremifene|mesh-list
110963734|NCT02506790|Metformin|metformin|mesh-list
110963735|NCT02506790|Melatonin|melatonin|mesh-list
110963736|NCT02506790|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110963737|NCT02506790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110963738|NCT02506790|Antioxidants|antioxidants|mesh-ancestor
110963739|NCT02506790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110963740|NCT02506790|Protective Agents|protective agents|mesh-ancestor
110963741|NCT02506790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110963742|NCT02506790|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110963743|NCT02506790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110963744|NCT02506790|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110963745|NCT02506790|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110963746|NCT02506790|Hormone Antagonists|hormone antagonists|mesh-ancestor
110963747|NCT02506790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110963748|NCT02506790|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110963749|NCT04500002|Isoniazid|isoniazid|mesh-list
110963750|NCT04500002|Misoprostol|misoprostol|mesh-list
110963751|NCT04500002|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110963752|NCT04500002|Abortifacient Agents|abortifacient agents|mesh-ancestor
110963753|NCT04500002|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110963754|NCT04500002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110963755|NCT04500002|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110963756|NCT04500002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110963757|NCT04500002|Oxytocics|oxytocics|mesh-ancestor
110963758|NCT04500002|Antitubercular Agents|antitubercular agents|mesh-ancestor
110963759|NCT04500002|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110963760|NCT04500002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110963761|NCT04500002|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
110963762|NCT04500002|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110963764|NCT04500002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110963765|NCT04500002|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110963766|NCT02515682|Equol|equol|mesh-list
110963767|NCT02515682|Phytoestrogens|phytoestrogens|mesh-ancestor
110963768|NCT02515682|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
110963769|NCT02515682|Estrogens|estrogens|mesh-ancestor
110963770|NCT02515682|Hormones|hormones|mesh-ancestor
110963771|NCT02515682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110963772|NCT02515682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110963773|NCT02515604|Misoprostol|misoprostol|mesh-list
110963774|NCT02515604|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110963775|NCT02515604|Abortifacient Agents|abortifacient agents|mesh-ancestor
110963776|NCT02515604|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110963777|NCT02515604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110963778|NCT02515604|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110963779|NCT02515604|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110963780|NCT02515604|Oxytocics|oxytocics|mesh-ancestor
110963781|NCT02510534|Menotropins|menotropins|mesh-list
110963782|NCT02510534|Progesterone|progesterone|mesh-list
110963783|NCT02510534|Progestins|progestins|mesh-ancestor
110963784|NCT02510534|Hormones|hormones|mesh-ancestor
110963785|NCT02510534|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110963786|NCT02510534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110963787|NCT02510534|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110963788|NCT02510534|Fertility Agents|fertility agents|mesh-ancestor
110963789|NCT02510534|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110963790|NCT02510612|Dexmedetomidine|dexmedetomidine|mesh-list
110963791|NCT02510612|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111490708|NCT01740726|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111490709|NCT01740726|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111490710|NCT01740726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110963792|NCT02510612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110963793|NCT02510612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110963794|NCT02510612|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110963795|NCT02510612|Analgesics|analgesics|mesh-ancestor
110963796|NCT02510612|Sensory System Agents|sensory system agents|mesh-ancestor
110963797|NCT02510612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110963798|NCT02510612|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110963799|NCT02510612|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110963800|NCT02510612|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110963801|NCT02510612|Adrenergic Agents|adrenergic agents|mesh-ancestor
110963802|NCT02510612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110963803|NCT02510612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110963804|NCT03749616|Acetaminophen|acetaminophen|mesh-list
110963805|NCT03749616|Ibuprofen|ibuprofen|mesh-list
110963806|NCT03749616|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110963807|NCT03749616|Analgesics|analgesics|mesh-ancestor
110963808|NCT03749616|Sensory System Agents|sensory system agents|mesh-ancestor
111490711|NCT01742208|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
111490712|NCT01742208|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111490713|NCT01742208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111490714|NCT01742208|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110963809|NCT03749616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110963810|NCT03749616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110963811|NCT03749616|Antipyretics|antipyretics|mesh-ancestor
110963812|NCT03749616|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110963813|NCT03749616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110963814|NCT03749616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110963815|NCT03749616|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110963816|NCT03749616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110963817|NCT03749616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110963818|NCT04532502|Anesthetics|anesthetics|mesh-list
110963819|NCT04532502|Anesthetics, Inhalation|anesthetics, inhalation|mesh-list
110963820|NCT04532502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110963821|NCT04532502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110963822|NCT04532502|Anesthetics, General|anesthetics, general|mesh-ancestor
110963823|NCT02515526|Tolbutamide|tolbutamide|mesh-list
110963824|NCT02515526|Ethanol|ethanol|mesh-list
110963825|NCT02515526|Digoxin|digoxin|mesh-list
110963826|NCT02515526|Midazolam|midazolam|mesh-list
110963827|NCT02515526|Dextromethorphan|dextromethorphan|mesh-list
110963828|NCT02515526|Caffeine|caffeine|mesh-list
110963829|NCT02515526|Omeprazole|omeprazole|mesh-list
110963830|NCT02515526|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110963831|NCT02515526|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110675904|NCT02597062|Cyclophosphamide|cyclophosphamide|mesh-list
110687708|NCT00316186|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110675905|NCT02597062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110675906|NCT02597062|Immunologic Factors|immunologic factors|mesh-ancestor
110675907|NCT02597062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110963832|NCT02515526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110963833|NCT02515526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110963834|NCT02515526|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110963835|NCT02515526|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110963836|NCT02515526|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110963837|NCT02515526|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110963838|NCT02515526|Anesthetics, General|anesthetics, general|mesh-ancestor
110963839|NCT02515526|Anesthetics|anesthetics|mesh-ancestor
110963840|NCT02515526|GABA Modulators|gaba modulators|mesh-ancestor
110963841|NCT02515526|GABA Agents|gaba agents|mesh-ancestor
110963842|NCT02515526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110963843|NCT02515526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111490715|NCT01742208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111490716|NCT01744704|Mitogens|mitogens|mesh-list
111490717|NCT01744704|Mitosis Modulators|mitosis modulators|mesh-ancestor
111490718|NCT01744704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111490719|NCT01746264|Vitamin D|vitamin d|mesh-list
111490720|NCT01746264|Cholecalciferol|cholecalciferol|mesh-list
111490721|NCT01746264|Vitamins|vitamins|mesh-ancestor
111490722|NCT01746264|Micronutrients|micronutrients|mesh-ancestor
111490723|NCT01746264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111490724|NCT01746264|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111490725|NCT01746264|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111490726|NCT01746420|Becaplermin|becaplermin|mesh-list
111490727|NCT01746420|Anticoagulants|anticoagulants|mesh-ancestor
110963844|NCT02515526|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110963845|NCT02515526|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110963846|NCT02515526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111490728|NCT01746420|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
111490729|NCT01746420|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111490730|NCT01746420|Growth Substances|growth substances|mesh-ancestor
110963847|NCT02515526|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110963848|NCT02515526|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110963849|NCT02515526|Purinergic Agents|purinergic agents|mesh-ancestor
110963850|NCT02515526|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110963851|NCT02515526|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110963852|NCT02515526|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110963853|NCT02515526|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110963854|NCT02515526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110963855|NCT02515526|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110963856|NCT02515526|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110963857|NCT02515526|Protective Agents|protective agents|mesh-ancestor
110963858|NCT02515526|Antitussive Agents|antitussive agents|mesh-ancestor
110963859|NCT02515526|Respiratory System Agents|respiratory system agents|mesh-ancestor
110963860|NCT02515526|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110963861|NCT02515526|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110963862|NCT02515526|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110963863|NCT02515448|Gentamicins|gentamicins|mesh-list
110963864|NCT02515448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110963865|NCT02515448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110963866|NCT02515448|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110963867|NCT02515448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110963868|NCT02515448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110963869|NCT02170857|Hyaluronic Acid|hyaluronic acid|mesh-list
110963870|NCT02170857|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110963871|NCT02170857|Immunologic Factors|immunologic factors|mesh-ancestor
110963872|NCT02170857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110963873|NCT02170857|Viscosupplements|viscosupplements|mesh-ancestor
110650338|NCT02538926|Cortisone|cortisone|mesh-list
110963874|NCT02170857|Protective Agents|protective agents|mesh-ancestor
110963875|NCT04460820|Doxorubicin|doxorubicin|mesh-list
110963876|NCT04460820|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110963877|NCT04460820|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110963878|NCT04460820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110963879|NCT04460820|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110963880|NCT04460820|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110963881|NCT04460820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110963882|NCT04460820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110963883|NCT02170935|Dabigatran|dabigatran|mesh-list
110963884|NCT02170935|Antithrombins|antithrombins|mesh-ancestor
110963885|NCT02170935|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110963886|NCT02170935|Protease Inhibitors|protease inhibitors|mesh-ancestor
110963887|NCT02170935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110963888|NCT02170935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110963889|NCT02170935|Anticoagulants|anticoagulants|mesh-ancestor
110963890|NCT03488316|Calcium|calcium|mesh-list
110963891|NCT03488316|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110963892|NCT03488316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110963893|NCT02510222|Magnesium Sulfate|magnesium sulfate|mesh-list
110963894|NCT02510222|Analgesics|analgesics|mesh-ancestor
110963895|NCT02510222|Sensory System Agents|sensory system agents|mesh-ancestor
110963896|NCT02510222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110963897|NCT02510222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110963898|NCT02510222|Anesthetics|anesthetics|mesh-ancestor
110963899|NCT02510222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110963900|NCT02510222|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110963901|NCT02510222|Anticonvulsants|anticonvulsants|mesh-ancestor
110963902|NCT02510222|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110963903|NCT02510222|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110963904|NCT02510222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110963905|NCT02510222|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110963906|NCT02510222|Tocolytic Agents|tocolytic agents|mesh-ancestor
110675978|NCT00993655|Paclitaxel|paclitaxel|mesh-list
110963907|NCT02510222|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110963908|NCT05100264|Acetic Acid|acetic acid|mesh-list
110963909|NCT05100264|Retinol acetate|retinol acetate|mesh-list
110963910|NCT05100264|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110963911|NCT05100264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110963912|NCT05100264|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111490731|NCT01746420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110963913|NCT05100264|Immunologic Factors|immunologic factors|mesh-ancestor
110963914|NCT05100264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110963915|NCT05100264|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110963916|NCT05100264|Protective Agents|protective agents|mesh-ancestor
110963917|NCT05100264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110963918|NCT02505776|Bimatoprost|bimatoprost|mesh-list
110963919|NCT02505776|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110963921|NCT02171013|Antithrombins|antithrombins|mesh-ancestor
110963922|NCT02171013|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110963923|NCT02171013|Protease Inhibitors|protease inhibitors|mesh-ancestor
110963924|NCT02171013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110963925|NCT02171013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110963926|NCT02171013|Anticoagulants|anticoagulants|mesh-ancestor
110963927|NCT02167425|Methadone|methadone|mesh-list
110963928|NCT02167425|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110963929|NCT02167425|Narcotics|narcotics|mesh-ancestor
110963930|NCT02167425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110963931|NCT02167425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110963932|NCT02167425|Analgesics|analgesics|mesh-ancestor
110963933|NCT02167425|Sensory System Agents|sensory system agents|mesh-ancestor
110963934|NCT02167425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110963935|NCT02167425|Antitussive Agents|antitussive agents|mesh-ancestor
110963936|NCT02167425|Respiratory System Agents|respiratory system agents|mesh-ancestor
110963937|NCT03111732|Pembrolizumab|pembrolizumab|mesh-list
110963938|NCT03111732|Capecitabine|capecitabine|mesh-list
110963939|NCT03111732|Oxaliplatin|oxaliplatin|mesh-list
110963940|NCT03111732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110963941|NCT03111732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110963942|NCT03111732|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110963943|NCT03111732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110963944|NCT03111732|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110963945|NCT03111732|Antimetabolites|antimetabolites|mesh-ancestor
110963946|NCT01663714|Tositumomab I-131|tositumomab i-131|mesh-list
110963947|NCT01663714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110963948|NCT02505386|Ertapenem|ertapenem|mesh-list
110963949|NCT02505386|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110963950|NCT02505386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110963951|NCT05507086|Anti-Infective Agents|anti-infective agents|mesh-list
110963952|NCT05507086|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110963953|NCT02514980|Ketamine|ketamine|mesh-list
110963954|NCT02514980|Bupivacaine|bupivacaine|mesh-list
110963955|NCT02514980|Anesthetics, Local|anesthetics, local|mesh-ancestor
110963956|NCT02514980|Anesthetics|anesthetics|mesh-ancestor
110963957|NCT02514980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110963958|NCT02514980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110963959|NCT02514980|Sensory System Agents|sensory system agents|mesh-ancestor
110963960|NCT02514980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110963961|NCT02514980|Analgesics|analgesics|mesh-ancestor
110963962|NCT02514980|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110963963|NCT02514980|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110963964|NCT02514980|Anesthetics, General|anesthetics, general|mesh-ancestor
110963965|NCT02514980|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110963966|NCT02514980|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110963967|NCT02514980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110963968|NCT02514980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110963969|NCT02165475|Loperamide|loperamide|mesh-list
110963970|NCT02165475|Antidiarrheals|antidiarrheals|mesh-list
110963971|NCT02165475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110963972|NCT04862338|Niacinamide|niacinamide|mesh-list
110963973|NCT04862338|Niacin|niacin|mesh-list
110963974|NCT04862338|Nicotinic Acids|nicotinic acids|mesh-list
110963975|NCT04862338|Vitamin B Complex|vitamin b complex|mesh-ancestor
110963976|NCT04862338|Vitamins|vitamins|mesh-ancestor
110963977|NCT04862338|Micronutrients|micronutrients|mesh-ancestor
110963978|NCT04862338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110963979|NCT04862338|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110963980|NCT04862338|Antimetabolites|antimetabolites|mesh-ancestor
111490732|NCT01749930|Timolol|timolol|mesh-list
111490733|NCT01749930|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111490734|NCT01749930|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111490735|NCT01749930|Adrenergic Agents|adrenergic agents|mesh-ancestor
111490736|NCT01749930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111490737|NCT01749930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111490738|NCT01749930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111490739|NCT01749930|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111490740|NCT01749930|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110963981|NCT04862338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111490741|NCT01750086|Denosumab|denosumab|mesh-list
111490742|NCT01750086|Alendronate|alendronate|mesh-list
111490743|NCT01750086|Teriparatide|teriparatide|mesh-list
110963982|NCT04862338|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110963983|NCT04862338|Vasodilator Agents|vasodilator agents|mesh-ancestor
111490744|NCT01750086|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110963984|NCT02171325|Irinotecan|irinotecan|mesh-list
110963985|NCT02171325|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110963986|NCT02171325|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110963987|NCT02171325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110963988|NCT02171325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110963989|NCT02171325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110963990|NCT02509286|Leucovorin|leucovorin|mesh-list
110963991|NCT02509286|Paclitaxel|paclitaxel|mesh-list
110963992|NCT02509286|Docetaxel|docetaxel|mesh-list
110963993|NCT02509286|Carboplatin|carboplatin|mesh-list
110963994|NCT02509286|Fluorouracil|fluorouracil|mesh-list
110963995|NCT02509286|Oxaliplatin|oxaliplatin|mesh-list
110963996|NCT02509286|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110963997|NCT02509286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110963998|NCT02509286|Tubulin Modulators|tubulin modulators|mesh-ancestor
110963999|NCT02509286|Antimitotic Agents|antimitotic agents|mesh-ancestor
110964000|NCT02509286|Mitosis Modulators|mitosis modulators|mesh-ancestor
110964001|NCT02509286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110964002|NCT02509286|Antimetabolites|antimetabolites|mesh-ancestor
110964003|NCT02509286|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110964004|NCT02509286|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110964005|NCT02509286|Immunologic Factors|immunologic factors|mesh-ancestor
110964006|NCT02509286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110964007|NCT02509286|Antidotes|antidotes|mesh-ancestor
110964008|NCT02509286|Protective Agents|protective agents|mesh-ancestor
110964009|NCT02509286|Vitamin B Complex|vitamin b complex|mesh-ancestor
110964010|NCT02509286|Vitamins|vitamins|mesh-ancestor
110964011|NCT02509286|Micronutrients|micronutrients|mesh-ancestor
110964012|NCT03065244|Infliximab|infliximab|mesh-list
110964013|NCT03065244|Immunoglobulins|immunoglobulins|mesh-list
110964014|NCT03065244|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110964015|NCT03065244|gamma-Globulins|gamma-globulins|mesh-list
110964016|NCT03065244|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110964017|NCT03065244|Immunologic Factors|immunologic factors|mesh-ancestor
110964018|NCT03065244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110964019|NCT03065244|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110964020|NCT03065244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110964021|NCT03065244|Dermatologic Agents|dermatologic agents|mesh-ancestor
110964022|NCT03065244|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110964023|NCT03065244|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110964024|NCT02171481|Dabigatran|dabigatran|mesh-list
110964025|NCT02171481|Antithrombins|antithrombins|mesh-ancestor
110964026|NCT02171481|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110964027|NCT02171481|Protease Inhibitors|protease inhibitors|mesh-ancestor
110964028|NCT02171481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110964029|NCT02171481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110964030|NCT02171481|Anticoagulants|anticoagulants|mesh-ancestor
110964031|NCT02171559|Enoxaparin|enoxaparin|mesh-list
110964032|NCT02171559|Dabigatran|dabigatran|mesh-list
110964033|NCT02171559|Anticoagulants|anticoagulants|mesh-ancestor
110964034|NCT02171559|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110964035|NCT02171559|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110964036|NCT02171559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110964037|NCT02171559|Antithrombins|antithrombins|mesh-ancestor
110964038|NCT02171559|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110964039|NCT02171559|Protease Inhibitors|protease inhibitors|mesh-ancestor
110964040|NCT02171559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110964041|NCT04901754|Apatinib|apatinib|mesh-list
110964042|NCT04901754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110964043|NCT04901754|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110964044|NCT04901754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110964045|NCT04901754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110964046|NCT02509208|Hemostatics|hemostatics|mesh-list
110964047|NCT02509208|Coagulants|coagulants|mesh-ancestor
110964048|NCT02504996|Acetaminophen|acetaminophen|mesh-list
110964049|NCT02504996|Morphine|morphine|mesh-list
110964050|NCT02504996|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110964051|NCT02504996|Narcotics|narcotics|mesh-ancestor
110964052|NCT02504996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110964053|NCT02504996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110964054|NCT02504996|Analgesics|analgesics|mesh-ancestor
111490745|NCT01750086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110964055|NCT02504996|Sensory System Agents|sensory system agents|mesh-ancestor
110964056|NCT02504996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110676130|NCT05139914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110676131|NCT05138835|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110676132|NCT05138835|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110429714|NCT01349101|Tacrolimus|tacrolimus|mesh-list
111490746|NCT01750086|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110676133|NCT05138835|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110964057|NCT02504996|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110964058|NCT02504996|Antipyretics|antipyretics|mesh-ancestor
110964059|NCT02509052|Leflunomide|leflunomide|mesh-list
110964060|NCT02509052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110964061|NCT02509052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110964062|NCT02509052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110964063|NCT02509052|Immunologic Factors|immunologic factors|mesh-ancestor
110964064|NCT02509052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110964065|NCT00100815|Bevacizumab|bevacizumab|mesh-list
110964066|NCT00100815|Gemcitabine|gemcitabine|mesh-list
110964067|NCT00100815|Capecitabine|capecitabine|mesh-list
110964068|NCT00100815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110964069|NCT00100815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110964070|NCT00100815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110964071|NCT00100815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110964072|NCT00100815|Growth Substances|growth substances|mesh-ancestor
110964073|NCT00100815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110964074|NCT00100815|Growth Inhibitors|growth inhibitors|mesh-ancestor
110964075|NCT00100815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110964076|NCT00100815|Antimetabolites|antimetabolites|mesh-ancestor
110964077|NCT00100815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110964078|NCT00708422|Travoprost|travoprost|mesh-list
110964079|NCT00708422|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110964080|NCT00708422|Latanoprost|latanoprost|mesh-list
110964081|NCT00708422|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110964082|NCT00708422|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110964083|NCT02514200|Riboflavin|riboflavin|mesh-list
110964084|NCT02514200|Vitamin B Complex|vitamin b complex|mesh-ancestor
110964085|NCT02514200|Vitamins|vitamins|mesh-ancestor
110964086|NCT02514200|Micronutrients|micronutrients|mesh-ancestor
110964087|NCT02514200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110964088|NCT02514200|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110964089|NCT02514200|Dermatologic Agents|dermatologic agents|mesh-ancestor
110964090|NCT02504450|Haloperidol|haloperidol|mesh-list
110964091|NCT02504450|Ziprasidone|ziprasidone|mesh-list
110964092|NCT02504450|Loxapine|loxapine|mesh-list
110964093|NCT02504450|Antiemetics|antiemetics|mesh-ancestor
110964094|NCT02504450|Autonomic Agents|autonomic agents|mesh-ancestor
110964095|NCT02504450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110964096|NCT02504450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110964097|NCT02504450|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110964098|NCT02504450|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110964099|NCT02504450|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110964100|NCT02504450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110964101|NCT02504450|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110964102|NCT02504450|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110964103|NCT02504450|Dopamine Agents|dopamine agents|mesh-ancestor
110964104|NCT02504450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110964105|NCT02504450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110964106|NCT02504450|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110964107|NCT02504450|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110964108|NCT02504450|Serotonin Agents|serotonin agents|mesh-ancestor
110964109|NCT02171637|Afatinib|afatinib|mesh-list
110964110|NCT02171637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111490747|NCT01750398|Methyltestosterone|methyltestosterone|mesh-list
111490748|NCT01750398|Leuprolide|leuprolide|mesh-list
111490749|NCT01750398|Goserelin|goserelin|mesh-list
111490750|NCT01750398|Testosterone|testosterone|mesh-list
111490751|NCT01750398|Testosterone undecanoate|testosterone undecanoate|mesh-list
111490752|NCT01750398|Testosterone enanthate|testosterone enanthate|mesh-list
111490753|NCT01750398|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
111490754|NCT01750398|Androgens|androgens|mesh-ancestor
111490755|NCT01750398|Hormones|hormones|mesh-ancestor
111490756|NCT01750398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111490757|NCT01750398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111490758|NCT01750398|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111490759|NCT01750398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111490760|NCT01750398|Anabolic Agents|anabolic agents|mesh-ancestor
110964111|NCT02171637|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110964112|NCT02171637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110964113|NCT02171637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110964114|NCT02171715|Afatinib|afatinib|mesh-list
110964115|NCT02171715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111490761|NCT01750398|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111490762|NCT01750398|Fertility Agents|fertility agents|mesh-ancestor
111490763|NCT01750398|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111490765|NCT01752426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110964116|NCT02171715|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110964117|NCT02171715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110964118|NCT02171715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110964119|NCT02504372|Pembrolizumab|pembrolizumab|mesh-list
110964120|NCT02504372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110964121|NCT02504372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110964122|NCT02504372|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110964123|NCT02504372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110964124|NCT02760069|Ondansetron|ondansetron|mesh-list
110964125|NCT02760069|Antiemetics|antiemetics|mesh-ancestor
110964126|NCT02760069|Autonomic Agents|autonomic agents|mesh-ancestor
110964127|NCT02760069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110964128|NCT02760069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110964129|NCT02760069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110964130|NCT02760069|Antipruritics|antipruritics|mesh-ancestor
110964131|NCT02760069|Dermatologic Agents|dermatologic agents|mesh-ancestor
110964132|NCT02760069|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110964133|NCT02760069|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110964134|NCT02760069|Serotonin Agents|serotonin agents|mesh-ancestor
110676207|NCT04998786|Hormones|hormones|mesh-ancestor
110964135|NCT02760069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110964136|NCT02760069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110964138|NCT02504138|Propofol|propofol|mesh-list
110964139|NCT02504138|Desflurane|desflurane|mesh-list
110964140|NCT02504138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110964141|NCT02504138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110964142|NCT02504138|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110964143|NCT02504138|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110964144|NCT02504138|Anesthetics, General|anesthetics, general|mesh-ancestor
110964145|NCT02504138|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110964146|NCT02508584|Antibodies|antibodies|mesh-list
110964147|NCT02508584|Immunologic Factors|immunologic factors|mesh-ancestor
110964148|NCT02508584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110964149|NCT02171793|Olodaterol|olodaterol|mesh-list
110964150|NCT02171793|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110964151|NCT02171793|Autonomic Agents|autonomic agents|mesh-ancestor
110964152|NCT02171793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110964153|NCT02171793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110964154|NCT02171793|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110964155|NCT02171793|Respiratory System Agents|respiratory system agents|mesh-ancestor
110964156|NCT02171871|Respiratory System Agents|respiratory system agents|mesh-list
110964157|NCT02508350|Daptomycin|daptomycin|mesh-list
110964158|NCT02508350|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110964159|NCT02508350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110964160|NCT02503826|Midazolam|midazolam|mesh-list
110964161|NCT02503826|Sufentanil|sufentanil|mesh-list
110964162|NCT02503826|Dsuvia|dsuvia|mesh-list
110964163|NCT02503826|Propofol|propofol|mesh-list
110964164|NCT02503826|Cisatracurium|cisatracurium|mesh-list
110964165|NCT02503826|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110964166|NCT02503826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110964167|NCT02503826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110964168|NCT02503826|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110964169|NCT02503826|Anesthetics, General|anesthetics, general|mesh-ancestor
110964170|NCT02503826|Anesthetics|anesthetics|mesh-ancestor
110964171|NCT02503826|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110964172|NCT02503826|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110964173|NCT02503826|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110964174|NCT02503826|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110964175|NCT02503826|GABA Modulators|gaba modulators|mesh-ancestor
110964176|NCT02503826|GABA Agents|gaba agents|mesh-ancestor
110964177|NCT02503826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110799550|NCT03752931|Vasodilator Agents|vasodilator agents|mesh-ancestor
110964178|NCT02503826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110964179|NCT02503826|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110964180|NCT02503826|Narcotics|narcotics|mesh-ancestor
110964181|NCT02503826|Analgesics|analgesics|mesh-ancestor
110964182|NCT02503826|Sensory System Agents|sensory system agents|mesh-ancestor
110964183|NCT02503826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110964184|NCT02503826|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
111490766|NCT01752426|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111490767|NCT01752426|Protective Agents|protective agents|mesh-ancestor
110964185|NCT02503826|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110964186|NCT03121664|Itraconazole|itraconazole|mesh-list
110964187|NCT03121664|Antifungal Agents|antifungal agents|mesh-ancestor
110964188|NCT03121664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110964189|NCT03121664|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110964190|NCT03121664|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110964191|NCT03121664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110964192|NCT03121664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110964193|NCT03121664|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110964194|NCT03121664|Hormone Antagonists|hormone antagonists|mesh-ancestor
110964195|NCT03121664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110964196|NCT03121664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110964197|NCT03121664|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110964198|NCT02503904|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110964199|NCT02503904|Metronidazole|metronidazole|mesh-list
110964200|NCT02503904|Lidocaine|lidocaine|mesh-list
110964201|NCT02503904|Epinephrine|epinephrine|mesh-list
110964202|NCT02503904|Anesthetics, Local|anesthetics, local|mesh-ancestor
110964203|NCT02503904|Anesthetics|anesthetics|mesh-ancestor
110964204|NCT02503904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110964205|NCT02503904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110964206|NCT02503904|Sensory System Agents|sensory system agents|mesh-ancestor
110964207|NCT02503904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110964208|NCT02503904|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110964209|NCT02503904|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110964210|NCT02503904|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110964211|NCT02503904|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110964212|NCT02503904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110964213|NCT02503904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110964214|NCT02503904|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110964215|NCT02503904|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110964216|NCT02503904|Adrenergic Agents|adrenergic agents|mesh-ancestor
110964217|NCT02503904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110964218|NCT02503904|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110964219|NCT02503904|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110964221|NCT02503904|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110964222|NCT02503904|Respiratory System Agents|respiratory system agents|mesh-ancestor
110964223|NCT02503904|Mydriatics|mydriatics|mesh-ancestor
110964224|NCT02503904|Sympathomimetics|sympathomimetics|mesh-ancestor
110964225|NCT02503904|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110964226|NCT02503904|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110964227|NCT02503904|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110964228|NCT02172105|Olodaterol|olodaterol|mesh-list
110964229|NCT02172105|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110964230|NCT02172105|Autonomic Agents|autonomic agents|mesh-ancestor
110964231|NCT02172105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110964232|NCT02172105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110964233|NCT02172105|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110964234|NCT02172105|Respiratory System Agents|respiratory system agents|mesh-ancestor
110964235|NCT03121352|Paclitaxel|paclitaxel|mesh-list
110964236|NCT03121352|Carboplatin|carboplatin|mesh-list
110964237|NCT03121352|Pembrolizumab|pembrolizumab|mesh-list
110964238|NCT03121352|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110964239|NCT03121352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110964240|NCT03121352|Tubulin Modulators|tubulin modulators|mesh-ancestor
110964241|NCT03121352|Antimitotic Agents|antimitotic agents|mesh-ancestor
110964242|NCT03121352|Mitosis Modulators|mitosis modulators|mesh-ancestor
110964243|NCT03121352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110964244|NCT03121352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110964245|NCT03121352|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110964246|NCT02513654|Lamotrigine|lamotrigine|mesh-list
110964247|NCT02513654|Anticonvulsants|anticonvulsants|mesh-ancestor
110964248|NCT02513654|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110964249|NCT02513654|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110964250|NCT02513654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110964251|NCT02513654|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110964252|NCT02513654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110964253|NCT02513654|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110964254|NCT02513654|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110964255|NCT02513654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111490768|NCT01752426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111490769|NCT01753362|Liraglutide|liraglutide|mesh-list
111490770|NCT01753362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111490771|NCT01753362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111490772|NCT01753362|Incretins|incretins|mesh-ancestor
111490773|NCT01753362|Hormones|hormones|mesh-ancestor
111490774|NCT01753362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111490775|NCT01758588|Interferons|interferons|mesh-list
111490776|NCT01758588|Interferon-alpha|interferon-alpha|mesh-list
110964256|NCT02513654|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110964257|NCT02513654|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110964258|NCT02513888|Vitamin D|vitamin d|mesh-list
110964259|NCT02513888|Vitamins|vitamins|mesh-ancestor
110964260|NCT02513888|Micronutrients|micronutrients|mesh-ancestor
110964261|NCT02513888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110964262|NCT02513888|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110964263|NCT00101595|Dasatinib|dasatinib|mesh-list
110964264|NCT00101595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110964265|NCT00101595|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110964266|NCT00101595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110964267|NCT00101595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110964268|NCT02174757|Doxycycline|doxycycline|mesh-list
110964269|NCT02174757|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110964270|NCT02174757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110964271|NCT02174757|Antimalarials|antimalarials|mesh-ancestor
110964272|NCT02174757|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110964273|NCT02174757|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110964274|NCT02168127|Methylphenidate|methylphenidate|mesh-list
110964275|NCT02168127|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110964276|NCT02168127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110964277|NCT02168127|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110964278|NCT02168127|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110964279|NCT02168127|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110964280|NCT02168127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110964281|NCT02168127|Dopamine Agents|dopamine agents|mesh-ancestor
110676355|NCT04848792|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110676356|NCT04848792|Protective Agents|protective agents|mesh-ancestor
110676357|NCT04848792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110676358|NCT04848792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110964282|NCT02168127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110964283|NCT02255955|Acetaminophen|acetaminophen|mesh-list
110964284|NCT02255955|Naproxen|naproxen|mesh-list
110964285|NCT02255955|Codeine|codeine|mesh-list
110964286|NCT02255955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110964287|NCT02255955|Analgesics|analgesics|mesh-ancestor
110964288|NCT02255955|Sensory System Agents|sensory system agents|mesh-ancestor
110964289|NCT02255955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110964290|NCT02255955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110964291|NCT02255955|Antipyretics|antipyretics|mesh-ancestor
110964292|NCT02255955|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110964293|NCT02255955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110964294|NCT02255955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110964295|NCT02255955|Gout Suppressants|gout suppressants|mesh-ancestor
110964296|NCT02255955|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110964297|NCT02255955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110964298|NCT02255955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110964299|NCT02255955|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110964300|NCT02255955|Narcotics|narcotics|mesh-ancestor
110964301|NCT02255955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110964302|NCT02255955|Antitussive Agents|antitussive agents|mesh-ancestor
110964303|NCT02255955|Respiratory System Agents|respiratory system agents|mesh-ancestor
110964304|NCT02172261|Glimepiride|glimepiride|mesh-list
110964305|NCT02172261|Empagliflozin|empagliflozin|mesh-list
110964306|NCT02172261|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110964307|NCT02172261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110964308|NCT02172261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110964309|NCT02172261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110964310|NCT02172261|Immunologic Factors|immunologic factors|mesh-ancestor
110964311|NCT02172261|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110964312|NCT02172261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110964313|NCT02501564|Naproxen|naproxen|mesh-list
110964314|NCT02501564|Codeine|codeine|mesh-list
110964315|NCT02501564|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110964316|NCT02501564|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110964317|NCT02501564|Analgesics|analgesics|mesh-ancestor
110964318|NCT02501564|Sensory System Agents|sensory system agents|mesh-ancestor
110964319|NCT02501564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110964320|NCT02501564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110964321|NCT02501564|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110698888|NCT00281697|Bevacizumab|bevacizumab|mesh-list
111490777|NCT01758588|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
111490778|NCT01758588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111490779|NCT01758588|Antiviral Agents|antiviral agents|mesh-ancestor
110964322|NCT02501564|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110964323|NCT02501564|Gout Suppressants|gout suppressants|mesh-ancestor
110964324|NCT02501564|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110964325|NCT02501564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110964326|NCT02501564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110964327|NCT02501564|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110964328|NCT02501564|Narcotics|narcotics|mesh-ancestor
110964329|NCT02501564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110964330|NCT02501564|Antitussive Agents|antitussive agents|mesh-ancestor
110964331|NCT02501564|Respiratory System Agents|respiratory system agents|mesh-ancestor
110964332|NCT02172339|Tiotropium Bromide|tiotropium bromide|mesh-list
110964333|NCT02172339|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110964334|NCT02172339|Autonomic Agents|autonomic agents|mesh-ancestor
110964335|NCT02172339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110964336|NCT02172339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110964337|NCT02172339|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110964338|NCT02172339|Respiratory System Agents|respiratory system agents|mesh-ancestor
110964339|NCT02172339|Parasympatholytics|parasympatholytics|mesh-ancestor
110964340|NCT02172339|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110964341|NCT02172339|Cholinergic Agents|cholinergic agents|mesh-ancestor
110964342|NCT02172339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110964343|NCT02172339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110964345|NCT02172417|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
110964346|NCT02172417|Cimetidine|cimetidine|mesh-list
110964347|NCT02172417|Tiotropium Bromide|tiotropium bromide|mesh-list
110964348|NCT02172417|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110964349|NCT02172417|Autonomic Agents|autonomic agents|mesh-ancestor
110964350|NCT02172417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110964351|NCT02172417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110964352|NCT02172417|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110964353|NCT02172417|Respiratory System Agents|respiratory system agents|mesh-ancestor
110964354|NCT02172417|Parasympatholytics|parasympatholytics|mesh-ancestor
110676436|NCT04629651|Captopril|captopril|mesh-list
110650488|NCT00733967|Varenicline|varenicline|mesh-list
110964355|NCT02172417|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110964356|NCT02172417|Cholinergic Agents|cholinergic agents|mesh-ancestor
110964358|NCT02172417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110964359|NCT02172417|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110964360|NCT02172417|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110964361|NCT02172417|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110964362|NCT02172417|Histamine Antagonists|histamine antagonists|mesh-ancestor
110964363|NCT02172417|Histamine Agents|histamine agents|mesh-ancestor
110964364|NCT02172417|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110964365|NCT02172417|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110964366|NCT02172417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110964367|NCT02168205|Pomalidomide|pomalidomide|mesh-list
110964368|NCT02168205|Caffeine|caffeine|mesh-list
110964369|NCT02168205|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110964370|NCT02168205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110964371|NCT02168205|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110964372|NCT02168205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110964373|NCT02168205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110964374|NCT02168205|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110964375|NCT02168205|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110964376|NCT02168205|Purinergic Agents|purinergic agents|mesh-ancestor
110964377|NCT02168205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110964378|NCT02168205|Immunologic Factors|immunologic factors|mesh-ancestor
110964379|NCT02168205|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110964380|NCT02168205|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110964381|NCT02168205|Growth Substances|growth substances|mesh-ancestor
110964382|NCT02168205|Growth Inhibitors|growth inhibitors|mesh-ancestor
110964383|NCT02168205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110964384|NCT03343652|Nivolumab|nivolumab|mesh-list
111490780|NCT01758588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111490781|NCT01758588|Immunologic Factors|immunologic factors|mesh-ancestor
111490782|NCT01758588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111490783|NCT01759602|Complement C1s|complement c1s|mesh-list
111490784|NCT01759602|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
111490785|NCT01759602|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
111490786|NCT01759602|Immunologic Factors|immunologic factors|mesh-ancestor
111490787|NCT01759602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110964385|NCT03343652|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110964386|NCT03343652|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111490788|NCT01759602|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
110964387|NCT03343652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110964388|NCT03343652|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110964389|NCT03343652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110964390|NCT03343652|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110964391|NCT03343652|Alkylating Agents|alkylating agents|mesh-ancestor
110964392|NCT02175069|Ropivacaine|ropivacaine|mesh-list
110964393|NCT02175069|Anesthetics, Local|anesthetics, local|mesh-ancestor
110964394|NCT02175069|Anesthetics|anesthetics|mesh-ancestor
110964395|NCT02175069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110964396|NCT02175069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110964397|NCT02175069|Sensory System Agents|sensory system agents|mesh-ancestor
110964398|NCT02175069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110964399|NCT04498520|Fulvestrant|fulvestrant|mesh-list
110964400|NCT04498520|Palbociclib|palbociclib|mesh-list
110964401|NCT04498520|Abexinostat|abexinostat|mesh-list
110964402|NCT04498520|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110964403|NCT04498520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110964404|NCT04498520|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110964405|NCT04498520|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110964406|NCT04498520|Hormone Antagonists|hormone antagonists|mesh-ancestor
110964407|NCT04498520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110964408|NCT04498520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110964409|NCT04498520|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110964410|NCT04498520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110964411|NCT04498520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110964412|NCT04498520|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110964414|NCT02172495|Tiotropium Bromide|tiotropium bromide|mesh-list
110964415|NCT02172495|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110964416|NCT02172495|Autonomic Agents|autonomic agents|mesh-ancestor
110964417|NCT02172495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110964418|NCT02172495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110964419|NCT02172495|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110964420|NCT02172495|Respiratory System Agents|respiratory system agents|mesh-ancestor
110964421|NCT02172495|Parasympatholytics|parasympatholytics|mesh-ancestor
110964422|NCT02172495|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110964423|NCT02172495|Cholinergic Agents|cholinergic agents|mesh-ancestor
110964424|NCT02172495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110964425|NCT02172495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110964426|NCT02172495|Anticonvulsants|anticonvulsants|mesh-ancestor
110964427|NCT02172573|Pramipexole|pramipexole|mesh-list
110964428|NCT02172573|Bromocriptine|bromocriptine|mesh-list
110964429|NCT02172573|Antioxidants|antioxidants|mesh-ancestor
110964430|NCT02172573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110964431|NCT02172573|Protective Agents|protective agents|mesh-ancestor
110964432|NCT02172573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110964433|NCT02172573|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110964434|NCT02172573|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110964435|NCT02172573|Dopamine Agonists|dopamine agonists|mesh-ancestor
110964436|NCT02172573|Dopamine Agents|dopamine agents|mesh-ancestor
110964437|NCT02172573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110964438|NCT02172573|Hormone Antagonists|hormone antagonists|mesh-ancestor
110964439|NCT02172573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110964440|NCT02175381|Carboplatin|carboplatin|mesh-list
110964441|NCT02175381|Gemcitabine|gemcitabine|mesh-list
110964442|NCT02175381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110964443|NCT02175381|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110964444|NCT02175381|Antimetabolites|antimetabolites|mesh-ancestor
110964445|NCT02175381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110964446|NCT03540225|Progesterone|progesterone|mesh-list
110964447|NCT03540225|Progestins|progestins|mesh-ancestor
110964448|NCT03540225|Hormones|hormones|mesh-ancestor
110964449|NCT03540225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110964450|NCT03540225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110964451|NCT02507648|Oseltamivir|oseltamivir|mesh-list
110964452|NCT02507648|Antiviral Agents|antiviral agents|mesh-ancestor
111490789|NCT01759602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111490790|NCT01760304|Budesonide|budesonide|mesh-list
111490791|NCT01760304|Formoterol Fumarate|formoterol fumarate|mesh-list
111490792|NCT01760304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111490793|NCT01760304|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111490794|NCT01760304|Autonomic Agents|autonomic agents|mesh-ancestor
111490795|NCT01760304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111490796|NCT01760304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110964453|NCT02507648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111490797|NCT01760304|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110964454|NCT02507648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110964455|NCT02507648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110964456|NCT02172729|Lidocaine|lidocaine|mesh-list
110964457|NCT02172729|Anesthetics, Local|anesthetics, local|mesh-ancestor
110964458|NCT02172729|Anesthetics|anesthetics|mesh-ancestor
110964459|NCT02172729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110964460|NCT02172729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110964461|NCT02172729|Sensory System Agents|sensory system agents|mesh-ancestor
110964462|NCT02172729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110964463|NCT02172729|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110964464|NCT02172729|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110964465|NCT02172729|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110964466|NCT02172729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110964467|NCT02172729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110964468|NCT02172807|Tiotropium Bromide|tiotropium bromide|mesh-list
110964469|NCT02172807|Oxitropium|oxitropium|mesh-list
110964470|NCT02172807|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110964471|NCT02172807|Autonomic Agents|autonomic agents|mesh-ancestor
110964472|NCT02172807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110964473|NCT02172807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110964474|NCT02172807|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110964475|NCT02172807|Respiratory System Agents|respiratory system agents|mesh-ancestor
110964476|NCT02172807|Parasympatholytics|parasympatholytics|mesh-ancestor
110964477|NCT02172807|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110964478|NCT02172807|Cholinergic Agents|cholinergic agents|mesh-ancestor
110964479|NCT02172807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110964480|NCT02172807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110964481|NCT04568421|Immunosuppressive Agents|immunosuppressive agents|mesh-list
110964482|NCT04568421|Immunologic Factors|immunologic factors|mesh-ancestor
110964483|NCT04568421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110964484|NCT02502968|Cytarabine|cytarabine|mesh-list
110964485|NCT02502968|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110964486|NCT02502968|Antimetabolites|antimetabolites|mesh-ancestor
110964487|NCT02502968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110964488|NCT02502968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110964489|NCT02502968|Antiviral Agents|antiviral agents|mesh-ancestor
110964490|NCT02502968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110964491|NCT02502968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110964492|NCT02502968|Immunologic Factors|immunologic factors|mesh-ancestor
110964493|NCT02502968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110964494|NCT02168751|Propofol|propofol|mesh-list
110964495|NCT02168751|Sevoflurane|sevoflurane|mesh-list
110964496|NCT02168751|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110964497|NCT02168751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110964498|NCT02168751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110964499|NCT02168751|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110964500|NCT02168751|Anesthetics, General|anesthetics, general|mesh-ancestor
110964501|NCT02168751|Anesthetics|anesthetics|mesh-ancestor
110964502|NCT02168751|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110676577|NCT04400474|Atezolizumab|atezolizumab|mesh-list
110964503|NCT02168751|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110964504|NCT02507570|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
110964505|NCT02507570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110964507|NCT03344042|Sufentanil|sufentanil|mesh-list
110964508|NCT03344042|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110964509|NCT03344042|Narcotics|narcotics|mesh-ancestor
110964510|NCT03344042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110964511|NCT03344042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110964512|NCT03344042|Analgesics|analgesics|mesh-ancestor
110964513|NCT03344042|Sensory System Agents|sensory system agents|mesh-ancestor
110964514|NCT03344042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110964515|NCT03344042|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110964516|NCT03344042|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110964517|NCT03344042|Anesthetics, General|anesthetics, general|mesh-ancestor
110964518|NCT03344042|Anesthetics|anesthetics|mesh-ancestor
110964519|NCT02175927|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110964520|NCT02175927|Amoxicillin|amoxicillin|mesh-list
110964521|NCT02175927|Metronidazole|metronidazole|mesh-list
110964522|NCT02175927|Tetracycline|tetracycline|mesh-list
110964523|NCT02175927|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
111490798|NCT01760304|Respiratory System Agents|respiratory system agents|mesh-ancestor
111490799|NCT01760304|Glucocorticoids|glucocorticoids|mesh-ancestor
111490800|NCT01760304|Hormones|hormones|mesh-ancestor
110964524|NCT02175927|Potassium Citrate|potassium citrate|mesh-list
111490801|NCT01760304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111490802|NCT01760304|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110964525|NCT02175927|Lansoprazole|lansoprazole|mesh-list
110964526|NCT02175927|Bismuth|bismuth|mesh-list
110964527|NCT02175927|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
110964528|NCT02175927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110964529|NCT02175927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110964530|NCT02175927|Antitubercular Agents|antitubercular agents|mesh-ancestor
110964531|NCT02175927|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110964532|NCT02175927|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110964533|NCT02175927|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110964534|NCT02175927|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110964535|NCT02175927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110964536|NCT02175927|Antacids|antacids|mesh-ancestor
110964537|NCT02175927|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110964538|NCT02175927|Diuretics|diuretics|mesh-ancestor
110964539|NCT02175927|Natriuretic Agents|natriuretic agents|mesh-ancestor
110964540|NCT02175927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110964541|NCT02175927|Expectorants|expectorants|mesh-ancestor
110964542|NCT02175927|Respiratory System Agents|respiratory system agents|mesh-ancestor
110964543|NCT00707486|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
110964544|NCT00707486|Hemostatics|hemostatics|mesh-ancestor
110964545|NCT00707486|Coagulants|coagulants|mesh-ancestor
110964546|NCT02496182|Pirfenidone|pirfenidone|mesh-list
110964547|NCT02496182|Analgesics|analgesics|mesh-ancestor
110964548|NCT02496182|Sensory System Agents|sensory system agents|mesh-ancestor
110964549|NCT02496182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110964550|NCT02496182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110964551|NCT02496182|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110964552|NCT02496182|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110964553|NCT02496182|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110964554|NCT02496182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110964555|NCT02496182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110964556|NCT02168907|Thioctic Acid|thioctic acid|mesh-list
110964557|NCT02168907|Rituximab|rituximab|mesh-list
110964558|NCT02168907|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110964559|NCT02168907|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110964560|NCT02168907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110964561|NCT02168907|Immunologic Factors|immunologic factors|mesh-ancestor
110964562|NCT02168907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110964563|NCT02168907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110964564|NCT02168907|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110964565|NCT02168907|Alkylating Agents|alkylating agents|mesh-ancestor
110964566|NCT02168907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110964567|NCT02168907|Antioxidants|antioxidants|mesh-ancestor
110964568|NCT02168907|Protective Agents|protective agents|mesh-ancestor
110964569|NCT02168907|Vitamin B Complex|vitamin b complex|mesh-ancestor
110964570|NCT02168907|Vitamins|vitamins|mesh-ancestor
110964571|NCT02168907|Micronutrients|micronutrients|mesh-ancestor
110964572|NCT02500784|Formoterol Fumarate|formoterol fumarate|mesh-list
110964573|NCT02500784|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110964574|NCT02500784|Autonomic Agents|autonomic agents|mesh-ancestor
110964575|NCT02500784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110964576|NCT02500784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110964577|NCT02500784|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110964578|NCT02500784|Respiratory System Agents|respiratory system agents|mesh-ancestor
110964579|NCT02500784|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110964580|NCT02500784|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110676724|NCT03870919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110964581|NCT02500784|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110964582|NCT02500784|Adrenergic Agents|adrenergic agents|mesh-ancestor
110964583|NCT02500784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110964584|NCT02500784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110964586|NCT02500940|Fluorouracil|fluorouracil|mesh-list
110964587|NCT02500940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110964588|NCT02500940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110964589|NCT02500940|Antimetabolites|antimetabolites|mesh-ancestor
110964590|NCT02500940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110964591|NCT02500940|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110964592|NCT02500940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110964593|NCT02500940|Immunologic Factors|immunologic factors|mesh-ancestor
110964594|NCT02500940|Antidotes|antidotes|mesh-ancestor
110964595|NCT02500940|Protective Agents|protective agents|mesh-ancestor
110964596|NCT02500940|Vitamin B Complex|vitamin b complex|mesh-ancestor
110964597|NCT02500940|Vitamins|vitamins|mesh-ancestor
110964598|NCT02500940|Micronutrients|micronutrients|mesh-ancestor
110964599|NCT02495636|Atezolizumab|atezolizumab|mesh-list
110964600|NCT02495636|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110964601|NCT02495636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110964602|NCT02495636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110964603|NCT02495636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110964604|NCT02169063|Listerine|listerine|mesh-list
110964605|NCT02169063|Fluorides|fluorides|mesh-list
110964606|NCT02169063|Sodium Fluoride|sodium fluoride|mesh-list
110964607|NCT02169063|Cariostatic Agents|cariostatic agents|mesh-ancestor
110964608|NCT02169063|Protective Agents|protective agents|mesh-ancestor
110964609|NCT02169063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110964610|NCT02169063|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110964611|NCT02169063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110964612|NCT04496882|Tenofovir|tenofovir|mesh-list
110964613|NCT04496882|Antiviral Agents|antiviral agents|mesh-ancestor
110964614|NCT04496882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110964615|NCT04496882|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110964616|NCT04496882|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110964617|NCT04496882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110964618|NCT04496882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110964619|NCT04496882|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110964620|NCT04496882|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110964621|NCT02502500|Celecoxib|celecoxib|mesh-list
110964622|NCT02502500|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110964623|NCT02502500|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110964624|NCT02502500|Analgesics|analgesics|mesh-ancestor
110964625|NCT02502500|Sensory System Agents|sensory system agents|mesh-ancestor
110964626|NCT02502500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110964627|NCT02502500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110964628|NCT02502500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110964629|NCT02502500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110964630|NCT02502500|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110964631|NCT02502500|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110964632|NCT02502500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110964633|NCT02502500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110964634|NCT02173665|Linagliptin|linagliptin|mesh-list
110964635|NCT02173665|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110964636|NCT02173665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110964637|NCT02173665|Incretins|incretins|mesh-ancestor
110964638|NCT02173665|Hormones|hormones|mesh-ancestor
110964639|NCT02173665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110964640|NCT02173665|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110964641|NCT02173665|Protease Inhibitors|protease inhibitors|mesh-ancestor
110964642|NCT02173665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110964643|NCT02173665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110964644|NCT02495324|Valsartan|valsartan|mesh-list
110964645|NCT02495324|Olmesartan|olmesartan|mesh-list
110964646|NCT02495324|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
110964647|NCT02495324|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110964648|NCT02495324|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110964649|NCT02495324|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110964650|NCT02495324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110964651|NCT02500238|Carbon Monoxide|carbon monoxide|mesh-list
110964652|NCT02500238|Antimetabolites|antimetabolites|mesh-ancestor
110964653|NCT02500238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110964654|NCT02500238|Gasotransmitters|gasotransmitters|mesh-ancestor
110964655|NCT02500238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110698918|NCT01070277|Alkylating Agents|alkylating agents|mesh-ancestor
111490803|NCT01760304|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111490804|NCT01760304|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111490805|NCT01760304|Adrenergic Agents|adrenergic agents|mesh-ancestor
111490806|NCT01760304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111490807|NCT01760304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111490808|NCT01763346|Metformin|metformin|mesh-list
111490809|NCT01763346|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111490810|NCT01763346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111490811|NCT01766466|Ticagrelor|ticagrelor|mesh-list
111490812|NCT01766466|Cangrelor|cangrelor|mesh-list
111490813|NCT01766466|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111490814|NCT01766466|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111490815|NCT01766466|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111490816|NCT01766466|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111490817|NCT01766466|Purinergic Agents|purinergic agents|mesh-ancestor
110650598|NCT00734123|Hormones|hormones|mesh-ancestor
111490818|NCT01766466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110964656|NCT02500238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110964657|NCT02256033|Istradefylline|istradefylline|mesh-list
110964658|NCT02256033|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
110964659|NCT02256033|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110964660|NCT02256033|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110964661|NCT02256033|Purinergic Agents|purinergic agents|mesh-ancestor
110964662|NCT02256033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110964663|NCT02256033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110964664|NCT02256033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110964665|NCT02502110|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110964666|NCT02502110|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110964667|NCT02502110|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110964668|NCT02502110|Antimetabolites|antimetabolites|mesh-ancestor
110964669|NCT02502110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110964670|NCT02502110|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110964671|NCT02502110|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110964672|NCT02502110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110964673|NCT02502344|Metformin|metformin|mesh-list
110964674|NCT02502344|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110964675|NCT02502344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110964676|NCT02174211|Ranibizumab|ranibizumab|mesh-list
110964677|NCT02174211|Aflibercept|aflibercept|mesh-list
110964678|NCT02174211|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110964679|NCT02174211|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110964680|NCT02174211|Growth Substances|growth substances|mesh-ancestor
110964681|NCT02174211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110964682|NCT02174211|Growth Inhibitors|growth inhibitors|mesh-ancestor
110964683|NCT02174211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110964684|NCT04496492|Tocotrienols|tocotrienols|mesh-list
110964685|NCT04496492|Vitamin E|vitamin e|mesh-list
110964686|NCT04496492|Tocopherols|tocopherols|mesh-list
110964687|NCT04496492|Antioxidants|antioxidants|mesh-ancestor
110964688|NCT04496492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110964689|NCT04496492|Protective Agents|protective agents|mesh-ancestor
110964690|NCT04496492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110964691|NCT04496492|Vitamins|vitamins|mesh-ancestor
110964692|NCT04496492|Micronutrients|micronutrients|mesh-ancestor
110964693|NCT02500004|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110964694|NCT02500004|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110964695|NCT02500004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110964696|NCT02502032|Cisatracurium|cisatracurium|mesh-list
110964697|NCT02502032|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110964698|NCT02502032|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110964699|NCT02502032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110964700|NCT02502032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110964701|NCT02494856|Naproxen|naproxen|mesh-list
110964702|NCT02494856|Esomeprazole|esomeprazole|mesh-list
110964703|NCT02494856|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110964704|NCT02494856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110964705|NCT02494856|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110964706|NCT02494856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110964707|NCT02494856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110964708|NCT02494856|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111490819|NCT01766466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111490820|NCT01766466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110964709|NCT02494856|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110964710|NCT02494856|Analgesics|analgesics|mesh-ancestor
111490821|NCT01769352|Prednisolone acetate|prednisolone acetate|mesh-list
111490822|NCT01769352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111490823|NCT01769586|Diphenhydramine|diphenhydramine|mesh-list
111490824|NCT01769586|Promethazine|promethazine|mesh-list
111490825|NCT01769586|Midazolam|midazolam|mesh-list
111490826|NCT01769586|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111490827|NCT01769586|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111490828|NCT01769586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111490829|NCT01769586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111490830|NCT01769586|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111490831|NCT01769586|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111490832|NCT01769586|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111490833|NCT01769586|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111490834|NCT01769586|Anesthetics, General|anesthetics, general|mesh-ancestor
111490835|NCT01769586|Anesthetics|anesthetics|mesh-ancestor
110964711|NCT02494856|Sensory System Agents|sensory system agents|mesh-ancestor
111490836|NCT01769586|GABA Modulators|gaba modulators|mesh-ancestor
111490837|NCT01769586|GABA Agents|gaba agents|mesh-ancestor
111490838|NCT01769586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111490839|NCT01769586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111490840|NCT01769586|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110964712|NCT02494856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110964713|NCT02494856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110964714|NCT02494856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110964715|NCT02494856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110964716|NCT02494856|Gout Suppressants|gout suppressants|mesh-ancestor
110964717|NCT02494856|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110964718|NCT04495010|Nivolumab|nivolumab|mesh-list
110964719|NCT04495010|Ipilimumab|ipilimumab|mesh-list
110964720|NCT04495010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110964721|NCT04495010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110964722|NCT04495010|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110964723|NCT04495010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110964724|NCT03343418|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
110964725|NCT03343418|Hemostatics|hemostatics|mesh-ancestor
110964726|NCT03343418|Coagulants|coagulants|mesh-ancestor
110964727|NCT03343418|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
110964728|NCT03343418|Natriuretic Agents|natriuretic agents|mesh-ancestor
110964729|NCT03343418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110964730|NCT02501798|Methylphenidate|methylphenidate|mesh-list
110964731|NCT02501798|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110964732|NCT02501798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110964733|NCT02501798|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110964734|NCT02501798|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110964735|NCT02501798|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110964736|NCT02501798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110964737|NCT02501798|Dopamine Agents|dopamine agents|mesh-ancestor
110964738|NCT02501798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110964739|NCT02169609|Interleukin-2|interleukin-2|mesh-list
110964740|NCT02169609|Dinutuximab|dinutuximab|mesh-list
110964741|NCT02169609|Isotretinoin|isotretinoin|mesh-list
110964742|NCT02169609|Sargramostim|sargramostim|mesh-list
110964743|NCT02169609|Immunologic Factors|immunologic factors|mesh-ancestor
110964744|NCT02169609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110964745|NCT02169609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110964746|NCT02169609|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110964747|NCT02169609|Analgesics|analgesics|mesh-ancestor
110964748|NCT02169609|Sensory System Agents|sensory system agents|mesh-ancestor
110964749|NCT02169609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110964750|NCT02169609|Dermatologic Agents|dermatologic agents|mesh-ancestor
110964751|NCT02499614|Crizotinib|crizotinib|mesh-list
110964752|NCT02499614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110964753|NCT02499614|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110964754|NCT02499614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110964755|NCT02499614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110964756|NCT02169843|Dexmedetomidine|dexmedetomidine|mesh-list
110964757|NCT02169843|Sevoflurane|sevoflurane|mesh-list
110964758|NCT02169843|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110964759|NCT02169843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110964760|NCT02169843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110964761|NCT02169843|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110964762|NCT02169843|Analgesics|analgesics|mesh-ancestor
110964763|NCT02169843|Sensory System Agents|sensory system agents|mesh-ancestor
110964764|NCT02169843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110964765|NCT02169843|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110964766|NCT02169843|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110964767|NCT02169843|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110964768|NCT02169843|Adrenergic Agents|adrenergic agents|mesh-ancestor
110964769|NCT02169843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111490841|NCT01769586|Anesthetics, Local|anesthetics, local|mesh-ancestor
111490842|NCT01769586|Sensory System Agents|sensory system agents|mesh-ancestor
111490843|NCT01769586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111490844|NCT01769586|Antiemetics|antiemetics|mesh-ancestor
111490845|NCT01769586|Autonomic Agents|autonomic agents|mesh-ancestor
111490846|NCT01769586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111490847|NCT01769586|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111490848|NCT01769586|Histamine Antagonists|histamine antagonists|mesh-ancestor
111490849|NCT01769586|Histamine Agents|histamine agents|mesh-ancestor
111490850|NCT01769586|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111490851|NCT01769586|Antipruritics|antipruritics|mesh-ancestor
111490852|NCT01769586|Dermatologic Agents|dermatologic agents|mesh-ancestor
111490853|NCT01773954|Aflibercept|aflibercept|mesh-list
110964770|NCT02169843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110698952|NCT00257920|Vitamins|vitamins|mesh-ancestor
110964771|NCT02169843|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110964772|NCT02169843|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110964773|NCT02169843|Anesthetics, General|anesthetics, general|mesh-ancestor
110964774|NCT02169843|Anesthetics|anesthetics|mesh-ancestor
110964775|NCT03341390|Aspirin|aspirin|mesh-list
110964776|NCT03341390|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110964777|NCT03341390|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110964778|NCT03341390|Analgesics|analgesics|mesh-ancestor
110964779|NCT03341390|Sensory System Agents|sensory system agents|mesh-ancestor
110964780|NCT03341390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110964781|NCT03341390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110964782|NCT03341390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110964783|NCT03341390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110964784|NCT03341390|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110964785|NCT03341390|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110964786|NCT03341390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110964787|NCT03341390|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110964788|NCT03341390|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110964789|NCT03341390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110964790|NCT03341390|Antipyretics|antipyretics|mesh-ancestor
110964791|NCT02174445|Imatinib Mesylate|imatinib mesylate|mesh-list
110964792|NCT02174445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110650648|NCT00733031|Gemcitabine|gemcitabine|mesh-list
110964793|NCT02174445|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110964794|NCT02174445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110964795|NCT02174445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110964796|NCT00707174|Imiquimod|imiquimod|mesh-list
110964797|NCT00707174|Tazarotene|tazarotene|mesh-list
110964798|NCT00707174|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110964799|NCT00707174|Immunologic Factors|immunologic factors|mesh-ancestor
110964800|NCT00707174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110964801|NCT00707174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110964802|NCT00707174|Interferon Inducers|interferon inducers|mesh-ancestor
110964803|NCT00707174|Dermatologic Agents|dermatologic agents|mesh-ancestor
110964804|NCT00707174|Keratolytic Agents|keratolytic agents|mesh-ancestor
110964805|NCT03341234|Bupivacaine|bupivacaine|mesh-list
110964806|NCT03341234|Anesthetics, Local|anesthetics, local|mesh-ancestor
110964807|NCT03341234|Anesthetics|anesthetics|mesh-ancestor
110964808|NCT03341234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110964809|NCT03341234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110964810|NCT03341234|Sensory System Agents|sensory system agents|mesh-ancestor
110964811|NCT03341234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110964812|NCT02499224|Monoclonal antibody YYB-101|monoclonal antibody yyb-101|mesh-list
110964813|NCT02499224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110964815|NCT03120494|Emtricitabine|emtricitabine|mesh-list
110964816|NCT03120494|Antiviral Agents|antiviral agents|mesh-ancestor
110964817|NCT03120494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110964818|NCT03120494|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110964819|NCT03120494|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110964820|NCT03120494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110964821|NCT03120494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110964822|NCT03120494|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110964823|NCT03120494|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110964824|NCT03537573|Analgesics, Opioid|analgesics, opioid|mesh-list
110964825|NCT03537573|Narcotics|narcotics|mesh-ancestor
110964826|NCT03537573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110964827|NCT03537573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110964828|NCT03537573|Analgesics|analgesics|mesh-ancestor
110964829|NCT03537573|Sensory System Agents|sensory system agents|mesh-ancestor
110964830|NCT03537573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110964831|NCT03120962|Famciclovir|famciclovir|mesh-list
110964832|NCT03120962|Oxycodone|oxycodone|mesh-list
110964833|NCT03120962|Gabapentin|gabapentin|mesh-list
110964834|NCT03120962|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110964835|NCT03120962|Narcotics|narcotics|mesh-ancestor
110964836|NCT03120962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110964837|NCT03120962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111490854|NCT01773954|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111490855|NCT01773954|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111490856|NCT01773954|Growth Substances|growth substances|mesh-ancestor
111490857|NCT01773954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111490858|NCT01773954|Growth Inhibitors|growth inhibitors|mesh-ancestor
111490859|NCT01773954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111490860|NCT01778634|Azithromycin|azithromycin|mesh-list
110964838|NCT03120962|Analgesics|analgesics|mesh-ancestor
110964839|NCT03120962|Sensory System Agents|sensory system agents|mesh-ancestor
110964840|NCT03120962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110964841|NCT03120962|Anticonvulsants|anticonvulsants|mesh-ancestor
111490861|NCT01778634|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110964842|NCT03120962|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110964843|NCT03120962|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110964844|NCT03120962|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110964845|NCT03120962|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110964846|NCT03120962|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110964847|NCT03120962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110964848|NCT03120962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110964849|NCT03120962|Antimanic Agents|antimanic agents|mesh-ancestor
110964850|NCT03120962|Antiviral Agents|antiviral agents|mesh-ancestor
110964851|NCT03120962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110964852|NCT03120962|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110964853|NCT03120962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110964854|NCT02178813|Minocycline|minocycline|mesh-list
110964855|NCT02178813|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110964856|NCT02178813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110964857|NCT03340922|Long-Acting Thyroid Stimulator|long-acting thyroid stimulator|mesh-list
110964858|NCT03340922|Immunologic Factors|immunologic factors|mesh-ancestor
110964859|NCT03340922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110964860|NCT02177253|Bromides|bromides|mesh-list
110964861|NCT02177253|Albuterol|albuterol|mesh-list
110964862|NCT02177253|Ipratropium|ipratropium|mesh-list
110964863|NCT02177253|Anticonvulsants|anticonvulsants|mesh-ancestor
110964864|NCT02177253|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110964865|NCT02177253|Autonomic Agents|autonomic agents|mesh-ancestor
110964866|NCT02177253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110964867|NCT02177253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110964868|NCT02177253|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110964869|NCT02177253|Respiratory System Agents|respiratory system agents|mesh-ancestor
110964870|NCT02177253|Tocolytic Agents|tocolytic agents|mesh-ancestor
110964871|NCT02177253|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110964872|NCT02177253|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110964873|NCT02177253|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110964874|NCT02177253|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110964875|NCT02177253|Adrenergic Agents|adrenergic agents|mesh-ancestor
110964876|NCT02177253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110964877|NCT02177253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110964878|NCT02177253|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110676949|NCT03283917|Dexamethasone acetate|dexamethasone acetate|mesh-list
110964879|NCT02177253|Cholinergic Agents|cholinergic agents|mesh-ancestor
110964880|NCT02177331|Lacidipine|lacidipine|mesh-list
110964881|NCT02177331|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110964882|NCT02177331|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110964883|NCT02177331|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110964884|NCT02177331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110964885|NCT02177331|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110964886|NCT02177331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110964887|NCT02177409|Amlodipine|amlodipine|mesh-list
110964888|NCT02177409|Telmisartan|telmisartan|mesh-list
110964889|NCT02177409|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110964890|NCT02177409|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110964891|NCT02177409|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110964892|NCT02177409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110964893|NCT02177409|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110964894|NCT02177409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110964895|NCT02177409|Vasodilator Agents|vasodilator agents|mesh-ancestor
110964896|NCT02177409|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110964897|NCT02177409|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110964898|NCT02170623|Pantoprazole|pantoprazole|mesh-list
110964899|NCT02170623|Dabigatran|dabigatran|mesh-list
110964900|NCT02170623|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110964901|NCT02170623|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110964902|NCT02170623|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110964903|NCT02170623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110964904|NCT02170623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110964905|NCT02170623|Antithrombins|antithrombins|mesh-ancestor
110964906|NCT02170623|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110964907|NCT02170623|Protease Inhibitors|protease inhibitors|mesh-ancestor
110964908|NCT02170623|Anticoagulants|anticoagulants|mesh-ancestor
111490862|NCT01778634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111490863|NCT01783236|Acetaminophen|acetaminophen|mesh-list
110964909|NCT02170701|Dabigatran|dabigatran|mesh-list
110964910|NCT02170701|Antithrombins|antithrombins|mesh-ancestor
111490864|NCT01783236|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111490865|NCT01783236|Analgesics|analgesics|mesh-ancestor
110964911|NCT02170701|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110964912|NCT02170701|Protease Inhibitors|protease inhibitors|mesh-ancestor
110964913|NCT02170701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110964914|NCT02170701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110964915|NCT02170701|Anticoagulants|anticoagulants|mesh-ancestor
110964916|NCT02498756|Ipilimumab|ipilimumab|mesh-list
110964917|NCT02498756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110964918|NCT02498756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110964919|NCT02498756|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110964920|NCT02498756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110964921|NCT03336632|Cyclosporine|cyclosporine|mesh-list
110964922|NCT03336632|Cyclophosphamide|cyclophosphamide|mesh-list
110964923|NCT03336632|Cyclosporins|cyclosporins|mesh-list
110964924|NCT03336632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110964925|NCT03336632|Immunologic Factors|immunologic factors|mesh-ancestor
110964926|NCT03336632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110964927|NCT03336632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110964928|NCT03336632|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110964929|NCT03336632|Alkylating Agents|alkylating agents|mesh-ancestor
110964930|NCT03336632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110964931|NCT03336632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110964932|NCT03336632|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110964933|NCT03336632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110964934|NCT03336632|Antifungal Agents|antifungal agents|mesh-ancestor
110964935|NCT03336632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110964936|NCT03336632|Dermatologic Agents|dermatologic agents|mesh-ancestor
110964937|NCT03336632|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110964938|NCT02498288|Isotretinoin|isotretinoin|mesh-list
110964939|NCT02498288|Dermatologic Agents|dermatologic agents|mesh-ancestor
110964940|NCT02756403|Azithromycin|azithromycin|mesh-list
110964941|NCT02756403|Metronidazole|metronidazole|mesh-list
110964942|NCT02756403|Doxycycline|doxycycline|mesh-list
110964943|NCT02756403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110964944|NCT02756403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110964945|NCT02756403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110964946|NCT02756403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110964947|NCT02756403|Antimalarials|antimalarials|mesh-ancestor
110964948|NCT02494466|Montelukast|montelukast|mesh-list
110964949|NCT02494466|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110964950|NCT02494466|Respiratory System Agents|respiratory system agents|mesh-ancestor
110964951|NCT02494466|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110964952|NCT02494466|Hormone Antagonists|hormone antagonists|mesh-ancestor
110677026|NCT03110978|Nivolumab|nivolumab|mesh-list
110964953|NCT02494466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110964954|NCT02494466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110964955|NCT02494466|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110964956|NCT02494466|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110964957|NCT02494466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110964958|NCT02177487|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110964959|NCT02177487|Telmisartan|telmisartan|mesh-list
110964960|NCT02177487|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
110964961|NCT02177487|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110964962|NCT02177487|Diuretics|diuretics|mesh-ancestor
110964963|NCT02177487|Natriuretic Agents|natriuretic agents|mesh-ancestor
110964964|NCT02177487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110964965|NCT02177487|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110964966|NCT02177487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110964967|NCT02177487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110964968|NCT02177487|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110964969|NCT02177487|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110964970|NCT02177643|Diacerein|diacerein|mesh-list
110964971|NCT02177643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110964972|NCT03340376|Doxorubicin|doxorubicin|mesh-list
110964973|NCT03340376|Atezolizumab|atezolizumab|mesh-list
110964974|NCT03340376|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110964975|NCT03340376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110964976|NCT03340376|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110964977|NCT03340376|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110964978|NCT03340376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110964979|NCT03340376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110964980|NCT03340376|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110964981|NCT03340376|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110964982|NCT02182167|Acetylcysteine|acetylcysteine|mesh-list
111490866|NCT01783236|Sensory System Agents|sensory system agents|mesh-ancestor
111490867|NCT01783236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110964984|NCT02182167|Antiviral Agents|antiviral agents|mesh-ancestor
110964985|NCT02182167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110964986|NCT02182167|Expectorants|expectorants|mesh-ancestor
110650665|NCT00113269|Basiliximab|basiliximab|mesh-list
110964987|NCT02182167|Respiratory System Agents|respiratory system agents|mesh-ancestor
110964988|NCT02182167|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110964989|NCT02182167|Antioxidants|antioxidants|mesh-ancestor
110964990|NCT02182167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110964991|NCT02182167|Protective Agents|protective agents|mesh-ancestor
110964992|NCT02182167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110964993|NCT02182167|Antidotes|antidotes|mesh-ancestor
110964994|NCT02182245|Paclitaxel|paclitaxel|mesh-list
110964995|NCT02182245|Carboplatin|carboplatin|mesh-list
110964996|NCT02182245|Nintedanib|nintedanib|mesh-list
110964997|NCT02182245|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110964998|NCT02182245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110964999|NCT02182245|Tubulin Modulators|tubulin modulators|mesh-ancestor
110965000|NCT02182245|Antimitotic Agents|antimitotic agents|mesh-ancestor
110965001|NCT02182245|Mitosis Modulators|mitosis modulators|mesh-ancestor
110965002|NCT02182245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110965003|NCT02182245|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110965004|NCT02182245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110965005|NCT05233124|Aspirin|aspirin|mesh-list
110965006|NCT05233124|Rivaroxaban|rivaroxaban|mesh-list
110965007|NCT05233124|Clopidogrel|clopidogrel|mesh-list
110965008|NCT05233124|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110965009|NCT05233124|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110965010|NCT05233124|Analgesics|analgesics|mesh-ancestor
110965011|NCT05233124|Sensory System Agents|sensory system agents|mesh-ancestor
110965012|NCT05233124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110965013|NCT05233124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110965014|NCT05233124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110965015|NCT05233124|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110965016|NCT05233124|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110965017|NCT05233124|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110965018|NCT05233124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110965019|NCT05233124|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110965020|NCT05233124|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110965021|NCT05233124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110965022|NCT05233124|Antipyretics|antipyretics|mesh-ancestor
110965023|NCT05233124|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110965024|NCT05233124|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110965025|NCT05233124|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110965026|NCT05233124|Purinergic Agents|purinergic agents|mesh-ancestor
110965027|NCT05233124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110965028|NCT05233124|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110965029|NCT05233124|Antithrombins|antithrombins|mesh-ancestor
110965030|NCT05233124|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110965031|NCT05233124|Protease Inhibitors|protease inhibitors|mesh-ancestor
110965032|NCT05233124|Anticoagulants|anticoagulants|mesh-ancestor
110965033|NCT03339752|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110965034|NCT03339752|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110965035|NCT03339752|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110965036|NCT03339752|Antimetabolites|antimetabolites|mesh-ancestor
110650672|NCT00113269|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110965037|NCT03339752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110965038|NCT03339752|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110965039|NCT03339752|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110965040|NCT03339752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110965041|NCT03339362|Methylprednisolone|methylprednisolone|mesh-list
110965042|NCT03339362|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110965043|NCT03339362|Bupivacaine|bupivacaine|mesh-list
111490868|NCT01783236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111490869|NCT01783236|Antipyretics|antipyretics|mesh-ancestor
110965044|NCT03339362|Anesthetics, Local|anesthetics, local|mesh-ancestor
111490870|NCT01783470|Mirabegron|mirabegron|mesh-list
111490871|NCT01783470|Adrenergic Agents|adrenergic agents|mesh-list
111490872|NCT01783470|Adrenergic Agonists|adrenergic agonists|mesh-list
111490873|NCT01783470|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
111490874|NCT01783470|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111490875|NCT01783470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110965045|NCT03339362|Anesthetics|anesthetics|mesh-ancestor
110965046|NCT03339362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110965047|NCT03339362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111490876|NCT01783470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110965048|NCT03339362|Sensory System Agents|sensory system agents|mesh-ancestor
110965049|NCT03339362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110965050|NCT03339362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110965052|NCT03339362|Autonomic Agents|autonomic agents|mesh-ancestor
110965053|NCT03339362|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110965054|NCT03339362|Glucocorticoids|glucocorticoids|mesh-ancestor
110965056|NCT03339362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110965057|NCT03339362|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110965058|NCT03339362|Protective Agents|protective agents|mesh-ancestor
110965059|NCT02497820|Aspirin|aspirin|mesh-list
110965060|NCT02497820|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110965061|NCT02497820|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110965062|NCT02497820|Analgesics|analgesics|mesh-ancestor
110965063|NCT02497820|Sensory System Agents|sensory system agents|mesh-ancestor
110965064|NCT02497820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110965065|NCT02497820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110965066|NCT02497820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110965067|NCT02497820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110965068|NCT02497820|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110965069|NCT02497820|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110965070|NCT02497820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110965071|NCT02497820|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110965072|NCT02497820|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110965073|NCT02497820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110965074|NCT02497820|Antipyretics|antipyretics|mesh-ancestor
110965075|NCT02497508|Nivolumab|nivolumab|mesh-list
110965076|NCT02497508|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110965077|NCT02497508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110965078|NCT02497508|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110965079|NCT02497508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110965080|NCT03338426|Atorvastatin|atorvastatin|mesh-list
110965081|NCT03338426|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110965082|NCT03338426|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110965083|NCT03338426|Antimetabolites|antimetabolites|mesh-ancestor
110965084|NCT03338426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110965085|NCT03338426|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110965086|NCT03338426|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110965087|NCT03338426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110965088|NCT03338348|Azacitidine|azacitidine|mesh-list
110965089|NCT03338348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110965090|NCT03338348|Antimetabolites|antimetabolites|mesh-ancestor
110965091|NCT03338348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110965092|NCT03338348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110965093|NCT03338348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110965094|NCT03334838|Nifurtimox|nifurtimox|mesh-list
110965095|NCT03334838|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
110965096|NCT03334838|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110965097|NCT03334838|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110965098|NCT03334838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110965099|NCT02497118|Vinorelbine|vinorelbine|mesh-list
110965100|NCT02497118|Endostatins|endostatins|mesh-list
110965101|NCT02497118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110965102|NCT02497118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110965104|NCT02497118|Antimitotic Agents|antimitotic agents|mesh-ancestor
110965105|NCT02497118|Mitosis Modulators|mitosis modulators|mesh-ancestor
110965106|NCT02497118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110965107|NCT02497118|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110965108|NCT02497118|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110965109|NCT02497118|Growth Substances|growth substances|mesh-ancestor
110965110|NCT02497118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110965111|NCT02497118|Growth Inhibitors|growth inhibitors|mesh-ancestor
110965112|NCT02496962|Atorvastatin|atorvastatin|mesh-list
110965113|NCT02496962|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110965114|NCT02496962|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110965115|NCT02496962|Antimetabolites|antimetabolites|mesh-ancestor
110965116|NCT02496962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110965117|NCT02496962|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110965118|NCT02496962|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110965119|NCT02496962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110965120|NCT03334136|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
110965121|NCT03334136|Calcifediol|calcifediol|mesh-list
110965122|NCT03334136|Vitamins|vitamins|mesh-ancestor
111490877|NCT01783470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110965123|NCT03334136|Micronutrients|micronutrients|mesh-ancestor
110965124|NCT03334136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110965125|NCT03334136|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110965126|NCT03120728|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110965127|NCT03120728|Etonogestrel|etonogestrel|mesh-list
110965128|NCT03120728|NuvaRing|nuvaring|mesh-list
110965129|NCT03120728|Contraceptive Agents|contraceptive agents|mesh-list
110965130|NCT03120728|Estradiol|estradiol|mesh-list
110965131|NCT03120728|Estrogens|estrogens|mesh-ancestor
110965132|NCT03120728|Hormones|hormones|mesh-ancestor
110965133|NCT03120728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110965134|NCT03120728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110965135|NCT03120728|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110965136|NCT03120728|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110965137|NCT03120728|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110965138|NCT03120728|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110965139|NCT03120728|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110965140|NCT02496650|Dexmedetomidine|dexmedetomidine|mesh-list
110965141|NCT02496650|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110965142|NCT02496650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110965143|NCT02496650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110965144|NCT02496650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110965145|NCT02496650|Analgesics|analgesics|mesh-ancestor
110965146|NCT02496650|Sensory System Agents|sensory system agents|mesh-ancestor
110965147|NCT02496650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110965148|NCT02496650|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110965149|NCT02496650|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110965150|NCT02496650|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110965151|NCT02496650|Adrenergic Agents|adrenergic agents|mesh-ancestor
110965152|NCT02496650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110965153|NCT02496650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110965154|NCT02492438|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110965155|NCT02492438|Immunologic Factors|immunologic factors|mesh-ancestor
110965156|NCT02492438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110965157|NCT03342170|Thrombin|thrombin|mesh-list
110965158|NCT03342170|Hemostatics|hemostatics|mesh-ancestor
110965159|NCT03342170|Coagulants|coagulants|mesh-ancestor
110965160|NCT03333824|Midazolam|midazolam|mesh-list
110965161|NCT03333824|Granisetron|granisetron|mesh-list
110965162|NCT03333824|Caffeine|caffeine|mesh-list
110965163|NCT03333824|Omeprazole|omeprazole|mesh-list
110965164|NCT03333824|Adavosertib|adavosertib|mesh-list
110965165|NCT03333824|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110965166|NCT03333824|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110650705|NCT00449644|Bedaquiline|bedaquiline|mesh-list
110965167|NCT03333824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110965168|NCT03333824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110965169|NCT03333824|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110965170|NCT03333824|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110965171|NCT03333824|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110965172|NCT03333824|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110965173|NCT03333824|Anesthetics, General|anesthetics, general|mesh-ancestor
110965174|NCT03333824|Anesthetics|anesthetics|mesh-ancestor
110965175|NCT03333824|GABA Modulators|gaba modulators|mesh-ancestor
111490878|NCT01783470|Urological Agents|urological agents|mesh-ancestor
111490879|NCT01783860|Azithromycin|azithromycin|mesh-list
111490880|NCT01783860|Doxycycline|doxycycline|mesh-list
111490881|NCT01783860|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111490882|NCT01783860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111490883|NCT01783860|Antimalarials|antimalarials|mesh-ancestor
111490884|NCT01783860|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111490885|NCT01783860|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111490886|NCT01785186|Pyridoxine|pyridoxine|mesh-list
111490887|NCT01785186|Moxifloxacin|moxifloxacin|mesh-list
111490888|NCT01785186|Rifampin|rifampin|mesh-list
111490889|NCT01785186|Isoniazid|isoniazid|mesh-list
111490890|NCT01785186|Pyrazinamide|pyrazinamide|mesh-list
111490891|NCT01785186|Ethambutol|ethambutol|mesh-list
111490892|NCT01785186|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111490893|NCT01785186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110965176|NCT03333824|GABA Agents|gaba agents|mesh-ancestor
110965177|NCT03333824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110965178|NCT03333824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110965179|NCT03333824|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110698990|NCT00231478|Antiemetics|antiemetics|mesh-ancestor
111490894|NCT01785186|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111490895|NCT01785186|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111490896|NCT01785186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110965180|NCT03333824|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110965181|NCT03333824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110965182|NCT03333824|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110965183|NCT03333824|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110965184|NCT03333824|Purinergic Agents|purinergic agents|mesh-ancestor
111490897|NCT01785186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111490898|NCT01785186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111490899|NCT01785186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110965185|NCT03333824|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110965186|NCT03333824|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110965187|NCT03333824|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110965188|NCT03333824|Antiemetics|antiemetics|mesh-ancestor
110965189|NCT03333824|Autonomic Agents|autonomic agents|mesh-ancestor
110965190|NCT03333824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110965191|NCT03333824|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110965192|NCT03333824|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110965193|NCT03333824|Serotonin Agents|serotonin agents|mesh-ancestor
110965195|NCT02496494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110965196|NCT02496494|Immunologic Factors|immunologic factors|mesh-ancestor
110965197|NCT02496494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110965198|NCT02496494|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110965199|NCT02496494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110965200|NCT02496494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110965201|NCT03333278|Vitamins|vitamins|mesh-list
110965202|NCT03333278|Ascorbic Acid|ascorbic acid|mesh-list
110965203|NCT03333278|Thiamine|thiamine|mesh-list
110965204|NCT03333278|Hydrocortisone|hydrocortisone|mesh-list
110965205|NCT03333278|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
110965206|NCT03333278|Micronutrients|micronutrients|mesh-ancestor
110965207|NCT03333278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110965208|NCT03333278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110965209|NCT03333278|Antioxidants|antioxidants|mesh-ancestor
110965210|NCT03333278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110965211|NCT03333278|Protective Agents|protective agents|mesh-ancestor
110965212|NCT03333278|Vitamin B Complex|vitamin b complex|mesh-ancestor
110965213|NCT04847596|Ofatumumab|ofatumumab|mesh-list
110965214|NCT04847596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110965215|NCT00706628|Nintedanib|nintedanib|mesh-list
110965216|NCT00706628|Afatinib|afatinib|mesh-list
110965217|NCT00706628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110965218|NCT00706628|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110965219|NCT00706628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110965220|NCT00706628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110965221|NCT05463614|Propranolol|propranolol|mesh-list
110965222|NCT05463614|Propafenone|propafenone|mesh-list
110965223|NCT05463614|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110965224|NCT05463614|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110965225|NCT05463614|Adrenergic Agents|adrenergic agents|mesh-ancestor
110965226|NCT05463614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110965227|NCT05463614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110965228|NCT05463614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110965229|NCT05463614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110965230|NCT05463614|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110965231|NCT05463614|Vasodilator Agents|vasodilator agents|mesh-ancestor
110965232|NCT05463614|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110965233|NCT05463614|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110965234|NCT05463614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110965235|NCT03332888|Rituximab|rituximab|mesh-list
110965236|NCT03332888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110965237|NCT03332888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110965238|NCT03332888|Immunologic Factors|immunologic factors|mesh-ancestor
110965239|NCT03332888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110965240|NCT03332888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110965241|NCT03332732|Metronidazole|metronidazole|mesh-list
110965242|NCT03332732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110965243|NCT03332732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110965244|NCT03332732|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110965245|NCT03332732|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110965246|NCT02492360|Cisplatin|cisplatin|mesh-list
110965247|NCT02492360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110965248|NCT02492282|Remifentanil|remifentanil|mesh-list
110965249|NCT02492282|Propofol|propofol|mesh-list
111490900|NCT01785186|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110965250|NCT02492282|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110965251|NCT02492282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110965252|NCT02492282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110965253|NCT02492282|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110965254|NCT02492282|Anesthetics, General|anesthetics, general|mesh-ancestor
110965255|NCT02492282|Anesthetics|anesthetics|mesh-ancestor
111490901|NCT01785186|Antitubercular Agents|antitubercular agents|mesh-ancestor
110965256|NCT02492282|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110965257|NCT02492282|Narcotics|narcotics|mesh-ancestor
110965258|NCT02492282|Analgesics|analgesics|mesh-ancestor
110965259|NCT02492282|Sensory System Agents|sensory system agents|mesh-ancestor
110965260|NCT02492282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110965261|NCT02492126|Citric Acid|citric acid|mesh-list
110965262|NCT02492126|Sodium Citrate|sodium citrate|mesh-list
110965263|NCT02492126|Anticoagulants|anticoagulants|mesh-ancestor
110965264|NCT02492126|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110965265|NCT02492126|Chelating Agents|chelating agents|mesh-ancestor
110965266|NCT02492126|Sequestering Agents|sequestering agents|mesh-ancestor
110965267|NCT02492126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110965268|NCT05464862|Lidocaine|lidocaine|mesh-list
110965269|NCT05464862|Anesthetics, Local|anesthetics, local|mesh-ancestor
110965270|NCT05464862|Anesthetics|anesthetics|mesh-ancestor
110965271|NCT05464862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110965272|NCT05464862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110965273|NCT05464862|Sensory System Agents|sensory system agents|mesh-ancestor
110965274|NCT05464862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110965275|NCT05464862|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110965276|NCT05464862|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110965277|NCT05464862|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110965278|NCT05464862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110965279|NCT05464862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110965280|NCT03324776|Insulin|insulin|mesh-list
110965281|NCT03324776|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110965282|NCT03324776|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110965283|NCT03324776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110965284|NCT02561806|Ustekinumab|ustekinumab|mesh-list
110965285|NCT02561806|Ixekizumab|ixekizumab|mesh-list
110965286|NCT02561806|Dermatologic Agents|dermatologic agents|mesh-ancestor
110965287|NCT03332576|Cyclophosphamide|cyclophosphamide|mesh-list
110965288|NCT03332576|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110965289|NCT03332576|Immunologic Factors|immunologic factors|mesh-ancestor
110965290|NCT03332576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110965291|NCT03332576|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110965292|NCT03332576|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110965293|NCT03332576|Alkylating Agents|alkylating agents|mesh-ancestor
110965294|NCT03332576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110965295|NCT03332576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110965296|NCT03332576|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110965297|NCT03330860|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
110965298|NCT03330860|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
110965299|NCT03330860|beta-Endorphin|beta-endorphin|mesh-list
110965300|NCT03330860|Hormones|hormones|mesh-ancestor
110965301|NCT03330860|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110965302|NCT03330860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110965303|NCT03330860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110965304|NCT03330860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110965305|NCT03324542|Ranibizumab|ranibizumab|mesh-list
110965306|NCT03324542|Aflibercept|aflibercept|mesh-list
110965307|NCT03324542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110965308|NCT03324542|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111490902|NCT01785186|Leprostatic Agents|leprostatic agents|mesh-ancestor
111490903|NCT01785186|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111490904|NCT01785186|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111490905|NCT01785186|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111490906|NCT01785186|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
111490907|NCT01785186|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
111490908|NCT01785186|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
111490909|NCT01785186|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111490910|NCT01785186|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
111490911|NCT01785186|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111490912|NCT01785186|Antimetabolites|antimetabolites|mesh-ancestor
111490913|NCT01785186|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111490914|NCT01785186|Vitamin B Complex|vitamin b complex|mesh-ancestor
111490915|NCT01785186|Vitamins|vitamins|mesh-ancestor
111490916|NCT01785186|Micronutrients|micronutrients|mesh-ancestor
111490917|NCT01785810|Maraviroc|maraviroc|mesh-list
111490918|NCT01785810|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110965310|NCT03324542|Growth Substances|growth substances|mesh-ancestor
110965311|NCT03324542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110965312|NCT03324542|Growth Inhibitors|growth inhibitors|mesh-ancestor
110965313|NCT03330782|Remifentanil|remifentanil|mesh-list
110965314|NCT03330782|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110965315|NCT03330782|Narcotics|narcotics|mesh-ancestor
110965316|NCT03330782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110965317|NCT03330782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110965318|NCT03330782|Analgesics|analgesics|mesh-ancestor
110965319|NCT03330782|Sensory System Agents|sensory system agents|mesh-ancestor
110965320|NCT03330782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110965321|NCT05506462|Ketamine|ketamine|mesh-list
110965322|NCT05506462|Analgesics|analgesics|mesh-ancestor
110965323|NCT05506462|Sensory System Agents|sensory system agents|mesh-ancestor
110965324|NCT05506462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110965325|NCT05506462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110965326|NCT05506462|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110965327|NCT05506462|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110965328|NCT05506462|Anesthetics, General|anesthetics, general|mesh-ancestor
110676890|NCT03348969|Mitomycins|mitomycins|mesh-list
110965329|NCT05506462|Anesthetics|anesthetics|mesh-ancestor
110965330|NCT05506462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110965331|NCT05506462|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110965332|NCT05506462|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110965333|NCT05506462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110965334|NCT05506462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110965335|NCT05501704|Tamoxifen|tamoxifen|mesh-list
110965336|NCT05501704|Anastrozole|anastrozole|mesh-list
110965337|NCT05501704|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110965338|NCT05501704|Hormone Antagonists|hormone antagonists|mesh-ancestor
110965339|NCT05501704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110965340|NCT05501704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110965341|NCT05501704|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110965342|NCT05501704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110965343|NCT05501704|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110965344|NCT05501704|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110965345|NCT05501704|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110965346|NCT05501704|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110965347|NCT05501704|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110965348|NCT05501704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110965349|NCT05501704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110965350|NCT05505994|Dapagliflozin|dapagliflozin|mesh-list
110965351|NCT05505994|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110965352|NCT05505994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110965353|NCT05505994|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110965354|NCT05505994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110965355|NCT02491268|Cilostazol|cilostazol|mesh-list
110965356|NCT02491268|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110965357|NCT02491268|Autonomic Agents|autonomic agents|mesh-ancestor
110965358|NCT02491268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110965359|NCT02491268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110965360|NCT02491268|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110965361|NCT02491268|Respiratory System Agents|respiratory system agents|mesh-ancestor
110965362|NCT02491268|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110965363|NCT02491268|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110965364|NCT02491268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110965365|NCT02491268|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110965366|NCT02491268|Vasodilator Agents|vasodilator agents|mesh-ancestor
110965367|NCT02491268|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110965368|NCT02491268|Protective Agents|protective agents|mesh-ancestor
110965369|NCT02491268|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110965370|NCT02491268|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110965371|NCT02491268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110965372|NCT03323684|Acetaminophen|acetaminophen|mesh-list
110965373|NCT03323684|Ketorolac|ketorolac|mesh-list
110965374|NCT03323684|Fentanyl|fentanyl|mesh-list
110965375|NCT03323684|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110965376|NCT03323684|Narcotics|narcotics|mesh-ancestor
110965377|NCT03323684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110965378|NCT03323684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110965379|NCT03323684|Analgesics|analgesics|mesh-ancestor
111490919|NCT01785810|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
111490920|NCT01785810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111490921|NCT01785810|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110965380|NCT03323684|Sensory System Agents|sensory system agents|mesh-ancestor
110965381|NCT03323684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110965382|NCT03323684|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110965383|NCT03323684|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110965384|NCT03323684|Anesthetics, General|anesthetics, general|mesh-ancestor
110965385|NCT03323684|Anesthetics|anesthetics|mesh-ancestor
110965386|NCT03323684|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110965387|NCT03323684|Antipyretics|antipyretics|mesh-ancestor
110965388|NCT03323684|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110965389|NCT03323684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110965390|NCT03323684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110965391|NCT03323684|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110965392|NCT03323684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110965393|NCT03323684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110965394|NCT02182401|Tolbutamide|tolbutamide|mesh-list
110965395|NCT02182401|Midazolam|midazolam|mesh-list
110965396|NCT02182401|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110965397|NCT02182401|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110965398|NCT02182401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110965399|NCT02182401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110965400|NCT02182401|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110965401|NCT02182401|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110965402|NCT02182401|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110965403|NCT02182401|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110965404|NCT02182401|Anesthetics, General|anesthetics, general|mesh-ancestor
110965405|NCT02182401|Anesthetics|anesthetics|mesh-ancestor
110965406|NCT02182401|GABA Modulators|gaba modulators|mesh-ancestor
110965407|NCT02182401|GABA Agents|gaba agents|mesh-ancestor
110965408|NCT02182401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110965409|NCT02182401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110965410|NCT02182401|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110965411|NCT04292080|Dimethyl Fumarate|dimethyl fumarate|mesh-list
110965412|NCT04292080|Dermatologic Agents|dermatologic agents|mesh-ancestor
110965413|NCT04292080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110965414|NCT04292080|Immunologic Factors|immunologic factors|mesh-ancestor
110965415|NCT04292080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110965416|NCT02177955|Midazolam|midazolam|mesh-list
110965417|NCT02177955|Diazepam|diazepam|mesh-list
110965418|NCT02177955|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110965419|NCT02177955|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110965420|NCT02177955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110965421|NCT02177955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110965422|NCT02177955|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110965423|NCT02177955|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110965424|NCT02177955|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110965425|NCT02177955|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110965426|NCT02177955|Anesthetics, General|anesthetics, general|mesh-ancestor
110965427|NCT02177955|Anesthetics|anesthetics|mesh-ancestor
110965428|NCT02177955|GABA Modulators|gaba modulators|mesh-ancestor
110965429|NCT02177955|GABA Agents|gaba agents|mesh-ancestor
110965430|NCT02177955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110965431|NCT02177955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110965432|NCT02177955|Anticonvulsants|anticonvulsants|mesh-ancestor
110965433|NCT02177955|Antiemetics|antiemetics|mesh-ancestor
110965434|NCT02177955|Autonomic Agents|autonomic agents|mesh-ancestor
110965435|NCT02177955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110965436|NCT02177955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110965437|NCT02177955|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110965438|NCT02177955|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110965439|NCT03323528|Benzalkonium Compounds|benzalkonium compounds|mesh-list
110965440|NCT03323528|Benzocaine|benzocaine|mesh-list
110965441|NCT03323528|Anesthetics, Local|anesthetics, local|mesh-ancestor
110965442|NCT03323528|Anesthetics|anesthetics|mesh-ancestor
110965443|NCT03323528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110965444|NCT03323528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110965445|NCT03323528|Sensory System Agents|sensory system agents|mesh-ancestor
110965446|NCT03323528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110965447|NCT03323528|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110965448|NCT03323528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110965449|NCT05501158|Tamoxifen|tamoxifen|mesh-list
111490922|NCT01785810|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110965450|NCT05501158|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110965451|NCT05501158|Hormone Antagonists|hormone antagonists|mesh-ancestor
111490923|NCT01785810|Antiviral Agents|antiviral agents|mesh-ancestor
111119095|NCT05388474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110965452|NCT05501158|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110965453|NCT05501158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110965454|NCT05501158|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110965455|NCT05501158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110965456|NCT05501158|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110965457|NCT05501158|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110965458|NCT05501158|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110965459|NCT03537807|Riluzole|riluzole|mesh-list
110965460|NCT03537807|Anticonvulsants|anticonvulsants|mesh-ancestor
110965461|NCT03537807|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110965462|NCT03537807|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110965463|NCT03537807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110965464|NCT03537807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110965465|NCT03537807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110965466|NCT03537807|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110965467|NCT03537807|Protective Agents|protective agents|mesh-ancestor
110965468|NCT02182479|Fenoterol|fenoterol|mesh-list
110965469|NCT02182479|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
110965470|NCT02182479|Ipratropium|ipratropium|mesh-list
110965471|NCT02182479|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110965472|NCT02182479|Autonomic Agents|autonomic agents|mesh-ancestor
110965473|NCT02182479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110965474|NCT02182479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110965475|NCT02182479|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110965476|NCT02182479|Respiratory System Agents|respiratory system agents|mesh-ancestor
110677557|NCT01001624|Hydroquinone|hydroquinone|mesh-list
110965477|NCT02182479|Sympathomimetics|sympathomimetics|mesh-ancestor
110965478|NCT02182479|Tocolytic Agents|tocolytic agents|mesh-ancestor
110965479|NCT02182479|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110965480|NCT02182479|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110965481|NCT02182479|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110965482|NCT02182479|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110965483|NCT02182479|Adrenergic Agents|adrenergic agents|mesh-ancestor
110965484|NCT02182479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110965485|NCT02182479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110965486|NCT02182479|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110965487|NCT02182479|Cholinergic Agents|cholinergic agents|mesh-ancestor
110965488|NCT02560558|Abatacept|abatacept|mesh-list
110965489|NCT02560558|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110965490|NCT02560558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110965491|NCT02560558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110965492|NCT02560558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110965493|NCT02560558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110965494|NCT02560558|Immunologic Factors|immunologic factors|mesh-ancestor
110965495|NCT02560558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110965496|NCT02560558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110965497|NCT03329456|Ropivacaine|ropivacaine|mesh-list
110965498|NCT03329456|Anesthetics, Local|anesthetics, local|mesh-ancestor
110965499|NCT03329456|Anesthetics|anesthetics|mesh-ancestor
110965500|NCT03329456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110965501|NCT03329456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110965502|NCT03329456|Sensory System Agents|sensory system agents|mesh-ancestor
110965503|NCT03329456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110965504|NCT02178033|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110965505|NCT02491736|Ketoprofen|ketoprofen|mesh-list
110965506|NCT02491736|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110965507|NCT02491736|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110965508|NCT02491736|Analgesics|analgesics|mesh-ancestor
110965509|NCT02491736|Sensory System Agents|sensory system agents|mesh-ancestor
110965510|NCT02491736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110965511|NCT02491736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110965512|NCT02491736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110965513|NCT02491736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110965514|NCT02491736|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110965515|NCT02491736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110965516|NCT02491736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110965517|NCT05501080|Spironolactone|spironolactone|mesh-list
110965518|NCT05501080|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110965519|NCT05501080|Hormone Antagonists|hormone antagonists|mesh-ancestor
111119096|NCT05388474|Immunologic Factors|immunologic factors|mesh-ancestor
111490924|NCT01785810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111490925|NCT01785810|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
111490926|NCT01786902|Hormones|hormones|mesh-list
111490927|NCT01786902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110965520|NCT05501080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110965521|NCT05501080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110965522|NCT05501080|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110965523|NCT05501080|Diuretics|diuretics|mesh-ancestor
110965524|NCT05501080|Natriuretic Agents|natriuretic agents|mesh-ancestor
110965525|NCT02491970|Fluticasone|fluticasone|mesh-list
110965526|NCT02491970|Xhance|xhance|mesh-list
110965527|NCT02491970|Formoterol Fumarate|formoterol fumarate|mesh-list
110965528|NCT02491970|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110965529|NCT02491970|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
110965530|NCT02491970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110965531|NCT02491970|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110965532|NCT02491970|Autonomic Agents|autonomic agents|mesh-ancestor
110965533|NCT02491970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110965534|NCT02491970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110965535|NCT02491970|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110965536|NCT02491970|Respiratory System Agents|respiratory system agents|mesh-ancestor
110965537|NCT02491970|Dermatologic Agents|dermatologic agents|mesh-ancestor
110965538|NCT02491970|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110965539|NCT02491970|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110965540|NCT02491970|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110965541|NCT02491970|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110965542|NCT02491970|Adrenergic Agents|adrenergic agents|mesh-ancestor
110965543|NCT02491970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110965544|NCT02491970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110965545|NCT02491970|Glucocorticoids|glucocorticoids|mesh-ancestor
110965546|NCT02491970|Hormones|hormones|mesh-ancestor
110965547|NCT02491970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110965548|NCT02491970|Sympathomimetics|sympathomimetics|mesh-ancestor
110965549|NCT02182557|Ketotifen|ketotifen|mesh-list
110677644|NCT00529802|Everolimus|everolimus|mesh-list
110965550|NCT02182557|Epinastine|epinastine|mesh-list
110965551|NCT02182557|Antipruritics|antipruritics|mesh-ancestor
110965552|NCT02182557|Dermatologic Agents|dermatologic agents|mesh-ancestor
110965553|NCT02182557|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110965554|NCT02182557|Histamine Antagonists|histamine antagonists|mesh-ancestor
110965555|NCT02182557|Histamine Agents|histamine agents|mesh-ancestor
110965556|NCT02182557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110965557|NCT02182557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110965558|NCT02182557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110965559|NCT02182557|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110965560|NCT02182635|Oxitropium|oxitropium|mesh-list
110965561|NCT02182635|Parasympatholytics|parasympatholytics|mesh-ancestor
110965562|NCT02182635|Autonomic Agents|autonomic agents|mesh-ancestor
110965563|NCT02182635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110965564|NCT02182635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110965565|NCT02182713|Bromides|bromides|mesh-list
110965566|NCT02182713|Albuterol|albuterol|mesh-list
110965567|NCT02182713|Ipratropium|ipratropium|mesh-list
110965568|NCT02182713|Anticonvulsants|anticonvulsants|mesh-ancestor
110965569|NCT02182713|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110965570|NCT02182713|Autonomic Agents|autonomic agents|mesh-ancestor
110965571|NCT02182713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110965572|NCT02182713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110965573|NCT02182713|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110965574|NCT02182713|Respiratory System Agents|respiratory system agents|mesh-ancestor
110965575|NCT02182713|Tocolytic Agents|tocolytic agents|mesh-ancestor
110965576|NCT02182713|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110965577|NCT02182713|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110965578|NCT02182713|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110965579|NCT02182713|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110965580|NCT02182713|Adrenergic Agents|adrenergic agents|mesh-ancestor
110965581|NCT02182713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110965582|NCT02182713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110965583|NCT02182713|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110965584|NCT02182713|Cholinergic Agents|cholinergic agents|mesh-ancestor
110965585|NCT03323372|Listerine|listerine|mesh-list
110965586|NCT03323372|Fluorides|fluorides|mesh-list
111490928|NCT01786902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111490929|NCT01787916|Liraglutide|liraglutide|mesh-list
111490930|NCT01787916|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111490931|NCT01787916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110965587|NCT03323372|Sodium Fluoride|sodium fluoride|mesh-list
110965588|NCT03323372|Cariostatic Agents|cariostatic agents|mesh-ancestor
110965589|NCT03323372|Protective Agents|protective agents|mesh-ancestor
110965590|NCT03323372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110965591|NCT03323372|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110965592|NCT03323372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110965593|NCT02180529|Methylphenidate|methylphenidate|mesh-list
110965594|NCT02180529|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110965595|NCT02180529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110965596|NCT02180529|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110965597|NCT02180529|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110965598|NCT02180529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110965599|NCT02180529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110965600|NCT02180529|Dopamine Agents|dopamine agents|mesh-ancestor
110965601|NCT02180529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110965602|NCT02182791|Nevirapine|nevirapine|mesh-list
110965603|NCT02182791|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110965604|NCT02182791|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110965605|NCT02182791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110965606|NCT02182791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110965607|NCT02182791|Antiviral Agents|antiviral agents|mesh-ancestor
110965608|NCT02182791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110965609|NCT02182791|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110965610|NCT02182791|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110965611|NCT02182791|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110965612|NCT02182791|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110965613|NCT03536325|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110965614|NCT03536325|Immunologic Factors|immunologic factors|mesh-ancestor
110965615|NCT03536325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110965616|NCT03536637|Hydrogen Peroxide|hydrogen peroxide|mesh-list
110965617|NCT03536637|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110965618|NCT03536637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110965619|NCT02488538|Fluoxetine|fluoxetine|mesh-list
110965620|NCT02488538|Contraceptive Agents|contraceptive agents|mesh-list
110965621|NCT02488538|Contraceptives, Oral|contraceptives, oral|mesh-list
110965622|NCT02488538|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
110965623|NCT02488538|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110965624|NCT02488538|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110965625|NCT02488538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110965626|NCT02488538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110965627|NCT02488538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110965628|NCT02488538|Serotonin Agents|serotonin agents|mesh-ancestor
110965629|NCT02488538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110965630|NCT02488538|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110965631|NCT02488538|Antidepressive Agents|antidepressive agents|mesh-ancestor
110965632|NCT02488538|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110965633|NCT02488538|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110965634|NCT02488538|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110965635|NCT02488538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110965636|NCT02488538|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110965637|NCT02488538|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110965638|NCT02568046|Leucovorin|leucovorin|mesh-list
110965639|NCT02568046|Fluorouracil|fluorouracil|mesh-list
110965640|NCT02568046|Irinotecan|irinotecan|mesh-list
110965641|NCT02568046|Antimetabolites|antimetabolites|mesh-ancestor
110965642|NCT02568046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110965643|NCT02568046|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110965644|NCT02568046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110965645|NCT02568046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110965646|NCT02568046|Immunologic Factors|immunologic factors|mesh-ancestor
110965647|NCT02568046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110965648|NCT02568046|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110965649|NCT02568046|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110965650|NCT02568046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110965651|NCT02568046|Antidotes|antidotes|mesh-ancestor
110965652|NCT02568046|Protective Agents|protective agents|mesh-ancestor
110965653|NCT02568046|Vitamin B Complex|vitamin b complex|mesh-ancestor
110965654|NCT02568046|Vitamins|vitamins|mesh-ancestor
110965655|NCT02568046|Micronutrients|micronutrients|mesh-ancestor
110965656|NCT03536481|Ensartinib|ensartinib|mesh-list
110965657|NCT03536481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110965658|NCT03536481|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110965659|NCT03536481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111119097|NCT05388474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111490933|NCT01787916|Hormones|hormones|mesh-ancestor
111490934|NCT01787916|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111490935|NCT01790490|Ketamine|ketamine|mesh-list
111490936|NCT01790490|Lorazepam|lorazepam|mesh-list
110965660|NCT03536481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110965661|NCT02488616|Insulin|insulin|mesh-list
110965662|NCT02488616|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110965663|NCT02488616|Hormones|hormones|mesh-list
110965664|NCT02488616|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110965665|NCT02488616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110965666|NCT02488616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110965667|NCT02256423|Ibuprofen|ibuprofen|mesh-list
110965668|NCT02256423|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110965669|NCT02256423|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110965670|NCT02256423|Analgesics|analgesics|mesh-ancestor
110965671|NCT02256423|Sensory System Agents|sensory system agents|mesh-ancestor
110965672|NCT02256423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110965673|NCT02256423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110965674|NCT02256423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110965675|NCT02256423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110965676|NCT02256423|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110965677|NCT02256423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110965678|NCT02256423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110965679|NCT03320486|Ketoconazole|ketoconazole|mesh-list
110965680|NCT03320486|Antifungal Agents|antifungal agents|mesh-ancestor
110965681|NCT03320486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110965682|NCT03320486|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110965683|NCT03320486|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110965684|NCT03320486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110965685|NCT03320486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110965686|NCT03320486|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110965687|NCT03320486|Hormone Antagonists|hormone antagonists|mesh-ancestor
110965688|NCT03320486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110965689|NCT03320486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110965690|NCT03320486|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110965691|NCT02567656|Tenalisib|tenalisib|mesh-list
110965692|NCT02567656|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
110965693|NCT02567656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110965694|NCT02567656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110965695|NCT02185833|Dirithromycin|dirithromycin|mesh-list
110965696|NCT02185833|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110965697|NCT02185833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110965698|NCT02180997|Tamsulosin|tamsulosin|mesh-list
110965699|NCT02180997|Solifenacin Succinate|solifenacin succinate|mesh-list
110965700|NCT02180997|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110965701|NCT02180997|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110965702|NCT02180997|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110965703|NCT02180997|Adrenergic Agents|adrenergic agents|mesh-ancestor
110965704|NCT02180997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110965705|NCT02180997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110965706|NCT02180997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110965707|NCT02180997|Urological Agents|urological agents|mesh-ancestor
110965708|NCT02180997|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110965709|NCT02180997|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110965710|NCT02180997|Cholinergic Agents|cholinergic agents|mesh-ancestor
110965711|NCT02560012|Sirolimus|sirolimus|mesh-list
110965712|NCT02560012|Everolimus|everolimus|mesh-list
110965713|NCT02560012|Temsirolimus|temsirolimus|mesh-list
110965714|NCT02560012|MTOR Inhibitors|mtor inhibitors|mesh-list
110965715|NCT02560012|Sorafenib|sorafenib|mesh-list
110965716|NCT02560012|Sunitinib|sunitinib|mesh-list
110965717|NCT02560012|Axitinib|axitinib|mesh-list
110965718|NCT02560012|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110965719|NCT02560012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110965720|NCT02560012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110965721|NCT02560012|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110965722|NCT02560012|Immunologic Factors|immunologic factors|mesh-ancestor
110965723|NCT02560012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110965724|NCT02560012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110965725|NCT02560012|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110965726|NCT02560012|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110965727|NCT02560012|Growth Substances|growth substances|mesh-ancestor
110965728|NCT02560012|Growth Inhibitors|growth inhibitors|mesh-ancestor
110965729|NCT02560012|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110965730|NCT02560012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110965732|NCT02560012|Antifungal Agents|antifungal agents|mesh-ancestor
110965733|NCT03320174|Tafenoquine|tafenoquine|mesh-list
110965734|NCT03320174|Antimalarials|antimalarials|mesh-ancestor
110965735|NCT03320174|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110965736|NCT03320174|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110965737|NCT03320174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110965738|NCT03328364|Docetaxel|docetaxel|mesh-list
110965739|NCT03328364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110965740|NCT03328364|Tubulin Modulators|tubulin modulators|mesh-ancestor
110965741|NCT03328364|Antimitotic Agents|antimitotic agents|mesh-ancestor
110965742|NCT03328364|Mitosis Modulators|mitosis modulators|mesh-ancestor
110965743|NCT03328364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110965744|NCT03328052|Antidepressive Agents|antidepressive agents|mesh-list
110965745|NCT03328052|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110965746|NCT04514302|Immunoglobulins|immunoglobulins|mesh-list
110965747|NCT04514302|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110965748|NCT04514302|Antibodies|antibodies|mesh-list
110965749|NCT04514302|Immunologic Factors|immunologic factors|mesh-ancestor
110965750|NCT04514302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110965751|NCT03319784|Triamcinolone|triamcinolone|mesh-list
110965752|NCT03319784|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110965753|NCT03319784|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110965754|NCT03319784|Ketorolac|ketorolac|mesh-list
110965755|NCT03319784|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110965756|NCT03319784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110965757|NCT03319784|Glucocorticoids|glucocorticoids|mesh-ancestor
110965758|NCT03319784|Hormones|hormones|mesh-ancestor
110965759|NCT03319784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110965760|NCT03319784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110965761|NCT03319784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110965762|NCT03319784|Immunologic Factors|immunologic factors|mesh-ancestor
110965763|NCT03319784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110965764|NCT03319784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110965765|NCT03319784|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110965766|NCT03319784|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110965767|NCT03319784|Analgesics|analgesics|mesh-ancestor
110965768|NCT03319784|Sensory System Agents|sensory system agents|mesh-ancestor
110965769|NCT03319784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110965770|NCT03319784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110965771|NCT03319784|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110965772|NCT03319706|Olmesartan|olmesartan|mesh-list
110676891|NCT03348969|Mitomycin|mitomycin|mesh-list
110965773|NCT03319706|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
110965774|NCT03319706|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110965775|NCT03319706|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110965776|NCT03319706|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110965777|NCT03319706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110965779|NCT05045170|Propofol|propofol|mesh-list
110965780|NCT05045170|Anesthetics|anesthetics|mesh-ancestor
110965781|NCT05045170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110965782|NCT05045170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110965783|NCT05045170|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110965784|NCT05045170|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110965785|NCT05045170|Analgesics|analgesics|mesh-ancestor
110965786|NCT05045170|Sensory System Agents|sensory system agents|mesh-ancestor
110965787|NCT05045170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110965788|NCT05045170|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110965789|NCT05045170|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110965790|NCT05045170|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110965791|NCT05045170|Adrenergic Agents|adrenergic agents|mesh-ancestor
110965792|NCT05045170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110965793|NCT05045170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110965794|NCT05045170|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110965795|NCT05045170|Anesthetics, General|anesthetics, general|mesh-ancestor
110965796|NCT05500690|Folic Acid|folic acid|mesh-list
110965797|NCT05500690|Hematinics|hematinics|mesh-ancestor
110965798|NCT05500690|Vitamin B Complex|vitamin b complex|mesh-ancestor
110965799|NCT05500690|Vitamins|vitamins|mesh-ancestor
110965800|NCT05500690|Micronutrients|micronutrients|mesh-ancestor
111490937|NCT01790490|Analgesics|analgesics|mesh-ancestor
111490938|NCT01790490|Sensory System Agents|sensory system agents|mesh-ancestor
111490939|NCT01790490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110965801|NCT05500690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110965802|NCT03322124|Octenidine|octenidine|mesh-list
110965803|NCT03322124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110965805|NCT04442984|Leucovorin|leucovorin|mesh-list
110965806|NCT04442984|Oxaliplatin|oxaliplatin|mesh-list
110965807|NCT04442984|Irinotecan|irinotecan|mesh-list
110965808|NCT04442984|Fluorouracil|fluorouracil|mesh-list
110965809|NCT04442984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110965810|NCT04442984|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110965811|NCT04442984|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110965812|NCT04442984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110965813|NCT04442984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110965814|NCT04442984|Antidotes|antidotes|mesh-ancestor
110965815|NCT04442984|Protective Agents|protective agents|mesh-ancestor
110965816|NCT04442984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110965817|NCT04442984|Vitamin B Complex|vitamin b complex|mesh-ancestor
110965818|NCT04442984|Vitamins|vitamins|mesh-ancestor
110965819|NCT04442984|Micronutrients|micronutrients|mesh-ancestor
110965820|NCT04442984|Antimetabolites|antimetabolites|mesh-ancestor
110965821|NCT04442984|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110965822|NCT04442984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110965823|NCT04442984|Immunologic Factors|immunologic factors|mesh-ancestor
110965824|NCT03327506|Alprazolam|alprazolam|mesh-list
110965825|NCT03327506|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110965826|NCT03327506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110965827|NCT03327506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110965828|NCT03327506|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110965829|NCT03327506|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110965830|NCT03327506|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110965831|NCT03327506|GABA Modulators|gaba modulators|mesh-ancestor
110965832|NCT03327506|GABA Agents|gaba agents|mesh-ancestor
110965833|NCT03327506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111490940|NCT01790490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111490941|NCT01790490|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110965834|NCT03327506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110965835|NCT02487914|Lidocaine|lidocaine|mesh-list
110965836|NCT02487914|Anesthetics, Local|anesthetics, local|mesh-ancestor
110965837|NCT02487914|Anesthetics|anesthetics|mesh-ancestor
110965838|NCT02487914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110965839|NCT02487914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110965840|NCT02487914|Sensory System Agents|sensory system agents|mesh-ancestor
110965841|NCT02487914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110965842|NCT02487914|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110965843|NCT02487914|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110965844|NCT02487914|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110965845|NCT02487914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110965846|NCT02487914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110965847|NCT02487680|Chromium|chromium|mesh-list
110965848|NCT02487680|Picolinic acid|picolinic acid|mesh-list
110965849|NCT02487680|Trace Elements|trace elements|mesh-ancestor
110965850|NCT02487680|Micronutrients|micronutrients|mesh-ancestor
110965851|NCT02487680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110965852|NCT02487680|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110965853|NCT02487680|Chelating Agents|chelating agents|mesh-ancestor
110965854|NCT02487680|Sequestering Agents|sequestering agents|mesh-ancestor
110965855|NCT02487680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110965856|NCT03319550|Caseins|caseins|mesh-list
110965857|NCT03319550|Chelating Agents|chelating agents|mesh-ancestor
110965858|NCT03319550|Sequestering Agents|sequestering agents|mesh-ancestor
110965859|NCT03319550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110965860|NCT04442906|Fentanyl|fentanyl|mesh-list
110965861|NCT04442906|Dexmedetomidine|dexmedetomidine|mesh-list
110965862|NCT04442906|Bupivacaine|bupivacaine|mesh-list
110965863|NCT04442906|Anesthetics, Local|anesthetics, local|mesh-ancestor
110965864|NCT04442906|Anesthetics|anesthetics|mesh-ancestor
110965865|NCT04442906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110965866|NCT04442906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110965867|NCT04442906|Sensory System Agents|sensory system agents|mesh-ancestor
110965868|NCT04442906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110965869|NCT04442906|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110965870|NCT04442906|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110965871|NCT04442906|Analgesics|analgesics|mesh-ancestor
111490942|NCT01790490|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111490943|NCT01790490|Anesthetics, General|anesthetics, general|mesh-ancestor
111490944|NCT01790490|Anesthetics|anesthetics|mesh-ancestor
110965872|NCT04442906|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110965873|NCT04442906|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110965874|NCT04442906|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111490945|NCT01790490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111490946|NCT01790490|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110965876|NCT04442906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110965877|NCT04442906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110965878|NCT04442906|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110965879|NCT04442906|Narcotics|narcotics|mesh-ancestor
110965880|NCT04442906|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110965881|NCT04442906|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110965882|NCT04442906|Anesthetics, General|anesthetics, general|mesh-ancestor
110965883|NCT04510012|Complement System Proteins|complement system proteins|mesh-list
110965884|NCT04510012|Immunologic Factors|immunologic factors|mesh-ancestor
110965885|NCT04510012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110965886|NCT03327350|Anticoagulants|anticoagulants|mesh-list
110965887|NCT03327272|Methylprednisolone|methylprednisolone|mesh-list
110965888|NCT03327272|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110965889|NCT03327272|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110965890|NCT03327272|Prednisolone|prednisolone|mesh-list
110965891|NCT03327272|Prednisolone acetate|prednisolone acetate|mesh-list
110965892|NCT03327272|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110965893|NCT03327272|Prednisolone phosphate|prednisolone phosphate|mesh-list
110965894|NCT03327272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110965895|NCT03327272|Antiemetics|antiemetics|mesh-ancestor
110965896|NCT03327272|Autonomic Agents|autonomic agents|mesh-ancestor
110965897|NCT03327272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110965898|NCT03327272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110965899|NCT03327272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110965900|NCT03327272|Glucocorticoids|glucocorticoids|mesh-ancestor
110965901|NCT03327272|Hormones|hormones|mesh-ancestor
110965902|NCT03327272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110965903|NCT03327272|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110965904|NCT03327272|Protective Agents|protective agents|mesh-ancestor
110965905|NCT03327272|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110965906|NCT03327272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110965907|NCT05508178|Vaccines|vaccines|mesh-list
110965908|NCT05508178|Immunologic Factors|immunologic factors|mesh-ancestor
110965909|NCT05508178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110965910|NCT03327116|Methotrexate|methotrexate|mesh-list
110965911|NCT03327116|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110965912|NCT03327116|Abortifacient Agents|abortifacient agents|mesh-ancestor
110965913|NCT03327116|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110965914|NCT03327116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110965915|NCT03327116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110965916|NCT03327116|Antimetabolites|antimetabolites|mesh-ancestor
110965917|NCT03327116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110965918|NCT03327116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110965919|NCT03327116|Dermatologic Agents|dermatologic agents|mesh-ancestor
110965920|NCT03327116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110965921|NCT03327116|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110965922|NCT03327116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110965923|NCT03327116|Immunologic Factors|immunologic factors|mesh-ancestor
110965924|NCT03327116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110678009|NCT00887003|Antiemetics|antiemetics|mesh-ancestor
110965925|NCT03327116|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110965926|NCT06036108|Brexpiprazole|brexpiprazole|mesh-list
110965927|NCT06036108|Serotonin Agents|serotonin agents|mesh-ancestor
110965928|NCT06036108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110965929|NCT06036108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110965930|NCT06036108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110965931|NCT06036108|Dopamine Agonists|dopamine agonists|mesh-ancestor
110965932|NCT06036108|Dopamine Agents|dopamine agents|mesh-ancestor
110965933|NCT06036095|Anesthetics|anesthetics|mesh-list
110965934|NCT06036095|Propofol|propofol|mesh-list
110965935|NCT06036095|Sevoflurane|sevoflurane|mesh-list
110965936|NCT06036095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110965937|NCT06036095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110965938|NCT06036095|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110965939|NCT06036095|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110965940|NCT06036095|Anesthetics, General|anesthetics, general|mesh-ancestor
110965941|NCT06036095|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110965942|NCT06036095|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110965943|NCT06036043|Botulinum Toxins|botulinum toxins|mesh-list
111490947|NCT01790490|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111490948|NCT01790490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110699057|NCT00404066|Dexamethasone|dexamethasone|mesh-list
110965944|NCT06036043|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110965945|NCT06036043|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110965946|NCT06036043|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110965947|NCT06036043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110965948|NCT06036043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110965949|NCT06036043|Cholinergic Agents|cholinergic agents|mesh-ancestor
110965950|NCT06036043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110965951|NCT06036043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110965952|NCT06036043|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110965953|NCT06036043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110965955|NCT06036030|Piperaquine|piperaquine|mesh-list
110965956|NCT06036030|Artenimol|artenimol|mesh-list
110965957|NCT06036030|Antimalarials|antimalarials|mesh-ancestor
110965958|NCT06036030|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110965959|NCT06036030|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110965960|NCT06036030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110965961|NCT06035978|Metoprolol|metoprolol|mesh-list
110965962|NCT06035978|Valsartan|valsartan|mesh-list
110965963|NCT06035978|Carvedilol|carvedilol|mesh-list
110965964|NCT06035978|Nebivolol|nebivolol|mesh-list
110965965|NCT06035978|Bisoprolol|bisoprolol|mesh-list
110965966|NCT06035978|Spironolactone|spironolactone|mesh-list
110965967|NCT06035978|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
110965968|NCT06035978|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110965969|NCT06035978|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110965970|NCT06035978|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110965971|NCT06035978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110965972|NCT06035978|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110965973|NCT06035978|Sympatholytics|sympatholytics|mesh-ancestor
110965974|NCT06035978|Autonomic Agents|autonomic agents|mesh-ancestor
110965975|NCT06035978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110965976|NCT06035978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110965977|NCT06035978|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110965978|NCT06035978|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110965979|NCT06035978|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110965980|NCT06035978|Adrenergic Agents|adrenergic agents|mesh-ancestor
110965981|NCT06035978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110965982|NCT06035978|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110965983|NCT06035978|Hormone Antagonists|hormone antagonists|mesh-ancestor
110965984|NCT06035978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110965985|NCT06035978|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110965986|NCT06035978|Diuretics|diuretics|mesh-ancestor
110965987|NCT06035978|Natriuretic Agents|natriuretic agents|mesh-ancestor
110965988|NCT06035978|Antioxidants|antioxidants|mesh-ancestor
110965989|NCT06035978|Protective Agents|protective agents|mesh-ancestor
110965990|NCT06035978|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110965991|NCT06035978|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110965992|NCT06035978|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110965993|NCT06035978|Vasodilator Agents|vasodilator agents|mesh-ancestor
110965994|NCT06035978|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110965995|NCT06035978|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110965996|NCT06035978|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
110965997|NCT06035978|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110965998|NCT06035978|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110965999|NCT06035900|Psilocin|psilocin|mesh-list
110966000|NCT06035900|Hallucinogens|hallucinogens|mesh-ancestor
110966001|NCT06035900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110966002|NCT06035900|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110966003|NCT06035757|Neostigmine|neostigmine|mesh-list
110966004|NCT06035757|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110966005|NCT06035757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110966006|NCT06035757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110966007|NCT06035757|Cholinergic Agents|cholinergic agents|mesh-ancestor
110966008|NCT06035757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110966009|NCT06035757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110966010|NCT06035757|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110966011|NCT06035757|Autonomic Agents|autonomic agents|mesh-ancestor
110966012|NCT06035757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110966013|NCT06035692|Ropivacaine|ropivacaine|mesh-list
110966014|NCT06035692|Anesthetics, Local|anesthetics, local|mesh-ancestor
110966015|NCT06035692|Anesthetics|anesthetics|mesh-ancestor
110966016|NCT06035692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111490949|NCT01790490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110966017|NCT06035692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110966018|NCT06035692|Sensory System Agents|sensory system agents|mesh-ancestor
110966019|NCT06035692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110966020|NCT06035679|Trastuzumab|trastuzumab|mesh-list
110966021|NCT06035679|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110966022|NCT06035679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110966023|NCT06035614|Tacrolimus|tacrolimus|mesh-list
110966024|NCT06035614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110966025|NCT06035614|Immunologic Factors|immunologic factors|mesh-ancestor
110966026|NCT06035614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110966027|NCT06035614|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110966028|NCT06035614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110966029|NCT06035614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110650884|NCT00515073|Paclitaxel|paclitaxel|mesh-list
110966030|NCT06035393|Glycopyrrolate|glycopyrrolate|mesh-list
110966031|NCT06035393|Bromides|bromides|mesh-list
110966032|NCT06035393|Maleic acid|maleic acid|mesh-list
110966033|NCT06035393|Anticonvulsants|anticonvulsants|mesh-ancestor
110966034|NCT06035393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110966035|NCT06035393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110966036|NCT06035393|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110966037|NCT06035393|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110966038|NCT06035393|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110966039|NCT06035393|Cholinergic Agents|cholinergic agents|mesh-ancestor
110966040|NCT06035393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110966041|NCT06035393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110966042|NCT06035315|Micronutrients|micronutrients|mesh-list
110966043|NCT06035315|Trace Elements|trace elements|mesh-list
110966044|NCT06035315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110966045|NCT06035224|Lenvatinib|lenvatinib|mesh-list
110966046|NCT06035224|Antibodies|antibodies|mesh-list
110966047|NCT06035224|Antibodies, Bispecific|antibodies, bispecific|mesh-list
110966048|NCT06035224|Immunologic Factors|immunologic factors|mesh-ancestor
110966049|NCT06035224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110966050|NCT06035224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110966051|NCT06035224|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110966052|NCT06035224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110966053|NCT06035224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110966054|NCT06035133|Bevacizumab|bevacizumab|mesh-list
110966055|NCT06035133|Cetuximab|cetuximab|mesh-list
110966056|NCT06035133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110966057|NCT06035133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110966058|NCT06035133|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110966059|NCT06035133|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110966060|NCT06035133|Growth Substances|growth substances|mesh-ancestor
110966061|NCT06035133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110966062|NCT06035133|Growth Inhibitors|growth inhibitors|mesh-ancestor
110966063|NCT06035081|Prednisolone|prednisolone|mesh-list
110966064|NCT06035081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110966065|NCT06035081|Glucocorticoids|glucocorticoids|mesh-ancestor
110966066|NCT06035081|Hormones|hormones|mesh-ancestor
110966067|NCT06035081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110966068|NCT06035081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110966069|NCT06035081|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110966070|NCT06035081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110966071|NCT06035055|Tazobactam|tazobactam|mesh-list
110966072|NCT06035055|Ceftolozane|ceftolozane|mesh-list
110966073|NCT06035055|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
110966074|NCT06035055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110678159|NCT04641338|Narcotics|narcotics|mesh-ancestor
110966075|NCT06035055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110966089|NCT06034938|Lamivudine|lamivudine|mesh-list
110966090|NCT06034938|Antiviral Agents|antiviral agents|mesh-ancestor
110966091|NCT06034938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110966092|NCT06034938|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110966093|NCT06034938|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110966094|NCT06034938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110966095|NCT06034938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110966096|NCT06034938|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110966097|NCT06034938|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111490950|NCT01790490|Anticonvulsants|anticonvulsants|mesh-ancestor
111490951|NCT01790490|Antiemetics|antiemetics|mesh-ancestor
111490952|NCT01790490|Autonomic Agents|autonomic agents|mesh-ancestor
111490953|NCT01790490|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111490954|NCT01790490|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111490955|NCT01790490|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110966098|NCT06034925|Valganciclovir|valganciclovir|mesh-list
111490956|NCT01790490|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110966099|NCT06034925|Maribavir|maribavir|mesh-list
110966100|NCT06034925|Antiviral Agents|antiviral agents|mesh-ancestor
110966101|NCT06034925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110966102|NCT06034860|Nivolumab|nivolumab|mesh-list
110966103|NCT06034860|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110966104|NCT06034860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110966105|NCT06034860|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110966106|NCT06034860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110966121|NCT06034691|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-list
110966122|NCT06034691|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110966123|NCT06034691|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110966124|NCT06034691|Antimetabolites|antimetabolites|mesh-ancestor
110966125|NCT06034691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110966126|NCT06034691|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110966127|NCT06034691|Protease Inhibitors|protease inhibitors|mesh-ancestor
110966128|NCT06034691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110966129|NCT06034691|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110966130|NCT06034626|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110966131|NCT06034626|Hyaluronic Acid|hyaluronic acid|mesh-list
110966132|NCT06034626|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110966133|NCT06034626|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110966134|NCT06034626|Immunologic Factors|immunologic factors|mesh-ancestor
110966135|NCT06034626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110966136|NCT06034626|Viscosupplements|viscosupplements|mesh-ancestor
110966137|NCT06034626|Protective Agents|protective agents|mesh-ancestor
110966138|NCT06034561|Dexamethasone|dexamethasone|mesh-list
110966139|NCT06034561|Doxorubicin|doxorubicin|mesh-list
110966140|NCT06034561|Methotrexate|methotrexate|mesh-list
110966141|NCT06034561|Vincristine|vincristine|mesh-list
110966142|NCT06034561|Bortezomib|bortezomib|mesh-list
110966143|NCT06034561|Asparaginase|asparaginase|mesh-list
110966144|NCT06034561|Pegaspargase|pegaspargase|mesh-list
110966145|NCT06034561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110966146|NCT06034561|Antiemetics|antiemetics|mesh-ancestor
110966147|NCT06034561|Autonomic Agents|autonomic agents|mesh-ancestor
110966148|NCT06034561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110966149|NCT06034561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110966150|NCT06034561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110966151|NCT06034561|Glucocorticoids|glucocorticoids|mesh-ancestor
110966152|NCT06034561|Hormones|hormones|mesh-ancestor
110966153|NCT06034561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110966154|NCT06034561|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110966155|NCT06034561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110966156|NCT06034561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110966157|NCT06034561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110966158|NCT06034561|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110966159|NCT06034561|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110966160|NCT06034561|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110966161|NCT06034561|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110966162|NCT06034561|Abortifacient Agents|abortifacient agents|mesh-ancestor
110966163|NCT06034561|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110966164|NCT06034561|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110966165|NCT06034561|Antimetabolites|antimetabolites|mesh-ancestor
110966166|NCT06034561|Dermatologic Agents|dermatologic agents|mesh-ancestor
110966167|NCT06034561|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110966168|NCT06034561|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110966169|NCT06034561|Immunologic Factors|immunologic factors|mesh-ancestor
110966170|NCT06034561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110966171|NCT06034561|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110966172|NCT06034561|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110966173|NCT06034561|Tubulin Modulators|tubulin modulators|mesh-ancestor
110966174|NCT06034561|Antimitotic Agents|antimitotic agents|mesh-ancestor
110966175|NCT06034561|Mitosis Modulators|mitosis modulators|mesh-ancestor
110966176|NCT06034470|Cytarabine|cytarabine|mesh-list
110966177|NCT06034470|Fludarabine|fludarabine|mesh-list
110966178|NCT06034470|Idarubicin|idarubicin|mesh-list
110966179|NCT06034470|Lenograstim|lenograstim|mesh-list
110966180|NCT06034470|Immunoconjugates|immunoconjugates|mesh-list
110966181|NCT06034470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110966182|NCT06034470|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110966183|NCT06034470|Antimetabolites|antimetabolites|mesh-ancestor
110966184|NCT06034470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111490957|NCT01790490|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111490958|NCT01790490|GABA Modulators|gaba modulators|mesh-ancestor
111490959|NCT01790490|GABA Agents|gaba agents|mesh-ancestor
110966185|NCT06034470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110966186|NCT06034470|Immunologic Factors|immunologic factors|mesh-ancestor
111490960|NCT01791972|Albuterol|albuterol|mesh-list
111490961|NCT01791972|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110966187|NCT06034470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110966188|NCT06034470|Antiviral Agents|antiviral agents|mesh-ancestor
110966189|NCT06034470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110966190|NCT06034470|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110966191|NCT06034470|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110966192|NCT06034470|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110966193|NCT06034470|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110966194|NCT06034470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110966195|NCT06034418|Betamethasone|betamethasone|mesh-list
110966196|NCT06034418|Lidocaine|lidocaine|mesh-list
110966197|NCT06034418|Anesthetics, Local|anesthetics, local|mesh-ancestor
110966198|NCT06034418|Anesthetics|anesthetics|mesh-ancestor
110966199|NCT06034418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110966200|NCT06034418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110966201|NCT06034418|Sensory System Agents|sensory system agents|mesh-ancestor
110966202|NCT06034418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110966203|NCT06034418|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110966204|NCT06034418|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110966205|NCT06034418|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110966206|NCT06034418|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110966207|NCT06034418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110966208|NCT06034418|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110966209|NCT06034418|Glucocorticoids|glucocorticoids|mesh-ancestor
110966210|NCT06034418|Hormones|hormones|mesh-ancestor
110966211|NCT06034418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110966212|NCT06034418|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110966213|NCT06034418|Respiratory System Agents|respiratory system agents|mesh-ancestor
110966214|NCT06034366|Atropine|atropine|mesh-list
110966215|NCT06034366|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110966216|NCT06034366|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110966217|NCT06034366|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110966218|NCT06034366|Autonomic Agents|autonomic agents|mesh-ancestor
110966219|NCT06034366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110966220|NCT06034366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110966221|NCT06034366|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110966222|NCT06034366|Respiratory System Agents|respiratory system agents|mesh-ancestor
110966223|NCT06034366|Mydriatics|mydriatics|mesh-ancestor
110966224|NCT06034366|Parasympatholytics|parasympatholytics|mesh-ancestor
110966225|NCT06034366|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110966226|NCT06034366|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110966227|NCT06034366|Cholinergic Agents|cholinergic agents|mesh-ancestor
110966228|NCT06034366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110966229|NCT06034366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110966230|NCT06034340|Lidocaine|lidocaine|mesh-list
110966231|NCT06034340|Anesthetics, Local|anesthetics, local|mesh-ancestor
110966232|NCT06034340|Anesthetics|anesthetics|mesh-ancestor
110966233|NCT06034340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110966234|NCT06034340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110966235|NCT06034340|Sensory System Agents|sensory system agents|mesh-ancestor
110966236|NCT06034340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110966237|NCT06034340|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110966238|NCT06034340|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110966239|NCT06034340|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110966240|NCT06034340|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110966241|NCT06034340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110966242|NCT06030713|Cefazolin|cefazolin|mesh-list
110966243|NCT06030713|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110966244|NCT06030713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110966245|NCT06021925|Antibodies|antibodies|mesh-list
110966246|NCT06021925|Immunologic Factors|immunologic factors|mesh-ancestor
110966247|NCT06021925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110966248|NCT06021600|Cladribine|cladribine|mesh-list
110966249|NCT06021600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110966250|NCT06021600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110966251|NCT06021600|Immunologic Factors|immunologic factors|mesh-ancestor
110966252|NCT06021600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110966253|NCT06021379|Trastuzumab|trastuzumab|mesh-list
110966254|NCT06021379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110966255|NCT06021379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110966256|NCT06005688|Carbamazepine|carbamazepine|mesh-list
110966257|NCT06005688|Anticonvulsants|anticonvulsants|mesh-ancestor
110966258|NCT06005688|Antimanic Agents|antimanic agents|mesh-ancestor
110966259|NCT06005688|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111119098|NCT05372744|Antidepressive Agents|antidepressive agents|mesh-list
111490962|NCT01791972|Autonomic Agents|autonomic agents|mesh-ancestor
110966260|NCT06005688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110966261|NCT06005688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110966262|NCT06005688|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110966263|NCT06005688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110966265|NCT06005688|Sensory System Agents|sensory system agents|mesh-ancestor
110966266|NCT06005688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110966267|NCT06005688|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110966268|NCT06005688|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110966269|NCT06005688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110966270|NCT06005688|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110966271|NCT06005688|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110966272|NCT06003933|Lidocaine|lidocaine|mesh-list
110966273|NCT06003933|Bupivacaine|bupivacaine|mesh-list
110966274|NCT06003933|Anesthetics, Local|anesthetics, local|mesh-ancestor
110966275|NCT06003933|Anesthetics|anesthetics|mesh-ancestor
110966276|NCT06003933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110966277|NCT06003933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110966278|NCT06003933|Sensory System Agents|sensory system agents|mesh-ancestor
110966279|NCT06003933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110966280|NCT06003933|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110966281|NCT06003933|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110966282|NCT06003933|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110966283|NCT06003933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110966284|NCT06003933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110966285|NCT05994807|Itraconazole|itraconazole|mesh-list
110650953|NCT00514917|Docetaxel|docetaxel|mesh-list
110966286|NCT05994807|Carbamazepine|carbamazepine|mesh-list
110966287|NCT05994807|Antifungal Agents|antifungal agents|mesh-ancestor
110966288|NCT05994807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110966289|NCT05994807|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110966290|NCT05994807|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110966291|NCT05994807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110966292|NCT05994807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110966293|NCT05994807|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110966294|NCT05994807|Hormone Antagonists|hormone antagonists|mesh-ancestor
110966295|NCT05994807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110966296|NCT05994807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110966297|NCT05994807|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110966298|NCT05994807|Anticonvulsants|anticonvulsants|mesh-ancestor
110678399|NCT00519896|Sunitinib|sunitinib|mesh-list
110966299|NCT05994807|Antimanic Agents|antimanic agents|mesh-ancestor
110966300|NCT05994807|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110966301|NCT05994807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110966302|NCT05994807|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110966303|NCT05994807|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110966305|NCT05994807|Sensory System Agents|sensory system agents|mesh-ancestor
110966306|NCT05994807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110966307|NCT05994807|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110966308|NCT05994807|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110966309|NCT05994807|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110966310|NCT05994807|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110966311|NCT05991401|Clarithromycin|clarithromycin|mesh-list
110966312|NCT05991401|Rifampin|rifampin|mesh-list
110966313|NCT05991401|DA-8010|da-8010|mesh-list
110966314|NCT05991401|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110966315|NCT05991401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110966316|NCT05991401|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110966317|NCT05991401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110966318|NCT05991401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110966319|NCT05991401|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110966320|NCT05991401|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110966321|NCT05991401|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110966322|NCT05991401|Antitubercular Agents|antitubercular agents|mesh-ancestor
110966323|NCT05991401|Leprostatic Agents|leprostatic agents|mesh-ancestor
110966324|NCT05991401|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110966325|NCT05991401|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110966326|NCT05991401|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110966327|NCT05991401|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
111490963|NCT01791972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111490964|NCT01791972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111490965|NCT01791972|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110966328|NCT05991401|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110966329|NCT05991401|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110966330|NCT05991401|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110966331|NCT05991401|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110966332|NCT05991401|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110966333|NCT05991401|Cholinergic Agents|cholinergic agents|mesh-ancestor
110966334|NCT05991401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110966335|NCT05991401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110966336|NCT05987241|Nivolumab|nivolumab|mesh-list
110966337|NCT05987241|Relatlimab|relatlimab|mesh-list
110966338|NCT05987241|Immunoglobulins|immunoglobulins|mesh-list
110966339|NCT05987241|Immunoglobulin G|immunoglobulin g|mesh-list
110966340|NCT05987241|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110966341|NCT05987241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110966342|NCT05987241|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110966343|NCT05987241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110966344|NCT05987241|Immunologic Factors|immunologic factors|mesh-ancestor
110966345|NCT05987241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110966346|NCT05957926|Hyaluronic Acid|hyaluronic acid|mesh-list
110966347|NCT05957926|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110966348|NCT05957926|Immunologic Factors|immunologic factors|mesh-ancestor
110966349|NCT05957926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110966350|NCT05957926|Viscosupplements|viscosupplements|mesh-ancestor
110966351|NCT05957926|Protective Agents|protective agents|mesh-ancestor
110966352|NCT05946902|Mirabegron|mirabegron|mesh-list
110966353|NCT05946902|Tolterodine Tartrate|tolterodine tartrate|mesh-list
110966354|NCT05946902|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
110966355|NCT05946902|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110966356|NCT05946902|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110966357|NCT05946902|Adrenergic Agents|adrenergic agents|mesh-ancestor
110966358|NCT05946902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110966359|NCT05946902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110966360|NCT05946902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110966361|NCT05946902|Urological Agents|urological agents|mesh-ancestor
110966362|NCT05946902|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110966363|NCT05946902|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110966364|NCT05946902|Cholinergic Agents|cholinergic agents|mesh-ancestor
110966365|NCT05941520|Tamoxifen|tamoxifen|mesh-list
110966366|NCT05941520|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110966367|NCT05941520|Hormone Antagonists|hormone antagonists|mesh-ancestor
110966368|NCT05941520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110966369|NCT05941520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110966370|NCT05941520|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110966371|NCT05941520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110966372|NCT05941520|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110966373|NCT05941520|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110966374|NCT05941520|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110966375|NCT05925686|Tramadol|tramadol|mesh-list
110966376|NCT05925686|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110966377|NCT05925686|Narcotics|narcotics|mesh-ancestor
110966378|NCT05925686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110966379|NCT05925686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110966380|NCT05925686|Analgesics|analgesics|mesh-ancestor
110966381|NCT05925686|Sensory System Agents|sensory system agents|mesh-ancestor
110966382|NCT05925686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110966383|NCT05919277|Antibodies|antibodies|mesh-list
110966384|NCT05919277|Immunoglobulins|immunoglobulins|mesh-list
110966385|NCT05919277|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110966386|NCT05919277|Immunoglobulin G|immunoglobulin g|mesh-list
110966387|NCT05919277|Immunologic Factors|immunologic factors|mesh-ancestor
110966388|NCT05919277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110966389|NCT05908734|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
110966390|NCT05908734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110966391|NCT05908734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110966392|NCT05898763|Pembrolizumab|pembrolizumab|mesh-list
110966393|NCT05898763|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
110966394|NCT05898763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110966395|NCT05898763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110966396|NCT05898763|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110966397|NCT05898763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110966398|NCT05898763|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111490966|NCT01791972|Respiratory System Agents|respiratory system agents|mesh-ancestor
111490967|NCT01791972|Tocolytic Agents|tocolytic agents|mesh-ancestor
110966399|NCT05898763|Immunologic Factors|immunologic factors|mesh-ancestor
111490968|NCT01791972|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111490969|NCT01791972|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110966400|NCT05898763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110966401|NCT05896839|Sirolimus|sirolimus|mesh-list
110966402|NCT05896839|Prednisone|prednisone|mesh-list
110966403|NCT05896839|Cortisone|cortisone|mesh-list
110966404|NCT05896839|Nivolumab|nivolumab|mesh-list
110966405|NCT05896839|Ipilimumab|ipilimumab|mesh-list
110966406|NCT05896839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110966407|NCT05896839|Glucocorticoids|glucocorticoids|mesh-ancestor
110966408|NCT05896839|Hormones|hormones|mesh-ancestor
110966409|NCT05896839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110966410|NCT05896839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110966411|NCT05896839|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110966412|NCT05896839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110966413|NCT05896839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110966414|NCT05896839|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110966415|NCT05896839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110966416|NCT05896839|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110966417|NCT05896839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110966418|NCT05896839|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110966419|NCT05896839|Antifungal Agents|antifungal agents|mesh-ancestor
110966420|NCT05896839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110966421|NCT05896839|Immunologic Factors|immunologic factors|mesh-ancestor
110966422|NCT05886036|Deoxyglucose|deoxyglucose|mesh-list
110966423|NCT05886036|Rituximab|rituximab|mesh-list
110966424|NCT05886036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110966425|NCT05886036|Antibodies|antibodies|mesh-list
110966426|NCT05886036|Immunoglobulins|immunoglobulins|mesh-list
110966427|NCT05886036|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110966428|NCT05886036|Antibodies, Bispecific|antibodies, bispecific|mesh-list
110966429|NCT05886036|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110966430|NCT05886036|Immunologic Factors|immunologic factors|mesh-ancestor
110966431|NCT05886036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110966432|NCT05886036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110966433|NCT05886036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110966434|NCT05886036|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110966435|NCT05886036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110966436|NCT05886036|Antimetabolites|antimetabolites|mesh-ancestor
110966437|NCT05886036|Antiviral Agents|antiviral agents|mesh-ancestor
110966438|NCT05886036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110966439|NCT05884398|Androgens|androgens|mesh-list
110966440|NCT05884398|Hormones|hormones|mesh-ancestor
110966441|NCT05884398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110966442|NCT05884398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110966443|NCT05884242|Adalimumab|adalimumab|mesh-list
110966444|NCT05884242|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110966445|NCT05884242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110966446|NCT05884242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110676892|NCT03348969|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110966447|NCT05878951|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110966448|NCT05878951|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110966449|NCT05878951|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110966450|NCT05878951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110966451|NCT05878951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110966452|NCT05878951|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110966453|NCT05878951|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110966454|NCT05878951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110966455|NCT05878951|Cholinergic Agents|cholinergic agents|mesh-ancestor
110966456|NCT05878951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110966458|NCT05868837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110966459|NCT05868837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110966460|NCT05868837|Immunologic Factors|immunologic factors|mesh-ancestor
110966461|NCT05868837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110966462|NCT05868837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110966463|NCT05866627|Famotidine|famotidine|mesh-list
110966464|NCT05866627|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110966465|NCT05866627|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110966466|NCT05866627|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110966467|NCT05866627|Histamine Antagonists|histamine antagonists|mesh-ancestor
110966468|NCT05866627|Histamine Agents|histamine agents|mesh-ancestor
110966469|NCT05866627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110966470|NCT05866627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110966471|NCT05866627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110966473|NCT05862285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110966474|NCT05862285|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110966475|NCT05862285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110966476|NCT05862285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110966477|NCT05848687|Dexamethasone|dexamethasone|mesh-list
110966478|NCT05848687|Methotrexate|methotrexate|mesh-list
110966479|NCT05848687|Bortezomib|bortezomib|mesh-list
110966480|NCT05848687|Asparaginase|asparaginase|mesh-list
110966481|NCT05848687|Mitoxantrone|mitoxantrone|mesh-list
110966482|NCT05848687|Mercaptopurine|mercaptopurine|mesh-list
110966483|NCT05848687|Vorinostat|vorinostat|mesh-list
110966484|NCT05848687|Blinatumomab|blinatumomab|mesh-list
110966485|NCT05848687|Pegaspargase|pegaspargase|mesh-list
110966486|NCT05848687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110966487|NCT05848687|Antiemetics|antiemetics|mesh-ancestor
110966488|NCT05848687|Autonomic Agents|autonomic agents|mesh-ancestor
110966489|NCT05848687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110966490|NCT05848687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110966491|NCT05848687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110966492|NCT05848687|Glucocorticoids|glucocorticoids|mesh-ancestor
110966493|NCT05848687|Hormones|hormones|mesh-ancestor
110966494|NCT05848687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110966495|NCT05848687|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110966496|NCT05848687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110966497|NCT05848687|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110966498|NCT05848687|Abortifacient Agents|abortifacient agents|mesh-ancestor
110966499|NCT05848687|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110966500|NCT05848687|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110966501|NCT05848687|Antimetabolites|antimetabolites|mesh-ancestor
110966502|NCT05848687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110966503|NCT05848687|Dermatologic Agents|dermatologic agents|mesh-ancestor
110966504|NCT05848687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110966505|NCT05848687|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110966506|NCT05848687|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110966507|NCT05848687|Immunologic Factors|immunologic factors|mesh-ancestor
110966508|NCT05848687|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110966509|NCT05848687|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110966510|NCT05848687|Analgesics|analgesics|mesh-ancestor
110966511|NCT05848687|Sensory System Agents|sensory system agents|mesh-ancestor
110966512|NCT05848687|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110966513|NCT05848687|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110966514|NCT05848687|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110966515|NCT05840510|Sirolimus|sirolimus|mesh-list
110966516|NCT05840510|Adagrasib|adagrasib|mesh-list
110966517|NCT05840510|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110966518|NCT05840510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110966519|NCT05840510|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110966520|NCT05840510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110966521|NCT05840510|Antifungal Agents|antifungal agents|mesh-ancestor
110678614|NCT01033149|Antidotes|antidotes|mesh-ancestor
110650994|NCT00504075|Immunologic Factors|immunologic factors|mesh-ancestor
110966522|NCT05840510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110966523|NCT05840510|Immunologic Factors|immunologic factors|mesh-ancestor
110966524|NCT05840510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110966525|NCT05836571|Nivolumab|nivolumab|mesh-list
110966526|NCT05836571|Ipilimumab|ipilimumab|mesh-list
110966527|NCT05836571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110966528|NCT05836571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110966529|NCT05836571|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110966530|NCT05836571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110966531|NCT05835284|Silicon|silicon|mesh-list
110966532|NCT05835284|Trace Elements|trace elements|mesh-ancestor
110966533|NCT05835284|Micronutrients|micronutrients|mesh-ancestor
110966534|NCT05835284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110966535|NCT05827874|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110966536|NCT05827874|Immunologic Factors|immunologic factors|mesh-ancestor
110966537|NCT05827874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110966538|NCT05811351|Prednisone|prednisone|mesh-list
110966539|NCT05811351|Triamcinolone|triamcinolone|mesh-list
110966540|NCT05811351|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111490970|NCT01791972|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111490971|NCT01791972|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111490972|NCT01791972|Adrenergic Agents|adrenergic agents|mesh-ancestor
110966541|NCT05811351|Glucocorticoids|glucocorticoids|mesh-ancestor
110966542|NCT05811351|Hormones|hormones|mesh-ancestor
110966543|NCT05811351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111119099|NCT05372744|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111490973|NCT01791972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110966544|NCT05811351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110966545|NCT05811351|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110966546|NCT05811351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110966547|NCT05786066|Ketamine|ketamine|mesh-list
110966548|NCT05786066|Analgesics|analgesics|mesh-ancestor
110966549|NCT05786066|Sensory System Agents|sensory system agents|mesh-ancestor
110966550|NCT05786066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110966551|NCT05786066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110966552|NCT05786066|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110966553|NCT05786066|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110966554|NCT05786066|Anesthetics, General|anesthetics, general|mesh-ancestor
110966555|NCT05786066|Anesthetics|anesthetics|mesh-ancestor
110966556|NCT05786066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110966557|NCT05786066|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110966558|NCT05786066|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110651017|NCT00736541|Acetylcysteine|acetylcysteine|mesh-list
110966559|NCT05786066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110966560|NCT05786066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110966561|NCT05776888|Ofatumumab|ofatumumab|mesh-list
110966562|NCT05776888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110966563|NCT05757869|Apixaban|apixaban|mesh-list
110966564|NCT05757869|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110966565|NCT05757869|Antithrombins|antithrombins|mesh-ancestor
110966566|NCT05757869|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110966567|NCT05757869|Protease Inhibitors|protease inhibitors|mesh-ancestor
110966568|NCT05757869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110966569|NCT05757869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110966570|NCT05757869|Anticoagulants|anticoagulants|mesh-ancestor
110966571|NCT05744648|Titanium dioxide|titanium dioxide|mesh-list
110966572|NCT05744648|Sunscreening Agents|sunscreening agents|mesh-ancestor
110966573|NCT05744648|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110966574|NCT05744648|Protective Agents|protective agents|mesh-ancestor
110966575|NCT05744648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110966576|NCT05744648|Dermatologic Agents|dermatologic agents|mesh-ancestor
110966577|NCT05744648|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110966578|NCT05731492|Macitentan|macitentan|mesh-list
110966579|NCT05731492|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
110966580|NCT05731492|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
110966581|NCT05731492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110966582|NCT05731492|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
110966583|NCT05724108|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
110966584|NCT05724108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110966585|NCT05724108|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110966586|NCT05711615|Doxorubicin|doxorubicin|mesh-list
110966587|NCT05711615|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110966588|NCT05711615|Peposertib|peposertib|mesh-list
110966589|NCT05711615|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110966590|NCT05711615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110966591|NCT05711615|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110966592|NCT05711615|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110966593|NCT05711615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110966594|NCT05711615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110678687|NCT06050512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110966595|NCT05711615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110966596|NCT05708053|Metformin|metformin|mesh-list
110966597|NCT05708053|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110966598|NCT05708053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110966599|NCT05705258|Aflibercept|aflibercept|mesh-list
110966600|NCT05705258|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110966601|NCT05705258|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110966602|NCT05705258|Growth Substances|growth substances|mesh-ancestor
110966603|NCT05705258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110966604|NCT05705258|Growth Inhibitors|growth inhibitors|mesh-ancestor
110966605|NCT05705258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110966606|NCT05669664|Leuprolide|leuprolide|mesh-list
110966607|NCT05669664|Androgen Antagonists|androgen antagonists|mesh-list
110966608|NCT05669664|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110966609|NCT05669664|Fertility Agents|fertility agents|mesh-ancestor
110966610|NCT05669664|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110966611|NCT05669664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110966612|NCT05669664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110966613|NCT05669664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110966614|NCT05669664|Hormone Antagonists|hormone antagonists|mesh-ancestor
111490974|NCT01791972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110966615|NCT05669664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110966616|NCT05661188|Atezolizumab|atezolizumab|mesh-list
110966617|NCT05661188|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110966618|NCT05661188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111490975|NCT01794702|Cytarabine|cytarabine|mesh-list
111490976|NCT01794702|Decitabine|decitabine|mesh-list
111490977|NCT01794702|Clofarabine|clofarabine|mesh-list
111490978|NCT01794702|Idarubicin|idarubicin|mesh-list
110966619|NCT05661188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110966620|NCT05661188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110966621|NCT05654467|Vaccines|vaccines|mesh-list
110966622|NCT05654467|Immunologic Factors|immunologic factors|mesh-ancestor
110966623|NCT05654467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110966624|NCT05653427|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
110966625|NCT05653427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110966626|NCT05653427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110966627|NCT05640674|Acetaminophen|acetaminophen|mesh-list
110966628|NCT05640674|Ibuprofen|ibuprofen|mesh-list
110966629|NCT05640674|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
110966630|NCT05640674|Hydrocodone|hydrocodone|mesh-list
110966631|NCT05640674|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110966632|NCT05640674|Analgesics|analgesics|mesh-ancestor
111490979|NCT01794702|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111490980|NCT01794702|Antimetabolites|antimetabolites|mesh-ancestor
111490981|NCT01794702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111490982|NCT01794702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111490983|NCT01794702|Antiviral Agents|antiviral agents|mesh-ancestor
111490984|NCT01794702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111490985|NCT01794702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110966633|NCT05640674|Sensory System Agents|sensory system agents|mesh-ancestor
110966634|NCT05640674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110966635|NCT05640674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110966636|NCT05640674|Antipyretics|antipyretics|mesh-ancestor
110966637|NCT05640674|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110966638|NCT05640674|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110966639|NCT05640674|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110966640|NCT05640674|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110966641|NCT05640674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110966642|NCT05640674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110966643|NCT05640674|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110966644|NCT05640674|Narcotics|narcotics|mesh-ancestor
110966645|NCT05640674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110966646|NCT05640674|Antitussive Agents|antitussive agents|mesh-ancestor
110966647|NCT05640674|Respiratory System Agents|respiratory system agents|mesh-ancestor
110966648|NCT05620784|Furosemide|furosemide|mesh-list
110966649|NCT05620784|Diuretics|diuretics|mesh-list
110966650|NCT05620784|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
110966651|NCT05620784|Natriuretic Agents|natriuretic agents|mesh-ancestor
110966652|NCT05620784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110966653|NCT05620784|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110966654|NCT05620784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110966655|NCT05586477|Diphenhydramine|diphenhydramine|mesh-list
110966656|NCT05586477|Promethazine|promethazine|mesh-list
110966657|NCT05586477|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110966658|NCT05586477|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110966659|NCT05586477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110651111|NCT00567398|Icodextrin|icodextrin|mesh-list
110966660|NCT05586477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110966661|NCT05586477|Anesthetics, Local|anesthetics, local|mesh-ancestor
110966662|NCT05586477|Anesthetics|anesthetics|mesh-ancestor
110966663|NCT05586477|Sensory System Agents|sensory system agents|mesh-ancestor
110966664|NCT05586477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110966665|NCT05586477|Antiemetics|antiemetics|mesh-ancestor
110966666|NCT05586477|Autonomic Agents|autonomic agents|mesh-ancestor
110966667|NCT05586477|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110966668|NCT05586477|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110966669|NCT05586477|Histamine Antagonists|histamine antagonists|mesh-ancestor
110678839|NCT06049576|Ipilimumab|ipilimumab|mesh-list
110966670|NCT05586477|Histamine Agents|histamine agents|mesh-ancestor
110966671|NCT05586477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110966672|NCT05586477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110966673|NCT05586477|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111490986|NCT01794702|Immunologic Factors|immunologic factors|mesh-ancestor
110966674|NCT05586477|Antipruritics|antipruritics|mesh-ancestor
111490987|NCT01794702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111490988|NCT01794702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110966675|NCT05586477|Dermatologic Agents|dermatologic agents|mesh-ancestor
110966676|NCT05575063|Hyaluronic Acid|hyaluronic acid|mesh-list
110966677|NCT05575063|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110966678|NCT05575063|Immunologic Factors|immunologic factors|mesh-ancestor
110966679|NCT05575063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110966680|NCT05575063|Viscosupplements|viscosupplements|mesh-ancestor
110966681|NCT05575063|Protective Agents|protective agents|mesh-ancestor
110966682|NCT05573724|Itraconazole|itraconazole|mesh-list
110966683|NCT05573724|Antifungal Agents|antifungal agents|mesh-ancestor
110966684|NCT05573724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110966685|NCT05573724|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110966686|NCT05573724|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110966687|NCT05573724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110966688|NCT05573724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110966689|NCT05573724|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110966690|NCT05573724|Hormone Antagonists|hormone antagonists|mesh-ancestor
110966691|NCT05573724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110966692|NCT05573724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110966693|NCT05573724|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110966694|NCT05572515|Dexamethasone|dexamethasone|mesh-list
110966695|NCT05572515|Bortezomib|bortezomib|mesh-list
110966696|NCT05572515|Pomalidomide|pomalidomide|mesh-list
110966697|NCT05572515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110966698|NCT05572515|Antiemetics|antiemetics|mesh-ancestor
110966699|NCT05572515|Autonomic Agents|autonomic agents|mesh-ancestor
110966700|NCT05572515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110966701|NCT05572515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110966702|NCT05572515|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110966703|NCT05572515|Glucocorticoids|glucocorticoids|mesh-ancestor
110966704|NCT05572515|Hormones|hormones|mesh-ancestor
110966705|NCT05572515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110966706|NCT05572515|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110966707|NCT05572515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110966708|NCT05572515|Immunologic Factors|immunologic factors|mesh-ancestor
110966709|NCT05572515|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110966710|NCT05572515|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110966711|NCT05572515|Growth Substances|growth substances|mesh-ancestor
110966712|NCT05572515|Growth Inhibitors|growth inhibitors|mesh-ancestor
110966713|NCT05567406|Belumosudil|belumosudil|mesh-list
110966714|NCT05567406|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110966715|NCT05567406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110966716|NCT05567406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110966717|NCT05564598|Valganciclovir|valganciclovir|mesh-list
110966718|NCT05564598|Ganciclovir|ganciclovir|mesh-list
110966719|NCT05564598|Antiviral Agents|antiviral agents|mesh-list
110966720|NCT05564598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110966721|NCT05564052|Rituximab|rituximab|mesh-list
110966722|NCT05564052|Lenalidomide|lenalidomide|mesh-list
110966723|NCT05564052|Bortezomib|bortezomib|mesh-list
110966724|NCT05564052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110966725|NCT05564052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110651155|NCT00736697|Moxidectin|moxidectin|mesh-list
110966726|NCT05564052|Immunologic Factors|immunologic factors|mesh-ancestor
110966727|NCT05564052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110966728|NCT05564052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110966729|NCT05564052|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110966730|NCT05564052|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110966731|NCT05564052|Growth Substances|growth substances|mesh-ancestor
110966732|NCT05564052|Growth Inhibitors|growth inhibitors|mesh-ancestor
110966733|NCT05550532|Aticaprant|aticaprant|mesh-list
110966734|NCT05550532|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110966735|NCT05550532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110966736|NCT05550532|Sensory System Agents|sensory system agents|mesh-ancestor
110966737|NCT05550532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110966738|NCT05535023|Cemiplimab|cemiplimab|mesh-list
110966739|NCT05535023|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110966740|NCT05535023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110966741|NCT05528510|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110966742|NCT05528510|Immunologic Factors|immunologic factors|mesh-ancestor
110966743|NCT05528510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110966744|NCT05521087|Cytarabine|cytarabine|mesh-list
110966745|NCT05521087|Dexamethasone|dexamethasone|mesh-list
110966747|NCT05521087|Vincristine|vincristine|mesh-list
110966748|NCT05521087|Pegaspargase|pegaspargase|mesh-list
111490989|NCT01794702|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111490990|NCT01794702|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110966749|NCT05521087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110966750|NCT05521087|Antiemetics|antiemetics|mesh-ancestor
110966751|NCT05521087|Autonomic Agents|autonomic agents|mesh-ancestor
110966752|NCT05521087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110966753|NCT05521087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110966754|NCT05521087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110966755|NCT05521087|Glucocorticoids|glucocorticoids|mesh-ancestor
110966756|NCT05521087|Hormones|hormones|mesh-ancestor
110966757|NCT05521087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110966758|NCT05521087|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110966759|NCT05521087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110966760|NCT05521087|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110966761|NCT05521087|Antimetabolites|antimetabolites|mesh-ancestor
110966762|NCT05521087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110966763|NCT05521087|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110966764|NCT05521087|Immunologic Factors|immunologic factors|mesh-ancestor
110966765|NCT05521087|Antiviral Agents|antiviral agents|mesh-ancestor
110966766|NCT05521087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110966767|NCT05521087|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110966768|NCT05521087|Tubulin Modulators|tubulin modulators|mesh-ancestor
110966769|NCT05521087|Antimitotic Agents|antimitotic agents|mesh-ancestor
110966770|NCT05521087|Mitosis Modulators|mitosis modulators|mesh-ancestor
110966771|NCT05518149|Aticaprant|aticaprant|mesh-list
110966772|NCT05518149|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110966773|NCT05518149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110966774|NCT05518149|Sensory System Agents|sensory system agents|mesh-ancestor
110966775|NCT05518149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110966776|NCT05509634|Dexamethasone|dexamethasone|mesh-list
110966777|NCT05509634|Dexamethasone acetate|dexamethasone acetate|mesh-list
110966778|NCT05509634|Palonosetron|palonosetron|mesh-list
110966779|NCT05509634|Fosaprepitant|fosaprepitant|mesh-list
110966780|NCT05509634|Aprepitant|aprepitant|mesh-list
110966781|NCT05509634|BB 1101|bb 1101|mesh-list
110966782|NCT05509634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110966783|NCT05509634|Antiemetics|antiemetics|mesh-ancestor
110966784|NCT05509634|Autonomic Agents|autonomic agents|mesh-ancestor
110966785|NCT05509634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110966786|NCT05509634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110966787|NCT05509634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110966788|NCT05509634|Glucocorticoids|glucocorticoids|mesh-ancestor
110966789|NCT05509634|Hormones|hormones|mesh-ancestor
110966790|NCT05509634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110966791|NCT05509634|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110966792|NCT05509634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110966793|NCT05509634|Protease Inhibitors|protease inhibitors|mesh-ancestor
110966794|NCT05509634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110966795|NCT05509634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110966796|NCT05509634|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110966797|NCT05509634|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110966798|NCT05509634|Serotonin Agents|serotonin agents|mesh-ancestor
110966799|NCT05509634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110966800|NCT05509634|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110966801|NCT05498428|Carboplatin|carboplatin|mesh-list
110966802|NCT05498428|Pemetrexed|pemetrexed|mesh-list
110966803|NCT05498428|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
110966804|NCT05498428|Heparin|heparin|mesh-list
110966805|NCT05498428|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
110966806|NCT05498428|Tinzaparin|tinzaparin|mesh-list
110966807|NCT05498428|Dalteparin|dalteparin|mesh-list
110966808|NCT05498428|Anticoagulants|anticoagulants|mesh-list
110966809|NCT05498428|Lazertinib|lazertinib|mesh-list
110966810|NCT05498428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110966811|NCT05498428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110966812|NCT05498428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110966813|NCT05498428|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110966814|NCT05498428|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110966815|NCT05498428|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110966816|NCT05498428|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110966817|NCT05498428|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110966818|NCT05498428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110966819|NCT05488314|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
110966820|NCT05488314|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111490991|NCT01794702|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111490992|NCT01795716|Imatinib Mesylate|imatinib mesylate|mesh-list
111490993|NCT01795716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111490994|NCT01795716|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110966821|NCT05488314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111490995|NCT01795716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110966822|NCT05477953|Nifurtimox|nifurtimox|mesh-list
110966823|NCT05477953|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
110966824|NCT05477953|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110966825|NCT05477953|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110966826|NCT05477953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110966827|NCT05455684|Aticaprant|aticaprant|mesh-list
110966828|NCT05455684|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110966829|NCT05455684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110966830|NCT05455684|Sensory System Agents|sensory system agents|mesh-ancestor
110966831|NCT05455684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110966832|NCT05455658|Vaccines|vaccines|mesh-list
110966833|NCT05455658|Sargramostim|sargramostim|mesh-list
110966834|NCT05455658|Immunologic Factors|immunologic factors|mesh-ancestor
110966835|NCT05455658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110966836|NCT05455320|Dexamethasone|dexamethasone|mesh-list
110966837|NCT05455320|Daratumumab|daratumumab|mesh-list
110966838|NCT05455320|Pomalidomide|pomalidomide|mesh-list
110966839|NCT05455320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110966840|NCT05455320|Antiemetics|antiemetics|mesh-ancestor
110966841|NCT05455320|Autonomic Agents|autonomic agents|mesh-ancestor
110966842|NCT05455320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110966843|NCT05455320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110966844|NCT05455320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110966845|NCT05455320|Glucocorticoids|glucocorticoids|mesh-ancestor
110966846|NCT05455320|Hormones|hormones|mesh-ancestor
110966847|NCT05455320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110966848|NCT05455320|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110966849|NCT05455320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110966850|NCT05455320|Immunologic Factors|immunologic factors|mesh-ancestor
110966851|NCT05455320|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110966852|NCT05455320|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110966853|NCT05455320|Growth Substances|growth substances|mesh-ancestor
110966854|NCT05455320|Growth Inhibitors|growth inhibitors|mesh-ancestor
110966855|NCT05453903|Cytarabine|cytarabine|mesh-list
110966856|NCT05453903|Azacitidine|azacitidine|mesh-list
110966857|NCT05453903|Daunorubicin|daunorubicin|mesh-list
110966858|NCT05453903|Venetoclax|venetoclax|mesh-list
110966859|NCT05453903|Idarubicin|idarubicin|mesh-list
110966860|NCT05453903|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110966861|NCT05453903|Antimetabolites|antimetabolites|mesh-ancestor
110966862|NCT05453903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110966863|NCT05453903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110966864|NCT05453903|Antiviral Agents|antiviral agents|mesh-ancestor
110966865|NCT05453903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110966866|NCT05453903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110966867|NCT05453903|Immunologic Factors|immunologic factors|mesh-ancestor
110966868|NCT05453903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110966869|NCT05453903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110966870|NCT05453903|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110966871|NCT05453903|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110966872|NCT05453903|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110966873|NCT05450718|Buprenorphine|buprenorphine|mesh-list
110966874|NCT05450718|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
110966875|NCT05450718|Naloxone|naloxone|mesh-list
110966876|NCT05450718|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110966877|NCT05450718|Narcotics|narcotics|mesh-ancestor
110966878|NCT05450718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110966879|NCT05450718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110966880|NCT05450718|Analgesics|analgesics|mesh-ancestor
110966881|NCT05450718|Sensory System Agents|sensory system agents|mesh-ancestor
110966882|NCT05450718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110966883|NCT05450718|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110966884|NCT05449366|Paclitaxel|paclitaxel|mesh-list
110966885|NCT05449366|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110966886|NCT05449366|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110966887|NCT05449366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110966888|NCT05449366|Tubulin Modulators|tubulin modulators|mesh-ancestor
110966889|NCT05449366|Antimitotic Agents|antimitotic agents|mesh-ancestor
110966890|NCT05449366|Mitosis Modulators|mitosis modulators|mesh-ancestor
110966891|NCT05449366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110966892|NCT05444530|Ipilimumab|ipilimumab|mesh-list
110966893|NCT05444530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110966894|NCT05444530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110966895|NCT05444530|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111490996|NCT01795716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111490997|NCT01810692|Tiotropium Bromide|tiotropium bromide|mesh-list
110966896|NCT05444530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110966897|NCT05438043|Dexamethasone|dexamethasone|mesh-list
111490998|NCT01810692|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110966898|NCT05438043|Lenalidomide|lenalidomide|mesh-list
110966899|NCT05438043|Daratumumab|daratumumab|mesh-list
110966900|NCT05438043|Pomalidomide|pomalidomide|mesh-list
111490999|NCT01810692|Autonomic Agents|autonomic agents|mesh-ancestor
111491000|NCT01810692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111491001|NCT01810692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110966901|NCT05438043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110966902|NCT05438043|Antiemetics|antiemetics|mesh-ancestor
110966903|NCT05438043|Autonomic Agents|autonomic agents|mesh-ancestor
110966904|NCT05438043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110966905|NCT05438043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110966906|NCT05438043|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110966907|NCT05438043|Glucocorticoids|glucocorticoids|mesh-ancestor
110966908|NCT05438043|Hormones|hormones|mesh-ancestor
110966909|NCT05438043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110966910|NCT05438043|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110966911|NCT05438043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110966912|NCT05438043|Immunologic Factors|immunologic factors|mesh-ancestor
110966913|NCT05438043|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110966914|NCT05438043|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110966915|NCT05438043|Growth Substances|growth substances|mesh-ancestor
110966916|NCT05438043|Growth Inhibitors|growth inhibitors|mesh-ancestor
110966917|NCT05432804|Temozolomide|temozolomide|mesh-list
110966918|NCT05432804|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110966919|NCT05432804|Alkylating Agents|alkylating agents|mesh-ancestor
110966920|NCT05432804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110966921|NCT05432804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110966922|NCT05427162|Epoprostenol|epoprostenol|mesh-list
110966923|NCT05427162|Tezosentan|tezosentan|mesh-list
110966924|NCT05427162|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110966925|NCT05427162|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110966926|NCT05427162|Vasodilator Agents|vasodilator agents|mesh-ancestor
110966927|NCT05415462|Vaccines|vaccines|mesh-list
110966928|NCT05415462|Immunologic Factors|immunologic factors|mesh-ancestor
110966929|NCT05415462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110966930|NCT05413122|Nicotine|nicotine|mesh-list
110966931|NCT05413122|Varenicline|varenicline|mesh-list
110966932|NCT05413122|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110966933|NCT05413122|Autonomic Agents|autonomic agents|mesh-ancestor
110966934|NCT05413122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110966935|NCT05413122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110966936|NCT05413122|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110966937|NCT05413122|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110966938|NCT05413122|Cholinergic Agents|cholinergic agents|mesh-ancestor
110966939|NCT05413122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110966940|NCT05413122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110966941|NCT05411094|Durvalumab|durvalumab|mesh-list
110966942|NCT05411094|Olaparib|olaparib|mesh-list
110966943|NCT05411094|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
110966944|NCT05411094|Immunoglobulins|immunoglobulins|mesh-list
110966945|NCT05411094|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110966946|NCT05411094|Immunoglobulin G|immunoglobulin g|mesh-list
110966947|NCT05411094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110966948|NCT05411094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110966949|NCT05411094|Immunologic Factors|immunologic factors|mesh-ancestor
110966950|NCT05411094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110966951|NCT05411094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110966952|NCT05411094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110966953|NCT05395494|Cycloserine|cycloserine|mesh-list
110966954|NCT05395494|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110966955|NCT05395494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110966956|NCT05395494|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110966957|NCT05395494|Antitubercular Agents|antitubercular agents|mesh-ancestor
110966958|NCT05395494|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110966959|NCT05395494|Antimetabolites|antimetabolites|mesh-ancestor
110966960|NCT05395494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110966961|NCT05389995|Potassium Citrate|potassium citrate|mesh-list
110966962|NCT05389995|Methamphetamine|methamphetamine|mesh-list
110966963|NCT05389995|Citric Acid|citric acid|mesh-list
111491002|NCT01810692|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111491003|NCT01810692|Respiratory System Agents|respiratory system agents|mesh-ancestor
111491004|NCT01810692|Parasympatholytics|parasympatholytics|mesh-ancestor
110966964|NCT05389995|Sodium Citrate|sodium citrate|mesh-list
111491005|NCT01810692|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110966965|NCT05389995|Anticoagulants|anticoagulants|mesh-ancestor
110966966|NCT05389995|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110966967|NCT05389995|Chelating Agents|chelating agents|mesh-ancestor
110966968|NCT05389995|Sequestering Agents|sequestering agents|mesh-ancestor
110966969|NCT05389995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110966970|NCT05389995|Diuretics|diuretics|mesh-ancestor
110966971|NCT05389995|Natriuretic Agents|natriuretic agents|mesh-ancestor
110966972|NCT05389995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110966973|NCT05389995|Expectorants|expectorants|mesh-ancestor
110966974|NCT05389995|Respiratory System Agents|respiratory system agents|mesh-ancestor
110966975|NCT05389995|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110966976|NCT05389995|Sympathomimetics|sympathomimetics|mesh-ancestor
110966978|NCT05389995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110966979|NCT05389995|Dopamine Agents|dopamine agents|mesh-ancestor
110966980|NCT05389995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110966981|NCT05389995|Adrenergic Agents|adrenergic agents|mesh-ancestor
110966982|NCT05389995|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110966983|NCT05389995|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110966984|NCT05389995|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110966985|NCT05389995|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110966986|NCT05379634|Glucocorticoids|glucocorticoids|mesh-list
110966987|NCT05379634|Hormones|hormones|mesh-ancestor
110966988|NCT05379634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110966989|NCT05379634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110966990|NCT05379595|Leucovorin|leucovorin|mesh-list
110966991|NCT05379595|Fluorouracil|fluorouracil|mesh-list
110966992|NCT05379595|Oxaliplatin|oxaliplatin|mesh-list
110966993|NCT05379595|Irinotecan|irinotecan|mesh-list
110966994|NCT05379595|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
110966995|NCT05379595|Antimetabolites|antimetabolites|mesh-ancestor
110966996|NCT05379595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110966997|NCT05379595|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110966998|NCT05379595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110966999|NCT05379595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110967000|NCT05379595|Immunologic Factors|immunologic factors|mesh-ancestor
110967001|NCT05379595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110967002|NCT05379595|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110967003|NCT05379595|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110967004|NCT05379595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110967005|NCT05379595|Antidotes|antidotes|mesh-ancestor
110967006|NCT05379595|Protective Agents|protective agents|mesh-ancestor
110967007|NCT05379595|Vitamin B Complex|vitamin b complex|mesh-ancestor
110967008|NCT05379595|Vitamins|vitamins|mesh-ancestor
110967009|NCT05379595|Micronutrients|micronutrients|mesh-ancestor
110967010|NCT05379595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110967011|NCT05367245|Butyric Acid|butyric acid|mesh-list
110967012|NCT05367245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110967013|NCT05367245|Histamine Antagonists|histamine antagonists|mesh-ancestor
110967014|NCT05367245|Histamine Agents|histamine agents|mesh-ancestor
110967015|NCT05367245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110967016|NCT05367245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110967017|NCT05347485|Cyclophosphamide|cyclophosphamide|mesh-list
110967018|NCT05347485|Fludarabine|fludarabine|mesh-list
110967019|NCT05347485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110967020|NCT05347485|Immunologic Factors|immunologic factors|mesh-ancestor
110967021|NCT05347485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110967022|NCT05347485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110967023|NCT05347485|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110967024|NCT05347485|Alkylating Agents|alkylating agents|mesh-ancestor
110967025|NCT05347485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110967026|NCT05347485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110967027|NCT05347485|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110967028|NCT05338775|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
110967029|NCT05338775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110967030|NCT05338775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110967031|NCT05338775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110967032|NCT05334433|Anesthetics|anesthetics|mesh-list
110967033|NCT05334433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110967034|NCT05334433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110967035|NCT05327309|Bleomycin|bleomycin|mesh-list
110967036|NCT05327309|Propranolol|propranolol|mesh-list
110967037|NCT05327309|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110967038|NCT05327309|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111491006|NCT01810692|Cholinergic Agents|cholinergic agents|mesh-ancestor
111491007|NCT01810692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111491008|NCT01810692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111491009|NCT01811940|Topiramate|topiramate|mesh-list
110967039|NCT05327309|Adrenergic Agents|adrenergic agents|mesh-ancestor
110967040|NCT05327309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110967041|NCT05327309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110967042|NCT05327309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110967043|NCT05327309|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110967044|NCT05327309|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110967045|NCT05327309|Vasodilator Agents|vasodilator agents|mesh-ancestor
110967046|NCT05327309|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110967047|NCT05327309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110967048|NCT05318794|Doxorubicin|doxorubicin|mesh-list
110967049|NCT05318794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110967050|NCT05318794|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110967057|NCT05312593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110967058|NCT05312593|Disinfectants|disinfectants|mesh-ancestor
110967066|NCT05275023|Tenofovir|tenofovir|mesh-list
110967067|NCT05275023|Entecavir|entecavir|mesh-list
110967068|NCT05275023|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
110967069|NCT05275023|Antiviral Agents|antiviral agents|mesh-ancestor
110967070|NCT05275023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110967071|NCT05275023|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110967072|NCT05275023|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110967073|NCT05275023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110967074|NCT05275023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110967075|NCT05275023|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110967076|NCT05275023|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110967077|NCT05275023|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110967078|NCT05275023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110967079|NCT05268003|Venetoclax|venetoclax|mesh-list
110967080|NCT05268003|Ponatinib|ponatinib|mesh-list
110967081|NCT05268003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110967082|NCT05268003|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110967083|NCT05268003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110967084|NCT05268003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110967085|NCT05266937|Paclitaxel|paclitaxel|mesh-list
110967086|NCT05266937|Carboplatin|carboplatin|mesh-list
110967087|NCT05266937|Atezolizumab|atezolizumab|mesh-list
110967088|NCT05266937|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110967089|NCT05266937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110967090|NCT05266937|Tubulin Modulators|tubulin modulators|mesh-ancestor
110967091|NCT05266937|Antimitotic Agents|antimitotic agents|mesh-ancestor
110967092|NCT05266937|Mitosis Modulators|mitosis modulators|mesh-ancestor
110967093|NCT05266937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110967094|NCT05266937|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110967095|NCT05266937|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110967096|NCT05264974|Vaccines|vaccines|mesh-list
110967097|NCT05264974|Immunologic Factors|immunologic factors|mesh-ancestor
110967098|NCT05264974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110967099|NCT05260671|Cetuximab|cetuximab|mesh-list
110967100|NCT05260671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110967101|NCT05260671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110967102|NCT05256901|Glycopyrrolate|glycopyrrolate|mesh-list
110967103|NCT05256901|Neostigmine|neostigmine|mesh-list
110967104|NCT05256901|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110967105|NCT05256901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110967106|NCT05256901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110967107|NCT05256901|Cholinergic Agents|cholinergic agents|mesh-ancestor
110967108|NCT05256901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110967109|NCT05256901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111491010|NCT01811940|Adderall|adderall|mesh-list
111491011|NCT01811940|Anticonvulsants|anticonvulsants|mesh-ancestor
111491012|NCT01811940|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111491013|NCT01811940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111491014|NCT01811940|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111491015|NCT01813734|Ponatinib|ponatinib|mesh-list
111491016|NCT01813734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111491017|NCT01813734|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111491018|NCT01813734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111491019|NCT01813734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111491020|NCT01818414|Vitamins|vitamins|mesh-list
111491021|NCT01818414|Folic Acid|folic acid|mesh-list
111491022|NCT01818414|Misoprostol|misoprostol|mesh-list
111491023|NCT01818414|Micronutrients|micronutrients|mesh-ancestor
111491024|NCT01818414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111491025|NCT01818414|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110699125|NCT00384930|Tadalafil|tadalafil|mesh-list
111491026|NCT01818414|Abortifacient Agents|abortifacient agents|mesh-ancestor
110967110|NCT05256901|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110967111|NCT05256901|Autonomic Agents|autonomic agents|mesh-ancestor
110967112|NCT05256901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110967113|NCT05256901|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110967114|NCT05256901|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110967115|NCT05256901|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110967116|NCT05252533|Ustekinumab|ustekinumab|mesh-list
110967117|NCT05252533|Dermatologic Agents|dermatologic agents|mesh-ancestor
110967118|NCT05250973|Dexamethasone|dexamethasone|mesh-list
110967119|NCT05250973|Cyclophosphamide|cyclophosphamide|mesh-list
110967120|NCT05250973|Bortezomib|bortezomib|mesh-list
110679206|NCT05712356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110967121|NCT05250973|Daratumumab|daratumumab|mesh-list
110679207|NCT05712356|Tubulin Modulators|tubulin modulators|mesh-ancestor
110679208|NCT05712356|Antimitotic Agents|antimitotic agents|mesh-ancestor
110679209|NCT05712356|Mitosis Modulators|mitosis modulators|mesh-ancestor
110967122|NCT05250973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110967123|NCT05250973|Immunologic Factors|immunologic factors|mesh-ancestor
110967124|NCT05250973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110967125|NCT05250973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110967126|NCT05250973|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110967127|NCT05250973|Alkylating Agents|alkylating agents|mesh-ancestor
110967128|NCT05250973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110967129|NCT05250973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110967130|NCT05250973|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110967131|NCT05250973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110967132|NCT05250973|Antiemetics|antiemetics|mesh-ancestor
110967133|NCT05250973|Autonomic Agents|autonomic agents|mesh-ancestor
110967134|NCT05250973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110967135|NCT05250973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110967136|NCT05250973|Glucocorticoids|glucocorticoids|mesh-ancestor
110967137|NCT05250973|Hormones|hormones|mesh-ancestor
110967138|NCT05250973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110967139|NCT05250973|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110967140|NCT05243524|Cyclophosphamide|cyclophosphamide|mesh-list
110967141|NCT05243524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110967142|NCT05243524|Immunologic Factors|immunologic factors|mesh-ancestor
110967143|NCT05243524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110967144|NCT05243524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110967145|NCT05243524|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110967146|NCT05243524|Alkylating Agents|alkylating agents|mesh-ancestor
110967147|NCT05243524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110967148|NCT05243524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110967149|NCT05243524|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110967150|NCT05242484|Golimumab|golimumab|mesh-list
110967151|NCT05242484|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110967152|NCT05242484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110967153|NCT05242484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110967154|NCT05242484|Immunologic Factors|immunologic factors|mesh-ancestor
110967155|NCT05242484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110967156|NCT05242471|Golimumab|golimumab|mesh-list
110967157|NCT05242471|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110967158|NCT05242471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110967159|NCT05242471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110967160|NCT05242471|Immunologic Factors|immunologic factors|mesh-ancestor
110967161|NCT05242471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110967162|NCT05226455|Azacitidine|azacitidine|mesh-list
110967163|NCT05226455|Venetoclax|venetoclax|mesh-list
110967164|NCT05226455|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110967165|NCT05226455|Antimetabolites|antimetabolites|mesh-ancestor
110967166|NCT05226455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110967167|NCT05226455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110967168|NCT05226455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110967169|NCT05215418|Topiramate|topiramate|mesh-list
110967170|NCT05215418|Phentermine|phentermine|mesh-list
111491027|NCT01818414|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111491028|NCT01818414|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111491029|NCT01818414|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111491030|NCT01818414|Oxytocics|oxytocics|mesh-ancestor
111491031|NCT01818414|Hematinics|hematinics|mesh-ancestor
111491032|NCT01818414|Vitamin B Complex|vitamin b complex|mesh-ancestor
111491033|NCT06020560|Dalteparin|dalteparin|mesh-list
111491034|NCT06020560|Tinzaparin|tinzaparin|mesh-list
110967171|NCT05215418|Anticonvulsants|anticonvulsants|mesh-ancestor
110967172|NCT05215418|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111491035|NCT06020560|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
111119100|NCT05362318|Nicotine|nicotine|mesh-list
111491036|NCT06020560|Anticoagulants|anticoagulants|mesh-ancestor
111491037|NCT06020560|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110967173|NCT05215418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110967174|NCT05215418|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110967175|NCT05215418|Appetite Depressants|appetite depressants|mesh-ancestor
110967176|NCT05215418|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110967177|NCT05215418|Sympathomimetics|sympathomimetics|mesh-ancestor
110967178|NCT05215418|Autonomic Agents|autonomic agents|mesh-ancestor
110967179|NCT05215418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110967180|NCT05215418|Adrenergic Agents|adrenergic agents|mesh-ancestor
110967181|NCT05215418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110967182|NCT05215418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110967183|NCT05211323|Bevacizumab|bevacizumab|mesh-list
110967184|NCT05211323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110967185|NCT05211323|Atezolizumab|atezolizumab|mesh-list
110967186|NCT05211323|Cisplatin|cisplatin|mesh-list
110967187|NCT05211323|Gemcitabine|gemcitabine|mesh-list
110967188|NCT05211323|Endothelial Growth Factors|endothelial growth factors|mesh-list
110967189|NCT05211323|Antibodies|antibodies|mesh-list
110967190|NCT05211323|Immunoglobulins|immunoglobulins|mesh-list
110967191|NCT05211323|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110967192|NCT05211323|Immunoglobulin G|immunoglobulin g|mesh-list
110967193|NCT05211323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110967194|NCT05211323|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110967195|NCT05211323|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110967196|NCT05211323|Growth Substances|growth substances|mesh-ancestor
110967197|NCT05211323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110967198|NCT05211323|Growth Inhibitors|growth inhibitors|mesh-ancestor
110967199|NCT05211323|Immunologic Factors|immunologic factors|mesh-ancestor
110967200|NCT05211323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110967202|NCT05211323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110967203|NCT05211323|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110967204|NCT05209425|Vitamin D|vitamin d|mesh-list
110967205|NCT05209425|Cholecalciferol|cholecalciferol|mesh-list
110967206|NCT05209425|Vitamins|vitamins|mesh-ancestor
110967207|NCT05209425|Micronutrients|micronutrients|mesh-ancestor
110967208|NCT05209425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110967209|NCT05209425|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110967210|NCT05209425|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110967211|NCT05197049|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110967212|NCT05197049|Immunologic Factors|immunologic factors|mesh-ancestor
110967213|NCT05197049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110967214|NCT05179876|Selexipag|selexipag|mesh-list
110967215|NCT05179876|Tadalafil|tadalafil|mesh-list
110967216|NCT05179876|Macitentan|macitentan|mesh-list
110967217|NCT05179876|Vasodilator Agents|vasodilator agents|mesh-ancestor
110967218|NCT05179876|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110967219|NCT05179876|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110967220|NCT05179876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110967221|NCT05179876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110967222|NCT05179876|Urological Agents|urological agents|mesh-ancestor
110967223|NCT05179876|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
110967224|NCT05179876|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
110967225|NCT05179876|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
110967226|NCT05179876|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110967227|NCT05177601|Cycloserine|cycloserine|mesh-list
110967228|NCT05177601|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110967229|NCT05177601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110967230|NCT05177601|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110967231|NCT05177601|Antitubercular Agents|antitubercular agents|mesh-ancestor
110967232|NCT05177601|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110967233|NCT05177601|Antimetabolites|antimetabolites|mesh-ancestor
110967234|NCT05177601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110967235|NCT05169957|Nivolumab|nivolumab|mesh-list
110967236|NCT05169957|Ipilimumab|ipilimumab|mesh-list
110967237|NCT05169957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110967238|NCT05169957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110967239|NCT05169957|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110967240|NCT05169957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110967241|NCT05169684|Docetaxel|docetaxel|mesh-list
110967242|NCT05169684|Nivolumab|nivolumab|mesh-list
110967243|NCT05169684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110967244|NCT05169684|Tubulin Modulators|tubulin modulators|mesh-ancestor
110967245|NCT05169684|Antimitotic Agents|antimitotic agents|mesh-ancestor
110967246|NCT05169684|Mitosis Modulators|mitosis modulators|mesh-ancestor
110967247|NCT05169684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111491038|NCT06020560|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110967248|NCT05169684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110967249|NCT05169684|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110967251|NCT05167825|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
110967252|NCT05167825|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
110967253|NCT05167825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110967254|NCT05167825|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
110967255|NCT05155709|Azacitidine|azacitidine|mesh-list
110967256|NCT05155709|Venetoclax|venetoclax|mesh-list
110967257|NCT05155709|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110967258|NCT05155709|Antimetabolites|antimetabolites|mesh-ancestor
110967259|NCT05155709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110967260|NCT05155709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110967261|NCT05155709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110967262|NCT05155033|Aldesleukin|aldesleukin|mesh-list
110967263|NCT05155033|Pembrolizumab|pembrolizumab|mesh-list
110967264|NCT05155033|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110967265|NCT05155033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110967266|NCT05155033|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110679357|NCT05578976|Rituximab|rituximab|mesh-list
110679358|NCT05578976|Doxorubicin|doxorubicin|mesh-list
110679359|NCT05578976|Vincristine|vincristine|mesh-list
110679360|NCT05578976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110679361|NCT05578976|Immunologic Factors|immunologic factors|mesh-ancestor
110679362|NCT05578976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110679363|NCT05578976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110967267|NCT05155033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110967268|NCT05155033|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110967269|NCT05155033|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110967270|NCT05155033|Antiviral Agents|antiviral agents|mesh-ancestor
110967271|NCT05155033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110967272|NCT05149781|Antihypertensive Agents|antihypertensive agents|mesh-list
110967274|NCT05132504|Folfirinox|folfirinox|mesh-list
110967275|NCT05132504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110967276|NCT05132504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110967277|NCT05132504|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110967278|NCT05132504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110967279|NCT05123599|Tenofovir|tenofovir|mesh-list
110967280|NCT05123599|Antiviral Agents|antiviral agents|mesh-ancestor
110967281|NCT05123599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110967282|NCT05123599|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110967283|NCT05123599|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110967284|NCT05123599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110967285|NCT05123599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110967286|NCT05123599|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110967287|NCT05123599|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110967288|NCT05092451|Cyclophosphamide|cyclophosphamide|mesh-list
110967289|NCT05092451|Fludarabine|fludarabine|mesh-list
110967290|NCT05092451|Fludarabine phosphate|fludarabine phosphate|mesh-list
110967291|NCT05092451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110967292|NCT05092451|Immunologic Factors|immunologic factors|mesh-ancestor
110967293|NCT05092451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110967294|NCT05092451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110967295|NCT05092451|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110967296|NCT05092451|Alkylating Agents|alkylating agents|mesh-ancestor
110967297|NCT05092451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110967298|NCT05092451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110967299|NCT05092451|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110967300|NCT05092451|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110967301|NCT05092451|Antimetabolites|antimetabolites|mesh-ancestor
110967302|NCT05092269|Ustekinumab|ustekinumab|mesh-list
110967303|NCT05092269|Dermatologic Agents|dermatologic agents|mesh-ancestor
110967304|NCT05087992|Bevacizumab|bevacizumab|mesh-list
110967305|NCT05087992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110967306|NCT05087992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110967307|NCT05087992|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110967308|NCT05087992|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110967309|NCT05087992|Growth Substances|growth substances|mesh-ancestor
110967310|NCT05087992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110967311|NCT05087992|Growth Inhibitors|growth inhibitors|mesh-ancestor
110967312|NCT05083182|Ustekinumab|ustekinumab|mesh-list
110967313|NCT05083182|Dermatologic Agents|dermatologic agents|mesh-ancestor
110967314|NCT05083169|Dexamethasone|dexamethasone|mesh-list
110967315|NCT05083169|Bortezomib|bortezomib|mesh-list
110967316|NCT05083169|Daratumumab|daratumumab|mesh-list
111491039|NCT06020560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111491040|NCT06020456|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
110967317|NCT05083169|Pomalidomide|pomalidomide|mesh-list
110967318|NCT05083169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110967319|NCT05083169|Antiemetics|antiemetics|mesh-ancestor
110967320|NCT05083169|Autonomic Agents|autonomic agents|mesh-ancestor
110967321|NCT05083169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110967322|NCT05083169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110967323|NCT05083169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110967324|NCT05083169|Glucocorticoids|glucocorticoids|mesh-ancestor
110967325|NCT05083169|Hormones|hormones|mesh-ancestor
110967326|NCT05083169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110967327|NCT05083169|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110679442|NCT05526989|Niraparib|niraparib|mesh-list
110679443|NCT05526989|Dostarlimab|dostarlimab|mesh-list
110679444|NCT05526989|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110679445|NCT05526989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110679446|NCT05526989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110679447|NCT05526989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110679448|NCT05526157|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
110679449|NCT05526157|Glucagon|glucagon|mesh-list
110679450|NCT05526157|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
110679451|NCT05526157|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110679452|NCT05526157|Hormones|hormones|mesh-ancestor
110679454|NCT05526157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110967328|NCT05083169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110967329|NCT05083169|Immunologic Factors|immunologic factors|mesh-ancestor
110967330|NCT05083169|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110967331|NCT05083169|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110967332|NCT05083169|Growth Substances|growth substances|mesh-ancestor
110967333|NCT05083169|Growth Inhibitors|growth inhibitors|mesh-ancestor
110967335|NCT05071664|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110967336|NCT05071664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110967337|NCT05071664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110967338|NCT05071664|Immunologic Factors|immunologic factors|mesh-ancestor
110967339|NCT05071664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110967340|NCT05053750|Paclitaxel|paclitaxel|mesh-list
110967341|NCT05053750|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110967342|NCT05053750|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110967343|NCT05053750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110967344|NCT05053750|Tubulin Modulators|tubulin modulators|mesh-ancestor
110967345|NCT05053750|Antimitotic Agents|antimitotic agents|mesh-ancestor
110967346|NCT05053750|Mitosis Modulators|mitosis modulators|mesh-ancestor
110967347|NCT05053750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110967348|NCT05050097|Lenalidomide|lenalidomide|mesh-list
110967349|NCT05050097|Pomalidomide|pomalidomide|mesh-list
110967350|NCT05050097|Daratumumab|daratumumab|mesh-list
110967351|NCT05050097|Immunologic Factors|immunologic factors|mesh-ancestor
110967352|NCT05050097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110967353|NCT05050097|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110967354|NCT05050097|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110967355|NCT05050097|Growth Substances|growth substances|mesh-ancestor
110967356|NCT05050097|Growth Inhibitors|growth inhibitors|mesh-ancestor
110967357|NCT05050097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110967358|NCT05039801|Paclitaxel|paclitaxel|mesh-list
110967359|NCT05039801|Bevacizumab|bevacizumab|mesh-list
110967360|NCT05039801|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110967361|NCT05039801|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110967362|NCT05039801|Endothelial Growth Factors|endothelial growth factors|mesh-list
110967363|NCT05039801|Antibodies|antibodies|mesh-list
110967364|NCT05039801|Immunoglobulins|immunoglobulins|mesh-list
110967365|NCT05039801|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110967366|NCT05039801|Immunoglobulin G|immunoglobulin g|mesh-list
110967367|NCT05039801|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110967368|NCT05039801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110967369|NCT05039801|Tubulin Modulators|tubulin modulators|mesh-ancestor
110967370|NCT05039801|Antimitotic Agents|antimitotic agents|mesh-ancestor
110967371|NCT05039801|Mitosis Modulators|mitosis modulators|mesh-ancestor
110967372|NCT05039801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110967373|NCT05039801|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110967374|NCT05039801|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110967375|NCT05039801|Growth Substances|growth substances|mesh-ancestor
111491041|NCT06020456|Hemostatics|hemostatics|mesh-ancestor
110967376|NCT05039801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110967377|NCT05039801|Growth Inhibitors|growth inhibitors|mesh-ancestor
110967378|NCT05039801|Immunologic Factors|immunologic factors|mesh-ancestor
110967379|NCT05039281|Atezolizumab|atezolizumab|mesh-list
110967380|NCT05039281|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110967381|NCT05039281|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110967382|NCT05039281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110967383|NCT05039281|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110967384|NCT05039281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110967385|NCT05039281|Immunologic Factors|immunologic factors|mesh-ancestor
110967386|NCT05039281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110967387|NCT05035836|Tamoxifen|tamoxifen|mesh-list
110967388|NCT05035836|Letrozole|letrozole|mesh-list
110967389|NCT05035836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110967390|NCT05035836|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110967391|NCT05035836|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110967392|NCT05035836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110967393|NCT05035836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110967394|NCT05035836|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110967395|NCT05035836|Hormone Antagonists|hormone antagonists|mesh-ancestor
110967396|NCT05035836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110967397|NCT05035836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110967398|NCT05035836|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110967399|NCT05035836|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110967400|NCT05035836|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110967401|NCT05035836|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110967402|NCT05031494|Paclitaxel|paclitaxel|mesh-list
110679503|NCT05452174|Mirtazapine|mirtazapine|mesh-list
110967403|NCT05031494|Gemcitabine|gemcitabine|mesh-list
110967404|NCT05031494|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110967405|NCT05031494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110967406|NCT05031494|Tubulin Modulators|tubulin modulators|mesh-ancestor
110967407|NCT05031494|Antimitotic Agents|antimitotic agents|mesh-ancestor
110967408|NCT05031494|Mitosis Modulators|mitosis modulators|mesh-ancestor
110967409|NCT05031494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110967410|NCT05031494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110967411|NCT05031494|Antimetabolites|antimetabolites|mesh-ancestor
110967412|NCT05019703|Atezolizumab|atezolizumab|mesh-list
110967413|NCT05019703|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110967414|NCT05019703|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110967415|NCT05019703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110967416|NCT05019703|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110967417|NCT05019703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110967418|NCT05019703|Immunologic Factors|immunologic factors|mesh-ancestor
110967419|NCT05019703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110967420|NCT05010681|Lenvatinib|lenvatinib|mesh-list
110967421|NCT05010681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110967422|NCT05010681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110967423|NCT05010681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110967424|NCT05010681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110967425|NCT05010668|Lenvatinib|lenvatinib|mesh-list
110967426|NCT05010668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110967427|NCT05010668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110967428|NCT05010668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110967429|NCT05010668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110967430|NCT05010122|Decitabine|decitabine|mesh-list
110967431|NCT05010122|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
110967432|NCT05010122|Venetoclax|venetoclax|mesh-list
110967433|NCT05010122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110967434|NCT05010122|Antimetabolites|antimetabolites|mesh-ancestor
110967435|NCT05010122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110967436|NCT05010122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110967437|NCT05010122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110967438|NCT05000294|Atezolizumab|atezolizumab|mesh-list
111491042|NCT06020456|Coagulants|coagulants|mesh-ancestor
111491043|NCT06020456|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
111491044|NCT06020456|Natriuretic Agents|natriuretic agents|mesh-ancestor
111491045|NCT06020456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111491046|NCT06020378|Hydroxychloroquine|hydroxychloroquine|mesh-list
111491047|NCT06020378|Antimalarials|antimalarials|mesh-ancestor
111491048|NCT06020378|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111491049|NCT06020378|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111491050|NCT06020378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111491051|NCT06020378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111491052|NCT06020378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111491053|NCT06020378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111491054|NCT06020352|Axitinib|axitinib|mesh-list
110967440|NCT05000294|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110967441|NCT05000294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110967442|NCT05000294|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110967443|NCT05000294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110967444|NCT05000294|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110967445|NCT05000294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110967446|NCT04999202|Pembrolizumab|pembrolizumab|mesh-list
110967447|NCT04999202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110967448|NCT04999202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110967449|NCT04999202|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110967450|NCT04999202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110967451|NCT04988295|Carboplatin|carboplatin|mesh-list
110967452|NCT04988295|Pemetrexed|pemetrexed|mesh-list
110967453|NCT04988295|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
110967454|NCT04988295|Lazertinib|lazertinib|mesh-list
110967455|NCT04988295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110967456|NCT04988295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110967457|NCT04988295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110967458|NCT04988295|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110967459|NCT04988295|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110967460|NCT04988295|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110967461|NCT04988295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110967462|NCT04983901|Vancomycin|vancomycin|mesh-list
110967463|NCT04983901|Meropenem|meropenem|mesh-list
110967464|NCT04983901|Tazobactam|tazobactam|mesh-list
110967465|NCT04983901|Linezolid|linezolid|mesh-list
110967466|NCT04983901|Piperacillin|piperacillin|mesh-list
110967467|NCT04983901|Daptomycin|daptomycin|mesh-list
110967468|NCT04983901|Imipenem|imipenem|mesh-list
110967469|NCT04983901|Cefepime|cefepime|mesh-list
110967470|NCT04983901|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
110967471|NCT04983901|Relebactam|relebactam|mesh-list
110967472|NCT04983901|Cilastatin|cilastatin|mesh-list
110967473|NCT04983901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110967474|NCT04983901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110967475|NCT04983901|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110967476|NCT04983901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110967477|NCT04983901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110967478|NCT04983901|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110967537|NCT04943341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110967538|NCT04943341|Glucocorticoids|glucocorticoids|mesh-ancestor
110967539|NCT04943341|Hormones|hormones|mesh-ancestor
110967540|NCT04943341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110967541|NCT04943341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110967542|NCT04943341|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110967543|NCT04943341|Immunologic Factors|immunologic factors|mesh-ancestor
110967544|NCT04943341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110967545|NCT04943341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110967546|NCT04940039|Risperidone|risperidone|mesh-list
110967547|NCT04940039|Paliperidone Palmitate|paliperidone palmitate|mesh-list
110967548|NCT04940039|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110967549|NCT04940039|Serotonin Agents|serotonin agents|mesh-ancestor
110967550|NCT04940039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110967551|NCT04940039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110967552|NCT04940039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110967553|NCT04940039|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110967554|NCT04940039|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110967555|NCT04940039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110967557|NCT04940039|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110967558|NCT04940039|Dopamine Agents|dopamine agents|mesh-ancestor
110967559|NCT04940039|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110967560|NCT04940039|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110967561|NCT04923893|Dexamethasone|dexamethasone|mesh-list
110967562|NCT04923893|Cyclophosphamide|cyclophosphamide|mesh-list
110967563|NCT04923893|Fludarabine|fludarabine|mesh-list
110967564|NCT04923893|Lenalidomide|lenalidomide|mesh-list
110967565|NCT04923893|Bortezomib|bortezomib|mesh-list
110699161|NCT01042704|Aspirin|aspirin|mesh-list
111491055|NCT06020352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111491056|NCT06020352|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111491057|NCT06020352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111491058|NCT06020352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111491059|NCT06020313|Resveratrol|resveratrol|mesh-list
111491060|NCT06020313|Antioxidants|antioxidants|mesh-ancestor
111491061|NCT06020313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110967566|NCT04923893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111491062|NCT06020313|Protective Agents|protective agents|mesh-ancestor
111491063|NCT06020313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110967567|NCT04923893|Immunologic Factors|immunologic factors|mesh-ancestor
110967568|NCT04923893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110967569|NCT04923893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110967570|NCT04923893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110967571|NCT04923893|Alkylating Agents|alkylating agents|mesh-ancestor
110967572|NCT04923893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110967573|NCT04923893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110967574|NCT04923893|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110967575|NCT04923893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110967577|NCT04923893|Autonomic Agents|autonomic agents|mesh-ancestor
110967578|NCT04923893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110967579|NCT04923893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110967580|NCT04923893|Glucocorticoids|glucocorticoids|mesh-ancestor
110967581|NCT04923893|Hormones|hormones|mesh-ancestor
110967582|NCT04923893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110967583|NCT04923893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110967584|NCT04923893|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110967585|NCT04923893|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110967586|NCT04923893|Growth Substances|growth substances|mesh-ancestor
110967587|NCT04923893|Growth Inhibitors|growth inhibitors|mesh-ancestor
110967588|NCT04919226|Leucovorin|leucovorin|mesh-list
110967589|NCT04919226|Folic Acid|folic acid|mesh-list
110967590|NCT04919226|Fluorouracil|fluorouracil|mesh-list
110967591|NCT04919226|Capecitabine|capecitabine|mesh-list
110967592|NCT04919226|Oxaliplatin|oxaliplatin|mesh-list
110967593|NCT04919226|Everolimus|everolimus|mesh-list
110967594|NCT04919226|Temozolomide|temozolomide|mesh-list
110967595|NCT04919226|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110967596|NCT04919226|Levoleucovorin|levoleucovorin|mesh-list
110967597|NCT04919226|Edotreotide|edotreotide|mesh-list
110967598|NCT04919226|Edotreotide lutetium LU-177|edotreotide lutetium lu-177|mesh-list
110967599|NCT04919226|Antimetabolites|antimetabolites|mesh-ancestor
110967600|NCT04919226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110967601|NCT04919226|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110967602|NCT04919226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110967603|NCT04919226|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110967604|NCT04919226|Immunologic Factors|immunologic factors|mesh-ancestor
110967605|NCT04919226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110967606|NCT04919226|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110967607|NCT04919226|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110967608|NCT04919226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110679729|NCT05116917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110679730|NCT05116917|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110679731|NCT05116917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110679732|NCT05113745|Reboxetine|reboxetine|mesh-list
110679733|NCT05113745|Antidepressive Agents|antidepressive agents|mesh-ancestor
110679734|NCT05113745|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110679735|NCT05113745|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110679736|NCT05113745|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110679737|NCT05113745|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110679738|NCT05113745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110679739|NCT05113745|Adrenergic Agents|adrenergic agents|mesh-ancestor
110679740|NCT05113745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110679741|NCT05113745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111491064|NCT06020313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111491065|NCT06020313|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111491066|NCT06020300|Pyridoxine|pyridoxine|mesh-list
111491067|NCT06020300|Pyridoxal|pyridoxal|mesh-list
111491068|NCT06020300|Vitamin B 6|vitamin b 6|mesh-list
111491069|NCT06020300|Colchicine|colchicine|mesh-list
111491070|NCT06020300|Gout Suppressants|gout suppressants|mesh-ancestor
111491071|NCT06020300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111491072|NCT06020300|Tubulin Modulators|tubulin modulators|mesh-ancestor
111491073|NCT06020300|Antimitotic Agents|antimitotic agents|mesh-ancestor
111491074|NCT06020300|Mitosis Modulators|mitosis modulators|mesh-ancestor
111491075|NCT06020300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111491076|NCT06020300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111491077|NCT06020300|Vitamin B Complex|vitamin b complex|mesh-ancestor
110679742|NCT05095857|Ketamine|ketamine|mesh-list
110679743|NCT05095857|Esketamine|esketamine|mesh-list
110679744|NCT05095857|Analgesics|analgesics|mesh-ancestor
111491078|NCT06020300|Vitamins|vitamins|mesh-ancestor
111491079|NCT06020300|Micronutrients|micronutrients|mesh-ancestor
110679745|NCT05095857|Sensory System Agents|sensory system agents|mesh-ancestor
110679746|NCT05095857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110679747|NCT05095857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110679748|NCT05095857|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110679749|NCT05095857|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110967609|NCT04919226|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110967610|NCT04919226|Alkylating Agents|alkylating agents|mesh-ancestor
110967611|NCT04919226|Antidotes|antidotes|mesh-ancestor
110967612|NCT04919226|Protective Agents|protective agents|mesh-ancestor
110967613|NCT04919226|Vitamin B Complex|vitamin b complex|mesh-ancestor
110967615|NCT04919226|Micronutrients|micronutrients|mesh-ancestor
110967616|NCT04919226|Hematinics|hematinics|mesh-ancestor
110967617|NCT04919226|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110967618|NCT04915612|Cytarabine|cytarabine|mesh-list
110967619|NCT04915612|Daunorubicin|daunorubicin|mesh-list
110967620|NCT04915612|Gemtuzumab|gemtuzumab|mesh-list
110967621|NCT04915612|Calicheamicins|calicheamicins|mesh-list
110967622|NCT04915612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110967623|NCT04915612|Antimetabolites|antimetabolites|mesh-ancestor
110967624|NCT04915612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110967625|NCT04915612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110967626|NCT04915612|Antiviral Agents|antiviral agents|mesh-ancestor
110967627|NCT04915612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110967628|NCT04915612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110967629|NCT04915612|Immunologic Factors|immunologic factors|mesh-ancestor
110967630|NCT04915612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110967631|NCT04915612|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110967632|NCT04915612|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110967633|NCT04915612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110967634|NCT04915612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110967635|NCT04915612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110967636|NCT04915612|Immunotoxins|immunotoxins|mesh-ancestor
110967637|NCT04915612|Immunoconjugates|immunoconjugates|mesh-ancestor
110967638|NCT04877821|Paclitaxel|paclitaxel|mesh-list
110967639|NCT04877821|Cyclophosphamide|cyclophosphamide|mesh-list
110967640|NCT04877821|Carboplatin|carboplatin|mesh-list
110967641|NCT04877821|Epirubicin|epirubicin|mesh-list
110967642|NCT04877821|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110967643|NCT04877821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110967644|NCT04877821|Tubulin Modulators|tubulin modulators|mesh-ancestor
110967645|NCT04877821|Antimitotic Agents|antimitotic agents|mesh-ancestor
110967646|NCT04877821|Mitosis Modulators|mitosis modulators|mesh-ancestor
110967647|NCT04877821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110967648|NCT04877821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110967649|NCT04877821|Immunologic Factors|immunologic factors|mesh-ancestor
110967650|NCT04877821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110967651|NCT04877821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110967652|NCT04877821|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110967653|NCT04877821|Alkylating Agents|alkylating agents|mesh-ancestor
110967654|NCT04877821|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110967655|NCT04877821|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110967656|NCT04877821|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110967657|NCT04877821|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110967658|NCT04877821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110967659|NCT04857645|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
110967660|NCT04857645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110967661|NCT04857645|Antimetabolites|antimetabolites|mesh-ancestor
110967662|NCT04857645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110967663|NCT04857645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110967664|NCT04848974|Cytarabine|cytarabine|mesh-list
110967665|NCT04848974|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
110967666|NCT04848974|Cladribine|cladribine|mesh-list
110967667|NCT04848974|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110967668|NCT04848974|Antimetabolites|antimetabolites|mesh-ancestor
110967669|NCT04848974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110967670|NCT04848974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110967671|NCT04848974|Antiviral Agents|antiviral agents|mesh-ancestor
110967672|NCT04848974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110967673|NCT04848974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111491080|NCT06020300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111491081|NCT06020196|Anesthetics|anesthetics|mesh-list
111491082|NCT06020196|Anesthetics, Local|anesthetics, local|mesh-list
111491083|NCT06020196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110967674|NCT04848974|Immunologic Factors|immunologic factors|mesh-ancestor
110699186|NCT01042704|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111491084|NCT06020196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111491085|NCT06020196|Sensory System Agents|sensory system agents|mesh-ancestor
111491086|NCT06020196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110967675|NCT04848974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110967676|NCT04844099|Piperaquine|piperaquine|mesh-list
110967677|NCT04844099|Artenimol|artenimol|mesh-list
110967678|NCT04844099|Antimalarials|antimalarials|mesh-ancestor
110967679|NCT04844099|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110967680|NCT04844099|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110967681|NCT04844099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110967682|NCT04837014|Acetaminophen|acetaminophen|mesh-list
110967683|NCT04837014|Naproxen|naproxen|mesh-list
110679805|NCT05014412|Dexamethasone|dexamethasone|mesh-list
110967684|NCT04837014|Hydromorphone|hydromorphone|mesh-list
110967685|NCT04837014|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110967686|NCT04837014|Analgesics|analgesics|mesh-ancestor
110967688|NCT04837014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110967689|NCT04837014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110967690|NCT04837014|Antipyretics|antipyretics|mesh-ancestor
110967691|NCT04837014|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110967692|NCT04837014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110967693|NCT04837014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110967694|NCT04837014|Gout Suppressants|gout suppressants|mesh-ancestor
110967695|NCT04837014|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110967696|NCT04837014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110967697|NCT04837014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110967698|NCT04837014|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110967699|NCT04837014|Narcotics|narcotics|mesh-ancestor
110967700|NCT04837014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110967701|NCT04834349|Pembrolizumab|pembrolizumab|mesh-list
110967702|NCT04834349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110967703|NCT04834349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110967704|NCT04834349|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110967705|NCT04834349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110967706|NCT04829318|Esketamine|esketamine|mesh-list
110967707|NCT04829318|Antidepressive Agents|antidepressive agents|mesh-ancestor
110967708|NCT04829318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110967709|NCT04821284|Leucovorin|leucovorin|mesh-list
110967710|NCT04821284|Paclitaxel|paclitaxel|mesh-list
110967711|NCT04821284|Gemcitabine|gemcitabine|mesh-list
110967712|NCT04821284|Fluorouracil|fluorouracil|mesh-list
110967713|NCT04821284|Oxaliplatin|oxaliplatin|mesh-list
110967714|NCT04821284|Irinotecan|irinotecan|mesh-list
110967715|NCT04821284|Calcium|calcium|mesh-list
110967716|NCT04821284|Levoleucovorin|levoleucovorin|mesh-list
110967717|NCT04821284|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110967718|NCT04821284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110967719|NCT04821284|Tubulin Modulators|tubulin modulators|mesh-ancestor
110967720|NCT04821284|Antimitotic Agents|antimitotic agents|mesh-ancestor
110967721|NCT04821284|Mitosis Modulators|mitosis modulators|mesh-ancestor
110967722|NCT04821284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110967723|NCT04821284|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110967724|NCT04821284|Antimetabolites|antimetabolites|mesh-ancestor
110967725|NCT04821284|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110967726|NCT04821284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110967727|NCT04821284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110967728|NCT04821284|Immunologic Factors|immunologic factors|mesh-ancestor
110967729|NCT04821284|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110967730|NCT04821284|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110967731|NCT04821284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110967732|NCT04821284|Antidotes|antidotes|mesh-ancestor
110967733|NCT04821284|Protective Agents|protective agents|mesh-ancestor
110967734|NCT04821284|Vitamin B Complex|vitamin b complex|mesh-ancestor
111491087|NCT06020144|Tofacitinib|tofacitinib|mesh-list
111491088|NCT06020144|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
111491089|NCT06020144|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111491090|NCT06020144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111491091|NCT06020144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111491092|NCT06019858|Vitamins|vitamins|mesh-list
111491093|NCT06019858|Micronutrients|micronutrients|mesh-ancestor
111491094|NCT06019858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111491095|NCT06019520|Acetylcysteine|acetylcysteine|mesh-list
110967735|NCT04821284|Vitamins|vitamins|mesh-ancestor
111491096|NCT06019520|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110967736|NCT04821284|Micronutrients|micronutrients|mesh-ancestor
110967737|NCT04802161|Cytarabine|cytarabine|mesh-list
110967738|NCT04802161|Thalidomide|thalidomide|mesh-list
110967739|NCT04802161|Daunorubicin|daunorubicin|mesh-list
110967740|NCT04802161|Pomalidomide|pomalidomide|mesh-list
111491097|NCT06019520|Antiviral Agents|antiviral agents|mesh-ancestor
110967741|NCT04802161|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110967742|NCT04802161|Antimetabolites|antimetabolites|mesh-ancestor
110967743|NCT04802161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110967744|NCT04802161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110967745|NCT04802161|Antiviral Agents|antiviral agents|mesh-ancestor
110651341|NCT02567981|Vitamin A|vitamin a|mesh-list
110967746|NCT04802161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110967747|NCT04802161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110967748|NCT04802161|Immunologic Factors|immunologic factors|mesh-ancestor
110967749|NCT04802161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110967750|NCT04802161|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110967751|NCT04802161|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110967752|NCT04802161|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110967753|NCT04802161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110967754|NCT04802161|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110967755|NCT04802161|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110967756|NCT04802161|Growth Substances|growth substances|mesh-ancestor
110967757|NCT04802161|Growth Inhibitors|growth inhibitors|mesh-ancestor
110967758|NCT04802161|Leprostatic Agents|leprostatic agents|mesh-ancestor
110967759|NCT04802161|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110967760|NCT04774393|Decitabine|decitabine|mesh-list
110967761|NCT04774393|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
110967762|NCT04774393|Venetoclax|venetoclax|mesh-list
110967763|NCT04774393|Ivosidenib|ivosidenib|mesh-list
110967764|NCT04774393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110967766|NCT04774393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110967767|NCT04774393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110967768|NCT04774393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110967769|NCT04767022|Paclitaxel|paclitaxel|mesh-list
110967770|NCT04767022|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110967771|NCT04767022|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110967772|NCT04767022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110967773|NCT04767022|Tubulin Modulators|tubulin modulators|mesh-ancestor
110967774|NCT04767022|Antimitotic Agents|antimitotic agents|mesh-ancestor
110967775|NCT04767022|Mitosis Modulators|mitosis modulators|mesh-ancestor
110967776|NCT04767022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110967777|NCT04762069|Lomustine|lomustine|mesh-list
110967778|NCT04762069|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110967779|NCT04762069|Alkylating Agents|alkylating agents|mesh-ancestor
110967780|NCT04762069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110967781|NCT04762069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110967782|NCT04751383|Dinutuximab|dinutuximab|mesh-list
110967783|NCT04751383|Magrolimab|magrolimab|mesh-list
110967784|NCT04751383|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110967785|NCT04751383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110967786|NCT04751383|Immunologic Factors|immunologic factors|mesh-ancestor
110967787|NCT04751383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110967788|NCT04751383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110967789|NCT04749797|Bupivacaine|bupivacaine|mesh-list
110967790|NCT04749797|Anesthetics, Local|anesthetics, local|mesh-ancestor
110967791|NCT04749797|Anesthetics|anesthetics|mesh-ancestor
110967792|NCT04749797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110967793|NCT04749797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110967794|NCT04749797|Sensory System Agents|sensory system agents|mesh-ancestor
110967795|NCT04749797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110967796|NCT04739800|Paclitaxel|paclitaxel|mesh-list
110967797|NCT04739800|Doxorubicin|doxorubicin|mesh-list
110967798|NCT04739800|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110967799|NCT04739800|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110967800|NCT04739800|Durvalumab|durvalumab|mesh-list
110967801|NCT04739800|Topotecan|topotecan|mesh-list
110967802|NCT04739800|Olaparib|olaparib|mesh-list
110967803|NCT04739800|Cediranib|cediranib|mesh-list
110967804|NCT04739800|Maleic acid|maleic acid|mesh-list
110967805|NCT04739800|Immunoglobulins|immunoglobulins|mesh-list
110967806|NCT04739800|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110967807|NCT04739800|Immunoglobulin G|immunoglobulin g|mesh-list
110967808|NCT04739800|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110967809|NCT04739800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110967810|NCT04739800|Tubulin Modulators|tubulin modulators|mesh-ancestor
110967811|NCT04739800|Antimitotic Agents|antimitotic agents|mesh-ancestor
110967812|NCT04739800|Mitosis Modulators|mitosis modulators|mesh-ancestor
111491098|NCT06019520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111491099|NCT06019520|Expectorants|expectorants|mesh-ancestor
110967813|NCT04739800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110967814|NCT04739800|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110699204|NCT01046838|Sildenafil Citrate|sildenafil citrate|mesh-list
111491100|NCT06019520|Respiratory System Agents|respiratory system agents|mesh-ancestor
111491101|NCT06019520|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110967815|NCT04739800|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111491102|NCT06019520|Antioxidants|antioxidants|mesh-ancestor
110967816|NCT04739800|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110967817|NCT04739800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110967818|NCT04739800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110967819|NCT04739800|Immunologic Factors|immunologic factors|mesh-ancestor
110967820|NCT04739800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110967821|NCT04739800|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110967822|NCT04739800|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110967823|NCT04739800|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110967824|NCT04722575|Atezolizumab|atezolizumab|mesh-list
110967825|NCT04722575|Vemurafenib|vemurafenib|mesh-list
110967826|NCT04722575|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110967827|NCT04722575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110967828|NCT04722575|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110967829|NCT04722575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110967830|NCT04722575|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110967831|NCT04722575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110967832|NCT04722146|Lenalidomide|lenalidomide|mesh-list
110967833|NCT04722146|Pomalidomide|pomalidomide|mesh-list
110967834|NCT04722146|Bortezomib|bortezomib|mesh-list
110967835|NCT04722146|Daratumumab|daratumumab|mesh-list
110967836|NCT04722146|Nirogacestat|nirogacestat|mesh-list
110967837|NCT04722146|Immunologic Factors|immunologic factors|mesh-ancestor
110967838|NCT04722146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110967839|NCT04722146|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110967840|NCT04722146|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110967841|NCT04722146|Growth Substances|growth substances|mesh-ancestor
110967842|NCT04722146|Growth Inhibitors|growth inhibitors|mesh-ancestor
110967843|NCT04722146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110967844|NCT04722146|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
110967845|NCT04722146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110967846|NCT04722146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110967847|NCT04699981|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110967848|NCT04699981|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
110967849|NCT04699981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110967850|NCT04699981|Antitubercular Agents|antitubercular agents|mesh-ancestor
110967851|NCT04695600|Botulinum Toxins|botulinum toxins|mesh-list
110967852|NCT04695600|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110967853|NCT04695600|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110967854|NCT04695600|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110967855|NCT04695600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110967856|NCT04695600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110967857|NCT04695600|Cholinergic Agents|cholinergic agents|mesh-ancestor
110967858|NCT04695600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110967859|NCT04695600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110967860|NCT04695600|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110967861|NCT04695600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110967863|NCT04685577|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110967864|NCT04685577|Analgesics|analgesics|mesh-ancestor
110967865|NCT04685577|Sensory System Agents|sensory system agents|mesh-ancestor
110967866|NCT04685577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110967867|NCT04685577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110967868|NCT04683029|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110967869|NCT04683029|Immunologic Factors|immunologic factors|mesh-ancestor
110967870|NCT04683029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110967871|NCT04673357|Ustekinumab|ustekinumab|mesh-list
110967872|NCT04673357|Dermatologic Agents|dermatologic agents|mesh-ancestor
110967873|NCT04671810|Eculizumab|eculizumab|mesh-list
110967874|NCT04671810|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
110967875|NCT04671810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110967876|NCT04671810|Immunologic Factors|immunologic factors|mesh-ancestor
110967877|NCT04671810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110967878|NCT04671667|Cisplatin|cisplatin|mesh-list
110967879|NCT04671667|Carboplatin|carboplatin|mesh-list
110967880|NCT04671667|Pembrolizumab|pembrolizumab|mesh-list
110967881|NCT04671667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110967882|NCT04671667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110967883|NCT04671667|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110967884|NCT04671667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110967885|NCT04667039|Ranibizumab|ranibizumab|mesh-list
111491103|NCT06019520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110967886|NCT04667039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110967887|NCT04667039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111491104|NCT06019520|Protective Agents|protective agents|mesh-ancestor
111491105|NCT06019520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110967888|NCT04667039|Growth Substances|growth substances|mesh-ancestor
110967889|NCT04667039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110967890|NCT04667039|Growth Inhibitors|growth inhibitors|mesh-ancestor
110967891|NCT04667039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110967892|NCT04658862|Gemcitabine|gemcitabine|mesh-list
110967893|NCT04658862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110967894|NCT04658862|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110967895|NCT04658862|Antimetabolites|antimetabolites|mesh-ancestor
110967896|NCT04658862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110967897|NCT04656652|Docetaxel|docetaxel|mesh-list
110967898|NCT04656652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110967899|NCT04656652|Tubulin Modulators|tubulin modulators|mesh-ancestor
110967900|NCT04656652|Antimitotic Agents|antimitotic agents|mesh-ancestor
110967901|NCT04656652|Mitosis Modulators|mitosis modulators|mesh-ancestor
110967902|NCT04656652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110967903|NCT04655755|Decitabine|decitabine|mesh-list
110967904|NCT04655755|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
110967905|NCT04655755|Venetoclax|venetoclax|mesh-list
110967906|NCT04655755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110967907|NCT04655755|Antimetabolites|antimetabolites|mesh-ancestor
110967908|NCT04655755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110967909|NCT04655755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110967910|NCT04655755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110967911|NCT04652960|Nivolumab|nivolumab|mesh-list
110967912|NCT04652960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110967913|NCT04652960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110967914|NCT04652960|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110967915|NCT04652960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110967916|NCT04641871|Irinotecan|irinotecan|mesh-list
110967917|NCT04641871|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110967918|NCT04641871|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110967919|NCT04641871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110967920|NCT04641871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110967921|NCT04641871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110967922|NCT04640623|Gemcitabine|gemcitabine|mesh-list
110967923|NCT04640623|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110967924|NCT04640623|Antimetabolites|antimetabolites|mesh-ancestor
110967925|NCT04640623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110967926|NCT04640623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110967927|NCT04633239|Olaparib|olaparib|mesh-list
110967928|NCT04633239|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
110967929|NCT04633239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110967930|NCT04633239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110967931|NCT04633239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110967932|NCT04630145|Clarithromycin|clarithromycin|mesh-list
110967933|NCT04630145|Rifampin|rifampin|mesh-list
110967934|NCT04630145|Ethambutol|ethambutol|mesh-list
110967935|NCT04630145|Rifabutin|rifabutin|mesh-list
110967936|NCT04630145|Bedaquiline|bedaquiline|mesh-list
110967937|NCT04630145|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110967938|NCT04630145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110967939|NCT04630145|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110967940|NCT04630145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110651369|NCT00926354|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110967941|NCT04630145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110967942|NCT04630145|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110967943|NCT04630145|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110967944|NCT04630145|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110967945|NCT04630145|Antitubercular Agents|antitubercular agents|mesh-ancestor
110967946|NCT04630145|Leprostatic Agents|leprostatic agents|mesh-ancestor
110967947|NCT04630145|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110967948|NCT04630145|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110967949|NCT04630145|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110967950|NCT04630145|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110967951|NCT04630145|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110967952|NCT04630145|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110967953|NCT04630145|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110967954|NCT04630028|Ustekinumab|ustekinumab|mesh-list
110967955|NCT04630028|Dermatologic Agents|dermatologic agents|mesh-ancestor
110967956|NCT04628988|Prednisone|prednisone|mesh-list
110967957|NCT04628988|Pulrodemstat besilate|pulrodemstat besilate|mesh-list
111491106|NCT06019520|Antidotes|antidotes|mesh-ancestor
110967958|NCT04628988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110967959|NCT04628988|Glucocorticoids|glucocorticoids|mesh-ancestor
110967960|NCT04628988|Hormones|hormones|mesh-ancestor
110967961|NCT04628988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110967962|NCT04628988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110967963|NCT04628988|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110967964|NCT04628988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110967965|NCT04628988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110967966|NCT04628988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110967967|NCT04621435|Copper|copper|mesh-list
110967968|NCT04621435|Trace Elements|trace elements|mesh-ancestor
110967969|NCT04621435|Micronutrients|micronutrients|mesh-ancestor
110967970|NCT04621435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110967971|NCT04619004|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
110967972|NCT04619004|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110967973|NCT04619004|Immunologic Factors|immunologic factors|mesh-ancestor
110967974|NCT04619004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110967975|NCT04619004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110967976|NCT04619004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110967977|NCT04615013|Leucovorin|leucovorin|mesh-list
110967978|NCT04615013|Paclitaxel|paclitaxel|mesh-list
110680110|NCT04553263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110680111|NCT04553263|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110327183|NCT02274051|Growth Substances|growth substances|mesh-ancestor
110680112|NCT04553263|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110680113|NCT04553263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110680114|NCT04553263|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110680115|NCT04547777|D2C7-(scdsFv)-PE38KDEL|d2c7-(scdsfv)-pe38kdel|mesh-list
110680116|NCT04547777|Immunoconjugates|immunoconjugates|mesh-ancestor
110680117|NCT04547777|Immunologic Factors|immunologic factors|mesh-ancestor
110967980|NCT04615013|Carboplatin|carboplatin|mesh-list
110967981|NCT04615013|Fluorouracil|fluorouracil|mesh-list
110967982|NCT04615013|Capecitabine|capecitabine|mesh-list
110967983|NCT04615013|Oxaliplatin|oxaliplatin|mesh-list
110967984|NCT04615013|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110967985|NCT04615013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110967986|NCT04615013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110967987|NCT04615013|Tubulin Modulators|tubulin modulators|mesh-ancestor
110967988|NCT04615013|Antimitotic Agents|antimitotic agents|mesh-ancestor
110967989|NCT04615013|Mitosis Modulators|mitosis modulators|mesh-ancestor
110967990|NCT04615013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110967991|NCT04615013|Antimetabolites|antimetabolites|mesh-ancestor
110967992|NCT04615013|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110967993|NCT04615013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110967994|NCT04615013|Immunologic Factors|immunologic factors|mesh-ancestor
110967995|NCT04615013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110967996|NCT04615013|Antidotes|antidotes|mesh-ancestor
110967997|NCT04615013|Protective Agents|protective agents|mesh-ancestor
110967998|NCT04615013|Vitamin B Complex|vitamin b complex|mesh-ancestor
110967999|NCT04615013|Vitamins|vitamins|mesh-ancestor
110968000|NCT04615013|Micronutrients|micronutrients|mesh-ancestor
110968001|NCT04606381|Lazertinib|lazertinib|mesh-list
110968002|NCT04606381|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110968003|NCT04606381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110968004|NCT04606381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110968005|NCT04599855|Esketamine|esketamine|mesh-list
110968006|NCT04599855|Antidepressive Agents|antidepressive agents|mesh-ancestor
110968007|NCT04599855|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110968008|NCT04598009|Imatinib Mesylate|imatinib mesylate|mesh-list
110968009|NCT04598009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110968010|NCT04598009|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110968011|NCT04598009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110968012|NCT04598009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110968013|NCT04592237|Carboplatin|carboplatin|mesh-list
110968014|NCT04592237|Niraparib|niraparib|mesh-list
110968015|NCT04592237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110968016|NCT04592237|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110968017|NCT04592237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110968018|NCT04592237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110968019|NCT04586426|Daratumumab|daratumumab|mesh-list
110968020|NCT04586426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110968021|NCT04585789|Tenofovir|tenofovir|mesh-list
111491107|NCT06019507|Mycophenolic Acid|mycophenolic acid|mesh-list
111491108|NCT06019507|Cyclophosphamide|cyclophosphamide|mesh-list
110968022|NCT04585789|Entecavir|entecavir|mesh-list
110968023|NCT04585789|JNJ-56136379|jnj-56136379|mesh-list
110968024|NCT04585789|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110968025|NCT04585789|Antiviral Agents|antiviral agents|mesh-ancestor
110968026|NCT04585789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110968027|NCT04585789|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110968028|NCT04585789|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110968030|NCT04585789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110968031|NCT04585789|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110968032|NCT04585789|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110968033|NCT04577833|Prednisone|prednisone|mesh-list
110968034|NCT04577833|Abiraterone Acetate|abiraterone acetate|mesh-list
110968035|NCT04577833|Niraparib|niraparib|mesh-list
110968036|NCT04577833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110968037|NCT04577833|Glucocorticoids|glucocorticoids|mesh-ancestor
110968038|NCT04577833|Hormones|hormones|mesh-ancestor
110968039|NCT04577833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110968040|NCT04577833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110968041|NCT04577833|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110968042|NCT04577833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110968043|NCT04577833|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110968044|NCT04577833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110968045|NCT04577833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110968046|NCT04577833|Hormone Antagonists|hormone antagonists|mesh-ancestor
110968047|NCT04577833|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110968048|NCT04577833|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110968049|NCT04565990|Selexipag|selexipag|mesh-list
110968050|NCT04565990|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110968051|NCT04547153|Docetaxel|docetaxel|mesh-list
110968052|NCT04547153|Fluorouracil|fluorouracil|mesh-list
110968053|NCT04547153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110968054|NCT04547153|Tubulin Modulators|tubulin modulators|mesh-ancestor
110968055|NCT04547153|Antimitotic Agents|antimitotic agents|mesh-ancestor
110968056|NCT04547153|Mitosis Modulators|mitosis modulators|mesh-ancestor
110968057|NCT04547153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110968058|NCT04547153|Antimetabolites|antimetabolites|mesh-ancestor
110968059|NCT04547153|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110968060|NCT04547153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110968061|NCT04547153|Immunologic Factors|immunologic factors|mesh-ancestor
110968062|NCT04547153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110968063|NCT04541017|Mogamulizumab|mogamulizumab|mesh-list
110968064|NCT04541017|Magrolimab|magrolimab|mesh-list
110968065|NCT04541017|Immunoglobulins|immunoglobulins|mesh-list
110968066|NCT04541017|Immunoglobulin G|immunoglobulin g|mesh-list
110968067|NCT04541017|Immunologic Factors|immunologic factors|mesh-ancestor
110968068|NCT04541017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110968069|NCT04541017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110968070|NCT04541017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110968071|NCT04535544|Tenofovir|tenofovir|mesh-list
110968072|NCT04535544|Entecavir|entecavir|mesh-list
110968073|NCT04535544|Antiviral Agents|antiviral agents|mesh-ancestor
110968074|NCT04535544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110968075|NCT04535544|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110968076|NCT04535544|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110968077|NCT04535544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110968078|NCT04535544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110968079|NCT04535544|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110968080|NCT04535544|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110968081|NCT04523493|Lenvatinib|lenvatinib|mesh-list
110968082|NCT04523493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110968083|NCT04523493|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110968084|NCT04523493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110968085|NCT04523493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110968086|NCT04523207|Relugolix|relugolix|mesh-list
110968087|NCT04523207|Androgen Antagonists|androgen antagonists|mesh-ancestor
110968088|NCT04523207|Hormone Antagonists|hormone antagonists|mesh-ancestor
110968089|NCT04523207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111491109|NCT06019507|Tacrolimus|tacrolimus|mesh-list
111491110|NCT06019507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111491111|NCT06019507|Immunologic Factors|immunologic factors|mesh-ancestor
111491112|NCT06019507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111491113|NCT06019507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111491114|NCT06019507|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111491115|NCT06019507|Alkylating Agents|alkylating agents|mesh-ancestor
111491116|NCT06019507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111491117|NCT06019507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111491118|NCT06019507|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111491119|NCT06019507|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110968090|NCT04523207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110968091|NCT04513912|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110968092|NCT04513912|Antidepressive Agents|antidepressive agents|mesh-ancestor
110968093|NCT04513912|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110968094|NCT04513912|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110968095|NCT04513912|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110968096|NCT04513912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110968097|NCT04513912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110968098|NCT04507919|Dabrafenib|dabrafenib|mesh-list
110968099|NCT04507919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110968100|NCT04507919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110968101|NCT04507919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110651407|NCT00700115|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110968102|NCT04507919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110968103|NCT04503668|Dexamethasone|dexamethasone|mesh-list
110968104|NCT04503668|Ondansetron|ondansetron|mesh-list
110968105|NCT04503668|Olanzapine|olanzapine|mesh-list
110968106|NCT04503668|Fosaprepitant|fosaprepitant|mesh-list
110968107|NCT04503668|Prochlorperazine|prochlorperazine|mesh-list
110968108|NCT04503668|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-list
110968109|NCT04503668|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110968110|NCT04503668|Antiemetics|antiemetics|mesh-ancestor
110968111|NCT04503668|Autonomic Agents|autonomic agents|mesh-ancestor
110968112|NCT04503668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110968113|NCT04503668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110968114|NCT04503668|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110968115|NCT04503668|Glucocorticoids|glucocorticoids|mesh-ancestor
110968116|NCT04503668|Hormones|hormones|mesh-ancestor
110968117|NCT04503668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110968118|NCT04503668|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110968119|NCT04503668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110968120|NCT04503668|Antipruritics|antipruritics|mesh-ancestor
110968121|NCT04503668|Dermatologic Agents|dermatologic agents|mesh-ancestor
110968122|NCT04503668|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110968123|NCT04503668|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110968124|NCT04503668|Serotonin Agents|serotonin agents|mesh-ancestor
110968125|NCT04503668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110968126|NCT04503668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110968127|NCT04503668|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110968128|NCT04503668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110968129|NCT04503668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110968130|NCT04503668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110968131|NCT04503668|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110968132|NCT04503668|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110968133|NCT04503668|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110968134|NCT04503668|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110968135|NCT04503668|Dopamine Agents|dopamine agents|mesh-ancestor
110968136|NCT04503551|Ranibizumab|ranibizumab|mesh-list
110968137|NCT04503551|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110968138|NCT04503551|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110968139|NCT04503551|Growth Substances|growth substances|mesh-ancestor
110968140|NCT04503551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110968141|NCT04503551|Growth Inhibitors|growth inhibitors|mesh-ancestor
110968142|NCT04503551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110968143|NCT04496960|Tofacitinib|tofacitinib|mesh-list
110968144|NCT04496960|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
110968145|NCT04496960|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110968146|NCT04496960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110968147|NCT04496960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110968148|NCT04487080|Osimertinib|osimertinib|mesh-list
110968149|NCT04487080|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
110968150|NCT04487080|Lazertinib|lazertinib|mesh-list
110968151|NCT04487080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110968152|NCT04487080|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110968153|NCT04487080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110968154|NCT04487080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110968155|NCT04487080|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110968156|NCT04485195|Procainamide|procainamide|mesh-list
110968157|NCT04485195|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111491121|NCT06019507|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111491122|NCT06019507|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110968158|NCT04485195|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110968159|NCT04485195|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110968160|NCT04485195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110968161|NCT04485195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110968162|NCT04485130|Disulfiram|disulfiram|mesh-list
110968163|NCT04485130|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110968164|NCT04485130|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
110544816|NCT00668538|Miconazole|miconazole|mesh-list
110968165|NCT04485130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110968166|NCT04485130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110968167|NCT04469491|Interferons|interferons|mesh-list
110968168|NCT04469491|Interferon Type I|interferon type i|mesh-list
110968169|NCT04469491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110968170|NCT04469491|Antiviral Agents|antiviral agents|mesh-ancestor
110968171|NCT04469491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110968172|NCT04460924|Integrase Inhibitors|integrase inhibitors|mesh-list
110968173|NCT04460924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110968174|NCT04460924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110968175|NCT04458948|Azithromycin|azithromycin|mesh-list
110968176|NCT04458948|Hydroxychloroquine|hydroxychloroquine|mesh-list
110968177|NCT04458948|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110968178|NCT04458948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110968179|NCT04458948|Antimalarials|antimalarials|mesh-ancestor
110968180|NCT04458948|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110968181|NCT04458948|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110968182|NCT04458948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110968183|NCT04458948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110968184|NCT04458948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110968185|NCT04458909|Cisplatin|cisplatin|mesh-list
110968186|NCT04458909|Carboplatin|carboplatin|mesh-list
110968187|NCT04458909|Gemcitabine|gemcitabine|mesh-list
110968188|NCT04458909|Nivolumab|nivolumab|mesh-list
110968189|NCT04458909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110968190|NCT04458909|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110968191|NCT04458909|Antimetabolites|antimetabolites|mesh-ancestor
110968192|NCT04458909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110968193|NCT04458909|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110968194|NCT04458909|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110968195|NCT04447716|Rituximab|rituximab|mesh-list
110968196|NCT04447716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110968197|NCT04447716|Lenalidomide|lenalidomide|mesh-list
110968198|NCT04447716|Venetoclax|venetoclax|mesh-list
110968199|NCT04447716|Piperidine|piperidine|mesh-list
110680343|NCT04278404|Dopamine Agents|dopamine agents|mesh-ancestor
110680344|NCT04278404|Antidepressive Agents|antidepressive agents|mesh-ancestor
110680345|NCT04278404|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110680346|NCT04278404|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110680347|NCT04278404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110968200|NCT04447716|Antibodies|antibodies|mesh-list
110968201|NCT04447716|Immunoglobulins|immunoglobulins|mesh-list
110968202|NCT04447716|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110968203|NCT04447716|Immunologic Factors|immunologic factors|mesh-ancestor
110968204|NCT04447716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110968205|NCT04447716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110968206|NCT04447716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110968207|NCT04447716|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110968208|NCT04447716|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110968209|NCT04447716|Growth Substances|growth substances|mesh-ancestor
110968210|NCT04447716|Growth Inhibitors|growth inhibitors|mesh-ancestor
110968211|NCT04447716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110968212|NCT04447716|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110968213|NCT04447716|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110968214|NCT04447716|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110968215|NCT04439539|Tenofovir|tenofovir|mesh-list
110968216|NCT04439539|JNJ-56136379|jnj-56136379|mesh-list
110968217|NCT04439539|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110968218|NCT04439539|Antiviral Agents|antiviral agents|mesh-ancestor
110968219|NCT04439539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110968220|NCT04439539|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110968221|NCT04439539|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110968222|NCT04439539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110968223|NCT04439539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111491123|NCT06019507|Antitubercular Agents|antitubercular agents|mesh-ancestor
110968224|NCT04439539|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111491124|NCT06019507|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110968225|NCT04439539|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110968226|NCT04439292|Trametinib|trametinib|mesh-list
110968227|NCT04439292|Dabrafenib|dabrafenib|mesh-list
110968228|NCT04439292|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
110651428|NCT00442546|Pregabalin|pregabalin|mesh-list
110968230|NCT04439292|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110968231|NCT04439292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110968232|NCT04439292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110968233|NCT04439292|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
110968234|NCT04439292|Protective Agents|protective agents|mesh-ancestor
110968235|NCT04439292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110968236|NCT04439292|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110968237|NCT04439292|Antioxidants|antioxidants|mesh-ancestor
110968238|NCT04432857|Pembrolizumab|pembrolizumab|mesh-list
110968239|NCT04432857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110968240|NCT04432857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110968241|NCT04432857|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110968242|NCT04432857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110968243|NCT04423718|Aflibercept|aflibercept|mesh-list
110968244|NCT04423718|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110968245|NCT04423718|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110968246|NCT04423718|Growth Substances|growth substances|mesh-ancestor
110968247|NCT04423718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110968248|NCT04423718|Growth Inhibitors|growth inhibitors|mesh-ancestor
110968249|NCT04423718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110968250|NCT04391049|Paclitaxel|paclitaxel|mesh-list
110968251|NCT04391049|Carboplatin|carboplatin|mesh-list
110968252|NCT04391049|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110968253|NCT04391049|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110968254|NCT04391049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110968255|NCT04391049|Tubulin Modulators|tubulin modulators|mesh-ancestor
110968256|NCT04391049|Antimitotic Agents|antimitotic agents|mesh-ancestor
110968257|NCT04391049|Mitosis Modulators|mitosis modulators|mesh-ancestor
110968258|NCT04391049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110968259|NCT04386746|Gemcitabine|gemcitabine|mesh-list
110968260|NCT04386746|Docetaxel|docetaxel|mesh-list
110968261|NCT04386746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110968262|NCT04386746|Antimetabolites|antimetabolites|mesh-ancestor
110968263|NCT04386746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110327475|NCT00480207|Vitamins|vitamins|mesh-ancestor
110680429|NCT04180488|Histamine Antagonists|histamine antagonists|mesh-list
110680430|NCT04180488|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
110680431|NCT04180488|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-list
110680432|NCT04180488|Histamine Agents|histamine agents|mesh-ancestor
110680433|NCT04180488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110680434|NCT04180488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110680435|NCT04180488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110680436|NCT04179864|Prednisone|prednisone|mesh-list
110680437|NCT04179864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110680438|NCT04179864|Glucocorticoids|glucocorticoids|mesh-ancestor
110680439|NCT04179864|Hormones|hormones|mesh-ancestor
110968264|NCT04386746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110968265|NCT04386746|Tubulin Modulators|tubulin modulators|mesh-ancestor
110968266|NCT04386746|Antimitotic Agents|antimitotic agents|mesh-ancestor
110968267|NCT04386746|Mitosis Modulators|mitosis modulators|mesh-ancestor
110968269|NCT04383119|Trabectedin|trabectedin|mesh-list
110968270|NCT04383119|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110968271|NCT04383119|Antimetabolites|antimetabolites|mesh-ancestor
110968272|NCT04383119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110968273|NCT04383119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110968274|NCT04383119|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110968275|NCT04383119|Alkylating Agents|alkylating agents|mesh-ancestor
110968276|NCT04381650|Pembrolizumab|pembrolizumab|mesh-list
110968277|NCT04381650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110968278|NCT04381650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110968279|NCT04381650|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110968280|NCT04381650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110968281|NCT04379596|Pembrolizumab|pembrolizumab|mesh-list
110968282|NCT04379596|Fluorouracil|fluorouracil|mesh-list
110968283|NCT04379596|Capecitabine|capecitabine|mesh-list
110968284|NCT04379596|Oxaliplatin|oxaliplatin|mesh-list
110968285|NCT04379596|Trastuzumab|trastuzumab|mesh-list
110968286|NCT04379596|Durvalumab|durvalumab|mesh-list
111491125|NCT06019507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111491126|NCT06019286|Hormones|hormones|mesh-list
110968287|NCT04379596|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
110968288|NCT04379596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110968289|NCT04379596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110968290|NCT04379596|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111491127|NCT06019286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110968291|NCT04379596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110968293|NCT04379596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110968294|NCT04379596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110968295|NCT04379596|Immunologic Factors|immunologic factors|mesh-ancestor
110968296|NCT04379596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110968297|NCT04379596|Immunoconjugates|immunoconjugates|mesh-ancestor
110968298|NCT04372108|Ustekinumab|ustekinumab|mesh-list
110968299|NCT04372108|Dermatologic Agents|dermatologic agents|mesh-ancestor
110968300|NCT04350502|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110968301|NCT04350502|Amoxicillin|amoxicillin|mesh-list
110968302|NCT04350502|Clavulanic Acids|clavulanic acids|mesh-list
110968303|NCT04350502|Clavulanic Acid|clavulanic acid|mesh-list
110968304|NCT04350502|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
110968305|NCT04350502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110968306|NCT04350502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110968307|NCT04350502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110968308|NCT04350502|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110968309|NCT04339101|Sirolimus|sirolimus|mesh-list
110968310|NCT04339101|Fludarabine|fludarabine|mesh-list
110968311|NCT04339101|Melphalan|melphalan|mesh-list
110968312|NCT04339101|Mechlorethamine|mechlorethamine|mesh-list
110968313|NCT04339101|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
110968314|NCT04339101|Tacrolimus|tacrolimus|mesh-list
110968315|NCT04339101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110968316|NCT04339101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110968317|NCT04339101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110968318|NCT04339101|Immunologic Factors|immunologic factors|mesh-ancestor
110968319|NCT04339101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110968320|NCT04339101|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110968321|NCT04339101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110968322|NCT04339101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110968323|NCT04339101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110968324|NCT04339101|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110968325|NCT04339101|Antifungal Agents|antifungal agents|mesh-ancestor
110968326|NCT04339101|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110968327|NCT04339101|Alkylating Agents|alkylating agents|mesh-ancestor
110968328|NCT04339101|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110968329|NCT04312659|Infliximab|infliximab|mesh-list
110968330|NCT04312659|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110968331|NCT04312659|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110968332|NCT04312659|Dermatologic Agents|dermatologic agents|mesh-ancestor
110968333|NCT04312659|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110968334|NCT04312659|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110968335|NCT04308785|Atezolizumab|atezolizumab|mesh-list
110968336|NCT04308785|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110968337|NCT04308785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110968338|NCT04308785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110680493|NCT03970096|Busulfan|busulfan|mesh-list
110968347|NCT04294134|Serotonin Agents|serotonin agents|mesh-ancestor
110968348|NCT04294134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110968349|NCT04294134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110968350|NCT04294134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110968351|NCT04274023|Dostarlimab|dostarlimab|mesh-list
110968352|NCT04274023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110968353|NCT04271475|Macitentan|macitentan|mesh-list
110968354|NCT04271475|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
110968355|NCT04271475|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
110968356|NCT04271475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110968357|NCT04271475|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
110968358|NCT04266301|Azacitidine|azacitidine|mesh-list
110968359|NCT04266301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110968360|NCT04266301|Antimetabolites|antimetabolites|mesh-ancestor
110968361|NCT04266301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110968362|NCT04266301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110968363|NCT04266301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110968364|NCT04246177|Pembrolizumab|pembrolizumab|mesh-list
110968365|NCT04246177|Lenvatinib|lenvatinib|mesh-list
110968366|NCT04246177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110968367|NCT04246177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110968368|NCT04246177|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110968369|NCT04246177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110968370|NCT04246177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111491128|NCT06019286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111491129|NCT06019130|Interferons|interferons|mesh-list
111491130|NCT06019130|Interferon-beta|interferon-beta|mesh-list
111491131|NCT06019130|Interferon beta-1a|interferon beta-1a|mesh-list
110968371|NCT04246177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110968372|NCT04222010|Anesthetics|anesthetics|mesh-list
110968373|NCT04222010|Ropivacaine|ropivacaine|mesh-list
110968374|NCT04222010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110968375|NCT04222010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110968376|NCT04222010|Anesthetics, Local|anesthetics, local|mesh-ancestor
110968377|NCT04222010|Sensory System Agents|sensory system agents|mesh-ancestor
110968378|NCT04222010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110968388|NCT04207060|Indomethacin|indomethacin|mesh-list
110968389|NCT04207060|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110968390|NCT04207060|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110968391|NCT04207060|Analgesics|analgesics|mesh-ancestor
110968392|NCT04207060|Sensory System Agents|sensory system agents|mesh-ancestor
110680566|NCT03781440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110680567|NCT03781440|Sensory System Agents|sensory system agents|mesh-ancestor
110327614|NCT00443235|Melphalan|melphalan|mesh-list
110680568|NCT03781440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110680569|NCT03781440|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110680570|NCT03781440|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110680571|NCT03781440|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110680572|NCT03781440|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110680573|NCT03781440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110680594|NCT03771612|Naproxen|naproxen|mesh-list
110680595|NCT03771612|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110680596|NCT03771612|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110680597|NCT03771612|Analgesics|analgesics|mesh-ancestor
110680598|NCT03771612|Sensory System Agents|sensory system agents|mesh-ancestor
110680599|NCT03771612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110680600|NCT03771612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110680601|NCT03771612|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110680602|NCT03771612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110968393|NCT04207060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110968394|NCT04207060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110968395|NCT04207060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110968396|NCT04207060|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110968397|NCT04207060|Gout Suppressants|gout suppressants|mesh-ancestor
110968398|NCT04207060|Tocolytic Agents|tocolytic agents|mesh-ancestor
110968399|NCT04207060|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110968400|NCT04207060|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110968401|NCT04207060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110968402|NCT04207060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110968403|NCT04205409|Nivolumab|nivolumab|mesh-list
110968404|NCT04205409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110968405|NCT04205409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110968406|NCT04205409|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110968407|NCT04205409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110968408|NCT04181827|Dexamethasone|dexamethasone|mesh-list
110968409|NCT04181827|Bortezomib|bortezomib|mesh-list
110968410|NCT04181827|Daratumumab|daratumumab|mesh-list
110968411|NCT04181827|Pomalidomide|pomalidomide|mesh-list
110968412|NCT04181827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110968413|NCT04181827|Antiemetics|antiemetics|mesh-ancestor
110968414|NCT04181827|Autonomic Agents|autonomic agents|mesh-ancestor
110968415|NCT04181827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110968416|NCT04181827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110968417|NCT04181827|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110968418|NCT04181827|Glucocorticoids|glucocorticoids|mesh-ancestor
110968419|NCT04181827|Hormones|hormones|mesh-ancestor
110968420|NCT04181827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110968421|NCT04181827|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110968422|NCT04181827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110968423|NCT04181827|Immunologic Factors|immunologic factors|mesh-ancestor
110968424|NCT04181827|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110968425|NCT04181827|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111491132|NCT06019130|Cisplatin|cisplatin|mesh-list
111491133|NCT06019130|Gemcitabine|gemcitabine|mesh-list
110968426|NCT04181827|Growth Substances|growth substances|mesh-ancestor
110968427|NCT04181827|Growth Inhibitors|growth inhibitors|mesh-ancestor
111491134|NCT06019130|Fluorouracil|fluorouracil|mesh-list
111491135|NCT06019130|Nivolumab|nivolumab|mesh-list
111491136|NCT06019130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111491137|NCT06019130|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110968428|NCT04179500|Moxifloxacin|moxifloxacin|mesh-list
110968429|NCT04179500|Pyrazinamide|pyrazinamide|mesh-list
110968430|NCT04179500|Bedaquiline|bedaquiline|mesh-list
110968431|NCT04179500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110968432|NCT04179500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110968433|NCT04179500|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110968434|NCT04179500|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110968435|NCT04179500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110968436|NCT04179500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110968437|NCT04179500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110968438|NCT04179500|Antitubercular Agents|antitubercular agents|mesh-ancestor
110968439|NCT04175600|Selexipag|selexipag|mesh-list
110968440|NCT04175600|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110968441|NCT04172675|Gemcitabine|gemcitabine|mesh-list
110968442|NCT04172675|Mitomycins|mitomycins|mesh-list
110968443|NCT04172675|Mitomycin|mitomycin|mesh-list
110968444|NCT04172675|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110968445|NCT04172675|Antimetabolites|antimetabolites|mesh-ancestor
110968446|NCT04172675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110968447|NCT04172675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110968448|NCT04172675|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110968449|NCT04172675|Alkylating Agents|alkylating agents|mesh-ancestor
110968450|NCT04172675|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110968451|NCT04172675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110968452|NCT04145700|Gemcitabine|gemcitabine|mesh-list
110968453|NCT04145700|Docetaxel|docetaxel|mesh-list
110968454|NCT04145700|Ramucirumab|ramucirumab|mesh-list
110968455|NCT04145700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110968456|NCT04145700|Antimetabolites|antimetabolites|mesh-ancestor
110968457|NCT04145700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110968458|NCT04145700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110968459|NCT04145700|Tubulin Modulators|tubulin modulators|mesh-ancestor
110680637|NCT03635983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110680638|NCT03635983|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110327689|NCT00480597|Tubulin Modulators|tubulin modulators|mesh-ancestor
110680639|NCT03635983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110680640|NCT03628209|Nivolumab|nivolumab|mesh-list
110680641|NCT03628209|Azacitidine|azacitidine|mesh-list
110680642|NCT03628209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110680647|NCT03628209|Antimetabolites|antimetabolites|mesh-ancestor
110968460|NCT04145700|Antimitotic Agents|antimitotic agents|mesh-ancestor
110968461|NCT04145700|Mitosis Modulators|mitosis modulators|mesh-ancestor
110968462|NCT04145349|Cyclophosphamide|cyclophosphamide|mesh-list
110968463|NCT04145349|Vinorelbine|vinorelbine|mesh-list
110968464|NCT04145349|Ramucirumab|ramucirumab|mesh-list
110968465|NCT04145349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110968466|NCT04145349|Immunologic Factors|immunologic factors|mesh-ancestor
110968467|NCT04145349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110968468|NCT04145349|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110968469|NCT04145349|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110968470|NCT04145349|Alkylating Agents|alkylating agents|mesh-ancestor
110968471|NCT04145349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110968472|NCT04145349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110968473|NCT04145349|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110968474|NCT04145349|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110968475|NCT04145349|Tubulin Modulators|tubulin modulators|mesh-ancestor
110968476|NCT04145349|Antimitotic Agents|antimitotic agents|mesh-ancestor
110968477|NCT04145349|Mitosis Modulators|mitosis modulators|mesh-ancestor
110968478|NCT04133636|Dexamethasone|dexamethasone|mesh-list
110968479|NCT04133636|Lenalidomide|lenalidomide|mesh-list
110968480|NCT04133636|Bortezomib|bortezomib|mesh-list
110968481|NCT04133636|Daratumumab|daratumumab|mesh-list
110968482|NCT04133636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110968483|NCT04133636|Antiemetics|antiemetics|mesh-ancestor
110968484|NCT04133636|Autonomic Agents|autonomic agents|mesh-ancestor
110968485|NCT04133636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110968486|NCT04133636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110968487|NCT04133636|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110968488|NCT04133636|Glucocorticoids|glucocorticoids|mesh-ancestor
111491138|NCT06019130|Antimetabolites|antimetabolites|mesh-ancestor
111491139|NCT06019130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110968489|NCT04133636|Hormones|hormones|mesh-ancestor
110968490|NCT04133636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110968491|NCT04133636|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110968492|NCT04133636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111491140|NCT06019130|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110968494|NCT04133636|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110968495|NCT04133636|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110968496|NCT04133636|Growth Substances|growth substances|mesh-ancestor
110968497|NCT04133636|Growth Inhibitors|growth inhibitors|mesh-ancestor
110968498|NCT04128683|Bromocriptine|bromocriptine|mesh-list
110968499|NCT04128683|Amisulpride|amisulpride|mesh-list
110968500|NCT04128683|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110968501|NCT04128683|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110968502|NCT04128683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110968503|NCT04128683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110968504|NCT04128683|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110968505|NCT04128683|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110968506|NCT04128683|Dopamine Agents|dopamine agents|mesh-ancestor
110968507|NCT04128683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110968508|NCT04128683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110968509|NCT04128683|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110968510|NCT04128683|Antidepressive Agents|antidepressive agents|mesh-ancestor
110968511|NCT04128683|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110968512|NCT04128683|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110968513|NCT04128683|Hormone Antagonists|hormone antagonists|mesh-ancestor
110968514|NCT04128683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110968515|NCT04128683|Dopamine Agonists|dopamine agonists|mesh-ancestor
110968516|NCT04128501|Azacitidine|azacitidine|mesh-list
110968517|NCT04128501|Venetoclax|venetoclax|mesh-list
110651555|NCT00938522|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110968518|NCT04128501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110968519|NCT04128501|Antimetabolites|antimetabolites|mesh-ancestor
110968520|NCT04128501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110968521|NCT04128501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110968522|NCT04128501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110968523|NCT04121260|Daratumumab|daratumumab|mesh-list
110968524|NCT04121260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110968525|NCT04108208|Androgens|androgens|mesh-list
110968526|NCT04108208|Hormones|hormones|mesh-ancestor
110968527|NCT04108208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110968528|NCT04108208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110968529|NCT04108195|Daratumumab|daratumumab|mesh-list
110968530|NCT04108195|Pomalidomide|pomalidomide|mesh-list
110968531|NCT04108195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110968532|NCT04108195|Immunologic Factors|immunologic factors|mesh-ancestor
110968533|NCT04108195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110968534|NCT04108195|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110968535|NCT04108195|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110968536|NCT04108195|Growth Substances|growth substances|mesh-ancestor
110968537|NCT04108195|Growth Inhibitors|growth inhibitors|mesh-ancestor
110968538|NCT04108156|Ranibizumab|ranibizumab|mesh-list
110968539|NCT04108156|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110968540|NCT04108156|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110968541|NCT04108156|Growth Substances|growth substances|mesh-ancestor
110968542|NCT04108156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110968543|NCT04108156|Growth Inhibitors|growth inhibitors|mesh-ancestor
110968544|NCT04108156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110968545|NCT04092270|Doxorubicin|doxorubicin|mesh-list
110968546|NCT04092270|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110968547|NCT04092270|Peposertib|peposertib|mesh-list
110968548|NCT04092270|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110968549|NCT04092270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110968550|NCT04092270|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110968551|NCT04092270|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110968552|NCT04092270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110968553|NCT04092270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110968554|NCT04092270|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110968555|NCT04090398|Paclitaxel|paclitaxel|mesh-list
110968556|NCT04090398|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110968557|NCT04090398|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
110968558|NCT04090398|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110968559|NCT04090398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110968560|NCT04090398|Tubulin Modulators|tubulin modulators|mesh-ancestor
110968561|NCT04090398|Antimitotic Agents|antimitotic agents|mesh-ancestor
110968562|NCT04090398|Mitosis Modulators|mitosis modulators|mesh-ancestor
110968563|NCT04090398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110968564|NCT04079738|Ixazomib|ixazomib|mesh-list
111491141|NCT06019130|Immunologic Factors|immunologic factors|mesh-ancestor
110968565|NCT04079738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110968566|NCT04079738|Protease Inhibitors|protease inhibitors|mesh-ancestor
110651561|NCT00938522|Vasodilator Agents|vasodilator agents|mesh-ancestor
110968568|NCT04079738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110968569|NCT04077463|Carboplatin|carboplatin|mesh-list
110968570|NCT04077463|Pemetrexed|pemetrexed|mesh-list
110968571|NCT04077463|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
110968572|NCT04077463|Lazertinib|lazertinib|mesh-list
110968573|NCT04077463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110968574|NCT04077463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110968575|NCT04077463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110968576|NCT04077463|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110968577|NCT04077463|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110968578|NCT04077463|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110968579|NCT04077463|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110968580|NCT04062266|Azacitidine|azacitidine|mesh-list
110968581|NCT04062266|Venetoclax|venetoclax|mesh-list
110968582|NCT04062266|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110968583|NCT04062266|Antimetabolites|antimetabolites|mesh-ancestor
110968584|NCT04062266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110968585|NCT04062266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110968586|NCT04062266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110968587|NCT04054635|Fluorides|fluorides|mesh-list
110968588|NCT04054635|Cariostatic Agents|cariostatic agents|mesh-ancestor
110968589|NCT04054635|Protective Agents|protective agents|mesh-ancestor
110968590|NCT04054635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110968591|NCT04034095|Prednisolone|prednisolone|mesh-list
110968592|NCT04034095|Docetaxel|docetaxel|mesh-list
110968593|NCT04034095|Bicalutamide|bicalutamide|mesh-list
110968594|NCT04034095|Androgens|androgens|mesh-list
110968595|NCT04034095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110968596|NCT04034095|Tubulin Modulators|tubulin modulators|mesh-ancestor
110968597|NCT04034095|Antimitotic Agents|antimitotic agents|mesh-ancestor
110968598|NCT04034095|Mitosis Modulators|mitosis modulators|mesh-ancestor
110968599|NCT04034095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110968600|NCT04034095|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110968601|NCT04034095|Glucocorticoids|glucocorticoids|mesh-ancestor
110968602|NCT04034095|Hormones|hormones|mesh-ancestor
110968603|NCT04034095|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110968604|NCT04034095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110968605|NCT04034095|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110968606|NCT04034095|Androgen Antagonists|androgen antagonists|mesh-ancestor
110968607|NCT04034095|Hormone Antagonists|hormone antagonists|mesh-ancestor
110968608|NCT04017247|Oxytocin|oxytocin|mesh-list
110968609|NCT04017247|Oxytocics|oxytocics|mesh-ancestor
110968610|NCT04017247|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110968611|NCT04017247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110968612|NCT04008030|Leucovorin|leucovorin|mesh-list
110680787|NCT03221426|Tubulin Modulators|tubulin modulators|mesh-ancestor
110968638|NCT04008030|Vitamin B Complex|vitamin b complex|mesh-ancestor
110968639|NCT04008030|Vitamins|vitamins|mesh-ancestor
110968640|NCT04008030|Micronutrients|micronutrients|mesh-ancestor
110968641|NCT03953898|Olaparib|olaparib|mesh-list
110968642|NCT03953898|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
110968643|NCT03953898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110968644|NCT03953898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110968645|NCT03953898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110968646|NCT03953235|Nivolumab|nivolumab|mesh-list
110968647|NCT03953235|Ipilimumab|ipilimumab|mesh-list
110968648|NCT03953235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110968649|NCT03953235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110968650|NCT03953235|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110968651|NCT03953235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110968652|NCT03946878|Venetoclax|venetoclax|mesh-list
110968653|NCT03946878|Acalabrutinib|acalabrutinib|mesh-list
110968654|NCT03946878|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
110968655|NCT03946878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110968656|NCT03946878|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110968657|NCT03946878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110968658|NCT03946878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110968685|NCT03901963|Lenalidomide|lenalidomide|mesh-list
110968686|NCT03901963|Daratumumab|daratumumab|mesh-list
110968687|NCT03901963|Immunologic Factors|immunologic factors|mesh-ancestor
110968688|NCT03901963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110968689|NCT03901963|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110968690|NCT03901963|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110968691|NCT03901963|Growth Substances|growth substances|mesh-ancestor
111491142|NCT06019130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111491143|NCT06019130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110968692|NCT03901963|Growth Inhibitors|growth inhibitors|mesh-ancestor
110968693|NCT03901963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110968694|NCT03897998|Naloxone|naloxone|mesh-list
110968695|NCT03897998|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110968696|NCT03897998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110968697|NCT03897998|Sensory System Agents|sensory system agents|mesh-ancestor
110968698|NCT03897998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110968699|NCT03896269|Cytarabine|cytarabine|mesh-list
110968700|NCT03896269|Daunorubicin|daunorubicin|mesh-list
110968701|NCT03896269|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110968702|NCT03896269|Antimetabolites|antimetabolites|mesh-ancestor
110968703|NCT03896269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110968704|NCT03896269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110968705|NCT03896269|Antiviral Agents|antiviral agents|mesh-ancestor
110968706|NCT03896269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110968707|NCT03896269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110968708|NCT03896269|Immunologic Factors|immunologic factors|mesh-ancestor
110968709|NCT03896269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110968710|NCT03896269|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110968711|NCT03896269|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110968712|NCT03896269|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110968713|NCT03896269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110968714|NCT03891706|Interleukin-2|interleukin-2|mesh-list
110968715|NCT03891706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110968716|NCT03891706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110968717|NCT03891706|Analgesics|analgesics|mesh-ancestor
110968718|NCT03891706|Sensory System Agents|sensory system agents|mesh-ancestor
110968719|NCT03891706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110968720|NCT03891706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110968721|NCT03878095|Olaparib|olaparib|mesh-list
110968722|NCT03878095|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
110968723|NCT03878095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110968724|NCT03878095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110968725|NCT03878095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110968726|NCT03876769|Tisagenlecleucel|tisagenlecleucel|mesh-list
110968727|NCT03876769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110968728|NCT03876769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110968729|NCT03860987|Prednisone|prednisone|mesh-list
110968730|NCT03860987|Goserelin|goserelin|mesh-list
110968731|NCT03860987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110968732|NCT03860987|Glucocorticoids|glucocorticoids|mesh-ancestor
110968733|NCT03860987|Hormones|hormones|mesh-ancestor
110968734|NCT03860987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110968735|NCT03860987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110968736|NCT03860987|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110968737|NCT03860987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110968738|NCT03852992|Minoxidil|minoxidil|mesh-list
110968739|NCT03852992|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110968740|NCT03852992|Vasodilator Agents|vasodilator agents|mesh-ancestor
110968741|NCT03847428|Bevacizumab|bevacizumab|mesh-list
110968742|NCT03847428|Durvalumab|durvalumab|mesh-list
110968743|NCT03847428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110968744|NCT03847428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110968745|NCT03847428|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110968746|NCT03847428|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110968747|NCT03847428|Growth Substances|growth substances|mesh-ancestor
110968748|NCT03847428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110968749|NCT03847428|Growth Inhibitors|growth inhibitors|mesh-ancestor
110968750|NCT03842228|Durvalumab|durvalumab|mesh-list
110968751|NCT03842228|Olaparib|olaparib|mesh-list
110968752|NCT03842228|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
110680939|NCT02793466|Immunologic Factors|immunologic factors|mesh-ancestor
110680940|NCT02793466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110680954|NCT02767557|Paclitaxel|paclitaxel|mesh-list
110680955|NCT02767557|Gemcitabine|gemcitabine|mesh-list
110680956|NCT02767557|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110680957|NCT02767557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110680958|NCT02767557|Tubulin Modulators|tubulin modulators|mesh-ancestor
110680959|NCT02767557|Antimitotic Agents|antimitotic agents|mesh-ancestor
110680960|NCT02767557|Mitosis Modulators|mitosis modulators|mesh-ancestor
110680961|NCT02767557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110680962|NCT02767557|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111491144|NCT06019130|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110680963|NCT02767557|Antimetabolites|antimetabolites|mesh-ancestor
110680964|NCT02638090|Pembrolizumab|pembrolizumab|mesh-list
111491145|NCT06019130|Antiviral Agents|antiviral agents|mesh-ancestor
111491146|NCT06019130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111491147|NCT06019130|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111491148|NCT06018948|Dexmedetomidine|dexmedetomidine|mesh-list
111491149|NCT06018948|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111491150|NCT06018948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110968753|NCT03842228|Immunoglobulins|immunoglobulins|mesh-list
110968754|NCT03842228|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110968755|NCT03842228|Immunoglobulin G|immunoglobulin g|mesh-list
110968756|NCT03842228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110968757|NCT03842228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110968758|NCT03842228|Immunologic Factors|immunologic factors|mesh-ancestor
110968759|NCT03842228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110968760|NCT03842228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110968761|NCT03842228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110968762|NCT03833479|Dostarlimab|dostarlimab|mesh-list
110968763|NCT03833479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110968764|NCT03832569|Pembrolizumab|pembrolizumab|mesh-list
110968765|NCT03832569|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110968766|NCT03832569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110968767|NCT03832569|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110968768|NCT03832569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110968769|NCT03831932|Osimertinib|osimertinib|mesh-list
110968770|NCT03831932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110968771|NCT03831932|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110968772|NCT03831932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110968773|NCT03831932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110968774|NCT03820726|Nintedanib|nintedanib|mesh-list
110968775|NCT03820726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110968776|NCT03820726|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110968777|NCT03820726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110968778|NCT03820726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110968779|NCT03774446|Roscovitine|roscovitine|mesh-list
110968780|NCT03774446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110968781|NCT03774446|Antiviral Agents|antiviral agents|mesh-ancestor
110968782|NCT03774446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110968783|NCT03774446|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110968784|NCT03774446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110968785|NCT03774446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110968786|NCT03767244|Androgens|androgens|mesh-list
110968787|NCT03767244|Hormones|hormones|mesh-ancestor
110968788|NCT03767244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110968789|NCT03767244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110968790|NCT03754634|Diacerein|diacerein|mesh-list
110968791|NCT03754634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110968792|NCT03745404|Lidocaine|lidocaine|mesh-list
110968793|NCT03745404|Anesthetics, Local|anesthetics, local|mesh-ancestor
110968794|NCT03745404|Anesthetics|anesthetics|mesh-ancestor
110968795|NCT03745404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110968796|NCT03745404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110968797|NCT03745404|Sensory System Agents|sensory system agents|mesh-ancestor
110968798|NCT03745404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110968799|NCT03745404|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110968800|NCT03745404|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110968801|NCT03745404|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110968802|NCT03745404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110968803|NCT03745404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110968804|NCT03737123|Carboplatin|carboplatin|mesh-list
110968805|NCT03737123|Gemcitabine|gemcitabine|mesh-list
110968806|NCT03737123|Docetaxel|docetaxel|mesh-list
110968807|NCT03737123|Atezolizumab|atezolizumab|mesh-list
110968808|NCT03737123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110968809|NCT03737123|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110968810|NCT03737123|Antimetabolites|antimetabolites|mesh-ancestor
110968811|NCT03737123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110968812|NCT03737123|Tubulin Modulators|tubulin modulators|mesh-ancestor
110968813|NCT03737123|Antimitotic Agents|antimitotic agents|mesh-ancestor
110968814|NCT03737123|Mitosis Modulators|mitosis modulators|mesh-ancestor
110968815|NCT03737123|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110968816|NCT03737123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111491151|NCT06018948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111491152|NCT06018948|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111491153|NCT06018948|Analgesics|analgesics|mesh-ancestor
111491154|NCT06018948|Sensory System Agents|sensory system agents|mesh-ancestor
110968817|NCT03703167|Rituximab|rituximab|mesh-list
111491155|NCT06018948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110968818|NCT03703167|Lenalidomide|lenalidomide|mesh-list
110968819|NCT03703167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110968820|NCT03703167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110968821|NCT03703167|Immunologic Factors|immunologic factors|mesh-ancestor
110968822|NCT03703167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110968823|NCT03703167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110968824|NCT03703167|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110968825|NCT03703167|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110968826|NCT03703167|Growth Substances|growth substances|mesh-ancestor
110681021|NCT02254278|Cisplatin|cisplatin|mesh-list
110968827|NCT03703167|Growth Inhibitors|growth inhibitors|mesh-ancestor
110968828|NCT03672539|Cytarabine|cytarabine|mesh-list
110968829|NCT03672539|Daunorubicin|daunorubicin|mesh-list
110968830|NCT03672539|Gemtuzumab|gemtuzumab|mesh-list
110968831|NCT03672539|Calicheamicins|calicheamicins|mesh-list
110968832|NCT03672539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110968833|NCT03672539|Antimetabolites|antimetabolites|mesh-ancestor
110968834|NCT03672539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110968835|NCT03672539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110968836|NCT03672539|Antiviral Agents|antiviral agents|mesh-ancestor
110968837|NCT03672539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110968838|NCT03672539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110968839|NCT03672539|Immunologic Factors|immunologic factors|mesh-ancestor
110968840|NCT03672539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110968841|NCT03672539|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110968842|NCT03672539|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110968843|NCT03672539|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110968844|NCT03672539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110968845|NCT03672539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110968846|NCT03672539|Immunotoxins|immunotoxins|mesh-ancestor
110968847|NCT03672539|Immunoconjugates|immunoconjugates|mesh-ancestor
110968848|NCT03652064|Dexamethasone|dexamethasone|mesh-list
110968849|NCT03652064|Lenalidomide|lenalidomide|mesh-list
110968850|NCT03652064|Bortezomib|bortezomib|mesh-list
110968851|NCT03652064|Daratumumab|daratumumab|mesh-list
110968852|NCT03652064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110968853|NCT03652064|Antiemetics|antiemetics|mesh-ancestor
110968854|NCT03652064|Autonomic Agents|autonomic agents|mesh-ancestor
110968855|NCT03652064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110968856|NCT03652064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110968857|NCT03652064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110968858|NCT03652064|Glucocorticoids|glucocorticoids|mesh-ancestor
110968859|NCT03652064|Hormones|hormones|mesh-ancestor
110968860|NCT03652064|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110968861|NCT03652064|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110968862|NCT03652064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110968863|NCT03652064|Immunologic Factors|immunologic factors|mesh-ancestor
110968864|NCT03652064|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110968865|NCT03652064|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110968866|NCT03652064|Growth Substances|growth substances|mesh-ancestor
110968867|NCT03652064|Growth Inhibitors|growth inhibitors|mesh-ancestor
110968868|NCT03639714|Nivolumab|nivolumab|mesh-list
110968869|NCT03639714|Ipilimumab|ipilimumab|mesh-list
110968870|NCT03639714|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110968871|NCT03639714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110968872|NCT03639714|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110968873|NCT03639714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110968874|NCT03629171|Cytarabine|cytarabine|mesh-list
110968875|NCT03629171|Daunorubicin|daunorubicin|mesh-list
110968876|NCT03629171|Venetoclax|venetoclax|mesh-list
110968877|NCT03629171|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110968878|NCT03629171|Antimetabolites|antimetabolites|mesh-ancestor
110968879|NCT03629171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110968880|NCT03629171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110968881|NCT03629171|Antiviral Agents|antiviral agents|mesh-ancestor
110968882|NCT03629171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111491156|NCT06018948|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111491157|NCT06018948|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111491158|NCT06018948|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111491159|NCT06018948|Adrenergic Agents|adrenergic agents|mesh-ancestor
110968883|NCT03629171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110968884|NCT03629171|Immunologic Factors|immunologic factors|mesh-ancestor
110968885|NCT03629171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110968886|NCT03629171|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110968887|NCT03629171|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110968888|NCT03629171|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110968889|NCT03629171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110968890|NCT03610490|Cyclophosphamide|cyclophosphamide|mesh-list
110968891|NCT03610490|Fludarabine|fludarabine|mesh-list
110968892|NCT03610490|Interleukin-2|interleukin-2|mesh-list
110968893|NCT03610490|Mitogens|mitogens|mesh-list
110968894|NCT03610490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110968895|NCT03610490|Immunologic Factors|immunologic factors|mesh-ancestor
110968896|NCT03610490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110968897|NCT03610490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110968898|NCT03610490|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110968899|NCT03610490|Alkylating Agents|alkylating agents|mesh-ancestor
110968900|NCT03610490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110968901|NCT03610490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110968902|NCT03610490|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110968903|NCT03610490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110968904|NCT03610490|Analgesics|analgesics|mesh-ancestor
110968905|NCT03610490|Sensory System Agents|sensory system agents|mesh-ancestor
110968906|NCT03610490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110968907|NCT03610490|Mitosis Modulators|mitosis modulators|mesh-ancestor
110968908|NCT03598257|Olaparib|olaparib|mesh-list
110968909|NCT03598257|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
110968910|NCT03598257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110968911|NCT03598257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110968912|NCT03598257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110968913|NCT03596645|Infliximab|infliximab|mesh-list
110968914|NCT03596645|Golimumab|golimumab|mesh-list
110968915|NCT03596645|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110968916|NCT03596645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110968917|NCT03596645|Dermatologic Agents|dermatologic agents|mesh-ancestor
110968918|NCT03596645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110968919|NCT03596645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110968920|NCT03596645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110968921|NCT03596645|Immunologic Factors|immunologic factors|mesh-ancestor
110968922|NCT03596645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110968923|NCT03587844|Brentuximab Vedotin|brentuximab vedotin|mesh-list
110968924|NCT03587844|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110968925|NCT03587844|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110968926|NCT03587844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110968927|NCT03587844|Immunotoxins|immunotoxins|mesh-ancestor
110968928|NCT03587844|Immunoconjugates|immunoconjugates|mesh-ancestor
110968929|NCT03587844|Immunologic Factors|immunologic factors|mesh-ancestor
110968930|NCT03587844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110968931|NCT03573310|JNJ-64619178|jnj-64619178|mesh-list
110968932|NCT03573310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110968933|NCT03573310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110968934|NCT03567876|Venetoclax|venetoclax|mesh-list
110968935|NCT03567876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110968936|NCT03518801|Cannabidiol|cannabidiol|mesh-list
110968937|NCT03518801|Anticonvulsants|anticonvulsants|mesh-ancestor
110968938|NCT03504397|Leucovorin|leucovorin|mesh-list
110968939|NCT03504397|Folic Acid|folic acid|mesh-list
110968940|NCT03504397|Fluorouracil|fluorouracil|mesh-list
110968941|NCT03504397|Oxaliplatin|oxaliplatin|mesh-list
110968942|NCT03504397|Levoleucovorin|levoleucovorin|mesh-list
110968943|NCT03504397|Antimetabolites|antimetabolites|mesh-ancestor
110968944|NCT03504397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110968945|NCT03504397|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110968946|NCT03504397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110968947|NCT03504397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110968948|NCT03504397|Immunologic Factors|immunologic factors|mesh-ancestor
110968949|NCT03504397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110968950|NCT03504397|Antidotes|antidotes|mesh-ancestor
110968951|NCT03504397|Protective Agents|protective agents|mesh-ancestor
110968952|NCT03504397|Vitamin B Complex|vitamin b complex|mesh-ancestor
110968953|NCT03504397|Vitamins|vitamins|mesh-ancestor
110968954|NCT03504397|Micronutrients|micronutrients|mesh-ancestor
110968955|NCT03504397|Hematinics|hematinics|mesh-ancestor
110968956|NCT03480334|Nivolumab|nivolumab|mesh-list
110968957|NCT03480334|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110968958|NCT03480334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110968959|NCT03480334|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111491160|NCT06018948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110968960|NCT03480334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110968961|NCT03467750|Ketorolac|ketorolac|mesh-list
111491161|NCT06018948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110968962|NCT03467750|Morphine|morphine|mesh-list
110968963|NCT03467750|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111491162|NCT06018883|Paclitaxel|paclitaxel|mesh-list
111491163|NCT06018883|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111491164|NCT06018883|Gemcitabine|gemcitabine|mesh-list
110968964|NCT03467750|Narcotics|narcotics|mesh-ancestor
110968965|NCT03467750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110968966|NCT03467750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110968967|NCT03467750|Analgesics|analgesics|mesh-ancestor
110968968|NCT03467750|Sensory System Agents|sensory system agents|mesh-ancestor
110968969|NCT03467750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110968970|NCT03467750|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110968971|NCT03467750|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110968972|NCT03467750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110968973|NCT03467750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110968974|NCT03467750|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110968975|NCT03467750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110968976|NCT03467750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110968977|NCT03466411|Ustekinumab|ustekinumab|mesh-list
110968978|NCT03466411|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110968979|NCT03466411|Dermatologic Agents|dermatologic agents|mesh-ancestor
110968980|NCT03466411|Immunologic Factors|immunologic factors|mesh-ancestor
110968981|NCT03466411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110968982|NCT03462342|Olaparib|olaparib|mesh-list
110968993|NCT03451851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110968994|NCT03451851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110968996|NCT03451851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110968997|NCT03451851|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110968998|NCT03451851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110968999|NCT03451851|Immunologic Factors|immunologic factors|mesh-ancestor
110969011|NCT03432741|Deoxyglucose|deoxyglucose|mesh-list
110969012|NCT03432741|Rituximab|rituximab|mesh-list
110969013|NCT03432741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110969014|NCT03432741|Pembrolizumab|pembrolizumab|mesh-list
110969015|NCT03432741|Nivolumab|nivolumab|mesh-list
110969016|NCT03432741|Trastuzumab|trastuzumab|mesh-list
110969017|NCT03432741|Obinutuzumab|obinutuzumab|mesh-list
110969018|NCT03432741|Gemcitabine|gemcitabine|mesh-list
110969019|NCT03432741|Daratumumab|daratumumab|mesh-list
110969020|NCT03432741|Romidepsin|romidepsin|mesh-list
110969021|NCT03432741|Belinostat|belinostat|mesh-list
110969022|NCT03432741|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
110969023|NCT03432741|Antibodies|antibodies|mesh-list
110969024|NCT03432741|Immunoglobulins|immunoglobulins|mesh-list
110969025|NCT03432741|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110969026|NCT03432741|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110969027|NCT03432741|Immunologic Factors|immunologic factors|mesh-ancestor
110969028|NCT03432741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110969029|NCT03432741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110969030|NCT03432741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110969031|NCT03432741|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110969032|NCT03432741|Antimetabolites|antimetabolites|mesh-ancestor
110969033|NCT03432741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110969034|NCT03432741|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110969035|NCT03432741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110969036|NCT03432741|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110969037|NCT03432741|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110969038|NCT03432741|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110969039|NCT03432741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110969040|NCT03432741|Antiviral Agents|antiviral agents|mesh-ancestor
110969041|NCT03425006|Pembrolizumab|pembrolizumab|mesh-list
110969042|NCT03425006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110969043|NCT03425006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110969044|NCT03425006|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110969045|NCT03425006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110969046|NCT03401073|Immunoglobulins|immunoglobulins|mesh-list
110969047|NCT03401073|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110969048|NCT03401073|Antibodies|antibodies|mesh-list
110969049|NCT03401073|gamma-Globulins|gamma-globulins|mesh-list
110969050|NCT03401073|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110969051|NCT03401073|Immunologic Factors|immunologic factors|mesh-ancestor
110969052|NCT03401073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110969053|NCT03390504|Docetaxel|docetaxel|mesh-list
110969054|NCT03390504|Pembrolizumab|pembrolizumab|mesh-list
110969055|NCT03390504|Mitogens|mitogens|mesh-list
111491165|NCT06018883|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110969056|NCT03390504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110681247|NCT00440271|Ritonavir|ritonavir|mesh-list
110969057|NCT03390504|Tubulin Modulators|tubulin modulators|mesh-ancestor
110969058|NCT03390504|Antimitotic Agents|antimitotic agents|mesh-ancestor
110969059|NCT03390504|Mitosis Modulators|mitosis modulators|mesh-ancestor
110969065|NCT03384641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110969066|NCT03384641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110969072|NCT03374800|Pantoprazole|pantoprazole|mesh-list
110969073|NCT03374800|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110969074|NCT03374800|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110969075|NCT03374800|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110969076|NCT03374800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110969077|NCT03374800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110969078|NCT03317392|Olaparib|olaparib|mesh-list
110969079|NCT03317392|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
110969080|NCT03317392|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
110969081|NCT03317392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110969082|NCT03317392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110969083|NCT03317392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110969084|NCT03315910|Nicotine|nicotine|mesh-list
110969085|NCT03315910|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110969086|NCT03315910|Autonomic Agents|autonomic agents|mesh-ancestor
110969087|NCT03315910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110969088|NCT03315910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110969089|NCT03315910|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110969090|NCT03315910|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110969091|NCT03315910|Cholinergic Agents|cholinergic agents|mesh-ancestor
110969092|NCT03315910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110969093|NCT03315910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110969094|NCT03301220|Daratumumab|daratumumab|mesh-list
110969095|NCT03301220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110969096|NCT03299049|Rilpivirine|rilpivirine|mesh-list
110969097|NCT03299049|Cabotegravir|cabotegravir|mesh-list
110969098|NCT03299049|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110969099|NCT03299049|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110969100|NCT03299049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110969101|NCT03299049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110969102|NCT03299049|Antiviral Agents|antiviral agents|mesh-ancestor
110969103|NCT03299049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110969104|NCT03299049|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110969105|NCT03299049|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110969106|NCT03299049|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110969107|NCT03299049|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110969108|NCT03253679|Adavosertib|adavosertib|mesh-list
110969109|NCT03253679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110969110|NCT03253679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110969111|NCT03234972|Dexamethasone|dexamethasone|mesh-list
110969112|NCT03234972|Bortezomib|bortezomib|mesh-list
110969113|NCT03234972|Daratumumab|daratumumab|mesh-list
110969114|NCT03234972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110969115|NCT03234972|Antiemetics|antiemetics|mesh-ancestor
110969116|NCT03234972|Autonomic Agents|autonomic agents|mesh-ancestor
110969117|NCT03234972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110969118|NCT03234972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110969119|NCT03234972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110969120|NCT03234972|Glucocorticoids|glucocorticoids|mesh-ancestor
110969121|NCT03234972|Hormones|hormones|mesh-ancestor
110969122|NCT03234972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110969123|NCT03234972|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110969124|NCT03234972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110969125|NCT03227419|Abatacept|abatacept|mesh-list
110969126|NCT03227419|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110969127|NCT03227419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110969128|NCT03227419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110969129|NCT03227419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110969130|NCT03227419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110969131|NCT03227419|Immunologic Factors|immunologic factors|mesh-ancestor
110969132|NCT03227419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110676893|NCT03348969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110969134|NCT03220022|Prednisone|prednisone|mesh-list
110969135|NCT03220022|Cortisone|cortisone|mesh-list
110969136|NCT03220022|Cyclophosphamide|cyclophosphamide|mesh-list
110969137|NCT03220022|Rituximab|rituximab|mesh-list
110969138|NCT03220022|Doxorubicin|doxorubicin|mesh-list
110969139|NCT03220022|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111491166|NCT06018883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111491167|NCT06018883|Tubulin Modulators|tubulin modulators|mesh-ancestor
111491168|NCT06018883|Antimitotic Agents|antimitotic agents|mesh-ancestor
110969140|NCT03220022|Etoposide|etoposide|mesh-list
110969141|NCT03220022|Vincristine|vincristine|mesh-list
110969142|NCT03220022|Etoposide phosphate|etoposide phosphate|mesh-list
110969143|NCT03220022|Podophyllotoxin|podophyllotoxin|mesh-list
110969144|NCT03220022|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110969146|NCT03220022|Immunoglobulins|immunoglobulins|mesh-list
110969147|NCT03220022|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110969148|NCT03220022|Lenograstim|lenograstim|mesh-list
110969149|NCT03220022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110969150|NCT03220022|Immunologic Factors|immunologic factors|mesh-ancestor
110969151|NCT03220022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110969152|NCT03220022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110969153|NCT03220022|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110969154|NCT03220022|Alkylating Agents|alkylating agents|mesh-ancestor
110969155|NCT03220022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110969156|NCT03220022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110969157|NCT03220022|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110969158|NCT03220022|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110969159|NCT03220022|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110969160|NCT03220022|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110969161|NCT03220022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110969162|NCT03220022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110969163|NCT03220022|Glucocorticoids|glucocorticoids|mesh-ancestor
110969164|NCT03220022|Hormones|hormones|mesh-ancestor
110969165|NCT03220022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110969166|NCT03220022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110969167|NCT03220022|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110969168|NCT03220022|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110969169|NCT03220022|Tubulin Modulators|tubulin modulators|mesh-ancestor
110969170|NCT03220022|Antimitotic Agents|antimitotic agents|mesh-ancestor
110969171|NCT03220022|Mitosis Modulators|mitosis modulators|mesh-ancestor
110969172|NCT03220022|Keratolytic Agents|keratolytic agents|mesh-ancestor
110969173|NCT03220022|Dermatologic Agents|dermatologic agents|mesh-ancestor
110969174|NCT03218488|Ustekinumab|ustekinumab|mesh-list
110969175|NCT03218488|Dermatologic Agents|dermatologic agents|mesh-ancestor
110969176|NCT03217812|Prednisone|prednisone|mesh-list
110969177|NCT03217812|Bortezomib|bortezomib|mesh-list
110969178|NCT03217812|Melphalan|melphalan|mesh-list
110969179|NCT03217812|Daratumumab|daratumumab|mesh-list
110969180|NCT03217812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110969181|NCT03217812|Glucocorticoids|glucocorticoids|mesh-ancestor
110969182|NCT03217812|Hormones|hormones|mesh-ancestor
110969183|NCT03217812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110969184|NCT03217812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110969185|NCT03217812|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110969186|NCT03217812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110969187|NCT03217812|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110969188|NCT03217812|Alkylating Agents|alkylating agents|mesh-ancestor
110969189|NCT03217812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110969190|NCT03217812|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110969191|NCT03217812|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110969192|NCT03217812|Immunologic Factors|immunologic factors|mesh-ancestor
110969193|NCT03212742|Temozolomide|temozolomide|mesh-list
110969194|NCT03212742|Olaparib|olaparib|mesh-list
110969195|NCT03212742|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110969196|NCT03212742|Alkylating Agents|alkylating agents|mesh-ancestor
110969197|NCT03212742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110969198|NCT03212742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110969199|NCT03212742|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110969200|NCT03212742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110969201|NCT03173560|Everolimus|everolimus|mesh-list
110969202|NCT03173560|Lenvatinib|lenvatinib|mesh-list
110969203|NCT03173560|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110969204|NCT03173560|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110969205|NCT03173560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110969206|NCT03173560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110676894|NCT03348969|Alkylating Agents|alkylating agents|mesh-ancestor
110969207|NCT03173560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110969208|NCT03173560|Immunologic Factors|immunologic factors|mesh-ancestor
110969209|NCT03173560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110969210|NCT03173560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110969211|NCT03170518|Canagliflozin|canagliflozin|mesh-list
110969212|NCT03170518|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110969213|NCT03170518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111491169|NCT06018883|Mitosis Modulators|mitosis modulators|mesh-ancestor
111491170|NCT06018883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110969214|NCT03170518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110969215|NCT03170518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110969216|NCT03127774|Sodium thiosulfate|sodium thiosulfate|mesh-list
110969217|NCT03127774|Antidotes|antidotes|mesh-ancestor
111491171|NCT06018883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111491172|NCT06018883|Antimetabolites|antimetabolites|mesh-ancestor
111491173|NCT06018805|Anesthetics|anesthetics|mesh-list
111491174|NCT06018805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111491175|NCT06018805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111491176|NCT06018766|Sirolimus|sirolimus|mesh-list
111491177|NCT06018766|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111491178|NCT06018766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111491179|NCT06018766|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111491180|NCT06018766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111491181|NCT06018766|Antifungal Agents|antifungal agents|mesh-ancestor
111491182|NCT06018766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111491183|NCT06018766|Immunologic Factors|immunologic factors|mesh-ancestor
111491184|NCT06018766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111491185|NCT06018727|Hydrocortisone|hydrocortisone|mesh-list
111491186|NCT06018727|Yohimbine|yohimbine|mesh-list
111491187|NCT06018727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111491188|NCT06018727|Mydriatics|mydriatics|mesh-ancestor
111491189|NCT06018727|Autonomic Agents|autonomic agents|mesh-ancestor
111491190|NCT06018727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111491191|NCT06018727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111491192|NCT06018727|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
111491193|NCT06018727|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111491194|NCT06018727|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110969218|NCT03127774|Protective Agents|protective agents|mesh-ancestor
110969219|NCT03127774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110969220|NCT03127774|Antioxidants|antioxidants|mesh-ancestor
110969221|NCT03127774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110969222|NCT03127774|Antitubercular Agents|antitubercular agents|mesh-ancestor
110969223|NCT03127774|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110969224|NCT03127774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110969225|NCT03127774|Chelating Agents|chelating agents|mesh-ancestor
110969226|NCT03127774|Sequestering Agents|sequestering agents|mesh-ancestor
110969227|NCT03116529|Immunomodulating Agents|immunomodulating agents|mesh-list
110969228|NCT03116529|Immunologic Factors|immunologic factors|mesh-ancestor
110969229|NCT03116529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110969230|NCT03074513|Bevacizumab|bevacizumab|mesh-list
110969231|NCT03074513|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110969232|NCT03074513|Atezolizumab|atezolizumab|mesh-list
110969233|NCT03074513|Endothelial Growth Factors|endothelial growth factors|mesh-list
110969234|NCT03074513|Antibodies|antibodies|mesh-list
110969235|NCT03074513|Immunoglobulins|immunoglobulins|mesh-list
110969236|NCT03074513|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110969237|NCT03074513|Immunoglobulin G|immunoglobulin g|mesh-list
110969238|NCT03074513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110969239|NCT03074513|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110969240|NCT03074513|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110969241|NCT03074513|Growth Substances|growth substances|mesh-ancestor
110969242|NCT03074513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110969243|NCT03074513|Growth Inhibitors|growth inhibitors|mesh-ancestor
110969244|NCT03074513|Immunologic Factors|immunologic factors|mesh-ancestor
110969245|NCT03074513|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110969246|NCT03074513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110969247|NCT03023124|Doxorubicin|doxorubicin|mesh-list
110969248|NCT03023124|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110969249|NCT03023124|Dacarbazine|dacarbazine|mesh-list
110969250|NCT03023124|Trabectedin|trabectedin|mesh-list
110969251|NCT03023124|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111491195|NCT06018727|Adrenergic Agents|adrenergic agents|mesh-ancestor
111491196|NCT06018727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111491197|NCT06018727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111491198|NCT06018727|Urological Agents|urological agents|mesh-ancestor
111491199|NCT06018675|Lidocaine|lidocaine|mesh-list
111491200|NCT06018675|Anesthetics, Local|anesthetics, local|mesh-ancestor
111491201|NCT06018675|Anesthetics|anesthetics|mesh-ancestor
110969252|NCT03023124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110969253|NCT03023124|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110969254|NCT03023124|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110969255|NCT03023124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110969256|NCT03023124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110699273|NCT00422942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111491202|NCT06018675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111491203|NCT06018675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110969257|NCT03023124|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110969258|NCT03023124|Alkylating Agents|alkylating agents|mesh-ancestor
111491204|NCT06018675|Sensory System Agents|sensory system agents|mesh-ancestor
111491205|NCT06018675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111491206|NCT06018675|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110969259|NCT03004833|Nivolumab|nivolumab|mesh-list
110969260|NCT03004833|Doxorubicin|doxorubicin|mesh-list
110969261|NCT03004833|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110969262|NCT03004833|Dacarbazine|dacarbazine|mesh-list
110969263|NCT03004833|Vinblastine|vinblastine|mesh-list
110969264|NCT03004833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110969265|NCT03004833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110969266|NCT03004833|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110969267|NCT03004833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110969268|NCT03004833|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110969269|NCT03004833|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110969270|NCT03004833|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110969271|NCT03004833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110969272|NCT03004833|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110969273|NCT03004833|Alkylating Agents|alkylating agents|mesh-ancestor
110969274|NCT03004833|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110969275|NCT03004833|Tubulin Modulators|tubulin modulators|mesh-ancestor
110969276|NCT03004833|Antimitotic Agents|antimitotic agents|mesh-ancestor
110969277|NCT03004833|Mitosis Modulators|mitosis modulators|mesh-ancestor
110969278|NCT02972840|Rituximab|rituximab|mesh-list
110969279|NCT02972840|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110681468|NCT01057264|Growth Substances|growth substances|mesh-ancestor
110969280|NCT02972840|Acalabrutinib|acalabrutinib|mesh-list
110969281|NCT02972840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110969282|NCT02972840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110969283|NCT02972840|Immunologic Factors|immunologic factors|mesh-ancestor
110969284|NCT02972840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110969285|NCT02972840|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110969286|NCT02972840|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110969287|NCT02972840|Alkylating Agents|alkylating agents|mesh-ancestor
110969288|NCT02972840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110969290|NCT02915263|Immunologic Factors|immunologic factors|mesh-ancestor
110969291|NCT02915263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110969292|NCT02893917|Olaparib|olaparib|mesh-list
110969293|NCT02893917|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
110969294|NCT02893917|Cediranib|cediranib|mesh-list
110969295|NCT02893917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110969296|NCT02893917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110969297|NCT02893917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110969298|NCT02893917|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110969299|NCT02879695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110969300|NCT02879695|Nivolumab|nivolumab|mesh-list
110969301|NCT02879695|Ipilimumab|ipilimumab|mesh-list
110969302|NCT02879695|Blinatumomab|blinatumomab|mesh-list
110969303|NCT02879695|Antibodies|antibodies|mesh-list
110969304|NCT02879695|Immunoglobulins|immunoglobulins|mesh-list
110969305|NCT02879695|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110969306|NCT02879695|Muromonab-CD3|muromonab-cd3|mesh-list
110969307|NCT02879695|Antibodies, Bispecific|antibodies, bispecific|mesh-list
110969308|NCT02879695|Immunologic Factors|immunologic factors|mesh-ancestor
110969309|NCT02879695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110969310|NCT02879695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110969311|NCT02879695|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110969312|NCT02879695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110969313|NCT02879695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110969314|NCT02825160|Iloprost|iloprost|mesh-list
110969315|NCT02825160|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110969316|NCT02825160|Vasodilator Agents|vasodilator agents|mesh-ancestor
110969317|NCT02730923|Anastrozole|anastrozole|mesh-list
110969318|NCT02730923|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110969319|NCT02730923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110969320|NCT02730923|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110969321|NCT02730923|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110969322|NCT02730923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110969323|NCT02730923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111491207|NCT06018675|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111491208|NCT06018675|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110969324|NCT02730923|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110969325|NCT02730923|Hormone Antagonists|hormone antagonists|mesh-ancestor
111119101|NCT05362318|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110969326|NCT02730923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110969328|NCT02631447|Nivolumab|nivolumab|mesh-list
110969329|NCT02631447|Ipilimumab|ipilimumab|mesh-list
110969330|NCT02631447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110969331|NCT02631447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110969332|NCT02631447|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110969333|NCT02631447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110969334|NCT02627443|Carboplatin|carboplatin|mesh-list
110969335|NCT02627443|Gemcitabine|gemcitabine|mesh-list
110969336|NCT02627443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110969337|NCT02627443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110969338|NCT02627443|Antimetabolites|antimetabolites|mesh-ancestor
110969339|NCT02627443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110969340|NCT02625961|Pembrolizumab|pembrolizumab|mesh-list
110969341|NCT02625961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110969342|NCT02625961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110969343|NCT02625961|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110969344|NCT02625961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110969345|NCT02609776|Carboplatin|carboplatin|mesh-list
110969346|NCT02609776|Pemetrexed|pemetrexed|mesh-list
110969347|NCT02609776|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
110969348|NCT02609776|Lazertinib|lazertinib|mesh-list
110969349|NCT02609776|Antibodies, Bispecific|antibodies, bispecific|mesh-list
110969350|NCT02609776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110969351|NCT02609776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110969352|NCT02609776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110969353|NCT02609776|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110969354|NCT02609776|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110969355|NCT02609776|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110969356|NCT02609776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110681545|NCT03742258|Hormones|hormones|mesh-ancestor
110969357|NCT02609776|Immunologic Factors|immunologic factors|mesh-ancestor
110969358|NCT02609776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110969359|NCT02595944|Nivolumab|nivolumab|mesh-list
110969360|NCT02595944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110969361|NCT02595944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110969362|NCT02595944|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110969363|NCT02595944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110969364|NCT02542852|Ritonavir|ritonavir|mesh-list
110969365|NCT02542852|Atazanavir Sulfate|atazanavir sulfate|mesh-list
110969366|NCT02542852|Dolutegravir|dolutegravir|mesh-list
110969367|NCT02542852|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110969368|NCT02542852|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110969369|NCT02542852|Protease Inhibitors|protease inhibitors|mesh-ancestor
110969370|NCT02542852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110969371|NCT02542852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110969372|NCT02542852|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110969373|NCT02542852|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110969374|NCT02542852|Antiviral Agents|antiviral agents|mesh-ancestor
110969375|NCT02542852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110969376|NCT02542852|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110969377|NCT02542852|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110969378|NCT02542852|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110969379|NCT02542852|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110969380|NCT02531516|Bicalutamide|bicalutamide|mesh-list
110969381|NCT02531516|Androgen Antagonists|androgen antagonists|mesh-ancestor
110969382|NCT02531516|Hormone Antagonists|hormone antagonists|mesh-ancestor
110969383|NCT02531516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110969384|NCT02531516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110969385|NCT02531516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110969386|NCT02520778|Osimertinib|osimertinib|mesh-list
110969387|NCT02520778|Navitoclax|navitoclax|mesh-list
110969388|NCT02520778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110969389|NCT02520778|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110969390|NCT02520778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110969391|NCT02520778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110969392|NCT02463266|Sulfamethazine|sulfamethazine|mesh-list
110969393|NCT02463266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110969394|NCT02424656|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110969395|NCT02424656|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111491209|NCT06018675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111119102|NCT05362318|Autonomic Agents|autonomic agents|mesh-ancestor
110969396|NCT02424656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110969397|NCT02390869|Rituximab|rituximab|mesh-list
110969398|NCT02390869|Lenalidomide|lenalidomide|mesh-list
110969399|NCT02390869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110969400|NCT02390869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110969401|NCT02390869|Immunologic Factors|immunologic factors|mesh-ancestor
110969402|NCT02390869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110969403|NCT02390869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110969404|NCT02390869|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110969405|NCT02390869|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110969406|NCT02390869|Growth Substances|growth substances|mesh-ancestor
110969407|NCT02390869|Growth Inhibitors|growth inhibitors|mesh-ancestor
110969408|NCT02354014|Bedaquiline|bedaquiline|mesh-list
110969409|NCT02354014|Diarylquinolines|diarylquinolines|mesh-list
110969410|NCT02354014|Antitubercular Agents|antitubercular agents|mesh-ancestor
110969411|NCT02354014|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110969412|NCT02354014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110969413|NCT02343952|Pembrolizumab|pembrolizumab|mesh-list
110969414|NCT02343952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110969415|NCT02343952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110969416|NCT02343952|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110969417|NCT02343952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110969418|NCT02316106|Daratumumab|daratumumab|mesh-list
110969419|NCT02316106|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110969420|NCT02316106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110969421|NCT02316106|Immunologic Factors|immunologic factors|mesh-ancestor
110969422|NCT02316106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110969423|NCT02275533|Nivolumab|nivolumab|mesh-list
110969424|NCT02275533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110969425|NCT02275533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110969426|NCT02275533|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110969427|NCT02275533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110969428|NCT02255799|Donepezil|donepezil|mesh-list
110969429|NCT02255799|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110969430|NCT02255799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110681621|NCT00353704|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110969431|NCT02255799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110969432|NCT02255799|Cholinergic Agents|cholinergic agents|mesh-ancestor
110969433|NCT02255799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110969434|NCT02255799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110969435|NCT02255799|Nootropic Agents|nootropic agents|mesh-ancestor
110969436|NCT02250937|Fludarabine|fludarabine|mesh-list
110969437|NCT02250937|Fludarabine phosphate|fludarabine phosphate|mesh-list
110969438|NCT02250937|Busulfan|busulfan|mesh-list
110969439|NCT02250937|Venetoclax|venetoclax|mesh-list
110969440|NCT02250937|Cladribine|cladribine|mesh-list
110969441|NCT02250937|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
110969442|NCT02250937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110969443|NCT02250937|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110969444|NCT02250937|Antimetabolites|antimetabolites|mesh-ancestor
110969445|NCT02250937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110969446|NCT02250937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110969447|NCT02250937|Immunologic Factors|immunologic factors|mesh-ancestor
110969448|NCT02250937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110969449|NCT02250937|Alkylating Agents|alkylating agents|mesh-ancestor
110969450|NCT02250937|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110969451|NCT02250937|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110969452|NCT02223208|Prednisone|prednisone|mesh-list
110969453|NCT02223208|Cyclophosphamide|cyclophosphamide|mesh-list
110969454|NCT02223208|Doxorubicin|doxorubicin|mesh-list
110969455|NCT02223208|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110969456|NCT02223208|Etoposide|etoposide|mesh-list
110969457|NCT02223208|Etoposide phosphate|etoposide phosphate|mesh-list
110969458|NCT02223208|Romidepsin|romidepsin|mesh-list
110969459|NCT02223208|Vincristine|vincristine|mesh-list
110969460|NCT02223208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110969461|NCT02223208|Immunologic Factors|immunologic factors|mesh-ancestor
110969462|NCT02223208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110969463|NCT02223208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110969464|NCT02223208|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110969465|NCT02223208|Alkylating Agents|alkylating agents|mesh-ancestor
110969466|NCT02223208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110969467|NCT02223208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110969468|NCT02223208|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110969469|NCT02223208|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111491210|NCT06018675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111491211|NCT06014944|Antibodies|antibodies|mesh-list
110969470|NCT02223208|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110969471|NCT02223208|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110969472|NCT02223208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110969473|NCT02223208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110969474|NCT02223208|Glucocorticoids|glucocorticoids|mesh-ancestor
110969475|NCT02223208|Hormones|hormones|mesh-ancestor
110969476|NCT02223208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110969477|NCT02223208|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110969478|NCT02223208|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110969479|NCT02223208|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110969480|NCT02223208|Tubulin Modulators|tubulin modulators|mesh-ancestor
110969481|NCT02223208|Antimitotic Agents|antimitotic agents|mesh-ancestor
110969482|NCT02223208|Mitosis Modulators|mitosis modulators|mesh-ancestor
110969483|NCT02188264|Cyclosporine|cyclosporine|mesh-list
110969484|NCT02188264|Cyclosporins|cyclosporins|mesh-list
110969485|NCT02188264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110969486|NCT02188264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110969487|NCT02188264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110969488|NCT02188264|Immunologic Factors|immunologic factors|mesh-ancestor
110969489|NCT02188264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110969490|NCT02188264|Antifungal Agents|antifungal agents|mesh-ancestor
110969491|NCT02188264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110969492|NCT02188264|Dermatologic Agents|dermatologic agents|mesh-ancestor
110969493|NCT02188264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110969494|NCT02188264|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110969495|NCT02160015|Rituximab|rituximab|mesh-list
110969496|NCT02160015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110969497|NCT02160015|Lenalidomide|lenalidomide|mesh-list
110969498|NCT02160015|Antibodies|antibodies|mesh-list
110969499|NCT02160015|Immunoglobulins|immunoglobulins|mesh-list
110969500|NCT02160015|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110969501|NCT02160015|Immunologic Factors|immunologic factors|mesh-ancestor
110969502|NCT02160015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110969503|NCT02160015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110969504|NCT02160015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110969505|NCT02160015|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110969506|NCT02160015|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110969507|NCT02160015|Growth Substances|growth substances|mesh-ancestor
110969508|NCT02160015|Growth Inhibitors|growth inhibitors|mesh-ancestor
110969510|NCT02123758|Abiraterone Acetate|abiraterone acetate|mesh-list
110969511|NCT02123758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110969512|NCT02123758|Glucocorticoids|glucocorticoids|mesh-ancestor
110969513|NCT02123758|Hormones|hormones|mesh-ancestor
110969514|NCT02123758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110969515|NCT02123758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110969516|NCT02123758|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110969517|NCT02123758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110969518|NCT02123758|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110969519|NCT02123758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110969520|NCT02123758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110969521|NCT02123758|Hormone Antagonists|hormone antagonists|mesh-ancestor
110969522|NCT02123758|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110969523|NCT02101944|Dexamethasone|dexamethasone|mesh-list
110969524|NCT02101944|Dexamethasone acetate|dexamethasone acetate|mesh-list
110969525|NCT02101944|Ichthammol|ichthammol|mesh-list
110969526|NCT02101944|BB 1101|bb 1101|mesh-list
110969527|NCT02101944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110969528|NCT02101944|Antiemetics|antiemetics|mesh-ancestor
110969529|NCT02101944|Autonomic Agents|autonomic agents|mesh-ancestor
110969530|NCT02101944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110969531|NCT02101944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110969532|NCT02101944|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110969533|NCT02101944|Glucocorticoids|glucocorticoids|mesh-ancestor
110969534|NCT02101944|Hormones|hormones|mesh-ancestor
110969535|NCT02101944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110969536|NCT02101944|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110969537|NCT02101944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110969538|NCT02101944|Protease Inhibitors|protease inhibitors|mesh-ancestor
110969539|NCT02101944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110969540|NCT02101944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110969541|NCT02101944|Dermatologic Agents|dermatologic agents|mesh-ancestor
110969542|NCT02015117|Trametinib|trametinib|mesh-list
111491212|NCT06014944|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111491213|NCT06014944|Immunologic Factors|immunologic factors|mesh-ancestor
110969543|NCT02015117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110969544|NCT02015117|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111491214|NCT06014944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110969545|NCT02015117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110969546|NCT02015117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110969547|NCT01998971|Acetaminophen|acetaminophen|mesh-list
110969548|NCT01998971|Diphenhydramine|diphenhydramine|mesh-list
110969549|NCT01998971|Promethazine|promethazine|mesh-list
110969550|NCT01998971|Thalidomide|thalidomide|mesh-list
110969551|NCT01998971|Dexamethasone|dexamethasone|mesh-list
110969553|NCT01998971|Lenalidomide|lenalidomide|mesh-list
110969554|NCT01998971|Melphalan|melphalan|mesh-list
110969555|NCT01998971|Bortezomib|bortezomib|mesh-list
110969556|NCT01998971|Daratumumab|daratumumab|mesh-list
110969557|NCT01998971|Pomalidomide|pomalidomide|mesh-list
110969558|NCT01998971|Montelukast|montelukast|mesh-list
110969559|NCT01998971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110969560|NCT01998971|Antiemetics|antiemetics|mesh-ancestor
110969561|NCT01998971|Autonomic Agents|autonomic agents|mesh-ancestor
110969562|NCT01998971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110969563|NCT01998971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110969564|NCT01998971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110969565|NCT01998971|Glucocorticoids|glucocorticoids|mesh-ancestor
110969566|NCT01998971|Hormones|hormones|mesh-ancestor
110969567|NCT01998971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110969568|NCT01998971|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110969569|NCT01998971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110969570|NCT01998971|Immunologic Factors|immunologic factors|mesh-ancestor
110969571|NCT01998971|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110969572|NCT01998971|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110969573|NCT01998971|Growth Substances|growth substances|mesh-ancestor
110969574|NCT01998971|Growth Inhibitors|growth inhibitors|mesh-ancestor
110969575|NCT01998971|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110969576|NCT01998971|Analgesics|analgesics|mesh-ancestor
110969577|NCT01998971|Sensory System Agents|sensory system agents|mesh-ancestor
110969578|NCT01998971|Antipyretics|antipyretics|mesh-ancestor
110969579|NCT01998971|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110681765|NCT00345046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110969580|NCT01998971|Alkylating Agents|alkylating agents|mesh-ancestor
110969581|NCT01998971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110969582|NCT01998971|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110969583|NCT01998971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110969584|NCT01998971|Leprostatic Agents|leprostatic agents|mesh-ancestor
110969585|NCT01998971|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110969586|NCT01998971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110969587|NCT01998971|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110969588|NCT01998971|Respiratory System Agents|respiratory system agents|mesh-ancestor
110969589|NCT01998971|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110969590|NCT01998971|Hormone Antagonists|hormone antagonists|mesh-ancestor
110969591|NCT01998971|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110969592|NCT01998971|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110969593|NCT01998971|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110969594|NCT01998971|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110969595|NCT01998971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110969596|NCT01998971|Anesthetics, Local|anesthetics, local|mesh-ancestor
110969597|NCT01998971|Anesthetics|anesthetics|mesh-ancestor
110969598|NCT01998971|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110969599|NCT01998971|Histamine Antagonists|histamine antagonists|mesh-ancestor
110969600|NCT01998971|Histamine Agents|histamine agents|mesh-ancestor
110969601|NCT01998971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110969602|NCT01998971|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110969603|NCT01998971|Antipruritics|antipruritics|mesh-ancestor
110969604|NCT01998971|Dermatologic Agents|dermatologic agents|mesh-ancestor
110969605|NCT01950390|Bevacizumab|bevacizumab|mesh-list
110969606|NCT01950390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110969607|NCT01950390|Ipilimumab|ipilimumab|mesh-list
110969608|NCT01950390|Endothelial Growth Factors|endothelial growth factors|mesh-list
110969609|NCT01950390|Antibodies|antibodies|mesh-list
110969610|NCT01950390|Immunoglobulins|immunoglobulins|mesh-list
110969611|NCT01950390|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110969612|NCT01950390|Immunoglobulin G|immunoglobulin g|mesh-list
111491215|NCT06014359|Dexmedetomidine|dexmedetomidine|mesh-list
110969613|NCT01950390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110969614|NCT01950390|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110969615|NCT01950390|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110969616|NCT01950390|Growth Substances|growth substances|mesh-ancestor
110969617|NCT01950390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110969618|NCT01950390|Growth Inhibitors|growth inhibitors|mesh-ancestor
110969619|NCT01950390|Immunologic Factors|immunologic factors|mesh-ancestor
111491216|NCT06014359|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110969620|NCT01950390|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110969621|NCT01950390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110969622|NCT01849146|Temozolomide|temozolomide|mesh-list
110969623|NCT01849146|Adavosertib|adavosertib|mesh-list
110969624|NCT01849146|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110969625|NCT01849146|Alkylating Agents|alkylating agents|mesh-ancestor
110969626|NCT01849146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110969627|NCT01849146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110969628|NCT01849146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110969629|NCT01829568|Rituximab|rituximab|mesh-list
110969630|NCT01829568|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110969631|NCT01829568|Lenalidomide|lenalidomide|mesh-list
110969632|NCT01829568|Antibodies|antibodies|mesh-list
110969633|NCT01829568|Immunoglobulins|immunoglobulins|mesh-list
110969634|NCT01829568|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110969635|NCT01829568|Immunologic Factors|immunologic factors|mesh-ancestor
110969636|NCT01829568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110969637|NCT01829568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110969638|NCT01829568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110969639|NCT01829568|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110969640|NCT01829568|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110969641|NCT01829568|Growth Substances|growth substances|mesh-ancestor
110969642|NCT01829568|Growth Inhibitors|growth inhibitors|mesh-ancestor
110969643|NCT01792687|Prednisone|prednisone|mesh-list
110969644|NCT01792687|Abiraterone Acetate|abiraterone acetate|mesh-list
110969645|NCT01792687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110969646|NCT01792687|Glucocorticoids|glucocorticoids|mesh-ancestor
110969647|NCT01792687|Hormones|hormones|mesh-ancestor
110969648|NCT01792687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110969649|NCT01792687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110969650|NCT01792687|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110969651|NCT01792687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110969652|NCT01792687|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110969653|NCT01792687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110969654|NCT01792687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110969655|NCT01792687|Hormone Antagonists|hormone antagonists|mesh-ancestor
110969656|NCT01792687|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110969657|NCT01710176|Gemcitabine|gemcitabine|mesh-list
110969658|NCT01710176|Docetaxel|docetaxel|mesh-list
110969659|NCT01710176|Etoposide|etoposide|mesh-list
110969660|NCT01710176|Epirubicin|epirubicin|mesh-list
110969661|NCT01710176|Ifosfamide|ifosfamide|mesh-list
110969662|NCT01710176|Isophosphamide mustard|isophosphamide mustard|mesh-list
110969663|NCT01710176|Dacarbazine|dacarbazine|mesh-list
110969664|NCT01710176|Trabectedin|trabectedin|mesh-list
110969665|NCT01710176|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110969666|NCT01710176|Antimetabolites|antimetabolites|mesh-ancestor
110969667|NCT01710176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110969668|NCT01710176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110969669|NCT01710176|Tubulin Modulators|tubulin modulators|mesh-ancestor
110969670|NCT01710176|Antimitotic Agents|antimitotic agents|mesh-ancestor
110969671|NCT01710176|Mitosis Modulators|mitosis modulators|mesh-ancestor
110969672|NCT01710176|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110969673|NCT01710176|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110969674|NCT01710176|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110969675|NCT01710176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110969676|NCT01710176|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110969677|NCT01710176|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110969678|NCT01710176|Alkylating Agents|alkylating agents|mesh-ancestor
110969679|NCT01695941|Rituximab|rituximab|mesh-list
110969680|NCT01695941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110969681|NCT01695941|Bortezomib|bortezomib|mesh-list
110969682|NCT01695941|Antibodies|antibodies|mesh-list
110969683|NCT01695941|Immunoglobulins|immunoglobulins|mesh-list
110969684|NCT01695941|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110969685|NCT01695941|Immunologic Factors|immunologic factors|mesh-ancestor
111491217|NCT06014359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111491218|NCT06014359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111491219|NCT06014359|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110969686|NCT01695941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110969687|NCT01695941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110969688|NCT01695941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111491220|NCT06014359|Analgesics|analgesics|mesh-ancestor
110969689|NCT01660971|Gemcitabine|gemcitabine|mesh-list
110969690|NCT01660971|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110969691|NCT01660971|Dasatinib|dasatinib|mesh-list
110969692|NCT01660971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110969693|NCT01660971|Antimetabolites|antimetabolites|mesh-ancestor
110799551|NCT03752931|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110969694|NCT01660971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110969695|NCT01660971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110969696|NCT01660971|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110969697|NCT01660971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110969698|NCT01639573|Alemtuzumab|alemtuzumab|mesh-list
110969699|NCT01639573|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110969700|NCT01639573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110969701|NCT01592370|Dexamethasone|dexamethasone|mesh-list
110969702|NCT01592370|Nivolumab|nivolumab|mesh-list
110969703|NCT01592370|Ipilimumab|ipilimumab|mesh-list
110969704|NCT01592370|Daratumumab|daratumumab|mesh-list
110969705|NCT01592370|Pomalidomide|pomalidomide|mesh-list
110969706|NCT01592370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110969707|NCT01592370|Antiemetics|antiemetics|mesh-ancestor
110969708|NCT01592370|Autonomic Agents|autonomic agents|mesh-ancestor
110969709|NCT01592370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110969710|NCT01592370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110969711|NCT01592370|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110969712|NCT01592370|Glucocorticoids|glucocorticoids|mesh-ancestor
110969713|NCT01592370|Hormones|hormones|mesh-ancestor
110969714|NCT01592370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110969715|NCT01592370|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110969716|NCT01592370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110969717|NCT01592370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110969718|NCT01592370|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110969719|NCT01592370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110969720|NCT01592370|Immunologic Factors|immunologic factors|mesh-ancestor
110969721|NCT01592370|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110969722|NCT01592370|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110969723|NCT01592370|Growth Substances|growth substances|mesh-ancestor
110969724|NCT01592370|Growth Inhibitors|growth inhibitors|mesh-ancestor
110969725|NCT01495637|Sargramostim|sargramostim|mesh-list
110969726|NCT01495637|Immunologic Factors|immunologic factors|mesh-ancestor
110969727|NCT01495637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110969728|NCT01437709|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110969729|NCT01437709|Ofatumumab|ofatumumab|mesh-list
110969730|NCT01437709|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110969731|NCT01437709|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110969732|NCT01437709|Alkylating Agents|alkylating agents|mesh-ancestor
110969733|NCT01437709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110969734|NCT01437709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110969735|NCT01437709|Immunologic Factors|immunologic factors|mesh-ancestor
110969736|NCT01437709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110969737|NCT01366144|Paclitaxel|paclitaxel|mesh-list
110969738|NCT01366144|Carboplatin|carboplatin|mesh-list
110969739|NCT01366144|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110969740|NCT01366144|Veliparib|veliparib|mesh-list
110969741|NCT01366144|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110969742|NCT01366144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110969743|NCT01366144|Tubulin Modulators|tubulin modulators|mesh-ancestor
110969744|NCT01366144|Antimitotic Agents|antimitotic agents|mesh-ancestor
110969745|NCT01366144|Mitosis Modulators|mitosis modulators|mesh-ancestor
110969746|NCT01366144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110969747|NCT01366144|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110969748|NCT01366144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110969749|NCT01364051|Cediranib|cediranib|mesh-list
110969750|NCT01364051|Maleic acid|maleic acid|mesh-list
110969751|NCT01364051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110969752|NCT01364051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110969753|NCT01364051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110969754|NCT01364051|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110969755|NCT01351909|Cyclophosphamide|cyclophosphamide|mesh-list
110969756|NCT01351909|Veliparib|veliparib|mesh-list
110969757|NCT01351909|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110969758|NCT01351909|Immunologic Factors|immunologic factors|mesh-ancestor
110969759|NCT01351909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110969760|NCT01351909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110969761|NCT01351909|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111491221|NCT06014359|Sensory System Agents|sensory system agents|mesh-ancestor
111491222|NCT06014359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110969762|NCT01351909|Alkylating Agents|alkylating agents|mesh-ancestor
110969763|NCT01351909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111491223|NCT06014359|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111491224|NCT06014359|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110969764|NCT01351909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110969765|NCT01351909|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110969766|NCT01351909|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110969767|NCT01351909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110969768|NCT01281176|Paclitaxel|paclitaxel|mesh-list
110969769|NCT01281176|Carboplatin|carboplatin|mesh-list
110969770|NCT01281176|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110969771|NCT01281176|Vorinostat|vorinostat|mesh-list
110969772|NCT01281176|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110969773|NCT01281176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110969774|NCT01281176|Tubulin Modulators|tubulin modulators|mesh-ancestor
110969775|NCT01281176|Antimitotic Agents|antimitotic agents|mesh-ancestor
110969776|NCT01281176|Mitosis Modulators|mitosis modulators|mesh-ancestor
110969777|NCT01281176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110969778|NCT01281176|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110969779|NCT01281176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110969780|NCT01149083|Carboplatin|carboplatin|mesh-list
110969781|NCT01149083|Veliparib|veliparib|mesh-list
110969782|NCT01149083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110969783|NCT01149083|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110969784|NCT01149083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110969785|NCT01149083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110969786|NCT01139970|Temozolomide|temozolomide|mesh-list
110969787|NCT01139970|Veliparib|veliparib|mesh-list
110969788|NCT01139970|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110969789|NCT01139970|Alkylating Agents|alkylating agents|mesh-ancestor
110969790|NCT01139970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110969791|NCT01139970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110969792|NCT01139970|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110969793|NCT01139970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110969794|NCT01093183|Cyclophosphamide|cyclophosphamide|mesh-list
110969795|NCT01093183|Lenalidomide|lenalidomide|mesh-list
110969796|NCT01093183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110969797|NCT01093183|Immunologic Factors|immunologic factors|mesh-ancestor
110969798|NCT01093183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110969799|NCT01093183|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110969800|NCT01093183|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110969801|NCT01093183|Alkylating Agents|alkylating agents|mesh-ancestor
110969802|NCT01093183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110969803|NCT01093183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110969804|NCT01093183|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110969805|NCT01093183|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110969806|NCT01093183|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110969807|NCT01093183|Growth Substances|growth substances|mesh-ancestor
110969808|NCT01093183|Growth Inhibitors|growth inhibitors|mesh-ancestor
110969809|NCT01013649|Gemcitabine|gemcitabine|mesh-list
110969810|NCT01013649|Fluorouracil|fluorouracil|mesh-list
110969811|NCT01013649|Capecitabine|capecitabine|mesh-list
110681998|NCT00404547|Ciclesonide|ciclesonide|mesh-list
110969812|NCT01013649|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110969813|NCT01013649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110969814|NCT01013649|Antimetabolites|antimetabolites|mesh-ancestor
110969815|NCT01013649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110969816|NCT01013649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110969817|NCT01013649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110969818|NCT01013649|Immunologic Factors|immunologic factors|mesh-ancestor
110969819|NCT01013649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110969820|NCT01013649|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110969821|NCT01013649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110969822|NCT00878163|Gemcitabine|gemcitabine|mesh-list
110969823|NCT00878163|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110969824|NCT00878163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110969825|NCT00878163|Antimetabolites|antimetabolites|mesh-ancestor
110969826|NCT00878163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110969827|NCT00878163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110969828|NCT00878163|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110969829|NCT00878163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110969830|NCT00777582|Olaparib|olaparib|mesh-list
110969831|NCT00777582|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110969832|NCT00777582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110969833|NCT00777582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110969834|NCT00777582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111491225|NCT06014359|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111491226|NCT06014359|Adrenergic Agents|adrenergic agents|mesh-ancestor
110969835|NCT00777036|Dasatinib|dasatinib|mesh-list
110969836|NCT00777036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110969837|NCT00777036|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110969838|NCT00777036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110969839|NCT00777036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110969840|NCT00740805|Cyclophosphamide|cyclophosphamide|mesh-list
110969841|NCT00740805|Doxorubicin|doxorubicin|mesh-list
110969842|NCT00740805|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110969843|NCT00740805|Veliparib|veliparib|mesh-list
110969844|NCT00740805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110969845|NCT00740805|Immunologic Factors|immunologic factors|mesh-ancestor
110969846|NCT00740805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110969847|NCT00740805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110969848|NCT00740805|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110969849|NCT00740805|Alkylating Agents|alkylating agents|mesh-ancestor
110969850|NCT00740805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110969851|NCT00740805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110969852|NCT00740805|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110969853|NCT00740805|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110969854|NCT00740805|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110969855|NCT00740805|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110969856|NCT00740805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110969857|NCT00740805|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110969858|NCT00588991|Carboplatin|carboplatin|mesh-list
110969859|NCT00588991|Topotecan|topotecan|mesh-list
110969860|NCT00588991|Veliparib|veliparib|mesh-list
110969861|NCT00588991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110969862|NCT00588991|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110969863|NCT00588991|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110969864|NCT00588991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110969865|NCT00588991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110969866|NCT00588991|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110969867|NCT00392353|Azacitidine|azacitidine|mesh-list
110969868|NCT00392353|Vorinostat|vorinostat|mesh-list
110969869|NCT00392353|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110969870|NCT00392353|Antimetabolites|antimetabolites|mesh-ancestor
110969871|NCT00392353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110969872|NCT00392353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110969873|NCT00392353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110969874|NCT00392353|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110969875|NCT00365157|Halichondrin B|halichondrin b|mesh-list
110969876|NCT00365157|Tubulin Modulators|tubulin modulators|mesh-ancestor
110969877|NCT00365157|Antimitotic Agents|antimitotic agents|mesh-ancestor
110969878|NCT00365157|Mitosis Modulators|mitosis modulators|mesh-ancestor
110969879|NCT00365157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110969880|NCT00365157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110969881|NCT00336063|Azacitidine|azacitidine|mesh-list
110969882|NCT00336063|Vorinostat|vorinostat|mesh-list
110969883|NCT00336063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110969884|NCT00336063|Antimetabolites|antimetabolites|mesh-ancestor
110969885|NCT00336063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110969886|NCT00336063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110969887|NCT00336063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110969888|NCT00336063|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110969889|NCT00268385|Temozolomide|temozolomide|mesh-list
110969890|NCT00268385|Vorinostat|vorinostat|mesh-list
110969891|NCT00268385|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110969892|NCT00268385|Alkylating Agents|alkylating agents|mesh-ancestor
110969893|NCT00268385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110969894|NCT00268385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110969895|NCT00268385|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110969896|NCT00268385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110969897|NCT00176644|Estradiol|estradiol|mesh-list
110969898|NCT00176644|Estrogens|estrogens|mesh-ancestor
110969899|NCT00176644|Hormones|hormones|mesh-ancestor
110969900|NCT00176644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110969901|NCT00176644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110969902|NCT00106171|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
110969903|NCT00106171|Antiviral Agents|antiviral agents|mesh-ancestor
110969904|NCT00106171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110969905|NCT00045201|Irinotecan|irinotecan|mesh-list
110969906|NCT00045201|Camptothecin|camptothecin|mesh-list
110969907|NCT00045201|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111491227|NCT06014359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111491228|NCT06014359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110969908|NCT00045201|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110969909|NCT00045201|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110969910|NCT00045201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110969911|NCT00045201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110969912|NCT00045201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110969913|NCT00045201|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110969914|NCT00045201|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110969916|NCT03326960|Sevoflurane|sevoflurane|mesh-list
110969917|NCT03326960|Desflurane|desflurane|mesh-list
110969918|NCT03326960|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110969919|NCT03326960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110969920|NCT03326960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110969921|NCT03326960|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110969922|NCT03326960|Anesthetics, General|anesthetics, general|mesh-ancestor
110969923|NCT03326960|Anesthetics|anesthetics|mesh-ancestor
110969924|NCT03326960|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110969925|NCT03326960|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110969926|NCT03319238|Ketamine|ketamine|mesh-list
110969927|NCT03319238|Analgesics|analgesics|mesh-ancestor
110969928|NCT03319238|Sensory System Agents|sensory system agents|mesh-ancestor
110969929|NCT03319238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110969930|NCT03319238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110969931|NCT03319238|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110969932|NCT03319238|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110969933|NCT03319238|Anesthetics, General|anesthetics, general|mesh-ancestor
110969934|NCT03319238|Anesthetics|anesthetics|mesh-ancestor
110969935|NCT03319238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110969936|NCT03319238|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110969937|NCT03319238|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110969938|NCT03319238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110969939|NCT03319238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110969940|NCT03321890|Prednisone|prednisone|mesh-list
110969941|NCT03321890|Cyclophosphamide|cyclophosphamide|mesh-list
110969942|NCT03321890|Methotrexate|methotrexate|mesh-list
110969943|NCT03321890|Etoposide|etoposide|mesh-list
110969944|NCT03321890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110969945|NCT03321890|Immunologic Factors|immunologic factors|mesh-ancestor
110969946|NCT03321890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110969947|NCT03321890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110969948|NCT03321890|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110969949|NCT03321890|Alkylating Agents|alkylating agents|mesh-ancestor
110969950|NCT03321890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110969951|NCT03321890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110969952|NCT03321890|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110969953|NCT03321890|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110969954|NCT03321890|Glucocorticoids|glucocorticoids|mesh-ancestor
110969955|NCT03321890|Hormones|hormones|mesh-ancestor
110969956|NCT03321890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110969957|NCT03321890|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110969958|NCT03321890|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110969959|NCT03321890|Abortifacient Agents|abortifacient agents|mesh-ancestor
110969960|NCT03321890|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110969961|NCT03321890|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110969962|NCT03321890|Antimetabolites|antimetabolites|mesh-ancestor
110969963|NCT03321890|Dermatologic Agents|dermatologic agents|mesh-ancestor
110969964|NCT03321890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110969965|NCT03321890|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110969966|NCT03321890|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110969967|NCT03321890|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110969968|NCT03321890|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110969969|NCT03321890|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110969970|NCT05464394|Tranexamic Acid|tranexamic acid|mesh-list
110969971|NCT05464394|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110969972|NCT05464394|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110969973|NCT05464394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110969974|NCT05464394|Hemostatics|hemostatics|mesh-ancestor
110969975|NCT05464394|Coagulants|coagulants|mesh-ancestor
110969976|NCT05499598|Vitamin A|vitamin a|mesh-list
110969977|NCT05499598|Vitamins|vitamins|mesh-ancestor
110969978|NCT05499598|Micronutrients|micronutrients|mesh-ancestor
111491229|NCT06011772|Leucovorin|leucovorin|mesh-list
111491230|NCT06011772|Bevacizumab|bevacizumab|mesh-list
111491231|NCT06011772|Cetuximab|cetuximab|mesh-list
110969979|NCT05499598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110969980|NCT04442750|Bupivacaine|bupivacaine|mesh-list
110969981|NCT04442750|Anesthetics, Local|anesthetics, local|mesh-ancestor
110969982|NCT04442750|Anesthetics|anesthetics|mesh-ancestor
110969983|NCT04442750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110969984|NCT04442750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110969985|NCT04442750|Sensory System Agents|sensory system agents|mesh-ancestor
110969986|NCT04442750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110969987|NCT02753127|Leucovorin|leucovorin|mesh-list
110969988|NCT02753127|Bevacizumab|bevacizumab|mesh-list
110969989|NCT02753127|Fluorouracil|fluorouracil|mesh-list
110969990|NCT02753127|Irinotecan|irinotecan|mesh-list
110969991|NCT02753127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110969992|NCT02753127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110969993|NCT02753127|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110969994|NCT02753127|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110969995|NCT02753127|Growth Substances|growth substances|mesh-ancestor
110969996|NCT02753127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110969997|NCT02753127|Growth Inhibitors|growth inhibitors|mesh-ancestor
110969998|NCT02753127|Antimetabolites|antimetabolites|mesh-ancestor
110969999|NCT02753127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110970000|NCT02753127|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110970001|NCT02753127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110970002|NCT02753127|Immunologic Factors|immunologic factors|mesh-ancestor
110970003|NCT02753127|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110970004|NCT02753127|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110970005|NCT02753127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110970006|NCT02753127|Antidotes|antidotes|mesh-ancestor
110970007|NCT02753127|Protective Agents|protective agents|mesh-ancestor
110970008|NCT02753127|Vitamin B Complex|vitamin b complex|mesh-ancestor
110970009|NCT02753127|Vitamins|vitamins|mesh-ancestor
110970010|NCT02753127|Micronutrients|micronutrients|mesh-ancestor
110970011|NCT03326258|Nivolumab|nivolumab|mesh-list
110970012|NCT03326258|Ipilimumab|ipilimumab|mesh-list
110970013|NCT03326258|Glembatumumab vedotin|glembatumumab vedotin|mesh-list
110970014|NCT03326258|Antibodies|antibodies|mesh-list
110970015|NCT03326258|Immunoglobulins|immunoglobulins|mesh-list
110970016|NCT03326258|Immunotoxins|immunotoxins|mesh-list
110970017|NCT03326258|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110970018|NCT03326258|Immunoconjugates|immunoconjugates|mesh-list
110970019|NCT03326258|Immunologic Factors|immunologic factors|mesh-ancestor
110970020|NCT03326258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110970021|NCT03326258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110970022|NCT03326258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110970023|NCT03326258|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110970024|NCT03326258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110970025|NCT03326102|Paclitaxel|paclitaxel|mesh-list
110970026|NCT03326102|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110970027|NCT03326102|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110970028|NCT03326102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110970029|NCT03326102|Tubulin Modulators|tubulin modulators|mesh-ancestor
110970030|NCT03326102|Antimitotic Agents|antimitotic agents|mesh-ancestor
110970031|NCT03326102|Mitosis Modulators|mitosis modulators|mesh-ancestor
110970032|NCT03326102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110970033|NCT02487212|Clobetasol|clobetasol|mesh-list
110970034|NCT02487212|Petrolatum|petrolatum|mesh-list
110970035|NCT02487212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110970036|NCT02487212|Glucocorticoids|glucocorticoids|mesh-ancestor
110970037|NCT02487212|Hormones|hormones|mesh-ancestor
110970038|NCT02487212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110970039|NCT02487212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110970041|NCT02487212|Dermatologic Agents|dermatologic agents|mesh-ancestor
110970042|NCT04583488|Docetaxel|docetaxel|mesh-list
110970043|NCT04583488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110970044|NCT04583488|Tubulin Modulators|tubulin modulators|mesh-ancestor
110970045|NCT04583488|Antimitotic Agents|antimitotic agents|mesh-ancestor
110970046|NCT04583488|Mitosis Modulators|mitosis modulators|mesh-ancestor
110970047|NCT04583488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110970048|NCT03318536|Granisetron|granisetron|mesh-list
110970049|NCT03318536|Serotonin|serotonin|mesh-list
110970050|NCT03318536|Antiemetics|antiemetics|mesh-ancestor
111491232|NCT06011772|Fluorouracil|fluorouracil|mesh-list
111491233|NCT06011772|Oxaliplatin|oxaliplatin|mesh-list
110970051|NCT03318536|Autonomic Agents|autonomic agents|mesh-ancestor
110970052|NCT03318536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110970053|NCT03318536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110970054|NCT03318536|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111491234|NCT06011772|Irinotecan|irinotecan|mesh-list
111491235|NCT06011772|Vaccines|vaccines|mesh-list
110970055|NCT03318536|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110970056|NCT03318536|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110970057|NCT03318536|Serotonin Agents|serotonin agents|mesh-ancestor
110970058|NCT03318536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110970059|NCT03318536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110970060|NCT03318536|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110970061|NCT03537027|Vitamin D|vitamin d|mesh-list
110970062|NCT03537027|Cholecalciferol|cholecalciferol|mesh-list
110970063|NCT03537027|Vitamins|vitamins|mesh-ancestor
110970064|NCT03537027|Micronutrients|micronutrients|mesh-ancestor
110970065|NCT03537027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110970066|NCT03537027|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110970067|NCT03537027|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110970068|NCT02183025|Meloxicam|meloxicam|mesh-list
110970069|NCT02183025|Mefenamic Acid|mefenamic acid|mesh-list
110970070|NCT02183025|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110970071|NCT02183025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110970072|NCT02183025|Analgesics|analgesics|mesh-ancestor
110970073|NCT02183025|Sensory System Agents|sensory system agents|mesh-ancestor
110970074|NCT02183025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110970075|NCT02183025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110970076|NCT02183025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110970077|NCT02183025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110970078|NCT02183025|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110970079|NCT02183025|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110970080|NCT02183025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110970081|NCT02183025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110970082|NCT04282174|Cyclophosphamide|cyclophosphamide|mesh-list
110970083|NCT04282174|Melphalan|melphalan|mesh-list
110970084|NCT04282174|Busulfan|busulfan|mesh-list
110970085|NCT04282174|Thiotepa|thiotepa|mesh-list
110970086|NCT04282174|Fludarabine|fludarabine|mesh-list
110970087|NCT04282174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110970088|NCT04282174|Immunologic Factors|immunologic factors|mesh-ancestor
110970089|NCT04282174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110970090|NCT04282174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110970091|NCT04282174|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110970092|NCT04282174|Alkylating Agents|alkylating agents|mesh-ancestor
110970093|NCT04282174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110970094|NCT04282174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110970095|NCT04282174|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110970096|NCT02181309|Meloxicam|meloxicam|mesh-list
110970097|NCT02181309|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110970098|NCT02181309|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110970099|NCT02181309|Analgesics|analgesics|mesh-ancestor
110970100|NCT02181309|Sensory System Agents|sensory system agents|mesh-ancestor
110970101|NCT02181309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110970102|NCT02181309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110970103|NCT02181309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110970104|NCT02181309|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110970105|NCT02181309|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110970106|NCT02181309|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110970107|NCT02181309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110970108|NCT02181309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110970109|NCT02186145|Metronidazole|metronidazole|mesh-list
110970110|NCT02186145|Nystatin|nystatin|mesh-list
110970111|NCT02186145|Dexamethasone|dexamethasone|mesh-list
110970112|NCT02186145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110970113|NCT02186145|Antiemetics|antiemetics|mesh-ancestor
110970114|NCT02186145|Autonomic Agents|autonomic agents|mesh-ancestor
110970115|NCT02186145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110970116|NCT02186145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110970117|NCT02186145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110970118|NCT02186145|Glucocorticoids|glucocorticoids|mesh-ancestor
110970120|NCT02186145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110970121|NCT02186145|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110970122|NCT02186145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110970123|NCT02186145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110970124|NCT02186145|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110970125|NCT02186145|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110970126|NCT02186145|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110970127|NCT02186145|Antifungal Agents|antifungal agents|mesh-ancestor
111491236|NCT06011772|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
110970128|NCT02186145|Ionophores|ionophores|mesh-ancestor
110699337|NCT01047072|Mycophenolic Acid|mycophenolic acid|mesh-list
111491237|NCT06011772|Immunologic Factors|immunologic factors|mesh-ancestor
111491239|NCT06011772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111491240|NCT06011772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111491241|NCT06011772|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111491242|NCT06011772|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111491243|NCT06011772|Growth Substances|growth substances|mesh-ancestor
111491244|NCT06011772|Growth Inhibitors|growth inhibitors|mesh-ancestor
111491245|NCT06011772|Antimetabolites|antimetabolites|mesh-ancestor
110970129|NCT02186145|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110970130|NCT02186145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110970131|NCT03325868|Ulipristal acetate|ulipristal acetate|mesh-list
110970132|NCT03325868|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110970133|NCT03325868|Contraceptive Agents|contraceptive agents|mesh-ancestor
110970134|NCT03325868|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110970135|NCT03325868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110970136|NCT03325868|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110970137|NCT02183103|Meloxicam|meloxicam|mesh-list
110970138|NCT02183103|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110970139|NCT02183103|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110970140|NCT02183103|Analgesics|analgesics|mesh-ancestor
110970141|NCT02183103|Sensory System Agents|sensory system agents|mesh-ancestor
110970142|NCT02183103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110970143|NCT02183103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110799552|NCT03752931|Sympathomimetics|sympathomimetics|mesh-ancestor
110970144|NCT02183103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110970145|NCT02183103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110970146|NCT02183103|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110970147|NCT02183103|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110970148|NCT02183103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110970149|NCT02183103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110970150|NCT03325790|Ebselen|ebselen|mesh-list
110970151|NCT03325790|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110970152|NCT03325790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110970153|NCT03325790|Analgesics|analgesics|mesh-ancestor
110970154|NCT03325790|Sensory System Agents|sensory system agents|mesh-ancestor
110970155|NCT03325790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110970156|NCT03325790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110970157|NCT03325790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110970158|NCT03325790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110970159|NCT03325790|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110970160|NCT03325790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110970161|NCT03325790|Antioxidants|antioxidants|mesh-ancestor
110970162|NCT03325790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110970163|NCT03325790|Protective Agents|protective agents|mesh-ancestor
110970164|NCT03325790|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110970165|NCT03325790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110970166|NCT03325790|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110970167|NCT02181543|Clonidine|clonidine|mesh-list
110970168|NCT02181543|Analgesics|analgesics|mesh-ancestor
110970169|NCT02181543|Sensory System Agents|sensory system agents|mesh-ancestor
110970170|NCT02181543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110970171|NCT02181543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110970172|NCT02181543|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110970173|NCT02181543|Sympatholytics|sympatholytics|mesh-ancestor
110970174|NCT02181543|Autonomic Agents|autonomic agents|mesh-ancestor
110970175|NCT02181543|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110970176|NCT02181543|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110970177|NCT02181543|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110970178|NCT02181543|Adrenergic Agents|adrenergic agents|mesh-ancestor
110970179|NCT02181543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110970180|NCT02181543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110970181|NCT02181621|Cadexomer iodine|cadexomer iodine|mesh-list
110970182|NCT02181621|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110970183|NCT02181621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110970184|NCT02490176|Liraglutide|liraglutide|mesh-list
110970185|NCT02490176|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110970186|NCT02490176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110970187|NCT02490176|Incretins|incretins|mesh-ancestor
110970188|NCT02490176|Hormones|hormones|mesh-ancestor
110970189|NCT02490176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110970190|NCT02183181|Meloxicam|meloxicam|mesh-list
110970191|NCT02183181|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110970192|NCT02183181|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110970193|NCT02183181|Analgesics|analgesics|mesh-ancestor
110970194|NCT02183181|Sensory System Agents|sensory system agents|mesh-ancestor
110970195|NCT02183181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110970196|NCT02183181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110970197|NCT02183181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110970198|NCT02183181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110970199|NCT02183181|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110970200|NCT02183181|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110970201|NCT02183181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110970202|NCT02183181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110970203|NCT02490098|Insulin|insulin|mesh-list
110970204|NCT02490098|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110970205|NCT02490098|Glucagon|glucagon|mesh-list
110970206|NCT02490098|Hormones|hormones|mesh-list
110970207|NCT02490098|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110970208|NCT02490098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110970209|NCT02490098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110970210|NCT02490098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110970211|NCT02486822|Oxytocin|oxytocin|mesh-list
110970212|NCT02486822|Oxytocics|oxytocics|mesh-ancestor
110970213|NCT02486822|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110970214|NCT02486822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110970215|NCT02186457|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110970216|NCT02186457|Polymyxins|polymyxins|mesh-list
110970217|NCT02186457|Polymyxin B|polymyxin b|mesh-list
110970218|NCT02186457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110970219|NCT02186535|Vitamin D|vitamin d|mesh-list
110970220|NCT02186535|Calcium|calcium|mesh-list
110970221|NCT02186535|Vitamins|vitamins|mesh-ancestor
110970222|NCT02186535|Micronutrients|micronutrients|mesh-ancestor
110970223|NCT02186535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110970224|NCT02186535|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110970225|NCT02186535|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110970226|NCT03325400|Fluorides|fluorides|mesh-list
110970227|NCT03325400|Cariostatic Agents|cariostatic agents|mesh-ancestor
110970228|NCT03325400|Protective Agents|protective agents|mesh-ancestor
110970229|NCT03325400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110970230|NCT02181933|Lamivudine|lamivudine|mesh-list
110970231|NCT02181933|Zidovudine|zidovudine|mesh-list
110970232|NCT02181933|Nevirapine|nevirapine|mesh-list
110970233|NCT02181933|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110970234|NCT02181933|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110970235|NCT02181933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110970236|NCT02181933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110970237|NCT02181933|Antiviral Agents|antiviral agents|mesh-ancestor
110970238|NCT02181933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110970239|NCT02181933|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110970240|NCT02181933|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110970241|NCT02181933|Antimetabolites|antimetabolites|mesh-ancestor
110970242|NCT02181933|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110970243|NCT02181933|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110970244|NCT02183337|Pioglitazone|pioglitazone|mesh-list
110970245|NCT02183337|Linagliptin|linagliptin|mesh-list
110970246|NCT02183337|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110970247|NCT02183337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110970248|NCT02183337|Incretins|incretins|mesh-ancestor
110970249|NCT02183337|Hormones|hormones|mesh-ancestor
110970250|NCT02183337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110970251|NCT02183337|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110970252|NCT02183337|Protease Inhibitors|protease inhibitors|mesh-ancestor
110970253|NCT02183337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110970254|NCT02183337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110970255|NCT02489786|Digoxin|digoxin|mesh-list
110970256|NCT02489786|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110970257|NCT02489786|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110970258|NCT02489786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110970259|NCT02489786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110970260|NCT02489786|Protective Agents|protective agents|mesh-ancestor
110970261|NCT02489786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110970262|NCT02489864|Terlipressin|terlipressin|mesh-list
110970263|NCT02489864|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110970264|NCT02489864|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110970265|NCT02182011|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
111491246|NCT06011772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110970266|NCT02182011|Tenecteplase|tenecteplase|mesh-list
110970267|NCT02182011|Streptokinase|streptokinase|mesh-list
110970268|NCT02182011|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110435847|NCT02658721|Mydriatics|mydriatics|mesh-ancestor
111491247|NCT06011772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110970269|NCT02182011|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110970270|NCT02182011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110970271|NCT02486744|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
110970272|NCT02486744|Hormones|hormones|mesh-ancestor
110970273|NCT02486744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110970274|NCT02486744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110970275|NCT02186769|Risperidone|risperidone|mesh-list
110970276|NCT02186769|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110970277|NCT02186769|Serotonin Agents|serotonin agents|mesh-ancestor
110970278|NCT02186769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110970279|NCT02186769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110970280|NCT02186769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110970281|NCT02186769|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110970282|NCT02186769|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110970283|NCT02186769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110970284|NCT02186769|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110970285|NCT02186769|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110970286|NCT02186769|Dopamine Agents|dopamine agents|mesh-ancestor
110970287|NCT02486432|Levodopa|levodopa|mesh-list
110970288|NCT02486432|Carbidopa|carbidopa|mesh-list
110970289|NCT02486432|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
110970290|NCT02486432|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110970291|NCT02486432|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110970292|NCT02486432|Dopamine Agents|dopamine agents|mesh-ancestor
110970293|NCT02486432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110970294|NCT02486432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110970295|NCT02486432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110970296|NCT02486432|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
110970297|NCT02486432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110970298|NCT02486432|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110970299|NCT02486432|Immunologic Factors|immunologic factors|mesh-ancestor
110970300|NCT02486432|Dopamine Agonists|dopamine agonists|mesh-ancestor
110970301|NCT02489240|Vitamin D|vitamin d|mesh-list
110970302|NCT02489240|Cholecalciferol|cholecalciferol|mesh-list
110970303|NCT02489240|Vitamins|vitamins|mesh-ancestor
110970304|NCT02489240|Micronutrients|micronutrients|mesh-ancestor
110970305|NCT02489240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110970306|NCT02489240|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110970307|NCT02489240|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110970308|NCT02183415|Linagliptin|linagliptin|mesh-list
110970309|NCT02183415|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110970310|NCT02183415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110970311|NCT02183415|Incretins|incretins|mesh-ancestor
110970312|NCT02183415|Hormones|hormones|mesh-ancestor
110970313|NCT02183415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110970314|NCT02183415|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110970315|NCT02183415|Protease Inhibitors|protease inhibitors|mesh-ancestor
110970316|NCT02183415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110970317|NCT02183415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110970318|NCT02486510|Maraviroc|maraviroc|mesh-list
110970319|NCT02486510|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110970320|NCT02486510|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110970321|NCT02486510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110970322|NCT02486510|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110970323|NCT02486510|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110970324|NCT02486510|Antiviral Agents|antiviral agents|mesh-ancestor
110970325|NCT02486510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110970326|NCT02486510|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
110970327|NCT04493528|Lidocaine|lidocaine|mesh-list
110970328|NCT04493528|Anesthetics, Local|anesthetics, local|mesh-ancestor
110970329|NCT04493528|Anesthetics|anesthetics|mesh-ancestor
110970330|NCT04493528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110970331|NCT04493528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110970332|NCT04493528|Sensory System Agents|sensory system agents|mesh-ancestor
110970333|NCT04493528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110970334|NCT04493528|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110970335|NCT04493528|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110970336|NCT04493528|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110970337|NCT04493528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110682537|NCT00897065|Antibodies|antibodies|mesh-list
110699350|NCT01047072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111491249|NCT06011772|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111491250|NCT06011772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110970338|NCT04493528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110970339|NCT02183493|Linagliptin|linagliptin|mesh-list
110970340|NCT02183493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110970341|NCT02183493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110970342|NCT02183493|Incretins|incretins|mesh-ancestor
110970343|NCT02183493|Hormones|hormones|mesh-ancestor
110970344|NCT02183493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110970345|NCT02183493|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110970346|NCT02183493|Protease Inhibitors|protease inhibitors|mesh-ancestor
110970347|NCT02183493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110970348|NCT02183493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110970349|NCT02187081|Sorafenib|sorafenib|mesh-list
110970350|NCT02187081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110970351|NCT02187081|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110970352|NCT02187081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110970353|NCT02187081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110970354|NCT02485106|Rifaximin|rifaximin|mesh-list
110970355|NCT02485106|Pentoxifylline|pentoxifylline|mesh-list
110970356|NCT02485106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110970357|NCT02485106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110970358|NCT02485106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110970359|NCT02485106|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110970360|NCT02485106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110970361|NCT02485106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110970362|NCT02485106|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110970363|NCT02485106|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110970364|NCT02485106|Protective Agents|protective agents|mesh-ancestor
110970365|NCT02485106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110970366|NCT02485106|Vasodilator Agents|vasodilator agents|mesh-ancestor
110970367|NCT02485106|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110970368|NCT02485106|Antioxidants|antioxidants|mesh-ancestor
110970369|NCT02485028|Mirodenafil|mirodenafil|mesh-list
110970370|NCT02485028|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110970371|NCT02485028|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110970372|NCT02485028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110970373|NCT02485028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110970374|NCT02183571|Metformin|metformin|mesh-list
110970375|NCT02183571|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110970376|NCT02183571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110970377|NCT03318146|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110970378|NCT03318146|Latanoprost|latanoprost|mesh-list
110970379|NCT03318146|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110970380|NCT02183649|Carbetapentane|carbetapentane|mesh-list
110970381|NCT02183649|Antitussive Agents|antitussive agents|mesh-ancestor
110970382|NCT02183649|Respiratory System Agents|respiratory system agents|mesh-ancestor
110970383|NCT02187315|Cisplatin|cisplatin|mesh-list
110970384|NCT02187315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110970385|NCT02256735|Moxifloxacin|moxifloxacin|mesh-list
110970386|NCT02256735|p-Hydroxyamphetamine|p-hydroxyamphetamine|mesh-list
110970387|NCT02256735|Ritobegron|ritobegron|mesh-list
110970388|NCT02256735|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110970389|NCT02256735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110970390|NCT02256735|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110970391|NCT02256735|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110970392|NCT02256735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110970393|NCT02256735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110970394|NCT02256735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110970395|NCT02256735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110970396|NCT02256735|Mydriatics|mydriatics|mesh-ancestor
110970397|NCT02256735|Autonomic Agents|autonomic agents|mesh-ancestor
110970398|NCT02256735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110970399|NCT02256735|Sympathomimetics|sympathomimetics|mesh-ancestor
110970400|NCT02256735|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
110970401|NCT02256735|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110970402|NCT02256735|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110970403|NCT02256735|Adrenergic Agents|adrenergic agents|mesh-ancestor
110970404|NCT02256735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110970405|NCT02183805|Cyclophosphamide|cyclophosphamide|mesh-list
111491251|NCT06011772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111491252|NCT06011772|Antidotes|antidotes|mesh-ancestor
110970406|NCT02183805|Carboplatin|carboplatin|mesh-list
110970407|NCT02183805|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110970408|NCT02183805|Paclitaxel|paclitaxel|mesh-list
110970409|NCT02183805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110970410|NCT02183805|Immunologic Factors|immunologic factors|mesh-ancestor
110682616|NCT01011114|Cinacalcet|cinacalcet|mesh-list
110970411|NCT02183805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110970412|NCT02183805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110970413|NCT02183805|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110970414|NCT02183805|Alkylating Agents|alkylating agents|mesh-ancestor
110970415|NCT02183805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110970416|NCT02183805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110970417|NCT02183805|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110970418|NCT02183805|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110970419|NCT02183805|Tubulin Modulators|tubulin modulators|mesh-ancestor
110970420|NCT02183805|Antimitotic Agents|antimitotic agents|mesh-ancestor
110970421|NCT02183805|Mitosis Modulators|mitosis modulators|mesh-ancestor
110970423|NCT03316352|Anesthetics|anesthetics|mesh-list
110970424|NCT03316352|Anesthetics, Local|anesthetics, local|mesh-ancestor
110970425|NCT03316352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110970426|NCT03316352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110970427|NCT03316352|Sensory System Agents|sensory system agents|mesh-ancestor
110970428|NCT03316352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110970429|NCT02187705|Telmisartan|telmisartan|mesh-list
110970430|NCT02187705|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110970431|NCT02187705|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110970432|NCT02187705|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110970433|NCT02187705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110970434|NCT03317912|Lidocaine|lidocaine|mesh-list
110970435|NCT03317912|Anesthetics, Local|anesthetics, local|mesh-ancestor
110970436|NCT03317912|Anesthetics|anesthetics|mesh-ancestor
110970437|NCT03317912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110970438|NCT03317912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110970439|NCT03317912|Sensory System Agents|sensory system agents|mesh-ancestor
110970440|NCT03317912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110970441|NCT03317912|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110970442|NCT03317912|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110970443|NCT03317912|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110970444|NCT03317912|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110970445|NCT03317912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110970446|NCT03321110|Ubiquinone|ubiquinone|mesh-list
110970447|NCT03321110|Coenzyme Q10|coenzyme q10|mesh-list
110970448|NCT03321110|Micronutrients|micronutrients|mesh-ancestor
110970449|NCT03321110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110970450|NCT03321110|Vitamins|vitamins|mesh-ancestor
110970451|NCT03317600|Lidocaine|lidocaine|mesh-list
110970452|NCT03317600|Anesthetics, Local|anesthetics, local|mesh-ancestor
110970453|NCT03317600|Anesthetics|anesthetics|mesh-ancestor
110970454|NCT03317600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110970455|NCT03317600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110970456|NCT03317600|Sensory System Agents|sensory system agents|mesh-ancestor
110970457|NCT03317600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110970458|NCT03317600|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110970459|NCT03317600|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110970460|NCT03317600|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110970461|NCT03317600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110970462|NCT03317600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110970463|NCT02184117|Adenosine|adenosine|mesh-list
110970464|NCT02184117|Analgesics|analgesics|mesh-ancestor
110970465|NCT02184117|Sensory System Agents|sensory system agents|mesh-ancestor
110970466|NCT02184117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110970467|NCT02184117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110970468|NCT02184117|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110970469|NCT02184117|Vasodilator Agents|vasodilator agents|mesh-ancestor
110970470|NCT02184117|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
110970471|NCT02184117|Purinergic Agonists|purinergic agonists|mesh-ancestor
110970472|NCT02184117|Purinergic Agents|purinergic agents|mesh-ancestor
110970473|NCT02184117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110970474|NCT02184117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110970475|NCT02184273|Dipyrone|dipyrone|mesh-list
110970476|NCT02184273|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110970477|NCT02184273|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110970478|NCT02184273|Analgesics|analgesics|mesh-ancestor
110970479|NCT02184273|Sensory System Agents|sensory system agents|mesh-ancestor
110970480|NCT02184273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111491253|NCT06011772|Protective Agents|protective agents|mesh-ancestor
111491254|NCT06011772|Vitamin B Complex|vitamin b complex|mesh-ancestor
111491255|NCT06011772|Vitamins|vitamins|mesh-ancestor
111491257|NCT06011772|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110970481|NCT02184273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110970482|NCT02184273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110970483|NCT02184273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110970484|NCT02184273|Antipyretics|antipyretics|mesh-ancestor
110970485|NCT02486198|Oxaliplatin|oxaliplatin|mesh-list
110682752|NCT00902135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110970486|NCT02486198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110970487|NCT02188173|Dexamethasone|dexamethasone|mesh-list
110970488|NCT02188173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110970489|NCT02188173|Antiemetics|antiemetics|mesh-ancestor
110970490|NCT02188173|Autonomic Agents|autonomic agents|mesh-ancestor
110970491|NCT02188173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110970492|NCT02188173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110970493|NCT02188173|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110970494|NCT02188173|Glucocorticoids|glucocorticoids|mesh-ancestor
110970495|NCT02188173|Hormones|hormones|mesh-ancestor
110970496|NCT02188173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110970497|NCT02188173|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110970498|NCT02188173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110970499|NCT02184351|Clotrimazole|clotrimazole|mesh-list
110970500|NCT02184351|Miconazole|miconazole|mesh-list
110970501|NCT02184351|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110970502|NCT02184351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110970503|NCT02184351|Antifungal Agents|antifungal agents|mesh-ancestor
110970504|NCT02184351|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110970505|NCT02184351|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110970506|NCT02184351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110970507|NCT02184351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110970508|NCT02184351|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110970509|NCT02184351|Hormone Antagonists|hormone antagonists|mesh-ancestor
110970510|NCT02184351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110970511|NCT02184351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110970512|NCT02184351|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110970513|NCT02184351|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110970514|NCT02184429|PF-06669571|pf-06669571|mesh-list
110970515|NCT02184429|Dopamine Agonists|dopamine agonists|mesh-ancestor
110970516|NCT02184429|Dopamine Agents|dopamine agents|mesh-ancestor
110970517|NCT02184429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110970518|NCT02184429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110970519|NCT02184429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110970520|NCT02484170|Mannitol|mannitol|mesh-list
110970521|NCT02484170|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110970522|NCT02484170|Diuretics|diuretics|mesh-ancestor
110970523|NCT02484170|Natriuretic Agents|natriuretic agents|mesh-ancestor
110970524|NCT02484170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110970525|NCT02188407|Propofol|propofol|mesh-list
110970526|NCT02188407|Sevoflurane|sevoflurane|mesh-list
110970527|NCT02188407|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110799553|NCT03752931|Autonomic Agents|autonomic agents|mesh-ancestor
110970528|NCT02188407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110970529|NCT02188407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110970530|NCT02188407|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110970531|NCT02188407|Anesthetics, General|anesthetics, general|mesh-ancestor
110970532|NCT02188407|Anesthetics|anesthetics|mesh-ancestor
110970533|NCT02188407|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110970534|NCT02188407|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110970535|NCT03317210|Epoetin Alfa|epoetin alfa|mesh-list
110970536|NCT03317210|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
110970537|NCT03317210|Hematinics|hematinics|mesh-ancestor
110970538|NCT02488694|Pemetrexed|pemetrexed|mesh-list
110970539|NCT02488694|Afatinib|afatinib|mesh-list
110970540|NCT02488694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110970541|NCT02488694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110970542|NCT02488694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110970543|NCT02488694|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110970544|NCT02488694|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110970545|NCT02488694|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110970546|NCT03316898|Memantine|memantine|mesh-list
110970547|NCT03316898|Donepezil|donepezil|mesh-list
110970548|NCT03316898|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111491258|NCT06011746|Ketamine|ketamine|mesh-list
111491259|NCT06011746|Levobupivacaine|levobupivacaine|mesh-list
110970549|NCT03316898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111491260|NCT06011746|Analgesics|analgesics|mesh-ancestor
111491261|NCT06011746|Sensory System Agents|sensory system agents|mesh-ancestor
110970550|NCT03316898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110970551|NCT03316898|Cholinergic Agents|cholinergic agents|mesh-ancestor
110970552|NCT03316898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110970553|NCT03316898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110970554|NCT03316898|Nootropic Agents|nootropic agents|mesh-ancestor
110970555|NCT03316898|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110970556|NCT03316898|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110970557|NCT03316898|Dopamine Agents|dopamine agents|mesh-ancestor
110970558|NCT03316898|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110970559|NCT03316898|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110970560|NCT02188953|Calcium, Dietary|calcium, dietary|mesh-list
110970561|NCT02188953|Calcium Carbonate|calcium carbonate|mesh-list
110970562|NCT02188953|Calcium|calcium|mesh-list
110970563|NCT02188953|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110970564|NCT02188953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110970565|NCT02188953|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110970566|NCT02188953|Antacids|antacids|mesh-ancestor
110970567|NCT02188953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110970568|NCT02188953|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110970569|NCT02184819|Riboflavin|riboflavin|mesh-list
110970570|NCT02184819|Simendan|simendan|mesh-list
110970571|NCT02184819|Vitamin B Complex|vitamin b complex|mesh-ancestor
110970572|NCT02184819|Vitamins|vitamins|mesh-ancestor
110970573|NCT02184819|Micronutrients|micronutrients|mesh-ancestor
110970574|NCT02184819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110970575|NCT02184819|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110970576|NCT02184819|Dermatologic Agents|dermatologic agents|mesh-ancestor
110970577|NCT02184819|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110970578|NCT02184819|Vasodilator Agents|vasodilator agents|mesh-ancestor
110970579|NCT02184819|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110970580|NCT02184819|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110970581|NCT02184819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110970582|NCT02184819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110970583|NCT02184819|Protective Agents|protective agents|mesh-ancestor
110970584|NCT02256813|Vitamin K|vitamin k|mesh-list
110970585|NCT02256813|Vitamin K 1|vitamin k 1|mesh-list
110970586|NCT02256813|Midazolam|midazolam|mesh-list
110970587|NCT02256813|Dextromethorphan|dextromethorphan|mesh-list
110970588|NCT02256813|Caffeine|caffeine|mesh-list
110970589|NCT02256813|Omeprazole|omeprazole|mesh-list
110970590|NCT02256813|Warfarin|warfarin|mesh-list
110970591|NCT02256813|Vitamins|vitamins|mesh-ancestor
110970592|NCT02256813|Micronutrients|micronutrients|mesh-ancestor
110970593|NCT02256813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110970594|NCT02256813|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110970595|NCT02256813|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110970596|NCT02256813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110970597|NCT02256813|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110970598|NCT02256813|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110970599|NCT02256813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110970600|NCT02256813|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110970601|NCT02256813|Anesthetics, General|anesthetics, general|mesh-ancestor
110970602|NCT02256813|Anesthetics|anesthetics|mesh-ancestor
110970603|NCT02256813|GABA Modulators|gaba modulators|mesh-ancestor
110970604|NCT02256813|GABA Agents|gaba agents|mesh-ancestor
110970605|NCT02256813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110970606|NCT02256813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110970607|NCT02256813|Anticoagulants|anticoagulants|mesh-ancestor
110970608|NCT02256813|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110970609|NCT02256813|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110970610|NCT02256813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110970611|NCT02256813|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110970612|NCT02256813|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110970613|NCT02256813|Purinergic Agents|purinergic agents|mesh-ancestor
110970614|NCT02256813|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110970615|NCT02256813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110970616|NCT02256813|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110970617|NCT02256813|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110970618|NCT02256813|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111491262|NCT06011746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111491263|NCT06011746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110970619|NCT02256813|Hemostatics|hemostatics|mesh-ancestor
110970620|NCT02256813|Coagulants|coagulants|mesh-ancestor
111491264|NCT06011746|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111491265|NCT06011746|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110970621|NCT02256813|Antitussive Agents|antitussive agents|mesh-ancestor
110970622|NCT02256813|Respiratory System Agents|respiratory system agents|mesh-ancestor
110699362|NCT00372060|Pioglitazone|pioglitazone|mesh-list
111491266|NCT06011746|Anesthetics, General|anesthetics, general|mesh-ancestor
110970623|NCT02256813|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110970624|NCT02256813|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110970625|NCT02479958|Chlorhexidine|chlorhexidine|mesh-list
110970626|NCT02479958|Anti-Infective Agents|anti-infective agents|mesh-list
110970627|NCT02479958|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110970628|NCT02479958|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110970629|NCT02479958|Disinfectants|disinfectants|mesh-ancestor
110970630|NCT02483624|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
110970631|NCT02483624|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110970632|NCT02483624|Protective Agents|protective agents|mesh-ancestor
110970633|NCT02483624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110970634|NCT02483624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110970635|NCT02184897|Lenograstim|lenograstim|mesh-list
110970636|NCT02184897|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110970637|NCT02184897|Immunologic Factors|immunologic factors|mesh-ancestor
110970638|NCT02184897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110970639|NCT02184975|Hemostatics|hemostatics|mesh-list
110970640|NCT02184975|Coagulants|coagulants|mesh-ancestor
110970641|NCT02189343|Thalidomide|thalidomide|mesh-list
110970642|NCT02189343|Dexamethasone|dexamethasone|mesh-list
110970643|NCT02189343|Dexamethasone acetate|dexamethasone acetate|mesh-list
110970644|NCT02189343|Pomalidomide|pomalidomide|mesh-list
110970645|NCT02189343|Ricolinostat|ricolinostat|mesh-list
110970646|NCT02189343|BB 1101|bb 1101|mesh-list
110970647|NCT02189343|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110970648|NCT02189343|Antiemetics|antiemetics|mesh-ancestor
110970649|NCT02189343|Autonomic Agents|autonomic agents|mesh-ancestor
110970650|NCT02189343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110970651|NCT02189343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110970652|NCT02189343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110970653|NCT02189343|Glucocorticoids|glucocorticoids|mesh-ancestor
110970654|NCT02189343|Hormones|hormones|mesh-ancestor
110970655|NCT02189343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110970656|NCT02189343|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110970657|NCT02189343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110970658|NCT02189343|Protease Inhibitors|protease inhibitors|mesh-ancestor
110970659|NCT02189343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110970660|NCT02189343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110970661|NCT02189343|Immunologic Factors|immunologic factors|mesh-ancestor
110970662|NCT02189343|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110970663|NCT02189343|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110970664|NCT02189343|Growth Substances|growth substances|mesh-ancestor
110970665|NCT02189343|Growth Inhibitors|growth inhibitors|mesh-ancestor
110970666|NCT02189343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110970667|NCT02189343|Leprostatic Agents|leprostatic agents|mesh-ancestor
110970668|NCT02189343|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110970669|NCT02189343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110970670|NCT02189343|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110970671|NCT03535701|Paclitaxel|paclitaxel|mesh-list
110970672|NCT03535701|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110970673|NCT03535701|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110970674|NCT03535701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110970675|NCT03535701|Tubulin Modulators|tubulin modulators|mesh-ancestor
110970676|NCT03535701|Antimitotic Agents|antimitotic agents|mesh-ancestor
110970677|NCT03535701|Mitosis Modulators|mitosis modulators|mesh-ancestor
110970678|NCT03535701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110970679|NCT02486276|Cilostazol|cilostazol|mesh-list
110970680|NCT02486276|Sumatriptan|sumatriptan|mesh-list
110970681|NCT02486276|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110970682|NCT02486276|Autonomic Agents|autonomic agents|mesh-ancestor
110970683|NCT02486276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110970684|NCT02486276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110970685|NCT02486276|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110970686|NCT02486276|Respiratory System Agents|respiratory system agents|mesh-ancestor
110970687|NCT02486276|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110970688|NCT02486276|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110970689|NCT02486276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110970690|NCT02486276|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110970691|NCT02486276|Vasodilator Agents|vasodilator agents|mesh-ancestor
110970692|NCT02486276|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110970693|NCT02486276|Protective Agents|protective agents|mesh-ancestor
110970694|NCT02486276|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
111491267|NCT06011746|Anesthetics|anesthetics|mesh-ancestor
110970695|NCT02486276|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110970696|NCT02486276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110699367|NCT00372060|Hormones|hormones|mesh-ancestor
111491268|NCT06011746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111491269|NCT06011746|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111491270|NCT06011746|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111491271|NCT06011746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111491272|NCT06011746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111491273|NCT06011746|Anesthetics, Local|anesthetics, local|mesh-ancestor
111491274|NCT06002607|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111491275|NCT06002607|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
111491276|NCT06002607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111491277|NCT06002607|Antitubercular Agents|antitubercular agents|mesh-ancestor
111491278|NCT05997134|Ketamine|ketamine|mesh-list
111491279|NCT05997134|Analgesics|analgesics|mesh-ancestor
111491280|NCT05997134|Sensory System Agents|sensory system agents|mesh-ancestor
111491281|NCT05997134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111491282|NCT05997134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111491283|NCT05997134|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111491284|NCT05997134|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110970697|NCT02486276|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110970698|NCT02486276|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110970699|NCT02486276|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110970700|NCT02486276|Serotonin Agents|serotonin agents|mesh-ancestor
110970701|NCT02486276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110970702|NCT02189577|Glycopyrrolate|glycopyrrolate|mesh-list
110970703|NCT02189577|Bromides|bromides|mesh-list
110970704|NCT02189577|Anticonvulsants|anticonvulsants|mesh-ancestor
110970705|NCT02189577|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110970706|NCT02189577|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110970707|NCT02189577|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110970708|NCT02189577|Cholinergic Agents|cholinergic agents|mesh-ancestor
110970709|NCT02189577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110970710|NCT02189577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110970711|NCT02189577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110970712|NCT02189655|Bupivacaine|bupivacaine|mesh-list
110970713|NCT02189655|Anesthetics, Local|anesthetics, local|mesh-ancestor
110970714|NCT02189655|Anesthetics|anesthetics|mesh-ancestor
110687804|NCT00467142|Leucovorin|leucovorin|mesh-list
110970715|NCT02189655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110970716|NCT02189655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110970717|NCT02189655|Sensory System Agents|sensory system agents|mesh-ancestor
110970718|NCT02189655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110970719|NCT04633863|Lubricant Eye Drops|lubricant eye drops|mesh-list
110970720|NCT04633863|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110970721|NCT04633863|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110970722|NCT02193633|Paclitaxel|paclitaxel|mesh-list
110970723|NCT02193633|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110970724|NCT02193633|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110970725|NCT02193633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110970726|NCT02193633|Tubulin Modulators|tubulin modulators|mesh-ancestor
110970727|NCT02193633|Antimitotic Agents|antimitotic agents|mesh-ancestor
110970728|NCT02193633|Mitosis Modulators|mitosis modulators|mesh-ancestor
110970729|NCT02193633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110970730|NCT03315338|Prednisone|prednisone|mesh-list
110970731|NCT03315338|Cortisone|cortisone|mesh-list
110970732|NCT03315338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110970733|NCT03315338|Glucocorticoids|glucocorticoids|mesh-ancestor
110970734|NCT03315338|Hormones|hormones|mesh-ancestor
110970735|NCT03315338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110970736|NCT03315338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110970737|NCT03315338|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110970738|NCT03315338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110970739|NCT02483156|Ribavirin|ribavirin|mesh-list
110970740|NCT02483156|Sofosbuvir|sofosbuvir|mesh-list
110970741|NCT02483156|Antimetabolites|antimetabolites|mesh-ancestor
110970742|NCT02483156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110970743|NCT02483156|Antiviral Agents|antiviral agents|mesh-ancestor
110970744|NCT02483156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110970745|NCT00706004|Lubiprostone|lubiprostone|mesh-list
110970746|NCT00706004|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
110970747|NCT00706004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110970748|NCT00706004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110970749|NCT02485340|Isosorbide|isosorbide|mesh-list
110970750|NCT02485340|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
110970751|NCT02485340|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
110970752|NCT02485340|Sumatriptan|sumatriptan|mesh-list
110970753|NCT02485340|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111491285|NCT05997134|Anesthetics, General|anesthetics, general|mesh-ancestor
111491286|NCT05997134|Anesthetics|anesthetics|mesh-ancestor
110970754|NCT02485340|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110970755|NCT02485340|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110970756|NCT02485340|Serotonin Agents|serotonin agents|mesh-ancestor
110970757|NCT02485340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110970758|NCT02485340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110970759|NCT02485340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110970760|NCT02485340|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110970761|NCT02485340|Diuretics|diuretics|mesh-ancestor
110970762|NCT02485340|Natriuretic Agents|natriuretic agents|mesh-ancestor
110970763|NCT02485340|Vasodilator Agents|vasodilator agents|mesh-ancestor
110970764|NCT02485340|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
110970765|NCT04492514|Mavrilimumab|mavrilimumab|mesh-list
110970766|NCT04492514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110970767|NCT02485262|Sofosbuvir|sofosbuvir|mesh-list
110970768|NCT02485262|Simeprevir|simeprevir|mesh-list
110970769|NCT02485262|Antiviral Agents|antiviral agents|mesh-ancestor
110970770|NCT02485262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110970771|NCT02485262|Protease Inhibitors|protease inhibitors|mesh-ancestor
110970772|NCT02485262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110970773|NCT02485262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110970774|NCT02479490|Prednisone|prednisone|mesh-list
110970775|NCT02479490|Everolimus|everolimus|mesh-list
110970776|NCT02479490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110970777|NCT02479490|Glucocorticoids|glucocorticoids|mesh-ancestor
110970778|NCT02479490|Hormones|hormones|mesh-ancestor
110970779|NCT02479490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110970780|NCT02479490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110970781|NCT02479490|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110970782|NCT02479490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110970783|NCT02479490|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110970784|NCT02479490|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110970785|NCT02479490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110970786|NCT02479490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110970787|NCT02479490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110970788|NCT02479490|Immunologic Factors|immunologic factors|mesh-ancestor
110970789|NCT02479256|Tamoxifen|tamoxifen|mesh-list
110970790|NCT02479256|Citric Acid|citric acid|mesh-list
110970791|NCT02479256|Sodium Citrate|sodium citrate|mesh-list
110970792|NCT02479256|Clomiphene|clomiphene|mesh-list
110970793|NCT02479256|Enclomiphene|enclomiphene|mesh-list
110970794|NCT02479256|Zuclomiphene|zuclomiphene|mesh-list
110970795|NCT02479256|Anticoagulants|anticoagulants|mesh-ancestor
110970796|NCT02479256|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110970797|NCT02479256|Chelating Agents|chelating agents|mesh-ancestor
110970798|NCT02479256|Sequestering Agents|sequestering agents|mesh-ancestor
110970799|NCT02479256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110970800|NCT02479256|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110970801|NCT02479256|Hormone Antagonists|hormone antagonists|mesh-ancestor
110970802|NCT02479256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110970803|NCT02479256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110970804|NCT02479256|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110970805|NCT02479256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110970806|NCT02479256|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110970807|NCT02479256|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110970808|NCT02479256|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110970809|NCT02479256|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110970810|NCT02479256|Fertility Agents|fertility agents|mesh-ancestor
110970811|NCT02479256|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110970812|NCT02482766|Poractant alfa|poractant alfa|mesh-list
110970813|NCT02482766|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
110970814|NCT02482766|Respiratory System Agents|respiratory system agents|mesh-ancestor
110970815|NCT04492280|Hydrocortisone|hydrocortisone|mesh-list
110970816|NCT04492280|Fludrocortisone|fludrocortisone|mesh-list
110970817|NCT04492280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110970818|NCT02479178|Docetaxel|docetaxel|mesh-list
110970819|NCT02479178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110970820|NCT02479178|Tubulin Modulators|tubulin modulators|mesh-ancestor
110970821|NCT02479178|Antimitotic Agents|antimitotic agents|mesh-ancestor
110970822|NCT02479178|Mitosis Modulators|mitosis modulators|mesh-ancestor
110970823|NCT02479178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111491287|NCT05997134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111491288|NCT05997134|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110970824|NCT03314792|Oxycodone|oxycodone|mesh-list
110970825|NCT03314792|Tapentadol|tapentadol|mesh-list
110970826|NCT03314792|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110970827|NCT03314792|Narcotics|narcotics|mesh-ancestor
110970828|NCT03314792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110970829|NCT03314792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110970830|NCT03314792|Analgesics|analgesics|mesh-ancestor
110970831|NCT03314792|Sensory System Agents|sensory system agents|mesh-ancestor
110970832|NCT03314792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110479105|NCT02591017|Anesthetics|anesthetics|mesh-ancestor
110970833|NCT03314792|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110970834|NCT03314792|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110970835|NCT03314792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110970836|NCT03314792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110970837|NCT03314792|Adrenergic Agents|adrenergic agents|mesh-ancestor
110970838|NCT03314792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110970839|NCT02476526|Acetylcysteine|acetylcysteine|mesh-list
110970840|NCT02476526|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110970841|NCT02476526|Antiviral Agents|antiviral agents|mesh-ancestor
110970842|NCT02476526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110970843|NCT02476526|Expectorants|expectorants|mesh-ancestor
110970844|NCT02476526|Respiratory System Agents|respiratory system agents|mesh-ancestor
110970845|NCT02476526|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110970846|NCT02476526|Antioxidants|antioxidants|mesh-ancestor
110970847|NCT02476526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110970848|NCT02476526|Protective Agents|protective agents|mesh-ancestor
110970849|NCT02476526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110970850|NCT02476526|Antidotes|antidotes|mesh-ancestor
110970851|NCT02479022|Insulin|insulin|mesh-list
110970852|NCT02479022|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110970853|NCT02479022|Insulin Glargine|insulin glargine|mesh-list
110970854|NCT02479022|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110970855|NCT02479022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110970856|NCT02476760|Insulin|insulin|mesh-list
110970857|NCT02476760|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110970858|NCT02476760|Metformin|metformin|mesh-list
110970859|NCT02476760|Pioglitazone|pioglitazone|mesh-list
110970860|NCT02476760|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110970861|NCT02476760|Liraglutide|liraglutide|mesh-list
110970862|NCT02476760|Exenatide|exenatide|mesh-list
110970863|NCT02476760|Glimepiride|glimepiride|mesh-list
110970864|NCT02476760|Rosiglitazone|rosiglitazone|mesh-list
110970865|NCT02476760|Vildagliptin|vildagliptin|mesh-list
110970866|NCT02476760|Saxagliptin|saxagliptin|mesh-list
110970867|NCT02476760|Acarbose|acarbose|mesh-list
110970868|NCT02476760|Hypoglycemic Agents|hypoglycemic agents|mesh-list
110970869|NCT02476760|Repaglinide|repaglinide|mesh-list
110970870|NCT02476760|Gliclazide|gliclazide|mesh-list
110970871|NCT02476760|Glipizide|glipizide|mesh-list
110970872|NCT02476760|Biguanides|biguanides|mesh-list
110970873|NCT02476760|Tolbutamide|tolbutamide|mesh-list
110970874|NCT02476760|Voglibose|voglibose|mesh-list
110970875|NCT02476760|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
110970876|NCT02476760|Nateglinide|nateglinide|mesh-list
110970877|NCT02476760|Miglitol|miglitol|mesh-list
110970878|NCT02476760|Troglitazone|troglitazone|mesh-list
110970879|NCT02476760|Meglitinide|meglitinide|mesh-list
110970880|NCT02476760|Acetohexamide|acetohexamide|mesh-list
110970881|NCT02476760|Phenformin|phenformin|mesh-list
110970882|NCT02476760|Chlorpropamide|chlorpropamide|mesh-list
110970883|NCT02476760|Buformin|buformin|mesh-list
110970884|NCT02476760|Glibornuride|glibornuride|mesh-list
110970885|NCT02476760|Tolazamide|tolazamide|mesh-list
110970886|NCT02476760|Carbutamide|carbutamide|mesh-list
110970887|NCT02476760|Gliquidone|gliquidone|mesh-list
110970888|NCT02476760|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
110970889|NCT02476760|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
110970890|NCT02476760|Incretins|incretins|mesh-list
110970891|NCT02476760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110970892|NCT02476760|Hormones|hormones|mesh-ancestor
110970893|NCT02476760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110970894|NCT02476760|Protease Inhibitors|protease inhibitors|mesh-ancestor
110970895|NCT02476760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110970896|NCT02476760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110970897|NCT02476760|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111491289|NCT05997134|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110970898|NCT02476760|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110970899|NCT02476760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110970900|NCT02476760|Immunologic Factors|immunologic factors|mesh-ancestor
111491290|NCT05997134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110970901|NCT05460338|Cholecalciferol|cholecalciferol|mesh-list
110970902|NCT05460338|Vitamin D|vitamin d|mesh-list
110970903|NCT05460338|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110970904|NCT05460338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110970905|NCT05460338|Vitamins|vitamins|mesh-ancestor
110970906|NCT05460338|Micronutrients|micronutrients|mesh-ancestor
110970907|NCT05460338|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110970908|NCT02476136|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110970909|NCT02476136|Fluoxetine|fluoxetine|mesh-list
110970910|NCT02476136|Paroxetine|paroxetine|mesh-list
110970911|NCT02476136|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
110970912|NCT02476136|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110970913|NCT02476136|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110970914|NCT02476136|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110970915|NCT02476136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110970916|NCT02476136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110970917|NCT02476136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110970918|NCT02476136|Analgesics|analgesics|mesh-ancestor
110970919|NCT02476136|Sensory System Agents|sensory system agents|mesh-ancestor
110970920|NCT02476136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110970921|NCT02476136|Antidepressive Agents|antidepressive agents|mesh-ancestor
110970922|NCT02476136|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110970923|NCT02476136|Dopamine Agents|dopamine agents|mesh-ancestor
110970924|NCT02476136|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110970925|NCT02476136|Serotonin Agents|serotonin agents|mesh-ancestor
110970926|NCT02476136|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110970927|NCT02476136|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110970928|NCT02476136|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110970929|NCT02476136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110970930|NCT05437094|Itraconazole|itraconazole|mesh-list
110970931|NCT05437094|Antifungal Agents|antifungal agents|mesh-ancestor
110970932|NCT05437094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110970933|NCT05437094|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110970934|NCT05437094|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110970935|NCT05437094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110970936|NCT05437094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110970937|NCT05437094|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110970938|NCT05437094|Hormone Antagonists|hormone antagonists|mesh-ancestor
110970939|NCT05437094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110970940|NCT05437094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110970941|NCT05437094|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110970942|NCT05413772|Temocillin|temocillin|mesh-list
110970943|NCT05413772|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110970944|NCT05413772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110970945|NCT05713292|Pirfenidone|pirfenidone|mesh-list
110970946|NCT05713292|Analgesics|analgesics|mesh-ancestor
110970947|NCT05713292|Sensory System Agents|sensory system agents|mesh-ancestor
110970948|NCT05713292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110970949|NCT05713292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110970950|NCT05713292|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110970951|NCT05713292|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110970952|NCT05713292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110970953|NCT05713292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110970954|NCT05713292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110970956|NCT02475824|Meperidine|meperidine|mesh-list
110970957|NCT02475824|Dexmedetomidine|dexmedetomidine|mesh-list
110970958|NCT02475824|Propofol|propofol|mesh-list
110970959|NCT02475824|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110970960|NCT02475824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110970961|NCT02475824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110970962|NCT02475824|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110970963|NCT02475824|Analgesics|analgesics|mesh-ancestor
110970964|NCT02475824|Sensory System Agents|sensory system agents|mesh-ancestor
110970965|NCT02475824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110970966|NCT02475824|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110970967|NCT02475824|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110970968|NCT02475824|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110970969|NCT02475824|Adrenergic Agents|adrenergic agents|mesh-ancestor
110970970|NCT02475824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110970971|NCT02475824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110970972|NCT02475824|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110970973|NCT02475824|Anesthetics, General|anesthetics, general|mesh-ancestor
110970974|NCT02475824|Anesthetics|anesthetics|mesh-ancestor
110970975|NCT02475824|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110970976|NCT02475824|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110970977|NCT02475824|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110970978|NCT02475824|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110970979|NCT02475824|GABA Modulators|gaba modulators|mesh-ancestor
111491291|NCT05997134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111491292|NCT05982990|Fluticasone|fluticasone|mesh-list
111491293|NCT05982990|Xhance|xhance|mesh-list
110970980|NCT02475824|GABA Agents|gaba agents|mesh-ancestor
110970981|NCT02475824|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110970982|NCT02475824|Narcotics|narcotics|mesh-ancestor
110970983|NCT02478242|Nafamostat|nafamostat|mesh-list
110970984|NCT02478242|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110970985|NCT02478242|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110970986|NCT02478242|Analgesics|analgesics|mesh-ancestor
110970987|NCT02478242|Sensory System Agents|sensory system agents|mesh-ancestor
110970988|NCT02478242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110970989|NCT02478242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110970990|NCT02478242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110970991|NCT02478242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110970992|NCT02478242|Anticoagulants|anticoagulants|mesh-ancestor
110970993|NCT02478242|Protease Inhibitors|protease inhibitors|mesh-ancestor
110970994|NCT02478242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110970995|NCT02478242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110970996|NCT02478242|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
110970997|NCT02478242|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110970998|NCT02478242|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
110970999|NCT02478242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110971000|NCT02478242|Immunologic Factors|immunologic factors|mesh-ancestor
110971001|NCT02475746|Itraconazole|itraconazole|mesh-list
110971002|NCT02475746|PF-06372865|pf-06372865|mesh-list
110971003|NCT02475746|Antifungal Agents|antifungal agents|mesh-ancestor
110971004|NCT02475746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110971005|NCT02475746|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110971006|NCT02475746|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110971007|NCT02475746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110971008|NCT02475746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110971009|NCT02475746|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110971010|NCT02475746|Hormone Antagonists|hormone antagonists|mesh-ancestor
110971011|NCT02475746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110971012|NCT02475746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110971013|NCT02475746|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110971014|NCT02475746|GABA Modulators|gaba modulators|mesh-ancestor
110971015|NCT02475746|GABA Agents|gaba agents|mesh-ancestor
110971016|NCT02475746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110971017|NCT05715164|Nicotine|nicotine|mesh-list
110971018|NCT05715164|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110971019|NCT05715164|Autonomic Agents|autonomic agents|mesh-ancestor
110971020|NCT05715164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110971021|NCT05715164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110971022|NCT05715164|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110971023|NCT05715164|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110971024|NCT05715164|Cholinergic Agents|cholinergic agents|mesh-ancestor
110971025|NCT05715164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110971026|NCT05715164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110971027|NCT02475356|Levonorgestrel|levonorgestrel|mesh-list
110971028|NCT02475356|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110971029|NCT02475356|Contraceptive Agents|contraceptive agents|mesh-ancestor
110971030|NCT02475356|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110971031|NCT02475356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110971032|NCT02475356|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110971033|NCT02475356|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110971034|NCT02475356|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110971035|NCT02480894|Maraviroc|maraviroc|mesh-list
110971036|NCT02480894|Fostemsavir|fostemsavir|mesh-list
110971037|NCT02480894|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110971038|NCT02480894|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110971039|NCT02480894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110971040|NCT02480894|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110971041|NCT02480894|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110971042|NCT02480894|Antiviral Agents|antiviral agents|mesh-ancestor
110971043|NCT02480894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110971044|NCT02480894|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
110971045|NCT02474654|Ketorolac|ketorolac|mesh-list
110971046|NCT02474654|Epinephrine|epinephrine|mesh-list
110971047|NCT02474654|Racepinephrine|racepinephrine|mesh-list
110971048|NCT02474654|Fentanyl|fentanyl|mesh-list
110971049|NCT02474654|Bupivacaine|bupivacaine|mesh-list
111491294|NCT05982990|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
111491295|NCT05982990|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
111491296|NCT05982990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111491297|NCT05982990|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110971050|NCT02474654|Epinephryl borate|epinephryl borate|mesh-list
111491298|NCT05982990|Autonomic Agents|autonomic agents|mesh-ancestor
110971051|NCT02474654|Anesthetics, Local|anesthetics, local|mesh-ancestor
110971052|NCT02474654|Anesthetics|anesthetics|mesh-ancestor
110971053|NCT02474654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110971054|NCT02474654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110971055|NCT02474654|Sensory System Agents|sensory system agents|mesh-ancestor
110971056|NCT02474654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110971057|NCT02474654|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110971058|NCT02474654|Narcotics|narcotics|mesh-ancestor
110971059|NCT02474654|Analgesics|analgesics|mesh-ancestor
110971060|NCT02474654|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110971061|NCT02474654|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110971062|NCT02474654|Anesthetics, General|anesthetics, general|mesh-ancestor
110971063|NCT02474654|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110971064|NCT02474654|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110971065|NCT02474654|Adrenergic Agents|adrenergic agents|mesh-ancestor
110971066|NCT02474654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110971067|NCT02474654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110971068|NCT02474654|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110971069|NCT02474654|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110971070|NCT02474654|Autonomic Agents|autonomic agents|mesh-ancestor
110971071|NCT02474654|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110971072|NCT02474654|Respiratory System Agents|respiratory system agents|mesh-ancestor
110971073|NCT02474654|Mydriatics|mydriatics|mesh-ancestor
110971074|NCT02474654|Sympathomimetics|sympathomimetics|mesh-ancestor
110971075|NCT02474654|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110971076|NCT02474654|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110971077|NCT02474654|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110971078|NCT02474654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110971079|NCT02474654|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110971080|NCT02474654|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110971081|NCT02474654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110971082|NCT02477852|Rifampin|rifampin|mesh-list
110971083|NCT02477852|Isoniazid|isoniazid|mesh-list
110971084|NCT02477852|Pyrazinamide|pyrazinamide|mesh-list
110971085|NCT02477852|Ethambutol|ethambutol|mesh-list
110971086|NCT02477852|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110971087|NCT02477852|Antitubercular Agents|antitubercular agents|mesh-ancestor
110971088|NCT02477852|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110971089|NCT02477852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110971090|NCT02477852|Leprostatic Agents|leprostatic agents|mesh-ancestor
110971091|NCT02477852|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110971092|NCT02477852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110971093|NCT02477852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110971094|NCT02477852|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110971095|NCT02477852|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110971096|NCT02477852|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110971097|NCT02477852|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110971098|NCT02477852|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110971099|NCT02477852|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110971100|NCT02477852|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
110971101|NCT02477852|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110971102|NCT02477852|Antimetabolites|antimetabolites|mesh-ancestor
110971103|NCT02477852|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110971104|NCT02474810|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
110971105|NCT02474810|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110971106|NCT02474810|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110971107|NCT02474810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110971108|NCT02725268|Paclitaxel|paclitaxel|mesh-list
110971109|NCT02725268|Serabelisib|serabelisib|mesh-list
110971110|NCT02725268|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110971111|NCT02725268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110971112|NCT02725268|Tubulin Modulators|tubulin modulators|mesh-ancestor
110971113|NCT02725268|Antimitotic Agents|antimitotic agents|mesh-ancestor
110971114|NCT02725268|Mitosis Modulators|mitosis modulators|mesh-ancestor
110971115|NCT02725268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110971116|NCT02725268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110971117|NCT05038592|Decitabine|decitabine|mesh-list
110971118|NCT05038592|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110971119|NCT05038592|Antimetabolites|antimetabolites|mesh-ancestor
110971120|NCT05038592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111491299|NCT05982990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111491300|NCT05982990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110971121|NCT05038592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110699396|NCT00396318|Tenecteplase|tenecteplase|mesh-list
111491301|NCT05982990|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111491302|NCT05982990|Respiratory System Agents|respiratory system agents|mesh-ancestor
111491303|NCT05982990|Dermatologic Agents|dermatologic agents|mesh-ancestor
110971122|NCT05038592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110971123|NCT00705536|Insulin|insulin|mesh-list
110971124|NCT00705536|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110971125|NCT00705536|Insulin Lispro|insulin lispro|mesh-list
110971126|NCT00705536|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110971127|NCT00705536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110971128|NCT02474420|Amlodipine|amlodipine|mesh-list
110971129|NCT02474420|Deferasirox|deferasirox|mesh-list
110971130|NCT02474420|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110971131|NCT02474420|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110971132|NCT02474420|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110971133|NCT02474420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110971134|NCT02474420|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110971135|NCT02474420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110971136|NCT02474420|Vasodilator Agents|vasodilator agents|mesh-ancestor
110971137|NCT02474420|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110971138|NCT02474420|Chelating Agents|chelating agents|mesh-ancestor
110971139|NCT02474420|Sequestering Agents|sequestering agents|mesh-ancestor
110971140|NCT02474186|Paclitaxel|paclitaxel|mesh-list
110971141|NCT02474186|Docetaxel|docetaxel|mesh-list
110971142|NCT02474186|Capecitabine|capecitabine|mesh-list
110971143|NCT02474186|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110971144|NCT02474186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110971145|NCT02474186|Tubulin Modulators|tubulin modulators|mesh-ancestor
110971146|NCT02474186|Antimitotic Agents|antimitotic agents|mesh-ancestor
110971147|NCT02474186|Mitosis Modulators|mitosis modulators|mesh-ancestor
110971148|NCT02474186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110971149|NCT02474186|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110971150|NCT02474186|Antimetabolites|antimetabolites|mesh-ancestor
110971151|NCT02477306|Rabeprazole|rabeprazole|mesh-list
110971152|NCT02477306|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110971153|NCT02477306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110971154|NCT02477306|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110971155|NCT02477306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110799554|NCT03752931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110971156|NCT02477306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110971157|NCT04868786|Mycophenolic Acid|mycophenolic acid|mesh-list
110971158|NCT04868786|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110971159|NCT04868786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110971160|NCT04868786|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110971161|NCT04868786|Antitubercular Agents|antitubercular agents|mesh-ancestor
110971162|NCT04868786|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110971163|NCT04868786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110971164|NCT04868786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110971165|NCT04868786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110971166|NCT02472626|Thioctic Acid|thioctic acid|mesh-list
110971167|NCT02472626|Cytarabine|cytarabine|mesh-list
110971168|NCT02472626|Daunorubicin|daunorubicin|mesh-list
110971169|NCT02472626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110971170|NCT02472626|Antimetabolites|antimetabolites|mesh-ancestor
110971171|NCT02472626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110971172|NCT02472626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110971173|NCT02472626|Antiviral Agents|antiviral agents|mesh-ancestor
110971174|NCT02472626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110688237|NCT01025700|Nabilone|nabilone|mesh-list
110971175|NCT02472626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110971176|NCT02472626|Immunologic Factors|immunologic factors|mesh-ancestor
110971177|NCT02472626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110971178|NCT02472626|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110971179|NCT02472626|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110971180|NCT02472626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110971181|NCT02472626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110971182|NCT02472626|Antioxidants|antioxidants|mesh-ancestor
110971183|NCT02472626|Protective Agents|protective agents|mesh-ancestor
110971184|NCT02472626|Vitamin B Complex|vitamin b complex|mesh-ancestor
110971185|NCT02472626|Vitamins|vitamins|mesh-ancestor
110971186|NCT02472626|Micronutrients|micronutrients|mesh-ancestor
110971187|NCT02472392|Cyclophosphamide|cyclophosphamide|mesh-list
110971188|NCT02472392|Melphalan|melphalan|mesh-list
110971189|NCT02472392|Busulfan|busulfan|mesh-list
110971190|NCT02472392|Fludarabine|fludarabine|mesh-list
110971191|NCT02472392|Thymoglobulin|thymoglobulin|mesh-list
110971192|NCT02472392|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110971193|NCT02472392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110971194|NCT02472392|Immunologic Factors|immunologic factors|mesh-ancestor
110971195|NCT02472392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111491304|NCT05982990|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110971196|NCT02472392|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110971197|NCT02472392|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110971198|NCT02472392|Alkylating Agents|alkylating agents|mesh-ancestor
110971199|NCT02472392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110971200|NCT02472392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110971201|NCT02472392|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110971202|NCT02472158|Chlorhexidine|chlorhexidine|mesh-list
110971203|NCT02472158|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110971204|NCT02472158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110971205|NCT02472158|Disinfectants|disinfectants|mesh-ancestor
110971206|NCT02472080|Gemcitabine|gemcitabine|mesh-list
110971207|NCT02472080|Oxaliplatin|oxaliplatin|mesh-list
110971208|NCT02472080|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110971209|NCT02472080|Antimetabolites|antimetabolites|mesh-ancestor
110971210|NCT02472080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110971211|NCT02472080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110971212|NCT02473562|Varenicline|varenicline|mesh-list
110971213|NCT02473562|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110971214|NCT02473562|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110971215|NCT02473562|Cholinergic Agents|cholinergic agents|mesh-ancestor
110971216|NCT02473562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110971217|NCT02473562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110971218|NCT02473562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110971219|NCT02724020|Everolimus|everolimus|mesh-list
110971220|NCT02724020|Serabelisib|serabelisib|mesh-list
110971221|NCT02724020|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110971222|NCT02724020|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110971223|NCT02724020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110971224|NCT02724020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110971225|NCT02724020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110971226|NCT02724020|Immunologic Factors|immunologic factors|mesh-ancestor
110971227|NCT02724020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110971228|NCT02724020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110971229|NCT02660034|Tislelizumab|tislelizumab|mesh-list
110971230|NCT02660034|Pamiparib|pamiparib|mesh-list
110971231|NCT02660034|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110971232|NCT02660034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110971233|NCT02660034|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110971234|NCT02660034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110971235|NCT02660034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110971236|NCT02816736|Valsartan|valsartan|mesh-list
110971237|NCT02816736|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
110971238|NCT02816736|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110971239|NCT02816736|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110971240|NCT02816736|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110971241|NCT02816736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110971242|NCT02477072|Heparin|heparin|mesh-list
110971243|NCT02477072|Calcium heparin|calcium heparin|mesh-list
110971244|NCT02477072|Anticoagulants|anticoagulants|mesh-ancestor
110971245|NCT02477072|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110971246|NCT02477072|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110971247|NCT02477072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110971248|NCT05103410|Aripiprazole|aripiprazole|mesh-list
110971249|NCT05103410|Antidepressive Agents|antidepressive agents|mesh-ancestor
110971250|NCT05103410|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110971251|NCT05103410|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110971252|NCT05103410|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110971253|NCT05103410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110971254|NCT05103410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110971255|NCT05103410|Dopamine Agonists|dopamine agonists|mesh-ancestor
110971256|NCT05103410|Dopamine Agents|dopamine agents|mesh-ancestor
110971257|NCT05103410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110971258|NCT05103410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110971259|NCT05103410|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110971260|NCT05103410|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110971261|NCT05103410|Serotonin Agents|serotonin agents|mesh-ancestor
110971262|NCT05103410|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110971263|NCT05103410|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111491305|NCT05982990|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111491306|NCT05982990|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111491307|NCT05982990|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111491308|NCT05982990|Adrenergic Agents|adrenergic agents|mesh-ancestor
110971264|NCT05103410|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110971265|NCT05103410|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110971266|NCT02472236|Digoxin|digoxin|mesh-list
110971267|NCT02472236|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110971268|NCT02472236|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110971269|NCT02472236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110971270|NCT02472236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110971271|NCT02472236|Protective Agents|protective agents|mesh-ancestor
110971272|NCT02472236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110971273|NCT03108872|Anticoagulants|anticoagulants|mesh-list
110971274|NCT02194491|AS2471907|as2471907|mesh-list
110971275|NCT02194491|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110971276|NCT02194491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110971277|NCT03487770|Aripiprazole|aripiprazole|mesh-list
110971278|NCT03487770|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110971279|NCT03487770|Antidepressive Agents|antidepressive agents|mesh-ancestor
110971280|NCT03487770|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110971281|NCT03487770|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110971282|NCT03487770|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110971283|NCT03487770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110971284|NCT03487770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110971285|NCT03487770|Dopamine Agonists|dopamine agonists|mesh-ancestor
110971286|NCT03487770|Dopamine Agents|dopamine agents|mesh-ancestor
110971287|NCT03487770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110479163|NCT01029717|Leprostatic Agents|leprostatic agents|mesh-ancestor
110971288|NCT03487770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110971289|NCT03487770|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110971290|NCT03487770|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110971291|NCT03487770|Serotonin Agents|serotonin agents|mesh-ancestor
110971292|NCT03487770|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110971293|NCT03487770|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110971294|NCT03487770|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110971295|NCT03487770|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110971296|NCT02473328|Ritonavir|ritonavir|mesh-list
110971297|NCT02473328|Atazanavir Sulfate|atazanavir sulfate|mesh-list
110971298|NCT02473328|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110971299|NCT02473328|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110971300|NCT02473328|Protease Inhibitors|protease inhibitors|mesh-ancestor
110971301|NCT02473328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110971302|NCT02473328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110971303|NCT02473328|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110971304|NCT02473328|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110971305|NCT02473328|Antiviral Agents|antiviral agents|mesh-ancestor
110971306|NCT02473328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110971307|NCT02473328|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110971308|NCT02473328|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110971309|NCT02473406|Thymalfasin|thymalfasin|mesh-list
110971310|NCT02473406|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110971311|NCT02473406|Immunologic Factors|immunologic factors|mesh-ancestor
110971312|NCT02473406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110971313|NCT02473094|Metformin|metformin|mesh-list
110971314|NCT02473094|Capecitabine|capecitabine|mesh-list
110971315|NCT02473094|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110971316|NCT02473094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110971317|NCT02473094|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110971318|NCT02473094|Antimetabolites|antimetabolites|mesh-ancestor
110971319|NCT02473094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110971320|NCT02473094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110971321|NCT03492138|Dexamethasone|dexamethasone|mesh-list
110971322|NCT03492138|Ixazomib|ixazomib|mesh-list
110971323|NCT03492138|TIC10 compound|tic10 compound|mesh-list
110971324|NCT03492138|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110971325|NCT03492138|Antiemetics|antiemetics|mesh-ancestor
110971326|NCT03492138|Autonomic Agents|autonomic agents|mesh-ancestor
110971327|NCT03492138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110971328|NCT03492138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110971329|NCT03492138|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110971330|NCT03492138|Glucocorticoids|glucocorticoids|mesh-ancestor
110971331|NCT03492138|Hormones|hormones|mesh-ancestor
110971332|NCT03492138|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110971333|NCT03492138|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110971334|NCT03492138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111491309|NCT05982990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111491310|NCT05982990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111491311|NCT05982990|Glucocorticoids|glucocorticoids|mesh-ancestor
111491312|NCT05982990|Hormones|hormones|mesh-ancestor
110971335|NCT03492138|Protease Inhibitors|protease inhibitors|mesh-ancestor
110971336|NCT03492138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110971337|NCT03492138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110971338|NCT02472938|Dimethyl Fumarate|dimethyl fumarate|mesh-list
110971339|NCT02472938|Dermatologic Agents|dermatologic agents|mesh-ancestor
110971340|NCT02472938|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110479172|NCT00790036|Everolimus|everolimus|mesh-list
110971341|NCT02472938|Immunologic Factors|immunologic factors|mesh-ancestor
110971342|NCT02472938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110971343|NCT03131700|Bevacizumab|bevacizumab|mesh-list
110971344|NCT03131700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110971345|NCT03131700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110971346|NCT03131700|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110971347|NCT03131700|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110971348|NCT03131700|Growth Substances|growth substances|mesh-ancestor
110971349|NCT03131700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110971350|NCT03131700|Growth Inhibitors|growth inhibitors|mesh-ancestor
110971351|NCT04706936|Cyclophosphamide|cyclophosphamide|mesh-list
110971352|NCT04706936|Fludarabine|fludarabine|mesh-list
110971353|NCT04706936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110971354|NCT04706936|Immunologic Factors|immunologic factors|mesh-ancestor
110971355|NCT04706936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110971356|NCT04706936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110971357|NCT04706936|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110971358|NCT04706936|Alkylating Agents|alkylating agents|mesh-ancestor
110971359|NCT04706936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110971360|NCT04706936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110971361|NCT04706936|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110971362|NCT02194881|Ivacaftor|ivacaftor|mesh-list
110971363|NCT02194881|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
110971364|NCT02194881|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110971365|NCT02194881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110971366|NCT02194179|Nevirapine|nevirapine|mesh-list
110971367|NCT02194179|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110971368|NCT02194179|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110971369|NCT02194179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110971370|NCT02194179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110971371|NCT02194179|Antiviral Agents|antiviral agents|mesh-ancestor
110971372|NCT02194179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110971373|NCT02194179|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110971374|NCT02194179|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110971375|NCT02194179|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110971376|NCT02194179|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110971377|NCT02194257|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110971378|NCT02194257|Ambroxol|ambroxol|mesh-list
110971379|NCT02194257|Expectorants|expectorants|mesh-ancestor
110971380|NCT02194257|Respiratory System Agents|respiratory system agents|mesh-ancestor
110971381|NCT02195115|Amitriptyline|amitriptyline|mesh-list
110971382|NCT02195115|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110971383|NCT02195115|Antidepressive Agents|antidepressive agents|mesh-ancestor
110971384|NCT02195115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110971385|NCT02195115|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110971386|NCT02195115|Analgesics|analgesics|mesh-ancestor
110971387|NCT02195115|Sensory System Agents|sensory system agents|mesh-ancestor
110971388|NCT02195115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110971389|NCT02195115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110971390|NCT02195115|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110971391|NCT02195115|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110971392|NCT02195115|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110971393|NCT02195115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110971394|NCT02195115|Adrenergic Agents|adrenergic agents|mesh-ancestor
110971395|NCT02195115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110971396|NCT02194335|Olcegepant|olcegepant|mesh-list
110971397|NCT02194335|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
110688480|NCT01026714|Analgesics|analgesics|mesh-ancestor
110971398|NCT02194335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110971399|NCT02194335|Analgesics|analgesics|mesh-ancestor
110971400|NCT02194335|Sensory System Agents|sensory system agents|mesh-ancestor
110971401|NCT02194335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110971402|NCT02194335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110971403|NCT02195973|Paclitaxel|paclitaxel|mesh-list
111491313|NCT05982990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110699409|NCT00381888|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111491314|NCT05982990|Sympathomimetics|sympathomimetics|mesh-ancestor
111491315|NCT05979740|Disitamab vedotin|disitamab vedotin|mesh-list
111491316|NCT05979740|Immunoconjugates|immunoconjugates|mesh-ancestor
110971404|NCT02195973|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110971405|NCT02195973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110971406|NCT02195973|Tubulin Modulators|tubulin modulators|mesh-ancestor
110971407|NCT02195973|Antimitotic Agents|antimitotic agents|mesh-ancestor
110971408|NCT02195973|Mitosis Modulators|mitosis modulators|mesh-ancestor
110971409|NCT02195973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110971410|NCT02196207|Antibodies, Bispecific|antibodies, bispecific|mesh-list
110971411|NCT02196207|Immunologic Factors|immunologic factors|mesh-ancestor
110971412|NCT02196207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110971413|NCT02195271|Melatonin|melatonin|mesh-list
110971414|NCT02195271|Antioxidants|antioxidants|mesh-ancestor
110971415|NCT02195271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110971416|NCT02195271|Protective Agents|protective agents|mesh-ancestor
110971417|NCT02195271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110971418|NCT02195271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110971419|NCT02196285|Vaccines|vaccines|mesh-list
110971420|NCT02196285|Immunologic Factors|immunologic factors|mesh-ancestor
110971421|NCT02196285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110971422|NCT04229979|Cytarabine|cytarabine|mesh-list
110971423|NCT04229979|Azacitidine|azacitidine|mesh-list
110971424|NCT04229979|Decitabine|decitabine|mesh-list
110971425|NCT04229979|Venetoclax|venetoclax|mesh-list
110971426|NCT04229979|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110971427|NCT04229979|Antimetabolites|antimetabolites|mesh-ancestor
110971428|NCT04229979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110971429|NCT04229979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110971430|NCT04229979|Antiviral Agents|antiviral agents|mesh-ancestor
110971431|NCT04229979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110971432|NCT04229979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110971433|NCT04229979|Immunologic Factors|immunologic factors|mesh-ancestor
110971434|NCT04229979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110971435|NCT04229979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110971436|NCT02196441|Bupivacaine|bupivacaine|mesh-list
110971437|NCT02196441|Anesthetics, Local|anesthetics, local|mesh-list
110971438|NCT02196441|Tetracaine|tetracaine|mesh-list
110971439|NCT02196441|Anesthetics|anesthetics|mesh-list
110971440|NCT02196441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110971441|NCT02196441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110971442|NCT02196441|Sensory System Agents|sensory system agents|mesh-ancestor
110971443|NCT02196441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110971444|NCT02195661|Melatonin|melatonin|mesh-list
110971445|NCT02195661|Chloral Hydrate|chloral hydrate|mesh-list
110971446|NCT02195661|Antioxidants|antioxidants|mesh-ancestor
110971447|NCT02195661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110971448|NCT02195661|Protective Agents|protective agents|mesh-ancestor
110971449|NCT02195661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110971450|NCT02195661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110971451|NCT02195661|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110971452|NCT03534297|Dapansutrile|dapansutrile|mesh-list
110971453|NCT03534297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110971454|NCT02195817|Nalmefene|nalmefene|mesh-list
110971455|NCT02195817|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110971456|NCT02195817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110971457|NCT02195817|Sensory System Agents|sensory system agents|mesh-ancestor
110971458|NCT02195817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110971459|NCT03534063|Analgesics, Opioid|analgesics, opioid|mesh-list
110971460|NCT03534063|Narcotics|narcotics|mesh-ancestor
110971461|NCT03534063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110971462|NCT03534063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110971463|NCT03534063|Analgesics|analgesics|mesh-ancestor
110971464|NCT03534063|Sensory System Agents|sensory system agents|mesh-ancestor
110971465|NCT03534063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110971466|NCT02197143|Esomeprazole|esomeprazole|mesh-list
110971467|NCT02197143|Ranitidine|ranitidine|mesh-list
110971468|NCT02197143|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
110971469|NCT02197143|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110971470|NCT02197143|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110971471|NCT02197143|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110479189|NCT00789958|Gemcitabine|gemcitabine|mesh-list
110971472|NCT02197143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110971473|NCT02197143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110971474|NCT02197143|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110971475|NCT02197143|Histamine Antagonists|histamine antagonists|mesh-ancestor
110971476|NCT02197143|Histamine Agents|histamine agents|mesh-ancestor
110971477|NCT02197143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110971478|NCT02197143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111491317|NCT05979740|Immunologic Factors|immunologic factors|mesh-ancestor
111491318|NCT05979740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111491319|NCT05976347|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110971479|NCT02096874|Bevacizumab|bevacizumab|mesh-list
110971480|NCT02096874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110971481|NCT02096874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110971482|NCT02096874|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110971483|NCT02096874|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110971484|NCT02096874|Growth Substances|growth substances|mesh-ancestor
110971485|NCT02096874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110971486|NCT02096874|Growth Inhibitors|growth inhibitors|mesh-ancestor
110971487|NCT02198547|Magnesium Sulfate|magnesium sulfate|mesh-list
110971488|NCT02198547|Ropivacaine|ropivacaine|mesh-list
110971489|NCT02198547|Anesthetics, Local|anesthetics, local|mesh-ancestor
110971490|NCT02198547|Anesthetics|anesthetics|mesh-ancestor
110971491|NCT02198547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110971492|NCT02198547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110971493|NCT02198547|Sensory System Agents|sensory system agents|mesh-ancestor
110971494|NCT02198547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110971495|NCT02198547|Analgesics|analgesics|mesh-ancestor
110971496|NCT02198547|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110971497|NCT02198547|Anticonvulsants|anticonvulsants|mesh-ancestor
110971498|NCT02198547|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110971499|NCT02198547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110971500|NCT02198547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110971501|NCT02198547|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110971502|NCT02198547|Tocolytic Agents|tocolytic agents|mesh-ancestor
110971503|NCT02198547|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110971504|NCT01024608|Beclomethasone|beclomethasone|mesh-list
110971505|NCT01024608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110971506|NCT01024608|Glucocorticoids|glucocorticoids|mesh-ancestor
110971508|NCT01024608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110971509|NCT01024608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110971510|NCT01024608|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110971511|NCT01024608|Respiratory System Agents|respiratory system agents|mesh-ancestor
110971512|NCT03489798|Alprostadil|alprostadil|mesh-list
110971513|NCT03489798|Misoprostol|misoprostol|mesh-list
110971514|NCT03489798|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110971515|NCT03489798|Abortifacient Agents|abortifacient agents|mesh-ancestor
110971516|NCT03489798|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110971517|NCT03489798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110971518|NCT03489798|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110971519|NCT03489798|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110971520|NCT03489798|Oxytocics|oxytocics|mesh-ancestor
110971521|NCT03489798|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110971522|NCT03489798|Vasodilator Agents|vasodilator agents|mesh-ancestor
110971523|NCT03489798|Urological Agents|urological agents|mesh-ancestor
110971524|NCT02031081|Prucalopride|prucalopride|mesh-list
110971525|NCT02031081|Laxatives|laxatives|mesh-ancestor
110971526|NCT02031081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110971527|NCT02031081|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
110971528|NCT02031081|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110971529|NCT02031081|Serotonin Agents|serotonin agents|mesh-ancestor
110971530|NCT02031081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110971531|NCT02031081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110971532|NCT02031081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110971533|NCT02198859|Lithium Carbonate|lithium carbonate|mesh-list
110971534|NCT02198859|Antidepressive Agents|antidepressive agents|mesh-ancestor
110971535|NCT02198859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110971536|NCT02198859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110971537|NCT02198859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110971538|NCT02198859|Antimanic Agents|antimanic agents|mesh-ancestor
110971539|NCT02198859|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110971540|NCT02198859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110971541|NCT02198859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110971542|NCT02199171|Carboplatin|carboplatin|mesh-list
110971543|NCT02199171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110971544|NCT00910650|Aldesleukin|aldesleukin|mesh-list
110971545|NCT00910650|Interleukin-2|interleukin-2|mesh-list
110971546|NCT00910650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110971547|NCT00910650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110971548|NCT00910650|Analgesics|analgesics|mesh-ancestor
110971549|NCT00910650|Sensory System Agents|sensory system agents|mesh-ancestor
111491320|NCT05976347|Fluoxetine|fluoxetine|mesh-list
110971550|NCT00910650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111491321|NCT05976347|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111491322|NCT05976347|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111491323|NCT05976347|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110971551|NCT00910650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110971552|NCT00910650|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110971553|NCT00910650|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110971554|NCT00910650|Antiviral Agents|antiviral agents|mesh-ancestor
110971555|NCT00910650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110971556|NCT02199327|Interferons|interferons|mesh-list
110971557|NCT02199327|Interferon-alpha|interferon-alpha|mesh-list
110971558|NCT02199327|Interferon alpha-2|interferon alpha-2|mesh-list
110971559|NCT02199327|Mitomycins|mitomycins|mesh-list
110971560|NCT02199327|Mitomycin|mitomycin|mesh-list
110971561|NCT02199327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110971562|NCT02199327|Antiviral Agents|antiviral agents|mesh-ancestor
110971563|NCT02199327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110971564|NCT02199327|Immunologic Factors|immunologic factors|mesh-ancestor
110971565|NCT02199327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110971566|NCT02199327|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110971567|NCT02199327|Alkylating Agents|alkylating agents|mesh-ancestor
110971568|NCT02199327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110971569|NCT02199327|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110971570|NCT02199327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110971571|NCT00756288|Photosensitizing Agents|photosensitizing agents|mesh-list
110971572|NCT00756288|Dermatologic Agents|dermatologic agents|mesh-ancestor
110971573|NCT02198001|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110971574|NCT02198001|Amoxicillin|amoxicillin|mesh-list
110971575|NCT02198001|Clavulanic Acid|clavulanic acid|mesh-list
110971576|NCT02198001|Clavulanic Acids|clavulanic acids|mesh-list
110971577|NCT02198001|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
110971578|NCT02198001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110971579|NCT02198001|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110971580|NCT02198001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110971581|NCT02198001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110971582|NCT05116800|Gemcitabine|gemcitabine|mesh-list
110971583|NCT05116800|Docetaxel|docetaxel|mesh-list
110971584|NCT05116800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110971585|NCT05116800|Antimetabolites|antimetabolites|mesh-ancestor
110971586|NCT05116800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110971587|NCT05116800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110971588|NCT05116800|Tubulin Modulators|tubulin modulators|mesh-ancestor
110971589|NCT05116800|Antimitotic Agents|antimitotic agents|mesh-ancestor
110971590|NCT05116800|Mitosis Modulators|mitosis modulators|mesh-ancestor
110971591|NCT04078737|Aspirin|aspirin|mesh-list
110971592|NCT04078737|Clopidogrel|clopidogrel|mesh-list
110971593|NCT04078737|Ticagrelor|ticagrelor|mesh-list
110971594|NCT04078737|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110971595|NCT04078737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110971596|NCT04078737|Analgesics|analgesics|mesh-ancestor
110971597|NCT04078737|Sensory System Agents|sensory system agents|mesh-ancestor
110971598|NCT04078737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110971599|NCT04078737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110971600|NCT04078737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110971601|NCT04078737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110971602|NCT04078737|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110971603|NCT04078737|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110971604|NCT04078737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110971605|NCT04078737|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110971606|NCT04078737|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110971607|NCT04078737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110971608|NCT04078737|Antipyretics|antipyretics|mesh-ancestor
110971609|NCT04078737|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110971610|NCT04078737|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110971611|NCT04078737|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110971612|NCT04078737|Purinergic Agents|purinergic agents|mesh-ancestor
110971613|NCT04078737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110971614|NCT03491904|Fasinumab|fasinumab|mesh-list
110971615|NCT03491904|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110971616|NCT03491904|Analgesics|analgesics|mesh-ancestor
110971617|NCT03491904|Sensory System Agents|sensory system agents|mesh-ancestor
110971618|NCT03491904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110971619|NCT03491904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110971620|NCT02199951|Piperaquine|piperaquine|mesh-list
110971621|NCT02199951|Artenimol|artenimol|mesh-list
110971622|NCT02199951|Antimalarials|antimalarials|mesh-ancestor
110971623|NCT02199951|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111491324|NCT05976347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111491325|NCT05976347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110971624|NCT02199951|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110971625|NCT02199951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110971626|NCT03533361|Lenvatinib|lenvatinib|mesh-list
110971627|NCT03533361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110971628|NCT03533361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110971629|NCT03533361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110971630|NCT03533361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110971631|NCT01433328|Lidocaine|lidocaine|mesh-list
110971632|NCT01433328|Anesthetics, Local|anesthetics, local|mesh-ancestor
110971633|NCT01433328|Anesthetics|anesthetics|mesh-ancestor
110971634|NCT01433328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110971635|NCT01433328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110971636|NCT01433328|Sensory System Agents|sensory system agents|mesh-ancestor
110971637|NCT01433328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110971638|NCT01433328|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110971639|NCT01433328|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110971640|NCT01433328|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110971641|NCT01433328|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110971642|NCT01433328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110971643|NCT02198469|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
110971644|NCT02198469|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110971645|NCT02198469|Dermatologic Agents|dermatologic agents|mesh-ancestor
110971646|NCT02200185|Morphine|morphine|mesh-list
110971647|NCT02200185|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110971648|NCT02200185|Narcotics|narcotics|mesh-ancestor
110971649|NCT02200185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110971650|NCT02200185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110971651|NCT02200185|Analgesics|analgesics|mesh-ancestor
110971652|NCT02200185|Sensory System Agents|sensory system agents|mesh-ancestor
110971653|NCT02200185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110971654|NCT02201043|Thalidomide|thalidomide|mesh-list
110971655|NCT02201043|Tolnaftate|tolnaftate|mesh-list
110971656|NCT02201043|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110971657|NCT02201043|Immunologic Factors|immunologic factors|mesh-ancestor
110971658|NCT02201043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110971659|NCT02201043|Leprostatic Agents|leprostatic agents|mesh-ancestor
110971660|NCT02201043|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110971661|NCT02201043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110971662|NCT02201043|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110971663|NCT02201043|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110971664|NCT02201043|Growth Substances|growth substances|mesh-ancestor
110971665|NCT02201043|Growth Inhibitors|growth inhibitors|mesh-ancestor
110971666|NCT02201043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110971667|NCT02201043|Antifungal Agents|antifungal agents|mesh-ancestor
110971668|NCT02201121|Phenylephrine|phenylephrine|mesh-list
110971669|NCT02201121|Dopamine|dopamine|mesh-list
110971670|NCT02201121|Oxymetazoline|oxymetazoline|mesh-list
110971671|NCT02201121|Ephedrine|ephedrine|mesh-list
110971672|NCT02201121|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110971673|NCT02201121|Mydriatics|mydriatics|mesh-ancestor
110971674|NCT02201121|Autonomic Agents|autonomic agents|mesh-ancestor
110971675|NCT02201121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110971676|NCT02201121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110971677|NCT02201121|Sympathomimetics|sympathomimetics|mesh-ancestor
110971678|NCT02201121|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110971679|NCT02201121|Nasal Decongestants|nasal decongestants|mesh-ancestor
110971680|NCT02201121|Respiratory System Agents|respiratory system agents|mesh-ancestor
110971681|NCT02201121|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110971682|NCT02201121|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110971683|NCT02201121|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110971684|NCT02201121|Adrenergic Agents|adrenergic agents|mesh-ancestor
110971685|NCT02201121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110971686|NCT02201121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110971687|NCT02201121|Protective Agents|protective agents|mesh-ancestor
110971688|NCT02201121|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110971689|NCT02201121|Dopamine Agents|dopamine agents|mesh-ancestor
110971690|NCT02200575|Telmisartan|telmisartan|mesh-list
110971691|NCT02200575|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110971692|NCT02200575|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110971693|NCT02200575|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110971694|NCT02200575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110971695|NCT02201199|Insulin|insulin|mesh-list
110971696|NCT02201199|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110971697|NCT02201199|Insulin Glargine|insulin glargine|mesh-list
111491326|NCT05976347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110971698|NCT02201199|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110971699|NCT02201199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110971700|NCT02200653|Losartan|losartan|mesh-list
110971701|NCT02200653|Telmisartan|telmisartan|mesh-list
110971702|NCT02200653|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110971703|NCT02200653|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110971704|NCT02200653|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110971705|NCT02200653|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110971706|NCT02200653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110971707|NCT03999411|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
110971708|NCT03999411|Nicotine|nicotine|mesh-list
110971709|NCT03999411|Antiviral Agents|antiviral agents|mesh-ancestor
110971710|NCT03999411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110971711|NCT03999411|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110971712|NCT03999411|Autonomic Agents|autonomic agents|mesh-ancestor
110971713|NCT03999411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110971714|NCT03999411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110971715|NCT03999411|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110971716|NCT03999411|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110971717|NCT03999411|Cholinergic Agents|cholinergic agents|mesh-ancestor
110971718|NCT03999411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110971719|NCT03999411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110971720|NCT05261997|Metformin|metformin|mesh-list
110971721|NCT05261997|Acarbose|acarbose|mesh-list
110971722|NCT05261997|Hypoglycemic Agents|hypoglycemic agents|mesh-list
110971723|NCT05261997|Pancreatin|pancreatin|mesh-list
110971724|NCT05261997|Pancrelipase|pancrelipase|mesh-list
110971725|NCT05261997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110971726|NCT05261997|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
110971727|NCT05261997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110971728|NCT05261997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110971729|NCT05261997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110971730|NCT02206425|Ascorbic Acid|ascorbic acid|mesh-list
110971731|NCT02206425|Dexamethasone|dexamethasone|mesh-list
110971732|NCT02206425|Dexamethasone acetate|dexamethasone acetate|mesh-list
110971733|NCT02206425|Prednisone|prednisone|mesh-list
110971734|NCT02206425|Cyclophosphamide|cyclophosphamide|mesh-list
110971735|NCT02206425|Melphalan|melphalan|mesh-list
110971736|NCT02206425|Doxorubicin|doxorubicin|mesh-list
110971737|NCT02206425|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110971738|NCT02206425|Lenalidomide|lenalidomide|mesh-list
110971739|NCT02206425|Pomalidomide|pomalidomide|mesh-list
110971740|NCT02206425|BB 1101|bb 1101|mesh-list
110971741|NCT02206425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110971742|NCT02206425|Immunologic Factors|immunologic factors|mesh-ancestor
110126416|NCT05105282|Anesthetics|anesthetics|mesh-list
110971743|NCT02206425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110971744|NCT02206425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110971745|NCT02206425|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110971746|NCT02206425|Alkylating Agents|alkylating agents|mesh-ancestor
110971747|NCT02206425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110971748|NCT02206425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110971749|NCT02206425|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110971750|NCT02206425|Vitamins|vitamins|mesh-ancestor
110971751|NCT02206425|Micronutrients|micronutrients|mesh-ancestor
110971752|NCT02206425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110971753|NCT02206425|Antiemetics|antiemetics|mesh-ancestor
110971754|NCT02206425|Autonomic Agents|autonomic agents|mesh-ancestor
110971755|NCT02206425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110971756|NCT02206425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110971757|NCT02206425|Glucocorticoids|glucocorticoids|mesh-ancestor
110971758|NCT02206425|Hormones|hormones|mesh-ancestor
110971759|NCT02206425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110971760|NCT02206425|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110971761|NCT02206425|Protease Inhibitors|protease inhibitors|mesh-ancestor
110971762|NCT02206425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110971763|NCT02206425|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110971764|NCT02206425|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110971765|NCT02206425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110971766|NCT02206425|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110971767|NCT02206425|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111491327|NCT05976347|Analgesics|analgesics|mesh-ancestor
111491328|NCT05976347|Sensory System Agents|sensory system agents|mesh-ancestor
110971768|NCT02206425|Growth Substances|growth substances|mesh-ancestor
110971769|NCT02206425|Growth Inhibitors|growth inhibitors|mesh-ancestor
110971770|NCT02206425|Antioxidants|antioxidants|mesh-ancestor
110971771|NCT02206425|Protective Agents|protective agents|mesh-ancestor
111491329|NCT05976347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111491330|NCT05976347|Antidepressive Agents|antidepressive agents|mesh-ancestor
111491331|NCT05976347|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110971772|NCT02201667|Aspirin|aspirin|mesh-list
110971773|NCT02201667|Clopidogrel|clopidogrel|mesh-list
110971774|NCT02201667|Ticagrelor|ticagrelor|mesh-list
110971775|NCT02201667|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110971776|NCT02201667|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110971777|NCT02201667|Analgesics|analgesics|mesh-ancestor
110971778|NCT02201667|Sensory System Agents|sensory system agents|mesh-ancestor
110971779|NCT02201667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110971780|NCT02201667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110971781|NCT02201667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110971782|NCT02201667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110971783|NCT02201667|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110971784|NCT02201667|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110971785|NCT02201667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110971786|NCT02201667|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110971787|NCT02201667|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110971788|NCT02201667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110971789|NCT02201667|Antipyretics|antipyretics|mesh-ancestor
110971790|NCT02201667|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110971791|NCT02201667|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110971792|NCT02201667|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110971793|NCT02201667|Purinergic Agents|purinergic agents|mesh-ancestor
110971794|NCT02201667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110971795|NCT02206503|Dexamethasone|dexamethasone|mesh-list
110971796|NCT02206503|Cyclophosphamide|cyclophosphamide|mesh-list
110971797|NCT02206503|Lenalidomide|lenalidomide|mesh-list
110971798|NCT02206503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110971799|NCT02206503|Immunologic Factors|immunologic factors|mesh-ancestor
110971800|NCT02206503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110971801|NCT02206503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110971802|NCT02206503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110971803|NCT02206503|Alkylating Agents|alkylating agents|mesh-ancestor
110971804|NCT02206503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110971805|NCT02206503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110971806|NCT02206503|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110971807|NCT02206503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110971808|NCT02206503|Antiemetics|antiemetics|mesh-ancestor
110971809|NCT02206503|Autonomic Agents|autonomic agents|mesh-ancestor
110971810|NCT02206503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110971811|NCT02206503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110971812|NCT02206503|Glucocorticoids|glucocorticoids|mesh-ancestor
110971813|NCT02206503|Hormones|hormones|mesh-ancestor
110971814|NCT02206503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110971815|NCT02206503|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110971816|NCT02206503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110971817|NCT02206503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110971818|NCT02206503|Growth Substances|growth substances|mesh-ancestor
110971819|NCT02206503|Growth Inhibitors|growth inhibitors|mesh-ancestor
110971820|NCT02206659|Telmisartan|telmisartan|mesh-list
110971821|NCT02206659|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110971822|NCT02206659|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110971823|NCT02206659|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110971824|NCT02206659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110971825|NCT02206737|Nicotine|nicotine|mesh-list
110971826|NCT02206737|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110971827|NCT02206737|Autonomic Agents|autonomic agents|mesh-ancestor
110971828|NCT02206737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110971829|NCT02206737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110971830|NCT02206737|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110971831|NCT02206737|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110971832|NCT02206737|Cholinergic Agents|cholinergic agents|mesh-ancestor
110971833|NCT02206737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110971834|NCT02206737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110971835|NCT03533127|Bevacizumab|bevacizumab|mesh-list
110971836|NCT03533127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110971837|NCT03533127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110971838|NCT03533127|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110971839|NCT03533127|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110971840|NCT03533127|Growth Substances|growth substances|mesh-ancestor
111491332|NCT05976347|Dopamine Agents|dopamine agents|mesh-ancestor
110971841|NCT03533127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110971843|NCT02207361|Paclitaxel|paclitaxel|mesh-list
110971844|NCT02207361|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110971845|NCT02207361|Carboplatin|carboplatin|mesh-list
110971846|NCT02207361|Epirubicin|epirubicin|mesh-list
110971847|NCT02207361|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110971848|NCT02207361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110971849|NCT02207361|Tubulin Modulators|tubulin modulators|mesh-ancestor
110971850|NCT02207361|Antimitotic Agents|antimitotic agents|mesh-ancestor
110971851|NCT02207361|Mitosis Modulators|mitosis modulators|mesh-ancestor
110971852|NCT02207361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110971853|NCT02207361|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110971854|NCT02207361|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110971855|NCT02207361|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110971856|NCT02207361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110971857|NCT02202525|Telmisartan|telmisartan|mesh-list
110971858|NCT02202525|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110971859|NCT02202525|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110971860|NCT02202525|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110971861|NCT02202525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110971862|NCT02202603|Teriparatide|teriparatide|mesh-list
110971863|NCT02202603|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110971864|NCT02202603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110971865|NCT02202603|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110971866|NCT02202993|Mibefradil|mibefradil|mesh-list
110971867|NCT02202993|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110971868|NCT02202993|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110971869|NCT02202993|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110479224|NCT04106752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110971870|NCT02202993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110971871|NCT02202993|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110971872|NCT02202993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110971873|NCT02202993|Vasodilator Agents|vasodilator agents|mesh-ancestor
110971874|NCT02202993|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110971875|NCT02202993|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110971876|NCT02202993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110971877|NCT02190357|Rifaximin|rifaximin|mesh-list
110971878|NCT02190357|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110971879|NCT02190357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110971880|NCT02190357|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110971881|NCT02257671|Contraceptive Agents|contraceptive agents|mesh-list
110971882|NCT02257671|Levonorgestrel|levonorgestrel|mesh-list
110971883|NCT02257671|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110971884|NCT02257671|Contraceptives, Oral|contraceptives, oral|mesh-list
110971885|NCT02257671|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110971886|NCT02257671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110971887|NCT02257671|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110971888|NCT02257671|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110971889|NCT02257671|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110971890|NCT02257671|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110971891|NCT02257671|Estrogens|estrogens|mesh-ancestor
110971892|NCT02257671|Hormones|hormones|mesh-ancestor
110971893|NCT02257671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110971894|NCT01460160|Dasatinib|dasatinib|mesh-list
110971895|NCT01460160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110971896|NCT01460160|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110971897|NCT01460160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110971898|NCT01460160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110971899|NCT02203227|Turmeric extract|turmeric extract|mesh-list
110971900|NCT02203227|Antioxidants|antioxidants|mesh-ancestor
110971901|NCT02203227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110971902|NCT02203227|Protective Agents|protective agents|mesh-ancestor
110971903|NCT02203227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110971904|NCT01170702|Ropivacaine|ropivacaine|mesh-list
110971905|NCT01170702|Anesthetics, Local|anesthetics, local|mesh-ancestor
110971906|NCT01170702|Anesthetics|anesthetics|mesh-ancestor
110971907|NCT01170702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110971908|NCT01170702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110971909|NCT01170702|Sensory System Agents|sensory system agents|mesh-ancestor
110971910|NCT01170702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111491333|NCT05976347|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111491334|NCT05976347|Serotonin Agents|serotonin agents|mesh-ancestor
111491335|NCT05976347|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111491336|NCT05976347|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110971911|NCT02203461|Ritonavir|ritonavir|mesh-list
110971912|NCT02203461|Lopinavir|lopinavir|mesh-list
110971913|NCT02203461|Darunavir|darunavir|mesh-list
110971914|NCT02203461|Tenofovir|tenofovir|mesh-list
110971915|NCT02203461|Emtricitabine|emtricitabine|mesh-list
110971916|NCT02203461|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110971917|NCT02203461|Cobicistat|cobicistat|mesh-list
110971918|NCT02203461|Elvitegravir|elvitegravir|mesh-list
110971919|NCT02203461|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110971920|NCT02203461|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110971921|NCT02203461|Protease Inhibitors|protease inhibitors|mesh-ancestor
110971922|NCT02203461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110971923|NCT02203461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110971924|NCT02203461|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110971925|NCT02203461|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110971926|NCT02203461|Antiviral Agents|antiviral agents|mesh-ancestor
110971927|NCT02203461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110971928|NCT02203461|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110971929|NCT02203461|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110971930|NCT02203461|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110971931|NCT02203461|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110971932|NCT02203461|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110971933|NCT02191059|Docetaxel|docetaxel|mesh-list
110971934|NCT02191059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110971935|NCT02191059|Tubulin Modulators|tubulin modulators|mesh-ancestor
110971936|NCT02191059|Antimitotic Agents|antimitotic agents|mesh-ancestor
110971937|NCT02191059|Mitosis Modulators|mitosis modulators|mesh-ancestor
110971938|NCT02191059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110971939|NCT02191215|Nevirapine|nevirapine|mesh-list
110971940|NCT02191215|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110971941|NCT02191215|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110971942|NCT02191215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110971943|NCT02191215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110971944|NCT02191215|Antiviral Agents|antiviral agents|mesh-ancestor
110971945|NCT02191215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110971946|NCT02191215|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110971947|NCT02191215|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110971948|NCT02191215|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110971949|NCT02191215|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110971950|NCT02209155|Verapamil|verapamil|mesh-list
110971951|NCT02209155|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110971952|NCT02209155|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110971953|NCT02209155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110971954|NCT02209155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110971955|NCT02209155|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110971956|NCT02209155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110971957|NCT02209155|Vasodilator Agents|vasodilator agents|mesh-ancestor
110971958|NCT03485118|Rituximab|rituximab|mesh-list
110971959|NCT03485118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110971960|NCT03485118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110971961|NCT03485118|Immunologic Factors|immunologic factors|mesh-ancestor
110971962|NCT03485118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110971963|NCT03485118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110971964|NCT02191293|Nevirapine|nevirapine|mesh-list
110971965|NCT02191293|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110971966|NCT02191293|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110971967|NCT02191293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110971968|NCT02191293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110971969|NCT02191293|Antiviral Agents|antiviral agents|mesh-ancestor
110971970|NCT02191293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110971971|NCT02191293|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110971972|NCT02191293|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110971973|NCT02191293|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110971974|NCT02191293|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110971975|NCT02880540|Fentanyl|fentanyl|mesh-list
110971976|NCT02880540|Dexmedetomidine|dexmedetomidine|mesh-list
110971977|NCT02880540|Morphine|morphine|mesh-list
110971978|NCT02880540|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110971979|NCT02880540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110971980|NCT02880540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110971981|NCT02880540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110971982|NCT02880540|Analgesics|analgesics|mesh-ancestor
110971983|NCT02880540|Sensory System Agents|sensory system agents|mesh-ancestor
110024423|NCT00004734|Folic Acid|folic acid|mesh-list
110971984|NCT02880540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110971985|NCT02880540|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110971986|NCT02880540|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110971987|NCT02880540|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110971988|NCT02880540|Adrenergic Agents|adrenergic agents|mesh-ancestor
110971989|NCT02880540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110971990|NCT02880540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110971991|NCT02880540|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110971992|NCT02880540|Narcotics|narcotics|mesh-ancestor
110971993|NCT02880540|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110971994|NCT02880540|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110971995|NCT02880540|Anesthetics, General|anesthetics, general|mesh-ancestor
110971996|NCT02880540|Anesthetics|anesthetics|mesh-ancestor
110971997|NCT02191371|Propofol|propofol|mesh-list
110971998|NCT02191371|Desflurane|desflurane|mesh-list
110971999|NCT02191371|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110972000|NCT02191371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110972001|NCT02191371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110972003|NCT02191371|Anesthetics, General|anesthetics, general|mesh-ancestor
110972004|NCT02191371|Anesthetics|anesthetics|mesh-ancestor
110972005|NCT02191371|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110972006|NCT03532737|Pembrolizumab|pembrolizumab|mesh-list
110972007|NCT03532737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110972008|NCT03532737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110972009|NCT03532737|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110972010|NCT03532737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110972011|NCT02741388|Cytarabine|cytarabine|mesh-list
110972012|NCT02741388|Dexamethasone|dexamethasone|mesh-list
110972013|NCT02741388|Rituximab|rituximab|mesh-list
110972014|NCT02741388|Gemcitabine|gemcitabine|mesh-list
110972015|NCT02741388|Oxaliplatin|oxaliplatin|mesh-list
110972016|NCT02741388|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110972017|NCT02741388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110972018|NCT02741388|Immunologic Factors|immunologic factors|mesh-ancestor
110972019|NCT02741388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110972020|NCT02741388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110972021|NCT02741388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110972022|NCT02741388|Antiemetics|antiemetics|mesh-ancestor
110972023|NCT02741388|Autonomic Agents|autonomic agents|mesh-ancestor
110972024|NCT02741388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110972025|NCT02741388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110972026|NCT02741388|Glucocorticoids|glucocorticoids|mesh-ancestor
110972027|NCT02741388|Hormones|hormones|mesh-ancestor
110972028|NCT02741388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110972029|NCT02741388|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110972030|NCT02741388|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110972031|NCT02741388|Antimetabolites|antimetabolites|mesh-ancestor
110972032|NCT02741388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110972033|NCT02741388|Antiviral Agents|antiviral agents|mesh-ancestor
110972034|NCT02741388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110972035|NCT02741388|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110972036|NCT02191527|Chrysarobin|chrysarobin|mesh-list
110972037|NCT02191527|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110972038|NCT02191527|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110972039|NCT02191527|Analgesics|analgesics|mesh-ancestor
110972040|NCT02191527|Sensory System Agents|sensory system agents|mesh-ancestor
110972041|NCT02191527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110972042|NCT02191527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110972043|NCT02191527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110972044|NCT02191527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110972045|NCT03484962|Antibodies|antibodies|mesh-list
110972046|NCT03484962|Antibodies, Bispecific|antibodies, bispecific|mesh-list
110972047|NCT03484962|Immunologic Factors|immunologic factors|mesh-ancestor
110972048|NCT03484962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110972049|NCT01331616|Bevacizumab|bevacizumab|mesh-list
110972050|NCT01331616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110972051|NCT01331616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110972052|NCT01331616|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110972053|NCT01331616|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110972054|NCT01331616|Growth Substances|growth substances|mesh-ancestor
111491337|NCT05976347|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111491338|NCT05976347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111491339|NCT05972655|Capecitabine|capecitabine|mesh-list
110972055|NCT01331616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110972056|NCT01331616|Growth Inhibitors|growth inhibitors|mesh-ancestor
111491340|NCT05972655|Oxaliplatin|oxaliplatin|mesh-list
111491341|NCT05972655|Antibodies|antibodies|mesh-list
111491342|NCT05972655|Immunologic Factors|immunologic factors|mesh-ancestor
111491343|NCT05972655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111491344|NCT05972655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111491345|NCT05972655|Antimetabolites|antimetabolites|mesh-ancestor
111491346|NCT05972655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110972057|NCT02209701|Porfiromycin|porfiromycin|mesh-list
110972058|NCT02209701|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110972059|NCT02209701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110972060|NCT02191839|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
110972061|NCT02191839|Protein C Inhibitor|protein c inhibitor|mesh-list
110972062|NCT02191839|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
110972063|NCT02191839|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110972064|NCT02191839|Protease Inhibitors|protease inhibitors|mesh-ancestor
110972065|NCT02191839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110972066|NCT02191839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110972067|NCT02204397|Ustekinumab|ustekinumab|mesh-list
110972068|NCT02204397|Dermatologic Agents|dermatologic agents|mesh-ancestor
110972069|NCT02192229|Vitamin D|vitamin d|mesh-list
110972070|NCT02192229|Cholecalciferol|cholecalciferol|mesh-list
110972071|NCT02192229|Vitamins|vitamins|mesh-ancestor
110972072|NCT02192229|Micronutrients|micronutrients|mesh-ancestor
110972073|NCT02192229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110972074|NCT02192229|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110972075|NCT02192229|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110689135|NCT00959621|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110972076|NCT02192463|Nevirapine|nevirapine|mesh-list
110972077|NCT02192463|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110972078|NCT02192463|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110972079|NCT02192463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110972080|NCT02192463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110972081|NCT02192463|Antiviral Agents|antiviral agents|mesh-ancestor
110972082|NCT02192463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110972083|NCT02192463|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110972084|NCT02192463|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110972085|NCT02192463|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110972086|NCT02192463|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110972087|NCT02204475|Interferons|interferons|mesh-list
110972088|NCT02204475|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110972089|NCT02204475|Grazoprevir|grazoprevir|mesh-list
110972090|NCT02204475|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
110972091|NCT02204475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110972092|NCT02204475|Antiviral Agents|antiviral agents|mesh-ancestor
110972093|NCT02204475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110972095|NCT02210169|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110972096|NCT02210169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110972097|NCT02210949|Epoetin Alfa|epoetin alfa|mesh-list
110972098|NCT02210949|Hematinics|hematinics|mesh-ancestor
110972099|NCT02204553|Panobinostat|panobinostat|mesh-list
110972100|NCT02204553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110972101|NCT02204553|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110972102|NCT02204553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110972103|NCT02204553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110972104|NCT01109004|Dexamethasone|dexamethasone|mesh-list
110972105|NCT01109004|Lenalidomide|lenalidomide|mesh-list
110972106|NCT01109004|Bortezomib|bortezomib|mesh-list
110972107|NCT01109004|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110972108|NCT01109004|Antiemetics|antiemetics|mesh-ancestor
110972109|NCT01109004|Autonomic Agents|autonomic agents|mesh-ancestor
110972110|NCT01109004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110972111|NCT01109004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110972112|NCT01109004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110972113|NCT01109004|Glucocorticoids|glucocorticoids|mesh-ancestor
110972114|NCT01109004|Hormones|hormones|mesh-ancestor
110972115|NCT01109004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110972116|NCT01109004|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110972117|NCT01109004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110972118|NCT01109004|Immunologic Factors|immunologic factors|mesh-ancestor
110972119|NCT01109004|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110972120|NCT01109004|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110972121|NCT01109004|Growth Substances|growth substances|mesh-ancestor
110972122|NCT01109004|Growth Inhibitors|growth inhibitors|mesh-ancestor
110972123|NCT02211729|Azithromycin|azithromycin|mesh-list
111491347|NCT05972655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110972124|NCT02211729|Pyrimethamine|pyrimethamine|mesh-list
110972125|NCT02211729|Sulfadoxine|sulfadoxine|mesh-list
110972126|NCT02211729|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
110972127|NCT02211729|Amodiaquine|amodiaquine|mesh-list
110972128|NCT02211729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110972129|NCT02211729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110972130|NCT02211729|Antimalarials|antimalarials|mesh-ancestor
110972131|NCT02211729|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110972132|NCT02211729|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110972133|NCT02211729|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110972134|NCT02211729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110972135|NCT02211729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110972136|NCT02211729|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110972137|NCT05151510|Lidocaine|lidocaine|mesh-list
110972138|NCT05151510|Anesthetics, Local|anesthetics, local|mesh-ancestor
110972139|NCT05151510|Anesthetics|anesthetics|mesh-ancestor
110972140|NCT05151510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110972141|NCT05151510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110972142|NCT05151510|Sensory System Agents|sensory system agents|mesh-ancestor
110972143|NCT05151510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110972144|NCT05151510|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110972145|NCT05151510|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110972146|NCT05151510|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110972147|NCT05151510|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110972148|NCT05151510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110972149|NCT02212119|Botulinum Toxins|botulinum toxins|mesh-list
110689210|NCT04009889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110972150|NCT02212119|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110972151|NCT02212119|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110972152|NCT02212119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110972153|NCT02212119|Cholinergic Agents|cholinergic agents|mesh-ancestor
110972154|NCT02212119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110972155|NCT02212119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110972156|NCT03484650|Lidocaine|lidocaine|mesh-list
110972157|NCT03484650|Anesthetics, Local|anesthetics, local|mesh-ancestor
110972158|NCT03484650|Anesthetics|anesthetics|mesh-ancestor
110972159|NCT03484650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110972160|NCT03484650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110972161|NCT03484650|Sensory System Agents|sensory system agents|mesh-ancestor
110972162|NCT03484650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110972163|NCT03484650|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110972164|NCT03484650|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110972165|NCT03484650|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110972166|NCT03484650|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110972167|NCT03484650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110972168|NCT02192697|Naquotinib|naquotinib|mesh-list
110972169|NCT02192697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110972170|NCT02192697|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110972171|NCT02192697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110972172|NCT02192697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110972173|NCT05153928|Norethindrone|norethindrone|mesh-list
110972174|NCT05153928|Norethindrone Acetate|norethindrone acetate|mesh-list
110972175|NCT05153928|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110972176|NCT05153928|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110972177|NCT05153928|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110972178|NCT05153928|Contraceptive Agents|contraceptive agents|mesh-ancestor
110972179|NCT05153928|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110972180|NCT05153928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110972181|NCT05153928|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110972182|NCT05153928|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110972183|NCT02214771|Fidaxomicin|fidaxomicin|mesh-list
110972184|NCT02214771|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110972185|NCT02214771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110972186|NCT02192853|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110972187|NCT02192853|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110972188|NCT02192853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110972189|NCT02192853|Incretins|incretins|mesh-ancestor
110972190|NCT02192853|Hormones|hormones|mesh-ancestor
110972191|NCT02192853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110972192|NCT02192853|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110972193|NCT02192853|Protease Inhibitors|protease inhibitors|mesh-ancestor
111491348|NCT05971719|Glycerol|glycerol|mesh-list
111491349|NCT05971719|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
111491350|NCT05971719|Protective Agents|protective agents|mesh-ancestor
111491351|NCT05971719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111491352|NCT05968690|Propranolol|propranolol|mesh-list
111491353|NCT05968690|Naltrexone|naltrexone|mesh-list
110972194|NCT02192853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110972195|NCT02192853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110972196|NCT05151042|Salicylic Acid|salicylic acid|mesh-list
110972197|NCT05151042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110972198|NCT05151042|Antifungal Agents|antifungal agents|mesh-ancestor
110972199|NCT05151042|Keratolytic Agents|keratolytic agents|mesh-ancestor
110972200|NCT05151042|Dermatologic Agents|dermatologic agents|mesh-ancestor
110972201|NCT04574154|Anesthetics|anesthetics|mesh-list
110972202|NCT04574154|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110972203|NCT04574154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110972204|NCT03484416|Vitamin D|vitamin d|mesh-list
110972205|NCT03484416|Calcium Carbonate|calcium carbonate|mesh-list
110972206|NCT03484416|Calcium|calcium|mesh-list
110972207|NCT03484416|Vitamins|vitamins|mesh-ancestor
110972208|NCT03484416|Micronutrients|micronutrients|mesh-ancestor
110972209|NCT03484416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110972210|NCT03484416|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110972211|NCT03484416|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110972212|NCT03484416|Antacids|antacids|mesh-ancestor
110972213|NCT03484416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110972214|NCT03484416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110972215|NCT02205255|Azithromycin|azithromycin|mesh-list
110972216|NCT02205255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110972217|NCT02205255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110972218|NCT02220153|Rozanolixizumab|rozanolixizumab|mesh-list
110972219|NCT02220153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110972220|NCT02220153|Immunologic Factors|immunologic factors|mesh-ancestor
110972221|NCT02220153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110972222|NCT03476772|Nalbuphine|nalbuphine|mesh-list
110972223|NCT03476772|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110972224|NCT03476772|Narcotics|narcotics|mesh-ancestor
110689291|NCT00963443|Aspirin|aspirin|mesh-list
110972225|NCT03476772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110972226|NCT03476772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110972227|NCT03476772|Analgesics|analgesics|mesh-ancestor
110972228|NCT03476772|Sensory System Agents|sensory system agents|mesh-ancestor
110972229|NCT03476772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110972230|NCT03535233|Triamcinolone|triamcinolone|mesh-list
110972231|NCT03535233|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110972232|NCT03535233|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110972233|NCT03535233|Clobetasol|clobetasol|mesh-list
110972234|NCT03535233|Minoxidil|minoxidil|mesh-list
110972235|NCT03535233|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110972236|NCT03535233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110972237|NCT03535233|Glucocorticoids|glucocorticoids|mesh-ancestor
110972238|NCT03535233|Hormones|hormones|mesh-ancestor
110972239|NCT03535233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110972240|NCT03535233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110972241|NCT03535233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110972242|NCT03535233|Immunologic Factors|immunologic factors|mesh-ancestor
110972243|NCT03535233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110972244|NCT03535233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110972245|NCT03535233|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110972246|NCT03535233|Vasodilator Agents|vasodilator agents|mesh-ancestor
110972247|NCT02205489|Cetirizine|cetirizine|mesh-list
110972248|NCT02205489|Acyclovir|acyclovir|mesh-list
110972249|NCT02205489|Ibuprofen|ibuprofen|mesh-list
110972250|NCT02205489|Methylprednisolone|methylprednisolone|mesh-list
110972251|NCT02205489|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110972252|NCT02205489|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110972253|NCT02205489|Prednisolone|prednisolone|mesh-list
110972254|NCT02205489|Prednisolone acetate|prednisolone acetate|mesh-list
110972255|NCT02205489|Alemtuzumab|alemtuzumab|mesh-list
110972256|NCT02205489|Esomeprazole|esomeprazole|mesh-list
110972257|NCT02205489|Ranitidine|ranitidine|mesh-list
110972258|NCT02205489|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110972259|NCT02205489|Prednisolone phosphate|prednisolone phosphate|mesh-list
110972260|NCT02205489|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110972261|NCT02205489|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110972262|NCT02205489|Analgesics|analgesics|mesh-ancestor
110972263|NCT02205489|Sensory System Agents|sensory system agents|mesh-ancestor
110972264|NCT02205489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111491354|NCT05968690|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111491355|NCT05968690|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111491356|NCT05968690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110972265|NCT02205489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110972266|NCT02205489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110972267|NCT02205489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111491357|NCT05968690|Sensory System Agents|sensory system agents|mesh-ancestor
111491358|NCT05968690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111491359|NCT05968690|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110972268|NCT02205489|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110972269|NCT02205489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110972270|NCT02205489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110972271|NCT02205489|Antiemetics|antiemetics|mesh-ancestor
110972272|NCT02205489|Autonomic Agents|autonomic agents|mesh-ancestor
110972273|NCT02205489|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110972274|NCT02205489|Glucocorticoids|glucocorticoids|mesh-ancestor
110972275|NCT02205489|Hormones|hormones|mesh-ancestor
110972276|NCT02205489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110972277|NCT02205489|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110972278|NCT02205489|Protective Agents|protective agents|mesh-ancestor
110972279|NCT02205489|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110972280|NCT02205489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110972281|NCT02205489|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110972282|NCT02205489|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110972283|NCT02205489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110972284|NCT02205489|Antiviral Agents|antiviral agents|mesh-ancestor
110972285|NCT02205489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110972286|NCT02205489|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110972287|NCT02205489|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110972288|NCT02205489|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110972289|NCT02205489|Histamine Antagonists|histamine antagonists|mesh-ancestor
110972290|NCT02205489|Histamine Agents|histamine agents|mesh-ancestor
110972291|NCT02205489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110972292|NCT02205489|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110972293|NCT02523846|Morphine|morphine|mesh-list
110972294|NCT02523846|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110972295|NCT02523846|Narcotics|narcotics|mesh-ancestor
110972296|NCT02523846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110972297|NCT02523846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110972298|NCT02523846|Analgesics|analgesics|mesh-ancestor
110972299|NCT02523846|Sensory System Agents|sensory system agents|mesh-ancestor
110972300|NCT02523846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110972301|NCT03484260|Testosterone|testosterone|mesh-list
110972302|NCT03484260|Androgens|androgens|mesh-ancestor
110972303|NCT03484260|Hormones|hormones|mesh-ancestor
110972304|NCT03484260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110972305|NCT03484260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110972306|NCT05195775|Tadalafil|tadalafil|mesh-list
110972307|NCT05195775|Vasodilator Agents|vasodilator agents|mesh-ancestor
110972308|NCT05195775|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110972309|NCT05195775|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110972310|NCT05195775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110972311|NCT05195775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110972312|NCT05195775|Urological Agents|urological agents|mesh-ancestor
110972313|NCT03480906|Latanoprost|latanoprost|mesh-list
110972314|NCT03480906|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110972315|NCT03480906|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110972316|NCT05262465|Azacitidine|azacitidine|mesh-list
110972317|NCT05262465|Venetoclax|venetoclax|mesh-list
110972318|NCT05262465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110972319|NCT05262465|Antimetabolites|antimetabolites|mesh-ancestor
110972320|NCT05262465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110972321|NCT05262465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110972322|NCT05262465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110972323|NCT02220621|Hyaluronic Acid|hyaluronic acid|mesh-list
110972324|NCT02220621|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110972325|NCT02220621|Immunologic Factors|immunologic factors|mesh-ancestor
110972326|NCT02220621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110972327|NCT02220621|Viscosupplements|viscosupplements|mesh-ancestor
110972328|NCT02220621|Protective Agents|protective agents|mesh-ancestor
110972329|NCT04370418|Fluorouracil|fluorouracil|mesh-list
110972330|NCT04370418|Antimetabolites|antimetabolites|mesh-ancestor
110972331|NCT04370418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110972332|NCT04370418|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110972333|NCT04370418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110972334|NCT04370418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110972335|NCT04370418|Immunologic Factors|immunologic factors|mesh-ancestor
110972336|NCT04370418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110972337|NCT02220777|Omeprazole|omeprazole|mesh-list
110972338|NCT02220777|ASP8477|asp8477|mesh-list
110972339|NCT02220777|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110437910|NCT04202536|Tenofovir|tenofovir|mesh-list
111491360|NCT05968690|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111491361|NCT05968690|Adrenergic Agents|adrenergic agents|mesh-ancestor
111491362|NCT05968690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110972340|NCT02220777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110972341|NCT02220777|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110972342|NCT02220777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110972343|NCT02220777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110972344|NCT03476616|Valsartan|valsartan|mesh-list
110972345|NCT03476616|Eplerenone|eplerenone|mesh-list
110972346|NCT03476616|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110972347|NCT03476616|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110972348|NCT03476616|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110972349|NCT03476616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110972350|NCT03476616|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110972351|NCT03476616|Hormone Antagonists|hormone antagonists|mesh-ancestor
110972352|NCT03476616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110479315|NCT00588094|Rituximab|rituximab|mesh-list
110972353|NCT03476616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110972354|NCT03476616|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110972355|NCT03476616|Diuretics|diuretics|mesh-ancestor
110972356|NCT03476616|Natriuretic Agents|natriuretic agents|mesh-ancestor
110972357|NCT02205879|Pregabalin|pregabalin|mesh-list
110972358|NCT02205879|Analgesics|analgesics|mesh-ancestor
110972359|NCT02205879|Sensory System Agents|sensory system agents|mesh-ancestor
110972360|NCT02205879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110972361|NCT02205879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110972362|NCT02205879|Anticonvulsants|anticonvulsants|mesh-ancestor
110972363|NCT02205879|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110972364|NCT02205879|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110972365|NCT02205879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110972366|NCT02205879|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110972367|NCT02205879|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110972368|NCT02205879|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110972369|NCT02205879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110972370|NCT02205879|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110972371|NCT03483948|Azacitidine|azacitidine|mesh-list
110972372|NCT03483948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110972373|NCT03483948|Antimetabolites|antimetabolites|mesh-ancestor
110972374|NCT03483948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110972375|NCT03483948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110972376|NCT03483948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110972378|NCT03483870|Granisetron|granisetron|mesh-list
110972379|NCT03483870|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110972380|NCT03483870|Narcotics|narcotics|mesh-ancestor
110972381|NCT03483870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110972382|NCT03483870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110972383|NCT03483870|Analgesics|analgesics|mesh-ancestor
110972384|NCT03483870|Sensory System Agents|sensory system agents|mesh-ancestor
110972385|NCT03483870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110972386|NCT03483870|Antiemetics|antiemetics|mesh-ancestor
110972387|NCT03483870|Autonomic Agents|autonomic agents|mesh-ancestor
110972388|NCT03483870|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110972389|NCT03483870|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110972390|NCT03483870|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110972391|NCT03483870|Serotonin Agents|serotonin agents|mesh-ancestor
110972392|NCT03483870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110972393|NCT03483870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110972394|NCT02221323|Insulin Lispro|insulin lispro|mesh-list
110972395|NCT02221323|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110972396|NCT02221323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110972397|NCT03480516|Fluorides|fluorides|mesh-list
110972398|NCT03480516|Sodium Fluoride|sodium fluoride|mesh-list
110972399|NCT03480516|Fluorides, Topical|fluorides, topical|mesh-list
110972400|NCT03480516|Cariostatic Agents|cariostatic agents|mesh-ancestor
110972401|NCT03480516|Protective Agents|protective agents|mesh-ancestor
110972402|NCT03480516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110972403|NCT02221401|Metformin|metformin|mesh-list
110972404|NCT02221401|Linagliptin|linagliptin|mesh-list
110972405|NCT02221401|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110972406|NCT02221401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110972407|NCT02221401|Incretins|incretins|mesh-ancestor
110972408|NCT02221401|Hormones|hormones|mesh-ancestor
110972409|NCT02221401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110972410|NCT02221401|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111491363|NCT05968690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110972411|NCT02221401|Protease Inhibitors|protease inhibitors|mesh-ancestor
110972412|NCT02221401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110972413|NCT02221401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110972415|NCT03483636|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
110972416|NCT03483636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110972417|NCT03483636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110972418|NCT03483636|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110972419|NCT03483636|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110972420|NCT03483636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110972421|NCT03483636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110972422|NCT02221479|Plerixafor|plerixafor|mesh-list
110972423|NCT02221479|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110972424|NCT02221479|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110972425|NCT02221479|Antiviral Agents|antiviral agents|mesh-ancestor
110972426|NCT02221479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110972427|NCT02221635|Risperidone|risperidone|mesh-list
110972428|NCT02221635|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110972429|NCT02221635|Serotonin Agents|serotonin agents|mesh-ancestor
110972430|NCT02221635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110972431|NCT02221635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110972432|NCT02221635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110972433|NCT02221635|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110972434|NCT02221635|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110972435|NCT02221635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110972436|NCT02221635|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110972437|NCT02221635|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110972438|NCT02221635|Dopamine Agents|dopamine agents|mesh-ancestor
110972439|NCT03480360|Mycophenolic Acid|mycophenolic acid|mesh-list
110972440|NCT03480360|Cyclophosphamide|cyclophosphamide|mesh-list
110972441|NCT03480360|Fludarabine|fludarabine|mesh-list
110972442|NCT03480360|Tacrolimus|tacrolimus|mesh-list
110972443|NCT03480360|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110972444|NCT03480360|Immunologic Factors|immunologic factors|mesh-ancestor
110972445|NCT03480360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110972446|NCT03480360|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110972447|NCT03480360|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110972448|NCT03480360|Alkylating Agents|alkylating agents|mesh-ancestor
110972449|NCT03480360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110972450|NCT03480360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110972451|NCT03480360|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110972452|NCT03480360|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110972453|NCT03480360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110972454|NCT03480360|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110972455|NCT03480360|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110972456|NCT03480360|Antitubercular Agents|antitubercular agents|mesh-ancestor
110972457|NCT03480360|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110972458|NCT03480360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110972459|NCT02723864|Veliparib|veliparib|mesh-list
110972460|NCT02723864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110972461|NCT02723864|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110972462|NCT02723864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110972463|NCT02723864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110972464|NCT02471690|Oritavancin|oritavancin|mesh-list
110972465|NCT02471690|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110972466|NCT02471690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110972467|NCT02225067|Calcium|calcium|mesh-list
110972468|NCT02225067|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110972469|NCT02225067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110972470|NCT03475758|Goserelin|goserelin|mesh-list
110972471|NCT03475758|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110972472|NCT03475758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110972473|NCT02231385|Acetic Acid|acetic acid|mesh-list
110972474|NCT02231385|Retinol acetate|retinol acetate|mesh-list
110972475|NCT02231385|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110972476|NCT02231385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110972477|NCT02231385|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110972478|NCT02231385|Immunologic Factors|immunologic factors|mesh-ancestor
110972479|NCT02231385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111491364|NCT05968690|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110972480|NCT02231385|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110972481|NCT02231385|Protective Agents|protective agents|mesh-ancestor
110972482|NCT02231385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110972483|NCT02523768|Basiliximab|basiliximab|mesh-list
110699457|NCT00280059|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111491365|NCT05968690|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110972484|NCT02523768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110972485|NCT02523768|Immunologic Factors|immunologic factors|mesh-ancestor
110972486|NCT02523768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110972487|NCT03479736|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110972488|NCT03479736|Fluoroquinolones|fluoroquinolones|mesh-list
110972489|NCT03479736|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
110972490|NCT03479736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110972491|NCT03479736|Antitubercular Agents|antitubercular agents|mesh-ancestor
110972492|NCT03479736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110972493|NCT03479736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110972494|NCT03479736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110972495|NCT03203642|XL647|xl647|mesh-list
110972496|NCT03203642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110972497|NCT03203642|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110972498|NCT03203642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110972499|NCT03203642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110972500|NCT03475680|Gentamicins|gentamicins|mesh-list
110972501|NCT03475680|Ornidazole|ornidazole|mesh-list
110972502|NCT03475680|Sennosides|sennosides|mesh-list
110972503|NCT03475680|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110972504|NCT03475680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110972505|NCT03475680|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110972506|NCT03475680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110972507|NCT03475680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110972508|NCT03475680|Laxatives|laxatives|mesh-ancestor
110972509|NCT03475680|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110972510|NCT03475680|Amebicides|amebicides|mesh-ancestor
110972511|NCT03475680|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110972512|NCT03475680|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110972513|NCT03475680|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
110972514|NCT04621136|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110972515|NCT04621136|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110972516|NCT03475524|Metformin|metformin|mesh-list
110972517|NCT03475524|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110972518|NCT03475524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110972519|NCT02259075|Botulinum Toxins|botulinum toxins|mesh-list
110972520|NCT02259075|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110972521|NCT02259075|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110972522|NCT02259075|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110972523|NCT02259075|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110972524|NCT02259075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110972525|NCT02259075|Cholinergic Agents|cholinergic agents|mesh-ancestor
110972526|NCT02259075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110972527|NCT02259075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110972528|NCT02259075|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110972529|NCT02259075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110972531|NCT02471846|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110972532|NCT02471846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110972533|NCT02471846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110972534|NCT02471846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110972535|NCT02472782|Teriparatide|teriparatide|mesh-list
110972536|NCT02472782|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110972537|NCT02472782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110972538|NCT02472782|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110972539|NCT02258607|Trametinib|trametinib|mesh-list
110972540|NCT02258607|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
110972541|NCT02258607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110972542|NCT02258607|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110972543|NCT02258607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110972544|NCT02258607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110972545|NCT03792750|Nivolumab|nivolumab|mesh-list
110972546|NCT03792750|Linrodostat|linrodostat|mesh-list
110972547|NCT03792750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110972548|NCT03792750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110972549|NCT03792750|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110972550|NCT03792750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110972551|NCT03792750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110972552|NCT02258763|Amoxicillin|amoxicillin|mesh-list
110972553|NCT02258763|Clavulanic Acid|clavulanic acid|mesh-list
110972554|NCT02258763|Clavulanic Acids|clavulanic acids|mesh-list
110972555|NCT02258763|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
110972556|NCT02258763|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111491367|NCT05962502|Irinotecan|irinotecan|mesh-list
111491368|NCT05962502|Cetuximab|cetuximab|mesh-list
110972557|NCT02258763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110972558|NCT02258763|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110972559|NCT02258763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110972560|NCT02258763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110972561|NCT02469974|Busulfan|busulfan|mesh-list
110972562|NCT02469974|Immunologic Factors|immunologic factors|mesh-ancestor
110972563|NCT02469974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110972564|NCT02469974|Alkylating Agents|alkylating agents|mesh-ancestor
110972565|NCT02469974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110972566|NCT02469974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110972567|NCT02469974|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110972568|NCT02469974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110972569|NCT02469974|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110972570|NCT02231931|Metformin|metformin|mesh-list
110972571|NCT02231931|Digoxin|digoxin|mesh-list
110972572|NCT02231931|Furosemide|furosemide|mesh-list
110972573|NCT02231931|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110972574|NCT02231931|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110972575|NCT02231931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110972576|NCT02231931|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110972577|NCT02231931|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110972578|NCT02231931|Antimetabolites|antimetabolites|mesh-ancestor
110972579|NCT02231931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110972580|NCT02231931|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110972581|NCT02231931|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110972582|NCT02231931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110972583|NCT02231931|Diuretics|diuretics|mesh-ancestor
110972584|NCT02231931|Natriuretic Agents|natriuretic agents|mesh-ancestor
110972585|NCT02231931|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110972586|NCT02231931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110972587|NCT02231931|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110972588|NCT02231931|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110972589|NCT02231931|Protective Agents|protective agents|mesh-ancestor
110972590|NCT03131622|Coal Tar|coal tar|mesh-list
110972591|NCT03131622|Keratolytic Agents|keratolytic agents|mesh-ancestor
110972592|NCT03131622|Dermatologic Agents|dermatologic agents|mesh-ancestor
110972593|NCT03482544|Pregabalin|pregabalin|mesh-list
110972594|NCT03482544|Analgesics|analgesics|mesh-ancestor
110972595|NCT03482544|Sensory System Agents|sensory system agents|mesh-ancestor
110972596|NCT03482544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110972597|NCT03482544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110972598|NCT03482544|Anticonvulsants|anticonvulsants|mesh-ancestor
110972599|NCT03482544|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110689662|NCT00325468|Denosumab|denosumab|mesh-list
110972600|NCT03482544|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110972601|NCT03482544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110972602|NCT03482544|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110972603|NCT03482544|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110972604|NCT03482544|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110972605|NCT03482544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110972606|NCT03482544|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110972607|NCT02750709|Nitisinone|nitisinone|mesh-list
110972608|NCT02750709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110972609|NCT02750709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110972610|NCT02222649|Vitamin D|vitamin d|mesh-list
110972611|NCT02222649|Cholecalciferol|cholecalciferol|mesh-list
110972612|NCT02222649|Vitamins|vitamins|mesh-ancestor
110972613|NCT02222649|Micronutrients|micronutrients|mesh-ancestor
110972614|NCT02222649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110972615|NCT02222649|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110972616|NCT02222649|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110972617|NCT02222727|Donepezil|donepezil|mesh-list
110972618|NCT02222727|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110972619|NCT02222727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110972620|NCT02222727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110972621|NCT02222727|Cholinergic Agents|cholinergic agents|mesh-ancestor
110972622|NCT02222727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110972623|NCT02222727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111491369|NCT05962502|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111491370|NCT05962502|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111491371|NCT05962502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110972624|NCT02222727|Nootropic Agents|nootropic agents|mesh-ancestor
110972625|NCT02723786|Mycophenolic Acid|mycophenolic acid|mesh-list
110972626|NCT02723786|Azathioprine|azathioprine|mesh-list
110972627|NCT02723786|Tacrolimus|tacrolimus|mesh-list
110972628|NCT02723786|Basiliximab|basiliximab|mesh-list
110972629|NCT02723786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110972630|NCT02723786|Immunologic Factors|immunologic factors|mesh-ancestor
110972631|NCT02723786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110972632|NCT02723786|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110972633|NCT02723786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110972634|NCT02723786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110972635|NCT02723786|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110972636|NCT02723786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110972637|NCT02723786|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110972638|NCT02723786|Antitubercular Agents|antitubercular agents|mesh-ancestor
110972639|NCT02723786|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110972640|NCT02723786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110972641|NCT02723786|Antimetabolites|antimetabolites|mesh-ancestor
110972642|NCT02723786|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110972643|NCT02723786|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110972644|NCT03310736|Hepcidins|hepcidins|mesh-list
110972645|NCT03310736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110972646|NCT02226783|Omeprazole|omeprazole|mesh-list
110972647|NCT02226783|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110972648|NCT02226783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110972649|NCT02226783|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110972650|NCT02226783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110972651|NCT02226783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110972652|NCT03482232|Acetaminophen|acetaminophen|mesh-list
110972653|NCT03482232|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110972654|NCT03482232|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
110972655|NCT03482232|Anti-Infective Agents|anti-infective agents|mesh-list
110972656|NCT03482232|Ibuprofen|ibuprofen|mesh-list
110972657|NCT03482232|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
110972658|NCT03482232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
110972659|NCT03482232|Hypolipidemic Agents|hypolipidemic agents|mesh-list
110972660|NCT03482232|Expectorants|expectorants|mesh-list
110972661|NCT03482232|Antitubercular Agents|antitubercular agents|mesh-ancestor
110972662|NCT03482232|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110972663|NCT03482232|Analgesics|analgesics|mesh-ancestor
110972664|NCT03482232|Sensory System Agents|sensory system agents|mesh-ancestor
110972665|NCT03482232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110972666|NCT03482232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110972667|NCT03482232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110972668|NCT03482232|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110972669|NCT03482232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110972670|NCT03482232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110972671|NCT03482232|Antipyretics|antipyretics|mesh-ancestor
110972672|NCT03482232|Antimetabolites|antimetabolites|mesh-ancestor
110972673|NCT03482232|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110689738|NCT00310804|Vaccines|vaccines|mesh-list
110972674|NCT03482232|Respiratory System Agents|respiratory system agents|mesh-ancestor
110972675|NCT02227017|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110972676|NCT04542200|Antibodies|antibodies|mesh-list
110972677|NCT04542200|Immunologic Factors|immunologic factors|mesh-ancestor
110972678|NCT04542200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110972679|NCT02227173|Flurbiprofen|flurbiprofen|mesh-list
110972680|NCT02227173|Digoxin|digoxin|mesh-list
110972681|NCT02227173|Montelukast|montelukast|mesh-list
110972682|NCT02227173|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110972683|NCT02227173|Respiratory System Agents|respiratory system agents|mesh-ancestor
110972684|NCT02227173|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110972685|NCT02227173|Hormone Antagonists|hormone antagonists|mesh-ancestor
110972686|NCT02227173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110972687|NCT02227173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110972688|NCT02227173|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110972689|NCT02227173|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110972690|NCT02227173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110972691|NCT02227173|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110972692|NCT02227173|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110972693|NCT02227173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111491372|NCT05962502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111491373|NCT05962502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110972694|NCT02227173|Protective Agents|protective agents|mesh-ancestor
110972695|NCT02227173|Analgesics|analgesics|mesh-ancestor
111491374|NCT05962502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110972696|NCT02227173|Sensory System Agents|sensory system agents|mesh-ancestor
110972697|NCT02227173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110972698|NCT02227173|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110972699|NCT02227173|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110972700|NCT02227173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110972701|NCT02227173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110972702|NCT02227173|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110972703|NCT02469740|Clopidogrel|clopidogrel|mesh-list
110972704|NCT02469740|Ticagrelor|ticagrelor|mesh-list
110972705|NCT02469740|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110972706|NCT02469740|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110972707|NCT02469740|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110972708|NCT02469740|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110972709|NCT02469740|Purinergic Agents|purinergic agents|mesh-ancestor
110972710|NCT02469740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110972711|NCT02469740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110972712|NCT02469740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110972713|NCT04432220|Apixaban|apixaban|mesh-list
110972714|NCT04432220|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110972715|NCT04432220|Antithrombins|antithrombins|mesh-ancestor
110972716|NCT04432220|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110972717|NCT04432220|Protease Inhibitors|protease inhibitors|mesh-ancestor
110972718|NCT04432220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110972719|NCT04432220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110972720|NCT04432220|Anticoagulants|anticoagulants|mesh-ancestor
110972721|NCT04405622|Gemcitabine|gemcitabine|mesh-list
110972722|NCT04405622|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110972723|NCT04405622|Antimetabolites|antimetabolites|mesh-ancestor
110972724|NCT04405622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110972725|NCT04405622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110972726|NCT03481998|Letrozole|letrozole|mesh-list
110972727|NCT03481998|Fulvestrant|fulvestrant|mesh-list
110972728|NCT03481998|Anastrozole|anastrozole|mesh-list
110972729|NCT03481998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110972730|NCT03481998|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110972731|NCT03481998|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110972732|NCT03481998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110972733|NCT03481998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110972734|NCT03481998|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110972735|NCT03481998|Hormone Antagonists|hormone antagonists|mesh-ancestor
110972736|NCT03481998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110972737|NCT03481998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110972738|NCT03481998|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110972739|NCT03481998|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110972740|NCT02723084|Ribavirin|ribavirin|mesh-list
110972741|NCT02723084|Sofosbuvir|sofosbuvir|mesh-list
110972742|NCT02723084|Antimetabolites|antimetabolites|mesh-ancestor
110972743|NCT02723084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110972744|NCT02723084|Antiviral Agents|antiviral agents|mesh-ancestor
110972745|NCT02723084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110972746|NCT02750943|Fluorides|fluorides|mesh-list
110972747|NCT02750943|Tin Fluorides|tin fluorides|mesh-list
110972748|NCT02750943|Fluorophosphate|fluorophosphate|mesh-list
110689805|NCT00974441|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110972749|NCT02750943|Cariostatic Agents|cariostatic agents|mesh-ancestor
110972750|NCT02750943|Protective Agents|protective agents|mesh-ancestor
110972751|NCT02750943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110972753|NCT03481920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110972754|NCT03481920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110972755|NCT02227797|Voriconazole|voriconazole|mesh-list
110972756|NCT02227797|Antifungal Agents|antifungal agents|mesh-ancestor
110972757|NCT02227797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110972758|NCT02227797|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110972759|NCT02227797|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110972760|NCT02227797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110972761|NCT02227797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110972762|NCT02227797|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110972763|NCT02227797|Hormone Antagonists|hormone antagonists|mesh-ancestor
110972764|NCT02227797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110972765|NCT02227797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110972766|NCT02227797|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111491375|NCT05957757|Tislelizumab|tislelizumab|mesh-list
111491376|NCT05957757|Disitamab vedotin|disitamab vedotin|mesh-list
110972767|NCT05784311|Metronidazole|metronidazole|mesh-list
111491377|NCT05957757|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110972768|NCT05784311|Cefuroxime|cefuroxime|mesh-list
110972769|NCT05784311|Cefuroxime axetil|cefuroxime axetil|mesh-list
110972770|NCT05784311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110972771|NCT05784311|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110972772|NCT05784311|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110972773|NCT05784311|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110972774|NCT05783778|Testosterone|testosterone|mesh-list
110972775|NCT05783778|Androgens|androgens|mesh-ancestor
110972776|NCT05783778|Hormones|hormones|mesh-ancestor
110972777|NCT05783778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110972778|NCT05783778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110972779|NCT05783609|Rituximab|rituximab|mesh-list
110972780|NCT05783609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110972781|NCT05783609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110972782|NCT05783609|Immunologic Factors|immunologic factors|mesh-ancestor
110972783|NCT05783609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110972784|NCT05783609|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110972785|NCT05783557|Clevidipine|clevidipine|mesh-list
110972786|NCT05783557|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110972787|NCT05783557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110972788|NCT05783557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110972789|NCT05783557|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110972790|NCT05783557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110972791|NCT05783518|Propofol|propofol|mesh-list
110972792|NCT05783518|Desflurane|desflurane|mesh-list
110972793|NCT05783518|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110972794|NCT05783518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110972795|NCT05783518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110972796|NCT05783518|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110972797|NCT05783518|Anesthetics, General|anesthetics, general|mesh-ancestor
110972798|NCT05783518|Anesthetics|anesthetics|mesh-ancestor
110972799|NCT05783518|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110972800|NCT05783492|Ketamine|ketamine|mesh-list
110972801|NCT05783492|Analgesics|analgesics|mesh-ancestor
110972802|NCT05783492|Sensory System Agents|sensory system agents|mesh-ancestor
110972803|NCT05783492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110972804|NCT05783492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110972805|NCT05783492|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110972806|NCT05783492|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110972807|NCT05783492|Anesthetics, General|anesthetics, general|mesh-ancestor
110972808|NCT05783492|Anesthetics|anesthetics|mesh-ancestor
110972809|NCT05783492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110972810|NCT05783492|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110972811|NCT05783492|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110972812|NCT05783492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110972813|NCT05783492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110972814|NCT05783479|Estradiol|estradiol|mesh-list
110972815|NCT05783479|Hyaluronic Acid|hyaluronic acid|mesh-list
110972816|NCT05783479|Estrogens|estrogens|mesh-ancestor
110972817|NCT05783479|Hormones|hormones|mesh-ancestor
110972818|NCT05783479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110972819|NCT05783479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110972820|NCT05783479|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110972821|NCT05783479|Immunologic Factors|immunologic factors|mesh-ancestor
110972822|NCT05783479|Viscosupplements|viscosupplements|mesh-ancestor
110972823|NCT05783479|Protective Agents|protective agents|mesh-ancestor
110972824|NCT05783453|Emollients|emollients|mesh-list
110972825|NCT05783453|Dermatologic Agents|dermatologic agents|mesh-ancestor
110972826|NCT05782933|Rituximab|rituximab|mesh-list
110972827|NCT05782933|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110972828|NCT05782933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110972829|NCT05782933|Immunologic Factors|immunologic factors|mesh-ancestor
110972830|NCT05782933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110972831|NCT05782933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110972832|NCT05782920|Hyaluronic Acid|hyaluronic acid|mesh-list
110972833|NCT05782920|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110972834|NCT05782920|Immunologic Factors|immunologic factors|mesh-ancestor
110972835|NCT05782920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110972836|NCT05782920|Viscosupplements|viscosupplements|mesh-ancestor
110972837|NCT05782920|Protective Agents|protective agents|mesh-ancestor
110972838|NCT05782777|Ezetimibe|ezetimibe|mesh-list
110972839|NCT05782777|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
111491378|NCT05957757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110972840|NCT05782777|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110972841|NCT05782777|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110972842|NCT05782777|Antimetabolites|antimetabolites|mesh-ancestor
111491379|NCT05957757|Immunoconjugates|immunoconjugates|mesh-ancestor
110972843|NCT05782777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110972844|NCT05782777|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110972845|NCT05782777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110972846|NCT05782764|Endostar protein|endostar protein|mesh-list
110972847|NCT05782764|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
110972848|NCT05782764|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110972849|NCT05782764|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110972850|NCT05782764|Growth Substances|growth substances|mesh-ancestor
110972851|NCT05782764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110972852|NCT05782764|Growth Inhibitors|growth inhibitors|mesh-ancestor
110972853|NCT05782764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110972854|NCT05782764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110972855|NCT05782764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110972856|NCT05782751|Mitogens|mitogens|mesh-list
110972857|NCT05782751|Mitosis Modulators|mitosis modulators|mesh-ancestor
110972858|NCT05782751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110972859|NCT05781074|Lenvatinib|lenvatinib|mesh-list
110972860|NCT05781074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110972861|NCT05781074|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110972862|NCT05781074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110972863|NCT05781074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110972864|NCT05780541|Remdesivir|remdesivir|mesh-list
110972865|NCT05780541|Antimetabolites|antimetabolites|mesh-ancestor
110972866|NCT05780541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110972867|NCT05780541|Antiviral Agents|antiviral agents|mesh-ancestor
110972868|NCT05780541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110972869|NCT05780463|Remdesivir|remdesivir|mesh-list
110972870|NCT05780463|Antimetabolites|antimetabolites|mesh-ancestor
110972871|NCT05780463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110972872|NCT05780463|Antiviral Agents|antiviral agents|mesh-ancestor
110972873|NCT05780463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110972874|NCT05780281|Remdesivir|remdesivir|mesh-list
110972875|NCT05780281|Sotrovimab|sotrovimab|mesh-list
110972876|NCT05780281|Antimetabolites|antimetabolites|mesh-ancestor
110972877|NCT05780281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110972878|NCT05780281|Antiviral Agents|antiviral agents|mesh-ancestor
110972879|NCT05780281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110972880|NCT05780268|Remdesivir|remdesivir|mesh-list
110972881|NCT05780268|Bamlanivimab|bamlanivimab|mesh-list
110972882|NCT05780268|Antimetabolites|antimetabolites|mesh-ancestor
110479363|NCT02706015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110972883|NCT05780268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110972884|NCT05780268|Antiviral Agents|antiviral agents|mesh-ancestor
110972885|NCT05780268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110972886|NCT05779657|Midazolam|midazolam|mesh-list
110972887|NCT05779657|Ketamine|ketamine|mesh-list
110972888|NCT05779657|Analgesics|analgesics|mesh-ancestor
110972889|NCT05779657|Sensory System Agents|sensory system agents|mesh-ancestor
110972890|NCT05779657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110972891|NCT05779657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110972892|NCT05779657|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110972893|NCT05779657|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110972894|NCT05779657|Anesthetics, General|anesthetics, general|mesh-ancestor
110972895|NCT05779657|Anesthetics|anesthetics|mesh-ancestor
110972896|NCT05779657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110972897|NCT05779657|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110972898|NCT05779657|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110972899|NCT05779657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110972900|NCT05779657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110972901|NCT05779657|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110972902|NCT05779657|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110972903|NCT05779657|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110972904|NCT05779657|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110972905|NCT05779657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110972907|NCT05779657|GABA Agents|gaba agents|mesh-ancestor
110972908|NCT05774054|Norepinephrine|norepinephrine|mesh-list
110972909|NCT05774054|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110972910|NCT05774054|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110972911|NCT05774054|Adrenergic Agents|adrenergic agents|mesh-ancestor
110972912|NCT05774054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110972913|NCT05774054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110972914|NCT05774054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110972915|NCT05774054|Sympathomimetics|sympathomimetics|mesh-ancestor
111491380|NCT05957757|Immunologic Factors|immunologic factors|mesh-ancestor
110972916|NCT05774054|Autonomic Agents|autonomic agents|mesh-ancestor
110972917|NCT05774054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111491381|NCT05957757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111491382|NCT05937776|Deoxyglucose|deoxyglucose|mesh-list
110972918|NCT05774054|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110972919|NCT05751148|Bupivacaine|bupivacaine|mesh-list
110972920|NCT05751148|Prilocaine|prilocaine|mesh-list
110972921|NCT05751148|Anesthetics, Local|anesthetics, local|mesh-ancestor
110972922|NCT05751148|Anesthetics|anesthetics|mesh-ancestor
110972923|NCT05751148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110972924|NCT05751148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110972925|NCT05751148|Sensory System Agents|sensory system agents|mesh-ancestor
110972926|NCT05751148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110972927|NCT05711199|Nitroglycerin|nitroglycerin|mesh-list
110972928|NCT05711199|Vasodilator Agents|vasodilator agents|mesh-ancestor
110972929|NCT05703971|Atezolizumab|atezolizumab|mesh-list
110972930|NCT05703971|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110972931|NCT05703971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110972932|NCT05703971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110972933|NCT05703971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110972934|NCT05703074|Niacinamide|niacinamide|mesh-list
110972935|NCT05703074|Niacin|niacin|mesh-list
110972936|NCT05703074|Nicotinic Acids|nicotinic acids|mesh-list
110972937|NCT05703074|Vitamin B Complex|vitamin b complex|mesh-ancestor
110972938|NCT05703074|Vitamins|vitamins|mesh-ancestor
110972939|NCT05703074|Micronutrients|micronutrients|mesh-ancestor
110972940|NCT05703074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110972941|NCT05703074|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110972942|NCT05703074|Antimetabolites|antimetabolites|mesh-ancestor
110972943|NCT05703074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110972944|NCT05703074|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110972945|NCT05703074|Vasodilator Agents|vasodilator agents|mesh-ancestor
110972946|NCT05701865|Ethanol|ethanol|mesh-list
110479370|NCT02707575|Ranibizumab|ranibizumab|mesh-list
110972947|NCT05701865|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110972948|NCT05701865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110972949|NCT05701865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110972950|NCT05701865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110972951|NCT05701345|Antidepressive Agents|antidepressive agents|mesh-list
110972952|NCT05701345|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110972953|NCT05674721|Ibuprofen|ibuprofen|mesh-list
110972954|NCT05674721|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110972955|NCT05674721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110972956|NCT05674721|Analgesics|analgesics|mesh-ancestor
110972957|NCT05674721|Sensory System Agents|sensory system agents|mesh-ancestor
110972958|NCT05674721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110972959|NCT05674721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110972960|NCT05674721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110972961|NCT05674721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110972962|NCT05674721|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110972963|NCT05674721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110972964|NCT05674721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110972965|NCT05664464|Sulfasalazine|sulfasalazine|mesh-list
110972966|NCT05664464|Temozolomide|temozolomide|mesh-list
110972967|NCT05664464|Gabapentin|gabapentin|mesh-list
110972968|NCT05664464|Memantine|memantine|mesh-list
110972969|NCT05664464|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110972970|NCT05664464|Alkylating Agents|alkylating agents|mesh-ancestor
110972971|NCT05664464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110972972|NCT05664464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110972973|NCT05664464|Analgesics|analgesics|mesh-ancestor
110972974|NCT05664464|Sensory System Agents|sensory system agents|mesh-ancestor
110972975|NCT05664464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110972976|NCT05664464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110972977|NCT05664464|Anticonvulsants|anticonvulsants|mesh-ancestor
110972978|NCT05664464|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110972979|NCT05664464|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110972980|NCT05664464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110972981|NCT05664464|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110972982|NCT05664464|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110972983|NCT05664464|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110972984|NCT05664464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110972985|NCT05664464|Antimanic Agents|antimanic agents|mesh-ancestor
110972986|NCT05664464|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110972987|NCT05664464|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110972988|NCT05664464|Dopamine Agents|dopamine agents|mesh-ancestor
110972989|NCT05664464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110972990|NCT05664464|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110972991|NCT05664464|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110972992|NCT05664464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111491383|NCT05937776|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110972993|NCT05664464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110972994|NCT05664464|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110972995|NCT05657457|Tenecteplase|tenecteplase|mesh-list
110972996|NCT05657457|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110972997|NCT05657457|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110972998|NCT05657457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110972999|NCT05646316|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110973000|NCT05635344|Pembrolizumab|pembrolizumab|mesh-list
110973001|NCT05635344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110973002|NCT05635344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110973003|NCT05635344|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110973004|NCT05635344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110973005|NCT05630989|Hydroxychloroquine|hydroxychloroquine|mesh-list
110973006|NCT05630989|Mitogens|mitogens|mesh-list
110973007|NCT05630989|Antimalarials|antimalarials|mesh-ancestor
110973008|NCT05630989|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110973009|NCT05630989|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110973010|NCT05630989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110973011|NCT05630989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110973012|NCT05630989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110973013|NCT05630989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110973014|NCT05630989|Mitosis Modulators|mitosis modulators|mesh-ancestor
110973015|NCT05626530|Letermovir|letermovir|mesh-list
110973016|NCT05626530|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110973017|NCT05626530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110973018|NCT05626530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110973019|NCT05626530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110973020|NCT05626530|Antiviral Agents|antiviral agents|mesh-ancestor
110973021|NCT05626530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110973022|NCT05601674|Anesthetics|anesthetics|mesh-list
110973023|NCT05601674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110973024|NCT05601674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110973025|NCT05527314|Fentanyl|fentanyl|mesh-list
110973026|NCT05527314|Remifentanil|remifentanil|mesh-list
110973027|NCT05527314|Sevoflurane|sevoflurane|mesh-list
110973028|NCT05527314|Cisatracurium|cisatracurium|mesh-list
110973029|NCT05527314|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110973030|NCT05527314|Narcotics|narcotics|mesh-ancestor
110973031|NCT05527314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110973032|NCT05527314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110973033|NCT05527314|Analgesics|analgesics|mesh-ancestor
110973034|NCT05527314|Sensory System Agents|sensory system agents|mesh-ancestor
110973035|NCT05527314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110973036|NCT05527314|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110973037|NCT05527314|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110973038|NCT05527314|Anesthetics, General|anesthetics, general|mesh-ancestor
110973039|NCT05527314|Anesthetics|anesthetics|mesh-ancestor
110973040|NCT05527314|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110973041|NCT05527314|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110973042|NCT05527314|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110973043|NCT05527314|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110973044|NCT05517122|Niacinamide|niacinamide|mesh-list
110973045|NCT05517122|Niacin|niacin|mesh-list
110973046|NCT05517122|Nicotinic Acids|nicotinic acids|mesh-list
110973047|NCT05517122|Vitamin B Complex|vitamin b complex|mesh-ancestor
110973048|NCT05517122|Vitamins|vitamins|mesh-ancestor
110973049|NCT05517122|Micronutrients|micronutrients|mesh-ancestor
110973050|NCT05517122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110973051|NCT05517122|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110973052|NCT05517122|Antimetabolites|antimetabolites|mesh-ancestor
110973053|NCT05517122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110973054|NCT05517122|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110973055|NCT05517122|Vasodilator Agents|vasodilator agents|mesh-ancestor
110973056|NCT05484505|Nicotine|nicotine|mesh-list
110973057|NCT05484505|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110973058|NCT05484505|Autonomic Agents|autonomic agents|mesh-ancestor
110973059|NCT05484505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111491384|NCT05937776|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
111491385|NCT05937776|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111491386|NCT05937776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111491387|NCT05937776|Antimetabolites|antimetabolites|mesh-ancestor
110973060|NCT05484505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110973061|NCT05484505|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110973062|NCT05484505|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111491388|NCT05937776|Antiviral Agents|antiviral agents|mesh-ancestor
111491389|NCT05937776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111491390|NCT05937776|Chelating Agents|chelating agents|mesh-ancestor
111491391|NCT05937776|Sequestering Agents|sequestering agents|mesh-ancestor
111491392|NCT05934227|Amoxicillin|amoxicillin|mesh-list
110973063|NCT05484505|Cholinergic Agents|cholinergic agents|mesh-ancestor
110973064|NCT05484505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110973065|NCT05484505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110973066|NCT05478161|Fexofenadine|fexofenadine|mesh-list
110973067|NCT05478161|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110973068|NCT05478161|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110973069|NCT05478161|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110973070|NCT05478161|Histamine Antagonists|histamine antagonists|mesh-ancestor
110973071|NCT05478161|Histamine Agents|histamine agents|mesh-ancestor
110973072|NCT05478161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110973073|NCT05478161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110973074|NCT05478161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110973075|NCT05476822|Antibodies|antibodies|mesh-list
110973076|NCT05476822|Immunologic Factors|immunologic factors|mesh-ancestor
110973077|NCT05476822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110973078|NCT05473364|Acetazolamide|acetazolamide|mesh-list
110973079|NCT05473364|Anticonvulsants|anticonvulsants|mesh-ancestor
110973080|NCT05473364|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110973081|NCT05473364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110973082|NCT05473364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110973083|NCT05473364|Diuretics|diuretics|mesh-ancestor
110973084|NCT05473364|Natriuretic Agents|natriuretic agents|mesh-ancestor
110973085|NCT05473364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110973086|NCT05413811|Fluorouracil|fluorouracil|mesh-list
110973087|NCT05413811|Antimetabolites|antimetabolites|mesh-ancestor
110973088|NCT05413811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110973089|NCT05413811|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110973090|NCT05413811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110973091|NCT05413811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110973092|NCT05413811|Immunologic Factors|immunologic factors|mesh-ancestor
110973093|NCT05413811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110973094|NCT05393804|Idecabtagene vicleucel|idecabtagene vicleucel|mesh-list
110973095|NCT05393804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110973096|NCT05393804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110973097|NCT05392608|Fulvestrant|fulvestrant|mesh-list
110973098|NCT05392608|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110973099|NCT05392608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110973100|NCT05392608|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110973101|NCT05392608|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110973102|NCT05392608|Hormone Antagonists|hormone antagonists|mesh-ancestor
110973103|NCT05392608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110973104|NCT05392608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110973105|NCT05382494|Mometasone Furoate|mometasone furoate|mesh-list
110973106|NCT05382494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110973107|NCT05382494|Dermatologic Agents|dermatologic agents|mesh-ancestor
110973108|NCT05382494|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110973109|NCT05351346|Prednisone|prednisone|mesh-list
110973110|NCT05351346|Cyclophosphamide|cyclophosphamide|mesh-list
110973111|NCT05351346|Rituximab|rituximab|mesh-list
110973112|NCT05351346|Doxorubicin|doxorubicin|mesh-list
110973113|NCT05351346|Vincristine|vincristine|mesh-list
110973114|NCT05351346|Lenalidomide|lenalidomide|mesh-list
110973115|NCT05351346|Decitabine|decitabine|mesh-list
110973116|NCT05351346|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110973117|NCT05351346|Immunologic Factors|immunologic factors|mesh-ancestor
110973118|NCT05351346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110973119|NCT05351346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110973120|NCT05351346|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110973121|NCT05351346|Alkylating Agents|alkylating agents|mesh-ancestor
110973122|NCT05351346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110973123|NCT05351346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110973124|NCT05351346|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110973125|NCT05351346|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110973126|NCT05351346|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110973127|NCT05351346|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110973128|NCT05351346|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110973129|NCT05351346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110973130|NCT05351346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111491393|NCT05934227|Metronidazole|metronidazole|mesh-list
110973131|NCT05351346|Glucocorticoids|glucocorticoids|mesh-ancestor
111491394|NCT05934227|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110973132|NCT05351346|Hormones|hormones|mesh-ancestor
111491395|NCT05934227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111491396|NCT05934227|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110973133|NCT05351346|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110973134|NCT05351346|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110973135|NCT05351346|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110973136|NCT05351346|Tubulin Modulators|tubulin modulators|mesh-ancestor
110973137|NCT05351346|Antimitotic Agents|antimitotic agents|mesh-ancestor
110973138|NCT05351346|Mitosis Modulators|mitosis modulators|mesh-ancestor
110973139|NCT05351346|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110973140|NCT05351346|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110973141|NCT05351346|Growth Substances|growth substances|mesh-ancestor
110973142|NCT05351346|Growth Inhibitors|growth inhibitors|mesh-ancestor
110973143|NCT05351346|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110973144|NCT05351346|Antimetabolites|antimetabolites|mesh-ancestor
110973145|NCT05323019|Ketamine|ketamine|mesh-list
110973146|NCT05323019|Esketamine|esketamine|mesh-list
110973147|NCT05323019|Analgesics|analgesics|mesh-ancestor
110973148|NCT05323019|Sensory System Agents|sensory system agents|mesh-ancestor
110973149|NCT05323019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110973150|NCT05323019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110973151|NCT05323019|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110973152|NCT05323019|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110973153|NCT05323019|Anesthetics, General|anesthetics, general|mesh-ancestor
110973154|NCT05323019|Anesthetics|anesthetics|mesh-ancestor
110973155|NCT05323019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110973156|NCT05323019|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110973157|NCT05323019|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110973158|NCT05323019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110973159|NCT05323019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110973160|NCT05323019|Antidepressive Agents|antidepressive agents|mesh-ancestor
110973161|NCT05323019|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110973162|NCT05276258|Bupivacaine|bupivacaine|mesh-list
110973163|NCT05276258|Anesthetics, Local|anesthetics, local|mesh-ancestor
110973164|NCT05276258|Anesthetics|anesthetics|mesh-ancestor
110973165|NCT05276258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110973166|NCT05276258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110973167|NCT05276258|Sensory System Agents|sensory system agents|mesh-ancestor
110973168|NCT05276258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110973169|NCT05233982|Olaparib|olaparib|mesh-list
110973170|NCT05233982|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110973171|NCT05233982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110973172|NCT05233982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110973173|NCT05233982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110973174|NCT05199493|Angiotensin II|angiotensin ii|mesh-list
110973175|NCT05199493|Giapreza|giapreza|mesh-list
110973176|NCT05199493|Angiotensinogen|angiotensinogen|mesh-list
110973177|NCT05199493|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110973178|NCT05199493|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110973179|NCT05199493|Protease Inhibitors|protease inhibitors|mesh-ancestor
110973180|NCT05199493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110973181|NCT05199493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110973182|NCT05112536|Paclitaxel|paclitaxel|mesh-list
110973183|NCT05112536|Carboplatin|carboplatin|mesh-list
110973184|NCT05112536|Doxorubicin|doxorubicin|mesh-list
110973185|NCT05112536|Pembrolizumab|pembrolizumab|mesh-list
110973186|NCT05112536|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110973187|NCT05112536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110973188|NCT05112536|Tubulin Modulators|tubulin modulators|mesh-ancestor
110973189|NCT05112536|Antimitotic Agents|antimitotic agents|mesh-ancestor
110973190|NCT05112536|Mitosis Modulators|mitosis modulators|mesh-ancestor
110973191|NCT05112536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110973192|NCT05112536|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110973193|NCT05112536|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110973194|NCT05112536|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110973195|NCT05112536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110973196|NCT05112536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110973197|NCT05112536|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110973198|NCT05109455|Proanthocyanidin|proanthocyanidin|mesh-list
110973199|NCT05109455|Procyanidin|procyanidin|mesh-list
110973200|NCT05109455|Antioxidants|antioxidants|mesh-ancestor
110973201|NCT05109455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110973202|NCT05109455|Protective Agents|protective agents|mesh-ancestor
110479402|NCT02588287|Antiviral Agents|antiviral agents|mesh-ancestor
110699488|NCT01039610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111491397|NCT05934227|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110973203|NCT05109455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110973204|NCT05109455|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110973205|NCT05109455|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110973206|NCT05109455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110973207|NCT05079360|Everolimus|everolimus|mesh-list
110973208|NCT05079360|Exemestane|exemestane|mesh-list
110973209|NCT05079360|Estrogens|estrogens|mesh-list
110973210|NCT05079360|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-list
110973211|NCT05079360|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-list
110973212|NCT05079360|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110973213|NCT05079360|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110973214|NCT05079360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110973215|NCT05079360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110973216|NCT05079360|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110973217|NCT05079360|Immunologic Factors|immunologic factors|mesh-ancestor
110973218|NCT05079360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110973219|NCT05079360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110973220|NCT05079360|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110973221|NCT05079360|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110973222|NCT05079360|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110973223|NCT05079360|Hormone Antagonists|hormone antagonists|mesh-ancestor
110973224|NCT05079360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110973225|NCT05079360|Hormones|hormones|mesh-ancestor
110973226|NCT05078060|Vaccines|vaccines|mesh-list
110973227|NCT05078060|Immunologic Factors|immunologic factors|mesh-ancestor
110973228|NCT05078060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110973229|NCT05063786|Capecitabine|capecitabine|mesh-list
110973230|NCT05063786|Trastuzumab|trastuzumab|mesh-list
110973231|NCT05063786|Vinorelbine|vinorelbine|mesh-list
110973232|NCT05063786|Fulvestrant|fulvestrant|mesh-list
110973233|NCT05063786|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110973234|NCT05063786|Antimetabolites|antimetabolites|mesh-ancestor
110973235|NCT05063786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110973236|NCT05063786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110973237|NCT05063786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110973238|NCT05063786|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110973239|NCT05063786|Tubulin Modulators|tubulin modulators|mesh-ancestor
110973240|NCT05063786|Antimitotic Agents|antimitotic agents|mesh-ancestor
110973241|NCT05063786|Mitosis Modulators|mitosis modulators|mesh-ancestor
110973242|NCT05063786|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110973243|NCT05063786|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110973244|NCT05063786|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110973245|NCT05063786|Hormone Antagonists|hormone antagonists|mesh-ancestor
110973246|NCT05063786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110973247|NCT05063786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110973248|NCT05012787|Vaccines|vaccines|mesh-list
110973249|NCT05012787|1018 oligonucleotide|1018 oligonucleotide|mesh-list
110973250|NCT05012787|Immunologic Factors|immunologic factors|mesh-ancestor
110973251|NCT05012787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110973252|NCT05012787|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110973253|NCT05005260|Bupivacaine|bupivacaine|mesh-list
110973254|NCT05005260|Anesthetics, Local|anesthetics, local|mesh-ancestor
110973255|NCT05005260|Anesthetics|anesthetics|mesh-ancestor
110973256|NCT05005260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110973257|NCT05005260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110973258|NCT05005260|Sensory System Agents|sensory system agents|mesh-ancestor
110973259|NCT05005260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110973260|NCT04990167|Bromides|bromides|mesh-list
110973261|NCT04990167|Tiotropium Bromide|tiotropium bromide|mesh-list
110973262|NCT04990167|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110973263|NCT04990167|Autonomic Agents|autonomic agents|mesh-ancestor
110973264|NCT04990167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110973265|NCT04990167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110973266|NCT04990167|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110973267|NCT04990167|Respiratory System Agents|respiratory system agents|mesh-ancestor
110973268|NCT04990167|Parasympatholytics|parasympatholytics|mesh-ancestor
110973269|NCT04990167|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111491399|NCT05933577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111491400|NCT05933577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111491401|NCT05933577|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111491402|NCT05933577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111491403|NCT05930782|Piperaquine|piperaquine|mesh-list
110973270|NCT04990167|Cholinergic Agents|cholinergic agents|mesh-ancestor
110699492|NCT00267189|Cyclosporine|cyclosporine|mesh-list
111491404|NCT05930782|Antimalarials|antimalarials|mesh-ancestor
111491405|NCT05930782|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110973271|NCT04990167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110973272|NCT04990167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110973273|NCT04990167|Anticonvulsants|anticonvulsants|mesh-ancestor
110973274|NCT04918927|Nitazoxanide|nitazoxanide|mesh-list
110973275|NCT04918927|Favipiravir|favipiravir|mesh-list
110973276|NCT04918927|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110973277|NCT04918927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110973278|NCT04918927|Antiviral Agents|antiviral agents|mesh-ancestor
110973279|NCT04907825|Warfarin|warfarin|mesh-list
110973280|NCT04907825|Anticoagulants|anticoagulants|mesh-list
110973281|NCT04907084|Fenofibrate|fenofibrate|mesh-list
110973282|NCT04907084|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110973283|NCT04907084|Antimetabolites|antimetabolites|mesh-ancestor
110973284|NCT04907084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110973285|NCT04907084|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110973286|NCT04893356|Dacarbazine|dacarbazine|mesh-list
110973287|NCT04893356|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110973288|NCT04893356|Alkylating Agents|alkylating agents|mesh-ancestor
110973289|NCT04893356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110973290|NCT04893356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110973291|NCT04857983|Memantine|memantine|mesh-list
110973292|NCT04857983|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110973293|NCT04857983|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110973294|NCT04857983|Dopamine Agents|dopamine agents|mesh-ancestor
110973295|NCT04857983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110973296|NCT04857983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110973297|NCT04857983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110973298|NCT04857983|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110973299|NCT04857983|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110973300|NCT04777708|Pembrolizumab|pembrolizumab|mesh-list
110973301|NCT04777708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110973302|NCT04777708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110973303|NCT04777708|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110973304|NCT04777708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110973305|NCT04763512|Caseins|caseins|mesh-list
110973306|NCT04763512|Chelating Agents|chelating agents|mesh-ancestor
110973307|NCT04763512|Sequestering Agents|sequestering agents|mesh-ancestor
110973308|NCT04763512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110973309|NCT04730349|Nivolumab|nivolumab|mesh-list
110973310|NCT04730349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110973311|NCT04730349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110973312|NCT04730349|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110973313|NCT04730349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110973314|NCT04602117|Paclitaxel|paclitaxel|mesh-list
110973315|NCT04602117|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110973316|NCT04602117|Trastuzumab|trastuzumab|mesh-list
110973317|NCT04602117|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110973318|NCT04602117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110973319|NCT04602117|Tubulin Modulators|tubulin modulators|mesh-ancestor
110973320|NCT04602117|Antimitotic Agents|antimitotic agents|mesh-ancestor
110973321|NCT04602117|Mitosis Modulators|mitosis modulators|mesh-ancestor
110973322|NCT04602117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110479422|NCT02705547|Antimetabolites|antimetabolites|mesh-ancestor
110973323|NCT04602117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110973324|NCT04601857|Pembrolizumab|pembrolizumab|mesh-list
110973325|NCT04601857|Futibatinib|futibatinib|mesh-list
110973326|NCT04601857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110973327|NCT04601857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110973328|NCT04601857|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110973329|NCT04601857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110973330|NCT04517396|Fenofibrate|fenofibrate|mesh-list
110973331|NCT04517396|Fenofibric acid|fenofibric acid|mesh-list
110973332|NCT04517396|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110973333|NCT04517396|Antimetabolites|antimetabolites|mesh-ancestor
110973334|NCT04517396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110973335|NCT04517396|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110973336|NCT04517396|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110973337|NCT04382352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110973338|NCT04382352|Trastuzumab|trastuzumab|mesh-list
110973339|NCT04382352|Antibodies|antibodies|mesh-list
110973340|NCT04382352|Immunoglobulins|immunoglobulins|mesh-list
110973341|NCT04382352|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111491406|NCT05930782|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111491407|NCT05930782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110973343|NCT04382352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110973344|NCT04382352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110973345|NCT04311424|Tirzepatide|tirzepatide|mesh-list
110973346|NCT04311424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110973347|NCT04311424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110973348|NCT04311424|Incretins|incretins|mesh-ancestor
110973349|NCT04311424|Hormones|hormones|mesh-ancestor
110973350|NCT04311424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110973351|NCT04301765|Testosterone|testosterone|mesh-list
110973353|NCT04301765|Hormones|hormones|mesh-ancestor
110973354|NCT04301765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110973355|NCT04301765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110973356|NCT04296396|Oxycodone|oxycodone|mesh-list
110973357|NCT04296396|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110973358|NCT04296396|Narcotics|narcotics|mesh-ancestor
110973359|NCT04296396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110973360|NCT04296396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110973361|NCT04296396|Analgesics|analgesics|mesh-ancestor
110973362|NCT04296396|Sensory System Agents|sensory system agents|mesh-ancestor
110973363|NCT04296396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110973364|NCT04291456|Minocycline|minocycline|mesh-list
110973365|NCT04291456|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110973366|NCT04291456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110973367|NCT04266977|Dexamethasone|dexamethasone|mesh-list
110973368|NCT04266977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110973369|NCT04266977|Antiemetics|antiemetics|mesh-ancestor
110973370|NCT04266977|Autonomic Agents|autonomic agents|mesh-ancestor
110973371|NCT04266977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110973372|NCT04266977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110973373|NCT04266977|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110973374|NCT04266977|Glucocorticoids|glucocorticoids|mesh-ancestor
110973375|NCT04266977|Hormones|hormones|mesh-ancestor
110973376|NCT04266977|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110973377|NCT04266977|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110973378|NCT04266977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110973379|NCT04172922|Sirolimus|sirolimus|mesh-list
110973380|NCT04172922|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110973381|NCT04172922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110973382|NCT04172922|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110973383|NCT04172922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110973384|NCT04172922|Antifungal Agents|antifungal agents|mesh-ancestor
110973385|NCT04172922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110973386|NCT04172922|Immunologic Factors|immunologic factors|mesh-ancestor
110973387|NCT04172922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110973388|NCT04139772|Docetaxel|docetaxel|mesh-list
110973389|NCT04139772|Abiraterone Acetate|abiraterone acetate|mesh-list
110973390|NCT04139772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110973391|NCT04139772|Tubulin Modulators|tubulin modulators|mesh-ancestor
110973392|NCT04139772|Antimitotic Agents|antimitotic agents|mesh-ancestor
110973393|NCT04139772|Mitosis Modulators|mitosis modulators|mesh-ancestor
110973394|NCT04139772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110973395|NCT04139772|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110973396|NCT04139772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110973397|NCT04139772|Hormone Antagonists|hormone antagonists|mesh-ancestor
110973398|NCT04139772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110973399|NCT04139772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110973400|NCT04139772|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110973401|NCT04091204|Olaparib|olaparib|mesh-list
110973402|NCT04091204|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110973403|NCT04091204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110973404|NCT04091204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110973405|NCT04091204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110973406|NCT04028245|Spartalizumab|spartalizumab|mesh-list
110973407|NCT04028245|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110973408|NCT04028245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110973409|NCT04028245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110973410|NCT04028245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110973411|NCT03975114|Durvalumab|durvalumab|mesh-list
111491408|NCT05930561|Aflibercept|aflibercept|mesh-list
110973412|NCT03975114|Tremelimumab|tremelimumab|mesh-list
110973413|NCT03975114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110973414|NCT03975114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111491409|NCT05930561|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111491410|NCT05930561|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110973415|NCT03955783|Venetoclax|venetoclax|mesh-list
110973416|NCT03955783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110973417|NCT03942120|Ustekinumab|ustekinumab|mesh-list
110973418|NCT03942120|Dermatologic Agents|dermatologic agents|mesh-ancestor
110973419|NCT03940742|Tirzepatide|tirzepatide|mesh-list
110973420|NCT03940742|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110973421|NCT03940742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110973422|NCT03940742|Incretins|incretins|mesh-ancestor
110973423|NCT03940742|Hormones|hormones|mesh-ancestor
110973424|NCT03940742|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110973425|NCT03893240|Antibodies|antibodies|mesh-list
110973426|NCT03893240|Antibodies, Blocking|antibodies, blocking|mesh-list
110973427|NCT03893240|Immunologic Factors|immunologic factors|mesh-ancestor
110973428|NCT03893240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110973429|NCT03875274|Morphine|morphine|mesh-list
110973430|NCT03875274|Ropivacaine|ropivacaine|mesh-list
110973431|NCT03875274|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110973432|NCT03875274|Narcotics|narcotics|mesh-ancestor
110973433|NCT03875274|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110973434|NCT03875274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110973435|NCT03875274|Analgesics|analgesics|mesh-ancestor
110973436|NCT03875274|Sensory System Agents|sensory system agents|mesh-ancestor
110973437|NCT03875274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110973438|NCT03875274|Anesthetics, Local|anesthetics, local|mesh-ancestor
110973439|NCT03875274|Anesthetics|anesthetics|mesh-ancestor
110973440|NCT03775850|Pembrolizumab|pembrolizumab|mesh-list
110973441|NCT03775850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110973442|NCT03775850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110973443|NCT03775850|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110973444|NCT03775850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110973445|NCT03762109|Dantrolene|dantrolene|mesh-list
110973446|NCT03762109|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110973447|NCT03762109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110973448|NCT03762109|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110973449|NCT03762109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110973450|NCT03732664|Pembrolizumab|pembrolizumab|mesh-list
110973451|NCT03732664|Nivolumab|nivolumab|mesh-list
110973452|NCT03732664|Durvalumab|durvalumab|mesh-list
110973453|NCT03732664|Tislelizumab|tislelizumab|mesh-list
111491411|NCT05930561|Growth Substances|growth substances|mesh-ancestor
111491412|NCT05930561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111491413|NCT05930561|Growth Inhibitors|growth inhibitors|mesh-ancestor
111491414|NCT05930561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111491415|NCT05915182|Budesonide|budesonide|mesh-list
111491416|NCT05915182|Glycopyrrolate|glycopyrrolate|mesh-list
111491417|NCT05915182|Bromides|bromides|mesh-list
111491418|NCT05915182|Formoterol Fumarate|formoterol fumarate|mesh-list
111491419|NCT05915182|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111491420|NCT05915182|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111491421|NCT05915182|Autonomic Agents|autonomic agents|mesh-ancestor
111491422|NCT05915182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111491423|NCT05915182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111491424|NCT05915182|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111491425|NCT05915182|Respiratory System Agents|respiratory system agents|mesh-ancestor
111491426|NCT05915182|Glucocorticoids|glucocorticoids|mesh-ancestor
111491427|NCT05915182|Hormones|hormones|mesh-ancestor
111491428|NCT05915182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111491429|NCT05915182|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111491430|NCT05915182|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111491431|NCT05915182|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111491432|NCT05915182|Adrenergic Agents|adrenergic agents|mesh-ancestor
111491433|NCT05915182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111491434|NCT05915182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111491435|NCT05915182|Anticonvulsants|anticonvulsants|mesh-ancestor
111491436|NCT05915182|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111491437|NCT05915182|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111491438|NCT05915182|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111491439|NCT05915182|Cholinergic Agents|cholinergic agents|mesh-ancestor
111491440|NCT05907213|Ketamine|ketamine|mesh-list
111491441|NCT05907213|Analgesics|analgesics|mesh-ancestor
111491442|NCT05907213|Sensory System Agents|sensory system agents|mesh-ancestor
111491443|NCT05907213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110973454|NCT03732664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110973455|NCT03732664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110699503|NCT00267189|Immunologic Factors|immunologic factors|mesh-ancestor
111491444|NCT05907213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111491445|NCT05907213|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111491446|NCT05907213|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111491447|NCT05907213|Anesthetics, General|anesthetics, general|mesh-ancestor
111491448|NCT05907213|Anesthetics|anesthetics|mesh-ancestor
110973456|NCT03732664|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110973457|NCT03732664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110973458|NCT03620032|Vinorelbine|vinorelbine|mesh-list
110973459|NCT03620032|Nimotuzumab|nimotuzumab|mesh-list
110973460|NCT03620032|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110973461|NCT03620032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110973462|NCT03620032|Tubulin Modulators|tubulin modulators|mesh-ancestor
110973463|NCT03620032|Antimitotic Agents|antimitotic agents|mesh-ancestor
110973464|NCT03620032|Mitosis Modulators|mitosis modulators|mesh-ancestor
110973465|NCT03620032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110973466|NCT03620032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110973467|NCT03410784|Paclitaxel|paclitaxel|mesh-list
110973468|NCT03410784|Carboplatin|carboplatin|mesh-list
110973469|NCT03410784|Pembrolizumab|pembrolizumab|mesh-list
110973470|NCT03410784|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110973471|NCT03410784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110973472|NCT03410784|Tubulin Modulators|tubulin modulators|mesh-ancestor
110973473|NCT03410784|Antimitotic Agents|antimitotic agents|mesh-ancestor
110973474|NCT03410784|Mitosis Modulators|mitosis modulators|mesh-ancestor
110973475|NCT03410784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110973476|NCT03410784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110973477|NCT03410784|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110973478|NCT03363841|Ibrexafungerp|ibrexafungerp|mesh-list
110973479|NCT03363841|Antifungal Agents|antifungal agents|mesh-ancestor
110973480|NCT03363841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110973481|NCT03355482|Methylprednisolone|methylprednisolone|mesh-list
110973482|NCT03355482|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110973483|NCT03355482|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110973484|NCT03355482|Prednisolone|prednisolone|mesh-list
110973485|NCT03355482|Prednisolone acetate|prednisolone acetate|mesh-list
110973486|NCT03355482|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110973487|NCT03355482|Prednisolone phosphate|prednisolone phosphate|mesh-list
110973488|NCT03355482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110973489|NCT03355482|Antiemetics|antiemetics|mesh-ancestor
110973490|NCT03355482|Autonomic Agents|autonomic agents|mesh-ancestor
110973491|NCT03355482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110973492|NCT03355482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110973493|NCT03355482|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110973494|NCT03355482|Glucocorticoids|glucocorticoids|mesh-ancestor
110973495|NCT03355482|Hormones|hormones|mesh-ancestor
110973496|NCT03355482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110973497|NCT03355482|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110973498|NCT03355482|Protective Agents|protective agents|mesh-ancestor
110973499|NCT03355482|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110973500|NCT03355482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110973501|NCT03315260|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
110973502|NCT03315260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110973503|NCT03310619|Nivolumab|nivolumab|mesh-list
110973504|NCT03310619|Durvalumab|durvalumab|mesh-list
110973505|NCT03310619|Relatlimab|relatlimab|mesh-list
110973506|NCT03310619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110973507|NCT03310619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110973508|NCT03310619|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110973509|NCT03310619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110973510|NCT03190785|Benzoic Acid|benzoic acid|mesh-list
110973511|NCT03190785|Antifungal Agents|antifungal agents|mesh-ancestor
110973512|NCT03190785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110973513|NCT03093064|Natalizumab|natalizumab|mesh-list
110973514|NCT03093064|Immunologic Factors|immunologic factors|mesh-ancestor
110973515|NCT03093064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110973516|NCT03060577|Evolocumab|evolocumab|mesh-list
110973517|NCT03060577|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
110973518|NCT03060577|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110973519|NCT03060577|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110973520|NCT03060577|Antimetabolites|antimetabolites|mesh-ancestor
110973521|NCT03060577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110973522|NCT03060577|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110973523|NCT03060577|Protease Inhibitors|protease inhibitors|mesh-ancestor
110973524|NCT03060577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110973525|NCT03060577|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111491449|NCT05907213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110973526|NCT02797275|Albuterol|albuterol|mesh-list
111491450|NCT05907213|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110973527|NCT02797275|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110973528|NCT02797275|Autonomic Agents|autonomic agents|mesh-ancestor
110973529|NCT02797275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110973530|NCT02797275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110973531|NCT02797275|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110973532|NCT02797275|Respiratory System Agents|respiratory system agents|mesh-ancestor
110973533|NCT02797275|Tocolytic Agents|tocolytic agents|mesh-ancestor
110973534|NCT02797275|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110973535|NCT02797275|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110973536|NCT02797275|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110973537|NCT02797275|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110973538|NCT02797275|Adrenergic Agents|adrenergic agents|mesh-ancestor
110973539|NCT02797275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110973540|NCT02797275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110973542|NCT02787005|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110973543|NCT02787005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110973544|NCT02787005|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110973545|NCT02787005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110973546|NCT02734290|Paclitaxel|paclitaxel|mesh-list
110973547|NCT02734290|Pembrolizumab|pembrolizumab|mesh-list
110973548|NCT02734290|Capecitabine|capecitabine|mesh-list
110973549|NCT02734290|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110973550|NCT02734290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110973551|NCT02734290|Tubulin Modulators|tubulin modulators|mesh-ancestor
110973552|NCT02734290|Antimitotic Agents|antimitotic agents|mesh-ancestor
110973553|NCT02734290|Mitosis Modulators|mitosis modulators|mesh-ancestor
110973554|NCT02734290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110973555|NCT02734290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110973556|NCT02734290|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110973557|NCT02734290|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110973558|NCT02734290|Antimetabolites|antimetabolites|mesh-ancestor
110973559|NCT02673333|Pembrolizumab|pembrolizumab|mesh-list
110973560|NCT02673333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110973561|NCT02673333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110973562|NCT02673333|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110973563|NCT02673333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110973564|NCT02633189|Bevacizumab|bevacizumab|mesh-list
110973565|NCT02633189|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110973566|NCT02633189|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110973567|NCT02633189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110973568|NCT02633189|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110973569|NCT02633189|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110973570|NCT02633189|Growth Substances|growth substances|mesh-ancestor
110973571|NCT02633189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110973572|NCT02633189|Growth Inhibitors|growth inhibitors|mesh-ancestor
110973573|NCT02633189|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110973574|NCT02633189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110973575|NCT02633189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110690633|NCT02535039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110973576|NCT02621242|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110973577|NCT02621242|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110973578|NCT02621242|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110973579|NCT02621242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110973580|NCT02621242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110973581|NCT02621242|Antiviral Agents|antiviral agents|mesh-ancestor
110973582|NCT02621242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110973583|NCT02621242|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110973584|NCT02621242|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110973585|NCT02601313|Cyclophosphamide|cyclophosphamide|mesh-list
110973586|NCT02601313|Fludarabine|fludarabine|mesh-list
110973587|NCT02601313|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
110973588|NCT02601313|Brexucabtagene autoleucel|brexucabtagene autoleucel|mesh-list
110973589|NCT02601313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110973590|NCT02601313|Immunologic Factors|immunologic factors|mesh-ancestor
110973591|NCT02601313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110973592|NCT02601313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110973593|NCT02601313|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110973594|NCT02601313|Alkylating Agents|alkylating agents|mesh-ancestor
110973595|NCT02601313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110973596|NCT02601313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110973597|NCT02601313|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110973598|NCT02601313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110973599|NCT02526368|Carbamide Peroxide|carbamide peroxide|mesh-list
110973600|NCT02526368|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110973601|NCT02526368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110973602|NCT02514083|Fludarabine|fludarabine|mesh-list
110973603|NCT02514083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110973604|NCT02500576|Aldesleukin|aldesleukin|mesh-list
110973605|NCT02500576|Cyclophosphamide|cyclophosphamide|mesh-list
110973606|NCT02500576|Pembrolizumab|pembrolizumab|mesh-list
110973607|NCT02500576|Fludarabine|fludarabine|mesh-list
110973608|NCT02500576|Fludarabine phosphate|fludarabine phosphate|mesh-list
110973609|NCT02500576|Interleukin-2|interleukin-2|mesh-list
110973610|NCT02500576|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110973611|NCT02500576|Immunologic Factors|immunologic factors|mesh-ancestor
110973612|NCT02500576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110973613|NCT02500576|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110973614|NCT02500576|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110973615|NCT02500576|Alkylating Agents|alkylating agents|mesh-ancestor
110973616|NCT02500576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110973617|NCT02500576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110973618|NCT02500576|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110973619|NCT02500576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110973620|NCT02500576|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110973621|NCT02500576|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110973622|NCT02500576|Antimetabolites|antimetabolites|mesh-ancestor
110973623|NCT02500576|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110973624|NCT02500576|Analgesics|analgesics|mesh-ancestor
110973625|NCT02500576|Sensory System Agents|sensory system agents|mesh-ancestor
110973626|NCT02500576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110973627|NCT02500576|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110973628|NCT02500576|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110973629|NCT02500576|Antiviral Agents|antiviral agents|mesh-ancestor
110973630|NCT02500576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110973631|NCT02395848|Fidaxomicin|fidaxomicin|mesh-list
110973632|NCT02395848|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110973633|NCT02395848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110973634|NCT02214381|Paclitaxel|paclitaxel|mesh-list
110973635|NCT02214381|Cyclophosphamide|cyclophosphamide|mesh-list
110973636|NCT02214381|Doxorubicin|doxorubicin|mesh-list
110973637|NCT02214381|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110973638|NCT02214381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110973639|NCT02214381|Tubulin Modulators|tubulin modulators|mesh-ancestor
110973640|NCT02214381|Antimitotic Agents|antimitotic agents|mesh-ancestor
110973641|NCT02214381|Mitosis Modulators|mitosis modulators|mesh-ancestor
110973642|NCT02214381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110973643|NCT02214381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110973644|NCT02214381|Immunologic Factors|immunologic factors|mesh-ancestor
110973645|NCT02214381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110973646|NCT02214381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110973647|NCT02214381|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110973648|NCT02214381|Alkylating Agents|alkylating agents|mesh-ancestor
110973649|NCT02214381|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110973650|NCT02214381|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110973651|NCT02214381|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110973652|NCT02214381|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110973653|NCT02214381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110973654|NCT02081326|BCG Vaccine|bcg vaccine|mesh-list
110973655|NCT02081326|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110973656|NCT02081326|Immunologic Factors|immunologic factors|mesh-ancestor
110973657|NCT02081326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110973659|NCT02061761|Relatlimab|relatlimab|mesh-list
110973660|NCT02061761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110973661|NCT02061761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110973662|NCT02061761|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110973663|NCT02061761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110973664|NCT01927068|Paclitaxel|paclitaxel|mesh-list
110973665|NCT01927068|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110973666|NCT01927068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111491451|NCT05907213|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111491452|NCT05907213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111491453|NCT05907213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111491454|NCT05907057|Azacitidine|azacitidine|mesh-list
110973667|NCT01927068|Tubulin Modulators|tubulin modulators|mesh-ancestor
110973668|NCT01927068|Antimitotic Agents|antimitotic agents|mesh-ancestor
111491455|NCT05907057|Ivosidenib|ivosidenib|mesh-list
111491456|NCT05907057|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110973669|NCT01927068|Mitosis Modulators|mitosis modulators|mesh-ancestor
110479472|NCT03354039|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110973670|NCT01927068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110973671|NCT01898104|Capecitabine|capecitabine|mesh-list
110973672|NCT01898104|Valproic Acid|valproic acid|mesh-list
110973673|NCT01898104|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110973674|NCT01898104|Antimetabolites|antimetabolites|mesh-ancestor
110973675|NCT01898104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110973676|NCT01898104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110973677|NCT01898104|Anticonvulsants|anticonvulsants|mesh-ancestor
110973678|NCT01898104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110973679|NCT01898104|GABA Agents|gaba agents|mesh-ancestor
110973680|NCT01898104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110973681|NCT01898104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110973682|NCT01898104|Antimanic Agents|antimanic agents|mesh-ancestor
110973683|NCT01898104|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110973684|NCT01898104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110973685|NCT01898104|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110973686|NCT01817452|Paclitaxel|paclitaxel|mesh-list
110973687|NCT01817452|Trastuzumab|trastuzumab|mesh-list
110973688|NCT01817452|Pertuzumab|pertuzumab|mesh-list
110973689|NCT01817452|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110973690|NCT01817452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110973691|NCT01817452|Tubulin Modulators|tubulin modulators|mesh-ancestor
110973692|NCT01817452|Antimitotic Agents|antimitotic agents|mesh-ancestor
110973693|NCT01817452|Mitosis Modulators|mitosis modulators|mesh-ancestor
110973694|NCT01817452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110973695|NCT01817452|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110973696|NCT01815242|Paclitaxel|paclitaxel|mesh-list
110973697|NCT01815242|Carboplatin|carboplatin|mesh-list
110973698|NCT01815242|Gemcitabine|gemcitabine|mesh-list
110973699|NCT01815242|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110973700|NCT01815242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110973701|NCT01815242|Tubulin Modulators|tubulin modulators|mesh-ancestor
110973702|NCT01815242|Antimitotic Agents|antimitotic agents|mesh-ancestor
110973703|NCT01815242|Mitosis Modulators|mitosis modulators|mesh-ancestor
110973704|NCT01815242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110973705|NCT01815242|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110973706|NCT01815242|Antimetabolites|antimetabolites|mesh-ancestor
110973707|NCT01802749|Paclitaxel|paclitaxel|mesh-list
110973708|NCT01802749|Bevacizumab|bevacizumab|mesh-list
110973709|NCT01802749|Carboplatin|carboplatin|mesh-list
110973710|NCT01802749|Gemcitabine|gemcitabine|mesh-list
110973711|NCT01802749|Doxorubicin|doxorubicin|mesh-list
110973712|NCT01802749|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110973713|NCT01802749|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110973714|NCT01802749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110973715|NCT01802749|Tubulin Modulators|tubulin modulators|mesh-ancestor
110973716|NCT01802749|Antimitotic Agents|antimitotic agents|mesh-ancestor
110973717|NCT01802749|Mitosis Modulators|mitosis modulators|mesh-ancestor
110973718|NCT01802749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110973719|NCT01802749|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110973720|NCT01802749|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110973721|NCT01802749|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110973722|NCT01802749|Growth Substances|growth substances|mesh-ancestor
110973723|NCT01802749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110973724|NCT01802749|Growth Inhibitors|growth inhibitors|mesh-ancestor
110973725|NCT01802749|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110973726|NCT01802749|Antimetabolites|antimetabolites|mesh-ancestor
110973727|NCT01802749|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110973728|NCT01802749|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110973729|NCT01802749|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110973730|NCT01802749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110973731|NCT01801904|Panitumumab|panitumumab|mesh-list
110973732|NCT01801904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110973733|NCT01801904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110973734|NCT01779206|Paclitaxel|paclitaxel|mesh-list
110973735|NCT01779206|Docetaxel|docetaxel|mesh-list
110973736|NCT01779206|Cyclophosphamide|cyclophosphamide|mesh-list
110973737|NCT01779206|Epirubicin|epirubicin|mesh-list
111491457|NCT05907057|Antimetabolites|antimetabolites|mesh-ancestor
111491458|NCT05907057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110973738|NCT01779206|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110479481|NCT02704923|Atropine|atropine|mesh-list
110973739|NCT01779206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110973740|NCT01779206|Tubulin Modulators|tubulin modulators|mesh-ancestor
110973741|NCT01779206|Antimitotic Agents|antimitotic agents|mesh-ancestor
110973742|NCT01779206|Mitosis Modulators|mitosis modulators|mesh-ancestor
110973743|NCT01779206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110973744|NCT01779206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110973745|NCT01779206|Immunologic Factors|immunologic factors|mesh-ancestor
110973746|NCT01779206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110973747|NCT01779206|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110973748|NCT01779206|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110973749|NCT01779206|Alkylating Agents|alkylating agents|mesh-ancestor
110973750|NCT01779206|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110973751|NCT01779206|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110973752|NCT01779206|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110973753|NCT01779206|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110973754|NCT01779206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110973755|NCT01745965|Trastuzumab|trastuzumab|mesh-list
110973756|NCT01745965|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110973757|NCT01745965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110973758|NCT01706120|Paclitaxel|paclitaxel|mesh-list
110973759|NCT01706120|Bevacizumab|bevacizumab|mesh-list
110973760|NCT01706120|Carboplatin|carboplatin|mesh-list
110973761|NCT01706120|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110973762|NCT01706120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110973763|NCT01706120|Tubulin Modulators|tubulin modulators|mesh-ancestor
110973764|NCT01706120|Antimitotic Agents|antimitotic agents|mesh-ancestor
110973765|NCT01706120|Mitosis Modulators|mitosis modulators|mesh-ancestor
110973766|NCT01706120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110973767|NCT01706120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110973768|NCT01706120|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110973769|NCT01706120|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110973770|NCT01706120|Growth Substances|growth substances|mesh-ancestor
110973771|NCT01706120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110973772|NCT01706120|Growth Inhibitors|growth inhibitors|mesh-ancestor
110973773|NCT01682941|Phytoestrogens|phytoestrogens|mesh-list
110973774|NCT01682941|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
110973775|NCT01682941|Estrogens|estrogens|mesh-ancestor
110973776|NCT01682941|Hormones|hormones|mesh-ancestor
110973777|NCT01682941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110973778|NCT01682941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110973779|NCT01656551|Gemcitabine|gemcitabine|mesh-list
110973780|NCT01656551|Pemetrexed|pemetrexed|mesh-list
110973781|NCT01656551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110973782|NCT01656551|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110973783|NCT01656551|Antimetabolites|antimetabolites|mesh-ancestor
110973784|NCT01656551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110973785|NCT01656551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110973786|NCT01656551|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110973787|NCT01656551|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110973788|NCT01649674|Magnesium citrate|magnesium citrate|mesh-list
110973789|NCT01649674|Picosulfate sodium|picosulfate sodium|mesh-list
110973790|NCT01649674|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110973791|NCT01649674|Cathartics|cathartics|mesh-ancestor
110973792|NCT01649674|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110973793|NCT01628211|Leucovorin|leucovorin|mesh-list
110973794|NCT01628211|Folic Acid|folic acid|mesh-list
110973795|NCT01628211|Fluorouracil|fluorouracil|mesh-list
110973796|NCT01628211|Oxaliplatin|oxaliplatin|mesh-list
110973797|NCT01628211|Levoleucovorin|levoleucovorin|mesh-list
110973798|NCT01628211|Antimetabolites|antimetabolites|mesh-ancestor
110973799|NCT01628211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110973800|NCT01628211|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110973801|NCT01628211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110690860|NCT00456300|Incretins|incretins|mesh-ancestor
110973802|NCT01628211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110973803|NCT01628211|Immunologic Factors|immunologic factors|mesh-ancestor
110973804|NCT01628211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110973805|NCT01628211|Antidotes|antidotes|mesh-ancestor
110973806|NCT01628211|Protective Agents|protective agents|mesh-ancestor
110973807|NCT01628211|Vitamin B Complex|vitamin b complex|mesh-ancestor
110973808|NCT01628211|Vitamins|vitamins|mesh-ancestor
110973809|NCT01628211|Micronutrients|micronutrients|mesh-ancestor
110973810|NCT01628211|Hematinics|hematinics|mesh-ancestor
110973811|NCT01593488|Cytarabine|cytarabine|mesh-list
110973812|NCT01593488|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110973813|NCT01593488|Antimetabolites|antimetabolites|mesh-ancestor
110973814|NCT01593488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110973815|NCT01593488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110973816|NCT01593488|Antiviral Agents|antiviral agents|mesh-ancestor
111491459|NCT05907057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111491460|NCT05907057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111491461|NCT05898022|Furosemide|furosemide|mesh-list
110973817|NCT01593488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110973818|NCT01593488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110973819|NCT01593488|Immunologic Factors|immunologic factors|mesh-ancestor
110973820|NCT01593488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110973821|NCT01405586|Gemcitabine|gemcitabine|mesh-list
110973822|NCT01405586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110973823|NCT01405586|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110973824|NCT01405586|Antimetabolites|antimetabolites|mesh-ancestor
110973825|NCT01405586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110973826|NCT01309230|Immunomodulating Agents|immunomodulating agents|mesh-list
110973827|NCT01309230|Immunologic Factors|immunologic factors|mesh-ancestor
110973828|NCT01309230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110973829|NCT01238692|Rituximab|rituximab|mesh-list
110973830|NCT01238692|Panobinostat|panobinostat|mesh-list
110973831|NCT01238692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110973832|NCT01238692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110973833|NCT01238692|Immunologic Factors|immunologic factors|mesh-ancestor
110973834|NCT01238692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110973835|NCT01238692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110973836|NCT01238692|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110973837|NCT01238692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110973838|NCT01238692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110973839|NCT01209871|Immunoglobulins|immunoglobulins|mesh-list
110973840|NCT01209871|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110973841|NCT01209871|Antibodies|antibodies|mesh-list
110973842|NCT01209871|Immunologic Factors|immunologic factors|mesh-ancestor
110973843|NCT01209871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110973844|NCT00996983|Ziconotide|ziconotide|mesh-list
110973845|NCT00996983|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110973846|NCT00996983|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110973847|NCT00996983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110973848|NCT00996983|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110973849|NCT00996983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110973850|NCT00996983|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110973851|NCT00996983|Protective Agents|protective agents|mesh-ancestor
110973852|NCT00996983|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110973853|NCT00996983|Analgesics|analgesics|mesh-ancestor
110973854|NCT00996983|Sensory System Agents|sensory system agents|mesh-ancestor
110973855|NCT00996983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110973856|NCT00660842|Paclitaxel|paclitaxel|mesh-list
110973857|NCT00660842|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110973858|NCT00660842|Carboplatin|carboplatin|mesh-list
110973859|NCT00660842|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110973860|NCT00660842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110973861|NCT00660842|Tubulin Modulators|tubulin modulators|mesh-ancestor
110973862|NCT00660842|Antimitotic Agents|antimitotic agents|mesh-ancestor
110973863|NCT00660842|Mitosis Modulators|mitosis modulators|mesh-ancestor
110973864|NCT00660842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110973865|NCT00657878|Paclitaxel|paclitaxel|mesh-list
110973866|NCT00657878|Carboplatin|carboplatin|mesh-list
110973867|NCT00657878|Gemcitabine|gemcitabine|mesh-list
110973868|NCT00657878|Doxorubicin|doxorubicin|mesh-list
110973869|NCT00657878|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110973870|NCT00657878|Topotecan|topotecan|mesh-list
110973871|NCT00657878|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110973872|NCT00657878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110973873|NCT00657878|Tubulin Modulators|tubulin modulators|mesh-ancestor
110973874|NCT00657878|Antimitotic Agents|antimitotic agents|mesh-ancestor
110973875|NCT00657878|Mitosis Modulators|mitosis modulators|mesh-ancestor
110973876|NCT00657878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110973877|NCT00657878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110973878|NCT00657878|Antimetabolites|antimetabolites|mesh-ancestor
110973879|NCT00657878|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110973880|NCT00657878|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110973881|NCT00657878|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110973883|NCT00657878|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110973884|NCT00642057|Tetrabenazine|tetrabenazine|mesh-list
110973885|NCT00642057|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110973886|NCT00642057|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110973887|NCT00642057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110973888|NCT00642057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110973889|NCT00642057|Adrenergic Agents|adrenergic agents|mesh-ancestor
110973890|NCT00642057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110973891|NCT00642057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110973892|NCT00526396|Cisplatin|cisplatin|mesh-list
110973893|NCT00526396|Etoposide|etoposide|mesh-list
110973894|NCT00526396|Etoposide phosphate|etoposide phosphate|mesh-list
110973895|NCT00526396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110973896|NCT00526396|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110973897|NCT00526396|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110973898|NCT00526396|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110973899|NCT00526396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110973900|NCT00526396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110973901|NCT00431704|Carboplatin|carboplatin|mesh-list
110973902|NCT00431704|Trastuzumab|trastuzumab|mesh-list
110973903|NCT00431704|Vinorelbine|vinorelbine|mesh-list
110973904|NCT00431704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110973905|NCT00431704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110973906|NCT00431704|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110973907|NCT00431704|Tubulin Modulators|tubulin modulators|mesh-ancestor
110973908|NCT00431704|Antimitotic Agents|antimitotic agents|mesh-ancestor
110973909|NCT00431704|Mitosis Modulators|mitosis modulators|mesh-ancestor
110973910|NCT00431704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110973911|NCT00412022|Tamoxifen|tamoxifen|mesh-list
110973912|NCT00412022|Zoledronic Acid|zoledronic acid|mesh-list
110973913|NCT00412022|Letrozole|letrozole|mesh-list
110973914|NCT00412022|Triptorelin Pamoate|triptorelin pamoate|mesh-list
110973915|NCT00412022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110973916|NCT00412022|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110973917|NCT00412022|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110973918|NCT00412022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110973919|NCT00412022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110973920|NCT00412022|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110973921|NCT00412022|Hormone Antagonists|hormone antagonists|mesh-ancestor
110973922|NCT00412022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110973923|NCT00412022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110973924|NCT00412022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110973925|NCT00412022|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110973926|NCT00412022|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110973927|NCT00412022|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110973928|NCT00412022|Luteolytic Agents|luteolytic agents|mesh-ancestor
110973929|NCT00412022|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110973930|NCT00412022|Contraceptive Agents|contraceptive agents|mesh-ancestor
110973931|NCT00412022|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110973932|NCT00412022|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110973933|NCT03474510|Bupivacaine|bupivacaine|mesh-list
110973934|NCT03474510|Ropivacaine|ropivacaine|mesh-list
110973935|NCT03474510|Anesthetics, Local|anesthetics, local|mesh-ancestor
110973936|NCT03474510|Anesthetics|anesthetics|mesh-ancestor
110973937|NCT03474510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110973938|NCT03474510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110973939|NCT03474510|Sensory System Agents|sensory system agents|mesh-ancestor
110973940|NCT03474510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110973941|NCT02470832|Itraconazole|itraconazole|mesh-list
110973942|NCT02470832|Antifungal Agents|antifungal agents|mesh-ancestor
110973943|NCT02470832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110973944|NCT02470832|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110973945|NCT02470832|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110973946|NCT02470832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110973947|NCT02470832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110973948|NCT02470832|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110973949|NCT02470832|Hormone Antagonists|hormone antagonists|mesh-ancestor
110973950|NCT02470832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110973951|NCT02470832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110973952|NCT02470832|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110973953|NCT05258682|Acetylcysteine|acetylcysteine|mesh-list
110973954|NCT05258682|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110973955|NCT05258682|Antiviral Agents|antiviral agents|mesh-ancestor
110973956|NCT05258682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110973957|NCT05258682|Expectorants|expectorants|mesh-ancestor
110973958|NCT05258682|Respiratory System Agents|respiratory system agents|mesh-ancestor
110973959|NCT05258682|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110973960|NCT05258682|Antioxidants|antioxidants|mesh-ancestor
110699552|NCT00371826|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111491462|NCT05898022|Diuretics|diuretics|mesh-ancestor
111491463|NCT05898022|Natriuretic Agents|natriuretic agents|mesh-ancestor
111491464|NCT05898022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111491465|NCT05898022|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110973961|NCT05258682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110973962|NCT05258682|Protective Agents|protective agents|mesh-ancestor
110973963|NCT05258682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110973964|NCT05258682|Antidotes|antidotes|mesh-ancestor
110973966|NCT02228031|Oxytocics|oxytocics|mesh-ancestor
110973967|NCT02228031|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110973968|NCT02228031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110973969|NCT02232399|Simendan|simendan|mesh-list
110973970|NCT02232399|Milrinone|milrinone|mesh-list
110973971|NCT02232399|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110973972|NCT02232399|Vasodilator Agents|vasodilator agents|mesh-ancestor
110973973|NCT02232399|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110973974|NCT02232399|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110973975|NCT02232399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110973976|NCT02232399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110973977|NCT02232399|Protective Agents|protective agents|mesh-ancestor
110973978|NCT02232399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110973979|NCT02232399|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110973980|NCT00704522|Ribavirin|ribavirin|mesh-list
110973981|NCT00704522|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110973982|NCT00704522|Antimetabolites|antimetabolites|mesh-ancestor
110973983|NCT00704522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110973984|NCT00704522|Antiviral Agents|antiviral agents|mesh-ancestor
110973985|NCT00704522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110973986|NCT04458558|Mifepristone|mifepristone|mesh-list
110973987|NCT04458558|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
110973988|NCT04458558|Abortifacient Agents|abortifacient agents|mesh-ancestor
110973989|NCT04458558|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110973990|NCT04458558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110973991|NCT04458558|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110973992|NCT04458558|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110973993|NCT04458558|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110973994|NCT04458558|Contraceptive Agents|contraceptive agents|mesh-ancestor
110973995|NCT04458558|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
110973996|NCT04458558|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
110973997|NCT04458558|Hormone Antagonists|hormone antagonists|mesh-ancestor
110973998|NCT04458558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110973999|NCT04458558|Luteolytic Agents|luteolytic agents|mesh-ancestor
110974000|NCT04458558|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110974001|NCT04458558|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
110974002|NCT03478332|Nitroglycerin|nitroglycerin|mesh-list
110974003|NCT03478332|Vasodilator Agents|vasodilator agents|mesh-ancestor
110974004|NCT03930498|Antibodies|antibodies|mesh-list
110974005|NCT03930498|Antibodies, Blocking|antibodies, blocking|mesh-list
110974006|NCT03930498|Immunologic Factors|immunologic factors|mesh-ancestor
110165882|NCT00000395|Folic Acid|folic acid|mesh-list
110974007|NCT03930498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110974008|NCT03817554|Dopamine|dopamine|mesh-list
110974009|NCT03817554|Pramipexole|pramipexole|mesh-list
110974010|NCT03817554|Dopamine Agonists|dopamine agonists|mesh-list
110974011|NCT03817554|Antioxidants|antioxidants|mesh-ancestor
110974012|NCT03817554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110974013|NCT03817554|Protective Agents|protective agents|mesh-ancestor
110974014|NCT03817554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110974015|NCT03817554|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110974016|NCT03817554|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110974017|NCT03817554|Dopamine Agents|dopamine agents|mesh-ancestor
110974018|NCT03817554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110974019|NCT03817554|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110974020|NCT03817554|Sympathomimetics|sympathomimetics|mesh-ancestor
110974021|NCT03817554|Autonomic Agents|autonomic agents|mesh-ancestor
110974022|NCT03817554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110974023|NCT02223819|Crizotinib|crizotinib|mesh-list
110974024|NCT02223819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110974025|NCT02223819|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110974026|NCT02223819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110974027|NCT02223819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110974029|NCT02723630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110974030|NCT02723630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110974031|NCT02723630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110974032|NCT02723630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110974033|NCT02866227|TOL-463|tol-463|mesh-list
111491466|NCT05898022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110974034|NCT02866227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110974035|NCT05258136|Antibodies|antibodies|mesh-list
110974036|NCT05258136|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111491467|NCT05898022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110974037|NCT05258136|Immunologic Factors|immunologic factors|mesh-ancestor
110974038|NCT05258136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110974039|NCT02224131|Aspirin|aspirin|mesh-list
110974040|NCT02224131|Clopidogrel|clopidogrel|mesh-list
110974041|NCT02224131|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110974042|NCT02224131|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110974043|NCT02224131|Analgesics|analgesics|mesh-ancestor
110974044|NCT02224131|Sensory System Agents|sensory system agents|mesh-ancestor
110974045|NCT02224131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110974046|NCT02224131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110974047|NCT02224131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110974048|NCT02224131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110974049|NCT02224131|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110974050|NCT02224131|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110974051|NCT02224131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110974052|NCT02224131|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110974053|NCT02224131|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110974054|NCT02224131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110974055|NCT02224131|Antipyretics|antipyretics|mesh-ancestor
110974056|NCT02224131|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110974057|NCT02224131|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110974058|NCT02224131|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110974059|NCT02224131|Purinergic Agents|purinergic agents|mesh-ancestor
110974060|NCT02224131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110974061|NCT02068586|Sunitinib|sunitinib|mesh-list
110974062|NCT02068586|Valproic Acid|valproic acid|mesh-list
110974063|NCT02068586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110974064|NCT02068586|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110974065|NCT02068586|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110974066|NCT02068586|Growth Substances|growth substances|mesh-ancestor
110974067|NCT02068586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110974068|NCT02068586|Growth Inhibitors|growth inhibitors|mesh-ancestor
110974069|NCT02068586|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110974070|NCT02068586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110974071|NCT02068586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110974072|NCT02068586|Anticonvulsants|anticonvulsants|mesh-ancestor
110974073|NCT02068586|GABA Agents|gaba agents|mesh-ancestor
110974074|NCT02068586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110974075|NCT02068586|Antimanic Agents|antimanic agents|mesh-ancestor
110974076|NCT02068586|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110974077|NCT02068586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110974078|NCT02068586|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110974079|NCT03473964|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
110974080|NCT03473964|Hormones|hormones|mesh-ancestor
110974081|NCT03473964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110974082|NCT03473964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110974083|NCT03309644|Iodine|iodine|mesh-list
110974084|NCT03309644|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110974085|NCT03309644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110974086|NCT03309644|Trace Elements|trace elements|mesh-ancestor
110974087|NCT03309644|Micronutrients|micronutrients|mesh-ancestor
110974088|NCT03309644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110974089|NCT03478020|Contraceptive Agents|contraceptive agents|mesh-list
110974090|NCT03478020|Contraceptives, Oral|contraceptives, oral|mesh-list
110974091|NCT03478020|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
110974092|NCT03478020|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110974093|NCT03478020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110974094|NCT03478020|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111491469|NCT05890963|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111491470|NCT05890963|Antiviral Agents|antiviral agents|mesh-ancestor
111491471|NCT05890963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111491472|NCT05890963|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111491473|NCT05889624|Amitriptyline|amitriptyline|mesh-list
111491474|NCT05889624|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
111491475|NCT05889624|Antidepressive Agents|antidepressive agents|mesh-ancestor
111491476|NCT05889624|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111491477|NCT05889624|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110974095|NCT02008292|Physostigmine|physostigmine|mesh-list
110974096|NCT02008292|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110974097|NCT02008292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111119103|NCT05362318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111491478|NCT05889624|Analgesics|analgesics|mesh-ancestor
111491479|NCT05889624|Sensory System Agents|sensory system agents|mesh-ancestor
111491480|NCT05889624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110974098|NCT02008292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110974099|NCT02008292|Cholinergic Agents|cholinergic agents|mesh-ancestor
110974100|NCT02008292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110974101|NCT02008292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110974102|NCT02008292|Miotics|miotics|mesh-ancestor
110974103|NCT02008292|Autonomic Agents|autonomic agents|mesh-ancestor
110974104|NCT02008292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110974105|NCT03477864|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110974106|NCT03477864|Ipilimumab|ipilimumab|mesh-list
110974107|NCT03477864|Cemiplimab|cemiplimab|mesh-list
110974108|NCT03477864|Antibodies|antibodies|mesh-list
110974109|NCT03477864|Immunoglobulins|immunoglobulins|mesh-list
110974110|NCT03477864|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110974111|NCT03477864|Immunologic Factors|immunologic factors|mesh-ancestor
110974112|NCT03477864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110974113|NCT03477864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110974114|NCT03477864|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110974115|NCT03477864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110974116|NCT02229045|Paclitaxel|paclitaxel|mesh-list
110974117|NCT02229045|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110974118|NCT02229045|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110974119|NCT02229045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110974120|NCT02229045|Tubulin Modulators|tubulin modulators|mesh-ancestor
110974121|NCT02229045|Antimitotic Agents|antimitotic agents|mesh-ancestor
110974122|NCT02229045|Mitosis Modulators|mitosis modulators|mesh-ancestor
110974123|NCT02229045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110974124|NCT02229123|Levetiracetam|levetiracetam|mesh-list
110974125|NCT02229123|Anticonvulsants|anticonvulsants|mesh-ancestor
110974126|NCT02229123|Nootropic Agents|nootropic agents|mesh-ancestor
110974127|NCT02229201|Propofol|propofol|mesh-list
110974128|NCT02229201|Sevoflurane|sevoflurane|mesh-list
110974129|NCT02229201|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110974130|NCT02229201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110974131|NCT02229201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110974132|NCT02229201|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110974133|NCT02229201|Anesthetics, General|anesthetics, general|mesh-ancestor
110974134|NCT02229201|Anesthetics|anesthetics|mesh-ancestor
110974135|NCT02229201|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110974136|NCT02229201|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110974137|NCT02224443|Fentanyl|fentanyl|mesh-list
110974138|NCT02224443|Midazolam|midazolam|mesh-list
110974139|NCT02224443|Dexmedetomidine|dexmedetomidine|mesh-list
110974140|NCT02224443|Remifentanil|remifentanil|mesh-list
110974141|NCT02224443|Propofol|propofol|mesh-list
110974142|NCT02224443|Etomidate|etomidate|mesh-list
110974143|NCT02224443|Sevoflurane|sevoflurane|mesh-list
110974144|NCT02224443|Atracurium|atracurium|mesh-list
110974145|NCT02224443|Cisatracurium|cisatracurium|mesh-list
110974146|NCT02224443|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110974147|NCT02224443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110974148|NCT02224443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110974149|NCT02224443|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110974150|NCT02224443|Analgesics|analgesics|mesh-ancestor
110974151|NCT02224443|Sensory System Agents|sensory system agents|mesh-ancestor
110974152|NCT02224443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110974153|NCT02224443|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110974154|NCT02224443|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110974155|NCT02224443|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110974156|NCT02224443|Adrenergic Agents|adrenergic agents|mesh-ancestor
110974157|NCT02224443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110974158|NCT02224443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110974159|NCT02224443|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110974160|NCT02224443|Anesthetics, General|anesthetics, general|mesh-ancestor
110974161|NCT02224443|Anesthetics|anesthetics|mesh-ancestor
110974162|NCT02224443|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110974163|NCT02224443|Narcotics|narcotics|mesh-ancestor
110974164|NCT02224443|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110974165|NCT02224443|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110974166|NCT02224443|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110974167|NCT02224443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110974168|NCT02224443|GABA Modulators|gaba modulators|mesh-ancestor
110974169|NCT02224443|GABA Agents|gaba agents|mesh-ancestor
110974170|NCT02224443|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110974171|NCT02224443|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110974172|NCT02224443|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110974173|NCT02224443|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111491481|NCT05889624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111491482|NCT05889624|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111491483|NCT05889624|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110974174|NCT02224443|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110974176|NCT02224443|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110974177|NCT02224443|Cholinergic Agents|cholinergic agents|mesh-ancestor
110974178|NCT01944800|Ticagrelor|ticagrelor|mesh-list
110974179|NCT01944800|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
110974180|NCT01944800|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110974181|NCT01944800|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110974182|NCT01944800|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110974183|NCT01944800|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110974184|NCT01944800|Purinergic Agents|purinergic agents|mesh-ancestor
110974185|NCT01944800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110974186|NCT01944800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110974187|NCT01944800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110974188|NCT03617367|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110974189|NCT03617367|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110974190|NCT03617367|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110974191|NCT03617367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110974192|NCT03617367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110974193|NCT03617367|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110974194|NCT03617367|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110974195|NCT03617367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110974196|NCT03617367|Cholinergic Agents|cholinergic agents|mesh-ancestor
110974197|NCT03617367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110974198|NCT02470676|Progesterone|progesterone|mesh-list
110974199|NCT02470676|Progestins|progestins|mesh-ancestor
110974200|NCT02470676|Hormones|hormones|mesh-ancestor
110479516|NCT02704767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110974201|NCT02470676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110974202|NCT02470676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110974203|NCT01933724|Prednisone|prednisone|mesh-list
110974204|NCT01933724|Glucocorticoids|glucocorticoids|mesh-list
110974205|NCT01933724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110974206|NCT01933724|Hormones|hormones|mesh-ancestor
110974207|NCT01933724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110974208|NCT01933724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110974209|NCT01933724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110974210|NCT01933724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110974211|NCT02229747|Diclofenac|diclofenac|mesh-list
110974212|NCT02229747|Meloxicam|meloxicam|mesh-list
110974213|NCT02229747|Nimesulide|nimesulide|mesh-list
110974214|NCT02229747|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110974215|NCT02229747|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110974216|NCT02229747|Analgesics|analgesics|mesh-ancestor
110974217|NCT02229747|Sensory System Agents|sensory system agents|mesh-ancestor
110974218|NCT02229747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110974219|NCT02229747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110974220|NCT02229747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110974221|NCT02229747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110974222|NCT02229747|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110974223|NCT02229747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110974224|NCT02229747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110974225|NCT02229747|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110974226|NCT02232789|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
110974227|NCT02232789|Hallucinogens|hallucinogens|mesh-ancestor
110974228|NCT02232789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110974229|NCT02232789|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110974230|NCT02232789|Serotonin Agents|serotonin agents|mesh-ancestor
110974231|NCT02232789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110974232|NCT02232789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110974233|NCT02232789|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110974234|NCT02232789|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110974235|NCT02232789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110974236|NCT02232789|Adrenergic Agents|adrenergic agents|mesh-ancestor
110974237|NCT03030222|Empagliflozin|empagliflozin|mesh-list
110974238|NCT03030222|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110974239|NCT03030222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110974240|NCT03030222|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110974241|NCT03030222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110974242|NCT02232945|Oseltamivir|oseltamivir|mesh-list
110974243|NCT02232945|Antiviral Agents|antiviral agents|mesh-ancestor
110974244|NCT02232945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110974245|NCT02232945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110974246|NCT02232945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110974247|NCT02546622|Factor VIII|factor viii|mesh-list
110974248|NCT02546622|Coagulants|coagulants|mesh-ancestor
110974249|NCT02229825|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110974250|NCT02229825|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110974251|NCT02229825|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110974252|NCT02229825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110974253|NCT02229825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110974254|NCT02229825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110974255|NCT02229825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110974256|NCT02229825|Analgesics|analgesics|mesh-ancestor
110974257|NCT02229825|Sensory System Agents|sensory system agents|mesh-ancestor
110974258|NCT02229825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110974259|NCT02229825|Antidepressive Agents|antidepressive agents|mesh-ancestor
110974260|NCT02229825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110974261|NCT02229825|Dopamine Agents|dopamine agents|mesh-ancestor
110974262|NCT03309566|Tenofovir|tenofovir|mesh-list
110974263|NCT03309566|Emtricitabine|emtricitabine|mesh-list
110974264|NCT03309566|Efavirenz|efavirenz|mesh-list
110974265|NCT03309566|Antiviral Agents|antiviral agents|mesh-ancestor
110974266|NCT03309566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110974267|NCT03309566|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110974268|NCT03309566|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110974269|NCT03309566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110974270|NCT03309566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110974271|NCT03309566|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110974272|NCT03309566|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110974273|NCT03309566|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110974274|NCT03309566|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110974275|NCT03309566|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110974276|NCT03309566|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110974277|NCT03309566|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110974278|NCT03309566|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110974279|NCT00735657|Iodine|iodine|mesh-list
110974280|NCT00735657|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110974281|NCT00735657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110974282|NCT00735657|Trace Elements|trace elements|mesh-ancestor
110974283|NCT00735657|Micronutrients|micronutrients|mesh-ancestor
110974284|NCT00735657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110974285|NCT04030143|Aripiprazole|aripiprazole|mesh-list
110974286|NCT04030143|Antidepressive Agents|antidepressive agents|mesh-ancestor
110974287|NCT04030143|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110974288|NCT04030143|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110974289|NCT04030143|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110974290|NCT04030143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110974291|NCT04030143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110974292|NCT04030143|Dopamine Agonists|dopamine agonists|mesh-ancestor
110974293|NCT04030143|Dopamine Agents|dopamine agents|mesh-ancestor
110974294|NCT04030143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110974295|NCT04030143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110974296|NCT04030143|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110974297|NCT04030143|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110974298|NCT04030143|Serotonin Agents|serotonin agents|mesh-ancestor
110974299|NCT04030143|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110974300|NCT04030143|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110974301|NCT04030143|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110974302|NCT04030143|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110974303|NCT02470442|Sevoflurane|sevoflurane|mesh-list
110974304|NCT02470442|Desflurane|desflurane|mesh-list
110974305|NCT02470442|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110974306|NCT02470442|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110974307|NCT02470442|Anesthetics, General|anesthetics, general|mesh-ancestor
110974308|NCT02470442|Anesthetics|anesthetics|mesh-ancestor
110974309|NCT02470442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110974310|NCT02470442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110974311|NCT01329939|Montelukast|montelukast|mesh-list
110024424|NCT00004734|Pyridoxine|pyridoxine|mesh-list
111491484|NCT05889624|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111491485|NCT05889624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111491486|NCT05889624|Adrenergic Agents|adrenergic agents|mesh-ancestor
110974312|NCT01329939|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111491487|NCT05889624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110974313|NCT01329939|Respiratory System Agents|respiratory system agents|mesh-ancestor
110974314|NCT01329939|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110974315|NCT01329939|Hormone Antagonists|hormone antagonists|mesh-ancestor
110974316|NCT01329939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110974317|NCT01329939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110974318|NCT01329939|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110974319|NCT01329939|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110974320|NCT01329939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110974321|NCT02499900|Glatiramer Acetate|glatiramer acetate|mesh-list
110974323|NCT02499900|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110974324|NCT02499900|Immunologic Factors|immunologic factors|mesh-ancestor
110691385|NCT00282568|Tacrolimus|tacrolimus|mesh-list
110974325|NCT02499900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110974326|NCT02499900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110974327|NCT02499900|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110974328|NCT04554693|Metronidazole|metronidazole|mesh-list
110974329|NCT04554693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110974330|NCT04554693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110974331|NCT04554693|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110974332|NCT04554693|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110974333|NCT02230371|Granisetron|granisetron|mesh-list
110974334|NCT02230371|Antiemetics|antiemetics|mesh-ancestor
110974335|NCT02230371|Autonomic Agents|autonomic agents|mesh-ancestor
110974336|NCT02230371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110974337|NCT02230371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110974338|NCT02230371|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110974339|NCT02230371|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110974340|NCT02230371|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110974341|NCT02230371|Serotonin Agents|serotonin agents|mesh-ancestor
110974342|NCT02230371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110974343|NCT02230371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110974344|NCT03313934|Hyaluronic Acid|hyaluronic acid|mesh-list
110974345|NCT03313934|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110974346|NCT03313934|Immunologic Factors|immunologic factors|mesh-ancestor
110974347|NCT03313934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110974348|NCT03313934|Viscosupplements|viscosupplements|mesh-ancestor
110974349|NCT03313934|Protective Agents|protective agents|mesh-ancestor
110974350|NCT03313856|Magnesium Oxide|magnesium oxide|mesh-list
110974351|NCT03313856|Antacids|antacids|mesh-ancestor
110974352|NCT03313856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110974353|NCT03313856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110974354|NCT05137626|Digoxin|digoxin|mesh-list
110974355|NCT05137626|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110974356|NCT05137626|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110974357|NCT05137626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110974358|NCT05137626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110974359|NCT05137626|Protective Agents|protective agents|mesh-ancestor
110974360|NCT05137626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110974361|NCT02233023|Dopamine|dopamine|mesh-list
110974362|NCT02233023|Pramipexole|pramipexole|mesh-list
110974363|NCT02233023|Bromocriptine|bromocriptine|mesh-list
110974364|NCT02233023|Dopamine Agonists|dopamine agonists|mesh-list
110974365|NCT02233023|Antioxidants|antioxidants|mesh-ancestor
110974366|NCT02233023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110974367|NCT02233023|Protective Agents|protective agents|mesh-ancestor
110974368|NCT02233023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110974369|NCT02233023|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110974370|NCT02233023|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110974371|NCT02233023|Dopamine Agents|dopamine agents|mesh-ancestor
110974372|NCT02233023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110974373|NCT02233023|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110974374|NCT02233023|Sympathomimetics|sympathomimetics|mesh-ancestor
110974375|NCT02233023|Autonomic Agents|autonomic agents|mesh-ancestor
110974376|NCT02233023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110974377|NCT02233023|Hormone Antagonists|hormone antagonists|mesh-ancestor
110974378|NCT02233023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110974379|NCT03710642|Prazosin|prazosin|mesh-list
110974380|NCT03710642|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111491488|NCT05884320|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
110974381|NCT03710642|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110974382|NCT03710642|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110974383|NCT03710642|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111491489|NCT05884320|Immunoconjugates|immunoconjugates|mesh-ancestor
111491490|NCT05884320|Immunologic Factors|immunologic factors|mesh-ancestor
110974384|NCT03710642|Adrenergic Agents|adrenergic agents|mesh-ancestor
110974385|NCT03710642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110974386|NCT03710642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110974387|NCT03710642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110974388|NCT02259309|Misoprostol|misoprostol|mesh-list
110974389|NCT02259309|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110974390|NCT02259309|Abortifacient Agents|abortifacient agents|mesh-ancestor
110974391|NCT02259309|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110974392|NCT02259309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110974393|NCT02259309|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110974394|NCT02259309|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110974395|NCT02259309|Oxytocics|oxytocics|mesh-ancestor
110974396|NCT04459026|Ropivacaine|ropivacaine|mesh-list
110974397|NCT04459026|Anesthetics, Local|anesthetics, local|mesh-ancestor
110974398|NCT04459026|Anesthetics|anesthetics|mesh-ancestor
110974399|NCT04459026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110974400|NCT04459026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110974401|NCT04459026|Sensory System Agents|sensory system agents|mesh-ancestor
110974402|NCT04459026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110974403|NCT03473418|Ketoconazole|ketoconazole|mesh-list
110974404|NCT03473418|Terconazole|terconazole|mesh-list
110974405|NCT03473418|Antifungal Agents|antifungal agents|mesh-ancestor
110974406|NCT03473418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110974407|NCT03473418|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110974408|NCT03473418|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110974409|NCT03473418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110974410|NCT03473418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110974411|NCT03473418|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110974412|NCT03473418|Hormone Antagonists|hormone antagonists|mesh-ancestor
110974413|NCT03473418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110974414|NCT03473418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110974415|NCT03473418|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110974416|NCT04282278|Apatinib|apatinib|mesh-list
110974417|NCT04282278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110974418|NCT04282278|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110974419|NCT04282278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110974420|NCT04282278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110974421|NCT00705224|Interferons|interferons|mesh-list
110974422|NCT00705224|Ribavirin|ribavirin|mesh-list
110974423|NCT00705224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110974424|NCT00705224|Antiviral Agents|antiviral agents|mesh-ancestor
110974425|NCT00705224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110974426|NCT00705224|Antimetabolites|antimetabolites|mesh-ancestor
110974427|NCT00705224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110974428|NCT02457156|Octreotide|octreotide|mesh-list
110974429|NCT02457156|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110974430|NCT02457156|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110974431|NCT02457156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110974432|NCT02523300|Methylprednisolone|methylprednisolone|mesh-list
110974433|NCT02523300|Glucocorticoids|glucocorticoids|mesh-list
110974434|NCT02523300|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110974435|NCT02523300|Antiemetics|antiemetics|mesh-ancestor
110974436|NCT02523300|Autonomic Agents|autonomic agents|mesh-ancestor
110974437|NCT02523300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110974438|NCT02523300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110974439|NCT02523300|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110974440|NCT02523300|Hormones|hormones|mesh-ancestor
110974441|NCT02523300|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110974442|NCT02523300|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110974443|NCT02523300|Protective Agents|protective agents|mesh-ancestor
110974444|NCT02325960|Insulin Glargine|insulin glargine|mesh-list
110974445|NCT02325960|Exenatide|exenatide|mesh-list
110974446|NCT02325960|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110974447|NCT02325960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110974448|NCT02325960|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110974449|NCT02325960|Incretins|incretins|mesh-ancestor
111491491|NCT05884320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111491492|NCT05880706|Osimertinib|osimertinib|mesh-list
111491493|NCT05880706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111491494|NCT05880706|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111491495|NCT05880706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111491496|NCT05880706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111491497|NCT05878184|Cyclophosphamide|cyclophosphamide|mesh-list
111491498|NCT05878184|Fludarabine|fludarabine|mesh-list
111491499|NCT05878184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111491500|NCT05878184|Immunologic Factors|immunologic factors|mesh-ancestor
110974450|NCT02325960|Hormones|hormones|mesh-ancestor
110974451|NCT02325960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110974452|NCT05265650|Nivolumab|nivolumab|mesh-list
110974453|NCT05265650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110974454|NCT05265650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110974455|NCT05265650|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110974456|NCT05265650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110974457|NCT02234349|Pancrelipase|pancrelipase|mesh-list
110974458|NCT02234349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110974459|NCT04458636|Prednisolone|prednisolone|mesh-list
110974460|NCT04458636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110974461|NCT04458636|Glucocorticoids|glucocorticoids|mesh-ancestor
110974462|NCT04458636|Hormones|hormones|mesh-ancestor
110974463|NCT04458636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110974464|NCT04458636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110974465|NCT04458636|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110974466|NCT04458636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110974467|NCT03304652|Zaleplon|zaleplon|mesh-list
110974468|NCT03304652|Anticonvulsants|anticonvulsants|mesh-ancestor
110974469|NCT03304652|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110974470|NCT03304652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110974471|NCT03304652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110974472|NCT03304652|GABA Modulators|gaba modulators|mesh-ancestor
110974473|NCT03304652|GABA Agents|gaba agents|mesh-ancestor
110974474|NCT03304652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110691538|NCT00541385|Antiviral Agents|antiviral agents|mesh-ancestor
110974475|NCT03304652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110974476|NCT03162783|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110974477|NCT03162783|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110974478|NCT02523144|Dexmedetomidine|dexmedetomidine|mesh-list
110974479|NCT02523144|Chloral Hydrate|chloral hydrate|mesh-list
110974480|NCT02523144|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110974481|NCT02523144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110974482|NCT02523144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110974483|NCT02523144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110974484|NCT02523144|Analgesics|analgesics|mesh-ancestor
110974485|NCT02523144|Sensory System Agents|sensory system agents|mesh-ancestor
110974486|NCT02523144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110974487|NCT02523144|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110974488|NCT02523144|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110974489|NCT02523144|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110974490|NCT02523144|Adrenergic Agents|adrenergic agents|mesh-ancestor
110974491|NCT02523144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110974492|NCT02523144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110974493|NCT00704132|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110974494|NCT00704132|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110974495|NCT00704132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110974496|NCT00704132|Incretins|incretins|mesh-ancestor
110974497|NCT00704132|Hormones|hormones|mesh-ancestor
110974498|NCT00704132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110974499|NCT00704132|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110974500|NCT00704132|Protease Inhibitors|protease inhibitors|mesh-ancestor
110974501|NCT00704132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110974502|NCT00704132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110974503|NCT03304496|Nitroglycerin|nitroglycerin|mesh-list
110974504|NCT03304496|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110974505|NCT03304496|Vasodilator Agents|vasodilator agents|mesh-ancestor
110974506|NCT03840837|Rivastigmine|rivastigmine|mesh-list
110974507|NCT03840837|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110974508|NCT03840837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110974509|NCT03840837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110974510|NCT03840837|Cholinergic Agents|cholinergic agents|mesh-ancestor
110974511|NCT03840837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110974512|NCT03840837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110974513|NCT03840837|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110974514|NCT03840837|Protective Agents|protective agents|mesh-ancestor
110974515|NCT03527238|Tacrolimus|tacrolimus|mesh-list
110974516|NCT03527238|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110974517|NCT03527238|Immunologic Factors|immunologic factors|mesh-ancestor
110974518|NCT03527238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111491501|NCT05878184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111491502|NCT05878184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111491503|NCT05878184|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111491504|NCT05878184|Alkylating Agents|alkylating agents|mesh-ancestor
110974519|NCT03527238|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110974520|NCT03527238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110974521|NCT03527238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110974522|NCT03832179|Dexamethasone|dexamethasone|mesh-list
110974523|NCT03832179|Bevacizumab|bevacizumab|mesh-list
110974524|NCT03832179|Ranibizumab|ranibizumab|mesh-list
110974525|NCT03832179|Aflibercept|aflibercept|mesh-list
110974526|NCT03832179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110974527|NCT03832179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110974528|NCT03832179|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110974529|NCT03832179|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110974530|NCT03832179|Growth Substances|growth substances|mesh-ancestor
110974531|NCT03832179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110974532|NCT03832179|Growth Inhibitors|growth inhibitors|mesh-ancestor
110974533|NCT03832179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110974534|NCT03832179|Antiemetics|antiemetics|mesh-ancestor
110974535|NCT03832179|Autonomic Agents|autonomic agents|mesh-ancestor
110974536|NCT03832179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110974537|NCT03832179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110974538|NCT03832179|Glucocorticoids|glucocorticoids|mesh-ancestor
110974539|NCT03832179|Hormones|hormones|mesh-ancestor
110974540|NCT03832179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110974541|NCT03832179|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110974542|NCT03123783|Nivolumab|nivolumab|mesh-list
110974543|NCT03123783|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110974544|NCT03123783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110974545|NCT03123783|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110974546|NCT03123783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110974547|NCT05154396|Loperamide|loperamide|mesh-list
110974548|NCT05154396|Antidiarrheals|antidiarrheals|mesh-ancestor
110974549|NCT05154396|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110974550|NCT04740645|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
110974551|NCT04740645|Hemostatics|hemostatics|mesh-ancestor
110974552|NCT04740645|Coagulants|coagulants|mesh-ancestor
110974553|NCT04740645|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
110974554|NCT04740645|Natriuretic Agents|natriuretic agents|mesh-ancestor
110974555|NCT04740645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110974556|NCT04735185|Anesthetics|anesthetics|mesh-list
110974557|NCT04735185|Anesthetics, Local|anesthetics, local|mesh-list
110974558|NCT04735185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110974559|NCT04735185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110974560|NCT04735185|Sensory System Agents|sensory system agents|mesh-ancestor
110974561|NCT04735185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110974562|NCT02802813|Primaquine|primaquine|mesh-list
110974563|NCT02802813|Piperaquine|piperaquine|mesh-list
110974564|NCT02802813|Artenimol|artenimol|mesh-list
110974565|NCT02802813|Artemisinins|artemisinins|mesh-list
110974566|NCT02802813|Antimalarials|antimalarials|mesh-ancestor
110974567|NCT02802813|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110974568|NCT02802813|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110974569|NCT02802813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110974570|NCT05134584|Lactulose|lactulose|mesh-list
110974571|NCT05134584|Linaclotide|linaclotide|mesh-list
110974572|NCT05134584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110974573|NCT05134584|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
110974574|NCT05134584|Enzyme Activators|enzyme activators|mesh-ancestor
110974575|NCT05134584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110974576|NCT05633277|Polidocanol|polidocanol|mesh-list
110974577|NCT05633277|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
110974578|NCT05633277|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110974579|NCT03312140|Choline|choline|mesh-list
110974580|NCT03312140|Lipotropic Agents|lipotropic agents|mesh-ancestor
110974581|NCT03312140|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110974582|NCT03312140|Antimetabolites|antimetabolites|mesh-ancestor
110974583|NCT03312140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110974584|NCT03312140|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110974585|NCT03312140|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110974586|NCT03312140|Nootropic Agents|nootropic agents|mesh-ancestor
110974587|NCT02233179|Calpastatin|calpastatin|mesh-list
110974588|NCT02233179|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
110974589|NCT02233179|Protease Inhibitors|protease inhibitors|mesh-ancestor
110974590|NCT02233179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110974591|NCT02233179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110974592|NCT03311984|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
111491505|NCT05878184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111491506|NCT05878184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111491507|NCT05878184|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111491508|NCT05877820|Lenvatinib|lenvatinib|mesh-list
111491509|NCT05877820|Tislelizumab|tislelizumab|mesh-list
111491510|NCT05877820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111491511|NCT05877820|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111491512|NCT05877820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110974593|NCT03311984|Dalteparin|dalteparin|mesh-list
110974594|NCT03311984|Anticoagulants|anticoagulants|mesh-ancestor
110974595|NCT03311984|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110974596|NCT03311984|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110974597|NCT03311984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110974598|NCT03311906|Hyaluronic Acid|hyaluronic acid|mesh-list
110974599|NCT03311906|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110974600|NCT03311906|Immunologic Factors|immunologic factors|mesh-ancestor
110974601|NCT03311906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110974602|NCT03311906|Viscosupplements|viscosupplements|mesh-ancestor
110974603|NCT03311906|Protective Agents|protective agents|mesh-ancestor
110974604|NCT04554459|Ponatinib|ponatinib|mesh-list
110974605|NCT04554459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110974606|NCT04554459|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110974607|NCT04554459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110974608|NCT04554459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110974609|NCT03311750|Panitumumab|panitumumab|mesh-list
110974610|NCT03311750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110974611|NCT03311750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110974612|NCT03311672|Pembrolizumab|pembrolizumab|mesh-list
110974613|NCT03311672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110974614|NCT03311672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110974615|NCT03311672|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110974616|NCT03311672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110974617|NCT03311516|Insulin|insulin|mesh-list
110974618|NCT03311516|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110974619|NCT03311516|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110974620|NCT03311516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110974621|NCT02811939|Dronabinol|dronabinol|mesh-list
110974622|NCT02811939|Hallucinogens|hallucinogens|mesh-ancestor
110974623|NCT02811939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110974624|NCT02811939|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110974625|NCT02811939|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110974626|NCT02811939|Analgesics|analgesics|mesh-ancestor
110974627|NCT02811939|Sensory System Agents|sensory system agents|mesh-ancestor
110974628|NCT02811939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110974629|NCT02811939|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
110974630|NCT02811939|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110974631|NCT02811939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110974632|NCT02811939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110974633|NCT02811939|Hormones|hormones|mesh-ancestor
110974634|NCT02811939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110974635|NCT01329549|Carboplatin|carboplatin|mesh-list
110974636|NCT01329549|Nintedanib|nintedanib|mesh-list
110974637|NCT01329549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110974638|NCT01329549|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110974639|NCT01329549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110974640|NCT01329549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110974641|NCT02234739|Voriconazole|voriconazole|mesh-list
110974642|NCT02234739|Antifungal Agents|antifungal agents|mesh-ancestor
110974643|NCT02234739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110974644|NCT02234739|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110974645|NCT02234739|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110974646|NCT02234739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110974647|NCT02234739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110479558|NCT05018221|Vitamins|vitamins|mesh-list
110974648|NCT02234739|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110974649|NCT02234739|Hormone Antagonists|hormone antagonists|mesh-ancestor
110974650|NCT02234739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110974651|NCT02234739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110974652|NCT02234739|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110974653|NCT02736474|Naltrexone|naltrexone|mesh-list
110974654|NCT02736474|Bupropion|bupropion|mesh-list
110974655|NCT02736474|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110974656|NCT02736474|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110974657|NCT02736474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110440225|NCT01157351|Aripiprazole|aripiprazole|mesh-list
110974658|NCT02736474|Sensory System Agents|sensory system agents|mesh-ancestor
110974659|NCT02736474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110974660|NCT02736474|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110974661|NCT02736474|Antidepressive Agents|antidepressive agents|mesh-ancestor
110974662|NCT02736474|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110974663|NCT02736474|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110974664|NCT02736474|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110974665|NCT02736474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110974666|NCT02736474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110974667|NCT02736474|Dopamine Agents|dopamine agents|mesh-ancestor
110974668|NCT02736474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110974669|NCT02736474|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110974670|NCT02736474|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110974671|NCT02736474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110974672|NCT03302390|Lidocaine|lidocaine|mesh-list
110974673|NCT03302390|Epinephrine|epinephrine|mesh-list
110974674|NCT03302390|Anesthetics, Local|anesthetics, local|mesh-ancestor
110974675|NCT03302390|Anesthetics|anesthetics|mesh-ancestor
110974676|NCT03302390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110974677|NCT03302390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110974678|NCT03302390|Sensory System Agents|sensory system agents|mesh-ancestor
110974679|NCT03302390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110974680|NCT03302390|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110974681|NCT03302390|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110974682|NCT03302390|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110974683|NCT03302390|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110974684|NCT03302390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110974685|NCT03302390|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110974686|NCT03302390|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110974687|NCT03302390|Adrenergic Agents|adrenergic agents|mesh-ancestor
110974688|NCT03302390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110974689|NCT03302390|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110974690|NCT03302390|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110974691|NCT03302390|Autonomic Agents|autonomic agents|mesh-ancestor
110974692|NCT03302390|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110974693|NCT03302390|Respiratory System Agents|respiratory system agents|mesh-ancestor
110974694|NCT03302390|Mydriatics|mydriatics|mesh-ancestor
110974695|NCT03302390|Sympathomimetics|sympathomimetics|mesh-ancestor
110974696|NCT03302390|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110974697|NCT03712371|Chitosan|chitosan|mesh-list
110974698|NCT03712371|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110974699|NCT03712371|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110974700|NCT03712371|Antimetabolites|antimetabolites|mesh-ancestor
110974701|NCT03712371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110974702|NCT03712371|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110974703|NCT03712371|Chelating Agents|chelating agents|mesh-ancestor
110974704|NCT03712371|Sequestering Agents|sequestering agents|mesh-ancestor
110974705|NCT03712371|Hemostatics|hemostatics|mesh-ancestor
110974706|NCT03712371|Coagulants|coagulants|mesh-ancestor
110974707|NCT03472950|Ranolazine|ranolazine|mesh-list
110974708|NCT03472950|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110974709|NCT03472950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110974710|NCT03472950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110974711|NCT03706521|Lorecivivint|lorecivivint|mesh-list
110974712|NCT03706521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110974713|NCT02259543|Tetracycline|tetracycline|mesh-list
110974714|NCT02259543|Citric Acid|citric acid|mesh-list
110974715|NCT02259543|Sodium Citrate|sodium citrate|mesh-list
110974716|NCT02259543|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110974717|NCT02259543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110974718|NCT02259543|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110974719|NCT02259543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110974720|NCT02259543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110974721|NCT02259543|Anticoagulants|anticoagulants|mesh-ancestor
110974722|NCT02259543|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110974723|NCT02259543|Chelating Agents|chelating agents|mesh-ancestor
110974724|NCT02259543|Sequestering Agents|sequestering agents|mesh-ancestor
110974725|NCT03301454|Paclitaxel|paclitaxel|mesh-list
110974726|NCT03301454|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110974727|NCT03301454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110974728|NCT03301454|Tubulin Modulators|tubulin modulators|mesh-ancestor
111491513|NCT05877820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110974729|NCT03301454|Antimitotic Agents|antimitotic agents|mesh-ancestor
111491514|NCT05877820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111491515|NCT05875077|Dexmedetomidine|dexmedetomidine|mesh-list
111491516|NCT05875077|Propofol|propofol|mesh-list
111491517|NCT05875077|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111491518|NCT05875077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110974730|NCT03301454|Mitosis Modulators|mitosis modulators|mesh-ancestor
110974731|NCT03301454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110974732|NCT04343235|Labetalol|labetalol|mesh-list
110974733|NCT04343235|Furosemide|furosemide|mesh-list
110974734|NCT04343235|Diuretics|diuretics|mesh-ancestor
110974735|NCT04343235|Natriuretic Agents|natriuretic agents|mesh-ancestor
110974736|NCT04343235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110974737|NCT04343235|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110974738|NCT04343235|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110974739|NCT04343235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110974740|NCT04343235|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110974741|NCT04343235|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110974742|NCT04343235|Adrenergic Agents|adrenergic agents|mesh-ancestor
110974743|NCT04343235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110974744|NCT04343235|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110974745|NCT04343235|Sympathomimetics|sympathomimetics|mesh-ancestor
110974746|NCT04343235|Autonomic Agents|autonomic agents|mesh-ancestor
110974747|NCT04343235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110974748|NCT04343235|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110974749|NCT04343235|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110974750|NCT05727410|Docetaxel|docetaxel|mesh-list
110974751|NCT05727410|Nivolumab|nivolumab|mesh-list
110974752|NCT05727410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110974753|NCT05727410|Tubulin Modulators|tubulin modulators|mesh-ancestor
110974754|NCT05727410|Antimitotic Agents|antimitotic agents|mesh-ancestor
110974755|NCT05727410|Mitosis Modulators|mitosis modulators|mesh-ancestor
110974756|NCT05727410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110974757|NCT05727410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110974758|NCT05727410|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110974759|NCT02467010|Dexamethasone|dexamethasone|mesh-list
110974760|NCT02467010|Cyclophosphamide|cyclophosphamide|mesh-list
110974761|NCT02467010|Bortezomib|bortezomib|mesh-list
110974762|NCT02467010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110974763|NCT02467010|Immunologic Factors|immunologic factors|mesh-ancestor
110974764|NCT02467010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110974765|NCT02467010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110974766|NCT02467010|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110974767|NCT02467010|Alkylating Agents|alkylating agents|mesh-ancestor
110974768|NCT02467010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110974769|NCT02467010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110974770|NCT02467010|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110974771|NCT02467010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110974772|NCT02467010|Antiemetics|antiemetics|mesh-ancestor
110974773|NCT02467010|Autonomic Agents|autonomic agents|mesh-ancestor
110974774|NCT02467010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110974775|NCT02467010|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110974776|NCT02467010|Glucocorticoids|glucocorticoids|mesh-ancestor
110974777|NCT02467010|Hormones|hormones|mesh-ancestor
110974778|NCT02467010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110974779|NCT02467010|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110974780|NCT02232555|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110974781|NCT02232555|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110974782|NCT02232555|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110974783|NCT02232555|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110974784|NCT02232555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110974785|NCT02232555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110974786|NCT02232555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110974787|NCT02232555|Analgesics|analgesics|mesh-ancestor
110974788|NCT02232555|Sensory System Agents|sensory system agents|mesh-ancestor
110974789|NCT02232555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110974790|NCT02232555|Antidepressive Agents|antidepressive agents|mesh-ancestor
110974791|NCT02232555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110974792|NCT02232555|Dopamine Agents|dopamine agents|mesh-ancestor
110974793|NCT02235519|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
110974794|NCT02235519|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110974795|NCT02235519|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110974796|NCT02235519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110974797|NCT00702650|Testosterone|testosterone|mesh-list
111491519|NCT05875077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110974798|NCT00702650|Androgens|androgens|mesh-ancestor
111491520|NCT05875077|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111491521|NCT05875077|Analgesics|analgesics|mesh-ancestor
110974800|NCT00702650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110974801|NCT00702650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110974802|NCT03230916|Relebactam|relebactam|mesh-list
110974803|NCT03230916|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110974804|NCT03230916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110974805|NCT03230916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110974806|NCT03230916|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110974807|NCT03230916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110974808|NCT04210713|Minocycline|minocycline|mesh-list
110974809|NCT04210713|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110974810|NCT04210713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110974811|NCT01337115|Ropivacaine|ropivacaine|mesh-list
110974812|NCT01337115|Anesthetics, Local|anesthetics, local|mesh-list
110974813|NCT01337115|Anesthetics|anesthetics|mesh-list
110974814|NCT01337115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110974815|NCT01337115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110974816|NCT01337115|Sensory System Agents|sensory system agents|mesh-ancestor
110974817|NCT01337115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110974818|NCT03761784|Tretinoin|tretinoin|mesh-list
110974819|NCT03761784|Benzoyl Peroxide|benzoyl peroxide|mesh-list
110974820|NCT03761784|Dermatologic Agents|dermatologic agents|mesh-ancestor
110974821|NCT03761784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110974822|NCT03761784|Keratolytic Agents|keratolytic agents|mesh-ancestor
110974823|NCT03300440|Vitamins|vitamins|mesh-list
110974824|NCT03300440|Biotin|biotin|mesh-list
110974825|NCT03300440|Vitamin B Complex|vitamin b complex|mesh-list
110974826|NCT03300440|Micronutrients|micronutrients|mesh-ancestor
110974827|NCT03300440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110974828|NCT02236065|Lenograstim|lenograstim|mesh-list
110974829|NCT02236065|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110974830|NCT02236065|Immunologic Factors|immunologic factors|mesh-ancestor
110974831|NCT02236065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110974832|NCT02467556|Morphine|morphine|mesh-list
110974833|NCT02467556|Memantine|memantine|mesh-list
110974834|NCT02467556|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110974835|NCT02467556|Narcotics|narcotics|mesh-ancestor
110974836|NCT02467556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110974837|NCT02467556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110974838|NCT02467556|Analgesics|analgesics|mesh-ancestor
110974839|NCT02467556|Sensory System Agents|sensory system agents|mesh-ancestor
110974840|NCT02467556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110974841|NCT02467556|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110974842|NCT02467556|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110974843|NCT02467556|Dopamine Agents|dopamine agents|mesh-ancestor
110974844|NCT02467556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110974845|NCT02467556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110974846|NCT02467556|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110479575|NCT05018221|Coagulants|coagulants|mesh-ancestor
110974847|NCT02467556|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110974848|NCT02262585|Telmisartan|telmisartan|mesh-list
110974849|NCT02262585|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110974850|NCT02262585|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110974851|NCT02262585|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110974852|NCT02262585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110974853|NCT03309176|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
110974854|NCT03309176|Medroxyprogesterone|medroxyprogesterone|mesh-list
110974855|NCT03309176|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110974856|NCT03309176|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110974857|NCT03309176|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110974858|NCT03309176|Contraceptive Agents|contraceptive agents|mesh-ancestor
110974859|NCT03309176|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110974860|NCT03309176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110974861|NCT03309176|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110974862|NCT03309176|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110974863|NCT03309176|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110974864|NCT03309176|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110974865|NCT03309176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110974866|NCT02602353|Loxoprofen|loxoprofen|mesh-list
111491522|NCT05875077|Sensory System Agents|sensory system agents|mesh-ancestor
110974867|NCT02602353|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111491523|NCT05875077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110974868|NCT02602353|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110974869|NCT02602353|Analgesics|analgesics|mesh-ancestor
110974870|NCT02602353|Sensory System Agents|sensory system agents|mesh-ancestor
110974871|NCT02602353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110974872|NCT02602353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110974873|NCT02602353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110974874|NCT02602353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110974876|NCT04983498|Antiemetics|antiemetics|mesh-ancestor
110974877|NCT04983498|Autonomic Agents|autonomic agents|mesh-ancestor
110974878|NCT04983498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110974879|NCT04983498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110974880|NCT04983498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110974881|NCT04983498|Antipruritics|antipruritics|mesh-ancestor
110974882|NCT04983498|Dermatologic Agents|dermatologic agents|mesh-ancestor
110974883|NCT04983498|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110974884|NCT04983498|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110974885|NCT04983498|Serotonin Agents|serotonin agents|mesh-ancestor
110974886|NCT04983498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110974887|NCT04983498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110974888|NCT03300362|Vaccines|vaccines|mesh-list
110974889|NCT03300362|Immunologic Factors|immunologic factors|mesh-ancestor
110974890|NCT03300362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110974891|NCT02467400|Propranolol|propranolol|mesh-list
110974892|NCT02467400|Atenolol|atenolol|mesh-list
110974893|NCT02467400|Nebivolol|nebivolol|mesh-list
110974894|NCT02467400|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110974895|NCT02467400|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110974896|NCT02467400|Adrenergic Agents|adrenergic agents|mesh-ancestor
110974897|NCT02467400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110974898|NCT02467400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110974899|NCT02467400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110974900|NCT02467400|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110974901|NCT02467400|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110974902|NCT02467400|Vasodilator Agents|vasodilator agents|mesh-ancestor
110974903|NCT02467400|Sympatholytics|sympatholytics|mesh-ancestor
110974904|NCT02467400|Autonomic Agents|autonomic agents|mesh-ancestor
110974905|NCT02467400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110974906|NCT02467400|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110974907|NCT02467400|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
110974908|NCT02467400|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110974909|NCT02467400|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110974910|NCT04002141|Letrozole|letrozole|mesh-list
110974911|NCT04002141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110974912|NCT04002141|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110974913|NCT04002141|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110479582|NCT05018221|Cathartics|cathartics|mesh-ancestor
110974914|NCT04002141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110974915|NCT04002141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110974916|NCT04002141|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110974917|NCT04002141|Hormone Antagonists|hormone antagonists|mesh-ancestor
110974918|NCT04002141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110974919|NCT04002141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110974920|NCT03308708|Norepinephrine|norepinephrine|mesh-list
110974921|NCT03308708|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110692007|NCT00264238|Memantine|memantine|mesh-list
110974922|NCT03308708|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110974923|NCT03308708|Adrenergic Agents|adrenergic agents|mesh-ancestor
110974924|NCT03308708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110974925|NCT03308708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110974926|NCT03308708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110974927|NCT03308708|Sympathomimetics|sympathomimetics|mesh-ancestor
110974928|NCT03308708|Autonomic Agents|autonomic agents|mesh-ancestor
110974929|NCT03308708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110974930|NCT03308708|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110974931|NCT02262741|Durvalumab|durvalumab|mesh-list
110974932|NCT02262741|Tremelimumab|tremelimumab|mesh-list
110974933|NCT02262741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110974934|NCT02262741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110974935|NCT00250341|Beclomethasone|beclomethasone|mesh-list
110974936|NCT00250341|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
110974937|NCT00250341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110974938|NCT00250341|Glucocorticoids|glucocorticoids|mesh-ancestor
110974939|NCT00250341|Hormones|hormones|mesh-ancestor
110974940|NCT00250341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110974941|NCT00250341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111491524|NCT05875077|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111491525|NCT05875077|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110974942|NCT00250341|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110974943|NCT00250341|Respiratory System Agents|respiratory system agents|mesh-ancestor
110974944|NCT00250341|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110974945|NCT00250341|Autonomic Agents|autonomic agents|mesh-ancestor
110974946|NCT00250341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110974947|NCT00250341|Sympathomimetics|sympathomimetics|mesh-ancestor
110974948|NCT05156970|Carboplatin|carboplatin|mesh-list
110974949|NCT05156970|Docetaxel|docetaxel|mesh-list
110974950|NCT05156970|Apatinib|apatinib|mesh-list
110974951|NCT05156970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110974952|NCT05156970|Tubulin Modulators|tubulin modulators|mesh-ancestor
110974953|NCT05156970|Antimitotic Agents|antimitotic agents|mesh-ancestor
110974954|NCT05156970|Mitosis Modulators|mitosis modulators|mesh-ancestor
110974955|NCT05156970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110974956|NCT05156970|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110974957|NCT05156970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110974958|NCT02233881|Ipratropium|ipratropium|mesh-list
110974959|NCT02233881|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110974960|NCT02233881|Autonomic Agents|autonomic agents|mesh-ancestor
110974961|NCT02233881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110974962|NCT02233881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110974963|NCT02233881|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110974964|NCT02233881|Respiratory System Agents|respiratory system agents|mesh-ancestor
110974965|NCT02233881|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110974966|NCT02233881|Cholinergic Agents|cholinergic agents|mesh-ancestor
110974967|NCT02233881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110974968|NCT02233881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110974969|NCT02234037|Decitabine|decitabine|mesh-list
110974970|NCT02234037|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110974971|NCT02234037|Antimetabolites|antimetabolites|mesh-ancestor
110974972|NCT02234037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110974973|NCT02234037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110974974|NCT02234037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110974975|NCT02234193|Lidocaine|lidocaine|mesh-list
110974976|NCT02234193|Epinephrine|epinephrine|mesh-list
110974977|NCT02234193|Anesthetics, Local|anesthetics, local|mesh-ancestor
110974978|NCT02234193|Anesthetics|anesthetics|mesh-ancestor
110974979|NCT02234193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110974980|NCT02234193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110974981|NCT02234193|Sensory System Agents|sensory system agents|mesh-ancestor
110974982|NCT02234193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110974983|NCT02234193|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110974984|NCT02234193|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110974985|NCT02234193|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110974986|NCT02234193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110974987|NCT02234193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110974988|NCT02234193|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110974989|NCT02234193|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110974990|NCT02234193|Adrenergic Agents|adrenergic agents|mesh-ancestor
110974991|NCT02234193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110974992|NCT02234193|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110974993|NCT02234193|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110974994|NCT02234193|Autonomic Agents|autonomic agents|mesh-ancestor
110974995|NCT02234193|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110974996|NCT02234193|Respiratory System Agents|respiratory system agents|mesh-ancestor
110974997|NCT02234193|Mydriatics|mydriatics|mesh-ancestor
110974999|NCT02234193|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110975000|NCT04476459|Apatinib|apatinib|mesh-list
110975001|NCT04476459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110975002|NCT04476459|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110975003|NCT04476459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110975004|NCT04476459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110975005|NCT02262897|Paclitaxel|paclitaxel|mesh-list
110975006|NCT02262897|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110975007|NCT02262897|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110975008|NCT02262897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110975009|NCT02262897|Tubulin Modulators|tubulin modulators|mesh-ancestor
110975010|NCT02262897|Antimitotic Agents|antimitotic agents|mesh-ancestor
110975011|NCT02262897|Mitosis Modulators|mitosis modulators|mesh-ancestor
110975012|NCT02262897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111491526|NCT05875077|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110975013|NCT02723006|Nivolumab|nivolumab|mesh-list
110975014|NCT02723006|Ipilimumab|ipilimumab|mesh-list
110975015|NCT02723006|Vedolizumab|vedolizumab|mesh-list
111491527|NCT05875077|Adrenergic Agents|adrenergic agents|mesh-ancestor
110975016|NCT02723006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111491528|NCT05875077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111491529|NCT05875077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110975017|NCT02723006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110975018|NCT02723006|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110975019|NCT02723006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110975020|NCT02723006|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110975021|NCT03308552|Paclitaxel|paclitaxel|mesh-list
110975022|NCT03308552|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110975023|NCT03308552|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110975024|NCT03308552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110975025|NCT03308552|Tubulin Modulators|tubulin modulators|mesh-ancestor
110975026|NCT03308552|Antimitotic Agents|antimitotic agents|mesh-ancestor
110975027|NCT03308552|Mitosis Modulators|mitosis modulators|mesh-ancestor
110975028|NCT03308552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110975029|NCT03308084|Dexamethasone|dexamethasone|mesh-list
110975030|NCT03308084|Methylprednisolone|methylprednisolone|mesh-list
110975031|NCT03308084|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110479594|NCT00785980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110975032|NCT03308084|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110975033|NCT03308084|Prednisolone|prednisolone|mesh-list
110975034|NCT03308084|Prednisolone acetate|prednisolone acetate|mesh-list
110975035|NCT03308084|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110975036|NCT03308084|Prednisolone phosphate|prednisolone phosphate|mesh-list
110975037|NCT03308084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110975038|NCT03308084|Antiemetics|antiemetics|mesh-ancestor
110975039|NCT03308084|Autonomic Agents|autonomic agents|mesh-ancestor
110975040|NCT03308084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110975041|NCT03308084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110975042|NCT03308084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110975043|NCT03308084|Glucocorticoids|glucocorticoids|mesh-ancestor
110975044|NCT03308084|Hormones|hormones|mesh-ancestor
110975045|NCT03308084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110975046|NCT03308084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110975047|NCT03308084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110975048|NCT03308084|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110975049|NCT03308084|Protective Agents|protective agents|mesh-ancestor
110975050|NCT00702962|Carboplatin|carboplatin|mesh-list
110975051|NCT00702962|Etoposide|etoposide|mesh-list
110975052|NCT00702962|Vorinostat|vorinostat|mesh-list
110975053|NCT00702962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110975054|NCT00702962|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110975055|NCT00702962|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110975056|NCT00702962|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110975057|NCT00702962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110975058|NCT00702962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110975059|NCT00702962|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110975060|NCT01379508|Tenofovir|tenofovir|mesh-list
110975061|NCT01379508|Telbivudine|telbivudine|mesh-list
110975062|NCT01379508|Antiviral Agents|antiviral agents|mesh-ancestor
110975063|NCT01379508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110975064|NCT01379508|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110975065|NCT01379508|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110975066|NCT01379508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110975067|NCT01379508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110975068|NCT01379508|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110975069|NCT01379508|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110975070|NCT05162430|Propofol|propofol|mesh-list
110975071|NCT05162430|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110975072|NCT05162430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110975073|NCT05162430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110975074|NCT05162430|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110975075|NCT05162430|Anesthetics, General|anesthetics, general|mesh-ancestor
110975076|NCT05162430|Anesthetics|anesthetics|mesh-ancestor
110975077|NCT05031026|Dexmedetomidine|dexmedetomidine|mesh-list
110975078|NCT05031026|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110975079|NCT05031026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110975080|NCT05031026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111491530|NCT05875077|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111491531|NCT05875077|Anesthetics, General|anesthetics, general|mesh-ancestor
111491532|NCT05875077|Anesthetics|anesthetics|mesh-ancestor
111491533|NCT05864846|Cannabidiol|cannabidiol|mesh-list
111491534|NCT05864846|Anticonvulsants|anticonvulsants|mesh-ancestor
110975081|NCT05031026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110975082|NCT05031026|Analgesics|analgesics|mesh-ancestor
111491535|NCT05852158|Cefazolin|cefazolin|mesh-list
111491536|NCT05852158|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111491537|NCT05852158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110975083|NCT05031026|Sensory System Agents|sensory system agents|mesh-ancestor
110975084|NCT05031026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110975085|NCT05031026|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110975086|NCT05031026|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110975087|NCT05031026|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110975088|NCT05031026|Adrenergic Agents|adrenergic agents|mesh-ancestor
110975089|NCT05031026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110975090|NCT05031026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110975091|NCT02264769|Carbetocin|carbetocin|mesh-list
110975092|NCT02264769|Oxytocics|oxytocics|mesh-ancestor
110975093|NCT02264769|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110975094|NCT02264769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110975095|NCT02264847|Clomiphene|clomiphene|mesh-list
110975096|NCT02264847|Enclomiphene|enclomiphene|mesh-list
110975097|NCT02264847|Zuclomiphene|zuclomiphene|mesh-list
110975098|NCT02264847|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
110975099|NCT02264847|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110975100|NCT02264847|Hormone Antagonists|hormone antagonists|mesh-ancestor
110975101|NCT02264847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110975102|NCT02264847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110975103|NCT02264847|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110975104|NCT02264847|Fertility Agents|fertility agents|mesh-ancestor
110975105|NCT02264847|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110975106|NCT02264847|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110975107|NCT02264847|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110975108|NCT04965506|Dulaglutide|dulaglutide|mesh-list
110975109|NCT04965506|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110975110|NCT04965506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110975111|NCT03469128|Sertraline|sertraline|mesh-list
110975112|NCT03469128|Antidepressive Agents|antidepressive agents|mesh-ancestor
110975113|NCT03469128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110975114|NCT03469128|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110975115|NCT03469128|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110975116|NCT03469128|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110975117|NCT03469128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110975118|NCT03469128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110975119|NCT03469128|Serotonin Agents|serotonin agents|mesh-ancestor
110975120|NCT03469128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110975121|NCT05161572|Oxaliplatin|oxaliplatin|mesh-list
110975122|NCT05161572|Tegafur|tegafur|mesh-list
110975123|NCT05161572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110975124|NCT05161572|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110975125|NCT05161572|Antimetabolites|antimetabolites|mesh-ancestor
110975126|NCT05161572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110975127|NCT03472170|Lactoferrin|lactoferrin|mesh-list
110975128|NCT03472170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110975129|NCT04156698|Docetaxel|docetaxel|mesh-list
110975130|NCT04156698|Capecitabine|capecitabine|mesh-list
110975131|NCT04156698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110975132|NCT04156698|Tubulin Modulators|tubulin modulators|mesh-ancestor
110975133|NCT04156698|Antimitotic Agents|antimitotic agents|mesh-ancestor
110975134|NCT04156698|Mitosis Modulators|mitosis modulators|mesh-ancestor
110975135|NCT04156698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110975136|NCT04156698|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110975137|NCT04156698|Antimetabolites|antimetabolites|mesh-ancestor
110975138|NCT03108326|Infliximab|infliximab|mesh-list
110975139|NCT03108326|Ustekinumab|ustekinumab|mesh-list
110975140|NCT03108326|Vedolizumab|vedolizumab|mesh-list
110975141|NCT03108326|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110975142|NCT03108326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110975143|NCT03108326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110975144|NCT03108326|Dermatologic Agents|dermatologic agents|mesh-ancestor
110975145|NCT03108326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110975146|NCT04964024|Antibodies|antibodies|mesh-list
110975147|NCT04964024|Immunologic Factors|immunologic factors|mesh-ancestor
110975148|NCT04964024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110975149|NCT02466542|Esmolol|esmolol|mesh-list
110975150|NCT02466542|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110975151|NCT02466542|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110975152|NCT02466542|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110975153|NCT02466542|Adrenergic Agents|adrenergic agents|mesh-ancestor
110975154|NCT02466542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110975155|NCT02466542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110440717|NCT00671281|Hemostatics|hemostatics|mesh-ancestor
111491538|NCT05850546|Prednisone|prednisone|mesh-list
110975156|NCT02466542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110975157|NCT05067270|Insulin Lispro|insulin lispro|mesh-list
110975158|NCT05067270|Treprostinil|treprostinil|mesh-list
110975159|NCT05067270|Citric Acid|citric acid|mesh-list
110975160|NCT05067270|Sodium Citrate|sodium citrate|mesh-list
110975161|NCT05067270|Anticoagulants|anticoagulants|mesh-ancestor
110975162|NCT05067270|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110975163|NCT05067270|Chelating Agents|chelating agents|mesh-ancestor
110975164|NCT05067270|Sequestering Agents|sequestering agents|mesh-ancestor
110975165|NCT05067270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110975166|NCT05067270|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110975167|NCT05067270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110975168|NCT05067270|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110975169|NCT01437735|Montelukast|montelukast|mesh-list
110975170|NCT01437735|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110975171|NCT01437735|Respiratory System Agents|respiratory system agents|mesh-ancestor
110975172|NCT01437735|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110975173|NCT01437735|Hormone Antagonists|hormone antagonists|mesh-ancestor
110975174|NCT01437735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110975175|NCT01437735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110975176|NCT01437735|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110975177|NCT01437735|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110975178|NCT01437735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110975179|NCT02722304|Protease Inhibitors|protease inhibitors|mesh-list
110975180|NCT02722304|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
110975181|NCT02722304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110975182|NCT02722304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110975183|NCT02722304|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
110975184|NCT02722304|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110975185|NCT03470610|Estradiol|estradiol|mesh-list
110975186|NCT03470610|Progesterone|progesterone|mesh-list
110975187|NCT03470610|Estrogens|estrogens|mesh-ancestor
110975188|NCT03470610|Hormones|hormones|mesh-ancestor
110975189|NCT03470610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110975190|NCT03470610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110975191|NCT03470610|Progestins|progestins|mesh-ancestor
110975192|NCT02509845|Anti-Infective Agents|anti-infective agents|mesh-list
110975193|NCT02509845|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110975194|NCT03307148|Paclitaxel|paclitaxel|mesh-list
110975195|NCT03307148|Gemcitabine|gemcitabine|mesh-list
110975196|NCT03307148|Tretinoin|tretinoin|mesh-list
110975197|NCT03307148|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110975198|NCT03307148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110975199|NCT03307148|Tubulin Modulators|tubulin modulators|mesh-ancestor
110975200|NCT03307148|Antimitotic Agents|antimitotic agents|mesh-ancestor
110975201|NCT03307148|Mitosis Modulators|mitosis modulators|mesh-ancestor
110975202|NCT03307148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110975203|NCT03307148|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110975204|NCT03307148|Antimetabolites|antimetabolites|mesh-ancestor
110975205|NCT03307148|Keratolytic Agents|keratolytic agents|mesh-ancestor
110975206|NCT03307148|Dermatologic Agents|dermatologic agents|mesh-ancestor
110975207|NCT03984591|Eplerenone|eplerenone|mesh-list
110975208|NCT03984591|Spironolactone|spironolactone|mesh-list
110975209|NCT03984591|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110975210|NCT03984591|Hormone Antagonists|hormone antagonists|mesh-ancestor
110975211|NCT03984591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110975212|NCT03984591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110975213|NCT03984591|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110975214|NCT03984591|Diuretics|diuretics|mesh-ancestor
110975215|NCT03984591|Natriuretic Agents|natriuretic agents|mesh-ancestor
110975216|NCT03984591|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110975217|NCT02503137|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110975218|NCT03470532|Epinephrine|epinephrine|mesh-list
110975219|NCT03470532|Racepinephrine|racepinephrine|mesh-list
110975220|NCT03470532|Carticaine|carticaine|mesh-list
110975221|NCT03470532|Mepivacaine|mepivacaine|mesh-list
110975222|NCT03470532|Epinephryl borate|epinephryl borate|mesh-list
110975223|NCT03470532|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110975224|NCT03470532|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110975225|NCT03470532|Adrenergic Agents|adrenergic agents|mesh-ancestor
110975226|NCT03470532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111491539|NCT05850546|Prednisolone|prednisolone|mesh-list
111491540|NCT05850546|Rituximab|rituximab|mesh-list
111491541|NCT05850546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111491542|NCT05850546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111491543|NCT05850546|Immunologic Factors|immunologic factors|mesh-ancestor
110699624|NCT00380874|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110975227|NCT03470532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110975228|NCT03470532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110975229|NCT03470532|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110975230|NCT03470532|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110975231|NCT03470532|Autonomic Agents|autonomic agents|mesh-ancestor
110975232|NCT03470532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110975233|NCT03470532|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110975234|NCT03470532|Respiratory System Agents|respiratory system agents|mesh-ancestor
110975235|NCT03470532|Mydriatics|mydriatics|mesh-ancestor
110975236|NCT03470532|Sympathomimetics|sympathomimetics|mesh-ancestor
110975237|NCT03470532|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110975238|NCT03470532|Anesthetics, Local|anesthetics, local|mesh-ancestor
110975239|NCT03470532|Anesthetics|anesthetics|mesh-ancestor
110975240|NCT03470532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110975241|NCT03470532|Sensory System Agents|sensory system agents|mesh-ancestor
110975242|NCT02502669|Finasteride|finasteride|mesh-list
110975243|NCT02502669|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
110975244|NCT02502669|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110975245|NCT02502669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110975246|NCT02502669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110975247|NCT02502669|Hormone Antagonists|hormone antagonists|mesh-ancestor
110975248|NCT02502669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110975249|NCT02502669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110975250|NCT02502669|Urological Agents|urological agents|mesh-ancestor
110975251|NCT03306914|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
110975252|NCT03306914|Plasma Substitutes|plasma substitutes|mesh-ancestor
110975253|NCT03306914|Blood Substitutes|blood substitutes|mesh-ancestor
110975254|NCT03306836|Heparin|heparin|mesh-list
110975255|NCT03306836|Calcium heparin|calcium heparin|mesh-list
110975256|NCT03306836|Anticoagulants|anticoagulants|mesh-ancestor
110975257|NCT03306836|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110975258|NCT03306836|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110975259|NCT03306836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110975260|NCT04487145|Piperaquine|piperaquine|mesh-list
110975261|NCT04487145|Artenimol|artenimol|mesh-list
110975262|NCT04487145|Antimalarials|antimalarials|mesh-ancestor
110975263|NCT04487145|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110975264|NCT04487145|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110975265|NCT04487145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110975266|NCT04780568|Osimertinib|osimertinib|mesh-list
110975267|NCT04780568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110975268|NCT04780568|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110975269|NCT04780568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110975270|NCT04780568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110975271|NCT00709956|Iloprost|iloprost|mesh-list
110975272|NCT00709956|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110975273|NCT00709956|Vasodilator Agents|vasodilator agents|mesh-ancestor
110975274|NCT02268201|Tacrolimus|tacrolimus|mesh-list
110975275|NCT02268201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110975276|NCT02268201|Immunologic Factors|immunologic factors|mesh-ancestor
110975277|NCT02268201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110975278|NCT02268201|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110975279|NCT02268201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110975280|NCT02268201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110975281|NCT03306602|Z 350|z 350|mesh-list
110975282|NCT03306602|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
110975283|NCT03306602|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110975284|NCT03306602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110975285|NCT03306602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110975286|NCT03306602|Hormone Antagonists|hormone antagonists|mesh-ancestor
110975287|NCT03306602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110975288|NCT03306602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110975289|NCT02268279|Solithromycin|solithromycin|mesh-list
110975290|NCT02268279|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110975291|NCT02268279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110975292|NCT02268357|Propranolol|propranolol|mesh-list
110975293|NCT02268357|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110975294|NCT02268357|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110975295|NCT02268357|Adrenergic Agents|adrenergic agents|mesh-ancestor
110975296|NCT02268357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111491544|NCT05850546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111491545|NCT05850546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111491546|NCT05850546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110975297|NCT02268357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110975298|NCT02268357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110975299|NCT02268357|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110975300|NCT02268357|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110975301|NCT02268357|Vasodilator Agents|vasodilator agents|mesh-ancestor
110975302|NCT02268435|Imatinib Mesylate|imatinib mesylate|mesh-list
110975303|NCT02268435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110975304|NCT02268435|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110975305|NCT02268435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110975306|NCT02268435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110975307|NCT02466464|Polyvinyl alcohol formaldehyde foam|polyvinyl alcohol formaldehyde foam|mesh-list
110975308|NCT02466464|Hemostatics|hemostatics|mesh-ancestor
110975309|NCT02466464|Coagulants|coagulants|mesh-ancestor
110975310|NCT01423149|Fosbretabulin|fosbretabulin|mesh-list
110975311|NCT01423149|Combretastatin|combretastatin|mesh-list
110975312|NCT01423149|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110975313|NCT01423149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110975314|NCT01423149|Tubulin Modulators|tubulin modulators|mesh-ancestor
110975315|NCT01423149|Antimitotic Agents|antimitotic agents|mesh-ancestor
110975316|NCT01423149|Mitosis Modulators|mitosis modulators|mesh-ancestor
110975317|NCT01423149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110975318|NCT03470454|Linagliptin|linagliptin|mesh-list
110975319|NCT03470454|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110975320|NCT03470454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110975321|NCT03470454|Incretins|incretins|mesh-ancestor
110975322|NCT03470454|Hormones|hormones|mesh-ancestor
110975323|NCT03470454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110975324|NCT03470454|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110975325|NCT03470454|Protease Inhibitors|protease inhibitors|mesh-ancestor
110975326|NCT03470454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110975327|NCT03470454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110975328|NCT03130842|Midazolam|midazolam|mesh-list
110975329|NCT03130842|Alprazolam|alprazolam|mesh-list
110975330|NCT03130842|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110975331|NCT03130842|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110975332|NCT03130842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110975333|NCT03130842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110975334|NCT03130842|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110975335|NCT03130842|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110975336|NCT03130842|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110975337|NCT03130842|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110975338|NCT03130842|Anesthetics, General|anesthetics, general|mesh-ancestor
110975339|NCT03130842|Anesthetics|anesthetics|mesh-ancestor
110975340|NCT03130842|GABA Modulators|gaba modulators|mesh-ancestor
110975341|NCT03130842|GABA Agents|gaba agents|mesh-ancestor
110975342|NCT03130842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110975343|NCT03130842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110975344|NCT03130764|Durvalumab|durvalumab|mesh-list
110975345|NCT03130764|Tremelimumab|tremelimumab|mesh-list
110975346|NCT03130764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110975347|NCT03130764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110975348|NCT01234779|Olanzapine|olanzapine|mesh-list
110975349|NCT01234779|Antiemetics|antiemetics|mesh-ancestor
110975350|NCT01234779|Autonomic Agents|autonomic agents|mesh-ancestor
110975351|NCT01234779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110975352|NCT01234779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110975353|NCT01234779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110975354|NCT01234779|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110975355|NCT01234779|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110975356|NCT01234779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110975357|NCT01234779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110975358|NCT01234779|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110975359|NCT01234779|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110975360|NCT01234779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110975361|NCT01234779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110975362|NCT01234779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110975363|NCT01234779|Serotonin Agents|serotonin agents|mesh-ancestor
110975364|NCT03223350|Capsaicin|capsaicin|mesh-list
110975365|NCT03223350|Antipruritics|antipruritics|mesh-ancestor
110975366|NCT03223350|Dermatologic Agents|dermatologic agents|mesh-ancestor
110975367|NCT03223350|Sensory System Agents|sensory system agents|mesh-ancestor
110479630|NCT00915694|Nelfinavir|nelfinavir|mesh-list
110975368|NCT03223350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110975369|NCT03223350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111491547|NCT05850546|Glucocorticoids|glucocorticoids|mesh-ancestor
111491548|NCT05850546|Hormones|hormones|mesh-ancestor
110975370|NCT03306368|Analgesics, Opioid|analgesics, opioid|mesh-list
110975371|NCT03306368|Narcotics|narcotics|mesh-ancestor
110975372|NCT03306368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110975373|NCT03306368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110975374|NCT03306368|Analgesics|analgesics|mesh-ancestor
110975375|NCT03306368|Sensory System Agents|sensory system agents|mesh-ancestor
110975376|NCT03306368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110975377|NCT02840136|Meropenem|meropenem|mesh-list
110975378|NCT02840136|Tazobactam|tazobactam|mesh-list
110975379|NCT02840136|Piperacillin|piperacillin|mesh-list
110975380|NCT02840136|Ceftazidime|ceftazidime|mesh-list
110975381|NCT02840136|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
110975382|NCT02840136|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110975383|NCT02840136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110975384|NCT02840136|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110975385|NCT02840136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110975386|NCT02840136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110975387|NCT03306290|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110975388|NCT03306290|Cefoxitin|cefoxitin|mesh-list
110975389|NCT03306290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110975390|NCT01616199|Vemurafenib|vemurafenib|mesh-list
110975391|NCT01616199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110975392|NCT01616199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110975393|NCT01616199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110975394|NCT01616199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110975395|NCT03306212|Botulinum Toxins|botulinum toxins|mesh-list
110975396|NCT03306212|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110975397|NCT03306212|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110975398|NCT03306212|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110975399|NCT03306212|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110975400|NCT03306212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110975401|NCT03306212|Cholinergic Agents|cholinergic agents|mesh-ancestor
110975402|NCT03306212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110975403|NCT03306212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110975404|NCT03306212|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110975405|NCT03306212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110975406|NCT04506138|Paclitaxel|paclitaxel|mesh-list
110975407|NCT04506138|Carboplatin|carboplatin|mesh-list
110975408|NCT04506138|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110975409|NCT04506138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110975410|NCT04506138|Tubulin Modulators|tubulin modulators|mesh-ancestor
110975411|NCT04506138|Antimitotic Agents|antimitotic agents|mesh-ancestor
110975412|NCT04506138|Mitosis Modulators|mitosis modulators|mesh-ancestor
110975413|NCT04506138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110975414|NCT01407003|Licogliflozin|licogliflozin|mesh-list
110975415|NCT01407003|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110975416|NCT01407003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110975417|NCT01407003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110975418|NCT01407003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110975419|NCT05346302|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110975420|NCT05346302|Immunologic Factors|immunologic factors|mesh-ancestor
110975421|NCT05346302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110975422|NCT01232595|Vancomycin|vancomycin|mesh-list
110975423|NCT01232595|LFF571|lff571|mesh-list
110975424|NCT01232595|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110975425|NCT01232595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110975426|NCT01231347|Gemcitabine|gemcitabine|mesh-list
110975427|NCT01231347|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110975428|NCT01231347|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110975429|NCT01231347|Antimetabolites|antimetabolites|mesh-ancestor
110975430|NCT01231347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110975431|NCT01231347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110975432|NCT01231347|Immunologic Factors|immunologic factors|mesh-ancestor
110975433|NCT01231347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110975434|NCT01230957|Vaccines|vaccines|mesh-list
110975435|NCT01230957|Immunologic Factors|immunologic factors|mesh-ancestor
110975436|NCT01230957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110975437|NCT01228383|Vaccines|vaccines|mesh-list
110975438|NCT01228383|Antibodies|antibodies|mesh-list
110975439|NCT01228383|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110975440|NCT01228383|Immunoglobulins|immunoglobulins|mesh-list
110975441|NCT01228383|gamma-Globulins|gamma-globulins|mesh-list
110975442|NCT01228383|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110975443|NCT01228383|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
111491549|NCT05850546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111491550|NCT05850546|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110975444|NCT01228383|Immunologic Factors|immunologic factors|mesh-ancestor
111491551|NCT05839951|Trifluridine|trifluridine|mesh-list
110975445|NCT01228383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110975446|NCT03305978|Ivermectin|ivermectin|mesh-list
110975447|NCT03305978|Selamectin|selamectin|mesh-list
110692528|NCT01048983|Dopamine Agents|dopamine agents|mesh-ancestor
110975448|NCT03305978|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110975449|NCT03305978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110975450|NCT01594983|Fenofibrate|fenofibrate|mesh-list
110975451|NCT01594983|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110975452|NCT01594983|Antimetabolites|antimetabolites|mesh-ancestor
110975453|NCT01594983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110975454|NCT01594983|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110975455|NCT03305510|Vitamin D|vitamin d|mesh-list
110975456|NCT03305510|Vitamins|vitamins|mesh-ancestor
110975457|NCT03305510|Micronutrients|micronutrients|mesh-ancestor
110975458|NCT03305510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110975459|NCT03305510|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110975460|NCT01224795|Peramivir|peramivir|mesh-list
110975461|NCT01224795|Antiviral Agents|antiviral agents|mesh-ancestor
110975462|NCT01224795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110975463|NCT01224795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110975464|NCT01224795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110975465|NCT01402401|Trastuzumab|trastuzumab|mesh-list
110975466|NCT01402401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110975467|NCT01402401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110975468|NCT02720510|Dexamethasone|dexamethasone|mesh-list
110975469|NCT02720510|Lenalidomide|lenalidomide|mesh-list
110975470|NCT02720510|Bortezomib|bortezomib|mesh-list
110975471|NCT02720510|Panobinostat|panobinostat|mesh-list
110975472|NCT02720510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110975473|NCT02720510|Antiemetics|antiemetics|mesh-ancestor
110975474|NCT02720510|Autonomic Agents|autonomic agents|mesh-ancestor
110975475|NCT02720510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110975476|NCT02720510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110975477|NCT02720510|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110975478|NCT02720510|Glucocorticoids|glucocorticoids|mesh-ancestor
110975479|NCT02720510|Hormones|hormones|mesh-ancestor
110975480|NCT02720510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110975481|NCT02720510|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110975482|NCT02720510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110975483|NCT02720510|Immunologic Factors|immunologic factors|mesh-ancestor
110975484|NCT02720510|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110975485|NCT02720510|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110975486|NCT02720510|Growth Substances|growth substances|mesh-ancestor
110975487|NCT02720510|Growth Inhibitors|growth inhibitors|mesh-ancestor
110975488|NCT02720510|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110975489|NCT02720510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110975490|NCT02720510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110975491|NCT01220271|Temozolomide|temozolomide|mesh-list
110975492|NCT01220271|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110975493|NCT01220271|Alkylating Agents|alkylating agents|mesh-ancestor
110975494|NCT01220271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110975495|NCT01220271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110975496|NCT02468102|Rivaroxaban|rivaroxaban|mesh-list
110975497|NCT02468102|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110975498|NCT02468102|Antithrombins|antithrombins|mesh-ancestor
110975499|NCT02468102|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110975500|NCT02468102|Protease Inhibitors|protease inhibitors|mesh-ancestor
110975501|NCT02468102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110975502|NCT02468102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110975503|NCT02468102|Anticoagulants|anticoagulants|mesh-ancestor
110975504|NCT01205061|Lidocaine|lidocaine|mesh-list
110975505|NCT01205061|Anesthetics, Local|anesthetics, local|mesh-ancestor
110975506|NCT01205061|Anesthetics|anesthetics|mesh-ancestor
110975507|NCT01205061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110975508|NCT01205061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110975509|NCT01205061|Sensory System Agents|sensory system agents|mesh-ancestor
110975510|NCT01205061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110975511|NCT01205061|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111491552|NCT05839951|Bevacizumab|bevacizumab|mesh-list
111491553|NCT05839951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111491554|NCT05839951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110975512|NCT01205061|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110975513|NCT01205061|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110975514|NCT01205061|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111119104|NCT05362318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111491555|NCT05839951|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111491556|NCT05839951|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110975515|NCT01205061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111491557|NCT05839951|Growth Substances|growth substances|mesh-ancestor
111491558|NCT05839951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111491559|NCT05839951|Growth Inhibitors|growth inhibitors|mesh-ancestor
111491560|NCT05839951|Antimetabolites|antimetabolites|mesh-ancestor
111491561|NCT05839951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111491562|NCT05839951|Antiviral Agents|antiviral agents|mesh-ancestor
111491563|NCT05839951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111491564|NCT05833529|Cocaine|cocaine|mesh-list
110975516|NCT01204749|Paclitaxel|paclitaxel|mesh-list
110975517|NCT01204749|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110975518|NCT01204749|Trebananib|trebananib|mesh-list
110975519|NCT01204749|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
110975520|NCT01204749|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110975521|NCT01204749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110975522|NCT01204749|Tubulin Modulators|tubulin modulators|mesh-ancestor
110975523|NCT01204749|Antimitotic Agents|antimitotic agents|mesh-ancestor
110975524|NCT01204749|Mitosis Modulators|mitosis modulators|mesh-ancestor
110975525|NCT01204749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110975526|NCT01204749|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110975527|NCT01204749|Growth Substances|growth substances|mesh-ancestor
110975528|NCT01204749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110975529|NCT01204749|Growth Inhibitors|growth inhibitors|mesh-ancestor
110975530|NCT02466698|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110975531|NCT02466698|Metronidazole|metronidazole|mesh-list
110975532|NCT02466698|Vancomycin|vancomycin|mesh-list
110975533|NCT02466698|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
110975534|NCT02466698|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
110975535|NCT02466698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110975536|NCT02466698|Antitubercular Agents|antitubercular agents|mesh-ancestor
110975537|NCT02466698|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110975538|NCT02466698|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110975539|NCT02466698|Laxatives|laxatives|mesh-ancestor
110975540|NCT02466698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110975541|NCT02720198|Milnacipran|milnacipran|mesh-list
110975542|NCT02720198|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110975543|NCT02720198|Levomilnacipran|levomilnacipran|mesh-list
110975544|NCT02720198|Antidepressive Agents|antidepressive agents|mesh-ancestor
110975545|NCT02720198|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110975546|NCT02720198|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110975547|NCT02720198|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110975548|NCT02720198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110975549|NCT02720198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110975550|NCT02720198|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110975551|NCT02720198|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110479648|NCT00785512|Nebivolol|nebivolol|mesh-list
110975552|NCT02720198|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110975553|NCT02720198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110975554|NCT02720198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110975555|NCT02720198|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110975556|NCT02720198|Analgesics|analgesics|mesh-ancestor
110975557|NCT02720198|Sensory System Agents|sensory system agents|mesh-ancestor
110975558|NCT02720198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110975559|NCT01193361|Interferons|interferons|mesh-list
110975560|NCT01193361|Ribavirin|ribavirin|mesh-list
110975561|NCT01193361|Interferon-alpha|interferon-alpha|mesh-list
110975562|NCT01193361|Interferon alpha-2|interferon alpha-2|mesh-list
110975563|NCT01193361|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110975564|NCT01193361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110975565|NCT01193361|Antiviral Agents|antiviral agents|mesh-ancestor
110975566|NCT01193361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110975567|NCT01193361|Antimetabolites|antimetabolites|mesh-ancestor
110975568|NCT01193361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110975569|NCT01193361|Immunologic Factors|immunologic factors|mesh-ancestor
110975570|NCT01193361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110975571|NCT02263677|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110975572|NCT02263677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110975573|NCT02263677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110975574|NCT02263677|Incretins|incretins|mesh-ancestor
110975575|NCT02263677|Hormones|hormones|mesh-ancestor
110975576|NCT02263677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110975577|NCT02263677|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110975578|NCT02263677|Protease Inhibitors|protease inhibitors|mesh-ancestor
110975579|NCT02263677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111491565|NCT05833529|Anesthetics, Local|anesthetics, local|mesh-ancestor
110975580|NCT02263677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110975582|NCT01390545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110975583|NCT01591473|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
110975584|NCT01591473|Poly I-C|poly i-c|mesh-list
110975585|NCT01591473|Antiviral Agents|antiviral agents|mesh-ancestor
110975586|NCT01591473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110975587|NCT01591473|Interferon Inducers|interferon inducers|mesh-ancestor
110975588|NCT01591473|Immunologic Factors|immunologic factors|mesh-ancestor
110975589|NCT01591473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110975590|NCT01192035|Ritonavir|ritonavir|mesh-list
110975591|NCT01192035|Lopinavir|lopinavir|mesh-list
110975592|NCT01192035|Nevirapine|nevirapine|mesh-list
110975593|NCT01192035|Efavirenz|efavirenz|mesh-list
110975594|NCT01192035|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110975595|NCT01192035|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110975596|NCT01192035|Protease Inhibitors|protease inhibitors|mesh-ancestor
110975597|NCT01192035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110975598|NCT01192035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110975599|NCT01192035|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110975600|NCT01192035|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110975601|NCT01192035|Antiviral Agents|antiviral agents|mesh-ancestor
110975602|NCT01192035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110975603|NCT01192035|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110975604|NCT01192035|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110975605|NCT01192035|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110975606|NCT01192035|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110975607|NCT01192035|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110975608|NCT01192035|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110975609|NCT01192035|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110975610|NCT01192035|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110975611|NCT01192035|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110975613|NCT01384383|Antiviral Agents|antiviral agents|mesh-ancestor
110975614|NCT01384383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110975615|NCT01557777|Navitoclax|navitoclax|mesh-list
110975616|NCT01557777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110975617|NCT02268825|Pembrolizumab|pembrolizumab|mesh-list
110975618|NCT02268825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110975619|NCT02268825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110975620|NCT02268825|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110975621|NCT02268825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110975622|NCT01381731|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110975623|NCT01381731|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110975624|NCT02268903|Furosemide|furosemide|mesh-list
110975625|NCT02268903|Diuretics|diuretics|mesh-list
110975626|NCT02268903|Natriuretic Agents|natriuretic agents|mesh-ancestor
110975627|NCT02268903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110975628|NCT02268903|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110975629|NCT02268903|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110975630|NCT02268903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110975631|NCT01369095|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110975632|NCT01369095|Escitalopram|escitalopram|mesh-list
110975633|NCT01369095|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110975634|NCT01369095|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110975635|NCT01369095|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110975636|NCT01369095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110975637|NCT01369095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110975638|NCT01369095|Serotonin Agents|serotonin agents|mesh-ancestor
110975639|NCT01369095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110975640|NCT01369095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110975641|NCT01369095|Antidepressive Agents|antidepressive agents|mesh-ancestor
110975642|NCT01369095|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110975643|NCT01369095|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110975644|NCT01369095|Analgesics|analgesics|mesh-ancestor
110975645|NCT01369095|Sensory System Agents|sensory system agents|mesh-ancestor
110975646|NCT01369095|Dopamine Agents|dopamine agents|mesh-ancestor
110975647|NCT02266173|Pertuzumab|pertuzumab|mesh-list
110975648|NCT02266173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110975649|NCT02266173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111491566|NCT05833529|Anesthetics|anesthetics|mesh-ancestor
111491567|NCT05833529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111491568|NCT05833529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111491569|NCT05833529|Sensory System Agents|sensory system agents|mesh-ancestor
111491570|NCT05833529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111491571|NCT05833529|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110975650|NCT01168713|Levofloxacin|levofloxacin|mesh-list
110975651|NCT01168713|Solithromycin|solithromycin|mesh-list
110975652|NCT01168713|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110975653|NCT01168713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110975654|NCT01168713|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110975655|NCT01168713|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110975656|NCT01168713|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110975657|NCT01168713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110975658|NCT01168713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110975659|NCT01168713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110975660|NCT01168713|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110975661|NCT01168713|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110975662|NCT02269293|Paclitaxel|paclitaxel|mesh-list
110975663|NCT02269293|Carboplatin|carboplatin|mesh-list
110975664|NCT02269293|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110975665|NCT02269293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110975666|NCT02269293|Tubulin Modulators|tubulin modulators|mesh-ancestor
110975667|NCT02269293|Antimitotic Agents|antimitotic agents|mesh-ancestor
110975668|NCT02269293|Mitosis Modulators|mitosis modulators|mesh-ancestor
110975669|NCT02269293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110975670|NCT01545453|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110975671|NCT01545453|Immunologic Factors|immunologic factors|mesh-ancestor
110975672|NCT01545453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110975673|NCT01366131|Paclitaxel|paclitaxel|mesh-list
110975674|NCT01366131|Bevacizumab|bevacizumab|mesh-list
110975675|NCT01366131|Carboplatin|carboplatin|mesh-list
110975676|NCT01366131|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110975677|NCT01366131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110975678|NCT01366131|Tubulin Modulators|tubulin modulators|mesh-ancestor
110975679|NCT01366131|Antimitotic Agents|antimitotic agents|mesh-ancestor
110975680|NCT01366131|Mitosis Modulators|mitosis modulators|mesh-ancestor
110975681|NCT01366131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110975682|NCT01366131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110975683|NCT01366131|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110975684|NCT01366131|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110975685|NCT01366131|Growth Substances|growth substances|mesh-ancestor
110975686|NCT01366131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110975687|NCT01366131|Growth Inhibitors|growth inhibitors|mesh-ancestor
110975688|NCT01365195|Ketamine|ketamine|mesh-list
110975689|NCT01365195|Analgesics|analgesics|mesh-ancestor
110975690|NCT01365195|Sensory System Agents|sensory system agents|mesh-ancestor
110975691|NCT01365195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110975692|NCT01365195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110975693|NCT01365195|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110975694|NCT01365195|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110975695|NCT01365195|Anesthetics, General|anesthetics, general|mesh-ancestor
110975696|NCT01365195|Anesthetics|anesthetics|mesh-ancestor
110975697|NCT01365195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110975698|NCT01365195|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110975699|NCT01365195|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110975700|NCT01365195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110975701|NCT01365195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110975702|NCT02269449|Hemostatics|hemostatics|mesh-list
110975703|NCT02269449|Coagulants|coagulants|mesh-ancestor
110975704|NCT01160601|Paclitaxel|paclitaxel|mesh-list
110975705|NCT01160601|Carboplatin|carboplatin|mesh-list
110975706|NCT01160601|Bavituximab|bavituximab|mesh-list
110975707|NCT01160601|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110975708|NCT01160601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110975709|NCT01160601|Tubulin Modulators|tubulin modulators|mesh-ancestor
110975710|NCT01160601|Antimitotic Agents|antimitotic agents|mesh-ancestor
110975711|NCT01160601|Mitosis Modulators|mitosis modulators|mesh-ancestor
110975712|NCT01160601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110975713|NCT01160601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110975714|NCT02269605|Bryostatin 1|bryostatin 1|mesh-list
110975715|NCT02269605|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110975716|NCT02269605|Immunologic Factors|immunologic factors|mesh-ancestor
110975717|NCT02269605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110975718|NCT02269605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111491572|NCT05833529|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110975719|NCT01356849|Atrasentan|atrasentan|mesh-list
111119105|NCT05362318|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111491573|NCT05833529|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111491574|NCT05833529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110975721|NCT01356849|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
110975722|NCT01356849|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
110975723|NCT01356849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110975724|NCT02266485|Pravastatin|pravastatin|mesh-list
110975725|NCT02266485|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110975726|NCT02266485|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110975727|NCT02266485|Antimetabolites|antimetabolites|mesh-ancestor
110975728|NCT02266485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110975729|NCT02266485|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110975730|NCT02266485|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110975731|NCT02266485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110975732|NCT02263989|Telmisartan|telmisartan|mesh-list
110975733|NCT02263989|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110975734|NCT02263989|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110975735|NCT02263989|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110975736|NCT02263989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110975737|NCT01516203|Rifampin|rifampin|mesh-list
110975738|NCT01516203|Isoniazid|isoniazid|mesh-list
110975739|NCT01516203|Pyrazinamide|pyrazinamide|mesh-list
110975740|NCT01516203|Ethambutol|ethambutol|mesh-list
110975741|NCT01516203|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110975742|NCT01516203|Antitubercular Agents|antitubercular agents|mesh-ancestor
110975743|NCT01516203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110975744|NCT01516203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110975745|NCT01516203|Leprostatic Agents|leprostatic agents|mesh-ancestor
110975746|NCT01516203|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110975747|NCT01516203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110975748|NCT01516203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110975749|NCT01516203|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110975750|NCT01516203|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110975751|NCT01516203|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110975752|NCT01516203|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110975753|NCT01516203|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110975754|NCT01516203|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110975755|NCT01516203|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
110975756|NCT01516203|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110975757|NCT01516203|Antimetabolites|antimetabolites|mesh-ancestor
110975758|NCT01516203|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110975759|NCT01321359|5-((2-(6-Amino-9H-purin-9-yl) ethyl) amino)-1-pentanol|5-((2-(6-amino-9h-purin-9-yl) ethyl) amino)-1-pentanol|mesh-list
110975760|NCT01321359|Adenylyl Cyclase Inhibitors|adenylyl cyclase inhibitors|mesh-ancestor
110975761|NCT01321359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110975762|NCT01321359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110975764|NCT00703118|Interferon alpha-2|interferon alpha-2|mesh-list
110975765|NCT00703118|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110975766|NCT00703118|Antimetabolites|antimetabolites|mesh-ancestor
110975767|NCT00703118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110975768|NCT00703118|Antiviral Agents|antiviral agents|mesh-ancestor
110975769|NCT00703118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110975770|NCT00703118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110975771|NCT01510119|Hydroxychloroquine|hydroxychloroquine|mesh-list
110975772|NCT01510119|Everolimus|everolimus|mesh-list
110975773|NCT01510119|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110975774|NCT01510119|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110975775|NCT01510119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110975776|NCT01510119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110975777|NCT01510119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110975778|NCT01510119|Immunologic Factors|immunologic factors|mesh-ancestor
110975779|NCT01510119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110975780|NCT01510119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110975781|NCT01510119|Antimalarials|antimalarials|mesh-ancestor
110975782|NCT01510119|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110975783|NCT01510119|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110975784|NCT01510119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110975785|NCT01510119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110975786|NCT01150695|Vaccines|vaccines|mesh-list
110975787|NCT01150695|Immunologic Factors|immunologic factors|mesh-ancestor
110975788|NCT01150695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110975789|NCT01302249|Timolol|timolol|mesh-list
110975790|NCT01302249|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110975792|NCT01302249|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110975793|NCT01302249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110975794|NCT01302249|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110975795|NCT01302249|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110975796|NCT01302249|Adrenergic Agents|adrenergic agents|mesh-ancestor
110975797|NCT01302249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110975798|NCT01302249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110975799|NCT01302249|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110975800|NCT01302249|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110975801|NCT02261636|Mesalamine|mesalamine|mesh-list
110975802|NCT02261636|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110975803|NCT02261636|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110975804|NCT02261636|Analgesics|analgesics|mesh-ancestor
110975805|NCT02261636|Sensory System Agents|sensory system agents|mesh-ancestor
110975806|NCT02261636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110975807|NCT02261636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110975808|NCT02261636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110975809|NCT02261636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110975810|NCT05191706|Dexamethasone|dexamethasone|mesh-list
110975811|NCT05191706|Prednisolone|prednisolone|mesh-list
110975812|NCT05191706|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110975813|NCT05191706|Methylprednisolone|methylprednisolone|mesh-list
110975814|NCT05191706|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110975815|NCT05191706|Prednisolone acetate|prednisolone acetate|mesh-list
110975816|NCT05191706|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110975817|NCT05191706|Prednisolone phosphate|prednisolone phosphate|mesh-list
110975818|NCT05191706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110975819|NCT05191706|Antiemetics|antiemetics|mesh-ancestor
110975820|NCT05191706|Autonomic Agents|autonomic agents|mesh-ancestor
110479671|NCT02702739|Ribavirin|ribavirin|mesh-list
110975821|NCT05191706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110975822|NCT05191706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110692898|NCT05357885|Antibodies|antibodies|mesh-list
110975823|NCT05191706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110975824|NCT05191706|Glucocorticoids|glucocorticoids|mesh-ancestor
110975825|NCT05191706|Hormones|hormones|mesh-ancestor
110975826|NCT05191706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110975827|NCT05191706|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110975828|NCT05191706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110975829|NCT05191706|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110975830|NCT05191706|Protective Agents|protective agents|mesh-ancestor
110975831|NCT01493505|Paclitaxel|paclitaxel|mesh-list
110975832|NCT01493505|Carboplatin|carboplatin|mesh-list
110975833|NCT01493505|Trebananib|trebananib|mesh-list
110975834|NCT01493505|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110975835|NCT01493505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110975836|NCT01493505|Tubulin Modulators|tubulin modulators|mesh-ancestor
110975837|NCT01493505|Antimitotic Agents|antimitotic agents|mesh-ancestor
110975838|NCT01493505|Mitosis Modulators|mitosis modulators|mesh-ancestor
110975839|NCT01493505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110975840|NCT01493505|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110975841|NCT01493505|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110975842|NCT01493505|Growth Substances|growth substances|mesh-ancestor
110975843|NCT01493505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110975844|NCT01493505|Growth Inhibitors|growth inhibitors|mesh-ancestor
110975845|NCT01301157|Calcipotriene|calcipotriene|mesh-list
110975846|NCT01301157|Dermatologic Agents|dermatologic agents|mesh-ancestor
110975847|NCT02264145|Norflurane|norflurane|mesh-list
110975848|NCT02264145|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110975849|NCT02264145|Anesthetics|anesthetics|mesh-ancestor
110975850|NCT02264145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110975851|NCT02264145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110975852|NCT02264301|Puerarin|puerarin|mesh-list
110975853|NCT02264301|Vasodilator Agents|vasodilator agents|mesh-ancestor
110975854|NCT02267109|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
110975855|NCT02267109|Antiviral Agents|antiviral agents|mesh-ancestor
110975856|NCT02267109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110975857|NCT04476069|Ibuprofen|ibuprofen|mesh-list
110975858|NCT04476069|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110975859|NCT04476069|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110975860|NCT04476069|Analgesics|analgesics|mesh-ancestor
110975861|NCT04476069|Sensory System Agents|sensory system agents|mesh-ancestor
110975862|NCT04476069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110975863|NCT04476069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110975864|NCT04476069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111491575|NCT05833529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110975865|NCT04476069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110975866|NCT04476069|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110975867|NCT04476069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110975868|NCT04476069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110975869|NCT01480479|Temozolomide|temozolomide|mesh-list
110975870|NCT01480479|Molgramostim|molgramostim|mesh-list
110975871|NCT01480479|Rindopepimut|rindopepimut|mesh-list
110975872|NCT01480479|Sargramostim|sargramostim|mesh-list
110975873|NCT01480479|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110975874|NCT01480479|Alkylating Agents|alkylating agents|mesh-ancestor
110975875|NCT01480479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110975876|NCT01480479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110975877|NCT01480479|Immunologic Factors|immunologic factors|mesh-ancestor
110975878|NCT01480479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110975879|NCT01480479|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110975880|NCT01116141|Folic Acid|folic acid|mesh-list
110975881|NCT01116141|Methotrexate|methotrexate|mesh-list
110975882|NCT01116141|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110975883|NCT01116141|Abortifacient Agents|abortifacient agents|mesh-ancestor
110975884|NCT01116141|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110975885|NCT01116141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110975886|NCT01116141|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110975887|NCT01116141|Antimetabolites|antimetabolites|mesh-ancestor
110975888|NCT01116141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110975889|NCT01116141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110975890|NCT01116141|Dermatologic Agents|dermatologic agents|mesh-ancestor
110975891|NCT01116141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110975892|NCT01116141|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110975893|NCT01116141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110975894|NCT01116141|Immunologic Factors|immunologic factors|mesh-ancestor
110975895|NCT01116141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110975896|NCT01116141|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110975897|NCT01116141|Hematinics|hematinics|mesh-ancestor
110975898|NCT01116141|Vitamin B Complex|vitamin b complex|mesh-ancestor
110975899|NCT01116141|Vitamins|vitamins|mesh-ancestor
110975900|NCT01116141|Micronutrients|micronutrients|mesh-ancestor
110975901|NCT01280565|Dacarbazine|dacarbazine|mesh-list
110975902|NCT01280565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110975903|NCT01280565|Alkylating Agents|alkylating agents|mesh-ancestor
110975904|NCT01280565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110975905|NCT01280565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110975906|NCT05627739|Mycophenolic Acid|mycophenolic acid|mesh-list
110975907|NCT05627739|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110975908|NCT05627739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110975909|NCT05627739|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110975910|NCT05627739|Antitubercular Agents|antitubercular agents|mesh-ancestor
110975911|NCT05627739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110975912|NCT05627739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110975913|NCT05627739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110975914|NCT05627739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110975915|NCT01113957|Doxorubicin|doxorubicin|mesh-list
110975916|NCT01113957|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110975917|NCT01113957|Temozolomide|temozolomide|mesh-list
110975918|NCT01113957|Veliparib|veliparib|mesh-list
110975919|NCT01113957|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110975920|NCT01113957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110975921|NCT01113957|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110975922|NCT01113957|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110975923|NCT01113957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110975924|NCT01113957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110975925|NCT01113957|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110975926|NCT01113957|Alkylating Agents|alkylating agents|mesh-ancestor
110975927|NCT01113957|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110975928|NCT01111773|Lidocaine|lidocaine|mesh-list
110975929|NCT01111773|Tetracaine|tetracaine|mesh-list
110975930|NCT01111773|Anesthetics, Local|anesthetics, local|mesh-ancestor
110975931|NCT01111773|Anesthetics|anesthetics|mesh-ancestor
110975932|NCT01111773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110975933|NCT01111773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110975934|NCT01111773|Sensory System Agents|sensory system agents|mesh-ancestor
110975935|NCT01111773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110975936|NCT01111773|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111491576|NCT05833529|Dopamine Agents|dopamine agents|mesh-ancestor
111119106|NCT05362318|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110975937|NCT01111773|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110975938|NCT01111773|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110975939|NCT01111773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110975940|NCT01111773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110975941|NCT01280331|Morphine|morphine|mesh-list
110975942|NCT01280331|Oxycodone|oxycodone|mesh-list
110975943|NCT01280331|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110975944|NCT01280331|Narcotics|narcotics|mesh-ancestor
110975945|NCT01280331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110975946|NCT01280331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110975947|NCT01280331|Analgesics|analgesics|mesh-ancestor
110975948|NCT01280331|Sensory System Agents|sensory system agents|mesh-ancestor
110975949|NCT01280331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110975950|NCT01266525|Donepezil|donepezil|mesh-list
110975951|NCT01266525|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110975952|NCT01266525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110975953|NCT01266525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110975954|NCT01266525|Cholinergic Agents|cholinergic agents|mesh-ancestor
110975955|NCT01266525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110975956|NCT01266525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110975957|NCT01266525|Nootropic Agents|nootropic agents|mesh-ancestor
110975958|NCT01265901|Cyclophosphamide|cyclophosphamide|mesh-list
110975959|NCT01265901|Sunitinib|sunitinib|mesh-list
110975960|NCT01265901|Molgramostim|molgramostim|mesh-list
110975961|NCT01265901|Sargramostim|sargramostim|mesh-list
110975962|NCT01265901|Immunologic Factors|immunologic factors|mesh-ancestor
110975963|NCT01265901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110975964|NCT01265901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110975965|NCT01265901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110975966|NCT01265901|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110975967|NCT01265901|Alkylating Agents|alkylating agents|mesh-ancestor
110975968|NCT01265901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110975969|NCT01265901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110975970|NCT01265901|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110975971|NCT01265901|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110975972|NCT01265901|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110975973|NCT01265901|Growth Substances|growth substances|mesh-ancestor
110975974|NCT01265901|Growth Inhibitors|growth inhibitors|mesh-ancestor
110975975|NCT01265901|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110975976|NCT01265901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110975977|NCT05231382|Leucovorin|leucovorin|mesh-list
110975978|NCT05231382|Fluorouracil|fluorouracil|mesh-list
110975979|NCT05231382|Raltitrexed|raltitrexed|mesh-list
110975980|NCT05231382|Oxaliplatin|oxaliplatin|mesh-list
110975981|NCT05231382|Antimetabolites|antimetabolites|mesh-ancestor
110975982|NCT05231382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110975983|NCT05231382|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110975984|NCT05231382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110975985|NCT05231382|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110975986|NCT05231382|Immunologic Factors|immunologic factors|mesh-ancestor
110975987|NCT05231382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110975988|NCT05231382|Antidotes|antidotes|mesh-ancestor
110975989|NCT05231382|Protective Agents|protective agents|mesh-ancestor
110975990|NCT05231382|Vitamin B Complex|vitamin b complex|mesh-ancestor
110975991|NCT05231382|Vitamins|vitamins|mesh-ancestor
110975992|NCT05231382|Micronutrients|micronutrients|mesh-ancestor
110975993|NCT05231382|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110975994|NCT05231382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110975995|NCT01262235|TKM-080301|tkm-080301|mesh-list
110975996|NCT01262235|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110975997|NCT01262235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110975998|NCT01262235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110975999|NCT01262001|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110976000|NCT01262001|Immunologic Factors|immunologic factors|mesh-ancestor
110976001|NCT01262001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110976002|NCT01460511|Epinephrine|epinephrine|mesh-list
110976003|NCT01460511|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110976004|NCT01460511|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110976005|NCT01460511|Adrenergic Agents|adrenergic agents|mesh-ancestor
110976006|NCT01460511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110976007|NCT01460511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110976008|NCT01460511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110976009|NCT01460511|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111491577|NCT05833529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111491578|NCT05799612|Interferons|interferons|mesh-list
110976010|NCT01460511|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110976011|NCT01460511|Autonomic Agents|autonomic agents|mesh-ancestor
110976012|NCT01460511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110976013|NCT01460511|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110976014|NCT01460511|Respiratory System Agents|respiratory system agents|mesh-ancestor
110976015|NCT01460511|Mydriatics|mydriatics|mesh-ancestor
110976016|NCT01460511|Sympathomimetics|sympathomimetics|mesh-ancestor
110976017|NCT01460511|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110976018|NCT03135171|Trastuzumab|trastuzumab|mesh-list
110976020|NCT03135171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110976021|NCT03135171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110976022|NCT01449591|Metronidazole|metronidazole|mesh-list
110976023|NCT01449591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110976024|NCT01449591|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110976025|NCT01449591|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110976026|NCT01449591|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110976027|NCT00909753|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
110976028|NCT00909753|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
110976029|NCT00909753|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110976030|NCT01444365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
110976031|NCT01444365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110976032|NCT01444365|Analgesics|analgesics|mesh-ancestor
110976033|NCT01444365|Sensory System Agents|sensory system agents|mesh-ancestor
110976034|NCT01444365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110976035|NCT01444365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110976036|NCT01444365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110976037|NCT01444365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110976038|NCT01098435|ALKS-33|alks-33|mesh-list
110976039|NCT01098435|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110976040|NCT01098435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110976041|NCT01098435|Sensory System Agents|sensory system agents|mesh-ancestor
110976042|NCT01098435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110976043|NCT00909597|Pioglitazone|pioglitazone|mesh-list
110976044|NCT00909597|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
110976045|NCT00909597|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110693126|NCT00438672|Hormones|hormones|mesh-ancestor
110976046|NCT00909597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110976047|NCT00909597|Incretins|incretins|mesh-ancestor
110976048|NCT00909597|Hormones|hormones|mesh-ancestor
110976049|NCT00909597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110976050|NCT01077297|Tezosentan|tezosentan|mesh-list
110976051|NCT01077297|Vasodilator Agents|vasodilator agents|mesh-ancestor
110976052|NCT05653245|Arginyl-glycyl-aspartic acid|arginyl-glycyl-aspartic acid|mesh-list
110976053|NCT05653245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110976054|NCT05379855|Atropine|atropine|mesh-list
110976055|NCT05379855|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110976056|NCT05379855|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110976057|NCT05379855|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110976058|NCT05379855|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110976059|NCT05379855|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110976060|NCT05379855|Autonomic Agents|autonomic agents|mesh-ancestor
110976061|NCT05379855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110976062|NCT05379855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110976063|NCT05379855|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110976064|NCT05379855|Respiratory System Agents|respiratory system agents|mesh-ancestor
110976065|NCT05379855|Mydriatics|mydriatics|mesh-ancestor
110976066|NCT05379855|Parasympatholytics|parasympatholytics|mesh-ancestor
110976067|NCT05379855|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110976068|NCT05379855|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110976069|NCT05379855|Cholinergic Agents|cholinergic agents|mesh-ancestor
110976070|NCT05379855|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110976071|NCT05379855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110976072|NCT02718326|Aflibercept|aflibercept|mesh-list
110976073|NCT02718326|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110976074|NCT02718326|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110976075|NCT02718326|Growth Substances|growth substances|mesh-ancestor
110976076|NCT02718326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110976077|NCT02718326|Growth Inhibitors|growth inhibitors|mesh-ancestor
110976078|NCT02718326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110976079|NCT03691584|Dimercaprol|dimercaprol|mesh-list
110976080|NCT03691584|Chelating Agents|chelating agents|mesh-ancestor
110976081|NCT03691584|Sequestering Agents|sequestering agents|mesh-ancestor
110976082|NCT03691584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111491579|NCT05799612|Interferon-alpha|interferon-alpha|mesh-list
111491580|NCT05799612|Interferon alpha-2|interferon alpha-2|mesh-list
110976083|NCT04655144|Dexamethasone|dexamethasone|mesh-list
110976084|NCT04655144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110976085|NCT04655144|Antiemetics|antiemetics|mesh-ancestor
111491581|NCT05799612|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110976086|NCT04655144|Autonomic Agents|autonomic agents|mesh-ancestor
110976087|NCT04655144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110976088|NCT04655144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110976089|NCT04655144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110976090|NCT04655144|Glucocorticoids|glucocorticoids|mesh-ancestor
110976091|NCT04655144|Hormones|hormones|mesh-ancestor
110976092|NCT04655144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110976093|NCT04655144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110976094|NCT04655144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110976095|NCT03468972|Immunosuppressive Agents|immunosuppressive agents|mesh-list
110976096|NCT03468972|Immunologic Factors|immunologic factors|mesh-ancestor
110976097|NCT03468972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110976098|NCT03600714|Interferons|interferons|mesh-list
110976099|NCT03600714|Ritonavir|ritonavir|mesh-list
110976100|NCT03600714|Lonafarnib|lonafarnib|mesh-list
110976101|NCT03600714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110976102|NCT03600714|Antiviral Agents|antiviral agents|mesh-ancestor
110976103|NCT03600714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110976104|NCT03600714|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110976105|NCT03600714|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110976106|NCT03600714|Protease Inhibitors|protease inhibitors|mesh-ancestor
110976107|NCT03600714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110976108|NCT03600714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110976109|NCT03600714|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110976110|NCT03600714|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110976111|NCT03600714|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110976112|NCT03600714|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110976113|NCT04590326|Cemiplimab|cemiplimab|mesh-list
110976114|NCT04590326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110976115|NCT04590326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110976116|NCT05163366|Ketamine|ketamine|mesh-list
110976117|NCT05163366|Morphine|morphine|mesh-list
110976118|NCT05163366|Analgesics|analgesics|mesh-ancestor
110976119|NCT05163366|Sensory System Agents|sensory system agents|mesh-ancestor
110976120|NCT05163366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110976121|NCT05163366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110976122|NCT05163366|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110976123|NCT05163366|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110976124|NCT05163366|Anesthetics, General|anesthetics, general|mesh-ancestor
110976125|NCT05163366|Anesthetics|anesthetics|mesh-ancestor
110976126|NCT05163366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110976127|NCT05163366|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110976128|NCT05163366|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110976129|NCT05163366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110976130|NCT05163366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110976131|NCT05163366|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110976132|NCT05163366|Narcotics|narcotics|mesh-ancestor
110976133|NCT00900783|Valacyclovir|valacyclovir|mesh-list
110976134|NCT00900783|Antiviral Agents|antiviral agents|mesh-ancestor
110976135|NCT00900783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110976136|NCT01035879|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110976137|NCT01035879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110976138|NCT01035879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110976139|NCT01035879|Incretins|incretins|mesh-ancestor
110976140|NCT01035879|Hormones|hormones|mesh-ancestor
110976141|NCT01035879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110976142|NCT01035879|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110976143|NCT01035879|Protease Inhibitors|protease inhibitors|mesh-ancestor
110976144|NCT01035879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110976145|NCT01035879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110976146|NCT01029873|Cisplatin|cisplatin|mesh-list
110976147|NCT01029873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110976148|NCT01024101|Paclitaxel|paclitaxel|mesh-list
110976149|NCT01024101|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110976150|NCT01024101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110976151|NCT01024101|Tubulin Modulators|tubulin modulators|mesh-ancestor
110976152|NCT01024101|Antimitotic Agents|antimitotic agents|mesh-ancestor
110976153|NCT01024101|Mitosis Modulators|mitosis modulators|mesh-ancestor
110976154|NCT01024101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110976155|NCT04489706|Arsenic Trioxide|arsenic trioxide|mesh-list
110976156|NCT04489706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111491582|NCT05799612|Paclitaxel|paclitaxel|mesh-list
110976157|NCT00818571|Vildagliptin|vildagliptin|mesh-list
111491583|NCT05799612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110976159|NCT00818571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110976160|NCT00818571|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110976161|NCT00818571|Protease Inhibitors|protease inhibitors|mesh-ancestor
110976162|NCT00818571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110976163|NCT00818571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110976164|NCT00818493|Acetaminophen|acetaminophen|mesh-list
110976165|NCT00818493|Morphine|morphine|mesh-list
110976166|NCT00818493|Oxycodone|oxycodone|mesh-list
110976167|NCT00818493|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110976168|NCT00818493|Narcotics|narcotics|mesh-ancestor
110976169|NCT00818493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110976170|NCT00818493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110976171|NCT00818493|Analgesics|analgesics|mesh-ancestor
110976172|NCT00818493|Sensory System Agents|sensory system agents|mesh-ancestor
110976173|NCT00818493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110976174|NCT00818493|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110976175|NCT00818493|Antipyretics|antipyretics|mesh-ancestor
110976176|NCT04455126|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110976177|NCT04455126|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110976178|NCT00893139|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110976179|NCT00893139|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110976180|NCT01378962|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110976181|NCT01378962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110976182|NCT01378962|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110976183|NCT01378962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110976184|NCT01378962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110976185|NCT00892203|Sumatriptan|sumatriptan|mesh-list
110976186|NCT00892203|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110976187|NCT00892203|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110976188|NCT00892203|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110976189|NCT00892203|Serotonin Agents|serotonin agents|mesh-ancestor
110976190|NCT00892203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110976191|NCT00892203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110976192|NCT00892203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110976193|NCT00810147|BMS 708163|bms 708163|mesh-list
110479738|NCT02603770|Lovastatin|lovastatin|mesh-list
110976194|NCT00810147|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
110976195|NCT00810147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110976196|NCT00810147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110976197|NCT04375956|Pembrolizumab|pembrolizumab|mesh-list
110976198|NCT04375956|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110976199|NCT04375956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110976200|NCT04375956|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110976201|NCT04375956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110976202|NCT04495478|Ramucirumab|ramucirumab|mesh-list
110976203|NCT04495478|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110976204|NCT04495478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110976205|NCT04495478|Immunologic Factors|immunologic factors|mesh-ancestor
110976206|NCT04495478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110976207|NCT04487444|Thymalfasin|thymalfasin|mesh-list
110976208|NCT04487444|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110976209|NCT04487444|Immunologic Factors|immunologic factors|mesh-ancestor
110976210|NCT04487444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110976211|NCT02717156|Pembrolizumab|pembrolizumab|mesh-list
110976212|NCT02717156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110976213|NCT02717156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110976214|NCT02717156|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110976215|NCT02717156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110976216|NCT00884715|Octreotide|octreotide|mesh-list
110976217|NCT00884715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110976218|NCT00884715|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110976219|NCT00884715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110976220|NCT03603080|Metformin|metformin|mesh-list
110976221|NCT03603080|Topiramate|topiramate|mesh-list
110976222|NCT03603080|Anti-Obesity Agents|anti-obesity agents|mesh-list
110976223|NCT03603080|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110976224|NCT03603080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110976225|NCT03603080|Anticonvulsants|anticonvulsants|mesh-ancestor
110976226|NCT01019187|Modafinil|modafinil|mesh-list
111491584|NCT05799612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110976227|NCT01019187|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111491585|NCT05799612|Tubulin Modulators|tubulin modulators|mesh-ancestor
111491586|NCT05799612|Antimitotic Agents|antimitotic agents|mesh-ancestor
111491587|NCT05799612|Mitosis Modulators|mitosis modulators|mesh-ancestor
111491588|NCT05799612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110976228|NCT01019187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110976229|NCT01019187|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
110976230|NCT01019187|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110976231|NCT01019187|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110976232|NCT01019187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110976234|NCT05088876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110976235|NCT05088876|Analgesics|analgesics|mesh-ancestor
110976236|NCT05088876|Sensory System Agents|sensory system agents|mesh-ancestor
110976237|NCT05088876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110976238|NCT05088876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110976239|NCT05088876|Antipyretics|antipyretics|mesh-ancestor
110976240|NCT05084508|Vaccines|vaccines|mesh-list
110976241|NCT05084508|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110976242|NCT05084508|Immunologic Factors|immunologic factors|mesh-ancestor
110976243|NCT05084508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110976244|NCT01018875|Donepezil|donepezil|mesh-list
110976245|NCT01018875|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110976246|NCT01018875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110976247|NCT01018875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110976248|NCT01018875|Cholinergic Agents|cholinergic agents|mesh-ancestor
110976249|NCT01018875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110976250|NCT01018875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110976251|NCT01018875|Nootropic Agents|nootropic agents|mesh-ancestor
110976252|NCT05390736|Vitamin D|vitamin d|mesh-list
110976253|NCT05390736|Vitamins|vitamins|mesh-ancestor
110976254|NCT05390736|Micronutrients|micronutrients|mesh-ancestor
110976255|NCT05390736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110976256|NCT05390736|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110976257|NCT00806403|Reteplase|reteplase|mesh-list
110976258|NCT00806403|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110976259|NCT00806403|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110479748|NCT04081909|Fentanyl|fentanyl|mesh-list
110976260|NCT00806403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110976261|NCT01007721|Fluticasone|fluticasone|mesh-list
110976262|NCT01007721|Xhance|xhance|mesh-list
110976263|NCT01007721|Montelukast|montelukast|mesh-list
110976264|NCT01007721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110976265|NCT01007721|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110976266|NCT01007721|Autonomic Agents|autonomic agents|mesh-ancestor
110976267|NCT01007721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110976268|NCT01007721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110976269|NCT01007721|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110976270|NCT01007721|Respiratory System Agents|respiratory system agents|mesh-ancestor
110976271|NCT01007721|Dermatologic Agents|dermatologic agents|mesh-ancestor
110976272|NCT01007721|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110976273|NCT01007721|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110976274|NCT01007721|Hormone Antagonists|hormone antagonists|mesh-ancestor
110976275|NCT01007721|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110976276|NCT01007721|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110976277|NCT01007721|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110976278|NCT01007721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110976279|NCT00701558|Gemcitabine|gemcitabine|mesh-list
110976280|NCT00701558|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110976281|NCT00701558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110976282|NCT00701558|Antimetabolites|antimetabolites|mesh-ancestor
110976283|NCT00701558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110976284|NCT00701558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110976285|NCT00701558|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110976286|NCT00701558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110976287|NCT03233828|Aldesleukin|aldesleukin|mesh-list
110976288|NCT03233828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110976289|NCT03233828|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110976290|NCT03233828|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111491589|NCT05799612|Antiviral Agents|antiviral agents|mesh-ancestor
111491590|NCT05799612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111491591|NCT05799612|Immunologic Factors|immunologic factors|mesh-ancestor
111491592|NCT05799612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111491593|NCT05776979|Lenalidomide|lenalidomide|mesh-list
111491594|NCT05776979|Immunologic Factors|immunologic factors|mesh-ancestor
111491595|NCT05776979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111491596|NCT05776979|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110976291|NCT03233828|Antiviral Agents|antiviral agents|mesh-ancestor
110976292|NCT03233828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110976293|NCT03882177|Vitamin B 6|vitamin b 6|mesh-list
110976294|NCT03882177|Pyridoxal|pyridoxal|mesh-list
111491597|NCT05776979|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111491598|NCT05776979|Growth Substances|growth substances|mesh-ancestor
111491599|NCT05776979|Growth Inhibitors|growth inhibitors|mesh-ancestor
110976295|NCT03882177|Pyridoxine|pyridoxine|mesh-list
110976296|NCT03882177|Pravastatin|pravastatin|mesh-list
110976297|NCT03882177|Vitamins|vitamins|mesh-ancestor
110976298|NCT03882177|Micronutrients|micronutrients|mesh-ancestor
110976299|NCT03882177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110976300|NCT03882177|Vitamin B Complex|vitamin b complex|mesh-ancestor
110976301|NCT03882177|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110976302|NCT03882177|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110976303|NCT03882177|Antimetabolites|antimetabolites|mesh-ancestor
110976304|NCT03882177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110976305|NCT03882177|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110976306|NCT03882177|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110976307|NCT03882177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110976308|NCT01007097|Glimepiride|glimepiride|mesh-list
110976309|NCT01007097|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110976310|NCT01007097|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110976311|NCT01007097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110976312|NCT01007097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110976313|NCT01007097|Immunologic Factors|immunologic factors|mesh-ancestor
110976314|NCT01663402|Alirocumab|alirocumab|mesh-list
110976315|NCT01663402|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
110976316|NCT01663402|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110976317|NCT01663402|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110976318|NCT01663402|Antimetabolites|antimetabolites|mesh-ancestor
110976319|NCT01663402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110976320|NCT01663402|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110976321|NCT01663402|Protease Inhibitors|protease inhibitors|mesh-ancestor
110976322|NCT01663402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110976323|NCT01663402|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110976324|NCT05115903|Adalimumab|adalimumab|mesh-list
110976325|NCT05115903|Infliximab|infliximab|mesh-list
110976326|NCT05115903|Golimumab|golimumab|mesh-list
110976327|NCT05115903|Certolizumab Pegol|certolizumab pegol|mesh-list
110976328|NCT05115903|Etanercept|etanercept|mesh-list
110976329|NCT05115903|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110976330|NCT05115903|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110976331|NCT05115903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110976332|NCT05115903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110976333|NCT05115903|Dermatologic Agents|dermatologic agents|mesh-ancestor
110976334|NCT05115903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110976335|NCT05115903|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110976336|NCT05115903|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110976337|NCT05115903|Analgesics|analgesics|mesh-ancestor
110976338|NCT05115903|Sensory System Agents|sensory system agents|mesh-ancestor
110976339|NCT05115903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110976340|NCT05115903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110976341|NCT05115903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110976342|NCT05115903|Immunologic Factors|immunologic factors|mesh-ancestor
110976343|NCT03223298|Botulinum Toxins|botulinum toxins|mesh-list
110976344|NCT03223298|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110976345|NCT03223298|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110976346|NCT03223298|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110976347|NCT03223298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110976348|NCT03223298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110976349|NCT03223298|Cholinergic Agents|cholinergic agents|mesh-ancestor
110976350|NCT03223298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110976351|NCT03223298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110976352|NCT03223298|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110976353|NCT03223298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110976354|NCT00869661|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110976355|NCT00869661|Interferon-alpha|interferon-alpha|mesh-list
110976356|NCT00869661|Ribavirin|ribavirin|mesh-list
110976357|NCT00869661|Antiviral Agents|antiviral agents|mesh-ancestor
110976358|NCT00869661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110976359|NCT00869661|Immunologic Factors|immunologic factors|mesh-ancestor
110976360|NCT00869661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110976361|NCT00869661|Antimetabolites|antimetabolites|mesh-ancestor
110976362|NCT00869661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111491600|NCT05776979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110976363|NCT03192566|Acetaminophen|acetaminophen|mesh-list
111491601|NCT05763875|Ezetimibe|ezetimibe|mesh-list
110976364|NCT03192566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110976365|NCT03192566|Analgesics|analgesics|mesh-ancestor
110976366|NCT03192566|Sensory System Agents|sensory system agents|mesh-ancestor
110976367|NCT03192566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110976368|NCT03192566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110976369|NCT03192566|Antipyretics|antipyretics|mesh-ancestor
110976370|NCT03296930|Ritonavir|ritonavir|mesh-list
110976371|NCT03296930|Ribavirin|ribavirin|mesh-list
110976372|NCT03296930|Sofosbuvir|sofosbuvir|mesh-list
110976373|NCT03296930|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110976374|NCT03296930|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110976375|NCT03296930|Protease Inhibitors|protease inhibitors|mesh-ancestor
110976376|NCT03296930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110976377|NCT03296930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110976378|NCT03296930|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110976379|NCT03296930|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110976380|NCT03296930|Antiviral Agents|antiviral agents|mesh-ancestor
110976381|NCT03296930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110976382|NCT03296930|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110976383|NCT03296930|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110976384|NCT03296930|Antimetabolites|antimetabolites|mesh-ancestor
110976385|NCT04607772|Rituximab|rituximab|mesh-list
110976386|NCT04607772|Gemcitabine|gemcitabine|mesh-list
110976387|NCT04607772|Oxaliplatin|oxaliplatin|mesh-list
111491602|NCT05763875|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111491603|NCT05763875|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111491604|NCT05763875|Antimetabolites|antimetabolites|mesh-ancestor
111491605|NCT05763875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111491606|NCT05763875|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111491607|NCT05748171|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
111491608|NCT05748171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111491609|NCT05748171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111491610|NCT05748171|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111491611|NCT05748171|Immunotoxins|immunotoxins|mesh-ancestor
111491612|NCT05748171|Immunoconjugates|immunoconjugates|mesh-ancestor
111491613|NCT05748171|Immunologic Factors|immunologic factors|mesh-ancestor
111491614|NCT05748171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111491615|NCT05727397|Aflibercept|aflibercept|mesh-list
111491616|NCT05727397|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111491617|NCT05727397|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110976388|NCT04607772|Lenalidomide|lenalidomide|mesh-list
110976389|NCT04607772|Venetoclax|venetoclax|mesh-list
110976390|NCT04607772|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110976391|NCT04607772|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
110976392|NCT04607772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110976393|NCT04607772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110976394|NCT04607772|Immunologic Factors|immunologic factors|mesh-ancestor
110976395|NCT04607772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110976396|NCT04607772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110976397|NCT04607772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110976398|NCT04607772|Antimetabolites|antimetabolites|mesh-ancestor
110976399|NCT04607772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110976400|NCT04607772|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110976401|NCT04607772|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110976402|NCT04607772|Growth Substances|growth substances|mesh-ancestor
110976403|NCT04607772|Growth Inhibitors|growth inhibitors|mesh-ancestor
110976404|NCT04607772|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110976405|NCT04607772|Alkylating Agents|alkylating agents|mesh-ancestor
110976406|NCT04607772|Immunoconjugates|immunoconjugates|mesh-ancestor
110976407|NCT02464124|Nitazoxanide|nitazoxanide|mesh-list
110976408|NCT02464124|Lactulose|lactulose|mesh-list
110976409|NCT02464124|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110976410|NCT02464124|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110976411|NCT02464124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110976412|NCT00859521|Levetiracetam|levetiracetam|mesh-list
110976413|NCT00859521|Anticonvulsants|anticonvulsants|mesh-ancestor
110976414|NCT00859521|Nootropic Agents|nootropic agents|mesh-ancestor
110976415|NCT05398770|Vitamin D|vitamin d|mesh-list
110976416|NCT05398770|Vitamins|vitamins|mesh-ancestor
110976417|NCT05398770|Micronutrients|micronutrients|mesh-ancestor
110976418|NCT05398770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110976419|NCT05398770|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110976420|NCT00843687|Risperidone|risperidone|mesh-list
111491618|NCT05727397|Growth Substances|growth substances|mesh-ancestor
111491619|NCT05727397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111491620|NCT05727397|Growth Inhibitors|growth inhibitors|mesh-ancestor
110976421|NCT00843687|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110976422|NCT00843687|Serotonin Agents|serotonin agents|mesh-ancestor
110976423|NCT00843687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110976424|NCT00843687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111491621|NCT05727397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110976425|NCT00843687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110976426|NCT00843687|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110976427|NCT00843687|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110976428|NCT00843687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110976429|NCT00843687|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110976430|NCT00843687|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110976431|NCT00843687|Dopamine Agents|dopamine agents|mesh-ancestor
110976433|NCT04642131|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110976434|NCT04642131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110976435|NCT04642131|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110976436|NCT04642131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110976437|NCT04642131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110976438|NCT04642131|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110976439|NCT04642131|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110976440|NCT04642131|Purinergic Agents|purinergic agents|mesh-ancestor
110976441|NCT04642131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110976442|NCT01001715|Fasinumab|fasinumab|mesh-list
110976443|NCT01001715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110976444|NCT01001715|Analgesics|analgesics|mesh-ancestor
110976445|NCT01001715|Sensory System Agents|sensory system agents|mesh-ancestor
110976446|NCT01001715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110976447|NCT01001715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110976448|NCT02463812|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
110976449|NCT02463812|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
110976450|NCT02463812|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
110976451|NCT02463812|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110976452|NCT00789633|Gemcitabine|gemcitabine|mesh-list
110976453|NCT00789633|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110976454|NCT00789633|Antimetabolites|antimetabolites|mesh-ancestor
110976455|NCT00789633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110976456|NCT00789633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110976457|NCT00788541|Hydrocortisone|hydrocortisone|mesh-list
110976458|NCT00788541|Anecortave|anecortave|mesh-list
110976459|NCT00788541|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110976460|NCT00788541|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110976461|NCT00788541|Growth Substances|growth substances|mesh-ancestor
110976462|NCT00788541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110976463|NCT00788541|Growth Inhibitors|growth inhibitors|mesh-ancestor
110976464|NCT00788541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110976465|NCT00788541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110976466|NCT03296540|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
110976467|NCT03296540|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110976468|NCT04489160|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
110976469|NCT04489160|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
110976470|NCT04489160|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110976471|NCT04489160|Immunologic Factors|immunologic factors|mesh-ancestor
110976472|NCT04489160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110976473|NCT00786201|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110976474|NCT00786201|Immunologic Factors|immunologic factors|mesh-ancestor
110976475|NCT00786201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110976476|NCT00841815|Amlodipine|amlodipine|mesh-list
110976477|NCT00841815|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110976478|NCT00841815|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110976479|NCT00841815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110976480|NCT00841815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110976481|NCT00841815|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110976482|NCT00841815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110976483|NCT00841815|Vasodilator Agents|vasodilator agents|mesh-ancestor
110976484|NCT03296306|Cisplatin|cisplatin|mesh-list
110976485|NCT03296306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110976486|NCT04440280|Acetylcysteine|acetylcysteine|mesh-list
110976487|NCT04440280|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110976488|NCT04440280|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110976489|NCT04440280|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110976490|NCT04440280|Antiviral Agents|antiviral agents|mesh-ancestor
110976491|NCT04440280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110976492|NCT04440280|Expectorants|expectorants|mesh-ancestor
110976493|NCT04440280|Respiratory System Agents|respiratory system agents|mesh-ancestor
110976494|NCT04440280|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110976495|NCT04440280|Antioxidants|antioxidants|mesh-ancestor
111491622|NCT05717153|Eflornithine|eflornithine|mesh-list
110976496|NCT04440280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110976497|NCT04440280|Protective Agents|protective agents|mesh-ancestor
111491623|NCT05717153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110976498|NCT04440280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110976500|NCT00841659|Paroxetine|paroxetine|mesh-list
110976501|NCT00841659|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110976502|NCT00841659|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110976503|NCT00841659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110976504|NCT00841659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110976505|NCT00841659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110976506|NCT00841659|Serotonin Agents|serotonin agents|mesh-ancestor
110976507|NCT00841659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110976508|NCT00841659|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110976509|NCT00841659|Antidepressive Agents|antidepressive agents|mesh-ancestor
110976510|NCT00841659|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110976511|NCT00841659|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110976512|NCT00841659|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110976513|NCT00841659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110976514|NCT04061252|Brodalumab|brodalumab|mesh-list
110976515|NCT04061252|Dermatologic Agents|dermatologic agents|mesh-ancestor
110976516|NCT04473417|Dapagliflozin|dapagliflozin|mesh-list
110976517|NCT04473417|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110976518|NCT04473417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110976519|NCT04473417|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110976520|NCT04473417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110976521|NCT01001091|Dexamethasone|dexamethasone|mesh-list
110976522|NCT01001091|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110976523|NCT01001091|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110976524|NCT01001091|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110976525|NCT01001091|Antiemetics|antiemetics|mesh-ancestor
110976526|NCT01001091|Autonomic Agents|autonomic agents|mesh-ancestor
110976527|NCT01001091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110976528|NCT01001091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110976529|NCT01001091|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110976530|NCT01001091|Glucocorticoids|glucocorticoids|mesh-ancestor
110976531|NCT01001091|Hormones|hormones|mesh-ancestor
110976532|NCT01001091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110976533|NCT01001091|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110976534|NCT01001091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110976535|NCT05076682|Cromolyn Sodium|cromolyn sodium|mesh-list
110976536|NCT05076682|Efavirenz|efavirenz|mesh-list
110976537|NCT05076682|Choline|choline|mesh-list
110976538|NCT05076682|Antibodies|antibodies|mesh-list
110976539|NCT05076682|Immunologic Factors|immunologic factors|mesh-ancestor
110976540|NCT05076682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110976541|NCT05076682|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110976542|NCT05076682|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110976543|NCT05076682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110976544|NCT05076682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110976545|NCT05076682|Antiviral Agents|antiviral agents|mesh-ancestor
110976546|NCT05076682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110976547|NCT05076682|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110976548|NCT05076682|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110976549|NCT05076682|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110976550|NCT05076682|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110976551|NCT05076682|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110976552|NCT05076682|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110976553|NCT05076682|Lipotropic Agents|lipotropic agents|mesh-ancestor
110976554|NCT05076682|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110976555|NCT05076682|Antimetabolites|antimetabolites|mesh-ancestor
110976556|NCT05076682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110976557|NCT05076682|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110976558|NCT05076682|Nootropic Agents|nootropic agents|mesh-ancestor
110976559|NCT05076682|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
110976560|NCT05076682|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111491624|NCT05717153|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
111491625|NCT05717153|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111491626|NCT05717153|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111491627|NCT05717153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111491628|NCT05717153|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
111491629|NCT05717153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111491630|NCT05717153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111491631|NCT05714059|Insulin|insulin|mesh-list
111491632|NCT05714059|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111491633|NCT05714059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110976561|NCT05076682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110976562|NCT05076682|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110976563|NCT05076682|Respiratory System Agents|respiratory system agents|mesh-ancestor
110976564|NCT00840879|Meloxicam|meloxicam|mesh-list
110976565|NCT00840879|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110976566|NCT00840879|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110976567|NCT00840879|Analgesics|analgesics|mesh-ancestor
110976568|NCT00840879|Sensory System Agents|sensory system agents|mesh-ancestor
110976569|NCT00840879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110976570|NCT00840879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110976571|NCT00840879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110976572|NCT00840879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110976573|NCT00840879|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110976574|NCT00840879|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110976575|NCT00840879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110976576|NCT00840879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110976578|NCT02163434|Metoclopramide|metoclopramide|mesh-list
110976579|NCT02163434|Analgesics|analgesics|mesh-ancestor
110976580|NCT02163434|Sensory System Agents|sensory system agents|mesh-ancestor
110976581|NCT02163434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110976582|NCT02163434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110976583|NCT02163434|Anticonvulsants|anticonvulsants|mesh-ancestor
110976584|NCT02163434|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110976585|NCT02163434|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110976586|NCT02163434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110976587|NCT02163434|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110976588|NCT02163434|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110976589|NCT02163434|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110976590|NCT02163434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110976591|NCT02163434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110976592|NCT02163434|Antimanic Agents|antimanic agents|mesh-ancestor
110976593|NCT02163434|Antiemetics|antiemetics|mesh-ancestor
110976594|NCT02163434|Autonomic Agents|autonomic agents|mesh-ancestor
110976595|NCT02163434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110976596|NCT02163434|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110976597|NCT02163434|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110976598|NCT02163434|Dopamine Agents|dopamine agents|mesh-ancestor
110976599|NCT00840411|Clarithromycin|clarithromycin|mesh-list
110976600|NCT00840411|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110976601|NCT00840411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110976602|NCT00840411|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110976603|NCT00840411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110976604|NCT00840411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110976605|NCT00840411|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110976606|NCT00840411|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110976607|NCT00840099|Amoxicillin|amoxicillin|mesh-list
110976608|NCT00840099|Clavulanic Acid|clavulanic acid|mesh-list
110976609|NCT00840099|Clavulanic Acids|clavulanic acids|mesh-list
110976610|NCT00840099|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
110976611|NCT00840099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110976612|NCT00840099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110976613|NCT00840099|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110976614|NCT00840099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110976615|NCT00840099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110976616|NCT03108248|Doxorubicin|doxorubicin|mesh-list
110976617|NCT03108248|Ethiodized Oil|ethiodized oil|mesh-list
110479799|NCT00919555|Tretinoin|tretinoin|mesh-list
110976618|NCT03108248|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
110976619|NCT03108248|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110976620|NCT03108248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110976621|NCT03108248|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111491634|NCT05711628|Carboplatin|carboplatin|mesh-list
111491635|NCT05711628|Gemcitabine|gemcitabine|mesh-list
111491636|NCT05711628|Doxorubicin|doxorubicin|mesh-list
111491637|NCT05711628|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111491638|NCT05711628|Pembrolizumab|pembrolizumab|mesh-list
111491639|NCT05711628|Etoposide|etoposide|mesh-list
111491640|NCT05711628|Etoposide phosphate|etoposide phosphate|mesh-list
111491641|NCT05711628|Vinorelbine|vinorelbine|mesh-list
111491642|NCT05711628|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
111491643|NCT05711628|Ifosfamide|ifosfamide|mesh-list
111491644|NCT05711628|Isophosphamide mustard|isophosphamide mustard|mesh-list
111491645|NCT05711628|Brentuximab Vedotin|brentuximab vedotin|mesh-list
111491646|NCT05711628|Podophyllotoxin|podophyllotoxin|mesh-list
111491647|NCT05711628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111491648|NCT05711628|Antibodies|antibodies|mesh-list
110976622|NCT03108248|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110976623|NCT03108248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110976624|NCT03108248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110976625|NCT03108248|Hemostatics|hemostatics|mesh-ancestor
110976626|NCT03108248|Coagulants|coagulants|mesh-ancestor
110976627|NCT00836901|Amoxicillin|amoxicillin|mesh-list
110976628|NCT00836901|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
110976629|NCT00836901|Clavulanic Acids|clavulanic acids|mesh-list
110976630|NCT00836901|Clavulanic Acid|clavulanic acid|mesh-list
110976631|NCT00836901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110976632|NCT00836901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110976633|NCT00836901|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110976634|NCT00836901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110976635|NCT00836901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110976636|NCT04460560|Terlipressin|terlipressin|mesh-list
110976637|NCT04460560|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110976638|NCT04460560|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110976639|NCT04537689|Cyclosporine|cyclosporine|mesh-list
110976640|NCT04537689|Methotrexate|methotrexate|mesh-list
110976641|NCT04537689|Ixekizumab|ixekizumab|mesh-list
110976642|NCT04537689|Acitretin|acitretin|mesh-list
110976643|NCT04537689|Cyclosporins|cyclosporins|mesh-list
110976644|NCT04537689|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110976645|NCT04537689|Abortifacient Agents|abortifacient agents|mesh-ancestor
110976646|NCT04537689|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110976647|NCT04537689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110976648|NCT04537689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110976649|NCT04537689|Antimetabolites|antimetabolites|mesh-ancestor
110693731|NCT04001231|Exenatide|exenatide|mesh-list
110976650|NCT04537689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110976651|NCT04537689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110976652|NCT04537689|Dermatologic Agents|dermatologic agents|mesh-ancestor
110976653|NCT04537689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110976654|NCT04537689|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110976655|NCT04537689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110976656|NCT04537689|Immunologic Factors|immunologic factors|mesh-ancestor
110976657|NCT04537689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110976658|NCT04537689|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110976659|NCT04537689|Antifungal Agents|antifungal agents|mesh-ancestor
110976660|NCT04537689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110976661|NCT04537689|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110976662|NCT04537689|Keratolytic Agents|keratolytic agents|mesh-ancestor
110976663|NCT03295760|Ubiquinone|ubiquinone|mesh-list
110976664|NCT03295760|Coenzyme Q10|coenzyme q10|mesh-list
110976665|NCT03295760|Micronutrients|micronutrients|mesh-ancestor
110976666|NCT03295760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110976667|NCT03295760|Vitamins|vitamins|mesh-ancestor
110976668|NCT05563012|Capecitabine|capecitabine|mesh-list
110976669|NCT05563012|Oxaliplatin|oxaliplatin|mesh-list
110976670|NCT05563012|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110976671|NCT05563012|Antimetabolites|antimetabolites|mesh-ancestor
110976672|NCT05563012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110976673|NCT05563012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110976674|NCT04501653|Methylphenidate|methylphenidate|mesh-list
110976675|NCT04501653|Psilocybin|psilocybin|mesh-list
110976676|NCT04501653|Psilocin|psilocin|mesh-list
110479805|NCT02979093|Oxytocin|oxytocin|mesh-list
110976677|NCT04501653|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110976678|NCT04501653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110976679|NCT04501653|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110976680|NCT04501653|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110976681|NCT04501653|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110976682|NCT04501653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110976683|NCT04501653|Dopamine Agents|dopamine agents|mesh-ancestor
110976684|NCT04501653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110976685|NCT04501653|Hallucinogens|hallucinogens|mesh-ancestor
110976686|NCT04501653|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110976687|NCT04730206|Molnupiravir|molnupiravir|mesh-list
110976688|NCT04730206|Camostat|camostat|mesh-list
110976689|NCT04730206|Protease Inhibitors|protease inhibitors|mesh-ancestor
110976690|NCT04730206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110976691|NCT04730206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110976692|NCT04730206|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
111491649|NCT05711628|Immunoglobulins|immunoglobulins|mesh-list
111491650|NCT05711628|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111491651|NCT05711628|Immunoconjugates|immunoconjugates|mesh-list
110976693|NCT04730206|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111491652|NCT05711628|Immunologic Factors|immunologic factors|mesh-ancestor
110976694|NCT04730206|Antiviral Agents|antiviral agents|mesh-ancestor
111491653|NCT05711628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111491654|NCT05711628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110976695|NCT04730206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110976696|NCT00990327|Adenosine|adenosine|mesh-list
110976697|NCT00990327|Analgesics|analgesics|mesh-ancestor
110976698|NCT00990327|Sensory System Agents|sensory system agents|mesh-ancestor
110976699|NCT00990327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110976700|NCT00990327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110976701|NCT00990327|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110976702|NCT00990327|Vasodilator Agents|vasodilator agents|mesh-ancestor
110976703|NCT00990327|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
110976704|NCT00990327|Purinergic Agonists|purinergic agonists|mesh-ancestor
110976705|NCT00990327|Purinergic Agents|purinergic agents|mesh-ancestor
110976706|NCT00990327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110976707|NCT00990327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110976708|NCT03050814|Leucovorin|leucovorin|mesh-list
110976709|NCT03050814|Bevacizumab|bevacizumab|mesh-list
110976710|NCT03050814|Avelumab|avelumab|mesh-list
110976711|NCT03050814|Fluorouracil|fluorouracil|mesh-list
110976712|NCT03050814|Capecitabine|capecitabine|mesh-list
110976713|NCT03050814|Oxaliplatin|oxaliplatin|mesh-list
110976714|NCT03050814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110976715|NCT03050814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110976716|NCT03050814|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110976717|NCT03050814|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110976718|NCT03050814|Growth Substances|growth substances|mesh-ancestor
110976719|NCT03050814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110976720|NCT03050814|Growth Inhibitors|growth inhibitors|mesh-ancestor
110976721|NCT03050814|Antimetabolites|antimetabolites|mesh-ancestor
110976722|NCT03050814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110976723|NCT03050814|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110976724|NCT03050814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110693803|NCT01034124|GABA Agents|gaba agents|mesh-ancestor
110976725|NCT03050814|Immunologic Factors|immunologic factors|mesh-ancestor
110976726|NCT03050814|Antidotes|antidotes|mesh-ancestor
110976727|NCT03050814|Protective Agents|protective agents|mesh-ancestor
110976728|NCT03050814|Vitamin B Complex|vitamin b complex|mesh-ancestor
110976730|NCT03050814|Micronutrients|micronutrients|mesh-ancestor
110976731|NCT02462174|Ketamine|ketamine|mesh-list
110976732|NCT02462174|Bupivacaine|bupivacaine|mesh-list
110976733|NCT02462174|Anesthetics, Local|anesthetics, local|mesh-ancestor
110976734|NCT02462174|Anesthetics|anesthetics|mesh-ancestor
110976735|NCT02462174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110976736|NCT02462174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110976737|NCT02462174|Sensory System Agents|sensory system agents|mesh-ancestor
110976738|NCT02462174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110976739|NCT02462174|Analgesics|analgesics|mesh-ancestor
110976740|NCT02462174|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110976741|NCT02462174|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110976742|NCT02462174|Anesthetics, General|anesthetics, general|mesh-ancestor
110976743|NCT02462174|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110976744|NCT02462174|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110976745|NCT02462174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110976746|NCT02462174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110976747|NCT02564146|Paclitaxel|paclitaxel|mesh-list
110976748|NCT02564146|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110976749|NCT02564146|Gemcitabine|gemcitabine|mesh-list
110976750|NCT02564146|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110976751|NCT02564146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110976752|NCT02564146|Tubulin Modulators|tubulin modulators|mesh-ancestor
110976753|NCT02564146|Antimitotic Agents|antimitotic agents|mesh-ancestor
110976754|NCT02564146|Mitosis Modulators|mitosis modulators|mesh-ancestor
110976755|NCT02564146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110976756|NCT02564146|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110976757|NCT02564146|Antimetabolites|antimetabolites|mesh-ancestor
110976758|NCT00981357|Naproxen|naproxen|mesh-list
110976759|NCT00981357|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110976760|NCT00981357|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110976761|NCT00981357|Analgesics|analgesics|mesh-ancestor
110976762|NCT00981357|Sensory System Agents|sensory system agents|mesh-ancestor
110976763|NCT00981357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111491655|NCT05711628|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111491656|NCT05711628|Antimetabolites|antimetabolites|mesh-ancestor
111491657|NCT05711628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110976764|NCT00981357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110976765|NCT00981357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110976766|NCT00981357|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110976767|NCT00981357|Gout Suppressants|gout suppressants|mesh-ancestor
110976768|NCT00981357|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110976769|NCT00981357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110976770|NCT00981357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110976772|NCT02462252|Methylprednisolone|methylprednisolone|mesh-list
110976773|NCT02462252|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110976774|NCT02462252|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110976775|NCT02462252|Cyclosporins|cyclosporins|mesh-list
110976776|NCT02462252|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110976777|NCT02462252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110976778|NCT02462252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110976779|NCT02462252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110976780|NCT02462252|Immunologic Factors|immunologic factors|mesh-ancestor
110976781|NCT02462252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110976782|NCT02462252|Antifungal Agents|antifungal agents|mesh-ancestor
110976783|NCT02462252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110976784|NCT02462252|Dermatologic Agents|dermatologic agents|mesh-ancestor
110976785|NCT02462252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110976786|NCT02462252|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110976787|NCT02462252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110976788|NCT02462252|Antiemetics|antiemetics|mesh-ancestor
110976789|NCT02462252|Autonomic Agents|autonomic agents|mesh-ancestor
110976790|NCT02462252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110976791|NCT02462252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110976792|NCT02462252|Glucocorticoids|glucocorticoids|mesh-ancestor
110976793|NCT02462252|Hormones|hormones|mesh-ancestor
110976794|NCT02462252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110976795|NCT02462252|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110976796|NCT02462252|Protective Agents|protective agents|mesh-ancestor
110976797|NCT02462252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110693876|NCT04000919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110976798|NCT02462252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110976799|NCT03130452|Amoxicillin|amoxicillin|mesh-list
110976800|NCT03130452|Metronidazole|metronidazole|mesh-list
110976801|NCT03130452|Clarithromycin|clarithromycin|mesh-list
110976802|NCT03130452|Lansoprazole|lansoprazole|mesh-list
110976803|NCT03130452|Dexlansoprazole|dexlansoprazole|mesh-list
110976804|NCT03130452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110976805|NCT03130452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110976806|NCT03130452|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110976807|NCT03130452|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110976808|NCT03130452|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110479817|NCT04766437|Ticagrelor|ticagrelor|mesh-list
110976809|NCT03130452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110976810|NCT03130452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110976811|NCT03130452|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110976812|NCT03130452|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110976813|NCT03130452|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110976814|NCT03130452|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110976815|NCT03130452|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110976816|NCT00979251|Oseltamivir|oseltamivir|mesh-list
110976817|NCT00979251|Amantadine|amantadine|mesh-list
110976818|NCT00979251|Antiviral Agents|antiviral agents|mesh-ancestor
110976819|NCT00979251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110976820|NCT00979251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110976821|NCT00979251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110976822|NCT00979251|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110976823|NCT00979251|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110976824|NCT00979251|Dopamine Agents|dopamine agents|mesh-ancestor
110976825|NCT00979251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110976826|NCT00979251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110976827|NCT00979251|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110976828|NCT00979251|Analgesics|analgesics|mesh-ancestor
110976829|NCT00979251|Sensory System Agents|sensory system agents|mesh-ancestor
110976830|NCT00979251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110976831|NCT04551352|Adalimumab|adalimumab|mesh-list
110976832|NCT04551352|Obinutuzumab|obinutuzumab|mesh-list
110976833|NCT04551352|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110976834|NCT04551352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110976835|NCT04551352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110976836|NCT04551352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110976837|NCT04551352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111491658|NCT05711628|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111491659|NCT05711628|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110976838|NCT05398224|Rituximab|rituximab|mesh-list
110976839|NCT05398224|Methotrexate|methotrexate|mesh-list
110976840|NCT05398224|Zanubrutinib|zanubrutinib|mesh-list
110976841|NCT05398224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110976842|NCT05398224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110976843|NCT05398224|Immunologic Factors|immunologic factors|mesh-ancestor
110976844|NCT05398224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110976845|NCT05398224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110976846|NCT05398224|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110976847|NCT05398224|Abortifacient Agents|abortifacient agents|mesh-ancestor
110976848|NCT05398224|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110976849|NCT05398224|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110976850|NCT05398224|Antimetabolites|antimetabolites|mesh-ancestor
110976851|NCT05398224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110976852|NCT05398224|Dermatologic Agents|dermatologic agents|mesh-ancestor
110976853|NCT05398224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110976854|NCT05398224|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110976855|NCT05398224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110976856|NCT05398224|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110976857|NCT05398224|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110976858|NCT04542304|Metolazone|metolazone|mesh-list
110976859|NCT04542304|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110976860|NCT04542304|Diuretics|diuretics|mesh-ancestor
110976861|NCT04542304|Natriuretic Agents|natriuretic agents|mesh-ancestor
110976862|NCT04542304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110976863|NCT04542304|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110976864|NCT04542304|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110976865|NCT04542304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110976866|NCT02463110|Sertraline|sertraline|mesh-list
110976867|NCT02463110|Antidepressive Agents|antidepressive agents|mesh-ancestor
110976868|NCT02463110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110976869|NCT02463110|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110976870|NCT02463110|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110976871|NCT02463110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110976872|NCT02463110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110976873|NCT02463110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110976874|NCT02463110|Serotonin Agents|serotonin agents|mesh-ancestor
110693950|NCT03983889|Fentanyl|fentanyl|mesh-list
110976875|NCT02463110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110976876|NCT05502952|Pentoxifylline|pentoxifylline|mesh-list
110976877|NCT05502952|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110976878|NCT05502952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110976879|NCT05502952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110976880|NCT05502952|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110976881|NCT05502952|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110976882|NCT05502952|Protective Agents|protective agents|mesh-ancestor
110976883|NCT05502952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110976884|NCT05502952|Vasodilator Agents|vasodilator agents|mesh-ancestor
110976885|NCT05502952|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110976886|NCT05502952|Antioxidants|antioxidants|mesh-ancestor
110976887|NCT00835575|Mirtazapine|mirtazapine|mesh-list
110976888|NCT00835575|Antidepressive Agents|antidepressive agents|mesh-ancestor
110976889|NCT00835575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110976890|NCT00835575|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110976891|NCT00835575|Histamine Antagonists|histamine antagonists|mesh-ancestor
110976892|NCT00835575|Histamine Agents|histamine agents|mesh-ancestor
110976893|NCT00835575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110976894|NCT00835575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110976895|NCT00835575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110976896|NCT00835575|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110976897|NCT00835575|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110976898|NCT00835575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110976899|NCT00835575|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
110976900|NCT00835575|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110976901|NCT00835575|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110976902|NCT00835575|Adrenergic Agents|adrenergic agents|mesh-ancestor
110976903|NCT00835575|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110976904|NCT00835575|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110976905|NCT00835575|Serotonin Agents|serotonin agents|mesh-ancestor
110976906|NCT00835575|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110976907|NCT00777309|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111491660|NCT05711628|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111491661|NCT05711628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111491662|NCT05711628|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111491663|NCT05711628|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110976908|NCT00777309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110976909|NCT00777309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110976910|NCT00777309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110976911|NCT00777309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110976912|NCT03295214|Acetaminophen|acetaminophen|mesh-list
110976913|NCT03295214|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110976914|NCT03295214|Analgesics|analgesics|mesh-ancestor
110976915|NCT03295214|Sensory System Agents|sensory system agents|mesh-ancestor
110976916|NCT03295214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110976917|NCT03295214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110976918|NCT03295214|Antipyretics|antipyretics|mesh-ancestor
110976919|NCT04604704|Niacinamide|niacinamide|mesh-list
110976921|NCT04604704|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110976922|NCT04604704|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110976923|NCT04604704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110976924|NCT04604704|Sensory System Agents|sensory system agents|mesh-ancestor
110976925|NCT04604704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110976926|NCT04604704|Vitamin B Complex|vitamin b complex|mesh-ancestor
110976927|NCT04604704|Vitamins|vitamins|mesh-ancestor
110976928|NCT04604704|Micronutrients|micronutrients|mesh-ancestor
110976929|NCT00776373|Cytarabine|cytarabine|mesh-list
110976930|NCT00776373|Sirolimus|sirolimus|mesh-list
110976931|NCT00776373|Etoposide|etoposide|mesh-list
110976932|NCT00776373|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110976933|NCT00776373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110976934|NCT00776373|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110976935|NCT00776373|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110976936|NCT00776373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110976937|NCT00776373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110976938|NCT00776373|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110976939|NCT00776373|Antimetabolites|antimetabolites|mesh-ancestor
110976940|NCT00776373|Antiviral Agents|antiviral agents|mesh-ancestor
110976941|NCT00776373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110976942|NCT00776373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110976943|NCT00776373|Immunologic Factors|immunologic factors|mesh-ancestor
110976944|NCT00776373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110976945|NCT00776373|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110976946|NCT00776373|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110976947|NCT00776373|Antifungal Agents|antifungal agents|mesh-ancestor
110976948|NCT00772785|Buprenorphine|buprenorphine|mesh-list
110694028|NCT00330681|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110976949|NCT00772785|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110976950|NCT00772785|Narcotics|narcotics|mesh-ancestor
110976951|NCT00772785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110976952|NCT00772785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110976953|NCT00772785|Analgesics|analgesics|mesh-ancestor
110976954|NCT00772785|Sensory System Agents|sensory system agents|mesh-ancestor
110976955|NCT00772785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110976956|NCT00772785|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110976957|NCT02461706|Cannabidiol|cannabidiol|mesh-list
110976958|NCT02461706|Anticonvulsants|anticonvulsants|mesh-ancestor
110976959|NCT05497570|Tenoxicam|tenoxicam|mesh-list
110976960|NCT05497570|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110976961|NCT05497570|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110976962|NCT05497570|Analgesics|analgesics|mesh-ancestor
110976963|NCT05497570|Sensory System Agents|sensory system agents|mesh-ancestor
110976964|NCT05497570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110976965|NCT05497570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110976966|NCT05497570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110976967|NCT05497570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110976968|NCT05497570|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110976969|NCT05497570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110976970|NCT05497570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110976971|NCT00963885|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110976972|NCT00963885|Lactams|lactams|mesh-list
110976973|NCT00963885|Antiviral Agents|antiviral agents|mesh-ancestor
110976974|NCT00963885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110976975|NCT00963885|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110976976|NCT05497492|Lidocaine|lidocaine|mesh-list
111491664|NCT05711628|Tubulin Modulators|tubulin modulators|mesh-ancestor
111491665|NCT05711628|Antimitotic Agents|antimitotic agents|mesh-ancestor
111491666|NCT05711628|Mitosis Modulators|mitosis modulators|mesh-ancestor
111491667|NCT05711628|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110976977|NCT05497492|Sufentanil|sufentanil|mesh-list
110976978|NCT05497492|Propofol|propofol|mesh-list
110976979|NCT05497492|Esketamine|esketamine|mesh-list
110976980|NCT05497492|Anesthetics, Local|anesthetics, local|mesh-ancestor
110976981|NCT05497492|Anesthetics|anesthetics|mesh-ancestor
111491668|NCT05711628|Alkylating Agents|alkylating agents|mesh-ancestor
110976982|NCT05497492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110976983|NCT05497492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110976984|NCT05497492|Sensory System Agents|sensory system agents|mesh-ancestor
110976985|NCT05497492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110976986|NCT05497492|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110976987|NCT05497492|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110976988|NCT05497492|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110976989|NCT05497492|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110976990|NCT05497492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110976991|NCT05497492|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110976992|NCT05497492|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110976993|NCT05497492|Anesthetics, General|anesthetics, general|mesh-ancestor
110976994|NCT05497492|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110976995|NCT05497492|Narcotics|narcotics|mesh-ancestor
110976996|NCT05497492|Analgesics|analgesics|mesh-ancestor
110976997|NCT05497492|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110976998|NCT05497492|Antidepressive Agents|antidepressive agents|mesh-ancestor
110976999|NCT05497492|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110977000|NCT00835497|Metformin|metformin|mesh-list
110977001|NCT00835497|Glipizide|glipizide|mesh-list
110977002|NCT00835497|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110977003|NCT00835497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110977004|NCT05005689|Fluorides|fluorides|mesh-list
110977005|NCT05005689|Sodium Fluoride|sodium fluoride|mesh-list
110977006|NCT05005689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110977007|NCT05005689|Cariostatic Agents|cariostatic agents|mesh-ancestor
110977008|NCT05005689|Protective Agents|protective agents|mesh-ancestor
110977009|NCT00763503|Calcitriol|calcitriol|mesh-list
110977010|NCT00763503|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110977011|NCT00763503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110977012|NCT00763503|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
110977013|NCT00763503|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110977014|NCT00763503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110977015|NCT00763503|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110977016|NCT00763503|Vitamins|vitamins|mesh-ancestor
110977017|NCT00763503|Micronutrients|micronutrients|mesh-ancestor
110977018|NCT00763503|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110977019|NCT00761709|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110977020|NCT00761709|Latanoprost|latanoprost|mesh-list
110977021|NCT00761709|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110977022|NCT00760539|Timolol|timolol|mesh-list
110977023|NCT00760539|Travoprost|travoprost|mesh-list
110977024|NCT00760539|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110977025|NCT00760539|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110977026|NCT00760539|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110977027|NCT00760539|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110977028|NCT00760539|Adrenergic Agents|adrenergic agents|mesh-ancestor
110977029|NCT00760539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110977030|NCT00760539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110977031|NCT00760539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110977032|NCT00760539|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110977033|NCT00760539|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110977034|NCT04976049|Aminolevulinic Acid|aminolevulinic acid|mesh-list
110977035|NCT04976049|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110977036|NCT04976049|Dermatologic Agents|dermatologic agents|mesh-ancestor
110977037|NCT00759135|Finasteride|finasteride|mesh-list
110977038|NCT00759135|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
110977039|NCT00759135|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110977040|NCT00759135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110977041|NCT00759135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110977042|NCT00759135|Hormone Antagonists|hormone antagonists|mesh-ancestor
110977043|NCT00759135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110977044|NCT00759135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110977045|NCT00759135|Urological Agents|urological agents|mesh-ancestor
110977046|NCT00835263|Lamotrigine|lamotrigine|mesh-list
110977047|NCT00835263|Anticonvulsants|anticonvulsants|mesh-ancestor
110977048|NCT00835263|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110977049|NCT00835263|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111491669|NCT05711628|Immunotoxins|immunotoxins|mesh-ancestor
111491670|NCT05711628|Keratolytic Agents|keratolytic agents|mesh-ancestor
111491671|NCT05711628|Dermatologic Agents|dermatologic agents|mesh-ancestor
111119107|NCT05362318|Cholinergic Agents|cholinergic agents|mesh-ancestor
111491672|NCT05704634|Cemiplimab|cemiplimab|mesh-list
111491673|NCT05704634|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111491674|NCT05704634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111491675|NCT05681039|Carboplatin|carboplatin|mesh-list
111491676|NCT05681039|Atezolizumab|atezolizumab|mesh-list
110977050|NCT00835263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110977051|NCT00835263|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110977052|NCT00835263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110977053|NCT00835263|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110977054|NCT00835263|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110977055|NCT00835263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110977056|NCT00835263|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110977057|NCT00835263|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110977059|NCT02639910|Idelalisib|idelalisib|mesh-list
110977060|NCT02639910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110977061|NCT02639910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110977062|NCT02639910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110977063|NCT04454580|Azacitidine|azacitidine|mesh-list
110977064|NCT04454580|Decitabine|decitabine|mesh-list
110977065|NCT04454580|Venetoclax|venetoclax|mesh-list
110977066|NCT04454580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110977067|NCT04454580|Antimetabolites|antimetabolites|mesh-ancestor
110977068|NCT04454580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110977069|NCT04454580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110977070|NCT04454580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110977071|NCT00948909|Donepezil|donepezil|mesh-list
110977072|NCT00948909|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110977073|NCT00948909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110977074|NCT00948909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110977075|NCT00948909|Cholinergic Agents|cholinergic agents|mesh-ancestor
110977076|NCT00948909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110977077|NCT00948909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110977078|NCT00948909|Nootropic Agents|nootropic agents|mesh-ancestor
110977079|NCT02522910|Docetaxel|docetaxel|mesh-list
110977080|NCT02522910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110977081|NCT02522910|Tubulin Modulators|tubulin modulators|mesh-ancestor
110977082|NCT02522910|Antimitotic Agents|antimitotic agents|mesh-ancestor
110977083|NCT02522910|Mitosis Modulators|mitosis modulators|mesh-ancestor
110977084|NCT02522910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110977085|NCT00948753|Maraviroc|maraviroc|mesh-list
110977086|NCT00948753|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110977087|NCT00948753|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110977088|NCT00948753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110977089|NCT00948753|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110977090|NCT00948753|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110977091|NCT00948753|Antiviral Agents|antiviral agents|mesh-ancestor
110977092|NCT00948753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110977093|NCT00948753|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
110977094|NCT05397834|Fluticasone|fluticasone|mesh-list
110977095|NCT05397834|Xhance|xhance|mesh-list
110977096|NCT05397834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110977097|NCT05397834|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110977098|NCT05397834|Autonomic Agents|autonomic agents|mesh-ancestor
110977099|NCT05397834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110977100|NCT05397834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110977101|NCT05397834|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110977102|NCT05397834|Respiratory System Agents|respiratory system agents|mesh-ancestor
110977103|NCT05397834|Dermatologic Agents|dermatologic agents|mesh-ancestor
110977104|NCT05397834|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110977105|NCT03134547|Sevoflurane|sevoflurane|mesh-list
110977106|NCT03134547|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110977107|NCT03134547|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110977108|NCT03134547|Anesthetics, General|anesthetics, general|mesh-ancestor
110977109|NCT03134547|Anesthetics|anesthetics|mesh-ancestor
110977110|NCT03134547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110977111|NCT03134547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110977112|NCT01963208|Ganaxolone|ganaxolone|mesh-list
110977113|NCT01963208|Neurosteroids|neurosteroids|mesh-ancestor
110977114|NCT01963208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110977115|NCT01963208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110977116|NCT01963208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110977117|NCT01963208|GABA Modulators|gaba modulators|mesh-ancestor
110977118|NCT01963208|GABA Agents|gaba agents|mesh-ancestor
110977119|NCT00834873|Carvedilol|carvedilol|mesh-list
110977120|NCT00834873|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110977121|NCT00834873|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111491677|NCT05681039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110977122|NCT00834873|Adrenergic Agents|adrenergic agents|mesh-ancestor
110977124|NCT00834873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110977125|NCT00834873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110977126|NCT00834873|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110977127|NCT00834873|Antioxidants|antioxidants|mesh-ancestor
110977128|NCT00834873|Protective Agents|protective agents|mesh-ancestor
110977129|NCT00834873|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110977130|NCT00834873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110977131|NCT00834873|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110977132|NCT00834873|Vasodilator Agents|vasodilator agents|mesh-ancestor
110977133|NCT00834873|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110977134|NCT00834873|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110977135|NCT01377480|Posaconazole|posaconazole|mesh-list
110977136|NCT01377480|Benzonidazole|benzonidazole|mesh-list
110977137|NCT01377480|Antifungal Agents|antifungal agents|mesh-ancestor
110977138|NCT01377480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110977139|NCT01377480|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
110977140|NCT01377480|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110977141|NCT01377480|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110977142|NCT01377480|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110977143|NCT01377480|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110977144|NCT01377480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110977145|NCT01377480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110977146|NCT01377480|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110977147|NCT01377480|Hormone Antagonists|hormone antagonists|mesh-ancestor
110977148|NCT01377480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110977149|NCT01377480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110977150|NCT01377480|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110977151|NCT01377480|Immunologic Factors|immunologic factors|mesh-ancestor
110977152|NCT04263909|Sufentanil|sufentanil|mesh-list
110977153|NCT04263909|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110977154|NCT04263909|Narcotics|narcotics|mesh-ancestor
110977155|NCT04263909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110977156|NCT04263909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110977157|NCT04263909|Analgesics|analgesics|mesh-ancestor
110977158|NCT04263909|Sensory System Agents|sensory system agents|mesh-ancestor
110977159|NCT04263909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110977160|NCT04263909|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110977161|NCT04263909|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110977162|NCT04263909|Anesthetics, General|anesthetics, general|mesh-ancestor
110977163|NCT04263909|Anesthetics|anesthetics|mesh-ancestor
110977164|NCT01421264|Gabapentin|gabapentin|mesh-list
110977165|NCT01421264|Analgesics|analgesics|mesh-ancestor
110977166|NCT01421264|Sensory System Agents|sensory system agents|mesh-ancestor
110977167|NCT01421264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110977168|NCT01421264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110977169|NCT01421264|Anticonvulsants|anticonvulsants|mesh-ancestor
110977170|NCT01421264|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110977171|NCT01421264|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110977172|NCT01421264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110977173|NCT01421264|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110977174|NCT01421264|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110977175|NCT01421264|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110977176|NCT01421264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110977177|NCT01421264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110977178|NCT01421264|Antimanic Agents|antimanic agents|mesh-ancestor
110977179|NCT04415840|Acetic Acid|acetic acid|mesh-list
110977180|NCT04415840|Retinol acetate|retinol acetate|mesh-list
110977181|NCT04415840|Lugol's solution|lugol's solution|mesh-list
110977182|NCT04415840|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110977183|NCT04415840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110977184|NCT04415840|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110977185|NCT04415840|Immunologic Factors|immunologic factors|mesh-ancestor
110977186|NCT04415840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110977187|NCT04415840|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110977188|NCT04415840|Protective Agents|protective agents|mesh-ancestor
110977189|NCT04415840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110977190|NCT04415840|Hemostatics|hemostatics|mesh-ancestor
110977191|NCT04415840|Coagulants|coagulants|mesh-ancestor
110977192|NCT04488614|Zoledronic Acid|zoledronic acid|mesh-list
110977193|NCT04488614|Estrogens|estrogens|mesh-list
111491678|NCT05681039|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111491679|NCT05681039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110699758|NCT00378534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110977194|NCT04488614|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110977195|NCT04488614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110977196|NCT04488614|Hormones|hormones|mesh-ancestor
110977197|NCT04488614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110977198|NCT00834795|Carvedilol|carvedilol|mesh-list
110977199|NCT00834795|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110977200|NCT00834795|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110977201|NCT00834795|Adrenergic Agents|adrenergic agents|mesh-ancestor
110977202|NCT00834795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110977203|NCT00834795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110977204|NCT00834795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110977205|NCT00834795|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110977206|NCT00834795|Antioxidants|antioxidants|mesh-ancestor
110977207|NCT00834795|Protective Agents|protective agents|mesh-ancestor
110977208|NCT00834795|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110977209|NCT00834795|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110977210|NCT00834795|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110977211|NCT00834795|Vasodilator Agents|vasodilator agents|mesh-ancestor
110977212|NCT00834795|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110977213|NCT00834795|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110977214|NCT00834717|Granisetron|granisetron|mesh-list
110977215|NCT00834717|Antiemetics|antiemetics|mesh-ancestor
110977216|NCT00834717|Autonomic Agents|autonomic agents|mesh-ancestor
110977217|NCT00834717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110977218|NCT00834717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110977219|NCT00834717|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110977220|NCT00834717|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110977221|NCT00834717|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110977222|NCT00834717|Serotonin Agents|serotonin agents|mesh-ancestor
110977223|NCT00834717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110977224|NCT00834717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110977225|NCT00834639|Valproic Acid|valproic acid|mesh-list
110977226|NCT00834639|Anticonvulsants|anticonvulsants|mesh-ancestor
110977227|NCT00834639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110977228|NCT00834639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110977229|NCT00834639|GABA Agents|gaba agents|mesh-ancestor
110977230|NCT00834639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110977231|NCT00834639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110977232|NCT00834639|Antimanic Agents|antimanic agents|mesh-ancestor
110977233|NCT00834639|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110977234|NCT00834639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110977235|NCT00834639|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110977236|NCT00834561|Lamotrigine|lamotrigine|mesh-list
110977237|NCT00834561|Anticonvulsants|anticonvulsants|mesh-ancestor
110977238|NCT00834561|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110977239|NCT00834561|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110977240|NCT00834561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110977241|NCT00834561|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110977242|NCT00834561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110977243|NCT00834561|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110977244|NCT00834561|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110977245|NCT00834561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110977246|NCT00834561|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110977247|NCT00834561|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110977248|NCT00754221|Reboxetine|reboxetine|mesh-list
110977249|NCT00754221|Antidepressive Agents|antidepressive agents|mesh-ancestor
110694331|NCT00998075|Esomeprazole|esomeprazole|mesh-list
110977250|NCT00754221|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110977251|NCT00754221|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110977252|NCT00754221|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110977253|NCT00754221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110977254|NCT00754221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110977255|NCT00754221|Adrenergic Agents|adrenergic agents|mesh-ancestor
110977256|NCT00754221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110977257|NCT00754221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110977258|NCT00834405|Leflunomide|leflunomide|mesh-list
110977259|NCT00834405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110977260|NCT00834405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111491680|NCT05681039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111491681|NCT05677490|Calcium, Dietary|calcium, dietary|mesh-list
111491682|NCT05677490|Leucovorin|leucovorin|mesh-list
111491683|NCT05677490|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
111491684|NCT05677490|Tetrahydrofolates|tetrahydrofolates|mesh-list
110977261|NCT00834405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111491685|NCT05677490|Fluorouracil|fluorouracil|mesh-list
110977262|NCT00834405|Immunologic Factors|immunologic factors|mesh-ancestor
110977263|NCT00834405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110977264|NCT00834249|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
110977265|NCT00834249|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110977266|NCT00834249|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110977267|NCT00834249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110977268|NCT00834249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110977269|NCT00834249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110977270|NCT00834249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110977271|NCT00834249|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110977272|NCT00834249|Antidepressive Agents|antidepressive agents|mesh-ancestor
110977273|NCT00834249|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110977274|NCT00751803|Eletriptan|eletriptan|mesh-list
110977275|NCT00751803|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110977276|NCT00751803|Serotonin Agents|serotonin agents|mesh-ancestor
110977277|NCT00751803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110977278|NCT00751803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110977279|NCT00751803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110977280|NCT05420961|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110977281|NCT05420961|Immunologic Factors|immunologic factors|mesh-ancestor
110977282|NCT05420961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110977283|NCT05402397|Losartan|losartan|mesh-list
110977284|NCT05402397|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110977285|NCT05402397|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110977286|NCT05402397|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110977287|NCT05402397|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110977288|NCT05402397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110977289|NCT00833937|Zolpidem|zolpidem|mesh-list
110977290|NCT00833937|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110977291|NCT00833937|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110977292|NCT00833937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110977293|NCT00833937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110977294|NCT00833937|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
110977295|NCT00833937|GABA Agonists|gaba agonists|mesh-ancestor
110977296|NCT00833937|GABA Agents|gaba agents|mesh-ancestor
110977297|NCT00833937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110977298|NCT00833937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110977299|NCT00831051|Morphine|morphine|mesh-list
110977300|NCT00831051|Oxycodone|oxycodone|mesh-list
110977301|NCT00831051|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110977302|NCT00831051|Narcotics|narcotics|mesh-ancestor
110977303|NCT00831051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110977304|NCT00831051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110977305|NCT00831051|Analgesics|analgesics|mesh-ancestor
110977306|NCT00831051|Sensory System Agents|sensory system agents|mesh-ancestor
110977307|NCT00831051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110977308|NCT00750633|Moxifloxacin|moxifloxacin|mesh-list
110977309|NCT00750633|Dexamethasone|dexamethasone|mesh-list
110977310|NCT00750633|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110977311|NCT00750633|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
110977312|NCT00750633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110977313|NCT00750633|Antiemetics|antiemetics|mesh-ancestor
110977314|NCT00750633|Autonomic Agents|autonomic agents|mesh-ancestor
110977315|NCT00750633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110977316|NCT00750633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110977317|NCT00750633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110977318|NCT00750633|Glucocorticoids|glucocorticoids|mesh-ancestor
110977319|NCT00750633|Hormones|hormones|mesh-ancestor
110977320|NCT00750633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110977321|NCT00750633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110977322|NCT00750633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110977323|NCT00750633|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110977324|NCT00750633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110977325|NCT00750633|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110977326|NCT00750633|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110977327|NCT00750633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110977328|NCT00750633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110977329|NCT00750243|Naproxen|naproxen|mesh-list
111491686|NCT05677490|Oxaliplatin|oxaliplatin|mesh-list
111491687|NCT05677490|Nivolumab|nivolumab|mesh-list
111491688|NCT05677490|Irinotecan|irinotecan|mesh-list
111491689|NCT05677490|Calcium|calcium|mesh-list
111491690|NCT05677490|Levoleucovorin|levoleucovorin|mesh-list
110977330|NCT00750243|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110977331|NCT00750243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110977332|NCT00750243|Analgesics|analgesics|mesh-ancestor
110977333|NCT00750243|Sensory System Agents|sensory system agents|mesh-ancestor
110977334|NCT00750243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110977335|NCT00750243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110977336|NCT00750243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110977337|NCT00750243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110977338|NCT00750243|Gout Suppressants|gout suppressants|mesh-ancestor
110977339|NCT00750243|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110977340|NCT00750243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110977341|NCT00750243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110977342|NCT00924170|Cyclophosphamide|cyclophosphamide|mesh-list
110977343|NCT00924170|Fludarabine|fludarabine|mesh-list
110977344|NCT00924170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110977345|NCT00924170|Immunologic Factors|immunologic factors|mesh-ancestor
110977346|NCT00924170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110977347|NCT00924170|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110977348|NCT00924170|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110977349|NCT00924170|Alkylating Agents|alkylating agents|mesh-ancestor
110977350|NCT00924170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110977351|NCT00924170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110977352|NCT00924170|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110977353|NCT04809285|Insulin|insulin|mesh-list
110977354|NCT04809285|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110977355|NCT04809285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110977356|NCT00920985|Contraceptive Agents|contraceptive agents|mesh-list
110977357|NCT00920985|Gestodene|gestodene|mesh-list
110977358|NCT00920985|Contraceptives, Oral|contraceptives, oral|mesh-list
110977359|NCT00920985|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110977360|NCT00920985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110977361|NCT00920985|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110977362|NCT00920985|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110977363|NCT00920985|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110977364|NCT00920985|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110977365|NCT00920985|Progestins|progestins|mesh-ancestor
110977366|NCT00920985|Hormones|hormones|mesh-ancestor
110977367|NCT00920985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110977368|NCT05388747|Cefuroxime|cefuroxime|mesh-list
110977369|NCT05388747|Cefuroxime axetil|cefuroxime axetil|mesh-list
110977370|NCT05388747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110977371|NCT05388747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110977372|NCT00828321|Ramipril|ramipril|mesh-list
110977373|NCT00828321|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110977374|NCT00828321|Protease Inhibitors|protease inhibitors|mesh-ancestor
110977375|NCT00828321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110977376|NCT00828321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110977377|NCT00828321|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110977378|NCT01352715|Ritonavir|ritonavir|mesh-list
110977379|NCT01352715|Lopinavir|lopinavir|mesh-list
110977380|NCT01352715|Tenofovir|tenofovir|mesh-list
110977381|NCT01352715|Lamivudine|lamivudine|mesh-list
110977382|NCT01352715|Emtricitabine|emtricitabine|mesh-list
110977383|NCT01352715|Zidovudine|zidovudine|mesh-list
110977384|NCT01352715|Raltegravir Potassium|raltegravir potassium|mesh-list
110977385|NCT01352715|Abacavir|abacavir|mesh-list
110977386|NCT01352715|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
110977387|NCT01352715|Dideoxynucleosides|dideoxynucleosides|mesh-list
110977388|NCT01352715|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110977389|NCT01352715|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110977390|NCT01352715|Protease Inhibitors|protease inhibitors|mesh-ancestor
110977391|NCT01352715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110977392|NCT01352715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110977393|NCT01352715|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110977394|NCT01352715|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110977395|NCT01352715|Antiviral Agents|antiviral agents|mesh-ancestor
110977396|NCT01352715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110977397|NCT01352715|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110977398|NCT01352715|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110977399|NCT01352715|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110977400|NCT01352715|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110977401|NCT01352715|Antimetabolites|antimetabolites|mesh-ancestor
110977402|NCT01352715|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110977403|NCT01352715|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110977404|NCT00743925|Atorvastatin|atorvastatin|mesh-list
110977405|NCT00743925|Varespladib methyl|varespladib methyl|mesh-list
111491691|NCT05677490|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110977406|NCT00743925|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110977407|NCT00743925|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110977408|NCT00743925|Antimetabolites|antimetabolites|mesh-ancestor
110977409|NCT00743925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110977410|NCT00743925|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110977411|NCT00743925|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110977412|NCT00743925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110977413|NCT00743925|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
110977414|NCT00738387|Docetaxel|docetaxel|mesh-list
110977415|NCT00738387|Vadimezan|vadimezan|mesh-list
110977416|NCT00738387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110977417|NCT00738387|Tubulin Modulators|tubulin modulators|mesh-ancestor
110977418|NCT00738387|Antimitotic Agents|antimitotic agents|mesh-ancestor
110977419|NCT00738387|Mitosis Modulators|mitosis modulators|mesh-ancestor
110977420|NCT00738387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110977421|NCT03710421|Cyclophosphamide|cyclophosphamide|mesh-list
110977422|NCT03710421|Fludarabine|fludarabine|mesh-list
110977423|NCT03710421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110977424|NCT03710421|Immunologic Factors|immunologic factors|mesh-ancestor
110977425|NCT03710421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110977426|NCT03710421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110977427|NCT03710421|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110977428|NCT03710421|Alkylating Agents|alkylating agents|mesh-ancestor
110977429|NCT03710421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110977430|NCT03710421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110977431|NCT03710421|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110977432|NCT00645177|Paclitaxel|paclitaxel|mesh-list
110977433|NCT00645177|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110977434|NCT00645177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110977435|NCT00645177|Tubulin Modulators|tubulin modulators|mesh-ancestor
110977436|NCT00645177|Antimitotic Agents|antimitotic agents|mesh-ancestor
110977437|NCT00645177|Mitosis Modulators|mitosis modulators|mesh-ancestor
110977438|NCT00645177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110977439|NCT00643383|Acetaminophen|acetaminophen|mesh-list
110977440|NCT00643383|Tramadol|tramadol|mesh-list
110977441|NCT00643383|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110977442|NCT00643383|Analgesics|analgesics|mesh-ancestor
110977443|NCT00643383|Sensory System Agents|sensory system agents|mesh-ancestor
110977444|NCT00643383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110977445|NCT00643383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110977446|NCT00643383|Antipyretics|antipyretics|mesh-ancestor
110977447|NCT00643383|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110977448|NCT00643383|Narcotics|narcotics|mesh-ancestor
110977449|NCT00643383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110977450|NCT02559622|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110977451|NCT02559622|Immunologic Factors|immunologic factors|mesh-ancestor
110977452|NCT02559622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110977453|NCT04285450|Vitamin K|vitamin k|mesh-list
110977454|NCT04285450|Vitamins|vitamins|mesh-ancestor
110977455|NCT04285450|Micronutrients|micronutrients|mesh-ancestor
110977456|NCT04285450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110977457|NCT04285450|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110977458|NCT04285450|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110977459|NCT04285450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110977460|NCT04285450|Hemostatics|hemostatics|mesh-ancestor
110977461|NCT04285450|Coagulants|coagulants|mesh-ancestor
110977462|NCT05497102|Lenalidomide|lenalidomide|mesh-list
110977463|NCT05497102|Immunologic Factors|immunologic factors|mesh-ancestor
110977464|NCT05497102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110977465|NCT05497102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110977466|NCT05497102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110977467|NCT05497102|Growth Substances|growth substances|mesh-ancestor
110977468|NCT05497102|Growth Inhibitors|growth inhibitors|mesh-ancestor
110977469|NCT05497102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110977470|NCT04016818|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110977471|NCT04016818|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110977472|NCT04016818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110977473|NCT05490160|Tranexamic Acid|tranexamic acid|mesh-list
110977474|NCT05490160|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111491692|NCT05677490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111491693|NCT05677490|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110977475|NCT05490160|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110977476|NCT05490160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110977477|NCT05490160|Hemostatics|hemostatics|mesh-ancestor
110977478|NCT05490160|Coagulants|coagulants|mesh-ancestor
110977479|NCT05495620|Dexamethasone|dexamethasone|mesh-list
110977480|NCT05495620|Lenalidomide|lenalidomide|mesh-list
110977481|NCT05495620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110977482|NCT05495620|Antiemetics|antiemetics|mesh-ancestor
110977483|NCT05495620|Autonomic Agents|autonomic agents|mesh-ancestor
110977484|NCT05495620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110977485|NCT05495620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110977486|NCT05495620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110977487|NCT05495620|Glucocorticoids|glucocorticoids|mesh-ancestor
110977488|NCT05495620|Hormones|hormones|mesh-ancestor
110977489|NCT05495620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110977490|NCT05495620|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110977491|NCT05495620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110977492|NCT05495620|Immunologic Factors|immunologic factors|mesh-ancestor
110977493|NCT05495620|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110977494|NCT05495620|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110977495|NCT05495620|Growth Substances|growth substances|mesh-ancestor
110977496|NCT05495620|Growth Inhibitors|growth inhibitors|mesh-ancestor
110977497|NCT05490082|Solifenacin Succinate|solifenacin succinate|mesh-list
110977498|NCT05490082|Mirabegron|mirabegron|mesh-list
110977499|NCT05490082|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110977500|NCT05490082|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110977501|NCT05490082|Cholinergic Agents|cholinergic agents|mesh-ancestor
110977502|NCT05490082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110977503|NCT05490082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110977504|NCT05490082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110977505|NCT05490082|Urological Agents|urological agents|mesh-ancestor
110977506|NCT05490082|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
110977507|NCT05490082|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110977508|NCT05490082|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110977509|NCT05490082|Adrenergic Agents|adrenergic agents|mesh-ancestor
110977510|NCT02559310|Moxifloxacin|moxifloxacin|mesh-list
110977511|NCT02559310|Linezolid|linezolid|mesh-list
110977512|NCT02559310|Lefamulin|lefamulin|mesh-list
110977513|NCT02559310|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110977514|NCT02559310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110977515|NCT02559310|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110977516|NCT02559310|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110977517|NCT02559310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110977518|NCT02559310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110977519|NCT02559310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110977520|NCT02559310|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110977521|NCT05489926|Pamiparib|pamiparib|mesh-list
110977522|NCT05489926|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110977523|NCT05489926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110977524|NCT05489926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110977525|NCT05489926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110977526|NCT05489848|Paclitaxel|paclitaxel|mesh-list
110977527|NCT05489848|Carboplatin|carboplatin|mesh-list
110977528|NCT05489848|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110977529|NCT05489848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110977530|NCT05489848|Tubulin Modulators|tubulin modulators|mesh-ancestor
110977531|NCT05489848|Antimitotic Agents|antimitotic agents|mesh-ancestor
110977532|NCT05489848|Mitosis Modulators|mitosis modulators|mesh-ancestor
110977533|NCT05489848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110977534|NCT03517449|Paclitaxel|paclitaxel|mesh-list
110977535|NCT03517449|Doxorubicin|doxorubicin|mesh-list
110977536|NCT03517449|Pembrolizumab|pembrolizumab|mesh-list
110977537|NCT03517449|Lenvatinib|lenvatinib|mesh-list
110977538|NCT03517449|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110977539|NCT03517449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110977540|NCT03517449|Tubulin Modulators|tubulin modulators|mesh-ancestor
110977541|NCT03517449|Antimitotic Agents|antimitotic agents|mesh-ancestor
110977542|NCT03517449|Mitosis Modulators|mitosis modulators|mesh-ancestor
110977543|NCT03517449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110977544|NCT03517449|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110977545|NCT03517449|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110977546|NCT03517449|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110694624|NCT05059535|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110977547|NCT03517449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110977548|NCT03517449|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111491694|NCT05677490|Antimetabolites|antimetabolites|mesh-ancestor
110699772|NCT00377676|Hormone Antagonists|hormone antagonists|mesh-ancestor
111491695|NCT05677490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110977549|NCT03517449|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111491696|NCT05677490|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110977550|NCT03517449|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110977551|NCT05489692|Leucovorin|leucovorin|mesh-list
110977552|NCT05489692|Fluorouracil|fluorouracil|mesh-list
110977553|NCT05489692|Oxaliplatin|oxaliplatin|mesh-list
110977554|NCT05489692|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
110977555|NCT05489692|Antimetabolites|antimetabolites|mesh-ancestor
110977556|NCT05489692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110977557|NCT05489692|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110977558|NCT05489692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110977559|NCT05489692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110977560|NCT05489692|Immunologic Factors|immunologic factors|mesh-ancestor
110977561|NCT05489692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110977562|NCT05489692|Antidotes|antidotes|mesh-ancestor
110977563|NCT05489692|Protective Agents|protective agents|mesh-ancestor
110977564|NCT05489692|Vitamin B Complex|vitamin b complex|mesh-ancestor
110977565|NCT05489692|Vitamins|vitamins|mesh-ancestor
110977566|NCT05489692|Micronutrients|micronutrients|mesh-ancestor
110977567|NCT05489692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110977568|NCT00721695|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110977569|NCT00721695|Mydriatics|mydriatics|mesh-list
110977570|NCT00721695|Autonomic Agents|autonomic agents|mesh-ancestor
110977571|NCT00721695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110977572|NCT00721695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110977573|NCT00625833|Reboxetine|reboxetine|mesh-list
110977574|NCT00625833|Antidepressive Agents|antidepressive agents|mesh-ancestor
110977575|NCT00625833|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110977576|NCT00625833|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110977577|NCT00625833|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110977578|NCT00625833|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110977579|NCT00625833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110977580|NCT00625833|Adrenergic Agents|adrenergic agents|mesh-ancestor
110977581|NCT00625833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110977582|NCT00625833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110977583|NCT03299036|Doxorubicin|doxorubicin|mesh-list
110977584|NCT03299036|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110977585|NCT03299036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110977586|NCT03299036|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110977587|NCT03299036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110977588|NCT03299036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110977589|NCT03299036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110977590|NCT03290846|Secretin|secretin|mesh-list
110977591|NCT03290846|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110977592|NCT03290846|Hormones|hormones|mesh-ancestor
110977593|NCT03290846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110977594|NCT03290846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110977595|NCT03298958|Sirolimus|sirolimus|mesh-list
110977596|NCT03298958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110977597|NCT03298958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110977598|NCT03298958|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110977599|NCT03298958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110977600|NCT03298958|Antifungal Agents|antifungal agents|mesh-ancestor
110977601|NCT03298958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110977602|NCT03298958|Immunologic Factors|immunologic factors|mesh-ancestor
110977603|NCT03298958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110977604|NCT03290456|Prednisone|prednisone|mesh-list
110977605|NCT03290456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110977606|NCT03290456|Glucocorticoids|glucocorticoids|mesh-ancestor
110977607|NCT03290456|Hormones|hormones|mesh-ancestor
110479929|NCT02701179|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110977608|NCT03290456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110977609|NCT03290456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110977610|NCT03290456|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110977611|NCT03290456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110977612|NCT02555878|Rivaroxaban|rivaroxaban|mesh-list
110977613|NCT02555878|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110977614|NCT02555878|Antithrombins|antithrombins|mesh-ancestor
110977615|NCT02555878|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110977616|NCT02555878|Protease Inhibitors|protease inhibitors|mesh-ancestor
110977617|NCT02555878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110977618|NCT02555878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110977619|NCT02555878|Anticoagulants|anticoagulants|mesh-ancestor
110977620|NCT03298646|Diclofenac|diclofenac|mesh-list
111491697|NCT05677490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110977621|NCT03298646|Lidocaine|lidocaine|mesh-list
110977622|NCT03298646|Anesthetics, Local|anesthetics, local|mesh-ancestor
111491698|NCT05677490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110977623|NCT03298646|Anesthetics|anesthetics|mesh-ancestor
110977624|NCT03298646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110977625|NCT03298646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110977626|NCT03298646|Sensory System Agents|sensory system agents|mesh-ancestor
110977627|NCT03298646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110977628|NCT03298646|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110977629|NCT03298646|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110977630|NCT03298646|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110977631|NCT03298646|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110977632|NCT03298646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110977633|NCT03298646|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110977634|NCT03298646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110977635|NCT03298646|Analgesics|analgesics|mesh-ancestor
110977636|NCT03298646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110977637|NCT03298646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110977638|NCT03298646|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110977639|NCT03298646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110977640|NCT05494060|Capecitabine|capecitabine|mesh-list
110977641|NCT05494060|Oxaliplatin|oxaliplatin|mesh-list
110977642|NCT05494060|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110977643|NCT05494060|Antimetabolites|antimetabolites|mesh-ancestor
110977644|NCT05494060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110977645|NCT05494060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110977646|NCT05488990|Calcitriol|calcitriol|mesh-list
110977647|NCT05488990|Calcipotriene|calcipotriene|mesh-list
110977648|NCT05488990|Dermatologic Agents|dermatologic agents|mesh-ancestor
110977649|NCT05488990|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110977650|NCT05488990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110977651|NCT05488990|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
110977652|NCT05488990|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110977653|NCT05488990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110977654|NCT05488990|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110977655|NCT05488990|Vitamins|vitamins|mesh-ancestor
110977656|NCT05488990|Micronutrients|micronutrients|mesh-ancestor
110977657|NCT05488990|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110977658|NCT03289520|Clopidogrel|clopidogrel|mesh-list
110977659|NCT03289520|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110977660|NCT03289520|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110977661|NCT03289520|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110977662|NCT03289520|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110977663|NCT03289520|Purinergic Agents|purinergic agents|mesh-ancestor
110977664|NCT03289520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110977665|NCT03289520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110977666|NCT03289520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110977667|NCT03293108|Vitamin D|vitamin d|mesh-list
110977668|NCT03293108|Denosumab|denosumab|mesh-list
110977669|NCT03293108|Calcium|calcium|mesh-list
110977670|NCT03293108|Vitamins|vitamins|mesh-ancestor
110977671|NCT03293108|Micronutrients|micronutrients|mesh-ancestor
110977672|NCT03293108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110977673|NCT03293108|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110977674|NCT03293108|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110977675|NCT03292796|Bimatoprost|bimatoprost|mesh-list
110977676|NCT03292796|Latanoprost|latanoprost|mesh-list
110977677|NCT03292796|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110977678|NCT03292796|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110977679|NCT03292796|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110977680|NCT03288896|Ethanol|ethanol|mesh-list
110977681|NCT03288896|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110977682|NCT03288896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110977683|NCT03288896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110977684|NCT03288896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110977685|NCT03288818|Mechlorethamine|mechlorethamine|mesh-list
110977686|NCT03288818|Alkylating Agents|alkylating agents|mesh-ancestor
110977687|NCT03288818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110977688|NCT03288818|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110977689|NCT03288818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110977690|NCT03292172|Atezolizumab|atezolizumab|mesh-list
110977691|NCT03292172|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110977692|NCT03292172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111491699|NCT05677490|Immunologic Factors|immunologic factors|mesh-ancestor
110977693|NCT03292172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111491700|NCT05677490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111491701|NCT05677490|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110977694|NCT03292172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110977696|NCT02461004|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110977697|NCT02461004|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110977698|NCT02461004|Antimetabolites|antimetabolites|mesh-ancestor
110977699|NCT02461004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110977700|NCT02461004|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110977701|NCT03288428|Morphine|morphine|mesh-list
110977702|NCT03288428|Nalbuphine|nalbuphine|mesh-list
110977703|NCT03288428|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110977704|NCT03288428|Narcotics|narcotics|mesh-ancestor
110977705|NCT03288428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110977706|NCT03288428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110977707|NCT03288428|Analgesics|analgesics|mesh-ancestor
110977708|NCT03288428|Sensory System Agents|sensory system agents|mesh-ancestor
110977709|NCT03288428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110977710|NCT03288350|Avelumab|avelumab|mesh-list
110977711|NCT03288350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110977712|NCT03288350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110977713|NCT00003224|Vaccines|vaccines|mesh-list
110977714|NCT00003224|Freund's Adjuvant|freund's adjuvant|mesh-list
110977715|NCT00003224|Immunologic Factors|immunologic factors|mesh-ancestor
110977716|NCT00003224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110977717|NCT00003224|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110977718|NCT03288038|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110977719|NCT03288038|Ezetimibe|ezetimibe|mesh-list
110977720|NCT03288038|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110977721|NCT03288038|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110977722|NCT03288038|Antimetabolites|antimetabolites|mesh-ancestor
110977723|NCT03288038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110977724|NCT03288038|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110977725|NCT03288038|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110977726|NCT03288038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110977727|NCT03287882|Micronutrients|micronutrients|mesh-list
110977728|NCT03287882|Trace Elements|trace elements|mesh-list
110977729|NCT03287882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110977730|NCT03291314|Avelumab|avelumab|mesh-list
110977731|NCT03291314|Axitinib|axitinib|mesh-list
110977732|NCT03291314|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110977733|NCT03291314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110977734|NCT03291314|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110977735|NCT03291314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110977736|NCT03291314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110977737|NCT03283202|Prednisone|prednisone|mesh-list
110977738|NCT03283202|Prednisolone|prednisolone|mesh-list
110977739|NCT03283202|Cyclophosphamide|cyclophosphamide|mesh-list
110977740|NCT03283202|Rituximab|rituximab|mesh-list
110977741|NCT03283202|Vincristine|vincristine|mesh-list
110977742|NCT03283202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110977743|NCT03283202|Immunologic Factors|immunologic factors|mesh-ancestor
110977744|NCT03283202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110977745|NCT03283202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110977746|NCT03283202|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110977747|NCT03283202|Alkylating Agents|alkylating agents|mesh-ancestor
110977748|NCT03283202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110977749|NCT03283202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110977750|NCT03283202|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110977751|NCT03283202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110977752|NCT03283202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110977753|NCT03283202|Glucocorticoids|glucocorticoids|mesh-ancestor
110977754|NCT03283202|Hormones|hormones|mesh-ancestor
110977755|NCT03283202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110977756|NCT03283202|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110977757|NCT03283202|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110977758|NCT03283202|Tubulin Modulators|tubulin modulators|mesh-ancestor
110977759|NCT03283202|Antimitotic Agents|antimitotic agents|mesh-ancestor
110977760|NCT03283202|Mitosis Modulators|mitosis modulators|mesh-ancestor
110977761|NCT03283046|Dexamethasone|dexamethasone|mesh-list
111491702|NCT05677490|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111491703|NCT05677490|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110977762|NCT03283046|Nivolumab|nivolumab|mesh-list
110977763|NCT03283046|Lenalidomide|lenalidomide|mesh-list
110977764|NCT03283046|Ipilimumab|ipilimumab|mesh-list
110977765|NCT03283046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110977766|NCT03283046|Antiemetics|antiemetics|mesh-ancestor
111491704|NCT05677490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110977767|NCT03283046|Autonomic Agents|autonomic agents|mesh-ancestor
110977768|NCT03283046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110977769|NCT03283046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110977770|NCT03283046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110977771|NCT03283046|Glucocorticoids|glucocorticoids|mesh-ancestor
110977772|NCT03283046|Hormones|hormones|mesh-ancestor
110977773|NCT03283046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110977774|NCT03283046|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110977775|NCT03283046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110977776|NCT03283046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110977777|NCT03283046|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110977778|NCT03283046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110977779|NCT03283046|Immunologic Factors|immunologic factors|mesh-ancestor
110977780|NCT03283046|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110977781|NCT03283046|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110977782|NCT03283046|Growth Substances|growth substances|mesh-ancestor
110977783|NCT03283046|Growth Inhibitors|growth inhibitors|mesh-ancestor
110977784|NCT03287180|Buprenorphine|buprenorphine|mesh-list
110977785|NCT03287180|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
110977786|NCT03287180|Naloxone|naloxone|mesh-list
110977787|NCT03287180|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110977788|NCT03287180|Narcotics|narcotics|mesh-ancestor
110977789|NCT03287180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110977790|NCT03287180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110977791|NCT03287180|Analgesics|analgesics|mesh-ancestor
110977792|NCT03287180|Sensory System Agents|sensory system agents|mesh-ancestor
110977793|NCT03287180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110977794|NCT03287180|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110977795|NCT02460146|CXA-10|cxa-10|mesh-list
110977796|NCT02460146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110977797|NCT02460302|Progesterone|progesterone|mesh-list
110977798|NCT02460302|Progestins|progestins|mesh-ancestor
110977799|NCT02460302|Hormones|hormones|mesh-ancestor
110977800|NCT02460302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110977801|NCT02460302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110977802|NCT03282188|Sargramostim|sargramostim|mesh-list
110977803|NCT03282188|Immunologic Factors|immunologic factors|mesh-ancestor
110977804|NCT03282188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110977805|NCT03384212|Cytarabine|cytarabine|mesh-list
110977806|NCT03384212|Fludarabine|fludarabine|mesh-list
110977807|NCT03384212|Busulfan|busulfan|mesh-list
110977808|NCT03384212|Cladribine|cladribine|mesh-list
110977809|NCT03384212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110977810|NCT03384212|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110977811|NCT03384212|Antimetabolites|antimetabolites|mesh-ancestor
110977812|NCT03384212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110977813|NCT03384212|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110977814|NCT03384212|Immunologic Factors|immunologic factors|mesh-ancestor
110977815|NCT03384212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110977816|NCT03384212|Antiviral Agents|antiviral agents|mesh-ancestor
110977817|NCT03384212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110977818|NCT03384212|Alkylating Agents|alkylating agents|mesh-ancestor
110977819|NCT03384212|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110977820|NCT03384212|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110977821|NCT02460068|Nivolumab|nivolumab|mesh-list
110977822|NCT02460068|Ipilimumab|ipilimumab|mesh-list
110977823|NCT02460068|Fotemustine|fotemustine|mesh-list
110977824|NCT02460068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110977825|NCT02460068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110977826|NCT02460068|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110977827|NCT02460068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110977828|NCT03286244|Paclitaxel|paclitaxel|mesh-list
110977829|NCT03286244|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110977830|NCT03286244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110977831|NCT03286244|Tubulin Modulators|tubulin modulators|mesh-ancestor
110977832|NCT03286244|Antimitotic Agents|antimitotic agents|mesh-ancestor
110977833|NCT03286244|Mitosis Modulators|mitosis modulators|mesh-ancestor
110977834|NCT03286244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110977835|NCT03282110|Citalopram|citalopram|mesh-list
110977836|NCT03282110|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110977837|NCT03282110|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110977838|NCT03282110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110977839|NCT03282110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110977840|NCT03282110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111491705|NCT05677490|Antidotes|antidotes|mesh-ancestor
110977841|NCT03282110|Serotonin Agents|serotonin agents|mesh-ancestor
111491706|NCT05677490|Protective Agents|protective agents|mesh-ancestor
111491707|NCT05677490|Vitamin B Complex|vitamin b complex|mesh-ancestor
111491709|NCT05677490|Micronutrients|micronutrients|mesh-ancestor
111491710|NCT05669482|Paclitaxel|paclitaxel|mesh-list
111491711|NCT05669482|Gemcitabine|gemcitabine|mesh-list
111491712|NCT05669482|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111491713|NCT05669482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111491714|NCT05669482|Tubulin Modulators|tubulin modulators|mesh-ancestor
111491715|NCT05669482|Antimitotic Agents|antimitotic agents|mesh-ancestor
111491716|NCT05669482|Mitosis Modulators|mitosis modulators|mesh-ancestor
111491717|NCT05669482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111491718|NCT05669482|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111491719|NCT05669482|Antimetabolites|antimetabolites|mesh-ancestor
111491720|NCT05658562|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
111491721|NCT05658562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111491722|NCT05658562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111491723|NCT05656664|Folic Acid|folic acid|mesh-list
111491724|NCT05656664|Hematinics|hematinics|mesh-ancestor
111491725|NCT05656664|Vitamin B Complex|vitamin b complex|mesh-ancestor
111491726|NCT05656664|Vitamins|vitamins|mesh-ancestor
111491727|NCT05656664|Micronutrients|micronutrients|mesh-ancestor
111491728|NCT05656664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111491729|NCT05644223|Edaravone|edaravone|mesh-list
111491730|NCT05644223|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111491731|NCT05644223|Antioxidants|antioxidants|mesh-ancestor
111491732|NCT05644223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111491733|NCT05644223|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111491734|NCT05644223|Protective Agents|protective agents|mesh-ancestor
111491735|NCT05644223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111491736|NCT05633147|Clarithromycin|clarithromycin|mesh-list
111491737|NCT05633147|Midazolam|midazolam|mesh-list
111491738|NCT05633147|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111491739|NCT05633147|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111491740|NCT05633147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111491741|NCT05633147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111491742|NCT05633147|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111491743|NCT05633147|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111491744|NCT05633147|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111491745|NCT05633147|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111491746|NCT05633147|Anesthetics, General|anesthetics, general|mesh-ancestor
111491747|NCT05633147|Anesthetics|anesthetics|mesh-ancestor
111491748|NCT05633147|GABA Modulators|gaba modulators|mesh-ancestor
111491749|NCT05633147|GABA Agents|gaba agents|mesh-ancestor
111491750|NCT05633147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111491751|NCT05633147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111491752|NCT05633147|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111491753|NCT05633147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111491754|NCT05633147|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111491755|NCT05633147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111491756|NCT05633147|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111491757|NCT05633147|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111491758|NCT05627232|Diphenhydramine|diphenhydramine|mesh-list
111491759|NCT05627232|Promethazine|promethazine|mesh-list
111491760|NCT05627232|Cytarabine|cytarabine|mesh-list
111491761|NCT05627232|Daunorubicin|daunorubicin|mesh-list
111491762|NCT05627232|Palbociclib|palbociclib|mesh-list
111491763|NCT05627232|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111491764|NCT05627232|Antimetabolites|antimetabolites|mesh-ancestor
111491765|NCT05627232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111491766|NCT05627232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111491767|NCT05627232|Antiviral Agents|antiviral agents|mesh-ancestor
111491768|NCT05627232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111491769|NCT05627232|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111491770|NCT05627232|Immunologic Factors|immunologic factors|mesh-ancestor
111491771|NCT05627232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111491772|NCT05627232|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111491773|NCT05627232|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111491774|NCT05627232|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111491775|NCT05627232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111491776|NCT05627232|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110977842|NCT03282110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111491777|NCT05627232|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111491778|NCT05627232|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111491779|NCT05627232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110977843|NCT03282110|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110977844|NCT03282110|Antidepressive Agents|antidepressive agents|mesh-ancestor
111491780|NCT05627232|Anesthetics, Local|anesthetics, local|mesh-ancestor
111491782|NCT05627232|Sensory System Agents|sensory system agents|mesh-ancestor
111491783|NCT05627232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111491784|NCT05627232|Antiemetics|antiemetics|mesh-ancestor
111491785|NCT05627232|Autonomic Agents|autonomic agents|mesh-ancestor
111491786|NCT05627232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111491787|NCT05627232|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111491788|NCT05627232|Histamine Antagonists|histamine antagonists|mesh-ancestor
111491789|NCT05627232|Histamine Agents|histamine agents|mesh-ancestor
110479994|NCT02699385|Autonomic Agents|autonomic agents|mesh-ancestor
111491790|NCT05627232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111491791|NCT05627232|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111491792|NCT05627232|Antipruritics|antipruritics|mesh-ancestor
111491793|NCT05627232|Dermatologic Agents|dermatologic agents|mesh-ancestor
111491794|NCT05625412|Docetaxel|docetaxel|mesh-list
111491795|NCT05625412|Capecitabine|capecitabine|mesh-list
111491796|NCT05625412|Nivolumab|nivolumab|mesh-list
111491797|NCT05625412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111491798|NCT05625412|Tubulin Modulators|tubulin modulators|mesh-ancestor
111491799|NCT05625412|Antimitotic Agents|antimitotic agents|mesh-ancestor
111491800|NCT05625412|Mitosis Modulators|mitosis modulators|mesh-ancestor
111491801|NCT05625412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111491802|NCT05625412|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111491803|NCT05625412|Antimetabolites|antimetabolites|mesh-ancestor
111491804|NCT05625412|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111491805|NCT05625412|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111491806|NCT05623020|Dexamethasone|dexamethasone|mesh-list
111491807|NCT05623020|Lenalidomide|lenalidomide|mesh-list
111491808|NCT05623020|Daratumumab|daratumumab|mesh-list
111491809|NCT05623020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111491810|NCT05623020|Antiemetics|antiemetics|mesh-ancestor
111491811|NCT05623020|Autonomic Agents|autonomic agents|mesh-ancestor
111491812|NCT05623020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111491813|NCT05623020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111491814|NCT05623020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111491815|NCT05623020|Glucocorticoids|glucocorticoids|mesh-ancestor
111491816|NCT05623020|Hormones|hormones|mesh-ancestor
111491817|NCT05623020|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111491818|NCT05623020|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111491819|NCT05623020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111491820|NCT05623020|Immunologic Factors|immunologic factors|mesh-ancestor
111491821|NCT05623020|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111491822|NCT05623020|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111491823|NCT05623020|Growth Substances|growth substances|mesh-ancestor
111491824|NCT05623020|Growth Inhibitors|growth inhibitors|mesh-ancestor
111491825|NCT05622318|Mycophenolic Acid|mycophenolic acid|mesh-list
111491826|NCT05622318|Cyclophosphamide|cyclophosphamide|mesh-list
111491827|NCT05622318|Tacrolimus|tacrolimus|mesh-list
111491828|NCT05622318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111491829|NCT05622318|Immunologic Factors|immunologic factors|mesh-ancestor
111491830|NCT05622318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111491831|NCT05622318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111491832|NCT05622318|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111491833|NCT05622318|Alkylating Agents|alkylating agents|mesh-ancestor
111491834|NCT05622318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111491835|NCT05622318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111491836|NCT05622318|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111491837|NCT05622318|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111491838|NCT05622318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111491839|NCT05622318|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111491840|NCT05622318|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111491841|NCT05622318|Antitubercular Agents|antitubercular agents|mesh-ancestor
111491842|NCT05622318|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111491843|NCT05622318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111491844|NCT05622071|Tislelizumab|tislelizumab|mesh-list
111491845|NCT05622071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111491846|NCT05622071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111491847|NCT05618808|Enoxaparin|enoxaparin|mesh-list
111491848|NCT05618808|Anticoagulants|anticoagulants|mesh-ancestor
111491849|NCT05618808|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111491850|NCT05618808|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111491851|NCT05618808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110977845|NCT03282110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111491852|NCT05611710|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
110977846|NCT03269786|Bilirubin|bilirubin|mesh-list
111491853|NCT05611710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111491854|NCT05610163|Leucovorin|leucovorin|mesh-list
111491855|NCT05610163|Fluorouracil|fluorouracil|mesh-list
111491856|NCT05610163|Capecitabine|capecitabine|mesh-list
111491857|NCT05610163|Oxaliplatin|oxaliplatin|mesh-list
111491858|NCT05610163|Irinotecan|irinotecan|mesh-list
111491859|NCT05610163|Calcium|calcium|mesh-list
111491860|NCT05610163|Levoleucovorin|levoleucovorin|mesh-list
111491861|NCT05610163|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111491862|NCT05610163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111491863|NCT05610163|Antimetabolites|antimetabolites|mesh-ancestor
111491864|NCT05610163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111491865|NCT05610163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111491866|NCT05610163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111491867|NCT05610163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111491868|NCT05610163|Immunologic Factors|immunologic factors|mesh-ancestor
111491869|NCT05610163|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111491870|NCT05610163|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111491871|NCT05610163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111491872|NCT05610163|Antidotes|antidotes|mesh-ancestor
111491873|NCT05610163|Protective Agents|protective agents|mesh-ancestor
111491874|NCT05610163|Vitamin B Complex|vitamin b complex|mesh-ancestor
111491875|NCT05610163|Vitamins|vitamins|mesh-ancestor
111491876|NCT05610163|Micronutrients|micronutrients|mesh-ancestor
111491877|NCT05604170|Ganaxolone|ganaxolone|mesh-list
111491878|NCT05604170|Neurosteroids|neurosteroids|mesh-ancestor
111491879|NCT05604170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111491880|NCT05604170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111491881|NCT05604170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111491882|NCT05604170|GABA Modulators|gaba modulators|mesh-ancestor
111491883|NCT05604170|GABA Agents|gaba agents|mesh-ancestor
111491884|NCT05569044|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111491885|NCT05563220|Everolimus|everolimus|mesh-list
111491886|NCT05563220|Palbociclib|palbociclib|mesh-list
111491887|NCT05563220|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111491888|NCT05563220|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111491889|NCT05563220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111491890|NCT05563220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111491891|NCT05563220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111491892|NCT05563220|Immunologic Factors|immunologic factors|mesh-ancestor
111491893|NCT05563220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111491894|NCT05563220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111491895|NCT05534984|Tecovirimat|tecovirimat|mesh-list
111491896|NCT05534984|Antiviral Agents|antiviral agents|mesh-ancestor
111491897|NCT05534984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111491898|NCT05528848|Fentanyl|fentanyl|mesh-list
111491899|NCT05528848|Carfentanil|carfentanil|mesh-list
111491900|NCT05528848|Naloxone|naloxone|mesh-list
111491901|NCT05528848|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111491902|NCT05528848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111491903|NCT05528848|Sensory System Agents|sensory system agents|mesh-ancestor
111491904|NCT05528848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111491905|NCT05528848|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111491906|NCT05528848|Narcotics|narcotics|mesh-ancestor
111491907|NCT05528848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111491908|NCT05528848|Analgesics|analgesics|mesh-ancestor
111491909|NCT05528848|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111491910|NCT05528848|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111491911|NCT05528848|Anesthetics, General|anesthetics, general|mesh-ancestor
111491912|NCT05528848|Anesthetics|anesthetics|mesh-ancestor
111491913|NCT05525065|Glucocorticoids|glucocorticoids|mesh-list
111491914|NCT05525065|Hormones|hormones|mesh-ancestor
111491915|NCT05525065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111491916|NCT05525065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111491917|NCT05497778|Paclitaxel|paclitaxel|mesh-list
111491918|NCT05497778|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111491919|NCT05497778|Gemcitabine|gemcitabine|mesh-list
111491920|NCT05497778|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111491921|NCT05497778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111491922|NCT05497778|Tubulin Modulators|tubulin modulators|mesh-ancestor
111491923|NCT05497778|Antimitotic Agents|antimitotic agents|mesh-ancestor
111491924|NCT05497778|Mitosis Modulators|mitosis modulators|mesh-ancestor
110977847|NCT03269786|Antioxidants|antioxidants|mesh-ancestor
110977848|NCT03269786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111491925|NCT05497778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111491926|NCT05497778|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111491927|NCT05497778|Antimetabolites|antimetabolites|mesh-ancestor
111491928|NCT05468489|Carboplatin|carboplatin|mesh-list
110977849|NCT03269786|Protective Agents|protective agents|mesh-ancestor
110977850|NCT03269786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110977851|NCT02459600|Cyclopentolate|cyclopentolate|mesh-list
110977852|NCT02459600|Mydriatics|mydriatics|mesh-ancestor
110977853|NCT02459600|Autonomic Agents|autonomic agents|mesh-ancestor
110977854|NCT02459600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110977855|NCT02459600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110977856|NCT02459600|Parasympatholytics|parasympatholytics|mesh-ancestor
110977857|NCT02459600|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111491929|NCT05468489|Etoposide|etoposide|mesh-list
111491930|NCT05468489|Etoposide phosphate|etoposide phosphate|mesh-list
111491931|NCT05468489|Atezolizumab|atezolizumab|mesh-list
111491932|NCT05468489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111491933|NCT05468489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111491934|NCT05468489|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111491935|NCT05468489|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111491936|NCT05468489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111491937|NCT05468489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111491938|NCT05468489|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111491939|NCT05468489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111491940|NCT05464719|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
111491941|NCT05464719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111491942|NCT05464719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111491943|NCT05459571|Dexamethasone|dexamethasone|mesh-list
111491944|NCT05459571|Cyclophosphamide|cyclophosphamide|mesh-list
111491945|NCT05459571|Fludarabine|fludarabine|mesh-list
111491946|NCT05459571|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
111491947|NCT05459571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111491948|NCT05459571|Immunologic Factors|immunologic factors|mesh-ancestor
111491949|NCT05459571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111491950|NCT05459571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111491951|NCT05459571|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111491952|NCT05459571|Alkylating Agents|alkylating agents|mesh-ancestor
111491953|NCT05459571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111491954|NCT05459571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111491955|NCT05459571|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111491956|NCT05459571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111491957|NCT05459571|Antiemetics|antiemetics|mesh-ancestor
111491958|NCT05459571|Autonomic Agents|autonomic agents|mesh-ancestor
111491959|NCT05459571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111491960|NCT05459571|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111491961|NCT05459571|Glucocorticoids|glucocorticoids|mesh-ancestor
111491962|NCT05459571|Hormones|hormones|mesh-ancestor
111491963|NCT05459571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111491964|NCT05459571|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111491965|NCT05459571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111491966|NCT05420948|Paclitaxel|paclitaxel|mesh-list
111491967|NCT05420948|Carboplatin|carboplatin|mesh-list
111491968|NCT05420948|Pembrolizumab|pembrolizumab|mesh-list
111491969|NCT05420948|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111491970|NCT05420948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111491971|NCT05420948|Tubulin Modulators|tubulin modulators|mesh-ancestor
111491972|NCT05420948|Antimitotic Agents|antimitotic agents|mesh-ancestor
111491973|NCT05420948|Mitosis Modulators|mitosis modulators|mesh-ancestor
111491974|NCT05420948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111491975|NCT05420948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111491976|NCT05420948|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111491977|NCT05418348|Nimodipine|nimodipine|mesh-list
111491978|NCT05418348|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111491979|NCT05418348|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111491980|NCT05418348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111491981|NCT05418348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111491982|NCT05418348|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111491983|NCT05418348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111491984|NCT05418348|Vasodilator Agents|vasodilator agents|mesh-ancestor
111491985|NCT05416320|Calcipotriene|calcipotriene|mesh-list
111491986|NCT05416320|Dermatologic Agents|dermatologic agents|mesh-ancestor
111491987|NCT05377606|Temazepam|temazepam|mesh-list
111491988|NCT05377606|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111491989|NCT05377606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111491990|NCT05377606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111491991|NCT05377606|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111491992|NCT05377606|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111491993|NCT05377606|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111491994|NCT05377606|GABA Modulators|gaba modulators|mesh-ancestor
111491996|NCT05377606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111491997|NCT05377606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111491998|NCT05376319|Rituximab|rituximab|mesh-list
111491999|NCT05376319|Obinutuzumab|obinutuzumab|mesh-list
111492000|NCT05376319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111492001|NCT05376319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111492002|NCT05376319|Immunologic Factors|immunologic factors|mesh-ancestor
111492003|NCT05376319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111492004|NCT05376319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111492005|NCT05372367|Itraconazole|itraconazole|mesh-list
111492006|NCT05372367|Rifampin|rifampin|mesh-list
111492007|NCT05372367|Antifungal Agents|antifungal agents|mesh-ancestor
111492008|NCT05372367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111492009|NCT05372367|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111492010|NCT05372367|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111492011|NCT05372367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111492012|NCT05372367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111492013|NCT05372367|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111492014|NCT05372367|Hormone Antagonists|hormone antagonists|mesh-ancestor
111492015|NCT05372367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111492016|NCT05372367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111492017|NCT05372367|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111492018|NCT05372367|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111492019|NCT05372367|Antitubercular Agents|antitubercular agents|mesh-ancestor
111492020|NCT05372367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111492021|NCT05372367|Leprostatic Agents|leprostatic agents|mesh-ancestor
111492022|NCT05372367|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111492023|NCT05372367|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111492024|NCT05372367|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111492025|NCT05372367|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
111492026|NCT05372367|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
111492027|NCT05372367|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
111492028|NCT05372367|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111492029|NCT05360784|Brimonidine Tartrate|brimonidine tartrate|mesh-list
111492030|NCT05360784|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111492031|NCT05360784|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111492032|NCT05360784|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111492033|NCT05360784|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111492034|NCT05360784|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111492035|NCT05360784|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111492036|NCT05360784|Adrenergic Agents|adrenergic agents|mesh-ancestor
111492037|NCT05360784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111492038|NCT05360784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111492039|NCT05360784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111492040|NCT05355701|Cetuximab|cetuximab|mesh-list
111492041|NCT05355701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111492042|NCT05355701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111492043|NCT05350371|Pirfenidone|pirfenidone|mesh-list
111492044|NCT05350371|Analgesics|analgesics|mesh-ancestor
111492045|NCT05350371|Sensory System Agents|sensory system agents|mesh-ancestor
111492046|NCT05350371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111492047|NCT05350371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111492048|NCT05350371|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111492049|NCT05350371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111492050|NCT05350371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111492051|NCT05350371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111492052|NCT05350371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111492053|NCT05348200|Clobetasol|clobetasol|mesh-list
111492054|NCT05348200|Lidocaine|lidocaine|mesh-list
111492055|NCT05348200|Halobetasol|halobetasol|mesh-list
111492056|NCT05348200|Anesthetics, Local|anesthetics, local|mesh-ancestor
111492057|NCT05348200|Anesthetics|anesthetics|mesh-ancestor
111492058|NCT05348200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111492059|NCT05348200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111492060|NCT05348200|Sensory System Agents|sensory system agents|mesh-ancestor
111492061|NCT05348200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111492062|NCT05348200|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111492063|NCT05348200|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111492064|NCT05348200|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110977858|NCT02459600|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110977859|NCT02459600|Cholinergic Agents|cholinergic agents|mesh-ancestor
111492065|NCT05348200|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111492066|NCT05348200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111492067|NCT05348200|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111492068|NCT05348200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111492069|NCT05348200|Glucocorticoids|glucocorticoids|mesh-ancestor
111492070|NCT05348200|Hormones|hormones|mesh-ancestor
111492071|NCT05348200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111492072|NCT05344625|Ketamine|ketamine|mesh-list
111492073|NCT05344625|Analgesics|analgesics|mesh-ancestor
111492074|NCT05344625|Sensory System Agents|sensory system agents|mesh-ancestor
111492075|NCT05344625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111492076|NCT05344625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111492077|NCT05344625|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111492078|NCT05344625|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111492079|NCT05344625|Anesthetics, General|anesthetics, general|mesh-ancestor
111492080|NCT05344625|Anesthetics|anesthetics|mesh-ancestor
111492081|NCT05344625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111492082|NCT05344625|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111492083|NCT05344625|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111492084|NCT05344625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111492085|NCT05344625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111492086|NCT05325502|Mannitol|mannitol|mesh-list
111492087|NCT05325502|Caffeine|caffeine|mesh-list
111492088|NCT05325502|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111492089|NCT05325502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111492090|NCT05325502|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111492091|NCT05325502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111492092|NCT05325502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111492093|NCT05325502|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
111492094|NCT05325502|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111492095|NCT05325502|Purinergic Agents|purinergic agents|mesh-ancestor
111492096|NCT05325502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111492097|NCT05325502|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
111492098|NCT05325502|Diuretics|diuretics|mesh-ancestor
111492099|NCT05325502|Natriuretic Agents|natriuretic agents|mesh-ancestor
111492100|NCT05323656|Pembrolizumab|pembrolizumab|mesh-list
111492101|NCT05323656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111492102|NCT05323656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111492103|NCT05323656|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110480045|NCT03236805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111492104|NCT05323656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111492105|NCT05295173|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
111492106|NCT05295173|Plasminogen|plasminogen|mesh-list
111492107|NCT05295173|Reteplase|reteplase|mesh-list
111492108|NCT05295173|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111492109|NCT05295173|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111492110|NCT05295173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111492111|NCT05289349|Propofol|propofol|mesh-list
111492112|NCT05289349|Sevoflurane|sevoflurane|mesh-list
111492113|NCT05289349|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111492114|NCT05289349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111492115|NCT05289349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111492116|NCT05289349|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111492117|NCT05289349|Anesthetics, General|anesthetics, general|mesh-ancestor
111492118|NCT05289349|Anesthetics|anesthetics|mesh-ancestor
111492119|NCT05289349|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111492120|NCT05289349|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111492121|NCT05285813|Acetaminophen|acetaminophen|mesh-list
111492122|NCT05285813|Diphenhydramine|diphenhydramine|mesh-list
111492123|NCT05285813|Promethazine|promethazine|mesh-list
111492124|NCT05285813|Dexamethasone|dexamethasone|mesh-list
111492125|NCT05285813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111492126|NCT05285813|Antiemetics|antiemetics|mesh-ancestor
111492127|NCT05285813|Autonomic Agents|autonomic agents|mesh-ancestor
111492128|NCT05285813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111492129|NCT05285813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111492130|NCT05285813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111492131|NCT05285813|Glucocorticoids|glucocorticoids|mesh-ancestor
111492132|NCT05285813|Hormones|hormones|mesh-ancestor
111492133|NCT05285813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111492134|NCT05285813|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111492135|NCT05285813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111492136|NCT05285813|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111492137|NCT05285813|Analgesics|analgesics|mesh-ancestor
111492138|NCT05285813|Sensory System Agents|sensory system agents|mesh-ancestor
110977860|NCT02459600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111492139|NCT05285813|Antipyretics|antipyretics|mesh-ancestor
111492140|NCT05285813|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111492141|NCT05285813|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111492142|NCT05285813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111492143|NCT05285813|Anesthetics, Local|anesthetics, local|mesh-ancestor
111492144|NCT05285813|Anesthetics|anesthetics|mesh-ancestor
111492145|NCT05285813|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111492146|NCT05285813|Histamine Antagonists|histamine antagonists|mesh-ancestor
111492147|NCT05285813|Histamine Agents|histamine agents|mesh-ancestor
111492148|NCT05285813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111492149|NCT05285813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111492150|NCT05285813|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111492151|NCT05285813|Antipruritics|antipruritics|mesh-ancestor
111492152|NCT05285813|Dermatologic Agents|dermatologic agents|mesh-ancestor
111492153|NCT05285384|Myeloma Proteins|myeloma proteins|mesh-list
111492154|NCT05285384|Paraproteins|paraproteins|mesh-list
111492155|NCT05285384|Immunologic Factors|immunologic factors|mesh-ancestor
111492156|NCT05285384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111492157|NCT05279417|Methotrexate|methotrexate|mesh-list
111492158|NCT05279417|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111492159|NCT05279417|Abortifacient Agents|abortifacient agents|mesh-ancestor
111492160|NCT05279417|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111492161|NCT05279417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111492162|NCT05279417|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111492163|NCT05279417|Antimetabolites|antimetabolites|mesh-ancestor
111492164|NCT05279417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111492165|NCT05279417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111492166|NCT05279417|Dermatologic Agents|dermatologic agents|mesh-ancestor
111492167|NCT05279417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111492168|NCT05279417|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111492169|NCT05279417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111492170|NCT05279417|Immunologic Factors|immunologic factors|mesh-ancestor
111492171|NCT05279417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111492172|NCT05279417|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111492173|NCT05267470|Paclitaxel|paclitaxel|mesh-list
111492174|NCT05267470|Docetaxel|docetaxel|mesh-list
111492175|NCT05267470|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111492176|NCT05267470|Carboplatin|carboplatin|mesh-list
111492177|NCT05267470|Pembrolizumab|pembrolizumab|mesh-list
111492178|NCT05267470|Bemarituzumab|bemarituzumab|mesh-list
111492179|NCT05267470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111492180|NCT05267470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111492181|NCT05267470|Tubulin Modulators|tubulin modulators|mesh-ancestor
111492182|NCT05267470|Antimitotic Agents|antimitotic agents|mesh-ancestor
111492183|NCT05267470|Mitosis Modulators|mitosis modulators|mesh-ancestor
111492184|NCT05267470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111492185|NCT05267470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111492186|NCT05267470|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111492187|NCT05247905|Capecitabine|capecitabine|mesh-list
111492188|NCT05247905|Temozolomide|temozolomide|mesh-list
111492189|NCT05247905|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
111492190|NCT05247905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111492191|NCT05247905|Antimetabolites|antimetabolites|mesh-ancestor
111492192|NCT05247905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111492193|NCT05247905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111492194|NCT05247905|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111492195|NCT05247905|Alkylating Agents|alkylating agents|mesh-ancestor
111492196|NCT05247905|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111492197|NCT05235737|Pembrolizumab|pembrolizumab|mesh-list
111492198|NCT05235737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111492199|NCT05235737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111492200|NCT05235737|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111492201|NCT05235737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111492202|NCT05185999|Icodextrin|icodextrin|mesh-list
111492203|NCT05185999|Dialysis Solutions|dialysis solutions|mesh-ancestor
111492204|NCT05185999|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111492205|NCT05175430|Paroxetine|paroxetine|mesh-list
111492206|NCT05175430|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
111492207|NCT05175430|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111492208|NCT05175430|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111492209|NCT05175430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111492210|NCT05175430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110977861|NCT02459600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110977862|NCT03269318|Theophylline|theophylline|mesh-list
110700258|NCT03972046|Trametinib|trametinib|mesh-list
111492211|NCT05175430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111492212|NCT05175430|Serotonin Agents|serotonin agents|mesh-ancestor
111492213|NCT05175430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111492214|NCT05175430|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111492215|NCT05175430|Antidepressive Agents|antidepressive agents|mesh-ancestor
111492216|NCT05175430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111492217|NCT05175430|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111492218|NCT05175430|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111492219|NCT05175430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111492220|NCT05175430|Hallucinogens|hallucinogens|mesh-ancestor
111492221|NCT05175430|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111492222|NCT05175430|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111492223|NCT05133791|Annexin A5|annexin a5|mesh-list
111492224|NCT05133791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111492225|NCT05133791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111492226|NCT05115513|Dronabinol|dronabinol|mesh-list
111492227|NCT05115513|Hallucinogens|hallucinogens|mesh-ancestor
111492228|NCT05115513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111492229|NCT05115513|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111492230|NCT05115513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111492231|NCT05115513|Analgesics|analgesics|mesh-ancestor
111492232|NCT05115513|Sensory System Agents|sensory system agents|mesh-ancestor
111492233|NCT05115513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111492234|NCT05115513|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
111492235|NCT05115513|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
111492236|NCT05115513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111492237|NCT05115513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111492238|NCT05115513|Hormones|hormones|mesh-ancestor
111492239|NCT05115513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111492240|NCT05105542|Cholinergic Agents|cholinergic agents|mesh-list
111492241|NCT05105542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111492242|NCT05105542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111492243|NCT05105542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111492244|NCT05101070|Pembrolizumab|pembrolizumab|mesh-list
111492245|NCT05101070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111492246|NCT05101070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111492247|NCT05101070|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111492248|NCT05101070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111492249|NCT05090566|Dexamethasone|dexamethasone|mesh-list
111492250|NCT05090566|Lenalidomide|lenalidomide|mesh-list
111492251|NCT05090566|Nirogacestat|nirogacestat|mesh-list
111492252|NCT05090566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111492253|NCT05090566|Antiemetics|antiemetics|mesh-ancestor
111492254|NCT05090566|Autonomic Agents|autonomic agents|mesh-ancestor
111492255|NCT05090566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111492256|NCT05090566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111492257|NCT05090566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111492258|NCT05090566|Glucocorticoids|glucocorticoids|mesh-ancestor
111492259|NCT05090566|Hormones|hormones|mesh-ancestor
111492260|NCT05090566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111492261|NCT05090566|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111492262|NCT05090566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111492263|NCT05090566|Immunologic Factors|immunologic factors|mesh-ancestor
111492264|NCT05090566|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111492265|NCT05090566|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111492266|NCT05090566|Growth Substances|growth substances|mesh-ancestor
111492267|NCT05090566|Growth Inhibitors|growth inhibitors|mesh-ancestor
111492268|NCT05090566|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
111492269|NCT05090566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111492270|NCT05090566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111492271|NCT05084053|Immunoglobulins|immunoglobulins|mesh-list
111492272|NCT05084053|Immunologic Factors|immunologic factors|mesh-ancestor
111492273|NCT05084053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111492274|NCT05079230|Azacitidine|azacitidine|mesh-list
111492275|NCT05079230|Venetoclax|venetoclax|mesh-list
111492276|NCT05079230|Magrolimab|magrolimab|mesh-list
111492277|NCT05079230|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111492278|NCT05079230|Antimetabolites|antimetabolites|mesh-ancestor
111492279|NCT05079230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111492280|NCT05079230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110977863|NCT03269318|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110977864|NCT03269318|Montelukast|montelukast|mesh-list
110977865|NCT03269318|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110977866|NCT03269318|Autonomic Agents|autonomic agents|mesh-ancestor
110977867|NCT03269318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110977868|NCT03269318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110700372|NCT00265785|Pemetrexed|pemetrexed|mesh-list
111492281|NCT05079230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111492282|NCT05079230|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111492283|NCT05057806|Empagliflozin|empagliflozin|mesh-list
111492284|NCT05057806|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111492285|NCT05057806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111492286|NCT05057806|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111492287|NCT05057806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111492288|NCT05041036|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-list
111492289|NCT05041036|Nirogacestat|nirogacestat|mesh-list
111492290|NCT05041036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111492291|NCT05041036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111492292|NCT05027945|Mycophenolic Acid|mycophenolic acid|mesh-list
111492293|NCT05027945|Sirolimus|sirolimus|mesh-list
111492294|NCT05027945|Cyclophosphamide|cyclophosphamide|mesh-list
111492295|NCT05027945|Busulfan|busulfan|mesh-list
111492296|NCT05027945|Fludarabine|fludarabine|mesh-list
111492297|NCT05027945|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111492298|NCT05027945|Immunologic Factors|immunologic factors|mesh-ancestor
111492299|NCT05027945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111492300|NCT05027945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111492301|NCT05027945|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111492302|NCT05027945|Alkylating Agents|alkylating agents|mesh-ancestor
111492303|NCT05027945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111492304|NCT05027945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111492305|NCT05027945|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111492306|NCT05027945|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111492307|NCT05027945|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111492308|NCT05027945|Antitubercular Agents|antitubercular agents|mesh-ancestor
111492309|NCT05027945|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111492310|NCT05027945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111492311|NCT05027945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111492312|NCT05027945|Antifungal Agents|antifungal agents|mesh-ancestor
111492313|NCT05011058|Valganciclovir|valganciclovir|mesh-list
111492314|NCT05011058|Antiviral Agents|antiviral agents|mesh-ancestor
111492315|NCT05011058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111492316|NCT04978298|Phenelzine|phenelzine|mesh-list
111492317|NCT04978298|Ozanimod|ozanimod|mesh-list
111492318|NCT04978298|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
111492319|NCT04978298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111492320|NCT04978298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111492321|NCT04978298|Immunologic Factors|immunologic factors|mesh-ancestor
111492322|NCT04978298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111492323|NCT04978298|Antidepressive Agents|antidepressive agents|mesh-ancestor
111492324|NCT04978298|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111492325|NCT04978298|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
111492326|NCT04978298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111492327|NCT04975919|Decitabine|decitabine|mesh-list
111492328|NCT04975919|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
111492329|NCT04975919|Venetoclax|venetoclax|mesh-list
111492330|NCT04975919|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111492331|NCT04975919|Antimetabolites|antimetabolites|mesh-ancestor
111492332|NCT04975919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111492333|NCT04975919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111492334|NCT04975919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111492335|NCT04921527|Paclitaxel|paclitaxel|mesh-list
111492336|NCT04921527|Chiauranib|chiauranib|mesh-list
111492337|NCT04921527|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111492338|NCT04921527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111492339|NCT04921527|Tubulin Modulators|tubulin modulators|mesh-ancestor
111492340|NCT04921527|Antimitotic Agents|antimitotic agents|mesh-ancestor
111492341|NCT04921527|Mitosis Modulators|mitosis modulators|mesh-ancestor
111492342|NCT04921527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111492343|NCT04921527|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111492344|NCT04921527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111492345|NCT04913220|Cemiplimab|cemiplimab|mesh-list
111492346|NCT04913220|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111492347|NCT04913220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111492348|NCT04902378|Insulin|insulin|mesh-list
111492349|NCT04902378|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111492350|NCT04902378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111492351|NCT04898504|Floxuridine|floxuridine|mesh-list
111492352|NCT04898504|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110977869|NCT03269318|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110977870|NCT03269318|Respiratory System Agents|respiratory system agents|mesh-ancestor
111492353|NCT04898504|Antimetabolites|antimetabolites|mesh-ancestor
111492354|NCT04898504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111492355|NCT04898504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111492356|NCT04882085|Ceftazidime|ceftazidime|mesh-list
111492357|NCT04882085|Avibactam|avibactam|mesh-list
111492358|NCT04882085|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
111492359|NCT04882085|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111492360|NCT04882085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111492361|NCT04882085|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
111492362|NCT04882085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111492363|NCT04882085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111492364|NCT04876079|Insulin|insulin|mesh-list
111492365|NCT04876079|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111492366|NCT04876079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111492367|NCT04857034|Deucravacitinib|deucravacitinib|mesh-list
111492368|NCT04857034|Dermatologic Agents|dermatologic agents|mesh-ancestor
111492369|NCT04857034|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111492370|NCT04857034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111492371|NCT04857034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111492372|NCT04845035|Cytarabine|cytarabine|mesh-list
111492373|NCT04845035|Methotrexate|methotrexate|mesh-list
111492374|NCT04845035|Dasatinib|dasatinib|mesh-list
111492375|NCT04845035|Ponatinib|ponatinib|mesh-list
111492376|NCT04845035|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111492377|NCT04845035|Abortifacient Agents|abortifacient agents|mesh-ancestor
111492378|NCT04845035|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111492379|NCT04845035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111492380|NCT04845035|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111492381|NCT04845035|Antimetabolites|antimetabolites|mesh-ancestor
111492382|NCT04845035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111492383|NCT04845035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111492384|NCT04845035|Dermatologic Agents|dermatologic agents|mesh-ancestor
111492385|NCT04845035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111492386|NCT04845035|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111492387|NCT04845035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111492388|NCT04845035|Immunologic Factors|immunologic factors|mesh-ancestor
111492389|NCT04845035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111492390|NCT04845035|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111492391|NCT04845035|Antiviral Agents|antiviral agents|mesh-ancestor
111492392|NCT04845035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111492393|NCT04845035|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111492394|NCT04811573|Thalidomide|thalidomide|mesh-list
111492395|NCT04811573|Apremilast|apremilast|mesh-list
111492396|NCT04811573|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111492397|NCT04811573|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111492398|NCT04811573|Analgesics|analgesics|mesh-ancestor
111492399|NCT04811573|Sensory System Agents|sensory system agents|mesh-ancestor
111492400|NCT04811573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111492401|NCT04811573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111492402|NCT04811573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111492403|NCT04811573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111492404|NCT04811573|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
111492405|NCT04811573|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111492406|NCT04811573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111492407|NCT04811573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111492408|NCT04811573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111492409|NCT04811573|Immunologic Factors|immunologic factors|mesh-ancestor
111492410|NCT04811573|Leprostatic Agents|leprostatic agents|mesh-ancestor
111492411|NCT04811573|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111492412|NCT04811573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111492413|NCT04811573|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111492414|NCT04811573|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111492415|NCT04811573|Growth Substances|growth substances|mesh-ancestor
111492416|NCT04811573|Growth Inhibitors|growth inhibitors|mesh-ancestor
111492417|NCT04811573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111492418|NCT04803201|Prednisone|prednisone|mesh-list
111492419|NCT04803201|Cyclophosphamide|cyclophosphamide|mesh-list
111492420|NCT04803201|Doxorubicin|doxorubicin|mesh-list
111492421|NCT04803201|Etoposide|etoposide|mesh-list
111492422|NCT04803201|Vincristine|vincristine|mesh-list
111492423|NCT04803201|Azacitidine|azacitidine|mesh-list
111492424|NCT04803201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111492425|NCT04803201|Immunologic Factors|immunologic factors|mesh-ancestor
111492426|NCT04803201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110977871|NCT03269318|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111492428|NCT04803201|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111492429|NCT04803201|Alkylating Agents|alkylating agents|mesh-ancestor
111492430|NCT04803201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111492431|NCT04803201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111492432|NCT04803201|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111492433|NCT04803201|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111492434|NCT04803201|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111492435|NCT04803201|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111492436|NCT04803201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111492437|NCT04803201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111492438|NCT04803201|Glucocorticoids|glucocorticoids|mesh-ancestor
111492439|NCT04803201|Hormones|hormones|mesh-ancestor
111492440|NCT04803201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111492441|NCT04803201|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111492442|NCT04803201|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111492443|NCT04803201|Tubulin Modulators|tubulin modulators|mesh-ancestor
111492444|NCT04803201|Antimitotic Agents|antimitotic agents|mesh-ancestor
111492445|NCT04803201|Mitosis Modulators|mitosis modulators|mesh-ancestor
111492446|NCT04803201|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111492447|NCT04803201|Antimetabolites|antimetabolites|mesh-ancestor
111492448|NCT04778397|Cytarabine|cytarabine|mesh-list
111492449|NCT04778397|Azacitidine|azacitidine|mesh-list
111492450|NCT04778397|Daunorubicin|daunorubicin|mesh-list
111492451|NCT04778397|Venetoclax|venetoclax|mesh-list
111492452|NCT04778397|Idarubicin|idarubicin|mesh-list
111492453|NCT04778397|Magrolimab|magrolimab|mesh-list
111492454|NCT04778397|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111492455|NCT04778397|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111492456|NCT04778397|Antimetabolites|antimetabolites|mesh-ancestor
111492457|NCT04778397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111492458|NCT04778397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111492459|NCT04778397|Antiviral Agents|antiviral agents|mesh-ancestor
111492460|NCT04778397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111492461|NCT04778397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111492462|NCT04778397|Immunologic Factors|immunologic factors|mesh-ancestor
111492463|NCT04778397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111492464|NCT04778397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111492465|NCT04778397|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111492466|NCT04778397|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111492467|NCT04778397|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111492468|NCT04778397|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111492469|NCT04778397|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111492470|NCT04774094|Ceftazidime|ceftazidime|mesh-list
111492471|NCT04774094|Avibactam|avibactam|mesh-list
111492472|NCT04774094|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
111492473|NCT04774094|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111492474|NCT04774094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111492475|NCT04774094|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
111492476|NCT04774094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111492477|NCT04774094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111492478|NCT04772079|Deucravacitinib|deucravacitinib|mesh-list
111492479|NCT04772079|Dermatologic Agents|dermatologic agents|mesh-ancestor
111492480|NCT04772079|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111492481|NCT04772079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111492482|NCT04772079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111492483|NCT04753437|Amoxicillin|amoxicillin|mesh-list
111492484|NCT04753437|Clarithromycin|clarithromycin|mesh-list
111492485|NCT04753437|Potassium Citrate|potassium citrate|mesh-list
111492486|NCT04753437|Esomeprazole|esomeprazole|mesh-list
110977872|NCT03269318|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110977873|NCT03269318|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110977874|NCT03269318|Adrenergic Agents|adrenergic agents|mesh-ancestor
110977875|NCT03269318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110977876|NCT03269318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110977877|NCT03269318|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110977878|NCT03269318|Hormone Antagonists|hormone antagonists|mesh-ancestor
110977879|NCT03269318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110977880|NCT03269318|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110977881|NCT03269318|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110977882|NCT03269318|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110977883|NCT03269318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111492487|NCT04753437|Bismuth|bismuth|mesh-list
110977884|NCT03269318|Vasodilator Agents|vasodilator agents|mesh-ancestor
111492488|NCT04753437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111492489|NCT04753437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111492490|NCT04753437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111492491|NCT04753437|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111492492|NCT04753437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111492493|NCT04753437|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111492494|NCT04753437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111492495|NCT04753437|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111492496|NCT04753437|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111492497|NCT04753437|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111492499|NCT04753437|Diuretics|diuretics|mesh-ancestor
111492500|NCT04753437|Natriuretic Agents|natriuretic agents|mesh-ancestor
111492501|NCT04753437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111492502|NCT04753437|Expectorants|expectorants|mesh-ancestor
111492503|NCT04753437|Respiratory System Agents|respiratory system agents|mesh-ancestor
111492504|NCT04744116|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
111492505|NCT04744116|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111492506|NCT04744116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111492507|NCT04744116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111492508|NCT04740671|Ranibizumab|ranibizumab|mesh-list
111492509|NCT04740671|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111492510|NCT04740671|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111492511|NCT04740671|Growth Substances|growth substances|mesh-ancestor
111492512|NCT04740671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111492513|NCT04740671|Growth Inhibitors|growth inhibitors|mesh-ancestor
111492514|NCT04740671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111492515|NCT04711109|Denosumab|denosumab|mesh-list
111492516|NCT04711109|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111492517|NCT04711109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111492518|NCT04703920|Talazoparib|talazoparib|mesh-list
111492519|NCT04703920|Belinostat|belinostat|mesh-list
111492520|NCT04703920|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111492521|NCT04703920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111492522|NCT04703920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111492523|NCT04703920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111492524|NCT04703920|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111492525|NCT04613557|Cyclophosphamide|cyclophosphamide|mesh-list
111492526|NCT04613557|Fludarabine|fludarabine|mesh-list
111492527|NCT04613557|Fludarabine phosphate|fludarabine phosphate|mesh-list
111492528|NCT04613557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111492529|NCT04613557|Immunologic Factors|immunologic factors|mesh-ancestor
111492530|NCT04613557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111492531|NCT04613557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111492532|NCT04613557|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111492533|NCT04613557|Alkylating Agents|alkylating agents|mesh-ancestor
111492534|NCT04613557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111492535|NCT04613557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111492536|NCT04613557|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111492537|NCT04613557|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111492538|NCT04613557|Antimetabolites|antimetabolites|mesh-ancestor
111492539|NCT04605094|Benralizumab|benralizumab|mesh-list
111492540|NCT04605094|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111492541|NCT04605094|Respiratory System Agents|respiratory system agents|mesh-ancestor
111492542|NCT04605081|Naltrexone|naltrexone|mesh-list
111492543|NCT04605081|Bupropion|bupropion|mesh-list
111492544|NCT04605081|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111492545|NCT04605081|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111492546|NCT04605081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111492547|NCT04605081|Sensory System Agents|sensory system agents|mesh-ancestor
111492548|NCT04605081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111492549|NCT04605081|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111492550|NCT04605081|Antidepressive Agents|antidepressive agents|mesh-ancestor
111492551|NCT04605081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110480096|NCT00616005|Irinotecan|irinotecan|mesh-list
111492552|NCT04605081|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111492553|NCT04605081|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111492554|NCT04605081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111492555|NCT04605081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111492556|NCT04605081|Dopamine Agents|dopamine agents|mesh-ancestor
111492557|NCT04605081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111492558|NCT04605081|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110977885|NCT03269318|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110977886|NCT03269318|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111492559|NCT04605081|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111492560|NCT04605081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111492561|NCT04600336|Oxybutynin|oxybutynin|mesh-list
111492562|NCT04600336|Parasympatholytics|parasympatholytics|mesh-ancestor
111492563|NCT04600336|Autonomic Agents|autonomic agents|mesh-ancestor
111492564|NCT04600336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111492565|NCT04600336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111492566|NCT04600336|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111492567|NCT04600336|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111492568|NCT04600336|Cholinergic Agents|cholinergic agents|mesh-ancestor
111492569|NCT04600336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111492570|NCT04600336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111492571|NCT04600336|Urological Agents|urological agents|mesh-ancestor
111492572|NCT04599504|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
111492573|NCT04599504|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111492574|NCT04599504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111492575|NCT04599504|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111492576|NCT04599504|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111492577|NCT04599504|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111492578|NCT04599504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111492579|NCT04599504|Dopamine Agents|dopamine agents|mesh-ancestor
111492580|NCT04599504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111492581|NCT04599478|Naltrexone|naltrexone|mesh-list
111492582|NCT04599478|Bupropion|bupropion|mesh-list
111492583|NCT04599478|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111492584|NCT04599478|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111492585|NCT04599478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111492586|NCT04599478|Sensory System Agents|sensory system agents|mesh-ancestor
111492587|NCT04599478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111492588|NCT04599478|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111492589|NCT04599478|Antidepressive Agents|antidepressive agents|mesh-ancestor
111492590|NCT04599478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111492591|NCT04599478|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111492592|NCT04599478|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111492593|NCT04599478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111492594|NCT04599478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111492595|NCT04599478|Dopamine Agents|dopamine agents|mesh-ancestor
111492596|NCT04599478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111492597|NCT04599478|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111492598|NCT04599478|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111492599|NCT04599478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111492600|NCT04578639|Rituximab|rituximab|mesh-list
111492601|NCT04578639|Ocrelizumab|ocrelizumab|mesh-list
111492602|NCT04578639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111492603|NCT04578639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111492604|NCT04578639|Immunologic Factors|immunologic factors|mesh-ancestor
111492605|NCT04578639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111492606|NCT04578639|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111492607|NCT04555577|Temozolomide|temozolomide|mesh-list
111492608|NCT04555577|Peposertib|peposertib|mesh-list
111492609|NCT04555577|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111492610|NCT04555577|Alkylating Agents|alkylating agents|mesh-ancestor
111492611|NCT04555577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111492612|NCT04555577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111492613|NCT04555577|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111492614|NCT04555577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111492615|NCT04530006|Amantadine|amantadine|mesh-list
111492616|NCT04530006|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111492617|NCT04530006|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111492618|NCT04530006|Antiviral Agents|antiviral agents|mesh-ancestor
111492619|NCT04530006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111492620|NCT04530006|Dopamine Agents|dopamine agents|mesh-ancestor
111492621|NCT04530006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111492622|NCT04530006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111492623|NCT04530006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111492624|NCT04530006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111492625|NCT04530006|Analgesics|analgesics|mesh-ancestor
111492626|NCT04530006|Sensory System Agents|sensory system agents|mesh-ancestor
111492627|NCT04530006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111492628|NCT04526210|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
110977887|NCT03269318|Purinergic Agents|purinergic agents|mesh-ancestor
111492629|NCT04526210|Choline|choline|mesh-list
110977888|NCT03284762|Rivaroxaban|rivaroxaban|mesh-list
110977890|NCT03284762|Antithrombins|antithrombins|mesh-ancestor
111492630|NCT04526210|Bupropion|bupropion|mesh-list
111492631|NCT04526210|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111492632|NCT04526210|Antidepressive Agents|antidepressive agents|mesh-ancestor
111492633|NCT04526210|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111492634|NCT04526210|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111492635|NCT04526210|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111492636|NCT04526210|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111492637|NCT04526210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111492638|NCT04526210|Dopamine Agents|dopamine agents|mesh-ancestor
111492639|NCT04526210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111492640|NCT04526210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111492641|NCT04526210|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111492642|NCT04526210|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111492643|NCT04526210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111492644|NCT04526210|Lipotropic Agents|lipotropic agents|mesh-ancestor
111492645|NCT04526210|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111492646|NCT04526210|Antimetabolites|antimetabolites|mesh-ancestor
111492647|NCT04526210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111492648|NCT04526210|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111492649|NCT04526210|Nootropic Agents|nootropic agents|mesh-ancestor
111492650|NCT04526210|Chelating Agents|chelating agents|mesh-ancestor
111492651|NCT04526210|Sequestering Agents|sequestering agents|mesh-ancestor
111492652|NCT04526210|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111492653|NCT04526210|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111492654|NCT04526210|Growth Substances|growth substances|mesh-ancestor
111492655|NCT04526210|Growth Inhibitors|growth inhibitors|mesh-ancestor
111492656|NCT04526210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111492657|NCT04522323|Lenvatinib|lenvatinib|mesh-list
111492658|NCT04522323|Axitinib|axitinib|mesh-list
111492659|NCT04522323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111492660|NCT04522323|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111492661|NCT04522323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111492662|NCT04522323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111492663|NCT04510311|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
111492664|NCT04510311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111492665|NCT04510311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111492666|NCT04510311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111492667|NCT04510311|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111492668|NCT04493164|Cytarabine|cytarabine|mesh-list
111492669|NCT04493164|Daunorubicin|daunorubicin|mesh-list
111492670|NCT04493164|Ivosidenib|ivosidenib|mesh-list
111492671|NCT04493164|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111492672|NCT04493164|Antimetabolites|antimetabolites|mesh-ancestor
111492673|NCT04493164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111492674|NCT04493164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111492675|NCT04493164|Antiviral Agents|antiviral agents|mesh-ancestor
111492676|NCT04493164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111492677|NCT04493164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111492678|NCT04493164|Immunologic Factors|immunologic factors|mesh-ancestor
111492679|NCT04493164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111492680|NCT04493164|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111492681|NCT04493164|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111492682|NCT04493164|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111492683|NCT04493164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111492684|NCT04457596|Trastuzumab|trastuzumab|mesh-list
111492685|NCT04457596|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
111492686|NCT04457596|Maytansine|maytansine|mesh-list
111492687|NCT04457596|Tucatinib|tucatinib|mesh-list
111492688|NCT04457596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111492689|NCT04457596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111492690|NCT04457596|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111492691|NCT04457596|Tubulin Modulators|tubulin modulators|mesh-ancestor
111492692|NCT04457596|Antimitotic Agents|antimitotic agents|mesh-ancestor
111492693|NCT04457596|Mitosis Modulators|mitosis modulators|mesh-ancestor
111492694|NCT04457596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111492695|NCT04457596|Immunotoxins|immunotoxins|mesh-ancestor
111492696|NCT04457596|Immunoconjugates|immunoconjugates|mesh-ancestor
111492697|NCT04457596|Immunologic Factors|immunologic factors|mesh-ancestor
111492698|NCT04457596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111492699|NCT04457596|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111492700|NCT04457596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111492701|NCT04455750|Leuprolide|leuprolide|mesh-list
111492702|NCT04455750|Goserelin|goserelin|mesh-list
111492703|NCT04455750|Rucaparib|rucaparib|mesh-list
111492704|NCT04455750|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111492705|NCT04455750|Fertility Agents|fertility agents|mesh-ancestor
111492706|NCT04455750|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111492707|NCT04455750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111492708|NCT04455750|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111492709|NCT04455750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111492710|NCT04455750|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111492711|NCT04455750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111492712|NCT04455750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111492713|NCT04435691|Azacitidine|azacitidine|mesh-list
111492714|NCT04435691|Venetoclax|venetoclax|mesh-list
111492715|NCT04435691|Magrolimab|magrolimab|mesh-list
111492716|NCT04435691|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111492717|NCT04435691|Antimetabolites|antimetabolites|mesh-ancestor
111492718|NCT04435691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111492719|NCT04435691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111492720|NCT04435691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111492721|NCT04435691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111492722|NCT04422652|Bupropion|bupropion|mesh-list
111492723|NCT04422652|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111492724|NCT04422652|Antidepressive Agents|antidepressive agents|mesh-ancestor
111492725|NCT04422652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111492726|NCT04422652|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111492727|NCT04422652|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111492728|NCT04422652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111492729|NCT04422652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111492730|NCT04422652|Dopamine Agents|dopamine agents|mesh-ancestor
111492731|NCT04422652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111492732|NCT04422652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111492733|NCT04422652|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111492734|NCT04422652|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111492735|NCT04422652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111492736|NCT04384692|Mycophenolic Acid|mycophenolic acid|mesh-list
111492737|NCT04384692|Cyclophosphamide|cyclophosphamide|mesh-list
111492738|NCT04384692|Melphalan|melphalan|mesh-list
111492739|NCT04384692|Busulfan|busulfan|mesh-list
111492740|NCT04384692|Mechlorethamine|mechlorethamine|mesh-list
111492741|NCT04384692|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
111492742|NCT04384692|Methotrexate|methotrexate|mesh-list
111492743|NCT04384692|Fludarabine|fludarabine|mesh-list
111492744|NCT04384692|Tacrolimus|tacrolimus|mesh-list
111492745|NCT04384692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111492746|NCT04384692|Immunologic Factors|immunologic factors|mesh-ancestor
111492747|NCT04384692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111492748|NCT04384692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111492749|NCT04384692|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111492750|NCT04384692|Alkylating Agents|alkylating agents|mesh-ancestor
111492751|NCT04384692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111492752|NCT04384692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111492753|NCT04384692|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111492754|NCT04384692|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111492755|NCT04384692|Abortifacient Agents|abortifacient agents|mesh-ancestor
111492756|NCT04384692|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111492757|NCT04384692|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110480107|NCT02698527|Anesthetics|anesthetics|mesh-ancestor
111492758|NCT04384692|Antimetabolites|antimetabolites|mesh-ancestor
111492759|NCT04384692|Dermatologic Agents|dermatologic agents|mesh-ancestor
111492760|NCT04384692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111492761|NCT04384692|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111492762|NCT04384692|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111492763|NCT04384692|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111492764|NCT04384692|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111492765|NCT04384692|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111492766|NCT04384692|Antitubercular Agents|antitubercular agents|mesh-ancestor
111492767|NCT04384692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111492768|NCT04384692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111492769|NCT04377451|Metformin|metformin|mesh-list
111492770|NCT04377451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111492771|NCT04377451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111492772|NCT04367311|Docetaxel|docetaxel|mesh-list
111492773|NCT04367311|Pemetrexed|pemetrexed|mesh-list
111492774|NCT04367311|Atezolizumab|atezolizumab|mesh-list
111492775|NCT04367311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110977891|NCT03284762|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110977892|NCT03284762|Protease Inhibitors|protease inhibitors|mesh-ancestor
111492776|NCT04367311|Tubulin Modulators|tubulin modulators|mesh-ancestor
111492777|NCT04367311|Antimitotic Agents|antimitotic agents|mesh-ancestor
111492778|NCT04367311|Mitosis Modulators|mitosis modulators|mesh-ancestor
111492779|NCT04367311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111492780|NCT04367311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111492781|NCT04367311|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111492782|NCT04367311|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111492783|NCT04367311|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111492784|NCT04367311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111492785|NCT04340141|Leucovorin|leucovorin|mesh-list
111492786|NCT04340141|Fluorouracil|fluorouracil|mesh-list
111492787|NCT04340141|Oxaliplatin|oxaliplatin|mesh-list
111492788|NCT04340141|Irinotecan|irinotecan|mesh-list
111492789|NCT04340141|Calcium|calcium|mesh-list
111492790|NCT04340141|Levoleucovorin|levoleucovorin|mesh-list
111492791|NCT04340141|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111492792|NCT04340141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111492793|NCT04340141|Antimetabolites|antimetabolites|mesh-ancestor
111492794|NCT04340141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111492795|NCT04340141|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111492796|NCT04340141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111492797|NCT04340141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111492798|NCT04340141|Immunologic Factors|immunologic factors|mesh-ancestor
111492799|NCT04340141|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111492800|NCT04340141|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111492801|NCT04340141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111492802|NCT04340141|Antidotes|antidotes|mesh-ancestor
111492803|NCT04340141|Protective Agents|protective agents|mesh-ancestor
111492804|NCT04340141|Vitamin B Complex|vitamin b complex|mesh-ancestor
111492805|NCT04340141|Vitamins|vitamins|mesh-ancestor
111492806|NCT04340141|Micronutrients|micronutrients|mesh-ancestor
111492807|NCT04338763|Gemcitabine|gemcitabine|mesh-list
111492808|NCT04338763|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111492809|NCT04338763|Antimetabolites|antimetabolites|mesh-ancestor
111492810|NCT04338763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111492811|NCT04338763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111492812|NCT04329325|Dexamethasone|dexamethasone|mesh-list
111492813|NCT04329325|Methotrexate|methotrexate|mesh-list
111492814|NCT04329325|Dasatinib|dasatinib|mesh-list
111492815|NCT04329325|Blinatumomab|blinatumomab|mesh-list
111492816|NCT04329325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111492817|NCT04329325|Antiemetics|antiemetics|mesh-ancestor
111492818|NCT04329325|Autonomic Agents|autonomic agents|mesh-ancestor
111492819|NCT04329325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111492820|NCT04329325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111492821|NCT04329325|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111492822|NCT04329325|Glucocorticoids|glucocorticoids|mesh-ancestor
111492823|NCT04329325|Hormones|hormones|mesh-ancestor
111492824|NCT04329325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111492825|NCT04329325|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111492826|NCT04329325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111492827|NCT04329325|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111492828|NCT04329325|Abortifacient Agents|abortifacient agents|mesh-ancestor
111492829|NCT04329325|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111492830|NCT04329325|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111492831|NCT04329325|Antimetabolites|antimetabolites|mesh-ancestor
111492832|NCT04329325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111492833|NCT04329325|Dermatologic Agents|dermatologic agents|mesh-ancestor
111492834|NCT04329325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111492835|NCT04329325|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111492836|NCT04329325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111492837|NCT04329325|Immunologic Factors|immunologic factors|mesh-ancestor
111492838|NCT04329325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111492839|NCT04329325|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111492840|NCT04329325|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111492841|NCT04238819|Irinotecan|irinotecan|mesh-list
111492842|NCT04238819|Temozolomide|temozolomide|mesh-list
111492843|NCT04238819|Dinutuximab|dinutuximab|mesh-list
111492844|NCT04238819|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111492845|NCT04238819|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111492846|NCT04238819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111492847|NCT04238819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111492848|NCT04238819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110977893|NCT03284762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110700873|NCT00357006|Contraceptive Agents|contraceptive agents|mesh-ancestor
111492849|NCT04238819|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111492850|NCT04238819|Alkylating Agents|alkylating agents|mesh-ancestor
111492851|NCT04209946|Pulmonary Surfactants|pulmonary surfactants|mesh-list
110977894|NCT03284762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111492852|NCT04209946|Respiratory System Agents|respiratory system agents|mesh-ancestor
111492853|NCT04190056|Tamoxifen|tamoxifen|mesh-list
111492854|NCT04190056|Pembrolizumab|pembrolizumab|mesh-list
111492855|NCT04190056|Vorinostat|vorinostat|mesh-list
111492856|NCT04190056|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111492857|NCT04190056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111492858|NCT04190056|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111492859|NCT04190056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111492860|NCT04190056|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111492861|NCT04190056|Hormone Antagonists|hormone antagonists|mesh-ancestor
111492862|NCT04190056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111492863|NCT04190056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111492864|NCT04190056|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111492865|NCT04190056|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111492866|NCT04190056|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111492867|NCT04190056|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111492868|NCT04190056|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111492869|NCT04190056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111492870|NCT04189757|Acalabrutinib|acalabrutinib|mesh-list
111492871|NCT04189757|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
111492872|NCT04189757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111492873|NCT04189757|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111492874|NCT04189757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111492875|NCT04189757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111492876|NCT04149964|Acetaminophen|acetaminophen|mesh-list
111492877|NCT04149964|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
111492878|NCT04149964|Oxycodone|oxycodone|mesh-list
111492879|NCT04149964|Hydrocodone|hydrocodone|mesh-list
111492880|NCT04149964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111492881|NCT04149964|Analgesics|analgesics|mesh-ancestor
111492882|NCT04149964|Sensory System Agents|sensory system agents|mesh-ancestor
111492883|NCT04149964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111492884|NCT04149964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111492885|NCT04149964|Antipyretics|antipyretics|mesh-ancestor
111492886|NCT04149964|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111492887|NCT04149964|Narcotics|narcotics|mesh-ancestor
111492888|NCT04149964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111492889|NCT04149964|Antitussive Agents|antitussive agents|mesh-ancestor
111492890|NCT04149964|Respiratory System Agents|respiratory system agents|mesh-ancestor
111492891|NCT04149964|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111492892|NCT04149964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111492893|NCT04149964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111492894|NCT04137107|Oxaliplatin|oxaliplatin|mesh-list
110556294|NCT00674102|Vadimezan|vadimezan|mesh-list
111492895|NCT04137107|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
111492896|NCT04137107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111492897|NCT04137107|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111492898|NCT04137107|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111492899|NCT04137107|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111492900|NCT04137107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111492901|NCT04137107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111492902|NCT04137107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111492903|NCT04137107|Analgesics|analgesics|mesh-ancestor
111492904|NCT04137107|Sensory System Agents|sensory system agents|mesh-ancestor
111492905|NCT04137107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111492906|NCT04137107|Antidepressive Agents|antidepressive agents|mesh-ancestor
111492907|NCT04137107|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111492908|NCT04137107|Dopamine Agents|dopamine agents|mesh-ancestor
111492909|NCT04131504|Adalimumab|adalimumab|mesh-list
111492910|NCT04131504|Infliximab|infliximab|mesh-list
111492911|NCT04131504|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111492912|NCT04131504|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111492913|NCT04131504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111492914|NCT04131504|Dermatologic Agents|dermatologic agents|mesh-ancestor
111492915|NCT04131504|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111492916|NCT04082572|Pembrolizumab|pembrolizumab|mesh-list
111492917|NCT04082572|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111492918|NCT04082572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111492919|NCT04082572|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111492920|NCT04082572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111492921|NCT04076579|Olaparib|olaparib|mesh-list
110977895|NCT03284762|Anticoagulants|anticoagulants|mesh-ancestor
110977896|NCT04172558|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111492923|NCT04076579|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111492924|NCT04076579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111492925|NCT04076579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111492926|NCT04076579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111492927|NCT04076579|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111492928|NCT04076579|Alkylating Agents|alkylating agents|mesh-ancestor
111492929|NCT04071366|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
111492930|NCT04071366|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111492931|NCT04071366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111492932|NCT04053322|Durvalumab|durvalumab|mesh-list
111492933|NCT04053322|Fulvestrant|fulvestrant|mesh-list
111492934|NCT04053322|Olaparib|olaparib|mesh-list
111492935|NCT04053322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111492936|NCT04053322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111492937|NCT04053322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111492938|NCT04053322|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
111492939|NCT04053322|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111492940|NCT04053322|Hormone Antagonists|hormone antagonists|mesh-ancestor
111492941|NCT04053322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111492942|NCT04053322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111492943|NCT04053322|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111492944|NCT04053322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111492945|NCT04053322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111492946|NCT04049110|Dapagliflozin|dapagliflozin|mesh-list
111492947|NCT04049110|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111492948|NCT04049110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111492949|NCT04049110|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111492950|NCT04049110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111492951|NCT04022239|Mycophenolic Acid|mycophenolic acid|mesh-list
111492952|NCT04022239|Cyclophosphamide|cyclophosphamide|mesh-list
111492953|NCT04022239|Melphalan|melphalan|mesh-list
111492954|NCT04022239|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
111492955|NCT04022239|Mechlorethamine|mechlorethamine|mesh-list
111492956|NCT04022239|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
111492957|NCT04022239|Rituximab|rituximab|mesh-list
111492958|NCT04022239|Fludarabine|fludarabine|mesh-list
111492959|NCT04022239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111492960|NCT04022239|Tacrolimus|tacrolimus|mesh-list
111492961|NCT04022239|Antibodies|antibodies|mesh-list
111492962|NCT04022239|Immunoglobulins|immunoglobulins|mesh-list
111492963|NCT04022239|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111492964|NCT04022239|Lenograstim|lenograstim|mesh-list
111492965|NCT04022239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111492966|NCT04022239|Immunologic Factors|immunologic factors|mesh-ancestor
111492967|NCT04022239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111492968|NCT04022239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111492969|NCT04022239|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111492970|NCT04022239|Alkylating Agents|alkylating agents|mesh-ancestor
111492971|NCT04022239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111492972|NCT04022239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111492973|NCT04022239|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111492974|NCT04022239|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111492975|NCT04022239|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111492976|NCT04022239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111492977|NCT04022239|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111492978|NCT04022239|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111492979|NCT04022239|Antitubercular Agents|antitubercular agents|mesh-ancestor
111492980|NCT04022239|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111492981|NCT04022239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111492982|NCT04015180|Aflibercept|aflibercept|mesh-list
111492983|NCT04015180|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111492984|NCT04015180|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111492985|NCT04015180|Growth Substances|growth substances|mesh-ancestor
111492986|NCT04015180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111492987|NCT04015180|Growth Inhibitors|growth inhibitors|mesh-ancestor
111492988|NCT04015180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111492989|NCT03994796|Adagrasib|adagrasib|mesh-list
111492990|NCT03994796|Entrectinib|entrectinib|mesh-list
111492991|NCT03994796|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111492992|NCT03994796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110977897|NCT04172558|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111492993|NCT03994796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111492994|NCT03994796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111492995|NCT03989466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111492996|NCT03989466|Alemtuzumab|alemtuzumab|mesh-list
111492997|NCT03989466|Antibodies|antibodies|mesh-list
111492998|NCT03989466|Immunoglobulins|immunoglobulins|mesh-list
111492999|NCT03989466|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111493000|NCT03989466|Immunologic Factors|immunologic factors|mesh-ancestor
111493001|NCT03989466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111493002|NCT03989466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111493003|NCT03974932|Acetaminophen|acetaminophen|mesh-list
111493004|NCT03974932|Ibuprofen|ibuprofen|mesh-list
111493005|NCT03974932|Celecoxib|celecoxib|mesh-list
111493006|NCT03974932|Bupivacaine|bupivacaine|mesh-list
111493007|NCT03974932|Anesthetics, Local|anesthetics, local|mesh-ancestor
111493008|NCT03974932|Anesthetics|anesthetics|mesh-ancestor
111493009|NCT03974932|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111493010|NCT03974932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111493011|NCT03974932|Sensory System Agents|sensory system agents|mesh-ancestor
111493012|NCT03974932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111493013|NCT03974932|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111493014|NCT03974932|Analgesics|analgesics|mesh-ancestor
111493015|NCT03974932|Antipyretics|antipyretics|mesh-ancestor
111493016|NCT03974932|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111493017|NCT03974932|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111493018|NCT03974932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111493019|NCT03974932|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111493020|NCT03974932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111493021|NCT03974932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111493022|NCT03974932|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111493023|NCT03944941|Cetuximab|cetuximab|mesh-list
111493024|NCT03944941|Avelumab|avelumab|mesh-list
111493025|NCT03944941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111493026|NCT03944941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111493027|NCT03910244|Pomalidomide|pomalidomide|mesh-list
111493028|NCT03910244|Immunologic Factors|immunologic factors|mesh-ancestor
111493029|NCT03910244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111493030|NCT03910244|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111493031|NCT03910244|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111493032|NCT03910244|Growth Substances|growth substances|mesh-ancestor
111493033|NCT03910244|Growth Inhibitors|growth inhibitors|mesh-ancestor
111493034|NCT03910244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111493035|NCT03856515|Nicotine|nicotine|mesh-list
111493036|NCT03856515|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111493037|NCT03856515|Autonomic Agents|autonomic agents|mesh-ancestor
111493038|NCT03856515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111493039|NCT03856515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111493040|NCT03856515|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111493041|NCT03856515|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111493042|NCT03856515|Cholinergic Agents|cholinergic agents|mesh-ancestor
111493043|NCT03856515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111493044|NCT03856515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111493045|NCT03777813|Leucovorin|leucovorin|mesh-list
111493046|NCT03777813|Oxaliplatin|oxaliplatin|mesh-list
111493047|NCT03777813|Durvalumab|durvalumab|mesh-list
111493048|NCT03777813|Levoleucovorin|levoleucovorin|mesh-list
111493049|NCT03777813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111493050|NCT03777813|Antidotes|antidotes|mesh-ancestor
111493051|NCT03777813|Protective Agents|protective agents|mesh-ancestor
111493052|NCT03777813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111493053|NCT03777813|Vitamin B Complex|vitamin b complex|mesh-ancestor
111493054|NCT03777813|Vitamins|vitamins|mesh-ancestor
111493055|NCT03777813|Micronutrients|micronutrients|mesh-ancestor
111493056|NCT03777813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111493057|NCT03761095|Dacarbazine|dacarbazine|mesh-list
111493058|NCT03761095|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111493059|NCT03761095|Alkylating Agents|alkylating agents|mesh-ancestor
111493060|NCT03761095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111493061|NCT03761095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111493062|NCT03754933|Fludarabine|fludarabine|mesh-list
111493063|NCT03754933|Fludarabine phosphate|fludarabine phosphate|mesh-list
111493064|NCT03754933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110977898|NCT04172558|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111493065|NCT03754933|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111493066|NCT03754933|Antimetabolites|antimetabolites|mesh-ancestor
110701097|NCT01582672|Sunitinib|sunitinib|mesh-list
111493067|NCT03754933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111493068|NCT03754933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111493069|NCT03754933|Immunologic Factors|immunologic factors|mesh-ancestor
111493070|NCT03754933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111493071|NCT03725878|Folic Acid|folic acid|mesh-list
111493072|NCT03725878|Hematinics|hematinics|mesh-ancestor
111493073|NCT03725878|Vitamin B Complex|vitamin b complex|mesh-ancestor
111493074|NCT03725878|Vitamins|vitamins|mesh-ancestor
111493075|NCT03725878|Micronutrients|micronutrients|mesh-ancestor
111493076|NCT03725878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111493077|NCT03718767|Nivolumab|nivolumab|mesh-list
111493078|NCT03718767|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111493079|NCT03718767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111493080|NCT03718767|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111493081|NCT03718767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111493082|NCT03717896|Thiamine|thiamine|mesh-list
111493083|NCT03717896|Vitamins|vitamins|mesh-ancestor
111493084|NCT03717896|Micronutrients|micronutrients|mesh-ancestor
111493085|NCT03717896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111493086|NCT03717896|Vitamin B Complex|vitamin b complex|mesh-ancestor
111493087|NCT03694262|Bevacizumab|bevacizumab|mesh-list
111493088|NCT03694262|Atezolizumab|atezolizumab|mesh-list
111493089|NCT03694262|Rucaparib|rucaparib|mesh-list
111493090|NCT03694262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111493091|NCT03694262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111493092|NCT03694262|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111493093|NCT03694262|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111493094|NCT03694262|Growth Substances|growth substances|mesh-ancestor
111493095|NCT03694262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111493096|NCT03694262|Growth Inhibitors|growth inhibitors|mesh-ancestor
111493097|NCT03694262|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111493098|NCT03694262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111493099|NCT03694262|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111493100|NCT03694262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111493101|NCT03639935|Nivolumab|nivolumab|mesh-list
111493102|NCT03639935|Rucaparib|rucaparib|mesh-list
111493103|NCT03639935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111493104|NCT03639935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111493105|NCT03639935|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111493106|NCT03639935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111493107|NCT03639935|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111493108|NCT03639935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111493109|NCT03624231|Durvalumab|durvalumab|mesh-list
111493110|NCT03624231|Tremelimumab|tremelimumab|mesh-list
111493111|NCT03624231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111493112|NCT03624231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111493113|NCT03609216|Gemcitabine|gemcitabine|mesh-list
111493114|NCT03609216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111493115|NCT03609216|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111493116|NCT03609216|Antimetabolites|antimetabolites|mesh-ancestor
111493117|NCT03609216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111493118|NCT03604315|Deoxyglucose|deoxyglucose|mesh-list
111493119|NCT03604315|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
111493120|NCT03604315|Fluorides|fluorides|mesh-list
111493121|NCT03604315|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111493122|NCT03604315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111493123|NCT03604315|Cariostatic Agents|cariostatic agents|mesh-ancestor
111493124|NCT03604315|Protective Agents|protective agents|mesh-ancestor
111493125|NCT03604315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111493126|NCT03604315|Antimetabolites|antimetabolites|mesh-ancestor
111493127|NCT03604315|Antiviral Agents|antiviral agents|mesh-ancestor
111493128|NCT03604315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111493129|NCT03564509|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
111493130|NCT03564509|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
111493131|NCT03564509|Hormones|hormones|mesh-ancestor
111493132|NCT03564509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111493133|NCT03564509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111493134|NCT03564509|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111493135|NCT03556384|Temozolomide|temozolomide|mesh-list
111493136|NCT03556384|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111493137|NCT03556384|Alkylating Agents|alkylating agents|mesh-ancestor
111493138|NCT03556384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111493139|NCT03556384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111493140|NCT03528694|Durvalumab|durvalumab|mesh-list
111493141|NCT03528694|BCG Vaccine|bcg vaccine|mesh-list
111493142|NCT03528694|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110977899|NCT04172558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110977900|NCT04172558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110977901|NCT04172558|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111493143|NCT03528694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111493144|NCT03528694|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111493145|NCT03528694|Immunologic Factors|immunologic factors|mesh-ancestor
111493146|NCT03528694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111493147|NCT03523858|Ocrelizumab|ocrelizumab|mesh-list
111493148|NCT03523858|Immunologic Factors|immunologic factors|mesh-ancestor
111493149|NCT03523858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111493150|NCT03486197|Pembrolizumab|pembrolizumab|mesh-list
111493151|NCT03486197|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111493152|NCT03486197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111493153|NCT03486197|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111493154|NCT03486197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111493155|NCT03477500|Cyclophosphamide|cyclophosphamide|mesh-list
111493156|NCT03477500|Alemtuzumab|alemtuzumab|mesh-list
111493157|NCT03477500|Cladribine|cladribine|mesh-list
111493158|NCT03477500|Ocrelizumab|ocrelizumab|mesh-list
111493159|NCT03477500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111493160|NCT03477500|Immunologic Factors|immunologic factors|mesh-ancestor
111493161|NCT03477500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111493162|NCT03477500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111493163|NCT03477500|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111493164|NCT03477500|Alkylating Agents|alkylating agents|mesh-ancestor
111493165|NCT03477500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111493166|NCT03477500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111493167|NCT03477500|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111493168|NCT03477500|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111493169|NCT03422822|Abrocitinib|abrocitinib|mesh-list
111493170|NCT03422822|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111493171|NCT03422822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111493172|NCT03422822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111493173|NCT03348670|Prednisone|prednisone|mesh-list
111493174|NCT03348670|Abiraterone Acetate|abiraterone acetate|mesh-list
111493175|NCT03348670|Relugolix|relugolix|mesh-list
111493176|NCT03348670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111493177|NCT03348670|Glucocorticoids|glucocorticoids|mesh-ancestor
111493178|NCT03348670|Hormones|hormones|mesh-ancestor
111493179|NCT03348670|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111493180|NCT03348670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111493181|NCT03348670|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111493182|NCT03348670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111493183|NCT03348670|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111493184|NCT03348670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111493185|NCT03348670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111493186|NCT03348670|Hormone Antagonists|hormone antagonists|mesh-ancestor
111493187|NCT03348670|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111493188|NCT03348670|Androgen Antagonists|androgen antagonists|mesh-ancestor
111493189|NCT03259503|Rituximab|rituximab|mesh-list
111493190|NCT03259503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111493191|NCT03259503|Gemcitabine|gemcitabine|mesh-list
111493192|NCT03259503|Melphalan|melphalan|mesh-list
111493193|NCT03259503|Busulfan|busulfan|mesh-list
111493194|NCT03259503|Olaparib|olaparib|mesh-list
111493195|NCT03259503|Mechlorethamine|mechlorethamine|mesh-list
111493196|NCT03259503|Vorinostat|vorinostat|mesh-list
111493197|NCT03259503|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
111493198|NCT03259503|Antibodies|antibodies|mesh-list
111493199|NCT03259503|Immunoglobulins|immunoglobulins|mesh-list
111493200|NCT03259503|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111493201|NCT03259503|Immunologic Factors|immunologic factors|mesh-ancestor
111493202|NCT03259503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111493203|NCT03259503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111493204|NCT03259503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111493205|NCT03259503|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111493206|NCT03259503|Antimetabolites|antimetabolites|mesh-ancestor
111493207|NCT03259503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111493208|NCT03259503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111493209|NCT03259503|Alkylating Agents|alkylating agents|mesh-ancestor
111493210|NCT03259503|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111493211|NCT03259503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111493212|NCT03259503|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111493213|NCT03259503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111493214|NCT03259503|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110977902|NCT04172558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111493215|NCT03242915|Carboplatin|carboplatin|mesh-list
111493216|NCT03242915|Pembrolizumab|pembrolizumab|mesh-list
110480155|NCT04213833|Analgesics|analgesics|mesh-ancestor
110977903|NCT04172558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111493217|NCT03242915|Pemetrexed|pemetrexed|mesh-list
111493218|NCT03242915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111493219|NCT03242915|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111493220|NCT03242915|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111493221|NCT03242915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111493222|NCT03242915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111493223|NCT03242915|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111493224|NCT03242915|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111493225|NCT03240016|Pembrolizumab|pembrolizumab|mesh-list
111493226|NCT03240016|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111493227|NCT03240016|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111493228|NCT03240016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111493229|NCT03240016|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111493230|NCT03240016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111493231|NCT03229499|Anastrozole|anastrozole|mesh-list
111493232|NCT03229499|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111493233|NCT03229499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111493234|NCT03229499|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111493235|NCT03229499|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111493236|NCT03229499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111493237|NCT03229499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111493238|NCT03229499|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111493239|NCT03229499|Hormone Antagonists|hormone antagonists|mesh-ancestor
111493240|NCT03229499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111493241|NCT03229499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111493242|NCT03224767|Vemurafenib|vemurafenib|mesh-list
111493243|NCT03224767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111493244|NCT03224767|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111493245|NCT03224767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111493246|NCT03224767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111493247|NCT03223025|Hormones|hormones|mesh-list
111493248|NCT03223025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111493249|NCT03223025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111493250|NCT03158129|Cisplatin|cisplatin|mesh-list
111493251|NCT03158129|Carboplatin|carboplatin|mesh-list
111493252|NCT03158129|Docetaxel|docetaxel|mesh-list
111493253|NCT03158129|Nivolumab|nivolumab|mesh-list
111493254|NCT03158129|Pemetrexed|pemetrexed|mesh-list
111493255|NCT03158129|Ipilimumab|ipilimumab|mesh-list
111493256|NCT03158129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111493257|NCT03158129|Tubulin Modulators|tubulin modulators|mesh-ancestor
111493258|NCT03158129|Antimitotic Agents|antimitotic agents|mesh-ancestor
111493259|NCT03158129|Mitosis Modulators|mitosis modulators|mesh-ancestor
111493260|NCT03158129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111493261|NCT03158129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111493262|NCT03158129|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111493263|NCT03158129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111493264|NCT03158129|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111493265|NCT03158129|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111493266|NCT03150693|Cytarabine|cytarabine|mesh-list
111493267|NCT03150693|Dexamethasone|dexamethasone|mesh-list
111493268|NCT03150693|Cyclophosphamide|cyclophosphamide|mesh-list
111493269|NCT03150693|Rituximab|rituximab|mesh-list
111493270|NCT03150693|Doxorubicin|doxorubicin|mesh-list
111493271|NCT03150693|Methotrexate|methotrexate|mesh-list
111493272|NCT03150693|Vincristine|vincristine|mesh-list
111493273|NCT03150693|Daunorubicin|daunorubicin|mesh-list
111493274|NCT03150693|Asparaginase|asparaginase|mesh-list
111493275|NCT03150693|Mercaptopurine|mercaptopurine|mesh-list
111493276|NCT03150693|Thioguanine|thioguanine|mesh-list
111493277|NCT03150693|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
111493278|NCT03150693|Pegaspargase|pegaspargase|mesh-list
111493279|NCT03150693|Allopurinol|allopurinol|mesh-list
111493280|NCT03150693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111493281|NCT03150693|Immunologic Factors|immunologic factors|mesh-ancestor
111493282|NCT03150693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111493283|NCT03150693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111493284|NCT03150693|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111493285|NCT03150693|Alkylating Agents|alkylating agents|mesh-ancestor
111493286|NCT03150693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111493287|NCT03150693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111493288|NCT03150693|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111493289|NCT03150693|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111493290|NCT03150693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111493291|NCT03150693|Antiemetics|antiemetics|mesh-ancestor
111493292|NCT03150693|Autonomic Agents|autonomic agents|mesh-ancestor
110977904|NCT04172558|Cholinergic Agents|cholinergic agents|mesh-ancestor
111493293|NCT03150693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111493294|NCT03150693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111493295|NCT03150693|Glucocorticoids|glucocorticoids|mesh-ancestor
111493296|NCT03150693|Hormones|hormones|mesh-ancestor
111493297|NCT03150693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111493298|NCT03150693|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111493299|NCT03150693|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111493300|NCT03150693|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111493301|NCT03150693|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111493302|NCT03150693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111493303|NCT03150693|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111493304|NCT03150693|Abortifacient Agents|abortifacient agents|mesh-ancestor
111493305|NCT03150693|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111493306|NCT03150693|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111493307|NCT03150693|Antimetabolites|antimetabolites|mesh-ancestor
111493308|NCT03150693|Dermatologic Agents|dermatologic agents|mesh-ancestor
111493309|NCT03150693|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111493310|NCT03150693|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111493311|NCT03150693|Antiviral Agents|antiviral agents|mesh-ancestor
111493312|NCT03150693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111493313|NCT03150693|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111493314|NCT03150693|Tubulin Modulators|tubulin modulators|mesh-ancestor
111493315|NCT03150693|Antimitotic Agents|antimitotic agents|mesh-ancestor
111493316|NCT03150693|Mitosis Modulators|mitosis modulators|mesh-ancestor
111493317|NCT03150693|Gout Suppressants|gout suppressants|mesh-ancestor
111493318|NCT03150693|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111493319|NCT03150693|Antioxidants|antioxidants|mesh-ancestor
111493320|NCT03150693|Protective Agents|protective agents|mesh-ancestor
111493321|NCT03150693|Immunotoxins|immunotoxins|mesh-ancestor
111493322|NCT03150693|Immunoconjugates|immunoconjugates|mesh-ancestor
111493323|NCT03120624|Iodine|iodine|mesh-list
111493324|NCT03120624|Interferons|interferons|mesh-list
111493325|NCT03120624|Interferon-beta|interferon-beta|mesh-list
111493326|NCT03120624|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
111493327|NCT03120624|Sodium Pertechnetate Tc 99m|sodium pertechnetate tc 99m|mesh-list
111493328|NCT03120624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111493329|NCT03120624|Antiviral Agents|antiviral agents|mesh-ancestor
111493330|NCT03120624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111493331|NCT03120624|Immunologic Factors|immunologic factors|mesh-ancestor
111493332|NCT03120624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111493333|NCT03120624|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111493334|NCT03120624|Trace Elements|trace elements|mesh-ancestor
111493335|NCT03120624|Micronutrients|micronutrients|mesh-ancestor
111493336|NCT03120624|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111493337|NCT03120624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111493338|NCT03120624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111493339|NCT03120624|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111493340|NCT03118037|Zaleplon|zaleplon|mesh-list
111493341|NCT03118037|Anticonvulsants|anticonvulsants|mesh-ancestor
111493342|NCT03118037|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111493343|NCT03118037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111493344|NCT03118037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111493345|NCT03118037|GABA Modulators|gaba modulators|mesh-ancestor
111493346|NCT03118037|GABA Agents|gaba agents|mesh-ancestor
111493347|NCT03118037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111493348|NCT03118037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111493349|NCT03099356|Sirolimus|sirolimus|mesh-list
111493350|NCT03099356|Cyclophosphamide|cyclophosphamide|mesh-list
111493351|NCT03099356|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111493352|NCT03099356|Immunologic Factors|immunologic factors|mesh-ancestor
111493353|NCT03099356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111493354|NCT03099356|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111493355|NCT03099356|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111493356|NCT03099356|Alkylating Agents|alkylating agents|mesh-ancestor
111493357|NCT03099356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111493358|NCT03099356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111493359|NCT03099356|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111493360|NCT03099356|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111493361|NCT03099356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111493362|NCT03099356|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111493363|NCT03099356|Antifungal Agents|antifungal agents|mesh-ancestor
110977905|NCT04172558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111493364|NCT03092518|Sodium thiosulfate|sodium thiosulfate|mesh-list
111493365|NCT03092518|Mitomycins|mitomycins|mesh-list
111493366|NCT03092518|Mitomycin|mitomycin|mesh-list
110977906|NCT03107858|Dopamine|dopamine|mesh-list
110977907|NCT03107858|Norepinephrine|norepinephrine|mesh-list
110977908|NCT03107858|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110977909|NCT03107858|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110977910|NCT03107858|Adrenergic Agents|adrenergic agents|mesh-ancestor
110977911|NCT03107858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110977912|NCT03107858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110977913|NCT03107858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111493367|NCT03092518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111493368|NCT03092518|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111493369|NCT03092518|Alkylating Agents|alkylating agents|mesh-ancestor
111493370|NCT03092518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111493371|NCT03092518|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111493372|NCT03092518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111493373|NCT03092518|Antidotes|antidotes|mesh-ancestor
111493374|NCT03092518|Protective Agents|protective agents|mesh-ancestor
111493375|NCT03092518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111493376|NCT03092518|Antioxidants|antioxidants|mesh-ancestor
111493377|NCT03092518|Antitubercular Agents|antitubercular agents|mesh-ancestor
111493378|NCT03092518|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111493379|NCT03092518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111493380|NCT03092518|Chelating Agents|chelating agents|mesh-ancestor
111493381|NCT03092518|Sequestering Agents|sequestering agents|mesh-ancestor
111493382|NCT03007030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111493383|NCT03007030|Brentuximab Vedotin|brentuximab vedotin|mesh-list
111493384|NCT03007030|Antibodies|antibodies|mesh-list
111493385|NCT03007030|Immunoglobulins|immunoglobulins|mesh-list
111493386|NCT03007030|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111493387|NCT03007030|Immunoconjugates|immunoconjugates|mesh-list
111493388|NCT03007030|Immunologic Factors|immunologic factors|mesh-ancestor
111493389|NCT03007030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111493390|NCT03007030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111493391|NCT03007030|Immunotoxins|immunotoxins|mesh-ancestor
111493392|NCT02960022|Prednisone|prednisone|mesh-list
111493393|NCT02960022|Abiraterone Acetate|abiraterone acetate|mesh-list
111493394|NCT02960022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111493395|NCT02960022|Glucocorticoids|glucocorticoids|mesh-ancestor
111493396|NCT02960022|Hormones|hormones|mesh-ancestor
111493397|NCT02960022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111493398|NCT02960022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111493399|NCT02960022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111493400|NCT02960022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111493401|NCT02960022|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111493402|NCT02960022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111493403|NCT02960022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111493404|NCT02960022|Hormone Antagonists|hormone antagonists|mesh-ancestor
111493405|NCT02960022|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111493406|NCT02938520|Rilpivirine|rilpivirine|mesh-list
111493407|NCT02938520|Cabotegravir|cabotegravir|mesh-list
111493408|NCT02938520|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111493409|NCT02938520|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111493410|NCT02938520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111493411|NCT02938520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111493412|NCT02938520|Antiviral Agents|antiviral agents|mesh-ancestor
111493413|NCT02938520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111493414|NCT02938520|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111493415|NCT02938520|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111493416|NCT02938520|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111493417|NCT02938520|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111493418|NCT02871219|Lenalidomide|lenalidomide|mesh-list
111493419|NCT02871219|Obinutuzumab|obinutuzumab|mesh-list
111493420|NCT02871219|Immunologic Factors|immunologic factors|mesh-ancestor
111493421|NCT02871219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111493422|NCT02871219|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111493423|NCT02871219|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111493424|NCT02871219|Growth Substances|growth substances|mesh-ancestor
111493425|NCT02871219|Growth Inhibitors|growth inhibitors|mesh-ancestor
111493426|NCT02871219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111493427|NCT02871219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111493428|NCT02830360|Amiodarone|amiodarone|mesh-list
111493429|NCT02830360|Sotalol|sotalol|mesh-list
111493430|NCT02830360|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111493431|NCT02830360|Vasodilator Agents|vasodilator agents|mesh-ancestor
110977914|NCT03107858|Sympathomimetics|sympathomimetics|mesh-ancestor
111493432|NCT02830360|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
111493433|NCT02830360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110977915|NCT03107858|Autonomic Agents|autonomic agents|mesh-ancestor
111493434|NCT02830360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111493435|NCT02830360|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111493436|NCT02830360|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111493437|NCT02830360|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111493438|NCT02830360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111493439|NCT02830360|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111493440|NCT02830360|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111493441|NCT02830360|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111493442|NCT02830360|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111493443|NCT02830360|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111493444|NCT02830360|Adrenergic Agents|adrenergic agents|mesh-ancestor
111493445|NCT02830360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111493446|NCT02830360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111493447|NCT02830360|Sympatholytics|sympatholytics|mesh-ancestor
111493448|NCT02830360|Autonomic Agents|autonomic agents|mesh-ancestor
111493449|NCT02830360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111493450|NCT02766465|Sirolimus|sirolimus|mesh-list
111493451|NCT02766465|Methotrexate|methotrexate|mesh-list
111493452|NCT02766465|Fludarabine|fludarabine|mesh-list
111493453|NCT02766465|Melphalan|melphalan|mesh-list
111493454|NCT02766465|Busulfan|busulfan|mesh-list
111493455|NCT02766465|Alemtuzumab|alemtuzumab|mesh-list
111493456|NCT02766465|Tacrolimus|tacrolimus|mesh-list
111493457|NCT02766465|Antilymphocyte Serum|antilymphocyte serum|mesh-list
111493458|NCT02766465|Thymoglobulin|thymoglobulin|mesh-list
111493459|NCT02766465|Lenograstim|lenograstim|mesh-list
111493460|NCT02766465|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111493461|NCT02766465|Abortifacient Agents|abortifacient agents|mesh-ancestor
111493462|NCT02766465|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111493463|NCT02766465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111493464|NCT02766465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111493465|NCT02766465|Antimetabolites|antimetabolites|mesh-ancestor
111493466|NCT02766465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111493467|NCT02766465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111493468|NCT02766465|Dermatologic Agents|dermatologic agents|mesh-ancestor
111493469|NCT02766465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111493470|NCT02766465|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111493471|NCT02766465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111493472|NCT02766465|Immunologic Factors|immunologic factors|mesh-ancestor
111493473|NCT02766465|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111493474|NCT02766465|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111493475|NCT02766465|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111493476|NCT02766465|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111493477|NCT02766465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111493478|NCT02766465|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111493479|NCT02766465|Antifungal Agents|antifungal agents|mesh-ancestor
111493480|NCT02766465|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111493481|NCT02766465|Alkylating Agents|alkylating agents|mesh-ancestor
111493482|NCT02766465|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111493483|NCT02766465|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111493484|NCT02766465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111493485|NCT02764541|Tamoxifen|tamoxifen|mesh-list
111493486|NCT02764541|Letrozole|letrozole|mesh-list
111493487|NCT02764541|Palbociclib|palbociclib|mesh-list
111493488|NCT02764541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111493489|NCT02764541|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111493490|NCT02764541|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111493491|NCT02764541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111493492|NCT02764541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111493493|NCT02764541|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111493494|NCT02764541|Hormone Antagonists|hormone antagonists|mesh-ancestor
111493495|NCT02764541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111493496|NCT02764541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111493497|NCT02764541|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111493498|NCT02764541|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111493499|NCT02764541|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111493500|NCT02764541|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111493501|NCT02764541|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111493502|NCT02720068|Leucovorin|leucovorin|mesh-list
111493503|NCT02720068|Pembrolizumab|pembrolizumab|mesh-list
111493504|NCT02720068|Fluorouracil|fluorouracil|mesh-list
111493505|NCT02720068|Oxaliplatin|oxaliplatin|mesh-list
111493506|NCT02720068|Irinotecan|irinotecan|mesh-list
111493507|NCT02720068|Lenvatinib|lenvatinib|mesh-list
111493508|NCT02720068|Calcium|calcium|mesh-list
110977916|NCT03107858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111493509|NCT02720068|Levoleucovorin|levoleucovorin|mesh-list
111493510|NCT02720068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111493511|NCT02720068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111493512|NCT02720068|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111493513|NCT02720068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111493514|NCT02720068|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111493515|NCT02720068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111493516|NCT02720068|Antimetabolites|antimetabolites|mesh-ancestor
111493517|NCT02720068|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111493518|NCT02720068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111493519|NCT02720068|Immunologic Factors|immunologic factors|mesh-ancestor
111493520|NCT02720068|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111493521|NCT02720068|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111493522|NCT02720068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111493523|NCT02720068|Antidotes|antidotes|mesh-ancestor
111493524|NCT02720068|Protective Agents|protective agents|mesh-ancestor
111493525|NCT02720068|Vitamin B Complex|vitamin b complex|mesh-ancestor
111493526|NCT02720068|Vitamins|vitamins|mesh-ancestor
111493527|NCT02720068|Micronutrients|micronutrients|mesh-ancestor
111493528|NCT02720068|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111493529|NCT02649790|Dexamethasone|dexamethasone|mesh-list
111493530|NCT02649790|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
111493531|NCT02649790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111493532|NCT02649790|Antiemetics|antiemetics|mesh-ancestor
111493533|NCT02649790|Autonomic Agents|autonomic agents|mesh-ancestor
111493534|NCT02649790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111493535|NCT02649790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111493536|NCT02649790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111493537|NCT02649790|Glucocorticoids|glucocorticoids|mesh-ancestor
111493538|NCT02649790|Hormones|hormones|mesh-ancestor
111493539|NCT02649790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111493540|NCT02649790|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111493541|NCT02649790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111493542|NCT02649790|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111493543|NCT02649790|Antimetabolites|antimetabolites|mesh-ancestor
111493544|NCT02649790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111493545|NCT02626455|Prednisone|prednisone|mesh-list
111493546|NCT02626455|Cyclophosphamide|cyclophosphamide|mesh-list
111493547|NCT02626455|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
111493548|NCT02626455|Rituximab|rituximab|mesh-list
111493549|NCT02626455|Doxorubicin|doxorubicin|mesh-list
111493550|NCT02626455|Vincristine|vincristine|mesh-list
111493551|NCT02626455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111493552|NCT02626455|Immunologic Factors|immunologic factors|mesh-ancestor
111493553|NCT02626455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111493554|NCT02626455|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111493555|NCT02626455|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111493556|NCT02626455|Alkylating Agents|alkylating agents|mesh-ancestor
111493557|NCT02626455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111493558|NCT02626455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111493559|NCT02626455|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111493560|NCT02626455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111493561|NCT02626455|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111493562|NCT02626455|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111493563|NCT02626455|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111493564|NCT02626455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111493565|NCT02626455|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111493566|NCT02626455|Glucocorticoids|glucocorticoids|mesh-ancestor
111493567|NCT02626455|Hormones|hormones|mesh-ancestor
111493568|NCT02626455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111493569|NCT02626455|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111493570|NCT02626455|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111493571|NCT02626455|Tubulin Modulators|tubulin modulators|mesh-ancestor
111493572|NCT02626455|Antimitotic Agents|antimitotic agents|mesh-ancestor
111493573|NCT02626455|Mitosis Modulators|mitosis modulators|mesh-ancestor
111493574|NCT02595060|Molgramostim|molgramostim|mesh-list
111493575|NCT02595060|Sargramostim|sargramostim|mesh-list
111493576|NCT02595060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111493577|NCT02595060|Immunologic Factors|immunologic factors|mesh-ancestor
111493578|NCT02595060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111493579|NCT02587065|Interferons|interferons|mesh-list
111493580|NCT02587065|Interferon-beta|interferon-beta|mesh-list
111493581|NCT02587065|Interferon beta-1a|interferon beta-1a|mesh-list
111493582|NCT02587065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111493583|NCT02587065|Antiviral Agents|antiviral agents|mesh-ancestor
111493584|NCT02587065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111493585|NCT02587065|Immunologic Factors|immunologic factors|mesh-ancestor
111493586|NCT02587065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111493587|NCT02587065|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111493588|NCT02492867|Paclitaxel|paclitaxel|mesh-list
111493589|NCT02492867|Carboplatin|carboplatin|mesh-list
111493590|NCT02492867|Durvalumab|durvalumab|mesh-list
111493591|NCT02492867|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111493592|NCT02492867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111493593|NCT02492867|Tubulin Modulators|tubulin modulators|mesh-ancestor
111493594|NCT02492867|Antimitotic Agents|antimitotic agents|mesh-ancestor
111493595|NCT02492867|Mitosis Modulators|mitosis modulators|mesh-ancestor
111493596|NCT02492867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111493597|NCT02492867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111493598|NCT02375204|Paclitaxel|paclitaxel|mesh-list
111493599|NCT02375204|Etoposide|etoposide|mesh-list
111493600|NCT02375204|Carboplatin|carboplatin|mesh-list
111493601|NCT02375204|Ifosfamide|ifosfamide|mesh-list
111493602|NCT02375204|Etoposide phosphate|etoposide phosphate|mesh-list
111493603|NCT02375204|Lenograstim|lenograstim|mesh-list
111493604|NCT02375204|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111493605|NCT02375204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111493606|NCT02375204|Tubulin Modulators|tubulin modulators|mesh-ancestor
111493607|NCT02375204|Antimitotic Agents|antimitotic agents|mesh-ancestor
111493608|NCT02375204|Mitosis Modulators|mitosis modulators|mesh-ancestor
111493609|NCT02375204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111493610|NCT02375204|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111493611|NCT02375204|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111493612|NCT02375204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111493613|NCT02375204|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111493614|NCT02375204|Immunologic Factors|immunologic factors|mesh-ancestor
111493615|NCT02375204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111493616|NCT02375204|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111493617|NCT02375204|Alkylating Agents|alkylating agents|mesh-ancestor
111493618|NCT02343042|Clarithromycin|clarithromycin|mesh-list
111493619|NCT02343042|Dexamethasone|dexamethasone|mesh-list
111493620|NCT02343042|Lenalidomide|lenalidomide|mesh-list
111493621|NCT02343042|Bortezomib|bortezomib|mesh-list
111493622|NCT02343042|Daratumumab|daratumumab|mesh-list
111493623|NCT02343042|Pomalidomide|pomalidomide|mesh-list
111493624|NCT02343042|Ixazomib|ixazomib|mesh-list
111493625|NCT02343042|Elotuzumab|elotuzumab|mesh-list
111493626|NCT02343042|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111493627|NCT02343042|Antiemetics|antiemetics|mesh-ancestor
111493628|NCT02343042|Autonomic Agents|autonomic agents|mesh-ancestor
111493629|NCT02343042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111493630|NCT02343042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111493631|NCT02343042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111493632|NCT02343042|Glucocorticoids|glucocorticoids|mesh-ancestor
111493633|NCT02343042|Hormones|hormones|mesh-ancestor
111493634|NCT02343042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111493635|NCT02343042|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111493636|NCT02343042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111493637|NCT02343042|Immunologic Factors|immunologic factors|mesh-ancestor
111493638|NCT02343042|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111493639|NCT02343042|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111493640|NCT02343042|Growth Substances|growth substances|mesh-ancestor
111493641|NCT02343042|Growth Inhibitors|growth inhibitors|mesh-ancestor
111493642|NCT02343042|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111493643|NCT02343042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111493644|NCT02343042|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111493645|NCT02343042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111493646|NCT02343042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111493647|NCT02343042|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111493648|NCT02343042|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111493649|NCT02343042|Protease Inhibitors|protease inhibitors|mesh-ancestor
111493650|NCT02339168|Metformin|metformin|mesh-list
111493651|NCT02339168|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111493652|NCT02339168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111493653|NCT02276495|Ketorolac|ketorolac|mesh-list
111493654|NCT02276495|Clonidine|clonidine|mesh-list
110977917|NCT03107858|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110977918|NCT03107858|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111493655|NCT02276495|Epinephrine|epinephrine|mesh-list
111493656|NCT02276495|Ropivacaine|ropivacaine|mesh-list
111493657|NCT02276495|Anesthetics, Local|anesthetics, local|mesh-ancestor
111493658|NCT02276495|Anesthetics|anesthetics|mesh-ancestor
111493659|NCT02276495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110977919|NCT03107858|Dopamine Agents|dopamine agents|mesh-ancestor
111493660|NCT02276495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111493661|NCT02276495|Sensory System Agents|sensory system agents|mesh-ancestor
111493662|NCT02276495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111493663|NCT02276495|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111493664|NCT02276495|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111493665|NCT02276495|Adrenergic Agents|adrenergic agents|mesh-ancestor
111493666|NCT02276495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111493667|NCT02276495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111493668|NCT02276495|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111493669|NCT02276495|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111493670|NCT02276495|Autonomic Agents|autonomic agents|mesh-ancestor
111493671|NCT02276495|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111493672|NCT02276495|Respiratory System Agents|respiratory system agents|mesh-ancestor
111493673|NCT02276495|Mydriatics|mydriatics|mesh-ancestor
111493674|NCT02276495|Sympathomimetics|sympathomimetics|mesh-ancestor
111493675|NCT02276495|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111493676|NCT02276495|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111493677|NCT02276495|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111493678|NCT02276495|Analgesics|analgesics|mesh-ancestor
111493679|NCT02276495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111493680|NCT02276495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111493681|NCT02276495|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111493682|NCT02276495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111493683|NCT02276495|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111493684|NCT02276495|Sympatholytics|sympatholytics|mesh-ancestor
111493685|NCT02276495|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111493686|NCT02269319|Linezolid|linezolid|mesh-list
111493687|NCT02269319|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111493688|NCT02269319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111493689|NCT02269319|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111493690|NCT02269319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111493691|NCT02269319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111493692|NCT02208375|Olaparib|olaparib|mesh-list
111493693|NCT02208375|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
111493694|NCT02208375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111493695|NCT02208375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111493696|NCT02208375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111493697|NCT02176967|Cyclophosphamide|cyclophosphamide|mesh-list
111493698|NCT02176967|Carboplatin|carboplatin|mesh-list
111493699|NCT02176967|Doxorubicin|doxorubicin|mesh-list
111493700|NCT02176967|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111493701|NCT02176967|Etoposide|etoposide|mesh-list
111493702|NCT02176967|Etoposide phosphate|etoposide phosphate|mesh-list
111493703|NCT02176967|Podophyllotoxin|podophyllotoxin|mesh-list
111493704|NCT02176967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111493705|NCT02176967|Immunologic Factors|immunologic factors|mesh-ancestor
111493706|NCT02176967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111493707|NCT02176967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111493708|NCT02176967|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111493709|NCT02176967|Alkylating Agents|alkylating agents|mesh-ancestor
111493710|NCT02176967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111493711|NCT02176967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111493712|NCT02176967|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111493713|NCT02176967|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111493714|NCT02176967|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111493715|NCT02176967|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111493716|NCT02176967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111493717|NCT02176967|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111493718|NCT02176967|Keratolytic Agents|keratolytic agents|mesh-ancestor
111493719|NCT02176967|Dermatologic Agents|dermatologic agents|mesh-ancestor
111493720|NCT02176967|Tubulin Modulators|tubulin modulators|mesh-ancestor
111493721|NCT02176967|Antimitotic Agents|antimitotic agents|mesh-ancestor
111493722|NCT02176967|Mitosis Modulators|mitosis modulators|mesh-ancestor
111493723|NCT02120404|Esmolol|esmolol|mesh-list
111493724|NCT02120404|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
111493725|NCT02120404|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111493726|NCT02120404|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111493727|NCT02120404|Adrenergic Agents|adrenergic agents|mesh-ancestor
111493728|NCT02120404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111493729|NCT02120404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111493730|NCT02120404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111493731|NCT02055456|Nandrolone Decanoate|nandrolone decanoate|mesh-list
111493732|NCT02055456|Nandrolone|nandrolone|mesh-list
111493733|NCT02055456|Nandrolone phenpropionate|nandrolone phenpropionate|mesh-list
111493734|NCT02055456|Androgens|androgens|mesh-ancestor
110977920|NCT03107858|Protective Agents|protective agents|mesh-ancestor
111493735|NCT02055456|Hormones|hormones|mesh-ancestor
111493736|NCT02055456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111493737|NCT02055456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111493738|NCT02055456|Anabolic Agents|anabolic agents|mesh-ancestor
111493739|NCT02055456|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111493740|NCT02031250|Carboplatin|carboplatin|mesh-list
111493741|NCT02031250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111493742|NCT01995669|Lenalidomide|lenalidomide|mesh-list
111493743|NCT01995669|Obinutuzumab|obinutuzumab|mesh-list
111493744|NCT01995669|Immunologic Factors|immunologic factors|mesh-ancestor
111493745|NCT01995669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111493746|NCT01995669|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111493747|NCT01995669|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111493748|NCT01995669|Growth Substances|growth substances|mesh-ancestor
111493749|NCT01995669|Growth Inhibitors|growth inhibitors|mesh-ancestor
111493750|NCT01995669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111493751|NCT01995669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111493752|NCT01880567|Rituximab|rituximab|mesh-list
111493753|NCT01880567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111493754|NCT01880567|Antibodies|antibodies|mesh-list
111493755|NCT01880567|Immunoglobulins|immunoglobulins|mesh-list
111493756|NCT01880567|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111493757|NCT01880567|Immunologic Factors|immunologic factors|mesh-ancestor
111493758|NCT01880567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111493759|NCT01880567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111493760|NCT01880567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111493761|NCT01750567|Metformin|metformin|mesh-list
111493762|NCT01750567|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111493763|NCT01750567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111493764|NCT01740557|Aldesleukin|aldesleukin|mesh-list
111493765|NCT01740557|Cyclophosphamide|cyclophosphamide|mesh-list
111493766|NCT01740557|Fludarabine|fludarabine|mesh-list
111493767|NCT01740557|Fludarabine phosphate|fludarabine phosphate|mesh-list
111493768|NCT01740557|Interleukin-2|interleukin-2|mesh-list
111493769|NCT01740557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111493770|NCT01740557|Immunologic Factors|immunologic factors|mesh-ancestor
111493771|NCT01740557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111493772|NCT01740557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111493773|NCT01740557|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111493774|NCT01740557|Alkylating Agents|alkylating agents|mesh-ancestor
111493775|NCT01740557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111493776|NCT01740557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111493777|NCT01740557|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111493778|NCT01740557|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111493779|NCT01740557|Antimetabolites|antimetabolites|mesh-ancestor
111493780|NCT01740557|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111493781|NCT01740557|Analgesics|analgesics|mesh-ancestor
111493782|NCT01740557|Sensory System Agents|sensory system agents|mesh-ancestor
111493783|NCT01740557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111493784|NCT01740557|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111493785|NCT01740557|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111493786|NCT01740557|Antiviral Agents|antiviral agents|mesh-ancestor
111493787|NCT01740557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111493788|NCT01705977|Belimumab|belimumab|mesh-list
111493789|NCT01705977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111493790|NCT01705977|Immunologic Factors|immunologic factors|mesh-ancestor
111493791|NCT01705977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111493792|NCT01686711|Pioglitazone|pioglitazone|mesh-list
111493793|NCT01686711|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111493794|NCT01686711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111493795|NCT01568177|Technetium tc-99m tetrofosmin|technetium tc-99m tetrofosmin|mesh-list
111493796|NCT01568177|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111493797|NCT01568177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111493798|NCT01503632|Mercaptopurine|mercaptopurine|mesh-list
111493799|NCT01503632|Antimetabolites|antimetabolites|mesh-ancestor
111493800|NCT01503632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111493801|NCT01503632|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111493802|NCT01503632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111493803|NCT01503632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111493804|NCT01503632|Immunologic Factors|immunologic factors|mesh-ancestor
110977921|NCT03269162|Docetaxel|docetaxel|mesh-list
111493805|NCT01503632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111493806|NCT01503632|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111493807|NCT01503632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110977922|NCT03269162|Pemetrexed|pemetrexed|mesh-list
110977923|NCT03269162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110977924|NCT03269162|Tubulin Modulators|tubulin modulators|mesh-ancestor
110977925|NCT03269162|Antimitotic Agents|antimitotic agents|mesh-ancestor
110977926|NCT03269162|Mitosis Modulators|mitosis modulators|mesh-ancestor
110977927|NCT03269162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110977928|NCT03269162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111493808|NCT01236560|Bevacizumab|bevacizumab|mesh-list
111493809|NCT01236560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111493810|NCT01236560|Temozolomide|temozolomide|mesh-list
111493811|NCT01236560|Vorinostat|vorinostat|mesh-list
111493812|NCT01236560|Endothelial Growth Factors|endothelial growth factors|mesh-list
111493813|NCT01236560|Antibodies|antibodies|mesh-list
111493814|NCT01236560|Immunoglobulins|immunoglobulins|mesh-list
111493815|NCT01236560|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111493816|NCT01236560|Immunoglobulin G|immunoglobulin g|mesh-list
111493817|NCT01236560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111493818|NCT01236560|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111493819|NCT01236560|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111493820|NCT01236560|Growth Substances|growth substances|mesh-ancestor
111493821|NCT01236560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111493822|NCT01236560|Growth Inhibitors|growth inhibitors|mesh-ancestor
111493823|NCT01236560|Immunologic Factors|immunologic factors|mesh-ancestor
111493824|NCT01236560|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111493825|NCT01236560|Alkylating Agents|alkylating agents|mesh-ancestor
111493826|NCT01236560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111493827|NCT01236560|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111493828|NCT01236560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111493829|NCT01231906|Cyclophosphamide|cyclophosphamide|mesh-list
111493830|NCT01231906|Ifosfamide|ifosfamide|mesh-list
111493831|NCT01231906|Isophosphamide mustard|isophosphamide mustard|mesh-list
111493832|NCT01231906|Doxorubicin|doxorubicin|mesh-list
111493833|NCT01231906|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111493834|NCT01231906|Etoposide|etoposide|mesh-list
111493835|NCT01231906|Vincristine|vincristine|mesh-list
111493836|NCT01231906|Etoposide phosphate|etoposide phosphate|mesh-list
111493837|NCT01231906|Topotecan|topotecan|mesh-list
111493838|NCT01231906|Podophyllotoxin|podophyllotoxin|mesh-list
111493839|NCT01231906|Dexrazoxane|dexrazoxane|mesh-list
111493840|NCT01231906|Razoxane|razoxane|mesh-list
111493841|NCT01231906|3,6-bis(5-chloro-2-piperidyl)-2,5-piperazinedione|3,6-bis(5-chloro-2-piperidyl)-2,5-piperazinedione|mesh-list
111493842|NCT01231906|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111493843|NCT01231906|Immunologic Factors|immunologic factors|mesh-ancestor
111493844|NCT01231906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111493845|NCT01231906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111493846|NCT01231906|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111493847|NCT01231906|Alkylating Agents|alkylating agents|mesh-ancestor
111493848|NCT01231906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111493849|NCT01231906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111493850|NCT01231906|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111493851|NCT01231906|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111493852|NCT01231906|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111493853|NCT01231906|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111493854|NCT01231906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111493855|NCT01231906|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111493856|NCT01231906|Tubulin Modulators|tubulin modulators|mesh-ancestor
111493857|NCT01231906|Antimitotic Agents|antimitotic agents|mesh-ancestor
111493858|NCT01231906|Mitosis Modulators|mitosis modulators|mesh-ancestor
111493859|NCT01231906|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111493860|NCT01231906|Keratolytic Agents|keratolytic agents|mesh-ancestor
111493861|NCT01231906|Dermatologic Agents|dermatologic agents|mesh-ancestor
111493862|NCT01231906|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111493863|NCT01231906|Protective Agents|protective agents|mesh-ancestor
111493864|NCT01174121|Aldesleukin|aldesleukin|mesh-list
111493865|NCT01174121|Cyclophosphamide|cyclophosphamide|mesh-list
111493866|NCT01174121|Pembrolizumab|pembrolizumab|mesh-list
111493867|NCT01174121|Fludarabine|fludarabine|mesh-list
111493868|NCT01174121|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111493869|NCT01174121|Immunologic Factors|immunologic factors|mesh-ancestor
111493870|NCT01174121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111493871|NCT01174121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111493872|NCT01174121|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111493873|NCT01174121|Alkylating Agents|alkylating agents|mesh-ancestor
111493874|NCT01174121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111493875|NCT01174121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111493876|NCT01174121|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111493877|NCT01174121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111493878|NCT01174121|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110977929|NCT03269162|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110977930|NCT03269162|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111493879|NCT01174121|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111493880|NCT01174121|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111493881|NCT01174121|Antiviral Agents|antiviral agents|mesh-ancestor
111493882|NCT01174121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111493884|NCT00887146|Temozolomide|temozolomide|mesh-list
111493885|NCT00887146|Procarbazine|procarbazine|mesh-list
111493886|NCT00887146|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111493887|NCT00887146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111493888|NCT00887146|Tubulin Modulators|tubulin modulators|mesh-ancestor
111493889|NCT00887146|Antimitotic Agents|antimitotic agents|mesh-ancestor
111493890|NCT00887146|Mitosis Modulators|mitosis modulators|mesh-ancestor
111493891|NCT00887146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111493892|NCT00887146|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111493893|NCT00887146|Alkylating Agents|alkylating agents|mesh-ancestor
111493894|NCT00788164|Imiquimod|imiquimod|mesh-list
111493895|NCT00788164|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111493896|NCT00788164|Immunologic Factors|immunologic factors|mesh-ancestor
111493897|NCT00788164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111493898|NCT00788164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111493899|NCT00788164|Interferon Inducers|interferon inducers|mesh-ancestor
111493900|NCT00468234|Nicotine|nicotine|mesh-list
111493901|NCT00468234|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111493902|NCT00468234|Autonomic Agents|autonomic agents|mesh-ancestor
111493903|NCT00468234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111493904|NCT00468234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111493905|NCT00468234|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111493906|NCT00468234|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111493907|NCT00468234|Cholinergic Agents|cholinergic agents|mesh-ancestor
111493908|NCT00468234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111493909|NCT00468234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111493910|NCT00354393|Methotrexate|methotrexate|mesh-list
111493911|NCT00354393|Vinorelbine|vinorelbine|mesh-list
111493912|NCT00354393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111493913|NCT00354393|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111493914|NCT00354393|Abortifacient Agents|abortifacient agents|mesh-ancestor
111493915|NCT00354393|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111493916|NCT00354393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111493917|NCT00354393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111493918|NCT00354393|Antimetabolites|antimetabolites|mesh-ancestor
111493919|NCT00354393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111493920|NCT00354393|Dermatologic Agents|dermatologic agents|mesh-ancestor
111493921|NCT00354393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111493922|NCT00354393|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111493923|NCT00354393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111493924|NCT00354393|Immunologic Factors|immunologic factors|mesh-ancestor
111493925|NCT00354393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111493926|NCT00354393|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111493927|NCT00354393|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111493928|NCT00354393|Tubulin Modulators|tubulin modulators|mesh-ancestor
111493929|NCT00354393|Antimitotic Agents|antimitotic agents|mesh-ancestor
111493930|NCT00354393|Mitosis Modulators|mitosis modulators|mesh-ancestor
111493931|NCT00304070|Cisplatin|cisplatin|mesh-list
111493932|NCT00304070|Doxorubicin|doxorubicin|mesh-list
111493933|NCT00304070|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111493934|NCT00304070|Etoposide|etoposide|mesh-list
111493935|NCT00304070|Etoposide phosphate|etoposide phosphate|mesh-list
111493936|NCT00304070|Podophyllotoxin|podophyllotoxin|mesh-list
111493937|NCT00304070|Mitotane|mitotane|mesh-list
111493938|NCT00304070|Lenograstim|lenograstim|mesh-list
111493939|NCT00304070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111493940|NCT00304070|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111493941|NCT00304070|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111493942|NCT00304070|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111493943|NCT00304070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111493944|NCT00304070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111493945|NCT00304070|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111493946|NCT00304070|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111493947|NCT00304070|Immunologic Factors|immunologic factors|mesh-ancestor
111493948|NCT00304070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111493949|NCT00304070|Keratolytic Agents|keratolytic agents|mesh-ancestor
111493950|NCT00304070|Dermatologic Agents|dermatologic agents|mesh-ancestor
111493951|NCT00304070|Tubulin Modulators|tubulin modulators|mesh-ancestor
111493952|NCT00304070|Antimitotic Agents|antimitotic agents|mesh-ancestor
110977931|NCT03284294|Cholecalciferol|cholecalciferol|mesh-list
111493953|NCT00304070|Mitosis Modulators|mitosis modulators|mesh-ancestor
111493954|NCT00304070|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111493955|NCT00160680|Levocetirizine|levocetirizine|mesh-list
111493956|NCT00160680|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
111493957|NCT00160680|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111493958|NCT00160680|Histamine Antagonists|histamine antagonists|mesh-ancestor
111493959|NCT00160680|Histamine Agents|histamine agents|mesh-ancestor
111493960|NCT00160680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111493961|NCT00160680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110480219|NCT02585947|Tenofovir|tenofovir|mesh-list
111493962|NCT00160680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111493963|NCT01820754|Paclitaxel|paclitaxel|mesh-list
111493964|NCT01820754|Carboplatin|carboplatin|mesh-list
111493965|NCT01820754|Ipilimumab|ipilimumab|mesh-list
111493966|NCT01820754|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111493967|NCT01820754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111493968|NCT01820754|Tubulin Modulators|tubulin modulators|mesh-ancestor
111493969|NCT01820754|Antimitotic Agents|antimitotic agents|mesh-ancestor
111493970|NCT01820754|Mitosis Modulators|mitosis modulators|mesh-ancestor
111493971|NCT01820754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111493972|NCT01820754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111493973|NCT01820754|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111493974|NCT01821378|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
111493975|NCT01821378|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111493976|NCT01821378|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111493977|NCT01821378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111493978|NCT01821378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111493979|NCT01821378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111493980|NCT01821378|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
111493981|NCT01821378|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111493982|NCT01821378|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111493983|NCT01821378|Adrenergic Agents|adrenergic agents|mesh-ancestor
111493984|NCT01821378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111493985|NCT01821378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111493986|NCT01821378|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111493987|NCT01821378|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111493988|NCT01821378|Serotonin Agents|serotonin agents|mesh-ancestor
111493989|NCT01821378|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111493990|NCT01821378|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111493991|NCT01821378|Dopamine Agents|dopamine agents|mesh-ancestor
111493992|NCT01822548|Metformin|metformin|mesh-list
111493993|NCT01822548|Vildagliptin|vildagliptin|mesh-list
111493994|NCT01822548|Glyburide|glyburide|mesh-list
111493995|NCT01822548|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111493996|NCT01822548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111493997|NCT01822548|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111493998|NCT01822548|Protease Inhibitors|protease inhibitors|mesh-ancestor
111493999|NCT01822548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111494000|NCT01822548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111494001|NCT01825122|Nadolol|nadolol|mesh-list
111494002|NCT01825122|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111494003|NCT01825122|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111494004|NCT01825122|Adrenergic Agents|adrenergic agents|mesh-ancestor
111494005|NCT01825122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111494006|NCT01825122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111494007|NCT01825122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111494008|NCT01825122|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111494009|NCT01825122|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111494010|NCT01825122|Sympatholytics|sympatholytics|mesh-ancestor
111494011|NCT01825122|Autonomic Agents|autonomic agents|mesh-ancestor
111494012|NCT01825122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111494013|NCT01825512|Deferasirox|deferasirox|mesh-list
111494014|NCT01825512|Deferiprone|deferiprone|mesh-list
111494015|NCT01825512|Iron Chelating Agents|iron chelating agents|mesh-ancestor
111494016|NCT01825512|Chelating Agents|chelating agents|mesh-ancestor
111494017|NCT01825512|Sequestering Agents|sequestering agents|mesh-ancestor
111494018|NCT01825512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111494019|NCT01827462|Vaccines|vaccines|mesh-list
111494020|NCT01827462|Immunologic Factors|immunologic factors|mesh-ancestor
111494021|NCT01827462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111494022|NCT01827930|Imatinib Mesylate|imatinib mesylate|mesh-list
110977933|NCT03284294|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110977934|NCT03284294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111494023|NCT01827930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111494024|NCT01827930|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111494025|NCT01827930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111494026|NCT01827930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111494027|NCT01828476|Hydroxychloroquine|hydroxychloroquine|mesh-list
111494028|NCT01828476|Navitoclax|navitoclax|mesh-list
111494029|NCT01828476|Antimalarials|antimalarials|mesh-ancestor
111494030|NCT01828476|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111494031|NCT01828476|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111494032|NCT01828476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111494033|NCT01828476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111494034|NCT01828476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111494035|NCT01828476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111494036|NCT01828476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111494037|NCT01828554|Capecitabine|capecitabine|mesh-list
111494038|NCT01828554|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111494039|NCT01828554|Antimetabolites|antimetabolites|mesh-ancestor
111494040|NCT01828554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111494041|NCT01828554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111494042|NCT01834404|Topiramate|topiramate|mesh-list
111494043|NCT01834404|Phentermine|phentermine|mesh-list
111494044|NCT01834404|Anticonvulsants|anticonvulsants|mesh-ancestor
111494045|NCT01834404|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111494046|NCT01834404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111494047|NCT01834404|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111494048|NCT01834404|Appetite Depressants|appetite depressants|mesh-ancestor
111494049|NCT01834404|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111494050|NCT01834404|Sympathomimetics|sympathomimetics|mesh-ancestor
111494051|NCT01834404|Autonomic Agents|autonomic agents|mesh-ancestor
111494052|NCT01834404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111494053|NCT01834404|Adrenergic Agents|adrenergic agents|mesh-ancestor
111494054|NCT01834404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111494055|NCT01834404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111494056|NCT01835262|Ketamine|ketamine|mesh-list
111494057|NCT01835262|Morphine|morphine|mesh-list
111494058|NCT01835262|Analgesics|analgesics|mesh-ancestor
111494059|NCT01835262|Sensory System Agents|sensory system agents|mesh-ancestor
111494060|NCT01835262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111494061|NCT01835262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111494062|NCT01835262|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111494063|NCT01835262|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111494064|NCT01835262|Anesthetics, General|anesthetics, general|mesh-ancestor
111494065|NCT01835262|Anesthetics|anesthetics|mesh-ancestor
111494066|NCT01835262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111494067|NCT01835262|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111494068|NCT01835262|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111494069|NCT01835262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111494070|NCT01835262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111494071|NCT01835262|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111494072|NCT01835262|Narcotics|narcotics|mesh-ancestor
111494073|NCT01835496|Deferiprone|deferiprone|mesh-list
111494074|NCT01835496|Iron Chelating Agents|iron chelating agents|mesh-ancestor
111494075|NCT01835496|Chelating Agents|chelating agents|mesh-ancestor
111494076|NCT01835496|Sequestering Agents|sequestering agents|mesh-ancestor
111494077|NCT01835496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111494078|NCT01766076|Atorvastatin|atorvastatin|mesh-list
111494079|NCT01766076|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111494080|NCT01766076|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111494081|NCT01766076|Antimetabolites|antimetabolites|mesh-ancestor
111494082|NCT01766076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111494083|NCT01766076|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111494084|NCT01766076|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111494085|NCT01766076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111494086|NCT01767792|Bevacizumab|bevacizumab|mesh-list
111494087|NCT01767792|Endothelial Growth Factors|endothelial growth factors|mesh-list
111494088|NCT01767792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111494089|NCT01767792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111494090|NCT01767792|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111494091|NCT01767792|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111494092|NCT01767792|Growth Substances|growth substances|mesh-ancestor
111494093|NCT01767792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111494094|NCT01767792|Growth Inhibitors|growth inhibitors|mesh-ancestor
111494095|NCT01797822|Dexamethasone|dexamethasone|mesh-list
111494096|NCT01797822|Lubricant Eye Drops|lubricant eye drops|mesh-list
110977936|NCT03284294|Micronutrients|micronutrients|mesh-ancestor
110977937|NCT03284294|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110977938|NCT02558296|Bexagliflozin|bexagliflozin|mesh-list
110977939|NCT02558296|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110977940|NCT02558296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110977941|NCT03268226|Beclomethasone|beclomethasone|mesh-list
110977942|NCT03268226|Glycopyrrolate|glycopyrrolate|mesh-list
110977943|NCT03268226|Formoterol Fumarate|formoterol fumarate|mesh-list
111494097|NCT01797822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111494098|NCT01797822|Antiemetics|antiemetics|mesh-ancestor
111494099|NCT01797822|Autonomic Agents|autonomic agents|mesh-ancestor
111494100|NCT01797822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111494101|NCT01797822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111494102|NCT01797822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111494103|NCT01797822|Glucocorticoids|glucocorticoids|mesh-ancestor
111494104|NCT01797822|Hormones|hormones|mesh-ancestor
111494105|NCT01797822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111494106|NCT01797822|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111494107|NCT01797822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111494108|NCT01797822|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
111494109|NCT01797822|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111494110|NCT01809054|Aspirin|aspirin|mesh-list
111494111|NCT01809054|Fondaparinux|fondaparinux|mesh-list
111494112|NCT01809054|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111494113|NCT01809054|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111494114|NCT01809054|Analgesics|analgesics|mesh-ancestor
111494115|NCT01809054|Sensory System Agents|sensory system agents|mesh-ancestor
111494116|NCT01809054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111494117|NCT01809054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111494118|NCT01809054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111494119|NCT01809054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111494120|NCT01809054|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111494121|NCT01809054|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111494122|NCT01809054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111494123|NCT01809054|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111494124|NCT01809054|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111494125|NCT01809054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111494126|NCT01809054|Antipyretics|antipyretics|mesh-ancestor
111494127|NCT01809054|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111494128|NCT01809054|Antithrombins|antithrombins|mesh-ancestor
111494129|NCT01809054|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111494130|NCT01809054|Protease Inhibitors|protease inhibitors|mesh-ancestor
111494131|NCT01809054|Anticoagulants|anticoagulants|mesh-ancestor
111494132|NCT01833546|Gemcitabine|gemcitabine|mesh-list
111494133|NCT01833546|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111494134|NCT01833546|Antimetabolites|antimetabolites|mesh-ancestor
111494135|NCT01833546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111494136|NCT01833546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111494137|NCT01842594|Sirolimus|sirolimus|mesh-list
111494138|NCT01842594|Hydroxychloroquine|hydroxychloroquine|mesh-list
111494139|NCT01842594|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111494140|NCT01842594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111494141|NCT01842594|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111494142|NCT01842594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111494143|NCT01842594|Antifungal Agents|antifungal agents|mesh-ancestor
111494144|NCT01842594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111494145|NCT01842594|Immunologic Factors|immunologic factors|mesh-ancestor
111494146|NCT01842594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111494147|NCT01842594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111494148|NCT01842594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111494149|NCT01842594|Antimalarials|antimalarials|mesh-ancestor
111494150|NCT01842594|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111494151|NCT01842594|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111494152|NCT01842594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111494153|NCT01843920|Trimethoprim|trimethoprim|mesh-list
111494154|NCT01843920|Polymyxins|polymyxins|mesh-list
111494155|NCT01843920|Polymyxin B|polymyxin b|mesh-list
111494156|NCT01843920|Prednisolone|prednisolone|mesh-list
111494157|NCT01843920|Timolol|timolol|mesh-list
111494158|NCT01843920|Dorzolamide|dorzolamide|mesh-list
111494159|NCT01843920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111494160|NCT01843920|Glucocorticoids|glucocorticoids|mesh-ancestor
111494161|NCT01843920|Hormones|hormones|mesh-ancestor
111494162|NCT01843920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111494163|NCT01843920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111494164|NCT01843920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111494165|NCT01843920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110977944|NCT03268226|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110977945|NCT03268226|Autonomic Agents|autonomic agents|mesh-ancestor
110977946|NCT03268226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110977947|NCT03268226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110977948|NCT03268226|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110977949|NCT03268226|Respiratory System Agents|respiratory system agents|mesh-ancestor
110977950|NCT03268226|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110977951|NCT03268226|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110977952|NCT03268226|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111494166|NCT01843920|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111494167|NCT01843920|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111494168|NCT01843920|Adrenergic Agents|adrenergic agents|mesh-ancestor
111494169|NCT01843920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111494170|NCT01843920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111494171|NCT01843920|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111494172|NCT01843920|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111494173|NCT01843920|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111494174|NCT01843920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111494175|NCT01843920|Antimalarials|antimalarials|mesh-ancestor
111494176|NCT01843920|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111494177|NCT01843920|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111494178|NCT01843920|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111494179|NCT01843920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111494180|NCT01843920|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111494181|NCT01843920|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
111494182|NCT01843920|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111494183|NCT01843920|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
111494184|NCT01843920|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111494185|NCT01844388|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
110977953|NCT03268226|Adrenergic Agents|adrenergic agents|mesh-ancestor
110977954|NCT03268226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110977955|NCT03268226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110977956|NCT03268226|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110977957|NCT03268226|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110977958|NCT03268226|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110977959|NCT03268226|Cholinergic Agents|cholinergic agents|mesh-ancestor
110977960|NCT03268226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110977961|NCT03268226|Glucocorticoids|glucocorticoids|mesh-ancestor
110977962|NCT03268226|Hormones|hormones|mesh-ancestor
111494186|NCT01844388|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111494187|NCT01844388|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111494188|NCT01844388|Laxatives|laxatives|mesh-ancestor
111494189|NCT01844388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111494190|NCT01845636|Atropine|atropine|mesh-list
111494191|NCT01845636|Donepezil|donepezil|mesh-list
111494192|NCT01845636|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111494193|NCT01845636|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111494194|NCT01845636|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111494195|NCT01845636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111494196|NCT01845636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111494197|NCT01845636|Cholinergic Agents|cholinergic agents|mesh-ancestor
111494198|NCT01845636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111494199|NCT01845636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111494200|NCT01845636|Nootropic Agents|nootropic agents|mesh-ancestor
111494201|NCT01845636|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111494202|NCT01845636|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111494203|NCT01845636|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111494204|NCT01845636|Autonomic Agents|autonomic agents|mesh-ancestor
111494205|NCT01845636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111494206|NCT01845636|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111494207|NCT01845636|Respiratory System Agents|respiratory system agents|mesh-ancestor
111494208|NCT01845636|Mydriatics|mydriatics|mesh-ancestor
111494209|NCT01845636|Parasympatholytics|parasympatholytics|mesh-ancestor
111494210|NCT01845636|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110480238|NCT04079725|Mitomycins|mitomycins|mesh-list
111494211|NCT01845636|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111494212|NCT01845792|Abiraterone Acetate|abiraterone acetate|mesh-list
111494213|NCT01845792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111494214|NCT01845792|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111494215|NCT01845792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111494216|NCT01845792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111494217|NCT01845792|Hormone Antagonists|hormone antagonists|mesh-ancestor
111494218|NCT01845792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111494219|NCT01845792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110702252|NCT01047956|Antitussive Agents|antitussive agents|mesh-ancestor
110977963|NCT03268226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111494220|NCT01845792|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111494221|NCT01846728|Estrogens|estrogens|mesh-list
111494222|NCT01846728|Hormones|hormones|mesh-ancestor
111494223|NCT01846728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111494224|NCT01846728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111494225|NCT01848054|Buprenorphine|buprenorphine|mesh-list
111494226|NCT01848054|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
111494227|NCT01848054|Naloxone|naloxone|mesh-list
111494228|NCT01848054|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111494229|NCT01848054|Narcotics|narcotics|mesh-ancestor
111494230|NCT01848054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111494231|NCT01848054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111494232|NCT01848054|Analgesics|analgesics|mesh-ancestor
111494233|NCT01848054|Sensory System Agents|sensory system agents|mesh-ancestor
111494234|NCT01848054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111494235|NCT01848054|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111494236|NCT01849068|Ezetimibe|ezetimibe|mesh-list
111494237|NCT01849068|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111494238|NCT01849068|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111494239|NCT01849068|Antimetabolites|antimetabolites|mesh-ancestor
111494240|NCT01849068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111494241|NCT01849068|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111494242|NCT01849692|Ranibizumab|ranibizumab|mesh-list
111494243|NCT01849692|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111494244|NCT01849692|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111494245|NCT01849692|Growth Substances|growth substances|mesh-ancestor
111494246|NCT01849692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111494247|NCT01849692|Growth Inhibitors|growth inhibitors|mesh-ancestor
111494248|NCT01849692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111494249|NCT01849770|Mexiletine|mexiletine|mesh-list
111494250|NCT01849770|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111494251|NCT01849770|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111494252|NCT01849770|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111494253|NCT01849770|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111494254|NCT01849770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111494255|NCT01850394|Tranexamic Acid|tranexamic acid|mesh-list
111494256|NCT01850394|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111494257|NCT01850394|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111494258|NCT01850394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111494259|NCT01850394|Hemostatics|hemostatics|mesh-ancestor
111494260|NCT01850394|Coagulants|coagulants|mesh-ancestor
111494261|NCT01852344|Methylphenidate|methylphenidate|mesh-list
111494262|NCT01852344|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111494263|NCT01852344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111494264|NCT01852344|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111494265|NCT01852344|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111494266|NCT01852344|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111494267|NCT01852344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111494268|NCT01852344|Dopamine Agents|dopamine agents|mesh-ancestor
111494269|NCT01852344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111494270|NCT01856712|Naltrexone|naltrexone|mesh-list
111494271|NCT01856712|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111494272|NCT01856712|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111494273|NCT01856712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111494274|NCT01856712|Sensory System Agents|sensory system agents|mesh-ancestor
111494275|NCT01856712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111494276|NCT01858428|Paclitaxel|paclitaxel|mesh-list
111494277|NCT01858428|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111494278|NCT01858428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111494279|NCT01858428|Tubulin Modulators|tubulin modulators|mesh-ancestor
111494280|NCT01858428|Antimitotic Agents|antimitotic agents|mesh-ancestor
111494281|NCT01858428|Mitosis Modulators|mitosis modulators|mesh-ancestor
111494282|NCT01858428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111494283|NCT01861002|Cytarabine|cytarabine|mesh-list
111494284|NCT01861002|Methotrexate|methotrexate|mesh-list
111494285|NCT01861002|Fludarabine phosphate|fludarabine phosphate|mesh-list
111494286|NCT01861002|Azacitidine|azacitidine|mesh-list
111494287|NCT01861002|Fludarabine|fludarabine|mesh-list
111494288|NCT01861002|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111494289|NCT01861002|Abortifacient Agents|abortifacient agents|mesh-ancestor
111494290|NCT01861002|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111494291|NCT01861002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111494292|NCT01861002|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111494293|NCT01861002|Antimetabolites|antimetabolites|mesh-ancestor
111494294|NCT01861002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111494295|NCT01861002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111494296|NCT01861002|Dermatologic Agents|dermatologic agents|mesh-ancestor
111494297|NCT01861002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111494298|NCT01861002|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111494299|NCT01861002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111494300|NCT01861002|Immunologic Factors|immunologic factors|mesh-ancestor
111494301|NCT01861002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111494302|NCT01861002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111494303|NCT01861002|Antiviral Agents|antiviral agents|mesh-ancestor
111494304|NCT01861002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111494305|NCT01870596|Cytarabine|cytarabine|mesh-list
111494306|NCT01870596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111494307|NCT01870596|Antimetabolites|antimetabolites|mesh-ancestor
111494308|NCT01870596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111494309|NCT01870596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111494310|NCT01870596|Antiviral Agents|antiviral agents|mesh-ancestor
111494311|NCT01870596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111494312|NCT01870596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111494313|NCT01870596|Immunologic Factors|immunologic factors|mesh-ancestor
111494314|NCT01870596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111494315|NCT01875510|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
111494316|NCT01875510|SMOFlipid|smoflipid|mesh-list
111494317|NCT01875510|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
111494318|NCT01875510|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
111494319|NCT01875510|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111494320|NCT01876212|Dasatinib|dasatinib|mesh-list
111494321|NCT01876212|Vaccines|vaccines|mesh-list
111494322|NCT01876212|Immunologic Factors|immunologic factors|mesh-ancestor
111494323|NCT01876212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111494324|NCT01876212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111494325|NCT01876212|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111494326|NCT01876212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111494327|NCT01876212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111494328|NCT01876992|Metformin|metformin|mesh-list
111494329|NCT01876992|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111494330|NCT01876992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111494331|NCT01877538|Donepezil|donepezil|mesh-list
111494332|NCT01877538|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111494333|NCT01877538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111494334|NCT01877538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111494335|NCT01877538|Cholinergic Agents|cholinergic agents|mesh-ancestor
111494336|NCT01877538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111494337|NCT01877538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111494338|NCT01877538|Nootropic Agents|nootropic agents|mesh-ancestor
111494339|NCT01878006|Morphine|morphine|mesh-list
111494340|NCT01878006|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111494341|NCT01878006|Narcotics|narcotics|mesh-ancestor
111494342|NCT01878006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111494343|NCT01878006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111494344|NCT01878006|Analgesics|analgesics|mesh-ancestor
111494345|NCT01878006|Sensory System Agents|sensory system agents|mesh-ancestor
111494346|NCT01878006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111494347|NCT01879332|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
111494348|NCT01879332|Anticonvulsants|anticonvulsants|mesh-ancestor
111494349|NCT01879332|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111494350|NCT01879332|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111494351|NCT01879332|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111494352|NCT01879332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111494353|NCT05327088|Dexmedetomidine|dexmedetomidine|mesh-list
111494354|NCT05327088|Nalbuphine|nalbuphine|mesh-list
111494355|NCT05327088|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111494356|NCT05327088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111494357|NCT05327088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111494358|NCT05327088|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111494359|NCT05327088|Analgesics|analgesics|mesh-ancestor
111494360|NCT05327088|Sensory System Agents|sensory system agents|mesh-ancestor
111494361|NCT05327088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111494362|NCT05327088|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111494363|NCT05327088|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111494364|NCT05327088|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111494365|NCT05327088|Adrenergic Agents|adrenergic agents|mesh-ancestor
111494366|NCT05327088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110702387|NCT03999203|Antioxidants|antioxidants|mesh-ancestor
110977964|NCT02737475|Cyclophosphamide|cyclophosphamide|mesh-list
111494367|NCT05327088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111494368|NCT05327088|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111494369|NCT05327088|Narcotics|narcotics|mesh-ancestor
111494370|NCT05290194|Capecitabine|capecitabine|mesh-list
111494371|NCT05290194|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
111494372|NCT05290194|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111494373|NCT05290194|Antimetabolites|antimetabolites|mesh-ancestor
111494374|NCT05290194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111494375|NCT05290194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111494376|NCT05290194|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111494377|NCT04774068|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111494378|NCT04774068|Romidepsin|romidepsin|mesh-list
111494379|NCT04774068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111494380|NCT04774068|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111494381|NCT04774068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111494382|NCT04774068|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111494383|NCT04774068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111494384|NCT04774068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111494385|NCT04103034|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
111494386|NCT04103034|Hemostatics|hemostatics|mesh-ancestor
111494387|NCT04103034|Coagulants|coagulants|mesh-ancestor
111494388|NCT04103034|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
111494389|NCT04103034|Natriuretic Agents|natriuretic agents|mesh-ancestor
111494390|NCT04103034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111494391|NCT03776760|Sofosbuvir|sofosbuvir|mesh-list
111494392|NCT03776760|Antiviral Agents|antiviral agents|mesh-ancestor
110127557|NCT01951430|Miconazole|miconazole|mesh-list
111494393|NCT03776760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111494394|NCT03191526|Mogamulizumab|mogamulizumab|mesh-list
111494395|NCT03191526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111494396|NCT01643460|Ethanol|ethanol|mesh-list
111494397|NCT01643460|Paclitaxel|paclitaxel|mesh-list
111494398|NCT01643460|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111494399|NCT01643460|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111494400|NCT01643460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111494401|NCT01643460|Tubulin Modulators|tubulin modulators|mesh-ancestor
111494402|NCT01643460|Antimitotic Agents|antimitotic agents|mesh-ancestor
111494403|NCT01643460|Mitosis Modulators|mitosis modulators|mesh-ancestor
111494404|NCT01643460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111494405|NCT01643460|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111494406|NCT01643460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111494407|NCT01643460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111494408|NCT01643460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111494409|NCT00954876|Capecitabine|capecitabine|mesh-list
111494410|NCT00954876|Cetuximab|cetuximab|mesh-list
111494411|NCT00954876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111494412|NCT00954876|Antimetabolites|antimetabolites|mesh-ancestor
111494413|NCT00954876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111494414|NCT00954876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111494415|NCT00954876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111494416|NCT05746728|Tislelizumab|tislelizumab|mesh-list
111494417|NCT05746728|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111494418|NCT05746728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111494419|NCT05714670|Curcumin|curcumin|mesh-list
111494420|NCT05714670|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111494421|NCT05714670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111494422|NCT05714670|Analgesics|analgesics|mesh-ancestor
111494423|NCT05714670|Sensory System Agents|sensory system agents|mesh-ancestor
111494424|NCT05714670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111494425|NCT05714670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111494426|NCT05714670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111494427|NCT05714670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111494428|NCT05714670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111494429|NCT05714670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111494430|NCT05714670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111494431|NCT05712018|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
111494432|NCT05712018|Plasma Substitutes|plasma substitutes|mesh-ancestor
111494433|NCT05712018|Blood Substitutes|blood substitutes|mesh-ancestor
111494434|NCT05606718|Dapagliflozin|dapagliflozin|mesh-list
111494435|NCT05606718|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111494436|NCT05606718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110977965|NCT02737475|Nivolumab|nivolumab|mesh-list
111494437|NCT05606718|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111494438|NCT05606718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110977966|NCT02737475|Ipilimumab|ipilimumab|mesh-list
111494439|NCT05472948|Capecitabine|capecitabine|mesh-list
110977967|NCT02737475|Vaccines|vaccines|mesh-list
110977968|NCT02737475|Immunologic Factors|immunologic factors|mesh-ancestor
111494440|NCT05472948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111494441|NCT05472948|Antimetabolites|antimetabolites|mesh-ancestor
111494442|NCT05472948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111494443|NCT05472948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111494444|NCT05215470|Nivolumab|nivolumab|mesh-list
111494445|NCT05215470|Ipilimumab|ipilimumab|mesh-list
111494446|NCT05215470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111494447|NCT05215470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111494448|NCT05215470|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111494449|NCT05215470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111494450|NCT05206500|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111494451|NCT05206500|Amoxicillin|amoxicillin|mesh-list
111494452|NCT05206500|Metronidazole|metronidazole|mesh-list
111494453|NCT05206500|Clindamycin|clindamycin|mesh-list
111494454|NCT05206500|Linezolid|linezolid|mesh-list
111494455|NCT05206500|Tetracycline|tetracycline|mesh-list
111494456|NCT05206500|Penicillins|penicillins|mesh-list
111494457|NCT05206500|Ampicillin|ampicillin|mesh-list
111494458|NCT05206500|Fosfomycin|fosfomycin|mesh-list
111494459|NCT05206500|Nitrofurantoin|nitrofurantoin|mesh-list
111494460|NCT05206500|Cephalosporins|cephalosporins|mesh-list
111494461|NCT05206500|Fluoroquinolones|fluoroquinolones|mesh-list
111494462|NCT05206500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111494463|NCT05206500|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111494464|NCT05206500|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111494465|NCT05206500|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111494466|NCT05206500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111494467|NCT05206500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111494468|NCT05206500|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111494469|NCT05206500|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111494470|NCT05151588|Docetaxel|docetaxel|mesh-list
111494471|NCT05151588|Fluorouracil|fluorouracil|mesh-list
111494472|NCT05151588|Cisplatin|cisplatin|mesh-list
111494473|NCT05151588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111494474|NCT05151588|Tubulin Modulators|tubulin modulators|mesh-ancestor
111494475|NCT05151588|Antimitotic Agents|antimitotic agents|mesh-ancestor
111494476|NCT05151588|Mitosis Modulators|mitosis modulators|mesh-ancestor
111494477|NCT05151588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111494478|NCT05151588|Antimetabolites|antimetabolites|mesh-ancestor
111494479|NCT05151588|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111494480|NCT05151588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111494481|NCT05151588|Immunologic Factors|immunologic factors|mesh-ancestor
111494482|NCT05151588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111494483|NCT04929834|Emollients|emollients|mesh-list
111494484|NCT04929834|Dermatologic Agents|dermatologic agents|mesh-ancestor
111494485|NCT04556838|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111494486|NCT04556838|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111494487|NCT04470804|Cyclosporine|cyclosporine|mesh-list
111494488|NCT04470804|Sirolimus|sirolimus|mesh-list
111494489|NCT04470804|Temsirolimus|temsirolimus|mesh-list
111494490|NCT04470804|MTOR Inhibitors|mtor inhibitors|mesh-list
111494491|NCT04470804|Cyclosporins|cyclosporins|mesh-list
111494492|NCT04470804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111494493|NCT04470804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111494494|NCT04470804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111494495|NCT04470804|Immunologic Factors|immunologic factors|mesh-ancestor
111494496|NCT04470804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111494497|NCT04470804|Antifungal Agents|antifungal agents|mesh-ancestor
111494498|NCT04470804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111494499|NCT04470804|Dermatologic Agents|dermatologic agents|mesh-ancestor
111494500|NCT04470804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111494501|NCT04470804|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111494502|NCT04470804|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111494503|NCT04470804|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111494504|NCT04470804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111494505|NCT04470804|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110977969|NCT02737475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110977970|NCT02737475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110977971|NCT02737475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110702532|NCT00129220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111494506|NCT04418466|Risperidone|risperidone|mesh-list
111494507|NCT04418466|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111494508|NCT04418466|Serotonin Agents|serotonin agents|mesh-ancestor
111494509|NCT04418466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111494510|NCT04418466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111494511|NCT04418466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111494512|NCT04418466|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111494513|NCT04418466|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111494514|NCT04418466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111494515|NCT04418466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111494516|NCT04418466|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111494517|NCT04418466|Dopamine Agents|dopamine agents|mesh-ancestor
111494518|NCT04360044|Dronabinol|dronabinol|mesh-list
111494519|NCT04360044|Cannabidiol|cannabidiol|mesh-list
111494520|NCT04360044|Anticonvulsants|anticonvulsants|mesh-ancestor
111494521|NCT04360044|Hallucinogens|hallucinogens|mesh-ancestor
111494522|NCT04360044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111494523|NCT04360044|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111494524|NCT04360044|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111494525|NCT04360044|Analgesics|analgesics|mesh-ancestor
111494526|NCT04360044|Sensory System Agents|sensory system agents|mesh-ancestor
111494527|NCT04360044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111494528|NCT04360044|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
111494529|NCT04360044|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
111494530|NCT04360044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111494531|NCT04360044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111494532|NCT04360044|Hormones|hormones|mesh-ancestor
111494533|NCT04360044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111494534|NCT04337814|Ibuprofen|ibuprofen|mesh-list
111494535|NCT04337814|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
111494536|NCT04337814|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111494537|NCT04337814|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111494538|NCT04337814|Analgesics|analgesics|mesh-ancestor
111494539|NCT04337814|Sensory System Agents|sensory system agents|mesh-ancestor
111494540|NCT04337814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111494541|NCT04337814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111494542|NCT04337814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111494543|NCT04337814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111494544|NCT04337814|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111494545|NCT04337814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111494546|NCT04337814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111494547|NCT04337814|Anesthetics, Local|anesthetics, local|mesh-ancestor
111494548|NCT04337814|Anesthetics|anesthetics|mesh-ancestor
111494549|NCT04337814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111494550|NCT04337814|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
111494551|NCT04336332|Azithromycin|azithromycin|mesh-list
111494552|NCT04336332|Hydroxychloroquine|hydroxychloroquine|mesh-list
111494553|NCT04336332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111494554|NCT04336332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111494555|NCT04336332|Antimalarials|antimalarials|mesh-ancestor
111494556|NCT04336332|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111494557|NCT04336332|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111494558|NCT04336332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111494559|NCT04336332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111494560|NCT04336332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111494561|NCT04230408|Paclitaxel|paclitaxel|mesh-list
111494562|NCT04230408|Carboplatin|carboplatin|mesh-list
111494563|NCT04230408|Durvalumab|durvalumab|mesh-list
111494564|NCT04230408|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111494565|NCT04230408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111494566|NCT04230408|Tubulin Modulators|tubulin modulators|mesh-ancestor
111494567|NCT04230408|Antimitotic Agents|antimitotic agents|mesh-ancestor
111494568|NCT04230408|Mitosis Modulators|mitosis modulators|mesh-ancestor
111494569|NCT04230408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111494570|NCT04230408|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111494571|NCT03064542|Carbimazole|carbimazole|mesh-list
111494572|NCT03064542|Antithyroid Agents|antithyroid agents|mesh-ancestor
111494573|NCT03064542|Hormone Antagonists|hormone antagonists|mesh-ancestor
111494574|NCT03064542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111494575|NCT03064542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111494576|NCT02718066|Nivolumab|nivolumab|mesh-list
111494577|NCT02718066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111494578|NCT02718066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111494579|NCT02718066|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111494580|NCT02718066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111494581|NCT01430442|Sumatriptan|sumatriptan|mesh-list
111494582|NCT01430442|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111494583|NCT01430442|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110977972|NCT02737475|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111494584|NCT01430442|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110977973|NCT02737475|Alkylating Agents|alkylating agents|mesh-ancestor
110977974|NCT02737475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111494585|NCT01430442|Serotonin Agents|serotonin agents|mesh-ancestor
111494586|NCT01430442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111494587|NCT01430442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111494588|NCT01430442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111494589|NCT01420926|Bortezomib|bortezomib|mesh-list
111494590|NCT01420926|Decitabine|decitabine|mesh-list
111494591|NCT01420926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111494592|NCT01420926|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111494593|NCT01420926|Antimetabolites|antimetabolites|mesh-ancestor
111494594|NCT01420926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111494595|NCT01420926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111494596|NCT01881828|Metformin|metformin|mesh-list
111494597|NCT01881828|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111494598|NCT01881828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111494599|NCT01887132|Donepezil|donepezil|mesh-list
111494600|NCT01887132|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111494601|NCT01887132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111494602|NCT01887132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111494603|NCT01887132|Cholinergic Agents|cholinergic agents|mesh-ancestor
111494604|NCT01887132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111494605|NCT01887132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111494606|NCT01887132|Nootropic Agents|nootropic agents|mesh-ancestor
111494607|NCT01887990|Ketamine|ketamine|mesh-list
111494608|NCT01887990|Analgesics|analgesics|mesh-ancestor
111494609|NCT01887990|Sensory System Agents|sensory system agents|mesh-ancestor
111494610|NCT01887990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111494611|NCT01887990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111494612|NCT01887990|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111494613|NCT01887990|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111494614|NCT01887990|Anesthetics, General|anesthetics, general|mesh-ancestor
111494615|NCT01887990|Anesthetics|anesthetics|mesh-ancestor
111494616|NCT01887990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111494617|NCT01887990|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111494618|NCT01887990|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111494619|NCT01887990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111494620|NCT01887990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111494621|NCT01890642|Lidocaine|lidocaine|mesh-list
111494622|NCT01890642|Anesthetics, Local|anesthetics, local|mesh-ancestor
111494623|NCT01890642|Anesthetics|anesthetics|mesh-ancestor
111494624|NCT01890642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111494625|NCT01890642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111494626|NCT01890642|Sensory System Agents|sensory system agents|mesh-ancestor
111494627|NCT01890642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111494628|NCT01890642|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111494629|NCT01890642|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111494630|NCT01890642|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111494631|NCT01890642|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111494632|NCT01890642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111494633|NCT01891968|Bortezomib|bortezomib|mesh-list
111494634|NCT01891968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111494635|NCT01901250|Fluorides|fluorides|mesh-list
111494636|NCT01901250|Fluorides, Topical|fluorides, topical|mesh-list
111494637|NCT01901250|Cariostatic Agents|cariostatic agents|mesh-ancestor
111494638|NCT01901250|Protective Agents|protective agents|mesh-ancestor
111494639|NCT01901250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111494640|NCT01904526|Guanfacine|guanfacine|mesh-list
111494641|NCT01904526|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111494642|NCT01904526|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111494643|NCT01904526|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111494644|NCT01904526|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111494645|NCT01904526|Adrenergic Agents|adrenergic agents|mesh-ancestor
111494646|NCT01904526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111494647|NCT01904526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111494648|NCT01904526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111494649|NCT01906866|Melatonin|melatonin|mesh-list
111494650|NCT01906866|Antioxidants|antioxidants|mesh-ancestor
111494651|NCT01906866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111494652|NCT01906866|Protective Agents|protective agents|mesh-ancestor
110977975|NCT02737475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111494653|NCT01906866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111494654|NCT01906866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111494655|NCT01907334|Fluticasone|fluticasone|mesh-list
111494656|NCT01907334|Xhance|xhance|mesh-list
111494657|NCT01907334|Albuterol|albuterol|mesh-list
111494658|NCT01907334|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
111494659|NCT01907334|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
111494660|NCT01907334|Methacholine Chloride|methacholine chloride|mesh-list
111494661|NCT01907334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111494662|NCT01907334|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111494663|NCT01907334|Autonomic Agents|autonomic agents|mesh-ancestor
111494664|NCT01907334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111494665|NCT01907334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111494666|NCT01907334|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111494667|NCT01907334|Respiratory System Agents|respiratory system agents|mesh-ancestor
111494668|NCT01907334|Dermatologic Agents|dermatologic agents|mesh-ancestor
111494669|NCT01907334|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111494670|NCT01907334|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111494671|NCT01907334|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111494672|NCT01907334|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111494673|NCT01907334|Adrenergic Agents|adrenergic agents|mesh-ancestor
111494674|NCT01907334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111494675|NCT01907334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111494676|NCT01907334|Tocolytic Agents|tocolytic agents|mesh-ancestor
111494677|NCT01907334|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111494678|NCT01907334|Glucocorticoids|glucocorticoids|mesh-ancestor
111494679|NCT01907334|Hormones|hormones|mesh-ancestor
111494680|NCT01907334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111494681|NCT01907334|Sympathomimetics|sympathomimetics|mesh-ancestor
111494682|NCT01907334|Miotics|miotics|mesh-ancestor
111494683|NCT01907334|Parasympathomimetics|parasympathomimetics|mesh-ancestor
111494684|NCT01907334|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
111494685|NCT01907334|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
111494686|NCT01907334|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111494687|NCT01907334|Cholinergic Agents|cholinergic agents|mesh-ancestor
111494688|NCT01907490|Benzyl Alcohol|benzyl alcohol|mesh-list
111494689|NCT01907490|Anesthetics, Local|anesthetics, local|mesh-ancestor
111494690|NCT01907490|Anesthetics|anesthetics|mesh-ancestor
111494691|NCT01907490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111494692|NCT01907490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111494693|NCT01907490|Sensory System Agents|sensory system agents|mesh-ancestor
111494694|NCT01907490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111494695|NCT01908972|Prednisolone|prednisolone|mesh-list
111494696|NCT01908972|Propranolol|propranolol|mesh-list
111494697|NCT01908972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111494698|NCT01908972|Glucocorticoids|glucocorticoids|mesh-ancestor
111494699|NCT01908972|Hormones|hormones|mesh-ancestor
111494700|NCT01908972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111494701|NCT01908972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111494702|NCT01908972|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111494703|NCT01908972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111494704|NCT01908972|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111494705|NCT01908972|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111494706|NCT01908972|Adrenergic Agents|adrenergic agents|mesh-ancestor
111494707|NCT01908972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111494708|NCT01908972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111494709|NCT01908972|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111494710|NCT01908972|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111494711|NCT01908972|Vasodilator Agents|vasodilator agents|mesh-ancestor
111494712|NCT01910064|Adapalene|adapalene|mesh-list
111494713|NCT01910064|Benzoyl Peroxide|benzoyl peroxide|mesh-list
111494714|NCT01910064|Dermatologic Agents|dermatologic agents|mesh-ancestor
111494715|NCT01910064|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111494716|NCT01910064|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111494717|NCT01910064|Analgesics|analgesics|mesh-ancestor
111494718|NCT01910064|Sensory System Agents|sensory system agents|mesh-ancestor
111494719|NCT01910064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111494720|NCT01910064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111494721|NCT01910064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111494722|NCT01910064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111494723|NCT01912716|Indomethacin|indomethacin|mesh-list
111494724|NCT01912716|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111494725|NCT01912716|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110977977|NCT02737475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110702746|NCT00127192|Protease Inhibitors|protease inhibitors|mesh-ancestor
111494726|NCT01912716|Analgesics|analgesics|mesh-ancestor
111494727|NCT01912716|Sensory System Agents|sensory system agents|mesh-ancestor
111494728|NCT01912716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111494729|NCT01912716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111494730|NCT01912716|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111494731|NCT01912716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111494732|NCT01912716|Gout Suppressants|gout suppressants|mesh-ancestor
111494733|NCT01912716|Tocolytic Agents|tocolytic agents|mesh-ancestor
111494734|NCT01912716|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111494735|NCT01912716|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111494736|NCT01912716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111494737|NCT01912716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111494738|NCT01920282|Nebivolol|nebivolol|mesh-list
111494739|NCT01920282|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111494740|NCT01920282|Vasodilator Agents|vasodilator agents|mesh-ancestor
111494741|NCT01920282|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
111494742|NCT01920282|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111494743|NCT01920282|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111494744|NCT01920282|Adrenergic Agents|adrenergic agents|mesh-ancestor
111494745|NCT01920282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111494746|NCT01920282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111494747|NCT01920282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111494748|NCT01921296|Cyclobenzaprine|cyclobenzaprine|mesh-list
111494749|NCT01921296|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
111494750|NCT01921296|Antidepressive Agents|antidepressive agents|mesh-ancestor
111494751|NCT01921296|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111494752|NCT01921296|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
111494753|NCT01921296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111494754|NCT01921296|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111494755|NCT01921296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111494756|NCT01921296|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111494757|NCT01921296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111494758|NCT01929642|Sirolimus|sirolimus|mesh-list
111494759|NCT01929642|Everolimus|everolimus|mesh-list
111494760|NCT01929642|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111494761|NCT01929642|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111494762|NCT01929642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111494763|NCT01929642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111494764|NCT01929642|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111494765|NCT01929642|Immunologic Factors|immunologic factors|mesh-ancestor
111494766|NCT01929642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111494767|NCT01929642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111494768|NCT01929642|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111494769|NCT01929642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111494770|NCT01929642|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111494771|NCT01929642|Antifungal Agents|antifungal agents|mesh-ancestor
111494772|NCT01932060|Oxytocin|oxytocin|mesh-list
111494773|NCT01932060|Oxytocics|oxytocics|mesh-ancestor
111494774|NCT01932060|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111494775|NCT01932060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111494776|NCT01933464|Cromolyn Sodium|cromolyn sodium|mesh-list
111494777|NCT01933464|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
111494778|NCT01933464|Immunologic Factors|immunologic factors|mesh-ancestor
111494779|NCT01933464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111494780|NCT01933464|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111494781|NCT01933464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111494782|NCT01933464|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111494783|NCT01933464|Respiratory System Agents|respiratory system agents|mesh-ancestor
111494784|NCT01933776|Vaccines|vaccines|mesh-list
111494785|NCT01933776|Immunologic Factors|immunologic factors|mesh-ancestor
111494786|NCT01933776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111494787|NCT01936896|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
111494788|NCT01936896|Protein C Inhibitor|protein c inhibitor|mesh-list
111494789|NCT01936896|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
111494790|NCT01936896|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111494791|NCT01936896|Protease Inhibitors|protease inhibitors|mesh-ancestor
111494792|NCT01936896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111494793|NCT01936896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111494794|NCT01937598|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111494795|NCT01937598|Liraglutide|liraglutide|mesh-list
111494796|NCT01937598|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111494797|NCT01937598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111494798|NCT01937598|Incretins|incretins|mesh-ancestor
111494799|NCT01937598|Hormones|hormones|mesh-ancestor
111494800|NCT01937598|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110977978|NCT02737475|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110977979|NCT02457806|Phenylephrine|phenylephrine|mesh-list
110977980|NCT02457806|Oxymetazoline|oxymetazoline|mesh-list
111494801|NCT01937598|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111494802|NCT01937598|Protease Inhibitors|protease inhibitors|mesh-ancestor
111494803|NCT01937598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111494804|NCT01937598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111494805|NCT01942668|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
111494806|NCT01942668|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
111494807|NCT01942668|Estradiol|estradiol|mesh-list
111494808|NCT01942668|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
111494809|NCT01942668|Progesterone|progesterone|mesh-list
111494810|NCT01942668|Estrogens|estrogens|mesh-ancestor
111494811|NCT01942668|Hormones|hormones|mesh-ancestor
111494812|NCT01942668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111494813|NCT01942668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111494814|NCT01942668|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111494815|NCT01942668|Contraceptive Agents|contraceptive agents|mesh-ancestor
111494816|NCT01942668|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111494817|NCT01942668|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111494818|NCT01942668|Progestins|progestins|mesh-ancestor
111494819|NCT01948518|Sildenafil Citrate|sildenafil citrate|mesh-list
111494820|NCT01948518|Vasodilator Agents|vasodilator agents|mesh-ancestor
111494821|NCT01948518|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111494822|NCT01948518|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111494823|NCT01948518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111494824|NCT01948518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111494825|NCT01948518|Urological Agents|urological agents|mesh-ancestor
111494826|NCT01948986|Ertugliflozin|ertugliflozin|mesh-list
111494827|NCT01948986|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111494828|NCT01948986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111494829|NCT01948986|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111494830|NCT01948986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111494831|NCT01949844|Regadenoson|regadenoson|mesh-list
111494832|NCT01949844|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
111494833|NCT01949844|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
111494834|NCT01949844|Purinergic Agonists|purinergic agonists|mesh-ancestor
111494835|NCT01949844|Purinergic Agents|purinergic agents|mesh-ancestor
111494836|NCT01949844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111494837|NCT01949844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111494838|NCT01949844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111494839|NCT01951950|Nicardipine|nicardipine|mesh-list
111494840|NCT01951950|Esmolol|esmolol|mesh-list
111494841|NCT01951950|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
111494842|NCT01951950|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111494843|NCT01951950|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111494844|NCT01951950|Adrenergic Agents|adrenergic agents|mesh-ancestor
111494845|NCT01951950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111494846|NCT01951950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111494847|NCT01951950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111494848|NCT01951950|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111494849|NCT01951950|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111494850|NCT01951950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111494851|NCT01951950|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111494852|NCT01951950|Vasodilator Agents|vasodilator agents|mesh-ancestor
111494853|NCT01953432|Doxazosin|doxazosin|mesh-list
111494854|NCT01953432|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111494855|NCT01953432|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111494856|NCT01953432|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111494857|NCT01953432|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111494858|NCT01953432|Adrenergic Agents|adrenergic agents|mesh-ancestor
111494859|NCT01953432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111494860|NCT01953432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111494861|NCT01953432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111494862|NCT01955382|Artesunate|artesunate|mesh-list
111494863|NCT01955382|Amodiaquine|amodiaquine|mesh-list
111494864|NCT01955382|Charcoal|charcoal|mesh-list
111494865|NCT01955382|Antimalarials|antimalarials|mesh-ancestor
111494866|NCT01955382|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111494867|NCT01955382|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111494868|NCT01955382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111494869|NCT01955382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111494870|NCT01955382|Antiviral Agents|antiviral agents|mesh-ancestor
111494871|NCT01955382|Schistosomicides|schistosomicides|mesh-ancestor
111494872|NCT01955382|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110977981|NCT02457806|Tetracaine|tetracaine|mesh-list
111494873|NCT01955382|Anthelmintics|anthelmintics|mesh-ancestor
111494874|NCT01955382|Antidotes|antidotes|mesh-ancestor
111494875|NCT01955382|Protective Agents|protective agents|mesh-ancestor
111494876|NCT01955382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111494877|NCT01957410|Ketamine|ketamine|mesh-list
111494878|NCT01957410|Analgesics|analgesics|mesh-ancestor
111494879|NCT01957410|Sensory System Agents|sensory system agents|mesh-ancestor
111494880|NCT01957410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111494881|NCT01957410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111494882|NCT01957410|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111494883|NCT01957410|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111494884|NCT01957410|Anesthetics, General|anesthetics, general|mesh-ancestor
111494885|NCT01957410|Anesthetics|anesthetics|mesh-ancestor
111494886|NCT01957410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111494887|NCT01957410|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111494888|NCT01957410|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111494889|NCT01957410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111494890|NCT01957410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111494891|NCT01958112|Trametinib|trametinib|mesh-list
111494892|NCT01958112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111494893|NCT01958112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111494894|NCT01958112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111494895|NCT01958112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111494896|NCT05739786|Vitamin D|vitamin d|mesh-list
111494897|NCT05739786|Cholecalciferol|cholecalciferol|mesh-list
111494898|NCT05739786|Vitamins|vitamins|mesh-ancestor
111494899|NCT05739786|Micronutrients|micronutrients|mesh-ancestor
111494900|NCT05739786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111494901|NCT05739786|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111494902|NCT05739786|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111494903|NCT05739630|Cytarabine|cytarabine|mesh-list
111494904|NCT05739630|Cyclophosphamide|cyclophosphamide|mesh-list
111494905|NCT05739630|Busulfan|busulfan|mesh-list
111494906|NCT05739630|Fludarabine|fludarabine|mesh-list
111494907|NCT05739630|Mitoxantrone|mitoxantrone|mesh-list
111494908|NCT05739630|Tacrolimus|tacrolimus|mesh-list
111494909|NCT05739630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111494910|NCT05739630|Immunologic Factors|immunologic factors|mesh-ancestor
111494911|NCT05739630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111494912|NCT05739630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111494913|NCT05739630|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111494914|NCT05739630|Alkylating Agents|alkylating agents|mesh-ancestor
111494915|NCT05739630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111494916|NCT05739630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111494917|NCT05739630|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111494918|NCT05739630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111494919|NCT05739630|Antimetabolites|antimetabolites|mesh-ancestor
111494920|NCT05739630|Antiviral Agents|antiviral agents|mesh-ancestor
111494921|NCT05739630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111494922|NCT05739630|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111494923|NCT05739630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111494924|NCT05739630|Analgesics|analgesics|mesh-ancestor
111494925|NCT05739630|Sensory System Agents|sensory system agents|mesh-ancestor
111494926|NCT05739630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111494927|NCT05739630|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111494928|NCT05739630|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111494929|NCT05738616|Lenvatinib|lenvatinib|mesh-list
111494930|NCT05738616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111494931|NCT05738616|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111494932|NCT05738616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111494933|NCT05738616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111494934|NCT05738460|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111494935|NCT05738460|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
111494936|NCT05738460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111494937|NCT05738460|Antitubercular Agents|antitubercular agents|mesh-ancestor
111494938|NCT05738382|Cetrorelix|cetrorelix|mesh-list
111494939|NCT05738382|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111494940|NCT05738382|Fertility Agents|fertility agents|mesh-ancestor
111494941|NCT05738382|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111494942|NCT05738382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111494943|NCT05738382|Hormone Antagonists|hormone antagonists|mesh-ancestor
111494944|NCT05738382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111494945|NCT05737680|Hydroxychloroquine|hydroxychloroquine|mesh-list
110977982|NCT02457806|Anesthetics, Local|anesthetics, local|mesh-ancestor
110977983|NCT02457806|Anesthetics|anesthetics|mesh-ancestor
111494946|NCT05737680|Colchicine|colchicine|mesh-list
111494947|NCT05737680|Antimalarials|antimalarials|mesh-ancestor
111494948|NCT05737680|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111494949|NCT05737680|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111494950|NCT05737680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111494951|NCT05737680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111494952|NCT05737680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111494953|NCT05737680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111494954|NCT05737680|Gout Suppressants|gout suppressants|mesh-ancestor
111494955|NCT05737680|Tubulin Modulators|tubulin modulators|mesh-ancestor
111494956|NCT05737680|Antimitotic Agents|antimitotic agents|mesh-ancestor
111494957|NCT05737680|Mitosis Modulators|mitosis modulators|mesh-ancestor
111494958|NCT05737680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110558447|NCT00499603|Everolimus|everolimus|mesh-list
111494959|NCT05735028|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
111494960|NCT05735028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111494961|NCT05735028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111494962|NCT05735028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111494963|NCT05725200|Gemcitabine|gemcitabine|mesh-list
111494964|NCT05725200|Methotrexate|methotrexate|mesh-list
111494965|NCT05725200|Pembrolizumab|pembrolizumab|mesh-list
111494966|NCT05725200|Trastuzumab|trastuzumab|mesh-list
111494967|NCT05725200|Cetuximab|cetuximab|mesh-list
111494968|NCT05725200|Everolimus|everolimus|mesh-list
111494969|NCT05725200|Venetoclax|venetoclax|mesh-list
111494970|NCT05725200|Dasatinib|dasatinib|mesh-list
111494971|NCT05725200|Palbociclib|palbociclib|mesh-list
111494972|NCT05725200|Crizotinib|crizotinib|mesh-list
111494973|NCT05725200|Panobinostat|panobinostat|mesh-list
111494974|NCT05725200|Talazoparib|talazoparib|mesh-list
111494975|NCT05725200|Idelalisib|idelalisib|mesh-list
111494976|NCT05725200|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111494977|NCT05725200|Antimetabolites|antimetabolites|mesh-ancestor
111494978|NCT05725200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111494979|NCT05725200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111494980|NCT05725200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111494981|NCT05725200|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111494982|NCT05725200|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111494983|NCT05725200|Abortifacient Agents|abortifacient agents|mesh-ancestor
111494984|NCT05725200|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111494985|NCT05725200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111494986|NCT05725200|Dermatologic Agents|dermatologic agents|mesh-ancestor
111494987|NCT05725200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111494988|NCT05725200|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111494989|NCT05725200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111494990|NCT05725200|Immunologic Factors|immunologic factors|mesh-ancestor
111494991|NCT05725200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111494992|NCT05725200|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111494993|NCT05725200|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111494994|NCT05725200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111494995|NCT05725200|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111494996|NCT05725200|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111494997|NCT05721144|Nitric Oxide|nitric oxide|mesh-list
111494998|NCT05721144|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111494999|NCT05721144|Autonomic Agents|autonomic agents|mesh-ancestor
111495000|NCT05721144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111495001|NCT05721144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111495002|NCT05721144|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111495003|NCT05721144|Respiratory System Agents|respiratory system agents|mesh-ancestor
111495004|NCT05721144|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111495005|NCT05721144|Antioxidants|antioxidants|mesh-ancestor
111495006|NCT05721144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111495007|NCT05721144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111495008|NCT05721144|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
111495009|NCT05721144|Vasodilator Agents|vasodilator agents|mesh-ancestor
111495010|NCT05721144|Gasotransmitters|gasotransmitters|mesh-ancestor
111495011|NCT05721144|Protective Agents|protective agents|mesh-ancestor
111495012|NCT05685732|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
111495013|NCT05685732|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111495014|NCT05685732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111495015|NCT05685732|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111495016|NCT05685732|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111495017|NCT05685732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110977984|NCT02457806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110703038|NCT00136084|Hormones|hormones|mesh-ancestor
111495018|NCT05685732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111495019|NCT05685732|Dopamine Agents|dopamine agents|mesh-ancestor
111495020|NCT05685732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110977985|NCT02457806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111495022|NCT05574894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111495023|NCT05574894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111495024|NCT05530278|Midazolam|midazolam|mesh-list
111495025|NCT05530278|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111495026|NCT05530278|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111495027|NCT05530278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111495028|NCT05530278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111495029|NCT05530278|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111495030|NCT05530278|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111495031|NCT05530278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111495032|NCT05530278|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111495033|NCT05530278|Anesthetics, General|anesthetics, general|mesh-ancestor
111495034|NCT05530278|Anesthetics|anesthetics|mesh-ancestor
111495035|NCT05530278|GABA Modulators|gaba modulators|mesh-ancestor
111495036|NCT05530278|GABA Agents|gaba agents|mesh-ancestor
111495037|NCT05530278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111495038|NCT05530278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111495039|NCT05436288|Hyaluronic Acid|hyaluronic acid|mesh-list
111495040|NCT05436288|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111495041|NCT05436288|Immunologic Factors|immunologic factors|mesh-ancestor
111495042|NCT05436288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111495043|NCT05436288|Viscosupplements|viscosupplements|mesh-ancestor
111495044|NCT05436288|Protective Agents|protective agents|mesh-ancestor
111495045|NCT05245734|Immunoglobulins|immunoglobulins|mesh-list
111495046|NCT05245734|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111495047|NCT05245734|Antibodies|antibodies|mesh-list
111495048|NCT05245734|gamma-Globulins|gamma-globulins|mesh-list
111495049|NCT05245734|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
111495050|NCT05245734|Immunologic Factors|immunologic factors|mesh-ancestor
111495051|NCT05245734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111495052|NCT05242692|Dexmedetomidine|dexmedetomidine|mesh-list
111495053|NCT05242692|Ketamine|ketamine|mesh-list
111495054|NCT05242692|Esketamine|esketamine|mesh-list
111495055|NCT05242692|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111495056|NCT05242692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111495057|NCT05242692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111495058|NCT05242692|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111495059|NCT05242692|Analgesics|analgesics|mesh-ancestor
111495060|NCT05242692|Sensory System Agents|sensory system agents|mesh-ancestor
111495061|NCT05242692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111495062|NCT05242692|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111495063|NCT05242692|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111495064|NCT05242692|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111495065|NCT05242692|Adrenergic Agents|adrenergic agents|mesh-ancestor
111495066|NCT05242692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111495067|NCT05242692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111495068|NCT05242692|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111495069|NCT05242692|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111495070|NCT05242692|Anesthetics, General|anesthetics, general|mesh-ancestor
111495071|NCT05242692|Anesthetics|anesthetics|mesh-ancestor
111495072|NCT05242692|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111495073|NCT05242692|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111495074|NCT05242692|Antidepressive Agents|antidepressive agents|mesh-ancestor
111495075|NCT05242692|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111495076|NCT05087940|Diuretics|diuretics|mesh-list
111495077|NCT05087940|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
111495078|NCT05087940|Natriuretic Agents|natriuretic agents|mesh-ancestor
111495079|NCT05087940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111495080|NCT05087940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111495081|NCT05087940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111495082|NCT04922658|Vinorelbine|vinorelbine|mesh-list
111495083|NCT04922658|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111495084|NCT04922658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111495085|NCT04922658|Tubulin Modulators|tubulin modulators|mesh-ancestor
111495086|NCT04922658|Antimitotic Agents|antimitotic agents|mesh-ancestor
111495087|NCT04922658|Mitosis Modulators|mitosis modulators|mesh-ancestor
111495088|NCT04922658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111495089|NCT04883346|Liraglutide|liraglutide|mesh-list
111495090|NCT04883346|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110977986|NCT02457806|Sensory System Agents|sensory system agents|mesh-ancestor
111495091|NCT04883346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111495092|NCT04883346|Incretins|incretins|mesh-ancestor
111495093|NCT04883346|Hormones|hormones|mesh-ancestor
111495094|NCT04883346|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111495095|NCT04438902|Osimertinib|osimertinib|mesh-list
111495096|NCT04438902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111495097|NCT04438902|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111495098|NCT04438902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111495099|NCT04438902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111495100|NCT04329390|Anticoagulants|anticoagulants|mesh-list
111495101|NCT04177602|Trifluridine|trifluridine|mesh-list
111495102|NCT04177602|Capecitabine|capecitabine|mesh-list
111495103|NCT04177602|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111495104|NCT04177602|Antimetabolites|antimetabolites|mesh-ancestor
111495105|NCT04177602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111495106|NCT04177602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111495107|NCT04177602|Antiviral Agents|antiviral agents|mesh-ancestor
111495108|NCT04177602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111495109|NCT03868956|Fibrin fragment D|fibrin fragment d|mesh-list
111495110|NCT03868956|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111495111|NCT03868956|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111495112|NCT03868956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111495113|NCT03868956|Hemostatics|hemostatics|mesh-ancestor
111495114|NCT03868956|Coagulants|coagulants|mesh-ancestor
111495115|NCT03816618|Fusidic Acid|fusidic acid|mesh-list
111495116|NCT03816618|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111495117|NCT03816618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111495118|NCT03816618|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111495119|NCT03816618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111495120|NCT03816618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111495121|NCT03616236|Buprenorphine|buprenorphine|mesh-list
111495122|NCT03616236|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
111495123|NCT03616236|Naloxone|naloxone|mesh-list
111495124|NCT03616236|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111495125|NCT03616236|Narcotics|narcotics|mesh-ancestor
111495126|NCT03616236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111495127|NCT03616236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111495128|NCT03616236|Analgesics|analgesics|mesh-ancestor
111495129|NCT03616236|Sensory System Agents|sensory system agents|mesh-ancestor
111495130|NCT03616236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111495131|NCT03616236|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111495132|NCT03551730|Enoxaparin|enoxaparin|mesh-list
111495133|NCT03551730|Enoxaparin sodium|enoxaparin sodium|mesh-list
111495134|NCT03551730|Anticoagulants|anticoagulants|mesh-ancestor
111495135|NCT03551730|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111495136|NCT03551730|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111495137|NCT03551730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111495138|NCT03366480|Paclitaxel|paclitaxel|mesh-list
111495139|NCT03366480|Carboplatin|carboplatin|mesh-list
111495140|NCT03366480|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111495141|NCT03366480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111495142|NCT03366480|Tubulin Modulators|tubulin modulators|mesh-ancestor
111495143|NCT03366480|Antimitotic Agents|antimitotic agents|mesh-ancestor
111495144|NCT03366480|Mitosis Modulators|mitosis modulators|mesh-ancestor
111495145|NCT03366480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111495146|NCT02867124|Naltrexone|naltrexone|mesh-list
111495147|NCT02867124|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111495148|NCT02867124|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111495149|NCT02867124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111495150|NCT02867124|Sensory System Agents|sensory system agents|mesh-ancestor
111495151|NCT02867124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111495152|NCT02534376|Simvastatin|simvastatin|mesh-list
111495153|NCT02534376|Ezetimibe|ezetimibe|mesh-list
111495154|NCT02534376|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111495155|NCT02534376|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111495156|NCT02534376|Antimetabolites|antimetabolites|mesh-ancestor
111495157|NCT02534376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111495158|NCT02534376|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111495159|NCT02534376|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111495160|NCT02534376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111495161|NCT02216838|Botulinum Toxins|botulinum toxins|mesh-list
111495162|NCT02216838|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111495163|NCT02216838|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111495164|NCT02216838|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111495165|NCT02216838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110977987|NCT02457806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110977988|NCT02457806|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110977989|NCT02457806|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110977990|NCT02457806|Adrenergic Agents|adrenergic agents|mesh-ancestor
111495166|NCT02216838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111495167|NCT02216838|Cholinergic Agents|cholinergic agents|mesh-ancestor
111495168|NCT02216838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111495169|NCT02216838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111495170|NCT02216838|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111495171|NCT02216838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111495172|NCT02065596|Fludarabine|fludarabine|mesh-list
111495173|NCT02065596|Fludarabine phosphate|fludarabine phosphate|mesh-list
111495174|NCT02065596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111495175|NCT02065596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111495176|NCT02065596|Antimetabolites|antimetabolites|mesh-ancestor
111495177|NCT02065596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111495178|NCT02065596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111495179|NCT02065596|Immunologic Factors|immunologic factors|mesh-ancestor
111495180|NCT02065596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111495181|NCT01976286|Salicylic Acid|salicylic acid|mesh-list
111495182|NCT01976286|Salicylates|salicylates|mesh-list
111495183|NCT01976286|Glycolic acid|glycolic acid|mesh-list
111495184|NCT01976286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111495185|NCT01976286|Antifungal Agents|antifungal agents|mesh-ancestor
111495186|NCT01976286|Keratolytic Agents|keratolytic agents|mesh-ancestor
111495187|NCT01976286|Dermatologic Agents|dermatologic agents|mesh-ancestor
111495188|NCT01976286|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111495189|NCT01976286|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111495190|NCT01976286|Analgesics|analgesics|mesh-ancestor
111495191|NCT01976286|Sensory System Agents|sensory system agents|mesh-ancestor
111495192|NCT01976286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111495193|NCT01976286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111495194|NCT01976286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111495195|NCT01976286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111495196|NCT01976286|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111495197|NCT01976286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111495198|NCT01976286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111495199|NCT01688076|Botulinum Toxins|botulinum toxins|mesh-list
111495200|NCT01688076|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111495201|NCT01688076|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111495202|NCT01688076|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111495203|NCT01688076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111495204|NCT01688076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111495205|NCT01688076|Cholinergic Agents|cholinergic agents|mesh-ancestor
111495206|NCT01688076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111495207|NCT01688076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111495208|NCT01688076|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111495209|NCT01688076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111495210|NCT01239030|Methylphenidate|methylphenidate|mesh-list
111495211|NCT01239030|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111495212|NCT01239030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111495213|NCT01239030|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111495214|NCT01239030|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111495215|NCT01239030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111495216|NCT01239030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111495217|NCT01239030|Dopamine Agents|dopamine agents|mesh-ancestor
111495218|NCT01239030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111495219|NCT01086540|Acetaminophen|acetaminophen|mesh-list
111495220|NCT01086540|Diphenhydramine|diphenhydramine|mesh-list
111495221|NCT01086540|Promethazine|promethazine|mesh-list
111495222|NCT01086540|Prednisone|prednisone|mesh-list
111495223|NCT01086540|Methylprednisolone|methylprednisolone|mesh-list
111495224|NCT01086540|Rituximab|rituximab|mesh-list
111495225|NCT01086540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111495226|NCT01086540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110480401|NCT00920725|Insulin Aspart|insulin aspart|mesh-list
111495227|NCT01086540|Immunologic Factors|immunologic factors|mesh-ancestor
111495228|NCT01086540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111495229|NCT01086540|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111495230|NCT01086540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111495231|NCT01086540|Glucocorticoids|glucocorticoids|mesh-ancestor
111495232|NCT01086540|Hormones|hormones|mesh-ancestor
110977991|NCT02457806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110977992|NCT02457806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110977993|NCT02457806|Sympathomimetics|sympathomimetics|mesh-ancestor
111495233|NCT01086540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110977994|NCT02457806|Autonomic Agents|autonomic agents|mesh-ancestor
110703257|NCT01059084|Valacyclovir|valacyclovir|mesh-list
110977995|NCT02457806|Nasal Decongestants|nasal decongestants|mesh-ancestor
111495234|NCT01086540|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111495235|NCT01086540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111495236|NCT01086540|Analgesics|analgesics|mesh-ancestor
111495237|NCT01086540|Sensory System Agents|sensory system agents|mesh-ancestor
111495238|NCT01086540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111495239|NCT01086540|Antipyretics|antipyretics|mesh-ancestor
111495240|NCT01086540|Antiemetics|antiemetics|mesh-ancestor
111495241|NCT01086540|Autonomic Agents|autonomic agents|mesh-ancestor
111495242|NCT01086540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111495243|NCT01086540|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111495244|NCT01086540|Protective Agents|protective agents|mesh-ancestor
111495245|NCT01086540|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111495246|NCT01086540|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111495247|NCT01086540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111495248|NCT01086540|Anesthetics, Local|anesthetics, local|mesh-ancestor
111495249|NCT01086540|Anesthetics|anesthetics|mesh-ancestor
111495250|NCT01086540|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111495251|NCT01086540|Histamine Antagonists|histamine antagonists|mesh-ancestor
111495252|NCT01086540|Histamine Agents|histamine agents|mesh-ancestor
111495253|NCT01086540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111495254|NCT01086540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111495255|NCT01086540|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111495256|NCT01086540|Antipruritics|antipruritics|mesh-ancestor
111495257|NCT01086540|Dermatologic Agents|dermatologic agents|mesh-ancestor
111495258|NCT01962870|Vasopressins|vasopressins|mesh-list
111495259|NCT01962870|Arginine Vasopressin|arginine vasopressin|mesh-list
111495260|NCT01962870|Hemostatics|hemostatics|mesh-ancestor
111495261|NCT01962870|Coagulants|coagulants|mesh-ancestor
111495262|NCT01962870|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111495263|NCT01962870|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
111495264|NCT01962870|Natriuretic Agents|natriuretic agents|mesh-ancestor
111495265|NCT01962870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111495266|NCT01965366|Dexamethasone|dexamethasone|mesh-list
111495267|NCT01965366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111495268|NCT01965366|Antiemetics|antiemetics|mesh-ancestor
111495269|NCT01965366|Autonomic Agents|autonomic agents|mesh-ancestor
111495270|NCT01965366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111495271|NCT01965366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111495272|NCT01965366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111495273|NCT01965366|Glucocorticoids|glucocorticoids|mesh-ancestor
111495274|NCT01965366|Hormones|hormones|mesh-ancestor
111495275|NCT01965366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111495276|NCT01965366|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111495277|NCT01965366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111495278|NCT01965756|Metformin|metformin|mesh-list
111495279|NCT01965756|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111495280|NCT01965756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111495281|NCT01967862|Listerine|listerine|mesh-list
111495282|NCT01967862|Fluorides|fluorides|mesh-list
111495283|NCT01967862|Sodium Fluoride|sodium fluoride|mesh-list
111495284|NCT01967862|Cariostatic Agents|cariostatic agents|mesh-ancestor
111495285|NCT01967862|Protective Agents|protective agents|mesh-ancestor
111495286|NCT01967862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111495287|NCT01967862|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111495288|NCT01967862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111495289|NCT01976988|Heparin|heparin|mesh-list
111495290|NCT01976988|Anticoagulants|anticoagulants|mesh-ancestor
111495291|NCT01976988|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111495292|NCT01976988|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111495293|NCT01976988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111495294|NCT01980654|Rituximab|rituximab|mesh-list
111495295|NCT01980654|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111495296|NCT01980654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111495297|NCT01980654|Immunologic Factors|immunologic factors|mesh-ancestor
111495298|NCT01980654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111495299|NCT01980654|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111495300|NCT01984398|Citric Acid|citric acid|mesh-list
111495301|NCT01984398|Sodium Citrate|sodium citrate|mesh-list
111495302|NCT01984398|Enclomiphene|enclomiphene|mesh-list
111495303|NCT01984398|Clomiphene|clomiphene|mesh-list
111495304|NCT01984398|Zuclomiphene|zuclomiphene|mesh-list
111495305|NCT01984398|Anticoagulants|anticoagulants|mesh-ancestor
110977996|NCT02457806|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110703335|NCT00520403|Antiviral Agents|antiviral agents|mesh-ancestor
111495306|NCT01984398|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
111495307|NCT01984398|Chelating Agents|chelating agents|mesh-ancestor
111495308|NCT01984398|Sequestering Agents|sequestering agents|mesh-ancestor
111495309|NCT01984398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111495310|NCT01984398|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111495311|NCT01984398|Hormone Antagonists|hormone antagonists|mesh-ancestor
111495312|NCT01984398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111495313|NCT01984398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111495314|NCT01984398|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111495315|NCT01984398|Fertility Agents|fertility agents|mesh-ancestor
111495316|NCT01984398|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111495317|NCT01984398|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111495318|NCT01984398|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111495319|NCT01987752|Timolol|timolol|mesh-list
111495320|NCT01987752|Brimonidine Tartrate|brimonidine tartrate|mesh-list
111495321|NCT01987752|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111495322|NCT01987752|Brimonidine Tartrate, Timolol Maleate Drug Combination|brimonidine tartrate, timolol maleate drug combination|mesh-list
111495323|NCT01987752|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111495324|NCT01987752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111495325|NCT01987752|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111495326|NCT01987752|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111495327|NCT01987752|Adrenergic Agents|adrenergic agents|mesh-ancestor
111495328|NCT01987752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111495329|NCT01987752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111495330|NCT01987752|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111495331|NCT01987752|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111495332|NCT01987752|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111495333|NCT01987752|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111495334|NCT01987752|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111495335|NCT01988922|Ketamine|ketamine|mesh-list
111495336|NCT01988922|Analgesics|analgesics|mesh-ancestor
111495337|NCT01988922|Sensory System Agents|sensory system agents|mesh-ancestor
111495338|NCT01988922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111495339|NCT01988922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111495340|NCT01988922|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111495341|NCT01988922|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111495342|NCT01988922|Anesthetics, General|anesthetics, general|mesh-ancestor
111495343|NCT01988922|Anesthetics|anesthetics|mesh-ancestor
111495344|NCT01988922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111495345|NCT01988922|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111495346|NCT01988922|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111495347|NCT01988922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111495348|NCT01988922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111495349|NCT01994538|Oxymetazoline|oxymetazoline|mesh-list
111495350|NCT01994538|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111495351|NCT01994538|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111495352|NCT01994538|Adrenergic Agents|adrenergic agents|mesh-ancestor
111495353|NCT01994538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111495354|NCT01994538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111495355|NCT01994538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111495356|NCT01994538|Sympathomimetics|sympathomimetics|mesh-ancestor
111495357|NCT01994538|Autonomic Agents|autonomic agents|mesh-ancestor
111495358|NCT01994538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111495359|NCT01994538|Nasal Decongestants|nasal decongestants|mesh-ancestor
111495360|NCT01994538|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111495361|NCT01994538|Respiratory System Agents|respiratory system agents|mesh-ancestor
111495362|NCT01998438|Tranexamic Acid|tranexamic acid|mesh-list
111495363|NCT01998438|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111495364|NCT01998438|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111495365|NCT01998438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111495366|NCT01998438|Hemostatics|hemostatics|mesh-ancestor
111495367|NCT01998438|Coagulants|coagulants|mesh-ancestor
111495368|NCT01999530|Prazosin|prazosin|mesh-list
111495369|NCT01999530|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111495370|NCT01999530|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111495371|NCT01999530|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111495372|NCT01999530|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111495373|NCT01999530|Adrenergic Agents|adrenergic agents|mesh-ancestor
111495374|NCT01999530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111495375|NCT01999530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111495376|NCT01999530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111495377|NCT01999920|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
111495378|NCT01999920|Antidepressive Agents|antidepressive agents|mesh-ancestor
111495379|NCT01999920|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111495380|NCT01999920|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111495381|NCT01999920|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111495382|NCT01999920|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111495383|NCT01999920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111495384|NCT01999920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111495385|NCT01999920|Serotonin Agents|serotonin agents|mesh-ancestor
111495386|NCT01999920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111495387|NCT01999920|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111495388|NCT01999920|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111495389|NCT02002650|Indomethacin|indomethacin|mesh-list
111495390|NCT02002650|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111495391|NCT02002650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111495392|NCT02002650|Analgesics|analgesics|mesh-ancestor
111495393|NCT02002650|Sensory System Agents|sensory system agents|mesh-ancestor
111495394|NCT02002650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111495395|NCT02002650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111495396|NCT02002650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111495397|NCT02002650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111495398|NCT02002650|Gout Suppressants|gout suppressants|mesh-ancestor
111495399|NCT02002650|Tocolytic Agents|tocolytic agents|mesh-ancestor
111495400|NCT02002650|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111495401|NCT02002650|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111495402|NCT02002650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111495403|NCT02002650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111495404|NCT02004132|Testosterone|testosterone|mesh-list
111495405|NCT02004132|Androgens|androgens|mesh-ancestor
111495406|NCT02004132|Hormones|hormones|mesh-ancestor
111495407|NCT02004132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111495408|NCT02004132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111495409|NCT02004366|Insulin Glargine|insulin glargine|mesh-list
111495410|NCT02004366|Linagliptin|linagliptin|mesh-list
111495411|NCT02004366|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111495412|NCT02004366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111495413|NCT02004366|Incretins|incretins|mesh-ancestor
111495414|NCT02004366|Hormones|hormones|mesh-ancestor
111495415|NCT02004366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111495416|NCT02004366|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111495417|NCT02004366|Protease Inhibitors|protease inhibitors|mesh-ancestor
111495418|NCT02004366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111495419|NCT02004366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111495420|NCT02004990|Povidone-Iodine|povidone-iodine|mesh-list
111495421|NCT02004990|Povidone|povidone|mesh-list
111495422|NCT02004990|Plasma Substitutes|plasma substitutes|mesh-ancestor
111495423|NCT02004990|Blood Substitutes|blood substitutes|mesh-ancestor
111495424|NCT02004990|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111495425|NCT02004990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111495426|NCT02006160|4-Aminopyridine|4-aminopyridine|mesh-list
111495427|NCT02006160|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
111495428|NCT02006160|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111495429|NCT02006160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111495430|NCT02011464|Bupivacaine|bupivacaine|mesh-list
111495431|NCT02011464|Anesthetics, Local|anesthetics, local|mesh-ancestor
111495432|NCT02011464|Anesthetics|anesthetics|mesh-ancestor
111495433|NCT02011464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111495434|NCT02011464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111495435|NCT02011464|Sensory System Agents|sensory system agents|mesh-ancestor
111495436|NCT02011464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111495437|NCT02058420|Tocotrienols|tocotrienols|mesh-list
111495438|NCT02058420|Vitamin E|vitamin e|mesh-list
111495439|NCT02058420|Tocopherols|tocopherols|mesh-list
111495440|NCT02058420|Antioxidants|antioxidants|mesh-ancestor
111495441|NCT02058420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111495442|NCT02058420|Protective Agents|protective agents|mesh-ancestor
111495443|NCT02058420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111495444|NCT02058420|Vitamins|vitamins|mesh-ancestor
111495445|NCT02058420|Micronutrients|micronutrients|mesh-ancestor
111495446|NCT02020278|Tolvaptan|tolvaptan|mesh-list
111495447|NCT02020278|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
111495448|NCT02020278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111495449|NCT02020278|Natriuretic Agents|natriuretic agents|mesh-ancestor
111495450|NCT02020278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111495451|NCT02024646|Brodalumab|brodalumab|mesh-list
111495452|NCT02024646|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111495453|NCT02024646|Dermatologic Agents|dermatologic agents|mesh-ancestor
111495454|NCT02024646|Immunologic Factors|immunologic factors|mesh-ancestor
110977997|NCT02457806|Respiratory System Agents|respiratory system agents|mesh-ancestor
110703500|NCT00518687|Vaccines|vaccines|mesh-list
111495455|NCT02024646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111495457|NCT02024724|Triamcinolone|triamcinolone|mesh-list
111495458|NCT02024724|Bupivacaine|bupivacaine|mesh-list
111495459|NCT02024724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111495460|NCT02024724|Antiemetics|antiemetics|mesh-ancestor
111495461|NCT02024724|Autonomic Agents|autonomic agents|mesh-ancestor
111495462|NCT02024724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111495463|NCT02024724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111495464|NCT02024724|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111495465|NCT02024724|Glucocorticoids|glucocorticoids|mesh-ancestor
111495466|NCT02024724|Hormones|hormones|mesh-ancestor
111495467|NCT02024724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111495468|NCT02024724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111495469|NCT02024724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111495470|NCT02024724|Anesthetics, Local|anesthetics, local|mesh-ancestor
111495471|NCT02024724|Anesthetics|anesthetics|mesh-ancestor
111495472|NCT02024724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111495473|NCT02024724|Sensory System Agents|sensory system agents|mesh-ancestor
111495474|NCT02025426|Phenylephrine|phenylephrine|mesh-list
111495475|NCT02025426|Oxymetazoline|oxymetazoline|mesh-list
111495476|NCT02025426|Ephedrine|ephedrine|mesh-list
111495477|NCT02025426|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111495478|NCT02025426|Mydriatics|mydriatics|mesh-ancestor
111495479|NCT02025426|Autonomic Agents|autonomic agents|mesh-ancestor
111495480|NCT02025426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111495481|NCT02025426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111495482|NCT02025426|Sympathomimetics|sympathomimetics|mesh-ancestor
111495483|NCT02025426|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111495484|NCT02025426|Nasal Decongestants|nasal decongestants|mesh-ancestor
111495485|NCT02025426|Respiratory System Agents|respiratory system agents|mesh-ancestor
111495486|NCT02025426|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111495487|NCT02025426|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111495488|NCT02025426|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111495489|NCT02025426|Adrenergic Agents|adrenergic agents|mesh-ancestor
111495490|NCT02025426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111495491|NCT02025426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111495492|NCT02025426|Protective Agents|protective agents|mesh-ancestor
111495493|NCT02025426|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111495494|NCT02028780|Dabigatran|dabigatran|mesh-list
111495495|NCT02028780|Antithrombins|antithrombins|mesh-ancestor
111495496|NCT02028780|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111495497|NCT02028780|Protease Inhibitors|protease inhibitors|mesh-ancestor
111495498|NCT02028780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111495499|NCT02028780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111495500|NCT02028780|Anticoagulants|anticoagulants|mesh-ancestor
111495501|NCT02029872|Chlorhexidine|chlorhexidine|mesh-list
111495502|NCT02029872|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
111495503|NCT02029872|Mupirocin|mupirocin|mesh-list
111495504|NCT02029872|Calcium|calcium|mesh-list
111495505|NCT02029872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111495506|NCT02029872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111495507|NCT02029872|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111495508|NCT02029872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111495509|NCT02029872|Disinfectants|disinfectants|mesh-ancestor
111495510|NCT02029872|Dermatologic Agents|dermatologic agents|mesh-ancestor
111495511|NCT02029872|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111495512|NCT02029872|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111495513|NCT02029872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111495514|NCT02029872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111495515|NCT02030574|Gemcitabine|gemcitabine|mesh-list
111495516|NCT02030574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111495517|NCT02030574|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111495518|NCT02030574|Antimetabolites|antimetabolites|mesh-ancestor
111495519|NCT02030574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111495520|NCT02032212|Nicotine|nicotine|mesh-list
111495521|NCT02032212|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111495522|NCT02032212|Autonomic Agents|autonomic agents|mesh-ancestor
111495523|NCT02032212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110977998|NCT02457806|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110977999|NCT02457806|Mydriatics|mydriatics|mesh-ancestor
110978000|NCT02457806|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110978001|NCT02457806|Protective Agents|protective agents|mesh-ancestor
111495524|NCT02032212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111495525|NCT02032212|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111495526|NCT02032212|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111495527|NCT02032212|Cholinergic Agents|cholinergic agents|mesh-ancestor
111495528|NCT02032212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111495529|NCT02032212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111495530|NCT02032758|Propranolol|propranolol|mesh-list
110480452|NCT04504123|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111495531|NCT02032758|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111495532|NCT02032758|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111495533|NCT02032758|Adrenergic Agents|adrenergic agents|mesh-ancestor
111495534|NCT02032758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111495535|NCT02032758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111495536|NCT02032758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111495537|NCT02032758|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111495538|NCT02032758|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111495539|NCT02032758|Vasodilator Agents|vasodilator agents|mesh-ancestor
111495540|NCT02036424|Dexamethasone|dexamethasone|mesh-list
111495541|NCT02036424|Bevacizumab|bevacizumab|mesh-list
111495542|NCT02036424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111495543|NCT02036424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111495544|NCT02036424|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111495545|NCT02036424|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111495546|NCT02036424|Growth Substances|growth substances|mesh-ancestor
111495547|NCT02036424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111495548|NCT02036424|Growth Inhibitors|growth inhibitors|mesh-ancestor
111495549|NCT02036424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111495550|NCT02036424|Antiemetics|antiemetics|mesh-ancestor
111495551|NCT02036424|Autonomic Agents|autonomic agents|mesh-ancestor
111495552|NCT02036424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111495553|NCT02036424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111495554|NCT02036424|Glucocorticoids|glucocorticoids|mesh-ancestor
111495555|NCT02036424|Hormones|hormones|mesh-ancestor
111495556|NCT02036424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111495557|NCT02036424|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111495558|NCT02044380|Afatinib|afatinib|mesh-list
111495559|NCT02044380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111495560|NCT02044380|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111495561|NCT02044380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111495562|NCT02044380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111495563|NCT02047032|Solifenacin Succinate|solifenacin succinate|mesh-list
111495564|NCT02047032|Cholinergic Antagonists|cholinergic antagonists|mesh-list
111495565|NCT02047032|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111495566|NCT02047032|Cholinergic Agents|cholinergic agents|mesh-ancestor
111495567|NCT02047032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111495568|NCT02047032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111495569|NCT02047032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111495570|NCT02047032|Urological Agents|urological agents|mesh-ancestor
111495571|NCT02047500|Paclitaxel|paclitaxel|mesh-list
111495572|NCT02047500|Gemcitabine|gemcitabine|mesh-list
111495573|NCT02047500|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111495574|NCT02047500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111495575|NCT02047500|Tubulin Modulators|tubulin modulators|mesh-ancestor
111495576|NCT02047500|Antimitotic Agents|antimitotic agents|mesh-ancestor
111495577|NCT02047500|Mitosis Modulators|mitosis modulators|mesh-ancestor
111495578|NCT02047500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111495579|NCT02047500|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111495580|NCT02047500|Antimetabolites|antimetabolites|mesh-ancestor
111495581|NCT02054754|HU 211|hu 211|mesh-list
111495582|NCT02054754|Dronabinol|dronabinol|mesh-list
111495583|NCT02054754|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111495584|NCT02054754|Antiemetics|antiemetics|mesh-ancestor
111495585|NCT02054754|Autonomic Agents|autonomic agents|mesh-ancestor
111495586|NCT02054754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111495587|NCT02054754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111495588|NCT02054754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111495589|NCT02054754|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111495590|NCT02054754|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111495591|NCT02054754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111495592|NCT02054754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111495593|NCT02054754|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111495594|NCT02054754|Protective Agents|protective agents|mesh-ancestor
111495595|NCT02054754|Hallucinogens|hallucinogens|mesh-ancestor
111495596|NCT02054754|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110978003|NCT02459756|Sodium Citrate|sodium citrate|mesh-list
110480466|NCT04077853|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
110978004|NCT02459756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110978005|NCT02459756|Anticoagulants|anticoagulants|mesh-ancestor
111495597|NCT02054754|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111495598|NCT02054754|Analgesics|analgesics|mesh-ancestor
111495599|NCT02054754|Sensory System Agents|sensory system agents|mesh-ancestor
111495600|NCT02054754|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
111495601|NCT02054754|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
111495602|NCT02054754|Hormones|hormones|mesh-ancestor
111495603|NCT02054754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111495604|NCT02057640|Dexamethasone|dexamethasone|mesh-list
111495605|NCT02057640|Ixazomib|ixazomib|mesh-list
111495606|NCT02057640|Panobinostat|panobinostat|mesh-list
111495607|NCT02057640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111495608|NCT02057640|Antiemetics|antiemetics|mesh-ancestor
111495609|NCT02057640|Autonomic Agents|autonomic agents|mesh-ancestor
111495610|NCT02057640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111495611|NCT02057640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111495612|NCT02057640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111495613|NCT02057640|Glucocorticoids|glucocorticoids|mesh-ancestor
111495614|NCT02057640|Hormones|hormones|mesh-ancestor
111495615|NCT02057640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111495616|NCT02057640|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111495617|NCT02057640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111495618|NCT02057640|Protease Inhibitors|protease inhibitors|mesh-ancestor
111495619|NCT02057640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111495620|NCT02057640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111495621|NCT02057640|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111495622|NCT02059902|Lidocaine|lidocaine|mesh-list
111495623|NCT02059902|Anesthetics, Local|anesthetics, local|mesh-ancestor
111495624|NCT02059902|Anesthetics|anesthetics|mesh-ancestor
111495625|NCT02059902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111495626|NCT02059902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111495627|NCT02059902|Sensory System Agents|sensory system agents|mesh-ancestor
111495628|NCT02059902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111495629|NCT02059902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111495630|NCT02059902|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111495631|NCT02059902|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111495632|NCT02059902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111495633|NCT02059902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111495634|NCT02061384|Calcitriol|calcitriol|mesh-list
111495635|NCT02061384|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
111495636|NCT02061384|Tretinoin|tretinoin|mesh-list
111495637|NCT02061384|Isotretinoin|isotretinoin|mesh-list
111495638|NCT02061384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111495639|NCT02061384|Keratolytic Agents|keratolytic agents|mesh-ancestor
111495640|NCT02061384|Dermatologic Agents|dermatologic agents|mesh-ancestor
111495641|NCT02061384|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111495642|NCT02061384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111495643|NCT02061384|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
111495644|NCT02061384|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111495645|NCT02061384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111495646|NCT02061384|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111495647|NCT02061384|Vitamins|vitamins|mesh-ancestor
111495648|NCT02061384|Micronutrients|micronutrients|mesh-ancestor
111495649|NCT02061384|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111495650|NCT02061774|Acetaminophen|acetaminophen|mesh-list
111495651|NCT02061774|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111495652|NCT02061774|Analgesics|analgesics|mesh-ancestor
111495653|NCT02061774|Sensory System Agents|sensory system agents|mesh-ancestor
111495654|NCT02061774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111495655|NCT02061774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111495656|NCT02061774|Antipyretics|antipyretics|mesh-ancestor
111495657|NCT02062710|Diphenhydramine|diphenhydramine|mesh-list
111495658|NCT02062710|Promethazine|promethazine|mesh-list
111495659|NCT02062710|Phenylephrine|phenylephrine|mesh-list
111495660|NCT02062710|Oxymetazoline|oxymetazoline|mesh-list
111495661|NCT02062710|Dextromethorphan|dextromethorphan|mesh-list
111495662|NCT02062710|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111495663|NCT02062710|Mydriatics|mydriatics|mesh-ancestor
110480473|NCT04502407|Cisplatin|cisplatin|mesh-list
111495664|NCT02062710|Autonomic Agents|autonomic agents|mesh-ancestor
111495665|NCT02062710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111495666|NCT02062710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110978006|NCT02459756|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
111495667|NCT02062710|Sympathomimetics|sympathomimetics|mesh-ancestor
111495668|NCT02062710|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111495669|NCT02062710|Nasal Decongestants|nasal decongestants|mesh-ancestor
111495670|NCT02062710|Respiratory System Agents|respiratory system agents|mesh-ancestor
110703695|NCT02531451|Ibuprofen|ibuprofen|mesh-list
110978007|NCT02459756|Chelating Agents|chelating agents|mesh-ancestor
111495671|NCT02062710|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111495672|NCT02062710|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111495673|NCT02062710|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111495674|NCT02062710|Adrenergic Agents|adrenergic agents|mesh-ancestor
111495675|NCT02062710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111495676|NCT02062710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111495677|NCT02062710|Protective Agents|protective agents|mesh-ancestor
111495678|NCT02062710|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111495679|NCT02062710|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111495680|NCT02062710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111495681|NCT02062710|Anesthetics, Local|anesthetics, local|mesh-ancestor
111495682|NCT02062710|Anesthetics|anesthetics|mesh-ancestor
111495683|NCT02062710|Sensory System Agents|sensory system agents|mesh-ancestor
111495684|NCT02062710|Antiemetics|antiemetics|mesh-ancestor
111495685|NCT02062710|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111495686|NCT02062710|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111495687|NCT02062710|Histamine Antagonists|histamine antagonists|mesh-ancestor
111495688|NCT02062710|Histamine Agents|histamine agents|mesh-ancestor
111495689|NCT02062710|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111495690|NCT02062710|Antipruritics|antipruritics|mesh-ancestor
111495691|NCT02062710|Dermatologic Agents|dermatologic agents|mesh-ancestor
111495692|NCT02062710|Antitussive Agents|antitussive agents|mesh-ancestor
111495693|NCT02062710|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111495694|NCT02062710|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111495695|NCT02064582|Leuprolide|leuprolide|mesh-list
111495696|NCT02064582|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111495697|NCT02064582|Fertility Agents|fertility agents|mesh-ancestor
111495698|NCT02064582|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111495699|NCT02064582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111495700|NCT02064582|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111495701|NCT02064582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111495702|NCT02069184|Acetaminophen|acetaminophen|mesh-list
111495703|NCT02069184|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111495704|NCT02069184|Analgesics|analgesics|mesh-ancestor
111495705|NCT02069184|Sensory System Agents|sensory system agents|mesh-ancestor
111495706|NCT02069184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111495707|NCT02069184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111495708|NCT02069184|Antipyretics|antipyretics|mesh-ancestor
111495709|NCT02134314|Complement C1s|complement c1s|mesh-list
111495710|NCT02134314|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
111495711|NCT02134314|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
111495712|NCT02134314|Immunologic Factors|immunologic factors|mesh-ancestor
111495713|NCT02134314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111495714|NCT02134314|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
111495715|NCT02134314|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111495716|NCT02135016|Lidocaine|lidocaine|mesh-list
111495717|NCT02135016|Anesthetics, Local|anesthetics, local|mesh-ancestor
111495718|NCT02135016|Anesthetics|anesthetics|mesh-ancestor
111495719|NCT02135016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111495720|NCT02135016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111495721|NCT02135016|Sensory System Agents|sensory system agents|mesh-ancestor
111495722|NCT02135016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111495723|NCT02135016|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111495724|NCT02135016|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111495725|NCT02135016|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111495726|NCT02135016|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111495727|NCT02135016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111495728|NCT02135094|Oxymetazoline|oxymetazoline|mesh-list
111495729|NCT02135094|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111495730|NCT02135094|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111495731|NCT02135094|Adrenergic Agents|adrenergic agents|mesh-ancestor
111495732|NCT02135094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111495733|NCT02135094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111495734|NCT02135094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111495735|NCT02135094|Sympathomimetics|sympathomimetics|mesh-ancestor
111495736|NCT02135094|Autonomic Agents|autonomic agents|mesh-ancestor
111495737|NCT02135094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111495738|NCT02135094|Nasal Decongestants|nasal decongestants|mesh-ancestor
111495739|NCT02135094|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111495740|NCT02135094|Respiratory System Agents|respiratory system agents|mesh-ancestor
110978008|NCT02459756|Sequestering Agents|sequestering agents|mesh-ancestor
110978010|NCT02557672|Hemostatics|hemostatics|mesh-ancestor
111495741|NCT02139540|Nitrous Oxide|nitrous oxide|mesh-list
110703786|NCT00255723|Etoposide|etoposide|mesh-list
111495742|NCT02139540|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111495743|NCT02139540|Anesthetics, General|anesthetics, general|mesh-ancestor
111495745|NCT02139540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111495746|NCT02139540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111495747|NCT02139540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111495748|NCT02139540|Analgesics|analgesics|mesh-ancestor
111495749|NCT02139540|Sensory System Agents|sensory system agents|mesh-ancestor
111495750|NCT02139540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111495751|NCT02148588|Lidocaine|lidocaine|mesh-list
111495752|NCT02148588|Anesthetics, Local|anesthetics, local|mesh-ancestor
111495753|NCT02148588|Anesthetics|anesthetics|mesh-ancestor
111495754|NCT02148588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111495755|NCT02148588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111495756|NCT02148588|Sensory System Agents|sensory system agents|mesh-ancestor
111495757|NCT02148588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111495758|NCT02148588|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111495759|NCT02148588|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111495760|NCT02148588|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111495761|NCT02148588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111495762|NCT02148588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111495763|NCT02149524|Trastuzumab|trastuzumab|mesh-list
111495764|NCT02149524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111495765|NCT02149524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111495766|NCT02154048|Dexamethasone|dexamethasone|mesh-list
111495767|NCT02154048|Ropivacaine|ropivacaine|mesh-list
111495768|NCT02154048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111495769|NCT02154048|Antiemetics|antiemetics|mesh-ancestor
111495770|NCT02154048|Autonomic Agents|autonomic agents|mesh-ancestor
111495771|NCT02154048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111495772|NCT02154048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111495773|NCT02154048|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111495774|NCT02154048|Glucocorticoids|glucocorticoids|mesh-ancestor
111495775|NCT02154048|Hormones|hormones|mesh-ancestor
111495776|NCT02154048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111495777|NCT02154048|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111495778|NCT02154048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111495779|NCT02154048|Anesthetics, Local|anesthetics, local|mesh-ancestor
111495780|NCT02154048|Anesthetics|anesthetics|mesh-ancestor
111495781|NCT02154048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111495782|NCT02154048|Sensory System Agents|sensory system agents|mesh-ancestor
111495783|NCT02156154|Acetaminophen|acetaminophen|mesh-list
111495784|NCT02156154|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111495785|NCT02156154|Analgesics|analgesics|mesh-ancestor
111495786|NCT02156154|Sensory System Agents|sensory system agents|mesh-ancestor
111495787|NCT02156154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111495788|NCT02156154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111495789|NCT02156154|Antipyretics|antipyretics|mesh-ancestor
111495790|NCT02158572|Contraceptive Agents|contraceptive agents|mesh-list
111495791|NCT02158572|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111495792|NCT02158572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111495793|NCT02159976|Amoxicillin|amoxicillin|mesh-list
111495794|NCT02159976|Metronidazole|metronidazole|mesh-list
111495795|NCT02159976|Clarithromycin|clarithromycin|mesh-list
111495796|NCT02159976|Tetracycline|tetracycline|mesh-list
111495797|NCT02159976|Pantoprazole|pantoprazole|mesh-list
111495798|NCT02159976|Bismuth|bismuth|mesh-list
111495799|NCT02159976|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111495800|NCT02159976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111495801|NCT02159976|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111495802|NCT02159976|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111495803|NCT02159976|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111495804|NCT02159976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111495805|NCT02159976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111495806|NCT02159976|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111495807|NCT02159976|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111495808|NCT02159976|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111495809|NCT02159976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111495810|NCT02159976|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111495811|NCT02159976|Antacids|antacids|mesh-ancestor
110978011|NCT02557672|Coagulants|coagulants|mesh-ancestor
110978012|NCT02458196|Mycophenolic Acid|mycophenolic acid|mesh-list
111495812|NCT02160288|Botulinum Toxins|botulinum toxins|mesh-list
111495813|NCT02160288|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111495814|NCT02160288|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111495815|NCT02160288|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111495816|NCT02160288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111495817|NCT02160288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110978013|NCT02458196|Prednisone|prednisone|mesh-list
111495818|NCT02160288|Cholinergic Agents|cholinergic agents|mesh-ancestor
111495819|NCT02160288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111495820|NCT02160288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111495821|NCT02160288|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111495822|NCT02160288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111495823|NCT02160990|Exenatide|exenatide|mesh-list
111495824|NCT02160990|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111495825|NCT02160990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111495826|NCT02160990|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111495827|NCT02160990|Incretins|incretins|mesh-ancestor
111495828|NCT02160990|Hormones|hormones|mesh-ancestor
111495829|NCT02160990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111495830|NCT02164422|Guanfacine|guanfacine|mesh-list
111495831|NCT02164422|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111495832|NCT02164422|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111495833|NCT02164422|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111495834|NCT02164422|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111495835|NCT02164422|Adrenergic Agents|adrenergic agents|mesh-ancestor
111495836|NCT02164422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111495837|NCT02164422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111495838|NCT02164422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111495839|NCT02170662|Bimatoprost|bimatoprost|mesh-list
111495840|NCT02170662|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111495841|NCT02173392|Brodalumab|brodalumab|mesh-list
111495842|NCT02173392|Dermatologic Agents|dermatologic agents|mesh-ancestor
111495843|NCT02178540|Tobramycin|tobramycin|mesh-list
111495844|NCT02178540|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111495845|NCT02178540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111495846|NCT02178696|Antidepressive Agents|antidepressive agents|mesh-list
111495847|NCT02178696|Citalopram|citalopram|mesh-list
111495848|NCT02178696|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111495849|NCT02178696|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111495850|NCT02178696|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111495851|NCT02178696|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111495852|NCT02178696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111495853|NCT02178696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111495854|NCT02178696|Serotonin Agents|serotonin agents|mesh-ancestor
111495855|NCT02178696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111495856|NCT02178696|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111495857|NCT02179788|Metformin|metformin|mesh-list
111495858|NCT02179788|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111495859|NCT02179788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111495860|NCT02180100|Fluconazole|fluconazole|mesh-list
111495861|NCT02180100|Terconazole|terconazole|mesh-list
111495862|NCT02180100|Antifungal Agents|antifungal agents|mesh-ancestor
111495863|NCT02180100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111495864|NCT02180100|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111495865|NCT02180100|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111495866|NCT02180100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111495867|NCT02180100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111495868|NCT02180100|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111495869|NCT02180100|Hormone Antagonists|hormone antagonists|mesh-ancestor
111495870|NCT02180100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111495871|NCT02180100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111495872|NCT02180100|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111495873|NCT02180100|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111495874|NCT02181426|Ketorolac|ketorolac|mesh-list
111495875|NCT02181426|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111495876|NCT02181426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111495877|NCT02181426|Analgesics|analgesics|mesh-ancestor
111495878|NCT02181426|Sensory System Agents|sensory system agents|mesh-ancestor
111495879|NCT02181426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111495880|NCT02181426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111495881|NCT02181426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111495882|NCT02181426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111495883|NCT02181426|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111495884|NCT02181426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110978014|NCT02458196|Prednisolone|prednisolone|mesh-list
110978015|NCT02458196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110978016|NCT02458196|Glucocorticoids|glucocorticoids|mesh-ancestor
110978017|NCT02458196|Hormones|hormones|mesh-ancestor
110703990|NCT00231777|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111495885|NCT02181426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111495886|NCT02192814|Lacosamide|lacosamide|mesh-list
111495887|NCT02192814|Anticonvulsants|anticonvulsants|mesh-ancestor
111495888|NCT02192814|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111495889|NCT02192814|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111495890|NCT02192814|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111495891|NCT02192814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111495892|NCT02195232|Quercetin|quercetin|mesh-list
111495893|NCT02195232|Antioxidants|antioxidants|mesh-ancestor
111495894|NCT02195232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111495895|NCT02195232|Protective Agents|protective agents|mesh-ancestor
111495896|NCT02195232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111495897|NCT02196168|Cisplatin|cisplatin|mesh-list
111495898|NCT02196168|Adavosertib|adavosertib|mesh-list
111495899|NCT02196168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111495900|NCT02196168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111495901|NCT02196168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111495902|NCT02201394|Aspirin|aspirin|mesh-list
111495903|NCT02201394|Ticagrelor|ticagrelor|mesh-list
110480519|NCT04304573|Calcium|calcium|mesh-list
111495904|NCT02201394|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111495905|NCT02201394|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111495906|NCT02201394|Analgesics|analgesics|mesh-ancestor
111495907|NCT02201394|Sensory System Agents|sensory system agents|mesh-ancestor
111495908|NCT02201394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111495909|NCT02201394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111495910|NCT02201394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111495911|NCT02201394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111495912|NCT02201394|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111495913|NCT02201394|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111495914|NCT02201394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111495915|NCT02201394|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111495916|NCT02201394|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111495917|NCT02201394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111495918|NCT02201394|Antipyretics|antipyretics|mesh-ancestor
111495919|NCT02201394|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111495920|NCT02201394|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111495921|NCT02201394|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111495922|NCT02201394|Purinergic Agents|purinergic agents|mesh-ancestor
111495923|NCT02201394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111495924|NCT02203578|Romidepsin|romidepsin|mesh-list
111495925|NCT02203578|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111495926|NCT02203578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111495927|NCT02203578|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111495928|NCT02203578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111495929|NCT02203578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111495930|NCT02206776|Midazolam|midazolam|mesh-list
111495931|NCT02206776|Ketamine|ketamine|mesh-list
111495932|NCT02206776|Analgesics|analgesics|mesh-ancestor
111495933|NCT02206776|Sensory System Agents|sensory system agents|mesh-ancestor
111495934|NCT02206776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111495935|NCT02206776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111495936|NCT02206776|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111495937|NCT02206776|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111495938|NCT02206776|Anesthetics, General|anesthetics, general|mesh-ancestor
111495939|NCT02206776|Anesthetics|anesthetics|mesh-ancestor
111495940|NCT02206776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111495941|NCT02206776|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111495942|NCT02206776|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111495943|NCT02206776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111495944|NCT02206776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111495945|NCT02206776|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111495946|NCT02206776|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111495947|NCT02206776|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111495948|NCT02206776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111495949|NCT02206776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111495950|NCT02206776|GABA Modulators|gaba modulators|mesh-ancestor
111495951|NCT02206776|GABA Agents|gaba agents|mesh-ancestor
111495952|NCT02209272|Lidocaine|lidocaine|mesh-list
111495953|NCT02209272|Benzyl Alcohol|benzyl alcohol|mesh-list
111495954|NCT02209272|Anesthetics, Local|anesthetics, local|mesh-ancestor
111495955|NCT02209272|Anesthetics|anesthetics|mesh-ancestor
111495956|NCT02209272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111495957|NCT02209272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111495958|NCT02209272|Sensory System Agents|sensory system agents|mesh-ancestor
110978018|NCT02458196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111495959|NCT02209272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111495961|NCT02209272|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111495962|NCT02209272|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111495963|NCT02209272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111495964|NCT02209272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111495965|NCT02214420|Ribavirin|ribavirin|mesh-list
111495966|NCT02214420|Sofosbuvir|sofosbuvir|mesh-list
111495967|NCT02214420|Simeprevir|simeprevir|mesh-list
111495968|NCT02214420|Antimetabolites|antimetabolites|mesh-ancestor
111495969|NCT02214420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111495970|NCT02214420|Antiviral Agents|antiviral agents|mesh-ancestor
111495971|NCT02214420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111495972|NCT02214420|Protease Inhibitors|protease inhibitors|mesh-ancestor
111495973|NCT02214420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111495974|NCT02215200|Lenograstim|lenograstim|mesh-list
111495975|NCT02215200|Thymoglobulin|thymoglobulin|mesh-list
111495976|NCT02215200|Antilymphocyte Serum|antilymphocyte serum|mesh-list
111495977|NCT02215200|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111495978|NCT02215200|Immunologic Factors|immunologic factors|mesh-ancestor
111495979|NCT02215200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111495980|NCT02215200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111495981|NCT02218320|Raltegravir Potassium|raltegravir potassium|mesh-list
111495982|NCT02218320|Dolutegravir|dolutegravir|mesh-list
111495983|NCT02218320|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111495984|NCT02218320|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111495985|NCT02218320|Antiviral Agents|antiviral agents|mesh-ancestor
111495986|NCT02218320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111495987|NCT02218320|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111495988|NCT02218320|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111495989|NCT02218320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111495990|NCT02218320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111495991|NCT02222610|Ranibizumab|ranibizumab|mesh-list
111495992|NCT02222610|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111495993|NCT02222610|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111495994|NCT02222610|Growth Substances|growth substances|mesh-ancestor
111495995|NCT02222610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111495996|NCT02222610|Growth Inhibitors|growth inhibitors|mesh-ancestor
111495997|NCT02222610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111495998|NCT02223702|Amoxicillin|amoxicillin|mesh-list
111495999|NCT02223702|Moxifloxacin|moxifloxacin|mesh-list
111496000|NCT02223702|Metronidazole|metronidazole|mesh-list
111496001|NCT02223702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111496002|NCT02223702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111496003|NCT02223702|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111496004|NCT02223702|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111496005|NCT02223702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110480571|NCT00783094|Tadalafil|tadalafil|mesh-list
111496006|NCT02223702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111496007|NCT02223702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111496008|NCT02223702|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111496009|NCT02223702|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111496010|NCT02225106|Methylphenidate|methylphenidate|mesh-list
111496011|NCT02225106|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111496012|NCT02225106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111496013|NCT02225106|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111496014|NCT02225106|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111496015|NCT02225106|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111496016|NCT02225106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111496017|NCT02225106|Dopamine Agents|dopamine agents|mesh-ancestor
111496018|NCT02225106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111496019|NCT02233296|Lasmiditan|lasmiditan|mesh-list
111496020|NCT02233296|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111496021|NCT02233296|Serotonin Agents|serotonin agents|mesh-ancestor
111496022|NCT02233296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110978019|NCT02458196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110978020|NCT02458196|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110978021|NCT02458196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110978022|NCT02458196|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110978023|NCT02458196|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110978024|NCT02458196|Antitubercular Agents|antitubercular agents|mesh-ancestor
110978025|NCT02458196|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110978026|NCT02458196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110978027|NCT02458196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111496024|NCT02233296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111496025|NCT02233998|Listerine|listerine|mesh-list
111496026|NCT02233998|Sodium Fluoride|sodium fluoride|mesh-list
111496027|NCT02233998|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111496028|NCT02233998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111496029|NCT02233998|Cariostatic Agents|cariostatic agents|mesh-ancestor
111496030|NCT02233998|Protective Agents|protective agents|mesh-ancestor
111496031|NCT02233998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111496032|NCT02237898|Carbon Monoxide|carbon monoxide|mesh-list
111496033|NCT02237898|Antimetabolites|antimetabolites|mesh-ancestor
111496034|NCT02237898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111496035|NCT02237898|Gasotransmitters|gasotransmitters|mesh-ancestor
111496036|NCT02237898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111496037|NCT02237898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111496038|NCT02239380|Lorazepam|lorazepam|mesh-list
111496039|NCT02239380|Anticonvulsants|anticonvulsants|mesh-ancestor
111496040|NCT02239380|Antiemetics|antiemetics|mesh-ancestor
111496041|NCT02239380|Autonomic Agents|autonomic agents|mesh-ancestor
111496042|NCT02239380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111496043|NCT02239380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111496044|NCT02239380|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111496045|NCT02239380|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111496046|NCT02239380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111496047|NCT02239380|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111496048|NCT02239380|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111496049|NCT02239380|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111496050|NCT02239380|GABA Modulators|gaba modulators|mesh-ancestor
111496051|NCT02239380|GABA Agents|gaba agents|mesh-ancestor
111496052|NCT02239380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111496053|NCT02239380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111496054|NCT02239770|Nicotine|nicotine|mesh-list
111496055|NCT02239770|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111496056|NCT02239770|Autonomic Agents|autonomic agents|mesh-ancestor
111496057|NCT02239770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111496058|NCT02239770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111496059|NCT02239770|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111496060|NCT02239770|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111496061|NCT02239770|Cholinergic Agents|cholinergic agents|mesh-ancestor
111496062|NCT02239770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111496063|NCT02239770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111496064|NCT02241486|Fentanyl|fentanyl|mesh-list
111496065|NCT02241486|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111496066|NCT02241486|Narcotics|narcotics|mesh-ancestor
111496067|NCT02241486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111496068|NCT02241486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111496069|NCT02241486|Analgesics|analgesics|mesh-ancestor
111496070|NCT02241486|Sensory System Agents|sensory system agents|mesh-ancestor
111496071|NCT02241486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111496072|NCT02241486|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111496073|NCT02241486|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111496074|NCT02241486|Anesthetics, General|anesthetics, general|mesh-ancestor
111496075|NCT02241486|Anesthetics|anesthetics|mesh-ancestor
111496076|NCT02244918|Nicotine|nicotine|mesh-list
111496077|NCT02244918|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111496078|NCT02244918|Autonomic Agents|autonomic agents|mesh-ancestor
111496079|NCT02244918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111496080|NCT02244918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111496081|NCT02244918|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111496082|NCT02244918|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111496083|NCT02244918|Cholinergic Agents|cholinergic agents|mesh-ancestor
111496084|NCT02244918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111496085|NCT02244918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111496086|NCT02250612|Timolol|timolol|mesh-list
111496087|NCT02250612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111496088|NCT02250612|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111496089|NCT02250612|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111496090|NCT02250612|Adrenergic Agents|adrenergic agents|mesh-ancestor
111496091|NCT02250612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111496092|NCT02250612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111496093|NCT02250612|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111496094|NCT02250612|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111496095|NCT02251236|Tenofovir|tenofovir|mesh-list
111496096|NCT02251236|Emtricitabine|emtricitabine|mesh-list
110704130|NCT00322374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111496097|NCT02251236|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
111496098|NCT02251236|Cobicistat|cobicistat|mesh-list
111496099|NCT02251236|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
111496100|NCT02251236|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
111496101|NCT02251236|Elvitegravir|elvitegravir|mesh-list
111496102|NCT02251236|Antiviral Agents|antiviral agents|mesh-ancestor
111496103|NCT02251236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111496104|NCT02251236|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111496105|NCT02251236|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111496106|NCT02251236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111496107|NCT02251236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111496108|NCT02251236|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111496109|NCT02251236|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111496110|NCT02251236|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111496111|NCT02251236|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111496112|NCT02251236|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111496113|NCT02251938|Sirolimus|sirolimus|mesh-list
111496114|NCT02251938|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111496115|NCT02251938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111496116|NCT02251938|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111496117|NCT02251938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111496118|NCT02251938|Antifungal Agents|antifungal agents|mesh-ancestor
111496119|NCT02251938|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111496120|NCT02251938|Immunologic Factors|immunologic factors|mesh-ancestor
111496121|NCT02251938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111496122|NCT02258412|Ethanol|ethanol|mesh-list
111496123|NCT02258412|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
111496124|NCT02258412|Hand Sanitizers|hand sanitizers|mesh-list
111496125|NCT02258412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111496126|NCT02258412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111496127|NCT02258412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111496128|NCT02258412|Disinfectants|disinfectants|mesh-ancestor
111496129|NCT02260440|Pembrolizumab|pembrolizumab|mesh-list
111496130|NCT02260440|Azacitidine|azacitidine|mesh-list
111496131|NCT02260440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111496132|NCT02260440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111496133|NCT02260440|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111496134|NCT02260440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111496135|NCT02260440|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111496136|NCT02260440|Antimetabolites|antimetabolites|mesh-ancestor
111496137|NCT02260440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111496138|NCT02267538|Dexmedetomidine|dexmedetomidine|mesh-list
111496139|NCT02267538|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111496140|NCT02267538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111496141|NCT02267538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111496142|NCT02267538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111496143|NCT02267538|Analgesics|analgesics|mesh-ancestor
111496144|NCT02267538|Sensory System Agents|sensory system agents|mesh-ancestor
111496145|NCT02267538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111496146|NCT02267538|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111496147|NCT02267538|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111496148|NCT02267538|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111496149|NCT02267538|Adrenergic Agents|adrenergic agents|mesh-ancestor
111496150|NCT02267538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111496151|NCT02267538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111496152|NCT02267772|Acetaminophen|acetaminophen|mesh-list
111496153|NCT02267772|Morphine|morphine|mesh-list
111496154|NCT02267772|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111496155|NCT02267772|Narcotics|narcotics|mesh-ancestor
111496156|NCT02267772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111496157|NCT02267772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111496158|NCT02267772|Analgesics|analgesics|mesh-ancestor
111496159|NCT02267772|Sensory System Agents|sensory system agents|mesh-ancestor
111496160|NCT02267772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111496161|NCT02267772|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111496162|NCT02267772|Antipyretics|antipyretics|mesh-ancestor
111496163|NCT02271906|Afatinib|afatinib|mesh-list
111496164|NCT02271906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111496165|NCT02271906|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111496166|NCT02271906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110978028|NCT02458196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110978029|NCT05207735|Capecitabine|capecitabine|mesh-list
110978030|NCT05207735|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111496167|NCT02271906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110978031|NCT05207735|Antimetabolites|antimetabolites|mesh-ancestor
111496168|NCT02274870|Bupivacaine|bupivacaine|mesh-list
111496169|NCT02274870|Anesthetics, Local|anesthetics, local|mesh-ancestor
111496170|NCT02274870|Anesthetics|anesthetics|mesh-ancestor
111496171|NCT02274870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111496172|NCT02274870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111496173|NCT02274870|Sensory System Agents|sensory system agents|mesh-ancestor
111496174|NCT02274870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111496175|NCT02281422|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
111496176|NCT02281422|Anticonvulsants|anticonvulsants|mesh-ancestor
111496177|NCT02281422|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111496178|NCT02281422|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111496179|NCT02281422|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111496180|NCT02281422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111496181|NCT02282514|Methylprednisolone|methylprednisolone|mesh-list
111496182|NCT02282514|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111496183|NCT02282514|Cyclophosphamide|cyclophosphamide|mesh-list
111496184|NCT02282514|Rituximab|rituximab|mesh-list
111496185|NCT02282514|Thymoglobulin|thymoglobulin|mesh-list
111496186|NCT02282514|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111496187|NCT02282514|Immunologic Factors|immunologic factors|mesh-ancestor
111496188|NCT02282514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111496189|NCT02282514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111496190|NCT02282514|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111496191|NCT02282514|Alkylating Agents|alkylating agents|mesh-ancestor
111496192|NCT02282514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111496193|NCT02282514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111496194|NCT02282514|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111496195|NCT02282514|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111496196|NCT02282514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111496197|NCT02282514|Antiemetics|antiemetics|mesh-ancestor
111496198|NCT02282514|Autonomic Agents|autonomic agents|mesh-ancestor
111496199|NCT02282514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111496200|NCT02282514|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111496201|NCT02282514|Glucocorticoids|glucocorticoids|mesh-ancestor
111496202|NCT02282514|Hormones|hormones|mesh-ancestor
111496203|NCT02282514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111496204|NCT02282514|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111496205|NCT02282514|Protective Agents|protective agents|mesh-ancestor
111496206|NCT02282514|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111496207|NCT02282904|Sirolimus|sirolimus|mesh-list
110480622|NCT00774046|Analgesics|analgesics|mesh-ancestor
111496208|NCT02282904|Cyclophosphamide|cyclophosphamide|mesh-list
111496209|NCT02282904|Busulfan|busulfan|mesh-list
111496210|NCT02282904|Fludarabine|fludarabine|mesh-list
111496211|NCT02282904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111496212|NCT02282904|Immunologic Factors|immunologic factors|mesh-ancestor
111496213|NCT02282904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111496214|NCT02282904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111496215|NCT02282904|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111496216|NCT02282904|Alkylating Agents|alkylating agents|mesh-ancestor
111496217|NCT02282904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111496218|NCT02282904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111496219|NCT02282904|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111496220|NCT02282904|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111496221|NCT02282904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111496222|NCT02282904|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111496223|NCT02282904|Antifungal Agents|antifungal agents|mesh-ancestor
111496224|NCT02283840|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
111496225|NCT02283840|Anticonvulsants|anticonvulsants|mesh-ancestor
111496226|NCT02283840|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111496227|NCT02283840|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111496228|NCT02283840|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111496229|NCT02283840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111496230|NCT02284386|Bupivacaine|bupivacaine|mesh-list
111496231|NCT02284386|Anesthetics, Local|anesthetics, local|mesh-ancestor
111496232|NCT02284386|Anesthetics|anesthetics|mesh-ancestor
111496233|NCT02284386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111496234|NCT02284386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111496235|NCT02284386|Sensory System Agents|sensory system agents|mesh-ancestor
111496236|NCT02284386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111496237|NCT02284464|Prednisone|prednisone|mesh-list
111496238|NCT02284464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110704289|NCT00384332|Olanzapine|olanzapine|mesh-list
111496239|NCT02284464|Glucocorticoids|glucocorticoids|mesh-ancestor
110978032|NCT05207735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111496240|NCT02284464|Hormones|hormones|mesh-ancestor
111496241|NCT02284464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111496242|NCT02284464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111496243|NCT02284464|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111496244|NCT02284464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111496245|NCT02284854|Carbamazepine|carbamazepine|mesh-list
111496246|NCT02284854|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
111496247|NCT02284854|Anticonvulsants|anticonvulsants|mesh-ancestor
111496248|NCT02284854|Antimanic Agents|antimanic agents|mesh-ancestor
111496249|NCT02284854|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111496250|NCT02284854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111496251|NCT02284854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111496252|NCT02284854|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111496253|NCT02284854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111496254|NCT02284854|Analgesics|analgesics|mesh-ancestor
111496255|NCT02284854|Sensory System Agents|sensory system agents|mesh-ancestor
111496256|NCT02284854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111496257|NCT02284854|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111496258|NCT02284854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111496259|NCT02284854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111496260|NCT02284854|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111496261|NCT02284854|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111496262|NCT02284854|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111496263|NCT02285634|Lidocaine|lidocaine|mesh-list
111496264|NCT02285634|Phenylephrine|phenylephrine|mesh-list
111496265|NCT02285634|Epinephrine|epinephrine|mesh-list
111496266|NCT02285634|Oxymetazoline|oxymetazoline|mesh-list
111496267|NCT02285634|Anesthetics, Local|anesthetics, local|mesh-ancestor
111496268|NCT02285634|Anesthetics|anesthetics|mesh-ancestor
111496269|NCT02285634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111496270|NCT02285634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111496271|NCT02285634|Sensory System Agents|sensory system agents|mesh-ancestor
111496272|NCT02285634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111496273|NCT02285634|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111496274|NCT02285634|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111496275|NCT02285634|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111496276|NCT02285634|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111496277|NCT02285634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111496278|NCT02285634|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111496279|NCT02285634|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111496280|NCT02285634|Adrenergic Agents|adrenergic agents|mesh-ancestor
111496281|NCT02285634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111496282|NCT02285634|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111496283|NCT02285634|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111496284|NCT02285634|Autonomic Agents|autonomic agents|mesh-ancestor
111496285|NCT02285634|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111496286|NCT02285634|Respiratory System Agents|respiratory system agents|mesh-ancestor
111496287|NCT02285634|Mydriatics|mydriatics|mesh-ancestor
111496288|NCT02285634|Sympathomimetics|sympathomimetics|mesh-ancestor
111496289|NCT02285634|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111496290|NCT02285634|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111496291|NCT02285634|Nasal Decongestants|nasal decongestants|mesh-ancestor
111496292|NCT02285634|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111496293|NCT02285634|Protective Agents|protective agents|mesh-ancestor
111496294|NCT02287350|Diclofenac|diclofenac|mesh-list
111496295|NCT02287350|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111496296|NCT02287350|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111496297|NCT02287350|Analgesics|analgesics|mesh-ancestor
111496298|NCT02287350|Sensory System Agents|sensory system agents|mesh-ancestor
111496299|NCT02287350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111496300|NCT02287350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111496301|NCT02287350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111496302|NCT02287350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111496303|NCT02287350|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111496304|NCT02287350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111496305|NCT02287350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111496306|NCT02288364|Lidocaine|lidocaine|mesh-list
111496307|NCT02288364|Anesthetics, Local|anesthetics, local|mesh-ancestor
111496308|NCT02288364|Anesthetics|anesthetics|mesh-ancestor
111496309|NCT02288364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111496310|NCT02288364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111496311|NCT02288364|Sensory System Agents|sensory system agents|mesh-ancestor
111496312|NCT02288364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110978033|NCT05207735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110978034|NCT03264638|Cyproterone Acetate|cyproterone acetate|mesh-list
110978035|NCT03264638|Cyproterone|cyproterone|mesh-list
110978036|NCT03264638|Cyproterone acetate, ethinyl estradiol drug combination|cyproterone acetate, ethinyl estradiol drug combination|mesh-list
110978037|NCT03264638|Androgen Antagonists|androgen antagonists|mesh-ancestor
110978038|NCT03264638|Hormone Antagonists|hormone antagonists|mesh-ancestor
110978039|NCT03264638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111496313|NCT02288364|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111496314|NCT02288364|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111496315|NCT02288364|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111496316|NCT02288364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111496317|NCT02288364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111496318|NCT02289222|Dexamethasone|dexamethasone|mesh-list
111496319|NCT02289222|Pembrolizumab|pembrolizumab|mesh-list
111496320|NCT02289222|Pomalidomide|pomalidomide|mesh-list
111496321|NCT02289222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111496322|NCT02289222|Antiemetics|antiemetics|mesh-ancestor
111496323|NCT02289222|Autonomic Agents|autonomic agents|mesh-ancestor
111496324|NCT02289222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111496325|NCT02289222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111496326|NCT02289222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111496327|NCT02289222|Glucocorticoids|glucocorticoids|mesh-ancestor
111496328|NCT02289222|Hormones|hormones|mesh-ancestor
111496329|NCT02289222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111496330|NCT02289222|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111496331|NCT02289222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111496332|NCT02289222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111496333|NCT02289222|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111496334|NCT02289222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111496335|NCT02289222|Immunologic Factors|immunologic factors|mesh-ancestor
111496336|NCT02289222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111496337|NCT02289222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111496338|NCT02289222|Growth Substances|growth substances|mesh-ancestor
111496339|NCT02289222|Growth Inhibitors|growth inhibitors|mesh-ancestor
111496340|NCT02291016|Formoterol Fumarate|formoterol fumarate|mesh-list
111496341|NCT02291016|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111496342|NCT02291016|Autonomic Agents|autonomic agents|mesh-ancestor
111496343|NCT02291016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111496344|NCT02291016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111496345|NCT02291016|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111496346|NCT02291016|Respiratory System Agents|respiratory system agents|mesh-ancestor
111496347|NCT02291016|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111496348|NCT02291016|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111496349|NCT02291016|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111496350|NCT02291016|Adrenergic Agents|adrenergic agents|mesh-ancestor
111496351|NCT02291016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111496352|NCT02291016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111496353|NCT02296164|Mechlorethamine|mechlorethamine|mesh-list
111496354|NCT02296164|Alkylating Agents|alkylating agents|mesh-ancestor
111496355|NCT02296164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111496356|NCT02296164|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111496357|NCT02296164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111496358|NCT02297100|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111496359|NCT02297100|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111496360|NCT02297100|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111496361|NCT02297100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111496362|NCT02297100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111496363|NCT02297100|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111496364|NCT02297100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111496365|NCT02297100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111496366|NCT02297100|Cholinergic Agents|cholinergic agents|mesh-ancestor
111496367|NCT02297100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111496368|NCT02299050|Bromocriptine|bromocriptine|mesh-list
111496369|NCT02299050|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111496370|NCT02299050|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111496371|NCT02299050|Hormone Antagonists|hormone antagonists|mesh-ancestor
111496372|NCT02299050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111496373|NCT02299050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111496374|NCT02299050|Dopamine Agonists|dopamine agonists|mesh-ancestor
111496375|NCT02299050|Dopamine Agents|dopamine agents|mesh-ancestor
110978040|NCT03264638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111496376|NCT02299050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111496377|NCT02299050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111496378|NCT02302092|Cefepime|cefepime|mesh-list
111496379|NCT02302092|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111496380|NCT02302092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111496381|NCT02303184|Aflibercept|aflibercept|mesh-list
111496382|NCT02303184|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111496383|NCT02303184|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111496384|NCT02303184|Growth Substances|growth substances|mesh-ancestor
111496385|NCT02303184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111496386|NCT02303184|Growth Inhibitors|growth inhibitors|mesh-ancestor
111496387|NCT02303184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111496388|NCT02304432|Cycloserine|cycloserine|mesh-list
111496389|NCT02304432|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111496390|NCT02304432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111496391|NCT02304432|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111496392|NCT02304432|Antitubercular Agents|antitubercular agents|mesh-ancestor
111496393|NCT02304432|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111496394|NCT02304432|Antimetabolites|antimetabolites|mesh-ancestor
111496395|NCT02304432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111496396|NCT02307318|Hemostatics|hemostatics|mesh-list
111496397|NCT02307318|Coagulants|coagulants|mesh-ancestor
111496398|NCT02312622|Irinotecan|irinotecan|mesh-list
111496399|NCT02312622|Etirinotecan pegol|etirinotecan pegol|mesh-list
110480731|NCT01071083|Methylprednisolone|methylprednisolone|mesh-list
111496400|NCT02312622|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111496401|NCT02312622|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111496402|NCT02312622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111496403|NCT02312622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111496404|NCT02312622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111496405|NCT02312622|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111496406|NCT02314104|Ropivacaine|ropivacaine|mesh-list
111496407|NCT02314104|Anesthetics, Local|anesthetics, local|mesh-ancestor
111496408|NCT02314104|Anesthetics|anesthetics|mesh-ancestor
111496409|NCT02314104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111496410|NCT02314104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111496411|NCT02314104|Sensory System Agents|sensory system agents|mesh-ancestor
111496412|NCT02314104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111496413|NCT02321748|Montelukast|montelukast|mesh-list
111496414|NCT02321748|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111496415|NCT02321748|Respiratory System Agents|respiratory system agents|mesh-ancestor
111496416|NCT02321748|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
111496417|NCT02321748|Hormone Antagonists|hormone antagonists|mesh-ancestor
111496418|NCT02321748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111496419|NCT02321748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111496420|NCT02321748|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
111496421|NCT02321748|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111496422|NCT02321748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111496423|NCT02322528|Loteprednol Etabonate|loteprednol etabonate|mesh-list
111496424|NCT02322528|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111496425|NCT02330094|Gabapentin|gabapentin|mesh-list
111496426|NCT02330094|Analgesics|analgesics|mesh-ancestor
111496427|NCT02330094|Sensory System Agents|sensory system agents|mesh-ancestor
111496428|NCT02330094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111496429|NCT02330094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111496430|NCT02330094|Anticonvulsants|anticonvulsants|mesh-ancestor
111496431|NCT02330094|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111496432|NCT02330094|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111496433|NCT02330094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111496434|NCT02330094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111496435|NCT02330094|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111496436|NCT02330094|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111496437|NCT02330094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111496438|NCT02330094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111496439|NCT02330094|Antimanic Agents|antimanic agents|mesh-ancestor
111496440|NCT02330172|Neostigmine|neostigmine|mesh-list
111496441|NCT02330172|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111496442|NCT02330172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111496443|NCT02330172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111496444|NCT02330172|Cholinergic Agents|cholinergic agents|mesh-ancestor
111496445|NCT02330172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111496446|NCT02330172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111496447|NCT02330172|Parasympathomimetics|parasympathomimetics|mesh-ancestor
111496448|NCT02330172|Autonomic Agents|autonomic agents|mesh-ancestor
111496449|NCT02330172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111496450|NCT02331108|Propofol|propofol|mesh-list
111496451|NCT02331108|Anesthetics|anesthetics|mesh-list
111496452|NCT02331108|Sevoflurane|sevoflurane|mesh-list
111496453|NCT02331108|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111496454|NCT02331108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111496455|NCT02331108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111496456|NCT02331108|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111496457|NCT02331108|Anesthetics, General|anesthetics, general|mesh-ancestor
111496458|NCT02331108|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111496459|NCT02331108|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111496460|NCT02332902|Everolimus|everolimus|mesh-list
111496461|NCT02332902|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111496462|NCT02332902|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111496463|NCT02332902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111496464|NCT02332902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111496465|NCT02332902|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111496466|NCT02332902|Immunologic Factors|immunologic factors|mesh-ancestor
111496467|NCT02332902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111496468|NCT02332902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111496469|NCT02340156|Temozolomide|temozolomide|mesh-list
111496470|NCT02340156|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111496471|NCT02340156|Alkylating Agents|alkylating agents|mesh-ancestor
111496472|NCT02340156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111496473|NCT02340156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111496474|NCT02343276|Nitroglycerin|nitroglycerin|mesh-list
111496475|NCT02343276|Vasodilator Agents|vasodilator agents|mesh-ancestor
111496476|NCT02348658|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
111496477|NCT02348658|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111496478|NCT02348658|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111496479|NCT02348658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111496480|NCT02351700|Ibuprofen|ibuprofen|mesh-list
111496481|NCT02351700|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111496482|NCT02351700|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111496483|NCT02351700|Analgesics|analgesics|mesh-ancestor
111496484|NCT02351700|Sensory System Agents|sensory system agents|mesh-ancestor
111496485|NCT02351700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111496486|NCT02351700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111496487|NCT02351700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111496488|NCT02351700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111496489|NCT02351700|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111496490|NCT02351700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111496491|NCT02351700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111496492|NCT02353806|Amlodipine|amlodipine|mesh-list
111496493|NCT02353806|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111496494|NCT02353806|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111496495|NCT02353806|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111496496|NCT02353806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111496497|NCT02353806|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111496498|NCT02353806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111496499|NCT02353806|Vasodilator Agents|vasodilator agents|mesh-ancestor
111496500|NCT02354352|Eplerenone|eplerenone|mesh-list
111496501|NCT02354352|Spironolactone|spironolactone|mesh-list
111496502|NCT02354352|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
111496503|NCT02354352|Hormone Antagonists|hormone antagonists|mesh-ancestor
111496504|NCT02354352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111496505|NCT02354352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111496506|NCT02354352|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
111496507|NCT02354352|Diuretics|diuretics|mesh-ancestor
111496508|NCT02354352|Natriuretic Agents|natriuretic agents|mesh-ancestor
111496509|NCT02354352|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111496510|NCT02355210|DEFB1 protein, human|defb1 protein, human|mesh-list
111496511|NCT02355210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111496512|NCT02357706|Acetaminophen|acetaminophen|mesh-list
111496513|NCT02357706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111496514|NCT02357706|Analgesics|analgesics|mesh-ancestor
111496515|NCT02357706|Sensory System Agents|sensory system agents|mesh-ancestor
111496516|NCT02357706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111496517|NCT02357706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111496518|NCT02357706|Antipyretics|antipyretics|mesh-ancestor
111496519|NCT02359110|Gabapentin|gabapentin|mesh-list
111496520|NCT02359110|Analgesics|analgesics|mesh-ancestor
110978041|NCT03264638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110978042|NCT03264638|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
111496521|NCT02359110|Sensory System Agents|sensory system agents|mesh-ancestor
111496522|NCT02359110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111496523|NCT02359110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111496524|NCT02359110|Anticonvulsants|anticonvulsants|mesh-ancestor
111496525|NCT02359110|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111496526|NCT02359110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111496527|NCT02359110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111496528|NCT02359110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111496529|NCT02359110|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111496530|NCT02359110|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111496531|NCT02359110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111496532|NCT02359110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111496533|NCT02359110|Antimanic Agents|antimanic agents|mesh-ancestor
111496535|NCT02360124|Cariostatic Agents|cariostatic agents|mesh-ancestor
111496536|NCT02360124|Protective Agents|protective agents|mesh-ancestor
111496537|NCT02360124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111496538|NCT02369172|Bupropion|bupropion|mesh-list
111496539|NCT02369172|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111496540|NCT02369172|Antidepressive Agents|antidepressive agents|mesh-ancestor
111496541|NCT02369172|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111496542|NCT02369172|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111496543|NCT02369172|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111496544|NCT02369172|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111496545|NCT02369172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111496546|NCT02369172|Dopamine Agents|dopamine agents|mesh-ancestor
111496547|NCT02369172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111496548|NCT02369172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111496549|NCT02369172|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111496550|NCT02369172|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111496551|NCT02369172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111496552|NCT02374164|Febuxostat|febuxostat|mesh-list
111496553|NCT02374164|Gout Suppressants|gout suppressants|mesh-ancestor
111496554|NCT02374164|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111496555|NCT02374398|Tranexamic Acid|tranexamic acid|mesh-list
111496556|NCT02374398|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111496557|NCT02374398|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111496558|NCT02374398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111496559|NCT02374398|Hemostatics|hemostatics|mesh-ancestor
111496560|NCT02374398|Coagulants|coagulants|mesh-ancestor
111496561|NCT02377752|Doxorubicin|doxorubicin|mesh-list
111496562|NCT02377752|Olaratumab|olaratumab|mesh-list
111496563|NCT02377752|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111496564|NCT02377752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111496565|NCT02377752|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111496566|NCT02377752|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111496567|NCT02377752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111496568|NCT02377752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111496569|NCT02379858|Alvimopan|alvimopan|mesh-list
111496570|NCT02379858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111496571|NCT02384070|Aspirin|aspirin|mesh-list
111496572|NCT02384070|Bivalirudin|bivalirudin|mesh-list
111496573|NCT02384070|Clopidogrel|clopidogrel|mesh-list
111496574|NCT02384070|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111496575|NCT02384070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111496576|NCT02384070|Analgesics|analgesics|mesh-ancestor
111496577|NCT02384070|Sensory System Agents|sensory system agents|mesh-ancestor
111496578|NCT02384070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111496579|NCT02384070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111496580|NCT02384070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111496581|NCT02384070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111496582|NCT02384070|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111496583|NCT02384070|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111496584|NCT02384070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111496585|NCT02384070|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111496586|NCT02384070|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111496587|NCT02384070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111496588|NCT02384070|Antipyretics|antipyretics|mesh-ancestor
111496589|NCT02384070|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111496590|NCT02384070|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111496591|NCT02384070|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111496592|NCT02384070|Purinergic Agents|purinergic agents|mesh-ancestor
110978043|NCT03264638|Contraceptive Agents|contraceptive agents|mesh-ancestor
111496593|NCT02384070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110978044|NCT03264638|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111496594|NCT02384070|Antithrombins|antithrombins|mesh-ancestor
111496595|NCT02384070|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111496596|NCT02384070|Protease Inhibitors|protease inhibitors|mesh-ancestor
111496597|NCT02384070|Anticoagulants|anticoagulants|mesh-ancestor
111496598|NCT02385240|Brimonidine Tartrate|brimonidine tartrate|mesh-list
111496599|NCT02385240|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111496600|NCT02385240|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111496601|NCT02385240|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111496602|NCT02385240|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111496603|NCT02385240|Adrenergic Agents|adrenergic agents|mesh-ancestor
111496604|NCT02385240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111496605|NCT02385240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111496606|NCT02385240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111496607|NCT02391714|Chlorhexidine|chlorhexidine|mesh-list
111496608|NCT02391714|Povidone-Iodine|povidone-iodine|mesh-list
111496609|NCT02391714|Nitrous Oxide|nitrous oxide|mesh-list
111496610|NCT02391714|Povidone|povidone|mesh-list
111496611|NCT02391714|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111496612|NCT02391714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111496613|NCT02391714|Disinfectants|disinfectants|mesh-ancestor
111496614|NCT02391714|Plasma Substitutes|plasma substitutes|mesh-ancestor
111496615|NCT02391714|Blood Substitutes|blood substitutes|mesh-ancestor
111496616|NCT02391714|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111496617|NCT02391714|Anesthetics, General|anesthetics, general|mesh-ancestor
111496618|NCT02391714|Anesthetics|anesthetics|mesh-ancestor
110480809|NCT04076137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111496619|NCT02391714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111496620|NCT02391714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111496621|NCT02391714|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111496622|NCT02391714|Analgesics|analgesics|mesh-ancestor
111496623|NCT02391714|Sensory System Agents|sensory system agents|mesh-ancestor
111496624|NCT02391714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111496625|NCT02395692|Temozolomide|temozolomide|mesh-list
111496626|NCT02395692|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111496627|NCT02395692|Alkylating Agents|alkylating agents|mesh-ancestor
111496628|NCT02395692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111496629|NCT02395692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111496630|NCT02397954|Ranibizumab|ranibizumab|mesh-list
111496631|NCT02397954|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111496632|NCT02397954|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111496633|NCT02397954|Growth Substances|growth substances|mesh-ancestor
111496634|NCT02397954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111496635|NCT02397954|Growth Inhibitors|growth inhibitors|mesh-ancestor
111496636|NCT02397954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111496637|NCT02401464|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
111496638|NCT02401464|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111496639|NCT02401464|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111496640|NCT02401464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111496641|NCT02401542|Docetaxel|docetaxel|mesh-list
111496642|NCT02401542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111496643|NCT02401542|Tubulin Modulators|tubulin modulators|mesh-ancestor
111496644|NCT02401542|Antimitotic Agents|antimitotic agents|mesh-ancestor
111496645|NCT02401542|Mitosis Modulators|mitosis modulators|mesh-ancestor
111496646|NCT02401542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111496647|NCT02411916|Misoprostol|misoprostol|mesh-list
111496648|NCT02411916|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111496649|NCT02411916|Abortifacient Agents|abortifacient agents|mesh-ancestor
111496650|NCT02411916|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111496651|NCT02411916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111496652|NCT02411916|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111496653|NCT02411916|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111496654|NCT02411916|Oxytocics|oxytocics|mesh-ancestor
111496655|NCT02413320|Paclitaxel|paclitaxel|mesh-list
111496656|NCT02413320|Docetaxel|docetaxel|mesh-list
111496657|NCT02413320|Cyclophosphamide|cyclophosphamide|mesh-list
111496658|NCT02413320|Carboplatin|carboplatin|mesh-list
111496659|NCT02413320|Doxorubicin|doxorubicin|mesh-list
111496660|NCT02413320|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111496661|NCT02413320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111496662|NCT02413320|Tubulin Modulators|tubulin modulators|mesh-ancestor
111496663|NCT02413320|Antimitotic Agents|antimitotic agents|mesh-ancestor
111496664|NCT02413320|Mitosis Modulators|mitosis modulators|mesh-ancestor
111496665|NCT02413320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111496666|NCT02413320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110978045|NCT04502381|Amphotericin B|amphotericin b|mesh-list
111496667|NCT02413320|Immunologic Factors|immunologic factors|mesh-ancestor
110978046|NCT04502381|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
111496668|NCT02413320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111496669|NCT02413320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111496670|NCT02413320|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111496671|NCT02413320|Alkylating Agents|alkylating agents|mesh-ancestor
111496672|NCT02413320|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111496673|NCT02413320|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111496674|NCT02413320|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111496675|NCT02413320|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111496676|NCT02413320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111496677|NCT05718882|Lenvatinib|lenvatinib|mesh-list
110480837|NCT00617877|Losartan|losartan|mesh-list
111496678|NCT05718882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111496679|NCT05718882|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111496680|NCT05718882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111496681|NCT05718882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111496682|NCT05718492|Leucovorin|leucovorin|mesh-list
111496683|NCT05718492|Fluorouracil|fluorouracil|mesh-list
111496684|NCT05718492|Oxaliplatin|oxaliplatin|mesh-list
111496685|NCT05718492|Antimetabolites|antimetabolites|mesh-ancestor
111496686|NCT05718492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111496687|NCT05718492|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111496688|NCT05718492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111496689|NCT05718492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111496690|NCT05718492|Immunologic Factors|immunologic factors|mesh-ancestor
111496691|NCT05718492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111496692|NCT05718492|Antidotes|antidotes|mesh-ancestor
111496693|NCT05718492|Protective Agents|protective agents|mesh-ancestor
111496694|NCT05718492|Vitamin B Complex|vitamin b complex|mesh-ancestor
111496695|NCT05718492|Vitamins|vitamins|mesh-ancestor
111496696|NCT05718492|Micronutrients|micronutrients|mesh-ancestor
111496697|NCT05718258|Venglustat|venglustat|mesh-list
111496698|NCT05718258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111496699|NCT05718258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111496700|NCT05718024|Dexmedetomidine|dexmedetomidine|mesh-list
111496701|NCT05718024|Remifentanil|remifentanil|mesh-list
111496702|NCT05718024|Propofol|propofol|mesh-list
111496703|NCT05718024|Esketamine|esketamine|mesh-list
111496704|NCT05718024|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111496705|NCT05718024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111496706|NCT05718024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111496707|NCT05718024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111496708|NCT05718024|Analgesics|analgesics|mesh-ancestor
111496709|NCT05718024|Sensory System Agents|sensory system agents|mesh-ancestor
111496710|NCT05718024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111496711|NCT05718024|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111496712|NCT05718024|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111496713|NCT05718024|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111496714|NCT05718024|Adrenergic Agents|adrenergic agents|mesh-ancestor
111496715|NCT05718024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111496716|NCT05718024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111496717|NCT05718024|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111496718|NCT05718024|Anesthetics, General|anesthetics, general|mesh-ancestor
111496719|NCT05718024|Anesthetics|anesthetics|mesh-ancestor
111496720|NCT05718024|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111496721|NCT05718024|Narcotics|narcotics|mesh-ancestor
111496722|NCT05718024|Antidepressive Agents|antidepressive agents|mesh-ancestor
111496723|NCT05718024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111496724|NCT05717790|Gemcitabine|gemcitabine|mesh-list
111496725|NCT05717790|Nimotuzumab|nimotuzumab|mesh-list
111496726|NCT05717790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111496727|NCT05717790|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111496728|NCT05717790|Antimetabolites|antimetabolites|mesh-ancestor
111496729|NCT05717790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111496730|NCT05717790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111496731|NCT05602272|Anesthetics|anesthetics|mesh-list
111496732|NCT05602272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111496733|NCT05602272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111496734|NCT05589792|Acetazolamide|acetazolamide|mesh-list
111496735|NCT05589792|Anticonvulsants|anticonvulsants|mesh-ancestor
111496736|NCT05589792|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
111496737|NCT05589792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110480844|NCT00617877|Diuretics|diuretics|mesh-ancestor
111496738|NCT05589792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111496739|NCT05589792|Diuretics|diuretics|mesh-ancestor
111496740|NCT05589792|Natriuretic Agents|natriuretic agents|mesh-ancestor
111496741|NCT05589792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110978047|NCT04502381|Deoxycholic Acid|deoxycholic acid|mesh-list
111496742|NCT05543694|Bupivacaine|bupivacaine|mesh-list
111496743|NCT05543694|Anesthetics, Local|anesthetics, local|mesh-ancestor
111496744|NCT05543694|Anesthetics|anesthetics|mesh-ancestor
111496745|NCT05543694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111496746|NCT05543694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111496747|NCT05543694|Sensory System Agents|sensory system agents|mesh-ancestor
111496748|NCT05543694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111496750|NCT05495568|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111496751|NCT05495568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111496752|NCT05495568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111496753|NCT05358834|Melatonin|melatonin|mesh-list
111496754|NCT05358834|Antioxidants|antioxidants|mesh-ancestor
111496755|NCT05358834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111496756|NCT05358834|Protective Agents|protective agents|mesh-ancestor
111496757|NCT05358834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111496758|NCT05358834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111496759|NCT05273346|Analgesics|analgesics|mesh-list
111496760|NCT05273346|Sensory System Agents|sensory system agents|mesh-ancestor
111496761|NCT05273346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111496762|NCT05273346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111496763|NCT05105256|Prednisolone|prednisolone|mesh-list
111496764|NCT05105256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111496765|NCT05105256|Glucocorticoids|glucocorticoids|mesh-ancestor
111496766|NCT05105256|Hormones|hormones|mesh-ancestor
111496767|NCT05105256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111496768|NCT05105256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111496769|NCT05105256|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111496770|NCT05105256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111496771|NCT04916886|Vaccines|vaccines|mesh-list
111496772|NCT04916886|Immunologic Factors|immunologic factors|mesh-ancestor
111496773|NCT04916886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111496774|NCT04907682|Ribavirin|ribavirin|mesh-list
111496775|NCT04907682|Favipiravir|favipiravir|mesh-list
111496776|NCT04907682|Antimetabolites|antimetabolites|mesh-ancestor
111496777|NCT04907682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111496778|NCT04907682|Antiviral Agents|antiviral agents|mesh-ancestor
111496779|NCT04907682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111496780|NCT04840992|Vaccines|vaccines|mesh-list
111496781|NCT04840992|Immunologic Factors|immunologic factors|mesh-ancestor
111496782|NCT04840992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111496783|NCT04793022|Anesthetics|anesthetics|mesh-list
111496784|NCT04793022|Propofol|propofol|mesh-list
111496785|NCT04793022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111496786|NCT04793022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111496787|NCT04793022|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111496788|NCT04793022|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111496789|NCT04793022|Anesthetics, General|anesthetics, general|mesh-ancestor
111496790|NCT04776018|Daratumumab|daratumumab|mesh-list
111496791|NCT04776018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111496792|NCT04750902|Listerine|listerine|mesh-list
111496793|NCT04750902|Fluorides|fluorides|mesh-list
111496794|NCT04750902|Sodium Fluoride|sodium fluoride|mesh-list
111496795|NCT04750902|Cariostatic Agents|cariostatic agents|mesh-ancestor
111496796|NCT04750902|Protective Agents|protective agents|mesh-ancestor
111496797|NCT04750902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111496798|NCT04750902|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111496799|NCT04750902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111496800|NCT04621500|Vitamin D|vitamin d|mesh-list
111496801|NCT04621500|Cholecalciferol|cholecalciferol|mesh-list
111496802|NCT04621500|Vitamins|vitamins|mesh-ancestor
111496803|NCT04621500|Micronutrients|micronutrients|mesh-ancestor
111496804|NCT04621500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111496805|NCT04621500|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111496806|NCT04621500|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111496807|NCT04567524|Risperidone|risperidone|mesh-list
111496808|NCT04567524|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111496809|NCT04567524|Serotonin Agents|serotonin agents|mesh-ancestor
111496810|NCT04567524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111496811|NCT04567524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111496812|NCT04567524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111496813|NCT04567524|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111496814|NCT04567524|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110978048|NCT04502381|Amebicides|amebicides|mesh-ancestor
110978049|NCT04502381|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111496815|NCT04567524|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111496816|NCT04567524|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110978050|NCT04502381|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111496817|NCT04567524|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111496818|NCT04567524|Dopamine Agents|dopamine agents|mesh-ancestor
111496819|NCT04481412|Cetirizine|cetirizine|mesh-list
111496820|NCT04481412|Ethanol|ethanol|mesh-list
111496821|NCT04481412|Minoxidil|minoxidil|mesh-list
111496822|NCT04481412|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111496823|NCT04481412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111496824|NCT04481412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111496825|NCT04481412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111496826|NCT04481412|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111496827|NCT04481412|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
111496828|NCT04481412|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111496829|NCT04481412|Histamine Antagonists|histamine antagonists|mesh-ancestor
111496830|NCT04481412|Histamine Agents|histamine agents|mesh-ancestor
111496831|NCT04481412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111496832|NCT04481412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111496833|NCT04481412|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111496834|NCT04481412|Vasodilator Agents|vasodilator agents|mesh-ancestor
111496835|NCT04317300|Varenicline|varenicline|mesh-list
111496836|NCT04317300|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111496837|NCT04317300|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111496838|NCT04317300|Cholinergic Agents|cholinergic agents|mesh-ancestor
111496839|NCT04317300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111496840|NCT04317300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111496841|NCT04317300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111496842|NCT04143204|Insulin|insulin|mesh-list
111496843|NCT04143204|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111496844|NCT04143204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111496845|NCT04031508|SMOFlipid|smoflipid|mesh-list
111496846|NCT04031508|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
111496847|NCT04031508|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
111496848|NCT04031508|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111496849|NCT03876288|Immunoglobulins|immunoglobulins|mesh-list
111496850|NCT03876288|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111496851|NCT03876288|gamma-Globulins|gamma-globulins|mesh-list
111496852|NCT03876288|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
111496853|NCT03876288|Immunologic Factors|immunologic factors|mesh-ancestor
111496854|NCT03876288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111496855|NCT03252522|Micronutrients|micronutrients|mesh-list
111496856|NCT03252522|Trace Elements|trace elements|mesh-list
111496857|NCT03252522|Antioxidants|antioxidants|mesh-list
111496858|NCT03252522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111496859|NCT03252522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111496860|NCT03252522|Protective Agents|protective agents|mesh-ancestor
111496861|NCT03191370|Anesthetics|anesthetics|mesh-list
111496862|NCT03191370|Anesthetics, Local|anesthetics, local|mesh-list
111496863|NCT03191370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111496864|NCT03191370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111496865|NCT03191370|Sensory System Agents|sensory system agents|mesh-ancestor
111496866|NCT03191370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111496867|NCT03179436|Pembrolizumab|pembrolizumab|mesh-list
111496868|NCT03179436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111496869|NCT03179436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111496870|NCT03179436|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111496871|NCT03179436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111496872|NCT03149874|Vaccines|vaccines|mesh-list
111496873|NCT03149874|Immunologic Factors|immunologic factors|mesh-ancestor
111496874|NCT03149874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111496875|NCT02834052|Poly I-C|poly i-c|mesh-list
111496876|NCT02834052|Pembrolizumab|pembrolizumab|mesh-list
111496877|NCT02834052|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
111496878|NCT02834052|Poly ICLC|poly iclc|mesh-list
111496879|NCT02834052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111496880|NCT02834052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111496881|NCT02834052|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111496882|NCT02834052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111496883|NCT02834052|Interferon Inducers|interferon inducers|mesh-ancestor
111496884|NCT02834052|Immunologic Factors|immunologic factors|mesh-ancestor
111496885|NCT02834052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111496886|NCT02834052|Laxatives|laxatives|mesh-ancestor
111496887|NCT02834052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111496888|NCT02834052|Antiviral Agents|antiviral agents|mesh-ancestor
111496889|NCT02834052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111496890|NCT02756364|Fulvestrant|fulvestrant|mesh-list
111496891|NCT02756364|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111496892|NCT02756364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111496893|NCT02756364|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
111496894|NCT02756364|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111496895|NCT02756364|Hormone Antagonists|hormone antagonists|mesh-ancestor
111496896|NCT02756364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111496897|NCT02756364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111496898|NCT02519322|Nivolumab|nivolumab|mesh-list
111496899|NCT02519322|Ipilimumab|ipilimumab|mesh-list
111496900|NCT02519322|Relatlimab|relatlimab|mesh-list
111496901|NCT02519322|Immunoglobulins|immunoglobulins|mesh-list
111496902|NCT02519322|Immunoglobulin G|immunoglobulin g|mesh-list
111496903|NCT02519322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111496904|NCT02519322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111496905|NCT02519322|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111496906|NCT02519322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111496907|NCT02519322|Immunologic Factors|immunologic factors|mesh-ancestor
111496908|NCT02519322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111496909|NCT02460042|Paclitaxel|paclitaxel|mesh-list
111496910|NCT02460042|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111496911|NCT02460042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111496912|NCT02460042|Tubulin Modulators|tubulin modulators|mesh-ancestor
111496913|NCT02460042|Antimitotic Agents|antimitotic agents|mesh-ancestor
111496914|NCT02460042|Mitosis Modulators|mitosis modulators|mesh-ancestor
111496915|NCT02460042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111496916|NCT05722548|Indomethacin|indomethacin|mesh-list
111496917|NCT05722548|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111496918|NCT05722548|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111496919|NCT05722548|Analgesics|analgesics|mesh-ancestor
111496920|NCT05722548|Sensory System Agents|sensory system agents|mesh-ancestor
110480889|NCT00618111|Granisetron|granisetron|mesh-list
111496921|NCT05722548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111496922|NCT05722548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111496923|NCT05722548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111496924|NCT05722548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111496925|NCT05722548|Gout Suppressants|gout suppressants|mesh-ancestor
111496926|NCT05722548|Tocolytic Agents|tocolytic agents|mesh-ancestor
111496927|NCT05722548|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111496928|NCT05722548|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111496929|NCT05722548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111496930|NCT05722548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111496931|NCT05722002|Acetaminophen|acetaminophen|mesh-list
111496932|NCT05722002|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111496933|NCT05722002|Analgesics|analgesics|mesh-ancestor
111496934|NCT05722002|Sensory System Agents|sensory system agents|mesh-ancestor
111496935|NCT05722002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111496936|NCT05722002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111496937|NCT05722002|Antipyretics|antipyretics|mesh-ancestor
111496938|NCT05721456|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
111496939|NCT05721456|Immunologic Factors|immunologic factors|mesh-ancestor
111496940|NCT05721456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111496941|NCT05721300|Interferons|interferons|mesh-list
111496942|NCT05721300|Tenofovir|tenofovir|mesh-list
111496943|NCT05721300|Entecavir|entecavir|mesh-list
111496944|NCT05721300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111496945|NCT05721300|Antiviral Agents|antiviral agents|mesh-ancestor
111496946|NCT05721300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111496947|NCT05721300|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111496948|NCT05721300|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111496949|NCT05721300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111496950|NCT05721300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111496951|NCT05721300|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111496952|NCT05721300|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111496953|NCT05720442|Mosapride|mosapride|mesh-list
111496954|NCT05720442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111496955|NCT05720442|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111496956|NCT05720442|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111496957|NCT05720442|Serotonin Agents|serotonin agents|mesh-ancestor
111496958|NCT05720442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111496959|NCT05720442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111496960|NCT05719818|Diphosphonates|diphosphonates|mesh-list
111496961|NCT05719818|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111496962|NCT05719818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111496963|NCT05719506|Dexmedetomidine|dexmedetomidine|mesh-list
111496964|NCT05719506|Ketamine|ketamine|mesh-list
111496965|NCT05719506|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110705001|NCT00357656|Factor VIII|factor viii|mesh-list
110978051|NCT04502381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110705094|NCT00095056|Protease Inhibitors|protease inhibitors|mesh-ancestor
111496966|NCT05719506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111496967|NCT05719506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111496968|NCT05719506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111496969|NCT05719506|Analgesics|analgesics|mesh-ancestor
111496970|NCT05719506|Sensory System Agents|sensory system agents|mesh-ancestor
111496971|NCT05719506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111496972|NCT05719506|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111496973|NCT05719506|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111496974|NCT05719506|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111496975|NCT05719506|Adrenergic Agents|adrenergic agents|mesh-ancestor
111496976|NCT05719506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111496977|NCT05719506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111496978|NCT05719506|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111496979|NCT05719506|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111496980|NCT05719506|Anesthetics, General|anesthetics, general|mesh-ancestor
111496981|NCT05719506|Anesthetics|anesthetics|mesh-ancestor
111496982|NCT05719506|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111496983|NCT05719506|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111496984|NCT05717166|Hormones|hormones|mesh-list
111496985|NCT05717166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111496986|NCT05717166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111496987|NCT05716932|Ranibizumab|ranibizumab|mesh-list
111496988|NCT05716932|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111496989|NCT05716932|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111496990|NCT05716932|Growth Substances|growth substances|mesh-ancestor
111496991|NCT05716932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111496992|NCT05716932|Growth Inhibitors|growth inhibitors|mesh-ancestor
111496993|NCT05716932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111496994|NCT05715840|Paclitaxel|paclitaxel|mesh-list
111496995|NCT05715840|Bevacizumab|bevacizumab|mesh-list
111496996|NCT05715840|Carboplatin|carboplatin|mesh-list
111496997|NCT05715840|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111496998|NCT05715840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111496999|NCT05715840|Tubulin Modulators|tubulin modulators|mesh-ancestor
111497000|NCT05715840|Antimitotic Agents|antimitotic agents|mesh-ancestor
111497001|NCT05715840|Mitosis Modulators|mitosis modulators|mesh-ancestor
111497002|NCT05715840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111497003|NCT05715840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111497004|NCT05715840|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111497005|NCT05715840|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111497006|NCT05715840|Growth Substances|growth substances|mesh-ancestor
111497007|NCT05715840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111497008|NCT05715840|Growth Inhibitors|growth inhibitors|mesh-ancestor
111497009|NCT05713734|Thrombin|thrombin|mesh-list
111497010|NCT05713734|Hemostatics|hemostatics|mesh-ancestor
111497011|NCT05713734|Coagulants|coagulants|mesh-ancestor
111497012|NCT05698758|Dexmedetomidine|dexmedetomidine|mesh-list
111497013|NCT05698758|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111497014|NCT05698758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111497015|NCT05698758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111497016|NCT05698758|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111497017|NCT05698758|Analgesics|analgesics|mesh-ancestor
111497018|NCT05698758|Sensory System Agents|sensory system agents|mesh-ancestor
111497019|NCT05698758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111497020|NCT05698758|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111497021|NCT05698758|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111497022|NCT05698758|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111497023|NCT05698758|Adrenergic Agents|adrenergic agents|mesh-ancestor
111497024|NCT05698758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111497025|NCT05698758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111497026|NCT05665062|Cyclophosphamide|cyclophosphamide|mesh-list
111497027|NCT05665062|Fludarabine|fludarabine|mesh-list
111497028|NCT05665062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111497029|NCT05665062|Immunologic Factors|immunologic factors|mesh-ancestor
111497030|NCT05665062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111497031|NCT05665062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111497032|NCT05665062|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111497033|NCT05665062|Alkylating Agents|alkylating agents|mesh-ancestor
111497034|NCT05665062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111497035|NCT05665062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111497036|NCT05665062|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111497037|NCT05557812|Eugenol|eugenol|mesh-list
110978052|NCT04502381|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111497038|NCT05557812|Zinc Oxide|zinc oxide|mesh-list
111497039|NCT05557812|Ferric Compounds|ferric compounds|mesh-list
111497040|NCT05557812|Dermatologic Agents|dermatologic agents|mesh-ancestor
111497041|NCT05557812|Sunscreening Agents|sunscreening agents|mesh-ancestor
111497042|NCT05557812|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111497043|NCT05557812|Protective Agents|protective agents|mesh-ancestor
111497044|NCT05557812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111497045|NCT05557812|Hematinics|hematinics|mesh-ancestor
111497046|NCT05557812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111497047|NCT05549466|Gemcitabine|gemcitabine|mesh-list
111497048|NCT05549466|Capecitabine|capecitabine|mesh-list
111497049|NCT05549466|Docetaxel|docetaxel|mesh-list
111497050|NCT05549466|Apatinib|apatinib|mesh-list
111497051|NCT05549466|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111497052|NCT05549466|Antimetabolites|antimetabolites|mesh-ancestor
111497053|NCT05549466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111497054|NCT05549466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111497055|NCT05549466|Tubulin Modulators|tubulin modulators|mesh-ancestor
111497056|NCT05549466|Antimitotic Agents|antimitotic agents|mesh-ancestor
111497057|NCT05549466|Mitosis Modulators|mitosis modulators|mesh-ancestor
111497058|NCT05549466|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111497059|NCT05549466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111497060|NCT05436678|Ciprofloxacin|ciprofloxacin|mesh-list
111497061|NCT05436678|Celecoxib|celecoxib|mesh-list
111497062|NCT05436678|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111497063|NCT05436678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111497064|NCT05436678|Analgesics|analgesics|mesh-ancestor
111497065|NCT05436678|Sensory System Agents|sensory system agents|mesh-ancestor
111497066|NCT05436678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111497067|NCT05436678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111497068|NCT05436678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111497069|NCT05436678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111497070|NCT05436678|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111497071|NCT05436678|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110128221|NCT05510063|Adalimumab|adalimumab|mesh-list
111497072|NCT05436678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111497073|NCT05436678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111497074|NCT05436678|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111497075|NCT05436678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111497076|NCT05436678|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111497077|NCT05436678|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111497078|NCT05436678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111497079|NCT05436678|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111497080|NCT05436678|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111497081|NCT05352282|Fentanyl|fentanyl|mesh-list
111497082|NCT05352282|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111497083|NCT05352282|Narcotics|narcotics|mesh-ancestor
111497084|NCT05352282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111497085|NCT05352282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111497086|NCT05352282|Analgesics|analgesics|mesh-ancestor
111497087|NCT05352282|Sensory System Agents|sensory system agents|mesh-ancestor
111497088|NCT05352282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111497089|NCT05352282|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111497090|NCT05352282|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111497091|NCT05352282|Anesthetics, General|anesthetics, general|mesh-ancestor
111497092|NCT05352282|Anesthetics|anesthetics|mesh-ancestor
111497093|NCT05322330|Cyclophosphamide|cyclophosphamide|mesh-list
111497094|NCT05322330|Fludarabine|fludarabine|mesh-list
111497095|NCT05322330|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111497096|NCT05322330|Immunologic Factors|immunologic factors|mesh-ancestor
111497097|NCT05322330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111497098|NCT05322330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111497099|NCT05322330|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111497100|NCT05322330|Alkylating Agents|alkylating agents|mesh-ancestor
111497101|NCT05322330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111497102|NCT05322330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111497103|NCT05322330|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111497104|NCT05312892|Amlodipine|amlodipine|mesh-list
111497105|NCT05312892|Antihypertensive Agents|antihypertensive agents|mesh-list
111497106|NCT05312892|Moxonidine|moxonidine|mesh-list
111497107|NCT05312892|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111497108|NCT05312892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111497109|NCT05312892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111497110|NCT05312892|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111497111|NCT05312892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110978053|NCT04502381|Antifungal Agents|antifungal agents|mesh-ancestor
111497112|NCT05312892|Vasodilator Agents|vasodilator agents|mesh-ancestor
111497113|NCT05309616|Ixekizumab|ixekizumab|mesh-list
111497114|NCT05309616|Dermatologic Agents|dermatologic agents|mesh-ancestor
111497115|NCT05278494|Dextromethorphan|dextromethorphan|mesh-list
111497116|NCT05278494|Antitussive Agents|antitussive agents|mesh-ancestor
111497117|NCT05278494|Respiratory System Agents|respiratory system agents|mesh-ancestor
111497118|NCT05278494|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111497119|NCT05278494|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111497120|NCT05278494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111497121|NCT05278494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111497122|NCT05278494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111497123|NCT05251038|Leucovorin|leucovorin|mesh-list
111497124|NCT05251038|Paclitaxel|paclitaxel|mesh-list
111497125|NCT05251038|Gemcitabine|gemcitabine|mesh-list
111497126|NCT05251038|Fluorouracil|fluorouracil|mesh-list
111497127|NCT05251038|Irinotecan|irinotecan|mesh-list
111497128|NCT05251038|Sotorasib|sotorasib|mesh-list
111497129|NCT05251038|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111497130|NCT05251038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111497131|NCT05251038|Tubulin Modulators|tubulin modulators|mesh-ancestor
111497132|NCT05251038|Antimitotic Agents|antimitotic agents|mesh-ancestor
111497133|NCT05251038|Mitosis Modulators|mitosis modulators|mesh-ancestor
111497134|NCT05251038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111497135|NCT05251038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111497136|NCT05251038|Antimetabolites|antimetabolites|mesh-ancestor
111497137|NCT05251038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111497138|NCT05251038|Immunologic Factors|immunologic factors|mesh-ancestor
111497139|NCT05251038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111497140|NCT05251038|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111497141|NCT05251038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111497142|NCT05251038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111497143|NCT05251038|Antidotes|antidotes|mesh-ancestor
111497144|NCT05251038|Protective Agents|protective agents|mesh-ancestor
111497145|NCT05251038|Vitamin B Complex|vitamin b complex|mesh-ancestor
111497146|NCT05251038|Vitamins|vitamins|mesh-ancestor
111497147|NCT05251038|Micronutrients|micronutrients|mesh-ancestor
111497148|NCT05251038|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111497149|NCT05251038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111497150|NCT05217498|Istradefylline|istradefylline|mesh-list
111497151|NCT05217498|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
111497152|NCT05217498|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
111497153|NCT05217498|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111497154|NCT05217498|Purinergic Agents|purinergic agents|mesh-ancestor
111497155|NCT05217498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111497156|NCT05217498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111497157|NCT05217498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111497158|NCT05091372|Lenalidomide|lenalidomide|mesh-list
111497159|NCT05091372|Immunologic Factors|immunologic factors|mesh-ancestor
111497160|NCT05091372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111497161|NCT05091372|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111497162|NCT05091372|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111497163|NCT05091372|Growth Substances|growth substances|mesh-ancestor
111497164|NCT05091372|Growth Inhibitors|growth inhibitors|mesh-ancestor
111497165|NCT05091372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111497166|NCT05027646|Granisetron|granisetron|mesh-list
111497167|NCT05027646|Antiemetics|antiemetics|mesh-ancestor
111497168|NCT05027646|Autonomic Agents|autonomic agents|mesh-ancestor
111497169|NCT05027646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111497170|NCT05027646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111497171|NCT05027646|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111497172|NCT05027646|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111497173|NCT05027646|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111497174|NCT05027646|Serotonin Agents|serotonin agents|mesh-ancestor
111497175|NCT05027646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111497176|NCT05027646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111497177|NCT04988646|Acyclovir|acyclovir|mesh-list
111497178|NCT04988646|Antiviral Agents|antiviral agents|mesh-ancestor
111497179|NCT04988646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111497180|NCT04924062|Cisplatin|cisplatin|mesh-list
111497181|NCT04924062|Gemcitabine|gemcitabine|mesh-list
111497182|NCT04924062|Pembrolizumab|pembrolizumab|mesh-list
111497183|NCT04924062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110978055|NCT04502381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111497184|NCT04924062|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111497185|NCT04924062|Antimetabolites|antimetabolites|mesh-ancestor
111497186|NCT04924062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111497187|NCT04924062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111497188|NCT04924062|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111497189|NCT04876638|Minocycline|minocycline|mesh-list
111497190|NCT04876638|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111497191|NCT04876638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111497192|NCT04754334|Insulin|insulin|mesh-list
111497193|NCT04754334|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111497194|NCT04754334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111497195|NCT04748796|Landiolol|landiolol|mesh-list
111497196|NCT04748796|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111497197|NCT04748796|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111497198|NCT04748796|Adrenergic Agents|adrenergic agents|mesh-ancestor
111497199|NCT04748796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111497200|NCT04748796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111497201|NCT04748796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111497202|NCT04748796|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111497203|NCT04625946|Metformin|metformin|mesh-list
111497204|NCT04625946|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111497205|NCT04625946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111497206|NCT04599816|Simendan|simendan|mesh-list
111497207|NCT04599816|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111497208|NCT04599816|Vasodilator Agents|vasodilator agents|mesh-ancestor
111497209|NCT04599816|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
111497210|NCT04599816|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111497211|NCT04599816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111497212|NCT04599816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111497213|NCT04599816|Protective Agents|protective agents|mesh-ancestor
111497214|NCT04599816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111497215|NCT04534218|Aspirin|aspirin|mesh-list
111497216|NCT04534218|Cyclophosphamide|cyclophosphamide|mesh-list
111497217|NCT04534218|Capecitabine|capecitabine|mesh-list
111497218|NCT04534218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111497219|NCT04534218|Immunologic Factors|immunologic factors|mesh-ancestor
111497220|NCT04534218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111497221|NCT04534218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111497222|NCT04534218|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111497223|NCT04534218|Alkylating Agents|alkylating agents|mesh-ancestor
111497224|NCT04534218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111497225|NCT04534218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111497226|NCT04534218|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111497227|NCT04534218|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111497228|NCT04534218|Antimetabolites|antimetabolites|mesh-ancestor
111497229|NCT04534218|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111497230|NCT04534218|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111497231|NCT04534218|Analgesics|analgesics|mesh-ancestor
111497232|NCT04534218|Sensory System Agents|sensory system agents|mesh-ancestor
111497233|NCT04534218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111497234|NCT04534218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111497235|NCT04534218|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111497236|NCT04534218|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111497237|NCT04534218|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111497238|NCT04534218|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111497239|NCT04534218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111497240|NCT04534218|Antipyretics|antipyretics|mesh-ancestor
111497241|NCT04531878|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
111497242|NCT04531878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111497243|NCT04509414|Midazolam|midazolam|mesh-list
111497244|NCT04509414|Dexmedetomidine|dexmedetomidine|mesh-list
111497245|NCT04509414|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111497246|NCT04509414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111497247|NCT04509414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111497248|NCT04509414|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111497249|NCT04509414|Analgesics|analgesics|mesh-ancestor
111497250|NCT04509414|Sensory System Agents|sensory system agents|mesh-ancestor
111497251|NCT04509414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111497252|NCT04509414|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111497253|NCT04509414|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111497254|NCT04509414|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111497255|NCT04509414|Adrenergic Agents|adrenergic agents|mesh-ancestor
111497256|NCT04509414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111497257|NCT04509414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110978057|NCT03264794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110978058|NCT03264794|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111497258|NCT04509414|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111497259|NCT04509414|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111497260|NCT04509414|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111497261|NCT04509414|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111497262|NCT04509414|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111497263|NCT04509414|Anesthetics, General|anesthetics, general|mesh-ancestor
111497265|NCT04509414|GABA Modulators|gaba modulators|mesh-ancestor
111497266|NCT04509414|GABA Agents|gaba agents|mesh-ancestor
111497267|NCT04320342|Beclomethasone|beclomethasone|mesh-list
111497268|NCT04320342|Glycopyrrolate|glycopyrrolate|mesh-list
111497269|NCT04320342|Bromides|bromides|mesh-list
111497270|NCT04320342|Formoterol Fumarate|formoterol fumarate|mesh-list
111497271|NCT04320342|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111497272|NCT04320342|Autonomic Agents|autonomic agents|mesh-ancestor
111497273|NCT04320342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111497274|NCT04320342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111497275|NCT04320342|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111497276|NCT04320342|Respiratory System Agents|respiratory system agents|mesh-ancestor
111497277|NCT04320342|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111497278|NCT04320342|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111497279|NCT04320342|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111497280|NCT04320342|Adrenergic Agents|adrenergic agents|mesh-ancestor
111497281|NCT04320342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111497282|NCT04320342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111497283|NCT04320342|Anticonvulsants|anticonvulsants|mesh-ancestor
111497284|NCT04320342|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111497285|NCT04320342|Glucocorticoids|glucocorticoids|mesh-ancestor
111497286|NCT04320342|Hormones|hormones|mesh-ancestor
111497287|NCT04320342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111497288|NCT04320342|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111497289|NCT04320342|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111497290|NCT04320342|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111497291|NCT04320342|Cholinergic Agents|cholinergic agents|mesh-ancestor
111497292|NCT04307550|Ethanol|ethanol|mesh-list
111497293|NCT04307550|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111497294|NCT04307550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111497295|NCT04307550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111497296|NCT04307550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111497297|NCT04134000|Atezolizumab|atezolizumab|mesh-list
111497298|NCT04134000|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111497299|NCT04134000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111497300|NCT04134000|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111497301|NCT04134000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111497302|NCT04095858|Methotrexate|methotrexate|mesh-list
111497303|NCT04095858|Tacrolimus|tacrolimus|mesh-list
111497304|NCT04095858|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111497305|NCT04095858|Abortifacient Agents|abortifacient agents|mesh-ancestor
111497306|NCT04095858|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111497307|NCT04095858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111497308|NCT04095858|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111497309|NCT04095858|Antimetabolites|antimetabolites|mesh-ancestor
111497310|NCT04095858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111497311|NCT04095858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111497312|NCT04095858|Dermatologic Agents|dermatologic agents|mesh-ancestor
111497313|NCT04095858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111497314|NCT04095858|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111497315|NCT04095858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111497316|NCT04095858|Immunologic Factors|immunologic factors|mesh-ancestor
111497317|NCT04095858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111497318|NCT04095858|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111497319|NCT04095858|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111497320|NCT03937986|Cocaine|cocaine|mesh-list
111497321|NCT03937986|Suvorexant|suvorexant|mesh-list
111497322|NCT03937986|Anesthetics, Local|anesthetics, local|mesh-ancestor
111497323|NCT03937986|Anesthetics|anesthetics|mesh-ancestor
111497324|NCT03937986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111497325|NCT03937986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111497326|NCT03937986|Sensory System Agents|sensory system agents|mesh-ancestor
111497327|NCT03937986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111497328|NCT03937986|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111497329|NCT03937986|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111497330|NCT03937986|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110978059|NCT03264794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111497331|NCT03937986|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111497332|NCT03937986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111497333|NCT03937986|Dopamine Agents|dopamine agents|mesh-ancestor
111497334|NCT03937986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111497335|NCT03937986|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111497336|NCT03937986|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111497337|NCT03937986|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
111497338|NCT03813030|Lidocaine|lidocaine|mesh-list
111497339|NCT03813030|Prilocaine|prilocaine|mesh-list
111497340|NCT03813030|Anesthetics, Local|anesthetics, local|mesh-ancestor
111497341|NCT03813030|Anesthetics|anesthetics|mesh-ancestor
111497342|NCT03813030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111497343|NCT03813030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111497344|NCT03813030|Sensory System Agents|sensory system agents|mesh-ancestor
111497345|NCT03813030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111497346|NCT03813030|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111497347|NCT03813030|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111497348|NCT03813030|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111497349|NCT03813030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111497350|NCT03813030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111497351|NCT03778944|Dopamine|dopamine|mesh-list
111497352|NCT03778944|Mannitol|mannitol|mesh-list
111497353|NCT03778944|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
111497354|NCT03778944|Diuretics|diuretics|mesh-ancestor
111497355|NCT03778944|Natriuretic Agents|natriuretic agents|mesh-ancestor
111497356|NCT03778944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111497357|NCT03778944|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111497358|NCT03778944|Sympathomimetics|sympathomimetics|mesh-ancestor
111497359|NCT03778944|Autonomic Agents|autonomic agents|mesh-ancestor
111497360|NCT03778944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111497361|NCT03778944|Dopamine Agents|dopamine agents|mesh-ancestor
111497362|NCT03778944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111497363|NCT03778944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111497364|NCT03778944|Protective Agents|protective agents|mesh-ancestor
111497365|NCT03653052|Durvalumab|durvalumab|mesh-list
110481147|NCT00618501|Vitamins|vitamins|mesh-ancestor
111497366|NCT03653052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111497367|NCT03653052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111497368|NCT03640728|Tenofovir|tenofovir|mesh-list
111497369|NCT03640728|Entecavir|entecavir|mesh-list
111497370|NCT03640728|Antiviral Agents|antiviral agents|mesh-ancestor
111497371|NCT03640728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111497372|NCT03640728|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111497373|NCT03640728|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111497374|NCT03640728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111497375|NCT03640728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111497376|NCT03640728|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111497377|NCT03640728|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111497378|NCT03529110|Trastuzumab|trastuzumab|mesh-list
111497379|NCT03529110|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
111497380|NCT03529110|Maytansine|maytansine|mesh-list
111497381|NCT03529110|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
111497382|NCT03529110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111497383|NCT03529110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111497384|NCT03529110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111497385|NCT03529110|Tubulin Modulators|tubulin modulators|mesh-ancestor
111497386|NCT03529110|Antimitotic Agents|antimitotic agents|mesh-ancestor
111497387|NCT03529110|Mitosis Modulators|mitosis modulators|mesh-ancestor
111497388|NCT03529110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111497389|NCT03529110|Immunotoxins|immunotoxins|mesh-ancestor
111497390|NCT03529110|Immunoconjugates|immunoconjugates|mesh-ancestor
111497391|NCT03529110|Immunologic Factors|immunologic factors|mesh-ancestor
111497392|NCT03529110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111497393|NCT03502746|Nivolumab|nivolumab|mesh-list
111497394|NCT03502746|Ramucirumab|ramucirumab|mesh-list
111497395|NCT03502746|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111497396|NCT03502746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111497397|NCT03502746|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111497398|NCT03502746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111497399|NCT03436368|Anesthetics|anesthetics|mesh-list
111497400|NCT03436368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111497401|NCT03436368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111497402|NCT03393780|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
110705470|NCT01050608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111497403|NCT03393780|Hormones|hormones|mesh-ancestor
111497404|NCT03393780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111497405|NCT03393780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111497406|NCT03367572|Dexamethasone|dexamethasone|mesh-list
111497407|NCT03367572|Dexamethasone acetate|dexamethasone acetate|mesh-list
111497408|NCT03367572|Olanzapine|olanzapine|mesh-list
111497409|NCT03367572|Palonosetron|palonosetron|mesh-list
111497410|NCT03367572|Prochlorperazine|prochlorperazine|mesh-list
111497411|NCT03367572|Ichthammol|ichthammol|mesh-list
111497412|NCT03367572|BB 1101|bb 1101|mesh-list
111497413|NCT03367572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111497414|NCT03367572|Antiemetics|antiemetics|mesh-ancestor
111497415|NCT03367572|Autonomic Agents|autonomic agents|mesh-ancestor
111497416|NCT03367572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111497417|NCT03367572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111497418|NCT03367572|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111497419|NCT03367572|Glucocorticoids|glucocorticoids|mesh-ancestor
111497420|NCT03367572|Hormones|hormones|mesh-ancestor
111497421|NCT03367572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111497422|NCT03367572|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111497423|NCT03367572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111497424|NCT03367572|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111497425|NCT03367572|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111497426|NCT03367572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111497427|NCT03367572|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111497428|NCT03367572|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111497429|NCT03367572|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111497430|NCT03367572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111497431|NCT03367572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111497432|NCT03367572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111497433|NCT03367572|Serotonin Agents|serotonin agents|mesh-ancestor
111497434|NCT03367572|Protease Inhibitors|protease inhibitors|mesh-ancestor
111497435|NCT03367572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111497436|NCT03367572|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111497437|NCT03367572|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111497438|NCT03367572|Dermatologic Agents|dermatologic agents|mesh-ancestor
111497439|NCT03367572|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111497440|NCT03367572|Dopamine Agents|dopamine agents|mesh-ancestor
111497441|NCT03202758|Durvalumab|durvalumab|mesh-list
111497442|NCT03202758|Tremelimumab|tremelimumab|mesh-list
111497443|NCT03202758|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111497444|NCT03202758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111497445|NCT03122262|Tenofovir|tenofovir|mesh-list
111497446|NCT03122262|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
111497447|NCT03122262|Dolutegravir|dolutegravir|mesh-list
111497448|NCT03122262|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
111497449|NCT03122262|Antiviral Agents|antiviral agents|mesh-ancestor
111497450|NCT03122262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111497451|NCT03122262|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111497452|NCT03122262|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111497453|NCT03122262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111497454|NCT03122262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111497455|NCT03122262|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111497456|NCT03122262|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111497457|NCT03122262|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111497458|NCT03122262|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111497459|NCT03051282|Enalapril|enalapril|mesh-list
111497460|NCT03051282|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
111497461|NCT03051282|Protease Inhibitors|protease inhibitors|mesh-ancestor
111497462|NCT03051282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111497463|NCT03051282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111497464|NCT03051282|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111497465|NCT03042546|Calcium|calcium|mesh-list
111497466|NCT03042546|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111497467|NCT03042546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111497468|NCT02734602|Ketamine|ketamine|mesh-list
111497469|NCT02734602|Analgesics|analgesics|mesh-ancestor
111497470|NCT02734602|Sensory System Agents|sensory system agents|mesh-ancestor
111497471|NCT02734602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111497472|NCT02734602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111497473|NCT02734602|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111497474|NCT02734602|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111497475|NCT02734602|Anesthetics, General|anesthetics, general|mesh-ancestor
110978060|NCT03264794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110978061|NCT02925923|Clopidogrel|clopidogrel|mesh-list
110978062|NCT02925923|Ticagrelor|ticagrelor|mesh-list
110978063|NCT02925923|Eptifibatide|eptifibatide|mesh-list
111497476|NCT02734602|Anesthetics|anesthetics|mesh-ancestor
111497477|NCT02734602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111497478|NCT02734602|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111497479|NCT02734602|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111497480|NCT02734602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111497481|NCT02734602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111497482|NCT02663622|Methotrexate|methotrexate|mesh-list
111497483|NCT02663622|Tacrolimus|tacrolimus|mesh-list
111497484|NCT02663622|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111497485|NCT02663622|Abortifacient Agents|abortifacient agents|mesh-ancestor
111497486|NCT02663622|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111497487|NCT02663622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111497488|NCT02663622|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111497489|NCT02663622|Antimetabolites|antimetabolites|mesh-ancestor
111497490|NCT02663622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111497491|NCT02663622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111497492|NCT02663622|Dermatologic Agents|dermatologic agents|mesh-ancestor
111497493|NCT02663622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111497494|NCT02663622|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111497495|NCT02663622|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111497496|NCT02663622|Immunologic Factors|immunologic factors|mesh-ancestor
111497497|NCT02663622|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111497498|NCT02663622|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111497499|NCT02663622|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111497500|NCT02420652|Aspirin|aspirin|mesh-list
111497501|NCT02420652|Metformin|metformin|mesh-list
111497502|NCT02420652|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111497503|NCT02420652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111497504|NCT02420652|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111497505|NCT02420652|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111497506|NCT02420652|Analgesics|analgesics|mesh-ancestor
111497507|NCT02420652|Sensory System Agents|sensory system agents|mesh-ancestor
111497508|NCT02420652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111497509|NCT02420652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111497510|NCT02420652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111497511|NCT02420652|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111497512|NCT02420652|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111497513|NCT02420652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111497514|NCT02420652|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111497515|NCT02420652|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111497516|NCT02420652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111497517|NCT02420652|Antipyretics|antipyretics|mesh-ancestor
111497518|NCT02257242|Rituximab|rituximab|mesh-list
111497519|NCT02257242|Vincristine|vincristine|mesh-list
111497520|NCT02257242|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
111497521|NCT02257242|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111497522|NCT02257242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111497523|NCT02257242|Immunologic Factors|immunologic factors|mesh-ancestor
111497524|NCT02257242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111497525|NCT02257242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111497526|NCT02257242|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111497527|NCT02257242|Tubulin Modulators|tubulin modulators|mesh-ancestor
111497528|NCT02257242|Antimitotic Agents|antimitotic agents|mesh-ancestor
111497529|NCT02257242|Mitosis Modulators|mitosis modulators|mesh-ancestor
111497530|NCT02257242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111497531|NCT02257242|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111497532|NCT02257242|Alkylating Agents|alkylating agents|mesh-ancestor
111497533|NCT02034630|Busulfan|busulfan|mesh-list
111497534|NCT02034630|Alkylating Agents|alkylating agents|mesh-ancestor
111497535|NCT02034630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111497536|NCT02034630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111497537|NCT02034630|Immunologic Factors|immunologic factors|mesh-ancestor
111497538|NCT02034630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111497539|NCT02034630|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111497540|NCT02034630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111497541|NCT02034630|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111497542|NCT02025036|Capecitabine|capecitabine|mesh-list
111497543|NCT02025036|Oxaliplatin|oxaliplatin|mesh-list
111497544|NCT02025036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111497545|NCT02025036|Antimetabolites|antimetabolites|mesh-ancestor
111497546|NCT02025036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111497547|NCT02025036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111497548|NCT01768338|Ofatumumab|ofatumumab|mesh-list
110978064|NCT02925923|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110978065|NCT02925923|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110978066|NCT02925923|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111497550|NCT00819546|Everolimus|everolimus|mesh-list
111497551|NCT00819546|Midostaurin|midostaurin|mesh-list
111497552|NCT00819546|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111497553|NCT00819546|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111497554|NCT00819546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111497555|NCT00819546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111497556|NCT00819546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111497557|NCT00819546|Immunologic Factors|immunologic factors|mesh-ancestor
111497558|NCT00819546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111497559|NCT00819546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111497560|NCT00596154|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111497561|NCT00596154|Cyclophosphamide|cyclophosphamide|mesh-list
111497562|NCT00596154|Busulfan|busulfan|mesh-list
111497563|NCT00596154|Thiotepa|thiotepa|mesh-list
111497564|NCT00596154|Rituximab|rituximab|mesh-list
111497565|NCT00596154|Methotrexate|methotrexate|mesh-list
111497566|NCT00596154|Vincristine|vincristine|mesh-list
111497567|NCT00596154|Procarbazine|procarbazine|mesh-list
111497568|NCT00596154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111497569|NCT00596154|Immunologic Factors|immunologic factors|mesh-ancestor
111497570|NCT00596154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111497571|NCT00596154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111497572|NCT00596154|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111497573|NCT00596154|Alkylating Agents|alkylating agents|mesh-ancestor
111497574|NCT00596154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111497575|NCT00596154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111497576|NCT00596154|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111497577|NCT00596154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111497578|NCT00596154|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111497579|NCT00596154|Abortifacient Agents|abortifacient agents|mesh-ancestor
111497580|NCT00596154|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111497581|NCT00596154|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111497582|NCT00596154|Antimetabolites|antimetabolites|mesh-ancestor
111497583|NCT00596154|Dermatologic Agents|dermatologic agents|mesh-ancestor
111497584|NCT00596154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110978067|NCT02925923|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110978068|NCT02925923|Purinergic Agents|purinergic agents|mesh-ancestor
110978069|NCT02925923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110978070|NCT02925923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110978071|NCT02925923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110978072|NCT03280316|Tolterodine Tartrate|tolterodine tartrate|mesh-list
110978073|NCT03280316|Botulinum Toxins|botulinum toxins|mesh-list
110978074|NCT03280316|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110978075|NCT03280316|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110978076|NCT03280316|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110978077|NCT03280316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110978078|NCT03280316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110978079|NCT03280316|Cholinergic Agents|cholinergic agents|mesh-ancestor
110978080|NCT03280316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110978081|NCT03280316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110978082|NCT03280316|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110978083|NCT03280316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110978084|NCT03280316|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110978085|NCT03280316|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110978086|NCT03280316|Urological Agents|urological agents|mesh-ancestor
110978088|NCT02410343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110978089|NCT02410343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110978090|NCT05234840|Triamcinolone|triamcinolone|mesh-list
110978091|NCT05234840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110978092|NCT05234840|Glucocorticoids|glucocorticoids|mesh-ancestor
110978093|NCT05234840|Hormones|hormones|mesh-ancestor
110978094|NCT05234840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110978095|NCT05234840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110978096|NCT03280004|Moxifloxacin|moxifloxacin|mesh-list
110978097|NCT03280004|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
110978098|NCT03280004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110978099|NCT03280004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110978100|NCT03280004|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110978101|NCT03280004|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111497585|NCT00596154|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110978102|NCT03280004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111497586|NCT00596154|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111497587|NCT00596154|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111497588|NCT00596154|Tubulin Modulators|tubulin modulators|mesh-ancestor
111497589|NCT00596154|Antimitotic Agents|antimitotic agents|mesh-ancestor
111497590|NCT00596154|Mitosis Modulators|mitosis modulators|mesh-ancestor
111497591|NCT00596154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111497593|NCT00281658|Lapatinib|lapatinib|mesh-list
111497594|NCT00281658|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111497595|NCT00281658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111497596|NCT00281658|Tubulin Modulators|tubulin modulators|mesh-ancestor
111497597|NCT00281658|Antimitotic Agents|antimitotic agents|mesh-ancestor
111497598|NCT00281658|Mitosis Modulators|mitosis modulators|mesh-ancestor
111497599|NCT00281658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111497600|NCT00281658|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111497601|NCT00281658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111497602|NCT02417844|Tamsulosin|tamsulosin|mesh-list
111497603|NCT02417844|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111497604|NCT02417844|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111497605|NCT02417844|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111497606|NCT02417844|Adrenergic Agents|adrenergic agents|mesh-ancestor
111497607|NCT02417844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111497608|NCT02417844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111497609|NCT02417844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111497610|NCT02417844|Urological Agents|urological agents|mesh-ancestor
111497611|NCT02418312|Famotidine|famotidine|mesh-list
111497612|NCT02418312|Histamine H2 Antagonists|histamine h2 antagonists|mesh-list
111497613|NCT02418312|Histamine|histamine|mesh-list
111497614|NCT02418312|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111497615|NCT02418312|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111497616|NCT02418312|Histamine Antagonists|histamine antagonists|mesh-ancestor
111497617|NCT02418312|Histamine Agents|histamine agents|mesh-ancestor
111497618|NCT02418312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111497619|NCT02418312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111497620|NCT02418312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111497621|NCT02418312|Histamine Agonists|histamine agonists|mesh-ancestor
111497622|NCT02421354|Nivolumab|nivolumab|mesh-list
111497623|NCT02421354|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111497624|NCT02421354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111497625|NCT02421354|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111497626|NCT02421354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111497627|NCT02422290|Ketamine|ketamine|mesh-list
111497628|NCT02422290|Analgesics|analgesics|mesh-ancestor
111497629|NCT02422290|Sensory System Agents|sensory system agents|mesh-ancestor
111497630|NCT02422290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111497631|NCT02422290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111497632|NCT02422290|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111497633|NCT02422290|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111497634|NCT02422290|Anesthetics, General|anesthetics, general|mesh-ancestor
111497635|NCT02422290|Anesthetics|anesthetics|mesh-ancestor
111497636|NCT02422290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111497637|NCT02422290|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111497638|NCT02422290|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111497639|NCT02422290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111497640|NCT02422290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111497641|NCT02430090|Fentanyl|fentanyl|mesh-list
111497642|NCT02430090|Sufentanil|sufentanil|mesh-list
111497643|NCT02430090|Levobupivacaine|levobupivacaine|mesh-list
111497644|NCT02430090|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111497645|NCT02430090|Narcotics|narcotics|mesh-ancestor
111497646|NCT02430090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111497647|NCT02430090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111497648|NCT02430090|Analgesics|analgesics|mesh-ancestor
111497649|NCT02430090|Sensory System Agents|sensory system agents|mesh-ancestor
111497650|NCT02430090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111497651|NCT02430090|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111497652|NCT02430090|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111497653|NCT02430090|Anesthetics, General|anesthetics, general|mesh-ancestor
111497654|NCT02430090|Anesthetics|anesthetics|mesh-ancestor
111497655|NCT02430090|Anesthetics, Local|anesthetics, local|mesh-ancestor
111497656|NCT02431572|Immunomodulating Agents|immunomodulating agents|mesh-list
111497657|NCT02431572|Immunologic Factors|immunologic factors|mesh-ancestor
111497658|NCT02431572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111497659|NCT02431650|Primaquine|primaquine|mesh-list
110978103|NCT03280004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111497660|NCT02431650|Antimalarials|antimalarials|mesh-ancestor
111497661|NCT02431650|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111497662|NCT02431650|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111497663|NCT02431650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111497664|NCT02437344|Naltrexone|naltrexone|mesh-list
111497665|NCT02437344|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111497666|NCT02437344|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111497667|NCT02437344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111497668|NCT02437344|Sensory System Agents|sensory system agents|mesh-ancestor
111497669|NCT02437344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111497670|NCT02440308|Bombesin|bombesin|mesh-list
111497671|NCT02440308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111497672|NCT02440308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110481266|NCT00768430|Ketamine|ketamine|mesh-list
111497673|NCT02440308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111497674|NCT02444988|Plasma-lyte 148|plasma-lyte 148|mesh-list
111497675|NCT02444988|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
111497676|NCT02444988|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111497677|NCT02448654|Tolcapone|tolcapone|mesh-list
111497678|NCT02448654|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111497679|NCT02448654|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111497680|NCT02448654|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
111497681|NCT02448654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111497682|NCT02448654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111497683|NCT02451150|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
111497684|NCT02451150|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111497685|NCT02451150|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111497686|NCT02451150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111497687|NCT02452866|Secnidazole|secnidazole|mesh-list
111497688|NCT02452866|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111497689|NCT02452866|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111497690|NCT02452866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111497691|NCT02462148|Dexamethasone|dexamethasone|mesh-list
111497692|NCT02462148|Dexamethasone acetate|dexamethasone acetate|mesh-list
111497693|NCT02462148|Epinephrine|epinephrine|mesh-list
111497694|NCT02462148|Bupivacaine|bupivacaine|mesh-list
111497695|NCT02462148|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
111497696|NCT02462148|BB 1101|bb 1101|mesh-list
111497697|NCT02462148|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111497698|NCT02462148|Antiemetics|antiemetics|mesh-ancestor
111497699|NCT02462148|Autonomic Agents|autonomic agents|mesh-ancestor
111497700|NCT02462148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111497701|NCT02462148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111497702|NCT02462148|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111497703|NCT02462148|Glucocorticoids|glucocorticoids|mesh-ancestor
111497704|NCT02462148|Hormones|hormones|mesh-ancestor
111497705|NCT02462148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111497706|NCT02462148|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111497707|NCT02462148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111497708|NCT02462148|Protease Inhibitors|protease inhibitors|mesh-ancestor
111497709|NCT02462148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111497710|NCT02462148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111497711|NCT02462148|Anesthetics, Local|anesthetics, local|mesh-ancestor
111497712|NCT02462148|Anesthetics|anesthetics|mesh-ancestor
111497713|NCT02462148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111497714|NCT02462148|Sensory System Agents|sensory system agents|mesh-ancestor
111497715|NCT02462148|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111497716|NCT02462148|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111497717|NCT02462148|Adrenergic Agents|adrenergic agents|mesh-ancestor
111497718|NCT02462148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111497719|NCT02462148|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111497720|NCT02462148|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111497721|NCT02462148|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111497722|NCT02462148|Respiratory System Agents|respiratory system agents|mesh-ancestor
111497723|NCT02462148|Mydriatics|mydriatics|mesh-ancestor
111497724|NCT02462148|Sympathomimetics|sympathomimetics|mesh-ancestor
111497725|NCT02462148|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111497726|NCT02462382|Ropivacaine|ropivacaine|mesh-list
111497727|NCT02462382|Anesthetics, Local|anesthetics, local|mesh-ancestor
111497728|NCT02462382|Anesthetics|anesthetics|mesh-ancestor
111497729|NCT02462382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111497730|NCT02462382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111497731|NCT02462382|Sensory System Agents|sensory system agents|mesh-ancestor
110978104|NCT03280004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111497732|NCT02462382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111497733|NCT02464176|Dexamethasone|dexamethasone|mesh-list
111497734|NCT02464176|Dexamethasone acetate|dexamethasone acetate|mesh-list
111497735|NCT02464176|Epinephrine|epinephrine|mesh-list
111497736|NCT02464176|Bupivacaine|bupivacaine|mesh-list
111497737|NCT02464176|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
111497739|NCT02464176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111497740|NCT02464176|Antiemetics|antiemetics|mesh-ancestor
111497741|NCT02464176|Autonomic Agents|autonomic agents|mesh-ancestor
111497742|NCT02464176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111497743|NCT02464176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111497744|NCT02464176|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111497745|NCT02464176|Glucocorticoids|glucocorticoids|mesh-ancestor
111497746|NCT02464176|Hormones|hormones|mesh-ancestor
111497747|NCT02464176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111497748|NCT02464176|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111497749|NCT02464176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111497750|NCT02464176|Protease Inhibitors|protease inhibitors|mesh-ancestor
111497751|NCT02464176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111497752|NCT02464176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111497753|NCT02464176|Anesthetics, Local|anesthetics, local|mesh-ancestor
111497754|NCT02464176|Anesthetics|anesthetics|mesh-ancestor
111497755|NCT02464176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111497756|NCT02464176|Sensory System Agents|sensory system agents|mesh-ancestor
111497757|NCT02464176|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111497758|NCT02464176|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111497759|NCT02464176|Adrenergic Agents|adrenergic agents|mesh-ancestor
111497760|NCT02464176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111497761|NCT02464176|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111497762|NCT02464176|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111497763|NCT02464176|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111497764|NCT02464176|Respiratory System Agents|respiratory system agents|mesh-ancestor
111497765|NCT02464176|Mydriatics|mydriatics|mesh-ancestor
111497766|NCT02464176|Sympathomimetics|sympathomimetics|mesh-ancestor
111497767|NCT02464176|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111497768|NCT02468700|Dexamethasone|dexamethasone|mesh-list
111497769|NCT02468700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111497770|NCT02468700|Antiemetics|antiemetics|mesh-ancestor
111497771|NCT02468700|Autonomic Agents|autonomic agents|mesh-ancestor
111497772|NCT02468700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111497773|NCT02468700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111497774|NCT02468700|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111497775|NCT02468700|Glucocorticoids|glucocorticoids|mesh-ancestor
111497776|NCT02468700|Hormones|hormones|mesh-ancestor
111497777|NCT02468700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111497778|NCT02468700|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111497779|NCT02468700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111497780|NCT02472522|Dexmedetomidine|dexmedetomidine|mesh-list
111497781|NCT02472522|Ropivacaine|ropivacaine|mesh-list
111497782|NCT02472522|Adrenergic Agonists|adrenergic agonists|mesh-list
111497783|NCT02472522|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111497784|NCT02472522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111497785|NCT02472522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111497786|NCT02472522|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111497787|NCT02472522|Analgesics|analgesics|mesh-ancestor
111497788|NCT02472522|Sensory System Agents|sensory system agents|mesh-ancestor
111497789|NCT02472522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111497790|NCT02472522|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111497791|NCT02472522|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111497792|NCT02472522|Adrenergic Agents|adrenergic agents|mesh-ancestor
111497793|NCT02472522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111497794|NCT02472522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111497795|NCT02472522|Anesthetics, Local|anesthetics, local|mesh-ancestor
111497796|NCT02472522|Anesthetics|anesthetics|mesh-ancestor
111497797|NCT02480166|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
111497798|NCT02480166|Antiviral Agents|antiviral agents|mesh-ancestor
111497799|NCT02480166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111497800|NCT02481258|5-chloro-2-(5-chlorothiophene-2-sulfonylamino)-N-(4-(morpholine-4-sulfonyl)phenyl)benzamide|5-chloro-2-(5-chlorothiophene-2-sulfonylamino)-n-(4-(morpholine-4-sulfonyl)phenyl)benzamide|mesh-list
111497801|NCT02481258|Enzyme Activators|enzyme activators|mesh-ancestor
111497802|NCT02481258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111497803|NCT02484222|Fentanyl|fentanyl|mesh-list
110978105|NCT03280004|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110978106|NCT03280004|Contraceptive Agents|contraceptive agents|mesh-ancestor
110705866|NCT03989336|Tubulin Modulators|tubulin modulators|mesh-ancestor
111497804|NCT02484222|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111497805|NCT02484222|Narcotics|narcotics|mesh-ancestor
111497806|NCT02484222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111497807|NCT02484222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111497808|NCT02484222|Analgesics|analgesics|mesh-ancestor
111497809|NCT02484222|Sensory System Agents|sensory system agents|mesh-ancestor
111497810|NCT02484222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111497811|NCT02484222|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111497812|NCT02484222|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111497813|NCT02484222|Anesthetics, General|anesthetics, general|mesh-ancestor
111497814|NCT02484222|Anesthetics|anesthetics|mesh-ancestor
111497816|NCT02486016|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111497817|NCT02486016|Narcotics|narcotics|mesh-ancestor
111497818|NCT02486016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111497819|NCT02486016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111497820|NCT02486016|Analgesics|analgesics|mesh-ancestor
110481349|NCT04075201|Vaccines|vaccines|mesh-list
111497821|NCT02486016|Sensory System Agents|sensory system agents|mesh-ancestor
111497822|NCT02486016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111497823|NCT02486016|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111497824|NCT02486016|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111497825|NCT02486016|Anesthetics, General|anesthetics, general|mesh-ancestor
111497826|NCT02486016|Anesthetics|anesthetics|mesh-ancestor
111497827|NCT02486328|Midazolam|midazolam|mesh-list
111497828|NCT02486328|Meperidine|meperidine|mesh-list
111497829|NCT02486328|Remifentanil|remifentanil|mesh-list
111497830|NCT02486328|Propofol|propofol|mesh-list
111497831|NCT02486328|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111497832|NCT02486328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111497833|NCT02486328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111497834|NCT02486328|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111497835|NCT02486328|Anesthetics, General|anesthetics, general|mesh-ancestor
111497836|NCT02486328|Anesthetics|anesthetics|mesh-ancestor
111497837|NCT02486328|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111497838|NCT02486328|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111497839|NCT02486328|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111497840|NCT02486328|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111497841|NCT02486328|GABA Modulators|gaba modulators|mesh-ancestor
111497842|NCT02486328|GABA Agents|gaba agents|mesh-ancestor
111497843|NCT02486328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111497844|NCT02486328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111497845|NCT02486328|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111497846|NCT02486328|Narcotics|narcotics|mesh-ancestor
111497847|NCT02486328|Analgesics|analgesics|mesh-ancestor
111497848|NCT02486328|Sensory System Agents|sensory system agents|mesh-ancestor
111497849|NCT02486328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111497850|NCT02491788|Suvorexant|suvorexant|mesh-list
111497851|NCT02491788|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111497852|NCT02491788|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111497853|NCT02491788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111497854|NCT02491788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111497855|NCT02491788|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
111497856|NCT02491788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111497857|NCT02491788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111497858|NCT02491944|Osimertinib|osimertinib|mesh-list
111497859|NCT02491944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111497860|NCT02491944|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111497861|NCT02491944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111497862|NCT02491944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111497863|NCT02492802|Posaconazole|posaconazole|mesh-list
111497864|NCT02492802|Antifungal Agents|antifungal agents|mesh-ancestor
111497865|NCT02492802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111497866|NCT02492802|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
111497867|NCT02492802|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111497868|NCT02492802|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111497869|NCT02492802|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111497870|NCT02492802|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111497871|NCT02492802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111497872|NCT02492802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111497873|NCT02492802|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111497874|NCT02492802|Hormone Antagonists|hormone antagonists|mesh-ancestor
111497875|NCT02492802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111497876|NCT02492802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110978107|NCT03280004|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110978108|NCT03280004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110978109|NCT03280004|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
111497878|NCT02495454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111497879|NCT02495454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111497880|NCT02500602|Doxazosin|doxazosin|mesh-list
111497881|NCT02500602|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111497882|NCT02500602|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111497883|NCT02500602|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111497884|NCT02500602|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111497885|NCT02500602|Adrenergic Agents|adrenergic agents|mesh-ancestor
111497886|NCT02500602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111497887|NCT02500602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111497888|NCT02500602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111497889|NCT02500836|Cocaine|cocaine|mesh-list
111497890|NCT02500836|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111497891|NCT02500836|Anesthetics, Local|anesthetics, local|mesh-ancestor
111497892|NCT02500836|Anesthetics|anesthetics|mesh-ancestor
111497893|NCT02500836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111497894|NCT02500836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111497895|NCT02500836|Sensory System Agents|sensory system agents|mesh-ancestor
111497896|NCT02500836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111497897|NCT02500836|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111497898|NCT02500836|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111497899|NCT02500836|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111497900|NCT02500836|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111497901|NCT02500836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111497902|NCT02500836|Dopamine Agents|dopamine agents|mesh-ancestor
111497903|NCT02500836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111497904|NCT02508636|Leuprolide|leuprolide|mesh-list
111497905|NCT02508636|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111497906|NCT02508636|Fertility Agents|fertility agents|mesh-ancestor
111497907|NCT02508636|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111497908|NCT02508636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111497909|NCT02508636|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111497910|NCT02508636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111497911|NCT02513940|Ibutilide|ibutilide|mesh-list
111497912|NCT02513940|Testosterone|testosterone|mesh-list
111497913|NCT02513940|Progesterone|progesterone|mesh-list
111497914|NCT02513940|Androgens|androgens|mesh-ancestor
111497915|NCT02513940|Hormones|hormones|mesh-ancestor
111497916|NCT02513940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111497917|NCT02513940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111497918|NCT02513940|Progestins|progestins|mesh-ancestor
111497919|NCT02513940|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111497920|NCT02515890|Midazolam|midazolam|mesh-list
111497921|NCT02515890|Dexmedetomidine|dexmedetomidine|mesh-list
111497922|NCT02515890|Ketamine|ketamine|mesh-list
111497923|NCT02515890|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111497924|NCT02515890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111497925|NCT02515890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111497926|NCT02515890|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111497927|NCT02515890|Analgesics|analgesics|mesh-ancestor
111497928|NCT02515890|Sensory System Agents|sensory system agents|mesh-ancestor
111497929|NCT02515890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111497930|NCT02515890|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111497931|NCT02515890|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111497932|NCT02515890|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111497933|NCT02515890|Adrenergic Agents|adrenergic agents|mesh-ancestor
111497934|NCT02515890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111497935|NCT02515890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111497936|NCT02515890|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111497937|NCT02515890|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111497938|NCT02515890|Anesthetics, General|anesthetics, general|mesh-ancestor
111497939|NCT02515890|Anesthetics|anesthetics|mesh-ancestor
111497940|NCT02515890|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111497941|NCT02515890|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111497942|NCT02515890|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111497943|NCT02515890|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111497944|NCT02515890|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111497945|NCT02515890|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111497946|NCT02515890|GABA Modulators|gaba modulators|mesh-ancestor
111497947|NCT02515890|GABA Agents|gaba agents|mesh-ancestor
111497948|NCT02517996|Lidocaine|lidocaine|mesh-list
111497949|NCT02517996|Anesthetics, Local|anesthetics, local|mesh-ancestor
111497950|NCT02517996|Anesthetics|anesthetics|mesh-ancestor
110978110|NCT03280004|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110978111|NCT03280004|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111497951|NCT02517996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111497952|NCT02517996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111497953|NCT02517996|Sensory System Agents|sensory system agents|mesh-ancestor
111497954|NCT02517996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111497955|NCT02517996|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111497956|NCT02517996|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111497957|NCT02517996|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111497958|NCT02517996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111497959|NCT02517996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111497960|NCT02525718|Dexamethasone|dexamethasone|mesh-list
111497961|NCT02525718|Epinephrine|epinephrine|mesh-list
111497962|NCT02525718|Bupivacaine|bupivacaine|mesh-list
111497963|NCT02525718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111497964|NCT02525718|Antiemetics|antiemetics|mesh-ancestor
111497965|NCT02525718|Autonomic Agents|autonomic agents|mesh-ancestor
111497966|NCT02525718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111497967|NCT02525718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111497968|NCT02525718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111497969|NCT02525718|Glucocorticoids|glucocorticoids|mesh-ancestor
111497970|NCT02525718|Hormones|hormones|mesh-ancestor
111497971|NCT02525718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111497972|NCT02525718|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111497973|NCT02525718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111497974|NCT02525718|Anesthetics, Local|anesthetics, local|mesh-ancestor
111497975|NCT02525718|Anesthetics|anesthetics|mesh-ancestor
111497976|NCT02525718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111497977|NCT02525718|Sensory System Agents|sensory system agents|mesh-ancestor
111497978|NCT02525718|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111497979|NCT02525718|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111497980|NCT02525718|Adrenergic Agents|adrenergic agents|mesh-ancestor
111497981|NCT02525718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111497982|NCT02525718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111497983|NCT02525718|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111497984|NCT02525718|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111497985|NCT02525718|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111497986|NCT02525718|Respiratory System Agents|respiratory system agents|mesh-ancestor
111497987|NCT02525718|Mydriatics|mydriatics|mesh-ancestor
111497988|NCT02525718|Sympathomimetics|sympathomimetics|mesh-ancestor
111497989|NCT02525718|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111497990|NCT02527512|Povidone-Iodine|povidone-iodine|mesh-list
111497991|NCT02527512|Povidone|povidone|mesh-list
111497992|NCT02527512|Plasma Substitutes|plasma substitutes|mesh-ancestor
111497993|NCT02527512|Blood Substitutes|blood substitutes|mesh-ancestor
111497994|NCT02527512|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111497995|NCT02527512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111497996|NCT02529072|Nivolumab|nivolumab|mesh-list
111497997|NCT02529072|Vaccines|vaccines|mesh-list
111497998|NCT02529072|Immunologic Factors|immunologic factors|mesh-ancestor
111497999|NCT02529072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111498000|NCT02529072|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111498001|NCT02529072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110481385|NCT00771472|Vorinostat|vorinostat|mesh-list
111498002|NCT02529072|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111498003|NCT02529072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111498004|NCT02530476|Sorafenib|sorafenib|mesh-list
111498005|NCT02530476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111498006|NCT02530476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111498007|NCT02530476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111498008|NCT02530476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110978112|NCT03434379|Bevacizumab|bevacizumab|mesh-list
110978113|NCT03434379|Atezolizumab|atezolizumab|mesh-list
110978115|NCT03434379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110706379|NCT01055522|Dacarbazine|dacarbazine|mesh-list
110978117|NCT03434379|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110978118|NCT03434379|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110978119|NCT03434379|Growth Substances|growth substances|mesh-ancestor
110978121|NCT03434379|Growth Inhibitors|growth inhibitors|mesh-ancestor
110706672|NCT03983460|Glucocorticoids|glucocorticoids|mesh-ancestor
110978122|NCT03434379|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110978123|NCT03434379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110706893|NCT00334802|Gemcitabine|gemcitabine|mesh-list
110978124|NCT03434379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110978125|NCT03434379|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110978126|NCT02459288|Clopidogrel|clopidogrel|mesh-list
110978127|NCT02459288|Ticagrelor|ticagrelor|mesh-list
110707113|NCT00332696|Prednisolone|prednisolone|mesh-list
110978128|NCT02459288|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110978129|NCT02459288|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110707262|NCT00156819|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110978130|NCT02459288|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110978131|NCT02459288|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110978132|NCT02459288|Purinergic Agents|purinergic agents|mesh-ancestor
110978133|NCT02459288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111119108|NCT05362318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110978134|NCT02459288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110425562|NCT01227512|Tolvaptan|tolvaptan|mesh-list
110978135|NCT02459288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110978136|NCT00734253|Pyridoxamine|pyridoxamine|mesh-list
110978137|NCT00734253|Vitamin B Complex|vitamin b complex|mesh-ancestor
110978138|NCT00734253|Vitamins|vitamins|mesh-ancestor
110978139|NCT00734253|Micronutrients|micronutrients|mesh-ancestor
110978140|NCT00734253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110978141|NCT00730665|Esomeprazole|esomeprazole|mesh-list
110978142|NCT00730665|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110978143|NCT00730665|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110978144|NCT00730665|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110978145|NCT00730665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110978146|NCT00730665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110978147|NCT00714597|Enoxaparin|enoxaparin|mesh-list
110978148|NCT00714597|Semuloparin|semuloparin|mesh-list
110425704|NCT04301583|Procyanidin|procyanidin|mesh-list
110978149|NCT00714597|Enoxaparin sodium|enoxaparin sodium|mesh-list
110978150|NCT00714597|Anticoagulants|anticoagulants|mesh-ancestor
110978151|NCT00714597|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110978152|NCT00714597|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110978153|NCT00714597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110978155|NCT03265886|Anesthetics, Local|anesthetics, local|mesh-ancestor
110978156|NCT03265886|Anesthetics|anesthetics|mesh-ancestor
110978157|NCT03265886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110978158|NCT03265886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110978159|NCT03265886|Sensory System Agents|sensory system agents|mesh-ancestor
110978160|NCT03265886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110978162|NCT00728091|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
110978163|NCT00728091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110978164|NCT00728091|Natriuretic Agents|natriuretic agents|mesh-ancestor
110978165|NCT00728091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110978167|NCT03275090|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
110978168|NCT03275090|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
110978170|NCT03382821|Dexamethasone|dexamethasone|mesh-list
110978171|NCT03382821|Dexamethasone acetate|dexamethasone acetate|mesh-list
110978172|NCT03382821|Triamcinolone|triamcinolone|mesh-list
110978173|NCT03382821|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110978174|NCT03382821|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110978175|NCT03382821|Lidocaine|lidocaine|mesh-list
110978176|NCT03382821|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
110978177|NCT03382821|BB 1101|bb 1101|mesh-list
110978179|NCT03382821|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110978180|NCT03382821|Antiemetics|antiemetics|mesh-ancestor
110709013|NCT01070628|Entacapone|entacapone|mesh-list
110978182|NCT03382821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110978183|NCT03382821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110978184|NCT03382821|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110978185|NCT03382821|Glucocorticoids|glucocorticoids|mesh-ancestor
110978187|NCT03382821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110978188|NCT03382821|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110709530|NCT00293384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110978189|NCT03382821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110978190|NCT03382821|Protease Inhibitors|protease inhibitors|mesh-ancestor
110978191|NCT03382821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110709753|NCT01021475|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110978192|NCT03382821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110978193|NCT03382821|Anesthetics, Local|anesthetics, local|mesh-ancestor
110978194|NCT03382821|Anesthetics|anesthetics|mesh-ancestor
110978195|NCT03382821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110978196|NCT03382821|Sensory System Agents|sensory system agents|mesh-ancestor
110710052|NCT00264498|Gefitinib|gefitinib|mesh-list
110978197|NCT03382821|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110710194|NCT01085656|Tubulin Modulators|tubulin modulators|mesh-ancestor
110710274|NCT03741244|Apatinib|apatinib|mesh-list
110978198|NCT03382821|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110710348|NCT00067990|Losartan|losartan|mesh-list
110710496|NCT00290732|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110978199|NCT03382821|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110978200|NCT03382821|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110978201|NCT03382821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110978202|NCT03382821|Immunologic Factors|immunologic factors|mesh-ancestor
110978203|NCT03263624|Tazarotene|tazarotene|mesh-list
110978204|NCT03263624|Dermatologic Agents|dermatologic agents|mesh-ancestor
110978205|NCT03263624|Keratolytic Agents|keratolytic agents|mesh-ancestor
110978207|NCT00711555|Ondansetron|ondansetron|mesh-list
110978208|NCT00711555|Aprepitant|aprepitant|mesh-list
110978209|NCT00711555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110978210|NCT00711555|Antiemetics|antiemetics|mesh-ancestor
110978211|NCT00711555|Autonomic Agents|autonomic agents|mesh-ancestor
110978212|NCT00711555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110978213|NCT00711555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110978214|NCT00711555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110978215|NCT00711555|Glucocorticoids|glucocorticoids|mesh-ancestor
110978216|NCT00711555|Hormones|hormones|mesh-ancestor
110978217|NCT00711555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110978218|NCT00711555|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110978219|NCT00711555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110978220|NCT00711555|Antipruritics|antipruritics|mesh-ancestor
110978221|NCT00711555|Dermatologic Agents|dermatologic agents|mesh-ancestor
110978222|NCT00711555|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110978223|NCT00711555|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110978224|NCT00711555|Serotonin Agents|serotonin agents|mesh-ancestor
110978225|NCT00711555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110978226|NCT00711555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110978227|NCT00711555|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110978229|NCT02280993|Dexamethasone|dexamethasone|mesh-list
110978230|NCT02280993|Cisplatin|cisplatin|mesh-list
110978231|NCT02280993|Brentuximab Vedotin|brentuximab vedotin|mesh-list
110978232|NCT02280993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110978233|NCT02280993|Antiemetics|antiemetics|mesh-ancestor
110978234|NCT02280993|Autonomic Agents|autonomic agents|mesh-ancestor
110978235|NCT02280993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110481408|NCT04348045|Durvalumab|durvalumab|mesh-list
110978236|NCT02280993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110978237|NCT02280993|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110978238|NCT02280993|Glucocorticoids|glucocorticoids|mesh-ancestor
110978239|NCT02280993|Hormones|hormones|mesh-ancestor
110978240|NCT02280993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110978241|NCT02280993|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110978242|NCT02280993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110978243|NCT02280993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110978244|NCT02280993|Immunotoxins|immunotoxins|mesh-ancestor
110978245|NCT02280993|Immunoconjugates|immunoconjugates|mesh-ancestor
110978246|NCT02280993|Immunologic Factors|immunologic factors|mesh-ancestor
110978247|NCT05488522|Bevacizumab|bevacizumab|mesh-list
110978248|NCT05488522|Atezolizumab|atezolizumab|mesh-list
110978249|NCT05488522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110978250|NCT05488522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110710979|NCT01091818|Anesthetics|anesthetics|mesh-ancestor
110978252|NCT05488522|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110978253|NCT05488522|Growth Substances|growth substances|mesh-ancestor
110978255|NCT05488522|Growth Inhibitors|growth inhibitors|mesh-ancestor
110711204|NCT01095172|Hormones|hormones|mesh-ancestor
110978256|NCT05488522|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110711269|NCT00458705|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110978257|NCT05488522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110978259|NCT05492968|Epinephrine|epinephrine|mesh-list
110978261|NCT05492968|Norepinephrine|norepinephrine|mesh-list
110978263|NCT05492968|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110978264|NCT05492968|Adrenergic Agents|adrenergic agents|mesh-ancestor
110978265|NCT05492968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110978266|NCT05492968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110978267|NCT05492968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110978268|NCT05492968|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110978269|NCT05492968|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110711850|NCT00279812|Antioxidants|antioxidants|mesh-ancestor
110978270|NCT05492968|Autonomic Agents|autonomic agents|mesh-ancestor
110978271|NCT05492968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110978272|NCT05492968|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110978273|NCT05492968|Respiratory System Agents|respiratory system agents|mesh-ancestor
110978274|NCT05492968|Mydriatics|mydriatics|mesh-ancestor
110978275|NCT05492968|Sympathomimetics|sympathomimetics|mesh-ancestor
110978276|NCT05492968|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110978277|NCT05492968|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110978278|NCT05492968|Nasal Decongestants|nasal decongestants|mesh-ancestor
110978279|NCT05492968|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110978280|NCT05492968|Protective Agents|protective agents|mesh-ancestor
110978281|NCT02457026|Triamcinolone|triamcinolone|mesh-list
110978282|NCT02457026|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110978283|NCT02457026|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110978284|NCT02457026|Aflibercept|aflibercept|mesh-list
110978286|NCT02457026|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110712587|NCT00264290|Valganciclovir|valganciclovir|mesh-list
110978287|NCT02457026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110712662|NCT03953326|Nitroprusside|nitroprusside|mesh-list
110978288|NCT02457026|Glucocorticoids|glucocorticoids|mesh-ancestor
110978289|NCT02457026|Hormones|hormones|mesh-ancestor
110978290|NCT02457026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110712807|NCT00443729|Protease Inhibitors|protease inhibitors|mesh-ancestor
110712882|NCT01031459|Antiviral Agents|antiviral agents|mesh-ancestor
110978291|NCT02457026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110978292|NCT02457026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110978293|NCT02457026|Immunologic Factors|immunologic factors|mesh-ancestor
110978294|NCT02457026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110978295|NCT02457026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110978296|NCT02457026|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110978297|NCT02457026|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110978299|NCT02457026|Growth Inhibitors|growth inhibitors|mesh-ancestor
110713346|NCT01101412|Antidotes|antidotes|mesh-ancestor
110978300|NCT02457026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110713413|NCT01033877|Vaccines|vaccines|mesh-list
110978301|NCT02457026|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110978302|NCT02457026|Dermatologic Agents|dermatologic agents|mesh-ancestor
110978303|NCT03919526|Cyclophosphamide|cyclophosphamide|mesh-list
110978305|NCT03919526|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110978306|NCT03919526|Immunologic Factors|immunologic factors|mesh-ancestor
110713626|NCT01087840|Antiviral Agents|antiviral agents|mesh-ancestor
110978307|NCT03919526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110978308|NCT03919526|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110978309|NCT03919526|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110978310|NCT03919526|Alkylating Agents|alkylating agents|mesh-ancestor
110713922|NCT00189488|Antimetabolites|antimetabolites|mesh-ancestor
110978311|NCT03919526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110714000|NCT00076336|Lamivudine|lamivudine|mesh-list
110978312|NCT03919526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110978313|NCT03919526|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110978314|NCT05492812|Melatonin|melatonin|mesh-list
110978315|NCT05492812|Chloral Hydrate|chloral hydrate|mesh-list
110978316|NCT05492812|Hydroxyzine|hydroxyzine|mesh-list
110978318|NCT05492812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110714208|NCT00076024|Docetaxel|docetaxel|mesh-list
110978319|NCT05492812|Protective Agents|protective agents|mesh-ancestor
110978320|NCT05492812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110978321|NCT05492812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110978322|NCT05492812|Antipruritics|antipruritics|mesh-ancestor
110978323|NCT05492812|Dermatologic Agents|dermatologic agents|mesh-ancestor
110978324|NCT05492812|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110714578|NCT01106872|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110978325|NCT05492812|Histamine Antagonists|histamine antagonists|mesh-ancestor
110714726|NCT01107808|Metformin|metformin|mesh-list
110978326|NCT05492812|Histamine Agents|histamine agents|mesh-ancestor
110978327|NCT05492812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110978328|NCT05492812|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110978329|NCT02458118|Secretin|secretin|mesh-list
110978330|NCT02458118|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110978331|NCT02458118|Hormones|hormones|mesh-ancestor
110978332|NCT02458118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110978333|NCT02458118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110978334|NCT05487742|Dexmedetomidine|dexmedetomidine|mesh-list
110978335|NCT05487742|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110978336|NCT05487742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110978337|NCT05487742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110978338|NCT05487742|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110978340|NCT05487742|Sensory System Agents|sensory system agents|mesh-ancestor
110978341|NCT05487742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110978342|NCT05487742|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110715097|NCT01112878|Clonidine|clonidine|mesh-list
110978343|NCT05487742|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110978344|NCT05487742|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110978345|NCT05487742|Adrenergic Agents|adrenergic agents|mesh-ancestor
110978346|NCT05487742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110978347|NCT05487742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110978348|NCT02457650|Cyclophosphamide|cyclophosphamide|mesh-list
110978349|NCT02457650|Fludarabine|fludarabine|mesh-list
110978350|NCT02457650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110978351|NCT02457650|Immunologic Factors|immunologic factors|mesh-ancestor
110978352|NCT02457650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110978353|NCT02457650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110978354|NCT02457650|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110978355|NCT02457650|Alkylating Agents|alkylating agents|mesh-ancestor
110978356|NCT02457650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110978357|NCT02457650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110978358|NCT02457650|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110715675|NCT03933280|Analgesics|analgesics|mesh-ancestor
110978360|NCT02456948|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110978361|NCT02456948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110978362|NCT05487508|Dexamethasone|dexamethasone|mesh-list
110978363|NCT05487508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110978364|NCT05487508|Antiemetics|antiemetics|mesh-ancestor
110978365|NCT05487508|Autonomic Agents|autonomic agents|mesh-ancestor
110978366|NCT05487508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110978367|NCT05487508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110978368|NCT05487508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110978369|NCT05487508|Glucocorticoids|glucocorticoids|mesh-ancestor
110978370|NCT05487508|Hormones|hormones|mesh-ancestor
110715809|NCT01123486|Narcotics|narcotics|mesh-ancestor
110978371|NCT05487508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110978372|NCT05487508|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110978373|NCT05487508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110978374|NCT02713490|Bupivacaine|bupivacaine|mesh-list
110978375|NCT02713490|Anesthetics, Local|anesthetics, local|mesh-ancestor
110978377|NCT02713490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110978378|NCT02713490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110978379|NCT02713490|Sensory System Agents|sensory system agents|mesh-ancestor
110978380|NCT02713490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110978381|NCT05491720|Risperidone|risperidone|mesh-list
110978382|NCT05491720|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110978383|NCT05491720|Serotonin Agents|serotonin agents|mesh-ancestor
110978384|NCT05491720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110716397|NCT03927352|Adalimumab|adalimumab|mesh-list
110978385|NCT05491720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110978386|NCT05491720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110978387|NCT05491720|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110978388|NCT05491720|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110716619|NCT03923842|Denosumab|denosumab|mesh-list
110978389|NCT05491720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110978390|NCT05491720|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110978391|NCT05491720|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110978392|NCT05491720|Dopamine Agents|dopamine agents|mesh-ancestor
110978393|NCT05387954|Anticoagulants|anticoagulants|mesh-list
110716837|NCT03769090|Autonomic Agents|autonomic agents|mesh-ancestor
110978394|NCT05387954|Factor Xa Inhibitors|factor xa inhibitors|mesh-list
110716909|NCT05480488|Midazolam|midazolam|mesh-list
110978395|NCT05387954|Antithrombins|antithrombins|mesh-ancestor
110978396|NCT05387954|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110978397|NCT05387954|Protease Inhibitors|protease inhibitors|mesh-ancestor
110978398|NCT05387954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110978399|NCT05387954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110978400|NCT03262688|Bupivacaine|bupivacaine|mesh-list
110978401|NCT03262688|Anesthetics, Local|anesthetics, local|mesh-ancestor
110978402|NCT03262688|Anesthetics|anesthetics|mesh-ancestor
110978403|NCT03262688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110978404|NCT03262688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110978405|NCT03262688|Sensory System Agents|sensory system agents|mesh-ancestor
110978406|NCT03262688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110978407|NCT05486884|Benzocaine|benzocaine|mesh-list
110978408|NCT05486884|Anesthetics, Local|anesthetics, local|mesh-ancestor
110978409|NCT05486884|Anesthetics|anesthetics|mesh-ancestor
110978410|NCT05486884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110717494|NCT00121641|Metformin|metformin|mesh-list
110717571|NCT01588925|Immunologic Factors|immunologic factors|mesh-ancestor
110717723|NCT00845026|Olanzapine|olanzapine|mesh-list
110717795|NCT01239004|Antimetabolites|antimetabolites|mesh-ancestor
110978411|NCT05486884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110978412|NCT05486884|Sensory System Agents|sensory system agents|mesh-ancestor
110978413|NCT05486884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110978414|NCT05485792|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110978415|NCT05485792|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110718020|NCT01239940|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110978416|NCT05485792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110978417|NCT05485402|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
110978418|NCT05485402|Phenylethyl Alcohol|phenylethyl alcohol|mesh-list
110978419|NCT05485402|4-hydroxyphenylethanol|4-hydroxyphenylethanol|mesh-list
110978420|NCT05485402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110978421|NCT05485402|Antioxidants|antioxidants|mesh-ancestor
110718235|NCT00420641|Serotonin Agents|serotonin agents|mesh-ancestor
110978422|NCT05485402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110978423|NCT05485402|Protective Agents|protective agents|mesh-ancestor
110978424|NCT05485402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110978425|NCT05485402|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110978426|NCT05485402|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110978427|NCT05485402|Disinfectants|disinfectants|mesh-ancestor
110978428|NCT05485402|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110978430|NCT03797924|Anesthetics, Local|anesthetics, local|mesh-ancestor
110978431|NCT03797924|Anesthetics|anesthetics|mesh-ancestor
110978432|NCT03797924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110978433|NCT03797924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110978434|NCT03797924|Sensory System Agents|sensory system agents|mesh-ancestor
110978435|NCT03797924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110978436|NCT05486650|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
110978437|NCT05486650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110978438|NCT05486650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110978439|NCT05486650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110978440|NCT05074628|Nitrofurantoin|nitrofurantoin|mesh-list
110978441|NCT05074628|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110978442|NCT05074628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110718740|NCT01257412|Dapagliflozin|dapagliflozin|mesh-list
110978443|NCT05074628|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110978444|NCT04273516|Rivaroxaban|rivaroxaban|mesh-list
110978445|NCT04273516|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110718898|NCT01258036|Hormones|hormones|mesh-list
110718954|NCT01258192|Paclitaxel|paclitaxel|mesh-list
110719029|NCT03892330|Cyclophosphamide|cyclophosphamide|mesh-list
110695520|NCT01027832|Piperacillin|piperacillin|mesh-list
110978446|NCT04273516|Antithrombins|antithrombins|mesh-ancestor
110978447|NCT04273516|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110978448|NCT04273516|Protease Inhibitors|protease inhibitors|mesh-ancestor
110978449|NCT04273516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110978450|NCT04273516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110978451|NCT04273516|Anticoagulants|anticoagulants|mesh-ancestor
110978452|NCT02458742|Morphine|morphine|mesh-list
110978453|NCT02458742|Bupivacaine|bupivacaine|mesh-list
110978454|NCT02458742|Anesthetics, Local|anesthetics, local|mesh-ancestor
110719400|NCT03647566|Listerine|listerine|mesh-list
110719467|NCT01157026|Tamoxifen|tamoxifen|mesh-list
110978456|NCT02458742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110978457|NCT02458742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110978458|NCT02458742|Sensory System Agents|sensory system agents|mesh-ancestor
110978459|NCT02458742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110978460|NCT02458742|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110978461|NCT02458742|Narcotics|narcotics|mesh-ancestor
110978462|NCT02458742|Analgesics|analgesics|mesh-ancestor
110978463|NCT02403310|Cytarabine|cytarabine|mesh-list
110978464|NCT02403310|Daunorubicin|daunorubicin|mesh-list
110978465|NCT02403310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110978466|NCT02403310|Antimetabolites|antimetabolites|mesh-ancestor
110978467|NCT02403310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110720052|NCT01281514|Carboplatin|carboplatin|mesh-list
110978468|NCT02403310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110978470|NCT02403310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110720275|NCT03870490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110978472|NCT02403310|Immunologic Factors|immunologic factors|mesh-ancestor
110978473|NCT02403310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110978474|NCT02403310|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110978475|NCT02403310|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110978476|NCT02403310|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110978477|NCT02403310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110978478|NCT01665274|Capecitabine|capecitabine|mesh-list
110720567|NCT00252564|Growth Inhibitors|growth inhibitors|mesh-ancestor
110978480|NCT01665274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110978481|NCT01665274|Antimetabolites|antimetabolites|mesh-ancestor
110720717|NCT00158262|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110978482|NCT01665274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110978483|NCT01665274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110978484|NCT05387876|Vitamin D|vitamin d|mesh-list
110978485|NCT05387876|Vitamins|vitamins|mesh-ancestor
110978486|NCT05387876|Micronutrients|micronutrients|mesh-ancestor
110720939|NCT01177852|Anesthetics|anesthetics|mesh-ancestor
110978487|NCT05387876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110978488|NCT05387876|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110978490|NCT04560166|Temozolomide|temozolomide|mesh-list
110978491|NCT04560166|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110978493|NCT04560166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110721314|NCT00149994|Protective Agents|protective agents|mesh-ancestor
110978494|NCT04560166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110978495|NCT04560166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110721389|NCT00149214|Cyclophosphamide|cyclophosphamide|mesh-list
110978496|NCT04560166|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110978497|NCT04560166|Alkylating Agents|alkylating agents|mesh-ancestor
110978498|NCT03262376|Vitamins|vitamins|mesh-list
110978499|NCT03262376|Micronutrients|micronutrients|mesh-ancestor
110978500|NCT03262376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110978501|NCT02456714|Folfirinox|folfirinox|mesh-list
110721636|NCT01290172|Hormones|hormones|mesh-ancestor
110978502|NCT02456714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110978503|NCT03258866|Rituximab|rituximab|mesh-list
110978504|NCT03258866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110978505|NCT03258866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110978506|NCT03258866|Immunologic Factors|immunologic factors|mesh-ancestor
110978507|NCT03258866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110978508|NCT03258866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110978509|NCT03258476|Guanfacine|guanfacine|mesh-list
110721761|NCT00146640|Prednisone|prednisone|mesh-list
110721821|NCT01291186|Epinephrine|epinephrine|mesh-list
110978511|NCT03258476|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110978512|NCT03258476|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110978513|NCT03258476|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110978514|NCT03258476|Adrenergic Agents|adrenergic agents|mesh-ancestor
110722191|NCT03847792|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110978515|NCT03258476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110722264|NCT01296958|Antinematodal Agents|antinematodal agents|mesh-ancestor
110978516|NCT03258476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110978517|NCT03258476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110978518|NCT03258398|Avelumab|avelumab|mesh-list
110978519|NCT03258398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110978520|NCT03258398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110978521|NCT03261596|Mebendazole|mebendazole|mesh-list
110978522|NCT03261596|Piperazine|piperazine|mesh-list
110978523|NCT03261596|Piperazine citrate|piperazine citrate|mesh-list
110978524|NCT03261596|DMP 777|dmp 777|mesh-list
110978525|NCT03261596|Antinematodal Agents|antinematodal agents|mesh-ancestor
110978526|NCT03261596|Anthelmintics|anthelmintics|mesh-ancestor
110978527|NCT03261596|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110978528|NCT03261596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110978529|NCT03261596|Tubulin Modulators|tubulin modulators|mesh-ancestor
110481471|NCT02705287|Vitamin D|vitamin d|mesh-list
110978530|NCT03261596|Antimitotic Agents|antimitotic agents|mesh-ancestor
110978531|NCT03261596|Mitosis Modulators|mitosis modulators|mesh-ancestor
110978532|NCT03261596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110722773|NCT03841474|Escitalopram|escitalopram|mesh-list
110978533|NCT03261596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110978534|NCT03261596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110978535|NCT03825874|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110978536|NCT03825874|Amikacin|amikacin|mesh-list
110978537|NCT03825874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110978538|NCT03772574|Nicotine|nicotine|mesh-list
110978539|NCT03772574|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110978540|NCT03772574|Autonomic Agents|autonomic agents|mesh-ancestor
110978541|NCT03772574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110722848|NCT03842488|Darunavir|darunavir|mesh-list
110978542|NCT03772574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110978543|NCT03772574|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110978544|NCT03772574|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110978545|NCT03772574|Cholinergic Agents|cholinergic agents|mesh-ancestor
110978546|NCT03772574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110978547|NCT03772574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110978548|NCT02456558|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110978549|NCT02456558|Deferiprone|deferiprone|mesh-list
110978550|NCT02456558|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110978551|NCT02456558|Chelating Agents|chelating agents|mesh-ancestor
110978552|NCT02456558|Sequestering Agents|sequestering agents|mesh-ancestor
110978553|NCT02456558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110978555|NCT03798080|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110978556|NCT03798080|Metformin|metformin|mesh-list
110978557|NCT03798080|Insulin Glargine|insulin glargine|mesh-list
110978558|NCT03798080|Lixisenatide|lixisenatide|mesh-list
110978559|NCT03798080|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110978560|NCT03798080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110978561|NCT03257930|Ethanol|ethanol|mesh-list
110978562|NCT03257930|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110978563|NCT03257930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110978564|NCT03257930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110978565|NCT03257930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110978566|NCT03257852|Methotrexate|methotrexate|mesh-list
110978567|NCT03257852|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110978568|NCT03257852|Abortifacient Agents|abortifacient agents|mesh-ancestor
110978569|NCT03257852|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110978570|NCT03257852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110978571|NCT03257852|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110978572|NCT03257852|Antimetabolites|antimetabolites|mesh-ancestor
110978573|NCT03257852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110978574|NCT03257852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110978575|NCT03257852|Dermatologic Agents|dermatologic agents|mesh-ancestor
110978576|NCT03257852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110723182|NCT05667220|Incretins|incretins|mesh-ancestor
110978577|NCT03257852|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110978578|NCT03257852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110978579|NCT03257852|Immunologic Factors|immunologic factors|mesh-ancestor
110978580|NCT03257852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110978581|NCT03257852|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110978582|NCT05498896|Paclitaxel|paclitaxel|mesh-list
110978583|NCT05498896|Cyclophosphamide|cyclophosphamide|mesh-list
110978584|NCT05498896|Doxorubicin|doxorubicin|mesh-list
110978585|NCT05498896|Atezolizumab|atezolizumab|mesh-list
110978586|NCT05498896|Ipatasertib|ipatasertib|mesh-list
110978587|NCT05498896|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110978588|NCT05498896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110978589|NCT05498896|Tubulin Modulators|tubulin modulators|mesh-ancestor
110978590|NCT05498896|Antimitotic Agents|antimitotic agents|mesh-ancestor
110978591|NCT05498896|Mitosis Modulators|mitosis modulators|mesh-ancestor
110978592|NCT05498896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110978593|NCT05498896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110978594|NCT05498896|Immunologic Factors|immunologic factors|mesh-ancestor
110978595|NCT05498896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110978597|NCT05498896|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110723613|NCT03816592|Anesthetics|anesthetics|mesh-list
110978598|NCT05498896|Alkylating Agents|alkylating agents|mesh-ancestor
110978599|NCT05498896|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110978600|NCT05498896|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110723905|NCT01303042|Insulin Lispro|insulin lispro|mesh-list
110978601|NCT05498896|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110695666|NCT00431496|Hormone Antagonists|hormone antagonists|mesh-ancestor
110978602|NCT05498896|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110978603|NCT05498896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110978604|NCT05498896|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110978605|NCT05498896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110978606|NCT05498896|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110978607|NCT02743221|Trifluridine|trifluridine|mesh-list
110978608|NCT02743221|Bevacizumab|bevacizumab|mesh-list
110978609|NCT02743221|Capecitabine|capecitabine|mesh-list
110724343|NCT01081002|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110978610|NCT02743221|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110724486|NCT05316220|Analgesics|analgesics|mesh-ancestor
110978611|NCT02743221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110978612|NCT02743221|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110978613|NCT02743221|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110978614|NCT02743221|Growth Substances|growth substances|mesh-ancestor
110724857|NCT03716050|Vasodilator Agents|vasodilator agents|mesh-ancestor
110978615|NCT02743221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110978616|NCT02743221|Growth Inhibitors|growth inhibitors|mesh-ancestor
110978617|NCT02743221|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110978619|NCT02743221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110978620|NCT02743221|Antiviral Agents|antiviral agents|mesh-ancestor
110978621|NCT02743221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110725232|NCT03776032|Hematinics|hematinics|mesh-ancestor
110978624|NCT03955887|Sequestering Agents|sequestering agents|mesh-ancestor
110978625|NCT03955887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110978626|NCT03260972|Chloroprocaine|chloroprocaine|mesh-list
110725382|NCT01309984|Propofol|propofol|mesh-list
110978627|NCT03260972|Anesthetics, Local|anesthetics, local|mesh-ancestor
110978628|NCT03260972|Anesthetics|anesthetics|mesh-ancestor
110725528|NCT03769714|Sensory System Agents|sensory system agents|mesh-ancestor
110978629|NCT03260972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110978630|NCT03260972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110725753|NCT03762928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110978631|NCT03260972|Sensory System Agents|sensory system agents|mesh-ancestor
110978632|NCT03260972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110978634|NCT03370263|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110978635|NCT03370263|Immunologic Factors|immunologic factors|mesh-ancestor
110978636|NCT03370263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110978637|NCT00692445|Mecamylamine|mecamylamine|mesh-list
110978638|NCT00692445|Dexetimide|dexetimide|mesh-list
110978639|NCT00692445|Citalopram|citalopram|mesh-list
110978640|NCT00692445|Escitalopram|escitalopram|mesh-list
110726115|NCT03759262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110978641|NCT00692445|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110978642|NCT00692445|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110978643|NCT00692445|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110978644|NCT00692445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110978645|NCT00692445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110978646|NCT00692445|Serotonin Agents|serotonin agents|mesh-ancestor
110978647|NCT00692445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110726414|NCT01072058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110978648|NCT00692445|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110978649|NCT00692445|Antidepressive Agents|antidepressive agents|mesh-ancestor
110978650|NCT00692445|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110481496|NCT03011671|Temozolomide|temozolomide|mesh-list
110978651|NCT00692445|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110978652|NCT00692445|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110978653|NCT00692445|Parasympatholytics|parasympatholytics|mesh-ancestor
110978654|NCT00692445|Autonomic Agents|autonomic agents|mesh-ancestor
110978655|NCT00692445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110978656|NCT00692445|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110726927|NCT00117156|Rituximab|rituximab|mesh-list
110978657|NCT00692445|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110978658|NCT00692445|Cholinergic Agents|cholinergic agents|mesh-ancestor
110978659|NCT00692445|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110978660|NCT00692445|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
110727075|NCT03697252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110978661|NCT00692445|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
110978662|NCT03929757|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
110978663|NCT03929757|Antiviral Agents|antiviral agents|mesh-ancestor
110978664|NCT03929757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110978665|NCT03256292|Testosterone|testosterone|mesh-list
110978666|NCT03256292|Androgens|androgens|mesh-ancestor
110978667|NCT03256292|Hormones|hormones|mesh-ancestor
110727295|NCT03749356|Tacrolimus|tacrolimus|mesh-list
110978668|NCT03256292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110978669|NCT03256292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110978671|NCT04473261|Cadexomer iodine|cadexomer iodine|mesh-list
110978672|NCT04473261|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110978673|NCT04473261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110978674|NCT04473261|Trace Elements|trace elements|mesh-ancestor
110978675|NCT04473261|Micronutrients|micronutrients|mesh-ancestor
110727373|NCT03963024|Treosulfan|treosulfan|mesh-list
110978676|NCT04473261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110978677|NCT01358968|Gemcitabine|gemcitabine|mesh-list
110978679|NCT01358968|Desipramine|desipramine|mesh-list
110727438|NCT04332874|Immunologic Factors|immunologic factors|mesh-ancestor
110978680|NCT01358968|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110978681|NCT01358968|Antimetabolites|antimetabolites|mesh-ancestor
110978682|NCT01358968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110978683|NCT01358968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110978684|NCT01358968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110978685|NCT01358968|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110978686|NCT01358968|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110978687|NCT01358968|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110978688|NCT01358968|Antidepressive Agents|antidepressive agents|mesh-ancestor
110978689|NCT01358968|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110978690|NCT01358968|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110978691|NCT01358968|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110978692|NCT01358968|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110978693|NCT01358968|Adrenergic Agents|adrenergic agents|mesh-ancestor
110978694|NCT01358968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110727583|NCT04124926|Lansoprazole|lansoprazole|mesh-list
110978695|NCT01358968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110727738|NCT01326650|Vitamin D|vitamin d|mesh-list
110978696|NCT02281305|Colchicine|colchicine|mesh-list
110978697|NCT02281305|Gout Suppressants|gout suppressants|mesh-ancestor
110978698|NCT02281305|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110978699|NCT02281305|Tubulin Modulators|tubulin modulators|mesh-ancestor
110978700|NCT02281305|Antimitotic Agents|antimitotic agents|mesh-ancestor
110978701|NCT02281305|Mitosis Modulators|mitosis modulators|mesh-ancestor
110978702|NCT02281305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110978703|NCT02281305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110978704|NCT00624351|Epratuzumab|epratuzumab|mesh-list
110978705|NCT00624351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110978706|NCT00624351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110978707|NCT03251690|Tenofovir|tenofovir|mesh-list
110978709|NCT03251690|Efavirenz|efavirenz|mesh-list
110978710|NCT03251690|Rilpivirine|rilpivirine|mesh-list
110978711|NCT03251690|Antiviral Agents|antiviral agents|mesh-ancestor
110728236|NCT00112502|Analgesics|analgesics|mesh-ancestor
110978712|NCT03251690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110978713|NCT03251690|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110978714|NCT03251690|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110978715|NCT03251690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110978716|NCT03251690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110978717|NCT03251690|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110978718|NCT03251690|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110978719|NCT03251690|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110978720|NCT03251690|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110978721|NCT03251690|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110978722|NCT03251690|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110978723|NCT03251690|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110978724|NCT03251690|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110978725|NCT03251768|Lenograstim|lenograstim|mesh-list
110978726|NCT03251768|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110978727|NCT03251768|Immunologic Factors|immunologic factors|mesh-ancestor
110978728|NCT03251768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110978729|NCT00687687|Paclitaxel|paclitaxel|mesh-list
110978730|NCT00687687|Carboplatin|carboplatin|mesh-list
110978731|NCT00687687|Iniparib|iniparib|mesh-list
110728309|NCT01080560|Immunologic Factors|immunologic factors|mesh-ancestor
110978732|NCT00687687|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110978733|NCT00687687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110978734|NCT00687687|Tubulin Modulators|tubulin modulators|mesh-ancestor
110978735|NCT00687687|Antimitotic Agents|antimitotic agents|mesh-ancestor
110978736|NCT00687687|Mitosis Modulators|mitosis modulators|mesh-ancestor
110728436|NCT01087554|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110978737|NCT00687687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110978738|NCT00687687|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110978739|NCT00687687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110978740|NCT00701090|Metformin|metformin|mesh-list
110978741|NCT00701090|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110978742|NCT00701090|Glimepiride|glimepiride|mesh-list
110978743|NCT00701090|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110978744|NCT00701090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110978745|NCT00701090|Incretins|incretins|mesh-ancestor
110978746|NCT00701090|Hormones|hormones|mesh-ancestor
110978747|NCT00701090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110978748|NCT00701090|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110978749|NCT00701090|Protease Inhibitors|protease inhibitors|mesh-ancestor
110978750|NCT00701090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110978751|NCT00701090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110978752|NCT00701090|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110978753|NCT00701090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110978754|NCT00701090|Immunologic Factors|immunologic factors|mesh-ancestor
110978755|NCT00614601|Vaccines|vaccines|mesh-list
110978756|NCT00614601|Immunologic Factors|immunologic factors|mesh-ancestor
110978757|NCT00614601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110978758|NCT02283489|Paclitaxel|paclitaxel|mesh-list
110978759|NCT02283489|Endostatins|endostatins|mesh-list
110978760|NCT02283489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110978761|NCT02283489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110978762|NCT02283489|Tubulin Modulators|tubulin modulators|mesh-ancestor
110978763|NCT02283489|Antimitotic Agents|antimitotic agents|mesh-ancestor
110978764|NCT02283489|Mitosis Modulators|mitosis modulators|mesh-ancestor
110978765|NCT02283489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110978766|NCT02283489|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110978767|NCT02283489|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110978768|NCT02283489|Growth Substances|growth substances|mesh-ancestor
110978769|NCT02283489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110978770|NCT02283489|Growth Inhibitors|growth inhibitors|mesh-ancestor
110978771|NCT02455232|Lidocaine|lidocaine|mesh-list
110728582|NCT00393029|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110978772|NCT02455232|Anesthetics, Local|anesthetics, local|mesh-ancestor
110978773|NCT02455232|Anesthetics|anesthetics|mesh-ancestor
110978774|NCT02455232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110978775|NCT02455232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110978776|NCT02455232|Sensory System Agents|sensory system agents|mesh-ancestor
110978777|NCT02455232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110978778|NCT02455232|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110978779|NCT02455232|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110978780|NCT02455232|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110978781|NCT02455232|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110481505|NCT03011671|Diuretics|diuretics|mesh-ancestor
110978782|NCT02455232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110978783|NCT03259958|Donepezil|donepezil|mesh-list
110978784|NCT03259958|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110978785|NCT03259958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110728840|NCT01085708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110978786|NCT03259958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110978787|NCT03259958|Cholinergic Agents|cholinergic agents|mesh-ancestor
110978788|NCT03259958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110978789|NCT03259958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110978790|NCT03259958|Nootropic Agents|nootropic agents|mesh-ancestor
110978791|NCT02923947|Osimertinib|osimertinib|mesh-list
110978792|NCT02923947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110978793|NCT02923947|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110978794|NCT02923947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110978795|NCT02923947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110978796|NCT00679731|Methotrexate|methotrexate|mesh-list
110978797|NCT00679731|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110978798|NCT00679731|Abortifacient Agents|abortifacient agents|mesh-ancestor
110978799|NCT00679731|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110978800|NCT00679731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110978801|NCT00679731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110978802|NCT00679731|Antimetabolites|antimetabolites|mesh-ancestor
110978803|NCT00679731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110978804|NCT00679731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110978805|NCT00679731|Dermatologic Agents|dermatologic agents|mesh-ancestor
110978806|NCT00679731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110978807|NCT00679731|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110728981|NCT00388583|Vaccines|vaccines|mesh-list
110729036|NCT00388037|Sunitinib|sunitinib|mesh-list
110978808|NCT00679731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110978809|NCT00679731|Immunologic Factors|immunologic factors|mesh-ancestor
110978810|NCT00679731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110978811|NCT00679731|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110978813|NCT02455856|Antifungal Agents|antifungal agents|mesh-ancestor
110978814|NCT02455856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110978815|NCT02455856|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110978816|NCT02455856|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110978817|NCT02455856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110978818|NCT02455856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110978819|NCT02455856|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110978820|NCT02455856|Hormone Antagonists|hormone antagonists|mesh-ancestor
110978821|NCT02455856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110978822|NCT02455856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110978823|NCT02455856|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110978824|NCT02283645|Minoxidil|minoxidil|mesh-list
110978825|NCT02283645|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110978826|NCT02283645|Vasodilator Agents|vasodilator agents|mesh-ancestor
110978827|NCT00602745|Fluorouracil|fluorouracil|mesh-list
110978828|NCT00602745|Antimetabolites|antimetabolites|mesh-ancestor
110978829|NCT00602745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110978830|NCT00602745|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110978831|NCT00602745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110978832|NCT00602745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110978833|NCT00602745|Immunologic Factors|immunologic factors|mesh-ancestor
110978834|NCT00602745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110978835|NCT03251222|Dexmedetomidine|dexmedetomidine|mesh-list
110978836|NCT03251222|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110729531|NCT00098774|Alkylating Agents|alkylating agents|mesh-ancestor
110978837|NCT03251222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110978838|NCT03251222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110978839|NCT03251222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110978841|NCT03251222|Sensory System Agents|sensory system agents|mesh-ancestor
110481513|NCT00628706|Analgesics|analgesics|mesh-ancestor
110978842|NCT03251222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110978843|NCT03251222|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110978844|NCT03251222|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110978845|NCT03251222|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110978846|NCT03251222|Adrenergic Agents|adrenergic agents|mesh-ancestor
110978847|NCT03251222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110978848|NCT03251222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110978849|NCT04487834|Simethicone|simethicone|mesh-list
110978850|NCT04487834|Antifoaming Agents|antifoaming agents|mesh-ancestor
110978851|NCT04487834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110978852|NCT04487834|Emollients|emollients|mesh-ancestor
110978853|NCT04487834|Dermatologic Agents|dermatologic agents|mesh-ancestor
110978854|NCT03250910|Ribavirin|ribavirin|mesh-list
110978855|NCT03250910|Sofosbuvir|sofosbuvir|mesh-list
110729747|NCT01324583|Hormones|hormones|mesh-ancestor
110978857|NCT03250910|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
110978858|NCT03250910|Antimetabolites|antimetabolites|mesh-ancestor
110729963|NCT03963752|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110978859|NCT03250910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110978860|NCT03250910|Antiviral Agents|antiviral agents|mesh-ancestor
110978861|NCT03250910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110978862|NCT02283801|Lamotrigine|lamotrigine|mesh-list
110978863|NCT02283801|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
110978864|NCT02283801|Anticonvulsants|anticonvulsants|mesh-ancestor
110978865|NCT02283801|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110978866|NCT02283801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110978867|NCT02283801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110978868|NCT02283801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110978869|NCT02283801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110730037|NCT00118287|Antimetabolites|antimetabolites|mesh-ancestor
110978871|NCT02283801|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110730104|NCT03605212|Febuxostat|febuxostat|mesh-list
110978872|NCT02283801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110978873|NCT02283801|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110978874|NCT02283801|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110978875|NCT02283801|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110978876|NCT02455154|Letrozole|letrozole|mesh-list
110978877|NCT02455154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110978878|NCT02455154|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110978879|NCT02455154|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110978880|NCT02455154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110978881|NCT02455154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110730314|NCT01087359|Melatonin|melatonin|mesh-list
110978882|NCT02455154|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110978883|NCT02455154|Hormone Antagonists|hormone antagonists|mesh-ancestor
110730464|NCT00079274|Leucovorin|leucovorin|mesh-list
110978884|NCT02455154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110978885|NCT02455154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110978886|NCT03254810|Adalimumab|adalimumab|mesh-list
110978887|NCT03254810|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110978888|NCT03254810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110978889|NCT03254810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110978890|NCT03255044|Atorvastatin|atorvastatin|mesh-list
110978891|NCT03255044|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110978892|NCT03255044|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110978893|NCT03255044|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110978894|NCT03255044|Antimetabolites|antimetabolites|mesh-ancestor
110978895|NCT03255044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110978896|NCT03255044|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110978897|NCT03255044|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110978898|NCT03255044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110978899|NCT00677079|Iniparib|iniparib|mesh-list
110978900|NCT00677079|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110978901|NCT00677079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110978902|NCT00677079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110978903|NCT00677079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110978904|NCT03245996|Atenolol|atenolol|mesh-list
110978905|NCT03245996|Nebivolol|nebivolol|mesh-list
110730812|NCT00095121|Antiviral Agents|antiviral agents|mesh-ancestor
110978907|NCT03245996|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110978909|NCT03245996|Autonomic Agents|autonomic agents|mesh-ancestor
110978910|NCT03245996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110978911|NCT03245996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110978912|NCT03245996|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110978913|NCT03245996|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110978914|NCT03245996|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110978915|NCT03245996|Adrenergic Agents|adrenergic agents|mesh-ancestor
110978916|NCT03245996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110978917|NCT03245996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110978918|NCT03245996|Vasodilator Agents|vasodilator agents|mesh-ancestor
110731035|NCT01091324|Dextromethorphan|dextromethorphan|mesh-list
110731093|NCT05781854|Sensory System Agents|sensory system agents|mesh-ancestor
110978919|NCT03245996|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
110978920|NCT03245996|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110978921|NCT03245996|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110978922|NCT02281929|Amoxicillin|amoxicillin|mesh-list
110978923|NCT02281929|Clavulanic Acids|clavulanic acids|mesh-list
110978924|NCT02281929|Clavulanic Acid|clavulanic acid|mesh-list
110978925|NCT02281929|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
110978926|NCT02281929|Prednisolone|prednisolone|mesh-list
110978927|NCT02281929|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110978928|NCT02281929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110978929|NCT02281929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110978930|NCT02281929|Glucocorticoids|glucocorticoids|mesh-ancestor
110978931|NCT02281929|Hormones|hormones|mesh-ancestor
110731304|NCT05733624|Cyclosporins|cyclosporins|mesh-list
110978932|NCT02281929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110978933|NCT02281929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110978934|NCT02281929|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110978935|NCT02281929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110731635|NCT04115878|Oxybutynin|oxybutynin|mesh-list
110978936|NCT02281929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110731720|NCT03878524|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110978937|NCT02281929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110731795|NCT03742505|Vitamins|vitamins|mesh-ancestor
110978938|NCT02281929|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110978939|NCT04424056|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
110978940|NCT04424056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110978941|NCT05478772|Fluconazole|fluconazole|mesh-list
110978942|NCT05478772|Antifungal Agents|antifungal agents|mesh-ancestor
110978943|NCT05478772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110978944|NCT05478772|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110978945|NCT05478772|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110978946|NCT05478772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110732099|NCT01955512|Clopidogrel|clopidogrel|mesh-list
110732160|NCT05657470|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110732240|NCT05532358|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110978947|NCT05478772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110732317|NCT05394740|Antidotes|antidotes|mesh-ancestor
110732390|NCT05137184|Analgesics|analgesics|mesh-ancestor
110978948|NCT05478772|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110978949|NCT05478772|Hormone Antagonists|hormone antagonists|mesh-ancestor
110978950|NCT05478772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110978951|NCT05478772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110978952|NCT05478772|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110978953|NCT05478772|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110978954|NCT02945852|Apatinib|apatinib|mesh-list
110978955|NCT02945852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110978956|NCT02945852|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110978957|NCT02945852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110978958|NCT02945852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110732706|NCT05933213|Hormones|hormones|mesh-ancestor
110978959|NCT03245528|Angiotensin II|angiotensin ii|mesh-list
110978960|NCT03245528|Giapreza|giapreza|mesh-list
110978961|NCT03245528|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110978962|NCT00495885|Volinanserin|volinanserin|mesh-list
110978963|NCT00495885|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110450521|NCT03761134|Metformin|metformin|mesh-list
110978964|NCT00495885|Serotonin Agents|serotonin agents|mesh-ancestor
110978965|NCT00495885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110978966|NCT00495885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110978967|NCT00495885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110978968|NCT03254186|Propranolol|propranolol|mesh-list
110978969|NCT03254186|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110978970|NCT03254186|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110978972|NCT03254186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110978973|NCT03254186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110978974|NCT03254186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110978975|NCT03254186|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110978977|NCT03254186|Vasodilator Agents|vasodilator agents|mesh-ancestor
110978978|NCT00589875|Valacyclovir|valacyclovir|mesh-list
110978979|NCT00589875|Antiviral Agents|antiviral agents|mesh-ancestor
110978980|NCT00589875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110978981|NCT03250598|Mitapivat|mitapivat|mesh-list
110978982|NCT03250598|Enzyme Activators|enzyme activators|mesh-ancestor
110733133|NCT05909618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110978983|NCT03250598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110978985|NCT05483062|Tin Fluorides|tin fluorides|mesh-list
110978986|NCT05483062|Cariostatic Agents|cariostatic agents|mesh-ancestor
110978987|NCT05483062|Protective Agents|protective agents|mesh-ancestor
110978988|NCT05483062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110978989|NCT02282085|Olanzapine|olanzapine|mesh-list
110978990|NCT02282085|Risperidone|risperidone|mesh-list
110978991|NCT02282085|Aripiprazole|aripiprazole|mesh-list
110978992|NCT02282085|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110978993|NCT02282085|Ziprasidone|ziprasidone|mesh-list
110978994|NCT02282085|Antipsychotic Agents|antipsychotic agents|mesh-list
110978995|NCT02282085|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
110978996|NCT02282085|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110978997|NCT02282085|Serotonin Agents|serotonin agents|mesh-ancestor
110978998|NCT02282085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110978999|NCT02282085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110979000|NCT02282085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110979001|NCT02282085|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110979002|NCT02282085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110979003|NCT02282085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110979004|NCT02282085|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110979005|NCT02282085|Dopamine Agents|dopamine agents|mesh-ancestor
110979006|NCT02282085|Antiemetics|antiemetics|mesh-ancestor
110979007|NCT02282085|Autonomic Agents|autonomic agents|mesh-ancestor
110979008|NCT02282085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110979009|NCT02282085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110979010|NCT02282085|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110979011|NCT02282085|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110979012|NCT02282085|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110979013|NCT02282085|Antidepressive Agents|antidepressive agents|mesh-ancestor
110979014|NCT02282085|Dopamine Agonists|dopamine agonists|mesh-ancestor
110979015|NCT02282085|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110733696|NCT05296837|Antimalarials|antimalarials|mesh-ancestor
110979016|NCT02282085|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110979017|NCT02282085|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110979018|NCT02282085|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110979019|NCT02282085|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
110979020|NCT02282085|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110979021|NCT02282085|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110979022|NCT02282085|Adrenergic Agents|adrenergic agents|mesh-ancestor
110979023|NCT03244592|Minocycline|minocycline|mesh-list
110979024|NCT03244592|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110979025|NCT03244592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110979026|NCT03253328|Acetylcysteine|acetylcysteine|mesh-list
110979027|NCT03253328|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110979028|NCT03253328|Antiviral Agents|antiviral agents|mesh-ancestor
110733815|NCT05117710|Ebselen|ebselen|mesh-list
110979029|NCT03253328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110979030|NCT03253328|Expectorants|expectorants|mesh-ancestor
110733897|NCT05085028|Pembrolizumab|pembrolizumab|mesh-list
110979031|NCT03253328|Respiratory System Agents|respiratory system agents|mesh-ancestor
110979032|NCT03253328|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110979033|NCT03253328|Antioxidants|antioxidants|mesh-ancestor
110734104|NCT04725188|Docetaxel|docetaxel|mesh-list
110979034|NCT03253328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110979035|NCT03253328|Protective Agents|protective agents|mesh-ancestor
110734187|NCT04557527|Hyaluronic Acid|hyaluronic acid|mesh-list
110979036|NCT03253328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110979037|NCT03253328|Antidotes|antidotes|mesh-ancestor
110979039|NCT03253250|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110979040|NCT03253250|Entecavir|entecavir|mesh-list
110979041|NCT03253250|Adefovir|adefovir|mesh-list
110979042|NCT03253250|Antiviral Agents|antiviral agents|mesh-ancestor
110979043|NCT03253250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110979044|NCT03253250|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110734398|NCT04267549|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110979045|NCT03253250|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110979046|NCT03253250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110734472|NCT04080804|Relatlimab|relatlimab|mesh-list
110734545|NCT03991884|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110979047|NCT03253250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110979048|NCT03253250|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110979049|NCT03253250|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110979050|NCT03253562|Metformin|metformin|mesh-list
110979051|NCT03253562|Vildagliptin|vildagliptin|mesh-list
110979052|NCT03253562|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110979053|NCT03253562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110979054|NCT03253562|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110979055|NCT03253562|Protease Inhibitors|protease inhibitors|mesh-ancestor
110979056|NCT03253562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110979057|NCT03253562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110979058|NCT03250052|Linagliptin|linagliptin|mesh-list
110979059|NCT03250052|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110979060|NCT03250052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110979061|NCT03250052|Incretins|incretins|mesh-ancestor
110979062|NCT03250052|Hormones|hormones|mesh-ancestor
110979063|NCT03250052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110734695|NCT03712878|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110734696|NCT03712878|Alkylating Agents|alkylating agents|mesh-ancestor
110734697|NCT03712878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110734698|NCT03712878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110734699|NCT03712878|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110734700|NCT03712878|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110734701|NCT03712878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110734702|NCT03712878|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110979064|NCT03250052|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110979065|NCT03250052|Protease Inhibitors|protease inhibitors|mesh-ancestor
110979066|NCT03250052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110979067|NCT03250052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110979069|NCT05478382|Analgesics|analgesics|mesh-ancestor
110979070|NCT05478382|Sensory System Agents|sensory system agents|mesh-ancestor
110979071|NCT05478382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110979072|NCT05478382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110979073|NCT05478382|Anticonvulsants|anticonvulsants|mesh-ancestor
110979074|NCT05478382|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110979075|NCT05478382|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110979076|NCT05478382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110979077|NCT05478382|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110979078|NCT05478382|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110979079|NCT05478382|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110979080|NCT05478382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110979081|NCT05478382|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110979082|NCT03244358|Epalrestat|epalrestat|mesh-list
110979083|NCT03244358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110979084|NCT03244358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110979085|NCT03249740|Sunitinib|sunitinib|mesh-list
110979086|NCT03249740|Aflibercept|aflibercept|mesh-list
110979087|NCT03249740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110979088|NCT03249740|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110979089|NCT03249740|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110979091|NCT03249740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110979092|NCT03249740|Growth Inhibitors|growth inhibitors|mesh-ancestor
110979093|NCT03249740|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110979094|NCT03249740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110735298|NCT02037048|Leucovorin|leucovorin|mesh-list
110735377|NCT01494662|Tubulin Modulators|tubulin modulators|mesh-ancestor
110979095|NCT03249740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110979096|NCT03057977|Empagliflozin|empagliflozin|mesh-list
110979097|NCT03057977|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110979098|NCT03057977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110735599|NCT00075946|Rituximab|rituximab|mesh-list
110979099|NCT03057977|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110979100|NCT03057977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110979101|NCT03249506|Dapagliflozin|dapagliflozin|mesh-list
110979102|NCT03249506|Empagliflozin|empagliflozin|mesh-list
110979103|NCT03249506|Canagliflozin|canagliflozin|mesh-list
110735694|NCT00046930|Cytarabine|cytarabine|mesh-list
110979104|NCT03249506|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
110979105|NCT03249506|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
110979107|NCT03249506|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
110979108|NCT03249506|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110979109|NCT03249506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110979110|NCT03249506|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110979111|NCT03249506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110979112|NCT03249506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110979113|NCT03249506|Hormones|hormones|mesh-ancestor
110979114|NCT03249506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110735981|NCT03815890|Nivolumab|nivolumab|mesh-list
110979115|NCT03249506|Incretins|incretins|mesh-ancestor
110979116|NCT03249506|Protease Inhibitors|protease inhibitors|mesh-ancestor
110979117|NCT03249506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110979119|NCT03249662|Anesthetics, Local|anesthetics, local|mesh-ancestor
110696200|NCT03996278|Thymoglobulin|thymoglobulin|mesh-list
110979120|NCT03249662|Anesthetics|anesthetics|mesh-ancestor
110979121|NCT03249662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110979122|NCT03249662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110979123|NCT03249662|Sensory System Agents|sensory system agents|mesh-ancestor
110979124|NCT03249662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110979126|NCT03249428|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110979127|NCT03249428|Autonomic Agents|autonomic agents|mesh-ancestor
110979128|NCT03249428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110979129|NCT03249428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110736404|NCT03509350|Antioxidants|antioxidants|mesh-ancestor
110979130|NCT03249428|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110979131|NCT03249428|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110979132|NCT03249428|Cholinergic Agents|cholinergic agents|mesh-ancestor
110979133|NCT03249428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110979134|NCT03249428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110979135|NCT03243500|Lidocaine|lidocaine|mesh-list
110979136|NCT03243500|Bupivacaine|bupivacaine|mesh-list
110979137|NCT03243500|Atracurium|atracurium|mesh-list
110979138|NCT03243500|Anesthetics, Local|anesthetics, local|mesh-ancestor
110979140|NCT03243500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110979141|NCT03243500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110979142|NCT03243500|Sensory System Agents|sensory system agents|mesh-ancestor
110979143|NCT03243500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110979144|NCT03243500|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110979145|NCT03243500|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110979146|NCT03243500|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110979147|NCT03243500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110979148|NCT03243500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110979149|NCT03243500|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110979150|NCT03243500|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110979151|NCT03243500|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110979152|NCT03243500|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
110979153|NCT03243500|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110979154|NCT03243500|Cholinergic Agents|cholinergic agents|mesh-ancestor
110979155|NCT03243500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110979156|NCT03238898|Botulinum Toxins|botulinum toxins|mesh-list
110979157|NCT03238898|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110979158|NCT03238898|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110979159|NCT03238898|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110979160|NCT03238898|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110979161|NCT03238898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110979162|NCT03238898|Cholinergic Agents|cholinergic agents|mesh-ancestor
110979163|NCT03238898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110979164|NCT03238898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110979165|NCT03238898|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110979166|NCT03238898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110979167|NCT03249194|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
110979168|NCT03249194|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
110979169|NCT03249194|Antiviral Agents|antiviral agents|mesh-list
110979170|NCT03249194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110979171|NCT04486508|Heparin|heparin|mesh-list
110979172|NCT04486508|Calcium heparin|calcium heparin|mesh-list
110979173|NCT04486508|Enoxaparin|enoxaparin|mesh-list
110979174|NCT04486508|Enoxaparin sodium|enoxaparin sodium|mesh-list
110979175|NCT04486508|Atorvastatin|atorvastatin|mesh-list
110979176|NCT04486508|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
110979177|NCT04486508|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110979178|NCT04486508|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110979179|NCT04486508|Antimetabolites|antimetabolites|mesh-ancestor
110979180|NCT04486508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110979181|NCT04486508|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110979182|NCT04486508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110979183|NCT04486508|Anticoagulants|anticoagulants|mesh-ancestor
110979184|NCT04486508|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110979185|NCT04486508|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110979186|NCT02552212|Certolizumab Pegol|certolizumab pegol|mesh-list
110979187|NCT02552212|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110979188|NCT02552212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110979189|NCT02552212|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110979190|NCT02552212|Immunologic Factors|immunologic factors|mesh-ancestor
110979191|NCT02552212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110979192|NCT02552212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110979193|NCT02454764|Interferons|interferons|mesh-list
110979194|NCT02454764|Tenofovir|tenofovir|mesh-list
110979196|NCT02454764|Interferon alpha-2|interferon alpha-2|mesh-list
110979197|NCT02454764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110979198|NCT02454764|Antiviral Agents|antiviral agents|mesh-ancestor
110979199|NCT02454764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110979200|NCT02454764|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110737985|NCT03948620|Penicillins|penicillins|mesh-list
110738060|NCT01101698|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110979201|NCT02454764|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110979202|NCT02454764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110979203|NCT02454764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110979204|NCT02454764|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110979205|NCT02454764|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110979206|NCT02454764|Immunologic Factors|immunologic factors|mesh-ancestor
110979207|NCT02454764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110979208|NCT00685919|Carbidopa|carbidopa|mesh-list
110979209|NCT00685919|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110979210|NCT00685919|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110979211|NCT00685919|Dopamine Agents|dopamine agents|mesh-ancestor
110738207|NCT01082289|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110979212|NCT00685919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110979213|NCT00685919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110979214|NCT00685919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110979215|NCT00685919|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
110738350|NCT05841056|Amiodarone|amiodarone|mesh-list
110979216|NCT00685919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110979217|NCT03243344|Surgiflo|surgiflo|mesh-list
110979218|NCT03243344|Hemostatics|hemostatics|mesh-ancestor
110979219|NCT03243344|Coagulants|coagulants|mesh-ancestor
110979220|NCT03243032|Ibuprofen|ibuprofen|mesh-list
110979221|NCT03243032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
110979222|NCT03243032|Anesthetics|anesthetics|mesh-list
110979223|NCT03243032|Anesthetics, Local|anesthetics, local|mesh-list
110979224|NCT03243032|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110738418|NCT05840913|Anesthetics, Local|anesthetics, local|mesh-ancestor
110979225|NCT03243032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110738500|NCT05583071|Rituximab|rituximab|mesh-list
110979226|NCT03243032|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110979227|NCT03243032|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110979228|NCT03243032|Analgesics|analgesics|mesh-ancestor
110979229|NCT03243032|Sensory System Agents|sensory system agents|mesh-ancestor
110979230|NCT03243032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110979231|NCT03243032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110979232|NCT03243032|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110979233|NCT03243032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110738855|NCT03727633|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110979234|NCT03243032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110979235|NCT03249038|Chrysarobin|chrysarobin|mesh-list
110739006|NCT02577406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110979236|NCT03249038|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110979237|NCT03249038|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110979238|NCT03249038|Analgesics|analgesics|mesh-ancestor
110979239|NCT03249038|Sensory System Agents|sensory system agents|mesh-ancestor
110979240|NCT03249038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110739225|NCT00077376|Carboplatin|carboplatin|mesh-list
110979241|NCT03249038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110739299|NCT00362297|Valacyclovir|valacyclovir|mesh-list
110979242|NCT03249038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110739447|NCT01052597|Analgesics|analgesics|mesh-ancestor
110979243|NCT03249038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110979245|NCT03061331|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
110979246|NCT03061331|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110739592|NCT01051271|Midazolam|midazolam|mesh-list
110739665|NCT05386706|Metformin|metformin|mesh-list
110739822|NCT00041132|Antiemetics|antiemetics|mesh-ancestor
110979247|NCT03061331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110979248|NCT00700778|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
110979249|NCT00700778|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110739960|NCT03991559|Antibodies|antibodies|mesh-list
110979250|NCT00700778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110979251|NCT05213585|Ivermectin|ivermectin|mesh-list
110979252|NCT05213585|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110979253|NCT05213585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110979254|NCT05482282|Vaccines|vaccines|mesh-list
110979255|NCT05482282|Immunologic Factors|immunologic factors|mesh-ancestor
110979256|NCT05482282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110979257|NCT05209529|Durvalumab|durvalumab|mesh-list
110979258|NCT05209529|Olaparib|olaparib|mesh-list
110979259|NCT05209529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110979260|NCT05209529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110979261|NCT05209529|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110979262|NCT05209529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110740174|NCT01109264|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110979263|NCT05209529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110979264|NCT04424134|Spironolactone|spironolactone|mesh-list
110979265|NCT04424134|Bromhexine|bromhexine|mesh-list
110979266|NCT04424134|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110979267|NCT04424134|Hormone Antagonists|hormone antagonists|mesh-ancestor
110740469|NCT03941990|Nitrous Oxide|nitrous oxide|mesh-list
110979268|NCT04424134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110979269|NCT04424134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110979270|NCT04424134|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110979271|NCT04424134|Diuretics|diuretics|mesh-ancestor
110979272|NCT04424134|Natriuretic Agents|natriuretic agents|mesh-ancestor
110979273|NCT04424134|Expectorants|expectorants|mesh-ancestor
110979274|NCT04424134|Respiratory System Agents|respiratory system agents|mesh-ancestor
110979275|NCT04486430|Salicylates|salicylates|mesh-list
110979276|NCT04486430|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110979277|NCT04486430|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110979278|NCT04486430|Analgesics|analgesics|mesh-ancestor
110979279|NCT04486430|Sensory System Agents|sensory system agents|mesh-ancestor
110979280|NCT04486430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110979281|NCT04486430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110979282|NCT04486430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110979283|NCT04486430|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110979284|NCT04486430|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110979285|NCT04486430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110979286|NCT04486430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110979287|NCT03248726|Bisacodyl|bisacodyl|mesh-list
110979288|NCT03248726|Cathartics|cathartics|mesh-ancestor
110979289|NCT03248726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110979290|NCT03248726|Laxatives|laxatives|mesh-ancestor
110979291|NCT05208827|Vitamin D|vitamin d|mesh-list
110979292|NCT05208827|Ergocalciferols|ergocalciferols|mesh-list
110979293|NCT05208827|Cholecalciferol|cholecalciferol|mesh-list
110979294|NCT05208827|Vitamins|vitamins|mesh-list
110979295|NCT05208827|Micronutrients|micronutrients|mesh-ancestor
110979296|NCT05208827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110979297|NCT05208827|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110979298|NCT05208827|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110979299|NCT04947059|Gemcitabine|gemcitabine|mesh-list
110979300|NCT04947059|Epirubicin|epirubicin|mesh-list
110979301|NCT04947059|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110979302|NCT04947059|Antimetabolites|antimetabolites|mesh-ancestor
110979303|NCT04947059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110979304|NCT04947059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110979305|NCT04947059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110979306|NCT04947059|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110979307|NCT04947059|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110979308|NCT04947059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110979309|NCT05481970|Dexamethasone|dexamethasone|mesh-list
110979310|NCT05481970|Lidocaine|lidocaine|mesh-list
110979311|NCT05481970|Fentanyl|fentanyl|mesh-list
110979312|NCT05481970|Dexmedetomidine|dexmedetomidine|mesh-list
110979313|NCT05481970|Ketamine|ketamine|mesh-list
110979314|NCT05481970|Propofol|propofol|mesh-list
110979315|NCT05481970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110741172|NCT01114100|Sertraline|sertraline|mesh-list
110979316|NCT05481970|Antiemetics|antiemetics|mesh-ancestor
110979317|NCT05481970|Autonomic Agents|autonomic agents|mesh-ancestor
110979318|NCT05481970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110979319|NCT05481970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110979320|NCT05481970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110979321|NCT05481970|Glucocorticoids|glucocorticoids|mesh-ancestor
110979322|NCT05481970|Hormones|hormones|mesh-ancestor
110741463|NCT05683054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110459294|NCT05565001|Cromakalim|cromakalim|mesh-list
110979323|NCT05481970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110979324|NCT05481970|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110979325|NCT05481970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110979326|NCT05481970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110979327|NCT05481970|Anesthetics, Local|anesthetics, local|mesh-ancestor
110979328|NCT05481970|Anesthetics|anesthetics|mesh-ancestor
110979329|NCT05481970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110979330|NCT05481970|Sensory System Agents|sensory system agents|mesh-ancestor
110459583|NCT04387071|Antibodies|antibodies|mesh-list
110979331|NCT05481970|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110979332|NCT05481970|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110979333|NCT05481970|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110741973|NCT05482516|Atezolizumab|atezolizumab|mesh-list
110979334|NCT05481970|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110979335|NCT05481970|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110979336|NCT05481970|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110979337|NCT05481970|Analgesics|analgesics|mesh-ancestor
110742120|NCT01220648|Interferon-alpha|interferon-alpha|mesh-list
110979338|NCT05481970|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110979339|NCT05481970|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110979340|NCT05481970|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110979341|NCT05481970|Adrenergic Agents|adrenergic agents|mesh-ancestor
110979342|NCT05481970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110979343|NCT05481970|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110979344|NCT05481970|Anesthetics, General|anesthetics, general|mesh-ancestor
110979345|NCT05481970|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110979346|NCT05481970|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110979347|NCT05481970|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110979350|NCT05481970|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110979351|NCT03248648|Ketamine|ketamine|mesh-list
110979352|NCT03248648|Neostigmine|neostigmine|mesh-list
110979353|NCT03248648|Analgesics|analgesics|mesh-ancestor
110979354|NCT03248648|Sensory System Agents|sensory system agents|mesh-ancestor
110979355|NCT03248648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110979356|NCT03248648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110979357|NCT03248648|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110979358|NCT03248648|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110979359|NCT03248648|Anesthetics, General|anesthetics, general|mesh-ancestor
110979361|NCT03248648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110979362|NCT03248648|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110979363|NCT03248648|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110742776|NCT01227200|Tramadol|tramadol|mesh-list
110979364|NCT03248648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110979365|NCT03248648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110979366|NCT03248648|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110979367|NCT03248648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110979368|NCT03248648|Cholinergic Agents|cholinergic agents|mesh-ancestor
110742913|NCT01229930|Paclitaxel|paclitaxel|mesh-list
110742992|NCT01231802|Vitamins|vitamins|mesh-ancestor
110979369|NCT03248648|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110979370|NCT03248648|Autonomic Agents|autonomic agents|mesh-ancestor
110979372|NCT03241784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110743444|NCT01141244|Sirolimus|sirolimus|mesh-list
110979373|NCT03241784|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110979374|NCT03241784|Analgesics|analgesics|mesh-ancestor
110979375|NCT03241784|Sensory System Agents|sensory system agents|mesh-ancestor
110979376|NCT03241784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110979377|NCT03241784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110979379|NCT03242096|Paclitaxel|paclitaxel|mesh-list
110979380|NCT03242096|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110979381|NCT03242096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110979382|NCT03242096|Tubulin Modulators|tubulin modulators|mesh-ancestor
110979383|NCT03242096|Antimitotic Agents|antimitotic agents|mesh-ancestor
110979384|NCT03242096|Mitosis Modulators|mitosis modulators|mesh-ancestor
110979385|NCT03242096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110979386|NCT03242096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110979387|NCT03242096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110979388|NCT03242096|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110979389|NCT03242096|Antifungal Agents|antifungal agents|mesh-ancestor
110979390|NCT03242096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110979391|NCT03242096|Immunologic Factors|immunologic factors|mesh-ancestor
110979392|NCT03242096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110979393|NCT03241472|Letrozole|letrozole|mesh-list
110979394|NCT03241472|Clomiphene|clomiphene|mesh-list
110979395|NCT03241472|Enclomiphene|enclomiphene|mesh-list
110979396|NCT03241472|Zuclomiphene|zuclomiphene|mesh-list
110979397|NCT03241472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110979398|NCT03241472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110979399|NCT03241472|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110979400|NCT03241472|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110979401|NCT03241472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110979402|NCT03241472|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110979403|NCT03241472|Hormone Antagonists|hormone antagonists|mesh-ancestor
110979404|NCT03241472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110979405|NCT03241472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110979406|NCT03241472|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110979407|NCT03241472|Fertility Agents|fertility agents|mesh-ancestor
110979408|NCT03241472|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110979409|NCT03241472|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110979410|NCT03241472|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110979411|NCT04313075|Leronlimab|leronlimab|mesh-list
110979412|NCT04313075|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110979413|NCT04313075|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110979414|NCT04313075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110979415|NCT04313075|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110979416|NCT04313075|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110979417|NCT04313075|Antiviral Agents|antiviral agents|mesh-ancestor
110979418|NCT04313075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110979419|NCT03241550|Isavuconazole|isavuconazole|mesh-list
110979420|NCT03241550|Antifungal Agents|antifungal agents|mesh-ancestor
110979421|NCT03241550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110979422|NCT03241706|Glucagon|glucagon|mesh-list
110979423|NCT03241706|Somatostatin|somatostatin|mesh-list
110979424|NCT03241706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110979425|NCT03241706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110979427|NCT03241706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110979428|NCT03237416|Midazolam|midazolam|mesh-list
110979429|NCT03237416|Dabigatran|dabigatran|mesh-list
110979430|NCT03237416|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110979431|NCT03237416|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110979432|NCT03237416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110744315|NCT01249352|Antimetabolites|antimetabolites|mesh-ancestor
110979433|NCT03237416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110979434|NCT03237416|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110744394|NCT03912740|Remifentanil|remifentanil|mesh-list
110979435|NCT03237416|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110979436|NCT03237416|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110979437|NCT03237416|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110979438|NCT03237416|Anesthetics, General|anesthetics, general|mesh-ancestor
110979439|NCT03237416|Anesthetics|anesthetics|mesh-ancestor
110979441|NCT03237416|GABA Agents|gaba agents|mesh-ancestor
110979442|NCT03237416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110979443|NCT03237416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110979444|NCT03237416|Antithrombins|antithrombins|mesh-ancestor
110979445|NCT03237416|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110979446|NCT03237416|Protease Inhibitors|protease inhibitors|mesh-ancestor
110979447|NCT03237416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110979448|NCT03237416|Anticoagulants|anticoagulants|mesh-ancestor
110979449|NCT05211011|Fosfomycin|fosfomycin|mesh-list
110979450|NCT05211011|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110979451|NCT05211011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110979452|NCT03247868|Botulinum Toxins|botulinum toxins|mesh-list
110979453|NCT03247868|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110979454|NCT03247868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110979455|NCT03247868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110979456|NCT03247868|Cholinergic Agents|cholinergic agents|mesh-ancestor
110979457|NCT03247868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110744678|NCT01148264|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110979458|NCT03247868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110979460|NCT04094519|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110979461|NCT04094519|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110979462|NCT04094519|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110979463|NCT04094519|Antimetabolites|antimetabolites|mesh-ancestor
110744738|NCT00086502|Metformin|metformin|mesh-list
110979464|NCT04094519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110979465|NCT04094519|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110979466|NCT04094519|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110979468|NCT04094519|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110979469|NCT04094519|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110979470|NCT04094519|Protective Agents|protective agents|mesh-ancestor
110979471|NCT04094519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110979472|NCT02189798|Imidacloprid|imidacloprid|mesh-list
110979473|NCT02189798|Cholinergic Agents|cholinergic agents|mesh-ancestor
110979474|NCT02189798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110979475|NCT02189798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110979476|NCT02189798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110979478|NCT03107702|Antioxidants|antioxidants|mesh-ancestor
110979479|NCT03107702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110979480|NCT03107702|Protective Agents|protective agents|mesh-ancestor
110979481|NCT03107702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110979482|NCT03107702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110979483|NCT02554318|Rifampin|rifampin|mesh-list
110979484|NCT02554318|Isoniazid|isoniazid|mesh-list
110979485|NCT02554318|Pyrazinamide|pyrazinamide|mesh-list
110979486|NCT02554318|Ethambutol|ethambutol|mesh-list
110979487|NCT02554318|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110979488|NCT02554318|Antitubercular Agents|antitubercular agents|mesh-ancestor
110979489|NCT02554318|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110979490|NCT02554318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110979491|NCT02554318|Leprostatic Agents|leprostatic agents|mesh-ancestor
110979492|NCT02554318|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110979493|NCT02554318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110979494|NCT02554318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110979495|NCT02554318|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110696583|NCT00437294|Capecitabine|capecitabine|mesh-list
110979496|NCT02554318|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110745016|NCT01148576|Antiviral Agents|antiviral agents|mesh-ancestor
110979497|NCT02554318|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110745068|NCT01151306|Antimetabolites|antimetabolites|mesh-ancestor
110979498|NCT02554318|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110979499|NCT02554318|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110979500|NCT02554318|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110979501|NCT02554318|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
110979502|NCT02554318|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110979503|NCT02554318|Antimetabolites|antimetabolites|mesh-ancestor
110979504|NCT02554318|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110979506|NCT03976973|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110979507|NCT03976973|Antiviral Agents|antiviral agents|mesh-ancestor
110979508|NCT03976973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110979509|NCT03976973|Expectorants|expectorants|mesh-ancestor
110979510|NCT03976973|Respiratory System Agents|respiratory system agents|mesh-ancestor
110979511|NCT03976973|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110979512|NCT03976973|Antioxidants|antioxidants|mesh-ancestor
110979513|NCT03976973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110979514|NCT03976973|Protective Agents|protective agents|mesh-ancestor
110979515|NCT03976973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110979516|NCT03976973|Antidotes|antidotes|mesh-ancestor
110979517|NCT04066751|Ivacaftor|ivacaftor|mesh-list
110979518|NCT04066751|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
110979519|NCT04066751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110979520|NCT04066751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110979521|NCT02550106|Omalizumab|omalizumab|mesh-list
110979522|NCT02550106|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110979523|NCT02550106|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110979524|NCT02550106|Respiratory System Agents|respiratory system agents|mesh-ancestor
110979525|NCT03237260|Vedolizumab|vedolizumab|mesh-list
110979526|NCT03237260|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110979527|NCT03247400|Atorvastatin|atorvastatin|mesh-list
110979528|NCT03247400|Simvastatin|simvastatin|mesh-list
110979529|NCT03247400|Calcium|calcium|mesh-list
110979530|NCT03247400|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110979531|NCT03247400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110745370|NCT03341806|Avelumab|avelumab|mesh-list
110979532|NCT03247400|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110979533|NCT03247400|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110979535|NCT03247400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110979536|NCT03247400|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110979537|NCT03247400|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110979538|NCT03247400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110745718|NCT03887858|Tamsulosin|tamsulosin|mesh-list
110745868|NCT03879746|Antidepressive Agents|antidepressive agents|mesh-ancestor
110979539|NCT05480566|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
110745953|NCT01263158|Oxytocin|oxytocin|mesh-list
110979541|NCT05480566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110979542|NCT05480566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110979543|NCT05480566|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110979545|NCT05480566|Respiratory System Agents|respiratory system agents|mesh-ancestor
110979546|NCT02453516|Epinephrine|epinephrine|mesh-list
110979547|NCT02453516|Ropivacaine|ropivacaine|mesh-list
110979548|NCT02453516|Anesthetics, Local|anesthetics, local|mesh-ancestor
110979549|NCT02453516|Anesthetics|anesthetics|mesh-ancestor
110979550|NCT02453516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110979551|NCT02453516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110746682|NCT02526758|Hormones|hormones|mesh-ancestor
110979552|NCT02453516|Sensory System Agents|sensory system agents|mesh-ancestor
110746751|NCT00367991|Epoetin Alfa|epoetin alfa|mesh-list
110979553|NCT02453516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110746827|NCT01274780|Ritonavir|ritonavir|mesh-list
110979554|NCT02453516|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110746891|NCT01172912|Dexamethasone|dexamethasone|mesh-list
110979555|NCT02453516|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110979556|NCT02453516|Adrenergic Agents|adrenergic agents|mesh-ancestor
110979557|NCT02453516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110747046|NCT01173926|Insulin|insulin|mesh-list
110979558|NCT02453516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110979559|NCT02453516|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110979560|NCT02453516|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110979561|NCT02453516|Autonomic Agents|autonomic agents|mesh-ancestor
110979562|NCT02453516|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110979563|NCT02453516|Respiratory System Agents|respiratory system agents|mesh-ancestor
110979564|NCT02453516|Mydriatics|mydriatics|mesh-ancestor
110979565|NCT02453516|Sympathomimetics|sympathomimetics|mesh-ancestor
110979567|NCT03716609|Magnesium citrate|magnesium citrate|mesh-list
110979568|NCT03716609|Citric Acid|citric acid|mesh-list
110747412|NCT01175486|Acarbose|acarbose|mesh-list
110979569|NCT03716609|Sodium Citrate|sodium citrate|mesh-list
110979570|NCT03716609|Anticoagulants|anticoagulants|mesh-ancestor
110979571|NCT03716609|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110979573|NCT03716609|Sequestering Agents|sequestering agents|mesh-ancestor
110979574|NCT03716609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110979575|NCT03716609|Cathartics|cathartics|mesh-ancestor
110979576|NCT03716609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110979577|NCT03709355|Clarithromycin|clarithromycin|mesh-list
110979578|NCT03709355|Rifampin|rifampin|mesh-list
110979579|NCT03709355|Rifabutin|rifabutin|mesh-list
110979580|NCT03709355|Elsulfavirine|elsulfavirine|mesh-list
110979581|NCT03709355|Omeprazole|omeprazole|mesh-list
110979582|NCT03709355|Atorvastatin|atorvastatin|mesh-list
110979583|NCT03709355|Levonorgestrel|levonorgestrel|mesh-list
110979584|NCT03709355|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110979585|NCT03709355|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
110979586|NCT03709355|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110979587|NCT03709355|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110979588|NCT03709355|Antimetabolites|antimetabolites|mesh-ancestor
110979589|NCT03709355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110979590|NCT03709355|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110979591|NCT03709355|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110979592|NCT03709355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110979593|NCT03709355|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110979594|NCT03709355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110979595|NCT03709355|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110979596|NCT03709355|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110979597|NCT03709355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110979598|NCT03709355|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110979599|NCT03709355|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110979600|NCT03709355|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110979601|NCT03709355|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110979602|NCT03709355|Contraceptive Agents|contraceptive agents|mesh-ancestor
110979603|NCT03709355|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110979604|NCT03709355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110979605|NCT03709355|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110979606|NCT03709355|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110979607|NCT03709355|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110979608|NCT03709355|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110979609|NCT03709355|Antitubercular Agents|antitubercular agents|mesh-ancestor
110979610|NCT03709355|Leprostatic Agents|leprostatic agents|mesh-ancestor
110979611|NCT03709355|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110979612|NCT03709355|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110979613|NCT03709355|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110979614|NCT03709355|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110979615|NCT03709355|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110979616|NCT03709355|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110979617|NCT03709355|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110979618|NCT03709355|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110979619|NCT03709355|Estrogens|estrogens|mesh-ancestor
110979620|NCT03709355|Hormones|hormones|mesh-ancestor
110979621|NCT03709355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110979622|NCT03709355|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110979623|NCT03709355|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110979624|NCT03709355|Antiviral Agents|antiviral agents|mesh-ancestor
110979625|NCT03709355|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110979626|NCT05209217|Ketamine|ketamine|mesh-list
110979627|NCT05209217|Analgesics|analgesics|mesh-ancestor
110979628|NCT05209217|Sensory System Agents|sensory system agents|mesh-ancestor
110979629|NCT05209217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110747641|NCT01179308|Anesthetics|anesthetics|mesh-list
110979630|NCT05209217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110747786|NCT01181414|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110979631|NCT05209217|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110747936|NCT01180322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110979632|NCT05209217|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110979633|NCT05209217|Anesthetics, General|anesthetics, general|mesh-ancestor
110979634|NCT05209217|Anesthetics|anesthetics|mesh-ancestor
110979635|NCT05209217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110979636|NCT05209217|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110979637|NCT05209217|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110979638|NCT05209217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110748377|NCT01177514|Antimanic Agents|antimanic agents|mesh-ancestor
110979639|NCT05209217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110979640|NCT01662310|Paliperidone Palmitate|paliperidone palmitate|mesh-list
110748456|NCT00058422|Glucocorticoids|glucocorticoids|mesh-ancestor
110979641|NCT01662310|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110979642|NCT01662310|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110979643|NCT01662310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110979645|NCT01662310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110748825|NCT01193816|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110979646|NCT01662310|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110979647|NCT01662310|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110979648|NCT01662310|Serotonin Agents|serotonin agents|mesh-ancestor
110979649|NCT01662310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110979650|NCT01662310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110748983|NCT01292174|Ibalizumab|ibalizumab|mesh-list
110979651|NCT01662310|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110979652|NCT01662310|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110979653|NCT01662310|Dopamine Agents|dopamine agents|mesh-ancestor
110979654|NCT00700622|Insulin|insulin|mesh-list
110979655|NCT00700622|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110685984|NCT00496470|Hormones|hormones|mesh-ancestor
110979656|NCT00700622|Insulin Glargine|insulin glargine|mesh-list
110979657|NCT00700622|Insulin Lispro|insulin lispro|mesh-list
110979658|NCT00700622|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110979659|NCT00700622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110979660|NCT03628625|Letrozole|letrozole|mesh-list
110979661|NCT03628625|Misoprostol|misoprostol|mesh-list
110979662|NCT03628625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110979663|NCT03628625|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110979664|NCT03628625|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110979665|NCT03628625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110979666|NCT03628625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110979667|NCT03628625|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110979668|NCT03628625|Hormone Antagonists|hormone antagonists|mesh-ancestor
110979669|NCT03628625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110979670|NCT03628625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110979671|NCT03628625|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110979672|NCT03628625|Abortifacient Agents|abortifacient agents|mesh-ancestor
110979673|NCT03628625|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110749342|NCT01296230|Hormones|hormones|mesh-list
110979674|NCT03628625|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110979675|NCT03628625|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110979677|NCT02553928|Memantine|memantine|mesh-list
110979679|NCT02553928|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110979680|NCT02553928|Dopamine Agents|dopamine agents|mesh-ancestor
110979681|NCT02553928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110749699|NCT01199432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110979682|NCT02553928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110979683|NCT02553928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110979684|NCT02553928|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110979685|NCT02553928|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110979687|NCT03908255|Micronutrients|micronutrients|mesh-ancestor
110979688|NCT03908255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110979689|NCT03246776|Triclosan|triclosan|mesh-list
110979690|NCT03246776|Halometasone|halometasone|mesh-list
110979691|NCT03246776|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110979692|NCT03246776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110979693|NCT03246776|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
110979694|NCT03246776|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110979695|NCT03246776|Antimetabolites|antimetabolites|mesh-ancestor
110750052|NCT05153668|Immunologic Factors|immunologic factors|mesh-ancestor
110979696|NCT03246776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110979697|NCT03246776|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110979698|NCT03246776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110979699|NCT03246776|Dermatologic Agents|dermatologic agents|mesh-ancestor
110979700|NCT03246776|Glucocorticoids|glucocorticoids|mesh-ancestor
110750421|NCT04472494|Abatacept|abatacept|mesh-list
110750494|NCT00304031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110979702|NCT03246776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110750642|NCT01064921|Vorinostat|vorinostat|mesh-list
110979703|NCT03246776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110979704|NCT03246386|Posaconazole|posaconazole|mesh-list
110979705|NCT03246386|Antifungal Agents|antifungal agents|mesh-ancestor
110979706|NCT03246386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110979707|NCT03246386|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
110979708|NCT03246386|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110979709|NCT03246386|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110979710|NCT03246386|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110751007|NCT00301067|Alkylating Agents|alkylating agents|mesh-ancestor
110979711|NCT03246386|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110979712|NCT03246386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110979713|NCT03246386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110979714|NCT03246386|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110979715|NCT03246386|Hormone Antagonists|hormone antagonists|mesh-ancestor
110979716|NCT03246386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110979717|NCT03246386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110979718|NCT03851081|Vincristine|vincristine|mesh-list
110979719|NCT03851081|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
110979720|NCT03851081|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110979721|NCT03851081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110979722|NCT03851081|Tubulin Modulators|tubulin modulators|mesh-ancestor
110979723|NCT03851081|Antimitotic Agents|antimitotic agents|mesh-ancestor
110979725|NCT03851081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110979726|NCT03851081|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110979727|NCT03851081|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110979728|NCT03851081|Immunotoxins|immunotoxins|mesh-ancestor
110979729|NCT03851081|Immunoconjugates|immunoconjugates|mesh-ancestor
110979731|NCT03851081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110979732|NCT03239600|Methotrexate|methotrexate|mesh-list
110751583|NCT01333774|Acarbose|acarbose|mesh-list
110979733|NCT03239600|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110979734|NCT03239600|Abortifacient Agents|abortifacient agents|mesh-ancestor
110979735|NCT03239600|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110751799|NCT01331434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110979736|NCT03239600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110979737|NCT03239600|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110979739|NCT03239600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110979740|NCT03239600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110979741|NCT03239600|Dermatologic Agents|dermatologic agents|mesh-ancestor
110979742|NCT03239600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110979743|NCT03239600|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110979744|NCT03239600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110979745|NCT03239600|Immunologic Factors|immunologic factors|mesh-ancestor
110979746|NCT03239600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110979747|NCT03239600|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110979749|NCT02966093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110752083|NCT01341262|Cyclophosphamide|cyclophosphamide|mesh-list
110979750|NCT02966093|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110979751|NCT02966093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110752325|NCT00546754|Losartan|losartan|mesh-list
110752381|NCT00282347|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110979752|NCT02966093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110979754|NCT03229616|Busulfan|busulfan|mesh-list
110979755|NCT03229616|Etoposide|etoposide|mesh-list
110979756|NCT03229616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110979757|NCT03229616|Immunologic Factors|immunologic factors|mesh-ancestor
110979758|NCT03229616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110979759|NCT03229616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110979760|NCT03229616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110979761|NCT03229616|Alkylating Agents|alkylating agents|mesh-ancestor
110979762|NCT03229616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110752899|NCT03794492|Mycophenolic Acid|mycophenolic acid|mesh-list
110979763|NCT03229616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110752975|NCT00274937|Cisplatin|cisplatin|mesh-list
110979764|NCT03229616|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110481706|NCT04211805|Immunologic Factors|immunologic factors|mesh-ancestor
110979765|NCT03229616|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110979766|NCT03229616|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110979767|NCT03229616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110979768|NCT03229616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110979769|NCT03234764|Immunomodulating Agents|immunomodulating agents|mesh-list
110979770|NCT03234764|Immunologic Factors|immunologic factors|mesh-ancestor
110753345|NCT01312298|Bupivacaine|bupivacaine|mesh-list
110979771|NCT03234764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110979772|NCT03234842|Paclitaxel|paclitaxel|mesh-list
110979773|NCT03234842|Carboplatin|carboplatin|mesh-list
110979774|NCT03234842|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110979776|NCT03234842|Tubulin Modulators|tubulin modulators|mesh-ancestor
110979777|NCT03234842|Antimitotic Agents|antimitotic agents|mesh-ancestor
110979778|NCT03234842|Mitosis Modulators|mitosis modulators|mesh-ancestor
110753710|NCT03779516|Sensory System Agents|sensory system agents|mesh-ancestor
110979779|NCT03234842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110979780|NCT03229148|Anesthetics|anesthetics|mesh-list
110979781|NCT03229148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110979782|NCT03229148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110979783|NCT03228992|Ibuprofen|ibuprofen|mesh-list
110754080|NCT03948022|Hormones|hormones|mesh-ancestor
110754155|NCT01346800|Ritonavir|ritonavir|mesh-list
110754156|NCT01346800|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
110754157|NCT01346800|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110754158|NCT01346800|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110754159|NCT01346800|Protease Inhibitors|protease inhibitors|mesh-ancestor
110754160|NCT01346800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110754161|NCT01346800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110754162|NCT01346800|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110979784|NCT03228992|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110979785|NCT03228992|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110754372|NCT00166504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110979787|NCT03228992|Sensory System Agents|sensory system agents|mesh-ancestor
110979788|NCT03228992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110754517|NCT03767036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110979789|NCT03228992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110979790|NCT03228992|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110979791|NCT03228992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110979792|NCT03228992|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110979793|NCT03228992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110979794|NCT03228992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110979795|NCT02452502|Atorvastatin|atorvastatin|mesh-list
110754737|NCT03522844|Serotonin Agents|serotonin agents|mesh-ancestor
110979796|NCT02452502|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110979797|NCT02452502|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110754844|NCT01349764|Vitamin D|vitamin d|mesh-list
110979798|NCT02452502|Antimetabolites|antimetabolites|mesh-ancestor
110754882|NCT00003702|Immunologic Factors|immunologic factors|mesh-ancestor
110754954|NCT00238433|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110755027|NCT01096212|Anesthetics, General|anesthetics, general|mesh-ancestor
110755103|NCT01357486|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110979799|NCT02452502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110755249|NCT01362400|Docetaxel|docetaxel|mesh-list
110979800|NCT02452502|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110979801|NCT02452502|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110979803|NCT03234296|Metronidazole|metronidazole|mesh-list
110755473|NCT00027846|Carboplatin|carboplatin|mesh-list
110979804|NCT03234296|Levofloxacin|levofloxacin|mesh-list
110979805|NCT03234296|Ertapenem|ertapenem|mesh-list
110979806|NCT03234296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110755624|NCT03756116|Autonomic Agents|autonomic agents|mesh-ancestor
110979807|NCT03234296|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110979808|NCT03234296|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110755696|NCT01584726|Analgesics|analgesics|mesh-ancestor
110979809|NCT03234296|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110755767|NCT04625972|Antiviral Agents|antiviral agents|mesh-ancestor
110979810|NCT03234296|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110979811|NCT03234296|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110979813|NCT03234296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110979814|NCT03234296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110979815|NCT03234296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110979816|NCT03234296|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110755911|NCT01325987|Cholecalciferol|cholecalciferol|mesh-list
110979817|NCT03234296|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110979819|NCT03228368|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110979820|NCT03228368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110979821|NCT03228368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110979822|NCT03228368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110979823|NCT03665129|Avdoralimab|avdoralimab|mesh-list
110979824|NCT03665129|Durvalumab|durvalumab|mesh-list
110979825|NCT03665129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110979826|NCT03665129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110979827|NCT03665129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110979828|NCT03665129|Antiviral Agents|antiviral agents|mesh-ancestor
110979829|NCT03665129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110979830|NCT03235700|Nicorandil|nicorandil|mesh-list
110979831|NCT03235700|Adenosine|adenosine|mesh-list
110979832|NCT03235700|Analgesics|analgesics|mesh-ancestor
110979833|NCT03235700|Sensory System Agents|sensory system agents|mesh-ancestor
110756489|NCT05261516|Tocolytic Agents|tocolytic agents|mesh-ancestor
110979834|NCT03235700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110979835|NCT03235700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110756561|NCT01358500|Analgesics|analgesics|mesh-ancestor
110979836|NCT03235700|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110979837|NCT03235700|Vasodilator Agents|vasodilator agents|mesh-ancestor
110979838|NCT03235700|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
110979839|NCT03235700|Purinergic Agonists|purinergic agonists|mesh-ancestor
110979840|NCT03235700|Purinergic Agents|purinergic agents|mesh-ancestor
110979841|NCT03235700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110756888|NCT00352534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110756960|NCT02529774|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110757031|NCT01112748|Lidocaine|lidocaine|mesh-list
110979842|NCT03235700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110979843|NCT03235700|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110979844|NCT03235700|Vitamin B Complex|vitamin b complex|mesh-ancestor
110979846|NCT03235700|Micronutrients|micronutrients|mesh-ancestor
110757254|NCT03792672|Anesthetics|anesthetics|mesh-ancestor
110979847|NCT03234062|Choline|choline|mesh-list
110979848|NCT03234062|Lipotropic Agents|lipotropic agents|mesh-ancestor
110979849|NCT03234062|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110757337|NCT01115478|Vitamin A|vitamin a|mesh-list
110979850|NCT03234062|Antimetabolites|antimetabolites|mesh-ancestor
110979851|NCT03234062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110979852|NCT03234062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110979853|NCT03234062|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110979854|NCT03234062|Nootropic Agents|nootropic agents|mesh-ancestor
110757540|NCT01118598|Vitamins|vitamins|mesh-ancestor
110979855|NCT05702879|Prednisolone|prednisolone|mesh-list
110979856|NCT05702879|Adalimumab|adalimumab|mesh-list
110979857|NCT05702879|Infliximab|infliximab|mesh-list
110979858|NCT05702879|Etanercept|etanercept|mesh-list
110979859|NCT05702879|Golimumab|golimumab|mesh-list
110757691|NCT04959760|Immunoglobulin G|immunoglobulin g|mesh-list
110979860|NCT05702879|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
110979861|NCT05702879|Ustekinumab|ustekinumab|mesh-list
110979862|NCT05702879|Vedolizumab|vedolizumab|mesh-list
110979863|NCT05702879|Ozanimod|ozanimod|mesh-list
110979864|NCT05702879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110979866|NCT05702879|Hormones|hormones|mesh-ancestor
110979867|NCT05702879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110979868|NCT05702879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110979869|NCT05702879|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110758058|NCT01219920|Vitamins|vitamins|mesh-ancestor
110979871|NCT05702879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110979872|NCT05702879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110979873|NCT05702879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110979874|NCT05702879|Dermatologic Agents|dermatologic agents|mesh-ancestor
110979875|NCT05702879|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110979876|NCT05702879|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110979877|NCT05702879|Analgesics|analgesics|mesh-ancestor
110979878|NCT05702879|Sensory System Agents|sensory system agents|mesh-ancestor
110979879|NCT05702879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110979880|NCT05702879|Immunologic Factors|immunologic factors|mesh-ancestor
110979881|NCT05702879|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
110979882|NCT05702879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110979883|NCT03235778|Biphenylylacetic acid|biphenylylacetic acid|mesh-list
110979884|NCT03235778|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110758142|NCT03117010|Etoposide|etoposide|mesh-list
110979885|NCT03235778|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110979887|NCT03235778|Sensory System Agents|sensory system agents|mesh-ancestor
110979888|NCT03235778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110758412|NCT01221402|Niacin|niacin|mesh-list
110979889|NCT03235778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110979890|NCT03235778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110979891|NCT03235778|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110979893|NCT04439513|Coagulants|coagulants|mesh-ancestor
110979894|NCT02452970|Gemcitabine|gemcitabine|mesh-list
110979895|NCT02452970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110758847|NCT03175978|Dermatologic Agents|dermatologic agents|mesh-ancestor
110979897|NCT02452970|Antimetabolites|antimetabolites|mesh-ancestor
110979898|NCT02452970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110759069|NCT01130922|Moxifloxacin|moxifloxacin|mesh-list
110979900|NCT03227900|Anesthetics, Local|anesthetics, local|mesh-ancestor
110979901|NCT03227900|Anesthetics|anesthetics|mesh-ancestor
110979902|NCT03227900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110979903|NCT03227900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110979904|NCT03227900|Sensory System Agents|sensory system agents|mesh-ancestor
110759304|NCT01233570|Tacrolimus|tacrolimus|mesh-list
110979905|NCT03227900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110979906|NCT03227900|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110979907|NCT03227900|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110979908|NCT03227900|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110979909|NCT03227900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110979910|NCT03227900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110979911|NCT03120182|Aspirin|aspirin|mesh-list
110759653|NCT01142778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110979912|NCT03120182|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110979913|NCT03120182|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110759799|NCT01140984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110979915|NCT03120182|Sensory System Agents|sensory system agents|mesh-ancestor
110979916|NCT03120182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110759875|NCT05849090|Clindamycin phosphate|clindamycin phosphate|mesh-list
110979917|NCT03120182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110979918|NCT03120182|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110979919|NCT03120182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110979920|NCT03120182|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110979921|NCT03120182|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110979922|NCT03120182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110979923|NCT03120182|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110979924|NCT03120182|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110759953|NCT05848102|Dapagliflozin|dapagliflozin|mesh-list
110979925|NCT03120182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110979926|NCT03120182|Antipyretics|antipyretics|mesh-ancestor
110979927|NCT02074436|Aminocaproic Acid|aminocaproic acid|mesh-list
110979928|NCT02074436|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110979929|NCT02074436|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110481754|NCT00628550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110979930|NCT02074436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110979931|NCT02074436|Hemostatics|hemostatics|mesh-ancestor
110979932|NCT02074436|Coagulants|coagulants|mesh-ancestor
110979933|NCT03227432|Dexamethasone|dexamethasone|mesh-list
110979934|NCT03227432|Nivolumab|nivolumab|mesh-list
110979935|NCT03227432|Pomalidomide|pomalidomide|mesh-list
110979936|NCT03227432|Elotuzumab|elotuzumab|mesh-list
110979937|NCT03227432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110979938|NCT03227432|Antiemetics|antiemetics|mesh-ancestor
110979939|NCT03227432|Autonomic Agents|autonomic agents|mesh-ancestor
110979940|NCT03227432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110697022|NCT00242710|Bazedoxifene|bazedoxifene|mesh-list
110979941|NCT03227432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110979942|NCT03227432|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110979943|NCT03227432|Glucocorticoids|glucocorticoids|mesh-ancestor
110979945|NCT03227432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110979946|NCT03227432|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110979947|NCT03227432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110979948|NCT03227432|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110979949|NCT03227432|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110979950|NCT03227432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110979951|NCT03227432|Immunologic Factors|immunologic factors|mesh-ancestor
110979952|NCT03227432|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110979953|NCT03227432|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110979954|NCT03227432|Growth Substances|growth substances|mesh-ancestor
110979955|NCT03227432|Growth Inhibitors|growth inhibitors|mesh-ancestor
110979956|NCT03222518|Acetaminophen|acetaminophen|mesh-list
110979957|NCT03222518|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
110979958|NCT03222518|Piroxicam|piroxicam|mesh-list
110760667|NCT05589181|Buprenorphine|buprenorphine|mesh-list
110979959|NCT03222518|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110979960|NCT03222518|Analgesics|analgesics|mesh-ancestor
110979961|NCT03222518|Sensory System Agents|sensory system agents|mesh-ancestor
110979962|NCT03222518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110979963|NCT03222518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110979964|NCT03222518|Antipyretics|antipyretics|mesh-ancestor
110979965|NCT03222518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110979966|NCT03222518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110979967|NCT03222518|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110979968|NCT03222518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110979969|NCT03222518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110979971|NCT01750281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110979972|NCT01750281|Tubulin Modulators|tubulin modulators|mesh-ancestor
110979973|NCT01750281|Antimitotic Agents|antimitotic agents|mesh-ancestor
110979974|NCT01750281|Mitosis Modulators|mitosis modulators|mesh-ancestor
110979975|NCT01750281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110979976|NCT03222206|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
110761027|NCT05159531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110979977|NCT03222206|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110979978|NCT03222206|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110979979|NCT03222206|Analgesics|analgesics|mesh-ancestor
110979980|NCT03222206|Sensory System Agents|sensory system agents|mesh-ancestor
110979981|NCT03222206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110979982|NCT03222206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110979983|NCT03222206|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110979984|NCT03222206|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110979985|NCT03221816|Folic Acid|folic acid|mesh-list
110979986|NCT03221816|Pyridoxine|pyridoxine|mesh-list
110979987|NCT03221816|Vitamin B 12|vitamin b 12|mesh-list
110979988|NCT03221816|Hematinics|hematinics|mesh-ancestor
110979989|NCT03221816|Vitamin B Complex|vitamin b complex|mesh-ancestor
110979990|NCT03221816|Vitamins|vitamins|mesh-ancestor
110979991|NCT03221816|Micronutrients|micronutrients|mesh-ancestor
110979992|NCT03221816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110979993|NCT03119636|Levodopa|levodopa|mesh-list
110979994|NCT03119636|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110979995|NCT03119636|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110979996|NCT03119636|Dopamine Agents|dopamine agents|mesh-ancestor
110979997|NCT03119636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110979998|NCT03119636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110979999|NCT03119636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110980000|NCT03226340|Niacin|niacin|mesh-list
110980001|NCT03226340|Amlodipine|amlodipine|mesh-list
110980002|NCT03226340|Telmisartan|telmisartan|mesh-list
110980003|NCT03226340|Chlorthalidone|chlorthalidone|mesh-list
110980004|NCT03226340|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110980005|NCT03226340|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110761288|NCT04978545|Disinfectants|disinfectants|mesh-ancestor
110980006|NCT03226340|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110761436|NCT04827147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110980007|NCT03226340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110761523|NCT04761614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110761598|NCT04699240|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110761599|NCT04699240|Hormone Antagonists|hormone antagonists|mesh-ancestor
110761600|NCT04699240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110761601|NCT04699240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110761602|NCT04699240|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110761603|NCT04699240|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110761604|NCT04688658|Nivolumab|nivolumab|mesh-list
110761605|NCT04688658|Axitinib|axitinib|mesh-list
110761606|NCT04688658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110761607|NCT04688658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110761608|NCT04688658|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110980008|NCT03226340|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110980009|NCT03226340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110980010|NCT03226340|Vasodilator Agents|vasodilator agents|mesh-ancestor
110980011|NCT03226340|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110761747|NCT04552223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110980012|NCT03226340|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110980013|NCT03226340|Diuretics|diuretics|mesh-ancestor
110980014|NCT03226340|Natriuretic Agents|natriuretic agents|mesh-ancestor
110980015|NCT03226340|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110697095|NCT00239356|Serotonin Agents|serotonin agents|mesh-ancestor
110980016|NCT03226340|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110980018|NCT03226340|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110762251|NCT03769155|Nivolumab|nivolumab|mesh-list
110980019|NCT03226340|Vitamin B Complex|vitamin b complex|mesh-ancestor
110980020|NCT03226340|Vitamins|vitamins|mesh-ancestor
110980021|NCT03226340|Micronutrients|micronutrients|mesh-ancestor
110980022|NCT03221504|Oxymetazoline|oxymetazoline|mesh-list
110980023|NCT03221504|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110762400|NCT03578081|Autonomic Agents|autonomic agents|mesh-ancestor
110762482|NCT03497975|Nalbuphine|nalbuphine|mesh-list
110980024|NCT03221504|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110980025|NCT03221504|Adrenergic Agents|adrenergic agents|mesh-ancestor
110762554|NCT03440190|Dopamine Agents|dopamine agents|mesh-ancestor
110980027|NCT03221504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110980028|NCT03221504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110980029|NCT03221504|Sympathomimetics|sympathomimetics|mesh-ancestor
110980030|NCT03221504|Autonomic Agents|autonomic agents|mesh-ancestor
110980031|NCT03221504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110980032|NCT03221504|Nasal Decongestants|nasal decongestants|mesh-ancestor
110980033|NCT03221504|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110980034|NCT03221504|Respiratory System Agents|respiratory system agents|mesh-ancestor
110762838|NCT02875314|Antimetabolites|antimetabolites|mesh-ancestor
110762914|NCT02792257|Hallucinogens|hallucinogens|mesh-ancestor
110980035|NCT03221582|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
110980036|NCT03221582|Antiviral Agents|antiviral agents|mesh-ancestor
110763061|NCT02403323|Etrolizumab|etrolizumab|mesh-list
110980037|NCT03221582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110980039|NCT03232034|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110763214|NCT02090998|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110980040|NCT03232034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110763289|NCT01606137|Nabiximols|nabiximols|mesh-list
110980043|NCT03225950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110980044|NCT03119948|Botulinum Toxins|botulinum toxins|mesh-list
110980045|NCT03119948|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110980046|NCT03119948|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110980047|NCT03119948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110763578|NCT05703425|Sulfasalazine|sulfasalazine|mesh-list
110980048|NCT03119948|Cholinergic Agents|cholinergic agents|mesh-ancestor
110980049|NCT03119948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110763653|NCT05389852|Analgesics|analgesics|mesh-ancestor
110980050|NCT03119948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110980051|NCT03232112|Exenatide|exenatide|mesh-list
110980052|NCT03232112|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110980053|NCT03232112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110980054|NCT03232112|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110980055|NCT03232112|Incretins|incretins|mesh-ancestor
110980056|NCT03232112|Hormones|hormones|mesh-ancestor
110980057|NCT03232112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110980058|NCT03000569|Levodopa|levodopa|mesh-list
110980060|NCT03000569|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110980061|NCT03000569|Dopamine Agents|dopamine agents|mesh-ancestor
110764251|NCT00219557|Axitinib|axitinib|mesh-list
110980062|NCT03000569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110980063|NCT03000569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110980064|NCT03000569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110980065|NCT02554786|Fluticasone|fluticasone|mesh-list
110980066|NCT02554786|Xhance|xhance|mesh-list
110980067|NCT02554786|Mometasone Furoate|mometasone furoate|mesh-list
110980068|NCT02554786|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110980069|NCT02554786|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110980070|NCT02554786|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110980071|NCT02554786|Autonomic Agents|autonomic agents|mesh-ancestor
110980072|NCT02554786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110980073|NCT02554786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110980074|NCT02554786|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110980075|NCT02554786|Respiratory System Agents|respiratory system agents|mesh-ancestor
110980076|NCT02554786|Dermatologic Agents|dermatologic agents|mesh-ancestor
110980077|NCT02554786|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110980078|NCT02554786|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110980079|NCT02554786|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110980080|NCT02554786|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110980081|NCT02554786|Adrenergic Agents|adrenergic agents|mesh-ancestor
110980082|NCT02554786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110980083|NCT02554786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110980084|NCT05202314|Immunomodulating Agents|immunomodulating agents|mesh-list
110980085|NCT05202314|Immunologic Factors|immunologic factors|mesh-ancestor
110980086|NCT05202314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110980087|NCT03225326|Carticaine|carticaine|mesh-list
110980088|NCT03225326|Anesthetics, Local|anesthetics, local|mesh-ancestor
110980089|NCT03225326|Anesthetics|anesthetics|mesh-ancestor
110980090|NCT03225326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110980091|NCT03225326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110697171|NCT00393042|Sympathomimetics|sympathomimetics|mesh-ancestor
110980092|NCT03225326|Sensory System Agents|sensory system agents|mesh-ancestor
110481797|NCT04304144|Cyclophosphamide|cyclophosphamide|mesh-list
110980093|NCT03225326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110980094|NCT03220880|Dexmedetomidine|dexmedetomidine|mesh-list
110980095|NCT03220880|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110980096|NCT03220880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110980097|NCT03220880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110980098|NCT03220880|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110980100|NCT03220880|Sensory System Agents|sensory system agents|mesh-ancestor
110980101|NCT03220880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110980102|NCT03220880|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110764821|NCT01375816|Leucovorin|leucovorin|mesh-list
110980104|NCT03220880|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110764883|NCT01244880|Ketamine|ketamine|mesh-list
110980105|NCT03220880|Adrenergic Agents|adrenergic agents|mesh-ancestor
110980107|NCT03220880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110980109|NCT02929589|Analgesics, Opioid|analgesics, opioid|mesh-list
110765172|NCT01148004|Antimetabolites|antimetabolites|mesh-ancestor
110980110|NCT02929589|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110980111|NCT02929589|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110980112|NCT02929589|Analgesics|analgesics|mesh-ancestor
110980113|NCT02929589|Sensory System Agents|sensory system agents|mesh-ancestor
110980114|NCT02929589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110980115|NCT02929589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110980116|NCT02929589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110980117|NCT02929589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110980118|NCT02929589|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110980119|NCT02929589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110980120|NCT02929589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110980121|NCT02929589|Narcotics|narcotics|mesh-ancestor
110980122|NCT02929589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110980123|NCT02910635|Moxifloxacin|moxifloxacin|mesh-list
110765549|NCT03922750|Insulin|insulin|mesh-list
110980124|NCT02910635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110980125|NCT02910635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110980126|NCT02910635|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110980127|NCT02910635|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110980128|NCT02910635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110980129|NCT02910635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110980130|NCT02910635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110980131|NCT02614547|Brexanolone|brexanolone|mesh-list
110980132|NCT02614547|Neurosteroids|neurosteroids|mesh-ancestor
110980133|NCT02614547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110765902|NCT05941494|Anesthetics, General|anesthetics, general|mesh-ancestor
110980134|NCT02614547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110980135|NCT02614547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110980136|NCT02614547|GABA Modulators|gaba modulators|mesh-ancestor
110980137|NCT02614547|GABA Agents|gaba agents|mesh-ancestor
110766128|NCT05751187|Hematinics|hematinics|mesh-ancestor
110980139|NCT04472481|Vitamin D|vitamin d|mesh-list
110980140|NCT04472481|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110980141|NCT04472481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110980142|NCT04472481|Vitamins|vitamins|mesh-ancestor
110980143|NCT04472481|Micronutrients|micronutrients|mesh-ancestor
110980144|NCT04472481|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110980145|NCT01233297|Azithromycin|azithromycin|mesh-list
110980146|NCT01233297|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110980147|NCT01233297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110980148|NCT04681079|Albuterol|albuterol|mesh-list
110980149|NCT04681079|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110980150|NCT04681079|Autonomic Agents|autonomic agents|mesh-ancestor
110980151|NCT04681079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110980152|NCT04681079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110980153|NCT04681079|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110980154|NCT04681079|Respiratory System Agents|respiratory system agents|mesh-ancestor
110980155|NCT04681079|Tocolytic Agents|tocolytic agents|mesh-ancestor
110980156|NCT04681079|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110766273|NCT05303311|Narcotics|narcotics|mesh-ancestor
110980157|NCT04681079|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110980158|NCT04681079|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110766332|NCT05130463|Incretins|incretins|mesh-ancestor
110980159|NCT04681079|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110980160|NCT04681079|Adrenergic Agents|adrenergic agents|mesh-ancestor
110766482|NCT04485013|Pembrolizumab|pembrolizumab|mesh-list
110980161|NCT04681079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110980162|NCT04681079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110980163|NCT00580125|Aripiprazole|aripiprazole|mesh-list
110980164|NCT00580125|Antidepressive Agents|antidepressive agents|mesh-ancestor
110980165|NCT00580125|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110766561|NCT04357587|Pembrolizumab|pembrolizumab|mesh-list
110980168|NCT00580125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110980169|NCT00580125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110980170|NCT00580125|Dopamine Agonists|dopamine agonists|mesh-ancestor
110980172|NCT00580125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110980173|NCT00580125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110766847|NCT03181763|Serotonin Agents|serotonin agents|mesh-ancestor
110766921|NCT02619253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110766997|NCT02008396|Serotonin Agents|serotonin agents|mesh-ancestor
110980174|NCT00580125|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110980175|NCT00580125|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110767125|NCT01163383|Iodine|iodine|mesh-list
110767147|NCT01039584|Butoconazole|butoconazole|mesh-list
110980176|NCT00580125|Serotonin Agents|serotonin agents|mesh-ancestor
110767219|NCT03899610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110980177|NCT00580125|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110980178|NCT00580125|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110767373|NCT03892512|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110980179|NCT00580125|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110980180|NCT00580125|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110980181|NCT00579189|Moxifloxacin|moxifloxacin|mesh-list
110980182|NCT00579189|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110980183|NCT00579189|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110980184|NCT00579189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110980185|NCT00579189|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110980186|NCT00579189|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110980187|NCT00579189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110980188|NCT00579189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110980189|NCT00579189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110980191|NCT00667953|Imatinib Mesylate|imatinib mesylate|mesh-list
110980192|NCT00667953|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110980193|NCT00667953|Alkylating Agents|alkylating agents|mesh-ancestor
110980194|NCT00667953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110980195|NCT00667953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110767515|NCT03888846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110767585|NCT03885180|Warfarin|warfarin|mesh-list
110980196|NCT00667953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110980197|NCT00667953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110980198|NCT00578955|Azithromycin|azithromycin|mesh-list
110980199|NCT00578955|Dexamethasone|dexamethasone|mesh-list
110980200|NCT00578955|Dexamethasone acetate|dexamethasone acetate|mesh-list
110980201|NCT00578955|BB 1101|bb 1101|mesh-list
110980202|NCT00578955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110980203|NCT00578955|Antiemetics|antiemetics|mesh-ancestor
110980204|NCT00578955|Autonomic Agents|autonomic agents|mesh-ancestor
110980205|NCT00578955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110980206|NCT00578955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110980207|NCT00578955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110980208|NCT00578955|Glucocorticoids|glucocorticoids|mesh-ancestor
110980209|NCT00578955|Hormones|hormones|mesh-ancestor
110980210|NCT00578955|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110980211|NCT00578955|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110980212|NCT00578955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110980213|NCT00578955|Protease Inhibitors|protease inhibitors|mesh-ancestor
110980214|NCT00578955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110980215|NCT00578955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110980216|NCT00578955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110980217|NCT00578955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110980218|NCT00576537|Immunomodulating Agents|immunomodulating agents|mesh-list
110980219|NCT00576537|Immunologic Factors|immunologic factors|mesh-ancestor
110768009|NCT01266486|Metformin|metformin|mesh-list
110980220|NCT00576537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110980221|NCT02282241|Melatonin|melatonin|mesh-list
110980222|NCT02282241|Antioxidants|antioxidants|mesh-ancestor
110768148|NCT01162824|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110768219|NCT01158846|Anticoagulants|anticoagulants|mesh-ancestor
110980223|NCT02282241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110980224|NCT02282241|Protective Agents|protective agents|mesh-ancestor
110980225|NCT02282241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110980226|NCT02282241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110980227|NCT02424851|Thalidomide|thalidomide|mesh-list
110980228|NCT02424851|Dexamethasone|dexamethasone|mesh-list
110980229|NCT02424851|Bortezomib|bortezomib|mesh-list
110768606|NCT01281540|Cisapride|cisapride|mesh-list
110980230|NCT02424851|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110768663|NCT01281696|Immunologic Factors|immunologic factors|mesh-ancestor
110768736|NCT05834582|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110980231|NCT02424851|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110980232|NCT02424851|Antiemetics|antiemetics|mesh-ancestor
110980233|NCT02424851|Autonomic Agents|autonomic agents|mesh-ancestor
110768898|NCT05753098|Clomiphene|clomiphene|mesh-list
110980234|NCT02424851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110980235|NCT02424851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110980236|NCT02424851|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110980238|NCT02424851|Hormones|hormones|mesh-ancestor
110980239|NCT02424851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110980240|NCT02424851|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110980241|NCT02424851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110980242|NCT02424851|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110980244|NCT02424851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110980245|NCT02424851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110980246|NCT02424851|Immunologic Factors|immunologic factors|mesh-ancestor
110980247|NCT02424851|Leprostatic Agents|leprostatic agents|mesh-ancestor
110980248|NCT02424851|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110980249|NCT02424851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110980250|NCT02424851|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110980251|NCT02424851|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110980252|NCT02424851|Growth Substances|growth substances|mesh-ancestor
110980253|NCT02424851|Growth Inhibitors|growth inhibitors|mesh-ancestor
110980254|NCT02284035|Raltegravir Potassium|raltegravir potassium|mesh-list
110980255|NCT02284035|Lamivudine|lamivudine|mesh-list
110980256|NCT02284035|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110980257|NCT02284035|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110980258|NCT02284035|Antiviral Agents|antiviral agents|mesh-ancestor
110980259|NCT02284035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110980260|NCT02284035|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110980261|NCT02284035|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110980262|NCT02284035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110980263|NCT02284035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110980264|NCT02284035|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110980265|NCT02284035|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110980266|NCT00484419|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110980267|NCT00484419|Rosiglitazone|rosiglitazone|mesh-list
110980268|NCT00484419|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
110980269|NCT00484419|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110980270|NCT00484419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110980271|NCT00484419|Incretins|incretins|mesh-ancestor
110980272|NCT00484419|Hormones|hormones|mesh-ancestor
110980273|NCT00484419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110980274|NCT00484419|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110980275|NCT00484419|Protease Inhibitors|protease inhibitors|mesh-ancestor
110980276|NCT00484419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110980277|NCT00484419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110980278|NCT00484419|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110980279|NCT00484419|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110769383|NCT03516812|Olaparib|olaparib|mesh-list
110980280|NCT00484419|Antimetabolites|antimetabolites|mesh-ancestor
110980281|NCT00484419|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110980282|NCT02273895|Scopolamine|scopolamine|mesh-list
110980283|NCT02273895|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
110980284|NCT02273895|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110980285|NCT02273895|Antiemetics|antiemetics|mesh-ancestor
110980286|NCT02273895|Autonomic Agents|autonomic agents|mesh-ancestor
110980287|NCT02273895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110980288|NCT02273895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110980289|NCT02273895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110980290|NCT02273895|Mydriatics|mydriatics|mesh-ancestor
110980291|NCT02273895|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110980292|NCT02273895|Cholinergic Agents|cholinergic agents|mesh-ancestor
110769657|NCT02366819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110980293|NCT02273895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110980294|NCT02273895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110980295|NCT02273895|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110980296|NCT02273895|Parasympatholytics|parasympatholytics|mesh-ancestor
110980297|NCT00480831|Paclitaxel|paclitaxel|mesh-list
110980298|NCT00480831|Bevacizumab|bevacizumab|mesh-list
110980299|NCT00480831|Carboplatin|carboplatin|mesh-list
110980300|NCT00480831|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110980301|NCT00480831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110980302|NCT00480831|Tubulin Modulators|tubulin modulators|mesh-ancestor
110980303|NCT00480831|Antimitotic Agents|antimitotic agents|mesh-ancestor
110980304|NCT00480831|Mitosis Modulators|mitosis modulators|mesh-ancestor
110980305|NCT00480831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110980306|NCT00480831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110980307|NCT00480831|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110980308|NCT00480831|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110980309|NCT00480831|Growth Substances|growth substances|mesh-ancestor
110770168|NCT01172028|Pemetrexed|pemetrexed|mesh-list
110980310|NCT00480831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110980311|NCT00480831|Growth Inhibitors|growth inhibitors|mesh-ancestor
110980313|NCT02549092|Carbidopa|carbidopa|mesh-list
110980314|NCT02549092|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
110980316|NCT02549092|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110980317|NCT02549092|Dopamine Agents|dopamine agents|mesh-ancestor
110980318|NCT02549092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110980319|NCT02549092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110980320|NCT02549092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110980321|NCT02549092|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
110980322|NCT02549092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110980323|NCT02549092|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110980324|NCT02549092|Immunologic Factors|immunologic factors|mesh-ancestor
110980325|NCT02549092|Dopamine Agonists|dopamine agonists|mesh-ancestor
110980326|NCT03220256|Lamotrigine|lamotrigine|mesh-list
110980327|NCT03220256|Anticonvulsants|anticonvulsants|mesh-ancestor
110980328|NCT03220256|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110980329|NCT03220256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110481840|NCT00770224|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110980330|NCT03220256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110980331|NCT03220256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110980332|NCT03220256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110980333|NCT03220256|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110980334|NCT03220256|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110980335|NCT03220256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110980336|NCT03220256|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110980337|NCT03220256|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110980338|NCT03220490|Timolol|timolol|mesh-list
110980339|NCT03220490|Brimonidine Tartrate|brimonidine tartrate|mesh-list
110980340|NCT03220490|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110980341|NCT03220490|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110980342|NCT03220490|Adrenergic Agents|adrenergic agents|mesh-ancestor
110980343|NCT03220490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110770508|NCT01285596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110770581|NCT02525172|Antimetabolites|antimetabolites|mesh-ancestor
110980344|NCT03220490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110980345|NCT03220490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110980346|NCT03220490|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110980347|NCT03220490|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110980348|NCT03220490|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110980349|NCT03220490|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110980350|NCT03220490|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110980351|NCT02553772|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
110980352|NCT02553772|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110771174|NCT01182246|Estrogens|estrogens|mesh-ancestor
110771251|NCT01290354|Lapatinib|lapatinib|mesh-list
110980353|NCT02553772|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110980354|NCT02553772|Laxatives|laxatives|mesh-ancestor
110771403|NCT01292694|Losartan|losartan|mesh-list
110980355|NCT02553772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110980356|NCT03119714|Pemirolast|pemirolast|mesh-list
110771491|NCT01293942|Irinotecan|irinotecan|mesh-list
110980357|NCT03119714|Histamine Antagonists|histamine antagonists|mesh-ancestor
110980358|NCT03119714|Histamine Agents|histamine agents|mesh-ancestor
110980359|NCT03119714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110980360|NCT03119714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110980361|NCT03119714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110980362|NCT00562887|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110980363|NCT00562887|Immunologic Factors|immunologic factors|mesh-ancestor
110980364|NCT00562887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110980365|NCT05468554|Metformin|metformin|mesh-list
110980366|NCT05468554|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110980367|NCT05468554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110980368|NCT04617821|Paclitaxel|paclitaxel|mesh-list
110980369|NCT04617821|Gemcitabine|gemcitabine|mesh-list
110980370|NCT04617821|Folfirinox|folfirinox|mesh-list
110771993|NCT02914366|Expectorants|expectorants|mesh-ancestor
110772069|NCT03726996|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110980371|NCT04617821|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110772143|NCT01200108|Autonomic Agents|autonomic agents|mesh-ancestor
110980372|NCT04617821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110980373|NCT04617821|Tubulin Modulators|tubulin modulators|mesh-ancestor
110980374|NCT04617821|Antimitotic Agents|antimitotic agents|mesh-ancestor
110980375|NCT04617821|Mitosis Modulators|mitosis modulators|mesh-ancestor
110772296|NCT03792516|Artesunate|artesunate|mesh-list
110980376|NCT04617821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110772363|NCT01201278|Insulin Lispro|insulin lispro|mesh-list
110980377|NCT04617821|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110980378|NCT04617821|Antimetabolites|antimetabolites|mesh-ancestor
110980379|NCT03219008|Lithium Carbonate|lithium carbonate|mesh-list
110980380|NCT03219008|Mirtazapine|mirtazapine|mesh-list
110980381|NCT03219008|Fluvoxamine|fluvoxamine|mesh-list
110980382|NCT03219008|Fluoxetine|fluoxetine|mesh-list
110980383|NCT03219008|Bupropion|bupropion|mesh-list
110980384|NCT03219008|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-list
110980385|NCT03219008|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110980386|NCT03219008|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110980387|NCT03219008|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110697466|NCT00209092|Capecitabine|capecitabine|mesh-list
110980388|NCT03219008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110980389|NCT03219008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110980390|NCT03219008|Serotonin Agents|serotonin agents|mesh-ancestor
110980391|NCT03219008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110980392|NCT03219008|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110772728|NCT02918292|Thymoglobulin|thymoglobulin|mesh-list
110980393|NCT03219008|Antidepressive Agents|antidepressive agents|mesh-ancestor
110980394|NCT03219008|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110772800|NCT01205022|Calcium|calcium|mesh-list
110980395|NCT03219008|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110980396|NCT03219008|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110980397|NCT03219008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110980398|NCT03219008|Antimanic Agents|antimanic agents|mesh-ancestor
110980399|NCT03219008|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110980400|NCT03219008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110980401|NCT03219008|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110980402|NCT03219008|Histamine Antagonists|histamine antagonists|mesh-ancestor
110980403|NCT03219008|Histamine Agents|histamine agents|mesh-ancestor
110980404|NCT03219008|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110980405|NCT03219008|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
110980406|NCT03219008|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110773097|NCT03347838|Nivolumab|nivolumab|mesh-list
110980407|NCT03219008|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110980408|NCT03219008|Adrenergic Agents|adrenergic agents|mesh-ancestor
110980409|NCT03219008|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110980410|NCT03219008|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110980411|NCT03219008|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110980412|NCT03219008|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110773161|NCT01384240|Proflavine|proflavine|mesh-list
110773227|NCT01381354|Protective Agents|protective agents|mesh-ancestor
110980413|NCT03219008|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110980414|NCT03219008|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111141327|NCT05472337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111141329|NCT05472259|Fluorouracil|fluorouracil|mesh-list
111141330|NCT05472259|Oxaliplatin|oxaliplatin|mesh-list
111141331|NCT05472259|Irinotecan|irinotecan|mesh-list
111141332|NCT05472259|Antimetabolites|antimetabolites|mesh-ancestor
111141333|NCT05472259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111141334|NCT05472259|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111141335|NCT05472259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111141336|NCT05472259|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111141337|NCT05472259|Immunologic Factors|immunologic factors|mesh-ancestor
111141338|NCT05472259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111141339|NCT05472259|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111141340|NCT05472259|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111141341|NCT05472259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111141342|NCT05472259|Antidotes|antidotes|mesh-ancestor
111141343|NCT05472259|Protective Agents|protective agents|mesh-ancestor
111141344|NCT05472259|Vitamin B Complex|vitamin b complex|mesh-ancestor
111141345|NCT05472259|Vitamins|vitamins|mesh-ancestor
111141346|NCT05472259|Micronutrients|micronutrients|mesh-ancestor
111141347|NCT04266145|Dexmedetomidine|dexmedetomidine|mesh-list
111141348|NCT04266145|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111141349|NCT04266145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111141350|NCT04266145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111141351|NCT04266145|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111141352|NCT04266145|Analgesics|analgesics|mesh-ancestor
111141353|NCT04266145|Sensory System Agents|sensory system agents|mesh-ancestor
111141354|NCT04266145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111141355|NCT04266145|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111141356|NCT04266145|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111141357|NCT04266145|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111141358|NCT04266145|Adrenergic Agents|adrenergic agents|mesh-ancestor
111141359|NCT04266145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111141360|NCT04266145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111141361|NCT03383419|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
111141362|NCT03383419|Antiviral Agents|antiviral agents|mesh-ancestor
111141363|NCT03383419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111141364|NCT05477017|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
111141365|NCT05477017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111141366|NCT05477017|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111141367|NCT05477017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111141368|NCT02554903|Macitentan|macitentan|mesh-list
111141369|NCT02554903|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
111141370|NCT02554903|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
111141371|NCT02554903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111141372|NCT02554903|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
111141373|NCT02332707|Ribavirin|ribavirin|mesh-list
111141374|NCT02332707|Grazoprevir|grazoprevir|mesh-list
111141375|NCT02332707|Ruzasvir|ruzasvir|mesh-list
111141376|NCT02332707|Uprifosbuvir|uprifosbuvir|mesh-list
111141377|NCT02332707|Antimetabolites|antimetabolites|mesh-ancestor
111141378|NCT02332707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111141379|NCT02332707|Antiviral Agents|antiviral agents|mesh-ancestor
111141380|NCT02332707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111141381|NCT02370615|Itraconazole|itraconazole|mesh-list
111141382|NCT02370615|Digoxin|digoxin|mesh-list
111141383|NCT02370615|Midazolam|midazolam|mesh-list
111141384|NCT02370615|Imarikiren hydrochloride|imarikiren hydrochloride|mesh-list
111141385|NCT02370615|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111141386|NCT02370615|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111141387|NCT02370615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111141388|NCT02370615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111141389|NCT02370615|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111141390|NCT02370615|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111141391|NCT02370615|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111141392|NCT02370615|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111141393|NCT02370615|Anesthetics, General|anesthetics, general|mesh-ancestor
111141394|NCT02370615|Anesthetics|anesthetics|mesh-ancestor
111141395|NCT02370615|GABA Modulators|gaba modulators|mesh-ancestor
111141396|NCT02370615|GABA Agents|gaba agents|mesh-ancestor
111141397|NCT02370615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111141398|NCT02370615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111141399|NCT02370615|Antifungal Agents|antifungal agents|mesh-ancestor
111141400|NCT02370615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111141401|NCT02370615|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111141402|NCT02370615|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111141403|NCT02370615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111141404|NCT02370615|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111141405|NCT02370615|Hormone Antagonists|hormone antagonists|mesh-ancestor
111141406|NCT02370615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111141407|NCT02370615|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111141408|NCT02370615|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111141409|NCT02370615|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111141410|NCT02370615|Protective Agents|protective agents|mesh-ancestor
111141411|NCT02307513|Apremilast|apremilast|mesh-list
111141412|NCT02307513|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111141413|NCT02307513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111141414|NCT02307513|Analgesics|analgesics|mesh-ancestor
111141415|NCT02307513|Sensory System Agents|sensory system agents|mesh-ancestor
110858437|NCT05573230|GABA Agents|gaba agents|mesh-ancestor
111141416|NCT02307513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111141417|NCT02307513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111141418|NCT02307513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111141419|NCT02307513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111141420|NCT02307513|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
111141421|NCT02307513|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111141422|NCT02307513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111141423|NCT02307513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111141424|NCT02328105|Paclitaxel|paclitaxel|mesh-list
111141425|NCT02328105|Carboplatin|carboplatin|mesh-list
111141426|NCT02328105|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111141427|NCT02328105|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111141428|NCT02328105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111141429|NCT02328105|Tubulin Modulators|tubulin modulators|mesh-ancestor
111141430|NCT02328105|Antimitotic Agents|antimitotic agents|mesh-ancestor
111141431|NCT02328105|Mitosis Modulators|mitosis modulators|mesh-ancestor
111141432|NCT02328105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111141433|NCT02305797|Lorazepam|lorazepam|mesh-list
111141434|NCT02305797|Anticonvulsants|anticonvulsants|mesh-ancestor
111141435|NCT02305797|Antiemetics|antiemetics|mesh-ancestor
111141436|NCT02305797|Autonomic Agents|autonomic agents|mesh-ancestor
111141437|NCT02305797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111141438|NCT02305797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111141439|NCT02305797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111141440|NCT02305797|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111141441|NCT02305797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111141442|NCT02305797|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111141443|NCT02305797|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111141444|NCT02305797|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111141445|NCT02305797|GABA Modulators|gaba modulators|mesh-ancestor
111141446|NCT02305797|GABA Agents|gaba agents|mesh-ancestor
111141447|NCT02305797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111141448|NCT02305797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111141449|NCT01646073|Adalimumab|adalimumab|mesh-list
111141450|NCT01646073|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111141451|NCT01646073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111141452|NCT01646073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111141453|NCT02551159|Carboplatin|carboplatin|mesh-list
111141454|NCT02551159|Fluorouracil|fluorouracil|mesh-list
111141455|NCT02551159|Cetuximab|cetuximab|mesh-list
111141456|NCT02551159|Durvalumab|durvalumab|mesh-list
111141457|NCT02551159|Tremelimumab|tremelimumab|mesh-list
111141458|NCT02551159|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111141459|NCT02551159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111141460|NCT02551159|Antimetabolites|antimetabolites|mesh-ancestor
111141461|NCT02551159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111141462|NCT02551159|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111141463|NCT02551159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111141464|NCT02551159|Immunologic Factors|immunologic factors|mesh-ancestor
110839435|NCT03764527|Anthelmintics|anthelmintics|mesh-ancestor
111141465|NCT02551159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111141466|NCT02551159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111141467|NCT04539379|Magnesium Sulfate|magnesium sulfate|mesh-list
111141468|NCT04539379|Analgesics|analgesics|mesh-ancestor
111141469|NCT04539379|Sensory System Agents|sensory system agents|mesh-ancestor
111141470|NCT04539379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111141471|NCT04539379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111141472|NCT04539379|Anesthetics|anesthetics|mesh-ancestor
111141473|NCT04539379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111141474|NCT04539379|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111141475|NCT04539379|Anticonvulsants|anticonvulsants|mesh-ancestor
111141476|NCT04539379|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111141477|NCT04539379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111141478|NCT04539379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111141479|NCT04539379|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111141480|NCT04539379|Tocolytic Agents|tocolytic agents|mesh-ancestor
111141481|NCT04539379|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111141482|NCT05470075|Tramadol|tramadol|mesh-list
111141483|NCT05470075|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111141484|NCT05470075|Narcotics|narcotics|mesh-ancestor
111141485|NCT05470075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111141486|NCT05470075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111141487|NCT05470075|Analgesics|analgesics|mesh-ancestor
111141488|NCT05470075|Sensory System Agents|sensory system agents|mesh-ancestor
111141489|NCT05470075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111141490|NCT05481619|Vedolizumab|vedolizumab|mesh-list
111141491|NCT05481619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111141492|NCT02305563|Cytarabine|cytarabine|mesh-list
111141493|NCT02305563|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111141494|NCT02305563|Antimetabolites|antimetabolites|mesh-ancestor
111141495|NCT02305563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111141496|NCT02305563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111141497|NCT02305563|Antiviral Agents|antiviral agents|mesh-ancestor
111141498|NCT02305563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111141499|NCT02305563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111141500|NCT02305563|Immunologic Factors|immunologic factors|mesh-ancestor
111141501|NCT02305563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111141502|NCT02304705|Sildenafil Citrate|sildenafil citrate|mesh-list
111141503|NCT02304705|Vasodilator Agents|vasodilator agents|mesh-ancestor
111141504|NCT02304705|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111141505|NCT02304705|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111141506|NCT02304705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111141507|NCT02304705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111141508|NCT02304705|Urological Agents|urological agents|mesh-ancestor
111141509|NCT02553499|Pembrolizumab|pembrolizumab|mesh-list
111141510|NCT02553499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111141511|NCT02553499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111141512|NCT02553499|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111141513|NCT02553499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111141514|NCT02553265|Carbidopa|carbidopa|mesh-list
111141515|NCT02553265|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111141516|NCT02553265|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111141517|NCT02553265|Dopamine Agents|dopamine agents|mesh-ancestor
111141518|NCT02553265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111141519|NCT02553265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111141520|NCT02553265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111141521|NCT02553265|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
111141522|NCT02553265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111141523|NCT03215095|Durvalumab|durvalumab|mesh-list
111141524|NCT03215095|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111141525|NCT03215095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111141526|NCT01663103|Rilonacept|rilonacept|mesh-list
111141527|NCT01663103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111141528|NCT05501639|Tiotropium Bromide|tiotropium bromide|mesh-list
111141529|NCT05501639|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111141530|NCT05501639|Autonomic Agents|autonomic agents|mesh-ancestor
111141531|NCT05501639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111141532|NCT05501639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111141533|NCT05501639|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111141534|NCT05501639|Respiratory System Agents|respiratory system agents|mesh-ancestor
111141535|NCT05501639|Parasympatholytics|parasympatholytics|mesh-ancestor
111141536|NCT05501639|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111141537|NCT05501639|Cholinergic Agents|cholinergic agents|mesh-ancestor
111141538|NCT05501639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111141539|NCT05501639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111141540|NCT04577963|Tislelizumab|tislelizumab|mesh-list
111141541|NCT04577963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111141542|NCT04577963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111141543|NCT04532645|Olaparib|olaparib|mesh-list
111141544|NCT04532645|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111141545|NCT04532645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111141546|NCT04532645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111141547|NCT04532645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111141548|NCT02560025|Cytarabine|cytarabine|mesh-list
111141549|NCT02560025|Daunorubicin|daunorubicin|mesh-list
111141550|NCT02560025|Idarubicin|idarubicin|mesh-list
111141551|NCT02560025|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111141552|NCT02560025|Antimetabolites|antimetabolites|mesh-ancestor
111141553|NCT02560025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111141554|NCT02560025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111141555|NCT02560025|Antiviral Agents|antiviral agents|mesh-ancestor
111141556|NCT02560025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111141557|NCT02560025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111141558|NCT02560025|Immunologic Factors|immunologic factors|mesh-ancestor
111141559|NCT02560025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111141560|NCT02560025|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111141561|NCT02560025|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111141562|NCT02560025|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111141563|NCT02560025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111141564|NCT05500937|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
110858614|NCT03296488|Fentanyl|fentanyl|mesh-list
111141565|NCT05500937|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
111141566|NCT05500937|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111141567|NCT04524455|Dexamethasone|dexamethasone|mesh-list
111141568|NCT04524455|Blinatumomab|blinatumomab|mesh-list
111141569|NCT04524455|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111141570|NCT04524455|Antiemetics|antiemetics|mesh-ancestor
111141571|NCT04524455|Autonomic Agents|autonomic agents|mesh-ancestor
111141572|NCT04524455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111141573|NCT04524455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111141574|NCT04524455|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111141575|NCT04524455|Glucocorticoids|glucocorticoids|mesh-ancestor
111141577|NCT04524455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111141578|NCT04524455|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111141579|NCT04524455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111141580|NCT04411901|Cholecalciferol|cholecalciferol|mesh-list
111141581|NCT04411901|Vitamin D|vitamin d|mesh-list
111141582|NCT04411901|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111141583|NCT04411901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111141584|NCT04411901|Vitamins|vitamins|mesh-ancestor
111141585|NCT04411901|Micronutrients|micronutrients|mesh-ancestor
111141586|NCT04411901|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111141587|NCT05508737|Trifluridine|trifluridine|mesh-list
111141588|NCT05508737|Pembrolizumab|pembrolizumab|mesh-list
111141589|NCT05508737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111141590|NCT05508737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111141591|NCT05508737|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111141592|NCT05508737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111141593|NCT05508737|Antimetabolites|antimetabolites|mesh-ancestor
111141594|NCT05508737|Antiviral Agents|antiviral agents|mesh-ancestor
111141595|NCT05508737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111141596|NCT05508035|Valsartan|valsartan|mesh-list
111141597|NCT05508035|Ramipril|ramipril|mesh-list
111141598|NCT05508035|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
111141599|NCT05508035|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111141600|NCT05508035|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111141601|NCT05508035|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111141602|NCT05508035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111141603|NCT05508035|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
111141604|NCT05508035|Protease Inhibitors|protease inhibitors|mesh-ancestor
111141605|NCT05508035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111141606|NCT02566889|Infliximab|infliximab|mesh-list
111141607|NCT02566889|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111141608|NCT02566889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111141609|NCT02566889|Dermatologic Agents|dermatologic agents|mesh-ancestor
111141610|NCT02566889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111141611|NCT02566889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111141612|NCT05507957|Chlorhexidine|chlorhexidine|mesh-list
111141613|NCT05507957|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
111141614|NCT05507957|Ethanol|ethanol|mesh-list
111141615|NCT05507957|Povidone-Iodine|povidone-iodine|mesh-list
111141616|NCT05507957|Disinfectants|disinfectants|mesh-list
111141617|NCT05507957|Povidone|povidone|mesh-list
111141618|NCT05507957|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111141619|NCT05507957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111141620|NCT05507957|Dermatologic Agents|dermatologic agents|mesh-ancestor
111141621|NCT05507957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111141622|NCT05507957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111141623|NCT05507957|Plasma Substitutes|plasma substitutes|mesh-ancestor
111141624|NCT05507957|Blood Substitutes|blood substitutes|mesh-ancestor
111141625|NCT04282109|Paclitaxel|paclitaxel|mesh-list
111141626|NCT04282109|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111141627|NCT04282109|Nivolumab|nivolumab|mesh-list
111141628|NCT04282109|Cetuximab|cetuximab|mesh-list
111141629|NCT04282109|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111141630|NCT04282109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111141631|NCT04282109|Tubulin Modulators|tubulin modulators|mesh-ancestor
111141632|NCT04282109|Antimitotic Agents|antimitotic agents|mesh-ancestor
111141633|NCT04282109|Mitosis Modulators|mitosis modulators|mesh-ancestor
111141634|NCT04282109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111141635|NCT04282109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111141636|NCT04282109|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111141637|NCT03150173|Buprenorphine|buprenorphine|mesh-list
111141638|NCT03150173|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111141639|NCT03150173|Narcotics|narcotics|mesh-ancestor
111141640|NCT03150173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111141641|NCT03150173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111141642|NCT03150173|Analgesics|analgesics|mesh-ancestor
111141643|NCT03150173|Sensory System Agents|sensory system agents|mesh-ancestor
111141644|NCT03150173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111141645|NCT03150173|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110481951|NCT00619905|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111141646|NCT05563571|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111141647|NCT05563571|Methylprednisolone|methylprednisolone|mesh-list
111141648|NCT05563571|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111141649|NCT05563571|Prednisolone|prednisolone|mesh-list
111141650|NCT05563571|Prednisolone acetate|prednisolone acetate|mesh-list
111141651|NCT05563571|Lidocaine|lidocaine|mesh-list
111141652|NCT05563571|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111141653|NCT05563571|Prednisolone phosphate|prednisolone phosphate|mesh-list
111141654|NCT05563571|Anesthetics, Local|anesthetics, local|mesh-ancestor
111141655|NCT05563571|Anesthetics|anesthetics|mesh-ancestor
111141656|NCT05563571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111141657|NCT05563571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111141658|NCT05563571|Sensory System Agents|sensory system agents|mesh-ancestor
111141659|NCT05563571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111141660|NCT05563571|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111141661|NCT05563571|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111141662|NCT05563571|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111141663|NCT05563571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111141664|NCT05563571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111141665|NCT05563571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111141666|NCT05563571|Antiemetics|antiemetics|mesh-ancestor
111141667|NCT05563571|Autonomic Agents|autonomic agents|mesh-ancestor
111141668|NCT05563571|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111141669|NCT05563571|Glucocorticoids|glucocorticoids|mesh-ancestor
111141670|NCT05563571|Hormones|hormones|mesh-ancestor
111141671|NCT05563571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111141672|NCT05563571|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111141673|NCT05563571|Protective Agents|protective agents|mesh-ancestor
111141674|NCT05563571|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111141675|NCT05563571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111141676|NCT02717507|Carvedilol|carvedilol|mesh-list
111141677|NCT02717507|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111141678|NCT02717507|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111141679|NCT02717507|Adrenergic Agents|adrenergic agents|mesh-ancestor
111141680|NCT02717507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111141681|NCT02717507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111141682|NCT02717507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111141683|NCT02717507|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111141685|NCT02717507|Protective Agents|protective agents|mesh-ancestor
111141686|NCT02717507|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111141687|NCT02717507|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111141688|NCT02717507|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111141689|NCT02717507|Vasodilator Agents|vasodilator agents|mesh-ancestor
111141690|NCT02717507|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111141691|NCT02717507|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111141692|NCT02489903|Paclitaxel|paclitaxel|mesh-list
111141693|NCT02489903|Etoposide|etoposide|mesh-list
111141694|NCT02489903|Vinorelbine|vinorelbine|mesh-list
111141695|NCT02489903|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111141696|NCT02489903|Carboplatin|carboplatin|mesh-list
111141697|NCT02489903|Gemcitabine|gemcitabine|mesh-list
111141698|NCT02489903|Irinotecan|irinotecan|mesh-list
111141699|NCT02489903|Pemetrexed|pemetrexed|mesh-list
111141701|NCT02489903|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111141702|NCT02489903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111141703|NCT02489903|Tubulin Modulators|tubulin modulators|mesh-ancestor
111141704|NCT02489903|Antimitotic Agents|antimitotic agents|mesh-ancestor
111141705|NCT02489903|Mitosis Modulators|mitosis modulators|mesh-ancestor
111141706|NCT02489903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111141707|NCT02489903|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111141708|NCT02489903|Antimetabolites|antimetabolites|mesh-ancestor
111141709|NCT02489903|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111141710|NCT02489903|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111141711|NCT02489903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111141712|NCT02489903|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111141713|NCT02489903|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111141714|NCT02489903|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111141715|NCT01174199|Sirolimus|sirolimus|mesh-list
111141716|NCT01174199|Vorinostat|vorinostat|mesh-list
111141717|NCT01174199|Temsirolimus|temsirolimus|mesh-list
111141718|NCT01174199|MTOR Inhibitors|mtor inhibitors|mesh-list
111141719|NCT01174199|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111141720|NCT01174199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111141721|NCT01174199|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111141722|NCT01174199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111141723|NCT01174199|Antifungal Agents|antifungal agents|mesh-ancestor
111141724|NCT01174199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111141725|NCT01174199|Immunologic Factors|immunologic factors|mesh-ancestor
111141726|NCT01174199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111141727|NCT01174199|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111141728|NCT01174199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111141729|NCT01174199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111141730|NCT01174199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111141731|NCT04356599|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
111141732|NCT04356599|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111141733|NCT04356599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111141734|NCT05562869|Abatacept|abatacept|mesh-list
111141735|NCT05562869|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111141736|NCT05562869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111141737|NCT05562869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111141738|NCT05562869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111141739|NCT05562869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111141740|NCT05562869|Immunologic Factors|immunologic factors|mesh-ancestor
111141741|NCT05562869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111141742|NCT05562869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111141743|NCT04085237|Ropivacaine|ropivacaine|mesh-list
111141744|NCT04085237|Anesthetics, Local|anesthetics, local|mesh-ancestor
111141745|NCT04085237|Anesthetics|anesthetics|mesh-ancestor
111141746|NCT04085237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111141747|NCT04085237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111141748|NCT04085237|Sensory System Agents|sensory system agents|mesh-ancestor
111141749|NCT04085237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111141750|NCT04080869|Vitamin A|vitamin a|mesh-list
111141751|NCT04080869|Tretinoin|tretinoin|mesh-list
111141752|NCT04080869|Retinol palmitate|retinol palmitate|mesh-list
111141753|NCT04080869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111141754|NCT04080869|Keratolytic Agents|keratolytic agents|mesh-ancestor
111141755|NCT04080869|Dermatologic Agents|dermatologic agents|mesh-ancestor
111141756|NCT04080869|Antioxidants|antioxidants|mesh-ancestor
111141757|NCT04080869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111141758|NCT04080869|Protective Agents|protective agents|mesh-ancestor
111141759|NCT04080869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111141760|NCT04080869|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
111141761|NCT04080869|Vitamins|vitamins|mesh-ancestor
111141762|NCT04080869|Micronutrients|micronutrients|mesh-ancestor
111141763|NCT00560495|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
111141764|NCT00560495|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
111141765|NCT00560495|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111141766|NCT00560495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111141767|NCT00560495|Chelating Agents|chelating agents|mesh-ancestor
111141768|NCT00560495|Sequestering Agents|sequestering agents|mesh-ancestor
111141769|NCT00560495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111141770|NCT00560495|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111141771|NCT00560495|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111141772|NCT00560495|Growth Substances|growth substances|mesh-ancestor
111141773|NCT00560495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111141774|NCT00560495|Growth Inhibitors|growth inhibitors|mesh-ancestor
111141775|NCT00560495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111141776|NCT02559713|Vedolizumab|vedolizumab|mesh-list
111141777|NCT02559713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111141778|NCT05499065|Cetuximab|cetuximab|mesh-list
111141779|NCT05499065|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111141780|NCT05499065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111141781|NCT04230161|Milbemycin oxime|milbemycin oxime|mesh-list
111141782|NCT04230161|Anthelmintics|anthelmintics|mesh-ancestor
111141783|NCT04230161|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111141784|NCT04230161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111141785|NCT04038437|Venetoclax|venetoclax|mesh-list
111141786|NCT04038437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111141787|NCT05491343|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
111141788|NCT05491343|Medroxyprogesterone|medroxyprogesterone|mesh-list
111141789|NCT05491343|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111141790|NCT05491343|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111141791|NCT05491343|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111141792|NCT05491343|Contraceptive Agents|contraceptive agents|mesh-ancestor
111141793|NCT05491343|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111141794|NCT05491343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111141795|NCT05491343|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111141796|NCT05491343|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111141797|NCT05491343|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
111141798|NCT05491343|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111141799|NCT05491343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111141800|NCT05498441|Quetiapine Fumarate|quetiapine fumarate|mesh-list
111141801|NCT05498441|Antidepressive Agents|antidepressive agents|mesh-ancestor
111141802|NCT05498441|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111141803|NCT05498441|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111141804|NCT05498441|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111141805|NCT05498441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111141806|NCT05498441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111141807|NCT05485883|Lenvatinib|lenvatinib|mesh-list
111141808|NCT05485883|Tislelizumab|tislelizumab|mesh-list
111141809|NCT05485883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111141810|NCT05485883|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111141811|NCT05485883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111141812|NCT05485883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111141813|NCT05485883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111141814|NCT04273607|Heparin|heparin|mesh-list
111141815|NCT04273607|Calcium heparin|calcium heparin|mesh-list
111141816|NCT04273607|Enoxaparin|enoxaparin|mesh-list
111141817|NCT04273607|Anticoagulants|anticoagulants|mesh-ancestor
111141818|NCT04273607|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111141819|NCT04273607|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111141820|NCT04273607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111141821|NCT05476081|Aspirin|aspirin|mesh-list
111141822|NCT05476081|Clopidogrel|clopidogrel|mesh-list
111141823|NCT05476081|Ticagrelor|ticagrelor|mesh-list
111141824|NCT05476081|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111141825|NCT05476081|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111141826|NCT05476081|Analgesics|analgesics|mesh-ancestor
111141827|NCT05476081|Sensory System Agents|sensory system agents|mesh-ancestor
111141828|NCT05476081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111141829|NCT05476081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111141830|NCT05476081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111141831|NCT05476081|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111141832|NCT05476081|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111141833|NCT05476081|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110481973|NCT00581893|Phenytoin|phenytoin|mesh-list
111141834|NCT05476081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111141835|NCT05476081|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111141836|NCT05476081|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111141837|NCT05476081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111141838|NCT05476081|Antipyretics|antipyretics|mesh-ancestor
111141839|NCT05476081|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111141840|NCT05476081|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111141841|NCT05476081|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111141842|NCT05476081|Purinergic Agents|purinergic agents|mesh-ancestor
111141843|NCT05476081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111141844|NCT05476003|Midazolam|midazolam|mesh-list
111141845|NCT05476003|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111141846|NCT05476003|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111141847|NCT05476003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111141848|NCT05476003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111141849|NCT05476003|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111141850|NCT05476003|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111141851|NCT05476003|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111141852|NCT05476003|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111141853|NCT05476003|Anesthetics, General|anesthetics, general|mesh-ancestor
111141854|NCT05476003|Anesthetics|anesthetics|mesh-ancestor
111141855|NCT05476003|GABA Modulators|gaba modulators|mesh-ancestor
111141856|NCT05476003|GABA Agents|gaba agents|mesh-ancestor
111141857|NCT05476003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111141858|NCT05476003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111141859|NCT02547649|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
111141860|NCT02547649|Immunologic Factors|immunologic factors|mesh-ancestor
111141861|NCT02547649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111141862|NCT03209479|Glatiramer Acetate|glatiramer acetate|mesh-list
111141863|NCT03209479|(T,G)-A-L|(t,g)-a-l|mesh-list
111141864|NCT03209479|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111141865|NCT03209479|Immunologic Factors|immunologic factors|mesh-ancestor
111141866|NCT03209479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110858893|NCT03108274|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111141867|NCT03209479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111141868|NCT03209479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111141869|NCT02535715|Insulin|insulin|mesh-list
111141870|NCT02535715|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111141871|NCT02535715|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111141872|NCT02535715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111141873|NCT02336815|Dexamethasone|dexamethasone|mesh-list
111141874|NCT02336815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111141875|NCT02336815|Antiemetics|antiemetics|mesh-ancestor
111141876|NCT02336815|Autonomic Agents|autonomic agents|mesh-ancestor
111141877|NCT02336815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111141878|NCT02336815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111141879|NCT02336815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111141880|NCT02336815|Glucocorticoids|glucocorticoids|mesh-ancestor
111141881|NCT02336815|Hormones|hormones|mesh-ancestor
111141882|NCT02336815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111141883|NCT02336815|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111141884|NCT02336815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111141885|NCT05434039|Diclofenac|diclofenac|mesh-list
111141886|NCT05434039|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111141887|NCT05434039|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111141888|NCT05434039|Analgesics|analgesics|mesh-ancestor
111141889|NCT05434039|Sensory System Agents|sensory system agents|mesh-ancestor
111141890|NCT05434039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111141891|NCT05434039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111141892|NCT05434039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111141893|NCT05434039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111141894|NCT05434039|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111141895|NCT05434039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111141896|NCT05434039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111141897|NCT05466175|Prednisone|prednisone|mesh-list
111141898|NCT05466175|Vincristine|vincristine|mesh-list
111141899|NCT05466175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111141900|NCT05466175|Glucocorticoids|glucocorticoids|mesh-ancestor
111141901|NCT05466175|Hormones|hormones|mesh-ancestor
111141902|NCT05466175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111141903|NCT05466175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111141904|NCT05466175|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111141905|NCT05466175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111141906|NCT05466175|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111141907|NCT05466175|Tubulin Modulators|tubulin modulators|mesh-ancestor
111141908|NCT05466175|Antimitotic Agents|antimitotic agents|mesh-ancestor
111141909|NCT05466175|Mitosis Modulators|mitosis modulators|mesh-ancestor
111141910|NCT05466175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111141911|NCT02546323|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111141912|NCT02546323|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111141913|NCT02546323|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111141914|NCT02546323|Antimetabolites|antimetabolites|mesh-ancestor
111141915|NCT02546323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111141916|NCT02546323|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111141917|NCT02546323|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111141918|NCT02546323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111141919|NCT02545933|Aspirin|aspirin|mesh-list
111141920|NCT02545933|Ticagrelor|ticagrelor|mesh-list
111141921|NCT02545933|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
111141922|NCT02545933|Vorapaxar|vorapaxar|mesh-list
111141923|NCT02545933|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111141924|NCT02545933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111141925|NCT02545933|Analgesics|analgesics|mesh-ancestor
111141926|NCT02545933|Sensory System Agents|sensory system agents|mesh-ancestor
111141927|NCT02545933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111141928|NCT02545933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111141929|NCT02545933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111141930|NCT02545933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111141931|NCT02545933|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111141932|NCT02545933|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111141933|NCT02545933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111141934|NCT02545933|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111141935|NCT02545933|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111141936|NCT02545933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111141937|NCT02545933|Antipyretics|antipyretics|mesh-ancestor
111141938|NCT02545933|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111141939|NCT02545933|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111141940|NCT02545933|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111141941|NCT02545933|Purinergic Agents|purinergic agents|mesh-ancestor
111141942|NCT02545933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111141943|NCT02545075|Ipilimumab|ipilimumab|mesh-list
111141944|NCT02545075|Dacarbazine|dacarbazine|mesh-list
111141945|NCT02545075|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111141946|NCT02545075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111141947|NCT02545075|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111141948|NCT02545075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111141949|NCT02545075|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111141950|NCT02545075|Alkylating Agents|alkylating agents|mesh-ancestor
111141951|NCT03007537|Epoetin Alfa|epoetin alfa|mesh-list
111141952|NCT03007537|Hematinics|hematinics|mesh-ancestor
111141953|NCT03004183|Valacyclovir|valacyclovir|mesh-list
111141954|NCT03004183|Pembrolizumab|pembrolizumab|mesh-list
111141955|NCT03004183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111141956|NCT03004183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111141957|NCT03004183|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111141958|NCT03004183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111141959|NCT03004183|Antiviral Agents|antiviral agents|mesh-ancestor
111141960|NCT03004183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111141961|NCT02544763|Cannabidiol|cannabidiol|mesh-list
111141962|NCT02544763|Anticonvulsants|anticonvulsants|mesh-ancestor
111141963|NCT02556203|Aspirin|aspirin|mesh-list
111141964|NCT02556203|Vitamin K|vitamin k|mesh-list
111141965|NCT02556203|Rivaroxaban|rivaroxaban|mesh-list
111141966|NCT02556203|Clopidogrel|clopidogrel|mesh-list
111141967|NCT02556203|Vitamins|vitamins|mesh-ancestor
111141968|NCT02556203|Micronutrients|micronutrients|mesh-ancestor
111141969|NCT02556203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111141970|NCT02556203|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111141971|NCT02556203|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111141972|NCT02556203|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111141973|NCT02556203|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111141974|NCT02556203|Purinergic Agents|purinergic agents|mesh-ancestor
111141975|NCT02556203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111141976|NCT02556203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111141977|NCT02556203|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111141978|NCT02556203|Antithrombins|antithrombins|mesh-ancestor
111141979|NCT02556203|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111141980|NCT02556203|Protease Inhibitors|protease inhibitors|mesh-ancestor
111141981|NCT02556203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111141982|NCT02556203|Anticoagulants|anticoagulants|mesh-ancestor
111141983|NCT02556203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111141984|NCT02556203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111141985|NCT02556203|Analgesics|analgesics|mesh-ancestor
111141986|NCT02556203|Sensory System Agents|sensory system agents|mesh-ancestor
111141987|NCT02556203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111141988|NCT02556203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111141989|NCT02556203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111141990|NCT02556203|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111141991|NCT02556203|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111141992|NCT02556203|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111141993|NCT02556203|Antipyretics|antipyretics|mesh-ancestor
111141994|NCT02556203|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111141995|NCT02556203|Hemostatics|hemostatics|mesh-ancestor
111141996|NCT02556203|Coagulants|coagulants|mesh-ancestor
111141997|NCT05485571|Methotrexate|methotrexate|mesh-list
111141998|NCT05485571|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111141999|NCT05485571|Abortifacient Agents|abortifacient agents|mesh-ancestor
111142000|NCT05485571|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111142001|NCT05485571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111142002|NCT05485571|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111142003|NCT05485571|Antimetabolites|antimetabolites|mesh-ancestor
111142004|NCT05485571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111142005|NCT05485571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111142006|NCT05485571|Dermatologic Agents|dermatologic agents|mesh-ancestor
111142007|NCT05485571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111142008|NCT05485571|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111142009|NCT05485571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111142010|NCT05485571|Immunologic Factors|immunologic factors|mesh-ancestor
111142011|NCT05485571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111142012|NCT05485571|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111142013|NCT05496725|Micafungin|micafungin|mesh-list
111142014|NCT05496725|Antifungal Agents|antifungal agents|mesh-ancestor
111142015|NCT05496725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111142016|NCT05490719|Cisplatin|cisplatin|mesh-list
111142017|NCT05490719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111142019|NCT04424459|Narcotics|narcotics|mesh-ancestor
111142020|NCT04424459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110482028|NCT04954989|Hematinics|hematinics|mesh-ancestor
111142021|NCT04424459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111142022|NCT04424459|Analgesics|analgesics|mesh-ancestor
111142023|NCT04424459|Sensory System Agents|sensory system agents|mesh-ancestor
111142024|NCT04424459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111142025|NCT05485259|Thioctic Acid|thioctic acid|mesh-list
111142026|NCT05485259|Antioxidants|antioxidants|mesh-ancestor
111142027|NCT05485259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111142028|NCT05485259|Protective Agents|protective agents|mesh-ancestor
111142029|NCT05485259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111142030|NCT05485259|Vitamin B Complex|vitamin b complex|mesh-ancestor
111142032|NCT05485259|Micronutrients|micronutrients|mesh-ancestor
111142033|NCT05490485|Cisplatin|cisplatin|mesh-list
111142034|NCT05490485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111142035|NCT05485103|Glycerol|glycerol|mesh-list
111142036|NCT05485103|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
111142037|NCT05485103|Protective Agents|protective agents|mesh-ancestor
111142038|NCT05485103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111142039|NCT05490407|Carboplatin|carboplatin|mesh-list
111142040|NCT05490407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111142041|NCT05490095|Everolimus|everolimus|mesh-list
111142042|NCT05490095|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111142043|NCT05490095|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111142044|NCT05490095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111142045|NCT05490095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111142046|NCT05490095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111142047|NCT05490095|Immunologic Factors|immunologic factors|mesh-ancestor
111142048|NCT05490095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111142049|NCT05490095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111142050|NCT04424381|Rivaroxaban|rivaroxaban|mesh-list
111142051|NCT04424381|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111142052|NCT04424381|Antithrombins|antithrombins|mesh-ancestor
111142053|NCT04424381|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111142054|NCT04424381|Protease Inhibitors|protease inhibitors|mesh-ancestor
111142055|NCT04424381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111142056|NCT04424381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111142057|NCT04424381|Anticoagulants|anticoagulants|mesh-ancestor
111142058|NCT05496179|Metoclopramide|metoclopramide|mesh-list
111142059|NCT05496179|Prucalopride|prucalopride|mesh-list
111142060|NCT05496179|Antiemetics|antiemetics|mesh-ancestor
111142061|NCT05496179|Autonomic Agents|autonomic agents|mesh-ancestor
111142062|NCT05496179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111142063|NCT05496179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111142064|NCT05496179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111142065|NCT05496179|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111142066|NCT05496179|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111142067|NCT05496179|Dopamine Agents|dopamine agents|mesh-ancestor
111142068|NCT05496179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111142069|NCT05496179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111142070|NCT05496179|Laxatives|laxatives|mesh-ancestor
111142071|NCT05496179|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
111142072|NCT05496179|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111142073|NCT05496179|Serotonin Agents|serotonin agents|mesh-ancestor
111142074|NCT05489939|Salicylates|salicylates|mesh-list
111142075|NCT05489939|Methyl salicylate|methyl salicylate|mesh-list
111142076|NCT05489939|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111142077|NCT05489939|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111142078|NCT05489939|Analgesics|analgesics|mesh-ancestor
111142079|NCT05489939|Sensory System Agents|sensory system agents|mesh-ancestor
111142080|NCT05489939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111142081|NCT05489939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111142082|NCT05489939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111142083|NCT05489939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111142084|NCT05489939|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111142085|NCT05489939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111142086|NCT05489939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111142087|NCT03999749|Nivolumab|nivolumab|mesh-list
111142088|NCT03999749|Ipilimumab|ipilimumab|mesh-list
111142089|NCT03999749|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111142090|NCT03999749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111142091|NCT03999749|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111142092|NCT03999749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111142093|NCT05483543|Pamiparib|pamiparib|mesh-list
111142094|NCT05483543|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111142095|NCT05483543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111142096|NCT05483543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111142097|NCT05483543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111142098|NCT04139213|Naltrexone|naltrexone|mesh-list
111142099|NCT04139213|Buprenorphine|buprenorphine|mesh-list
111142100|NCT04139213|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
111142101|NCT04139213|Naloxone|naloxone|mesh-list
111142102|NCT04139213|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111142103|NCT04139213|Narcotics|narcotics|mesh-ancestor
111142104|NCT04139213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111142105|NCT04139213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111142106|NCT04139213|Analgesics|analgesics|mesh-ancestor
111142107|NCT04139213|Sensory System Agents|sensory system agents|mesh-ancestor
111142108|NCT04139213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111142109|NCT04139213|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111142110|NCT04139213|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111142111|NCT05494775|Mitogens|mitogens|mesh-list
111142112|NCT05494775|Endothelial Growth Factors|endothelial growth factors|mesh-list
111142113|NCT05494775|Mitosis Modulators|mitosis modulators|mesh-ancestor
111142114|NCT05494775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111142115|NCT05494775|Growth Substances|growth substances|mesh-ancestor
111142116|NCT05494775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111142117|NCT05488925|Vitamin E|vitamin e|mesh-list
111142118|NCT05488925|Diclofenac|diclofenac|mesh-list
111142119|NCT05488925|Piroxicam|piroxicam|mesh-list
111142120|NCT05488925|Tramadol|tramadol|mesh-list
111142121|NCT05488925|Vitamins|vitamins|mesh-ancestor
111142122|NCT05488925|Micronutrients|micronutrients|mesh-ancestor
111142123|NCT05488925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111142124|NCT05488925|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111142125|NCT05488925|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111142126|NCT05488925|Analgesics|analgesics|mesh-ancestor
110482059|NCT04208763|Imipenem|imipenem|mesh-list
111142127|NCT05488925|Sensory System Agents|sensory system agents|mesh-ancestor
111142128|NCT05488925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111142129|NCT05488925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111142130|NCT05488925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111142131|NCT05488925|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111142132|NCT05488925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111142133|NCT05488925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111142134|NCT05488925|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111142135|NCT05488925|Narcotics|narcotics|mesh-ancestor
111142136|NCT05488925|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111142137|NCT05488925|Antioxidants|antioxidants|mesh-ancestor
111142138|NCT05488925|Protective Agents|protective agents|mesh-ancestor
111142139|NCT05482763|Itraconazole|itraconazole|mesh-list
111142140|NCT05482763|Terbinafine|terbinafine|mesh-list
111142141|NCT05482763|Ciclopirox|ciclopirox|mesh-list
111142142|NCT05482763|Amorolfine|amorolfine|mesh-list
111142143|NCT05482763|Antifungal Agents|antifungal agents|mesh-ancestor
111142144|NCT05482763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111142145|NCT05482763|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111142146|NCT05482763|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111142147|NCT05482763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111142148|NCT05482763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111142149|NCT05482763|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111142150|NCT05482763|Hormone Antagonists|hormone antagonists|mesh-ancestor
111142151|NCT05482763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111142152|NCT05482763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111142153|NCT05482763|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111142154|NCT05482373|Oleuropein|oleuropein|mesh-list
111142155|NCT05482373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111142156|NCT05482373|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111142157|NCT05482373|Vasodilator Agents|vasodilator agents|mesh-ancestor
111142158|NCT05482295|Vaccines|vaccines|mesh-list
111142159|NCT05482295|Immunologic Factors|immunologic factors|mesh-ancestor
111142160|NCT05482295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111142161|NCT04245839|Cyclophosphamide|cyclophosphamide|mesh-list
111142162|NCT04245839|Fludarabine|fludarabine|mesh-list
111142163|NCT04245839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111142164|NCT04245839|Immunologic Factors|immunologic factors|mesh-ancestor
111142165|NCT04245839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111142166|NCT04245839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111142167|NCT04245839|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111142168|NCT04245839|Alkylating Agents|alkylating agents|mesh-ancestor
111142169|NCT04245839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111142170|NCT04245839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111142171|NCT04245839|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111142173|NCT05494307|Danazol|danazol|mesh-list
111142174|NCT05494307|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111142175|NCT05494307|Autonomic Agents|autonomic agents|mesh-ancestor
111142176|NCT05494307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111142177|NCT05494307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111142178|NCT05494307|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111142179|NCT05494307|Respiratory System Agents|respiratory system agents|mesh-ancestor
111142180|NCT05494307|Sympathomimetics|sympathomimetics|mesh-ancestor
111142181|NCT05494307|Tocolytic Agents|tocolytic agents|mesh-ancestor
111142182|NCT05494307|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111142183|NCT05494307|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111142184|NCT05494307|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111142185|NCT05494307|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111142186|NCT05494307|Adrenergic Agents|adrenergic agents|mesh-ancestor
111142187|NCT05494307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111142188|NCT05494307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111142189|NCT05494307|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111142190|NCT05494307|Hormone Antagonists|hormone antagonists|mesh-ancestor
111142191|NCT05494307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111142193|NCT04051619|Oxytocics|oxytocics|mesh-ancestor
111142194|NCT04051619|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111142195|NCT04051619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111142196|NCT05487521|Methylprednisolone|methylprednisolone|mesh-list
111142197|NCT05487521|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111142198|NCT05487521|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111142199|NCT05487521|Prednisolone|prednisolone|mesh-list
111142200|NCT05487521|Prednisolone acetate|prednisolone acetate|mesh-list
111142201|NCT05487521|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111142202|NCT05487521|Prednisolone phosphate|prednisolone phosphate|mesh-list
111142203|NCT05487521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111142204|NCT05487521|Antiemetics|antiemetics|mesh-ancestor
111142205|NCT05487521|Autonomic Agents|autonomic agents|mesh-ancestor
111142206|NCT05487521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111142207|NCT05487521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111142208|NCT05487521|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111142209|NCT05487521|Glucocorticoids|glucocorticoids|mesh-ancestor
111142210|NCT05487521|Hormones|hormones|mesh-ancestor
111142211|NCT05487521|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111142212|NCT05487521|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111142213|NCT05487521|Protective Agents|protective agents|mesh-ancestor
111142214|NCT05487521|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111142215|NCT05487521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111142216|NCT05481281|Dexmedetomidine|dexmedetomidine|mesh-list
111142217|NCT05481281|Ketamine|ketamine|mesh-list
111142218|NCT05481281|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111142219|NCT05481281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111142220|NCT05481281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111142221|NCT05481281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111142222|NCT05481281|Analgesics|analgesics|mesh-ancestor
111142223|NCT05481281|Sensory System Agents|sensory system agents|mesh-ancestor
111142224|NCT05481281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111142225|NCT05481281|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111142226|NCT05481281|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111142227|NCT05481281|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111142228|NCT05481281|Adrenergic Agents|adrenergic agents|mesh-ancestor
111142229|NCT05481281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111142230|NCT05481281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111142231|NCT05481281|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111142232|NCT05481281|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111142233|NCT05481281|Anesthetics, General|anesthetics, general|mesh-ancestor
111142234|NCT05481281|Anesthetics|anesthetics|mesh-ancestor
111142235|NCT05481281|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111142236|NCT05481281|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111142237|NCT05487443|Gemcitabine|gemcitabine|mesh-list
111142238|NCT05487443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111142239|NCT05487443|Antimetabolites|antimetabolites|mesh-ancestor
111142240|NCT05487443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111142241|NCT05487443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111142242|NCT02558231|Selexipag|selexipag|mesh-list
111142243|NCT02558231|Tadalafil|tadalafil|mesh-list
111142244|NCT02558231|Macitentan|macitentan|mesh-list
111142245|NCT02558231|Vasodilator Agents|vasodilator agents|mesh-ancestor
111142246|NCT02558231|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111142247|NCT02558231|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111142248|NCT02558231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111142249|NCT02558231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111142250|NCT02558231|Urological Agents|urological agents|mesh-ancestor
111142251|NCT02558231|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
111142252|NCT02558231|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
111142253|NCT02558231|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
111142254|NCT02558231|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111142256|NCT05486819|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110482103|NCT00622011|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111142257|NCT05486819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111142258|NCT05486819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111142259|NCT05486819|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111142260|NCT05486819|Anesthetics, General|anesthetics, general|mesh-ancestor
111142262|NCT05480111|Anesthetics|anesthetics|mesh-list
111142263|NCT05480111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111142264|NCT05480111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111142265|NCT05475431|Bismuth|bismuth|mesh-list
111142266|NCT05475431|Antacids|antacids|mesh-ancestor
111142267|NCT05475431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111142268|NCT05475431|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111142269|NCT05492669|Lidocaine|lidocaine|mesh-list
111142270|NCT05492669|Anesthetics, Local|anesthetics, local|mesh-ancestor
111142271|NCT05492669|Anesthetics|anesthetics|mesh-ancestor
111142272|NCT05492669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111142273|NCT05492669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111142274|NCT05492669|Sensory System Agents|sensory system agents|mesh-ancestor
111142275|NCT05492669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111142276|NCT05492669|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111142277|NCT05492669|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111142278|NCT05492669|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111142279|NCT05492669|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111142280|NCT05492669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111142281|NCT05492591|Valacyclovir|valacyclovir|mesh-list
111142282|NCT05492591|Antiviral Agents|antiviral agents|mesh-ancestor
111142283|NCT05492591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111142284|NCT02554721|Aspirin|aspirin|mesh-list
111142285|NCT02554721|Cilostazol|cilostazol|mesh-list
111142286|NCT02554721|Clopidogrel|clopidogrel|mesh-list
111142287|NCT02554721|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111142288|NCT02554721|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111142289|NCT02554721|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111142290|NCT02554721|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111142291|NCT02554721|Purinergic Agents|purinergic agents|mesh-ancestor
111142292|NCT02554721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111142293|NCT02554721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111142294|NCT02554721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111142295|NCT02554721|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111142296|NCT02554721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111142297|NCT02554721|Analgesics|analgesics|mesh-ancestor
111142298|NCT02554721|Sensory System Agents|sensory system agents|mesh-ancestor
111142299|NCT02554721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111142300|NCT02554721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111142301|NCT02554721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111142302|NCT02554721|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111142303|NCT02554721|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111142304|NCT02554721|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111142305|NCT02554721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111142306|NCT02554721|Antipyretics|antipyretics|mesh-ancestor
111142307|NCT02554721|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111142308|NCT02554721|Autonomic Agents|autonomic agents|mesh-ancestor
111142309|NCT02554721|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111142310|NCT02554721|Respiratory System Agents|respiratory system agents|mesh-ancestor
111142311|NCT02554721|Vasodilator Agents|vasodilator agents|mesh-ancestor
111142312|NCT02554721|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111142313|NCT02554721|Protective Agents|protective agents|mesh-ancestor
111142314|NCT02554721|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
111142315|NCT02554721|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111142316|NCT03810911|Darbepoetin alfa|darbepoetin alfa|mesh-list
111142317|NCT03810911|Hematinics|hematinics|mesh-ancestor
111142318|NCT02552225|Amitriptyline|amitriptyline|mesh-list
111142319|NCT02552225|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
111142321|NCT02552225|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111142322|NCT02552225|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111142323|NCT02552225|Analgesics|analgesics|mesh-ancestor
111142324|NCT02552225|Sensory System Agents|sensory system agents|mesh-ancestor
111142325|NCT02552225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110482109|NCT03936309|Lidocaine|lidocaine|mesh-list
111142326|NCT02552225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111142327|NCT02552225|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111142328|NCT02552225|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111142329|NCT02552225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111142330|NCT02552225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111142331|NCT02552225|Adrenergic Agents|adrenergic agents|mesh-ancestor
111142332|NCT02552225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111142333|NCT02552147|Nicotine|nicotine|mesh-list
111142334|NCT02552147|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111142335|NCT02552147|Autonomic Agents|autonomic agents|mesh-ancestor
111142336|NCT02552147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111142337|NCT02552147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111142338|NCT02552147|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111142339|NCT02552147|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111142340|NCT02552147|Cholinergic Agents|cholinergic agents|mesh-ancestor
111142341|NCT02552147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111142342|NCT02552147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111142343|NCT05479487|Apatinib|apatinib|mesh-list
111142344|NCT05479487|Fluzoparib|fluzoparib|mesh-list
111142345|NCT05479487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111142346|NCT05479487|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111142347|NCT05479487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111142348|NCT05479487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111142349|NCT05479487|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111142350|NCT05479175|Ibuprofen|ibuprofen|mesh-list
111142351|NCT05479175|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111142352|NCT05479175|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111142353|NCT05479175|Analgesics|analgesics|mesh-ancestor
111142354|NCT05479175|Sensory System Agents|sensory system agents|mesh-ancestor
111142355|NCT05479175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111142356|NCT05479175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111142357|NCT05479175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111142358|NCT05479175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111142359|NCT05479175|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111142360|NCT05479175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111142361|NCT05479175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111142362|NCT02534935|Vaccines|vaccines|mesh-list
111142363|NCT02534935|Immunologic Factors|immunologic factors|mesh-ancestor
111142364|NCT02534935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111142365|NCT02544451|Ivacaftor|ivacaftor|mesh-list
111142366|NCT02544451|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
111142367|NCT02544451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111142368|NCT02544451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111142369|NCT02551991|Leucovorin|leucovorin|mesh-list
111142370|NCT02551991|Fluorouracil|fluorouracil|mesh-list
111142371|NCT02551991|Oxaliplatin|oxaliplatin|mesh-list
111142372|NCT02551991|Antimetabolites|antimetabolites|mesh-ancestor
111142373|NCT02551991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111142374|NCT02551991|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111142375|NCT02551991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111142376|NCT02551991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111142377|NCT02551991|Immunologic Factors|immunologic factors|mesh-ancestor
111142378|NCT02551991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111142379|NCT02551991|Antidotes|antidotes|mesh-ancestor
111142380|NCT02551991|Protective Agents|protective agents|mesh-ancestor
111142381|NCT02551991|Vitamin B Complex|vitamin b complex|mesh-ancestor
111142382|NCT02551991|Vitamins|vitamins|mesh-ancestor
111142383|NCT02551991|Micronutrients|micronutrients|mesh-ancestor
111142384|NCT05491811|Bevacizumab|bevacizumab|mesh-list
111142385|NCT05491811|Ensartinib|ensartinib|mesh-list
111142386|NCT05491811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111142387|NCT05491811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111142388|NCT05491811|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111142389|NCT05491811|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111142390|NCT05491811|Growth Substances|growth substances|mesh-ancestor
111142391|NCT05491811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111142392|NCT05491811|Growth Inhibitors|growth inhibitors|mesh-ancestor
111142393|NCT05491811|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111142394|NCT05491811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111142395|NCT05491811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111142397|NCT05478785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111142398|NCT02865551|Anesthetics|anesthetics|mesh-list
111142399|NCT02865551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111142400|NCT02865551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111142401|NCT05478083|Leuprolide|leuprolide|mesh-list
111142402|NCT05478083|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111142403|NCT05478083|Fertility Agents|fertility agents|mesh-ancestor
111142404|NCT05478083|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111142405|NCT05478083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111142406|NCT05478083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111142407|NCT05478083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111142408|NCT02544217|6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid|6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid|mesh-list
111142409|NCT02544217|Antioxidants|antioxidants|mesh-ancestor
111142410|NCT02544217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111142411|NCT02544217|Protective Agents|protective agents|mesh-ancestor
111142412|NCT02544217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111142413|NCT05427565|Caffeine|caffeine|mesh-list
111142414|NCT05427565|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111142415|NCT05427565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111142416|NCT05427565|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111142417|NCT05427565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111142418|NCT05427565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111142419|NCT05427565|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
111142420|NCT05427565|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111142421|NCT05427565|Purinergic Agents|purinergic agents|mesh-ancestor
111142422|NCT05427565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111142423|NCT02533453|Exenatide|exenatide|mesh-list
111142424|NCT02533453|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111142425|NCT02533453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111142426|NCT02533453|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111142427|NCT02533453|Incretins|incretins|mesh-ancestor
111142428|NCT02533453|Hormones|hormones|mesh-ancestor
111142429|NCT02533453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111142430|NCT05424835|Capecitabine|capecitabine|mesh-list
111142431|NCT05424835|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111142432|NCT05424835|Antimetabolites|antimetabolites|mesh-ancestor
111142433|NCT05424835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111142434|NCT05424835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111142435|NCT02533375|Adalimumab|adalimumab|mesh-list
111142436|NCT02533375|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111142437|NCT02533375|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111142438|NCT02533375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111142439|NCT01553149|Lenalidomide|lenalidomide|mesh-list
111142440|NCT01553149|Immunologic Factors|immunologic factors|mesh-ancestor
111142441|NCT01553149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111142442|NCT01553149|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111142443|NCT01553149|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111142444|NCT01553149|Growth Substances|growth substances|mesh-ancestor
111142445|NCT01553149|Growth Inhibitors|growth inhibitors|mesh-ancestor
111142446|NCT01553149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111142447|NCT02551055|Paclitaxel|paclitaxel|mesh-list
111142448|NCT02551055|Docetaxel|docetaxel|mesh-list
111142449|NCT02551055|Serabelisib|serabelisib|mesh-list
111142450|NCT02551055|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111142451|NCT02551055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111142452|NCT02551055|Tubulin Modulators|tubulin modulators|mesh-ancestor
111142453|NCT02551055|Antimitotic Agents|antimitotic agents|mesh-ancestor
111142454|NCT02551055|Mitosis Modulators|mitosis modulators|mesh-ancestor
111142455|NCT02551055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111142456|NCT02551055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111142457|NCT05470673|Metronidazole|metronidazole|mesh-list
111142458|NCT05470673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111142459|NCT05470673|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111142460|NCT05470673|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111142461|NCT05470673|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111142462|NCT05459285|Dulaglutide|dulaglutide|mesh-list
111142463|NCT05459285|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111142464|NCT05459285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111142465|NCT02542943|Fluorides|fluorides|mesh-list
111142466|NCT02542943|Cariostatic Agents|cariostatic agents|mesh-ancestor
111142467|NCT02542943|Protective Agents|protective agents|mesh-ancestor
111142468|NCT02542943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111142469|NCT03284957|Everolimus|everolimus|mesh-list
111142470|NCT03284957|Palbociclib|palbociclib|mesh-list
111142471|NCT03284957|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111142472|NCT03284957|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111142473|NCT03284957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111142474|NCT03284957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111142475|NCT03284957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111142476|NCT03284957|Immunologic Factors|immunologic factors|mesh-ancestor
111142477|NCT03284957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111142478|NCT03284957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111142479|NCT02542631|Insulin|insulin|mesh-list
111142480|NCT02542631|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111142481|NCT02542631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111142482|NCT02542631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111142483|NCT05477615|Carboplatin|carboplatin|mesh-list
111142484|NCT05477615|Pemetrexed|pemetrexed|mesh-list
111142485|NCT05477615|Lazertinib|lazertinib|mesh-list
111142486|NCT05477615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111142487|NCT05477615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111142488|NCT05477615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111142489|NCT05477615|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111142490|NCT05477615|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111142491|NCT05477615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111142492|NCT02710097|Ethanol|ethanol|mesh-list
111142493|NCT02710097|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111142494|NCT02710097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111142495|NCT02710097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111142496|NCT02710097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111142497|NCT02529553|LY3076226|ly3076226|mesh-list
111142498|NCT02529553|Immunoconjugates|immunoconjugates|mesh-ancestor
111142499|NCT02529553|Immunologic Factors|immunologic factors|mesh-ancestor
111142500|NCT02529553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111142501|NCT02547935|Dapagliflozin|dapagliflozin|mesh-list
111142502|NCT02547935|Saxagliptin|saxagliptin|mesh-list
111142503|NCT02547935|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111142504|NCT02547935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111142505|NCT02547935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111142506|NCT02547935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111142507|NCT02547935|Incretins|incretins|mesh-ancestor
111142508|NCT02547935|Hormones|hormones|mesh-ancestor
111142509|NCT02547935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111142510|NCT02547935|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111142511|NCT02547935|Protease Inhibitors|protease inhibitors|mesh-ancestor
111142512|NCT02547935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111142513|NCT04258111|Antibodies|antibodies|mesh-list
111142514|NCT04258111|Immunoglobulins|immunoglobulins|mesh-list
111142515|NCT04258111|Immunologic Factors|immunologic factors|mesh-ancestor
111142516|NCT04258111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111142517|NCT02327169|Paclitaxel|paclitaxel|mesh-list
111142518|NCT02327169|Irinotecan|irinotecan|mesh-list
111142519|NCT02327169|Cetuximab|cetuximab|mesh-list
111142520|NCT02327169|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111142521|NCT02327169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111142522|NCT02327169|Tubulin Modulators|tubulin modulators|mesh-ancestor
111142523|NCT02327169|Antimitotic Agents|antimitotic agents|mesh-ancestor
111142524|NCT02327169|Mitosis Modulators|mitosis modulators|mesh-ancestor
111142525|NCT02327169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111142526|NCT02327169|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111142527|NCT02327169|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111142528|NCT02327169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111142529|NCT02327169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111142530|NCT02327013|Vortioxetine|vortioxetine|mesh-list
111142531|NCT02327013|Antidepressive Agents|antidepressive agents|mesh-ancestor
111142532|NCT02327013|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111142533|NCT02327013|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111142534|NCT02327013|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111142535|NCT02327013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111142536|NCT02327013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111142537|NCT02327013|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111142538|NCT02327013|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111142539|NCT02327013|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111142540|NCT02327013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111142541|NCT02327013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111142542|NCT02327013|Serotonin Agents|serotonin agents|mesh-ancestor
111142543|NCT02327013|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111142544|NCT02327013|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111142545|NCT02327013|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111142546|NCT02327013|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111142547|NCT02301975|Fluticasone|fluticasone|mesh-list
111142549|NCT02301975|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
111142550|NCT02301975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111142551|NCT02301975|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111142552|NCT02301975|Autonomic Agents|autonomic agents|mesh-ancestor
111142553|NCT02301975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111142554|NCT02301975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111142555|NCT02301975|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111142556|NCT02301975|Respiratory System Agents|respiratory system agents|mesh-ancestor
111142557|NCT02301975|Dermatologic Agents|dermatologic agents|mesh-ancestor
111142558|NCT02301975|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111142559|NCT02301975|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111142560|NCT02301975|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111142561|NCT02301975|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111142562|NCT02301975|Adrenergic Agents|adrenergic agents|mesh-ancestor
111142563|NCT02301975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111142564|NCT02301975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111142565|NCT04882839|Psilocybin|psilocybin|mesh-list
111142566|NCT04882839|Hallucinogens|hallucinogens|mesh-ancestor
111142567|NCT04882839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111142568|NCT04882839|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111142569|NCT02300259|Itraconazole|itraconazole|mesh-list
111142570|NCT02300259|Diltiazem|diltiazem|mesh-list
111142571|NCT02300259|Tadalafil|tadalafil|mesh-list
111142572|NCT02300259|Simvastatin|simvastatin|mesh-list
111142573|NCT02300259|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111142574|NCT02300259|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111142575|NCT02300259|Antimetabolites|antimetabolites|mesh-ancestor
111142576|NCT02300259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111142577|NCT02300259|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111142578|NCT02300259|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111142579|NCT02300259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111142580|NCT02300259|Antifungal Agents|antifungal agents|mesh-ancestor
111142581|NCT02300259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111142582|NCT02300259|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111142583|NCT02300259|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111142584|NCT02300259|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111142585|NCT02300259|Hormone Antagonists|hormone antagonists|mesh-ancestor
111142586|NCT02300259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111142587|NCT02300259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111142588|NCT02300259|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111142589|NCT02300259|Vasodilator Agents|vasodilator agents|mesh-ancestor
111142590|NCT02300259|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111142591|NCT02300259|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111142592|NCT02300259|Urological Agents|urological agents|mesh-ancestor
111142593|NCT02300259|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111142594|NCT02300259|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111142595|NCT02300259|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111142596|NCT02300259|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111142597|NCT02300103|Sofosbuvir|sofosbuvir|mesh-list
111142598|NCT02300103|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
111142599|NCT02300103|Velpatasvir|velpatasvir|mesh-list
111142600|NCT02300103|Antiviral Agents|antiviral agents|mesh-ancestor
111142601|NCT02300103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111142602|NCT02326467|Chlorhexidine|chlorhexidine|mesh-list
111142603|NCT02326467|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
111142604|NCT02326467|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111142605|NCT02326467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111142606|NCT02326467|Disinfectants|disinfectants|mesh-ancestor
111142607|NCT02326467|Dermatologic Agents|dermatologic agents|mesh-ancestor
111142608|NCT02299635|Nirogacestat|nirogacestat|mesh-list
111142609|NCT02299635|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
111142610|NCT02299635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111142611|NCT02299635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111142612|NCT02366091|Methotrexate|methotrexate|mesh-list
111142613|NCT02366091|Colchicine|colchicine|mesh-list
111142614|NCT02366091|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111142615|NCT02366091|Abortifacient Agents|abortifacient agents|mesh-ancestor
111142616|NCT02366091|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111142617|NCT02366091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111142618|NCT02366091|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111142620|NCT02366091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111142621|NCT02366091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111142622|NCT02366091|Dermatologic Agents|dermatologic agents|mesh-ancestor
111142623|NCT02366091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111142624|NCT02366091|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111142625|NCT02366091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111142626|NCT02366091|Immunologic Factors|immunologic factors|mesh-ancestor
111142627|NCT02366091|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111142628|NCT02366091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111142629|NCT02366091|Gout Suppressants|gout suppressants|mesh-ancestor
111142630|NCT02366091|Tubulin Modulators|tubulin modulators|mesh-ancestor
111142631|NCT02366091|Antimitotic Agents|antimitotic agents|mesh-ancestor
111142632|NCT02366091|Mitosis Modulators|mitosis modulators|mesh-ancestor
111142633|NCT05476679|Celecoxib|celecoxib|mesh-list
111142634|NCT05476679|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111142635|NCT05476679|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111142636|NCT05476679|Analgesics|analgesics|mesh-ancestor
111142637|NCT05476679|Sensory System Agents|sensory system agents|mesh-ancestor
110839542|NCT03420040|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111142638|NCT05476679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111142639|NCT05476679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111142640|NCT05476679|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111142641|NCT05476679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111142642|NCT05476679|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111142643|NCT05476679|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111142644|NCT05476679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111142645|NCT05476679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111142646|NCT02546765|Acetaminophen|acetaminophen|mesh-list
111142647|NCT02546765|Dexmedetomidine|dexmedetomidine|mesh-list
111142648|NCT02546765|Propofol|propofol|mesh-list
111142649|NCT02546765|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111142650|NCT02546765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111142651|NCT02546765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111142652|NCT02546765|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111142653|NCT02546765|Analgesics|analgesics|mesh-ancestor
111142654|NCT02546765|Sensory System Agents|sensory system agents|mesh-ancestor
111142655|NCT02546765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111142656|NCT02546765|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111142657|NCT02546765|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111142658|NCT02546765|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111142659|NCT02546765|Adrenergic Agents|adrenergic agents|mesh-ancestor
111142660|NCT02546765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111142661|NCT02546765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111142662|NCT02546765|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111142663|NCT02546765|Anesthetics, General|anesthetics, general|mesh-ancestor
111142664|NCT02546765|Anesthetics|anesthetics|mesh-ancestor
111142665|NCT02546765|Antipyretics|antipyretics|mesh-ancestor
111142666|NCT02553629|Rocuronium|rocuronium|mesh-list
111142667|NCT02553629|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
111142668|NCT02553629|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
111142669|NCT02553629|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111142670|NCT02553629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111142671|NCT02553629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111142672|NCT03555851|Cyclophosphamide|cyclophosphamide|mesh-list
111142673|NCT03555851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111142674|NCT03555851|Immunologic Factors|immunologic factors|mesh-ancestor
111142675|NCT03555851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111142676|NCT03555851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111142677|NCT03555851|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111142678|NCT03555851|Alkylating Agents|alkylating agents|mesh-ancestor
111142679|NCT03555851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111142680|NCT03555851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111142681|NCT03555851|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111142682|NCT03029351|Exenatide|exenatide|mesh-list
111142683|NCT03029351|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111142684|NCT03029351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111142685|NCT03029351|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111142686|NCT03029351|Incretins|incretins|mesh-ancestor
111142687|NCT03029351|Hormones|hormones|mesh-ancestor
111142688|NCT03029351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111142689|NCT02325219|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110859758|NCT05561738|Niacin|niacin|mesh-list
111142690|NCT02325219|Immunologic Factors|immunologic factors|mesh-ancestor
111142691|NCT02325219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111142692|NCT02365233|Insulin|insulin|mesh-list
111142693|NCT02365233|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111142694|NCT02365233|Pioglitazone|pioglitazone|mesh-list
111142695|NCT02365233|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111142696|NCT02365233|Insulin Glargine|insulin glargine|mesh-list
111142697|NCT02365233|Saxagliptin|saxagliptin|mesh-list
111142698|NCT02365233|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
111142699|NCT02365233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111142700|NCT02365233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111142701|NCT02365233|Incretins|incretins|mesh-ancestor
111142702|NCT02365233|Hormones|hormones|mesh-ancestor
111142703|NCT02365233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111142704|NCT02365233|Protease Inhibitors|protease inhibitors|mesh-ancestor
111142705|NCT02365233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111142706|NCT02365233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111142707|NCT02364999|Paclitaxel|paclitaxel|mesh-list
111142708|NCT02364999|Bevacizumab|bevacizumab|mesh-list
111142709|NCT02364999|Carboplatin|carboplatin|mesh-list
111142710|NCT02364999|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111142711|NCT02364999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111142712|NCT02364999|Tubulin Modulators|tubulin modulators|mesh-ancestor
111142713|NCT02364999|Antimitotic Agents|antimitotic agents|mesh-ancestor
111142714|NCT02364999|Mitosis Modulators|mitosis modulators|mesh-ancestor
111142715|NCT02364999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111142716|NCT02364999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111142717|NCT02364999|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111142718|NCT02364999|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111142719|NCT02364999|Growth Substances|growth substances|mesh-ancestor
111142720|NCT02364999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111142721|NCT02364999|Growth Inhibitors|growth inhibitors|mesh-ancestor
111142722|NCT02363283|Glembatumumab vedotin|glembatumumab vedotin|mesh-list
111142723|NCT02363283|Immunoconjugates|immunoconjugates|mesh-list
111142725|NCT02363283|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111142726|NCT02363283|Immunologic Factors|immunologic factors|mesh-ancestor
111142727|NCT02363283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111142728|NCT02363283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111142729|NCT02363283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111142730|NCT02321319|Hydromorphone|hydromorphone|mesh-list
111142731|NCT02321319|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111142732|NCT02321319|Narcotics|narcotics|mesh-ancestor
111142733|NCT02321319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111142734|NCT02321319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111142735|NCT02321319|Analgesics|analgesics|mesh-ancestor
111142736|NCT02321319|Sensory System Agents|sensory system agents|mesh-ancestor
111142737|NCT02321319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111142738|NCT02088541|Cytarabine|cytarabine|mesh-list
111142739|NCT02088541|Hydroxyurea|hydroxyurea|mesh-list
111142740|NCT02088541|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111142741|NCT02088541|Antimetabolites|antimetabolites|mesh-ancestor
111142742|NCT02088541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111142743|NCT02088541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111142744|NCT02088541|Antiviral Agents|antiviral agents|mesh-ancestor
111142745|NCT02088541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111142746|NCT02088541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111142747|NCT02088541|Immunologic Factors|immunologic factors|mesh-ancestor
111142748|NCT02088541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111142749|NCT02088541|Antisickling Agents|antisickling agents|mesh-ancestor
111142750|NCT02088541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111142751|NCT02088541|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111142752|NCT02294019|Ibuprofen|ibuprofen|mesh-list
111142753|NCT02294019|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111142754|NCT02294019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111142755|NCT02294019|Analgesics|analgesics|mesh-ancestor
111142756|NCT02294019|Sensory System Agents|sensory system agents|mesh-ancestor
111142757|NCT02294019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111142758|NCT02294019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111142759|NCT02294019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111142760|NCT02294019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111142761|NCT02294019|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111142762|NCT02294019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111142763|NCT02294019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110859795|NCT05552287|Infliximab|infliximab|mesh-list
111142764|NCT02320149|Sarecycline|sarecycline|mesh-list
111142765|NCT02320149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111142766|NCT02320149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111142767|NCT02320149|Dermatologic Agents|dermatologic agents|mesh-ancestor
111142768|NCT05405725|Denosumab|denosumab|mesh-list
111142769|NCT05405725|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111142770|NCT05405725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111142771|NCT02293863|Oseltamivir|oseltamivir|mesh-list
111142772|NCT02293863|Antiviral Agents|antiviral agents|mesh-ancestor
111142773|NCT02293863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111142774|NCT02293863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111142775|NCT02293863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111142776|NCT02293395|Aspirin|aspirin|mesh-list
111142777|NCT02293395|Rivaroxaban|rivaroxaban|mesh-list
111142778|NCT02293395|Clopidogrel|clopidogrel|mesh-list
111142779|NCT02293395|Ticagrelor|ticagrelor|mesh-list
110839553|NCT03413410|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111142780|NCT02293395|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111142781|NCT02293395|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111142783|NCT02293395|Sensory System Agents|sensory system agents|mesh-ancestor
111142784|NCT02293395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111142785|NCT02293395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111142786|NCT02293395|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111142787|NCT02293395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111142788|NCT02293395|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111142789|NCT02293395|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111142790|NCT02293395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111142791|NCT02293395|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111142792|NCT02293395|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111142793|NCT02293395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111142794|NCT02293395|Antipyretics|antipyretics|mesh-ancestor
111142795|NCT02293395|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111142796|NCT02293395|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111142797|NCT02293395|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111142798|NCT02293395|Purinergic Agents|purinergic agents|mesh-ancestor
111142799|NCT02293395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111142800|NCT02293395|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111142801|NCT02293395|Antithrombins|antithrombins|mesh-ancestor
111142802|NCT02293395|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111142803|NCT02293395|Protease Inhibitors|protease inhibitors|mesh-ancestor
111142804|NCT02293395|Anticoagulants|anticoagulants|mesh-ancestor
111142805|NCT05447065|Vitamin D|vitamin d|mesh-list
111142806|NCT05447065|Vitamins|vitamins|mesh-ancestor
111142807|NCT05447065|Micronutrients|micronutrients|mesh-ancestor
111142808|NCT05447065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111142809|NCT05447065|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111142810|NCT05401357|Bimatoprost|bimatoprost|mesh-list
111142811|NCT05401357|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111142812|NCT05401357|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111142813|NCT05401357|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111142814|NCT05401279|Gemcitabine|gemcitabine|mesh-list
111142815|NCT05401279|Tislelizumab|tislelizumab|mesh-list
111142816|NCT05401279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111142817|NCT05401279|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111142818|NCT05401279|Antimetabolites|antimetabolites|mesh-ancestor
111142819|NCT05401279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111142820|NCT05401279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111142821|NCT05451095|Ketamine|ketamine|mesh-list
111142822|NCT05451095|Analgesics|analgesics|mesh-ancestor
111142823|NCT05451095|Sensory System Agents|sensory system agents|mesh-ancestor
111142824|NCT05451095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111142825|NCT05451095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111142826|NCT05451095|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111142827|NCT05451095|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111142828|NCT05451095|Anesthetics, General|anesthetics, general|mesh-ancestor
111142829|NCT05451095|Anesthetics|anesthetics|mesh-ancestor
111142830|NCT05451095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111142831|NCT05451095|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111142832|NCT05451095|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111142833|NCT05451095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111142834|NCT05451095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111142835|NCT02954081|Apremilast|apremilast|mesh-list
111142836|NCT02954081|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111142837|NCT02954081|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111142838|NCT02954081|Analgesics|analgesics|mesh-ancestor
111142839|NCT02954081|Sensory System Agents|sensory system agents|mesh-ancestor
111142840|NCT02954081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111142841|NCT02954081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111142842|NCT02954081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111142843|NCT02954081|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110482231|NCT04138641|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111142844|NCT02954081|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
111142845|NCT02954081|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111142846|NCT02954081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111142847|NCT02954081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111142848|NCT02532283|Oseltamivir|oseltamivir|mesh-list
111142849|NCT02532283|Antiviral Agents|antiviral agents|mesh-ancestor
111142850|NCT02532283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111142851|NCT02532283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111142852|NCT02532283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111142853|NCT01349959|Azacitidine|azacitidine|mesh-list
111142854|NCT01349959|Entinostat|entinostat|mesh-list
111142855|NCT01349959|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
111142856|NCT01349959|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111142857|NCT01349959|Antimetabolites|antimetabolites|mesh-ancestor
111142858|NCT01349959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111142859|NCT01349959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111142860|NCT01349959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111142861|NCT01349881|Eflornithine|eflornithine|mesh-list
111142862|NCT01349881|Sulindac|sulindac|mesh-list
111142863|NCT01349881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111142864|NCT01349881|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
111142865|NCT01349881|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111142866|NCT01349881|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111142867|NCT01349881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111142868|NCT01349881|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
111142869|NCT01349881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111142870|NCT01349881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111142871|NCT01349881|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111142872|NCT01349881|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111142873|NCT01349881|Analgesics|analgesics|mesh-ancestor
111142874|NCT01349881|Sensory System Agents|sensory system agents|mesh-ancestor
111142875|NCT01349881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111142876|NCT01349881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111142877|NCT01349881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111142878|NCT01349881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111142879|NCT01349881|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111142880|NCT05417971|Fludarabine|fludarabine|mesh-list
111142881|NCT05417971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111142882|NCT05398705|Cepharanthine|cepharanthine|mesh-list
111142883|NCT05398705|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111142884|NCT05398705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111142885|NCT05398705|Analgesics|analgesics|mesh-ancestor
111142886|NCT05398705|Sensory System Agents|sensory system agents|mesh-ancestor
111142887|NCT05398705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111142888|NCT05398705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111142889|NCT05398705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111142890|NCT05398705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111142891|NCT05398705|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111142892|NCT05398705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111142893|NCT05398705|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111142894|NCT05398705|Protective Agents|protective agents|mesh-ancestor
111142895|NCT05415865|Lidocaine|lidocaine|mesh-list
111142896|NCT05415865|Anesthetics, Local|anesthetics, local|mesh-ancestor
111142897|NCT05415865|Anesthetics|anesthetics|mesh-ancestor
111142898|NCT05415865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111142899|NCT05415865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111142900|NCT05415865|Sensory System Agents|sensory system agents|mesh-ancestor
111142901|NCT05415865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111142902|NCT05415865|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111142903|NCT05415865|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111142904|NCT05415865|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111142905|NCT05415865|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111142906|NCT05415865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111142907|NCT05415709|Paclitaxel|paclitaxel|mesh-list
111142908|NCT05415709|Cisplatin|cisplatin|mesh-list
111142909|NCT05415709|Carboplatin|carboplatin|mesh-list
111142910|NCT05415709|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111142911|NCT05415709|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110839564|NCT03419806|Dopamine Agents|dopamine agents|mesh-ancestor
111142912|NCT05415709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111142913|NCT05415709|Tubulin Modulators|tubulin modulators|mesh-ancestor
111142914|NCT05415709|Antimitotic Agents|antimitotic agents|mesh-ancestor
111142915|NCT05415709|Mitosis Modulators|mitosis modulators|mesh-ancestor
111142916|NCT05415709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111142917|NCT02552303|Modafinil|modafinil|mesh-list
111142918|NCT02552303|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111142919|NCT02552303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111142920|NCT02552303|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
111142921|NCT02552303|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111142922|NCT02552303|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111142923|NCT02552303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111142924|NCT01660711|Leucovorin|leucovorin|mesh-list
111142925|NCT01660711|Fluorouracil|fluorouracil|mesh-list
111142926|NCT01660711|Oxaliplatin|oxaliplatin|mesh-list
111142927|NCT01660711|Irinotecan|irinotecan|mesh-list
111142928|NCT01660711|Antimetabolites|antimetabolites|mesh-ancestor
111142929|NCT01660711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111142930|NCT01660711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111142931|NCT01660711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111142932|NCT01660711|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111142933|NCT01660711|Immunologic Factors|immunologic factors|mesh-ancestor
111142934|NCT01660711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111142935|NCT01660711|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111142936|NCT01660711|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111142937|NCT01660711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111142938|NCT01660711|Antidotes|antidotes|mesh-ancestor
111142939|NCT01660711|Protective Agents|protective agents|mesh-ancestor
111142940|NCT01660711|Vitamin B Complex|vitamin b complex|mesh-ancestor
111142941|NCT01660711|Vitamins|vitamins|mesh-ancestor
111142942|NCT01660711|Micronutrients|micronutrients|mesh-ancestor
111142943|NCT02544113|Thymoglobulin|thymoglobulin|mesh-list
111142944|NCT02544113|Antilymphocyte Serum|antilymphocyte serum|mesh-list
111142945|NCT02544113|Immunologic Factors|immunologic factors|mesh-ancestor
111142946|NCT02544113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111142947|NCT02544113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111142948|NCT02538965|Lenalidomide|lenalidomide|mesh-list
111142949|NCT02538965|Immunologic Factors|immunologic factors|mesh-ancestor
111142950|NCT02538965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111142951|NCT02538965|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111142952|NCT02538965|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111142953|NCT02538965|Growth Substances|growth substances|mesh-ancestor
111142954|NCT02538965|Growth Inhibitors|growth inhibitors|mesh-ancestor
111142955|NCT02538965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111142956|NCT02543801|Ketorolac|ketorolac|mesh-list
111142957|NCT02543801|Clonidine|clonidine|mesh-list
111142958|NCT02543801|Epinephrine|epinephrine|mesh-list
111142959|NCT02543801|Bupivacaine|bupivacaine|mesh-list
111142960|NCT02543801|Ropivacaine|ropivacaine|mesh-list
111142961|NCT02543801|Anesthetics, Local|anesthetics, local|mesh-ancestor
111142962|NCT02543801|Anesthetics|anesthetics|mesh-ancestor
111142963|NCT02543801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111142964|NCT02543801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111142965|NCT02543801|Sensory System Agents|sensory system agents|mesh-ancestor
111142966|NCT02543801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111142967|NCT02543801|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111142968|NCT02543801|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111142969|NCT02543801|Adrenergic Agents|adrenergic agents|mesh-ancestor
111142970|NCT02543801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111142971|NCT02543801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111142972|NCT02543801|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111142973|NCT02543801|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111142974|NCT02543801|Autonomic Agents|autonomic agents|mesh-ancestor
111142975|NCT02543801|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111142976|NCT02543801|Respiratory System Agents|respiratory system agents|mesh-ancestor
111142977|NCT02543801|Mydriatics|mydriatics|mesh-ancestor
111142978|NCT02543801|Sympathomimetics|sympathomimetics|mesh-ancestor
111142979|NCT02543801|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111142980|NCT02543801|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111142981|NCT02543801|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111142982|NCT02543801|Analgesics|analgesics|mesh-ancestor
111142983|NCT02543801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111142984|NCT02543801|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111142985|NCT02543801|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111142986|NCT02543801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111142987|NCT02543801|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111142988|NCT02543801|Sympatholytics|sympatholytics|mesh-ancestor
111142989|NCT02543801|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111142990|NCT02481635|Paclitaxel|paclitaxel|mesh-list
111142991|NCT02481635|Gemcitabine|gemcitabine|mesh-list
111142992|NCT02481635|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111142993|NCT02481635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111142994|NCT02481635|Tubulin Modulators|tubulin modulators|mesh-ancestor
111142995|NCT02481635|Antimitotic Agents|antimitotic agents|mesh-ancestor
111142996|NCT02481635|Mitosis Modulators|mitosis modulators|mesh-ancestor
111142997|NCT02481635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111142998|NCT02481635|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111142999|NCT02481635|Antimetabolites|antimetabolites|mesh-ancestor
111143000|NCT02470091|Denosumab|denosumab|mesh-list
111143001|NCT02470091|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111143002|NCT02470091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111143003|NCT02362503|Fostemsavir|fostemsavir|mesh-list
111143004|NCT02362503|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111143005|NCT02362503|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111143006|NCT02362503|Antiviral Agents|antiviral agents|mesh-ancestor
111143007|NCT02362503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111143008|NCT02362503|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
111143009|NCT02362503|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
111143010|NCT02362503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111143011|NCT05411159|Analgesics, Opioid|analgesics, opioid|mesh-list
111143012|NCT05411159|Anesthetics|anesthetics|mesh-list
111143013|NCT05411159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111143014|NCT05411159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111143015|NCT05411159|Narcotics|narcotics|mesh-ancestor
111143016|NCT05411159|Analgesics|analgesics|mesh-ancestor
111143017|NCT05411159|Sensory System Agents|sensory system agents|mesh-ancestor
111143018|NCT05411159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111143019|NCT02362425|Acetylcysteine|acetylcysteine|mesh-list
111143020|NCT02362425|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111143021|NCT02362425|Antiviral Agents|antiviral agents|mesh-ancestor
111143022|NCT02362425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111143023|NCT02362425|Expectorants|expectorants|mesh-ancestor
111143024|NCT02362425|Respiratory System Agents|respiratory system agents|mesh-ancestor
111143025|NCT02362425|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111143026|NCT02362425|Antioxidants|antioxidants|mesh-ancestor
111143027|NCT02362425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111143028|NCT02362425|Protective Agents|protective agents|mesh-ancestor
111143029|NCT02362425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111143030|NCT02362425|Antidotes|antidotes|mesh-ancestor
111143031|NCT02362269|Vitamin D|vitamin d|mesh-list
111143032|NCT02362269|Vitamins|vitamins|mesh-ancestor
111143033|NCT02362269|Micronutrients|micronutrients|mesh-ancestor
111143034|NCT02362269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111143035|NCT02362269|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111143036|NCT02529995|Osimertinib|osimertinib|mesh-list
111143037|NCT02529995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111143038|NCT02529995|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111143039|NCT02529995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111143040|NCT02529995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111143041|NCT02319759|Ustekinumab|ustekinumab|mesh-list
111143042|NCT02319759|Dermatologic Agents|dermatologic agents|mesh-ancestor
111143043|NCT02318667|Golimumab|golimumab|mesh-list
111143044|NCT02318667|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111143045|NCT02318667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111143046|NCT02318667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111143047|NCT02318667|Immunologic Factors|immunologic factors|mesh-ancestor
111143048|NCT02318667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111143049|NCT02292771|Vasotocin|vasotocin|mesh-list
111143050|NCT02292771|Atosiban|atosiban|mesh-list
111143051|NCT02292771|Hormone Antagonists|hormone antagonists|mesh-ancestor
111143052|NCT02292771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111143053|NCT02292771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111143054|NCT02292771|Tocolytic Agents|tocolytic agents|mesh-ancestor
111143055|NCT02292771|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111143056|NCT02292771|Oxytocics|oxytocics|mesh-ancestor
111143057|NCT02292771|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111143058|NCT02291913|Tamoxifen|tamoxifen|mesh-list
111143059|NCT02291913|Everolimus|everolimus|mesh-list
111143060|NCT02291913|Letrozole|letrozole|mesh-list
111143061|NCT02291913|Fulvestrant|fulvestrant|mesh-list
111143062|NCT02291913|Anastrozole|anastrozole|mesh-list
111143063|NCT02291913|Exemestane|exemestane|mesh-list
111143064|NCT02291913|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111143065|NCT02291913|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111143066|NCT02291913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111143067|NCT02291913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111143068|NCT02291913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111143069|NCT02291913|Immunologic Factors|immunologic factors|mesh-ancestor
111143070|NCT02291913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111143071|NCT02291913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111143072|NCT02291913|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111143073|NCT02291913|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111143074|NCT02291913|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111143075|NCT02291913|Hormone Antagonists|hormone antagonists|mesh-ancestor
111143076|NCT02291913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111143077|NCT02291913|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111143078|NCT02291913|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111143079|NCT02291913|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111143080|NCT02291913|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111143081|NCT02291913|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
111143082|NCT02291679|Linaclotide|linaclotide|mesh-list
111143083|NCT02291679|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
111143084|NCT02291679|Enzyme Activators|enzyme activators|mesh-ancestor
111143085|NCT02291679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111143086|NCT02291679|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111143087|NCT02291601|Chlorhexidine|chlorhexidine|mesh-list
111143088|NCT02291601|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
111143089|NCT02291601|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111143090|NCT02291601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111143091|NCT02291601|Disinfectants|disinfectants|mesh-ancestor
111143092|NCT02291601|Dermatologic Agents|dermatologic agents|mesh-ancestor
111143093|NCT02360475|Vaccines|vaccines|mesh-list
111143094|NCT02360475|Immunologic Factors|immunologic factors|mesh-ancestor
111143095|NCT02360475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111143096|NCT02360397|Ranolazine|ranolazine|mesh-list
111143097|NCT02360397|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111143098|NCT02360397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111143099|NCT02360397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111143100|NCT02317809|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
111143101|NCT02317809|Hormones|hormones|mesh-ancestor
111143102|NCT02317809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111143103|NCT02317809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111143104|NCT02359851|Pembrolizumab|pembrolizumab|mesh-list
111143105|NCT02359851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111143106|NCT02359851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111143107|NCT02359851|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111143108|NCT02359851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111143109|NCT01607905|Acetaminophen|acetaminophen|mesh-list
111143110|NCT01607905|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111143111|NCT01607905|Analgesics|analgesics|mesh-ancestor
111143112|NCT01607905|Sensory System Agents|sensory system agents|mesh-ancestor
111143113|NCT01607905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111143114|NCT01607905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111143115|NCT01607905|Antipyretics|antipyretics|mesh-ancestor
111143116|NCT02389543|Dexamethasone|dexamethasone|mesh-list
111143117|NCT02389543|Lenalidomide|lenalidomide|mesh-list
111143118|NCT02389543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111143119|NCT02389543|Antiemetics|antiemetics|mesh-ancestor
111143120|NCT02389543|Autonomic Agents|autonomic agents|mesh-ancestor
111143121|NCT02389543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111143122|NCT02389543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111143123|NCT02389543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111143124|NCT02389543|Glucocorticoids|glucocorticoids|mesh-ancestor
111143125|NCT02389543|Hormones|hormones|mesh-ancestor
111143126|NCT02389543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111143127|NCT02389543|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111143128|NCT02389543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111143129|NCT02389543|Immunologic Factors|immunologic factors|mesh-ancestor
111143130|NCT02389543|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111143131|NCT02389543|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111143132|NCT02389543|Growth Substances|growth substances|mesh-ancestor
111143133|NCT02389543|Growth Inhibitors|growth inhibitors|mesh-ancestor
111143134|NCT05441605|Chlorhexidine|chlorhexidine|mesh-list
111143135|NCT05441605|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111143136|NCT05441605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111143137|NCT05441605|Disinfectants|disinfectants|mesh-ancestor
111143138|NCT00843037|Sunitinib|sunitinib|mesh-list
111143139|NCT00843037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111143140|NCT00843037|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111143141|NCT00843037|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111143142|NCT00843037|Growth Substances|growth substances|mesh-ancestor
111143143|NCT00843037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111143144|NCT00843037|Growth Inhibitors|growth inhibitors|mesh-ancestor
111143145|NCT00843037|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111143146|NCT00843037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111143147|NCT00843037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111143148|NCT05441527|Muramidase|muramidase|mesh-list
111143149|NCT05441527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111143150|NCT02531035|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
111143151|NCT02531035|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111143152|NCT02531035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111143153|NCT02531035|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111143154|NCT02531035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111143155|NCT05004805|Methylene Blue|methylene blue|mesh-list
111143156|NCT05004805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111143157|NCT05004805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111143159|NCT04261387|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111143160|NCT04261387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111143161|NCT04261387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111143162|NCT05411965|Pioglitazone|pioglitazone|mesh-list
111143163|NCT05411965|Dapagliflozin|dapagliflozin|mesh-list
111143164|NCT05411965|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111143165|NCT05411965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111143166|NCT05411965|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111143167|NCT05411965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111143168|NCT04261075|Durvalumab|durvalumab|mesh-list
111143169|NCT04261075|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111143170|NCT04261075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111143171|NCT05436769|Clarithromycin|clarithromycin|mesh-list
111143172|NCT05436769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111143173|NCT05436769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111143174|NCT05436769|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111143175|NCT05436769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111143176|NCT05436769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111143177|NCT05436769|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111143178|NCT05436769|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111143179|NCT05378737|Exatecan|exatecan|mesh-list
111143180|NCT05378737|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111143181|NCT05378737|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111143182|NCT05378737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111143183|NCT05378737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111143184|NCT05378737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111143185|NCT03929029|Nivolumab|nivolumab|mesh-list
111143186|NCT03929029|Ipilimumab|ipilimumab|mesh-list
111143187|NCT03929029|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
111143188|NCT03929029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111143189|NCT03929029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111143190|NCT03929029|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111143191|NCT03929029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111143192|NCT03929029|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111143193|NCT03929029|Immunologic Factors|immunologic factors|mesh-ancestor
111143194|NCT03929029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111143195|NCT01659853|Azelaic acid|azelaic acid|mesh-list
111143196|NCT01659853|Brimonidine Tartrate|brimonidine tartrate|mesh-list
111143197|NCT01659853|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111143198|NCT01659853|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111143199|NCT01659853|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111143200|NCT01659853|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111143201|NCT01659853|Adrenergic Agents|adrenergic agents|mesh-ancestor
111143202|NCT01659853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111143203|NCT01659853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111143204|NCT01659853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111143205|NCT01659853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111143206|NCT01659853|Dermatologic Agents|dermatologic agents|mesh-ancestor
111143207|NCT05376553|Docetaxel|docetaxel|mesh-list
111143208|NCT05376553|Cemiplimab|cemiplimab|mesh-list
111143209|NCT05376553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111143210|NCT05376553|Tubulin Modulators|tubulin modulators|mesh-ancestor
111143211|NCT05376553|Antimitotic Agents|antimitotic agents|mesh-ancestor
111143212|NCT05376553|Mitosis Modulators|mitosis modulators|mesh-ancestor
111143213|NCT05376553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111143214|NCT05376553|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111143215|NCT05385367|Anesthetics|anesthetics|mesh-list
111143216|NCT05385367|Anesthetics, General|anesthetics, general|mesh-list
111143217|NCT05385367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111143218|NCT05385367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111143219|NCT05576389|Fluzoparib|fluzoparib|mesh-list
111143220|NCT05576389|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111143221|NCT05576389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111143222|NCT05576389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111143223|NCT05576389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111143224|NCT05341609|Ritonavir|ritonavir|mesh-list
111143225|NCT05341609|Nirmatrelvir|nirmatrelvir|mesh-list
111143226|NCT05341609|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
111143227|NCT05341609|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111143228|NCT05341609|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111143229|NCT05341609|Protease Inhibitors|protease inhibitors|mesh-ancestor
111143230|NCT05341609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111143231|NCT05341609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111143232|NCT05341609|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111143233|NCT05341609|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111143234|NCT05341609|Antiviral Agents|antiviral agents|mesh-ancestor
111143235|NCT05341609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111143236|NCT05341609|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111143237|NCT05341609|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111143238|NCT05371015|Ropivacaine|ropivacaine|mesh-list
111143239|NCT05371015|Anesthetics, Local|anesthetics, local|mesh-ancestor
111143240|NCT05371015|Anesthetics|anesthetics|mesh-ancestor
111143241|NCT05371015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111143242|NCT05371015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111143243|NCT05371015|Sensory System Agents|sensory system agents|mesh-ancestor
111143244|NCT05371015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111143245|NCT02531113|Ozanimod|ozanimod|mesh-list
111143246|NCT02531113|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
111143247|NCT02531113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111143248|NCT02531113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111143249|NCT02531113|Immunologic Factors|immunologic factors|mesh-ancestor
111143250|NCT02531113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111143251|NCT05509933|Budesonide|budesonide|mesh-list
111143252|NCT05509933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111143253|NCT05509933|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111143254|NCT05509933|Autonomic Agents|autonomic agents|mesh-ancestor
111143255|NCT05509933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111143256|NCT05509933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111143257|NCT05509933|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111143258|NCT05509933|Respiratory System Agents|respiratory system agents|mesh-ancestor
111143259|NCT05509933|Glucocorticoids|glucocorticoids|mesh-ancestor
111143260|NCT05509933|Hormones|hormones|mesh-ancestor
111143261|NCT05509933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111143262|NCT04248595|Azacitidine|azacitidine|mesh-list
111143263|NCT04248595|Homoharringtonine|homoharringtonine|mesh-list
111143264|NCT04248595|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111143265|NCT04248595|Antimetabolites|antimetabolites|mesh-ancestor
111143266|NCT04248595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111143267|NCT04248595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111143268|NCT04248595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111143269|NCT04248595|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111143270|NCT04248595|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111143271|NCT05334277|Bevacizumab|bevacizumab|mesh-list
111143272|NCT05334277|Carboplatin|carboplatin|mesh-list
111143274|NCT05334277|Aflutinib|aflutinib|mesh-list
111143275|NCT05334277|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111143276|NCT05334277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111143277|NCT05334277|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111143278|NCT05334277|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111143279|NCT05334277|Growth Substances|growth substances|mesh-ancestor
111143280|NCT05334277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111143281|NCT05334277|Growth Inhibitors|growth inhibitors|mesh-ancestor
111143282|NCT05334277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111143283|NCT05334277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111143284|NCT05334277|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111143285|NCT05334277|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111143286|NCT05334277|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111143287|NCT05332717|Melatonin|melatonin|mesh-list
111143288|NCT05332717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111143290|NCT05332717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111143291|NCT05332717|Protective Agents|protective agents|mesh-ancestor
111143292|NCT05332717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111143293|NCT05300269|Capecitabine|capecitabine|mesh-list
111143294|NCT05300269|Oxaliplatin|oxaliplatin|mesh-list
111143295|NCT05300269|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111143296|NCT05300269|Antimetabolites|antimetabolites|mesh-ancestor
111143297|NCT05300269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111143298|NCT05300269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111143299|NCT05325853|Proxymetacaine|proxymetacaine|mesh-list
111143300|NCT05325853|Propoxycaine|propoxycaine|mesh-list
111143301|NCT05325853|Anesthetics, Local|anesthetics, local|mesh-ancestor
111143302|NCT05325853|Anesthetics|anesthetics|mesh-ancestor
111143303|NCT05325853|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111143304|NCT05325853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111143305|NCT05325853|Sensory System Agents|sensory system agents|mesh-ancestor
111143306|NCT05325853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111143307|NCT05353933|Pantoprazole|pantoprazole|mesh-list
111143308|NCT05353933|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111143309|NCT05353933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111143310|NCT05353933|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111143311|NCT05353933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111143312|NCT05353933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111143313|NCT05352685|Propofol|propofol|mesh-list
111143314|NCT05352685|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111143315|NCT05352685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111143316|NCT05352685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111143317|NCT05352685|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111143318|NCT05352685|Anesthetics, General|anesthetics, general|mesh-ancestor
111143319|NCT05352685|Anesthetics|anesthetics|mesh-ancestor
111143320|NCT05351593|Lenalidomide|lenalidomide|mesh-list
111143321|NCT05351593|Immunologic Factors|immunologic factors|mesh-ancestor
111143322|NCT05351593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111143323|NCT05351593|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111143324|NCT05351593|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111143325|NCT05351593|Growth Substances|growth substances|mesh-ancestor
111143326|NCT05351593|Growth Inhibitors|growth inhibitors|mesh-ancestor
111143327|NCT05351593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111143328|NCT05321875|Candesartan|candesartan|mesh-list
111143329|NCT05321875|Candesartan cilexetil|candesartan cilexetil|mesh-list
111143330|NCT05321875|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111143331|NCT05321875|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111143332|NCT05321875|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110839595|NCT04893915|Fludarabine|fludarabine|mesh-list
111143333|NCT05321875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111143335|NCT05347069|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111143336|NCT05347069|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111143337|NCT05347069|Analgesics|analgesics|mesh-ancestor
111143338|NCT05347069|Sensory System Agents|sensory system agents|mesh-ancestor
111143339|NCT05347069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111143340|NCT05347069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111143341|NCT05347069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111143342|NCT05347069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111143343|NCT05347069|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111143344|NCT05347069|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111143345|NCT05347069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111143346|NCT05347069|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111143347|NCT05347069|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111143348|NCT05347069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111143349|NCT05347069|Antipyretics|antipyretics|mesh-ancestor
111143350|NCT05516953|Baclofen|baclofen|mesh-list
111143351|NCT05516953|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
111143352|NCT05516953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111143353|NCT05516953|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111143354|NCT05516953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111143355|NCT05516953|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
111143356|NCT05516953|GABA Agonists|gaba agonists|mesh-ancestor
111143357|NCT05516953|GABA Agents|gaba agents|mesh-ancestor
111143358|NCT05516953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111143359|NCT05516953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111143360|NCT02522767|Mesalamine|mesalamine|mesh-list
111143361|NCT02522767|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110860395|NCT04729517|Histamine Agents|histamine agents|mesh-ancestor
111143362|NCT02522767|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111143363|NCT02522767|Analgesics|analgesics|mesh-ancestor
111143364|NCT02522767|Sensory System Agents|sensory system agents|mesh-ancestor
111143365|NCT02522767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111143366|NCT02522767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111143367|NCT02522767|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111143368|NCT02522767|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111143369|NCT02522377|Midazolam|midazolam|mesh-list
111143370|NCT02522377|Ketamine|ketamine|mesh-list
111143371|NCT02522377|Analgesics|analgesics|mesh-ancestor
111143372|NCT02522377|Sensory System Agents|sensory system agents|mesh-ancestor
111143373|NCT02522377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111143374|NCT02522377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111143375|NCT02522377|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111143376|NCT02522377|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111143377|NCT02522377|Anesthetics, General|anesthetics, general|mesh-ancestor
111143378|NCT02522377|Anesthetics|anesthetics|mesh-ancestor
111143379|NCT02522377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110482387|NCT02697045|Serotonin Agents|serotonin agents|mesh-ancestor
111143380|NCT02522377|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111143381|NCT02522377|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111143382|NCT02522377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111143383|NCT02522377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111143384|NCT02522377|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111143385|NCT02522377|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111143386|NCT02522377|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111143387|NCT02522377|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111143388|NCT02522377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111143389|NCT02522377|GABA Modulators|gaba modulators|mesh-ancestor
111143390|NCT02522377|GABA Agents|gaba agents|mesh-ancestor
111143391|NCT05318755|Testosterone|testosterone|mesh-list
111143392|NCT05318755|Androgens|androgens|mesh-ancestor
111143393|NCT05318755|Hormones|hormones|mesh-ancestor
111143394|NCT05318755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111143395|NCT05318755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111143396|NCT05267743|Lansoprazole|lansoprazole|mesh-list
111143397|NCT05267743|Dexlansoprazole|dexlansoprazole|mesh-list
111143398|NCT05267743|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111143399|NCT05267743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111143400|NCT05267743|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111143401|NCT05267743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111143402|NCT05267743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111143404|NCT05291845|Immunologic Factors|immunologic factors|mesh-ancestor
111143405|NCT05291845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111143406|NCT05314621|Fluticasone|fluticasone|mesh-list
111143407|NCT05314621|Xhance|xhance|mesh-list
111143408|NCT05314621|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
111143409|NCT05314621|Dextrans|dextrans|mesh-list
111143410|NCT05314621|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111143411|NCT05314621|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111143412|NCT05314621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111143413|NCT05314621|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111143414|NCT05314621|Autonomic Agents|autonomic agents|mesh-ancestor
111143415|NCT05314621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111143416|NCT05314621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111143417|NCT05314621|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111143418|NCT05314621|Respiratory System Agents|respiratory system agents|mesh-ancestor
111143419|NCT05314621|Dermatologic Agents|dermatologic agents|mesh-ancestor
111143420|NCT05314621|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111143421|NCT05314621|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111143422|NCT05314621|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111143423|NCT05314621|Analgesics|analgesics|mesh-ancestor
111143424|NCT05314621|Sensory System Agents|sensory system agents|mesh-ancestor
111143425|NCT05314621|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111143426|NCT05314621|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
111143427|NCT05314621|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111143428|NCT05314621|Histamine Antagonists|histamine antagonists|mesh-ancestor
111143429|NCT05314621|Histamine Agents|histamine agents|mesh-ancestor
111143430|NCT05314621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111143431|NCT05314621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111143432|NCT05314621|Anticoagulants|anticoagulants|mesh-ancestor
111143433|NCT05314621|Plasma Substitutes|plasma substitutes|mesh-ancestor
111143434|NCT05314621|Blood Substitutes|blood substitutes|mesh-ancestor
111143435|NCT05263609|Pembrolizumab|pembrolizumab|mesh-list
111143436|NCT05263609|Axitinib|axitinib|mesh-list
111143437|NCT05263609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111143438|NCT05263609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111143439|NCT05263609|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111143440|NCT05263609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111143441|NCT05263609|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111143442|NCT05263609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111143444|NCT05313997|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111143445|NCT05313997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111143446|NCT05313997|Analgesics|analgesics|mesh-ancestor
111143447|NCT05313997|Sensory System Agents|sensory system agents|mesh-ancestor
111143448|NCT05313997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111143449|NCT05313997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111143450|NCT05313997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111143451|NCT05313997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111143452|NCT05313997|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111143453|NCT05313997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111143454|NCT05313997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111143455|NCT05259241|Thrombin|thrombin|mesh-list
111143456|NCT05259241|Hemostatics|hemostatics|mesh-ancestor
111143457|NCT05259241|Coagulants|coagulants|mesh-ancestor
111143458|NCT01657903|Listerine|listerine|mesh-list
111143459|NCT01657903|Fluorides|fluorides|mesh-list
111143460|NCT01657903|Sodium Fluoride|sodium fluoride|mesh-list
111143461|NCT01657903|Cariostatic Agents|cariostatic agents|mesh-ancestor
111143462|NCT01657903|Protective Agents|protective agents|mesh-ancestor
111143463|NCT01657903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111143464|NCT01657903|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111143465|NCT01657903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111143466|NCT05256823|Celecoxib|celecoxib|mesh-list
111143467|NCT05256823|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111143468|NCT05256823|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111143469|NCT05256823|Analgesics|analgesics|mesh-ancestor
111143470|NCT05256823|Sensory System Agents|sensory system agents|mesh-ancestor
111143471|NCT05256823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110839604|NCT04893915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111143472|NCT05256823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111143473|NCT05256823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111143474|NCT05256823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111143475|NCT05256823|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111143476|NCT05256823|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111143477|NCT05256823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111143478|NCT05256823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111143479|NCT04243837|Pirfenidone|pirfenidone|mesh-list
111143480|NCT04243837|Analgesics|analgesics|mesh-ancestor
111143481|NCT04243837|Sensory System Agents|sensory system agents|mesh-ancestor
111143482|NCT04243837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111143483|NCT04243837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111143484|NCT04243837|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111143485|NCT04243837|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111143486|NCT04243837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111143487|NCT04243837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111143488|NCT04243837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111143489|NCT05253937|Epinephrine|epinephrine|mesh-list
111143490|NCT05253937|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111143491|NCT05253937|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111143492|NCT05253937|Adrenergic Agents|adrenergic agents|mesh-ancestor
111143493|NCT05253937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111143494|NCT05253937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111143495|NCT05253937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111143496|NCT05253937|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111143497|NCT05253937|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111143498|NCT05253937|Autonomic Agents|autonomic agents|mesh-ancestor
111143499|NCT05253937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111143500|NCT05253937|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111143501|NCT05253937|Respiratory System Agents|respiratory system agents|mesh-ancestor
111143502|NCT05253937|Mydriatics|mydriatics|mesh-ancestor
111143503|NCT05253937|Sympathomimetics|sympathomimetics|mesh-ancestor
111143504|NCT05253937|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111143505|NCT05218603|Bortezomib|bortezomib|mesh-list
111143506|NCT05218603|Daratumumab|daratumumab|mesh-list
111143507|NCT05218603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111143508|NCT05214001|Almotriptan|almotriptan|mesh-list
111143509|NCT05214001|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111143510|NCT05214001|Serotonin Agents|serotonin agents|mesh-ancestor
111143511|NCT05214001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111143512|NCT05214001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111143513|NCT05214001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111143514|NCT05280223|Dexmedetomidine|dexmedetomidine|mesh-list
111143515|NCT05280223|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111143516|NCT05280223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111143517|NCT05280223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111143518|NCT05280223|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111143519|NCT05280223|Analgesics|analgesics|mesh-ancestor
111143520|NCT05280223|Sensory System Agents|sensory system agents|mesh-ancestor
111143521|NCT05280223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111143522|NCT05280223|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111143523|NCT05280223|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111143524|NCT05280223|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111143525|NCT05280223|Adrenergic Agents|adrenergic agents|mesh-ancestor
111143526|NCT05280223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111143527|NCT05280223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111143528|NCT05277337|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111143529|NCT05277337|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111143530|NCT05277337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111143531|NCT05277337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111143532|NCT05277337|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111143533|NCT05277337|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110839610|NCT03419494|Doxorubicin|doxorubicin|mesh-list
111143534|NCT05277337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111143535|NCT05277337|Cholinergic Agents|cholinergic agents|mesh-ancestor
111143536|NCT05277337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111143537|NCT05248945|Carbamazepine|carbamazepine|mesh-list
111143538|NCT05248945|Anticonvulsants|anticonvulsants|mesh-ancestor
111143539|NCT05248945|Antimanic Agents|antimanic agents|mesh-ancestor
111143540|NCT05248945|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111143541|NCT05248945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111143542|NCT05248945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111143543|NCT05248945|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111143544|NCT05248945|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111143545|NCT05248945|Analgesics|analgesics|mesh-ancestor
111143546|NCT05248945|Sensory System Agents|sensory system agents|mesh-ancestor
111143547|NCT05248945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111143548|NCT05248945|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111143549|NCT05248945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111143550|NCT05248945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111143551|NCT05248945|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111143552|NCT05248945|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111143553|NCT04239313|Vaccines|vaccines|mesh-list
111143554|NCT04239313|Immunologic Factors|immunologic factors|mesh-ancestor
111143555|NCT04239313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111143556|NCT05209867|Cannabidiol|cannabidiol|mesh-list
111143557|NCT05209867|Anticonvulsants|anticonvulsants|mesh-ancestor
111143558|NCT05273827|Paclitaxel|paclitaxel|mesh-list
111143559|NCT05273827|Pemetrexed|pemetrexed|mesh-list
111143560|NCT05273827|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111143561|NCT05273827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111143562|NCT05273827|Tubulin Modulators|tubulin modulators|mesh-ancestor
111143563|NCT05273827|Antimitotic Agents|antimitotic agents|mesh-ancestor
111143564|NCT05273827|Mitosis Modulators|mitosis modulators|mesh-ancestor
111143565|NCT05273827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111143566|NCT05273827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111143567|NCT05273827|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111143568|NCT05273827|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111143569|NCT05209711|Lidocaine|lidocaine|mesh-list
111143570|NCT05209711|Anesthetics, Local|anesthetics, local|mesh-ancestor
111143571|NCT05209711|Anesthetics|anesthetics|mesh-ancestor
111143572|NCT05209711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111143573|NCT05209711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111143574|NCT05209711|Sensory System Agents|sensory system agents|mesh-ancestor
111143575|NCT05209711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111143576|NCT05209711|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110482416|NCT01028651|Treprostinil|treprostinil|mesh-list
111143577|NCT05209711|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111143578|NCT05209711|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111143579|NCT05209711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111143580|NCT05209711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111143581|NCT05243563|Clobetasol|clobetasol|mesh-list
111143582|NCT05243563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111143583|NCT05243563|Glucocorticoids|glucocorticoids|mesh-ancestor
111143584|NCT05243563|Hormones|hormones|mesh-ancestor
111143585|NCT05243563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111143586|NCT05243563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111143587|NCT05272969|Vitamin D|vitamin d|mesh-list
111143588|NCT05272969|Calcium|calcium|mesh-list
111143589|NCT05272969|Vitamins|vitamins|mesh-ancestor
111143590|NCT05272969|Micronutrients|micronutrients|mesh-ancestor
111143591|NCT05272969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111143592|NCT05272969|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111143593|NCT05272969|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111143594|NCT05208619|Anesthetics|anesthetics|mesh-list
111143595|NCT05208619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111143596|NCT05208619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111143597|NCT05206747|Methamphetamine|methamphetamine|mesh-list
111143598|NCT05206747|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111143599|NCT05206747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111143600|NCT05206747|Sympathomimetics|sympathomimetics|mesh-ancestor
111143601|NCT05206747|Autonomic Agents|autonomic agents|mesh-ancestor
111143602|NCT05206747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111143603|NCT05206747|Dopamine Agents|dopamine agents|mesh-ancestor
111143604|NCT05206747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111143605|NCT05206747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111143606|NCT05206747|Adrenergic Agents|adrenergic agents|mesh-ancestor
111143607|NCT05206747|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111143608|NCT05206747|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111143609|NCT05206747|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111143610|NCT05206747|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111143611|NCT05206435|Nicotine|nicotine|mesh-list
111143612|NCT05206435|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111143613|NCT05206435|Autonomic Agents|autonomic agents|mesh-ancestor
111143614|NCT05206435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111143615|NCT05206435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111143616|NCT05206435|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111143617|NCT05206435|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111143618|NCT05206435|Cholinergic Agents|cholinergic agents|mesh-ancestor
111143619|NCT05206435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111143620|NCT05206435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111143621|NCT05205811|Zonisamide|zonisamide|mesh-list
111143622|NCT05205811|Bupropion|bupropion|mesh-list
111143623|NCT05205811|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111143624|NCT05205811|Antidepressive Agents|antidepressive agents|mesh-ancestor
111143625|NCT05205811|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111143626|NCT05205811|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111143627|NCT05205811|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111143628|NCT05205811|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111143629|NCT05205811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111143630|NCT05205811|Dopamine Agents|dopamine agents|mesh-ancestor
111143631|NCT05205811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111143632|NCT05205811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111143633|NCT05205811|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111143634|NCT05205811|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111143635|NCT05205811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111143636|NCT05205811|Anticonvulsants|anticonvulsants|mesh-ancestor
111143637|NCT05205811|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111143638|NCT05205811|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111143639|NCT05166967|Antilymphocyte Serum|antilymphocyte serum|mesh-list
111143640|NCT05166967|Immunologic Factors|immunologic factors|mesh-ancestor
111143641|NCT05166967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111143642|NCT05166967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111143643|NCT05166343|Epinephrine|epinephrine|mesh-list
111143644|NCT05166343|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111143645|NCT05166343|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111143646|NCT05166343|Adrenergic Agents|adrenergic agents|mesh-ancestor
111143647|NCT05166343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111143648|NCT05166343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111143649|NCT05166343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111143650|NCT05166343|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111143651|NCT05166343|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111143652|NCT05166343|Autonomic Agents|autonomic agents|mesh-ancestor
111143653|NCT05166343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111143654|NCT05166343|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111143655|NCT05166343|Respiratory System Agents|respiratory system agents|mesh-ancestor
111143656|NCT05166343|Mydriatics|mydriatics|mesh-ancestor
111143657|NCT05166343|Sympathomimetics|sympathomimetics|mesh-ancestor
111143658|NCT05166343|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111143659|NCT01656733|Nicotine|nicotine|mesh-list
111143660|NCT01656733|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111143661|NCT01656733|Autonomic Agents|autonomic agents|mesh-ancestor
111143662|NCT01656733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111143663|NCT01656733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111143664|NCT01656733|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111143665|NCT01656733|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111143666|NCT01656733|Cholinergic Agents|cholinergic agents|mesh-ancestor
111143667|NCT01656733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111143668|NCT01656733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111143669|NCT05236543|Itraconazole|itraconazole|mesh-list
111143670|NCT05236543|Antifungal Agents|antifungal agents|mesh-ancestor
111143671|NCT05236543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111143672|NCT05236543|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111143673|NCT05236543|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111143674|NCT05236543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111143675|NCT05236543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111143676|NCT05236543|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111143677|NCT05236543|Hormone Antagonists|hormone antagonists|mesh-ancestor
111143678|NCT05236543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111143679|NCT05236543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111143680|NCT05236543|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111143681|NCT05157841|Bupivacaine|bupivacaine|mesh-list
111143682|NCT05157841|Anesthetics, Local|anesthetics, local|mesh-ancestor
111143683|NCT05157841|Anesthetics|anesthetics|mesh-ancestor
111143684|NCT05157841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111143685|NCT05157841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111143686|NCT05157841|Sensory System Agents|sensory system agents|mesh-ancestor
111143687|NCT05157841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111143688|NCT05225155|Enoxaparin|enoxaparin|mesh-list
111143689|NCT05225155|Anticoagulants|anticoagulants|mesh-ancestor
111143690|NCT05225155|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111143691|NCT05225155|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111143692|NCT05225155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111143693|NCT05190445|Paclitaxel|paclitaxel|mesh-list
111143694|NCT05190445|Ramucirumab|ramucirumab|mesh-list
111143695|NCT05190445|Tucatinib|tucatinib|mesh-list
111143696|NCT05190445|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111143697|NCT05190445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111143698|NCT05190445|Tubulin Modulators|tubulin modulators|mesh-ancestor
111143699|NCT05190445|Antimitotic Agents|antimitotic agents|mesh-ancestor
111143700|NCT05190445|Mitosis Modulators|mitosis modulators|mesh-ancestor
111143701|NCT05190445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111143702|NCT05190445|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111143703|NCT05190445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111143704|NCT05189977|Propranolol|propranolol|mesh-list
111143705|NCT05189977|Prazosin|prazosin|mesh-list
111143706|NCT05189977|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111143707|NCT05189977|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111143708|NCT05189977|Adrenergic Agents|adrenergic agents|mesh-ancestor
111143709|NCT05189977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111143710|NCT05189977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111143711|NCT05189977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111143712|NCT05189977|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111143713|NCT05189977|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111143714|NCT05189977|Vasodilator Agents|vasodilator agents|mesh-ancestor
111143715|NCT05189977|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111143716|NCT05189977|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111143717|NCT05148949|Vaccines|vaccines|mesh-list
111143718|NCT05148949|Immunologic Factors|immunologic factors|mesh-ancestor
111143719|NCT05148949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111143720|NCT05107999|Doxepin|doxepin|mesh-list
111143721|NCT05107999|Antidepressive Agents|antidepressive agents|mesh-list
111143722|NCT05107999|Neurotransmitter Agents|neurotransmitter agents|mesh-list
111143723|NCT05107999|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111143724|NCT05107999|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111143725|NCT05107999|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111143726|NCT05107999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111143727|NCT05107999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111143728|NCT05107999|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
111143729|NCT05107999|Histamine Antagonists|histamine antagonists|mesh-ancestor
111143730|NCT05107999|Histamine Agents|histamine agents|mesh-ancestor
111143731|NCT05107999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111143732|NCT05186545|Fulvestrant|fulvestrant|mesh-list
111143733|NCT05186545|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110860781|NCT03564340|Cemiplimab|cemiplimab|mesh-list
111143734|NCT05186545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111143735|NCT05186545|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
111143736|NCT05186545|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111143737|NCT05186545|Hormone Antagonists|hormone antagonists|mesh-ancestor
111143738|NCT05186545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111143739|NCT05186545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111143740|NCT05107765|Pioglitazone|pioglitazone|mesh-list
111143741|NCT05107765|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111143742|NCT05107765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111143743|NCT05183737|Propolis|propolis|mesh-list
111143744|NCT05183737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111143745|NCT05177419|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
111143746|NCT05177419|Hallucinogens|hallucinogens|mesh-ancestor
111143747|NCT05177419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111143748|NCT05177419|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111143749|NCT05177419|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111143750|NCT05177419|Serotonin Agents|serotonin agents|mesh-ancestor
111143751|NCT05177419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111143752|NCT05177419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111143753|NCT05177419|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111143754|NCT05094427|Anesthetics|anesthetics|mesh-list
111143755|NCT05094427|Anesthetics, Local|anesthetics, local|mesh-list
111143756|NCT05094427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111143757|NCT05094427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111143758|NCT05094427|Sensory System Agents|sensory system agents|mesh-ancestor
111143759|NCT05094427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111143760|NCT05175781|Dexmedetomidine|dexmedetomidine|mesh-list
111143761|NCT05175781|Ketamine|ketamine|mesh-list
111143762|NCT05175781|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111143763|NCT05175781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110482448|NCT01028027|Hormones|hormones|mesh-ancestor
111143764|NCT05175781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111143765|NCT05175781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111143766|NCT05175781|Analgesics|analgesics|mesh-ancestor
111143767|NCT05175781|Sensory System Agents|sensory system agents|mesh-ancestor
111143768|NCT05175781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111143769|NCT05175781|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111143770|NCT05175781|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111143771|NCT05175781|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111143772|NCT05175781|Adrenergic Agents|adrenergic agents|mesh-ancestor
111143773|NCT05175781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111143774|NCT05175781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111143775|NCT05175781|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111143776|NCT05175781|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111143777|NCT05175781|Anesthetics, General|anesthetics, general|mesh-ancestor
111143778|NCT05175781|Anesthetics|anesthetics|mesh-ancestor
111143779|NCT05175781|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111143780|NCT05175781|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111143781|NCT04421911|Diclofenac|diclofenac|mesh-list
111143782|NCT04421911|Ketoprofen|ketoprofen|mesh-list
111143783|NCT04421911|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111143784|NCT04421911|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111143785|NCT04421911|Analgesics|analgesics|mesh-ancestor
111143786|NCT04421911|Sensory System Agents|sensory system agents|mesh-ancestor
111143787|NCT04421911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111143788|NCT04421911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111143789|NCT04421911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111143790|NCT04421911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111143791|NCT04421911|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111143792|NCT04421911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111143793|NCT04421911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111143794|NCT05174611|Vitamin D|vitamin d|mesh-list
111143795|NCT05174611|Cholecalciferol|cholecalciferol|mesh-list
111143796|NCT05174611|Vitamins|vitamins|mesh-ancestor
111143797|NCT05174611|Micronutrients|micronutrients|mesh-ancestor
111143798|NCT05174611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111143799|NCT05174611|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110839640|NCT03413020|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111143800|NCT05174611|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111143802|NCT05133817|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
111143803|NCT05133817|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111143804|NCT05133817|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111143805|NCT05133817|Adrenergic Agents|adrenergic agents|mesh-ancestor
111143806|NCT05133817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111143807|NCT05133817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111143808|NCT05133817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111143809|NCT05133817|Sympathomimetics|sympathomimetics|mesh-ancestor
111143810|NCT05133817|Autonomic Agents|autonomic agents|mesh-ancestor
111143811|NCT05133817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111143812|NCT05171335|Lenvatinib|lenvatinib|mesh-list
111143813|NCT05171335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111143814|NCT05171335|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111143815|NCT05171335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111143816|NCT05171335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111143817|NCT02522299|Nemiralisib|nemiralisib|mesh-list
111143818|NCT02522299|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111143819|NCT02522299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111143820|NCT02522299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111143821|NCT01365091|Metformin|metformin|mesh-list
111143822|NCT01365091|Saxagliptin|saxagliptin|mesh-list
111143823|NCT01365091|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111143824|NCT01365091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111143825|NCT01365091|Incretins|incretins|mesh-ancestor
111143826|NCT01365091|Hormones|hormones|mesh-ancestor
111143827|NCT01365091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111143828|NCT01365091|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111143829|NCT01365091|Protease Inhibitors|protease inhibitors|mesh-ancestor
111143830|NCT01365091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111143831|NCT01365091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111143832|NCT05082025|Fulvestrant|fulvestrant|mesh-list
111143833|NCT05082025|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111143834|NCT05082025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111143835|NCT05082025|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
111143836|NCT05082025|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111143837|NCT05082025|Hormone Antagonists|hormone antagonists|mesh-ancestor
111143838|NCT05082025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111143839|NCT05082025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111143840|NCT05079763|Monolaurin|monolaurin|mesh-list
111143841|NCT05079763|Cariostatic Agents|cariostatic agents|mesh-ancestor
111143842|NCT05079763|Protective Agents|protective agents|mesh-ancestor
111143843|NCT05079763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111143844|NCT05050981|Hormones|hormones|mesh-list
111143845|NCT05050981|Serotonin|serotonin|mesh-list
111143846|NCT05050981|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
111143847|NCT05050981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111143848|NCT05050981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111143849|NCT05050981|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111143850|NCT05050981|Serotonin Agents|serotonin agents|mesh-ancestor
111143851|NCT05050981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111143852|NCT05050981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111143853|NCT05050981|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111143854|NCT05050981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111143855|NCT05065645|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111143856|NCT01364467|Phenylpropanolamine|phenylpropanolamine|mesh-list
111143857|NCT01364467|Guaifenesin|guaifenesin|mesh-list
111143858|NCT01364467|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
111143859|NCT01364467|Expectorants|expectorants|mesh-ancestor
111143860|NCT01364467|Respiratory System Agents|respiratory system agents|mesh-ancestor
111143861|NCT01364467|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111143862|NCT01364467|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111143863|NCT01364467|Adrenergic Agents|adrenergic agents|mesh-ancestor
111143864|NCT01364467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111143865|NCT01364467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111143866|NCT01364467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111143867|NCT01364467|Appetite Depressants|appetite depressants|mesh-ancestor
111143868|NCT01364467|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111143869|NCT01364467|Sympathomimetics|sympathomimetics|mesh-ancestor
111143870|NCT01364467|Autonomic Agents|autonomic agents|mesh-ancestor
111143871|NCT01364467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111143872|NCT01364467|Nasal Decongestants|nasal decongestants|mesh-ancestor
111143873|NCT01364467|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111143874|NCT04226365|Nortriptyline|nortriptyline|mesh-list
111143875|NCT04226365|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
111143876|NCT04226365|Antidepressive Agents|antidepressive agents|mesh-ancestor
111143877|NCT04226365|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111143878|NCT04226365|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111143879|NCT04226365|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111143880|NCT04226365|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111143881|NCT04226365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111143882|NCT04226365|Adrenergic Agents|adrenergic agents|mesh-ancestor
111143883|NCT04226365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111143884|NCT04226365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111143885|NCT05062837|Apatinib|apatinib|mesh-list
111143886|NCT05062837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111143887|NCT05062837|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111143888|NCT05062837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110482468|NCT02870036|Leucovorin|leucovorin|mesh-list
111143889|NCT05062837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111143890|NCT05110417|Bromides|bromides|mesh-list
111143891|NCT05110417|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
111143892|NCT05110417|Anticonvulsants|anticonvulsants|mesh-ancestor
111143893|NCT05110417|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111143894|NCT05110417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111143895|NCT05110417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111143896|NCT05110417|Cholinergic Agents|cholinergic agents|mesh-ancestor
111143897|NCT05110417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111143898|NCT05110417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111143899|NCT05031481|Butoconazole|butoconazole|mesh-list
111143900|NCT05031481|Antifungal Agents|antifungal agents|mesh-ancestor
111143901|NCT05031481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111143902|NCT05057767|Midazolam|midazolam|mesh-list
111143903|NCT05057767|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111143904|NCT05057767|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111143905|NCT05057767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111143906|NCT05057767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111143907|NCT05057767|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111143908|NCT05057767|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111143909|NCT05057767|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111143910|NCT05057767|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111143911|NCT05057767|Anesthetics, General|anesthetics, general|mesh-ancestor
111143912|NCT05057767|Anesthetics|anesthetics|mesh-ancestor
111143913|NCT05057767|GABA Modulators|gaba modulators|mesh-ancestor
111143914|NCT05057767|GABA Agents|gaba agents|mesh-ancestor
111143915|NCT05057767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111143916|NCT05057767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111143917|NCT04997317|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
111143918|NCT04997317|Edotreotide lutetium LU-177|edotreotide lutetium lu-177|mesh-list
111143919|NCT04997317|Chelating Agents|chelating agents|mesh-ancestor
111143920|NCT04997317|Sequestering Agents|sequestering agents|mesh-ancestor
111143921|NCT04997317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111143922|NCT04997317|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111143923|NCT04997239|Vaccines|vaccines|mesh-list
111143924|NCT04997239|Immunologic Factors|immunologic factors|mesh-ancestor
111143925|NCT04997239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111143926|NCT04216693|Digoxin|digoxin|mesh-list
111143927|NCT04216693|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111143928|NCT04216693|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111143929|NCT04216693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111143930|NCT04216693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111143931|NCT04216693|Protective Agents|protective agents|mesh-ancestor
111143932|NCT04216693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111143933|NCT01364389|Prednisone|prednisone|mesh-list
111143934|NCT01364389|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111143935|NCT01364389|Glucocorticoids|glucocorticoids|mesh-ancestor
111143936|NCT01364389|Hormones|hormones|mesh-ancestor
111143937|NCT01364389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111143938|NCT01364389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111143939|NCT01364389|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111143940|NCT01364389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111143942|NCT05054881|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111143943|NCT05054881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111143944|NCT05054881|Trace Elements|trace elements|mesh-ancestor
111143945|NCT05054881|Micronutrients|micronutrients|mesh-ancestor
111143946|NCT05054881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111143947|NCT04949425|Adavosertib|adavosertib|mesh-list
111143948|NCT04949425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111143949|NCT04949425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111143950|NCT04203901|Nivolumab|nivolumab|mesh-list
111143951|NCT04203901|Ipilimumab|ipilimumab|mesh-list
111143952|NCT04203901|Everolimus|everolimus|mesh-list
111143953|NCT04203901|Lenvatinib|lenvatinib|mesh-list
111143954|NCT04203901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111143955|NCT04203901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111143956|NCT04203901|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111143957|NCT04203901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111143958|NCT04203901|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111143959|NCT04203901|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111143960|NCT04203901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111143961|NCT04203901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111143962|NCT04203901|Immunologic Factors|immunologic factors|mesh-ancestor
111143963|NCT04203901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111143964|NCT04421209|Propranolol|propranolol|mesh-list
111143965|NCT04421209|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111143966|NCT04421209|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111143967|NCT04421209|Adrenergic Agents|adrenergic agents|mesh-ancestor
111143968|NCT04421209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111143969|NCT04421209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111143970|NCT04421209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111143971|NCT04421209|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111143972|NCT04421209|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111143973|NCT04421209|Vasodilator Agents|vasodilator agents|mesh-ancestor
111143974|NCT04984837|Gemcitabine|gemcitabine|mesh-list
111143975|NCT04984837|Oxaliplatin|oxaliplatin|mesh-list
111143976|NCT04984837|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111143977|NCT04984837|Antimetabolites|antimetabolites|mesh-ancestor
111143978|NCT04984837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111143979|NCT04984837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111143980|NCT04983121|Antibodies|antibodies|mesh-list
111143981|NCT04983121|Mitogens|mitogens|mesh-list
111143982|NCT04983121|Immunoconjugates|immunoconjugates|mesh-list
111143983|NCT04983121|Immunologic Factors|immunologic factors|mesh-ancestor
111143984|NCT04983121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111143985|NCT04983121|Mitosis Modulators|mitosis modulators|mesh-ancestor
111143986|NCT04983121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111143987|NCT02291289|Bevacizumab|bevacizumab|mesh-list
111143988|NCT02291289|Trastuzumab|trastuzumab|mesh-list
111143989|NCT02291289|Cetuximab|cetuximab|mesh-list
111143990|NCT02291289|Atezolizumab|atezolizumab|mesh-list
111143991|NCT02291289|Pertuzumab|pertuzumab|mesh-list
111143992|NCT02291289|Capecitabine|capecitabine|mesh-list
111143993|NCT02291289|Fluorouracil|fluorouracil|mesh-list
111143994|NCT02291289|Vemurafenib|vemurafenib|mesh-list
111143995|NCT02291289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111143996|NCT02291289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111143997|NCT02291289|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111143998|NCT02291289|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111143999|NCT02291289|Growth Substances|growth substances|mesh-ancestor
111144000|NCT02291289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111144001|NCT02291289|Growth Inhibitors|growth inhibitors|mesh-ancestor
111144002|NCT02291289|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111144003|NCT02291289|Antimetabolites|antimetabolites|mesh-ancestor
111144004|NCT02291289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111144005|NCT02291289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111144006|NCT02291289|Immunologic Factors|immunologic factors|mesh-ancestor
111144007|NCT02291289|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111144008|NCT02291289|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111144009|NCT02291289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111144010|NCT02317575|Insulin Lispro|insulin lispro|mesh-list
111144011|NCT02317575|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111144012|NCT02317575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111144013|NCT02289963|Alirocumab|alirocumab|mesh-list
111144014|NCT02289963|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111144015|NCT02289963|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
111144016|NCT02289963|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111144017|NCT02289963|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111144018|NCT02289963|Antimetabolites|antimetabolites|mesh-ancestor
111144019|NCT02289963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111144020|NCT02289963|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111144021|NCT02289963|Protease Inhibitors|protease inhibitors|mesh-ancestor
111144022|NCT02289963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111144023|NCT02289963|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111144024|NCT02289963|Immunologic Factors|immunologic factors|mesh-ancestor
111144025|NCT02289963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111144026|NCT02358369|Timolol|timolol|mesh-list
111144027|NCT02358369|Bimatoprost|bimatoprost|mesh-list
111144028|NCT02358369|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111144029|NCT02358369|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110482493|NCT04296422|Ibuprofen|ibuprofen|mesh-list
111144030|NCT02358369|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111144031|NCT02358369|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111144032|NCT02358369|Adrenergic Agents|adrenergic agents|mesh-ancestor
111144033|NCT02358369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111144034|NCT02358369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111144035|NCT02358369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111144036|NCT02358369|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111144037|NCT02358369|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111144038|NCT02316171|Mitomycins|mitomycins|mesh-list
111144039|NCT02316171|Mitomycin|mitomycin|mesh-list
111144040|NCT02316171|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111144041|NCT02316171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111144042|NCT02316171|Alkylating Agents|alkylating agents|mesh-ancestor
111144043|NCT02316171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111144044|NCT02316171|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111144045|NCT02316171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111144046|NCT02315625|Everolimus|everolimus|mesh-list
111144047|NCT02315625|Sunitinib|sunitinib|mesh-list
111144048|NCT02315625|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111144049|NCT02315625|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111144050|NCT02315625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111144051|NCT02315625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111144052|NCT02315625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111144053|NCT02315625|Immunologic Factors|immunologic factors|mesh-ancestor
111144054|NCT02315625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111144055|NCT02315625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111144056|NCT02315625|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111144057|NCT02315625|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111144058|NCT02315625|Growth Substances|growth substances|mesh-ancestor
111144059|NCT02315625|Growth Inhibitors|growth inhibitors|mesh-ancestor
111144060|NCT02357979|Fluorides|fluorides|mesh-list
111144061|NCT02357979|Cariostatic Agents|cariostatic agents|mesh-ancestor
111144062|NCT02357979|Protective Agents|protective agents|mesh-ancestor
111144063|NCT02357979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111144064|NCT02357901|Buprenorphine|buprenorphine|mesh-list
111144065|NCT02357901|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
111144066|NCT02357901|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111144067|NCT02357901|Narcotics|narcotics|mesh-ancestor
111144068|NCT02357901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111144069|NCT02357901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111144070|NCT02357901|Analgesics|analgesics|mesh-ancestor
111144071|NCT02357901|Sensory System Agents|sensory system agents|mesh-ancestor
111144072|NCT02357901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111144073|NCT02357901|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111144074|NCT01601847|Vitamin D|vitamin d|mesh-list
111144075|NCT01601847|Cholecalciferol|cholecalciferol|mesh-list
111144076|NCT01601847|Vitamins|vitamins|mesh-ancestor
111144077|NCT01601847|Micronutrients|micronutrients|mesh-ancestor
111144078|NCT01601847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111144079|NCT01601847|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111144080|NCT01601847|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111144081|NCT02515279|Ribavirin|ribavirin|mesh-list
111144082|NCT02515279|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
111144083|NCT02515279|Antimetabolites|antimetabolites|mesh-ancestor
111144084|NCT02515279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111144085|NCT02515279|Antiviral Agents|antiviral agents|mesh-ancestor
111144086|NCT02515279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111144087|NCT02515045|Moxifloxacin|moxifloxacin|mesh-list
111144088|NCT02515045|Prednisolone|prednisolone|mesh-list
111144089|NCT02515045|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111144090|NCT02515045|Methylprednisolone|methylprednisolone|mesh-list
111144091|NCT02515045|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111144092|NCT02515045|Prednisolone acetate|prednisolone acetate|mesh-list
111144093|NCT02515045|Nepafenac|nepafenac|mesh-list
111144094|NCT02515045|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111144095|NCT02515045|Prednisolone phosphate|prednisolone phosphate|mesh-list
111144096|NCT02515045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111144097|NCT02515045|Glucocorticoids|glucocorticoids|mesh-ancestor
111144098|NCT02515045|Hormones|hormones|mesh-ancestor
111144099|NCT02515045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111144100|NCT02515045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111144101|NCT02515045|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111144102|NCT02515045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111144103|NCT02515045|Antiemetics|antiemetics|mesh-ancestor
111144104|NCT02515045|Autonomic Agents|autonomic agents|mesh-ancestor
111144105|NCT02515045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111144106|NCT02515045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111144107|NCT02515045|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111144108|NCT02515045|Protective Agents|protective agents|mesh-ancestor
110861162|NCT01906853|Vaccines|vaccines|mesh-list
111144109|NCT02515045|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111144110|NCT02515045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111144111|NCT02515045|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111144112|NCT02515045|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111144113|NCT02515045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111144114|NCT02515045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111144115|NCT02515045|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111144116|NCT02515045|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111144117|NCT02515045|Analgesics|analgesics|mesh-ancestor
111144118|NCT02515045|Sensory System Agents|sensory system agents|mesh-ancestor
111144119|NCT02515045|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111144120|NCT02513485|Levodopa|levodopa|mesh-list
111144121|NCT02513485|Carbidopa|carbidopa|mesh-list
111144122|NCT02513485|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111144123|NCT02513485|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111144124|NCT02513485|Dopamine Agents|dopamine agents|mesh-ancestor
111144125|NCT02513485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111144126|NCT02513485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111144127|NCT02513485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111144128|NCT02513485|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
111144129|NCT02513485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111144130|NCT02289417|Apremilast|apremilast|mesh-list
111144131|NCT02289417|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111144132|NCT02289417|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111144133|NCT02289417|Analgesics|analgesics|mesh-ancestor
111144134|NCT02289417|Sensory System Agents|sensory system agents|mesh-ancestor
111144135|NCT02289417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111144136|NCT02289417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111144137|NCT02289417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111144138|NCT02289417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111144139|NCT02289417|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
111144140|NCT02289417|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111144141|NCT02289417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111144142|NCT02289417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111144143|NCT02512861|Bupivacaine|bupivacaine|mesh-list
111144144|NCT02512861|Anesthetics, Local|anesthetics, local|mesh-ancestor
111144145|NCT02512861|Anesthetics|anesthetics|mesh-ancestor
111144146|NCT02512861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111144147|NCT02512861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111144148|NCT02512861|Sensory System Agents|sensory system agents|mesh-ancestor
111144149|NCT02512861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111144151|NCT04979065|Vitamins|vitamins|mesh-ancestor
111144152|NCT04979065|Micronutrients|micronutrients|mesh-ancestor
111144153|NCT04979065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111144154|NCT04979065|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111144155|NCT02288325|Milnacipran|milnacipran|mesh-list
111144156|NCT02288325|Levomilnacipran|levomilnacipran|mesh-list
111144157|NCT02288325|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111144158|NCT02288325|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111144159|NCT02288325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111144160|NCT02288325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111144161|NCT02288325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111144162|NCT02288325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111144163|NCT02288325|Antidepressive Agents|antidepressive agents|mesh-ancestor
111144164|NCT02288325|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111144165|NCT02288325|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111144166|NCT02288325|Analgesics|analgesics|mesh-ancestor
111144167|NCT02288325|Sensory System Agents|sensory system agents|mesh-ancestor
111144168|NCT02288325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111144169|NCT04978051|Icatibant|icatibant|mesh-list
111144170|NCT04978051|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111144171|NCT04978051|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111144172|NCT04978051|Analgesics|analgesics|mesh-ancestor
111144173|NCT04978051|Sensory System Agents|sensory system agents|mesh-ancestor
111144174|NCT04978051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111144175|NCT04978051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111144176|NCT04978051|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111144177|NCT04978051|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111144178|NCT04978051|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
111144179|NCT04978051|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
111144180|NCT04978051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111144181|NCT04978051|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
111144182|NCT04978051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111144183|NCT04978051|Immunologic Factors|immunologic factors|mesh-ancestor
111144185|NCT04214353|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111144186|NCT04214353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111144187|NCT05010421|Clobetasol|clobetasol|mesh-list
111144188|NCT05010421|Emollients|emollients|mesh-list
111144189|NCT05010421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111144190|NCT05010421|Glucocorticoids|glucocorticoids|mesh-ancestor
111144191|NCT05010421|Hormones|hormones|mesh-ancestor
111144192|NCT05010421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111144193|NCT05010421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111144194|NCT05010421|Dermatologic Agents|dermatologic agents|mesh-ancestor
111144195|NCT02504827|Ceftazidime|ceftazidime|mesh-list
111144196|NCT02504827|Avibactam|avibactam|mesh-list
111144197|NCT02504827|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
111144198|NCT02504827|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111144199|NCT02504827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111144200|NCT02504827|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
111144201|NCT02504827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111144202|NCT02504827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111144203|NCT02504671|Folic Acid|folic acid|mesh-list
111144204|NCT02504671|Hematinics|hematinics|mesh-ancestor
111144205|NCT02504671|Vitamin B Complex|vitamin b complex|mesh-ancestor
111144206|NCT02504671|Vitamins|vitamins|mesh-ancestor
111144207|NCT02504671|Micronutrients|micronutrients|mesh-ancestor
111144208|NCT02504671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111144209|NCT02314143|Trametinib|trametinib|mesh-list
111144210|NCT02314143|Dabrafenib|dabrafenib|mesh-list
111144211|NCT02314143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111144212|NCT02314143|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111144213|NCT02314143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111144214|NCT02314143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111144215|NCT02503501|Insulin glulisine|insulin glulisine|mesh-list
111144216|NCT02503501|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111144217|NCT02503501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111144218|NCT05007613|Atezolizumab|atezolizumab|mesh-list
110482532|NCT00997334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111144219|NCT05007613|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111144220|NCT05007613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111144221|NCT05007613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111144222|NCT05007613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111144223|NCT04970407|Botulinum Toxins|botulinum toxins|mesh-list
111144224|NCT04970407|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111144225|NCT04970407|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111144226|NCT04970407|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
111144227|NCT04970407|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111144228|NCT04970407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111144229|NCT04970407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111144230|NCT04970407|Cholinergic Agents|cholinergic agents|mesh-ancestor
111144231|NCT04970407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111144232|NCT04970407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111144233|NCT04970407|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111144234|NCT04970407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111144235|NCT02501629|Reslizumab|reslizumab|mesh-list
111144236|NCT02501629|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111144237|NCT02501629|Respiratory System Agents|respiratory system agents|mesh-ancestor
111144238|NCT02501473|Rituximab|rituximab|mesh-list
111144239|NCT02501473|Pembrolizumab|pembrolizumab|mesh-list
111144240|NCT02501473|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111144241|NCT02501473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111144242|NCT02501473|Immunologic Factors|immunologic factors|mesh-ancestor
111144243|NCT02501473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111144244|NCT02501473|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111144245|NCT02501473|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111144246|NCT02501473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111144247|NCT02501161|Insulin|insulin|mesh-list
111144248|NCT02501161|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111144249|NCT02501161|Insulin Glargine|insulin glargine|mesh-list
111144250|NCT02501161|Liraglutide|liraglutide|mesh-list
111144251|NCT02501161|Xultophy|xultophy|mesh-list
111144252|NCT02501161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111144253|NCT02501161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111144254|NCT02501161|Incretins|incretins|mesh-ancestor
111144255|NCT02501161|Hormones|hormones|mesh-ancestor
111144256|NCT02501161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111144257|NCT04966585|Posaconazole|posaconazole|mesh-list
111144258|NCT04966585|Antifungal Agents|antifungal agents|mesh-ancestor
111144259|NCT04966585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111144260|NCT04966585|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
111144261|NCT04966585|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111144262|NCT04966585|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111144263|NCT04966585|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111144264|NCT04966585|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111144265|NCT04966585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111144266|NCT04966585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111144267|NCT04966585|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111144268|NCT04966585|Hormone Antagonists|hormone antagonists|mesh-ancestor
111144269|NCT04966585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111144270|NCT04966585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111144271|NCT04205539|Dexmedetomidine|dexmedetomidine|mesh-list
111144272|NCT04205539|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111144273|NCT04205539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111144274|NCT04205539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111144275|NCT04205539|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111144276|NCT04205539|Analgesics|analgesics|mesh-ancestor
111144277|NCT04205539|Sensory System Agents|sensory system agents|mesh-ancestor
111144278|NCT04205539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111144279|NCT04205539|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111144280|NCT04205539|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111144281|NCT04205539|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111144282|NCT04205539|Adrenergic Agents|adrenergic agents|mesh-ancestor
111144283|NCT04205539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111144284|NCT04205539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111144285|NCT02313909|Aspirin|aspirin|mesh-list
111144286|NCT02313909|Rivaroxaban|rivaroxaban|mesh-list
111144287|NCT02313909|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111144288|NCT02313909|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111144289|NCT02313909|Analgesics|analgesics|mesh-ancestor
111144290|NCT02313909|Sensory System Agents|sensory system agents|mesh-ancestor
111144291|NCT02313909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111144292|NCT02313909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111144293|NCT02313909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111144294|NCT02313909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111144295|NCT02313909|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111144296|NCT02313909|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111144297|NCT02313909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111144298|NCT02313909|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111144299|NCT02313909|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111144300|NCT02313909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111144301|NCT02313909|Antipyretics|antipyretics|mesh-ancestor
111144302|NCT02313909|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111144303|NCT02313909|Antithrombins|antithrombins|mesh-ancestor
111144304|NCT02313909|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111144305|NCT02313909|Protease Inhibitors|protease inhibitors|mesh-ancestor
111144306|NCT02313909|Anticoagulants|anticoagulants|mesh-ancestor
111144307|NCT02287467|Immunoglobulins|immunoglobulins|mesh-list
111144308|NCT02287467|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111144309|NCT02287467|Antibodies|antibodies|mesh-list
111144310|NCT02287467|gamma-Globulins|gamma-globulins|mesh-list
111144311|NCT02287467|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
111144312|NCT02287467|Immunologic Factors|immunologic factors|mesh-ancestor
111144313|NCT02287467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111144314|NCT02287233|Cytarabine|cytarabine|mesh-list
111144315|NCT02287233|Venetoclax|venetoclax|mesh-list
111144316|NCT02287233|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111144317|NCT02287233|Antimetabolites|antimetabolites|mesh-ancestor
111144318|NCT02287233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111144319|NCT02287233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111144320|NCT02287233|Antiviral Agents|antiviral agents|mesh-ancestor
111144321|NCT02287233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111144322|NCT02287233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111144323|NCT02287233|Immunologic Factors|immunologic factors|mesh-ancestor
111144324|NCT02287233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111144325|NCT01646385|Etanercept|etanercept|mesh-list
111144326|NCT01646385|Antirheumatic Agents|antirheumatic agents|mesh-list
111144327|NCT01646385|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111144328|NCT01646385|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111144329|NCT01646385|Analgesics|analgesics|mesh-ancestor
111144330|NCT01646385|Sensory System Agents|sensory system agents|mesh-ancestor
111144331|NCT01646385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111144332|NCT01646385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111144333|NCT01646385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111144334|NCT01646385|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111144335|NCT01646385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111144336|NCT01646385|Immunologic Factors|immunologic factors|mesh-ancestor
111144338|NCT02286843|Pertuzumab|pertuzumab|mesh-list
111144339|NCT02286843|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111144340|NCT02286843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111144341|NCT02281773|BI 409306|bi 409306|mesh-list
111144342|NCT02281773|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111144343|NCT02281773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111144344|NCT02281773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111144345|NCT02354235|Canagliflozin|canagliflozin|mesh-list
111144346|NCT02354235|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110482546|NCT04369664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111144347|NCT02354235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111144348|NCT02354235|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111144349|NCT02354235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111144350|NCT02284893|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111144351|NCT02284893|Dapagliflozin|dapagliflozin|mesh-list
111144352|NCT02284893|Saxagliptin|saxagliptin|mesh-list
111144353|NCT02284893|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111144354|NCT02284893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111144355|NCT02284893|Incretins|incretins|mesh-ancestor
111144357|NCT02284893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111144358|NCT02284893|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111144359|NCT02284893|Protease Inhibitors|protease inhibitors|mesh-ancestor
111144360|NCT02284893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111144361|NCT02284893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111144362|NCT02284893|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111144363|NCT02483611|Lidocaine|lidocaine|mesh-list
111144364|NCT02483611|Magnesium Sulfate|magnesium sulfate|mesh-list
111144365|NCT02483611|Cisatracurium|cisatracurium|mesh-list
111144366|NCT02483611|Anesthetics, Local|anesthetics, local|mesh-ancestor
111144367|NCT02483611|Anesthetics|anesthetics|mesh-ancestor
111144368|NCT02483611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111144369|NCT02483611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111144370|NCT02483611|Sensory System Agents|sensory system agents|mesh-ancestor
111144371|NCT02483611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111144372|NCT02483611|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111144373|NCT02483611|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111144374|NCT02483611|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111144375|NCT02483611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111144376|NCT02483611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111144377|NCT02483611|Analgesics|analgesics|mesh-ancestor
111144378|NCT02483611|Anticonvulsants|anticonvulsants|mesh-ancestor
111144379|NCT02483611|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111144380|NCT02483611|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111144381|NCT02483611|Tocolytic Agents|tocolytic agents|mesh-ancestor
111144382|NCT02483611|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111144383|NCT02483611|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
111144384|NCT02483611|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111144385|NCT02482129|Dexamethasone|dexamethasone|mesh-list
111144386|NCT02482129|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111144387|NCT02482129|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111144388|NCT02482129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111144389|NCT02482129|Antiemetics|antiemetics|mesh-ancestor
111144390|NCT02482129|Autonomic Agents|autonomic agents|mesh-ancestor
111144391|NCT02482129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111144392|NCT02482129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111144393|NCT02482129|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111144394|NCT02482129|Glucocorticoids|glucocorticoids|mesh-ancestor
111144395|NCT02482129|Hormones|hormones|mesh-ancestor
111144396|NCT02482129|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111144397|NCT02482129|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111144398|NCT02482129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111144399|NCT02495857|Hyaluronic Acid|hyaluronic acid|mesh-list
111144400|NCT02495857|Viscosupplements|viscosupplements|mesh-list
111144401|NCT02495857|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111144402|NCT02495857|Immunologic Factors|immunologic factors|mesh-ancestor
111144403|NCT02495857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111144404|NCT02495857|Protective Agents|protective agents|mesh-ancestor
111144405|NCT02495389|Mirabegron|mirabegron|mesh-list
111144406|NCT02495389|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
111144407|NCT02495389|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111144408|NCT02495389|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111144409|NCT02495389|Adrenergic Agents|adrenergic agents|mesh-ancestor
111144410|NCT02495389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111144411|NCT02495389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111144412|NCT02495389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111144413|NCT02495389|Urological Agents|urological agents|mesh-ancestor
111144414|NCT02495233|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111144415|NCT02495233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111144416|NCT02495233|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111144417|NCT02495233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111144418|NCT02495233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111144419|NCT02495077|Acetaminophen|acetaminophen|mesh-list
111144420|NCT02495077|Diphenhydramine|diphenhydramine|mesh-list
111144421|NCT02495077|Promethazine|promethazine|mesh-list
111144422|NCT02495077|Loratadine|loratadine|mesh-list
111144423|NCT02495077|Mycophenolic Acid|mycophenolic acid|mesh-list
111144424|NCT02495077|Prednisone|prednisone|mesh-list
111144425|NCT02495077|Methylprednisolone|methylprednisolone|mesh-list
111144426|NCT02495077|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111144427|NCT02495077|Infliximab|infliximab|mesh-list
111144428|NCT02495077|Tacrolimus|tacrolimus|mesh-list
111144429|NCT02495077|Thymoglobulin|thymoglobulin|mesh-list
111144430|NCT02495077|Antilymphocyte Serum|antilymphocyte serum|mesh-list
111144431|NCT02495077|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111144432|NCT02495077|Glucocorticoids|glucocorticoids|mesh-ancestor
111144433|NCT02495077|Hormones|hormones|mesh-ancestor
111144434|NCT02495077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111144435|NCT02495077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111144436|NCT02495077|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111144437|NCT02495077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111144438|NCT02495077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111144439|NCT02495077|Immunologic Factors|immunologic factors|mesh-ancestor
111144440|NCT02495077|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111144441|NCT02495077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111144442|NCT02495077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111144443|NCT02495077|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111144444|NCT02495077|Analgesics|analgesics|mesh-ancestor
111144445|NCT02495077|Sensory System Agents|sensory system agents|mesh-ancestor
111144446|NCT02495077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111144447|NCT02495077|Antipyretics|antipyretics|mesh-ancestor
111144448|NCT02495077|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111144449|NCT02495077|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111144450|NCT02495077|Antitubercular Agents|antitubercular agents|mesh-ancestor
111144451|NCT02495077|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111144452|NCT02495077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111144453|NCT02495077|Antiemetics|antiemetics|mesh-ancestor
111144454|NCT02495077|Autonomic Agents|autonomic agents|mesh-ancestor
111144455|NCT02495077|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111144456|NCT02495077|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111144457|NCT02495077|Protective Agents|protective agents|mesh-ancestor
111144458|NCT02495077|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111144459|NCT02495077|Dermatologic Agents|dermatologic agents|mesh-ancestor
111144460|NCT02495077|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111144461|NCT02495077|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111144462|NCT02495077|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111144463|NCT02495077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111144464|NCT02495077|Anesthetics, Local|anesthetics, local|mesh-ancestor
111144465|NCT02495077|Anesthetics|anesthetics|mesh-ancestor
111144466|NCT02495077|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111144467|NCT02495077|Histamine Antagonists|histamine antagonists|mesh-ancestor
111144468|NCT02495077|Histamine Agents|histamine agents|mesh-ancestor
111144469|NCT02495077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111144470|NCT02495077|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111144471|NCT02495077|Antipruritics|antipruritics|mesh-ancestor
111144472|NCT02495077|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
111144473|NCT02278341|Epoetin Alfa|epoetin alfa|mesh-list
111144474|NCT02278341|Darbepoetin alfa|darbepoetin alfa|mesh-list
111144475|NCT02278341|Hematinics|hematinics|mesh-ancestor
111144476|NCT02278263|Tranexamic Acid|tranexamic acid|mesh-list
111144477|NCT02278263|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111144478|NCT02278263|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111144479|NCT02278263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111144480|NCT02278263|Hemostatics|hemostatics|mesh-ancestor
111144481|NCT02278263|Coagulants|coagulants|mesh-ancestor
111144482|NCT02494921|Prednisone|prednisone|mesh-list
111144483|NCT02494921|Docetaxel|docetaxel|mesh-list
110861540|NCT02459938|Glucagon|glucagon|mesh-list
111144484|NCT02494921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111144486|NCT02494921|Antimitotic Agents|antimitotic agents|mesh-ancestor
111144487|NCT02494921|Mitosis Modulators|mitosis modulators|mesh-ancestor
111144488|NCT02494921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111144489|NCT02494921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111144490|NCT02494921|Glucocorticoids|glucocorticoids|mesh-ancestor
111144491|NCT02494921|Hormones|hormones|mesh-ancestor
111144492|NCT02494921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111144493|NCT02494921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111144494|NCT02494921|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111144495|NCT01653847|Mycophenolic Acid|mycophenolic acid|mesh-list
111144496|NCT01653847|Everolimus|everolimus|mesh-list
111144497|NCT01653847|Tacrolimus|tacrolimus|mesh-list
111144498|NCT01653847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111144499|NCT01653847|Immunologic Factors|immunologic factors|mesh-ancestor
111144500|NCT01653847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111144501|NCT01653847|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111144502|NCT01653847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111144503|NCT01653847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111144504|NCT01653847|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111144505|NCT01653847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111144506|NCT01653847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111144507|NCT01653847|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111144508|NCT01653847|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111144509|NCT01653847|Antitubercular Agents|antitubercular agents|mesh-ancestor
111144510|NCT01653847|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111144511|NCT01653847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111144512|NCT02493751|Avelumab|avelumab|mesh-list
111144513|NCT02493751|Axitinib|axitinib|mesh-list
111144514|NCT02493751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111144515|NCT02493751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111144516|NCT02493751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111144517|NCT02493751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111144518|NCT02493751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111144519|NCT02493517|Lanreotide|lanreotide|mesh-list
111144520|NCT02493517|Somatostatin|somatostatin|mesh-list
111144521|NCT02493517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111144522|NCT02493517|Hormones|hormones|mesh-ancestor
111144523|NCT02493517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111144524|NCT02493517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111144525|NCT02493361|Pembrolizumab|pembrolizumab|mesh-list
111144526|NCT02493361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111144527|NCT02493361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111144528|NCT02493361|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110482572|NCT00996944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111144529|NCT02493361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111144530|NCT04959799|Dalbavancin|dalbavancin|mesh-list
111144531|NCT04959799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111144532|NCT04959799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111144533|NCT04959331|Fosfomycin|fosfomycin|mesh-list
111144534|NCT04959331|Nitrofurantoin|nitrofurantoin|mesh-list
111144535|NCT04959331|Amdinocillin Pivoxil|amdinocillin pivoxil|mesh-list
111144536|NCT04959331|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111144537|NCT04959331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111144538|NCT04959331|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111144539|NCT02478463|Cabotegravir|cabotegravir|mesh-list
111144540|NCT02478463|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111144541|NCT02478463|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111144542|NCT02478463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111144543|NCT02478463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111144544|NCT02478463|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111144545|NCT02478463|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111144546|NCT02478463|Antiviral Agents|antiviral agents|mesh-ancestor
111144547|NCT02478463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111144548|NCT02491411|Dexamethasone|dexamethasone|mesh-list
111144549|NCT02491411|Dexamethasone acetate|dexamethasone acetate|mesh-list
111144550|NCT02491411|Ichthammol|ichthammol|mesh-list
111144551|NCT02491411|BB 1101|bb 1101|mesh-list
111144552|NCT02491411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111144553|NCT02491411|Antiemetics|antiemetics|mesh-ancestor
111144554|NCT02491411|Autonomic Agents|autonomic agents|mesh-ancestor
111144555|NCT02491411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111144556|NCT02491411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111144557|NCT02491411|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111144558|NCT02491411|Glucocorticoids|glucocorticoids|mesh-ancestor
111144559|NCT02491411|Hormones|hormones|mesh-ancestor
111144560|NCT02491411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111144561|NCT02491411|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111144562|NCT02491411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111144563|NCT02491411|Protease Inhibitors|protease inhibitors|mesh-ancestor
111144564|NCT02491411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111144565|NCT02491411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111144566|NCT02491411|Dermatologic Agents|dermatologic agents|mesh-ancestor
111144567|NCT02517463|Ulipristal acetate|ulipristal acetate|mesh-list
111144568|NCT02517463|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111144569|NCT02517463|Contraceptive Agents|contraceptive agents|mesh-ancestor
111144570|NCT02517463|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111144571|NCT02517463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110482599|NCT04301375|Tubulin Modulators|tubulin modulators|mesh-ancestor
111144572|NCT02517463|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111144573|NCT02490475|Docetaxel|docetaxel|mesh-list
111144574|NCT02490475|Pertuzumab|pertuzumab|mesh-list
111144575|NCT02490475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111144576|NCT02490475|Tubulin Modulators|tubulin modulators|mesh-ancestor
111144577|NCT02490475|Antimitotic Agents|antimitotic agents|mesh-ancestor
111144578|NCT02490475|Mitosis Modulators|mitosis modulators|mesh-ancestor
111144579|NCT02490475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111144580|NCT02490475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111144581|NCT02477839|Lacosamide|lacosamide|mesh-list
111144582|NCT02477839|Anticonvulsants|anticonvulsants|mesh-ancestor
111144583|NCT02477839|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111144584|NCT02477839|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111144585|NCT02477839|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111144586|NCT02477839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111144587|NCT04939987|Acetaminophen|acetaminophen|mesh-list
111144588|NCT04939987|Ketorolac|ketorolac|mesh-list
111144589|NCT04939987|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
111144590|NCT04939987|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
111144591|NCT04939987|Ketamine|ketamine|mesh-list
111144592|NCT04939987|Oxycodone|oxycodone|mesh-list
111144593|NCT04939987|Gabapentin|gabapentin|mesh-list
111144594|NCT04939987|Tramadol|tramadol|mesh-list
111144595|NCT04939987|Hydrocodone|hydrocodone|mesh-list
111144596|NCT04939987|Analgesics, Opioid|analgesics, opioid|mesh-list
111144597|NCT04939987|Analgesics|analgesics|mesh-ancestor
111144598|NCT04939987|Sensory System Agents|sensory system agents|mesh-ancestor
111144599|NCT04939987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111144600|NCT04939987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111144601|NCT04939987|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111144602|NCT04939987|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111144603|NCT04939987|Anesthetics, General|anesthetics, general|mesh-ancestor
111144604|NCT04939987|Anesthetics|anesthetics|mesh-ancestor
111144605|NCT04939987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111144606|NCT04939987|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111144607|NCT04939987|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111144608|NCT04939987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111144609|NCT04939987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111144610|NCT04939987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111144611|NCT04939987|Antipyretics|antipyretics|mesh-ancestor
111144612|NCT04939987|Narcotics|narcotics|mesh-ancestor
111144613|NCT04939987|Anticonvulsants|anticonvulsants|mesh-ancestor
111144614|NCT04939987|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111144615|NCT04939987|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111144616|NCT04939987|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111144617|NCT04939987|Antimanic Agents|antimanic agents|mesh-ancestor
111144618|NCT04939987|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111144619|NCT04939987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111144620|NCT04939987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111144621|NCT04939987|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111144622|NCT04939987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111144623|NCT04939987|Antitussive Agents|antitussive agents|mesh-ancestor
111144624|NCT04939987|Respiratory System Agents|respiratory system agents|mesh-ancestor
111144625|NCT02477527|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
111144626|NCT02477527|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111144627|NCT02477527|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111144628|NCT02477527|Antiviral Agents|antiviral agents|mesh-ancestor
111144629|NCT02477527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111144630|NCT02477215|Dexamethasone|dexamethasone|mesh-list
111144631|NCT02477215|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
111144632|NCT02477215|Ixazomib|ixazomib|mesh-list
111144633|NCT02477215|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110861684|NCT03157089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111144634|NCT02477215|Antiemetics|antiemetics|mesh-ancestor
111144635|NCT02477215|Autonomic Agents|autonomic agents|mesh-ancestor
111144636|NCT02477215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111144637|NCT02477215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111144638|NCT02477215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111144639|NCT02477215|Glucocorticoids|glucocorticoids|mesh-ancestor
111144640|NCT02477215|Hormones|hormones|mesh-ancestor
111144641|NCT02477215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111144642|NCT02477215|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111144643|NCT02477215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111144644|NCT02477215|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111144645|NCT02477215|Alkylating Agents|alkylating agents|mesh-ancestor
111144646|NCT02477215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111144647|NCT02477215|Protease Inhibitors|protease inhibitors|mesh-ancestor
111144648|NCT02477215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111144649|NCT02487199|Ritonavir|ritonavir|mesh-list
111144650|NCT02487199|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111144651|NCT02487199|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111144652|NCT02487199|Protease Inhibitors|protease inhibitors|mesh-ancestor
111144653|NCT02487199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111144654|NCT02487199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111144655|NCT02487199|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111144656|NCT02487199|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111144657|NCT02487199|Antiviral Agents|antiviral agents|mesh-ancestor
111144658|NCT02487199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111144659|NCT02487199|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111144660|NCT02487199|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111144661|NCT02475733|Metronidazole|metronidazole|mesh-list
111144662|NCT02475733|Meropenem|meropenem|mesh-list
111144663|NCT02475733|Ceftazidime|ceftazidime|mesh-list
111144664|NCT02475733|Avibactam|avibactam|mesh-list
111144665|NCT02475733|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
111144666|NCT02475733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111144667|NCT02475733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111144668|NCT02475733|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111144669|NCT02475733|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111144670|NCT02475733|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
111144671|NCT02475733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111144672|NCT02475733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111144673|NCT02486653|Tamsulosin|tamsulosin|mesh-list
111144674|NCT02486653|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111144675|NCT02486653|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111144676|NCT02486653|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111144677|NCT02486653|Adrenergic Agents|adrenergic agents|mesh-ancestor
111144678|NCT02486653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111144679|NCT02486653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111144680|NCT02486653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111144681|NCT02486653|Urological Agents|urological agents|mesh-ancestor
111144682|NCT02475265|Levonorgestrel|levonorgestrel|mesh-list
111144683|NCT02475265|Estradiol|estradiol|mesh-list
111144684|NCT02475265|Estrogens|estrogens|mesh-ancestor
111144685|NCT02475265|Hormones|hormones|mesh-ancestor
111144686|NCT02475265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111144687|NCT02475265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111144688|NCT02475265|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111144689|NCT02475265|Contraceptive Agents|contraceptive agents|mesh-ancestor
111144690|NCT02475265|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111144691|NCT02475265|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111144692|NCT02475265|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111144693|NCT02475265|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111144694|NCT02450539|Docetaxel|docetaxel|mesh-list
111144695|NCT02450539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111144696|NCT02450539|Tubulin Modulators|tubulin modulators|mesh-ancestor
111144697|NCT02450539|Antimitotic Agents|antimitotic agents|mesh-ancestor
111144698|NCT02450539|Mitosis Modulators|mitosis modulators|mesh-ancestor
111144699|NCT02450539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111144700|NCT02449915|Bupivacaine|bupivacaine|mesh-list
111144701|NCT02449915|Anesthetics, Local|anesthetics, local|mesh-ancestor
111144702|NCT02449915|Anesthetics|anesthetics|mesh-ancestor
111144703|NCT02449915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111144704|NCT02449915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111144705|NCT02449915|Sensory System Agents|sensory system agents|mesh-ancestor
111144706|NCT02449915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110861758|NCT01338753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111144707|NCT02472847|Dronabinol|dronabinol|mesh-list
111144708|NCT02472847|Hallucinogens|hallucinogens|mesh-ancestor
111144709|NCT02472847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111144710|NCT02472847|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111144711|NCT02472847|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111144712|NCT02472847|Analgesics|analgesics|mesh-ancestor
111144713|NCT02472847|Sensory System Agents|sensory system agents|mesh-ancestor
111144714|NCT02472847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111144715|NCT02472847|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
111144716|NCT02472847|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
111144717|NCT02472847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111144718|NCT02472847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111144719|NCT02472847|Hormones|hormones|mesh-ancestor
111144720|NCT02472847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111144721|NCT02472145|Decitabine|decitabine|mesh-list
111144722|NCT02472145|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111144723|NCT02472145|Antimetabolites|antimetabolites|mesh-ancestor
111144724|NCT02472145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111144725|NCT02472145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111144726|NCT02472145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111144727|NCT02418949|Cyproheptadine|cyproheptadine|mesh-list
111144728|NCT02418949|Antipruritics|antipruritics|mesh-ancestor
111144729|NCT02418949|Dermatologic Agents|dermatologic agents|mesh-ancestor
111144730|NCT02418949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111144731|NCT02418949|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111144732|NCT02418949|Histamine Antagonists|histamine antagonists|mesh-ancestor
111144733|NCT02418949|Histamine Agents|histamine agents|mesh-ancestor
111144734|NCT02418949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111144735|NCT02418949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111144736|NCT02418949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111144737|NCT02418949|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111144738|NCT02418949|Serotonin Agents|serotonin agents|mesh-ancestor
111144739|NCT02418949|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111144740|NCT04912765|Nivolumab|nivolumab|mesh-list
111144741|NCT04912765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111144742|NCT04912765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111144743|NCT04912765|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111144744|NCT04912765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111144745|NCT02448043|Bimatoprost|bimatoprost|mesh-list
111144746|NCT02448043|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111144747|NCT02447887|Interferon alpha-2|interferon alpha-2|mesh-list
111144748|NCT02447887|Ixazomib|ixazomib|mesh-list
111144749|NCT02447887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111144750|NCT02447887|Protease Inhibitors|protease inhibitors|mesh-ancestor
111144751|NCT02447887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111144752|NCT02447887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111144753|NCT02447887|Antiviral Agents|antiviral agents|mesh-ancestor
111144754|NCT02447887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111144755|NCT02470429|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111144756|NCT02470429|Lubricant Eye Drops|lubricant eye drops|mesh-list
111144757|NCT02470429|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111144758|NCT02417935|Pregabalin|pregabalin|mesh-list
111144759|NCT02417935|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
111144760|NCT02417935|Analgesics|analgesics|mesh-ancestor
111144761|NCT02417935|Sensory System Agents|sensory system agents|mesh-ancestor
111144762|NCT02417935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111144763|NCT02417935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111144764|NCT02417935|Anticonvulsants|anticonvulsants|mesh-ancestor
111144765|NCT02417935|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111144766|NCT02417935|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111144767|NCT02417935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111144768|NCT02417935|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111144769|NCT02417935|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111144770|NCT02417935|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111144771|NCT02417935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111144772|NCT02417935|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111144773|NCT02417935|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111144774|NCT02417935|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111144775|NCT02417935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111144776|NCT02417935|Antidepressive Agents|antidepressive agents|mesh-ancestor
111144777|NCT02417935|Dopamine Agents|dopamine agents|mesh-ancestor
111144778|NCT02447029|Lidocaine|lidocaine|mesh-list
111144779|NCT02447029|Anesthetics, Local|anesthetics, local|mesh-ancestor
111144780|NCT02447029|Anesthetics|anesthetics|mesh-ancestor
111144781|NCT02447029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111144782|NCT02447029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111144783|NCT02447029|Sensory System Agents|sensory system agents|mesh-ancestor
111144784|NCT02447029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111144785|NCT02447029|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111144786|NCT02447029|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111144787|NCT02447029|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111144788|NCT02447029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111144789|NCT02447029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111144790|NCT02416453|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
111144791|NCT02416453|Antiviral Agents|antiviral agents|mesh-ancestor
111144792|NCT02416453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111144793|NCT02469961|Dexmedetomidine|dexmedetomidine|mesh-list
111144794|NCT02469961|Propofol|propofol|mesh-list
111144795|NCT02469961|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110839758|NCT05170828|Mycophenolic Acid|mycophenolic acid|mesh-list
111144796|NCT02469961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111144797|NCT02469961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111144798|NCT02469961|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111144799|NCT02469961|Analgesics|analgesics|mesh-ancestor
111144800|NCT02469961|Sensory System Agents|sensory system agents|mesh-ancestor
111144801|NCT02469961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111144802|NCT02469961|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111144803|NCT02469961|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111144804|NCT02469961|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111144805|NCT02469961|Adrenergic Agents|adrenergic agents|mesh-ancestor
111144806|NCT02469961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111144807|NCT02469961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111144808|NCT02469961|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111144809|NCT02469961|Anesthetics, General|anesthetics, general|mesh-ancestor
111144810|NCT02469961|Anesthetics|anesthetics|mesh-ancestor
111144811|NCT02415595|BMS-955176|bms-955176|mesh-list
111144812|NCT02415595|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111144813|NCT02415595|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111144814|NCT02415595|Antiviral Agents|antiviral agents|mesh-ancestor
111144815|NCT02415595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111144816|NCT02446717|Ribavirin|ribavirin|mesh-list
111144817|NCT02446717|Antimetabolites|antimetabolites|mesh-ancestor
111144818|NCT02446717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111144819|NCT02446717|Antiviral Agents|antiviral agents|mesh-ancestor
111144820|NCT02446717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111144821|NCT02469415|Azacitidine|azacitidine|mesh-list
111144822|NCT02469415|Decitabine|decitabine|mesh-list
111144823|NCT02469415|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111144824|NCT02469415|Antimetabolites|antimetabolites|mesh-ancestor
111144825|NCT02469415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111144826|NCT02469415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111144827|NCT02469415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111144828|NCT02446171|Naloxegol|naloxegol|mesh-list
111144829|NCT02446171|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111144830|NCT02446171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111144831|NCT02446171|Sensory System Agents|sensory system agents|mesh-ancestor
111144832|NCT02446171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111144833|NCT02446015|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111144834|NCT02446015|Lubricant Eye Drops|lubricant eye drops|mesh-list
111144835|NCT02446015|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111144836|NCT02415127|Interferons|interferons|mesh-list
111144837|NCT02415127|Interferon-gamma|interferon-gamma|mesh-list
111144838|NCT02415127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111144839|NCT02415127|Antiviral Agents|antiviral agents|mesh-ancestor
111144840|NCT02415127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111144841|NCT02468557|Paclitaxel|paclitaxel|mesh-list
111144842|NCT02468557|Idelalisib|idelalisib|mesh-list
111144843|NCT02468557|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111144844|NCT02468557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111144845|NCT02468557|Tubulin Modulators|tubulin modulators|mesh-ancestor
111144846|NCT02468557|Antimitotic Agents|antimitotic agents|mesh-ancestor
111144847|NCT02468557|Mitosis Modulators|mitosis modulators|mesh-ancestor
111144848|NCT02468557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111144849|NCT02468557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111144850|NCT02413489|Daratumumab|daratumumab|mesh-list
111144851|NCT02413489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111144852|NCT02413333|Contact Lens Solutions|contact lens solutions|mesh-list
111144853|NCT02413333|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111144854|NCT02413333|Disinfectants|disinfectants|mesh-ancestor
111144855|NCT02413333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111144856|NCT02444533|Bupivacaine|bupivacaine|mesh-list
111144857|NCT02444533|Anesthetics, Local|anesthetics, local|mesh-ancestor
111144859|NCT02444533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111144860|NCT02444533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111144861|NCT02444533|Sensory System Agents|sensory system agents|mesh-ancestor
111144862|NCT02444533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111144863|NCT01651039|Dexamethasone|dexamethasone|mesh-list
111144864|NCT01651039|Lenalidomide|lenalidomide|mesh-list
111144865|NCT01651039|Panobinostat|panobinostat|mesh-list
111144866|NCT01651039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111144867|NCT01651039|Antiemetics|antiemetics|mesh-ancestor
111144868|NCT01651039|Autonomic Agents|autonomic agents|mesh-ancestor
111144869|NCT01651039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111144870|NCT01651039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111144871|NCT01651039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111144872|NCT01651039|Glucocorticoids|glucocorticoids|mesh-ancestor
111144873|NCT01651039|Hormones|hormones|mesh-ancestor
111144874|NCT01651039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111144875|NCT01651039|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111144876|NCT01651039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111144877|NCT01651039|Immunologic Factors|immunologic factors|mesh-ancestor
111144878|NCT01651039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111144879|NCT01651039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111144880|NCT01651039|Growth Substances|growth substances|mesh-ancestor
111144881|NCT01651039|Growth Inhibitors|growth inhibitors|mesh-ancestor
111144882|NCT01651039|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111144883|NCT01651039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111144884|NCT01651039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111144885|NCT02349633|Palbociclib|palbociclib|mesh-list
111144886|NCT02349633|Avelumab|avelumab|mesh-list
111144887|NCT02349633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111144888|NCT02349633|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111144889|NCT02349633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110482723|NCT01018511|Adrenergic Agents|adrenergic agents|mesh-ancestor
111144890|NCT02349633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111144891|NCT02349633|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111144892|NCT02275611|Oxytocin|oxytocin|mesh-list
111144893|NCT02275611|Oxytocics|oxytocics|mesh-ancestor
111144894|NCT02275611|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111144895|NCT02275611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111144896|NCT04875585|Pembrolizumab|pembrolizumab|mesh-list
111144897|NCT04875585|Lenvatinib|lenvatinib|mesh-list
111144898|NCT04875585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111144899|NCT04875585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111144900|NCT04875585|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111144901|NCT04875585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111144902|NCT04875585|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111144903|NCT04875585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111144904|NCT02273973|Letrozole|letrozole|mesh-list
111144905|NCT02273973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111144906|NCT02273973|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111144907|NCT02273973|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111144908|NCT02273973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111144909|NCT02273973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111144910|NCT02273973|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111144911|NCT02273973|Hormone Antagonists|hormone antagonists|mesh-ancestor
111144912|NCT02273973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111144913|NCT02273973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111144914|NCT05649111|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111144915|NCT05649111|Difluprednate|difluprednate|mesh-list
111144916|NCT05649111|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111144917|NCT05649111|Glucocorticoids|glucocorticoids|mesh-ancestor
111144918|NCT05649111|Hormones|hormones|mesh-ancestor
111144919|NCT05649111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110839785|NCT03411850|Abatacept|abatacept|mesh-list
111144920|NCT05649111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111144921|NCT02465515|rGLP-1 protein|rglp-1 protein|mesh-list
111144922|NCT02465515|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
111144923|NCT02465515|Incretins|incretins|mesh-ancestor
111144924|NCT02465515|Hormones|hormones|mesh-ancestor
111144925|NCT02465515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111144926|NCT02465515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111144927|NCT05561361|Spironolactone|spironolactone|mesh-list
111144928|NCT05561361|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
111144929|NCT05561361|Hormone Antagonists|hormone antagonists|mesh-ancestor
111144930|NCT05561361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111144931|NCT05561361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111144932|NCT05561361|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
111144933|NCT05561361|Diuretics|diuretics|mesh-ancestor
111144934|NCT05561361|Natriuretic Agents|natriuretic agents|mesh-ancestor
111144935|NCT02412631|Varenicline|varenicline|mesh-list
111144936|NCT02412631|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111144937|NCT02412631|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111144938|NCT02412631|Cholinergic Agents|cholinergic agents|mesh-ancestor
111144939|NCT02412631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111144940|NCT02412631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111144941|NCT02412631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111144942|NCT02272803|Dexamethasone|dexamethasone|mesh-list
111144943|NCT02272803|Lenalidomide|lenalidomide|mesh-list
111144945|NCT02272803|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111144946|NCT02272803|Antiemetics|antiemetics|mesh-ancestor
111144947|NCT02272803|Autonomic Agents|autonomic agents|mesh-ancestor
111144948|NCT02272803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111144949|NCT02272803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111144950|NCT02272803|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111144951|NCT02272803|Glucocorticoids|glucocorticoids|mesh-ancestor
111144952|NCT02272803|Hormones|hormones|mesh-ancestor
111144953|NCT02272803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111144954|NCT02272803|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111144955|NCT02272803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111144956|NCT02272803|Immunologic Factors|immunologic factors|mesh-ancestor
111144957|NCT02272803|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111144958|NCT02272803|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111144959|NCT02272803|Growth Substances|growth substances|mesh-ancestor
111144960|NCT02272803|Growth Inhibitors|growth inhibitors|mesh-ancestor
111144961|NCT02272725|Ibuprofen|ibuprofen|mesh-list
111144962|NCT02272725|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111144963|NCT02272725|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111144964|NCT02272725|Analgesics|analgesics|mesh-ancestor
111144965|NCT02272725|Sensory System Agents|sensory system agents|mesh-ancestor
111144966|NCT02272725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111144967|NCT02272725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111144968|NCT02272725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111144969|NCT02272725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111144970|NCT02272725|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111144971|NCT02272725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111144972|NCT02272725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111144973|NCT01650805|Imatinib Mesylate|imatinib mesylate|mesh-list
111144974|NCT01650805|Ponatinib|ponatinib|mesh-list
111144975|NCT01650805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111144976|NCT01650805|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111144977|NCT01650805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111144978|NCT01650805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111144979|NCT02442349|Osimertinib|osimertinib|mesh-list
111144980|NCT02442349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111144981|NCT02442349|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111144982|NCT02442349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111144983|NCT02442349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111144984|NCT02442271|Ritonavir|ritonavir|mesh-list
111144985|NCT02442271|Ribavirin|ribavirin|mesh-list
111144986|NCT02442271|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111144987|NCT02442271|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111144988|NCT02442271|Protease Inhibitors|protease inhibitors|mesh-ancestor
110839806|NCT03410836|Lidocaine|lidocaine|mesh-list
111144989|NCT02442271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111144990|NCT02442271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111144991|NCT02442271|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111144992|NCT02442271|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111144993|NCT02442271|Antiviral Agents|antiviral agents|mesh-ancestor
111144994|NCT02442271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111144995|NCT02442271|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111144996|NCT02442271|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111144997|NCT02442271|Antimetabolites|antimetabolites|mesh-ancestor
111144998|NCT02463409|Theophylline|theophylline|mesh-list
111144999|NCT02463409|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111145000|NCT02463409|Autonomic Agents|autonomic agents|mesh-ancestor
111145001|NCT02463409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111145002|NCT02463409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110862053|NCT03276598|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
111145003|NCT02463409|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111145004|NCT02463409|Respiratory System Agents|respiratory system agents|mesh-ancestor
111145005|NCT02463409|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111145006|NCT02463409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111145007|NCT02463409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111145008|NCT02463409|Vasodilator Agents|vasodilator agents|mesh-ancestor
111145009|NCT02463409|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
111145010|NCT02463409|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111145011|NCT02463409|Purinergic Agents|purinergic agents|mesh-ancestor
111145012|NCT02463409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111145013|NCT02528357|Pembrolizumab|pembrolizumab|mesh-list
111145014|NCT02528357|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111145015|NCT02528357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111145016|NCT02528357|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111145017|NCT02528357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111145018|NCT04910503|Dexamethasone|dexamethasone|mesh-list
111145019|NCT04910503|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
111145020|NCT04910503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111145021|NCT04910503|Antiemetics|antiemetics|mesh-ancestor
111145022|NCT04910503|Autonomic Agents|autonomic agents|mesh-ancestor
111145023|NCT04910503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111145024|NCT04910503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111145025|NCT04910503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111145026|NCT04910503|Glucocorticoids|glucocorticoids|mesh-ancestor
111145027|NCT04910503|Hormones|hormones|mesh-ancestor
111145028|NCT04910503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111145029|NCT04910503|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111145030|NCT04910503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111145031|NCT04910425|Fluorides|fluorides|mesh-list
111145032|NCT04910425|Cariostatic Agents|cariostatic agents|mesh-ancestor
111145033|NCT04910425|Protective Agents|protective agents|mesh-ancestor
111145034|NCT04910425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111145035|NCT02463331|Chloroquine|chloroquine|mesh-list
111145036|NCT02463331|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
111145037|NCT02463331|Prednisone|prednisone|mesh-list
111145038|NCT02463331|Azathioprine|azathioprine|mesh-list
111145039|NCT02463331|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111145040|NCT02463331|Glucocorticoids|glucocorticoids|mesh-ancestor
111145041|NCT02463331|Hormones|hormones|mesh-ancestor
111145042|NCT02463331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111145043|NCT02463331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111145044|NCT02463331|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111145045|NCT02463331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111145046|NCT02463331|Amebicides|amebicides|mesh-ancestor
111145047|NCT02463331|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111145048|NCT02463331|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111145049|NCT02463331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111145050|NCT02463331|Antimalarials|antimalarials|mesh-ancestor
111145051|NCT02463331|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111145052|NCT02463331|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111145053|NCT02463331|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111145054|NCT02463331|Analgesics|analgesics|mesh-ancestor
111145055|NCT02463331|Sensory System Agents|sensory system agents|mesh-ancestor
111145056|NCT02463331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111145057|NCT02463331|Filaricides|filaricides|mesh-ancestor
111145058|NCT02463331|Antinematodal Agents|antinematodal agents|mesh-ancestor
111145059|NCT02463331|Anthelmintics|anthelmintics|mesh-ancestor
111145060|NCT02463331|Antimetabolites|antimetabolites|mesh-ancestor
111145061|NCT02463331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111145062|NCT02463331|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111145063|NCT02463331|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111145064|NCT02463331|Immunologic Factors|immunologic factors|mesh-ancestor
111145065|NCT02463097|Insulin|insulin|mesh-list
111145066|NCT02463097|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111145067|NCT02463097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111145068|NCT05427149|Magnesium Sulfate|magnesium sulfate|mesh-list
111145069|NCT05427149|Analgesics|analgesics|mesh-ancestor
111145070|NCT05427149|Sensory System Agents|sensory system agents|mesh-ancestor
111145071|NCT05427149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111145072|NCT05427149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111145073|NCT05427149|Anesthetics|anesthetics|mesh-ancestor
111145074|NCT05427149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111145075|NCT05427149|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111145076|NCT05427149|Anticonvulsants|anticonvulsants|mesh-ancestor
111145077|NCT05427149|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111145078|NCT05427149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111145079|NCT05427149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111145080|NCT05427149|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111145081|NCT05427149|Tocolytic Agents|tocolytic agents|mesh-ancestor
111145082|NCT05427149|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111145084|NCT02462473|Risperidone|risperidone|mesh-list
111145085|NCT02462473|Aripiprazole|aripiprazole|mesh-list
111145086|NCT02462473|Quetiapine Fumarate|quetiapine fumarate|mesh-list
111145087|NCT02462473|Paliperidone Palmitate|paliperidone palmitate|mesh-list
111145088|NCT02462473|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111145089|NCT02462473|Serotonin Agents|serotonin agents|mesh-ancestor
111145090|NCT02462473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111145091|NCT02462473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111145092|NCT02462473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111145093|NCT02462473|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111145094|NCT02462473|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111145095|NCT02462473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111145096|NCT02462473|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111145097|NCT02462473|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111145098|NCT02462473|Dopamine Agents|dopamine agents|mesh-ancestor
111145099|NCT02462473|Antiemetics|antiemetics|mesh-ancestor
111145100|NCT02462473|Autonomic Agents|autonomic agents|mesh-ancestor
111145101|NCT02462473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111145102|NCT02462473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111145103|NCT02462473|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111145104|NCT02462473|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111145105|NCT02462473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111145106|NCT02462473|Antidepressive Agents|antidepressive agents|mesh-ancestor
111145107|NCT02462473|Dopamine Agonists|dopamine agonists|mesh-ancestor
111145108|NCT02462473|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111145109|NCT02462473|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111145110|NCT02462473|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111145111|NCT02462473|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111145112|NCT02440789|Sirolimus|sirolimus|mesh-list
111145113|NCT02440789|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111145115|NCT02440789|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111145116|NCT02440789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111145117|NCT02440789|Antifungal Agents|antifungal agents|mesh-ancestor
111145118|NCT02440789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111145119|NCT02440789|Immunologic Factors|immunologic factors|mesh-ancestor
111145120|NCT02440789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111145121|NCT02538107|Epoetin Alfa|epoetin alfa|mesh-list
111145122|NCT02538107|Hematinics|hematinics|mesh-ancestor
111145123|NCT02272413|Bevacizumab|bevacizumab|mesh-list
111145124|NCT02272413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111145125|NCT02272413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111145126|NCT02272413|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111145127|NCT02272413|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111145128|NCT02272413|Growth Substances|growth substances|mesh-ancestor
111145129|NCT02272413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111145130|NCT02272413|Growth Inhibitors|growth inhibitors|mesh-ancestor
111145131|NCT05648799|Molnupiravir|molnupiravir|mesh-list
111145132|NCT05648799|Antiviral Agents|antiviral agents|mesh-ancestor
111145133|NCT05648799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111145134|NCT02120807|Certolizumab Pegol|certolizumab pegol|mesh-list
111145135|NCT02120807|Pemetrexed|pemetrexed|mesh-list
111145136|NCT02120807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111145137|NCT02120807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111145138|NCT02120807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111145139|NCT02120807|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111145140|NCT02120807|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111145141|NCT02120807|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111145142|NCT02120807|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111145143|NCT02120807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111145144|NCT02120807|Immunologic Factors|immunologic factors|mesh-ancestor
111145145|NCT02120807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111145146|NCT02120807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111145147|NCT02532647|Midazolam|midazolam|mesh-list
111145148|NCT02532647|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111145149|NCT02532647|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111145150|NCT02532647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111145151|NCT02532647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111145152|NCT02532647|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111145153|NCT02532647|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111145154|NCT02532647|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111145155|NCT02532647|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111145156|NCT02532647|Anesthetics, General|anesthetics, general|mesh-ancestor
111145157|NCT02532647|Anesthetics|anesthetics|mesh-ancestor
111145158|NCT02532647|GABA Modulators|gaba modulators|mesh-ancestor
111145159|NCT02532647|GABA Agents|gaba agents|mesh-ancestor
111145160|NCT02532647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111145161|NCT02532647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111145162|NCT05443061|Nitroglycerin|nitroglycerin|mesh-list
111145163|NCT05443061|Vasodilator Agents|vasodilator agents|mesh-ancestor
111145164|NCT02537015|Bimatoprost|bimatoprost|mesh-list
111145165|NCT02537015|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111145166|NCT01660763|Sufentanil|sufentanil|mesh-list
111145167|NCT01660763|Dsuvia|dsuvia|mesh-list
111145168|NCT01660763|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111145169|NCT01660763|Narcotics|narcotics|mesh-ancestor
111145170|NCT01660763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111145171|NCT01660763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111145172|NCT01660763|Analgesics|analgesics|mesh-ancestor
111145173|NCT01660763|Sensory System Agents|sensory system agents|mesh-ancestor
111145174|NCT01660763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111145175|NCT01660763|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111145176|NCT01660763|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111145177|NCT01660763|Anesthetics, General|anesthetics, general|mesh-ancestor
111145178|NCT01660763|Anesthetics|anesthetics|mesh-ancestor
111145179|NCT01937117|Trastuzumab|trastuzumab|mesh-list
111145180|NCT01937117|Pertuzumab|pertuzumab|mesh-list
111145181|NCT01937117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111145182|NCT01937117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111145183|NCT02268045|Rituximab|rituximab|mesh-list
111145184|NCT02268045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111145185|NCT02268045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111145186|NCT02268045|Immunologic Factors|immunologic factors|mesh-ancestor
111145187|NCT02268045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111145188|NCT02268045|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111145189|NCT02267187|Anesthetics|anesthetics|mesh-list
111145190|NCT02267187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111145191|NCT02267187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111145192|NCT01638533|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111145193|NCT01638533|Romidepsin|romidepsin|mesh-list
111145194|NCT01638533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111145195|NCT01638533|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111145196|NCT01638533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111145197|NCT01638533|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111145198|NCT01638533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111145199|NCT01638533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111145200|NCT01641939|Trastuzumab|trastuzumab|mesh-list
111145201|NCT01641939|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
111145202|NCT01641939|Maytansine|maytansine|mesh-list
111145203|NCT01641939|Taxane|taxane|mesh-list
111145204|NCT01641939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111145205|NCT01641939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111145206|NCT01641939|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111145207|NCT01641939|Tubulin Modulators|tubulin modulators|mesh-ancestor
111145208|NCT01641939|Antimitotic Agents|antimitotic agents|mesh-ancestor
111145209|NCT01641939|Mitosis Modulators|mitosis modulators|mesh-ancestor
111145210|NCT01641939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111145211|NCT01641939|Immunotoxins|immunotoxins|mesh-ancestor
111145212|NCT01641939|Immunoconjugates|immunoconjugates|mesh-ancestor
111145213|NCT01641939|Immunologic Factors|immunologic factors|mesh-ancestor
111145214|NCT01641939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111145215|NCT02409355|Carboplatin|carboplatin|mesh-list
111145216|NCT02409355|Gemcitabine|gemcitabine|mesh-list
111145217|NCT02409355|Atezolizumab|atezolizumab|mesh-list
111145218|NCT02409355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111145219|NCT02409355|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111145220|NCT02409355|Antimetabolites|antimetabolites|mesh-ancestor
111145221|NCT02409355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111145222|NCT02409355|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111145223|NCT02409355|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111145224|NCT02438371|Indomethacin|indomethacin|mesh-list
111145225|NCT02438371|Nifedipine|nifedipine|mesh-list
111145226|NCT02438371|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111145227|NCT02438371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111145228|NCT02438371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111145229|NCT02438371|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111145230|NCT02438371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111145231|NCT02438371|Vasodilator Agents|vasodilator agents|mesh-ancestor
111145233|NCT02438371|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111145234|NCT02438371|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111145235|NCT02438371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111145236|NCT02438371|Analgesics|analgesics|mesh-ancestor
111145237|NCT02438371|Sensory System Agents|sensory system agents|mesh-ancestor
111145238|NCT02438371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111145239|NCT02438371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111145240|NCT02438371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111145241|NCT02438371|Gout Suppressants|gout suppressants|mesh-ancestor
111145242|NCT02438371|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111145243|NCT02438371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111145244|NCT02438137|Dimethyl Fumarate|dimethyl fumarate|mesh-list
111145245|NCT02438137|Dermatologic Agents|dermatologic agents|mesh-ancestor
111145246|NCT02438137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111145247|NCT02438137|Immunologic Factors|immunologic factors|mesh-ancestor
111145248|NCT02438137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111145249|NCT04920565|Polymyxins|polymyxins|mesh-list
111145250|NCT04920565|Polymyxin B|polymyxin b|mesh-list
111145251|NCT04920565|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111145252|NCT04920565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111145253|NCT04909021|Vaccines|vaccines|mesh-list
111145254|NCT04909021|Immunologic Factors|immunologic factors|mesh-ancestor
111145255|NCT04909021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111145257|NCT02460991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111145258|NCT02460991|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111145259|NCT02460991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111145260|NCT02460991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111145261|NCT02459899|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
111145262|NCT02459899|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111145263|NCT02459899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111145264|NCT02459899|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111145265|NCT02459899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111145266|NCT02436889|Mirabegron|mirabegron|mesh-list
111145267|NCT02436889|Tolterodine Tartrate|tolterodine tartrate|mesh-list
111145268|NCT02436889|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
111145269|NCT02436889|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111145270|NCT02436889|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111145271|NCT02436889|Adrenergic Agents|adrenergic agents|mesh-ancestor
111145272|NCT02436889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111145273|NCT02436889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111145274|NCT02436889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111145275|NCT02436889|Urological Agents|urological agents|mesh-ancestor
111145276|NCT02436889|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111145277|NCT02436889|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111145278|NCT02436889|Cholinergic Agents|cholinergic agents|mesh-ancestor
111145279|NCT02436577|Ticagrelor|ticagrelor|mesh-list
111145280|NCT02436577|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111145281|NCT02436577|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111145282|NCT02436577|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111145283|NCT02436577|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111145284|NCT02436577|Purinergic Agents|purinergic agents|mesh-ancestor
111145285|NCT02436577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111145286|NCT02436577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111145287|NCT02436577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111145288|NCT02459665|Metronidazole|metronidazole|mesh-list
111145289|NCT02459665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111145290|NCT02459665|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111145291|NCT02459665|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111145292|NCT02459665|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111145293|NCT02265237|Ritonavir|ritonavir|mesh-list
111145294|NCT02265237|Ribavirin|ribavirin|mesh-list
111145295|NCT02265237|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111145296|NCT02265237|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111145297|NCT02265237|Protease Inhibitors|protease inhibitors|mesh-ancestor
111145298|NCT02265237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111145299|NCT02265237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111145300|NCT02265237|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111145301|NCT02265237|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111145302|NCT02265237|Antiviral Agents|antiviral agents|mesh-ancestor
111145303|NCT02265237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111145304|NCT02265237|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111145305|NCT02265237|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111145307|NCT04874025|Palbociclib|palbociclib|mesh-list
111145308|NCT04874025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110482841|NCT00991952|Growth Inhibitors|growth inhibitors|mesh-ancestor
111145309|NCT04874025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111145310|NCT04874025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111145311|NCT04874025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111145312|NCT02263365|Loperamide|loperamide|mesh-list
111145313|NCT02263365|Antidiarrheals|antidiarrheals|mesh-list
111145314|NCT02263365|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111145315|NCT04858269|Paclitaxel|paclitaxel|mesh-list
111145316|NCT04858269|Carboplatin|carboplatin|mesh-list
111145317|NCT04858269|Pembrolizumab|pembrolizumab|mesh-list
111145318|NCT04858269|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111145319|NCT04858269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111145320|NCT04858269|Tubulin Modulators|tubulin modulators|mesh-ancestor
111145321|NCT04858269|Antimitotic Agents|antimitotic agents|mesh-ancestor
111145322|NCT04858269|Mitosis Modulators|mitosis modulators|mesh-ancestor
111145323|NCT04858269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111145324|NCT04858269|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111145325|NCT04858269|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111145326|NCT02261493|Botulinum Toxins|botulinum toxins|mesh-list
111145327|NCT02261493|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111145328|NCT02261493|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111145329|NCT02261493|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111145330|NCT02261493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111145331|NCT02261493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111145332|NCT02261493|Cholinergic Agents|cholinergic agents|mesh-ancestor
111145333|NCT02261493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111145334|NCT02261493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111145335|NCT02261493|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111145336|NCT02261493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111145338|NCT02260791|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111145339|NCT02260791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111145340|NCT02260791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111145341|NCT02260635|Evacetrapib|evacetrapib|mesh-list
111145342|NCT02260635|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111145343|NCT02260635|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111145344|NCT02260635|Antimetabolites|antimetabolites|mesh-ancestor
111145345|NCT02260635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111145346|NCT02260635|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111145347|NCT02259231|Nivolumab|nivolumab|mesh-list
111145348|NCT02259231|Ipilimumab|ipilimumab|mesh-list
111145349|NCT02259231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111145350|NCT02259231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111145351|NCT02259231|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111145352|NCT02259231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111145353|NCT02258529|Rituximab|rituximab|mesh-list
111145354|NCT02258529|Idelalisib|idelalisib|mesh-list
111145355|NCT02258529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111145356|NCT02258529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111145357|NCT02258529|Immunologic Factors|immunologic factors|mesh-ancestor
111145358|NCT02258529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111145359|NCT02258529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111145360|NCT02258529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111145361|NCT02258529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111145362|NCT02256969|Sulfacetamide|sulfacetamide|mesh-list
111145363|NCT02256969|Prednisolone|prednisolone|mesh-list
111145364|NCT02256969|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111145365|NCT02256969|Methylprednisolone|methylprednisolone|mesh-list
111145366|NCT02256969|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111145367|NCT02256969|Prednisolone acetate|prednisolone acetate|mesh-list
111145368|NCT02256969|Mineral Oil|mineral oil|mesh-list
111145369|NCT02256969|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111145370|NCT02256969|Prednisolone phosphate|prednisolone phosphate|mesh-list
111145371|NCT02256969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111145372|NCT02256969|Glucocorticoids|glucocorticoids|mesh-ancestor
111145373|NCT02256969|Hormones|hormones|mesh-ancestor
111145374|NCT02256969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111145375|NCT02256969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111145376|NCT02256969|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111145377|NCT02256969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111145378|NCT02256969|Antiemetics|antiemetics|mesh-ancestor
111145379|NCT02256969|Autonomic Agents|autonomic agents|mesh-ancestor
111145380|NCT02256969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111145381|NCT02256969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111145382|NCT02256969|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111145383|NCT02256969|Protective Agents|protective agents|mesh-ancestor
111145384|NCT02256969|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111145385|NCT02256969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111145386|NCT02256969|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111145387|NCT02256969|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111145388|NCT02256969|Emollients|emollients|mesh-ancestor
111145389|NCT02256969|Dermatologic Agents|dermatologic agents|mesh-ancestor
111145391|NCT02256267|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111145392|NCT02256267|Antitubercular Agents|antitubercular agents|mesh-ancestor
111145393|NCT02256267|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111145394|NCT02256267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111145395|NCT02256267|Leprostatic Agents|leprostatic agents|mesh-ancestor
111145396|NCT02256267|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111145397|NCT02256267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111145398|NCT02256267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111145399|NCT02256267|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111145400|NCT02256267|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111145401|NCT02256267|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
111145402|NCT02256267|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
111145403|NCT02256267|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
111145404|NCT02256267|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111145405|NCT05429463|Paclitaxel|paclitaxel|mesh-list
111145406|NCT05429463|Carboplatin|carboplatin|mesh-list
111145407|NCT05429463|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111145408|NCT05429463|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111145409|NCT05429463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111145410|NCT05429463|Tubulin Modulators|tubulin modulators|mesh-ancestor
111145411|NCT05429463|Antimitotic Agents|antimitotic agents|mesh-ancestor
111145412|NCT05429463|Mitosis Modulators|mitosis modulators|mesh-ancestor
111145413|NCT05429463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111145414|NCT02255565|Methylphenidate|methylphenidate|mesh-list
111145415|NCT02255565|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111145416|NCT02255565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111145417|NCT02255565|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111145418|NCT02255565|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111145419|NCT02255565|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111145420|NCT02255565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111145421|NCT02255565|Dopamine Agents|dopamine agents|mesh-ancestor
111145422|NCT02255565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111145423|NCT01640301|Aldesleukin|aldesleukin|mesh-list
111145424|NCT01640301|Cyclophosphamide|cyclophosphamide|mesh-list
111145425|NCT01640301|Fludarabine|fludarabine|mesh-list
111145426|NCT01640301|Fludarabine phosphate|fludarabine phosphate|mesh-list
111145427|NCT01640301|Interleukin-2|interleukin-2|mesh-list
111145428|NCT01640301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111145429|NCT01640301|Immunologic Factors|immunologic factors|mesh-ancestor
111145430|NCT01640301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111145431|NCT01640301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111145432|NCT01640301|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111145433|NCT01640301|Alkylating Agents|alkylating agents|mesh-ancestor
111145434|NCT01640301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111145435|NCT01640301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111145436|NCT01640301|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111145437|NCT01640301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111145438|NCT01640301|Antimetabolites|antimetabolites|mesh-ancestor
111145439|NCT01640301|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111145440|NCT01640301|Analgesics|analgesics|mesh-ancestor
111145441|NCT01640301|Sensory System Agents|sensory system agents|mesh-ancestor
111145442|NCT01640301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111145443|NCT01640301|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111145444|NCT01640301|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111145445|NCT01640301|Antiviral Agents|antiviral agents|mesh-ancestor
111145446|NCT01640301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111145447|NCT01642407|Sildenafil Citrate|sildenafil citrate|mesh-list
111145448|NCT01642407|Vasodilator Agents|vasodilator agents|mesh-ancestor
110839869|NCT03410524|Emollients|emollients|mesh-ancestor
111145449|NCT01642407|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111145450|NCT01642407|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111145451|NCT01642407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110676990|NCT03233724|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111145452|NCT01642407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111145453|NCT01642407|Urological Agents|urological agents|mesh-ancestor
111145454|NCT02255097|Pembrolizumab|pembrolizumab|mesh-list
111145455|NCT02255097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111145456|NCT02255097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111145457|NCT02255097|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111145458|NCT02255097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111145460|NCT02254551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111145461|NCT05640375|Methylprednisolone|methylprednisolone|mesh-list
111145462|NCT05640375|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111145463|NCT05640375|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111145464|NCT05640375|Prednisolone|prednisolone|mesh-list
111145465|NCT05640375|Prednisolone acetate|prednisolone acetate|mesh-list
111145466|NCT05640375|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111145467|NCT05640375|Prednisolone phosphate|prednisolone phosphate|mesh-list
111145468|NCT05640375|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111145469|NCT05640375|Antiemetics|antiemetics|mesh-ancestor
111145470|NCT05640375|Autonomic Agents|autonomic agents|mesh-ancestor
111145471|NCT05640375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111145472|NCT05640375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111145473|NCT05640375|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111145474|NCT05640375|Glucocorticoids|glucocorticoids|mesh-ancestor
111145475|NCT05640375|Hormones|hormones|mesh-ancestor
111145476|NCT05640375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111145477|NCT05640375|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111145478|NCT05640375|Protective Agents|protective agents|mesh-ancestor
110839873|NCT02713776|Hormones|hormones|mesh-ancestor
111145479|NCT05640375|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111145480|NCT05640375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111145481|NCT01641237|Listerine|listerine|mesh-list
111145482|NCT01641237|Fluorides|fluorides|mesh-list
111145483|NCT01641237|Sodium Fluoride|sodium fluoride|mesh-list
111145484|NCT01641237|Cariostatic Agents|cariostatic agents|mesh-ancestor
111145485|NCT01641237|Protective Agents|protective agents|mesh-ancestor
111145486|NCT01641237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111145487|NCT01641237|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111145488|NCT01641237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111145489|NCT05650437|Vitamin D|vitamin d|mesh-list
111145490|NCT05650437|Vitamins|vitamins|mesh-ancestor
111145491|NCT05650437|Micronutrients|micronutrients|mesh-ancestor
111145492|NCT05650437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111145493|NCT05650437|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111145494|NCT05617209|Thrombin|thrombin|mesh-list
111145495|NCT05617209|Hemostatics|hemostatics|mesh-ancestor
111145496|NCT05617209|Coagulants|coagulants|mesh-ancestor
111145497|NCT01639833|Hemostatics|hemostatics|mesh-list
111145498|NCT01639833|Coagulants|coagulants|mesh-ancestor
111145499|NCT01639131|Gemcitabine|gemcitabine|mesh-list
111145500|NCT01639131|Docetaxel|docetaxel|mesh-list
111145501|NCT01639131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111145502|NCT01639131|Antimetabolites|antimetabolites|mesh-ancestor
111145503|NCT01639131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111145504|NCT01639131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111145505|NCT01639131|Tubulin Modulators|tubulin modulators|mesh-ancestor
111145506|NCT01639131|Antimitotic Agents|antimitotic agents|mesh-ancestor
111145507|NCT01639131|Mitosis Modulators|mitosis modulators|mesh-ancestor
111145508|NCT01641159|Buspirone|buspirone|mesh-list
111145509|NCT01641159|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111145510|NCT01641159|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111145511|NCT01641159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111145512|NCT01641159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111145513|NCT01641159|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111145514|NCT01641159|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111145515|NCT01641159|Serotonin Agents|serotonin agents|mesh-ancestor
111145516|NCT01641159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111145517|NCT01641159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111145518|NCT01641081|Formoterol Fumarate|formoterol fumarate|mesh-list
111145519|NCT01641081|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111145520|NCT01641081|Autonomic Agents|autonomic agents|mesh-ancestor
111145521|NCT01641081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111145522|NCT01641081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111145523|NCT01641081|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111145524|NCT01641081|Respiratory System Agents|respiratory system agents|mesh-ancestor
111145525|NCT01641081|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111145526|NCT01641081|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111145527|NCT01641081|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111145528|NCT01641081|Adrenergic Agents|adrenergic agents|mesh-ancestor
111145529|NCT01641081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111145530|NCT01641081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111145531|NCT01640925|Chlorhexidine|chlorhexidine|mesh-list
111145532|NCT01640925|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
111145533|NCT01640925|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111145534|NCT01640925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111145535|NCT01640925|Disinfectants|disinfectants|mesh-ancestor
111145536|NCT01640925|Dermatologic Agents|dermatologic agents|mesh-ancestor
111145537|NCT05369481|Minoxidil|minoxidil|mesh-list
111145538|NCT05369481|Sildenafil Citrate|sildenafil citrate|mesh-list
111145539|NCT05369481|Vasodilator Agents|vasodilator agents|mesh-ancestor
111145540|NCT05369481|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111145541|NCT05369481|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111145542|NCT05369481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111145543|NCT05369481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111145544|NCT05369481|Urological Agents|urological agents|mesh-ancestor
111145545|NCT05369481|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111145546|NCT04853589|Hyaluronic Acid|hyaluronic acid|mesh-list
111145547|NCT04853589|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111145548|NCT04853589|Immunologic Factors|immunologic factors|mesh-ancestor
111145549|NCT04853589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111145550|NCT04853589|Viscosupplements|viscosupplements|mesh-ancestor
111145551|NCT04853589|Protective Agents|protective agents|mesh-ancestor
111145552|NCT01638429|Rifaximin|rifaximin|mesh-list
111145553|NCT01638429|Neomycin|neomycin|mesh-list
111145554|NCT01638429|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111145555|NCT01638429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111145556|NCT01638429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111145557|NCT01638429|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111145558|NCT01638429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111145559|NCT01638429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111145560|NCT04853511|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
111145561|NCT04853511|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111145562|NCT04853511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111145563|NCT04853355|Spironolactone|spironolactone|mesh-list
111145564|NCT04853355|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
111145565|NCT04853355|Hormone Antagonists|hormone antagonists|mesh-ancestor
111145566|NCT04853355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111145567|NCT04853355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111145568|NCT04853355|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
111145569|NCT04853355|Diuretics|diuretics|mesh-ancestor
111145570|NCT04853355|Natriuretic Agents|natriuretic agents|mesh-ancestor
111145571|NCT05369091|Simvastatin|simvastatin|mesh-list
111145572|NCT05369091|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111145573|NCT05369091|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111145574|NCT05369091|Antimetabolites|antimetabolites|mesh-ancestor
111145575|NCT05369091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111145576|NCT05369091|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111145577|NCT05369091|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111145578|NCT05369091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111145579|NCT01601535|Irinotecan|irinotecan|mesh-list
111145580|NCT01601535|Temozolomide|temozolomide|mesh-list
111145581|NCT01601535|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111145582|NCT01601535|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111145583|NCT01601535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111145584|NCT01601535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111145585|NCT01601535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111145586|NCT01601535|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111145587|NCT01601535|Alkylating Agents|alkylating agents|mesh-ancestor
111145588|NCT05422365|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111145589|NCT05422365|Immunoglobulins|immunoglobulins|mesh-list
111145590|NCT05422365|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111145591|NCT05422365|Antibodies|antibodies|mesh-list
111145592|NCT05422365|gamma-Globulins|gamma-globulins|mesh-list
111145593|NCT05422365|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
111145594|NCT05422365|Immunologic Factors|immunologic factors|mesh-ancestor
111145595|NCT05422365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111145596|NCT04641273|Pregabalin|pregabalin|mesh-list
111145597|NCT04641273|Analgesics|analgesics|mesh-ancestor
111145598|NCT04641273|Sensory System Agents|sensory system agents|mesh-ancestor
111145599|NCT04641273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111145600|NCT04641273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111145601|NCT04641273|Anticonvulsants|anticonvulsants|mesh-ancestor
111145602|NCT04641273|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111145603|NCT04641273|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111145604|NCT04641273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111145605|NCT04641273|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111145606|NCT04641273|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111145607|NCT04641273|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111145608|NCT04641273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111145609|NCT04641273|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111145611|NCT04586985|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111145612|NCT04586985|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111145613|NCT04586985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111145614|NCT04586985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111145615|NCT04586985|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111145616|NCT04586985|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111145617|NCT04586985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111145618|NCT04586985|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111145619|NCT04586985|Anesthetics, General|anesthetics, general|mesh-ancestor
111145620|NCT04586985|Anesthetics|anesthetics|mesh-ancestor
111145621|NCT04586985|GABA Modulators|gaba modulators|mesh-ancestor
111145622|NCT04586985|GABA Agents|gaba agents|mesh-ancestor
111145623|NCT04586985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111145624|NCT04586985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111145625|NCT05244057|Interferons|interferons|mesh-list
111145626|NCT05244057|Tenofovir|tenofovir|mesh-list
111145627|NCT05244057|Interferon-alpha|interferon-alpha|mesh-list
111145628|NCT05244057|Interferon alpha-2|interferon alpha-2|mesh-list
111145629|NCT05244057|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
111145630|NCT05244057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111145631|NCT05244057|Antiviral Agents|antiviral agents|mesh-ancestor
111145632|NCT05244057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111145633|NCT05244057|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111145634|NCT05244057|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111145635|NCT05244057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111145636|NCT05244057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111145637|NCT05244057|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111145638|NCT05244057|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111145639|NCT05244057|Immunologic Factors|immunologic factors|mesh-ancestor
111145640|NCT05244057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111145641|NCT05408403|Anesthetics|anesthetics|mesh-list
111145642|NCT05408403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111145643|NCT05408403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111145644|NCT04830735|Dasatinib|dasatinib|mesh-list
111145645|NCT04830735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111145646|NCT04830735|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111145647|NCT04830735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111145648|NCT04830735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111145649|NCT05335317|Hormones|hormones|mesh-list
111145650|NCT05335317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111145651|NCT05335317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111145652|NCT04419441|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
111145653|NCT04419441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111145654|NCT04419441|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111145655|NCT04419441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111145656|NCT05329779|Pregnanolone|pregnanolone|mesh-list
111145657|NCT05329779|Brexanolone|brexanolone|mesh-list
111145658|NCT05329779|Anesthetics|anesthetics|mesh-ancestor
111145659|NCT05329779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111145660|NCT05329779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111145661|NCT05329779|Neurosteroids|neurosteroids|mesh-ancestor
111145662|NCT05329779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111145663|NCT05329779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111145664|NCT05329779|GABA Modulators|gaba modulators|mesh-ancestor
111145665|NCT05329779|GABA Agents|gaba agents|mesh-ancestor
111145666|NCT04464759|Hydroxychloroquine|hydroxychloroquine|mesh-list
111145667|NCT04464759|Nivolumab|nivolumab|mesh-list
111145668|NCT04464759|Ipilimumab|ipilimumab|mesh-list
111145669|NCT04464759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111145670|NCT04464759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111145671|NCT04464759|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111145672|NCT04464759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111145673|NCT04464759|Antimalarials|antimalarials|mesh-ancestor
111145674|NCT04464759|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111145675|NCT04464759|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111145676|NCT04464759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111145677|NCT04464759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111145678|NCT04464759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111145679|NCT04850937|Esketamine|esketamine|mesh-list
111145680|NCT04850937|Antidepressive Agents|antidepressive agents|mesh-ancestor
111145681|NCT04850937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111145682|NCT01363713|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111145683|NCT01363713|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111145684|NCT04411329|Dexamethasone|dexamethasone|mesh-list
111145685|NCT04411329|Dexmedetomidine|dexmedetomidine|mesh-list
111145686|NCT04411329|Bupivacaine|bupivacaine|mesh-list
111145687|NCT04411329|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111145688|NCT04411329|Antiemetics|antiemetics|mesh-ancestor
111145689|NCT04411329|Autonomic Agents|autonomic agents|mesh-ancestor
111145690|NCT04411329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111145691|NCT04411329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111145692|NCT04411329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111145693|NCT04411329|Glucocorticoids|glucocorticoids|mesh-ancestor
111145694|NCT04411329|Hormones|hormones|mesh-ancestor
111145695|NCT04411329|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111145696|NCT04411329|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111145697|NCT04411329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111145698|NCT04411329|Anesthetics, Local|anesthetics, local|mesh-ancestor
111145699|NCT04411329|Anesthetics|anesthetics|mesh-ancestor
111145700|NCT04411329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111145701|NCT04411329|Sensory System Agents|sensory system agents|mesh-ancestor
111145702|NCT04411329|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111145703|NCT04411329|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111145704|NCT04411329|Analgesics|analgesics|mesh-ancestor
111145705|NCT04411329|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111145706|NCT04411329|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111145707|NCT04411329|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111145708|NCT04411329|Adrenergic Agents|adrenergic agents|mesh-ancestor
111145709|NCT04411329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111145710|NCT04411329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111145711|NCT05171673|Diclofenac|diclofenac|mesh-list
111145712|NCT05171673|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
111145713|NCT05171673|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111145714|NCT05171673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111145715|NCT05171673|Analgesics|analgesics|mesh-ancestor
111145716|NCT05171673|Sensory System Agents|sensory system agents|mesh-ancestor
111145717|NCT05171673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111145718|NCT05171673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111145719|NCT05171673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111145720|NCT05171673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111145721|NCT05171673|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111145722|NCT05171673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111145723|NCT05171673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111145724|NCT05147415|Metoprolol|metoprolol|mesh-list
111145725|NCT05147415|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111145726|NCT05147415|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111145727|NCT05147415|Sympatholytics|sympatholytics|mesh-ancestor
111145728|NCT05147415|Autonomic Agents|autonomic agents|mesh-ancestor
111145729|NCT05147415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111145730|NCT05147415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111145731|NCT05147415|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
111145732|NCT05147415|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111145733|NCT05147415|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111145734|NCT05147415|Adrenergic Agents|adrenergic agents|mesh-ancestor
111145735|NCT05147415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111145736|NCT05147415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111145737|NCT04390581|Lidocaine|lidocaine|mesh-list
111145738|NCT04390581|Anesthetics, Local|anesthetics, local|mesh-ancestor
111145739|NCT04390581|Anesthetics|anesthetics|mesh-ancestor
111145740|NCT04390581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111145741|NCT04390581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111145742|NCT04390581|Sensory System Agents|sensory system agents|mesh-ancestor
111145743|NCT04390581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111145744|NCT04390581|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111145745|NCT04390581|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111145746|NCT04390581|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111145747|NCT04390581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111145748|NCT04390581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111145749|NCT04183335|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
111145750|NCT04183335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111145751|NCT04183335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111145753|NCT04254549|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111145754|NCT04254549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111145755|NCT04254549|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111145756|NCT04225767|Calcium|calcium|mesh-list
111145757|NCT04225767|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111145758|NCT04225767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111145759|NCT04820673|Sarecycline|sarecycline|mesh-list
111145760|NCT04820673|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111145761|NCT04820673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111145762|NCT04820673|Dermatologic Agents|dermatologic agents|mesh-ancestor
111145763|NCT04114539|Ecopipam|ecopipam|mesh-list
111145764|NCT04114539|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111145765|NCT04114539|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111145766|NCT04114539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111145767|NCT04114539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111145768|NCT04114539|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111145769|NCT04114539|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111145770|NCT04114539|Dopamine Agents|dopamine agents|mesh-ancestor
111145771|NCT04114539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111145772|NCT04114539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111145773|NCT03263559|Cyclophosphamide|cyclophosphamide|mesh-list
111145774|NCT03263559|Thiotepa|thiotepa|mesh-list
111145775|NCT03263559|Fludarabine|fludarabine|mesh-list
111145776|NCT03263559|Hydroxyurea|hydroxyurea|mesh-list
111145777|NCT03263559|Thymoglobulin|thymoglobulin|mesh-list
111145778|NCT03263559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111145779|NCT03263559|Immunologic Factors|immunologic factors|mesh-ancestor
111145780|NCT03263559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111145781|NCT03263559|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111145782|NCT03263559|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111145783|NCT03263559|Alkylating Agents|alkylating agents|mesh-ancestor
111145784|NCT03263559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111145785|NCT03263559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111145786|NCT03263559|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111145787|NCT03263559|Antisickling Agents|antisickling agents|mesh-ancestor
111145788|NCT03263559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111145789|NCT03263559|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111145790|NCT03256149|Dexamethasone|dexamethasone|mesh-list
111145791|NCT03256149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111145792|NCT03256149|Antiemetics|antiemetics|mesh-ancestor
111145793|NCT03256149|Autonomic Agents|autonomic agents|mesh-ancestor
111145794|NCT03256149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111145795|NCT03256149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111145796|NCT03256149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111145797|NCT03256149|Glucocorticoids|glucocorticoids|mesh-ancestor
111145798|NCT03256149|Hormones|hormones|mesh-ancestor
111145799|NCT03256149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111145800|NCT03256149|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111145801|NCT03256149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111145802|NCT03253263|Mecasermin|mecasermin|mesh-list
111145803|NCT03253263|Growth Substances|growth substances|mesh-ancestor
111145804|NCT03253263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111145805|NCT01636947|Dexamethasone|dexamethasone|mesh-list
111145806|NCT01636947|Dexamethasone acetate|dexamethasone acetate|mesh-list
111145807|NCT01636947|Ondansetron|ondansetron|mesh-list
111145808|NCT01636947|Aprepitant|aprepitant|mesh-list
111145809|NCT01636947|Fosaprepitant|fosaprepitant|mesh-list
111145810|NCT01636947|Metoclopramide|metoclopramide|mesh-list
111145811|NCT01636947|Granisetron|granisetron|mesh-list
111145812|NCT01636947|Tropisetron|tropisetron|mesh-list
111145813|NCT01636947|Dolasetron|dolasetron|mesh-list
111145814|NCT01636947|Alizapride|alizapride|mesh-list
111145815|NCT01636947|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
111145816|NCT01636947|BB 1101|bb 1101|mesh-list
111145817|NCT01636947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111145818|NCT01636947|Antiemetics|antiemetics|mesh-ancestor
111145819|NCT01636947|Autonomic Agents|autonomic agents|mesh-ancestor
111145820|NCT01636947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111145821|NCT01636947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111145822|NCT01636947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111145823|NCT01636947|Glucocorticoids|glucocorticoids|mesh-ancestor
111145824|NCT01636947|Hormones|hormones|mesh-ancestor
110482934|NCT00627887|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111145825|NCT01636947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111145826|NCT01636947|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111145827|NCT01636947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111145828|NCT01636947|Protease Inhibitors|protease inhibitors|mesh-ancestor
111145829|NCT01636947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111145830|NCT01636947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111145831|NCT01636947|Antipruritics|antipruritics|mesh-ancestor
111145832|NCT01636947|Dermatologic Agents|dermatologic agents|mesh-ancestor
111145833|NCT01636947|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111145834|NCT01636947|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111145835|NCT01636947|Serotonin Agents|serotonin agents|mesh-ancestor
111145836|NCT01636947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111145837|NCT01636947|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
111145838|NCT01636947|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111145839|NCT01636947|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111145840|NCT01636947|Dopamine Agents|dopamine agents|mesh-ancestor
111145841|NCT03052725|Reslizumab|reslizumab|mesh-list
111145842|NCT03052725|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111145843|NCT03052725|Respiratory System Agents|respiratory system agents|mesh-ancestor
111145844|NCT02980341|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
111145845|NCT02980341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111145846|NCT02980341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111145847|NCT04793919|Tretinoin|tretinoin|mesh-list
111145848|NCT04793919|Arsenic Trioxide|arsenic trioxide|mesh-list
111145849|NCT04793919|Gemtuzumab|gemtuzumab|mesh-list
111145850|NCT04793919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111145851|NCT04793919|Keratolytic Agents|keratolytic agents|mesh-ancestor
111145852|NCT04793919|Dermatologic Agents|dermatologic agents|mesh-ancestor
111145853|NCT04793919|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111145854|NCT04793919|Immunotoxins|immunotoxins|mesh-ancestor
111145855|NCT04793919|Immunoconjugates|immunoconjugates|mesh-ancestor
111145856|NCT04793919|Immunologic Factors|immunologic factors|mesh-ancestor
111145857|NCT04793919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111145858|NCT02817633|Carboplatin|carboplatin|mesh-list
111145859|NCT02817633|Docetaxel|docetaxel|mesh-list
111145860|NCT02817633|Nivolumab|nivolumab|mesh-list
111145861|NCT02817633|Pemetrexed|pemetrexed|mesh-list
111145862|NCT02817633|Dostarlimab|dostarlimab|mesh-list
111145863|NCT02817633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111145864|NCT02817633|Tubulin Modulators|tubulin modulators|mesh-ancestor
111145865|NCT02817633|Antimitotic Agents|antimitotic agents|mesh-ancestor
111145866|NCT02817633|Mitosis Modulators|mitosis modulators|mesh-ancestor
111145867|NCT02817633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111145868|NCT02817633|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111145869|NCT02817633|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111145870|NCT02817633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111145871|NCT02817633|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111145872|NCT02817633|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111145873|NCT02775435|Paclitaxel|paclitaxel|mesh-list
111145874|NCT02775435|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111145875|NCT02775435|Carboplatin|carboplatin|mesh-list
111145876|NCT02775435|Pembrolizumab|pembrolizumab|mesh-list
111145877|NCT02775435|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111145878|NCT02775435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111145879|NCT02775435|Tubulin Modulators|tubulin modulators|mesh-ancestor
111145880|NCT02775435|Antimitotic Agents|antimitotic agents|mesh-ancestor
111145881|NCT02775435|Mitosis Modulators|mitosis modulators|mesh-ancestor
111145882|NCT02775435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111145883|NCT02775435|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111145884|NCT02775435|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111145885|NCT02774421|Trastuzumab|trastuzumab|mesh-list
111145886|NCT02774421|Molgramostim|molgramostim|mesh-list
111145887|NCT02774421|Sargramostim|sargramostim|mesh-list
111145888|NCT02774421|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111145889|NCT02774421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111145890|NCT02774421|Immunologic Factors|immunologic factors|mesh-ancestor
111145891|NCT02774421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111145892|NCT04791969|Naltrexone|naltrexone|mesh-list
111145893|NCT04791969|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111145894|NCT04791969|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111145895|NCT04791969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111145896|NCT04791969|Sensory System Agents|sensory system agents|mesh-ancestor
111145897|NCT04791969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111145898|NCT05651373|Hydroxychloroquine|hydroxychloroquine|mesh-list
111145899|NCT05651373|Prednisone|prednisone|mesh-list
110839941|NCT03393988|Anesthetics|anesthetics|mesh-ancestor
111145900|NCT05651373|Certolizumab Pegol|certolizumab pegol|mesh-list
111145901|NCT05651373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111145902|NCT05651373|Glucocorticoids|glucocorticoids|mesh-ancestor
111145903|NCT05651373|Hormones|hormones|mesh-ancestor
111145904|NCT05651373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111145905|NCT05651373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111145906|NCT05651373|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111145907|NCT05651373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111145908|NCT05651373|Antimalarials|antimalarials|mesh-ancestor
111145909|NCT05651373|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111145910|NCT05651373|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111145911|NCT05651373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111145912|NCT05651373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111145913|NCT05651373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111145914|NCT05651373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111145915|NCT05651373|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111145916|NCT05651373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111145917|NCT05651373|Immunologic Factors|immunologic factors|mesh-ancestor
111145918|NCT03905889|Sunitinib|sunitinib|mesh-list
111145919|NCT03905889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111145920|NCT03905889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111145921|NCT03905889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111145922|NCT03905889|Growth Substances|growth substances|mesh-ancestor
111145923|NCT03905889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111145924|NCT03905889|Growth Inhibitors|growth inhibitors|mesh-ancestor
111145925|NCT03905889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111145926|NCT03905889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111145927|NCT03905889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111145928|NCT04804059|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111145929|NCT03846765|Phenylephrine|phenylephrine|mesh-list
111145930|NCT03846765|Dobutamine|dobutamine|mesh-list
111145931|NCT03846765|Oxymetazoline|oxymetazoline|mesh-list
111145932|NCT03846765|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111145933|NCT03846765|Mydriatics|mydriatics|mesh-ancestor
111145934|NCT03846765|Autonomic Agents|autonomic agents|mesh-ancestor
111145935|NCT03846765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111145936|NCT03846765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111145937|NCT03846765|Sympathomimetics|sympathomimetics|mesh-ancestor
111145938|NCT03846765|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111145939|NCT03846765|Nasal Decongestants|nasal decongestants|mesh-ancestor
111145940|NCT03846765|Respiratory System Agents|respiratory system agents|mesh-ancestor
111145941|NCT03846765|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111145942|NCT03846765|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111145943|NCT03846765|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111145944|NCT03846765|Adrenergic Agents|adrenergic agents|mesh-ancestor
111145945|NCT03846765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111145946|NCT03846765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111145947|NCT03846765|Protective Agents|protective agents|mesh-ancestor
111145948|NCT03846765|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
111145949|NCT03846765|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111145950|NCT05163405|Bortezomib|bortezomib|mesh-list
111145951|NCT05163405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111145952|NCT02311179|Cimetidine|cimetidine|mesh-list
111145953|NCT02311179|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111145954|NCT02311179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111145955|NCT02311179|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
111145956|NCT02311179|Histamine Antagonists|histamine antagonists|mesh-ancestor
111145957|NCT02311179|Histamine Agents|histamine agents|mesh-ancestor
111145958|NCT02311179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111145959|NCT02311179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111145960|NCT02311179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111145961|NCT02311179|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111145962|NCT02311179|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111145963|NCT02311179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111145964|NCT04801953|Nimodipine|nimodipine|mesh-list
111145965|NCT04801953|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111145966|NCT04801953|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111145967|NCT04801953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111145968|NCT04801953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111145969|NCT04801953|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110839953|NCT03410212|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111145970|NCT04801953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111145971|NCT04801953|Vasodilator Agents|vasodilator agents|mesh-ancestor
111145972|NCT01635153|Micronutrients|micronutrients|mesh-list
111145973|NCT01635153|Trace Elements|trace elements|mesh-list
111145974|NCT01635153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111145975|NCT04446039|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
111145976|NCT04446039|Vortioxetine|vortioxetine|mesh-list
111145977|NCT04446039|Mirtazapine|mirtazapine|mesh-list
111145978|NCT04446039|Bupropion|bupropion|mesh-list
111145979|NCT04446039|Fluoxetine|fluoxetine|mesh-list
111145980|NCT04446039|Paroxetine|paroxetine|mesh-list
111145981|NCT04446039|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
111145982|NCT04446039|Sertraline|sertraline|mesh-list
111145983|NCT04446039|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
111145984|NCT04446039|Tianeptine|tianeptine|mesh-list
111145985|NCT04446039|Escitalopram|escitalopram|mesh-list
111145986|NCT04446039|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111145987|NCT04446039|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111145988|NCT04446039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111145989|NCT04446039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111145990|NCT04446039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111145991|NCT04446039|Serotonin Agents|serotonin agents|mesh-ancestor
111145992|NCT04446039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111145993|NCT04446039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111145994|NCT04446039|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111145995|NCT04446039|Antidepressive Agents|antidepressive agents|mesh-ancestor
111145996|NCT04446039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111145997|NCT04446039|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111145998|NCT04446039|Dopamine Agents|dopamine agents|mesh-ancestor
111145999|NCT04446039|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111146000|NCT04446039|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111146001|NCT04446039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111146002|NCT04446039|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111146003|NCT04446039|Analgesics|analgesics|mesh-ancestor
111146004|NCT04446039|Sensory System Agents|sensory system agents|mesh-ancestor
111146005|NCT04446039|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111146006|NCT04446039|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111146007|NCT04446039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111146008|NCT04446039|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111146009|NCT04446039|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111146010|NCT04446039|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111146011|NCT04446039|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111146012|NCT04446039|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111146013|NCT04446039|Histamine Antagonists|histamine antagonists|mesh-ancestor
111146014|NCT04446039|Histamine Agents|histamine agents|mesh-ancestor
111146015|NCT04446039|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
111146016|NCT04446039|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111146017|NCT04446039|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111146018|NCT04446039|Adrenergic Agents|adrenergic agents|mesh-ancestor
111146019|NCT04446039|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111146020|NCT04446039|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
111146021|NCT04192773|Lidocaine|lidocaine|mesh-list
111146022|NCT04192773|Anesthetics, Local|anesthetics, local|mesh-ancestor
111146023|NCT04192773|Anesthetics|anesthetics|mesh-ancestor
110839956|NCT03397264|Aflibercept|aflibercept|mesh-list
111146024|NCT04192773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111146025|NCT04192773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111146026|NCT04192773|Sensory System Agents|sensory system agents|mesh-ancestor
111146027|NCT04192773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111146028|NCT04192773|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111146029|NCT04192773|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111146030|NCT04192773|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111146031|NCT04192773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111146032|NCT04192773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111146033|NCT05031897|Mycophenolic Acid|mycophenolic acid|mesh-list
111146034|NCT05031897|Cyclophosphamide|cyclophosphamide|mesh-list
111146035|NCT05031897|Melphalan|melphalan|mesh-list
111146036|NCT05031897|Fludarabine|fludarabine|mesh-list
111146037|NCT05031897|Tacrolimus|tacrolimus|mesh-list
111146038|NCT05031897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111146039|NCT05031897|Immunologic Factors|immunologic factors|mesh-ancestor
111146040|NCT05031897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111146041|NCT05031897|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111146042|NCT05031897|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111146043|NCT05031897|Alkylating Agents|alkylating agents|mesh-ancestor
111146044|NCT05031897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111146045|NCT05031897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111146046|NCT05031897|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111146047|NCT05031897|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111146048|NCT05031897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111146049|NCT05031897|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111146050|NCT05031897|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111146051|NCT05031897|Antitubercular Agents|antitubercular agents|mesh-ancestor
111146052|NCT05031897|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111146053|NCT05031897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110676991|NCT03233724|Antimetabolites|antimetabolites|mesh-ancestor
111146054|NCT03591861|Carmustine|carmustine|mesh-list
111146055|NCT03591861|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111146056|NCT03591861|Alkylating Agents|alkylating agents|mesh-ancestor
111146057|NCT03591861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111146058|NCT03591861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111146059|NCT01600053|Lenalidomide|lenalidomide|mesh-list
111146060|NCT01600053|Immunologic Factors|immunologic factors|mesh-ancestor
111146061|NCT01600053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111146062|NCT01600053|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111146063|NCT01600053|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111146064|NCT01600053|Growth Substances|growth substances|mesh-ancestor
111146065|NCT01600053|Growth Inhibitors|growth inhibitors|mesh-ancestor
111146066|NCT01600053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111146067|NCT03569241|Androgens|androgens|mesh-list
111146068|NCT03569241|Hormones|hormones|mesh-ancestor
111146069|NCT03569241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111146070|NCT03569241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111146071|NCT04716387|Milbemycin oxime|milbemycin oxime|mesh-list
111146072|NCT04716387|Anthelmintics|anthelmintics|mesh-ancestor
111146073|NCT04716387|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111146074|NCT04716387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111146075|NCT01068249|Everolimus|everolimus|mesh-list
111146076|NCT01068249|Letrozole|letrozole|mesh-list
111146077|NCT01068249|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111146078|NCT01068249|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111146079|NCT01068249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111146080|NCT01068249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111146081|NCT01068249|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111146082|NCT01068249|Immunologic Factors|immunologic factors|mesh-ancestor
111146083|NCT01068249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111146084|NCT01068249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111146085|NCT01068249|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111146086|NCT01068249|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111146087|NCT01068249|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111146088|NCT01068249|Hormone Antagonists|hormone antagonists|mesh-ancestor
111146089|NCT01068249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111146090|NCT01035099|Letrozole|letrozole|mesh-list
111146091|NCT01035099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111146092|NCT01035099|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111146093|NCT01035099|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111146094|NCT01035099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111146095|NCT01035099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111146096|NCT01035099|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111146097|NCT01035099|Hormone Antagonists|hormone antagonists|mesh-ancestor
111146098|NCT01035099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111146099|NCT01035099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111146101|NCT03560349|Anesthetics, Local|anesthetics, local|mesh-ancestor
111146102|NCT03560349|Anesthetics|anesthetics|mesh-ancestor
111146103|NCT03560349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111146104|NCT03560349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111146105|NCT03560349|Sensory System Agents|sensory system agents|mesh-ancestor
111146106|NCT03560349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111146107|NCT03560349|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111146108|NCT03560349|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111146109|NCT03560349|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111146110|NCT03560349|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111146111|NCT03560349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111146112|NCT04435431|Mesdopetam|mesdopetam|mesh-list
111146113|NCT04435431|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111146114|NCT04435431|Dopamine Agents|dopamine agents|mesh-ancestor
111146115|NCT04435431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111146116|NCT04435431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111146117|NCT04435431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111146118|NCT02246673|Febuxostat|febuxostat|mesh-list
111146119|NCT02246673|Verinurad|verinurad|mesh-list
111146120|NCT02246673|Gout Suppressants|gout suppressants|mesh-ancestor
111146121|NCT02246673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111146122|NCT03532425|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
111146123|NCT03532425|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111146124|NCT03532425|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111146125|NCT03532425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111146126|NCT03532425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111146127|NCT03532425|Antiviral Agents|antiviral agents|mesh-ancestor
111146128|NCT03532425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111146129|NCT03532425|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111146130|NCT03532425|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111146131|NCT04191447|Budesonide|budesonide|mesh-list
111146132|NCT04191447|Formoterol Fumarate|formoterol fumarate|mesh-list
111146133|NCT04191447|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
111146134|NCT04191447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111146135|NCT04191447|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111146136|NCT04191447|Autonomic Agents|autonomic agents|mesh-ancestor
111146137|NCT04191447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111146138|NCT04191447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111146139|NCT04191447|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111146140|NCT04191447|Respiratory System Agents|respiratory system agents|mesh-ancestor
111146141|NCT04191447|Glucocorticoids|glucocorticoids|mesh-ancestor
111146142|NCT04191447|Hormones|hormones|mesh-ancestor
111146143|NCT04191447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111146144|NCT04191447|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111146145|NCT04191447|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111146146|NCT04191447|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111146147|NCT04191447|Adrenergic Agents|adrenergic agents|mesh-ancestor
111146148|NCT04191447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111146149|NCT04191447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111146150|NCT04274361|Ketamine|ketamine|mesh-list
111146151|NCT04274361|Analgesics|analgesics|mesh-ancestor
111146152|NCT04274361|Sensory System Agents|sensory system agents|mesh-ancestor
111146153|NCT04274361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111146154|NCT04274361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111146155|NCT04274361|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111146156|NCT04274361|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111146157|NCT04274361|Anesthetics, General|anesthetics, general|mesh-ancestor
111146158|NCT04274361|Anesthetics|anesthetics|mesh-ancestor
111146159|NCT04274361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111146160|NCT04274361|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111146161|NCT04274361|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111146162|NCT04274361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111146163|NCT04274361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111146164|NCT04251819|Baclofen|baclofen|mesh-list
111146165|NCT04251819|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
111146166|NCT04251819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111146167|NCT04251819|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111146168|NCT04251819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111146169|NCT04251819|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
111146170|NCT04251819|GABA Agonists|gaba agonists|mesh-ancestor
111146171|NCT04251819|GABA Agents|gaba agents|mesh-ancestor
111146172|NCT04251819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111146173|NCT04251819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111146174|NCT02243631|Probenecid|probenecid|mesh-list
111146175|NCT02243631|Uricosuric Agents|uricosuric agents|mesh-ancestor
111146176|NCT02243631|Gout Suppressants|gout suppressants|mesh-ancestor
111146177|NCT02243631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111146178|NCT02242305|Scopolamine|scopolamine|mesh-list
111146179|NCT02242305|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
111146180|NCT02242305|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111146181|NCT02242305|Antiemetics|antiemetics|mesh-ancestor
111146182|NCT02242305|Autonomic Agents|autonomic agents|mesh-ancestor
111146183|NCT02242305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111146184|NCT02242305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111146185|NCT02242305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111146186|NCT02242305|Mydriatics|mydriatics|mesh-ancestor
111146187|NCT02242305|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111146188|NCT02242305|Cholinergic Agents|cholinergic agents|mesh-ancestor
111146189|NCT02242305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111146190|NCT02242305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111146191|NCT02242305|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111146192|NCT02242305|Parasympatholytics|parasympatholytics|mesh-ancestor
111146193|NCT02240121|Rifaximin|rifaximin|mesh-list
111146194|NCT02240121|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111146195|NCT02240121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111146196|NCT02240121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111146197|NCT02238483|AZD7624|azd7624|mesh-list
111146198|NCT02238483|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111146199|NCT02238483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111146200|NCT02238483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111146201|NCT01632891|Ritonavir|ritonavir|mesh-list
111146202|NCT01632891|Lopinavir|lopinavir|mesh-list
111146203|NCT01632891|Tenofovir|tenofovir|mesh-list
111146204|NCT01632891|Emtricitabine|emtricitabine|mesh-list
111146205|NCT01632891|Nevirapine|nevirapine|mesh-list
111146206|NCT01632891|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
111146207|NCT01632891|Efavirenz|efavirenz|mesh-list
111146208|NCT01632891|Trimethoprim|trimethoprim|mesh-list
111146209|NCT01632891|Sulfamethoxazole|sulfamethoxazole|mesh-list
111146210|NCT01632891|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111146211|NCT01632891|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111146212|NCT01632891|Protease Inhibitors|protease inhibitors|mesh-ancestor
111146213|NCT01632891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111146214|NCT01632891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111146215|NCT01632891|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111146216|NCT01632891|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111146217|NCT01632891|Antiviral Agents|antiviral agents|mesh-ancestor
111146218|NCT01632891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111146219|NCT01632891|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111146220|NCT01632891|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111146221|NCT01632891|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111146222|NCT01632891|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111146223|NCT01632891|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110839989|NCT03405454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111146224|NCT01632891|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111146225|NCT01632891|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111146226|NCT01632891|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111146227|NCT01632891|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111146228|NCT01632891|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111146229|NCT01632891|Antimalarials|antimalarials|mesh-ancestor
111146230|NCT01632891|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111146231|NCT01632891|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111146232|NCT01632891|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111146233|NCT01632891|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111146234|NCT01632891|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
111146235|NCT02208843|Afatinib|afatinib|mesh-list
111146236|NCT02208843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111146237|NCT02208843|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111146238|NCT02208843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111146239|NCT02208843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111146240|NCT02208063|Vancomycin|vancomycin|mesh-list
111146241|NCT02208063|Cefazolin|cefazolin|mesh-list
111146242|NCT02208063|Daptomycin|daptomycin|mesh-list
111146243|NCT02208063|Penicillins|penicillins|mesh-list
111146244|NCT02208063|Cloxacillin|cloxacillin|mesh-list
111146245|NCT02208063|Oxacillin|oxacillin|mesh-list
111146246|NCT02208063|Nafcillin|nafcillin|mesh-list
111146247|NCT02208063|Telavancin|telavancin|mesh-list
111146248|NCT02208063|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111146249|NCT02208063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111146250|NCT03729609|Brentuximab Vedotin|brentuximab vedotin|mesh-list
111146251|NCT03729609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111146252|NCT03729609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111146253|NCT03729609|Immunotoxins|immunotoxins|mesh-ancestor
111146254|NCT03729609|Immunoconjugates|immunoconjugates|mesh-ancestor
111146255|NCT03729609|Immunologic Factors|immunologic factors|mesh-ancestor
111146256|NCT03729609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111146257|NCT02207907|Listerine|listerine|mesh-list
111146258|NCT02207907|Fluorides|fluorides|mesh-list
111146259|NCT02207907|Sodium Fluoride|sodium fluoride|mesh-list
111146260|NCT02207907|Cariostatic Agents|cariostatic agents|mesh-ancestor
111146261|NCT02207907|Protective Agents|protective agents|mesh-ancestor
111146262|NCT02207907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111146263|NCT02207907|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111146264|NCT02207907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111146265|NCT02207829|Tiotropium Bromide|tiotropium bromide|mesh-list
111146266|NCT02207829|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111146267|NCT02207829|Autonomic Agents|autonomic agents|mesh-ancestor
111146268|NCT02207829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111146269|NCT02207829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111146270|NCT02207829|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111146271|NCT02207829|Respiratory System Agents|respiratory system agents|mesh-ancestor
111146272|NCT02207829|Parasympatholytics|parasympatholytics|mesh-ancestor
111146273|NCT02207829|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111146274|NCT02207829|Cholinergic Agents|cholinergic agents|mesh-ancestor
111146275|NCT02207829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111146276|NCT02207829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111146277|NCT02237157|Gemcitabine|gemcitabine|mesh-list
111146278|NCT02237157|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111146279|NCT02237157|Antimetabolites|antimetabolites|mesh-ancestor
110839996|NCT05168176|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111146280|NCT02237157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111146281|NCT02237157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111146283|NCT02236611|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111146284|NCT02236611|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111146285|NCT02236611|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111146286|NCT02236611|Cholinergic Agents|cholinergic agents|mesh-ancestor
111146287|NCT02236611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111146288|NCT02236611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111146289|NCT02236611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111146290|NCT02233803|Budesonide|budesonide|mesh-list
111146291|NCT02233803|Albuterol|albuterol|mesh-list
111146292|NCT02233803|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
111146293|NCT02233803|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111146294|NCT02233803|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111146295|NCT02233803|Autonomic Agents|autonomic agents|mesh-ancestor
111146296|NCT02233803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111146297|NCT02233803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111146298|NCT02233803|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111146299|NCT02233803|Respiratory System Agents|respiratory system agents|mesh-ancestor
111146300|NCT02233803|Glucocorticoids|glucocorticoids|mesh-ancestor
111146301|NCT02233803|Hormones|hormones|mesh-ancestor
111146302|NCT02233803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111146303|NCT02233803|Tocolytic Agents|tocolytic agents|mesh-ancestor
111146304|NCT02233803|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111146305|NCT02233803|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111146306|NCT02233803|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111146307|NCT02233803|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111146308|NCT02233803|Adrenergic Agents|adrenergic agents|mesh-ancestor
111146309|NCT02233803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111146310|NCT02233803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111146311|NCT02233647|Cocaine|cocaine|mesh-list
111146312|NCT02233647|Anesthetics, Local|anesthetics, local|mesh-ancestor
111146313|NCT02233647|Anesthetics|anesthetics|mesh-ancestor
111146314|NCT02233647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111146315|NCT02233647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111146316|NCT02233647|Sensory System Agents|sensory system agents|mesh-ancestor
111146317|NCT02233647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111146318|NCT02233647|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111146319|NCT02233647|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111146320|NCT02233647|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111146321|NCT02233647|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111146322|NCT02233647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111146323|NCT02233647|Dopamine Agents|dopamine agents|mesh-ancestor
111146324|NCT02233647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111146325|NCT01632579|Celecoxib|celecoxib|mesh-list
111146326|NCT01632579|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111146327|NCT01632579|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111146328|NCT01632579|Analgesics|analgesics|mesh-ancestor
111146329|NCT01632579|Sensory System Agents|sensory system agents|mesh-ancestor
111146330|NCT01632579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111146331|NCT01632579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111146332|NCT01632579|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111146333|NCT01632579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111146334|NCT01632579|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111146335|NCT01632579|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111146336|NCT01632579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111146337|NCT01632579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111146338|NCT01632345|Efavirenz|efavirenz|mesh-list
111146339|NCT01632345|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
111146340|NCT01632345|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111146341|NCT01632345|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111146342|NCT01632345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111146343|NCT01632345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111146344|NCT01632345|Antiviral Agents|antiviral agents|mesh-ancestor
111146345|NCT01632345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111146346|NCT01632345|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111146347|NCT01632345|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111146348|NCT01632345|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111146349|NCT01632345|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111146350|NCT01632345|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111146351|NCT01632345|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111146352|NCT01632345|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111146353|NCT01632345|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111146354|NCT02232243|Hydroxychloroquine|hydroxychloroquine|mesh-list
111146355|NCT02232243|Antimalarials|antimalarials|mesh-ancestor
111146356|NCT02232243|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111146357|NCT02232243|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111146358|NCT02232243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111146359|NCT02232243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111146360|NCT02232243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111146361|NCT02232243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111146362|NCT02205333|Rituximab|rituximab|mesh-list
111146363|NCT02205333|Durvalumab|durvalumab|mesh-list
111146364|NCT02205333|Tremelimumab|tremelimumab|mesh-list
111146365|NCT02205333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110482989|NCT04073173|Analgesics|analgesics|mesh-list
111146366|NCT02205333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111146367|NCT02205333|Immunologic Factors|immunologic factors|mesh-ancestor
111146368|NCT02205333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111146369|NCT02205333|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111146370|NCT04776369|Lidocaine|lidocaine|mesh-list
111146371|NCT04776369|Magnesium Sulfate|magnesium sulfate|mesh-list
111146372|NCT04776369|Anesthetics, Local|anesthetics, local|mesh-ancestor
111146373|NCT04776369|Anesthetics|anesthetics|mesh-ancestor
111146374|NCT04776369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111146375|NCT04776369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111146376|NCT04776369|Sensory System Agents|sensory system agents|mesh-ancestor
111146377|NCT04776369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111146378|NCT04776369|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111146379|NCT04776369|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111146380|NCT04776369|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111146381|NCT04776369|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111146382|NCT04776369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111146383|NCT04776369|Analgesics|analgesics|mesh-ancestor
111146384|NCT04776369|Anticonvulsants|anticonvulsants|mesh-ancestor
111146385|NCT04776369|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111146386|NCT04776369|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111146387|NCT04776369|Tocolytic Agents|tocolytic agents|mesh-ancestor
111146388|NCT04776369|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111146389|NCT02230527|Clopidogrel|clopidogrel|mesh-list
111146390|NCT02230527|Ticagrelor|ticagrelor|mesh-list
111146391|NCT02230527|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111146392|NCT02230527|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111146393|NCT02230527|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111146394|NCT02230527|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111146395|NCT02230527|Purinergic Agents|purinergic agents|mesh-ancestor
111146396|NCT02230527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111146397|NCT02230527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111146398|NCT02230527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111146399|NCT03155061|Nivolumab|nivolumab|mesh-list
111146400|NCT03155061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111146401|NCT03155061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111146402|NCT03155061|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111146403|NCT03155061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111146404|NCT02227875|Insulin Glargine|insulin glargine|mesh-list
111146405|NCT02227875|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111146406|NCT02227875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111146407|NCT02203149|Grazoprevir|grazoprevir|mesh-list
111146408|NCT02203149|Antiviral Agents|antiviral agents|mesh-ancestor
111146409|NCT02203149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111146410|NCT02202837|Etanercept|etanercept|mesh-list
111146411|NCT02202837|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111146412|NCT02202837|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110482995|NCT00628121|Cetrorelix|cetrorelix|mesh-list
111146413|NCT02202837|Analgesics|analgesics|mesh-ancestor
111146415|NCT02202837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111146416|NCT02202837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111146417|NCT02202837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111146418|NCT02202837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111146419|NCT02202837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111146420|NCT02202837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111146421|NCT02202837|Immunologic Factors|immunologic factors|mesh-ancestor
111146422|NCT02226549|Sofosbuvir|sofosbuvir|mesh-list
110863483|NCT01353729|Zanamivir|zanamivir|mesh-list
111146423|NCT02226549|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
111146424|NCT02226549|Ledipasvir|ledipasvir|mesh-list
111146425|NCT02226549|Antiviral Agents|antiviral agents|mesh-ancestor
111146426|NCT02226549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111146427|NCT02226003|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111146428|NCT02226003|Glimepiride|glimepiride|mesh-list
111146429|NCT02226003|Ertugliflozin|ertugliflozin|mesh-list
111146430|NCT02226003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111146431|NCT02226003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111146432|NCT02226003|Incretins|incretins|mesh-ancestor
111146433|NCT02226003|Hormones|hormones|mesh-ancestor
111146434|NCT02226003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111146435|NCT02226003|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111146436|NCT02226003|Protease Inhibitors|protease inhibitors|mesh-ancestor
111146437|NCT02226003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111146438|NCT02226003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111146439|NCT02226003|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111146440|NCT02226003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111146441|NCT02226003|Immunologic Factors|immunologic factors|mesh-ancestor
111146442|NCT02226003|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111146443|NCT02469519|Dexamethasone|dexamethasone|mesh-list
111146444|NCT02469519|Betamethasone|betamethasone|mesh-list
111146445|NCT02469519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111146446|NCT02469519|Antiemetics|antiemetics|mesh-ancestor
111146447|NCT02469519|Autonomic Agents|autonomic agents|mesh-ancestor
111146448|NCT02469519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111146449|NCT02469519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111146450|NCT02469519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111146451|NCT02469519|Glucocorticoids|glucocorticoids|mesh-ancestor
111146452|NCT02469519|Hormones|hormones|mesh-ancestor
111146453|NCT02469519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111146454|NCT02469519|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111146455|NCT02469519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111146456|NCT02469519|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111146457|NCT02469519|Respiratory System Agents|respiratory system agents|mesh-ancestor
111146458|NCT01634139|Tiotropium Bromide|tiotropium bromide|mesh-list
111146459|NCT01634139|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111146460|NCT01634139|Autonomic Agents|autonomic agents|mesh-ancestor
111146461|NCT01634139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111146462|NCT01634139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111146463|NCT01634139|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111146464|NCT01634139|Respiratory System Agents|respiratory system agents|mesh-ancestor
111146465|NCT01634139|Parasympatholytics|parasympatholytics|mesh-ancestor
111146466|NCT01634139|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111146467|NCT01634139|Cholinergic Agents|cholinergic agents|mesh-ancestor
111146468|NCT01634139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111146469|NCT01634139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111146470|NCT02404441|Spartalizumab|spartalizumab|mesh-list
110483029|NCT01017029|Everolimus|everolimus|mesh-list
111146471|NCT02404441|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111146472|NCT02404441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111146473|NCT02404441|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111146474|NCT02404441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111146475|NCT02101281|Mitogens|mitogens|mesh-list
111146476|NCT02101281|Mitosis Modulators|mitosis modulators|mesh-ancestor
111146477|NCT02101281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111146478|NCT02224599|Cyclophosphamide|cyclophosphamide|mesh-list
111146479|NCT02224599|Imiquimod|imiquimod|mesh-list
111146480|NCT02224599|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111146481|NCT02224599|Immunologic Factors|immunologic factors|mesh-ancestor
111146482|NCT02224599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111146483|NCT02224599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111146484|NCT02224599|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111146485|NCT02224599|Alkylating Agents|alkylating agents|mesh-ancestor
111146486|NCT02224599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111146487|NCT02224599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111146488|NCT02224599|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111146489|NCT02224599|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111146490|NCT02224599|Interferon Inducers|interferon inducers|mesh-ancestor
111146491|NCT04763577|Bradykinin|bradykinin|mesh-list
111146492|NCT04763577|Kininogens|kininogens|mesh-list
111146493|NCT04763577|Vasodilator Agents|vasodilator agents|mesh-ancestor
111146494|NCT04763577|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
111146495|NCT04763577|Protease Inhibitors|protease inhibitors|mesh-ancestor
111146496|NCT04763577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111146497|NCT04763577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111146498|NCT02201901|Sofosbuvir|sofosbuvir|mesh-list
111146499|NCT02201901|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
111146500|NCT02201901|Velpatasvir|velpatasvir|mesh-list
111146501|NCT02201901|Antiviral Agents|antiviral agents|mesh-ancestor
111146502|NCT02201901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111146503|NCT02224053|Osimertinib|osimertinib|mesh-list
111146504|NCT02224053|Omeprazole|omeprazole|mesh-list
111146505|NCT02224053|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111146506|NCT02224053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111146507|NCT02224053|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111146508|NCT02224053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111146509|NCT02224053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111146510|NCT02224053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111146511|NCT02224053|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111146512|NCT04762875|Plerixafor|plerixafor|mesh-list
111146513|NCT04762875|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111146514|NCT04762875|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111146515|NCT04762875|Antiviral Agents|antiviral agents|mesh-ancestor
111146516|NCT04762875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111146517|NCT04774107|Ribavirin|ribavirin|mesh-list
111146518|NCT04774107|Antimetabolites|antimetabolites|mesh-ancestor
111146519|NCT04774107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111146520|NCT04774107|Antiviral Agents|antiviral agents|mesh-ancestor
111146521|NCT04774107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111146522|NCT02457793|Ravoxertinib|ravoxertinib|mesh-list
111146523|NCT02457793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111146524|NCT02457793|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111146525|NCT02457793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111146526|NCT02457793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111146527|NCT02434939|Ketamine|ketamine|mesh-list
111146528|NCT02434939|Morphine|morphine|mesh-list
111146529|NCT02434939|Analgesics|analgesics|mesh-ancestor
111146530|NCT02434939|Sensory System Agents|sensory system agents|mesh-ancestor
111146531|NCT02434939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111146532|NCT02434939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110483043|NCT00714649|Cetuximab|cetuximab|mesh-list
111146533|NCT02434939|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111146534|NCT02434939|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111146535|NCT02434939|Anesthetics, General|anesthetics, general|mesh-ancestor
111146536|NCT02434939|Anesthetics|anesthetics|mesh-ancestor
110840037|NCT03321006|Analgesics|analgesics|mesh-ancestor
111146537|NCT02434939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111146538|NCT02434939|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111146539|NCT02434939|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111146540|NCT02434939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111146541|NCT02434939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111146542|NCT02434939|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111146543|NCT02434939|Narcotics|narcotics|mesh-ancestor
111146544|NCT02457325|Carticaine|carticaine|mesh-list
111146545|NCT02457325|Anesthetics, Local|anesthetics, local|mesh-ancestor
111146546|NCT02457325|Anesthetics|anesthetics|mesh-ancestor
111146547|NCT02457325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111146548|NCT02457325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111146549|NCT02457325|Sensory System Agents|sensory system agents|mesh-ancestor
111146550|NCT02457325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111146551|NCT02434081|Nivolumab|nivolumab|mesh-list
111146552|NCT02434081|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111146553|NCT02434081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111146554|NCT02434081|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111146555|NCT02434081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111146556|NCT02222493|Infliximab|infliximab|mesh-list
111146557|NCT02222493|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111146558|NCT02222493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111146559|NCT02222493|Dermatologic Agents|dermatologic agents|mesh-ancestor
111146560|NCT02222493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111146561|NCT02222493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111146562|NCT01439997|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
111146563|NCT01439997|Hemostatics|hemostatics|mesh-ancestor
111146564|NCT01439997|Coagulants|coagulants|mesh-ancestor
111146565|NCT01439997|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
111146566|NCT01439997|Natriuretic Agents|natriuretic agents|mesh-ancestor
111146567|NCT01439997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111146568|NCT02403271|Durvalumab|durvalumab|mesh-list
111146569|NCT02403271|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111146570|NCT02403271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111146571|NCT02219685|Sofosbuvir|sofosbuvir|mesh-list
111146572|NCT02219685|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
111146573|NCT02219685|Ledipasvir|ledipasvir|mesh-list
111146574|NCT02219685|Antiviral Agents|antiviral agents|mesh-ancestor
111146575|NCT02219685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111146577|NCT02457247|Antacids|antacids|mesh-ancestor
111146578|NCT02457247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111146579|NCT02457247|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111146580|NCT04929535|Hydrogen Peroxide|hydrogen peroxide|mesh-list
111146581|NCT04929535|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111146582|NCT04929535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111146583|NCT02198235|Dexamethasone|dexamethasone|mesh-list
111146584|NCT02198235|Buprenorphine|buprenorphine|mesh-list
111146585|NCT02198235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111146586|NCT02198235|Antiemetics|antiemetics|mesh-ancestor
111146587|NCT02198235|Autonomic Agents|autonomic agents|mesh-ancestor
111146588|NCT02198235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111146589|NCT02198235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111146590|NCT02198235|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111146591|NCT02198235|Glucocorticoids|glucocorticoids|mesh-ancestor
111146592|NCT02198235|Hormones|hormones|mesh-ancestor
111146593|NCT02198235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111146594|NCT02198235|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111146595|NCT02198235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111146596|NCT02198235|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111146597|NCT02198235|Narcotics|narcotics|mesh-ancestor
111146598|NCT02198235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111146599|NCT02198235|Analgesics|analgesics|mesh-ancestor
111146600|NCT02198235|Sensory System Agents|sensory system agents|mesh-ancestor
111146601|NCT02198235|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111146602|NCT00346125|Doxorubicin|doxorubicin|mesh-list
111146603|NCT00346125|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111146604|NCT00346125|Ifosfamide|ifosfamide|mesh-list
111146605|NCT00346125|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
111146606|NCT00346125|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111146607|NCT00346125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110557649|NCT04660097|Durvalumab|durvalumab|mesh-list
111146608|NCT00346125|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111146609|NCT00346125|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111146610|NCT00346125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111146611|NCT00346125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111146612|NCT00346125|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111146613|NCT00346125|Alkylating Agents|alkylating agents|mesh-ancestor
111146614|NCT00346125|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111146615|NCT02217501|Aspirin|aspirin|mesh-list
111146616|NCT02217501|Clopidogrel|clopidogrel|mesh-list
111146617|NCT02217501|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111146618|NCT02217501|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111146619|NCT02217501|Analgesics|analgesics|mesh-ancestor
111146620|NCT02217501|Sensory System Agents|sensory system agents|mesh-ancestor
111146621|NCT02217501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111146622|NCT02217501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111146623|NCT02217501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111146624|NCT02217501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111146625|NCT02217501|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111146626|NCT02217501|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111146627|NCT02217501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111146628|NCT02217501|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111146629|NCT02217501|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111146630|NCT02217501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111146631|NCT02217501|Antipyretics|antipyretics|mesh-ancestor
111146632|NCT02217501|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111146633|NCT02217501|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111146634|NCT02217501|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111146635|NCT02217501|Purinergic Agents|purinergic agents|mesh-ancestor
111146636|NCT02217501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111146637|NCT01649869|Valganciclovir|valganciclovir|mesh-list
111146638|NCT01649869|Antiviral Agents|antiviral agents|mesh-ancestor
111146639|NCT01649869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111146640|NCT02197377|Chlorhexidine|chlorhexidine|mesh-list
111146641|NCT02197377|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111146642|NCT02197377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111146643|NCT02197377|Disinfectants|disinfectants|mesh-ancestor
111146644|NCT02399449|Ferric gluconate|ferric gluconate|mesh-list
111146645|NCT02399449|Ferric Compounds|ferric compounds|mesh-list
111146646|NCT02399449|Hematinics|hematinics|mesh-ancestor
111146647|NCT02217345|Hormones|hormones|mesh-list
111146648|NCT02217345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111146649|NCT02217345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111146650|NCT02428855|Dasatinib|dasatinib|mesh-list
111146651|NCT02428855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111146652|NCT02428855|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111146653|NCT02428855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111146654|NCT02428855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111146656|NCT02428699|Liver Extracts|liver extracts|mesh-list
111146657|NCT02428699|Hematinics|hematinics|mesh-ancestor
111146658|NCT02428699|Vitamins|vitamins|mesh-ancestor
111146659|NCT02428699|Micronutrients|micronutrients|mesh-ancestor
111146660|NCT02428699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111146661|NCT02428231|Dimethyl Fumarate|dimethyl fumarate|mesh-list
111146662|NCT02428231|Dermatologic Agents|dermatologic agents|mesh-ancestor
111146663|NCT02428231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111146664|NCT02428231|Immunologic Factors|immunologic factors|mesh-ancestor
111146665|NCT02428231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111146666|NCT02397889|Midazolam|midazolam|mesh-list
111146667|NCT02397889|Ketamine|ketamine|mesh-list
111146668|NCT02397889|Analgesics|analgesics|mesh-ancestor
111146669|NCT02397889|Sensory System Agents|sensory system agents|mesh-ancestor
111146670|NCT02397889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111146671|NCT02397889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111146672|NCT02397889|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111146673|NCT02397889|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111146674|NCT02397889|Anesthetics, General|anesthetics, general|mesh-ancestor
111146675|NCT02397889|Anesthetics|anesthetics|mesh-ancestor
111146676|NCT02397889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111146677|NCT02397889|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111146678|NCT02397889|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111146679|NCT02397889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111146680|NCT02397889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111146681|NCT02397889|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111146682|NCT02397889|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111146683|NCT02397889|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111146684|NCT02397889|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111146685|NCT02397889|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111146686|NCT02397889|GABA Modulators|gaba modulators|mesh-ancestor
111146687|NCT02397889|GABA Agents|gaba agents|mesh-ancestor
111146688|NCT02396953|Lanreotide|lanreotide|mesh-list
111146689|NCT02396953|Somatostatin|somatostatin|mesh-list
111146690|NCT02396953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111146691|NCT02396953|Hormones|hormones|mesh-ancestor
111146692|NCT02396953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111146693|NCT02396953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111146694|NCT02387983|Posaconazole|posaconazole|mesh-list
111146695|NCT02387983|Antifungal Agents|antifungal agents|mesh-ancestor
111146696|NCT02387983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111146697|NCT02387983|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
111146698|NCT02387983|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111146699|NCT02387983|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111146700|NCT02387983|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111146701|NCT02387983|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111146702|NCT02387983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111146703|NCT02387983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111146704|NCT02387983|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111146705|NCT02387983|Hormone Antagonists|hormone antagonists|mesh-ancestor
111146706|NCT02387983|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111146707|NCT02387983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111146708|NCT02395627|Tamoxifen|tamoxifen|mesh-list
111146709|NCT02395627|Pembrolizumab|pembrolizumab|mesh-list
111146710|NCT02395627|Vorinostat|vorinostat|mesh-list
111146711|NCT02395627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111146712|NCT02395627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111146713|NCT02395627|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111146714|NCT02395627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111146715|NCT02395627|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111146716|NCT02395627|Hormone Antagonists|hormone antagonists|mesh-ancestor
111146717|NCT02395627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111146718|NCT02395627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111146719|NCT02395627|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111146720|NCT02395627|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111146721|NCT02395627|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111146722|NCT02395627|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111146723|NCT02395627|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111146724|NCT02395627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111146725|NCT02395081|Vitamin D|vitamin d|mesh-list
111146726|NCT02395081|Ergocalciferols|ergocalciferols|mesh-list
111146727|NCT02395081|Cholecalciferol|cholecalciferol|mesh-list
111146728|NCT02395081|Vitamins|vitamins|mesh-list
111146729|NCT02395081|Micronutrients|micronutrients|mesh-ancestor
111146730|NCT02395081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110483072|NCT00710437|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111146731|NCT02395081|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111146732|NCT02395081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111146733|NCT02425111|Vedolizumab|vedolizumab|mesh-list
111146734|NCT02425111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111146735|NCT02393755|Capecitabine|capecitabine|mesh-list
111146736|NCT02393755|Nintedanib|nintedanib|mesh-list
111146737|NCT02393755|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
111146738|NCT02393755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111146739|NCT02393755|Antimetabolites|antimetabolites|mesh-ancestor
111146740|NCT02393755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111146741|NCT02393755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111146742|NCT02393755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111146743|NCT02393755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111146744|NCT02393209|Docetaxel|docetaxel|mesh-list
111146745|NCT02393209|Serabelisib|serabelisib|mesh-list
111146746|NCT02393209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111146747|NCT02393209|Tubulin Modulators|tubulin modulators|mesh-ancestor
111146748|NCT02393209|Antimitotic Agents|antimitotic agents|mesh-ancestor
111146749|NCT02393209|Mitosis Modulators|mitosis modulators|mesh-ancestor
111146750|NCT02393209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111146751|NCT02393209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111146752|NCT02424097|Listerine|listerine|mesh-list
111146753|NCT02424097|Fluorides|fluorides|mesh-list
111146754|NCT02424097|Sodium Fluoride|sodium fluoride|mesh-list
111146755|NCT02424097|Fluorides, Topical|fluorides, topical|mesh-list
111146756|NCT02424097|Cariostatic Agents|cariostatic agents|mesh-ancestor
111146757|NCT02424097|Protective Agents|protective agents|mesh-ancestor
111146758|NCT02424097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111146759|NCT02424097|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111146760|NCT02424097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111146761|NCT02392507|Paclitaxel|paclitaxel|mesh-list
111146762|NCT02392507|Carboplatin|carboplatin|mesh-list
111146763|NCT02392507|Necitumumab|necitumumab|mesh-list
111146764|NCT02392507|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111146765|NCT02392507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111146766|NCT02392507|Tubulin Modulators|tubulin modulators|mesh-ancestor
111146767|NCT02392507|Antimitotic Agents|antimitotic agents|mesh-ancestor
111146768|NCT02392507|Mitosis Modulators|mitosis modulators|mesh-ancestor
111146769|NCT02392507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111146770|NCT02392507|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111146771|NCT04904341|Cerebrolysin|cerebrolysin|mesh-list
111146772|NCT04904341|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111146773|NCT04904341|Protective Agents|protective agents|mesh-ancestor
111146774|NCT04904341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111146775|NCT04904341|Nootropic Agents|nootropic agents|mesh-ancestor
111146776|NCT02385799|Sertraline|sertraline|mesh-list
111146777|NCT02385799|Antidepressive Agents|antidepressive agents|mesh-ancestor
111146778|NCT02385799|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111146779|NCT02385799|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111146780|NCT02385799|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111146781|NCT02385799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111146782|NCT02385799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111146783|NCT02385799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111146784|NCT02385799|Serotonin Agents|serotonin agents|mesh-ancestor
111146785|NCT02385799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111146786|NCT02422303|Ketamine|ketamine|mesh-list
111146787|NCT02422303|Analgesics|analgesics|mesh-ancestor
111146788|NCT02422303|Sensory System Agents|sensory system agents|mesh-ancestor
111146789|NCT02422303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111146790|NCT02422303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111146791|NCT02422303|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111146792|NCT02422303|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111146793|NCT02422303|Anesthetics, General|anesthetics, general|mesh-ancestor
111146794|NCT02422303|Anesthetics|anesthetics|mesh-ancestor
111146795|NCT02422303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111146796|NCT02422303|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111146797|NCT02422303|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111146798|NCT02422303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111146799|NCT02422303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111146800|NCT02391961|4-Aminopyridine|4-aminopyridine|mesh-list
111146801|NCT02391961|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
111146802|NCT02391961|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111146803|NCT02391961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111146804|NCT02384941|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
110576796|NCT02610062|AGS67E|ags67e|mesh-list
111146805|NCT02384941|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111146806|NCT02384941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111146807|NCT02384941|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111146808|NCT02384941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111146810|NCT02384395|Abacavir|abacavir|mesh-list
111146811|NCT02384395|Dolutegravir|dolutegravir|mesh-list
111146812|NCT02384395|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111146813|NCT02384395|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111146814|NCT02384395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111146815|NCT02384395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111146816|NCT02384395|Antiviral Agents|antiviral agents|mesh-ancestor
111146817|NCT02384395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111146818|NCT02384395|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111146819|NCT02384395|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111146820|NCT02384395|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111146821|NCT02384395|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111146822|NCT02391337|Digoxin|digoxin|mesh-list
111146823|NCT02391337|Bisoprolol|bisoprolol|mesh-list
111146824|NCT02391337|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111146825|NCT02391337|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111146826|NCT02391337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111146827|NCT02391337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111146828|NCT02391337|Protective Agents|protective agents|mesh-ancestor
111146829|NCT02391337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111146830|NCT02391337|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111146831|NCT02391337|Sympatholytics|sympatholytics|mesh-ancestor
111146832|NCT02391337|Autonomic Agents|autonomic agents|mesh-ancestor
111146833|NCT02391337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111146834|NCT02391337|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
111146835|NCT02391337|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111146836|NCT02391337|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111146837|NCT02391337|Adrenergic Agents|adrenergic agents|mesh-ancestor
111146838|NCT02391337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111146839|NCT01649791|Lenalidomide|lenalidomide|mesh-list
111146840|NCT01649791|Immunologic Factors|immunologic factors|mesh-ancestor
111146841|NCT01649791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111146842|NCT01649791|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111146843|NCT01649791|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111146844|NCT01649791|Growth Substances|growth substances|mesh-ancestor
111146845|NCT01649791|Growth Inhibitors|growth inhibitors|mesh-ancestor
111146846|NCT01649791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111146847|NCT02347657|Ivacaftor|ivacaftor|mesh-list
111146848|NCT02347657|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
111146849|NCT02347657|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111146850|NCT02347657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111146851|NCT02346721|Sofosbuvir|sofosbuvir|mesh-list
111146852|NCT02346721|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
111146853|NCT02346721|Velpatasvir|velpatasvir|mesh-list
111146854|NCT02346721|Antiviral Agents|antiviral agents|mesh-ancestor
111146855|NCT02346721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111146856|NCT02388997|Omalizumab|omalizumab|mesh-list
111146857|NCT02388997|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111146858|NCT02388997|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111146859|NCT02388997|Respiratory System Agents|respiratory system agents|mesh-ancestor
111146860|NCT02345161|Budesonide|budesonide|mesh-list
111146861|NCT02345161|Albuterol|albuterol|mesh-list
111146862|NCT02345161|Formoterol Fumarate|formoterol fumarate|mesh-list
111146863|NCT02345161|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
111146864|NCT02345161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111146865|NCT02345161|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111146866|NCT02345161|Autonomic Agents|autonomic agents|mesh-ancestor
111146867|NCT02345161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111146868|NCT02345161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111146869|NCT02345161|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111146870|NCT02345161|Respiratory System Agents|respiratory system agents|mesh-ancestor
111146871|NCT02345161|Glucocorticoids|glucocorticoids|mesh-ancestor
111146872|NCT02345161|Hormones|hormones|mesh-ancestor
111146873|NCT02345161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111146874|NCT02345161|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111146875|NCT02345161|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111146876|NCT02345161|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111146877|NCT02345161|Adrenergic Agents|adrenergic agents|mesh-ancestor
111146878|NCT02345161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111146879|NCT02345161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111146880|NCT02345161|Tocolytic Agents|tocolytic agents|mesh-ancestor
111146881|NCT02345161|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111146882|NCT02251275|Tolvaptan|tolvaptan|mesh-list
111146883|NCT02251275|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
111146884|NCT02251275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111146885|NCT02251275|Natriuretic Agents|natriuretic agents|mesh-ancestor
111146886|NCT02251275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111146887|NCT02379637|Acetylcysteine|acetylcysteine|mesh-list
111146888|NCT02379637|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111146889|NCT02379637|Antiviral Agents|antiviral agents|mesh-ancestor
111146890|NCT02379637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111146891|NCT02379637|Expectorants|expectorants|mesh-ancestor
111146892|NCT02379637|Respiratory System Agents|respiratory system agents|mesh-ancestor
111146893|NCT02379637|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111146894|NCT02379637|Antioxidants|antioxidants|mesh-ancestor
111146895|NCT02379637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111146896|NCT02379637|Protective Agents|protective agents|mesh-ancestor
111146897|NCT02379637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111146898|NCT02379637|Antidotes|antidotes|mesh-ancestor
111146899|NCT02195583|Zinc|zinc|mesh-list
111146900|NCT02195583|Listerine|listerine|mesh-list
111146901|NCT02195583|Fluorides|fluorides|mesh-list
111146902|NCT02195583|Sodium Fluoride|sodium fluoride|mesh-list
111146903|NCT02195583|Cariostatic Agents|cariostatic agents|mesh-ancestor
111146904|NCT02195583|Protective Agents|protective agents|mesh-ancestor
111146905|NCT02195583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111146906|NCT02195583|Trace Elements|trace elements|mesh-ancestor
111146907|NCT02195583|Micronutrients|micronutrients|mesh-ancestor
111146908|NCT02195583|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111146909|NCT02195583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111146910|NCT02379091|Leucovorin|leucovorin|mesh-list
111146911|NCT02379091|Folic Acid|folic acid|mesh-list
111146912|NCT02379091|Methotrexate|methotrexate|mesh-list
111146913|NCT02379091|Levoleucovorin|levoleucovorin|mesh-list
111146914|NCT02379091|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111146915|NCT02379091|Abortifacient Agents|abortifacient agents|mesh-ancestor
111146916|NCT02379091|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111146917|NCT02379091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111146918|NCT02379091|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111146919|NCT02379091|Antimetabolites|antimetabolites|mesh-ancestor
111146920|NCT02379091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111146921|NCT02379091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111146922|NCT02379091|Dermatologic Agents|dermatologic agents|mesh-ancestor
111146923|NCT02379091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111146924|NCT02379091|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111146925|NCT02379091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111146926|NCT02379091|Immunologic Factors|immunologic factors|mesh-ancestor
111146927|NCT02379091|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111146928|NCT02379091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111146929|NCT02379091|Antidotes|antidotes|mesh-ancestor
111146930|NCT02379091|Protective Agents|protective agents|mesh-ancestor
111146931|NCT02379091|Vitamin B Complex|vitamin b complex|mesh-ancestor
111146932|NCT02379091|Vitamins|vitamins|mesh-ancestor
111146933|NCT02379091|Micronutrients|micronutrients|mesh-ancestor
111146934|NCT02379091|Hematinics|hematinics|mesh-ancestor
111146935|NCT02378935|Sofosbuvir|sofosbuvir|mesh-list
111146936|NCT02378935|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
111146937|NCT02378935|Velpatasvir|velpatasvir|mesh-list
111146938|NCT02378935|Antiviral Agents|antiviral agents|mesh-ancestor
111146939|NCT02378935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111146940|NCT02250651|Timolol|timolol|mesh-list
111146941|NCT02250651|Bimatoprost|bimatoprost|mesh-list
111146942|NCT02250651|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110840095|NCT03396250|Anesthetics|anesthetics|mesh-ancestor
111146943|NCT02250651|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111146944|NCT02250651|Adrenergic Agents|adrenergic agents|mesh-ancestor
111146945|NCT02250651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111146946|NCT02250651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111146947|NCT02250651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111146948|NCT02250651|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111146949|NCT02250651|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111146950|NCT02214225|Vaccines|vaccines|mesh-list
111146951|NCT02214225|Immunologic Factors|immunologic factors|mesh-ancestor
111146952|NCT02214225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111146954|NCT02249949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111146955|NCT02249091|Cytarabine|cytarabine|mesh-list
111146956|NCT02249091|Idarubicin|idarubicin|mesh-list
111146957|NCT02249091|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111146958|NCT02249091|Antimetabolites|antimetabolites|mesh-ancestor
111146959|NCT02249091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111146960|NCT02249091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111146961|NCT02249091|Antiviral Agents|antiviral agents|mesh-ancestor
111146962|NCT02249091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111146963|NCT02249091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111146964|NCT02249091|Immunologic Factors|immunologic factors|mesh-ancestor
111146965|NCT02249091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111146966|NCT02249091|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111146967|NCT02249091|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111146968|NCT02249091|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111146969|NCT02249091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111146970|NCT02213055|Permethrin|permethrin|mesh-list
111146971|NCT02213055|Malathion|malathion|mesh-list
111146972|NCT02213055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111146973|NCT02213055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111146974|NCT02213055|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111146975|NCT02213055|Cholinergic Agents|cholinergic agents|mesh-ancestor
111146976|NCT02213055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111146977|NCT02213055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111146978|NCT02309515|Lenalidomide|lenalidomide|mesh-list
111146979|NCT02309515|Vaccines|vaccines|mesh-list
111146980|NCT02309515|Immunologic Factors|immunologic factors|mesh-ancestor
111146981|NCT02309515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111146982|NCT02309515|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111146983|NCT02309515|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111146984|NCT02309515|Growth Substances|growth substances|mesh-ancestor
111146985|NCT02309515|Growth Inhibitors|growth inhibitors|mesh-ancestor
111146986|NCT02309515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111146987|NCT02309359|Methotrexate|methotrexate|mesh-list
111146988|NCT02309359|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111146989|NCT02309359|Abortifacient Agents|abortifacient agents|mesh-ancestor
111146990|NCT02309359|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111146991|NCT02309359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111146992|NCT02309359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111146993|NCT02309359|Antimetabolites|antimetabolites|mesh-ancestor
111146994|NCT02309359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111146995|NCT02309359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111146996|NCT02309359|Dermatologic Agents|dermatologic agents|mesh-ancestor
111146997|NCT02309359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111146998|NCT02309359|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111146999|NCT02309359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111147000|NCT02309359|Immunologic Factors|immunologic factors|mesh-ancestor
111147001|NCT02309359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111147002|NCT02309359|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111147003|NCT02375971|Ranibizumab|ranibizumab|mesh-list
111147004|NCT02375971|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111147005|NCT02375971|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111147006|NCT02375971|Growth Substances|growth substances|mesh-ancestor
111147007|NCT02375971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111147008|NCT02375971|Growth Inhibitors|growth inhibitors|mesh-ancestor
111147009|NCT02375971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111147010|NCT04886323|Itraconazole|itraconazole|mesh-list
111147011|NCT04886323|Antifungal Agents|antifungal agents|mesh-ancestor
111147012|NCT04886323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111147013|NCT04886323|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111147014|NCT04886323|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111147015|NCT04886323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111147016|NCT04886323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111147017|NCT04886323|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111147018|NCT04886323|Hormone Antagonists|hormone antagonists|mesh-ancestor
111147019|NCT04886323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111147020|NCT04886323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111147021|NCT04886323|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111147022|NCT02212197|Leuprolide|leuprolide|mesh-list
111147023|NCT02212197|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111147024|NCT02212197|Fertility Agents|fertility agents|mesh-ancestor
111147025|NCT02212197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111147026|NCT02212197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111147027|NCT02212197|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111147028|NCT02212197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111147029|NCT02193165|Triclosan|triclosan|mesh-list
111147030|NCT02193165|Cetylpyridinium|cetylpyridinium|mesh-list
111147031|NCT02193165|Fluorides|fluorides|mesh-list
111147032|NCT02193165|Tin Fluorides|tin fluorides|mesh-list
111147033|NCT02193165|Cariostatic Agents|cariostatic agents|mesh-ancestor
111147034|NCT02193165|Protective Agents|protective agents|mesh-ancestor
111147035|NCT02193165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111147036|NCT02193165|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111147037|NCT02193165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111147038|NCT02193165|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
111147039|NCT02193165|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111147040|NCT02193165|Antimetabolites|antimetabolites|mesh-ancestor
111147041|NCT02193165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111147042|NCT02193165|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111147043|NCT01617460|Aripiprazole|aripiprazole|mesh-list
111147044|NCT01617460|Antidepressive Agents|antidepressive agents|mesh-ancestor
111147045|NCT01617460|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111147046|NCT01617460|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111147047|NCT01617460|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111147048|NCT01617460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111147049|NCT01617460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111147050|NCT01617460|Dopamine Agonists|dopamine agonists|mesh-ancestor
111147051|NCT01617460|Dopamine Agents|dopamine agents|mesh-ancestor
111147052|NCT01617460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111147053|NCT01617460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111147054|NCT01617460|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111147055|NCT01617460|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111147056|NCT01617460|Serotonin Agents|serotonin agents|mesh-ancestor
111147057|NCT01617460|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111147058|NCT01617460|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111147059|NCT01617460|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111147060|NCT01617460|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111147061|NCT01889602|Topiramate|topiramate|mesh-list
111147062|NCT01889602|Lorazepam|lorazepam|mesh-list
111147063|NCT01889602|Anticonvulsants|anticonvulsants|mesh-ancestor
111147064|NCT01889602|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111147065|NCT01889602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111147066|NCT01889602|Antiemetics|antiemetics|mesh-ancestor
111147067|NCT01889602|Autonomic Agents|autonomic agents|mesh-ancestor
111147068|NCT01889602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111147069|NCT01889602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111147070|NCT01889602|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111147071|NCT01889602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111147072|NCT01889602|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111147073|NCT01889602|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111147074|NCT01889602|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111147075|NCT01889602|GABA Modulators|gaba modulators|mesh-ancestor
111147076|NCT01889602|GABA Agents|gaba agents|mesh-ancestor
111147077|NCT01889602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111147078|NCT01889602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111147079|NCT01935700|Colchicine|colchicine|mesh-list
111147080|NCT01935700|Gout Suppressants|gout suppressants|mesh-ancestor
111147081|NCT01935700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111147082|NCT01935700|Tubulin Modulators|tubulin modulators|mesh-ancestor
111147083|NCT01935700|Antimitotic Agents|antimitotic agents|mesh-ancestor
111147084|NCT01935700|Mitosis Modulators|mitosis modulators|mesh-ancestor
111147085|NCT01935700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111147086|NCT01935700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111147087|NCT01618162|Liraglutide|liraglutide|mesh-list
111147088|NCT01618162|Xultophy|xultophy|mesh-list
111147089|NCT01618162|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111147090|NCT01618162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111147091|NCT01618162|Incretins|incretins|mesh-ancestor
111147092|NCT01618162|Hormones|hormones|mesh-ancestor
111147093|NCT01618162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111147094|NCT04771767|Ketamine|ketamine|mesh-list
111147095|NCT04771767|Analgesics|analgesics|mesh-ancestor
111147096|NCT04771767|Sensory System Agents|sensory system agents|mesh-ancestor
111147097|NCT04771767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111147098|NCT04771767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111147099|NCT04771767|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111147100|NCT04771767|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111147101|NCT04771767|Anesthetics, General|anesthetics, general|mesh-ancestor
111147102|NCT04771767|Anesthetics|anesthetics|mesh-ancestor
111147103|NCT04771767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111147104|NCT04771767|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111147106|NCT04771767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111147107|NCT04771767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111147108|NCT02341417|Cinacalcet|cinacalcet|mesh-list
111147109|NCT02341417|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111147110|NCT02341417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111147111|NCT02341417|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
111147112|NCT02341417|Hormone Antagonists|hormone antagonists|mesh-ancestor
111147113|NCT02341417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111147114|NCT02340949|Leucovorin|leucovorin|mesh-list
111147115|NCT02340949|Oxaliplatin|oxaliplatin|mesh-list
111147116|NCT02340949|Aflibercept|aflibercept|mesh-list
111147117|NCT02340949|Fluorouracil|fluorouracil|mesh-list
111147118|NCT02340949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111147119|NCT02340949|Antidotes|antidotes|mesh-ancestor
111147120|NCT02340949|Protective Agents|protective agents|mesh-ancestor
111147121|NCT02340949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111147122|NCT02340949|Vitamin B Complex|vitamin b complex|mesh-ancestor
111147123|NCT02340949|Vitamins|vitamins|mesh-ancestor
111147124|NCT02340949|Micronutrients|micronutrients|mesh-ancestor
111147125|NCT02340949|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111147126|NCT02340949|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111147127|NCT02340949|Growth Substances|growth substances|mesh-ancestor
111147128|NCT02340949|Growth Inhibitors|growth inhibitors|mesh-ancestor
111147129|NCT02340949|Antimetabolites|antimetabolites|mesh-ancestor
111147130|NCT02340949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111147131|NCT02340949|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111147132|NCT02340949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111147133|NCT02340949|Immunologic Factors|immunologic factors|mesh-ancestor
111147134|NCT02374957|Cilostazol|cilostazol|mesh-list
111147135|NCT02374957|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111147136|NCT02374957|Autonomic Agents|autonomic agents|mesh-ancestor
111147137|NCT02374957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111147138|NCT02374957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111147139|NCT02374957|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111147140|NCT02374957|Respiratory System Agents|respiratory system agents|mesh-ancestor
111147141|NCT02374957|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111147142|NCT02374957|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111147143|NCT02374957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111147144|NCT02374957|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111147145|NCT02374957|Vasodilator Agents|vasodilator agents|mesh-ancestor
111147146|NCT02374957|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111147147|NCT02374957|Protective Agents|protective agents|mesh-ancestor
111147148|NCT02374957|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
111147149|NCT02374957|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111147150|NCT02374957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111147151|NCT02308033|Metronidazole|metronidazole|mesh-list
111147152|NCT02308033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111147153|NCT02308033|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111147154|NCT02308033|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111147155|NCT02308033|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111147156|NCT02339155|Diphenhydramine|diphenhydramine|mesh-list
111147157|NCT02339155|Promethazine|promethazine|mesh-list
111147158|NCT02339155|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111147159|NCT02339155|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111147160|NCT02339155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111147161|NCT02339155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111147162|NCT02339155|Anesthetics, Local|anesthetics, local|mesh-ancestor
111147163|NCT02339155|Anesthetics|anesthetics|mesh-ancestor
111147164|NCT02339155|Sensory System Agents|sensory system agents|mesh-ancestor
111147165|NCT02339155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111147166|NCT02339155|Antiemetics|antiemetics|mesh-ancestor
111147167|NCT02339155|Autonomic Agents|autonomic agents|mesh-ancestor
111147168|NCT02339155|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111147169|NCT02339155|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111147170|NCT02339155|Histamine Antagonists|histamine antagonists|mesh-ancestor
111147171|NCT02339155|Histamine Agents|histamine agents|mesh-ancestor
111147172|NCT02339155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111147173|NCT02339155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111147174|NCT02339155|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111147175|NCT02339155|Antipruritics|antipruritics|mesh-ancestor
111147176|NCT02339155|Dermatologic Agents|dermatologic agents|mesh-ancestor
111147177|NCT02170077|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
111147178|NCT02170077|Anticonvulsants|anticonvulsants|mesh-ancestor
111147179|NCT02170077|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111147180|NCT02170077|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111147181|NCT02170077|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111147182|NCT02170077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111147184|NCT02210091|BAX 855|bax 855|mesh-list
111147185|NCT02210091|Coagulants|coagulants|mesh-ancestor
111147186|NCT02338999|Pioglitazone|pioglitazone|mesh-list
111147187|NCT02338999|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111147188|NCT02338999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111147189|NCT02169219|Prednisone|prednisone|mesh-list
111147190|NCT02169219|Rituximab|rituximab|mesh-list
111147191|NCT02169219|Glucocorticoids|glucocorticoids|mesh-list
111147192|NCT02169219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111147193|NCT02169219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111147194|NCT02169219|Immunologic Factors|immunologic factors|mesh-ancestor
111147195|NCT02169219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111147196|NCT02169219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111147197|NCT02169219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111147198|NCT02169219|Hormones|hormones|mesh-ancestor
111147199|NCT02169219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111147200|NCT02169219|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111147201|NCT02191137|Riociguat|riociguat|mesh-list
111147202|NCT02191137|Enzyme Activators|enzyme activators|mesh-ancestor
111147203|NCT02191137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111147204|NCT02168439|Midazolam|midazolam|mesh-list
111147205|NCT02168439|Dexmedetomidine|dexmedetomidine|mesh-list
111147206|NCT02168439|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111147207|NCT02168439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111147208|NCT02168439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111147209|NCT02168439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111147210|NCT02168439|Analgesics|analgesics|mesh-ancestor
111147211|NCT02168439|Sensory System Agents|sensory system agents|mesh-ancestor
111147212|NCT02168439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111147213|NCT02168439|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111147214|NCT02168439|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111147215|NCT02168439|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111147216|NCT02168439|Adrenergic Agents|adrenergic agents|mesh-ancestor
111147217|NCT02168439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111147218|NCT02168439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111147219|NCT02168439|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111147220|NCT02168439|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111147221|NCT02168439|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111147222|NCT02168439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111147223|NCT02168439|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111147224|NCT02168439|Anesthetics, General|anesthetics, general|mesh-ancestor
111147225|NCT02168439|Anesthetics|anesthetics|mesh-ancestor
111147226|NCT02168439|GABA Modulators|gaba modulators|mesh-ancestor
111147227|NCT02168439|GABA Agents|gaba agents|mesh-ancestor
111147228|NCT02338843|Angiotensin II|angiotensin ii|mesh-list
111147229|NCT02338843|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111147230|NCT02135445|Relugolix|relugolix|mesh-list
111147231|NCT02135445|Androgen Antagonists|androgen antagonists|mesh-ancestor
111147232|NCT02135445|Hormone Antagonists|hormone antagonists|mesh-ancestor
111147233|NCT02135445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111147234|NCT02135445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111147235|NCT02374099|Azacitidine|azacitidine|mesh-list
111147236|NCT02374099|Fulvestrant|fulvestrant|mesh-list
111147237|NCT02374099|Cc-486|cc-486|mesh-list
111147238|NCT02374099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111147239|NCT02374099|Antimetabolites|antimetabolites|mesh-ancestor
111147240|NCT02374099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111147241|NCT02374099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111147242|NCT02374099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111147243|NCT02374099|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111147244|NCT02374099|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
111147245|NCT02374099|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111147246|NCT02374099|Hormone Antagonists|hormone antagonists|mesh-ancestor
111147247|NCT02374099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111147248|NCT02374099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111147249|NCT02134977|Leuprolide|leuprolide|mesh-list
111147250|NCT02134977|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111147251|NCT02134977|Fertility Agents|fertility agents|mesh-ancestor
111147252|NCT02134977|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111147253|NCT02134977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111147254|NCT02134977|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111147255|NCT02134977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111147256|NCT02374021|Hydroxychloroquine|hydroxychloroquine|mesh-list
111147258|NCT02374021|Adalimumab|adalimumab|mesh-list
111147259|NCT02374021|Etanercept|etanercept|mesh-list
111147260|NCT02374021|Methotrexate|methotrexate|mesh-list
111147261|NCT02374021|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111147262|NCT02374021|Abortifacient Agents|abortifacient agents|mesh-ancestor
111147263|NCT02374021|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111147264|NCT02374021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111147265|NCT02374021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111147266|NCT02374021|Antimetabolites|antimetabolites|mesh-ancestor
110483216|NCT00714961|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111147267|NCT02374021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111147268|NCT02374021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111147269|NCT02374021|Dermatologic Agents|dermatologic agents|mesh-ancestor
111147270|NCT02374021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111147271|NCT02374021|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111147272|NCT02374021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111147273|NCT02374021|Immunologic Factors|immunologic factors|mesh-ancestor
111147274|NCT02374021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111147275|NCT02374021|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111147276|NCT02374021|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111147277|NCT02374021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111147278|NCT02374021|Antimalarials|antimalarials|mesh-ancestor
111147279|NCT02374021|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111147280|NCT02374021|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111147281|NCT02374021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111147282|NCT02374021|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111147283|NCT02374021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111147284|NCT02374021|Analgesics|analgesics|mesh-ancestor
111147285|NCT02374021|Sensory System Agents|sensory system agents|mesh-ancestor
111147286|NCT02374021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111147287|NCT02374021|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111147288|NCT02372383|Azithromycin|azithromycin|mesh-list
111147289|NCT02372383|Rifampin|rifampin|mesh-list
111147290|NCT02372383|Ethambutol|ethambutol|mesh-list
111147291|NCT02372383|Pancrelipase|pancrelipase|mesh-list
111147292|NCT02372383|Pancreatin|pancreatin|mesh-list
111147293|NCT02372383|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110840124|NCT03763669|Micronutrients|micronutrients|mesh-ancestor
111147294|NCT02372383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111147295|NCT02372383|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111147296|NCT02372383|Antitubercular Agents|antitubercular agents|mesh-ancestor
111147297|NCT02372383|Leprostatic Agents|leprostatic agents|mesh-ancestor
111147298|NCT02372383|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111147299|NCT02372383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111147300|NCT02372383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111147301|NCT02372383|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111147302|NCT02372383|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111147303|NCT02372383|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
111147304|NCT02372383|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
111147305|NCT02372383|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
111147306|NCT02372383|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111147307|NCT02372383|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111147308|NCT01648699|Hydromorphone|hydromorphone|mesh-list
111147309|NCT01648699|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111147310|NCT01648699|Narcotics|narcotics|mesh-ancestor
111147311|NCT01648699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111147312|NCT01648699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111147313|NCT01648699|Analgesics|analgesics|mesh-ancestor
111147314|NCT01648699|Sensory System Agents|sensory system agents|mesh-ancestor
111147315|NCT01648699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111147316|NCT02134353|Mannitol|mannitol|mesh-list
111147317|NCT02134353|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
111147318|NCT02134353|Diuretics|diuretics|mesh-ancestor
111147319|NCT02134353|Natriuretic Agents|natriuretic agents|mesh-ancestor
111147320|NCT02134353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111147321|NCT01646125|Docetaxel|docetaxel|mesh-list
111147322|NCT01646125|Pemetrexed|pemetrexed|mesh-list
111147323|NCT01646125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111147324|NCT01646125|Tubulin Modulators|tubulin modulators|mesh-ancestor
111147325|NCT01646125|Antimitotic Agents|antimitotic agents|mesh-ancestor
111147326|NCT01646125|Mitosis Modulators|mitosis modulators|mesh-ancestor
111147327|NCT01646125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111147328|NCT01646125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111147329|NCT01646125|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111147330|NCT01646125|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111147331|NCT01362790|Cyclophosphamide|cyclophosphamide|mesh-list
111147332|NCT01362790|Pentostatin|pentostatin|mesh-list
111147333|NCT01362790|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111147334|NCT01362790|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111147335|NCT01362790|Immunologic Factors|immunologic factors|mesh-ancestor
110483227|NCT01013753|Olodaterol|olodaterol|mesh-list
111147336|NCT01362790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111147337|NCT01362790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111147338|NCT01362790|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111147339|NCT01362790|Alkylating Agents|alkylating agents|mesh-ancestor
111147340|NCT01362790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111147341|NCT01362790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111147342|NCT01362790|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111147343|NCT01362790|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
111147344|NCT01362790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111147346|NCT02167893|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111147347|NCT02167893|Fertility Agents|fertility agents|mesh-ancestor
111147348|NCT02167893|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111147349|NCT02167893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111147350|NCT02167893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111147351|NCT02167893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111147352|NCT02167035|Brimonidine Tartrate, Timolol Maleate Drug Combination|brimonidine tartrate, timolol maleate drug combination|mesh-list
111147353|NCT02167035|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111147354|NCT02167035|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111147355|NCT02167035|Adrenergic Agents|adrenergic agents|mesh-ancestor
111147356|NCT02167035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111147357|NCT02167035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111147358|NCT02167035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111147359|NCT02167035|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111147360|NCT02167035|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111147361|NCT02167035|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111147362|NCT01615198|Olmesartan|olmesartan|mesh-list
111147363|NCT01615198|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
111147364|NCT01615198|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111147365|NCT01615198|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111147366|NCT01615198|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111147367|NCT01615198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111147368|NCT02337907|Donepezil|donepezil|mesh-list
111147369|NCT02337907|BI 409306|bi 409306|mesh-list
111147370|NCT02337907|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111147371|NCT02337907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111147372|NCT02337907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111147373|NCT02337907|Cholinergic Agents|cholinergic agents|mesh-ancestor
111147374|NCT02337907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111147375|NCT02337907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111147376|NCT02337907|Nootropic Agents|nootropic agents|mesh-ancestor
111147377|NCT02337907|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111147378|NCT01913470|Losartan|losartan|mesh-list
111147379|NCT01913470|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111147380|NCT01913470|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111147381|NCT01913470|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111147382|NCT01913470|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111147383|NCT01913470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111147384|NCT02166333|Vitamin D|vitamin d|mesh-list
111147385|NCT02166333|Ergocalciferols|ergocalciferols|mesh-list
111147386|NCT02166333|Cholecalciferol|cholecalciferol|mesh-list
111147387|NCT02166333|Vitamins|vitamins|mesh-list
111147388|NCT02166333|Micronutrients|micronutrients|mesh-ancestor
111147389|NCT02166333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111147390|NCT02166333|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111147391|NCT02166333|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111147392|NCT02132949|Paclitaxel|paclitaxel|mesh-list
111147393|NCT02132949|Docetaxel|docetaxel|mesh-list
111147394|NCT02132949|Cyclophosphamide|cyclophosphamide|mesh-list
111147395|NCT02132949|Doxorubicin|doxorubicin|mesh-list
111147396|NCT02132949|Fluorouracil|fluorouracil|mesh-list
111147397|NCT02132949|Trastuzumab|trastuzumab|mesh-list
111147398|NCT02132949|Epirubicin|epirubicin|mesh-list
111147399|NCT02132949|Pertuzumab|pertuzumab|mesh-list
111147400|NCT02132949|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111147401|NCT02132949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111147402|NCT02132949|Tubulin Modulators|tubulin modulators|mesh-ancestor
110864462|NCT03206944|Analgesics|analgesics|mesh-ancestor
111147403|NCT02132949|Antimitotic Agents|antimitotic agents|mesh-ancestor
111147404|NCT02132949|Mitosis Modulators|mitosis modulators|mesh-ancestor
111147405|NCT02132949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111147406|NCT02132949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111147407|NCT02132949|Immunologic Factors|immunologic factors|mesh-ancestor
111147408|NCT02132949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111147409|NCT02132949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111147410|NCT02132949|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111147411|NCT02132949|Alkylating Agents|alkylating agents|mesh-ancestor
111147412|NCT02132949|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111147413|NCT02132949|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111147414|NCT02132949|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111147415|NCT02132949|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111147416|NCT02132949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111147417|NCT02132949|Antimetabolites|antimetabolites|mesh-ancestor
111147418|NCT02132949|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111147419|NCT02132949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111147420|NCT02165397|Rituximab|rituximab|mesh-list
111147421|NCT02165397|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111147422|NCT02165397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111147423|NCT02165397|Immunologic Factors|immunologic factors|mesh-ancestor
111147424|NCT02165397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111147425|NCT02165397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111147426|NCT02132637|Insulin|insulin|mesh-list
111147427|NCT02132637|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111147428|NCT02132637|Insulin Glargine|insulin glargine|mesh-list
111147429|NCT02132637|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111147430|NCT02132637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111147431|NCT02164929|Acetaminophen|acetaminophen|mesh-list
111147432|NCT02164929|Dexamethasone|dexamethasone|mesh-list
111147433|NCT02164929|Lidocaine|lidocaine|mesh-list
111147434|NCT02164929|Epinephrine|epinephrine|mesh-list
111147435|NCT02164929|Midazolam|midazolam|mesh-list
111147436|NCT02164929|Hydromorphone|hydromorphone|mesh-list
111147437|NCT02164929|Ropivacaine|ropivacaine|mesh-list
111147438|NCT02164929|Propofol|propofol|mesh-list
111147439|NCT02164929|Sevoflurane|sevoflurane|mesh-list
111147440|NCT02164929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111147441|NCT02164929|Antiemetics|antiemetics|mesh-ancestor
111147442|NCT02164929|Autonomic Agents|autonomic agents|mesh-ancestor
111147443|NCT02164929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111147444|NCT02164929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111147445|NCT02164929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111147446|NCT02164929|Glucocorticoids|glucocorticoids|mesh-ancestor
111147447|NCT02164929|Hormones|hormones|mesh-ancestor
111147448|NCT02164929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111147449|NCT02164929|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111147450|NCT02164929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111147451|NCT02164929|Anesthetics, Local|anesthetics, local|mesh-ancestor
111147452|NCT02164929|Anesthetics|anesthetics|mesh-ancestor
111147453|NCT02164929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111147454|NCT02164929|Sensory System Agents|sensory system agents|mesh-ancestor
111147455|NCT02164929|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111147456|NCT02164929|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111147457|NCT02164929|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111147458|NCT02164929|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111147459|NCT02164929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111147460|NCT02164929|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111147461|NCT02164929|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111147462|NCT02164929|Anesthetics, General|anesthetics, general|mesh-ancestor
111147463|NCT02164929|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111147464|NCT02164929|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111147465|NCT02164929|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111147466|NCT02164929|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111147467|NCT02164929|GABA Modulators|gaba modulators|mesh-ancestor
111147468|NCT02164929|GABA Agents|gaba agents|mesh-ancestor
111147469|NCT02164929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111147470|NCT02164929|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111147471|NCT02164929|Analgesics|analgesics|mesh-ancestor
111147472|NCT02164929|Antipyretics|antipyretics|mesh-ancestor
111147473|NCT02164929|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111147474|NCT02164929|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111147475|NCT02164929|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111147476|NCT02164929|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111147477|NCT02164929|Adrenergic Agents|adrenergic agents|mesh-ancestor
111147478|NCT02164929|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111147479|NCT02164929|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111147481|NCT02164929|Respiratory System Agents|respiratory system agents|mesh-ancestor
111147482|NCT02164929|Mydriatics|mydriatics|mesh-ancestor
111147483|NCT02164929|Sympathomimetics|sympathomimetics|mesh-ancestor
111147484|NCT02164929|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111147485|NCT02164929|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111147486|NCT02164929|Narcotics|narcotics|mesh-ancestor
111147487|NCT01888432|Everolimus|everolimus|mesh-list
111147488|NCT01888432|Tacrolimus|tacrolimus|mesh-list
111147489|NCT01888432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111147490|NCT01888432|Immunologic Factors|immunologic factors|mesh-ancestor
111147491|NCT01888432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111147492|NCT01888432|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111147493|NCT01888432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111147494|NCT01888432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111147495|NCT01888432|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111147496|NCT01888432|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111147497|NCT01888432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111147498|NCT02188719|Acetaminophen|acetaminophen|mesh-list
111147499|NCT02188719|Diphenhydramine|diphenhydramine|mesh-list
111147500|NCT02188719|Promethazine|promethazine|mesh-list
111147501|NCT02188719|Mycophenolic Acid|mycophenolic acid|mesh-list
111147502|NCT02188719|Valganciclovir|valganciclovir|mesh-list
111147503|NCT02188719|Ganciclovir|ganciclovir|mesh-list
111147504|NCT02188719|Anti-Infective Agents|anti-infective agents|mesh-list
111147505|NCT02188719|Prednisone|prednisone|mesh-list
111147506|NCT02188719|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111147507|NCT02188719|Everolimus|everolimus|mesh-list
111147508|NCT02188719|Liver Extracts|liver extracts|mesh-list
111147509|NCT02188719|Tacrolimus|tacrolimus|mesh-list
111147510|NCT02188719|Thymoglobulin|thymoglobulin|mesh-list
111147511|NCT02188719|Antilymphocyte Serum|antilymphocyte serum|mesh-list
111147512|NCT02188719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111147513|NCT02188719|Glucocorticoids|glucocorticoids|mesh-ancestor
111147514|NCT02188719|Hormones|hormones|mesh-ancestor
111147515|NCT02188719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111147516|NCT02188719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111147517|NCT02188719|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111147518|NCT02188719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111147519|NCT02188719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111147520|NCT02188719|Immunologic Factors|immunologic factors|mesh-ancestor
111147521|NCT02188719|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111147522|NCT02188719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111147523|NCT02188719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111147524|NCT02188719|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111147525|NCT02188719|Analgesics|analgesics|mesh-ancestor
111147526|NCT02188719|Sensory System Agents|sensory system agents|mesh-ancestor
111147527|NCT02188719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111147528|NCT02188719|Antipyretics|antipyretics|mesh-ancestor
111147529|NCT02188719|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111147530|NCT02188719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111147531|NCT02188719|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111147532|NCT02188719|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111147533|NCT02188719|Antitubercular Agents|antitubercular agents|mesh-ancestor
111147534|NCT02188719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111147535|NCT02188719|Hematinics|hematinics|mesh-ancestor
111147536|NCT02188719|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111147537|NCT02188719|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111147538|NCT02188719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111147539|NCT02188719|Anesthetics, Local|anesthetics, local|mesh-ancestor
111147540|NCT02188719|Anesthetics|anesthetics|mesh-ancestor
111147541|NCT02188719|Antiemetics|antiemetics|mesh-ancestor
111147542|NCT02188719|Autonomic Agents|autonomic agents|mesh-ancestor
111147543|NCT02188719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111147544|NCT02188719|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111147545|NCT02188719|Histamine Antagonists|histamine antagonists|mesh-ancestor
111147546|NCT02188719|Histamine Agents|histamine agents|mesh-ancestor
111147547|NCT02188719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111147548|NCT02188719|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111147549|NCT02188719|Antipruritics|antipruritics|mesh-ancestor
111147550|NCT02188719|Dermatologic Agents|dermatologic agents|mesh-ancestor
111147551|NCT02188719|Antiviral Agents|antiviral agents|mesh-ancestor
111147552|NCT02188719|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111147553|NCT02188719|Protective Agents|protective agents|mesh-ancestor
111147554|NCT01933672|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111147555|NCT01933672|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111147556|NCT01933672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111147557|NCT01933672|Incretins|incretins|mesh-ancestor
111147558|NCT01933672|Hormones|hormones|mesh-ancestor
111147559|NCT01933672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111147560|NCT01933672|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111147561|NCT01933672|Protease Inhibitors|protease inhibitors|mesh-ancestor
111147562|NCT01933672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111147563|NCT01933672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111147564|NCT02132247|Diclofenac|diclofenac|mesh-list
111147565|NCT02132247|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
111147566|NCT02132247|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111147567|NCT02132247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111147568|NCT02132247|Analgesics|analgesics|mesh-ancestor
111147569|NCT02132247|Sensory System Agents|sensory system agents|mesh-ancestor
111147570|NCT02132247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111147571|NCT02132247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111147572|NCT02132247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111147573|NCT02132247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111147574|NCT02132247|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111147575|NCT02132247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111147576|NCT02132247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111147577|NCT01629381|Rivaroxaban|rivaroxaban|mesh-list
111147578|NCT01629381|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111147579|NCT01629381|Antithrombins|antithrombins|mesh-ancestor
111147580|NCT01629381|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111147581|NCT01629381|Protease Inhibitors|protease inhibitors|mesh-ancestor
111147582|NCT01629381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111147583|NCT01629381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111147584|NCT01629381|Anticoagulants|anticoagulants|mesh-ancestor
111147585|NCT05269017|Vitamin D|vitamin d|mesh-list
111147586|NCT05269017|Cholecalciferol|cholecalciferol|mesh-list
111147587|NCT05269017|Budesonide|budesonide|mesh-list
111147588|NCT05269017|Vitamins|vitamins|mesh-ancestor
111147589|NCT05269017|Micronutrients|micronutrients|mesh-ancestor
111147590|NCT05269017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111147591|NCT05269017|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111147592|NCT05269017|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111147593|NCT05269017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111147594|NCT05269017|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111147595|NCT05269017|Autonomic Agents|autonomic agents|mesh-ancestor
111147596|NCT05269017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111147597|NCT05269017|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111147598|NCT05269017|Respiratory System Agents|respiratory system agents|mesh-ancestor
111147599|NCT05269017|Glucocorticoids|glucocorticoids|mesh-ancestor
111147600|NCT05269017|Hormones|hormones|mesh-ancestor
111147601|NCT05269017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111147602|NCT01628913|Everolimus|everolimus|mesh-list
111147603|NCT01628913|Dactolisib|dactolisib|mesh-list
111147604|NCT01628913|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111147605|NCT01628913|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111147606|NCT01628913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111147607|NCT01628913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111147608|NCT01628913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111147609|NCT01628913|Immunologic Factors|immunologic factors|mesh-ancestor
111147610|NCT01628913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111147611|NCT01628913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111147612|NCT02164383|Nicotine|nicotine|mesh-list
111147613|NCT02164383|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111147614|NCT02164383|Autonomic Agents|autonomic agents|mesh-ancestor
111147615|NCT02164383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111147616|NCT02164383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111147617|NCT02164383|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111147618|NCT02164383|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111147619|NCT02164383|Cholinergic Agents|cholinergic agents|mesh-ancestor
111147620|NCT02164383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111147621|NCT02164383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111147622|NCT02131233|Raltegravir Potassium|raltegravir potassium|mesh-list
111147623|NCT02131233|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
111147624|NCT02131233|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111147625|NCT02131233|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111147626|NCT02131233|Antiviral Agents|antiviral agents|mesh-ancestor
111147627|NCT02131233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111147628|NCT02131233|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111147629|NCT02131233|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111147630|NCT02131233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111147631|NCT02131233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110676992|NCT03233724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111147632|NCT02131233|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111147633|NCT02131233|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111147634|NCT02131155|Afatinib|afatinib|mesh-list
111147635|NCT02131155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111147636|NCT02131155|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111147637|NCT02131155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111147638|NCT02131155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111147639|NCT01933594|Romidepsin|romidepsin|mesh-list
111147640|NCT01933594|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111147641|NCT01933594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111147642|NCT01933594|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111147643|NCT01933594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111147644|NCT01933594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111147645|NCT01912768|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111147646|NCT02305849|Methotrexate|methotrexate|mesh-list
111147647|NCT02305849|Peficitinib|peficitinib|mesh-list
111147648|NCT02305849|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111147649|NCT02305849|Abortifacient Agents|abortifacient agents|mesh-ancestor
111147650|NCT02305849|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111147651|NCT02305849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111147652|NCT02305849|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111147653|NCT02305849|Antimetabolites|antimetabolites|mesh-ancestor
111147654|NCT02305849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111147655|NCT02305849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111147656|NCT02305849|Dermatologic Agents|dermatologic agents|mesh-ancestor
111147657|NCT02305849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111147658|NCT02305849|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111147659|NCT02305849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111147660|NCT02305849|Immunologic Factors|immunologic factors|mesh-ancestor
111147661|NCT02305849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111147662|NCT02305849|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111147663|NCT02371759|Anesthetics|anesthetics|mesh-list
111147664|NCT02371759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111147665|NCT02371759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111147666|NCT02531633|Prednisone|prednisone|mesh-list
111147667|NCT02531633|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111147668|NCT02531633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111147669|NCT02531633|Glucocorticoids|glucocorticoids|mesh-ancestor
111147670|NCT02531633|Hormones|hormones|mesh-ancestor
111147671|NCT02531633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111147672|NCT02531633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111147673|NCT02531633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111147674|NCT02531633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111147675|NCT02531633|Immunologic Factors|immunologic factors|mesh-ancestor
111147676|NCT02536313|Sofosbuvir|sofosbuvir|mesh-list
111147677|NCT02536313|Velpatasvir|velpatasvir|mesh-list
111147678|NCT02536313|Antiviral Agents|antiviral agents|mesh-ancestor
111147679|NCT02536313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111147680|NCT05412875|Nicotine|nicotine|mesh-list
111147681|NCT05412875|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111147682|NCT05412875|Autonomic Agents|autonomic agents|mesh-ancestor
111147683|NCT05412875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111147684|NCT05412875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111147685|NCT05412875|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111147686|NCT05412875|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111147687|NCT05412875|Cholinergic Agents|cholinergic agents|mesh-ancestor
111147688|NCT05412875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111147689|NCT05412875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111147690|NCT02187861|Rituximab|rituximab|mesh-list
111147691|NCT02187861|Venetoclax|venetoclax|mesh-list
111147692|NCT02187861|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
111147693|NCT02187861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111147694|NCT02187861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111147695|NCT02187861|Immunologic Factors|immunologic factors|mesh-ancestor
111147696|NCT02187861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111147697|NCT02187861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111147698|NCT02187861|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111147699|NCT02187861|Alkylating Agents|alkylating agents|mesh-ancestor
111147700|NCT02187861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111147701|NCT05379179|Fentanyl|fentanyl|mesh-list
111147702|NCT05379179|Ketamine|ketamine|mesh-list
111147703|NCT05379179|Analgesics|analgesics|mesh-ancestor
111147704|NCT05379179|Sensory System Agents|sensory system agents|mesh-ancestor
110483313|NCT00715273|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111147705|NCT05379179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111147706|NCT05379179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111147708|NCT05379179|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111147709|NCT05379179|Anesthetics, General|anesthetics, general|mesh-ancestor
111147710|NCT05379179|Anesthetics|anesthetics|mesh-ancestor
111147711|NCT05379179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111147712|NCT05379179|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111147713|NCT05379179|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111147714|NCT05379179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111147715|NCT05379179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111147716|NCT05379179|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111147717|NCT05379179|Narcotics|narcotics|mesh-ancestor
111147718|NCT05379179|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111147719|NCT05383001|Durvalumab|durvalumab|mesh-list
111147720|NCT05383001|Tremelimumab|tremelimumab|mesh-list
111147721|NCT05383001|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111147722|NCT05383001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111147723|NCT02527421|Betamethasone|betamethasone|mesh-list
111147724|NCT02527421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111147725|NCT02527421|Glucocorticoids|glucocorticoids|mesh-ancestor
111147726|NCT02527421|Hormones|hormones|mesh-ancestor
111147727|NCT02527421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111147728|NCT02527421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111147729|NCT02527421|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111147730|NCT02527421|Respiratory System Agents|respiratory system agents|mesh-ancestor
111147731|NCT05610371|Lidocaine|lidocaine|mesh-list
111147732|NCT05610371|Anesthetics, Local|anesthetics, local|mesh-ancestor
111147733|NCT05610371|Anesthetics|anesthetics|mesh-ancestor
111147734|NCT05610371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111147735|NCT05610371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111147736|NCT05610371|Sensory System Agents|sensory system agents|mesh-ancestor
111147737|NCT05610371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111147738|NCT05610371|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111147739|NCT05610371|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111147740|NCT05610371|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111147741|NCT05610371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111147742|NCT05610371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111147743|NCT02163759|Adalimumab|adalimumab|mesh-list
111147744|NCT02163759|Etrolizumab|etrolizumab|mesh-list
111147745|NCT02163759|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111147746|NCT02163759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111147747|NCT02163759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111147748|NCT02163759|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111147749|NCT02163759|Immunologic Factors|immunologic factors|mesh-ancestor
111147750|NCT02163759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111147751|NCT02336737|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
111147752|NCT02336737|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111147753|NCT02336737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111147754|NCT02163447|Pyrimethamine|pyrimethamine|mesh-list
111147755|NCT02163447|Piperaquine|piperaquine|mesh-list
111147756|NCT02163447|Sulfadoxine|sulfadoxine|mesh-list
111147757|NCT02163447|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
111147758|NCT02163447|Artenimol|artenimol|mesh-list
111147759|NCT02163447|Artemisinins|artemisinins|mesh-list
111147760|NCT02163447|Antimalarials|antimalarials|mesh-ancestor
111147761|NCT02163447|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111147762|NCT02163447|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111147763|NCT02163447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111147764|NCT02163447|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111147765|NCT02163447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111147766|NCT02163447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111147767|NCT02163447|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111147768|NCT01887418|Methyltestosterone|methyltestosterone|mesh-list
111147769|NCT01887418|Testosterone|testosterone|mesh-list
111147770|NCT01887418|Testosterone undecanoate|testosterone undecanoate|mesh-list
111147771|NCT01887418|Testosterone enanthate|testosterone enanthate|mesh-list
111147772|NCT01887418|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
111147773|NCT01887418|Androgens|androgens|mesh-ancestor
111147774|NCT01887418|Hormones|hormones|mesh-ancestor
111147775|NCT01887418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111147776|NCT01887418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111147777|NCT01887418|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111147778|NCT01887418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111147779|NCT01887418|Anabolic Agents|anabolic agents|mesh-ancestor
111147780|NCT01912612|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
111147781|NCT01912612|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111147782|NCT01912612|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111147783|NCT01912612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111147784|NCT01912612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111147785|NCT01912612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111147786|NCT01912612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111147787|NCT01912612|Analgesics|analgesics|mesh-ancestor
111147788|NCT01912612|Sensory System Agents|sensory system agents|mesh-ancestor
111147789|NCT01912612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111147790|NCT01912612|Antidepressive Agents|antidepressive agents|mesh-ancestor
111147791|NCT01912612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111147792|NCT01912612|Dopamine Agents|dopamine agents|mesh-ancestor
111147793|NCT02302807|Paclitaxel|paclitaxel|mesh-list
111147794|NCT02302807|Docetaxel|docetaxel|mesh-list
111147795|NCT02302807|Atezolizumab|atezolizumab|mesh-list
111147796|NCT02302807|Antibodies|antibodies|mesh-list
111147797|NCT02302807|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111147798|NCT02302807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111147799|NCT02302807|Tubulin Modulators|tubulin modulators|mesh-ancestor
111147800|NCT02302807|Antimitotic Agents|antimitotic agents|mesh-ancestor
111147801|NCT02302807|Mitosis Modulators|mitosis modulators|mesh-ancestor
111147802|NCT02302807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111147803|NCT02302807|Immunologic Factors|immunologic factors|mesh-ancestor
111147804|NCT02302807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111147805|NCT02302807|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111147806|NCT02302807|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111147807|NCT01931566|Pioglitazone|pioglitazone|mesh-list
111147808|NCT01931566|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111147809|NCT01931566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111147810|NCT05372939|Adalimumab|adalimumab|mesh-list
111147811|NCT05372939|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111147812|NCT05372939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111147813|NCT05372939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111147814|NCT01912456|Complement C1s|complement c1s|mesh-list
111147815|NCT01912456|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
111147816|NCT01912456|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
111147817|NCT01912456|Immunologic Factors|immunologic factors|mesh-ancestor
111147818|NCT01912456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111147819|NCT01912456|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
111147820|NCT01912456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111147821|NCT04251065|Daratumumab|daratumumab|mesh-list
111147822|NCT04251065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111147823|NCT01885936|Albuterol|albuterol|mesh-list
111147824|NCT01885936|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111147825|NCT01885936|Autonomic Agents|autonomic agents|mesh-ancestor
111147826|NCT01885936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111147827|NCT01885936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111147828|NCT01885936|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111147829|NCT01885936|Respiratory System Agents|respiratory system agents|mesh-ancestor
111147830|NCT01885936|Tocolytic Agents|tocolytic agents|mesh-ancestor
111147831|NCT01885936|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111147832|NCT01885936|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111147833|NCT01885936|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111147834|NCT01885936|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111147835|NCT01885936|Adrenergic Agents|adrenergic agents|mesh-ancestor
111147836|NCT01885936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111147837|NCT01885936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111147838|NCT05305859|Azacitidine|azacitidine|mesh-list
111147839|NCT05305859|Venetoclax|venetoclax|mesh-list
111147840|NCT05305859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111147841|NCT05305859|Antimetabolites|antimetabolites|mesh-ancestor
111147842|NCT05305859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111147843|NCT05305859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111147844|NCT05305859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111147845|NCT05368415|Norepinephrine|norepinephrine|mesh-list
111147846|NCT05368415|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111147847|NCT05368415|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111147848|NCT05368415|Adrenergic Agents|adrenergic agents|mesh-ancestor
111147849|NCT05368415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111147850|NCT05368415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111147851|NCT05368415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111147852|NCT05368415|Sympathomimetics|sympathomimetics|mesh-ancestor
111147853|NCT05368415|Autonomic Agents|autonomic agents|mesh-ancestor
110840168|NCT04919317|Antiemetics|antiemetics|mesh-ancestor
111147854|NCT05368415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110864918|NCT04484506|Hormones|hormones|mesh-ancestor
111147855|NCT05368415|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111147856|NCT05529173|Povidone-Iodine|povidone-iodine|mesh-list
111147857|NCT05529173|Povidone|povidone|mesh-list
111147858|NCT05529173|Plasma Substitutes|plasma substitutes|mesh-ancestor
111147859|NCT05529173|Blood Substitutes|blood substitutes|mesh-ancestor
111147860|NCT05529173|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111147861|NCT05529173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111147862|NCT05335109|Xenon|xenon|mesh-list
111147863|NCT05335109|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111147864|NCT05335109|Anesthetics, General|anesthetics, general|mesh-ancestor
111147865|NCT05335109|Anesthetics|anesthetics|mesh-ancestor
111147866|NCT05335109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111147867|NCT05335109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111147868|NCT05333237|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111147869|NCT01912222|Ixazomib|ixazomib|mesh-list
111147870|NCT01912222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111147871|NCT01912222|Protease Inhibitors|protease inhibitors|mesh-ancestor
111147872|NCT01912222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111147873|NCT01912222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111147874|NCT05366933|Folic Acid|folic acid|mesh-list
111147875|NCT05366933|Vitamin B Complex|vitamin b complex|mesh-list
111147876|NCT05366933|Vitamins|vitamins|mesh-ancestor
111147877|NCT05366933|Micronutrients|micronutrients|mesh-ancestor
111147878|NCT05366933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111147879|NCT05366933|Hematinics|hematinics|mesh-ancestor
110483329|NCT01013285|Growth Inhibitors|growth inhibitors|mesh-ancestor
111147880|NCT04250207|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111147881|NCT05500703|Dexmedetomidine|dexmedetomidine|mesh-list
111147882|NCT05500703|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111147883|NCT05500703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111147884|NCT05500703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111147885|NCT05500703|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111147886|NCT05500703|Analgesics|analgesics|mesh-ancestor
111147887|NCT05500703|Sensory System Agents|sensory system agents|mesh-ancestor
111147888|NCT05500703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111147889|NCT05500703|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111147890|NCT05500703|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111147891|NCT05500703|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111147892|NCT05500703|Adrenergic Agents|adrenergic agents|mesh-ancestor
111147893|NCT05500703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111147894|NCT05500703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111147895|NCT05331521|Vincristine|vincristine|mesh-list
111147896|NCT05331521|Temozolomide|temozolomide|mesh-list
111147897|NCT05331521|Lomustine|lomustine|mesh-list
111147898|NCT05331521|Procarbazine|procarbazine|mesh-list
111147899|NCT05331521|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111147900|NCT05331521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111147901|NCT05331521|Tubulin Modulators|tubulin modulators|mesh-ancestor
111147902|NCT05331521|Antimitotic Agents|antimitotic agents|mesh-ancestor
111147903|NCT05331521|Mitosis Modulators|mitosis modulators|mesh-ancestor
111147904|NCT05331521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111147905|NCT05331521|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111147906|NCT05331521|Alkylating Agents|alkylating agents|mesh-ancestor
111147907|NCT02525861|Protease Inhibitors|protease inhibitors|mesh-list
111147908|NCT02525861|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
111147909|NCT02525861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111147910|NCT02525861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111147911|NCT02525861|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
111147912|NCT02525861|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111147913|NCT02524847|Methoxsalen|methoxsalen|mesh-list
111147914|NCT02524847|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111147915|NCT02524847|Dermatologic Agents|dermatologic agents|mesh-ancestor
111147916|NCT04422275|Budesonide|budesonide|mesh-list
111147917|NCT04422275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111147918|NCT04422275|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111147919|NCT04422275|Autonomic Agents|autonomic agents|mesh-ancestor
111147920|NCT04422275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111147921|NCT04422275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111147922|NCT04422275|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111147923|NCT04422275|Respiratory System Agents|respiratory system agents|mesh-ancestor
111147925|NCT04422275|Hormones|hormones|mesh-ancestor
111147926|NCT04422275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111147927|NCT05361941|Tobramycin|tobramycin|mesh-list
111147928|NCT05361941|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111147929|NCT05361941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111147930|NCT05324735|Pentoxifylline|pentoxifylline|mesh-list
111147931|NCT05324735|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111147932|NCT05324735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111147933|NCT05324735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111147934|NCT05324735|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111147935|NCT05324735|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111147936|NCT05324735|Protective Agents|protective agents|mesh-ancestor
111147937|NCT05324735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111147938|NCT05324735|Vasodilator Agents|vasodilator agents|mesh-ancestor
111147939|NCT05324735|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111147940|NCT05324735|Antioxidants|antioxidants|mesh-ancestor
111147941|NCT05359055|Itraconazole|itraconazole|mesh-list
111147942|NCT05359055|Rifampin|rifampin|mesh-list
111147943|NCT05359055|Antifungal Agents|antifungal agents|mesh-ancestor
111147944|NCT05359055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111147945|NCT05359055|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111147946|NCT05359055|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111147947|NCT05359055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111147948|NCT05359055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111147949|NCT05359055|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111147950|NCT05359055|Hormone Antagonists|hormone antagonists|mesh-ancestor
111147951|NCT05359055|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111147952|NCT05359055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111147953|NCT05359055|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111147954|NCT05359055|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111147955|NCT05359055|Antitubercular Agents|antitubercular agents|mesh-ancestor
111147956|NCT05359055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111147957|NCT05359055|Leprostatic Agents|leprostatic agents|mesh-ancestor
111147958|NCT05359055|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111147959|NCT05359055|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111147960|NCT05359055|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111147961|NCT05359055|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
111147962|NCT05359055|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
111147963|NCT05359055|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
111147964|NCT05359055|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111147965|NCT02524379|Glyburide|glyburide|mesh-list
111147966|NCT02524379|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111147967|NCT02524379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111147968|NCT02524145|Isoproterenol|isoproterenol|mesh-list
111147969|NCT02524145|Glycopyrrolate|glycopyrrolate|mesh-list
111147970|NCT02524145|Dexmedetomidine|dexmedetomidine|mesh-list
111147971|NCT02524145|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111147972|NCT02524145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111147973|NCT02524145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111147974|NCT02524145|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111147975|NCT02524145|Analgesics|analgesics|mesh-ancestor
111147976|NCT02524145|Sensory System Agents|sensory system agents|mesh-ancestor
111147977|NCT02524145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111147978|NCT02524145|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111147979|NCT02524145|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111147980|NCT02524145|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111147981|NCT02524145|Adrenergic Agents|adrenergic agents|mesh-ancestor
111147982|NCT02524145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111147983|NCT02524145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111147984|NCT02524145|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111147985|NCT02524145|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111147986|NCT02524145|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111147987|NCT02524145|Cholinergic Agents|cholinergic agents|mesh-ancestor
111147988|NCT02524145|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111147989|NCT02524145|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111147990|NCT02524145|Autonomic Agents|autonomic agents|mesh-ancestor
111147991|NCT02524145|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111147992|NCT02524145|Respiratory System Agents|respiratory system agents|mesh-ancestor
111147993|NCT02524145|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111147994|NCT02524145|Sympathomimetics|sympathomimetics|mesh-ancestor
111147995|NCT02524145|Protective Agents|protective agents|mesh-ancestor
111147996|NCT05357417|Bevacizumab|bevacizumab|mesh-list
111147997|NCT05357417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111147998|NCT05357417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111147999|NCT05357417|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111148000|NCT05357417|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111148001|NCT05357417|Growth Substances|growth substances|mesh-ancestor
111148002|NCT05357417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111148003|NCT05357417|Growth Inhibitors|growth inhibitors|mesh-ancestor
111148004|NCT01658813|Interferons|interferons|mesh-list
111148006|NCT01658813|Antimetabolites|antimetabolites|mesh-ancestor
111148007|NCT01658813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111148008|NCT01658813|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111148009|NCT01658813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111148010|NCT01658813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111148011|NCT01658813|Immunologic Factors|immunologic factors|mesh-ancestor
111148012|NCT01658813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111148013|NCT01658813|Antiviral Agents|antiviral agents|mesh-ancestor
111148014|NCT01658813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111148015|NCT02187471|Pregabalin|pregabalin|mesh-list
111148016|NCT02187471|Analgesics|analgesics|mesh-ancestor
111148017|NCT02187471|Sensory System Agents|sensory system agents|mesh-ancestor
111148018|NCT02187471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111148019|NCT02187471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111148020|NCT02187471|Anticonvulsants|anticonvulsants|mesh-ancestor
111148021|NCT02187471|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111148022|NCT02187471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111148023|NCT02187471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111148024|NCT02187471|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111148025|NCT02187471|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111148026|NCT02187471|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111148027|NCT02187471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111148028|NCT02187471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111148029|NCT02525471|RNS60|rns60|mesh-list
111148030|NCT02525471|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111148031|NCT02525471|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111148032|NCT02525471|Analgesics|analgesics|mesh-ancestor
111148033|NCT02525471|Sensory System Agents|sensory system agents|mesh-ancestor
111148034|NCT02525471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111148035|NCT02525471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111148036|NCT02525471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111148037|NCT02525471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111148038|NCT02525471|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111148039|NCT05284409|Acetaminophen|acetaminophen|mesh-list
111148040|NCT05284409|Dexamethasone|dexamethasone|mesh-list
111148041|NCT05284409|Meperidine|meperidine|mesh-list
111148042|NCT05284409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111148043|NCT05284409|Antiemetics|antiemetics|mesh-ancestor
111148044|NCT05284409|Autonomic Agents|autonomic agents|mesh-ancestor
111148045|NCT05284409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111148046|NCT05284409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111148047|NCT05284409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111148048|NCT05284409|Glucocorticoids|glucocorticoids|mesh-ancestor
111148049|NCT05284409|Hormones|hormones|mesh-ancestor
111148050|NCT05284409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111148051|NCT05284409|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111148052|NCT05284409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111148053|NCT05284409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111148054|NCT05284409|Analgesics|analgesics|mesh-ancestor
111148055|NCT05284409|Sensory System Agents|sensory system agents|mesh-ancestor
111148056|NCT05284409|Antipyretics|antipyretics|mesh-ancestor
111148057|NCT05284409|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111148058|NCT05284409|Narcotics|narcotics|mesh-ancestor
111148059|NCT05284409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111148060|NCT05284409|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111148061|NCT02523599|Bupivacaine|bupivacaine|mesh-list
111148062|NCT02523599|Anesthetics, Local|anesthetics, local|mesh-ancestor
111148063|NCT02523599|Anesthetics|anesthetics|mesh-ancestor
111148064|NCT02523599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111148065|NCT02523599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111148066|NCT02523599|Sensory System Agents|sensory system agents|mesh-ancestor
111148067|NCT02523599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111148068|NCT05354999|Caffeine|caffeine|mesh-list
111148069|NCT05354999|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111148070|NCT05354999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111148071|NCT05354999|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111148072|NCT05354999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111148073|NCT05354999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111148074|NCT05354999|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
111148075|NCT05354999|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111148076|NCT05354999|Purinergic Agents|purinergic agents|mesh-ancestor
111148077|NCT05354999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111148078|NCT02187159|Pregabalin|pregabalin|mesh-list
111148079|NCT02187159|Analgesics|analgesics|mesh-ancestor
111148080|NCT02187159|Sensory System Agents|sensory system agents|mesh-ancestor
111148081|NCT02187159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111148082|NCT02187159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111148083|NCT02187159|Anticonvulsants|anticonvulsants|mesh-ancestor
111148084|NCT02187159|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111148085|NCT02187159|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111148086|NCT02187159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111148087|NCT02187159|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111148088|NCT02187159|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111148089|NCT02187159|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111148090|NCT02187159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111148091|NCT02187159|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111148092|NCT02335411|Pembrolizumab|pembrolizumab|mesh-list
111148093|NCT02335411|Capecitabine|capecitabine|mesh-list
111148094|NCT02335411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111148095|NCT02335411|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111148096|NCT02335411|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111148097|NCT02335411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111148098|NCT02335411|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111148099|NCT02335411|Antimetabolites|antimetabolites|mesh-ancestor
111148100|NCT02186301|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111148101|NCT02186301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111148102|NCT02186301|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111148103|NCT02186301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111148104|NCT02186301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111148105|NCT02161731|Warfarin|warfarin|mesh-list
111148106|NCT02161731|Evacetrapib|evacetrapib|mesh-list
111148107|NCT02161731|Anticoagulants|anticoagulants|mesh-ancestor
111148108|NCT02161731|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111148109|NCT02161731|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111148110|NCT02161731|Antimetabolites|antimetabolites|mesh-ancestor
111148111|NCT02161731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111148112|NCT02161731|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111148113|NCT02124759|Sevelamer|sevelamer|mesh-list
111148114|NCT02124759|Chelating Agents|chelating agents|mesh-ancestor
111148115|NCT02124759|Sequestering Agents|sequestering agents|mesh-ancestor
111148116|NCT02124759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111148117|NCT02302339|Pembrolizumab|pembrolizumab|mesh-list
111148118|NCT02302339|Nivolumab|nivolumab|mesh-list
111148119|NCT02302339|Glembatumumab vedotin|glembatumumab vedotin|mesh-list
111148120|NCT02302339|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111148121|NCT02302339|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111148122|NCT02302339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111148123|NCT02302339|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111148124|NCT02302339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111148125|NCT02302339|Immunoconjugates|immunoconjugates|mesh-ancestor
111148126|NCT02302339|Immunologic Factors|immunologic factors|mesh-ancestor
111148127|NCT02302339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111148128|NCT04895917|Daratumumab|daratumumab|mesh-list
111148129|NCT04895917|Pomalidomide|pomalidomide|mesh-list
111148130|NCT04895917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111148131|NCT04895917|Immunologic Factors|immunologic factors|mesh-ancestor
111148132|NCT04895917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111148133|NCT04895917|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111148134|NCT04895917|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111148135|NCT04895917|Growth Substances|growth substances|mesh-ancestor
111148136|NCT04895917|Growth Inhibitors|growth inhibitors|mesh-ancestor
111148137|NCT02161575|Ranibizumab|ranibizumab|mesh-list
111148138|NCT02161575|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111148139|NCT02161575|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111148140|NCT02161575|Growth Substances|growth substances|mesh-ancestor
111148141|NCT02161575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111148142|NCT02161575|Growth Inhibitors|growth inhibitors|mesh-ancestor
111148143|NCT02161575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111148144|NCT02161185|Midazolam|midazolam|mesh-list
111148145|NCT02161185|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111148146|NCT02161185|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111148147|NCT02161185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111148148|NCT02161185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111148149|NCT02161185|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111148150|NCT02161185|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111148151|NCT02161185|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111148152|NCT02161185|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111148153|NCT02161185|Anesthetics, General|anesthetics, general|mesh-ancestor
111148154|NCT02161185|Anesthetics|anesthetics|mesh-ancestor
111148156|NCT02161185|GABA Agents|gaba agents|mesh-ancestor
111148157|NCT02161185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111148158|NCT02161185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111148159|NCT02159469|Methyltestosterone|methyltestosterone|mesh-list
111148160|NCT02159469|Testosterone|testosterone|mesh-list
111148161|NCT02159469|Testosterone undecanoate|testosterone undecanoate|mesh-list
111148162|NCT02159469|Testosterone enanthate|testosterone enanthate|mesh-list
111148163|NCT02159469|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
111148164|NCT02159469|Androgens|androgens|mesh-ancestor
111148165|NCT02159469|Hormones|hormones|mesh-ancestor
111148166|NCT02159469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111148167|NCT02159469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111148168|NCT02159469|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111148169|NCT02159469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111148170|NCT02159469|Anabolic Agents|anabolic agents|mesh-ancestor
111148171|NCT02123511|Acetylcysteine|acetylcysteine|mesh-list
111148172|NCT02123511|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111148173|NCT02123511|Antiviral Agents|antiviral agents|mesh-ancestor
111148174|NCT02123511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111148175|NCT02123511|Expectorants|expectorants|mesh-ancestor
111148176|NCT02123511|Respiratory System Agents|respiratory system agents|mesh-ancestor
111148177|NCT02123511|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111148178|NCT02123511|Antioxidants|antioxidants|mesh-ancestor
111148179|NCT02123511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111148180|NCT02123511|Protective Agents|protective agents|mesh-ancestor
111148181|NCT02123511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111148182|NCT02123511|Antidotes|antidotes|mesh-ancestor
111148183|NCT04746339|Apixaban|apixaban|mesh-list
111148184|NCT04746339|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111148185|NCT04746339|Antithrombins|antithrombins|mesh-ancestor
111148186|NCT04746339|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111148187|NCT04746339|Protease Inhibitors|protease inhibitors|mesh-ancestor
111148188|NCT04746339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111148189|NCT04746339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111148190|NCT04746339|Anticoagulants|anticoagulants|mesh-ancestor
111148191|NCT02301403|Nicotine|nicotine|mesh-list
111148192|NCT02301403|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111148193|NCT02301403|Autonomic Agents|autonomic agents|mesh-ancestor
111148194|NCT02301403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111148195|NCT02301403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111148196|NCT02301403|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111148197|NCT02301403|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111148198|NCT02301403|Cholinergic Agents|cholinergic agents|mesh-ancestor
111148199|NCT02301403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111148200|NCT02301403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111148201|NCT02333383|Adalimumab|adalimumab|mesh-list
111148202|NCT02333383|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111148203|NCT02333383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111148204|NCT02333383|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111148205|NCT02369341|Vaccines|vaccines|mesh-list
111148206|NCT02369341|Immunologic Factors|immunologic factors|mesh-ancestor
111148207|NCT02369341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111148208|NCT02121795|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
111148209|NCT02121795|Antiviral Agents|antiviral agents|mesh-ancestor
111148210|NCT02121795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111148211|NCT02158533|Naltrexone|naltrexone|mesh-list
111148212|NCT02158533|Buprenorphine|buprenorphine|mesh-list
111148213|NCT02158533|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111148214|NCT02158533|Narcotics|narcotics|mesh-ancestor
111148215|NCT02158533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111148216|NCT02158533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111148217|NCT02158533|Analgesics|analgesics|mesh-ancestor
111148218|NCT02158533|Sensory System Agents|sensory system agents|mesh-ancestor
111148219|NCT02158533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111148220|NCT02158533|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111148221|NCT02158533|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111148222|NCT02120469|Everolimus|everolimus|mesh-list
111148223|NCT02120469|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111148224|NCT02120469|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111148225|NCT02120469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111148226|NCT02120469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111148227|NCT02120469|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111148228|NCT02120469|Immunologic Factors|immunologic factors|mesh-ancestor
111148229|NCT02120469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111148230|NCT02120469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111148231|NCT02180061|Pembrolizumab|pembrolizumab|mesh-list
111148232|NCT02180061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111148233|NCT02180061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111148234|NCT02180061|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111148235|NCT02180061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111148236|NCT02120157|Mycophenolic Acid|mycophenolic acid|mesh-list
111148237|NCT02120157|Cyclophosphamide|cyclophosphamide|mesh-list
111148238|NCT02120157|Busulfan|busulfan|mesh-list
111148239|NCT02120157|Tacrolimus|tacrolimus|mesh-list
111148240|NCT02120157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111148241|NCT02120157|Immunologic Factors|immunologic factors|mesh-ancestor
111148242|NCT02120157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111148243|NCT02120157|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111148244|NCT02120157|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111148245|NCT02120157|Alkylating Agents|alkylating agents|mesh-ancestor
111148246|NCT02120157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111148247|NCT02120157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111148248|NCT02120157|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111148249|NCT02120157|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111148250|NCT02120157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111148251|NCT02120157|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111148252|NCT02120157|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111148253|NCT02120157|Antitubercular Agents|antitubercular agents|mesh-ancestor
111148254|NCT02120157|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111148255|NCT02120157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111148256|NCT01365455|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111148257|NCT01365455|Immunologic Factors|immunologic factors|mesh-ancestor
111148258|NCT01365455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111148259|NCT02155881|Ciclesonide|ciclesonide|mesh-list
111148260|NCT02155881|Glucocorticoids|glucocorticoids|mesh-ancestor
111148261|NCT02155881|Hormones|hormones|mesh-ancestor
111148262|NCT02155881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111148263|NCT02155881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111148264|NCT02155881|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111148265|NCT05279807|Amlodipine|amlodipine|mesh-list
111148266|NCT05279807|Zofenopril|zofenopril|mesh-list
111148267|NCT05279807|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111148268|NCT05279807|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111148269|NCT05279807|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111148270|NCT05279807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111148271|NCT05279807|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111148272|NCT05279807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111148273|NCT05279807|Vasodilator Agents|vasodilator agents|mesh-ancestor
111148274|NCT05279807|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
111148275|NCT05279807|Protease Inhibitors|protease inhibitors|mesh-ancestor
111148276|NCT05279807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111148277|NCT05319431|Lenvatinib|lenvatinib|mesh-list
111148278|NCT05319431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111148279|NCT05319431|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111148280|NCT05319431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111148281|NCT05319431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111148282|NCT05276531|Progesterone|progesterone|mesh-list
111148283|NCT05276531|Progestins|progestins|mesh-ancestor
111148284|NCT05276531|Hormones|hormones|mesh-ancestor
111148285|NCT05276531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111148286|NCT05276531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111148287|NCT01658579|Insulin|insulin|mesh-list
111148288|NCT01658579|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111148289|NCT01658579|Insulin Glargine|insulin glargine|mesh-list
111148290|NCT01658579|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111148291|NCT01658579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111148292|NCT05561309|Ropivacaine|ropivacaine|mesh-list
111148293|NCT05561309|Anesthetics, Local|anesthetics, local|mesh-ancestor
111148294|NCT05561309|Anesthetics|anesthetics|mesh-ancestor
111148295|NCT05561309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111148296|NCT05561309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111148297|NCT05561309|Sensory System Agents|sensory system agents|mesh-ancestor
111148298|NCT05561309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111148299|NCT05268497|Antidepressive Agents|antidepressive agents|mesh-list
111148300|NCT05268497|Esketamine|esketamine|mesh-list
111148301|NCT05268497|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111148302|NCT05266859|Calcium|calcium|mesh-list
111148303|NCT05266859|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111148304|NCT05266859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111148305|NCT05346731|Dexamethasone|dexamethasone|mesh-list
111148306|NCT05346731|Ondansetron|ondansetron|mesh-list
111148308|NCT05346731|Aprepitant|aprepitant|mesh-list
111148309|NCT05346731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111148310|NCT05346731|Antiemetics|antiemetics|mesh-ancestor
111148311|NCT05346731|Autonomic Agents|autonomic agents|mesh-ancestor
111148312|NCT05346731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111148313|NCT05346731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111148314|NCT05346731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111148315|NCT05346731|Glucocorticoids|glucocorticoids|mesh-ancestor
111148316|NCT05346731|Hormones|hormones|mesh-ancestor
111148317|NCT05346731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111148318|NCT05346731|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111148319|NCT05346731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111148320|NCT05346731|Antipruritics|antipruritics|mesh-ancestor
111148321|NCT05346731|Dermatologic Agents|dermatologic agents|mesh-ancestor
111148322|NCT05346731|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111148323|NCT05346731|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111148324|NCT05346731|Serotonin Agents|serotonin agents|mesh-ancestor
111148325|NCT05346731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111148326|NCT05346731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111148327|NCT05346731|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111148328|NCT05346731|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111148329|NCT05346731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111148330|NCT05346731|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111148331|NCT05346731|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111148332|NCT05346731|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111148333|NCT05346731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111148334|NCT05346731|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
111148335|NCT02118597|Interferons|interferons|mesh-list
111148336|NCT02118597|Ribavirin|ribavirin|mesh-list
111148337|NCT02118597|Simeprevir|simeprevir|mesh-list
111148338|NCT02118597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111148339|NCT02118597|Antiviral Agents|antiviral agents|mesh-ancestor
111148340|NCT02118597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111148342|NCT02118597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111148343|NCT02118597|Protease Inhibitors|protease inhibitors|mesh-ancestor
111148344|NCT02118597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111148345|NCT05218889|Paclitaxel|paclitaxel|mesh-list
111148346|NCT05218889|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111148347|NCT05218889|Gemcitabine|gemcitabine|mesh-list
111148348|NCT05218889|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111148349|NCT05218889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111148350|NCT05218889|Tubulin Modulators|tubulin modulators|mesh-ancestor
111148351|NCT05218889|Antimitotic Agents|antimitotic agents|mesh-ancestor
111148352|NCT05218889|Mitosis Modulators|mitosis modulators|mesh-ancestor
111148353|NCT05218889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111148354|NCT05218889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111148355|NCT05218889|Antimetabolites|antimetabolites|mesh-ancestor
111148356|NCT02117349|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
111148357|NCT02117349|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
111148358|NCT02117349|Hemostatics|hemostatics|mesh-ancestor
111148359|NCT02117349|Coagulants|coagulants|mesh-ancestor
111148360|NCT02177175|Carvedilol|carvedilol|mesh-list
111148361|NCT02177175|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111148362|NCT02177175|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111148363|NCT02177175|Adrenergic Agents|adrenergic agents|mesh-ancestor
111148364|NCT02177175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111148365|NCT02177175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111148366|NCT02177175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111148367|NCT02177175|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111148368|NCT02177175|Antioxidants|antioxidants|mesh-ancestor
111148369|NCT02177175|Protective Agents|protective agents|mesh-ancestor
111148370|NCT02177175|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111148371|NCT02177175|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111148372|NCT02177175|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111148373|NCT02177175|Vasodilator Agents|vasodilator agents|mesh-ancestor
111148374|NCT02177175|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111148375|NCT02177175|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111148376|NCT01657877|Calcium|calcium|mesh-list
111148377|NCT01657877|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111148378|NCT01657877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111148379|NCT05254925|Sunscreening Agents|sunscreening agents|mesh-list
110865437|NCT05058404|Rituximab|rituximab|mesh-list
111148380|NCT05254925|Petrolatum|petrolatum|mesh-list
111148381|NCT05254925|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111148382|NCT05254925|Protective Agents|protective agents|mesh-ancestor
111148383|NCT05254925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111148384|NCT05254925|Dermatologic Agents|dermatologic agents|mesh-ancestor
111148386|NCT05205473|Lidocaine|lidocaine|mesh-list
111148387|NCT05205473|Anesthetics|anesthetics|mesh-list
111148388|NCT05205473|Anesthetics, Local|anesthetics, local|mesh-ancestor
111148389|NCT05205473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111148390|NCT05205473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111148391|NCT05205473|Sensory System Agents|sensory system agents|mesh-ancestor
111148392|NCT05205473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111148393|NCT05205473|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111148394|NCT05205473|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111148395|NCT05205473|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111148396|NCT05205473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111148397|NCT05205473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111148398|NCT05253053|Paclitaxel|paclitaxel|mesh-list
111148399|NCT05253053|Atezolizumab|atezolizumab|mesh-list
111148400|NCT05253053|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111148401|NCT05253053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111148402|NCT05253053|Tubulin Modulators|tubulin modulators|mesh-ancestor
111148403|NCT05253053|Antimitotic Agents|antimitotic agents|mesh-ancestor
111148404|NCT05253053|Mitosis Modulators|mitosis modulators|mesh-ancestor
111148405|NCT05253053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111148406|NCT05253053|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111148407|NCT05253053|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111148408|NCT04422197|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111148409|NCT04422197|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111148410|NCT04422197|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111148411|NCT04422197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111148412|NCT04422197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111148413|NCT04422197|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111148414|NCT04422197|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111148415|NCT04422197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111148416|NCT04422197|Cholinergic Agents|cholinergic agents|mesh-ancestor
111148417|NCT04422197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111148418|NCT02175771|Fluticasone|fluticasone|mesh-list
111148419|NCT02175771|Xhance|xhance|mesh-list
111148420|NCT02175771|Albuterol|albuterol|mesh-list
111148421|NCT02175771|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
111148422|NCT02175771|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
111148423|NCT02175771|Adrenergic Agonists|adrenergic agonists|mesh-list
111148424|NCT02175771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111148425|NCT02175771|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111148426|NCT02175771|Autonomic Agents|autonomic agents|mesh-ancestor
111148427|NCT02175771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111148428|NCT02175771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111148429|NCT02175771|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111148430|NCT02175771|Respiratory System Agents|respiratory system agents|mesh-ancestor
111148431|NCT02175771|Dermatologic Agents|dermatologic agents|mesh-ancestor
111148432|NCT02175771|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111148433|NCT02175771|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111148434|NCT02175771|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111148435|NCT02175771|Adrenergic Agents|adrenergic agents|mesh-ancestor
111148436|NCT02175771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111148437|NCT02175771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111148438|NCT02175771|Tocolytic Agents|tocolytic agents|mesh-ancestor
111148439|NCT02175771|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111148440|NCT02175771|Glucocorticoids|glucocorticoids|mesh-ancestor
111148441|NCT02175771|Hormones|hormones|mesh-ancestor
111148442|NCT02175771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111148443|NCT02175771|Sympathomimetics|sympathomimetics|mesh-ancestor
111148444|NCT01657799|Veliparib|veliparib|mesh-list
111148445|NCT01657799|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111148446|NCT01657799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111148447|NCT01657799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111148448|NCT01657799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111148449|NCT02116803|Fulvestrant|fulvestrant|mesh-list
111148450|NCT02116803|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111148451|NCT02116803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111148452|NCT02116803|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
111148453|NCT02116803|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111148455|NCT02116803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111148456|NCT02116803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111148457|NCT02115321|Grazoprevir|grazoprevir|mesh-list
111148458|NCT02115321|Antiviral Agents|antiviral agents|mesh-ancestor
111148459|NCT02115321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111148460|NCT05248841|Insulin Glargine|insulin glargine|mesh-list
111148461|NCT05248841|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111148462|NCT05248841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111148463|NCT05248139|Prednisolone|prednisolone|mesh-list
111148464|NCT05248139|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111148465|NCT05248139|Methylprednisolone|methylprednisolone|mesh-list
111148466|NCT05248139|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111148467|NCT05248139|Prednisolone acetate|prednisolone acetate|mesh-list
111148468|NCT05248139|Triamcinolone|triamcinolone|mesh-list
111148469|NCT05248139|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
111148470|NCT05248139|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111148471|NCT05248139|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111148472|NCT05248139|Prednisolone phosphate|prednisolone phosphate|mesh-list
111148473|NCT05248139|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111148474|NCT05248139|Glucocorticoids|glucocorticoids|mesh-ancestor
111148475|NCT05248139|Hormones|hormones|mesh-ancestor
111148476|NCT05248139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111148477|NCT05248139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111148478|NCT05248139|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111148479|NCT05248139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111148480|NCT05248139|Antiemetics|antiemetics|mesh-ancestor
111148481|NCT05248139|Autonomic Agents|autonomic agents|mesh-ancestor
111148482|NCT05248139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111148483|NCT05248139|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111148484|NCT05248139|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111148485|NCT05248139|Protective Agents|protective agents|mesh-ancestor
111148486|NCT05248139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111148487|NCT05248139|Immunologic Factors|immunologic factors|mesh-ancestor
111148488|NCT05248139|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111148489|NCT05247125|Melatonin|melatonin|mesh-list
111148490|NCT05247125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111148491|NCT05247125|Antioxidants|antioxidants|mesh-ancestor
111148492|NCT05247125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111148493|NCT05247125|Protective Agents|protective agents|mesh-ancestor
111148494|NCT05247125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111148495|NCT05154383|Vaccines|vaccines|mesh-list
111148496|NCT05154383|Immunologic Factors|immunologic factors|mesh-ancestor
111148497|NCT05154383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111148498|NCT05196815|Dobutamine|dobutamine|mesh-list
111148499|NCT05196815|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111148500|NCT05196815|Sympathomimetics|sympathomimetics|mesh-ancestor
111148501|NCT05196815|Autonomic Agents|autonomic agents|mesh-ancestor
111148502|NCT05196815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111148503|NCT05196815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111148504|NCT05196815|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
111148505|NCT05196815|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111148506|NCT05196815|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111148507|NCT05196815|Adrenergic Agents|adrenergic agents|mesh-ancestor
111148508|NCT05196815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111148509|NCT05196815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111148510|NCT05196815|Protective Agents|protective agents|mesh-ancestor
111148511|NCT05245877|Enoxaparin|enoxaparin|mesh-list
111148512|NCT05245877|Dalteparin|dalteparin|mesh-list
111148513|NCT05245877|Tinzaparin|tinzaparin|mesh-list
111148514|NCT05245877|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
111148515|NCT05245877|Anticoagulants|anticoagulants|mesh-ancestor
111148516|NCT05245877|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111148517|NCT05245877|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111148518|NCT05245877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111148519|NCT02367781|Paclitaxel|paclitaxel|mesh-list
111148520|NCT02367781|Carboplatin|carboplatin|mesh-list
111148521|NCT02367781|Pemetrexed|pemetrexed|mesh-list
111148522|NCT02367781|Atezolizumab|atezolizumab|mesh-list
111148523|NCT02367781|Antibodies|antibodies|mesh-list
111148524|NCT02367781|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111148525|NCT02367781|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111148526|NCT02367781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111148527|NCT02367781|Tubulin Modulators|tubulin modulators|mesh-ancestor
111148528|NCT02367781|Antimitotic Agents|antimitotic agents|mesh-ancestor
110865589|NCT02449252|Prednisone|prednisone|mesh-list
111148529|NCT02367781|Mitosis Modulators|mitosis modulators|mesh-ancestor
111148530|NCT02367781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111148531|NCT02367781|Immunologic Factors|immunologic factors|mesh-ancestor
111148532|NCT02367781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111148533|NCT02367781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111148534|NCT02367781|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111148535|NCT02367781|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111148536|NCT02367781|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111148537|NCT02367781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111148538|NCT05191277|Antidepressive Agents|antidepressive agents|mesh-list
111148539|NCT05191277|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111148540|NCT04242173|Cemiplimab|cemiplimab|mesh-list
111148541|NCT04242173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111148542|NCT04242173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111148543|NCT05239091|Lidocaine|lidocaine|mesh-list
111148544|NCT05239091|Anesthetics, Local|anesthetics, local|mesh-list
111148545|NCT05239091|Anesthetics|anesthetics|mesh-list
111148546|NCT05239091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111148547|NCT05239091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111148548|NCT05239091|Sensory System Agents|sensory system agents|mesh-ancestor
111148549|NCT05239091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111148550|NCT05239091|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111148551|NCT05239091|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111148552|NCT05239091|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111148553|NCT05239091|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111148554|NCT05239091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111148556|NCT02152371|Insulin Glargine|insulin glargine|mesh-list
111148557|NCT02152371|Dulaglutide|dulaglutide|mesh-list
111148558|NCT02152371|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111148559|NCT02152371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111148560|NCT02332291|Bupropion|bupropion|mesh-list
111148561|NCT02332291|Escitalopram|escitalopram|mesh-list
111148562|NCT02332291|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111148563|NCT02332291|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111148564|NCT02332291|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111148565|NCT02332291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111148566|NCT02332291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111148567|NCT02332291|Serotonin Agents|serotonin agents|mesh-ancestor
111148568|NCT02332291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111148569|NCT02332291|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111148570|NCT02332291|Antidepressive Agents|antidepressive agents|mesh-ancestor
111148571|NCT02332291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111148572|NCT02332291|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111148573|NCT02332291|Dopamine Agents|dopamine agents|mesh-ancestor
111148574|NCT02332291|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111148575|NCT02332291|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111148576|NCT02332291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111148577|NCT01656395|Montelukast|montelukast|mesh-list
111148578|NCT01656395|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111148579|NCT01656395|Respiratory System Agents|respiratory system agents|mesh-ancestor
111148580|NCT01656395|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
111148581|NCT01656395|Hormone Antagonists|hormone antagonists|mesh-ancestor
111148582|NCT01656395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111148583|NCT01656395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111148584|NCT01656395|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
111148585|NCT01656395|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111148586|NCT01656395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111148587|NCT02114931|Adalimumab|adalimumab|mesh-list
111148588|NCT02114931|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111148589|NCT02114931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111148590|NCT02114931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111148591|NCT05185739|Pembrolizumab|pembrolizumab|mesh-list
111148592|NCT05185739|Lenvatinib|lenvatinib|mesh-list
111148593|NCT05185739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111148594|NCT05185739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111148595|NCT05185739|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111148596|NCT05185739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111148597|NCT05185739|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111148598|NCT05185739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111148599|NCT01657019|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
111148600|NCT01657019|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110865662|NCT02448550|Heparin|heparin|mesh-list
111148601|NCT01657019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111148602|NCT01657019|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111148603|NCT01657019|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111148604|NCT01657019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111148605|NCT01657019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111148606|NCT01657019|Dopamine Agents|dopamine agents|mesh-ancestor
111148607|NCT01657019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111148608|NCT05181605|Folfirinox|folfirinox|mesh-list
111148609|NCT05181605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111148610|NCT02300311|Nicotinic Acids|nicotinic acids|mesh-list
111148611|NCT02300311|Capsaicin|capsaicin|mesh-list
111148612|NCT02300311|Nonivamide|nonivamide|mesh-list
111148613|NCT02300311|Vitamin B Complex|vitamin b complex|mesh-ancestor
111148614|NCT02300311|Vitamins|vitamins|mesh-ancestor
111148616|NCT02300311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111148617|NCT02300311|Sensory System Agents|sensory system agents|mesh-ancestor
111148618|NCT02300311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111148619|NCT02300311|Antipruritics|antipruritics|mesh-ancestor
111148620|NCT02300311|Dermatologic Agents|dermatologic agents|mesh-ancestor
111148621|NCT05141903|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111148622|NCT05141903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111148623|NCT05140499|Bupivacaine|bupivacaine|mesh-list
111148624|NCT05140499|Anesthetics, Local|anesthetics, local|mesh-ancestor
111148625|NCT05140499|Anesthetics|anesthetics|mesh-ancestor
111148626|NCT05140499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111148627|NCT05140499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111148628|NCT05140499|Sensory System Agents|sensory system agents|mesh-ancestor
111148629|NCT05140499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111148630|NCT04229381|Coal Tar|coal tar|mesh-list
111148631|NCT04229381|Keratolytic Agents|keratolytic agents|mesh-ancestor
111148632|NCT04229381|Dermatologic Agents|dermatologic agents|mesh-ancestor
111148633|NCT05178485|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
111148634|NCT05178485|Bupivacaine|bupivacaine|mesh-list
111148635|NCT05178485|Anesthetics, Local|anesthetics, local|mesh-ancestor
111148636|NCT05178485|Anesthetics|anesthetics|mesh-ancestor
111148637|NCT05178485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111148638|NCT05178485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111148639|NCT05178485|Sensory System Agents|sensory system agents|mesh-ancestor
111148640|NCT05178485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111148641|NCT05178485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111148642|NCT05178485|Glucocorticoids|glucocorticoids|mesh-ancestor
111148643|NCT05178485|Hormones|hormones|mesh-ancestor
111148644|NCT05178485|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111148645|NCT05178485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111148646|NCT05178485|Immunologic Factors|immunologic factors|mesh-ancestor
111148647|NCT05228951|Trastuzumab|trastuzumab|mesh-list
111148648|NCT05228951|Letrozole|letrozole|mesh-list
111148649|NCT05228951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111148650|NCT05228951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111148651|NCT05228951|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111148652|NCT05228951|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111148653|NCT05228951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111148654|NCT05228951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111148655|NCT05228951|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111148656|NCT05228951|Hormone Antagonists|hormone antagonists|mesh-ancestor
111148657|NCT05228951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111148658|NCT05228951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111148659|NCT05174039|Miglustat|miglustat|mesh-list
111148660|NCT05174039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111148661|NCT05174039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111148662|NCT05174039|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111148663|NCT05174039|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111148664|NCT05174039|Antiviral Agents|antiviral agents|mesh-ancestor
111148665|NCT05174039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111148666|NCT05174039|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
111148667|NCT05174039|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111148668|NCT05174039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111148669|NCT05138549|Beta Carotene|beta carotene|mesh-list
111148670|NCT05138549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111148671|NCT05138549|Provitamins|provitamins|mesh-ancestor
111148672|NCT05138549|Vitamins|vitamins|mesh-ancestor
111148673|NCT05138549|Micronutrients|micronutrients|mesh-ancestor
111148674|NCT02175225|Deferoxamine|deferoxamine|mesh-list
111148675|NCT02175225|Siderophores|siderophores|mesh-ancestor
111148676|NCT02175225|Iron Chelating Agents|iron chelating agents|mesh-ancestor
111148677|NCT02175225|Chelating Agents|chelating agents|mesh-ancestor
111148678|NCT02175225|Sequestering Agents|sequestering agents|mesh-ancestor
111148679|NCT02175225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111148680|NCT05170841|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
111148681|NCT05170841|Tramadol|tramadol|mesh-list
111148682|NCT05170841|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111148683|NCT05170841|Narcotics|narcotics|mesh-ancestor
111148684|NCT05170841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111148685|NCT05170841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111148686|NCT05170841|Analgesics|analgesics|mesh-ancestor
111148687|NCT05170841|Sensory System Agents|sensory system agents|mesh-ancestor
111148688|NCT05170841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111148689|NCT05170841|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111148690|NCT05170841|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111148691|NCT05170841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111148692|NCT05170841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111148693|NCT05135273|Vaccines|vaccines|mesh-list
111148694|NCT05135273|Immunologic Factors|immunologic factors|mesh-ancestor
111148695|NCT05135273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111148696|NCT02299375|Albuterol|albuterol|mesh-list
111148697|NCT02299375|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111148698|NCT02299375|Autonomic Agents|autonomic agents|mesh-ancestor
111148699|NCT02299375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111148700|NCT02299375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111148701|NCT02299375|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111148702|NCT02299375|Respiratory System Agents|respiratory system agents|mesh-ancestor
111148703|NCT02299375|Tocolytic Agents|tocolytic agents|mesh-ancestor
111148704|NCT02299375|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111148705|NCT02299375|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111148706|NCT02299375|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111148707|NCT02299375|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111148708|NCT02299375|Adrenergic Agents|adrenergic agents|mesh-ancestor
111148709|NCT02299375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111148710|NCT02299375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111148711|NCT02151591|Varenicline|varenicline|mesh-list
111148712|NCT02151591|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111148713|NCT02151591|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111148714|NCT02151591|Cholinergic Agents|cholinergic agents|mesh-ancestor
111148715|NCT02151591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111148716|NCT02151591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111148717|NCT02151591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111148718|NCT02174523|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
111148719|NCT02174523|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111148720|NCT02174523|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111148721|NCT02174523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111148722|NCT02174523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111148723|NCT02174523|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111148724|NCT02174523|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
111148725|NCT02174523|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111148726|NCT02174523|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111148727|NCT02174523|Adrenergic Agents|adrenergic agents|mesh-ancestor
111148728|NCT02174523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111148729|NCT02174523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111148730|NCT02174523|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111148731|NCT02174523|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111148732|NCT02174523|Serotonin Agents|serotonin agents|mesh-ancestor
111148733|NCT02174523|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111148734|NCT02174523|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111148735|NCT02174523|Dopamine Agents|dopamine agents|mesh-ancestor
111148736|NCT04881799|Topiramate|topiramate|mesh-list
111148737|NCT04881799|Phentermine|phentermine|mesh-list
111148738|NCT04881799|Anticonvulsants|anticonvulsants|mesh-ancestor
111148739|NCT04881799|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111148740|NCT04881799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111148741|NCT04881799|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111148742|NCT04881799|Appetite Depressants|appetite depressants|mesh-ancestor
111148743|NCT04881799|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111148744|NCT04881799|Sympathomimetics|sympathomimetics|mesh-ancestor
111148745|NCT04881799|Autonomic Agents|autonomic agents|mesh-ancestor
111148746|NCT04881799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111148747|NCT04881799|Adrenergic Agents|adrenergic agents|mesh-ancestor
111148748|NCT04881799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111148749|NCT04881799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111148750|NCT02297815|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111148751|NCT02297815|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
111148752|NCT02297815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111148753|NCT02297815|Antitubercular Agents|antitubercular agents|mesh-ancestor
111148754|NCT02114385|Vaccines|vaccines|mesh-list
111148755|NCT02114385|Immunologic Factors|immunologic factors|mesh-ancestor
111148756|NCT02114385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111148757|NCT05098457|Lidocaine|lidocaine|mesh-list
111148758|NCT05098457|Anesthetics, Local|anesthetics, local|mesh-ancestor
111148759|NCT05098457|Anesthetics|anesthetics|mesh-ancestor
111148760|NCT05098457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111148761|NCT05098457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111148762|NCT05098457|Sensory System Agents|sensory system agents|mesh-ancestor
111148763|NCT05098457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111148764|NCT05098457|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111148765|NCT05098457|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111148766|NCT05098457|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111148767|NCT05098457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111148768|NCT05098457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111148769|NCT02114151|Sofosbuvir|sofosbuvir|mesh-list
111148770|NCT02114151|Simeprevir|simeprevir|mesh-list
111148771|NCT02114151|Antiviral Agents|antiviral agents|mesh-ancestor
111148772|NCT02114151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111148773|NCT02114151|Protease Inhibitors|protease inhibitors|mesh-ancestor
111148774|NCT02114151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111148775|NCT02114151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111148776|NCT05220293|Betamethasone|betamethasone|mesh-list
111148777|NCT05220293|Betamethasone Valerate|betamethasone valerate|mesh-list
111148778|NCT05220293|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
111148779|NCT05220293|Betamethasone benzoate|betamethasone benzoate|mesh-list
111148780|NCT05220293|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
111148781|NCT05220293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111148782|NCT05220293|Glucocorticoids|glucocorticoids|mesh-ancestor
111148783|NCT05220293|Hormones|hormones|mesh-ancestor
111148784|NCT05220293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111148785|NCT05220293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111148786|NCT05220293|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111148787|NCT05220293|Respiratory System Agents|respiratory system agents|mesh-ancestor
111148788|NCT02297503|Botulinum Toxins|botulinum toxins|mesh-list
111148789|NCT02297503|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111148790|NCT02297503|Hyaluronic Acid|hyaluronic acid|mesh-list
111148791|NCT02297503|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111148792|NCT02297503|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111148793|NCT02297503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111148794|NCT02297503|Cholinergic Agents|cholinergic agents|mesh-ancestor
111148795|NCT02297503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111148796|NCT02297503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111148797|NCT02297503|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111148798|NCT02297503|Immunologic Factors|immunologic factors|mesh-ancestor
111148799|NCT02297503|Viscosupplements|viscosupplements|mesh-ancestor
111148800|NCT02297503|Protective Agents|protective agents|mesh-ancestor
111148801|NCT02366767|Insulin|insulin|mesh-list
111148802|NCT02366767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111148803|NCT02366767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111148804|NCT02149875|Cerebrolysin|cerebrolysin|mesh-list
111148805|NCT02149875|3-n-butylphthalide|3-n-butylphthalide|mesh-list
111148806|NCT02149875|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111148807|NCT02149875|Protective Agents|protective agents|mesh-ancestor
111148808|NCT02149875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111148809|NCT02149875|Nootropic Agents|nootropic agents|mesh-ancestor
111148810|NCT02149875|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111148811|NCT05124899|Sunscreening Agents|sunscreening agents|mesh-list
111148812|NCT05124899|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111148813|NCT05124899|Protective Agents|protective agents|mesh-ancestor
111148814|NCT05124899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111148815|NCT05124899|Dermatologic Agents|dermatologic agents|mesh-ancestor
111148816|NCT02112045|Melphalan|melphalan|mesh-list
111148817|NCT02112045|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111148818|NCT02112045|Alkylating Agents|alkylating agents|mesh-ancestor
111148819|NCT02112045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111148820|NCT02112045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111148821|NCT02112045|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111148822|NCT02112045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111148823|NCT02112045|Immunologic Factors|immunologic factors|mesh-ancestor
111148824|NCT02112045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111148825|NCT02147691|Azelaic acid|azelaic acid|mesh-list
111148826|NCT02147691|Brimonidine Tartrate|brimonidine tartrate|mesh-list
111148827|NCT02147691|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111148828|NCT02147691|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111148829|NCT02147691|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111148830|NCT02147691|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111148831|NCT02147691|Adrenergic Agents|adrenergic agents|mesh-ancestor
111148832|NCT02147691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111148833|NCT02147691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111148834|NCT02147691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111148835|NCT02147691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111148836|NCT02147691|Dermatologic Agents|dermatologic agents|mesh-ancestor
111148837|NCT01655693|Doxorubicin|doxorubicin|mesh-list
111148838|NCT01655693|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111148839|NCT01655693|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111148840|NCT01655693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111148841|NCT01655693|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111148842|NCT01655693|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111148843|NCT01655693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111148844|NCT01655693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111148845|NCT05090657|Chlorhexidine|chlorhexidine|mesh-list
111148846|NCT05090657|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
111148847|NCT05090657|Methylene Blue|methylene blue|mesh-list
111148848|NCT05090657|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111148849|NCT05090657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111148850|NCT05090657|Disinfectants|disinfectants|mesh-ancestor
111148851|NCT05090657|Dermatologic Agents|dermatologic agents|mesh-ancestor
111148852|NCT05090657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111148853|NCT05090657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111148854|NCT05048849|Somatomedin B|somatomedin b|mesh-list
111148855|NCT05048849|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
111148856|NCT05048849|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111148857|NCT05048849|Protease Inhibitors|protease inhibitors|mesh-ancestor
111148858|NCT05048849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111148859|NCT05048849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111148860|NCT01656161|Triptorelin Pamoate|triptorelin pamoate|mesh-list
111148861|NCT01656161|Luteolytic Agents|luteolytic agents|mesh-ancestor
111148862|NCT01656161|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111148863|NCT01656161|Contraceptive Agents|contraceptive agents|mesh-ancestor
111148864|NCT01656161|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110483498|NCT00988208|Glucocorticoids|glucocorticoids|mesh-ancestor
111148865|NCT01656161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111148866|NCT01656161|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111148867|NCT01656161|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111148868|NCT01656161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111148870|NCT05046431|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111148871|NCT05046431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111148872|NCT05046431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111148873|NCT05046431|Immunologic Factors|immunologic factors|mesh-ancestor
111148874|NCT05046431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111148875|NCT04751877|Dexamethasone|dexamethasone|mesh-list
111148876|NCT04751877|Lenalidomide|lenalidomide|mesh-list
111148877|NCT04751877|Bortezomib|bortezomib|mesh-list
111148878|NCT04751877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111148879|NCT04751877|Antiemetics|antiemetics|mesh-ancestor
111148880|NCT04751877|Autonomic Agents|autonomic agents|mesh-ancestor
111148881|NCT04751877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111148882|NCT04751877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111148883|NCT04751877|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111148884|NCT04751877|Glucocorticoids|glucocorticoids|mesh-ancestor
111148885|NCT04751877|Hormones|hormones|mesh-ancestor
111148886|NCT04751877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111148887|NCT04751877|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111148888|NCT04751877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111148889|NCT04751877|Immunologic Factors|immunologic factors|mesh-ancestor
111148890|NCT04751877|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111148891|NCT04751877|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111148892|NCT04751877|Growth Substances|growth substances|mesh-ancestor
111148893|NCT04751877|Growth Inhibitors|growth inhibitors|mesh-ancestor
111148894|NCT02147067|Ranolazine|ranolazine|mesh-list
111148895|NCT02147067|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111148896|NCT02147067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111148897|NCT02147067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111148898|NCT02107131|Ranibizumab|ranibizumab|mesh-list
110840247|NCT03320850|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111148899|NCT02107131|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111148900|NCT02107131|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111148901|NCT02107131|Growth Substances|growth substances|mesh-ancestor
111148902|NCT02107131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111148903|NCT02107131|Growth Inhibitors|growth inhibitors|mesh-ancestor
111148904|NCT02107131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111148905|NCT02106975|Ascorbic Acid|ascorbic acid|mesh-list
111148906|NCT02106975|Vitamins|vitamins|mesh-ancestor
111148907|NCT02106975|Micronutrients|micronutrients|mesh-ancestor
111148908|NCT02106975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111148909|NCT02106975|Antioxidants|antioxidants|mesh-ancestor
111148910|NCT02106975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111148911|NCT02106975|Protective Agents|protective agents|mesh-ancestor
111148912|NCT05133765|Insulin|insulin|mesh-list
111148913|NCT05133765|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111148914|NCT05133765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111148915|NCT02520011|Cytarabine|cytarabine|mesh-list
111148916|NCT02520011|Mitoxantrone|mitoxantrone|mesh-list
111148917|NCT02520011|Alvocidib|alvocidib|mesh-list
111148918|NCT02520011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111148919|NCT02520011|Antimetabolites|antimetabolites|mesh-ancestor
111148920|NCT02520011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111148921|NCT02520011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111148922|NCT02520011|Antiviral Agents|antiviral agents|mesh-ancestor
111148923|NCT02520011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111148924|NCT02520011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111148925|NCT02520011|Immunologic Factors|immunologic factors|mesh-ancestor
111148926|NCT02520011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111148927|NCT02520011|Analgesics|analgesics|mesh-ancestor
111148928|NCT02520011|Sensory System Agents|sensory system agents|mesh-ancestor
111148929|NCT02520011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111148930|NCT02520011|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111148931|NCT02520011|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111148932|NCT02520011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111148933|NCT02520011|Growth Inhibitors|growth inhibitors|mesh-ancestor
111148934|NCT02520011|Growth Substances|growth substances|mesh-ancestor
111148935|NCT02520011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111148936|NCT05037539|Fentanyl|fentanyl|mesh-list
111148937|NCT05037539|Morphine|morphine|mesh-list
111148938|NCT05037539|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111148939|NCT05037539|Narcotics|narcotics|mesh-ancestor
111148940|NCT05037539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111148941|NCT05037539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111148942|NCT05037539|Analgesics|analgesics|mesh-ancestor
111148943|NCT05037539|Sensory System Agents|sensory system agents|mesh-ancestor
111148944|NCT05037539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111148945|NCT05037539|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111148946|NCT05037539|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111148947|NCT05037539|Anesthetics, General|anesthetics, general|mesh-ancestor
111148948|NCT05037539|Anesthetics|anesthetics|mesh-ancestor
111148949|NCT02519231|Naproxen|naproxen|mesh-list
111148950|NCT02519231|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111148951|NCT02519231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111148952|NCT02519231|Analgesics|analgesics|mesh-ancestor
111148953|NCT02519231|Sensory System Agents|sensory system agents|mesh-ancestor
111148954|NCT02519231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111148955|NCT02519231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111148956|NCT02519231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111148957|NCT02519231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110483560|NCT04089553|Durvalumab|durvalumab|mesh-list
111148958|NCT02519231|Gout Suppressants|gout suppressants|mesh-ancestor
111148959|NCT02519231|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111148960|NCT02519231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111148961|NCT02519231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111148962|NCT02106351|Botulinum Toxins|botulinum toxins|mesh-list
111148963|NCT02106351|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111148964|NCT02106351|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111148965|NCT02106351|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111148966|NCT02106351|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111148967|NCT02106351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111148969|NCT02106351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111148970|NCT02106351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111148971|NCT02106351|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111148972|NCT02106351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111148973|NCT02075073|Trastuzumab|trastuzumab|mesh-list
111148974|NCT02075073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111148975|NCT02075073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111148976|NCT04738149|Bimatoprost|bimatoprost|mesh-list
111148977|NCT04738149|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111148978|NCT04995497|Lidocaine|lidocaine|mesh-list
111148979|NCT04995497|Anesthetics, Local|anesthetics, local|mesh-ancestor
111148980|NCT04995497|Anesthetics|anesthetics|mesh-ancestor
111148981|NCT04995497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111148982|NCT04995497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111148983|NCT04995497|Sensory System Agents|sensory system agents|mesh-ancestor
111148984|NCT04995497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111148985|NCT04995497|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111148986|NCT04995497|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111148987|NCT04995497|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111148988|NCT04995497|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111148989|NCT04995497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111148990|NCT05060627|Dexamethasone|dexamethasone|mesh-list
111148991|NCT05060627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111148992|NCT05060627|Antiemetics|antiemetics|mesh-ancestor
111148993|NCT05060627|Autonomic Agents|autonomic agents|mesh-ancestor
111148994|NCT05060627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111148995|NCT05060627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111148996|NCT05060627|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111148997|NCT05060627|Glucocorticoids|glucocorticoids|mesh-ancestor
111148998|NCT05060627|Hormones|hormones|mesh-ancestor
111148999|NCT05060627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111149000|NCT05060627|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111149001|NCT05060627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111149002|NCT04421105|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
111149003|NCT04421105|Hallucinogens|hallucinogens|mesh-ancestor
111149004|NCT04421105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111149005|NCT04421105|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111149006|NCT04421105|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111149007|NCT04421105|Serotonin Agents|serotonin agents|mesh-ancestor
111149008|NCT04421105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111149009|NCT04421105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111149010|NCT04421105|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111149011|NCT05024747|Nicotine|nicotine|mesh-list
111149012|NCT05024747|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111149013|NCT05024747|Autonomic Agents|autonomic agents|mesh-ancestor
111149014|NCT05024747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111149015|NCT05024747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111149016|NCT05024747|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111149017|NCT05024747|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111149018|NCT05024747|Cholinergic Agents|cholinergic agents|mesh-ancestor
111149019|NCT05024747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111149020|NCT05024747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111149021|NCT05056883|Ivermectin|ivermectin|mesh-list
111149022|NCT05056883|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111149023|NCT05056883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111149024|NCT04991597|Lidocaine|lidocaine|mesh-list
111149025|NCT04991597|Epinephrine|epinephrine|mesh-list
111149026|NCT04991597|Racepinephrine|racepinephrine|mesh-list
111149027|NCT04991597|Epinephryl borate|epinephryl borate|mesh-list
111149028|NCT04991597|Anesthetics, Local|anesthetics, local|mesh-ancestor
111149029|NCT04991597|Anesthetics|anesthetics|mesh-ancestor
111149030|NCT04991597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111149031|NCT04991597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111149032|NCT04991597|Sensory System Agents|sensory system agents|mesh-ancestor
111149033|NCT04991597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111149034|NCT04991597|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111149035|NCT04991597|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111149036|NCT04991597|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111149037|NCT04991597|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111149038|NCT04991597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111149039|NCT04991597|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111149040|NCT04991597|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111149041|NCT04991597|Adrenergic Agents|adrenergic agents|mesh-ancestor
111149042|NCT04991597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111149043|NCT04991597|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111149044|NCT04991597|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111149045|NCT04991597|Autonomic Agents|autonomic agents|mesh-ancestor
111149046|NCT04991597|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111149047|NCT04991597|Respiratory System Agents|respiratory system agents|mesh-ancestor
111149048|NCT04991597|Mydriatics|mydriatics|mesh-ancestor
111149049|NCT04991597|Sympathomimetics|sympathomimetics|mesh-ancestor
111149050|NCT04991597|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111149051|NCT04949867|Glucagon|glucagon|mesh-list
111149052|NCT04949867|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110676993|NCT03230734|Docetaxel|docetaxel|mesh-list
111149053|NCT04949867|Hormones|hormones|mesh-ancestor
111149054|NCT04949867|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111149055|NCT04949867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111149056|NCT05018117|Nicotine|nicotine|mesh-list
111149057|NCT05018117|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111149058|NCT05018117|Autonomic Agents|autonomic agents|mesh-ancestor
111149059|NCT05018117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111149060|NCT05018117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111149061|NCT05018117|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111149062|NCT05018117|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111149063|NCT05018117|Cholinergic Agents|cholinergic agents|mesh-ancestor
111149064|NCT05018117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111149065|NCT05018117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111149066|NCT05016869|Capecitabine|capecitabine|mesh-list
111149067|NCT05016869|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111149068|NCT05016869|Antimetabolites|antimetabolites|mesh-ancestor
111149069|NCT05016869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111149070|NCT05016869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111149071|NCT02141997|Adalimumab|adalimumab|mesh-list
111149072|NCT02141997|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111149073|NCT02141997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111149074|NCT02141997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111149075|NCT04411433|Azithromycin|azithromycin|mesh-list
111149076|NCT04411433|Hydroxychloroquine|hydroxychloroquine|mesh-list
111149077|NCT04411433|Favipiravir|favipiravir|mesh-list
111149078|NCT04411433|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111149079|NCT04411433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111149080|NCT04411433|Antimalarials|antimalarials|mesh-ancestor
111149081|NCT04411433|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111149082|NCT04411433|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111149083|NCT04411433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111149084|NCT04411433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111149085|NCT04411433|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111149086|NCT04411433|Antiviral Agents|antiviral agents|mesh-ancestor
111149087|NCT04987463|Sirolimus|sirolimus|mesh-list
111149088|NCT04987463|Vigabatrin|vigabatrin|mesh-list
111149089|NCT04987463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111149090|NCT04987463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111149091|NCT04987463|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111149092|NCT04987463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111149093|NCT04987463|Antifungal Agents|antifungal agents|mesh-ancestor
111149094|NCT04987463|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111149095|NCT04987463|Immunologic Factors|immunologic factors|mesh-ancestor
111149096|NCT04987463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111149097|NCT04987463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111149098|NCT04987463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111149099|NCT04987463|Anticonvulsants|anticonvulsants|mesh-ancestor
111149100|NCT04987463|GABA Agents|gaba agents|mesh-ancestor
111149101|NCT04987463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111149102|NCT05012735|Pantothenic Acid|pantothenic acid|mesh-list
111149103|NCT05012735|Provitamins|provitamins|mesh-list
111149104|NCT05012735|Vitamins|vitamins|mesh-ancestor
111149105|NCT05012735|Micronutrients|micronutrients|mesh-ancestor
111149106|NCT05012735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111149107|NCT05012735|Vitamin B Complex|vitamin b complex|mesh-ancestor
111149108|NCT02519777|Dolutegravir|dolutegravir|mesh-list
111149109|NCT02519777|Maraviroc|maraviroc|mesh-list
111149110|NCT02519777|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111149111|NCT02519777|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111149113|NCT02519777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111149114|NCT02519777|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111149115|NCT02519777|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111149116|NCT02519777|Antiviral Agents|antiviral agents|mesh-ancestor
111149117|NCT02519777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111149118|NCT02519777|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
111149119|NCT02519777|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
111149120|NCT02519777|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
111149121|NCT05008913|Adavosertib|adavosertib|mesh-list
111149122|NCT05008913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111149123|NCT05008913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111149124|NCT04982705|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111149125|NCT04982705|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111149126|NCT04982705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111149127|NCT04982705|Incretins|incretins|mesh-ancestor
111149128|NCT04982705|Hormones|hormones|mesh-ancestor
111149129|NCT04982705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111149130|NCT04982705|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111149131|NCT04982705|Protease Inhibitors|protease inhibitors|mesh-ancestor
111149132|NCT04982705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111149133|NCT04982705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111149134|NCT04944095|Antibodies|antibodies|mesh-list
111149135|NCT04944095|Immunologic Factors|immunologic factors|mesh-ancestor
111149136|NCT04944095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111149137|NCT02141295|Leucovorin|leucovorin|mesh-list
111149138|NCT02141295|Folic Acid|folic acid|mesh-list
111149139|NCT02141295|Bevacizumab|bevacizumab|mesh-list
111149140|NCT02141295|Oxaliplatin|oxaliplatin|mesh-list
111149141|NCT02141295|Levoleucovorin|levoleucovorin|mesh-list
111149142|NCT02141295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111149143|NCT02141295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111149144|NCT02141295|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111149145|NCT02141295|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111149146|NCT02141295|Growth Substances|growth substances|mesh-ancestor
111149147|NCT02141295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111149148|NCT02141295|Growth Inhibitors|growth inhibitors|mesh-ancestor
111149149|NCT02141295|Antidotes|antidotes|mesh-ancestor
111149150|NCT02141295|Protective Agents|protective agents|mesh-ancestor
111149151|NCT02141295|Vitamin B Complex|vitamin b complex|mesh-ancestor
111149152|NCT02141295|Vitamins|vitamins|mesh-ancestor
111149153|NCT02141295|Micronutrients|micronutrients|mesh-ancestor
111149154|NCT02141295|Hematinics|hematinics|mesh-ancestor
111149155|NCT02514551|Paclitaxel|paclitaxel|mesh-list
111149156|NCT02514551|Ramucirumab|ramucirumab|mesh-list
111149157|NCT02514551|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111149158|NCT02514551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111149159|NCT02514551|Tubulin Modulators|tubulin modulators|mesh-ancestor
111149160|NCT02514551|Antimitotic Agents|antimitotic agents|mesh-ancestor
111149161|NCT02514551|Mitosis Modulators|mitosis modulators|mesh-ancestor
111149162|NCT02514551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111149163|NCT02141217|Amoxicillin|amoxicillin|mesh-list
111149164|NCT02141217|Clindamycin|clindamycin|mesh-list
111149165|NCT02141217|Clindamycin palmitate|clindamycin palmitate|mesh-list
111149166|NCT02141217|Clindamycin phosphate|clindamycin phosphate|mesh-list
111149167|NCT02141217|Clavulanic Acid|clavulanic acid|mesh-list
111149168|NCT02141217|Clavulanic Acids|clavulanic acids|mesh-list
111149169|NCT02141217|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
111149170|NCT02141217|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111149171|NCT02141217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111149172|NCT02141217|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111149173|NCT02141217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111149174|NCT02141217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111149175|NCT02141217|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
111149176|NCT02514473|Ivacaftor|ivacaftor|mesh-list
111149177|NCT02514473|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
111149178|NCT02514473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111149179|NCT02514473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111149180|NCT02513771|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111149181|NCT02513771|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111149182|NCT02513771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111149183|NCT02513771|Incretins|incretins|mesh-ancestor
111149184|NCT02513771|Hormones|hormones|mesh-ancestor
111149185|NCT02513771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111149186|NCT02513771|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111149187|NCT02513771|Protease Inhibitors|protease inhibitors|mesh-ancestor
111149188|NCT02513771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111149189|NCT02513771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111149190|NCT02513459|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111149191|NCT02513459|Immunologic Factors|immunologic factors|mesh-ancestor
111149192|NCT02513459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111149193|NCT02069379|Metformin|metformin|mesh-list
111149194|NCT02069379|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111149195|NCT02069379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111149196|NCT02511431|Ritonavir|ritonavir|mesh-list
111149197|NCT02511431|Lonafarnib|lonafarnib|mesh-list
111149198|NCT02511431|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111149199|NCT02511431|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111149200|NCT02511431|Protease Inhibitors|protease inhibitors|mesh-ancestor
111149201|NCT02511431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111149202|NCT02511431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111149203|NCT02511431|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110866266|NCT03789318|Acetaminophen|acetaminophen|mesh-list
111149204|NCT02511431|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111149205|NCT02511431|Antiviral Agents|antiviral agents|mesh-ancestor
111149206|NCT02511431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111149207|NCT02511431|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111149208|NCT02511431|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111149209|NCT02137785|Aminolevulinic Acid|aminolevulinic acid|mesh-list
111149210|NCT02137785|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111149211|NCT02137785|Dermatologic Agents|dermatologic agents|mesh-ancestor
111149212|NCT05003453|Palmidrol|palmidrol|mesh-list
111149213|NCT05003453|Analgesics|analgesics|mesh-ancestor
111149214|NCT05003453|Sensory System Agents|sensory system agents|mesh-ancestor
111149215|NCT05003453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111149216|NCT05003453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111149217|NCT05003453|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111149218|NCT05003453|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111149219|NCT05003453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111149220|NCT05003453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111149221|NCT05003453|Antiviral Agents|antiviral agents|mesh-ancestor
111149222|NCT05003453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111149223|NCT05003453|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
111149224|NCT05003453|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
111149225|NCT05003453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111149226|NCT05003453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111149227|NCT05003453|Hormones|hormones|mesh-ancestor
111149228|NCT05003453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111149229|NCT01655069|Solifenacin Succinate|solifenacin succinate|mesh-list
111149230|NCT01655069|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111149231|NCT01655069|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111149232|NCT01655069|Cholinergic Agents|cholinergic agents|mesh-ancestor
111149233|NCT01655069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111149234|NCT01655069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111149235|NCT01655069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111149236|NCT01655069|Urological Agents|urological agents|mesh-ancestor
111149237|NCT01654601|Clozapine|clozapine|mesh-list
111149238|NCT01654601|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111149239|NCT01654601|Serotonin Agents|serotonin agents|mesh-ancestor
111149240|NCT01654601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111149241|NCT01654601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111149242|NCT01654601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111149243|NCT01654601|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111149244|NCT01654601|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111149245|NCT01654601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111149246|NCT01654601|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111149247|NCT01654601|GABA Antagonists|gaba antagonists|mesh-ancestor
111149248|NCT01654601|GABA Agents|gaba agents|mesh-ancestor
111149249|NCT04978649|Amlodipine|amlodipine|mesh-list
111149250|NCT04978649|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111149251|NCT04978649|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111149252|NCT04978649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111149253|NCT04978649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111149254|NCT04978649|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111149255|NCT04978649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111149256|NCT04978649|Vasodilator Agents|vasodilator agents|mesh-ancestor
111149257|NCT02508935|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
111149258|NCT02508935|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111149259|NCT02508935|Narcotics|narcotics|mesh-ancestor
111149260|NCT02508935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111149261|NCT02508935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111149262|NCT02508935|Analgesics|analgesics|mesh-ancestor
111149263|NCT02508935|Sensory System Agents|sensory system agents|mesh-ancestor
111149264|NCT02508935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111149265|NCT02508935|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111149266|NCT02508935|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111149267|NCT02508935|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111149268|NCT02508935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111149269|NCT02507375|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111149270|NCT02507375|Pertuzumab|pertuzumab|mesh-list
111149271|NCT02507375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111149272|NCT02507375|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111149273|NCT02507375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111149274|NCT02507375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111149275|NCT02507375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111149276|NCT02507219|Ibuprofen|ibuprofen|mesh-list
111149277|NCT02507219|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111149278|NCT02507219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111149280|NCT02507219|Sensory System Agents|sensory system agents|mesh-ancestor
111149281|NCT02507219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111149282|NCT02507219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111149283|NCT02507219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111149284|NCT02507219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111149285|NCT02507219|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111149286|NCT02507219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111149287|NCT02507219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111149288|NCT02483975|Albuterol|albuterol|mesh-list
111149289|NCT02483975|Montelukast|montelukast|mesh-list
111149290|NCT02483975|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111149291|NCT02483975|Respiratory System Agents|respiratory system agents|mesh-ancestor
111149292|NCT02483975|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
111149293|NCT02483975|Hormone Antagonists|hormone antagonists|mesh-ancestor
111149294|NCT02483975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111149295|NCT02483975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111149296|NCT02483975|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
111149297|NCT02483975|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111149298|NCT02483975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111149299|NCT02483975|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111149300|NCT02483975|Autonomic Agents|autonomic agents|mesh-ancestor
111149301|NCT02483975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111149302|NCT02483975|Tocolytic Agents|tocolytic agents|mesh-ancestor
111149303|NCT02483975|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111149304|NCT02483975|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111149305|NCT02483975|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111149306|NCT02483975|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111149307|NCT02483975|Adrenergic Agents|adrenergic agents|mesh-ancestor
111149308|NCT02483975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111149309|NCT02047227|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
111149310|NCT02047227|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
111149311|NCT02047227|Hormones|hormones|mesh-ancestor
111149312|NCT02047227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111149313|NCT02047227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111149314|NCT02047227|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111149315|NCT02483585|Erenumab|erenumab|mesh-list
111149316|NCT02483585|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
111149317|NCT02483585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111149318|NCT02483585|Analgesics|analgesics|mesh-ancestor
111149319|NCT02483585|Sensory System Agents|sensory system agents|mesh-ancestor
111149320|NCT02483585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111149321|NCT02483585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111149322|NCT02101983|Cytarabine|cytarabine|mesh-list
111149323|NCT02101983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111149324|NCT02101983|Antimetabolites|antimetabolites|mesh-ancestor
111149325|NCT02101983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111149326|NCT02101983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111149327|NCT02101983|Antiviral Agents|antiviral agents|mesh-ancestor
111149328|NCT02101983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111149329|NCT02101983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111149330|NCT02101983|Immunologic Factors|immunologic factors|mesh-ancestor
111149331|NCT02101983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111149332|NCT04974281|Lenvatinib|lenvatinib|mesh-list
111149333|NCT04974281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111149334|NCT04974281|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111149335|NCT04974281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111149336|NCT04974281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111149337|NCT02503865|Orlistat|orlistat|mesh-list
111149338|NCT02503865|Diltiazem|diltiazem|mesh-list
111149339|NCT02503865|Atorvastatin|atorvastatin|mesh-list
111149340|NCT02503865|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111149341|NCT02503865|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111149342|NCT02503865|Antimetabolites|antimetabolites|mesh-ancestor
111149343|NCT02503865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111149344|NCT02503865|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111149345|NCT02503865|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111149346|NCT02503865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111149347|NCT02503865|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111149348|NCT02503865|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111149349|NCT02503865|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111149350|NCT02503865|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111149351|NCT02503865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111149352|NCT02503865|Vasodilator Agents|vasodilator agents|mesh-ancestor
111149353|NCT02503865|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111149354|NCT02481947|Laxatives|laxatives|mesh-list
111149355|NCT02481947|Lubiprostone|lubiprostone|mesh-list
111149356|NCT02481947|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
111149357|NCT02481947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111149358|NCT02481947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111149359|NCT02481947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111149360|NCT02503085|Ibuprofen|ibuprofen|mesh-list
111149361|NCT02503085|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111149362|NCT02503085|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111149363|NCT02503085|Analgesics|analgesics|mesh-ancestor
111149364|NCT02503085|Sensory System Agents|sensory system agents|mesh-ancestor
111149365|NCT02503085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111149366|NCT02503085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111149367|NCT02503085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111149368|NCT02503085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111149369|NCT02503085|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111149370|NCT02503085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111149371|NCT02503085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111149373|NCT02502149|Coagulants|coagulants|mesh-ancestor
111149374|NCT02480621|Bupivacaine|bupivacaine|mesh-list
111149375|NCT02480621|Anesthetics, Local|anesthetics, local|mesh-ancestor
111149376|NCT02480621|Anesthetics|anesthetics|mesh-ancestor
111149377|NCT02480621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111149378|NCT02480621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111149379|NCT02480621|Sensory System Agents|sensory system agents|mesh-ancestor
111149380|NCT02480621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111149381|NCT02046603|Methotrexate|methotrexate|mesh-list
111149382|NCT02046603|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111149383|NCT02046603|Abortifacient Agents|abortifacient agents|mesh-ancestor
111149384|NCT02046603|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111149385|NCT02046603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111149386|NCT02046603|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111149387|NCT02046603|Antimetabolites|antimetabolites|mesh-ancestor
111149388|NCT02046603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111149389|NCT02046603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111149390|NCT02046603|Dermatologic Agents|dermatologic agents|mesh-ancestor
111149391|NCT02046603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111149392|NCT02046603|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111149393|NCT02046603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111149394|NCT02046603|Immunologic Factors|immunologic factors|mesh-ancestor
111149395|NCT02046603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111149396|NCT02046603|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111149397|NCT02046369|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
111149398|NCT02046369|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111149399|NCT02046369|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111149400|NCT02046369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111149401|NCT02046369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111149402|NCT02046369|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111149403|NCT02046369|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
111149404|NCT02046369|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111149405|NCT02046369|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111149406|NCT02046369|Adrenergic Agents|adrenergic agents|mesh-ancestor
111149407|NCT02046369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111149408|NCT02046369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111149409|NCT02046369|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111149410|NCT02046369|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111149411|NCT02046369|Serotonin Agents|serotonin agents|mesh-ancestor
111149412|NCT02046369|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111149413|NCT02046369|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111149414|NCT02046369|Dopamine Agents|dopamine agents|mesh-ancestor
111149415|NCT02101359|Tetracaine|tetracaine|mesh-list
111149416|NCT02101359|Tropicamide|tropicamide|mesh-list
111149417|NCT02101359|Mydriatics|mydriatics|mesh-list
111149418|NCT02101359|Anesthetics, Local|anesthetics, local|mesh-ancestor
111149419|NCT02101359|Anesthetics|anesthetics|mesh-ancestor
111149420|NCT02101359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111149421|NCT02101359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111149422|NCT02101359|Sensory System Agents|sensory system agents|mesh-ancestor
111149423|NCT02101359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111149424|NCT02101359|Autonomic Agents|autonomic agents|mesh-ancestor
111149425|NCT02101359|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111149426|NCT02101359|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111149427|NCT02101359|Cholinergic Agents|cholinergic agents|mesh-ancestor
111149428|NCT02101359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111149429|NCT02101359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111149430|NCT02100969|Immunoglobulins|immunoglobulins|mesh-list
111149431|NCT02100969|gamma-Globulins|gamma-globulins|mesh-list
111149432|NCT02100969|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111149433|NCT02100969|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
111149434|NCT02100969|Immunologic Factors|immunologic factors|mesh-ancestor
111149435|NCT02100969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111149436|NCT01885000|Brimonidine Tartrate|brimonidine tartrate|mesh-list
111149437|NCT01885000|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111149438|NCT01885000|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111149439|NCT01885000|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111149440|NCT01885000|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111149441|NCT01885000|Adrenergic Agents|adrenergic agents|mesh-ancestor
111149442|NCT01885000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111149443|NCT01885000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111149444|NCT01885000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111149445|NCT01883362|Midostaurin|midostaurin|mesh-list
111149446|NCT01883362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111149447|NCT01883362|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111149448|NCT01883362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111149449|NCT01883362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111149450|NCT04724967|Dimenhydrinate|dimenhydrinate|mesh-list
111149451|NCT04724967|Antiemetics|antiemetics|mesh-ancestor
111149452|NCT04724967|Autonomic Agents|autonomic agents|mesh-ancestor
111149453|NCT04724967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111149454|NCT04724967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111149455|NCT04724967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111149456|NCT04724967|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111149457|NCT04724967|Histamine Antagonists|histamine antagonists|mesh-ancestor
111149458|NCT04724967|Histamine Agents|histamine agents|mesh-ancestor
111149459|NCT04724967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111149460|NCT04724967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111149461|NCT02045979|Adalimumab|adalimumab|mesh-list
111149462|NCT02045979|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111149463|NCT02045979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111149464|NCT02045979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111149465|NCT04703751|Nitroglycerin|nitroglycerin|mesh-list
111149466|NCT04703751|Vasodilator Agents|vasodilator agents|mesh-ancestor
111149467|NCT04734405|Fluconazole|fluconazole|mesh-list
111149468|NCT04734405|Antifungal Agents|antifungal agents|mesh-ancestor
111149469|NCT04734405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111149470|NCT04734405|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111149471|NCT04734405|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111149472|NCT04734405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111149473|NCT04734405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111149474|NCT04734405|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111149475|NCT04734405|Hormone Antagonists|hormone antagonists|mesh-ancestor
111149476|NCT04734405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111149477|NCT04734405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111149478|NCT04734405|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111149479|NCT04734405|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111149480|NCT01911442|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
111149481|NCT01911442|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111149482|NCT01911442|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111149483|NCT01911442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111149484|NCT01911442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111149485|NCT01911442|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111149486|NCT01911442|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
111149487|NCT01911442|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111149488|NCT01911442|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111149489|NCT01911442|Adrenergic Agents|adrenergic agents|mesh-ancestor
111149490|NCT01911442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111149491|NCT01911442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111149492|NCT01911442|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111149493|NCT01911442|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111149494|NCT01911442|Serotonin Agents|serotonin agents|mesh-ancestor
111149495|NCT01911442|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111149497|NCT01911442|Dopamine Agents|dopamine agents|mesh-ancestor
111149498|NCT01928758|Nicotine|nicotine|mesh-list
111149499|NCT01928758|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111149500|NCT01928758|Autonomic Agents|autonomic agents|mesh-ancestor
111149501|NCT01928758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111149502|NCT01928758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111149503|NCT01928758|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111149504|NCT01928758|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111149505|NCT01928758|Cholinergic Agents|cholinergic agents|mesh-ancestor
111149506|NCT01928758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111149507|NCT01928758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111149508|NCT01614886|Rivastigmine|rivastigmine|mesh-list
111149509|NCT01614886|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111149510|NCT01614886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111149511|NCT01614886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111149512|NCT01614886|Cholinergic Agents|cholinergic agents|mesh-ancestor
111149513|NCT01614886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111149514|NCT01614886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111149515|NCT01614886|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111149516|NCT01614886|Protective Agents|protective agents|mesh-ancestor
111149517|NCT04622254|Botulinum Toxins|botulinum toxins|mesh-list
111149518|NCT04622254|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111149519|NCT04622254|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111149520|NCT04622254|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
111149521|NCT04622254|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111149522|NCT04622254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111149523|NCT04622254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111149524|NCT04622254|Cholinergic Agents|cholinergic agents|mesh-ancestor
111149525|NCT04622254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111149526|NCT04622254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111149527|NCT04622254|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111149528|NCT04622254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111149529|NCT04171726|Edoxaban|edoxaban|mesh-list
111149530|NCT04171726|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111149531|NCT04171726|Antithrombins|antithrombins|mesh-ancestor
111149532|NCT04171726|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111149533|NCT04171726|Protease Inhibitors|protease inhibitors|mesh-ancestor
111149534|NCT04171726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111149535|NCT04171726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111149536|NCT04171726|Anticoagulants|anticoagulants|mesh-ancestor
111149537|NCT02100657|Dexamethasone|dexamethasone|mesh-list
111149538|NCT02100657|Bortezomib|bortezomib|mesh-list
111149539|NCT02100657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111149540|NCT02100657|Antiemetics|antiemetics|mesh-ancestor
110483634|NCT00719095|Naltrexone|naltrexone|mesh-list
111149541|NCT02100657|Autonomic Agents|autonomic agents|mesh-ancestor
111149542|NCT02100657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111149543|NCT02100657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111149544|NCT02100657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111149545|NCT02100657|Glucocorticoids|glucocorticoids|mesh-ancestor
111149546|NCT02100657|Hormones|hormones|mesh-ancestor
111149547|NCT02100657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111149548|NCT02100657|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111149549|NCT02100657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111149550|NCT02067663|Levonorgestrel|levonorgestrel|mesh-list
111149551|NCT02067663|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111149552|NCT02067663|Contraceptive Agents|contraceptive agents|mesh-ancestor
111149553|NCT02067663|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111149554|NCT02067663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111149555|NCT02067663|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111149556|NCT02067663|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111149557|NCT02067663|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111149558|NCT01909804|Ribavirin|ribavirin|mesh-list
111149559|NCT01909804|Antiviral Agents|antiviral agents|mesh-ancestor
111149560|NCT01909804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111149561|NCT01909804|Antimetabolites|antimetabolites|mesh-ancestor
111149562|NCT01909804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111149563|NCT01880086|Clomiphene|clomiphene|mesh-list
111149564|NCT01880086|Enclomiphene|enclomiphene|mesh-list
111149565|NCT01880086|Zuclomiphene|zuclomiphene|mesh-list
111149566|NCT01880086|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111149567|NCT01880086|Hormone Antagonists|hormone antagonists|mesh-ancestor
111149568|NCT01880086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111149569|NCT01880086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110866649|NCT02653092|Heparin|heparin|mesh-list
111149570|NCT01880086|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111149571|NCT01880086|Fertility Agents|fertility agents|mesh-ancestor
111149572|NCT01880086|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111149573|NCT01880086|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111149574|NCT01880086|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111149575|NCT01879618|Dalteparin|dalteparin|mesh-list
111149576|NCT01879618|Anticoagulants|anticoagulants|mesh-ancestor
111149577|NCT01879618|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111149578|NCT01879618|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111149579|NCT01879618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110579531|NCT02610881|Iron|iron|mesh-list
111149580|NCT01926886|Trastuzumab|trastuzumab|mesh-list
111149581|NCT01926886|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111149582|NCT01926886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111149583|NCT01909336|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111149584|NCT01925950|Beclomethasone|beclomethasone|mesh-list
111149585|NCT01925950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111149586|NCT01925950|Glucocorticoids|glucocorticoids|mesh-ancestor
111149587|NCT01925950|Hormones|hormones|mesh-ancestor
111149588|NCT01925950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111149589|NCT01925950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111149590|NCT01925950|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111149591|NCT01925950|Respiratory System Agents|respiratory system agents|mesh-ancestor
111149592|NCT04415320|Ensartinib|ensartinib|mesh-list
111149593|NCT04415320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111149594|NCT04415320|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111149595|NCT04415320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111149596|NCT04415320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111149597|NCT01878292|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
111149598|NCT01878292|Antidepressive Agents|antidepressive agents|mesh-ancestor
111149599|NCT01878292|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111149600|NCT01878292|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111149601|NCT01878292|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111149602|NCT01878292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111149603|NCT01878292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111149604|NCT01878292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111149605|NCT01878292|Serotonin Agents|serotonin agents|mesh-ancestor
111149606|NCT01878292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111149607|NCT01878292|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111149608|NCT01878292|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111149609|NCT01907854|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111149610|NCT01907854|Liraglutide|liraglutide|mesh-list
111149611|NCT01907854|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111149612|NCT01907854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111149613|NCT01907854|Incretins|incretins|mesh-ancestor
111149614|NCT01907854|Hormones|hormones|mesh-ancestor
111149615|NCT01907854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111149616|NCT01907854|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111149617|NCT01907854|Protease Inhibitors|protease inhibitors|mesh-ancestor
111149618|NCT01907854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111149619|NCT01907854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111149620|NCT02480153|Adalimumab|adalimumab|mesh-list
111149621|NCT02480153|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111149622|NCT02480153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111149623|NCT02480153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111149624|NCT04972253|Infigratinib|infigratinib|mesh-list
111149625|NCT04972253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111149626|NCT02500979|Insulin|insulin|mesh-list
111149627|NCT02500979|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111149628|NCT02500979|Insulin Lispro|insulin lispro|mesh-list
111149629|NCT02500979|Pramlintide|pramlintide|mesh-list
111149630|NCT02500979|Islet Amyloid Polypeptide|islet amyloid polypeptide|mesh-list
111149631|NCT02500979|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111149632|NCT02500979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111149633|NCT02500979|Appetite Depressants|appetite depressants|mesh-ancestor
111149634|NCT02500979|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111149635|NCT02500979|Amylin Receptor Agonists|amylin receptor agonists|mesh-ancestor
111149636|NCT02500979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111149638|NCT02500901|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111149639|NCT02500901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111149640|NCT02500901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111149641|NCT02500901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111149642|NCT01877668|Adalimumab|adalimumab|mesh-list
111149643|NCT01877668|Tofacitinib|tofacitinib|mesh-list
111149644|NCT01877668|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111149645|NCT01877668|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111149646|NCT01877668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111149647|NCT01877668|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
111149648|NCT01877668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111149649|NCT01877668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111149650|NCT01877668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111149651|NCT01906372|Hormones|hormones|mesh-list
111149652|NCT01906372|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
111149653|NCT01906372|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
111149654|NCT01906372|beta-Endorphin|beta-endorphin|mesh-list
111149655|NCT01906372|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111149656|NCT01906372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111149657|NCT01906372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111149658|NCT01906372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111149659|NCT01925170|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
111149660|NCT01925170|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111149661|NCT01925170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111149662|NCT01876810|Gemfibrozil|gemfibrozil|mesh-list
111149663|NCT01876810|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111149664|NCT01876810|Antimetabolites|antimetabolites|mesh-ancestor
111149665|NCT01876810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111149666|NCT01876810|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111149667|NCT01876810|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
111149668|NCT01876810|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111149669|NCT01876810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111149670|NCT01876732|Vitamin B 12|vitamin b 12|mesh-list
111149671|NCT01876732|Hydroxocobalamin|hydroxocobalamin|mesh-list
111149672|NCT01876732|Vitamins|vitamins|mesh-ancestor
111149673|NCT01876732|Micronutrients|micronutrients|mesh-ancestor
111149674|NCT01876732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111149675|NCT01876732|Vitamin B Complex|vitamin b complex|mesh-ancestor
111149676|NCT01876732|Hematinics|hematinics|mesh-ancestor
111149677|NCT01905592|Niraparib|niraparib|mesh-list
111149678|NCT01905592|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111149679|NCT01905592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111149680|NCT01905592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111149681|NCT01905592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111149682|NCT02500121|Pembrolizumab|pembrolizumab|mesh-list
111149683|NCT02500121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111149684|NCT02500121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111149685|NCT02500121|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111149686|NCT02500121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111149687|NCT01875250|Metronidazole|metronidazole|mesh-list
111149688|NCT01875250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111149689|NCT01875250|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111149690|NCT01875250|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111149691|NCT01875250|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111149692|NCT01904032|Vitamin D|vitamin d|mesh-list
111149693|NCT01904032|Ergocalciferols|ergocalciferols|mesh-list
111149694|NCT01904032|Cholecalciferol|cholecalciferol|mesh-list
111149695|NCT01904032|Vitamins|vitamins|mesh-list
111149696|NCT01904032|Micronutrients|micronutrients|mesh-ancestor
111149697|NCT01904032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111149698|NCT01904032|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111149699|NCT01904032|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111149700|NCT01921270|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111149701|NCT01921270|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111149702|NCT01921270|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111149703|NCT01921270|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111149704|NCT01921270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111149705|NCT01921270|Cholinergic Agents|cholinergic agents|mesh-ancestor
111149706|NCT01921270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111149707|NCT01921270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111149708|NCT01921270|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111149709|NCT01921270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111149710|NCT02325739|Spartalizumab|spartalizumab|mesh-list
111149711|NCT02325739|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111149712|NCT02325739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111149713|NCT02325739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111149714|NCT02325739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111149715|NCT01903720|Dexamethasone|dexamethasone|mesh-list
110866785|NCT03182296|Hormones|hormones|mesh-ancestor
111149716|NCT01903720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111149717|NCT01903720|Antiemetics|antiemetics|mesh-ancestor
111149718|NCT01903720|Autonomic Agents|autonomic agents|mesh-ancestor
111149719|NCT01903720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111149720|NCT01903720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111149721|NCT01903720|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111149722|NCT01903720|Glucocorticoids|glucocorticoids|mesh-ancestor
111149723|NCT01903720|Hormones|hormones|mesh-ancestor
111149724|NCT01903720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111149725|NCT01903720|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111149726|NCT01903720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111149727|NCT02366689|Triclosan|triclosan|mesh-list
111149728|NCT02366689|Cetylpyridinium|cetylpyridinium|mesh-list
111149729|NCT02366689|Fluorides|fluorides|mesh-list
111149730|NCT02366689|Tin Fluorides|tin fluorides|mesh-list
111149731|NCT02366689|Cariostatic Agents|cariostatic agents|mesh-ancestor
111149732|NCT02366689|Protective Agents|protective agents|mesh-ancestor
111149733|NCT02366689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111149734|NCT02366689|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111149735|NCT02366689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111149736|NCT02366689|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
111149737|NCT02366689|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111149738|NCT02366689|Antimetabolites|antimetabolites|mesh-ancestor
111149739|NCT02366689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111149740|NCT02366689|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111149741|NCT01903252|Mesalamine|mesalamine|mesh-list
111149742|NCT01903252|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111149743|NCT01903252|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111149744|NCT01903252|Analgesics|analgesics|mesh-ancestor
111149745|NCT01903252|Sensory System Agents|sensory system agents|mesh-ancestor
111149746|NCT01903252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111149747|NCT01903252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111149748|NCT01903252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111149749|NCT01903252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111149750|NCT01613716|Dexamethasone|dexamethasone|mesh-list
111149751|NCT01613716|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111149752|NCT01613716|Antiemetics|antiemetics|mesh-ancestor
111149753|NCT01613716|Autonomic Agents|autonomic agents|mesh-ancestor
111149754|NCT01613716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111149755|NCT01613716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111149756|NCT01613716|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111149757|NCT01613716|Glucocorticoids|glucocorticoids|mesh-ancestor
111149758|NCT01613716|Hormones|hormones|mesh-ancestor
111149759|NCT01613716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111149760|NCT01613716|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111149761|NCT01613716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111149762|NCT05112952|Lazertinib|lazertinib|mesh-list
111149763|NCT05112952|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111149764|NCT05112952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111149765|NCT05112952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111149766|NCT01872910|Celecoxib|celecoxib|mesh-list
111149767|NCT01872910|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111149768|NCT01872910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111149770|NCT01872910|Sensory System Agents|sensory system agents|mesh-ancestor
111149771|NCT01872910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111149772|NCT01872910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111149773|NCT01872910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111149774|NCT01872910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111149775|NCT01872910|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111149776|NCT01872910|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111149777|NCT01872910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111149778|NCT01872910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111149779|NCT01920568|Vitamin D|vitamin d|mesh-list
111149780|NCT01920568|Zoledronic Acid|zoledronic acid|mesh-list
111149781|NCT01920568|Denosumab|denosumab|mesh-list
111149782|NCT01920568|Calcium|calcium|mesh-list
111149783|NCT01920568|Vitamins|vitamins|mesh-ancestor
111149784|NCT01920568|Micronutrients|micronutrients|mesh-ancestor
111149785|NCT01920568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111149786|NCT01920568|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111149787|NCT01920568|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111149788|NCT01901848|Bupropion|bupropion|mesh-list
111149789|NCT01901848|Nicotine|nicotine|mesh-list
111149790|NCT01901848|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111149791|NCT01901848|Autonomic Agents|autonomic agents|mesh-ancestor
110866861|NCT05602675|Antimetabolites|antimetabolites|mesh-ancestor
111149792|NCT01901848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111149793|NCT01901848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111149794|NCT01901848|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111149795|NCT01901848|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111149796|NCT01901848|Cholinergic Agents|cholinergic agents|mesh-ancestor
111149797|NCT01901848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111149798|NCT01901848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111149799|NCT01901848|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111149800|NCT01901848|Antidepressive Agents|antidepressive agents|mesh-ancestor
111149801|NCT01901848|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111149802|NCT01901848|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111149803|NCT01901848|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111149804|NCT01901848|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111149805|NCT01901848|Dopamine Agents|dopamine agents|mesh-ancestor
111149806|NCT01901848|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111149807|NCT01901848|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111149808|NCT01901848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111149809|NCT01901614|Anesthetics|anesthetics|mesh-list
111149810|NCT01901614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111149811|NCT01901614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111149812|NCT02499575|Bupivacaine|bupivacaine|mesh-list
111149813|NCT02499575|Ropivacaine|ropivacaine|mesh-list
111149814|NCT02499575|Anesthetics, Local|anesthetics, local|mesh-ancestor
111149815|NCT02499575|Anesthetics|anesthetics|mesh-ancestor
111149816|NCT02499575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111149817|NCT02499575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111149818|NCT02499575|Sensory System Agents|sensory system agents|mesh-ancestor
111149819|NCT02499575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111149820|NCT02065791|Canagliflozin|canagliflozin|mesh-list
111149821|NCT02065791|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111149822|NCT02065791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111149823|NCT02065791|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111149824|NCT02065791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111149825|NCT02499029|Acetylcysteine|acetylcysteine|mesh-list
111149826|NCT02499029|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111149827|NCT02499029|Antiviral Agents|antiviral agents|mesh-ancestor
111149828|NCT02499029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111149829|NCT02499029|Expectorants|expectorants|mesh-ancestor
111149830|NCT02499029|Respiratory System Agents|respiratory system agents|mesh-ancestor
111149831|NCT02499029|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111149832|NCT02499029|Antioxidants|antioxidants|mesh-ancestor
111149833|NCT02499029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111149834|NCT02499029|Protective Agents|protective agents|mesh-ancestor
111149835|NCT02499029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111149836|NCT02499029|Antidotes|antidotes|mesh-ancestor
111149837|NCT04939883|Carvedilol|carvedilol|mesh-list
111149838|NCT04939883|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111149839|NCT04939883|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111149840|NCT04939883|Adrenergic Agents|adrenergic agents|mesh-ancestor
111149841|NCT04939883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111149842|NCT04939883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111149843|NCT04939883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111149844|NCT04939883|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111149845|NCT04939883|Antioxidants|antioxidants|mesh-ancestor
111149846|NCT04939883|Protective Agents|protective agents|mesh-ancestor
111149847|NCT04939883|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111149848|NCT04939883|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111149849|NCT04939883|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111149850|NCT04939883|Vasodilator Agents|vasodilator agents|mesh-ancestor
111149851|NCT04939883|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111149852|NCT04939883|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111149853|NCT02065713|Golimumab|golimumab|mesh-list
111149854|NCT02065713|Methotrexate|methotrexate|mesh-list
111149855|NCT02065713|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111149856|NCT02065713|Abortifacient Agents|abortifacient agents|mesh-ancestor
111149857|NCT02065713|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111149858|NCT02065713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111149859|NCT02065713|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111149860|NCT02065713|Antimetabolites|antimetabolites|mesh-ancestor
111149861|NCT02065713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111149862|NCT02065713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111149863|NCT02065713|Dermatologic Agents|dermatologic agents|mesh-ancestor
111149864|NCT02065713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111149865|NCT02065713|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111149866|NCT02065713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111149867|NCT02065713|Immunologic Factors|immunologic factors|mesh-ancestor
111149868|NCT02065713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111149869|NCT02065713|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111149870|NCT02065713|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111149871|NCT02065713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111149872|NCT02497781|Ceftazidime|ceftazidime|mesh-list
111149873|NCT02497781|Cefepime|cefepime|mesh-list
111149874|NCT02497781|Avibactam|avibactam|mesh-list
110483683|NCT00612495|Fluorouracil|fluorouracil|mesh-list
111149875|NCT02497781|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
111149876|NCT02497781|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111149877|NCT02497781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111149878|NCT02497781|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
111149879|NCT02497781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111149880|NCT02497781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111149881|NCT02497469|Adalimumab|adalimumab|mesh-list
111149882|NCT02497469|Vedolizumab|vedolizumab|mesh-list
111149883|NCT02497469|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111149884|NCT02497469|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111149885|NCT02497469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111149886|NCT02497469|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111149887|NCT02497391|Evacetrapib|evacetrapib|mesh-list
111149888|NCT02497391|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111149889|NCT02497391|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111149890|NCT02497391|Antimetabolites|antimetabolites|mesh-ancestor
111149891|NCT02497391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111149892|NCT02497391|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111149893|NCT02476175|Mirabegron|mirabegron|mesh-list
111149894|NCT02476175|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
111149895|NCT02476175|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111149896|NCT02476175|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111149898|NCT02476175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111149899|NCT02476175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111149900|NCT02476175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111149901|NCT02476175|Urological Agents|urological agents|mesh-ancestor
111149902|NCT02065557|Adalimumab|adalimumab|mesh-list
111149903|NCT02065557|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111149904|NCT02065557|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111149905|NCT02065557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111149906|NCT02065245|Penicillins|penicillins|mesh-list
111149907|NCT02065245|Streptomycin|streptomycin|mesh-list
111149908|NCT02065245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111149909|NCT02065245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111149910|NCT02065245|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111149911|NCT02065245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111149912|NCT02065245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111149913|NCT02063217|Sodium Oxybate|sodium oxybate|mesh-list
111149914|NCT02063217|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111149915|NCT02063217|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111149916|NCT02063217|Anesthetics, General|anesthetics, general|mesh-ancestor
111149917|NCT02063217|Anesthetics|anesthetics|mesh-ancestor
111149918|NCT02063217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111149919|NCT02063217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111149920|NCT02497001|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
111149921|NCT02497001|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111149922|NCT02497001|Respiratory System Agents|respiratory system agents|mesh-ancestor
111149923|NCT04182555|Bilirubin|bilirubin|mesh-list
111149924|NCT04182555|Antioxidants|antioxidants|mesh-ancestor
111149925|NCT04182555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111149926|NCT04182555|Protective Agents|protective agents|mesh-ancestor
111149927|NCT04182555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111149928|NCT02366143|Paclitaxel|paclitaxel|mesh-list
111149929|NCT02366143|Bevacizumab|bevacizumab|mesh-list
111149930|NCT02366143|Carboplatin|carboplatin|mesh-list
111149931|NCT02366143|Atezolizumab|atezolizumab|mesh-list
111149932|NCT02366143|Antibodies|antibodies|mesh-list
111149933|NCT02366143|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111149934|NCT02366143|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111149935|NCT02366143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111149936|NCT02366143|Tubulin Modulators|tubulin modulators|mesh-ancestor
111149937|NCT02366143|Antimitotic Agents|antimitotic agents|mesh-ancestor
111149938|NCT02366143|Mitosis Modulators|mitosis modulators|mesh-ancestor
111149939|NCT02366143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111149940|NCT02366143|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111149941|NCT02366143|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111149942|NCT02366143|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111149943|NCT02366143|Growth Substances|growth substances|mesh-ancestor
111149944|NCT02366143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110413284|NCT03909165|Atropine|atropine|mesh-list
111149945|NCT02366143|Growth Inhibitors|growth inhibitors|mesh-ancestor
111149946|NCT02366143|Immunologic Factors|immunologic factors|mesh-ancestor
111149947|NCT02366143|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111149948|NCT02098395|Liraglutide|liraglutide|mesh-list
111149949|NCT02098395|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111149950|NCT02098395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111149951|NCT02098395|Incretins|incretins|mesh-ancestor
111149952|NCT02098395|Hormones|hormones|mesh-ancestor
111149953|NCT02098395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111149954|NCT02365519|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111149955|NCT02365519|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111149956|NCT02096835|Dexamethasone|dexamethasone|mesh-list
111149957|NCT02096835|Tropisetron|tropisetron|mesh-list
111149958|NCT02096835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111149959|NCT02096835|Antiemetics|antiemetics|mesh-ancestor
111149960|NCT02096835|Autonomic Agents|autonomic agents|mesh-ancestor
111149961|NCT02096835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111149962|NCT02096835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111149963|NCT02096835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111149964|NCT02096835|Glucocorticoids|glucocorticoids|mesh-ancestor
111149965|NCT02096835|Hormones|hormones|mesh-ancestor
111149966|NCT02096835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111149967|NCT02096835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111149968|NCT02096835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111149969|NCT02096835|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111149970|NCT02096835|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111149971|NCT02096835|Serotonin Agents|serotonin agents|mesh-ancestor
111149972|NCT02096835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111149973|NCT02096835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111149974|NCT02294773|Letrozole|letrozole|mesh-list
111149975|NCT02294773|Clomiphene|clomiphene|mesh-list
111149976|NCT02294773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111149977|NCT02294773|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111149978|NCT02294773|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111149979|NCT02294773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111149980|NCT02294773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111149981|NCT02294773|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111149982|NCT02294773|Hormone Antagonists|hormone antagonists|mesh-ancestor
111149983|NCT02294773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111149984|NCT02294773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111149985|NCT02294773|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111149986|NCT02294773|Fertility Agents|fertility agents|mesh-ancestor
111149987|NCT02294773|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111149988|NCT02294773|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111149989|NCT02294773|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111149990|NCT02365285|Heparin|heparin|mesh-list
111149991|NCT02365285|Galantamine|galantamine|mesh-list
111149992|NCT02365285|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
111149993|NCT02365285|Anticoagulants|anticoagulants|mesh-ancestor
111149994|NCT02365285|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111149995|NCT02365285|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111149996|NCT02365285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111149997|NCT02365285|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
111149998|NCT02365285|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
110483703|NCT00719173|Antiemetics|antiemetics|mesh-ancestor
111149999|NCT02365285|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111150000|NCT02365285|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111150001|NCT02365285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111150002|NCT02365285|Cholinergic Agents|cholinergic agents|mesh-ancestor
111150003|NCT02365285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111150004|NCT02365285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111150005|NCT02365285|Parasympathomimetics|parasympathomimetics|mesh-ancestor
111150006|NCT02365285|Autonomic Agents|autonomic agents|mesh-ancestor
111150007|NCT02365285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111150008|NCT02365285|Nootropic Agents|nootropic agents|mesh-ancestor
111150009|NCT02041299|Deferiprone|deferiprone|mesh-list
111150010|NCT02041299|Deferoxamine|deferoxamine|mesh-list
111150011|NCT02041299|Iron Chelating Agents|iron chelating agents|mesh-ancestor
111150012|NCT02041299|Chelating Agents|chelating agents|mesh-ancestor
111150013|NCT02041299|Sequestering Agents|sequestering agents|mesh-ancestor
111150014|NCT02041299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110867087|NCT03689114|Anticonvulsants|anticonvulsants|mesh-list
111150015|NCT02041299|Siderophores|siderophores|mesh-ancestor
111150016|NCT01645735|Vancomycin|vancomycin|mesh-list
111150017|NCT01645735|Ceftriaxone|ceftriaxone|mesh-list
111150018|NCT01645735|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
111150019|NCT01645735|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111150020|NCT01645735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111150021|NCT01645111|Clevidipine|clevidipine|mesh-list
111150022|NCT01645111|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111150023|NCT01645111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111150024|NCT01645111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111150025|NCT01645111|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111150026|NCT01645111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111150027|NCT02364037|Contraceptive Agents|contraceptive agents|mesh-list
111150028|NCT02364037|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111150029|NCT02364037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111150030|NCT01919164|Mitogens|mitogens|mesh-list
111150031|NCT01919164|Mitosis Modulators|mitosis modulators|mesh-ancestor
111150032|NCT01919164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111150033|NCT01901224|Metformin|metformin|mesh-list
111150034|NCT01901224|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111150035|NCT01901224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111150037|NCT01901146|Trastuzumab|trastuzumab|mesh-list
111150038|NCT01901146|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111150039|NCT01901146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111150040|NCT01901146|Tubulin Modulators|tubulin modulators|mesh-ancestor
111150041|NCT01901146|Antimitotic Agents|antimitotic agents|mesh-ancestor
111150042|NCT01901146|Mitosis Modulators|mitosis modulators|mesh-ancestor
111150043|NCT01901146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111150044|NCT01901146|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111150045|NCT01644643|Metronidazole|metronidazole|mesh-list
111150046|NCT01644643|Ceftazidime|ceftazidime|mesh-list
111150047|NCT01644643|Avibactam|avibactam|mesh-list
111150048|NCT01644643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111150049|NCT01644643|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111150050|NCT01644643|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111150051|NCT01644643|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111150052|NCT01644643|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
111150053|NCT01644643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111150054|NCT01644643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111150055|NCT01864174|Metformin|metformin|mesh-list
111150056|NCT01864174|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111150057|NCT01864174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111150058|NCT04420351|Aspirin|aspirin|mesh-list
111150059|NCT04420351|Clopidogrel|clopidogrel|mesh-list
111150060|NCT04420351|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111150061|NCT04420351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111150062|NCT04420351|Analgesics|analgesics|mesh-ancestor
111150063|NCT04420351|Sensory System Agents|sensory system agents|mesh-ancestor
111150064|NCT04420351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111150065|NCT04420351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111150066|NCT04420351|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111150067|NCT04420351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111150068|NCT04420351|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111150069|NCT04420351|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111150070|NCT04420351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111150071|NCT04420351|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111150072|NCT04420351|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111150073|NCT04420351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111150074|NCT04420351|Antipyretics|antipyretics|mesh-ancestor
111150075|NCT04420351|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111150076|NCT04420351|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111150077|NCT04420351|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111150078|NCT04420351|Purinergic Agents|purinergic agents|mesh-ancestor
111150079|NCT04420351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111150080|NCT01900444|Vaccines|vaccines|mesh-list
111150081|NCT01900444|Immunologic Factors|immunologic factors|mesh-ancestor
111150082|NCT01900444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111150083|NCT02496221|rGLP-1 protein|rglp-1 protein|mesh-list
111150084|NCT02496221|Incretins|incretins|mesh-ancestor
111150085|NCT02496221|Hormones|hormones|mesh-ancestor
111150086|NCT02496221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111150087|NCT02496221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111150088|NCT02475629|Ibalizumab|ibalizumab|mesh-list
111150089|NCT02475629|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111150090|NCT02475629|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111150091|NCT02475629|Antiviral Agents|antiviral agents|mesh-ancestor
111150092|NCT02475629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111150093|NCT01653743|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
111150094|NCT01653743|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
111150095|NCT01653743|Hormones|hormones|mesh-ancestor
111150096|NCT01653743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111150097|NCT01653743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111150098|NCT01653743|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111150099|NCT02293993|Guadecitabine|guadecitabine|mesh-list
111150100|NCT02293993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111150101|NCT02322775|Benralizumab|benralizumab|mesh-list
111150102|NCT02322775|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111150103|NCT02322775|Respiratory System Agents|respiratory system agents|mesh-ancestor
111150104|NCT01646827|Aripiprazole|aripiprazole|mesh-list
111150105|NCT01646827|Antidepressive Agents|antidepressive agents|mesh-ancestor
111150106|NCT01646827|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111150108|NCT01646827|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111150109|NCT01646827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111150110|NCT01646827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111150111|NCT01646827|Dopamine Agonists|dopamine agonists|mesh-ancestor
111150112|NCT01646827|Dopamine Agents|dopamine agents|mesh-ancestor
111150113|NCT01646827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111150114|NCT01646827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111150115|NCT01646827|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111150116|NCT01646827|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111150117|NCT01646827|Serotonin Agents|serotonin agents|mesh-ancestor
111150118|NCT01646827|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111150119|NCT01646827|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111150120|NCT01646827|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111150121|NCT01646827|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111150122|NCT02360995|Triclosan|triclosan|mesh-list
111150123|NCT02360995|Cetylpyridinium|cetylpyridinium|mesh-list
111150124|NCT02360995|Fluorides|fluorides|mesh-list
111150125|NCT02360995|Tin Fluorides|tin fluorides|mesh-list
111150126|NCT02360995|Cariostatic Agents|cariostatic agents|mesh-ancestor
111150127|NCT02360995|Protective Agents|protective agents|mesh-ancestor
111150128|NCT02360995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111150129|NCT02360995|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111150130|NCT02360995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111150131|NCT02360995|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
111150132|NCT02360995|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111150133|NCT02360995|Antimetabolites|antimetabolites|mesh-ancestor
110483775|NCT02686047|Hylan|hylan|mesh-list
111150134|NCT02360995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111150135|NCT02360995|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111150136|NCT02359903|Infliximab|infliximab|mesh-list
111150137|NCT02359903|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111150138|NCT02359903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111150139|NCT02359903|Dermatologic Agents|dermatologic agents|mesh-ancestor
111150140|NCT02359903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111150141|NCT02359903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111150142|NCT02291419|Aspirin|aspirin|mesh-list
111150143|NCT02291419|Ticagrelor|ticagrelor|mesh-list
111150144|NCT02291419|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111150145|NCT02291419|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111150146|NCT02291419|Analgesics|analgesics|mesh-ancestor
111150147|NCT02291419|Sensory System Agents|sensory system agents|mesh-ancestor
111150148|NCT02291419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111150149|NCT02291419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111150150|NCT02291419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111150151|NCT02291419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111150152|NCT02291419|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111150153|NCT02291419|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111150154|NCT02291419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111150155|NCT02291419|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111150156|NCT02291419|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111150157|NCT02291419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111150158|NCT02291419|Antipyretics|antipyretics|mesh-ancestor
111150159|NCT02291419|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111150160|NCT02291419|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111150161|NCT02291419|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111150162|NCT02291419|Purinergic Agents|purinergic agents|mesh-ancestor
111150163|NCT02291419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111150164|NCT02319031|Ribavirin|ribavirin|mesh-list
111150165|NCT02319031|Sofosbuvir|sofosbuvir|mesh-list
110867237|NCT03988907|Midazolam|midazolam|mesh-list
111150166|NCT02319031|Antimetabolites|antimetabolites|mesh-ancestor
111150167|NCT02319031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111150168|NCT02319031|Antiviral Agents|antiviral agents|mesh-ancestor
111150169|NCT02319031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111150170|NCT02359435|Amoxicillin|amoxicillin|mesh-list
111150171|NCT02359435|Metronidazole|metronidazole|mesh-list
111150172|NCT02359435|Clarithromycin|clarithromycin|mesh-list
111150173|NCT02359435|Pantoprazole|pantoprazole|mesh-list
111150174|NCT02359435|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111150175|NCT02359435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111150176|NCT02359435|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111150177|NCT02359435|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111150179|NCT02359435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111150180|NCT02359435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111150181|NCT02359435|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111150182|NCT02359435|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111150183|NCT02359435|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111150184|NCT02359435|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111150185|NCT02359435|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111150186|NCT04599868|Magnesium Sulfate|magnesium sulfate|mesh-list
111150187|NCT04599868|Analgesics|analgesics|mesh-ancestor
111150188|NCT04599868|Sensory System Agents|sensory system agents|mesh-ancestor
111150189|NCT04599868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111150190|NCT04599868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111150191|NCT04599868|Anesthetics|anesthetics|mesh-ancestor
111150192|NCT04599868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111150193|NCT04599868|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111150194|NCT04599868|Anticonvulsants|anticonvulsants|mesh-ancestor
111150195|NCT04599868|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111150196|NCT04599868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111150197|NCT04599868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111150198|NCT04599868|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111150199|NCT04599868|Tocolytic Agents|tocolytic agents|mesh-ancestor
111150200|NCT04599868|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111150201|NCT01900054|Bepotastine besilate|bepotastine besilate|mesh-list
111150202|NCT01900054|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111150203|NCT01612156|Lidocaine|lidocaine|mesh-list
111150204|NCT01612156|Anesthetics, Local|anesthetics, local|mesh-ancestor
111150205|NCT01612156|Anesthetics|anesthetics|mesh-ancestor
111150206|NCT01612156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111150207|NCT01612156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111150208|NCT01612156|Sensory System Agents|sensory system agents|mesh-ancestor
111150209|NCT01612156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111150210|NCT01612156|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111150211|NCT01612156|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111150212|NCT01612156|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111150213|NCT01612156|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111150214|NCT01612156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111150215|NCT01899742|Tiotropium Bromide|tiotropium bromide|mesh-list
111150216|NCT01899742|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111150217|NCT01899742|Autonomic Agents|autonomic agents|mesh-ancestor
111150218|NCT01899742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111150219|NCT01899742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111150220|NCT01899742|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111150221|NCT01899742|Respiratory System Agents|respiratory system agents|mesh-ancestor
111150222|NCT01899742|Parasympatholytics|parasympatholytics|mesh-ancestor
111150223|NCT01899742|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111150224|NCT01899742|Cholinergic Agents|cholinergic agents|mesh-ancestor
111150225|NCT01899742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111150226|NCT01899742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111150227|NCT01615822|Artefenomel|artefenomel|mesh-list
111150228|NCT01615822|Antimalarials|antimalarials|mesh-ancestor
111150229|NCT01615822|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111150230|NCT01615822|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111150231|NCT01615822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111150232|NCT01613326|Glycopyrrolate|glycopyrrolate|mesh-list
111150233|NCT01613326|Albuterol|albuterol|mesh-list
111150234|NCT01613326|Tiotropium Bromide|tiotropium bromide|mesh-list
111150235|NCT01613326|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111150236|NCT01613326|Autonomic Agents|autonomic agents|mesh-ancestor
111150237|NCT01613326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111150238|NCT01613326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111150239|NCT01613326|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111150240|NCT01613326|Respiratory System Agents|respiratory system agents|mesh-ancestor
111150241|NCT01613326|Parasympatholytics|parasympatholytics|mesh-ancestor
111150242|NCT01613326|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111150243|NCT01613326|Cholinergic Agents|cholinergic agents|mesh-ancestor
111150244|NCT01613326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111150245|NCT01613326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111150246|NCT01613326|Tocolytic Agents|tocolytic agents|mesh-ancestor
111150247|NCT01613326|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111150248|NCT01613326|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111150249|NCT01613326|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111150250|NCT01613326|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111150251|NCT01613326|Adrenergic Agents|adrenergic agents|mesh-ancestor
111150252|NCT01613326|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111150253|NCT01613326|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111150254|NCT01898806|Triamcinolone|triamcinolone|mesh-list
111150255|NCT01898806|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
111150256|NCT01898806|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
111150257|NCT01898806|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
111150258|NCT01898806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111150259|NCT01898806|Glucocorticoids|glucocorticoids|mesh-ancestor
111150260|NCT01898806|Hormones|hormones|mesh-ancestor
111150261|NCT01898806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111150262|NCT01898806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111150263|NCT01898806|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111150264|NCT01898806|Immunologic Factors|immunologic factors|mesh-ancestor
111150265|NCT01898806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111150266|NCT01898806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111150267|NCT02291029|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111150268|NCT02291029|Immunologic Factors|immunologic factors|mesh-ancestor
111150269|NCT02291029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111150270|NCT02290873|Midazolam|midazolam|mesh-list
111150271|NCT02290873|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111150272|NCT02290873|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111150273|NCT02290873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111150274|NCT02290873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111150275|NCT02290873|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111150276|NCT02290873|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111150277|NCT02290873|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111150278|NCT02290873|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111150279|NCT02290873|Anesthetics, General|anesthetics, general|mesh-ancestor
111150280|NCT02290873|Anesthetics|anesthetics|mesh-ancestor
111150281|NCT02290873|GABA Modulators|gaba modulators|mesh-ancestor
111150282|NCT02290873|GABA Agents|gaba agents|mesh-ancestor
111150283|NCT02290873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111150284|NCT02290873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111150285|NCT02358343|Sertraline|sertraline|mesh-list
111150286|NCT02358343|Antidepressive Agents|antidepressive agents|mesh-list
111150287|NCT02358343|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111150288|NCT02358343|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111150289|NCT02358343|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111150290|NCT02358343|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111150291|NCT02358343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111150292|NCT02358343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111150293|NCT02358343|Serotonin Agents|serotonin agents|mesh-ancestor
111150294|NCT02358343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111150295|NCT02318095|Paclitaxel|paclitaxel|mesh-list
111150296|NCT02318095|Gemcitabine|gemcitabine|mesh-list
111150297|NCT02318095|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111150298|NCT02318095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111150299|NCT02318095|Tubulin Modulators|tubulin modulators|mesh-ancestor
111150300|NCT02318095|Antimitotic Agents|antimitotic agents|mesh-ancestor
111150301|NCT02318095|Mitosis Modulators|mitosis modulators|mesh-ancestor
111150302|NCT02318095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111150303|NCT02318095|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111150304|NCT02318095|Antimetabolites|antimetabolites|mesh-ancestor
111150305|NCT02317627|Belumosudil|belumosudil|mesh-list
111150306|NCT02317627|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111150307|NCT02317627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111150308|NCT02317627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111150309|NCT02517905|Bupivacaine|bupivacaine|mesh-list
111150310|NCT02517905|Anesthetics, Local|anesthetics, local|mesh-ancestor
111150311|NCT02517905|Anesthetics|anesthetics|mesh-ancestor
111150312|NCT02517905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111150313|NCT02517905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111150314|NCT02517905|Sensory System Agents|sensory system agents|mesh-ancestor
111150315|NCT02517905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111150317|NCT02473913|Antioxidants|antioxidants|mesh-ancestor
111150318|NCT02473913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111150319|NCT02473913|Protective Agents|protective agents|mesh-ancestor
111150320|NCT02473913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111150321|NCT02316847|Diazepam|diazepam|mesh-list
111150322|NCT02316847|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111150323|NCT02316847|Anticonvulsants|anticonvulsants|mesh-ancestor
111150324|NCT02316847|Antiemetics|antiemetics|mesh-ancestor
111150325|NCT02316847|Autonomic Agents|autonomic agents|mesh-ancestor
111150326|NCT02316847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111150327|NCT02316847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111150328|NCT02316847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111150329|NCT02316847|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111150330|NCT02316847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111150331|NCT02316847|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
111150332|NCT02316847|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111150333|NCT02316847|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111150334|NCT02316847|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111150335|NCT02316847|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111150336|NCT02316847|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111150337|NCT02316847|Anesthetics, General|anesthetics, general|mesh-ancestor
111150338|NCT02316847|Anesthetics|anesthetics|mesh-ancestor
111150339|NCT02316847|GABA Modulators|gaba modulators|mesh-ancestor
111150340|NCT02316847|GABA Agents|gaba agents|mesh-ancestor
111150341|NCT02316847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111150342|NCT02316847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111150343|NCT02473445|Cysteamine|cysteamine|mesh-list
111150344|NCT02473445|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
111150345|NCT02473445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111150346|NCT02473367|Raltegravir Potassium|raltegravir potassium|mesh-list
111150347|NCT02473367|Antacids|antacids|mesh-list
111150348|NCT02473367|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111150349|NCT02473367|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111150350|NCT02473367|Antiviral Agents|antiviral agents|mesh-ancestor
111150351|NCT02473367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111150352|NCT02473367|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111150353|NCT02473367|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111150354|NCT02473367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111150355|NCT02473367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111150356|NCT02473367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111150357|NCT04965701|Osimertinib|osimertinib|mesh-list
111150358|NCT04965701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111150359|NCT04965701|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111150360|NCT04965701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111150361|NCT04965701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111150362|NCT02316613|Rituximab|rituximab|mesh-list
111150363|NCT02316613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111150364|NCT02316613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111150365|NCT02316613|Immunologic Factors|immunologic factors|mesh-ancestor
111150366|NCT02316613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111150367|NCT02316613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111150368|NCT02492165|Vaccines|vaccines|mesh-list
111150369|NCT02492165|Immunologic Factors|immunologic factors|mesh-ancestor
111150370|NCT02492165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111150371|NCT02354599|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111150372|NCT02354599|Immunologic Factors|immunologic factors|mesh-ancestor
111150373|NCT02354599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111150374|NCT02286895|Vaccines|vaccines|mesh-list
111150375|NCT02286895|Immunologic Factors|immunologic factors|mesh-ancestor
111150376|NCT02286895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111150377|NCT02472977|Nivolumab|nivolumab|mesh-list
111150378|NCT02472977|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111150379|NCT02472977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111150380|NCT02472977|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111150381|NCT02472977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111150382|NCT02060487|Sildenafil Citrate|sildenafil citrate|mesh-list
111150383|NCT02060487|Citric Acid|citric acid|mesh-list
111150384|NCT02060487|Sodium Citrate|sodium citrate|mesh-list
111150385|NCT02060487|Anticoagulants|anticoagulants|mesh-ancestor
111150386|NCT02060487|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
111150387|NCT02060487|Chelating Agents|chelating agents|mesh-ancestor
111150388|NCT02060487|Sequestering Agents|sequestering agents|mesh-ancestor
111150389|NCT02060487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111150390|NCT02060487|Vasodilator Agents|vasodilator agents|mesh-ancestor
111150391|NCT02060487|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111150392|NCT02060487|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111150393|NCT02060487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111150394|NCT02060487|Urological Agents|urological agents|mesh-ancestor
111150395|NCT02059239|Cytarabine|cytarabine|mesh-list
111150396|NCT02059239|Rituximab|rituximab|mesh-list
111150397|NCT02059239|Alemtuzumab|alemtuzumab|mesh-list
111150398|NCT02059239|Etoposide|etoposide|mesh-list
111150399|NCT02059239|Melphalan|melphalan|mesh-list
111150400|NCT02059239|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
111150401|NCT02059239|Carmustine|carmustine|mesh-list
111150402|NCT02059239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111150403|NCT02059239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111150404|NCT02059239|Immunologic Factors|immunologic factors|mesh-ancestor
111150405|NCT02059239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111150406|NCT02059239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111150407|NCT02059239|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111150408|NCT02059239|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111150409|NCT02059239|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111150410|NCT02059239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111150411|NCT02059239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111150412|NCT02059239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111150413|NCT02059239|Antimetabolites|antimetabolites|mesh-ancestor
111150414|NCT02059239|Antiviral Agents|antiviral agents|mesh-ancestor
111150415|NCT02059239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111150416|NCT02059239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111150417|NCT02059239|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111150418|NCT02059239|Alkylating Agents|alkylating agents|mesh-ancestor
111150419|NCT02059239|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111150420|NCT02059161|Insulin|insulin|mesh-list
111150421|NCT02059161|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111150422|NCT02059161|Insulin Glargine|insulin glargine|mesh-list
111150423|NCT02059161|MK-1293|mk-1293|mesh-list
111150424|NCT02059161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111150425|NCT02059161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111150426|NCT02059161|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111150427|NCT02059161|Antimetabolites|antimetabolites|mesh-ancestor
111150428|NCT02059161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111150429|NCT02059161|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111150430|NCT01897714|Dexamethasone|dexamethasone|mesh-list
111150431|NCT01897714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111150432|NCT01897714|Antiemetics|antiemetics|mesh-ancestor
111150433|NCT01897714|Autonomic Agents|autonomic agents|mesh-ancestor
111150434|NCT01897714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111150435|NCT01897714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111150436|NCT01897714|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111150437|NCT01897714|Glucocorticoids|glucocorticoids|mesh-ancestor
111150438|NCT01897714|Hormones|hormones|mesh-ancestor
111150439|NCT01897714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111150440|NCT01897714|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111150441|NCT01897714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111150442|NCT01861522|Bepotastine besilate|bepotastine besilate|mesh-list
111150443|NCT01861522|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111150444|NCT01860976|Abatacept|abatacept|mesh-list
111150445|NCT01860976|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111150446|NCT01860976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111150447|NCT01860976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111150448|NCT01860976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111150449|NCT01860976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111150450|NCT01860976|Immunologic Factors|immunologic factors|mesh-ancestor
111150451|NCT01860976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111150452|NCT01860976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111150453|NCT01860040|Gemcitabine|gemcitabine|mesh-list
111150454|NCT01860040|Pemetrexed|pemetrexed|mesh-list
111150455|NCT01860040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111150456|NCT01860040|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111150457|NCT01860040|Antimetabolites|antimetabolites|mesh-ancestor
111150458|NCT01860040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111150459|NCT01860040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111150460|NCT01860040|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111150461|NCT01860040|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111150462|NCT04618744|Insulin|insulin|mesh-list
111150463|NCT04618744|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111150464|NCT04618744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111150465|NCT04618744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111150466|NCT01896934|Sertraline|sertraline|mesh-list
110867546|NCT05032950|Anesthetics|anesthetics|mesh-ancestor
111150468|NCT01896934|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111150469|NCT01896934|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111150470|NCT01896934|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111150471|NCT01896934|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111150472|NCT01896934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111150473|NCT01896934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111150474|NCT01896934|Serotonin Agents|serotonin agents|mesh-ancestor
111150475|NCT01896934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111150476|NCT02039505|Vedolizumab|vedolizumab|mesh-list
111150477|NCT02039505|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111150478|NCT02095197|Triamcinolone|triamcinolone|mesh-list
111150479|NCT02095197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111150480|NCT02095197|Glucocorticoids|glucocorticoids|mesh-ancestor
111150481|NCT02095197|Hormones|hormones|mesh-ancestor
111150482|NCT02095197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111150483|NCT02095197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111150484|NCT02039427|Dexamethasone|dexamethasone|mesh-list
111150485|NCT02039427|Ketorolac|ketorolac|mesh-list
111150486|NCT02039427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111150487|NCT02039427|Antiemetics|antiemetics|mesh-ancestor
111150488|NCT02039427|Autonomic Agents|autonomic agents|mesh-ancestor
111150489|NCT02039427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111150490|NCT02039427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111150491|NCT02039427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111150492|NCT02039427|Glucocorticoids|glucocorticoids|mesh-ancestor
111150493|NCT02039427|Hormones|hormones|mesh-ancestor
111150494|NCT02039427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111150495|NCT02039427|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111150496|NCT02039427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111150497|NCT02039427|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111150498|NCT02039427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111150499|NCT02039427|Analgesics|analgesics|mesh-ancestor
111150500|NCT02039427|Sensory System Agents|sensory system agents|mesh-ancestor
111150501|NCT02039427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111150502|NCT02039427|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111150503|NCT02039427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111150504|NCT02039427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111150505|NCT02094885|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
111150506|NCT02094885|Hemostatics|hemostatics|mesh-ancestor
111150507|NCT02094885|Coagulants|coagulants|mesh-ancestor
111150508|NCT01896856|Trifluridine|trifluridine|mesh-list
111150509|NCT01896856|Irinotecan|irinotecan|mesh-list
111150510|NCT01896856|Guadecitabine|guadecitabine|mesh-list
111150511|NCT01896856|Azacitidine|azacitidine|mesh-list
111150512|NCT01896856|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111150513|NCT01896856|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111150514|NCT01896856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111150515|NCT01896856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111150516|NCT01896856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111150517|NCT01896856|Antimetabolites|antimetabolites|mesh-ancestor
111150518|NCT01896856|Antiviral Agents|antiviral agents|mesh-ancestor
111150519|NCT01896856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111150520|NCT01896856|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111150521|NCT01896700|Methylphenidate|methylphenidate|mesh-list
111150522|NCT01896700|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111150523|NCT01896700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111150524|NCT01896700|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111150525|NCT01896700|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111150526|NCT01896700|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111150527|NCT01896700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111150528|NCT01896700|Dopamine Agents|dopamine agents|mesh-ancestor
111150529|NCT01896700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111150531|NCT01896232|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111150532|NCT01896232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111150533|NCT01896232|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
111150534|NCT01896232|Hormone Antagonists|hormone antagonists|mesh-ancestor
111150535|NCT01896232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111150536|NCT02460224|Spartalizumab|spartalizumab|mesh-list
111150537|NCT02460224|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111150538|NCT02460224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110867619|NCT01354743|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111150539|NCT02460224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111150540|NCT02460224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111150541|NCT02058537|Bethanechol|bethanechol|mesh-list
111150542|NCT02058537|Parasympathomimetics|parasympathomimetics|mesh-ancestor
111150543|NCT02058537|Autonomic Agents|autonomic agents|mesh-ancestor
111150544|NCT02058537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111150545|NCT02058537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111150546|NCT02058537|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
111150547|NCT02058537|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111150548|NCT02058537|Cholinergic Agents|cholinergic agents|mesh-ancestor
111150549|NCT02058537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111150550|NCT02058537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111150551|NCT01612000|Hemagglutinins|hemagglutinins|mesh-list
111150552|NCT01612000|Agglutinins|agglutinins|mesh-ancestor
111150553|NCT01612000|Immunologic Factors|immunologic factors|mesh-ancestor
111150554|NCT01612000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111150555|NCT01612000|Coagulants|coagulants|mesh-ancestor
111150556|NCT02409680|Aspirin|aspirin|mesh-list
111150557|NCT02409680|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111150558|NCT02409680|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111150559|NCT02409680|Analgesics|analgesics|mesh-ancestor
111150560|NCT02409680|Sensory System Agents|sensory system agents|mesh-ancestor
111150561|NCT02409680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111150562|NCT02409680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111150563|NCT02409680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111150564|NCT02409680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111150565|NCT02409680|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110483895|NCT04290884|Hemostatics|hemostatics|mesh-ancestor
111150566|NCT02409680|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111150567|NCT02409680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111150568|NCT02409680|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111150569|NCT02409680|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111150570|NCT02409680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111150571|NCT02409680|Antipyretics|antipyretics|mesh-ancestor
111150572|NCT01894984|Risperidone|risperidone|mesh-list
111150573|NCT01894984|Antipsychotic Agents|antipsychotic agents|mesh-list
111150574|NCT01894984|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111150575|NCT01894984|Serotonin Agents|serotonin agents|mesh-ancestor
111150576|NCT01894984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111150577|NCT01894984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111150578|NCT01894984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111150579|NCT01894984|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111150580|NCT01894984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111150581|NCT01894984|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111150582|NCT01894984|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111150583|NCT01894984|Dopamine Agents|dopamine agents|mesh-ancestor
111150584|NCT02375672|Pembrolizumab|pembrolizumab|mesh-list
111150585|NCT02375672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111150586|NCT02375672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111150587|NCT02375672|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111150588|NCT02375672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111150589|NCT02491463|Vaccines|vaccines|mesh-list
111150590|NCT02491463|Immunologic Factors|immunologic factors|mesh-ancestor
111150591|NCT02491463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111150592|NCT02038881|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
111150593|NCT02038881|Antiviral Agents|antiviral agents|mesh-ancestor
111150594|NCT02038881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111150596|NCT01857622|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111150597|NCT01857622|Antithrombins|antithrombins|mesh-ancestor
111150598|NCT01857622|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111150599|NCT01857622|Protease Inhibitors|protease inhibitors|mesh-ancestor
111150600|NCT01857622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111150601|NCT01857622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111150602|NCT01857622|Anticoagulants|anticoagulants|mesh-ancestor
111150603|NCT01857310|Folic Acid|folic acid|mesh-list
111150604|NCT01857310|Hematinics|hematinics|mesh-ancestor
111150605|NCT01857310|Vitamin B Complex|vitamin b complex|mesh-ancestor
111150606|NCT01857310|Vitamins|vitamins|mesh-ancestor
111150607|NCT01857310|Micronutrients|micronutrients|mesh-ancestor
111150608|NCT01857310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111150609|NCT02472353|Metformin|metformin|mesh-list
111150610|NCT02472353|Doxorubicin|doxorubicin|mesh-list
111150611|NCT02472353|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111150612|NCT02472353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111150613|NCT02472353|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111150614|NCT02472353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111150615|NCT02472353|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111150616|NCT02472353|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111150617|NCT02472353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111150618|NCT02472353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111150619|NCT02314117|Fluorouracil|fluorouracil|mesh-list
111150620|NCT02314117|Capecitabine|capecitabine|mesh-list
111150621|NCT02314117|Ramucirumab|ramucirumab|mesh-list
111150622|NCT02314117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111150623|NCT02314117|Antimetabolites|antimetabolites|mesh-ancestor
111150624|NCT02314117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111150625|NCT02314117|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111150626|NCT02314117|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111150627|NCT02314117|Immunologic Factors|immunologic factors|mesh-ancestor
111150628|NCT02314117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111150629|NCT02058147|Insulin|insulin|mesh-list
111150630|NCT02058147|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111150631|NCT02058147|Metformin|metformin|mesh-list
111150632|NCT02058147|Insulin Glargine|insulin glargine|mesh-list
111150633|NCT02058147|Lixisenatide|lixisenatide|mesh-list
111150634|NCT02058147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111150635|NCT02058147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111150636|NCT02489981|Tiotropium Bromide|tiotropium bromide|mesh-list
111150637|NCT02489981|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111150638|NCT02489981|Autonomic Agents|autonomic agents|mesh-ancestor
111150639|NCT02489981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111150640|NCT02489981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111150641|NCT02489981|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111150642|NCT02489981|Respiratory System Agents|respiratory system agents|mesh-ancestor
111150643|NCT02489981|Parasympatholytics|parasympatholytics|mesh-ancestor
111150644|NCT02489981|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111150645|NCT02489981|Cholinergic Agents|cholinergic agents|mesh-ancestor
111150646|NCT02489981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111150647|NCT02489981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111150648|NCT02471183|Selexipag|selexipag|mesh-list
111150649|NCT02471183|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111150650|NCT04964063|Listerine|listerine|mesh-list
111150651|NCT04964063|Fluorides|fluorides|mesh-list
111150652|NCT04964063|Sodium Fluoride|sodium fluoride|mesh-list
111150653|NCT04964063|Cariostatic Agents|cariostatic agents|mesh-ancestor
111150654|NCT04964063|Protective Agents|protective agents|mesh-ancestor
111150655|NCT04964063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111150656|NCT04964063|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111150657|NCT04964063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111150658|NCT04204967|Fentanyl|fentanyl|mesh-list
111150659|NCT04204967|Remifentanil|remifentanil|mesh-list
111150660|NCT04204967|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111150661|NCT04204967|Narcotics|narcotics|mesh-ancestor
111150662|NCT04204967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111150663|NCT04204967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111150664|NCT04204967|Analgesics|analgesics|mesh-ancestor
111150665|NCT04204967|Sensory System Agents|sensory system agents|mesh-ancestor
111150666|NCT04204967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111150667|NCT04204967|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110840406|NCT03297021|Antipruritics|antipruritics|mesh-ancestor
111150668|NCT04204967|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111150670|NCT04204967|Anesthetics|anesthetics|mesh-ancestor
111150671|NCT01855828|Paclitaxel|paclitaxel|mesh-list
111150672|NCT01855828|Cyclophosphamide|cyclophosphamide|mesh-list
111150673|NCT01855828|Fluorouracil|fluorouracil|mesh-list
111150674|NCT01855828|Trastuzumab|trastuzumab|mesh-list
111150675|NCT01855828|Epirubicin|epirubicin|mesh-list
111150676|NCT01855828|Pertuzumab|pertuzumab|mesh-list
111150677|NCT01855828|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111150678|NCT01855828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111150679|NCT01855828|Tubulin Modulators|tubulin modulators|mesh-ancestor
111150680|NCT01855828|Antimitotic Agents|antimitotic agents|mesh-ancestor
111150681|NCT01855828|Mitosis Modulators|mitosis modulators|mesh-ancestor
111150682|NCT01855828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111150683|NCT01855828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111150684|NCT01855828|Immunologic Factors|immunologic factors|mesh-ancestor
111150685|NCT01855828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111150686|NCT01855828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111150687|NCT01855828|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111150688|NCT01855828|Alkylating Agents|alkylating agents|mesh-ancestor
111150689|NCT01855828|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111150690|NCT01855828|Antimetabolites|antimetabolites|mesh-ancestor
111150691|NCT01855828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111150692|NCT01855828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111150693|NCT01855828|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111150694|NCT01855828|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111150695|NCT01855828|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111150696|NCT01855828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111150697|NCT04417335|BCG Vaccine|bcg vaccine|mesh-list
111150698|NCT04417335|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111150699|NCT04417335|Immunologic Factors|immunologic factors|mesh-ancestor
111150700|NCT04417335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111150701|NCT02351167|Nicotine|nicotine|mesh-list
111150702|NCT02351167|Varenicline|varenicline|mesh-list
111150703|NCT02351167|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111150704|NCT02351167|Autonomic Agents|autonomic agents|mesh-ancestor
111150705|NCT02351167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111150706|NCT02351167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111150707|NCT02351167|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111150708|NCT02351167|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111150709|NCT02351167|Cholinergic Agents|cholinergic agents|mesh-ancestor
111150710|NCT02351167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111150711|NCT02351167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111150712|NCT02350309|Lemborexant|lemborexant|mesh-list
111150713|NCT02350309|Flurazepam|flurazepam|mesh-list
111150714|NCT02350309|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
111150715|NCT02350309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111150716|NCT02350309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111150717|NCT02350309|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111150718|NCT02350309|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111150719|NCT02350309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111150720|NCT02350309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111150721|NCT02350309|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111150722|NCT02350309|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111150723|NCT02350309|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111150724|NCT02350309|GABA Modulators|gaba modulators|mesh-ancestor
111150725|NCT02350309|GABA Agents|gaba agents|mesh-ancestor
111150726|NCT02038647|Paclitaxel|paclitaxel|mesh-list
111150727|NCT02038647|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111150728|NCT02038647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111150729|NCT02038647|Tubulin Modulators|tubulin modulators|mesh-ancestor
111150730|NCT02038647|Antimitotic Agents|antimitotic agents|mesh-ancestor
111150731|NCT02038647|Mitosis Modulators|mitosis modulators|mesh-ancestor
111150732|NCT02038647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111150733|NCT02057757|Nitazoxanide|nitazoxanide|mesh-list
111150734|NCT02057757|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111150735|NCT02057757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111150736|NCT02037477|Esomeprazole|esomeprazole|mesh-list
111150737|NCT02037477|Rabeprazole|rabeprazole|mesh-list
111150738|NCT02037477|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111150739|NCT02037477|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111150740|NCT02037477|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111150741|NCT02037477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111150742|NCT02037477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111150743|NCT02057523|Hormones|hormones|mesh-list
111150744|NCT02057523|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
111150745|NCT02057523|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
111150746|NCT02057523|beta-Endorphin|beta-endorphin|mesh-list
111150747|NCT02057523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111150748|NCT02057523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111150749|NCT02057523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111150750|NCT02057523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111150751|NCT02037165|Celecoxib|celecoxib|mesh-list
111150752|NCT02037165|Pregabalin|pregabalin|mesh-list
111150753|NCT02037165|Analgesics|analgesics|mesh-ancestor
111150754|NCT02037165|Sensory System Agents|sensory system agents|mesh-ancestor
111150755|NCT02037165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111150756|NCT02037165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111150757|NCT02037165|Anticonvulsants|anticonvulsants|mesh-ancestor
111150758|NCT02037165|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111150759|NCT02037165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111150760|NCT02037165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111150761|NCT02037165|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111150762|NCT02037165|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111150763|NCT02037165|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111150764|NCT02037165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111150765|NCT02037165|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111150766|NCT02037165|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110867843|NCT01355367|Nifedipine|nifedipine|mesh-list
111150767|NCT02037165|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111150768|NCT02037165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111150770|NCT02037165|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111150771|NCT02037165|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111150772|NCT02037165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111150773|NCT02470403|Licogliflozin|licogliflozin|mesh-list
111150774|NCT02470403|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111150775|NCT02470403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111150776|NCT02470403|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111150777|NCT02470403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111150778|NCT01855750|Prednisone|prednisone|mesh-list
111150779|NCT01855750|Cyclophosphamide|cyclophosphamide|mesh-list
111150780|NCT01855750|Rituximab|rituximab|mesh-list
111150781|NCT01855750|Doxorubicin|doxorubicin|mesh-list
111150782|NCT01855750|Vincristine|vincristine|mesh-list
111150783|NCT01855750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111150784|NCT01855750|Immunologic Factors|immunologic factors|mesh-ancestor
111150785|NCT01855750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111150786|NCT01855750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111150787|NCT01855750|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111150788|NCT01855750|Alkylating Agents|alkylating agents|mesh-ancestor
111150789|NCT01855750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111150790|NCT01855750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111150791|NCT01855750|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111150792|NCT01855750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111150793|NCT01855750|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111150794|NCT01855750|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111150795|NCT01855750|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111150796|NCT01855750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111150797|NCT01855750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111150798|NCT01855750|Glucocorticoids|glucocorticoids|mesh-ancestor
111150799|NCT01855750|Hormones|hormones|mesh-ancestor
111150800|NCT01855750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111150801|NCT01855750|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111150802|NCT01855750|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111150803|NCT01855750|Tubulin Modulators|tubulin modulators|mesh-ancestor
111150804|NCT01855750|Antimitotic Agents|antimitotic agents|mesh-ancestor
111150805|NCT01855750|Mitosis Modulators|mitosis modulators|mesh-ancestor
111150806|NCT04963439|Macitentan|macitentan|mesh-list
111150807|NCT04963439|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
111150808|NCT04963439|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
111150809|NCT04963439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111150810|NCT04963439|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
111150811|NCT01622673|Raltegravir Potassium|raltegravir potassium|mesh-list
111150812|NCT01622673|Calcium Carbonate|calcium carbonate|mesh-list
111150813|NCT01622673|Aluminum Hydroxide|aluminum hydroxide|mesh-list
111150814|NCT01622673|Antacids|antacids|mesh-list
111150815|NCT01622673|Aluminum hydroxide, magnesium hydroxide, drug combination|aluminum hydroxide, magnesium hydroxide, drug combination|mesh-list
111150816|NCT01622673|Aluminum hydroxide, magnesium hydroxide, simethicone drug combination|aluminum hydroxide, magnesium hydroxide, simethicone drug combination|mesh-list
111150817|NCT01622673|Anti-Ulcer Agents|anti-ulcer agents|mesh-list
111150818|NCT01622673|TEMPO|tempo|mesh-list
111150819|NCT01622673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111150820|NCT01622673|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111150821|NCT01622673|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111150822|NCT01622673|Antiviral Agents|antiviral agents|mesh-ancestor
111150823|NCT01622673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111150824|NCT01622673|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111150825|NCT01622673|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111150826|NCT01622673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111150827|NCT01622673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111150828|NCT01622673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111150829|NCT01622673|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111150830|NCT01622673|Immunologic Factors|immunologic factors|mesh-ancestor
111150831|NCT01622673|Antioxidants|antioxidants|mesh-ancestor
111150832|NCT01622673|Protective Agents|protective agents|mesh-ancestor
111150833|NCT02469077|Morphine|morphine|mesh-list
111150834|NCT02469077|Naloxone|naloxone|mesh-list
111150835|NCT02469077|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111150836|NCT02469077|Narcotics|narcotics|mesh-ancestor
111150837|NCT02469077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111150838|NCT02469077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111150839|NCT02469077|Analgesics|analgesics|mesh-ancestor
110867916|NCT04275531|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111150840|NCT02469077|Sensory System Agents|sensory system agents|mesh-ancestor
111150841|NCT02469077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111150842|NCT02469077|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111150843|NCT02486627|Levofloxacin|levofloxacin|mesh-list
111150844|NCT02486627|Meropenem|meropenem|mesh-list
111150845|NCT02486627|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111150846|NCT02486627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111150847|NCT02486627|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111150848|NCT02486627|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111150849|NCT02486627|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111150850|NCT02486627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111150851|NCT02486627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111150852|NCT02486627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111150853|NCT02486627|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111150854|NCT02486627|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111150855|NCT02282293|Piperaquine|piperaquine|mesh-list
111150856|NCT02282293|Trimethoprim|trimethoprim|mesh-list
111150857|NCT02282293|Artenimol|artenimol|mesh-list
111150858|NCT02282293|Sulfamethoxazole|sulfamethoxazole|mesh-list
111150859|NCT02282293|Antimalarials|antimalarials|mesh-ancestor
111150860|NCT02282293|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111150861|NCT02282293|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111150862|NCT02282293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111150863|NCT02282293|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111150864|NCT02282293|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111150865|NCT02282293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111150866|NCT02282293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111150867|NCT02282293|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111150868|NCT02282293|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
111150869|NCT02282293|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111150870|NCT01854658|Glycopyrrolate|glycopyrrolate|mesh-list
111150871|NCT01854658|Formoterol Fumarate|formoterol fumarate|mesh-list
111150872|NCT01854658|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111150873|NCT01854658|Autonomic Agents|autonomic agents|mesh-ancestor
111150874|NCT01854658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111150875|NCT01854658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111150876|NCT01854658|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111150877|NCT01854658|Respiratory System Agents|respiratory system agents|mesh-ancestor
111150878|NCT01854658|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111150879|NCT01854658|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111150880|NCT01854658|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111150881|NCT01854658|Adrenergic Agents|adrenergic agents|mesh-ancestor
111150882|NCT01854658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111150883|NCT01854658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111150884|NCT01854658|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111150885|NCT01854658|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111150886|NCT01854658|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111150887|NCT01854658|Cholinergic Agents|cholinergic agents|mesh-ancestor
111150888|NCT01892020|Insulin|insulin|mesh-list
111150889|NCT01892020|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111150890|NCT01892020|Insulin Aspart|insulin aspart|mesh-list
111150891|NCT01892020|Biphasic Insulins|biphasic insulins|mesh-list
111150892|NCT01892020|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111150893|NCT01892020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111150894|NCT02485691|Prednisone|prednisone|mesh-list
111150895|NCT02485691|Abiraterone Acetate|abiraterone acetate|mesh-list
111150896|NCT02485691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111150897|NCT02485691|Glucocorticoids|glucocorticoids|mesh-ancestor
111150898|NCT02485691|Hormones|hormones|mesh-ancestor
111150899|NCT02485691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111150900|NCT02485691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111150901|NCT02485691|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111150902|NCT02485691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111150903|NCT02485691|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111150904|NCT02485691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111150905|NCT02485691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111150906|NCT02485691|Hormone Antagonists|hormone antagonists|mesh-ancestor
111150907|NCT02485691|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111150908|NCT02517515|Ritonavir|ritonavir|mesh-list
111150909|NCT02517515|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111150910|NCT02517515|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111150911|NCT02517515|Protease Inhibitors|protease inhibitors|mesh-ancestor
111150912|NCT02517515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111150913|NCT02517515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110867994|NCT03620253|Modafinil|modafinil|mesh-list
111150914|NCT02517515|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111150915|NCT02517515|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111150916|NCT02517515|Antiviral Agents|antiviral agents|mesh-ancestor
111150917|NCT02517515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111150918|NCT02517515|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111150919|NCT02517515|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111150920|NCT01891864|Etanercept|etanercept|mesh-list
111150922|NCT01891864|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111150923|NCT01891864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111150924|NCT01891864|Analgesics|analgesics|mesh-ancestor
111150925|NCT01891864|Sensory System Agents|sensory system agents|mesh-ancestor
111150926|NCT01891864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111150927|NCT01891864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111150928|NCT01891864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111150929|NCT01891864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111150930|NCT01891864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111150931|NCT01891864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111150932|NCT01891864|Immunologic Factors|immunologic factors|mesh-ancestor
111150933|NCT01891864|Dermatologic Agents|dermatologic agents|mesh-ancestor
111150934|NCT02484911|Dexamethasone|dexamethasone|mesh-list
111150935|NCT02484911|Olanzapine|olanzapine|mesh-list
111150936|NCT02484911|Aprepitant|aprepitant|mesh-list
111150937|NCT02484911|Palonosetron|palonosetron|mesh-list
111150938|NCT02484911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111150939|NCT02484911|Antiemetics|antiemetics|mesh-ancestor
111150940|NCT02484911|Autonomic Agents|autonomic agents|mesh-ancestor
111150941|NCT02484911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111150942|NCT02484911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111150943|NCT02484911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111150944|NCT02484911|Glucocorticoids|glucocorticoids|mesh-ancestor
111150945|NCT02484911|Hormones|hormones|mesh-ancestor
111150946|NCT02484911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111150947|NCT02484911|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111150948|NCT02484911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111150949|NCT02484911|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111150950|NCT02484911|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111150951|NCT02484911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111150952|NCT02484911|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111150953|NCT02484911|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111150954|NCT02484911|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111150955|NCT02484911|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111150956|NCT02484911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111150957|NCT02484911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111150958|NCT02484911|Serotonin Agents|serotonin agents|mesh-ancestor
111150959|NCT02484911|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
111150960|NCT02484911|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111150961|NCT02484911|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111150962|NCT04306367|Pembrolizumab|pembrolizumab|mesh-list
111150963|NCT04306367|Olaparib|olaparib|mesh-list
111150964|NCT04306367|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111150965|NCT04306367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111150966|NCT04306367|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111150967|NCT04306367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111150968|NCT04306367|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111150969|NCT04306367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111150970|NCT04616014|Insulin|insulin|mesh-list
111150971|NCT04616014|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111150972|NCT04616014|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111150973|NCT04616014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111150974|NCT02451917|Insulin|insulin|mesh-list
111150975|NCT02451917|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111150976|NCT02451917|Insulin Glargine|insulin glargine|mesh-list
111150977|NCT02451917|Insulin, Isophane|insulin, isophane|mesh-list
111150978|NCT02451917|Isophane Insulin, Human|isophane insulin, human|mesh-list
111150979|NCT02451917|Isophane insulin, beef|isophane insulin, beef|mesh-list
111150980|NCT02451917|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111150981|NCT02451917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111150982|NCT02349451|Adalimumab|adalimumab|mesh-list
111150983|NCT02349451|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111150984|NCT02349451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111150985|NCT02349451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110414385|NCT05433961|Xenon|xenon|mesh-list
111150986|NCT04956263|Dapagliflozin|dapagliflozin|mesh-list
111150987|NCT04956263|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111150988|NCT04956263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111150989|NCT04956263|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111150990|NCT04956263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111150991|NCT02409368|Nivolumab|nivolumab|mesh-list
111150992|NCT02409368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111150993|NCT02409368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111150994|NCT02409368|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111150995|NCT02409368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111150996|NCT04891484|Ondansetron|ondansetron|mesh-list
111150997|NCT04891484|Antiemetics|antiemetics|mesh-ancestor
111150998|NCT04891484|Autonomic Agents|autonomic agents|mesh-ancestor
111150999|NCT04891484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111151000|NCT04891484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111151001|NCT04891484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111151002|NCT04891484|Antipruritics|antipruritics|mesh-ancestor
111151003|NCT04891484|Dermatologic Agents|dermatologic agents|mesh-ancestor
111151004|NCT04891484|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111151005|NCT04891484|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111151006|NCT04891484|Serotonin Agents|serotonin agents|mesh-ancestor
111151007|NCT04891484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111151008|NCT04891484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111151009|NCT01853644|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
111151010|NCT01853644|Tivozanib|tivozanib|mesh-list
111151011|NCT01853644|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111151012|NCT01853644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111151013|NCT01853644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111151014|NCT01853254|Ribavirin|ribavirin|mesh-list
111151015|NCT01853254|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
111151016|NCT01853254|Antimetabolites|antimetabolites|mesh-ancestor
111151017|NCT01853254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111151018|NCT01853254|Antiviral Agents|antiviral agents|mesh-ancestor
111151019|NCT01853254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111151020|NCT02373098|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
111151021|NCT02373098|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
111151022|NCT02373098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111151023|NCT02373098|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111151024|NCT02373098|Immunologic Factors|immunologic factors|mesh-ancestor
111151025|NCT02373098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111151026|NCT01853176|Bupivacaine|bupivacaine|mesh-list
111151027|NCT01853176|Anesthetics, Local|anesthetics, local|mesh-ancestor
111151028|NCT01853176|Anesthetics|anesthetics|mesh-ancestor
111151029|NCT01853176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111151030|NCT01853176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111151031|NCT01853176|Sensory System Agents|sensory system agents|mesh-ancestor
111151032|NCT01853176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111151033|NCT01852942|Losartan|losartan|mesh-list
111151034|NCT01852942|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111151035|NCT01852942|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111151036|NCT01852942|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111151037|NCT01852942|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111151038|NCT01852942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111151039|NCT01852162|Dabigatran|dabigatran|mesh-list
111151040|NCT01852162|Antithrombins|antithrombins|mesh-ancestor
111151041|NCT01852162|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111151042|NCT01852162|Protease Inhibitors|protease inhibitors|mesh-ancestor
111151043|NCT01852162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111151044|NCT01852162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111151045|NCT01852162|Anticoagulants|anticoagulants|mesh-ancestor
111151046|NCT01835470|Abatacept|abatacept|mesh-list
111151047|NCT01835470|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111151048|NCT01835470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111151049|NCT01835470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111151050|NCT01835470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111151051|NCT01835470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111151052|NCT01835470|Immunologic Factors|immunologic factors|mesh-ancestor
111151053|NCT01835470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111151054|NCT01835470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111151055|NCT02451137|Insulin|insulin|mesh-list
111151056|NCT02451137|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111151057|NCT02451137|Insulin Glargine|insulin glargine|mesh-list
111151058|NCT02451137|Insulin Detemir|insulin detemir|mesh-list
111151059|NCT02451137|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111151060|NCT02451137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111151061|NCT02372006|Afatinib|afatinib|mesh-list
111151062|NCT02372006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111151063|NCT02372006|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111151064|NCT02372006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111151065|NCT02372006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111151066|NCT02406248|Ticagrelor|ticagrelor|mesh-list
111151067|NCT02406248|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111151068|NCT02406248|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111151069|NCT02406248|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111151070|NCT02406248|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111151071|NCT02406248|Purinergic Agents|purinergic agents|mesh-ancestor
111151072|NCT02406248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111151073|NCT02406248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111151074|NCT02406248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111151075|NCT02450903|Ceritinib|ceritinib|mesh-list
111151076|NCT02450903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111151077|NCT02450903|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111151078|NCT02450903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111151079|NCT02450903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111151080|NCT02371616|Listerine|listerine|mesh-list
111151081|NCT02371616|Calcium|calcium|mesh-list
111151082|NCT02371616|Fluorides|fluorides|mesh-list
111151083|NCT02371616|Sodium Fluoride|sodium fluoride|mesh-list
111151084|NCT02371616|Fluorophosphate|fluorophosphate|mesh-list
111151085|NCT02371616|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111151086|NCT02371616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111151087|NCT02371616|Cariostatic Agents|cariostatic agents|mesh-ancestor
111151088|NCT02371616|Protective Agents|protective agents|mesh-ancestor
111151089|NCT02371616|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111151090|NCT02371616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111151091|NCT01835158|Sunitinib|sunitinib|mesh-list
111151092|NCT01835158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111151093|NCT01835158|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111151094|NCT01835158|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111151095|NCT01835158|Growth Substances|growth substances|mesh-ancestor
111151096|NCT01835158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111151097|NCT01835158|Growth Inhibitors|growth inhibitors|mesh-ancestor
111151098|NCT01835158|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111151099|NCT01835158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111151100|NCT01835158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111151101|NCT01833832|Sodium thiosulfate|sodium thiosulfate|mesh-list
111151102|NCT01833832|Antidotes|antidotes|mesh-ancestor
111151103|NCT01833832|Protective Agents|protective agents|mesh-ancestor
111151104|NCT01833832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111151105|NCT01833832|Antioxidants|antioxidants|mesh-ancestor
111151106|NCT01833832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111151107|NCT01833832|Antitubercular Agents|antitubercular agents|mesh-ancestor
111151108|NCT01833832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111151109|NCT01833832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111151110|NCT01833832|Chelating Agents|chelating agents|mesh-ancestor
111151111|NCT01833832|Sequestering Agents|sequestering agents|mesh-ancestor
111151112|NCT01850602|Sevelamer|sevelamer|mesh-list
111151113|NCT01850602|Chelating Agents|chelating agents|mesh-ancestor
111151114|NCT01850602|Sequestering Agents|sequestering agents|mesh-ancestor
111151115|NCT01850602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111151116|NCT02405780|Adalimumab|adalimumab|mesh-list
111151117|NCT02405780|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111151118|NCT02405780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111151119|NCT02405780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111151120|NCT02369510|Epinephrine|epinephrine|mesh-list
111151121|NCT02369510|Racepinephrine|racepinephrine|mesh-list
111151122|NCT02369510|Epinephryl borate|epinephryl borate|mesh-list
111151123|NCT02369510|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111151124|NCT02369510|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111151125|NCT02369510|Adrenergic Agents|adrenergic agents|mesh-ancestor
111151126|NCT02369510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111151127|NCT02369510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111151128|NCT02369510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111151129|NCT02369510|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111151130|NCT02369510|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111151131|NCT02369510|Autonomic Agents|autonomic agents|mesh-ancestor
111151132|NCT02369510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111151133|NCT02369510|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111151134|NCT02369510|Respiratory System Agents|respiratory system agents|mesh-ancestor
111151135|NCT02369510|Mydriatics|mydriatics|mesh-ancestor
111151136|NCT02369510|Sympathomimetics|sympathomimetics|mesh-ancestor
111151137|NCT02369510|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111151138|NCT01650194|Prednisone|prednisone|mesh-list
111151139|NCT01650194|Abiraterone Acetate|abiraterone acetate|mesh-list
111151140|NCT01650194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111151142|NCT01650194|Hormones|hormones|mesh-ancestor
111151143|NCT01650194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111151144|NCT01650194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111151145|NCT01650194|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111151146|NCT01650194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111151147|NCT01650194|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111151148|NCT01650194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111151149|NCT01650194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111151150|NCT01650194|Hormone Antagonists|hormone antagonists|mesh-ancestor
111151151|NCT01650194|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111151152|NCT02404220|Dexamethasone|dexamethasone|mesh-list
111151153|NCT02404220|Vincristine|vincristine|mesh-list
111151154|NCT02404220|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111151155|NCT02404220|Antiemetics|antiemetics|mesh-ancestor
111151156|NCT02404220|Autonomic Agents|autonomic agents|mesh-ancestor
111151157|NCT02404220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111151158|NCT02404220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111151159|NCT02404220|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111151160|NCT02404220|Glucocorticoids|glucocorticoids|mesh-ancestor
111151161|NCT02404220|Hormones|hormones|mesh-ancestor
111151162|NCT02404220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111151163|NCT02404220|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111151164|NCT02404220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111151165|NCT02404220|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111151166|NCT02404220|Tubulin Modulators|tubulin modulators|mesh-ancestor
111151167|NCT02404220|Antimitotic Agents|antimitotic agents|mesh-ancestor
111151168|NCT02404220|Mitosis Modulators|mitosis modulators|mesh-ancestor
111151169|NCT02404220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111151170|NCT02366468|Ranibizumab|ranibizumab|mesh-list
111151171|NCT02366468|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111151172|NCT02366468|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111151173|NCT02366468|Growth Substances|growth substances|mesh-ancestor
111151174|NCT02366468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111151175|NCT02366468|Growth Inhibitors|growth inhibitors|mesh-ancestor
111151176|NCT02366468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111151177|NCT02335346|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110483952|NCT00993044|Bevacizumab|bevacizumab|mesh-list
111151178|NCT02335346|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111151179|NCT02335346|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111151180|NCT02335346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111151181|NCT02335346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111151182|NCT02335346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111151183|NCT02335346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111151184|NCT02335346|Analgesics|analgesics|mesh-ancestor
111151185|NCT02335346|Sensory System Agents|sensory system agents|mesh-ancestor
111151186|NCT02335346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111151187|NCT02335346|Antidepressive Agents|antidepressive agents|mesh-ancestor
111151188|NCT02335346|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111151189|NCT02335346|Dopamine Agents|dopamine agents|mesh-ancestor
111151190|NCT02403674|Tenofovir|tenofovir|mesh-list
111151191|NCT02403674|Lamivudine|lamivudine|mesh-list
111151192|NCT02403674|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
111151193|NCT02403674|Antiviral Agents|antiviral agents|mesh-ancestor
111151194|NCT02403674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111151195|NCT02403674|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111151196|NCT02403674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111151197|NCT02403674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111151198|NCT02403674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111151199|NCT02403674|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111151200|NCT02403674|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111151201|NCT02401256|Efavirenz|efavirenz|mesh-list
111151202|NCT02401256|Bupropion|bupropion|mesh-list
111151203|NCT02401256|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111151204|NCT02401256|Montelukast|montelukast|mesh-list
111151205|NCT02401256|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111151206|NCT02401256|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111151207|NCT02401256|Antimetabolites|antimetabolites|mesh-ancestor
111151208|NCT02401256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111151209|NCT02401256|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111151210|NCT02401256|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111151211|NCT02401256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111151212|NCT02401256|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111151213|NCT02401256|Antidepressive Agents|antidepressive agents|mesh-ancestor
111151214|NCT02401256|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111151215|NCT02401256|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111151216|NCT02401256|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111151217|NCT02401256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111151218|NCT02401256|Dopamine Agents|dopamine agents|mesh-ancestor
111151219|NCT02401256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111151220|NCT02401256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111151221|NCT02401256|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111151222|NCT02401256|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111151223|NCT02401256|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111151224|NCT02401256|Respiratory System Agents|respiratory system agents|mesh-ancestor
111151225|NCT02401256|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
111151226|NCT02401256|Hormone Antagonists|hormone antagonists|mesh-ancestor
111151227|NCT02401256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111151228|NCT02401256|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
111151229|NCT02401256|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111151230|NCT02401256|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111151231|NCT02401256|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111151232|NCT02401256|Antiviral Agents|antiviral agents|mesh-ancestor
111151233|NCT02401256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111151234|NCT02401256|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111151235|NCT02401256|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111151236|NCT02401256|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111151237|NCT02401256|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111151238|NCT02349295|Ixekizumab|ixekizumab|mesh-list
111151239|NCT02349295|Dermatologic Agents|dermatologic agents|mesh-ancestor
111151240|NCT04877587|Gemcitabine|gemcitabine|mesh-list
111151241|NCT04877587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111151242|NCT04877587|Antimetabolites|antimetabolites|mesh-ancestor
111151243|NCT04877587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111151244|NCT04877587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111151245|NCT02284243|Dexmedetomidine|dexmedetomidine|mesh-list
111151246|NCT02284243|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111151247|NCT02284243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111151248|NCT02284243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111151249|NCT02284243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111151250|NCT02284243|Analgesics|analgesics|mesh-ancestor
111151251|NCT02284243|Sensory System Agents|sensory system agents|mesh-ancestor
111151252|NCT02284243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111151253|NCT02284243|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111151254|NCT02284243|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111151255|NCT02284243|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111151256|NCT02284243|Adrenergic Agents|adrenergic agents|mesh-ancestor
111151257|NCT02284243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111151258|NCT02284243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111151259|NCT02284009|rGLP-1 protein|rglp-1 protein|mesh-list
111151260|NCT02284009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111151261|NCT02284009|Incretins|incretins|mesh-ancestor
111151262|NCT02284009|Hormones|hormones|mesh-ancestor
111151263|NCT02284009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111151264|NCT02400476|Budesonide|budesonide|mesh-list
111151265|NCT02400476|Loperamide|loperamide|mesh-list
111151266|NCT02400476|Antidiarrheals|antidiarrheals|mesh-list
111151267|NCT02400476|Colestipol|colestipol|mesh-list
111151268|NCT02400476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111151269|NCT02400476|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111151270|NCT02400476|Autonomic Agents|autonomic agents|mesh-ancestor
111151271|NCT02400476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111151272|NCT02400476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111151273|NCT02400476|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111151274|NCT02400476|Respiratory System Agents|respiratory system agents|mesh-ancestor
111151275|NCT02400476|Glucocorticoids|glucocorticoids|mesh-ancestor
111151276|NCT02400476|Hormones|hormones|mesh-ancestor
111151277|NCT02400476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111151278|NCT02400476|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111151279|NCT02400476|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111151280|NCT02400476|Antimetabolites|antimetabolites|mesh-ancestor
111151281|NCT02400476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111151282|NCT02400476|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111151283|NCT02400476|Sequestering Agents|sequestering agents|mesh-ancestor
111151284|NCT02363738|Infliximab|infliximab|mesh-list
111151285|NCT02363738|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111151286|NCT02363738|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111151287|NCT02363738|Dermatologic Agents|dermatologic agents|mesh-ancestor
111151288|NCT02363738|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111151289|NCT02363738|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111151290|NCT02331680|Tolvaptan|tolvaptan|mesh-list
111151291|NCT02331680|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
111151292|NCT02331680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111151293|NCT02331680|Natriuretic Agents|natriuretic agents|mesh-ancestor
111151294|NCT02331680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111151295|NCT02349061|Ustekinumab|ustekinumab|mesh-list
111151296|NCT02349061|Dermatologic Agents|dermatologic agents|mesh-ancestor
111151297|NCT02331368|Pembrolizumab|pembrolizumab|mesh-list
111151298|NCT02331368|Lenalidomide|lenalidomide|mesh-list
111151299|NCT02331368|Melphalan|melphalan|mesh-list
111151300|NCT02331368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111151301|NCT02331368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111151302|NCT02331368|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111151303|NCT02331368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111151304|NCT02331368|Immunologic Factors|immunologic factors|mesh-ancestor
111151305|NCT02331368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111151306|NCT02331368|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111151307|NCT02331368|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111151308|NCT02331368|Growth Substances|growth substances|mesh-ancestor
111151309|NCT02331368|Growth Inhibitors|growth inhibitors|mesh-ancestor
111151310|NCT02331368|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111151311|NCT02331368|Alkylating Agents|alkylating agents|mesh-ancestor
111151312|NCT02331368|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111151313|NCT02331368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111151314|NCT02280421|Cyclosporine|cyclosporine|mesh-list
111151315|NCT02280421|Cyclosporins|cyclosporins|mesh-list
111151316|NCT02280421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111151317|NCT02280421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111151318|NCT02280421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111151319|NCT02280421|Immunologic Factors|immunologic factors|mesh-ancestor
111151320|NCT02280421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111151321|NCT02280421|Antifungal Agents|antifungal agents|mesh-ancestor
111151322|NCT02280421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111151323|NCT02280421|Dermatologic Agents|dermatologic agents|mesh-ancestor
111151324|NCT02280421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111151325|NCT02280421|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111151326|NCT04906382|Paclitaxel|paclitaxel|mesh-list
111151327|NCT04906382|Carboplatin|carboplatin|mesh-list
111151328|NCT04906382|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111151329|NCT04906382|Tislelizumab|tislelizumab|mesh-list
111151330|NCT04906382|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111151331|NCT04906382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111151332|NCT04906382|Tubulin Modulators|tubulin modulators|mesh-ancestor
111151333|NCT04906382|Antimitotic Agents|antimitotic agents|mesh-ancestor
111151334|NCT04906382|Mitosis Modulators|mitosis modulators|mesh-ancestor
111151335|NCT04906382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111151336|NCT04906382|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111151337|NCT02362412|Quetiapine Fumarate|quetiapine fumarate|mesh-list
111151338|NCT02362412|Antidepressive Agents|antidepressive agents|mesh-ancestor
111151339|NCT02362412|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111151340|NCT02362412|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111151341|NCT02362412|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111151342|NCT02362412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111151343|NCT02362412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111151344|NCT02347813|Pioglitazone|pioglitazone|mesh-list
111151345|NCT02347813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111151346|NCT02347813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111151347|NCT02359994|Hemostatics|hemostatics|mesh-list
111151348|NCT02359994|Coagulants|coagulants|mesh-ancestor
111151349|NCT04905446|Niacinamide|niacinamide|mesh-list
111151350|NCT04905446|Niacin|niacin|mesh-list
111151351|NCT04905446|Nicotinic Acids|nicotinic acids|mesh-list
111151352|NCT04905446|Vitamin B Complex|vitamin b complex|mesh-ancestor
111151353|NCT04905446|Vitamins|vitamins|mesh-ancestor
111151354|NCT04905446|Micronutrients|micronutrients|mesh-ancestor
111151355|NCT04905446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111151356|NCT04905446|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111151357|NCT04905446|Antimetabolites|antimetabolites|mesh-ancestor
111151358|NCT04905446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111151359|NCT04905446|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111151360|NCT04905446|Vasodilator Agents|vasodilator agents|mesh-ancestor
111151361|NCT02326298|Certolizumab Pegol|certolizumab pegol|mesh-list
111151362|NCT02326298|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111151363|NCT02326298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111151364|NCT02326298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111151365|NCT02326298|Immunologic Factors|immunologic factors|mesh-ancestor
111151366|NCT02326298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111151367|NCT02326298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111151369|NCT02279719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111151370|NCT02279719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111151371|NCT02279719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111151372|NCT02279719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111151373|NCT02279407|Dapagliflozin|dapagliflozin|mesh-list
111151374|NCT02279407|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111151375|NCT02279407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111151376|NCT02279407|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111151377|NCT02279407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111151378|NCT02326220|Alirocumab|alirocumab|mesh-list
111151379|NCT02326220|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
111151380|NCT02326220|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111151381|NCT02326220|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111151382|NCT02326220|Antimetabolites|antimetabolites|mesh-ancestor
111151383|NCT02326220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111151384|NCT02326220|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111151385|NCT02326220|Protease Inhibitors|protease inhibitors|mesh-ancestor
111151386|NCT02326220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111151387|NCT02326220|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111151388|NCT02358668|PAZ320|paz320|mesh-list
111151389|NCT02358668|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111151390|NCT02358668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111151391|NCT02282605|Chlorhexidine|chlorhexidine|mesh-list
111151392|NCT02282605|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
111151393|NCT02282605|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111151394|NCT02282605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111151395|NCT02282605|Disinfectants|disinfectants|mesh-ancestor
111151396|NCT02282605|Dermatologic Agents|dermatologic agents|mesh-ancestor
111151397|NCT02282527|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
111151398|NCT02282527|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
111151399|NCT02282527|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111151400|NCT02282527|Protease Inhibitors|protease inhibitors|mesh-ancestor
111151401|NCT02282527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111151402|NCT02282527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111151403|NCT05650099|Cimetidine|cimetidine|mesh-list
111151404|NCT05650099|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111151405|NCT05650099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111151406|NCT05650099|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
111151407|NCT05650099|Histamine Antagonists|histamine antagonists|mesh-ancestor
111151408|NCT05650099|Histamine Agents|histamine agents|mesh-ancestor
111151409|NCT05650099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111151410|NCT05650099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111151411|NCT05650099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111151412|NCT05650099|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111151413|NCT05650099|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111151414|NCT05650099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111151415|NCT02278471|Losartan|losartan|mesh-list
111151416|NCT02278471|Amlodipine|amlodipine|mesh-list
111151417|NCT02278471|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
111151418|NCT02278471|Atorvastatin|atorvastatin|mesh-list
111151419|NCT02278471|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111151420|NCT02278471|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111151421|NCT02278471|Antimetabolites|antimetabolites|mesh-ancestor
111151422|NCT02278471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111151423|NCT02278471|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111151424|NCT02278471|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111151425|NCT02278471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111151426|NCT02278471|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111151427|NCT02278471|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111151428|NCT02278471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110840535|NCT05239390|Dronabinol|dronabinol|mesh-list
111151429|NCT02278471|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111151430|NCT02278471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111151431|NCT02278471|Vasodilator Agents|vasodilator agents|mesh-ancestor
111151432|NCT02278471|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111151433|NCT02278471|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111151434|NCT02278471|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111151436|NCT02278471|Natriuretic Agents|natriuretic agents|mesh-ancestor
111151437|NCT02278471|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
111151439|NCT05565235|Bupivacaine|bupivacaine|mesh-list
111151440|NCT05565235|Anesthetics, Local|anesthetics, local|mesh-ancestor
111151441|NCT05565235|Anesthetics|anesthetics|mesh-ancestor
111151442|NCT05565235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111151443|NCT05565235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111151444|NCT05565235|Sensory System Agents|sensory system agents|mesh-ancestor
111151445|NCT05565235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111151446|NCT05565235|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111151447|NCT05565235|Narcotics|narcotics|mesh-ancestor
111151448|NCT05565235|Analgesics|analgesics|mesh-ancestor
111151449|NCT02278003|Propofol|propofol|mesh-list
111151450|NCT02278003|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111151451|NCT02278003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111151452|NCT02278003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111151453|NCT02278003|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111151454|NCT02278003|Anesthetics, General|anesthetics, general|mesh-ancestor
111151455|NCT02278003|Anesthetics|anesthetics|mesh-ancestor
111151456|NCT02277769|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111151457|NCT02277769|Immunologic Factors|immunologic factors|mesh-ancestor
111151458|NCT02277769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111151459|NCT02277691|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
111151460|NCT02277691|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111151461|NCT02277691|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111151462|NCT02277691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111151463|NCT02395172|Docetaxel|docetaxel|mesh-list
111151464|NCT02395172|Avelumab|avelumab|mesh-list
111151465|NCT02395172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111151466|NCT02395172|Tubulin Modulators|tubulin modulators|mesh-ancestor
111151467|NCT02395172|Antimitotic Agents|antimitotic agents|mesh-ancestor
111151468|NCT02395172|Mitosis Modulators|mitosis modulators|mesh-ancestor
111151469|NCT02395172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111151470|NCT02395172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111151471|NCT04876027|Dulaglutide|dulaglutide|mesh-list
111151472|NCT04876027|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111151473|NCT04876027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111151474|NCT02358044|Ribavirin|ribavirin|mesh-list
111151475|NCT02358044|Sofosbuvir|sofosbuvir|mesh-list
111151476|NCT02358044|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
111151477|NCT02358044|Grazoprevir|grazoprevir|mesh-list
111151478|NCT02358044|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
111151479|NCT02358044|Antimetabolites|antimetabolites|mesh-ancestor
111151480|NCT02358044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111151481|NCT02358044|Antiviral Agents|antiviral agents|mesh-ancestor
111151482|NCT02358044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111151483|NCT05536219|Antibodies|antibodies|mesh-list
111151484|NCT05536219|Immunologic Factors|immunologic factors|mesh-ancestor
111151485|NCT05536219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111151486|NCT05649241|Nicotine|nicotine|mesh-list
111151487|NCT05649241|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111151488|NCT05649241|Autonomic Agents|autonomic agents|mesh-ancestor
111151489|NCT05649241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111151490|NCT05649241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111151491|NCT05649241|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111151492|NCT05649241|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111151493|NCT05649241|Cholinergic Agents|cholinergic agents|mesh-ancestor
111151494|NCT05649241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110840536|NCT05239390|Hallucinogens|hallucinogens|mesh-ancestor
111151495|NCT05649241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111151496|NCT02272777|Imatinib Mesylate|imatinib mesylate|mesh-list
111151497|NCT02272777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111151498|NCT02272777|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111151499|NCT02272777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111151500|NCT02272777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111151501|NCT02357810|Topotecan|topotecan|mesh-list
111151502|NCT02357810|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111151503|NCT02357810|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111151504|NCT02357810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111151505|NCT02357810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111151506|NCT02357810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111151507|NCT02357576|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
111151508|NCT02357576|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
111151509|NCT02357576|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
111151510|NCT02357576|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111151511|NCT01850446|Oseltamivir|oseltamivir|mesh-list
111151512|NCT01850446|Antiviral Agents|antiviral agents|mesh-ancestor
111151513|NCT01850446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111151514|NCT01850446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111151515|NCT01850446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111151516|NCT01644175|Alirocumab|alirocumab|mesh-list
111151517|NCT01644175|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111151518|NCT01644175|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
111151519|NCT01644175|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111151520|NCT01644175|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111151521|NCT01644175|Antimetabolites|antimetabolites|mesh-ancestor
111151522|NCT01644175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111151523|NCT01644175|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111151524|NCT01644175|Protease Inhibitors|protease inhibitors|mesh-ancestor
111151525|NCT01644175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111151526|NCT01644175|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111151527|NCT01644175|Immunologic Factors|immunologic factors|mesh-ancestor
111151528|NCT01644175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111151529|NCT04856761|Capecitabine|capecitabine|mesh-list
111151530|NCT04856761|Tegafur|tegafur|mesh-list
110414930|NCT03648892|Raclopride|raclopride|mesh-list
111151531|NCT04856761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111151532|NCT04856761|Antimetabolites|antimetabolites|mesh-ancestor
111151533|NCT04856761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111151534|NCT04856761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111151535|NCT01832038|Lacosamide|lacosamide|mesh-list
111151536|NCT01832038|Anticonvulsants|anticonvulsants|mesh-ancestor
111151537|NCT01832038|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111151538|NCT01832038|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111151539|NCT01832038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111151540|NCT01832038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111151541|NCT01849588|Sorafenib|sorafenib|mesh-list
111151542|NCT01849588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111151543|NCT01849588|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111151544|NCT01849588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111151545|NCT01849588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111151546|NCT02357342|Sirolimus|sirolimus|mesh-list
111151547|NCT02357342|Aflibercept|aflibercept|mesh-list
111151548|NCT02357342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111151549|NCT02357342|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111151550|NCT02357342|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111151551|NCT02357342|Growth Substances|growth substances|mesh-ancestor
111151552|NCT02357342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111151553|NCT02357342|Growth Inhibitors|growth inhibitors|mesh-ancestor
111151554|NCT02357342|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111151555|NCT02357342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111151556|NCT02357342|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111151557|NCT02357342|Antifungal Agents|antifungal agents|mesh-ancestor
111151558|NCT02357342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111151559|NCT02357342|Immunologic Factors|immunologic factors|mesh-ancestor
111151560|NCT02325518|Timolol|timolol|mesh-list
111151561|NCT02325518|Dorzolamide|dorzolamide|mesh-list
111151562|NCT02325518|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111151563|NCT02325518|Maleic acid|maleic acid|mesh-list
111151564|NCT02325518|Brinzolamide|brinzolamide|mesh-list
111151565|NCT02325518|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111151566|NCT02325518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111151567|NCT02325518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111151568|NCT02325518|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111151569|NCT02325518|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111151570|NCT02325518|Adrenergic Agents|adrenergic agents|mesh-ancestor
111151571|NCT02325518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111151572|NCT02325518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111151573|NCT02325518|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111151574|NCT02325518|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111151575|NCT02325518|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
111151576|NCT02270983|Linaclotide|linaclotide|mesh-list
111151577|NCT02270983|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
111151578|NCT02270983|Enzyme Activators|enzyme activators|mesh-ancestor
111151579|NCT02270983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111151580|NCT02270983|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111151581|NCT02449889|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
111151582|NCT02449889|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111151583|NCT02449889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111151584|NCT02324270|Diclofenac|diclofenac|mesh-list
111151585|NCT02324270|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
111151586|NCT02324270|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111151587|NCT02324270|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111151589|NCT02324270|Sensory System Agents|sensory system agents|mesh-ancestor
111151590|NCT02324270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111151591|NCT02324270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111151592|NCT02324270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111151593|NCT02324270|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111151594|NCT02324270|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111151595|NCT02324270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111151596|NCT02324270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111151597|NCT05648071|Pemetrexed|pemetrexed|mesh-list
111151598|NCT05648071|Nedaplatin|nedaplatin|mesh-list
111151599|NCT05648071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111151600|NCT05648071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111151601|NCT05648071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111151602|NCT05648071|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111151603|NCT05648071|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111151604|NCT01849276|Metformin|metformin|mesh-list
111151605|NCT01849276|Cytarabine|cytarabine|mesh-list
111151606|NCT01849276|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111151607|NCT01849276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111151608|NCT01849276|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111151609|NCT01849276|Antimetabolites|antimetabolites|mesh-ancestor
111151610|NCT01849276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111151611|NCT01849276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111151612|NCT01849276|Antiviral Agents|antiviral agents|mesh-ancestor
111151613|NCT01849276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111151614|NCT01849276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111151615|NCT01849276|Immunologic Factors|immunologic factors|mesh-ancestor
111151616|NCT02465489|Deferiprone|deferiprone|mesh-list
111151617|NCT02465489|Iron Chelating Agents|iron chelating agents|mesh-ancestor
111151618|NCT02465489|Chelating Agents|chelating agents|mesh-ancestor
111151619|NCT02465489|Sequestering Agents|sequestering agents|mesh-ancestor
111151620|NCT02465489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111151621|NCT04953923|Moxifloxacin|moxifloxacin|mesh-list
111151622|NCT04953923|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111151623|NCT04953923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111151624|NCT04953923|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111151625|NCT04953923|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111151626|NCT04953923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111151627|NCT04953923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111151628|NCT04953923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111151629|NCT01601821|Sirolimus|sirolimus|mesh-list
111151630|NCT01601821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111151631|NCT01601821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111151632|NCT01601821|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111151633|NCT01601821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111151634|NCT01601821|Antifungal Agents|antifungal agents|mesh-ancestor
111151635|NCT01601821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111151636|NCT01601821|Immunologic Factors|immunologic factors|mesh-ancestor
111151637|NCT01601821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111151638|NCT01846624|Decitabine|decitabine|mesh-list
111151639|NCT01846624|Azacitidine|azacitidine|mesh-list
111151640|NCT01846624|Midostaurin|midostaurin|mesh-list
111151641|NCT01846624|Staurosporine|staurosporine|mesh-list
111151642|NCT01846624|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111151643|NCT01846624|Antimetabolites|antimetabolites|mesh-ancestor
111151644|NCT01846624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111151645|NCT01846624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111151646|NCT01846624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111151647|NCT01846624|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111151648|NCT01827670|Fluorides|fluorides|mesh-list
111151649|NCT01827670|Tin Fluorides|tin fluorides|mesh-list
111151650|NCT01827670|Fluorophosphate|fluorophosphate|mesh-list
111151651|NCT01827670|Cariostatic Agents|cariostatic agents|mesh-ancestor
111151652|NCT01827670|Protective Agents|protective agents|mesh-ancestor
111151653|NCT01827670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111151654|NCT01844830|Phenylephrine|phenylephrine|mesh-list
111151655|NCT01844830|Oxymetazoline|oxymetazoline|mesh-list
111151656|NCT01844830|Tetracaine|tetracaine|mesh-list
111151657|NCT01844830|Anesthetics, Local|anesthetics, local|mesh-ancestor
111151658|NCT01844830|Anesthetics|anesthetics|mesh-ancestor
111151659|NCT01844830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111151660|NCT01844830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111151661|NCT01844830|Sensory System Agents|sensory system agents|mesh-ancestor
111151662|NCT01844830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111151663|NCT01844830|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111151664|NCT01844830|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111151665|NCT01844830|Adrenergic Agents|adrenergic agents|mesh-ancestor
111151666|NCT01844830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111151667|NCT01844830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111151668|NCT01844830|Sympathomimetics|sympathomimetics|mesh-ancestor
111151669|NCT01844830|Autonomic Agents|autonomic agents|mesh-ancestor
111151670|NCT01844830|Nasal Decongestants|nasal decongestants|mesh-ancestor
111151671|NCT01844830|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111151672|NCT01844830|Respiratory System Agents|respiratory system agents|mesh-ancestor
111151673|NCT01844830|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111151674|NCT01844830|Mydriatics|mydriatics|mesh-ancestor
111151675|NCT01844830|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111151676|NCT01844830|Protective Agents|protective agents|mesh-ancestor
111151677|NCT02323334|Itraconazole|itraconazole|mesh-list
111151678|NCT02323334|Antifungal Agents|antifungal agents|mesh-ancestor
111151679|NCT02323334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110840577|NCT05239078|Anesthetics|anesthetics|mesh-list
111151680|NCT02323334|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111151681|NCT02323334|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111151683|NCT02323334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111151684|NCT02323334|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111151685|NCT02323334|Hormone Antagonists|hormone antagonists|mesh-ancestor
111151686|NCT02323334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111151687|NCT02323334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111151688|NCT02323334|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111151689|NCT02322866|Sarecycline|sarecycline|mesh-list
111151690|NCT02322866|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111151691|NCT02322866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111151692|NCT02322866|Dermatologic Agents|dermatologic agents|mesh-ancestor
111151693|NCT01827046|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
111151694|NCT01827046|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111151695|NCT01827046|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111151696|NCT01827046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111151697|NCT02356562|Ritonavir|ritonavir|mesh-list
111151698|NCT02356562|Ribavirin|ribavirin|mesh-list
111151699|NCT02356562|Sofosbuvir|sofosbuvir|mesh-list
111151700|NCT02356562|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111151701|NCT02356562|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111151702|NCT02356562|Protease Inhibitors|protease inhibitors|mesh-ancestor
111151703|NCT02356562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111151704|NCT02356562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111151705|NCT02356562|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111151706|NCT02356562|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111151707|NCT02356562|Antiviral Agents|antiviral agents|mesh-ancestor
111151708|NCT02356562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111151709|NCT02356562|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111151710|NCT02356562|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111151711|NCT02356562|Antimetabolites|antimetabolites|mesh-ancestor
111151712|NCT02354690|Cyclophosphamide|cyclophosphamide|mesh-list
111151713|NCT02354690|Fludarabine|fludarabine|mesh-list
111151714|NCT02354690|Interleukin-2|interleukin-2|mesh-list
111151715|NCT02354690|Vemurafenib|vemurafenib|mesh-list
111151716|NCT02354690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111151717|NCT02354690|Immunologic Factors|immunologic factors|mesh-ancestor
111151718|NCT02354690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111151719|NCT02354690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111151720|NCT02354690|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111151721|NCT02354690|Alkylating Agents|alkylating agents|mesh-ancestor
111151722|NCT02354690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111151723|NCT02354690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111151724|NCT02354690|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111151725|NCT02354690|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111151726|NCT02354690|Analgesics|analgesics|mesh-ancestor
111151727|NCT02354690|Sensory System Agents|sensory system agents|mesh-ancestor
111151728|NCT02354690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111151729|NCT02354690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111151730|NCT02354690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111151731|NCT02354222|Canagliflozin|canagliflozin|mesh-list
111151732|NCT02354222|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111151733|NCT02354222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111151734|NCT02354222|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111151735|NCT02354222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111151736|NCT02351960|Dexlansoprazole|dexlansoprazole|mesh-list
111151737|NCT02351960|Lansoprazole|lansoprazole|mesh-list
111151738|NCT02351960|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111151739|NCT02351960|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111151740|NCT02351960|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111151741|NCT02351960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111151742|NCT02351960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111151743|NCT02351180|Beclomethasone|beclomethasone|mesh-list
111151744|NCT02351180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111151745|NCT02351180|Glucocorticoids|glucocorticoids|mesh-ancestor
111151746|NCT02351180|Hormones|hormones|mesh-ancestor
111151747|NCT02351180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111151748|NCT02351180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111151749|NCT02351180|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111151750|NCT02351180|Respiratory System Agents|respiratory system agents|mesh-ancestor
111151751|NCT02350478|Linagliptin|linagliptin|mesh-list
111151752|NCT02350478|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111151753|NCT02350478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111151754|NCT02350478|Incretins|incretins|mesh-ancestor
111151755|NCT02350478|Hormones|hormones|mesh-ancestor
111151756|NCT02350478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111151757|NCT02350478|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111151758|NCT02350478|Protease Inhibitors|protease inhibitors|mesh-ancestor
111151759|NCT02350478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111151760|NCT02350478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111151761|NCT02349542|Bupivacaine|bupivacaine|mesh-list
111151762|NCT02349542|Anesthetics, Local|anesthetics, local|mesh-ancestor
111151763|NCT02349542|Anesthetics|anesthetics|mesh-ancestor
111151764|NCT02349542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111151765|NCT02349542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111151766|NCT02349542|Sensory System Agents|sensory system agents|mesh-ancestor
111151767|NCT02349542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111151768|NCT02321930|Tofacitinib|tofacitinib|mesh-list
111151769|NCT02321930|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
111151770|NCT02321930|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111151771|NCT02321930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111151772|NCT02321930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111151773|NCT02264821|Morphine|morphine|mesh-list
111151774|NCT02264821|Ropivacaine|ropivacaine|mesh-list
111151775|NCT02264821|Anesthetics, Local|anesthetics, local|mesh-list
111151776|NCT02264821|Anesthetics|anesthetics|mesh-list
111151777|NCT02264821|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111151778|NCT02264821|Narcotics|narcotics|mesh-ancestor
111151779|NCT02264821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111151780|NCT02264821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111151781|NCT02264821|Analgesics|analgesics|mesh-ancestor
111151782|NCT02264821|Sensory System Agents|sensory system agents|mesh-ancestor
111151783|NCT02264821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111151784|NCT04854889|Decitabine|decitabine|mesh-list
111151785|NCT04854889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111151786|NCT04854889|Antimetabolites|antimetabolites|mesh-ancestor
111151787|NCT04854889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111151788|NCT04854889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111151789|NCT04854889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111151790|NCT02261467|Botulinum Toxins|botulinum toxins|mesh-list
111151791|NCT02261467|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111151792|NCT02261467|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110484014|NCT00639873|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111151793|NCT02261467|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111151794|NCT02261467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111151795|NCT02261467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111151796|NCT02261467|Cholinergic Agents|cholinergic agents|mesh-ancestor
111151797|NCT02261467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111151798|NCT02261467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111151799|NCT02261467|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111151800|NCT02261467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111151801|NCT05341843|Sertraline|sertraline|mesh-list
111151802|NCT05341843|Antidepressive Agents|antidepressive agents|mesh-ancestor
111151803|NCT05341843|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111151804|NCT05341843|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111151805|NCT05341843|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111151806|NCT05341843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111151807|NCT05341843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110868893|NCT03680612|Cefepime|cefepime|mesh-list
111151808|NCT05341843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111151809|NCT05341843|Serotonin Agents|serotonin agents|mesh-ancestor
111151810|NCT05341843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111151812|NCT05646199|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111151813|NCT05646199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111151814|NCT02320058|Nivolumab|nivolumab|mesh-list
111151815|NCT02320058|Ipilimumab|ipilimumab|mesh-list
111151816|NCT02320058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111151817|NCT02320058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111151818|NCT02320058|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111151819|NCT02320058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111151820|NCT02319668|Chlorhexidine|chlorhexidine|mesh-list
111151821|NCT02319668|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
111151822|NCT02319668|Listerine|listerine|mesh-list
111151823|NCT02319668|Fluorides|fluorides|mesh-list
111151824|NCT02319668|Sodium Fluoride|sodium fluoride|mesh-list
111151825|NCT02319668|Cariostatic Agents|cariostatic agents|mesh-ancestor
111151826|NCT02319668|Protective Agents|protective agents|mesh-ancestor
111151827|NCT02319668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111151828|NCT02319668|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111151829|NCT02319668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111151830|NCT02319668|Disinfectants|disinfectants|mesh-ancestor
111151831|NCT02319668|Dermatologic Agents|dermatologic agents|mesh-ancestor
111151832|NCT02092467|Adalimumab|adalimumab|mesh-list
111151833|NCT02092467|Etanercept|etanercept|mesh-list
111151834|NCT02092467|Tofacitinib|tofacitinib|mesh-list
111151835|NCT02092467|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111151836|NCT02092467|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111151837|NCT02092467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111151838|NCT02092467|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111151839|NCT02092467|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111151840|NCT02092467|Analgesics|analgesics|mesh-ancestor
111151841|NCT02092467|Sensory System Agents|sensory system agents|mesh-ancestor
111151842|NCT02092467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111151843|NCT02092467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111151844|NCT02092467|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111151845|NCT02092467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111151846|NCT02092467|Immunologic Factors|immunologic factors|mesh-ancestor
111151847|NCT02092467|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
111151848|NCT02092467|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111151849|NCT02092467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111151850|NCT02092467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111151851|NCT04420871|Capecitabine|capecitabine|mesh-list
111151852|NCT04420871|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111151853|NCT04420871|Antimetabolites|antimetabolites|mesh-ancestor
111151854|NCT04420871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111151855|NCT04420871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111151856|NCT02349386|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
111151857|NCT02349386|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
111151858|NCT02349386|Estradiol|estradiol|mesh-list
111151859|NCT02349386|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
111151860|NCT02349386|Estrogens|estrogens|mesh-ancestor
111151861|NCT02349386|Hormones|hormones|mesh-ancestor
111151862|NCT02349386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110484020|NCT04291118|Autonomic Agents|autonomic agents|mesh-ancestor
111151863|NCT02349386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111151864|NCT02349386|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111151865|NCT02349386|Contraceptive Agents|contraceptive agents|mesh-ancestor
111151866|NCT02349386|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111151867|NCT02349386|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111151868|NCT04892888|Vaccines|vaccines|mesh-list
111151869|NCT04892888|Immunologic Factors|immunologic factors|mesh-ancestor
111151870|NCT04892888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111151871|NCT02036775|Ambroxol|ambroxol|mesh-list
111151872|NCT02036775|Expectorants|expectorants|mesh-ancestor
111151873|NCT02036775|Respiratory System Agents|respiratory system agents|mesh-ancestor
111151874|NCT02034591|Apixaban|apixaban|mesh-list
111151875|NCT02034591|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111151876|NCT02034591|Antithrombins|antithrombins|mesh-ancestor
111151877|NCT02034591|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111151878|NCT02034591|Protease Inhibitors|protease inhibitors|mesh-ancestor
111151879|NCT02034591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111151880|NCT02034591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111151881|NCT02034591|Anticoagulants|anticoagulants|mesh-ancestor
111151882|NCT02091921|Ticagrelor|ticagrelor|mesh-list
110868969|NCT03010176|Pembrolizumab|pembrolizumab|mesh-list
111151883|NCT02091921|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111151884|NCT02091921|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111151885|NCT02091921|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111151886|NCT02091921|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111151887|NCT02091921|Purinergic Agents|purinergic agents|mesh-ancestor
111151888|NCT02091921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111151889|NCT02091921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111151890|NCT02091921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111151891|NCT04716933|Carboplatin|carboplatin|mesh-list
111151892|NCT04716933|Pembrolizumab|pembrolizumab|mesh-list
111151893|NCT04716933|Pemetrexed|pemetrexed|mesh-list
111151894|NCT04716933|Lenvatinib|lenvatinib|mesh-list
111151895|NCT04716933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111151896|NCT04716933|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111151897|NCT04716933|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111151898|NCT04716933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111151899|NCT04716933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111151900|NCT04716933|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111151901|NCT04716933|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111151902|NCT04716933|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111151903|NCT02034513|Insulin|insulin|mesh-list
111151904|NCT02034513|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111151905|NCT02034513|Insulin Glargine|insulin glargine|mesh-list
111151906|NCT02034513|Insulin Aspart|insulin aspart|mesh-list
111151907|NCT02034513|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111151908|NCT02034513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111151909|NCT02461745|Ribavirin|ribavirin|mesh-list
111151910|NCT02461745|Ritonavir|ritonavir|mesh-list
111151911|NCT02461745|Antimetabolites|antimetabolites|mesh-ancestor
111151912|NCT02461745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111151913|NCT02461745|Antiviral Agents|antiviral agents|mesh-ancestor
111151914|NCT02461745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111151915|NCT02461745|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111151916|NCT02461745|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111151917|NCT02461745|Protease Inhibitors|protease inhibitors|mesh-ancestor
111151918|NCT02461745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111151919|NCT02461745|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111151920|NCT02461745|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111151921|NCT02461745|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111151922|NCT02461745|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111151923|NCT02034435|Amlodipine|amlodipine|mesh-list
111151924|NCT02034435|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111151925|NCT02034435|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111151926|NCT02034435|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111151927|NCT02034435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111151928|NCT02034435|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111151929|NCT02034435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111151930|NCT02034435|Vasodilator Agents|vasodilator agents|mesh-ancestor
111151931|NCT02033889|Insulin|insulin|mesh-list
111151932|NCT02033889|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111151933|NCT02033889|Metformin|metformin|mesh-list
111151934|NCT02033889|Insulin Glargine|insulin glargine|mesh-list
111151935|NCT02033889|Glimepiride|glimepiride|mesh-list
111151936|NCT02033889|Insulin Detemir|insulin detemir|mesh-list
111151937|NCT02033889|Ertugliflozin|ertugliflozin|mesh-list
111151938|NCT02033889|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111151939|NCT02033889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111151940|NCT02033889|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111151941|NCT02033889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111151942|NCT02033889|Immunologic Factors|immunologic factors|mesh-ancestor
111151943|NCT02033889|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111151944|NCT02033889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111151945|NCT02447003|Pembrolizumab|pembrolizumab|mesh-list
111151946|NCT02447003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111151947|NCT02447003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111151948|NCT02447003|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111151949|NCT02447003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111151950|NCT04594018|Minoxidil|minoxidil|mesh-list
111151951|NCT04594018|Finasteride|finasteride|mesh-list
111151952|NCT04594018|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111151953|NCT04594018|Vasodilator Agents|vasodilator agents|mesh-ancestor
111151954|NCT04594018|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
111151955|NCT04594018|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111151956|NCT04594018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111151957|NCT04594018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110869043|NCT05189769|Levonorgestrel|levonorgestrel|mesh-list
111151958|NCT04594018|Hormone Antagonists|hormone antagonists|mesh-ancestor
111151959|NCT04594018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111151960|NCT04594018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111151961|NCT04594018|Urological Agents|urological agents|mesh-ancestor
111151962|NCT02054481|Ustekinumab|ustekinumab|mesh-list
111151963|NCT02054481|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111151964|NCT02054481|Dermatologic Agents|dermatologic agents|mesh-ancestor
111151965|NCT02054481|Immunologic Factors|immunologic factors|mesh-ancestor
111151966|NCT02054481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111151967|NCT02054325|Polidocanol|polidocanol|mesh-list
111151968|NCT02054325|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
111151969|NCT02054325|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111151970|NCT02091375|Cannabidiol|cannabidiol|mesh-list
111151971|NCT02091375|Anticonvulsants|anticonvulsants|mesh-ancestor
111151972|NCT02032875|Ribavirin|ribavirin|mesh-list
111151973|NCT02032875|Sofosbuvir|sofosbuvir|mesh-list
111151974|NCT02032875|Antimetabolites|antimetabolites|mesh-ancestor
111151975|NCT02032875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111151976|NCT02032875|Antiviral Agents|antiviral agents|mesh-ancestor
111151977|NCT02032875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111151978|NCT02032407|Dapsone|dapsone|mesh-list
111151979|NCT02032407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111151980|NCT02032407|Antimalarials|antimalarials|mesh-ancestor
111151981|NCT02032407|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111151982|NCT02032407|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111151983|NCT02032407|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111151984|NCT02032407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111151985|NCT02032407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111151986|NCT02032407|Leprostatic Agents|leprostatic agents|mesh-ancestor
111151987|NCT02032407|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111151988|NCT01843660|Acetaminophen|acetaminophen|mesh-list
111151989|NCT01843660|Tramadol|tramadol|mesh-list
111151990|NCT01843660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111151991|NCT01843660|Analgesics|analgesics|mesh-ancestor
111151992|NCT01843660|Sensory System Agents|sensory system agents|mesh-ancestor
111151993|NCT01843660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111151994|NCT01843660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111151995|NCT01843660|Antipyretics|antipyretics|mesh-ancestor
111151996|NCT01843660|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111151997|NCT01843660|Narcotics|narcotics|mesh-ancestor
111151998|NCT01843660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111151999|NCT02032173|Ranibizumab|ranibizumab|mesh-list
111152000|NCT02032173|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111152001|NCT02032173|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111152002|NCT02032173|Growth Substances|growth substances|mesh-ancestor
111152003|NCT02032173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111152004|NCT02032173|Growth Inhibitors|growth inhibitors|mesh-ancestor
111152005|NCT02032173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111152006|NCT02461589|Liraglutide|liraglutide|mesh-list
111152007|NCT02461589|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111152008|NCT02461589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111152009|NCT02461589|Incretins|incretins|mesh-ancestor
111152010|NCT02461589|Hormones|hormones|mesh-ancestor
111152011|NCT02461589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111152012|NCT02089737|Panitumumab|panitumumab|mesh-list
111152013|NCT02089737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111152014|NCT02089737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111152015|NCT02089347|Vaccines|vaccines|mesh-list
111152016|NCT02089347|Immunologic Factors|immunologic factors|mesh-ancestor
111152017|NCT02089347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111152018|NCT02419469|Cytarabine|cytarabine|mesh-list
111152019|NCT02419469|Dexamethasone|dexamethasone|mesh-list
111152020|NCT02419469|Prednisone|prednisone|mesh-list
110840610|NCT03755089|Lidocaine|lidocaine|mesh-list
111152021|NCT02419469|Dexamethasone acetate|dexamethasone acetate|mesh-list
111152022|NCT02419469|Cyclophosphamide|cyclophosphamide|mesh-list
111152023|NCT02419469|Rituximab|rituximab|mesh-list
111152024|NCT02419469|Doxorubicin|doxorubicin|mesh-list
111152025|NCT02419469|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111152026|NCT02419469|Methotrexate|methotrexate|mesh-list
111152027|NCT02419469|Vincristine|vincristine|mesh-list
111152028|NCT02419469|Daunorubicin|daunorubicin|mesh-list
111152029|NCT02419469|Asparaginase|asparaginase|mesh-list
111152030|NCT02419469|Mercaptopurine|mercaptopurine|mesh-list
111152031|NCT02419469|Ofatumumab|ofatumumab|mesh-list
111152032|NCT02419469|Pegaspargase|pegaspargase|mesh-list
111152033|NCT02419469|Thioguanine|thioguanine|mesh-list
111152034|NCT02419469|BB 1101|bb 1101|mesh-list
111152035|NCT02419469|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111152036|NCT02419469|Immunologic Factors|immunologic factors|mesh-ancestor
111152037|NCT02419469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111152038|NCT02419469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111152039|NCT02419469|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111152040|NCT02419469|Alkylating Agents|alkylating agents|mesh-ancestor
111152041|NCT02419469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111152042|NCT02419469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111152043|NCT02419469|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111152044|NCT02419469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111152045|NCT02419469|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111152046|NCT02419469|Antiemetics|antiemetics|mesh-ancestor
111152047|NCT02419469|Autonomic Agents|autonomic agents|mesh-ancestor
111152048|NCT02419469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111152049|NCT02419469|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111152050|NCT02419469|Glucocorticoids|glucocorticoids|mesh-ancestor
111152051|NCT02419469|Hormones|hormones|mesh-ancestor
111152052|NCT02419469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111152053|NCT02419469|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111152054|NCT02419469|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111152055|NCT02419469|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111152056|NCT02419469|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111152057|NCT02419469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111152058|NCT02419469|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111152059|NCT02419469|Abortifacient Agents|abortifacient agents|mesh-ancestor
111152060|NCT02419469|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111152061|NCT02419469|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111152062|NCT02419469|Antimetabolites|antimetabolites|mesh-ancestor
111152063|NCT02419469|Dermatologic Agents|dermatologic agents|mesh-ancestor
111152064|NCT02419469|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111152065|NCT02419469|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111152066|NCT02419469|Antiviral Agents|antiviral agents|mesh-ancestor
111152067|NCT02419469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111152068|NCT02419469|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111152069|NCT02419469|Tubulin Modulators|tubulin modulators|mesh-ancestor
111152070|NCT02419469|Antimitotic Agents|antimitotic agents|mesh-ancestor
111152071|NCT02419469|Mitosis Modulators|mitosis modulators|mesh-ancestor
111152072|NCT02419469|Protease Inhibitors|protease inhibitors|mesh-ancestor
111152073|NCT04687761|Cytarabine|cytarabine|mesh-list
111152074|NCT04687761|Azacitidine|azacitidine|mesh-list
111152075|NCT04687761|Venetoclax|venetoclax|mesh-list
111152076|NCT04687761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111152077|NCT04687761|Antimetabolites|antimetabolites|mesh-ancestor
111152078|NCT04687761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111152079|NCT04687761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111152080|NCT04687761|Antiviral Agents|antiviral agents|mesh-ancestor
111152081|NCT04687761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111152082|NCT04687761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111152083|NCT04687761|Immunologic Factors|immunologic factors|mesh-ancestor
111152084|NCT04687761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111152085|NCT04687761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111152086|NCT02419313|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
111152087|NCT02419313|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111152088|NCT02419313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111152089|NCT02419313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111152090|NCT02419313|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110840617|NCT03755089|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111152091|NCT02419313|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111152092|NCT02419313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111152093|NCT02419313|Cholinergic Agents|cholinergic agents|mesh-ancestor
111152094|NCT02419313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111152095|NCT04730583|Deoxycholic Acid|deoxycholic acid|mesh-list
111152096|NCT04730583|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
111152097|NCT04730583|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111152098|NCT04730193|Caffeine|caffeine|mesh-list
111152099|NCT04730193|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111152100|NCT04730193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111152101|NCT04730193|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111152102|NCT04730193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111152103|NCT04730193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111152104|NCT04730193|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
111152105|NCT04730193|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111152106|NCT04730193|Purinergic Agents|purinergic agents|mesh-ancestor
111152107|NCT04730193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111152108|NCT02088957|Phenytoin|phenytoin|mesh-list
111152109|NCT02088957|Brivaracetam|brivaracetam|mesh-list
111152110|NCT02088957|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111152111|NCT02088957|Anticonvulsants|anticonvulsants|mesh-ancestor
111152112|NCT02088957|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111152113|NCT02088957|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111152114|NCT02088957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111152115|NCT02088957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111152116|NCT02088957|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
111152117|NCT02088957|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111152118|NCT02088177|Naltrexone|naltrexone|mesh-list
111152119|NCT02088177|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111152120|NCT02088177|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111152121|NCT02088177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111152122|NCT02088177|Sensory System Agents|sensory system agents|mesh-ancestor
111152123|NCT02088177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111152124|NCT02030535|Tiotropium Bromide|tiotropium bromide|mesh-list
111152125|NCT02030535|Olodaterol|olodaterol|mesh-list
111152126|NCT02030535|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111152127|NCT02030535|Autonomic Agents|autonomic agents|mesh-ancestor
111152128|NCT02030535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111152129|NCT02030535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111152130|NCT02030535|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111152131|NCT02030535|Respiratory System Agents|respiratory system agents|mesh-ancestor
111152132|NCT02030535|Parasympatholytics|parasympatholytics|mesh-ancestor
111152133|NCT02030535|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111152134|NCT02030535|Cholinergic Agents|cholinergic agents|mesh-ancestor
111152135|NCT02030535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111152136|NCT02030535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111152137|NCT02029989|Chrysarobin|chrysarobin|mesh-list
111152138|NCT02029989|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111152139|NCT02029989|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111152140|NCT02029989|Analgesics|analgesics|mesh-ancestor
111152141|NCT02029989|Sensory System Agents|sensory system agents|mesh-ancestor
110484040|NCT02868944|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111152142|NCT02029989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111152143|NCT02029989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111152144|NCT02029989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111152145|NCT02029989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111152146|NCT02048241|Guanfacine|guanfacine|mesh-list
111152147|NCT02048241|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111152148|NCT02048241|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111152149|NCT02048241|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111152150|NCT02048241|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111152151|NCT02048241|Adrenergic Agents|adrenergic agents|mesh-ancestor
111152152|NCT02048241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111152153|NCT02048241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111152154|NCT02048241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111152155|NCT02087943|Thalidomide|thalidomide|mesh-list
111152156|NCT02087943|Apremilast|apremilast|mesh-list
111152157|NCT02087943|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111152158|NCT02087943|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111152159|NCT02087943|Analgesics|analgesics|mesh-ancestor
111152160|NCT02087943|Sensory System Agents|sensory system agents|mesh-ancestor
111152161|NCT02087943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111152162|NCT02087943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111152163|NCT02087943|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111152164|NCT02087943|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111152165|NCT02087943|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
111152166|NCT02087943|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111152167|NCT02087943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111152168|NCT02087943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111152169|NCT02087943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111152170|NCT02087943|Immunologic Factors|immunologic factors|mesh-ancestor
111152171|NCT02087943|Leprostatic Agents|leprostatic agents|mesh-ancestor
111152172|NCT02087943|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111152173|NCT02087943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111152174|NCT02087943|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111152175|NCT02087943|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111152176|NCT02087943|Growth Substances|growth substances|mesh-ancestor
111152177|NCT02087943|Growth Inhibitors|growth inhibitors|mesh-ancestor
111152178|NCT02087943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111152179|NCT04685811|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
111152180|NCT04685811|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111152181|NCT04685811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111152183|NCT04709211|Anesthetics, Local|anesthetics, local|mesh-ancestor
111152184|NCT04709211|Anesthetics|anesthetics|mesh-ancestor
111152185|NCT04709211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111152186|NCT04709211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111152187|NCT04709211|Sensory System Agents|sensory system agents|mesh-ancestor
111152188|NCT04709211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111152190|NCT02443883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111152191|NCT02087241|Carboplatin|carboplatin|mesh-list
111152192|NCT02087241|Pemetrexed|pemetrexed|mesh-list
111152193|NCT02087241|Adavosertib|adavosertib|mesh-list
111152194|NCT02087241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111152195|NCT02087241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111152196|NCT02087241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111152197|NCT02087241|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111152198|NCT02087241|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111152199|NCT02087085|Brimonidine Tartrate|brimonidine tartrate|mesh-list
111152200|NCT02087085|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111152201|NCT02087085|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111152202|NCT02087085|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111152203|NCT02087085|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111152204|NCT02087085|Adrenergic Agents|adrenergic agents|mesh-ancestor
111152205|NCT02087085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111152206|NCT02087085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111152207|NCT02087085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111152208|NCT02443337|Necitumumab|necitumumab|mesh-list
111152209|NCT02443337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111152210|NCT02443337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111152211|NCT02443103|Guanabenz|guanabenz|mesh-list
111152212|NCT02443103|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111152213|NCT02443103|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111152214|NCT02443103|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111152215|NCT02443103|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111152216|NCT02443103|Adrenergic Agents|adrenergic agents|mesh-ancestor
111152217|NCT02443103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111152218|NCT02443103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111152219|NCT02443103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111152220|NCT02022657|Tenofovir|tenofovir|mesh-list
111152221|NCT02022657|Emtricitabine|emtricitabine|mesh-list
111152222|NCT02022657|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
111152223|NCT02022657|Antiviral Agents|antiviral agents|mesh-ancestor
111152224|NCT02022657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111152225|NCT02022657|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111152226|NCT02022657|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111152227|NCT02022657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111152228|NCT02022657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111152229|NCT02022657|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111152230|NCT02022657|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111152231|NCT02021643|Sofosbuvir|sofosbuvir|mesh-list
111152232|NCT02021643|Ribavirin|ribavirin|mesh-list
111152233|NCT02021643|Antiviral Agents|antiviral agents|mesh-ancestor
111152234|NCT02021643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111152235|NCT02021643|Antimetabolites|antimetabolites|mesh-ancestor
111152236|NCT02021643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111152237|NCT02415959|Pancrelipase|pancrelipase|mesh-list
111152238|NCT02415959|Pancreatin|pancreatin|mesh-list
111152239|NCT02415959|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111152240|NCT02021331|Cimetidine|cimetidine|mesh-list
111152241|NCT02021331|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111152242|NCT02021331|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111152243|NCT02021331|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
111152244|NCT02021331|Histamine Antagonists|histamine antagonists|mesh-ancestor
111152245|NCT02021331|Histamine Agents|histamine agents|mesh-ancestor
111152246|NCT02021331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111152247|NCT02021331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111152248|NCT02021331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111152249|NCT02021331|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111152250|NCT02021331|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111152251|NCT02021331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111152252|NCT04681833|Vaccines|vaccines|mesh-list
111152253|NCT04681833|Immunologic Factors|immunologic factors|mesh-ancestor
111152254|NCT04681833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111152255|NCT02441309|Ifosfamide|ifosfamide|mesh-list
111152256|NCT02441309|Mifamurtide|mifamurtide|mesh-list
111152257|NCT02441309|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111152258|NCT02441309|Alkylating Agents|alkylating agents|mesh-ancestor
111152259|NCT02441309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111152260|NCT02441309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111152261|NCT02441309|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111152262|NCT02441309|Immunologic Factors|immunologic factors|mesh-ancestor
111152263|NCT02441309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111152264|NCT01652729|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111152265|NCT01652729|Exenatide|exenatide|mesh-list
111152266|NCT01652729|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111152267|NCT01652729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111152268|NCT01652729|Incretins|incretins|mesh-ancestor
111152269|NCT01652729|Hormones|hormones|mesh-ancestor
111152270|NCT01652729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111152271|NCT01652729|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111152272|NCT01652729|Protease Inhibitors|protease inhibitors|mesh-ancestor
111152273|NCT01652729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111152274|NCT01652729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111152275|NCT01652729|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111152276|NCT02083965|Factor VIII|factor viii|mesh-list
111152277|NCT02083965|Coagulants|coagulants|mesh-ancestor
111152278|NCT02438813|Deoxycholic Acid|deoxycholic acid|mesh-list
111152279|NCT02438813|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
111152280|NCT02438813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111152281|NCT02458469|Buspirone|buspirone|mesh-list
111152282|NCT02458469|Trazodone|trazodone|mesh-list
111152283|NCT02458469|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111152284|NCT02458469|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111152285|NCT02458469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111152286|NCT02458469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111152287|NCT02458469|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111152288|NCT02458469|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111152289|NCT02458469|Serotonin Agents|serotonin agents|mesh-ancestor
111152290|NCT02458469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111152291|NCT02458469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111152292|NCT02458469|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111152293|NCT02458469|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111152294|NCT02458469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111152295|NCT02458469|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110840635|NCT03289533|Avelumab|avelumab|mesh-list
111152296|NCT02458469|Antidepressive Agents|antidepressive agents|mesh-ancestor
111152297|NCT01843348|Cyclosporine|cyclosporine|mesh-list
111152298|NCT01843348|Mycophenolic Acid|mycophenolic acid|mesh-list
111152299|NCT01843348|Everolimus|everolimus|mesh-list
111152300|NCT01843348|Tacrolimus|tacrolimus|mesh-list
111152301|NCT01843348|Cyclosporins|cyclosporins|mesh-list
111152302|NCT01843348|Basiliximab|basiliximab|mesh-list
111152303|NCT01843348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111152304|NCT01843348|Immunologic Factors|immunologic factors|mesh-ancestor
111152305|NCT01843348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111152306|NCT01843348|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111152307|NCT01843348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111152308|NCT01843348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111152309|NCT01843348|Antifungal Agents|antifungal agents|mesh-ancestor
111152310|NCT01843348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111152311|NCT01843348|Dermatologic Agents|dermatologic agents|mesh-ancestor
111152312|NCT01843348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111152313|NCT01843348|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111152314|NCT01843348|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111152315|NCT01843348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111152316|NCT01843348|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111152317|NCT01843348|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111152318|NCT01843348|Antitubercular Agents|antitubercular agents|mesh-ancestor
111152319|NCT01843348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111152320|NCT01825876|Warfarin|warfarin|mesh-list
111152321|NCT01825876|Evacetrapib|evacetrapib|mesh-list
111152322|NCT01825876|Anticoagulants|anticoagulants|mesh-ancestor
111152323|NCT01825876|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111152324|NCT01825876|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111152325|NCT01825876|Antimetabolites|antimetabolites|mesh-ancestor
111152326|NCT01825876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111152327|NCT01825876|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111152328|NCT01825798|Metformin|metformin|mesh-list
111152329|NCT01825798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111152330|NCT01825798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111152331|NCT02412761|Amlodipine|amlodipine|mesh-list
111152332|NCT02412761|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
111152333|NCT02412761|Lisinopril|lisinopril|mesh-list
111152334|NCT02412761|Calcium Channel Blockers|calcium channel blockers|mesh-list
111152335|NCT02412761|Diuretics|diuretics|mesh-list
111152336|NCT02412761|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
111152337|NCT02412761|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
111152338|NCT02412761|Enzyme Inhibitors|enzyme inhibitors|mesh-list
111152339|NCT02412761|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110484056|NCT00719797|Fluorouracil|fluorouracil|mesh-list
111152340|NCT02412761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111152341|NCT02412761|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111152342|NCT02412761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111152343|NCT02412761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111152344|NCT02412761|Vasodilator Agents|vasodilator agents|mesh-ancestor
111152345|NCT02412761|Natriuretic Agents|natriuretic agents|mesh-ancestor
111152346|NCT02412761|Protease Inhibitors|protease inhibitors|mesh-ancestor
111152347|NCT02412761|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111152348|NCT02412761|Protective Agents|protective agents|mesh-ancestor
111152349|NCT01842334|Nicotine|nicotine|mesh-list
111152350|NCT01842334|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111152351|NCT01842334|Autonomic Agents|autonomic agents|mesh-ancestor
111152352|NCT01842334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111152353|NCT01842334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111152354|NCT01842334|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111152355|NCT01842334|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111152356|NCT01842334|Cholinergic Agents|cholinergic agents|mesh-ancestor
111152357|NCT01842334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111152358|NCT01842334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111152359|NCT02457611|Sofosbuvir|sofosbuvir|mesh-list
111152360|NCT02457611|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
111152361|NCT02457611|Ledipasvir|ledipasvir|mesh-list
111152362|NCT02457611|Antiviral Agents|antiviral agents|mesh-ancestor
111152363|NCT02457611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111152364|NCT02083653|Fluorouracil|fluorouracil|mesh-list
111152365|NCT02083653|Capecitabine|capecitabine|mesh-list
110840642|NCT03395002|Fluticasone|fluticasone|mesh-list
111152366|NCT02083653|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111152367|NCT02083653|Antimetabolites|antimetabolites|mesh-ancestor
111152368|NCT02083653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111152369|NCT02083653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111152370|NCT02083653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111152371|NCT02083653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111152372|NCT02083653|Immunologic Factors|immunologic factors|mesh-ancestor
111152373|NCT02083653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111152374|NCT02436239|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
111152375|NCT02436239|Antidepressive Agents|antidepressive agents|mesh-ancestor
111152376|NCT02436239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111152377|NCT02436239|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111152378|NCT02436239|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111152379|NCT02436239|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111152380|NCT02436239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111152381|NCT02436239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111152382|NCT02436239|Serotonin Agents|serotonin agents|mesh-ancestor
111152383|NCT02436239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111152384|NCT02436239|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111152385|NCT02436239|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111152386|NCT02026011|Naltrexone|naltrexone|mesh-list
111152387|NCT02026011|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111152388|NCT02026011|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111152389|NCT02026011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111152390|NCT02026011|Sensory System Agents|sensory system agents|mesh-ancestor
111152391|NCT02026011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111152392|NCT02456909|Morphine|morphine|mesh-list
111152393|NCT02456909|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111152394|NCT02456909|Narcotics|narcotics|mesh-ancestor
111152395|NCT02456909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111152396|NCT02456909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111152397|NCT02456909|Analgesics|analgesics|mesh-ancestor
111152398|NCT02456909|Sensory System Agents|sensory system agents|mesh-ancestor
111152399|NCT02456909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111152400|NCT02025621|Simendan|simendan|mesh-list
111152401|NCT02025621|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111152402|NCT02025621|Vasodilator Agents|vasodilator agents|mesh-ancestor
111152403|NCT02025621|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
111152404|NCT02025621|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111152405|NCT02025621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111152406|NCT02025621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111152407|NCT02025621|Protective Agents|protective agents|mesh-ancestor
111152408|NCT02025621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111152409|NCT04729023|Temazepam|temazepam|mesh-list
111152410|NCT04729023|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111152411|NCT04729023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111152412|NCT04729023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111152413|NCT04729023|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111152414|NCT04729023|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111152415|NCT04729023|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111152416|NCT04729023|GABA Modulators|gaba modulators|mesh-ancestor
111152417|NCT04729023|GABA Agents|gaba agents|mesh-ancestor
111152418|NCT04729023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111152419|NCT04729023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111152420|NCT02020941|Dexamethasone|dexamethasone|mesh-list
111152421|NCT02020941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111152422|NCT02020941|Antiemetics|antiemetics|mesh-ancestor
111152423|NCT02020941|Autonomic Agents|autonomic agents|mesh-ancestor
111152424|NCT02020941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111152425|NCT02020941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111152426|NCT02020941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111152427|NCT02020941|Glucocorticoids|glucocorticoids|mesh-ancestor
111152428|NCT02020941|Hormones|hormones|mesh-ancestor
111152429|NCT02020941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111152430|NCT02020941|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111152431|NCT02020941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111152432|NCT01823224|Acetaminophen|acetaminophen|mesh-list
111152433|NCT01823224|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111152434|NCT01823224|Analgesics|analgesics|mesh-ancestor
111152435|NCT01823224|Sensory System Agents|sensory system agents|mesh-ancestor
111152436|NCT01823224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111152437|NCT01823224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111152438|NCT01823224|Antipyretics|antipyretics|mesh-ancestor
111152439|NCT01840228|Progesterone|progesterone|mesh-list
111152440|NCT01840228|Progestins|progestins|mesh-ancestor
111152441|NCT01840228|Hormones|hormones|mesh-ancestor
111152442|NCT01840228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111152443|NCT01840228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111152444|NCT01823146|Oxytocin|oxytocin|mesh-list
111152445|NCT01823146|Oxytocics|oxytocics|mesh-ancestor
111152446|NCT01823146|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111152447|NCT01823146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111152448|NCT02083185|Leuprolide|leuprolide|mesh-list
111152449|NCT02083185|Relugolix|relugolix|mesh-list
111152450|NCT02083185|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111152451|NCT02083185|Fertility Agents|fertility agents|mesh-ancestor
111152452|NCT02083185|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111152453|NCT02083185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111152454|NCT02083185|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111152455|NCT02083185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111152456|NCT02083185|Androgen Antagonists|androgen antagonists|mesh-ancestor
111152457|NCT02083185|Hormone Antagonists|hormone antagonists|mesh-ancestor
111152458|NCT02083185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111152459|NCT02412371|Paclitaxel|paclitaxel|mesh-list
111152460|NCT02412371|Carboplatin|carboplatin|mesh-list
111152461|NCT02412371|Veliparib|veliparib|mesh-list
111152462|NCT02412371|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111152463|NCT02412371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111152464|NCT02412371|Tubulin Modulators|tubulin modulators|mesh-ancestor
111152465|NCT02412371|Antimitotic Agents|antimitotic agents|mesh-ancestor
111152466|NCT02412371|Mitosis Modulators|mitosis modulators|mesh-ancestor
111152467|NCT02412371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111152468|NCT02412371|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111152469|NCT02412371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111152470|NCT01822756|Paclitaxel|paclitaxel|mesh-list
111152471|NCT01822756|Gemcitabine|gemcitabine|mesh-list
111152472|NCT01822756|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110484081|NCT00719797|Micronutrients|micronutrients|mesh-ancestor
111152473|NCT01822756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111152474|NCT01822756|Tubulin Modulators|tubulin modulators|mesh-ancestor
111152475|NCT01822756|Antimitotic Agents|antimitotic agents|mesh-ancestor
111152476|NCT01822756|Mitosis Modulators|mitosis modulators|mesh-ancestor
111152477|NCT01822756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111152478|NCT01822756|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111152479|NCT01822756|Antimetabolites|antimetabolites|mesh-ancestor
111152480|NCT01822678|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
111152481|NCT01822678|Anticonvulsants|anticonvulsants|mesh-ancestor
111152482|NCT01822678|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111152483|NCT01822678|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111152484|NCT01822678|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111152485|NCT01822678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111152486|NCT01838590|Sofosbuvir|sofosbuvir|mesh-list
111152487|NCT01838590|Antiviral Agents|antiviral agents|mesh-ancestor
111152488|NCT01838590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111152489|NCT01611298|Vaccines|vaccines|mesh-list
111152490|NCT01611298|Immunologic Factors|immunologic factors|mesh-ancestor
111152491|NCT01611298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111152492|NCT01822132|Naltrexone|naltrexone|mesh-list
111152493|NCT01822132|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111152494|NCT01822132|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111152495|NCT01822132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111152496|NCT01822132|Sensory System Agents|sensory system agents|mesh-ancestor
111152497|NCT01822132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111152498|NCT01821898|Budesonide|budesonide|mesh-list
111152499|NCT01821898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111152500|NCT01821898|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111152501|NCT01821898|Autonomic Agents|autonomic agents|mesh-ancestor
111152502|NCT01821898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111152503|NCT01821898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111152504|NCT01821898|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111152505|NCT01821898|Respiratory System Agents|respiratory system agents|mesh-ancestor
111152506|NCT01821898|Glucocorticoids|glucocorticoids|mesh-ancestor
111152507|NCT01821898|Hormones|hormones|mesh-ancestor
111152508|NCT01821898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111152509|NCT02411591|Necitumumab|necitumumab|mesh-list
111152510|NCT02411591|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111152511|NCT02411591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111152512|NCT02411201|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
111152513|NCT02411201|Chelating Agents|chelating agents|mesh-ancestor
111152514|NCT02411201|Sequestering Agents|sequestering agents|mesh-ancestor
111152515|NCT02411201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111152516|NCT01838044|Celecoxib|celecoxib|mesh-list
111152517|NCT01838044|Pregabalin|pregabalin|mesh-list
111152518|NCT01838044|Analgesics|analgesics|mesh-ancestor
111152519|NCT01838044|Sensory System Agents|sensory system agents|mesh-ancestor
111152520|NCT01838044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111152521|NCT01838044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111152522|NCT01838044|Anticonvulsants|anticonvulsants|mesh-ancestor
111152523|NCT01838044|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111152524|NCT01838044|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111152525|NCT01838044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111152526|NCT01838044|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111152527|NCT01838044|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111152528|NCT01838044|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111152529|NCT01838044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111152530|NCT01838044|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111152531|NCT01838044|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111152532|NCT01838044|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111152533|NCT01838044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111152534|NCT01838044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111152535|NCT01838044|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111152536|NCT01838044|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111152537|NCT01838044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111152538|NCT02435147|Denosumab|denosumab|mesh-list
111152539|NCT02435147|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111152540|NCT02435147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111152541|NCT02435069|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111152542|NCT02435069|Glycerol|glycerol|mesh-list
111152543|NCT02435069|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
111152544|NCT02435069|Protective Agents|protective agents|mesh-ancestor
111152545|NCT02435069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111152546|NCT04917731|Botulinum Toxins|botulinum toxins|mesh-list
111152547|NCT04917731|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111152548|NCT04917731|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111152549|NCT04917731|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111152550|NCT04917731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111152551|NCT04917731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111152552|NCT04917731|Cholinergic Agents|cholinergic agents|mesh-ancestor
111152553|NCT04917731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111152554|NCT04917731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111152555|NCT04917731|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111152556|NCT04917731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111152557|NCT01820572|Cyclosporine|cyclosporine|mesh-list
111152558|NCT01820572|Abatacept|abatacept|mesh-list
111152559|NCT01820572|Tacrolimus|tacrolimus|mesh-list
111152560|NCT01820572|Cyclosporins|cyclosporins|mesh-list
111152561|NCT01820572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111152562|NCT01820572|Immunologic Factors|immunologic factors|mesh-ancestor
111152563|NCT01820572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111152564|NCT01820572|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111152565|NCT01820572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111152566|NCT01820572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111152567|NCT01820572|Antifungal Agents|antifungal agents|mesh-ancestor
111152568|NCT01820572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111152569|NCT01820572|Dermatologic Agents|dermatologic agents|mesh-ancestor
111152570|NCT01820572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111152571|NCT01820572|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111152572|NCT01820572|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111152573|NCT01820572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111152574|NCT01610596|Halobetasol|halobetasol|mesh-list
111152575|NCT01610596|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111152576|NCT01818700|Buprenorphine|buprenorphine|mesh-list
111152577|NCT01818700|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111152578|NCT01818700|Narcotics|narcotics|mesh-ancestor
111152579|NCT01818700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111152580|NCT01818700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111152581|NCT01818700|Analgesics|analgesics|mesh-ancestor
111152582|NCT01818700|Sensory System Agents|sensory system agents|mesh-ancestor
111152583|NCT01818700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111152584|NCT01818700|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111152585|NCT01817764|Fluticasone|fluticasone|mesh-list
111152587|NCT01817764|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
111152588|NCT01817764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111152589|NCT01817764|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111152590|NCT01817764|Autonomic Agents|autonomic agents|mesh-ancestor
111152591|NCT01817764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111152592|NCT01817764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111152593|NCT01817764|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111152594|NCT01817764|Respiratory System Agents|respiratory system agents|mesh-ancestor
111152595|NCT01817764|Dermatologic Agents|dermatologic agents|mesh-ancestor
111152596|NCT01817764|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111152597|NCT01817764|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111152598|NCT01817764|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111152599|NCT01817764|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111152600|NCT01817764|Adrenergic Agents|adrenergic agents|mesh-ancestor
111152601|NCT01817764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111152602|NCT01817764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111152603|NCT04726618|Xenon|xenon|mesh-list
111152604|NCT04726618|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111152605|NCT04726618|Anesthetics, General|anesthetics, general|mesh-ancestor
111152606|NCT04726618|Anesthetics|anesthetics|mesh-ancestor
111152607|NCT04726618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111152608|NCT04726618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111152609|NCT01817530|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
111152610|NCT01817530|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
111152611|NCT01817530|Norethindrone|norethindrone|mesh-list
111152612|NCT01817530|Norethindrone Acetate|norethindrone acetate|mesh-list
111152613|NCT01817530|Estradiol|estradiol|mesh-list
111152614|NCT01817530|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
111152615|NCT01817530|Estrogens|estrogens|mesh-ancestor
111152616|NCT01817530|Hormones|hormones|mesh-ancestor
111152617|NCT01817530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111152618|NCT01817530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111152619|NCT01817530|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111152620|NCT01817530|Contraceptive Agents|contraceptive agents|mesh-ancestor
111152621|NCT01817530|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111152622|NCT01817530|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111152623|NCT01817530|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111152624|NCT01817530|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111152625|NCT01817530|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111152626|NCT01816984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111152627|NCT01816984|Cetuximab|cetuximab|mesh-list
111152628|NCT01816984|Antibodies|antibodies|mesh-list
111152629|NCT01816984|Immunoglobulins|immunoglobulins|mesh-list
111152630|NCT01816984|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111152631|NCT01816984|Immunologic Factors|immunologic factors|mesh-ancestor
111152632|NCT01816984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111152633|NCT01816984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111152634|NCT01816594|Paclitaxel|paclitaxel|mesh-list
111152635|NCT01816594|Trastuzumab|trastuzumab|mesh-list
111152636|NCT01816594|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111152637|NCT01816594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111152638|NCT01816594|Tubulin Modulators|tubulin modulators|mesh-ancestor
111152639|NCT01816594|Antimitotic Agents|antimitotic agents|mesh-ancestor
111152640|NCT01816594|Mitosis Modulators|mitosis modulators|mesh-ancestor
111152641|NCT01816594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111152642|NCT01816594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111152643|NCT02453711|Liraglutide|liraglutide|mesh-list
111152644|NCT02453711|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111152645|NCT02453711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111152646|NCT02453711|Incretins|incretins|mesh-ancestor
111152647|NCT02453711|Hormones|hormones|mesh-ancestor
111152648|NCT02453711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111152649|NCT02453555|Empagliflozin|empagliflozin|mesh-list
111152650|NCT02453555|Linagliptin|linagliptin|mesh-list
111152651|NCT02453555|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111152652|NCT02453555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111152653|NCT02453555|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111152654|NCT02453555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111152655|NCT02453555|Incretins|incretins|mesh-ancestor
111152656|NCT02453555|Hormones|hormones|mesh-ancestor
111152657|NCT02453555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111152658|NCT02453555|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111152659|NCT02453555|Protease Inhibitors|protease inhibitors|mesh-ancestor
111152660|NCT02453555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111152661|NCT02453321|Bupivacaine|bupivacaine|mesh-list
111152662|NCT02453321|Anesthetics, Local|anesthetics, local|mesh-ancestor
111152663|NCT02453321|Anesthetics|anesthetics|mesh-ancestor
111152664|NCT02453321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111152665|NCT02453321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111152666|NCT02453321|Sensory System Agents|sensory system agents|mesh-ancestor
111152667|NCT02453321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111152668|NCT01610284|Fulvestrant|fulvestrant|mesh-list
111152669|NCT01610284|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111152670|NCT01610284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111152671|NCT01610284|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
111152672|NCT01610284|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111152673|NCT01610284|Hormone Antagonists|hormone antagonists|mesh-ancestor
111152674|NCT01610284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111152675|NCT01610284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111152676|NCT02452463|Durvalumab|durvalumab|mesh-list
111152677|NCT02452463|Nintedanib|nintedanib|mesh-list
111152678|NCT02452463|Immunoglobulins|immunoglobulins|mesh-list
111152679|NCT02452463|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111152680|NCT02452463|Immunoglobulin G|immunoglobulin g|mesh-list
111152681|NCT02452463|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
111152682|NCT02452463|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111152683|NCT02452463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111152684|NCT02452463|Immunologic Factors|immunologic factors|mesh-ancestor
111152685|NCT02452463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111152686|NCT02452463|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111152687|NCT02452463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111152688|NCT02452463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111152689|NCT03628391|Haloperidol|haloperidol|mesh-list
111152690|NCT03628391|Haloperidol decanoate|haloperidol decanoate|mesh-list
111152691|NCT03628391|Antiemetics|antiemetics|mesh-ancestor
111152692|NCT03628391|Autonomic Agents|autonomic agents|mesh-ancestor
111152693|NCT03628391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111152694|NCT03628391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111152695|NCT03628391|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111152696|NCT03628391|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111152697|NCT03628391|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111152698|NCT03628391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111152699|NCT03628391|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111152700|NCT03628391|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111152701|NCT03628391|Dopamine Agents|dopamine agents|mesh-ancestor
111152702|NCT03628391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111152703|NCT03628391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111152704|NCT03628391|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111152705|NCT01610206|Gemcitabine|gemcitabine|mesh-list
111152706|NCT01610206|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111152707|NCT01610206|Antimetabolites|antimetabolites|mesh-ancestor
111152708|NCT01610206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111152709|NCT01610206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111152710|NCT01816048|Listerine|listerine|mesh-list
111152711|NCT01816048|Fluorides|fluorides|mesh-list
111152712|NCT01816048|Sodium Fluoride|sodium fluoride|mesh-list
111152713|NCT01816048|Cariostatic Agents|cariostatic agents|mesh-ancestor
111152714|NCT01816048|Protective Agents|protective agents|mesh-ancestor
111152715|NCT01816048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111152716|NCT01816048|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111152717|NCT01816048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111152718|NCT01612858|Metformin|metformin|mesh-list
111152719|NCT01612858|Pioglitazone|pioglitazone|mesh-list
111152720|NCT01612858|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111152721|NCT01612858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111152722|NCT01612702|Dexamethasone|dexamethasone|mesh-list
111152723|NCT01612702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111152724|NCT01612702|Antiemetics|antiemetics|mesh-ancestor
111152725|NCT01612702|Autonomic Agents|autonomic agents|mesh-ancestor
111152726|NCT01612702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111152727|NCT01612702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111152728|NCT01612702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111152729|NCT01612702|Glucocorticoids|glucocorticoids|mesh-ancestor
111152730|NCT01612702|Hormones|hormones|mesh-ancestor
111152731|NCT01612702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111152732|NCT01612702|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111152733|NCT01612702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111152734|NCT02431559|Doxorubicin|doxorubicin|mesh-list
111152735|NCT02431559|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111152736|NCT02431559|Durvalumab|durvalumab|mesh-list
111152737|NCT02431559|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111152738|NCT02431559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111152739|NCT02431559|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111152740|NCT02431559|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111152741|NCT02431559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111152742|NCT02431559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111152743|NCT02431559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111152744|NCT01652573|Calcitonin|calcitonin|mesh-list
111152745|NCT01652573|Salmon calcitonin|salmon calcitonin|mesh-list
111152746|NCT01652573|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
111152747|NCT01652573|Katacalcin|katacalcin|mesh-list
111152748|NCT01652573|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111152749|NCT01652573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111152750|NCT01652573|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111152751|NCT01652573|Vasodilator Agents|vasodilator agents|mesh-ancestor
111152752|NCT02388191|Naproxen|naproxen|mesh-list
110484105|NCT03258723|Metformin|metformin|mesh-list
111152753|NCT02388191|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111152754|NCT02388191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111152755|NCT02388191|Analgesics|analgesics|mesh-ancestor
111152756|NCT02388191|Sensory System Agents|sensory system agents|mesh-ancestor
111152757|NCT02388191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111152758|NCT02388191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111152759|NCT02388191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111152760|NCT02388191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111152761|NCT02388191|Gout Suppressants|gout suppressants|mesh-ancestor
111152762|NCT02388191|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111152763|NCT02388191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111152764|NCT02388191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111152765|NCT01815736|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
111152766|NCT01815736|Antiviral Agents|antiviral agents|mesh-ancestor
111152767|NCT01815736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111152768|NCT01815736|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111152769|NCT01815736|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111152770|NCT02387957|Bevacizumab|bevacizumab|mesh-list
111152771|NCT02387957|Ranibizumab|ranibizumab|mesh-list
111152772|NCT02387957|Aflibercept|aflibercept|mesh-list
111152773|NCT02387957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111152774|NCT02387957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111152775|NCT02387957|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111152776|NCT02387957|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111152778|NCT02387957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111152779|NCT02387957|Growth Inhibitors|growth inhibitors|mesh-ancestor
111152780|NCT01815580|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
111152781|NCT01815580|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
111152782|NCT01815580|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111152783|NCT01815580|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111152784|NCT01815580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111152785|NCT01815580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111152786|NCT01815580|Antiviral Agents|antiviral agents|mesh-ancestor
111152787|NCT01815580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111152788|NCT01815580|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111152789|NCT01815580|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111152790|NCT01799590|Topiramate|topiramate|mesh-list
111152791|NCT01799590|Anticonvulsants|anticonvulsants|mesh-ancestor
111152792|NCT01799590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111152793|NCT01799590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111152794|NCT04902131|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111152795|NCT04902131|Menotropins|menotropins|mesh-list
111152796|NCT04902131|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111152797|NCT04902131|Fertility Agents|fertility agents|mesh-ancestor
111152798|NCT04902131|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111152799|NCT04902131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111152800|NCT01815424|Tofacitinib|tofacitinib|mesh-list
111152801|NCT01815424|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
111152802|NCT01815424|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111152803|NCT01815424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111152804|NCT01815424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111152805|NCT02431247|Tenofovir|tenofovir|mesh-list
111152806|NCT02431247|Emtricitabine|emtricitabine|mesh-list
111152807|NCT02431247|Darunavir|darunavir|mesh-list
111152808|NCT02431247|Cobicistat|cobicistat|mesh-list
111152809|NCT02431247|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
111152810|NCT02431247|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
111152811|NCT02431247|Antiviral Agents|antiviral agents|mesh-ancestor
111152812|NCT02431247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111152813|NCT02431247|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111152814|NCT02431247|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111152815|NCT02431247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111152816|NCT02431247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111152817|NCT02431247|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111152818|NCT02431247|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111152819|NCT02431247|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111152820|NCT02431247|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111152821|NCT02431247|Protease Inhibitors|protease inhibitors|mesh-ancestor
111152822|NCT02431247|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111152823|NCT02431247|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111152824|NCT01814878|Acetaminophen|acetaminophen|mesh-list
111152825|NCT01814878|Tramadol|tramadol|mesh-list
111152826|NCT01814878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111152827|NCT01814878|Analgesics|analgesics|mesh-ancestor
111152828|NCT01814878|Sensory System Agents|sensory system agents|mesh-ancestor
111152829|NCT01814878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111152830|NCT01814878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111152831|NCT01814878|Antipyretics|antipyretics|mesh-ancestor
111152832|NCT01814878|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111152833|NCT01814878|Narcotics|narcotics|mesh-ancestor
111152834|NCT01814878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111152835|NCT01814800|Immunoglobulins|immunoglobulins|mesh-list
111152836|NCT01814800|Immunologic Factors|immunologic factors|mesh-ancestor
111152837|NCT01814800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111152838|NCT02407223|Ustekinumab|ustekinumab|mesh-list
111152839|NCT02407223|Dermatologic Agents|dermatologic agents|mesh-ancestor
111152840|NCT04602754|Calcium, Dietary|calcium, dietary|mesh-list
111152841|NCT04602754|Empagliflozin|empagliflozin|mesh-list
111152842|NCT04602754|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111152843|NCT04602754|Calcium|calcium|mesh-list
111152844|NCT04602754|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111152845|NCT04602754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111152846|NCT04602754|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111152847|NCT04602754|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111152848|NCT04602754|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111152849|NCT04602754|Antimetabolites|antimetabolites|mesh-ancestor
111152850|NCT04602754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111152851|NCT04602754|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111152852|NCT04602754|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111152853|NCT04602754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111152854|NCT04602754|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111152855|NCT04602754|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111152856|NCT01813474|Olaparib|olaparib|mesh-list
111152857|NCT01813474|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111152858|NCT01813474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110870008|NCT05074290|Taxane|taxane|mesh-list
111152859|NCT01813474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111152860|NCT01813474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111152861|NCT01868542|Insulin Detemir|insulin detemir|mesh-list
111152862|NCT01868542|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111152863|NCT01868542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111152864|NCT01797094|Botulinum Toxins|botulinum toxins|mesh-list
111152865|NCT01797094|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111152866|NCT01797094|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111152867|NCT01797094|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111152868|NCT01797094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111152869|NCT01797094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111152870|NCT01797094|Cholinergic Agents|cholinergic agents|mesh-ancestor
111152871|NCT01797094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111152872|NCT01797094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111152873|NCT01797094|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111152874|NCT01797094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111152875|NCT02383589|Mycophenolic Acid|mycophenolic acid|mesh-list
111152876|NCT02383589|Rituximab|rituximab|mesh-list
111152877|NCT02383589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111152878|NCT02383589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111152879|NCT02383589|Immunologic Factors|immunologic factors|mesh-ancestor
111152880|NCT02383589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111152881|NCT02383589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111152882|NCT02383589|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111152883|NCT02383589|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111152884|NCT02383589|Antitubercular Agents|antitubercular agents|mesh-ancestor
111152885|NCT02383589|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111152886|NCT02383589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111152887|NCT02383589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111152888|NCT02383589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111152889|NCT01810432|Evacetrapib|evacetrapib|mesh-list
111152890|NCT01810432|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111152891|NCT01810432|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111152892|NCT01810432|Antimetabolites|antimetabolites|mesh-ancestor
111152893|NCT01810432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111152894|NCT01810432|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111152895|NCT02404805|Dolutegravir|dolutegravir|mesh-list
111152896|NCT02404805|Simeprevir|simeprevir|mesh-list
111152897|NCT02404805|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111152898|NCT02404805|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111152899|NCT02404805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111152900|NCT02404805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111152901|NCT02404805|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111152902|NCT02404805|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111152903|NCT02404805|Antiviral Agents|antiviral agents|mesh-ancestor
111152904|NCT02404805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111152905|NCT02404805|Protease Inhibitors|protease inhibitors|mesh-ancestor
111152906|NCT02430311|Paclitaxel|paclitaxel|mesh-list
111152907|NCT02430311|Olaparib|olaparib|mesh-list
111152908|NCT02430311|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111152909|NCT02430311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111152910|NCT02430311|Tubulin Modulators|tubulin modulators|mesh-ancestor
111152911|NCT02430311|Antimitotic Agents|antimitotic agents|mesh-ancestor
111152912|NCT02430311|Mitosis Modulators|mitosis modulators|mesh-ancestor
111152913|NCT02430311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111152914|NCT02430311|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111152915|NCT02430311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111152916|NCT02383433|Gemcitabine|gemcitabine|mesh-list
111152917|NCT02383433|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111152918|NCT02383433|Antimetabolites|antimetabolites|mesh-ancestor
111152919|NCT02383433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111152920|NCT02383433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111152921|NCT02383355|Raltegravir Potassium|raltegravir potassium|mesh-list
111152922|NCT02383355|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111152923|NCT02383355|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111152924|NCT02383355|Antiviral Agents|antiviral agents|mesh-ancestor
111152925|NCT02383355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111152926|NCT02383355|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111152927|NCT02383355|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111152928|NCT02383355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111152929|NCT02383355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111152930|NCT02404493|Decanoic acid|decanoic acid|mesh-list
111152931|NCT02404493|Antifungal Agents|antifungal agents|mesh-ancestor
111152932|NCT02404493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111152933|NCT02379221|Lidocaine|lidocaine|mesh-list
111152934|NCT02379221|Epinephrine|epinephrine|mesh-list
111152935|NCT02379221|Benzocaine|benzocaine|mesh-list
111152936|NCT02379221|Anesthetics, Local|anesthetics, local|mesh-ancestor
111152937|NCT02379221|Anesthetics|anesthetics|mesh-ancestor
111152938|NCT02379221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111152939|NCT02379221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111152940|NCT02379221|Sensory System Agents|sensory system agents|mesh-ancestor
111152941|NCT02379221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111152942|NCT02379221|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111152943|NCT02379221|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111152944|NCT02379221|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111152945|NCT02379221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111152946|NCT02379221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111152947|NCT02379221|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111152948|NCT02379221|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111152949|NCT02379221|Adrenergic Agents|adrenergic agents|mesh-ancestor
111152950|NCT02379221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111152951|NCT02379221|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111152952|NCT02379221|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111152953|NCT02379221|Autonomic Agents|autonomic agents|mesh-ancestor
111152954|NCT02379221|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111152955|NCT02379221|Respiratory System Agents|respiratory system agents|mesh-ancestor
111152956|NCT02379221|Mydriatics|mydriatics|mesh-ancestor
111152957|NCT02379221|Sympathomimetics|sympathomimetics|mesh-ancestor
110484121|NCT02684799|Cenicriviroc|cenicriviroc|mesh-list
111152958|NCT02379221|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111152959|NCT02404103|Flunisolide|flunisolide|mesh-list
111152960|NCT02404103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111152961|NCT02404103|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111152962|NCT02404103|Respiratory System Agents|respiratory system agents|mesh-ancestor
111152963|NCT02404025|Thymoglobulin|thymoglobulin|mesh-list
111152964|NCT02404025|Immunologic Factors|immunologic factors|mesh-ancestor
111152965|NCT02404025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111152966|NCT02404025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111152967|NCT02403635|Midazolam|midazolam|mesh-list
111152968|NCT02403635|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111152969|NCT02403635|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111152970|NCT02403635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111152971|NCT02403635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111152972|NCT02403635|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111152973|NCT02403635|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111152974|NCT02403635|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111152975|NCT02403635|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111152976|NCT02403635|Anesthetics, General|anesthetics, general|mesh-ancestor
111152977|NCT02403635|Anesthetics|anesthetics|mesh-ancestor
111152978|NCT02403635|GABA Modulators|gaba modulators|mesh-ancestor
111152979|NCT02403635|GABA Agents|gaba agents|mesh-ancestor
111152980|NCT02403635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111152981|NCT02403635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111152982|NCT02402933|Glucagon|glucagon|mesh-list
111152983|NCT02402933|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
111152984|NCT02402933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111152985|NCT02402933|Hormones|hormones|mesh-ancestor
111152986|NCT02402933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111152987|NCT02402933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111152988|NCT02402933|Incretins|incretins|mesh-ancestor
111152989|NCT01796470|Idelalisib|idelalisib|mesh-list
111152990|NCT01796470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111152991|NCT01796470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111152992|NCT01796470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111152993|NCT04414852|Apatinib|apatinib|mesh-list
111152994|NCT04414852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111152995|NCT04414852|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111152996|NCT04414852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111152997|NCT04414852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111152998|NCT04415008|Cytarabine|cytarabine|mesh-list
111152999|NCT04415008|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111153000|NCT04415008|Antimetabolites|antimetabolites|mesh-ancestor
111153001|NCT04415008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111153002|NCT04415008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111153003|NCT04415008|Antiviral Agents|antiviral agents|mesh-ancestor
111153004|NCT04415008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111153005|NCT04415008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111153006|NCT04415008|Immunologic Factors|immunologic factors|mesh-ancestor
111153007|NCT04415008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111153008|NCT01810042|Ranibizumab|ranibizumab|mesh-list
111153009|NCT01810042|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111153010|NCT01810042|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111153011|NCT01810042|Growth Substances|growth substances|mesh-ancestor
111153012|NCT01810042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111153013|NCT01810042|Growth Inhibitors|growth inhibitors|mesh-ancestor
111153014|NCT01810042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111153015|NCT01808248|Sofosbuvir|sofosbuvir|mesh-list
111153016|NCT01808248|Antiviral Agents|antiviral agents|mesh-ancestor
111153017|NCT01808248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111153018|NCT01867294|Doxycycline|doxycycline|mesh-list
111153019|NCT01867294|Hydrocortisone|hydrocortisone|mesh-list
111153020|NCT01867294|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
111153021|NCT01867294|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
111153022|NCT01867294|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
111153023|NCT01867294|Spironolactone|spironolactone|mesh-list
111153024|NCT01867294|Sunscreening Agents|sunscreening agents|mesh-list
111153025|NCT01867294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111153026|NCT01867294|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110416428|NCT01283009|Prednisolone|prednisolone|mesh-list
111153027|NCT01867294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111153028|NCT01867294|Antimalarials|antimalarials|mesh-ancestor
111153029|NCT01867294|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111153030|NCT01867294|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111153031|NCT01867294|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
111153032|NCT01867294|Hormone Antagonists|hormone antagonists|mesh-ancestor
111153033|NCT01867294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111153034|NCT01867294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111153035|NCT01867294|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
111153036|NCT01867294|Diuretics|diuretics|mesh-ancestor
111153037|NCT01867294|Natriuretic Agents|natriuretic agents|mesh-ancestor
111153038|NCT01867294|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111153039|NCT01867294|Protective Agents|protective agents|mesh-ancestor
111153040|NCT01867294|Dermatologic Agents|dermatologic agents|mesh-ancestor
111153041|NCT02423291|Brentuximab Vedotin|brentuximab vedotin|mesh-list
111153042|NCT02423291|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111153043|NCT02423291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111153044|NCT02423291|Immunotoxins|immunotoxins|mesh-ancestor
111153045|NCT02423291|Immunoconjugates|immunoconjugates|mesh-ancestor
111153046|NCT02423291|Immunologic Factors|immunologic factors|mesh-ancestor
111153047|NCT02423291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111153048|NCT02401529|Acetaminophen|acetaminophen|mesh-list
111153049|NCT02401529|Dexamethasone|dexamethasone|mesh-list
111153050|NCT02401529|Prednisolone|prednisolone|mesh-list
111153051|NCT02401529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111153052|NCT02401529|Antiemetics|antiemetics|mesh-ancestor
111153053|NCT02401529|Autonomic Agents|autonomic agents|mesh-ancestor
111153054|NCT02401529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111153055|NCT02401529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111153056|NCT02401529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111153057|NCT02401529|Glucocorticoids|glucocorticoids|mesh-ancestor
111153058|NCT02401529|Hormones|hormones|mesh-ancestor
111153059|NCT02401529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111153060|NCT02401529|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111153061|NCT02401529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111153062|NCT02401529|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111153063|NCT02401529|Analgesics|analgesics|mesh-ancestor
111153064|NCT02401529|Sensory System Agents|sensory system agents|mesh-ancestor
111153065|NCT02401529|Antipyretics|antipyretics|mesh-ancestor
111153066|NCT01866826|Rifaximin|rifaximin|mesh-list
111153067|NCT01866826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111153068|NCT01866826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111153069|NCT01866826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111153070|NCT01865812|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
111153071|NCT01865812|Cathartics|cathartics|mesh-ancestor
111153072|NCT01865812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111153073|NCT01808092|Meropenem|meropenem|mesh-list
111153074|NCT01808092|Ceftazidime|ceftazidime|mesh-list
111153075|NCT01808092|Avibactam|avibactam|mesh-list
111153076|NCT01808092|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
111153077|NCT01808092|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111153078|NCT01808092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111153079|NCT01808092|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
111153080|NCT01808092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111153081|NCT01808092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111153082|NCT01807234|Ketorolac|ketorolac|mesh-list
111153083|NCT01807234|Sumatriptan|sumatriptan|mesh-list
111153084|NCT01807234|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111153085|NCT01807234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111153086|NCT01807234|Analgesics|analgesics|mesh-ancestor
111153087|NCT01807234|Sensory System Agents|sensory system agents|mesh-ancestor
111153088|NCT01807234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111153089|NCT01807234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111153090|NCT01807234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111153091|NCT01807234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111153092|NCT01807234|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111153093|NCT01807234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111153094|NCT01807234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111153095|NCT01807234|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111153096|NCT01807234|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111153097|NCT01807234|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111153098|NCT01807234|Serotonin Agents|serotonin agents|mesh-ancestor
111153099|NCT01807234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111153100|NCT02421887|Antioxidants|antioxidants|mesh-list
111153101|NCT02421887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111153102|NCT02421887|Protective Agents|protective agents|mesh-ancestor
111153103|NCT02421887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111153104|NCT01789606|Ibuprofen|ibuprofen|mesh-list
111153105|NCT01789606|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111153106|NCT01789606|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111153107|NCT01789606|Analgesics|analgesics|mesh-ancestor
111153108|NCT01789606|Sensory System Agents|sensory system agents|mesh-ancestor
111153109|NCT01789606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111153110|NCT01789606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111153111|NCT01789606|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111153112|NCT01789606|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111153113|NCT01789606|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111153114|NCT01789606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111153115|NCT01789606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111153116|NCT01788358|Candesartan|candesartan|mesh-list
111153117|NCT01788358|Candesartan cilexetil|candesartan cilexetil|mesh-list
111153118|NCT01788358|Nifedipine|nifedipine|mesh-list
111153119|NCT01788358|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111153120|NCT01788358|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111153121|NCT01788358|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111153122|NCT01788358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111153123|NCT01788358|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110840703|NCT03697993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111153124|NCT01788358|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111153125|NCT01788358|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111153126|NCT01788358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111153127|NCT01788358|Vasodilator Agents|vasodilator agents|mesh-ancestor
111153128|NCT01788358|Tocolytic Agents|tocolytic agents|mesh-ancestor
111153129|NCT01788358|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111153130|NCT01773070|Ritonavir|ritonavir|mesh-list
111153131|NCT01773070|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111153132|NCT01773070|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111153133|NCT01773070|Protease Inhibitors|protease inhibitors|mesh-ancestor
111153134|NCT01773070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111153135|NCT01773070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111153136|NCT01773070|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111153137|NCT01773070|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111153138|NCT01773070|Antiviral Agents|antiviral agents|mesh-ancestor
111153139|NCT01773070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111153140|NCT01773070|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111153141|NCT01773070|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111153142|NCT01772368|Fluticasone|fluticasone|mesh-list
111153144|NCT01772368|Albuterol|albuterol|mesh-list
111153145|NCT01772368|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
111153146|NCT01772368|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
111153147|NCT01772368|Adrenergic Agonists|adrenergic agonists|mesh-list
111153148|NCT01772368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111153149|NCT01772368|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111153150|NCT01772368|Autonomic Agents|autonomic agents|mesh-ancestor
111153151|NCT01772368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111153152|NCT01772368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111153153|NCT01772368|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111153154|NCT01772368|Respiratory System Agents|respiratory system agents|mesh-ancestor
111153155|NCT01772368|Dermatologic Agents|dermatologic agents|mesh-ancestor
111153156|NCT01772368|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111153157|NCT01772368|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111153158|NCT01772368|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111153159|NCT01772368|Adrenergic Agents|adrenergic agents|mesh-ancestor
111153160|NCT01772368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111153161|NCT01772368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111153162|NCT01772368|Tocolytic Agents|tocolytic agents|mesh-ancestor
111153163|NCT01772368|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111153164|NCT01772368|Glucocorticoids|glucocorticoids|mesh-ancestor
111153165|NCT01772368|Hormones|hormones|mesh-ancestor
111153166|NCT01772368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111153167|NCT01772368|Sympathomimetics|sympathomimetics|mesh-ancestor
111153168|NCT01806298|Hormones|hormones|mesh-list
111153169|NCT01806298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111153170|NCT01806298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111153171|NCT01772134|Fluticasone|fluticasone|mesh-list
111153172|NCT01772134|Xhance|xhance|mesh-list
111153173|NCT01772134|Bromides|bromides|mesh-list
111153174|NCT01772134|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
111153175|NCT01772134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111153176|NCT01772134|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111153177|NCT01772134|Autonomic Agents|autonomic agents|mesh-ancestor
111153178|NCT01772134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111153179|NCT01772134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111153180|NCT01772134|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111153181|NCT01772134|Respiratory System Agents|respiratory system agents|mesh-ancestor
111153182|NCT01772134|Dermatologic Agents|dermatologic agents|mesh-ancestor
111153183|NCT01772134|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111153184|NCT01772134|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111153185|NCT01772134|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111153186|NCT01772134|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111153187|NCT01772134|Adrenergic Agents|adrenergic agents|mesh-ancestor
111153188|NCT01772134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111153189|NCT01772134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111153190|NCT01772134|Anticonvulsants|anticonvulsants|mesh-ancestor
111153191|NCT02017899|Vaccines|vaccines|mesh-list
111153192|NCT02017899|Immunologic Factors|immunologic factors|mesh-ancestor
111153193|NCT02017899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111153194|NCT01993329|Mitomycin|mitomycin|mesh-list
111153195|NCT01993329|Cisplatin|cisplatin|mesh-list
111153196|NCT01993329|Ifosfamide|ifosfamide|mesh-list
111153197|NCT01993329|Mesna|mesna|mesh-list
111153198|NCT01993329|Protective Agents|protective agents|mesh-ancestor
111153199|NCT01993329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111153200|NCT01993329|Alkylating Agents|alkylating agents|mesh-ancestor
111153201|NCT01993329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111153202|NCT01993329|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111153203|NCT01993329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111153204|NCT01993329|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111153205|NCT01993329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111153206|NCT01993329|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111153207|NCT02016183|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
111153208|NCT02016183|Candesartan|candesartan|mesh-list
111153209|NCT02016183|Candesartan cilexetil|candesartan cilexetil|mesh-list
111153210|NCT02016183|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111153211|NCT02016183|Diuretics|diuretics|mesh-ancestor
111153212|NCT02016183|Natriuretic Agents|natriuretic agents|mesh-ancestor
111153213|NCT02016183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111153214|NCT02016183|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
111153215|NCT02016183|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111153216|NCT02016183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111153217|NCT02016183|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111153218|NCT02016183|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111153219|NCT02421419|Dexamethasone|dexamethasone|mesh-list
111153220|NCT02421419|Dexamethasone acetate|dexamethasone acetate|mesh-list
111153221|NCT02421419|Lidocaine|lidocaine|mesh-list
111153222|NCT02421419|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
111153223|NCT02421419|BB 1101|bb 1101|mesh-list
111153224|NCT02421419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111153225|NCT02421419|Antiemetics|antiemetics|mesh-ancestor
111153226|NCT02421419|Autonomic Agents|autonomic agents|mesh-ancestor
111153227|NCT02421419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111153228|NCT02421419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111153229|NCT02421419|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111153230|NCT02421419|Glucocorticoids|glucocorticoids|mesh-ancestor
111153231|NCT02421419|Hormones|hormones|mesh-ancestor
110484146|NCT00992108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111153232|NCT02421419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111153233|NCT02421419|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111153234|NCT02421419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111153235|NCT02421419|Anesthetics, Local|anesthetics, local|mesh-ancestor
110870332|NCT03167164|Antidotes|antidotes|mesh-ancestor
111153237|NCT02421419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111153238|NCT02421419|Sensory System Agents|sensory system agents|mesh-ancestor
111153239|NCT02421419|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111153240|NCT02421419|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111153241|NCT02421419|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111153242|NCT02421419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111153243|NCT02421419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111153244|NCT02421419|Protease Inhibitors|protease inhibitors|mesh-ancestor
111153245|NCT02421419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111153246|NCT02420717|Leucovorin|leucovorin|mesh-list
111153247|NCT02420717|Cytarabine|cytarabine|mesh-list
111153248|NCT02420717|Dexamethasone|dexamethasone|mesh-list
111153249|NCT02420717|Dexamethasone acetate|dexamethasone acetate|mesh-list
111153250|NCT02420717|Prednisone|prednisone|mesh-list
111153251|NCT02420717|Cortisone|cortisone|mesh-list
111153252|NCT02420717|Cyclophosphamide|cyclophosphamide|mesh-list
111153253|NCT02420717|Rituximab|rituximab|mesh-list
111153254|NCT02420717|Doxorubicin|doxorubicin|mesh-list
111153255|NCT02420717|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111153256|NCT02420717|Methotrexate|methotrexate|mesh-list
111153257|NCT02420717|Vincristine|vincristine|mesh-list
111153258|NCT02420717|Daunorubicin|daunorubicin|mesh-list
111153259|NCT02420717|Dasatinib|dasatinib|mesh-list
111153260|NCT02420717|Mercaptopurine|mercaptopurine|mesh-list
111153261|NCT02420717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111153262|NCT02420717|Antibodies|antibodies|mesh-list
111153263|NCT02420717|Immunoglobulins|immunoglobulins|mesh-list
111153264|NCT02420717|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111153265|NCT02420717|BB 1101|bb 1101|mesh-list
111153266|NCT02420717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111153267|NCT02420717|Immunologic Factors|immunologic factors|mesh-ancestor
111153268|NCT02420717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111153269|NCT02420717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111153270|NCT02420717|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111153271|NCT02420717|Alkylating Agents|alkylating agents|mesh-ancestor
111153272|NCT02420717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111153273|NCT02420717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111153274|NCT02420717|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111153275|NCT02420717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111153276|NCT02420717|Antiemetics|antiemetics|mesh-ancestor
111153277|NCT02420717|Autonomic Agents|autonomic agents|mesh-ancestor
111153278|NCT02420717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111153279|NCT02420717|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111153280|NCT02420717|Glucocorticoids|glucocorticoids|mesh-ancestor
111153281|NCT02420717|Hormones|hormones|mesh-ancestor
111153282|NCT02420717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111153283|NCT02420717|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111153284|NCT02420717|Protease Inhibitors|protease inhibitors|mesh-ancestor
111153285|NCT02420717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111153286|NCT02420717|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111153287|NCT02420717|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111153288|NCT02420717|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111153289|NCT02420717|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111153290|NCT02420717|Abortifacient Agents|abortifacient agents|mesh-ancestor
111153291|NCT02420717|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111153292|NCT02420717|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111153293|NCT02420717|Antimetabolites|antimetabolites|mesh-ancestor
111153294|NCT02420717|Dermatologic Agents|dermatologic agents|mesh-ancestor
111153295|NCT02420717|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111153296|NCT02420717|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111153297|NCT02420717|Antiviral Agents|antiviral agents|mesh-ancestor
111153298|NCT02420717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111153299|NCT02420717|Antidotes|antidotes|mesh-ancestor
111153300|NCT02420717|Protective Agents|protective agents|mesh-ancestor
111153301|NCT02420717|Vitamin B Complex|vitamin b complex|mesh-ancestor
111153302|NCT02420717|Vitamins|vitamins|mesh-ancestor
111153303|NCT02420717|Micronutrients|micronutrients|mesh-ancestor
111153304|NCT02420717|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111153305|NCT02420717|Tubulin Modulators|tubulin modulators|mesh-ancestor
111153306|NCT02420717|Antimitotic Agents|antimitotic agents|mesh-ancestor
111153307|NCT02420717|Mitosis Modulators|mitosis modulators|mesh-ancestor
111153308|NCT02420717|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111153309|NCT02016105|Adalimumab|adalimumab|mesh-list
111153310|NCT02016105|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111153311|NCT02016105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111153312|NCT02016105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111153313|NCT02400749|Apremilast|apremilast|mesh-list
111153314|NCT02400749|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111153315|NCT02400749|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111153316|NCT02400749|Analgesics|analgesics|mesh-ancestor
111153317|NCT02400749|Sensory System Agents|sensory system agents|mesh-ancestor
111153318|NCT02400749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111153319|NCT02400749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111153320|NCT02400749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111153321|NCT02400749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111153322|NCT02400749|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
111153323|NCT02400749|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111153324|NCT02400749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111153325|NCT02400749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111153326|NCT02420327|Galantamine|galantamine|mesh-list
111153327|NCT02420327|Nicotine|nicotine|mesh-list
111153328|NCT02420327|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111153329|NCT02420327|Autonomic Agents|autonomic agents|mesh-ancestor
111153330|NCT02420327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111153331|NCT02420327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111153332|NCT02420327|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111153333|NCT02420327|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111153334|NCT02420327|Cholinergic Agents|cholinergic agents|mesh-ancestor
111153335|NCT02420327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111153336|NCT02420327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111153337|NCT02420327|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111153338|NCT02420327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111153339|NCT02420327|Parasympathomimetics|parasympathomimetics|mesh-ancestor
111153340|NCT02420327|Nootropic Agents|nootropic agents|mesh-ancestor
111153341|NCT02374853|Vancomycin|vancomycin|mesh-list
111153342|NCT02374853|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111153343|NCT02374853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111153344|NCT02015793|Adalimumab|adalimumab|mesh-list
111153345|NCT02015793|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111153346|NCT02015793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111153347|NCT02015793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111153348|NCT02347631|Dipivefrin|dipivefrin|mesh-list
111153349|NCT02347631|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111153350|NCT02347631|Adrenergic Agents|adrenergic agents|mesh-ancestor
111153351|NCT02347631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111153352|NCT02347631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111153353|NCT02347631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111153354|NCT02015637|Ceftriaxone|ceftriaxone|mesh-list
111153355|NCT02015637|Delafloxacin|delafloxacin|mesh-list
111153356|NCT02015637|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111153357|NCT02015637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111153358|NCT02347085|Glycopyrrolate|glycopyrrolate|mesh-list
111153359|NCT02347085|Formoterol Fumarate|formoterol fumarate|mesh-list
111153360|NCT02347085|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111153361|NCT02347085|Autonomic Agents|autonomic agents|mesh-ancestor
111153362|NCT02347085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111153363|NCT02347085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111153364|NCT02347085|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111153365|NCT02347085|Respiratory System Agents|respiratory system agents|mesh-ancestor
111153366|NCT02347085|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111153367|NCT02347085|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111153368|NCT02347085|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111153369|NCT02347085|Adrenergic Agents|adrenergic agents|mesh-ancestor
111153370|NCT02347085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111153371|NCT02347085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111153372|NCT02347085|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111153373|NCT02347085|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110484162|NCT02684487|Vitamin D|vitamin d|mesh-list
111153374|NCT02347085|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111153375|NCT02347085|Cholinergic Agents|cholinergic agents|mesh-ancestor
111153376|NCT01621191|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
111153377|NCT01621191|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111153378|NCT01621191|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111153379|NCT01621191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111153380|NCT01621191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111153381|NCT01621191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111153382|NCT01621191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111153383|NCT01621191|Analgesics|analgesics|mesh-ancestor
111153384|NCT01621191|Sensory System Agents|sensory system agents|mesh-ancestor
111153385|NCT01621191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111153386|NCT01621191|Antidepressive Agents|antidepressive agents|mesh-ancestor
111153387|NCT01621191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111153389|NCT02343263|Bupivacaine|bupivacaine|mesh-list
111153390|NCT02343263|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
111153391|NCT02343263|Anesthetics, Local|anesthetics, local|mesh-ancestor
111153392|NCT02343263|Anesthetics|anesthetics|mesh-ancestor
111153393|NCT02343263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111153394|NCT02343263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111153395|NCT02343263|Sensory System Agents|sensory system agents|mesh-ancestor
111153396|NCT02343263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111153397|NCT02343263|Hemostatics|hemostatics|mesh-ancestor
111153398|NCT02343263|Coagulants|coagulants|mesh-ancestor
111153399|NCT02342639|Rifaximin|rifaximin|mesh-list
111153400|NCT02342639|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111153401|NCT02342639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111153402|NCT02342639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111153403|NCT01625091|Naltrexone|naltrexone|mesh-list
111153404|NCT01625091|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111153405|NCT01625091|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111153406|NCT01625091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111153407|NCT01625091|Sensory System Agents|sensory system agents|mesh-ancestor
111153408|NCT01625091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111153409|NCT02396537|Lidocaine|lidocaine|mesh-list
111153410|NCT02396537|Midazolam|midazolam|mesh-list
111153411|NCT02396537|Anesthetics, Local|anesthetics, local|mesh-ancestor
111153412|NCT02396537|Anesthetics|anesthetics|mesh-ancestor
111153413|NCT02396537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111153414|NCT02396537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111153415|NCT02396537|Sensory System Agents|sensory system agents|mesh-ancestor
111153416|NCT02396537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111153417|NCT02396537|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111153418|NCT02396537|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111153419|NCT02396537|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111153420|NCT02396537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111153421|NCT02396537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111153422|NCT02396537|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111153423|NCT02396537|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111153424|NCT02396537|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111153425|NCT02396537|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111153426|NCT02396537|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111153427|NCT02396537|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111153428|NCT02396537|Anesthetics, General|anesthetics, general|mesh-ancestor
111153429|NCT02396537|GABA Modulators|gaba modulators|mesh-ancestor
111153430|NCT02396537|GABA Agents|gaba agents|mesh-ancestor
111153431|NCT02396537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111153432|NCT01624467|Necitumumab|necitumumab|mesh-list
111153433|NCT01624467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111153434|NCT01624467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111153435|NCT01624233|Ixekizumab|ixekizumab|mesh-list
111153436|NCT01624233|Dermatologic Agents|dermatologic agents|mesh-ancestor
111153437|NCT01993017|Bupropion|bupropion|mesh-list
111153438|NCT01993017|Sertraline|sertraline|mesh-list
111153439|NCT01993017|Antidepressive Agents|antidepressive agents|mesh-list
111153440|NCT01993017|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111153441|NCT01993017|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111153442|NCT01993017|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111153443|NCT01993017|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111153444|NCT01993017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111153445|NCT01993017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111153446|NCT01993017|Dopamine Agents|dopamine agents|mesh-ancestor
111153447|NCT01993017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110484163|NCT02684487|Cholecalciferol|cholecalciferol|mesh-list
111153448|NCT01993017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111153449|NCT01993017|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111153450|NCT01993017|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111153451|NCT01993017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111153452|NCT01993017|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111153453|NCT01993017|Serotonin Agents|serotonin agents|mesh-ancestor
111153454|NCT01988493|Sorafenib|sorafenib|mesh-list
111153455|NCT01988493|Tepotinib|tepotinib|mesh-list
111153456|NCT01988493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111153457|NCT01988493|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111153458|NCT01988493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111153459|NCT01988493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111153460|NCT02081079|Sofosbuvir|sofosbuvir|mesh-list
111153461|NCT02081079|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
111153462|NCT02081079|Ledipasvir|ledipasvir|mesh-list
111153463|NCT02081079|Antiviral Agents|antiviral agents|mesh-ancestor
111153464|NCT02081079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111153465|NCT02081001|Glucagon|glucagon|mesh-list
111153466|NCT02081001|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111153467|NCT02081001|Hormones|hormones|mesh-ancestor
111153468|NCT02081001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111153469|NCT02081001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111153470|NCT02080221|Leucovorin|leucovorin|mesh-list
111153471|NCT02080221|Oxaliplatin|oxaliplatin|mesh-list
111153472|NCT02080221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111153473|NCT02080221|Antidotes|antidotes|mesh-ancestor
111153474|NCT02080221|Protective Agents|protective agents|mesh-ancestor
111153475|NCT02080221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111153476|NCT02080221|Vitamin B Complex|vitamin b complex|mesh-ancestor
111153477|NCT02080221|Vitamins|vitamins|mesh-ancestor
111153478|NCT02080221|Micronutrients|micronutrients|mesh-ancestor
111153479|NCT02014467|Vitamin D|vitamin d|mesh-list
111153480|NCT02014467|Denosumab|denosumab|mesh-list
111153481|NCT02014467|Calcium|calcium|mesh-list
111153482|NCT02014467|Vitamins|vitamins|mesh-ancestor
111153483|NCT02014467|Micronutrients|micronutrients|mesh-ancestor
111153484|NCT02014467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111153485|NCT02014467|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111153486|NCT02014467|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111153487|NCT02013765|Trastuzumab|trastuzumab|mesh-list
111153488|NCT02013765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111153489|NCT02013765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111153490|NCT02013609|Brexpiprazole|brexpiprazole|mesh-list
111153491|NCT02013609|Serotonin Agents|serotonin agents|mesh-ancestor
111153492|NCT02013609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111153493|NCT02013609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111153494|NCT02013609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111153495|NCT02013609|Dopamine Agonists|dopamine agonists|mesh-ancestor
111153496|NCT02013609|Dopamine Agents|dopamine agents|mesh-ancestor
111153497|NCT02013531|Brexpiprazole|brexpiprazole|mesh-list
111153498|NCT02013531|Serotonin Agents|serotonin agents|mesh-ancestor
111153499|NCT02013531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111153500|NCT02013531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111153501|NCT02013531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111153502|NCT02013531|Dopamine Agonists|dopamine agonists|mesh-ancestor
111153503|NCT02013531|Dopamine Agents|dopamine agents|mesh-ancestor
111153504|NCT01988103|Thalidomide|thalidomide|mesh-list
111153505|NCT01988103|Apremilast|apremilast|mesh-list
111153506|NCT01988103|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111153507|NCT01988103|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111153508|NCT01988103|Analgesics|analgesics|mesh-ancestor
111153509|NCT01988103|Sensory System Agents|sensory system agents|mesh-ancestor
111153510|NCT01988103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111153511|NCT01988103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111153512|NCT01988103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111153513|NCT01988103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111153514|NCT01988103|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
111153515|NCT01988103|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111153516|NCT01988103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110484165|NCT02684487|Micronutrients|micronutrients|mesh-ancestor
111153517|NCT01988103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111153518|NCT01988103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111153519|NCT01988103|Immunologic Factors|immunologic factors|mesh-ancestor
111153520|NCT01988103|Leprostatic Agents|leprostatic agents|mesh-ancestor
111153521|NCT01988103|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111153522|NCT01988103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111153523|NCT01988103|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111153524|NCT01988103|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111153525|NCT01988103|Growth Substances|growth substances|mesh-ancestor
111153526|NCT01988103|Growth Inhibitors|growth inhibitors|mesh-ancestor
111153527|NCT01988103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111153528|NCT02013375|Sirolimus|sirolimus|mesh-list
111153529|NCT02013375|Cyclophosphamide|cyclophosphamide|mesh-list
111153530|NCT02013375|Alemtuzumab|alemtuzumab|mesh-list
111153531|NCT02013375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111153532|NCT02013375|Immunologic Factors|immunologic factors|mesh-ancestor
111153533|NCT02013375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111153534|NCT02013375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111153535|NCT02013375|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111153536|NCT02013375|Alkylating Agents|alkylating agents|mesh-ancestor
111153537|NCT02013375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110840741|NCT03756727|Antioxidants|antioxidants|mesh-ancestor
111153538|NCT02013375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111153539|NCT02013375|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111153540|NCT02013375|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111153541|NCT02013375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111153542|NCT02013375|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111153543|NCT02013375|Antifungal Agents|antifungal agents|mesh-ancestor
111153544|NCT02013375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111153545|NCT02079519|Bevacizumab|bevacizumab|mesh-list
111153546|NCT02079519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111153547|NCT02079519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111153548|NCT02079519|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111153549|NCT02079519|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111153550|NCT02079519|Growth Substances|growth substances|mesh-ancestor
111153551|NCT02079519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111153552|NCT02079519|Growth Inhibitors|growth inhibitors|mesh-ancestor
111153553|NCT02078817|Ketamine|ketamine|mesh-list
111153554|NCT02078817|Analgesics|analgesics|mesh-ancestor
111153555|NCT02078817|Sensory System Agents|sensory system agents|mesh-ancestor
111153556|NCT02078817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111153557|NCT02078817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111153558|NCT02078817|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111153559|NCT02078817|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111153560|NCT02078817|Anesthetics, General|anesthetics, general|mesh-ancestor
111153561|NCT02078817|Anesthetics|anesthetics|mesh-ancestor
111153562|NCT02078817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111153563|NCT02078817|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111153564|NCT02078817|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111153565|NCT02078817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111153566|NCT02078817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111153567|NCT02011113|Dexamethasone|dexamethasone|mesh-list
111153568|NCT02011113|Pomalidomide|pomalidomide|mesh-list
111153569|NCT02011113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111153570|NCT02011113|Antiemetics|antiemetics|mesh-ancestor
111153571|NCT02011113|Autonomic Agents|autonomic agents|mesh-ancestor
111153572|NCT02011113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111153573|NCT02011113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111153574|NCT02011113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111153575|NCT02011113|Glucocorticoids|glucocorticoids|mesh-ancestor
111153576|NCT02011113|Hormones|hormones|mesh-ancestor
111153577|NCT02011113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111153578|NCT02011113|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111153579|NCT02011113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111153580|NCT02011113|Immunologic Factors|immunologic factors|mesh-ancestor
111153581|NCT02011113|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111153582|NCT02011113|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111153583|NCT02011113|Growth Substances|growth substances|mesh-ancestor
111153584|NCT02011113|Growth Inhibitors|growth inhibitors|mesh-ancestor
111153585|NCT01807156|Tivozanib|tivozanib|mesh-list
111153586|NCT01807156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111153587|NCT01807156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111153588|NCT01807156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111153589|NCT01987479|Methotrexate|methotrexate|mesh-list
111153590|NCT01987479|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111153591|NCT01987479|Abortifacient Agents|abortifacient agents|mesh-ancestor
111153592|NCT01987479|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111153593|NCT01987479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111153594|NCT01987479|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111153595|NCT01987479|Antimetabolites|antimetabolites|mesh-ancestor
111153596|NCT01987479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111153597|NCT01987479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111153598|NCT01987479|Dermatologic Agents|dermatologic agents|mesh-ancestor
111153599|NCT01987479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111153600|NCT01987479|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111153601|NCT01987479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111153602|NCT01987479|Immunologic Factors|immunologic factors|mesh-ancestor
111153603|NCT01987479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110840745|NCT03398434|Apixaban|apixaban|mesh-list
111153604|NCT01987479|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111153605|NCT01620489|Liraglutide|liraglutide|mesh-list
111153606|NCT01620489|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111153607|NCT01620489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111153608|NCT01620489|Incretins|incretins|mesh-ancestor
111153609|NCT01620489|Hormones|hormones|mesh-ancestor
111153610|NCT01620489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111153611|NCT02010567|Capecitabine|capecitabine|mesh-list
111153612|NCT02010567|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111153613|NCT02010567|Antimetabolites|antimetabolites|mesh-ancestor
110870700|NCT03106402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111153614|NCT02010567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111153615|NCT02010567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111153616|NCT01806064|Axitinib|axitinib|mesh-list
111153617|NCT01806064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111153618|NCT01806064|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111153619|NCT01806064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111153620|NCT01806064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111153621|NCT01787188|Meloxicam|meloxicam|mesh-list
111153622|NCT01787188|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111153623|NCT01787188|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111153624|NCT01787188|Analgesics|analgesics|mesh-ancestor
111153625|NCT01787188|Sensory System Agents|sensory system agents|mesh-ancestor
111153626|NCT01787188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111153627|NCT01787188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111153628|NCT01787188|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111153629|NCT01787188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111153630|NCT01787188|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111153631|NCT01787188|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111153632|NCT01787188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111153633|NCT01787188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111153634|NCT01787032|Ketoconazole|ketoconazole|mesh-list
111153635|NCT01787032|Voriconazole|voriconazole|mesh-list
111153636|NCT01787032|Antifungal Agents|antifungal agents|mesh-ancestor
111153637|NCT01787032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111153638|NCT01787032|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111153639|NCT01787032|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111153640|NCT01787032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111153641|NCT01787032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111153642|NCT01787032|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111153643|NCT01787032|Hormone Antagonists|hormone antagonists|mesh-ancestor
111153644|NCT01787032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111153645|NCT01787032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111153646|NCT01787032|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111153647|NCT01737268|Quetiapine Fumarate|quetiapine fumarate|mesh-list
111153648|NCT01737268|Antidepressive Agents|antidepressive agents|mesh-ancestor
111153649|NCT01737268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111153650|NCT01737268|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111153651|NCT01737268|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111153652|NCT01737268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111153653|NCT01737268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111153654|NCT01769404|Insulin Glargine|insulin glargine|mesh-list
111153655|NCT01769404|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111153656|NCT01769404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111153657|NCT01786174|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
111153658|NCT01786174|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
111153659|NCT01786174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111153660|NCT01786174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111153661|NCT01786174|Immunologic Factors|immunologic factors|mesh-ancestor
111153662|NCT01786174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111153663|NCT01768858|Adalimumab|adalimumab|mesh-list
111153664|NCT01768858|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111153665|NCT01768858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111153666|NCT01768858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111153667|NCT01736254|Gemfibrozil|gemfibrozil|mesh-list
111153668|NCT01736254|Evacetrapib|evacetrapib|mesh-list
111153669|NCT01736254|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111153670|NCT01736254|Antimetabolites|antimetabolites|mesh-ancestor
111153671|NCT01736254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111153672|NCT01736254|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111153673|NCT01736254|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
111153674|NCT01736254|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111153675|NCT01736254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111153676|NCT01736254|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111153677|NCT01785472|Olmesartan|olmesartan|mesh-list
111153678|NCT01785472|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
111153679|NCT01785472|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
111153680|NCT01785472|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111153681|NCT01785472|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111153682|NCT01785472|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111153683|NCT01785472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110676994|NCT03230734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111153684|NCT01785160|Raltegravir Potassium|raltegravir potassium|mesh-list
111153686|NCT01785160|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111153687|NCT01785160|Antiviral Agents|antiviral agents|mesh-ancestor
111153688|NCT01785160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111153689|NCT01785160|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111153690|NCT01785160|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111153691|NCT01785160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111153692|NCT01785160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111153693|NCT01736176|Levodopa|levodopa|mesh-list
111153694|NCT01736176|Carbidopa|carbidopa|mesh-list
111153695|NCT01736176|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
111153696|NCT01736176|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111153697|NCT01736176|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111153698|NCT01736176|Dopamine Agents|dopamine agents|mesh-ancestor
111153699|NCT01736176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111153700|NCT01736176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111153701|NCT01736176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111153702|NCT01736176|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
111153703|NCT01736176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111153704|NCT01736176|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111153705|NCT01736176|Immunologic Factors|immunologic factors|mesh-ancestor
111153706|NCT01736176|Dopamine Agonists|dopamine agonists|mesh-ancestor
111153707|NCT01735630|Inositol|inositol|mesh-list
111153708|NCT01735630|Vitamin B Complex|vitamin b complex|mesh-ancestor
111153709|NCT01735630|Vitamins|vitamins|mesh-ancestor
111153710|NCT01735630|Micronutrients|micronutrients|mesh-ancestor
111153711|NCT01735630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111153712|NCT04575922|Nivolumab|nivolumab|mesh-list
111153713|NCT04575922|Ipilimumab|ipilimumab|mesh-list
111153714|NCT04575922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111153715|NCT04575922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111153716|NCT04575922|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111153717|NCT04575922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111153718|NCT01735396|Abiraterone Acetate|abiraterone acetate|mesh-list
111153719|NCT01735396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111153720|NCT01735396|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111153721|NCT01735396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111153722|NCT01735396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111153723|NCT01735396|Hormone Antagonists|hormone antagonists|mesh-ancestor
111153724|NCT01735396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111153725|NCT01735396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111153726|NCT01735396|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111153727|NCT01734850|Busulfan|busulfan|mesh-list
111153728|NCT01734850|Alkylating Agents|alkylating agents|mesh-ancestor
111153729|NCT01734850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111153730|NCT01734850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111153731|NCT01734850|Immunologic Factors|immunologic factors|mesh-ancestor
111153732|NCT01734850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111153733|NCT01734850|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111153734|NCT01734850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111153735|NCT01734850|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111153736|NCT01766050|Abatacept|abatacept|mesh-list
111153737|NCT01766050|Losartan|losartan|mesh-list
111153738|NCT01766050|Midazolam|midazolam|mesh-list
111153740|NCT01766050|Caffeine|caffeine|mesh-list
111153741|NCT01766050|Omeprazole|omeprazole|mesh-list
111153742|NCT01766050|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111153743|NCT01766050|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111153744|NCT01766050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111153745|NCT01766050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111153746|NCT01766050|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111153747|NCT01766050|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111153748|NCT01766050|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111153749|NCT01766050|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111153750|NCT01766050|Anesthetics, General|anesthetics, general|mesh-ancestor
111153751|NCT01766050|Anesthetics|anesthetics|mesh-ancestor
111153752|NCT01766050|GABA Modulators|gaba modulators|mesh-ancestor
111153753|NCT01766050|GABA Agents|gaba agents|mesh-ancestor
111153754|NCT01766050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111153755|NCT01766050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111153756|NCT01766050|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111153757|NCT01766050|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111153758|NCT01766050|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111153759|NCT01766050|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111153760|NCT01766050|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111153761|NCT01766050|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111153762|NCT01766050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111153763|NCT01766050|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
111153764|NCT01766050|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111153765|NCT01766050|Purinergic Agents|purinergic agents|mesh-ancestor
111153766|NCT01766050|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111153767|NCT01766050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111153768|NCT01766050|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111153769|NCT01766050|Antitussive Agents|antitussive agents|mesh-ancestor
111153770|NCT01766050|Respiratory System Agents|respiratory system agents|mesh-ancestor
111153771|NCT01766050|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111153772|NCT01766050|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111153773|NCT01766050|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111153774|NCT01766050|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111153775|NCT01766050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111153776|NCT01766050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111153777|NCT01766050|Immunologic Factors|immunologic factors|mesh-ancestor
111153778|NCT01766050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111153779|NCT02341625|Nivolumab|nivolumab|mesh-list
111153780|NCT02341625|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111153781|NCT02341625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111153782|NCT02341625|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111153783|NCT02341625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111153784|NCT02370095|Treprostinil|treprostinil|mesh-list
111153785|NCT02370095|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111153786|NCT02370095|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111153787|NCT01783678|Sofosbuvir|sofosbuvir|mesh-list
111153788|NCT01783678|Antiviral Agents|antiviral agents|mesh-ancestor
111153789|NCT01783678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111153790|NCT01734772|Dabigatran|dabigatran|mesh-list
111153791|NCT01734772|Ticagrelor|ticagrelor|mesh-list
111153792|NCT01734772|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111153793|NCT01734772|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111153794|NCT01734772|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111153795|NCT01734772|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111153796|NCT01734772|Purinergic Agents|purinergic agents|mesh-ancestor
111153797|NCT01734772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111153798|NCT01734772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111153799|NCT01734772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111153800|NCT01734772|Antithrombins|antithrombins|mesh-ancestor
111153801|NCT01734772|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110840764|NCT03394222|Autonomic Agents|autonomic agents|mesh-ancestor
111153803|NCT01734772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111153804|NCT01734772|Anticoagulants|anticoagulants|mesh-ancestor
111153805|NCT02340221|Fulvestrant|fulvestrant|mesh-list
111153806|NCT02340221|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111153807|NCT02340221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111153808|NCT02340221|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
111153809|NCT02340221|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111153810|NCT02340221|Hormone Antagonists|hormone antagonists|mesh-ancestor
111153811|NCT02340221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111153812|NCT02340221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111153813|NCT02395055|Adalimumab|adalimumab|mesh-list
111153814|NCT02395055|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111153815|NCT02395055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111153816|NCT02395055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111153817|NCT02369159|Oseltamivir|oseltamivir|mesh-list
111153818|NCT02369159|Peramivir|peramivir|mesh-list
111153819|NCT02369159|Antiviral Agents|antiviral agents|mesh-ancestor
111153820|NCT02369159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111153821|NCT02369159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111153822|NCT02369159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111153823|NCT02394665|Temozolomide|temozolomide|mesh-list
111153824|NCT02394665|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111153825|NCT02394665|Alkylating Agents|alkylating agents|mesh-ancestor
111153826|NCT02394665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111153827|NCT02394665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111153828|NCT02367833|Contraceptive Agents|contraceptive agents|mesh-list
111153829|NCT02367833|NuvaRing|nuvaring|mesh-list
111153830|NCT02367833|Contraceptives, Oral|contraceptives, oral|mesh-list
111153831|NCT02367833|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
111153832|NCT02367833|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111153833|NCT02367833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111153834|NCT02367833|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111153835|NCT02367833|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111153836|NCT02338193|Metformin|metformin|mesh-list
111153837|NCT02338193|Dapagliflozin|dapagliflozin|mesh-list
111153838|NCT02338193|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111153839|NCT02338193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111153840|NCT02338193|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111153841|NCT02338193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111153842|NCT01783444|Capecitabine|capecitabine|mesh-list
111153843|NCT01783444|Everolimus|everolimus|mesh-list
111153844|NCT01783444|Exemestane|exemestane|mesh-list
111153845|NCT01783444|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111153846|NCT01783444|Antimetabolites|antimetabolites|mesh-ancestor
111153847|NCT01783444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111153848|NCT01783444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111153849|NCT01783444|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111153850|NCT01783444|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111153851|NCT01783444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111153852|NCT01783444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111153853|NCT01783444|Immunologic Factors|immunologic factors|mesh-ancestor
111153854|NCT01783444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111153855|NCT01783444|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111153856|NCT01783444|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111153857|NCT01783444|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111153858|NCT01783444|Hormone Antagonists|hormone antagonists|mesh-ancestor
111153859|NCT01783444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111153860|NCT02367131|Empagliflozin|empagliflozin|mesh-list
111153861|NCT02367131|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111153862|NCT02367131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111153863|NCT02367131|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111153864|NCT02367131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111153866|NCT01608724|Incretins|incretins|mesh-ancestor
111153867|NCT01608724|Hormones|hormones|mesh-ancestor
111153868|NCT01608724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111153869|NCT01608724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111153870|NCT01608724|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111153871|NCT01608724|Protease Inhibitors|protease inhibitors|mesh-ancestor
111153872|NCT01608724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111153873|NCT01608724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111153874|NCT01608724|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111153875|NCT02366195|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
111153876|NCT02366195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111153877|NCT02366195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111153878|NCT04905251|Misoprostol|misoprostol|mesh-list
111153879|NCT04905251|Mifepristone|mifepristone|mesh-list
111153880|NCT04905251|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111153881|NCT04905251|Abortifacient Agents|abortifacient agents|mesh-ancestor
111153882|NCT04905251|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111153883|NCT04905251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111153884|NCT04905251|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111153885|NCT04905251|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111153886|NCT04905251|Oxytocics|oxytocics|mesh-ancestor
111153887|NCT04905251|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
111153888|NCT04905251|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111153889|NCT04905251|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111153890|NCT04905251|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111153891|NCT04905251|Contraceptive Agents|contraceptive agents|mesh-ancestor
111153892|NCT04905251|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
111153893|NCT04905251|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
111153894|NCT04905251|Hormone Antagonists|hormone antagonists|mesh-ancestor
111153895|NCT04905251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111153896|NCT04905251|Luteolytic Agents|luteolytic agents|mesh-ancestor
111153897|NCT04905251|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111153898|NCT04905251|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
111153899|NCT02364947|Nalmefene|nalmefene|mesh-list
111153900|NCT02364947|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111153901|NCT02364947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111153902|NCT02364947|Sensory System Agents|sensory system agents|mesh-ancestor
111153903|NCT02364947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111153904|NCT02337491|Bevacizumab|bevacizumab|mesh-list
111153905|NCT02337491|Pembrolizumab|pembrolizumab|mesh-list
111153906|NCT02337491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111153907|NCT02337491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111153908|NCT02337491|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111153909|NCT02337491|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111153910|NCT02337491|Growth Substances|growth substances|mesh-ancestor
111153911|NCT02337491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111153912|NCT02337491|Growth Inhibitors|growth inhibitors|mesh-ancestor
111153913|NCT02337491|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111153914|NCT02337491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111153915|NCT01765582|Leucovorin|leucovorin|mesh-list
111153916|NCT01765582|Folic Acid|folic acid|mesh-list
111153917|NCT01765582|Bevacizumab|bevacizumab|mesh-list
111153918|NCT01765582|Fluorouracil|fluorouracil|mesh-list
111153919|NCT01765582|Capecitabine|capecitabine|mesh-list
111153920|NCT01765582|Oxaliplatin|oxaliplatin|mesh-list
111153921|NCT01765582|Irinotecan|irinotecan|mesh-list
111153922|NCT01765582|Levoleucovorin|levoleucovorin|mesh-list
111153923|NCT01765582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111153924|NCT01765582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111153925|NCT01765582|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111153926|NCT01765582|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111153927|NCT01765582|Growth Substances|growth substances|mesh-ancestor
110840789|NCT02813200|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111153928|NCT01765582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111153929|NCT01765582|Growth Inhibitors|growth inhibitors|mesh-ancestor
111153931|NCT01765582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111153932|NCT01765582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111153933|NCT01765582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111153934|NCT01765582|Immunologic Factors|immunologic factors|mesh-ancestor
111153935|NCT01765582|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111153936|NCT01765582|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111153937|NCT01765582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111153938|NCT01765582|Antidotes|antidotes|mesh-ancestor
111153939|NCT01765582|Protective Agents|protective agents|mesh-ancestor
111153940|NCT01765582|Vitamin B Complex|vitamin b complex|mesh-ancestor
111153941|NCT01765582|Vitamins|vitamins|mesh-ancestor
111153942|NCT01765582|Micronutrients|micronutrients|mesh-ancestor
111153943|NCT01765582|Hematinics|hematinics|mesh-ancestor
111153944|NCT04413838|Nivolumab|nivolumab|mesh-list
111153945|NCT04413838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111153946|NCT04413838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111153947|NCT04413838|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111153948|NCT04413838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111153949|NCT01649375|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111153950|NCT01649375|Immunologic Factors|immunologic factors|mesh-ancestor
111153951|NCT01649375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111153952|NCT01648283|Methadone|methadone|mesh-list
111153953|NCT01648283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111153954|NCT01648283|Narcotics|narcotics|mesh-ancestor
111153955|NCT01648283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111153956|NCT01648283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111153957|NCT01648283|Analgesics|analgesics|mesh-ancestor
111153958|NCT01648283|Sensory System Agents|sensory system agents|mesh-ancestor
111153959|NCT01648283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111153960|NCT01648283|Antitussive Agents|antitussive agents|mesh-ancestor
111153961|NCT01648283|Respiratory System Agents|respiratory system agents|mesh-ancestor
111153962|NCT01649297|Empagliflozin|empagliflozin|mesh-list
111153963|NCT01649297|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111153964|NCT01649297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111153965|NCT01649297|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111153966|NCT01649297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111153967|NCT01648205|Ranolazine|ranolazine|mesh-list
111153968|NCT01648205|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111153969|NCT01648205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111153970|NCT01648205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111153971|NCT02362451|Vaccines|vaccines|mesh-list
111153972|NCT02362451|Immunologic Factors|immunologic factors|mesh-ancestor
111153973|NCT02362451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111153974|NCT01765270|Saxagliptin|saxagliptin|mesh-list
111153975|NCT01765270|Incretins|incretins|mesh-ancestor
111153976|NCT01765270|Hormones|hormones|mesh-ancestor
111153977|NCT01765270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111153978|NCT01765270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111153979|NCT01765270|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111153980|NCT01765270|Protease Inhibitors|protease inhibitors|mesh-ancestor
111153981|NCT01765270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111153982|NCT01765270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111153983|NCT01765270|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111153984|NCT01733758|Liraglutide|liraglutide|mesh-list
111153985|NCT01733758|rGLP-1 protein|rglp-1 protein|mesh-list
111153986|NCT01733758|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
111153987|NCT01733758|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111153988|NCT01733758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111153989|NCT01733758|Incretins|incretins|mesh-ancestor
111153990|NCT01733758|Hormones|hormones|mesh-ancestor
111153991|NCT01733758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111153992|NCT01607554|Irinotecan|irinotecan|mesh-list
111153993|NCT01607554|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111153994|NCT01607554|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111153995|NCT01607554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111153996|NCT01607554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111153997|NCT01607554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111153998|NCT01607476|Corticosterone|corticosterone|mesh-list
111153999|NCT01607476|Flutemetamol|flutemetamol|mesh-list
111154000|NCT01607476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111154001|NCT01607476|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111154002|NCT01607476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111154003|NCT01765192|Montelukast|montelukast|mesh-list
111154004|NCT01765192|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111154005|NCT01765192|Respiratory System Agents|respiratory system agents|mesh-ancestor
111154006|NCT01765192|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
111154007|NCT01765192|Hormone Antagonists|hormone antagonists|mesh-ancestor
111154008|NCT01765192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111154009|NCT01765192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111154010|NCT01765192|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
111154011|NCT01765192|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111154012|NCT01765192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111154013|NCT01733680|Amiloride|amiloride|mesh-list
111154014|NCT01733680|Diuretics|diuretics|mesh-ancestor
111154015|NCT01733680|Natriuretic Agents|natriuretic agents|mesh-ancestor
111154016|NCT01733680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111154017|NCT01733680|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
111154018|NCT01733680|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111154019|NCT01733680|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111154020|NCT01733680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111154021|NCT01733680|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
111154022|NCT01733680|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
111154023|NCT04892498|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
111154024|NCT04892498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111154025|NCT04892498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111154026|NCT04892498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111154027|NCT04887506|Prednisone|prednisone|mesh-list
111154028|NCT04887506|Abiraterone Acetate|abiraterone acetate|mesh-list
111154029|NCT04887506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111154030|NCT04887506|Glucocorticoids|glucocorticoids|mesh-ancestor
111154031|NCT04887506|Hormones|hormones|mesh-ancestor
111154032|NCT04887506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111154033|NCT04887506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111154034|NCT04887506|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111154035|NCT04887506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111154036|NCT04887506|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111154037|NCT04887506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111154038|NCT04887506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111154039|NCT04887506|Hormone Antagonists|hormone antagonists|mesh-ancestor
111154040|NCT04887506|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111154041|NCT02336165|Bevacizumab|bevacizumab|mesh-list
111154042|NCT02336165|Durvalumab|durvalumab|mesh-list
111154043|NCT02336165|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111154044|NCT02336165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111154045|NCT02336165|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111154046|NCT02336165|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110417449|NCT02867566|Rituximab|rituximab|mesh-list
111154047|NCT02336165|Growth Substances|growth substances|mesh-ancestor
111154048|NCT02336165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111154049|NCT02336165|Growth Inhibitors|growth inhibitors|mesh-ancestor
111154050|NCT02360111|Cyclophosphamide|cyclophosphamide|mesh-list
111154051|NCT02360111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111154052|NCT02360111|Immunologic Factors|immunologic factors|mesh-ancestor
111154053|NCT02360111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111154055|NCT02360111|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111154056|NCT02360111|Alkylating Agents|alkylating agents|mesh-ancestor
111154057|NCT02360111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111154058|NCT02360111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111154059|NCT02360111|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111154060|NCT02319044|Durvalumab|durvalumab|mesh-list
111154061|NCT02319044|Tremelimumab|tremelimumab|mesh-list
111154062|NCT02319044|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111154063|NCT02319044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110840800|NCT02813200|Glucocorticoids|glucocorticoids|mesh-ancestor
111154064|NCT02319044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111154065|NCT02319044|Immunologic Factors|immunologic factors|mesh-ancestor
111154066|NCT02319044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111154067|NCT01649765|Belimumab|belimumab|mesh-list
111154068|NCT01649765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111154069|NCT01649765|Immunologic Factors|immunologic factors|mesh-ancestor
111154070|NCT01649765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111154071|NCT02317016|Osimertinib|osimertinib|mesh-list
111154072|NCT02317016|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111154073|NCT02317016|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111154074|NCT02317016|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111154075|NCT02317016|Antimetabolites|antimetabolites|mesh-ancestor
111154076|NCT02317016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111154077|NCT02317016|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111154078|NCT02317016|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111154079|NCT02317016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111154080|NCT02317016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111154081|NCT02317016|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111154082|NCT02311478|Copper|copper|mesh-list
111154083|NCT02311478|Contraceptive Agents|contraceptive agents|mesh-list
111154084|NCT02311478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111154085|NCT02311478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111154086|NCT02311478|Trace Elements|trace elements|mesh-ancestor
111154087|NCT02311478|Micronutrients|micronutrients|mesh-ancestor
111154088|NCT02281760|Trametinib|trametinib|mesh-list
111154089|NCT02281760|Dabrafenib|dabrafenib|mesh-list
111154090|NCT02281760|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
111154091|NCT02281760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111154092|NCT02281760|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111154093|NCT02281760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111154094|NCT02281760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111154095|NCT02281760|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
111154096|NCT02281760|Protective Agents|protective agents|mesh-ancestor
111154097|NCT02281760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111154098|NCT02281760|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111154099|NCT02281760|Antioxidants|antioxidants|mesh-ancestor
111154100|NCT02390531|Bevacizumab|bevacizumab|mesh-list
111154101|NCT02390531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111154102|NCT02390531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111154103|NCT02390531|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111154104|NCT02390531|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111154105|NCT02390531|Growth Substances|growth substances|mesh-ancestor
111154106|NCT02390531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111154107|NCT02390531|Growth Inhibitors|growth inhibitors|mesh-ancestor
111154108|NCT02390219|Ivacaftor|ivacaftor|mesh-list
111154109|NCT02390219|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
111154110|NCT02390219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111154111|NCT02390219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111154112|NCT02334215|Methadone|methadone|mesh-list
111154113|NCT02334215|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111154114|NCT02334215|Narcotics|narcotics|mesh-ancestor
111154115|NCT02334215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111154116|NCT02334215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111154117|NCT02334215|Analgesics|analgesics|mesh-ancestor
111154118|NCT02334215|Sensory System Agents|sensory system agents|mesh-ancestor
110484228|NCT04096144|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
111154119|NCT02334215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111154120|NCT02334215|Antitussive Agents|antitussive agents|mesh-ancestor
111154121|NCT02334215|Respiratory System Agents|respiratory system agents|mesh-ancestor
111154122|NCT02359877|Interferons|interferons|mesh-list
111154123|NCT02359877|Interferon-beta|interferon-beta|mesh-list
111154124|NCT02359877|Interferon beta-1a|interferon beta-1a|mesh-list
111154125|NCT02359877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111154126|NCT02359877|Antiviral Agents|antiviral agents|mesh-ancestor
110871223|NCT03707899|Amlodipine|amlodipine|mesh-list
111154127|NCT02359877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111154128|NCT02359877|Immunologic Factors|immunologic factors|mesh-ancestor
111154129|NCT02359877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111154130|NCT02359877|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110840806|NCT03750721|Rifampin|rifampin|mesh-list
111154131|NCT02389829|Diphenhydramine|diphenhydramine|mesh-list
111154132|NCT02389829|Promethazine|promethazine|mesh-list
111154133|NCT02389829|Hydromorphone|hydromorphone|mesh-list
111154134|NCT02389829|Prochlorperazine|prochlorperazine|mesh-list
111154135|NCT02389829|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111154136|NCT02389829|Narcotics|narcotics|mesh-ancestor
111154137|NCT02389829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111154138|NCT02389829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111154139|NCT02389829|Analgesics|analgesics|mesh-ancestor
111154140|NCT02389829|Sensory System Agents|sensory system agents|mesh-ancestor
111154141|NCT02389829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111154142|NCT02389829|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111154143|NCT02389829|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111154144|NCT02389829|Anesthetics, Local|anesthetics, local|mesh-ancestor
111154145|NCT02389829|Anesthetics|anesthetics|mesh-ancestor
111154146|NCT02389829|Antiemetics|antiemetics|mesh-ancestor
111154147|NCT02389829|Autonomic Agents|autonomic agents|mesh-ancestor
111154148|NCT02389829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111154149|NCT02389829|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111154150|NCT02389829|Histamine Antagonists|histamine antagonists|mesh-ancestor
111154151|NCT02389829|Histamine Agents|histamine agents|mesh-ancestor
111154152|NCT02389829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111154153|NCT02389829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111154154|NCT02389829|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111154155|NCT02389829|Antipruritics|antipruritics|mesh-ancestor
111154156|NCT02389829|Dermatologic Agents|dermatologic agents|mesh-ancestor
111154157|NCT02389829|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111154158|NCT02389829|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111154159|NCT02389829|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111154160|NCT02389829|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111154161|NCT02389829|Dopamine Agents|dopamine agents|mesh-ancestor
111154162|NCT02358863|Leucovorin|leucovorin|mesh-list
111154163|NCT02358863|Cisplatin|cisplatin|mesh-list
111154164|NCT02358863|Docetaxel|docetaxel|mesh-list
111154165|NCT02358863|Capecitabine|capecitabine|mesh-list
111154166|NCT02358863|Oxaliplatin|oxaliplatin|mesh-list
111154167|NCT02358863|Irinotecan|irinotecan|mesh-list
111154168|NCT02358863|Epirubicin|epirubicin|mesh-list
111154169|NCT02358863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111154170|NCT02358863|Tubulin Modulators|tubulin modulators|mesh-ancestor
111154171|NCT02358863|Antimitotic Agents|antimitotic agents|mesh-ancestor
111154172|NCT02358863|Mitosis Modulators|mitosis modulators|mesh-ancestor
111154173|NCT02358863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111154174|NCT02358863|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111154175|NCT02358863|Antimetabolites|antimetabolites|mesh-ancestor
111154176|NCT02358863|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111154177|NCT02358863|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111154178|NCT02358863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111154179|NCT02358863|Antidotes|antidotes|mesh-ancestor
111154180|NCT02358863|Protective Agents|protective agents|mesh-ancestor
111154181|NCT02358863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111154182|NCT02358863|Vitamin B Complex|vitamin b complex|mesh-ancestor
111154183|NCT02358863|Vitamins|vitamins|mesh-ancestor
111154184|NCT02358863|Micronutrients|micronutrients|mesh-ancestor
111154185|NCT02358863|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111154186|NCT02358863|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111154187|NCT02358473|Docetaxel|docetaxel|mesh-list
111154188|NCT02358473|Mogamulizumab|mogamulizumab|mesh-list
111154189|NCT02358473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111154190|NCT02358473|Tubulin Modulators|tubulin modulators|mesh-ancestor
111154191|NCT02358473|Antimitotic Agents|antimitotic agents|mesh-ancestor
111154192|NCT02358473|Mitosis Modulators|mitosis modulators|mesh-ancestor
111154193|NCT02358473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111154194|NCT02357459|Triamcinolone|triamcinolone|mesh-list
111154195|NCT02357459|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
111154196|NCT02357459|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
111154197|NCT02357459|FX006|fx006|mesh-list
111154198|NCT02357459|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
111154199|NCT02357459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111154200|NCT02357459|Glucocorticoids|glucocorticoids|mesh-ancestor
111154201|NCT02357459|Hormones|hormones|mesh-ancestor
111154202|NCT02357459|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111154203|NCT02357459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111154204|NCT02357459|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111154205|NCT02357459|Immunologic Factors|immunologic factors|mesh-ancestor
111154206|NCT02357459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111154207|NCT02357459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111154208|NCT02332889|Decitabine|decitabine|mesh-list
111154209|NCT02332889|Poly ICLC|poly iclc|mesh-list
111154210|NCT02332889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111154211|NCT02332889|Antimetabolites|antimetabolites|mesh-ancestor
111154212|NCT02332889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111154213|NCT02332889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111154214|NCT02332889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111154215|NCT02332889|Interferon Inducers|interferon inducers|mesh-ancestor
111154216|NCT02332889|Immunologic Factors|immunologic factors|mesh-ancestor
111154217|NCT02332889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111154218|NCT02357147|Pemetrexed|pemetrexed|mesh-list
111154219|NCT02357147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111154220|NCT02357147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111154221|NCT02357147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111154222|NCT02357147|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111154223|NCT02357147|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111154224|NCT02332655|Cannabidiol|cannabidiol|mesh-list
111154225|NCT02332655|Anticonvulsants|anticonvulsants|mesh-ancestor
111154226|NCT02388737|Lansoprazole|lansoprazole|mesh-list
111154227|NCT02388737|Dexlansoprazole|dexlansoprazole|mesh-list
111154228|NCT02388737|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111154229|NCT02388737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111154230|NCT02388737|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111154231|NCT02388737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111154232|NCT02388737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111154233|NCT02355665|Nicotine|nicotine|mesh-list
111154234|NCT02355665|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111154235|NCT02355665|Autonomic Agents|autonomic agents|mesh-ancestor
111154236|NCT02355665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111154237|NCT02355665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111154238|NCT02355665|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111154239|NCT02355665|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111154240|NCT02355665|Cholinergic Agents|cholinergic agents|mesh-ancestor
111154241|NCT02355665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111154242|NCT02355665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111154243|NCT02010255|Sofosbuvir|sofosbuvir|mesh-list
111154244|NCT02010255|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
111154245|NCT02010255|Ledipasvir|ledipasvir|mesh-list
111154246|NCT02010255|Antiviral Agents|antiviral agents|mesh-ancestor
111154247|NCT02010255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111154248|NCT02330549|Cenicriviroc|cenicriviroc|mesh-list
111154249|NCT02330549|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
111154250|NCT02330549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111154251|NCT02330549|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111154252|NCT02330549|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110484247|NCT00720265|Tacrolimus|tacrolimus|mesh-list
111154253|NCT02330549|Antiviral Agents|antiviral agents|mesh-ancestor
111154254|NCT02330549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111154255|NCT01620177|Ethanol|ethanol|mesh-list
111154256|NCT01620177|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111154257|NCT01620177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111154258|NCT01620177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111154259|NCT01620177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111154260|NCT01986855|Ertugliflozin|ertugliflozin|mesh-list
111154261|NCT01986855|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111154262|NCT01986855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111154263|NCT01986855|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111154264|NCT01986855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111154265|NCT02353871|Botulinum Toxins|botulinum toxins|mesh-list
111154266|NCT02353871|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111154267|NCT02353871|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111154268|NCT02353871|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111154269|NCT02353871|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111154270|NCT02353871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111154271|NCT02353871|Cholinergic Agents|cholinergic agents|mesh-ancestor
111154272|NCT02353871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111154273|NCT02353871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111154274|NCT02353871|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111154275|NCT02353871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111154276|NCT02009397|Ipilimumab|ipilimumab|mesh-list
111154277|NCT02009397|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111154278|NCT02009397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111154279|NCT02009397|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111154280|NCT02009397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111154281|NCT02312219|Folic Acid|folic acid|mesh-list
111154282|NCT02312219|Methotrexate|methotrexate|mesh-list
110871380|NCT02684344|Tamsulosin|tamsulosin|mesh-list
111154283|NCT02312219|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111154284|NCT02312219|Abortifacient Agents|abortifacient agents|mesh-ancestor
111154285|NCT02312219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111154286|NCT02312219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111154287|NCT02312219|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111154288|NCT02312219|Antimetabolites|antimetabolites|mesh-ancestor
111154289|NCT02312219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111154290|NCT02312219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111154291|NCT02312219|Dermatologic Agents|dermatologic agents|mesh-ancestor
111154292|NCT02312219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111154293|NCT02312219|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111154294|NCT02312219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111154295|NCT02312219|Immunologic Factors|immunologic factors|mesh-ancestor
111154296|NCT02312219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111154297|NCT02312219|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111154298|NCT02312219|Hematinics|hematinics|mesh-ancestor
111154299|NCT02312219|Vitamin B Complex|vitamin b complex|mesh-ancestor
111154300|NCT02312219|Vitamins|vitamins|mesh-ancestor
111154301|NCT02312219|Micronutrients|micronutrients|mesh-ancestor
111154302|NCT01986231|Glucagon|glucagon|mesh-list
111154303|NCT01986231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111154304|NCT01986231|Hormones|hormones|mesh-ancestor
111154305|NCT01986231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111154306|NCT01986231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111154307|NCT02312063|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111154308|NCT02312063|Glimepiride|glimepiride|mesh-list
111154309|NCT02312063|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111154310|NCT02312063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111154311|NCT02312063|Incretins|incretins|mesh-ancestor
111154312|NCT02312063|Hormones|hormones|mesh-ancestor
111154313|NCT02312063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111154314|NCT02312063|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111154315|NCT02312063|Protease Inhibitors|protease inhibitors|mesh-ancestor
111154316|NCT02312063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111154317|NCT02312063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111154318|NCT02312063|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111154319|NCT02312063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111154320|NCT02312063|Immunologic Factors|immunologic factors|mesh-ancestor
111154321|NCT02353169|Dexmedetomidine|dexmedetomidine|mesh-list
111154322|NCT02353169|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111154323|NCT02353169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111154324|NCT02353169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111154325|NCT02353169|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111154326|NCT02353169|Analgesics|analgesics|mesh-ancestor
111154327|NCT02353169|Sensory System Agents|sensory system agents|mesh-ancestor
111154328|NCT02353169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111154329|NCT02353169|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111154330|NCT02353169|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111154331|NCT02353169|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111154332|NCT02353169|Adrenergic Agents|adrenergic agents|mesh-ancestor
111154333|NCT02353169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111154334|NCT02353169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111154335|NCT02009163|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
111154336|NCT02009163|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111154337|NCT02009163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111154338|NCT02009163|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111154339|NCT02009163|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111154340|NCT02009163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111154341|NCT02009163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111154342|NCT02009163|Dopamine Agents|dopamine agents|mesh-ancestor
111154343|NCT02009163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111154344|NCT01983969|Pyridoxine|pyridoxine|mesh-list
111154345|NCT01983969|Dexamethasone|dexamethasone|mesh-list
111154346|NCT01983969|Rituximab|rituximab|mesh-list
111154347|NCT01983969|Gemcitabine|gemcitabine|mesh-list
111154348|NCT01983969|Azacitidine|azacitidine|mesh-list
111154349|NCT01983969|Melphalan|melphalan|mesh-list
111154350|NCT01983969|Busulfan|busulfan|mesh-list
111154351|NCT01983969|Vorinostat|vorinostat|mesh-list
111154352|NCT01983969|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111154353|NCT01983969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111154354|NCT01983969|Immunologic Factors|immunologic factors|mesh-ancestor
111154355|NCT01983969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111154356|NCT01983969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111154357|NCT01983969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111154358|NCT01983969|Antiemetics|antiemetics|mesh-ancestor
111154359|NCT01983969|Autonomic Agents|autonomic agents|mesh-ancestor
111154360|NCT01983969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111154361|NCT01983969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111154362|NCT01983969|Glucocorticoids|glucocorticoids|mesh-ancestor
111154363|NCT01983969|Hormones|hormones|mesh-ancestor
111154364|NCT01983969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111154365|NCT01983969|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111154366|NCT01983969|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111154367|NCT01983969|Antimetabolites|antimetabolites|mesh-ancestor
111154368|NCT01983969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111154369|NCT01983969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111154370|NCT01983969|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111154371|NCT01983969|Alkylating Agents|alkylating agents|mesh-ancestor
111154372|NCT01983969|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111154373|NCT01983969|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111154374|NCT01983969|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111154375|NCT01983969|Vitamin B Complex|vitamin b complex|mesh-ancestor
111154376|NCT01983969|Vitamins|vitamins|mesh-ancestor
111154377|NCT01983969|Micronutrients|micronutrients|mesh-ancestor
111154378|NCT02008773|Valacyclovir|valacyclovir|mesh-list
111154379|NCT02008773|Antiviral Agents|antiviral agents|mesh-ancestor
111154380|NCT02008773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111154381|NCT02257567|Rituximab|rituximab|mesh-list
111154382|NCT02257567|Obinutuzumab|obinutuzumab|mesh-list
111154383|NCT02257567|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
111154384|NCT02257567|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111154385|NCT02257567|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
111154386|NCT02257567|Immunoconjugates|immunoconjugates|mesh-list
111154387|NCT02257567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111154388|NCT02257567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111154389|NCT02257567|Immunologic Factors|immunologic factors|mesh-ancestor
111154390|NCT02257567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111154391|NCT02257567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111154392|NCT02257567|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111154393|NCT02257567|Alkylating Agents|alkylating agents|mesh-ancestor
111154394|NCT02257567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111154395|NCT01642615|Dexlansoprazole|dexlansoprazole|mesh-list
111154396|NCT01642615|Lansoprazole|lansoprazole|mesh-list
111154397|NCT01642615|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111154398|NCT01642615|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111154399|NCT01642615|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111154400|NCT01642615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111154401|NCT01642615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111154402|NCT03571945|Anesthetics|anesthetics|mesh-list
111154403|NCT03571945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111154404|NCT03571945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111154405|NCT02311361|Durvalumab|durvalumab|mesh-list
111154406|NCT02311361|Tremelimumab|tremelimumab|mesh-list
111154407|NCT02311361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111154408|NCT02311361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111154409|NCT02329223|Omalizumab|omalizumab|mesh-list
111154410|NCT02329223|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111154411|NCT02329223|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111154412|NCT02329223|Respiratory System Agents|respiratory system agents|mesh-ancestor
111154414|NCT05302297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111154415|NCT05302297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111154416|NCT02310581|Buprenorphine|buprenorphine|mesh-list
111154417|NCT02310581|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111154418|NCT02310581|Narcotics|narcotics|mesh-ancestor
111154419|NCT02310581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111154420|NCT02310581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111154421|NCT02310581|Analgesics|analgesics|mesh-ancestor
111154422|NCT02310581|Sensory System Agents|sensory system agents|mesh-ancestor
111154423|NCT02310581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111154424|NCT02310581|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111154425|NCT04892693|Talazoparib|talazoparib|mesh-list
111154426|NCT04892693|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111154427|NCT04892693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111154428|NCT04892693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111154429|NCT04892693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111154430|NCT02309411|Rivaroxaban|rivaroxaban|mesh-list
111154431|NCT02309411|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111154432|NCT02309411|Antithrombins|antithrombins|mesh-ancestor
111154433|NCT02309411|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111154434|NCT02309411|Protease Inhibitors|protease inhibitors|mesh-ancestor
111154435|NCT02309411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111154436|NCT02309411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111154437|NCT02309411|Anticoagulants|anticoagulants|mesh-ancestor
111154438|NCT02008227|Docetaxel|docetaxel|mesh-list
111154439|NCT02008227|Atezolizumab|atezolizumab|mesh-list
111154440|NCT02008227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111154441|NCT02008227|Tubulin Modulators|tubulin modulators|mesh-ancestor
111154442|NCT02008227|Antimitotic Agents|antimitotic agents|mesh-ancestor
111154443|NCT02008227|Mitosis Modulators|mitosis modulators|mesh-ancestor
111154444|NCT02008227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111154445|NCT02008227|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111154446|NCT02008227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111154447|NCT02348723|Warfarin|warfarin|mesh-list
111154448|NCT02348723|Dabigatran|dabigatran|mesh-list
111154449|NCT02348723|Anticoagulants|anticoagulants|mesh-ancestor
111154450|NCT02348723|Antithrombins|antithrombins|mesh-ancestor
111154451|NCT02348723|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111154452|NCT02348723|Protease Inhibitors|protease inhibitors|mesh-ancestor
111154453|NCT02348723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111154454|NCT02348723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111154455|NCT02006667|Gemcitabine|gemcitabine|mesh-list
111154456|NCT02006667|Trastuzumab|trastuzumab|mesh-list
111154457|NCT02006667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111154458|NCT02006667|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111154459|NCT02006667|Antimetabolites|antimetabolites|mesh-ancestor
111154460|NCT02006667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111154461|NCT02006667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111154462|NCT01983111|Acetaminophen|acetaminophen|mesh-list
111154463|NCT01983111|Buprenorphine|buprenorphine|mesh-list
111154464|NCT01983111|Tramadol|tramadol|mesh-list
111154465|NCT01983111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111154466|NCT01983111|Analgesics|analgesics|mesh-ancestor
111154467|NCT01983111|Sensory System Agents|sensory system agents|mesh-ancestor
111154468|NCT01983111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111154469|NCT01983111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111154470|NCT01983111|Antipyretics|antipyretics|mesh-ancestor
111154471|NCT01983111|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111154472|NCT01983111|Narcotics|narcotics|mesh-ancestor
111154473|NCT01983111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111154474|NCT01983111|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111154475|NCT04672941|Bromides|bromides|mesh-list
111154476|NCT04672941|Tiotropium Bromide|tiotropium bromide|mesh-list
111154477|NCT04672941|Olodaterol|olodaterol|mesh-list
111154478|NCT04672941|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111154479|NCT04672941|Autonomic Agents|autonomic agents|mesh-ancestor
111154480|NCT04672941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111154481|NCT04672941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111154482|NCT04672941|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111154483|NCT04672941|Respiratory System Agents|respiratory system agents|mesh-ancestor
111154484|NCT04672941|Parasympatholytics|parasympatholytics|mesh-ancestor
111154485|NCT04672941|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111154486|NCT04672941|Cholinergic Agents|cholinergic agents|mesh-ancestor
111154487|NCT04672941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111154488|NCT04672941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111154489|NCT04672941|Anticonvulsants|anticonvulsants|mesh-ancestor
111154490|NCT02348489|Guadecitabine|guadecitabine|mesh-list
111154491|NCT02348489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111154492|NCT01966107|Bromides|bromides|mesh-list
111154493|NCT01966107|Anticonvulsants|anticonvulsants|mesh-ancestor
111154494|NCT01982331|Vaccines|vaccines|mesh-list
111154495|NCT01982331|Immunologic Factors|immunologic factors|mesh-ancestor
111154496|NCT01982331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111154497|NCT02326025|Doxorubicin|doxorubicin|mesh-list
111154498|NCT02326025|Olaratumab|olaratumab|mesh-list
111154499|NCT02326025|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111154500|NCT02326025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111154501|NCT02326025|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111154502|NCT02326025|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111154503|NCT02326025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111154504|NCT02326025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111154505|NCT01619865|Edotreotide|edotreotide|mesh-list
110871609|NCT03674606|Aspirin|aspirin|mesh-list
111154506|NCT01619865|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111154507|NCT01619865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111154508|NCT02006121|Apomorphine|apomorphine|mesh-list
111154509|NCT02006121|Emetics|emetics|mesh-ancestor
111154510|NCT02006121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111154511|NCT02006121|Autonomic Agents|autonomic agents|mesh-ancestor
111154512|NCT02006121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111154513|NCT02006121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111154514|NCT02006121|Dopamine Agonists|dopamine agonists|mesh-ancestor
111154515|NCT02006121|Dopamine Agents|dopamine agents|mesh-ancestor
111154516|NCT02006121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111154517|NCT02006121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111154518|NCT02005887|Letrozole|letrozole|mesh-list
111154519|NCT02005887|Triptorelin Pamoate|triptorelin pamoate|mesh-list
111154520|NCT02005887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111154521|NCT02005887|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111154522|NCT02005887|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111154523|NCT02005887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111154524|NCT02005887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111154525|NCT02005887|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111154526|NCT02005887|Hormone Antagonists|hormone antagonists|mesh-ancestor
111154527|NCT02005887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111154528|NCT02005887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111154529|NCT02005887|Luteolytic Agents|luteolytic agents|mesh-ancestor
111154530|NCT02005887|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111154531|NCT02005887|Contraceptive Agents|contraceptive agents|mesh-ancestor
111154532|NCT02005887|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111154533|NCT02005887|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111154534|NCT02005887|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111154535|NCT01981473|Infliximab|infliximab|mesh-list
111154536|NCT01981473|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111154537|NCT01981473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111154538|NCT01981473|Dermatologic Agents|dermatologic agents|mesh-ancestor
111154539|NCT01981473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111154540|NCT01981473|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111154541|NCT02005029|Erythromycin|erythromycin|mesh-list
111154542|NCT02005029|Erythromycin Estolate|erythromycin estolate|mesh-list
111154543|NCT02005029|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
111154544|NCT02005029|Erythromycin stearate|erythromycin stearate|mesh-list
111154545|NCT02005029|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111154546|NCT02005029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111154547|NCT02005029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111154548|NCT02005029|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111154549|NCT02005029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111154550|NCT02005029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111154551|NCT04672005|Leucovorin|leucovorin|mesh-list
111154552|NCT04672005|Paclitaxel|paclitaxel|mesh-list
111154553|NCT04672005|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111154554|NCT04672005|Gemcitabine|gemcitabine|mesh-list
111154555|NCT04672005|Oxaliplatin|oxaliplatin|mesh-list
111154556|NCT04672005|Irinotecan|irinotecan|mesh-list
111154557|NCT04672005|Folfirinox|folfirinox|mesh-list
111154558|NCT04672005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111154559|NCT04672005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111154560|NCT04672005|Tubulin Modulators|tubulin modulators|mesh-ancestor
111154561|NCT04672005|Antimitotic Agents|antimitotic agents|mesh-ancestor
111154562|NCT04672005|Mitosis Modulators|mitosis modulators|mesh-ancestor
111154563|NCT04672005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111154564|NCT04672005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111154565|NCT04672005|Antimetabolites|antimetabolites|mesh-ancestor
111154566|NCT04672005|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111154567|NCT04672005|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111154568|NCT04672005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111154569|NCT04672005|Antidotes|antidotes|mesh-ancestor
111154570|NCT04672005|Protective Agents|protective agents|mesh-ancestor
111154571|NCT04672005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111154572|NCT04672005|Vitamin B Complex|vitamin b complex|mesh-ancestor
111154573|NCT04672005|Vitamins|vitamins|mesh-ancestor
111154574|NCT04672005|Micronutrients|micronutrients|mesh-ancestor
111154575|NCT04416399|Budesonide|budesonide|mesh-list
111154576|NCT04416399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111154577|NCT04416399|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111154578|NCT04416399|Autonomic Agents|autonomic agents|mesh-ancestor
111154579|NCT04416399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111154580|NCT04416399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111154581|NCT04416399|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111154582|NCT04416399|Respiratory System Agents|respiratory system agents|mesh-ancestor
111154583|NCT04416399|Glucocorticoids|glucocorticoids|mesh-ancestor
111154584|NCT04416399|Hormones|hormones|mesh-ancestor
111154585|NCT04416399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111154586|NCT02282345|Talazoparib|talazoparib|mesh-list
111154587|NCT02282345|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111154588|NCT02282345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111154589|NCT02282345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111154590|NCT02282345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111154591|NCT01732822|Clopidogrel|clopidogrel|mesh-list
111154592|NCT01732822|Ticagrelor|ticagrelor|mesh-list
111154593|NCT01732822|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111154594|NCT01732822|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111154595|NCT01732822|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111154596|NCT01732822|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111154597|NCT01732822|Purinergic Agents|purinergic agents|mesh-ancestor
111154598|NCT01732822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111154599|NCT01732822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111154600|NCT01732822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111154601|NCT02004093|Paclitaxel|paclitaxel|mesh-list
111154602|NCT02004093|Carboplatin|carboplatin|mesh-list
111154603|NCT02004093|Gemcitabine|gemcitabine|mesh-list
111154604|NCT02004093|Pertuzumab|pertuzumab|mesh-list
111154605|NCT02004093|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111154606|NCT02004093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111154607|NCT02004093|Tubulin Modulators|tubulin modulators|mesh-ancestor
111154608|NCT02004093|Antimitotic Agents|antimitotic agents|mesh-ancestor
111154609|NCT02004093|Mitosis Modulators|mitosis modulators|mesh-ancestor
111154610|NCT02004093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111154611|NCT02004093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111154612|NCT02004093|Antimetabolites|antimetabolites|mesh-ancestor
111154613|NCT02004093|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111154614|NCT01641367|Tenofovir|tenofovir|mesh-list
111154615|NCT01641367|Emtricitabine|emtricitabine|mesh-list
111154616|NCT01641367|Raltegravir Potassium|raltegravir potassium|mesh-list
111154617|NCT01641367|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
111154618|NCT01641367|Darunavir|darunavir|mesh-list
111154619|NCT01641367|Etravirine|etravirine|mesh-list
111154620|NCT01641367|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
111154621|NCT01641367|Protease Inhibitors|protease inhibitors|mesh-list
111154622|NCT01641367|Antiviral Agents|antiviral agents|mesh-ancestor
111154623|NCT01641367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111154624|NCT01641367|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111154625|NCT01641367|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111154626|NCT01641367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110840845|NCT01481272|Antiviral Agents|antiviral agents|mesh-ancestor
111154627|NCT01641367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111154628|NCT01641367|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111154629|NCT01641367|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111154630|NCT01641367|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111154631|NCT01641367|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111154632|NCT01641367|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111154633|NCT02325713|Praziquantel|praziquantel|mesh-list
111154634|NCT02325713|Anthelmintics|anthelmintics|mesh-ancestor
111154635|NCT02325713|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111154636|NCT02325713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111154637|NCT04877639|Dexmedetomidine|dexmedetomidine|mesh-list
111154638|NCT04877639|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111154639|NCT04877639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111154640|NCT04877639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111154641|NCT04877639|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111154642|NCT04877639|Analgesics|analgesics|mesh-ancestor
111154643|NCT04877639|Sensory System Agents|sensory system agents|mesh-ancestor
111154644|NCT04877639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111154645|NCT04877639|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111154646|NCT04877639|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111154647|NCT04877639|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111154648|NCT04877639|Adrenergic Agents|adrenergic agents|mesh-ancestor
111154649|NCT04877639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111154650|NCT04877639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111154651|NCT02325401|Metformin|metformin|mesh-list
111154652|NCT02325401|Cisplatin|cisplatin|mesh-list
111154653|NCT02325401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111154654|NCT02325401|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111154655|NCT02325401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111154656|NCT02324699|Prednisone|prednisone|mesh-list
111154657|NCT02324699|Vedolizumab|vedolizumab|mesh-list
111154658|NCT02324699|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111154659|NCT02324699|Glucocorticoids|glucocorticoids|mesh-ancestor
111154660|NCT02324699|Hormones|hormones|mesh-ancestor
111154661|NCT02324699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111154662|NCT02324699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111154663|NCT02324699|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111154664|NCT02324699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111154665|NCT02324699|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111154666|NCT01979523|Trametinib|trametinib|mesh-list
111154667|NCT01979523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111154668|NCT01979523|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111154669|NCT01979523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111154670|NCT01979523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111154671|NCT02255461|Palbociclib|palbociclib|mesh-list
111154672|NCT02255461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111154673|NCT02255461|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111154674|NCT02255461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111154675|NCT02255461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111154676|NCT01764022|Paclitaxel|paclitaxel|mesh-list
111154677|NCT01764022|Trastuzumab|trastuzumab|mesh-list
111154678|NCT01764022|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111154679|NCT01764022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111154680|NCT01764022|Tubulin Modulators|tubulin modulators|mesh-ancestor
111154681|NCT01764022|Antimitotic Agents|antimitotic agents|mesh-ancestor
111154682|NCT01764022|Mitosis Modulators|mitosis modulators|mesh-ancestor
111154683|NCT01764022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111154684|NCT01764022|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111154685|NCT02003391|Timolol|timolol|mesh-list
111154686|NCT02003391|Travoprost|travoprost|mesh-list
111154687|NCT02003391|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111154688|NCT02003391|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
111154689|NCT02003391|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111154690|NCT02003391|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111154691|NCT02003391|Adrenergic Agents|adrenergic agents|mesh-ancestor
111154692|NCT02003391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111154693|NCT02003391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111154694|NCT02003391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111154695|NCT02003391|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110840847|NCT01481272|Antidotes|antidotes|mesh-ancestor
111154697|NCT02254681|Gemcitabine|gemcitabine|mesh-list
111154698|NCT02254681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111154699|NCT02254681|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111154700|NCT02254681|Antimetabolites|antimetabolites|mesh-ancestor
111154701|NCT02254681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111154702|NCT01965327|Interferons|interferons|mesh-list
111154703|NCT01965327|Interferon-gamma|interferon-gamma|mesh-list
111154704|NCT01965327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111154705|NCT01965327|Antiviral Agents|antiviral agents|mesh-ancestor
111154706|NCT01965327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111154707|NCT01639729|Sufentanil|sufentanil|mesh-list
111154708|NCT01639729|Dsuvia|dsuvia|mesh-list
111154709|NCT01639729|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111154710|NCT01639729|Narcotics|narcotics|mesh-ancestor
111154711|NCT01639729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111154712|NCT01639729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111154713|NCT01639729|Analgesics|analgesics|mesh-ancestor
111154714|NCT01639729|Sensory System Agents|sensory system agents|mesh-ancestor
111154715|NCT01639729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111154716|NCT01639729|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111154717|NCT01639729|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111154718|NCT01639729|Anesthetics, General|anesthetics, general|mesh-ancestor
111154719|NCT01639729|Anesthetics|anesthetics|mesh-ancestor
111154720|NCT02002221|Metformin|metformin|mesh-list
111154721|NCT02002221|Vildagliptin|vildagliptin|mesh-list
111154722|NCT02002221|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111154723|NCT02002221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111154724|NCT02002221|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111154725|NCT02002221|Protease Inhibitors|protease inhibitors|mesh-ancestor
111154726|NCT02002221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111154727|NCT02002221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111154728|NCT05650723|Venetoclax|venetoclax|mesh-list
111154729|NCT05650723|Obinutuzumab|obinutuzumab|mesh-list
111154730|NCT05650723|Zanubrutinib|zanubrutinib|mesh-list
111154731|NCT05650723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111154732|NCT05650723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111154733|NCT05650723|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111154734|NCT05650723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111154735|NCT05650723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111154736|NCT05247697|Mirtazapine|mirtazapine|mesh-list
111154737|NCT05247697|Antidepressive Agents|antidepressive agents|mesh-ancestor
111154738|NCT05247697|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111154739|NCT05247697|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111154740|NCT05247697|Histamine Antagonists|histamine antagonists|mesh-ancestor
111154741|NCT05247697|Histamine Agents|histamine agents|mesh-ancestor
111154742|NCT05247697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111154743|NCT05247697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111154744|NCT05247697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111154745|NCT05247697|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111154746|NCT05247697|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111154747|NCT05247697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111154748|NCT05247697|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
111154749|NCT05247697|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111154750|NCT05247697|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111154751|NCT05247697|Adrenergic Agents|adrenergic agents|mesh-ancestor
111154752|NCT05247697|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111154753|NCT05247697|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111154754|NCT05247697|Serotonin Agents|serotonin agents|mesh-ancestor
111154755|NCT05247697|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111154756|NCT05100199|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111154757|NCT05100199|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111154758|NCT05100199|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111154759|NCT05100199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111154760|NCT05100199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111154761|NCT05100199|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111154762|NCT05100199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111154763|NCT05100199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111154764|NCT05100199|Cholinergic Agents|cholinergic agents|mesh-ancestor
111154765|NCT05100199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111154767|NCT02001987|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111154769|NCT02001987|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111154770|NCT02001987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111154771|NCT02001987|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111154772|NCT02001987|Antimetabolites|antimetabolites|mesh-ancestor
111154773|NCT02001987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111154774|NCT02001987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111154775|NCT02001987|Dermatologic Agents|dermatologic agents|mesh-ancestor
111154776|NCT02001987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111154777|NCT02001987|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111154778|NCT02001987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111154779|NCT02001987|Immunologic Factors|immunologic factors|mesh-ancestor
111154780|NCT02001987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111154781|NCT02001987|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111154782|NCT01763164|Dacarbazine|dacarbazine|mesh-list
111154783|NCT01763164|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111154784|NCT01763164|Alkylating Agents|alkylating agents|mesh-ancestor
111154785|NCT01763164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111154786|NCT01763164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111154787|NCT01782742|Bexarotene|bexarotene|mesh-list
111154788|NCT01782742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111154789|NCT01732588|Artefenomel|artefenomel|mesh-list
111154790|NCT01732588|Antimalarials|antimalarials|mesh-ancestor
111154791|NCT01732588|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111154792|NCT01732588|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111154793|NCT01732588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111154794|NCT01639339|Belimumab|belimumab|mesh-list
111154795|NCT01639339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111154796|NCT01639339|Immunologic Factors|immunologic factors|mesh-ancestor
111154797|NCT01639339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111154798|NCT01641133|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
111154799|NCT01641133|Immunologic Factors|immunologic factors|mesh-ancestor
111154800|NCT01641133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111154801|NCT04836637|Calcium, Dietary|calcium, dietary|mesh-list
111154802|NCT04836637|Calcium Carbonate|calcium carbonate|mesh-list
111154803|NCT04836637|Calcium|calcium|mesh-list
111154804|NCT04836637|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111154805|NCT04836637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111154806|NCT04836637|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111154807|NCT04836637|Antacids|antacids|mesh-ancestor
111154808|NCT04836637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111154809|NCT04836637|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111154810|NCT04419259|Erenumab|erenumab|mesh-list
111154811|NCT04419259|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
111154812|NCT04419259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111154813|NCT04419259|Analgesics|analgesics|mesh-ancestor
111154814|NCT04419259|Sensory System Agents|sensory system agents|mesh-ancestor
111154815|NCT04419259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111154816|NCT04419259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111154817|NCT02000427|Blinatumomab|blinatumomab|mesh-list
111154818|NCT02000427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111154819|NCT04845217|Peppermint oil|peppermint oil|mesh-list
111154820|NCT04845217|Antiemetics|antiemetics|mesh-ancestor
111154821|NCT04845217|Autonomic Agents|autonomic agents|mesh-ancestor
111154822|NCT04845217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111154823|NCT04845217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111154824|NCT04845217|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111154825|NCT04845217|Parasympatholytics|parasympatholytics|mesh-ancestor
111154826|NCT05359393|Tislelizumab|tislelizumab|mesh-list
111154827|NCT05359393|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111154828|NCT05359393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111154829|NCT01600885|Guanfacine|guanfacine|mesh-list
111154830|NCT01600885|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111154831|NCT01600885|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111154832|NCT01600885|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111154833|NCT01600885|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111154834|NCT01600885|Adrenergic Agents|adrenergic agents|mesh-ancestor
111154835|NCT01600885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111154836|NCT01600885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111154837|NCT01600885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111154838|NCT04625257|Antibodies|antibodies|mesh-list
111154839|NCT04625257|Immunologic Factors|immunologic factors|mesh-ancestor
111154840|NCT04625257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111154841|NCT05369377|Zanubrutinib|zanubrutinib|mesh-list
111154842|NCT05369377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111154843|NCT05369377|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111154844|NCT05369377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111154845|NCT05369377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111154846|NCT04832269|Methylprednisolone|methylprednisolone|mesh-list
111154847|NCT04832269|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111154848|NCT04832269|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111154849|NCT04832269|Prednisolone|prednisolone|mesh-list
111154850|NCT04832269|Prednisolone acetate|prednisolone acetate|mesh-list
111154851|NCT04832269|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111154852|NCT04832269|Prednisolone phosphate|prednisolone phosphate|mesh-list
111154853|NCT04832269|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111154854|NCT04832269|Antiemetics|antiemetics|mesh-ancestor
111154855|NCT04832269|Autonomic Agents|autonomic agents|mesh-ancestor
111154856|NCT04832269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111154857|NCT04832269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111154858|NCT04832269|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111154859|NCT04832269|Glucocorticoids|glucocorticoids|mesh-ancestor
111154860|NCT04832269|Hormones|hormones|mesh-ancestor
111154861|NCT04832269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111154862|NCT04832269|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111154863|NCT04832269|Protective Agents|protective agents|mesh-ancestor
111154864|NCT04832269|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111154865|NCT04832269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111154866|NCT04608331|Dexmedetomidine|dexmedetomidine|mesh-list
111154867|NCT04608331|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111154868|NCT04608331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111154869|NCT04608331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111154870|NCT04608331|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111154871|NCT04608331|Analgesics|analgesics|mesh-ancestor
111154872|NCT04608331|Sensory System Agents|sensory system agents|mesh-ancestor
111154873|NCT04608331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111154874|NCT04608331|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111154875|NCT04608331|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111154876|NCT04608331|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111154877|NCT04608331|Adrenergic Agents|adrenergic agents|mesh-ancestor
111154878|NCT04608331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111154879|NCT04608331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111154880|NCT01637077|Pregabalin|pregabalin|mesh-list
111154881|NCT01637077|Analgesics|analgesics|mesh-ancestor
111154882|NCT01637077|Sensory System Agents|sensory system agents|mesh-ancestor
111154883|NCT01637077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110676995|NCT03230734|Tubulin Modulators|tubulin modulators|mesh-ancestor
111154884|NCT01637077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111154885|NCT01637077|Anticonvulsants|anticonvulsants|mesh-ancestor
111154886|NCT01637077|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111154887|NCT01637077|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111154888|NCT01637077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111154889|NCT01637077|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111154890|NCT01637077|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111154891|NCT01637077|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111154892|NCT01637077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111154893|NCT01637077|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111154894|NCT02308163|Etanercept|etanercept|mesh-list
111154895|NCT02308163|Peficitinib|peficitinib|mesh-list
111154896|NCT02308163|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111154897|NCT02308163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111154898|NCT02308163|Analgesics|analgesics|mesh-ancestor
111154899|NCT02308163|Sensory System Agents|sensory system agents|mesh-ancestor
111154900|NCT02308163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111154901|NCT02308163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111154902|NCT02308163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111154903|NCT02308163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111154904|NCT02308163|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111154905|NCT02308163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111154906|NCT02308163|Immunologic Factors|immunologic factors|mesh-ancestor
111154907|NCT02308163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111154908|NCT02308163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111154909|NCT04001647|Ascorbic Acid|ascorbic acid|mesh-list
111154910|NCT04001647|Nitroprusside|nitroprusside|mesh-list
111154911|NCT04001647|Acetylcholine|acetylcholine|mesh-list
111154912|NCT04001647|Vitamins|vitamins|mesh-ancestor
111154913|NCT04001647|Micronutrients|micronutrients|mesh-ancestor
111154914|NCT04001647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111154915|NCT04001647|Antioxidants|antioxidants|mesh-ancestor
111154916|NCT04001647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111154917|NCT04001647|Protective Agents|protective agents|mesh-ancestor
111154918|NCT04001647|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111154919|NCT04001647|Vasodilator Agents|vasodilator agents|mesh-ancestor
111154920|NCT04001647|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
111154921|NCT04001647|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111154922|NCT04001647|Cholinergic Agents|cholinergic agents|mesh-ancestor
111154923|NCT04001647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111154924|NCT03939637|Immunoglobulins|immunoglobulins|mesh-list
111154925|NCT03939637|Antibodies|antibodies|mesh-list
111154926|NCT03939637|gamma-Globulins|gamma-globulins|mesh-list
111154927|NCT03939637|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111154928|NCT03939637|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
111154929|NCT03939637|Immunologic Factors|immunologic factors|mesh-ancestor
111154930|NCT03939637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111154931|NCT04880707|Anesthetics|anesthetics|mesh-list
111154932|NCT04880707|Anesthetics, Local|anesthetics, local|mesh-list
111154933|NCT04880707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111154934|NCT04880707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111154935|NCT04880707|Sensory System Agents|sensory system agents|mesh-ancestor
111154936|NCT04880707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111154937|NCT01999335|Dexamethasone|dexamethasone|mesh-list
111154938|NCT01999335|Pomalidomide|pomalidomide|mesh-list
111154939|NCT01999335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111154940|NCT01999335|Antiemetics|antiemetics|mesh-ancestor
111154941|NCT01999335|Autonomic Agents|autonomic agents|mesh-ancestor
111154942|NCT01999335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111154943|NCT01999335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111154944|NCT01999335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111154945|NCT01999335|Glucocorticoids|glucocorticoids|mesh-ancestor
111154946|NCT01999335|Hormones|hormones|mesh-ancestor
111154947|NCT01999335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111154948|NCT01999335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111154949|NCT01999335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111154950|NCT01999335|Immunologic Factors|immunologic factors|mesh-ancestor
111154951|NCT01999335|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111154952|NCT01999335|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111154953|NCT01999335|Growth Substances|growth substances|mesh-ancestor
111154954|NCT01999335|Growth Inhibitors|growth inhibitors|mesh-ancestor
111154955|NCT01999179|Heparin|heparin|mesh-list
111154956|NCT01999179|Enoxaparin|enoxaparin|mesh-list
111154957|NCT01999179|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
111154958|NCT01999179|Tinzaparin|tinzaparin|mesh-list
111154959|NCT01999179|Dalteparin|dalteparin|mesh-list
111154960|NCT01999179|Rivaroxaban|rivaroxaban|mesh-list
111154961|NCT01999179|Dabigatran|dabigatran|mesh-list
111154963|NCT01999179|Anticoagulants|anticoagulants|mesh-list
111154964|NCT01999179|Edoxaban|edoxaban|mesh-list
111154965|NCT01999179|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111154966|NCT01999179|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111154967|NCT01999179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111154968|NCT01999179|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111154969|NCT01999179|Antithrombins|antithrombins|mesh-ancestor
111154970|NCT01999179|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111154971|NCT01999179|Protease Inhibitors|protease inhibitors|mesh-ancestor
111154972|NCT01999179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111154973|NCT01977729|Sertraline|sertraline|mesh-list
111154974|NCT01977729|Antidepressive Agents|antidepressive agents|mesh-ancestor
111154975|NCT01977729|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111154976|NCT01977729|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111154977|NCT01977729|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111154978|NCT01977729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111154979|NCT01977729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111154980|NCT01977729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111154981|NCT01977729|Serotonin Agents|serotonin agents|mesh-ancestor
111154982|NCT01977729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111154983|NCT01998399|Ticagrelor|ticagrelor|mesh-list
111154984|NCT01998399|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111154985|NCT01998399|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111154986|NCT01998399|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111154987|NCT01998399|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111154988|NCT01998399|Purinergic Agents|purinergic agents|mesh-ancestor
111154989|NCT01998399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111154990|NCT01998399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111154991|NCT01998399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111154992|NCT01761292|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
111154993|NCT01761292|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111154994|NCT01761292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111154995|NCT01761292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111154996|NCT01731886|Dexamethasone|dexamethasone|mesh-list
111154997|NCT01731886|Cyclophosphamide|cyclophosphamide|mesh-list
111154998|NCT01731886|Melphalan|melphalan|mesh-list
111154999|NCT01731886|Lenalidomide|lenalidomide|mesh-list
111155000|NCT01731886|Lenograstim|lenograstim|mesh-list
111155001|NCT01731886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111155002|NCT01731886|Immunologic Factors|immunologic factors|mesh-ancestor
111155003|NCT01731886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111155004|NCT01731886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111155005|NCT01731886|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111155006|NCT01731886|Alkylating Agents|alkylating agents|mesh-ancestor
111155007|NCT01731886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111155008|NCT01731886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111155009|NCT01731886|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111155010|NCT01731886|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111155011|NCT01731886|Antiemetics|antiemetics|mesh-ancestor
111155012|NCT01731886|Autonomic Agents|autonomic agents|mesh-ancestor
111155013|NCT01731886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111155014|NCT01731886|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111155015|NCT01731886|Glucocorticoids|glucocorticoids|mesh-ancestor
111155016|NCT01731886|Hormones|hormones|mesh-ancestor
111155017|NCT01731886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111155018|NCT01731886|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111155019|NCT01731886|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111155020|NCT01731886|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111155021|NCT01731886|Growth Substances|growth substances|mesh-ancestor
111155022|NCT01731886|Growth Inhibitors|growth inhibitors|mesh-ancestor
111155023|NCT01731886|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111155024|NCT01759420|Ondansetron|ondansetron|mesh-list
111155025|NCT01759420|Antiemetics|antiemetics|mesh-ancestor
111155026|NCT01759420|Autonomic Agents|autonomic agents|mesh-ancestor
111155027|NCT01759420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111155028|NCT01759420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111155029|NCT01759420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111155030|NCT01759420|Antipruritics|antipruritics|mesh-ancestor
111155031|NCT01759420|Dermatologic Agents|dermatologic agents|mesh-ancestor
111155032|NCT01759420|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111155033|NCT01759420|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111155034|NCT01759420|Serotonin Agents|serotonin agents|mesh-ancestor
111155035|NCT01759420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111155036|NCT01759420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111155037|NCT01781026|Vemurafenib|vemurafenib|mesh-list
111155038|NCT01781026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111155039|NCT01781026|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111155040|NCT01781026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111155041|NCT01781026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111155042|NCT01729156|Metformin|metformin|mesh-list
111155043|NCT01729156|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111155044|NCT01729156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111155045|NCT01779700|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
111155046|NCT01779700|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
111155047|NCT01779700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111155048|NCT01779700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111155049|NCT01779700|Immunologic Factors|immunologic factors|mesh-ancestor
111155050|NCT01779700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111155051|NCT01963611|Glatiramer Acetate|glatiramer acetate|mesh-list
111155052|NCT01963611|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111155053|NCT01963611|Immunologic Factors|immunologic factors|mesh-ancestor
111155054|NCT01963611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111155055|NCT01963611|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111155056|NCT01963611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111155057|NCT01975701|Infigratinib|infigratinib|mesh-list
111155058|NCT01975701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111155059|NCT01962987|Diclofenac|diclofenac|mesh-list
111155060|NCT01962987|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111155061|NCT01962987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111155062|NCT01962987|Analgesics|analgesics|mesh-ancestor
111155063|NCT01962987|Sensory System Agents|sensory system agents|mesh-ancestor
111155064|NCT01962987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111155065|NCT01962987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111155066|NCT01962987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111155067|NCT01962987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111155068|NCT01962987|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111155069|NCT01962987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111155070|NCT01962987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111155071|NCT01962441|Sofosbuvir|sofosbuvir|mesh-list
111155072|NCT01962441|Antiviral Agents|antiviral agents|mesh-ancestor
111155073|NCT01962441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111155074|NCT01638013|Peficitinib|peficitinib|mesh-list
111155075|NCT01638013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111155076|NCT01638013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111155077|NCT01638013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111155078|NCT01638013|Immunologic Factors|immunologic factors|mesh-ancestor
111155079|NCT01638013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111155080|NCT01637623|Allopurinol|allopurinol|mesh-list
111155081|NCT01637623|Losartan|losartan|mesh-list
111155082|NCT01637623|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111155083|NCT01637623|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111155084|NCT01637623|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111155085|NCT01637623|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111155086|NCT01637623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111155087|NCT01637623|Antimetabolites|antimetabolites|mesh-ancestor
111155088|NCT01637623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111155089|NCT01637623|Gout Suppressants|gout suppressants|mesh-ancestor
111155090|NCT01637623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111155091|NCT01637623|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111155092|NCT01637623|Antioxidants|antioxidants|mesh-ancestor
111155093|NCT01637623|Protective Agents|protective agents|mesh-ancestor
111155094|NCT01637623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111155095|NCT01995825|Lamotrigine|lamotrigine|mesh-list
111155096|NCT01995825|Anticonvulsants|anticonvulsants|mesh-list
111155097|NCT01995825|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111155098|NCT01995825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111155099|NCT01995825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111155100|NCT01995825|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111155101|NCT01995825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111155102|NCT01995825|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111155103|NCT01995825|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111155104|NCT01995825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111155105|NCT01995825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111155106|NCT01995825|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111155107|NCT04267081|Venetoclax|venetoclax|mesh-list
111155108|NCT04267081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110676996|NCT03230734|Antimitotic Agents|antimitotic agents|mesh-ancestor
111155110|NCT04792567|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
111155111|NCT04792567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111155112|NCT04792567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111155113|NCT04792567|Immunologic Factors|immunologic factors|mesh-ancestor
111155114|NCT04792567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111155115|NCT04419025|Acetylcysteine|acetylcysteine|mesh-list
111155116|NCT04419025|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111155117|NCT04419025|Antiviral Agents|antiviral agents|mesh-ancestor
111155118|NCT04419025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111155119|NCT04419025|Expectorants|expectorants|mesh-ancestor
111155120|NCT04419025|Respiratory System Agents|respiratory system agents|mesh-ancestor
111155121|NCT04419025|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111155122|NCT04419025|Antioxidants|antioxidants|mesh-ancestor
111155123|NCT04419025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111155124|NCT04419025|Protective Agents|protective agents|mesh-ancestor
111155125|NCT04419025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111155126|NCT04419025|Antidotes|antidotes|mesh-ancestor
111155127|NCT04781647|Interferons|interferons|mesh-list
111155128|NCT04781647|Interferon-alpha|interferon-alpha|mesh-list
111155129|NCT04781647|Entecavir|entecavir|mesh-list
111155130|NCT04781647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111155131|NCT04781647|Antiviral Agents|antiviral agents|mesh-ancestor
111155132|NCT04781647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111155133|NCT04781647|Immunologic Factors|immunologic factors|mesh-ancestor
111155134|NCT04781647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111155135|NCT05259787|Propofol|propofol|mesh-list
111155136|NCT05259787|Etomidate|etomidate|mesh-list
111155137|NCT05259787|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111155138|NCT05259787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111155139|NCT05259787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111155140|NCT05259787|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111155141|NCT05259787|Anesthetics, General|anesthetics, general|mesh-ancestor
111155142|NCT05259787|Anesthetics|anesthetics|mesh-ancestor
111155143|NCT03565159|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
111155144|NCT03565159|Immunologic Factors|immunologic factors|mesh-ancestor
111155145|NCT03565159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111155146|NCT01756456|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111155147|NCT01756456|Mitogens|mitogens|mesh-list
111155148|NCT01756456|Mitosis Modulators|mitosis modulators|mesh-ancestor
111155149|NCT01756456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111155150|NCT05226325|Dexmedetomidine|dexmedetomidine|mesh-list
111155151|NCT05226325|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111155152|NCT05226325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111155153|NCT05226325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111155154|NCT05226325|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111155155|NCT05226325|Analgesics|analgesics|mesh-ancestor
111155156|NCT05226325|Sensory System Agents|sensory system agents|mesh-ancestor
111155157|NCT05226325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111155158|NCT05226325|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111155159|NCT05226325|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111155160|NCT05226325|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111155161|NCT05226325|Adrenergic Agents|adrenergic agents|mesh-ancestor
111155162|NCT05226325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111155163|NCT05226325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111155164|NCT05221021|Mirabegron|mirabegron|mesh-list
111155165|NCT05221021|Estradiol|estradiol|mesh-list
111155166|NCT05221021|Estrogens|estrogens|mesh-list
111155167|NCT05221021|Hormones|hormones|mesh-ancestor
111155168|NCT05221021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111155169|NCT05221021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111155170|NCT05221021|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
111155171|NCT05221021|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111155172|NCT05221021|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111155173|NCT05221021|Adrenergic Agents|adrenergic agents|mesh-ancestor
111155174|NCT05221021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111155175|NCT05221021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111155176|NCT05221021|Urological Agents|urological agents|mesh-ancestor
111155177|NCT03167437|Vorinostat|vorinostat|mesh-list
111155178|NCT03167437|Ustekinumab|ustekinumab|mesh-list
111155179|NCT03167437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110872291|NCT02579044|Everolimus|everolimus|mesh-list
111155180|NCT03167437|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111155181|NCT03167437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111155182|NCT03167437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111155183|NCT03167437|Dermatologic Agents|dermatologic agents|mesh-ancestor
111155184|NCT03164473|Rituximab|rituximab|mesh-list
111155185|NCT03164473|Azathioprine|azathioprine|mesh-list
111155186|NCT03164473|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111155187|NCT03164473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111155188|NCT03164473|Immunologic Factors|immunologic factors|mesh-ancestor
111155189|NCT03164473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111155190|NCT03164473|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111155191|NCT03164473|Antimetabolites|antimetabolites|mesh-ancestor
111155192|NCT03164473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111155193|NCT03164473|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111155194|NCT03164473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111155195|NCT05218915|Dulaglutide|dulaglutide|mesh-list
111155196|NCT05218915|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111155197|NCT05218915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111155198|NCT01995201|Methotrexate|methotrexate|mesh-list
111155199|NCT01995201|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111155200|NCT01995201|Abortifacient Agents|abortifacient agents|mesh-ancestor
111155201|NCT01995201|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111155202|NCT01995201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111155203|NCT01995201|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111155204|NCT01995201|Antimetabolites|antimetabolites|mesh-ancestor
111155205|NCT01995201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111155206|NCT01995201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111155207|NCT01995201|Dermatologic Agents|dermatologic agents|mesh-ancestor
111155208|NCT01995201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111155209|NCT01995201|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111155210|NCT01995201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111155211|NCT01995201|Immunologic Factors|immunologic factors|mesh-ancestor
111155212|NCT01995201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111155213|NCT01995201|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111155214|NCT01636687|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111155215|NCT01636687|Immunologic Factors|immunologic factors|mesh-ancestor
111155216|NCT01636687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111155217|NCT05165641|Anesthetics|anesthetics|mesh-list
111155218|NCT05165641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111155219|NCT05165641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111155220|NCT04796467|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
111155221|NCT04796467|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111155222|NCT04796467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111155223|NCT05814432|Amphotericin B|amphotericin b|mesh-list
111155224|NCT05814432|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
111155225|NCT05814432|Amebicides|amebicides|mesh-ancestor
111155226|NCT05814432|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111155227|NCT05814432|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111155228|NCT05814432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111155229|NCT05814432|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111155230|NCT05814432|Antifungal Agents|antifungal agents|mesh-ancestor
111155231|NCT05814302|Acetaminophen|acetaminophen|mesh-list
111155232|NCT05814302|Ibuprofen|ibuprofen|mesh-list
111155233|NCT05814302|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111155234|NCT05814302|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111155235|NCT05814302|Analgesics|analgesics|mesh-ancestor
111155236|NCT05814302|Sensory System Agents|sensory system agents|mesh-ancestor
111155237|NCT05814302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111155238|NCT05814302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111155239|NCT05814302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111155240|NCT05814302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111155241|NCT05814302|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111155242|NCT05814302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110484462|NCT02538081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111155243|NCT05814302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111155244|NCT05814302|Antipyretics|antipyretics|mesh-ancestor
111155245|NCT05814159|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
111155246|NCT05814159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111155247|NCT05814068|Antihypertensive Agents|antihypertensive agents|mesh-list
111155249|NCT05813951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111155250|NCT05813951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111155251|NCT05813951|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111155252|NCT05813951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111155253|NCT05813951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111155254|NCT05813821|Anti-Infective Agents|anti-infective agents|mesh-list
111155255|NCT05813821|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111155256|NCT05813691|Antibodies|antibodies|mesh-list
111155257|NCT05813691|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
111155258|NCT05813691|Immunologic Factors|immunologic factors|mesh-ancestor
111155259|NCT05813691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111155260|NCT05813665|Denosumab|denosumab|mesh-list
111155261|NCT05813665|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111155262|NCT05813665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111155263|NCT05813600|Ritonavir|ritonavir|mesh-list
111155264|NCT05813600|Nirmatrelvir|nirmatrelvir|mesh-list
111155265|NCT05813600|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
111155266|NCT05813600|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111155267|NCT05813600|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111155268|NCT05813600|Protease Inhibitors|protease inhibitors|mesh-ancestor
111155269|NCT05813600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111155270|NCT05813600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111155271|NCT05813600|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111155272|NCT05813600|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111155273|NCT05813600|Antiviral Agents|antiviral agents|mesh-ancestor
111155274|NCT05813600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111155275|NCT05813600|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111155276|NCT05813600|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111155277|NCT05813561|Fexuprazan|fexuprazan|mesh-list
111155278|NCT05813561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111155279|NCT05813522|Aflutinib|aflutinib|mesh-list
111155280|NCT05813522|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111155281|NCT05813522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111155282|NCT05813522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111155283|NCT05813496|Thioctic Acid|thioctic acid|mesh-list
111155284|NCT05813496|Antioxidants|antioxidants|mesh-ancestor
111155285|NCT05813496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111155286|NCT05813496|Protective Agents|protective agents|mesh-ancestor
111155287|NCT05813496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111155288|NCT05813496|Vitamin B Complex|vitamin b complex|mesh-ancestor
111155289|NCT05813496|Vitamins|vitamins|mesh-ancestor
111155290|NCT05813496|Micronutrients|micronutrients|mesh-ancestor
111155291|NCT05813470|Omalizumab|omalizumab|mesh-list
111155292|NCT05813470|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111155293|NCT05813470|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111155294|NCT05813470|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111155295|NCT05813470|Respiratory System Agents|respiratory system agents|mesh-ancestor
111155296|NCT05813470|Immunologic Factors|immunologic factors|mesh-ancestor
111155297|NCT05813470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111155298|NCT05813405|Antihypertensive Agents|antihypertensive agents|mesh-list
111155299|NCT05813366|Vitamin B 6|vitamin b 6|mesh-list
111155300|NCT05813366|Pyridoxal|pyridoxal|mesh-list
111155301|NCT05813366|Pyridoxine|pyridoxine|mesh-list
111155302|NCT05813366|Tryptophan|tryptophan|mesh-list
111155303|NCT05813366|Vitamins|vitamins|mesh-ancestor
111155304|NCT05813366|Micronutrients|micronutrients|mesh-ancestor
111155305|NCT05813366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111155306|NCT05813366|Vitamin B Complex|vitamin b complex|mesh-ancestor
111155307|NCT05813366|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111155308|NCT05813366|Antidepressive Agents|antidepressive agents|mesh-ancestor
111155309|NCT05813366|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111155310|NCT05813314|Natriuretic Peptide, C-Type|natriuretic peptide, c-type|mesh-list
111155311|NCT05813314|Natriuretic Agents|natriuretic agents|mesh-ancestor
111155312|NCT05813314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111155313|NCT05813249|Tocopherols|tocopherols|mesh-list
111155314|NCT05813249|Vitamin E|vitamin e|mesh-list
111155315|NCT05813249|Tocotrienols|tocotrienols|mesh-list
111155316|NCT05813249|alpha-Tocopherol|alpha-tocopherol|mesh-list
111155317|NCT05813249|Antioxidants|antioxidants|mesh-ancestor
111155318|NCT05813249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111155319|NCT05813249|Protective Agents|protective agents|mesh-ancestor
111155320|NCT05813249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111155322|NCT05813249|Micronutrients|micronutrients|mesh-ancestor
111155323|NCT05813184|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111155324|NCT05813184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111155325|NCT05813145|Fenofibrate|fenofibrate|mesh-list
111155326|NCT05813145|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111155327|NCT05813145|Antimetabolites|antimetabolites|mesh-ancestor
111155328|NCT05813145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111155329|NCT05813145|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111155330|NCT05813106|Dexmedetomidine|dexmedetomidine|mesh-list
111155331|NCT05813106|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111155332|NCT05813106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111155333|NCT05813106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111155334|NCT05813106|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111155335|NCT05813106|Analgesics|analgesics|mesh-ancestor
111155336|NCT05813106|Sensory System Agents|sensory system agents|mesh-ancestor
111155337|NCT05813106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111155338|NCT05813106|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111155340|NCT05813106|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111155341|NCT05813106|Adrenergic Agents|adrenergic agents|mesh-ancestor
111155342|NCT05813106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111155343|NCT05813106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111155344|NCT05813015|Docetaxel|docetaxel|mesh-list
111155345|NCT05813015|Tegafur|tegafur|mesh-list
111155346|NCT05813015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111155347|NCT05813015|Tubulin Modulators|tubulin modulators|mesh-ancestor
111155348|NCT05813015|Antimitotic Agents|antimitotic agents|mesh-ancestor
111155349|NCT05813015|Mitosis Modulators|mitosis modulators|mesh-ancestor
111155350|NCT05813015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111155351|NCT05813015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111155352|NCT05813015|Antimetabolites|antimetabolites|mesh-ancestor
111155353|NCT05808582|Fulvestrant|fulvestrant|mesh-list
111155354|NCT05808582|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111155355|NCT05808582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111155356|NCT05808582|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
111155357|NCT05808582|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111155358|NCT05808582|Hormone Antagonists|hormone antagonists|mesh-ancestor
111155359|NCT05808582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111155360|NCT05808582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111155361|NCT05796804|Anesthetics|anesthetics|mesh-list
111155362|NCT05796804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111155363|NCT05796804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111155364|NCT05788874|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
111155365|NCT05788874|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111155366|NCT05788874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111155367|NCT05788289|Lenalidomide|lenalidomide|mesh-list
111155368|NCT05788289|Immunologic Factors|immunologic factors|mesh-ancestor
111155369|NCT05788289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111155370|NCT05788289|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111155371|NCT05788289|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111155372|NCT05788289|Growth Substances|growth substances|mesh-ancestor
111155373|NCT05788289|Growth Inhibitors|growth inhibitors|mesh-ancestor
111155374|NCT05788289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111155375|NCT05775887|Vaccines|vaccines|mesh-list
111155376|NCT05775887|Immunologic Factors|immunologic factors|mesh-ancestor
111155377|NCT05775887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111155378|NCT05757388|Acetaminophen|acetaminophen|mesh-list
111155379|NCT05757388|Parecoxib|parecoxib|mesh-list
111155380|NCT05757388|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111155381|NCT05757388|Analgesics|analgesics|mesh-ancestor
111155382|NCT05757388|Sensory System Agents|sensory system agents|mesh-ancestor
111155383|NCT05757388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111155384|NCT05757388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111155385|NCT05757388|Antipyretics|antipyretics|mesh-ancestor
111155386|NCT05757388|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111155387|NCT05757388|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111155388|NCT05757388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111155389|NCT05757388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111155390|NCT05757388|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111155391|NCT05757388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111155392|NCT05757388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111155393|NCT05755334|Ropivacaine|ropivacaine|mesh-list
111155394|NCT05755334|Anesthetics, Local|anesthetics, local|mesh-ancestor
111155395|NCT05755334|Anesthetics|anesthetics|mesh-ancestor
111155396|NCT05755334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111155397|NCT05755334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111155398|NCT05755334|Sensory System Agents|sensory system agents|mesh-ancestor
111155399|NCT05755334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111155400|NCT05749393|Heparin|heparin|mesh-list
111155401|NCT05749393|Calcium heparin|calcium heparin|mesh-list
111155402|NCT05749393|Anticoagulants|anticoagulants|mesh-ancestor
111155403|NCT05749393|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111155404|NCT05749393|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111155405|NCT05749393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111155406|NCT05732883|Dexamethasone|dexamethasone|mesh-list
111155407|NCT05732883|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111155408|NCT05732883|Antiemetics|antiemetics|mesh-ancestor
111155409|NCT05732883|Autonomic Agents|autonomic agents|mesh-ancestor
111155410|NCT05732883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111155411|NCT05732883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111155412|NCT05732883|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111155413|NCT05732883|Glucocorticoids|glucocorticoids|mesh-ancestor
111155414|NCT05732883|Hormones|hormones|mesh-ancestor
111155415|NCT05732883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111155416|NCT05732883|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111155417|NCT05732883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111155418|NCT05715814|Empagliflozin|empagliflozin|mesh-list
111155419|NCT05715814|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111155420|NCT05715814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111155421|NCT05715814|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111155422|NCT05715814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111155423|NCT05688735|Isosorbide|isosorbide|mesh-list
111155424|NCT05688735|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
111155425|NCT05688735|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
111155426|NCT05688735|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
111155427|NCT05688735|Diuretics|diuretics|mesh-ancestor
111155428|NCT05688735|Natriuretic Agents|natriuretic agents|mesh-ancestor
111155429|NCT05688735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111155430|NCT05688735|Vasodilator Agents|vasodilator agents|mesh-ancestor
111155431|NCT05688735|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
111155432|NCT05688735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111155433|NCT05674994|Prednisone|prednisone|mesh-list
111155434|NCT05674994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111155435|NCT05674994|Glucocorticoids|glucocorticoids|mesh-ancestor
111155436|NCT05674994|Hormones|hormones|mesh-ancestor
111155437|NCT05674994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111155438|NCT05674994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110484492|NCT02866448|Antipyretics|antipyretics|mesh-ancestor
111155439|NCT05674994|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111155440|NCT05674994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111155441|NCT05662397|Cemiplimab|cemiplimab|mesh-list
111155442|NCT05662397|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111155443|NCT05662397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111155444|NCT05627596|Nicotine|nicotine|mesh-list
111155445|NCT05627596|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111155446|NCT05627596|Autonomic Agents|autonomic agents|mesh-ancestor
111155447|NCT05627596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111155448|NCT05627596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111155449|NCT05627596|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111155450|NCT05627596|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111155451|NCT05627596|Cholinergic Agents|cholinergic agents|mesh-ancestor
111155452|NCT05627596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111155453|NCT05627596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111155454|NCT05582798|Protease Inhibitors|protease inhibitors|mesh-list
111155455|NCT05582798|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
111155456|NCT05582798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111155457|NCT05582798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111155458|NCT05582798|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
111155459|NCT05582798|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111155460|NCT05552196|Carbamazepine|carbamazepine|mesh-list
111155461|NCT05552196|Ponesimod|ponesimod|mesh-list
111155462|NCT05552196|Anticonvulsants|anticonvulsants|mesh-ancestor
111155463|NCT05552196|Antimanic Agents|antimanic agents|mesh-ancestor
111155464|NCT05552196|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111155465|NCT05552196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111155466|NCT05552196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111155468|NCT05552196|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111155469|NCT05552196|Analgesics|analgesics|mesh-ancestor
111155470|NCT05552196|Sensory System Agents|sensory system agents|mesh-ancestor
111155471|NCT05552196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111155472|NCT05552196|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111155473|NCT05552196|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111155474|NCT05552196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111155475|NCT05552196|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111155476|NCT05552196|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111155477|NCT05552196|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
111155478|NCT05552196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111155479|NCT05552196|Immunologic Factors|immunologic factors|mesh-ancestor
111155480|NCT05538247|Indomethacin|indomethacin|mesh-list
111155481|NCT05538247|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111155482|NCT05538247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111155483|NCT05538247|Analgesics|analgesics|mesh-ancestor
111155484|NCT05538247|Sensory System Agents|sensory system agents|mesh-ancestor
111155485|NCT05538247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111155486|NCT05538247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111155487|NCT05538247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111155488|NCT05538247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111155489|NCT05538247|Gout Suppressants|gout suppressants|mesh-ancestor
111155490|NCT05538247|Tocolytic Agents|tocolytic agents|mesh-ancestor
111155491|NCT05538247|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111155492|NCT05538247|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111155493|NCT05538247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111155494|NCT05538247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111155495|NCT05536414|Escitalopram|escitalopram|mesh-list
111155496|NCT05536414|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111155497|NCT05536414|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111155498|NCT05536414|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111155499|NCT05536414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111155500|NCT05536414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111155501|NCT05536414|Serotonin Agents|serotonin agents|mesh-ancestor
110484501|NCT00720577|Antimetabolites|antimetabolites|mesh-ancestor
111155502|NCT05536414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111155503|NCT05496192|Nivolumab|nivolumab|mesh-list
111155504|NCT05496192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111155505|NCT05496192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111155506|NCT05496192|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111155507|NCT05496192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111155508|NCT05472623|Nivolumab|nivolumab|mesh-list
111155509|NCT05472623|Adagrasib|adagrasib|mesh-list
111155510|NCT05472623|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111155511|NCT05472623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111155512|NCT05472623|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111155513|NCT05472623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111155514|NCT05438394|Melphalan|melphalan|mesh-list
111155515|NCT05438394|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111155516|NCT05438394|Alkylating Agents|alkylating agents|mesh-ancestor
111155517|NCT05438394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111155518|NCT05438394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111155519|NCT05438394|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111155520|NCT05438394|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111155521|NCT05438394|Immunologic Factors|immunologic factors|mesh-ancestor
111155522|NCT05438394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111155523|NCT05386030|Lidocaine|lidocaine|mesh-list
111155524|NCT05386030|Anesthetics, Local|anesthetics, local|mesh-ancestor
111155525|NCT05386030|Anesthetics|anesthetics|mesh-ancestor
111155526|NCT05386030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111155527|NCT05386030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111155528|NCT05386030|Sensory System Agents|sensory system agents|mesh-ancestor
111155529|NCT05386030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111155530|NCT05386030|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111155531|NCT05386030|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111155532|NCT05386030|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111155533|NCT05386030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111155534|NCT05386030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111155536|NCT05287568|Cc-486|cc-486|mesh-list
111155537|NCT05287568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111155538|NCT05287191|Magnesium Sulfate|magnesium sulfate|mesh-list
111155539|NCT05287191|Digoxin|digoxin|mesh-list
111155540|NCT05287191|Amiodarone|amiodarone|mesh-list
111155541|NCT05287191|Analgesics|analgesics|mesh-ancestor
111155542|NCT05287191|Sensory System Agents|sensory system agents|mesh-ancestor
111155543|NCT05287191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111155544|NCT05287191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111155545|NCT05287191|Anesthetics|anesthetics|mesh-ancestor
111155546|NCT05287191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111155547|NCT05287191|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111155548|NCT05287191|Anticonvulsants|anticonvulsants|mesh-ancestor
111155549|NCT05287191|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111155550|NCT05287191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111155551|NCT05287191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111155552|NCT05287191|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111155553|NCT05287191|Tocolytic Agents|tocolytic agents|mesh-ancestor
111155554|NCT05287191|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111155555|NCT05287191|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111155556|NCT05287191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111155557|NCT05287191|Protective Agents|protective agents|mesh-ancestor
111155558|NCT05287191|Vasodilator Agents|vasodilator agents|mesh-ancestor
111155559|NCT05287191|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
111155560|NCT05287191|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111155561|NCT05287191|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111155562|NCT05287191|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111155563|NCT05287191|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111155564|NCT05287191|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111155565|NCT05287191|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111155567|NCT05259046|Vitamin K|vitamin k|mesh-list
111155568|NCT05259046|Menaquinone 7|menaquinone 7|mesh-list
111155569|NCT05259046|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111155570|NCT05259046|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111155571|NCT05259046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111155572|NCT05259046|Hemostatics|hemostatics|mesh-ancestor
111155573|NCT05259046|Coagulants|coagulants|mesh-ancestor
111155574|NCT05259046|Vitamins|vitamins|mesh-ancestor
111155575|NCT05259046|Micronutrients|micronutrients|mesh-ancestor
111155576|NCT05259046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111155577|NCT05206682|Leuprolide|leuprolide|mesh-list
111155578|NCT05206682|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111155579|NCT05206682|Fertility Agents|fertility agents|mesh-ancestor
111155580|NCT05206682|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111155581|NCT05206682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111155582|NCT05206682|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111155583|NCT05206682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111155584|NCT05197842|Prednisone|prednisone|mesh-list
111155585|NCT05197842|Cyclophosphamide|cyclophosphamide|mesh-list
111155586|NCT05197842|Glucocorticoids|glucocorticoids|mesh-list
111155587|NCT05197842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111155588|NCT05197842|Immunologic Factors|immunologic factors|mesh-ancestor
111155589|NCT05197842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111155590|NCT05197842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111155591|NCT05197842|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111155592|NCT05197842|Alkylating Agents|alkylating agents|mesh-ancestor
111155593|NCT05197842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111155594|NCT05197842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111155595|NCT05197842|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111155596|NCT05197842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111155597|NCT05197842|Hormones|hormones|mesh-ancestor
111155598|NCT05197842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111155599|NCT05197842|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111155600|NCT05129748|Sodium thiosulfate|sodium thiosulfate|mesh-list
111155601|NCT05129748|Mannitol|mannitol|mesh-list
111155602|NCT05129748|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
111155603|NCT05129748|Diuretics|diuretics|mesh-ancestor
111155604|NCT05129748|Natriuretic Agents|natriuretic agents|mesh-ancestor
111155605|NCT05129748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111155606|NCT05129748|Antidotes|antidotes|mesh-ancestor
111155607|NCT05129748|Protective Agents|protective agents|mesh-ancestor
111155608|NCT05129748|Antioxidants|antioxidants|mesh-ancestor
111155609|NCT05129748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111155610|NCT05129748|Antitubercular Agents|antitubercular agents|mesh-ancestor
111155611|NCT05129748|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111155612|NCT05129748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111155613|NCT05129748|Chelating Agents|chelating agents|mesh-ancestor
111155614|NCT05129748|Sequestering Agents|sequestering agents|mesh-ancestor
111155615|NCT05127746|Donepezil|donepezil|mesh-list
111155616|NCT05127746|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111155617|NCT05127746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111155618|NCT05127746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111155619|NCT05127746|Cholinergic Agents|cholinergic agents|mesh-ancestor
111155620|NCT05127746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111155621|NCT05127746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111155622|NCT05127746|Nootropic Agents|nootropic agents|mesh-ancestor
111155623|NCT05054998|Deoxyglucose|deoxyglucose|mesh-list
111155624|NCT05054998|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
111155625|NCT05054998|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111155626|NCT05054998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111155627|NCT05054998|Antimetabolites|antimetabolites|mesh-ancestor
111155628|NCT05054998|Antiviral Agents|antiviral agents|mesh-ancestor
111155629|NCT05054998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111155630|NCT05024552|Cytarabine|cytarabine|mesh-list
111155631|NCT05024552|Daunorubicin|daunorubicin|mesh-list
111155632|NCT05024552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111155633|NCT05024552|Antimetabolites|antimetabolites|mesh-ancestor
111155634|NCT05024552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111155636|NCT05024552|Antiviral Agents|antiviral agents|mesh-ancestor
111155637|NCT05024552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111155638|NCT05024552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111155639|NCT05024552|Immunologic Factors|immunologic factors|mesh-ancestor
111155640|NCT05024552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111155641|NCT05024552|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111155642|NCT05024552|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111155643|NCT05024552|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111155644|NCT05024552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111155645|NCT04933084|Analgesics, Opioid|analgesics, opioid|mesh-list
111155646|NCT04933084|Narcotics|narcotics|mesh-ancestor
111155647|NCT04933084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111155648|NCT04933084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111155649|NCT04933084|Analgesics|analgesics|mesh-ancestor
111155650|NCT04933084|Sensory System Agents|sensory system agents|mesh-ancestor
111155651|NCT04933084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111155652|NCT04930887|Bupivacaine|bupivacaine|mesh-list
111155653|NCT04930887|Anesthetics, Local|anesthetics, local|mesh-ancestor
111155654|NCT04930887|Anesthetics|anesthetics|mesh-ancestor
111155655|NCT04930887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111155656|NCT04930887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111155657|NCT04930887|Sensory System Agents|sensory system agents|mesh-ancestor
111155658|NCT04930887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111155659|NCT04863248|Docetaxel|docetaxel|mesh-list
111155660|NCT04863248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111155661|NCT04863248|Tubulin Modulators|tubulin modulators|mesh-ancestor
111155662|NCT04863248|Antimitotic Agents|antimitotic agents|mesh-ancestor
111155663|NCT04863248|Mitosis Modulators|mitosis modulators|mesh-ancestor
111155664|NCT04863248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111155665|NCT04815902|Losartan|losartan|mesh-list
111155666|NCT04815902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111155667|NCT04815902|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111155668|NCT04815902|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111155669|NCT04815902|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111155670|NCT04815902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111155671|NCT04807140|Paclitaxel|paclitaxel|mesh-list
111155672|NCT04807140|Carboplatin|carboplatin|mesh-list
111155673|NCT04807140|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111155674|NCT04807140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111155675|NCT04807140|Tubulin Modulators|tubulin modulators|mesh-ancestor
111155676|NCT04807140|Antimitotic Agents|antimitotic agents|mesh-ancestor
111155677|NCT04807140|Mitosis Modulators|mitosis modulators|mesh-ancestor
111155678|NCT04807140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111155679|NCT04759248|Trastuzumab|trastuzumab|mesh-list
111155680|NCT04759248|Atezolizumab|atezolizumab|mesh-list
111155681|NCT04759248|Vinorelbine|vinorelbine|mesh-list
111155682|NCT04759248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111155683|NCT04759248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111155684|NCT04759248|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111155685|NCT04759248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111155686|NCT04759248|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111155687|NCT04759248|Tubulin Modulators|tubulin modulators|mesh-ancestor
111155688|NCT04759248|Antimitotic Agents|antimitotic agents|mesh-ancestor
111155689|NCT04759248|Mitosis Modulators|mitosis modulators|mesh-ancestor
111155690|NCT04756726|Dexamethasone|dexamethasone|mesh-list
111155691|NCT04756726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111155692|NCT04756726|Antiemetics|antiemetics|mesh-ancestor
111155693|NCT04756726|Autonomic Agents|autonomic agents|mesh-ancestor
111155694|NCT04756726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111155695|NCT04756726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111155696|NCT04756726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111155697|NCT04756726|Glucocorticoids|glucocorticoids|mesh-ancestor
111155698|NCT04756726|Hormones|hormones|mesh-ancestor
111155699|NCT04756726|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111155700|NCT04756726|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111155701|NCT04756726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111155702|NCT04704505|Androgens|androgens|mesh-list
111155703|NCT04704505|Hormones|hormones|mesh-ancestor
111155704|NCT04704505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111155705|NCT04704505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111155706|NCT04558918|Eculizumab|eculizumab|mesh-list
111155707|NCT04558918|Ravulizumab|ravulizumab|mesh-list
111155709|NCT04558918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111155710|NCT04558918|Immunologic Factors|immunologic factors|mesh-ancestor
111155711|NCT04558918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111155712|NCT04529278|Liraglutide|liraglutide|mesh-list
111155713|NCT04529278|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111155714|NCT04529278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111155715|NCT04529278|Incretins|incretins|mesh-ancestor
111155716|NCT04529278|Hormones|hormones|mesh-ancestor
111155717|NCT04529278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111155718|NCT04526730|Nivolumab|nivolumab|mesh-list
111155719|NCT04526730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111155720|NCT04526730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111155721|NCT04526730|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111155722|NCT04526730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111155723|NCT04503148|Propofol|propofol|mesh-list
111155724|NCT04503148|Anesthetics|anesthetics|mesh-list
111155725|NCT04503148|Anesthetics, General|anesthetics, general|mesh-list
111155726|NCT04503148|Anesthetics, Inhalation|anesthetics, inhalation|mesh-list
111155727|NCT04503148|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111155728|NCT04503148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111155729|NCT04503148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111155730|NCT04503148|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111155731|NCT04498832|Vaccines|vaccines|mesh-list
111155732|NCT04498832|Immunologic Factors|immunologic factors|mesh-ancestor
111155733|NCT04498832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111155734|NCT04493203|Nivolumab|nivolumab|mesh-list
111155735|NCT04493203|Axitinib|axitinib|mesh-list
111155736|NCT04493203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111155737|NCT04493203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111155738|NCT04493203|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111155739|NCT04493203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111155740|NCT04493203|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111155741|NCT04493203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111155742|NCT04429516|Morphine|morphine|mesh-list
111155743|NCT04429516|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111155744|NCT04429516|Narcotics|narcotics|mesh-ancestor
111155745|NCT04429516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111155746|NCT04429516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111155747|NCT04429516|Analgesics|analgesics|mesh-ancestor
111155748|NCT04429516|Sensory System Agents|sensory system agents|mesh-ancestor
111155749|NCT04429516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111155750|NCT04417452|Adrenergic Agents|adrenergic agents|mesh-list
111155751|NCT04417452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111155752|NCT04417452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111155753|NCT04417452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111155754|NCT04412096|Timolol|timolol|mesh-list
111155755|NCT04412096|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111155756|NCT04412096|Latanoprost|latanoprost|mesh-list
111155757|NCT04412096|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111155758|NCT04412096|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111155759|NCT04412096|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111155760|NCT04412096|Adrenergic Agents|adrenergic agents|mesh-ancestor
111155761|NCT04412096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111155762|NCT04412096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111155763|NCT04412096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111155764|NCT04412096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111155765|NCT04412096|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111155766|NCT04405167|Dexamethasone|dexamethasone|mesh-list
111155767|NCT04405167|Lenalidomide|lenalidomide|mesh-list
111155768|NCT04405167|Ixazomib|ixazomib|mesh-list
111155769|NCT04405167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111155770|NCT04405167|Antiemetics|antiemetics|mesh-ancestor
111155771|NCT04405167|Autonomic Agents|autonomic agents|mesh-ancestor
111155772|NCT04405167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111155773|NCT04405167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111155774|NCT04405167|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111155775|NCT04405167|Glucocorticoids|glucocorticoids|mesh-ancestor
111155776|NCT04405167|Hormones|hormones|mesh-ancestor
111155777|NCT04405167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111155778|NCT04405167|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111155779|NCT04405167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111155780|NCT04405167|Protease Inhibitors|protease inhibitors|mesh-ancestor
111155781|NCT04405167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110872883|NCT03727763|Cetuximab|cetuximab|mesh-list
111155782|NCT04405167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111155783|NCT04405167|Immunologic Factors|immunologic factors|mesh-ancestor
111155784|NCT04405167|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111155785|NCT04405167|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111155786|NCT04405167|Growth Substances|growth substances|mesh-ancestor
111155787|NCT04405167|Growth Inhibitors|growth inhibitors|mesh-ancestor
111155788|NCT04388852|Ipilimumab|ipilimumab|mesh-list
111155789|NCT04388852|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111155790|NCT04388852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111155791|NCT04388852|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111155792|NCT04388852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111155793|NCT04357951|Cycloserine|cycloserine|mesh-list
111155794|NCT04357951|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111155795|NCT04357951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111155796|NCT04357951|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111155797|NCT04357951|Antitubercular Agents|antitubercular agents|mesh-ancestor
111155798|NCT04357951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111155799|NCT04357951|Antimetabolites|antimetabolites|mesh-ancestor
111155800|NCT04357951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111155801|NCT04285229|Ixekizumab|ixekizumab|mesh-list
111155802|NCT04285229|Dermatologic Agents|dermatologic agents|mesh-ancestor
111155803|NCT04282668|Tretinoin|tretinoin|mesh-list
111155804|NCT04282668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111155805|NCT04282668|Keratolytic Agents|keratolytic agents|mesh-ancestor
111155806|NCT04282668|Dermatologic Agents|dermatologic agents|mesh-ancestor
111155807|NCT04259060|Hydroxocobalamin|hydroxocobalamin|mesh-list
111155808|NCT04259060|Vitamin B 12|vitamin b 12|mesh-list
111155809|NCT04259060|Hematinics|hematinics|mesh-ancestor
111155810|NCT04259060|Vitamin B Complex|vitamin b complex|mesh-ancestor
111155811|NCT04259060|Vitamins|vitamins|mesh-ancestor
111155812|NCT04259060|Micronutrients|micronutrients|mesh-ancestor
111155813|NCT04259060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111155814|NCT04219904|Deoxyglucose|deoxyglucose|mesh-list
111155815|NCT04219904|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
111155816|NCT04219904|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111155817|NCT04219904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111155818|NCT04219904|Antimetabolites|antimetabolites|mesh-ancestor
111155819|NCT04219904|Antiviral Agents|antiviral agents|mesh-ancestor
111155820|NCT04219904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111155821|NCT04218240|Lofexidine|lofexidine|mesh-list
111155822|NCT04218240|Pregabalin|pregabalin|mesh-list
111155823|NCT04218240|Analgesics|analgesics|mesh-ancestor
111155824|NCT04218240|Sensory System Agents|sensory system agents|mesh-ancestor
111155825|NCT04218240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111155826|NCT04218240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111155827|NCT04218240|Anticonvulsants|anticonvulsants|mesh-ancestor
111155828|NCT04218240|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111155829|NCT04218240|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111155830|NCT04218240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111155831|NCT04218240|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111155832|NCT04218240|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111155833|NCT04218240|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111155834|NCT04218240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111155835|NCT04218240|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111155836|NCT04218240|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111155837|NCT04218240|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111155838|NCT04218240|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111155839|NCT04218240|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111155840|NCT04218240|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111155841|NCT04218240|Adrenergic Agents|adrenergic agents|mesh-ancestor
111155842|NCT04218240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111155843|NCT04212793|Bevacizumab|bevacizumab|mesh-list
111155844|NCT04212793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111155845|NCT04212793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111155846|NCT04212793|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111155847|NCT04212793|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111155848|NCT04212793|Growth Substances|growth substances|mesh-ancestor
111155849|NCT04212793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111155850|NCT04212793|Growth Inhibitors|growth inhibitors|mesh-ancestor
111155851|NCT04084951|Nivolumab|nivolumab|mesh-list
111155852|NCT04084951|Ipilimumab|ipilimumab|mesh-list
111155853|NCT04084951|Atezolizumab|atezolizumab|mesh-list
111155854|NCT04084951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111155855|NCT04084951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111155856|NCT04084951|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111155857|NCT04084951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111155858|NCT04083898|Prednisone|prednisone|mesh-list
111155859|NCT04083898|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
111155860|NCT04083898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111155861|NCT04083898|Glucocorticoids|glucocorticoids|mesh-ancestor
111155862|NCT04083898|Hormones|hormones|mesh-ancestor
111155863|NCT04083898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111155864|NCT04083898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111155865|NCT04083898|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111155866|NCT04083898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111155867|NCT04083898|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111155868|NCT04083898|Alkylating Agents|alkylating agents|mesh-ancestor
111155869|NCT04083898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111155870|NCT04035837|Interferons|interferons|mesh-list
111155871|NCT04035837|Interferon-alpha|interferon-alpha|mesh-list
111155872|NCT04035837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111155873|NCT04035837|Antiviral Agents|antiviral agents|mesh-ancestor
111155874|NCT04035837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111155875|NCT04035837|Immunologic Factors|immunologic factors|mesh-ancestor
111155876|NCT04035837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111155877|NCT04022135|Folic Acid|folic acid|mesh-list
111155878|NCT04022135|Hematinics|hematinics|mesh-ancestor
111155879|NCT04022135|Vitamin B Complex|vitamin b complex|mesh-ancestor
111155880|NCT04022135|Vitamins|vitamins|mesh-ancestor
111155881|NCT04022135|Micronutrients|micronutrients|mesh-ancestor
111155882|NCT04022135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111155883|NCT04001777|Osimertinib|osimertinib|mesh-list
111155884|NCT04001777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111155885|NCT04001777|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111155886|NCT04001777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111155887|NCT04001777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111155888|NCT03987802|Insulin Aspart|insulin aspart|mesh-list
111155889|NCT03987802|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111155890|NCT03987802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111155891|NCT03983668|Pembrolizumab|pembrolizumab|mesh-list
111155892|NCT03983668|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111155893|NCT03983668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111155894|NCT03983668|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111155895|NCT03983668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111155896|NCT03977012|Buprenorphine|buprenorphine|mesh-list
111155897|NCT03977012|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111155898|NCT03977012|Narcotics|narcotics|mesh-ancestor
110484560|NCT00577993|Rituximab|rituximab|mesh-list
111155899|NCT03977012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111155900|NCT03977012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111155901|NCT03977012|Analgesics|analgesics|mesh-ancestor
111155902|NCT03977012|Sensory System Agents|sensory system agents|mesh-ancestor
111155903|NCT03977012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111155904|NCT03977012|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111155905|NCT03915964|Adalimumab|adalimumab|mesh-list
111155906|NCT03915964|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
111155907|NCT03915964|Etanercept|etanercept|mesh-list
111155908|NCT03915964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111155909|NCT03915964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111155910|NCT03915964|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111155911|NCT03915964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111155912|NCT03915964|Analgesics|analgesics|mesh-ancestor
111155913|NCT03915964|Sensory System Agents|sensory system agents|mesh-ancestor
111155914|NCT03915964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111155915|NCT03915964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111155916|NCT03915964|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111155917|NCT03915964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111155918|NCT03915964|Immunologic Factors|immunologic factors|mesh-ancestor
111155919|NCT03907423|Metformin|metformin|mesh-list
111155920|NCT03907423|Glimepiride|glimepiride|mesh-list
111155921|NCT03907423|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111155922|NCT03907423|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111155923|NCT03907423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111155924|NCT03907423|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111155925|NCT03907423|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111155926|NCT03907423|Antimetabolites|antimetabolites|mesh-ancestor
111155927|NCT03907423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111155928|NCT03907423|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111155929|NCT03907423|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111155930|NCT03907423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111155931|NCT03907423|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111155932|NCT03907423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111155933|NCT03907423|Immunologic Factors|immunologic factors|mesh-ancestor
110840946|NCT04401384|Vitamins|vitamins|mesh-ancestor
111155935|NCT03897621|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111155936|NCT03897621|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111155937|NCT03897621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111155938|NCT03897621|Hemostatics|hemostatics|mesh-ancestor
111155939|NCT03897621|Coagulants|coagulants|mesh-ancestor
111155940|NCT03809884|Potassium Citrate|potassium citrate|mesh-list
111155941|NCT03809884|Diuretics|diuretics|mesh-ancestor
111155942|NCT03809884|Natriuretic Agents|natriuretic agents|mesh-ancestor
111155943|NCT03809884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111155944|NCT03809884|Expectorants|expectorants|mesh-ancestor
111155945|NCT03809884|Respiratory System Agents|respiratory system agents|mesh-ancestor
111155946|NCT03805594|Pembrolizumab|pembrolizumab|mesh-list
111155947|NCT03805594|177Lu-PSMA-617|177lu-psma-617|mesh-list
111155948|NCT03805594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111155949|NCT03805594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111155950|NCT03805594|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111155951|NCT03805594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111155952|NCT03805594|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111155953|NCT03768427|Atorvastatin|atorvastatin|mesh-list
111155954|NCT03768427|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111155955|NCT03768427|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111155956|NCT03768427|Antimetabolites|antimetabolites|mesh-ancestor
111155957|NCT03768427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111155958|NCT03768427|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111155959|NCT03768427|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111155960|NCT03768427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111155961|NCT03758781|Nivolumab|nivolumab|mesh-list
111155962|NCT03758781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111155963|NCT03758781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111155964|NCT03758781|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111155965|NCT03758781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111155966|NCT03746080|Plerixafor|plerixafor|mesh-list
111155967|NCT03746080|Temozolomide|temozolomide|mesh-list
111155968|NCT03746080|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111155969|NCT03746080|Alkylating Agents|alkylating agents|mesh-ancestor
111155970|NCT03746080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111155971|NCT03746080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111155972|NCT03746080|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111155973|NCT03746080|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111155974|NCT03746080|Antiviral Agents|antiviral agents|mesh-ancestor
111155975|NCT03746080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111155976|NCT03737994|Cisplatin|cisplatin|mesh-list
111155977|NCT03737994|Carboplatin|carboplatin|mesh-list
111155978|NCT03737994|Pemetrexed|pemetrexed|mesh-list
111155979|NCT03737994|Crizotinib|crizotinib|mesh-list
111155980|NCT03737994|Ceritinib|ceritinib|mesh-list
111155981|NCT03737994|Ensartinib|ensartinib|mesh-list
111155982|NCT03737994|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
111155983|NCT03737994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111155984|NCT03737994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111155985|NCT03737994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111155986|NCT03737994|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111155987|NCT03737994|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111155988|NCT03737994|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111155989|NCT03724149|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
111155990|NCT03724149|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
111155991|NCT03724149|Antiviral Agents|antiviral agents|mesh-ancestor
111155992|NCT03724149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111155993|NCT03572933|Pregnanolone|pregnanolone|mesh-list
111155994|NCT03572933|Ganaxolone|ganaxolone|mesh-list
111155995|NCT03572933|Neurosteroids|neurosteroids|mesh-ancestor
111155996|NCT03572933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111155997|NCT03572933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111155998|NCT03572933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111155999|NCT03572933|GABA Modulators|gaba modulators|mesh-ancestor
111156000|NCT03572933|GABA Agents|gaba agents|mesh-ancestor
111156001|NCT03572933|Anesthetics|anesthetics|mesh-ancestor
111156002|NCT03572933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111156003|NCT03558152|Vedolizumab|vedolizumab|mesh-list
111156004|NCT03558152|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111156005|NCT03477175|Sorafenib|sorafenib|mesh-list
111156006|NCT03477175|Lenvatinib|lenvatinib|mesh-list
111156007|NCT03477175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111156008|NCT03477175|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111156009|NCT03477175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111156010|NCT03477175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111156011|NCT03461406|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
111156012|NCT03461406|Hemostatics|hemostatics|mesh-ancestor
111156013|NCT03461406|Coagulants|coagulants|mesh-ancestor
111156014|NCT03431974|Aminopterin|aminopterin|mesh-list
111156015|NCT03431974|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111156016|NCT03431974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111156017|NCT03431974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111156018|NCT03416335|Pembrolizumab|pembrolizumab|mesh-list
111156019|NCT03416335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111156020|NCT03416335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111156021|NCT03416335|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111156022|NCT03416335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111156023|NCT03311308|Metformin|metformin|mesh-list
111156024|NCT03311308|Pembrolizumab|pembrolizumab|mesh-list
111156025|NCT03311308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111156026|NCT03311308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111156027|NCT03311308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111156028|NCT03311308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111156029|NCT03311308|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111156030|NCT03311308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111156031|NCT03279393|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
111156032|NCT03279393|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111156033|NCT03279393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111156034|NCT03179449|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
111156035|NCT03179449|Hematinics|hematinics|mesh-ancestor
111156036|NCT03179449|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
111156037|NCT03179449|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111156038|NCT02915744|Paclitaxel|paclitaxel|mesh-list
111156039|NCT02915744|Vinorelbine|vinorelbine|mesh-list
111156040|NCT02915744|Docetaxel|docetaxel|mesh-list
111156041|NCT02915744|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111156042|NCT02915744|Gemcitabine|gemcitabine|mesh-list
111156043|NCT02915744|Etirinotecan pegol|etirinotecan pegol|mesh-list
111156044|NCT02915744|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111156045|NCT02915744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111156046|NCT02915744|Tubulin Modulators|tubulin modulators|mesh-ancestor
111156047|NCT02915744|Antimitotic Agents|antimitotic agents|mesh-ancestor
110484631|NCT02866370|Paclitaxel|paclitaxel|mesh-list
111156048|NCT02915744|Mitosis Modulators|mitosis modulators|mesh-ancestor
111156049|NCT02915744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111156050|NCT02915744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111156051|NCT02915744|Antimetabolites|antimetabolites|mesh-ancestor
111156052|NCT02915744|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111156053|NCT02915744|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111156054|NCT02915744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111156056|NCT02782949|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111156057|NCT02782949|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111156058|NCT02782949|Analgesics|analgesics|mesh-ancestor
111156059|NCT02782949|Sensory System Agents|sensory system agents|mesh-ancestor
111156060|NCT02782949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111156061|NCT02782949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111156062|NCT02782949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111156063|NCT02782949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111156064|NCT02782949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111156065|NCT02782949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111156066|NCT02782949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111156067|NCT02736656|Viloxazine|viloxazine|mesh-list
111156068|NCT02736656|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111156069|NCT02736656|Antidepressive Agents|antidepressive agents|mesh-ancestor
111156070|NCT02736656|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111156071|NCT02736656|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111156072|NCT02736656|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111156073|NCT02736656|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111156074|NCT02736656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111156075|NCT02736656|Adrenergic Agents|adrenergic agents|mesh-ancestor
111156076|NCT02736656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111156077|NCT02736656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111156078|NCT02506933|Vaccines|vaccines|mesh-list
111156079|NCT02506933|Immunologic Factors|immunologic factors|mesh-ancestor
111156080|NCT02506933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111156081|NCT02491632|Dexamethasone|dexamethasone|mesh-list
111156082|NCT02491632|Dexamethasone acetate|dexamethasone acetate|mesh-list
110676997|NCT03230734|Mitosis Modulators|mitosis modulators|mesh-ancestor
111156083|NCT02491632|Ichthammol|ichthammol|mesh-list
111156084|NCT02491632|BB 1101|bb 1101|mesh-list
111156085|NCT02491632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111156086|NCT02491632|Antiemetics|antiemetics|mesh-ancestor
111156087|NCT02491632|Autonomic Agents|autonomic agents|mesh-ancestor
111156088|NCT02491632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111156089|NCT02491632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111156090|NCT02491632|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111156091|NCT02491632|Glucocorticoids|glucocorticoids|mesh-ancestor
111156092|NCT02491632|Hormones|hormones|mesh-ancestor
111156093|NCT02491632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111156094|NCT02491632|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111156095|NCT02491632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111156096|NCT02491632|Protease Inhibitors|protease inhibitors|mesh-ancestor
111156097|NCT02491632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110484648|NCT02866370|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111156098|NCT02491632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111156099|NCT02491632|Dermatologic Agents|dermatologic agents|mesh-ancestor
111156100|NCT02409810|Dexmedetomidine|dexmedetomidine|mesh-list
111156101|NCT02409810|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111156102|NCT02409810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111156103|NCT02409810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111156104|NCT02409810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111156105|NCT02409810|Analgesics|analgesics|mesh-ancestor
111156106|NCT02409810|Sensory System Agents|sensory system agents|mesh-ancestor
111156107|NCT02409810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111156108|NCT02409810|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111156109|NCT02409810|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111156110|NCT02409810|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111156111|NCT02409810|Adrenergic Agents|adrenergic agents|mesh-ancestor
111156112|NCT02409810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111156113|NCT02409810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111156114|NCT02324608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111156115|NCT02324608|Cetuximab|cetuximab|mesh-list
111156116|NCT02324608|Antibodies|antibodies|mesh-list
111156117|NCT02324608|Immunoglobulins|immunoglobulins|mesh-list
111156118|NCT02324608|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111156119|NCT02324608|Immunologic Factors|immunologic factors|mesh-ancestor
111156120|NCT02324608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111156121|NCT02324608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111156122|NCT02206815|Aspirin|aspirin|mesh-list
111156123|NCT02206815|Warfarin|warfarin|mesh-list
111156124|NCT02206815|Clopidogrel|clopidogrel|mesh-list
111156125|NCT02206815|Ticagrelor|ticagrelor|mesh-list
111156126|NCT02206815|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111156127|NCT02206815|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111156128|NCT02206815|Analgesics|analgesics|mesh-ancestor
111156129|NCT02206815|Sensory System Agents|sensory system agents|mesh-ancestor
111156130|NCT02206815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111156131|NCT02206815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111156132|NCT02206815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111156133|NCT02206815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111156134|NCT02206815|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111156135|NCT02206815|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111156136|NCT02206815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111156137|NCT02206815|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111156138|NCT02206815|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111156139|NCT02206815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111156140|NCT02206815|Antipyretics|antipyretics|mesh-ancestor
111156141|NCT02206815|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111156142|NCT02206815|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111156143|NCT02206815|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111156144|NCT02206815|Purinergic Agents|purinergic agents|mesh-ancestor
111156145|NCT02206815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111156146|NCT02206815|Anticoagulants|anticoagulants|mesh-ancestor
111156147|NCT02175680|Leronlimab|leronlimab|mesh-list
111156148|NCT02175680|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
111156149|NCT02175680|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
111156150|NCT02175680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111156151|NCT02175680|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111156152|NCT02175680|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111156153|NCT02175680|Antiviral Agents|antiviral agents|mesh-ancestor
111156154|NCT02175680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111156155|NCT01983462|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
111156156|NCT01983462|Clonidine|clonidine|mesh-list
111156157|NCT01983462|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111156158|NCT01983462|Diuretics|diuretics|mesh-ancestor
111156159|NCT01983462|Natriuretic Agents|natriuretic agents|mesh-ancestor
111156160|NCT01983462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111156161|NCT01983462|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
111156162|NCT01983462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111156163|NCT01983462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111156164|NCT01983462|Analgesics|analgesics|mesh-ancestor
111156165|NCT01983462|Sensory System Agents|sensory system agents|mesh-ancestor
111156166|NCT01983462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111156167|NCT01983462|Sympatholytics|sympatholytics|mesh-ancestor
111156168|NCT01983462|Autonomic Agents|autonomic agents|mesh-ancestor
111156169|NCT01983462|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111156170|NCT01983462|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111156171|NCT01983462|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111156172|NCT01983462|Adrenergic Agents|adrenergic agents|mesh-ancestor
111156173|NCT01983462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111156174|NCT01779375|Metformin|metformin|mesh-list
111156175|NCT01779375|Insulin Glargine|insulin glargine|mesh-list
111156176|NCT01779375|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111156177|NCT01779375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111156178|NCT01559935|Clarithromycin|clarithromycin|mesh-list
111156179|NCT01559935|Dexamethasone|dexamethasone|mesh-list
111156180|NCT01559935|Dexamethasone acetate|dexamethasone acetate|mesh-list
111156181|NCT01559935|Lenalidomide|lenalidomide|mesh-list
111156182|NCT01559935|BB 1101|bb 1101|mesh-list
111156183|NCT01559935|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111156184|NCT01559935|Antiemetics|antiemetics|mesh-ancestor
111156185|NCT01559935|Autonomic Agents|autonomic agents|mesh-ancestor
111156186|NCT01559935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111156187|NCT01559935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111156188|NCT01559935|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111156189|NCT01559935|Glucocorticoids|glucocorticoids|mesh-ancestor
111156190|NCT01559935|Hormones|hormones|mesh-ancestor
111156191|NCT01559935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111156192|NCT01559935|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111156193|NCT01559935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111156194|NCT01559935|Protease Inhibitors|protease inhibitors|mesh-ancestor
111156195|NCT01559935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111156196|NCT01559935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111156197|NCT01559935|Immunologic Factors|immunologic factors|mesh-ancestor
111156198|NCT01559935|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111156199|NCT01559935|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111156200|NCT01559935|Growth Substances|growth substances|mesh-ancestor
111156201|NCT01559935|Growth Inhibitors|growth inhibitors|mesh-ancestor
111156202|NCT01559935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111156203|NCT01559935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111156204|NCT01559935|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111156205|NCT01559935|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111156206|NCT01559935|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111156207|NCT00981058|Gemcitabine|gemcitabine|mesh-list
111156208|NCT00981058|Necitumumab|necitumumab|mesh-list
111156209|NCT00981058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111156210|NCT00981058|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111156211|NCT00981058|Antimetabolites|antimetabolites|mesh-ancestor
111156212|NCT00981058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111156213|NCT00981058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111156214|NCT00667069|Triptorelin Pamoate|triptorelin pamoate|mesh-list
111156215|NCT00667069|Luteolytic Agents|luteolytic agents|mesh-ancestor
111156216|NCT00667069|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111156217|NCT00667069|Contraceptive Agents|contraceptive agents|mesh-ancestor
111156218|NCT00667069|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111156219|NCT00667069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111156220|NCT00667069|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111156221|NCT00667069|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111156222|NCT00667069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111156223|NCT00565851|Paclitaxel|paclitaxel|mesh-list
111156224|NCT00565851|Docetaxel|docetaxel|mesh-list
111156225|NCT00565851|Bevacizumab|bevacizumab|mesh-list
111156226|NCT00565851|Carboplatin|carboplatin|mesh-list
111156227|NCT00565851|Gemcitabine|gemcitabine|mesh-list
111156228|NCT00565851|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111156229|NCT00565851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111156230|NCT00565851|Endothelial Growth Factors|endothelial growth factors|mesh-list
111156231|NCT00565851|Antibodies|antibodies|mesh-list
111156232|NCT00565851|Immunoglobulins|immunoglobulins|mesh-list
111156233|NCT00565851|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110873319|NCT02386462|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111156234|NCT00565851|Immunoglobulin G|immunoglobulin g|mesh-list
111156235|NCT00565851|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111156236|NCT00565851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111156237|NCT00565851|Tubulin Modulators|tubulin modulators|mesh-ancestor
111156238|NCT00565851|Antimitotic Agents|antimitotic agents|mesh-ancestor
111156239|NCT00565851|Mitosis Modulators|mitosis modulators|mesh-ancestor
111156240|NCT00565851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111156241|NCT00565851|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111156242|NCT00565851|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111156243|NCT00565851|Growth Substances|growth substances|mesh-ancestor
111156244|NCT00565851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111156245|NCT00565851|Growth Inhibitors|growth inhibitors|mesh-ancestor
111156246|NCT00565851|Immunologic Factors|immunologic factors|mesh-ancestor
111156247|NCT00565851|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111156248|NCT00565851|Antimetabolites|antimetabolites|mesh-ancestor
111156249|NCT00238563|Triamcinolone|triamcinolone|mesh-list
111156250|NCT00238563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111156251|NCT00238563|Glucocorticoids|glucocorticoids|mesh-ancestor
111156252|NCT00238563|Hormones|hormones|mesh-ancestor
111156253|NCT00238563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111156254|NCT00238563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111156255|NCT04499677|Ritonavir|ritonavir|mesh-list
111156256|NCT04499677|Lopinavir|lopinavir|mesh-list
111156257|NCT04499677|Favipiravir|favipiravir|mesh-list
111156258|NCT04499677|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111156259|NCT04499677|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111156260|NCT04499677|Protease Inhibitors|protease inhibitors|mesh-ancestor
111156261|NCT04499677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110586279|NCT02589444|Vitamin D|vitamin d|mesh-list
111156262|NCT04499677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111156263|NCT04499677|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111156264|NCT04499677|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111156265|NCT04499677|Antiviral Agents|antiviral agents|mesh-ancestor
111156266|NCT04499677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111156267|NCT04499677|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111156268|NCT04499677|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111156269|NCT05652751|Mitogens|mitogens|mesh-list
111156270|NCT05652751|Mitosis Modulators|mitosis modulators|mesh-ancestor
111156271|NCT05652751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111156272|NCT02909335|Mycophenolic Acid|mycophenolic acid|mesh-list
111156273|NCT02909335|Prednisone|prednisone|mesh-list
111156274|NCT02909335|Methylprednisolone|methylprednisolone|mesh-list
111156275|NCT02909335|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111156276|NCT02909335|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111156277|NCT02909335|Prednisolone|prednisolone|mesh-list
111156278|NCT02909335|Prednisolone acetate|prednisolone acetate|mesh-list
111156279|NCT02909335|Everolimus|everolimus|mesh-list
111156280|NCT02909335|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111156281|NCT02909335|Prednisolone phosphate|prednisolone phosphate|mesh-list
111156282|NCT02909335|Tacrolimus|tacrolimus|mesh-list
111156283|NCT02909335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111156284|NCT02909335|Glucocorticoids|glucocorticoids|mesh-ancestor
111156285|NCT02909335|Hormones|hormones|mesh-ancestor
111156286|NCT02909335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111156287|NCT02909335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111156288|NCT02909335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111156289|NCT02909335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111156290|NCT02909335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111156291|NCT02909335|Immunologic Factors|immunologic factors|mesh-ancestor
111156292|NCT02909335|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111156293|NCT02909335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111156294|NCT02909335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110484750|NCT00640575|Hormones|hormones|mesh-ancestor
111156295|NCT02909335|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111156296|NCT02909335|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111156297|NCT02909335|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111156298|NCT02909335|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111156299|NCT02909335|Antitubercular Agents|antitubercular agents|mesh-ancestor
111156300|NCT02909335|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111156301|NCT02909335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111156302|NCT02909335|Antiemetics|antiemetics|mesh-ancestor
111156303|NCT02909335|Autonomic Agents|autonomic agents|mesh-ancestor
111156304|NCT02909335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111156305|NCT02909335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111156306|NCT02909335|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111156307|NCT02909335|Protective Agents|protective agents|mesh-ancestor
111156308|NCT04417699|Oxaliplatin|oxaliplatin|mesh-list
111156309|NCT04417699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111156310|NCT05652517|Ethanol|ethanol|mesh-list
111156311|NCT05652517|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111156312|NCT05652517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111156313|NCT05652517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111156314|NCT05652517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111156315|NCT04806373|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
111156316|NCT04806373|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111156317|NCT04806373|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111156318|NCT04806373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111156319|NCT03998293|Somatostatin|somatostatin|mesh-list
111156320|NCT03998293|Hormones|hormones|mesh-ancestor
111156321|NCT03998293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111156322|NCT03998293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111156323|NCT01606306|Fluticasone|fluticasone|mesh-list
111156324|NCT01606306|Xhance|xhance|mesh-list
111156325|NCT01606306|Montelukast|montelukast|mesh-list
111156326|NCT01606306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111156327|NCT01606306|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111156328|NCT01606306|Autonomic Agents|autonomic agents|mesh-ancestor
111156329|NCT01606306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111156330|NCT01606306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111156331|NCT01606306|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111156332|NCT01606306|Respiratory System Agents|respiratory system agents|mesh-ancestor
111156333|NCT01606306|Dermatologic Agents|dermatologic agents|mesh-ancestor
111156334|NCT01606306|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111156335|NCT01606306|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
111156336|NCT01606306|Hormone Antagonists|hormone antagonists|mesh-ancestor
111156337|NCT01606306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111156338|NCT01606306|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
111156339|NCT01606306|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111156340|NCT01606306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111156341|NCT01753570|Interferon-beta|interferon-beta|mesh-list
111156342|NCT01753570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111156343|NCT01753570|Antiviral Agents|antiviral agents|mesh-ancestor
111156344|NCT01753570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111156345|NCT01753570|Immunologic Factors|immunologic factors|mesh-ancestor
111156346|NCT01753570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111156347|NCT01753336|Botulinum Toxins|botulinum toxins|mesh-list
111156348|NCT01753336|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111156349|NCT01753336|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111156350|NCT01753336|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111156351|NCT01753336|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111156352|NCT01753336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111156353|NCT01753336|Cholinergic Agents|cholinergic agents|mesh-ancestor
111156354|NCT01753336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111156355|NCT01753336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111156356|NCT01753336|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111156357|NCT01753336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111156358|NCT01777282|Biguanides|biguanides|mesh-list
111156359|NCT01777282|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
111156360|NCT01777282|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
111156361|NCT01777282|rGLP-1 protein|rglp-1 protein|mesh-list
111156362|NCT01777282|Incretins|incretins|mesh-ancestor
111156363|NCT01777282|Hormones|hormones|mesh-ancestor
111156364|NCT01777282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111156365|NCT01777282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111156366|NCT01777282|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111156367|NCT01777282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111156368|NCT01777282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111156369|NCT04571632|Pembrolizumab|pembrolizumab|mesh-list
111156370|NCT04571632|Ipilimumab|ipilimumab|mesh-list
111156371|NCT04571632|Avelumab|avelumab|mesh-list
111156372|NCT04571632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111156373|NCT04571632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111156374|NCT04571632|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111156375|NCT04571632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111156376|NCT01975389|Bococizumab|bococizumab|mesh-list
111156377|NCT01975389|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111156378|NCT01975389|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111156379|NCT01975389|Antimetabolites|antimetabolites|mesh-ancestor
111156380|NCT01975389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111156381|NCT01975389|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111156382|NCT01974141|Dapsone|dapsone|mesh-list
110873467|NCT04694248|Aspirin|aspirin|mesh-list
111156383|NCT01974141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111156384|NCT01974141|Antimalarials|antimalarials|mesh-ancestor
111156385|NCT01974141|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111156386|NCT01974141|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111156387|NCT01974141|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111156388|NCT01974141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111156389|NCT01974141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111156390|NCT01974141|Leprostatic Agents|leprostatic agents|mesh-ancestor
111156391|NCT01974141|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111156392|NCT01945593|Factor VIII|factor viii|mesh-list
111156393|NCT01945593|BAX 855|bax 855|mesh-list
111156394|NCT01945593|Coagulants|coagulants|mesh-ancestor
111156395|NCT01945281|Amphotericin B|amphotericin b|mesh-list
111156396|NCT01945281|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
111156397|NCT01945281|Caspofungin|caspofungin|mesh-list
111156398|NCT01945281|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
111156399|NCT01945281|Deoxycholic Acid|deoxycholic acid|mesh-list
111156400|NCT01945281|Amebicides|amebicides|mesh-ancestor
111156401|NCT01945281|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110841014|NCT05213312|Paclitaxel|paclitaxel|mesh-list
111156402|NCT01945281|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110484808|NCT04184115|Mydriatics|mydriatics|mesh-ancestor
111156403|NCT01945281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111156404|NCT01945281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111156405|NCT01945281|Antifungal Agents|antifungal agents|mesh-ancestor
111156406|NCT01945281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111156407|NCT01945281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111156408|NCT01945281|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
111156409|NCT01945281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111156410|NCT01961349|Propofol|propofol|mesh-list
111156411|NCT01961349|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
111156412|NCT01961349|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111156413|NCT01961349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111156414|NCT01961349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111156415|NCT01961349|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111156416|NCT01961349|Anesthetics, General|anesthetics, general|mesh-ancestor
111156417|NCT01961349|Anesthetics|anesthetics|mesh-ancestor
111156418|NCT01961349|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
111156419|NCT01961349|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
111156420|NCT01961349|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111156421|NCT01944969|Brexpiprazole|brexpiprazole|mesh-list
111156422|NCT01944969|Serotonin Agents|serotonin agents|mesh-ancestor
111156423|NCT01944969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111156424|NCT01944969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111156425|NCT01944969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111156426|NCT01944969|Dopamine Agonists|dopamine agonists|mesh-ancestor
111156427|NCT01944969|Dopamine Agents|dopamine agents|mesh-ancestor
111156428|NCT04661397|Tenofovir|tenofovir|mesh-list
111156429|NCT04661397|Emtricitabine|emtricitabine|mesh-list
111156430|NCT04661397|Darunavir|darunavir|mesh-list
111156431|NCT04661397|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
111156432|NCT04661397|Cobicistat|cobicistat|mesh-list
111156433|NCT04661397|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
111156434|NCT04661397|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
111156435|NCT04661397|Antiviral Agents|antiviral agents|mesh-ancestor
111156436|NCT04661397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111156437|NCT04661397|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111156438|NCT04661397|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111156439|NCT04661397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111156440|NCT04661397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111156441|NCT04661397|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111156442|NCT04661397|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111156443|NCT04661397|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111156444|NCT04661397|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111156445|NCT04661397|Protease Inhibitors|protease inhibitors|mesh-ancestor
111156446|NCT04661397|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111156447|NCT04661397|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111156448|NCT01973439|Abacavir|abacavir|mesh-list
111156449|NCT01973439|Dideoxynucleosides|dideoxynucleosides|mesh-list
111156450|NCT01973439|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111156451|NCT01973439|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111156452|NCT01973439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111156453|NCT01973439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111156454|NCT01973439|Antiviral Agents|antiviral agents|mesh-ancestor
111156455|NCT01973439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111156456|NCT01973439|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111156457|NCT01973439|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111156458|NCT01973439|Antimetabolites|antimetabolites|mesh-ancestor
111156459|NCT01973283|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
111156460|NCT01973283|Antidepressive Agents|antidepressive agents|mesh-list
111156461|NCT01973283|Escitalopram|escitalopram|mesh-list
111156462|NCT01973283|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111156463|NCT01973283|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111156464|NCT01973283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111156465|NCT01973283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111156466|NCT01973283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111156467|NCT01973283|Serotonin Agents|serotonin agents|mesh-ancestor
111156468|NCT01973283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111156469|NCT01973283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111156470|NCT01973283|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111156471|NCT01973283|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111156472|NCT01973283|Analgesics|analgesics|mesh-ancestor
111156473|NCT01973283|Sensory System Agents|sensory system agents|mesh-ancestor
111156474|NCT01973283|Dopamine Agents|dopamine agents|mesh-ancestor
111156475|NCT01972659|Magnesium Sulfate|magnesium sulfate|mesh-list
111156476|NCT01972659|Analgesics|analgesics|mesh-ancestor
111156477|NCT01972659|Sensory System Agents|sensory system agents|mesh-ancestor
111156478|NCT01972659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111156479|NCT01972659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111156480|NCT01972659|Anesthetics|anesthetics|mesh-ancestor
111156481|NCT01972659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111156482|NCT01972659|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111156483|NCT01972659|Anticonvulsants|anticonvulsants|mesh-ancestor
111156484|NCT01972659|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111156485|NCT01972659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111156486|NCT01972659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111156487|NCT01972659|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111156488|NCT01972659|Tocolytic Agents|tocolytic agents|mesh-ancestor
111156489|NCT01972659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111156490|NCT01942785|Brexpiprazole|brexpiprazole|mesh-list
111156491|NCT01942785|Serotonin Agents|serotonin agents|mesh-ancestor
111156492|NCT01942785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111156493|NCT01942785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111156494|NCT01942785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111156495|NCT01942785|Dopamine Agonists|dopamine agonists|mesh-ancestor
111156496|NCT01942785|Dopamine Agents|dopamine agents|mesh-ancestor
111156497|NCT01774786|Fluorouracil|fluorouracil|mesh-list
111156498|NCT01774786|Capecitabine|capecitabine|mesh-list
111156499|NCT01774786|Trastuzumab|trastuzumab|mesh-list
111156501|NCT01774786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111156502|NCT01774786|Antimetabolites|antimetabolites|mesh-ancestor
111156503|NCT01774786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111156504|NCT01774786|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111156505|NCT01774786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111156506|NCT01774786|Immunologic Factors|immunologic factors|mesh-ancestor
111156507|NCT01774786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111156508|NCT01774786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111156509|NCT01942161|Aripiprazole|aripiprazole|mesh-list
111156510|NCT01942161|Antidepressive Agents|antidepressive agents|mesh-ancestor
111156511|NCT01942161|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111156512|NCT01942161|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111156513|NCT01942161|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111156514|NCT01942161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111156515|NCT01942161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111156516|NCT01942161|Dopamine Agonists|dopamine agonists|mesh-ancestor
111156517|NCT01942161|Dopamine Agents|dopamine agents|mesh-ancestor
111156518|NCT01942161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111156519|NCT01942161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111156520|NCT01942161|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111156521|NCT01942161|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111156522|NCT01942161|Serotonin Agents|serotonin agents|mesh-ancestor
111156523|NCT01942161|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111156524|NCT01942161|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111156525|NCT01942161|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111156526|NCT01942161|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111156527|NCT01971645|Dexamethasone|dexamethasone|mesh-list
111156528|NCT01971645|Ropivacaine|ropivacaine|mesh-list
111156529|NCT01971645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111156530|NCT01971645|Antiemetics|antiemetics|mesh-ancestor
111156531|NCT01971645|Autonomic Agents|autonomic agents|mesh-ancestor
111156532|NCT01971645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111156533|NCT01971645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111156534|NCT01971645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111156535|NCT01971645|Glucocorticoids|glucocorticoids|mesh-ancestor
111156536|NCT01971645|Hormones|hormones|mesh-ancestor
111156537|NCT01971645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111156538|NCT01971645|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111156539|NCT01971645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111156540|NCT01971645|Anesthetics, Local|anesthetics, local|mesh-ancestor
111156541|NCT01971645|Anesthetics|anesthetics|mesh-ancestor
111156542|NCT01971645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111156543|NCT01971645|Sensory System Agents|sensory system agents|mesh-ancestor
111156544|NCT01941537|Fezakinumab|fezakinumab|mesh-list
111156545|NCT01941537|Dermatologic Agents|dermatologic agents|mesh-ancestor
111156546|NCT01960413|Hydroxyurea|hydroxyurea|mesh-list
111156547|NCT01960413|Montelukast|montelukast|mesh-list
111156548|NCT01960413|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111156549|NCT01960413|Respiratory System Agents|respiratory system agents|mesh-ancestor
111156550|NCT01960413|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
111156551|NCT01960413|Hormone Antagonists|hormone antagonists|mesh-ancestor
111156552|NCT01960413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111156553|NCT01960413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111156554|NCT01960413|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
111156555|NCT01960413|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111156556|NCT01960413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111156557|NCT01960413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111156558|NCT01960413|Antisickling Agents|antisickling agents|mesh-ancestor
111156559|NCT01960413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111156560|NCT01960413|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111156561|NCT01970475|Adalimumab|adalimumab|mesh-list
111156562|NCT01970475|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111156563|NCT01970475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111156564|NCT01970475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111156565|NCT01939977|Calcifediol|calcifediol|mesh-list
111156566|NCT01939977|Vitamins|vitamins|mesh-ancestor
111156567|NCT01939977|Micronutrients|micronutrients|mesh-ancestor
111156568|NCT01939977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111156569|NCT01939977|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111156570|NCT01939899|Ixazomib|ixazomib|mesh-list
111156571|NCT01939899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111156572|NCT01939899|Protease Inhibitors|protease inhibitors|mesh-ancestor
111156573|NCT01939899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111156574|NCT01939899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111156575|NCT01970397|Hyaluronic Acid|hyaluronic acid|mesh-list
111156576|NCT01970397|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111156577|NCT01970397|Immunologic Factors|immunologic factors|mesh-ancestor
111156578|NCT01970397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111156579|NCT01970397|Viscosupplements|viscosupplements|mesh-ancestor
111156580|NCT01970397|Protective Agents|protective agents|mesh-ancestor
111156581|NCT01970241|Insulin|insulin|mesh-list
111156582|NCT01970241|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111156583|NCT01970241|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111156584|NCT01970241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111156585|NCT01728376|Daptomycin|daptomycin|mesh-list
111156586|NCT01728376|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110484843|NCT00754624|Insulin|insulin|mesh-list
111156587|NCT01728376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111156588|NCT02488759|Nivolumab|nivolumab|mesh-list
111156589|NCT02488759|Ipilimumab|ipilimumab|mesh-list
111156590|NCT02488759|Relatlimab|relatlimab|mesh-list
111156591|NCT02488759|Daratumumab|daratumumab|mesh-list
111156592|NCT02488759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111156593|NCT02488759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111156594|NCT02488759|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111156595|NCT02488759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111156596|NCT02217709|Phenelzine|phenelzine|mesh-list
111156597|NCT02217709|Antidepressive Agents|antidepressive agents|mesh-ancestor
111156598|NCT02217709|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111156599|NCT02217709|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
111156600|NCT02217709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111156601|NCT02217709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111156602|NCT02161783|Cyclophosphamide|cyclophosphamide|mesh-list
111156603|NCT02161783|Fludarabine|fludarabine|mesh-list
111156604|NCT02161783|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111156605|NCT02161783|Immunologic Factors|immunologic factors|mesh-ancestor
111156606|NCT02161783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110873694|NCT01313377|Gemcitabine|gemcitabine|mesh-list
111156607|NCT02161783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111156608|NCT02161783|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111156609|NCT02161783|Alkylating Agents|alkylating agents|mesh-ancestor
111156610|NCT02161783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111156611|NCT02161783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111156612|NCT02161783|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111156613|NCT02158507|Lapatinib|lapatinib|mesh-list
111156614|NCT02158507|Veliparib|veliparib|mesh-list
111156615|NCT02158507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111156616|NCT02158507|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111156617|NCT02158507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111156618|NCT02158507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111156619|NCT02158507|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111156620|NCT04791553|Cenobamate|cenobamate|mesh-list
111156621|NCT04791553|Anticonvulsants|anticonvulsants|mesh-ancestor
111156622|NCT05651347|Melatonin|melatonin|mesh-list
111156623|NCT05651347|Antioxidants|antioxidants|mesh-ancestor
111156624|NCT05651347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111156625|NCT05651347|Protective Agents|protective agents|mesh-ancestor
111156626|NCT05651347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111156627|NCT05651347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111156628|NCT05651269|Gemcitabine|gemcitabine|mesh-list
111156629|NCT05651269|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111156630|NCT05651269|Antimetabolites|antimetabolites|mesh-ancestor
111156631|NCT05651269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111156632|NCT05651269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111156633|NCT01707004|Vidarabine|vidarabine|mesh-list
111156634|NCT01707004|Mycophenolic Acid|mycophenolic acid|mesh-list
111156635|NCT01707004|Cyclophosphamide|cyclophosphamide|mesh-list
111156636|NCT01707004|Busulfan|busulfan|mesh-list
111156637|NCT01707004|Fludarabine|fludarabine|mesh-list
111156638|NCT01707004|Fludarabine phosphate|fludarabine phosphate|mesh-list
111156639|NCT01707004|Azacitidine|azacitidine|mesh-list
111156640|NCT01707004|Decitabine|decitabine|mesh-list
111156641|NCT01707004|Tacrolimus|tacrolimus|mesh-list
111156642|NCT01707004|Lenograstim|lenograstim|mesh-list
111156643|NCT01707004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111156644|NCT01707004|Immunologic Factors|immunologic factors|mesh-ancestor
111156645|NCT01707004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111156646|NCT01707004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111156647|NCT01707004|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111156648|NCT01707004|Alkylating Agents|alkylating agents|mesh-ancestor
111156649|NCT01707004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111156650|NCT01707004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111156651|NCT01707004|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111156652|NCT01707004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111156653|NCT01707004|Antimetabolites|antimetabolites|mesh-ancestor
111156654|NCT01707004|Antiviral Agents|antiviral agents|mesh-ancestor
111156655|NCT01707004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111156656|NCT01707004|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111156657|NCT01707004|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111156658|NCT01707004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111156659|NCT01707004|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111156660|NCT01707004|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111156661|NCT01707004|Antitubercular Agents|antitubercular agents|mesh-ancestor
111156662|NCT01707004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111156663|NCT01939197|Ritonavir|ritonavir|mesh-list
111156664|NCT01939197|Ribavirin|ribavirin|mesh-list
111156665|NCT01939197|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111156666|NCT01939197|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111156667|NCT01939197|Protease Inhibitors|protease inhibitors|mesh-ancestor
111156668|NCT01939197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111156669|NCT01939197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111156670|NCT01939197|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111156671|NCT01939197|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111156672|NCT01939197|Antiviral Agents|antiviral agents|mesh-ancestor
111156673|NCT01939197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111156674|NCT01939197|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111156675|NCT01939197|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111156676|NCT01939197|Antimetabolites|antimetabolites|mesh-ancestor
111156677|NCT01969851|Lacosamide|lacosamide|mesh-list
111156678|NCT01969851|Anticonvulsants|anticonvulsants|mesh-ancestor
111156679|NCT01969851|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111156680|NCT01969851|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111156681|NCT01969851|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111156682|NCT01969851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111156684|NCT01938573|Cisplatin|cisplatin|mesh-list
111156685|NCT01938573|Gemcitabine|gemcitabine|mesh-list
111156686|NCT01938573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111156687|NCT01938573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111156688|NCT01938573|Antimetabolites|antimetabolites|mesh-ancestor
111156689|NCT01938573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111156690|NCT01938573|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111156691|NCT01938573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111156692|NCT01938573|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111156693|NCT01938573|Antifungal Agents|antifungal agents|mesh-ancestor
111156694|NCT01938573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111156695|NCT01938573|Immunologic Factors|immunologic factors|mesh-ancestor
111156696|NCT01938573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111156697|NCT05546515|Suvorexant|suvorexant|mesh-list
111156698|NCT05546515|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-list
111156699|NCT05546515|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111156700|NCT05546515|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111156701|NCT05546515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111156702|NCT05546515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111156703|NCT05546515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111156704|NCT05546515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111156705|NCT04789837|Cilostazol|cilostazol|mesh-list
111156706|NCT04789837|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111156707|NCT04789837|Autonomic Agents|autonomic agents|mesh-ancestor
111156708|NCT04789837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111156709|NCT04789837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111156710|NCT04789837|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111156711|NCT04789837|Respiratory System Agents|respiratory system agents|mesh-ancestor
111156712|NCT04789837|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111156713|NCT04789837|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110484866|NCT00726505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111156714|NCT04789837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111156715|NCT04789837|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111156716|NCT04789837|Vasodilator Agents|vasodilator agents|mesh-ancestor
111156717|NCT04789837|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111156718|NCT04789837|Protective Agents|protective agents|mesh-ancestor
111156719|NCT04789837|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
111156720|NCT04789837|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111156721|NCT04789837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111156722|NCT03522259|Rivaroxaban|rivaroxaban|mesh-list
111156723|NCT03522259|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111156724|NCT03522259|Antithrombins|antithrombins|mesh-ancestor
111156725|NCT03522259|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111156726|NCT03522259|Protease Inhibitors|protease inhibitors|mesh-ancestor
111156727|NCT03522259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111156728|NCT03522259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111156729|NCT03522259|Anticoagulants|anticoagulants|mesh-ancestor
111156730|NCT01937871|Tadalafil|tadalafil|mesh-list
111156731|NCT01937871|Tamsulosin|tamsulosin|mesh-list
111156732|NCT01937871|Vasodilator Agents|vasodilator agents|mesh-ancestor
111156733|NCT01937871|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111156734|NCT01937871|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111156735|NCT01937871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111156736|NCT01937871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111156737|NCT01937871|Urological Agents|urological agents|mesh-ancestor
111156738|NCT01937871|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111156739|NCT01937871|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111156740|NCT01937871|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111156741|NCT01937871|Adrenergic Agents|adrenergic agents|mesh-ancestor
111156742|NCT01937871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111156743|NCT01937871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111156744|NCT02740699|Atorvastatin|atorvastatin|mesh-list
111156745|NCT02740699|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111156746|NCT02740699|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111156747|NCT02740699|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111156748|NCT02740699|Antimetabolites|antimetabolites|mesh-ancestor
111156749|NCT02740699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111156750|NCT02740699|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111156751|NCT02740699|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111156752|NCT02740699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111156753|NCT01287091|Rabeprazole|rabeprazole|mesh-list
111156754|NCT01287091|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111156755|NCT01287091|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111156756|NCT01287091|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111156757|NCT01287091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111156758|NCT01287091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111156759|NCT01269463|Methylphenidate|methylphenidate|mesh-list
111156760|NCT01269463|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111156761|NCT01269463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111156762|NCT01269463|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111156763|NCT01269463|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111156764|NCT01269463|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111156765|NCT01269463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111156766|NCT01269463|Dopamine Agents|dopamine agents|mesh-ancestor
111156767|NCT01269463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111156768|NCT02539459|Everolimus|everolimus|mesh-list
111156769|NCT02539459|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111156770|NCT02539459|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111156771|NCT02539459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111156772|NCT02539459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110484888|NCT02571283|Epinephrine|epinephrine|mesh-list
111156773|NCT02539459|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111156774|NCT02539459|Immunologic Factors|immunologic factors|mesh-ancestor
111156775|NCT02539459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111156776|NCT02539459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111156777|NCT01706926|Mavrilimumab|mavrilimumab|mesh-list
111156778|NCT01706926|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111156779|NCT01706926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111156780|NCT01706926|Immunologic Factors|immunologic factors|mesh-ancestor
111156781|NCT01706926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111156782|NCT01634113|Bromides|bromides|mesh-list
111156783|NCT01634113|Tiotropium Bromide|tiotropium bromide|mesh-list
111156784|NCT01634113|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111156785|NCT01634113|Autonomic Agents|autonomic agents|mesh-ancestor
111156786|NCT01634113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111156787|NCT01634113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111156788|NCT01634113|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111156789|NCT01634113|Respiratory System Agents|respiratory system agents|mesh-ancestor
111156790|NCT01634113|Parasympatholytics|parasympatholytics|mesh-ancestor
111156791|NCT01634113|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111156792|NCT01634113|Cholinergic Agents|cholinergic agents|mesh-ancestor
111156793|NCT01634113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111156794|NCT01634113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111156795|NCT01634113|Anticonvulsants|anticonvulsants|mesh-ancestor
111156796|NCT01937715|Bevacizumab|bevacizumab|mesh-list
111156797|NCT01937715|Gedatolisib|gedatolisib|mesh-list
111156798|NCT01937715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111156799|NCT01937715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111156800|NCT01937715|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111156801|NCT01937715|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111156802|NCT01937715|Growth Substances|growth substances|mesh-ancestor
111156803|NCT01937715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111156804|NCT01937715|Growth Inhibitors|growth inhibitors|mesh-ancestor
111156805|NCT01937715|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111156806|NCT01937715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111156807|NCT01937715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111156808|NCT01937559|Tranexamic Acid|tranexamic acid|mesh-list
111156809|NCT01937559|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111156810|NCT01937559|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111156811|NCT01937559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111156812|NCT01937559|Hemostatics|hemostatics|mesh-ancestor
111156813|NCT01937559|Coagulants|coagulants|mesh-ancestor
111156814|NCT01918371|Ranibizumab|ranibizumab|mesh-list
111156815|NCT01918371|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111156816|NCT01918371|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111156817|NCT01918371|Growth Substances|growth substances|mesh-ancestor
111156818|NCT01918371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111156819|NCT01918371|Growth Inhibitors|growth inhibitors|mesh-ancestor
111156820|NCT01918371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111156821|NCT01916967|Desloratadine|desloratadine|mesh-list
111156822|NCT01916967|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111156823|NCT01916967|Cholinergic Agents|cholinergic agents|mesh-ancestor
111156824|NCT01916967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111156825|NCT01916967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111156826|NCT01916967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111156827|NCT01916967|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
111156828|NCT01916967|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111156829|NCT01916967|Histamine Antagonists|histamine antagonists|mesh-ancestor
111156830|NCT01916967|Histamine Agents|histamine agents|mesh-ancestor
111156831|NCT01959243|Brimonidine Tartrate|brimonidine tartrate|mesh-list
111156832|NCT01959243|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111156833|NCT01959243|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111156834|NCT01959243|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111156835|NCT01959243|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111156836|NCT01959243|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111156837|NCT01959243|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111156838|NCT01959243|Adrenergic Agents|adrenergic agents|mesh-ancestor
111156839|NCT01959243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111156840|NCT01959243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111156841|NCT01959243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111156842|NCT01916109|Carboplatin|carboplatin|mesh-list
111156843|NCT01916109|Gemcitabine|gemcitabine|mesh-list
111156844|NCT01916109|Panitumumab|panitumumab|mesh-list
111156845|NCT01916109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111156846|NCT01916109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111156847|NCT01916109|Antimetabolites|antimetabolites|mesh-ancestor
111156848|NCT01916109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111156849|NCT01916109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111156850|NCT01958619|Artefenomel|artefenomel|mesh-list
111156851|NCT01958619|Antimalarials|antimalarials|mesh-ancestor
111156852|NCT01958619|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111156853|NCT01958619|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111156854|NCT01958619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111156856|NCT01726270|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111156857|NCT01726270|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111156858|NCT01726270|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111156859|NCT01726270|Adrenergic Agents|adrenergic agents|mesh-ancestor
111156860|NCT01726270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111156861|NCT01726270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111156862|NCT01726270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111156863|NCT01726270|Urological Agents|urological agents|mesh-ancestor
111156864|NCT00942331|Bevacizumab|bevacizumab|mesh-list
111156865|NCT00942331|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111156866|NCT00942331|Cisplatin|cisplatin|mesh-list
111156867|NCT00942331|Gemcitabine|gemcitabine|mesh-list
111156868|NCT00942331|Endothelial Growth Factors|endothelial growth factors|mesh-list
111156869|NCT00942331|Antibodies|antibodies|mesh-list
111156870|NCT00942331|Immunoglobulins|immunoglobulins|mesh-list
111156871|NCT00942331|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111156872|NCT00942331|Immunoglobulin G|immunoglobulin g|mesh-list
111156873|NCT00942331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111156874|NCT00942331|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111156875|NCT00942331|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111156876|NCT00942331|Growth Substances|growth substances|mesh-ancestor
111156877|NCT00942331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111156878|NCT00942331|Growth Inhibitors|growth inhibitors|mesh-ancestor
111156879|NCT00942331|Immunologic Factors|immunologic factors|mesh-ancestor
111156880|NCT00942331|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111156881|NCT00942331|Antimetabolites|antimetabolites|mesh-ancestor
111156882|NCT00942331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111156883|NCT00630565|Dexamethasone|dexamethasone|mesh-list
111156884|NCT00630565|Cyclophosphamide|cyclophosphamide|mesh-list
111156885|NCT00630565|Busulfan|busulfan|mesh-list
111156886|NCT00630565|Etoposide|etoposide|mesh-list
111156887|NCT00630565|Sargramostim|sargramostim|mesh-list
111156888|NCT00630565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111156889|NCT00630565|Immunologic Factors|immunologic factors|mesh-ancestor
111156890|NCT00630565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111156891|NCT00630565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111156892|NCT00630565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111156893|NCT00630565|Alkylating Agents|alkylating agents|mesh-ancestor
111156894|NCT00630565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111156895|NCT00630565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111156896|NCT00630565|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111156897|NCT00630565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111156898|NCT00630565|Antiemetics|antiemetics|mesh-ancestor
111156899|NCT00630565|Autonomic Agents|autonomic agents|mesh-ancestor
111156900|NCT00630565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111156901|NCT00630565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111156902|NCT00630565|Glucocorticoids|glucocorticoids|mesh-ancestor
111156903|NCT00630565|Hormones|hormones|mesh-ancestor
111156904|NCT00630565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111156905|NCT00630565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111156906|NCT00630565|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111156907|NCT00630565|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111156908|NCT00630565|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111156909|NCT00630565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111156910|NCT01914393|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
111156911|NCT01914393|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111156912|NCT01914393|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111156913|NCT01914393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111156914|NCT01914393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111156915|NCT01914393|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111156916|NCT01914393|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
111156917|NCT01914393|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111156918|NCT01914393|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111156919|NCT01914393|Adrenergic Agents|adrenergic agents|mesh-ancestor
111156920|NCT01914393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111156921|NCT01914393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111156922|NCT01914393|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111156923|NCT01914393|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111156924|NCT01914393|Serotonin Agents|serotonin agents|mesh-ancestor
111156925|NCT01914393|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111156926|NCT01914393|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111156927|NCT01914393|Dopamine Agents|dopamine agents|mesh-ancestor
111156929|NCT01545271|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111156930|NCT01545271|Anesthetics, General|anesthetics, general|mesh-ancestor
111156931|NCT01545271|Anesthetics|anesthetics|mesh-ancestor
111156932|NCT01545271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111156933|NCT01545271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111156934|NCT01931865|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
111156935|NCT01931865|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111156936|NCT01931865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111156937|NCT01931865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111156938|NCT01931865|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111156939|NCT01931865|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111156940|NCT01931865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111156941|NCT01931865|Cholinergic Agents|cholinergic agents|mesh-ancestor
111156942|NCT01931865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111156943|NCT01617447|Aripiprazole|aripiprazole|mesh-list
111156944|NCT01617447|Antidepressive Agents|antidepressive agents|mesh-ancestor
111156945|NCT01617447|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111156946|NCT01617447|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111156947|NCT01617447|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111156948|NCT01617447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111156949|NCT01617447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111156950|NCT01617447|Dopamine Agonists|dopamine agonists|mesh-ancestor
111156951|NCT01617447|Dopamine Agents|dopamine agents|mesh-ancestor
111156952|NCT01617447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111156953|NCT01617447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111156954|NCT01617447|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111156955|NCT01617447|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111156956|NCT01617447|Serotonin Agents|serotonin agents|mesh-ancestor
111156957|NCT01617447|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111156958|NCT01617447|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111156959|NCT01617447|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111156960|NCT01617447|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111156961|NCT00432679|Rosiglitazone|rosiglitazone|mesh-list
111156962|NCT00432679|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111156963|NCT00432679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111156964|NCT04798027|Vaccines|vaccines|mesh-list
111156965|NCT04798027|Immunologic Factors|immunologic factors|mesh-ancestor
111156966|NCT04798027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111156967|NCT04797325|Prednisolone|prednisolone|mesh-list
111156968|NCT04797325|Infliximab|infliximab|mesh-list
111156969|NCT04797325|Vedolizumab|vedolizumab|mesh-list
111156970|NCT04797325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111156971|NCT04797325|Glucocorticoids|glucocorticoids|mesh-ancestor
111156972|NCT04797325|Hormones|hormones|mesh-ancestor
111156973|NCT04797325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111156974|NCT04797325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111156975|NCT04797325|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111156976|NCT04797325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111156977|NCT04797325|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111156978|NCT04797325|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111156979|NCT04797325|Dermatologic Agents|dermatologic agents|mesh-ancestor
111156980|NCT04797325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111156981|NCT02246647|Mannitol|mannitol|mesh-list
111156982|NCT02246647|Lactulose|lactulose|mesh-list
111156983|NCT02246647|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
111156984|NCT02246647|Diuretics|diuretics|mesh-ancestor
111156985|NCT02246647|Natriuretic Agents|natriuretic agents|mesh-ancestor
111156986|NCT02246647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111156987|NCT02246647|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111156988|NCT02244619|Acetaminophen|acetaminophen|mesh-list
111156989|NCT02244619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111156990|NCT02244619|Analgesics|analgesics|mesh-ancestor
111156991|NCT02244619|Sensory System Agents|sensory system agents|mesh-ancestor
111156992|NCT02244619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111156993|NCT02244619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111156994|NCT02244619|Antipyretics|antipyretics|mesh-ancestor
111156995|NCT02243371|Cyclophosphamide|cyclophosphamide|mesh-list
111156996|NCT02243371|Nivolumab|nivolumab|mesh-list
111156997|NCT02243371|Immunologic Factors|immunologic factors|mesh-ancestor
111156998|NCT02243371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111156999|NCT02243371|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111157000|NCT02243371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111157001|NCT02243371|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111157002|NCT02243371|Alkylating Agents|alkylating agents|mesh-ancestor
111157003|NCT02243371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111157004|NCT02243371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111157005|NCT02243371|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111157006|NCT02243371|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111157007|NCT02243371|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111157008|NCT01931475|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
111157009|NCT01931475|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111157010|NCT01931475|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111157011|NCT01931475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111157012|NCT01931475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111157013|NCT01931475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111157014|NCT01931475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111157015|NCT01931475|Analgesics|analgesics|mesh-ancestor
111157016|NCT01931475|Sensory System Agents|sensory system agents|mesh-ancestor
111157017|NCT01931475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111157018|NCT01931475|Antidepressive Agents|antidepressive agents|mesh-ancestor
111157019|NCT01931475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111157020|NCT01931475|Dopamine Agents|dopamine agents|mesh-ancestor
111157021|NCT04630821|Sodium Hypochlorite|sodium hypochlorite|mesh-list
111157023|NCT04630821|Disinfectants|disinfectants|mesh-ancestor
111157024|NCT04630821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111157025|NCT01646177|Etanercept|etanercept|mesh-list
111157026|NCT01646177|Ixekizumab|ixekizumab|mesh-list
111157027|NCT01646177|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111157028|NCT01646177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111157029|NCT01646177|Analgesics|analgesics|mesh-ancestor
111157030|NCT01646177|Sensory System Agents|sensory system agents|mesh-ancestor
111157031|NCT01646177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111157032|NCT01646177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111157033|NCT01646177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111157034|NCT01646177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111157035|NCT01646177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111157036|NCT01646177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111157037|NCT01646177|Immunologic Factors|immunologic factors|mesh-ancestor
111157038|NCT01646177|Dermatologic Agents|dermatologic agents|mesh-ancestor
111157039|NCT01929135|Atorvastatin|atorvastatin|mesh-list
111157040|NCT01929135|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111157041|NCT01929135|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111157042|NCT01929135|Antimetabolites|antimetabolites|mesh-ancestor
111157043|NCT01929135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111157044|NCT01929135|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111157045|NCT01929135|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111157046|NCT01929135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111157047|NCT01911429|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
111157048|NCT01911429|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111157049|NCT01911429|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111157050|NCT01911429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111157051|NCT01911429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111157052|NCT01911429|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111157053|NCT01911429|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
111157054|NCT01911429|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111157055|NCT01911429|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111157056|NCT01911429|Adrenergic Agents|adrenergic agents|mesh-ancestor
111157057|NCT01911429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111157058|NCT01911429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111157059|NCT01911429|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111157060|NCT01911429|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111157061|NCT01911429|Serotonin Agents|serotonin agents|mesh-ancestor
111157062|NCT01911429|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111157063|NCT01911429|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111157064|NCT01911429|Dopamine Agents|dopamine agents|mesh-ancestor
111157065|NCT02324153|Riboflavin|riboflavin|mesh-list
111157066|NCT02324153|Vitamin B Complex|vitamin b complex|mesh-ancestor
111157067|NCT02324153|Vitamins|vitamins|mesh-ancestor
111157068|NCT02324153|Micronutrients|micronutrients|mesh-ancestor
111157069|NCT02324153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111157070|NCT02324153|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111157071|NCT02324153|Dermatologic Agents|dermatologic agents|mesh-ancestor
111157072|NCT02280473|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
111157073|NCT02280473|Laxatives|laxatives|mesh-ancestor
111157074|NCT02280473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111157075|NCT02308007|Metronidazole|metronidazole|mesh-list
111157076|NCT02308007|Terconazole|terconazole|mesh-list
111157077|NCT02308007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111157078|NCT02308007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111157079|NCT02308007|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111157080|NCT02308007|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111157081|NCT02308007|Antifungal Agents|antifungal agents|mesh-ancestor
111157082|NCT01910181|Vemurafenib|vemurafenib|mesh-list
111157083|NCT01910181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111157084|NCT01910181|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111157085|NCT01910181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111157086|NCT01910181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111157087|NCT04885907|Vaccines|vaccines|mesh-list
111157088|NCT04885907|Immunologic Factors|immunologic factors|mesh-ancestor
111157089|NCT04885907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111157090|NCT01957215|Indomethacin|indomethacin|mesh-list
111157091|NCT01957215|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110841069|NCT03288987|Vitamins|vitamins|mesh-ancestor
111157092|NCT01957215|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111157093|NCT01957215|Analgesics|analgesics|mesh-ancestor
111157094|NCT01957215|Sensory System Agents|sensory system agents|mesh-ancestor
111157095|NCT01957215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111157096|NCT01957215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111157097|NCT01957215|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111157098|NCT01957215|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111157099|NCT01957215|Gout Suppressants|gout suppressants|mesh-ancestor
111157100|NCT01957215|Tocolytic Agents|tocolytic agents|mesh-ancestor
111157101|NCT01957215|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111157102|NCT01957215|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111157103|NCT01957215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111157104|NCT01957215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111157105|NCT01928433|Ciprofloxacin|ciprofloxacin|mesh-list
111157106|NCT01928433|Finafloxacin|finafloxacin|mesh-list
111157107|NCT01928433|Fluoroquinolones|fluoroquinolones|mesh-list
111157108|NCT01928433|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111157109|NCT01928433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111157110|NCT01928433|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111157111|NCT01928433|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111157112|NCT01928433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111157113|NCT01928433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111157114|NCT01928433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111157115|NCT01928433|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111157116|NCT01928433|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111157117|NCT01928433|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111157118|NCT01928433|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111157119|NCT02322281|Paclitaxel|paclitaxel|mesh-list
111157120|NCT02322281|Docetaxel|docetaxel|mesh-list
111157121|NCT02322281|Gemcitabine|gemcitabine|mesh-list
111157122|NCT02322281|Pemetrexed|pemetrexed|mesh-list
111157123|NCT02322281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111157124|NCT02322281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111157125|NCT02322281|Tubulin Modulators|tubulin modulators|mesh-ancestor
111157126|NCT02322281|Antimitotic Agents|antimitotic agents|mesh-ancestor
110874217|NCT02661178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111157127|NCT02322281|Mitosis Modulators|mitosis modulators|mesh-ancestor
111157128|NCT02322281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111157129|NCT02322281|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111157130|NCT02322281|Antimetabolites|antimetabolites|mesh-ancestor
111157131|NCT02322281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111157132|NCT02322281|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111157133|NCT02322281|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111157134|NCT02243293|Ribavirin|ribavirin|mesh-list
111157135|NCT02243293|Antimetabolites|antimetabolites|mesh-ancestor
111157136|NCT02243293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111157137|NCT02243293|Antiviral Agents|antiviral agents|mesh-ancestor
111157138|NCT02243293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111157139|NCT02322047|Prazosin|prazosin|mesh-list
111157140|NCT02322047|Naltrexone|naltrexone|mesh-list
111157141|NCT02322047|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111157142|NCT02322047|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111157143|NCT02322047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111157144|NCT02322047|Sensory System Agents|sensory system agents|mesh-ancestor
111157145|NCT02322047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111157146|NCT02322047|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111157147|NCT02322047|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111157148|NCT02322047|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111157149|NCT02322047|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111157150|NCT02322047|Adrenergic Agents|adrenergic agents|mesh-ancestor
111157151|NCT02322047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111157152|NCT02322047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111157153|NCT02254291|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111157154|NCT02254291|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111157155|NCT02254291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111157156|NCT02254291|Incretins|incretins|mesh-ancestor
111157157|NCT02254291|Hormones|hormones|mesh-ancestor
111157158|NCT02254291|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111157159|NCT02254291|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111157160|NCT02254291|Protease Inhibitors|protease inhibitors|mesh-ancestor
111157161|NCT02254291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110841073|NCT01379846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111157162|NCT02254291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111157163|NCT02277743|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111157164|NCT02277743|Immunologic Factors|immunologic factors|mesh-ancestor
111157165|NCT02277743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111157166|NCT02320721|Insulin|insulin|mesh-list
111157167|NCT02320721|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111157168|NCT02320721|Insulin Glargine|insulin glargine|mesh-list
111157169|NCT02320721|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111157170|NCT02320721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111157171|NCT02320487|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
111157172|NCT02320487|Obinutuzumab|obinutuzumab|mesh-list
111157173|NCT02320487|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111157174|NCT02320487|Alkylating Agents|alkylating agents|mesh-ancestor
111157175|NCT02320487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111157176|NCT02320487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111157177|NCT02320487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111157178|NCT04197089|Vitamin D|vitamin d|mesh-list
111157179|NCT04197089|Cholecalciferol|cholecalciferol|mesh-list
111157180|NCT04197089|Vitamins|vitamins|mesh-ancestor
111157181|NCT04197089|Micronutrients|micronutrients|mesh-ancestor
111157182|NCT04197089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111157183|NCT04197089|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111157184|NCT04197089|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111157185|NCT02252965|Metformin|metformin|mesh-list
111157186|NCT02252965|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111157187|NCT02252965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111157188|NCT02251717|Sofosbuvir|sofosbuvir|mesh-list
111157189|NCT02251717|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
111157190|NCT02251717|Ledipasvir|ledipasvir|mesh-list
111157191|NCT02251717|Antiviral Agents|antiviral agents|mesh-ancestor
111157192|NCT02251717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111157193|NCT02242201|Ketorolac|ketorolac|mesh-list
111157194|NCT02242201|Epinephrine|epinephrine|mesh-list
111157195|NCT02242201|Bupivacaine|bupivacaine|mesh-list
111157196|NCT02242201|Ropivacaine|ropivacaine|mesh-list
111157197|NCT02242201|Anesthetics, Local|anesthetics, local|mesh-ancestor
111157198|NCT02242201|Anesthetics|anesthetics|mesh-ancestor
111157199|NCT02242201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111157200|NCT02242201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111157201|NCT02242201|Sensory System Agents|sensory system agents|mesh-ancestor
111157202|NCT02242201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111157203|NCT02242201|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111157204|NCT02242201|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111157205|NCT02242201|Adrenergic Agents|adrenergic agents|mesh-ancestor
111157206|NCT02242201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111157207|NCT02242201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111157208|NCT02242201|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111157209|NCT02242201|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111157210|NCT02242201|Autonomic Agents|autonomic agents|mesh-ancestor
111157211|NCT02242201|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111157212|NCT02242201|Respiratory System Agents|respiratory system agents|mesh-ancestor
111157213|NCT02242201|Mydriatics|mydriatics|mesh-ancestor
111157214|NCT02242201|Sympathomimetics|sympathomimetics|mesh-ancestor
111157215|NCT02242201|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111157216|NCT02242201|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111157217|NCT02242201|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111157218|NCT02242201|Analgesics|analgesics|mesh-ancestor
111157219|NCT02242201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111157220|NCT02242201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111157221|NCT02242201|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111157222|NCT02242201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111157223|NCT02242045|Idelalisib|idelalisib|mesh-list
111157224|NCT02242045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111157225|NCT02242045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111157226|NCT02242045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111157227|NCT02241889|Pancrelipase|pancrelipase|mesh-list
111157228|NCT02241889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111157229|NCT02241187|Cetuximab|cetuximab|mesh-list
111157230|NCT02241187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111157231|NCT02241187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111157232|NCT02249767|Tretinoin|tretinoin|mesh-list
111157233|NCT02249767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111157234|NCT02249767|Keratolytic Agents|keratolytic agents|mesh-ancestor
111157235|NCT02249767|Dermatologic Agents|dermatologic agents|mesh-ancestor
111157236|NCT02238379|Oxytocin|oxytocin|mesh-list
111157237|NCT02238379|Oxytocics|oxytocics|mesh-ancestor
111157238|NCT02238379|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111157239|NCT02238379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111157240|NCT02207491|Timolol|timolol|mesh-list
111157241|NCT02207491|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111157242|NCT02207491|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111157243|NCT02207491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111157244|NCT02207491|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111157245|NCT02207491|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111157246|NCT02207491|Adrenergic Agents|adrenergic agents|mesh-ancestor
111157247|NCT02207491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111157248|NCT02207491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111157249|NCT02207491|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111157250|NCT02207491|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111157251|NCT02315066|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111157252|NCT02315066|Immunoglobulin G|immunoglobulin g|mesh-list
111157253|NCT02315066|Immunologic Factors|immunologic factors|mesh-ancestor
111157254|NCT02315066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111157255|NCT02207413|Vaccines|vaccines|mesh-list
111157256|NCT02207413|Immunologic Factors|immunologic factors|mesh-ancestor
111157257|NCT02207413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111157258|NCT02276027|Ceritinib|ceritinib|mesh-list
111157259|NCT02276027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111157260|NCT02276027|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111157261|NCT02276027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111157262|NCT02276027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111157263|NCT02233543|Glycopyrrolate|glycopyrrolate|mesh-list
111157264|NCT02233543|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111157265|NCT02233543|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111157266|NCT02233543|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111157267|NCT02233543|Cholinergic Agents|cholinergic agents|mesh-ancestor
111157268|NCT02233543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111157269|NCT02233543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111157270|NCT02233543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111157271|NCT04761133|Povidone-Iodine|povidone-iodine|mesh-list
111157272|NCT04761133|Povidone|povidone|mesh-list
111157273|NCT04761133|Plasma Substitutes|plasma substitutes|mesh-ancestor
111157274|NCT04761133|Blood Substitutes|blood substitutes|mesh-ancestor
111157275|NCT04761133|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111157276|NCT04761133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111157277|NCT02233309|Anesthetics|anesthetics|mesh-list
111157278|NCT02233309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111157279|NCT02233309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111157280|NCT02280044|Rifaximin|rifaximin|mesh-list
111157281|NCT02280044|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110874378|NCT02363764|Dimercaprol|dimercaprol|mesh-list
111157282|NCT02280044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111157284|NCT02308748|Moxifloxacin|moxifloxacin|mesh-list
111157285|NCT02308748|Lidocaine|lidocaine|mesh-list
111157286|NCT02308748|Mexiletine|mexiletine|mesh-list
111157287|NCT02308748|Dofetilide|dofetilide|mesh-list
111157288|NCT02308748|Diltiazem|diltiazem|mesh-list
111157289|NCT02308748|Anesthetics, Local|anesthetics, local|mesh-ancestor
111157290|NCT02308748|Anesthetics|anesthetics|mesh-ancestor
111157291|NCT02308748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111157292|NCT02308748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111157293|NCT02308748|Sensory System Agents|sensory system agents|mesh-ancestor
111157294|NCT02308748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111157295|NCT02308748|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111157296|NCT02308748|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111157297|NCT02308748|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111157298|NCT02308748|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111157299|NCT02308748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111157300|NCT02308748|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111157301|NCT02308748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111157302|NCT02308748|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111157303|NCT02308748|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111157304|NCT02308748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111157305|NCT02308748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111157306|NCT02308748|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111157307|NCT02308748|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111157308|NCT02308748|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111157309|NCT02308748|Vasodilator Agents|vasodilator agents|mesh-ancestor
111157310|NCT02308748|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
111157311|NCT04745689|Carboplatin|carboplatin|mesh-list
111157312|NCT04745689|Etoposide|etoposide|mesh-list
111157313|NCT04745689|Durvalumab|durvalumab|mesh-list
111157314|NCT04745689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111157315|NCT04745689|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111157316|NCT04745689|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111157317|NCT04745689|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111157318|NCT04745689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111157319|NCT04745689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111157320|NCT04745689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111157321|NCT02308124|Midodrine|midodrine|mesh-list
111157322|NCT02308124|Bromides|bromides|mesh-list
111157323|NCT02308124|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
111157324|NCT02308124|Anticonvulsants|anticonvulsants|mesh-ancestor
111157325|NCT02308124|Sympathomimetics|sympathomimetics|mesh-ancestor
111157326|NCT02308124|Autonomic Agents|autonomic agents|mesh-ancestor
111157327|NCT02308124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111157328|NCT02308124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111157329|NCT02308124|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111157330|NCT02308124|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111157331|NCT02308124|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111157332|NCT02308124|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111157333|NCT02308124|Adrenergic Agents|adrenergic agents|mesh-ancestor
111157334|NCT02308124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111157335|NCT02308124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111157336|NCT02308124|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111157337|NCT02308124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111157338|NCT02308124|Cholinergic Agents|cholinergic agents|mesh-ancestor
111157339|NCT02232061|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
111157340|NCT02232061|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
111157341|NCT02232061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111157342|NCT02232061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111157343|NCT02232061|Immunologic Factors|immunologic factors|mesh-ancestor
111157344|NCT02232061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111157345|NCT02275481|Tiotropium Bromide|tiotropium bromide|mesh-list
111157346|NCT02275481|Formoterol Fumarate|formoterol fumarate|mesh-list
111157347|NCT02275481|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111157348|NCT02275481|Autonomic Agents|autonomic agents|mesh-ancestor
111157349|NCT02275481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111157350|NCT02275481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111157351|NCT02275481|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111157352|NCT02275481|Respiratory System Agents|respiratory system agents|mesh-ancestor
111157353|NCT02275481|Parasympatholytics|parasympatholytics|mesh-ancestor
111157354|NCT02275481|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111157355|NCT02275481|Cholinergic Agents|cholinergic agents|mesh-ancestor
111157356|NCT02275481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111157357|NCT02275481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111157358|NCT02275481|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111157359|NCT02275481|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111157360|NCT02275481|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111157361|NCT02275481|Adrenergic Agents|adrenergic agents|mesh-ancestor
111157362|NCT02308046|Terconazole|terconazole|mesh-list
111157363|NCT02308046|Antifungal Agents|antifungal agents|mesh-ancestor
111157364|NCT02308046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111157365|NCT02318693|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111157366|NCT02318693|Glyburide|glyburide|mesh-list
111157367|NCT02318693|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111157368|NCT02318693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111157369|NCT02318693|Incretins|incretins|mesh-ancestor
111157370|NCT02318693|Hormones|hormones|mesh-ancestor
111157371|NCT02318693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111157372|NCT02318693|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111157373|NCT02318693|Protease Inhibitors|protease inhibitors|mesh-ancestor
111157374|NCT02318693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111157375|NCT02318693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111157376|NCT02230891|Carvedilol|carvedilol|mesh-list
111157377|NCT02230891|Spironolactone|spironolactone|mesh-list
111157378|NCT02230891|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
111157379|NCT02230891|Hormone Antagonists|hormone antagonists|mesh-ancestor
111157380|NCT02230891|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111157381|NCT02230891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111157382|NCT02230891|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
111157383|NCT02230891|Diuretics|diuretics|mesh-ancestor
111157384|NCT02230891|Natriuretic Agents|natriuretic agents|mesh-ancestor
111157385|NCT02230891|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111157386|NCT02230891|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111157387|NCT02230891|Adrenergic Agents|adrenergic agents|mesh-ancestor
111157388|NCT02230891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111157389|NCT02230891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111157390|NCT02230891|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111157391|NCT02230891|Antioxidants|antioxidants|mesh-ancestor
111157392|NCT02230891|Protective Agents|protective agents|mesh-ancestor
111157393|NCT02230891|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111157394|NCT02230891|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111157395|NCT02230891|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111157396|NCT02230891|Vasodilator Agents|vasodilator agents|mesh-ancestor
111157397|NCT02230891|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111157398|NCT02230891|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111157399|NCT02302859|Nicotine|nicotine|mesh-list
111157400|NCT02302859|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111157401|NCT02302859|Autonomic Agents|autonomic agents|mesh-ancestor
111157402|NCT02302859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111157403|NCT02302859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111157404|NCT02302859|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111157405|NCT02302859|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111157406|NCT02302859|Cholinergic Agents|cholinergic agents|mesh-ancestor
111157407|NCT02302859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111157408|NCT02302859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111157409|NCT02274311|Clomiphene|clomiphene|mesh-list
111157410|NCT02274311|Enclomiphene|enclomiphene|mesh-list
111157411|NCT02274311|Zuclomiphene|zuclomiphene|mesh-list
111157412|NCT02274311|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111157413|NCT02274311|Hormone Antagonists|hormone antagonists|mesh-ancestor
111157414|NCT02274311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111157415|NCT02274311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111157416|NCT02274311|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111157417|NCT02274311|Fertility Agents|fertility agents|mesh-ancestor
111157418|NCT02274311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111157419|NCT02274311|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111157420|NCT02274311|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111157421|NCT02316353|Complement C1s|complement c1s|mesh-list
111157422|NCT02316353|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
111157423|NCT02316353|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
111157424|NCT02316353|Immunologic Factors|immunologic factors|mesh-ancestor
111157425|NCT02316353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111157426|NCT02316353|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
111157427|NCT02316353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111157428|NCT02279732|Paclitaxel|paclitaxel|mesh-list
111157429|NCT02279732|Carboplatin|carboplatin|mesh-list
111157430|NCT02279732|Ipilimumab|ipilimumab|mesh-list
111157431|NCT02279732|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111157432|NCT02279732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111157433|NCT02279732|Tubulin Modulators|tubulin modulators|mesh-ancestor
111157434|NCT02279732|Antimitotic Agents|antimitotic agents|mesh-ancestor
111157435|NCT02279732|Mitosis Modulators|mitosis modulators|mesh-ancestor
111157436|NCT02279732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111157437|NCT02279732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111157438|NCT02279732|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111157439|NCT05649956|Letrozole|letrozole|mesh-list
111157440|NCT05649956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111157441|NCT05649956|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111157442|NCT05649956|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111157443|NCT05649956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111157444|NCT05649956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111157445|NCT05649956|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111157446|NCT05649956|Hormone Antagonists|hormone antagonists|mesh-ancestor
111157447|NCT05649956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111157448|NCT05649956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111157449|NCT04876430|Meropenem|meropenem|mesh-list
111157450|NCT04876430|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111157451|NCT04876430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111157452|NCT02305238|Aflibercept|aflibercept|mesh-list
111157453|NCT02305238|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111157454|NCT02305238|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111157455|NCT02305238|Growth Substances|growth substances|mesh-ancestor
111157456|NCT02305238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111157457|NCT02305238|Growth Inhibitors|growth inhibitors|mesh-ancestor
111157458|NCT02305238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111157459|NCT02304926|Simvastatin|simvastatin|mesh-list
111157460|NCT02304926|Ezetimibe|ezetimibe|mesh-list
111157461|NCT02304926|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
111157462|NCT02304926|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111157463|NCT02304926|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111157464|NCT02304926|Antimetabolites|antimetabolites|mesh-ancestor
111157465|NCT02304926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111157466|NCT02304926|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111157467|NCT02304926|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111157468|NCT02304926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111157469|NCT01646255|Levodopa|levodopa|mesh-list
111157470|NCT01646255|Rotigotine|rotigotine|mesh-list
111157471|NCT01646255|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111157472|NCT01646255|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111157473|NCT01646255|Dopamine Agents|dopamine agents|mesh-ancestor
111157474|NCT01646255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111157475|NCT01646255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111157476|NCT01646255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111157477|NCT01646255|Dopamine Agonists|dopamine agonists|mesh-ancestor
111157478|NCT02203591|Ethanol|ethanol|mesh-list
111157479|NCT02203591|Chlorhexidine|chlorhexidine|mesh-list
111157480|NCT02203591|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
111157481|NCT02203591|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111157482|NCT02203591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111157483|NCT02203591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111157484|NCT02203591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111157485|NCT02203591|Disinfectants|disinfectants|mesh-ancestor
111157486|NCT02203591|Dermatologic Agents|dermatologic agents|mesh-ancestor
111157487|NCT01642277|Solifenacin Succinate|solifenacin succinate|mesh-list
111157488|NCT01642277|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111157489|NCT01642277|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111157490|NCT01642277|Cholinergic Agents|cholinergic agents|mesh-ancestor
111157491|NCT01642277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111157492|NCT01642277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111157493|NCT01642277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111157494|NCT01642277|Urological Agents|urological agents|mesh-ancestor
111157495|NCT02230189|Methacholine Chloride|methacholine chloride|mesh-list
111157496|NCT02230189|Miotics|miotics|mesh-ancestor
111157497|NCT02230189|Autonomic Agents|autonomic agents|mesh-ancestor
111157498|NCT02230189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111157499|NCT02230189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111157500|NCT02230189|Parasympathomimetics|parasympathomimetics|mesh-ancestor
111157501|NCT02230189|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
111157502|NCT02230189|Respiratory System Agents|respiratory system agents|mesh-ancestor
111157503|NCT02230189|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
110874595|NCT01382238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111157504|NCT02230189|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111157505|NCT02230189|Cholinergic Agents|cholinergic agents|mesh-ancestor
111157506|NCT02230189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111157507|NCT02230189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111157509|NCT02304302|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111157510|NCT02304302|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111157512|NCT02304302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111157513|NCT02304302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111157514|NCT02304302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111157515|NCT02304302|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111157516|NCT02304302|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111157517|NCT02276612|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
111157518|NCT02276612|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111157519|NCT02276612|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111157520|NCT02276612|Antiviral Agents|antiviral agents|mesh-ancestor
111157521|NCT02276612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111157522|NCT02301143|Paclitaxel|paclitaxel|mesh-list
111157523|NCT02301143|Gemcitabine|gemcitabine|mesh-list
111157524|NCT02301143|Capecitabine|capecitabine|mesh-list
111157525|NCT02301143|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111157526|NCT02301143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111157527|NCT02301143|Tubulin Modulators|tubulin modulators|mesh-ancestor
111157528|NCT02301143|Antimitotic Agents|antimitotic agents|mesh-ancestor
111157529|NCT02301143|Mitosis Modulators|mitosis modulators|mesh-ancestor
111157530|NCT02301143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111157531|NCT02301143|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111157532|NCT02301143|Antimetabolites|antimetabolites|mesh-ancestor
111157533|NCT02276222|Glycopyrrolate|glycopyrrolate|mesh-list
111157534|NCT02276222|Tiotropium Bromide|tiotropium bromide|mesh-list
110485097|NCT00640887|Ritonavir|ritonavir|mesh-list
111157535|NCT02276222|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111157536|NCT02276222|Autonomic Agents|autonomic agents|mesh-ancestor
111157537|NCT02276222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111157538|NCT02276222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111157539|NCT02276222|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111157540|NCT02276222|Respiratory System Agents|respiratory system agents|mesh-ancestor
111157541|NCT02276222|Parasympatholytics|parasympatholytics|mesh-ancestor
111157542|NCT02276222|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111157543|NCT02276222|Cholinergic Agents|cholinergic agents|mesh-ancestor
111157544|NCT02276222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111157545|NCT02276222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111157546|NCT02276222|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111157547|NCT02276222|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111157548|NCT02275052|Albuterol|albuterol|mesh-list
111157549|NCT02275052|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111157550|NCT02275052|Autonomic Agents|autonomic agents|mesh-ancestor
111157551|NCT02275052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111157552|NCT02275052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111157553|NCT02275052|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111157554|NCT02275052|Respiratory System Agents|respiratory system agents|mesh-ancestor
111157555|NCT02275052|Tocolytic Agents|tocolytic agents|mesh-ancestor
111157556|NCT02275052|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111157557|NCT02275052|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111157558|NCT02275052|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111157559|NCT02275052|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111157560|NCT02275052|Adrenergic Agents|adrenergic agents|mesh-ancestor
111157561|NCT02275052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111157562|NCT02275052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111157563|NCT05649020|Prilocaine|prilocaine|mesh-list
111157564|NCT05649020|Anesthetics, Local|anesthetics, local|mesh-ancestor
111157565|NCT05649020|Anesthetics|anesthetics|mesh-ancestor
111157566|NCT05649020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111157567|NCT05649020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111157568|NCT05649020|Sensory System Agents|sensory system agents|mesh-ancestor
111157569|NCT05649020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111157570|NCT04869488|Prednisone|prednisone|mesh-list
111157571|NCT04869488|Apatinib|apatinib|mesh-list
111157572|NCT04869488|Abiraterone Acetate|abiraterone acetate|mesh-list
111157573|NCT04869488|Fluzoparib|fluzoparib|mesh-list
111157574|NCT04869488|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111157575|NCT04869488|Glucocorticoids|glucocorticoids|mesh-ancestor
111157576|NCT04869488|Hormones|hormones|mesh-ancestor
111157577|NCT04869488|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111157578|NCT04869488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111157579|NCT04869488|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111157580|NCT04869488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111157581|NCT04869488|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111157582|NCT04869488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111157583|NCT04869488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111157584|NCT04869488|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111157585|NCT04869488|Hormone Antagonists|hormone antagonists|mesh-ancestor
111157586|NCT04869488|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111157587|NCT04869488|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111157588|NCT02274038|Pemetrexed|pemetrexed|mesh-list
111157589|NCT02274038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111157590|NCT02274038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111157591|NCT02274038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111157592|NCT02274038|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111157593|NCT02274038|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111157594|NCT01646021|Sirolimus|sirolimus|mesh-list
111157595|NCT01646021|Temsirolimus|temsirolimus|mesh-list
111157596|NCT01646021|MTOR Inhibitors|mtor inhibitors|mesh-list
111157597|NCT01646021|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111157598|NCT01646021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111157599|NCT01646021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111157600|NCT01646021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111157601|NCT01646021|Immunologic Factors|immunologic factors|mesh-ancestor
111157602|NCT01646021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111157603|NCT01646021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111157604|NCT01646021|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111157605|NCT01646021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111157606|NCT01646021|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111157607|NCT01646021|Antifungal Agents|antifungal agents|mesh-ancestor
111157608|NCT01750918|Fluorouracil|fluorouracil|mesh-list
111157609|NCT01750918|Panitumumab|panitumumab|mesh-list
111157610|NCT01750918|Trametinib|trametinib|mesh-list
111157611|NCT01750918|Dabrafenib|dabrafenib|mesh-list
111157612|NCT01750918|Antimetabolites|antimetabolites|mesh-ancestor
111157613|NCT01750918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111157614|NCT01750918|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111157615|NCT01750918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111157616|NCT01750918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111157617|NCT01750918|Immunologic Factors|immunologic factors|mesh-ancestor
111157618|NCT01750918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111157619|NCT01750918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111157620|NCT01750918|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111157621|NCT01750918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111157622|NCT01750840|Cimetidine|cimetidine|mesh-list
111157623|NCT01750840|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111157624|NCT01750840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111157625|NCT01750840|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
111157626|NCT01750840|Histamine Antagonists|histamine antagonists|mesh-ancestor
111157627|NCT01750840|Histamine Agents|histamine agents|mesh-ancestor
111157628|NCT01750840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111157629|NCT01750840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111157630|NCT01750840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111157631|NCT01750840|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111157632|NCT01750840|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111157633|NCT01750840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111157634|NCT01606228|Paliperidone Palmitate|paliperidone palmitate|mesh-list
111157635|NCT01606228|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111157636|NCT01606228|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111157637|NCT01606228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111157638|NCT01606228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111157639|NCT01606228|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111157640|NCT01606228|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111157641|NCT01606228|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111157642|NCT01606228|Serotonin Agents|serotonin agents|mesh-ancestor
111157643|NCT01606228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111157644|NCT01606228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111157645|NCT01606228|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111157646|NCT01606228|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111157647|NCT01606228|Dopamine Agents|dopamine agents|mesh-ancestor
111157648|NCT02269943|Azacitidine|azacitidine|mesh-list
111157649|NCT02269943|Cc-486|cc-486|mesh-list
111157650|NCT02269943|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111157651|NCT02269943|Antimetabolites|antimetabolites|mesh-ancestor
111157652|NCT02269943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111157653|NCT02269943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111157654|NCT02269943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111157655|NCT01605370|Metoprolol|metoprolol|mesh-list
111157656|NCT01605370|Nebivolol|nebivolol|mesh-list
111157657|NCT01605370|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111157658|NCT01605370|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111157659|NCT01605370|Sympatholytics|sympatholytics|mesh-ancestor
111157660|NCT01605370|Autonomic Agents|autonomic agents|mesh-ancestor
111157661|NCT01605370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111157662|NCT01605370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111157663|NCT01605370|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
111157664|NCT01605370|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111157665|NCT01605370|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111157666|NCT01605370|Adrenergic Agents|adrenergic agents|mesh-ancestor
111157667|NCT01605370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111157668|NCT01605370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111157669|NCT01605370|Vasodilator Agents|vasodilator agents|mesh-ancestor
111157670|NCT01605370|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
111157671|NCT01605370|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111157672|NCT01605370|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111157673|NCT01605136|Afamelanotide|afamelanotide|mesh-list
111157674|NCT01605136|Dermatologic Agents|dermatologic agents|mesh-ancestor
111157675|NCT01706146|Rivaroxaban|rivaroxaban|mesh-list
111157676|NCT01706146|Apixaban|apixaban|mesh-list
111157677|NCT01706146|Dabigatran|dabigatran|mesh-list
111157678|NCT01706146|Anticoagulants|anticoagulants|mesh-list
111157679|NCT01706146|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111157680|NCT01706146|Antithrombins|antithrombins|mesh-ancestor
111157681|NCT01706146|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111157682|NCT01706146|Protease Inhibitors|protease inhibitors|mesh-ancestor
111157683|NCT01706146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111157684|NCT01706146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111157685|NCT02269241|Drospirenone|drospirenone|mesh-list
111157686|NCT02269241|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
111157687|NCT02269241|Hormone Antagonists|hormone antagonists|mesh-ancestor
111157688|NCT02269241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111157689|NCT02269241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111157690|NCT02269241|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
111157691|NCT02269241|Diuretics|diuretics|mesh-ancestor
111157692|NCT02269241|Natriuretic Agents|natriuretic agents|mesh-ancestor
111157693|NCT01750294|Chlorthalidone|chlorthalidone|mesh-list
111157694|NCT01750294|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111157695|NCT01750294|Diuretics|diuretics|mesh-ancestor
111157696|NCT01750294|Natriuretic Agents|natriuretic agents|mesh-ancestor
111157697|NCT01750294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111157698|NCT01750294|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110841128|NCT01377428|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111157699|NCT01750294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111157700|NCT01750294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111157701|NCT01749982|Choline|choline|mesh-list
111157702|NCT01749982|Betaine|betaine|mesh-list
111157703|NCT01749982|Lipotropic Agents|lipotropic agents|mesh-ancestor
111157704|NCT01749982|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111157705|NCT01749982|Antimetabolites|antimetabolites|mesh-ancestor
111157706|NCT01749982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111157707|NCT01749982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111157708|NCT01749982|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111157709|NCT01749982|Nootropic Agents|nootropic agents|mesh-ancestor
111157710|NCT02269163|Immunoglobulins|immunoglobulins|mesh-list
111157711|NCT02269163|Antibodies|antibodies|mesh-list
111157712|NCT02269163|gamma-Globulins|gamma-globulins|mesh-list
111157713|NCT02269163|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111157714|NCT02269163|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
111157715|NCT02269163|Immunoglobulin G|immunoglobulin g|mesh-list
111157716|NCT02269163|Immunologic Factors|immunologic factors|mesh-ancestor
111157717|NCT02269163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111157718|NCT01749826|Morphine|morphine|mesh-list
111157719|NCT01749826|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111157720|NCT01749826|Narcotics|narcotics|mesh-ancestor
111157721|NCT01749826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111157722|NCT01749826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111157723|NCT01749826|Analgesics|analgesics|mesh-ancestor
111157724|NCT01749826|Sensory System Agents|sensory system agents|mesh-ancestor
111157725|NCT01749826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111157726|NCT01724866|Cyclophosphamide|cyclophosphamide|mesh-list
111157727|NCT01724866|Docetaxel|docetaxel|mesh-list
111157728|NCT01724866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111157729|NCT01724866|Immunologic Factors|immunologic factors|mesh-ancestor
111157730|NCT01724866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111157731|NCT01724866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111157732|NCT01724866|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111157733|NCT01724866|Alkylating Agents|alkylating agents|mesh-ancestor
111157734|NCT01724866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111157735|NCT01724866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111157736|NCT01724866|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111157737|NCT01724866|Tubulin Modulators|tubulin modulators|mesh-ancestor
111157738|NCT01724866|Antimitotic Agents|antimitotic agents|mesh-ancestor
111157739|NCT01724866|Mitosis Modulators|mitosis modulators|mesh-ancestor
111157740|NCT02266433|Dexamethasone|dexamethasone|mesh-list
111157741|NCT02266433|Ketorolac|ketorolac|mesh-list
111157742|NCT02266433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111157743|NCT02266433|Antiemetics|antiemetics|mesh-ancestor
111157744|NCT02266433|Autonomic Agents|autonomic agents|mesh-ancestor
111157745|NCT02266433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111157746|NCT02266433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111157747|NCT02266433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111157748|NCT02266433|Glucocorticoids|glucocorticoids|mesh-ancestor
111157749|NCT02266433|Hormones|hormones|mesh-ancestor
111157750|NCT02266433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111157751|NCT02266433|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111157752|NCT02266433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111157753|NCT02266433|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111157754|NCT02266433|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111157755|NCT02266433|Analgesics|analgesics|mesh-ancestor
111157756|NCT02266433|Sensory System Agents|sensory system agents|mesh-ancestor
111157757|NCT02266433|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111157758|NCT02266433|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111157759|NCT02266433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111157760|NCT02266433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111157761|NCT02273726|Epoetin Alfa|epoetin alfa|mesh-list
111157762|NCT02273726|Hematinics|hematinics|mesh-ancestor
111157763|NCT01723228|Rasagiline|rasagiline|mesh-list
111157764|NCT01723228|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
111157765|NCT01723228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111157766|NCT01723228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111157767|NCT01723228|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111157768|NCT01723228|Protective Agents|protective agents|mesh-ancestor
111157769|NCT01723228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111157770|NCT02273180|Insulin|insulin|mesh-list
111157771|NCT02273180|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111157772|NCT02273180|Insulin Glargine|insulin glargine|mesh-list
111157773|NCT02273180|Insulin Lispro|insulin lispro|mesh-list
111157774|NCT02273180|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111157775|NCT02273180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111157776|NCT01745380|Phenylephrine|phenylephrine|mesh-list
111157777|NCT01745380|Oxymetazoline|oxymetazoline|mesh-list
111157778|NCT01745380|Tetracaine|tetracaine|mesh-list
111157779|NCT01745380|Anesthetics, Local|anesthetics, local|mesh-ancestor
111157780|NCT01745380|Anesthetics|anesthetics|mesh-ancestor
111157781|NCT01745380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111157782|NCT01745380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111157783|NCT01745380|Sensory System Agents|sensory system agents|mesh-ancestor
111157784|NCT01745380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111157785|NCT01745380|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111157786|NCT01745380|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111157787|NCT01745380|Adrenergic Agents|adrenergic agents|mesh-ancestor
111157788|NCT01745380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111157789|NCT01745380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111157790|NCT01745380|Sympathomimetics|sympathomimetics|mesh-ancestor
111157791|NCT01745380|Autonomic Agents|autonomic agents|mesh-ancestor
111157792|NCT01745380|Nasal Decongestants|nasal decongestants|mesh-ancestor
111157793|NCT01745380|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111157794|NCT01745380|Respiratory System Agents|respiratory system agents|mesh-ancestor
111157795|NCT01745380|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111157796|NCT01745380|Mydriatics|mydriatics|mesh-ancestor
111157797|NCT01745380|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111157798|NCT01745380|Protective Agents|protective agents|mesh-ancestor
111157799|NCT04550104|Olaparib|olaparib|mesh-list
111157800|NCT04550104|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111157801|NCT04550104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111157802|NCT04550104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111157803|NCT04550104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111157804|NCT05648318|Lactulose|lactulose|mesh-list
111157805|NCT05648318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111157806|NCT02203513|Prexasertib|prexasertib|mesh-list
111157807|NCT02203513|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111157808|NCT02203513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111157809|NCT02203513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111157810|NCT01703260|Pioglitazone|pioglitazone|mesh-list
111157811|NCT01703260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111157812|NCT01703260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111157813|NCT02299388|Liraglutide|liraglutide|mesh-list
111157814|NCT02299388|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111157815|NCT02299388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111157816|NCT02299388|Incretins|incretins|mesh-ancestor
111157818|NCT02299388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111157819|NCT02202577|Chlorhexidine|chlorhexidine|mesh-list
111157820|NCT02202577|Povidone-Iodine|povidone-iodine|mesh-list
111157821|NCT02202577|Povidone|povidone|mesh-list
111157822|NCT02202577|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111157823|NCT02202577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111157824|NCT02202577|Disinfectants|disinfectants|mesh-ancestor
111157825|NCT02202577|Plasma Substitutes|plasma substitutes|mesh-ancestor
111157826|NCT02202577|Blood Substitutes|blood substitutes|mesh-ancestor
111157827|NCT01723072|Omalizumab|omalizumab|mesh-list
111157828|NCT01723072|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111157829|NCT01723072|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110841141|NCT03252015|Lasmiditan|lasmiditan|mesh-list
111157830|NCT01723072|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111157831|NCT01723072|Respiratory System Agents|respiratory system agents|mesh-ancestor
111157832|NCT01723072|Immunologic Factors|immunologic factors|mesh-ancestor
111157833|NCT01723072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111157834|NCT02169505|Brentuximab Vedotin|brentuximab vedotin|mesh-list
111157835|NCT02169505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111157836|NCT02169505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111157837|NCT02169505|Immunotoxins|immunotoxins|mesh-ancestor
111157838|NCT02169505|Immunoconjugates|immunoconjugates|mesh-ancestor
111157839|NCT02169505|Immunologic Factors|immunologic factors|mesh-ancestor
111157840|NCT02169505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111157841|NCT01909791|Aflibercept|aflibercept|mesh-list
111157842|NCT01909791|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111157843|NCT01909791|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111157844|NCT01909791|Growth Substances|growth substances|mesh-ancestor
111157845|NCT01909791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111157846|NCT01909791|Growth Inhibitors|growth inhibitors|mesh-ancestor
111157847|NCT01909791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111157848|NCT02202499|Varenicline|varenicline|mesh-list
111157849|NCT02202499|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111157850|NCT02202499|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111157851|NCT02202499|Cholinergic Agents|cholinergic agents|mesh-ancestor
111157852|NCT02202499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111157853|NCT02202499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111157854|NCT02202499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111157855|NCT02227849|Canagliflozin|canagliflozin|mesh-list
111157856|NCT02227849|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111157857|NCT02227849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111157858|NCT02227849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111157859|NCT02227849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111157860|NCT02169271|Aspirin|aspirin|mesh-list
111157861|NCT02169271|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111157862|NCT02169271|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111157863|NCT02169271|Analgesics|analgesics|mesh-ancestor
111157864|NCT02169271|Sensory System Agents|sensory system agents|mesh-ancestor
111157865|NCT02169271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111157866|NCT02169271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111157867|NCT02169271|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111157868|NCT02169271|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111157869|NCT02169271|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111157870|NCT02169271|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111157871|NCT02169271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111157872|NCT02169271|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111157873|NCT02169271|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111157874|NCT02169271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111157875|NCT02169271|Antipyretics|antipyretics|mesh-ancestor
111157876|NCT01644188|Ezetimibe|ezetimibe|mesh-list
111157877|NCT01644188|Alirocumab|alirocumab|mesh-list
111157878|NCT01644188|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111157879|NCT01644188|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111157880|NCT01644188|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111157881|NCT01644188|Antimetabolites|antimetabolites|mesh-ancestor
111157882|NCT01644188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111157883|NCT01644188|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111157884|NCT01644188|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
111157885|NCT01644188|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111157886|NCT01644188|Protease Inhibitors|protease inhibitors|mesh-ancestor
111157887|NCT01644188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111157888|NCT01644188|Immunologic Factors|immunologic factors|mesh-ancestor
111157889|NCT01644188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111157890|NCT02201953|Sofosbuvir|sofosbuvir|mesh-list
111157891|NCT02201953|Antiviral Agents|antiviral agents|mesh-ancestor
111157892|NCT02201953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111157893|NCT02271854|Diclofenac|diclofenac|mesh-list
111157894|NCT02271854|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111157895|NCT02271854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111157896|NCT02271854|Analgesics|analgesics|mesh-ancestor
111157897|NCT02271854|Sensory System Agents|sensory system agents|mesh-ancestor
111157898|NCT02271854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111157899|NCT02271854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110841155|NCT03083132|Modafinil|modafinil|mesh-list
111157900|NCT02271854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111157901|NCT02271854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111157902|NCT02271854|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111157903|NCT02271854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111157904|NCT02271854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111157906|NCT02296892|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111157907|NCT02296892|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111157908|NCT02296892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111157909|NCT02296892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111157910|NCT02296892|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111157911|NCT02296892|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111157912|NCT02296892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111157913|NCT02296892|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111157914|NCT02296892|Anesthetics, General|anesthetics, general|mesh-ancestor
111157915|NCT02296892|Anesthetics|anesthetics|mesh-ancestor
111157916|NCT02296892|GABA Modulators|gaba modulators|mesh-ancestor
111157917|NCT02296892|GABA Agents|gaba agents|mesh-ancestor
111157918|NCT02296892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111157919|NCT02296892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111157920|NCT02168803|Evacetrapib|evacetrapib|mesh-list
111157921|NCT02168803|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111157922|NCT02168803|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111157923|NCT02168803|Antimetabolites|antimetabolites|mesh-ancestor
111157924|NCT02168803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111157925|NCT02168803|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111157926|NCT02201329|Azacitidine|azacitidine|mesh-list
111157927|NCT02201329|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111157928|NCT02201329|Antimetabolites|antimetabolites|mesh-ancestor
111157929|NCT02201329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111157930|NCT02201329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111157931|NCT02201329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111157932|NCT01927419|Nivolumab|nivolumab|mesh-list
111157933|NCT01927419|Ipilimumab|ipilimumab|mesh-list
111157934|NCT01927419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111157935|NCT01927419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111157936|NCT01927419|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111157937|NCT01927419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111157938|NCT02168491|Insulin Glargine|insulin glargine|mesh-list
111157939|NCT02168491|Lixisenatide|lixisenatide|mesh-list
111157940|NCT02168491|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111157941|NCT02168491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111157942|NCT01721746|Paclitaxel|paclitaxel|mesh-list
111157943|NCT01721746|Carboplatin|carboplatin|mesh-list
111157944|NCT01721746|Nivolumab|nivolumab|mesh-list
111157945|NCT01721746|Dacarbazine|dacarbazine|mesh-list
111157946|NCT01721746|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111157947|NCT01721746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111157948|NCT01721746|Tubulin Modulators|tubulin modulators|mesh-ancestor
111157949|NCT01721746|Antimitotic Agents|antimitotic agents|mesh-ancestor
111157950|NCT01721746|Mitosis Modulators|mitosis modulators|mesh-ancestor
111157951|NCT01721746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111157952|NCT01721746|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111157953|NCT01721746|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111157954|NCT01721746|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111157955|NCT01721746|Alkylating Agents|alkylating agents|mesh-ancestor
111157956|NCT02225665|Cyclophosphamide|cyclophosphamide|mesh-list
111157957|NCT02225665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111157958|NCT02225665|Immunologic Factors|immunologic factors|mesh-ancestor
111157959|NCT02225665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111157960|NCT02225665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111157961|NCT02225665|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111157962|NCT02225665|Alkylating Agents|alkylating agents|mesh-ancestor
111157963|NCT02225665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111157964|NCT02225665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111157965|NCT02225665|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111157966|NCT02225587|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
111157967|NCT02225587|Immunologic Factors|immunologic factors|mesh-ancestor
111157968|NCT02225587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111157969|NCT02296424|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111157970|NCT02296424|Immunologic Factors|immunologic factors|mesh-ancestor
111157971|NCT02296424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111157972|NCT02296190|Etripamil|etripamil|mesh-list
111157973|NCT02296190|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111157974|NCT02296190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111157975|NCT02296190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111157976|NCT02296190|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111157977|NCT02296190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111157978|NCT04875026|Fluorouracil|fluorouracil|mesh-list
111157979|NCT04875026|Antimetabolites|antimetabolites|mesh-ancestor
111157980|NCT04875026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111157981|NCT04875026|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111157982|NCT04875026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111157983|NCT04875026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111157984|NCT04875026|Immunologic Factors|immunologic factors|mesh-ancestor
111157985|NCT04875026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111157986|NCT02296112|Trametinib|trametinib|mesh-list
111157987|NCT02296112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111157988|NCT02296112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111157989|NCT02296112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111157990|NCT02296112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111157991|NCT02269670|Tamoxifen|tamoxifen|mesh-list
111157992|NCT02269670|Everolimus|everolimus|mesh-list
111157993|NCT02269670|Letrozole|letrozole|mesh-list
111157994|NCT02269670|Fulvestrant|fulvestrant|mesh-list
111157995|NCT02269670|Anastrozole|anastrozole|mesh-list
111157996|NCT02269670|Megestrol|megestrol|mesh-list
111157997|NCT02269670|Megestrol Acetate|megestrol acetate|mesh-list
111157998|NCT02269670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111157999|NCT02269670|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111158000|NCT02269670|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111158001|NCT02269670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111158002|NCT02269670|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111158003|NCT02269670|Immunologic Factors|immunologic factors|mesh-ancestor
111158004|NCT02269670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111158005|NCT02269670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111158006|NCT02269670|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111158007|NCT02269670|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111158008|NCT02269670|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111158009|NCT02269670|Hormone Antagonists|hormone antagonists|mesh-ancestor
111158010|NCT02269670|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111158011|NCT02269670|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111158012|NCT02269670|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111158013|NCT02269670|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111158014|NCT02269670|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111158015|NCT02269670|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
111158016|NCT02269670|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111158017|NCT02269670|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111158018|NCT02269670|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111158019|NCT02269670|Contraceptive Agents|contraceptive agents|mesh-ancestor
111158020|NCT02269670|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111158021|NCT02269670|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111158022|NCT02269670|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111158023|NCT02269670|Appetite Stimulants|appetite stimulants|mesh-ancestor
111158024|NCT02269670|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111158025|NCT02225353|Progesterone|progesterone|mesh-list
111158026|NCT02225353|Progestins|progestins|mesh-ancestor
111158027|NCT02225353|Hormones|hormones|mesh-ancestor
111158028|NCT02225353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110875114|NCT02353078|Sucralfate|sucralfate|mesh-list
111158029|NCT02225353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111158030|NCT01641926|Interferons|interferons|mesh-list
111158031|NCT01641926|Interferon-alpha|interferon-alpha|mesh-list
111158032|NCT01641926|Interferon alpha-2|interferon alpha-2|mesh-list
111158033|NCT01641926|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
111158034|NCT01641926|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
111158035|NCT01641926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111158036|NCT01641926|Antiviral Agents|antiviral agents|mesh-ancestor
111158037|NCT01641926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111158038|NCT01641926|Immunologic Factors|immunologic factors|mesh-ancestor
111158039|NCT01641926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111158040|NCT02294786|Capecitabine|capecitabine|mesh-list
111158041|NCT02294786|Lapatinib|lapatinib|mesh-list
111158042|NCT02294786|Octreotide|octreotide|mesh-list
111158043|NCT02294786|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111158044|NCT02294786|Antimetabolites|antimetabolites|mesh-ancestor
111158045|NCT02294786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111158046|NCT02294786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111158047|NCT02294786|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111158048|NCT02294786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111158049|NCT02294786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111158050|NCT02294786|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111158051|NCT04880876|Eluxadoline|eluxadoline|mesh-list
111158052|NCT04880876|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111158053|NCT01927341|Panitumumab|panitumumab|mesh-list
111158054|NCT01927341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111158055|NCT01927341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111158056|NCT02294474|Insulin|insulin|mesh-list
111158057|NCT02294474|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111158058|NCT02294474|Insulin Glargine|insulin glargine|mesh-list
111158059|NCT02294474|Insulin Lispro|insulin lispro|mesh-list
111158060|NCT02294474|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111158061|NCT02294474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111158062|NCT02168101|Ixazomib|ixazomib|mesh-list
111158063|NCT02168101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111158064|NCT02168101|Protease Inhibitors|protease inhibitors|mesh-ancestor
111158065|NCT02168101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111158066|NCT02168101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111158067|NCT02298179|Aluminum Hydroxide|aluminum hydroxide|mesh-list
111158068|NCT02298179|MF59 oil emulsion|mf59 oil emulsion|mesh-list
111158069|NCT02298179|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111158070|NCT02298179|Immunologic Factors|immunologic factors|mesh-ancestor
111158071|NCT02298179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111158072|NCT02298179|Antacids|antacids|mesh-ancestor
111158073|NCT02298179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111158074|NCT02298179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111158075|NCT02298023|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
111158076|NCT02298023|Hemostatics|hemostatics|mesh-ancestor
111158077|NCT02298023|Coagulants|coagulants|mesh-ancestor
111158078|NCT02296931|Magnesium Sulfate|magnesium sulfate|mesh-list
111158079|NCT02296931|Analgesics|analgesics|mesh-ancestor
111158080|NCT02296931|Sensory System Agents|sensory system agents|mesh-ancestor
111158081|NCT02296931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111158082|NCT02296931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111158083|NCT02296931|Anesthetics|anesthetics|mesh-ancestor
111158084|NCT02296931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111158085|NCT02296931|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111158086|NCT02296931|Anticonvulsants|anticonvulsants|mesh-ancestor
111158087|NCT02296931|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111158088|NCT02296931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111158089|NCT02296931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111158090|NCT02296931|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111158091|NCT02296931|Tocolytic Agents|tocolytic agents|mesh-ancestor
111158092|NCT02296931|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111158093|NCT02166697|Candesartan|candesartan|mesh-list
111158094|NCT02166697|Candesartan cilexetil|candesartan cilexetil|mesh-list
111158095|NCT02166697|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111158096|NCT02166697|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111158097|NCT02166697|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111158098|NCT02166697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111158099|NCT04764721|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
111158100|NCT04764721|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111158101|NCT04764721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110875209|NCT03504917|Balovaptan|balovaptan|mesh-list
111158102|NCT02197897|Tamoxifen|tamoxifen|mesh-list
111158103|NCT02197897|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111158104|NCT02197897|Hormone Antagonists|hormone antagonists|mesh-ancestor
111158105|NCT02197897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111158106|NCT02197897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111158107|NCT02197897|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111158108|NCT02197897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110588153|NCT00737373|Leucovorin|leucovorin|mesh-list
111158109|NCT02197897|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111158110|NCT02197897|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111158111|NCT02197897|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111158112|NCT02196259|Ketamine|ketamine|mesh-list
111158113|NCT02196259|Anesthetics, Dissociative|anesthetics, dissociative|mesh-list
111158114|NCT02196259|Anesthetics|anesthetics|mesh-list
111158115|NCT02196259|Analgesics|analgesics|mesh-ancestor
111158116|NCT02196259|Sensory System Agents|sensory system agents|mesh-ancestor
111158117|NCT02196259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111158118|NCT02196259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111158119|NCT02196259|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111158120|NCT02196259|Anesthetics, General|anesthetics, general|mesh-ancestor
111158121|NCT02196259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111158122|NCT02196259|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111158123|NCT02196259|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111158124|NCT02196259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111158125|NCT02196259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111158126|NCT02294396|Solifenacin Succinate|solifenacin succinate|mesh-list
111158127|NCT02294396|Mirabegron|mirabegron|mesh-list
111158128|NCT02294396|Tolterodine Tartrate|tolterodine tartrate|mesh-list
111158129|NCT02294396|Propiverine|propiverine|mesh-list
111158130|NCT02294396|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111158131|NCT02294396|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111158132|NCT02294396|Cholinergic Agents|cholinergic agents|mesh-ancestor
111158133|NCT02294396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111158134|NCT02294396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111158135|NCT02294396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111158136|NCT02294396|Urological Agents|urological agents|mesh-ancestor
111158137|NCT02294396|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
111158138|NCT02294396|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111158139|NCT02294396|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111158140|NCT02294396|Adrenergic Agents|adrenergic agents|mesh-ancestor
111158141|NCT02294396|Parasympatholytics|parasympatholytics|mesh-ancestor
111158142|NCT02294396|Autonomic Agents|autonomic agents|mesh-ancestor
111158143|NCT02294396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111158144|NCT02164981|Nitroprusside|nitroprusside|mesh-list
110485154|NCT00730249|Methylphenidate|methylphenidate|mesh-list
111158145|NCT02164981|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111158146|NCT02164981|Vasodilator Agents|vasodilator agents|mesh-ancestor
111158147|NCT02164981|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
111158148|NCT02164981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111158149|NCT01908699|Beraprost|beraprost|mesh-list
111158150|NCT01908699|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111158151|NCT01908699|Vasodilator Agents|vasodilator agents|mesh-ancestor
111158152|NCT01363011|Darunavir|darunavir|mesh-list
111158153|NCT01363011|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
111158154|NCT01363011|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111158155|NCT01363011|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111158156|NCT01363011|Protease Inhibitors|protease inhibitors|mesh-ancestor
111158157|NCT01363011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111158158|NCT01363011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111158159|NCT01363011|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111158160|NCT01363011|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111158161|NCT01363011|Antiviral Agents|antiviral agents|mesh-ancestor
111158162|NCT01363011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111158163|NCT02263547|Teriflunomide|teriflunomide|mesh-list
111158164|NCT02263547|Colestipol|colestipol|mesh-list
111158165|NCT02263547|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111158166|NCT02263547|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111158167|NCT02263547|Analgesics|analgesics|mesh-ancestor
111158168|NCT02263547|Sensory System Agents|sensory system agents|mesh-ancestor
111158169|NCT02263547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111158170|NCT02263547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111158171|NCT02263547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111158172|NCT02263547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111158173|NCT02263547|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111158174|NCT02263547|Immunologic Factors|immunologic factors|mesh-ancestor
111158175|NCT02263547|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111158176|NCT02263547|Antimetabolites|antimetabolites|mesh-ancestor
111158177|NCT02263547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111158178|NCT02263547|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111158179|NCT02263547|Sequestering Agents|sequestering agents|mesh-ancestor
111158181|NCT01925703|Hematinics|hematinics|mesh-ancestor
111158182|NCT01617681|Valsartan|valsartan|mesh-list
111158183|NCT01617681|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111158184|NCT01617681|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111158185|NCT01617681|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111158186|NCT01617681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111158187|NCT02263079|Interferons|interferons|mesh-list
111158188|NCT02263079|Interferon-alpha|interferon-alpha|mesh-list
111158189|NCT02263079|Lamivudine|lamivudine|mesh-list
111158190|NCT02263079|Interferon alpha-2|interferon alpha-2|mesh-list
111158191|NCT02263079|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
111158192|NCT02263079|Entecavir|entecavir|mesh-list
111158193|NCT02263079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111158194|NCT02263079|Antiviral Agents|antiviral agents|mesh-ancestor
111158195|NCT02263079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111158196|NCT02263079|Immunologic Factors|immunologic factors|mesh-ancestor
111158197|NCT02263079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111158198|NCT02263079|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111158199|NCT02263079|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111158200|NCT02263079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111158201|NCT02263079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111158202|NCT02263079|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111158203|NCT02263079|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111158204|NCT02260817|Choline|choline|mesh-list
111158205|NCT02260817|Lipotropic Agents|lipotropic agents|mesh-ancestor
111158206|NCT02260817|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111158207|NCT02260817|Antimetabolites|antimetabolites|mesh-ancestor
111158208|NCT02260817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111158209|NCT02260817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111158210|NCT02260817|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111158211|NCT02260817|Nootropic Agents|nootropic agents|mesh-ancestor
111158212|NCT04873193|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111158213|NCT04873193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111158214|NCT01642589|Vaccines|vaccines|mesh-list
111158215|NCT01642589|Immunologic Factors|immunologic factors|mesh-ancestor
111158216|NCT01642589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111158217|NCT01954251|Vaccines|vaccines|mesh-list
111158218|NCT01954251|Immunologic Factors|immunologic factors|mesh-ancestor
111158219|NCT01954251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111158220|NCT04643925|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
111158221|NCT04643925|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111158222|NCT04643925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111158223|NCT02257385|Albuterol|albuterol|mesh-list
111158224|NCT02257385|Tiotropium Bromide|tiotropium bromide|mesh-list
111158225|NCT02257385|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111158226|NCT02257385|Autonomic Agents|autonomic agents|mesh-ancestor
111158227|NCT02257385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111158228|NCT02257385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111158229|NCT02257385|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111158230|NCT02257385|Respiratory System Agents|respiratory system agents|mesh-ancestor
111158231|NCT02257385|Parasympatholytics|parasympatholytics|mesh-ancestor
111158232|NCT02257385|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111158233|NCT02257385|Cholinergic Agents|cholinergic agents|mesh-ancestor
111158234|NCT02257385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111158235|NCT02257385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111158236|NCT02257385|Tocolytic Agents|tocolytic agents|mesh-ancestor
111158237|NCT02257385|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111158238|NCT02257385|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111158239|NCT02257385|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111158240|NCT02257385|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111158241|NCT02257385|Adrenergic Agents|adrenergic agents|mesh-ancestor
111158242|NCT01629667|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111158243|NCT01629667|Immunologic Factors|immunologic factors|mesh-ancestor
110841175|NCT01382888|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111158244|NCT01629667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111158245|NCT01645280|Methotrexate|methotrexate|mesh-list
111158246|NCT01645280|Ustekinumab|ustekinumab|mesh-list
111158247|NCT01645280|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111158248|NCT01645280|Abortifacient Agents|abortifacient agents|mesh-ancestor
111158249|NCT01645280|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111158250|NCT01645280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111158251|NCT01645280|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111158252|NCT01645280|Antimetabolites|antimetabolites|mesh-ancestor
111158253|NCT01645280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111158254|NCT01645280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111158255|NCT01645280|Dermatologic Agents|dermatologic agents|mesh-ancestor
111158256|NCT01645280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111158257|NCT01645280|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111158258|NCT01645280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111158259|NCT01645280|Immunologic Factors|immunologic factors|mesh-ancestor
111158260|NCT01645280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111158261|NCT01645280|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111158262|NCT01629589|Vaccines|vaccines|mesh-list
111158263|NCT01629589|Immunologic Factors|immunologic factors|mesh-ancestor
111158264|NCT01629589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111158265|NCT04188223|Vaccines|vaccines|mesh-list
111158266|NCT04188223|Immunologic Factors|immunologic factors|mesh-ancestor
111158267|NCT04188223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111158268|NCT02220907|Canagliflozin|canagliflozin|mesh-list
111158269|NCT02220907|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111158270|NCT02220907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111158271|NCT02220907|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111158272|NCT02220907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111158273|NCT01601873|Heparin|heparin|mesh-list
111158274|NCT01601873|Anticoagulants|anticoagulants|mesh-ancestor
111158275|NCT01601873|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111158276|NCT01601873|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111158277|NCT01601873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111158278|NCT02194933|Brexpiprazole|brexpiprazole|mesh-list
111158279|NCT02194933|Serotonin Agents|serotonin agents|mesh-ancestor
111158280|NCT02194933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111158281|NCT02194933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111158282|NCT02194933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111158283|NCT02194933|Dopamine Agonists|dopamine agonists|mesh-ancestor
111158284|NCT02194933|Dopamine Agents|dopamine agents|mesh-ancestor
111158285|NCT04420247|Hydroxychloroquine|hydroxychloroquine|mesh-list
111158286|NCT04420247|Chloroquine|chloroquine|mesh-list
111158287|NCT04420247|Antimalarials|antimalarials|mesh-ancestor
111158288|NCT04420247|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111158289|NCT04420247|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111158290|NCT04420247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111158291|NCT04420247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111158292|NCT04420247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111158293|NCT04420247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111158294|NCT04420247|Amebicides|amebicides|mesh-ancestor
111158295|NCT01644890|Paclitaxel|paclitaxel|mesh-list
111158296|NCT01644890|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111158297|NCT01644890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111158298|NCT01644890|Tubulin Modulators|tubulin modulators|mesh-ancestor
111158299|NCT01644890|Antimitotic Agents|antimitotic agents|mesh-ancestor
111158300|NCT01644890|Mitosis Modulators|mitosis modulators|mesh-ancestor
111158301|NCT01644890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111158302|NCT04865237|Remdesivir|remdesivir|mesh-list
111158303|NCT04865237|Antimetabolites|antimetabolites|mesh-ancestor
111158304|NCT04865237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110841193|NCT03077438|Vaccines|vaccines|mesh-list
111158306|NCT04865237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111158307|NCT01628965|Rotigotine|rotigotine|mesh-list
111158308|NCT01628965|Dopamine Agonists|dopamine agonists|mesh-ancestor
111158309|NCT01628965|Dopamine Agents|dopamine agents|mesh-ancestor
111158310|NCT01628965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111158311|NCT01628965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111158312|NCT01628965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111158313|NCT01644734|Tiotropium Bromide|tiotropium bromide|mesh-list
111158314|NCT01644734|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111158315|NCT01644734|Autonomic Agents|autonomic agents|mesh-ancestor
111158316|NCT01644734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111158317|NCT01644734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111158318|NCT01644734|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111158319|NCT01644734|Respiratory System Agents|respiratory system agents|mesh-ancestor
111158320|NCT01644734|Parasympatholytics|parasympatholytics|mesh-ancestor
111158321|NCT01644734|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111158322|NCT01644734|Cholinergic Agents|cholinergic agents|mesh-ancestor
111158323|NCT01644734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111158324|NCT01644734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111158325|NCT02255279|Vaccines|vaccines|mesh-list
111158326|NCT02255279|Immunologic Factors|immunologic factors|mesh-ancestor
111158327|NCT02255279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111158328|NCT02293538|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111158329|NCT02293538|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111158330|NCT02266706|Tazobactam|tazobactam|mesh-list
111158331|NCT02266706|Ceftolozane|ceftolozane|mesh-list
111158332|NCT02266706|Cephalosporins|cephalosporins|mesh-list
111158333|NCT02266706|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
111158334|NCT02266706|Penicillanic Acid|penicillanic acid|mesh-list
111158335|NCT02266706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111158336|NCT02266706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111158337|NCT02266706|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
111158338|NCT02266706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111158339|NCT02266706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111158340|NCT02266706|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111158341|NCT02292719|Ritonavir|ritonavir|mesh-list
111158342|NCT02292719|Ribavirin|ribavirin|mesh-list
111158343|NCT02292719|Sofosbuvir|sofosbuvir|mesh-list
111158344|NCT02292719|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111158345|NCT02292719|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111158346|NCT02292719|Protease Inhibitors|protease inhibitors|mesh-ancestor
111158347|NCT02292719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111158348|NCT02292719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111158349|NCT02292719|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111158350|NCT02292719|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111158351|NCT02292719|Antiviral Agents|antiviral agents|mesh-ancestor
111158352|NCT02292719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111158353|NCT02292719|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111158354|NCT02292719|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111158355|NCT02292719|Antimetabolites|antimetabolites|mesh-ancestor
111158356|NCT02291549|Mometasone Furoate|mometasone furoate|mesh-list
111158357|NCT02291549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111158358|NCT02291549|Dermatologic Agents|dermatologic agents|mesh-ancestor
111158359|NCT02291549|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111158360|NCT02264990|Paclitaxel|paclitaxel|mesh-list
111158361|NCT02264990|Carboplatin|carboplatin|mesh-list
111158362|NCT02264990|Pemetrexed|pemetrexed|mesh-list
111158363|NCT02264990|Veliparib|veliparib|mesh-list
111158364|NCT02264990|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111158365|NCT02264990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111158366|NCT02264990|Tubulin Modulators|tubulin modulators|mesh-ancestor
111158367|NCT02264990|Antimitotic Agents|antimitotic agents|mesh-ancestor
111158368|NCT02264990|Mitosis Modulators|mitosis modulators|mesh-ancestor
111158369|NCT02264990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111158370|NCT02264990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111158371|NCT02264990|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111158372|NCT02264990|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111158373|NCT02264990|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111158374|NCT02289833|Trastuzumab|trastuzumab|mesh-list
111158375|NCT02289833|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
111158376|NCT02289833|Maytansine|maytansine|mesh-list
111158377|NCT02289833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111158378|NCT02289833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111158379|NCT02289833|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111158380|NCT02289833|Tubulin Modulators|tubulin modulators|mesh-ancestor
111158381|NCT02289833|Antimitotic Agents|antimitotic agents|mesh-ancestor
111158382|NCT02289833|Mitosis Modulators|mitosis modulators|mesh-ancestor
111158383|NCT02289833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111158384|NCT02289833|Immunotoxins|immunotoxins|mesh-ancestor
111158385|NCT02289833|Immunoconjugates|immunoconjugates|mesh-ancestor
111158386|NCT02289833|Immunologic Factors|immunologic factors|mesh-ancestor
111158387|NCT02289833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111158388|NCT01702558|Capecitabine|capecitabine|mesh-list
111158389|NCT01702558|Trastuzumab|trastuzumab|mesh-list
111158390|NCT01702558|Maytansine|maytansine|mesh-list
111158391|NCT01702558|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
111158392|NCT01702558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111158393|NCT01702558|Antimetabolites|antimetabolites|mesh-ancestor
111158394|NCT01702558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111158395|NCT01702558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111158396|NCT01702558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111158397|NCT01702558|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111158398|NCT01702558|Tubulin Modulators|tubulin modulators|mesh-ancestor
111158399|NCT01702558|Antimitotic Agents|antimitotic agents|mesh-ancestor
111158400|NCT01702558|Mitosis Modulators|mitosis modulators|mesh-ancestor
111158401|NCT01702558|Immunotoxins|immunotoxins|mesh-ancestor
111158402|NCT01702558|Immunoconjugates|immunoconjugates|mesh-ancestor
111158403|NCT01702558|Immunologic Factors|immunologic factors|mesh-ancestor
111158404|NCT01702558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111158405|NCT02194465|Spironolactone|spironolactone|mesh-list
110875487|NCT03562481|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111158407|NCT02194465|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
111158408|NCT02194465|Mineralocorticoids|mineralocorticoids|mesh-list
111158409|NCT02194465|Vasodilator Agents|vasodilator agents|mesh-ancestor
111158410|NCT02194465|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111158411|NCT02194465|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111158412|NCT02194465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111158413|NCT02194465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111158414|NCT02194465|Urological Agents|urological agents|mesh-ancestor
111158415|NCT02194465|Hormone Antagonists|hormone antagonists|mesh-ancestor
111158416|NCT02194465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111158417|NCT02194465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111158418|NCT02194465|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
111158419|NCT02194465|Diuretics|diuretics|mesh-ancestor
111158420|NCT02194465|Natriuretic Agents|natriuretic agents|mesh-ancestor
111158421|NCT02194465|Hormones|hormones|mesh-ancestor
111158422|NCT01720264|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111158423|NCT01720264|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111158424|NCT01720264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111158425|NCT01720264|Incretins|incretins|mesh-ancestor
111158426|NCT01720264|Hormones|hormones|mesh-ancestor
111158427|NCT01720264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111158428|NCT01720264|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111158429|NCT01720264|Protease Inhibitors|protease inhibitors|mesh-ancestor
111158430|NCT01720264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111158431|NCT01720264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111158432|NCT04564846|Insulin|insulin|mesh-list
111158433|NCT04564846|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111158434|NCT04564846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111158435|NCT01702246|Simvastatin|simvastatin|mesh-list
111158436|NCT01702246|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111158437|NCT01702246|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111158438|NCT01702246|Antimetabolites|antimetabolites|mesh-ancestor
111158439|NCT01702246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111158440|NCT01702246|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110841202|NCT02183870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111158441|NCT01702246|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111158442|NCT01702246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111158443|NCT01631227|Eprosartan|eprosartan|mesh-list
111158444|NCT01631227|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111158445|NCT01631227|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
111158446|NCT01631227|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111158447|NCT01631227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111158448|NCT05645861|Benzocaine|benzocaine|mesh-list
111158449|NCT05645861|Anesthetics, Local|anesthetics, local|mesh-ancestor
111158450|NCT05645861|Anesthetics|anesthetics|mesh-ancestor
111158451|NCT05645861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111158452|NCT05645861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111158453|NCT05645861|Sensory System Agents|sensory system agents|mesh-ancestor
111158454|NCT05645861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111158455|NCT01719172|Hemostatics|hemostatics|mesh-list
111158456|NCT01719172|Coagulants|coagulants|mesh-ancestor
111158457|NCT02285855|Metformin|metformin|mesh-list
111158458|NCT02285855|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111158459|NCT02285855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111158460|NCT02285153|Aspirin|aspirin|mesh-list
111158461|NCT02285153|Acetylsalicylic acid lysinate|acetylsalicylic acid lysinate|mesh-list
111158462|NCT02285153|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111158463|NCT02285153|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111158464|NCT02285153|Analgesics|analgesics|mesh-ancestor
111158465|NCT02285153|Sensory System Agents|sensory system agents|mesh-ancestor
111158466|NCT02285153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111158467|NCT02285153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111158468|NCT02285153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111158469|NCT02285153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111158470|NCT02285153|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111158471|NCT02285153|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111158472|NCT02285153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111158473|NCT02285153|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111158474|NCT02285153|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111158475|NCT02285153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111158476|NCT02285153|Antipyretics|antipyretics|mesh-ancestor
111158477|NCT01632241|Belimumab|belimumab|mesh-list
111158478|NCT01632241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110875564|NCT02349958|Doxorubicin|doxorubicin|mesh-list
111158479|NCT01632241|Immunologic Factors|immunologic factors|mesh-ancestor
111158480|NCT01632241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111158481|NCT02263508|Pembrolizumab|pembrolizumab|mesh-list
111158482|NCT02263508|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
111158483|NCT02263508|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111158484|NCT02263508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111158485|NCT02263508|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111158486|NCT02263508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111158487|NCT01741792|Blinatumomab|blinatumomab|mesh-list
111158488|NCT01741792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111158489|NCT02289950|Farletuzumab|farletuzumab|mesh-list
111158490|NCT02289950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111158491|NCT02288312|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
111158492|NCT02288312|Anticonvulsants|anticonvulsants|mesh-ancestor
111158493|NCT02288312|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111158494|NCT02288312|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111158495|NCT02288312|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111158496|NCT02288312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111158497|NCT01740388|Besifloxacin|besifloxacin|mesh-list
111158498|NCT01740388|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111158499|NCT01740388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111158500|NCT01740388|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111158501|NCT01740388|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111158502|NCT01740388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111158503|NCT01740388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111158504|NCT01740388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111158505|NCT01740154|Sunitinib|sunitinib|mesh-list
111158506|NCT01740154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111158507|NCT01740154|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111158508|NCT01740154|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111158509|NCT01740154|Growth Substances|growth substances|mesh-ancestor
111158510|NCT01740154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111158511|NCT01740154|Growth Inhibitors|growth inhibitors|mesh-ancestor
111158512|NCT01740154|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111158513|NCT01740154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111158514|NCT01740154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111158515|NCT02287610|Prednisone|prednisone|mesh-list
111158516|NCT02287610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111158517|NCT02287610|Glucocorticoids|glucocorticoids|mesh-ancestor
111158518|NCT02287610|Hormones|hormones|mesh-ancestor
111158519|NCT02287610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111158520|NCT02287610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111158521|NCT02287610|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111158522|NCT02287610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111158523|NCT02262728|Sofosbuvir|sofosbuvir|mesh-list
111158524|NCT02262728|Simeprevir|simeprevir|mesh-list
111158525|NCT02262728|Antiviral Agents|antiviral agents|mesh-ancestor
111158526|NCT02262728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111158527|NCT02262728|Protease Inhibitors|protease inhibitors|mesh-ancestor
111158528|NCT02262728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111158529|NCT02262728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111158530|NCT01717768|Testosterone|testosterone|mesh-list
111158531|NCT01717768|Androgens|androgens|mesh-ancestor
111158532|NCT01717768|Hormones|hormones|mesh-ancestor
111158533|NCT01717768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111158534|NCT01717768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111158535|NCT02260934|Acetaminophen|acetaminophen|mesh-list
111158536|NCT02260934|Diphenhydramine|diphenhydramine|mesh-list
111158537|NCT02260934|Promethazine|promethazine|mesh-list
111158538|NCT02260934|Prednisone|prednisone|mesh-list
111158539|NCT02260934|Methylprednisolone|methylprednisolone|mesh-list
111158540|NCT02260934|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111158541|NCT02260934|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111158542|NCT02260934|Prednisolone|prednisolone|mesh-list
111158543|NCT02260934|Prednisolone acetate|prednisolone acetate|mesh-list
111158544|NCT02260934|Cyclophosphamide|cyclophosphamide|mesh-list
111158545|NCT02260934|Rituximab|rituximab|mesh-list
111158546|NCT02260934|Belimumab|belimumab|mesh-list
111158547|NCT02260934|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111158548|NCT02260934|Prednisolone phosphate|prednisolone phosphate|mesh-list
111158549|NCT02260934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111158550|NCT02260934|Immunologic Factors|immunologic factors|mesh-ancestor
111158551|NCT02260934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111158552|NCT02260934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111158553|NCT02260934|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111158554|NCT02260934|Alkylating Agents|alkylating agents|mesh-ancestor
111158555|NCT02260934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111158557|NCT02260934|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111158558|NCT02260934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111158559|NCT02260934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111158560|NCT02260934|Glucocorticoids|glucocorticoids|mesh-ancestor
111158561|NCT02260934|Hormones|hormones|mesh-ancestor
111158562|NCT02260934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111158563|NCT02260934|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111158564|NCT02260934|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111158565|NCT02260934|Analgesics|analgesics|mesh-ancestor
111158566|NCT02260934|Sensory System Agents|sensory system agents|mesh-ancestor
111158567|NCT02260934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111158568|NCT02260934|Antipyretics|antipyretics|mesh-ancestor
111158569|NCT02260934|Antiemetics|antiemetics|mesh-ancestor
111158570|NCT02260934|Autonomic Agents|autonomic agents|mesh-ancestor
111158571|NCT02260934|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111158572|NCT02260934|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111158573|NCT02260934|Protective Agents|protective agents|mesh-ancestor
111158574|NCT02260934|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111158575|NCT02260934|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111158576|NCT02260934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111158577|NCT02260934|Anesthetics, Local|anesthetics, local|mesh-ancestor
111158578|NCT02260934|Anesthetics|anesthetics|mesh-ancestor
111158579|NCT02260934|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111158580|NCT02260934|Histamine Antagonists|histamine antagonists|mesh-ancestor
111158581|NCT02260934|Histamine Agents|histamine agents|mesh-ancestor
111158582|NCT02260934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111158583|NCT02260934|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111158584|NCT02260934|Antipruritics|antipruritics|mesh-ancestor
111158585|NCT02260934|Dermatologic Agents|dermatologic agents|mesh-ancestor
111158586|NCT02260388|Mexiletine|mexiletine|mesh-list
111158587|NCT02260388|Pregabalin|pregabalin|mesh-list
111158588|NCT02260388|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
111158589|NCT02260388|Nortriptyline|nortriptyline|mesh-list
111158590|NCT02260388|Analgesics|analgesics|mesh-ancestor
111158591|NCT02260388|Sensory System Agents|sensory system agents|mesh-ancestor
111158592|NCT02260388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111158593|NCT02260388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111158594|NCT02260388|Anticonvulsants|anticonvulsants|mesh-ancestor
111158595|NCT02260388|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111158596|NCT02260388|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111158597|NCT02260388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111158598|NCT02260388|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111158599|NCT02260388|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111158600|NCT02260388|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111158601|NCT02260388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111158602|NCT02260388|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111158603|NCT02260388|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111158604|NCT02260388|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111158605|NCT02260388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111158606|NCT02260388|Antidepressive Agents|antidepressive agents|mesh-ancestor
111158607|NCT02260388|Dopamine Agents|dopamine agents|mesh-ancestor
111158608|NCT02260388|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
111158609|NCT02260388|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111158610|NCT02260388|Adrenergic Agents|adrenergic agents|mesh-ancestor
111158611|NCT02260388|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111158612|NCT02260388|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111158613|NCT02260388|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111158614|NCT02260154|Mebeverine|mebeverine|mesh-list
111158615|NCT02260154|Alverine|alverine|mesh-list
111158616|NCT02260154|Anticonvulsants|anticonvulsants|mesh-ancestor
111158617|NCT02260154|Parasympatholytics|parasympatholytics|mesh-ancestor
111158618|NCT02260154|Autonomic Agents|autonomic agents|mesh-ancestor
110841237|NCT02890992|Antimetabolites|antimetabolites|mesh-ancestor
111158619|NCT02260154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111158620|NCT02260154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111158621|NCT01643408|Asparaginase|asparaginase|mesh-list
111158622|NCT01643408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111158623|NCT02283788|Moxifloxacin|moxifloxacin|mesh-list
111158624|NCT02283788|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
111158625|NCT02283788|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111158626|NCT02283788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111158627|NCT02283788|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111158628|NCT02283788|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111158629|NCT02283788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111158630|NCT02283788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111158631|NCT02283788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111158632|NCT02283788|Anticonvulsants|anticonvulsants|mesh-ancestor
111158633|NCT02283788|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111158634|NCT02283788|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111158635|NCT02283788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111158636|NCT01739764|Vemurafenib|vemurafenib|mesh-list
111158637|NCT01739764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111158638|NCT01739764|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111158639|NCT01739764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111158640|NCT01739764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111158641|NCT01700530|Simvastatin|simvastatin|mesh-list
111158642|NCT01700530|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
111158643|NCT01700530|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111158644|NCT01700530|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111158645|NCT01700530|Antimetabolites|antimetabolites|mesh-ancestor
111158646|NCT01700530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111158647|NCT01700530|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111158648|NCT01700530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111158649|NCT01717456|Loperamide|loperamide|mesh-list
111158650|NCT01717456|Antidiarrheals|antidiarrheals|mesh-list
111158651|NCT01717456|Laxatives|laxatives|mesh-list
111158652|NCT01717456|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111158653|NCT01716754|Omalizumab|omalizumab|mesh-list
111158654|NCT01716754|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111158655|NCT01716754|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111158656|NCT01716754|Respiratory System Agents|respiratory system agents|mesh-ancestor
111158657|NCT01698814|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
111158658|NCT01698814|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111158659|NCT01698814|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111158660|NCT01698814|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111158661|NCT01698814|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111158662|NCT01698814|Analgesics|analgesics|mesh-ancestor
111158663|NCT01698814|Sensory System Agents|sensory system agents|mesh-ancestor
111158664|NCT01698814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111158665|NCT01698814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111158666|NCT01698814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111158667|NCT01698814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111158668|NCT01698814|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111158669|NCT01698814|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
111158670|NCT01698814|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111158671|NCT01698814|Histamine Antagonists|histamine antagonists|mesh-ancestor
111158672|NCT01698814|Histamine Agents|histamine agents|mesh-ancestor
111158673|NCT01698814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111158674|NCT01698814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111158675|NCT01738594|Romidepsin|romidepsin|mesh-list
111158676|NCT01738594|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111158677|NCT01738594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111158678|NCT01738594|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111158679|NCT01738594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111158680|NCT01738594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111158681|NCT01697956|Beclomethasone|beclomethasone|mesh-list
111158682|NCT01697956|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111158683|NCT01697956|Glucocorticoids|glucocorticoids|mesh-ancestor
111158684|NCT01697956|Hormones|hormones|mesh-ancestor
110485212|NCT02682225|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111158685|NCT01697956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110841263|NCT05274984|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111158686|NCT01697956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111158687|NCT01697956|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111158688|NCT01697956|Respiratory System Agents|respiratory system agents|mesh-ancestor
111158689|NCT01697800|Tadalafil|tadalafil|mesh-list
111158690|NCT01697800|Vasodilator Agents|vasodilator agents|mesh-ancestor
111158691|NCT01697800|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111158692|NCT01697800|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111158693|NCT01697800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111158694|NCT01697800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111158695|NCT01697800|Urological Agents|urological agents|mesh-ancestor
111158696|NCT04553770|Trastuzumab|trastuzumab|mesh-list
111158697|NCT04553770|Anastrozole|anastrozole|mesh-list
111158698|NCT04553770|Camptothecin|camptothecin|mesh-list
111158699|NCT04553770|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
111158700|NCT04553770|Immunoconjugates|immunoconjugates|mesh-list
111158701|NCT04553770|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111158702|NCT04553770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111158703|NCT04553770|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111158704|NCT04553770|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111158705|NCT04553770|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111158706|NCT04553770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111158707|NCT04553770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111158708|NCT04553770|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111158709|NCT04553770|Hormone Antagonists|hormone antagonists|mesh-ancestor
111158710|NCT04553770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111158711|NCT04553770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111158712|NCT04553770|Immunologic Factors|immunologic factors|mesh-ancestor
111158713|NCT04553770|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111158714|NCT04553770|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111158715|NCT04553770|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111158716|NCT01644500|Glimepiride|glimepiride|mesh-list
111158717|NCT01644500|Dulaglutide|dulaglutide|mesh-list
111158718|NCT01644500|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111158719|NCT01644500|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111158720|NCT01644500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111158721|NCT01644500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111158722|NCT01644500|Immunologic Factors|immunologic factors|mesh-ancestor
111158723|NCT04877834|Dexlansoprazole|dexlansoprazole|mesh-list
111158724|NCT04877834|Lansoprazole|lansoprazole|mesh-list
111158725|NCT04877834|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111158726|NCT04877834|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111158727|NCT04877834|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111158728|NCT04877834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111158729|NCT04877834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111158731|NCT01604824|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
111158732|NCT01604824|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111158733|NCT01604824|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111158734|NCT01604824|Antimetabolites|antimetabolites|mesh-ancestor
111158735|NCT01604824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111158736|NCT01604824|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111158737|NCT01604824|Protease Inhibitors|protease inhibitors|mesh-ancestor
111158738|NCT01604824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111158739|NCT01604824|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111158740|NCT01716052|Ibuprofen|ibuprofen|mesh-list
111158741|NCT01716052|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111158742|NCT01716052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111158743|NCT01716052|Analgesics|analgesics|mesh-ancestor
111158744|NCT01716052|Sensory System Agents|sensory system agents|mesh-ancestor
111158745|NCT01716052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111158746|NCT01716052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111158747|NCT01716052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111158748|NCT01716052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111158749|NCT01716052|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111158750|NCT01716052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110841268|NCT05274672|Ciprofloxacin|ciprofloxacin|mesh-list
111158751|NCT01716052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111158752|NCT01641692|Albuterol|albuterol|mesh-list
111158753|NCT01641692|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111158754|NCT01641692|Autonomic Agents|autonomic agents|mesh-ancestor
111158755|NCT01641692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111158756|NCT01641692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111158757|NCT01641692|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111158758|NCT01641692|Respiratory System Agents|respiratory system agents|mesh-ancestor
111158759|NCT01641692|Tocolytic Agents|tocolytic agents|mesh-ancestor
111158760|NCT01641692|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111158761|NCT01641692|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111158762|NCT01641692|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111158763|NCT01641692|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111158764|NCT01641692|Adrenergic Agents|adrenergic agents|mesh-ancestor
111158765|NCT01641692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111158766|NCT01641692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111158767|NCT01682512|Rituximab|rituximab|mesh-list
111158768|NCT01682512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111158769|NCT01682512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111158770|NCT01682512|Immunologic Factors|immunologic factors|mesh-ancestor
111158771|NCT01682512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111158772|NCT01682512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111158773|NCT04863716|Fentanyl|fentanyl|mesh-list
111158774|NCT04863716|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111158775|NCT04863716|Narcotics|narcotics|mesh-ancestor
111158776|NCT04863716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111158777|NCT04863716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111158779|NCT04863716|Sensory System Agents|sensory system agents|mesh-ancestor
111158780|NCT04863716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111158781|NCT04863716|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111158782|NCT04863716|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111158783|NCT04863716|Anesthetics, General|anesthetics, general|mesh-ancestor
111158784|NCT04863716|Anesthetics|anesthetics|mesh-ancestor
111158785|NCT04135352|Pembrolizumab|pembrolizumab|mesh-list
111158786|NCT04135352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111158787|NCT04135352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111158788|NCT04135352|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111158789|NCT04135352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111158790|NCT01715896|Golimumab|golimumab|mesh-list
111158791|NCT01715896|Mavrilimumab|mavrilimumab|mesh-list
111158792|NCT01715896|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111158793|NCT01715896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111158794|NCT01715896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111158795|NCT01715896|Immunologic Factors|immunologic factors|mesh-ancestor
111158796|NCT01715896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111158797|NCT01715896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111158798|NCT05642702|Vitamins|vitamins|mesh-list
111158799|NCT05642702|Ascorbic Acid|ascorbic acid|mesh-list
111158800|NCT05642702|Niacinamide|niacinamide|mesh-list
111158801|NCT05642702|Niacin|niacin|mesh-list
111158802|NCT05642702|Nicotinic Acids|nicotinic acids|mesh-list
111158803|NCT05642702|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111158804|NCT05642702|Micronutrients|micronutrients|mesh-ancestor
111158805|NCT05642702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111158806|NCT05642702|Antioxidants|antioxidants|mesh-ancestor
111158807|NCT05642702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111158808|NCT05642702|Protective Agents|protective agents|mesh-ancestor
111158809|NCT05642702|Vitamin B Complex|vitamin b complex|mesh-ancestor
111158810|NCT05642702|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111158811|NCT05642702|Antimetabolites|antimetabolites|mesh-ancestor
111158812|NCT05642702|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111158813|NCT05642702|Vasodilator Agents|vasodilator agents|mesh-ancestor
111158814|NCT02254772|Ipilimumab|ipilimumab|mesh-list
110485225|NCT04066231|Erythromycin stearate|erythromycin stearate|mesh-list
111158815|NCT02254772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111158816|NCT02254772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111158817|NCT02254772|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111158818|NCT02254772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111158819|NCT01682044|Rituximab|rituximab|mesh-list
111158820|NCT01682044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111158821|NCT01682044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111158822|NCT01682044|Immunologic Factors|immunologic factors|mesh-ancestor
111158823|NCT01682044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111158824|NCT01682044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111158825|NCT05640596|Betamethasone|betamethasone|mesh-list
111158826|NCT05640596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111158827|NCT05640596|Glucocorticoids|glucocorticoids|mesh-ancestor
111158828|NCT05640596|Hormones|hormones|mesh-ancestor
111158829|NCT05640596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111158830|NCT05640596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111158831|NCT05640596|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111158832|NCT05640596|Respiratory System Agents|respiratory system agents|mesh-ancestor
111158833|NCT05651126|Psilocybin|psilocybin|mesh-list
111158834|NCT05651126|Hallucinogens|hallucinogens|mesh-ancestor
111158835|NCT05651126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111158836|NCT05651126|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111158837|NCT01696942|Mesalamine|mesalamine|mesh-list
111158838|NCT01696942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111158839|NCT01696942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111158840|NCT01696942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111158841|NCT01696942|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111158842|NCT01696942|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111158843|NCT01696942|Analgesics|analgesics|mesh-ancestor
111158844|NCT01696942|Sensory System Agents|sensory system agents|mesh-ancestor
111158845|NCT01696942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111158846|NCT05493566|Aldesleukin|aldesleukin|mesh-list
111158847|NCT05493566|Pembrolizumab|pembrolizumab|mesh-list
111158848|NCT05493566|Interleukin-2|interleukin-2|mesh-list
111158849|NCT05493566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111158850|NCT05493566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111158851|NCT05493566|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110875936|NCT02348788|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
111158852|NCT05493566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111158853|NCT05493566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111158854|NCT05493566|Analgesics|analgesics|mesh-ancestor
111158855|NCT05493566|Sensory System Agents|sensory system agents|mesh-ancestor
111158856|NCT05493566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111158857|NCT05493566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111158858|NCT05493566|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111158859|NCT05493566|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111158860|NCT05493566|Antiviral Agents|antiviral agents|mesh-ancestor
111158861|NCT05493566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111158862|NCT04871204|Octreotide|octreotide|mesh-list
111158863|NCT04871204|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111158864|NCT04871204|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111158865|NCT04871204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111158866|NCT05650268|Vitamin D|vitamin d|mesh-list
111158867|NCT05650268|Ergocalciferols|ergocalciferols|mesh-list
111158868|NCT05650268|Cholecalciferol|cholecalciferol|mesh-list
111158869|NCT05650268|Vitamins|vitamins|mesh-list
111158870|NCT05650268|Micronutrients|micronutrients|mesh-ancestor
111158871|NCT05650268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111158872|NCT05650268|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111158873|NCT05650268|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111158874|NCT04835870|Prednisone|prednisone|mesh-list
111158875|NCT04835870|Cyclophosphamide|cyclophosphamide|mesh-list
111158876|NCT04835870|Rituximab|rituximab|mesh-list
111158877|NCT04835870|Doxorubicin|doxorubicin|mesh-list
111158878|NCT04835870|Vincristine|vincristine|mesh-list
111158879|NCT04835870|Zanubrutinib|zanubrutinib|mesh-list
111158880|NCT04835870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111158881|NCT04835870|Immunologic Factors|immunologic factors|mesh-ancestor
111158882|NCT04835870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111158883|NCT04835870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111158884|NCT04835870|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111158885|NCT04835870|Alkylating Agents|alkylating agents|mesh-ancestor
111158886|NCT04835870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111158887|NCT04835870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111158888|NCT04835870|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111158889|NCT04835870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111158890|NCT04835870|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111158891|NCT04835870|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111158892|NCT04835870|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111158893|NCT04835870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111158894|NCT04835870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111158895|NCT04835870|Glucocorticoids|glucocorticoids|mesh-ancestor
111158897|NCT04835870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111158898|NCT04835870|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111158899|NCT04835870|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111158900|NCT04835870|Tubulin Modulators|tubulin modulators|mesh-ancestor
111158901|NCT04835870|Antimitotic Agents|antimitotic agents|mesh-ancestor
111158902|NCT04835870|Mitosis Modulators|mitosis modulators|mesh-ancestor
111158903|NCT04835870|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111158904|NCT01639040|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111158905|NCT01639040|Immunologic Factors|immunologic factors|mesh-ancestor
111158906|NCT01639040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111158907|NCT04834388|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
111158908|NCT04834388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111158909|NCT04834310|Clindamycin|clindamycin|mesh-list
111158910|NCT04834310|Clindamycin palmitate|clindamycin palmitate|mesh-list
111158911|NCT04834310|Clindamycin phosphate|clindamycin phosphate|mesh-list
111158912|NCT04834310|Cefazolin|cefazolin|mesh-list
111158913|NCT04834310|Cephalexin|cephalexin|mesh-list
111158914|NCT04834310|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111158915|NCT04834310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111158916|NCT04834310|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111158917|NCT04834310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111158918|NCT04834310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111158919|NCT05372198|Immunomodulating Agents|immunomodulating agents|mesh-list
111158920|NCT05372198|Immunologic Factors|immunologic factors|mesh-ancestor
111158921|NCT05372198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111158922|NCT05359406|Tislelizumab|tislelizumab|mesh-list
111158923|NCT05359406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111158924|NCT05359406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110876017|NCT02337712|Etoposide|etoposide|mesh-list
111158925|NCT04654208|Palbociclib|palbociclib|mesh-list
111158926|NCT04654208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111158927|NCT04654208|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111158928|NCT04654208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111158929|NCT04654208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111158930|NCT05357846|Paclitaxel|paclitaxel|mesh-list
111158931|NCT05357846|Cisplatin|cisplatin|mesh-list
111158932|NCT05357846|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111158933|NCT05357846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111158934|NCT05357846|Tubulin Modulators|tubulin modulators|mesh-ancestor
111158935|NCT05357846|Antimitotic Agents|antimitotic agents|mesh-ancestor
111158936|NCT05357846|Mitosis Modulators|mitosis modulators|mesh-ancestor
111158937|NCT05357846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111158938|NCT04844216|Lidocaine|lidocaine|mesh-list
111158939|NCT04844216|Hyaluronic Acid|hyaluronic acid|mesh-list
111158940|NCT04844216|Anesthetics, Local|anesthetics, local|mesh-ancestor
111158941|NCT04844216|Anesthetics|anesthetics|mesh-ancestor
111158942|NCT04844216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111158943|NCT04844216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111158944|NCT04844216|Sensory System Agents|sensory system agents|mesh-ancestor
111158945|NCT04844216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111158946|NCT04844216|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111158947|NCT04844216|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111158948|NCT04844216|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111158949|NCT04844216|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111158950|NCT04844216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111158951|NCT04844216|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111158952|NCT04844216|Immunologic Factors|immunologic factors|mesh-ancestor
111158953|NCT04844216|Viscosupplements|viscosupplements|mesh-ancestor
111158954|NCT04844216|Protective Agents|protective agents|mesh-ancestor
111158956|NCT05345678|Tremelimumab|tremelimumab|mesh-list
111158957|NCT05345678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111158958|NCT05345678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111158959|NCT05327738|Atezolizumab|atezolizumab|mesh-list
111158960|NCT05327738|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111158961|NCT05327738|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111158962|NCT05327738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111158963|NCT05327738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111158964|NCT05327738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111158965|NCT05327738|Immunologic Factors|immunologic factors|mesh-ancestor
111158966|NCT05327738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111158967|NCT04419662|Phenylephrine|phenylephrine|mesh-list
111158968|NCT04419662|Oxymetazoline|oxymetazoline|mesh-list
111158969|NCT04419662|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111158970|NCT04419662|Mydriatics|mydriatics|mesh-ancestor
111158971|NCT04419662|Autonomic Agents|autonomic agents|mesh-ancestor
111158972|NCT04419662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111158973|NCT04419662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111158974|NCT04419662|Sympathomimetics|sympathomimetics|mesh-ancestor
111158975|NCT04419662|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111158976|NCT04419662|Nasal Decongestants|nasal decongestants|mesh-ancestor
111158977|NCT04419662|Respiratory System Agents|respiratory system agents|mesh-ancestor
111158978|NCT04419662|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111158979|NCT04419662|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111158980|NCT04419662|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111158981|NCT04419662|Adrenergic Agents|adrenergic agents|mesh-ancestor
111158982|NCT04419662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111158983|NCT04419662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111158984|NCT04419662|Protective Agents|protective agents|mesh-ancestor
111158985|NCT04589546|Niacinamide|niacinamide|mesh-list
111158986|NCT04589546|Niacin|niacin|mesh-list
111158987|NCT04589546|Nicotinic Acids|nicotinic acids|mesh-list
111158988|NCT04589546|Vitamin B Complex|vitamin b complex|mesh-ancestor
111158989|NCT04589546|Vitamins|vitamins|mesh-ancestor
111158990|NCT04589546|Micronutrients|micronutrients|mesh-ancestor
111158991|NCT04589546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111158992|NCT04589546|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111158993|NCT04589546|Antimetabolites|antimetabolites|mesh-ancestor
111158994|NCT04589546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111158995|NCT04589546|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111158996|NCT04589546|Vasodilator Agents|vasodilator agents|mesh-ancestor
111158997|NCT05369468|Dexmedetomidine|dexmedetomidine|mesh-list
111158998|NCT05369468|Bupivacaine|bupivacaine|mesh-list
111158999|NCT05369468|Anesthetics, Local|anesthetics, local|mesh-ancestor
111159000|NCT05369468|Anesthetics|anesthetics|mesh-ancestor
111159001|NCT05369468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111159002|NCT05369468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110876084|NCT03722303|Cortisone|cortisone|mesh-list
111159003|NCT05369468|Sensory System Agents|sensory system agents|mesh-ancestor
111159004|NCT05369468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111159005|NCT05369468|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111159006|NCT05369468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111159007|NCT05369468|Analgesics|analgesics|mesh-ancestor
111159008|NCT05369468|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111159009|NCT05369468|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111159010|NCT05369468|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111159011|NCT05369468|Adrenergic Agents|adrenergic agents|mesh-ancestor
111159012|NCT05369468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111159013|NCT05369468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111159014|NCT02164513|Fluticasone|fluticasone|mesh-list
111159017|NCT02164513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111159018|NCT02164513|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111159019|NCT02164513|Autonomic Agents|autonomic agents|mesh-ancestor
111159020|NCT02164513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111159021|NCT02164513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111159022|NCT02164513|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111159023|NCT02164513|Respiratory System Agents|respiratory system agents|mesh-ancestor
111159024|NCT02164513|Dermatologic Agents|dermatologic agents|mesh-ancestor
111159025|NCT02164513|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111159026|NCT02164513|Anticonvulsants|anticonvulsants|mesh-ancestor
111159027|NCT04532372|Leflunomide|leflunomide|mesh-list
111159028|NCT04532372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111159029|NCT04532372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111159030|NCT04532372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111159031|NCT04532372|Immunologic Factors|immunologic factors|mesh-ancestor
111159032|NCT04532372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111159033|NCT04513184|Dexamethasone|dexamethasone|mesh-list
111159034|NCT04513184|Dexamethasone acetate|dexamethasone acetate|mesh-list
111159035|NCT04513184|BB 1101|bb 1101|mesh-list
111159036|NCT04513184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111159037|NCT04513184|Antiemetics|antiemetics|mesh-ancestor
111159038|NCT04513184|Autonomic Agents|autonomic agents|mesh-ancestor
111159039|NCT04513184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111159040|NCT04513184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111159041|NCT04513184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111159042|NCT04513184|Glucocorticoids|glucocorticoids|mesh-ancestor
111159043|NCT04513184|Hormones|hormones|mesh-ancestor
111159044|NCT04513184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111159045|NCT04513184|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111159046|NCT04513184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111159047|NCT04513184|Protease Inhibitors|protease inhibitors|mesh-ancestor
111159048|NCT04513184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111159049|NCT04513184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111159050|NCT04756531|Nirmatrelvir|nirmatrelvir|mesh-list
111159051|NCT04756531|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111159052|NCT04756531|Protease Inhibitors|protease inhibitors|mesh-ancestor
111159053|NCT04756531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111159054|NCT04756531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111159055|NCT04756531|Antiviral Agents|antiviral agents|mesh-ancestor
111159056|NCT04756531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111159057|NCT02218489|Loteprednol Etabonate|loteprednol etabonate|mesh-list
111159058|NCT02218489|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111159059|NCT01713946|Everolimus|everolimus|mesh-list
111159060|NCT01713946|Anticonvulsants|anticonvulsants|mesh-list
111159061|NCT01713946|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111159062|NCT01713946|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111159063|NCT01713946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111159064|NCT01713946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111159066|NCT01713946|Immunologic Factors|immunologic factors|mesh-ancestor
111159067|NCT01713946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111159068|NCT01713946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111159069|NCT04464512|Sufentanil|sufentanil|mesh-list
111159070|NCT04464512|Buprenorphine|buprenorphine|mesh-list
111159071|NCT04464512|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111159072|NCT04464512|Narcotics|narcotics|mesh-ancestor
111159073|NCT04464512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111159074|NCT04464512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111159075|NCT04464512|Analgesics|analgesics|mesh-ancestor
111159076|NCT04464512|Sensory System Agents|sensory system agents|mesh-ancestor
111159077|NCT04464512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111159078|NCT04464512|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111159079|NCT04464512|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111159080|NCT04464512|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111159081|NCT04464512|Anesthetics, General|anesthetics, general|mesh-ancestor
111159083|NCT05369234|Sucralfate|sucralfate|mesh-list
111159084|NCT05369234|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111159085|NCT05369234|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111159086|NCT04827446|Methamphetamine|methamphetamine|mesh-list
111159087|NCT04827446|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111159088|NCT04827446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111159089|NCT04827446|Sympathomimetics|sympathomimetics|mesh-ancestor
111159090|NCT04827446|Autonomic Agents|autonomic agents|mesh-ancestor
111159091|NCT04827446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111159092|NCT04827446|Dopamine Agents|dopamine agents|mesh-ancestor
111159093|NCT04827446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111159094|NCT04827446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111159095|NCT04827446|Adrenergic Agents|adrenergic agents|mesh-ancestor
111159096|NCT04827446|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111159097|NCT04827446|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111159098|NCT04827446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111159099|NCT04827446|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111159100|NCT02191579|Topiramate|topiramate|mesh-list
111159101|NCT02191579|Botulinum Toxins|botulinum toxins|mesh-list
111159102|NCT02191579|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111159103|NCT02191579|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111159104|NCT02191579|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111159105|NCT02191579|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111159106|NCT02191579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111159107|NCT02191579|Cholinergic Agents|cholinergic agents|mesh-ancestor
111159108|NCT02191579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111159109|NCT02191579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111159110|NCT02191579|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111159111|NCT02191579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111159112|NCT02191579|Anticonvulsants|anticonvulsants|mesh-ancestor
111159113|NCT02191579|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111159114|NCT05324462|Xultophy|xultophy|mesh-list
111159115|NCT05324462|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111159116|NCT05324462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111159117|NCT05324462|Incretins|incretins|mesh-ancestor
111159118|NCT05324462|Hormones|hormones|mesh-ancestor
111159119|NCT05324462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111159120|NCT01363700|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
111159121|NCT01363700|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111159122|NCT01363700|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111159123|NCT01363700|Epinastine|epinastine|mesh-list
111159124|NCT01363700|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111159125|NCT01363700|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111159126|NCT01363700|Analgesics|analgesics|mesh-ancestor
111159127|NCT01363700|Sensory System Agents|sensory system agents|mesh-ancestor
111159128|NCT01363700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111159129|NCT01363700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111159130|NCT01363700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111159131|NCT01363700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111159132|NCT01363700|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111159133|NCT01363700|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
111159134|NCT01363700|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111159135|NCT01363700|Histamine Antagonists|histamine antagonists|mesh-ancestor
111159136|NCT01363700|Histamine Agents|histamine agents|mesh-ancestor
111159137|NCT01363700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111159138|NCT01363700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111159139|NCT04372706|Pembrolizumab|pembrolizumab|mesh-list
111159140|NCT04372706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111159141|NCT04372706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111159142|NCT04372706|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111159143|NCT04372706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111159144|NCT04178642|Idarubicin|idarubicin|mesh-list
111159145|NCT04178642|Ethiodized Oil|ethiodized oil|mesh-list
111159146|NCT04178642|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111159147|NCT04178642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111159148|NCT04178642|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111159149|NCT04178642|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111159150|NCT04178642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111159151|NCT04178642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111159152|NCT04157894|Milbemycin oxime|milbemycin oxime|mesh-list
111159153|NCT04157894|Anthelmintics|anthelmintics|mesh-ancestor
111159154|NCT04157894|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111159155|NCT04157894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111159156|NCT04838288|Tacrolimus|tacrolimus|mesh-list
111159157|NCT04838288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111159158|NCT04838288|Immunologic Factors|immunologic factors|mesh-ancestor
111159159|NCT04838288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111159160|NCT04838288|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111159161|NCT04838288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111159162|NCT04838288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111159163|NCT04327934|Methyltestosterone|methyltestosterone|mesh-list
111159164|NCT04327934|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
111159165|NCT04327934|Testosterone|testosterone|mesh-list
111159166|NCT04327934|Testosterone undecanoate|testosterone undecanoate|mesh-list
111159167|NCT04327934|Testosterone enanthate|testosterone enanthate|mesh-list
111159168|NCT04327934|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
111159169|NCT04327934|Hormones|hormones|mesh-ancestor
111159170|NCT04327934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111159171|NCT04327934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111159172|NCT04327934|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111159173|NCT04327934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111159174|NCT04327934|Anabolic Agents|anabolic agents|mesh-ancestor
111159175|NCT04327934|Androgens|androgens|mesh-ancestor
111159176|NCT04791566|Dexamethasone|dexamethasone|mesh-list
111159177|NCT04791566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111159178|NCT04791566|Antiemetics|antiemetics|mesh-ancestor
111159179|NCT04791566|Autonomic Agents|autonomic agents|mesh-ancestor
111159180|NCT04791566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111159181|NCT04791566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111159182|NCT04791566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111159183|NCT04791566|Glucocorticoids|glucocorticoids|mesh-ancestor
111159184|NCT04791566|Hormones|hormones|mesh-ancestor
111159185|NCT04791566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111159186|NCT04791566|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111159187|NCT04791566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111159188|NCT04129736|Teriflunomide|teriflunomide|mesh-list
111159189|NCT04129736|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111159190|NCT04129736|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111159191|NCT04129736|Analgesics|analgesics|mesh-ancestor
111159192|NCT04129736|Sensory System Agents|sensory system agents|mesh-ancestor
111159193|NCT04129736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111159194|NCT04129736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111159195|NCT04129736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111159196|NCT04129736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111159197|NCT04129736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111159198|NCT04129736|Immunologic Factors|immunologic factors|mesh-ancestor
111159199|NCT01637402|Prednisone|prednisone|mesh-list
111159200|NCT01637402|Abiraterone Acetate|abiraterone acetate|mesh-list
111159201|NCT01637402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111159202|NCT01637402|Glucocorticoids|glucocorticoids|mesh-ancestor
111159203|NCT01637402|Hormones|hormones|mesh-ancestor
111159204|NCT01637402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111159205|NCT01637402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111159206|NCT01637402|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111159207|NCT01637402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111159208|NCT01637402|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111159209|NCT01637402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111159210|NCT01637402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111159211|NCT01637402|Hormone Antagonists|hormone antagonists|mesh-ancestor
111159212|NCT01637402|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111159213|NCT04419038|Mitomycins|mitomycins|mesh-list
111159214|NCT04419038|Mitomycin|mitomycin|mesh-list
111159215|NCT04419038|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111159216|NCT04419038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111159217|NCT04419038|Alkylating Agents|alkylating agents|mesh-ancestor
111159218|NCT04419038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111159219|NCT04419038|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111159220|NCT04419038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111159221|NCT02217475|Cenicriviroc|cenicriviroc|mesh-list
111159222|NCT02217475|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
111159223|NCT02217475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111159224|NCT02217475|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111159225|NCT02217475|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111159226|NCT02217475|Antiviral Agents|antiviral agents|mesh-ancestor
111159227|NCT02217475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110876318|NCT03437447|Praziquantel|praziquantel|mesh-list
111159228|NCT04818944|Tirofiban|tirofiban|mesh-list
111159229|NCT04818944|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111159230|NCT04818944|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111159231|NCT04818944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111159232|NCT04818944|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111159233|NCT02189941|Deferiprone|deferiprone|mesh-list
111159234|NCT02189941|Iron Chelating Agents|iron chelating agents|mesh-ancestor
111159235|NCT02189941|Chelating Agents|chelating agents|mesh-ancestor
111159236|NCT02189941|Sequestering Agents|sequestering agents|mesh-ancestor
111159237|NCT02189941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111159238|NCT01601132|Colchicine|colchicine|mesh-list
111159239|NCT01601132|Theophylline|theophylline|mesh-list
111159240|NCT01601132|Gout Suppressants|gout suppressants|mesh-ancestor
111159241|NCT01601132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111159242|NCT01601132|Tubulin Modulators|tubulin modulators|mesh-ancestor
111159243|NCT01601132|Antimitotic Agents|antimitotic agents|mesh-ancestor
111159244|NCT01601132|Mitosis Modulators|mitosis modulators|mesh-ancestor
111159245|NCT01601132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111159246|NCT01601132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111159247|NCT01601132|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111159248|NCT01601132|Autonomic Agents|autonomic agents|mesh-ancestor
111159249|NCT01601132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111159250|NCT01601132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111159251|NCT01601132|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111159252|NCT01601132|Respiratory System Agents|respiratory system agents|mesh-ancestor
111159253|NCT01601132|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111159254|NCT01601132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111159255|NCT01601132|Vasodilator Agents|vasodilator agents|mesh-ancestor
111159256|NCT01601132|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
111159257|NCT01601132|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111159258|NCT01601132|Purinergic Agents|purinergic agents|mesh-ancestor
111159259|NCT01601132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111159260|NCT04836962|Dexamethasone|dexamethasone|mesh-list
111159261|NCT04836962|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111159262|NCT04836962|Antiemetics|antiemetics|mesh-ancestor
111159263|NCT04836962|Autonomic Agents|autonomic agents|mesh-ancestor
111159264|NCT04836962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111159265|NCT04836962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111159266|NCT04836962|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111159267|NCT04836962|Glucocorticoids|glucocorticoids|mesh-ancestor
111159268|NCT04836962|Hormones|hormones|mesh-ancestor
111159269|NCT04836962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111159270|NCT04836962|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111159271|NCT04836962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111159272|NCT05289440|Esketamine|esketamine|mesh-list
111159273|NCT05289440|Antidepressive Agents|antidepressive agents|mesh-ancestor
111159274|NCT05289440|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111159275|NCT04016090|Folic Acid|folic acid|mesh-list
111159276|NCT04016090|Hematinics|hematinics|mesh-ancestor
111159277|NCT04016090|Vitamin B Complex|vitamin b complex|mesh-ancestor
111159278|NCT04016090|Vitamins|vitamins|mesh-ancestor
111159279|NCT04016090|Micronutrients|micronutrients|mesh-ancestor
111159280|NCT04016090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111159281|NCT04809974|Niacinamide|niacinamide|mesh-list
111159282|NCT04809974|Vitamins|vitamins|mesh-ancestor
111159283|NCT04809974|Micronutrients|micronutrients|mesh-ancestor
111159284|NCT04809974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111159285|NCT04809974|Vitamin B Complex|vitamin b complex|mesh-ancestor
111159286|NCT04691960|Metformin|metformin|mesh-list
111159287|NCT04691960|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111159288|NCT04691960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111159289|NCT04809038|Magnesium Sulfate|magnesium sulfate|mesh-list
111159290|NCT04809038|Analgesics|analgesics|mesh-ancestor
111159291|NCT04809038|Sensory System Agents|sensory system agents|mesh-ancestor
111159292|NCT04809038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111159293|NCT04809038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111159294|NCT04809038|Anesthetics|anesthetics|mesh-ancestor
111159295|NCT04809038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111159296|NCT04809038|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111159297|NCT04809038|Anticonvulsants|anticonvulsants|mesh-ancestor
111159298|NCT04809038|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111159299|NCT04809038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111159300|NCT04809038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111159301|NCT04809038|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111159302|NCT04809038|Tocolytic Agents|tocolytic agents|mesh-ancestor
111159303|NCT04809038|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111159304|NCT05221190|Lidocaine|lidocaine|mesh-list
111159305|NCT05221190|Anesthetics, Local|anesthetics, local|mesh-ancestor
111159307|NCT05221190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111159308|NCT05221190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111159309|NCT05221190|Sensory System Agents|sensory system agents|mesh-ancestor
111159310|NCT05221190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111159311|NCT05221190|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111159312|NCT05221190|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111159313|NCT05221190|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111159314|NCT05221190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111159315|NCT05221190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111159316|NCT04816682|Silymarin|silymarin|mesh-list
111159317|NCT04816682|Antioxidants|antioxidants|mesh-ancestor
111159318|NCT04816682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111159319|NCT04816682|Protective Agents|protective agents|mesh-ancestor
111159320|NCT04816682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111159321|NCT02162719|Paclitaxel|paclitaxel|mesh-list
111159322|NCT02162719|Ipatasertib|ipatasertib|mesh-list
111159323|NCT02162719|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111159324|NCT02162719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111159325|NCT02162719|Tubulin Modulators|tubulin modulators|mesh-ancestor
111159326|NCT02162719|Antimitotic Agents|antimitotic agents|mesh-ancestor
111159327|NCT02162719|Mitosis Modulators|mitosis modulators|mesh-ancestor
111159328|NCT02162719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111159329|NCT02162719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111159330|NCT02162719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111159331|NCT04808882|Tinzaparin|tinzaparin|mesh-list
111159332|NCT04808882|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
111159333|NCT04808882|Dalteparin|dalteparin|mesh-list
111159334|NCT04808882|Anticoagulants|anticoagulants|mesh-ancestor
111159335|NCT04808882|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111159336|NCT04808882|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111159337|NCT04808882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111159338|NCT05652374|Nitrofurantoin|nitrofurantoin|mesh-list
111159339|NCT05652374|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111159340|NCT05652374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111159341|NCT05652374|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111159342|NCT01636076|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
111159343|NCT01636076|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111159344|NCT01636076|Autonomic Agents|autonomic agents|mesh-ancestor
111159345|NCT01636076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111159346|NCT01636076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111159347|NCT01636076|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111159348|NCT01636076|Respiratory System Agents|respiratory system agents|mesh-ancestor
111159349|NCT01636076|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111159350|NCT01636076|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111159351|NCT01636076|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111159352|NCT01636076|Adrenergic Agents|adrenergic agents|mesh-ancestor
111159353|NCT01636076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111159354|NCT01636076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111159355|NCT04794842|Phenol|phenol|mesh-list
111159356|NCT04794842|Tetracaine|tetracaine|mesh-list
111159357|NCT04794842|Anesthetics, Local|anesthetics, local|mesh-ancestor
111159358|NCT04794842|Anesthetics|anesthetics|mesh-ancestor
111159359|NCT04794842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111159360|NCT04794842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111159361|NCT04794842|Sensory System Agents|sensory system agents|mesh-ancestor
111159362|NCT04794842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111159363|NCT04794842|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111159364|NCT04794842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111159365|NCT04794842|Disinfectants|disinfectants|mesh-ancestor
111159366|NCT04794842|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
111159367|NCT04794842|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111159368|NCT03029000|Lenograstim|lenograstim|mesh-list
111159369|NCT03029000|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111159370|NCT03029000|Immunologic Factors|immunologic factors|mesh-ancestor
111159371|NCT03029000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111159372|NCT03783182|Betamethasone|betamethasone|mesh-list
111159373|NCT03783182|Betamethasone Valerate|betamethasone valerate|mesh-list
111159374|NCT03783182|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
111159375|NCT03783182|Betamethasone benzoate|betamethasone benzoate|mesh-list
111159376|NCT03783182|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
110876462|NCT03697408|Everolimus|everolimus|mesh-list
111159377|NCT03783182|Glucocorticoids|glucocorticoids|mesh-ancestor
111159378|NCT03783182|Hormones|hormones|mesh-ancestor
111159379|NCT03783182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111159380|NCT03783182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111159381|NCT03783182|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111159382|NCT03783182|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111159383|NCT03783182|Respiratory System Agents|respiratory system agents|mesh-ancestor
111159385|NCT03760484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111159386|NCT03760484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111159387|NCT05651750|Fluticasone|fluticasone|mesh-list
111159388|NCT05651750|Xhance|xhance|mesh-list
111159389|NCT05651750|Montelukast|montelukast|mesh-list
111159390|NCT05651750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111159391|NCT05651750|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111159392|NCT05651750|Autonomic Agents|autonomic agents|mesh-ancestor
111159393|NCT05651750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111159394|NCT05651750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111159395|NCT05651750|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111159396|NCT05651750|Respiratory System Agents|respiratory system agents|mesh-ancestor
111159397|NCT05651750|Dermatologic Agents|dermatologic agents|mesh-ancestor
111159398|NCT05651750|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111159399|NCT05651750|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
111159400|NCT05651750|Hormone Antagonists|hormone antagonists|mesh-ancestor
111159401|NCT05651750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111159402|NCT05651750|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
111159403|NCT05651750|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111159404|NCT05651750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111159405|NCT02160145|Tolvaptan|tolvaptan|mesh-list
111159406|NCT02160145|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
111159407|NCT02160145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111159408|NCT02160145|Natriuretic Agents|natriuretic agents|mesh-ancestor
111159409|NCT02160145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111159410|NCT02216071|Ciprofloxacin|ciprofloxacin|mesh-list
111159411|NCT02216071|Dexamethasone|dexamethasone|mesh-list
111159412|NCT02216071|Dexamethasone acetate|dexamethasone acetate|mesh-list
111159413|NCT02216071|BB 1101|bb 1101|mesh-list
111159414|NCT02216071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111159415|NCT02216071|Antiemetics|antiemetics|mesh-ancestor
111159416|NCT02216071|Autonomic Agents|autonomic agents|mesh-ancestor
111159417|NCT02216071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111159418|NCT02216071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111159419|NCT02216071|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111159420|NCT02216071|Glucocorticoids|glucocorticoids|mesh-ancestor
111159421|NCT02216071|Hormones|hormones|mesh-ancestor
111159422|NCT02216071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111159423|NCT02216071|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111159424|NCT02216071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111159425|NCT02216071|Protease Inhibitors|protease inhibitors|mesh-ancestor
111159426|NCT02216071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111159427|NCT02216071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111159428|NCT02216071|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111159429|NCT02216071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111159430|NCT02216071|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111159431|NCT02216071|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111159432|NCT02216071|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111159433|NCT02216071|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111159434|NCT01681576|Valsartan|valsartan|mesh-list
111159435|NCT01681576|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
111159436|NCT01681576|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111159437|NCT01681576|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111159438|NCT01681576|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111159439|NCT01681576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111159440|NCT02188459|Bupropion|bupropion|mesh-list
111159441|NCT02188459|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111159442|NCT02188459|Antidepressive Agents|antidepressive agents|mesh-ancestor
111159443|NCT02188459|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111159444|NCT02188459|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110841389|NCT01378754|Fospropofol|fospropofol|mesh-list
111159445|NCT02188459|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111159446|NCT02188459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111159447|NCT02188459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111159448|NCT02188459|Dopamine Agents|dopamine agents|mesh-ancestor
111159449|NCT02188459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111159450|NCT02188459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111159451|NCT02188459|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111159452|NCT02188459|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111159453|NCT02188459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111159454|NCT02743364|Simvastatin|simvastatin|mesh-list
111159455|NCT02743364|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111159456|NCT02743364|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111159457|NCT02743364|Antimetabolites|antimetabolites|mesh-ancestor
111159458|NCT02743364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111159459|NCT02743364|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111159460|NCT02743364|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111159461|NCT02743364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111159462|NCT02214121|Ticagrelor|ticagrelor|mesh-list
111159463|NCT02214121|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110485337|NCT00641589|Epoetin Alfa|epoetin alfa|mesh-list
111159464|NCT02214121|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111159465|NCT02214121|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111159466|NCT02214121|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111159467|NCT02214121|Purinergic Agents|purinergic agents|mesh-ancestor
111159468|NCT02214121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111159469|NCT02214121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111159470|NCT02214121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111159471|NCT01681186|Lansoprazole|lansoprazole|mesh-list
111159472|NCT01681186|Dexlansoprazole|dexlansoprazole|mesh-list
111159473|NCT01681186|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111159474|NCT01681186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111159475|NCT01681186|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111159476|NCT01681186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111159477|NCT01681186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111159478|NCT01695772|Bevacizumab|bevacizumab|mesh-list
111159479|NCT01695772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111159480|NCT01695772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111159481|NCT01695772|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111159482|NCT01695772|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111159483|NCT01695772|Growth Substances|growth substances|mesh-ancestor
111159484|NCT01695772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111159485|NCT01695772|Growth Inhibitors|growth inhibitors|mesh-ancestor
111159486|NCT02159521|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
111159487|NCT02159521|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111159488|NCT02159521|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111159489|NCT02159521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111159490|NCT01636934|Minocycline|minocycline|mesh-list
111159491|NCT01636934|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111159492|NCT01636934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111159493|NCT01712854|Budesonide|budesonide|mesh-list
111159494|NCT01712854|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
111159495|NCT01712854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111159496|NCT01712854|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111159497|NCT01712854|Autonomic Agents|autonomic agents|mesh-ancestor
111159498|NCT01712854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111159499|NCT01712854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111159500|NCT01712854|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111159501|NCT01712854|Respiratory System Agents|respiratory system agents|mesh-ancestor
111159502|NCT01712854|Glucocorticoids|glucocorticoids|mesh-ancestor
111159503|NCT01712854|Hormones|hormones|mesh-ancestor
111159504|NCT01712854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111159505|NCT02986594|Aspirin|aspirin|mesh-list
111159506|NCT02986594|Heparin|heparin|mesh-list
111159507|NCT02986594|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111159508|NCT02986594|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111159509|NCT02986594|Analgesics|analgesics|mesh-ancestor
111159510|NCT02986594|Sensory System Agents|sensory system agents|mesh-ancestor
111159511|NCT02986594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110841409|NCT02826512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111159512|NCT02986594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111159513|NCT02986594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111159514|NCT02986594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111159515|NCT02986594|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111159516|NCT02986594|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111159517|NCT02986594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111159518|NCT02986594|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111159519|NCT02986594|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111159520|NCT02986594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111159521|NCT02986594|Antipyretics|antipyretics|mesh-ancestor
110876610|NCT02329288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111159523|NCT02159365|Dexamethasone|dexamethasone|mesh-list
111159524|NCT02159365|Lenalidomide|lenalidomide|mesh-list
111159525|NCT02159365|Elotuzumab|elotuzumab|mesh-list
111159526|NCT02159365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111159527|NCT02159365|Antiemetics|antiemetics|mesh-ancestor
111159528|NCT02159365|Autonomic Agents|autonomic agents|mesh-ancestor
111159529|NCT02159365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111159530|NCT02159365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111159531|NCT02159365|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111159532|NCT02159365|Glucocorticoids|glucocorticoids|mesh-ancestor
111159533|NCT02159365|Hormones|hormones|mesh-ancestor
111159534|NCT02159365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111159535|NCT02159365|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111159536|NCT02159365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111159537|NCT02159365|Immunologic Factors|immunologic factors|mesh-ancestor
111159538|NCT02159365|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111159539|NCT02159365|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111159540|NCT02159365|Growth Substances|growth substances|mesh-ancestor
111159541|NCT02159365|Growth Inhibitors|growth inhibitors|mesh-ancestor
111159542|NCT02072200|Prednisone|prednisone|mesh-list
111159543|NCT02072200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111159544|NCT02072200|Glucocorticoids|glucocorticoids|mesh-ancestor
111159545|NCT02072200|Hormones|hormones|mesh-ancestor
111159546|NCT02072200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111159547|NCT02072200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111159548|NCT02072200|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111159549|NCT02072200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111159550|NCT01691794|Ritonavir|ritonavir|mesh-list
111159551|NCT01691794|Atazanavir Sulfate|atazanavir sulfate|mesh-list
111159552|NCT01691794|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111159553|NCT01691794|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111159554|NCT01691794|Protease Inhibitors|protease inhibitors|mesh-ancestor
111159555|NCT01691794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111159556|NCT01691794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111159557|NCT01691794|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111159558|NCT01691794|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111159559|NCT01691794|Antiviral Agents|antiviral agents|mesh-ancestor
111159560|NCT01691794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111159561|NCT01691794|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111159562|NCT01691794|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111159563|NCT02159053|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111159564|NCT02159053|Immunologic Factors|immunologic factors|mesh-ancestor
111159565|NCT02159053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111159566|NCT02158975|Ixazomib|ixazomib|mesh-list
111159567|NCT02158975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111159568|NCT02158975|Protease Inhibitors|protease inhibitors|mesh-ancestor
111159569|NCT02158975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111159570|NCT02158975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111159571|NCT02661464|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
111159572|NCT02661464|Antiviral Agents|antiviral agents|mesh-ancestor
111159573|NCT02661464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111159574|NCT02158039|Ethanol|ethanol|mesh-list
111159575|NCT02158039|Lidocaine|lidocaine|mesh-list
111159576|NCT02158039|Anesthetics, Local|anesthetics, local|mesh-ancestor
111159577|NCT02158039|Anesthetics|anesthetics|mesh-ancestor
111159578|NCT02158039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111159579|NCT02158039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111159580|NCT02158039|Sensory System Agents|sensory system agents|mesh-ancestor
111159581|NCT02158039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111159582|NCT02158039|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111159583|NCT02158039|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111159584|NCT02158039|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111159585|NCT02158039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111159586|NCT02158039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111159587|NCT02158039|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111159588|NCT02158039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111159589|NCT03563222|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
111159590|NCT03563222|SMOFlipid|smoflipid|mesh-list
111159591|NCT03563222|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
111159592|NCT03563222|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
111159593|NCT03563222|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111159594|NCT02490800|Lisavanbulin|lisavanbulin|mesh-list
111159595|NCT02490800|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111159596|NCT02490800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111159597|NCT02490800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111159598|NCT02490800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111159599|NCT01635764|Adalimumab|adalimumab|mesh-list
111159600|NCT01635764|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111159601|NCT01635764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111159602|NCT01635764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111159603|NCT04810598|Venetoclax|venetoclax|mesh-list
111159604|NCT04810598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111159605|NCT04627064|Belzutifan|belzutifan|mesh-list
111159606|NCT04627064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111159607|NCT04511078|Panitumumab|panitumumab|mesh-list
111159608|NCT04511078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111159609|NCT04511078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111159610|NCT02158052|Tacrolimus|tacrolimus|mesh-list
111159611|NCT02158052|Antilymphocyte Serum|antilymphocyte serum|mesh-list
111159612|NCT02158052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111159613|NCT02158052|Immunologic Factors|immunologic factors|mesh-ancestor
111159614|NCT02158052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111159615|NCT02158052|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111159616|NCT02158052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111159617|NCT02158052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111159618|NCT01635218|Fluoxetine|fluoxetine|mesh-list
111159619|NCT01635218|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111159620|NCT01635218|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111159621|NCT01635218|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111159622|NCT01635218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111159623|NCT01635218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111159624|NCT01635218|Serotonin Agents|serotonin agents|mesh-ancestor
111159625|NCT01635218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111159626|NCT01635218|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111159627|NCT01635218|Antidepressive Agents|antidepressive agents|mesh-ancestor
111159628|NCT01635218|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111159629|NCT01635218|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111159630|NCT01635218|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111159631|NCT01635218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111159632|NCT05351684|Dolutegravir|dolutegravir|mesh-list
111159633|NCT05351684|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111159634|NCT05351684|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111159635|NCT05351684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111159636|NCT05351684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111159637|NCT05351684|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111159638|NCT05351684|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111159639|NCT05351684|Antiviral Agents|antiviral agents|mesh-ancestor
111159640|NCT05351684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111159641|NCT02049866|Denosumab|denosumab|mesh-list
111159642|NCT02049866|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111159643|NCT02049866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111159644|NCT04274894|Testosterone|testosterone|mesh-list
111159646|NCT04274894|Hormones|hormones|mesh-ancestor
111159647|NCT04274894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111159648|NCT04274894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111159649|NCT04786964|Folic Acid|folic acid|mesh-list
111159650|NCT04786964|Vitamin B 12|vitamin b 12|mesh-list
111159651|NCT04786964|Dexamethasone|dexamethasone|mesh-list
111159652|NCT04786964|Carboplatin|carboplatin|mesh-list
111159653|NCT04786964|Pemetrexed|pemetrexed|mesh-list
111159654|NCT04786964|Vitamins|vitamins|mesh-ancestor
111159655|NCT04786964|Micronutrients|micronutrients|mesh-ancestor
111159656|NCT04786964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111159657|NCT04786964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111159658|NCT04786964|Antiemetics|antiemetics|mesh-ancestor
111159659|NCT04786964|Autonomic Agents|autonomic agents|mesh-ancestor
111159660|NCT04786964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111159661|NCT04786964|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111159662|NCT04786964|Glucocorticoids|glucocorticoids|mesh-ancestor
111159663|NCT04786964|Hormones|hormones|mesh-ancestor
111159664|NCT04786964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111159665|NCT04786964|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111159666|NCT04786964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111159667|NCT04786964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111159668|NCT04786964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111159669|NCT04786964|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111159670|NCT04786964|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111159671|NCT04786964|Hematinics|hematinics|mesh-ancestor
111159672|NCT04786964|Vitamin B Complex|vitamin b complex|mesh-ancestor
111159673|NCT04269200|Paclitaxel|paclitaxel|mesh-list
111159674|NCT04269200|Carboplatin|carboplatin|mesh-list
111159675|NCT04269200|Durvalumab|durvalumab|mesh-list
111159676|NCT04269200|Olaparib|olaparib|mesh-list
111159677|NCT04269200|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111159678|NCT04269200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111159679|NCT04269200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111159680|NCT04269200|Tubulin Modulators|tubulin modulators|mesh-ancestor
111159681|NCT04269200|Antimitotic Agents|antimitotic agents|mesh-ancestor
111159682|NCT04269200|Mitosis Modulators|mitosis modulators|mesh-ancestor
111159683|NCT04269200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111159684|NCT04269200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111159685|NCT04269200|Immunologic Factors|immunologic factors|mesh-ancestor
111159686|NCT04269200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111159687|NCT04269200|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111159688|NCT04269200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111159689|NCT02213263|Rituximab|rituximab|mesh-list
111159690|NCT02213263|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111159691|NCT02213263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111159692|NCT02213263|Immunologic Factors|immunologic factors|mesh-ancestor
111159693|NCT02213263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111159694|NCT02213263|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111159695|NCT04781036|Chlorhexidine|chlorhexidine|mesh-list
111159696|NCT04781036|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111159697|NCT04781036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110485403|NCT00760474|Pregabalin|pregabalin|mesh-list
111159698|NCT04781036|Disinfectants|disinfectants|mesh-ancestor
111159699|NCT04216784|Furosemide|furosemide|mesh-list
111159700|NCT04216784|Diuretics|diuretics|mesh-ancestor
111159701|NCT04216784|Natriuretic Agents|natriuretic agents|mesh-ancestor
111159702|NCT04216784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111159703|NCT04216784|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
111159704|NCT04216784|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111159705|NCT04216784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111159706|NCT05173298|Bevacizumab|bevacizumab|mesh-list
111159707|NCT05173298|Atezolizumab|atezolizumab|mesh-list
111159708|NCT05173298|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111159709|NCT05173298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111159710|NCT05173298|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111159711|NCT05173298|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111159712|NCT05173298|Growth Substances|growth substances|mesh-ancestor
111159713|NCT05173298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111159714|NCT05173298|Growth Inhibitors|growth inhibitors|mesh-ancestor
111159715|NCT05173298|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110841427|NCT05132660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111159716|NCT05173298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111159717|NCT05168930|Venetoclax|venetoclax|mesh-list
111159718|NCT05168930|Zanubrutinib|zanubrutinib|mesh-list
111159719|NCT05168930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111159720|NCT05168930|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111159721|NCT05168930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111159722|NCT05168930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111159723|NCT05170724|Remibrutinib|remibrutinib|mesh-list
111159724|NCT05170724|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111159725|NCT05170724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111159726|NCT05170724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111159727|NCT01975064|Propofol|propofol|mesh-list
111159728|NCT01975064|Sevoflurane|sevoflurane|mesh-list
111159729|NCT01975064|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111159730|NCT01975064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111159731|NCT01975064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111159732|NCT01975064|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111159733|NCT01975064|Anesthetics, General|anesthetics, general|mesh-ancestor
111159734|NCT01975064|Anesthetics|anesthetics|mesh-ancestor
111159735|NCT01975064|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111159736|NCT01975064|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111159737|NCT02210689|Clindamycin|clindamycin|mesh-list
111159738|NCT02210689|Clindamycin palmitate|clindamycin palmitate|mesh-list
111159739|NCT02210689|Clindamycin phosphate|clindamycin phosphate|mesh-list
111159740|NCT02210689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111159741|NCT02210689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111159742|NCT02210689|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111159743|NCT02210689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110876836|NCT03073200|Ixekizumab|ixekizumab|mesh-list
111159744|NCT02210689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111159745|NCT02209597|Bupropion|bupropion|mesh-list
111159746|NCT02209597|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111159747|NCT02209597|Antidepressive Agents|antidepressive agents|mesh-ancestor
111159748|NCT02209597|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111159749|NCT02209597|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111159750|NCT02209597|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111159751|NCT02209597|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111159752|NCT02209597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111159753|NCT02209597|Dopamine Agents|dopamine agents|mesh-ancestor
111159754|NCT02209597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111159755|NCT02209597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111159756|NCT02209597|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111159757|NCT02209597|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111159758|NCT02209597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111159759|NCT01469156|Ranibizumab|ranibizumab|mesh-list
111159760|NCT01469156|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111159761|NCT01469156|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111159762|NCT01469156|Growth Substances|growth substances|mesh-ancestor
111159763|NCT01469156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111159764|NCT01469156|Growth Inhibitors|growth inhibitors|mesh-ancestor
111159765|NCT01469156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111159766|NCT04191434|Budesonide|budesonide|mesh-list
111159767|NCT04191434|Formoterol Fumarate|formoterol fumarate|mesh-list
111159768|NCT04191434|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
111159769|NCT04191434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111159770|NCT04191434|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111159771|NCT04191434|Autonomic Agents|autonomic agents|mesh-ancestor
111159772|NCT04191434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111159773|NCT04191434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111159774|NCT04191434|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111159775|NCT04191434|Respiratory System Agents|respiratory system agents|mesh-ancestor
111159776|NCT04191434|Glucocorticoids|glucocorticoids|mesh-ancestor
111159777|NCT04191434|Hormones|hormones|mesh-ancestor
111159778|NCT04191434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111159779|NCT04191434|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111159780|NCT04191434|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111159781|NCT04191434|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111159782|NCT04191434|Adrenergic Agents|adrenergic agents|mesh-ancestor
111159783|NCT04191434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111159784|NCT04191434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111159785|NCT03835676|Treprostinil|treprostinil|mesh-list
111159786|NCT03835676|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111159787|NCT03651128|Dexamethasone|dexamethasone|mesh-list
111159788|NCT03651128|Lenalidomide|lenalidomide|mesh-list
111159789|NCT03651128|Bortezomib|bortezomib|mesh-list
111159790|NCT03651128|Daratumumab|daratumumab|mesh-list
111159791|NCT03651128|Pomalidomide|pomalidomide|mesh-list
111159792|NCT03651128|Ixazomib|ixazomib|mesh-list
111159793|NCT03651128|Elotuzumab|elotuzumab|mesh-list
111159794|NCT03651128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111159795|NCT03651128|Antiemetics|antiemetics|mesh-ancestor
111159796|NCT03651128|Autonomic Agents|autonomic agents|mesh-ancestor
111159797|NCT03651128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111159798|NCT03651128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111159799|NCT03651128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111159800|NCT03651128|Glucocorticoids|glucocorticoids|mesh-ancestor
111159801|NCT03651128|Hormones|hormones|mesh-ancestor
111159802|NCT03651128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111159803|NCT03651128|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111159804|NCT03651128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111159805|NCT03651128|Immunologic Factors|immunologic factors|mesh-ancestor
111159806|NCT03651128|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111159807|NCT03651128|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111159808|NCT03651128|Growth Substances|growth substances|mesh-ancestor
111159809|NCT03651128|Growth Inhibitors|growth inhibitors|mesh-ancestor
111159810|NCT03651128|Protease Inhibitors|protease inhibitors|mesh-ancestor
111159811|NCT03651128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111159812|NCT03651128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111159813|NCT00664898|Bortezomib|bortezomib|mesh-list
111159814|NCT00664898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111159815|NCT04827992|Analgesics, Opioid|analgesics, opioid|mesh-list
111159816|NCT04827992|Narcotics|narcotics|mesh-ancestor
111159817|NCT04827992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111159818|NCT04827992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111159819|NCT04827992|Analgesics|analgesics|mesh-ancestor
111159820|NCT04827992|Sensory System Agents|sensory system agents|mesh-ancestor
111159821|NCT04827992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111159822|NCT04776980|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
111159823|NCT04776980|Hematinics|hematinics|mesh-ancestor
111159824|NCT04776980|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
111159825|NCT04776980|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111159826|NCT02187055|Adalimumab|adalimumab|mesh-list
111159827|NCT02187055|Methotrexate|methotrexate|mesh-list
111159828|NCT02187055|Tofacitinib|tofacitinib|mesh-list
111159829|NCT02187055|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111159830|NCT02187055|Abortifacient Agents|abortifacient agents|mesh-ancestor
111159831|NCT02187055|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111159832|NCT02187055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111159833|NCT02187055|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111159834|NCT02187055|Antimetabolites|antimetabolites|mesh-ancestor
111159835|NCT02187055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111159836|NCT02187055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111159837|NCT02187055|Dermatologic Agents|dermatologic agents|mesh-ancestor
111159838|NCT02187055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111159839|NCT02187055|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111159840|NCT02187055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111159841|NCT02187055|Immunologic Factors|immunologic factors|mesh-ancestor
111159842|NCT02187055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111159843|NCT02187055|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111159844|NCT02187055|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111159845|NCT02187055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111159846|NCT02187055|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
111159847|NCT02187055|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111159849|NCT00119366|Cyclosporine|cyclosporine|mesh-list
111159850|NCT00119366|Mycophenolic Acid|mycophenolic acid|mesh-list
111159851|NCT00119366|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111159852|NCT00119366|Fludarabine|fludarabine|mesh-list
111159853|NCT00119366|Fludarabine phosphate|fludarabine phosphate|mesh-list
111159854|NCT00119366|Antibodies|antibodies|mesh-list
111159855|NCT00119366|Immunoglobulins|immunoglobulins|mesh-list
111159856|NCT00119366|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111159857|NCT00119366|Cyclosporins|cyclosporins|mesh-list
111159858|NCT00119366|Immunologic Factors|immunologic factors|mesh-ancestor
111159859|NCT00119366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111159860|NCT00119366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111159861|NCT00119366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111159862|NCT00119366|Antimetabolites|antimetabolites|mesh-ancestor
111159863|NCT00119366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111159864|NCT00119366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111159865|NCT00119366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111159866|NCT00119366|Antifungal Agents|antifungal agents|mesh-ancestor
111159867|NCT00119366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111159868|NCT00119366|Dermatologic Agents|dermatologic agents|mesh-ancestor
111159869|NCT00119366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111159870|NCT00119366|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111159871|NCT00119366|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111159872|NCT00119366|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111159873|NCT00119366|Antitubercular Agents|antitubercular agents|mesh-ancestor
111159874|NCT00119366|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111159875|NCT00119366|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111159876|NCT00119366|Trace Elements|trace elements|mesh-ancestor
111159877|NCT00119366|Micronutrients|micronutrients|mesh-ancestor
111159878|NCT02246660|Resveratrol|resveratrol|mesh-list
111159879|NCT02246660|Antioxidants|antioxidants|mesh-ancestor
111159880|NCT02246660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111159881|NCT02246660|Protective Agents|protective agents|mesh-ancestor
111159882|NCT02246660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111159883|NCT02246660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111159884|NCT02246660|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111159885|NCT02246582|Insulin|insulin|mesh-list
111159886|NCT02246582|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111159887|NCT02246582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111159888|NCT02137369|Dexetimide|dexetimide|mesh-list
111159889|NCT02137369|Citalopram|citalopram|mesh-list
111159890|NCT02137369|Sertraline|sertraline|mesh-list
111159891|NCT02137369|Antidepressive Agents|antidepressive agents|mesh-list
111159892|NCT02137369|Escitalopram|escitalopram|mesh-list
111159893|NCT02137369|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
111159894|NCT02137369|Serotonin|serotonin|mesh-list
111159895|NCT02137369|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111159896|NCT02137369|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111159897|NCT02137369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111159898|NCT02137369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111159899|NCT02137369|Serotonin Agents|serotonin agents|mesh-ancestor
111159900|NCT02137369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111159901|NCT02137369|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111159902|NCT02137369|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111159903|NCT02137369|Parasympatholytics|parasympatholytics|mesh-ancestor
111159904|NCT02137369|Autonomic Agents|autonomic agents|mesh-ancestor
111159905|NCT02137369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111159906|NCT02137369|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111159907|NCT02137369|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111159908|NCT02137369|Cholinergic Agents|cholinergic agents|mesh-ancestor
111159909|NCT02137369|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111159910|NCT02137369|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111159911|NCT02137369|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111159912|NCT02155309|Scopolamine|scopolamine|mesh-list
111159913|NCT02155309|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
111159914|NCT02155309|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111159915|NCT02155309|Antiemetics|antiemetics|mesh-ancestor
111159916|NCT02155309|Autonomic Agents|autonomic agents|mesh-ancestor
111159917|NCT02155309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111159918|NCT02155309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111159919|NCT02155309|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111159920|NCT02155309|Mydriatics|mydriatics|mesh-ancestor
111159921|NCT02155309|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111159922|NCT02155309|Cholinergic Agents|cholinergic agents|mesh-ancestor
111159923|NCT02155309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111159924|NCT02155309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111159925|NCT02155309|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111159926|NCT02155309|Parasympatholytics|parasympatholytics|mesh-ancestor
111159927|NCT02186821|Ceritinib|ceritinib|mesh-list
111159928|NCT02186821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111159929|NCT02186821|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111159930|NCT02186821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111159931|NCT02186821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111159932|NCT01710358|Adalimumab|adalimumab|mesh-list
111159933|NCT01710358|Methotrexate|methotrexate|mesh-list
111159934|NCT01710358|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111159935|NCT01710358|Abortifacient Agents|abortifacient agents|mesh-ancestor
111159936|NCT01710358|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111159937|NCT01710358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111159938|NCT01710358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111159939|NCT01710358|Antimetabolites|antimetabolites|mesh-ancestor
111159940|NCT01710358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111159941|NCT01710358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111159942|NCT01710358|Dermatologic Agents|dermatologic agents|mesh-ancestor
111159943|NCT01710358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111159944|NCT01710358|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111159945|NCT01710358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111159946|NCT01710358|Immunologic Factors|immunologic factors|mesh-ancestor
111159947|NCT01710358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111159948|NCT01710358|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111159949|NCT01710358|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111159950|NCT01710358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111159951|NCT01633112|Glatiramer Acetate|glatiramer acetate|mesh-list
111159952|NCT01633112|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
111159953|NCT01633112|(T,G)-A-L|(t,g)-a-l|mesh-list
111159954|NCT01633112|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
111159955|NCT01633112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111159956|NCT01633112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111159957|NCT01633112|Immunologic Factors|immunologic factors|mesh-ancestor
111159958|NCT01633112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111159959|NCT01633112|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111159960|NCT01633112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111159961|NCT03455270|Palbociclib|palbociclib|mesh-list
111159962|NCT03455270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111159963|NCT03455270|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111159964|NCT03455270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111159965|NCT03455270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111159966|NCT01691482|Albuterol|albuterol|mesh-list
111159967|NCT01691482|Ipratropium|ipratropium|mesh-list
111159968|NCT01691482|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110166615|NCT00000482|Niacin|niacin|mesh-list
111159969|NCT01691482|Autonomic Agents|autonomic agents|mesh-ancestor
110877073|NCT03144856|Apatinib|apatinib|mesh-list
111159970|NCT01691482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111159971|NCT01691482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111159972|NCT01691482|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111159973|NCT01691482|Respiratory System Agents|respiratory system agents|mesh-ancestor
111159974|NCT01691482|Tocolytic Agents|tocolytic agents|mesh-ancestor
111159975|NCT01691482|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111159976|NCT01691482|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111159977|NCT01691482|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111159978|NCT01691482|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111159979|NCT01691482|Adrenergic Agents|adrenergic agents|mesh-ancestor
111159980|NCT01691482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110841460|NCT01858922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111159981|NCT01691482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111159982|NCT01691482|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111159983|NCT01691482|Cholinergic Agents|cholinergic agents|mesh-ancestor
111159984|NCT01710046|Tofacitinib|tofacitinib|mesh-list
111159985|NCT01710046|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
111159986|NCT01710046|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111159987|NCT01710046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111159988|NCT01710046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111159989|NCT02154529|Trastuzumab|trastuzumab|mesh-list
111159990|NCT02154529|XL647|xl647|mesh-list
111159991|NCT02154529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111159992|NCT02154529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111159993|NCT02154529|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111159994|NCT02154529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111159995|NCT02154529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111159996|NCT02154139|Leuprolide|leuprolide|mesh-list
111159997|NCT02154139|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111159998|NCT02154139|Fertility Agents|fertility agents|mesh-ancestor
111159999|NCT02154139|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111160000|NCT02154139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111160001|NCT02154139|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111160002|NCT02154139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111160003|NCT02154061|Metronidazole|metronidazole|mesh-list
111160004|NCT02154061|Vancomycin|vancomycin|mesh-list
111160005|NCT02154061|Neomycin|neomycin|mesh-list
111160006|NCT02154061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111160007|NCT02154061|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111160008|NCT02154061|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111160009|NCT02154061|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111160010|NCT02154061|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111160011|NCT02154061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111160012|NCT02154061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111160013|NCT01907217|Methohexital|methohexital|mesh-list
111160014|NCT01907217|Succinylcholine|succinylcholine|mesh-list
111160015|NCT01907217|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
111160016|NCT01907217|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
111160017|NCT01907217|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111160018|NCT01907217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111160019|NCT01907217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111160020|NCT01907217|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111160021|NCT01907217|Anesthetics, General|anesthetics, general|mesh-ancestor
111160022|NCT01907217|Anesthetics|anesthetics|mesh-ancestor
111160023|NCT01907217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111160024|NCT01953783|Ixazomib|ixazomib|mesh-list
111160025|NCT01953783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111160026|NCT01953783|Protease Inhibitors|protease inhibitors|mesh-ancestor
111160027|NCT01953783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111160028|NCT01953783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111160029|NCT02134015|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111160030|NCT02134015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111160031|NCT02134015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111160032|NCT02134015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111160033|NCT02134015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111160034|NCT04619979|Anesthetics|anesthetics|mesh-list
111160035|NCT04619979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111160036|NCT04619979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111160037|NCT01630135|Fluticasone|fluticasone|mesh-list
111160038|NCT01630135|Xhance|xhance|mesh-list
111160039|NCT01630135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111160040|NCT01630135|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111160041|NCT01630135|Autonomic Agents|autonomic agents|mesh-ancestor
111160042|NCT01630135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111160043|NCT01630135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111160044|NCT01630135|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111160045|NCT01630135|Respiratory System Agents|respiratory system agents|mesh-ancestor
111160046|NCT01630135|Dermatologic Agents|dermatologic agents|mesh-ancestor
111160047|NCT01630135|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111160048|NCT01691248|Fidaxomicin|fidaxomicin|mesh-list
111160049|NCT01691248|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111160050|NCT01691248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111160051|NCT01924767|Empagliflozin|empagliflozin|mesh-list
111160052|NCT01924767|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111160053|NCT01924767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111160054|NCT01924767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111160055|NCT01924767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111160056|NCT01691092|Ketamine|ketamine|mesh-list
111160057|NCT01691092|Analgesics|analgesics|mesh-ancestor
111160058|NCT01691092|Sensory System Agents|sensory system agents|mesh-ancestor
111160059|NCT01691092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111160060|NCT01691092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111160061|NCT01691092|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111160062|NCT01691092|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111160063|NCT01691092|Anesthetics, General|anesthetics, general|mesh-ancestor
111160064|NCT01691092|Anesthetics|anesthetics|mesh-ancestor
111160065|NCT01691092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111160066|NCT01691092|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111160067|NCT01691092|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111160068|NCT01691092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111160069|NCT01691092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111160070|NCT02133001|Esketamine|esketamine|mesh-list
111160071|NCT02133001|Antidepressive Agents|antidepressive agents|mesh-ancestor
111160072|NCT02133001|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111160073|NCT01709578|Hydroxychloroquine|hydroxychloroquine|mesh-list
111160074|NCT01709578|Sulfasalazine|sulfasalazine|mesh-list
111160075|NCT01709578|Methotrexate|methotrexate|mesh-list
111160076|NCT01709578|Leflunomide|leflunomide|mesh-list
111160077|NCT01709578|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111160078|NCT01709578|Abortifacient Agents|abortifacient agents|mesh-ancestor
111160079|NCT01709578|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111160080|NCT01709578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111160081|NCT01709578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111160082|NCT01709578|Antimetabolites|antimetabolites|mesh-ancestor
111160083|NCT01709578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111160084|NCT01709578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111160085|NCT01709578|Dermatologic Agents|dermatologic agents|mesh-ancestor
111160086|NCT01709578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111160087|NCT01709578|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111160088|NCT01709578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111160089|NCT01709578|Immunologic Factors|immunologic factors|mesh-ancestor
111160090|NCT01709578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111160091|NCT01709578|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111160092|NCT01709578|Antimalarials|antimalarials|mesh-ancestor
111160093|NCT01709578|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111160094|NCT01709578|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111160095|NCT01709578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111160096|NCT01709578|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111160097|NCT01709578|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111160098|NCT01709578|Analgesics|analgesics|mesh-ancestor
111160099|NCT01709578|Sensory System Agents|sensory system agents|mesh-ancestor
111160100|NCT01709578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111160101|NCT01709578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111160102|NCT01709578|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111160103|NCT02132767|Digoxin|digoxin|mesh-list
111160104|NCT02132767|Amiodarone|amiodarone|mesh-list
111160105|NCT02132767|Calcium Channel Blockers|calcium channel blockers|mesh-list
111160106|NCT02132767|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111160107|NCT02132767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111160108|NCT02132767|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111160109|NCT02132767|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111160110|NCT02132767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111160111|NCT02132767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111160112|NCT02132767|Protective Agents|protective agents|mesh-ancestor
111160113|NCT02132767|Vasodilator Agents|vasodilator agents|mesh-ancestor
111160114|NCT02132767|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
111160115|NCT02132767|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111160116|NCT02132767|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111160117|NCT02132767|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111160118|NCT02132767|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111160119|NCT02132767|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110877207|NCT04629378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111160120|NCT02132767|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111160121|NCT02132767|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111160122|NCT02153905|Aldesleukin|aldesleukin|mesh-list
111160123|NCT02153905|Cyclophosphamide|cyclophosphamide|mesh-list
111160124|NCT02153905|Fludarabine|fludarabine|mesh-list
111160125|NCT02153905|Interleukin-2|interleukin-2|mesh-list
111160126|NCT02153905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111160127|NCT02153905|Immunologic Factors|immunologic factors|mesh-ancestor
111160128|NCT02153905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111160129|NCT02153905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111160130|NCT02153905|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111160131|NCT02153905|Alkylating Agents|alkylating agents|mesh-ancestor
111160132|NCT02153905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111160133|NCT02153905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111160134|NCT02153905|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111160135|NCT02153905|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111160136|NCT02153905|Analgesics|analgesics|mesh-ancestor
111160137|NCT02153905|Sensory System Agents|sensory system agents|mesh-ancestor
111160138|NCT02153905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111160139|NCT02153905|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111160140|NCT02153905|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111160141|NCT02153905|Antiviral Agents|antiviral agents|mesh-ancestor
111160142|NCT02153905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111160143|NCT04752631|Tenecteplase|tenecteplase|mesh-list
111160144|NCT04752631|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111160145|NCT04752631|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111160146|NCT04752631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111160147|NCT04546672|Neostigmine|neostigmine|mesh-list
111160148|NCT04546672|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111160149|NCT04546672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111160150|NCT04546672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111160151|NCT04546672|Cholinergic Agents|cholinergic agents|mesh-ancestor
111160152|NCT04546672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111160153|NCT04546672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111160154|NCT04546672|Parasympathomimetics|parasympathomimetics|mesh-ancestor
111160155|NCT04546672|Autonomic Agents|autonomic agents|mesh-ancestor
110841478|NCT01858922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111160156|NCT04546672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111160157|NCT02244944|Ezetimibe|ezetimibe|mesh-list
111160158|NCT02244944|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111160159|NCT02244944|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111160160|NCT02244944|Antimetabolites|antimetabolites|mesh-ancestor
111160161|NCT02244944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111160162|NCT02244944|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111160163|NCT01689532|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111160164|NCT01689532|Immunologic Factors|immunologic factors|mesh-ancestor
111160165|NCT01689532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111160166|NCT01591096|Plasminogen|plasminogen|mesh-list
111160167|NCT01591096|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
111160168|NCT01591096|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111160169|NCT01591096|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111160170|NCT01591096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111160171|NCT01953003|Capecitabine|capecitabine|mesh-list
111160172|NCT01953003|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111160173|NCT01953003|Antimetabolites|antimetabolites|mesh-ancestor
111160174|NCT01953003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111160175|NCT01953003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111160176|NCT01709500|Atorvastatin|atorvastatin|mesh-list
111160177|NCT01709500|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111160178|NCT01709500|Simvastatin|simvastatin|mesh-list
111160179|NCT01709500|Alirocumab|alirocumab|mesh-list
111160180|NCT01709500|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111160181|NCT01709500|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111160182|NCT01709500|Antimetabolites|antimetabolites|mesh-ancestor
111160183|NCT01709500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111160184|NCT01709500|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111160185|NCT01709500|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111160186|NCT01709500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111160187|NCT01709500|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
111160188|NCT01709500|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111160189|NCT01709500|Protease Inhibitors|protease inhibitors|mesh-ancestor
111160190|NCT01599806|Ciprofloxacin|ciprofloxacin|mesh-list
111160191|NCT01599806|Ceftazidime|ceftazidime|mesh-list
111160192|NCT01599806|Avibactam|avibactam|mesh-list
111160193|NCT01599806|Doripenem|doripenem|mesh-list
111160194|NCT01599806|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
111160195|NCT01599806|Trimethoprim|trimethoprim|mesh-list
111160196|NCT01599806|Sulfamethoxazole|sulfamethoxazole|mesh-list
111160197|NCT01599806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111160198|NCT01599806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111160199|NCT01599806|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111160200|NCT01599806|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111160201|NCT01599806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111160202|NCT01599806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111160203|NCT01599806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111160204|NCT01599806|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111160205|NCT01599806|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111160206|NCT01599806|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111160207|NCT01599806|Antimalarials|antimalarials|mesh-ancestor
111160208|NCT01599806|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111160209|NCT01599806|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111160210|NCT01599806|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111160211|NCT01599806|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111160212|NCT01599806|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
111160213|NCT01599806|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
111160214|NCT01599325|Azacitidine|azacitidine|mesh-list
111160215|NCT01599325|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111160216|NCT01599325|Antimetabolites|antimetabolites|mesh-ancestor
111160217|NCT01599325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111160218|NCT01599325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111160219|NCT01599325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111160220|NCT01924299|Fluconazole|fluconazole|mesh-list
111160221|NCT01924299|Ketoconazole|ketoconazole|mesh-list
111160222|NCT01924299|Antifungal Agents|antifungal agents|mesh-ancestor
111160223|NCT01924299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111160224|NCT01924299|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111160225|NCT01924299|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111160226|NCT01924299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111160227|NCT01924299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111160228|NCT01924299|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111160229|NCT01924299|Hormone Antagonists|hormone antagonists|mesh-ancestor
111160230|NCT01924299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111160231|NCT01924299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111160232|NCT01924299|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111160233|NCT01924299|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111160234|NCT01924299|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111160236|NCT02182999|Anesthetics, Local|anesthetics, local|mesh-ancestor
111160237|NCT02182999|Anesthetics|anesthetics|mesh-ancestor
111160238|NCT02182999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111160239|NCT02182999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111160240|NCT02182999|Sensory System Agents|sensory system agents|mesh-ancestor
111160241|NCT02182999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111160242|NCT01598311|Vancomycin|vancomycin|mesh-list
111160243|NCT01598311|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111160244|NCT01598311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111160245|NCT02208050|4-Aminopyridine|4-aminopyridine|mesh-list
111160246|NCT02208050|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
111160247|NCT02208050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111160248|NCT02208050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111160249|NCT02978222|Molgramostim|molgramostim|mesh-list
111160250|NCT02978222|Sargramostim|sargramostim|mesh-list
111160251|NCT02978222|Immunologic Factors|immunologic factors|mesh-ancestor
111160252|NCT02978222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111160253|NCT02978222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111160254|NCT02181673|Golimumab|golimumab|mesh-list
111160255|NCT02181673|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111160256|NCT02181673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111160257|NCT02181673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111160258|NCT02181673|Immunologic Factors|immunologic factors|mesh-ancestor
111160259|NCT02181673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111160260|NCT02152345|Methylprednisolone|methylprednisolone|mesh-list
111160261|NCT02152345|Abatacept|abatacept|mesh-list
111160262|NCT02152345|Tacrolimus|tacrolimus|mesh-list
111160263|NCT02152345|Antilymphocyte Serum|antilymphocyte serum|mesh-list
111160264|NCT02152345|Thymoglobulin|thymoglobulin|mesh-list
111160265|NCT02152345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111160266|NCT02152345|Immunologic Factors|immunologic factors|mesh-ancestor
111160267|NCT02152345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111160268|NCT02152345|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110877376|NCT05285228|Fluorides|fluorides|mesh-list
111160269|NCT02152345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111160270|NCT02152345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111160271|NCT02152345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111160272|NCT02152345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111160273|NCT02152345|Antiemetics|antiemetics|mesh-ancestor
111160274|NCT02152345|Autonomic Agents|autonomic agents|mesh-ancestor
111160275|NCT02152345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111160276|NCT02152345|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111160277|NCT02152345|Glucocorticoids|glucocorticoids|mesh-ancestor
111160278|NCT02152345|Hormones|hormones|mesh-ancestor
111160279|NCT02152345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111160280|NCT02152345|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111160281|NCT02152345|Protective Agents|protective agents|mesh-ancestor
111160282|NCT02152345|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111160283|NCT02152345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111160284|NCT02152345|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111160285|NCT02180659|Buprenorphine|buprenorphine|mesh-list
111160286|NCT02180659|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111160287|NCT02180659|Narcotics|narcotics|mesh-ancestor
111160288|NCT02180659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111160289|NCT02180659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111160290|NCT02180659|Analgesics|analgesics|mesh-ancestor
111160291|NCT02180659|Sensory System Agents|sensory system agents|mesh-ancestor
111160292|NCT02180659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111160293|NCT02180659|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111160294|NCT02207816|Vaccines|vaccines|mesh-list
111160295|NCT02207816|Immunologic Factors|immunologic factors|mesh-ancestor
111160296|NCT02207816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111160297|NCT05156606|Testosterone|testosterone|mesh-list
111160298|NCT05156606|Androgens|androgens|mesh-ancestor
111160299|NCT05156606|Hormones|hormones|mesh-ancestor
111160300|NCT05156606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111160301|NCT05156606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111160302|NCT02241512|Ibuprofen|ibuprofen|mesh-list
111160303|NCT02241512|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111160304|NCT02241512|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111160305|NCT02241512|Analgesics|analgesics|mesh-ancestor
111160306|NCT02241512|Sensory System Agents|sensory system agents|mesh-ancestor
111160307|NCT02241512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111160308|NCT02241512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111160309|NCT02241512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111160310|NCT02241512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111160311|NCT02241512|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111160312|NCT02241512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111160313|NCT02241512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111160314|NCT01709110|Vitamin D|vitamin d|mesh-list
111160315|NCT01709110|Teriparatide|teriparatide|mesh-list
111160316|NCT01709110|Risedronic Acid|risedronic acid|mesh-list
111160317|NCT01709110|Calcium|calcium|mesh-list
111160318|NCT01709110|Vitamins|vitamins|mesh-ancestor
111160319|NCT01709110|Micronutrients|micronutrients|mesh-ancestor
111160320|NCT01709110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111160321|NCT01709110|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111160322|NCT01709110|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111160323|NCT01709110|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111160324|NCT01709110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111160325|NCT01709110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111160326|NCT02240108|Rifaximin|rifaximin|mesh-list
111160327|NCT02240108|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111160328|NCT02240108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111160329|NCT02240108|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111160330|NCT01590082|Doxycycline|doxycycline|mesh-list
111160331|NCT01590082|Temozolomide|temozolomide|mesh-list
111160332|NCT01590082|Ipilimumab|ipilimumab|mesh-list
111160333|NCT01590082|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111160334|NCT01590082|Alkylating Agents|alkylating agents|mesh-ancestor
111160335|NCT01590082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111160336|NCT01590082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111160337|NCT01590082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111160338|NCT01590082|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111160339|NCT01590082|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111160340|NCT01590082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111160341|NCT01590082|Antimalarials|antimalarials|mesh-ancestor
111160342|NCT01590082|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111160343|NCT01590082|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111160344|NCT02203916|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
111160345|NCT02203916|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111160346|NCT02203916|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111160347|NCT02203916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111160349|NCT02179177|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111160350|NCT02179177|Antithrombins|antithrombins|mesh-ancestor
111160351|NCT02179177|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111160352|NCT02179177|Protease Inhibitors|protease inhibitors|mesh-ancestor
111160353|NCT02179177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111160354|NCT02179177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111160355|NCT02179177|Anticoagulants|anticoagulants|mesh-ancestor
111160356|NCT02239094|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
111160357|NCT02239094|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111160358|NCT02239094|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111160359|NCT02239094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111160360|NCT02239094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111160361|NCT02239094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111160362|NCT02239094|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
111160363|NCT02239094|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111160364|NCT02239094|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111160365|NCT02239094|Adrenergic Agents|adrenergic agents|mesh-ancestor
111160366|NCT02239094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111160367|NCT02239094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111160368|NCT02239094|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111160369|NCT02239094|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111160370|NCT02239094|Serotonin Agents|serotonin agents|mesh-ancestor
111160371|NCT02239094|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111160372|NCT02239094|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111160373|NCT02239094|Dopamine Agents|dopamine agents|mesh-ancestor
111160374|NCT02129647|Axitinib|axitinib|mesh-list
111160375|NCT02129647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111160376|NCT02129647|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111160377|NCT02129647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111160378|NCT02129647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111160379|NCT02238626|Ibudilast|ibudilast|mesh-list
111160380|NCT02238626|Riluzole|riluzole|mesh-list
111160381|NCT02238626|Anticonvulsants|anticonvulsants|mesh-ancestor
111160382|NCT02238626|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111160383|NCT02238626|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111160384|NCT02238626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111160385|NCT02238626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111160386|NCT02238626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111160387|NCT02238626|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111160388|NCT02238626|Protective Agents|protective agents|mesh-ancestor
111160389|NCT02238626|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111160390|NCT02238626|Autonomic Agents|autonomic agents|mesh-ancestor
111160391|NCT02238626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111160392|NCT02238626|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111160393|NCT02238626|Respiratory System Agents|respiratory system agents|mesh-ancestor
111160394|NCT02238626|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111160395|NCT02238626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111160396|NCT02238626|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111160397|NCT02238626|Vasodilator Agents|vasodilator agents|mesh-ancestor
111160398|NCT02151643|Iron|iron|mesh-list
111160399|NCT02151643|Trace Elements|trace elements|mesh-ancestor
111160400|NCT02151643|Micronutrients|micronutrients|mesh-ancestor
111160401|NCT02151643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111160402|NCT02203838|Risperidone|risperidone|mesh-list
111160403|NCT02203838|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111160404|NCT02203838|Serotonin Agents|serotonin agents|mesh-ancestor
111160405|NCT02203838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111160406|NCT02203838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111160407|NCT02203838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111160408|NCT02203838|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111160409|NCT02203838|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111160410|NCT02203838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111160411|NCT02203838|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111160412|NCT02203838|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111160413|NCT02203838|Dopamine Agents|dopamine agents|mesh-ancestor
111160414|NCT02178709|Leucovorin|leucovorin|mesh-list
111160415|NCT02178709|Oxaliplatin|oxaliplatin|mesh-list
111160416|NCT02178709|Irinotecan|irinotecan|mesh-list
111160417|NCT02178709|Folfirinox|folfirinox|mesh-list
110877508|NCT03712475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111160418|NCT02178709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111160419|NCT02178709|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111160420|NCT02178709|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111160421|NCT02178709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111160422|NCT02178709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111160423|NCT02178709|Antidotes|antidotes|mesh-ancestor
111160424|NCT02178709|Protective Agents|protective agents|mesh-ancestor
111160425|NCT02178709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111160426|NCT02178709|Vitamin B Complex|vitamin b complex|mesh-ancestor
111160427|NCT02178709|Vitamins|vitamins|mesh-ancestor
111160428|NCT02178709|Micronutrients|micronutrients|mesh-ancestor
111160429|NCT02238080|Epoetin Alfa|epoetin alfa|mesh-list
111160430|NCT02238080|Hematinics|hematinics|mesh-ancestor
111160431|NCT02178553|Bupivacaine|bupivacaine|mesh-list
111160432|NCT02178553|Anesthetics, Local|anesthetics, local|mesh-ancestor
111160433|NCT02178553|Anesthetics|anesthetics|mesh-ancestor
111160434|NCT02178553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111160435|NCT02178553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111160436|NCT02178553|Sensory System Agents|sensory system agents|mesh-ancestor
111160437|NCT02178553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111160438|NCT01627327|Fluticasone|fluticasone|mesh-list
111160439|NCT01627327|Xhance|xhance|mesh-list
111160440|NCT01627327|Bromides|bromides|mesh-list
111160441|NCT01627327|Tiotropium Bromide|tiotropium bromide|mesh-list
111160442|NCT01627327|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111160443|NCT01627327|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111160444|NCT01627327|Autonomic Agents|autonomic agents|mesh-ancestor
111160445|NCT01627327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111160446|NCT01627327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111160447|NCT01627327|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111160448|NCT01627327|Respiratory System Agents|respiratory system agents|mesh-ancestor
111160449|NCT01627327|Dermatologic Agents|dermatologic agents|mesh-ancestor
111160450|NCT01627327|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111160451|NCT01627327|Parasympatholytics|parasympatholytics|mesh-ancestor
111160452|NCT01627327|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111160453|NCT01627327|Cholinergic Agents|cholinergic agents|mesh-ancestor
111160454|NCT01627327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111160455|NCT01627327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111160456|NCT01627327|Anticonvulsants|anticonvulsants|mesh-ancestor
111160457|NCT01627249|Bevacizumab|bevacizumab|mesh-list
111160458|NCT01627249|Ranibizumab|ranibizumab|mesh-list
111160459|NCT01627249|Aflibercept|aflibercept|mesh-list
111160460|NCT01627249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111160461|NCT01627249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111160462|NCT01627249|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111160463|NCT01627249|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111160464|NCT01627249|Growth Substances|growth substances|mesh-ancestor
111160465|NCT01627249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111160466|NCT01627249|Growth Inhibitors|growth inhibitors|mesh-ancestor
111160467|NCT01688830|Dabigatran|dabigatran|mesh-list
111160468|NCT01688830|Antithrombins|antithrombins|mesh-ancestor
111160469|NCT01688830|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111160470|NCT01688830|Protease Inhibitors|protease inhibitors|mesh-ancestor
111160471|NCT01688830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111160472|NCT01688830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111160473|NCT01688830|Anticoagulants|anticoagulants|mesh-ancestor
111160474|NCT01604278|Glycopyrrolate|glycopyrrolate|mesh-list
111160475|NCT01604278|Bromides|bromides|mesh-list
111160476|NCT01604278|Anticonvulsants|anticonvulsants|mesh-ancestor
111160477|NCT01604278|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111160478|NCT01604278|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111160479|NCT01604278|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111160480|NCT01604278|Cholinergic Agents|cholinergic agents|mesh-ancestor
111160481|NCT01604278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111160482|NCT01604278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111160483|NCT01604278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111160485|NCT01687270|Ribavirin|ribavirin|mesh-list
111160486|NCT01687270|Antiviral Agents|antiviral agents|mesh-ancestor
111160487|NCT01687270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111160488|NCT01687270|Antimetabolites|antimetabolites|mesh-ancestor
111160489|NCT01687270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111160490|NCT01588990|Leucovorin|leucovorin|mesh-list
111160491|NCT01588990|Bevacizumab|bevacizumab|mesh-list
111160492|NCT01588990|Capecitabine|capecitabine|mesh-list
111160493|NCT01588990|Oxaliplatin|oxaliplatin|mesh-list
111160494|NCT01588990|Irinotecan|irinotecan|mesh-list
111160495|NCT01588990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111160496|NCT01588990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111160497|NCT01588990|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111160498|NCT01588990|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111160499|NCT01588990|Growth Substances|growth substances|mesh-ancestor
111160500|NCT01588990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111160501|NCT01588990|Growth Inhibitors|growth inhibitors|mesh-ancestor
111160502|NCT01588990|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111160503|NCT01588990|Antimetabolites|antimetabolites|mesh-ancestor
111160504|NCT01588990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111160505|NCT01588990|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111160506|NCT01588990|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111160507|NCT01588990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111160509|NCT01588990|Protective Agents|protective agents|mesh-ancestor
111160510|NCT01588990|Vitamin B Complex|vitamin b complex|mesh-ancestor
111160511|NCT01588990|Vitamins|vitamins|mesh-ancestor
111160512|NCT01588990|Micronutrients|micronutrients|mesh-ancestor
111160513|NCT02126839|Albuterol|albuterol|mesh-list
111160514|NCT02126839|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111160515|NCT02126839|Autonomic Agents|autonomic agents|mesh-ancestor
111160516|NCT02126839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111160517|NCT02126839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111160518|NCT02126839|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111160519|NCT02126839|Respiratory System Agents|respiratory system agents|mesh-ancestor
111160520|NCT02126839|Tocolytic Agents|tocolytic agents|mesh-ancestor
111160521|NCT02126839|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111160522|NCT02126839|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111160523|NCT02126839|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111160524|NCT02126839|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111160525|NCT02126839|Adrenergic Agents|adrenergic agents|mesh-ancestor
111160526|NCT02126839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111160527|NCT02126839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111160528|NCT04747795|Ascorbic Acid|ascorbic acid|mesh-list
111160529|NCT04747795|Vitamins|vitamins|mesh-ancestor
111160530|NCT04747795|Micronutrients|micronutrients|mesh-ancestor
111160531|NCT04747795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111160532|NCT04747795|Antioxidants|antioxidants|mesh-ancestor
111160533|NCT04747795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111160534|NCT04747795|Protective Agents|protective agents|mesh-ancestor
111160535|NCT02125279|Calcitriol|calcitriol|mesh-list
111160536|NCT02125279|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111160537|NCT02125279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111160538|NCT02125279|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
111160539|NCT02125279|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111160540|NCT02125279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111160541|NCT02125279|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111160542|NCT02125279|Vitamins|vitamins|mesh-ancestor
111160543|NCT02125279|Micronutrients|micronutrients|mesh-ancestor
111160544|NCT02125279|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111160545|NCT02124811|Minocycline|minocycline|mesh-list
111160546|NCT02124811|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111160547|NCT02124811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111160548|NCT02148445|Nicotine|nicotine|mesh-list
111160549|NCT02148445|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111160550|NCT02148445|Autonomic Agents|autonomic agents|mesh-ancestor
111160551|NCT02148445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111160552|NCT02148445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111160553|NCT02148445|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111160554|NCT02148445|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111160555|NCT02148445|Cholinergic Agents|cholinergic agents|mesh-ancestor
111160556|NCT02148445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111160557|NCT02148445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111160558|NCT02147587|Tofacitinib|tofacitinib|mesh-list
111160559|NCT02147587|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
111160560|NCT02147587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111160561|NCT02147587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111160562|NCT02147587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111160563|NCT02147197|Ulipristal acetate|ulipristal acetate|mesh-list
111160564|NCT02147197|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111160565|NCT02147197|Contraceptive Agents|contraceptive agents|mesh-ancestor
111160566|NCT02147197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111160567|NCT02147197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111160568|NCT02147197|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111160569|NCT04751929|Atezolizumab|atezolizumab|mesh-list
111160570|NCT04751929|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111160571|NCT04751929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111160572|NCT04751929|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111160573|NCT04751929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111160574|NCT02176291|Buprenorphine|buprenorphine|mesh-list
111160575|NCT02176291|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111160576|NCT02176291|Narcotics|narcotics|mesh-ancestor
110166627|NCT00000482|Vitamins|vitamins|mesh-ancestor
111160577|NCT02176291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111160578|NCT02176291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111160579|NCT02176291|Analgesics|analgesics|mesh-ancestor
111160580|NCT02176291|Sensory System Agents|sensory system agents|mesh-ancestor
111160581|NCT02176291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111160582|NCT02176291|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111160583|NCT02175745|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
111160584|NCT02175745|Dopamine Agents|dopamine agents|mesh-ancestor
111160585|NCT02175745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111160586|NCT02175745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111160587|NCT02175745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111160588|NCT02175277|Darbepoetin alfa|darbepoetin alfa|mesh-list
111160589|NCT02175277|Hematinics|hematinics|mesh-ancestor
111160590|NCT01568866|Dexamethasone|dexamethasone|mesh-list
111160592|NCT01568866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111160593|NCT01568866|Antiemetics|antiemetics|mesh-ancestor
111160594|NCT01568866|Autonomic Agents|autonomic agents|mesh-ancestor
111160595|NCT01568866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111160596|NCT01568866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111160597|NCT01568866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111160598|NCT01568866|Glucocorticoids|glucocorticoids|mesh-ancestor
111160599|NCT01568866|Hormones|hormones|mesh-ancestor
111160600|NCT01568866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111160601|NCT01568866|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111160602|NCT01568866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111160603|NCT01567852|Ketamine|ketamine|mesh-list
111160604|NCT01567852|Methohexital|methohexital|mesh-list
111160605|NCT01567852|Analgesics|analgesics|mesh-ancestor
111160606|NCT01567852|Sensory System Agents|sensory system agents|mesh-ancestor
111160607|NCT01567852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111160608|NCT01567852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111160609|NCT01567852|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111160610|NCT01567852|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111160611|NCT01567852|Anesthetics, General|anesthetics, general|mesh-ancestor
111160612|NCT01567852|Anesthetics|anesthetics|mesh-ancestor
111160613|NCT01567852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110841571|NCT05069012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111160614|NCT01567852|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111160615|NCT01567852|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111160616|NCT01567852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111160617|NCT01567852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111160618|NCT01587274|Acetaminophen|acetaminophen|mesh-list
111160619|NCT01587274|Naproxen|naproxen|mesh-list
111160620|NCT01587274|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
111160621|NCT01587274|Oxycodone|oxycodone|mesh-list
111160622|NCT01587274|Cyclobenzaprine|cyclobenzaprine|mesh-list
111160623|NCT01587274|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111160624|NCT01587274|Analgesics|analgesics|mesh-ancestor
111160625|NCT01587274|Sensory System Agents|sensory system agents|mesh-ancestor
111160626|NCT01587274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111160627|NCT01587274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111160628|NCT01587274|Antipyretics|antipyretics|mesh-ancestor
111160629|NCT01587274|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111160630|NCT01587274|Narcotics|narcotics|mesh-ancestor
111160631|NCT01587274|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111160632|NCT01587274|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111160633|NCT01587274|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111160634|NCT01587274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111160635|NCT01587274|Gout Suppressants|gout suppressants|mesh-ancestor
111160636|NCT01587274|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111160637|NCT01587274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111160638|NCT01587274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111160639|NCT01587274|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
111160640|NCT01587274|Antidepressive Agents|antidepressive agents|mesh-ancestor
111160641|NCT01587274|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111160642|NCT01587274|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
111160643|NCT01587274|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111160644|NCT01587274|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111160645|NCT01587118|Asenapine|asenapine|mesh-list
111160646|NCT01587118|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111160647|NCT01587118|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111160648|NCT01587118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111160649|NCT01587118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111160650|NCT01587118|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111160651|NCT01905657|Docetaxel|docetaxel|mesh-list
111160652|NCT01905657|Pembrolizumab|pembrolizumab|mesh-list
111160653|NCT01905657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111160654|NCT01905657|Tubulin Modulators|tubulin modulators|mesh-ancestor
111160655|NCT01905657|Antimitotic Agents|antimitotic agents|mesh-ancestor
111160656|NCT01905657|Mitosis Modulators|mitosis modulators|mesh-ancestor
111160657|NCT01905657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111160658|NCT01905657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111160659|NCT01905657|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111160660|NCT02202980|Sofosbuvir|sofosbuvir|mesh-list
111160661|NCT02202980|Antiviral Agents|antiviral agents|mesh-ancestor
111160662|NCT02202980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111160663|NCT01952145|Insulin|insulin|mesh-list
111160664|NCT01952145|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111160665|NCT01952145|Insulin Glargine|insulin glargine|mesh-list
111160666|NCT01952145|Liraglutide|liraglutide|mesh-list
111160667|NCT01952145|Xultophy|xultophy|mesh-list
111160668|NCT01952145|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111160669|NCT01952145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111160670|NCT01952145|Incretins|incretins|mesh-ancestor
111160671|NCT01952145|Hormones|hormones|mesh-ancestor
111160672|NCT01952145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111160673|NCT01923363|Tazobactam|tazobactam|mesh-list
111160674|NCT01923363|Piperacillin|piperacillin|mesh-list
111160675|NCT01923363|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
111160676|NCT01923363|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111160677|NCT01923363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111160678|NCT01923363|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
111160679|NCT01923363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111160680|NCT01923363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111160681|NCT01904721|Bimatoprost|bimatoprost|mesh-list
111160682|NCT01904721|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111160683|NCT01904721|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111160684|NCT01922739|Hydrocodone|hydrocodone|mesh-list
111160685|NCT01922739|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111160686|NCT01922739|Narcotics|narcotics|mesh-ancestor
111160687|NCT01922739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111160688|NCT01922739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111160689|NCT01922739|Analgesics|analgesics|mesh-ancestor
111160690|NCT01922739|Sensory System Agents|sensory system agents|mesh-ancestor
111160691|NCT01922739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111160692|NCT01922739|Antitussive Agents|antitussive agents|mesh-ancestor
111160693|NCT01922739|Respiratory System Agents|respiratory system agents|mesh-ancestor
111160694|NCT02236988|Thalidomide|thalidomide|mesh-list
111160695|NCT02236988|Apremilast|apremilast|mesh-list
111160696|NCT02236988|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111160697|NCT02236988|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111160698|NCT02236988|Analgesics|analgesics|mesh-ancestor
111160699|NCT02236988|Sensory System Agents|sensory system agents|mesh-ancestor
111160700|NCT02236988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111160701|NCT02236988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111160702|NCT02236988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111160703|NCT02236988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111160704|NCT02236988|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
111160705|NCT02236988|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111160706|NCT02236988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111160707|NCT02236988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111160708|NCT02236988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111160709|NCT02236988|Immunologic Factors|immunologic factors|mesh-ancestor
111160710|NCT02236988|Leprostatic Agents|leprostatic agents|mesh-ancestor
111160711|NCT02236988|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111160712|NCT02236988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111160713|NCT02236988|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111160714|NCT02236988|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111160715|NCT02236988|Growth Substances|growth substances|mesh-ancestor
111160716|NCT02236988|Growth Inhibitors|growth inhibitors|mesh-ancestor
111160717|NCT02236988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111160718|NCT02236520|Chlorthalidone|chlorthalidone|mesh-list
111160719|NCT02236520|Spironolactone|spironolactone|mesh-list
111160720|NCT02236520|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
111160721|NCT02236520|Hormone Antagonists|hormone antagonists|mesh-ancestor
110877816|NCT05207904|Paclitaxel|paclitaxel|mesh-list
111160722|NCT02236520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111160723|NCT02236520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111160724|NCT02236520|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
111160725|NCT02236520|Diuretics|diuretics|mesh-ancestor
111160726|NCT02236520|Natriuretic Agents|natriuretic agents|mesh-ancestor
111160727|NCT02236520|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111160728|NCT02236520|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
111160729|NCT02236520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111160730|NCT02236520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111160731|NCT04769414|Gemcitabine|gemcitabine|mesh-list
111160732|NCT04769414|Fluorouracil|fluorouracil|mesh-list
111160733|NCT04769414|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111160734|NCT04769414|Antimetabolites|antimetabolites|mesh-ancestor
111160735|NCT04769414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111160736|NCT04769414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111160737|NCT04769414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111160738|NCT04769414|Immunologic Factors|immunologic factors|mesh-ancestor
111160739|NCT04769414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111160740|NCT01922271|Glycopyrrolate|glycopyrrolate|mesh-list
111160741|NCT01922271|Albuterol|albuterol|mesh-list
111160742|NCT01922271|Tiotropium Bromide|tiotropium bromide|mesh-list
111160743|NCT01922271|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111160744|NCT01922271|Autonomic Agents|autonomic agents|mesh-ancestor
111160745|NCT01922271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111160746|NCT01922271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111160747|NCT01922271|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111160748|NCT01922271|Respiratory System Agents|respiratory system agents|mesh-ancestor
111160749|NCT01922271|Parasympatholytics|parasympatholytics|mesh-ancestor
111160750|NCT01922271|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111160751|NCT01922271|Cholinergic Agents|cholinergic agents|mesh-ancestor
111160752|NCT01922271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111160753|NCT01922271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111160754|NCT01922271|Tocolytic Agents|tocolytic agents|mesh-ancestor
110841590|NCT02888106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111160755|NCT01922271|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111160756|NCT01922271|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111160757|NCT01922271|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111160758|NCT01922271|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111160759|NCT01922271|Adrenergic Agents|adrenergic agents|mesh-ancestor
111160760|NCT01922271|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111160761|NCT01922271|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111160762|NCT02236130|Acetaminophen|acetaminophen|mesh-list
111160763|NCT02236130|Morphine|morphine|mesh-list
111160764|NCT02236130|Hydrocodone|hydrocodone|mesh-list
111160765|NCT02236130|Analgesics|analgesics|mesh-list
111160766|NCT02236130|Anesthetics|anesthetics|mesh-list
111160767|NCT02236130|Ropivacaine|ropivacaine|mesh-list
111160768|NCT02236130|Anesthetics, Local|anesthetics, local|mesh-list
111160769|NCT02236130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111160770|NCT02236130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111160771|NCT02236130|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111160772|NCT02236130|Narcotics|narcotics|mesh-ancestor
111160773|NCT02236130|Sensory System Agents|sensory system agents|mesh-ancestor
111160774|NCT02236130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111160775|NCT02236130|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111160776|NCT02236130|Antipyretics|antipyretics|mesh-ancestor
111160777|NCT02236130|Antitussive Agents|antitussive agents|mesh-ancestor
111160778|NCT02236130|Respiratory System Agents|respiratory system agents|mesh-ancestor
111160779|NCT05153564|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
111160780|NCT05153564|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
110485515|NCT00641979|Hormones|hormones|mesh-ancestor
111160781|NCT05153564|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111160782|NCT05153564|Contraceptive Agents|contraceptive agents|mesh-ancestor
111160783|NCT05153564|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111160784|NCT05153564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111160785|NCT05153564|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
111160786|NCT05153564|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111160787|NCT05153564|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111160788|NCT05153564|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111160789|NCT05153564|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111160790|NCT05153564|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
111160791|NCT05153564|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
111160792|NCT05153564|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
111160793|NCT01641809|Tenofovir|tenofovir|mesh-list
111160794|NCT01641809|Lamivudine|lamivudine|mesh-list
111160795|NCT01641809|Emtricitabine|emtricitabine|mesh-list
111160796|NCT01641809|Efavirenz|efavirenz|mesh-list
111160797|NCT01641809|Abacavir|abacavir|mesh-list
111160798|NCT01641809|Rilpivirine|rilpivirine|mesh-list
111160799|NCT01641809|Cabotegravir|cabotegravir|mesh-list
111160800|NCT01641809|Antiviral Agents|antiviral agents|mesh-ancestor
111160801|NCT01641809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111160802|NCT01641809|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111160803|NCT01641809|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111160804|NCT01641809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111160805|NCT01641809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111160806|NCT01641809|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111160807|NCT01641809|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111160808|NCT01641809|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111160809|NCT01641809|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111160810|NCT01641809|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111160811|NCT01641809|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111160812|NCT01641809|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111160813|NCT01641809|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111160814|NCT01641809|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111160815|NCT01641809|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111160816|NCT01632566|Celecoxib|celecoxib|mesh-list
111160817|NCT01632566|Simvastatin|simvastatin|mesh-list
111160818|NCT01632566|LY3031207|ly3031207|mesh-list
111160819|NCT01632566|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111160820|NCT01632566|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111160821|NCT01632566|Antimetabolites|antimetabolites|mesh-ancestor
111160822|NCT01632566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111160823|NCT01632566|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111160824|NCT01632566|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111160825|NCT01632566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111160826|NCT01632566|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111160827|NCT01632566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111160828|NCT01632566|Analgesics|analgesics|mesh-ancestor
111160829|NCT01632566|Sensory System Agents|sensory system agents|mesh-ancestor
111160830|NCT01632566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111160831|NCT01632566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111160832|NCT01632566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111160833|NCT01632566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111160834|NCT01632566|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111160835|NCT01632566|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111160836|NCT01632566|Prostaglandin Antagonists|prostaglandin antagonists|mesh-ancestor
111160837|NCT01632566|Hormone Antagonists|hormone antagonists|mesh-ancestor
111160838|NCT01632566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111160839|NCT02254304|Interferons|interferons|mesh-list
111160840|NCT02254304|Interferon-beta|interferon-beta|mesh-list
111160841|NCT02254304|Interferon beta-1a|interferon beta-1a|mesh-list
111160842|NCT02254304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111160843|NCT02254304|Antiviral Agents|antiviral agents|mesh-ancestor
111160844|NCT02254304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111160845|NCT02254304|Immunologic Factors|immunologic factors|mesh-ancestor
111160846|NCT02254304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111160847|NCT02254304|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111160848|NCT05650151|Vitamin D|vitamin d|mesh-list
111160849|NCT05650151|Vitamins|vitamins|mesh-ancestor
111160850|NCT05650151|Micronutrients|micronutrients|mesh-ancestor
111160851|NCT05650151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111160852|NCT05650151|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111160853|NCT02174731|Epoetin Alfa|epoetin alfa|mesh-list
111160854|NCT02174731|Hematinics|hematinics|mesh-ancestor
111160855|NCT01922037|Omalizumab|omalizumab|mesh-list
111160856|NCT01922037|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111160857|NCT01922037|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111160858|NCT01922037|Respiratory System Agents|respiratory system agents|mesh-ancestor
111160859|NCT02282813|Calcitriol|calcitriol|mesh-list
111160860|NCT02282813|Calcifediol|calcifediol|mesh-list
111160861|NCT02282813|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
111160862|NCT02282813|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111160863|NCT02282813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111160864|NCT02282813|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
111160865|NCT02282813|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111160866|NCT02282813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111160867|NCT02282813|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111160868|NCT02282813|Vitamins|vitamins|mesh-ancestor
111160869|NCT02282813|Micronutrients|micronutrients|mesh-ancestor
111160870|NCT02282813|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111160871|NCT05638529|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
111160872|NCT05638529|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110877955|NCT05733000|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111160873|NCT05638529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111160874|NCT04859465|Doxorubicin|doxorubicin|mesh-list
111160875|NCT04859465|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111160876|NCT04859465|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111160877|NCT04859465|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111160878|NCT04859465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111160879|NCT04859465|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111160880|NCT04859465|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111160881|NCT04859465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111160882|NCT04859465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111160883|NCT02121847|Cyclosporine|cyclosporine|mesh-list
111160884|NCT02121847|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
111160885|NCT02121847|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111160886|NCT02121847|Lubricant Eye Drops|lubricant eye drops|mesh-list
111160887|NCT02121847|Cyclosporins|cyclosporins|mesh-list
111160888|NCT02121847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111160889|NCT02121847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111160890|NCT02121847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111160891|NCT02121847|Immunologic Factors|immunologic factors|mesh-ancestor
111160892|NCT02121847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110841598|NCT03793010|Hormones|hormones|mesh-ancestor
111160893|NCT02121847|Antifungal Agents|antifungal agents|mesh-ancestor
111160894|NCT02121847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111160895|NCT02121847|Dermatologic Agents|dermatologic agents|mesh-ancestor
111160896|NCT02121847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111160897|NCT02121847|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111160898|NCT02121847|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111160899|NCT02121847|Laxatives|laxatives|mesh-ancestor
111160900|NCT02121847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111160901|NCT01586806|Dexamethasone|dexamethasone|mesh-list
111160902|NCT01586806|Dexamethasone acetate|dexamethasone acetate|mesh-list
111160903|NCT01586806|Bupivacaine|bupivacaine|mesh-list
111160904|NCT01586806|BB 1101|bb 1101|mesh-list
111160905|NCT01586806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111160906|NCT01586806|Antiemetics|antiemetics|mesh-ancestor
111160907|NCT01586806|Autonomic Agents|autonomic agents|mesh-ancestor
111160908|NCT01586806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111160909|NCT01586806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111160910|NCT01586806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111160911|NCT01586806|Glucocorticoids|glucocorticoids|mesh-ancestor
111160912|NCT01586806|Hormones|hormones|mesh-ancestor
111160913|NCT01586806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111160914|NCT01586806|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111160915|NCT01586806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111160916|NCT01586806|Protease Inhibitors|protease inhibitors|mesh-ancestor
111160917|NCT01586806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111160918|NCT01586806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111160919|NCT01586806|Anesthetics, Local|anesthetics, local|mesh-ancestor
111160920|NCT01586806|Anesthetics|anesthetics|mesh-ancestor
111160921|NCT01586806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111160922|NCT01586806|Sensory System Agents|sensory system agents|mesh-ancestor
111160923|NCT05631041|Silymarin|silymarin|mesh-list
111160924|NCT05631041|Antioxidants|antioxidants|mesh-ancestor
111160925|NCT05631041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111160926|NCT05631041|Protective Agents|protective agents|mesh-ancestor
111160927|NCT05631041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111160928|NCT02144077|Aminolevulinic Acid|aminolevulinic acid|mesh-list
111160929|NCT02144077|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
111160930|NCT02144077|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111160931|NCT02144077|Dermatologic Agents|dermatologic agents|mesh-ancestor
111160932|NCT05544071|Sertraline|sertraline|mesh-list
111160933|NCT05544071|Antidepressive Agents|antidepressive agents|mesh-ancestor
111160934|NCT05544071|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111160935|NCT05544071|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111160936|NCT05544071|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111160937|NCT05544071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111160938|NCT05544071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111160939|NCT05544071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111160940|NCT05544071|Serotonin Agents|serotonin agents|mesh-ancestor
111160941|NCT05544071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111160942|NCT02143843|Bimatoprost|bimatoprost|mesh-list
111160943|NCT02143843|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111160944|NCT01586338|Hylan|hylan|mesh-list
111160945|NCT01586338|Viscosupplements|viscosupplements|mesh-ancestor
111160946|NCT01586338|Protective Agents|protective agents|mesh-ancestor
111160947|NCT01586338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111160948|NCT02143141|Morphine|morphine|mesh-list
111160950|NCT02143141|Narcotics|narcotics|mesh-ancestor
111160951|NCT02143141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111160952|NCT02143141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111160953|NCT02143141|Analgesics|analgesics|mesh-ancestor
111160954|NCT02143141|Sensory System Agents|sensory system agents|mesh-ancestor
111160955|NCT02143141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111160956|NCT01566604|Glycopyrrolate|glycopyrrolate|mesh-list
111160957|NCT01566604|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111160958|NCT01566604|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111160959|NCT01566604|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111160960|NCT01566604|Cholinergic Agents|cholinergic agents|mesh-ancestor
111160961|NCT01566604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111160962|NCT01566604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111160963|NCT01566604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111160964|NCT05497583|Factor VIII|factor viii|mesh-list
111160965|NCT05497583|Coagulants|coagulants|mesh-ancestor
111160967|NCT02253992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111160968|NCT02253992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111160969|NCT02253992|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111160970|NCT02253992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111160971|NCT02252588|Chlorhexidine|chlorhexidine|mesh-list
111160972|NCT02252588|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111160973|NCT02252588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111160974|NCT02252588|Disinfectants|disinfectants|mesh-ancestor
111160975|NCT01585558|Tamoxifen|tamoxifen|mesh-list
111160976|NCT01585558|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111160977|NCT01585558|Hormone Antagonists|hormone antagonists|mesh-ancestor
111160978|NCT01585558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111160979|NCT01585558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111160980|NCT01585558|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111160981|NCT01585558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111160982|NCT01585558|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111160983|NCT01585558|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111160984|NCT01585558|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111160985|NCT01585246|Saw palmetto extract|saw palmetto extract|mesh-list
111160986|NCT01585246|Urological Agents|urological agents|mesh-ancestor
111160987|NCT01585168|Memantine|memantine|mesh-list
111160988|NCT01585168|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111160989|NCT01585168|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111160990|NCT01585168|Dopamine Agents|dopamine agents|mesh-ancestor
111160991|NCT01585168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111160992|NCT01585168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111160993|NCT01585168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111160994|NCT01585168|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111160995|NCT01585168|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111160996|NCT02231918|Pramipexole|pramipexole|mesh-list
111160997|NCT02231918|Antioxidants|antioxidants|mesh-ancestor
111160998|NCT02231918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111160999|NCT02231918|Protective Agents|protective agents|mesh-ancestor
111161000|NCT02231918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111161001|NCT02231918|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111161002|NCT02231918|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111161003|NCT02231918|Dopamine Agonists|dopamine agonists|mesh-ancestor
111161004|NCT02231918|Dopamine Agents|dopamine agents|mesh-ancestor
111161005|NCT02231918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111161006|NCT02199314|Desflurane|desflurane|mesh-list
111161007|NCT02199314|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111161008|NCT02199314|Anesthetics, General|anesthetics, general|mesh-ancestor
111161009|NCT02199314|Anesthetics|anesthetics|mesh-ancestor
111161010|NCT02199314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111161011|NCT02199314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111161012|NCT02199080|Fibrin fragment D|fibrin fragment d|mesh-list
111161013|NCT02199080|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111161014|NCT02199080|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111161015|NCT02199080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111161016|NCT02199080|Hemostatics|hemostatics|mesh-ancestor
111161017|NCT02199080|Coagulants|coagulants|mesh-ancestor
111161018|NCT02197520|Insulin|insulin|mesh-list
111161019|NCT02197520|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111161020|NCT02197520|Insulin Glargine|insulin glargine|mesh-list
111161021|NCT02197520|Insulin Lispro|insulin lispro|mesh-list
111161022|NCT02197520|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110878109|NCT05732532|Anesthetics|anesthetics|mesh-ancestor
111161023|NCT02197520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111161024|NCT02230904|Rotigotine|rotigotine|mesh-list
111161025|NCT02230904|Dopamine Agonists|dopamine agonists|mesh-ancestor
111161026|NCT02230904|Dopamine Agents|dopamine agents|mesh-ancestor
111161027|NCT02230904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111161028|NCT02230904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111161029|NCT02230904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111161030|NCT02196506|Brexpiprazole|brexpiprazole|mesh-list
111161031|NCT02196506|Serotonin Agents|serotonin agents|mesh-ancestor
111161032|NCT02196506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111161033|NCT02196506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111161034|NCT02196506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111161036|NCT02196506|Dopamine Agents|dopamine agents|mesh-ancestor
111161037|NCT02228720|Mometasone Furoate|mometasone furoate|mesh-list
111161038|NCT02228720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111161039|NCT02228720|Dermatologic Agents|dermatologic agents|mesh-ancestor
111161040|NCT02228720|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111161041|NCT01640951|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111161042|NCT01640951|Immunologic Factors|immunologic factors|mesh-ancestor
111161043|NCT01640951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111161044|NCT02228096|Tisagenlecleucel|tisagenlecleucel|mesh-list
111161045|NCT02228096|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111161046|NCT02228096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111161047|NCT01683994|Prednisone|prednisone|mesh-list
111161048|NCT01683994|Docetaxel|docetaxel|mesh-list
111161049|NCT01683994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111161050|NCT01683994|Tubulin Modulators|tubulin modulators|mesh-ancestor
111161051|NCT01683994|Antimitotic Agents|antimitotic agents|mesh-ancestor
111161052|NCT01683994|Mitosis Modulators|mitosis modulators|mesh-ancestor
111161053|NCT01683994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111161054|NCT01683994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111161055|NCT01683994|Glucocorticoids|glucocorticoids|mesh-ancestor
111161056|NCT01683994|Hormones|hormones|mesh-ancestor
111161057|NCT01683994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111161058|NCT01683994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111161059|NCT01683994|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111161060|NCT02247440|Interferons|interferons|mesh-list
111161061|NCT02247440|Ribavirin|ribavirin|mesh-list
111161062|NCT02247440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111161063|NCT02247440|Antiviral Agents|antiviral agents|mesh-ancestor
111161064|NCT02247440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111161065|NCT02247440|Antimetabolites|antimetabolites|mesh-ancestor
111161066|NCT02247440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111161067|NCT04857203|Vitamin D|vitamin d|mesh-list
111161068|NCT04857203|Vitamins|vitamins|mesh-ancestor
111161069|NCT04857203|Micronutrients|micronutrients|mesh-ancestor
111161070|NCT04857203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111161071|NCT04857203|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111161072|NCT05381597|Fluorouracil|fluorouracil|mesh-list
111161073|NCT05381597|Calcipotriene|calcipotriene|mesh-list
111161074|NCT05381597|Antimetabolites|antimetabolites|mesh-ancestor
111161075|NCT05381597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111161076|NCT05381597|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111161077|NCT05381597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111161078|NCT05381597|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111161079|NCT05381597|Immunologic Factors|immunologic factors|mesh-ancestor
111161080|NCT05381597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111161081|NCT05381597|Dermatologic Agents|dermatologic agents|mesh-ancestor
111161082|NCT01683838|4-Aminopyridine|4-aminopyridine|mesh-list
111161083|NCT01683838|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
111161084|NCT01683838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111161085|NCT01683838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111161086|NCT05417165|Vaccines|vaccines|mesh-list
111161087|NCT05417165|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
111161088|NCT05417165|Immunologic Factors|immunologic factors|mesh-ancestor
111161089|NCT05417165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111161090|NCT04660643|Tirzepatide|tirzepatide|mesh-list
111161091|NCT04660643|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111161092|NCT04660643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111161093|NCT04660643|Incretins|incretins|mesh-ancestor
111161094|NCT04660643|Hormones|hormones|mesh-ancestor
111161095|NCT04660643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110878186|NCT05077449|Fulvestrant|fulvestrant|mesh-list
111161096|NCT04659317|Oxycodone|oxycodone|mesh-list
111161097|NCT04659317|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111161098|NCT04659317|Narcotics|narcotics|mesh-ancestor
111161099|NCT04659317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111161100|NCT04659317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111161101|NCT04659317|Analgesics|analgesics|mesh-ancestor
111161103|NCT04659317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111161104|NCT03602261|Calcifediol|calcifediol|mesh-list
111161105|NCT03602261|Vitamins|vitamins|mesh-ancestor
111161106|NCT03602261|Micronutrients|micronutrients|mesh-ancestor
111161107|NCT03602261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111161108|NCT03602261|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111161109|NCT02141659|Relugolix|relugolix|mesh-list
111161110|NCT02141659|Androgen Antagonists|androgen antagonists|mesh-ancestor
111161111|NCT02141659|Hormone Antagonists|hormone antagonists|mesh-ancestor
111161112|NCT02141659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111161113|NCT02141659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111161114|NCT02121301|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111161115|NCT02121301|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111161116|NCT05422703|Analgesics|analgesics|mesh-list
111161117|NCT05422703|Sensory System Agents|sensory system agents|mesh-ancestor
111161118|NCT05422703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110485551|NCT02678949|Dermatologic Agents|dermatologic agents|mesh-ancestor
111161119|NCT05422703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111161120|NCT02227862|Insulin Glargine|insulin glargine|mesh-list
111161121|NCT02227862|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111161122|NCT02227862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111161123|NCT02120833|Decanoic acid|decanoic acid|mesh-list
111161124|NCT02120833|Antifungal Agents|antifungal agents|mesh-ancestor
111161125|NCT02120833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111161126|NCT04615949|Cannabidiol|cannabidiol|mesh-list
111161127|NCT04615949|Anticonvulsants|anticonvulsants|mesh-ancestor
111161128|NCT02170207|Lansoprazole|lansoprazole|mesh-list
111161129|NCT02170207|Dexlansoprazole|dexlansoprazole|mesh-list
111161130|NCT02170207|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111161131|NCT02170207|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111161132|NCT02170207|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111161133|NCT02170207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111161134|NCT02170207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111161135|NCT02227784|Atorvastatin|atorvastatin|mesh-list
111161136|NCT02227784|Ezetimibe|ezetimibe|mesh-list
111161137|NCT02227784|Evacetrapib|evacetrapib|mesh-list
111161138|NCT02227784|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110841625|NCT05121714|Fluvoxamine|fluvoxamine|mesh-list
111161139|NCT02227784|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111161140|NCT02227784|Antimetabolites|antimetabolites|mesh-ancestor
111161141|NCT02227784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111161142|NCT02227784|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111161143|NCT02227784|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111161144|NCT02227784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111161145|NCT04577417|Methylphenidate|methylphenidate|mesh-list
111161146|NCT04577417|Amphetamine|amphetamine|mesh-list
111161147|NCT04577417|Adderall|adderall|mesh-list
111161148|NCT04577417|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
111161149|NCT04577417|Dextroamphetamine|dextroamphetamine|mesh-list
111161150|NCT04577417|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111161151|NCT04577417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111161152|NCT04577417|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111161153|NCT04577417|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111161154|NCT04577417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111161155|NCT04577417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111161156|NCT04577417|Dopamine Agents|dopamine agents|mesh-ancestor
111161157|NCT04577417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111161158|NCT04577417|Sympathomimetics|sympathomimetics|mesh-ancestor
111161159|NCT04577417|Autonomic Agents|autonomic agents|mesh-ancestor
111161160|NCT04577417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111161161|NCT04577417|Adrenergic Agents|adrenergic agents|mesh-ancestor
111161162|NCT04577417|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111161163|NCT01683058|Aripiprazole|aripiprazole|mesh-list
111161164|NCT01683058|Antidepressive Agents|antidepressive agents|mesh-ancestor
111161165|NCT01683058|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111161166|NCT01683058|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111161167|NCT01683058|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111161168|NCT01683058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111161169|NCT01683058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111161170|NCT01683058|Dopamine Agonists|dopamine agonists|mesh-ancestor
111161171|NCT01683058|Dopamine Agents|dopamine agents|mesh-ancestor
111161172|NCT01683058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111161173|NCT01683058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111161174|NCT01683058|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111161175|NCT01683058|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111161176|NCT01683058|Serotonin Agents|serotonin agents|mesh-ancestor
111161177|NCT01683058|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111161178|NCT01683058|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111161179|NCT01683058|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111161180|NCT01683058|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111161181|NCT02193776|Moxifloxacin|moxifloxacin|mesh-list
111161182|NCT02193776|Rifampin|rifampin|mesh-list
111161183|NCT02193776|Isoniazid|isoniazid|mesh-list
111161184|NCT02193776|Pyrazinamide|pyrazinamide|mesh-list
111161185|NCT02193776|Ethambutol|ethambutol|mesh-list
111161186|NCT02193776|Bedaquiline|bedaquiline|mesh-list
111161187|NCT02193776|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111161188|NCT02193776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111161189|NCT02193776|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111161190|NCT02193776|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111161191|NCT02193776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111161192|NCT02193776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111161193|NCT02193776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111161194|NCT02193776|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111161195|NCT02193776|Antitubercular Agents|antitubercular agents|mesh-ancestor
111161196|NCT02193776|Leprostatic Agents|leprostatic agents|mesh-ancestor
111161197|NCT02193776|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111161198|NCT02193776|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111161199|NCT02193776|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111161200|NCT02193776|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
111161201|NCT02193776|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
111161202|NCT02193776|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
111161203|NCT02193776|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111161204|NCT02193776|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
111161205|NCT02193776|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111161206|NCT02193776|Antimetabolites|antimetabolites|mesh-ancestor
111161207|NCT02193776|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111161209|NCT02170064|Anticonvulsants|anticonvulsants|mesh-ancestor
111161210|NCT02170064|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111161211|NCT02170064|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111161212|NCT02170064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111161213|NCT02170064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111161214|NCT02169830|Topiramate|topiramate|mesh-list
111161215|NCT02169830|Nortriptyline|nortriptyline|mesh-list
111161216|NCT02169830|Anticonvulsants|anticonvulsants|mesh-ancestor
111161217|NCT02169830|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111161218|NCT02169830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111161219|NCT02169830|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
111161220|NCT02169830|Antidepressive Agents|antidepressive agents|mesh-ancestor
111161221|NCT02169830|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111161222|NCT02169830|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111161223|NCT02169830|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111161224|NCT02169830|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111161225|NCT02169830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111161226|NCT02169830|Adrenergic Agents|adrenergic agents|mesh-ancestor
111161227|NCT02169830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111161228|NCT04854551|Naltrexone|naltrexone|mesh-list
111161229|NCT04854551|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111161230|NCT04854551|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111161231|NCT04854551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111161232|NCT04854551|Sensory System Agents|sensory system agents|mesh-ancestor
111161233|NCT04854551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111161234|NCT04536467|Goserelin|goserelin|mesh-list
111161235|NCT04536467|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111161236|NCT04536467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111161237|NCT05341349|Pembrolizumab|pembrolizumab|mesh-list
111161238|NCT05341349|Nivolumab|nivolumab|mesh-list
111161239|NCT05341349|Ipilimumab|ipilimumab|mesh-list
111161240|NCT05341349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111161241|NCT05341349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111161242|NCT05341349|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111161243|NCT05341349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111161244|NCT04530149|Acetaminophen|acetaminophen|mesh-list
111161245|NCT04530149|Bupivacaine|bupivacaine|mesh-list
111161246|NCT04530149|Anesthetics, Local|anesthetics, local|mesh-ancestor
111161247|NCT04530149|Anesthetics|anesthetics|mesh-ancestor
111161248|NCT04530149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111161249|NCT04530149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111161250|NCT04530149|Sensory System Agents|sensory system agents|mesh-ancestor
111161251|NCT04530149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111161252|NCT04530149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111161254|NCT04530149|Antipyretics|antipyretics|mesh-ancestor
111161255|NCT04525547|Nintedanib|nintedanib|mesh-list
111161256|NCT04525547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111161257|NCT04525547|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111161258|NCT04525547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111161259|NCT04525547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111161260|NCT02169284|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111161261|NCT02169284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111161262|NCT02169284|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111161263|NCT02169284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111161264|NCT02169284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111161265|NCT02119819|Metformin|metformin|mesh-list
111161266|NCT02119819|Exenatide|exenatide|mesh-list
111161267|NCT02119819|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111161268|NCT02119819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111161269|NCT02119819|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111161270|NCT02119819|Incretins|incretins|mesh-ancestor
111161271|NCT02119819|Hormones|hormones|mesh-ancestor
111161272|NCT02119819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111161273|NCT04766450|Acetylcysteine|acetylcysteine|mesh-list
111161274|NCT04766450|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111161275|NCT04766450|Antiviral Agents|antiviral agents|mesh-ancestor
111161276|NCT04766450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111161277|NCT04766450|Expectorants|expectorants|mesh-ancestor
111161278|NCT04766450|Respiratory System Agents|respiratory system agents|mesh-ancestor
111161279|NCT04766450|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111161280|NCT04766450|Antioxidants|antioxidants|mesh-ancestor
111161281|NCT04766450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111161282|NCT04766450|Protective Agents|protective agents|mesh-ancestor
111161283|NCT04766450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111161284|NCT04766450|Antidotes|antidotes|mesh-ancestor
111161285|NCT02168816|Moxifloxacin|moxifloxacin|mesh-list
111161286|NCT02168816|Metronidazole|metronidazole|mesh-list
111161287|NCT02168816|Vancomycin|vancomycin|mesh-list
111161288|NCT02168816|Ciprofloxacin|ciprofloxacin|mesh-list
111161289|NCT02168816|Clindamycin|clindamycin|mesh-list
111161290|NCT02168816|Meropenem|meropenem|mesh-list
111161291|NCT02168816|Tazobactam|tazobactam|mesh-list
111161292|NCT02168816|Linezolid|linezolid|mesh-list
111161293|NCT02168816|Piperacillin|piperacillin|mesh-list
111161294|NCT02168816|Daptomycin|daptomycin|mesh-list
111161295|NCT02168816|Cefepime|cefepime|mesh-list
111161296|NCT02168816|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
111161297|NCT02168816|Aztreonam|aztreonam|mesh-list
111161298|NCT02168816|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111161299|NCT02168816|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
111161300|NCT02168816|Trimethoprim|trimethoprim|mesh-list
111161301|NCT02168816|Sulfamethoxazole|sulfamethoxazole|mesh-list
111161302|NCT02168816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111161303|NCT02168816|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111161304|NCT02168816|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111161305|NCT02168816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111161306|NCT02168816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111161307|NCT02168816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111161308|NCT02168816|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111161309|NCT02168816|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111161310|NCT02168816|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111161311|NCT02168816|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111161312|NCT02168816|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111161313|NCT02168816|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
111161314|NCT02168816|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111161315|NCT02168816|Antimalarials|antimalarials|mesh-ancestor
111161316|NCT02168816|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111161317|NCT02168816|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111161318|NCT02168816|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
111161319|NCT01584232|Insulin Glargine|insulin glargine|mesh-list
111161320|NCT01584232|Dulaglutide|dulaglutide|mesh-list
111161321|NCT01584232|Biguanides|biguanides|mesh-list
111161322|NCT01584232|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111161323|NCT01584232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111161324|NCT02119663|Capecitabine|capecitabine|mesh-list
111161325|NCT02119663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111161326|NCT02119663|Antimetabolites|antimetabolites|mesh-ancestor
111161327|NCT02119663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110485570|NCT00642135|Sympathomimetics|sympathomimetics|mesh-ancestor
111161328|NCT02119663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111161329|NCT04481009|Paclitaxel|paclitaxel|mesh-list
111161330|NCT04481009|Gemcitabine|gemcitabine|mesh-list
111161331|NCT04481009|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111161332|NCT04481009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111161333|NCT04481009|Tubulin Modulators|tubulin modulators|mesh-ancestor
111161334|NCT04481009|Antimitotic Agents|antimitotic agents|mesh-ancestor
111161335|NCT04481009|Mitosis Modulators|mitosis modulators|mesh-ancestor
111161336|NCT04481009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111161337|NCT04481009|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111161338|NCT04481009|Antimetabolites|antimetabolites|mesh-ancestor
111161339|NCT05327231|Docetaxel|docetaxel|mesh-list
111161340|NCT05327231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111161341|NCT05327231|Tubulin Modulators|tubulin modulators|mesh-ancestor
111161342|NCT05327231|Antimitotic Agents|antimitotic agents|mesh-ancestor
111161343|NCT05327231|Mitosis Modulators|mitosis modulators|mesh-ancestor
111161344|NCT05327231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111161345|NCT04418102|Palmitic Acid|palmitic acid|mesh-list
111161346|NCT04418102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111161347|NCT04418102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111161348|NCT01628107|Epoetin Alfa|epoetin alfa|mesh-list
111161349|NCT01628107|Hematinics|hematinics|mesh-ancestor
111161350|NCT04745377|Antibodies|antibodies|mesh-list
111161351|NCT04745377|Immunologic Factors|immunologic factors|mesh-ancestor
111161352|NCT04745377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111161353|NCT01583530|Belimumab|belimumab|mesh-list
111161354|NCT01583530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111161355|NCT01583530|Immunologic Factors|immunologic factors|mesh-ancestor
111161356|NCT01583530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111161357|NCT01639001|Carboplatin|carboplatin|mesh-list
111161358|NCT01639001|Pemetrexed|pemetrexed|mesh-list
111161359|NCT01639001|Crizotinib|crizotinib|mesh-list
111161360|NCT01639001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111161361|NCT01639001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111161362|NCT01639001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111161363|NCT01639001|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111161364|NCT01639001|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111161365|NCT01639001|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111161366|NCT02168270|Ascorbic Acid|ascorbic acid|mesh-list
111161367|NCT02168270|Temozolomide|temozolomide|mesh-list
111161368|NCT02168270|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111161369|NCT02168270|Alkylating Agents|alkylating agents|mesh-ancestor
111161370|NCT02168270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111161371|NCT02168270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111161372|NCT02168270|Antioxidants|antioxidants|mesh-ancestor
111161373|NCT02168270|Protective Agents|protective agents|mesh-ancestor
111161374|NCT02168270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111161375|NCT02168270|Vitamins|vitamins|mesh-ancestor
111161376|NCT02168270|Micronutrients|micronutrients|mesh-ancestor
111161377|NCT02167256|Saracatinib|saracatinib|mesh-list
111161378|NCT02167256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111161379|NCT02167256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111161380|NCT02167256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111161381|NCT02166476|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111161382|NCT02166476|Levofloxacin|levofloxacin|mesh-list
111161383|NCT02166476|Meropenem|meropenem|mesh-list
111161384|NCT02166476|Tazobactam|tazobactam|mesh-list
111161385|NCT02166476|Piperacillin|piperacillin|mesh-list
111161386|NCT02166476|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
111161387|NCT02166476|Vaborbactam|vaborbactam|mesh-list
111161388|NCT02166476|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-list
111161389|NCT02166476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111161390|NCT02166476|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111161391|NCT02166476|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111161392|NCT02166476|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111161393|NCT02166476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111161394|NCT02166476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111161395|NCT02166476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111161396|NCT02166476|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111161397|NCT02166476|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111161398|NCT02224274|Clopidogrel|clopidogrel|mesh-list
111161399|NCT02224274|Ticagrelor|ticagrelor|mesh-list
111161400|NCT02224274|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111161401|NCT02224274|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111161402|NCT02224274|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111161403|NCT02224274|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111161404|NCT02224274|Purinergic Agents|purinergic agents|mesh-ancestor
111161405|NCT02224274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111161406|NCT02224274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111161407|NCT02224274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111161408|NCT05219669|Nalmefene|nalmefene|mesh-list
111161409|NCT05219669|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111161410|NCT05219669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111161411|NCT05219669|Sensory System Agents|sensory system agents|mesh-ancestor
111161412|NCT05219669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111161413|NCT04763252|Coal Tar|coal tar|mesh-list
111161414|NCT04763252|Keratolytic Agents|keratolytic agents|mesh-ancestor
111161415|NCT04763252|Dermatologic Agents|dermatologic agents|mesh-ancestor
111161416|NCT05369039|Prednisolone|prednisolone|mesh-list
111161417|NCT05369039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111161418|NCT05369039|Glucocorticoids|glucocorticoids|mesh-ancestor
111161419|NCT05369039|Hormones|hormones|mesh-ancestor
111161420|NCT05369039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111161421|NCT05369039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111161422|NCT05369039|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111161423|NCT05369039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111161424|NCT04373369|Atezolizumab|atezolizumab|mesh-list
111161425|NCT04373369|Vorolanib|vorolanib|mesh-list
111161426|NCT04373369|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111161427|NCT04373369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111161428|NCT04373369|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111161429|NCT04373369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111161430|NCT04373369|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111161431|NCT04373369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111161432|NCT04285853|Oxycodone|oxycodone|mesh-list
111161433|NCT04285853|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111161434|NCT04285853|Narcotics|narcotics|mesh-ancestor
111161435|NCT04285853|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111161436|NCT04285853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111161437|NCT04285853|Analgesics|analgesics|mesh-ancestor
111161438|NCT04285853|Sensory System Agents|sensory system agents|mesh-ancestor
111161439|NCT04285853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111161440|NCT04791059|Sufentanil|sufentanil|mesh-list
111161441|NCT04791059|Dexmedetomidine|dexmedetomidine|mesh-list
111161442|NCT04791059|Ketamine|ketamine|mesh-list
111161443|NCT04791059|Esketamine|esketamine|mesh-list
111161444|NCT04791059|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111161445|NCT04791059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111161446|NCT04791059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111161447|NCT04791059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111161448|NCT04791059|Analgesics|analgesics|mesh-ancestor
111161449|NCT04791059|Sensory System Agents|sensory system agents|mesh-ancestor
111161450|NCT04791059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111161451|NCT04791059|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111161452|NCT04791059|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111161453|NCT04791059|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111161454|NCT04791059|Adrenergic Agents|adrenergic agents|mesh-ancestor
111161455|NCT04791059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111161456|NCT04791059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111161457|NCT04791059|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111161458|NCT04791059|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111161459|NCT04791059|Anesthetics, General|anesthetics, general|mesh-ancestor
111161460|NCT04791059|Anesthetics|anesthetics|mesh-ancestor
111161461|NCT04791059|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111161462|NCT04791059|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111161463|NCT04791059|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111161464|NCT04791059|Narcotics|narcotics|mesh-ancestor
111161465|NCT04791059|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111161466|NCT04791059|Antidepressive Agents|antidepressive agents|mesh-ancestor
111161467|NCT04791059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111161468|NCT05398913|Rimonabant|rimonabant|mesh-list
111161469|NCT05398913|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111161470|NCT05398913|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
111161471|NCT05398913|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
111161472|NCT05398913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111161473|NCT05398913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111161474|NCT05398913|Hormones|hormones|mesh-ancestor
111161475|NCT05398913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111161476|NCT05398913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111161477|NCT04260347|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
111161479|NCT04260347|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111161480|NCT04260347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111161481|NCT01583374|Thalidomide|thalidomide|mesh-list
111161482|NCT01583374|Apremilast|apremilast|mesh-list
111161483|NCT01583374|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111161484|NCT01583374|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111161485|NCT01583374|Analgesics|analgesics|mesh-ancestor
111161486|NCT01583374|Sensory System Agents|sensory system agents|mesh-ancestor
111161487|NCT01583374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111161488|NCT01583374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111161489|NCT01583374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111161490|NCT01583374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111161491|NCT01583374|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
111161492|NCT01583374|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111161493|NCT01583374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111161494|NCT01583374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111161495|NCT01583374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111161496|NCT01583374|Immunologic Factors|immunologic factors|mesh-ancestor
111161497|NCT01583374|Leprostatic Agents|leprostatic agents|mesh-ancestor
111161498|NCT01583374|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111161499|NCT01583374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111161500|NCT01583374|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111161501|NCT01583374|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111161502|NCT01583374|Growth Substances|growth substances|mesh-ancestor
111161503|NCT01583374|Growth Inhibitors|growth inhibitors|mesh-ancestor
111161504|NCT01583374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111161505|NCT04245215|Ustekinumab|ustekinumab|mesh-list
111161506|NCT04245215|Dermatologic Agents|dermatologic agents|mesh-ancestor
111161507|NCT05387759|Moxifloxacin|moxifloxacin|mesh-list
111161508|NCT05387759|Aticaprant|aticaprant|mesh-list
111161509|NCT05387759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111161510|NCT05387759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111161511|NCT05387759|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111161512|NCT05387759|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111161513|NCT05387759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111161514|NCT05387759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111161515|NCT05387759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111161516|NCT05387759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111161517|NCT05387759|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111161518|NCT05387759|Sensory System Agents|sensory system agents|mesh-ancestor
111161519|NCT05387759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111161520|NCT02222714|Protein C|protein c|mesh-list
111161521|NCT02222714|Anticoagulants|anticoagulants|mesh-ancestor
111161522|NCT02222714|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111161523|NCT02222714|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111161524|NCT02222714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111161525|NCT04809311|Insulin|insulin|mesh-list
111161526|NCT04809311|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111161527|NCT04809311|Glucagon|glucagon|mesh-list
111161528|NCT04809311|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
111161529|NCT04809311|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111161530|NCT04809311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110485594|NCT02600260|Enoxaparin|enoxaparin|mesh-list
111161531|NCT04809311|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111161532|NCT04809311|Hormones|hormones|mesh-ancestor
111161533|NCT04809311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111161534|NCT04809311|Incretins|incretins|mesh-ancestor
111161535|NCT04145219|Immunomodulating Agents|immunomodulating agents|mesh-list
111161536|NCT04145219|Immunologic Factors|immunologic factors|mesh-ancestor
111161537|NCT04145219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111161538|NCT03184571|Pembrolizumab|pembrolizumab|mesh-list
111161539|NCT03184571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111161540|NCT03184571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111161541|NCT03184571|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111161542|NCT03184571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111161543|NCT02164916|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111161545|NCT02164916|Irinotecan|irinotecan|mesh-list
111161546|NCT02164916|Camptothecin|camptothecin|mesh-list
111161547|NCT02164916|Vemurafenib|vemurafenib|mesh-list
111161548|NCT02164916|Antibodies|antibodies|mesh-list
111161549|NCT02164916|Immunoglobulins|immunoglobulins|mesh-list
111161550|NCT02164916|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111161551|NCT02164916|Immunoglobulin G|immunoglobulin g|mesh-list
111161552|NCT02164916|Mitogens|mitogens|mesh-list
111161553|NCT02164916|Immunologic Factors|immunologic factors|mesh-ancestor
111161554|NCT02164916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111161555|NCT02164916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111161556|NCT02164916|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111161557|NCT02164916|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111161558|NCT02164916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111161559|NCT02164916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111161560|NCT02164916|Mitosis Modulators|mitosis modulators|mesh-ancestor
111161561|NCT02164916|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111161562|NCT02164916|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111161563|NCT04091867|Cetuximab|cetuximab|mesh-list
111161564|NCT04091867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111161565|NCT04091867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111161566|NCT04060277|Acetic Acid|acetic acid|mesh-list
111161567|NCT04060277|Letermovir|letermovir|mesh-list
111161568|NCT04060277|Vaccines|vaccines|mesh-list
111161569|NCT04060277|Immunologic Factors|immunologic factors|mesh-ancestor
111161570|NCT04060277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111161571|NCT04060277|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111161572|NCT04060277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111161573|NCT04060277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111161574|NCT04060277|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111161575|NCT04060277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111161576|NCT04060277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111161577|NCT04060277|Antiviral Agents|antiviral agents|mesh-ancestor
111161578|NCT05651789|Propranolol|propranolol|mesh-list
111161579|NCT05651789|Carvedilol|carvedilol|mesh-list
111161580|NCT05651789|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
111161581|NCT05651789|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111161582|NCT05651789|Adrenergic Agents|adrenergic agents|mesh-ancestor
111161583|NCT05651789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111161584|NCT05651789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111161585|NCT05651789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111161586|NCT05651789|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111161587|NCT05651789|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111161588|NCT05651789|Vasodilator Agents|vasodilator agents|mesh-ancestor
111161589|NCT05651789|Antioxidants|antioxidants|mesh-ancestor
111161590|NCT05651789|Protective Agents|protective agents|mesh-ancestor
111161591|NCT05651789|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111161592|NCT05651789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111161593|NCT05651789|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111161594|NCT05651789|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111161595|NCT05651789|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111161596|NCT02999477|Paclitaxel|paclitaxel|mesh-list
111161597|NCT02999477|Pembrolizumab|pembrolizumab|mesh-list
111161598|NCT02999477|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111161599|NCT02999477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111161600|NCT02999477|Tubulin Modulators|tubulin modulators|mesh-ancestor
111161601|NCT02999477|Antimitotic Agents|antimitotic agents|mesh-ancestor
111161602|NCT02999477|Mitosis Modulators|mitosis modulators|mesh-ancestor
111161603|NCT02999477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111161604|NCT02999477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111161605|NCT02999477|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111161606|NCT02222558|Testosterone|testosterone|mesh-list
111161607|NCT02222558|Androgens|androgens|mesh-ancestor
111161608|NCT02222558|Hormones|hormones|mesh-ancestor
111161609|NCT02222558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111161610|NCT02222558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111161611|NCT02975999|Vasopressins|vasopressins|mesh-list
111161612|NCT02975999|Arginine Vasopressin|arginine vasopressin|mesh-list
111161613|NCT02975999|Hemostatics|hemostatics|mesh-ancestor
111161614|NCT02975999|Coagulants|coagulants|mesh-ancestor
111161615|NCT02975999|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111161616|NCT02975999|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
111161617|NCT02975999|Natriuretic Agents|natriuretic agents|mesh-ancestor
111161618|NCT02975999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111161619|NCT02188784|Iron|iron|mesh-list
111161620|NCT02188784|Trace Elements|trace elements|mesh-ancestor
111161621|NCT02188784|Micronutrients|micronutrients|mesh-ancestor
111161622|NCT02188784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111161623|NCT02222246|Morphine|morphine|mesh-list
111161624|NCT02222246|Hydromorphone|hydromorphone|mesh-list
111161625|NCT02222246|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111161626|NCT02222246|Narcotics|narcotics|mesh-ancestor
111161627|NCT02222246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110878710|NCT01318122|Hormones|hormones|mesh-ancestor
111161628|NCT02222246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111161629|NCT02222246|Analgesics|analgesics|mesh-ancestor
111161630|NCT02222246|Sensory System Agents|sensory system agents|mesh-ancestor
111161631|NCT02222246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111161632|NCT02188160|Loteprednol Etabonate|loteprednol etabonate|mesh-list
111161633|NCT02188160|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111161634|NCT04013555|Acetylcysteine|acetylcysteine|mesh-list
111161635|NCT04013555|Tryptophan|tryptophan|mesh-list
111161636|NCT04013555|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111161637|NCT04013555|Antiviral Agents|antiviral agents|mesh-ancestor
111161638|NCT04013555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111161639|NCT04013555|Expectorants|expectorants|mesh-ancestor
111161640|NCT04013555|Respiratory System Agents|respiratory system agents|mesh-ancestor
111161641|NCT04013555|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111161642|NCT04013555|Antioxidants|antioxidants|mesh-ancestor
111161643|NCT04013555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111161644|NCT04013555|Protective Agents|protective agents|mesh-ancestor
111161645|NCT04013555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111161646|NCT04013555|Antidotes|antidotes|mesh-ancestor
111161647|NCT04013555|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111161648|NCT04013555|Antidepressive Agents|antidepressive agents|mesh-ancestor
111161649|NCT04013555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111161650|NCT02220998|Sofosbuvir|sofosbuvir|mesh-list
111161651|NCT02220998|Antiviral Agents|antiviral agents|mesh-ancestor
111161652|NCT02220998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111161653|NCT02220920|Canagliflozin|canagliflozin|mesh-list
111161654|NCT02220920|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111161655|NCT02220920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111161656|NCT02220920|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111161657|NCT02220920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111161658|NCT03966053|Trifluoperazine|trifluoperazine|mesh-list
111161659|NCT03966053|Antiemetics|antiemetics|mesh-ancestor
111161660|NCT03966053|Autonomic Agents|autonomic agents|mesh-ancestor
111161661|NCT03966053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111161662|NCT03966053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111161663|NCT03966053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111161664|NCT03966053|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111161665|NCT03966053|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111161666|NCT03966053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111161667|NCT03966053|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111161668|NCT03966053|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111161669|NCT03966053|Dopamine Agents|dopamine agents|mesh-ancestor
111161670|NCT03966053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111161671|NCT03966053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111161672|NCT04790279|Amlodipine|amlodipine|mesh-list
111161673|NCT04790279|Nifedipine|nifedipine|mesh-list
111161674|NCT04790279|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111161675|NCT04790279|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111161676|NCT04790279|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111161677|NCT04790279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111161678|NCT04790279|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111161679|NCT04790279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111161680|NCT04790279|Vasodilator Agents|vasodilator agents|mesh-ancestor
110841718|NCT03753685|Ensartinib|ensartinib|mesh-list
111161682|NCT04790279|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111161683|NCT03877289|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111161684|NCT03877289|Oxybutynin|oxybutynin|mesh-list
111161685|NCT03877289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111161686|NCT03877289|Parasympatholytics|parasympatholytics|mesh-ancestor
111161687|NCT03877289|Autonomic Agents|autonomic agents|mesh-ancestor
111161688|NCT03877289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111161689|NCT03877289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111161690|NCT03877289|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111161691|NCT03877289|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111161692|NCT03877289|Cholinergic Agents|cholinergic agents|mesh-ancestor
111161693|NCT03877289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111161694|NCT03877289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111161695|NCT03877289|Urological Agents|urological agents|mesh-ancestor
111161696|NCT05554679|Metformin|metformin|mesh-list
111161697|NCT05554679|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111161698|NCT05554679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111161699|NCT05494619|Immunoglobulins|immunoglobulins|mesh-list
111161700|NCT05494619|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111161701|NCT05494619|Antibodies|antibodies|mesh-list
111161702|NCT05494619|gamma-Globulins|gamma-globulins|mesh-list
111161703|NCT05494619|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
111161704|NCT05494619|Immunologic Factors|immunologic factors|mesh-ancestor
110878782|NCT03389555|Vitamins|vitamins|mesh-list
111161705|NCT05494619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111161706|NCT01634555|Leucovorin|leucovorin|mesh-list
111161707|NCT01634555|Folic Acid|folic acid|mesh-list
111161708|NCT01634555|Fluorouracil|fluorouracil|mesh-list
111161709|NCT01634555|Irinotecan|irinotecan|mesh-list
111161710|NCT01634555|Ramucirumab|ramucirumab|mesh-list
111161711|NCT01634555|Levoleucovorin|levoleucovorin|mesh-list
111161712|NCT01634555|Antimetabolites|antimetabolites|mesh-ancestor
111161713|NCT01634555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111161714|NCT01634555|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111161715|NCT01634555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111161716|NCT01634555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111161717|NCT01634555|Immunologic Factors|immunologic factors|mesh-ancestor
111161718|NCT01634555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111161719|NCT01634555|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111161720|NCT01634555|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111161721|NCT01634555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111161722|NCT01634555|Antidotes|antidotes|mesh-ancestor
111161723|NCT01634555|Protective Agents|protective agents|mesh-ancestor
111161724|NCT01634555|Vitamin B Complex|vitamin b complex|mesh-ancestor
111161725|NCT01634555|Vitamins|vitamins|mesh-ancestor
111161726|NCT01634555|Micronutrients|micronutrients|mesh-ancestor
111161727|NCT01634555|Hematinics|hematinics|mesh-ancestor
111161728|NCT05355155|Bevacizumab|bevacizumab|mesh-list
111161729|NCT05355155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111161730|NCT05355155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111161731|NCT05355155|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111161732|NCT05355155|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111161733|NCT05355155|Growth Substances|growth substances|mesh-ancestor
111161734|NCT05355155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111161735|NCT05355155|Growth Inhibitors|growth inhibitors|mesh-ancestor
111161736|NCT01634243|Rotigotine|rotigotine|mesh-list
111161737|NCT01634243|Dopamine Agonists|dopamine agonists|mesh-ancestor
111161738|NCT01634243|Dopamine Agents|dopamine agents|mesh-ancestor
111161739|NCT01634243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111161740|NCT01634243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111161741|NCT01634243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111161742|NCT01542034|Deoxycholic Acid|deoxycholic acid|mesh-list
111161743|NCT01542034|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
111161744|NCT01542034|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111161745|NCT04814615|Daratumumab|daratumumab|mesh-list
111161746|NCT04814615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111161747|NCT03800693|Leucovorin|leucovorin|mesh-list
111161748|NCT03800693|Fluorouracil|fluorouracil|mesh-list
111161749|NCT03800693|Oxaliplatin|oxaliplatin|mesh-list
111161750|NCT03800693|Antimetabolites|antimetabolites|mesh-ancestor
111161751|NCT03800693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111161752|NCT03800693|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110841724|NCT05172050|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111161753|NCT03800693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111161754|NCT03800693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111161755|NCT03800693|Immunologic Factors|immunologic factors|mesh-ancestor
111161756|NCT03800693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111161757|NCT03800693|Antidotes|antidotes|mesh-ancestor
111161758|NCT03800693|Protective Agents|protective agents|mesh-ancestor
111161759|NCT03800693|Vitamin B Complex|vitamin b complex|mesh-ancestor
111161760|NCT03800693|Vitamins|vitamins|mesh-ancestor
111161761|NCT03800693|Micronutrients|micronutrients|mesh-ancestor
111161762|NCT04814537|Bupivacaine|bupivacaine|mesh-list
111161763|NCT04814537|Anesthetics, Local|anesthetics, local|mesh-ancestor
111161764|NCT04814537|Anesthetics|anesthetics|mesh-ancestor
111161765|NCT04814537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111161766|NCT04814537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111161767|NCT04814537|Sensory System Agents|sensory system agents|mesh-ancestor
111161768|NCT04814537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111161769|NCT01582282|Psyllium|psyllium|mesh-list
111161770|NCT01582282|Calcium polycarbophil|calcium polycarbophil|mesh-list
111161771|NCT01582282|Cathartics|cathartics|mesh-ancestor
111161772|NCT01582282|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111161773|NCT01582282|Antidiarrheals|antidiarrheals|mesh-ancestor
111161774|NCT01599650|Ranibizumab|ranibizumab|mesh-list
111161775|NCT01599650|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111161776|NCT01599650|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111161777|NCT01599650|Growth Substances|growth substances|mesh-ancestor
111161778|NCT01599650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111161779|NCT01599650|Growth Inhibitors|growth inhibitors|mesh-ancestor
111161780|NCT01599650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111161781|NCT03774875|Apremilast|apremilast|mesh-list
111161782|NCT03774875|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111161783|NCT03774875|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111161785|NCT03774875|Sensory System Agents|sensory system agents|mesh-ancestor
111161786|NCT03774875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111161787|NCT03774875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111161788|NCT03774875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111161789|NCT03774875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111161790|NCT03774875|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
111161791|NCT03774875|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111161792|NCT03774875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111161793|NCT03774875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111161794|NCT01563172|Listerine|listerine|mesh-list
111161795|NCT01563172|Fluorides|fluorides|mesh-list
111161796|NCT01563172|Sodium Fluoride|sodium fluoride|mesh-list
111161797|NCT01563172|Cariostatic Agents|cariostatic agents|mesh-ancestor
111161798|NCT01563172|Protective Agents|protective agents|mesh-ancestor
111161799|NCT01563172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111161800|NCT01563172|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111161801|NCT01563172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111161802|NCT04755764|Atenolol|atenolol|mesh-list
111161803|NCT04755764|Labetalol|labetalol|mesh-list
111161804|NCT04755764|Nifedipine|nifedipine|mesh-list
111161805|NCT04755764|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111161806|NCT04755764|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111161807|NCT04755764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111161808|NCT04755764|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111161809|NCT04755764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111161810|NCT04755764|Vasodilator Agents|vasodilator agents|mesh-ancestor
111161811|NCT04755764|Tocolytic Agents|tocolytic agents|mesh-ancestor
111161812|NCT04755764|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111161813|NCT04755764|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111161814|NCT04755764|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111161815|NCT04755764|Sympatholytics|sympatholytics|mesh-ancestor
111161816|NCT04755764|Autonomic Agents|autonomic agents|mesh-ancestor
111161817|NCT04755764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111161818|NCT04755764|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
111161819|NCT04755764|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111161820|NCT04755764|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111161821|NCT04755764|Adrenergic Agents|adrenergic agents|mesh-ancestor
111161822|NCT04755764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111161823|NCT04755764|Sympathomimetics|sympathomimetics|mesh-ancestor
111161824|NCT04755764|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111161825|NCT04755764|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111161826|NCT02161718|Olanzapine|olanzapine|mesh-list
111161827|NCT02161718|Antiemetics|antiemetics|mesh-ancestor
111161828|NCT02161718|Autonomic Agents|autonomic agents|mesh-ancestor
111161829|NCT02161718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111161830|NCT02161718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111161831|NCT02161718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111161832|NCT02161718|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111161833|NCT02161718|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111161834|NCT02161718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111161835|NCT02161718|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111161836|NCT02161718|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110485653|NCT00759148|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111161837|NCT02161718|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111161838|NCT02161718|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111161839|NCT02161718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111161840|NCT02161718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111161841|NCT02161718|Serotonin Agents|serotonin agents|mesh-ancestor
111161842|NCT02074631|Vitamin D|vitamin d|mesh-list
111161843|NCT02074631|Cholecalciferol|cholecalciferol|mesh-list
111161844|NCT02074631|Ergocalciferols|ergocalciferols|mesh-list
111161845|NCT02074631|Pamidronate|pamidronate|mesh-list
111161846|NCT02074631|Calcium|calcium|mesh-list
111161847|NCT02074631|Vitamins|vitamins|mesh-ancestor
111161848|NCT02074631|Micronutrients|micronutrients|mesh-ancestor
111161849|NCT02074631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111161850|NCT02074631|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111161851|NCT02074631|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111161852|NCT04813991|Ibuprofen|ibuprofen|mesh-list
111161853|NCT04813991|Oxycodone|oxycodone|mesh-list
111161854|NCT04813991|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111161855|NCT04813991|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111161856|NCT04813991|Analgesics|analgesics|mesh-ancestor
111161857|NCT04813991|Sensory System Agents|sensory system agents|mesh-ancestor
111161858|NCT04813991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111161859|NCT04813991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111161860|NCT04813991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111161861|NCT04813991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111161862|NCT04813991|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111161863|NCT04813991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111161864|NCT04813991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111161865|NCT04813991|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111161867|NCT04813991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111161868|NCT03624101|Ivacaftor|ivacaftor|mesh-list
111161869|NCT03624101|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
111161870|NCT03624101|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111161871|NCT03624101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111161872|NCT02218736|Aticaprant|aticaprant|mesh-list
111161873|NCT02218736|Narcotic Antagonists|narcotic antagonists|mesh-list
111161874|NCT02218736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111161875|NCT02218736|Sensory System Agents|sensory system agents|mesh-ancestor
111161876|NCT02218736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111161877|NCT01580488|Calcitriol|calcitriol|mesh-list
111161878|NCT01580488|Calcipotriene|calcipotriene|mesh-list
111161879|NCT01580488|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111161880|NCT01580488|Dermatologic Agents|dermatologic agents|mesh-ancestor
111161881|NCT01580488|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111161882|NCT01580488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111161883|NCT01580488|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
111161884|NCT01580488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111161885|NCT01580488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111161886|NCT01580488|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111161887|NCT01580488|Vitamins|vitamins|mesh-ancestor
111161888|NCT01580488|Micronutrients|micronutrients|mesh-ancestor
111161889|NCT01580488|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111161890|NCT01580020|Dexamethasone|dexamethasone|mesh-list
111161891|NCT01580020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111161892|NCT01580020|Antiemetics|antiemetics|mesh-ancestor
111161893|NCT01580020|Autonomic Agents|autonomic agents|mesh-ancestor
111161894|NCT01580020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111161895|NCT01580020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111161896|NCT01580020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111161897|NCT01580020|Glucocorticoids|glucocorticoids|mesh-ancestor
111161898|NCT01580020|Hormones|hormones|mesh-ancestor
111161899|NCT01580020|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111161900|NCT01580020|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111161901|NCT01580020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111161902|NCT01579318|Interleukin-12|interleukin-12|mesh-list
111161903|NCT01579318|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111161904|NCT01579318|Immunologic Factors|immunologic factors|mesh-ancestor
111161905|NCT01579318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111161906|NCT01579318|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111161907|NCT01579318|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111161908|NCT01579318|Growth Substances|growth substances|mesh-ancestor
111161909|NCT01579318|Growth Inhibitors|growth inhibitors|mesh-ancestor
111161910|NCT01579318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111161911|NCT01578850|Etanercept|etanercept|mesh-list
111161912|NCT01578850|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111161913|NCT01578850|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111161914|NCT01578850|Analgesics|analgesics|mesh-ancestor
111161915|NCT01578850|Sensory System Agents|sensory system agents|mesh-ancestor
111161916|NCT01578850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111161917|NCT01578850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111161918|NCT01578850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111161919|NCT01578850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111161920|NCT01578850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111161921|NCT01578850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111161922|NCT01578850|Immunologic Factors|immunologic factors|mesh-ancestor
111161923|NCT01539538|Sufentanil|sufentanil|mesh-list
111161924|NCT01539538|Morphine|morphine|mesh-list
111161925|NCT01539538|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111161926|NCT01539538|Narcotics|narcotics|mesh-ancestor
111161927|NCT01539538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111161928|NCT01539538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111161929|NCT01539538|Analgesics|analgesics|mesh-ancestor
111161930|NCT01539538|Sensory System Agents|sensory system agents|mesh-ancestor
111161931|NCT01539538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111161932|NCT01539538|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110879016|NCT02236572|Everolimus|everolimus|mesh-list
111161933|NCT01539538|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111161934|NCT01539538|Anesthetics, General|anesthetics, general|mesh-ancestor
111161935|NCT01539538|Anesthetics|anesthetics|mesh-ancestor
111161936|NCT01562548|Phenylpropanolamine|phenylpropanolamine|mesh-list
111161937|NCT01562548|Guaifenesin|guaifenesin|mesh-list
111161938|NCT01562548|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
111161939|NCT01562548|Expectorants|expectorants|mesh-ancestor
111161940|NCT01562548|Respiratory System Agents|respiratory system agents|mesh-ancestor
110841760|NCT01265537|Tacrolimus|tacrolimus|mesh-list
111161941|NCT01562548|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111161942|NCT01562548|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111161943|NCT01562548|Adrenergic Agents|adrenergic agents|mesh-ancestor
111161944|NCT01562548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111161945|NCT01562548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111161946|NCT01562548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111161947|NCT01562548|Appetite Depressants|appetite depressants|mesh-ancestor
111161948|NCT01562548|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111161949|NCT01562548|Sympathomimetics|sympathomimetics|mesh-ancestor
111161950|NCT01562548|Autonomic Agents|autonomic agents|mesh-ancestor
111161951|NCT01562548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111161952|NCT01562548|Nasal Decongestants|nasal decongestants|mesh-ancestor
111161953|NCT01562548|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111161955|NCT03027934|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
111161956|NCT03027934|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111161957|NCT03027934|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111161958|NCT03027934|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111161959|NCT03027934|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111161960|NCT03027934|Purinergic Agents|purinergic agents|mesh-ancestor
111161961|NCT03027934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111161962|NCT03027934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111161963|NCT03027934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111161964|NCT01562314|Cannabidiol|cannabidiol|mesh-list
111161965|NCT01562314|Anticonvulsants|anticonvulsants|mesh-ancestor
111161966|NCT01539226|Dapivirine|dapivirine|mesh-list
111161967|NCT01539226|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111161968|NCT01539226|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111161969|NCT01539226|Antiviral Agents|antiviral agents|mesh-ancestor
111161970|NCT01539226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111161971|NCT01537120|Vildagliptin|vildagliptin|mesh-list
111161972|NCT01537120|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111161973|NCT01537120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111161974|NCT01537120|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111161975|NCT01537120|Protease Inhibitors|protease inhibitors|mesh-ancestor
111161976|NCT01537120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111161977|NCT01537120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111161978|NCT01537042|Rotigotine|rotigotine|mesh-list
111161979|NCT01537042|Dopamine Agonists|dopamine agonists|mesh-ancestor
111161980|NCT01537042|Dopamine Agents|dopamine agents|mesh-ancestor
111161981|NCT01537042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111161982|NCT01537042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111161983|NCT01537042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111161984|NCT01536574|Ropinirole|ropinirole|mesh-list
111161985|NCT01536574|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111161986|NCT01536574|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111161987|NCT01536574|Dopamine Agonists|dopamine agonists|mesh-ancestor
111161988|NCT01536574|Dopamine Agents|dopamine agents|mesh-ancestor
111161989|NCT01536574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111161990|NCT01536574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111161991|NCT01536574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111161992|NCT04410094|Itraconazole|itraconazole|mesh-list
111161993|NCT04410094|Rifampin|rifampin|mesh-list
111161994|NCT04410094|Lazertinib|lazertinib|mesh-list
111161995|NCT04410094|Antifungal Agents|antifungal agents|mesh-ancestor
111161996|NCT04410094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111161997|NCT04410094|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111161998|NCT04410094|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111161999|NCT04410094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111162000|NCT04410094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111162001|NCT04410094|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111162002|NCT04410094|Hormone Antagonists|hormone antagonists|mesh-ancestor
111162003|NCT04410094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111162004|NCT04410094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111162005|NCT04410094|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110879085|NCT05178654|Antiviral Agents|antiviral agents|mesh-ancestor
111162006|NCT04410094|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111162007|NCT04410094|Antitubercular Agents|antitubercular agents|mesh-ancestor
111162008|NCT04410094|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110485718|NCT02674737|Flurbiprofen|flurbiprofen|mesh-list
111162009|NCT04410094|Leprostatic Agents|leprostatic agents|mesh-ancestor
111162010|NCT04410094|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111162011|NCT04410094|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111162012|NCT04410094|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111162013|NCT04410094|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
111162014|NCT04410094|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
111162015|NCT04410094|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
111162016|NCT04410094|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111162017|NCT04410094|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111162018|NCT01576042|Amiodarone|amiodarone|mesh-list
111162019|NCT01576042|Sotalol|sotalol|mesh-list
111162020|NCT01576042|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111162021|NCT01576042|Vasodilator Agents|vasodilator agents|mesh-ancestor
111162022|NCT01576042|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
111162023|NCT01576042|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111162024|NCT01576042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111162025|NCT01576042|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111162026|NCT01576042|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111162027|NCT01576042|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111162028|NCT01576042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111162029|NCT01576042|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111162030|NCT01576042|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111162031|NCT01576042|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111162032|NCT01576042|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111162033|NCT01576042|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111162034|NCT01576042|Adrenergic Agents|adrenergic agents|mesh-ancestor
111162035|NCT01576042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111162036|NCT01576042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111162037|NCT01576042|Sympatholytics|sympatholytics|mesh-ancestor
111162038|NCT01576042|Autonomic Agents|autonomic agents|mesh-ancestor
111162039|NCT01576042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111162040|NCT01536262|Tiotropium Bromide|tiotropium bromide|mesh-list
111162041|NCT01536262|Olodaterol|olodaterol|mesh-list
111162042|NCT01536262|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111162043|NCT01536262|Autonomic Agents|autonomic agents|mesh-ancestor
111162044|NCT01536262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111162045|NCT01536262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111162046|NCT01536262|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111162047|NCT01536262|Respiratory System Agents|respiratory system agents|mesh-ancestor
111162048|NCT01536262|Parasympatholytics|parasympatholytics|mesh-ancestor
111162049|NCT01536262|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111162050|NCT01536262|Cholinergic Agents|cholinergic agents|mesh-ancestor
111162051|NCT01536262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111162052|NCT01536262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111162053|NCT04102618|Trastuzumab|trastuzumab|mesh-list
111162054|NCT04102618|Atezolizumab|atezolizumab|mesh-list
111162055|NCT04102618|Letrozole|letrozole|mesh-list
111162056|NCT04102618|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111162057|NCT04102618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111162058|NCT04102618|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111162059|NCT04102618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111162060|NCT04102618|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111162061|NCT04102618|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111162062|NCT04102618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111162063|NCT04102618|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111162064|NCT04102618|Hormone Antagonists|hormone antagonists|mesh-ancestor
111162065|NCT04102618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111162066|NCT04102618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111162067|NCT01575028|Bupivacaine|bupivacaine|mesh-list
111162068|NCT01575028|Ropivacaine|ropivacaine|mesh-list
111162069|NCT01575028|Anesthetics, Local|anesthetics, local|mesh-ancestor
111162070|NCT01575028|Anesthetics|anesthetics|mesh-ancestor
111162071|NCT01575028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111162072|NCT01575028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111162073|NCT01575028|Sensory System Agents|sensory system agents|mesh-ancestor
111162074|NCT01575028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111162075|NCT04963283|Nivolumab|nivolumab|mesh-list
111162076|NCT04963283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111162077|NCT04963283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110879165|NCT05197374|Estradiol|estradiol|mesh-list
111162078|NCT04963283|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111162079|NCT04963283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111162081|NCT04443569|Anesthetics, Local|anesthetics, local|mesh-ancestor
111162082|NCT04443569|Anesthetics|anesthetics|mesh-ancestor
111162083|NCT04443569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111162084|NCT04443569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111162085|NCT04443569|Sensory System Agents|sensory system agents|mesh-ancestor
111162086|NCT04443569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111162087|NCT04443569|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111162088|NCT04443569|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111162089|NCT04443569|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111162090|NCT04443569|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111162091|NCT04443569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111162092|NCT01792583|Modafinil|modafinil|mesh-list
111162093|NCT01792583|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111162094|NCT01792583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111162095|NCT01792583|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
111162096|NCT01792583|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111162097|NCT01792583|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111162098|NCT01792583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111162099|NCT03508895|Caseins|caseins|mesh-list
111162100|NCT03508895|Chelating Agents|chelating agents|mesh-ancestor
111162101|NCT03508895|Sequestering Agents|sequestering agents|mesh-ancestor
111162102|NCT03508895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111162103|NCT04566653|Calcium|calcium|mesh-list
111162104|NCT04566653|Polystyrene sulfonic acid|polystyrene sulfonic acid|mesh-list
111162105|NCT04566653|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111162106|NCT04566653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111162107|NCT04566653|Chelating Agents|chelating agents|mesh-ancestor
111162108|NCT04566653|Sequestering Agents|sequestering agents|mesh-ancestor
111162109|NCT04566653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111162110|NCT01574716|Gemcitabine|gemcitabine|mesh-list
111162111|NCT01574716|Docetaxel|docetaxel|mesh-list
111162112|NCT01574716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111162113|NCT01574716|Antimetabolites|antimetabolites|mesh-ancestor
111162114|NCT01574716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111162115|NCT01574716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111162116|NCT01574716|Tubulin Modulators|tubulin modulators|mesh-ancestor
111162117|NCT01574716|Antimitotic Agents|antimitotic agents|mesh-ancestor
111162118|NCT01574716|Mitosis Modulators|mitosis modulators|mesh-ancestor
111162119|NCT02161562|Omalizumab|omalizumab|mesh-list
111162120|NCT02161562|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111162121|NCT02161562|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111162122|NCT02161562|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111162123|NCT02161562|Respiratory System Agents|respiratory system agents|mesh-ancestor
111162124|NCT02161562|Immunologic Factors|immunologic factors|mesh-ancestor
111162125|NCT02161562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111162127|NCT01559116|Olodaterol|olodaterol|mesh-list
111162128|NCT01559116|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111162129|NCT01559116|Autonomic Agents|autonomic agents|mesh-ancestor
111162130|NCT01559116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111162131|NCT01559116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111162132|NCT01559116|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111162133|NCT01559116|Respiratory System Agents|respiratory system agents|mesh-ancestor
111162134|NCT01559116|Parasympatholytics|parasympatholytics|mesh-ancestor
111162135|NCT01559116|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111162136|NCT01559116|Cholinergic Agents|cholinergic agents|mesh-ancestor
111162137|NCT01559116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111162138|NCT01559116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111162139|NCT01574326|Sevelamer|sevelamer|mesh-list
111162140|NCT01574326|Chelating Agents|chelating agents|mesh-ancestor
111162141|NCT01574326|Sequestering Agents|sequestering agents|mesh-ancestor
111162142|NCT01574326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111162143|NCT01574248|Icatibant|icatibant|mesh-list
111162144|NCT01574248|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111162145|NCT01574248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111162146|NCT01574248|Analgesics|analgesics|mesh-ancestor
111162147|NCT01574248|Sensory System Agents|sensory system agents|mesh-ancestor
111162148|NCT01574248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111162149|NCT01574248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110879236|NCT05570526|Melatonin|melatonin|mesh-list
111162150|NCT01574248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111162151|NCT01574248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111162152|NCT01574248|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
111162153|NCT01574248|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
111162154|NCT01574248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111162155|NCT01574248|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
111162156|NCT01574248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111162157|NCT01574248|Immunologic Factors|immunologic factors|mesh-ancestor
111162158|NCT04761094|Insulin|insulin|mesh-list
111162159|NCT04761094|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111162160|NCT04761094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111162161|NCT01557946|Citalopram|citalopram|mesh-list
111162162|NCT01557946|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111162163|NCT01557946|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111162164|NCT01557946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111162165|NCT01557946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111162166|NCT01557946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111162167|NCT01557946|Serotonin Agents|serotonin agents|mesh-ancestor
111162168|NCT01557946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111162169|NCT01557946|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110485775|NCT04065919|Autonomic Agents|autonomic agents|mesh-ancestor
111162170|NCT01557946|Antidepressive Agents|antidepressive agents|mesh-ancestor
111162171|NCT01557946|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111162172|NCT01534078|Doxorubicin|doxorubicin|mesh-list
111162173|NCT01534078|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111162174|NCT01534078|Brentuximab Vedotin|brentuximab vedotin|mesh-list
111162175|NCT01534078|Dacarbazine|dacarbazine|mesh-list
111162176|NCT01534078|Vinblastine|vinblastine|mesh-list
111162177|NCT01534078|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111162178|NCT01534078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111162179|NCT01534078|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111162180|NCT01534078|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111162181|NCT01534078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111162182|NCT01534078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111162183|NCT01534078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111162184|NCT01534078|Immunotoxins|immunotoxins|mesh-ancestor
111162185|NCT01534078|Immunoconjugates|immunoconjugates|mesh-ancestor
111162186|NCT01534078|Immunologic Factors|immunologic factors|mesh-ancestor
111162187|NCT01534078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111162188|NCT01534078|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111162189|NCT01534078|Alkylating Agents|alkylating agents|mesh-ancestor
111162190|NCT01534078|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111162191|NCT01534078|Tubulin Modulators|tubulin modulators|mesh-ancestor
111162192|NCT01534078|Antimitotic Agents|antimitotic agents|mesh-ancestor
111162193|NCT01534078|Mitosis Modulators|mitosis modulators|mesh-ancestor
111162194|NCT03919942|Chlorhexidine|chlorhexidine|mesh-list
111162195|NCT03919942|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111162196|NCT03919942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111162197|NCT03919942|Disinfectants|disinfectants|mesh-ancestor
111162198|NCT02161406|Abatacept|abatacept|mesh-list
111162199|NCT02161406|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111162200|NCT02161406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111162201|NCT02161406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111162202|NCT02161406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111162203|NCT02161406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111162204|NCT02161406|Immunologic Factors|immunologic factors|mesh-ancestor
111162205|NCT02161406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111162206|NCT02161406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111162207|NCT01573000|Tositumomab I-131|tositumomab i-131|mesh-list
111162208|NCT01573000|Antibodies|antibodies|mesh-list
111162209|NCT01573000|Immunoglobulins|immunoglobulins|mesh-list
111162210|NCT01573000|Immunologic Factors|immunologic factors|mesh-ancestor
111162211|NCT01573000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111162212|NCT01573000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111162213|NCT01572844|Sodium thiosulfate|sodium thiosulfate|mesh-list
111162214|NCT01572844|Antidotes|antidotes|mesh-ancestor
111162215|NCT01572844|Protective Agents|protective agents|mesh-ancestor
111162216|NCT01572844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111162217|NCT01572844|Antioxidants|antioxidants|mesh-ancestor
111162218|NCT01572844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111162219|NCT01572844|Antitubercular Agents|antitubercular agents|mesh-ancestor
111162220|NCT01572844|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111162221|NCT01572844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111162222|NCT01572844|Chelating Agents|chelating agents|mesh-ancestor
111162223|NCT01572844|Sequestering Agents|sequestering agents|mesh-ancestor
111162224|NCT01533922|Tiotropium Bromide|tiotropium bromide|mesh-list
111162225|NCT01533922|Olodaterol|olodaterol|mesh-list
111162226|NCT01533922|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111162227|NCT01533922|Autonomic Agents|autonomic agents|mesh-ancestor
111162228|NCT01533922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111162229|NCT01533922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111162230|NCT01533922|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111162231|NCT01533922|Respiratory System Agents|respiratory system agents|mesh-ancestor
111162232|NCT01533922|Parasympatholytics|parasympatholytics|mesh-ancestor
111162233|NCT01533922|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111162234|NCT01533922|Cholinergic Agents|cholinergic agents|mesh-ancestor
111162235|NCT01533922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111162236|NCT01533922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111162237|NCT01533688|Bisacodyl|bisacodyl|mesh-list
111162238|NCT01533688|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111162239|NCT01533688|Cathartics|cathartics|mesh-ancestor
110485778|NCT04065919|Mydriatics|mydriatics|mesh-ancestor
111162240|NCT01533688|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111162241|NCT01533688|Laxatives|laxatives|mesh-ancestor
111162242|NCT01532908|Sofosbuvir|sofosbuvir|mesh-list
111162243|NCT01532908|Antiviral Agents|antiviral agents|mesh-ancestor
111162244|NCT01532908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111162245|NCT02160626|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111162246|NCT02217878|Morphine|morphine|mesh-list
111162247|NCT02217878|Ticagrelor|ticagrelor|mesh-list
111162248|NCT02217878|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111162249|NCT02217878|Narcotics|narcotics|mesh-ancestor
111162250|NCT02217878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111162251|NCT02217878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111162252|NCT02217878|Analgesics|analgesics|mesh-ancestor
111162253|NCT02217878|Sensory System Agents|sensory system agents|mesh-ancestor
111162254|NCT02217878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111162255|NCT02217878|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111162256|NCT02217878|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111162257|NCT02217878|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111162258|NCT02217878|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111162259|NCT02217878|Purinergic Agents|purinergic agents|mesh-ancestor
111162260|NCT02217878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111162261|NCT02217878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111162262|NCT02217566|Prednisone|prednisone|mesh-list
111162263|NCT02217566|Abiraterone Acetate|abiraterone acetate|mesh-list
111162264|NCT02217566|Androgens|androgens|mesh-list
111162265|NCT02217566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111162266|NCT02217566|Glucocorticoids|glucocorticoids|mesh-ancestor
111162267|NCT02217566|Hormones|hormones|mesh-ancestor
111162268|NCT02217566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111162269|NCT02217566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111162270|NCT02217566|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111162271|NCT02217566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111162272|NCT02217566|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111162273|NCT02217566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111162274|NCT02217566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111162275|NCT02217566|Hormone Antagonists|hormone antagonists|mesh-ancestor
111162276|NCT02217566|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111162277|NCT02217410|Mycophenolic Acid|mycophenolic acid|mesh-list
111162278|NCT02217410|Tacrolimus|tacrolimus|mesh-list
111162279|NCT02217410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111162280|NCT02217410|Immunologic Factors|immunologic factors|mesh-ancestor
111162281|NCT02217410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111162282|NCT02217410|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111162283|NCT02217410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111162284|NCT02217410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111162285|NCT02217410|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111162286|NCT02217410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111162287|NCT02217410|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111162288|NCT02217410|Antitubercular Agents|antitubercular agents|mesh-ancestor
111162289|NCT02217410|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111162290|NCT02217410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111162291|NCT02217332|Pramipexole|pramipexole|mesh-list
111162292|NCT02217332|Antioxidants|antioxidants|mesh-ancestor
111162293|NCT02217332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111162294|NCT02217332|Protective Agents|protective agents|mesh-ancestor
111162295|NCT02217332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111162296|NCT02217332|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111162297|NCT02217332|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111162298|NCT02217332|Dopamine Agonists|dopamine agonists|mesh-ancestor
111162299|NCT02217332|Dopamine Agents|dopamine agents|mesh-ancestor
110879383|NCT03328897|Omalizumab|omalizumab|mesh-list
111162300|NCT02217332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111162302|NCT02184572|Immunologic Factors|immunologic factors|mesh-ancestor
111162303|NCT02184572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111162304|NCT02181842|Pioglitazone|pioglitazone|mesh-list
111162305|NCT02181842|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111162306|NCT02181842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111162307|NCT01632020|Metformin|metformin|mesh-list
111162308|NCT01632020|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111162309|NCT01632020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111162310|NCT02181296|Ropivacaine|ropivacaine|mesh-list
111162311|NCT02181296|Anesthetics, Local|anesthetics, local|mesh-ancestor
111162312|NCT02181296|Anesthetics|anesthetics|mesh-ancestor
111162313|NCT02181296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111162314|NCT02181296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111162315|NCT02181296|Sensory System Agents|sensory system agents|mesh-ancestor
111162316|NCT02181296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111162317|NCT02158442|Clavulanic Acid|clavulanic acid|mesh-list
111162318|NCT02158442|Ticarcillin-clavulanic acid|ticarcillin-clavulanic acid|mesh-list
111162319|NCT02158442|Ticarcillin|ticarcillin|mesh-list
111162320|NCT02158442|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
111162321|NCT02158442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111162322|NCT02158442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111162323|NCT02158442|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111162324|NCT02158442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111162325|NCT02158364|Vaccines|vaccines|mesh-list
111162326|NCT02158364|Immunologic Factors|immunologic factors|mesh-ancestor
111162327|NCT02158364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111162328|NCT02180672|Fluticasone|fluticasone|mesh-list
111162329|NCT02180672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111162330|NCT02180672|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111162331|NCT02180672|Autonomic Agents|autonomic agents|mesh-ancestor
111162332|NCT02180672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111162333|NCT02180672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111162334|NCT02180672|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111162335|NCT02180672|Respiratory System Agents|respiratory system agents|mesh-ancestor
111162336|NCT02180672|Dermatologic Agents|dermatologic agents|mesh-ancestor
111162337|NCT02180672|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111162338|NCT01920711|Valsartan|valsartan|mesh-list
111162339|NCT01920711|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
111162340|NCT01920711|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111162341|NCT01920711|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111162342|NCT01920711|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111162343|NCT01920711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111162344|NCT02180438|Tenofovir|tenofovir|mesh-list
111162345|NCT02180438|Emtricitabine|emtricitabine|mesh-list
111162346|NCT02180438|Cobicistat|cobicistat|mesh-list
111162347|NCT02180438|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
111162348|NCT02180438|Elvitegravir|elvitegravir|mesh-list
111162349|NCT02180438|Antiviral Agents|antiviral agents|mesh-ancestor
111162350|NCT02180438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111162351|NCT02180438|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111162352|NCT02180438|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111162353|NCT02180438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111162354|NCT02180438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111162355|NCT02180438|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111162356|NCT02180438|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111162357|NCT02180438|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111162358|NCT02180438|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111162359|NCT02180438|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111162360|NCT02157116|Docetaxel|docetaxel|mesh-list
111162361|NCT02157116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111162362|NCT02157116|Tubulin Modulators|tubulin modulators|mesh-ancestor
111162363|NCT02157116|Antimitotic Agents|antimitotic agents|mesh-ancestor
110485794|NCT00970268|Bromides|bromides|mesh-list
111162364|NCT02157116|Mitosis Modulators|mitosis modulators|mesh-ancestor
111162365|NCT02157116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111162366|NCT01920555|Midazolam|midazolam|mesh-list
111162367|NCT01920555|Ketamine|ketamine|mesh-list
111162368|NCT01920555|Analgesics|analgesics|mesh-ancestor
111162369|NCT01920555|Sensory System Agents|sensory system agents|mesh-ancestor
111162370|NCT01920555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111162371|NCT01920555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110879456|NCT03262441|Mycophenolic Acid|mycophenolic acid|mesh-list
111162372|NCT01920555|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111162373|NCT01920555|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111162374|NCT01920555|Anesthetics, General|anesthetics, general|mesh-ancestor
111162375|NCT01920555|Anesthetics|anesthetics|mesh-ancestor
111162376|NCT01920555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111162377|NCT01920555|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111162378|NCT01920555|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111162379|NCT01920555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111162380|NCT01920555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111162381|NCT01920555|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111162382|NCT01920555|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111162383|NCT01920555|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111162384|NCT01920555|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111162385|NCT01920555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111162386|NCT01920555|GABA Modulators|gaba modulators|mesh-ancestor
111162387|NCT01920555|GABA Agents|gaba agents|mesh-ancestor
111162388|NCT02156804|Nivolumab|nivolumab|mesh-list
111162389|NCT02156804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111162390|NCT02156804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111162391|NCT02156804|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111162392|NCT02156804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111162393|NCT02156492|Atorvastatin|atorvastatin|mesh-list
111162394|NCT02156492|Simvastatin|simvastatin|mesh-list
111162395|NCT02156492|Evacetrapib|evacetrapib|mesh-list
111162396|NCT02156492|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111162397|NCT02156492|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111162398|NCT02156492|Antimetabolites|antimetabolites|mesh-ancestor
111162399|NCT02156492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111162400|NCT02156492|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111162401|NCT02156492|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111162402|NCT02156492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111162403|NCT01920477|Ofatumumab|ofatumumab|mesh-list
111162404|NCT01920477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111162405|NCT04641195|Vitamin D|vitamin d|mesh-list
111162406|NCT04641195|Ergocalciferols|ergocalciferols|mesh-list
111162407|NCT04641195|Cholecalciferol|cholecalciferol|mesh-list
111162408|NCT04641195|Vitamins|vitamins|mesh-list
111162409|NCT04641195|Zinc|zinc|mesh-list
111162410|NCT04641195|Micronutrients|micronutrients|mesh-ancestor
111162411|NCT04641195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111162412|NCT04641195|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111162413|NCT04641195|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111162414|NCT04641195|Trace Elements|trace elements|mesh-ancestor
111162415|NCT02213042|Trastuzumab|trastuzumab|mesh-list
111162416|NCT02213042|Lapatinib|lapatinib|mesh-list
111162417|NCT02213042|Aromatase Inhibitors|aromatase inhibitors|mesh-list
111162418|NCT02213042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111162419|NCT02213042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111162420|NCT02213042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111162421|NCT02213042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111162422|NCT02213042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111162423|NCT02213042|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111162424|NCT02213042|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111162425|NCT02213042|Hormone Antagonists|hormone antagonists|mesh-ancestor
111162426|NCT02213042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111162427|NCT02213042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111162428|NCT04418180|Fenofibrate|fenofibrate|mesh-list
111162429|NCT04418180|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111162430|NCT04418180|Antimetabolites|antimetabolites|mesh-ancestor
111162431|NCT04418180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111162432|NCT04418180|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111162433|NCT02212730|Pembrolizumab|pembrolizumab|mesh-list
111162434|NCT02212730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111162435|NCT02212730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111162436|NCT02212730|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111162437|NCT02212730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111162438|NCT02178956|Paclitaxel|paclitaxel|mesh-list
111162439|NCT02178956|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111162440|NCT02178956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111162441|NCT02178956|Tubulin Modulators|tubulin modulators|mesh-ancestor
111162442|NCT02178956|Antimitotic Agents|antimitotic agents|mesh-ancestor
111162443|NCT02178956|Mitosis Modulators|mitosis modulators|mesh-ancestor
111162444|NCT02178956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111162445|NCT02211638|Candesartan|candesartan|mesh-list
111162446|NCT02211638|Candesartan cilexetil|candesartan cilexetil|mesh-list
111162447|NCT02211638|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111162448|NCT02211638|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111162449|NCT02211638|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111162450|NCT02211638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111162452|NCT02178566|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111162453|NCT02211014|Acalabrutinib|acalabrutinib|mesh-list
111162454|NCT02211014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111162455|NCT01631864|Amlodipine|amlodipine|mesh-list
111162456|NCT01631864|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
111162457|NCT01631864|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111162458|NCT01631864|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111162459|NCT01631864|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111162460|NCT01631864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111162461|NCT01631864|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111162462|NCT01631864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111162463|NCT01631864|Vasodilator Agents|vasodilator agents|mesh-ancestor
111162464|NCT01631864|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111162465|NCT01557244|Fesoterodine|fesoterodine|mesh-list
111162466|NCT01557244|Oxybutynin|oxybutynin|mesh-list
111162467|NCT01557244|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111162468|NCT01557244|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111162469|NCT01557244|Cholinergic Agents|cholinergic agents|mesh-ancestor
111162470|NCT01557244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111162471|NCT01557244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111162472|NCT01557244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111162473|NCT01557244|Urological Agents|urological agents|mesh-ancestor
111162474|NCT01557244|Parasympatholytics|parasympatholytics|mesh-ancestor
111162475|NCT01557244|Autonomic Agents|autonomic agents|mesh-ancestor
111162476|NCT01557244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111162477|NCT02177942|Micronutrients|micronutrients|mesh-list
111162478|NCT02177942|Trace Elements|trace elements|mesh-list
111162479|NCT02177942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111162480|NCT02155322|Interferons|interferons|mesh-list
111162481|NCT02155322|Interferon-alpha|interferon-alpha|mesh-list
111162482|NCT02155322|Interferon alpha-2|interferon alpha-2|mesh-list
111162483|NCT02155322|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
111162484|NCT02155322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111162485|NCT02155322|Antiviral Agents|antiviral agents|mesh-ancestor
111162486|NCT02155322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111162487|NCT02155322|Immunologic Factors|immunologic factors|mesh-ancestor
111162488|NCT02155322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111162489|NCT02209454|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
111162490|NCT02209454|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111162491|NCT02209454|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111162492|NCT02209454|Analgesics|analgesics|mesh-ancestor
111162493|NCT02209454|Sensory System Agents|sensory system agents|mesh-ancestor
111162494|NCT02209454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111162495|NCT02209454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111162496|NCT02209454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111162497|NCT02209454|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111162498|NCT01557166|Liraglutide|liraglutide|mesh-list
111162499|NCT01557166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111162500|NCT01557166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111162501|NCT01557166|Incretins|incretins|mesh-ancestor
111162502|NCT01557166|Hormones|hormones|mesh-ancestor
111162503|NCT01557166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111162504|NCT01556932|Diphenhydramine|diphenhydramine|mesh-list
111162505|NCT01556932|Promethazine|promethazine|mesh-list
111162506|NCT01556932|Lorazepam|lorazepam|mesh-list
111162507|NCT01556932|Haloperidol|haloperidol|mesh-list
111162508|NCT01556932|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111162509|NCT01556932|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111162510|NCT01556932|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111162511|NCT01556932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111162512|NCT01556932|Anesthetics, Local|anesthetics, local|mesh-ancestor
111162513|NCT01556932|Anesthetics|anesthetics|mesh-ancestor
111162514|NCT01556932|Sensory System Agents|sensory system agents|mesh-ancestor
111162515|NCT01556932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111162516|NCT01556932|Antiemetics|antiemetics|mesh-ancestor
111162517|NCT01556932|Autonomic Agents|autonomic agents|mesh-ancestor
111162518|NCT01556932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111162519|NCT01556932|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111162520|NCT01556932|Histamine Antagonists|histamine antagonists|mesh-ancestor
111162521|NCT01556932|Histamine Agents|histamine agents|mesh-ancestor
111162522|NCT01556932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111162523|NCT01556932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111162524|NCT01556932|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111162525|NCT01556932|Antipruritics|antipruritics|mesh-ancestor
111162526|NCT01556932|Dermatologic Agents|dermatologic agents|mesh-ancestor
111162527|NCT01556932|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111162528|NCT01556932|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111162529|NCT01556932|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111162530|NCT01556932|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111162531|NCT01556932|Dopamine Agents|dopamine agents|mesh-ancestor
111162532|NCT01556932|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111162533|NCT01556932|Anticonvulsants|anticonvulsants|mesh-ancestor
111162534|NCT01556932|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111162535|NCT01556932|GABA Modulators|gaba modulators|mesh-ancestor
111162536|NCT01556932|GABA Agents|gaba agents|mesh-ancestor
111162537|NCT02985736|Desoximetasone|desoximetasone|mesh-list
111162538|NCT02985736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111162539|NCT02985736|Glucocorticoids|glucocorticoids|mesh-ancestor
111162540|NCT02985736|Hormones|hormones|mesh-ancestor
111162541|NCT02985736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110841826|NCT02162420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111162542|NCT02985736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111162543|NCT02985658|Cisplatin|cisplatin|mesh-list
111162544|NCT02985658|Vinorelbine|vinorelbine|mesh-list
111162545|NCT02985658|Veliparib|veliparib|mesh-list
111162546|NCT02985658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111162547|NCT02985658|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111162548|NCT02985658|Tubulin Modulators|tubulin modulators|mesh-ancestor
111162549|NCT02985658|Antimitotic Agents|antimitotic agents|mesh-ancestor
111162550|NCT02985658|Mitosis Modulators|mitosis modulators|mesh-ancestor
111162551|NCT02985658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111162552|NCT02985658|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111162553|NCT02985658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111162554|NCT02177786|Selonsertib|selonsertib|mesh-list
111162555|NCT02177786|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111162556|NCT02177786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111162557|NCT02177786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111162558|NCT02153918|Metronidazole|metronidazole|mesh-list
111162559|NCT02153918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111162560|NCT02153918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111162561|NCT02153918|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111162562|NCT02153918|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111162563|NCT04752566|Eculizumab|eculizumab|mesh-list
111162564|NCT04752566|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
111162565|NCT04752566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111162566|NCT04752566|Immunologic Factors|immunologic factors|mesh-ancestor
111162567|NCT04752566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111162568|NCT01571362|Naltrexone|naltrexone|mesh-list
111162569|NCT01571362|Oxycodone|oxycodone|mesh-list
111162570|NCT01571362|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111162571|NCT01571362|Narcotics|narcotics|mesh-ancestor
111162572|NCT01571362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111162573|NCT01571362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111162574|NCT01571362|Analgesics|analgesics|mesh-ancestor
111162575|NCT01571362|Sensory System Agents|sensory system agents|mesh-ancestor
111162576|NCT01571362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111162577|NCT01571362|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111162578|NCT01571362|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111162579|NCT01571284|Aflibercept|aflibercept|mesh-list
111162580|NCT01571284|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111162581|NCT01571284|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111162582|NCT01571284|Growth Substances|growth substances|mesh-ancestor
111162583|NCT01571284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111162584|NCT01571284|Growth Inhibitors|growth inhibitors|mesh-ancestor
111162585|NCT01571284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111162586|NCT02137772|Letermovir|letermovir|mesh-list
111162587|NCT02137772|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111162588|NCT02137772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111162589|NCT02137772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111162590|NCT02137772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111162591|NCT02137772|Antiviral Agents|antiviral agents|mesh-ancestor
111162592|NCT02137772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111162593|NCT01555138|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
111162594|NCT01555138|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111162595|NCT01555138|Autonomic Agents|autonomic agents|mesh-ancestor
111162596|NCT01555138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111162597|NCT01555138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111162598|NCT01555138|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111162599|NCT01555138|Respiratory System Agents|respiratory system agents|mesh-ancestor
111162600|NCT01555138|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111162601|NCT01555138|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111162602|NCT01555138|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111162603|NCT01555138|Adrenergic Agents|adrenergic agents|mesh-ancestor
111162604|NCT01555138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111162605|NCT01555138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111162606|NCT02137226|Adalimumab|adalimumab|mesh-list
111162607|NCT02137226|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111162608|NCT02137226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111162609|NCT02137226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111162610|NCT01530334|Gefitinib|gefitinib|mesh-list
111162611|NCT01530334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111162612|NCT01530334|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111162613|NCT01530334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111162614|NCT01530334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111162615|NCT01570192|Vancomycin|vancomycin|mesh-list
111162616|NCT01570192|Gentamicins|gentamicins|mesh-list
111162617|NCT01570192|Meropenem|meropenem|mesh-list
111162618|NCT01570192|Linezolid|linezolid|mesh-list
111162619|NCT01570192|Tobramycin|tobramycin|mesh-list
111162620|NCT01570192|Amikacin|amikacin|mesh-list
111162621|NCT01570192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111162622|NCT01570192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111162623|NCT01570192|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111162624|NCT01570192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111162625|NCT01570192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111162626|NCT02136914|Amantadine|amantadine|mesh-list
111162627|NCT02136914|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111162628|NCT02136914|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111162629|NCT02136914|Antiviral Agents|antiviral agents|mesh-ancestor
111162630|NCT02136914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111162631|NCT02136914|Dopamine Agents|dopamine agents|mesh-ancestor
111162632|NCT02136914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111162633|NCT02136914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111162634|NCT02136914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111162635|NCT02136914|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111162636|NCT02136914|Analgesics|analgesics|mesh-ancestor
111162637|NCT02136914|Sensory System Agents|sensory system agents|mesh-ancestor
111162638|NCT02136914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111162639|NCT01529632|Glycopyrrolate|glycopyrrolate|mesh-list
111162640|NCT01529632|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111162641|NCT01529632|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111162642|NCT01529632|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111162643|NCT01529632|Cholinergic Agents|cholinergic agents|mesh-ancestor
111162644|NCT01529632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111162645|NCT01529632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111162646|NCT01529632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111162647|NCT01554514|Rituximab|rituximab|mesh-list
111162648|NCT01554514|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111162649|NCT01554514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111162650|NCT01554514|Immunologic Factors|immunologic factors|mesh-ancestor
111162651|NCT01554514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111162652|NCT01554514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111162653|NCT01553188|Prednisone|prednisone|mesh-list
111162654|NCT01553188|Trebananib|trebananib|mesh-list
111162655|NCT01553188|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111162656|NCT01553188|Glucocorticoids|glucocorticoids|mesh-ancestor
111162657|NCT01553188|Hormones|hormones|mesh-ancestor
111162658|NCT01553188|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111162659|NCT01553188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111162660|NCT01553188|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111162661|NCT01553188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111162662|NCT01553188|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111162663|NCT01553188|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111162664|NCT01553188|Growth Substances|growth substances|mesh-ancestor
111162665|NCT01553188|Growth Inhibitors|growth inhibitors|mesh-ancestor
111162666|NCT02175758|Ribavirin|ribavirin|mesh-list
111162667|NCT02175758|Sofosbuvir|sofosbuvir|mesh-list
111162668|NCT02175758|Antimetabolites|antimetabolites|mesh-ancestor
111162669|NCT02175758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111162670|NCT02175758|Antiviral Agents|antiviral agents|mesh-ancestor
110841848|NCT01237769|Vitamin D|vitamin d|mesh-list
111162671|NCT02175758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111162672|NCT01599104|Olmesartan|olmesartan|mesh-list
111162673|NCT01599104|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
111162674|NCT01599104|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111162675|NCT01599104|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111162676|NCT01599104|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111162677|NCT01599104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111162678|NCT01552954|Angiotensin II|angiotensin ii|mesh-list
111162679|NCT01552954|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111162680|NCT01518244|Timolol|timolol|mesh-list
111162681|NCT01518244|Brinzolamide|brinzolamide|mesh-list
111162682|NCT01518244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111162683|NCT01518244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111162684|NCT01518244|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111162685|NCT01518244|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111162686|NCT01518244|Adrenergic Agents|adrenergic agents|mesh-ancestor
111162687|NCT01518244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111162688|NCT01518244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111162689|NCT01518244|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111162690|NCT01518244|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111162691|NCT01518244|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
111162692|NCT01552408|Ranibizumab|ranibizumab|mesh-list
111162693|NCT01552408|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111162694|NCT01552408|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111162695|NCT01552408|Growth Substances|growth substances|mesh-ancestor
111162696|NCT01552408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111162697|NCT01552408|Growth Inhibitors|growth inhibitors|mesh-ancestor
111162698|NCT01552408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111162699|NCT02174276|Tenofovir|tenofovir|mesh-list
111162700|NCT02174276|Antiviral Agents|antiviral agents|mesh-ancestor
111162701|NCT02174276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111162702|NCT02174276|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111162703|NCT02174276|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111162704|NCT02174276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111162705|NCT02174276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111162706|NCT02174276|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111162707|NCT02174276|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111162708|NCT01527682|Dorzolamide|dorzolamide|mesh-list
111162709|NCT01527682|Latanoprost|latanoprost|mesh-list
111162710|NCT01527682|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
111162711|NCT01527682|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111162712|NCT01527682|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111162713|NCT01527682|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
111162714|NCT01527682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111162715|NCT01527682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111162716|NCT01516216|Vitamin D|vitamin d|mesh-list
111162717|NCT01516216|Leucovorin|leucovorin|mesh-list
111162718|NCT01516216|Bevacizumab|bevacizumab|mesh-list
111162719|NCT01516216|Fluorouracil|fluorouracil|mesh-list
111162720|NCT01516216|Oxaliplatin|oxaliplatin|mesh-list
111162721|NCT01516216|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111162722|NCT01516216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111162723|NCT01516216|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111162724|NCT01516216|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111162725|NCT01516216|Growth Substances|growth substances|mesh-ancestor
111162726|NCT01516216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111162727|NCT01516216|Growth Inhibitors|growth inhibitors|mesh-ancestor
111162728|NCT01516216|Vitamins|vitamins|mesh-ancestor
111162729|NCT01516216|Micronutrients|micronutrients|mesh-ancestor
111162730|NCT01516216|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111162731|NCT01516216|Antimetabolites|antimetabolites|mesh-ancestor
111162732|NCT01516216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111162733|NCT01516216|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111162734|NCT01516216|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111162735|NCT01516216|Immunologic Factors|immunologic factors|mesh-ancestor
111162736|NCT01516216|Antidotes|antidotes|mesh-ancestor
110485872|NCT04178655|Hemostatics|hemostatics|mesh-ancestor
111162737|NCT01516216|Protective Agents|protective agents|mesh-ancestor
111162738|NCT01516216|Vitamin B Complex|vitamin b complex|mesh-ancestor
111162739|NCT01950819|Cyclosporine|cyclosporine|mesh-list
111162740|NCT01950819|Prednisone|prednisone|mesh-list
111162741|NCT01950819|Methylprednisolone|methylprednisolone|mesh-list
111162742|NCT01950819|Tacrolimus|tacrolimus|mesh-list
111162743|NCT01950819|Thymoglobulin|thymoglobulin|mesh-list
111162744|NCT01950819|Cyclosporins|cyclosporins|mesh-list
111162745|NCT01950819|Basiliximab|basiliximab|mesh-list
111162746|NCT01950819|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111162747|NCT01950819|Glucocorticoids|glucocorticoids|mesh-ancestor
111162748|NCT01950819|Hormones|hormones|mesh-ancestor
111162749|NCT01950819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111162750|NCT01950819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111162751|NCT01950819|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111162752|NCT01950819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111162753|NCT01950819|Antiemetics|antiemetics|mesh-ancestor
111162754|NCT01950819|Autonomic Agents|autonomic agents|mesh-ancestor
111162755|NCT01950819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111162756|NCT01950819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111162757|NCT01950819|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111162758|NCT01950819|Protective Agents|protective agents|mesh-ancestor
111162759|NCT01950819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111162760|NCT01950819|Immunologic Factors|immunologic factors|mesh-ancestor
111162761|NCT01950819|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111162762|NCT01950819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111162763|NCT01950819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111162764|NCT01950819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111162765|NCT01950819|Antifungal Agents|antifungal agents|mesh-ancestor
111162766|NCT01950819|Dermatologic Agents|dermatologic agents|mesh-ancestor
111162767|NCT01950819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111162768|NCT01514422|Minocycline|minocycline|mesh-list
111162769|NCT01514422|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111162770|NCT01514422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111162771|NCT01524796|Pregabalin|pregabalin|mesh-list
111162772|NCT01524796|Analgesics|analgesics|mesh-ancestor
111162773|NCT01524796|Sensory System Agents|sensory system agents|mesh-ancestor
111162774|NCT01524796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111162775|NCT01524796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111162776|NCT01524796|Anticonvulsants|anticonvulsants|mesh-ancestor
111162777|NCT01524796|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111162778|NCT01524796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111162779|NCT01524796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111162780|NCT01524796|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111162781|NCT01524796|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111162782|NCT01524796|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111162783|NCT01524796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111162784|NCT01524796|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111162785|NCT01547728|Antithrombins|antithrombins|mesh-list
111162786|NCT01547728|Antithrombin III|antithrombin iii|mesh-list
111162787|NCT01547728|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111162788|NCT01547728|Protease Inhibitors|protease inhibitors|mesh-ancestor
111162789|NCT01547728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111162790|NCT01547728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111162791|NCT01547728|Anticoagulants|anticoagulants|mesh-ancestor
111162792|NCT01523392|Clopidogrel|clopidogrel|mesh-list
111162793|NCT01523392|Ticagrelor|ticagrelor|mesh-list
111162794|NCT01523392|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111162795|NCT01523392|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111162796|NCT01523392|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111162797|NCT01523392|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111162798|NCT01523392|Purinergic Agents|purinergic agents|mesh-ancestor
111162799|NCT01523392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111162800|NCT01523392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111162801|NCT01523392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111162802|NCT01512160|Ibuprofen|ibuprofen|mesh-list
111162803|NCT01512160|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111162804|NCT01512160|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111162805|NCT01512160|Analgesics|analgesics|mesh-ancestor
111162806|NCT01512160|Sensory System Agents|sensory system agents|mesh-ancestor
111162807|NCT01512160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111162808|NCT01512160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111162809|NCT01512160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111162810|NCT01512160|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111162811|NCT01512160|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111162812|NCT01512160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111162813|NCT01512160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111162815|NCT01950741|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111162816|NCT01950741|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111162817|NCT01950741|Growth Substances|growth substances|mesh-ancestor
111162818|NCT01950741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111162819|NCT01950741|Growth Inhibitors|growth inhibitors|mesh-ancestor
111162820|NCT01950741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111162821|NCT01950273|Rituximab|rituximab|mesh-list
111162822|NCT01950273|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111162823|NCT01950273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111162824|NCT01950273|Immunologic Factors|immunologic factors|mesh-ancestor
111162825|NCT01950273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111162826|NCT01950273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111162827|NCT01919229|Letrozole|letrozole|mesh-list
111162828|NCT01919229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111162829|NCT01919229|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111162830|NCT01919229|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111162831|NCT01919229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111162832|NCT01919229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111162833|NCT01919229|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111162834|NCT01919229|Hormone Antagonists|hormone antagonists|mesh-ancestor
111162835|NCT01919229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111162836|NCT01919229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111162837|NCT01511536|Prednisone|prednisone|mesh-list
111162838|NCT01511536|Abiraterone Acetate|abiraterone acetate|mesh-list
111162839|NCT01511536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111162840|NCT01511536|Glucocorticoids|glucocorticoids|mesh-ancestor
111162841|NCT01511536|Hormones|hormones|mesh-ancestor
111162842|NCT01511536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111162843|NCT01511536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111162844|NCT01511536|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111162845|NCT01511536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111162846|NCT01511536|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111162847|NCT01511536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111162848|NCT01511536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111162849|NCT01511536|Hormone Antagonists|hormone antagonists|mesh-ancestor
111162850|NCT01511536|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111162851|NCT01510912|Diclofenac|diclofenac|mesh-list
111162852|NCT01510912|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111162853|NCT01510912|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111162854|NCT01510912|Analgesics|analgesics|mesh-ancestor
111162855|NCT01510912|Sensory System Agents|sensory system agents|mesh-ancestor
111162856|NCT01510912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111162857|NCT01510912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111162858|NCT01510912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111162859|NCT01510912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111162860|NCT01510912|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111162861|NCT01510912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111162862|NCT01510912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111162863|NCT01510756|Sorafenib|sorafenib|mesh-list
111162864|NCT01510756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111162865|NCT01510756|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111162866|NCT01510756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111162867|NCT01510756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111162868|NCT01522456|Tretinoin|tretinoin|mesh-list
111162869|NCT01522456|Dermatologic Agents|dermatologic agents|mesh-ancestor
111162870|NCT01522456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111162871|NCT01522456|Keratolytic Agents|keratolytic agents|mesh-ancestor
111162872|NCT01521364|Clarithromycin|clarithromycin|mesh-list
111162873|NCT01521364|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111162874|NCT01521364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111162875|NCT01521364|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111162876|NCT01521364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111162877|NCT01521364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111162878|NCT01521364|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111162879|NCT01521364|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111162880|NCT01545388|Metformin|metformin|mesh-list
111162881|NCT01545388|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111162883|NCT01545388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111162884|NCT01545388|Incretins|incretins|mesh-ancestor
111162885|NCT01545388|Hormones|hormones|mesh-ancestor
111162886|NCT01545388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111162887|NCT01545388|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111162888|NCT01545388|Protease Inhibitors|protease inhibitors|mesh-ancestor
111162889|NCT01545388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111162890|NCT01545388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111162891|NCT01545076|Immunoglobulin G|immunoglobulin g|mesh-list
111162892|NCT01545076|Immunologic Factors|immunologic factors|mesh-ancestor
111162893|NCT01545076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111162894|NCT01544920|Interferons|interferons|mesh-list
111162895|NCT01544920|Ribavirin|ribavirin|mesh-list
111162896|NCT01544920|Interferon-alpha|interferon-alpha|mesh-list
111162897|NCT01544920|Interferon alpha-2|interferon alpha-2|mesh-list
111162898|NCT01544920|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
111162899|NCT01544920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110879978|NCT05682209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111162900|NCT01544920|Antiviral Agents|antiviral agents|mesh-ancestor
111162901|NCT01544920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111162902|NCT01544920|Antimetabolites|antimetabolites|mesh-ancestor
111162903|NCT01544920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111162904|NCT01544920|Immunologic Factors|immunologic factors|mesh-ancestor
111162905|NCT01544920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111162906|NCT01519960|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
111162907|NCT01519960|Interferon-alpha|interferon-alpha|mesh-list
111162908|NCT01519960|Antiviral Agents|antiviral agents|mesh-ancestor
111162909|NCT01519960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111162910|NCT01519960|Immunologic Factors|immunologic factors|mesh-ancestor
111162911|NCT01519960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111162913|NCT01543204|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111162914|NCT01543204|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111162915|NCT01543204|Analgesics|analgesics|mesh-ancestor
111162916|NCT01543204|Sensory System Agents|sensory system agents|mesh-ancestor
111162917|NCT01543204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111162918|NCT01543204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111162919|NCT01543204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111162920|NCT01543204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111162921|NCT01543204|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111162922|NCT01543204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111162923|NCT01543204|Immunologic Factors|immunologic factors|mesh-ancestor
111162924|NCT01518946|Midodrine|midodrine|mesh-list
111162925|NCT01518946|Sympathomimetics|sympathomimetics|mesh-ancestor
111162926|NCT01518946|Autonomic Agents|autonomic agents|mesh-ancestor
110485918|NCT05273775|Antimetabolites|antimetabolites|mesh-ancestor
111162927|NCT01518946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111162928|NCT01518946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111162929|NCT01518946|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111162930|NCT01518946|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111162931|NCT01518946|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111162932|NCT01518946|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111162933|NCT01518946|Adrenergic Agents|adrenergic agents|mesh-ancestor
111162934|NCT01518946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111162935|NCT01518946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111162936|NCT01507246|Morphine|morphine|mesh-list
111162937|NCT01507246|Bupivacaine|bupivacaine|mesh-list
111162938|NCT01507246|Anesthetics, Local|anesthetics, local|mesh-ancestor
111162939|NCT01507246|Anesthetics|anesthetics|mesh-ancestor
111162940|NCT01507246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111162941|NCT01507246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111162942|NCT01507246|Sensory System Agents|sensory system agents|mesh-ancestor
111162943|NCT01507246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111162944|NCT01507246|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111162945|NCT01507246|Narcotics|narcotics|mesh-ancestor
111162946|NCT01507246|Analgesics|analgesics|mesh-ancestor
111162947|NCT03870022|Carbon Monoxide|carbon monoxide|mesh-list
111162948|NCT03870022|Antimetabolites|antimetabolites|mesh-ancestor
111162949|NCT03870022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111162950|NCT03870022|Gasotransmitters|gasotransmitters|mesh-ancestor
111162951|NCT03870022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111162952|NCT03870022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111162953|NCT02073448|Adapalene|adapalene|mesh-list
111162954|NCT02073448|Benzoyl Peroxide|benzoyl peroxide|mesh-list
111162955|NCT02073448|Dermatologic Agents|dermatologic agents|mesh-ancestor
111162956|NCT02073448|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111162957|NCT02073448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111162958|NCT02073448|Analgesics|analgesics|mesh-ancestor
111162959|NCT02073448|Sensory System Agents|sensory system agents|mesh-ancestor
111162960|NCT02073448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111162961|NCT02073448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111162962|NCT02073448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111162963|NCT02073448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111162964|NCT01487200|Triamcinolone|triamcinolone|mesh-list
111162965|NCT01487200|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
111162966|NCT01487200|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
111162967|NCT01487200|FX006|fx006|mesh-list
111162968|NCT01487200|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
111162969|NCT01487200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111162970|NCT01487200|Glucocorticoids|glucocorticoids|mesh-ancestor
111162971|NCT01487200|Hormones|hormones|mesh-ancestor
111162972|NCT01487200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111162973|NCT01487200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111162974|NCT01487200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111162975|NCT01487200|Immunologic Factors|immunologic factors|mesh-ancestor
111162976|NCT01487200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111162977|NCT01487200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111162978|NCT01486966|Insulin|insulin|mesh-list
111162979|NCT01486966|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111162980|NCT01486966|Metformin|metformin|mesh-list
111162981|NCT01486966|Insulin Aspart|insulin aspart|mesh-list
111162982|NCT01486966|Insulin Detemir|insulin detemir|mesh-list
111162983|NCT01486966|Isophane Insulin, Human|isophane insulin, human|mesh-list
111162984|NCT01486966|Insulin, Isophane|insulin, isophane|mesh-list
111162985|NCT01486966|Isophane insulin, beef|isophane insulin, beef|mesh-list
111162986|NCT01486966|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111162987|NCT01486966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111162988|NCT04080076|Tacrolimus|tacrolimus|mesh-list
111162989|NCT04080076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111162990|NCT04080076|Immunologic Factors|immunologic factors|mesh-ancestor
111162991|NCT04080076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111162992|NCT04080076|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111162993|NCT04080076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111162994|NCT04080076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111162995|NCT01900431|Leucovorin|leucovorin|mesh-list
111162996|NCT01900431|Folic Acid|folic acid|mesh-list
111162997|NCT01900431|Prednisone|prednisone|mesh-list
111162998|NCT01900431|Methotrexate|methotrexate|mesh-list
111162999|NCT01900431|Levoleucovorin|levoleucovorin|mesh-list
111163000|NCT01900431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111163001|NCT01900431|Glucocorticoids|glucocorticoids|mesh-ancestor
111163002|NCT01900431|Hormones|hormones|mesh-ancestor
111163003|NCT01900431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111163004|NCT01900431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111163005|NCT01900431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111163006|NCT01900431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111163007|NCT01900431|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111163008|NCT01900431|Abortifacient Agents|abortifacient agents|mesh-ancestor
111163009|NCT01900431|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111163010|NCT01900431|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111163011|NCT01900431|Antimetabolites|antimetabolites|mesh-ancestor
111163012|NCT01900431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111163013|NCT01900431|Dermatologic Agents|dermatologic agents|mesh-ancestor
111163014|NCT01900431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111163015|NCT01900431|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111163016|NCT01900431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111163017|NCT01900431|Immunologic Factors|immunologic factors|mesh-ancestor
111163018|NCT01900431|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111163019|NCT01900431|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111163020|NCT01900431|Antidotes|antidotes|mesh-ancestor
111163021|NCT01900431|Protective Agents|protective agents|mesh-ancestor
111163022|NCT01900431|Vitamin B Complex|vitamin b complex|mesh-ancestor
111163023|NCT01900431|Vitamins|vitamins|mesh-ancestor
111163024|NCT01900431|Micronutrients|micronutrients|mesh-ancestor
111163025|NCT01900431|Hematinics|hematinics|mesh-ancestor
111163026|NCT01948791|Rivastigmine|rivastigmine|mesh-list
111163027|NCT01948791|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111163028|NCT01948791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111163029|NCT01948791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111163030|NCT01948791|Cholinergic Agents|cholinergic agents|mesh-ancestor
111163031|NCT01948791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111163032|NCT01948791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111163033|NCT01948791|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111163034|NCT01948791|Protective Agents|protective agents|mesh-ancestor
111163035|NCT01898091|Ascorbic Acid|ascorbic acid|mesh-list
111163036|NCT01898091|Glycerol|glycerol|mesh-list
111163037|NCT01898091|Antioxidants|antioxidants|mesh-ancestor
111163038|NCT01898091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111163039|NCT01898091|Protective Agents|protective agents|mesh-ancestor
111163040|NCT01898091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111163041|NCT01898091|Vitamins|vitamins|mesh-ancestor
111163042|NCT01898091|Micronutrients|micronutrients|mesh-ancestor
111163043|NCT01898091|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
111163044|NCT01947855|Empagliflozin|empagliflozin|mesh-list
111163045|NCT01947855|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111163046|NCT01947855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111163047|NCT01947855|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111163048|NCT01947855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111163049|NCT01888497|Diphenhydramine|diphenhydramine|mesh-list
111163050|NCT01888497|Promethazine|promethazine|mesh-list
111163051|NCT01888497|Triazolam|triazolam|mesh-list
111163052|NCT01888497|Gabapentin|gabapentin|mesh-list
111163053|NCT01888497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111163054|NCT01888497|Analgesics|analgesics|mesh-ancestor
111163055|NCT01888497|Sensory System Agents|sensory system agents|mesh-ancestor
111163056|NCT01888497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111163057|NCT01888497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111163058|NCT01888497|Anticonvulsants|anticonvulsants|mesh-ancestor
111163059|NCT01888497|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111163060|NCT01888497|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111163061|NCT01888497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111163062|NCT01888497|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111163063|NCT01888497|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111163064|NCT01888497|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111163065|NCT01888497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111163066|NCT01888497|Antimanic Agents|antimanic agents|mesh-ancestor
111163067|NCT01888497|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111163068|NCT01888497|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111163069|NCT01888497|Anesthetics, Local|anesthetics, local|mesh-ancestor
111163070|NCT01888497|Anesthetics|anesthetics|mesh-ancestor
111163071|NCT01888497|Antiemetics|antiemetics|mesh-ancestor
111163072|NCT01888497|Autonomic Agents|autonomic agents|mesh-ancestor
111163073|NCT01888497|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111163074|NCT01888497|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111163075|NCT01888497|Histamine Antagonists|histamine antagonists|mesh-ancestor
111163076|NCT01888497|Histamine Agents|histamine agents|mesh-ancestor
111163077|NCT01888497|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111163078|NCT01888497|Antipruritics|antipruritics|mesh-ancestor
111163079|NCT01888497|Dermatologic Agents|dermatologic agents|mesh-ancestor
111163080|NCT01888497|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111163081|NCT01888497|GABA Modulators|gaba modulators|mesh-ancestor
111163082|NCT01888497|GABA Agents|gaba agents|mesh-ancestor
111163083|NCT01485796|Immunoglobulins|immunoglobulins|mesh-list
111163084|NCT01485796|Antibodies|antibodies|mesh-list
111163085|NCT01485796|gamma-Globulins|gamma-globulins|mesh-list
111163086|NCT01485796|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111163087|NCT01485796|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
111163088|NCT01485796|Immunologic Factors|immunologic factors|mesh-ancestor
111163089|NCT01485796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111163090|NCT01897233|Ivacaftor|ivacaftor|mesh-list
111163091|NCT01897233|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
111163092|NCT01897233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111163093|NCT01897233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111163094|NCT01887717|Sorafenib|sorafenib|mesh-list
111163095|NCT01887717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111163096|NCT01887717|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111163097|NCT01887717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111163098|NCT01887717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111163099|NCT01463098|Zolpidem|zolpidem|mesh-list
111163100|NCT01463098|Lemborexant|lemborexant|mesh-list
111163101|NCT01463098|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111163102|NCT01463098|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111163103|NCT01463098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111163104|NCT01463098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111163105|NCT01463098|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
111163106|NCT01463098|GABA Agonists|gaba agonists|mesh-ancestor
111163107|NCT01463098|GABA Agents|gaba agents|mesh-ancestor
111163108|NCT01463098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111163109|NCT01463098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111163110|NCT01463098|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
111163111|NCT01462942|Bromides|bromides|mesh-list
111163112|NCT01462942|Formoterol Fumarate|formoterol fumarate|mesh-list
111163113|NCT01462942|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111163114|NCT01462942|Autonomic Agents|autonomic agents|mesh-ancestor
111163115|NCT01462942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111163116|NCT01462942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111163117|NCT01462942|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111163118|NCT01462942|Respiratory System Agents|respiratory system agents|mesh-ancestor
111163119|NCT01462942|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111163120|NCT01462942|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111163121|NCT01462942|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111163122|NCT01462942|Adrenergic Agents|adrenergic agents|mesh-ancestor
111163123|NCT01462942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111163124|NCT01462942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111163125|NCT01462942|Anticonvulsants|anticonvulsants|mesh-ancestor
111163126|NCT01462630|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110880211|NCT05178745|Irinotecan|irinotecan|mesh-list
111163127|NCT01462630|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111163128|NCT01462630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111163129|NCT01504204|Adapalene|adapalene|mesh-list
111163130|NCT01504204|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
111163131|NCT01504204|Benzoyl Peroxide|benzoyl peroxide|mesh-list
111163132|NCT01504204|Dermatologic Agents|dermatologic agents|mesh-ancestor
111163133|NCT01504204|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111163134|NCT01504204|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111163135|NCT01504204|Analgesics|analgesics|mesh-ancestor
111163136|NCT01504204|Sensory System Agents|sensory system agents|mesh-ancestor
110485989|NCT00644631|Urological Agents|urological agents|mesh-ancestor
111163137|NCT01504204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111163138|NCT01504204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111163139|NCT01504204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111163140|NCT01504204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111163141|NCT01485640|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
111163142|NCT01485640|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111163143|NCT01485640|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111163144|NCT01485640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111163145|NCT01485640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111163146|NCT01485640|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111163147|NCT01485640|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
111163148|NCT01485640|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111163149|NCT01485640|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111163150|NCT01485640|Adrenergic Agents|adrenergic agents|mesh-ancestor
111163151|NCT01485640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111163152|NCT01485640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111163153|NCT01485640|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111163154|NCT01485640|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111163155|NCT01485640|Serotonin Agents|serotonin agents|mesh-ancestor
111163156|NCT01485640|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111163157|NCT01485640|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111163158|NCT01485640|Dopamine Agents|dopamine agents|mesh-ancestor
111163159|NCT02118961|Vaccines|vaccines|mesh-list
111163160|NCT02118961|Immunologic Factors|immunologic factors|mesh-ancestor
111163161|NCT02118961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111163162|NCT02140645|Linagliptin|linagliptin|mesh-list
111163163|NCT02140645|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111163164|NCT02140645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111163165|NCT02140645|Incretins|incretins|mesh-ancestor
111163166|NCT02140645|Hormones|hormones|mesh-ancestor
111163167|NCT02140645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111163168|NCT02140645|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111163169|NCT02140645|Protease Inhibitors|protease inhibitors|mesh-ancestor
111163170|NCT02140645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111163171|NCT02140645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111163172|NCT02140411|Ranibizumab|ranibizumab|mesh-list
111163173|NCT02140411|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111163174|NCT02140411|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111163175|NCT02140411|Growth Substances|growth substances|mesh-ancestor
111163176|NCT02140411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111163177|NCT02140411|Growth Inhibitors|growth inhibitors|mesh-ancestor
111163178|NCT02140411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111163179|NCT02139943|Canagliflozin|canagliflozin|mesh-list
111163180|NCT02139943|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111163181|NCT02139943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111163182|NCT02139943|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111163183|NCT02139943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111163184|NCT01485172|Ropinirole|ropinirole|mesh-list
111163185|NCT01485172|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111163186|NCT01485172|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111163187|NCT01485172|Dopamine Agonists|dopamine agonists|mesh-ancestor
111163188|NCT01485172|Dopamine Agents|dopamine agents|mesh-ancestor
111163189|NCT01485172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111163190|NCT01485172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111163191|NCT01485172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111163192|NCT02105701|Ribavirin|ribavirin|mesh-list
111163193|NCT02105701|Grazoprevir|grazoprevir|mesh-list
111163194|NCT02105701|Antimetabolites|antimetabolites|mesh-ancestor
111163195|NCT02105701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111163196|NCT02105701|Antiviral Agents|antiviral agents|mesh-ancestor
111163197|NCT02105701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111163198|NCT04411225|Cannabidiol|cannabidiol|mesh-list
111163199|NCT04411225|Anticonvulsants|anticonvulsants|mesh-ancestor
111163200|NCT01502956|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111163201|NCT01502956|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111163202|NCT01502956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111163203|NCT01502956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111163204|NCT01502956|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111163205|NCT01502956|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111163206|NCT01502956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111163208|NCT01502956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111163209|NCT01502644|Morphine|morphine|mesh-list
111163210|NCT01502644|Oxycodone|oxycodone|mesh-list
111163211|NCT01502644|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111163212|NCT01502644|Narcotics|narcotics|mesh-ancestor
111163213|NCT01502644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111163214|NCT01502644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111163215|NCT01502644|Analgesics|analgesics|mesh-ancestor
111163216|NCT01502644|Sensory System Agents|sensory system agents|mesh-ancestor
111163217|NCT01502644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111163218|NCT01462318|Vitamin K|vitamin k|mesh-list
111163219|NCT01462318|Midazolam|midazolam|mesh-list
111163220|NCT01462318|Dextromethorphan|dextromethorphan|mesh-list
111163221|NCT01462318|Caffeine|caffeine|mesh-list
111163222|NCT01462318|Omeprazole|omeprazole|mesh-list
111163223|NCT01462318|Warfarin|warfarin|mesh-list
111163224|NCT01462318|Daclizumab|daclizumab|mesh-list
111163225|NCT01462318|Vitamins|vitamins|mesh-ancestor
111163226|NCT01462318|Micronutrients|micronutrients|mesh-ancestor
111163227|NCT01462318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111163228|NCT01462318|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111163229|NCT01462318|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111163230|NCT01462318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111163231|NCT01462318|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111163232|NCT01462318|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111163233|NCT01462318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111163234|NCT01462318|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111163235|NCT01462318|Anesthetics, General|anesthetics, general|mesh-ancestor
111163236|NCT01462318|Anesthetics|anesthetics|mesh-ancestor
111163237|NCT01462318|GABA Modulators|gaba modulators|mesh-ancestor
111163238|NCT01462318|GABA Agents|gaba agents|mesh-ancestor
111163239|NCT01462318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111163240|NCT01462318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111163241|NCT01462318|Anticoagulants|anticoagulants|mesh-ancestor
111163242|NCT01462318|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111163243|NCT01462318|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110486042|NCT00738829|Antimetabolites|antimetabolites|mesh-ancestor
111163244|NCT01462318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111163245|NCT01462318|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
111163246|NCT01462318|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111163247|NCT01462318|Purinergic Agents|purinergic agents|mesh-ancestor
111163248|NCT01462318|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111163249|NCT01462318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111163250|NCT01462318|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111163251|NCT01462318|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111163252|NCT01462318|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111163253|NCT01462318|Hemostatics|hemostatics|mesh-ancestor
111163254|NCT01462318|Coagulants|coagulants|mesh-ancestor
111163255|NCT01462318|Antitussive Agents|antitussive agents|mesh-ancestor
111163256|NCT01462318|Respiratory System Agents|respiratory system agents|mesh-ancestor
111163257|NCT01462318|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111163258|NCT01462318|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111163259|NCT01462318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111163260|NCT01462318|Immunologic Factors|immunologic factors|mesh-ancestor
111163261|NCT01485094|Pregabalin|pregabalin|mesh-list
111163262|NCT01485094|Analgesics|analgesics|mesh-ancestor
111163263|NCT01485094|Sensory System Agents|sensory system agents|mesh-ancestor
111163264|NCT01485094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111163265|NCT01485094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111163266|NCT01485094|Anticonvulsants|anticonvulsants|mesh-ancestor
111163267|NCT01485094|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111163268|NCT01485094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111163269|NCT01485094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111163270|NCT01485094|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111163271|NCT01485094|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111163272|NCT01485094|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111163273|NCT01485094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111163274|NCT01485094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111163275|NCT04079686|Cefazolin|cefazolin|mesh-list
111163276|NCT04079686|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111163277|NCT04079686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111163278|NCT01502410|Sorafenib|sorafenib|mesh-list
111163279|NCT01502410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111163280|NCT01502410|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111163281|NCT01502410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111163282|NCT01502410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111163284|NCT04757636|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111163285|NCT04757636|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111163286|NCT04757636|Growth Substances|growth substances|mesh-ancestor
111163287|NCT04757636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111163288|NCT04757636|Growth Inhibitors|growth inhibitors|mesh-ancestor
111163289|NCT04757636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111163290|NCT02132312|Phenylephrine|phenylephrine|mesh-list
111163291|NCT02132312|Oxymetazoline|oxymetazoline|mesh-list
111163292|NCT02132312|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111163293|NCT02132312|Mydriatics|mydriatics|mesh-ancestor
111163294|NCT02132312|Autonomic Agents|autonomic agents|mesh-ancestor
111163295|NCT02132312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111163296|NCT02132312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111163297|NCT02132312|Sympathomimetics|sympathomimetics|mesh-ancestor
110486064|NCT00738985|Simvastatin|simvastatin|mesh-list
111163298|NCT02132312|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111163299|NCT02132312|Nasal Decongestants|nasal decongestants|mesh-ancestor
111163300|NCT02132312|Respiratory System Agents|respiratory system agents|mesh-ancestor
111163301|NCT02132312|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111163302|NCT02132312|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111163303|NCT02132312|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111163304|NCT02132312|Adrenergic Agents|adrenergic agents|mesh-ancestor
111163305|NCT02132312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111163306|NCT02132312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111163307|NCT02132312|Protective Agents|protective agents|mesh-ancestor
111163308|NCT02150954|Oxytocin|oxytocin|mesh-list
111163309|NCT02150954|Oxytocics|oxytocics|mesh-ancestor
111163310|NCT02150954|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111163311|NCT02150954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111163312|NCT04188392|Pimavanserin|pimavanserin|mesh-list
111163313|NCT04188392|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111163314|NCT04188392|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111163315|NCT04188392|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111163316|NCT04188392|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111163317|NCT04188392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111163318|NCT04188392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111163319|NCT04188392|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111163320|NCT04188392|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111163321|NCT04188392|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111163322|NCT04188392|Serotonin Agents|serotonin agents|mesh-ancestor
111163323|NCT04188392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111163324|NCT04188392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111163325|NCT02170298|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
111163326|NCT02170298|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111163327|NCT02170298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111163328|NCT02170298|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111163329|NCT02170298|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111163330|NCT02170298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111163331|NCT02170298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111163332|NCT02170298|Dopamine Agents|dopamine agents|mesh-ancestor
111163333|NCT02170298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111163334|NCT02131064|Carboplatin|carboplatin|mesh-list
111163335|NCT02131064|Docetaxel|docetaxel|mesh-list
111163336|NCT02131064|Trastuzumab|trastuzumab|mesh-list
111163337|NCT02131064|Pertuzumab|pertuzumab|mesh-list
111163338|NCT02131064|Maytansine|maytansine|mesh-list
111163339|NCT02131064|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
111163340|NCT02131064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111163341|NCT02131064|Tubulin Modulators|tubulin modulators|mesh-ancestor
111163342|NCT02131064|Antimitotic Agents|antimitotic agents|mesh-ancestor
111163343|NCT02131064|Mitosis Modulators|mitosis modulators|mesh-ancestor
111163344|NCT02131064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111163345|NCT02131064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111163346|NCT02131064|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111163347|NCT02131064|Immunotoxins|immunotoxins|mesh-ancestor
111163348|NCT02131064|Immunoconjugates|immunoconjugates|mesh-ancestor
111163349|NCT02131064|Immunologic Factors|immunologic factors|mesh-ancestor
111163350|NCT02131064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111163351|NCT02130284|Insulin|insulin|mesh-list
111163352|NCT02130284|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111163353|NCT02130284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110880438|NCT05176925|Tislelizumab|tislelizumab|mesh-list
111163354|NCT02130284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111163355|NCT04749212|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
111163356|NCT04749212|Natriuretic Agents|natriuretic agents|mesh-ancestor
111163357|NCT04749212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111163358|NCT04748822|Ethanol|ethanol|mesh-list
111163359|NCT04748822|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111163360|NCT04748822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111163361|NCT04748822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111163362|NCT04748822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111163363|NCT04739150|Nintedanib|nintedanib|mesh-list
111163364|NCT04739150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111163365|NCT04739150|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111163366|NCT04739150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111163367|NCT04739150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111163368|NCT02147132|Nicotine|nicotine|mesh-list
111163369|NCT02147132|Varenicline|varenicline|mesh-list
111163370|NCT02147132|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111163371|NCT02147132|Autonomic Agents|autonomic agents|mesh-ancestor
111163372|NCT02147132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111163373|NCT02147132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111163374|NCT02147132|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111163375|NCT02147132|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111163376|NCT02147132|Cholinergic Agents|cholinergic agents|mesh-ancestor
111163377|NCT02147132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111163378|NCT02147132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111163379|NCT02146430|Pregabalin|pregabalin|mesh-list
111163380|NCT02146430|Analgesics|analgesics|mesh-ancestor
111163381|NCT02146430|Sensory System Agents|sensory system agents|mesh-ancestor
111163382|NCT02146430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111163383|NCT02146430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111163384|NCT02146430|Anticonvulsants|anticonvulsants|mesh-ancestor
111163385|NCT02146430|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111163386|NCT02146430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111163387|NCT02146430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111163388|NCT02146430|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111163389|NCT02146430|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111163390|NCT02146430|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111163391|NCT02146430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111163392|NCT02146430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111163393|NCT02129192|Amlodipine|amlodipine|mesh-list
111163394|NCT02129192|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111163395|NCT02129192|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111163396|NCT02129192|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111163397|NCT02129192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111163398|NCT02129192|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111163399|NCT02129192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111163400|NCT02129192|Vasodilator Agents|vasodilator agents|mesh-ancestor
111163401|NCT02128490|Naproxen|naproxen|mesh-list
111163402|NCT02128490|Colchicine|colchicine|mesh-list
111163403|NCT02128490|Febuxostat|febuxostat|mesh-list
111163404|NCT02128490|Lansoprazole|lansoprazole|mesh-list
111163405|NCT02128490|Dexlansoprazole|dexlansoprazole|mesh-list
111163406|NCT02128490|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111163407|NCT02128490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111163408|NCT02128490|Analgesics|analgesics|mesh-ancestor
111163409|NCT02128490|Sensory System Agents|sensory system agents|mesh-ancestor
111163410|NCT02128490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111163411|NCT02128490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111163412|NCT02128490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111163413|NCT02128490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111163414|NCT02128490|Gout Suppressants|gout suppressants|mesh-ancestor
111163415|NCT02128490|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111163416|NCT02128490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111163417|NCT02128490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111163418|NCT02128490|Tubulin Modulators|tubulin modulators|mesh-ancestor
111163419|NCT02128490|Antimitotic Agents|antimitotic agents|mesh-ancestor
111163420|NCT02128490|Mitosis Modulators|mitosis modulators|mesh-ancestor
111163421|NCT02128490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111163422|NCT02128490|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111163423|NCT02128490|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111163424|NCT02128490|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111163425|NCT02105636|Docetaxel|docetaxel|mesh-list
111163426|NCT02105636|Nivolumab|nivolumab|mesh-list
111163427|NCT02105636|Methotrexate|methotrexate|mesh-list
111163428|NCT02105636|Cetuximab|cetuximab|mesh-list
111163429|NCT02105636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111163430|NCT02105636|Tubulin Modulators|tubulin modulators|mesh-ancestor
111163431|NCT02105636|Antimitotic Agents|antimitotic agents|mesh-ancestor
111163432|NCT02105636|Mitosis Modulators|mitosis modulators|mesh-ancestor
111163433|NCT02105636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110593510|NCT00785421|Vitamins|vitamins|mesh-ancestor
111163434|NCT02105636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111163435|NCT02105636|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111163436|NCT02105636|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111163437|NCT02105636|Abortifacient Agents|abortifacient agents|mesh-ancestor
111163438|NCT02105636|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111163439|NCT02105636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111163440|NCT02105636|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111163441|NCT02105636|Antimetabolites|antimetabolites|mesh-ancestor
111163442|NCT02105636|Dermatologic Agents|dermatologic agents|mesh-ancestor
111163443|NCT02105636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111163444|NCT02105636|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111163445|NCT02105636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111163446|NCT02105636|Immunologic Factors|immunologic factors|mesh-ancestor
111163447|NCT02105636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111163448|NCT02105636|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111163449|NCT01626872|Risperidone|risperidone|mesh-list
111163450|NCT01626872|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111163451|NCT01626872|Serotonin Agents|serotonin agents|mesh-ancestor
111163452|NCT01626872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111163453|NCT01626872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111163454|NCT01626872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111163455|NCT01626872|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111163456|NCT01626872|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111163457|NCT01626872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111163458|NCT01626872|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111163459|NCT01626872|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111163460|NCT01626872|Dopamine Agents|dopamine agents|mesh-ancestor
111163461|NCT01598090|Ribavirin|ribavirin|mesh-list
111163462|NCT01598090|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
111163463|NCT01598090|Antimetabolites|antimetabolites|mesh-ancestor
111163464|NCT01598090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111163465|NCT01598090|Antiviral Agents|antiviral agents|mesh-ancestor
111163466|NCT01598090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111163467|NCT02145182|Eculizumab|eculizumab|mesh-list
111163468|NCT02145182|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
111163469|NCT02145182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111163470|NCT02145182|Immunologic Factors|immunologic factors|mesh-ancestor
111163471|NCT02145182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111163472|NCT02145026|Epoetin Alfa|epoetin alfa|mesh-list
111163473|NCT02145026|Hematinics|hematinics|mesh-ancestor
111163474|NCT02144012|Docetaxel|docetaxel|mesh-list
111163475|NCT02144012|Trastuzumab|trastuzumab|mesh-list
111163476|NCT02144012|Maytansine|maytansine|mesh-list
111163477|NCT02144012|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
111163478|NCT02144012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111163479|NCT02144012|Tubulin Modulators|tubulin modulators|mesh-ancestor
111163480|NCT02144012|Antimitotic Agents|antimitotic agents|mesh-ancestor
111163481|NCT02144012|Mitosis Modulators|mitosis modulators|mesh-ancestor
111163482|NCT02144012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111163483|NCT02144012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111163484|NCT02144012|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111163485|NCT02144012|Immunotoxins|immunotoxins|mesh-ancestor
111163486|NCT02144012|Immunoconjugates|immunoconjugates|mesh-ancestor
111163487|NCT02144012|Immunologic Factors|immunologic factors|mesh-ancestor
111163488|NCT02144012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111163489|NCT02103062|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111163490|NCT02103062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111163491|NCT02141672|Cyclosporine|cyclosporine|mesh-list
111163492|NCT02141672|Antifungal Agents|antifungal agents|mesh-ancestor
111163493|NCT02141672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111163494|NCT02141672|Dermatologic Agents|dermatologic agents|mesh-ancestor
111163495|NCT02141672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111163496|NCT02141672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111163497|NCT02141672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111163498|NCT02141672|Immunologic Factors|immunologic factors|mesh-ancestor
111163499|NCT02141672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111163500|NCT02141672|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111163501|NCT02141672|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111163502|NCT01628120|Epoetin Alfa|epoetin alfa|mesh-list
111163503|NCT01628120|Hematinics|hematinics|mesh-ancestor
111163504|NCT02125604|Dimethyl Fumarate|dimethyl fumarate|mesh-list
111163505|NCT02125604|Dermatologic Agents|dermatologic agents|mesh-ancestor
111163506|NCT02125604|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111163507|NCT02125604|Immunologic Factors|immunologic factors|mesh-ancestor
111163508|NCT02125604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111163509|NCT02124746|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
111163510|NCT02124746|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111163511|NCT02124746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111163512|NCT02124746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111163513|NCT02123966|Sirolimus|sirolimus|mesh-list
111163514|NCT02123966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111163515|NCT02123966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111163516|NCT02123966|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111163517|NCT02123966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111163518|NCT02123966|Antifungal Agents|antifungal agents|mesh-ancestor
111163519|NCT02123966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111163520|NCT02123966|Immunologic Factors|immunologic factors|mesh-ancestor
111163521|NCT02123966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111163522|NCT02123576|Pentoxifylline|pentoxifylline|mesh-list
111163523|NCT02123576|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111163524|NCT02123576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111163525|NCT02123576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111163526|NCT02123576|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111163527|NCT02123576|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111163528|NCT02123576|Protective Agents|protective agents|mesh-ancestor
111163529|NCT02123576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111163530|NCT02123576|Vasodilator Agents|vasodilator agents|mesh-ancestor
111163531|NCT02123576|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111163532|NCT02123576|Antioxidants|antioxidants|mesh-ancestor
111163533|NCT05235347|Sotrovimab|sotrovimab|mesh-list
111163534|NCT05235347|Antiviral Agents|antiviral agents|mesh-ancestor
111163535|NCT05235347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111163536|NCT03368729|Trastuzumab|trastuzumab|mesh-list
111163537|NCT03368729|Niraparib|niraparib|mesh-list
111163538|NCT03368729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111163539|NCT03368729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111163540|NCT03368729|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111163541|NCT03368729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111163542|NCT03368729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111163543|NCT02140970|Ibuprofen|ibuprofen|mesh-list
111163544|NCT02140970|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111163545|NCT02140970|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111163546|NCT02140970|Analgesics|analgesics|mesh-ancestor
111163547|NCT02140970|Sensory System Agents|sensory system agents|mesh-ancestor
111163548|NCT02140970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111163549|NCT02140970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111163550|NCT02140970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111163551|NCT02140970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111163552|NCT02140970|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111163553|NCT02140970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111163554|NCT02140970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111163555|NCT02101112|Apixaban|apixaban|mesh-list
111163556|NCT02101112|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111163557|NCT02101112|Antithrombins|antithrombins|mesh-ancestor
111163558|NCT02101112|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111163559|NCT02101112|Protease Inhibitors|protease inhibitors|mesh-ancestor
111163560|NCT02101112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111163561|NCT02101112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111163562|NCT02101112|Anticoagulants|anticoagulants|mesh-ancestor
111163563|NCT02139644|Fluticasone|fluticasone|mesh-list
111163564|NCT02139644|Xhance|xhance|mesh-list
111163565|NCT02139644|Beclomethasone|beclomethasone|mesh-list
111163566|NCT02139644|Albuterol|albuterol|mesh-list
111163567|NCT02139644|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
111163568|NCT02139644|Adrenergic Agonists|adrenergic agonists|mesh-list
111163569|NCT02139644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111163570|NCT02139644|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111163571|NCT02139644|Autonomic Agents|autonomic agents|mesh-ancestor
111163572|NCT02139644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111163573|NCT02139644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111163574|NCT02139644|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111163575|NCT02139644|Respiratory System Agents|respiratory system agents|mesh-ancestor
111163576|NCT02139644|Dermatologic Agents|dermatologic agents|mesh-ancestor
111163577|NCT02139644|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111163578|NCT02139644|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111163579|NCT02139644|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111163580|NCT02139644|Adrenergic Agents|adrenergic agents|mesh-ancestor
111163581|NCT02139644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111163582|NCT02139644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111163583|NCT02139644|Tocolytic Agents|tocolytic agents|mesh-ancestor
111163584|NCT02139644|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111163585|NCT02139644|Glucocorticoids|glucocorticoids|mesh-ancestor
111163586|NCT02139644|Hormones|hormones|mesh-ancestor
110486120|NCT00737113|Hormones|hormones|mesh-list
111163587|NCT02139644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111163588|NCT02100644|Lamotrigine|lamotrigine|mesh-list
111163589|NCT02100644|Anticonvulsants|anticonvulsants|mesh-ancestor
111163590|NCT02100644|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111163591|NCT02100644|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111163592|NCT02100644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111163593|NCT02100644|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111163594|NCT02100644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111163595|NCT02100644|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111163596|NCT02100644|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111163597|NCT02100644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111163598|NCT02100644|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111163599|NCT02100644|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111163600|NCT02074982|Ustekinumab|ustekinumab|mesh-list
111163601|NCT02074982|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111163602|NCT02074982|Immunologic Factors|immunologic factors|mesh-ancestor
111163603|NCT02074982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111163604|NCT02074982|Dermatologic Agents|dermatologic agents|mesh-ancestor
111163605|NCT04150913|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
111163606|NCT04150913|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
111163607|NCT04150913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111163608|NCT04150913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111163609|NCT04150913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111163610|NCT04798001|Vaccines|vaccines|mesh-list
111163611|NCT04798001|Immunologic Factors|immunologic factors|mesh-ancestor
111163612|NCT04798001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111163613|NCT02074514|Sofosbuvir|sofosbuvir|mesh-list
111163614|NCT02074514|Antiviral Agents|antiviral agents|mesh-ancestor
111163615|NCT02074514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111163616|NCT04073303|Botulinum Toxins|botulinum toxins|mesh-list
111163617|NCT04073303|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111163618|NCT04073303|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111163619|NCT04073303|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111163620|NCT04073303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111163621|NCT04073303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111163622|NCT04073303|Cholinergic Agents|cholinergic agents|mesh-ancestor
111163623|NCT04073303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111163624|NCT04073303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111163625|NCT04073303|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111163626|NCT04073303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111163627|NCT04070573|Aspirin|aspirin|mesh-list
111163628|NCT04070573|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111163629|NCT04070573|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111163630|NCT04070573|Analgesics|analgesics|mesh-ancestor
111163631|NCT04070573|Sensory System Agents|sensory system agents|mesh-ancestor
111163632|NCT04070573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111163633|NCT04070573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111163634|NCT04070573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111163635|NCT04070573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111163636|NCT04070573|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111163637|NCT04070573|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111163638|NCT04070573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111163639|NCT04070573|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111163640|NCT04070573|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111163641|NCT04070573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111163642|NCT04070573|Antipyretics|antipyretics|mesh-ancestor
111163643|NCT02099708|Lansoprazole|lansoprazole|mesh-list
111163644|NCT02099708|Dexlansoprazole|dexlansoprazole|mesh-list
111163645|NCT02099708|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111163646|NCT02099708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110593743|NCT02400242|Hormones|hormones|mesh-ancestor
111163647|NCT02099708|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111163648|NCT02099708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111163649|NCT02099708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111163651|NCT02073656|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
111163652|NCT02073656|Ledipasvir|ledipasvir|mesh-list
111163653|NCT02073656|Antiviral Agents|antiviral agents|mesh-ancestor
111163654|NCT02073656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110799555|NCT03752931|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
111163655|NCT04061213|Technetium Tc 99m 1,1-diphosphonopropane-2,3-dicarboxylic acid|technetium tc 99m 1,1-diphosphonopropane-2,3-dicarboxylic acid|mesh-list
111163656|NCT04061213|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111163657|NCT04061213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111163659|NCT02209181|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111163660|NCT02209181|Analgesics|analgesics|mesh-ancestor
111163661|NCT02209181|Sensory System Agents|sensory system agents|mesh-ancestor
111163662|NCT02209181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111163663|NCT02209181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111163664|NCT02209181|Antipyretics|antipyretics|mesh-ancestor
111163665|NCT02242487|Levodopa|levodopa|mesh-list
111163666|NCT02242487|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111163667|NCT02242487|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111163668|NCT02242487|Dopamine Agents|dopamine agents|mesh-ancestor
111163669|NCT02242487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111163670|NCT02242487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111163671|NCT02242487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111163672|NCT02241785|Natalizumab|natalizumab|mesh-list
111163673|NCT02241785|Immunologic Factors|immunologic factors|mesh-ancestor
111163674|NCT02241785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111163675|NCT02241551|Paclitaxel|paclitaxel|mesh-list
111163676|NCT02241551|Gemcitabine|gemcitabine|mesh-list
111163677|NCT02241551|Fluorouracil|fluorouracil|mesh-list
111163678|NCT02241551|Oxaliplatin|oxaliplatin|mesh-list
111163679|NCT02241551|Irinotecan|irinotecan|mesh-list
111163680|NCT02241551|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111163681|NCT02241551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111163682|NCT02241551|Tubulin Modulators|tubulin modulators|mesh-ancestor
111163683|NCT02241551|Antimitotic Agents|antimitotic agents|mesh-ancestor
111163684|NCT02241551|Mitosis Modulators|mitosis modulators|mesh-ancestor
111163685|NCT02241551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111163686|NCT02241551|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111163687|NCT02241551|Antimetabolites|antimetabolites|mesh-ancestor
111163688|NCT02241551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111163689|NCT02241551|Immunologic Factors|immunologic factors|mesh-ancestor
111163690|NCT02241551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111163691|NCT02241551|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111163692|NCT02241551|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111163693|NCT02241551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111163694|NCT02207621|Timolol|timolol|mesh-list
111163695|NCT02207621|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111163696|NCT02207621|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111163697|NCT02207621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111163698|NCT02207621|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111163699|NCT02207621|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111163700|NCT02207621|Adrenergic Agents|adrenergic agents|mesh-ancestor
111163701|NCT02207621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111163702|NCT02207621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111163703|NCT02207621|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111163704|NCT02207621|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111163705|NCT02240693|BI 409306|bi 409306|mesh-list
111163706|NCT02240693|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110841936|NCT01147523|Diuretics|diuretics|mesh-ancestor
111163707|NCT02240693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111163708|NCT02240693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111163709|NCT02239679|Aminolevulinic Acid|aminolevulinic acid|mesh-list
111163710|NCT02239679|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111163711|NCT02239679|Dermatologic Agents|dermatologic agents|mesh-ancestor
111163712|NCT02072096|Metformin|metformin|mesh-list
111163713|NCT02072096|Insulin Glargine|insulin glargine|mesh-list
111163714|NCT02072096|Pioglitazone|pioglitazone|mesh-list
111163715|NCT02072096|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111163716|NCT02072096|Liraglutide|liraglutide|mesh-list
111163717|NCT02072096|Exenatide|exenatide|mesh-list
111163718|NCT02072096|Glimepiride|glimepiride|mesh-list
111163719|NCT02072096|Linagliptin|linagliptin|mesh-list
111163720|NCT02072096|Acarbose|acarbose|mesh-list
111163721|NCT02072096|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111163722|NCT02072096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111163723|NCT02072096|Incretins|incretins|mesh-ancestor
111163724|NCT02072096|Hormones|hormones|mesh-ancestor
111163725|NCT02072096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111163726|NCT02072096|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111163727|NCT02072096|Protease Inhibitors|protease inhibitors|mesh-ancestor
111163728|NCT02072096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111163729|NCT02072096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111163730|NCT02072096|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111163731|NCT02072096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111163732|NCT02072096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111163733|NCT02072096|Immunologic Factors|immunologic factors|mesh-ancestor
111163734|NCT02072096|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
111163735|NCT01631825|Rotigotine|rotigotine|mesh-list
111163736|NCT01631825|Dopamine Agonists|dopamine agonists|mesh-ancestor
111163737|NCT01631825|Dopamine Agents|dopamine agents|mesh-ancestor
111163738|NCT01631825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111163739|NCT01631825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111163740|NCT01631825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111163741|NCT02071082|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
111163742|NCT02071082|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111163743|NCT02071082|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111163744|NCT02071082|Antiviral Agents|antiviral agents|mesh-ancestor
111163745|NCT02071082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111163746|NCT03836105|Cemiplimab|cemiplimab|mesh-list
111163747|NCT03836105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111163748|NCT03836105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111163749|NCT02123108|Mycophenolic Acid|mycophenolic acid|mesh-list
111163750|NCT02123108|Tacrolimus|tacrolimus|mesh-list
111163751|NCT02123108|Basiliximab|basiliximab|mesh-list
111163752|NCT02123108|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111163753|NCT02123108|Immunologic Factors|immunologic factors|mesh-ancestor
111163754|NCT02123108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111163755|NCT02123108|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111163756|NCT02123108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111163757|NCT02123108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111163758|NCT02123108|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111163759|NCT02123108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111163760|NCT02123108|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111163761|NCT02123108|Antitubercular Agents|antitubercular agents|mesh-ancestor
111163762|NCT02123108|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111163763|NCT02123108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111163764|NCT02121392|Bupivacaine|bupivacaine|mesh-list
111163765|NCT02121392|Anesthetics, Local|anesthetics, local|mesh-ancestor
111163766|NCT02121392|Anesthetics|anesthetics|mesh-ancestor
111163767|NCT02121392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111163768|NCT02121392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111163769|NCT02121392|Sensory System Agents|sensory system agents|mesh-ancestor
111163770|NCT02121392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111163771|NCT02097056|Donepezil|donepezil|mesh-list
111163772|NCT02097056|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111163773|NCT02097056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111163774|NCT02097056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111163775|NCT02097056|Cholinergic Agents|cholinergic agents|mesh-ancestor
111163776|NCT02097056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111163777|NCT02097056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111163778|NCT02097056|Nootropic Agents|nootropic agents|mesh-ancestor
111163779|NCT02121002|Diclofenac|diclofenac|mesh-list
110841950|NCT01251107|Prednisone|prednisone|mesh-list
111163780|NCT02121002|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111163781|NCT02121002|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111163782|NCT02121002|Analgesics|analgesics|mesh-ancestor
111163783|NCT02121002|Sensory System Agents|sensory system agents|mesh-ancestor
111163784|NCT02121002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111163785|NCT02121002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111163786|NCT02121002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111163787|NCT02121002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111163788|NCT02121002|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111163789|NCT02121002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111163790|NCT02121002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111163791|NCT02096900|Midazolam|midazolam|mesh-list
111163792|NCT02096900|Zolpidem|zolpidem|mesh-list
111163793|NCT02096900|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111163794|NCT02096900|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111163795|NCT02096900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111163796|NCT02096900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111163797|NCT02096900|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111163798|NCT02096900|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111163799|NCT02096900|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111163800|NCT02096900|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111163801|NCT02096900|Anesthetics, General|anesthetics, general|mesh-ancestor
111163802|NCT02096900|Anesthetics|anesthetics|mesh-ancestor
111163803|NCT02096900|GABA Modulators|gaba modulators|mesh-ancestor
111163804|NCT02096900|GABA Agents|gaba agents|mesh-ancestor
111163805|NCT02096900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111163806|NCT02096900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111163807|NCT02096900|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111163808|NCT02096900|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
111163809|NCT02096900|GABA Agonists|gaba agonists|mesh-ancestor
111163810|NCT02120924|Azelaic acid|azelaic acid|mesh-list
111163811|NCT02120924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111163812|NCT02120924|Dermatologic Agents|dermatologic agents|mesh-ancestor
111163813|NCT02096744|Clonidine|clonidine|mesh-list
111163814|NCT02096744|Analgesics|analgesics|mesh-ancestor
111163815|NCT02096744|Sensory System Agents|sensory system agents|mesh-ancestor
111163816|NCT02096744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111163817|NCT02096744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111163818|NCT02096744|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111163819|NCT02096744|Sympatholytics|sympatholytics|mesh-ancestor
111163820|NCT02096744|Autonomic Agents|autonomic agents|mesh-ancestor
111163821|NCT02096744|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111163822|NCT02096744|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111163823|NCT02096744|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111163824|NCT02096744|Adrenergic Agents|adrenergic agents|mesh-ancestor
111163825|NCT02096744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111163826|NCT02096744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111163827|NCT02096042|Azacitidine|azacitidine|mesh-list
111163828|NCT02096042|Brentuximab Vedotin|brentuximab vedotin|mesh-list
111163829|NCT02096042|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111163830|NCT02096042|Antimetabolites|antimetabolites|mesh-ancestor
110486191|NCT00739531|Nitric Oxide|nitric oxide|mesh-list
111163831|NCT02096042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111163832|NCT02096042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111163833|NCT02096042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111163834|NCT02096042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111163835|NCT02096042|Immunotoxins|immunotoxins|mesh-ancestor
111163836|NCT02096042|Immunoconjugates|immunoconjugates|mesh-ancestor
111163837|NCT02096042|Immunologic Factors|immunologic factors|mesh-ancestor
111163838|NCT02096042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111163839|NCT02120300|Sofosbuvir|sofosbuvir|mesh-list
111163840|NCT02120300|Antiviral Agents|antiviral agents|mesh-ancestor
111163841|NCT02120300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111163842|NCT02069366|Dronabinol|dronabinol|mesh-list
111163843|NCT02069366|Hallucinogens|hallucinogens|mesh-ancestor
111163844|NCT02069366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111163845|NCT02069366|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111163846|NCT02069366|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111163847|NCT02069366|Analgesics|analgesics|mesh-ancestor
111163848|NCT02069366|Sensory System Agents|sensory system agents|mesh-ancestor
111163849|NCT02069366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111163850|NCT02069366|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
111163851|NCT02069366|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
111163852|NCT02069366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111163853|NCT02069366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111163855|NCT02069366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111163856|NCT04732208|Mydriatics|mydriatics|mesh-list
111163857|NCT04732208|Autonomic Agents|autonomic agents|mesh-ancestor
111163858|NCT04732208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111163859|NCT04732208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111163860|NCT02068508|Pioglitazone|pioglitazone|mesh-list
111163861|NCT02068508|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111163862|NCT02068508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111163863|NCT02207231|Adalimumab|adalimumab|mesh-list
111163864|NCT02207231|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111163865|NCT02207231|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111163866|NCT02207231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111163867|NCT02207231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111163868|NCT02207231|Immunologic Factors|immunologic factors|mesh-ancestor
111163869|NCT02207231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111163870|NCT02206685|Methadone|methadone|mesh-list
111163871|NCT02206685|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111163872|NCT02206685|Narcotics|narcotics|mesh-ancestor
111163873|NCT02206685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111163874|NCT02206685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111163875|NCT02206685|Analgesics|analgesics|mesh-ancestor
111163876|NCT02206685|Sensory System Agents|sensory system agents|mesh-ancestor
111163877|NCT02206685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111163878|NCT02206685|Antitussive Agents|antitussive agents|mesh-ancestor
110880947|NCT01268579|Antiviral Agents|antiviral agents|mesh-ancestor
111163879|NCT02206685|Respiratory System Agents|respiratory system agents|mesh-ancestor
111163880|NCT02095106|Calpastatin|calpastatin|mesh-list
111163881|NCT02095106|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
111163882|NCT02095106|Protease Inhibitors|protease inhibitors|mesh-ancestor
111163883|NCT02095106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111163884|NCT02095106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111163885|NCT01634165|Insulin Glargine|insulin glargine|mesh-list
111163886|NCT01634165|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111163887|NCT01634165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111163888|NCT02235311|Pantoprazole|pantoprazole|mesh-list
111163889|NCT02235311|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111163890|NCT02235311|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111163891|NCT02235311|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111163892|NCT02235311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111163893|NCT02235311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111163894|NCT02235077|Spironolactone|spironolactone|mesh-list
111163895|NCT02235077|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
111163896|NCT02235077|Hormone Antagonists|hormone antagonists|mesh-ancestor
111163897|NCT02235077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111163898|NCT02235077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111163899|NCT02235077|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
111163900|NCT02235077|Diuretics|diuretics|mesh-ancestor
111163901|NCT02235077|Natriuretic Agents|natriuretic agents|mesh-ancestor
111163902|NCT02234141|Selonsertib|selonsertib|mesh-list
111163903|NCT02234141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111163904|NCT02234141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111163905|NCT02234141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111163907|NCT01896531|Fluorouracil|fluorouracil|mesh-list
111163908|NCT01896531|Oxaliplatin|oxaliplatin|mesh-list
111163909|NCT01896531|Ipatasertib|ipatasertib|mesh-list
111163910|NCT01896531|Antimetabolites|antimetabolites|mesh-ancestor
111163911|NCT01896531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111163912|NCT01896531|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111163913|NCT01896531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111163914|NCT01896531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111163915|NCT01896531|Immunologic Factors|immunologic factors|mesh-ancestor
111163916|NCT01896531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111163918|NCT01896531|Protective Agents|protective agents|mesh-ancestor
111163919|NCT01896531|Vitamin B Complex|vitamin b complex|mesh-ancestor
111163920|NCT01896531|Vitamins|vitamins|mesh-ancestor
111163921|NCT01896531|Micronutrients|micronutrients|mesh-ancestor
111163922|NCT01896531|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111163923|NCT01896531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111163924|NCT01618305|Lamivudine|lamivudine|mesh-list
111163925|NCT01618305|Zidovudine|zidovudine|mesh-list
111163926|NCT01618305|Efavirenz|efavirenz|mesh-list
111163927|NCT01618305|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
111163928|NCT01618305|Raltegravir Potassium|raltegravir potassium|mesh-list
111163929|NCT01618305|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111163930|NCT01618305|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111163931|NCT01618305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111163932|NCT01618305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111163933|NCT01618305|Antiviral Agents|antiviral agents|mesh-ancestor
111163934|NCT01618305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111163935|NCT01618305|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111163936|NCT01618305|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111163937|NCT01618305|Antimetabolites|antimetabolites|mesh-ancestor
111163938|NCT01618305|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111163939|NCT01618305|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111163940|NCT01618305|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111163941|NCT01618305|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111163942|NCT01618305|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111163943|NCT01618305|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111163944|NCT01618305|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111163945|NCT01618305|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111163946|NCT01896297|Dabigatran|dabigatran|mesh-list
111163947|NCT01896297|Antithrombins|antithrombins|mesh-ancestor
111163948|NCT01896297|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111163949|NCT01896297|Protease Inhibitors|protease inhibitors|mesh-ancestor
111163950|NCT01896297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111163951|NCT01896297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111163952|NCT01896297|Anticoagulants|anticoagulants|mesh-ancestor
111163953|NCT01884675|Ambrisentan|ambrisentan|mesh-list
111163954|NCT01884675|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111163956|NCT01884597|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111163957|NCT01884597|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111163958|NCT01884597|Growth Substances|growth substances|mesh-ancestor
111163959|NCT01884597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111163960|NCT01884597|Growth Inhibitors|growth inhibitors|mesh-ancestor
111163961|NCT01884597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111163962|NCT01864005|Clopidogrel|clopidogrel|mesh-list
111163963|NCT01864005|Ticagrelor|ticagrelor|mesh-list
111163964|NCT01864005|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111163965|NCT01864005|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111163966|NCT01864005|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111163967|NCT01864005|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111163968|NCT01864005|Purinergic Agents|purinergic agents|mesh-ancestor
111163969|NCT01864005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111163970|NCT01864005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111163971|NCT01864005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111163972|NCT01863771|Golimumab|golimumab|mesh-list
111163973|NCT01863771|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111163974|NCT01863771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111163975|NCT01863771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111163976|NCT01863771|Immunologic Factors|immunologic factors|mesh-ancestor
111163977|NCT01863771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111163978|NCT01894581|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
111163979|NCT01894581|Hormones|hormones|mesh-ancestor
110841976|NCT01251107|Hormones|hormones|mesh-ancestor
111163980|NCT01894581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111163981|NCT01894581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111163983|NCT02203331|Leuprolide|leuprolide|mesh-list
111163984|NCT02203331|Levonorgestrel|levonorgestrel|mesh-list
111163985|NCT02203331|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111163986|NCT02203331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111163987|NCT02203331|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111163988|NCT02203331|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111163989|NCT02203331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111163990|NCT02203331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111163991|NCT02203331|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111163992|NCT02203331|Hormone Antagonists|hormone antagonists|mesh-ancestor
111163993|NCT02203331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111163994|NCT02203331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111163995|NCT02203331|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111163996|NCT02203331|Fertility Agents|fertility agents|mesh-ancestor
111163997|NCT02203331|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111163998|NCT02203331|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111163999|NCT02203331|Contraceptive Agents|contraceptive agents|mesh-ancestor
111164000|NCT02203331|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111164001|NCT02203331|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111164002|NCT02203331|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111164003|NCT01893411|Botulinum Toxins|botulinum toxins|mesh-list
111164004|NCT01893411|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111164005|NCT01893411|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111164006|NCT01893411|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
111164007|NCT01893411|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111164008|NCT01893411|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111164009|NCT01893411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111164010|NCT01893411|Cholinergic Agents|cholinergic agents|mesh-ancestor
111164011|NCT01893411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111164012|NCT01893411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111164013|NCT01893411|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111164014|NCT01893411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111164015|NCT01862991|Digoxin|digoxin|mesh-list
111164016|NCT01862991|Misoprostol|misoprostol|mesh-list
111164017|NCT01862991|Mifepristone|mifepristone|mesh-list
111164018|NCT01862991|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111164019|NCT01862991|Abortifacient Agents|abortifacient agents|mesh-ancestor
111164020|NCT01862991|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111164021|NCT01862991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111164022|NCT01862991|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111164023|NCT01862991|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111164024|NCT01862991|Oxytocics|oxytocics|mesh-ancestor
111164025|NCT01862991|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111164026|NCT01862991|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111164027|NCT01862991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111164028|NCT01862991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111164029|NCT01862991|Protective Agents|protective agents|mesh-ancestor
111164030|NCT01862991|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
111164031|NCT01862991|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111164032|NCT01862991|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111164033|NCT01862991|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111164034|NCT01862991|Contraceptive Agents|contraceptive agents|mesh-ancestor
111164035|NCT01862991|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
111164036|NCT01862991|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
111164037|NCT01862991|Hormone Antagonists|hormone antagonists|mesh-ancestor
111164038|NCT01862991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111164039|NCT01862991|Luteolytic Agents|luteolytic agents|mesh-ancestor
111164040|NCT01862991|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111164041|NCT01862991|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
111164042|NCT02202551|Amantadine|amantadine|mesh-list
111164043|NCT02202551|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111164044|NCT02202551|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111164045|NCT02202551|Antiviral Agents|antiviral agents|mesh-ancestor
111164046|NCT02202551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111164047|NCT02202551|Dopamine Agents|dopamine agents|mesh-ancestor
111164048|NCT02202551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111164049|NCT02202551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111164050|NCT02202551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111164051|NCT02202551|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111164053|NCT02202551|Sensory System Agents|sensory system agents|mesh-ancestor
111164054|NCT02202551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111164055|NCT02118337|Nivolumab|nivolumab|mesh-list
111164056|NCT02118337|Durvalumab|durvalumab|mesh-list
111164057|NCT02118337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111164058|NCT02118337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111164059|NCT02118337|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111164060|NCT02118337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111164061|NCT05131555|Histamine H2 Antagonists|histamine h2 antagonists|mesh-list
111164062|NCT05131555|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
111164063|NCT05131555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111164064|NCT05131555|Histamine Antagonists|histamine antagonists|mesh-ancestor
111164065|NCT05131555|Histamine Agents|histamine agents|mesh-ancestor
111164066|NCT05131555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111164067|NCT05131555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111164068|NCT02105467|Grazoprevir|grazoprevir|mesh-list
111164069|NCT02105467|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
111164070|NCT02105467|Antiviral Agents|antiviral agents|mesh-ancestor
111164071|NCT02105467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111164072|NCT02202161|Metformin|metformin|mesh-list
111164073|NCT02202161|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111164074|NCT02202161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111164075|NCT02202161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111164076|NCT02202161|Incretins|incretins|mesh-ancestor
111164077|NCT02202161|Hormones|hormones|mesh-ancestor
111164078|NCT02202161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111164079|NCT02202161|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111164080|NCT02202161|Protease Inhibitors|protease inhibitors|mesh-ancestor
111164081|NCT02202161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111164082|NCT02202161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111164083|NCT03109847|Metformin|metformin|mesh-list
111164084|NCT03109847|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111164085|NCT03109847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111164086|NCT01461928|Rituximab|rituximab|mesh-list
111164087|NCT01461928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111164088|NCT01461928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111164089|NCT01461928|Immunologic Factors|immunologic factors|mesh-ancestor
111164090|NCT01461928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111164091|NCT01461928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111164092|NCT02623205|Escitalopram|escitalopram|mesh-list
111164093|NCT02623205|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111164094|NCT02623205|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111164095|NCT02623205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111164096|NCT02623205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111164097|NCT02623205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111164098|NCT02623205|Serotonin Agents|serotonin agents|mesh-ancestor
111164099|NCT02623205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111164100|NCT01500694|Guanfacine|guanfacine|mesh-list
111164101|NCT01500694|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111164102|NCT01500694|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111164103|NCT01500694|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111164104|NCT01500694|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111164105|NCT01500694|Adrenergic Agents|adrenergic agents|mesh-ancestor
111164106|NCT01500694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111164107|NCT01500694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111164108|NCT01500694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111164109|NCT01500382|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111164110|NCT01500382|Tolterodine Tartrate|tolterodine tartrate|mesh-list
111164111|NCT01500382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111164112|NCT01500382|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111164113|NCT01500382|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111164114|NCT01500382|Cholinergic Agents|cholinergic agents|mesh-ancestor
111164115|NCT01500382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111164116|NCT01500382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111164117|NCT01500382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111164118|NCT01500382|Urological Agents|urological agents|mesh-ancestor
111164121|NCT02137837|Anastrozole|anastrozole|mesh-list
111164122|NCT02137837|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111164123|NCT02137837|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111164124|NCT02137837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111164125|NCT02137837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111164126|NCT02137837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111164127|NCT02137837|Immunologic Factors|immunologic factors|mesh-ancestor
111164128|NCT02137837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111164129|NCT02137837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111164130|NCT02137837|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111164131|NCT02137837|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
111164132|NCT02137837|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111164133|NCT02137837|Hormone Antagonists|hormone antagonists|mesh-ancestor
111164134|NCT02137837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111164135|NCT02137837|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110486276|NCT05560009|Levodopa|levodopa|mesh-list
111164136|NCT02137837|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111164137|NCT01483690|Dexamethasone|dexamethasone|mesh-list
111164138|NCT01483690|Dexamethasone acetate|dexamethasone acetate|mesh-list
111164139|NCT01483690|Methotrexate|methotrexate|mesh-list
111164140|NCT01483690|Vincristine|vincristine|mesh-list
111164141|NCT01483690|Decitabine|decitabine|mesh-list
111164142|NCT01483690|Asparaginase|asparaginase|mesh-list
111164143|NCT01483690|Mitoxantrone|mitoxantrone|mesh-list
111164144|NCT01483690|Vorinostat|vorinostat|mesh-list
111164145|NCT01483690|Pegaspargase|pegaspargase|mesh-list
111164146|NCT01483690|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
111164147|NCT01483690|BB 1101|bb 1101|mesh-list
111164148|NCT01483690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111164149|NCT01483690|Antiemetics|antiemetics|mesh-ancestor
111164150|NCT01483690|Autonomic Agents|autonomic agents|mesh-ancestor
111164151|NCT01483690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111164152|NCT01483690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111164153|NCT01483690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111164154|NCT01483690|Glucocorticoids|glucocorticoids|mesh-ancestor
111164155|NCT01483690|Hormones|hormones|mesh-ancestor
111164156|NCT01483690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111164157|NCT01483690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111164158|NCT01483690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111164159|NCT01483690|Protease Inhibitors|protease inhibitors|mesh-ancestor
111164160|NCT01483690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111164161|NCT01483690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111164162|NCT01483690|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111164163|NCT01483690|Abortifacient Agents|abortifacient agents|mesh-ancestor
111164164|NCT01483690|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111164165|NCT01483690|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111164166|NCT01483690|Antimetabolites|antimetabolites|mesh-ancestor
111164167|NCT01483690|Dermatologic Agents|dermatologic agents|mesh-ancestor
111164168|NCT01483690|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111164169|NCT01483690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111164170|NCT01483690|Immunologic Factors|immunologic factors|mesh-ancestor
111164171|NCT01483690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111164172|NCT01483690|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111164173|NCT01483690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111164174|NCT01483690|Tubulin Modulators|tubulin modulators|mesh-ancestor
111164175|NCT01483690|Antimitotic Agents|antimitotic agents|mesh-ancestor
111164176|NCT01483690|Mitosis Modulators|mitosis modulators|mesh-ancestor
111164177|NCT01483690|Analgesics|analgesics|mesh-ancestor
111164178|NCT01483690|Sensory System Agents|sensory system agents|mesh-ancestor
111164179|NCT01483690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111164180|NCT01483690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111164181|NCT01483690|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111164182|NCT01483144|Eflornithine|eflornithine|mesh-list
111164183|NCT01483144|Sulindac|sulindac|mesh-list
111164184|NCT01483144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111164185|NCT01483144|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
111164186|NCT01483144|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111164187|NCT01483144|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111164188|NCT01483144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111164189|NCT01483144|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
111164190|NCT01483144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111164191|NCT01483144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111164192|NCT01483144|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111164193|NCT01483144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111164194|NCT01483144|Analgesics|analgesics|mesh-ancestor
111164195|NCT01483144|Sensory System Agents|sensory system agents|mesh-ancestor
111164196|NCT01483144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111164197|NCT01483144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111164198|NCT01483144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111164199|NCT01483144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111164200|NCT01483144|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111164201|NCT01881789|Dexamethasone|dexamethasone|mesh-list
111164202|NCT01881789|Cyclophosphamide|cyclophosphamide|mesh-list
111164203|NCT01881789|Lenalidomide|lenalidomide|mesh-list
111164204|NCT01881789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111164205|NCT01881789|Immunologic Factors|immunologic factors|mesh-ancestor
110486284|NCT05560009|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111164206|NCT01881789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111164207|NCT01881789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111164208|NCT01881789|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111164209|NCT01881789|Alkylating Agents|alkylating agents|mesh-ancestor
111164210|NCT01881789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111164211|NCT01881789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111164212|NCT01881789|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111164213|NCT01881789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111164214|NCT01881789|Antiemetics|antiemetics|mesh-ancestor
111164215|NCT01881789|Autonomic Agents|autonomic agents|mesh-ancestor
111164216|NCT01881789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111164217|NCT01881789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111164218|NCT01881789|Glucocorticoids|glucocorticoids|mesh-ancestor
111164219|NCT01881789|Hormones|hormones|mesh-ancestor
111164220|NCT01881789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111164221|NCT01881789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111164222|NCT01881789|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111164223|NCT01881789|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111164224|NCT01881789|Growth Substances|growth substances|mesh-ancestor
111164225|NCT01881789|Growth Inhibitors|growth inhibitors|mesh-ancestor
111164226|NCT02075203|BCG Vaccine|bcg vaccine|mesh-list
111164227|NCT02075203|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111164228|NCT02075203|Immunologic Factors|immunologic factors|mesh-ancestor
111164229|NCT02075203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111164230|NCT01892163|Dexamethasone|dexamethasone|mesh-list
111164231|NCT01892163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111164232|NCT01892163|Antiemetics|antiemetics|mesh-ancestor
111164233|NCT01892163|Autonomic Agents|autonomic agents|mesh-ancestor
111164234|NCT01892163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111164235|NCT01892163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111164236|NCT01892163|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111164237|NCT01892163|Glucocorticoids|glucocorticoids|mesh-ancestor
111164238|NCT01892163|Hormones|hormones|mesh-ancestor
111164239|NCT01892163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111164240|NCT01892163|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111164241|NCT01892163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111164242|NCT01500226|Dexamethasone|dexamethasone|mesh-list
111164243|NCT01500226|Granisetron|granisetron|mesh-list
111164244|NCT01500226|Rolapitant|rolapitant|mesh-list
111164245|NCT01500226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111164246|NCT01500226|Antiemetics|antiemetics|mesh-ancestor
111164247|NCT01500226|Autonomic Agents|autonomic agents|mesh-ancestor
111164248|NCT01500226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110881320|NCT03271151|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111164249|NCT01500226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111164250|NCT01500226|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111164251|NCT01500226|Glucocorticoids|glucocorticoids|mesh-ancestor
111164252|NCT01500226|Hormones|hormones|mesh-ancestor
111164253|NCT01500226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111164254|NCT01500226|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111164255|NCT01500226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111164256|NCT01500226|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111164257|NCT01500226|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111164258|NCT01500226|Serotonin Agents|serotonin agents|mesh-ancestor
111164259|NCT01500226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111164260|NCT01500226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111164261|NCT01500226|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
111164262|NCT02075047|Ziprasidone|ziprasidone|mesh-list
111164263|NCT02075047|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111164264|NCT02075047|Serotonin Agents|serotonin agents|mesh-ancestor
111164265|NCT02075047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111164266|NCT02075047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111164267|NCT02075047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111164268|NCT02075047|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111164269|NCT02075047|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111164270|NCT02075047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111164271|NCT02075047|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111164272|NCT02075047|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111164273|NCT02075047|Dopamine Agents|dopamine agents|mesh-ancestor
111164274|NCT01859793|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111164275|NCT01859793|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111164276|NCT01859793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111164277|NCT01859793|Incretins|incretins|mesh-ancestor
111164278|NCT01859793|Hormones|hormones|mesh-ancestor
111164279|NCT01859793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111164280|NCT01859793|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111164281|NCT01859793|Protease Inhibitors|protease inhibitors|mesh-ancestor
111164282|NCT01859793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111164283|NCT01859793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111164284|NCT01859715|Oxycodone|oxycodone|mesh-list
111164285|NCT01859715|Hydrocodone|hydrocodone|mesh-list
111164286|NCT01859715|Ondansetron|ondansetron|mesh-list
111164287|NCT01859715|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111164288|NCT01859715|Narcotics|narcotics|mesh-ancestor
111164289|NCT01859715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111164290|NCT01859715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111164291|NCT01859715|Analgesics|analgesics|mesh-ancestor
111164292|NCT01859715|Sensory System Agents|sensory system agents|mesh-ancestor
111164293|NCT01859715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111164294|NCT01859715|Antiemetics|antiemetics|mesh-ancestor
111164295|NCT01859715|Autonomic Agents|autonomic agents|mesh-ancestor
111164296|NCT01859715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111164297|NCT01859715|Antipruritics|antipruritics|mesh-ancestor
111164298|NCT01859715|Dermatologic Agents|dermatologic agents|mesh-ancestor
111164299|NCT01859715|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111164300|NCT01859715|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111164301|NCT01859715|Serotonin Agents|serotonin agents|mesh-ancestor
111164302|NCT01859715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111164303|NCT01859715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111164304|NCT01859715|Antitussive Agents|antitussive agents|mesh-ancestor
111164305|NCT01859715|Respiratory System Agents|respiratory system agents|mesh-ancestor
111164306|NCT04590495|Cannabidiol|cannabidiol|mesh-list
111164307|NCT04590495|Anticonvulsants|anticonvulsants|mesh-ancestor
111164308|NCT01461538|Brentuximab Vedotin|brentuximab vedotin|mesh-list
111164309|NCT01461538|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111164310|NCT01461538|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111164311|NCT01461538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111164312|NCT01461538|Immunotoxins|immunotoxins|mesh-ancestor
111164314|NCT01461538|Immunologic Factors|immunologic factors|mesh-ancestor
111164315|NCT01461538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111164316|NCT02117479|Capecitabine|capecitabine|mesh-list
111164317|NCT02117479|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111164318|NCT02117479|Antimetabolites|antimetabolites|mesh-ancestor
111164319|NCT02117479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111164320|NCT02117479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111164321|NCT01482910|Aflibercept|aflibercept|mesh-list
111164322|NCT01482910|Verteporfin|verteporfin|mesh-list
110881392|NCT04701281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111164323|NCT01482910|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111164324|NCT01482910|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111164325|NCT01482910|Growth Substances|growth substances|mesh-ancestor
111164326|NCT01482910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111164327|NCT01482910|Growth Inhibitors|growth inhibitors|mesh-ancestor
111164328|NCT01482910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111164329|NCT01482910|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111164330|NCT01482910|Dermatologic Agents|dermatologic agents|mesh-ancestor
111164331|NCT04077190|Cortisone|cortisone|mesh-list
111164332|NCT04077190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111164333|NCT02103439|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
111164334|NCT02103439|Antiviral Agents|antiviral agents|mesh-ancestor
111164335|NCT02103439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111164336|NCT02229539|Diphenhydramine|diphenhydramine|mesh-list
111164337|NCT02229539|Promethazine|promethazine|mesh-list
111164338|NCT02229539|Lidocaine|lidocaine|mesh-list
111164339|NCT02229539|Doxepin|doxepin|mesh-list
111164340|NCT02229539|Antacids|antacids|mesh-list
111164341|NCT02229539|Anesthetics, Local|anesthetics, local|mesh-ancestor
111164342|NCT02229539|Anesthetics|anesthetics|mesh-ancestor
111164343|NCT02229539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111164344|NCT02229539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111164345|NCT02229539|Sensory System Agents|sensory system agents|mesh-ancestor
111164346|NCT02229539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111164347|NCT02229539|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111164348|NCT02229539|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111164349|NCT02229539|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111164350|NCT02229539|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111164351|NCT02229539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111164352|NCT02229539|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111164353|NCT02229539|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111164354|NCT02229539|Antiemetics|antiemetics|mesh-ancestor
111164355|NCT02229539|Autonomic Agents|autonomic agents|mesh-ancestor
111164356|NCT02229539|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111164357|NCT02229539|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111164358|NCT02229539|Histamine Antagonists|histamine antagonists|mesh-ancestor
111164359|NCT02229539|Histamine Agents|histamine agents|mesh-ancestor
111164360|NCT02229539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111164361|NCT02229539|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111164362|NCT02229539|Antipruritics|antipruritics|mesh-ancestor
111164363|NCT02229539|Dermatologic Agents|dermatologic agents|mesh-ancestor
111164364|NCT02229539|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
111164365|NCT02229539|Antidepressive Agents|antidepressive agents|mesh-ancestor
111164366|NCT02229539|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111164367|NCT01835223|Tivozanib|tivozanib|mesh-list
111164368|NCT01835223|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111164369|NCT01835223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111164370|NCT01835223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111164371|NCT02229383|Exenatide|exenatide|mesh-list
111164372|NCT02229383|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111164373|NCT02229383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111164374|NCT02229383|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111164375|NCT02229383|Incretins|incretins|mesh-ancestor
111164376|NCT02229383|Hormones|hormones|mesh-ancestor
111164377|NCT02229383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111164378|NCT01499368|Omeprazole|omeprazole|mesh-list
111164379|NCT01499368|Famotidine|famotidine|mesh-list
111164380|NCT01499368|Lafutidine|lafutidine|mesh-list
111164381|NCT01499368|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111164382|NCT01499368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111164383|NCT01499368|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111164384|NCT01499368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111164385|NCT01499368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111164386|NCT01499368|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
111164387|NCT01499368|Histamine Antagonists|histamine antagonists|mesh-ancestor
111164388|NCT01499368|Histamine Agents|histamine agents|mesh-ancestor
111164389|NCT01499368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111164390|NCT01499368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111164391|NCT01835145|Temozolomide|temozolomide|mesh-list
111164392|NCT01835145|Dacarbazine|dacarbazine|mesh-list
111164393|NCT01835145|Imidazole|imidazole|mesh-list
111164394|NCT01835145|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111164395|NCT01835145|Alkylating Agents|alkylating agents|mesh-ancestor
111164396|NCT01835145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111164397|NCT01835145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111164398|NCT01835145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111164399|NCT02229227|Insulin|insulin|mesh-list
111164400|NCT02229227|Insulin Glargine|insulin glargine|mesh-list
110881484|NCT01965132|Adalimumab|adalimumab|mesh-list
111164401|NCT02229227|Insulin Lispro|insulin lispro|mesh-list
111164402|NCT02229227|rGLP-1 protein|rglp-1 protein|mesh-list
111164403|NCT02229227|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111164404|NCT02229227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111164405|NCT02229227|Incretins|incretins|mesh-ancestor
111164406|NCT02229227|Hormones|hormones|mesh-ancestor
111164407|NCT02229227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111164408|NCT01499290|Metronidazole|metronidazole|mesh-list
111164409|NCT01499290|Meropenem|meropenem|mesh-list
111164410|NCT01499290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111164411|NCT01499290|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111164412|NCT01499290|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111164413|NCT01499290|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111164414|NCT01833897|Cycloserine|cycloserine|mesh-list
111164415|NCT01833897|Ketamine|ketamine|mesh-list
111164416|NCT01833897|Olanzapine|olanzapine|mesh-list
111164417|NCT01833897|Quetiapine Fumarate|quetiapine fumarate|mesh-list
111164418|NCT01833897|Fluoxetine|fluoxetine|mesh-list
111164419|NCT01833897|Analgesics|analgesics|mesh-ancestor
111164420|NCT01833897|Sensory System Agents|sensory system agents|mesh-ancestor
111164421|NCT01833897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111164422|NCT01833897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111164423|NCT01833897|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111164424|NCT01833897|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111164425|NCT01833897|Anesthetics, General|anesthetics, general|mesh-ancestor
111164426|NCT01833897|Anesthetics|anesthetics|mesh-ancestor
111164427|NCT01833897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111164428|NCT01833897|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111164429|NCT01833897|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111164430|NCT01833897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111164431|NCT01833897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111164432|NCT01833897|Antiemetics|antiemetics|mesh-ancestor
111164433|NCT01833897|Autonomic Agents|autonomic agents|mesh-ancestor
111164434|NCT01833897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111164435|NCT01833897|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111164436|NCT01833897|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111164437|NCT01833897|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111164438|NCT01833897|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111164439|NCT01833897|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111164440|NCT01833897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111164441|NCT01833897|Serotonin Agents|serotonin agents|mesh-ancestor
111164442|NCT01833897|Antidepressive Agents|antidepressive agents|mesh-ancestor
111164443|NCT01833897|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111164444|NCT01833897|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111164445|NCT01833897|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111164446|NCT01833897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111164447|NCT01833897|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111164448|NCT01833897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111164449|NCT01833897|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111164450|NCT01833897|Antitubercular Agents|antitubercular agents|mesh-ancestor
111164451|NCT01833897|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111164452|NCT01833897|Antimetabolites|antimetabolites|mesh-ancestor
111164453|NCT02226653|Evacetrapib|evacetrapib|mesh-list
111164454|NCT02226653|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111164455|NCT02226653|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111164456|NCT02226653|Antimetabolites|antimetabolites|mesh-ancestor
111164457|NCT02226653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111164458|NCT02226653|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111164460|NCT02201771|Ticagrelor|ticagrelor|mesh-list
111164461|NCT02201771|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111164462|NCT02201771|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111164463|NCT02201771|Analgesics|analgesics|mesh-ancestor
111164464|NCT02201771|Sensory System Agents|sensory system agents|mesh-ancestor
111164465|NCT02201771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111164466|NCT02201771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111164467|NCT02201771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111164468|NCT02201771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111164469|NCT02201771|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111164470|NCT02201771|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111164471|NCT02201771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111164472|NCT02201771|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111164473|NCT02201771|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111164474|NCT02201771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111164475|NCT02201771|Antipyretics|antipyretics|mesh-ancestor
111164476|NCT02201771|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111164477|NCT02201771|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111164478|NCT02201771|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111164479|NCT02201771|Purinergic Agents|purinergic agents|mesh-ancestor
111164480|NCT02201771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111164481|NCT01460368|Moxifloxacin|moxifloxacin|mesh-list
111164482|NCT01460368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111164483|NCT01460368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111164484|NCT01460368|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111164485|NCT01460368|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111164486|NCT01460368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111164487|NCT01460368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111164488|NCT01460368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111164489|NCT01460290|Asenapine|asenapine|mesh-list
111164490|NCT01460290|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111164491|NCT01460290|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111164492|NCT01460290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111164493|NCT01460290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111164494|NCT01460290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111164495|NCT01459666|Hemagglutinins|hemagglutinins|mesh-list
111164496|NCT01459666|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111164497|NCT01459666|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111164498|NCT01459666|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111164499|NCT01459666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111164500|NCT01459666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111164501|NCT01459666|Cholinergic Agents|cholinergic agents|mesh-ancestor
111164502|NCT01459666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111164503|NCT01459666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111164504|NCT01459666|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111164505|NCT01459666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111164506|NCT01459666|Agglutinins|agglutinins|mesh-ancestor
111164507|NCT01459666|Immunologic Factors|immunologic factors|mesh-ancestor
111164508|NCT01459666|Coagulants|coagulants|mesh-ancestor
111164509|NCT01645475|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
111164510|NCT01645475|Hemostatics|hemostatics|mesh-ancestor
111164511|NCT01645475|Coagulants|coagulants|mesh-ancestor
111164512|NCT01645475|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
111164513|NCT01645475|Natriuretic Agents|natriuretic agents|mesh-ancestor
111164514|NCT01645475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111164515|NCT04767113|Heparin|heparin|mesh-list
111164516|NCT04767113|Calcium heparin|calcium heparin|mesh-list
111164517|NCT04767113|Anticoagulants|anticoagulants|mesh-ancestor
111164518|NCT04767113|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111164519|NCT04767113|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111164520|NCT04767113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111164521|NCT02199509|Levetiracetam|levetiracetam|mesh-list
111164522|NCT02199509|Anticonvulsants|anticonvulsants|mesh-ancestor
111164523|NCT02199509|Nootropic Agents|nootropic agents|mesh-ancestor
111164525|NCT01458574|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
111164526|NCT01458574|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111164527|NCT01458574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111164528|NCT01458574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111164529|NCT02224703|Cannabidiol|cannabidiol|mesh-list
111164530|NCT02224703|Anticonvulsants|anticonvulsants|mesh-ancestor
111164531|NCT01458106|Factor VIII|factor viii|mesh-list
111164532|NCT01458106|Coagulants|coagulants|mesh-ancestor
111164533|NCT01457950|Denosumab|denosumab|mesh-list
111164534|NCT01457950|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111164535|NCT01457950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111164536|NCT01499134|Metoprolol|metoprolol|mesh-list
111164537|NCT01499134|Nebivolol|nebivolol|mesh-list
111164538|NCT01499134|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111164539|NCT01499134|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111164540|NCT01499134|Sympatholytics|sympatholytics|mesh-ancestor
111164541|NCT01499134|Autonomic Agents|autonomic agents|mesh-ancestor
111164542|NCT01499134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111164543|NCT01499134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111164544|NCT01499134|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
111164545|NCT01499134|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111164546|NCT01499134|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111164547|NCT01499134|Adrenergic Agents|adrenergic agents|mesh-ancestor
111164548|NCT01499134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111164549|NCT01499134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111164550|NCT01499134|Vasodilator Agents|vasodilator agents|mesh-ancestor
111164551|NCT01499134|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
111164552|NCT01499134|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111164553|NCT01499134|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111164554|NCT02198651|Adalimumab|adalimumab|mesh-list
111164555|NCT02198651|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111164556|NCT02198651|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111164557|NCT02198651|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111164558|NCT03026842|Cytarabine|cytarabine|mesh-list
111164559|NCT03026842|Decitabine|decitabine|mesh-list
111164560|NCT03026842|Daunorubicin|daunorubicin|mesh-list
111164561|NCT03026842|Mitoxantrone|mitoxantrone|mesh-list
111164562|NCT03026842|Aclacinomycins|aclacinomycins|mesh-list
111164563|NCT03026842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111164564|NCT03026842|Antimetabolites|antimetabolites|mesh-ancestor
111164565|NCT03026842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111164566|NCT03026842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111164567|NCT03026842|Antiviral Agents|antiviral agents|mesh-ancestor
111164568|NCT03026842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111164569|NCT03026842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111164570|NCT03026842|Immunologic Factors|immunologic factors|mesh-ancestor
111164571|NCT03026842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111164572|NCT03026842|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111164573|NCT03026842|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111164574|NCT03026842|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111164575|NCT03026842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111164576|NCT03026842|Analgesics|analgesics|mesh-ancestor
111164577|NCT03026842|Sensory System Agents|sensory system agents|mesh-ancestor
111164578|NCT03026842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111164579|NCT03026842|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111164580|NCT01498822|Oxcarbazepine|oxcarbazepine|mesh-list
111164581|NCT01498822|Levetiracetam|levetiracetam|mesh-list
111164582|NCT01498822|Anticonvulsants|anticonvulsants|mesh-ancestor
111164583|NCT01498822|Nootropic Agents|nootropic agents|mesh-ancestor
111164584|NCT01498822|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111164585|NCT01498822|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111164586|NCT01498822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111164587|NCT01498822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111164588|NCT01498822|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111164589|NCT01498822|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111164590|NCT01498120|Rotigotine|rotigotine|mesh-list
111164591|NCT01498120|Dopamine Agonists|dopamine agonists|mesh-ancestor
111164592|NCT01498120|Dopamine Agents|dopamine agents|mesh-ancestor
111164593|NCT01498120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111164594|NCT01498120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111164595|NCT01498120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111164596|NCT01497262|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
111164597|NCT01497262|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
111164598|NCT01497262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111164599|NCT01497262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111164600|NCT01497262|Immunologic Factors|immunologic factors|mesh-ancestor
111164601|NCT01497262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111164602|NCT02224625|Chlorhexidine|chlorhexidine|mesh-list
111164603|NCT02224625|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
111164604|NCT02224625|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111164605|NCT02224625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111164606|NCT02224625|Disinfectants|disinfectants|mesh-ancestor
111164607|NCT02224625|Dermatologic Agents|dermatologic agents|mesh-ancestor
111164608|NCT01195493|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111164609|NCT02197247|Rifampin|rifampin|mesh-list
111164610|NCT02197247|Osimertinib|osimertinib|mesh-list
111164611|NCT02197247|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111164612|NCT02197247|Antitubercular Agents|antitubercular agents|mesh-ancestor
111164613|NCT02197247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110486398|NCT04173039|Antibodies|antibodies|mesh-list
111164614|NCT02197247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111164615|NCT02197247|Leprostatic Agents|leprostatic agents|mesh-ancestor
111164616|NCT02197247|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111164617|NCT02197247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111164618|NCT02197247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111164619|NCT02197247|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111164620|NCT02197247|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111164621|NCT02197247|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
111164622|NCT02197247|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
111164623|NCT02197247|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
111164624|NCT02197247|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111164625|NCT02197247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111164626|NCT02197247|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111164627|NCT02224157|Budesonide|budesonide|mesh-list
111164628|NCT02224157|Terbutaline|terbutaline|mesh-list
110881687|NCT05320926|Aspirin|aspirin|mesh-list
111164629|NCT02224157|Formoterol Fumarate|formoterol fumarate|mesh-list
111164630|NCT02224157|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111164631|NCT02224157|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111164632|NCT02224157|Autonomic Agents|autonomic agents|mesh-ancestor
111164633|NCT02224157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111164634|NCT02224157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111164635|NCT02224157|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111164636|NCT02224157|Respiratory System Agents|respiratory system agents|mesh-ancestor
111164637|NCT02224157|Glucocorticoids|glucocorticoids|mesh-ancestor
111164638|NCT02224157|Hormones|hormones|mesh-ancestor
111164639|NCT02224157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111164640|NCT02224157|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111164641|NCT02224157|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111164642|NCT02224157|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111164643|NCT02224157|Adrenergic Agents|adrenergic agents|mesh-ancestor
111164644|NCT02224157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111164645|NCT02224157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111164646|NCT02224157|Sympathomimetics|sympathomimetics|mesh-ancestor
111164647|NCT02224157|Tocolytic Agents|tocolytic agents|mesh-ancestor
111164648|NCT02224157|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111164649|NCT02196701|Adalimumab|adalimumab|mesh-list
111164650|NCT02196701|Methotrexate|methotrexate|mesh-list
111164651|NCT02196701|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111164652|NCT02196701|Abortifacient Agents|abortifacient agents|mesh-ancestor
111164653|NCT02196701|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111164654|NCT02196701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111164655|NCT02196701|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111164656|NCT02196701|Antimetabolites|antimetabolites|mesh-ancestor
111164657|NCT02196701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111164658|NCT02196701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111164659|NCT02196701|Dermatologic Agents|dermatologic agents|mesh-ancestor
111164660|NCT02196701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111164661|NCT02196701|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111164662|NCT02196701|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111164663|NCT02196701|Immunologic Factors|immunologic factors|mesh-ancestor
111164664|NCT02196701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111164665|NCT02196701|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111164666|NCT02196701|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111164667|NCT02196701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111164668|NCT01481116|Glimepiride|glimepiride|mesh-list
111164669|NCT01481116|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111164670|NCT01481116|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111164671|NCT01481116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111164672|NCT01481116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111164673|NCT01481116|Immunologic Factors|immunologic factors|mesh-ancestor
111164674|NCT02222207|Ranibizumab|ranibizumab|mesh-list
111164675|NCT02222207|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111164676|NCT02222207|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111164677|NCT02222207|Growth Substances|growth substances|mesh-ancestor
111164678|NCT02222207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111164679|NCT02222207|Growth Inhibitors|growth inhibitors|mesh-ancestor
111164680|NCT02222207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110486416|NCT00648531|Balsalazide|balsalazide|mesh-list
111164681|NCT02195687|Botulinum Toxins|botulinum toxins|mesh-list
111164682|NCT02195687|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111164683|NCT02195687|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111164684|NCT02195687|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111164685|NCT02195687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111164686|NCT02195687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111164687|NCT02195687|Cholinergic Agents|cholinergic agents|mesh-ancestor
111164688|NCT02195687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111164689|NCT02195687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111164690|NCT02195687|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111164691|NCT02195687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111164692|NCT02252081|Metformin|metformin|mesh-list
111164693|NCT02252081|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111164694|NCT02252081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111164695|NCT01623752|Etanercept|etanercept|mesh-list
111164696|NCT01623752|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111164697|NCT01623752|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111164698|NCT01623752|Analgesics|analgesics|mesh-ancestor
111164699|NCT01623752|Sensory System Agents|sensory system agents|mesh-ancestor
111164700|NCT01623752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111164701|NCT01623752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110881758|NCT03242759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111164702|NCT01623752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111164703|NCT01623752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111164704|NCT01623752|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111164705|NCT01623752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111164706|NCT01623752|Immunologic Factors|immunologic factors|mesh-ancestor
111164707|NCT01623596|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
111164708|NCT01623596|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
111164709|NCT01623596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111164710|NCT01623596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111164711|NCT01623596|Immunologic Factors|immunologic factors|mesh-ancestor
111164712|NCT01623596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111164714|NCT02219477|Ribavirin|ribavirin|mesh-list
111164715|NCT02219477|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111164716|NCT02219477|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111164717|NCT02219477|Protease Inhibitors|protease inhibitors|mesh-ancestor
111164718|NCT02219477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111164719|NCT02219477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111164720|NCT02219477|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111164721|NCT02219477|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111164722|NCT02219477|Antiviral Agents|antiviral agents|mesh-ancestor
111164723|NCT02219477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111164724|NCT02219477|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111164725|NCT02219477|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111164726|NCT02219477|Antimetabolites|antimetabolites|mesh-ancestor
111164727|NCT02093390|Fluconazole|fluconazole|mesh-list
111164728|NCT02093390|Atorvastatin|atorvastatin|mesh-list
111164729|NCT02093390|Relugolix|relugolix|mesh-list
111164730|NCT02093390|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111164731|NCT02093390|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111164732|NCT02093390|Antimetabolites|antimetabolites|mesh-ancestor
110842045|NCT04892420|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111164733|NCT02093390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111164734|NCT02093390|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111164735|NCT02093390|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111164736|NCT02093390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111164737|NCT02093390|Antifungal Agents|antifungal agents|mesh-ancestor
111164738|NCT02093390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111164739|NCT02093390|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111164740|NCT02093390|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111164741|NCT02093390|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111164742|NCT02093390|Hormone Antagonists|hormone antagonists|mesh-ancestor
111164743|NCT02093390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111164744|NCT02093390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111164745|NCT02093390|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111164746|NCT02093390|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111164747|NCT02093390|Androgen Antagonists|androgen antagonists|mesh-ancestor
111164749|NCT02219087|Anesthetics, Local|anesthetics, local|mesh-ancestor
111164750|NCT02219087|Anesthetics|anesthetics|mesh-ancestor
111164751|NCT02219087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111164752|NCT02219087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111164753|NCT02219087|Sensory System Agents|sensory system agents|mesh-ancestor
111164754|NCT02219087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111164755|NCT02248961|Losartan|losartan|mesh-list
111164756|NCT02248961|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111164757|NCT02248961|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111164758|NCT02248961|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111164759|NCT02248961|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111164760|NCT02248961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111164761|NCT02219009|Aripiprazole|aripiprazole|mesh-list
111164762|NCT02219009|Antidepressive Agents|antidepressive agents|mesh-ancestor
111164763|NCT02219009|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111164764|NCT02219009|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111164765|NCT02219009|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111164766|NCT02219009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111164767|NCT02219009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111164768|NCT02219009|Dopamine Agonists|dopamine agonists|mesh-ancestor
111164769|NCT02219009|Dopamine Agents|dopamine agents|mesh-ancestor
111164770|NCT02219009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111164771|NCT02219009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111164772|NCT02219009|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111164773|NCT02219009|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111164774|NCT02219009|Serotonin Agents|serotonin agents|mesh-ancestor
111164775|NCT02219009|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111164776|NCT02219009|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111164777|NCT02219009|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111164778|NCT02219009|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111164780|NCT01456936|Nicotine|nicotine|mesh-list
111164781|NCT01456936|Varenicline|varenicline|mesh-list
111164782|NCT01456936|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111164783|NCT01456936|Autonomic Agents|autonomic agents|mesh-ancestor
111164784|NCT01456936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111164785|NCT01456936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111164786|NCT01456936|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111164787|NCT01456936|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111164788|NCT01456936|Cholinergic Agents|cholinergic agents|mesh-ancestor
111164789|NCT01456936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111164790|NCT01456936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111164791|NCT01456936|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111164792|NCT01456936|Antidepressive Agents|antidepressive agents|mesh-ancestor
111164793|NCT01456936|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111164794|NCT01456936|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111164795|NCT01456936|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111164796|NCT01456936|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111164797|NCT01456936|Dopamine Agents|dopamine agents|mesh-ancestor
111164798|NCT01456936|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111164799|NCT01456936|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111164800|NCT01456936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111164801|NCT01456780|Loteprednol Etabonate|loteprednol etabonate|mesh-list
111164802|NCT01456780|Tobramycin|tobramycin|mesh-list
111164803|NCT01456780|Lubricant Eye Drops|lubricant eye drops|mesh-list
111164804|NCT01456780|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111164805|NCT01456780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111164806|NCT01456780|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
111164807|NCT01456780|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111164808|NCT01456780|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111164809|NCT01480258|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
111164810|NCT01480258|Immunologic Factors|immunologic factors|mesh-ancestor
111164811|NCT01480258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111164812|NCT01479868|Interferons|interferons|mesh-list
111164813|NCT01479868|Ribavirin|ribavirin|mesh-list
111164814|NCT01479868|Interferon-alpha|interferon-alpha|mesh-list
111164815|NCT01479868|Interferon alpha-2|interferon alpha-2|mesh-list
111164816|NCT01479868|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
111164817|NCT01479868|Simeprevir|simeprevir|mesh-list
111164818|NCT01479868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111164819|NCT01479868|Antiviral Agents|antiviral agents|mesh-ancestor
111164820|NCT01479868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111164821|NCT01479868|Antimetabolites|antimetabolites|mesh-ancestor
111164822|NCT01479868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111164823|NCT01479868|Immunologic Factors|immunologic factors|mesh-ancestor
111164824|NCT01479868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111164825|NCT01479868|Protease Inhibitors|protease inhibitors|mesh-ancestor
111164826|NCT01479868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111164827|NCT01455220|Natalizumab|natalizumab|mesh-list
111164828|NCT01455220|Immunologic Factors|immunologic factors|mesh-ancestor
111164829|NCT01455220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111164830|NCT01454596|Aldesleukin|aldesleukin|mesh-list
111164831|NCT01454596|Cyclophosphamide|cyclophosphamide|mesh-list
111164832|NCT01454596|Fludarabine|fludarabine|mesh-list
111164833|NCT01454596|Mitogens|mitogens|mesh-list
111164834|NCT01454596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111164835|NCT01454596|Immunologic Factors|immunologic factors|mesh-ancestor
111164836|NCT01454596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111164837|NCT01454596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111164838|NCT01454596|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111164839|NCT01454596|Alkylating Agents|alkylating agents|mesh-ancestor
111164840|NCT01454596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111164841|NCT01454596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111164842|NCT01454596|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111164843|NCT01454596|Mitosis Modulators|mitosis modulators|mesh-ancestor
111164844|NCT01454596|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111164845|NCT01454596|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111164846|NCT01454596|Antiviral Agents|antiviral agents|mesh-ancestor
111164847|NCT01454596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110881914|NCT04748757|Annexin A5|annexin a5|mesh-list
111164848|NCT01454284|Insulin Lispro|insulin lispro|mesh-list
111164849|NCT01454284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111164850|NCT01454284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111164851|NCT04541290|Tacrolimus|tacrolimus|mesh-list
111164852|NCT04541290|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111164853|NCT04541290|Immunologic Factors|immunologic factors|mesh-ancestor
111164854|NCT04541290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111164855|NCT04541290|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111164856|NCT04541290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111164857|NCT04541290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111164858|NCT01495702|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
111164859|NCT01495702|Antiviral Agents|antiviral agents|mesh-ancestor
111164860|NCT01495702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111164861|NCT01495702|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111164862|NCT01495702|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111164863|NCT01495000|Denosumab|denosumab|mesh-list
111164864|NCT01495000|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111164865|NCT01495000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111164866|NCT01494610|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
111164867|NCT01494610|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111164868|NCT01494610|Autonomic Agents|autonomic agents|mesh-ancestor
111164869|NCT01494610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110594949|NCT02345850|Methotrexate|methotrexate|mesh-list
111164870|NCT01494610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111164871|NCT01494610|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111164872|NCT01494610|Respiratory System Agents|respiratory system agents|mesh-ancestor
111164873|NCT01494610|Glucocorticoids|glucocorticoids|mesh-ancestor
111164874|NCT01494610|Hormones|hormones|mesh-ancestor
111164875|NCT01494610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111164876|NCT01494610|Sympathomimetics|sympathomimetics|mesh-ancestor
111164877|NCT02116777|Temozolomide|temozolomide|mesh-list
111164878|NCT02116777|Talazoparib|talazoparib|mesh-list
111164879|NCT02116777|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111164880|NCT02116777|Alkylating Agents|alkylating agents|mesh-ancestor
111164881|NCT02116777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111164882|NCT02116777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111164883|NCT02116777|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111164884|NCT02116777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111164885|NCT01494532|Ropinirole|ropinirole|mesh-list
111164886|NCT01494532|Levodopa|levodopa|mesh-list
111164887|NCT01494532|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
111164888|NCT01494532|Dopamine Agents|dopamine agents|mesh-ancestor
111164889|NCT01494532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111164890|NCT01494532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111164891|NCT01494532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111164892|NCT01494532|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111164893|NCT01494532|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111164894|NCT01494532|Dopamine Agonists|dopamine agonists|mesh-ancestor
111164895|NCT02191397|Dexetimide|dexetimide|mesh-list
111164896|NCT02191397|Citalopram|citalopram|mesh-list
111164897|NCT02191397|Bupropion|bupropion|mesh-list
111164898|NCT02191397|Escitalopram|escitalopram|mesh-list
111164899|NCT02191397|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111164900|NCT02191397|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111164901|NCT02191397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111164902|NCT02191397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111164903|NCT02191397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111164904|NCT02191397|Serotonin Agents|serotonin agents|mesh-ancestor
111164905|NCT02191397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111164906|NCT02191397|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111164907|NCT02191397|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111164908|NCT02191397|Parasympatholytics|parasympatholytics|mesh-ancestor
111164909|NCT02191397|Autonomic Agents|autonomic agents|mesh-ancestor
111164910|NCT02191397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111164911|NCT02191397|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111164912|NCT02191397|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111164913|NCT02191397|Cholinergic Agents|cholinergic agents|mesh-ancestor
111164914|NCT02191397|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111164915|NCT02191397|Antidepressive Agents|antidepressive agents|mesh-ancestor
111164916|NCT02191397|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111164917|NCT02191397|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111164918|NCT02191397|Dopamine Agents|dopamine agents|mesh-ancestor
111164919|NCT02191397|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111164920|NCT02191397|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111164921|NCT02191397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111164922|NCT01630811|Quinidine|quinidine|mesh-list
110881992|NCT03701022|Apatinib|apatinib|mesh-list
111164923|NCT01630811|Dextromethorphan|dextromethorphan|mesh-list
111164924|NCT01630811|Antitussive Agents|antitussive agents|mesh-ancestor
111164925|NCT01630811|Respiratory System Agents|respiratory system agents|mesh-ancestor
111164926|NCT01630811|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111164927|NCT01630811|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111164928|NCT01630811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111164929|NCT01630811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111164930|NCT01630811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110842058|NCT04707534|Dexamethasone|dexamethasone|mesh-list
111164931|NCT01630811|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111164932|NCT01630811|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111164933|NCT01630811|Adrenergic Agents|adrenergic agents|mesh-ancestor
111164934|NCT01630811|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111164935|NCT01630811|Antimalarials|antimalarials|mesh-ancestor
111164936|NCT01630811|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111164937|NCT01630811|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111164938|NCT01630811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111164939|NCT01630811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111164940|NCT01630811|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111164941|NCT01630811|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111164942|NCT01630811|Cholinergic Agents|cholinergic agents|mesh-ancestor
111164943|NCT01630811|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111164944|NCT01630811|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111164945|NCT01630811|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111164946|NCT01630811|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111164947|NCT01630811|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111164948|NCT02170025|Riociguat|riociguat|mesh-list
111164949|NCT02170025|Enzyme Activators|enzyme activators|mesh-ancestor
111164950|NCT02170025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111164951|NCT02169791|Ixazomib|ixazomib|mesh-list
111164952|NCT02169791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111164953|NCT02169791|Protease Inhibitors|protease inhibitors|mesh-ancestor
111164954|NCT02169791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111164955|NCT02169791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111164956|NCT02216357|Ifetroban|ifetroban|mesh-list
111164957|NCT02216357|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111164958|NCT01492426|Ribavirin|ribavirin|mesh-list
111164959|NCT01492426|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
111164960|NCT01492426|Antimetabolites|antimetabolites|mesh-ancestor
111164961|NCT01492426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111164962|NCT01492426|Antiviral Agents|antiviral agents|mesh-ancestor
111164963|NCT01492426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111164964|NCT01453348|Vaccines|vaccines|mesh-list
111164965|NCT01453348|Immunologic Factors|immunologic factors|mesh-ancestor
111164966|NCT01453348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111164967|NCT01475734|rGLP-1 protein|rglp-1 protein|mesh-list
111164968|NCT01475734|Incretins|incretins|mesh-ancestor
111164969|NCT01475734|Hormones|hormones|mesh-ancestor
111164970|NCT01475734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111164971|NCT01475734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111164972|NCT02189837|Atorvastatin|atorvastatin|mesh-list
111164973|NCT02189837|Evolocumab|evolocumab|mesh-list
111164974|NCT02189837|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111164975|NCT02189837|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111164976|NCT02189837|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111164977|NCT02189837|Antimetabolites|antimetabolites|mesh-ancestor
111164978|NCT02189837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111164979|NCT02189837|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111164980|NCT02189837|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111164981|NCT02189837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111164982|NCT02189837|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
111164983|NCT02189837|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111164984|NCT02189837|Protease Inhibitors|protease inhibitors|mesh-ancestor
111164985|NCT02189837|Immunologic Factors|immunologic factors|mesh-ancestor
111164986|NCT02189837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111164987|NCT02216123|Chloroquine|chloroquine|mesh-list
111164988|NCT02216123|Primaquine|primaquine|mesh-list
111164989|NCT02216123|Tafenoquine|tafenoquine|mesh-list
111164990|NCT02216123|Amebicides|amebicides|mesh-ancestor
111164991|NCT02216123|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111164992|NCT02216123|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111164993|NCT02216123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111164994|NCT02216123|Antimalarials|antimalarials|mesh-ancestor
111164995|NCT02216123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111164996|NCT01490866|Leucovorin|leucovorin|mesh-list
111164997|NCT01490866|Bevacizumab|bevacizumab|mesh-list
111164998|NCT01490866|Fluorouracil|fluorouracil|mesh-list
111164999|NCT01490866|Oxaliplatin|oxaliplatin|mesh-list
111165000|NCT01490866|Axitinib|axitinib|mesh-list
111165001|NCT01490866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111165002|NCT01490866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111165003|NCT01490866|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111165004|NCT01490866|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111165005|NCT01490866|Growth Substances|growth substances|mesh-ancestor
111165006|NCT01490866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111165007|NCT01490866|Growth Inhibitors|growth inhibitors|mesh-ancestor
111165008|NCT01490866|Antimetabolites|antimetabolites|mesh-ancestor
111165009|NCT01490866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111165010|NCT01490866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111165011|NCT01490866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111165012|NCT01490866|Immunologic Factors|immunologic factors|mesh-ancestor
111165013|NCT01490866|Antidotes|antidotes|mesh-ancestor
111165014|NCT01490866|Protective Agents|protective agents|mesh-ancestor
111165015|NCT01490866|Vitamin B Complex|vitamin b complex|mesh-ancestor
111165016|NCT01490866|Vitamins|vitamins|mesh-ancestor
111165017|NCT01490866|Micronutrients|micronutrients|mesh-ancestor
111165018|NCT01490866|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111165019|NCT01490866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111165020|NCT02215967|Cyclophosphamide|cyclophosphamide|mesh-list
111165021|NCT02215967|Fludarabine|fludarabine|mesh-list
111165022|NCT02215967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111165023|NCT02215967|Immunologic Factors|immunologic factors|mesh-ancestor
111165024|NCT02215967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111165025|NCT02215967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111165026|NCT02215967|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111165027|NCT02215967|Alkylating Agents|alkylating agents|mesh-ancestor
111165028|NCT02215967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111165029|NCT02215967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111165030|NCT02215967|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111165031|NCT02168387|Acetylcysteine|acetylcysteine|mesh-list
111165032|NCT02168387|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111165033|NCT02168387|Antiviral Agents|antiviral agents|mesh-ancestor
111165034|NCT02168387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111165035|NCT02168387|Expectorants|expectorants|mesh-ancestor
111165036|NCT02168387|Respiratory System Agents|respiratory system agents|mesh-ancestor
111165037|NCT02168387|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111165038|NCT02168387|Antioxidants|antioxidants|mesh-ancestor
111165039|NCT02168387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111165040|NCT02168387|Protective Agents|protective agents|mesh-ancestor
111165041|NCT02168387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111165042|NCT02168387|Antidotes|antidotes|mesh-ancestor
111165043|NCT04418219|Interferons|interferons|mesh-list
111165044|NCT04418219|Interferon-alpha|interferon-alpha|mesh-list
111165045|NCT04418219|Interferon alpha-2|interferon alpha-2|mesh-list
111165046|NCT04418219|Cyclophosphamide|cyclophosphamide|mesh-list
111165047|NCT04418219|Pembrolizumab|pembrolizumab|mesh-list
111165048|NCT04418219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111165049|NCT04418219|Immunologic Factors|immunologic factors|mesh-ancestor
111165050|NCT04418219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111165051|NCT04418219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111165052|NCT04418219|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111165053|NCT04418219|Alkylating Agents|alkylating agents|mesh-ancestor
111165054|NCT04418219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111165055|NCT04418219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111165056|NCT04418219|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111165057|NCT04418219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111165058|NCT04418219|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111165059|NCT04418219|Antiviral Agents|antiviral agents|mesh-ancestor
111165060|NCT04418219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111165061|NCT02167451|Maraviroc|maraviroc|mesh-list
111165062|NCT02167451|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
111165063|NCT02167451|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
111165064|NCT02167451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111165065|NCT02167451|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111165066|NCT02167451|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111165067|NCT02167451|Antiviral Agents|antiviral agents|mesh-ancestor
111165068|NCT02167451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111165069|NCT02167451|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
111165070|NCT02167139|Adalimumab|adalimumab|mesh-list
111165071|NCT02167139|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111165072|NCT02167139|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111165073|NCT02167139|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111165075|NCT02116309|Epinephrine|epinephrine|mesh-list
110882138|NCT03702738|Acetylcysteine|acetylcysteine|mesh-list
111165076|NCT02116309|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111165077|NCT02116309|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111165078|NCT02116309|Adrenergic Agents|adrenergic agents|mesh-ancestor
111165079|NCT02116309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111165080|NCT02116309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111165081|NCT02116309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111165082|NCT02116309|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111165083|NCT02116309|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111165084|NCT02116309|Autonomic Agents|autonomic agents|mesh-ancestor
111165085|NCT02116309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111165086|NCT02116309|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111165087|NCT02116309|Respiratory System Agents|respiratory system agents|mesh-ancestor
111165088|NCT02116309|Mydriatics|mydriatics|mesh-ancestor
111165089|NCT02116309|Sympathomimetics|sympathomimetics|mesh-ancestor
111165090|NCT02116309|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110486452|NCT02662647|Antimetabolites|antimetabolites|mesh-ancestor
111165091|NCT02116309|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111165092|NCT02116309|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111165093|NCT02116309|Analgesics|analgesics|mesh-ancestor
111165094|NCT02116309|Sensory System Agents|sensory system agents|mesh-ancestor
111165095|NCT02116309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111165096|NCT02116309|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111165097|NCT02116309|Gout Suppressants|gout suppressants|mesh-ancestor
111165098|NCT02116309|Tocolytic Agents|tocolytic agents|mesh-ancestor
111165099|NCT02116309|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111165100|NCT02116309|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111165101|NCT02116309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111165102|NCT01474486|Ergocalciferols|ergocalciferols|mesh-list
111165103|NCT01474486|Thiamine|thiamine|mesh-list
111165104|NCT01474486|Micronutrients|micronutrients|mesh-list
111165105|NCT01474486|Trace Elements|trace elements|mesh-list
111165106|NCT01474486|Vitamins|vitamins|mesh-ancestor
111165107|NCT01474486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111165108|NCT01474486|Vitamin B Complex|vitamin b complex|mesh-ancestor
111165109|NCT01474486|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111165110|NCT01474486|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111165111|NCT01451398|Insulin|insulin|mesh-list
111165112|NCT01451398|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111165113|NCT01451398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111165114|NCT02073565|Everolimus|everolimus|mesh-list
111165115|NCT02073565|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111165116|NCT02073565|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111165117|NCT02073565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111165118|NCT02073565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111165119|NCT02073565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111165120|NCT02073565|Immunologic Factors|immunologic factors|mesh-ancestor
111165121|NCT02073565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111165122|NCT02073565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111165123|NCT02071225|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
111165124|NCT02071225|Obinutuzumab|obinutuzumab|mesh-list
111165125|NCT02071225|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111165126|NCT02071225|Alkylating Agents|alkylating agents|mesh-ancestor
111165127|NCT02071225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111165128|NCT02071225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111165129|NCT02071225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111165130|NCT01450696|Capecitabine|capecitabine|mesh-list
111165131|NCT01450696|Trastuzumab|trastuzumab|mesh-list
111165132|NCT01450696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111165133|NCT01450696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111165134|NCT01450696|Antimetabolites|antimetabolites|mesh-ancestor
111165135|NCT01450696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110842081|NCT05761730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111165136|NCT01450696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111165138|NCT02070991|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
111165139|NCT02070991|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
111165140|NCT02070991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111165141|NCT02070991|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
111165142|NCT01490086|Aripiprazole|aripiprazole|mesh-list
111165143|NCT01490086|RP5063|rp5063|mesh-list
111165144|NCT01490086|Antidepressive Agents|antidepressive agents|mesh-ancestor
111165145|NCT01490086|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111165146|NCT01490086|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111165147|NCT01490086|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111165148|NCT01490086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111165149|NCT01490086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111165150|NCT01490086|Dopamine Agonists|dopamine agonists|mesh-ancestor
111165152|NCT01490086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111165153|NCT01490086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111165154|NCT01490086|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111165155|NCT01490086|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111165156|NCT01490086|Serotonin Agents|serotonin agents|mesh-ancestor
111165157|NCT01490086|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111165158|NCT01490086|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111165159|NCT01490086|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111165160|NCT01490086|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111165161|NCT02113579|Fluorides|fluorides|mesh-list
111165162|NCT02113579|Cariostatic Agents|cariostatic agents|mesh-ancestor
111165163|NCT02113579|Protective Agents|protective agents|mesh-ancestor
111165164|NCT02113579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111165165|NCT01474018|Bromocriptine|bromocriptine|mesh-list
111165166|NCT01474018|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111165167|NCT01474018|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111165168|NCT01474018|Hormone Antagonists|hormone antagonists|mesh-ancestor
111165169|NCT01474018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111165170|NCT01474018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111165171|NCT01474018|Dopamine Agonists|dopamine agonists|mesh-ancestor
111165172|NCT01474018|Dopamine Agents|dopamine agents|mesh-ancestor
111165173|NCT01474018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111165174|NCT01474018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111165175|NCT02100475|Insulin|insulin|mesh-list
111165176|NCT02100475|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111165177|NCT02100475|Insulin Aspart|insulin aspart|mesh-list
111165178|NCT02100475|Liraglutide|liraglutide|mesh-list
111165179|NCT02100475|Xultophy|xultophy|mesh-list
111165180|NCT02100475|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111165181|NCT02100475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111165182|NCT02100475|Incretins|incretins|mesh-ancestor
111165183|NCT02100475|Hormones|hormones|mesh-ancestor
111165184|NCT02100475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111165185|NCT04075240|Aspirin|aspirin|mesh-list
111165186|NCT04075240|Rivaroxaban|rivaroxaban|mesh-list
111165187|NCT04075240|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111165188|NCT04075240|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111165189|NCT04075240|Analgesics|analgesics|mesh-ancestor
111165190|NCT04075240|Sensory System Agents|sensory system agents|mesh-ancestor
111165191|NCT04075240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111165192|NCT04075240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111165193|NCT04075240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111165194|NCT04075240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111165195|NCT04075240|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111165196|NCT04075240|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111165197|NCT04075240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111165198|NCT04075240|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111165199|NCT04075240|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111165200|NCT04075240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111165201|NCT04075240|Antipyretics|antipyretics|mesh-ancestor
111165202|NCT04075240|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111165203|NCT04075240|Antithrombins|antithrombins|mesh-ancestor
111165204|NCT04075240|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111165205|NCT04075240|Protease Inhibitors|protease inhibitors|mesh-ancestor
111165206|NCT04075240|Anticoagulants|anticoagulants|mesh-ancestor
111165207|NCT02070757|Meropenem|meropenem|mesh-list
111165208|NCT02070757|Tazobactam|tazobactam|mesh-list
111165209|NCT02070757|Ceftolozane|ceftolozane|mesh-list
111165210|NCT02070757|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
111165211|NCT02070757|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111165212|NCT02070757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111165213|NCT02070757|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
111165214|NCT02070757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111165215|NCT02070757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111165216|NCT02070757|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111165217|NCT02100319|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
111165218|NCT02100319|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111165219|NCT02100319|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111165220|NCT02100319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111165221|NCT01625845|Pentoxifylline|pentoxifylline|mesh-list
111165222|NCT01625845|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110882281|NCT03336333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111165223|NCT01625845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111165224|NCT01625845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111165225|NCT01625845|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111165226|NCT01625845|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111165228|NCT01625845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111165229|NCT01625845|Vasodilator Agents|vasodilator agents|mesh-ancestor
111165230|NCT01625845|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111165231|NCT01625845|Antioxidants|antioxidants|mesh-ancestor
111165232|NCT01473940|Gemcitabine|gemcitabine|mesh-list
111165233|NCT01473940|Ipilimumab|ipilimumab|mesh-list
111165234|NCT01473940|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111165235|NCT01473940|Antibodies|antibodies|mesh-list
111165236|NCT01473940|Immunoglobulins|immunoglobulins|mesh-list
111165237|NCT01473940|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111165238|NCT01473940|Immunologic Factors|immunologic factors|mesh-ancestor
111165239|NCT01473940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111165240|NCT01473940|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111165241|NCT01473940|Antimetabolites|antimetabolites|mesh-ancestor
111165242|NCT01473940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111165243|NCT01473940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111165244|NCT01473940|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111165245|NCT01832727|Dexamethasone|dexamethasone|mesh-list
111165246|NCT01832727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111165247|NCT01832727|Antiemetics|antiemetics|mesh-ancestor
111165248|NCT01832727|Autonomic Agents|autonomic agents|mesh-ancestor
111165249|NCT01832727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111165250|NCT01832727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111165251|NCT01832727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111165252|NCT01832727|Glucocorticoids|glucocorticoids|mesh-ancestor
111165253|NCT01832727|Hormones|hormones|mesh-ancestor
111165254|NCT01832727|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111165255|NCT01832727|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111165256|NCT01832727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111165257|NCT01473394|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
111165258|NCT01473394|Antidepressive Agents|antidepressive agents|mesh-ancestor
111165259|NCT01473394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110842095|NCT00159588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111165260|NCT01473394|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111165261|NCT01473394|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111165262|NCT01473394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111165263|NCT01473394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111165264|NCT01473394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111165265|NCT01473394|Serotonin Agents|serotonin agents|mesh-ancestor
111165266|NCT01473394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111165267|NCT01473394|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111165268|NCT01473394|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111165269|NCT04408144|Dydrogesterone|dydrogesterone|mesh-list
111165270|NCT04408144|Progestins|progestins|mesh-ancestor
111165271|NCT04408144|Hormones|hormones|mesh-ancestor
111165272|NCT04408144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111165273|NCT04408144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111165274|NCT01449682|Dexamethasone|dexamethasone|mesh-list
111165275|NCT01449682|Dexamethasone acetate|dexamethasone acetate|mesh-list
111165276|NCT01449682|BB 1101|bb 1101|mesh-list
111165277|NCT01449682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111165278|NCT01449682|Antiemetics|antiemetics|mesh-ancestor
111165279|NCT01449682|Autonomic Agents|autonomic agents|mesh-ancestor
111165280|NCT01449682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111165281|NCT01449682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111165282|NCT01449682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111165283|NCT01449682|Glucocorticoids|glucocorticoids|mesh-ancestor
111165284|NCT01449682|Hormones|hormones|mesh-ancestor
111165285|NCT01449682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111165286|NCT01449682|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111165287|NCT01449682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111165288|NCT01449682|Protease Inhibitors|protease inhibitors|mesh-ancestor
111165289|NCT01449682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111165290|NCT01449682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111165291|NCT01831791|Dutasteride|dutasteride|mesh-list
111165292|NCT01831791|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
111165293|NCT01831791|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111165294|NCT01831791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111165295|NCT01831791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111165296|NCT01831791|Hormone Antagonists|hormone antagonists|mesh-ancestor
111165297|NCT01831791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111165298|NCT01831791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111165299|NCT01857531|Nicotine|nicotine|mesh-list
111165300|NCT01857531|Ganaxolone|ganaxolone|mesh-list
111165301|NCT01857531|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111165302|NCT01857531|Autonomic Agents|autonomic agents|mesh-ancestor
111165303|NCT01857531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111165304|NCT01857531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111165305|NCT01857531|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111165306|NCT01857531|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111165307|NCT01857531|Cholinergic Agents|cholinergic agents|mesh-ancestor
111165308|NCT01857531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111165309|NCT01857531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111165310|NCT01857531|Neurosteroids|neurosteroids|mesh-ancestor
111165311|NCT01857531|GABA Modulators|gaba modulators|mesh-ancestor
111165312|NCT01857531|GABA Agents|gaba agents|mesh-ancestor
111165313|NCT02166047|Vesatolimod|vesatolimod|mesh-list
111165314|NCT02166047|Antiviral Agents|antiviral agents|mesh-ancestor
110842127|NCT04349917|Methylphenidate|methylphenidate|mesh-list
110842128|NCT04349917|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110842129|NCT04349917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110842130|NCT04349917|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110842131|NCT04349917|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110842132|NCT04349917|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110842133|NCT04349917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111165315|NCT02166047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111165316|NCT01831089|Paclitaxel|paclitaxel|mesh-list
111165317|NCT01831089|Bevacizumab|bevacizumab|mesh-list
111165318|NCT01831089|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111165319|NCT01831089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111165320|NCT01831089|Tubulin Modulators|tubulin modulators|mesh-ancestor
111165321|NCT01831089|Antimitotic Agents|antimitotic agents|mesh-ancestor
111165322|NCT01831089|Mitosis Modulators|mitosis modulators|mesh-ancestor
111165323|NCT01831089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111165324|NCT01831089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111165325|NCT01831089|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111165326|NCT01831089|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111165327|NCT01831089|Growth Substances|growth substances|mesh-ancestor
111165328|NCT01831089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111165329|NCT01831089|Growth Inhibitors|growth inhibitors|mesh-ancestor
111165330|NCT02111785|Dexamethasone|dexamethasone|mesh-list
111165331|NCT02111785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111165332|NCT02111785|Antiemetics|antiemetics|mesh-ancestor
111165333|NCT02111785|Autonomic Agents|autonomic agents|mesh-ancestor
111165334|NCT02111785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110486496|NCT00648999|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111165335|NCT02111785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111165336|NCT02111785|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111165337|NCT02111785|Glucocorticoids|glucocorticoids|mesh-ancestor
111165338|NCT02111785|Hormones|hormones|mesh-ancestor
111165339|NCT02111785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111165340|NCT02111785|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111165341|NCT02111785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111165342|NCT02068495|Amlodipine|amlodipine|mesh-list
111165343|NCT02068495|Candesartan|candesartan|mesh-list
111165344|NCT02068495|Candesartan cilexetil|candesartan cilexetil|mesh-list
111165345|NCT02068495|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111165346|NCT02068495|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111165347|NCT02068495|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111165348|NCT02068495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111165349|NCT02068495|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111165350|NCT02068495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111165351|NCT02068495|Vasodilator Agents|vasodilator agents|mesh-ancestor
111165352|NCT02068495|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111165353|NCT02068495|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111165354|NCT02097823|Olanzapine|olanzapine|mesh-list
111165355|NCT02097823|Aprepitant|aprepitant|mesh-list
111165356|NCT02097823|Antiemetics|antiemetics|mesh-ancestor
111165357|NCT02097823|Autonomic Agents|autonomic agents|mesh-ancestor
111165358|NCT02097823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111165359|NCT02097823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111165360|NCT02097823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111165361|NCT02097823|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111165362|NCT02097823|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111165363|NCT02097823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111165364|NCT02097823|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111165365|NCT02097823|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111165366|NCT02097823|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111165367|NCT02097823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111165368|NCT02097823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111165369|NCT02097823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110882431|NCT03692286|Calcium, Dietary|calcium, dietary|mesh-list
111165371|NCT02097823|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
111165373|NCT01857063|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111165374|NCT01857063|Respiratory System Agents|respiratory system agents|mesh-ancestor
111165375|NCT01857063|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
111165376|NCT01857063|Hormone Antagonists|hormone antagonists|mesh-ancestor
111165377|NCT01857063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111165378|NCT01857063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111165379|NCT01857063|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
111165380|NCT01857063|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111165381|NCT01857063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111165382|NCT01856907|Metformin|metformin|mesh-list
111165383|NCT01856907|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111165384|NCT01856907|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111165385|NCT01856907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111165386|NCT01856907|Incretins|incretins|mesh-ancestor
111165387|NCT01856907|Hormones|hormones|mesh-ancestor
111165388|NCT01856907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111165389|NCT01856907|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111165390|NCT01856907|Protease Inhibitors|protease inhibitors|mesh-ancestor
111165391|NCT01856907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111165392|NCT01856907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111165393|NCT02097745|Rituximab|rituximab|mesh-list
111165394|NCT02097745|Methotrexate|methotrexate|mesh-list
111165395|NCT02097745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111165396|NCT02097745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111165397|NCT02097745|Immunologic Factors|immunologic factors|mesh-ancestor
111165398|NCT02097745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111165399|NCT02097745|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111165400|NCT02097745|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111165401|NCT02097745|Abortifacient Agents|abortifacient agents|mesh-ancestor
111165402|NCT02097745|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110842151|NCT04691856|Analgesics|analgesics|mesh-ancestor
111165403|NCT02097745|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111165404|NCT02097745|Antimetabolites|antimetabolites|mesh-ancestor
111165405|NCT02097745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111165406|NCT02097745|Dermatologic Agents|dermatologic agents|mesh-ancestor
111165407|NCT02097745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111165408|NCT02097745|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111165409|NCT02097745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111165410|NCT02097745|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111165411|NCT02111083|Insulin Lispro|insulin lispro|mesh-list
111165412|NCT02111083|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111165413|NCT02111083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111165414|NCT01629563|Ulipristal acetate|ulipristal acetate|mesh-list
111165415|NCT01629563|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111165416|NCT01629563|Contraceptive Agents|contraceptive agents|mesh-ancestor
111165417|NCT01629563|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111165418|NCT01629563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111165419|NCT01629563|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111165420|NCT02212379|Raltegravir Potassium|raltegravir potassium|mesh-list
111165421|NCT02212379|Etravirine|etravirine|mesh-list
111165422|NCT02212379|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111165423|NCT02212379|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111165424|NCT02212379|Antiviral Agents|antiviral agents|mesh-ancestor
111165425|NCT02212379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111165426|NCT02212379|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111165427|NCT02212379|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111165428|NCT02212379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111165429|NCT02212379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111165430|NCT02212379|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111165431|NCT02212379|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111165432|NCT02187809|Clobazam|clobazam|mesh-list
111165433|NCT02187809|Anticonvulsants|anticonvulsants|mesh-ancestor
111165434|NCT02187809|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111165435|NCT02187809|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111165436|NCT02187809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111165437|NCT02187809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111165438|NCT02187809|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111165439|NCT02187809|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
111165440|NCT02187809|GABA Agonists|gaba agonists|mesh-ancestor
111165441|NCT02187809|GABA Agents|gaba agents|mesh-ancestor
111165442|NCT02187809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111165443|NCT02187809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111165444|NCT02110225|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111165445|NCT02110225|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111165446|NCT02110225|Mitogens|mitogens|mesh-list
111165447|NCT02110225|Mitosis Modulators|mitosis modulators|mesh-ancestor
111165448|NCT02110225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111165449|NCT04756505|Interleukin-12|interleukin-12|mesh-list
111165450|NCT04756505|Immunoglobulin G|immunoglobulin g|mesh-list
111165451|NCT04756505|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111165452|NCT04756505|Immunologic Factors|immunologic factors|mesh-ancestor
111165453|NCT04756505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111165454|NCT04756505|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111165455|NCT04756505|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111165456|NCT04756505|Growth Substances|growth substances|mesh-ancestor
111165457|NCT04756505|Growth Inhibitors|growth inhibitors|mesh-ancestor
111165458|NCT04756505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111165459|NCT04750655|Moxifloxacin|moxifloxacin|mesh-list
111165460|NCT04750655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111165461|NCT04750655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111165462|NCT04750655|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111165463|NCT04750655|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111165464|NCT04750655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111165465|NCT04750655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111165466|NCT04750655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111165467|NCT02162771|Prednisone|prednisone|mesh-list
111165468|NCT02162771|Prednisolone|prednisolone|mesh-list
111165469|NCT02162771|Cyclophosphamide|cyclophosphamide|mesh-list
111165470|NCT02162771|Rituximab|rituximab|mesh-list
111165471|NCT02162771|Vincristine|vincristine|mesh-list
111165472|NCT02162771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111165473|NCT02162771|Immunologic Factors|immunologic factors|mesh-ancestor
111165474|NCT02162771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111165475|NCT02162771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111165476|NCT02162771|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111165477|NCT02162771|Alkylating Agents|alkylating agents|mesh-ancestor
111165478|NCT02162771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111165479|NCT02162771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111165480|NCT02162771|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111165481|NCT02162771|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111165482|NCT02162771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111165483|NCT02162771|Glucocorticoids|glucocorticoids|mesh-ancestor
111165485|NCT02162771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111165486|NCT02162771|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111165487|NCT02162771|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111165488|NCT02162771|Tubulin Modulators|tubulin modulators|mesh-ancestor
111165489|NCT02162771|Antimitotic Agents|antimitotic agents|mesh-ancestor
111165490|NCT02162771|Mitosis Modulators|mitosis modulators|mesh-ancestor
111165491|NCT02160041|Infigratinib|infigratinib|mesh-list
111165492|NCT02160041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111165493|NCT02186873|Golimumab|golimumab|mesh-list
111165494|NCT02186873|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111165495|NCT02186873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111165496|NCT02186873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111165497|NCT02186873|Immunologic Factors|immunologic factors|mesh-ancestor
111165498|NCT02186873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111165499|NCT02096263|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
111165500|NCT02096263|Immunologic Factors|immunologic factors|mesh-ancestor
111165501|NCT02096263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111165502|NCT01830543|Aspirin|aspirin|mesh-list
111165503|NCT01830543|Vitamin K|vitamin k|mesh-list
111165504|NCT01830543|Rivaroxaban|rivaroxaban|mesh-list
111165505|NCT01830543|Clopidogrel|clopidogrel|mesh-list
111165506|NCT01830543|Ticagrelor|ticagrelor|mesh-list
111165507|NCT01830543|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
111165508|NCT01830543|Vitamins|vitamins|mesh-ancestor
111165509|NCT01830543|Micronutrients|micronutrients|mesh-ancestor
111165510|NCT01830543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111165511|NCT01830543|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111165512|NCT01830543|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111165513|NCT01830543|Analgesics|analgesics|mesh-ancestor
111165514|NCT01830543|Sensory System Agents|sensory system agents|mesh-ancestor
111165515|NCT01830543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111165516|NCT01830543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111165517|NCT01830543|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110882582|NCT04733235|Progesterone|progesterone|mesh-list
111165518|NCT01830543|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111165519|NCT01830543|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111165520|NCT01830543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111165521|NCT01830543|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111165522|NCT01830543|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111165523|NCT01830543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111165524|NCT01830543|Antipyretics|antipyretics|mesh-ancestor
111165525|NCT01830543|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111165526|NCT01830543|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111165527|NCT01830543|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111165528|NCT01830543|Purinergic Agents|purinergic agents|mesh-ancestor
111165529|NCT01830543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111165530|NCT01830543|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111165531|NCT01830543|Antithrombins|antithrombins|mesh-ancestor
111165532|NCT01830543|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111165533|NCT01830543|Protease Inhibitors|protease inhibitors|mesh-ancestor
111165534|NCT01830543|Anticoagulants|anticoagulants|mesh-ancestor
111165535|NCT01830543|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111165536|NCT01830543|Hemostatics|hemostatics|mesh-ancestor
111165537|NCT01830543|Coagulants|coagulants|mesh-ancestor
111165538|NCT02109445|Paclitaxel|paclitaxel|mesh-list
111165539|NCT02109445|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111165540|NCT02109445|Gemcitabine|gemcitabine|mesh-list
111165541|NCT02109445|Nirogacestat|nirogacestat|mesh-list
111165542|NCT02109445|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111165543|NCT02109445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111165544|NCT02109445|Tubulin Modulators|tubulin modulators|mesh-ancestor
111165545|NCT02109445|Antimitotic Agents|antimitotic agents|mesh-ancestor
111165546|NCT02109445|Mitosis Modulators|mitosis modulators|mesh-ancestor
111165547|NCT02109445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111165548|NCT02109445|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111165549|NCT02109445|Antimetabolites|antimetabolites|mesh-ancestor
111165550|NCT02109445|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
111165551|NCT02109445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111165552|NCT02109133|Rocuronium|rocuronium|mesh-list
111165553|NCT02109133|Atracurium|atracurium|mesh-list
111165554|NCT02109133|Neostigmine|neostigmine|mesh-list
111165555|NCT02109133|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
111165556|NCT02109133|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
111165557|NCT02109133|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111165558|NCT02109133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111165559|NCT02109133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111165560|NCT02109133|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111165561|NCT02109133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111165562|NCT02109133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111165563|NCT02109133|Cholinergic Agents|cholinergic agents|mesh-ancestor
111165564|NCT02109133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111165565|NCT02109133|Parasympathomimetics|parasympathomimetics|mesh-ancestor
111165566|NCT02109133|Autonomic Agents|autonomic agents|mesh-ancestor
111165567|NCT02109133|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
111165568|NCT02109133|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111165569|NCT01623271|Gabapentin|gabapentin|mesh-list
111165570|NCT01623271|Analgesics|analgesics|mesh-ancestor
111165571|NCT01623271|Sensory System Agents|sensory system agents|mesh-ancestor
111165572|NCT01623271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111165573|NCT01623271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111165574|NCT01623271|Anticonvulsants|anticonvulsants|mesh-ancestor
111165575|NCT01623271|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111165576|NCT01623271|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111165577|NCT01623271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111165578|NCT01623271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111165579|NCT01623271|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111165580|NCT01623271|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111165581|NCT01623271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111165582|NCT01623271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111165583|NCT01623271|Antimanic Agents|antimanic agents|mesh-ancestor
111165584|NCT02095951|Ethanol|ethanol|mesh-list
111165585|NCT02095951|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111165586|NCT02095951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111165587|NCT02095951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111165588|NCT02095951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111165589|NCT02095873|Resveratrol|resveratrol|mesh-list
111165590|NCT02095873|Antioxidants|antioxidants|mesh-ancestor
111165591|NCT02095873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111165592|NCT02095873|Protective Agents|protective agents|mesh-ancestor
111165593|NCT02095873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111165594|NCT02095873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111165595|NCT02095873|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111165596|NCT02094937|Fluticasone|fluticasone|mesh-list
111165597|NCT02094937|Xhance|xhance|mesh-list
111165598|NCT02094937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111165599|NCT02094937|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111165600|NCT02094937|Autonomic Agents|autonomic agents|mesh-ancestor
111165601|NCT02094937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111165602|NCT02094937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111165603|NCT02094937|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111165604|NCT02094937|Respiratory System Agents|respiratory system agents|mesh-ancestor
111165605|NCT02094937|Dermatologic Agents|dermatologic agents|mesh-ancestor
110486525|NCT00649077|Meloxicam|meloxicam|mesh-list
111165606|NCT02094937|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111165607|NCT04724629|Aldesleukin|aldesleukin|mesh-list
111165608|NCT04724629|Colchicine|colchicine|mesh-list
111165609|NCT04724629|Ixekizumab|ixekizumab|mesh-list
111165610|NCT04724629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111165611|NCT04724629|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111165612|NCT04724629|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111165613|NCT04724629|Antiviral Agents|antiviral agents|mesh-ancestor
111165614|NCT04724629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111165615|NCT04724629|Gout Suppressants|gout suppressants|mesh-ancestor
111165616|NCT04724629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111165617|NCT04724629|Tubulin Modulators|tubulin modulators|mesh-ancestor
111165618|NCT04724629|Antimitotic Agents|antimitotic agents|mesh-ancestor
111165619|NCT04724629|Mitosis Modulators|mitosis modulators|mesh-ancestor
111165620|NCT04724629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111165621|NCT04724629|Dermatologic Agents|dermatologic agents|mesh-ancestor
111165622|NCT02186015|Vitamin D|vitamin d|mesh-list
111165623|NCT02186015|Ergocalciferols|ergocalciferols|mesh-list
111165624|NCT02186015|Cholecalciferol|cholecalciferol|mesh-list
111165625|NCT02186015|Vitamins|vitamins|mesh-list
111165626|NCT02186015|Micronutrients|micronutrients|mesh-ancestor
111165627|NCT02186015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111165628|NCT02186015|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111165629|NCT02186015|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111165630|NCT02066389|Upadacitinib|upadacitinib|mesh-list
111165631|NCT02066389|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
111165632|NCT02066389|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111165633|NCT02066389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111165634|NCT02066389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111165635|NCT02066389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111165636|NCT02106403|Disinfectants|disinfectants|mesh-list
111165637|NCT02106403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111165638|NCT02133131|Sofosbuvir|sofosbuvir|mesh-list
111165639|NCT02133131|Grazoprevir|grazoprevir|mesh-list
111165640|NCT02133131|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
111165641|NCT02133131|Antiviral Agents|antiviral agents|mesh-ancestor
111165642|NCT02133131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111165643|NCT02106325|Diphenhydramine|diphenhydramine|mesh-list
111165644|NCT02106325|Promethazine|promethazine|mesh-list
111165645|NCT02106325|Ketamine|ketamine|mesh-list
111165646|NCT02106325|Analgesics|analgesics|mesh-ancestor
111165647|NCT02106325|Sensory System Agents|sensory system agents|mesh-ancestor
111165648|NCT02106325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111165649|NCT02106325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111165650|NCT02106325|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111165651|NCT02106325|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111165652|NCT02106325|Anesthetics, General|anesthetics, general|mesh-ancestor
111165653|NCT02106325|Anesthetics|anesthetics|mesh-ancestor
111165654|NCT02106325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111165655|NCT02106325|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111165656|NCT02106325|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111165657|NCT02106325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111165658|NCT02106325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111165659|NCT02106325|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111165660|NCT02106325|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111165661|NCT02106325|Anesthetics, Local|anesthetics, local|mesh-ancestor
111165662|NCT02106325|Antiemetics|antiemetics|mesh-ancestor
111165663|NCT02106325|Autonomic Agents|autonomic agents|mesh-ancestor
111165664|NCT02106325|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111165665|NCT02106325|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111165666|NCT02106325|Histamine Antagonists|histamine antagonists|mesh-ancestor
111165667|NCT02106325|Histamine Agents|histamine agents|mesh-ancestor
111165668|NCT02106325|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111165669|NCT02106325|Antipruritics|antipruritics|mesh-ancestor
111165670|NCT02106325|Dermatologic Agents|dermatologic agents|mesh-ancestor
111165671|NCT02184611|Bromides|bromides|mesh-list
111165672|NCT02184611|Anticonvulsants|anticonvulsants|mesh-ancestor
111165673|NCT02066311|Nelfinavir|nelfinavir|mesh-list
111165674|NCT02066311|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111165675|NCT02066311|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111165676|NCT02066311|Protease Inhibitors|protease inhibitors|mesh-ancestor
111165677|NCT02066311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111165678|NCT02066311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111165679|NCT02066311|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111165680|NCT02066311|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111165681|NCT02066311|Antiviral Agents|antiviral agents|mesh-ancestor
111165682|NCT02066311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111165684|NCT01625611|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111165685|NCT01625611|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111165686|NCT01625611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111165687|NCT01625611|Sensory System Agents|sensory system agents|mesh-ancestor
111165688|NCT01625611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111165689|NCT02159807|Fentanyl|fentanyl|mesh-list
111165690|NCT02159807|Bupivacaine|bupivacaine|mesh-list
111165691|NCT02159807|Anesthetics, Local|anesthetics, local|mesh-ancestor
111165692|NCT02159807|Anesthetics|anesthetics|mesh-ancestor
111165693|NCT02159807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111165694|NCT02159807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111165695|NCT02159807|Sensory System Agents|sensory system agents|mesh-ancestor
111165696|NCT02159807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111165697|NCT02159807|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111165698|NCT02159807|Narcotics|narcotics|mesh-ancestor
111165699|NCT02159807|Analgesics|analgesics|mesh-ancestor
111165700|NCT02159807|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111165701|NCT02159807|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111165702|NCT02159807|Anesthetics, General|anesthetics, general|mesh-ancestor
111165703|NCT02183675|Amlodipine|amlodipine|mesh-list
111165704|NCT02183675|Telmisartan|telmisartan|mesh-list
111165705|NCT02183675|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
111165706|NCT02183675|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
111165707|NCT02183675|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111165708|NCT02183675|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111165709|NCT02183675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111165710|NCT02183675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111165711|NCT02183675|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111165712|NCT02183675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111165713|NCT02183675|Vasodilator Agents|vasodilator agents|mesh-ancestor
111165714|NCT02183675|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111165715|NCT02183675|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111165716|NCT02183675|Diuretics|diuretics|mesh-ancestor
111165717|NCT02183675|Natriuretic Agents|natriuretic agents|mesh-ancestor
111165718|NCT02183675|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
111165719|NCT02183519|Capsaicin|capsaicin|mesh-list
111165720|NCT02183519|Antipruritics|antipruritics|mesh-ancestor
111165721|NCT02183519|Dermatologic Agents|dermatologic agents|mesh-ancestor
111165722|NCT02183519|Sensory System Agents|sensory system agents|mesh-ancestor
111165723|NCT02183519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111165724|NCT02183519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111165725|NCT02132195|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
111165726|NCT02132195|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
111165727|NCT02132195|beta-Endorphin|beta-endorphin|mesh-list
111165728|NCT02132195|Hormones|hormones|mesh-ancestor
111165729|NCT02132195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111165730|NCT02132195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111165731|NCT02132195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111165732|NCT02132195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111165733|NCT02182895|Saxagliptin|saxagliptin|mesh-list
111165734|NCT02182895|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
111165735|NCT02182895|Incretins|incretins|mesh-ancestor
111165736|NCT02182895|Hormones|hormones|mesh-ancestor
111165737|NCT02182895|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111165738|NCT02182895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111165739|NCT02182895|Protease Inhibitors|protease inhibitors|mesh-ancestor
111165740|NCT02182895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111165741|NCT02182895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111165742|NCT02182895|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111165743|NCT01625377|Mycophenolic Acid|mycophenolic acid|mesh-list
111165744|NCT01625377|Everolimus|everolimus|mesh-list
111165745|NCT01625377|Tacrolimus|tacrolimus|mesh-list
111165746|NCT01625377|Basiliximab|basiliximab|mesh-list
111165747|NCT01625377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110882815|NCT01568931|Coal Tar|coal tar|mesh-list
111165749|NCT01625377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111165750|NCT01625377|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111165751|NCT01625377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111165752|NCT01625377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111165753|NCT01625377|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111165754|NCT01625377|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111165755|NCT01625377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111165756|NCT01625377|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111165757|NCT01625377|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111165758|NCT01625377|Antitubercular Agents|antitubercular agents|mesh-ancestor
111165759|NCT01625377|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111165760|NCT01625377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111165761|NCT02132117|Phenylephrine|phenylephrine|mesh-list
111165762|NCT02132117|Oxymetazoline|oxymetazoline|mesh-list
111165763|NCT02132117|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111165764|NCT02132117|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111165765|NCT02132117|Adrenergic Agents|adrenergic agents|mesh-ancestor
111165766|NCT02132117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111165767|NCT02132117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111165768|NCT02132117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111165769|NCT02132117|Sympathomimetics|sympathomimetics|mesh-ancestor
111165770|NCT02132117|Autonomic Agents|autonomic agents|mesh-ancestor
111165771|NCT02132117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111165772|NCT02132117|Nasal Decongestants|nasal decongestants|mesh-ancestor
111165773|NCT02132117|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111165774|NCT02132117|Respiratory System Agents|respiratory system agents|mesh-ancestor
111165775|NCT02132117|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111165776|NCT02132117|Mydriatics|mydriatics|mesh-ancestor
111165777|NCT02132117|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111165778|NCT02132117|Protective Agents|protective agents|mesh-ancestor
111165779|NCT02047045|Prucalopride|prucalopride|mesh-list
111165780|NCT02047045|Serotonin|serotonin|mesh-list
111165781|NCT02047045|Laxatives|laxatives|mesh-ancestor
111165782|NCT02047045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111165783|NCT02047045|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
111165784|NCT02047045|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111165785|NCT02047045|Serotonin Agents|serotonin agents|mesh-ancestor
111165786|NCT02047045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111165787|NCT02047045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111165788|NCT02047045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111165789|NCT02131259|Afatinib|afatinib|mesh-list
111165790|NCT02131259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111165791|NCT02131259|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111165792|NCT02131259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111165793|NCT02131259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111165794|NCT01829295|Mycophenolic Acid|mycophenolic acid|mesh-list
111165795|NCT01829295|Prednisone|prednisone|mesh-list
111165796|NCT01829295|Methotrexate|methotrexate|mesh-list
111165797|NCT01829295|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111165798|NCT01829295|Glucocorticoids|glucocorticoids|mesh-ancestor
111165799|NCT01829295|Hormones|hormones|mesh-ancestor
111165800|NCT01829295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111165801|NCT01829295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111165802|NCT01829295|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111165803|NCT01829295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111165804|NCT01829295|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111165805|NCT01829295|Abortifacient Agents|abortifacient agents|mesh-ancestor
111165806|NCT01829295|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111165807|NCT01829295|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111165808|NCT01829295|Antimetabolites|antimetabolites|mesh-ancestor
111165809|NCT01829295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111165810|NCT01829295|Dermatologic Agents|dermatologic agents|mesh-ancestor
111165811|NCT01829295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111165812|NCT01829295|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111165813|NCT01829295|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111165814|NCT01829295|Immunologic Factors|immunologic factors|mesh-ancestor
111165815|NCT01829295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111165816|NCT01829295|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111165817|NCT01829295|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111165818|NCT01829295|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111165819|NCT01829295|Antitubercular Agents|antitubercular agents|mesh-ancestor
111165820|NCT01829295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110882905|NCT03680976|CXA-10|cxa-10|mesh-list
111165821|NCT01829295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111165822|NCT02157935|Formoterol Fumarate|formoterol fumarate|mesh-list
111165823|NCT02157935|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
111165824|NCT02157935|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111165825|NCT02157935|Autonomic Agents|autonomic agents|mesh-ancestor
111165826|NCT02157935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111165827|NCT02157935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111165828|NCT02157935|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111165829|NCT02157935|Respiratory System Agents|respiratory system agents|mesh-ancestor
111165830|NCT02157935|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111165831|NCT02157935|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111165832|NCT02157935|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111165833|NCT02157935|Adrenergic Agents|adrenergic agents|mesh-ancestor
111165834|NCT02157935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111165835|NCT02157935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111165836|NCT02093221|Protease Inhibitors|protease inhibitors|mesh-list
111165837|NCT02093221|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
111165838|NCT02093221|Protein C Inhibitor|protein c inhibitor|mesh-list
111165839|NCT02093221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111165840|NCT02093221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111165841|NCT02093221|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
111165842|NCT02093221|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111165843|NCT01623115|Alirocumab|alirocumab|mesh-list
111165844|NCT01623115|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111165845|NCT01623115|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
111165846|NCT01623115|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111165847|NCT01623115|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111165848|NCT01623115|Antimetabolites|antimetabolites|mesh-ancestor
111165849|NCT01623115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111165850|NCT01623115|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111165851|NCT01623115|Protease Inhibitors|protease inhibitors|mesh-ancestor
111165852|NCT01623115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111165853|NCT01623115|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111165854|NCT01623115|Immunologic Factors|immunologic factors|mesh-ancestor
111165855|NCT01623115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111165856|NCT02092285|Golimumab|golimumab|mesh-list
111165857|NCT02092285|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111165858|NCT02092285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111165859|NCT02092285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111165860|NCT02092285|Immunologic Factors|immunologic factors|mesh-ancestor
111165861|NCT02092285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111165862|NCT02091739|Botulinum Toxins|botulinum toxins|mesh-list
111165863|NCT02091739|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111165864|NCT02091739|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111165865|NCT02091739|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
111165866|NCT02091739|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111165867|NCT02091739|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111165868|NCT02091739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111165869|NCT02091739|Cholinergic Agents|cholinergic agents|mesh-ancestor
111165870|NCT02091739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111165871|NCT02091739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111165872|NCT02091739|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111165873|NCT02091739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111165874|NCT02045875|Mometasone Furoate|mometasone furoate|mesh-list
111165875|NCT02045875|Formoterol Fumarate|formoterol fumarate|mesh-list
111165876|NCT02045875|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111165877|NCT02045875|Autonomic Agents|autonomic agents|mesh-ancestor
111165878|NCT02045875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111165879|NCT02045875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111165880|NCT02045875|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111165881|NCT02045875|Respiratory System Agents|respiratory system agents|mesh-ancestor
111165882|NCT02045875|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111165883|NCT02045875|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111165884|NCT02045875|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111165885|NCT02045875|Adrenergic Agents|adrenergic agents|mesh-ancestor
111165886|NCT02045875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111165887|NCT02045875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111165888|NCT02045875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111165889|NCT02045875|Dermatologic Agents|dermatologic agents|mesh-ancestor
111165890|NCT02045875|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111165891|NCT01827267|Sirolimus|sirolimus|mesh-list
111165892|NCT01827267|Temsirolimus|temsirolimus|mesh-list
111165893|NCT01827267|MTOR Inhibitors|mtor inhibitors|mesh-list
111165894|NCT01827267|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111165895|NCT01827267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111165896|NCT01827267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111165897|NCT01827267|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111165898|NCT01827267|Immunologic Factors|immunologic factors|mesh-ancestor
111165899|NCT01827267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111165900|NCT01827267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111165901|NCT01827267|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111165902|NCT01827267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111165903|NCT01827267|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111165904|NCT01827267|Antifungal Agents|antifungal agents|mesh-ancestor
111165905|NCT01827111|Paclitaxel|paclitaxel|mesh-list
111165906|NCT01827111|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111165907|NCT01827111|Ipilimumab|ipilimumab|mesh-list
111165908|NCT01827111|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111165909|NCT01827111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111165910|NCT01827111|Tubulin Modulators|tubulin modulators|mesh-ancestor
111165911|NCT01827111|Antimitotic Agents|antimitotic agents|mesh-ancestor
111165912|NCT01827111|Mitosis Modulators|mitosis modulators|mesh-ancestor
111165913|NCT01827111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111165914|NCT01827111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111165915|NCT01827111|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111165916|NCT02064439|Rivaroxaban|rivaroxaban|mesh-list
111165917|NCT02064439|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111165918|NCT02064439|Antithrombins|antithrombins|mesh-ancestor
111165919|NCT02064439|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111165920|NCT02064439|Protease Inhibitors|protease inhibitors|mesh-ancestor
111165921|NCT02064439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111165922|NCT02064439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111165923|NCT02064439|Anticoagulants|anticoagulants|mesh-ancestor
111165924|NCT02130557|Imatinib Mesylate|imatinib mesylate|mesh-list
111165925|NCT02130557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111165926|NCT02130557|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111165927|NCT02130557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111165928|NCT02130557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111165929|NCT01854645|Bromides|bromides|mesh-list
111165930|NCT01854645|Tiotropium Bromide|tiotropium bromide|mesh-list
111165931|NCT01854645|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111165932|NCT01854645|Autonomic Agents|autonomic agents|mesh-ancestor
111165933|NCT01854645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111165934|NCT01854645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111165935|NCT01854645|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111165936|NCT01854645|Respiratory System Agents|respiratory system agents|mesh-ancestor
111165938|NCT01854645|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111165939|NCT01854645|Cholinergic Agents|cholinergic agents|mesh-ancestor
111165940|NCT01854645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111165941|NCT01854645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111165942|NCT01854645|Anticonvulsants|anticonvulsants|mesh-ancestor
111165943|NCT04418089|Simvastatin|simvastatin|mesh-list
111165944|NCT04418089|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111165945|NCT04418089|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111165946|NCT04418089|Antimetabolites|antimetabolites|mesh-ancestor
111165947|NCT04418089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111165948|NCT04418089|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111165949|NCT04418089|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111165950|NCT04418089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111165951|NCT01825941|Diphenhydramine|diphenhydramine|mesh-list
111165952|NCT01825941|Promethazine|promethazine|mesh-list
111165953|NCT01825941|Metoclopramide|metoclopramide|mesh-list
110486548|NCT02656095|Anticoagulants|anticoagulants|mesh-ancestor
111165954|NCT01825941|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111165955|NCT01825941|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111165956|NCT01825941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111165957|NCT01825941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111165958|NCT01825941|Anesthetics, Local|anesthetics, local|mesh-ancestor
111165959|NCT01825941|Anesthetics|anesthetics|mesh-ancestor
111165960|NCT01825941|Sensory System Agents|sensory system agents|mesh-ancestor
111165961|NCT01825941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111165962|NCT01825941|Antiemetics|antiemetics|mesh-ancestor
111165963|NCT01825941|Autonomic Agents|autonomic agents|mesh-ancestor
111165964|NCT01825941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111165965|NCT01825941|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111165966|NCT01825941|Histamine Antagonists|histamine antagonists|mesh-ancestor
111165967|NCT01825941|Histamine Agents|histamine agents|mesh-ancestor
111165968|NCT01825941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111165969|NCT01825941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111165970|NCT01825941|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111165971|NCT01825941|Antipruritics|antipruritics|mesh-ancestor
111165972|NCT01825941|Dermatologic Agents|dermatologic agents|mesh-ancestor
111165973|NCT01825941|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111165974|NCT01825941|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111165975|NCT01825941|Dopamine Agents|dopamine agents|mesh-ancestor
111165976|NCT02044159|Hydrocortisone|hydrocortisone|mesh-list
111165977|NCT02044159|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
111165978|NCT02044159|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111165979|NCT02180165|Voriconazole|voriconazole|mesh-list
111165980|NCT02180165|Posaconazole|posaconazole|mesh-list
111165981|NCT02180165|Antifungal Agents|antifungal agents|mesh-ancestor
111165982|NCT02180165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111165983|NCT02180165|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111165984|NCT02180165|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111165985|NCT02180165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111165986|NCT02180165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111165987|NCT02180165|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111165988|NCT02180165|Hormone Antagonists|hormone antagonists|mesh-ancestor
111165989|NCT02180165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111165990|NCT02180165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111165991|NCT02180165|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111165992|NCT02180165|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
111165993|NCT02180165|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111165994|NCT02180165|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111165995|NCT02155985|Aspirin|aspirin|mesh-list
111165996|NCT02155985|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111165997|NCT02155985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111165998|NCT02155985|Analgesics|analgesics|mesh-ancestor
111165999|NCT02155985|Sensory System Agents|sensory system agents|mesh-ancestor
111166000|NCT02155985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111166001|NCT02155985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111166002|NCT02155985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111166003|NCT02155985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111166004|NCT02155985|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111166005|NCT02155985|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111166006|NCT02155985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111166007|NCT02155985|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111166008|NCT02155985|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111166009|NCT02155985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111166010|NCT02155985|Antipyretics|antipyretics|mesh-ancestor
111166011|NCT02155829|Riluzole|riluzole|mesh-list
111166012|NCT02155829|Anticonvulsants|anticonvulsants|mesh-ancestor
111166013|NCT02155829|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111166014|NCT02155829|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111166015|NCT02155829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111166016|NCT02155829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111166017|NCT02155829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111166018|NCT02155829|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111166019|NCT02155829|Protective Agents|protective agents|mesh-ancestor
111166020|NCT02178995|Methylphenidate|methylphenidate|mesh-list
111166021|NCT02178995|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111166022|NCT02178995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111166023|NCT02178995|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111166024|NCT02178995|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111166025|NCT02178995|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111166026|NCT02178995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111166027|NCT02178995|Dopamine Agents|dopamine agents|mesh-ancestor
111166028|NCT02178995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111166029|NCT02154425|Certolizumab Pegol|certolizumab pegol|mesh-list
111166030|NCT02154425|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111166031|NCT02154425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111166032|NCT02154425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111166033|NCT02154425|Immunologic Factors|immunologic factors|mesh-ancestor
111166034|NCT02154425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111166035|NCT02154425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111166036|NCT02154347|Mitiglinide|mitiglinide|mesh-list
111166037|NCT02154347|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111166038|NCT02154347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111166039|NCT01627067|Metformin|metformin|mesh-list
111166040|NCT01627067|Everolimus|everolimus|mesh-list
111166041|NCT01627067|Exemestane|exemestane|mesh-list
111166042|NCT01627067|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111166043|NCT01627067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111166045|NCT01627067|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111166046|NCT01627067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111166047|NCT01627067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111166048|NCT01627067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111166049|NCT01627067|Immunologic Factors|immunologic factors|mesh-ancestor
111166050|NCT01627067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111166051|NCT01627067|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111166052|NCT01627067|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111166053|NCT01627067|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111166054|NCT01627067|Hormone Antagonists|hormone antagonists|mesh-ancestor
111166055|NCT01627067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111166056|NCT02178059|Terbutaline|terbutaline|mesh-list
111166057|NCT02178059|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111166058|NCT02178059|Autonomic Agents|autonomic agents|mesh-ancestor
111166059|NCT02178059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111166060|NCT02178059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111166061|NCT02178059|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110842280|NCT02527733|Growth Substances|growth substances|mesh-ancestor
111166062|NCT02178059|Respiratory System Agents|respiratory system agents|mesh-ancestor
111166063|NCT02178059|Sympathomimetics|sympathomimetics|mesh-ancestor
111166064|NCT02178059|Tocolytic Agents|tocolytic agents|mesh-ancestor
111166065|NCT02178059|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111166066|NCT02178059|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111166067|NCT02178059|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111166068|NCT02178059|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111166069|NCT02178059|Adrenergic Agents|adrenergic agents|mesh-ancestor
111166070|NCT02178059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111166071|NCT02178059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111166072|NCT02128217|Ribavirin|ribavirin|mesh-list
111166073|NCT02128217|Sofosbuvir|sofosbuvir|mesh-list
111166074|NCT02128217|Ledipasvir|ledipasvir|mesh-list
111166075|NCT02128217|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
111166076|NCT02128217|Antimetabolites|antimetabolites|mesh-ancestor
111166077|NCT02128217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111166078|NCT02128217|Antiviral Agents|antiviral agents|mesh-ancestor
111166079|NCT02128217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111166080|NCT01628549|Sarecycline|sarecycline|mesh-list
111166081|NCT01628549|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111166082|NCT01628549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111166083|NCT01628549|Dermatologic Agents|dermatologic agents|mesh-ancestor
111166084|NCT02127125|Sevelamer|sevelamer|mesh-list
111166085|NCT02127125|Chelating Agents|chelating agents|mesh-ancestor
111166086|NCT02127125|Sequestering Agents|sequestering agents|mesh-ancestor
110799556|NCT03752931|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111166087|NCT02127125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111166088|NCT02090413|Aspirin|aspirin|mesh-list
111166089|NCT02090413|Dimethyl Fumarate|dimethyl fumarate|mesh-list
111166090|NCT02090413|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111166091|NCT02090413|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111166092|NCT02090413|Analgesics|analgesics|mesh-ancestor
111166093|NCT02090413|Sensory System Agents|sensory system agents|mesh-ancestor
111166094|NCT02090413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111166095|NCT02090413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111166096|NCT02090413|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111166097|NCT02090413|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111166098|NCT02090413|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111166099|NCT02090413|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111166100|NCT02090413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111166101|NCT02090413|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111166102|NCT02090413|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111166103|NCT02090413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111166104|NCT02090413|Antipyretics|antipyretics|mesh-ancestor
111166105|NCT02090413|Dermatologic Agents|dermatologic agents|mesh-ancestor
111166106|NCT02090413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111166107|NCT02090413|Immunologic Factors|immunologic factors|mesh-ancestor
111166108|NCT02125877|Deferasirox|deferasirox|mesh-list
111166109|NCT02125877|Iron Chelating Agents|iron chelating agents|mesh-ancestor
111166110|NCT02125877|Chelating Agents|chelating agents|mesh-ancestor
111166111|NCT02125877|Sequestering Agents|sequestering agents|mesh-ancestor
111166112|NCT02125877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111166113|NCT01598987|Cyclosporine|cyclosporine|mesh-list
111166114|NCT01598987|Everolimus|everolimus|mesh-list
111166115|NCT01598987|Tacrolimus|tacrolimus|mesh-list
111166116|NCT01598987|Cyclosporins|cyclosporins|mesh-list
111166117|NCT01598987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110883194|NCT03022578|Lomustine|lomustine|mesh-list
111166118|NCT01598987|Immunologic Factors|immunologic factors|mesh-ancestor
111166119|NCT01598987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111166120|NCT01598987|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111166121|NCT01598987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111166122|NCT01598987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111166123|NCT01598987|Antifungal Agents|antifungal agents|mesh-ancestor
111166124|NCT01598987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111166125|NCT01598987|Dermatologic Agents|dermatologic agents|mesh-ancestor
111166126|NCT01598987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111166128|NCT01598987|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111166129|NCT01598987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111166130|NCT02062879|Ketamine|ketamine|mesh-list
111166131|NCT02062879|Hydromorphone|hydromorphone|mesh-list
111166132|NCT02062879|Analgesics|analgesics|mesh-ancestor
111166133|NCT02062879|Sensory System Agents|sensory system agents|mesh-ancestor
111166134|NCT02062879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111166135|NCT02062879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111166136|NCT02062879|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111166137|NCT02062879|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111166138|NCT02062879|Anesthetics, General|anesthetics, general|mesh-ancestor
111166139|NCT02062879|Anesthetics|anesthetics|mesh-ancestor
111166140|NCT02062879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111166141|NCT02062879|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111166142|NCT02062879|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111166143|NCT02062879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111166144|NCT02062879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111166145|NCT02062879|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111166146|NCT02062879|Narcotics|narcotics|mesh-ancestor
111166147|NCT02062645|Amlodipine|amlodipine|mesh-list
111166148|NCT02062645|Valsartan|valsartan|mesh-list
111166149|NCT02062645|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
111166150|NCT02062645|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111166151|NCT02062645|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111166152|NCT02062645|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111166153|NCT02062645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111166154|NCT02062645|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110486573|NCT02655705|Antifungal Agents|antifungal agents|mesh-ancestor
111166155|NCT02062645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111166156|NCT02062645|Vasodilator Agents|vasodilator agents|mesh-ancestor
111166157|NCT02062645|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111166158|NCT02062645|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111166159|NCT04700839|Metformin|metformin|mesh-list
111166160|NCT04700839|Canagliflozin|canagliflozin|mesh-list
111166161|NCT04700839|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
111166162|NCT04700839|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111166163|NCT04700839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111166164|NCT04700839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111166165|NCT02043301|Bococizumab|bococizumab|mesh-list
111166166|NCT02043301|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111166167|NCT02043301|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111166168|NCT02043301|Antimetabolites|antimetabolites|mesh-ancestor
111166169|NCT02043301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111166170|NCT02043301|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111166171|NCT01598753|Tramadol|tramadol|mesh-list
111166172|NCT01598753|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111166173|NCT01598753|Narcotics|narcotics|mesh-ancestor
111166174|NCT01598753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111166175|NCT01598753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111166176|NCT01598753|Analgesics|analgesics|mesh-ancestor
111166177|NCT01598753|Sensory System Agents|sensory system agents|mesh-ancestor
111166178|NCT01598753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111166179|NCT01824693|Mycophenolic Acid|mycophenolic acid|mesh-list
111166180|NCT01824693|Cyclophosphamide|cyclophosphamide|mesh-list
111166181|NCT01824693|Melphalan|melphalan|mesh-list
111166182|NCT01824693|Busulfan|busulfan|mesh-list
111166183|NCT01824693|Mechlorethamine|mechlorethamine|mesh-list
111166184|NCT01824693|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
111166185|NCT01824693|Fludarabine|fludarabine|mesh-list
111166186|NCT01824693|Fludarabine phosphate|fludarabine phosphate|mesh-list
111166187|NCT01824693|Tacrolimus|tacrolimus|mesh-list
111166188|NCT01824693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111166189|NCT01824693|Immunologic Factors|immunologic factors|mesh-ancestor
111166190|NCT01824693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111166191|NCT01824693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111166192|NCT01824693|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111166193|NCT01824693|Alkylating Agents|alkylating agents|mesh-ancestor
111166194|NCT01824693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111166195|NCT01824693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111166196|NCT01824693|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111166197|NCT01824693|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111166198|NCT01824693|Antimetabolites|antimetabolites|mesh-ancestor
111166199|NCT01824693|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111166200|NCT01824693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111166201|NCT01824693|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111166202|NCT01824693|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111166203|NCT01824693|Antitubercular Agents|antitubercular agents|mesh-ancestor
111166204|NCT01824693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111166205|NCT01824693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111166206|NCT02176655|Aspirin|aspirin|mesh-list
111166207|NCT02176655|Sumatriptan|sumatriptan|mesh-list
111166208|NCT02176655|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111166209|NCT02176655|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111166210|NCT02176655|Analgesics|analgesics|mesh-ancestor
111166211|NCT02176655|Sensory System Agents|sensory system agents|mesh-ancestor
111166212|NCT02176655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111166213|NCT02176655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111166214|NCT02176655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111166215|NCT02176655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111166216|NCT02176655|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111166217|NCT02176655|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111166218|NCT02176655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111166219|NCT02176655|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111166220|NCT02176655|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111166221|NCT02176655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111166222|NCT02176655|Antipyretics|antipyretics|mesh-ancestor
111166223|NCT02176655|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111166224|NCT02176655|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111166225|NCT02176655|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111166226|NCT02176655|Serotonin Agents|serotonin agents|mesh-ancestor
111166227|NCT02176655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111166228|NCT01622569|Fluticasone|fluticasone|mesh-list
111166229|NCT01622569|Xhance|xhance|mesh-list
111166230|NCT01622569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111166231|NCT01622569|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111166232|NCT01622569|Autonomic Agents|autonomic agents|mesh-ancestor
111166233|NCT01622569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111166234|NCT01622569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111166235|NCT01622569|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111166236|NCT01622569|Respiratory System Agents|respiratory system agents|mesh-ancestor
111166237|NCT01622569|Dermatologic Agents|dermatologic agents|mesh-ancestor
111166238|NCT01622569|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111166239|NCT04747301|Dinoprostone|dinoprostone|mesh-list
111166240|NCT04747301|Oxytocics|oxytocics|mesh-ancestor
111166241|NCT04747301|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111166242|NCT04747301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111166243|NCT02152163|Ibuprofen|ibuprofen|mesh-list
111166244|NCT02152163|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111166245|NCT02152163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111166246|NCT02152163|Analgesics|analgesics|mesh-ancestor
111166247|NCT02152163|Sensory System Agents|sensory system agents|mesh-ancestor
111166248|NCT02152163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111166249|NCT02152163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111166250|NCT02152163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111166251|NCT02152163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111166252|NCT02152163|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111166253|NCT02152163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111166254|NCT02152163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111166255|NCT02152007|Sirolimus|sirolimus|mesh-list
111166256|NCT02152007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111166257|NCT02152007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111166258|NCT02152007|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111166259|NCT02152007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111166260|NCT02152007|Antifungal Agents|antifungal agents|mesh-ancestor
111166261|NCT02152007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111166262|NCT02152007|Immunologic Factors|immunologic factors|mesh-ancestor
111166263|NCT02152007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111166264|NCT02151851|Certolizumab Pegol|certolizumab pegol|mesh-list
111166265|NCT02151851|Methotrexate|methotrexate|mesh-list
111166266|NCT02151851|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111166267|NCT02151851|Abortifacient Agents|abortifacient agents|mesh-ancestor
111166268|NCT02151851|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111166269|NCT02151851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111166270|NCT02151851|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111166271|NCT02151851|Antimetabolites|antimetabolites|mesh-ancestor
111166272|NCT02151851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111166273|NCT02151851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111166274|NCT02151851|Dermatologic Agents|dermatologic agents|mesh-ancestor
111166275|NCT02151851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111166276|NCT02151851|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111166277|NCT02151851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111166278|NCT02151851|Immunologic Factors|immunologic factors|mesh-ancestor
111166279|NCT02151851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111166280|NCT02151851|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111166281|NCT02151851|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111166282|NCT02151851|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111166283|NCT02176421|Lidocaine|lidocaine|mesh-list
111166284|NCT02176421|Anesthetics, Local|anesthetics, local|mesh-ancestor
111166285|NCT02176421|Anesthetics|anesthetics|mesh-ancestor
111166286|NCT02176421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111166287|NCT02176421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111166288|NCT02176421|Sensory System Agents|sensory system agents|mesh-ancestor
111166289|NCT02176421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111166290|NCT02176421|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111166291|NCT02176421|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111166292|NCT02176421|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111166293|NCT02176421|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111166294|NCT02176421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111166295|NCT02042443|Calcium, Dietary|calcium, dietary|mesh-list
111166296|NCT02042443|Leucovorin|leucovorin|mesh-list
111166297|NCT02042443|Folic Acid|folic acid|mesh-list
111166298|NCT02042443|Fluorouracil|fluorouracil|mesh-list
111166299|NCT02042443|Capecitabine|capecitabine|mesh-list
111166300|NCT02042443|Trametinib|trametinib|mesh-list
111166301|NCT02042443|Calcium|calcium|mesh-list
111166302|NCT02042443|Levoleucovorin|levoleucovorin|mesh-list
111166303|NCT02042443|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111166304|NCT02042443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111166305|NCT02042443|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111166306|NCT02042443|Antimetabolites|antimetabolites|mesh-ancestor
111166307|NCT02042443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111166308|NCT02042443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111166309|NCT02042443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111166310|NCT02042443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111166311|NCT02042443|Immunologic Factors|immunologic factors|mesh-ancestor
111166312|NCT02042443|Antidotes|antidotes|mesh-ancestor
111166313|NCT02042443|Protective Agents|protective agents|mesh-ancestor
111166314|NCT02042443|Vitamin B Complex|vitamin b complex|mesh-ancestor
111166315|NCT02042443|Vitamins|vitamins|mesh-ancestor
111166316|NCT02042443|Micronutrients|micronutrients|mesh-ancestor
111166317|NCT02042443|Hematinics|hematinics|mesh-ancestor
111166318|NCT02042443|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111166319|NCT02042443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111166320|NCT02118896|Tacrolimus|tacrolimus|mesh-list
111166321|NCT02118896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111166322|NCT02118896|Immunologic Factors|immunologic factors|mesh-ancestor
111166323|NCT02118896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111166324|NCT02118896|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110842314|NCT01149629|Droxidopa|droxidopa|mesh-list
111166326|NCT02118896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111166327|NCT02124707|Paclitaxel|paclitaxel|mesh-list
111166328|NCT02124707|Carboplatin|carboplatin|mesh-list
111166329|NCT02124707|Cetuximab|cetuximab|mesh-list
111166330|NCT02124707|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111166331|NCT02124707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111166332|NCT02124707|Tubulin Modulators|tubulin modulators|mesh-ancestor
111166333|NCT02124707|Antimitotic Agents|antimitotic agents|mesh-ancestor
111166334|NCT02124707|Mitosis Modulators|mitosis modulators|mesh-ancestor
111166335|NCT02124707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111166336|NCT02124707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111166337|NCT04723862|Spironolactone|spironolactone|mesh-list
111166338|NCT04723862|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
111166339|NCT04723862|Hormone Antagonists|hormone antagonists|mesh-ancestor
111166340|NCT04723862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111166341|NCT04723862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111166342|NCT04723862|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
111166343|NCT04723862|Diuretics|diuretics|mesh-ancestor
111166344|NCT04723862|Natriuretic Agents|natriuretic agents|mesh-ancestor
111166345|NCT02092220|Pancrelipase|pancrelipase|mesh-list
111166346|NCT02092220|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111166347|NCT02066402|Linezolid|linezolid|mesh-list
111166348|NCT02066402|Tedizolid|tedizolid|mesh-list
111166349|NCT02066402|Oxazolidinones|oxazolidinones|mesh-list
111166350|NCT02066402|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111166351|NCT02066402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111166352|NCT02066402|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111166353|NCT02066402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111166354|NCT02066402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111166355|NCT02060383|Metformin|metformin|mesh-list
111166356|NCT02060383|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111166357|NCT02060383|Liraglutide|liraglutide|mesh-list
111166358|NCT02060383|Pasireotide|pasireotide|mesh-list
111166359|NCT02060383|Somatostatin|somatostatin|mesh-list
111166360|NCT02060383|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111166361|NCT02060383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111166362|NCT02060383|Incretins|incretins|mesh-ancestor
111166363|NCT02060383|Hormones|hormones|mesh-ancestor
111166364|NCT02060383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111166365|NCT02060383|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111166366|NCT02060383|Protease Inhibitors|protease inhibitors|mesh-ancestor
111166367|NCT02060383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111166368|NCT02060383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111166369|NCT02086591|Doxycycline|doxycycline|mesh-list
111166370|NCT02086591|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111166371|NCT02086591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111166372|NCT02086591|Antimalarials|antimalarials|mesh-ancestor
111166373|NCT02086591|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111166374|NCT02086591|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111166375|NCT02065622|Adalimumab|adalimumab|mesh-list
111166376|NCT02065622|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111166377|NCT02065622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111166378|NCT02065622|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111166379|NCT02117648|Clarithromycin|clarithromycin|mesh-list
111166380|NCT02117648|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111166381|NCT02117648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111166382|NCT02117648|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111166383|NCT02117648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111166384|NCT02117648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111166385|NCT02117648|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111166386|NCT02117648|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111166387|NCT02124161|Vaccines|vaccines|mesh-list
111166388|NCT02124161|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
111166389|NCT02124161|Immunologic Factors|immunologic factors|mesh-ancestor
111166390|NCT02124161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111166391|NCT02117570|Vaccines|vaccines|mesh-list
111166392|NCT02117570|Immunologic Factors|immunologic factors|mesh-ancestor
111166393|NCT02117570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111166394|NCT02123459|Cephalexin|cephalexin|mesh-list
111166395|NCT02123459|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111166396|NCT02123459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111166397|NCT01853475|Artefenomel|artefenomel|mesh-list
111166398|NCT01853475|Antimalarials|antimalarials|mesh-ancestor
111166399|NCT01853475|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111166400|NCT01853475|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111166401|NCT01853475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111166402|NCT04411160|Nitric Oxide|nitric oxide|mesh-list
111166403|NCT04411160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111166404|NCT04411160|Antioxidants|antioxidants|mesh-ancestor
111166405|NCT04411160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111166406|NCT04411160|Protective Agents|protective agents|mesh-ancestor
111166407|NCT04411160|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111166408|NCT04411160|Autonomic Agents|autonomic agents|mesh-ancestor
111166409|NCT04411160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111166410|NCT04411160|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111166411|NCT04411160|Respiratory System Agents|respiratory system agents|mesh-ancestor
111166412|NCT04411160|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111166413|NCT04411160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111166414|NCT04411160|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
111166415|NCT04411160|Vasodilator Agents|vasodilator agents|mesh-ancestor
111166416|NCT04411160|Gasotransmitters|gasotransmitters|mesh-ancestor
111166417|NCT02151773|Vaccines|vaccines|mesh-list
111166418|NCT02151773|Immunologic Factors|immunologic factors|mesh-ancestor
111166419|NCT02151773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111166420|NCT02151461|Metformin|metformin|mesh-list
111166421|NCT02151461|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111166422|NCT02151461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111166423|NCT02091986|Budesonide|budesonide|mesh-list
111166424|NCT02091986|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
111166425|NCT02091986|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111166426|NCT02091986|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111166427|NCT02091986|Autonomic Agents|autonomic agents|mesh-ancestor
111166428|NCT02091986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111166429|NCT02091986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111166430|NCT02091986|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111166431|NCT02091986|Respiratory System Agents|respiratory system agents|mesh-ancestor
111166432|NCT02091986|Glucocorticoids|glucocorticoids|mesh-ancestor
111166433|NCT02091986|Hormones|hormones|mesh-ancestor
111166434|NCT02091986|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111166435|NCT02117024|Paclitaxel|paclitaxel|mesh-list
111166436|NCT02117024|Vinorelbine|vinorelbine|mesh-list
111166437|NCT02117024|Docetaxel|docetaxel|mesh-list
111166438|NCT02117024|Cyclophosphamide|cyclophosphamide|mesh-list
111166439|NCT02117024|Gemcitabine|gemcitabine|mesh-list
111166440|NCT02117024|Pemetrexed|pemetrexed|mesh-list
111166441|NCT02117024|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111166442|NCT02117024|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110842337|NCT03907163|Hormones|hormones|mesh-ancestor
111166443|NCT02117024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111166444|NCT02117024|Tubulin Modulators|tubulin modulators|mesh-ancestor
111166445|NCT02117024|Antimitotic Agents|antimitotic agents|mesh-ancestor
111166446|NCT02117024|Mitosis Modulators|mitosis modulators|mesh-ancestor
111166447|NCT02117024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111166448|NCT02117024|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111166449|NCT02117024|Immunologic Factors|immunologic factors|mesh-ancestor
111166450|NCT02117024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111166451|NCT02117024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111166452|NCT02117024|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111166453|NCT02117024|Alkylating Agents|alkylating agents|mesh-ancestor
111166454|NCT02117024|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111166455|NCT02117024|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111166456|NCT02117024|Antimetabolites|antimetabolites|mesh-ancestor
111166457|NCT02117024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111166458|NCT02117024|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111166459|NCT02117024|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111166460|NCT02117024|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111166461|NCT02064920|Donepezil|donepezil|mesh-list
111166462|NCT02064920|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111166463|NCT02064920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111166464|NCT02064920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111166465|NCT02064920|Cholinergic Agents|cholinergic agents|mesh-ancestor
111166466|NCT02064920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111166467|NCT02064920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111166468|NCT02064920|Nootropic Agents|nootropic agents|mesh-ancestor
111166469|NCT02151149|Paclitaxel|paclitaxel|mesh-list
111166470|NCT02151149|Carboplatin|carboplatin|mesh-list
111166471|NCT02151149|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111166472|NCT02151149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111166473|NCT02151149|Tubulin Modulators|tubulin modulators|mesh-ancestor
111166474|NCT02151149|Antimitotic Agents|antimitotic agents|mesh-ancestor
111166475|NCT02151149|Mitosis Modulators|mitosis modulators|mesh-ancestor
111166476|NCT02151149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111166477|NCT02150213|Dexamethasone|dexamethasone|mesh-list
111166478|NCT02150213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111166479|NCT02150213|Antiemetics|antiemetics|mesh-ancestor
111166480|NCT02150213|Autonomic Agents|autonomic agents|mesh-ancestor
111166481|NCT02150213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111166482|NCT02150213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111166483|NCT02150213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111166484|NCT02150213|Glucocorticoids|glucocorticoids|mesh-ancestor
111166485|NCT02150213|Hormones|hormones|mesh-ancestor
111166486|NCT02150213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111166487|NCT02150213|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111166488|NCT02150213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111166489|NCT02091362|Metformin|metformin|mesh-list
111166490|NCT02091362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111166491|NCT02091362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111166492|NCT02091206|Cannabidiol|cannabidiol|mesh-list
111166493|NCT02091206|Anticonvulsants|anticonvulsants|mesh-ancestor
111166494|NCT02062658|Ketamine|ketamine|mesh-list
111166495|NCT02062658|Analgesics|analgesics|mesh-ancestor
111166496|NCT02062658|Sensory System Agents|sensory system agents|mesh-ancestor
111166497|NCT02062658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111166498|NCT02062658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111166499|NCT02062658|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111166500|NCT02062658|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111166501|NCT02062658|Anesthetics, General|anesthetics, general|mesh-ancestor
111166502|NCT02062658|Anesthetics|anesthetics|mesh-ancestor
111166503|NCT02062658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111166504|NCT02062658|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111166505|NCT02062658|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111166506|NCT02062658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111166507|NCT02062658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111166508|NCT02115308|Regadenoson|regadenoson|mesh-list
111166509|NCT02115308|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
111166510|NCT02115308|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
111166511|NCT02115308|Purinergic Agonists|purinergic agonists|mesh-ancestor
111166512|NCT02115308|Purinergic Agents|purinergic agents|mesh-ancestor
111166513|NCT02115308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111166514|NCT02115308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111166515|NCT02115308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111166516|NCT02114684|Moxifloxacin|moxifloxacin|mesh-list
111166517|NCT02114684|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111166518|NCT02114684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111166519|NCT02114684|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111166520|NCT02114684|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111166521|NCT02114684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111166522|NCT02114684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111166523|NCT02114684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111166524|NCT02090114|Methyltestosterone|methyltestosterone|mesh-list
111166525|NCT02090114|Abiraterone Acetate|abiraterone acetate|mesh-list
111166526|NCT02090114|Testosterone|testosterone|mesh-list
111166527|NCT02090114|Testosterone undecanoate|testosterone undecanoate|mesh-list
111166528|NCT02090114|Testosterone enanthate|testosterone enanthate|mesh-list
111166529|NCT02090114|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
111166530|NCT02090114|Androgens|androgens|mesh-ancestor
111166531|NCT02090114|Hormones|hormones|mesh-ancestor
111166532|NCT02090114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111166533|NCT02090114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111166534|NCT02090114|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111166535|NCT02090114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111166536|NCT02090114|Anabolic Agents|anabolic agents|mesh-ancestor
111166537|NCT02090114|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111166538|NCT02090114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111166539|NCT02090114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111166540|NCT02090114|Hormone Antagonists|hormone antagonists|mesh-ancestor
111166541|NCT02090114|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111166542|NCT04742036|Paclitaxel|paclitaxel|mesh-list
111166543|NCT04742036|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111166544|NCT04742036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111166545|NCT04742036|Tubulin Modulators|tubulin modulators|mesh-ancestor
111166546|NCT04742036|Antimitotic Agents|antimitotic agents|mesh-ancestor
111166547|NCT04742036|Mitosis Modulators|mitosis modulators|mesh-ancestor
111166548|NCT04742036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111166549|NCT02111564|Rivaroxaban|rivaroxaban|mesh-list
111166550|NCT02111564|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111166551|NCT02111564|Antithrombins|antithrombins|mesh-ancestor
111166552|NCT02111564|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111166553|NCT02111564|Protease Inhibitors|protease inhibitors|mesh-ancestor
111166554|NCT02111564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111166555|NCT02111564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111166556|NCT02111564|Anticoagulants|anticoagulants|mesh-ancestor
111166557|NCT02111096|Metformin|metformin|mesh-list
111166558|NCT02111096|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111166559|NCT02111096|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111166560|NCT02111096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111166561|NCT02111096|Incretins|incretins|mesh-ancestor
111166562|NCT02111096|Hormones|hormones|mesh-ancestor
111166563|NCT02111096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111166564|NCT02111096|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111166565|NCT02111096|Protease Inhibitors|protease inhibitors|mesh-ancestor
111166566|NCT02111096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111166567|NCT02111096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111166568|NCT02110706|Rituximab|rituximab|mesh-list
111166569|NCT02110706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110883635|NCT03666546|Dopamine Agents|dopamine agents|mesh-ancestor
111166570|NCT02110706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111166571|NCT02110706|Immunologic Factors|immunologic factors|mesh-ancestor
111166572|NCT02110706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111166573|NCT02110706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111166574|NCT02110238|Hyaluronic Acid|hyaluronic acid|mesh-list
111166575|NCT02110238|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111166576|NCT02110238|Immunologic Factors|immunologic factors|mesh-ancestor
111166577|NCT02110238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111166578|NCT02110238|Viscosupplements|viscosupplements|mesh-ancestor
111166579|NCT02110238|Protective Agents|protective agents|mesh-ancestor
111166580|NCT02107898|Alirocumab|alirocumab|mesh-list
111166581|NCT02107898|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111166582|NCT02107898|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
111166583|NCT02107898|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111166584|NCT02107898|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111166585|NCT02107898|Antimetabolites|antimetabolites|mesh-ancestor
111166586|NCT02107898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111166587|NCT02107898|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111166588|NCT02107898|Protease Inhibitors|protease inhibitors|mesh-ancestor
111166589|NCT02107898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111166590|NCT02107898|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111166591|NCT02107898|Immunologic Factors|immunologic factors|mesh-ancestor
111166592|NCT02107898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111166593|NCT02058836|Botulinum Toxins|botulinum toxins|mesh-list
111166594|NCT02058836|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111166595|NCT02058836|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111166596|NCT02058836|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111166597|NCT02058836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111166598|NCT02058836|Cholinergic Agents|cholinergic agents|mesh-ancestor
111166599|NCT02058836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111166600|NCT02058836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111166601|NCT02058836|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111166602|NCT02058836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111166603|NCT02107274|Azithromycin|azithromycin|mesh-list
111166604|NCT02107274|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111166605|NCT02107274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111166606|NCT02173769|Tiotropium Bromide|tiotropium bromide|mesh-list
111166607|NCT02173769|Olodaterol|olodaterol|mesh-list
111166608|NCT02173769|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111166609|NCT02173769|Autonomic Agents|autonomic agents|mesh-ancestor
111166610|NCT02173769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111166611|NCT02173769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111166612|NCT02173769|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111166613|NCT02173769|Respiratory System Agents|respiratory system agents|mesh-ancestor
111166614|NCT02173769|Parasympatholytics|parasympatholytics|mesh-ancestor
111166615|NCT02173769|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111166616|NCT02173769|Cholinergic Agents|cholinergic agents|mesh-ancestor
111166617|NCT02173769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111166618|NCT02173769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111166619|NCT02121509|Metformin|metformin|mesh-list
111166620|NCT02121509|Linagliptin|linagliptin|mesh-list
111166621|NCT02121509|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111166622|NCT02121509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111166623|NCT02121509|Incretins|incretins|mesh-ancestor
111166624|NCT02121509|Hormones|hormones|mesh-ancestor
111166625|NCT02121509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111166626|NCT02121509|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111166627|NCT02121509|Protease Inhibitors|protease inhibitors|mesh-ancestor
111166628|NCT02121509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111166629|NCT02121509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111166630|NCT02149199|Budesonide|budesonide|mesh-list
111166631|NCT02149199|Terbutaline|terbutaline|mesh-list
111166632|NCT02149199|Formoterol Fumarate|formoterol fumarate|mesh-list
111166633|NCT02149199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111166634|NCT02149199|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111166635|NCT02149199|Autonomic Agents|autonomic agents|mesh-ancestor
111166636|NCT02149199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111166637|NCT02149199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111166638|NCT02149199|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111166639|NCT02149199|Respiratory System Agents|respiratory system agents|mesh-ancestor
111166640|NCT02149199|Glucocorticoids|glucocorticoids|mesh-ancestor
111166641|NCT02149199|Hormones|hormones|mesh-ancestor
111166642|NCT02149199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111166643|NCT02149199|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110883711|NCT03637361|Narcotics|narcotics|mesh-ancestor
111166644|NCT02149199|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111166645|NCT02149199|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111166646|NCT02149199|Adrenergic Agents|adrenergic agents|mesh-ancestor
111166647|NCT02149199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111166648|NCT02149199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111166649|NCT02149199|Sympathomimetics|sympathomimetics|mesh-ancestor
111166650|NCT02149199|Tocolytic Agents|tocolytic agents|mesh-ancestor
111166651|NCT02149199|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111166652|NCT02120417|Capecitabine|capecitabine|mesh-list
111166653|NCT02120417|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111166654|NCT02120417|Antimetabolites|antimetabolites|mesh-ancestor
111166655|NCT02120417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111166656|NCT02120417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111166657|NCT02147561|Botulinum Toxins|botulinum toxins|mesh-list
111166658|NCT02147561|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111166659|NCT02147561|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111166660|NCT02147561|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111166661|NCT02147561|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111166662|NCT02147561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111166663|NCT02147561|Cholinergic Agents|cholinergic agents|mesh-ancestor
111166664|NCT02147561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111166665|NCT02147561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111166666|NCT02147561|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111166667|NCT02147561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111166668|NCT02058368|Tamsulosin|tamsulosin|mesh-list
111166669|NCT02058368|Dutasteride|dutasteride|mesh-list
111166670|NCT02058368|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111166671|NCT02058368|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111166672|NCT02058368|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111166673|NCT02058368|Adrenergic Agents|adrenergic agents|mesh-ancestor
111166674|NCT02058368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111166675|NCT02058368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111166676|NCT02058368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111166677|NCT02058368|Urological Agents|urological agents|mesh-ancestor
111166678|NCT02058368|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
111166679|NCT02058368|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111166680|NCT02058368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111166681|NCT02058368|Hormone Antagonists|hormone antagonists|mesh-ancestor
111166682|NCT02058368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111166683|NCT02058290|Morphine|morphine|mesh-list
111166684|NCT02058290|Bupivacaine|bupivacaine|mesh-list
111166685|NCT02058290|Anesthetics, Local|anesthetics, local|mesh-ancestor
111166686|NCT02058290|Anesthetics|anesthetics|mesh-ancestor
111166687|NCT02058290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111166688|NCT02058290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111166689|NCT02058290|Sensory System Agents|sensory system agents|mesh-ancestor
111166690|NCT02058290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111166691|NCT02058290|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111166692|NCT02058290|Narcotics|narcotics|mesh-ancestor
111166693|NCT02058290|Analgesics|analgesics|mesh-ancestor
111166694|NCT04718480|Fluvoxamine|fluvoxamine|mesh-list
111166695|NCT04718480|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111166696|NCT04718480|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111166697|NCT04718480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111166698|NCT04718480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111166699|NCT04718480|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111166700|NCT04718480|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111166701|NCT04718480|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111166702|NCT04718480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111166703|NCT04718480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111166704|NCT04718480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111166705|NCT04718480|Serotonin Agents|serotonin agents|mesh-ancestor
111166706|NCT04718480|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111166707|NCT04718480|Antidepressive Agents|antidepressive agents|mesh-ancestor
111166708|NCT04718480|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111166709|NCT04718480|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111166710|NCT04718480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111166711|NCT04718480|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111166712|NCT02106884|Paclitaxel|paclitaxel|mesh-list
111166713|NCT02106884|Gemcitabine|gemcitabine|mesh-list
111166714|NCT02106884|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111166715|NCT02106884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111166716|NCT02106884|Tubulin Modulators|tubulin modulators|mesh-ancestor
111166717|NCT02106884|Antimitotic Agents|antimitotic agents|mesh-ancestor
111166718|NCT02106884|Mitosis Modulators|mitosis modulators|mesh-ancestor
111166719|NCT02106884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111166720|NCT02106884|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111166722|NCT02081690|Macitentan|macitentan|mesh-list
111166723|NCT02081690|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
111166724|NCT02081690|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
111166725|NCT02081690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111166726|NCT02081690|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
111166727|NCT01625000|Risperidone|risperidone|mesh-list
111166728|NCT01625000|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111166729|NCT01625000|Serotonin Agents|serotonin agents|mesh-ancestor
111166730|NCT01625000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111166731|NCT01625000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111166732|NCT01625000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111166733|NCT01625000|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111166734|NCT01625000|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111166735|NCT01625000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111166736|NCT01625000|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111166737|NCT01625000|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111166738|NCT01625000|Dopamine Agents|dopamine agents|mesh-ancestor
111166739|NCT02057198|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111166740|NCT02057198|Metronidazole|metronidazole|mesh-list
111166741|NCT02057198|Vancomycin|vancomycin|mesh-list
111166742|NCT02057198|Fidaxomicin|fidaxomicin|mesh-list
111166743|NCT02057198|Amebicides|amebicides|mesh-list
111166744|NCT02057198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111166745|NCT02057198|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111166746|NCT02057198|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111166747|NCT02056340|Atorvastatin|atorvastatin|mesh-list
111166748|NCT02056340|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111166749|NCT02056340|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111166750|NCT02056340|Antimetabolites|antimetabolites|mesh-ancestor
111166751|NCT02056340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111166752|NCT02056340|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111166753|NCT02056340|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111166754|NCT02056340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111166755|NCT04726592|Ketoprofen|ketoprofen|mesh-list
111166756|NCT04726592|Clorazepate Dipotassium|clorazepate dipotassium|mesh-list
111166757|NCT04726592|Metoclopramide|metoclopramide|mesh-list
111166758|NCT04726592|Antiemetics|antiemetics|mesh-ancestor
111166759|NCT04726592|Autonomic Agents|autonomic agents|mesh-ancestor
111166760|NCT04726592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111166761|NCT04726592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111166762|NCT04726592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111166763|NCT04726592|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111166764|NCT04726592|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111166765|NCT04726592|Dopamine Agents|dopamine agents|mesh-ancestor
111166766|NCT04726592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111166767|NCT04726592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111166768|NCT04726592|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111166769|NCT04726592|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111166770|NCT04726592|Analgesics|analgesics|mesh-ancestor
111166771|NCT04726592|Sensory System Agents|sensory system agents|mesh-ancestor
111166772|NCT04726592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111166773|NCT04726592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111166774|NCT04726592|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111166775|NCT04726592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111166776|NCT04726592|Anticonvulsants|anticonvulsants|mesh-ancestor
111166777|NCT04726592|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111166778|NCT04726592|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111166779|NCT04726592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111166780|NCT04726592|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111166781|NCT04726592|GABA Modulators|gaba modulators|mesh-ancestor
111166782|NCT04726592|GABA Agents|gaba agents|mesh-ancestor
111166783|NCT02046122|Cytarabine|cytarabine|mesh-list
111166784|NCT02046122|Idarubicin|idarubicin|mesh-list
111166785|NCT02046122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111166786|NCT02046122|Antimetabolites|antimetabolites|mesh-ancestor
111166787|NCT02046122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111166788|NCT02046122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111166789|NCT02046122|Antiviral Agents|antiviral agents|mesh-ancestor
111166790|NCT02046122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111166791|NCT02046122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111166792|NCT02046122|Immunologic Factors|immunologic factors|mesh-ancestor
111166793|NCT02046122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111166794|NCT02046122|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111166795|NCT02046122|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111166796|NCT02046122|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111166797|NCT02046122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111166798|NCT02080832|Dexetimide|dexetimide|mesh-list
111166799|NCT02080832|Citalopram|citalopram|mesh-list
111166800|NCT02080832|Escitalopram|escitalopram|mesh-list
111166801|NCT02080832|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111166802|NCT02080832|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111166803|NCT02080832|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111166804|NCT02080832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111166805|NCT02080832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111166806|NCT02080832|Serotonin Agents|serotonin agents|mesh-ancestor
111166807|NCT02080832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111166808|NCT02080832|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111166809|NCT02080832|Antidepressive Agents|antidepressive agents|mesh-ancestor
111166810|NCT02080832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111166811|NCT02080832|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111166812|NCT02080832|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111166813|NCT02080832|Parasympatholytics|parasympatholytics|mesh-ancestor
111166814|NCT02080832|Autonomic Agents|autonomic agents|mesh-ancestor
111166815|NCT02080832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111166816|NCT02080832|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111166817|NCT02080832|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111166818|NCT02080832|Cholinergic Agents|cholinergic agents|mesh-ancestor
111166819|NCT02078960|Homoharringtonine|homoharringtonine|mesh-list
111166820|NCT02078960|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111166821|NCT02078960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111166822|NCT02078960|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111166823|NCT02078960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111166824|NCT02078960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111166825|NCT02078102|Meloxicam|meloxicam|mesh-list
111166826|NCT02078102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111166827|NCT02078102|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111166828|NCT02078102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111166829|NCT02078102|Analgesics|analgesics|mesh-ancestor
111166830|NCT02078102|Sensory System Agents|sensory system agents|mesh-ancestor
111166831|NCT02078102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111166832|NCT02078102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111166833|NCT02078102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111166834|NCT02078102|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111166835|NCT02078102|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111166836|NCT02078102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111166837|NCT02078102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111166838|NCT02054702|Aripiprazole|aripiprazole|mesh-list
111166839|NCT02054702|Brexpiprazole|brexpiprazole|mesh-list
111166840|NCT02054702|Antidepressive Agents|antidepressive agents|mesh-ancestor
111166841|NCT02054702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111166842|NCT02054702|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111166843|NCT02054702|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111166844|NCT02054702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111166845|NCT02054702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111166846|NCT02054702|Dopamine Agonists|dopamine agonists|mesh-ancestor
111166847|NCT02054702|Dopamine Agents|dopamine agents|mesh-ancestor
111166848|NCT02054702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111166849|NCT02054702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111166850|NCT02054702|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111166851|NCT02054702|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111166852|NCT02054702|Serotonin Agents|serotonin agents|mesh-ancestor
111166853|NCT02054702|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111166854|NCT02054702|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111166855|NCT02054702|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111166856|NCT02054702|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111166857|NCT02044094|Buprenorphine|buprenorphine|mesh-list
111166858|NCT02044094|Hydromorphone|hydromorphone|mesh-list
111166860|NCT02044094|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111166861|NCT02044094|Narcotics|narcotics|mesh-ancestor
111166862|NCT02044094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111166863|NCT02044094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111166864|NCT02044094|Analgesics|analgesics|mesh-ancestor
110883935|NCT05384366|Mitosis Modulators|mitosis modulators|mesh-ancestor
111166866|NCT02044094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111166867|NCT02044094|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111166868|NCT02053610|Rituximab|rituximab|mesh-list
111166869|NCT02053610|Obinutuzumab|obinutuzumab|mesh-list
111166870|NCT02053610|Chlorambucil|chlorambucil|mesh-list
111166871|NCT02053610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111166872|NCT02053610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111166873|NCT02053610|Immunologic Factors|immunologic factors|mesh-ancestor
111166874|NCT02053610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111166875|NCT02053610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111166876|NCT02053610|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111166877|NCT02053610|Alkylating Agents|alkylating agents|mesh-ancestor
111166878|NCT02053610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111166879|NCT02075606|Lanreotide|lanreotide|mesh-list
111166880|NCT02075606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111166881|NCT04701008|Ketamine|ketamine|mesh-list
111166882|NCT04701008|Analgesics|analgesics|mesh-ancestor
111166883|NCT04701008|Sensory System Agents|sensory system agents|mesh-ancestor
111166884|NCT04701008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111166885|NCT04701008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111166886|NCT04701008|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111166887|NCT04701008|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111166888|NCT04701008|Anesthetics, General|anesthetics, general|mesh-ancestor
111166889|NCT04701008|Anesthetics|anesthetics|mesh-ancestor
111166890|NCT04701008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111166891|NCT04701008|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111166892|NCT04701008|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111166893|NCT04701008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111166894|NCT04701008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111166895|NCT04700696|Analgesics, Opioid|analgesics, opioid|mesh-list
111166896|NCT04700696|Narcotics|narcotics|mesh-ancestor
111166897|NCT04700696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111166898|NCT04700696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111166899|NCT04700696|Analgesics|analgesics|mesh-ancestor
111166900|NCT04700696|Sensory System Agents|sensory system agents|mesh-ancestor
111166901|NCT04700696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111166902|NCT02052440|Baclofen|baclofen|mesh-list
111166903|NCT02052440|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
111166904|NCT02052440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111166905|NCT02052440|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111166906|NCT02052440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111166907|NCT02052440|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
111166908|NCT02052440|GABA Agonists|gaba agonists|mesh-ancestor
111166909|NCT02052440|GABA Agents|gaba agents|mesh-ancestor
111166910|NCT02052440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111166911|NCT02052440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111166912|NCT02049944|Cefazolin|cefazolin|mesh-list
111166913|NCT02049944|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111166914|NCT02049944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111166915|NCT01621880|Methylprednisolone|methylprednisolone|mesh-list
111166916|NCT01621880|Bevacizumab|bevacizumab|mesh-list
111166917|NCT01621880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111166918|NCT01621880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111166919|NCT01621880|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111166920|NCT01621880|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111166921|NCT01621880|Growth Substances|growth substances|mesh-ancestor
111166922|NCT01621880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111166923|NCT01621880|Growth Inhibitors|growth inhibitors|mesh-ancestor
111166924|NCT01621880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111166925|NCT01621880|Antiemetics|antiemetics|mesh-ancestor
111166926|NCT01621880|Autonomic Agents|autonomic agents|mesh-ancestor
111166927|NCT01621880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111166928|NCT01621880|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111166929|NCT01621880|Glucocorticoids|glucocorticoids|mesh-ancestor
111166930|NCT01621880|Hormones|hormones|mesh-ancestor
111166931|NCT01621880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111166932|NCT01621880|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111166933|NCT01621880|Protective Agents|protective agents|mesh-ancestor
111166934|NCT02041429|Paclitaxel|paclitaxel|mesh-list
111166935|NCT02041429|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111166936|NCT02041429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111166937|NCT02041429|Tubulin Modulators|tubulin modulators|mesh-ancestor
111166938|NCT02041429|Antimitotic Agents|antimitotic agents|mesh-ancestor
111166939|NCT02041429|Mitosis Modulators|mitosis modulators|mesh-ancestor
111166940|NCT02041429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111166941|NCT02083783|Amphetamine|amphetamine|mesh-list
111166942|NCT02083783|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111166943|NCT02083783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111166944|NCT02083783|Sympathomimetics|sympathomimetics|mesh-ancestor
111166945|NCT02083783|Autonomic Agents|autonomic agents|mesh-ancestor
111166946|NCT02083783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111166947|NCT02083783|Dopamine Agents|dopamine agents|mesh-ancestor
111166948|NCT02083783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111166949|NCT02083783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111166950|NCT02083783|Adrenergic Agents|adrenergic agents|mesh-ancestor
111166951|NCT02083783|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111166952|NCT02083783|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111166953|NCT02083783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111166954|NCT02083783|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111166955|NCT02059135|Antithrombins|antithrombins|mesh-list
111166956|NCT02059135|Antithrombin III|antithrombin iii|mesh-list
111166957|NCT02059135|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111166958|NCT02059135|Protease Inhibitors|protease inhibitors|mesh-ancestor
111166959|NCT02059135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111166960|NCT02059135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111166961|NCT02059135|Anticoagulants|anticoagulants|mesh-ancestor
111166962|NCT04720105|Halobetasol|halobetasol|mesh-list
111166963|NCT04720105|Tazarotene|tazarotene|mesh-list
111166964|NCT04720105|Dermatologic Agents|dermatologic agents|mesh-ancestor
111166965|NCT04720105|Keratolytic Agents|keratolytic agents|mesh-ancestor
111166966|NCT04720105|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111166967|NCT04695769|Ribavirin|ribavirin|mesh-list
111166968|NCT04695769|Sofosbuvir|sofosbuvir|mesh-list
111166969|NCT04695769|Velpatasvir|velpatasvir|mesh-list
111166970|NCT04695769|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
111166971|NCT04695769|Antimetabolites|antimetabolites|mesh-ancestor
111166972|NCT04695769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111166973|NCT04695769|Antiviral Agents|antiviral agents|mesh-ancestor
111166974|NCT04695769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111166975|NCT02038933|Nivolumab|nivolumab|mesh-list
111166976|NCT02038933|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111166977|NCT02038933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111166978|NCT02038933|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111166979|NCT02038933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111166980|NCT02081599|Insulin|insulin|mesh-list
111166981|NCT02081599|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111166982|NCT02081599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111166983|NCT02038153|Lenalidomide|lenalidomide|mesh-list
111166984|NCT02038153|Immunologic Factors|immunologic factors|mesh-ancestor
111166985|NCT02038153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111166986|NCT02038153|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111166987|NCT02038153|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111166988|NCT02038153|Growth Substances|growth substances|mesh-ancestor
111166989|NCT02038153|Growth Inhibitors|growth inhibitors|mesh-ancestor
111166990|NCT02038153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111166991|NCT02079805|Telmisartan|telmisartan|mesh-list
111166992|NCT02079805|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
111166993|NCT02079805|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111166994|NCT02079805|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111166995|NCT02079805|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111166996|NCT02079805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111166997|NCT02037295|Vancomycin|vancomycin|mesh-list
111166998|NCT02037295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111166999|NCT02037295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111167000|NCT02079649|Dexamethasone|dexamethasone|mesh-list
111167001|NCT02079649|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111167002|NCT02079649|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111167003|NCT02079649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111167004|NCT02079649|Antiemetics|antiemetics|mesh-ancestor
111167005|NCT02079649|Autonomic Agents|autonomic agents|mesh-ancestor
111167006|NCT02079649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111167007|NCT02079649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111167008|NCT02079649|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111167009|NCT02079649|Glucocorticoids|glucocorticoids|mesh-ancestor
111167010|NCT02079649|Hormones|hormones|mesh-ancestor
111167011|NCT02079649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111167012|NCT02079649|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111167013|NCT02079649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111167014|NCT02036515|Metformin|metformin|mesh-list
111167015|NCT02036515|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111167016|NCT02036515|Glimepiride|glimepiride|mesh-list
111167017|NCT02036515|Ertugliflozin|ertugliflozin|mesh-list
111167018|NCT02036515|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111167019|NCT02036515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111167020|NCT02036515|Incretins|incretins|mesh-ancestor
111167021|NCT02036515|Hormones|hormones|mesh-ancestor
111167022|NCT02036515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111167023|NCT02036515|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111167024|NCT02036515|Protease Inhibitors|protease inhibitors|mesh-ancestor
111167025|NCT02036515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111167026|NCT02036515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111167027|NCT02036515|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111167028|NCT02036515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111167029|NCT02036515|Immunologic Factors|immunologic factors|mesh-ancestor
111167030|NCT02036515|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111167031|NCT02078713|Contraceptive Agents|contraceptive agents|mesh-list
111167032|NCT02078713|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111167033|NCT02078713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111167034|NCT02035267|Deoxycholic Acid|deoxycholic acid|mesh-list
111167035|NCT02035267|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
111167036|NCT02035267|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111167037|NCT05887479|Botulinum Toxins|botulinum toxins|mesh-list
111167038|NCT05887479|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111167039|NCT05887479|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111167040|NCT05887479|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111167041|NCT05887479|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111167042|NCT05887479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111167043|NCT05887479|Cholinergic Agents|cholinergic agents|mesh-ancestor
111167044|NCT05887479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111167045|NCT05887479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111167046|NCT05887479|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111167047|NCT05887479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111167048|NCT05887375|Glycopyrrolate|glycopyrrolate|mesh-list
111167049|NCT05887375|Bromides|bromides|mesh-list
111167050|NCT05887375|Rocuronium|rocuronium|mesh-list
111167051|NCT05887375|Neostigmine|neostigmine|mesh-list
111167052|NCT05887375|Anticonvulsants|anticonvulsants|mesh-ancestor
111167053|NCT05887375|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
111167054|NCT05887375|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
111167055|NCT05887375|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110842395|NCT03905837|Lidocaine|lidocaine|mesh-list
111167056|NCT05887375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111167057|NCT05887375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111167058|NCT05887375|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111167059|NCT05887375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111167060|NCT05887375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111167061|NCT05887375|Cholinergic Agents|cholinergic agents|mesh-ancestor
111167062|NCT05887375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111167063|NCT05887375|Parasympathomimetics|parasympathomimetics|mesh-ancestor
111167064|NCT05887375|Autonomic Agents|autonomic agents|mesh-ancestor
111167065|NCT05887375|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111167066|NCT05887375|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111167067|NCT05887375|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111167068|NCT05887258|Analgesics, Opioid|analgesics, opioid|mesh-list
111167069|NCT05887258|Anesthetics|anesthetics|mesh-list
111167070|NCT05887258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111167071|NCT05887258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111167072|NCT05887258|Narcotics|narcotics|mesh-ancestor
111167073|NCT05887258|Analgesics|analgesics|mesh-ancestor
111167074|NCT05887258|Sensory System Agents|sensory system agents|mesh-ancestor
111167075|NCT05887258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111167076|NCT05887219|Azelaic acid|azelaic acid|mesh-list
111167077|NCT05887219|Tranexamic Acid|tranexamic acid|mesh-list
111167078|NCT05887219|Hydroquinone|hydroquinone|mesh-list
111167079|NCT05887219|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111167080|NCT05887219|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111167081|NCT05887219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111167082|NCT05887219|Hemostatics|hemostatics|mesh-ancestor
111167083|NCT05887219|Coagulants|coagulants|mesh-ancestor
111167084|NCT05887219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111167085|NCT05887219|Dermatologic Agents|dermatologic agents|mesh-ancestor
111167086|NCT05887219|Antioxidants|antioxidants|mesh-ancestor
111167087|NCT05887219|Protective Agents|protective agents|mesh-ancestor
111167088|NCT05887219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111167089|NCT05887219|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111167090|NCT05886998|Heparin|heparin|mesh-list
111167091|NCT05886998|Anticoagulants|anticoagulants|mesh-ancestor
111167092|NCT05886998|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111167093|NCT05886998|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111167094|NCT05886998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111167095|NCT05886933|Fexuprazan|fexuprazan|mesh-list
111167096|NCT05886933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111167097|NCT05886829|Chlorpheniramine|chlorpheniramine|mesh-list
111167098|NCT05886829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111167099|NCT05886829|Antipruritics|antipruritics|mesh-ancestor
111167100|NCT05886829|Dermatologic Agents|dermatologic agents|mesh-ancestor
111167101|NCT05886829|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111167102|NCT05886829|Histamine Antagonists|histamine antagonists|mesh-ancestor
111167103|NCT05886829|Histamine Agents|histamine agents|mesh-ancestor
111167104|NCT05886829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111167105|NCT05886829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111167106|NCT05886829|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111167107|NCT05886790|Vaccines|vaccines|mesh-list
111167108|NCT05886790|Immunologic Factors|immunologic factors|mesh-ancestor
111167109|NCT05886790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111167110|NCT05886660|Scopolamine|scopolamine|mesh-list
111167111|NCT05886660|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
111167112|NCT05886660|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111167113|NCT05886660|Antiemetics|antiemetics|mesh-ancestor
111167114|NCT05886660|Autonomic Agents|autonomic agents|mesh-ancestor
111167115|NCT05886660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111167116|NCT05886660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111167117|NCT05886660|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111167118|NCT05886660|Mydriatics|mydriatics|mesh-ancestor
111167119|NCT05886660|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111167120|NCT05886660|Cholinergic Agents|cholinergic agents|mesh-ancestor
111167121|NCT05886660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111167122|NCT05886660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111167123|NCT05886660|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111167124|NCT05886660|Parasympatholytics|parasympatholytics|mesh-ancestor
111167125|NCT05886465|Bevacizumab|bevacizumab|mesh-list
111167126|NCT05886465|Atezolizumab|atezolizumab|mesh-list
111167127|NCT05886465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111167128|NCT05886465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111167129|NCT05886465|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111167130|NCT05886465|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111167131|NCT05886465|Growth Substances|growth substances|mesh-ancestor
111167132|NCT05886465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111167133|NCT05886465|Growth Inhibitors|growth inhibitors|mesh-ancestor
111167134|NCT05886465|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111167135|NCT05886465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111167136|NCT05886439|Pembrolizumab|pembrolizumab|mesh-list
111167137|NCT05886439|Durvalumab|durvalumab|mesh-list
111167138|NCT05886439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111167139|NCT05886439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111167140|NCT05886439|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111167141|NCT05886439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111167142|NCT05886257|Bevacizumab|bevacizumab|mesh-list
111167143|NCT05886257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111167144|NCT05886257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111167145|NCT05886257|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111167146|NCT05886257|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111167147|NCT05886257|Growth Substances|growth substances|mesh-ancestor
111167148|NCT05886257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111167149|NCT05886257|Growth Inhibitors|growth inhibitors|mesh-ancestor
111167150|NCT05886192|Vasopressins|vasopressins|mesh-list
111167151|NCT05886192|Arginine Vasopressin|arginine vasopressin|mesh-list
111167152|NCT05886192|Norepinephrine|norepinephrine|mesh-list
111167153|NCT05886192|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111167154|NCT05886192|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111167155|NCT05886192|Adrenergic Agents|adrenergic agents|mesh-ancestor
111167156|NCT05886192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111167157|NCT05886192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111167158|NCT05886192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110842443|NCT03905759|Colchicine|colchicine|mesh-list
111167159|NCT05886192|Sympathomimetics|sympathomimetics|mesh-ancestor
111167160|NCT05886192|Autonomic Agents|autonomic agents|mesh-ancestor
111167161|NCT05886192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111167162|NCT05886192|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111167163|NCT05886192|Hemostatics|hemostatics|mesh-ancestor
111167164|NCT05886192|Coagulants|coagulants|mesh-ancestor
111167165|NCT05886192|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
111167166|NCT05886192|Natriuretic Agents|natriuretic agents|mesh-ancestor
111167168|NCT05886127|Coagulants|coagulants|mesh-ancestor
111167169|NCT05886088|Dapagliflozin|dapagliflozin|mesh-list
111167170|NCT05886088|Linagliptin|linagliptin|mesh-list
111167171|NCT05886088|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111167172|NCT05886088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111167173|NCT05886088|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111167174|NCT05886088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111167175|NCT05886088|Incretins|incretins|mesh-ancestor
111167176|NCT05886088|Hormones|hormones|mesh-ancestor
111167177|NCT05886088|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111167178|NCT05886088|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111167179|NCT05886088|Protease Inhibitors|protease inhibitors|mesh-ancestor
111167180|NCT05886088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111167181|NCT05885919|Edaravone|edaravone|mesh-list
111167182|NCT05885919|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111167183|NCT05885919|Antioxidants|antioxidants|mesh-ancestor
111167184|NCT05885919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111167185|NCT05885919|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111167186|NCT05885919|Protective Agents|protective agents|mesh-ancestor
111167187|NCT05885919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111167188|NCT05885802|Anesthetics|anesthetics|mesh-list
111167189|NCT05885802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111167190|NCT05885802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111167191|NCT05885776|Trastuzumab|trastuzumab|mesh-list
111167192|NCT05885776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111167193|NCT05885776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111167194|NCT05885646|Sulthiame|sulthiame|mesh-list
111167195|NCT05885646|Anticonvulsants|anticonvulsants|mesh-ancestor
111167196|NCT05884372|Vitamin D|vitamin d|mesh-list
111167197|NCT05884372|Denosumab|denosumab|mesh-list
111167198|NCT05884372|Eldecalcitol|eldecalcitol|mesh-list
111167199|NCT05884372|Calcium|calcium|mesh-list
111167200|NCT05884372|Vitamins|vitamins|mesh-ancestor
111167201|NCT05884372|Micronutrients|micronutrients|mesh-ancestor
111167202|NCT05884372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111167203|NCT05884372|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111167204|NCT05884372|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111167206|NCT05882643|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111167207|NCT05882643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111167208|NCT05882643|Trace Elements|trace elements|mesh-ancestor
111167209|NCT05882643|Micronutrients|micronutrients|mesh-ancestor
111167210|NCT05882643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111167211|NCT05877430|Pembrolizumab|pembrolizumab|mesh-list
111167212|NCT05877430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111167213|NCT05877430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111167214|NCT05877430|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111167215|NCT05877430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111167216|NCT05802056|Calcium, Dietary|calcium, dietary|mesh-list
111167217|NCT05802056|Leucovorin|leucovorin|mesh-list
111167218|NCT05802056|Folic Acid|folic acid|mesh-list
111167219|NCT05802056|Aldesleukin|aldesleukin|mesh-list
111167220|NCT05802056|Fluorouracil|fluorouracil|mesh-list
111167221|NCT05802056|Oxaliplatin|oxaliplatin|mesh-list
111167222|NCT05802056|Nivolumab|nivolumab|mesh-list
111167223|NCT05802056|Interleukin-2|interleukin-2|mesh-list
111167224|NCT05802056|Calcium|calcium|mesh-list
111167226|NCT05802056|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111167227|NCT05802056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111167228|NCT05802056|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111167229|NCT05802056|Antimetabolites|antimetabolites|mesh-ancestor
111167230|NCT05802056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111167231|NCT05802056|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111167232|NCT05802056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111167233|NCT05802056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111167234|NCT05802056|Immunologic Factors|immunologic factors|mesh-ancestor
111167235|NCT05802056|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111167236|NCT05802056|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111167237|NCT05802056|Antidotes|antidotes|mesh-ancestor
111167238|NCT05802056|Protective Agents|protective agents|mesh-ancestor
111167239|NCT05802056|Vitamin B Complex|vitamin b complex|mesh-ancestor
111167240|NCT05802056|Vitamins|vitamins|mesh-ancestor
111167241|NCT05802056|Micronutrients|micronutrients|mesh-ancestor
111167242|NCT05802056|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111167243|NCT05802056|Analgesics|analgesics|mesh-ancestor
110884316|NCT03941093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111167244|NCT05802056|Sensory System Agents|sensory system agents|mesh-ancestor
111167245|NCT05802056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111167247|NCT05802056|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111167248|NCT05802056|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111167249|NCT05802056|Antiviral Agents|antiviral agents|mesh-ancestor
111167250|NCT05802056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111167251|NCT05794477|Paclitaxel|paclitaxel|mesh-list
111167252|NCT05794477|Carboplatin|carboplatin|mesh-list
111167253|NCT05794477|Pemetrexed|pemetrexed|mesh-list
111167254|NCT05794477|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111167255|NCT05794477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111167256|NCT05794477|Tubulin Modulators|tubulin modulators|mesh-ancestor
111167257|NCT05794477|Antimitotic Agents|antimitotic agents|mesh-ancestor
111167258|NCT05794477|Mitosis Modulators|mitosis modulators|mesh-ancestor
111167259|NCT05794477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111167260|NCT05794477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111167261|NCT05794477|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111167262|NCT05794477|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111167263|NCT05789381|Magnesium Sulfate|magnesium sulfate|mesh-list
111167264|NCT05789381|Analgesics|analgesics|mesh-ancestor
111167265|NCT05789381|Sensory System Agents|sensory system agents|mesh-ancestor
111167266|NCT05789381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111167267|NCT05789381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111167268|NCT05789381|Anesthetics|anesthetics|mesh-ancestor
111167269|NCT05789381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111167270|NCT05789381|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111167271|NCT05789381|Anticonvulsants|anticonvulsants|mesh-ancestor
111167272|NCT05789381|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111167273|NCT05789381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111167274|NCT05789381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111167275|NCT05789381|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111167276|NCT05789381|Tocolytic Agents|tocolytic agents|mesh-ancestor
111167277|NCT05789381|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111167278|NCT05773989|Clopidogrel|clopidogrel|mesh-list
111167279|NCT05773989|Ticagrelor|ticagrelor|mesh-list
110486722|NCT00737971|Hormones|hormones|mesh-ancestor
111167280|NCT05773989|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
111167281|NCT05773989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111167282|NCT05773989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111167283|NCT05773989|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111167284|NCT05773989|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110842473|NCT05208398|Warfarin|warfarin|mesh-list
111167285|NCT05773989|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111167286|NCT05773989|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111167287|NCT05773989|Purinergic Agents|purinergic agents|mesh-ancestor
111167288|NCT05773989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111167290|NCT05769478|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111167291|NCT05769478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111167292|NCT05769478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111167293|NCT05769478|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
111167294|NCT05769478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111167295|NCT05769478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111167296|NCT05745701|Cyclosporine|cyclosporine|mesh-list
111167297|NCT05745701|Itraconazole|itraconazole|mesh-list
111167298|NCT05745701|Cyclosporins|cyclosporins|mesh-list
111167299|NCT05745701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111167300|NCT05745701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111167301|NCT05745701|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111167302|NCT05745701|Immunologic Factors|immunologic factors|mesh-ancestor
111167303|NCT05745701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111167304|NCT05745701|Antifungal Agents|antifungal agents|mesh-ancestor
111167305|NCT05745701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111167306|NCT05745701|Dermatologic Agents|dermatologic agents|mesh-ancestor
111167307|NCT05745701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111167308|NCT05745701|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111167309|NCT05745701|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111167310|NCT05745701|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111167311|NCT05745701|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111167312|NCT05745701|Hormone Antagonists|hormone antagonists|mesh-ancestor
111167313|NCT05745701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111167314|NCT05745701|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111167315|NCT05742594|Lazertinib|lazertinib|mesh-list
111167316|NCT05742594|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111167317|NCT05742594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111167318|NCT05742594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111167320|NCT05741086|Evolocumab|evolocumab|mesh-list
111167321|NCT05741086|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111167322|NCT05741086|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111167323|NCT05741086|Antimetabolites|antimetabolites|mesh-ancestor
111167324|NCT05741086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111167325|NCT05741086|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111167326|NCT05741086|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111167327|NCT05741086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111167328|NCT05741086|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
111167329|NCT05741086|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111167331|NCT05722262|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3H),2'-(2H)pyran)-3',4',5'-triol|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3h),2'-(2h)pyran)-3',4',5'-triol|mesh-list
111167332|NCT05722262|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111167333|NCT05722262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111167334|NCT05722262|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111167335|NCT05722262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111167336|NCT05713994|Bevacizumab|bevacizumab|mesh-list
111167337|NCT05713994|Atezolizumab|atezolizumab|mesh-list
111167338|NCT05713994|Sorafenib|sorafenib|mesh-list
111167339|NCT05713994|Apatinib|apatinib|mesh-list
111167340|NCT05713994|Lenvatinib|lenvatinib|mesh-list
111167341|NCT05713994|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
111167342|NCT05713994|Antibodies|antibodies|mesh-list
111167343|NCT05713994|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111167344|NCT05713994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111167345|NCT05713994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111167346|NCT05713994|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111167347|NCT05713994|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111167348|NCT05713994|Growth Substances|growth substances|mesh-ancestor
111167349|NCT05713994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111167350|NCT05713994|Growth Inhibitors|growth inhibitors|mesh-ancestor
111167351|NCT05713994|Immunologic Factors|immunologic factors|mesh-ancestor
111167352|NCT05713994|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111167353|NCT05713994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111167354|NCT05713994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111167355|NCT05710887|Nitrous Oxide|nitrous oxide|mesh-list
111167356|NCT05710887|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111167357|NCT05710887|Anesthetics, General|anesthetics, general|mesh-ancestor
111167358|NCT05710887|Anesthetics|anesthetics|mesh-ancestor
111167359|NCT05710887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111167360|NCT05710887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111167361|NCT05710887|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111167362|NCT05710887|Analgesics|analgesics|mesh-ancestor
111167363|NCT05710887|Sensory System Agents|sensory system agents|mesh-ancestor
111167364|NCT05710887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111167365|NCT05707351|Factor VIII|factor viii|mesh-list
111167366|NCT05707351|BAX 855|bax 855|mesh-list
111167367|NCT05707351|Coagulants|coagulants|mesh-ancestor
111167368|NCT05657041|Clopidogrel|clopidogrel|mesh-list
111167369|NCT05657041|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
111167370|NCT05657041|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111167371|NCT05657041|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111167372|NCT05657041|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111167373|NCT05657041|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111167374|NCT05657041|Purinergic Agents|purinergic agents|mesh-ancestor
111167375|NCT05657041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111167376|NCT05657041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111167377|NCT05657041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111167378|NCT05656599|Letermovir|letermovir|mesh-list
111167379|NCT05656599|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111167380|NCT05656599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111167381|NCT05656599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110842516|NCT01254071|Adrenergic Agents|adrenergic agents|mesh-ancestor
111167382|NCT05656599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111167383|NCT05656599|Antiviral Agents|antiviral agents|mesh-ancestor
111167384|NCT05656599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111167385|NCT05607420|Alemtuzumab|alemtuzumab|mesh-list
111167386|NCT05607420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111167387|NCT05607420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111167388|NCT05607316|Metformin|metformin|mesh-list
111167389|NCT05607316|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111167390|NCT05607316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111167391|NCT05605587|Leflunomide|leflunomide|mesh-list
111167392|NCT05605587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111167393|NCT05605587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111167394|NCT05605587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111167395|NCT05605587|Immunologic Factors|immunologic factors|mesh-ancestor
111167396|NCT05605587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111167397|NCT05582993|Factor VIII|factor viii|mesh-list
111167398|NCT05582993|Coagulants|coagulants|mesh-ancestor
111167399|NCT05581758|Sotorasib|sotorasib|mesh-list
111167400|NCT05581758|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111167401|NCT05581758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111167402|NCT05581758|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111167403|NCT05581758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111167404|NCT05554146|Dronabinol|dronabinol|mesh-list
111167405|NCT05554146|Hallucinogens|hallucinogens|mesh-ancestor
111167406|NCT05554146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111167407|NCT05554146|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111167408|NCT05554146|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111167409|NCT05554146|Analgesics|analgesics|mesh-ancestor
111167410|NCT05554146|Sensory System Agents|sensory system agents|mesh-ancestor
111167411|NCT05554146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111167412|NCT05554146|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
111167413|NCT05554146|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
111167414|NCT05554146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111167415|NCT05554146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111167416|NCT05554146|Hormones|hormones|mesh-ancestor
111167417|NCT05554146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111167418|NCT05553301|Vaccines|vaccines|mesh-list
111167419|NCT05553301|Immunologic Factors|immunologic factors|mesh-ancestor
111167420|NCT05553301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111167421|NCT05535738|Fluticasone|fluticasone|mesh-list
111167422|NCT05535738|Xhance|xhance|mesh-list
111167423|NCT05535738|Adalimumab|adalimumab|mesh-list
111167424|NCT05535738|Triamcinolone|triamcinolone|mesh-list
111167425|NCT05535738|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
111167426|NCT05535738|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
111167427|NCT05535738|Betamethasone|betamethasone|mesh-list
111167428|NCT05535738|Betamethasone Valerate|betamethasone valerate|mesh-list
111167429|NCT05535738|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
111167430|NCT05535738|Betamethasone benzoate|betamethasone benzoate|mesh-list
111167431|NCT05535738|Ustekinumab|ustekinumab|mesh-list
111167432|NCT05535738|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
111167433|NCT05535738|Squaric acid dibutyl ester|squaric acid dibutyl ester|mesh-list
111167434|NCT05535738|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
111167435|NCT05535738|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111167436|NCT05535738|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111167437|NCT05535738|Autonomic Agents|autonomic agents|mesh-ancestor
111167438|NCT05535738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111167439|NCT05535738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111167440|NCT05535738|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111167441|NCT05535738|Respiratory System Agents|respiratory system agents|mesh-ancestor
111167442|NCT05535738|Dermatologic Agents|dermatologic agents|mesh-ancestor
111167443|NCT05535738|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111167444|NCT05535738|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111167445|NCT05535738|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111167446|NCT05535738|Glucocorticoids|glucocorticoids|mesh-ancestor
111167447|NCT05535738|Hormones|hormones|mesh-ancestor
111167448|NCT05535738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111167449|NCT05535738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111167450|NCT05535738|Immunologic Factors|immunologic factors|mesh-ancestor
111167451|NCT05535738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111167452|NCT05535738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111167453|NCT05535738|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111167454|NCT05518110|Hydroxychloroquine|hydroxychloroquine|mesh-list
111167455|NCT05518110|Trametinib|trametinib|mesh-list
111167456|NCT05518110|Antimalarials|antimalarials|mesh-ancestor
111167457|NCT05518110|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111167458|NCT05518110|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111167459|NCT05518110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111167460|NCT05518110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111167461|NCT05518110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111167462|NCT05518110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111167463|NCT05518110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111167464|NCT05518110|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111167465|NCT05486481|Dexamethasone|dexamethasone|mesh-list
111167466|NCT05486481|Venetoclax|venetoclax|mesh-list
111167467|NCT05486481|Daratumumab|daratumumab|mesh-list
111167468|NCT05486481|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111167469|NCT05486481|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111167470|NCT05486481|Antiemetics|antiemetics|mesh-ancestor
111167471|NCT05486481|Autonomic Agents|autonomic agents|mesh-ancestor
111167472|NCT05486481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111167473|NCT05486481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111167474|NCT05486481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111167475|NCT05486481|Glucocorticoids|glucocorticoids|mesh-ancestor
111167476|NCT05486481|Hormones|hormones|mesh-ancestor
111167477|NCT05486481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111167478|NCT05486481|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111167479|NCT05486481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111167480|NCT05486481|Immunologic Factors|immunologic factors|mesh-ancestor
111167481|NCT05441410|Artesunate|artesunate|mesh-list
111167482|NCT05441410|Pyronaridine|pyronaridine|mesh-list
111167483|NCT05441410|Pyronaridine tetraphosphate, artesunate drug combination|pyronaridine tetraphosphate, artesunate drug combination|mesh-list
111167484|NCT05441410|Antimalarials|antimalarials|mesh-ancestor
111167485|NCT05441410|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111167486|NCT05441410|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111167487|NCT05441410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111167488|NCT05441410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111167489|NCT05441410|Antiviral Agents|antiviral agents|mesh-ancestor
111167490|NCT05441410|Schistosomicides|schistosomicides|mesh-ancestor
111167491|NCT05441410|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
111167492|NCT05441410|Anthelmintics|anthelmintics|mesh-ancestor
111167493|NCT05431595|Valproic Acid|valproic acid|mesh-list
111167494|NCT05431595|Haloperidol|haloperidol|mesh-list
111167495|NCT05431595|Chlorpromazine|chlorpromazine|mesh-list
111167496|NCT05431595|Haloperidol decanoate|haloperidol decanoate|mesh-list
111167497|NCT05431595|Antiemetics|antiemetics|mesh-ancestor
111167498|NCT05431595|Autonomic Agents|autonomic agents|mesh-ancestor
111167499|NCT05431595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111167500|NCT05431595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111167501|NCT05431595|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111167502|NCT05431595|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111167503|NCT05431595|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111167504|NCT05431595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111167505|NCT05431595|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111167506|NCT05431595|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111167507|NCT05431595|Dopamine Agents|dopamine agents|mesh-ancestor
111167508|NCT05431595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111167509|NCT05431595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111167510|NCT05431595|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111167511|NCT05431595|Anticonvulsants|anticonvulsants|mesh-ancestor
111167512|NCT05431595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111167513|NCT05431595|GABA Agents|gaba agents|mesh-ancestor
111167514|NCT05431595|Antimanic Agents|antimanic agents|mesh-ancestor
111167515|NCT05351489|Dexmedetomidine|dexmedetomidine|mesh-list
111167516|NCT05351489|Bupivacaine|bupivacaine|mesh-list
111167517|NCT05351489|Anesthetics, Local|anesthetics, local|mesh-ancestor
111167518|NCT05351489|Anesthetics|anesthetics|mesh-ancestor
110842548|NCT02528123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111167519|NCT05351489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111167520|NCT05351489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111167521|NCT05351489|Sensory System Agents|sensory system agents|mesh-ancestor
111167522|NCT05351489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111167523|NCT05351489|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111167524|NCT05351489|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111167526|NCT05351489|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111167527|NCT05351489|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111167528|NCT05351489|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111167529|NCT05351489|Adrenergic Agents|adrenergic agents|mesh-ancestor
111167530|NCT05351489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111167531|NCT05351489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111167532|NCT05345717|Abatacept|abatacept|mesh-list
111167533|NCT05345717|Proteasome Inhibitors|proteasome inhibitors|mesh-list
111167534|NCT05345717|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111167535|NCT05345717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111167536|NCT05345717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111167537|NCT05345717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111167538|NCT05345717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111167539|NCT05345717|Immunologic Factors|immunologic factors|mesh-ancestor
111167540|NCT05345717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111167541|NCT05345717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111167542|NCT05345717|Protease Inhibitors|protease inhibitors|mesh-ancestor
111167544|NCT05327127|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3H),2'-(2H)pyran)-3',4',5'-triol|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3h),2'-(2h)pyran)-3',4',5'-triol|mesh-list
111167545|NCT05327127|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111167546|NCT05327127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111167547|NCT05327127|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111167548|NCT05327127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111167549|NCT05256537|Mycophenolic Acid|mycophenolic acid|mesh-list
111167550|NCT05256537|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111167551|NCT05256537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111167552|NCT05256537|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111167553|NCT05256537|Antitubercular Agents|antitubercular agents|mesh-ancestor
110486753|NCT04316169|Antimalarials|antimalarials|mesh-ancestor
111167554|NCT05256537|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111167555|NCT05256537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111167556|NCT05256537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111167557|NCT05256537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111167558|NCT05245968|Sunitinib|sunitinib|mesh-list
111167559|NCT05245968|Imatinib Mesylate|imatinib mesylate|mesh-list
111167560|NCT05245968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111167561|NCT05245968|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111167562|NCT05245968|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111167563|NCT05245968|Growth Substances|growth substances|mesh-ancestor
111167564|NCT05245968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111167565|NCT05245968|Growth Inhibitors|growth inhibitors|mesh-ancestor
111167566|NCT05245968|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111167567|NCT05245968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111167568|NCT05245968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111167569|NCT05220514|PK 11195|pk 11195|mesh-list
111167570|NCT05220514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111167571|NCT05194969|Petrolatum|petrolatum|mesh-list
111167572|NCT05194969|Emollients|emollients|mesh-ancestor
111167573|NCT05194969|Dermatologic Agents|dermatologic agents|mesh-ancestor
111167574|NCT05181735|Luspatercept|luspatercept|mesh-list
111167575|NCT05181735|Hematinics|hematinics|mesh-ancestor
111167576|NCT05166239|Lenvatinib|lenvatinib|mesh-list
111167577|NCT05166239|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
111167578|NCT05166239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111167579|NCT05166239|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111167580|NCT05166239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111167581|NCT05166239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111167582|NCT05166239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111167583|NCT05145296|Daratumumab|daratumumab|mesh-list
111167584|NCT05145296|Abatacept|abatacept|mesh-list
111167585|NCT05145296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111167586|NCT05145296|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111167587|NCT05145296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111167588|NCT05145296|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111167590|NCT05145296|Immunologic Factors|immunologic factors|mesh-ancestor
111167591|NCT05145296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111167592|NCT05145296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111167593|NCT05122767|Dolutegravir|dolutegravir|mesh-list
111167594|NCT05122767|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111167595|NCT05122767|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111167596|NCT05122767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111167597|NCT05122767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111167598|NCT05122767|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111167599|NCT05122767|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111167600|NCT05122767|Antiviral Agents|antiviral agents|mesh-ancestor
111167601|NCT05122767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111167602|NCT05100654|Doxycycline|doxycycline|mesh-list
111167603|NCT05100654|Ciprofloxacin|ciprofloxacin|mesh-list
111167604|NCT05100654|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
111167605|NCT05100654|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
111167606|NCT05100654|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111167607|NCT05100654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111167608|NCT05100654|Antimalarials|antimalarials|mesh-ancestor
111167609|NCT05100654|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111167610|NCT05100654|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111167611|NCT05100654|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111167612|NCT05100654|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111167613|NCT05100654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110884690|NCT03659058|Antimitotic Agents|antimitotic agents|mesh-ancestor
111167614|NCT05100654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111167615|NCT05100654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111167616|NCT05100654|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111167617|NCT05100654|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111167618|NCT05100654|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
111167619|NCT05100654|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111167620|NCT05095922|Valsartan|valsartan|mesh-list
111167621|NCT05095922|Calcium Dobesilate|calcium dobesilate|mesh-list
111167622|NCT05095922|Calcium|calcium|mesh-list
111167623|NCT05095922|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111167624|NCT05095922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111167625|NCT05095922|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111167626|NCT05095922|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111167627|NCT05095922|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111167628|NCT05095922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111167629|NCT05095922|Hemostatics|hemostatics|mesh-ancestor
111167630|NCT05095922|Coagulants|coagulants|mesh-ancestor
111167631|NCT05062980|Docetaxel|docetaxel|mesh-list
111167632|NCT05062980|Pembrolizumab|pembrolizumab|mesh-list
111167633|NCT05062980|Ramucirumab|ramucirumab|mesh-list
111167634|NCT05062980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111167635|NCT05062980|Tubulin Modulators|tubulin modulators|mesh-ancestor
111167636|NCT05062980|Antimitotic Agents|antimitotic agents|mesh-ancestor
111167637|NCT05062980|Mitosis Modulators|mitosis modulators|mesh-ancestor
111167638|NCT05062980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111167639|NCT05062980|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111167640|NCT05062980|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111167641|NCT04924322|Enoxaparin|enoxaparin|mesh-list
111167642|NCT04924322|Anticoagulants|anticoagulants|mesh-ancestor
111167643|NCT04924322|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111167644|NCT04924322|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111167645|NCT04924322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111167646|NCT04907253|Quercetin|quercetin|mesh-list
111167647|NCT04907253|Antioxidants|antioxidants|mesh-ancestor
111167648|NCT04907253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111167649|NCT04907253|Protective Agents|protective agents|mesh-ancestor
111167650|NCT04907253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111167651|NCT04898023|Ascorbic Acid|ascorbic acid|mesh-list
111167652|NCT04898023|Antioxidants|antioxidants|mesh-ancestor
111167653|NCT04898023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111167654|NCT04898023|Protective Agents|protective agents|mesh-ancestor
111167655|NCT04898023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111167656|NCT04898023|Vitamins|vitamins|mesh-ancestor
111167657|NCT04898023|Micronutrients|micronutrients|mesh-ancestor
111167658|NCT04875715|Hydroquinone|hydroquinone|mesh-list
111167659|NCT04875715|Antioxidants|antioxidants|mesh-ancestor
111167660|NCT04875715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111167661|NCT04875715|Protective Agents|protective agents|mesh-ancestor
111167662|NCT04875715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111167663|NCT04875715|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111167664|NCT04875702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
111167665|NCT04875702|Allopurinol|allopurinol|mesh-list
111167666|NCT04875702|Antimetabolites|antimetabolites|mesh-ancestor
111167667|NCT04875702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111167668|NCT04875702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111167669|NCT04875702|Gout Suppressants|gout suppressants|mesh-ancestor
111167670|NCT04875702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111167671|NCT04875702|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111167672|NCT04875702|Antioxidants|antioxidants|mesh-ancestor
111167673|NCT04875702|Protective Agents|protective agents|mesh-ancestor
111167674|NCT04875702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111167675|NCT04836429|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
111167676|NCT04836429|Trioxsalen|trioxsalen|mesh-list
111167677|NCT04836429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111167678|NCT04836429|Dermatologic Agents|dermatologic agents|mesh-ancestor
111167679|NCT04836429|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111167680|NCT04822467|Ethanol|ethanol|mesh-list
111167681|NCT04822467|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111167682|NCT04822467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111167683|NCT04822467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111167684|NCT04822467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111167685|NCT04801368|Anesthetics|anesthetics|mesh-list
111167686|NCT04801368|Anesthetics, Local|anesthetics, local|mesh-list
111167687|NCT04801368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111167688|NCT04801368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111167689|NCT04801368|Sensory System Agents|sensory system agents|mesh-ancestor
110842597|NCT01256021|Cholinergic Agents|cholinergic agents|mesh-ancestor
111167690|NCT04801368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111167691|NCT04769713|Ropivacaine|ropivacaine|mesh-list
111167692|NCT04769713|Anesthetics, Local|anesthetics, local|mesh-ancestor
111167693|NCT04769713|Anesthetics|anesthetics|mesh-ancestor
111167694|NCT04769713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111167695|NCT04769713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111167696|NCT04769713|Sensory System Agents|sensory system agents|mesh-ancestor
111167697|NCT04769713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111167698|NCT04728581|Quetiapine Fumarate|quetiapine fumarate|mesh-list
111167699|NCT04728581|Mirtazapine|mirtazapine|mesh-list
111167700|NCT04728581|Antidepressive Agents|antidepressive agents|mesh-ancestor
111167701|NCT04728581|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111167702|NCT04728581|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111167703|NCT04728581|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111167704|NCT04728581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111167705|NCT04728581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111167706|NCT04728581|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111167707|NCT04728581|Histamine Antagonists|histamine antagonists|mesh-ancestor
111167708|NCT04728581|Histamine Agents|histamine agents|mesh-ancestor
111167709|NCT04728581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111167710|NCT04728581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111167711|NCT04728581|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111167712|NCT04728581|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
111167713|NCT04728581|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111167714|NCT04728581|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111167715|NCT04728581|Adrenergic Agents|adrenergic agents|mesh-ancestor
111167716|NCT04728581|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111167717|NCT04728581|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111167718|NCT04728581|Serotonin Agents|serotonin agents|mesh-ancestor
111167719|NCT04728581|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111167720|NCT04677543|Azithromycin|azithromycin|mesh-list
111167722|NCT04677543|Ethambutol|ethambutol|mesh-list
111167723|NCT04677543|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111167724|NCT04677543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111167725|NCT04677543|Antitubercular Agents|antitubercular agents|mesh-ancestor
111167726|NCT04662840|Anesthetics|anesthetics|mesh-list
111167727|NCT04662840|Anesthetics, Local|anesthetics, local|mesh-list
111167728|NCT04662840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111167729|NCT04662840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111167730|NCT04662840|Sensory System Agents|sensory system agents|mesh-ancestor
111167731|NCT04662840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111167732|NCT04544293|Molgramostim|molgramostim|mesh-list
111167733|NCT04544293|Sargramostim|sargramostim|mesh-list
111167734|NCT04544293|Immunologic Factors|immunologic factors|mesh-ancestor
111167735|NCT04544293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111167736|NCT04544293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111167737|NCT04413201|Osimertinib|osimertinib|mesh-list
111167738|NCT04413201|Afatinib|afatinib|mesh-list
111167739|NCT04413201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111167740|NCT04413201|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111167741|NCT04413201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111167742|NCT04413201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111167743|NCT04254627|Etanercept|etanercept|mesh-list
111167744|NCT04254627|Mifepristone|mifepristone|mesh-list
111167745|NCT04254627|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111167746|NCT04254627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111167747|NCT04254627|Analgesics|analgesics|mesh-ancestor
111167748|NCT04254627|Sensory System Agents|sensory system agents|mesh-ancestor
111167749|NCT04254627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111167750|NCT04254627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111167751|NCT04254627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111167752|NCT04254627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111167753|NCT04254627|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111167754|NCT04254627|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111167755|NCT04254627|Immunologic Factors|immunologic factors|mesh-ancestor
111167756|NCT04254627|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
110842604|NCT04320745|Hormones|hormones|mesh-ancestor
111167757|NCT04254627|Abortifacient Agents|abortifacient agents|mesh-ancestor
111167758|NCT04254627|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111167759|NCT04254627|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111167760|NCT04254627|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111167761|NCT04254627|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111167762|NCT04254627|Contraceptive Agents|contraceptive agents|mesh-ancestor
111167763|NCT04254627|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
111167764|NCT04254627|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
111167765|NCT04254627|Hormone Antagonists|hormone antagonists|mesh-ancestor
111167766|NCT04254627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111167767|NCT04254627|Luteolytic Agents|luteolytic agents|mesh-ancestor
111167768|NCT04254627|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111167769|NCT04254627|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
111167770|NCT04160052|Azacitidine|azacitidine|mesh-list
111167771|NCT04160052|Venetoclax|venetoclax|mesh-list
111167772|NCT04160052|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111167773|NCT04160052|Antimetabolites|antimetabolites|mesh-ancestor
111167774|NCT04160052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111167775|NCT04160052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111167776|NCT04160052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111167777|NCT04139902|Dostarlimab|dostarlimab|mesh-list
111167778|NCT04139902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111167779|NCT04136366|Methotrexate|methotrexate|mesh-list
111167780|NCT04136366|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111167781|NCT04136366|Abortifacient Agents|abortifacient agents|mesh-ancestor
111167782|NCT04136366|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111167783|NCT04136366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111167784|NCT04136366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111167785|NCT04136366|Antimetabolites|antimetabolites|mesh-ancestor
111167786|NCT04136366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111167787|NCT04136366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111167788|NCT04136366|Dermatologic Agents|dermatologic agents|mesh-ancestor
111167789|NCT04136366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111167790|NCT04136366|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111167791|NCT04136366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111167792|NCT04136366|Immunologic Factors|immunologic factors|mesh-ancestor
111167793|NCT04136366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111167794|NCT04136366|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111167795|NCT04124432|Nicotine|nicotine|mesh-list
111167796|NCT04124432|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111167797|NCT04124432|Autonomic Agents|autonomic agents|mesh-ancestor
110486805|NCT00741169|Antiviral Agents|antiviral agents|mesh-ancestor
111167798|NCT04124432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111167799|NCT04124432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111167800|NCT04124432|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111167801|NCT04124432|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111167802|NCT04124432|Cholinergic Agents|cholinergic agents|mesh-ancestor
111167803|NCT04124432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111167804|NCT04124432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111167805|NCT04091217|Bevacizumab|bevacizumab|mesh-list
111167806|NCT04091217|Atezolizumab|atezolizumab|mesh-list
111167807|NCT04091217|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111167808|NCT04091217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111167809|NCT04091217|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111167810|NCT04091217|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111167811|NCT04091217|Growth Substances|growth substances|mesh-ancestor
111167812|NCT04091217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111167813|NCT04091217|Growth Inhibitors|growth inhibitors|mesh-ancestor
111167814|NCT04091217|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111167815|NCT04091217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111167816|NCT04060862|Fulvestrant|fulvestrant|mesh-list
111167817|NCT04060862|Palbociclib|palbociclib|mesh-list
111167818|NCT04060862|Ipatasertib|ipatasertib|mesh-list
111167819|NCT04060862|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111167820|NCT04060862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111167821|NCT04060862|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
111167822|NCT04060862|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111167823|NCT04060862|Hormone Antagonists|hormone antagonists|mesh-ancestor
110842608|NCT01254461|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111167824|NCT04060862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111167825|NCT04060862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111167826|NCT04060862|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111167827|NCT04060862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111167828|NCT04060862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111167829|NCT03811847|Methylphenidate|methylphenidate|mesh-list
111167830|NCT03811847|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111167831|NCT03811847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111167832|NCT03811847|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111167833|NCT03811847|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111167834|NCT03811847|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111167835|NCT03811847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111167836|NCT03811847|Dopamine Agents|dopamine agents|mesh-ancestor
111167837|NCT03811847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111167838|NCT03809000|Leuprolide|leuprolide|mesh-list
111167839|NCT03809000|Goserelin|goserelin|mesh-list
111167840|NCT03809000|Bicalutamide|bicalutamide|mesh-list
111167841|NCT03809000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111167842|NCT03809000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111167843|NCT03809000|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111167844|NCT03809000|Fertility Agents|fertility agents|mesh-ancestor
111167845|NCT03809000|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111167846|NCT03809000|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111167847|NCT03809000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111167848|NCT03809000|Androgen Antagonists|androgen antagonists|mesh-ancestor
111167849|NCT03809000|Hormone Antagonists|hormone antagonists|mesh-ancestor
111167850|NCT03698552|Epratuzumab|epratuzumab|mesh-list
111167851|NCT03698552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111167852|NCT03698552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111167853|NCT03600350|Nivolumab|nivolumab|mesh-list
111167854|NCT03600350|Sargramostim|sargramostim|mesh-list
111167855|NCT03600350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110486812|NCT00741325|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111167856|NCT03600350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111167857|NCT03600350|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111167858|NCT03600350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111167859|NCT03600350|Immunologic Factors|immunologic factors|mesh-ancestor
111167860|NCT03600350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111167861|NCT03598595|Hydroxychloroquine|hydroxychloroquine|mesh-list
111167862|NCT03598595|Gemcitabine|gemcitabine|mesh-list
111167863|NCT03598595|Docetaxel|docetaxel|mesh-list
111167864|NCT03598595|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111167865|NCT03598595|Antimetabolites|antimetabolites|mesh-ancestor
111167866|NCT03598595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111167867|NCT03598595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111167868|NCT03598595|Tubulin Modulators|tubulin modulators|mesh-ancestor
111167869|NCT03598595|Antimitotic Agents|antimitotic agents|mesh-ancestor
111167870|NCT03598595|Mitosis Modulators|mitosis modulators|mesh-ancestor
111167871|NCT03598595|Antimalarials|antimalarials|mesh-ancestor
111167872|NCT03598595|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111167873|NCT03598595|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111167874|NCT03598595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111167875|NCT03598595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111167876|NCT03598595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111167877|NCT03590054|Pembrolizumab|pembrolizumab|mesh-list
111167878|NCT03590054|Abexinostat|abexinostat|mesh-list
111167879|NCT03590054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111167880|NCT03590054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111167881|NCT03590054|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111167882|NCT03590054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111167883|NCT03590054|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111167884|NCT03590054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111167885|NCT03568097|Avelumab|avelumab|mesh-list
111167886|NCT03568097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111167887|NCT03568097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111167888|NCT03546582|Pembrolizumab|pembrolizumab|mesh-list
111167889|NCT03546582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111167890|NCT03546582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111167891|NCT03546582|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111167892|NCT03546582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111167893|NCT03384238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111167894|NCT03384238|Panitumumab|panitumumab|mesh-list
111167895|NCT03384238|Antibodies|antibodies|mesh-list
111167896|NCT03384238|Immunoglobulins|immunoglobulins|mesh-list
111167897|NCT03384238|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111167898|NCT03384238|Immunologic Factors|immunologic factors|mesh-ancestor
111167899|NCT03384238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111167900|NCT03384238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111167901|NCT03226249|Deoxyglucose|deoxyglucose|mesh-list
111167902|NCT03226249|Doxorubicin|doxorubicin|mesh-list
111167903|NCT03226249|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111167904|NCT03226249|Pembrolizumab|pembrolizumab|mesh-list
111167905|NCT03226249|Dacarbazine|dacarbazine|mesh-list
111167906|NCT03226249|Vinblastine|vinblastine|mesh-list
111167907|NCT03226249|Imidazole|imidazole|mesh-list
111167908|NCT03226249|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
111167909|NCT03226249|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111167910|NCT03226249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111167911|NCT03226249|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111167912|NCT03226249|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111167913|NCT03226249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111167914|NCT03226249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111167915|NCT03226249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111167916|NCT03226249|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111167917|NCT03226249|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111167918|NCT03226249|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111167919|NCT03226249|Alkylating Agents|alkylating agents|mesh-ancestor
111167920|NCT03226249|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111167921|NCT03226249|Tubulin Modulators|tubulin modulators|mesh-ancestor
111167922|NCT03226249|Antimitotic Agents|antimitotic agents|mesh-ancestor
111167923|NCT03226249|Mitosis Modulators|mitosis modulators|mesh-ancestor
111167924|NCT03226249|Antimetabolites|antimetabolites|mesh-ancestor
111167925|NCT03226249|Antiviral Agents|antiviral agents|mesh-ancestor
111167926|NCT03226249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111167927|NCT03184155|Nicardipine|nicardipine|mesh-list
111167928|NCT03184155|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111167929|NCT03184155|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111167930|NCT03184155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111167931|NCT03184155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111167932|NCT03184155|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111167933|NCT03184155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111167934|NCT03184155|Vasodilator Agents|vasodilator agents|mesh-ancestor
111167935|NCT03172624|Nivolumab|nivolumab|mesh-list
111167936|NCT03172624|Ipilimumab|ipilimumab|mesh-list
111167937|NCT03172624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111167938|NCT03172624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111167939|NCT03172624|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111167940|NCT03172624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111167941|NCT03101748|Paclitaxel|paclitaxel|mesh-list
111167942|NCT03101748|Cyclophosphamide|cyclophosphamide|mesh-list
111167943|NCT03101748|Doxorubicin|doxorubicin|mesh-list
111167944|NCT03101748|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111167945|NCT03101748|Trastuzumab|trastuzumab|mesh-list
111167946|NCT03101748|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111167947|NCT03101748|Daunorubicin|daunorubicin|mesh-list
111167948|NCT03101748|Pertuzumab|pertuzumab|mesh-list
111167949|NCT03101748|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
111167950|NCT03101748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111167951|NCT03101748|Antibodies|antibodies|mesh-list
111167952|NCT03101748|Immunoglobulins|immunoglobulins|mesh-list
111167953|NCT03101748|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111167954|NCT03101748|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111167955|NCT03101748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111167956|NCT03101748|Tubulin Modulators|tubulin modulators|mesh-ancestor
111167957|NCT03101748|Antimitotic Agents|antimitotic agents|mesh-ancestor
111167958|NCT03101748|Mitosis Modulators|mitosis modulators|mesh-ancestor
111167959|NCT03101748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111167960|NCT03101748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111167961|NCT03101748|Immunologic Factors|immunologic factors|mesh-ancestor
111167962|NCT03101748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111167963|NCT03101748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111167964|NCT03101748|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111167965|NCT03101748|Alkylating Agents|alkylating agents|mesh-ancestor
111167966|NCT03101748|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111167967|NCT03101748|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111167968|NCT03101748|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111167969|NCT03101748|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111167970|NCT03101748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111167971|NCT03085147|Olaparib|olaparib|mesh-list
111167972|NCT03085147|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111167973|NCT03085147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111167974|NCT03085147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111167975|NCT03085147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111167976|NCT03063944|Azacitidine|azacitidine|mesh-list
111167977|NCT03063944|Decitabine|decitabine|mesh-list
111167978|NCT03063944|Venetoclax|venetoclax|mesh-list
111167979|NCT03063944|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111167980|NCT03063944|Antimetabolites|antimetabolites|mesh-ancestor
111167981|NCT03063944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111167982|NCT03063944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111167983|NCT03063944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111167984|NCT03062631|Amifampridine|amifampridine|mesh-list
111167985|NCT03062631|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111167986|NCT03062631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111167987|NCT03062631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111167988|NCT03062631|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
111167989|NCT03062631|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111167990|NCT03062631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111167991|NCT02941926|Letrozole|letrozole|mesh-list
111167992|NCT02941926|Leuprolide|leuprolide|mesh-list
111167993|NCT02941926|Goserelin|goserelin|mesh-list
111167994|NCT02941926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111167995|NCT02941926|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111167996|NCT02941926|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111167997|NCT02941926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111167998|NCT02941926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111167999|NCT02941926|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111168000|NCT02941926|Hormone Antagonists|hormone antagonists|mesh-ancestor
111168001|NCT02941926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111168002|NCT02941926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111168003|NCT02941926|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111168004|NCT02941926|Fertility Agents|fertility agents|mesh-ancestor
111168005|NCT02941926|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111168006|NCT02941926|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111168007|NCT02910700|Nivolumab|nivolumab|mesh-list
111168008|NCT02910700|Trametinib|trametinib|mesh-list
111168009|NCT02910700|Dabrafenib|dabrafenib|mesh-list
111168010|NCT02910700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111168011|NCT02910700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111168012|NCT02910700|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111168013|NCT02910700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111168014|NCT02910700|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111168015|NCT02910700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111168016|NCT02849548|Suvorexant|suvorexant|mesh-list
111168017|NCT02849548|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111168018|NCT02849548|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111168019|NCT02849548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111168020|NCT02849548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111168021|NCT02849548|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
111168022|NCT02849548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111168023|NCT02849548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111168024|NCT02780310|Lenvatinib|lenvatinib|mesh-list
111168025|NCT02780310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111168026|NCT02780310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111168027|NCT02780310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111168028|NCT02780310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111168029|NCT02758431|Methyltestosterone|methyltestosterone|mesh-list
111168030|NCT02758431|Anastrozole|anastrozole|mesh-list
111168031|NCT02758431|Testosterone|testosterone|mesh-list
111168032|NCT02758431|Testosterone undecanoate|testosterone undecanoate|mesh-list
111168033|NCT02758431|Testosterone enanthate|testosterone enanthate|mesh-list
111168034|NCT02758431|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
111168035|NCT02758431|Aromatase Inhibitors|aromatase inhibitors|mesh-list
111168036|NCT02758431|Acyline|acyline|mesh-list
111168037|NCT02758431|Hormone Antagonists|hormone antagonists|mesh-list
111168038|NCT02758431|Hormones|hormones|mesh-ancestor
111168039|NCT02758431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111168040|NCT02758431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111168041|NCT02758431|Androgens|androgens|mesh-ancestor
111168042|NCT02758431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111168043|NCT02758431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111168044|NCT02758431|Anabolic Agents|anabolic agents|mesh-ancestor
111168045|NCT02758431|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111168046|NCT02758431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111168047|NCT02758431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111168048|NCT02758431|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111168049|NCT02756000|Dobutamine|dobutamine|mesh-list
111168050|NCT02756000|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111168051|NCT02756000|Sympathomimetics|sympathomimetics|mesh-ancestor
111168052|NCT02756000|Autonomic Agents|autonomic agents|mesh-ancestor
111168053|NCT02756000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111168054|NCT02756000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111168055|NCT02756000|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
111168056|NCT02756000|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111168057|NCT02756000|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111168058|NCT02756000|Adrenergic Agents|adrenergic agents|mesh-ancestor
111168059|NCT02756000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111168060|NCT02756000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111168061|NCT02756000|Protective Agents|protective agents|mesh-ancestor
111168063|NCT02601365|Sargramostim|sargramostim|mesh-list
111168064|NCT02601365|Immunologic Factors|immunologic factors|mesh-ancestor
111168065|NCT02601365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111168066|NCT02601365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111168067|NCT02583893|Cytarabine|cytarabine|mesh-list
111168068|NCT02583893|Sirolimus|sirolimus|mesh-list
111168069|NCT02583893|Etoposide|etoposide|mesh-list
111168070|NCT02583893|Mitoxantrone|mitoxantrone|mesh-list
111168071|NCT02583893|Etoposide phosphate|etoposide phosphate|mesh-list
111168072|NCT02583893|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111168073|NCT02583893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111168074|NCT02583893|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111168075|NCT02583893|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111168076|NCT02583893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111168077|NCT02583893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111168078|NCT02583893|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111168079|NCT02583893|Antimetabolites|antimetabolites|mesh-ancestor
111168080|NCT02583893|Antiviral Agents|antiviral agents|mesh-ancestor
111168081|NCT02583893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111168082|NCT02583893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111168083|NCT02583893|Immunologic Factors|immunologic factors|mesh-ancestor
111168084|NCT02583893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111168085|NCT02583893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111168086|NCT02583893|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111168087|NCT02583893|Antifungal Agents|antifungal agents|mesh-ancestor
111168088|NCT02583893|Analgesics|analgesics|mesh-ancestor
111168089|NCT02583893|Sensory System Agents|sensory system agents|mesh-ancestor
111168090|NCT02583893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111168091|NCT02520154|Paclitaxel|paclitaxel|mesh-list
111168092|NCT02520154|Carboplatin|carboplatin|mesh-list
111168093|NCT02520154|Pembrolizumab|pembrolizumab|mesh-list
111168094|NCT02520154|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111168095|NCT02520154|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111168096|NCT02520154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111168097|NCT02520154|Tubulin Modulators|tubulin modulators|mesh-ancestor
111168098|NCT02520154|Antimitotic Agents|antimitotic agents|mesh-ancestor
110842634|NCT03063086|Autonomic Agents|autonomic agents|mesh-ancestor
111168099|NCT02520154|Mitosis Modulators|mitosis modulators|mesh-ancestor
111168100|NCT02520154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111168101|NCT02520154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111168102|NCT02520154|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111168103|NCT02411448|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111168104|NCT02411448|Gefitinib|gefitinib|mesh-list
111168105|NCT02411448|Osimertinib|osimertinib|mesh-list
111168106|NCT02411448|Ramucirumab|ramucirumab|mesh-list
111168107|NCT02411448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111168108|NCT02411448|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111168109|NCT02411448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111168110|NCT02411448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111168111|NCT02107144|Trimetazidine|trimetazidine|mesh-list
111168112|NCT02107144|Vasodilator Agents|vasodilator agents|mesh-ancestor
111168113|NCT01860170|Cyclophosphamide|cyclophosphamide|mesh-list
111168114|NCT01860170|Bortezomib|bortezomib|mesh-list
111168115|NCT01860170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111168116|NCT01860170|Immunologic Factors|immunologic factors|mesh-ancestor
111168117|NCT01860170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111168118|NCT01860170|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111168119|NCT01860170|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111168120|NCT01860170|Alkylating Agents|alkylating agents|mesh-ancestor
111168121|NCT01860170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111168122|NCT01860170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111168123|NCT01860170|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111168124|NCT01847274|Niraparib|niraparib|mesh-list
111168125|NCT01847274|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111168126|NCT01847274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111168127|NCT01847274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111168128|NCT01847274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111168129|NCT01566695|Azacitidine|azacitidine|mesh-list
111168130|NCT01566695|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111168131|NCT01566695|Antimetabolites|antimetabolites|mesh-ancestor
111168132|NCT01566695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111168133|NCT01566695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111168134|NCT01566695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111168135|NCT01471106|Dasatinib|dasatinib|mesh-list
111168136|NCT01471106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111168137|NCT01471106|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111168138|NCT01471106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111168139|NCT01471106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111168141|NCT01330446|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111168142|NCT01330446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111168143|NCT01330446|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
111168144|NCT01330446|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111168145|NCT01330446|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111168146|NCT01330446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111168147|NCT00866554|Tamoxifen|tamoxifen|mesh-list
111168148|NCT00866554|Bicalutamide|bicalutamide|mesh-list
111168149|NCT00866554|Dutasteride|dutasteride|mesh-list
111168150|NCT00866554|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111168151|NCT00866554|Hormone Antagonists|hormone antagonists|mesh-ancestor
111168152|NCT00866554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111168153|NCT00866554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111168154|NCT00866554|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111168155|NCT00866554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111168156|NCT00866554|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111168157|NCT00866554|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111168158|NCT00866554|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111168159|NCT00866554|Androgen Antagonists|androgen antagonists|mesh-ancestor
111168160|NCT00866554|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
111168161|NCT00866554|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111168162|NCT00866554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111168163|NCT00866554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111168164|NCT00645931|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
111168165|NCT00645931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111168166|NCT00645931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111168167|NCT00452023|Interferons|interferons|mesh-list
111168168|NCT00452023|Interferon-alpha|interferon-alpha|mesh-list
111168169|NCT00452023|Interferon alpha-2|interferon alpha-2|mesh-list
111168170|NCT00452023|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
111168171|NCT00452023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111168172|NCT00452023|Antiviral Agents|antiviral agents|mesh-ancestor
111168173|NCT00452023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111168174|NCT00452023|Immunologic Factors|immunologic factors|mesh-ancestor
111168175|NCT00452023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111168176|NCT00442104|Ganaxolone|ganaxolone|mesh-list
111168177|NCT00442104|Neurosteroids|neurosteroids|mesh-ancestor
111168178|NCT00442104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111168179|NCT00442104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111168180|NCT00442104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111168181|NCT00442104|GABA Modulators|gaba modulators|mesh-ancestor
111168182|NCT00442104|GABA Agents|gaba agents|mesh-ancestor
111168183|NCT00441896|Ganaxolone|ganaxolone|mesh-list
111168184|NCT00441896|Neurosteroids|neurosteroids|mesh-ancestor
111168185|NCT00441896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110486911|NCT05740969|Melatonin|melatonin|mesh-list
111168186|NCT00441896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111168187|NCT00441896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111168188|NCT00441896|GABA Modulators|gaba modulators|mesh-ancestor
111168189|NCT00441896|GABA Agents|gaba agents|mesh-ancestor
111168190|NCT00254423|Dasatinib|dasatinib|mesh-list
111168191|NCT00254423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111168192|NCT00254423|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111168193|NCT00254423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111168194|NCT00254423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111168195|NCT00202800|Gemcitabine|gemcitabine|mesh-list
111168196|NCT00202800|Etoposide|etoposide|mesh-list
111168197|NCT00202800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111168198|NCT00202800|Antimetabolites|antimetabolites|mesh-ancestor
111168199|NCT00202800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111168200|NCT00202800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111168201|NCT00202800|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111168202|NCT00202800|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111168203|NCT00202800|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111168204|NCT00202800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111168205|NCT00194714|Vaccines|vaccines|mesh-list
111168206|NCT00194714|Immunologic Factors|immunologic factors|mesh-ancestor
111168207|NCT00194714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111168208|NCT02034877|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
111168209|NCT02034877|Immunologic Factors|immunologic factors|mesh-ancestor
111168210|NCT02034877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111168211|NCT02034799|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
111168212|NCT02034799|Hemostatics|hemostatics|mesh-ancestor
111168213|NCT02034799|Coagulants|coagulants|mesh-ancestor
111168214|NCT02057575|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111168215|NCT02057575|Latanoprost|latanoprost|mesh-list
111168216|NCT02057575|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111168217|NCT02077465|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111168218|NCT02077465|Immunologic Factors|immunologic factors|mesh-ancestor
111168219|NCT02077465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111168220|NCT02034565|Apixaban|apixaban|mesh-list
111168221|NCT02034565|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111168222|NCT02034565|Antithrombins|antithrombins|mesh-ancestor
111168223|NCT02034565|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111168224|NCT02034565|Protease Inhibitors|protease inhibitors|mesh-ancestor
111168225|NCT02034565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111168226|NCT02034565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111168227|NCT02034565|Anticoagulants|anticoagulants|mesh-ancestor
111168228|NCT02075515|Vaccines|vaccines|mesh-list
111168229|NCT02075515|Immunologic Factors|immunologic factors|mesh-ancestor
111168230|NCT02075515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111168231|NCT04682587|Pembrolizumab|pembrolizumab|mesh-list
111168232|NCT04682587|Avelumab|avelumab|mesh-list
111168233|NCT04682587|Axitinib|axitinib|mesh-list
111168234|NCT04682587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111168235|NCT04682587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111168236|NCT04682587|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111168237|NCT04682587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111168238|NCT04682587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111168239|NCT04682587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111168240|NCT04417543|Memantine|memantine|mesh-list
111168241|NCT04417543|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111168242|NCT04417543|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111168243|NCT04417543|Dopamine Agents|dopamine agents|mesh-ancestor
111168244|NCT04417543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111168245|NCT04417543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111168246|NCT04417543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111168247|NCT04417543|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111168248|NCT04417543|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111168249|NCT02021318|Darbepoetin alfa|darbepoetin alfa|mesh-list
111168250|NCT02021318|Hematinics|hematinics|mesh-ancestor
111168251|NCT02020616|Metformin|metformin|mesh-list
111168252|NCT02020616|Exenatide|exenatide|mesh-list
111168253|NCT02020616|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111168254|NCT02020616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111168255|NCT02020616|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111168256|NCT02020616|Incretins|incretins|mesh-ancestor
111168257|NCT02020616|Hormones|hormones|mesh-ancestor
111168258|NCT02020616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111168259|NCT02048072|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
111168260|NCT02048072|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
111168261|NCT02048072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111168262|NCT02048072|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111168263|NCT02048072|Immunologic Factors|immunologic factors|mesh-ancestor
111168264|NCT02048072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111168265|NCT01622660|Gemcitabine|gemcitabine|mesh-list
111168266|NCT01622660|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111168267|NCT01622660|Antimetabolites|antimetabolites|mesh-ancestor
111168268|NCT01622660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111168269|NCT01622660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111168270|NCT04697498|Anesthetics|anesthetics|mesh-list
111168271|NCT04697498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111168272|NCT04697498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111168273|NCT02019602|Certolizumab Pegol|certolizumab pegol|mesh-list
111168274|NCT02019602|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111168275|NCT02019602|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111168276|NCT02019602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111168277|NCT02019602|Immunologic Factors|immunologic factors|mesh-ancestor
111168278|NCT02019602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111168279|NCT02019602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111168280|NCT02040428|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
111168281|NCT02040428|Hemostatics|hemostatics|mesh-ancestor
111168282|NCT02040428|Coagulants|coagulants|mesh-ancestor
111168283|NCT02018822|Urethane|urethane|mesh-list
111168284|NCT02018822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111168285|NCT02018822|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111168286|NCT02018822|Anesthetics, General|anesthetics, general|mesh-ancestor
111168287|NCT02018822|Anesthetics|anesthetics|mesh-ancestor
111168288|NCT02018822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111168289|NCT02018822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111168290|NCT02055157|Natriuretic Peptide, C-Type|natriuretic peptide, c-type|mesh-list
111168291|NCT02055157|Natriuretic Agents|natriuretic agents|mesh-ancestor
111168292|NCT02055157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111168293|NCT02022007|Metformin|metformin|mesh-list
111168294|NCT02022007|Saxagliptin|saxagliptin|mesh-list
111168295|NCT02022007|Biguanides|biguanides|mesh-list
111168296|NCT02022007|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
111168297|NCT02022007|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111168298|NCT02022007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111168299|NCT02022007|Incretins|incretins|mesh-ancestor
111168300|NCT02022007|Hormones|hormones|mesh-ancestor
111168301|NCT02022007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111168302|NCT02022007|Protease Inhibitors|protease inhibitors|mesh-ancestor
111168303|NCT02022007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111168304|NCT02022007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111168305|NCT04689919|Rivaroxaban|rivaroxaban|mesh-list
111168306|NCT04689919|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111168307|NCT04689919|Antithrombins|antithrombins|mesh-ancestor
111168308|NCT04689919|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111168309|NCT04689919|Protease Inhibitors|protease inhibitors|mesh-ancestor
111168310|NCT04689919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111168311|NCT04689919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111168312|NCT04689919|Anticoagulants|anticoagulants|mesh-ancestor
111168313|NCT04680949|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
111168314|NCT04680949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111168315|NCT02053753|Denosumab|denosumab|mesh-list
111168316|NCT02053753|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111168317|NCT02053753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111168318|NCT02019979|Metformin|metformin|mesh-list
111168319|NCT02019979|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111168320|NCT02019979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111168321|NCT02019667|(3-aminopropyl)(n-butyl)phosphinic acid|(3-aminopropyl)(n-butyl)phosphinic acid|mesh-list
111168322|NCT02019667|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111168323|NCT02019667|Protective Agents|protective agents|mesh-ancestor
111168324|NCT02019667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111168325|NCT02019667|GABA Antagonists|gaba antagonists|mesh-ancestor
111168326|NCT02019667|GABA Agents|gaba agents|mesh-ancestor
111168327|NCT02019667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111168328|NCT02019667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111168329|NCT02030821|Tranexamic Acid|tranexamic acid|mesh-list
111168330|NCT02030821|Aminocaproic Acid|aminocaproic acid|mesh-list
111168331|NCT02030821|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111168332|NCT02030821|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111168333|NCT02030821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111168334|NCT02030821|Hemostatics|hemostatics|mesh-ancestor
111168335|NCT02030821|Coagulants|coagulants|mesh-ancestor
111168336|NCT02052739|Brexanolone|brexanolone|mesh-list
111168337|NCT02052739|Neurosteroids|neurosteroids|mesh-ancestor
111168338|NCT02052739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111168339|NCT02052739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111168340|NCT02052739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111168341|NCT02052739|GABA Modulators|gaba modulators|mesh-ancestor
111168342|NCT02052739|GABA Agents|gaba agents|mesh-ancestor
111168343|NCT02019277|Paclitaxel|paclitaxel|mesh-list
111168344|NCT02019277|Docetaxel|docetaxel|mesh-list
111168345|NCT02019277|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111168346|NCT02019277|Trastuzumab|trastuzumab|mesh-list
111168347|NCT02019277|Pertuzumab|pertuzumab|mesh-list
111168348|NCT02019277|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111168349|NCT02019277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111168350|NCT02019277|Tubulin Modulators|tubulin modulators|mesh-ancestor
111168351|NCT02019277|Antimitotic Agents|antimitotic agents|mesh-ancestor
111168352|NCT02019277|Mitosis Modulators|mitosis modulators|mesh-ancestor
111168353|NCT02019277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111168354|NCT02019277|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111168355|NCT01823835|Palbociclib|palbociclib|mesh-list
111168356|NCT01823835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111168357|NCT01823835|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111168358|NCT01823835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111168359|NCT01823835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111168360|NCT01823679|Capecitabine|capecitabine|mesh-list
111168361|NCT01823679|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110885451|NCT02858180|Ledipasvir|ledipasvir|mesh-list
111168362|NCT01823679|Antimetabolites|antimetabolites|mesh-ancestor
111168363|NCT01823679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111168364|NCT01823679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111168365|NCT01823289|Itraconazole|itraconazole|mesh-list
111168366|NCT01823289|Antifungal Agents|antifungal agents|mesh-ancestor
111168367|NCT01823289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111168368|NCT01823289|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111168369|NCT01823289|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111168370|NCT01823289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111168371|NCT01823289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111168372|NCT01823289|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111168373|NCT01823289|Hormone Antagonists|hormone antagonists|mesh-ancestor
111168374|NCT01823289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111168375|NCT01823289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111168376|NCT01823289|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111168377|NCT01822899|Fluticasone|fluticasone|mesh-list
111168378|NCT01822899|Xhance|xhance|mesh-list
111168379|NCT01822899|Bromides|bromides|mesh-list
111168380|NCT01822899|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
111168381|NCT01822899|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110842648|NCT03904745|Hormone Antagonists|hormone antagonists|mesh-ancestor
111168382|NCT01822899|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111168383|NCT01822899|Autonomic Agents|autonomic agents|mesh-ancestor
111168384|NCT01822899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111168385|NCT01822899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111168386|NCT01822899|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111168387|NCT01822899|Respiratory System Agents|respiratory system agents|mesh-ancestor
111168388|NCT01822899|Dermatologic Agents|dermatologic agents|mesh-ancestor
111168389|NCT01822899|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111168390|NCT01822899|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111168391|NCT01822899|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111168392|NCT01822899|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111168393|NCT01822899|Adrenergic Agents|adrenergic agents|mesh-ancestor
111168394|NCT01822899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111168395|NCT01822899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111168396|NCT01822899|Anticonvulsants|anticonvulsants|mesh-ancestor
111168398|NCT01822821|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111168399|NCT01822821|Analgesics|analgesics|mesh-ancestor
111168400|NCT01822821|Sensory System Agents|sensory system agents|mesh-ancestor
111168401|NCT01822821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111168402|NCT01822821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111168403|NCT01822821|Antipyretics|antipyretics|mesh-ancestor
111168404|NCT01822665|Acetaminophen|acetaminophen|mesh-list
111168405|NCT01822665|Ibuprofen|ibuprofen|mesh-list
111168406|NCT01822665|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111168407|NCT01822665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111168408|NCT01822665|Analgesics|analgesics|mesh-ancestor
111168409|NCT01822665|Sensory System Agents|sensory system agents|mesh-ancestor
111168410|NCT01822665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111168411|NCT01822665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111168412|NCT01822665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111168413|NCT01822665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111168414|NCT01822665|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111168415|NCT01822665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111168416|NCT01822665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111168417|NCT01822665|Antipyretics|antipyretics|mesh-ancestor
111168418|NCT01822587|Propranolol|propranolol|mesh-list
111168419|NCT01822587|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111168420|NCT01822587|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111168421|NCT01822587|Adrenergic Agents|adrenergic agents|mesh-ancestor
111168422|NCT01822587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111168423|NCT01822587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111168424|NCT01822587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111168425|NCT01822587|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111168426|NCT01822587|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111168427|NCT01822587|Vasodilator Agents|vasodilator agents|mesh-ancestor
111168428|NCT01821963|Interferons|interferons|mesh-list
111168429|NCT01821963|Ribavirin|ribavirin|mesh-list
111168430|NCT01821963|Interferon-alpha|interferon-alpha|mesh-list
111168431|NCT01821963|Interferon alpha-2|interferon alpha-2|mesh-list
111168432|NCT01821963|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
111168433|NCT01821963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111168434|NCT01821963|Antiviral Agents|antiviral agents|mesh-ancestor
111168435|NCT01821963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111168436|NCT01821963|Antimetabolites|antimetabolites|mesh-ancestor
111168437|NCT01821963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111168439|NCT01821963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111168440|NCT01821729|Leucovorin|leucovorin|mesh-list
111168441|NCT01821729|Fluorouracil|fluorouracil|mesh-list
111168442|NCT01821729|Oxaliplatin|oxaliplatin|mesh-list
111168443|NCT01821729|Folfirinox|folfirinox|mesh-list
111168444|NCT01821729|Losartan|losartan|mesh-list
111168445|NCT01821729|Antimetabolites|antimetabolites|mesh-ancestor
111168446|NCT01821729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111168447|NCT01821729|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111168448|NCT01821729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111168449|NCT01821729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111168450|NCT01821729|Immunologic Factors|immunologic factors|mesh-ancestor
111168451|NCT01821729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111168452|NCT01821729|Antidotes|antidotes|mesh-ancestor
111168453|NCT01821729|Protective Agents|protective agents|mesh-ancestor
111168454|NCT01821729|Vitamin B Complex|vitamin b complex|mesh-ancestor
111168455|NCT01821729|Vitamins|vitamins|mesh-ancestor
111168456|NCT01821729|Micronutrients|micronutrients|mesh-ancestor
111168457|NCT01821729|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111168458|NCT01821729|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111168459|NCT01821729|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111168460|NCT01821729|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111168462|NCT01820637|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111168463|NCT01820637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111168464|NCT01820637|Tubulin Modulators|tubulin modulators|mesh-ancestor
111168465|NCT01820637|Antimitotic Agents|antimitotic agents|mesh-ancestor
111168466|NCT01820637|Mitosis Modulators|mitosis modulators|mesh-ancestor
111168467|NCT01820637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111168468|NCT01850823|Mometasone Furoate|mometasone furoate|mesh-list
111168469|NCT01850823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111168470|NCT01850823|Dermatologic Agents|dermatologic agents|mesh-ancestor
111168471|NCT01850823|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111168472|NCT01820559|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
111168473|NCT01820559|Anticonvulsants|anticonvulsants|mesh-ancestor
111168474|NCT01820559|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111168475|NCT01820559|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111168476|NCT01820559|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111168477|NCT01820559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111168478|NCT02171429|Adalimumab|adalimumab|mesh-list
111168479|NCT02171429|Etrolizumab|etrolizumab|mesh-list
111168480|NCT02171429|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111168481|NCT02171429|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111168482|NCT02171429|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111168483|NCT02171429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111168484|NCT02171429|Immunologic Factors|immunologic factors|mesh-ancestor
111168485|NCT02171429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111168486|NCT01818141|Vancomycin|vancomycin|mesh-list
111168487|NCT01818141|Fidaxomicin|fidaxomicin|mesh-list
111168488|NCT01818141|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111168489|NCT01818141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111168490|NCT01849497|Evolocumab|evolocumab|mesh-list
111168491|NCT01849497|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111168492|NCT01849497|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
111168493|NCT01849497|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111168494|NCT01849497|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111168495|NCT01849497|Antimetabolites|antimetabolites|mesh-ancestor
111168496|NCT01849497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111168497|NCT01849497|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111168498|NCT01849497|Protease Inhibitors|protease inhibitors|mesh-ancestor
111168499|NCT01849497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111168500|NCT01849497|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111168501|NCT01849497|Immunologic Factors|immunologic factors|mesh-ancestor
111168502|NCT01849497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111168503|NCT04170465|Metformin|metformin|mesh-list
111168504|NCT04170465|Paclitaxel|paclitaxel|mesh-list
111168505|NCT04170465|Cyclophosphamide|cyclophosphamide|mesh-list
111168506|NCT04170465|Doxorubicin|doxorubicin|mesh-list
111168507|NCT04170465|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111168508|NCT04170465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111168509|NCT04170465|Tubulin Modulators|tubulin modulators|mesh-ancestor
111168510|NCT04170465|Antimitotic Agents|antimitotic agents|mesh-ancestor
111168511|NCT04170465|Mitosis Modulators|mitosis modulators|mesh-ancestor
111168512|NCT04170465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111168513|NCT04170465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111168514|NCT04170465|Immunologic Factors|immunologic factors|mesh-ancestor
111168515|NCT04170465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111168516|NCT04170465|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111168517|NCT04170465|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111168518|NCT04170465|Alkylating Agents|alkylating agents|mesh-ancestor
111168519|NCT04170465|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111168520|NCT04170465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111168521|NCT04170465|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111168522|NCT04170465|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111168523|NCT04170465|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111168524|NCT04170465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111168525|NCT01816893|Hypoglycemic Agents|hypoglycemic agents|mesh-list
111168526|NCT01816893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111168527|NCT01847313|Liraglutide|liraglutide|mesh-list
111168529|NCT01847313|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
111168530|NCT01847313|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111168531|NCT01847313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111168532|NCT01847313|Incretins|incretins|mesh-ancestor
111168533|NCT01847313|Hormones|hormones|mesh-ancestor
111168534|NCT01847313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111168535|NCT01847313|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111168536|NCT02117687|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
111168537|NCT02117687|Hyaluronic Acid|hyaluronic acid|mesh-list
111168538|NCT02117687|Glycerol|glycerol|mesh-list
111168539|NCT02117687|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111168540|NCT02117687|Immunologic Factors|immunologic factors|mesh-ancestor
111168541|NCT02117687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111168542|NCT02117687|Viscosupplements|viscosupplements|mesh-ancestor
111168543|NCT02117687|Protective Agents|protective agents|mesh-ancestor
111168544|NCT02117687|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
111168545|NCT02117687|Laxatives|laxatives|mesh-ancestor
111168546|NCT02117687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111168547|NCT02141633|Fluticasone|fluticasone|mesh-list
111168548|NCT02141633|Xhance|xhance|mesh-list
111168549|NCT02141633|Albuterol|albuterol|mesh-list
111168550|NCT02141633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111168551|NCT02141633|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111168552|NCT02141633|Autonomic Agents|autonomic agents|mesh-ancestor
111168553|NCT02141633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111168554|NCT02141633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111168555|NCT02141633|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111168556|NCT02141633|Respiratory System Agents|respiratory system agents|mesh-ancestor
111168557|NCT02141633|Dermatologic Agents|dermatologic agents|mesh-ancestor
111168558|NCT02141633|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111168559|NCT02141633|Tocolytic Agents|tocolytic agents|mesh-ancestor
111168560|NCT02141633|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111168561|NCT02141633|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111168562|NCT02141633|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111168563|NCT02141633|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111168564|NCT02141633|Adrenergic Agents|adrenergic agents|mesh-ancestor
111168565|NCT02141633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111168566|NCT02141633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111168567|NCT01846611|Dexamethasone|dexamethasone|mesh-list
111168568|NCT01846611|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111168569|NCT01846611|Doxorubicin|doxorubicin|mesh-list
111168570|NCT01846611|Trabectedin|trabectedin|mesh-list
111168571|NCT01846611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111168572|NCT01846611|Antiemetics|antiemetics|mesh-ancestor
111168573|NCT01846611|Autonomic Agents|autonomic agents|mesh-ancestor
111168574|NCT01846611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111168575|NCT01846611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111168576|NCT01846611|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111168577|NCT01846611|Glucocorticoids|glucocorticoids|mesh-ancestor
111168578|NCT01846611|Hormones|hormones|mesh-ancestor
111168579|NCT01846611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111168580|NCT01846611|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111168581|NCT01846611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111168582|NCT01846611|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111168583|NCT01846611|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111168584|NCT01846611|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111168585|NCT01846611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111168586|NCT01846611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111168587|NCT01846611|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111168588|NCT01846611|Alkylating Agents|alkylating agents|mesh-ancestor
111168589|NCT01846299|Ranibizumab|ranibizumab|mesh-list
110885677|NCT02186834|Dexamethasone|dexamethasone|mesh-list
111168590|NCT01846299|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111168591|NCT01846299|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111168592|NCT01846299|Growth Substances|growth substances|mesh-ancestor
111168593|NCT01846299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111168594|NCT01846299|Growth Inhibitors|growth inhibitors|mesh-ancestor
111168595|NCT01846299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111168596|NCT01628393|Ozanimod|ozanimod|mesh-list
111168597|NCT01628393|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
111168598|NCT01628393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110842660|NCT03898583|Calcitriol|calcitriol|mesh-list
111168599|NCT01628393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111168600|NCT01628393|Immunologic Factors|immunologic factors|mesh-ancestor
111168601|NCT01628393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111168603|NCT01846221|Fentanyl|fentanyl|mesh-list
111168604|NCT01846221|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111168605|NCT01846221|Narcotics|narcotics|mesh-ancestor
111168606|NCT01846221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111168607|NCT01846221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111168608|NCT01846221|Analgesics|analgesics|mesh-ancestor
111168609|NCT01846221|Sensory System Agents|sensory system agents|mesh-ancestor
111168610|NCT01846221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111168611|NCT01846221|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111168612|NCT01846221|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111168613|NCT01846221|Anesthetics, General|anesthetics, general|mesh-ancestor
111168614|NCT01846221|Anesthetics|anesthetics|mesh-ancestor
111168615|NCT01846221|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111168616|NCT01846221|Sympatholytics|sympatholytics|mesh-ancestor
111168617|NCT01846221|Autonomic Agents|autonomic agents|mesh-ancestor
111168618|NCT01846221|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111168619|NCT01846221|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111168620|NCT01846221|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111168621|NCT01846221|Adrenergic Agents|adrenergic agents|mesh-ancestor
111168622|NCT01846221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111168623|NCT01846221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111168624|NCT01845831|Metformin|metformin|mesh-list
111168625|NCT01845831|Insulin Glargine|insulin glargine|mesh-list
111168626|NCT01845831|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111168627|NCT01845831|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111168628|NCT01845831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111168629|NCT01845831|Incretins|incretins|mesh-ancestor
111168630|NCT01845831|Hormones|hormones|mesh-ancestor
111168631|NCT01845831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111168632|NCT01845831|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111168633|NCT01845831|Protease Inhibitors|protease inhibitors|mesh-ancestor
111168634|NCT01845831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111168635|NCT01845831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111168636|NCT01844895|Abatacept|abatacept|mesh-list
111168637|NCT01844895|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110487009|NCT00651651|Adrenergic Agents|adrenergic agents|mesh-ancestor
111168638|NCT01844895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111168639|NCT01844895|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111168640|NCT01844895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111168641|NCT01844895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111168642|NCT01844895|Immunologic Factors|immunologic factors|mesh-ancestor
111168643|NCT01844895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111168644|NCT01844895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111168645|NCT02116361|Botulinum Toxins|botulinum toxins|mesh-list
111168646|NCT02116361|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111168647|NCT02116361|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111168648|NCT02116361|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111168649|NCT02116361|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111168650|NCT02116361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111168651|NCT02116361|Cholinergic Agents|cholinergic agents|mesh-ancestor
111168652|NCT02116361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111168653|NCT02116361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111168654|NCT02116361|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111168655|NCT02116361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111168656|NCT04594239|Lidocaine|lidocaine|mesh-list
111168657|NCT04594239|Hyaluronic Acid|hyaluronic acid|mesh-list
111168658|NCT04594239|Anesthetics, Local|anesthetics, local|mesh-ancestor
111168659|NCT04594239|Anesthetics|anesthetics|mesh-ancestor
111168660|NCT04594239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111168661|NCT04594239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111168662|NCT04594239|Sensory System Agents|sensory system agents|mesh-ancestor
111168663|NCT04594239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110885755|NCT03080493|Anticonvulsants|anticonvulsants|mesh-ancestor
111168665|NCT04594239|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111168666|NCT04594239|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111168667|NCT04594239|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111168668|NCT04594239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111168669|NCT04594239|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111168670|NCT04594239|Immunologic Factors|immunologic factors|mesh-ancestor
111168671|NCT04594239|Viscosupplements|viscosupplements|mesh-ancestor
111168672|NCT04594239|Protective Agents|protective agents|mesh-ancestor
111168673|NCT04585737|Tenofovir|tenofovir|mesh-list
111168674|NCT04585737|Lamivudine|lamivudine|mesh-list
111168675|NCT04585737|Emtricitabine|emtricitabine|mesh-list
111168676|NCT04585737|Dolutegravir|dolutegravir|mesh-list
111168677|NCT04585737|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
111168678|NCT04585737|Antiviral Agents|antiviral agents|mesh-ancestor
111168679|NCT04585737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111168680|NCT04585737|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111168681|NCT04585737|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111168682|NCT04585737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111168683|NCT04585737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111168684|NCT04585737|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111168685|NCT04585737|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111168686|NCT04585737|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111168687|NCT04585737|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111168688|NCT01814553|Afatinib|afatinib|mesh-list
111168689|NCT01814553|Loperamide|loperamide|mesh-list
111168690|NCT01814553|Antidiarrheals|antidiarrheals|mesh-list
111168691|NCT01814553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111168692|NCT01814553|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111168693|NCT01814553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111168694|NCT01814553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111168695|NCT01814553|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111168696|NCT02116205|Vaccines|vaccines|mesh-list
111168697|NCT02116205|Immunologic Factors|immunologic factors|mesh-ancestor
111168698|NCT02116205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111168699|NCT01844583|Rifampin|rifampin|mesh-list
111168700|NCT01844583|Esomeprazole|esomeprazole|mesh-list
111168701|NCT01844583|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111168702|NCT01844583|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111168703|NCT01844583|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111168704|NCT01844583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111168705|NCT01844583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111168706|NCT01844583|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111168707|NCT01844583|Antitubercular Agents|antitubercular agents|mesh-ancestor
111168708|NCT01844583|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111168709|NCT01844583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111168710|NCT01844583|Leprostatic Agents|leprostatic agents|mesh-ancestor
111168711|NCT01844583|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111168712|NCT01844583|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111168713|NCT01844583|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111168714|NCT01844583|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
111168715|NCT01844583|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
111168716|NCT01844583|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
111168717|NCT01844583|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111168718|NCT02115113|Everolimus|everolimus|mesh-list
111168719|NCT02115113|Tacrolimus|tacrolimus|mesh-list
111168720|NCT02115113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111168721|NCT02115113|Immunologic Factors|immunologic factors|mesh-ancestor
111168722|NCT02115113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111168723|NCT02115113|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111168724|NCT02115113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111168725|NCT02115113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111168726|NCT02115113|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111168727|NCT02115113|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111168728|NCT02115113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111168729|NCT02114177|Sofosbuvir|sofosbuvir|mesh-list
111168730|NCT02114177|Simeprevir|simeprevir|mesh-list
111168731|NCT02114177|Antiviral Agents|antiviral agents|mesh-ancestor
111168732|NCT02114177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111168733|NCT02114177|Protease Inhibitors|protease inhibitors|mesh-ancestor
111168734|NCT02114177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111168735|NCT02114177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111168736|NCT02138825|Riociguat|riociguat|mesh-list
111168737|NCT02138825|Enzyme Activators|enzyme activators|mesh-ancestor
110885837|NCT03654612|Apatinib|apatinib|mesh-list
111168738|NCT02138825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111168739|NCT02138747|Mirabegron|mirabegron|mesh-list
111168740|NCT02138747|Tolterodine Tartrate|tolterodine tartrate|mesh-list
111168741|NCT02138747|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
111168742|NCT02138747|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111168743|NCT02138747|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111168744|NCT02138747|Adrenergic Agents|adrenergic agents|mesh-ancestor
111168745|NCT02138747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111168746|NCT02138747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111168747|NCT02138747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111168748|NCT02138747|Urological Agents|urological agents|mesh-ancestor
111168749|NCT02138747|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111168750|NCT02138747|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111168751|NCT02138747|Cholinergic Agents|cholinergic agents|mesh-ancestor
111168752|NCT02105285|Carteolol|carteolol|mesh-list
111168753|NCT02105285|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111168754|NCT02105285|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111168755|NCT02105285|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111168756|NCT02105285|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111168757|NCT02105285|Adrenergic Agents|adrenergic agents|mesh-ancestor
111168758|NCT02105285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111168759|NCT02105285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111168760|NCT02105285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111168761|NCT02105285|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111168762|NCT02105285|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111168763|NCT02105285|Sympatholytics|sympatholytics|mesh-ancestor
111168764|NCT02105285|Autonomic Agents|autonomic agents|mesh-ancestor
111168765|NCT02105285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111168766|NCT01621490|Nivolumab|nivolumab|mesh-list
111168767|NCT01621490|Ipilimumab|ipilimumab|mesh-list
111168768|NCT01621490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111168769|NCT01621490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111168770|NCT01621490|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111168771|NCT01621490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111168772|NCT02030041|Vitamin D|vitamin d|mesh-list
111168773|NCT02030041|Cholecalciferol|cholecalciferol|mesh-list
111168774|NCT02030041|Simvastatin|simvastatin|mesh-list
111168775|NCT02030041|Vitamins|vitamins|mesh-ancestor
111168776|NCT02030041|Micronutrients|micronutrients|mesh-ancestor
111168777|NCT02030041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111168778|NCT02030041|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111168779|NCT02030041|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111168780|NCT02030041|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111168781|NCT02030041|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111168782|NCT02030041|Antimetabolites|antimetabolites|mesh-ancestor
111168783|NCT02030041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111168784|NCT02030041|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111168785|NCT02030041|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111168786|NCT02030041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111168787|NCT01994720|Aspirin|aspirin|mesh-list
111168788|NCT01994720|Ticagrelor|ticagrelor|mesh-list
111168789|NCT01994720|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111168790|NCT01994720|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111168791|NCT01994720|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111168792|NCT01994720|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111168793|NCT01994720|Purinergic Agents|purinergic agents|mesh-ancestor
111168794|NCT01994720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111168795|NCT01994720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111168796|NCT01994720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111168797|NCT01994720|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111168798|NCT01994720|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111168799|NCT01994720|Analgesics|analgesics|mesh-ancestor
111168800|NCT01994720|Sensory System Agents|sensory system agents|mesh-ancestor
111168801|NCT01994720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111168802|NCT01994720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111168803|NCT01994720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111168804|NCT01994720|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111168805|NCT01994720|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111168806|NCT01994720|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111168807|NCT01994720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111168808|NCT01994720|Antipyretics|antipyretics|mesh-ancestor
111168809|NCT01814397|Letrozole|letrozole|mesh-list
111168810|NCT01814397|Anastrozole|anastrozole|mesh-list
111168811|NCT01814397|Exemestane|exemestane|mesh-list
111168812|NCT01814397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111168813|NCT01814397|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111168814|NCT01814397|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111168815|NCT01814397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111168816|NCT01814397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111168817|NCT01814397|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111168818|NCT01814397|Hormone Antagonists|hormone antagonists|mesh-ancestor
111168819|NCT01814397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111168820|NCT01814397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111168821|NCT01814397|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111168822|NCT01844115|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
111168823|NCT01844115|Antidepressive Agents|antidepressive agents|mesh-ancestor
111168824|NCT01844115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111168825|NCT01844115|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111168826|NCT01844115|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111168827|NCT01844115|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111168828|NCT01844115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111168829|NCT01844115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111168830|NCT01844115|Serotonin Agents|serotonin agents|mesh-ancestor
111168831|NCT01844115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111168832|NCT01844115|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111168833|NCT01844115|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111168835|NCT02018042|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111168836|NCT02018042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111168837|NCT02018042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111168838|NCT02018042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111168839|NCT02018042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111168840|NCT02018042|Immunologic Factors|immunologic factors|mesh-ancestor
111168841|NCT02018042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111168842|NCT02018042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111168843|NCT02017171|Allopurinol|allopurinol|mesh-list
111168844|NCT02017171|Antimetabolites|antimetabolites|mesh-ancestor
111168845|NCT02017171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111168846|NCT02017171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111168847|NCT02017171|Gout Suppressants|gout suppressants|mesh-ancestor
111168848|NCT02017171|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111168849|NCT02017171|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111168850|NCT02017171|Antioxidants|antioxidants|mesh-ancestor
111168851|NCT02017171|Protective Agents|protective agents|mesh-ancestor
111168852|NCT02017171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111168853|NCT04686097|Sclerosing Solutions|sclerosing solutions|mesh-list
111168854|NCT04686097|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111168855|NCT02029417|Cytarabine|cytarabine|mesh-list
111168856|NCT02029417|Decitabine|decitabine|mesh-list
111168857|NCT02029417|Azacitidine|azacitidine|mesh-list
111168858|NCT02029417|Homoharringtonine|homoharringtonine|mesh-list
111168859|NCT02029417|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111168860|NCT02029417|Antimetabolites|antimetabolites|mesh-ancestor
111168861|NCT02029417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111168862|NCT02029417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111168863|NCT02029417|Antiviral Agents|antiviral agents|mesh-ancestor
111168864|NCT02029417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111168865|NCT02029417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111168866|NCT02029417|Immunologic Factors|immunologic factors|mesh-ancestor
111168867|NCT02029417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111168868|NCT02029417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111168869|NCT02029417|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111168870|NCT02029417|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111168871|NCT02016716|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111168872|NCT02016716|Immunologic Factors|immunologic factors|mesh-ancestor
111168873|NCT02016716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111168874|NCT02050321|Vemurafenib|vemurafenib|mesh-list
111168875|NCT02050321|Acitretin|acitretin|mesh-list
111168876|NCT02050321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111168877|NCT02050321|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111168878|NCT02050321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111168879|NCT02050321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111168880|NCT02050321|Keratolytic Agents|keratolytic agents|mesh-ancestor
111168881|NCT02050321|Dermatologic Agents|dermatologic agents|mesh-ancestor
111168882|NCT02017015|Paclitaxel|paclitaxel|mesh-list
111168884|NCT02017015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111168885|NCT02017015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111168886|NCT02017015|Tubulin Modulators|tubulin modulators|mesh-ancestor
111168887|NCT02017015|Antimitotic Agents|antimitotic agents|mesh-ancestor
111168888|NCT02017015|Mitosis Modulators|mitosis modulators|mesh-ancestor
111168889|NCT02017015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111168890|NCT02017015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111168891|NCT02017015|Antimetabolites|antimetabolites|mesh-ancestor
111168892|NCT02016625|Cyclosporine|cyclosporine|mesh-list
111168893|NCT02016625|Tacrolimus|tacrolimus|mesh-list
111168894|NCT02016625|Cyclosporins|cyclosporins|mesh-list
111168895|NCT02016625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111168896|NCT02016625|Immunologic Factors|immunologic factors|mesh-ancestor
111168897|NCT02016625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111168898|NCT02016625|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111168899|NCT02016625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111168900|NCT02016625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111168901|NCT02016625|Antifungal Agents|antifungal agents|mesh-ancestor
111168902|NCT02016625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111168903|NCT02016625|Dermatologic Agents|dermatologic agents|mesh-ancestor
110487046|NCT02646657|Vedolizumab|vedolizumab|mesh-list
111168904|NCT02016625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111168905|NCT02016482|Adalimumab|adalimumab|mesh-list
111168906|NCT02016482|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111168907|NCT02016482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111168908|NCT02016482|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111168909|NCT02028871|Insulin|insulin|mesh-list
111168910|NCT02028871|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111168911|NCT02028871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111168912|NCT02028715|Acetaminophen|acetaminophen|mesh-list
111168913|NCT02028715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111168914|NCT02028715|Analgesics|analgesics|mesh-ancestor
111168915|NCT02028715|Sensory System Agents|sensory system agents|mesh-ancestor
111168916|NCT02028715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111168917|NCT02028715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111168918|NCT02028715|Antipyretics|antipyretics|mesh-ancestor
111168919|NCT02016170|Ticagrelor|ticagrelor|mesh-list
111168920|NCT02016170|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
111168921|NCT02016170|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111168922|NCT02016170|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111168923|NCT02016170|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111168924|NCT02016170|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111168925|NCT02016170|Purinergic Agents|purinergic agents|mesh-ancestor
111168926|NCT02016170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111168927|NCT02016170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111168928|NCT02016170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111168929|NCT02015546|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
111168930|NCT02015546|Antidepressive Agents|antidepressive agents|mesh-ancestor
111168931|NCT02015546|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111168932|NCT02015546|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111168933|NCT02015546|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111168934|NCT02015546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111168935|NCT02015546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111168936|NCT02015546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111168937|NCT02015546|Serotonin Agents|serotonin agents|mesh-ancestor
111168938|NCT02015546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111168939|NCT02015546|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111168940|NCT02015546|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111168941|NCT02038790|Buprenorphine|buprenorphine|mesh-list
111168942|NCT02038790|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
111168943|NCT02038790|Naloxone|naloxone|mesh-list
111168944|NCT02038790|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111168945|NCT02038790|Narcotics|narcotics|mesh-ancestor
111168946|NCT02038790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111168947|NCT02038790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111168948|NCT02038790|Analgesics|analgesics|mesh-ancestor
111168949|NCT02038790|Sensory System Agents|sensory system agents|mesh-ancestor
111168950|NCT02038790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111168951|NCT02038790|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111168953|NCT02027311|Meperidine|meperidine|mesh-list
111168954|NCT02027311|Etomidate|etomidate|mesh-list
111168955|NCT02027311|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111168956|NCT02027311|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111168957|NCT02027311|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111168958|NCT02027311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111168959|NCT02027311|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111168960|NCT02027311|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111168961|NCT02027311|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111168962|NCT02027311|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111168963|NCT02027311|Anesthetics, General|anesthetics, general|mesh-ancestor
111168964|NCT02027311|Anesthetics|anesthetics|mesh-ancestor
111168965|NCT02027311|GABA Modulators|gaba modulators|mesh-ancestor
111168966|NCT02027311|GABA Agents|gaba agents|mesh-ancestor
111168967|NCT02027311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111168968|NCT02027311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111168969|NCT02027311|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111168970|NCT02027311|Narcotics|narcotics|mesh-ancestor
111168971|NCT02027311|Analgesics|analgesics|mesh-ancestor
111168972|NCT02027311|Sensory System Agents|sensory system agents|mesh-ancestor
111168973|NCT02027311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111168974|NCT02047903|Afatinib|afatinib|mesh-list
111168975|NCT02047903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111168976|NCT02047903|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111168977|NCT02047903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111168978|NCT02047903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111168979|NCT02026141|Dexmedetomidine|dexmedetomidine|mesh-list
111168980|NCT02026141|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111168981|NCT02026141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111168982|NCT02026141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111168983|NCT02026141|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111168984|NCT02026141|Analgesics|analgesics|mesh-ancestor
111168985|NCT02026141|Sensory System Agents|sensory system agents|mesh-ancestor
111168986|NCT02026141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111168987|NCT02026141|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111168988|NCT02026141|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111168989|NCT02026141|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111168990|NCT02026141|Adrenergic Agents|adrenergic agents|mesh-ancestor
111168991|NCT02026141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111168992|NCT02026141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111168993|NCT02025907|Canagliflozin|canagliflozin|mesh-list
111168994|NCT02025907|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111168995|NCT02025907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111168996|NCT02025907|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111168997|NCT02025907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111168998|NCT02025751|Metoclopramide|metoclopramide|mesh-list
111168999|NCT02025751|Antiemetics|antiemetics|mesh-ancestor
111169000|NCT02025751|Autonomic Agents|autonomic agents|mesh-ancestor
111169001|NCT02025751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111169002|NCT02025751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111169003|NCT02025751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111169004|NCT02025751|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111169005|NCT02025751|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111169006|NCT02025751|Dopamine Agents|dopamine agents|mesh-ancestor
111169007|NCT02025751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111169008|NCT02025751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111169009|NCT01812837|Aminolevulinic Acid|aminolevulinic acid|mesh-list
111169010|NCT01812837|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111169011|NCT01812837|Dermatologic Agents|dermatologic agents|mesh-ancestor
111169012|NCT02024971|Metformin|metformin|mesh-list
111169013|NCT02024971|Pioglitazone|pioglitazone|mesh-list
111169014|NCT02024971|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111169015|NCT02024971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111169016|NCT01843023|Naltrexone|naltrexone|mesh-list
111169017|NCT01843023|Buprenorphine|buprenorphine|mesh-list
111169018|NCT01843023|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111169019|NCT01843023|Narcotics|narcotics|mesh-ancestor
111169020|NCT01843023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111169021|NCT01843023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111169022|NCT01843023|Analgesics|analgesics|mesh-ancestor
111169023|NCT01843023|Sensory System Agents|sensory system agents|mesh-ancestor
110842683|NCT03898193|Montelukast|montelukast|mesh-list
111169024|NCT01843023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111169025|NCT01843023|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111169026|NCT01843023|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111169027|NCT01812759|Fentanyl|fentanyl|mesh-list
111169028|NCT01812759|Hydromorphone|hydromorphone|mesh-list
111169029|NCT01812759|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111169030|NCT01812759|Narcotics|narcotics|mesh-ancestor
111169031|NCT01812759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111169032|NCT01812759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111169033|NCT01812759|Analgesics|analgesics|mesh-ancestor
111169034|NCT01812759|Sensory System Agents|sensory system agents|mesh-ancestor
111169035|NCT01812759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111169036|NCT01812759|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110886127|NCT03604796|Antipyretics|antipyretics|mesh-ancestor
111169038|NCT01812759|Anesthetics, General|anesthetics, general|mesh-ancestor
111169039|NCT01812759|Anesthetics|anesthetics|mesh-ancestor
111169040|NCT01812057|Dexamethasone|dexamethasone|mesh-list
111169041|NCT01812057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111169042|NCT01812057|Antiemetics|antiemetics|mesh-ancestor
111169043|NCT01812057|Autonomic Agents|autonomic agents|mesh-ancestor
111169044|NCT01812057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111169045|NCT01812057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111169046|NCT01812057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111169047|NCT01812057|Glucocorticoids|glucocorticoids|mesh-ancestor
111169048|NCT01812057|Hormones|hormones|mesh-ancestor
111169049|NCT01812057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111169050|NCT01812057|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111169051|NCT01812057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111169052|NCT01842633|Acetaminophen|acetaminophen|mesh-list
111169053|NCT01842633|Ibuprofen|ibuprofen|mesh-list
111169054|NCT01842633|Caffeine|caffeine|mesh-list
111169055|NCT01842633|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111169056|NCT01842633|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111169057|NCT01842633|Analgesics|analgesics|mesh-ancestor
111169058|NCT01842633|Sensory System Agents|sensory system agents|mesh-ancestor
111169059|NCT01842633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111169060|NCT01842633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111169061|NCT01842633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111169062|NCT01842633|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111169063|NCT01842633|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111169064|NCT01842633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111169065|NCT01842633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111169066|NCT01842633|Antipyretics|antipyretics|mesh-ancestor
111169067|NCT01842633|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111169068|NCT01842633|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111169069|NCT01842633|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
111169070|NCT01842633|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111169071|NCT01842633|Purinergic Agents|purinergic agents|mesh-ancestor
111169072|NCT01842633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111169073|NCT01841697|Metformin|metformin|mesh-list
111169074|NCT01841697|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111169075|NCT01841697|Glimepiride|glimepiride|mesh-list
111169076|NCT01841697|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111169077|NCT01841697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111169078|NCT01841697|Incretins|incretins|mesh-ancestor
111169079|NCT01841697|Hormones|hormones|mesh-ancestor
111169080|NCT01841697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111169081|NCT01841697|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111169082|NCT01841697|Protease Inhibitors|protease inhibitors|mesh-ancestor
111169083|NCT01841697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111169084|NCT01841697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111169085|NCT01841697|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111169086|NCT01841697|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111169087|NCT01841697|Immunologic Factors|immunologic factors|mesh-ancestor
111169088|NCT01809327|Metformin|metformin|mesh-list
111169089|NCT01809327|Canagliflozin|canagliflozin|mesh-list
111169090|NCT01809327|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111169091|NCT01809327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111169092|NCT01809327|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111169093|NCT01809327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111169094|NCT03272139|Bupivacaine|bupivacaine|mesh-list
111169095|NCT03272139|Anesthetics, Local|anesthetics, local|mesh-ancestor
111169096|NCT03272139|Anesthetics|anesthetics|mesh-ancestor
111169097|NCT03272139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111169098|NCT03272139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111169099|NCT03272139|Sensory System Agents|sensory system agents|mesh-ancestor
111169100|NCT03272139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111169101|NCT01808313|Ambrisentan|ambrisentan|mesh-list
111169102|NCT01808313|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111169103|NCT01840605|Ketotifen|ketotifen|mesh-list
111169104|NCT01840605|Bepotastine besilate|bepotastine besilate|mesh-list
111169105|NCT01840605|Antipruritics|antipruritics|mesh-ancestor
111169106|NCT01840605|Dermatologic Agents|dermatologic agents|mesh-ancestor
111169107|NCT01840605|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111169108|NCT01840605|Histamine Antagonists|histamine antagonists|mesh-ancestor
111169109|NCT01840605|Histamine Agents|histamine agents|mesh-ancestor
111169110|NCT01840605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111169111|NCT01840605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111169112|NCT01840605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111169113|NCT01840605|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111169114|NCT02023879|Alirocumab|alirocumab|mesh-list
111169115|NCT02023879|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111169116|NCT02023879|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
111169117|NCT02023879|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111169118|NCT02023879|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111169119|NCT02023879|Antimetabolites|antimetabolites|mesh-ancestor
111169120|NCT02023879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111169121|NCT02023879|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111169122|NCT02023879|Protease Inhibitors|protease inhibitors|mesh-ancestor
111169123|NCT02023879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111169124|NCT02023879|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111169125|NCT02023879|Immunologic Factors|immunologic factors|mesh-ancestor
111169126|NCT02023879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111169127|NCT02014441|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
111169128|NCT02014441|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111169129|NCT02014441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111169130|NCT02013817|Cyclophosphamide|cyclophosphamide|mesh-list
111169131|NCT02013817|Rituximab|rituximab|mesh-list
111169132|NCT02013817|Fludarabine|fludarabine|mesh-list
111169133|NCT02013817|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111169134|NCT02013817|Immunologic Factors|immunologic factors|mesh-ancestor
111169135|NCT02013817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111169136|NCT02013817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111169137|NCT02013817|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111169138|NCT02013817|Alkylating Agents|alkylating agents|mesh-ancestor
111169139|NCT02013817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111169140|NCT02013817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111169141|NCT02013817|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111169142|NCT02013817|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111169143|NCT02023099|Ritonavir|ritonavir|mesh-list
111169144|NCT02023099|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111169145|NCT02023099|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111169146|NCT02023099|Protease Inhibitors|protease inhibitors|mesh-ancestor
111169147|NCT02023099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111169148|NCT02023099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111169149|NCT02023099|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111169150|NCT02023099|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111169151|NCT02023099|Antiviral Agents|antiviral agents|mesh-ancestor
111169152|NCT02023099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111169153|NCT02023099|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111169154|NCT02023099|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111169155|NCT02013037|Eculizumab|eculizumab|mesh-list
111169156|NCT02013037|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
111169157|NCT02013037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111169158|NCT02013037|Immunologic Factors|immunologic factors|mesh-ancestor
111169159|NCT02013037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111169160|NCT04416607|Menotropins|menotropins|mesh-list
111169161|NCT04416607|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111169162|NCT04416607|Fertility Agents|fertility agents|mesh-ancestor
111169163|NCT04416607|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111169164|NCT04416607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111169165|NCT01967173|Fluticasone|fluticasone|mesh-list
111169166|NCT01967173|Xhance|xhance|mesh-list
111169167|NCT01967173|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
111169168|NCT01967173|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111169169|NCT01967173|Autonomic Agents|autonomic agents|mesh-ancestor
111169170|NCT01967173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111169171|NCT01967173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111169172|NCT01967173|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111169173|NCT01967173|Respiratory System Agents|respiratory system agents|mesh-ancestor
111169174|NCT01967173|Glucocorticoids|glucocorticoids|mesh-ancestor
111169175|NCT01967173|Hormones|hormones|mesh-ancestor
111169176|NCT01967173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111169177|NCT01967173|Sympathomimetics|sympathomimetics|mesh-ancestor
111169178|NCT01967173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111169179|NCT01967173|Dermatologic Agents|dermatologic agents|mesh-ancestor
111169180|NCT01967173|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111169181|NCT01993927|Voglibose|voglibose|mesh-list
111169182|NCT01993927|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111169183|NCT01993927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111169184|NCT01993927|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
111169185|NCT01993927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111169186|NCT01993927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111169188|NCT02012959|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
111169189|NCT02012959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111169190|NCT02012959|Natriuretic Agents|natriuretic agents|mesh-ancestor
111169191|NCT02012959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111169192|NCT02012491|Misoprostol|misoprostol|mesh-list
111169193|NCT02012491|Mifepristone|mifepristone|mesh-list
111169194|NCT02012491|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111169195|NCT02012491|Abortifacient Agents|abortifacient agents|mesh-ancestor
111169196|NCT02012491|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111169197|NCT02012491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111169198|NCT02012491|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111169199|NCT02012491|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111169200|NCT02012491|Oxytocics|oxytocics|mesh-ancestor
111169201|NCT02012491|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
111169202|NCT02012491|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111169203|NCT02012491|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111169204|NCT02012491|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111169205|NCT02012491|Contraceptive Agents|contraceptive agents|mesh-ancestor
111169206|NCT02012491|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
111169207|NCT02012491|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
111169208|NCT02012491|Hormone Antagonists|hormone antagonists|mesh-ancestor
111169209|NCT02012491|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111169210|NCT02012491|Luteolytic Agents|luteolytic agents|mesh-ancestor
111169211|NCT02012491|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111169212|NCT02012491|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
111169213|NCT02038010|Trastuzumab|trastuzumab|mesh-list
111169214|NCT02038010|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
111169215|NCT02038010|Maytansine|maytansine|mesh-list
111169216|NCT02038010|Immunoconjugates|immunoconjugates|mesh-list
111169217|NCT02038010|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-list
111169218|NCT02038010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111169219|NCT02038010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111169220|NCT02038010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111169221|NCT02038010|Tubulin Modulators|tubulin modulators|mesh-ancestor
111169222|NCT02038010|Antimitotic Agents|antimitotic agents|mesh-ancestor
111169223|NCT02038010|Mitosis Modulators|mitosis modulators|mesh-ancestor
111169224|NCT02038010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111169226|NCT02038010|Immunologic Factors|immunologic factors|mesh-ancestor
111169227|NCT02038010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111169228|NCT02038010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111169229|NCT04678154|Vancomycin|vancomycin|mesh-list
111169230|NCT04678154|Tobramycin|tobramycin|mesh-list
111169231|NCT04678154|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111169232|NCT04678154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111169233|NCT04178798|Acalabrutinib|acalabrutinib|mesh-list
111169234|NCT04178798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111169235|NCT01989572|Sargramostim|sargramostim|mesh-list
111169236|NCT01989572|Immunologic Factors|immunologic factors|mesh-ancestor
111169237|NCT01989572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111169238|NCT01988402|Allopurinol|allopurinol|mesh-list
111169239|NCT01988402|Antimetabolites|antimetabolites|mesh-ancestor
111169240|NCT01988402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111169241|NCT01988402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111169242|NCT01988402|Gout Suppressants|gout suppressants|mesh-ancestor
111169243|NCT01988402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111169244|NCT01988402|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111169245|NCT01988402|Antioxidants|antioxidants|mesh-ancestor
111169246|NCT01988402|Protective Agents|protective agents|mesh-ancestor
111169247|NCT01988402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111169248|NCT01988090|Vitamin D|vitamin d|mesh-list
111169249|NCT01988090|Ergocalciferols|ergocalciferols|mesh-list
111169250|NCT01988090|Cholecalciferol|cholecalciferol|mesh-list
111169251|NCT01988090|Vitamins|vitamins|mesh-list
111169252|NCT01988090|Micronutrients|micronutrients|mesh-ancestor
111169253|NCT01988090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111169254|NCT01988090|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111169255|NCT01988090|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111169256|NCT02011945|Nivolumab|nivolumab|mesh-list
111169257|NCT02011945|Dasatinib|dasatinib|mesh-list
111169258|NCT02011945|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111169259|NCT02011945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111169260|NCT02011945|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111169261|NCT02011945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111169262|NCT02011945|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111169264|NCT02013830|Bevacizumab|bevacizumab|mesh-list
111169265|NCT02013830|Capecitabine|capecitabine|mesh-list
111169266|NCT02013830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111169267|NCT02013830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111169268|NCT02013830|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111169269|NCT02013830|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111169270|NCT02013830|Growth Substances|growth substances|mesh-ancestor
111169271|NCT02013830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111169272|NCT02013830|Growth Inhibitors|growth inhibitors|mesh-ancestor
111169273|NCT02013830|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111169274|NCT02013830|Antimetabolites|antimetabolites|mesh-ancestor
111169275|NCT02013830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111169276|NCT02010775|Botulinum Toxins|botulinum toxins|mesh-list
111169277|NCT02010775|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111169278|NCT02010775|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111169279|NCT02010775|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111169280|NCT02010775|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111169281|NCT02010775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111169282|NCT02010775|Cholinergic Agents|cholinergic agents|mesh-ancestor
111169283|NCT02010775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111169284|NCT02010775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111169285|NCT02010775|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111169286|NCT02010775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111169287|NCT01619059|Metformin|metformin|mesh-list
111169288|NCT01619059|Dapagliflozin|dapagliflozin|mesh-list
111169289|NCT01619059|Saxagliptin|saxagliptin|mesh-list
111169290|NCT01619059|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111169291|NCT01619059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111169292|NCT01619059|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111169293|NCT01619059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111169294|NCT01619059|Incretins|incretins|mesh-ancestor
111169295|NCT01619059|Hormones|hormones|mesh-ancestor
110842710|NCT01254617|Immunologic Factors|immunologic factors|mesh-ancestor
111169296|NCT01619059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111169297|NCT01619059|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111169298|NCT01619059|Protease Inhibitors|protease inhibitors|mesh-ancestor
111169299|NCT01619059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111169300|NCT04691804|Prednisone|prednisone|mesh-list
111169301|NCT04691804|Abiraterone Acetate|abiraterone acetate|mesh-list
111169302|NCT04691804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111169303|NCT04691804|Glucocorticoids|glucocorticoids|mesh-ancestor
111169304|NCT04691804|Hormones|hormones|mesh-ancestor
111169305|NCT04691804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111169306|NCT04691804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111169307|NCT04691804|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111169308|NCT04691804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111169309|NCT04691804|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111169310|NCT04691804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111169311|NCT04691804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111169312|NCT04691804|Hormone Antagonists|hormone antagonists|mesh-ancestor
111169313|NCT04691804|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111169314|NCT02013206|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111169315|NCT02013206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111169316|NCT02013206|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111169317|NCT02013206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111169318|NCT02013206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111169319|NCT01807923|Ivacaftor|ivacaftor|mesh-list
111169320|NCT01807923|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
111169321|NCT01807923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111169322|NCT01807923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111169323|NCT01966003|Paclitaxel|paclitaxel|mesh-list
111169324|NCT01966003|Bevacizumab|bevacizumab|mesh-list
111169325|NCT01966003|Carboplatin|carboplatin|mesh-list
111169326|NCT01966003|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111169327|NCT01966003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111169328|NCT01966003|Tubulin Modulators|tubulin modulators|mesh-ancestor
111169329|NCT01966003|Antimitotic Agents|antimitotic agents|mesh-ancestor
111169330|NCT01966003|Mitosis Modulators|mitosis modulators|mesh-ancestor
111169331|NCT01966003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111169332|NCT01966003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111169333|NCT01966003|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111169334|NCT01966003|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111169335|NCT01966003|Growth Substances|growth substances|mesh-ancestor
111169336|NCT01966003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111169337|NCT01966003|Growth Inhibitors|growth inhibitors|mesh-ancestor
111169338|NCT01839279|Moxifloxacin|moxifloxacin|mesh-list
111169339|NCT01839279|Tizanidine|tizanidine|mesh-list
111169340|NCT01839279|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111169341|NCT01839279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111169342|NCT01839279|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111169343|NCT01839279|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111169344|NCT01839279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111169345|NCT01839279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111169346|NCT01839279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111169347|NCT01839279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111169348|NCT01839279|Analgesics|analgesics|mesh-ancestor
111169349|NCT01839279|Sensory System Agents|sensory system agents|mesh-ancestor
111169350|NCT01839279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111169351|NCT01839279|Anticonvulsants|anticonvulsants|mesh-ancestor
111169352|NCT01839279|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
111169353|NCT01839279|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111169354|NCT01839279|Parasympatholytics|parasympatholytics|mesh-ancestor
111169355|NCT01839279|Autonomic Agents|autonomic agents|mesh-ancestor
111169356|NCT01839279|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111169357|NCT01839279|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111169358|NCT01839279|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111169359|NCT01839279|Adrenergic Agents|adrenergic agents|mesh-ancestor
111169360|NCT01839279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111169361|NCT01965535|Sofosbuvir|sofosbuvir|mesh-list
111169362|NCT01965535|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
111169363|NCT01965535|Ledipasvir|ledipasvir|mesh-list
111169364|NCT01965535|Antiviral Agents|antiviral agents|mesh-ancestor
111169365|NCT01965535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111169366|NCT01964755|Leucovorin|leucovorin|mesh-list
111169367|NCT01964755|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
111169368|NCT01964755|Tetrahydrofolates|tetrahydrofolates|mesh-list
111169369|NCT01964755|Zidovudine|zidovudine|mesh-list
111169370|NCT01964755|Rituximab|rituximab|mesh-list
111169371|NCT01964755|Doxorubicin|doxorubicin|mesh-list
111169372|NCT01964755|Methotrexate|methotrexate|mesh-list
111169373|NCT01964755|Hydroxyurea|hydroxyurea|mesh-list
111169374|NCT01964755|Levoleucovorin|levoleucovorin|mesh-list
111169375|NCT01964755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111169376|NCT01964755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111169377|NCT01964755|Immunologic Factors|immunologic factors|mesh-ancestor
111169378|NCT01964755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111169379|NCT01964755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111169380|NCT01964755|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111169381|NCT01964755|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111169382|NCT01964755|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111169383|NCT01964755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111169384|NCT01964755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111169385|NCT01964755|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111169386|NCT01964755|Abortifacient Agents|abortifacient agents|mesh-ancestor
111169387|NCT01964755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111169388|NCT01964755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111169389|NCT01964755|Antimetabolites|antimetabolites|mesh-ancestor
111169390|NCT01964755|Dermatologic Agents|dermatologic agents|mesh-ancestor
111169391|NCT01964755|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111169392|NCT01964755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111169393|NCT01964755|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111169394|NCT01964755|Antidotes|antidotes|mesh-ancestor
111169395|NCT01964755|Protective Agents|protective agents|mesh-ancestor
111169396|NCT01964755|Vitamin B Complex|vitamin b complex|mesh-ancestor
111169397|NCT01964755|Vitamins|vitamins|mesh-ancestor
111169398|NCT01964755|Micronutrients|micronutrients|mesh-ancestor
111169399|NCT01964755|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111169400|NCT01964755|Antiviral Agents|antiviral agents|mesh-ancestor
111169401|NCT01964755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111169402|NCT01964755|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111169403|NCT01964755|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111169404|NCT01964755|Antisickling Agents|antisickling agents|mesh-ancestor
111169405|NCT01991743|Bupivacaine|bupivacaine|mesh-list
111169406|NCT01991743|Anesthetics, Local|anesthetics, local|mesh-ancestor
111169407|NCT01991743|Anesthetics|anesthetics|mesh-ancestor
110886508|NCT05461833|Autonomic Agents|autonomic agents|mesh-ancestor
111169408|NCT01991743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111169409|NCT01991743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111169410|NCT01991743|Sensory System Agents|sensory system agents|mesh-ancestor
111169411|NCT01991743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111169412|NCT01991197|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111169413|NCT01991197|Gliclazide|gliclazide|mesh-list
111169414|NCT01991197|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111169415|NCT01991197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111169416|NCT01991197|Incretins|incretins|mesh-ancestor
111169417|NCT01991197|Hormones|hormones|mesh-ancestor
111169418|NCT01991197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111169419|NCT01991197|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111169420|NCT01991197|Protease Inhibitors|protease inhibitors|mesh-ancestor
111169421|NCT01991197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111169422|NCT01991197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111169423|NCT01990573|Methadone|methadone|mesh-list
111169424|NCT01990573|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111169425|NCT01990573|Narcotics|narcotics|mesh-ancestor
111169426|NCT01990573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111169427|NCT01990573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111169428|NCT01990573|Analgesics|analgesics|mesh-ancestor
111169429|NCT01990573|Sensory System Agents|sensory system agents|mesh-ancestor
111169430|NCT01990573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111169431|NCT01990573|Antitussive Agents|antitussive agents|mesh-ancestor
111169432|NCT01990573|Respiratory System Agents|respiratory system agents|mesh-ancestor
111169433|NCT01990339|Lansoprazole|lansoprazole|mesh-list
111169434|NCT01990339|Dexlansoprazole|dexlansoprazole|mesh-list
111169435|NCT01990339|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111169436|NCT01990339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111169437|NCT01990339|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111169438|NCT01990339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111169439|NCT01990339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111169440|NCT02007577|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
111169441|NCT02007577|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111169442|NCT02007577|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111169443|NCT02007577|Analgesics|analgesics|mesh-ancestor
111169444|NCT02007577|Sensory System Agents|sensory system agents|mesh-ancestor
111169445|NCT02007577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111169446|NCT02007577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111169447|NCT02007577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111169448|NCT02007577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111169449|NCT01990261|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111169450|NCT01990261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111169451|NCT01990261|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111169452|NCT01990261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111169453|NCT01990261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111169454|NCT01962493|Chlorhexidine|chlorhexidine|mesh-list
111169455|NCT01962493|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
111169456|NCT01962493|Listerine|listerine|mesh-list
111169457|NCT01962493|Fluorides|fluorides|mesh-list
111169458|NCT01962493|Sodium Fluoride|sodium fluoride|mesh-list
111169459|NCT01962493|Cariostatic Agents|cariostatic agents|mesh-ancestor
111169460|NCT01962493|Protective Agents|protective agents|mesh-ancestor
111169461|NCT01962493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111169462|NCT01962493|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111169463|NCT01962493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111169464|NCT01962493|Disinfectants|disinfectants|mesh-ancestor
111169465|NCT01962493|Dermatologic Agents|dermatologic agents|mesh-ancestor
111169466|NCT01989169|Midazolam|midazolam|mesh-list
111169467|NCT01989169|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111169468|NCT01989169|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111169469|NCT01989169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111169470|NCT01989169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111169471|NCT01989169|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111169472|NCT01989169|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111169473|NCT01989169|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111169474|NCT01989169|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111169475|NCT01989169|Anesthetics, General|anesthetics, general|mesh-ancestor
111169476|NCT01989169|Anesthetics|anesthetics|mesh-ancestor
111169477|NCT01989169|GABA Modulators|gaba modulators|mesh-ancestor
111169478|NCT01989169|GABA Agents|gaba agents|mesh-ancestor
111169479|NCT01989169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111169480|NCT01989169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111169481|NCT01988779|Levofloxacin|levofloxacin|mesh-list
111169482|NCT01988779|Ofloxacin|ofloxacin|mesh-list
111169483|NCT01988779|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111169484|NCT01988779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111169485|NCT01988779|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111169486|NCT01988779|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111169487|NCT01988779|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111169488|NCT01988779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111169489|NCT01988779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111169490|NCT01988779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111169491|NCT01988779|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111169492|NCT01988779|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111169493|NCT01987765|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111169494|NCT01987765|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111169495|NCT01987232|Carboplatin|carboplatin|mesh-list
111169496|NCT01987232|Etoposide|etoposide|mesh-list
111169497|NCT01987232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111169498|NCT01987232|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111169499|NCT01987232|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111169500|NCT01987232|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111169501|NCT01987232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111169502|NCT01987232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111169503|NCT04676204|Teriflunomide|teriflunomide|mesh-list
111169504|NCT04676204|Cladribine|cladribine|mesh-list
111169505|NCT04676204|Dimethyl Fumarate|dimethyl fumarate|mesh-list
111169506|NCT04676204|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
111169507|NCT04676204|Ozanimod|ozanimod|mesh-list
111169508|NCT04676204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111169509|NCT04676204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111169510|NCT04676204|Immunologic Factors|immunologic factors|mesh-ancestor
110842723|NCT01150331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111169511|NCT04676204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111169512|NCT04676204|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
111169513|NCT04676204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111169514|NCT04676204|Dermatologic Agents|dermatologic agents|mesh-ancestor
111169515|NCT04676204|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111169516|NCT04676204|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111169517|NCT04676204|Analgesics|analgesics|mesh-ancestor
111169518|NCT04676204|Sensory System Agents|sensory system agents|mesh-ancestor
111169519|NCT04676204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111169520|NCT04676204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111169521|NCT04676204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111169522|NCT02010632|Clopidogrel|clopidogrel|mesh-list
111169523|NCT02010632|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111169524|NCT02010632|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111169525|NCT02010632|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111169526|NCT02010632|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111169527|NCT02010632|Purinergic Agents|purinergic agents|mesh-ancestor
111169528|NCT02010632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111169529|NCT02010632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111169530|NCT02010632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111169531|NCT01986062|Amphetamine|amphetamine|mesh-list
111169532|NCT01986062|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111169533|NCT01986062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111169534|NCT01986062|Sympathomimetics|sympathomimetics|mesh-ancestor
111169535|NCT01986062|Autonomic Agents|autonomic agents|mesh-ancestor
111169536|NCT01986062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111169537|NCT01986062|Dopamine Agents|dopamine agents|mesh-ancestor
111169538|NCT01986062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111169539|NCT01986062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111169540|NCT01986062|Adrenergic Agents|adrenergic agents|mesh-ancestor
111169541|NCT01986062|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111169542|NCT01986062|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111169543|NCT01986062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111169544|NCT01986062|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111169545|NCT01985126|Acetaminophen|acetaminophen|mesh-list
111169546|NCT01985126|Diphenhydramine|diphenhydramine|mesh-list
111169547|NCT01985126|Promethazine|promethazine|mesh-list
111169548|NCT01985126|Methylprednisolone|methylprednisolone|mesh-list
111169549|NCT01985126|Daratumumab|daratumumab|mesh-list
111169550|NCT01985126|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111169551|NCT01985126|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111169552|NCT01985126|Analgesics|analgesics|mesh-ancestor
111169553|NCT01985126|Sensory System Agents|sensory system agents|mesh-ancestor
111169554|NCT01985126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111169555|NCT01985126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111169556|NCT01985126|Antipyretics|antipyretics|mesh-ancestor
111169557|NCT01985126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111169558|NCT01985126|Antiemetics|antiemetics|mesh-ancestor
111169559|NCT01985126|Autonomic Agents|autonomic agents|mesh-ancestor
111169560|NCT01985126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111169561|NCT01985126|Glucocorticoids|glucocorticoids|mesh-ancestor
111169562|NCT01985126|Hormones|hormones|mesh-ancestor
111169563|NCT01985126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111169564|NCT01985126|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111169565|NCT01985126|Protective Agents|protective agents|mesh-ancestor
111169566|NCT01985126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111169567|NCT01985126|Immunologic Factors|immunologic factors|mesh-ancestor
111169568|NCT01985126|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111169569|NCT01985126|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111169570|NCT01985126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111169571|NCT01985126|Anesthetics, Local|anesthetics, local|mesh-ancestor
111169572|NCT01985126|Anesthetics|anesthetics|mesh-ancestor
111169573|NCT01985126|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111169574|NCT01985126|Histamine Antagonists|histamine antagonists|mesh-ancestor
111169575|NCT01985126|Histamine Agents|histamine agents|mesh-ancestor
111169576|NCT01985126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111169577|NCT01985126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111169578|NCT01985126|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111169579|NCT01985126|Antipruritics|antipruritics|mesh-ancestor
111169580|NCT01985126|Dermatologic Agents|dermatologic agents|mesh-ancestor
111169581|NCT01984892|Poly ICLC|poly iclc|mesh-list
111169582|NCT01984892|Interferon Inducers|interferon inducers|mesh-ancestor
111169583|NCT01984892|Immunologic Factors|immunologic factors|mesh-ancestor
111169584|NCT01984892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111169585|NCT01807221|Eplerenone|eplerenone|mesh-list
111169586|NCT01807221|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
111169587|NCT01807221|Hormone Antagonists|hormone antagonists|mesh-ancestor
111169588|NCT01807221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111169589|NCT01807221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111169590|NCT01807221|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
111169591|NCT01807221|Diuretics|diuretics|mesh-ancestor
111169592|NCT01807221|Natriuretic Agents|natriuretic agents|mesh-ancestor
111169593|NCT01807221|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111169594|NCT02031458|Atezolizumab|atezolizumab|mesh-list
111169595|NCT02031458|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111169596|NCT02031458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111169597|NCT02031458|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111169598|NCT02031458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111169599|NCT01806597|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111169600|NCT01806597|Immunologic Factors|immunologic factors|mesh-ancestor
111169601|NCT01806597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111169602|NCT01610037|Tiotropium Bromide|tiotropium bromide|mesh-list
111169603|NCT01610037|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111169604|NCT01610037|Autonomic Agents|autonomic agents|mesh-ancestor
111169605|NCT01610037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111169606|NCT01610037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111169607|NCT01610037|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111169608|NCT01610037|Respiratory System Agents|respiratory system agents|mesh-ancestor
111169609|NCT01610037|Parasympatholytics|parasympatholytics|mesh-ancestor
111169610|NCT01610037|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111169611|NCT01610037|Cholinergic Agents|cholinergic agents|mesh-ancestor
111169612|NCT01610037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111169613|NCT01610037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111169614|NCT04687514|Dulaglutide|dulaglutide|mesh-list
111169615|NCT04687514|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111169616|NCT04687514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111169617|NCT01837797|Brexpiprazole|brexpiprazole|mesh-list
111169618|NCT01837797|Serotonin Agents|serotonin agents|mesh-ancestor
111169619|NCT01837797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111169620|NCT01837797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111169621|NCT01837797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111169622|NCT01837797|Dopamine Agonists|dopamine agonists|mesh-ancestor
111169623|NCT01837797|Dopamine Agents|dopamine agents|mesh-ancestor
111169624|NCT01984424|Atorvastatin|atorvastatin|mesh-list
111169626|NCT01984424|Evolocumab|evolocumab|mesh-list
111169627|NCT01984424|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111169628|NCT01984424|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111169629|NCT01984424|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111169630|NCT01984424|Antimetabolites|antimetabolites|mesh-ancestor
111169631|NCT01984424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111169632|NCT01984424|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111169633|NCT01984424|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111169634|NCT01984424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111169635|NCT01984424|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
111169636|NCT01984424|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111169637|NCT01984424|Protease Inhibitors|protease inhibitors|mesh-ancestor
111169638|NCT01984424|Immunologic Factors|immunologic factors|mesh-ancestor
111169639|NCT01984424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111169641|NCT01837719|Cobicistat|cobicistat|mesh-list
111169642|NCT01837719|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111169643|NCT01837719|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111169644|NCT01837719|Protease Inhibitors|protease inhibitors|mesh-ancestor
111169645|NCT01837719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111169646|NCT01837719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111169647|NCT01837719|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111169648|NCT01837719|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111169649|NCT01837719|Antiviral Agents|antiviral agents|mesh-ancestor
111169650|NCT01837719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111169651|NCT01837719|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111169652|NCT01837719|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111169653|NCT01984268|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
111169654|NCT01984268|Hormones|hormones|mesh-ancestor
111169655|NCT01984268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111169656|NCT01984268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111169657|NCT02009384|Ipilimumab|ipilimumab|mesh-list
111169658|NCT02009384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111169659|NCT02009384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111169660|NCT02009384|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111169661|NCT02009384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111169662|NCT01805037|Rituximab|rituximab|mesh-list
111169663|NCT01805037|Brentuximab Vedotin|brentuximab vedotin|mesh-list
111169664|NCT01805037|Antibodies|antibodies|mesh-list
111169665|NCT01805037|Immunoglobulins|immunoglobulins|mesh-list
111169666|NCT01805037|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111169667|NCT01805037|Immunoconjugates|immunoconjugates|mesh-list
111169668|NCT01805037|Immunologic Factors|immunologic factors|mesh-ancestor
111169669|NCT01805037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111169670|NCT01805037|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111169671|NCT01805037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111169672|NCT01805037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111169673|NCT01805037|Immunotoxins|immunotoxins|mesh-ancestor
111169674|NCT01803711|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
111169675|NCT01803711|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111169676|NCT01803711|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111169677|NCT01803711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111169678|NCT01803711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111169679|NCT01803711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111169680|NCT01803711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111169681|NCT01803711|Antidepressive Agents|antidepressive agents|mesh-ancestor
111169682|NCT01803711|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111169683|NCT01836549|Imetelstat|imetelstat|mesh-list
111169684|NCT01836549|Motesanib diphosphate|motesanib diphosphate|mesh-list
111169685|NCT01836549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111169686|NCT01836549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111169687|NCT01836549|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111169688|NCT01836471|Fluticasone|fluticasone|mesh-list
111169689|NCT01836471|Xhance|xhance|mesh-list
111169690|NCT01836471|Indoleacetic Acids|indoleacetic acids|mesh-list
110842761|NCT02898506|Liraglutide|liraglutide|mesh-list
111169691|NCT01836471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111169692|NCT01836471|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111169693|NCT01836471|Autonomic Agents|autonomic agents|mesh-ancestor
111169694|NCT01836471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111169695|NCT01836471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111169696|NCT01836471|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111169697|NCT01836471|Respiratory System Agents|respiratory system agents|mesh-ancestor
111169698|NCT01836471|Dermatologic Agents|dermatologic agents|mesh-ancestor
111169699|NCT01836471|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111169700|NCT01836471|Plant Growth Regulators|plant growth regulators|mesh-ancestor
111169701|NCT01836471|Growth Substances|growth substances|mesh-ancestor
111169702|NCT02030600|Insulin|insulin|mesh-list
111169703|NCT02030600|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111169704|NCT02030600|Insulin Glargine|insulin glargine|mesh-list
111169705|NCT02030600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111169706|NCT02030600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111169707|NCT01802775|Aspirin|aspirin|mesh-list
111169708|NCT01802775|Edoxaban|edoxaban|mesh-list
111169709|NCT01802775|Clopidogrel|clopidogrel|mesh-list
111169710|NCT01802775|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111169711|NCT01802775|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111169712|NCT01802775|Analgesics|analgesics|mesh-ancestor
111169713|NCT01802775|Sensory System Agents|sensory system agents|mesh-ancestor
111169714|NCT01802775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111169715|NCT01802775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111169716|NCT01802775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111169717|NCT01802775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111169718|NCT01802775|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111169719|NCT01802775|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111169720|NCT01802775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111169721|NCT01802775|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111169722|NCT01802775|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111169723|NCT01802775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111169724|NCT01802775|Antipyretics|antipyretics|mesh-ancestor
111169725|NCT01802775|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111169726|NCT01802775|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111169727|NCT01802775|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111169728|NCT01802775|Purinergic Agents|purinergic agents|mesh-ancestor
111169729|NCT01802775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111169730|NCT01802775|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111169731|NCT01802775|Antithrombins|antithrombins|mesh-ancestor
111169732|NCT01802775|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111169733|NCT01802775|Protease Inhibitors|protease inhibitors|mesh-ancestor
111169734|NCT01802775|Anticoagulants|anticoagulants|mesh-ancestor
111169735|NCT01802385|Sertraline|sertraline|mesh-list
111169736|NCT01802385|Antidepressive Agents|antidepressive agents|mesh-ancestor
111169737|NCT01802385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111169738|NCT01802385|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111169739|NCT01802385|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111169740|NCT01802385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111169741|NCT01802385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111169742|NCT01802385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111169743|NCT01802385|Serotonin Agents|serotonin agents|mesh-ancestor
111169744|NCT01802385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111169745|NCT01773993|Pregabalin|pregabalin|mesh-list
111169746|NCT01773993|Analgesics|analgesics|mesh-ancestor
111169747|NCT01773993|Sensory System Agents|sensory system agents|mesh-ancestor
111169748|NCT01773993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111169749|NCT01773993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111169750|NCT01773993|Anticonvulsants|anticonvulsants|mesh-ancestor
111169751|NCT01773993|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111169752|NCT01773993|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111169753|NCT01773993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111169754|NCT01773993|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111169755|NCT01773993|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111169756|NCT01773993|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111169757|NCT01773993|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111169758|NCT01773993|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111169759|NCT01802073|Vancomycin|vancomycin|mesh-list
111169760|NCT01802073|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111169761|NCT01802073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111169762|NCT01607073|Verapamil|verapamil|mesh-list
111169763|NCT01607073|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111169764|NCT01607073|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111169765|NCT01607073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111169766|NCT01607073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111169767|NCT01607073|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111169768|NCT01607073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111169769|NCT01607073|Vasodilator Agents|vasodilator agents|mesh-ancestor
111169770|NCT01801917|Siponimod|siponimod|mesh-list
111169771|NCT01801917|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
111169772|NCT01801917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111169773|NCT01801917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111169774|NCT01801917|Immunologic Factors|immunologic factors|mesh-ancestor
111169775|NCT01801917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111169776|NCT02008916|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111169777|NCT02008916|Immunologic Factors|immunologic factors|mesh-ancestor
111169778|NCT02008916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111169779|NCT01772823|Tenofovir|tenofovir|mesh-list
111169780|NCT01772823|Emtricitabine|emtricitabine|mesh-list
111169781|NCT01772823|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
111169782|NCT01772823|Antiviral Agents|antiviral agents|mesh-ancestor
110886882|NCT01314833|Immunologic Factors|immunologic factors|mesh-ancestor
111169783|NCT01772823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111169784|NCT01772823|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111169785|NCT01772823|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111169786|NCT01772823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111169787|NCT01772823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111169788|NCT01772823|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111169789|NCT01772823|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111169790|NCT04177082|Riboflavin|riboflavin|mesh-list
111169791|NCT04177082|Vitamin B Complex|vitamin b complex|mesh-ancestor
111169792|NCT04177082|Vitamins|vitamins|mesh-ancestor
111169793|NCT04177082|Micronutrients|micronutrients|mesh-ancestor
111169794|NCT04177082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111169795|NCT04177082|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111169796|NCT04177082|Dermatologic Agents|dermatologic agents|mesh-ancestor
111169797|NCT01982942|Ibudilast|ibudilast|mesh-list
111169798|NCT01982942|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111169799|NCT01982942|Autonomic Agents|autonomic agents|mesh-ancestor
111169800|NCT01982942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111169801|NCT01982942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111169802|NCT01982942|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111169803|NCT01982942|Respiratory System Agents|respiratory system agents|mesh-ancestor
111169804|NCT01982942|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111169805|NCT01982942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111169806|NCT01982942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111169807|NCT01982942|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111169808|NCT01982942|Vasodilator Agents|vasodilator agents|mesh-ancestor
111169809|NCT01769469|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
111169810|NCT01769469|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111169811|NCT01769469|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111169812|NCT01769469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111169813|NCT01769469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111169814|NCT01769469|Antiviral Agents|antiviral agents|mesh-ancestor
111169815|NCT01769469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111169816|NCT01769469|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111169817|NCT01769469|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111169818|NCT01769391|Paclitaxel|paclitaxel|mesh-list
111169819|NCT01769391|Carboplatin|carboplatin|mesh-list
111169820|NCT01769391|Necitumumab|necitumumab|mesh-list
111169821|NCT01769391|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111169822|NCT01769391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111169823|NCT01769391|Tubulin Modulators|tubulin modulators|mesh-ancestor
111169824|NCT01769391|Antimitotic Agents|antimitotic agents|mesh-ancestor
111169825|NCT01769391|Mitosis Modulators|mitosis modulators|mesh-ancestor
111169826|NCT01769391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111169827|NCT01769391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111169828|NCT01767987|Ranolazine|ranolazine|mesh-list
111169829|NCT01767987|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111169830|NCT01767987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111169831|NCT01767987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111169832|NCT01767909|Insulin|insulin|mesh-list
111169833|NCT01767909|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111169834|NCT01767909|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111169835|NCT01767909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111169836|NCT02029274|Siponimod|siponimod|mesh-list
111169837|NCT02029274|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
111169838|NCT02029274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111169839|NCT02029274|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111169840|NCT02029274|Immunologic Factors|immunologic factors|mesh-ancestor
111169841|NCT02029274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111169842|NCT02008370|Bupivacaine|bupivacaine|mesh-list
111169843|NCT02008370|Anesthetics, Local|anesthetics, local|mesh-ancestor
111169844|NCT02008370|Anesthetics|anesthetics|mesh-ancestor
111169845|NCT02008370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111169846|NCT02008370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111169847|NCT02008370|Sensory System Agents|sensory system agents|mesh-ancestor
111169848|NCT02008370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111169849|NCT01981616|Vedolizumab|vedolizumab|mesh-list
111169850|NCT01981616|Vaccines|vaccines|mesh-list
111169851|NCT01981616|Immunologic Factors|immunologic factors|mesh-ancestor
111169852|NCT01981616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111169853|NCT01981616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111169854|NCT01962103|Paclitaxel|paclitaxel|mesh-list
111169855|NCT01962103|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110886964|NCT03620513|Sympathomimetics|sympathomimetics|mesh-ancestor
111169856|NCT01962103|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111169857|NCT01962103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111169858|NCT01962103|Tubulin Modulators|tubulin modulators|mesh-ancestor
111169859|NCT01962103|Antimitotic Agents|antimitotic agents|mesh-ancestor
111169860|NCT01962103|Mitosis Modulators|mitosis modulators|mesh-ancestor
111169861|NCT01962103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111169862|NCT01961323|Nebivolol|nebivolol|mesh-list
111169863|NCT01961323|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111169864|NCT01961323|Vasodilator Agents|vasodilator agents|mesh-ancestor
111169865|NCT01961323|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
111169866|NCT01961323|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111169867|NCT01961323|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111169868|NCT01961323|Adrenergic Agents|adrenergic agents|mesh-ancestor
111169869|NCT01961323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111169870|NCT01961323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111169871|NCT01961323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111169872|NCT04186403|Brexpiprazole|brexpiprazole|mesh-list
111169873|NCT04186403|Serotonin Agents|serotonin agents|mesh-ancestor
111169874|NCT04186403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111169875|NCT04186403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111169876|NCT04186403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111169877|NCT04186403|Dopamine Agonists|dopamine agonists|mesh-ancestor
111169878|NCT04186403|Dopamine Agents|dopamine agents|mesh-ancestor
111169879|NCT01960855|Upadacitinib|upadacitinib|mesh-list
111169880|NCT01960855|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
111169881|NCT01960855|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111169882|NCT01960855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111169883|NCT01960855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111169884|NCT01960855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111169885|NCT02007434|Loratadine|loratadine|mesh-list
111169886|NCT02007434|Ibuprofen|ibuprofen|mesh-list
111169887|NCT02007434|Lidocaine|lidocaine|mesh-list
111169888|NCT02007434|Epinephrine|epinephrine|mesh-list
111169889|NCT02007434|Deoxycholic Acid|deoxycholic acid|mesh-list
111169890|NCT02007434|Anesthetics, Local|anesthetics, local|mesh-ancestor
111169891|NCT02007434|Anesthetics|anesthetics|mesh-ancestor
111169892|NCT02007434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111169893|NCT02007434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111169894|NCT02007434|Sensory System Agents|sensory system agents|mesh-ancestor
111169895|NCT02007434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111169896|NCT02007434|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111169897|NCT02007434|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111169898|NCT02007434|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111169899|NCT02007434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111169900|NCT02007434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111169901|NCT02007434|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111169902|NCT02007434|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111169903|NCT02007434|Analgesics|analgesics|mesh-ancestor
111169904|NCT02007434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111169905|NCT02007434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111169906|NCT02007434|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111169907|NCT02007434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111169908|NCT02007434|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111169909|NCT02007434|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111169910|NCT02007434|Adrenergic Agents|adrenergic agents|mesh-ancestor
111169911|NCT02007434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111169912|NCT02007434|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111169913|NCT02007434|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111169914|NCT02007434|Autonomic Agents|autonomic agents|mesh-ancestor
111169915|NCT02007434|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111169916|NCT02007434|Respiratory System Agents|respiratory system agents|mesh-ancestor
111169917|NCT02007434|Mydriatics|mydriatics|mesh-ancestor
111169918|NCT02007434|Sympathomimetics|sympathomimetics|mesh-ancestor
111169919|NCT02007434|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111169920|NCT02007434|Antipruritics|antipruritics|mesh-ancestor
111169921|NCT02007434|Dermatologic Agents|dermatologic agents|mesh-ancestor
111169922|NCT02007434|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111169923|NCT02007434|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
111169924|NCT02007434|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111169925|NCT02007434|Histamine Antagonists|histamine antagonists|mesh-ancestor
111169926|NCT02007434|Histamine Agents|histamine agents|mesh-ancestor
111169927|NCT02007434|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
111169928|NCT02007434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111169929|NCT01987453|Sofosbuvir|sofosbuvir|mesh-list
111169930|NCT01987453|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
111169932|NCT01987453|Antiviral Agents|antiviral agents|mesh-ancestor
111169933|NCT01987453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110842792|NCT03893591|Anticoagulants|anticoagulants|mesh-ancestor
111169934|NCT02006641|(2-(6-fluoro-1H-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|(2-(6-fluoro-1h-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|mesh-list
111169935|NCT02006641|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111169936|NCT02006641|Serotonin Agents|serotonin agents|mesh-ancestor
111169937|NCT02006641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111169938|NCT02006641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111169939|NCT02006641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111169940|NCT01959919|Factor VIII|factor viii|mesh-list
111169941|NCT01959919|Coagulants|coagulants|mesh-ancestor
111169942|NCT01986907|Ranibizumab|ranibizumab|mesh-list
111169943|NCT01986907|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111169944|NCT01986907|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111169945|NCT01986907|Growth Substances|growth substances|mesh-ancestor
111169946|NCT01986907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111169947|NCT01986907|Growth Inhibitors|growth inhibitors|mesh-ancestor
111169948|NCT01986907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111169949|NCT01959841|Valacyclovir|valacyclovir|mesh-list
111169950|NCT01959841|Antiviral Agents|antiviral agents|mesh-ancestor
111169951|NCT01959841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111169952|NCT02005627|Immunomodulating Agents|immunomodulating agents|mesh-list
111169953|NCT02005627|Immunologic Factors|immunologic factors|mesh-list
111169954|NCT02005627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111169955|NCT02073929|Liraglutide|liraglutide|mesh-list
111169956|NCT02073929|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111169957|NCT02073929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111169958|NCT02073929|Incretins|incretins|mesh-ancestor
111169959|NCT02073929|Hormones|hormones|mesh-ancestor
111169960|NCT02073929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111169961|NCT02113007|Rituximab|rituximab|mesh-list
111169962|NCT02113007|Temozolomide|temozolomide|mesh-list
111169963|NCT02113007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111169964|NCT02113007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111169965|NCT02113007|Immunologic Factors|immunologic factors|mesh-ancestor
111169966|NCT02113007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111169967|NCT02113007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111169968|NCT02113007|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111169969|NCT02113007|Alkylating Agents|alkylating agents|mesh-ancestor
111169970|NCT02113007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111169971|NCT02005471|Rituximab|rituximab|mesh-list
111169972|NCT02005471|Venetoclax|venetoclax|mesh-list
111169973|NCT02005471|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
111169974|NCT02005471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111169975|NCT02005471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111169976|NCT02005471|Immunologic Factors|immunologic factors|mesh-ancestor
111169977|NCT02005471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111169978|NCT02005471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111169979|NCT02005471|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111169980|NCT02005471|Alkylating Agents|alkylating agents|mesh-ancestor
111169981|NCT02005471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111169982|NCT02104505|Tocopherols|tocopherols|mesh-list
111169983|NCT02104505|Vitamin E|vitamin e|mesh-list
111169984|NCT02104505|Tocotrienols|tocotrienols|mesh-list
111169985|NCT02104505|alpha-Tocopherol|alpha-tocopherol|mesh-list
111169986|NCT02104505|gamma-Tocopherol|gamma-tocopherol|mesh-list
111169987|NCT02104505|Antioxidants|antioxidants|mesh-ancestor
111169988|NCT02104505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111169989|NCT02104505|Protective Agents|protective agents|mesh-ancestor
111169990|NCT02104505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111169991|NCT02104505|Vitamins|vitamins|mesh-ancestor
111169992|NCT02104505|Micronutrients|micronutrients|mesh-ancestor
111169993|NCT02111603|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
111169994|NCT02111603|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111169995|NCT02111603|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111169996|NCT02111603|Antimetabolites|antimetabolites|mesh-ancestor
111169997|NCT02111603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111169998|NCT02111603|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111169999|NCT02111369|Propranolol|propranolol|mesh-list
111170000|NCT02111369|Botulinum Toxins|botulinum toxins|mesh-list
111170001|NCT02111369|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111170002|NCT02111369|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110887111|NCT02849171|Nootropic Agents|nootropic agents|mesh-ancestor
111170003|NCT02111369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111170004|NCT02111369|Cholinergic Agents|cholinergic agents|mesh-ancestor
111170005|NCT02111369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111170006|NCT02111369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111170007|NCT02111369|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111170008|NCT02111369|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111170009|NCT02111369|Adrenergic Agents|adrenergic agents|mesh-ancestor
111170010|NCT02111369|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111170011|NCT02111369|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111170012|NCT02111369|Vasodilator Agents|vasodilator agents|mesh-ancestor
111170013|NCT02069093|Dexamethasone|dexamethasone|mesh-list
111170014|NCT02069093|Everolimus|everolimus|mesh-list
111170015|NCT02069093|Exemestane|exemestane|mesh-list
111170016|NCT02069093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111170017|NCT02069093|Antiemetics|antiemetics|mesh-ancestor
111170018|NCT02069093|Autonomic Agents|autonomic agents|mesh-ancestor
111170019|NCT02069093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111170020|NCT02069093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111170021|NCT02069093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111170022|NCT02069093|Glucocorticoids|glucocorticoids|mesh-ancestor
111170023|NCT02069093|Hormones|hormones|mesh-ancestor
111170024|NCT02069093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111170025|NCT02069093|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111170026|NCT02069093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111170027|NCT02069093|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111170028|NCT02069093|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111170029|NCT02069093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111170030|NCT02069093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111170031|NCT02069093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111170032|NCT02069093|Immunologic Factors|immunologic factors|mesh-ancestor
111170033|NCT02069093|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111170034|NCT02069093|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111170035|NCT02069093|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111170036|NCT02069093|Hormone Antagonists|hormone antagonists|mesh-ancestor
111170037|NCT02109029|Insulin|insulin|mesh-list
111170038|NCT02109029|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111170039|NCT02109029|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111170040|NCT02109029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111170041|NCT02007278|Metformin|metformin|mesh-list
111170042|NCT02007278|Glimepiride|glimepiride|mesh-list
111170043|NCT02007278|Vildagliptin|vildagliptin|mesh-list
111170044|NCT02007278|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111170045|NCT02007278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111170046|NCT02007278|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111170047|NCT02007278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111170048|NCT02007278|Immunologic Factors|immunologic factors|mesh-ancestor
111170049|NCT02007278|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111170050|NCT02007278|Protease Inhibitors|protease inhibitors|mesh-ancestor
111170051|NCT02007278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111170052|NCT02007278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111170053|NCT02028338|Dapivirine|dapivirine|mesh-list
111170054|NCT02028338|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111170055|NCT02028338|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111170056|NCT02028338|Antiviral Agents|antiviral agents|mesh-ancestor
111170057|NCT02028338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111170059|NCT01625897|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111170060|NCT01625897|Serotonin Agents|serotonin agents|mesh-ancestor
111170061|NCT01625897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111170062|NCT01625897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111170063|NCT01625897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111170064|NCT01625897|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111170065|NCT01625897|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111170066|NCT01625897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111170067|NCT01625897|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111170068|NCT01625897|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111170069|NCT01625897|Dopamine Agents|dopamine agents|mesh-ancestor
111170070|NCT02106923|Metformin|metformin|mesh-list
111170071|NCT02106923|Empagliflozin|empagliflozin|mesh-list
111170072|NCT02106923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111170073|NCT02106923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111170074|NCT02106923|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111170075|NCT02106923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111170076|NCT02006732|Tiotropium Bromide|tiotropium bromide|mesh-list
111170077|NCT02006732|Olodaterol|olodaterol|mesh-list
111170078|NCT02006732|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111170079|NCT02006732|Autonomic Agents|autonomic agents|mesh-ancestor
111170080|NCT02006732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111170081|NCT02006732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111170082|NCT02006732|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111170083|NCT02006732|Respiratory System Agents|respiratory system agents|mesh-ancestor
111170084|NCT02006732|Parasympatholytics|parasympatholytics|mesh-ancestor
111170085|NCT02006732|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111170086|NCT02006732|Cholinergic Agents|cholinergic agents|mesh-ancestor
111170087|NCT02006732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111170088|NCT02006732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111170089|NCT02098733|Pioglitazone|pioglitazone|mesh-list
111170090|NCT02098733|Glimepiride|glimepiride|mesh-list
111170091|NCT02098733|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111170092|NCT02098733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111170093|NCT02098733|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111170094|NCT02098733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111170095|NCT02098733|Immunologic Factors|immunologic factors|mesh-ancestor
111170096|NCT02098109|Plerixafor|plerixafor|mesh-list
111170097|NCT02098109|Lenograstim|lenograstim|mesh-list
111170098|NCT02098109|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111170099|NCT02098109|Immunologic Factors|immunologic factors|mesh-ancestor
111170100|NCT02098109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111170101|NCT02098109|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111170102|NCT02098109|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111170103|NCT02098109|Antiviral Agents|antiviral agents|mesh-ancestor
111170104|NCT02098109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111170105|NCT02097719|Timolol|timolol|mesh-list
111170106|NCT02097719|Bimatoprost|bimatoprost|mesh-list
111170107|NCT02097719|Travoprost|travoprost|mesh-list
111170108|NCT02097719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111170109|NCT02097719|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111170110|NCT02097719|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111170111|NCT02097719|Adrenergic Agents|adrenergic agents|mesh-ancestor
111170112|NCT02097719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111170113|NCT02097719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111170114|NCT02097719|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110842857|NCT03897413|Antacids|antacids|mesh-list
111170116|NCT01449370|Serabelisib|serabelisib|mesh-list
111170117|NCT01449370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111170118|NCT01449370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111170119|NCT02066129|Fluticasone|fluticasone|mesh-list
111170120|NCT02066129|Xhance|xhance|mesh-list
111170121|NCT02066129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111170122|NCT02066129|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111170123|NCT02066129|Autonomic Agents|autonomic agents|mesh-ancestor
111170124|NCT02066129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111170125|NCT02066129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111170126|NCT02066129|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111170127|NCT02066129|Respiratory System Agents|respiratory system agents|mesh-ancestor
111170128|NCT02066129|Dermatologic Agents|dermatologic agents|mesh-ancestor
111170129|NCT02066129|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111170130|NCT04417985|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
111170131|NCT04417985|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111170132|NCT04417985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111170133|NCT02106455|Risedronic Acid|risedronic acid|mesh-list
111170135|NCT02106455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111170136|NCT02106455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111170137|NCT02106455|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111170138|NCT02106455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111170139|NCT02106455|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111170140|NCT02006654|(2-(6-fluoro-1H-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|(2-(6-fluoro-1h-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|mesh-list
111170141|NCT02006654|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111170142|NCT02006654|Serotonin Agents|serotonin agents|mesh-ancestor
111170143|NCT02006654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111170144|NCT02006654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111170145|NCT02006654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111170146|NCT02006576|Ibuprofen|ibuprofen|mesh-list
111170147|NCT02006576|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111170148|NCT02006576|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111170149|NCT02006576|Analgesics|analgesics|mesh-ancestor
111170150|NCT02006576|Sensory System Agents|sensory system agents|mesh-ancestor
111170151|NCT02006576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111170152|NCT02006576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111170153|NCT02006576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111170154|NCT02006576|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111170155|NCT02006576|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111170156|NCT02006576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111170157|NCT02006576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111170158|NCT01448824|Ketoconazole|ketoconazole|mesh-list
111170159|NCT01448824|Evacetrapib|evacetrapib|mesh-list
111170160|NCT01448824|Antifungal Agents|antifungal agents|mesh-ancestor
111170161|NCT01448824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111170162|NCT01448824|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111170163|NCT01448824|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111170164|NCT01448824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111170165|NCT01448824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111170166|NCT01448824|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111170167|NCT01448824|Hormone Antagonists|hormone antagonists|mesh-ancestor
111170168|NCT01448824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111170169|NCT01448824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111170170|NCT01448824|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111170171|NCT01448824|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111170172|NCT01448824|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111170173|NCT01448824|Antimetabolites|antimetabolites|mesh-ancestor
111170174|NCT01448824|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111170175|NCT02005562|Cyclosporine|cyclosporine|mesh-list
111170176|NCT02005562|Mycophenolic Acid|mycophenolic acid|mesh-list
111170177|NCT02005562|Methylprednisolone|methylprednisolone|mesh-list
111170178|NCT02005562|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111170179|NCT02005562|Cyclosporins|cyclosporins|mesh-list
111170180|NCT02005562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111170181|NCT02005562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111170182|NCT02005562|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111170183|NCT02005562|Immunologic Factors|immunologic factors|mesh-ancestor
111170184|NCT02005562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111170185|NCT02005562|Antifungal Agents|antifungal agents|mesh-ancestor
111170186|NCT02005562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111170187|NCT02005562|Dermatologic Agents|dermatologic agents|mesh-ancestor
111170188|NCT02005562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111170189|NCT02005562|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111170190|NCT02005562|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111170191|NCT02005562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111170192|NCT02005562|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111170193|NCT02005562|Antitubercular Agents|antitubercular agents|mesh-ancestor
111170194|NCT02005562|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111170195|NCT02005562|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111170196|NCT02005562|Antiemetics|antiemetics|mesh-ancestor
111170197|NCT02005562|Autonomic Agents|autonomic agents|mesh-ancestor
111170198|NCT02005562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111170199|NCT02005562|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111170200|NCT02005562|Glucocorticoids|glucocorticoids|mesh-ancestor
111170201|NCT02005562|Hormones|hormones|mesh-ancestor
111170202|NCT02005562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111170203|NCT02005562|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111170204|NCT02005562|Protective Agents|protective agents|mesh-ancestor
111170205|NCT02005562|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111170206|NCT01448044|Interferons|interferons|mesh-list
111170207|NCT01448044|Ribavirin|ribavirin|mesh-list
111170208|NCT01448044|Interferon-alpha|interferon-alpha|mesh-list
111170209|NCT01448044|Interferon alpha-2|interferon alpha-2|mesh-list
111170210|NCT01448044|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
111170211|NCT01448044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111170212|NCT01448044|Antiviral Agents|antiviral agents|mesh-ancestor
111170213|NCT01448044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111170214|NCT01448044|Antimetabolites|antimetabolites|mesh-ancestor
111170215|NCT01448044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111170216|NCT01448044|Immunologic Factors|immunologic factors|mesh-ancestor
111170217|NCT01448044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111170218|NCT01472380|Efavirenz|efavirenz|mesh-list
111170219|NCT01472380|Fenofibric acid|fenofibric acid|mesh-list
111170220|NCT01472380|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111170221|NCT01472380|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111170222|NCT01472380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111170223|NCT01472380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111170224|NCT01472380|Antiviral Agents|antiviral agents|mesh-ancestor
111170225|NCT01472380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111170226|NCT01472380|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111170227|NCT01472380|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111170228|NCT01472380|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111170229|NCT01472380|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111170230|NCT01472380|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111170231|NCT01472380|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111170232|NCT01472380|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111170233|NCT01472380|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111170234|NCT01472380|Antimetabolites|antimetabolites|mesh-ancestor
111170235|NCT01472380|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111170236|NCT01447576|Antidepressive Agents|antidepressive agents|mesh-list
111170237|NCT01447576|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111170238|NCT01447420|Ribavirin|ribavirin|mesh-list
111170239|NCT01447420|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
111170240|NCT01447420|Antimetabolites|antimetabolites|mesh-ancestor
111170241|NCT01447420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111170242|NCT01447420|Antiviral Agents|antiviral agents|mesh-ancestor
111170243|NCT01447420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111170244|NCT01446874|Chlorhexidine|chlorhexidine|mesh-list
111170245|NCT01446874|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111170246|NCT01446874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111170247|NCT01446874|Disinfectants|disinfectants|mesh-ancestor
111170248|NCT01439074|Sulfadiazine|sulfadiazine|mesh-list
111170249|NCT01439074|Silver Sulfadiazine|silver sulfadiazine|mesh-list
111170250|NCT01439074|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111170251|NCT01439074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111170252|NCT01439074|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111170253|NCT01439074|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111170254|NCT01439074|Coccidiostats|coccidiostats|mesh-ancestor
111170255|NCT01439074|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111170256|NCT01438840|Maleic acid|maleic acid|mesh-list
111170257|NCT01438840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111170258|NCT01438840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111170259|NCT01471054|Dexamethasone|dexamethasone|mesh-list
111170260|NCT01471054|Bevacizumab|bevacizumab|mesh-list
111170261|NCT01471054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111170262|NCT01471054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111170263|NCT01471054|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111170264|NCT01471054|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111170265|NCT01471054|Growth Substances|growth substances|mesh-ancestor
111170266|NCT01471054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111170267|NCT01471054|Growth Inhibitors|growth inhibitors|mesh-ancestor
111170268|NCT01471054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111170269|NCT01471054|Antiemetics|antiemetics|mesh-ancestor
111170270|NCT01471054|Autonomic Agents|autonomic agents|mesh-ancestor
111170271|NCT01471054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111170272|NCT01471054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111170273|NCT01471054|Glucocorticoids|glucocorticoids|mesh-ancestor
111170274|NCT01471054|Hormones|hormones|mesh-ancestor
111170275|NCT01471054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111170276|NCT01471054|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111170277|NCT01978184|Hydroxychloroquine|hydroxychloroquine|mesh-list
111170278|NCT01978184|Gemcitabine|gemcitabine|mesh-list
111170279|NCT01978184|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111170280|NCT01978184|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111170281|NCT01978184|Antimetabolites|antimetabolites|mesh-ancestor
111170282|NCT01978184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111170283|NCT01978184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111170284|NCT01978184|Antimalarials|antimalarials|mesh-ancestor
111170285|NCT01978184|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111170286|NCT01978184|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111170287|NCT01978184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111170288|NCT01978184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111170289|NCT01978184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111170291|NCT01445548|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111170292|NCT01445548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111170293|NCT01445548|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111170294|NCT01445548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111170295|NCT01445548|Antifungal Agents|antifungal agents|mesh-ancestor
111170296|NCT01445548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111170297|NCT01445548|Immunologic Factors|immunologic factors|mesh-ancestor
111170298|NCT01445548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111170299|NCT01977794|Amlodipine|amlodipine|mesh-list
111170300|NCT01977794|Bisoprolol|bisoprolol|mesh-list
111170301|NCT01977794|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111170302|NCT01977794|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111170303|NCT01977794|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111170304|NCT01977794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111170305|NCT01977794|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111170306|NCT01977794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111170307|NCT01977794|Vasodilator Agents|vasodilator agents|mesh-ancestor
111170308|NCT01977794|Sympatholytics|sympatholytics|mesh-ancestor
111170309|NCT01977794|Autonomic Agents|autonomic agents|mesh-ancestor
111170310|NCT01977794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111170311|NCT01977794|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
111170312|NCT01977794|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111170313|NCT01977794|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111170314|NCT01977794|Adrenergic Agents|adrenergic agents|mesh-ancestor
111170315|NCT01977794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111170316|NCT02005484|Trastuzumab|trastuzumab|mesh-list
111170317|NCT02005484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111170318|NCT02005484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111170319|NCT01597973|Meropenem|meropenem|mesh-list
111170320|NCT01597973|Colistin|colistin|mesh-list
111170321|NCT01597973|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111170322|NCT01597973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111170323|NCT02047253|Acyclovir|acyclovir|mesh-list
111170324|NCT02047253|Dexamethasone|dexamethasone|mesh-list
111170325|NCT02047253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111170326|NCT02047253|Antiemetics|antiemetics|mesh-ancestor
111170327|NCT02047253|Autonomic Agents|autonomic agents|mesh-ancestor
111170328|NCT02047253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111170329|NCT02047253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111170330|NCT02047253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111170331|NCT02047253|Glucocorticoids|glucocorticoids|mesh-ancestor
111170332|NCT02047253|Hormones|hormones|mesh-ancestor
111170333|NCT02047253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111170334|NCT02047253|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111170335|NCT02047253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111170336|NCT02047253|Antiviral Agents|antiviral agents|mesh-ancestor
111170337|NCT02047253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111170338|NCT02096705|Dapagliflozin|dapagliflozin|mesh-list
111170339|NCT02096705|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111170340|NCT02096705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110487254|NCT02863406|Dimercaprol|dimercaprol|mesh-list
111170341|NCT02096705|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111170342|NCT02096705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111170343|NCT02096003|Morphine|morphine|mesh-list
111170344|NCT02096003|Hydromorphone|hydromorphone|mesh-list
111170345|NCT02096003|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111170346|NCT02096003|Narcotics|narcotics|mesh-ancestor
111170347|NCT02096003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111170348|NCT02096003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111170349|NCT02096003|Analgesics|analgesics|mesh-ancestor
111170350|NCT02096003|Sensory System Agents|sensory system agents|mesh-ancestor
111170351|NCT02096003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111170352|NCT02095535|Chlorhexidine|chlorhexidine|mesh-list
111170353|NCT02095535|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110887482|NCT04876677|Glucocorticoids|glucocorticoids|mesh-ancestor
111170354|NCT02095535|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111170355|NCT02095535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111170356|NCT02095535|Disinfectants|disinfectants|mesh-ancestor
111170357|NCT02095535|Dermatologic Agents|dermatologic agents|mesh-ancestor
111170358|NCT02059187|Insulin|insulin|mesh-list
111170359|NCT02059187|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111170360|NCT02059187|Insulin Glargine|insulin glargine|mesh-list
111170361|NCT02059187|MK-1293|mk-1293|mesh-list
111170362|NCT02059187|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111170363|NCT02059187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111170364|NCT02059187|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111170365|NCT02059187|Antimetabolites|antimetabolites|mesh-ancestor
111170366|NCT02059187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111170367|NCT02059187|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111170368|NCT02043899|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
111170369|NCT02043899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111170370|NCT02043899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111170371|NCT02043899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111170372|NCT02043899|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111170373|NCT01622231|Fluticasone|fluticasone|mesh-list
111170374|NCT01622231|Xhance|xhance|mesh-list
111170375|NCT01622231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111170376|NCT01622231|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111170377|NCT01622231|Autonomic Agents|autonomic agents|mesh-ancestor
111170378|NCT01622231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111170379|NCT01622231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111170380|NCT01622231|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111170381|NCT01622231|Respiratory System Agents|respiratory system agents|mesh-ancestor
111170382|NCT01622231|Dermatologic Agents|dermatologic agents|mesh-ancestor
111170383|NCT01622231|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111170384|NCT02042183|Lubiprostone|lubiprostone|mesh-list
111170385|NCT02042183|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
111170386|NCT02042183|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111170387|NCT02042183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111170388|NCT02058095|Tadalafil|tadalafil|mesh-list
111170389|NCT02058095|Vasodilator Agents|vasodilator agents|mesh-ancestor
111170390|NCT02058095|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111170391|NCT02058095|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111170392|NCT02058095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111170393|NCT02058095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111170394|NCT02058095|Urological Agents|urological agents|mesh-ancestor
111170395|NCT02023112|Ritonavir|ritonavir|mesh-list
111170396|NCT02023112|Ribavirin|ribavirin|mesh-list
111170397|NCT02023112|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111170398|NCT02023112|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111170399|NCT02023112|Protease Inhibitors|protease inhibitors|mesh-ancestor
111170400|NCT02023112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111170401|NCT02023112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111170402|NCT02023112|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111170403|NCT02023112|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111170404|NCT02023112|Antiviral Agents|antiviral agents|mesh-ancestor
111170405|NCT02023112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111170406|NCT02023112|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111170407|NCT02023112|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111170408|NCT02023112|Antimetabolites|antimetabolites|mesh-ancestor
111170409|NCT04670666|Metformin|metformin|mesh-list
111170410|NCT04670666|Empagliflozin|empagliflozin|mesh-list
111170411|NCT04670666|Linagliptin|linagliptin|mesh-list
111170412|NCT04670666|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111170413|NCT04670666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111170414|NCT04670666|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111170415|NCT04670666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111170416|NCT04670666|Incretins|incretins|mesh-ancestor
111170417|NCT04670666|Hormones|hormones|mesh-ancestor
111170418|NCT04670666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111170419|NCT04670666|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111170420|NCT04670666|Protease Inhibitors|protease inhibitors|mesh-ancestor
111170421|NCT04670666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111170422|NCT01976624|Timolol|timolol|mesh-list
111170423|NCT01976624|Bimatoprost|bimatoprost|mesh-list
111170424|NCT01976624|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111170425|NCT01976624|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111170426|NCT01976624|Adrenergic Agents|adrenergic agents|mesh-ancestor
111170427|NCT01976624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111170428|NCT01976624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111170429|NCT01976624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110887556|NCT03578042|Diuretics|diuretics|mesh-ancestor
111170430|NCT01976624|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111170431|NCT01976624|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111170432|NCT02041091|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111170433|NCT02041091|Immunologic Factors|immunologic factors|mesh-ancestor
111170434|NCT02041091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111170435|NCT04717973|Vitamin D|vitamin d|mesh-list
111170436|NCT04717973|Vitamins|vitamins|mesh-list
111170437|NCT04717973|Vitamin B 12|vitamin b 12|mesh-list
111170438|NCT04717973|Hydroxocobalamin|hydroxocobalamin|mesh-list
111170439|NCT04717973|Micronutrients|micronutrients|mesh-ancestor
111170440|NCT04717973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111170441|NCT04717973|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111170442|NCT04717973|Vitamin B Complex|vitamin b complex|mesh-ancestor
111170443|NCT04717973|Hematinics|hematinics|mesh-ancestor
111170444|NCT02057549|Haloperidol|haloperidol|mesh-list
111170445|NCT02057549|Haloperidol decanoate|haloperidol decanoate|mesh-list
111170446|NCT02057549|Antiemetics|antiemetics|mesh-ancestor
111170447|NCT02057549|Autonomic Agents|autonomic agents|mesh-ancestor
110487285|NCT00967616|Antidotes|antidotes|mesh-ancestor
111170448|NCT02057549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111170449|NCT02057549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111170450|NCT02057549|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111170451|NCT02057549|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111170452|NCT02057549|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111170453|NCT02057549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111170454|NCT02057549|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111170455|NCT02057549|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111170456|NCT02057549|Dopamine Agents|dopamine agents|mesh-ancestor
111170457|NCT02057549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111170458|NCT02057549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111170459|NCT02057549|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111170460|NCT02057393|Methylene Blue|methylene blue|mesh-list
111170461|NCT02057393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111170462|NCT02057393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111170463|NCT02040779|Beclomethasone|beclomethasone|mesh-list
111170464|NCT02040779|Albuterol|albuterol|mesh-list
111170465|NCT02040779|Bronchodilator Agents|bronchodilator agents|mesh-list
111170466|NCT02040779|Autonomic Agents|autonomic agents|mesh-ancestor
111170467|NCT02040779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111170468|NCT02040779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111170469|NCT02040779|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111170470|NCT02040779|Respiratory System Agents|respiratory system agents|mesh-ancestor
111170471|NCT02040779|Tocolytic Agents|tocolytic agents|mesh-ancestor
111170472|NCT02040779|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111170473|NCT02040779|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111170474|NCT02040779|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111170475|NCT02040779|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111170476|NCT02040779|Adrenergic Agents|adrenergic agents|mesh-ancestor
111170477|NCT02040779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111170478|NCT02040779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111170479|NCT02040779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111170480|NCT02040779|Glucocorticoids|glucocorticoids|mesh-ancestor
111170481|NCT02040779|Hormones|hormones|mesh-ancestor
111170482|NCT02040779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111170483|NCT02056301|Morphine|morphine|mesh-list
111170484|NCT02056301|Hydromorphone|hydromorphone|mesh-list
111170485|NCT02056301|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111170486|NCT02056301|Narcotics|narcotics|mesh-ancestor
111170487|NCT02056301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111170488|NCT02056301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111170489|NCT02056301|Analgesics|analgesics|mesh-ancestor
111170490|NCT02056301|Sensory System Agents|sensory system agents|mesh-ancestor
111170491|NCT02056301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111170492|NCT01967576|Axitinib|axitinib|mesh-list
111170493|NCT01967576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111170494|NCT01967576|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111170495|NCT01967576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111170496|NCT01967576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111170497|NCT02003534|Brimonidine Tartrate|brimonidine tartrate|mesh-list
111170498|NCT02003534|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111170499|NCT02003534|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111170500|NCT02003534|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111170501|NCT02003534|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111170502|NCT02003534|Adrenergic Agents|adrenergic agents|mesh-ancestor
111170503|NCT02003534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111170504|NCT02003534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111170505|NCT02003534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111170506|NCT01976312|Ranibizumab|ranibizumab|mesh-list
111170507|NCT01976312|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111170508|NCT01976312|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111170509|NCT01976312|Growth Substances|growth substances|mesh-ancestor
111170510|NCT01976312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111170511|NCT01976312|Growth Inhibitors|growth inhibitors|mesh-ancestor
111170512|NCT01976312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111170513|NCT02053493|Isosorbide|isosorbide|mesh-list
111170514|NCT02053493|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
111170515|NCT02053493|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
111170516|NCT02053493|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
111170517|NCT02053493|Diuretics|diuretics|mesh-ancestor
111170518|NCT02053493|Natriuretic Agents|natriuretic agents|mesh-ancestor
111170519|NCT02053493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111170520|NCT02053493|Vasodilator Agents|vasodilator agents|mesh-ancestor
111170521|NCT02053493|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
111170522|NCT02053493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111170523|NCT02003144|Eculizumab|eculizumab|mesh-list
111170524|NCT02003144|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
111170525|NCT02003144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111170526|NCT02003144|Immunologic Factors|immunologic factors|mesh-ancestor
111170527|NCT02003144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111170528|NCT02038907|Vaccines|vaccines|mesh-list
111170529|NCT02038907|Immunologic Factors|immunologic factors|mesh-ancestor
111170530|NCT02038907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111170531|NCT02052011|Ranolazine|ranolazine|mesh-list
111170532|NCT02052011|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111170533|NCT02052011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111170534|NCT02052011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111170535|NCT02051933|Botulinum Toxins|botulinum toxins|mesh-list
111170536|NCT02051933|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111170537|NCT02051933|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111170538|NCT02051933|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111170539|NCT02051933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111170540|NCT02051933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111170541|NCT02051933|Cholinergic Agents|cholinergic agents|mesh-ancestor
111170542|NCT02051933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111170543|NCT02051933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111170544|NCT02051933|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111170545|NCT02051933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111170546|NCT02035553|Pimavanserin|pimavanserin|mesh-list
111170547|NCT02035553|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111170548|NCT02035553|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111170549|NCT02035553|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111170550|NCT02035553|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111170551|NCT02035553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111170552|NCT02035553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111170553|NCT02035553|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111170554|NCT02035553|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111170555|NCT02035553|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111170556|NCT02035553|Serotonin Agents|serotonin agents|mesh-ancestor
111170557|NCT02035553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111170558|NCT02035553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111170559|NCT01445080|Sorafenib|sorafenib|mesh-list
111170560|NCT01445080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111170561|NCT01445080|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111170562|NCT01445080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111170563|NCT01445080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111170564|NCT04709471|Nicotine|nicotine|mesh-list
111170565|NCT04709471|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111170566|NCT04709471|Autonomic Agents|autonomic agents|mesh-ancestor
111170567|NCT04709471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111170568|NCT04709471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111170569|NCT04709471|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111170570|NCT04709471|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111170571|NCT04709471|Cholinergic Agents|cholinergic agents|mesh-ancestor
111170572|NCT04709471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111170573|NCT04709471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111170574|NCT01959529|Insulin|insulin|mesh-list
111170575|NCT01959529|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111170576|NCT01959529|Insulin Glargine|insulin glargine|mesh-list
111170577|NCT01959529|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111170578|NCT01959529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111170579|NCT02033369|Pramipexole|pramipexole|mesh-list
111170580|NCT02033369|Antioxidants|antioxidants|mesh-ancestor
110487316|NCT00653757|Leuprolide|leuprolide|mesh-list
110887704|NCT03645642|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111170581|NCT02033369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111170582|NCT02033369|Protective Agents|protective agents|mesh-ancestor
111170583|NCT02033369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111170584|NCT02033369|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111170585|NCT02033369|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111170586|NCT02033369|Dopamine Agonists|dopamine agonists|mesh-ancestor
111170587|NCT02033369|Dopamine Agents|dopamine agents|mesh-ancestor
111170588|NCT02033369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111170589|NCT02032901|Sofosbuvir|sofosbuvir|mesh-list
111170590|NCT02032901|Antiviral Agents|antiviral agents|mesh-ancestor
111170591|NCT02032901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111170592|NCT04681469|Niraparib|niraparib|mesh-list
111170593|NCT04681469|Dostarlimab|dostarlimab|mesh-list
111170594|NCT04681469|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111170595|NCT04681469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111170596|NCT04681469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111170597|NCT04681469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111170598|NCT01986751|Clonidine|clonidine|mesh-list
111170599|NCT01986751|Ropivacaine|ropivacaine|mesh-list
111170600|NCT01986751|Anesthetics, Local|anesthetics, local|mesh-ancestor
111170601|NCT01986751|Anesthetics|anesthetics|mesh-ancestor
111170602|NCT01986751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111170603|NCT01986751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111170604|NCT01986751|Sensory System Agents|sensory system agents|mesh-ancestor
111170605|NCT01986751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111170606|NCT01986751|Analgesics|analgesics|mesh-ancestor
111170607|NCT01986751|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111170608|NCT01986751|Sympatholytics|sympatholytics|mesh-ancestor
111170609|NCT01986751|Autonomic Agents|autonomic agents|mesh-ancestor
111170610|NCT01986751|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111170611|NCT01986751|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111170612|NCT01986751|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111170613|NCT01986751|Adrenergic Agents|adrenergic agents|mesh-ancestor
111170614|NCT01986751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111170615|NCT01986751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111170616|NCT01438060|Aripiprazole|aripiprazole|mesh-list
111170617|NCT01438060|Antidepressive Agents|antidepressive agents|mesh-ancestor
111170618|NCT01438060|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111170619|NCT01438060|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111170620|NCT01438060|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111170621|NCT01438060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111170622|NCT01438060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111170623|NCT01438060|Dopamine Agonists|dopamine agonists|mesh-ancestor
111170624|NCT01438060|Dopamine Agents|dopamine agents|mesh-ancestor
111170625|NCT01438060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111170626|NCT01438060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111170627|NCT01438060|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111170628|NCT01438060|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111170629|NCT01438060|Serotonin Agents|serotonin agents|mesh-ancestor
111170630|NCT01438060|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111170631|NCT01438060|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111170632|NCT01438060|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111170633|NCT01438060|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111170634|NCT01444300|4-Aminopyridine|4-aminopyridine|mesh-list
111170635|NCT01444300|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
111170636|NCT01444300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111170637|NCT01444300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111170638|NCT01443364|Certolizumab Pegol|certolizumab pegol|mesh-list
111170639|NCT01443364|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111170640|NCT01443364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111170641|NCT01443364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111170642|NCT01443364|Immunologic Factors|immunologic factors|mesh-ancestor
111170643|NCT01443364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111170644|NCT01443364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111170645|NCT02020577|Cetuximab|cetuximab|mesh-list
111170646|NCT02020577|Afatinib|afatinib|mesh-list
110487324|NCT00654225|Atorvastatin|atorvastatin|mesh-list
111170647|NCT02020577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111170648|NCT02020577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111170649|NCT02020577|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111170650|NCT02020577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111170651|NCT02020577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111170652|NCT02020031|Vancomycin|vancomycin|mesh-list
111170653|NCT02020031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110887779|NCT01335685|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111170654|NCT02020031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111170655|NCT02030405|Ixazomib|ixazomib|mesh-list
111170656|NCT02030405|Proteasome Inhibitors|proteasome inhibitors|mesh-list
111170657|NCT02030405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111170658|NCT02030405|Protease Inhibitors|protease inhibitors|mesh-ancestor
111170659|NCT02030405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111170660|NCT02030405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111170661|NCT01975376|Bococizumab|bococizumab|mesh-list
111170662|NCT01975376|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111170663|NCT01975376|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111170664|NCT01975376|Antimetabolites|antimetabolites|mesh-ancestor
111170665|NCT01975376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111170666|NCT01975376|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111170667|NCT01443130|Chloroquine|chloroquine|mesh-list
111170668|NCT01443130|Pyrimethamine|pyrimethamine|mesh-list
111170669|NCT01443130|Sulfadoxine|sulfadoxine|mesh-list
111170670|NCT01443130|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
111170671|NCT01443130|Amebicides|amebicides|mesh-ancestor
111170672|NCT01443130|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111170673|NCT01443130|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111170674|NCT01443130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111170675|NCT01443130|Antimalarials|antimalarials|mesh-ancestor
111170676|NCT01443130|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111170677|NCT01443130|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111170678|NCT01443130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111170679|NCT01443130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111170680|NCT01443130|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111170681|NCT01436500|Ifetroban|ifetroban|mesh-list
111170682|NCT01436500|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111170683|NCT01958827|Adalimumab|adalimumab|mesh-list
111170684|NCT01958827|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111170685|NCT01958827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111170686|NCT01958827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111170687|NCT04670653|Mometasone Furoate|mometasone furoate|mesh-list
111170688|NCT04670653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111170689|NCT04670653|Dermatologic Agents|dermatologic agents|mesh-ancestor
111170690|NCT04670653|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111170691|NCT01436110|Fluticasone|fluticasone|mesh-list
111170692|NCT01436110|Xhance|xhance|mesh-list
111170693|NCT01436110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111170694|NCT01436110|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111170695|NCT01436110|Autonomic Agents|autonomic agents|mesh-ancestor
111170696|NCT01436110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111170697|NCT01436110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111170698|NCT01436110|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111170699|NCT01436110|Respiratory System Agents|respiratory system agents|mesh-ancestor
111170700|NCT01436110|Dermatologic Agents|dermatologic agents|mesh-ancestor
111170701|NCT01436110|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111170702|NCT01619852|Lidocaine|lidocaine|mesh-list
111170703|NCT01619852|Anesthetics, Local|anesthetics, local|mesh-ancestor
111170704|NCT01619852|Anesthetics|anesthetics|mesh-ancestor
111170705|NCT01619852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111170706|NCT01619852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111170707|NCT01619852|Sensory System Agents|sensory system agents|mesh-ancestor
111170708|NCT01619852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111170709|NCT01619852|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111170710|NCT01619852|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111170711|NCT01619852|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111170712|NCT01619852|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111170713|NCT01619852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111170714|NCT04069936|Nivolumab|nivolumab|mesh-list
111170715|NCT04069936|Tadalafil|tadalafil|mesh-list
111170716|NCT04069936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111170717|NCT04069936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111170718|NCT04069936|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111170719|NCT04069936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111170720|NCT04069936|Vasodilator Agents|vasodilator agents|mesh-ancestor
111170721|NCT04069936|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111170722|NCT04069936|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111170723|NCT04069936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111170724|NCT04069936|Urological Agents|urological agents|mesh-ancestor
111170725|NCT02000882|Capecitabine|capecitabine|mesh-list
111170726|NCT02000882|Trastuzumab|trastuzumab|mesh-list
111170727|NCT02000882|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111170728|NCT02000882|Antimetabolites|antimetabolites|mesh-ancestor
111170729|NCT02000882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111170730|NCT02000882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111170731|NCT02000882|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111170732|NCT04666129|Prednisone|prednisone|mesh-list
111170733|NCT04666129|Methylprednisolone|methylprednisolone|mesh-list
111170734|NCT04666129|Docetaxel|docetaxel|mesh-list
111170735|NCT04666129|Relugolix|relugolix|mesh-list
111170736|NCT04666129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111170737|NCT04666129|Tubulin Modulators|tubulin modulators|mesh-ancestor
111170738|NCT04666129|Antimitotic Agents|antimitotic agents|mesh-ancestor
111170739|NCT04666129|Mitosis Modulators|mitosis modulators|mesh-ancestor
111170740|NCT04666129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111170741|NCT04666129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111170742|NCT04666129|Glucocorticoids|glucocorticoids|mesh-ancestor
111170743|NCT04666129|Hormones|hormones|mesh-ancestor
111170744|NCT04666129|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111170745|NCT04666129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111170746|NCT04666129|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111170747|NCT04666129|Antiemetics|antiemetics|mesh-ancestor
111170748|NCT04666129|Autonomic Agents|autonomic agents|mesh-ancestor
111170749|NCT04666129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111170750|NCT04666129|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111170751|NCT04666129|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111170752|NCT04666129|Protective Agents|protective agents|mesh-ancestor
111170753|NCT04666129|Androgen Antagonists|androgen antagonists|mesh-ancestor
111170754|NCT04666129|Hormone Antagonists|hormone antagonists|mesh-ancestor
111170755|NCT04666051|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
111170756|NCT04666051|Hemostatics|hemostatics|mesh-ancestor
111170757|NCT04666051|Coagulants|coagulants|mesh-ancestor
111170758|NCT01965704|Ondansetron|ondansetron|mesh-list
111170759|NCT01965704|Antiemetics|antiemetics|mesh-ancestor
111170760|NCT01965704|Autonomic Agents|autonomic agents|mesh-ancestor
111170761|NCT01965704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111170762|NCT01965704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111170763|NCT01965704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111170764|NCT01965704|Antipruritics|antipruritics|mesh-ancestor
111170765|NCT01965704|Dermatologic Agents|dermatologic agents|mesh-ancestor
111170766|NCT01965704|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111170767|NCT01965704|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111170768|NCT01965704|Serotonin Agents|serotonin agents|mesh-ancestor
111170769|NCT01965704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110487346|NCT00654303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111170770|NCT01965704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111170771|NCT02003365|Triamcinolone|triamcinolone|mesh-list
111170772|NCT02003365|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
111170773|NCT02003365|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
111170774|NCT02003365|FX006|fx006|mesh-list
111170775|NCT02003365|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
111170776|NCT02003365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111170777|NCT02003365|Glucocorticoids|glucocorticoids|mesh-ancestor
111170778|NCT02003365|Hormones|hormones|mesh-ancestor
111170779|NCT02003365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111170780|NCT02003365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111170781|NCT02003365|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111170782|NCT02003365|Immunologic Factors|immunologic factors|mesh-ancestor
111170783|NCT02003365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111170784|NCT02003365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111170785|NCT01975220|Metformin|metformin|mesh-list
111170786|NCT01975220|Empagliflozin|empagliflozin|mesh-list
111170787|NCT01975220|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111170788|NCT01975220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111170789|NCT01975220|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111170790|NCT01975220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111170791|NCT01974752|Dacarbazine|dacarbazine|mesh-list
111170792|NCT01974752|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111170793|NCT01974752|Alkylating Agents|alkylating agents|mesh-ancestor
111170794|NCT01974752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111170795|NCT01974752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111170796|NCT01999946|Naltrexone|naltrexone|mesh-list
111170797|NCT01999946|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111170798|NCT01999946|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111170799|NCT01999946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111170800|NCT01999946|Sensory System Agents|sensory system agents|mesh-ancestor
111170801|NCT01999946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111170802|NCT01958281|Sofosbuvir|sofosbuvir|mesh-list
111170803|NCT01958281|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
111170804|NCT01958281|Antiviral Agents|antiviral agents|mesh-ancestor
111170805|NCT01958281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111170806|NCT02002975|Pioglitazone|pioglitazone|mesh-list
111170807|NCT02002975|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111170808|NCT02002975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111170809|NCT02001181|Tofacitinib|tofacitinib|mesh-list
111170810|NCT02001181|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
111170811|NCT02001181|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111170812|NCT02001181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111170813|NCT02001181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111170814|NCT04176055|Haloperidol|haloperidol|mesh-list
111170815|NCT04176055|Haloperidol decanoate|haloperidol decanoate|mesh-list
111170816|NCT04176055|Antiemetics|antiemetics|mesh-ancestor
111170817|NCT04176055|Autonomic Agents|autonomic agents|mesh-ancestor
111170818|NCT04176055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111170819|NCT04176055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111170820|NCT04176055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111170821|NCT04176055|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111170822|NCT04176055|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111170823|NCT04176055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111170824|NCT04176055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111170825|NCT04176055|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111170826|NCT04176055|Dopamine Agents|dopamine agents|mesh-ancestor
111170827|NCT04176055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111170828|NCT04176055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111170830|NCT04659278|Peppermint oil|peppermint oil|mesh-list
111170831|NCT04659278|Antiemetics|antiemetics|mesh-ancestor
111170832|NCT04659278|Autonomic Agents|autonomic agents|mesh-ancestor
111170833|NCT04659278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111170834|NCT04659278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111170835|NCT04659278|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111170836|NCT04659278|Parasympatholytics|parasympatholytics|mesh-ancestor
111170837|NCT01999868|Abatacept|abatacept|mesh-list
111170838|NCT01999868|Ustekinumab|ustekinumab|mesh-list
111170839|NCT01999868|Immunoglobulins|immunoglobulins|mesh-list
111170840|NCT01999868|Immunologic Factors|immunologic factors|mesh-ancestor
111170841|NCT01999868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111170842|NCT01999868|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111170843|NCT01999868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111170844|NCT01999868|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111170845|NCT01999868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111170846|NCT01999868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111170847|NCT01999868|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111170848|NCT01999868|Dermatologic Agents|dermatologic agents|mesh-ancestor
111170849|NCT03511963|Bevacizumab|bevacizumab|mesh-list
111170850|NCT03511963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111170851|NCT03511963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111170852|NCT03511963|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111170853|NCT03511963|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111170854|NCT03511963|Growth Substances|growth substances|mesh-ancestor
111170855|NCT03511963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111170856|NCT03511963|Growth Inhibitors|growth inhibitors|mesh-ancestor
111170857|NCT01999322|Insulin|insulin|mesh-list
111170858|NCT01999322|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111170859|NCT01999322|Insulin Aspart|insulin aspart|mesh-list
111170860|NCT01999322|Insulin, Long-Acting|insulin, long-acting|mesh-list
111170861|NCT01999322|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
111170862|NCT01999322|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111170863|NCT01999322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111170864|NCT01964924|Trametinib|trametinib|mesh-list
111170865|NCT01964924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111170866|NCT01964924|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111170867|NCT01964924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111170868|NCT01964924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111170869|NCT01964378|Morphine|morphine|mesh-list
111170870|NCT01964378|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111170871|NCT01964378|Narcotics|narcotics|mesh-ancestor
111170872|NCT01964378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111170873|NCT01964378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111170874|NCT01964378|Analgesics|analgesics|mesh-ancestor
111170875|NCT01964378|Sensory System Agents|sensory system agents|mesh-ancestor
111170876|NCT01964378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111170877|NCT01442038|Ranolazine|ranolazine|mesh-list
111170878|NCT01442038|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111170879|NCT01442038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111170880|NCT01442038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111170881|NCT01998919|Carboplatin|carboplatin|mesh-list
111170882|NCT01998919|Gemcitabine|gemcitabine|mesh-list
111170883|NCT01998919|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111170884|NCT01998919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111170885|NCT01998919|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111170886|NCT01998919|Antimetabolites|antimetabolites|mesh-ancestor
111170887|NCT01998919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111170888|NCT01998919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111170889|NCT01998919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111170890|NCT01964300|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
111170891|NCT01964300|Antiviral Agents|antiviral agents|mesh-ancestor
111170892|NCT01964300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111170893|NCT01972724|Metformin|metformin|mesh-list
111170894|NCT01972724|Pioglitazone|pioglitazone|mesh-list
111170895|NCT01972724|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111170896|NCT01972724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111170897|NCT01441960|Rocuronium|rocuronium|mesh-list
111170898|NCT01441960|Succinylcholine|succinylcholine|mesh-list
111170899|NCT01441960|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
111170900|NCT01441960|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
111170901|NCT01441960|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111170902|NCT01441960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111170903|NCT01441960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111170904|NCT01441960|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
111170905|NCT01955707|Natalizumab|natalizumab|mesh-list
111170906|NCT01955707|Immunologic Factors|immunologic factors|mesh-ancestor
111170907|NCT01955707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111170908|NCT01435798|Dextromethorphan|dextromethorphan|mesh-list
111170909|NCT01435798|Antitussive Agents|antitussive agents|mesh-ancestor
111170910|NCT01435798|Respiratory System Agents|respiratory system agents|mesh-ancestor
111170911|NCT01435798|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111170912|NCT01435798|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111170913|NCT01435798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111170914|NCT01435798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111170915|NCT01435798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111170916|NCT01955161|(2-(6-fluoro-1H-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|(2-(6-fluoro-1h-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|mesh-list
111170917|NCT01955161|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111170918|NCT01955161|Serotonin Agents|serotonin agents|mesh-ancestor
111170919|NCT01955161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111170920|NCT01955161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111170921|NCT01955161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111170923|NCT01441414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111170924|NCT01441414|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111170925|NCT01441414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111170926|NCT01441414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111170927|NCT01954927|Gabapentin|gabapentin|mesh-list
111170928|NCT01954927|Analgesics|analgesics|mesh-ancestor
111170929|NCT01954927|Sensory System Agents|sensory system agents|mesh-ancestor
111170930|NCT01954927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111170931|NCT01954927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111170932|NCT01954927|Anticonvulsants|anticonvulsants|mesh-ancestor
111170933|NCT01954927|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111170934|NCT01954927|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111170935|NCT01954927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111170936|NCT01954927|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111170937|NCT01954927|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111170938|NCT01954927|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111170939|NCT01954927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111170940|NCT01954927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110487407|NCT04285268|Bortezomib|bortezomib|mesh-list
111170941|NCT01954927|Antimanic Agents|antimanic agents|mesh-ancestor
111170942|NCT01953913|Afatinib|afatinib|mesh-list
111170943|NCT01953913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111170944|NCT01953913|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111170945|NCT01953913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111170946|NCT01953913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111170947|NCT01970540|Doxorubicin|doxorubicin|mesh-list
111170948|NCT01970540|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111170949|NCT01970540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111170950|NCT01970540|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111170951|NCT01970540|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111170952|NCT01970540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110888083|NCT02847494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111170953|NCT01970540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111170954|NCT01996826|Bevacizumab|bevacizumab|mesh-list
111170955|NCT01996826|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
111170956|NCT01996826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111170957|NCT01996826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111170958|NCT01996826|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111170959|NCT01996826|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111170960|NCT01996826|Growth Substances|growth substances|mesh-ancestor
111170961|NCT01996826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111170962|NCT01996826|Growth Inhibitors|growth inhibitors|mesh-ancestor
111170963|NCT01996826|Laxatives|laxatives|mesh-ancestor
111170964|NCT01996826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111170965|NCT01621178|Insulin|insulin|mesh-list
111170966|NCT01621178|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111170967|NCT01621178|Insulin Glargine|insulin glargine|mesh-list
111170968|NCT01621178|Insulin Lispro|insulin lispro|mesh-list
111170969|NCT01621178|Dulaglutide|dulaglutide|mesh-list
111170970|NCT01621178|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111170971|NCT01621178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111170972|NCT01962974|Golimumab|golimumab|mesh-list
111170973|NCT01962974|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111170974|NCT01962974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111170975|NCT01962974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111170976|NCT01962974|Immunologic Factors|immunologic factors|mesh-ancestor
111170977|NCT01962974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111170978|NCT01962896|Sirolimus|sirolimus|mesh-list
111170979|NCT01962896|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111170980|NCT01962896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111170981|NCT01962896|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111170982|NCT01962896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111170983|NCT01962896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111170984|NCT01962896|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111170985|NCT01962896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111170986|NCT01962896|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111170987|NCT01962896|Antifungal Agents|antifungal agents|mesh-ancestor
111170988|NCT01962896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111170989|NCT01962896|Immunologic Factors|immunologic factors|mesh-ancestor
111170990|NCT01962896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111170991|NCT01970462|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111170992|NCT01970462|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111170993|NCT01970462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111170994|NCT01970462|Incretins|incretins|mesh-ancestor
111170995|NCT01970462|Hormones|hormones|mesh-ancestor
111170996|NCT01970462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111170997|NCT01970462|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111170998|NCT01970462|Protease Inhibitors|protease inhibitors|mesh-ancestor
111170999|NCT01970462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111171000|NCT01970462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111171001|NCT01958671|Metformin|metformin|mesh-list
111171002|NCT01958671|Glimepiride|glimepiride|mesh-list
111171003|NCT01958671|Ertugliflozin|ertugliflozin|mesh-list
111171004|NCT01958671|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111171005|NCT01958671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111171006|NCT01958671|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111171007|NCT01958671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111171008|NCT01958671|Immunologic Factors|immunologic factors|mesh-ancestor
111171009|NCT01958671|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111171010|NCT01958671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111171011|NCT01995266|Asunaprevir|asunaprevir|mesh-list
111171012|NCT01995266|Protease Inhibitors|protease inhibitors|mesh-ancestor
111171013|NCT01995266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111171014|NCT01995266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111171015|NCT01969058|Isotretinoin|isotretinoin|mesh-list
111171016|NCT01969058|Dermatologic Agents|dermatologic agents|mesh-ancestor
111171017|NCT01968980|Bococizumab|bococizumab|mesh-list
111171018|NCT01968980|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111171019|NCT01968980|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111171020|NCT01968980|Antimetabolites|antimetabolites|mesh-ancestor
111171021|NCT01968980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111171022|NCT01968980|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111171023|NCT01968434|Carbocysteine|carbocysteine|mesh-list
111171024|NCT01968434|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111171025|NCT01968434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111171026|NCT01968434|Expectorants|expectorants|mesh-ancestor
111171027|NCT01968434|Respiratory System Agents|respiratory system agents|mesh-ancestor
111171028|NCT01946438|Vaccines|vaccines|mesh-list
111171030|NCT01946438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111171031|NCT01618214|Insulin Aspart|insulin aspart|mesh-list
111171032|NCT01618214|Biphasic Insulins|biphasic insulins|mesh-list
111171033|NCT01618214|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
111171034|NCT01618214|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111171035|NCT01618214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111171036|NCT01917656|Metformin|metformin|mesh-list
111171037|NCT01917656|Liraglutide|liraglutide|mesh-list
111171038|NCT01917656|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111171039|NCT01917656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111171040|NCT01917656|Incretins|incretins|mesh-ancestor
111171041|NCT01917656|Hormones|hormones|mesh-ancestor
111171042|NCT01917656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111171043|NCT02017535|Fluoxetine|fluoxetine|mesh-list
111171044|NCT02017535|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111171045|NCT02017535|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111171046|NCT02017535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111171047|NCT02017535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111171048|NCT02017535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111171049|NCT02017535|Serotonin Agents|serotonin agents|mesh-ancestor
111171050|NCT02017535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111171051|NCT02017535|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111171052|NCT02017535|Antidepressive Agents|antidepressive agents|mesh-ancestor
111171053|NCT02017535|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111171054|NCT02017535|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111171055|NCT02017535|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111171056|NCT02017535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111171057|NCT01944098|Lidocaine|lidocaine|mesh-list
111171058|NCT01944098|Anesthetics, Local|anesthetics, local|mesh-ancestor
111171059|NCT01944098|Anesthetics|anesthetics|mesh-ancestor
111171060|NCT01944098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111171061|NCT01944098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111171062|NCT01944098|Sensory System Agents|sensory system agents|mesh-ancestor
111171063|NCT01944098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111171064|NCT01944098|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111171065|NCT01944098|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111171066|NCT01944098|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111171067|NCT01944098|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111171068|NCT01944098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111171069|NCT01943552|Bromides|bromides|mesh-list
111171070|NCT01943552|Ipratropium|ipratropium|mesh-list
111171071|NCT01943552|Anticonvulsants|anticonvulsants|mesh-ancestor
111171072|NCT01943552|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111171073|NCT01943552|Autonomic Agents|autonomic agents|mesh-ancestor
111171074|NCT01943552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111171075|NCT01943552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111171076|NCT01943552|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111171077|NCT01943552|Respiratory System Agents|respiratory system agents|mesh-ancestor
111171078|NCT01943552|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111171079|NCT01943552|Cholinergic Agents|cholinergic agents|mesh-ancestor
111171080|NCT01943552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111171081|NCT01943552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111171082|NCT01915940|Timolol|timolol|mesh-list
111171083|NCT01915940|Bimatoprost|bimatoprost|mesh-list
111171084|NCT01915940|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111171085|NCT01915940|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111171086|NCT01915940|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111171087|NCT01915940|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111171088|NCT01915940|Adrenergic Agents|adrenergic agents|mesh-ancestor
111171089|NCT01915940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111171090|NCT01915940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111171091|NCT01915940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111171092|NCT01915940|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111171093|NCT01915940|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111171094|NCT01914926|Metoprolol|metoprolol|mesh-list
111171095|NCT01914926|Diltiazem|diltiazem|mesh-list
111171096|NCT01914926|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111171097|NCT01914926|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111171098|NCT01914926|Sympatholytics|sympatholytics|mesh-ancestor
111171099|NCT01914926|Autonomic Agents|autonomic agents|mesh-ancestor
111171100|NCT01914926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110888231|NCT03568916|Protease Inhibitors|protease inhibitors|mesh-ancestor
111171101|NCT01914926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111171102|NCT01914926|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
111171103|NCT01914926|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111171104|NCT01914926|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111171106|NCT01914926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111171107|NCT01914926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111171108|NCT01914926|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111171109|NCT01914926|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111171110|NCT01914926|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111171111|NCT01914926|Vasodilator Agents|vasodilator agents|mesh-ancestor
111171112|NCT05119166|Niacinamide|niacinamide|mesh-list
111171113|NCT05119166|Niacin|niacin|mesh-list
111171114|NCT05119166|Nicotinic Acids|nicotinic acids|mesh-list
111171115|NCT05119166|Azithromycin|azithromycin|mesh-list
111171116|NCT05119166|Vitamins|vitamins|mesh-ancestor
111171117|NCT05119166|Micronutrients|micronutrients|mesh-ancestor
111171118|NCT05119166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111171119|NCT05119166|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111171120|NCT05119166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111171121|NCT05119166|Vitamin B Complex|vitamin b complex|mesh-ancestor
111171122|NCT05119166|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111171123|NCT05119166|Antimetabolites|antimetabolites|mesh-ancestor
111171124|NCT05119166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111171125|NCT05119166|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111171126|NCT05119166|Vasodilator Agents|vasodilator agents|mesh-ancestor
111171127|NCT01942148|Aripiprazole|aripiprazole|mesh-list
111171128|NCT01942148|Antidepressive Agents|antidepressive agents|mesh-ancestor
111171129|NCT01942148|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111171130|NCT01942148|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111171131|NCT01942148|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110487429|NCT00970502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111171132|NCT01942148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111171133|NCT01942148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111171134|NCT01942148|Dopamine Agonists|dopamine agonists|mesh-ancestor
111171135|NCT01942148|Dopamine Agents|dopamine agents|mesh-ancestor
111171136|NCT01942148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111171137|NCT01942148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111171138|NCT01942148|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111171139|NCT01942148|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111171140|NCT01942148|Serotonin Agents|serotonin agents|mesh-ancestor
111171141|NCT01942148|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111171142|NCT01942148|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111171143|NCT01942148|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111171144|NCT01942148|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111171145|NCT02030015|Miglustat|miglustat|mesh-list
111171146|NCT02030015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111171147|NCT02030015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111171148|NCT02030015|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111171149|NCT02030015|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111171150|NCT02030015|Antiviral Agents|antiviral agents|mesh-ancestor
111171151|NCT02030015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111171152|NCT02030015|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
111171153|NCT02030015|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111171154|NCT02030015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111171155|NCT02029235|Acetaminophen|acetaminophen|mesh-list
111171156|NCT02029235|Ibuprofen|ibuprofen|mesh-list
111171157|NCT02029235|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
111171158|NCT02029235|Hydrocodone|hydrocodone|mesh-list
111171159|NCT02029235|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111171160|NCT02029235|Analgesics|analgesics|mesh-ancestor
111171161|NCT02029235|Sensory System Agents|sensory system agents|mesh-ancestor
111171162|NCT02029235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111171163|NCT02029235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111171164|NCT02029235|Antipyretics|antipyretics|mesh-ancestor
111171165|NCT02029235|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111171166|NCT02029235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110842996|NCT03892421|Cytarabine|cytarabine|mesh-list
111171167|NCT02029235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111171168|NCT02029235|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111171169|NCT02029235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111171170|NCT02029235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111171171|NCT02029235|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111171172|NCT02029235|Narcotics|narcotics|mesh-ancestor
111171173|NCT02029235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111171174|NCT02029235|Antitussive Agents|antitussive agents|mesh-ancestor
111171175|NCT02029235|Respiratory System Agents|respiratory system agents|mesh-ancestor
111171176|NCT01617434|Liraglutide|liraglutide|mesh-list
111171177|NCT01617434|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111171178|NCT01617434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111171179|NCT01617434|Incretins|incretins|mesh-ancestor
111171180|NCT01617434|Hormones|hormones|mesh-ancestor
111171181|NCT01617434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111171182|NCT01940900|Ranibizumab|ranibizumab|mesh-list
111171183|NCT01940900|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111171184|NCT01940900|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111171185|NCT01940900|Growth Substances|growth substances|mesh-ancestor
111171186|NCT01940900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111171187|NCT01940900|Growth Inhibitors|growth inhibitors|mesh-ancestor
111171188|NCT01940900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111171189|NCT01911260|Chelating Agents|chelating agents|mesh-list
111171190|NCT01911260|Sequestering Agents|sequestering agents|mesh-ancestor
111171191|NCT01911260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111171192|NCT02015819|Leucovorin|leucovorin|mesh-list
111171193|NCT02015819|Flucytosine|flucytosine|mesh-list
111171194|NCT02015819|Calcium|calcium|mesh-list
111171195|NCT02015819|Levoleucovorin|levoleucovorin|mesh-list
111171196|NCT02015819|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111171197|NCT02015819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111171198|NCT02015819|Antidotes|antidotes|mesh-ancestor
111171199|NCT02015819|Protective Agents|protective agents|mesh-ancestor
111171200|NCT02015819|Vitamin B Complex|vitamin b complex|mesh-ancestor
111171201|NCT02015819|Vitamins|vitamins|mesh-ancestor
111171202|NCT02015819|Micronutrients|micronutrients|mesh-ancestor
111171203|NCT02015819|Antifungal Agents|antifungal agents|mesh-ancestor
111171204|NCT02015819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111171205|NCT02015819|Antimetabolites|antimetabolites|mesh-ancestor
111171206|NCT02015819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111171207|NCT01939496|Canagliflozin|canagliflozin|mesh-list
111171208|NCT01939496|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111171209|NCT01939496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111171210|NCT01939496|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111171211|NCT01939496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111171212|NCT01939028|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111171213|NCT01938716|Gemcitabine|gemcitabine|mesh-list
111171214|NCT01938716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111171215|NCT01938716|Antimetabolites|antimetabolites|mesh-ancestor
111171216|NCT01938716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111171217|NCT01938716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111171218|NCT01937390|Bromides|bromides|mesh-list
111171219|NCT01937390|Tiotropium Bromide|tiotropium bromide|mesh-list
111171220|NCT01937390|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111171221|NCT01937390|Autonomic Agents|autonomic agents|mesh-ancestor
111171222|NCT01937390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111171223|NCT01937390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111171224|NCT01937390|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111171225|NCT01937390|Respiratory System Agents|respiratory system agents|mesh-ancestor
111171226|NCT01937390|Parasympatholytics|parasympatholytics|mesh-ancestor
111171227|NCT01937390|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111171228|NCT01937390|Cholinergic Agents|cholinergic agents|mesh-ancestor
111171229|NCT01937390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111171230|NCT01937390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111171231|NCT01937390|Anticonvulsants|anticonvulsants|mesh-ancestor
111171232|NCT02028767|Metformin|metformin|mesh-list
111171233|NCT02028767|Empagliflozin|empagliflozin|mesh-list
111171234|NCT02028767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111171235|NCT02028767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111171236|NCT02028767|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111171237|NCT02028767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111171239|NCT04683965|Pemetrexed|pemetrexed|mesh-list
111171240|NCT04683965|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111171241|NCT04683965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111171242|NCT04683965|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111171243|NCT04683965|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111171244|NCT04683965|Growth Substances|growth substances|mesh-ancestor
111171245|NCT04683965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111171246|NCT04683965|Growth Inhibitors|growth inhibitors|mesh-ancestor
111171247|NCT04683965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110888382|NCT01340521|Zuclomiphene|zuclomiphene|mesh-list
111171248|NCT04683965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111171249|NCT04683965|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111171250|NCT04683965|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111171251|NCT02015195|Ethanol|ethanol|mesh-list
111171252|NCT02015195|Acetic Acid|acetic acid|mesh-list
111171253|NCT02015195|Retinol acetate|retinol acetate|mesh-list
111171254|NCT02015195|Lidocaine|lidocaine|mesh-list
111171255|NCT02015195|Anesthetics, Local|anesthetics, local|mesh-ancestor
111171256|NCT02015195|Anesthetics|anesthetics|mesh-ancestor
111171257|NCT02015195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111171258|NCT02015195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111171259|NCT02015195|Sensory System Agents|sensory system agents|mesh-ancestor
111171260|NCT02015195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111171261|NCT02015195|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111171262|NCT02015195|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111171263|NCT02015195|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111171264|NCT02015195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110799557|NCT03752931|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111171265|NCT02015195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111171266|NCT02015195|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111171267|NCT02015195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111171268|NCT02015195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111171269|NCT02015195|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111171270|NCT02015195|Immunologic Factors|immunologic factors|mesh-ancestor
111171271|NCT02015195|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
111171272|NCT02015195|Protective Agents|protective agents|mesh-ancestor
111171273|NCT02015195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111171274|NCT02025725|Metoclopramide|metoclopramide|mesh-list
111171275|NCT02025725|Antiemetics|antiemetics|mesh-ancestor
111171276|NCT02025725|Autonomic Agents|autonomic agents|mesh-ancestor
111171277|NCT02025725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111171278|NCT02025725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111171279|NCT02025725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111171280|NCT02025725|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111171281|NCT02025725|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111171282|NCT02025725|Dopamine Agents|dopamine agents|mesh-ancestor
111171283|NCT02025725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111171284|NCT02025725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111171285|NCT02025179|Teriparatide|teriparatide|mesh-list
111171286|NCT02025179|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111171287|NCT02025179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111171288|NCT02025179|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111171289|NCT02013791|Cyclosporine|cyclosporine|mesh-list
111171290|NCT02013791|Cyclosporins|cyclosporins|mesh-list
111171291|NCT02013791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110843013|NCT03892421|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111171292|NCT02013791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111171294|NCT02013791|Immunologic Factors|immunologic factors|mesh-ancestor
111171295|NCT02013791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111171296|NCT02013791|Antifungal Agents|antifungal agents|mesh-ancestor
111171297|NCT02013791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111171298|NCT02013791|Dermatologic Agents|dermatologic agents|mesh-ancestor
111171299|NCT02013791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111171300|NCT02013791|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111171301|NCT02024867|Trimethoprim|trimethoprim|mesh-list
111171302|NCT02024867|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
111171303|NCT02024867|Sulfamethoxazole|sulfamethoxazole|mesh-list
111171304|NCT02024867|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111171305|NCT02024867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111171306|NCT02024867|Antimalarials|antimalarials|mesh-ancestor
111171307|NCT02024867|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111171308|NCT02024867|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111171309|NCT02024867|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111171310|NCT02024867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111171311|NCT02024867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111171312|NCT02024867|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111171313|NCT02024867|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
111171314|NCT02024867|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111171315|NCT02024867|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111171316|NCT02023697|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
111171317|NCT02023697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111171318|NCT01951417|Adapalene|adapalene|mesh-list
111171319|NCT01951417|Benzoyl Peroxide|benzoyl peroxide|mesh-list
111171320|NCT01951417|Dermatologic Agents|dermatologic agents|mesh-ancestor
111171321|NCT01951417|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111171322|NCT01951417|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111171323|NCT01951417|Analgesics|analgesics|mesh-ancestor
111171324|NCT01951417|Sensory System Agents|sensory system agents|mesh-ancestor
111171325|NCT01951417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111171326|NCT01951417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111171327|NCT01951417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111171328|NCT01951417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111171329|NCT02023151|Omalizumab|omalizumab|mesh-list
111171330|NCT02023151|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111171331|NCT02023151|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111171332|NCT02023151|Respiratory System Agents|respiratory system agents|mesh-ancestor
111171333|NCT01979185|Simvastatin|simvastatin|mesh-list
111171334|NCT01979185|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111171335|NCT01979185|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111171336|NCT01979185|Antimetabolites|antimetabolites|mesh-ancestor
111171337|NCT01979185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111171338|NCT01979185|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111171339|NCT01979185|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111171340|NCT01979185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111171341|NCT01946425|Vaccines|vaccines|mesh-list
111171342|NCT01946425|Immunologic Factors|immunologic factors|mesh-ancestor
111171343|NCT01946425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111171344|NCT01937312|Brimonidine Tartrate|brimonidine tartrate|mesh-list
111171345|NCT01937312|Travoprost|travoprost|mesh-list
111171346|NCT01937312|Brinzolamide|brinzolamide|mesh-list
111171347|NCT01937312|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111171348|NCT01937312|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111171349|NCT01937312|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111171350|NCT01937312|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111171351|NCT01937312|Adrenergic Agents|adrenergic agents|mesh-ancestor
111171352|NCT01937312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111171353|NCT01937312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111171354|NCT01937312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111171355|NCT01937312|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
111171356|NCT01937312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111171357|NCT01935128|Everolimus|everolimus|mesh-list
111171358|NCT01935128|Tacrolimus|tacrolimus|mesh-list
111171359|NCT01935128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111171360|NCT01935128|Immunologic Factors|immunologic factors|mesh-ancestor
111171361|NCT01935128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111171362|NCT01935128|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111171363|NCT01935128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111171364|NCT01935128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111171365|NCT01935128|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111171366|NCT01935128|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111171367|NCT01935128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111171368|NCT01934972|Cycloserine|cycloserine|mesh-list
111171369|NCT01934972|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111171370|NCT01934972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111171371|NCT01934972|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111171372|NCT01934972|Antitubercular Agents|antitubercular agents|mesh-ancestor
111171373|NCT01934972|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111171374|NCT01934972|Antimetabolites|antimetabolites|mesh-ancestor
111171375|NCT01934972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111171376|NCT01959230|Brimonidine Tartrate|brimonidine tartrate|mesh-list
111171377|NCT01959230|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111171378|NCT01959230|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111171379|NCT01959230|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111171380|NCT01959230|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111171381|NCT01959230|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111171382|NCT01959230|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111171383|NCT01959230|Adrenergic Agents|adrenergic agents|mesh-ancestor
111171384|NCT01959230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111171385|NCT01959230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111171386|NCT01959230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111171387|NCT01977937|Gabapentin|gabapentin|mesh-list
111171388|NCT01977937|Analgesics|analgesics|mesh-ancestor
111171389|NCT01977937|Sensory System Agents|sensory system agents|mesh-ancestor
111171390|NCT01977937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111171391|NCT01977937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111171392|NCT01977937|Anticonvulsants|anticonvulsants|mesh-ancestor
111171393|NCT01977937|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111171394|NCT01977937|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111171395|NCT01977937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111171396|NCT01977937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110888535|NCT01342627|Sorafenib|sorafenib|mesh-list
111171397|NCT01977937|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111171398|NCT01977937|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110487468|NCT00967226|Glucocorticoids|glucocorticoids|mesh-ancestor
111171399|NCT01977937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111171400|NCT01977937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111171401|NCT01977937|Antimanic Agents|antimanic agents|mesh-ancestor
111171402|NCT02015663|Tobramycin|tobramycin|mesh-list
111171403|NCT02015663|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111171404|NCT02015663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111171405|NCT01978093|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
111171406|NCT01978093|Immunologic Factors|immunologic factors|mesh-ancestor
111171407|NCT01978093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111171408|NCT01951105|Naproxen|naproxen|mesh-list
111171409|NCT01951105|Levodopa|levodopa|mesh-list
111171410|NCT01951105|Carbidopa|carbidopa|mesh-list
111171411|NCT01951105|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
111171412|NCT01951105|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111171413|NCT01951105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111171414|NCT01951105|Analgesics|analgesics|mesh-ancestor
111171415|NCT01951105|Sensory System Agents|sensory system agents|mesh-ancestor
111171416|NCT01951105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111171417|NCT01951105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111171418|NCT01951105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111171419|NCT01951105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111171420|NCT01951105|Gout Suppressants|gout suppressants|mesh-ancestor
111171421|NCT01951105|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111171422|NCT01951105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111171423|NCT01951105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111171424|NCT01951105|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111171425|NCT01951105|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111171426|NCT01951105|Dopamine Agents|dopamine agents|mesh-ancestor
111171427|NCT01951105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111171428|NCT01951105|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
111171429|NCT01951105|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111171430|NCT01951105|Immunologic Factors|immunologic factors|mesh-ancestor
111171431|NCT01951105|Dopamine Agonists|dopamine agonists|mesh-ancestor
111171432|NCT01958918|Ranibizumab|ranibizumab|mesh-list
111171433|NCT01958918|Aflibercept|aflibercept|mesh-list
111171434|NCT01958918|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111171435|NCT01958918|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111171436|NCT01958918|Growth Substances|growth substances|mesh-ancestor
111171437|NCT01958918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111171438|NCT01958918|Growth Inhibitors|growth inhibitors|mesh-ancestor
111171439|NCT01958918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111171440|NCT01945489|Botulinum Toxins|botulinum toxins|mesh-list
111171441|NCT01945489|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111171442|NCT01945489|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111171443|NCT01945489|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111171444|NCT01945489|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111171445|NCT01945489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111171446|NCT01945489|Cholinergic Agents|cholinergic agents|mesh-ancestor
111171447|NCT01945489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111171448|NCT01945489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111171449|NCT01945489|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111171450|NCT01945489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111171451|NCT01934894|Lapatinib|lapatinib|mesh-list
111171452|NCT01934894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111171453|NCT01934894|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111171454|NCT01934894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111171455|NCT01934894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111171456|NCT01950169|Vitamin D|vitamin d|mesh-list
111171457|NCT01950169|Cholecalciferol|cholecalciferol|mesh-list
111171458|NCT01950169|Risedronic Acid|risedronic acid|mesh-list
111171459|NCT01950169|Diphosphonates|diphosphonates|mesh-list
111171460|NCT01950169|Calcium|calcium|mesh-list
111171461|NCT01950169|Vitamins|vitamins|mesh-ancestor
111171462|NCT01950169|Micronutrients|micronutrients|mesh-ancestor
111171463|NCT01950169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111171464|NCT01950169|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111171465|NCT01950169|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111171466|NCT01950169|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111171467|NCT01950169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111171468|NCT01950169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111171469|NCT01909466|Aripiprazole|aripiprazole|mesh-list
111171470|NCT01909466|Antidepressive Agents|antidepressive agents|mesh-ancestor
111171471|NCT01909466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111171472|NCT01909466|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111171473|NCT01909466|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111171474|NCT01909466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111171475|NCT01909466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111171476|NCT01909466|Dopamine Agonists|dopamine agonists|mesh-ancestor
111171477|NCT01909466|Dopamine Agents|dopamine agents|mesh-ancestor
111171478|NCT01909466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111171479|NCT01909466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111171480|NCT01909466|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111171481|NCT01909466|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111171482|NCT01909466|Serotonin Agents|serotonin agents|mesh-ancestor
111171483|NCT01909466|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111171484|NCT01909466|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111171485|NCT01909466|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111171486|NCT01909466|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111171487|NCT01977625|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
111171488|NCT01977625|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111171489|NCT01977625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111171490|NCT01977625|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111171491|NCT01977625|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111171492|NCT01977625|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111171493|NCT01977625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111171494|NCT01977625|Dopamine Agents|dopamine agents|mesh-ancestor
111171497|NCT01995071|Antimetabolites|antimetabolites|mesh-ancestor
111171498|NCT01995071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111171499|NCT01995071|Antiviral Agents|antiviral agents|mesh-ancestor
111171500|NCT01995071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111171501|NCT01994837|Venetoclax|venetoclax|mesh-list
111171502|NCT01994837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111171503|NCT02010593|Dapivirine|dapivirine|mesh-list
111171504|NCT02010593|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111171505|NCT02010593|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111171506|NCT02010593|Antiviral Agents|antiviral agents|mesh-ancestor
111171507|NCT02010593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111171508|NCT01994291|Ranibizumab|ranibizumab|mesh-list
111171509|NCT01994291|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111171510|NCT01994291|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111171511|NCT01994291|Growth Substances|growth substances|mesh-ancestor
111171512|NCT01994291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111171513|NCT01994291|Growth Inhibitors|growth inhibitors|mesh-ancestor
111171514|NCT01994291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111171515|NCT01993823|Clotrimazole|clotrimazole|mesh-list
111171516|NCT01993823|Miconazole|miconazole|mesh-list
111171517|NCT01993823|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111171518|NCT01993823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111171519|NCT01993823|Antifungal Agents|antifungal agents|mesh-ancestor
111171520|NCT01993823|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110799558|NCT03752931|Adrenergic Agents|adrenergic agents|mesh-ancestor
111171521|NCT01993823|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111171522|NCT01993823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111171523|NCT01993823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111171524|NCT01993823|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111171525|NCT01993823|Hormone Antagonists|hormone antagonists|mesh-ancestor
111171526|NCT01993823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111171527|NCT01993823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111171528|NCT01993823|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111171529|NCT01993823|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111171530|NCT01993667|Acetazolamide|acetazolamide|mesh-list
111171531|NCT01993667|Anticonvulsants|anticonvulsants|mesh-ancestor
111171532|NCT01993667|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
111171533|NCT01993667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111171534|NCT01993667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111171535|NCT01993667|Diuretics|diuretics|mesh-ancestor
111171536|NCT01993667|Natriuretic Agents|natriuretic agents|mesh-ancestor
111171537|NCT01993667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111171538|NCT01934192|Metoclopramide|metoclopramide|mesh-list
111171539|NCT01934192|Antiemetics|antiemetics|mesh-ancestor
111171540|NCT01934192|Autonomic Agents|autonomic agents|mesh-ancestor
111171541|NCT01934192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111171542|NCT01934192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111171543|NCT01934192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110888691|NCT03567434|Ethanol|ethanol|mesh-list
111171544|NCT01934192|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111171545|NCT01934192|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111171546|NCT01934192|Dopamine Agents|dopamine agents|mesh-ancestor
111171547|NCT01934192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111171548|NCT01934192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111171549|NCT01933880|Methylphenidate|methylphenidate|mesh-list
111171550|NCT01933880|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111171551|NCT01933880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111171552|NCT01933880|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111171553|NCT01933880|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111171554|NCT01933880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111171555|NCT01933880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111171556|NCT01933880|Dopamine Agents|dopamine agents|mesh-ancestor
111171557|NCT01933880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111171558|NCT02008877|Sirolimus|sirolimus|mesh-list
111171559|NCT02008877|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111171560|NCT02008877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111171561|NCT02008877|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111171562|NCT02008877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111171563|NCT02008877|Antifungal Agents|antifungal agents|mesh-ancestor
111171564|NCT02008877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111171565|NCT02008877|Immunologic Factors|immunologic factors|mesh-ancestor
111171566|NCT02008877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111171567|NCT01933334|Pirfenidone|pirfenidone|mesh-list
111171568|NCT01933334|Analgesics|analgesics|mesh-ancestor
111171569|NCT01933334|Sensory System Agents|sensory system agents|mesh-ancestor
111171570|NCT01933334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111171571|NCT01933334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111171572|NCT01933334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111171573|NCT01933334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111171574|NCT01933334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111171575|NCT01933334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111171576|NCT01933334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111171577|NCT01908140|Fluticasone|fluticasone|mesh-list
111171578|NCT01908140|Bromides|bromides|mesh-list
111171579|NCT01908140|Formoterol Fumarate|formoterol fumarate|mesh-list
111171580|NCT01908140|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
111171581|NCT01908140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111171582|NCT01908140|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111171583|NCT01908140|Autonomic Agents|autonomic agents|mesh-ancestor
111171584|NCT01908140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111171585|NCT01908140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111171586|NCT01908140|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111171587|NCT01908140|Respiratory System Agents|respiratory system agents|mesh-ancestor
111171588|NCT01908140|Dermatologic Agents|dermatologic agents|mesh-ancestor
111171589|NCT01908140|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111171590|NCT01908140|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111171591|NCT01908140|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111171592|NCT01908140|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111171593|NCT01908140|Adrenergic Agents|adrenergic agents|mesh-ancestor
111171594|NCT01908140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111171595|NCT01908140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111171596|NCT01908140|Anticonvulsants|anticonvulsants|mesh-ancestor
111171597|NCT02008565|Loperamide|loperamide|mesh-list
111171598|NCT02008565|Antidiarrheals|antidiarrheals|mesh-list
111171599|NCT02008565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111171600|NCT01931150|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111171601|NCT01931150|Dapsone|dapsone|mesh-list
111171602|NCT01931150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111171603|NCT01931150|Antimalarials|antimalarials|mesh-ancestor
111171604|NCT01931150|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111171605|NCT01931150|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111171606|NCT01931150|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111171607|NCT01931150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111171608|NCT01931150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111171609|NCT01931150|Leprostatic Agents|leprostatic agents|mesh-ancestor
111171610|NCT01906346|Cocaine|cocaine|mesh-list
111171611|NCT01906346|Anesthetics, Local|anesthetics, local|mesh-ancestor
111171612|NCT01906346|Anesthetics|anesthetics|mesh-ancestor
111171613|NCT01906346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111171614|NCT01906346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111171615|NCT01906346|Sensory System Agents|sensory system agents|mesh-ancestor
111171616|NCT01906346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111171617|NCT01906346|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111171618|NCT01906346|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111171619|NCT01906346|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111171620|NCT01906346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111171621|NCT01906346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111171622|NCT01906346|Dopamine Agents|dopamine agents|mesh-ancestor
111171623|NCT01906346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111171624|NCT04645004|Aspirin|aspirin|mesh-list
111171625|NCT04645004|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111171626|NCT04645004|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111171627|NCT04645004|Analgesics|analgesics|mesh-ancestor
111171628|NCT04645004|Sensory System Agents|sensory system agents|mesh-ancestor
111171629|NCT04645004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111171630|NCT04645004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111171631|NCT04645004|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111171632|NCT04645004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111171633|NCT04645004|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111171634|NCT04645004|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111171635|NCT04645004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111171636|NCT04645004|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111171637|NCT04645004|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111171638|NCT04645004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111171639|NCT04645004|Antipyretics|antipyretics|mesh-ancestor
111171640|NCT01929980|Bortezomib|bortezomib|mesh-list
111171641|NCT01929980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111171642|NCT01363076|Ketorolac|ketorolac|mesh-list
111171643|NCT01363076|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
111171644|NCT01363076|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111171645|NCT01363076|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111171646|NCT01363076|Analgesics|analgesics|mesh-ancestor
111171647|NCT01363076|Sensory System Agents|sensory system agents|mesh-ancestor
111171648|NCT01363076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111171649|NCT01363076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111171650|NCT01363076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111171651|NCT01363076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111171652|NCT01363076|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111171653|NCT01363076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111171654|NCT01363076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111171655|NCT01929044|Anisodamine|anisodamine|mesh-list
111171656|NCT01929044|Scopolamine|scopolamine|mesh-list
111171657|NCT01929044|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
111171658|NCT01929044|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111171659|NCT01929044|Antiemetics|antiemetics|mesh-ancestor
111171660|NCT01929044|Autonomic Agents|autonomic agents|mesh-ancestor
111171661|NCT01929044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111171662|NCT01929044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111171663|NCT01929044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111171664|NCT01929044|Mydriatics|mydriatics|mesh-ancestor
111171665|NCT01929044|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111171666|NCT01929044|Cholinergic Agents|cholinergic agents|mesh-ancestor
111171667|NCT01929044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111171668|NCT01929044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111171669|NCT01929044|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111171670|NCT01929044|Parasympatholytics|parasympatholytics|mesh-ancestor
111171671|NCT01929044|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111171672|NCT01929044|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111171673|NCT01929044|Adrenergic Agents|adrenergic agents|mesh-ancestor
111171674|NCT01929044|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111171675|NCT01929044|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111171676|NCT01929044|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111171677|NCT01929044|Analgesics|analgesics|mesh-ancestor
111171678|NCT01929044|Sensory System Agents|sensory system agents|mesh-ancestor
111171679|NCT01929044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111171680|NCT01929044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111171681|NCT01929044|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111171682|NCT01929044|Vasodilator Agents|vasodilator agents|mesh-ancestor
111171683|NCT01929044|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111171684|NCT01929044|Antioxidants|antioxidants|mesh-ancestor
111171685|NCT01929044|Protective Agents|protective agents|mesh-ancestor
111171686|NCT01957202|Levocabastine|levocabastine|mesh-list
111171687|NCT01957202|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
111171688|NCT01957202|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111171689|NCT01957202|Histamine Antagonists|histamine antagonists|mesh-ancestor
111171690|NCT01957202|Histamine Agents|histamine agents|mesh-ancestor
111171691|NCT01957202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111171692|NCT01957202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110888837|NCT03564704|Hormones|hormones|mesh-ancestor
111171693|NCT01957202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111171694|NCT01616654|Tazarotene|tazarotene|mesh-list
111171695|NCT01616654|Trifarotene|trifarotene|mesh-list
111171696|NCT01616654|Dermatologic Agents|dermatologic agents|mesh-ancestor
111171697|NCT01616654|Keratolytic Agents|keratolytic agents|mesh-ancestor
111171698|NCT01902290|Brodalumab|brodalumab|mesh-list
111171699|NCT01902290|Dermatologic Agents|dermatologic agents|mesh-ancestor
111171700|NCT01467466|Acetylcysteine|acetylcysteine|mesh-list
111171701|NCT01467466|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111171702|NCT01467466|Antiviral Agents|antiviral agents|mesh-ancestor
111171703|NCT01467466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111171704|NCT01467466|Expectorants|expectorants|mesh-ancestor
111171705|NCT01467466|Respiratory System Agents|respiratory system agents|mesh-ancestor
111171706|NCT01467466|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111171707|NCT01467466|Antioxidants|antioxidants|mesh-ancestor
110843057|NCT01152593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111171708|NCT01467466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111171709|NCT01467466|Protective Agents|protective agents|mesh-ancestor
111171710|NCT01467466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111171712|NCT01441180|Sofosbuvir|sofosbuvir|mesh-list
111171713|NCT01441180|Ribavirin|ribavirin|mesh-list
111171714|NCT01441180|Antiviral Agents|antiviral agents|mesh-ancestor
111171715|NCT01441180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111171716|NCT01441180|Antimetabolites|antimetabolites|mesh-ancestor
111171717|NCT01441180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111171718|NCT01441102|Dextromethorphan|dextromethorphan|mesh-list
111171719|NCT01441102|Antitussive Agents|antitussive agents|mesh-ancestor
111171720|NCT01441102|Respiratory System Agents|respiratory system agents|mesh-ancestor
111171721|NCT01441102|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111171722|NCT01441102|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111171723|NCT01441102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111171724|NCT01441102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111171725|NCT01441102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111171726|NCT04061980|Nivolumab|nivolumab|mesh-list
111171727|NCT04061980|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111171728|NCT04061980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111171729|NCT04061980|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111171730|NCT04061980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111171731|NCT01467076|Alprostadil|alprostadil|mesh-list
111171732|NCT01467076|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111171733|NCT01467076|Vasodilator Agents|vasodilator agents|mesh-ancestor
111171734|NCT01467076|Urological Agents|urological agents|mesh-ancestor
111171735|NCT01466062|Palivizumab|palivizumab|mesh-list
111171736|NCT01466062|Antiviral Agents|antiviral agents|mesh-ancestor
111171737|NCT01466062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111171738|NCT04504864|Aspirin|aspirin|mesh-list
111171739|NCT04504864|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111171740|NCT04504864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111171741|NCT04504864|Analgesics|analgesics|mesh-ancestor
111171742|NCT04504864|Sensory System Agents|sensory system agents|mesh-ancestor
111171743|NCT04504864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111171744|NCT04504864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111171745|NCT04504864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111171746|NCT04504864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111171747|NCT04504864|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111171748|NCT04504864|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111171749|NCT04504864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111171750|NCT04504864|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111171751|NCT04504864|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111171752|NCT04504864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111171753|NCT04504864|Antipyretics|antipyretics|mesh-ancestor
111171754|NCT04060342|Paclitaxel|paclitaxel|mesh-list
111171755|NCT04060342|Gemcitabine|gemcitabine|mesh-list
111171756|NCT04060342|Pembrolizumab|pembrolizumab|mesh-list
111171757|NCT04060342|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111171758|NCT04060342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111171759|NCT04060342|Tubulin Modulators|tubulin modulators|mesh-ancestor
111171760|NCT04060342|Antimitotic Agents|antimitotic agents|mesh-ancestor
111171761|NCT04060342|Mitosis Modulators|mitosis modulators|mesh-ancestor
111171762|NCT04060342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111171763|NCT04060342|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111171764|NCT04060342|Antimetabolites|antimetabolites|mesh-ancestor
111171765|NCT04060342|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110888903|NCT03150589|Ranibizumab|ranibizumab|mesh-list
111171766|NCT04060342|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111171767|NCT01435018|Tenofovir|tenofovir|mesh-list
111171768|NCT01435018|Emtricitabine|emtricitabine|mesh-list
111171769|NCT01435018|Efavirenz|efavirenz|mesh-list
111171770|NCT01435018|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
111171771|NCT01435018|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
111171772|NCT01435018|Paclitaxel|paclitaxel|mesh-list
111171773|NCT01435018|Etoposide|etoposide|mesh-list
111171774|NCT01435018|Vincristine|vincristine|mesh-list
111171775|NCT01435018|Bleomycin|bleomycin|mesh-list
111171776|NCT01435018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111171777|NCT01435018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111171778|NCT01435018|Tubulin Modulators|tubulin modulators|mesh-ancestor
111171779|NCT01435018|Antimitotic Agents|antimitotic agents|mesh-ancestor
111171780|NCT01435018|Mitosis Modulators|mitosis modulators|mesh-ancestor
111171781|NCT01435018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111171782|NCT01435018|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111171783|NCT01435018|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111171784|NCT01435018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111171785|NCT01435018|Antiviral Agents|antiviral agents|mesh-ancestor
111171786|NCT01435018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111171787|NCT01435018|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111171788|NCT01435018|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111171789|NCT01435018|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111171790|NCT01435018|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111171791|NCT01435018|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111171792|NCT01435018|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111171793|NCT01435018|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111171794|NCT01435018|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111171795|NCT01435018|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111171796|NCT01435018|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111171797|NCT01435018|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111171798|NCT01419184|Vancomycin|vancomycin|mesh-list
111171799|NCT01419184|Daptomycin|daptomycin|mesh-list
111171800|NCT01419184|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111171801|NCT01419184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111171802|NCT01417156|Nintedanib|nintedanib|mesh-list
111171803|NCT01417156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111171804|NCT01417156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111171805|NCT01417156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111171806|NCT01417156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111171807|NCT01417078|Diazepam|diazepam|mesh-list
111171808|NCT01417078|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111171809|NCT01417078|Anticonvulsants|anticonvulsants|mesh-ancestor
111171810|NCT01417078|Antiemetics|antiemetics|mesh-ancestor
111171811|NCT01417078|Autonomic Agents|autonomic agents|mesh-ancestor
111171812|NCT01417078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111171813|NCT01417078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111171814|NCT01417078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111171815|NCT01417078|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111171816|NCT01417078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111171817|NCT01417078|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
111171818|NCT01417078|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111171819|NCT01417078|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111171820|NCT01417078|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111171821|NCT01417078|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111171822|NCT01417078|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111171823|NCT01417078|Anesthetics, General|anesthetics, general|mesh-ancestor
111171824|NCT01417078|Anesthetics|anesthetics|mesh-ancestor
111171825|NCT01417078|GABA Modulators|gaba modulators|mesh-ancestor
111171826|NCT01417078|GABA Agents|gaba agents|mesh-ancestor
111171827|NCT01417078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111171828|NCT01417078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111171829|NCT01954394|Alirocumab|alirocumab|mesh-list
111171830|NCT01954394|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
111171831|NCT01954394|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111171832|NCT01954394|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111171833|NCT01954394|Antimetabolites|antimetabolites|mesh-ancestor
111171834|NCT01954394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111171835|NCT01954394|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111171836|NCT01954394|Protease Inhibitors|protease inhibitors|mesh-ancestor
111171837|NCT01954394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111171838|NCT01954394|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111171839|NCT01464424|Bimatoprost|bimatoprost|mesh-list
111171840|NCT01464424|Travoprost|travoprost|mesh-list
110487538|NCT02861378|Adrenergic Agents|adrenergic agents|mesh-ancestor
111171841|NCT01464424|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111171842|NCT01464424|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110888981|NCT02833844|Evolocumab|evolocumab|mesh-list
111171843|NCT01464424|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111171844|NCT01902134|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
111171845|NCT01902134|Tramadol|tramadol|mesh-list
111171846|NCT01902134|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111171847|NCT01902134|Narcotics|narcotics|mesh-ancestor
111171848|NCT01902134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111171849|NCT01902134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111171850|NCT01902134|Analgesics|analgesics|mesh-ancestor
111171851|NCT01902134|Sensory System Agents|sensory system agents|mesh-ancestor
111171852|NCT01902134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111171853|NCT01902134|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111171854|NCT01902134|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111171855|NCT01902134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111171856|NCT01902134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111171857|NCT01954082|Inositol|inositol|mesh-list
111171858|NCT01954082|Vitamin B Complex|vitamin b complex|mesh-ancestor
111171859|NCT01954082|Vitamins|vitamins|mesh-ancestor
111171860|NCT01954082|Micronutrients|micronutrients|mesh-ancestor
111171861|NCT01954082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111171862|NCT01417000|Cyclophosphamide|cyclophosphamide|mesh-list
111171863|NCT01417000|Pancrelipase|pancrelipase|mesh-list
111171864|NCT01417000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111171865|NCT01417000|Immunologic Factors|immunologic factors|mesh-ancestor
111171866|NCT01417000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111171867|NCT01417000|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111171868|NCT01417000|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111171869|NCT01417000|Alkylating Agents|alkylating agents|mesh-ancestor
111171870|NCT01417000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111171871|NCT01417000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111171872|NCT01417000|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111171873|NCT01417000|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111171874|NCT01415986|Temoporfin|temoporfin|mesh-list
111171875|NCT01415986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111171876|NCT01415986|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111171877|NCT01415986|Dermatologic Agents|dermatologic agents|mesh-ancestor
111171878|NCT01415518|Budesonide|budesonide|mesh-list
111171879|NCT01415518|Theophylline|theophylline|mesh-list
111171880|NCT01415518|Formoterol Fumarate|formoterol fumarate|mesh-list
111171881|NCT01415518|Ipratropium|ipratropium|mesh-list
111171882|NCT01415518|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
111171883|NCT01415518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111171884|NCT01415518|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111171885|NCT01415518|Autonomic Agents|autonomic agents|mesh-ancestor
111171886|NCT01415518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111171887|NCT01415518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111171888|NCT01415518|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111171889|NCT01415518|Respiratory System Agents|respiratory system agents|mesh-ancestor
111171890|NCT01415518|Glucocorticoids|glucocorticoids|mesh-ancestor
111171891|NCT01415518|Hormones|hormones|mesh-ancestor
111171892|NCT01415518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111171893|NCT01415518|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111171894|NCT01415518|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111171895|NCT01415518|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111171896|NCT01415518|Adrenergic Agents|adrenergic agents|mesh-ancestor
111171897|NCT01415518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111171898|NCT01415518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111171899|NCT01415518|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111171900|NCT01415518|Cholinergic Agents|cholinergic agents|mesh-ancestor
111171901|NCT01415518|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111171902|NCT01415518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110487559|NCT04284644|Anesthetics|anesthetics|mesh-ancestor
111171903|NCT01415518|Vasodilator Agents|vasodilator agents|mesh-ancestor
111171904|NCT01415518|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
111171905|NCT01415518|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111171906|NCT01415518|Purinergic Agents|purinergic agents|mesh-ancestor
111171907|NCT01393600|Tetrabenazine|tetrabenazine|mesh-list
111171908|NCT01393600|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110843078|NCT05667077|Analgesics|analgesics|mesh-ancestor
111171909|NCT01393600|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111171910|NCT01393600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111171911|NCT01393600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111171912|NCT01393600|Adrenergic Agents|adrenergic agents|mesh-ancestor
111171913|NCT01393600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111171914|NCT01393600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111171916|NCT04767178|Ibuprofen|ibuprofen|mesh-list
110889053|NCT03564158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111171917|NCT04767178|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111171918|NCT04767178|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111171919|NCT04767178|Analgesics|analgesics|mesh-ancestor
111171920|NCT04767178|Sensory System Agents|sensory system agents|mesh-ancestor
111171921|NCT04767178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111171922|NCT04767178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111171923|NCT04767178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111171924|NCT04767178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111171925|NCT04767178|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111171926|NCT04767178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111171927|NCT04767178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111171928|NCT04767178|Antipyretics|antipyretics|mesh-ancestor
111171929|NCT01432600|Dexamethasone|dexamethasone|mesh-list
111171930|NCT01432600|Cyclophosphamide|cyclophosphamide|mesh-list
111171931|NCT01432600|Pomalidomide|pomalidomide|mesh-list
111171932|NCT01432600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111171933|NCT01432600|Immunologic Factors|immunologic factors|mesh-ancestor
111171934|NCT01432600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111171935|NCT01432600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111171936|NCT01432600|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111171937|NCT01432600|Alkylating Agents|alkylating agents|mesh-ancestor
111171938|NCT01432600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111171939|NCT01432600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111171940|NCT01432600|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111171941|NCT01432600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111171942|NCT01432600|Antiemetics|antiemetics|mesh-ancestor
111171943|NCT01432600|Autonomic Agents|autonomic agents|mesh-ancestor
111171944|NCT01432600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111171945|NCT01432600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111171946|NCT01432600|Glucocorticoids|glucocorticoids|mesh-ancestor
111171947|NCT01432600|Hormones|hormones|mesh-ancestor
111171948|NCT01432600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111171949|NCT01432600|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111171950|NCT01432600|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111171951|NCT01432600|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111171952|NCT01432600|Growth Substances|growth substances|mesh-ancestor
111171953|NCT01432600|Growth Inhibitors|growth inhibitors|mesh-ancestor
111171954|NCT01432444|Aripiprazole|aripiprazole|mesh-list
111171955|NCT01432444|Antidepressive Agents|antidepressive agents|mesh-ancestor
111171956|NCT01432444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111171957|NCT01432444|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111171958|NCT01432444|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111171959|NCT01432444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111171960|NCT01432444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111171961|NCT01432444|Dopamine Agonists|dopamine agonists|mesh-ancestor
111171962|NCT01432444|Dopamine Agents|dopamine agents|mesh-ancestor
111171963|NCT01432444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111171964|NCT01432444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111171965|NCT01432444|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111171966|NCT01432444|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111171967|NCT01432444|Serotonin Agents|serotonin agents|mesh-ancestor
111171968|NCT01432444|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111171969|NCT01432444|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111171970|NCT01432444|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111171971|NCT01432444|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111171972|NCT01415440|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
111171973|NCT01415440|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111171974|NCT01415440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111171975|NCT01415440|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111171976|NCT01415440|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111171977|NCT01415440|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111171978|NCT01415440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111171979|NCT01415440|Dopamine Agents|dopamine agents|mesh-ancestor
111171980|NCT01415440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111171981|NCT01932788|Vitamin D|vitamin d|mesh-list
111171982|NCT01932788|Cholecalciferol|cholecalciferol|mesh-list
111171983|NCT01932788|Vitamins|vitamins|mesh-list
111171984|NCT01932788|Micronutrients|micronutrients|mesh-ancestor
111171985|NCT01932788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111171986|NCT01932788|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111171987|NCT01932788|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111171988|NCT01431976|Lamotrigine|lamotrigine|mesh-list
111171989|NCT01431976|Anticonvulsants|anticonvulsants|mesh-ancestor
111171990|NCT01431976|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111171991|NCT01431976|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111171992|NCT01431976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111171993|NCT01431976|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111171994|NCT01431976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111171995|NCT01431976|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111171996|NCT01431976|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111171997|NCT01431976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111171998|NCT01431976|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111171999|NCT01431976|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111172000|NCT01413958|Loratadine|loratadine|mesh-list
111172001|NCT01413958|Phenylephrine|phenylephrine|mesh-list
111172002|NCT01413958|Oxymetazoline|oxymetazoline|mesh-list
111172003|NCT01413958|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111172004|NCT01413958|Mydriatics|mydriatics|mesh-ancestor
111172005|NCT01413958|Autonomic Agents|autonomic agents|mesh-ancestor
111172006|NCT01413958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111172007|NCT01413958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111172008|NCT01413958|Sympathomimetics|sympathomimetics|mesh-ancestor
111172009|NCT01413958|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111172010|NCT01413958|Nasal Decongestants|nasal decongestants|mesh-ancestor
111172011|NCT01413958|Respiratory System Agents|respiratory system agents|mesh-ancestor
111172012|NCT01413958|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111172013|NCT01413958|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111172014|NCT01413958|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111172015|NCT01413958|Adrenergic Agents|adrenergic agents|mesh-ancestor
111172016|NCT01413958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111172017|NCT01413958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111172018|NCT01413958|Protective Agents|protective agents|mesh-ancestor
111172019|NCT01413958|Antipruritics|antipruritics|mesh-ancestor
111172020|NCT01413958|Dermatologic Agents|dermatologic agents|mesh-ancestor
111172021|NCT01413958|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111172022|NCT01413958|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
111172023|NCT01413958|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111172024|NCT01413958|Histamine Antagonists|histamine antagonists|mesh-ancestor
111172025|NCT01413958|Histamine Agents|histamine agents|mesh-ancestor
111172026|NCT01413178|Melphalan|melphalan|mesh-list
111172027|NCT01413178|Busulfan|busulfan|mesh-list
111172028|NCT01413178|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111172029|NCT01413178|Alkylating Agents|alkylating agents|mesh-ancestor
111172030|NCT01413178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111172031|NCT01413178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111172032|NCT01413178|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111172033|NCT01413178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111172034|NCT01413178|Immunologic Factors|immunologic factors|mesh-ancestor
111172035|NCT01413178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111172036|NCT01412944|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111172037|NCT01412944|Immunologic Factors|immunologic factors|mesh-ancestor
111172038|NCT01412944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111172039|NCT03025906|Valproic Acid|valproic acid|mesh-list
111172040|NCT03025906|Phenobarbital|phenobarbital|mesh-list
111172041|NCT03025906|Anticonvulsants|anticonvulsants|mesh-ancestor
111172042|NCT03025906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111172043|NCT03025906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111172044|NCT03025906|GABA Agents|gaba agents|mesh-ancestor
111172045|NCT03025906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111172046|NCT03025906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111172047|NCT03025906|Antimanic Agents|antimanic agents|mesh-ancestor
111172048|NCT03025906|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111172049|NCT03025906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111172050|NCT03025906|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111172051|NCT03025906|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111172052|NCT03025906|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111172053|NCT03025906|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111172054|NCT03025906|GABA Modulators|gaba modulators|mesh-ancestor
111172055|NCT03025906|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111172056|NCT03025906|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111172057|NCT03025906|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111172059|NCT04053712|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111172060|NCT04053712|Hormones|hormones|mesh-ancestor
111172061|NCT04053712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111172062|NCT04053712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111172063|NCT01798485|Docetaxel|docetaxel|mesh-list
111172064|NCT01798485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111172065|NCT01798485|Tubulin Modulators|tubulin modulators|mesh-ancestor
111172066|NCT01798485|Antimitotic Agents|antimitotic agents|mesh-ancestor
111172067|NCT01798485|Mitosis Modulators|mitosis modulators|mesh-ancestor
111172068|NCT01798485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111172069|NCT01767519|Solifenacin Succinate|solifenacin succinate|mesh-list
111172070|NCT01767519|Botulinum Toxins|botulinum toxins|mesh-list
111172071|NCT01767519|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111172072|NCT01767519|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111172073|NCT01767519|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111172074|NCT01767519|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111172075|NCT01767519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111172076|NCT01767519|Cholinergic Agents|cholinergic agents|mesh-ancestor
111172077|NCT01767519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111172078|NCT01767519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111172079|NCT01767519|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111172080|NCT01767519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111172081|NCT01767519|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111172082|NCT01767519|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111172083|NCT01767519|Urological Agents|urological agents|mesh-ancestor
111172084|NCT01797081|Botulinum Toxins|botulinum toxins|mesh-list
111172085|NCT01797081|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111172086|NCT01797081|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111172087|NCT01797081|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111172088|NCT01797081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111172089|NCT01797081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111172090|NCT01797081|Cholinergic Agents|cholinergic agents|mesh-ancestor
111172091|NCT01797081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111172092|NCT01797081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111172093|NCT01797081|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111172094|NCT01797081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111172095|NCT01794117|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
111172096|NCT01794117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111172097|NCT01765569|Vemurafenib|vemurafenib|mesh-list
111172098|NCT01765569|Digoxin|digoxin|mesh-list
111172099|NCT01765569|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111172100|NCT01765569|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111172101|NCT01765569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111172102|NCT01765569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111172103|NCT01765569|Protective Agents|protective agents|mesh-ancestor
111172104|NCT01765569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111172105|NCT01765569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111172106|NCT01765569|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111172107|NCT04414605|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111172108|NCT04414605|Immunologic Factors|immunologic factors|mesh-ancestor
111172109|NCT04414605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111172110|NCT01609023|Rituximab|rituximab|mesh-list
111172111|NCT01609023|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111172112|NCT01609023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111172113|NCT01609023|Immunologic Factors|immunologic factors|mesh-ancestor
111172114|NCT01609023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111172115|NCT01609023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111172116|NCT01765179|Methyltestosterone|methyltestosterone|mesh-list
111172117|NCT01765179|Testosterone|testosterone|mesh-list
111172118|NCT01765179|Testosterone undecanoate|testosterone undecanoate|mesh-list
111172119|NCT01765179|Testosterone enanthate|testosterone enanthate|mesh-list
111172120|NCT01765179|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
111172121|NCT01765179|Androgens|androgens|mesh-ancestor
111172123|NCT01765179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111172124|NCT01765179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111172125|NCT01765179|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111172126|NCT01765179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111172127|NCT01765179|Anabolic Agents|anabolic agents|mesh-ancestor
111172128|NCT01793883|Laninamivir|laninamivir|mesh-list
111172129|NCT01793883|Zanamivir|zanamivir|mesh-list
111172130|NCT01793883|Antiviral Agents|antiviral agents|mesh-ancestor
111172131|NCT01793883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111172132|NCT01793883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111172133|NCT01793883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111172134|NCT01953692|Pembrolizumab|pembrolizumab|mesh-list
111172135|NCT01953692|Lenalidomide|lenalidomide|mesh-list
111172136|NCT01953692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111172137|NCT01953692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111172138|NCT01953692|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111172139|NCT01953692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111172140|NCT01953692|Immunologic Factors|immunologic factors|mesh-ancestor
111172141|NCT01953692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111172142|NCT01953692|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111172143|NCT01953692|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111172144|NCT01953692|Growth Substances|growth substances|mesh-ancestor
111172145|NCT01953692|Growth Inhibitors|growth inhibitors|mesh-ancestor
111172146|NCT01791153|Prednisone|prednisone|mesh-list
111172147|NCT01791153|Methotrexate|methotrexate|mesh-list
111172148|NCT01791153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111172149|NCT01791153|Glucocorticoids|glucocorticoids|mesh-ancestor
111172150|NCT01791153|Hormones|hormones|mesh-ancestor
111172151|NCT01791153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111172152|NCT01791153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111172153|NCT01791153|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111172154|NCT01791153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111172155|NCT01791153|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111172156|NCT01791153|Abortifacient Agents|abortifacient agents|mesh-ancestor
111172157|NCT01791153|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111172158|NCT01791153|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111172159|NCT01791153|Antimetabolites|antimetabolites|mesh-ancestor
111172160|NCT01791153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111172161|NCT01791153|Dermatologic Agents|dermatologic agents|mesh-ancestor
111172162|NCT01791153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111172163|NCT01791153|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111172164|NCT01791153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111172165|NCT01791153|Immunologic Factors|immunologic factors|mesh-ancestor
111172166|NCT01791153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111172167|NCT01791153|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111172168|NCT01926782|Alirocumab|alirocumab|mesh-list
111172169|NCT01926782|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111172170|NCT01926782|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
111172171|NCT01926782|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111172172|NCT01926782|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111172173|NCT01926782|Antimetabolites|antimetabolites|mesh-ancestor
111172174|NCT01926782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111172175|NCT01926782|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111172176|NCT01926782|Protease Inhibitors|protease inhibitors|mesh-ancestor
111172177|NCT01926782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111172178|NCT01926782|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111172179|NCT01926782|Immunologic Factors|immunologic factors|mesh-ancestor
111172180|NCT01926782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111172181|NCT01926626|Moclobemide|moclobemide|mesh-list
111172182|NCT01926626|Nicotine|nicotine|mesh-list
111172183|NCT01926626|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111172184|NCT01926626|Autonomic Agents|autonomic agents|mesh-ancestor
110843095|NCT01152749|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111172185|NCT01926626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111172186|NCT01926626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111172187|NCT01926626|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111172188|NCT01926626|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111172189|NCT01926626|Cholinergic Agents|cholinergic agents|mesh-ancestor
111172190|NCT01926626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111172191|NCT01926626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111172192|NCT01926626|Antidepressive Agents|antidepressive agents|mesh-ancestor
111172193|NCT01926626|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111172194|NCT01926626|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
111172195|NCT01926626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111172196|NCT01900730|Valproic Acid|valproic acid|mesh-list
111172197|NCT01900730|Anticonvulsants|anticonvulsants|mesh-ancestor
111172198|NCT01900730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111172199|NCT01900730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111172200|NCT01900730|GABA Agents|gaba agents|mesh-ancestor
111172201|NCT01900730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111172202|NCT01900730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111172203|NCT01900730|Antimanic Agents|antimanic agents|mesh-ancestor
111172204|NCT01900730|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111172205|NCT01900730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111172206|NCT01900730|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111172207|NCT01952834|Vancomycin|vancomycin|mesh-list
111172208|NCT01952834|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111172209|NCT01952834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111172210|NCT01952054|Denosumab|denosumab|mesh-list
111172211|NCT01952054|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111172212|NCT01952054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111172213|NCT01925768|Apremilast|apremilast|mesh-list
111172214|NCT01925768|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111172215|NCT01925768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111172216|NCT01925768|Analgesics|analgesics|mesh-ancestor
111172217|NCT01925768|Sensory System Agents|sensory system agents|mesh-ancestor
111172218|NCT01925768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111172219|NCT01925768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111172220|NCT01925768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111172221|NCT01925768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111172222|NCT01925768|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
111172223|NCT01925768|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111172224|NCT01925768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111172225|NCT01925768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111172226|NCT01431274|Tiotropium Bromide|tiotropium bromide|mesh-list
111172227|NCT01431274|Olodaterol|olodaterol|mesh-list
111172228|NCT01431274|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111172229|NCT01431274|Autonomic Agents|autonomic agents|mesh-ancestor
111172230|NCT01431274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111172231|NCT01431274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111172232|NCT01431274|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111172233|NCT01431274|Respiratory System Agents|respiratory system agents|mesh-ancestor
111172234|NCT01431274|Parasympatholytics|parasympatholytics|mesh-ancestor
111172235|NCT01431274|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111172236|NCT01431274|Cholinergic Agents|cholinergic agents|mesh-ancestor
111172237|NCT01431274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111172238|NCT01431274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111172239|NCT01991795|Ticagrelor|ticagrelor|mesh-list
111172240|NCT01991795|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111172241|NCT01991795|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111172242|NCT01991795|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111172243|NCT01991795|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111172244|NCT01991795|Purinergic Agents|purinergic agents|mesh-ancestor
111172245|NCT01991795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111172246|NCT01991795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111172247|NCT01991795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111172248|NCT02076100|Ruzasvir|ruzasvir|mesh-list
111172249|NCT02076100|Antiviral Agents|antiviral agents|mesh-ancestor
111172250|NCT02076100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111172251|NCT01411774|Cycloserine|cycloserine|mesh-list
111172252|NCT01411774|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111172253|NCT01411774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111172254|NCT01411774|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111172256|NCT01411774|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111172257|NCT01411774|Antimetabolites|antimetabolites|mesh-ancestor
111172258|NCT01411774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111172259|NCT01410604|Metformin|metformin|mesh-list
111172260|NCT01410604|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111172261|NCT01410604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111172262|NCT01410448|Cyclosporine|cyclosporine|mesh-list
111172263|NCT01410448|Mycophenolic Acid|mycophenolic acid|mesh-list
111172264|NCT01410448|Everolimus|everolimus|mesh-list
111172265|NCT01410448|Cyclosporins|cyclosporins|mesh-list
111172266|NCT01410448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111172267|NCT01410448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111172268|NCT01410448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111172269|NCT01410448|Immunologic Factors|immunologic factors|mesh-ancestor
111172270|NCT01410448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111172271|NCT01410448|Antifungal Agents|antifungal agents|mesh-ancestor
111172272|NCT01410448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111172273|NCT01410448|Dermatologic Agents|dermatologic agents|mesh-ancestor
111172274|NCT01410448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111172275|NCT01410448|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111172276|NCT01410448|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111172277|NCT01410448|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111172278|NCT01410448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111172279|NCT01410448|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111172280|NCT01410448|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111172281|NCT01410448|Antitubercular Agents|antitubercular agents|mesh-ancestor
111172282|NCT01410448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111172283|NCT04037176|Omalizumab|omalizumab|mesh-list
111172284|NCT04037176|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111172285|NCT04037176|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111172286|NCT04037176|Respiratory System Agents|respiratory system agents|mesh-ancestor
111172287|NCT01430104|Teriparatide|teriparatide|mesh-list
111172288|NCT01430104|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111172289|NCT01430104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111172290|NCT01430104|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111172291|NCT01990859|Ipilimumab|ipilimumab|mesh-list
111172292|NCT01990859|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111172293|NCT01990859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111172294|NCT01990859|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111172295|NCT01990859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111172296|NCT02093897|Factor VIII|factor viii|mesh-list
111172297|NCT02093897|Coagulants|coagulants|mesh-ancestor
111172298|NCT01976845|Midazolam|midazolam|mesh-list
111172299|NCT01976845|Propofol|propofol|mesh-list
111172300|NCT01976845|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111172301|NCT01976845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111172302|NCT01976845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111172303|NCT01976845|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111172304|NCT01976845|Anesthetics, General|anesthetics, general|mesh-ancestor
111172305|NCT01976845|Anesthetics|anesthetics|mesh-ancestor
111172306|NCT01976845|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111172307|NCT01976845|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111172308|NCT01976845|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111172309|NCT01976845|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111172310|NCT01976845|GABA Modulators|gaba modulators|mesh-ancestor
111172311|NCT01976845|GABA Agents|gaba agents|mesh-ancestor
111172312|NCT01976845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111172313|NCT01976845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111172314|NCT01989689|Etanercept|etanercept|mesh-list
111172315|NCT01989689|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111172316|NCT01989689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111172317|NCT01989689|Analgesics|analgesics|mesh-ancestor
111172318|NCT01989689|Sensory System Agents|sensory system agents|mesh-ancestor
111172319|NCT01989689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111172320|NCT01989689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111172321|NCT01989689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111172322|NCT01989689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110843110|NCT01259531|Adrenergic Agents|adrenergic agents|mesh-ancestor
111172323|NCT01989689|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111172324|NCT01989689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111172325|NCT01989689|Immunologic Factors|immunologic factors|mesh-ancestor
111172327|NCT01942993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111172328|NCT01942993|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111172329|NCT01942993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111172330|NCT01942993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111172331|NCT01989455|Deferiprone|deferiprone|mesh-list
111172332|NCT01989455|Iron Chelating Agents|iron chelating agents|mesh-ancestor
111172333|NCT01989455|Chelating Agents|chelating agents|mesh-ancestor
111172334|NCT01989455|Sequestering Agents|sequestering agents|mesh-ancestor
111172335|NCT01989455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111172336|NCT01987895|Vancomycin|vancomycin|mesh-list
111172337|NCT01987895|Oxazolidinones|oxazolidinones|mesh-list
111172338|NCT01987895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111172339|NCT01987895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111172340|NCT01987895|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111172341|NCT01987895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111172342|NCT01987895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111172343|NCT01618669|Regadenoson|regadenoson|mesh-list
111172344|NCT01618669|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
111172345|NCT01618669|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
111172346|NCT01618669|Purinergic Agonists|purinergic agonists|mesh-ancestor
111172347|NCT01618669|Purinergic Agents|purinergic agents|mesh-ancestor
111172348|NCT01618669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111172349|NCT01618669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111172350|NCT01618669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111172351|NCT01390948|Bevacizumab|bevacizumab|mesh-list
111172352|NCT01390948|Temozolomide|temozolomide|mesh-list
111172353|NCT01390948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111172354|NCT01390948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111172355|NCT01390948|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111172356|NCT01390948|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111172357|NCT01390948|Growth Substances|growth substances|mesh-ancestor
111172358|NCT01390948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111172359|NCT01390948|Growth Inhibitors|growth inhibitors|mesh-ancestor
111172360|NCT01390948|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111172361|NCT01390948|Alkylating Agents|alkylating agents|mesh-ancestor
111172362|NCT01390948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111172363|NCT03842722|Protoporphyrin IX|protoporphyrin ix|mesh-list
111172364|NCT03842722|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111172365|NCT03842722|Dermatologic Agents|dermatologic agents|mesh-ancestor
111172366|NCT01429792|Ribavirin|ribavirin|mesh-list
111172367|NCT01429792|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
111172368|NCT01429792|Antimetabolites|antimetabolites|mesh-ancestor
111172369|NCT01429792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111172370|NCT01429792|Antiviral Agents|antiviral agents|mesh-ancestor
111172371|NCT01429792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111172372|NCT01940887|Bevacizumab|bevacizumab|mesh-list
111172373|NCT01940887|Aflibercept|aflibercept|mesh-list
111172374|NCT01940887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111172375|NCT01940887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111172376|NCT01940887|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111172377|NCT01940887|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111172378|NCT01940887|Growth Substances|growth substances|mesh-ancestor
111172379|NCT01940887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111172380|NCT01940887|Growth Inhibitors|growth inhibitors|mesh-ancestor
111172381|NCT01925612|Prednisone|prednisone|mesh-list
111172382|NCT01925612|Cyclophosphamide|cyclophosphamide|mesh-list
111172383|NCT01925612|Rituximab|rituximab|mesh-list
111172384|NCT01925612|Doxorubicin|doxorubicin|mesh-list
111172385|NCT01925612|Vincristine|vincristine|mesh-list
111172386|NCT01925612|Brentuximab Vedotin|brentuximab vedotin|mesh-list
111172387|NCT01925612|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111172388|NCT01925612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111172389|NCT01925612|Immunologic Factors|immunologic factors|mesh-ancestor
111172390|NCT01925612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111172391|NCT01925612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111172392|NCT01925612|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111172393|NCT01925612|Alkylating Agents|alkylating agents|mesh-ancestor
111172394|NCT01925612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111172395|NCT01925612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111172396|NCT01925612|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111172397|NCT01925612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111172398|NCT01925612|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111172399|NCT01925612|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111172400|NCT01925612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111172401|NCT01925612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111172402|NCT01925612|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111172403|NCT01925612|Glucocorticoids|glucocorticoids|mesh-ancestor
111172404|NCT01925612|Hormones|hormones|mesh-ancestor
111172405|NCT01925612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111172406|NCT01925612|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111172407|NCT01925612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111172408|NCT01925612|Tubulin Modulators|tubulin modulators|mesh-ancestor
111172409|NCT01925612|Antimitotic Agents|antimitotic agents|mesh-ancestor
111172410|NCT01925612|Mitosis Modulators|mitosis modulators|mesh-ancestor
111172411|NCT01925612|Immunotoxins|immunotoxins|mesh-ancestor
111172412|NCT01925612|Immunoconjugates|immunoconjugates|mesh-ancestor
111172413|NCT02093663|Mesalamine|mesalamine|mesh-list
111172414|NCT02093663|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111172415|NCT02093663|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111172416|NCT02093663|Analgesics|analgesics|mesh-ancestor
111172417|NCT02093663|Sensory System Agents|sensory system agents|mesh-ancestor
111172418|NCT02093663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110487616|NCT00757588|Insulin|insulin|mesh-list
111172419|NCT02093663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111172420|NCT02093663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111172421|NCT02093663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111172422|NCT01408888|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111172423|NCT01408888|Dulaglutide|dulaglutide|mesh-list
111172424|NCT01408888|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111172425|NCT01408888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111172426|NCT01408888|Incretins|incretins|mesh-ancestor
111172427|NCT01408888|Hormones|hormones|mesh-ancestor
111172428|NCT01408888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111172429|NCT01408888|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111172430|NCT01408888|Protease Inhibitors|protease inhibitors|mesh-ancestor
111172431|NCT01408888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111172432|NCT01408888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111172433|NCT01918033|Desloratadine|desloratadine|mesh-list
111172434|NCT01918033|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111172435|NCT01918033|Cholinergic Agents|cholinergic agents|mesh-ancestor
111172436|NCT01918033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111172437|NCT01918033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111172438|NCT01918033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111172439|NCT01918033|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
111172440|NCT01918033|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111172441|NCT01918033|Histamine Antagonists|histamine antagonists|mesh-ancestor
111172443|NCT01408732|Sodium Tetradecyl Sulfate|sodium tetradecyl sulfate|mesh-list
111172444|NCT01408732|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
111172445|NCT01408732|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111172446|NCT01390402|Aldesleukin|aldesleukin|mesh-list
111172447|NCT01390402|Methotrexate|methotrexate|mesh-list
111172448|NCT01390402|Fludarabine phosphate|fludarabine phosphate|mesh-list
111172449|NCT01390402|Fludarabine|fludarabine|mesh-list
111172450|NCT01390402|Busulfan|busulfan|mesh-list
111172451|NCT01390402|Interleukin-2|interleukin-2|mesh-list
111172452|NCT01390402|Tacrolimus|tacrolimus|mesh-list
111172453|NCT01390402|Thymoglobulin|thymoglobulin|mesh-list
111172454|NCT01390402|Antilymphocyte Serum|antilymphocyte serum|mesh-list
111172455|NCT01390402|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111172456|NCT01390402|Abortifacient Agents|abortifacient agents|mesh-ancestor
111172457|NCT01390402|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110843118|NCT03061214|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111172458|NCT01390402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111172459|NCT01390402|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111172460|NCT01390402|Antimetabolites|antimetabolites|mesh-ancestor
111172461|NCT01390402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111172462|NCT01390402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111172463|NCT01390402|Dermatologic Agents|dermatologic agents|mesh-ancestor
111172464|NCT01390402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111172465|NCT01390402|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111172466|NCT01390402|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111172467|NCT01390402|Immunologic Factors|immunologic factors|mesh-ancestor
111172468|NCT01390402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111172469|NCT01390402|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111172470|NCT01390402|Antiviral Agents|antiviral agents|mesh-ancestor
111172471|NCT01390402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111172472|NCT01390402|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111172473|NCT01390402|Alkylating Agents|alkylating agents|mesh-ancestor
111172474|NCT01390402|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111172475|NCT01390402|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111172476|NCT01390402|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111172477|NCT01390402|Analgesics|analgesics|mesh-ancestor
111172478|NCT01390402|Sensory System Agents|sensory system agents|mesh-ancestor
111172479|NCT01390402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111172480|NCT01390402|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111172481|NCT01390402|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111172482|NCT04661683|Charcoal|charcoal|mesh-list
111172483|NCT04661683|Antidotes|antidotes|mesh-ancestor
111172484|NCT04661683|Protective Agents|protective agents|mesh-ancestor
111172485|NCT04661683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111172486|NCT01428076|Polidocanol|polidocanol|mesh-list
111172487|NCT01428076|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
111172488|NCT01428076|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111172489|NCT01900652|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111172490|NCT01900652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111172491|NCT01900652|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111172492|NCT01900652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111172493|NCT01900652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111172494|NCT02093351|Tamoxifen|tamoxifen|mesh-list
111172495|NCT02093351|Letrozole|letrozole|mesh-list
111172496|NCT02093351|Olaparib|olaparib|mesh-list
111172497|NCT02093351|Anastrozole|anastrozole|mesh-list
111172498|NCT02093351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111172499|NCT02093351|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111172500|NCT02093351|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111172501|NCT02093351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111172502|NCT02093351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111172503|NCT02093351|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111172504|NCT02093351|Hormone Antagonists|hormone antagonists|mesh-ancestor
111172505|NCT02093351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111172506|NCT02093351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111172507|NCT02093351|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111172508|NCT02093351|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111172509|NCT02093351|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111172510|NCT02093351|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111172511|NCT02093351|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111172512|NCT02078284|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
111172513|NCT02078284|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
111172514|NCT02078284|Protective Agents|protective agents|mesh-ancestor
111172515|NCT02078284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111172516|NCT02078284|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111172517|NCT02078284|Antioxidants|antioxidants|mesh-ancestor
111172518|NCT02078284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111172520|NCT02092961|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111172521|NCT02092961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111172522|NCT02092961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111172523|NCT01940497|Paclitaxel|paclitaxel|mesh-list
111172524|NCT01940497|Docetaxel|docetaxel|mesh-list
111172525|NCT01940497|Doxorubicin|doxorubicin|mesh-list
111172526|NCT01940497|Trastuzumab|trastuzumab|mesh-list
111172527|NCT01940497|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111172528|NCT01940497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111172529|NCT01940497|Tubulin Modulators|tubulin modulators|mesh-ancestor
111172530|NCT01940497|Antimitotic Agents|antimitotic agents|mesh-ancestor
111172531|NCT01940497|Mitosis Modulators|mitosis modulators|mesh-ancestor
111172532|NCT01940497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111172533|NCT01940497|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111172534|NCT01940497|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111172535|NCT01940497|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111172536|NCT01940497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111172537|NCT01940497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111172538|NCT01987505|Rituximab|rituximab|mesh-list
111172539|NCT01987505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111172540|NCT01987505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111172541|NCT01987505|Immunologic Factors|immunologic factors|mesh-ancestor
111172542|NCT01987505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111172543|NCT01987505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111172544|NCT01923896|Cycloserine|cycloserine|mesh-list
111172545|NCT01923896|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111172546|NCT01923896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111172547|NCT01923896|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111172548|NCT01923896|Antitubercular Agents|antitubercular agents|mesh-ancestor
111172549|NCT01923896|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111172550|NCT01923896|Antimetabolites|antimetabolites|mesh-ancestor
111172551|NCT01923896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111172552|NCT01938625|Cyclosporine|cyclosporine|mesh-list
111172553|NCT01938625|Ribavirin|ribavirin|mesh-list
111172554|NCT01938625|Simeprevir|simeprevir|mesh-list
111172555|NCT01938625|Tacrolimus|tacrolimus|mesh-list
111172556|NCT01938625|Cyclosporins|cyclosporins|mesh-list
111172557|NCT01938625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111172558|NCT01938625|Immunologic Factors|immunologic factors|mesh-ancestor
111172559|NCT01938625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111172560|NCT01938625|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111172561|NCT01938625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111172562|NCT01938625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111172563|NCT01938625|Antifungal Agents|antifungal agents|mesh-ancestor
111172564|NCT01938625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111172565|NCT01938625|Dermatologic Agents|dermatologic agents|mesh-ancestor
111172566|NCT01938625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111172567|NCT01938625|Antimetabolites|antimetabolites|mesh-ancestor
111172568|NCT01938625|Antiviral Agents|antiviral agents|mesh-ancestor
111172569|NCT01938625|Protease Inhibitors|protease inhibitors|mesh-ancestor
111172570|NCT01975675|Sofosbuvir|sofosbuvir|mesh-list
111172571|NCT01975675|Antiviral Agents|antiviral agents|mesh-ancestor
111172572|NCT01975675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111172573|NCT01975285|Dexamethasone|dexamethasone|mesh-list
111172574|NCT01975285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111172575|NCT01975285|Antiemetics|antiemetics|mesh-ancestor
111172576|NCT01975285|Autonomic Agents|autonomic agents|mesh-ancestor
111172577|NCT01975285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111172578|NCT01975285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111172579|NCT01975285|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111172580|NCT01975285|Glucocorticoids|glucocorticoids|mesh-ancestor
111172581|NCT01975285|Hormones|hormones|mesh-ancestor
111172582|NCT01975285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111172583|NCT01975285|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111172584|NCT01975285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111172585|NCT01974817|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
111172586|NCT01974817|Immunologic Factors|immunologic factors|mesh-ancestor
111172587|NCT01974817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111172588|NCT04624399|Atezolizumab|atezolizumab|mesh-list
111172589|NCT04624399|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111172590|NCT04624399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111172591|NCT04624399|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111172592|NCT04624399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111172593|NCT01915849|Licogliflozin|licogliflozin|mesh-list
111172594|NCT01915849|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111172595|NCT01915849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111172596|NCT01915849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111172597|NCT01915849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111172598|NCT01915303|Cabergoline|cabergoline|mesh-list
111172599|NCT01915303|Pasireotide|pasireotide|mesh-list
111172600|NCT01915303|Hormones|hormones|mesh-ancestor
111172601|NCT01915303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111172602|NCT01915303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111172603|NCT01915303|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111172604|NCT01915303|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111172605|NCT01915303|Dopamine Agonists|dopamine agonists|mesh-ancestor
111172606|NCT01915303|Dopamine Agents|dopamine agents|mesh-ancestor
111172607|NCT01915303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111172608|NCT01915303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111172609|NCT01987427|Phentermine|phentermine|mesh-list
111172610|NCT01987427|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111172611|NCT01987427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111172612|NCT01987427|Appetite Depressants|appetite depressants|mesh-ancestor
111172613|NCT01987427|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111172614|NCT01987427|Sympathomimetics|sympathomimetics|mesh-ancestor
111172615|NCT01987427|Autonomic Agents|autonomic agents|mesh-ancestor
111172616|NCT01987427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111172617|NCT01987427|Adrenergic Agents|adrenergic agents|mesh-ancestor
111172618|NCT01987427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111172619|NCT01987427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111172620|NCT01937299|Brimonidine Tartrate|brimonidine tartrate|mesh-list
111172621|NCT01937299|Travoprost|travoprost|mesh-list
111172622|NCT01937299|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111172623|NCT01937299|Brinzolamide|brinzolamide|mesh-list
111172624|NCT01937299|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111172625|NCT01937299|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111172626|NCT01937299|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111172627|NCT01937299|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111172628|NCT01937299|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111172629|NCT01937299|Adrenergic Agents|adrenergic agents|mesh-ancestor
111172630|NCT01937299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111172631|NCT01937299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111172632|NCT01937299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111172633|NCT01937299|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
111172634|NCT01937299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111172635|NCT01606761|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111172636|NCT01606761|Immunologic Factors|immunologic factors|mesh-ancestor
111172637|NCT01606761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111172638|NCT01597557|Magnesium Sulfate|magnesium sulfate|mesh-list
111172639|NCT01597557|Analgesics|analgesics|mesh-ancestor
111172640|NCT01597557|Sensory System Agents|sensory system agents|mesh-ancestor
111172641|NCT01597557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111172642|NCT01597557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111172643|NCT01597557|Anesthetics|anesthetics|mesh-ancestor
111172644|NCT01597557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111172645|NCT01597557|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111172646|NCT01597557|Anticonvulsants|anticonvulsants|mesh-ancestor
111172647|NCT01597557|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111172648|NCT01597557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111172649|NCT01597557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111172650|NCT01597557|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111172651|NCT01597557|Tocolytic Agents|tocolytic agents|mesh-ancestor
111172652|NCT01597557|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111172653|NCT01914757|Benralizumab|benralizumab|mesh-list
111172654|NCT01914757|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111172655|NCT01914757|Respiratory System Agents|respiratory system agents|mesh-ancestor
111172656|NCT02003573|Decitabine|decitabine|mesh-list
111172657|NCT02003573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111172658|NCT02003573|Antimetabolites|antimetabolites|mesh-ancestor
111172659|NCT02003573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111172660|NCT02003573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111172661|NCT02003573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111172662|NCT01789281|Everolimus|everolimus|mesh-list
111172663|NCT01789281|Octreotide|octreotide|mesh-list
111172664|NCT01789281|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111172665|NCT01789281|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111172666|NCT01789281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111172667|NCT01789281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111172668|NCT01789281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111172669|NCT01789281|Immunologic Factors|immunologic factors|mesh-ancestor
111172670|NCT01789281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111172671|NCT01789281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111172672|NCT01789281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111172673|NCT01789281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111172674|NCT01789203|Ciprofloxacin|ciprofloxacin|mesh-list
111172675|NCT01789203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111172676|NCT01789203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111172677|NCT01789203|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111172678|NCT01789203|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111172679|NCT01789203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111172680|NCT01789203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111172681|NCT01789203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111172682|NCT01789203|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111172683|NCT01789203|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111172684|NCT01789047|Topiramate|topiramate|mesh-list
111172685|NCT01789047|Amantadine|amantadine|mesh-list
111172686|NCT01789047|Anticonvulsants|anticonvulsants|mesh-ancestor
111172687|NCT01789047|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111172688|NCT01789047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111172689|NCT01789047|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111172690|NCT01789047|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111172691|NCT01789047|Antiviral Agents|antiviral agents|mesh-ancestor
111172692|NCT01789047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111172693|NCT01789047|Dopamine Agents|dopamine agents|mesh-ancestor
111172694|NCT01789047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111172695|NCT01789047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111172696|NCT01789047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111172697|NCT01789047|Analgesics|analgesics|mesh-ancestor
111172698|NCT01789047|Sensory System Agents|sensory system agents|mesh-ancestor
111172699|NCT01789047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111172700|NCT01617187|Olanzapine|olanzapine|mesh-list
111172701|NCT01617187|Asenapine|asenapine|mesh-list
111172702|NCT01617187|Antiemetics|antiemetics|mesh-ancestor
111172703|NCT01617187|Autonomic Agents|autonomic agents|mesh-ancestor
111172704|NCT01617187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111172705|NCT01617187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111172706|NCT01617187|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111172707|NCT01617187|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111172708|NCT01617187|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111172709|NCT01617187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111172710|NCT01617187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111172711|NCT01617187|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111172712|NCT01617187|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111172713|NCT01617187|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111172714|NCT01617187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111172715|NCT01617187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111172716|NCT01617187|Serotonin Agents|serotonin agents|mesh-ancestor
111172717|NCT01759407|Epinephrine|epinephrine|mesh-list
111172718|NCT01759407|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111172719|NCT01759407|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111172720|NCT01759407|Adrenergic Agents|adrenergic agents|mesh-ancestor
111172721|NCT01759407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111172722|NCT01759407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111172723|NCT01759407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111172724|NCT01759407|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111172725|NCT01759407|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111172726|NCT01759407|Autonomic Agents|autonomic agents|mesh-ancestor
111172727|NCT01759407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111172728|NCT01759407|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111172729|NCT01759407|Respiratory System Agents|respiratory system agents|mesh-ancestor
111172730|NCT01759407|Mydriatics|mydriatics|mesh-ancestor
111172731|NCT01759407|Sympathomimetics|sympathomimetics|mesh-ancestor
111172732|NCT01759407|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111172733|NCT01787331|Itraconazole|itraconazole|mesh-list
111172734|NCT01787331|Antifungal Agents|antifungal agents|mesh-ancestor
111172735|NCT01787331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111172736|NCT01787331|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111172737|NCT01787331|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111172738|NCT01787331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111172739|NCT01787331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111172740|NCT01787331|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111172741|NCT01787331|Hormone Antagonists|hormone antagonists|mesh-ancestor
111172742|NCT01787331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111172743|NCT01787331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111172744|NCT01787331|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111172745|NCT01787097|Formoterol Fumarate|formoterol fumarate|mesh-list
111172746|NCT01787097|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
111172747|NCT01787097|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111172748|NCT01787097|Autonomic Agents|autonomic agents|mesh-ancestor
111172749|NCT01787097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111172750|NCT01787097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111172751|NCT01787097|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111172752|NCT01787097|Respiratory System Agents|respiratory system agents|mesh-ancestor
111172753|NCT01787097|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111172754|NCT01787097|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111172755|NCT01787097|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111172756|NCT01787097|Adrenergic Agents|adrenergic agents|mesh-ancestor
111172757|NCT01787097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111172758|NCT01787097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111172759|NCT01757691|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
111172760|NCT01757691|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
111172761|NCT01757691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111172762|NCT01757691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111172763|NCT01757691|Immunologic Factors|immunologic factors|mesh-ancestor
111172764|NCT01757691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111172765|NCT01786707|Metformin|metformin|mesh-list
111172766|NCT01786707|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111172767|NCT01786707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111172768|NCT01786551|Eplerenone|eplerenone|mesh-list
111172769|NCT01786551|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
111172770|NCT01786551|Hormone Antagonists|hormone antagonists|mesh-ancestor
111172771|NCT01786551|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111172772|NCT01786551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111172773|NCT01786551|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
111172774|NCT01786551|Diuretics|diuretics|mesh-ancestor
111172775|NCT01786551|Natriuretic Agents|natriuretic agents|mesh-ancestor
111172776|NCT01786551|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111172777|NCT01973569|Denosumab|denosumab|mesh-list
111172778|NCT01973569|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111172779|NCT01973569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111172780|NCT01951586|Zoledronic Acid|zoledronic acid|mesh-list
111172781|NCT01951586|Denosumab|denosumab|mesh-list
111172782|NCT01951586|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111172783|NCT01951586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111172784|NCT04643678|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
111172785|NCT04643678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111172786|NCT04641728|Pembrolizumab|pembrolizumab|mesh-list
111172787|NCT04641728|Olaparib|olaparib|mesh-list
111172788|NCT04641728|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111172789|NCT04641728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111172790|NCT04641728|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111172791|NCT04641728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111172792|NCT04641728|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111172793|NCT04641728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111172794|NCT01756833|Doxycycline|doxycycline|mesh-list
111172795|NCT01756833|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111172796|NCT01756833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111172797|NCT01756833|Antimalarials|antimalarials|mesh-ancestor
111172798|NCT01756833|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111172799|NCT01756833|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111172800|NCT01785615|Atorvastatin|atorvastatin|mesh-list
111172801|NCT01785615|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111172802|NCT01785615|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111172803|NCT01785615|Antimetabolites|antimetabolites|mesh-ancestor
111172804|NCT01785615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111172805|NCT01785615|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111172806|NCT01785615|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111172807|NCT01785615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111172808|NCT01784523|Hydroxychloroquine|hydroxychloroquine|mesh-list
111172809|NCT01784523|Antimalarials|antimalarials|mesh-ancestor
111172810|NCT01784523|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111172811|NCT01784523|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111172812|NCT01784523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111172813|NCT01784523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111172814|NCT01784523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111172815|NCT01784523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111172816|NCT01784211|Insulin Glargine|insulin glargine|mesh-list
111172817|NCT01784211|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111172818|NCT01784211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111172819|NCT01783821|Budesonide|budesonide|mesh-list
111172820|NCT01783821|Formoterol Fumarate|formoterol fumarate|mesh-list
111172821|NCT01783821|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111172822|NCT01783821|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111172823|NCT01783821|Autonomic Agents|autonomic agents|mesh-ancestor
111172824|NCT01783821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111172825|NCT01783821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111172826|NCT01783821|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111172827|NCT01783821|Respiratory System Agents|respiratory system agents|mesh-ancestor
111172828|NCT01783821|Glucocorticoids|glucocorticoids|mesh-ancestor
111172829|NCT01783821|Hormones|hormones|mesh-ancestor
111172830|NCT01783821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111172831|NCT01783821|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111172832|NCT01783821|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111172833|NCT01783821|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111172834|NCT01783821|Adrenergic Agents|adrenergic agents|mesh-ancestor
111172835|NCT01783821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111172836|NCT01783821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111172837|NCT01608087|Bevacizumab|bevacizumab|mesh-list
111172838|NCT01608087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111172839|NCT01608087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111172840|NCT01608087|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111172841|NCT01608087|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111172842|NCT01608087|Growth Substances|growth substances|mesh-ancestor
111172843|NCT01608087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111172844|NCT01608087|Growth Inhibitors|growth inhibitors|mesh-ancestor
111172845|NCT01912963|Trastuzumab|trastuzumab|mesh-list
111172846|NCT01912963|Pertuzumab|pertuzumab|mesh-list
111172847|NCT01912963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111172848|NCT01912963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111172849|NCT01912807|Ondansetron|ondansetron|mesh-list
111172850|NCT01912807|Antiemetics|antiemetics|mesh-ancestor
111172851|NCT01912807|Autonomic Agents|autonomic agents|mesh-ancestor
111172852|NCT01912807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111172853|NCT01912807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111172854|NCT01912807|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111172855|NCT01912807|Antipruritics|antipruritics|mesh-ancestor
111172856|NCT01912807|Dermatologic Agents|dermatologic agents|mesh-ancestor
111172857|NCT01912807|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111172858|NCT01912807|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111172859|NCT01912807|Serotonin Agents|serotonin agents|mesh-ancestor
111172860|NCT01912807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111172861|NCT01912807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111172862|NCT01782885|Acetaminophen|acetaminophen|mesh-list
111172863|NCT01782885|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111172864|NCT01782885|Analgesics|analgesics|mesh-ancestor
111172865|NCT01782885|Sensory System Agents|sensory system agents|mesh-ancestor
111172866|NCT01782885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111172867|NCT01782885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111172868|NCT01782885|Antipyretics|antipyretics|mesh-ancestor
111172869|NCT01754493|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
111172870|NCT01754493|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111172871|NCT01754493|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111172872|NCT01754493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111172873|NCT01754493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111172874|NCT01754493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111172875|NCT01754493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111172877|NCT01754493|Sensory System Agents|sensory system agents|mesh-ancestor
111172878|NCT01754493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111172879|NCT01754493|Antidepressive Agents|antidepressive agents|mesh-ancestor
111172880|NCT01754493|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111172881|NCT01754493|Dopamine Agents|dopamine agents|mesh-ancestor
111172882|NCT01972789|Ranibizumab|ranibizumab|mesh-list
111172883|NCT01972789|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111172884|NCT01972789|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111172885|NCT01972789|Growth Substances|growth substances|mesh-ancestor
111172886|NCT01972789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110890026|NCT05654090|Cefoperazone|cefoperazone|mesh-list
111172887|NCT01972789|Growth Inhibitors|growth inhibitors|mesh-ancestor
111172888|NCT01972789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111172889|NCT01910389|Tadalafil|tadalafil|mesh-list
111172890|NCT01910389|Vasodilator Agents|vasodilator agents|mesh-ancestor
111172891|NCT01910389|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111172892|NCT01910389|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111172893|NCT01910389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111172894|NCT01910389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111172895|NCT01910389|Urological Agents|urological agents|mesh-ancestor
111172896|NCT01970995|Menthol|menthol|mesh-list
111172897|NCT01970995|Antipruritics|antipruritics|mesh-ancestor
111172898|NCT01970995|Dermatologic Agents|dermatologic agents|mesh-ancestor
111172899|NCT01970527|Ipilimumab|ipilimumab|mesh-list
111172900|NCT01970527|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111172901|NCT01970527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111172902|NCT01970527|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111172903|NCT01970527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111172904|NCT01408576|Epratuzumab|epratuzumab|mesh-list
111172905|NCT01408576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111172906|NCT01408576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111172907|NCT01427920|Insulin Aspart|insulin aspart|mesh-list
111172908|NCT01427920|Biphasic Insulins|biphasic insulins|mesh-list
111172909|NCT01427920|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
111172910|NCT01427920|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111172911|NCT01427920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111172912|NCT01427608|Olanzapine|olanzapine|mesh-list
111172913|NCT01427608|Sertraline|sertraline|mesh-list
111172914|NCT01427608|Antiemetics|antiemetics|mesh-ancestor
111172915|NCT01427608|Autonomic Agents|autonomic agents|mesh-ancestor
111172916|NCT01427608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111172917|NCT01427608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111172918|NCT01427608|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111172919|NCT01427608|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111172920|NCT01427608|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111172921|NCT01427608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111172922|NCT01427608|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111172923|NCT01427608|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111172924|NCT01427608|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111172925|NCT01427608|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111172926|NCT01427608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111172927|NCT01427608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111172928|NCT01427608|Serotonin Agents|serotonin agents|mesh-ancestor
111172929|NCT01427608|Antidepressive Agents|antidepressive agents|mesh-ancestor
111172930|NCT01408030|Bevacizumab|bevacizumab|mesh-list
111172931|NCT01408030|Tranexamic Acid|tranexamic acid|mesh-list
111172932|NCT01408030|Endothelial Growth Factors|endothelial growth factors|mesh-list
111172933|NCT01408030|Estrogens|estrogens|mesh-list
111172934|NCT01408030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111172935|NCT01408030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111172936|NCT01408030|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111172937|NCT01408030|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111172938|NCT01408030|Growth Substances|growth substances|mesh-ancestor
111172939|NCT01408030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111172940|NCT01408030|Growth Inhibitors|growth inhibitors|mesh-ancestor
111172941|NCT01408030|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111172942|NCT01408030|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111172943|NCT01408030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111172944|NCT01408030|Hemostatics|hemostatics|mesh-ancestor
111172945|NCT01408030|Coagulants|coagulants|mesh-ancestor
111172946|NCT01408030|Hormones|hormones|mesh-ancestor
111172947|NCT01408030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111172948|NCT02985424|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
111172949|NCT02985424|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111172950|NCT02985424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111172951|NCT01897532|Linagliptin|linagliptin|mesh-list
111172952|NCT01897532|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111172953|NCT01897532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111172954|NCT01897532|Incretins|incretins|mesh-ancestor
111172955|NCT01897532|Hormones|hormones|mesh-ancestor
111172956|NCT01897532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111172957|NCT01897532|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111172958|NCT01897532|Protease Inhibitors|protease inhibitors|mesh-ancestor
111172959|NCT01897532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111172960|NCT01897532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111172961|NCT04641026|Deuterium Oxide|deuterium oxide|mesh-list
111172962|NCT04641026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111172963|NCT04641026|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111172964|NCT04641026|Protective Agents|protective agents|mesh-ancestor
111172965|NCT04641026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111172966|NCT04173416|Analgesics, Opioid|analgesics, opioid|mesh-list
111172967|NCT04173416|Narcotics|narcotics|mesh-ancestor
111172968|NCT04173416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111172969|NCT04173416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111172970|NCT04173416|Analgesics|analgesics|mesh-ancestor
110487745|NCT05972928|Incretins|incretins|mesh-ancestor
111172971|NCT04173416|Sensory System Agents|sensory system agents|mesh-ancestor
111172972|NCT04173416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111172973|NCT01896128|Modafinil|modafinil|mesh-list
111172974|NCT01896128|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111172975|NCT01896128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111172976|NCT01896128|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
111172977|NCT01896128|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111172978|NCT01896128|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111172979|NCT01896128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111172980|NCT01949870|Gemcitabine|gemcitabine|mesh-list
111172981|NCT01949870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111172982|NCT01949870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111172983|NCT01949870|Antimetabolites|antimetabolites|mesh-ancestor
111172984|NCT01949870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111172985|NCT01922258|Brexpiprazole|brexpiprazole|mesh-list
111172986|NCT01922258|Serotonin Agents|serotonin agents|mesh-ancestor
111172987|NCT01922258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111172988|NCT01922258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111172989|NCT01922258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111172990|NCT01922258|Dopamine Agonists|dopamine agonists|mesh-ancestor
111172991|NCT01922258|Dopamine Agents|dopamine agents|mesh-ancestor
111172992|NCT01406938|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111172993|NCT01406938|Immunologic Factors|immunologic factors|mesh-ancestor
111172994|NCT01406938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111172995|NCT01405924|Dexamethasone|dexamethasone|mesh-list
111172996|NCT01405924|Fosaprepitant|fosaprepitant|mesh-list
111172997|NCT01405924|Aprepitant|aprepitant|mesh-list
111172998|NCT01405924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111172999|NCT01405924|Antiemetics|antiemetics|mesh-ancestor
111173000|NCT01405924|Autonomic Agents|autonomic agents|mesh-ancestor
111173001|NCT01405924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111173002|NCT01405924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111173003|NCT01405924|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111173004|NCT01405924|Glucocorticoids|glucocorticoids|mesh-ancestor
111173005|NCT01405924|Hormones|hormones|mesh-ancestor
111173006|NCT01405924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111173007|NCT01405924|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111173008|NCT01405924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111173009|NCT01405924|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
111173010|NCT01405924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111173011|NCT01405924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111173013|NCT01426438|Niacin|niacin|mesh-list
111173014|NCT01426438|Fenofibrate|fenofibrate|mesh-list
111173015|NCT01426438|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111173016|NCT01426438|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111173017|NCT01426438|Analgesics|analgesics|mesh-ancestor
111173018|NCT01426438|Sensory System Agents|sensory system agents|mesh-ancestor
111173019|NCT01426438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111173020|NCT01426438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111173021|NCT01426438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111173022|NCT01426438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111173023|NCT01426438|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111173024|NCT01426438|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111173025|NCT01426438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111173026|NCT01426438|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111173027|NCT01426438|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111173028|NCT01426438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111173029|NCT01426438|Antipyretics|antipyretics|mesh-ancestor
111173030|NCT01426438|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111173031|NCT01426438|Antimetabolites|antimetabolites|mesh-ancestor
111173032|NCT01426438|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111173033|NCT01426438|Vasodilator Agents|vasodilator agents|mesh-ancestor
111173034|NCT01426438|Vitamin B Complex|vitamin b complex|mesh-ancestor
111173035|NCT01426438|Vitamins|vitamins|mesh-ancestor
111173036|NCT01426438|Micronutrients|micronutrients|mesh-ancestor
111173037|NCT01782495|Ritonavir|ritonavir|mesh-list
111173038|NCT01782495|Ribavirin|ribavirin|mesh-list
110487767|NCT05972902|Progestins|progestins|mesh-ancestor
111173039|NCT01782495|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111173040|NCT01782495|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111173041|NCT01782495|Protease Inhibitors|protease inhibitors|mesh-ancestor
111173042|NCT01782495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111173043|NCT01782495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111173044|NCT01782495|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111173045|NCT01782495|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111173046|NCT01782495|Antiviral Agents|antiviral agents|mesh-ancestor
111173047|NCT01782495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111173048|NCT01782495|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111173049|NCT01782495|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111173050|NCT01782495|Antimetabolites|antimetabolites|mesh-ancestor
111173051|NCT01922102|Ranibizumab|ranibizumab|mesh-list
111173052|NCT01922102|Verteporfin|verteporfin|mesh-list
111173053|NCT01922102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111173054|NCT01922102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111173055|NCT01922102|Growth Substances|growth substances|mesh-ancestor
111173056|NCT01922102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111173057|NCT01922102|Growth Inhibitors|growth inhibitors|mesh-ancestor
111173058|NCT01922102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111173059|NCT01922102|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111173060|NCT01922102|Dermatologic Agents|dermatologic agents|mesh-ancestor
111173061|NCT01405768|Lidocaine|lidocaine|mesh-list
111173062|NCT01405768|Anesthetics, Local|anesthetics, local|mesh-ancestor
111173063|NCT01405768|Anesthetics|anesthetics|mesh-ancestor
111173064|NCT01405768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111173065|NCT01405768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111173066|NCT01405768|Sensory System Agents|sensory system agents|mesh-ancestor
111173067|NCT01405768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111173068|NCT01405768|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111173069|NCT01405768|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111173070|NCT01405768|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111173071|NCT01405768|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111173072|NCT01405768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111173073|NCT01913353|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
111173074|NCT01913353|Antiviral Agents|antiviral agents|mesh-ancestor
111173075|NCT01913353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111173076|NCT01754259|Ranolazine|ranolazine|mesh-list
111173077|NCT01754259|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111173078|NCT01754259|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111173079|NCT01754259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111173080|NCT01405456|Eplerenone|eplerenone|mesh-list
110843167|NCT03888677|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111173081|NCT01405456|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
111173082|NCT01405456|Hormone Antagonists|hormone antagonists|mesh-ancestor
111173083|NCT01405456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111173084|NCT01405456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111173085|NCT01405456|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
111173086|NCT01405456|Diuretics|diuretics|mesh-ancestor
111173087|NCT01405456|Natriuretic Agents|natriuretic agents|mesh-ancestor
111173088|NCT01405456|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111173089|NCT01404208|Cycloserine|cycloserine|mesh-list
111173090|NCT01404208|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111173091|NCT01404208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111173092|NCT01404208|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111173093|NCT01404208|Antitubercular Agents|antitubercular agents|mesh-ancestor
111173094|NCT01404208|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111173095|NCT01404208|Antimetabolites|antimetabolites|mesh-ancestor
111173096|NCT01404208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111173097|NCT01617668|Paclitaxel|paclitaxel|mesh-list
111173098|NCT01617668|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110487770|NCT05972785|Calcium|calcium|mesh-list
111173099|NCT01617668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111173100|NCT01617668|Tubulin Modulators|tubulin modulators|mesh-ancestor
111173101|NCT01617668|Antimitotic Agents|antimitotic agents|mesh-ancestor
111173102|NCT01617668|Mitosis Modulators|mitosis modulators|mesh-ancestor
111173103|NCT01617668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111173104|NCT01895270|Isradipine|isradipine|mesh-list
111173105|NCT01895270|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111173106|NCT01895270|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111173107|NCT01895270|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111173108|NCT01895270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111173109|NCT01895270|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111173110|NCT01895270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111173111|NCT01895270|Vasodilator Agents|vasodilator agents|mesh-ancestor
111173112|NCT01424644|Vaccines|vaccines|mesh-list
111173113|NCT01424644|Immunologic Factors|immunologic factors|mesh-ancestor
111173114|NCT01424644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111173115|NCT01403116|Methyltestosterone|methyltestosterone|mesh-list
111173116|NCT01403116|Testosterone|testosterone|mesh-list
111173117|NCT01403116|Testosterone undecanoate|testosterone undecanoate|mesh-list
111173118|NCT01403116|Testosterone enanthate|testosterone enanthate|mesh-list
111173119|NCT01403116|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
111173120|NCT01403116|Androgens|androgens|mesh-ancestor
111173121|NCT01403116|Hormones|hormones|mesh-ancestor
111173122|NCT01403116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111173123|NCT01403116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111173124|NCT01403116|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111173125|NCT01403116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111173126|NCT01403116|Anabolic Agents|anabolic agents|mesh-ancestor
111173127|NCT01753401|Prednisone|prednisone|mesh-list
111173128|NCT01753401|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
111173129|NCT01753401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111173130|NCT01753401|Glucocorticoids|glucocorticoids|mesh-ancestor
111173131|NCT01753401|Hormones|hormones|mesh-ancestor
111173132|NCT01753401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111173133|NCT01753401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111173134|NCT01753401|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111173135|NCT01753401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111173136|NCT01894568|Insulin|insulin|mesh-list
111173137|NCT01894568|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111173138|NCT01894568|Insulin Glargine|insulin glargine|mesh-list
111173139|NCT01894568|Pioglitazone|pioglitazone|mesh-list
111173140|NCT01894568|Biguanides|biguanides|mesh-list
111173141|NCT01894568|Hypoglycemic Agents|hypoglycemic agents|mesh-list
111173142|NCT01894568|Meglitinide|meglitinide|mesh-list
111173143|NCT01894568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111173144|NCT01920152|Hyaluronic Acid|hyaluronic acid|mesh-list
111173145|NCT01920152|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111173146|NCT01920152|Immunologic Factors|immunologic factors|mesh-ancestor
111173147|NCT01920152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111173148|NCT01920152|Viscosupplements|viscosupplements|mesh-ancestor
111173149|NCT01920152|Protective Agents|protective agents|mesh-ancestor
111173150|NCT01752933|Guadecitabine|guadecitabine|mesh-list
111173151|NCT01752933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111173152|NCT01752855|Adalimumab|adalimumab|mesh-list
110843171|NCT03888677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111173153|NCT01752855|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111173154|NCT01752855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111173155|NCT01752855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111173156|NCT01402492|Naltrexone|naltrexone|mesh-list
111173157|NCT01402492|Buprenorphine|buprenorphine|mesh-list
111173158|NCT01402492|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
111173159|NCT01402492|Naloxone|naloxone|mesh-list
111173160|NCT01402492|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111173161|NCT01402492|Narcotics|narcotics|mesh-ancestor
111173162|NCT01402492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111173163|NCT01402492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111173164|NCT01402492|Analgesics|analgesics|mesh-ancestor
110487781|NCT05972772|Azithromycin|azithromycin|mesh-list
111173165|NCT01402492|Sensory System Agents|sensory system agents|mesh-ancestor
111173166|NCT01402492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111173167|NCT01402492|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111173168|NCT01402492|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111173169|NCT01894256|Olaparib|olaparib|mesh-list
111173170|NCT01894256|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111173171|NCT01894256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111173172|NCT01894256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111173173|NCT01894256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111173174|NCT01780935|Ranibizumab|ranibizumab|mesh-list
111173175|NCT01780935|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111173176|NCT01780935|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111173177|NCT01780935|Growth Substances|growth substances|mesh-ancestor
111173178|NCT01780935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111173179|NCT01780935|Growth Inhibitors|growth inhibitors|mesh-ancestor
111173180|NCT01780935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111173181|NCT01422538|Mannitol|mannitol|mesh-list
111173182|NCT01422538|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
111173183|NCT01422538|Diuretics|diuretics|mesh-ancestor
111173184|NCT01422538|Natriuretic Agents|natriuretic agents|mesh-ancestor
111173185|NCT01422538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111173186|NCT01422382|Diltiazem|diltiazem|mesh-list
111173187|NCT01422382|Pitavastatin|pitavastatin|mesh-list
111173188|NCT01422382|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111173189|NCT01422382|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111173190|NCT01422382|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111173191|NCT01422382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111173192|NCT01422382|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111173193|NCT01422382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111173194|NCT01422382|Vasodilator Agents|vasodilator agents|mesh-ancestor
111173195|NCT01422382|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111173196|NCT01422382|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111173197|NCT01422382|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111173198|NCT01422382|Antimetabolites|antimetabolites|mesh-ancestor
111173199|NCT01422382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111173200|NCT01422382|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111173201|NCT01401322|Lenalidomide|lenalidomide|mesh-list
111173202|NCT01401322|Immunologic Factors|immunologic factors|mesh-ancestor
111173203|NCT01401322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111173204|NCT01401322|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111173205|NCT01401322|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111173206|NCT01401322|Growth Substances|growth substances|mesh-ancestor
111173207|NCT01401322|Growth Inhibitors|growth inhibitors|mesh-ancestor
111173208|NCT01401322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111173209|NCT01401010|Doripenem|doripenem|mesh-list
111173210|NCT01401010|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111173211|NCT01401010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111173212|NCT01400932|Benzoyl Peroxide|benzoyl peroxide|mesh-list
111173213|NCT01400932|Dermatologic Agents|dermatologic agents|mesh-ancestor
111173214|NCT01890746|Cytarabine|cytarabine|mesh-list
111173215|NCT01890746|Daunorubicin|daunorubicin|mesh-list
111173216|NCT01890746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111173217|NCT01890746|Antimetabolites|antimetabolites|mesh-ancestor
111173218|NCT01890746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111173219|NCT01890746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111173220|NCT01890746|Antiviral Agents|antiviral agents|mesh-ancestor
111173221|NCT01890746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111173222|NCT01890746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111173223|NCT01890746|Immunologic Factors|immunologic factors|mesh-ancestor
111173224|NCT01890746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111173225|NCT01890746|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111173226|NCT01890746|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111173227|NCT01890746|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111173228|NCT01890746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111173229|NCT01422304|Atropine|atropine|mesh-list
111173230|NCT01422304|Glycopyrrolate|glycopyrrolate|mesh-list
111173231|NCT01422304|Neostigmine|neostigmine|mesh-list
111173232|NCT01422304|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111173233|NCT01422304|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111173234|NCT01422304|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111173235|NCT01422304|Autonomic Agents|autonomic agents|mesh-ancestor
111173236|NCT01422304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111173237|NCT01422304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111173238|NCT01422304|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111173239|NCT01422304|Respiratory System Agents|respiratory system agents|mesh-ancestor
111173240|NCT01422304|Mydriatics|mydriatics|mesh-ancestor
111173241|NCT01422304|Parasympatholytics|parasympatholytics|mesh-ancestor
111173242|NCT01422304|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111173243|NCT01422304|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111173244|NCT01422304|Cholinergic Agents|cholinergic agents|mesh-ancestor
111173245|NCT01422304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111173246|NCT01422304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111173247|NCT01422304|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111173248|NCT01422304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111173249|NCT01422304|Parasympathomimetics|parasympathomimetics|mesh-ancestor
111173250|NCT01387516|Nicotine|nicotine|mesh-list
111173251|NCT01387516|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111173252|NCT01387516|Autonomic Agents|autonomic agents|mesh-ancestor
111173253|NCT01387516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111173254|NCT01387516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111173255|NCT01387516|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111173256|NCT01387516|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111173257|NCT01387516|Cholinergic Agents|cholinergic agents|mesh-ancestor
111173258|NCT01387516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111173259|NCT01387516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111173260|NCT01421134|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
110890401|NCT02060006|Analgesics|analgesics|mesh-ancestor
111173261|NCT01421134|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111173262|NCT01421134|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111173263|NCT01421134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111173264|NCT01421134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111173265|NCT01421134|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111173266|NCT01421134|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
111173267|NCT01421134|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111173268|NCT01421134|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111173269|NCT01421134|Adrenergic Agents|adrenergic agents|mesh-ancestor
111173270|NCT01421134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111173271|NCT01421134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111173272|NCT01421134|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111173273|NCT01421134|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111173274|NCT01421134|Serotonin Agents|serotonin agents|mesh-ancestor
111173275|NCT01421134|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111173276|NCT01421134|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111173278|NCT01894022|Ambrisentan|ambrisentan|mesh-list
111173279|NCT01894022|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111173280|NCT01386970|Lamivudine|lamivudine|mesh-list
111173281|NCT01386970|Zidovudine|zidovudine|mesh-list
111173282|NCT01386970|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
111173283|NCT01386970|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111173284|NCT01386970|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111173285|NCT01386970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111173286|NCT01386970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111173287|NCT01386970|Antiviral Agents|antiviral agents|mesh-ancestor
111173288|NCT01386970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111173289|NCT01386970|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111173290|NCT01386970|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111173291|NCT01386970|Antimetabolites|antimetabolites|mesh-ancestor
111173292|NCT01385566|Vaccines|vaccines|mesh-list
111173293|NCT01385566|Immunologic Factors|immunologic factors|mesh-ancestor
111173294|NCT01385566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111173295|NCT05365984|Carbon Monoxide|carbon monoxide|mesh-list
111173296|NCT05365984|Antimetabolites|antimetabolites|mesh-ancestor
111173297|NCT05365984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111173298|NCT05365984|Gasotransmitters|gasotransmitters|mesh-ancestor
111173299|NCT05365984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111173300|NCT05365984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111173301|NCT01780545|Docetaxel|docetaxel|mesh-list
111173302|NCT01780545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111173303|NCT01780545|Tubulin Modulators|tubulin modulators|mesh-ancestor
111173304|NCT01780545|Antimitotic Agents|antimitotic agents|mesh-ancestor
111173305|NCT01780545|Mitosis Modulators|mitosis modulators|mesh-ancestor
111173306|NCT01780545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111173307|NCT01780389|Milnacipran|milnacipran|mesh-list
111173308|NCT01780389|Levomilnacipran|levomilnacipran|mesh-list
111173309|NCT01780389|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111173310|NCT01780389|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111173311|NCT01780389|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111173312|NCT01780389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111173313|NCT01780389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111173314|NCT01780389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111173315|NCT01780389|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111173316|NCT01780389|Analgesics|analgesics|mesh-ancestor
111173317|NCT01780389|Sensory System Agents|sensory system agents|mesh-ancestor
111173318|NCT01780389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111173319|NCT01780389|Antidepressive Agents|antidepressive agents|mesh-ancestor
111173320|NCT01780389|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111173321|NCT01778985|Estrogens|estrogens|mesh-list
111173322|NCT01778985|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
111173323|NCT01778985|Hormones|hormones|mesh-ancestor
111173324|NCT01778985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111173325|NCT01778985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111173326|NCT01865084|Tadalafil|tadalafil|mesh-list
111173327|NCT01865084|Vasodilator Agents|vasodilator agents|mesh-ancestor
111173328|NCT01865084|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111173329|NCT01865084|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111173330|NCT01865084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111173331|NCT01865084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111173332|NCT01865084|Urological Agents|urological agents|mesh-ancestor
111173333|NCT01385098|Calcium, Dietary|calcium, dietary|mesh-list
111173334|NCT01385098|Vitamin D|vitamin d|mesh-list
111173335|NCT01385098|Ergocalciferols|ergocalciferols|mesh-list
111173336|NCT01385098|Cholecalciferol|cholecalciferol|mesh-list
111173337|NCT01385098|Vitamins|vitamins|mesh-list
111173338|NCT01385098|Calcium|calcium|mesh-list
111173339|NCT01385098|Micronutrients|micronutrients|mesh-ancestor
111173340|NCT01385098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111173341|NCT01385098|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111173342|NCT01385098|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111173343|NCT01398514|Escitalopram|escitalopram|mesh-list
111173344|NCT01398514|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110843200|NCT03912389|Carboplatin|carboplatin|mesh-list
111173345|NCT01398514|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111173346|NCT01398514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111173347|NCT01398514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111173348|NCT01398514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111173349|NCT01398514|Serotonin Agents|serotonin agents|mesh-ancestor
111173350|NCT01398514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111173351|NCT03025282|Betamethasone|betamethasone|mesh-list
111173352|NCT03025282|Betamethasone Valerate|betamethasone valerate|mesh-list
111173353|NCT03025282|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111173354|NCT03025282|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111173355|NCT03025282|Glucocorticoids|glucocorticoids|mesh-ancestor
111173356|NCT03025282|Hormones|hormones|mesh-ancestor
111173357|NCT03025282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111173358|NCT03025282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111173359|NCT03025282|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111173360|NCT03025282|Respiratory System Agents|respiratory system agents|mesh-ancestor
111173361|NCT01778049|Empagliflozin|empagliflozin|mesh-list
111173362|NCT01778049|Linagliptin|linagliptin|mesh-list
111173363|NCT01778049|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111173364|NCT01778049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111173365|NCT01778049|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111173366|NCT01778049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111173367|NCT01778049|Incretins|incretins|mesh-ancestor
111173368|NCT01778049|Hormones|hormones|mesh-ancestor
111173369|NCT01778049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111173370|NCT01778049|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111173371|NCT01778049|Protease Inhibitors|protease inhibitors|mesh-ancestor
111173372|NCT01778049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111173373|NCT01777581|Milnacipran|milnacipran|mesh-list
111173374|NCT01777581|Levomilnacipran|levomilnacipran|mesh-list
111173375|NCT01777581|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111173376|NCT01777581|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111173377|NCT01777581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111173378|NCT01777581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111173379|NCT01777581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111173380|NCT01777581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111173381|NCT01777581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111173382|NCT01777581|Analgesics|analgesics|mesh-ancestor
111173383|NCT01777581|Sensory System Agents|sensory system agents|mesh-ancestor
111173384|NCT01777581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111173385|NCT01777581|Antidepressive Agents|antidepressive agents|mesh-ancestor
111173386|NCT01777581|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111173387|NCT01864148|Interferons|interferons|mesh-list
111173388|NCT01864148|Interferon-beta|interferon-beta|mesh-list
111173389|NCT01864148|Interferon beta-1a|interferon beta-1a|mesh-list
111173390|NCT01864148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111173391|NCT01864148|Antiviral Agents|antiviral agents|mesh-ancestor
111173392|NCT01864148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111173393|NCT01864148|Immunologic Factors|immunologic factors|mesh-ancestor
111173394|NCT01864148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111173395|NCT01864148|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111173396|NCT01890122|Metformin|metformin|mesh-list
111173397|NCT01890122|Alogliptin|alogliptin|mesh-list
111173398|NCT01890122|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111173399|NCT01890122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111173400|NCT01890122|Incretins|incretins|mesh-ancestor
111173401|NCT01890122|Hormones|hormones|mesh-ancestor
111173402|NCT01890122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111173403|NCT01890122|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111173404|NCT01890122|Protease Inhibitors|protease inhibitors|mesh-ancestor
111173405|NCT01890122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111173406|NCT01890122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111173407|NCT01397890|Budesonide|budesonide|mesh-list
111173408|NCT01397890|Formoterol Fumarate|formoterol fumarate|mesh-list
111173409|NCT01397890|Tiotropium Bromide|tiotropium bromide|mesh-list
111173410|NCT01397890|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
111173411|NCT01397890|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110843207|NCT01147757|Remifentanil|remifentanil|mesh-list
111173412|NCT01397890|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111173413|NCT01397890|Autonomic Agents|autonomic agents|mesh-ancestor
111173414|NCT01397890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111173415|NCT01397890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111173416|NCT01397890|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111173417|NCT01397890|Respiratory System Agents|respiratory system agents|mesh-ancestor
111173418|NCT01397890|Glucocorticoids|glucocorticoids|mesh-ancestor
111173419|NCT01397890|Hormones|hormones|mesh-ancestor
111173420|NCT01397890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111173421|NCT01397890|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111173422|NCT01397890|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111173423|NCT01397890|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111173424|NCT01397890|Adrenergic Agents|adrenergic agents|mesh-ancestor
111173425|NCT01397890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111173426|NCT01397890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111173427|NCT01397890|Parasympatholytics|parasympatholytics|mesh-ancestor
111173428|NCT01397890|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111173429|NCT01397890|Cholinergic Agents|cholinergic agents|mesh-ancestor
111173430|NCT01777269|Tamsulosin|tamsulosin|mesh-list
111173431|NCT01777269|Dutasteride|dutasteride|mesh-list
111173432|NCT01777269|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111173433|NCT01777269|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111173434|NCT01777269|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111173435|NCT01777269|Adrenergic Agents|adrenergic agents|mesh-ancestor
111173436|NCT01777269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111173437|NCT01777269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111173438|NCT01777269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111173439|NCT01777269|Urological Agents|urological agents|mesh-ancestor
111173440|NCT01777269|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
111173441|NCT01777269|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111173442|NCT01777269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111173443|NCT01777269|Hormone Antagonists|hormone antagonists|mesh-ancestor
111173444|NCT01777269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111173445|NCT04024696|Abexinostat|abexinostat|mesh-list
111173446|NCT04024696|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111173447|NCT04024696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111173448|NCT04024696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111173449|NCT01777191|Ixekizumab|ixekizumab|mesh-list
111173450|NCT01777191|Dermatologic Agents|dermatologic agents|mesh-ancestor
111173451|NCT01896050|Tamoxifen|tamoxifen|mesh-list
111173452|NCT01896050|Letrozole|letrozole|mesh-list
111173453|NCT01896050|Anastrozole|anastrozole|mesh-list
111173454|NCT01896050|Exemestane|exemestane|mesh-list
111173455|NCT01896050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111173456|NCT01896050|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111173457|NCT01896050|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111173458|NCT01896050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111173459|NCT01896050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111173460|NCT01896050|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111173461|NCT01896050|Hormone Antagonists|hormone antagonists|mesh-ancestor
111173462|NCT01896050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111173463|NCT01896050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111173464|NCT01896050|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111173465|NCT01896050|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111173466|NCT01896050|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111173467|NCT01896050|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111173468|NCT01775787|Menthol|menthol|mesh-list
111173469|NCT01775787|Nicotine|nicotine|mesh-list
111173470|NCT01775787|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111173471|NCT01775787|Autonomic Agents|autonomic agents|mesh-ancestor
111173472|NCT01775787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111173473|NCT01775787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111173474|NCT01775787|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111173475|NCT01775787|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111173476|NCT01775787|Cholinergic Agents|cholinergic agents|mesh-ancestor
111173477|NCT01775787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111173478|NCT01775787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111173479|NCT01775787|Antipruritics|antipruritics|mesh-ancestor
111173480|NCT01775787|Dermatologic Agents|dermatologic agents|mesh-ancestor
111173482|NCT01775475|Cyclophosphamide|cyclophosphamide|mesh-list
111173483|NCT01775475|Lomustine|lomustine|mesh-list
111173484|NCT01775475|Doxorubicin|doxorubicin|mesh-list
111173485|NCT01775475|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111173486|NCT01775475|Etoposide|etoposide|mesh-list
111173487|NCT01775475|Vincristine|vincristine|mesh-list
111173488|NCT01775475|Etoposide phosphate|etoposide phosphate|mesh-list
111173489|NCT01775475|Procarbazine|procarbazine|mesh-list
111173490|NCT01775475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111173491|NCT01775475|Immunologic Factors|immunologic factors|mesh-ancestor
111173492|NCT01775475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111173493|NCT01775475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111173494|NCT01775475|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111173495|NCT01775475|Alkylating Agents|alkylating agents|mesh-ancestor
111173496|NCT01775475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111173497|NCT01775475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111173498|NCT01775475|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111173499|NCT01775475|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111173500|NCT01775475|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111173501|NCT01775475|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111173502|NCT01775475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111173503|NCT01775475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111173504|NCT01775475|Glucocorticoids|glucocorticoids|mesh-ancestor
111173505|NCT01775475|Hormones|hormones|mesh-ancestor
111173506|NCT01775475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111173507|NCT01775475|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111173508|NCT01775475|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111173509|NCT01775475|Tubulin Modulators|tubulin modulators|mesh-ancestor
111173510|NCT01775475|Antimitotic Agents|antimitotic agents|mesh-ancestor
111173511|NCT01775475|Mitosis Modulators|mitosis modulators|mesh-ancestor
111173512|NCT01774929|Fentanyl|fentanyl|mesh-list
111173513|NCT01774929|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111173514|NCT01774929|Narcotics|narcotics|mesh-ancestor
111173515|NCT01774929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111173516|NCT01774929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111173517|NCT01774929|Analgesics|analgesics|mesh-ancestor
111173518|NCT01774929|Sensory System Agents|sensory system agents|mesh-ancestor
111173519|NCT01774929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111173520|NCT01774929|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111173521|NCT01774929|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111173522|NCT01774929|Anesthetics, General|anesthetics, general|mesh-ancestor
111173523|NCT01774929|Anesthetics|anesthetics|mesh-ancestor
111173524|NCT01774305|Dexmedetomidine|dexmedetomidine|mesh-list
111173525|NCT01774305|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111173526|NCT01774305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111173527|NCT01774305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111173528|NCT01774305|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111173529|NCT01774305|Analgesics|analgesics|mesh-ancestor
111173530|NCT01774305|Sensory System Agents|sensory system agents|mesh-ancestor
111173531|NCT01774305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111173532|NCT01774305|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111173533|NCT01774305|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111173534|NCT01774305|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111173535|NCT01774305|Adrenergic Agents|adrenergic agents|mesh-ancestor
111173536|NCT01774305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111173537|NCT01774305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111173538|NCT01397422|Amantadine|amantadine|mesh-list
111173539|NCT01397422|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111173540|NCT01397422|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111173541|NCT01397422|Antiviral Agents|antiviral agents|mesh-ancestor
111173542|NCT01397422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111173543|NCT01397422|Dopamine Agents|dopamine agents|mesh-ancestor
111173544|NCT01397422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111173545|NCT01397422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111173546|NCT01397422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111173547|NCT01397422|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111173548|NCT01397422|Analgesics|analgesics|mesh-ancestor
111173549|NCT01397422|Sensory System Agents|sensory system agents|mesh-ancestor
111173550|NCT01397422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111173551|NCT01736475|Factor VIII|factor viii|mesh-list
111173553|NCT01736475|Coagulants|coagulants|mesh-ancestor
111173554|NCT01863680|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
111173555|NCT01863680|Hormones|hormones|mesh-list
111173556|NCT01863680|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
111173557|NCT01863680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111173558|NCT01863680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111173559|NCT01863680|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111173560|NCT01747629|Albuterol|albuterol|mesh-list
111173561|NCT01747629|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111173562|NCT01747629|Autonomic Agents|autonomic agents|mesh-ancestor
111173563|NCT01747629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111173564|NCT01747629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111173565|NCT01747629|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111173566|NCT01747629|Respiratory System Agents|respiratory system agents|mesh-ancestor
111173567|NCT01747629|Tocolytic Agents|tocolytic agents|mesh-ancestor
111173568|NCT01747629|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111173569|NCT01747629|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111173570|NCT01747629|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111173571|NCT01747629|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111173572|NCT01747629|Adrenergic Agents|adrenergic agents|mesh-ancestor
111173573|NCT01747629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111173574|NCT01747629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111173575|NCT01863368|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111173576|NCT01863368|Lubricant Eye Drops|lubricant eye drops|mesh-list
111173577|NCT01863368|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111173578|NCT01886690|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
111173579|NCT01886690|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111173580|NCT01886690|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111173581|NCT01886690|Laxatives|laxatives|mesh-ancestor
111173582|NCT01886690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111173583|NCT01885208|Exenatide|exenatide|mesh-list
111173584|NCT01885208|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111173585|NCT01885208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111173586|NCT01885208|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111173587|NCT01885208|Incretins|incretins|mesh-ancestor
111173588|NCT01885208|Hormones|hormones|mesh-ancestor
111173589|NCT01885208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111173590|NCT01859702|Moxifloxacin|moxifloxacin|mesh-list
111173591|NCT01859702|Dexamethasone|dexamethasone|mesh-list
111173592|NCT01859702|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111173593|NCT01859702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111173594|NCT01859702|Antiemetics|antiemetics|mesh-ancestor
111173595|NCT01859702|Autonomic Agents|autonomic agents|mesh-ancestor
111173596|NCT01859702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111173597|NCT01859702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111173598|NCT01859702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111173599|NCT01859702|Glucocorticoids|glucocorticoids|mesh-ancestor
111173600|NCT01859702|Hormones|hormones|mesh-ancestor
111173601|NCT01859702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111173602|NCT01859702|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111173603|NCT01859702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111173604|NCT01859702|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111173605|NCT01859702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111173606|NCT01859702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111173607|NCT01859702|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111173608|NCT01859702|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111173609|NCT01859702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111173610|NCT01859702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111173611|NCT01747551|Leucovorin|leucovorin|mesh-list
111173612|NCT01747551|Fluorouracil|fluorouracil|mesh-list
111173613|NCT01747551|Oxaliplatin|oxaliplatin|mesh-list
111173614|NCT01747551|Aflibercept|aflibercept|mesh-list
111173615|NCT01747551|Antimetabolites|antimetabolites|mesh-ancestor
111173616|NCT01747551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111173617|NCT01747551|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111173618|NCT01747551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111173619|NCT01747551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111173620|NCT01747551|Immunologic Factors|immunologic factors|mesh-ancestor
111173621|NCT01747551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111173622|NCT01747551|Antidotes|antidotes|mesh-ancestor
111173623|NCT01747551|Protective Agents|protective agents|mesh-ancestor
111173624|NCT01747551|Vitamin B Complex|vitamin b complex|mesh-ancestor
111173625|NCT01747551|Vitamins|vitamins|mesh-ancestor
111173626|NCT01747551|Micronutrients|micronutrients|mesh-ancestor
111173627|NCT01747551|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111173628|NCT01747551|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111173629|NCT01747551|Growth Substances|growth substances|mesh-ancestor
111173630|NCT01747551|Growth Inhibitors|growth inhibitors|mesh-ancestor
111173631|NCT01859390|Antioxidants|antioxidants|mesh-list
111173632|NCT01859390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111173633|NCT01859390|Protective Agents|protective agents|mesh-ancestor
111173634|NCT01859390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111173635|NCT01858766|Ribavirin|ribavirin|mesh-list
110890777|NCT03615768|Clindamycin|clindamycin|mesh-list
111173636|NCT01858766|Antiviral Agents|antiviral agents|mesh-ancestor
111173637|NCT01858766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111173638|NCT01858766|Antimetabolites|antimetabolites|mesh-ancestor
111173639|NCT01858766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111173640|NCT01745367|Paclitaxel|paclitaxel|mesh-list
111173641|NCT01745367|Tivozanib|tivozanib|mesh-list
111173642|NCT01745367|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111173643|NCT01745367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111173644|NCT01745367|Tubulin Modulators|tubulin modulators|mesh-ancestor
111173645|NCT01745367|Antimitotic Agents|antimitotic agents|mesh-ancestor
111173646|NCT01745367|Mitosis Modulators|mitosis modulators|mesh-ancestor
111173647|NCT01745367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111173648|NCT01745367|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111173649|NCT01745367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111173650|NCT01733121|Tetrabenazine|tetrabenazine|mesh-list
111173651|NCT01733121|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111173652|NCT01733121|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111173653|NCT01733121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111173654|NCT01733121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111173655|NCT01733121|Adrenergic Agents|adrenergic agents|mesh-ancestor
111173656|NCT01733121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111173657|NCT01733121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111173658|NCT01383928|Dexamethasone|dexamethasone|mesh-list
111173659|NCT01383928|Lenalidomide|lenalidomide|mesh-list
111173660|NCT01383928|Ixazomib|ixazomib|mesh-list
111173661|NCT01383928|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111173662|NCT01383928|Antiemetics|antiemetics|mesh-ancestor
111173663|NCT01383928|Autonomic Agents|autonomic agents|mesh-ancestor
111173664|NCT01383928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111173665|NCT01383928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111173666|NCT01383928|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111173667|NCT01383928|Glucocorticoids|glucocorticoids|mesh-ancestor
111173668|NCT01383928|Hormones|hormones|mesh-ancestor
111173669|NCT01383928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111173670|NCT01383928|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111173671|NCT01383928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111173672|NCT01383928|Immunologic Factors|immunologic factors|mesh-ancestor
111173673|NCT01383928|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111173674|NCT01383928|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111173675|NCT01383928|Growth Substances|growth substances|mesh-ancestor
111173676|NCT01383928|Growth Inhibitors|growth inhibitors|mesh-ancestor
111173677|NCT01383928|Protease Inhibitors|protease inhibitors|mesh-ancestor
111173678|NCT01383928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111173679|NCT01383928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111173680|NCT04023604|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111173681|NCT04023604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111173682|NCT05893225|Metformin|metformin|mesh-list
111173683|NCT05893225|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111173684|NCT05893225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111173685|NCT05893147|Lactams|lactams|mesh-list
111173686|NCT05893147|Cephalosporins|cephalosporins|mesh-list
111173687|NCT05893147|beta-Lactams|beta-lactams|mesh-list
111173688|NCT05893147|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111173689|NCT05893147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111173690|NCT05893108|Triamcinolone|triamcinolone|mesh-list
111173691|NCT05893108|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
111173692|NCT05893108|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
111173693|NCT05893108|Losartan|losartan|mesh-list
111173694|NCT05893108|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
111173695|NCT05893108|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111173696|NCT05893108|Glucocorticoids|glucocorticoids|mesh-ancestor
111173697|NCT05893108|Hormones|hormones|mesh-ancestor
111173698|NCT05893108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111173699|NCT05893108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111173700|NCT05893108|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111173701|NCT05893108|Immunologic Factors|immunologic factors|mesh-ancestor
111173702|NCT05893108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111173703|NCT05893108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111173704|NCT05893108|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111173705|NCT05893108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111173706|NCT05893108|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111173707|NCT05893108|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111173708|NCT05892705|Dexmedetomidine|dexmedetomidine|mesh-list
111173709|NCT05892705|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111173710|NCT05892705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111173711|NCT05892705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111173712|NCT05892705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111173714|NCT05892705|Sensory System Agents|sensory system agents|mesh-ancestor
111173715|NCT05892705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111173716|NCT05892705|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111173717|NCT05892705|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111173718|NCT05892705|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111173719|NCT05892705|Adrenergic Agents|adrenergic agents|mesh-ancestor
111173720|NCT05892705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111173721|NCT05892705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111173722|NCT05892471|Propofol|propofol|mesh-list
111173723|NCT05892471|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111173724|NCT05892471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111173725|NCT05892471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111173726|NCT05892471|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111173727|NCT05892471|Anesthetics, General|anesthetics, general|mesh-ancestor
111173728|NCT05892471|Anesthetics|anesthetics|mesh-ancestor
111173729|NCT05892068|Tucatinib|tucatinib|mesh-list
111173730|NCT05892068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111173731|NCT05892068|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111173732|NCT05892068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111173733|NCT05892068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111173734|NCT05892042|Rivaroxaban|rivaroxaban|mesh-list
111173735|NCT05892042|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111173736|NCT05892042|Antithrombins|antithrombins|mesh-ancestor
111173737|NCT05892042|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111173738|NCT05892042|Protease Inhibitors|protease inhibitors|mesh-ancestor
111173739|NCT05892042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111173740|NCT05892042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111173741|NCT05892042|Anticoagulants|anticoagulants|mesh-ancestor
111173742|NCT05891561|Pertuzumab|pertuzumab|mesh-list
111173743|NCT05891561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111173744|NCT05891561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111173745|NCT05890118|Ustekinumab|ustekinumab|mesh-list
111173746|NCT05890118|Dermatologic Agents|dermatologic agents|mesh-ancestor
111173747|NCT05889949|Sorafenib|sorafenib|mesh-list
111173748|NCT05889949|Lenvatinib|lenvatinib|mesh-list
111173749|NCT05889949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111173750|NCT05889949|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111173751|NCT05889949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111173752|NCT05889949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111173753|NCT05887804|Triamcinolone|triamcinolone|mesh-list
111173754|NCT05887804|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
111173755|NCT05887804|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
111173756|NCT05887804|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
111173757|NCT05887804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111173758|NCT05887804|Glucocorticoids|glucocorticoids|mesh-ancestor
111173759|NCT05887804|Hormones|hormones|mesh-ancestor
110843233|NCT01154465|Povidone-Iodine|povidone-iodine|mesh-list
111173760|NCT05887804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111173761|NCT05887804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111173762|NCT05887804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111173763|NCT05887804|Immunologic Factors|immunologic factors|mesh-ancestor
111173764|NCT05887804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111173765|NCT05887804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111173766|NCT05808725|Amlodipine|amlodipine|mesh-list
111173767|NCT05808725|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111173768|NCT05808725|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111173769|NCT05808725|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111173770|NCT05808725|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111173771|NCT05808725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111173772|NCT05808725|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111173773|NCT05808725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111173774|NCT05808725|Vasodilator Agents|vasodilator agents|mesh-ancestor
111173775|NCT05792540|Dapagliflozin|dapagliflozin|mesh-list
111173776|NCT05792540|Fluoxetine|fluoxetine|mesh-list
111173777|NCT05792540|Atorvastatin|atorvastatin|mesh-list
111173778|NCT05792540|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111173779|NCT05792540|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111173780|NCT05792540|Antimetabolites|antimetabolites|mesh-ancestor
111173781|NCT05792540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111173782|NCT05792540|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111173783|NCT05792540|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111173784|NCT05792540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111173785|NCT05792540|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111173786|NCT05792540|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111173787|NCT05792540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111173788|NCT05792540|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111173789|NCT05792540|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111173790|NCT05792540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111173791|NCT05792540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111173792|NCT05792540|Serotonin Agents|serotonin agents|mesh-ancestor
111173793|NCT05792540|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111173794|NCT05792540|Antidepressive Agents|antidepressive agents|mesh-ancestor
111173795|NCT05792540|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111173796|NCT05792540|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111173797|NCT05792540|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111173798|NCT05780879|Venetoclax|venetoclax|mesh-list
111173799|NCT05780879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111173800|NCT05780307|Antibodies, Bispecific|antibodies, bispecific|mesh-list
111173801|NCT05780307|Immunologic Factors|immunologic factors|mesh-ancestor
111173802|NCT05780307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111173803|NCT05776134|Brexucabtagene autoleucel|brexucabtagene autoleucel|mesh-list
111173804|NCT05776134|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111173805|NCT05776134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111173806|NCT05746208|Pembrolizumab|pembrolizumab|mesh-list
111173807|NCT05746208|Lenvatinib|lenvatinib|mesh-list
111173808|NCT05746208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111173809|NCT05746208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111173810|NCT05746208|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111173811|NCT05746208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111173812|NCT05746208|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111173813|NCT05746208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111173814|NCT05710666|Trastuzumab|trastuzumab|mesh-list
111173815|NCT05710666|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
111173816|NCT05710666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111173817|NCT05710666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111173818|NCT05710666|Immunoconjugates|immunoconjugates|mesh-ancestor
111173819|NCT05710666|Immunologic Factors|immunologic factors|mesh-ancestor
111173820|NCT05710666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111173821|NCT05700214|Lidocaine|lidocaine|mesh-list
111173822|NCT05700214|Ropivacaine|ropivacaine|mesh-list
111173823|NCT05700214|Anesthetics, Local|anesthetics, local|mesh-ancestor
111173824|NCT05700214|Anesthetics|anesthetics|mesh-ancestor
111173825|NCT05700214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111173826|NCT05700214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111173827|NCT05700214|Sensory System Agents|sensory system agents|mesh-ancestor
110843239|NCT01260623|Glucocorticoids|glucocorticoids|mesh-ancestor
111173828|NCT05700214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111173829|NCT05700214|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111173830|NCT05700214|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111173831|NCT05700214|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111173832|NCT05700214|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111173833|NCT05700214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111173834|NCT05700045|Dexmedetomidine|dexmedetomidine|mesh-list
111173835|NCT05700045|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111173836|NCT05700045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111173837|NCT05700045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111173838|NCT05700045|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111173839|NCT05700045|Analgesics|analgesics|mesh-ancestor
111173840|NCT05700045|Sensory System Agents|sensory system agents|mesh-ancestor
111173841|NCT05700045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111173842|NCT05700045|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111173843|NCT05700045|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110437299|NCT01124604|Tapentadol|tapentadol|mesh-list
111173844|NCT05700045|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111173845|NCT05700045|Adrenergic Agents|adrenergic agents|mesh-ancestor
111173846|NCT05700045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111173847|NCT05700045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111173848|NCT05676294|Olanzapine|olanzapine|mesh-list
111173849|NCT05676294|Antiemetics|antiemetics|mesh-ancestor
111173850|NCT05676294|Autonomic Agents|autonomic agents|mesh-ancestor
111173851|NCT05676294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111173852|NCT05676294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111173853|NCT05676294|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111173854|NCT05676294|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111173855|NCT05676294|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111173856|NCT05676294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111173857|NCT05676294|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111173858|NCT05676294|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111173859|NCT05676294|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111173860|NCT05676294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111173861|NCT05676294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111173862|NCT05676294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111173864|NCT05659576|Sucralfate|sucralfate|mesh-list
111173865|NCT05659576|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111173866|NCT05659576|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111173867|NCT05638867|Aspirin|aspirin|mesh-list
111173868|NCT05638867|Rivaroxaban|rivaroxaban|mesh-list
111173869|NCT05638867|Clopidogrel|clopidogrel|mesh-list
111173870|NCT05638867|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111173871|NCT05638867|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111173872|NCT05638867|Analgesics|analgesics|mesh-ancestor
111173873|NCT05638867|Sensory System Agents|sensory system agents|mesh-ancestor
111173874|NCT05638867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111173875|NCT05638867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111173876|NCT05638867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111173877|NCT05638867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111173878|NCT05638867|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111173879|NCT05638867|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111173880|NCT05638867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111173881|NCT05638867|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111173882|NCT05638867|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111173883|NCT05638867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111173884|NCT05638867|Antipyretics|antipyretics|mesh-ancestor
111173885|NCT05638867|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111173886|NCT05638867|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111173887|NCT05638867|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111173888|NCT05638867|Purinergic Agents|purinergic agents|mesh-ancestor
111173889|NCT05638867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111173890|NCT05638867|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111173891|NCT05638867|Antithrombins|antithrombins|mesh-ancestor
111173892|NCT05638867|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111173893|NCT05638867|Protease Inhibitors|protease inhibitors|mesh-ancestor
111173894|NCT05638867|Anticoagulants|anticoagulants|mesh-ancestor
111173895|NCT05600686|Prednisone|prednisone|mesh-list
111173896|NCT05600686|Cortisone|cortisone|mesh-list
111173897|NCT05600686|Cyclophosphamide|cyclophosphamide|mesh-list
111173899|NCT05600686|Doxorubicin|doxorubicin|mesh-list
111173900|NCT05600686|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111173901|NCT05600686|Etoposide|etoposide|mesh-list
111173902|NCT05600686|Vincristine|vincristine|mesh-list
111173903|NCT05600686|Etoposide phosphate|etoposide phosphate|mesh-list
111173904|NCT05600686|Daunorubicin|daunorubicin|mesh-list
111173905|NCT05600686|Podophyllotoxin|podophyllotoxin|mesh-list
111173906|NCT05600686|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
111173907|NCT05600686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111173908|NCT05600686|Antibodies|antibodies|mesh-list
111173909|NCT05600686|Immunoglobulins|immunoglobulins|mesh-list
111173910|NCT05600686|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111173911|NCT05600686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111173912|NCT05600686|Immunologic Factors|immunologic factors|mesh-ancestor
111173913|NCT05600686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111173914|NCT05600686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111173915|NCT05600686|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111173916|NCT05600686|Alkylating Agents|alkylating agents|mesh-ancestor
110799559|NCT03752931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111173917|NCT05600686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111173918|NCT05600686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111173919|NCT05600686|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111173920|NCT05600686|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111173921|NCT05600686|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111173922|NCT05600686|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111173923|NCT05600686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111173924|NCT05600686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111173925|NCT05600686|Glucocorticoids|glucocorticoids|mesh-ancestor
111173926|NCT05600686|Hormones|hormones|mesh-ancestor
111173927|NCT05600686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111173928|NCT05600686|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111173929|NCT05600686|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111173930|NCT05600686|Tubulin Modulators|tubulin modulators|mesh-ancestor
111173931|NCT05600686|Antimitotic Agents|antimitotic agents|mesh-ancestor
110891080|NCT01343225|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111173932|NCT05600686|Mitosis Modulators|mitosis modulators|mesh-ancestor
111173934|NCT05600686|Dermatologic Agents|dermatologic agents|mesh-ancestor
111173935|NCT05585034|Pembrolizumab|pembrolizumab|mesh-list
111173936|NCT05585034|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111173937|NCT05585034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111173938|NCT05585034|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111173939|NCT05585034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111173940|NCT05564338|Tislelizumab|tislelizumab|mesh-list
111173941|NCT05564338|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111173942|NCT05564338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111173943|NCT05545384|Rituximab|rituximab|mesh-list
111173944|NCT05545384|Azathioprine|azathioprine|mesh-list
111173945|NCT05545384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111173946|NCT05545384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111173947|NCT05545384|Immunologic Factors|immunologic factors|mesh-ancestor
111173948|NCT05545384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111173949|NCT05545384|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111173950|NCT05545384|Antimetabolites|antimetabolites|mesh-ancestor
111173951|NCT05545384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111173952|NCT05545384|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111173953|NCT05545384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111173954|NCT05536284|Bisoprolol|bisoprolol|mesh-list
111173955|NCT05536284|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111173956|NCT05536284|Sympatholytics|sympatholytics|mesh-ancestor
111173957|NCT05536284|Autonomic Agents|autonomic agents|mesh-ancestor
111173958|NCT05536284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111173959|NCT05536284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111173960|NCT05536284|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
111173961|NCT05536284|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111173962|NCT05536284|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111173963|NCT05536284|Adrenergic Agents|adrenergic agents|mesh-ancestor
111173964|NCT05536284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111173965|NCT05536284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111173966|NCT05456490|Bupivacaine|bupivacaine|mesh-list
111173967|NCT05456490|Anesthetics, Local|anesthetics, local|mesh-ancestor
111173968|NCT05456490|Anesthetics|anesthetics|mesh-ancestor
111173969|NCT05456490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111173970|NCT05456490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111173971|NCT05456490|Sensory System Agents|sensory system agents|mesh-ancestor
111173972|NCT05456490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111173973|NCT05409391|Insulin|insulin|mesh-list
111173974|NCT05409391|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111173975|NCT05409391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111173976|NCT05394493|Avelumab|avelumab|mesh-list
111173977|NCT05394493|Axitinib|axitinib|mesh-list
111173978|NCT05394493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111173979|NCT05394493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111173980|NCT05394493|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111173981|NCT05394493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111173982|NCT05394493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111173983|NCT05372354|Dexamethasone|dexamethasone|mesh-list
111173984|NCT05372354|Trametinib|trametinib|mesh-list
111173985|NCT05372354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111173986|NCT05372354|Antiemetics|antiemetics|mesh-ancestor
111173987|NCT05372354|Autonomic Agents|autonomic agents|mesh-ancestor
111173988|NCT05372354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111173989|NCT05372354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111173990|NCT05372354|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111173991|NCT05372354|Glucocorticoids|glucocorticoids|mesh-ancestor
111173992|NCT05372354|Hormones|hormones|mesh-ancestor
111173993|NCT05372354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111173994|NCT05372354|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111173995|NCT05372354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111173996|NCT05372354|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111173997|NCT05372354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111173998|NCT05372354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111173999|NCT05367063|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111174000|NCT05367063|Canagliflozin|canagliflozin|mesh-list
111174001|NCT05367063|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111174002|NCT05367063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111174003|NCT05367063|Incretins|incretins|mesh-ancestor
111174004|NCT05367063|Hormones|hormones|mesh-ancestor
111174005|NCT05367063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110891162|NCT05208801|Morphine|morphine|mesh-list
111174006|NCT05367063|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111174007|NCT05367063|Protease Inhibitors|protease inhibitors|mesh-ancestor
111174008|NCT05367063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111174009|NCT05367063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111174010|NCT05367063|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111174011|NCT05358548|Paclitaxel|paclitaxel|mesh-list
111174012|NCT05358548|Carboplatin|carboplatin|mesh-list
111174013|NCT05358548|Pembrolizumab|pembrolizumab|mesh-list
111174014|NCT05358548|Fluorouracil|fluorouracil|mesh-list
111174015|NCT05358548|Pemetrexed|pemetrexed|mesh-list
111174016|NCT05358548|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111174017|NCT05358548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111174018|NCT05358548|Tubulin Modulators|tubulin modulators|mesh-ancestor
111174019|NCT05358548|Antimitotic Agents|antimitotic agents|mesh-ancestor
111174020|NCT05358548|Mitosis Modulators|mitosis modulators|mesh-ancestor
111174021|NCT05358548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111174022|NCT05358548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111174023|NCT05358548|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111174024|NCT05358548|Antimetabolites|antimetabolites|mesh-ancestor
111174025|NCT05358548|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111174026|NCT05358548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111174027|NCT05358548|Immunologic Factors|immunologic factors|mesh-ancestor
111174028|NCT05358548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111174029|NCT05358548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111174030|NCT05358548|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111174031|NCT05358548|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111174032|NCT05274477|4-Aminopyridine|4-aminopyridine|mesh-list
111174033|NCT05274477|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
111174034|NCT05274477|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110487948|NCT05963139|Morphine|morphine|mesh-list
111174035|NCT05274477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111174036|NCT05262556|Nivolumab|nivolumab|mesh-list
111174037|NCT05262556|Ipilimumab|ipilimumab|mesh-list
111174038|NCT05262556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111174039|NCT05262556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111174040|NCT05262556|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111174041|NCT05262556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111174042|NCT05244070|Cyclophosphamide|cyclophosphamide|mesh-list
111174043|NCT05244070|Fludarabine|fludarabine|mesh-list
111174044|NCT05244070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111174045|NCT05244070|Immunologic Factors|immunologic factors|mesh-ancestor
111174046|NCT05244070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111174047|NCT05244070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111174048|NCT05244070|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111174049|NCT05244070|Alkylating Agents|alkylating agents|mesh-ancestor
111174050|NCT05244070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111174051|NCT05244070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111174052|NCT05244070|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111174053|NCT05236777|Natalizumab|natalizumab|mesh-list
111174054|NCT05236777|Immunologic Factors|immunologic factors|mesh-ancestor
111174055|NCT05236777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111174056|NCT05222607|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
111174057|NCT05222607|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111174058|NCT05222607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111174059|NCT05222607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111174060|NCT05222607|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111174061|NCT05222607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111174062|NCT05222607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111174063|NCT05222607|Cholinergic Agents|cholinergic agents|mesh-ancestor
111174064|NCT05222607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111174066|NCT05205486|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111174067|NCT05205486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111174068|NCT05167409|Pembrolizumab|pembrolizumab|mesh-list
111174069|NCT05167409|Cetuximab|cetuximab|mesh-list
111174070|NCT05167409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111174071|NCT05167409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111174072|NCT05167409|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111174073|NCT05167409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111174074|NCT05161195|Tamoxifen|tamoxifen|mesh-list
111174075|NCT05161195|Letrozole|letrozole|mesh-list
111174076|NCT05161195|Fulvestrant|fulvestrant|mesh-list
111174077|NCT05161195|Anastrozole|anastrozole|mesh-list
111174078|NCT05161195|Goserelin|goserelin|mesh-list
111174079|NCT05161195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111174080|NCT05161195|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111174081|NCT05161195|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111174082|NCT05161195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111174083|NCT05161195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111174084|NCT05161195|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111174085|NCT05161195|Hormone Antagonists|hormone antagonists|mesh-ancestor
111174086|NCT05161195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111174087|NCT05161195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111174088|NCT05161195|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111174089|NCT05161195|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111174090|NCT05161195|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111174091|NCT05161195|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111174092|NCT05161195|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
111174094|NCT05096117|Analgesics|analgesics|mesh-ancestor
111174095|NCT05096117|Sensory System Agents|sensory system agents|mesh-ancestor
111174096|NCT05096117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111174097|NCT05096117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111174098|NCT05096117|GABA Modulators|gaba modulators|mesh-ancestor
111174099|NCT05096117|GABA Agents|gaba agents|mesh-ancestor
111174100|NCT05096117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111174101|NCT05096117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111174102|NCT05072093|Tenofovir|tenofovir|mesh-list
111174103|NCT05072093|Emtricitabine|emtricitabine|mesh-list
111174104|NCT05072093|Cabotegravir|cabotegravir|mesh-list
111174105|NCT05072093|Doxycycline|doxycycline|mesh-list
111174106|NCT05072093|Antiviral Agents|antiviral agents|mesh-ancestor
111174107|NCT05072093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111174108|NCT05072093|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111174109|NCT05072093|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111174110|NCT05072093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111174111|NCT05072093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111174112|NCT05072093|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111174113|NCT05072093|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111174114|NCT05072093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111174115|NCT05072093|Antimalarials|antimalarials|mesh-ancestor
111174116|NCT05072093|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111174117|NCT05072093|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111174118|NCT05072093|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111174119|NCT05072093|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111174120|NCT05047718|Vaccines|vaccines|mesh-list
111174121|NCT05047718|Immunologic Factors|immunologic factors|mesh-ancestor
111174122|NCT05047718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111174123|NCT05027633|Carboplatin|carboplatin|mesh-list
111174124|NCT05027633|Docetaxel|docetaxel|mesh-list
111174125|NCT05027633|Pembrolizumab|pembrolizumab|mesh-list
111174126|NCT05027633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111174127|NCT05027633|Tubulin Modulators|tubulin modulators|mesh-ancestor
111174128|NCT05027633|Antimitotic Agents|antimitotic agents|mesh-ancestor
111174129|NCT05027633|Mitosis Modulators|mitosis modulators|mesh-ancestor
111174130|NCT05027633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111174131|NCT05027633|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111174132|NCT05027633|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111174133|NCT04979052|Interferons|interferons|mesh-list
111174134|NCT04979052|Interferon-gamma|interferon-gamma|mesh-list
111174135|NCT04979052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111174136|NCT04979052|Antiviral Agents|antiviral agents|mesh-ancestor
111174137|NCT04979052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111174138|NCT04978584|Prednisone|prednisone|mesh-list
111174139|NCT04978584|Cortisone|cortisone|mesh-list
111174140|NCT04978584|Cyclophosphamide|cyclophosphamide|mesh-list
111174141|NCT04978584|Rituximab|rituximab|mesh-list
111174142|NCT04978584|Doxorubicin|doxorubicin|mesh-list
111174143|NCT04978584|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111174144|NCT04978584|Vincristine|vincristine|mesh-list
111174145|NCT04978584|Lenalidomide|lenalidomide|mesh-list
111174146|NCT04978584|Acalabrutinib|acalabrutinib|mesh-list
111174147|NCT04978584|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111174148|NCT04978584|Antibodies|antibodies|mesh-list
111174149|NCT04978584|Immunoglobulins|immunoglobulins|mesh-list
111174150|NCT04978584|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111174151|NCT04978584|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
111174152|NCT04978584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111174153|NCT04978584|Immunologic Factors|immunologic factors|mesh-ancestor
111174154|NCT04978584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111174155|NCT04978584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111174156|NCT04978584|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111174157|NCT04978584|Alkylating Agents|alkylating agents|mesh-ancestor
111174158|NCT04978584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111174159|NCT04978584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111174160|NCT04978584|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111174161|NCT04978584|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111174162|NCT04978584|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111174163|NCT04978584|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111174164|NCT04978584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111174165|NCT04978584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111174166|NCT04978584|Glucocorticoids|glucocorticoids|mesh-ancestor
111174167|NCT04978584|Hormones|hormones|mesh-ancestor
110799560|NCT03758235|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111174168|NCT04978584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111174169|NCT04978584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111174170|NCT04978584|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111174171|NCT04978584|Tubulin Modulators|tubulin modulators|mesh-ancestor
111174172|NCT04978584|Antimitotic Agents|antimitotic agents|mesh-ancestor
111174173|NCT04978584|Mitosis Modulators|mitosis modulators|mesh-ancestor
111174174|NCT04978584|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111174175|NCT04978584|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111174176|NCT04978584|Growth Substances|growth substances|mesh-ancestor
111174177|NCT04978584|Growth Inhibitors|growth inhibitors|mesh-ancestor
111174178|NCT04978584|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111174179|NCT04954820|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
111174180|NCT04954820|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110843262|NCT01153217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111174181|NCT04954820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111174182|NCT04950608|Psilocybin|psilocybin|mesh-list
111174183|NCT04950608|Hallucinogens|hallucinogens|mesh-ancestor
111174184|NCT04950608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111174185|NCT04950608|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111174186|NCT04940052|Trametinib|trametinib|mesh-list
111174187|NCT04940052|Dabrafenib|dabrafenib|mesh-list
111174188|NCT04940052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111174189|NCT04940052|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111174190|NCT04940052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111174191|NCT04940052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111174192|NCT04898621|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111174193|NCT04851613|Fulvestrant|fulvestrant|mesh-list
111174194|NCT04851613|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111174195|NCT04851613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111174196|NCT04851613|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
111174197|NCT04851613|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111174198|NCT04851613|Hormone Antagonists|hormone antagonists|mesh-ancestor
111174199|NCT04851613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111174200|NCT04851613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111174201|NCT04820933|Tenofovir|tenofovir|mesh-list
111174202|NCT04820933|Emtricitabine|emtricitabine|mesh-list
111174203|NCT04820933|Antiviral Agents|antiviral agents|mesh-ancestor
111174204|NCT04820933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111174205|NCT04820933|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111174206|NCT04820933|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111174207|NCT04820933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111174208|NCT04820933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111174209|NCT04820933|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111174210|NCT04820933|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111174211|NCT04677816|Vitamin D|vitamin d|mesh-list
111174212|NCT04677816|Cholecalciferol|cholecalciferol|mesh-list
111174213|NCT04677816|Vitamins|vitamins|mesh-ancestor
111174214|NCT04677816|Micronutrients|micronutrients|mesh-ancestor
111174215|NCT04677816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111174216|NCT04677816|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111174217|NCT04677816|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111174218|NCT04628026|Venetoclax|venetoclax|mesh-list
111174219|NCT04628026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111174220|NCT04605861|Liraglutide|liraglutide|mesh-list
111174221|NCT04605861|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111174222|NCT04605861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111174223|NCT04605861|Incretins|incretins|mesh-ancestor
111174224|NCT04605861|Hormones|hormones|mesh-ancestor
111174225|NCT04605861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111174226|NCT04564443|Calcium|calcium|mesh-list
111174227|NCT04564443|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111174228|NCT04564443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111174229|NCT04530630|Emtricitabine|emtricitabine|mesh-list
111174230|NCT04530630|Antiviral Agents|antiviral agents|mesh-ancestor
111174231|NCT04530630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110891381|NCT03612180|Metoprolol|metoprolol|mesh-list
111174232|NCT04530630|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111174233|NCT04530630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111174234|NCT04530630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111174235|NCT04530630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111174236|NCT04530630|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111174237|NCT04530630|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111174238|NCT04469764|Letrozole|letrozole|mesh-list
111174239|NCT04469764|Anastrozole|anastrozole|mesh-list
111174240|NCT04469764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111174241|NCT04469764|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111174242|NCT04469764|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111174243|NCT04469764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111174244|NCT04469764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111174245|NCT04469764|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111174246|NCT04469764|Hormone Antagonists|hormone antagonists|mesh-ancestor
111174247|NCT04469764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111174248|NCT04469764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111174249|NCT04469764|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111174250|NCT04439188|GSK2636771|gsk2636771|mesh-list
111174251|NCT04439188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111174252|NCT04439188|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111174253|NCT04439188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111174254|NCT04439188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111174256|NCT04439149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111174257|NCT04439149|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111174258|NCT04439149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111174259|NCT04439149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111174260|NCT04416737|Insulin|insulin|mesh-list
111174261|NCT04416737|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111174262|NCT04416737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111174263|NCT04364607|Neostigmine|neostigmine|mesh-list
111174264|NCT04364607|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111174265|NCT04364607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111174266|NCT04364607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111174267|NCT04364607|Cholinergic Agents|cholinergic agents|mesh-ancestor
111174268|NCT04364607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111174269|NCT04364607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111174270|NCT04364607|Parasympathomimetics|parasympathomimetics|mesh-ancestor
111174271|NCT04364607|Autonomic Agents|autonomic agents|mesh-ancestor
111174272|NCT04364607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111174273|NCT04348383|Defibrotide|defibrotide|mesh-list
111174274|NCT04348383|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111174275|NCT04348383|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111174276|NCT04348383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111174277|NCT04348383|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111174278|NCT04323202|Pembrolizumab|pembrolizumab|mesh-list
111174279|NCT04323202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111174280|NCT04323202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111174281|NCT04323202|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111174282|NCT04323202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111174283|NCT04305691|Ixazomib|ixazomib|mesh-list
111174284|NCT04305691|Glycine|glycine|mesh-list
111174285|NCT04305691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111174286|NCT04305691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111174287|NCT04305691|Protease Inhibitors|protease inhibitors|mesh-ancestor
111174288|NCT04305691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111174289|NCT04305691|Glycine Agents|glycine agents|mesh-ancestor
111174290|NCT04305691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111174291|NCT04305691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111174292|NCT04263792|Trimethoprim|trimethoprim|mesh-list
111174293|NCT04263792|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111174294|NCT04263792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111174295|NCT04263792|Antimalarials|antimalarials|mesh-ancestor
111174296|NCT04263792|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111174297|NCT04263792|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111174298|NCT04263792|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111174299|NCT04263792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111174300|NCT04263792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111174301|NCT04263792|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110487993|NCT05924256|Leuprolide|leuprolide|mesh-list
111174302|NCT04263792|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
111174303|NCT04263792|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110891449|NCT04192266|Estrogens|estrogens|mesh-ancestor
111174304|NCT04230564|Azacitidine|azacitidine|mesh-list
111174305|NCT04230564|Venetoclax|venetoclax|mesh-list
111174306|NCT04230564|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111174307|NCT04230564|Antimetabolites|antimetabolites|mesh-ancestor
111174308|NCT04230564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111174309|NCT04230564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111174310|NCT04230564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111174311|NCT04218409|Oxycodone|oxycodone|mesh-list
111174312|NCT04218409|Oxytocin|oxytocin|mesh-list
111174313|NCT04218409|Oxytocics|oxytocics|mesh-ancestor
111174314|NCT04218409|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111174315|NCT04218409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111174316|NCT04218409|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111174317|NCT04218409|Narcotics|narcotics|mesh-ancestor
111174318|NCT04218409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111174319|NCT04218409|Analgesics|analgesics|mesh-ancestor
111174320|NCT04218409|Sensory System Agents|sensory system agents|mesh-ancestor
111174321|NCT04218409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111174322|NCT04085172|Guanfacine|guanfacine|mesh-list
111174324|NCT04085172|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111174325|NCT04085172|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111174326|NCT04085172|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111174327|NCT04085172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111174328|NCT04085172|Adrenergic Agents|adrenergic agents|mesh-ancestor
111174329|NCT04085172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111174330|NCT04085172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111174331|NCT04085172|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111174332|NCT04085172|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111174333|NCT04085172|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111174334|NCT04085172|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111174335|NCT04081545|Analgesics, Opioid|analgesics, opioid|mesh-list
111174336|NCT04081545|Analgesics|analgesics|mesh-list
111174337|NCT04081545|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
111174338|NCT04081545|Anesthetics|anesthetics|mesh-list
111174339|NCT04081545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111174340|NCT04081545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111174341|NCT04081545|Narcotics|narcotics|mesh-ancestor
111174342|NCT04081545|Sensory System Agents|sensory system agents|mesh-ancestor
111174343|NCT04081545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111174344|NCT04076527|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
111174345|NCT04076527|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
111174346|NCT04076527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111174347|NCT04064697|Valganciclovir|valganciclovir|mesh-list
111174348|NCT04064697|Antiviral Agents|antiviral agents|mesh-ancestor
111174349|NCT04064697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111174350|NCT03980561|Varenicline|varenicline|mesh-list
111174351|NCT03980561|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111174352|NCT03980561|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111174353|NCT03980561|Cholinergic Agents|cholinergic agents|mesh-ancestor
111174354|NCT03980561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111174355|NCT03980561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111174356|NCT03980561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111174357|NCT03921424|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
111174358|NCT03921424|Immunologic Factors|immunologic factors|mesh-ancestor
111174359|NCT03921424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111174360|NCT03896230|Ketamine|ketamine|mesh-list
111174361|NCT03896230|Analgesics|analgesics|mesh-ancestor
111174362|NCT03896230|Sensory System Agents|sensory system agents|mesh-ancestor
111174363|NCT03896230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111174364|NCT03896230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111174365|NCT03896230|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111174366|NCT03896230|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111174367|NCT03896230|Anesthetics, General|anesthetics, general|mesh-ancestor
111174368|NCT03896230|Anesthetics|anesthetics|mesh-ancestor
111174369|NCT03896230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111174370|NCT03896230|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111174371|NCT03896230|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111174372|NCT03896230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111174373|NCT03896230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111174374|NCT03878316|Oxytocin|oxytocin|mesh-list
111174375|NCT03878316|Oxytocics|oxytocics|mesh-ancestor
111174376|NCT03878316|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111174377|NCT03878316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111174378|NCT03854929|Azithromycin|azithromycin|mesh-list
110891580|NCT01356043|Niacin|niacin|mesh-list
111174379|NCT03854929|Ciprofloxacin|ciprofloxacin|mesh-list
111174380|NCT03854929|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111174381|NCT03854929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111174382|NCT03854929|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111174383|NCT03854929|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111174384|NCT03854929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111174385|NCT03854929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111174386|NCT03854929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111174387|NCT03854929|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111174388|NCT03854929|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111174389|NCT03852628|Naltrexone|naltrexone|mesh-list
111174390|NCT03852628|Buprenorphine|buprenorphine|mesh-list
111174391|NCT03852628|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111174392|NCT03852628|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110843269|NCT01261169|Mycophenolic Acid|mycophenolic acid|mesh-list
111174393|NCT03852628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111174394|NCT03852628|Sensory System Agents|sensory system agents|mesh-ancestor
111174395|NCT03852628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111174396|NCT03852628|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111174397|NCT03852628|Narcotics|narcotics|mesh-ancestor
111174398|NCT03852628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111174399|NCT03852628|Analgesics|analgesics|mesh-ancestor
111174400|NCT03826524|Epinephrine|epinephrine|mesh-list
111174401|NCT03826524|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111174402|NCT03826524|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111174403|NCT03826524|Adrenergic Agents|adrenergic agents|mesh-ancestor
111174404|NCT03826524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111174405|NCT03826524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111174406|NCT03826524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111174407|NCT03826524|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111174408|NCT03826524|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111174409|NCT03826524|Autonomic Agents|autonomic agents|mesh-ancestor
111174410|NCT03826524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111174411|NCT03826524|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111174412|NCT03826524|Respiratory System Agents|respiratory system agents|mesh-ancestor
111174413|NCT03826524|Mydriatics|mydriatics|mesh-ancestor
111174414|NCT03826524|Sympathomimetics|sympathomimetics|mesh-ancestor
111174415|NCT03826524|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111174416|NCT03741426|Durvalumab|durvalumab|mesh-list
111174417|NCT03741426|Olaparib|olaparib|mesh-list
111174418|NCT03741426|Cediranib|cediranib|mesh-list
111174419|NCT03741426|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111174420|NCT03741426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111174421|NCT03741426|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111174422|NCT03741426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111174423|NCT03741426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111174424|NCT03741426|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111174425|NCT03698162|Bevacizumab|bevacizumab|mesh-list
111174426|NCT03698162|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111174427|NCT03698162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111174428|NCT03698162|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111174429|NCT03698162|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111174430|NCT03698162|Growth Substances|growth substances|mesh-ancestor
111174431|NCT03698162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111174432|NCT03698162|Growth Inhibitors|growth inhibitors|mesh-ancestor
111174433|NCT03623633|Denosumab|denosumab|mesh-list
111174434|NCT03623633|Alendronate|alendronate|mesh-list
111174435|NCT03623633|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
110437919|NCT02794402|Exenatide|exenatide|mesh-list
111174436|NCT03623633|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111174437|NCT03623633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111174438|NCT03623633|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111174439|NCT03623633|Hormone Antagonists|hormone antagonists|mesh-ancestor
111174440|NCT03623633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111174441|NCT03623633|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111174442|NCT03623633|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111174443|NCT03602976|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
111174444|NCT03602976|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
111174445|NCT03602976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111174446|NCT03554174|Psilocybin|psilocybin|mesh-list
111174447|NCT03554174|Hallucinogens|hallucinogens|mesh-ancestor
111174448|NCT03554174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111174449|NCT03554174|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111174450|NCT03508440|Prednisone|prednisone|mesh-list
111174451|NCT03508440|Prednisolone|prednisolone|mesh-list
111174452|NCT03508440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111174453|NCT03508440|Glucocorticoids|glucocorticoids|mesh-ancestor
111174454|NCT03508440|Hormones|hormones|mesh-ancestor
111174455|NCT03508440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111174456|NCT03508440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111174457|NCT03508440|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111174458|NCT03508440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111174459|NCT03474107|Paclitaxel|paclitaxel|mesh-list
111174460|NCT03474107|Docetaxel|docetaxel|mesh-list
111174461|NCT03474107|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111174462|NCT03474107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111174463|NCT03474107|Tubulin Modulators|tubulin modulators|mesh-ancestor
111174464|NCT03474107|Antimitotic Agents|antimitotic agents|mesh-ancestor
111174465|NCT03474107|Mitosis Modulators|mitosis modulators|mesh-ancestor
111174466|NCT03474107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111174467|NCT03445845|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
111174468|NCT03445845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111174469|NCT03422861|Nabilone|nabilone|mesh-list
111174470|NCT03422861|Antiemetics|antiemetics|mesh-ancestor
111174471|NCT03422861|Autonomic Agents|autonomic agents|mesh-ancestor
111174472|NCT03422861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111174473|NCT03422861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111174474|NCT03422861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111174475|NCT03422861|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111174476|NCT03422861|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111174477|NCT03422861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111174478|NCT03422861|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111174479|NCT03421496|Cannabidiol|cannabidiol|mesh-list
111174480|NCT03421496|Vigabatrin|vigabatrin|mesh-list
111174481|NCT03421496|Anticonvulsants|anticonvulsants|mesh-ancestor
111174482|NCT03421496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111174483|NCT03421496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111174484|NCT03421496|GABA Agents|gaba agents|mesh-ancestor
111174485|NCT03421496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111174486|NCT03421496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111174487|NCT03401320|Letrozole|letrozole|mesh-list
111174488|NCT03401320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111174489|NCT03401320|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111174490|NCT03401320|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111174491|NCT03401320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111174492|NCT03401320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111174493|NCT03401320|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111174494|NCT03401320|Hormone Antagonists|hormone antagonists|mesh-ancestor
111174495|NCT03401320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111174496|NCT03401320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111174497|NCT03278106|Trifluridine|trifluridine|mesh-list
111174498|NCT03278106|Antimetabolites|antimetabolites|mesh-ancestor
110488010|NCT05904470|Ruzasvir|ruzasvir|mesh-list
111174499|NCT03278106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111174500|NCT03278106|Antiviral Agents|antiviral agents|mesh-ancestor
111174501|NCT03278106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111174502|NCT03255252|Cisplatin|cisplatin|mesh-list
111174503|NCT03255252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111174504|NCT03203525|Leucovorin|leucovorin|mesh-list
111174505|NCT03203525|Sirolimus|sirolimus|mesh-list
111174506|NCT03203525|Bevacizumab|bevacizumab|mesh-list
111174507|NCT03203525|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111174508|NCT03203525|Doxorubicin|doxorubicin|mesh-list
111174509|NCT03203525|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111174510|NCT03203525|Fluorouracil|fluorouracil|mesh-list
111174511|NCT03203525|Oxaliplatin|oxaliplatin|mesh-list
111174512|NCT03203525|Temsirolimus|temsirolimus|mesh-list
111174513|NCT03203525|MTOR Inhibitors|mtor inhibitors|mesh-list
111174514|NCT03203525|Endothelial Growth Factors|endothelial growth factors|mesh-list
111174515|NCT03203525|Antibodies|antibodies|mesh-list
111174516|NCT03203525|Immunoglobulins|immunoglobulins|mesh-list
111174517|NCT03203525|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111174518|NCT03203525|Immunoglobulin G|immunoglobulin g|mesh-list
111174519|NCT03203525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111174520|NCT03203525|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111174521|NCT03203525|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111174522|NCT03203525|Growth Substances|growth substances|mesh-ancestor
111174523|NCT03203525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111174524|NCT03203525|Growth Inhibitors|growth inhibitors|mesh-ancestor
111174525|NCT03203525|Immunologic Factors|immunologic factors|mesh-ancestor
111174526|NCT03203525|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111174527|NCT03203525|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111174528|NCT03203525|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111174529|NCT03203525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111174530|NCT03203525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111174531|NCT03203525|Antimetabolites|antimetabolites|mesh-ancestor
111174532|NCT03203525|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111174533|NCT03203525|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111174534|NCT03203525|Antidotes|antidotes|mesh-ancestor
111174535|NCT03203525|Protective Agents|protective agents|mesh-ancestor
111174536|NCT03203525|Vitamin B Complex|vitamin b complex|mesh-ancestor
111174537|NCT03203525|Vitamins|vitamins|mesh-ancestor
111174538|NCT03203525|Micronutrients|micronutrients|mesh-ancestor
111174539|NCT03203525|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111174540|NCT03203525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111174541|NCT03203525|Antifungal Agents|antifungal agents|mesh-ancestor
111174542|NCT03203525|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111174543|NCT03192215|Aspirin|aspirin|mesh-list
111174544|NCT03192215|Apixaban|apixaban|mesh-list
111174545|NCT03192215|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111174546|NCT03192215|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111174547|NCT03192215|Analgesics|analgesics|mesh-ancestor
111174548|NCT03192215|Sensory System Agents|sensory system agents|mesh-ancestor
111174549|NCT03192215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111174550|NCT03192215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111174551|NCT03192215|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111174552|NCT03192215|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111174553|NCT03192215|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111174554|NCT03192215|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111174555|NCT03192215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111174556|NCT03192215|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111174557|NCT03192215|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111174558|NCT03192215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111174559|NCT03192215|Antipyretics|antipyretics|mesh-ancestor
111174560|NCT03192215|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111174561|NCT03192215|Antithrombins|antithrombins|mesh-ancestor
111174562|NCT03192215|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111174563|NCT03192215|Protease Inhibitors|protease inhibitors|mesh-ancestor
111174564|NCT03192215|Anticoagulants|anticoagulants|mesh-ancestor
111174565|NCT03118986|Olanzapine|olanzapine|mesh-list
111174566|NCT03118986|Antiemetics|antiemetics|mesh-ancestor
111174567|NCT03118986|Autonomic Agents|autonomic agents|mesh-ancestor
111174568|NCT03118986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111174569|NCT03118986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111174570|NCT03118986|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111174571|NCT03118986|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111174572|NCT03118986|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111174573|NCT03118986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111174574|NCT03118986|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111174575|NCT03118986|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111174576|NCT03118986|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111174577|NCT03118986|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111174578|NCT03118986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111174579|NCT03118986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111174580|NCT03118986|Serotonin Agents|serotonin agents|mesh-ancestor
111174581|NCT03052608|Crizotinib|crizotinib|mesh-list
111174582|NCT03052608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111174583|NCT03052608|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111174584|NCT03052608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111174585|NCT03052608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111174586|NCT02914639|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111174587|NCT02914639|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111174588|NCT02865018|Cetirizine|cetirizine|mesh-list
111174589|NCT02865018|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111174590|NCT02865018|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
111174591|NCT02865018|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111174592|NCT02865018|Histamine Antagonists|histamine antagonists|mesh-ancestor
111174593|NCT02865018|Histamine Agents|histamine agents|mesh-ancestor
111174594|NCT02865018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111174595|NCT02865018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111174596|NCT02865018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111174597|NCT02795143|Isotretinoin|isotretinoin|mesh-list
111174598|NCT02795143|Dermatologic Agents|dermatologic agents|mesh-ancestor
111174599|NCT02790736|Propranolol|propranolol|mesh-list
111174600|NCT02790736|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111174601|NCT02790736|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111174602|NCT02790736|Adrenergic Agents|adrenergic agents|mesh-ancestor
111174603|NCT02790736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111174604|NCT02790736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110604762|NCT00894712|Sulforaphane|sulforaphane|mesh-list
111174605|NCT02790736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111174606|NCT02790736|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111174607|NCT02790736|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111174608|NCT02790736|Vasodilator Agents|vasodilator agents|mesh-ancestor
111174609|NCT02773238|Deoxyglucose|deoxyglucose|mesh-list
111174610|NCT02773238|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
111174611|NCT02773238|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
111174612|NCT02773238|Technetium Tc 99m Aggregated Albumin|technetium tc 99m aggregated albumin|mesh-list
111174613|NCT02773238|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111174614|NCT02773238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111174615|NCT02773238|Antimetabolites|antimetabolites|mesh-ancestor
111174616|NCT02773238|Antiviral Agents|antiviral agents|mesh-ancestor
111174617|NCT02773238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111174618|NCT02704208|Nicotine|nicotine|mesh-list
111174619|NCT02704208|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111174620|NCT02704208|Autonomic Agents|autonomic agents|mesh-ancestor
111174621|NCT02704208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111174622|NCT02704208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111174623|NCT02704208|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111174624|NCT02704208|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111174625|NCT02704208|Cholinergic Agents|cholinergic agents|mesh-ancestor
111174626|NCT02704208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111174627|NCT02704208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111174628|NCT02553460|Leucovorin|leucovorin|mesh-list
111174629|NCT02553460|Cytarabine|cytarabine|mesh-list
111174630|NCT02553460|Dexamethasone|dexamethasone|mesh-list
111174631|NCT02553460|Hydrocortisone|hydrocortisone|mesh-list
111174632|NCT02553460|Cyclophosphamide|cyclophosphamide|mesh-list
111174633|NCT02553460|Methotrexate|methotrexate|mesh-list
111174634|NCT02553460|Etoposide|etoposide|mesh-list
111174635|NCT02553460|Vincristine|vincristine|mesh-list
111174636|NCT02553460|Bortezomib|bortezomib|mesh-list
111174637|NCT02553460|Asparaginase|asparaginase|mesh-list
111174638|NCT02553460|Mitoxantrone|mitoxantrone|mesh-list
111174639|NCT02553460|Mercaptopurine|mercaptopurine|mesh-list
111174640|NCT02553460|Vorinostat|vorinostat|mesh-list
111174641|NCT02553460|Pegaspargase|pegaspargase|mesh-list
111174642|NCT02553460|Levoleucovorin|levoleucovorin|mesh-list
111174643|NCT02553460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111174644|NCT02553460|Immunologic Factors|immunologic factors|mesh-ancestor
111174645|NCT02553460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111174646|NCT02553460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111174647|NCT02553460|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111174648|NCT02553460|Alkylating Agents|alkylating agents|mesh-ancestor
111174649|NCT02553460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111174650|NCT02553460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111174651|NCT02553460|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111174652|NCT02553460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111174653|NCT02553460|Antiemetics|antiemetics|mesh-ancestor
111174654|NCT02553460|Autonomic Agents|autonomic agents|mesh-ancestor
111174655|NCT02553460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111174656|NCT02553460|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111174657|NCT02553460|Glucocorticoids|glucocorticoids|mesh-ancestor
111174658|NCT02553460|Hormones|hormones|mesh-ancestor
111174659|NCT02553460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111174660|NCT02553460|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111174661|NCT02553460|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111174662|NCT02553460|Abortifacient Agents|abortifacient agents|mesh-ancestor
111174663|NCT02553460|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111174664|NCT02553460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111174665|NCT02553460|Antimetabolites|antimetabolites|mesh-ancestor
111174666|NCT02553460|Dermatologic Agents|dermatologic agents|mesh-ancestor
111174667|NCT02553460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111174668|NCT02553460|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111174669|NCT02553460|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111174670|NCT02553460|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111174671|NCT02553460|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111174672|NCT02553460|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111174673|NCT02553460|Antiviral Agents|antiviral agents|mesh-ancestor
111174674|NCT02553460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111174675|NCT02553460|Antidotes|antidotes|mesh-ancestor
111174676|NCT02553460|Protective Agents|protective agents|mesh-ancestor
111174677|NCT02553460|Vitamin B Complex|vitamin b complex|mesh-ancestor
111174678|NCT02553460|Vitamins|vitamins|mesh-ancestor
111174679|NCT02553460|Micronutrients|micronutrients|mesh-ancestor
111174680|NCT02553460|Tubulin Modulators|tubulin modulators|mesh-ancestor
111174681|NCT02553460|Antimitotic Agents|antimitotic agents|mesh-ancestor
111174682|NCT02553460|Mitosis Modulators|mitosis modulators|mesh-ancestor
110891829|NCT03131479|Licogliflozin|licogliflozin|mesh-list
111174683|NCT02553460|Analgesics|analgesics|mesh-ancestor
111174684|NCT02553460|Sensory System Agents|sensory system agents|mesh-ancestor
111174685|NCT02553460|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111174686|NCT02516670|Vitamins|vitamins|mesh-list
111174687|NCT02516670|Ascorbic Acid|ascorbic acid|mesh-list
111174688|NCT02516670|Docetaxel|docetaxel|mesh-list
111174689|NCT02516670|Micronutrients|micronutrients|mesh-ancestor
111174690|NCT02516670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111174691|NCT02516670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111174692|NCT02516670|Tubulin Modulators|tubulin modulators|mesh-ancestor
111174693|NCT02516670|Antimitotic Agents|antimitotic agents|mesh-ancestor
111174694|NCT02516670|Mitosis Modulators|mitosis modulators|mesh-ancestor
111174695|NCT02516670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111174696|NCT02516670|Antioxidants|antioxidants|mesh-ancestor
111174697|NCT02516670|Protective Agents|protective agents|mesh-ancestor
111174698|NCT02315898|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
111174699|NCT02315898|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111174700|NCT02315898|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111174701|NCT02315898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111174702|NCT02315326|Rituximab|rituximab|mesh-list
111174703|NCT02315326|Methotrexate|methotrexate|mesh-list
111174704|NCT02315326|Procarbazine|procarbazine|mesh-list
111174705|NCT02315326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111174706|NCT02315326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111174707|NCT02315326|Immunologic Factors|immunologic factors|mesh-ancestor
111174708|NCT02315326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111174709|NCT02315326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111174710|NCT02315326|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111174711|NCT02315326|Abortifacient Agents|abortifacient agents|mesh-ancestor
111174712|NCT02315326|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111174713|NCT02315326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111174714|NCT02315326|Antimetabolites|antimetabolites|mesh-ancestor
111174715|NCT02315326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111174716|NCT02315326|Dermatologic Agents|dermatologic agents|mesh-ancestor
111174717|NCT02315326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111174718|NCT02315326|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111174719|NCT02315326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111174720|NCT02315326|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111174721|NCT02280525|Cytarabine|cytarabine|mesh-list
111174722|NCT02280525|Cyclophosphamide|cyclophosphamide|mesh-list
111174723|NCT02280525|Rituximab|rituximab|mesh-list
111174724|NCT02280525|Fludarabine|fludarabine|mesh-list
111174725|NCT02280525|Fludarabine phosphate|fludarabine phosphate|mesh-list
111174726|NCT02280525|Lenalidomide|lenalidomide|mesh-list
111174727|NCT02280525|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111174728|NCT02280525|Immunologic Factors|immunologic factors|mesh-ancestor
111174729|NCT02280525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111174730|NCT02280525|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111174731|NCT02280525|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111174732|NCT02280525|Alkylating Agents|alkylating agents|mesh-ancestor
111174733|NCT02280525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111174734|NCT02280525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111174735|NCT02280525|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111174736|NCT02280525|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111174737|NCT02280525|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111174738|NCT02280525|Antimetabolites|antimetabolites|mesh-ancestor
111174739|NCT02280525|Antiviral Agents|antiviral agents|mesh-ancestor
111174740|NCT02280525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111174741|NCT02280525|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111174742|NCT02280525|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111174743|NCT02280525|Growth Substances|growth substances|mesh-ancestor
111174744|NCT02280525|Growth Inhibitors|growth inhibitors|mesh-ancestor
111174745|NCT02157883|Itraconazole|itraconazole|mesh-list
111174746|NCT02157883|Osimertinib|osimertinib|mesh-list
111174747|NCT02157883|Antifungal Agents|antifungal agents|mesh-ancestor
111174748|NCT02157883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111174749|NCT02157883|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111174750|NCT02157883|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111174751|NCT02157883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111174752|NCT02157883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111174753|NCT02157883|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111174754|NCT02157883|Hormone Antagonists|hormone antagonists|mesh-ancestor
111174755|NCT02157883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111174756|NCT02157883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111174757|NCT02157883|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111174758|NCT02157883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111174759|NCT02157883|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111174760|NCT02091141|Trastuzumab|trastuzumab|mesh-list
111174761|NCT02091141|Atezolizumab|atezolizumab|mesh-list
111174762|NCT02091141|Pertuzumab|pertuzumab|mesh-list
111174763|NCT02091141|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111174764|NCT02091141|Vemurafenib|vemurafenib|mesh-list
111174765|NCT02091141|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111174766|NCT02091141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111174767|NCT02091141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111174768|NCT02091141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111174769|NCT02091141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111174770|NCT02091141|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111174771|NCT02066181|Sorafenib|sorafenib|mesh-list
111174772|NCT02066181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111174773|NCT02066181|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111174774|NCT02066181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111174775|NCT02066181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111174776|NCT01972217|Prednisone|prednisone|mesh-list
111174777|NCT01972217|Prednisolone|prednisolone|mesh-list
111174778|NCT01972217|Olaparib|olaparib|mesh-list
111174779|NCT01972217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111174780|NCT01972217|Glucocorticoids|glucocorticoids|mesh-ancestor
111174781|NCT01972217|Hormones|hormones|mesh-ancestor
111174782|NCT01972217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111174783|NCT01972217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111174784|NCT01972217|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111174785|NCT01972217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111174786|NCT01972217|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111174787|NCT01972217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111174788|NCT01972217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111174789|NCT01970865|Crizotinib|crizotinib|mesh-list
111174790|NCT01970865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111174791|NCT01970865|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111174792|NCT01970865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111174793|NCT01970865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111174794|NCT01928576|Nivolumab|nivolumab|mesh-list
111174795|NCT01928576|Azacitidine|azacitidine|mesh-list
111174796|NCT01928576|Entinostat|entinostat|mesh-list
111174797|NCT01928576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111174798|NCT01928576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111174799|NCT01928576|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111174800|NCT01928576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111174801|NCT01928576|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111174802|NCT01928576|Antimetabolites|antimetabolites|mesh-ancestor
111174803|NCT01928576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111174804|NCT01928576|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111174805|NCT01869114|Sirolimus|sirolimus|mesh-list
111174806|NCT01869114|Azacitidine|azacitidine|mesh-list
111174807|NCT01869114|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111174808|NCT01869114|Antimetabolites|antimetabolites|mesh-ancestor
111174809|NCT01869114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111174810|NCT01869114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111174811|NCT01869114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111174812|NCT01869114|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111174813|NCT01869114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111174814|NCT01869114|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111174815|NCT01869114|Antifungal Agents|antifungal agents|mesh-ancestor
111174816|NCT01869114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111174817|NCT01869114|Immunologic Factors|immunologic factors|mesh-ancestor
111174818|NCT01869114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111174819|NCT01843751|Buprenorphine|buprenorphine|mesh-list
111174820|NCT01843751|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
111174821|NCT01843751|Naloxone|naloxone|mesh-list
111174822|NCT01843751|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111174823|NCT01843751|Narcotics|narcotics|mesh-ancestor
111174824|NCT01843751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111174825|NCT01843751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111174826|NCT01843751|Analgesics|analgesics|mesh-ancestor
111174827|NCT01843751|Sensory System Agents|sensory system agents|mesh-ancestor
111174828|NCT01843751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111174829|NCT01843751|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111174830|NCT01756248|Aflibercept|aflibercept|mesh-list
111174831|NCT01756248|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111174832|NCT01756248|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111174833|NCT01756248|Growth Substances|growth substances|mesh-ancestor
111174834|NCT01756248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111174835|NCT01756248|Growth Inhibitors|growth inhibitors|mesh-ancestor
111174836|NCT01756248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111174837|NCT01744652|Dasatinib|dasatinib|mesh-list
111174838|NCT01744652|Crizotinib|crizotinib|mesh-list
111174839|NCT01744652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110799561|NCT03758235|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
111174840|NCT01744652|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111174841|NCT01744652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111174842|NCT01744652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111174843|NCT01711541|Paclitaxel|paclitaxel|mesh-list
111174844|NCT01711541|Cisplatin|cisplatin|mesh-list
111174845|NCT01711541|Carboplatin|carboplatin|mesh-list
111174846|NCT01711541|Fluorouracil|fluorouracil|mesh-list
111174847|NCT01711541|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111174848|NCT01711541|Hydroxyurea|hydroxyurea|mesh-list
111174849|NCT01711541|Veliparib|veliparib|mesh-list
111174850|NCT01711541|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111174851|NCT01711541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111174852|NCT01711541|Tubulin Modulators|tubulin modulators|mesh-ancestor
111174853|NCT01711541|Antimitotic Agents|antimitotic agents|mesh-ancestor
111174854|NCT01711541|Mitosis Modulators|mitosis modulators|mesh-ancestor
111174855|NCT01711541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111174856|NCT01711541|Antimetabolites|antimetabolites|mesh-ancestor
111174857|NCT01711541|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111174858|NCT01711541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111174859|NCT01711541|Immunologic Factors|immunologic factors|mesh-ancestor
111174860|NCT01711541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111174861|NCT01711541|Antisickling Agents|antisickling agents|mesh-ancestor
111174862|NCT01711541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111174863|NCT01711541|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111174864|NCT01711541|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111174865|NCT01370512|Droxidopa|droxidopa|mesh-list
111174866|NCT01370512|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
111174867|NCT01370512|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111174868|NCT01370512|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111174869|NCT01370512|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111174870|NCT01370512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111174871|NCT01370512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111174872|NCT01370512|Cholinergic Agents|cholinergic agents|mesh-ancestor
111174873|NCT01370512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111174874|NCT01370512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111174875|NCT00215813|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
111174876|NCT00215813|Poly I-C|poly i-c|mesh-list
111174877|NCT00215813|Antiviral Agents|antiviral agents|mesh-ancestor
111174878|NCT00215813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111174879|NCT00215813|Interferon Inducers|interferon inducers|mesh-ancestor
111174880|NCT00215813|Immunologic Factors|immunologic factors|mesh-ancestor
111174881|NCT00215813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111174882|NCT00179465|Tiagabine|tiagabine|mesh-list
111174883|NCT00179465|Antipsychotic Agents|antipsychotic agents|mesh-list
111174884|NCT00179465|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110605033|NCT00606502|Hematinics|hematinics|mesh-ancestor
111174885|NCT00179465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111174886|NCT00179465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111174887|NCT00179465|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111174888|NCT00179465|Anticonvulsants|anticonvulsants|mesh-ancestor
111174889|NCT00179465|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
111174890|NCT00179465|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111174891|NCT00179465|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111174892|NCT00179465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111174893|NCT00179465|GABA Agents|gaba agents|mesh-ancestor
111174894|NCT00179465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111174895|NCT00134030|Interferons|interferons|mesh-list
111174896|NCT00134030|Interferon-alpha|interferon-alpha|mesh-list
111174897|NCT00134030|Interferon alpha-2|interferon alpha-2|mesh-list
111174898|NCT00134030|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
111174899|NCT00134030|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
111174900|NCT00134030|Cisplatin|cisplatin|mesh-list
111174901|NCT00134030|Doxorubicin|doxorubicin|mesh-list
111174902|NCT00134030|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111174903|NCT00134030|Methotrexate|methotrexate|mesh-list
111174904|NCT00134030|Etoposide|etoposide|mesh-list
111174905|NCT00134030|Etoposide phosphate|etoposide phosphate|mesh-list
111174906|NCT00134030|Ifosfamide|ifosfamide|mesh-list
111174907|NCT00134030|Isophosphamide mustard|isophosphamide mustard|mesh-list
111174908|NCT00134030|Podophyllotoxin|podophyllotoxin|mesh-list
111174909|NCT00134030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111174910|NCT00134030|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111174911|NCT00134030|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111174912|NCT00134030|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111174913|NCT00134030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111174914|NCT00134030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111174915|NCT00134030|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111174916|NCT00134030|Abortifacient Agents|abortifacient agents|mesh-ancestor
111174917|NCT00134030|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111174918|NCT00134030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111174919|NCT00134030|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111174920|NCT00134030|Antimetabolites|antimetabolites|mesh-ancestor
111174921|NCT00134030|Dermatologic Agents|dermatologic agents|mesh-ancestor
111174922|NCT00134030|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111174923|NCT00134030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111174924|NCT00134030|Immunologic Factors|immunologic factors|mesh-ancestor
111174925|NCT00134030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111174926|NCT00134030|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111174927|NCT00134030|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111174928|NCT00134030|Antiviral Agents|antiviral agents|mesh-ancestor
111174929|NCT00134030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111174930|NCT00134030|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111174931|NCT00134030|Alkylating Agents|alkylating agents|mesh-ancestor
111174932|NCT00134030|Keratolytic Agents|keratolytic agents|mesh-ancestor
111174933|NCT00134030|Tubulin Modulators|tubulin modulators|mesh-ancestor
111174934|NCT00134030|Antimitotic Agents|antimitotic agents|mesh-ancestor
111174935|NCT00134030|Mitosis Modulators|mitosis modulators|mesh-ancestor
111174936|NCT01382446|Chlorhexidine|chlorhexidine|mesh-list
111174937|NCT01382446|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
111174938|NCT01382446|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111174939|NCT01382446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111174940|NCT01382446|Disinfectants|disinfectants|mesh-ancestor
111174941|NCT01382446|Dermatologic Agents|dermatologic agents|mesh-ancestor
111174942|NCT01381900|Metformin|metformin|mesh-list
111174943|NCT01381900|Canagliflozin|canagliflozin|mesh-list
111174944|NCT01381900|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111174945|NCT01381900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111174946|NCT01381900|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111174947|NCT01381900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111174949|NCT01744197|Tetracaine|tetracaine|mesh-list
111174950|NCT01744197|Anesthetics, Local|anesthetics, local|mesh-ancestor
111174951|NCT01744197|Anesthetics|anesthetics|mesh-ancestor
111174952|NCT01744197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111174953|NCT01744197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111174954|NCT01744197|Sensory System Agents|sensory system agents|mesh-ancestor
111174955|NCT01744197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111174956|NCT01744197|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111174957|NCT01744197|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111174958|NCT01744197|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111174959|NCT01744197|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111174960|NCT01744197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111174961|NCT04565301|Dexamethasone|dexamethasone|mesh-list
111174962|NCT04565301|Neostigmine|neostigmine|mesh-list
111174963|NCT04565301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111174964|NCT04565301|Antiemetics|antiemetics|mesh-ancestor
111174965|NCT04565301|Autonomic Agents|autonomic agents|mesh-ancestor
111174966|NCT04565301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111174967|NCT04565301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111174968|NCT04565301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111174969|NCT04565301|Glucocorticoids|glucocorticoids|mesh-ancestor
111174970|NCT04565301|Hormones|hormones|mesh-ancestor
111174971|NCT04565301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111174972|NCT04565301|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111174973|NCT04565301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111174974|NCT04565301|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111174975|NCT04565301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111174976|NCT04565301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111174977|NCT04565301|Cholinergic Agents|cholinergic agents|mesh-ancestor
111174978|NCT04565301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111174979|NCT04565301|Parasympathomimetics|parasympathomimetics|mesh-ancestor
111174980|NCT01743027|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
111174981|NCT01743027|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111174982|NCT01743027|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111174983|NCT01743027|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111174984|NCT01743027|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111174985|NCT01743027|Analgesics|analgesics|mesh-ancestor
111174986|NCT01743027|Sensory System Agents|sensory system agents|mesh-ancestor
111174987|NCT01743027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111174988|NCT01743027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111174990|NCT01743027|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111174991|NCT01743027|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111174992|NCT01743027|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
111174993|NCT01743027|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111174994|NCT01743027|Histamine Antagonists|histamine antagonists|mesh-ancestor
111174995|NCT01743027|Histamine Agents|histamine agents|mesh-ancestor
111174996|NCT01743027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111174997|NCT01743027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111174998|NCT01380730|Evolocumab|evolocumab|mesh-list
111174999|NCT01380730|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111175000|NCT01380730|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
111175001|NCT01380730|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111175002|NCT01380730|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111175003|NCT01380730|Antimetabolites|antimetabolites|mesh-ancestor
111175004|NCT01380730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111175005|NCT01380730|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111175006|NCT01380730|Protease Inhibitors|protease inhibitors|mesh-ancestor
111175007|NCT01380730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111175008|NCT01380730|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111175009|NCT01380730|Immunologic Factors|immunologic factors|mesh-ancestor
111175010|NCT01380730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111175011|NCT04010968|Venetoclax|venetoclax|mesh-list
111175012|NCT04010968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111175013|NCT01395784|Pioglitazone|pioglitazone|mesh-list
111175014|NCT01395784|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111175015|NCT01395784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111175017|NCT01380184|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111175018|NCT01380184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111175019|NCT01380184|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111175020|NCT01380184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111175021|NCT01380184|Antifungal Agents|antifungal agents|mesh-ancestor
111175022|NCT01380184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111175023|NCT01380184|Immunologic Factors|immunologic factors|mesh-ancestor
111175024|NCT01380184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111175025|NCT00002826|Paclitaxel|paclitaxel|mesh-list
111175026|NCT00002826|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111175027|NCT00002826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111175028|NCT00002826|Tubulin Modulators|tubulin modulators|mesh-ancestor
111175029|NCT00002826|Antimitotic Agents|antimitotic agents|mesh-ancestor
111175030|NCT00002826|Mitosis Modulators|mitosis modulators|mesh-ancestor
111175031|NCT00002826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111175032|NCT01395316|Alemtuzumab|alemtuzumab|mesh-list
111175033|NCT01395316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111175034|NCT01395316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111175035|NCT04331938|Anesthetics|anesthetics|mesh-list
111175036|NCT04331938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111175037|NCT04331938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111175038|NCT01731951|Imetelstat|imetelstat|mesh-list
111175039|NCT01731951|Motesanib diphosphate|motesanib diphosphate|mesh-list
111175040|NCT01731951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111175041|NCT01731951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111175042|NCT01731951|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111175043|NCT01741545|Interferons|interferons|mesh-list
111175044|NCT01741545|Ribavirin|ribavirin|mesh-list
111175045|NCT01741545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111175046|NCT01741545|Antiviral Agents|antiviral agents|mesh-ancestor
111175047|NCT01741545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111175048|NCT01741545|Antimetabolites|antimetabolites|mesh-ancestor
111175049|NCT01741545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111175050|NCT01884350|Apixaban|apixaban|mesh-list
111175051|NCT01884350|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111175052|NCT01884350|Antithrombins|antithrombins|mesh-ancestor
111175053|NCT01884350|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111175054|NCT01884350|Protease Inhibitors|protease inhibitors|mesh-ancestor
111175055|NCT01884350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111175056|NCT01884350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111175057|NCT01884350|Anticoagulants|anticoagulants|mesh-ancestor
111175058|NCT01614795|Sirolimus|sirolimus|mesh-list
111175059|NCT01614795|Temsirolimus|temsirolimus|mesh-list
111175060|NCT01614795|MTOR Inhibitors|mtor inhibitors|mesh-list
111175061|NCT01614795|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111175062|NCT01614795|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111175063|NCT01614795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111175064|NCT01614795|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111175065|NCT01614795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111175066|NCT01614795|Antifungal Agents|antifungal agents|mesh-ancestor
111175067|NCT01614795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111175068|NCT01614795|Immunologic Factors|immunologic factors|mesh-ancestor
111175069|NCT01614795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111175070|NCT01614795|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111175071|NCT01614795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111175072|NCT01614795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111175073|NCT01834586|Anesthetics|anesthetics|mesh-list
111175074|NCT01834586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111175075|NCT01834586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111175076|NCT01614093|Oxytocin|oxytocin|mesh-list
111175077|NCT01614093|Oxytocics|oxytocics|mesh-ancestor
111175078|NCT01614093|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111175079|NCT01614093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111175080|NCT04559607|Apatinib|apatinib|mesh-list
111175081|NCT04559607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111175082|NCT04559607|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111175083|NCT04559607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111175084|NCT04559607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111175085|NCT01834274|Metformin|metformin|mesh-list
111175086|NCT01834274|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111175087|NCT01834274|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111175088|NCT01834274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111175090|NCT01834274|Hormones|hormones|mesh-ancestor
111175091|NCT01834274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111175092|NCT01834274|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111175093|NCT01834274|Protease Inhibitors|protease inhibitors|mesh-ancestor
111175094|NCT01834274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110799562|NCT03758235|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111175095|NCT01834274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111175096|NCT01739595|Enclomiphene|enclomiphene|mesh-list
111175097|NCT01739595|Clomiphene|clomiphene|mesh-list
111175098|NCT01739595|Zuclomiphene|zuclomiphene|mesh-list
111175099|NCT01739595|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111175100|NCT01739595|Hormone Antagonists|hormone antagonists|mesh-ancestor
111175101|NCT01739595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111175102|NCT01739595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111175103|NCT01739595|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111175104|NCT01739595|Fertility Agents|fertility agents|mesh-ancestor
111175105|NCT01739595|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111175106|NCT01739595|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111175107|NCT01739595|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111175108|NCT01738971|Progestins|progestins|mesh-list
111175109|NCT01738971|Hormones|hormones|mesh-ancestor
111175110|NCT01738971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111175111|NCT01738971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111175112|NCT01738503|Buprenorphine|buprenorphine|mesh-list
111175113|NCT01738503|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111175114|NCT01738503|Narcotics|narcotics|mesh-ancestor
111175115|NCT01738503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111175116|NCT01738503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111175117|NCT01738503|Analgesics|analgesics|mesh-ancestor
111175118|NCT01738503|Sensory System Agents|sensory system agents|mesh-ancestor
111175119|NCT01738503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111175120|NCT01738503|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111175121|NCT01738191|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
111175122|NCT01738191|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111175123|NCT01738191|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111175124|NCT01738191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111175125|NCT01738191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111175126|NCT01738191|Adrenergic Agents|adrenergic agents|mesh-ancestor
111175127|NCT01738191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111175128|NCT01738191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111175129|NCT01737879|Epoetin Alfa|epoetin alfa|mesh-list
111175130|NCT01737879|Hematinics|hematinics|mesh-ancestor
111175131|NCT01605825|4-Aminopyridine|4-aminopyridine|mesh-list
111175132|NCT01605825|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
111175133|NCT01605825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111175134|NCT01605825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111175135|NCT01726335|Risperidone|risperidone|mesh-list
111175136|NCT01726335|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111175137|NCT01726335|Serotonin Agents|serotonin agents|mesh-ancestor
111175138|NCT01726335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111175139|NCT01726335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111175140|NCT01726335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111175141|NCT01726335|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111175142|NCT01726335|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111175143|NCT01726335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111175144|NCT01726335|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111175145|NCT01726335|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111175146|NCT01726335|Dopamine Agents|dopamine agents|mesh-ancestor
111175147|NCT01726023|Metronidazole|metronidazole|mesh-list
111175148|NCT01726023|Meropenem|meropenem|mesh-list
111175149|NCT01726023|Ceftazidime|ceftazidime|mesh-list
111175150|NCT01726023|Avibactam|avibactam|mesh-list
111175151|NCT01726023|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
111175152|NCT01726023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111175153|NCT01726023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110488105|NCT05680857|Ubiquinone|ubiquinone|mesh-list
111175154|NCT01726023|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111175155|NCT01726023|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110843332|NCT03885947|GABA Agents|gaba agents|mesh-ancestor
111175156|NCT01726023|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
111175157|NCT01726023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111175158|NCT01726023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111175159|NCT01877187|Ethiodized Oil|ethiodized oil|mesh-list
111175160|NCT01877187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111175161|NCT04609761|Immunoglobulins|immunoglobulins|mesh-list
111175162|NCT04609761|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111175163|NCT04609761|Antibodies|antibodies|mesh-list
111175164|NCT04609761|gamma-Globulins|gamma-globulins|mesh-list
111175165|NCT04609761|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
111175166|NCT04609761|Immunologic Factors|immunologic factors|mesh-ancestor
111175167|NCT04609761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111175168|NCT01858532|Atrasentan|atrasentan|mesh-list
111175169|NCT01858532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111175170|NCT01858532|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
111175171|NCT01858532|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
111175172|NCT01858532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111175173|NCT04613960|Magnesium Sulfate|magnesium sulfate|mesh-list
111175174|NCT04613960|Analgesics|analgesics|mesh-ancestor
111175175|NCT04613960|Sensory System Agents|sensory system agents|mesh-ancestor
111175176|NCT04613960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111175177|NCT04613960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111175178|NCT04613960|Anesthetics|anesthetics|mesh-ancestor
111175179|NCT04613960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111175180|NCT04613960|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111175181|NCT04613960|Anticonvulsants|anticonvulsants|mesh-ancestor
111175182|NCT04613960|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111175183|NCT04613960|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111175184|NCT04613960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111175185|NCT04613960|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111175186|NCT04613960|Tocolytic Agents|tocolytic agents|mesh-ancestor
111175187|NCT04613960|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111175188|NCT01857206|Vaccines|vaccines|mesh-list
111175189|NCT01857206|Immunologic Factors|immunologic factors|mesh-ancestor
111175190|NCT01857206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111175191|NCT01882088|Psyllium|psyllium|mesh-list
111175192|NCT01882088|Cathartics|cathartics|mesh-ancestor
111175193|NCT01882088|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111175194|NCT01722669|Quercetin|quercetin|mesh-list
111175195|NCT01722669|Antioxidants|antioxidants|mesh-ancestor
111175196|NCT01722669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111175197|NCT01722669|Protective Agents|protective agents|mesh-ancestor
111175198|NCT01722669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111175199|NCT01707147|Linagliptin|linagliptin|mesh-list
111175200|NCT01707147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111175201|NCT01707147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111175202|NCT01707147|Incretins|incretins|mesh-ancestor
111175203|NCT01707147|Hormones|hormones|mesh-ancestor
111175204|NCT01707147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111175205|NCT01707147|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111175206|NCT01707147|Protease Inhibitors|protease inhibitors|mesh-ancestor
111175207|NCT01707147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111175208|NCT01707147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111175209|NCT01876251|Docetaxel|docetaxel|mesh-list
111175210|NCT01876251|Nirogacestat|nirogacestat|mesh-list
111175211|NCT01876251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111175212|NCT01876251|Tubulin Modulators|tubulin modulators|mesh-ancestor
111175213|NCT01876251|Antimitotic Agents|antimitotic agents|mesh-ancestor
111175214|NCT01876251|Mitosis Modulators|mitosis modulators|mesh-ancestor
111175215|NCT01876251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111175216|NCT01876251|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
111175217|NCT01876251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111175218|NCT01875237|Methylprednisolone|methylprednisolone|mesh-list
111175219|NCT01875237|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111175220|NCT01875237|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111175221|NCT01875237|Prednisolone|prednisolone|mesh-list
111175222|NCT01875237|Prednisolone acetate|prednisolone acetate|mesh-list
111175223|NCT01875237|Methotrexate|methotrexate|mesh-list
111175224|NCT01875237|Fludarabine phosphate|fludarabine phosphate|mesh-list
111175225|NCT01875237|Fludarabine|fludarabine|mesh-list
111175226|NCT01875237|Melphalan|melphalan|mesh-list
111175227|NCT01875237|Alemtuzumab|alemtuzumab|mesh-list
111175228|NCT01875237|Tacrolimus|tacrolimus|mesh-list
111175229|NCT01875237|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111175230|NCT01875237|Prednisolone phosphate|prednisolone phosphate|mesh-list
111175231|NCT01875237|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111175232|NCT01875237|Abortifacient Agents|abortifacient agents|mesh-ancestor
111175233|NCT01875237|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111175234|NCT01875237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111175235|NCT01875237|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111175236|NCT01875237|Antimetabolites|antimetabolites|mesh-ancestor
111175237|NCT01875237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111175238|NCT01875237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111175239|NCT01875237|Dermatologic Agents|dermatologic agents|mesh-ancestor
111175240|NCT01875237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111175241|NCT01875237|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111175242|NCT01875237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111175243|NCT01875237|Immunologic Factors|immunologic factors|mesh-ancestor
111175244|NCT01875237|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111175245|NCT01875237|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111175246|NCT01875237|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111175247|NCT01875237|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111175248|NCT01875237|Antiemetics|antiemetics|mesh-ancestor
111175249|NCT01875237|Autonomic Agents|autonomic agents|mesh-ancestor
111175250|NCT01875237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111175251|NCT01875237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111175252|NCT01875237|Glucocorticoids|glucocorticoids|mesh-ancestor
111175253|NCT01875237|Hormones|hormones|mesh-ancestor
111175254|NCT01875237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111175255|NCT01875237|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111175256|NCT01875237|Protective Agents|protective agents|mesh-ancestor
111175257|NCT01875237|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111175258|NCT01875237|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111175259|NCT01875237|Alkylating Agents|alkylating agents|mesh-ancestor
111175260|NCT01875237|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111175261|NCT01875237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111175262|NCT01874535|Esomeprazole|esomeprazole|mesh-list
111175263|NCT01874535|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111175264|NCT01874535|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111175265|NCT01874535|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111175266|NCT01874535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111175267|NCT01874535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111175268|NCT01722045|Aflibercept|aflibercept|mesh-list
111175269|NCT01722045|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111175270|NCT01722045|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111175271|NCT01722045|Growth Substances|growth substances|mesh-ancestor
111175272|NCT01722045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111175273|NCT01722045|Growth Inhibitors|growth inhibitors|mesh-ancestor
111175274|NCT01722045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111175275|NCT01721109|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
111175276|NCT01721109|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111175277|NCT01721109|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111175278|NCT01721109|Antiviral Agents|antiviral agents|mesh-ancestor
111175279|NCT01721109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111175280|NCT01874145|Glatiramer Acetate|glatiramer acetate|mesh-list
111175281|NCT01874145|(T,G)-A-L|(t,g)-a-l|mesh-list
111175282|NCT01874145|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111175283|NCT01874145|Immunologic Factors|immunologic factors|mesh-ancestor
111175284|NCT01874145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111175285|NCT01874145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111175286|NCT01874145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111175287|NCT04415385|Apatinib|apatinib|mesh-list
111175288|NCT04415385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111175289|NCT04415385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111175290|NCT04415385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110799563|NCT03758235|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111175291|NCT04415385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111175292|NCT01720797|Chlorhexidine|chlorhexidine|mesh-list
111175293|NCT01720797|Anesthetics|anesthetics|mesh-list
111175294|NCT01720797|Anesthetics, Local|anesthetics, local|mesh-list
111175295|NCT01720797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111175296|NCT01720797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111175297|NCT01720797|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111175298|NCT01720797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111175299|NCT01720797|Disinfectants|disinfectants|mesh-ancestor
111175300|NCT01720797|Sensory System Agents|sensory system agents|mesh-ancestor
111175301|NCT01720797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111175302|NCT01831466|Tofacitinib|tofacitinib|mesh-list
111175303|NCT01831466|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
111175304|NCT01831466|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111175305|NCT01831466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111175306|NCT01831466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111175307|NCT01881230|Paclitaxel|paclitaxel|mesh-list
111175308|NCT01881230|Carboplatin|carboplatin|mesh-list
111175309|NCT01881230|Gemcitabine|gemcitabine|mesh-list
111175310|NCT01881230|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111175311|NCT01881230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111175312|NCT01881230|Tubulin Modulators|tubulin modulators|mesh-ancestor
111175313|NCT01881230|Antimitotic Agents|antimitotic agents|mesh-ancestor
111175314|NCT01881230|Mitosis Modulators|mitosis modulators|mesh-ancestor
111175315|NCT01881230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111175316|NCT01881230|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111175317|NCT01881230|Antimetabolites|antimetabolites|mesh-ancestor
111175318|NCT01856114|Fentanyl|fentanyl|mesh-list
111175319|NCT01856114|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111175320|NCT01856114|Narcotics|narcotics|mesh-ancestor
111175321|NCT01856114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111175322|NCT01856114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111175323|NCT01856114|Analgesics|analgesics|mesh-ancestor
111175324|NCT01856114|Sensory System Agents|sensory system agents|mesh-ancestor
111175325|NCT01856114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111175326|NCT01856114|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111175327|NCT01856114|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111175328|NCT01856114|Anesthetics, General|anesthetics, general|mesh-ancestor
111175329|NCT01856114|Anesthetics|anesthetics|mesh-ancestor
111175330|NCT01614470|Ivacaftor|ivacaftor|mesh-list
111175331|NCT01614470|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
111175332|NCT01614470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111175333|NCT01614470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111175334|NCT01880528|Lisinopril|lisinopril|mesh-list
111175335|NCT01880528|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
111175336|NCT01880528|Protease Inhibitors|protease inhibitors|mesh-ancestor
111175337|NCT01880528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111175338|NCT01880528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111175339|NCT01880528|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111175340|NCT01880528|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111175341|NCT01880528|Protective Agents|protective agents|mesh-ancestor
111175342|NCT01880528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111175343|NCT01854944|Brexpiprazole|brexpiprazole|mesh-list
111175344|NCT01854944|Serotonin Agents|serotonin agents|mesh-ancestor
111175345|NCT01854944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111175346|NCT01854944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111175347|NCT01854944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111175348|NCT01854944|Dopamine Agonists|dopamine agonists|mesh-ancestor
111175349|NCT01854944|Dopamine Agents|dopamine agents|mesh-ancestor
111175350|NCT01854710|Moxifloxacin|moxifloxacin|mesh-list
111175351|NCT01854710|Loxapine|loxapine|mesh-list
111175352|NCT01854710|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111175353|NCT01854710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111175354|NCT01854710|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111175355|NCT01854710|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111175356|NCT01854710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110488128|NCT05574101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111175357|NCT01854710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111175358|NCT01854710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111175359|NCT01854710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111175360|NCT01854710|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111175361|NCT01854710|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111175362|NCT01854710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111175363|NCT01854710|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111175364|NCT01854710|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111175366|NCT01854710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111175367|NCT01828034|Gemcitabine|gemcitabine|mesh-list
111175368|NCT01828034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111175369|NCT01828034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111175370|NCT01828034|Antimetabolites|antimetabolites|mesh-ancestor
111175371|NCT01828034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111175372|NCT01853696|Loteprednol Etabonate|loteprednol etabonate|mesh-list
111175373|NCT01853696|Prednisolone|prednisolone|mesh-list
111175374|NCT01853696|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111175375|NCT01853696|Methylprednisolone|methylprednisolone|mesh-list
111175376|NCT01853696|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111175377|NCT01853696|Prednisolone acetate|prednisolone acetate|mesh-list
111175378|NCT01853696|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111175379|NCT01853696|Prednisolone phosphate|prednisolone phosphate|mesh-list
111175380|NCT01853696|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111175381|NCT01853696|Glucocorticoids|glucocorticoids|mesh-ancestor
111175382|NCT01853696|Hormones|hormones|mesh-ancestor
111175383|NCT01853696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111175384|NCT01853696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111175385|NCT01853696|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111175386|NCT01853696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111175387|NCT01853696|Antiemetics|antiemetics|mesh-ancestor
111175388|NCT01853696|Autonomic Agents|autonomic agents|mesh-ancestor
111175389|NCT01853696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111175390|NCT01853696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111175391|NCT01853696|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111175392|NCT01853696|Protective Agents|protective agents|mesh-ancestor
111175393|NCT01853696|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111175394|NCT01719861|Desipramine|desipramine|mesh-list
111175395|NCT01719861|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
111175396|NCT01719861|Antidepressive Agents|antidepressive agents|mesh-ancestor
111175397|NCT01719861|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111175398|NCT01719861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111175399|NCT01719861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111175400|NCT01719861|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111175401|NCT01719861|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111175402|NCT01719861|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111175403|NCT01719861|Adrenergic Agents|adrenergic agents|mesh-ancestor
111175404|NCT01719861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111175405|NCT01719861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111175406|NCT01853618|Tremelimumab|tremelimumab|mesh-list
111175407|NCT01853618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111175408|NCT01719783|Vaccines|vaccines|mesh-list
111175409|NCT01719783|Immunologic Factors|immunologic factors|mesh-ancestor
111175410|NCT01719783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111175411|NCT01878890|Efavirenz|efavirenz|mesh-list
111175412|NCT01878890|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111175413|NCT01878890|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111175414|NCT01878890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111175415|NCT01878890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111175416|NCT01878890|Antiviral Agents|antiviral agents|mesh-ancestor
111175417|NCT01878890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111175418|NCT01878890|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111175419|NCT01878890|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111175420|NCT01878890|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111175421|NCT01878890|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111175422|NCT01878890|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111175423|NCT01878890|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111175424|NCT01827332|Oxytocin|oxytocin|mesh-list
111175425|NCT01827332|Oxytocics|oxytocics|mesh-ancestor
111175426|NCT01827332|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111175427|NCT01827332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111175428|NCT01719003|Metformin|metformin|mesh-list
111175429|NCT01719003|Empagliflozin|empagliflozin|mesh-list
111175430|NCT01719003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111175431|NCT01719003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111175432|NCT01719003|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111175433|NCT01719003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111175434|NCT01853228|Cytarabine|cytarabine|mesh-list
111175435|NCT01853228|Decitabine|decitabine|mesh-list
111175436|NCT01853228|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111175437|NCT01853228|Antimetabolites|antimetabolites|mesh-ancestor
111175438|NCT01853228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111175439|NCT01853228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111175440|NCT01853228|Antiviral Agents|antiviral agents|mesh-ancestor
111175441|NCT01853228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111175442|NCT01853228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111175443|NCT01853228|Immunologic Factors|immunologic factors|mesh-ancestor
111175444|NCT01853228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111175445|NCT01853228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111175446|NCT01705587|Teriparatide|teriparatide|mesh-list
111175447|NCT01705587|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111175448|NCT01705587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111175449|NCT01705587|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111175450|NCT01705509|Ranolazine|ranolazine|mesh-list
111175451|NCT01705509|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111175452|NCT01705509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111175453|NCT01705509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111175454|NCT01853072|Prednisolone|prednisolone|mesh-list
111175455|NCT01853072|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111175456|NCT01853072|Methylprednisolone|methylprednisolone|mesh-list
111175457|NCT01853072|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111175458|NCT01853072|Prednisolone acetate|prednisolone acetate|mesh-list
111175459|NCT01853072|Nepafenac|nepafenac|mesh-list
111175460|NCT01853072|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111175461|NCT01853072|Prednisolone phosphate|prednisolone phosphate|mesh-list
111175462|NCT01853072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111175463|NCT01853072|Glucocorticoids|glucocorticoids|mesh-ancestor
111175464|NCT01853072|Hormones|hormones|mesh-ancestor
111175465|NCT01853072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111175466|NCT01853072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111175467|NCT01853072|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111175468|NCT01853072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111175469|NCT01853072|Antiemetics|antiemetics|mesh-ancestor
111175470|NCT01853072|Autonomic Agents|autonomic agents|mesh-ancestor
111175471|NCT01853072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111175472|NCT01853072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111175473|NCT01853072|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111175474|NCT01853072|Protective Agents|protective agents|mesh-ancestor
111175475|NCT01853072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111175476|NCT01853072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111175477|NCT01853072|Analgesics|analgesics|mesh-ancestor
111175478|NCT01853072|Sensory System Agents|sensory system agents|mesh-ancestor
111175479|NCT01853072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111175480|NCT01717287|Raltegravir Potassium|raltegravir potassium|mesh-list
111175481|NCT01717287|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
111175482|NCT01717287|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111175483|NCT01717287|Antiviral Agents|antiviral agents|mesh-ancestor
111175484|NCT01717287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111175485|NCT01717287|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111175486|NCT01717287|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111175487|NCT01717287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111175488|NCT01717287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111175489|NCT01827254|Sunitinib|sunitinib|mesh-list
111175490|NCT01827254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111175491|NCT01827254|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111175492|NCT01827254|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111175493|NCT01827254|Growth Substances|growth substances|mesh-ancestor
111175494|NCT01827254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111175495|NCT01827254|Growth Inhibitors|growth inhibitors|mesh-ancestor
111175496|NCT01827254|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111175497|NCT01827254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111175498|NCT01827254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111175499|NCT01824602|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
111175500|NCT01824602|Anticonvulsants|anticonvulsants|mesh-ancestor
111175501|NCT01824602|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111175502|NCT01824602|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111175503|NCT01824602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111175504|NCT01824602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111175505|NCT01704651|Alvimopan|alvimopan|mesh-list
111175506|NCT01704651|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111175507|NCT04609592|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
111175508|NCT04609592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111175509|NCT04609592|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111175510|NCT01876082|Methotrexate|methotrexate|mesh-list
111175511|NCT01876082|Vinblastine|vinblastine|mesh-list
111175512|NCT01876082|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111175513|NCT01876082|Abortifacient Agents|abortifacient agents|mesh-ancestor
111175514|NCT01876082|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111175515|NCT01876082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111175516|NCT01876082|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111175517|NCT01876082|Antimetabolites|antimetabolites|mesh-ancestor
111175518|NCT01876082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111175519|NCT01876082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111175520|NCT01876082|Dermatologic Agents|dermatologic agents|mesh-ancestor
111175521|NCT01876082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111175522|NCT01876082|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111175523|NCT01876082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111175524|NCT01876082|Immunologic Factors|immunologic factors|mesh-ancestor
111175525|NCT01876082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111175526|NCT01876082|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111175527|NCT01876082|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111175528|NCT01876082|Tubulin Modulators|tubulin modulators|mesh-ancestor
111175529|NCT01876082|Antimitotic Agents|antimitotic agents|mesh-ancestor
111175530|NCT01876082|Mitosis Modulators|mitosis modulators|mesh-ancestor
111175531|NCT01716585|Ribavirin|ribavirin|mesh-list
111175532|NCT01716585|Antimetabolites|antimetabolites|mesh-ancestor
111175533|NCT01716585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111175534|NCT01716585|Antiviral Agents|antiviral agents|mesh-ancestor
111175535|NCT01716585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111175536|NCT01852292|Paclitaxel|paclitaxel|mesh-list
111175537|NCT01852292|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111175538|NCT01852292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111175539|NCT01852292|Tubulin Modulators|tubulin modulators|mesh-ancestor
111175540|NCT01852292|Antimitotic Agents|antimitotic agents|mesh-ancestor
111175541|NCT01852292|Mitosis Modulators|mitosis modulators|mesh-ancestor
111175542|NCT01852292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111175543|NCT01715805|Cariprazine|cariprazine|mesh-list
111175544|NCT01715805|Antidepressive Agents|antidepressive agents|mesh-list
111175545|NCT01715805|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111175546|NCT01715805|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111175547|NCT01715805|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111175548|NCT01715805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111175549|NCT01715805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111175550|NCT01852214|Ticagrelor|ticagrelor|mesh-list
111175551|NCT01852214|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
111175552|NCT01852214|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111175553|NCT01852214|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111175554|NCT01852214|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111175555|NCT01852214|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111175556|NCT01852214|Purinergic Agents|purinergic agents|mesh-ancestor
111175557|NCT01852214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111175558|NCT01852214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111175559|NCT01852214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111175560|NCT01393990|Tamoxifen|tamoxifen|mesh-list
111175561|NCT01393990|Midazolam|midazolam|mesh-list
111175562|NCT01393990|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111175563|NCT01393990|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111175564|NCT01393990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111175565|NCT01393990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111175566|NCT01393990|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111175567|NCT01393990|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111175568|NCT01393990|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111175569|NCT01393990|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111175570|NCT01393990|Anesthetics, General|anesthetics, general|mesh-ancestor
111175571|NCT01393990|Anesthetics|anesthetics|mesh-ancestor
111175572|NCT01393990|GABA Modulators|gaba modulators|mesh-ancestor
111175573|NCT01393990|GABA Agents|gaba agents|mesh-ancestor
111175574|NCT01393990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111175575|NCT01393990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111175576|NCT01393990|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111175577|NCT01393990|Hormone Antagonists|hormone antagonists|mesh-ancestor
111175578|NCT01393990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111175579|NCT01393990|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111175580|NCT01393990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111175581|NCT01393990|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111175582|NCT01393990|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111175583|NCT01393990|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111175584|NCT00210184|Leucovorin|leucovorin|mesh-list
111175585|NCT00210184|Fluorouracil|fluorouracil|mesh-list
111175586|NCT00210184|Irinotecan|irinotecan|mesh-list
111175587|NCT00210184|Antimetabolites|antimetabolites|mesh-ancestor
111175588|NCT00210184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111175589|NCT00210184|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111175590|NCT00210184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111175591|NCT00210184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111175592|NCT00210184|Immunologic Factors|immunologic factors|mesh-ancestor
111175593|NCT00210184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111175594|NCT00210184|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111175595|NCT00210184|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111175596|NCT00210184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111175597|NCT00210184|Antidotes|antidotes|mesh-ancestor
111175598|NCT00210184|Protective Agents|protective agents|mesh-ancestor
111175599|NCT00210184|Vitamin B Complex|vitamin b complex|mesh-ancestor
111175600|NCT00210184|Vitamins|vitamins|mesh-ancestor
111175601|NCT00210184|Micronutrients|micronutrients|mesh-ancestor
111175602|NCT00210964|Linezolid|linezolid|mesh-list
111175603|NCT00210964|Ceftazidime|ceftazidime|mesh-list
111175604|NCT00210964|Ceftobiprole|ceftobiprole|mesh-list
111175605|NCT00210964|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
111175606|NCT00210964|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111175607|NCT00210964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111175608|NCT00210964|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111175609|NCT00210964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111175610|NCT00210964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111175611|NCT05630638|Dolutegravir|dolutegravir|mesh-list
111175612|NCT05630638|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111175613|NCT05630638|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111175614|NCT05630638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110799564|NCT03758235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111175615|NCT05630638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111175616|NCT05630638|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111175617|NCT05630638|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111175618|NCT05630638|Antiviral Agents|antiviral agents|mesh-ancestor
111175619|NCT05630638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111175620|NCT03593434|Xenon|xenon|mesh-list
111175621|NCT03593434|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111175622|NCT03593434|Anesthetics, General|anesthetics, general|mesh-ancestor
111175623|NCT03593434|Anesthetics|anesthetics|mesh-ancestor
111175624|NCT03593434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111175625|NCT03593434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111175626|NCT03792958|Vorolanib|vorolanib|mesh-list
111175627|NCT03792958|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111175628|NCT03792958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111175629|NCT03792958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111175630|NCT03989362|Ipilimumab|ipilimumab|mesh-list
111175631|NCT03989362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111175632|NCT03989362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111175633|NCT03989362|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111175634|NCT03989362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111175635|NCT03599596|Pyrimethamine|pyrimethamine|mesh-list
111175636|NCT03599596|Sulfadoxine|sulfadoxine|mesh-list
111175637|NCT03599596|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
111175638|NCT03599596|Antimalarials|antimalarials|mesh-ancestor
111175639|NCT03599596|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111175640|NCT03599596|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111175641|NCT03599596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111175642|NCT03599596|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111175643|NCT03599596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111175644|NCT03599596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111175645|NCT03599596|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111175646|NCT04407130|Doxycycline|doxycycline|mesh-list
111175647|NCT04407130|Ivermectin|ivermectin|mesh-list
111175648|NCT04407130|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111175649|NCT04407130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111175650|NCT04407130|Antimalarials|antimalarials|mesh-ancestor
111175651|NCT04407130|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111175652|NCT04407130|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111175653|NCT03599284|Clopidogrel|clopidogrel|mesh-list
111175654|NCT03599284|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111175655|NCT03599284|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111175656|NCT03599284|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111175657|NCT03599284|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111175658|NCT03599284|Purinergic Agents|purinergic agents|mesh-ancestor
111175659|NCT03599284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111175660|NCT03599284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111175661|NCT03599284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111175662|NCT03024814|Acetaminophen|acetaminophen|mesh-list
111175663|NCT03024814|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111175664|NCT03024814|Analgesics|analgesics|mesh-ancestor
111175665|NCT03024814|Sensory System Agents|sensory system agents|mesh-ancestor
111175666|NCT03024814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111175667|NCT03024814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111175668|NCT03024814|Antipyretics|antipyretics|mesh-ancestor
111175669|NCT03024502|Clotrimazole|clotrimazole|mesh-list
111175670|NCT03024502|Miconazole|miconazole|mesh-list
111175671|NCT03024502|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111175672|NCT03024502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111175673|NCT03024502|Antifungal Agents|antifungal agents|mesh-ancestor
111175674|NCT03024502|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111175675|NCT03024502|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111175676|NCT03024502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111175677|NCT03024502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111175678|NCT03024502|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111175679|NCT03024502|Hormone Antagonists|hormone antagonists|mesh-ancestor
110488175|NCT05327686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111175680|NCT03024502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111175681|NCT03024502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111175682|NCT03024502|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111175683|NCT03024502|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111175684|NCT03024580|Tamoxifen|tamoxifen|mesh-list
111175685|NCT03024580|Letrozole|letrozole|mesh-list
111175686|NCT03024580|Fulvestrant|fulvestrant|mesh-list
111175687|NCT03024580|Anastrozole|anastrozole|mesh-list
111175688|NCT03024580|Exemestane|exemestane|mesh-list
111175689|NCT03024580|Megestrol|megestrol|mesh-list
111175690|NCT03024580|Megestrol Acetate|megestrol acetate|mesh-list
111175691|NCT03024580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111175692|NCT03024580|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111175693|NCT03024580|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111175694|NCT03024580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111175695|NCT03024580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111175696|NCT03024580|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111175697|NCT03024580|Hormone Antagonists|hormone antagonists|mesh-ancestor
111175698|NCT03024580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111175699|NCT03024580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111175700|NCT03024580|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111175701|NCT03024580|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111175702|NCT03024580|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111175703|NCT03024580|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111175704|NCT03024580|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
111175705|NCT03024580|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111175706|NCT03024580|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111175707|NCT03024580|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111175708|NCT03024580|Contraceptive Agents|contraceptive agents|mesh-ancestor
111175709|NCT03024580|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111175710|NCT03024580|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111175711|NCT03024580|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111175712|NCT03024580|Appetite Stimulants|appetite stimulants|mesh-ancestor
111175713|NCT03024580|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111175714|NCT01851590|Terbinafine|terbinafine|mesh-list
111175715|NCT01851590|Amorolfine|amorolfine|mesh-list
111175716|NCT01851590|Antifungal Agents|antifungal agents|mesh-ancestor
111175717|NCT01851590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111175718|NCT01851590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111175719|NCT01851590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111175721|NCT03598816|Tremelimumab|tremelimumab|mesh-list
111175722|NCT03598816|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111175723|NCT03598816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111175724|NCT05633758|Metolazone|metolazone|mesh-list
111175725|NCT05633758|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111175726|NCT05633758|Diuretics|diuretics|mesh-ancestor
111175727|NCT05633758|Natriuretic Agents|natriuretic agents|mesh-ancestor
111175728|NCT05633758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111175729|NCT05633758|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
111175730|NCT05633758|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111175731|NCT05633758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111175732|NCT03598738|Esomeprazole|esomeprazole|mesh-list
111175733|NCT03598738|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111175734|NCT03598738|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111175735|NCT03598738|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111175736|NCT03598738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111175737|NCT03598738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111175738|NCT03594214|Vitamin D|vitamin d|mesh-list
111175739|NCT03594214|Vitamins|vitamins|mesh-ancestor
111175740|NCT03594214|Micronutrients|micronutrients|mesh-ancestor
111175741|NCT03594214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111175742|NCT03594214|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111175743|NCT04003948|Ibogaine|ibogaine|mesh-list
111175744|NCT04003948|Hallucinogens|hallucinogens|mesh-ancestor
111175745|NCT04003948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111175746|NCT04003948|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111175747|NCT04003948|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111175748|NCT04003948|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111175749|NCT04003948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111175750|NCT04003948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111175751|NCT03598582|Epoetin Alfa|epoetin alfa|mesh-list
111175752|NCT03598582|Hematinics|hematinics|mesh-ancestor
111175753|NCT01852058|Botulinum Toxins|botulinum toxins|mesh-list
111175754|NCT01852058|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111175755|NCT01852058|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111175756|NCT01852058|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111175757|NCT01852058|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111175758|NCT01852058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111175759|NCT01852058|Cholinergic Agents|cholinergic agents|mesh-ancestor
111175760|NCT01852058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111175761|NCT01852058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111175762|NCT01852058|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111175763|NCT01852058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111175764|NCT03593668|Metformin|metformin|mesh-list
111175765|NCT03593668|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111175766|NCT03593668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111175767|NCT03598348|Capecitabine|capecitabine|mesh-list
111175768|NCT03598348|Apatinib|apatinib|mesh-list
111175769|NCT03598348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111175770|NCT03598348|Antimetabolites|antimetabolites|mesh-ancestor
111175771|NCT03598348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111175772|NCT03598348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111175773|NCT03598348|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111175774|NCT03598348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111175775|NCT03976258|Naltrexone|naltrexone|mesh-list
111175776|NCT03976258|Buprenorphine|buprenorphine|mesh-list
111175777|NCT03976258|Methadone|methadone|mesh-list
111175778|NCT03976258|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
111175779|NCT03976258|Heroin|heroin|mesh-list
111175780|NCT03976258|Naloxone|naloxone|mesh-list
111175781|NCT03976258|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111175782|NCT03976258|Narcotics|narcotics|mesh-ancestor
111175783|NCT03976258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111175784|NCT03976258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111175785|NCT03976258|Analgesics|analgesics|mesh-ancestor
111175786|NCT03976258|Sensory System Agents|sensory system agents|mesh-ancestor
111175787|NCT03976258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111175788|NCT03976258|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111175789|NCT03976258|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111175790|NCT03976258|Antitussive Agents|antitussive agents|mesh-ancestor
111175791|NCT03976258|Respiratory System Agents|respiratory system agents|mesh-ancestor
111175792|NCT03598192|Sufentanil|sufentanil|mesh-list
111175793|NCT03598192|Dsuvia|dsuvia|mesh-list
111175794|NCT03598192|Ropivacaine|ropivacaine|mesh-list
111175795|NCT03598192|Anesthetics, Local|anesthetics, local|mesh-ancestor
111175796|NCT03598192|Anesthetics|anesthetics|mesh-ancestor
111175797|NCT03598192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111175798|NCT03598192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111175799|NCT03598192|Sensory System Agents|sensory system agents|mesh-ancestor
111175800|NCT03598192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111175801|NCT03598192|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111175802|NCT03598192|Narcotics|narcotics|mesh-ancestor
111175803|NCT03598192|Analgesics|analgesics|mesh-ancestor
111175804|NCT03598192|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111175805|NCT03598192|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111175806|NCT03598192|Anesthetics, General|anesthetics, general|mesh-ancestor
111175807|NCT04003246|Durvalumab|durvalumab|mesh-list
111175808|NCT04003246|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111175809|NCT04003246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111175810|NCT04003246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111175811|NCT04003246|Immunologic Factors|immunologic factors|mesh-ancestor
111175812|NCT04003246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111175813|NCT00218296|Lobeline|lobeline|mesh-list
111175814|NCT00218296|Nicotine|nicotine|mesh-list
111175815|NCT00218296|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111175816|NCT00218296|Autonomic Agents|autonomic agents|mesh-ancestor
111175817|NCT00218296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111175818|NCT00218296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111175819|NCT00218296|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111175820|NCT00218296|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111175821|NCT00218296|Cholinergic Agents|cholinergic agents|mesh-ancestor
111175822|NCT00218296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111175823|NCT00218296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111175824|NCT00218296|Respiratory System Agents|respiratory system agents|mesh-ancestor
111175825|NCT00217672|Bevacizumab|bevacizumab|mesh-list
111175826|NCT00217672|Docetaxel|docetaxel|mesh-list
111175827|NCT00217672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111175828|NCT00217672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111175829|NCT00217672|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111175830|NCT00217672|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111175831|NCT00217672|Growth Substances|growth substances|mesh-ancestor
111175832|NCT00217672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111175833|NCT00217672|Growth Inhibitors|growth inhibitors|mesh-ancestor
111175834|NCT00217672|Tubulin Modulators|tubulin modulators|mesh-ancestor
111175835|NCT00217672|Antimitotic Agents|antimitotic agents|mesh-ancestor
111175836|NCT00217672|Mitosis Modulators|mitosis modulators|mesh-ancestor
111175837|NCT00217672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111175838|NCT00216736|Dexamethasone|dexamethasone|mesh-list
111175839|NCT00216736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111175840|NCT00216736|Antiemetics|antiemetics|mesh-ancestor
111175841|NCT00216736|Autonomic Agents|autonomic agents|mesh-ancestor
111175842|NCT00216736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111175843|NCT00216736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111175844|NCT00216736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111175845|NCT00216736|Glucocorticoids|glucocorticoids|mesh-ancestor
111175846|NCT00216736|Hormones|hormones|mesh-ancestor
111175847|NCT00216736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111175848|NCT00216736|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111175849|NCT00216736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111175850|NCT01850030|Progesterone|progesterone|mesh-list
111175851|NCT01850030|Dydrogesterone|dydrogesterone|mesh-list
111175852|NCT01850030|Progestins|progestins|mesh-ancestor
111175853|NCT01850030|Hormones|hormones|mesh-ancestor
111175854|NCT01850030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111175855|NCT01850030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111175856|NCT00215644|Capecitabine|capecitabine|mesh-list
111175857|NCT00215644|Epirubicin|epirubicin|mesh-list
111175858|NCT00215644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111175859|NCT00215644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111175860|NCT00215644|Antimetabolites|antimetabolites|mesh-ancestor
111175861|NCT00215644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111175862|NCT00215644|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111175863|NCT00215644|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111175864|NCT00215644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111175865|NCT00215644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111175866|NCT00213148|Anastrozole|anastrozole|mesh-list
111175867|NCT00213148|Citric Acid|citric acid|mesh-list
111175868|NCT00213148|Sodium Citrate|sodium citrate|mesh-list
111175869|NCT00213148|Clomiphene|clomiphene|mesh-list
111175870|NCT00213148|Enclomiphene|enclomiphene|mesh-list
111175871|NCT00213148|Zuclomiphene|zuclomiphene|mesh-list
111175872|NCT00213148|Anticoagulants|anticoagulants|mesh-ancestor
111175873|NCT00213148|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
111175874|NCT00213148|Chelating Agents|chelating agents|mesh-ancestor
111175875|NCT00213148|Sequestering Agents|sequestering agents|mesh-ancestor
111175876|NCT00213148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111175877|NCT00213148|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111175878|NCT00213148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111175879|NCT00213148|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111175880|NCT00213148|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111175881|NCT00213148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111175882|NCT00213148|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111175883|NCT00213148|Hormone Antagonists|hormone antagonists|mesh-ancestor
111175884|NCT00213148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111175885|NCT00213148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111175886|NCT00213148|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111175887|NCT00213148|Fertility Agents|fertility agents|mesh-ancestor
111175888|NCT00213148|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110893035|NCT02296801|Letrozole|letrozole|mesh-list
111175889|NCT00213148|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111175890|NCT00213148|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111175892|NCT01704261|Glimepiride|glimepiride|mesh-list
111175893|NCT01704261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111175894|NCT01704261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111175895|NCT01704261|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111175896|NCT01704261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111175897|NCT01704261|Immunologic Factors|immunologic factors|mesh-ancestor
111175898|NCT00212758|Hormones|hormones|mesh-list
111175899|NCT00212758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111175900|NCT00212758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111175901|NCT01824290|Tadalafil|tadalafil|mesh-list
111175902|NCT01824290|Vasodilator Agents|vasodilator agents|mesh-ancestor
111175903|NCT01824290|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111175904|NCT01824290|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111175905|NCT01824290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111175906|NCT01824290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111175907|NCT01824290|Urological Agents|urological agents|mesh-ancestor
111175908|NCT03592342|Clobetasol|clobetasol|mesh-list
111175909|NCT03592342|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111175910|NCT03592342|Glucocorticoids|glucocorticoids|mesh-ancestor
111175911|NCT03592342|Hormones|hormones|mesh-ancestor
111175912|NCT03592342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111175913|NCT03592342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111175914|NCT01715415|Ribavirin|ribavirin|mesh-list
111175915|NCT01715415|Antimetabolites|antimetabolites|mesh-ancestor
111175916|NCT01715415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111175917|NCT01715415|Antiviral Agents|antiviral agents|mesh-ancestor
111175918|NCT01715415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111175919|NCT00211510|Insulin|insulin|mesh-list
111175920|NCT00211510|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111175921|NCT00211510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111175922|NCT04198636|Denosumab|denosumab|mesh-list
111175923|NCT04198636|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111175924|NCT04198636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111175925|NCT04414995|Acetaminophen|acetaminophen|mesh-list
111175926|NCT04414995|Ibuprofen|ibuprofen|mesh-list
111175927|NCT04414995|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111175928|NCT04414995|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111175929|NCT04414995|Analgesics|analgesics|mesh-ancestor
111175930|NCT04414995|Sensory System Agents|sensory system agents|mesh-ancestor
111175931|NCT04414995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111175932|NCT04414995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111175933|NCT04414995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111175934|NCT04414995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111175935|NCT04414995|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111175936|NCT04414995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111175937|NCT04414995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111175938|NCT04414995|Antipyretics|antipyretics|mesh-ancestor
111175939|NCT01869699|Acetaminophen|acetaminophen|mesh-list
111175940|NCT01869699|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111175941|NCT01869699|Analgesics|analgesics|mesh-ancestor
111175942|NCT01869699|Sensory System Agents|sensory system agents|mesh-ancestor
111175943|NCT01869699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111175944|NCT01869699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111175945|NCT01869699|Antipyretics|antipyretics|mesh-ancestor
111175946|NCT01875848|Buprenorphine|buprenorphine|mesh-list
111175947|NCT01875848|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
111175948|NCT01875848|Naloxone|naloxone|mesh-list
111175949|NCT01875848|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111175950|NCT01875848|Narcotics|narcotics|mesh-ancestor
111175951|NCT01875848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111175952|NCT01875848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111175953|NCT01875848|Analgesics|analgesics|mesh-ancestor
111175954|NCT01875848|Sensory System Agents|sensory system agents|mesh-ancestor
111175955|NCT01875848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111175956|NCT01875848|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111175957|NCT03591172|Propolis|propolis|mesh-list
111175958|NCT03591172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111175959|NCT04197622|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
111175960|NCT04197622|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111175961|NCT04197622|Diuretics|diuretics|mesh-ancestor
110893105|NCT02073097|Alkylating Agents|alkylating agents|mesh-ancestor
111175962|NCT04197622|Natriuretic Agents|natriuretic agents|mesh-ancestor
111175963|NCT04197622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111175964|NCT04197622|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
111175965|NCT04197622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111175966|NCT04197622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111175968|NCT03595930|Xhance|xhance|mesh-list
111175969|NCT03595930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111175970|NCT03595930|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111175971|NCT03595930|Autonomic Agents|autonomic agents|mesh-ancestor
111175972|NCT03595930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111175973|NCT03595930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111175974|NCT03595930|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111175975|NCT03595930|Respiratory System Agents|respiratory system agents|mesh-ancestor
111175976|NCT03595930|Dermatologic Agents|dermatologic agents|mesh-ancestor
111175977|NCT03595930|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111175978|NCT03595852|Cefazolin|cefazolin|mesh-list
111175979|NCT03595852|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111175980|NCT03595852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111175981|NCT04191382|Letrozole|letrozole|mesh-list
111175982|NCT04191382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111175983|NCT04191382|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111175984|NCT04191382|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111175985|NCT04191382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111175986|NCT04191382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111175987|NCT04191382|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111175988|NCT04191382|Hormone Antagonists|hormone antagonists|mesh-ancestor
111175989|NCT04191382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111175990|NCT04191382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111175991|NCT01703091|Docetaxel|docetaxel|mesh-list
111175992|NCT01703091|Ramucirumab|ramucirumab|mesh-list
111175993|NCT01703091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111175994|NCT01703091|Tubulin Modulators|tubulin modulators|mesh-ancestor
111175995|NCT01703091|Antimitotic Agents|antimitotic agents|mesh-ancestor
111175996|NCT01703091|Mitosis Modulators|mitosis modulators|mesh-ancestor
111175997|NCT01703091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111175998|NCT04196998|Tenofovir|tenofovir|mesh-list
111175999|NCT04196998|Entecavir|entecavir|mesh-list
111176000|NCT04196998|Antiviral Agents|antiviral agents|mesh-ancestor
111176001|NCT04196998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111176002|NCT04196998|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111176003|NCT04196998|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111176004|NCT04196998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111176005|NCT04196998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111176006|NCT04196998|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111176007|NCT04196998|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111176008|NCT04196452|Ipilimumab|ipilimumab|mesh-list
111176009|NCT04196452|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111176010|NCT04196452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111176011|NCT04196452|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111176012|NCT04196452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111176013|NCT01867671|Immunomodulating Agents|immunomodulating agents|mesh-list
110488226|NCT05150431|Parecoxib|parecoxib|mesh-list
111176014|NCT01867671|Immunologic Factors|immunologic factors|mesh-list
111176015|NCT01867671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111176016|NCT03967054|Ivermectin|ivermectin|mesh-list
111176017|NCT03967054|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111176018|NCT03967054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111176019|NCT01702311|Insulin Aspart|insulin aspart|mesh-list
111176020|NCT01702311|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111176021|NCT01702311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111176022|NCT04196608|Tazobactam|tazobactam|mesh-list
111176023|NCT04196608|Imipenem|imipenem|mesh-list
111176024|NCT04196608|Ceftolozane|ceftolozane|mesh-list
111176025|NCT04196608|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
111176026|NCT04196608|Relebactam|relebactam|mesh-list
111176027|NCT04196608|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111176028|NCT04196608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111176029|NCT04196608|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
111176030|NCT04196608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111176031|NCT04196608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111176032|NCT04196608|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111176033|NCT04022200|Paclitaxel|paclitaxel|mesh-list
111176034|NCT04022200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111176035|NCT04022200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111176036|NCT04022200|Tubulin Modulators|tubulin modulators|mesh-ancestor
111176037|NCT04022200|Antimitotic Agents|antimitotic agents|mesh-ancestor
111176038|NCT04022200|Mitosis Modulators|mitosis modulators|mesh-ancestor
111176039|NCT04022200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111176040|NCT04552743|Plerixafor|plerixafor|mesh-list
111176041|NCT04552743|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111176042|NCT04552743|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111176043|NCT04552743|Antiviral Agents|antiviral agents|mesh-ancestor
111176044|NCT04552743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111176045|NCT03590080|Methylprednisolone|methylprednisolone|mesh-list
111176046|NCT03590080|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111176047|NCT03590080|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111176048|NCT03590080|Prednisolone|prednisolone|mesh-list
111176049|NCT03590080|Prednisolone acetate|prednisolone acetate|mesh-list
111176050|NCT03590080|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111176051|NCT03590080|Prednisolone phosphate|prednisolone phosphate|mesh-list
111176052|NCT03590080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111176053|NCT03590080|Antiemetics|antiemetics|mesh-ancestor
111176054|NCT03590080|Autonomic Agents|autonomic agents|mesh-ancestor
111176055|NCT03590080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111176056|NCT03590080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111176057|NCT03590080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111176058|NCT03590080|Glucocorticoids|glucocorticoids|mesh-ancestor
111176059|NCT03590080|Hormones|hormones|mesh-ancestor
111176060|NCT03590080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111176061|NCT03590080|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111176062|NCT03590080|Protective Agents|protective agents|mesh-ancestor
111176063|NCT03590080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111176064|NCT03590080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111176065|NCT04028362|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
111176066|NCT04028362|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111176067|NCT04028362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111176068|NCT04028362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111176069|NCT03594058|Solabegron|solabegron|mesh-list
110488233|NCT05150431|Analgesics|analgesics|mesh-ancestor
111176070|NCT03594058|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
111176071|NCT03594058|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111176072|NCT03594058|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111176073|NCT03594058|Adrenergic Agents|adrenergic agents|mesh-ancestor
111176074|NCT03594058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111176075|NCT03594058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111176076|NCT03594058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111176078|NCT04194658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111176079|NCT04194658|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111176080|NCT04194658|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111176081|NCT04194658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111176082|NCT04194658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111176083|NCT04194658|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111176084|NCT04194658|Hormone Antagonists|hormone antagonists|mesh-ancestor
111176085|NCT04194658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111176086|NCT04194658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111176087|NCT04028518|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
111176088|NCT04028518|Plasminogen|plasminogen|mesh-list
111176089|NCT04028518|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111176090|NCT04028518|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111176091|NCT04028518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111176092|NCT04747678|Ivermectin|ivermectin|mesh-list
111176093|NCT04747678|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111176094|NCT04747678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111176095|NCT04027972|Glycopyrrolate|glycopyrrolate|mesh-list
111176096|NCT04027972|Neostigmine|neostigmine|mesh-list
111176097|NCT04027972|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111176098|NCT04027972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111176099|NCT04027972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111176100|NCT04027972|Cholinergic Agents|cholinergic agents|mesh-ancestor
111176101|NCT04027972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111176102|NCT04027972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111176103|NCT04027972|Parasympathomimetics|parasympathomimetics|mesh-ancestor
111176104|NCT04027972|Autonomic Agents|autonomic agents|mesh-ancestor
111176105|NCT04027972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111176106|NCT04027972|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111176107|NCT04027972|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111176108|NCT04027972|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111176109|NCT04191928|Apixaban|apixaban|mesh-list
111176110|NCT04191928|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111176111|NCT04191928|Antithrombins|antithrombins|mesh-ancestor
111176112|NCT04191928|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111176113|NCT04191928|Protease Inhibitors|protease inhibitors|mesh-ancestor
111176114|NCT04191928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111176115|NCT04191928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111176116|NCT04191928|Anticoagulants|anticoagulants|mesh-ancestor
111176117|NCT04199494|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111176118|NCT04199494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111176119|NCT04027192|Midazolam|midazolam|mesh-list
111176120|NCT04027192|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111176121|NCT04027192|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111176122|NCT04027192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111176123|NCT04027192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111176124|NCT04027192|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111176125|NCT04027192|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111176126|NCT04027192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111176127|NCT04027192|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111176128|NCT04027192|Anesthetics, General|anesthetics, general|mesh-ancestor
111176129|NCT04027192|Anesthetics|anesthetics|mesh-ancestor
111176130|NCT04027192|GABA Modulators|gaba modulators|mesh-ancestor
111176131|NCT04027192|GABA Agents|gaba agents|mesh-ancestor
111176132|NCT04027192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111176133|NCT04027192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111176134|NCT04406506|Erythromycin|erythromycin|mesh-list
111176135|NCT04406506|Erythromycin Estolate|erythromycin estolate|mesh-list
111176136|NCT04406506|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
111176137|NCT04406506|Erythromycin stearate|erythromycin stearate|mesh-list
111176138|NCT04406506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111176139|NCT04406506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111176140|NCT04406506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111176141|NCT04406506|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111176142|NCT04406506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111176143|NCT04406506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111176144|NCT03828292|Dexamethasone|dexamethasone|mesh-list
111176146|NCT03828292|Pomalidomide|pomalidomide|mesh-list
111176147|NCT03828292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111176148|NCT03828292|Antiemetics|antiemetics|mesh-ancestor
111176149|NCT03828292|Autonomic Agents|autonomic agents|mesh-ancestor
111176150|NCT03828292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111176151|NCT03828292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111176152|NCT03828292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111176153|NCT03828292|Glucocorticoids|glucocorticoids|mesh-ancestor
111176154|NCT03828292|Hormones|hormones|mesh-ancestor
111176155|NCT03828292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111176156|NCT03828292|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111176157|NCT03828292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111176158|NCT03828292|Immunologic Factors|immunologic factors|mesh-ancestor
111176159|NCT03828292|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111176160|NCT03828292|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111176161|NCT03828292|Growth Substances|growth substances|mesh-ancestor
111176162|NCT03828292|Growth Inhibitors|growth inhibitors|mesh-ancestor
111176163|NCT04191694|Ondansetron|ondansetron|mesh-list
111176164|NCT04191694|Antiemetics|antiemetics|mesh-ancestor
111176165|NCT04191694|Autonomic Agents|autonomic agents|mesh-ancestor
111176166|NCT04191694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111176167|NCT04191694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111176168|NCT04191694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111176169|NCT04191694|Antipruritics|antipruritics|mesh-ancestor
111176170|NCT04191694|Dermatologic Agents|dermatologic agents|mesh-ancestor
111176171|NCT04191694|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111176172|NCT04191694|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111176173|NCT04191694|Serotonin Agents|serotonin agents|mesh-ancestor
111176174|NCT04191694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111176175|NCT04191694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111176176|NCT04026022|Fentanyl|fentanyl|mesh-list
111176177|NCT04026022|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111176178|NCT04026022|Narcotics|narcotics|mesh-ancestor
111176179|NCT04026022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111176180|NCT04026022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111176181|NCT04026022|Analgesics|analgesics|mesh-ancestor
111176182|NCT04026022|Sensory System Agents|sensory system agents|mesh-ancestor
111176183|NCT04026022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111176184|NCT04026022|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111176185|NCT04026022|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111176186|NCT04026022|Anesthetics, General|anesthetics, general|mesh-ancestor
111176187|NCT04026022|Anesthetics|anesthetics|mesh-ancestor
110893331|NCT02087540|Antimetabolites|antimetabolites|mesh-ancestor
111176188|NCT04020406|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111176189|NCT04020406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111176190|NCT04020328|Prednisone|prednisone|mesh-list
111176191|NCT04020328|Leflunomide|leflunomide|mesh-list
111176192|NCT04020328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111176193|NCT04020328|Glucocorticoids|glucocorticoids|mesh-ancestor
111176194|NCT04020328|Hormones|hormones|mesh-ancestor
111176195|NCT04020328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111176196|NCT04020328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111176197|NCT04020328|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111176198|NCT04020328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111176199|NCT04020328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111176200|NCT04020328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111176201|NCT04020328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111176202|NCT04020328|Immunologic Factors|immunologic factors|mesh-ancestor
111176203|NCT04020094|Atezolizumab|atezolizumab|mesh-list
111176204|NCT04020094|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111176205|NCT04020094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111176206|NCT04020094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111176207|NCT04020094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111176208|NCT02080468|Norgestimate|norgestimate|mesh-list
111176209|NCT02080468|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111176210|NCT02080468|Contraceptive Agents|contraceptive agents|mesh-ancestor
110843400|NCT01155791|Tubulin Modulators|tubulin modulators|mesh-ancestor
111176211|NCT02080468|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111176212|NCT02080468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111176213|NCT02080468|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111176214|NCT02080468|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111176215|NCT02080468|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111176216|NCT04020016|Nalbuphine|nalbuphine|mesh-list
111176217|NCT04020016|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111176218|NCT04020016|Narcotics|narcotics|mesh-ancestor
111176219|NCT04020016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111176220|NCT04020016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111176221|NCT04020016|Analgesics|analgesics|mesh-ancestor
111176222|NCT04020016|Sensory System Agents|sensory system agents|mesh-ancestor
111176223|NCT04020016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111176224|NCT01874054|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
111176225|NCT01874054|Brentuximab Vedotin|brentuximab vedotin|mesh-list
111176226|NCT01874054|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111176227|NCT01874054|Alkylating Agents|alkylating agents|mesh-ancestor
111176228|NCT01874054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111176229|NCT01874054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111176230|NCT01874054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111176231|NCT01874054|Immunotoxins|immunotoxins|mesh-ancestor
111176232|NCT01874054|Immunoconjugates|immunoconjugates|mesh-ancestor
111176233|NCT01874054|Immunologic Factors|immunologic factors|mesh-ancestor
111176234|NCT01874054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111176235|NCT04029610|Lidocaine|lidocaine|mesh-list
111176236|NCT04029610|Epinephrine|epinephrine|mesh-list
111176237|NCT04029610|Racepinephrine|racepinephrine|mesh-list
111176238|NCT04029610|Epinephryl borate|epinephryl borate|mesh-list
111176239|NCT04029610|Anesthetics, Local|anesthetics, local|mesh-ancestor
111176240|NCT04029610|Anesthetics|anesthetics|mesh-ancestor
111176241|NCT04029610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111176242|NCT04029610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111176243|NCT04029610|Sensory System Agents|sensory system agents|mesh-ancestor
111176244|NCT04029610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111176245|NCT04029610|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111176246|NCT04029610|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111176247|NCT04029610|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111176248|NCT04029610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111176249|NCT04029610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111176250|NCT04029610|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111176251|NCT04029610|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111176252|NCT04029610|Adrenergic Agents|adrenergic agents|mesh-ancestor
111176253|NCT04029610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111176254|NCT04029610|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111176255|NCT04029610|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111176256|NCT04029610|Autonomic Agents|autonomic agents|mesh-ancestor
111176257|NCT04029610|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111176258|NCT04029610|Respiratory System Agents|respiratory system agents|mesh-ancestor
111176259|NCT04029610|Mydriatics|mydriatics|mesh-ancestor
111176260|NCT04029610|Sympathomimetics|sympathomimetics|mesh-ancestor
111176261|NCT04029610|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111176262|NCT04026880|Methyltestosterone|methyltestosterone|mesh-list
111176263|NCT04026880|Testosterone|testosterone|mesh-list
110893431|NCT02091908|Lactitol|lactitol|mesh-list
111176264|NCT04026880|Testosterone undecanoate|testosterone undecanoate|mesh-list
111176266|NCT04026880|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
111176267|NCT04026880|Androgens|androgens|mesh-ancestor
111176268|NCT04026880|Hormones|hormones|mesh-ancestor
111176269|NCT04026880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111176270|NCT04026880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111176271|NCT04026880|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111176272|NCT04026880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111176273|NCT04026880|Anabolic Agents|anabolic agents|mesh-ancestor
111176274|NCT04024384|Daratumumab|daratumumab|mesh-list
111176275|NCT04024384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111176276|NCT04023760|Apixaban|apixaban|mesh-list
111176277|NCT04023760|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111176278|NCT04023760|Antithrombins|antithrombins|mesh-ancestor
111176279|NCT04023760|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111176280|NCT04023760|Protease Inhibitors|protease inhibitors|mesh-ancestor
111176281|NCT04023760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110843406|NCT01155791|Hormones|hormones|mesh-ancestor
111176282|NCT04023760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111176283|NCT04023760|Anticoagulants|anticoagulants|mesh-ancestor
111176284|NCT04020718|Nicotine|nicotine|mesh-list
111176285|NCT04020718|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111176286|NCT04020718|Autonomic Agents|autonomic agents|mesh-ancestor
111176287|NCT04020718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111176288|NCT04020718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111176289|NCT04020718|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111176290|NCT04020718|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111176291|NCT04020718|Cholinergic Agents|cholinergic agents|mesh-ancestor
111176292|NCT04020718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111176293|NCT04020718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111176294|NCT04027348|Dexamethasone|dexamethasone|mesh-list
111176295|NCT04027348|Octreotide|octreotide|mesh-list
111176296|NCT04027348|Metoclopramide|metoclopramide|mesh-list
111176297|NCT04027348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111176298|NCT04027348|Antiemetics|antiemetics|mesh-ancestor
111176299|NCT04027348|Autonomic Agents|autonomic agents|mesh-ancestor
111176300|NCT04027348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111176301|NCT04027348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111176302|NCT04027348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111176303|NCT04027348|Glucocorticoids|glucocorticoids|mesh-ancestor
111176304|NCT04027348|Hormones|hormones|mesh-ancestor
111176305|NCT04027348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111176306|NCT04027348|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111176307|NCT04027348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111176308|NCT04027348|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111176309|NCT04027348|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111176310|NCT04027348|Dopamine Agents|dopamine agents|mesh-ancestor
111176311|NCT04027348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111176312|NCT04027348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111176313|NCT04195204|Tropisetron|tropisetron|mesh-list
111176314|NCT04195204|Antiemetics|antiemetics|mesh-ancestor
111176315|NCT04195204|Autonomic Agents|autonomic agents|mesh-ancestor
111176316|NCT04195204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111176317|NCT04195204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111176318|NCT04195204|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111176319|NCT04195204|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111176320|NCT04195204|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111176321|NCT04195204|Serotonin Agents|serotonin agents|mesh-ancestor
111176322|NCT04195204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111176323|NCT04195204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111176324|NCT04023292|Tamoxifen|tamoxifen|mesh-list
111176325|NCT04023292|Letrozole|letrozole|mesh-list
111176326|NCT04023292|Exemestane|exemestane|mesh-list
111176327|NCT04023292|Anastrozole|anastrozole|mesh-list
111176328|NCT04023292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111176329|NCT04023292|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111176330|NCT04023292|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111176331|NCT04023292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111176332|NCT04023292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111176333|NCT04023292|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111176334|NCT04023292|Hormone Antagonists|hormone antagonists|mesh-ancestor
111176335|NCT04023292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111176336|NCT04023292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111176337|NCT04023292|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110893483|NCT02092376|Vitamins|vitamins|mesh-ancestor
111176338|NCT04023292|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111176339|NCT04023292|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111176340|NCT04023292|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111176341|NCT03022240|Ondansetron|ondansetron|mesh-list
111176342|NCT03022240|Propofol|propofol|mesh-list
111176343|NCT03022240|Sevoflurane|sevoflurane|mesh-list
111176344|NCT03022240|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111176345|NCT03022240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111176346|NCT03022240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111176347|NCT03022240|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111176348|NCT03022240|Anesthetics, General|anesthetics, general|mesh-ancestor
111176349|NCT03022240|Anesthetics|anesthetics|mesh-ancestor
111176350|NCT03022240|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111176351|NCT03022240|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111176352|NCT03022240|Antiemetics|antiemetics|mesh-ancestor
111176353|NCT03022240|Autonomic Agents|autonomic agents|mesh-ancestor
111176354|NCT03022240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111176355|NCT03022240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111176356|NCT03022240|Antipruritics|antipruritics|mesh-ancestor
111176357|NCT03022240|Dermatologic Agents|dermatologic agents|mesh-ancestor
111176358|NCT03022240|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111176359|NCT03022240|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111176360|NCT03022240|Serotonin Agents|serotonin agents|mesh-ancestor
111176361|NCT03022240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111176362|NCT03022240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111176363|NCT02704390|Methylphenidate|methylphenidate|mesh-list
111176364|NCT02704390|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111176365|NCT02704390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111176366|NCT02704390|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111176367|NCT02704390|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111176368|NCT02704390|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111176369|NCT02704390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111176370|NCT02704390|Dopamine Agents|dopamine agents|mesh-ancestor
111176371|NCT02704390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111176372|NCT04147390|Mycophenolic Acid|mycophenolic acid|mesh-list
111176373|NCT04147390|Tacrolimus|tacrolimus|mesh-list
111176374|NCT04147390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111176375|NCT04147390|Immunologic Factors|immunologic factors|mesh-ancestor
111176376|NCT04147390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111176377|NCT04147390|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111176378|NCT04147390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111176379|NCT04147390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111176380|NCT04147390|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111176381|NCT04147390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111176382|NCT04147390|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111176383|NCT04147390|Antitubercular Agents|antitubercular agents|mesh-ancestor
111176384|NCT04147390|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111176385|NCT04147390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111176386|NCT02708680|Atezolizumab|atezolizumab|mesh-list
111176387|NCT02708680|Entinostat|entinostat|mesh-list
111176388|NCT02708680|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111176389|NCT02708680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111176390|NCT02708680|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111176391|NCT02708680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111176392|NCT02708680|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111176393|NCT02708680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111176394|NCT03932656|Psychotropic Drugs|psychotropic drugs|mesh-list
111176395|NCT03931642|Blinatumomab|blinatumomab|mesh-list
111176396|NCT03931642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111176397|NCT04021420|Nivolumab|nivolumab|mesh-list
111176398|NCT04021420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111176399|NCT04021420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111176400|NCT04021420|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111176401|NCT04021420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111176402|NCT04144582|Docetaxel|docetaxel|mesh-list
111176403|NCT04144582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111176404|NCT04144582|Tubulin Modulators|tubulin modulators|mesh-ancestor
111176405|NCT04144582|Antimitotic Agents|antimitotic agents|mesh-ancestor
111176406|NCT04144582|Mitosis Modulators|mitosis modulators|mesh-ancestor
110488277|NCT05013502|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111176407|NCT04144582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111176408|NCT01611974|Maribavir|maribavir|mesh-list
111176409|NCT01611974|Antiviral Agents|antiviral agents|mesh-ancestor
111176410|NCT01611974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110893559|NCT02093000|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111176411|NCT01871870|Pancrelipase|pancrelipase|mesh-list
111176412|NCT01871870|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111176413|NCT02080780|Clarithromycin|clarithromycin|mesh-list
111176414|NCT02080780|Diltiazem|diltiazem|mesh-list
111176415|NCT02080780|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111176416|NCT02080780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111176417|NCT02080780|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111176418|NCT02080780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111176419|NCT02080780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111176420|NCT02080780|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111176421|NCT02080780|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111176422|NCT02080780|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111176423|NCT02080780|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111176424|NCT02080780|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111176425|NCT02080780|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111176426|NCT02080780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111176427|NCT02080780|Vasodilator Agents|vasodilator agents|mesh-ancestor
111176428|NCT01871558|Metformin|metformin|mesh-list
111176429|NCT01871558|Vildagliptin|vildagliptin|mesh-list
111176430|NCT01871558|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111176431|NCT01871558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111176432|NCT01871558|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111176433|NCT01871558|Protease Inhibitors|protease inhibitors|mesh-ancestor
111176434|NCT01871558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111176435|NCT01871558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111176436|NCT01711359|Folic Acid|folic acid|mesh-list
111176437|NCT01711359|Methotrexate|methotrexate|mesh-list
111176438|NCT01711359|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111176439|NCT01711359|Abortifacient Agents|abortifacient agents|mesh-ancestor
111176440|NCT01711359|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111176441|NCT01711359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111176442|NCT01711359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111176443|NCT01711359|Antimetabolites|antimetabolites|mesh-ancestor
111176444|NCT01711359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111176445|NCT01711359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111176446|NCT01711359|Dermatologic Agents|dermatologic agents|mesh-ancestor
111176447|NCT01711359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111176448|NCT01711359|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111176449|NCT01711359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111176450|NCT01711359|Immunologic Factors|immunologic factors|mesh-ancestor
111176451|NCT01711359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111176452|NCT01711359|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111176453|NCT01711359|Hematinics|hematinics|mesh-ancestor
111176454|NCT01711359|Vitamin B Complex|vitamin b complex|mesh-ancestor
111176455|NCT01711359|Vitamins|vitamins|mesh-ancestor
111176456|NCT01711359|Micronutrients|micronutrients|mesh-ancestor
111176457|NCT04140136|Tocotrienols|tocotrienols|mesh-list
111176458|NCT04140136|Vitamin E|vitamin e|mesh-list
111176459|NCT04140136|Tocopherols|tocopherols|mesh-list
111176460|NCT04140136|Antioxidants|antioxidants|mesh-ancestor
111176461|NCT04140136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111176462|NCT04140136|Protective Agents|protective agents|mesh-ancestor
111176463|NCT04140136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111176464|NCT04140136|Vitamins|vitamins|mesh-ancestor
111176465|NCT04140136|Micronutrients|micronutrients|mesh-ancestor
111176466|NCT04146532|Aspirin|aspirin|mesh-list
111176467|NCT04146532|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111176468|NCT04146532|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111176469|NCT04146532|Analgesics|analgesics|mesh-ancestor
111176470|NCT04146532|Sensory System Agents|sensory system agents|mesh-ancestor
111176471|NCT04146532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111176472|NCT04146532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111176473|NCT04146532|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111176474|NCT04146532|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111176475|NCT04146532|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111176476|NCT04146532|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111176477|NCT04146532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111176478|NCT04146532|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111176479|NCT04146532|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111176480|NCT04146532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111176481|NCT04146532|Antipyretics|antipyretics|mesh-ancestor
111176482|NCT03929224|Bacitracin|bacitracin|mesh-list
111176483|NCT03929224|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111176484|NCT03929224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111176485|NCT03929224|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111176486|NCT04146610|Antibodies|antibodies|mesh-list
111176488|NCT04146610|Immunologic Factors|immunologic factors|mesh-ancestor
111176489|NCT04146610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111176490|NCT04146376|Tranexamic Acid|tranexamic acid|mesh-list
111176491|NCT04146376|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111176492|NCT04146376|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111176493|NCT04146376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111176494|NCT04146376|Hemostatics|hemostatics|mesh-ancestor
111176495|NCT04146376|Coagulants|coagulants|mesh-ancestor
111176497|NCT01710657|Anticonvulsants|anticonvulsants|mesh-ancestor
111176498|NCT01710657|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111176499|NCT01710657|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111176500|NCT01710657|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111176501|NCT01710657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111176502|NCT03021772|Dexamethasone|dexamethasone|mesh-list
111176503|NCT03021772|Neostigmine|neostigmine|mesh-list
111176504|NCT03021772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111176505|NCT03021772|Antiemetics|antiemetics|mesh-ancestor
111176506|NCT03021772|Autonomic Agents|autonomic agents|mesh-ancestor
111176507|NCT03021772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111176508|NCT03021772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111176509|NCT03021772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111176510|NCT03021772|Glucocorticoids|glucocorticoids|mesh-ancestor
111176511|NCT03021772|Hormones|hormones|mesh-ancestor
111176512|NCT03021772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111176513|NCT03021772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111176514|NCT03021772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111176515|NCT03021772|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111176516|NCT03021772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111176517|NCT03021772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111176518|NCT03021772|Cholinergic Agents|cholinergic agents|mesh-ancestor
111176519|NCT03021772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111176520|NCT03021772|Parasympathomimetics|parasympathomimetics|mesh-ancestor
111176521|NCT04149262|Insulin Aspart|insulin aspart|mesh-list
111176522|NCT04149262|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111176523|NCT04149262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111176524|NCT05581420|Ferrous fumarate|ferrous fumarate|mesh-list
111176525|NCT05581420|Trace Elements|trace elements|mesh-ancestor
111176526|NCT05581420|Micronutrients|micronutrients|mesh-ancestor
111176527|NCT05581420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111176528|NCT03904498|Tolcapone|tolcapone|mesh-list
111176529|NCT03904498|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111176530|NCT03904498|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111176531|NCT03904498|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
111176532|NCT03904498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111176533|NCT03904498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111176534|NCT04405960|Alfacalcidol|alfacalcidol|mesh-list
111176535|NCT04405960|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
111176536|NCT04405960|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111176537|NCT04405960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111176538|NCT04405960|Vitamins|vitamins|mesh-ancestor
111176539|NCT04405960|Micronutrients|micronutrients|mesh-ancestor
111176540|NCT03945604|Apatinib|apatinib|mesh-list
111176541|NCT03945604|Fluzoparib|fluzoparib|mesh-list
111176542|NCT03945604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111176543|NCT03945604|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111176544|NCT03945604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111176545|NCT03945604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111176546|NCT03945604|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111176547|NCT03944356|Trametinib|trametinib|mesh-list
111176548|NCT03944356|Dabrafenib|dabrafenib|mesh-list
111176549|NCT03944356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111176550|NCT03944356|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111176551|NCT03944356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111176552|NCT03944356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111176553|NCT01701063|Ribavirin|ribavirin|mesh-list
111176554|NCT01701063|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
111176555|NCT01701063|Antimetabolites|antimetabolites|mesh-ancestor
111176556|NCT01701063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111176557|NCT01701063|Antiviral Agents|antiviral agents|mesh-ancestor
111176558|NCT01701063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111176559|NCT03920722|Rituximab|rituximab|mesh-list
111176560|NCT03920722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110893723|NCT02099240|Cefprozil|cefprozil|mesh-list
111176561|NCT03920722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111176563|NCT03920722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111176564|NCT03920722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111176565|NCT05580094|Anesthetics|anesthetics|mesh-list
111176566|NCT05580094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111176567|NCT05580094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111176568|NCT05589766|Niacinamide|niacinamide|mesh-list
111176569|NCT05589766|Niacin|niacin|mesh-list
111176570|NCT05589766|Nicotinic Acids|nicotinic acids|mesh-list
111176571|NCT05589766|Vitamin B Complex|vitamin b complex|mesh-ancestor
111176572|NCT05589766|Vitamins|vitamins|mesh-ancestor
111176573|NCT05589766|Micronutrients|micronutrients|mesh-ancestor
111176574|NCT05589766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111176575|NCT05589766|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111176576|NCT05589766|Antimetabolites|antimetabolites|mesh-ancestor
111176577|NCT05589766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111176578|NCT05589766|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111176579|NCT05589766|Vasodilator Agents|vasodilator agents|mesh-ancestor
111176580|NCT05586100|Cetuximab|cetuximab|mesh-list
111176581|NCT05586100|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111176582|NCT05586100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111176583|NCT05585086|Peppermint oil|peppermint oil|mesh-list
111176584|NCT05585086|Antiemetics|antiemetics|mesh-ancestor
111176585|NCT05585086|Autonomic Agents|autonomic agents|mesh-ancestor
111176586|NCT05585086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111176587|NCT05585086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111176588|NCT05585086|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111176589|NCT05585086|Parasympatholytics|parasympatholytics|mesh-ancestor
111176590|NCT01710501|Interferons|interferons|mesh-list
111176591|NCT01710501|Ribavirin|ribavirin|mesh-list
111176592|NCT01710501|Interferon-alpha|interferon-alpha|mesh-list
111176593|NCT01710501|Interferon alpha-2|interferon alpha-2|mesh-list
111176594|NCT01710501|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
111176595|NCT01710501|Grazoprevir|grazoprevir|mesh-list
111176596|NCT01710501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111176597|NCT01710501|Antiviral Agents|antiviral agents|mesh-ancestor
111176598|NCT01710501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111176599|NCT01710501|Antimetabolites|antimetabolites|mesh-ancestor
111176600|NCT01710501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111176601|NCT01710501|Immunologic Factors|immunologic factors|mesh-ancestor
111176602|NCT01710501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111176603|NCT05583058|Hormones|hormones|mesh-list
111176604|NCT05583058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111176605|NCT05583058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111176606|NCT01700829|Midazolam|midazolam|mesh-list
111176607|NCT01700829|Ketamine|ketamine|mesh-list
111176608|NCT01700829|Analgesics|analgesics|mesh-ancestor
111176609|NCT01700829|Sensory System Agents|sensory system agents|mesh-ancestor
111176610|NCT01700829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111176611|NCT01700829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111176612|NCT01700829|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111176613|NCT01700829|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111176614|NCT01700829|Anesthetics, General|anesthetics, general|mesh-ancestor
111176615|NCT01700829|Anesthetics|anesthetics|mesh-ancestor
111176616|NCT01700829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111176617|NCT01700829|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111176618|NCT01700829|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111176619|NCT01700829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111176620|NCT01700829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111176621|NCT01700829|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111176622|NCT01700829|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111176623|NCT01700829|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111176624|NCT01700829|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111176625|NCT01700829|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111176626|NCT01700829|GABA Modulators|gaba modulators|mesh-ancestor
111176627|NCT01700829|GABA Agents|gaba agents|mesh-ancestor
111176628|NCT04143880|Progesterone|progesterone|mesh-list
111176629|NCT04143880|Progestins|progestins|mesh-ancestor
111176630|NCT04143880|Hormones|hormones|mesh-ancestor
111176631|NCT04143880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111176632|NCT04143880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111176633|NCT04144192|Lidocaine|lidocaine|mesh-list
111176634|NCT04144192|Anesthetics, Local|anesthetics, local|mesh-ancestor
111176635|NCT04144192|Anesthetics|anesthetics|mesh-ancestor
111176636|NCT04144192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111176637|NCT04144192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111176638|NCT04144192|Sensory System Agents|sensory system agents|mesh-ancestor
111176639|NCT04144192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111176640|NCT04144192|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111176641|NCT04144192|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111176642|NCT04144192|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111176643|NCT04144192|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111176644|NCT04144192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111176645|NCT01710345|Sufentanil|sufentanil|mesh-list
111176646|NCT01710345|Dsuvia|dsuvia|mesh-list
111176647|NCT01710345|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111176648|NCT01710345|Narcotics|narcotics|mesh-ancestor
111176649|NCT01710345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111176650|NCT01710345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111176651|NCT01710345|Analgesics|analgesics|mesh-ancestor
111176652|NCT01710345|Sensory System Agents|sensory system agents|mesh-ancestor
111176653|NCT01710345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111176654|NCT01710345|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111176655|NCT01710345|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111176656|NCT01710345|Anesthetics, General|anesthetics, general|mesh-ancestor
111176657|NCT01710345|Anesthetics|anesthetics|mesh-ancestor
111176658|NCT03022006|Grazoprevir|grazoprevir|mesh-list
111176659|NCT03022006|Antiviral Agents|antiviral agents|mesh-ancestor
111176660|NCT03022006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111176661|NCT04143256|Menthol|menthol|mesh-list
111176662|NCT04143256|Antipruritics|antipruritics|mesh-ancestor
111176663|NCT04143256|Dermatologic Agents|dermatologic agents|mesh-ancestor
111176664|NCT04143412|Ramipril|ramipril|mesh-list
111176665|NCT04143412|Eplerenone|eplerenone|mesh-list
111176666|NCT04143412|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
111176667|NCT04143412|Protease Inhibitors|protease inhibitors|mesh-ancestor
111176668|NCT04143412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111176669|NCT04143412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111176670|NCT04143412|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111176671|NCT04143412|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
111176672|NCT04143412|Hormone Antagonists|hormone antagonists|mesh-ancestor
111176673|NCT04143412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111176674|NCT04143412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111176675|NCT04143412|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
111176676|NCT04143412|Diuretics|diuretics|mesh-ancestor
111176677|NCT04143412|Natriuretic Agents|natriuretic agents|mesh-ancestor
111176678|NCT05582278|Lenvatinib|lenvatinib|mesh-list
111176679|NCT05582278|Tislelizumab|tislelizumab|mesh-list
110488314|NCT04909853|Ritonavir|ritonavir|mesh-list
111176680|NCT05582278|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
111176681|NCT05582278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111176682|NCT05582278|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111176683|NCT05582278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111176684|NCT05582278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111176685|NCT05582278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111176686|NCT01710033|Tofacitinib|tofacitinib|mesh-list
111176687|NCT01710033|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
111176688|NCT01710033|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111176689|NCT01710033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111176690|NCT01710033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111176692|NCT01822496|Etoposide|etoposide|mesh-list
111176693|NCT01822496|Podophyllotoxin|podophyllotoxin|mesh-list
111176694|NCT01822496|Cisplatin|cisplatin|mesh-list
111176695|NCT01822496|Carboplatin|carboplatin|mesh-list
111176696|NCT01822496|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111176697|NCT01822496|Etoposide phosphate|etoposide phosphate|mesh-list
111176698|NCT01822496|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111176699|NCT01822496|Crizotinib|crizotinib|mesh-list
111176700|NCT01822496|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
111176701|NCT01822496|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111176702|NCT01822496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111176703|NCT01822496|Tubulin Modulators|tubulin modulators|mesh-ancestor
111176704|NCT01822496|Antimitotic Agents|antimitotic agents|mesh-ancestor
111176705|NCT01822496|Mitosis Modulators|mitosis modulators|mesh-ancestor
111176706|NCT01822496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111176707|NCT01822496|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111176708|NCT01822496|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111176709|NCT01822496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111176710|NCT01822496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111176711|NCT01822496|Keratolytic Agents|keratolytic agents|mesh-ancestor
111176712|NCT01822496|Dermatologic Agents|dermatologic agents|mesh-ancestor
111176713|NCT01867047|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
111176714|NCT01867047|Protease Inhibitors|protease inhibitors|mesh-ancestor
111176715|NCT01867047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111176716|NCT01867047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111176717|NCT03588988|Dexmedetomidine|dexmedetomidine|mesh-list
111176718|NCT03588988|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111176719|NCT03588988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111176720|NCT03588988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111176721|NCT03588988|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111176722|NCT03588988|Analgesics|analgesics|mesh-ancestor
111176723|NCT03588988|Sensory System Agents|sensory system agents|mesh-ancestor
111176724|NCT03588988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111176725|NCT03588988|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111176726|NCT03588988|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111176727|NCT03588988|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111176728|NCT03588988|Adrenergic Agents|adrenergic agents|mesh-ancestor
111176729|NCT03588988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111176730|NCT03588988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111176731|NCT04414137|Daptomycin|daptomycin|mesh-list
111176732|NCT04414137|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111176733|NCT04414137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111176734|NCT01821560|Baclofen|baclofen|mesh-list
111176735|NCT01821560|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
111176736|NCT01821560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111176737|NCT01821560|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111176738|NCT01821560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111176739|NCT01821560|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
111176740|NCT01821560|GABA Agonists|gaba agonists|mesh-ancestor
111176741|NCT01821560|GABA Agents|gaba agents|mesh-ancestor
111176742|NCT01821560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111176743|NCT01821560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111176744|NCT05580328|Hematoporphyrins|hematoporphyrins|mesh-list
111176745|NCT05580328|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111176746|NCT05580328|Dermatologic Agents|dermatologic agents|mesh-ancestor
111176747|NCT03588676|Melatonin|melatonin|mesh-list
111176748|NCT03588676|Antioxidants|antioxidants|mesh-ancestor
111176749|NCT03588676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111176750|NCT03588676|Protective Agents|protective agents|mesh-ancestor
111176751|NCT03588676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111176752|NCT03588676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111176753|NCT01846442|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
111176754|NCT01846442|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111176755|NCT01846442|Immunologic Factors|immunologic factors|mesh-ancestor
111176756|NCT01846442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111176757|NCT01709721|Hydromorphone|hydromorphone|mesh-list
111176758|NCT01709721|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111176759|NCT01709721|Narcotics|narcotics|mesh-ancestor
111176760|NCT01709721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111176761|NCT01709721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111176763|NCT01709721|Sensory System Agents|sensory system agents|mesh-ancestor
111176764|NCT01709721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111176765|NCT01866657|Phenylephrine|phenylephrine|mesh-list
111176766|NCT01866657|Dopamine|dopamine|mesh-list
111176767|NCT01866657|Ephedrine|ephedrine|mesh-list
111176768|NCT01866657|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
111176769|NCT01866657|Propofol|propofol|mesh-list
111176770|NCT01866657|Sevoflurane|sevoflurane|mesh-list
111176771|NCT01866657|Anesthetics|anesthetics|mesh-ancestor
111176772|NCT01866657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111176773|NCT01866657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111176774|NCT01866657|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111176775|NCT01866657|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111176776|NCT01866657|Anesthetics, General|anesthetics, general|mesh-ancestor
111176777|NCT01866657|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111176778|NCT01866657|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111176779|NCT01866657|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111176780|NCT01866657|Mydriatics|mydriatics|mesh-ancestor
111176781|NCT01866657|Autonomic Agents|autonomic agents|mesh-ancestor
111176782|NCT01866657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111176783|NCT01866657|Sympathomimetics|sympathomimetics|mesh-ancestor
111176784|NCT01866657|Nasal Decongestants|nasal decongestants|mesh-ancestor
111176785|NCT01866657|Respiratory System Agents|respiratory system agents|mesh-ancestor
111176786|NCT01866657|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111176787|NCT01866657|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111176788|NCT01866657|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111176789|NCT01866657|Adrenergic Agents|adrenergic agents|mesh-ancestor
111176791|NCT01866657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111176792|NCT01866657|Protective Agents|protective agents|mesh-ancestor
111176793|NCT01866657|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111176794|NCT01866657|Dopamine Agents|dopamine agents|mesh-ancestor
111176795|NCT03584152|Acetaminophen|acetaminophen|mesh-list
111176796|NCT03584152|Ibuprofen|ibuprofen|mesh-list
111176797|NCT03584152|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111176798|NCT03584152|Analgesics|analgesics|mesh-ancestor
111176799|NCT03584152|Sensory System Agents|sensory system agents|mesh-ancestor
111176800|NCT03584152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111176801|NCT03584152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111176802|NCT03584152|Antipyretics|antipyretics|mesh-ancestor
111176803|NCT03584152|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111176804|NCT03584152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111176805|NCT03584152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111176806|NCT03584152|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111176807|NCT03584152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111176808|NCT03584152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111176809|NCT03589690|Thioctic Acid|thioctic acid|mesh-list
111176810|NCT03589690|Antioxidants|antioxidants|mesh-ancestor
111176811|NCT03589690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111176812|NCT03589690|Protective Agents|protective agents|mesh-ancestor
111176813|NCT03589690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111176814|NCT03589690|Vitamin B Complex|vitamin b complex|mesh-ancestor
111176815|NCT03589690|Vitamins|vitamins|mesh-ancestor
111176816|NCT03589690|Micronutrients|micronutrients|mesh-ancestor
111176817|NCT03587194|Apremilast|apremilast|mesh-list
111176818|NCT03587194|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111176819|NCT03587194|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111176820|NCT03587194|Analgesics|analgesics|mesh-ancestor
111176821|NCT03587194|Sensory System Agents|sensory system agents|mesh-ancestor
111176822|NCT03587194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111176823|NCT03587194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111176824|NCT03587194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111176825|NCT03587194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111176826|NCT03587194|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
111176827|NCT03587194|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111176828|NCT03587194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111176829|NCT03587194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111176830|NCT01699815|Acetaminophen|acetaminophen|mesh-list
111176831|NCT01699815|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111176832|NCT01699815|Analgesics|analgesics|mesh-ancestor
111176833|NCT01699815|Sensory System Agents|sensory system agents|mesh-ancestor
110843455|NCT01264133|Adefovir|adefovir|mesh-list
111176834|NCT01699815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111176835|NCT01699815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111176836|NCT01699815|Antipyretics|antipyretics|mesh-ancestor
111176837|NCT03589222|Dexamethasone|dexamethasone|mesh-list
111176838|NCT03589222|Bortezomib|bortezomib|mesh-list
111176839|NCT03589222|Daratumumab|daratumumab|mesh-list
111176840|NCT03589222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111176841|NCT03589222|Antiemetics|antiemetics|mesh-ancestor
111176842|NCT03589222|Autonomic Agents|autonomic agents|mesh-ancestor
111176843|NCT03589222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111176844|NCT03589222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111176845|NCT03589222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111176846|NCT03589222|Glucocorticoids|glucocorticoids|mesh-ancestor
111176847|NCT03589222|Hormones|hormones|mesh-ancestor
111176848|NCT03589222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111176849|NCT03589222|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111176850|NCT03589222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111176851|NCT01846208|Immunomodulating Agents|immunomodulating agents|mesh-list
111176852|NCT01846208|Immunologic Factors|immunologic factors|mesh-ancestor
111176853|NCT01846208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111176854|NCT03589066|Rotigotine|rotigotine|mesh-list
111176855|NCT03589066|Dopamine Agonists|dopamine agonists|mesh-ancestor
111176856|NCT03589066|Dopamine Agents|dopamine agents|mesh-ancestor
111176857|NCT03589066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111176858|NCT03589066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111176859|NCT03589066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111176860|NCT03020368|Diclofenac|diclofenac|mesh-list
111176861|NCT03020368|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111176862|NCT03020368|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111176863|NCT03020368|Analgesics|analgesics|mesh-ancestor
111176864|NCT03020368|Sensory System Agents|sensory system agents|mesh-ancestor
111176865|NCT03020368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111176866|NCT03020368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111176867|NCT03020368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111176868|NCT03020368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111176869|NCT03020368|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111176870|NCT03020368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111176871|NCT03020368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111176872|NCT03581422|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
111176873|NCT03581422|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111176874|NCT03581422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111176875|NCT05702944|Phenoxybenzamine|phenoxybenzamine|mesh-list
111176876|NCT05702944|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111176877|NCT05702944|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111176878|NCT05702944|Adrenergic Agents|adrenergic agents|mesh-ancestor
111176879|NCT05702944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111176880|NCT05702944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111176881|NCT05702944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111176882|NCT05702944|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111176883|NCT05702944|Vasodilator Agents|vasodilator agents|mesh-ancestor
111176884|NCT03580876|Azathioprine|azathioprine|mesh-list
111176885|NCT03580876|Antimetabolites|antimetabolites|mesh-ancestor
111176886|NCT03580876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111176887|NCT03580876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111176888|NCT03580876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111176889|NCT03580876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111176890|NCT03580876|Immunologic Factors|immunologic factors|mesh-ancestor
111176891|NCT03580876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111176892|NCT03580876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111176893|NCT03586024|Pembrolizumab|pembrolizumab|mesh-list
111176894|NCT03586024|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111176895|NCT03586024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111176896|NCT03586024|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111176897|NCT03586024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111176898|NCT03585556|Prednisolone|prednisolone|mesh-list
111176899|NCT03585556|Ranibizumab|ranibizumab|mesh-list
111176900|NCT03585556|Aflibercept|aflibercept|mesh-list
111176901|NCT03585556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111176902|NCT03585556|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111176903|NCT03585556|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111176904|NCT03585556|Growth Substances|growth substances|mesh-ancestor
111176905|NCT03585556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111176906|NCT03585556|Growth Inhibitors|growth inhibitors|mesh-ancestor
111176907|NCT03585556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111176908|NCT03585556|Glucocorticoids|glucocorticoids|mesh-ancestor
111176909|NCT03585556|Hormones|hormones|mesh-ancestor
111176910|NCT03585556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111176911|NCT03585556|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111176912|NCT05702398|Vitamins|vitamins|mesh-list
111176913|NCT05702398|Vitamin A|vitamin a|mesh-list
111176914|NCT05702398|Niacin|niacin|mesh-list
111176915|NCT05702398|Niacinamide|niacinamide|mesh-list
111176916|NCT05702398|Nicotinic Acids|nicotinic acids|mesh-list
111176917|NCT05702398|Micronutrients|micronutrients|mesh-ancestor
111176918|NCT05702398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111176919|NCT05702398|Vitamin B Complex|vitamin b complex|mesh-ancestor
111176920|NCT05702398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111176921|NCT05702398|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111176922|NCT05702398|Antimetabolites|antimetabolites|mesh-ancestor
111176923|NCT05702398|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111176924|NCT05702398|Vasodilator Agents|vasodilator agents|mesh-ancestor
111176925|NCT01709409|Poractant alfa|poractant alfa|mesh-list
111176926|NCT01709409|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
111176927|NCT01709409|Respiratory System Agents|respiratory system agents|mesh-ancestor
111176928|NCT01698879|Gemtuzumab|gemtuzumab|mesh-list
111176929|NCT01698879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111176930|NCT01698879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111176931|NCT01698879|Immunotoxins|immunotoxins|mesh-ancestor
111176932|NCT01698879|Immunoconjugates|immunoconjugates|mesh-ancestor
111176933|NCT01698879|Immunologic Factors|immunologic factors|mesh-ancestor
111176934|NCT01698879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111176935|NCT02335294|Morphine|morphine|mesh-list
111176936|NCT02335294|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111176937|NCT02335294|Narcotics|narcotics|mesh-ancestor
111176938|NCT02335294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111176939|NCT02335294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111176940|NCT02335294|Analgesics|analgesics|mesh-ancestor
111176941|NCT02335294|Sensory System Agents|sensory system agents|mesh-ancestor
111176942|NCT02335294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111176944|NCT01698801|Lenalidomide|lenalidomide|mesh-list
111176945|NCT01698801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111176946|NCT01698801|Antiemetics|antiemetics|mesh-ancestor
111176947|NCT01698801|Autonomic Agents|autonomic agents|mesh-ancestor
111176948|NCT01698801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111176949|NCT01698801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111176950|NCT01698801|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111176951|NCT01698801|Glucocorticoids|glucocorticoids|mesh-ancestor
111176952|NCT01698801|Hormones|hormones|mesh-ancestor
111176953|NCT01698801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111176954|NCT01698801|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111176955|NCT01698801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111176956|NCT01698801|Immunologic Factors|immunologic factors|mesh-ancestor
111176957|NCT01698801|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111176958|NCT01698801|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111176959|NCT01698801|Growth Substances|growth substances|mesh-ancestor
111176960|NCT01698801|Growth Inhibitors|growth inhibitors|mesh-ancestor
111176961|NCT03735628|Nivolumab|nivolumab|mesh-list
111176962|NCT03735628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111176963|NCT03735628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111176964|NCT03735628|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111176965|NCT03735628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111176966|NCT01682811|Aminolevulinic Acid|aminolevulinic acid|mesh-list
111176967|NCT01682811|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111176968|NCT01682811|Dermatologic Agents|dermatologic agents|mesh-ancestor
111176969|NCT03580018|Tranexamic Acid|tranexamic acid|mesh-list
111176970|NCT03580018|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111176971|NCT03580018|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111176972|NCT03580018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111176973|NCT03580018|Hemostatics|hemostatics|mesh-ancestor
111176974|NCT03580018|Coagulants|coagulants|mesh-ancestor
111176975|NCT03584854|Carboprost|carboprost|mesh-list
111176976|NCT03584854|Dinoprost|dinoprost|mesh-list
111176977|NCT03584854|Dinoprost tromethamine|dinoprost tromethamine|mesh-list
111176978|NCT03584854|Methylergonovine|methylergonovine|mesh-list
111176979|NCT03584854|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111176980|NCT03584854|Abortifacient Agents|abortifacient agents|mesh-ancestor
111176981|NCT03584854|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111176982|NCT03584854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111176983|NCT03584854|Oxytocics|oxytocics|mesh-ancestor
111176984|NCT03584698|Evening primrose oil|evening primrose oil|mesh-list
111176985|NCT03584698|Misoprostol|misoprostol|mesh-list
111176986|NCT03584698|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111176987|NCT03584698|Abortifacient Agents|abortifacient agents|mesh-ancestor
111176988|NCT03584698|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111176989|NCT03584698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111176990|NCT03584698|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111176991|NCT03584698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111176992|NCT03584698|Oxytocics|oxytocics|mesh-ancestor
111176993|NCT03584698|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111176994|NCT03584698|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111176995|NCT03584698|Analgesics|analgesics|mesh-ancestor
111176996|NCT03584698|Sensory System Agents|sensory system agents|mesh-ancestor
111176997|NCT03584698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111176998|NCT03584698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111176999|NCT03584698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111177000|NCT03584698|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111177001|NCT03584698|Antimetabolites|antimetabolites|mesh-ancestor
111177002|NCT03584698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111177003|NCT03584698|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111177004|NCT03584698|Dermatologic Agents|dermatologic agents|mesh-ancestor
111177005|NCT01682031|Selenium|selenium|mesh-list
111177006|NCT01682031|Antioxidants|antioxidants|mesh-ancestor
111177007|NCT01682031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111177008|NCT01682031|Protective Agents|protective agents|mesh-ancestor
111177009|NCT01682031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111177010|NCT01682031|Trace Elements|trace elements|mesh-ancestor
111177011|NCT01682031|Micronutrients|micronutrients|mesh-ancestor
111177012|NCT03020134|Ritonavir|ritonavir|mesh-list
111177013|NCT03020134|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111177014|NCT03020134|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111177015|NCT03020134|Protease Inhibitors|protease inhibitors|mesh-ancestor
111177016|NCT03020134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111177017|NCT03020134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111177018|NCT03020134|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111177019|NCT03020134|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111177020|NCT03020134|Antiviral Agents|antiviral agents|mesh-ancestor
111177021|NCT03020134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111177022|NCT03020134|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111177023|NCT03020134|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111177024|NCT03020056|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111177025|NCT03020056|Antioxidants|antioxidants|mesh-list
111177026|NCT03020056|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111177027|NCT03020056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111177028|NCT03020056|Protective Agents|protective agents|mesh-ancestor
111177029|NCT03020056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111177030|NCT03026062|Durvalumab|durvalumab|mesh-list
111177031|NCT03026062|Ipilimumab|ipilimumab|mesh-list
111177032|NCT03026062|Tremelimumab|tremelimumab|mesh-list
111177033|NCT03026062|Immunoglobulins|immunoglobulins|mesh-list
111177034|NCT03026062|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111177035|NCT03026062|Immunoglobulin G|immunoglobulin g|mesh-list
111177036|NCT03026062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111177037|NCT03026062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111177038|NCT03026062|Immunologic Factors|immunologic factors|mesh-ancestor
111177039|NCT03026062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111177040|NCT03026062|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111177041|NCT03026062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111177042|NCT03584074|Celecoxib|celecoxib|mesh-list
111177043|NCT03584074|Pregabalin|pregabalin|mesh-list
111177044|NCT03584074|Analgesics|analgesics|mesh-ancestor
110843471|NCT03883841|Hematinics|hematinics|mesh-ancestor
111177045|NCT03584074|Sensory System Agents|sensory system agents|mesh-ancestor
111177046|NCT03584074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111177047|NCT03584074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111177049|NCT03584074|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111177050|NCT03584074|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111177051|NCT03584074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110488422|NCT04519944|Anticoagulants|anticoagulants|mesh-ancestor
111177052|NCT03584074|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111177053|NCT03584074|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111177054|NCT03584074|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111177055|NCT03584074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111177056|NCT03584074|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111177057|NCT03584074|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111177058|NCT03584074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111177059|NCT03584074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111177060|NCT03584074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111177061|NCT03584074|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111177062|NCT03584074|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111177063|NCT03584074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111177064|NCT03583138|Buprenorphine|buprenorphine|mesh-list
111177065|NCT03583138|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111177066|NCT03583138|Narcotics|narcotics|mesh-ancestor
111177067|NCT03583138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111177068|NCT03583138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111177069|NCT03583138|Analgesics|analgesics|mesh-ancestor
111177070|NCT03583138|Sensory System Agents|sensory system agents|mesh-ancestor
111177071|NCT03583138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111177072|NCT03583138|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111177073|NCT03153514|Obinutuzumab|obinutuzumab|mesh-list
111177074|NCT03153514|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111177075|NCT03153514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111177076|NCT03020602|Ubiquinone|ubiquinone|mesh-list
111177077|NCT03020602|Coenzyme Q10|coenzyme q10|mesh-list
111177078|NCT03020602|Micronutrients|micronutrients|mesh-ancestor
111177079|NCT03020602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111177080|NCT03020602|Vitamins|vitamins|mesh-ancestor
111177081|NCT01567527|Aripiprazole|aripiprazole|mesh-list
111177082|NCT01567527|Antidepressive Agents|antidepressive agents|mesh-ancestor
111177083|NCT01567527|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111177084|NCT01567527|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111177085|NCT01567527|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111177086|NCT01567527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111177087|NCT01567527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111177088|NCT01567527|Dopamine Agonists|dopamine agonists|mesh-ancestor
111177089|NCT01567527|Dopamine Agents|dopamine agents|mesh-ancestor
111177090|NCT01567527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111177091|NCT01567527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111177092|NCT01567527|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111177093|NCT01567527|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111177094|NCT01567527|Serotonin Agents|serotonin agents|mesh-ancestor
111177095|NCT01567527|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111177096|NCT01567527|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111177097|NCT01567527|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111177098|NCT01567527|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111177099|NCT03159988|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
111177100|NCT03159988|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111177101|NCT03159988|Vasodilator Agents|vasodilator agents|mesh-ancestor
111177103|NCT03159598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111177104|NCT03159598|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111177105|NCT03159598|Anesthetics, General|anesthetics, general|mesh-ancestor
111177106|NCT03159598|Anesthetics|anesthetics|mesh-ancestor
111177107|NCT03159598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111177108|NCT03159598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111177109|NCT01818752|Prednisone|prednisone|mesh-list
111177110|NCT01818752|Bortezomib|bortezomib|mesh-list
111177111|NCT01818752|Melphalan|melphalan|mesh-list
111177112|NCT01818752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111177113|NCT01818752|Glucocorticoids|glucocorticoids|mesh-ancestor
111177114|NCT01818752|Hormones|hormones|mesh-ancestor
111177115|NCT01818752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111177116|NCT01818752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111177117|NCT01818752|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111177118|NCT01818752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111177119|NCT01818752|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111177120|NCT01818752|Alkylating Agents|alkylating agents|mesh-ancestor
111177121|NCT01818752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111177122|NCT01818752|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111177123|NCT01818752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111177124|NCT01818752|Immunologic Factors|immunologic factors|mesh-ancestor
111177125|NCT03582280|Calcium Carbonate|calcium carbonate|mesh-list
111177127|NCT03582280|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111177128|NCT03582280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111177129|NCT03582280|Antacids|antacids|mesh-ancestor
111177130|NCT03582280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111177131|NCT03582280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111177132|NCT03159754|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111177133|NCT03159754|Metronidazole|metronidazole|mesh-list
111177134|NCT03159754|Ciprofloxacin|ciprofloxacin|mesh-list
111177135|NCT03159754|Tazobactam|tazobactam|mesh-list
111177136|NCT03159754|Piperacillin|piperacillin|mesh-list
111177137|NCT03159754|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
111177138|NCT03159754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111177139|NCT03159754|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111177140|NCT03159754|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111177141|NCT03159754|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111177142|NCT03159754|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111177143|NCT03159754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111177144|NCT03159754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111177145|NCT03159754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111177146|NCT03159754|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111177147|NCT03159754|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111177148|NCT03159754|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
111177149|NCT05701384|Lazertinib|lazertinib|mesh-list
111177150|NCT05701384|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111177151|NCT05701384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111177152|NCT05701384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111177153|NCT01362608|Triamcinolone|triamcinolone|mesh-list
111177154|NCT01362608|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
111177155|NCT01362608|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
111177156|NCT01362608|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
111177157|NCT01362608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111177158|NCT01362608|Glucocorticoids|glucocorticoids|mesh-ancestor
111177159|NCT01362608|Hormones|hormones|mesh-ancestor
111177160|NCT01362608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111177161|NCT01362608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111177162|NCT01362608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111177163|NCT01362608|Immunologic Factors|immunologic factors|mesh-ancestor
111177164|NCT01362608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111177165|NCT01362608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111177166|NCT03581968|Pancrelipase|pancrelipase|mesh-list
111177167|NCT03581968|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111177168|NCT03158584|Morphine|morphine|mesh-list
111177169|NCT03158584|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111177170|NCT03158584|Narcotics|narcotics|mesh-ancestor
111177171|NCT03158584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111177172|NCT03158584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111177173|NCT03158584|Analgesics|analgesics|mesh-ancestor
111177174|NCT03158584|Sensory System Agents|sensory system agents|mesh-ancestor
111177175|NCT03158584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111177176|NCT04765228|Doxorubicin|doxorubicin|mesh-list
111177177|NCT04765228|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111177178|NCT04765228|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111177179|NCT04765228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111177180|NCT04765228|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110843484|NCT03880877|Vitamins|vitamins|mesh-ancestor
111177181|NCT04765228|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111177182|NCT04765228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111177183|NCT04765228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110799565|NCT03758235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111177184|NCT01818596|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
111177185|NCT01818596|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111177186|NCT01818596|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111177187|NCT01818596|Antiviral Agents|antiviral agents|mesh-ancestor
111177188|NCT01818596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111177189|NCT04140448|Ranibizumab|ranibizumab|mesh-list
111177190|NCT04140448|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111177191|NCT04140448|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111177192|NCT04140448|Growth Substances|growth substances|mesh-ancestor
111177193|NCT04140448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111177194|NCT04140448|Growth Inhibitors|growth inhibitors|mesh-ancestor
111177195|NCT04140448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111177196|NCT03156322|Fentanyl|fentanyl|mesh-list
111177197|NCT03156322|Bupivacaine|bupivacaine|mesh-list
111177198|NCT03156322|Anesthetics, Local|anesthetics, local|mesh-ancestor
111177199|NCT03156322|Anesthetics|anesthetics|mesh-ancestor
111177200|NCT03156322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111177201|NCT03156322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111177202|NCT03156322|Sensory System Agents|sensory system agents|mesh-ancestor
111177203|NCT03156322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111177204|NCT03156322|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111177205|NCT03156322|Narcotics|narcotics|mesh-ancestor
111177206|NCT03156322|Analgesics|analgesics|mesh-ancestor
111177207|NCT03156322|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111177208|NCT03156322|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111177209|NCT03156322|Anesthetics, General|anesthetics, general|mesh-ancestor
111177210|NCT03156088|Neurotransmitter Agents|neurotransmitter agents|mesh-list
111177211|NCT03156088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111177212|NCT03156088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111177213|NCT04140058|Ondansetron|ondansetron|mesh-list
111177214|NCT04140058|Antiemetics|antiemetics|mesh-ancestor
111177215|NCT04140058|Autonomic Agents|autonomic agents|mesh-ancestor
111177216|NCT04140058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111177217|NCT04140058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111177218|NCT04140058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111177219|NCT04140058|Antipruritics|antipruritics|mesh-ancestor
111177220|NCT04140058|Dermatologic Agents|dermatologic agents|mesh-ancestor
111177221|NCT04140058|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111177222|NCT04140058|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111177223|NCT04140058|Serotonin Agents|serotonin agents|mesh-ancestor
111177224|NCT04140058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111177225|NCT04140058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111177226|NCT02899078|Nivolumab|nivolumab|mesh-list
111177227|NCT02899078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111177228|NCT02899078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111177229|NCT02899078|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111177230|NCT02899078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111177231|NCT01670734|Alirocumab|alirocumab|mesh-list
111177232|NCT01670734|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
111177233|NCT01670734|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111177234|NCT01670734|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111177235|NCT01670734|Antimetabolites|antimetabolites|mesh-ancestor
111177236|NCT01670734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111177237|NCT01670734|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111177238|NCT01670734|Protease Inhibitors|protease inhibitors|mesh-ancestor
111177239|NCT01670734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111177240|NCT01670734|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111177241|NCT01670890|Cisplatin|cisplatin|mesh-list
111177242|NCT01670890|Temozolomide|temozolomide|mesh-list
111177243|NCT01670890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111177244|NCT01670890|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111177245|NCT01670890|Alkylating Agents|alkylating agents|mesh-ancestor
111177246|NCT01670890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111177247|NCT04551196|Acetaminophen|acetaminophen|mesh-list
111177248|NCT04551196|Ibuprofen|ibuprofen|mesh-list
111177249|NCT04551196|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111177250|NCT04551196|Analgesics|analgesics|mesh-ancestor
111177251|NCT04551196|Sensory System Agents|sensory system agents|mesh-ancestor
111177252|NCT04551196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111177253|NCT04551196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111177254|NCT04551196|Antipyretics|antipyretics|mesh-ancestor
111177255|NCT04551196|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111177256|NCT04551196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111177257|NCT04551196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111177258|NCT04551196|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111177259|NCT04551196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111177260|NCT04551196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111177261|NCT01923298|Estradiol|estradiol|mesh-list
111177262|NCT01923298|Estrogens|estrogens|mesh-ancestor
111177263|NCT01923298|Hormones|hormones|mesh-ancestor
111177264|NCT01923298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111177265|NCT01923298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111177266|NCT05212246|Imiquimod|imiquimod|mesh-list
111177267|NCT05212246|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111177268|NCT05212246|Immunologic Factors|immunologic factors|mesh-ancestor
111177269|NCT05212246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111177270|NCT05212246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111177271|NCT05212246|Interferon Inducers|interferon inducers|mesh-ancestor
111177272|NCT04297618|Lifitegrast|lifitegrast|mesh-list
111177273|NCT04297618|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
111177274|NCT04297618|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111177275|NCT03154918|Dexamethasone|dexamethasone|mesh-list
111177276|NCT03154918|Gemcitabine|gemcitabine|mesh-list
111177277|NCT03154918|Etoposide|etoposide|mesh-list
111177278|NCT03154918|Ifosfamide|ifosfamide|mesh-list
111177279|NCT03154918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111177280|NCT03154918|Antiemetics|antiemetics|mesh-ancestor
111177281|NCT03154918|Autonomic Agents|autonomic agents|mesh-ancestor
111177282|NCT03154918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111177283|NCT03154918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111177284|NCT03154918|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111177285|NCT03154918|Glucocorticoids|glucocorticoids|mesh-ancestor
111177286|NCT03154918|Hormones|hormones|mesh-ancestor
111177287|NCT03154918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111177288|NCT03154918|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111177289|NCT03154918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111177290|NCT03154918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111177291|NCT03154918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111177292|NCT03154918|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111177293|NCT03154918|Antimetabolites|antimetabolites|mesh-ancestor
111177294|NCT03154918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111177295|NCT03154918|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111177296|NCT03154918|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111177297|NCT03154918|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111177298|NCT03154918|Alkylating Agents|alkylating agents|mesh-ancestor
111177299|NCT01671904|Rituximab|rituximab|mesh-list
111177300|NCT01671904|Obinutuzumab|obinutuzumab|mesh-list
111177301|NCT01671904|Venetoclax|venetoclax|mesh-list
111177302|NCT01671904|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
111177303|NCT01671904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111177304|NCT01671904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111177305|NCT01671904|Immunologic Factors|immunologic factors|mesh-ancestor
111177306|NCT01671904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111177307|NCT01671904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111177308|NCT01671904|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111177309|NCT01671904|Alkylating Agents|alkylating agents|mesh-ancestor
111177310|NCT01671904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111177311|NCT01671982|Tenofovir|tenofovir|mesh-list
111177312|NCT01671982|Antiviral Agents|antiviral agents|mesh-ancestor
111177313|NCT01671982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111177314|NCT01671982|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111177315|NCT01671982|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111177316|NCT01671982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111177317|NCT01671982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111177319|NCT01671982|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111177320|NCT04040452|Ketorolac|ketorolac|mesh-list
111177321|NCT04040452|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111177322|NCT04040452|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111177323|NCT04040452|Analgesics|analgesics|mesh-ancestor
111177324|NCT04040452|Sensory System Agents|sensory system agents|mesh-ancestor
111177325|NCT04040452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111177326|NCT04040452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111177327|NCT04040452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111177328|NCT04040452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111177329|NCT04040452|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111177330|NCT04040452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111177331|NCT04040452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111177332|NCT04027894|Rifamycins|rifamycins|mesh-list
111177333|NCT04027894|Rifamycin SV|rifamycin sv|mesh-list
111177334|NCT04027894|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111177335|NCT04027894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111177336|NCT04027894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111177337|NCT02564068|Oxytocin|oxytocin|mesh-list
111177338|NCT02564068|Oxytocics|oxytocics|mesh-ancestor
111177339|NCT02564068|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111177340|NCT02564068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111177341|NCT03154528|Vitamin D|vitamin d|mesh-list
111177342|NCT03154528|Vitamins|vitamins|mesh-ancestor
111177343|NCT03154528|Micronutrients|micronutrients|mesh-ancestor
111177344|NCT03154528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111177345|NCT03154528|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111177346|NCT03154372|Metronidazole|metronidazole|mesh-list
111177347|NCT03154372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111177348|NCT03154372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111177349|NCT03154372|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111177350|NCT03154372|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111177351|NCT01676506|Ranibizumab|ranibizumab|mesh-list
111177352|NCT01676506|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111177353|NCT01676506|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111177354|NCT01676506|Growth Substances|growth substances|mesh-ancestor
111177355|NCT01676506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111177356|NCT01676506|Growth Inhibitors|growth inhibitors|mesh-ancestor
111177357|NCT01676506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111177358|NCT03154294|Paclitaxel|paclitaxel|mesh-list
111177359|NCT03154294|Serabelisib|serabelisib|mesh-list
111177360|NCT03154294|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111177361|NCT03154294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111177362|NCT03154294|Tubulin Modulators|tubulin modulators|mesh-ancestor
111177363|NCT03154294|Antimitotic Agents|antimitotic agents|mesh-ancestor
111177364|NCT03154294|Mitosis Modulators|mitosis modulators|mesh-ancestor
111177365|NCT03154294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111177366|NCT03154294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111177367|NCT03154606|Calcium|calcium|mesh-list
111177368|NCT03154606|Caseins|caseins|mesh-list
111177369|NCT03154606|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111177370|NCT03154606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111177371|NCT03154606|Chelating Agents|chelating agents|mesh-ancestor
111177372|NCT03154606|Sequestering Agents|sequestering agents|mesh-ancestor
111177373|NCT03154606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111177374|NCT01672450|Ipilimumab|ipilimumab|mesh-list
111177375|NCT01672450|Interleukin-2|interleukin-2|mesh-list
111177376|NCT01672450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111177377|NCT01672450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111177378|NCT01672450|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111177379|NCT01672450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111177380|NCT01672450|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111177381|NCT01672450|Analgesics|analgesics|mesh-ancestor
111177382|NCT01672450|Sensory System Agents|sensory system agents|mesh-ancestor
111177383|NCT01672450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111177384|NCT01672450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111177385|NCT01854268|Capsaicin|capsaicin|mesh-list
111177386|NCT01854268|Antipruritics|antipruritics|mesh-ancestor
111177387|NCT01854268|Dermatologic Agents|dermatologic agents|mesh-ancestor
111177388|NCT01854268|Sensory System Agents|sensory system agents|mesh-ancestor
111177389|NCT01854268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111177390|NCT01854268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110894572|NCT04988425|Antiemetics|antiemetics|mesh-ancestor
111177391|NCT01672606|Rocuronium|rocuronium|mesh-list
111177392|NCT01672606|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
111177393|NCT01672606|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
111177394|NCT01672606|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110488456|NCT04353661|Azithromycin|azithromycin|mesh-list
111177395|NCT01672606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111177396|NCT01672606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111177397|NCT01594281|Ranibizumab|ranibizumab|mesh-list
111177398|NCT01594281|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110843498|NCT01264289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111177399|NCT01594281|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111177400|NCT01594281|Growth Substances|growth substances|mesh-ancestor
111177401|NCT01594281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111177402|NCT01594281|Growth Inhibitors|growth inhibitors|mesh-ancestor
111177403|NCT01594281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111177404|NCT04964050|Captopril, hydrochlorothiazide drug combination|captopril, hydrochlorothiazide drug combination|mesh-list
111177405|NCT04964050|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
111177406|NCT04964050|Protease Inhibitors|protease inhibitors|mesh-ancestor
111177407|NCT04964050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111177408|NCT04964050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111177409|NCT04964050|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111177410|NCT04964050|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
111177411|NCT04964050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111177412|NCT04964050|Diuretics|diuretics|mesh-ancestor
111177413|NCT04964050|Natriuretic Agents|natriuretic agents|mesh-ancestor
111177414|NCT04964050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111177415|NCT03526900|Atezolizumab|atezolizumab|mesh-list
111177416|NCT03526900|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111177417|NCT03526900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111177418|NCT03526900|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111177419|NCT03526900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111177420|NCT03420742|Midazolam|midazolam|mesh-list
111177421|NCT03420742|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111177422|NCT03420742|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111177423|NCT03420742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111177424|NCT03420742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111177425|NCT03420742|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111177426|NCT03420742|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111177427|NCT03420742|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111177428|NCT03420742|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111177429|NCT03420742|Anesthetics, General|anesthetics, general|mesh-ancestor
111177430|NCT03420742|Anesthetics|anesthetics|mesh-ancestor
111177431|NCT03420742|GABA Modulators|gaba modulators|mesh-ancestor
111177432|NCT03420742|GABA Agents|gaba agents|mesh-ancestor
111177433|NCT03420742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111177434|NCT03420742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111177435|NCT01818284|Plerixafor|plerixafor|mesh-list
111177436|NCT01818284|Lenograstim|lenograstim|mesh-list
111177437|NCT01818284|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111177438|NCT01818284|Immunologic Factors|immunologic factors|mesh-ancestor
111177439|NCT01818284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111177440|NCT01818284|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111177441|NCT01818284|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111177442|NCT01818284|Antiviral Agents|antiviral agents|mesh-ancestor
111177443|NCT01818284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111177444|NCT02081014|Glucagon|glucagon|mesh-list
111177445|NCT02081014|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
111177446|NCT02081014|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111177447|NCT02081014|Hormones|hormones|mesh-ancestor
111177448|NCT02081014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111177449|NCT02081014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111177450|NCT02081014|Incretins|incretins|mesh-ancestor
111177451|NCT03025594|Ketorolac|ketorolac|mesh-list
111177452|NCT03025594|Epinephrine|epinephrine|mesh-list
111177453|NCT03025594|Levobupivacaine|levobupivacaine|mesh-list
111177454|NCT03025594|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111177455|NCT03025594|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111177456|NCT03025594|Adrenergic Agents|adrenergic agents|mesh-ancestor
111177457|NCT03025594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111177458|NCT03025594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111177459|NCT03025594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111177460|NCT03025594|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111177461|NCT03025594|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111177462|NCT03025594|Autonomic Agents|autonomic agents|mesh-ancestor
111177463|NCT03025594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111177464|NCT03025594|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111177465|NCT03025594|Respiratory System Agents|respiratory system agents|mesh-ancestor
111177467|NCT03025594|Sympathomimetics|sympathomimetics|mesh-ancestor
111177468|NCT03025594|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110843500|NCT01264289|Hormone Antagonists|hormone antagonists|mesh-ancestor
111177469|NCT03025594|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111177470|NCT03025594|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111177471|NCT03025594|Analgesics|analgesics|mesh-ancestor
111177472|NCT03025594|Sensory System Agents|sensory system agents|mesh-ancestor
111177473|NCT03025594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111177474|NCT03025594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111177475|NCT03025594|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111177476|NCT03025594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111177477|NCT03025594|Anesthetics, Local|anesthetics, local|mesh-ancestor
111177478|NCT03025594|Anesthetics|anesthetics|mesh-ancestor
111177479|NCT03025594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111177480|NCT04404946|Phenylephrine|phenylephrine|mesh-list
111177481|NCT04404946|Oxymetazoline|oxymetazoline|mesh-list
111177482|NCT04404946|Norepinephrine|norepinephrine|mesh-list
111177483|NCT04404946|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111177484|NCT04404946|Mydriatics|mydriatics|mesh-ancestor
111177485|NCT04404946|Autonomic Agents|autonomic agents|mesh-ancestor
111177486|NCT04404946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111177487|NCT04404946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111177488|NCT04404946|Sympathomimetics|sympathomimetics|mesh-ancestor
111177489|NCT04404946|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111177490|NCT04404946|Nasal Decongestants|nasal decongestants|mesh-ancestor
111177491|NCT04404946|Respiratory System Agents|respiratory system agents|mesh-ancestor
111177492|NCT04404946|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111177493|NCT04404946|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111177494|NCT04404946|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111177495|NCT04404946|Adrenergic Agents|adrenergic agents|mesh-ancestor
111177496|NCT04404946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111177497|NCT04404946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111177498|NCT04404946|Protective Agents|protective agents|mesh-ancestor
111177499|NCT01673542|Lidocaine|lidocaine|mesh-list
111177500|NCT01673542|Prilocaine|prilocaine|mesh-list
111177501|NCT01673542|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
111177502|NCT01673542|Anesthetics, Local|anesthetics, local|mesh-ancestor
111177503|NCT01673542|Anesthetics|anesthetics|mesh-ancestor
111177504|NCT01673542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111177505|NCT01673542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111177506|NCT01673542|Sensory System Agents|sensory system agents|mesh-ancestor
111177507|NCT01673542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111177508|NCT01673542|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111177509|NCT01673542|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111177510|NCT01673542|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111177511|NCT01673542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111177512|NCT01673542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111177513|NCT01673542|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
111177514|NCT04804540|Vedolizumab|vedolizumab|mesh-list
111177515|NCT04804540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111177516|NCT01610492|Belimumab|belimumab|mesh-list
111177517|NCT01610492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111177518|NCT01610492|Immunologic Factors|immunologic factors|mesh-ancestor
111177519|NCT01610492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111177520|NCT01817582|Loteprednol Etabonate|loteprednol etabonate|mesh-list
111177521|NCT01817582|Cyclosporine|cyclosporine|mesh-list
111177522|NCT01817582|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111177523|NCT01817582|Lubricant Eye Drops|lubricant eye drops|mesh-list
111177524|NCT01817582|Cyclosporins|cyclosporins|mesh-list
111177525|NCT01817582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111177526|NCT01817582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111177527|NCT01817582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111177528|NCT01817582|Immunologic Factors|immunologic factors|mesh-ancestor
111177529|NCT01817582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111177530|NCT01817582|Antifungal Agents|antifungal agents|mesh-ancestor
111177531|NCT01817582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111177532|NCT01817582|Dermatologic Agents|dermatologic agents|mesh-ancestor
111177533|NCT01817582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111177534|NCT01817582|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111177535|NCT01817582|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111177536|NCT01817582|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111177537|NCT01594125|Nintedanib|nintedanib|mesh-list
111177538|NCT01594125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111177539|NCT01594125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111177540|NCT01594125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110894716|NCT02251184|Vasodilator Agents|vasodilator agents|mesh-ancestor
111177541|NCT01594125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111177542|NCT01592409|Dronabinol|dronabinol|mesh-list
111177543|NCT01592409|Hallucinogens|hallucinogens|mesh-ancestor
111177544|NCT01592409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111177545|NCT01592409|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111177546|NCT01592409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111177547|NCT01592409|Analgesics|analgesics|mesh-ancestor
111177548|NCT01592409|Sensory System Agents|sensory system agents|mesh-ancestor
111177549|NCT01592409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111177550|NCT01592409|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
111177551|NCT01592409|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
111177552|NCT01592409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111177553|NCT01592409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111177554|NCT01592409|Hormones|hormones|mesh-ancestor
111177555|NCT01592409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111177556|NCT02081638|Aspirin|aspirin|mesh-list
111177557|NCT02081638|Atorvastatin|atorvastatin|mesh-list
111177558|NCT02081638|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111177559|NCT02081638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111177560|NCT02081638|Analgesics|analgesics|mesh-ancestor
111177561|NCT02081638|Sensory System Agents|sensory system agents|mesh-ancestor
111177562|NCT02081638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111177563|NCT02081638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111177564|NCT02081638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111177565|NCT02081638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111177566|NCT02081638|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111177567|NCT02081638|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111177568|NCT02081638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111177569|NCT02081638|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111177570|NCT02081638|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111177571|NCT02081638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111177572|NCT02081638|Antipyretics|antipyretics|mesh-ancestor
111177573|NCT02081638|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111177574|NCT02081638|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111177575|NCT02081638|Antimetabolites|antimetabolites|mesh-ancestor
111177576|NCT02081638|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111177577|NCT02081638|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111177578|NCT04603508|Calcium, Dietary|calcium, dietary|mesh-list
111177579|NCT04603508|Empagliflozin|empagliflozin|mesh-list
111177580|NCT04603508|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111177581|NCT04603508|Calcium|calcium|mesh-list
111177582|NCT04603508|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111177583|NCT04603508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111177584|NCT04603508|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111177585|NCT04603508|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111177586|NCT04603508|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111177587|NCT04603508|Antimetabolites|antimetabolites|mesh-ancestor
111177588|NCT04603508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111177589|NCT04603508|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111177590|NCT04603508|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111177591|NCT04603508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111177592|NCT04603508|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111177593|NCT04603508|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111177594|NCT01674166|Prucalopride|prucalopride|mesh-list
111177595|NCT01674166|Laxatives|laxatives|mesh-ancestor
111177596|NCT01674166|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111177597|NCT01674166|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
111177598|NCT01674166|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111177599|NCT01674166|Serotonin Agents|serotonin agents|mesh-ancestor
111177600|NCT01674166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111177601|NCT01674166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111177602|NCT01674166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111177603|NCT02235688|Gemcitabine|gemcitabine|mesh-list
111177604|NCT02235688|Doxorubicin|doxorubicin|mesh-list
111177605|NCT02235688|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111177606|NCT02235688|Antimetabolites|antimetabolites|mesh-ancestor
111177607|NCT02235688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111177608|NCT02235688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111177609|NCT02235688|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111177610|NCT02235688|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111177611|NCT02235688|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111177612|NCT02235688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110894791|NCT02109614|Niacin|niacin|mesh-list
111177613|NCT03152578|Capsaicin|capsaicin|mesh-list
111177614|NCT03152578|Antipruritics|antipruritics|mesh-ancestor
111177615|NCT03152578|Dermatologic Agents|dermatologic agents|mesh-ancestor
111177616|NCT03152578|Sensory System Agents|sensory system agents|mesh-ancestor
111177617|NCT03152578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111177618|NCT03152578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111177619|NCT01065532|Paclitaxel|paclitaxel|mesh-list
111177620|NCT01065532|Everolimus|everolimus|mesh-list
111177621|NCT01065532|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111177622|NCT01065532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111177623|NCT01065532|Tubulin Modulators|tubulin modulators|mesh-ancestor
111177624|NCT01065532|Antimitotic Agents|antimitotic agents|mesh-ancestor
111177625|NCT01065532|Mitosis Modulators|mitosis modulators|mesh-ancestor
111177626|NCT01065532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111177627|NCT01065532|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111177628|NCT01065532|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111177629|NCT01065532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111177630|NCT01065532|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111177631|NCT01065532|Immunologic Factors|immunologic factors|mesh-ancestor
111177632|NCT01065532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111177633|NCT04764916|Bupivacaine|bupivacaine|mesh-list
111177634|NCT04764916|Anesthetics, Local|anesthetics, local|mesh-ancestor
111177635|NCT04764916|Anesthetics|anesthetics|mesh-ancestor
111177636|NCT04764916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111177637|NCT04764916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111177638|NCT04764916|Sensory System Agents|sensory system agents|mesh-ancestor
111177639|NCT04764916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111177640|NCT01674868|Fluoxetine|fluoxetine|mesh-list
111177641|NCT01674868|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111177642|NCT01674868|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111177643|NCT01674868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111177644|NCT01674868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111177645|NCT01674868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111177646|NCT01674868|Serotonin Agents|serotonin agents|mesh-ancestor
111177647|NCT01674868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111177648|NCT01674868|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111177649|NCT01674868|Antidepressive Agents|antidepressive agents|mesh-ancestor
111177650|NCT01674868|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111177651|NCT01674868|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111177652|NCT01674868|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111177653|NCT01674868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111177654|NCT01674946|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
110488490|NCT04154982|Antidotes|antidotes|mesh-ancestor
111177655|NCT01674946|Bile Acids and Salts|bile acids and salts|mesh-list
111177656|NCT01674946|Cathartics|cathartics|mesh-ancestor
111177657|NCT01674946|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111177658|NCT01675024|Rotigotine|rotigotine|mesh-list
111177659|NCT01675024|Dopamine Agonists|dopamine agonists|mesh-ancestor
111177660|NCT01675024|Dopamine Agents|dopamine agents|mesh-ancestor
111177661|NCT01675024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111177662|NCT01675024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111177663|NCT01675024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111177664|NCT03883828|Chlorhexidine|chlorhexidine|mesh-list
110843518|NCT03880409|Anesthetics|anesthetics|mesh-ancestor
111177665|NCT03883828|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
111177667|NCT03883828|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111177668|NCT03883828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111177669|NCT03883828|Disinfectants|disinfectants|mesh-ancestor
111177670|NCT03883828|Dermatologic Agents|dermatologic agents|mesh-ancestor
111177671|NCT03883828|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111177672|NCT03883828|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111177673|NCT03883828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111177674|NCT03883828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111177675|NCT02081950|Enoxaparin|enoxaparin|mesh-list
111177676|NCT02081950|Enoxaparin sodium|enoxaparin sodium|mesh-list
111177677|NCT02081950|Anticoagulants|anticoagulants|mesh-ancestor
111177678|NCT02081950|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111177679|NCT02081950|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111177680|NCT02081950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111177681|NCT01675648|Lofexidine|lofexidine|mesh-list
111177682|NCT01675648|Clonidine|clonidine|mesh-list
111177683|NCT01675648|Diazepam|diazepam|mesh-list
111177684|NCT01675648|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111177685|NCT01675648|Anticonvulsants|anticonvulsants|mesh-ancestor
111177686|NCT01675648|Antiemetics|antiemetics|mesh-ancestor
111177687|NCT01675648|Autonomic Agents|autonomic agents|mesh-ancestor
111177688|NCT01675648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111177689|NCT01675648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111177691|NCT01675648|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111177692|NCT01675648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111177693|NCT01675648|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
111177694|NCT01675648|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111177695|NCT01675648|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111177696|NCT01675648|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111177697|NCT01675648|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111177698|NCT01675648|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111177699|NCT01675648|Anesthetics, General|anesthetics, general|mesh-ancestor
111177700|NCT01675648|Anesthetics|anesthetics|mesh-ancestor
111177701|NCT01675648|GABA Modulators|gaba modulators|mesh-ancestor
111177702|NCT01675648|GABA Agents|gaba agents|mesh-ancestor
111177703|NCT01675648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111177704|NCT01675648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111177705|NCT01675648|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111177706|NCT01675648|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111177707|NCT01675648|Sensory System Agents|sensory system agents|mesh-ancestor
111177708|NCT01675648|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111177709|NCT01675648|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111177710|NCT01675648|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111177711|NCT01675648|Adrenergic Agents|adrenergic agents|mesh-ancestor
111177712|NCT01675648|Analgesics|analgesics|mesh-ancestor
111177713|NCT01675648|Sympatholytics|sympatholytics|mesh-ancestor
111177714|NCT01566435|Paclitaxel|paclitaxel|mesh-list
111177715|NCT01566435|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111177716|NCT01566435|Fluorouracil|fluorouracil|mesh-list
111177717|NCT01566435|Cetuximab|cetuximab|mesh-list
111177718|NCT01566435|Antibodies|antibodies|mesh-list
111177719|NCT01566435|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111177720|NCT01566435|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111177721|NCT01566435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111177722|NCT01566435|Tubulin Modulators|tubulin modulators|mesh-ancestor
111177723|NCT01566435|Antimitotic Agents|antimitotic agents|mesh-ancestor
111177724|NCT01566435|Mitosis Modulators|mitosis modulators|mesh-ancestor
111177725|NCT01566435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111177726|NCT01566435|Immunologic Factors|immunologic factors|mesh-ancestor
111177727|NCT01566435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111177728|NCT01566435|Antimetabolites|antimetabolites|mesh-ancestor
111177729|NCT01566435|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111177730|NCT01566435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111177731|NCT01566435|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111177732|NCT01675804|Methylphenidate|methylphenidate|mesh-list
111177733|NCT01675804|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111177734|NCT01675804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111177735|NCT01675804|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111177736|NCT01675804|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111177738|NCT01675804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111177739|NCT01675804|Dopamine Agents|dopamine agents|mesh-ancestor
111177740|NCT01675804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111177741|NCT01696695|Capecitabine|capecitabine|mesh-list
111177742|NCT01696695|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111177743|NCT01696695|Antimetabolites|antimetabolites|mesh-ancestor
111177744|NCT01696695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111177745|NCT01696695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111177746|NCT05261386|Betadex|betadex|mesh-list
111177747|NCT05261386|Sequestering Agents|sequestering agents|mesh-ancestor
111177748|NCT05261386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111177749|NCT03899805|Pembrolizumab|pembrolizumab|mesh-list
111177750|NCT03899805|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111177751|NCT03899805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111177752|NCT03899805|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111177753|NCT03899805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111177754|NCT03861988|Ketamine|ketamine|mesh-list
111177755|NCT03861988|Analgesics|analgesics|mesh-ancestor
111177756|NCT03861988|Sensory System Agents|sensory system agents|mesh-ancestor
111177757|NCT03861988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111177758|NCT03861988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111177759|NCT03861988|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111177760|NCT03861988|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111177761|NCT03861988|Anesthetics, General|anesthetics, general|mesh-ancestor
111177762|NCT03861988|Anesthetics|anesthetics|mesh-ancestor
111177763|NCT03861988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111177764|NCT03861988|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111177766|NCT03861988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111177767|NCT03861988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111177768|NCT03755440|Antibodies|antibodies|mesh-list
111177769|NCT03755440|Immunologic Factors|immunologic factors|mesh-ancestor
111177770|NCT03755440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111177771|NCT03749902|Misoprostol|misoprostol|mesh-list
111177772|NCT03749902|Oxytocin|oxytocin|mesh-list
111177773|NCT03749902|Oxytocics|oxytocics|mesh-ancestor
111177774|NCT03749902|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111177775|NCT03749902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111177776|NCT03749902|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111177777|NCT03749902|Abortifacient Agents|abortifacient agents|mesh-ancestor
111177778|NCT03749902|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111177779|NCT03749902|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111177780|NCT01565889|Ritonavir|ritonavir|mesh-list
111177781|NCT01565889|Ribavirin|ribavirin|mesh-list
111177782|NCT01565889|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111177783|NCT01565889|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111177784|NCT01565889|Protease Inhibitors|protease inhibitors|mesh-ancestor
111177785|NCT01565889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111177786|NCT01565889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111177787|NCT01565889|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111177788|NCT01565889|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111177789|NCT01565889|Antiviral Agents|antiviral agents|mesh-ancestor
111177790|NCT01565889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111177791|NCT01565889|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111177792|NCT01565889|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111177793|NCT01565889|Antimetabolites|antimetabolites|mesh-ancestor
111177794|NCT01696071|Tiotropium Bromide|tiotropium bromide|mesh-list
111177795|NCT01696071|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111177796|NCT01696071|Autonomic Agents|autonomic agents|mesh-ancestor
111177797|NCT01696071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111177798|NCT01696071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111177799|NCT01696071|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111177800|NCT01696071|Respiratory System Agents|respiratory system agents|mesh-ancestor
111177801|NCT01696071|Parasympatholytics|parasympatholytics|mesh-ancestor
111177802|NCT01696071|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111177803|NCT01696071|Cholinergic Agents|cholinergic agents|mesh-ancestor
111177804|NCT01696071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111177805|NCT01696071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111177806|NCT01591863|Fidaxomicin|fidaxomicin|mesh-list
111177807|NCT01591863|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111177808|NCT01591863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111177809|NCT01591785|Retapamulin|retapamulin|mesh-list
111177810|NCT01591785|Petrolatum|petrolatum|mesh-list
111177811|NCT01591785|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111177812|NCT01591785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111177813|NCT01591785|Emollients|emollients|mesh-ancestor
111177814|NCT01591785|Dermatologic Agents|dermatologic agents|mesh-ancestor
111177815|NCT03654040|Cyclophosphamide|cyclophosphamide|mesh-list
111177816|NCT03654040|Everolimus|everolimus|mesh-list
111177817|NCT03654040|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111177818|NCT03654040|Immunologic Factors|immunologic factors|mesh-ancestor
111177819|NCT03654040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111177820|NCT03654040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111177821|NCT03654040|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111177822|NCT03654040|Alkylating Agents|alkylating agents|mesh-ancestor
111177823|NCT03654040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111177824|NCT03654040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111177825|NCT03654040|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111177826|NCT03654040|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111177827|NCT03654040|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111177828|NCT03654040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111177829|NCT03844048|Venetoclax|venetoclax|mesh-list
111177830|NCT03844048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111177831|NCT03833440|Docetaxel|docetaxel|mesh-list
111177832|NCT03833440|Durvalumab|durvalumab|mesh-list
111177833|NCT03833440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111177834|NCT03833440|Tubulin Modulators|tubulin modulators|mesh-ancestor
111177835|NCT03833440|Antimitotic Agents|antimitotic agents|mesh-ancestor
111177836|NCT03833440|Mitosis Modulators|mitosis modulators|mesh-ancestor
111177837|NCT03833440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110895020|NCT02120066|Plasminogen|plasminogen|mesh-list
111177838|NCT03833440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111177840|NCT01677442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111177841|NCT01677442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111177842|NCT01695135|Prednisone|prednisone|mesh-list
111177843|NCT01695135|Abiraterone Acetate|abiraterone acetate|mesh-list
111177844|NCT01695135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111177845|NCT01695135|Glucocorticoids|glucocorticoids|mesh-ancestor
111177846|NCT01695135|Hormones|hormones|mesh-ancestor
110799566|NCT03758235|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111177847|NCT01695135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111177848|NCT01695135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111177849|NCT01695135|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111177850|NCT01695135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111177851|NCT01695135|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111177852|NCT01695135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111177853|NCT01695135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111177854|NCT01695135|Hormone Antagonists|hormone antagonists|mesh-ancestor
111177855|NCT01695135|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111177856|NCT01590771|Metformin|metformin|mesh-list
111177857|NCT01590771|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111177858|NCT01590771|Glimepiride|glimepiride|mesh-list
111177859|NCT01590771|Gliclazide|gliclazide|mesh-list
111177860|NCT01590771|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111177861|NCT01590771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111177862|NCT01590771|Incretins|incretins|mesh-ancestor
111177863|NCT01590771|Hormones|hormones|mesh-ancestor
111177864|NCT01590771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111177865|NCT01590771|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111177866|NCT01590771|Protease Inhibitors|protease inhibitors|mesh-ancestor
111177867|NCT01590771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111177868|NCT01590771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111177869|NCT01590771|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111177870|NCT01590771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111177871|NCT01590771|Immunologic Factors|immunologic factors|mesh-ancestor
111177872|NCT04764058|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
111177873|NCT04764058|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111177874|NCT04764058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111177875|NCT04764058|Protease Inhibitors|protease inhibitors|mesh-ancestor
111177876|NCT04764058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111177877|NCT04764058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111177878|NCT03735316|Vitamin B 12|vitamin b 12|mesh-list
111177879|NCT03735316|Hydroxocobalamin|hydroxocobalamin|mesh-list
111177880|NCT03735316|Vitamins|vitamins|mesh-ancestor
111177881|NCT03735316|Micronutrients|micronutrients|mesh-ancestor
111177882|NCT03735316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111177883|NCT03735316|Vitamin B Complex|vitamin b complex|mesh-ancestor
111177884|NCT03735316|Hematinics|hematinics|mesh-ancestor
111177885|NCT01694433|Vitamin D|vitamin d|mesh-list
111177886|NCT01694433|Calcitriol|calcitriol|mesh-list
111177887|NCT01694433|Calcipotriene|calcipotriene|mesh-list
111177888|NCT01694433|Vitamins|vitamins|mesh-ancestor
111177889|NCT01694433|Micronutrients|micronutrients|mesh-ancestor
111177890|NCT01694433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111177891|NCT01694433|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111177892|NCT01694433|Dermatologic Agents|dermatologic agents|mesh-ancestor
111177893|NCT01694433|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111177894|NCT01694433|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
111177895|NCT01694433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111177896|NCT01694433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111177897|NCT01694433|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111177898|NCT01693185|Midazolam|midazolam|mesh-list
111177899|NCT01693185|Meperidine|meperidine|mesh-list
111177900|NCT01693185|Remifentanil|remifentanil|mesh-list
111177901|NCT01693185|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111177902|NCT01693185|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111177903|NCT01693185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111177904|NCT01693185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111177905|NCT01693185|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111177906|NCT01693185|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111177907|NCT01693185|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111177908|NCT01693185|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111177909|NCT01693185|Anesthetics, General|anesthetics, general|mesh-ancestor
111177910|NCT01693185|Anesthetics|anesthetics|mesh-ancestor
111177911|NCT01693185|GABA Modulators|gaba modulators|mesh-ancestor
111177912|NCT01693185|GABA Agents|gaba agents|mesh-ancestor
111177913|NCT01693185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111177914|NCT01693185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111177915|NCT01693185|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111177917|NCT01693185|Analgesics|analgesics|mesh-ancestor
111177918|NCT01693185|Sensory System Agents|sensory system agents|mesh-ancestor
111177919|NCT01693185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111177920|NCT03824938|Aspirin|aspirin|mesh-list
111177921|NCT03824938|Acetaminophen|acetaminophen|mesh-list
111177922|NCT03824938|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111177923|NCT03824938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111177924|NCT03824938|Analgesics|analgesics|mesh-ancestor
111177925|NCT03824938|Sensory System Agents|sensory system agents|mesh-ancestor
111177926|NCT03824938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111177927|NCT03824938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111177928|NCT03824938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111177929|NCT03824938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111177930|NCT03824938|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111177931|NCT03824938|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111177932|NCT03824938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111177933|NCT03824938|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111177934|NCT03824938|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111177935|NCT03824938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111177936|NCT03824938|Antipyretics|antipyretics|mesh-ancestor
111177937|NCT03630640|Nivolumab|nivolumab|mesh-list
111177938|NCT03630640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111177939|NCT03630640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111177940|NCT03630640|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111177941|NCT03630640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111177942|NCT03625726|Thrombin|thrombin|mesh-list
111177943|NCT03625726|Hemostatics|hemostatics|mesh-ancestor
111177944|NCT03625726|Coagulants|coagulants|mesh-ancestor
111177945|NCT03814954|Epinephrine|epinephrine|mesh-list
111177946|NCT03814954|Albuterol|albuterol|mesh-list
111177947|NCT03814954|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111177948|NCT03814954|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111177949|NCT03814954|Adrenergic Agents|adrenergic agents|mesh-ancestor
111177950|NCT03814954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111177951|NCT03814954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111177952|NCT03814954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111177953|NCT03814954|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111177954|NCT03814954|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111177955|NCT03814954|Autonomic Agents|autonomic agents|mesh-ancestor
111177956|NCT03814954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111177957|NCT03814954|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111177958|NCT03814954|Respiratory System Agents|respiratory system agents|mesh-ancestor
111177959|NCT03814954|Mydriatics|mydriatics|mesh-ancestor
111177960|NCT03814954|Sympathomimetics|sympathomimetics|mesh-ancestor
111177961|NCT03814954|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111177962|NCT03814954|Tocolytic Agents|tocolytic agents|mesh-ancestor
111177963|NCT03814954|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111177964|NCT03814954|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111177965|NCT03813160|Dronabinol|dronabinol|mesh-list
111177966|NCT03813160|Lenabasum|lenabasum|mesh-list
111177967|NCT03813160|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
111177968|NCT03813160|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
111177969|NCT03813160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111177970|NCT03813160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111177971|NCT03813160|Hormones|hormones|mesh-ancestor
111177972|NCT03813160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111177973|NCT03813160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111177974|NCT03813160|Hallucinogens|hallucinogens|mesh-ancestor
111177975|NCT03813160|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111177976|NCT03813160|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111177977|NCT03813160|Analgesics|analgesics|mesh-ancestor
111177978|NCT03813160|Sensory System Agents|sensory system agents|mesh-ancestor
111177979|NCT03813160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111177980|NCT03619252|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111177981|NCT03619252|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
111177982|NCT03619252|Immunologic Factors|immunologic factors|mesh-ancestor
111177983|NCT03619252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111177984|NCT03619252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111177985|NCT03807856|Dabigatran|dabigatran|mesh-list
111177986|NCT03807856|Antithrombins|antithrombins|mesh-ancestor
111177987|NCT03807856|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111177988|NCT03807856|Protease Inhibitors|protease inhibitors|mesh-ancestor
111177989|NCT03807856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111177990|NCT03807856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111177991|NCT03807856|Anticoagulants|anticoagulants|mesh-ancestor
111177992|NCT03806530|Gabapentin|gabapentin|mesh-list
111177993|NCT03806530|Ropinirole|ropinirole|mesh-list
111177994|NCT03806530|Analgesics|analgesics|mesh-ancestor
111177995|NCT03806530|Sensory System Agents|sensory system agents|mesh-ancestor
111177996|NCT03806530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111177997|NCT03806530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111177998|NCT03806530|Anticonvulsants|anticonvulsants|mesh-ancestor
111177999|NCT03806530|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111178000|NCT03806530|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111178001|NCT03806530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111178002|NCT03806530|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111178003|NCT03806530|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111178004|NCT03806530|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111178005|NCT03806530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111178006|NCT03806530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111178007|NCT03806530|Antimanic Agents|antimanic agents|mesh-ancestor
111178008|NCT03806530|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111178009|NCT03806530|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111178010|NCT03806530|Dopamine Agonists|dopamine agonists|mesh-ancestor
111178012|NCT00003820|Rituximab|rituximab|mesh-list
111178013|NCT00003820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111178014|NCT00003820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111178015|NCT00003820|Immunologic Factors|immunologic factors|mesh-ancestor
111178016|NCT00003820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111178017|NCT00003820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111178018|NCT01693029|Epoetin Alfa|epoetin alfa|mesh-list
111178019|NCT01693029|Hematinics|hematinics|mesh-ancestor
111178020|NCT01589445|Metformin|metformin|mesh-list
111178021|NCT01589445|Pioglitazone|pioglitazone|mesh-list
111178022|NCT01589445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111178023|NCT01589445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111178024|NCT01561989|Vitamin D|vitamin d|mesh-list
111178025|NCT01561989|Cholecalciferol|cholecalciferol|mesh-list
111178026|NCT01561989|Vaccines|vaccines|mesh-list
111178027|NCT01561989|Immunologic Factors|immunologic factors|mesh-ancestor
111178028|NCT01561989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111178029|NCT01561989|Vitamins|vitamins|mesh-ancestor
111178030|NCT01561989|Micronutrients|micronutrients|mesh-ancestor
111178031|NCT01561989|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111178032|NCT01561989|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111178033|NCT00004054|Paclitaxel|paclitaxel|mesh-list
111178034|NCT00004054|Etoposide|etoposide|mesh-list
111178035|NCT00004054|Bicalutamide|bicalutamide|mesh-list
111178036|NCT00004054|Flutamide|flutamide|mesh-list
111178037|NCT00004054|Estramustine|estramustine|mesh-list
111178038|NCT00004054|Warfarin|warfarin|mesh-list
111178039|NCT00004054|Hormones|hormones|mesh-list
111178040|NCT00004054|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
111178041|NCT00004054|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111178042|NCT00004054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111178043|NCT00004054|Tubulin Modulators|tubulin modulators|mesh-ancestor
111178044|NCT00004054|Antimitotic Agents|antimitotic agents|mesh-ancestor
111178045|NCT00004054|Mitosis Modulators|mitosis modulators|mesh-ancestor
111178046|NCT00004054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111178047|NCT00004054|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111178048|NCT00004054|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111178049|NCT00004054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111178050|NCT00004054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111178051|NCT00004054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111178052|NCT00004054|Anticoagulants|anticoagulants|mesh-ancestor
110488552|NCT04012138|Tocolytic Agents|tocolytic agents|mesh-ancestor
111178053|NCT00004054|Androgen Antagonists|androgen antagonists|mesh-ancestor
111178054|NCT00004054|Hormone Antagonists|hormone antagonists|mesh-ancestor
111178055|NCT00004054|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111178056|NCT00004054|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111178057|NCT00004054|Alkylating Agents|alkylating agents|mesh-ancestor
111178058|NCT01587885|Omeprazole|omeprazole|mesh-list
111178059|NCT01587885|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111178060|NCT01587885|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111178061|NCT01587885|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111178062|NCT01587885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111178063|NCT01587885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111178064|NCT03802240|Pemetrexed|pemetrexed|mesh-list
111178065|NCT03802240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111178066|NCT03802240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111178067|NCT03802240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111178068|NCT03802240|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111178069|NCT03802240|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111178071|NCT01587651|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
111178072|NCT01587651|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111178073|NCT01587651|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111178074|NCT01587651|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111178075|NCT01587651|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111178076|NCT01587651|Purinergic Agents|purinergic agents|mesh-ancestor
111178077|NCT01587651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111178078|NCT01587651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111178079|NCT01587651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111178080|NCT04763434|Dexamethasone|dexamethasone|mesh-list
111178081|NCT04763434|Dexmedetomidine|dexmedetomidine|mesh-list
111178082|NCT04763434|Ropivacaine|ropivacaine|mesh-list
111178083|NCT04763434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111178084|NCT04763434|Antiemetics|antiemetics|mesh-ancestor
111178085|NCT04763434|Autonomic Agents|autonomic agents|mesh-ancestor
111178086|NCT04763434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111178087|NCT04763434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111178088|NCT04763434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111178089|NCT04763434|Glucocorticoids|glucocorticoids|mesh-ancestor
111178090|NCT04763434|Hormones|hormones|mesh-ancestor
111178091|NCT04763434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111178092|NCT04763434|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111178093|NCT04763434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111178094|NCT04763434|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111178095|NCT04763434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111178096|NCT04763434|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111178097|NCT04763434|Analgesics|analgesics|mesh-ancestor
111178098|NCT04763434|Sensory System Agents|sensory system agents|mesh-ancestor
111178099|NCT04763434|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111178100|NCT04763434|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111178101|NCT04763434|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111178102|NCT04763434|Adrenergic Agents|adrenergic agents|mesh-ancestor
111178103|NCT04763434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111178104|NCT04763434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111178105|NCT04763434|Anesthetics, Local|anesthetics, local|mesh-ancestor
111178106|NCT04763434|Anesthetics|anesthetics|mesh-ancestor
111178107|NCT04762966|Metformin|metformin|mesh-list
111178108|NCT04762966|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111178109|NCT04762966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111178110|NCT03602560|Seladelpar|seladelpar|mesh-list
111178111|NCT03602560|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111178112|NCT03602560|Antimetabolites|antimetabolites|mesh-ancestor
110488557|NCT04012138|Adrenergic Agents|adrenergic agents|mesh-ancestor
111178113|NCT03602560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111178114|NCT03602560|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111178115|NCT03797326|Pembrolizumab|pembrolizumab|mesh-list
111178116|NCT03797326|Lenvatinib|lenvatinib|mesh-list
111178117|NCT03797326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111178118|NCT03797326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111178119|NCT03797326|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111178120|NCT03797326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111178121|NCT03797326|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111178122|NCT03797326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111178123|NCT00779116|Cetirizine|cetirizine|mesh-list
111178124|NCT00779116|Desloratadine|desloratadine|mesh-list
111178125|NCT00779116|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111178126|NCT00779116|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
111178127|NCT00779116|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111178128|NCT00779116|Histamine Antagonists|histamine antagonists|mesh-ancestor
111178129|NCT00779116|Histamine Agents|histamine agents|mesh-ancestor
111178130|NCT00779116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111178131|NCT00779116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111178132|NCT00779116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111178133|NCT00779116|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111178134|NCT00779116|Cholinergic Agents|cholinergic agents|mesh-ancestor
111178135|NCT01691781|Lisinopril|lisinopril|mesh-list
111178136|NCT01691781|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
111178137|NCT01691781|Protease Inhibitors|protease inhibitors|mesh-ancestor
111178138|NCT01691781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111178139|NCT01691781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111178140|NCT01691781|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111178141|NCT01691781|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111178142|NCT01691781|Protective Agents|protective agents|mesh-ancestor
111178143|NCT01691781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111178144|NCT01561755|Immunoglobulins|immunoglobulins|mesh-list
111178145|NCT01561755|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111178146|NCT01561755|Antibodies|antibodies|mesh-list
111178147|NCT01561755|gamma-Globulins|gamma-globulins|mesh-list
111178148|NCT01561755|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
111178149|NCT01561755|Immunologic Factors|immunologic factors|mesh-ancestor
111178150|NCT01561755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111178151|NCT03789214|Suvorexant|suvorexant|mesh-list
111178152|NCT03789214|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111178153|NCT03789214|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111178154|NCT03789214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111178155|NCT03789214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111178156|NCT03789214|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
111178157|NCT03789214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111178158|NCT03789214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111178159|NCT04124367|Cerebrolysin|cerebrolysin|mesh-list
111178160|NCT04124367|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111178161|NCT04124367|Protective Agents|protective agents|mesh-ancestor
111178162|NCT04124367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111178163|NCT04124367|Nootropic Agents|nootropic agents|mesh-ancestor
111178164|NCT01560507|Bupropion|bupropion|mesh-list
111178165|NCT01560507|Nicotine|nicotine|mesh-list
111178166|NCT01560507|Varenicline|varenicline|mesh-list
111178167|NCT01560507|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111178168|NCT01560507|Autonomic Agents|autonomic agents|mesh-ancestor
111178169|NCT01560507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111178170|NCT01560507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111178171|NCT01560507|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111178172|NCT01560507|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111178173|NCT01560507|Cholinergic Agents|cholinergic agents|mesh-ancestor
111178174|NCT01560507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111178175|NCT01560507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111178176|NCT01560507|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111178177|NCT01560507|Antidepressive Agents|antidepressive agents|mesh-ancestor
111178178|NCT01560507|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111178179|NCT01560507|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111178180|NCT01560507|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111178181|NCT01560507|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111178182|NCT01560507|Dopamine Agents|dopamine agents|mesh-ancestor
111178183|NCT01560507|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111178184|NCT01560507|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111178185|NCT01560507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111178186|NCT03694834|Pembrolizumab|pembrolizumab|mesh-list
111178187|NCT03694834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111178188|NCT03694834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111178189|NCT03694834|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111178190|NCT03694834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111178191|NCT03586414|Ubiquinone|ubiquinone|mesh-list
111178192|NCT03586414|Micronutrients|micronutrients|mesh-ancestor
111178193|NCT03586414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111178194|NCT03684538|Zinc|zinc|mesh-list
111178195|NCT03684538|Trace Elements|trace elements|mesh-ancestor
111178196|NCT03684538|Micronutrients|micronutrients|mesh-ancestor
111178197|NCT03684538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111178198|NCT03682978|Baclofen|baclofen|mesh-list
111178199|NCT03682978|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
111178200|NCT03682978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111178201|NCT03682978|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111178202|NCT03682978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111178203|NCT03682978|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
111178204|NCT03682978|GABA Agonists|gaba agonists|mesh-ancestor
111178205|NCT03682978|GABA Agents|gaba agents|mesh-ancestor
111178206|NCT03682978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111178207|NCT03682978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111178208|NCT03676192|Bevacizumab|bevacizumab|mesh-list
111178209|NCT03676192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111178210|NCT03676192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111178211|NCT03676192|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111178212|NCT03676192|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111178213|NCT03676192|Growth Substances|growth substances|mesh-ancestor
111178214|NCT03676192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111178215|NCT03676192|Growth Inhibitors|growth inhibitors|mesh-ancestor
111178216|NCT01584843|Botulinum Toxins|botulinum toxins|mesh-list
111178217|NCT01584843|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111178218|NCT01584843|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111178219|NCT01584843|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111178220|NCT01584843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111178221|NCT01584843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111178222|NCT01584843|Cholinergic Agents|cholinergic agents|mesh-ancestor
111178223|NCT01584843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111178224|NCT01584843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111178225|NCT01584843|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111178226|NCT01584843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111178227|NCT03580408|Nivolumab|nivolumab|mesh-list
111178228|NCT03580408|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111178229|NCT03580408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111178230|NCT03580408|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111178231|NCT03580408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111178232|NCT03775096|Carvedilol|carvedilol|mesh-list
111178233|NCT03775096|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111178234|NCT03775096|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111178235|NCT03775096|Adrenergic Agents|adrenergic agents|mesh-ancestor
111178236|NCT03775096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111178237|NCT03775096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111178238|NCT03775096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111178239|NCT03775096|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111178240|NCT03775096|Antioxidants|antioxidants|mesh-ancestor
111178241|NCT03775096|Protective Agents|protective agents|mesh-ancestor
111178242|NCT03775096|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111178243|NCT03775096|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111178244|NCT03775096|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111178245|NCT03775096|Vasodilator Agents|vasodilator agents|mesh-ancestor
111178246|NCT03775096|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111178247|NCT03775096|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111178248|NCT03675256|Vaccines|vaccines|mesh-list
111178249|NCT03675256|Immunologic Factors|immunologic factors|mesh-ancestor
111178250|NCT03675256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111178251|NCT03766750|Dapagliflozin|dapagliflozin|mesh-list
111178252|NCT03766750|Linagliptin|linagliptin|mesh-list
111178253|NCT03766750|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111178254|NCT03766750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111178255|NCT03766750|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111178256|NCT03766750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111178257|NCT03766750|Incretins|incretins|mesh-ancestor
111178258|NCT03766750|Hormones|hormones|mesh-ancestor
111178259|NCT03766750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111178260|NCT03766750|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111178261|NCT03766750|Protease Inhibitors|protease inhibitors|mesh-ancestor
111178262|NCT03766750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111178263|NCT04762810|Cyclophosphamide|cyclophosphamide|mesh-list
111178264|NCT04762810|Glucocorticoids|glucocorticoids|mesh-list
111178265|NCT04762810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111178266|NCT04762810|Immunologic Factors|immunologic factors|mesh-ancestor
111178267|NCT04762810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111178268|NCT04762810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111178269|NCT04762810|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111178270|NCT04762810|Alkylating Agents|alkylating agents|mesh-ancestor
111178271|NCT04762810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111178272|NCT04762810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111178273|NCT04762810|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111178274|NCT04762810|Hormones|hormones|mesh-ancestor
111178275|NCT04762810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111178276|NCT03674242|Carboplatin|carboplatin|mesh-list
111178277|NCT03674242|Gemcitabine|gemcitabine|mesh-list
111178278|NCT03674242|Asparaginase|asparaginase|mesh-list
111178279|NCT03674242|Eryaspase|eryaspase|mesh-list
111178280|NCT03674242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111178281|NCT03674242|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111178282|NCT03674242|Antimetabolites|antimetabolites|mesh-ancestor
111178283|NCT03674242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111178284|NCT04761952|Infliximab|infliximab|mesh-list
111178285|NCT04761952|Azathioprine|azathioprine|mesh-list
111178286|NCT04761952|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111178287|NCT04761952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111178288|NCT04761952|Dermatologic Agents|dermatologic agents|mesh-ancestor
111178290|NCT04761952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111178291|NCT04761952|Antimetabolites|antimetabolites|mesh-ancestor
111178292|NCT04761952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111178293|NCT04761952|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111178294|NCT04761952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111178295|NCT04761952|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111178296|NCT04761952|Immunologic Factors|immunologic factors|mesh-ancestor
111178297|NCT04761952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111178298|NCT03673072|Gemcitabine|gemcitabine|mesh-list
111178299|NCT03673072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111178300|NCT03673072|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111178301|NCT03673072|Antimetabolites|antimetabolites|mesh-ancestor
111178302|NCT03673072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111178303|NCT01690299|Etanercept|etanercept|mesh-list
111178304|NCT01690299|Apremilast|apremilast|mesh-list
111178305|NCT01690299|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111178306|NCT01690299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111178307|NCT01690299|Analgesics|analgesics|mesh-ancestor
111178308|NCT01690299|Sensory System Agents|sensory system agents|mesh-ancestor
111178309|NCT01690299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111178310|NCT01690299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111178311|NCT01690299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111178312|NCT01690299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111178313|NCT01690299|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111178314|NCT01690299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111178315|NCT01690299|Immunologic Factors|immunologic factors|mesh-ancestor
111178316|NCT01690299|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
111178317|NCT01690299|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111178318|NCT01690299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111178319|NCT01690299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111178320|NCT03570814|Azithromycin|azithromycin|mesh-list
111178321|NCT03570814|Ivermectin|ivermectin|mesh-list
111178322|NCT03570814|Albendazole|albendazole|mesh-list
111178323|NCT03570814|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111178324|NCT03570814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111178325|NCT03570814|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111178326|NCT03570814|Anthelmintics|anthelmintics|mesh-ancestor
111178327|NCT03570814|Anticestodal Agents|anticestodal agents|mesh-ancestor
111178328|NCT03570814|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
111178329|NCT03570814|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111178330|NCT03570814|Tubulin Modulators|tubulin modulators|mesh-ancestor
111178331|NCT03570814|Antimitotic Agents|antimitotic agents|mesh-ancestor
111178332|NCT03570814|Mitosis Modulators|mitosis modulators|mesh-ancestor
111178333|NCT03570814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111178334|NCT03570814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111178335|NCT00723736|Desloratadine|desloratadine|mesh-list
111178336|NCT00723736|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111178337|NCT00723736|Cholinergic Agents|cholinergic agents|mesh-ancestor
111178338|NCT00723736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111178339|NCT00723736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111178340|NCT00723736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111178341|NCT00723736|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
111178342|NCT00723736|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111178343|NCT00723736|Histamine Antagonists|histamine antagonists|mesh-ancestor
111178344|NCT00723736|Histamine Agents|histamine agents|mesh-ancestor
111178345|NCT00305344|Vaccines|vaccines|mesh-list
111178346|NCT00305344|Immunologic Factors|immunologic factors|mesh-ancestor
111178347|NCT00305344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111178348|NCT01690143|Melphalan|melphalan|mesh-list
111178349|NCT01690143|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111178350|NCT01690143|Alkylating Agents|alkylating agents|mesh-ancestor
111178351|NCT01690143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111178352|NCT01690143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111178353|NCT01690143|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111178354|NCT01690143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111178355|NCT01690143|Immunologic Factors|immunologic factors|mesh-ancestor
111178356|NCT01690143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111178357|NCT05347498|Febuxostat|febuxostat|mesh-list
111178358|NCT05347498|Gout Suppressants|gout suppressants|mesh-ancestor
111178359|NCT05347498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111178360|NCT01677364|Oxytocin|oxytocin|mesh-list
111178361|NCT01677364|Oxytocics|oxytocics|mesh-ancestor
111178362|NCT01677364|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110895537|NCT03606018|Insulin Lispro|insulin lispro|mesh-list
111178363|NCT01677364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111178364|NCT03563248|Nivolumab|nivolumab|mesh-list
111178365|NCT03563248|Folfirinox|folfirinox|mesh-list
111178366|NCT03563248|Losartan|losartan|mesh-list
111178367|NCT03563248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111178368|NCT03563248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111178369|NCT03563248|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111178370|NCT03563248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111178371|NCT03563248|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111178372|NCT03563248|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111178373|NCT03563248|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111178374|NCT03563248|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111178375|NCT04403776|Tofacitinib|tofacitinib|mesh-list
111178376|NCT04403776|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
111178377|NCT04403776|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111178378|NCT04403776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111178379|NCT04403776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111178380|NCT03559348|Leucovorin|leucovorin|mesh-list
111178381|NCT03559348|Gemcitabine|gemcitabine|mesh-list
111178382|NCT03559348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111178383|NCT03559348|Antimetabolites|antimetabolites|mesh-ancestor
111178384|NCT03559348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111178385|NCT03559348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111178386|NCT03559348|Antidotes|antidotes|mesh-ancestor
111178387|NCT03559348|Protective Agents|protective agents|mesh-ancestor
111178388|NCT03559348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111178389|NCT03559348|Vitamin B Complex|vitamin b complex|mesh-ancestor
111178390|NCT03559348|Vitamins|vitamins|mesh-ancestor
111178391|NCT03559348|Micronutrients|micronutrients|mesh-ancestor
111178392|NCT04762030|Paclitaxel|paclitaxel|mesh-list
111178393|NCT04762030|Carboplatin|carboplatin|mesh-list
111178394|NCT04762030|Durvalumab|durvalumab|mesh-list
111178395|NCT04762030|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111178396|NCT04762030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111178397|NCT04762030|Tubulin Modulators|tubulin modulators|mesh-ancestor
111178398|NCT04762030|Antimitotic Agents|antimitotic agents|mesh-ancestor
111178399|NCT04762030|Mitosis Modulators|mitosis modulators|mesh-ancestor
111178400|NCT04762030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111178401|NCT04762030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111178402|NCT01559259|Acetaminophen|acetaminophen|mesh-list
111178403|NCT01559259|Ibuprofen|ibuprofen|mesh-list
111178404|NCT01559259|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111178405|NCT01559259|Analgesics|analgesics|mesh-ancestor
111178406|NCT01559259|Sensory System Agents|sensory system agents|mesh-ancestor
111178407|NCT01559259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111178408|NCT01559259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111178409|NCT01559259|Antipyretics|antipyretics|mesh-ancestor
111178410|NCT01559259|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111178411|NCT01559259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111178412|NCT01559259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111178413|NCT01559259|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111178414|NCT01559259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111178415|NCT01559259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111178416|NCT03088306|Acetaminophen|acetaminophen|mesh-list
111178417|NCT03088306|Fentanyl|fentanyl|mesh-list
111178418|NCT03088306|Ketamine|ketamine|mesh-list
111178419|NCT03088306|Gabapentin|gabapentin|mesh-list
111178420|NCT03088306|Hydromorphone|hydromorphone|mesh-list
111178421|NCT03088306|Anesthetics|anesthetics|mesh-ancestor
111178422|NCT03088306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111178423|NCT03088306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111178424|NCT03088306|Analgesics|analgesics|mesh-ancestor
111178425|NCT03088306|Sensory System Agents|sensory system agents|mesh-ancestor
111178426|NCT03088306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111178427|NCT03088306|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111178428|NCT03088306|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111178429|NCT03088306|Anesthetics, General|anesthetics, general|mesh-ancestor
111178430|NCT03088306|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111178431|NCT03088306|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111178432|NCT03088306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111178433|NCT03088306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110843584|NCT01263353|Everolimus|everolimus|mesh-list
111178434|NCT03088306|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111178436|NCT03088306|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111178437|NCT03088306|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110895617|NCT03552770|Bevacizumab|bevacizumab|mesh-list
111178438|NCT03088306|Antipyretics|antipyretics|mesh-ancestor
111178439|NCT03088306|Anticonvulsants|anticonvulsants|mesh-ancestor
111178440|NCT03088306|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111178441|NCT03088306|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111178442|NCT03088306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111178443|NCT03088306|Antimanic Agents|antimanic agents|mesh-ancestor
111178444|NCT01672762|Ipragliflozin|ipragliflozin|mesh-list
111178445|NCT01672762|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111178446|NCT01672762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111178447|NCT01672762|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111178448|NCT01672762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111178449|NCT03088384|Ketamine|ketamine|mesh-list
111178450|NCT03088384|Analgesics|analgesics|mesh-ancestor
111178451|NCT03088384|Sensory System Agents|sensory system agents|mesh-ancestor
111178452|NCT03088384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111178453|NCT03088384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111178454|NCT03088384|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111178455|NCT03088384|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111178456|NCT03088384|Anesthetics, General|anesthetics, general|mesh-ancestor
111178457|NCT03088384|Anesthetics|anesthetics|mesh-ancestor
111178458|NCT03088384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111178459|NCT03088384|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111178460|NCT03088384|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111178461|NCT03088384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111178462|NCT03088384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111178463|NCT01677598|Ustekinumab|ustekinumab|mesh-list
111178464|NCT01677598|Dermatologic Agents|dermatologic agents|mesh-ancestor
111178465|NCT01677754|Memantine|memantine|mesh-list
111178466|NCT01677754|Rivastigmine|rivastigmine|mesh-list
111178467|NCT01677754|Donepezil|donepezil|mesh-list
111178468|NCT01677754|Galantamine|galantamine|mesh-list
111178469|NCT01677754|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111178470|NCT01677754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111178471|NCT01677754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111178472|NCT01677754|Cholinergic Agents|cholinergic agents|mesh-ancestor
111178473|NCT01677754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111178474|NCT01677754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111178475|NCT01677754|Nootropic Agents|nootropic agents|mesh-ancestor
111178476|NCT01677754|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111178477|NCT01677754|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111178478|NCT01677754|Dopamine Agents|dopamine agents|mesh-ancestor
111178479|NCT01677754|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111178480|NCT01677754|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111178481|NCT01677754|Parasympathomimetics|parasympathomimetics|mesh-ancestor
111178482|NCT01677754|Autonomic Agents|autonomic agents|mesh-ancestor
111178483|NCT01677754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111178484|NCT01677754|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111178485|NCT01677754|Protective Agents|protective agents|mesh-ancestor
111178486|NCT01670500|Cyclophosphamide|cyclophosphamide|mesh-list
111178487|NCT01670500|Cisplatin|cisplatin|mesh-list
111178488|NCT01670500|Doxorubicin|doxorubicin|mesh-list
111178489|NCT01670500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111178490|NCT01670500|Immunologic Factors|immunologic factors|mesh-ancestor
111178491|NCT01670500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111178492|NCT01670500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111178493|NCT01670500|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111178494|NCT01670500|Alkylating Agents|alkylating agents|mesh-ancestor
111178495|NCT01670500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111178496|NCT01670500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111178497|NCT01670500|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111178498|NCT01670500|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111178499|NCT01670500|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111178500|NCT01670500|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111178501|NCT01670500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111178502|NCT01678612|Copper|copper|mesh-list
111178503|NCT01678612|Trace Elements|trace elements|mesh-ancestor
111178504|NCT01678612|Micronutrients|micronutrients|mesh-ancestor
111178505|NCT01678612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111178506|NCT03525574|Ivacaftor|ivacaftor|mesh-list
111178507|NCT03525574|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
111178508|NCT03525574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111178509|NCT03525574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111178510|NCT02402920|Cisplatin|cisplatin|mesh-list
111178511|NCT02402920|Carboplatin|carboplatin|mesh-list
111178512|NCT02402920|Pembrolizumab|pembrolizumab|mesh-list
111178513|NCT02402920|Etoposide|etoposide|mesh-list
111178514|NCT02402920|Etoposide phosphate|etoposide phosphate|mesh-list
111178515|NCT02402920|Podophyllotoxin|podophyllotoxin|mesh-list
111178516|NCT02402920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111178517|NCT02402920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111178518|NCT02402920|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111178519|NCT02402920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111178520|NCT02402920|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111178521|NCT02402920|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111178522|NCT02402920|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111178523|NCT02402920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111178524|NCT02402920|Keratolytic Agents|keratolytic agents|mesh-ancestor
111178525|NCT02402920|Dermatologic Agents|dermatologic agents|mesh-ancestor
111178526|NCT02402920|Tubulin Modulators|tubulin modulators|mesh-ancestor
111178527|NCT02402920|Antimitotic Agents|antimitotic agents|mesh-ancestor
111178528|NCT02402920|Mitosis Modulators|mitosis modulators|mesh-ancestor
111178529|NCT02405260|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111178530|NCT02405260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111178531|NCT02405260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111178532|NCT02405260|Incretins|incretins|mesh-ancestor
111178533|NCT02405260|Hormones|hormones|mesh-ancestor
111178534|NCT02405260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111178535|NCT02405260|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111178536|NCT02405260|Protease Inhibitors|protease inhibitors|mesh-ancestor
111178537|NCT02405260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111178538|NCT02405260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111178539|NCT03519646|Eliglustat|eliglustat|mesh-list
111178540|NCT03519646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111178541|NCT03519646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111178542|NCT02984722|Metformin|metformin|mesh-list
111178543|NCT02984722|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111178544|NCT02984722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111178545|NCT02401750|Naltrexone|naltrexone|mesh-list
111178546|NCT02401750|Oxycodone|oxycodone|mesh-list
111178547|NCT02401750|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111178548|NCT02401750|Narcotics|narcotics|mesh-ancestor
111178549|NCT02401750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111178550|NCT02401750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111178551|NCT02401750|Analgesics|analgesics|mesh-ancestor
111178552|NCT02401750|Sensory System Agents|sensory system agents|mesh-ancestor
111178553|NCT02401750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111178554|NCT02401750|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111178555|NCT02401750|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111178556|NCT03087136|polysaccharide-K|polysaccharide-k|mesh-list
111178557|NCT03087136|Antibodies|antibodies|mesh-list
111178558|NCT03087136|Immunologic Factors|immunologic factors|mesh-ancestor
111178559|NCT03087136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111178560|NCT03087136|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111178561|NCT03087136|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110843606|NCT01156649|Acetaminophen|acetaminophen|mesh-list
111178562|NCT03087136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111178563|NCT03087136|Antiviral Agents|antiviral agents|mesh-ancestor
111178564|NCT03087136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111178565|NCT03087136|Interferon Inducers|interferon inducers|mesh-ancestor
111178566|NCT03087136|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111178567|NCT03087136|Protective Agents|protective agents|mesh-ancestor
111178568|NCT01689519|Vemurafenib|vemurafenib|mesh-list
111178569|NCT01689519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111178570|NCT01689519|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111178571|NCT01689519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111178572|NCT01689519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111178574|NCT01689363|Histamine Agonists|histamine agonists|mesh-ancestor
111178575|NCT01689363|Histamine Agents|histamine agents|mesh-ancestor
111178576|NCT01689363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111178577|NCT01689363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111178578|NCT01689363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111178579|NCT03455140|BCT-100|bct-100|mesh-list
111178580|NCT03455140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111178581|NCT03502018|Bupivacaine|bupivacaine|mesh-list
111178582|NCT03502018|Anesthetics, Local|anesthetics, local|mesh-ancestor
111178583|NCT03502018|Anesthetics|anesthetics|mesh-ancestor
111178584|NCT03502018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111178585|NCT03502018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111178586|NCT03502018|Sensory System Agents|sensory system agents|mesh-ancestor
111178587|NCT03502018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111178588|NCT01689207|Aztreonam|aztreonam|mesh-list
111178589|NCT01689207|Avibactam|avibactam|mesh-list
111178590|NCT01689207|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111178591|NCT01689207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111178592|NCT01689207|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
111178593|NCT01689207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111178594|NCT01689207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111178595|NCT00089284|Rituximab|rituximab|mesh-list
111178596|NCT00089284|Motexafin gadolinium|motexafin gadolinium|mesh-list
111178597|NCT00089284|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111178598|NCT00089284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111178599|NCT00089284|Immunologic Factors|immunologic factors|mesh-ancestor
111178600|NCT00089284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111178601|NCT00089284|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111178602|NCT00089284|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111178603|NCT00089284|Dermatologic Agents|dermatologic agents|mesh-ancestor
111178604|NCT01688973|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111178605|NCT01688973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111178606|NCT01688973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111178607|NCT01688973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111178608|NCT01688973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111178609|NCT00087646|Ribavirin|ribavirin|mesh-list
111178610|NCT00087646|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
111178611|NCT00087646|Interferon-alpha|interferon-alpha|mesh-list
111178612|NCT00087646|Antimetabolites|antimetabolites|mesh-ancestor
111178613|NCT00087646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111178614|NCT00087646|Antiviral Agents|antiviral agents|mesh-ancestor
111178615|NCT00087646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111178616|NCT00087646|Immunologic Factors|immunologic factors|mesh-ancestor
111178617|NCT00087646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111178618|NCT03492658|Methotrexate|methotrexate|mesh-list
111178619|NCT03492658|Abatacept|abatacept|mesh-list
111178620|NCT03492658|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111178621|NCT03492658|Abortifacient Agents|abortifacient agents|mesh-ancestor
111178622|NCT03492658|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111178623|NCT03492658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111178624|NCT03492658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111178625|NCT03492658|Antimetabolites|antimetabolites|mesh-ancestor
111178626|NCT03492658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111178627|NCT03492658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111178628|NCT03492658|Dermatologic Agents|dermatologic agents|mesh-ancestor
111178629|NCT03492658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111178630|NCT03492658|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111178631|NCT03492658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111178632|NCT03492658|Immunologic Factors|immunologic factors|mesh-ancestor
111178633|NCT03492658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111178634|NCT03492658|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111178635|NCT03492658|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111178636|NCT03492658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111178637|NCT03085654|Oxytocin|oxytocin|mesh-list
111178638|NCT03085654|Oxytocics|oxytocics|mesh-ancestor
111178639|NCT03085654|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111178640|NCT03085654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111178641|NCT00087568|Ribavirin|ribavirin|mesh-list
111178642|NCT00087568|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
111178643|NCT00087568|Antimetabolites|antimetabolites|mesh-ancestor
111178644|NCT00087568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111178645|NCT00087568|Antiviral Agents|antiviral agents|mesh-ancestor
111178646|NCT00087568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111178647|NCT04402762|Enoxaparin|enoxaparin|mesh-list
111178648|NCT04402762|Enoxaparin sodium|enoxaparin sodium|mesh-list
111178649|NCT04402762|Anticoagulants|anticoagulants|mesh-ancestor
111178650|NCT04402762|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111178651|NCT04402762|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111178652|NCT04402762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111178653|NCT00085540|Romidepsin|romidepsin|mesh-list
111178654|NCT00085540|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111178655|NCT00085540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111178656|NCT00085540|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111178657|NCT00085540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111178658|NCT00085540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111178659|NCT01688739|Erenumab|erenumab|mesh-list
111178660|NCT01688739|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
111178661|NCT01688739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111178662|NCT01688739|Analgesics|analgesics|mesh-ancestor
111178663|NCT01688739|Sensory System Agents|sensory system agents|mesh-ancestor
111178664|NCT01688739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111178665|NCT01688739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111178666|NCT00084838|Calcium, Dietary|calcium, dietary|mesh-list
111178668|NCT00084838|Cytarabine|cytarabine|mesh-list
111178669|NCT00084838|Dactinomycin|dactinomycin|mesh-list
111178670|NCT00084838|Hydrocortisone|hydrocortisone|mesh-list
111178671|NCT00084838|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
111178672|NCT00084838|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
111178673|NCT00084838|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
111178674|NCT00084838|Cyclophosphamide|cyclophosphamide|mesh-list
111178675|NCT00084838|Temozolomide|temozolomide|mesh-list
111178676|NCT00084838|Cisplatin|cisplatin|mesh-list
111178677|NCT00084838|Doxorubicin|doxorubicin|mesh-list
111178678|NCT00084838|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111178679|NCT00084838|Methotrexate|methotrexate|mesh-list
111178680|NCT00084838|Etoposide|etoposide|mesh-list
111178681|NCT00084838|Vincristine|vincristine|mesh-list
111178682|NCT00084838|Dexrazoxane|dexrazoxane|mesh-list
111178683|NCT00084838|Razoxane|razoxane|mesh-list
111178684|NCT00084838|Lenograstim|lenograstim|mesh-list
111178685|NCT00084838|Calcium|calcium|mesh-list
111178686|NCT00084838|Levoleucovorin|levoleucovorin|mesh-list
111178687|NCT00084838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111178688|NCT00084838|Immunologic Factors|immunologic factors|mesh-ancestor
111178689|NCT00084838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111178690|NCT00084838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111178691|NCT00084838|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111178692|NCT00084838|Alkylating Agents|alkylating agents|mesh-ancestor
111178693|NCT00084838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111178694|NCT00084838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111178695|NCT00084838|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111178696|NCT00084838|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111178697|NCT00084838|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111178698|NCT00084838|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111178699|NCT00084838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111178700|NCT00084838|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111178701|NCT00084838|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111178702|NCT00084838|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111178703|NCT00084838|Abortifacient Agents|abortifacient agents|mesh-ancestor
111178704|NCT00084838|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111178705|NCT00084838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111178706|NCT00084838|Antimetabolites|antimetabolites|mesh-ancestor
111178707|NCT00084838|Dermatologic Agents|dermatologic agents|mesh-ancestor
111178708|NCT00084838|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111178709|NCT00084838|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111178710|NCT00084838|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111178711|NCT00084838|Antiviral Agents|antiviral agents|mesh-ancestor
111178712|NCT00084838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111178713|NCT00084838|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111178714|NCT00084838|Antidotes|antidotes|mesh-ancestor
111178715|NCT00084838|Protective Agents|protective agents|mesh-ancestor
111178716|NCT00084838|Vitamin B Complex|vitamin b complex|mesh-ancestor
111178717|NCT00084838|Vitamins|vitamins|mesh-ancestor
111178718|NCT00084838|Micronutrients|micronutrients|mesh-ancestor
111178719|NCT00084838|Tubulin Modulators|tubulin modulators|mesh-ancestor
111178720|NCT00084838|Antimitotic Agents|antimitotic agents|mesh-ancestor
111178721|NCT00084838|Mitosis Modulators|mitosis modulators|mesh-ancestor
111178722|NCT00084838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111178723|NCT00084838|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111178724|NCT00084838|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111178725|NCT00084838|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111178726|NCT01558089|Etanercept|etanercept|mesh-list
111178727|NCT01558089|Methotrexate|methotrexate|mesh-list
111178728|NCT01558089|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111178729|NCT01558089|Abortifacient Agents|abortifacient agents|mesh-ancestor
111178730|NCT01558089|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111178731|NCT01558089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111178732|NCT01558089|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111178733|NCT01558089|Antimetabolites|antimetabolites|mesh-ancestor
111178734|NCT01558089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111178735|NCT01558089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111178736|NCT01558089|Dermatologic Agents|dermatologic agents|mesh-ancestor
111178737|NCT01558089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111178738|NCT01558089|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111178739|NCT01558089|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111178740|NCT01558089|Immunologic Factors|immunologic factors|mesh-ancestor
110895915|NCT03256045|Protease Inhibitors|protease inhibitors|mesh-ancestor
111178741|NCT01558089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111178742|NCT01558089|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111178743|NCT01558089|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111178744|NCT01558089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111178745|NCT01558089|Analgesics|analgesics|mesh-ancestor
111178746|NCT01558089|Sensory System Agents|sensory system agents|mesh-ancestor
111178747|NCT01558089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111178748|NCT01558089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111178749|NCT01558089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111178751|NCT00084682|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111178752|NCT00084682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111178753|NCT00084682|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111178754|NCT00084682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111178755|NCT00084682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111178756|NCT01556997|Amlodipine|amlodipine|mesh-list
111178757|NCT01556997|Perindopril|perindopril|mesh-list
111178758|NCT01556997|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111178759|NCT01556997|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111178760|NCT01556997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111178761|NCT01556997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111178762|NCT01556997|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111178763|NCT01556997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111178764|NCT01556997|Vasodilator Agents|vasodilator agents|mesh-ancestor
111178765|NCT01556997|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
111178766|NCT01556997|Protease Inhibitors|protease inhibitors|mesh-ancestor
111178767|NCT01556997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111178768|NCT00082888|Tipifarnib|tipifarnib|mesh-list
111178769|NCT00082888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111178770|NCT03085186|Crizotinib|crizotinib|mesh-list
111178771|NCT03085186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111178772|NCT03085186|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111178773|NCT03085186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111178774|NCT03085186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111178775|NCT03084952|Meglumine Antimoniate|meglumine antimoniate|mesh-list
111178776|NCT03084952|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111178777|NCT03084952|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111178778|NCT03084952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111178779|NCT00082810|Fulvestrant|fulvestrant|mesh-list
111178780|NCT00082810|Tipifarnib|tipifarnib|mesh-list
111178781|NCT00082810|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111178782|NCT00082810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111178783|NCT00082810|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
111178784|NCT00082810|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111178785|NCT00082810|Hormone Antagonists|hormone antagonists|mesh-ancestor
111178786|NCT00082810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111178787|NCT00082810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111178788|NCT03085030|Antioxidants|antioxidants|mesh-list
111178789|NCT03085030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111178790|NCT03085030|Protective Agents|protective agents|mesh-ancestor
111178791|NCT03085030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111178792|NCT03443128|Vinorelbine|vinorelbine|mesh-list
111178793|NCT03443128|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111178794|NCT03443128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111178795|NCT03443128|Tubulin Modulators|tubulin modulators|mesh-ancestor
111178796|NCT03443128|Antimitotic Agents|antimitotic agents|mesh-ancestor
111178797|NCT03443128|Mitosis Modulators|mitosis modulators|mesh-ancestor
111178798|NCT03443128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111178799|NCT03437746|Methylprednisolone|methylprednisolone|mesh-list
111178800|NCT03437746|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111178801|NCT03437746|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111178802|NCT03437746|Prednisolone|prednisolone|mesh-list
111178803|NCT03437746|Prednisolone acetate|prednisolone acetate|mesh-list
111178804|NCT03437746|Anesthetics|anesthetics|mesh-list
111178805|NCT03437746|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111178806|NCT03437746|Prednisolone phosphate|prednisolone phosphate|mesh-list
111178807|NCT03437746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111178808|NCT03437746|Antiemetics|antiemetics|mesh-ancestor
111178809|NCT03437746|Autonomic Agents|autonomic agents|mesh-ancestor
111178810|NCT03437746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111178811|NCT03437746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111178812|NCT03437746|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111178813|NCT03437746|Glucocorticoids|glucocorticoids|mesh-ancestor
111178814|NCT03437746|Hormones|hormones|mesh-ancestor
111178815|NCT03437746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110895992|NCT03118765|Bromides|bromides|mesh-list
111178816|NCT03437746|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111178817|NCT03437746|Protective Agents|protective agents|mesh-ancestor
111178818|NCT03437746|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111178819|NCT03437746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111178820|NCT03437746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111178822|NCT03084250|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
111178823|NCT03084250|Entecavir|entecavir|mesh-list
111178824|NCT03084250|Adefovir|adefovir|mesh-list
111178825|NCT03084250|Antiviral Agents|antiviral agents|mesh-ancestor
111178826|NCT03084250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111178827|NCT03084250|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110843636|NCT01156883|Dexamethasone|dexamethasone|mesh-list
111178828|NCT03084250|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111178829|NCT03084250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111178830|NCT03084250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111178831|NCT03084250|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111178832|NCT03084250|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111178834|NCT01688037|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111178835|NCT01688037|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111178836|NCT01688037|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111178837|NCT01688037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111178838|NCT01688037|Adrenergic Agents|adrenergic agents|mesh-ancestor
111178839|NCT01688037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111178840|NCT01688037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111178841|NCT03084328|Vitamin D|vitamin d|mesh-list
111178842|NCT03084328|Vitamins|vitamins|mesh-ancestor
111178843|NCT03084328|Micronutrients|micronutrients|mesh-ancestor
111178844|NCT03084328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111178845|NCT03084328|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111178846|NCT03435718|Albendazole|albendazole|mesh-list
111178847|NCT03435718|Oxfendazole|oxfendazole|mesh-list
111178848|NCT03435718|Anthelmintics|anthelmintics|mesh-ancestor
111178849|NCT03435718|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111178850|NCT03435718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111178851|NCT03435718|Anticestodal Agents|anticestodal agents|mesh-ancestor
111178852|NCT03435718|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
111178853|NCT03435718|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111178854|NCT03435718|Tubulin Modulators|tubulin modulators|mesh-ancestor
111178855|NCT03435718|Antimitotic Agents|antimitotic agents|mesh-ancestor
111178856|NCT03435718|Mitosis Modulators|mitosis modulators|mesh-ancestor
111178857|NCT03435718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111178858|NCT03435718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111178859|NCT03435718|Antinematodal Agents|antinematodal agents|mesh-ancestor
111178860|NCT01678690|Gemcitabine|gemcitabine|mesh-list
111178861|NCT01678690|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111178862|NCT01678690|Antimetabolites|antimetabolites|mesh-ancestor
111178863|NCT01678690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111178864|NCT01678690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111178865|NCT01679080|Zoledronic Acid|zoledronic acid|mesh-list
111178866|NCT01679080|Teriparatide|teriparatide|mesh-list
111178867|NCT01679080|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111178868|NCT01679080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111178869|NCT01679080|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111178870|NCT03083782|Cyclosporine|cyclosporine|mesh-list
111178871|NCT03083782|Apixaban|apixaban|mesh-list
111178872|NCT03083782|Tacrolimus|tacrolimus|mesh-list
111178873|NCT03083782|Cyclosporins|cyclosporins|mesh-list
111178874|NCT03083782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111178875|NCT03083782|Immunologic Factors|immunologic factors|mesh-ancestor
111178876|NCT03083782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111178877|NCT03083782|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111178878|NCT03083782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111178879|NCT03083782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111178880|NCT03083782|Antifungal Agents|antifungal agents|mesh-ancestor
111178881|NCT03083782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111178882|NCT03083782|Dermatologic Agents|dermatologic agents|mesh-ancestor
111178883|NCT03083782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111178884|NCT03083782|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111178885|NCT03083782|Antithrombins|antithrombins|mesh-ancestor
111178886|NCT03083782|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111178887|NCT03083782|Protease Inhibitors|protease inhibitors|mesh-ancestor
111178888|NCT03083782|Anticoagulants|anticoagulants|mesh-ancestor
111178889|NCT03471442|Bupivacaine|bupivacaine|mesh-list
111178890|NCT03471442|Ropivacaine|ropivacaine|mesh-list
111178891|NCT03471442|Anesthetics, Local|anesthetics, local|mesh-list
111178892|NCT03471442|Anesthetics|anesthetics|mesh-list
111178893|NCT03471442|Anesthetics, General|anesthetics, general|mesh-list
111178894|NCT03471442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110843649|NCT01156883|Vindesine|vindesine|mesh-list
111178895|NCT03471442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111178896|NCT03471442|Sensory System Agents|sensory system agents|mesh-ancestor
111178897|NCT03471442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111178898|NCT01679392|Ropivacaine|ropivacaine|mesh-list
111178899|NCT01679392|Anesthetics, Local|anesthetics, local|mesh-ancestor
111178900|NCT01679392|Anesthetics|anesthetics|mesh-ancestor
111178901|NCT01679392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111178902|NCT01679392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111178903|NCT01679392|Sensory System Agents|sensory system agents|mesh-ancestor
111178904|NCT01679392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111178905|NCT03083080|Epinephrine|epinephrine|mesh-list
111178906|NCT03083080|Ropivacaine|ropivacaine|mesh-list
111178907|NCT03083080|Anesthetics, Local|anesthetics, local|mesh-ancestor
111178908|NCT03083080|Anesthetics|anesthetics|mesh-ancestor
111178909|NCT03083080|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111178910|NCT03083080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111178911|NCT03083080|Sensory System Agents|sensory system agents|mesh-ancestor
111178912|NCT03083080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111178913|NCT03083080|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111178914|NCT03083080|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111178915|NCT03083080|Adrenergic Agents|adrenergic agents|mesh-ancestor
111178916|NCT03083080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111178917|NCT03083080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111178918|NCT03083080|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111178919|NCT03083080|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111178920|NCT03083080|Autonomic Agents|autonomic agents|mesh-ancestor
111178921|NCT03083080|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111178922|NCT03083080|Respiratory System Agents|respiratory system agents|mesh-ancestor
111178923|NCT03083080|Mydriatics|mydriatics|mesh-ancestor
111178924|NCT03083080|Sympathomimetics|sympathomimetics|mesh-ancestor
111178925|NCT03083080|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111178927|NCT03082300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111178928|NCT03082300|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111178929|NCT03082300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111178930|NCT03082300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111178931|NCT01679860|Alemtuzumab|alemtuzumab|mesh-list
111178932|NCT01679860|Immunomodulating Agents|immunomodulating agents|mesh-list
111178933|NCT01679860|Immunologic Factors|immunologic factors|mesh-list
110488657|NCT03505762|Glucocorticoids|glucocorticoids|mesh-ancestor
111178934|NCT01679860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111178935|NCT01679860|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111178936|NCT01679860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111178937|NCT05346952|Carboplatin|carboplatin|mesh-list
111178938|NCT05346952|Pemetrexed|pemetrexed|mesh-list
111178939|NCT05346952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111178940|NCT05346952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111178941|NCT05346952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111178942|NCT05346952|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111178943|NCT05346952|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111178944|NCT03081442|Misoprostol|misoprostol|mesh-list
111178945|NCT03081442|Contraceptive Agents|contraceptive agents|mesh-list
111178946|NCT03081442|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111178947|NCT03081442|Abortifacient Agents|abortifacient agents|mesh-ancestor
111178948|NCT03081442|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111178949|NCT03081442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111178950|NCT03081442|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111178951|NCT03081442|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111178952|NCT03081442|Oxytocics|oxytocics|mesh-ancestor
111178953|NCT03431194|Midodrine|midodrine|mesh-list
111178954|NCT03431194|Sympathomimetics|sympathomimetics|mesh-ancestor
111178955|NCT03431194|Autonomic Agents|autonomic agents|mesh-ancestor
111178956|NCT03431194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111178957|NCT03431194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111178958|NCT03431194|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111178959|NCT03431194|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111178960|NCT03431194|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111178961|NCT03431194|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111178962|NCT03431194|Adrenergic Agents|adrenergic agents|mesh-ancestor
111178963|NCT03431194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111178964|NCT03431194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111178965|NCT03080740|Metronidazole|metronidazole|mesh-list
111178966|NCT03080740|Clindamycin|clindamycin|mesh-list
111178967|NCT03080740|Clindamycin palmitate|clindamycin palmitate|mesh-list
111178968|NCT03080740|Clindamycin phosphate|clindamycin phosphate|mesh-list
111178969|NCT03080740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111178970|NCT03080740|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111178971|NCT03080740|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111178972|NCT03080740|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111178973|NCT03080740|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111178974|NCT03080740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111178975|NCT03080740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111178976|NCT03081832|Oxytocin|oxytocin|mesh-list
111178977|NCT03081832|Oxytocics|oxytocics|mesh-ancestor
111178978|NCT03081832|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111178979|NCT03081832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111178980|NCT05345938|Mitoxantrone|mitoxantrone|mesh-list
111178981|NCT05345938|Analgesics|analgesics|mesh-ancestor
111178982|NCT05345938|Sensory System Agents|sensory system agents|mesh-ancestor
111178983|NCT05345938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111178984|NCT05345938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111178985|NCT05345938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111178986|NCT05345938|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111178987|NCT05345938|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111178988|NCT05345938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111178989|NCT05345938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111178990|NCT03080350|Fentanyl|fentanyl|mesh-list
111178991|NCT03080350|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111178992|NCT03080350|Narcotics|narcotics|mesh-ancestor
111178993|NCT03080350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111178994|NCT03080350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111178995|NCT03080350|Analgesics|analgesics|mesh-ancestor
111178996|NCT03080350|Sensory System Agents|sensory system agents|mesh-ancestor
111178997|NCT03080350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111178998|NCT03080350|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111178999|NCT03080350|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110488658|NCT03505762|Hormones|hormones|mesh-ancestor
111179000|NCT03080350|Anesthetics, General|anesthetics, general|mesh-ancestor
111179001|NCT03080350|Anesthetics|anesthetics|mesh-ancestor
111179002|NCT03080194|Paliperidone Palmitate|paliperidone palmitate|mesh-list
111179003|NCT03080194|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111179004|NCT03080194|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111179005|NCT03080194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111179006|NCT03080194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111179007|NCT03080194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111179008|NCT03080194|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111179009|NCT03080194|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111179010|NCT03080194|Serotonin Agents|serotonin agents|mesh-ancestor
111179011|NCT03080194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111179012|NCT03080194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111179013|NCT03080194|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111179014|NCT03080194|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111179015|NCT03080194|Dopamine Agents|dopamine agents|mesh-ancestor
111179016|NCT01610336|Gefitinib|gefitinib|mesh-list
111179017|NCT01610336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111179018|NCT01610336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111179019|NCT01610336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111179020|NCT01610336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111179021|NCT03323866|Mometasone Furoate|mometasone furoate|mesh-list
111179022|NCT03323866|Budesonide|budesonide|mesh-list
111179023|NCT03323866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111179024|NCT03323866|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111179025|NCT03323866|Autonomic Agents|autonomic agents|mesh-ancestor
111179026|NCT03323866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111179027|NCT03323866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111179028|NCT03323866|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111179029|NCT03323866|Respiratory System Agents|respiratory system agents|mesh-ancestor
111179030|NCT03323866|Glucocorticoids|glucocorticoids|mesh-ancestor
111179031|NCT03323866|Hormones|hormones|mesh-ancestor
111179032|NCT03323866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111179033|NCT03323866|Dermatologic Agents|dermatologic agents|mesh-ancestor
111179034|NCT03323866|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111179035|NCT05688670|Ropivacaine|ropivacaine|mesh-list
111179036|NCT05688670|Anesthetics|anesthetics|mesh-ancestor
111179037|NCT05688670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111179038|NCT05688670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111179039|NCT05688670|Anesthetics, Local|anesthetics, local|mesh-ancestor
111179040|NCT05688670|Sensory System Agents|sensory system agents|mesh-ancestor
111179041|NCT05688670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111179042|NCT05684848|Resveratrol|resveratrol|mesh-list
111179043|NCT05684848|Antioxidants|antioxidants|mesh-ancestor
111179044|NCT05684848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111179045|NCT05684848|Protective Agents|protective agents|mesh-ancestor
111179046|NCT05684848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111179047|NCT05684848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111179048|NCT05684848|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111179050|NCT03366298|Racepinephrine|racepinephrine|mesh-list
111179051|NCT03366298|Epinephryl borate|epinephryl borate|mesh-list
111179052|NCT03366298|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111179053|NCT03366298|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111179054|NCT03366298|Adrenergic Agents|adrenergic agents|mesh-ancestor
111179055|NCT03366298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110488672|NCT03439046|Fulvestrant|fulvestrant|mesh-list
111179056|NCT03366298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111179057|NCT03366298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111179058|NCT03366298|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111179059|NCT03366298|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111179060|NCT03366298|Autonomic Agents|autonomic agents|mesh-ancestor
111179061|NCT03366298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111179062|NCT03366298|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111179063|NCT03366298|Respiratory System Agents|respiratory system agents|mesh-ancestor
111179064|NCT03366298|Mydriatics|mydriatics|mesh-ancestor
111179065|NCT03366298|Sympathomimetics|sympathomimetics|mesh-ancestor
111179066|NCT03366298|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111179067|NCT05688436|Interferons|interferons|mesh-list
111179068|NCT05688436|Interferon-beta|interferon-beta|mesh-list
111179069|NCT05688436|Alemtuzumab|alemtuzumab|mesh-list
111179070|NCT05688436|Glatiramer Acetate|glatiramer acetate|mesh-list
111179071|NCT05688436|Ocrelizumab|ocrelizumab|mesh-list
111179072|NCT05688436|Natalizumab|natalizumab|mesh-list
111179073|NCT05688436|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
111179074|NCT05688436|(T,G)-A-L|(t,g)-a-l|mesh-list
111179075|NCT05688436|Siponimod|siponimod|mesh-list
111179076|NCT05688436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111179077|NCT05688436|Antiviral Agents|antiviral agents|mesh-ancestor
111179078|NCT05688436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111179079|NCT05688436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111179080|NCT05688436|Immunologic Factors|immunologic factors|mesh-ancestor
111179081|NCT05688436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111179082|NCT05688436|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
111179083|NCT05688436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111179084|NCT05688436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111179085|NCT05688436|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111179086|NCT05688436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111179087|NCT05688202|Acetaminophen|acetaminophen|mesh-list
111179088|NCT05688202|Lidocaine|lidocaine|mesh-list
111179089|NCT05688202|Prilocaine|prilocaine|mesh-list
111179090|NCT05688202|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
111179091|NCT05688202|Anesthetics, Local|anesthetics, local|mesh-ancestor
111179092|NCT05688202|Anesthetics|anesthetics|mesh-ancestor
111179093|NCT05688202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111179094|NCT05688202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111179095|NCT05688202|Sensory System Agents|sensory system agents|mesh-ancestor
111179096|NCT05688202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111179097|NCT05688202|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111179098|NCT05688202|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111179099|NCT05688202|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111179100|NCT05688202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111179101|NCT05688202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111179102|NCT05688202|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111179103|NCT05688202|Analgesics|analgesics|mesh-ancestor
111179104|NCT05688202|Antipyretics|antipyretics|mesh-ancestor
111179105|NCT05688202|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
111179106|NCT05688124|Esomeprazole|esomeprazole|mesh-list
111179107|NCT05688124|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111179108|NCT05688124|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111179109|NCT05688124|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111179110|NCT05688124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111179111|NCT05688124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111179112|NCT01842620|Metformin|metformin|mesh-list
111179113|NCT01842620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111179114|NCT01842620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111179115|NCT04760704|Antibodies|antibodies|mesh-list
111179116|NCT04760704|Immunologic Factors|immunologic factors|mesh-ancestor
111179117|NCT04760704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111179118|NCT01931839|Ivacaftor|ivacaftor|mesh-list
111179119|NCT01931839|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
111179120|NCT01931839|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111179121|NCT01931839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110488686|NCT03406156|Obinutuzumab|obinutuzumab|mesh-list
111179123|NCT01842308|Mechlorethamine|mechlorethamine|mesh-list
111179124|NCT01842308|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
111179125|NCT01842308|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111179126|NCT01842308|Alkylating Agents|alkylating agents|mesh-ancestor
111179127|NCT01842308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111179128|NCT01842308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111179129|NCT01842308|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111179130|NCT01842308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111179131|NCT01842308|Immunologic Factors|immunologic factors|mesh-ancestor
111179132|NCT01842308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111179133|NCT01931059|Risperidone|risperidone|mesh-list
111179134|NCT01931059|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111179135|NCT01931059|Serotonin Agents|serotonin agents|mesh-ancestor
111179136|NCT01931059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111179137|NCT01931059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111179138|NCT01931059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111179139|NCT01931059|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111179140|NCT01931059|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111179141|NCT01931059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111179142|NCT01931059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111179143|NCT01931059|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111179144|NCT01931059|Dopamine Agents|dopamine agents|mesh-ancestor
111179145|NCT01841762|Macitentan|macitentan|mesh-list
111179146|NCT01841762|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
111179147|NCT01841762|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
111179148|NCT01841762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111179149|NCT01841762|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
111179150|NCT03301636|Pembrolizumab|pembrolizumab|mesh-list
111179151|NCT03301636|Nivolumab|nivolumab|mesh-list
111179152|NCT03301636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111179153|NCT03301636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111179154|NCT03301636|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111179155|NCT03301636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111179156|NCT04602494|Varenicline|varenicline|mesh-list
111179157|NCT04602494|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111179158|NCT04602494|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111179159|NCT04602494|Cholinergic Agents|cholinergic agents|mesh-ancestor
111179160|NCT04602494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111179161|NCT04602494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111179162|NCT04602494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111179163|NCT05640232|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
111179164|NCT05640232|Parasympatholytics|parasympatholytics|mesh-ancestor
111179165|NCT05640232|Autonomic Agents|autonomic agents|mesh-ancestor
111179166|NCT05640232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111179167|NCT05640232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111179168|NCT05640232|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111179169|NCT05640232|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111179170|NCT05640232|Cholinergic Agents|cholinergic agents|mesh-ancestor
111179171|NCT05640232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111179172|NCT05640232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111179173|NCT01970371|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111179174|NCT01970371|Meropenem|meropenem|mesh-list
111179175|NCT01970371|Colistin|colistin|mesh-list
111179176|NCT01970371|Tigecycline|tigecycline|mesh-list
111179177|NCT01970371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111179178|NCT01970371|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111179179|NCT01970371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111179180|NCT01970371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111179181|NCT04171700|Rucaparib|rucaparib|mesh-list
111179182|NCT04171700|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111179183|NCT04171700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111179184|NCT04171700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111179185|NCT04171700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111179186|NCT05604742|Belimumab|belimumab|mesh-list
111179187|NCT05604742|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111179188|NCT05604742|Immunologic Factors|immunologic factors|mesh-ancestor
111179189|NCT05604742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110896364|NCT05417087|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111179190|NCT03350386|Oxaprozin|oxaprozin|mesh-list
111179191|NCT03350386|Dotinurad|dotinurad|mesh-list
111179192|NCT03350386|Uricosuric Agents|uricosuric agents|mesh-ancestor
111179193|NCT03350386|Gout Suppressants|gout suppressants|mesh-ancestor
111179194|NCT03350386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111179195|NCT03350386|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111179196|NCT03350386|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111179197|NCT03350386|Analgesics|analgesics|mesh-ancestor
111179198|NCT03350386|Sensory System Agents|sensory system agents|mesh-ancestor
111179199|NCT03350386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111179200|NCT03350386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111179201|NCT03350386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111179202|NCT03350386|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111179203|NCT03350386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111179204|NCT03350386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111179205|NCT05567458|Luspatercept|luspatercept|mesh-list
111179206|NCT05567458|Hematinics|hematinics|mesh-ancestor
111179207|NCT03344692|Alirocumab|alirocumab|mesh-list
111179208|NCT03344692|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
111179209|NCT03344692|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111179210|NCT03344692|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111179211|NCT03344692|Antimetabolites|antimetabolites|mesh-ancestor
111179212|NCT03344692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111179213|NCT03344692|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111179214|NCT03344692|Protease Inhibitors|protease inhibitors|mesh-ancestor
111179215|NCT03344692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111179216|NCT03344692|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111179217|NCT05305924|Fulvestrant|fulvestrant|mesh-list
111179218|NCT05305924|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111179219|NCT05305924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111179220|NCT05305924|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
111179221|NCT05305924|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111179222|NCT05305924|Hormone Antagonists|hormone antagonists|mesh-ancestor
111179223|NCT05305924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111179224|NCT05305924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111179225|NCT05548582|Acetaminophen|acetaminophen|mesh-list
111179226|NCT05548582|Ibuprofen|ibuprofen|mesh-list
111179227|NCT05548582|Oxycodone|oxycodone|mesh-list
111179228|NCT05548582|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111179229|NCT05548582|Analgesics|analgesics|mesh-ancestor
111179230|NCT05548582|Sensory System Agents|sensory system agents|mesh-ancestor
111179231|NCT05548582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111179232|NCT05548582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111179233|NCT05548582|Antipyretics|antipyretics|mesh-ancestor
111179234|NCT05548582|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111179235|NCT05548582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111179236|NCT05548582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111179237|NCT05548582|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111179238|NCT05548582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111179239|NCT05548582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111179240|NCT05548582|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111179241|NCT05548582|Narcotics|narcotics|mesh-ancestor
111179242|NCT05548582|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111179243|NCT01839188|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
111179244|NCT01839188|Immunologic Factors|immunologic factors|mesh-ancestor
111179245|NCT01839188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111179246|NCT05223088|Oxaliplatin|oxaliplatin|mesh-list
111179247|NCT05223088|Apatinib|apatinib|mesh-list
111179248|NCT05223088|Tislelizumab|tislelizumab|mesh-list
111179249|NCT05223088|Tegafur|tegafur|mesh-list
111179250|NCT05223088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111179251|NCT05223088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111179252|NCT05223088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111179253|NCT05223088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111179254|NCT05223088|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111179255|NCT05223088|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111179256|NCT05223088|Antimetabolites|antimetabolites|mesh-ancestor
111179257|NCT01838876|Cariprazine|cariprazine|mesh-list
111179258|NCT01838876|Antidepressive Agents|antidepressive agents|mesh-list
111179259|NCT01838876|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111179260|NCT01838876|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111179261|NCT01838876|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111179262|NCT01838876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111179263|NCT01838876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111179264|NCT03279250|Prednisone|prednisone|mesh-list
110896436|NCT05358639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111179265|NCT03279250|Cortisone|cortisone|mesh-list
111179266|NCT03279250|Abiraterone Acetate|abiraterone acetate|mesh-list
111179268|NCT03279250|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
111179269|NCT03279250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111179270|NCT03279250|Glucocorticoids|glucocorticoids|mesh-ancestor
111179271|NCT03279250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111179272|NCT03279250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111179273|NCT03279250|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111179274|NCT03279250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111179275|NCT03279250|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111179276|NCT03279250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111179277|NCT03279250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111179278|NCT03279250|Hormone Antagonists|hormone antagonists|mesh-ancestor
111179279|NCT03279250|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111179280|NCT01838642|Ponatinib|ponatinib|mesh-list
111179281|NCT01838642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111179282|NCT01838642|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111179283|NCT01838642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111179284|NCT01838642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111179285|NCT05181046|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111179286|NCT05181046|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111179287|NCT01813058|Tranexamic Acid|tranexamic acid|mesh-list
111179288|NCT01813058|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111179289|NCT01813058|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111179290|NCT01813058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111179291|NCT01813058|Hemostatics|hemostatics|mesh-ancestor
111179292|NCT01813058|Coagulants|coagulants|mesh-ancestor
111179293|NCT05491330|Ritonavir|ritonavir|mesh-list
111179294|NCT05491330|Nirmatrelvir|nirmatrelvir|mesh-list
111179295|NCT05491330|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
111179296|NCT05491330|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111179297|NCT05491330|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111179298|NCT05491330|Protease Inhibitors|protease inhibitors|mesh-ancestor
111179299|NCT05491330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111179300|NCT05491330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111179301|NCT05491330|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111179302|NCT05491330|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111179303|NCT05491330|Antiviral Agents|antiviral agents|mesh-ancestor
111179304|NCT05491330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111179305|NCT05491330|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110843688|NCT01156961|Paclitaxel|paclitaxel|mesh-list
111179306|NCT05491330|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111179308|NCT01811732|Aztreonam|aztreonam|mesh-list
111179309|NCT01811732|Delafloxacin|delafloxacin|mesh-list
111179310|NCT01811732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111179311|NCT01811732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111179312|NCT05139004|Fludarabine|fludarabine|mesh-list
111179313|NCT05139004|Fludarabine phosphate|fludarabine phosphate|mesh-list
111179314|NCT05139004|Melphalan|melphalan|mesh-list
111179315|NCT05139004|Mechlorethamine|mechlorethamine|mesh-list
111179316|NCT05139004|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
111179317|NCT05139004|Basiliximab|basiliximab|mesh-list
111179318|NCT05139004|Mitogens|mitogens|mesh-list
111179319|NCT05139004|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
111179320|NCT05139004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111179321|NCT05139004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111179322|NCT05139004|Antimetabolites|antimetabolites|mesh-ancestor
111179323|NCT05139004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111179324|NCT05139004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111179325|NCT05139004|Immunologic Factors|immunologic factors|mesh-ancestor
111179326|NCT05139004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111179327|NCT05139004|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111179328|NCT05139004|Alkylating Agents|alkylating agents|mesh-ancestor
111179329|NCT05139004|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111179330|NCT05139004|Mitosis Modulators|mitosis modulators|mesh-ancestor
111179331|NCT05139004|Chelating Agents|chelating agents|mesh-ancestor
111179332|NCT05139004|Sequestering Agents|sequestering agents|mesh-ancestor
111179333|NCT01811186|Oxycodone|oxycodone|mesh-list
111179334|NCT01811186|Naloxone|naloxone|mesh-list
111179335|NCT01811186|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111179336|NCT01811186|Narcotics|narcotics|mesh-ancestor
111179337|NCT01811186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111179338|NCT01811186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111179339|NCT01811186|Analgesics|analgesics|mesh-ancestor
111179340|NCT01811186|Sensory System Agents|sensory system agents|mesh-ancestor
111179341|NCT01811186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111179342|NCT01811186|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111179343|NCT01866098|Naltrexone|naltrexone|mesh-list
111179344|NCT01866098|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111179345|NCT01866098|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111179346|NCT01866098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111179347|NCT01866098|Sensory System Agents|sensory system agents|mesh-ancestor
111179348|NCT01866098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111179349|NCT04885972|Triamcinolone|triamcinolone|mesh-list
111179350|NCT04885972|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
111179351|NCT04885972|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
111179352|NCT04885972|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
111179353|NCT04885972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111179354|NCT04885972|Glucocorticoids|glucocorticoids|mesh-ancestor
111179355|NCT04885972|Hormones|hormones|mesh-ancestor
111179356|NCT04885972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111179357|NCT04885972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111179358|NCT04885972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111179359|NCT04885972|Immunologic Factors|immunologic factors|mesh-ancestor
111179360|NCT04885972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111179361|NCT04885972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111179362|NCT04039750|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111179363|NCT04039750|Clindamycin|clindamycin|mesh-list
111179364|NCT04039750|Gentamicins|gentamicins|mesh-list
111179365|NCT04039750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111179366|NCT04039750|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111179367|NCT04039750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111179368|NCT04039750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111179369|NCT03985540|Methamphetamine|methamphetamine|mesh-list
111179370|NCT03985540|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111179371|NCT03985540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111179372|NCT03985540|Sympathomimetics|sympathomimetics|mesh-ancestor
110843702|NCT01159301|Sorafenib|sorafenib|mesh-list
111179373|NCT03985540|Autonomic Agents|autonomic agents|mesh-ancestor
111179374|NCT03985540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111179375|NCT03985540|Dopamine Agents|dopamine agents|mesh-ancestor
111179376|NCT03985540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111179377|NCT03985540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111179378|NCT03985540|Adrenergic Agents|adrenergic agents|mesh-ancestor
111179379|NCT03985540|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111179380|NCT03985540|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111179381|NCT03985540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111179382|NCT03985540|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111179383|NCT04858360|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
111179384|NCT04858360|Anesthetics, Local|anesthetics, local|mesh-ancestor
111179385|NCT04858360|Anesthetics|anesthetics|mesh-ancestor
111179386|NCT04858360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111179387|NCT04858360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111179388|NCT04858360|Sensory System Agents|sensory system agents|mesh-ancestor
111179389|NCT04858360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111179390|NCT04858360|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
111179391|NCT01865552|Etanercept|etanercept|mesh-list
111179392|NCT01865552|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111179393|NCT01865552|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111179394|NCT01865552|Analgesics|analgesics|mesh-ancestor
111179395|NCT01865552|Sensory System Agents|sensory system agents|mesh-ancestor
111179396|NCT01865552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111179397|NCT01865552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111179398|NCT01865552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111179399|NCT01865552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111179400|NCT01865552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111179401|NCT01865552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111179402|NCT01865552|Immunologic Factors|immunologic factors|mesh-ancestor
111179403|NCT01809314|Epoetin Alfa|epoetin alfa|mesh-list
111179404|NCT01809314|Hematinics|hematinics|mesh-ancestor
111179405|NCT05185024|Iron|iron|mesh-list
111179406|NCT05185024|Trace Elements|trace elements|mesh-ancestor
111179407|NCT05185024|Micronutrients|micronutrients|mesh-ancestor
111179408|NCT05185024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111179409|NCT01808690|Metformin|metformin|mesh-list
111179410|NCT01808690|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111179411|NCT01808690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111179412|NCT04583618|Vaccines|vaccines|mesh-list
111179413|NCT04583618|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
111179414|NCT04583618|Immunologic Factors|immunologic factors|mesh-ancestor
111179415|NCT04583618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111179416|NCT04413734|Cisplatin|cisplatin|mesh-list
111179417|NCT04413734|Gemcitabine|gemcitabine|mesh-list
111179418|NCT04413734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111179419|NCT04413734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111179420|NCT04413734|Antimetabolites|antimetabolites|mesh-ancestor
111179421|NCT04413734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111179422|NCT03229798|Sumatriptan|sumatriptan|mesh-list
111179423|NCT03229798|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111179424|NCT03229798|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111179425|NCT03229798|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111179426|NCT03229798|Serotonin Agents|serotonin agents|mesh-ancestor
111179427|NCT03229798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111179428|NCT03229798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111179429|NCT03229798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111179430|NCT04805944|Dolutegravir|dolutegravir|mesh-list
111179431|NCT04805944|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111179432|NCT04805944|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111179433|NCT04805944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111179434|NCT04805944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111179435|NCT04805944|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111179436|NCT04805944|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111179437|NCT04805944|Antiviral Agents|antiviral agents|mesh-ancestor
111179438|NCT04805944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111179439|NCT03906292|Niacinamide|niacinamide|mesh-list
111179440|NCT03906292|Imatinib Mesylate|imatinib mesylate|mesh-list
111179441|NCT03906292|Dasatinib|dasatinib|mesh-list
110843709|NCT01159379|Ertapenem|ertapenem|mesh-list
111179442|NCT03906292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111179443|NCT03906292|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111179444|NCT03906292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111179445|NCT03906292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111179446|NCT03906292|Vitamin B Complex|vitamin b complex|mesh-ancestor
111179447|NCT03906292|Vitamins|vitamins|mesh-ancestor
111179448|NCT03906292|Micronutrients|micronutrients|mesh-ancestor
111179449|NCT03906292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111179450|NCT03229174|Droxidopa|droxidopa|mesh-list
111179451|NCT03229174|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111179452|NCT03229174|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111179453|NCT03227926|Panitumumab|panitumumab|mesh-list
111179454|NCT03227926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111179455|NCT03227926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111179456|NCT03615742|Budesonide|budesonide|mesh-list
111179457|NCT03615742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111179458|NCT03615742|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111179459|NCT03615742|Autonomic Agents|autonomic agents|mesh-ancestor
111179460|NCT03615742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111179461|NCT03615742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111179462|NCT03615742|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111179463|NCT03615742|Respiratory System Agents|respiratory system agents|mesh-ancestor
111179464|NCT03615742|Glucocorticoids|glucocorticoids|mesh-ancestor
111179465|NCT03615742|Hormones|hormones|mesh-ancestor
111179466|NCT03615742|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111179467|NCT01363297|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
111179468|NCT01363297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111179469|NCT01363297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111179470|NCT01363297|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111179471|NCT01363297|Immunotoxins|immunotoxins|mesh-ancestor
111179472|NCT01363297|Immunoconjugates|immunoconjugates|mesh-ancestor
111179473|NCT01363297|Immunologic Factors|immunologic factors|mesh-ancestor
111179474|NCT01363297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111179475|NCT04756804|Ethanol|ethanol|mesh-list
111179476|NCT04756804|Chlorhexidine|chlorhexidine|mesh-list
111179477|NCT04756804|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
111179478|NCT04756804|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111179479|NCT04756804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111179480|NCT04756804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111179481|NCT04756804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111179482|NCT04756804|Disinfectants|disinfectants|mesh-ancestor
111179483|NCT04756804|Dermatologic Agents|dermatologic agents|mesh-ancestor
111179484|NCT03199924|Diclofenac|diclofenac|mesh-list
111179485|NCT03199924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
111179486|NCT03199924|Lidocaine|lidocaine|mesh-list
111179487|NCT03199924|Magnesium Sulfate|magnesium sulfate|mesh-list
111179488|NCT03199924|Anesthetics, Local|anesthetics, local|mesh-ancestor
111179489|NCT03199924|Anesthetics|anesthetics|mesh-ancestor
111179490|NCT03199924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111179491|NCT03199924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111179492|NCT03199924|Sensory System Agents|sensory system agents|mesh-ancestor
111179493|NCT03199924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111179494|NCT03199924|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111179495|NCT03199924|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111179496|NCT03199924|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111179497|NCT03199924|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111179498|NCT03199924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111179499|NCT03199924|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111179500|NCT03199924|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111179501|NCT03199924|Analgesics|analgesics|mesh-ancestor
111179502|NCT03199924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111179503|NCT03199924|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111179504|NCT03199924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111179505|NCT03199924|Anticonvulsants|anticonvulsants|mesh-ancestor
111179506|NCT03199924|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111179507|NCT03199924|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111179508|NCT03199924|Tocolytic Agents|tocolytic agents|mesh-ancestor
110843715|NCT01159847|Incretins|incretins|mesh-ancestor
111179509|NCT03199924|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111179510|NCT03199300|Trastuzumab|trastuzumab|mesh-list
111179511|NCT03199300|Bleomycin|bleomycin|mesh-list
111179512|NCT03199300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111179513|NCT03199300|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111179514|NCT03199300|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111179515|NCT04746430|Dexamethasone|dexamethasone|mesh-list
111179516|NCT04746430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111179517|NCT04746430|Antiemetics|antiemetics|mesh-ancestor
111179518|NCT04746430|Autonomic Agents|autonomic agents|mesh-ancestor
111179519|NCT04746430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111179520|NCT04746430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111179521|NCT04746430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111179522|NCT04746430|Glucocorticoids|glucocorticoids|mesh-ancestor
111179523|NCT04746430|Hormones|hormones|mesh-ancestor
111179524|NCT04746430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111179525|NCT04746430|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111179526|NCT04746430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111179527|NCT03642028|Suvorexant|suvorexant|mesh-list
111179528|NCT03642028|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111179529|NCT03642028|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111179530|NCT03642028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111179531|NCT03642028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111179532|NCT03642028|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
111179533|NCT03642028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111179534|NCT03642028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111179535|NCT04402138|Acalabrutinib|acalabrutinib|mesh-list
111179536|NCT04402138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111179537|NCT03197662|Oxytocin|oxytocin|mesh-list
111179538|NCT03197662|Oxytocics|oxytocics|mesh-ancestor
111179539|NCT03197662|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111179540|NCT03197662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111179541|NCT03247582|Edoxaban|edoxaban|mesh-list
111179542|NCT03247582|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111179543|NCT03247582|Antithrombins|antithrombins|mesh-ancestor
111179544|NCT03247582|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111179545|NCT03247582|Protease Inhibitors|protease inhibitors|mesh-ancestor
111179546|NCT03247582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111179547|NCT03247582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111179548|NCT03247582|Anticoagulants|anticoagulants|mesh-ancestor
111179549|NCT01808612|Fluoxetine|fluoxetine|mesh-list
111179550|NCT01808612|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111179551|NCT01808612|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111179552|NCT01808612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111179553|NCT01808612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111179554|NCT01808612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111179555|NCT01808612|Serotonin Agents|serotonin agents|mesh-ancestor
111179556|NCT01808612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111179557|NCT01808612|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111179558|NCT01808612|Antidepressive Agents|antidepressive agents|mesh-ancestor
111179559|NCT01808612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111179560|NCT01808612|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111179561|NCT01808612|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111179562|NCT01808612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111179563|NCT01908829|Solifenacin Succinate|solifenacin succinate|mesh-list
111179564|NCT01908829|Mirabegron|mirabegron|mesh-list
111179565|NCT01908829|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111179566|NCT01908829|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110896765|NCT04722601|Cc-486|cc-486|mesh-list
110488760|NCT03068624|Aldesleukin|aldesleukin|mesh-list
111179567|NCT01908829|Cholinergic Agents|cholinergic agents|mesh-ancestor
111179568|NCT01908829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111179569|NCT01908829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111179570|NCT01908829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111179571|NCT01908829|Urological Agents|urological agents|mesh-ancestor
111179572|NCT01908829|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
111179573|NCT01908829|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111179574|NCT01908829|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111179575|NCT01908829|Adrenergic Agents|adrenergic agents|mesh-ancestor
111179576|NCT01773122|Dapsone|dapsone|mesh-list
111179577|NCT01773122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111179578|NCT01773122|Antimalarials|antimalarials|mesh-ancestor
111179579|NCT01773122|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111179580|NCT01773122|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111179581|NCT01773122|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111179582|NCT01773122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111179583|NCT01773122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111179584|NCT01773122|Leprostatic Agents|leprostatic agents|mesh-ancestor
111179585|NCT01773122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111179586|NCT01808534|Isophosphamide mustard|isophosphamide mustard|mesh-list
111179587|NCT01808534|Ifosfamide|ifosfamide|mesh-list
111179588|NCT01808534|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111179589|NCT01808534|Alkylating Agents|alkylating agents|mesh-ancestor
111179590|NCT01808534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111179591|NCT01808534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111179592|NCT03221140|Anti-Infective Agents|anti-infective agents|mesh-list
111179593|NCT03221140|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111179594|NCT03218800|Ertapenem|ertapenem|mesh-list
111179595|NCT03218800|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111179596|NCT03218800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111179597|NCT01802216|Minocycline|minocycline|mesh-list
111179598|NCT01802216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111179599|NCT01802216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111179600|NCT03621904|Tamoxifen|tamoxifen|mesh-list
111179601|NCT03621904|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-list
111179602|NCT03621904|Antineoplastic Agents|antineoplastic agents|mesh-list
111179603|NCT03621904|Progesterone|progesterone|mesh-list
111179604|NCT03621904|Aromatase Inhibitors|aromatase inhibitors|mesh-list
111179605|NCT03621904|Progestins|progestins|mesh-ancestor
111179606|NCT03621904|Hormones|hormones|mesh-ancestor
111179607|NCT03621904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111179608|NCT03621904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111179609|NCT03621904|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111179610|NCT03621904|Hormone Antagonists|hormone antagonists|mesh-ancestor
111179611|NCT03621904|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111179612|NCT03621904|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111179613|NCT03621904|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111179614|NCT03621904|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111179615|NCT03621904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110799567|NCT03758235|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111179616|NCT03621904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111179617|NCT01808144|Febuxostat|febuxostat|mesh-list
111179618|NCT01808144|Lesinurad|lesinurad|mesh-list
111179619|NCT01808144|Gout Suppressants|gout suppressants|mesh-ancestor
111179620|NCT01808144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111179621|NCT01808144|Uricosuric Agents|uricosuric agents|mesh-ancestor
111179622|NCT02085070|Pembrolizumab|pembrolizumab|mesh-list
111179623|NCT02085070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111179624|NCT02085070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111179625|NCT02085070|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111179626|NCT02085070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111179627|NCT01604343|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111179628|NCT01604343|Immunologic Factors|immunologic factors|mesh-ancestor
111179629|NCT01604343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111179630|NCT01801436|Bortezomib|bortezomib|mesh-list
111179631|NCT01801436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111179632|NCT01771250|Insulin|insulin|mesh-list
111179633|NCT01771250|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111179634|NCT01771250|Insulin Glargine|insulin glargine|mesh-list
111179635|NCT01771250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111179636|NCT01771250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111179637|NCT03568708|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
111179638|NCT03568708|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
111179639|NCT03568708|Estradiol|estradiol|mesh-list
111179640|NCT03568708|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
111179641|NCT03568708|Estrogens|estrogens|mesh-list
111179642|NCT03568708|Hormones|hormones|mesh-ancestor
110843722|NCT02539160|Ticagrelor|ticagrelor|mesh-list
111179643|NCT03568708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111179644|NCT03568708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111179645|NCT03568708|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111179647|NCT03568708|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111179648|NCT03568708|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111179649|NCT04305106|Bevacizumab|bevacizumab|mesh-list
111179650|NCT04305106|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111179651|NCT04305106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111179652|NCT04305106|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111179653|NCT04305106|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111179654|NCT04305106|Growth Substances|growth substances|mesh-ancestor
111179655|NCT04305106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111179656|NCT04305106|Growth Inhibitors|growth inhibitors|mesh-ancestor
111179657|NCT01770392|Rifampin|rifampin|mesh-list
111179658|NCT01770392|Nintedanib|nintedanib|mesh-list
111179659|NCT01770392|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111179660|NCT01770392|Antitubercular Agents|antitubercular agents|mesh-ancestor
111179661|NCT01770392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111179662|NCT01770392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111179663|NCT01770392|Leprostatic Agents|leprostatic agents|mesh-ancestor
111179664|NCT01770392|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111179665|NCT01770392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111179666|NCT01770392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111179667|NCT01770392|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111179668|NCT01770392|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111179669|NCT01770392|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
111179670|NCT01770392|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
111179671|NCT01770392|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
111179672|NCT01770392|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111179673|NCT01770392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111179674|NCT01770392|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111179675|NCT01603641|Botulinum Toxins|botulinum toxins|mesh-list
111179676|NCT01603641|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111179677|NCT01603641|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111179678|NCT01603641|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111179679|NCT01603641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111179680|NCT01603641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111179681|NCT01603641|Cholinergic Agents|cholinergic agents|mesh-ancestor
111179682|NCT01603641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111179683|NCT01603641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111179684|NCT01603641|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111179685|NCT01603641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111179686|NCT03492112|Sofosbuvir|sofosbuvir|mesh-list
111179687|NCT03492112|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
111179688|NCT03492112|Velpatasvir|velpatasvir|mesh-list
111179689|NCT03492112|Antiviral Agents|antiviral agents|mesh-ancestor
111179690|NCT03492112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111179691|NCT01556763|Antipsychotic Agents|antipsychotic agents|mesh-list
111179692|NCT01556763|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111179693|NCT01556763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111179694|NCT01556763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111179695|NCT01556763|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111179696|NCT04397458|Dexamethasone|dexamethasone|mesh-list
111179697|NCT04397458|Bupivacaine|bupivacaine|mesh-list
111179698|NCT04397458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111179699|NCT04397458|Antiemetics|antiemetics|mesh-ancestor
111179700|NCT04397458|Autonomic Agents|autonomic agents|mesh-ancestor
111179701|NCT04397458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111179702|NCT04397458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111179703|NCT04397458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111179704|NCT04397458|Glucocorticoids|glucocorticoids|mesh-ancestor
111179705|NCT04397458|Hormones|hormones|mesh-ancestor
111179706|NCT04397458|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110843737|NCT01266005|Entecavir|entecavir|mesh-list
111179707|NCT04397458|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111179708|NCT04397458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111179709|NCT04397458|Anesthetics, Local|anesthetics, local|mesh-ancestor
111179710|NCT04397458|Anesthetics|anesthetics|mesh-ancestor
111179711|NCT04397458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111179712|NCT04397458|Sensory System Agents|sensory system agents|mesh-ancestor
111179713|NCT04398316|Lidocaine|lidocaine|mesh-list
111179714|NCT04398316|Hydromorphone|hydromorphone|mesh-list
111179715|NCT04398316|Anesthetics, Local|anesthetics, local|mesh-ancestor
111179716|NCT04398316|Anesthetics|anesthetics|mesh-ancestor
111179717|NCT04398316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111179718|NCT04398316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111179719|NCT04398316|Sensory System Agents|sensory system agents|mesh-ancestor
111179720|NCT04398316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111179721|NCT04398316|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111179722|NCT04398316|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111179723|NCT04398316|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111179724|NCT04398316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111179725|NCT04398316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111179726|NCT04398316|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111179727|NCT04398316|Narcotics|narcotics|mesh-ancestor
111179728|NCT04398316|Analgesics|analgesics|mesh-ancestor
111179729|NCT01576575|Rifampin|rifampin|mesh-list
111179730|NCT01576575|Ketoconazole|ketoconazole|mesh-list
111179731|NCT01576575|Buprenorphine|buprenorphine|mesh-list
111179732|NCT01576575|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111179733|NCT01576575|Narcotics|narcotics|mesh-ancestor
111179734|NCT01576575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111179735|NCT01576575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111179736|NCT01576575|Analgesics|analgesics|mesh-ancestor
111179737|NCT01576575|Sensory System Agents|sensory system agents|mesh-ancestor
111179738|NCT01576575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111179739|NCT01576575|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111179740|NCT01576575|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111179741|NCT01576575|Antitubercular Agents|antitubercular agents|mesh-ancestor
111179742|NCT01576575|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111179743|NCT01576575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111179744|NCT01576575|Leprostatic Agents|leprostatic agents|mesh-ancestor
111179745|NCT01576575|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111179746|NCT01576575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111179747|NCT01576575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111179748|NCT01576575|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111179749|NCT01576575|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111179750|NCT01576575|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
111179751|NCT01576575|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
111179752|NCT01576575|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
111179753|NCT01576575|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111179754|NCT01576575|Antifungal Agents|antifungal agents|mesh-ancestor
111179755|NCT01576575|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111179756|NCT01576575|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111179757|NCT01576575|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111179758|NCT01576575|Hormone Antagonists|hormone antagonists|mesh-ancestor
111179759|NCT01576575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111179760|NCT01576575|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111179761|NCT05051566|Esomeprazole|esomeprazole|mesh-list
111179762|NCT05051566|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111179763|NCT05051566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111179764|NCT05051566|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111179765|NCT05051566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111179766|NCT05051566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111179767|NCT01576341|Epoetin Alfa|epoetin alfa|mesh-list
111179768|NCT01576341|Hematinics|hematinics|mesh-ancestor
111179769|NCT04226248|Rivastigmine|rivastigmine|mesh-list
111179770|NCT04226248|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111179771|NCT04226248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111179772|NCT04226248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111179773|NCT04226248|Cholinergic Agents|cholinergic agents|mesh-ancestor
111179774|NCT04226248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111179775|NCT04226248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111179776|NCT04226248|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111179777|NCT04226248|Protective Agents|protective agents|mesh-ancestor
111179778|NCT04398004|Clarithromycin|clarithromycin|mesh-list
111179779|NCT04398004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111179780|NCT04398004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111179781|NCT04398004|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111179782|NCT04398004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111179783|NCT04398004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111179784|NCT04398004|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111179785|NCT04398004|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111179787|NCT01687413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111179788|NCT01555671|Meperidine|meperidine|mesh-list
111179789|NCT01555671|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111179790|NCT01555671|Narcotics|narcotics|mesh-ancestor
111179791|NCT01555671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111179792|NCT01555671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111179793|NCT01555671|Analgesics|analgesics|mesh-ancestor
111179794|NCT01555671|Sensory System Agents|sensory system agents|mesh-ancestor
111179795|NCT01555671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111179796|NCT01555671|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111179797|NCT03226756|Nivolumab|nivolumab|mesh-list
111179798|NCT03226756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111179799|NCT03226756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111179800|NCT03226756|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111179801|NCT03226756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111179802|NCT01807598|Brentuximab Vedotin|brentuximab vedotin|mesh-list
111179803|NCT01807598|Immunoconjugates|immunoconjugates|mesh-list
111179804|NCT01807598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111179805|NCT01807598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111179806|NCT01807598|Immunotoxins|immunotoxins|mesh-ancestor
111179807|NCT01807598|Immunologic Factors|immunologic factors|mesh-ancestor
111179808|NCT01807598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111179809|NCT01801280|Mycophenolic Acid|mycophenolic acid|mesh-list
111179810|NCT01801280|Pantoprazole|pantoprazole|mesh-list
111179811|NCT01801280|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111179812|NCT01801280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111179813|NCT01801280|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111179814|NCT01801280|Antitubercular Agents|antitubercular agents|mesh-ancestor
111179815|NCT01801280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111179816|NCT01801280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111179817|NCT01801280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111179818|NCT01801280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111179819|NCT01801280|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111179820|NCT01801280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111179821|NCT01801280|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111179822|NCT01769456|Tenofovir|tenofovir|mesh-list
111179823|NCT01769456|Emtricitabine|emtricitabine|mesh-list
111179824|NCT01769456|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
111179825|NCT01769456|Antiviral Agents|antiviral agents|mesh-ancestor
111179826|NCT01769456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111179827|NCT01769456|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111179828|NCT01769456|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111179829|NCT01769456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111179830|NCT01769456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111179831|NCT01769456|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111179832|NCT01769456|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111179833|NCT01769378|Glimepiride|glimepiride|mesh-list
111179834|NCT01769378|Dulaglutide|dulaglutide|mesh-list
111179835|NCT01769378|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111179836|NCT01769378|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111179837|NCT01769378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111179838|NCT01769378|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111179839|NCT01769378|Immunologic Factors|immunologic factors|mesh-ancestor
111179840|NCT01807520|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111179841|NCT01807520|Immunologic Factors|immunologic factors|mesh-ancestor
111179842|NCT01807520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111179843|NCT01555125|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111179844|NCT01555125|Immunologic Factors|immunologic factors|mesh-ancestor
111179845|NCT01555125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111179846|NCT01768286|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
111179847|NCT01768286|Ledipasvir|ledipasvir|mesh-list
111179848|NCT01768286|Antiviral Agents|antiviral agents|mesh-ancestor
111179849|NCT01768286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111179850|NCT01800968|Liraglutide|liraglutide|mesh-list
111179851|NCT01800968|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111179852|NCT01800968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111179853|NCT01800968|Incretins|incretins|mesh-ancestor
111179854|NCT01800968|Hormones|hormones|mesh-ancestor
111179855|NCT01800968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111179856|NCT01687257|Sofosbuvir|sofosbuvir|mesh-list
111179857|NCT01687257|Antiviral Agents|antiviral agents|mesh-ancestor
111179858|NCT01687257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111179859|NCT01806740|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
111179860|NCT01806740|Chelating Agents|chelating agents|mesh-ancestor
111179861|NCT01806740|Sequestering Agents|sequestering agents|mesh-ancestor
111179862|NCT01806740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111179863|NCT01687101|Menthol|menthol|mesh-list
110897032|NCT04014803|Aspirin|aspirin|mesh-list
111179865|NCT01687101|Dermatologic Agents|dermatologic agents|mesh-ancestor
111179866|NCT01968967|Bococizumab|bococizumab|mesh-list
111179867|NCT01968967|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111179868|NCT01968967|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111179869|NCT01968967|Antimetabolites|antimetabolites|mesh-ancestor
111179870|NCT01968967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111179871|NCT01968967|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111179872|NCT01806662|Ustekinumab|ustekinumab|mesh-list
111179873|NCT01806662|Dermatologic Agents|dermatologic agents|mesh-ancestor
111179874|NCT01930045|Raltegravir Potassium|raltegravir potassium|mesh-list
111179875|NCT01930045|Aluminum hydroxide, magnesium hydroxide, drug combination|aluminum hydroxide, magnesium hydroxide, drug combination|mesh-list
111179876|NCT01930045|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111179877|NCT01930045|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111179878|NCT01930045|Antiviral Agents|antiviral agents|mesh-ancestor
111179879|NCT01930045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111179880|NCT01930045|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111179881|NCT01930045|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111179882|NCT01930045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111179883|NCT01930045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111179884|NCT01930045|Antacids|antacids|mesh-ancestor
111179885|NCT01930045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111179886|NCT04631263|Hyaluronic Acid|hyaluronic acid|mesh-list
111179887|NCT04631263|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111179888|NCT04631263|Immunologic Factors|immunologic factors|mesh-ancestor
111179889|NCT04631263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111179890|NCT04631263|Viscosupplements|viscosupplements|mesh-ancestor
111179891|NCT04631263|Protective Agents|protective agents|mesh-ancestor
111179893|NCT01929343|Anesthetics, Local|anesthetics, local|mesh-ancestor
111179894|NCT01929343|Anesthetics|anesthetics|mesh-ancestor
111179895|NCT01929343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111179896|NCT01929343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111179897|NCT01929343|Sensory System Agents|sensory system agents|mesh-ancestor
111179898|NCT01929343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111179899|NCT01929343|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111179900|NCT01929343|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111179901|NCT01929343|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111179902|NCT01929343|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111179903|NCT01929343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111179904|NCT01806584|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
111179905|NCT01806584|Hemostatics|hemostatics|mesh-ancestor
111179906|NCT01806584|Coagulants|coagulants|mesh-ancestor
111179907|NCT01798706|Lixisenatide|lixisenatide|mesh-list
111179908|NCT01798706|Hypoglycemic Agents|hypoglycemic agents|mesh-list
111179909|NCT01798706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111179910|NCT01767194|Sirolimus|sirolimus|mesh-list
111179911|NCT01767194|Irinotecan|irinotecan|mesh-list
111179912|NCT01767194|Camptothecin|camptothecin|mesh-list
111179913|NCT01767194|Temozolomide|temozolomide|mesh-list
111179914|NCT01767194|Temsirolimus|temsirolimus|mesh-list
111179915|NCT01767194|Dinutuximab|dinutuximab|mesh-list
111179916|NCT01767194|MTOR Inhibitors|mtor inhibitors|mesh-list
111179917|NCT01767194|Sargramostim|sargramostim|mesh-list
111179918|NCT01767194|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111179919|NCT01767194|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111179920|NCT01767194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111179921|NCT01767194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111179922|NCT01767194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111179923|NCT01767194|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111179924|NCT01767194|Alkylating Agents|alkylating agents|mesh-ancestor
111179925|NCT01767194|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111179926|NCT01767194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111179927|NCT01767194|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111179928|NCT01767194|Antifungal Agents|antifungal agents|mesh-ancestor
111179929|NCT01767194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111179930|NCT01767194|Immunologic Factors|immunologic factors|mesh-ancestor
111179931|NCT01767194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111179932|NCT01767194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111179933|NCT01767194|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111179934|NCT01575873|Denosumab|denosumab|mesh-list
111179935|NCT01575873|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111179936|NCT01575873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111179937|NCT04276636|Calcium Carbonate|calcium carbonate|mesh-list
111179938|NCT04276636|Antacids|antacids|mesh-ancestor
111179939|NCT04276636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111179940|NCT04276636|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111179941|NCT00002644|Tamoxifen|tamoxifen|mesh-list
111179942|NCT00002644|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111179943|NCT00002644|Hormone Antagonists|hormone antagonists|mesh-ancestor
111179944|NCT00002644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111179945|NCT00002644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111179946|NCT00002644|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111179947|NCT00002644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111179948|NCT00002644|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111179949|NCT00002644|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111179950|NCT00002644|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111179951|NCT01575561|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
111179952|NCT01575561|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111179953|NCT01575561|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111179954|NCT01575561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111179955|NCT01575561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111179956|NCT01575561|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111179957|NCT01575561|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
111179958|NCT01575561|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111179959|NCT01575561|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111179960|NCT01575561|Adrenergic Agents|adrenergic agents|mesh-ancestor
111179961|NCT01575561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111179962|NCT01575561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111179963|NCT01575561|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111179964|NCT01575561|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111179966|NCT01575561|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111179967|NCT01575561|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111179968|NCT01575561|Dopamine Agents|dopamine agents|mesh-ancestor
111179969|NCT04397770|Temozolomide|temozolomide|mesh-list
111179970|NCT04397770|Apatinib|apatinib|mesh-list
111179971|NCT04397770|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111179972|NCT04397770|Alkylating Agents|alkylating agents|mesh-ancestor
111179973|NCT04397770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111179974|NCT04397770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111179975|NCT04397770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111179976|NCT04397770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111179977|NCT03082846|Temozolomide|temozolomide|mesh-list
111179978|NCT03082846|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111179979|NCT03082846|Alkylating Agents|alkylating agents|mesh-ancestor
111179980|NCT03082846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111179981|NCT03082846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111179982|NCT01609790|Bevacizumab|bevacizumab|mesh-list
111179983|NCT01609790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111179984|NCT01609790|Trebananib|trebananib|mesh-list
111179985|NCT01609790|Endothelial Growth Factors|endothelial growth factors|mesh-list
111179986|NCT01609790|Antibodies|antibodies|mesh-list
111179987|NCT01609790|Immunoglobulins|immunoglobulins|mesh-list
111179988|NCT01609790|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111179989|NCT01609790|Immunoglobulin G|immunoglobulin g|mesh-list
111179990|NCT01609790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111179991|NCT01609790|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111179992|NCT01609790|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111179993|NCT01609790|Growth Substances|growth substances|mesh-ancestor
111179994|NCT01609790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111179995|NCT01609790|Growth Inhibitors|growth inhibitors|mesh-ancestor
111179996|NCT01609790|Immunologic Factors|immunologic factors|mesh-ancestor
111179997|NCT01767116|Ribavirin|ribavirin|mesh-list
111179998|NCT01767116|Antimetabolites|antimetabolites|mesh-ancestor
111179999|NCT01767116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111180000|NCT01767116|Antiviral Agents|antiviral agents|mesh-ancestor
111180001|NCT01767116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111180002|NCT01574703|Bupropion|bupropion|mesh-list
111180003|NCT01574703|Nicotine|nicotine|mesh-list
111180004|NCT01574703|Varenicline|varenicline|mesh-list
111180005|NCT01574703|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111180006|NCT01574703|Autonomic Agents|autonomic agents|mesh-ancestor
111180007|NCT01574703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110488844|NCT02861898|Cetuximab|cetuximab|mesh-list
111180008|NCT01574703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111180009|NCT01574703|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111180010|NCT01574703|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111180011|NCT01574703|Cholinergic Agents|cholinergic agents|mesh-ancestor
111180012|NCT01574703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110897180|NCT03660930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111180013|NCT01574703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111180014|NCT01574703|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111180015|NCT01574703|Antidepressive Agents|antidepressive agents|mesh-ancestor
111180016|NCT01574703|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111180017|NCT01574703|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111180018|NCT01574703|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111180019|NCT01574703|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111180020|NCT01574703|Dopamine Agents|dopamine agents|mesh-ancestor
111180021|NCT01574703|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111180022|NCT01574703|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111180023|NCT01574703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111180024|NCT01686633|Fluticasone|fluticasone|mesh-list
111180025|NCT01686633|Xhance|xhance|mesh-list
111180026|NCT01686633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111180027|NCT01686633|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111180028|NCT01686633|Autonomic Agents|autonomic agents|mesh-ancestor
111180029|NCT01686633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111180030|NCT01686633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111180031|NCT01686633|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111180032|NCT01686633|Respiratory System Agents|respiratory system agents|mesh-ancestor
111180033|NCT01686633|Dermatologic Agents|dermatologic agents|mesh-ancestor
111180034|NCT01686633|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111180035|NCT03180034|Vaccines|vaccines|mesh-list
111180036|NCT03180034|Immunologic Factors|immunologic factors|mesh-ancestor
111180037|NCT03180034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111180038|NCT03141424|Fluticasone|fluticasone|mesh-list
111180039|NCT03141424|Mometasone Furoate|mometasone furoate|mesh-list
111180040|NCT03141424|Ciclesonide|ciclesonide|mesh-list
111180041|NCT03141424|Budesonide|budesonide|mesh-list
111180042|NCT03141424|Beclomethasone|beclomethasone|mesh-list
111180043|NCT03141424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111180044|NCT03141424|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111180045|NCT03141424|Autonomic Agents|autonomic agents|mesh-ancestor
111180046|NCT03141424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111180047|NCT03141424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111180048|NCT03141424|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111180049|NCT03141424|Respiratory System Agents|respiratory system agents|mesh-ancestor
111180050|NCT03141424|Dermatologic Agents|dermatologic agents|mesh-ancestor
111180051|NCT03141424|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111180052|NCT03141424|Glucocorticoids|glucocorticoids|mesh-ancestor
111180053|NCT03141424|Hormones|hormones|mesh-ancestor
111180054|NCT03141424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111180055|NCT03614494|Piroxicam|piroxicam|mesh-list
111180056|NCT03614494|Levonorgestrel|levonorgestrel|mesh-list
111180057|NCT03614494|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111180058|NCT03614494|Contraceptive Agents|contraceptive agents|mesh-ancestor
111180059|NCT03614494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111180060|NCT03614494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111180061|NCT03614494|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111180062|NCT03614494|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111180063|NCT03614494|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111180064|NCT03614494|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111180065|NCT03614494|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111180066|NCT03614494|Analgesics|analgesics|mesh-ancestor
111180067|NCT03614494|Sensory System Agents|sensory system agents|mesh-ancestor
111180068|NCT03614494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111180069|NCT03614494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111180070|NCT03614494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111180071|NCT03614494|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111180072|NCT03614494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111180073|NCT03614494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111180074|NCT03028155|Oxaliplatin|oxaliplatin|mesh-list
111180075|NCT03028155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111180076|NCT05245708|Oxytocin|oxytocin|mesh-list
111180077|NCT05245708|Oxytocics|oxytocics|mesh-ancestor
111180078|NCT05245708|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111180079|NCT05245708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111180080|NCT01922596|Ropivacaine|ropivacaine|mesh-list
111180081|NCT01922596|Anesthetics, Local|anesthetics, local|mesh-ancestor
111180082|NCT01922596|Anesthetics|anesthetics|mesh-ancestor
111180083|NCT01922596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111180084|NCT01922596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111180085|NCT01922596|Sensory System Agents|sensory system agents|mesh-ancestor
111180086|NCT01922596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111180087|NCT01573767|Fluticasone|fluticasone|mesh-list
110897255|NCT03415854|Paclitaxel|paclitaxel|mesh-list
111180088|NCT01573767|Xhance|xhance|mesh-list
111180089|NCT01573767|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111180090|NCT01573767|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111180091|NCT01573767|Autonomic Agents|autonomic agents|mesh-ancestor
111180092|NCT01573767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111180093|NCT01573767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111180094|NCT01573767|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111180095|NCT01573767|Respiratory System Agents|respiratory system agents|mesh-ancestor
111180096|NCT01573767|Dermatologic Agents|dermatologic agents|mesh-ancestor
111180097|NCT01573767|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111180098|NCT03133546|Bevacizumab|bevacizumab|mesh-list
111180099|NCT03133546|Osimertinib|osimertinib|mesh-list
111180100|NCT03133546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111180101|NCT03133546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111180102|NCT03133546|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111180103|NCT03133546|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111180104|NCT03133546|Growth Substances|growth substances|mesh-ancestor
111180105|NCT03133546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111180106|NCT03133546|Growth Inhibitors|growth inhibitors|mesh-ancestor
111180107|NCT03133546|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111180108|NCT03133546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111180109|NCT03133546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111180110|NCT01551303|Oxytocin|oxytocin|mesh-list
111180111|NCT01551303|Oxytocics|oxytocics|mesh-ancestor
111180112|NCT01551303|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111180113|NCT01551303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111180114|NCT01685073|Zolpidem|zolpidem|mesh-list
111180115|NCT01685073|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111180116|NCT01685073|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111180117|NCT01685073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111180118|NCT01685073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111180119|NCT01685073|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
111180120|NCT01685073|GABA Agonists|gaba agonists|mesh-ancestor
111180121|NCT01685073|GABA Agents|gaba agents|mesh-ancestor
111180122|NCT01685073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111180123|NCT01685073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111180124|NCT05241028|Ensartinib|ensartinib|mesh-list
111180125|NCT05241028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111180126|NCT05241028|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111180127|NCT05241028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111180128|NCT05241028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111180129|NCT01572675|Celecoxib|celecoxib|mesh-list
111180130|NCT01572675|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111180131|NCT01572675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111180132|NCT01572675|Analgesics|analgesics|mesh-ancestor
111180133|NCT01572675|Sensory System Agents|sensory system agents|mesh-ancestor
111180134|NCT01572675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111180135|NCT01572675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111180136|NCT01572675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111180137|NCT01572675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111180138|NCT01572675|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111180139|NCT01572675|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111180140|NCT01572675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111180141|NCT01572675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111180142|NCT05929937|Analgesics, Opioid|analgesics, opioid|mesh-list
111180143|NCT05929937|Narcotics|narcotics|mesh-ancestor
111180144|NCT05929937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111180145|NCT05929937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111180146|NCT05929937|Analgesics|analgesics|mesh-ancestor
111180147|NCT05929937|Sensory System Agents|sensory system agents|mesh-ancestor
111180148|NCT05929937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111180149|NCT05929794|Metronidazole|metronidazole|mesh-list
111180150|NCT05929794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111180151|NCT05929794|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111180152|NCT05929794|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111180153|NCT05929794|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111180154|NCT05929755|Methylprednisolone|methylprednisolone|mesh-list
111180155|NCT05929755|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111180156|NCT05929755|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111180157|NCT05929755|Prednisolone|prednisolone|mesh-list
111180158|NCT05929755|Prednisolone acetate|prednisolone acetate|mesh-list
111180159|NCT05929755|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111180160|NCT05929755|Prednisolone phosphate|prednisolone phosphate|mesh-list
111180161|NCT05929755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111180162|NCT05929755|Antiemetics|antiemetics|mesh-ancestor
111180163|NCT05929755|Autonomic Agents|autonomic agents|mesh-ancestor
111180164|NCT05929755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111180165|NCT05929755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111180166|NCT05929755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111180167|NCT05929755|Glucocorticoids|glucocorticoids|mesh-ancestor
111180168|NCT05929755|Hormones|hormones|mesh-ancestor
111180169|NCT05929755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111180170|NCT05929755|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111180171|NCT05929755|Protective Agents|protective agents|mesh-ancestor
111180172|NCT05929755|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111180173|NCT05929755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111180175|NCT05929664|Immunoglobulins|immunoglobulins|mesh-list
111180176|NCT05929664|Immunoglobulin G|immunoglobulin g|mesh-list
111180177|NCT05929664|Immunologic Factors|immunologic factors|mesh-ancestor
111180178|NCT05929664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111180179|NCT05929664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111180180|NCT05929664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111180181|NCT05929456|Cetuximab|cetuximab|mesh-list
111180182|NCT05929456|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111180183|NCT05929456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111180184|NCT05929339|Oxytocin|oxytocin|mesh-list
111180185|NCT05929339|Oxytocics|oxytocics|mesh-ancestor
111180186|NCT05929339|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111180187|NCT05929339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111180188|NCT05928988|Itraconazole|itraconazole|mesh-list
111180189|NCT05928988|Antifungal Agents|antifungal agents|mesh-ancestor
111180190|NCT05928988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111180191|NCT05928988|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111180192|NCT05928988|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111180193|NCT05928988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111180194|NCT05928988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111180195|NCT05928988|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111180196|NCT05928988|Hormone Antagonists|hormone antagonists|mesh-ancestor
111180197|NCT05928988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111180198|NCT05928988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111180199|NCT05928988|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111180200|NCT05928780|Fluzoparib|fluzoparib|mesh-list
111180201|NCT05928780|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111180202|NCT05928780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111180203|NCT05928780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111180204|NCT05928780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111180205|NCT05928741|Vitamin D|vitamin d|mesh-list
111180206|NCT05928741|Cholecalciferol|cholecalciferol|mesh-list
111180207|NCT05928741|Vitamins|vitamins|mesh-ancestor
111180208|NCT05928741|Micronutrients|micronutrients|mesh-ancestor
111180209|NCT05928741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111180210|NCT05928741|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111180211|NCT05928741|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111180212|NCT05928728|Colchicine|colchicine|mesh-list
111180213|NCT05928728|Gout Suppressants|gout suppressants|mesh-ancestor
111180214|NCT05928728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111180215|NCT05928728|Tubulin Modulators|tubulin modulators|mesh-ancestor
111180216|NCT05928728|Antimitotic Agents|antimitotic agents|mesh-ancestor
111180217|NCT05928728|Mitosis Modulators|mitosis modulators|mesh-ancestor
111180218|NCT05928728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111180219|NCT05928728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111180220|NCT05928689|Propranolol|propranolol|mesh-list
111180221|NCT05928689|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111180222|NCT05928689|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111180223|NCT05928689|Adrenergic Agents|adrenergic agents|mesh-ancestor
111180224|NCT05928689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111180225|NCT05928689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111180226|NCT05928689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111180227|NCT05928689|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111180228|NCT05928689|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111180229|NCT05928689|Vasodilator Agents|vasodilator agents|mesh-ancestor
111180230|NCT05928546|Quercetin|quercetin|mesh-list
111180231|NCT05928546|Antioxidants|antioxidants|mesh-ancestor
111180232|NCT05928546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111180233|NCT05928546|Protective Agents|protective agents|mesh-ancestor
111180234|NCT05928546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111180235|NCT05928039|Adalimumab|adalimumab|mesh-list
111180236|NCT05928039|Infliximab|infliximab|mesh-list
111180237|NCT05928039|Interleukin-12|interleukin-12|mesh-list
111180238|NCT05928039|Interleukin-23|interleukin-23|mesh-list
111180239|NCT05928039|Ustekinumab|ustekinumab|mesh-list
111180240|NCT05928039|Vedolizumab|vedolizumab|mesh-list
111180241|NCT05928039|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111180242|NCT05928039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111180243|NCT05928039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111180244|NCT05928039|Dermatologic Agents|dermatologic agents|mesh-ancestor
111180245|NCT05928039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111180246|NCT05928039|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111180247|NCT05928039|Immunologic Factors|immunologic factors|mesh-ancestor
111180248|NCT05928039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111180249|NCT05928039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111180250|NCT05928039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111180251|NCT05928039|Growth Substances|growth substances|mesh-ancestor
111180252|NCT05928039|Growth Inhibitors|growth inhibitors|mesh-ancestor
111180253|NCT05928039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111180254|NCT05928000|Tenofovir|tenofovir|mesh-list
111180255|NCT05928000|Entecavir|entecavir|mesh-list
111180256|NCT05928000|Antiviral Agents|antiviral agents|mesh-ancestor
111180257|NCT05928000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111180258|NCT05928000|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111180259|NCT05928000|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111180260|NCT05928000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111180261|NCT05928000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111180262|NCT05928000|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111180263|NCT05928000|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111180264|NCT05927233|Methylprednisolone|methylprednisolone|mesh-list
111180265|NCT05927233|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111180266|NCT05927233|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111180267|NCT05927233|Prednisolone|prednisolone|mesh-list
111180268|NCT05927233|Prednisolone acetate|prednisolone acetate|mesh-list
111180269|NCT05927233|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111180270|NCT05927233|Prednisolone phosphate|prednisolone phosphate|mesh-list
111180271|NCT05927233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111180272|NCT05927233|Antiemetics|antiemetics|mesh-ancestor
111180273|NCT05927233|Autonomic Agents|autonomic agents|mesh-ancestor
111180274|NCT05927233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111180275|NCT05927233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111180276|NCT05927233|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111180277|NCT05927233|Glucocorticoids|glucocorticoids|mesh-ancestor
111180278|NCT05927233|Hormones|hormones|mesh-ancestor
111180279|NCT05927233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111180280|NCT05927233|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111180281|NCT05927233|Protective Agents|protective agents|mesh-ancestor
111180282|NCT05927233|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111180283|NCT05927233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111180284|NCT05887609|Olaparib|olaparib|mesh-list
111180285|NCT05887609|Maytansine|maytansine|mesh-list
111180286|NCT05887609|Mirvetuximab soravtansine|mirvetuximab soravtansine|mesh-list
111180287|NCT05887609|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111180288|NCT05887609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111180289|NCT05887609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111180290|NCT05887609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111180291|NCT05887609|Immunoconjugates|immunoconjugates|mesh-ancestor
111180292|NCT05887609|Immunologic Factors|immunologic factors|mesh-ancestor
111180293|NCT05887609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111180294|NCT05887609|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111180295|NCT05887609|Tubulin Modulators|tubulin modulators|mesh-ancestor
111180296|NCT05887609|Antimitotic Agents|antimitotic agents|mesh-ancestor
111180297|NCT05887609|Mitosis Modulators|mitosis modulators|mesh-ancestor
111180298|NCT05873218|Ephedrine|ephedrine|mesh-list
111180299|NCT05873218|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111180300|NCT05873218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111180301|NCT05873218|Sympathomimetics|sympathomimetics|mesh-ancestor
111180302|NCT05873218|Autonomic Agents|autonomic agents|mesh-ancestor
111180303|NCT05873218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111180304|NCT05873218|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111180305|NCT05873218|Adrenergic Agents|adrenergic agents|mesh-ancestor
111180306|NCT05873218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111180307|NCT05873218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111180308|NCT05872204|Letrozole|letrozole|mesh-list
111180309|NCT05872204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111180310|NCT05872204|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111180311|NCT05872204|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111180312|NCT05872204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111180313|NCT05872204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111180314|NCT05872204|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111180315|NCT05872204|Hormone Antagonists|hormone antagonists|mesh-ancestor
111180316|NCT05872204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111180317|NCT05872204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111180319|NCT05839366|Propofol|propofol|mesh-list
111180320|NCT05839366|Esketamine|esketamine|mesh-list
111180321|NCT05839366|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111180322|NCT05839366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111180323|NCT05839366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111180324|NCT05839366|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111180325|NCT05839366|Anesthetics, General|anesthetics, general|mesh-ancestor
111180326|NCT05839366|Anesthetics|anesthetics|mesh-ancestor
111180327|NCT05839366|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111180328|NCT05839366|Narcotics|narcotics|mesh-ancestor
111180329|NCT05839366|Analgesics|analgesics|mesh-ancestor
111180330|NCT05839366|Sensory System Agents|sensory system agents|mesh-ancestor
111180331|NCT05839366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111180332|NCT05839366|Antidepressive Agents|antidepressive agents|mesh-ancestor
111180333|NCT05839366|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111180334|NCT05839158|Mupirocin|mupirocin|mesh-list
111180335|NCT05839158|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111180336|NCT05839158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111180337|NCT05839158|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111180338|NCT05839158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111180339|NCT05839158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111180340|NCT05827549|Blinatumomab|blinatumomab|mesh-list
111180341|NCT05827549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111180342|NCT05820685|Dronabinol|dronabinol|mesh-list
111180343|NCT05820685|Hallucinogens|hallucinogens|mesh-ancestor
111180344|NCT05820685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111180345|NCT05820685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111180346|NCT05820685|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111180347|NCT05820685|Analgesics|analgesics|mesh-ancestor
111180348|NCT05820685|Sensory System Agents|sensory system agents|mesh-ancestor
111180349|NCT05820685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111180350|NCT05820685|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
111180351|NCT05820685|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
111180352|NCT05820685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111180353|NCT05820685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111180354|NCT05820685|Hormones|hormones|mesh-ancestor
111180355|NCT05820685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111180356|NCT05704933|Nivolumab|nivolumab|mesh-list
111180357|NCT05704933|Ipilimumab|ipilimumab|mesh-list
111180358|NCT05704933|Relatlimab|relatlimab|mesh-list
111180359|NCT05704933|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111180360|NCT05704933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111180361|NCT05704933|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111180362|NCT05704933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111180363|NCT05694364|Cyclophosphamide|cyclophosphamide|mesh-list
111180364|NCT05694364|Fludarabine|fludarabine|mesh-list
111180365|NCT05694364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111180366|NCT05694364|Immunologic Factors|immunologic factors|mesh-ancestor
111180367|NCT05694364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111180368|NCT05694364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111180369|NCT05694364|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111180370|NCT05694364|Alkylating Agents|alkylating agents|mesh-ancestor
111180371|NCT05694364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111180372|NCT05694364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111180373|NCT05694364|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111180374|NCT05676476|Antihypertensive Agents|antihypertensive agents|mesh-list
111180375|NCT05660525|Nicotine|nicotine|mesh-list
111180376|NCT05660525|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111180377|NCT05660525|Autonomic Agents|autonomic agents|mesh-ancestor
111180378|NCT05660525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111180379|NCT05660525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111180380|NCT05660525|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111180381|NCT05660525|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111180382|NCT05660525|Cholinergic Agents|cholinergic agents|mesh-ancestor
111180383|NCT05660525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111180384|NCT05660525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111180385|NCT05497804|Dexamethasone|dexamethasone|mesh-list
111180386|NCT05497804|Dexamethasone acetate|dexamethasone acetate|mesh-list
111180387|NCT05497804|Lenalidomide|lenalidomide|mesh-list
111180388|NCT05497804|Daratumumab|daratumumab|mesh-list
111180389|NCT05497804|Ichthammol|ichthammol|mesh-list
111180390|NCT05497804|BB 1101|bb 1101|mesh-list
111180391|NCT05497804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111180393|NCT05497804|Autonomic Agents|autonomic agents|mesh-ancestor
111180394|NCT05497804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111180395|NCT05497804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111180396|NCT05497804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111180397|NCT05497804|Glucocorticoids|glucocorticoids|mesh-ancestor
111180398|NCT05497804|Hormones|hormones|mesh-ancestor
111180399|NCT05497804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111180400|NCT05497804|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111180401|NCT05497804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111180402|NCT05497804|Protease Inhibitors|protease inhibitors|mesh-ancestor
111180403|NCT05497804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111180404|NCT05497804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111180405|NCT05497804|Immunologic Factors|immunologic factors|mesh-ancestor
111180406|NCT05497804|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111180407|NCT05497804|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111180408|NCT05497804|Growth Substances|growth substances|mesh-ancestor
111180409|NCT05497804|Growth Inhibitors|growth inhibitors|mesh-ancestor
111180410|NCT05497804|Dermatologic Agents|dermatologic agents|mesh-ancestor
111180411|NCT05490511|Cannabidiol|cannabidiol|mesh-list
111180412|NCT05490511|Tacrolimus|tacrolimus|mesh-list
111180413|NCT05490511|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111180414|NCT05490511|Immunologic Factors|immunologic factors|mesh-ancestor
111180415|NCT05490511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111180416|NCT05490511|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111180417|NCT05490511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111180418|NCT05490511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111180419|NCT05490511|Anticonvulsants|anticonvulsants|mesh-ancestor
111180420|NCT05441280|Pimavanserin|pimavanserin|mesh-list
111180421|NCT05441280|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111180422|NCT05441280|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111180423|NCT05441280|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111180424|NCT05441280|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111180425|NCT05441280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111180426|NCT05441280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111180427|NCT05441280|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111180428|NCT05441280|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111180429|NCT05441280|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111180430|NCT05441280|Serotonin Agents|serotonin agents|mesh-ancestor
111180431|NCT05441280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111180432|NCT05441280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111180433|NCT05413161|Omalizumab|omalizumab|mesh-list
111180434|NCT05413161|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111180435|NCT05413161|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111180436|NCT05413161|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111180437|NCT05413161|Respiratory System Agents|respiratory system agents|mesh-ancestor
111180438|NCT05413161|Immunologic Factors|immunologic factors|mesh-ancestor
111180439|NCT05413161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111180440|NCT05378750|Diuretics|diuretics|mesh-list
111180441|NCT05378750|Natriuretic Agents|natriuretic agents|mesh-ancestor
111180442|NCT05378750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111180443|NCT05362955|Fluorouracil|fluorouracil|mesh-list
111180444|NCT05362955|Antimetabolites|antimetabolites|mesh-ancestor
111180445|NCT05362955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111180446|NCT05362955|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111180447|NCT05362955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111180448|NCT05362955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111180449|NCT05362955|Immunologic Factors|immunologic factors|mesh-ancestor
111180450|NCT05362955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111180451|NCT05343169|Naloxone|naloxone|mesh-list
111180452|NCT05343169|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111180453|NCT05343169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111180454|NCT05343169|Sensory System Agents|sensory system agents|mesh-ancestor
111180455|NCT05343169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111180456|NCT05319587|Cytarabine|cytarabine|mesh-list
111180457|NCT05319587|Annamycin|annamycin|mesh-list
111180458|NCT05319587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111180459|NCT05319587|Antimetabolites|antimetabolites|mesh-ancestor
111180460|NCT05319587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111180461|NCT05319587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111180462|NCT05319587|Antiviral Agents|antiviral agents|mesh-ancestor
111180463|NCT05319587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111180464|NCT05319587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111180465|NCT05319587|Immunologic Factors|immunologic factors|mesh-ancestor
111180466|NCT05319587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111180467|NCT05319587|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111180468|NCT05316116|Siltuximab|siltuximab|mesh-list
111180469|NCT05316116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111180470|NCT05269706|Cannabidiol|cannabidiol|mesh-list
111180471|NCT05269706|Anticonvulsants|anticonvulsants|mesh-ancestor
111180472|NCT05257824|Aspirin|aspirin|mesh-list
111180473|NCT05257824|Clopidogrel|clopidogrel|mesh-list
111180474|NCT05257824|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111180475|NCT05257824|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111180476|NCT05257824|Analgesics|analgesics|mesh-ancestor
111180477|NCT05257824|Sensory System Agents|sensory system agents|mesh-ancestor
111180478|NCT05257824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111180479|NCT05257824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111180480|NCT05257824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111180481|NCT05257824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111180482|NCT05257824|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111180483|NCT05257824|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111180484|NCT05257824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111180485|NCT05257824|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111180486|NCT05257824|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111180487|NCT05257824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111180488|NCT05257824|Antipyretics|antipyretics|mesh-ancestor
111180489|NCT05257824|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111180490|NCT05257824|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111180491|NCT05257824|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111180492|NCT05257824|Purinergic Agents|purinergic agents|mesh-ancestor
111180493|NCT05257824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111180494|NCT05228314|Aluminum Hydroxide|aluminum hydroxide|mesh-list
111180495|NCT05228314|Vaccines|vaccines|mesh-list
111180496|NCT05228314|Aluminum sulfate|aluminum sulfate|mesh-list
111180497|NCT05228314|Immunologic Factors|immunologic factors|mesh-ancestor
111180498|NCT05228314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111180499|NCT05228314|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111180500|NCT05228314|Antacids|antacids|mesh-ancestor
111180501|NCT05228314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111180502|NCT05228314|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111180503|NCT05216328|Magnesium Hydroxide|magnesium hydroxide|mesh-list
111180504|NCT05216328|Antacids|antacids|mesh-ancestor
111180505|NCT05216328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111180506|NCT05216328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111180507|NCT05183854|Vaccines|vaccines|mesh-list
111180508|NCT05183854|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
111180509|NCT05183854|Immunologic Factors|immunologic factors|mesh-ancestor
111180510|NCT05183854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111180511|NCT05167760|Apraclonidine|apraclonidine|mesh-list
111180512|NCT05167760|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111180513|NCT05167760|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111180514|NCT05167760|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111180515|NCT05167760|Adrenergic Agents|adrenergic agents|mesh-ancestor
111180516|NCT05167760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111180517|NCT05167760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111180518|NCT05167760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111180519|NCT05127590|Pembrolizumab|pembrolizumab|mesh-list
111180520|NCT05127590|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111180521|NCT05127590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111180522|NCT05127590|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111180523|NCT05127590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111180524|NCT05116891|Leucovorin|leucovorin|mesh-list
111180525|NCT05116891|Cisplatin|cisplatin|mesh-list
111180526|NCT05116891|Gemcitabine|gemcitabine|mesh-list
111180527|NCT05116891|Docetaxel|docetaxel|mesh-list
111180528|NCT05116891|Fluorouracil|fluorouracil|mesh-list
110488931|NCT02358031|Cetuximab|cetuximab|mesh-list
111180529|NCT05116891|Oxaliplatin|oxaliplatin|mesh-list
111180530|NCT05116891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111180531|NCT05116891|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111180532|NCT05116891|Antimetabolites|antimetabolites|mesh-ancestor
111180533|NCT05116891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111180534|NCT05116891|Tubulin Modulators|tubulin modulators|mesh-ancestor
111180535|NCT05116891|Antimitotic Agents|antimitotic agents|mesh-ancestor
111180536|NCT05116891|Mitosis Modulators|mitosis modulators|mesh-ancestor
111180537|NCT05116891|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111180538|NCT05116891|Immunologic Factors|immunologic factors|mesh-ancestor
111180539|NCT05116891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111180540|NCT05116891|Antidotes|antidotes|mesh-ancestor
111180541|NCT05116891|Protective Agents|protective agents|mesh-ancestor
111180542|NCT05116891|Vitamin B Complex|vitamin b complex|mesh-ancestor
111180543|NCT05116891|Vitamins|vitamins|mesh-ancestor
111180544|NCT05116891|Micronutrients|micronutrients|mesh-ancestor
111180545|NCT05069038|Palbociclib|palbociclib|mesh-list
111180546|NCT05069038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111180547|NCT05069038|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111180548|NCT05069038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111180549|NCT05069038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111180550|NCT05060549|Cariprazine|cariprazine|mesh-list
111180551|NCT05060549|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111180552|NCT05060549|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111180553|NCT05060549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111180554|NCT05060549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111180555|NCT05060549|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111180556|NCT05020912|Aminolevulinic Acid|aminolevulinic acid|mesh-list
111180557|NCT05020912|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111180558|NCT05020912|Dermatologic Agents|dermatologic agents|mesh-ancestor
111180559|NCT04983030|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
111180560|NCT04983030|Antiviral Agents|antiviral agents|mesh-ancestor
111180561|NCT04983030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111180562|NCT04973566|Hydroxychloroquine|hydroxychloroquine|mesh-list
111180563|NCT04973566|Etanercept|etanercept|mesh-list
111180564|NCT04973566|Antimalarials|antimalarials|mesh-ancestor
111180565|NCT04973566|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111180566|NCT04973566|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111180567|NCT04973566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111180568|NCT04973566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111180569|NCT04973566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111180570|NCT04973566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111180571|NCT04973566|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111180572|NCT04973566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111180574|NCT04973566|Sensory System Agents|sensory system agents|mesh-ancestor
111180575|NCT04973566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111180576|NCT04973566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111180577|NCT04973566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111180578|NCT04973566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111180579|NCT04973566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111180580|NCT04973566|Immunologic Factors|immunologic factors|mesh-ancestor
111180581|NCT04863885|Nivolumab|nivolumab|mesh-list
111180582|NCT04863885|Ipilimumab|ipilimumab|mesh-list
111180583|NCT04863885|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
111180584|NCT04863885|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111180585|NCT04863885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111180586|NCT04863885|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111180587|NCT04863885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111180588|NCT04863885|Immunoconjugates|immunoconjugates|mesh-ancestor
111180589|NCT04863885|Immunologic Factors|immunologic factors|mesh-ancestor
111180590|NCT04863885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111180591|NCT04856189|Pembrolizumab|pembrolizumab|mesh-list
111180592|NCT04856189|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111180593|NCT04856189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111180594|NCT04856189|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110488938|NCT02270814|Cisplatin|cisplatin|mesh-list
111180595|NCT04856189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111180596|NCT04855929|Ipilimumab|ipilimumab|mesh-list
111180597|NCT04855929|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111180598|NCT04855929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111180599|NCT04855929|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111180600|NCT04855929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111180601|NCT04760496|Oxytocin|oxytocin|mesh-list
111180602|NCT04760496|Oxytocics|oxytocics|mesh-ancestor
111180603|NCT04760496|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111180604|NCT04760496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111180605|NCT04722822|Vaccines|vaccines|mesh-list
111180606|NCT04722822|Immunologic Factors|immunologic factors|mesh-ancestor
111180607|NCT04722822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111180608|NCT04690192|Gemcitabine|gemcitabine|mesh-list
111180609|NCT04690192|Melphalan|melphalan|mesh-list
111180610|NCT04690192|Busulfan|busulfan|mesh-list
111180611|NCT04690192|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111180612|NCT04690192|Antimetabolites|antimetabolites|mesh-ancestor
111180613|NCT04690192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111180614|NCT04690192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111180615|NCT04690192|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110897785|NCT03602898|Antimetabolites|antimetabolites|mesh-ancestor
111180616|NCT04690192|Alkylating Agents|alkylating agents|mesh-ancestor
111180617|NCT04690192|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111180618|NCT04690192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111180619|NCT04690192|Immunologic Factors|immunologic factors|mesh-ancestor
111180620|NCT04690192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111180621|NCT04682431|Pembrolizumab|pembrolizumab|mesh-list
111180622|NCT04682431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111180623|NCT04682431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111180624|NCT04682431|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111180625|NCT04682431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111180626|NCT04631029|Carboplatin|carboplatin|mesh-list
111180628|NCT04631029|Etoposide phosphate|etoposide phosphate|mesh-list
111180629|NCT04631029|Atezolizumab|atezolizumab|mesh-list
111180630|NCT04631029|Podophyllotoxin|podophyllotoxin|mesh-list
111180631|NCT04631029|Entinostat|entinostat|mesh-list
111180632|NCT04631029|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111180633|NCT04631029|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
111180634|NCT04631029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111180635|NCT04631029|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111180636|NCT04631029|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111180637|NCT04631029|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111180638|NCT04631029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111180639|NCT04631029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111180640|NCT04631029|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111180641|NCT04631029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111180642|NCT04631029|Immunologic Factors|immunologic factors|mesh-ancestor
111180643|NCT04631029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111180644|NCT04631029|Keratolytic Agents|keratolytic agents|mesh-ancestor
111180645|NCT04631029|Dermatologic Agents|dermatologic agents|mesh-ancestor
111180646|NCT04631029|Tubulin Modulators|tubulin modulators|mesh-ancestor
111180647|NCT04631029|Antimitotic Agents|antimitotic agents|mesh-ancestor
111180648|NCT04631029|Mitosis Modulators|mitosis modulators|mesh-ancestor
111180650|NCT04563507|Palbociclib|palbociclib|mesh-list
111180651|NCT04563507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111180652|NCT04563507|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111180653|NCT04563507|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111180654|NCT04563507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111180655|NCT04563507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111180656|NCT04563507|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111180657|NCT04563507|Hormone Antagonists|hormone antagonists|mesh-ancestor
111180658|NCT04563507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110488948|NCT02258451|Everolimus|everolimus|mesh-list
111180659|NCT04563507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111180660|NCT04563507|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111180661|NCT04515641|Islatravir|islatravir|mesh-list
111180662|NCT04515641|Antiviral Agents|antiviral agents|mesh-ancestor
111180663|NCT04515641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111180664|NCT04515641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111180665|NCT04515641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111180666|NCT04515641|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111180667|NCT04515641|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111180668|NCT04515641|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111180669|NCT04474366|Ropivacaine|ropivacaine|mesh-list
111180670|NCT04474366|Anesthetics, Local|anesthetics, local|mesh-ancestor
111180671|NCT04474366|Anesthetics|anesthetics|mesh-ancestor
111180672|NCT04474366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111180673|NCT04474366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111180674|NCT04474366|Sensory System Agents|sensory system agents|mesh-ancestor
111180675|NCT04474366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111180676|NCT04465643|Nivolumab|nivolumab|mesh-list
111180677|NCT04465643|Ipilimumab|ipilimumab|mesh-list
111180678|NCT04465643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111180679|NCT04465643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111180680|NCT04465643|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111180681|NCT04465643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111180682|NCT04431453|Remdesivir|remdesivir|mesh-list
111180683|NCT04431453|Antimetabolites|antimetabolites|mesh-ancestor
111180684|NCT04431453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111180685|NCT04431453|Antiviral Agents|antiviral agents|mesh-ancestor
111180686|NCT04431453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111180687|NCT04422431|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
111180688|NCT04422431|Choline|choline|mesh-list
111180689|NCT04422431|Lipotropic Agents|lipotropic agents|mesh-ancestor
110897867|NCT02128646|Ketorolac|ketorolac|mesh-list
111180690|NCT04422431|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111180691|NCT04422431|Antimetabolites|antimetabolites|mesh-ancestor
111180692|NCT04422431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111180693|NCT04422431|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111180694|NCT04422431|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111180695|NCT04422431|Nootropic Agents|nootropic agents|mesh-ancestor
111180696|NCT04422431|Chelating Agents|chelating agents|mesh-ancestor
111180697|NCT04422431|Sequestering Agents|sequestering agents|mesh-ancestor
111180698|NCT04422431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111180699|NCT04422431|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111180700|NCT04422431|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111180701|NCT04422431|Growth Substances|growth substances|mesh-ancestor
111180702|NCT04422431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111180703|NCT04422431|Growth Inhibitors|growth inhibitors|mesh-ancestor
111180704|NCT04422431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111180705|NCT04416451|Rituximab|rituximab|mesh-list
111180706|NCT04416451|Venetoclax|venetoclax|mesh-list
111180707|NCT04416451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111180708|NCT04416451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111180709|NCT04416451|Immunologic Factors|immunologic factors|mesh-ancestor
111180710|NCT04416451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111180711|NCT04416451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111180712|NCT04406649|Dihydroergotamine|dihydroergotamine|mesh-list
111180713|NCT04406649|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111180714|NCT04406649|Dopamine Agonists|dopamine agonists|mesh-ancestor
111180715|NCT04406649|Dopamine Agents|dopamine agents|mesh-ancestor
111180716|NCT04406649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111180717|NCT04406649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111180718|NCT04406649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111180719|NCT04406649|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111180720|NCT04406649|Analgesics|analgesics|mesh-ancestor
111180721|NCT04406649|Sensory System Agents|sensory system agents|mesh-ancestor
111180722|NCT04406649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111180723|NCT04316390|Vitamins|vitamins|mesh-list
111180724|NCT04316390|Ascorbic Acid|ascorbic acid|mesh-list
111180725|NCT04316390|Micronutrients|micronutrients|mesh-ancestor
111180726|NCT04316390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111180727|NCT04316390|Antioxidants|antioxidants|mesh-ancestor
111180728|NCT04316390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111180729|NCT04316390|Protective Agents|protective agents|mesh-ancestor
111180730|NCT04236414|Olaparib|olaparib|mesh-list
111180731|NCT04236414|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111180732|NCT04236414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111180733|NCT04236414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111180734|NCT04236414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111180735|NCT04228042|Infigratinib|infigratinib|mesh-list
111180736|NCT04228042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111180737|NCT04171817|Chlorhexidine|chlorhexidine|mesh-list
111180738|NCT04171817|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111180739|NCT04171817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111180740|NCT04171817|Disinfectants|disinfectants|mesh-ancestor
111180741|NCT04163952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111180742|NCT04163952|Panitumumab|panitumumab|mesh-list
111180743|NCT04163952|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
111180744|NCT04163952|Antibodies|antibodies|mesh-list
111180745|NCT04163952|Immunoglobulins|immunoglobulins|mesh-list
111180746|NCT04163952|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111180747|NCT04163952|Immunologic Factors|immunologic factors|mesh-ancestor
111180748|NCT04163952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111180749|NCT04163952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111180750|NCT04152863|Pembrolizumab|pembrolizumab|mesh-list
111180751|NCT04152863|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111180752|NCT04152863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111180753|NCT04152863|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111180754|NCT04152863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111180755|NCT04129554|Tenofovir|tenofovir|mesh-list
111180756|NCT04129554|Entecavir|entecavir|mesh-list
111180757|NCT04129554|JNJ-56136379|jnj-56136379|mesh-list
111180758|NCT04129554|Antiviral Agents|antiviral agents|mesh-ancestor
111180759|NCT04129554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111180760|NCT04129554|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111180761|NCT04129554|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111180762|NCT04129554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111180763|NCT04129554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111180764|NCT04129554|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111180765|NCT04129554|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111180766|NCT04109729|Nivolumab|nivolumab|mesh-list
111180767|NCT04109729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111180768|NCT04109729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111180769|NCT04109729|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111180770|NCT04109729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111180771|NCT04106856|Losartan|losartan|mesh-list
111180772|NCT04106856|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111180773|NCT04106856|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111180774|NCT04106856|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111180775|NCT04106856|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111180776|NCT04106856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111180777|NCT04098666|Metformin|metformin|mesh-list
111180778|NCT04098666|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111180779|NCT04098666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111180780|NCT04049513|Cyclophosphamide|cyclophosphamide|mesh-list
111180781|NCT04049513|Fludarabine|fludarabine|mesh-list
111180782|NCT04049513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111180783|NCT04049513|Immunologic Factors|immunologic factors|mesh-ancestor
111180784|NCT04049513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111180785|NCT04049513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111180786|NCT04049513|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111180787|NCT04049513|Alkylating Agents|alkylating agents|mesh-ancestor
111180788|NCT04049513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111180789|NCT04049513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111180790|NCT04049513|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111180791|NCT04002180|Vedolizumab|vedolizumab|mesh-list
111180792|NCT04002180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111180793|NCT03997123|Paclitaxel|paclitaxel|mesh-list
111180794|NCT03997123|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111180795|NCT03997123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111180796|NCT03997123|Tubulin Modulators|tubulin modulators|mesh-ancestor
111180797|NCT03997123|Antimitotic Agents|antimitotic agents|mesh-ancestor
111180798|NCT03997123|Mitosis Modulators|mitosis modulators|mesh-ancestor
111180799|NCT03997123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111180800|NCT03968419|Pembrolizumab|pembrolizumab|mesh-list
111180801|NCT03968419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111180802|NCT03968419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111180803|NCT03968419|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111180804|NCT03968419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111180805|NCT03924986|Tislelizumab|tislelizumab|mesh-list
111180806|NCT03924986|Gemcitabine|gemcitabine|mesh-list
111180807|NCT03924986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111180808|NCT03924986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111180809|NCT03924986|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111180810|NCT03924986|Antimetabolites|antimetabolites|mesh-ancestor
111180811|NCT03924986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111180812|NCT03904550|Rocuronium|rocuronium|mesh-list
111180813|NCT03904550|Cisatracurium|cisatracurium|mesh-list
111180814|NCT03904550|Neostigmine|neostigmine|mesh-list
111180815|NCT03904550|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
111180816|NCT03904550|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
111180817|NCT03904550|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111180818|NCT03904550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111180819|NCT03904550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111180820|NCT03904550|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111180821|NCT03904550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111180822|NCT03904550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111180823|NCT03904550|Cholinergic Agents|cholinergic agents|mesh-ancestor
111180824|NCT03904550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111180825|NCT03904550|Parasympathomimetics|parasympathomimetics|mesh-ancestor
111180826|NCT03904550|Autonomic Agents|autonomic agents|mesh-ancestor
111180827|NCT03866577|Immunoglobulins|immunoglobulins|mesh-list
111180828|NCT03866577|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111180829|NCT03866577|Antibodies|antibodies|mesh-list
111180830|NCT03866577|gamma-Globulins|gamma-globulins|mesh-list
111180831|NCT03866577|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
111180832|NCT03866577|Immunologic Factors|immunologic factors|mesh-ancestor
110843883|NCT03232983|Insulin Lispro|insulin lispro|mesh-list
111180833|NCT03866577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111180834|NCT03834883|Ibutilide|ibutilide|mesh-list
111180835|NCT03834883|Progesterone|progesterone|mesh-list
111180836|NCT03834883|Progestins|progestins|mesh-ancestor
111180837|NCT03834883|Hormones|hormones|mesh-ancestor
111180838|NCT03834883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111180839|NCT03834883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111180840|NCT03834883|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111180842|NCT03822468|Anastrozole|anastrozole|mesh-list
111180843|NCT03822468|Goserelin|goserelin|mesh-list
111180844|NCT03822468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111180845|NCT03822468|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111180846|NCT03822468|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111180847|NCT03822468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111180848|NCT03822468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111180849|NCT03822468|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111180850|NCT03822468|Hormone Antagonists|hormone antagonists|mesh-ancestor
111180851|NCT03822468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111180852|NCT03822468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111180853|NCT03822468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111180854|NCT03816332|Prednisone|prednisone|mesh-list
111180855|NCT03816332|Cortisone|cortisone|mesh-list
111180856|NCT03816332|Nivolumab|nivolumab|mesh-list
111180857|NCT03816332|Ipilimumab|ipilimumab|mesh-list
111180858|NCT03816332|Tacrolimus|tacrolimus|mesh-list
111180859|NCT03816332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111180860|NCT03816332|Glucocorticoids|glucocorticoids|mesh-ancestor
111180861|NCT03816332|Hormones|hormones|mesh-ancestor
111180862|NCT03816332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111180863|NCT03816332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111180864|NCT03816332|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111180865|NCT03816332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111180866|NCT03816332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111180867|NCT03816332|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111180868|NCT03816332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111180869|NCT03816332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111180870|NCT03816332|Immunologic Factors|immunologic factors|mesh-ancestor
111180871|NCT03816332|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111180872|NCT03816332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111180873|NCT03810807|Osimertinib|osimertinib|mesh-list
111180874|NCT03810807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111180875|NCT03810807|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111180876|NCT03810807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111180877|NCT03810807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111180878|NCT03759288|Adalimumab|adalimumab|mesh-list
111180879|NCT03759288|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111180880|NCT03759288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111180881|NCT03759288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111180882|NCT03693014|Pembrolizumab|pembrolizumab|mesh-list
111180883|NCT03693014|Nivolumab|nivolumab|mesh-list
111180884|NCT03693014|Ipilimumab|ipilimumab|mesh-list
111180885|NCT03693014|Atezolizumab|atezolizumab|mesh-list
111180886|NCT03693014|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111180887|NCT03693014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111180888|NCT03693014|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111180889|NCT03693014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111180890|NCT03684980|Leucovorin|leucovorin|mesh-list
111180891|NCT03684980|Rituximab|rituximab|mesh-list
111180892|NCT03684980|Methotrexate|methotrexate|mesh-list
111180893|NCT03684980|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111180894|NCT03684980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111180895|NCT03684980|Immunologic Factors|immunologic factors|mesh-ancestor
111180896|NCT03684980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111180897|NCT03684980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111180898|NCT03684980|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111180899|NCT03684980|Abortifacient Agents|abortifacient agents|mesh-ancestor
111180900|NCT03684980|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111180901|NCT03684980|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111180902|NCT03684980|Antimetabolites|antimetabolites|mesh-ancestor
111180903|NCT03684980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111180904|NCT03684980|Dermatologic Agents|dermatologic agents|mesh-ancestor
111180905|NCT03684980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111180906|NCT03684980|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111180907|NCT03684980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111180908|NCT03684980|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111180909|NCT03684980|Antidotes|antidotes|mesh-ancestor
111180910|NCT03684980|Protective Agents|protective agents|mesh-ancestor
111180911|NCT03684980|Vitamin B Complex|vitamin b complex|mesh-ancestor
111180912|NCT03684980|Vitamins|vitamins|mesh-ancestor
111180913|NCT03684980|Micronutrients|micronutrients|mesh-ancestor
111180914|NCT03672487|Benzonidazole|benzonidazole|mesh-list
111180915|NCT03672487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111180916|NCT03672487|Immunologic Factors|immunologic factors|mesh-ancestor
111180917|NCT03672487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111180918|NCT03672487|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
111180919|NCT03672487|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111180920|NCT03672487|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111180921|NCT03672487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111180922|NCT03666559|Azacitidine|azacitidine|mesh-list
111180923|NCT03666559|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111180924|NCT03666559|Antimetabolites|antimetabolites|mesh-ancestor
111180925|NCT03666559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111180926|NCT03666559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111180927|NCT03666559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111180928|NCT03662022|Rifampin|rifampin|mesh-list
111180929|NCT03662022|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111180930|NCT03662022|Antitubercular Agents|antitubercular agents|mesh-ancestor
111180931|NCT03662022|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111180932|NCT03662022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111180933|NCT03662022|Leprostatic Agents|leprostatic agents|mesh-ancestor
111180934|NCT03662022|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111180935|NCT03662022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111180936|NCT03662022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111180937|NCT03662022|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111180938|NCT03662022|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111180939|NCT03662022|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
111180940|NCT03662022|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
111180941|NCT03662022|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
111180942|NCT03662022|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111180943|NCT03648996|Allopurinol|allopurinol|mesh-list
111180944|NCT03648996|Antimetabolites|antimetabolites|mesh-ancestor
111180945|NCT03648996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111180946|NCT03648996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111180947|NCT03648996|Gout Suppressants|gout suppressants|mesh-ancestor
111180948|NCT03648996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111180949|NCT03648996|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111180950|NCT03648996|Antioxidants|antioxidants|mesh-ancestor
111180951|NCT03648996|Protective Agents|protective agents|mesh-ancestor
111180952|NCT03648996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111180953|NCT03611738|Docetaxel|docetaxel|mesh-list
111180954|NCT03611738|Ceritinib|ceritinib|mesh-list
111180955|NCT03611738|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
111180956|NCT03611738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111180957|NCT03611738|Tubulin Modulators|tubulin modulators|mesh-ancestor
111180958|NCT03611738|Antimitotic Agents|antimitotic agents|mesh-ancestor
111180959|NCT03611738|Mitosis Modulators|mitosis modulators|mesh-ancestor
111180960|NCT03611738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111180961|NCT03611738|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111180962|NCT03611738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111180964|NCT03585465|Capecitabine|capecitabine|mesh-list
111180965|NCT03585465|Nivolumab|nivolumab|mesh-list
111180966|NCT03585465|Vinblastine|vinblastine|mesh-list
111180967|NCT03585465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111180968|NCT03585465|Immunologic Factors|immunologic factors|mesh-ancestor
111180969|NCT03585465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111180970|NCT03585465|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111180971|NCT03585465|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111180972|NCT03585465|Alkylating Agents|alkylating agents|mesh-ancestor
111180973|NCT03585465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111180974|NCT03585465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111180975|NCT03585465|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111180976|NCT03585465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111180977|NCT03585465|Antimetabolites|antimetabolites|mesh-ancestor
111180978|NCT03585465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111180979|NCT03585465|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111180980|NCT03585465|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111180981|NCT03585465|Tubulin Modulators|tubulin modulators|mesh-ancestor
111180982|NCT03585465|Antimitotic Agents|antimitotic agents|mesh-ancestor
111180983|NCT03585465|Mitosis Modulators|mitosis modulators|mesh-ancestor
111180984|NCT03523312|Capecitabine|capecitabine|mesh-list
111180985|NCT03523312|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111180986|NCT03523312|Antimetabolites|antimetabolites|mesh-ancestor
111180987|NCT03523312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111180988|NCT03523312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111180989|NCT03471624|Tenofovir|tenofovir|mesh-list
111180990|NCT03471624|Antiviral Agents|antiviral agents|mesh-ancestor
110898164|NCT03633175|Progesterone|progesterone|mesh-list
111180991|NCT03471624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111180992|NCT03471624|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111180993|NCT03471624|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111180994|NCT03471624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111180995|NCT03471624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111180996|NCT03471624|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111180997|NCT03471624|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111180998|NCT03471143|Betadex|betadex|mesh-list
111180999|NCT03471143|Sequestering Agents|sequestering agents|mesh-ancestor
111181000|NCT03471143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111181001|NCT03459807|Antihypertensive Agents|antihypertensive agents|mesh-list
111181002|NCT03449238|Pembrolizumab|pembrolizumab|mesh-list
111181003|NCT03449238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111181004|NCT03449238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111181005|NCT03449238|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111181006|NCT03449238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111181007|NCT03439293|Dexamethasone|dexamethasone|mesh-list
111181008|NCT03439293|Daratumumab|daratumumab|mesh-list
111181009|NCT03439293|Ixazomib|ixazomib|mesh-list
111181010|NCT03439293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111181011|NCT03439293|Antiemetics|antiemetics|mesh-ancestor
111181012|NCT03439293|Autonomic Agents|autonomic agents|mesh-ancestor
111181013|NCT03439293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111181014|NCT03439293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111181015|NCT03439293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111181016|NCT03439293|Glucocorticoids|glucocorticoids|mesh-ancestor
111181017|NCT03439293|Hormones|hormones|mesh-ancestor
111181018|NCT03439293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111181019|NCT03439293|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111181020|NCT03439293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111181021|NCT03439293|Protease Inhibitors|protease inhibitors|mesh-ancestor
111181022|NCT03439293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111181023|NCT03439293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111181024|NCT03423979|Paclitaxel|paclitaxel|mesh-list
111181025|NCT03423979|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111181026|NCT03423979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111181027|NCT03423979|Tubulin Modulators|tubulin modulators|mesh-ancestor
111181028|NCT03423979|Antimitotic Agents|antimitotic agents|mesh-ancestor
110489008|NCT00878254|Leucovorin|leucovorin|mesh-list
111181029|NCT03423979|Mitosis Modulators|mitosis modulators|mesh-ancestor
111181030|NCT03423979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111181031|NCT03404778|Cimetidine|cimetidine|mesh-list
111181032|NCT03404778|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111181033|NCT03404778|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111181034|NCT03404778|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
111181035|NCT03404778|Histamine Antagonists|histamine antagonists|mesh-ancestor
111181037|NCT03404778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111181038|NCT03404778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111181039|NCT03404778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111181040|NCT03404778|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111181041|NCT03404778|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111181042|NCT03404778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111181043|NCT03258554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111181044|NCT03258554|Cetuximab|cetuximab|mesh-list
111181045|NCT03258554|Durvalumab|durvalumab|mesh-list
111181046|NCT03258554|Antibodies|antibodies|mesh-list
111181047|NCT03258554|Immunoglobulins|immunoglobulins|mesh-list
111181048|NCT03258554|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111181049|NCT03258554|Immunoglobulin G|immunoglobulin g|mesh-list
111181050|NCT03258554|Immunologic Factors|immunologic factors|mesh-ancestor
111181051|NCT03258554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111181052|NCT03258554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111181053|NCT03239210|Ondansetron|ondansetron|mesh-list
111181054|NCT03239210|Antiemetics|antiemetics|mesh-ancestor
111181055|NCT03239210|Autonomic Agents|autonomic agents|mesh-ancestor
111181056|NCT03239210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111181057|NCT03239210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111181058|NCT03239210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111181059|NCT03239210|Antipruritics|antipruritics|mesh-ancestor
111181060|NCT03239210|Dermatologic Agents|dermatologic agents|mesh-ancestor
111181061|NCT03239210|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111181062|NCT03239210|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111181063|NCT03239210|Serotonin Agents|serotonin agents|mesh-ancestor
111181064|NCT03239210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111181065|NCT03239210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111181066|NCT03196466|Topiramate|topiramate|mesh-list
111181067|NCT03196466|Pregabalin|pregabalin|mesh-list
111181068|NCT03196466|Lamotrigine|lamotrigine|mesh-list
111181069|NCT03196466|Zonisamide|zonisamide|mesh-list
111181070|NCT03196466|Lacosamide|lacosamide|mesh-list
111181071|NCT03196466|Carbamazepine|carbamazepine|mesh-list
111181072|NCT03196466|Phenytoin|phenytoin|mesh-list
111181073|NCT03196466|Oxcarbazepine|oxcarbazepine|mesh-list
111181074|NCT03196466|Rufinamide|rufinamide|mesh-list
111181075|NCT03196466|Cannabidiol|cannabidiol|mesh-list
111181076|NCT03196466|Levetiracetam|levetiracetam|mesh-list
111181077|NCT03196466|Valproic Acid|valproic acid|mesh-list
111181078|NCT03196466|Brivaracetam|brivaracetam|mesh-list
111181079|NCT03196466|Phenobarbital|phenobarbital|mesh-list
111181080|NCT03196466|Clobazam|clobazam|mesh-list
111181081|NCT03196466|Ethosuximide|ethosuximide|mesh-list
111181082|NCT03196466|Stiripentol|stiripentol|mesh-list
111181083|NCT03196466|Tiagabine|tiagabine|mesh-list
111181084|NCT03196466|Primidone|primidone|mesh-list
111181085|NCT03196466|Felbamate|felbamate|mesh-list
111181086|NCT03196466|Analgesics|analgesics|mesh-ancestor
111181087|NCT03196466|Sensory System Agents|sensory system agents|mesh-ancestor
111181088|NCT03196466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111181089|NCT03196466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111181090|NCT03196466|Anticonvulsants|anticonvulsants|mesh-ancestor
111181091|NCT03196466|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111181092|NCT03196466|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111181093|NCT03196466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111181094|NCT03196466|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111181095|NCT03196466|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111181096|NCT03196466|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111181097|NCT03196466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111181098|NCT03196466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111181099|NCT03196466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111181100|NCT03196466|Nootropic Agents|nootropic agents|mesh-ancestor
111181101|NCT03196466|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111181102|NCT03196466|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111181103|NCT03196466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111181104|NCT03196466|GABA Agents|gaba agents|mesh-ancestor
110843919|NCT04102345|Zolpidem|zolpidem|mesh-list
111181105|NCT03196466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111181106|NCT03196466|Antimanic Agents|antimanic agents|mesh-ancestor
111181107|NCT03196466|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111181108|NCT03196466|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111181109|NCT03196466|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111181110|NCT03196466|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111181111|NCT03196466|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
111181112|NCT03196466|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111181113|NCT03196466|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111181114|NCT03196466|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111181115|NCT03196466|GABA Modulators|gaba modulators|mesh-ancestor
111181116|NCT03196466|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111181117|NCT03196466|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
111181118|NCT03196466|GABA Agonists|gaba agonists|mesh-ancestor
111181119|NCT03196466|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
111181120|NCT03196466|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111181121|NCT03184870|Leucovorin|leucovorin|mesh-list
111181122|NCT03184870|Paclitaxel|paclitaxel|mesh-list
111181123|NCT03184870|Gemcitabine|gemcitabine|mesh-list
111181124|NCT03184870|Fluorouracil|fluorouracil|mesh-list
111181125|NCT03184870|Nivolumab|nivolumab|mesh-list
111181126|NCT03184870|Irinotecan|irinotecan|mesh-list
111181127|NCT03184870|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111181128|NCT03184870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111181129|NCT03184870|Tubulin Modulators|tubulin modulators|mesh-ancestor
111181130|NCT03184870|Antimitotic Agents|antimitotic agents|mesh-ancestor
111181131|NCT03184870|Mitosis Modulators|mitosis modulators|mesh-ancestor
111181132|NCT03184870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111181133|NCT03184870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111181134|NCT03184870|Antimetabolites|antimetabolites|mesh-ancestor
111181135|NCT03184870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111181136|NCT03184870|Immunologic Factors|immunologic factors|mesh-ancestor
111181137|NCT03184870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111181138|NCT03184870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111181139|NCT03184870|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111181140|NCT03184870|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111181141|NCT03184870|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111181142|NCT03184870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110898322|NCT01363037|Maraviroc|maraviroc|mesh-list
111181143|NCT03184870|Antidotes|antidotes|mesh-ancestor
111181144|NCT03184870|Protective Agents|protective agents|mesh-ancestor
111181145|NCT03184870|Vitamin B Complex|vitamin b complex|mesh-ancestor
111181146|NCT03184870|Vitamins|vitamins|mesh-ancestor
111181147|NCT03184870|Micronutrients|micronutrients|mesh-ancestor
111181148|NCT03122522|Nivolumab|nivolumab|mesh-list
111181149|NCT03122522|Ipilimumab|ipilimumab|mesh-list
111181150|NCT03122522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111181151|NCT03122522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111181152|NCT03122522|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111181153|NCT03122522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111181154|NCT03118232|Chlorhexidine|chlorhexidine|mesh-list
111181155|NCT03118232|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
111181156|NCT03118232|Povidone-Iodine|povidone-iodine|mesh-list
111181157|NCT03118232|Povidone|povidone|mesh-list
111181158|NCT03118232|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111181159|NCT03118232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111181160|NCT03118232|Disinfectants|disinfectants|mesh-ancestor
111181161|NCT03118232|Dermatologic Agents|dermatologic agents|mesh-ancestor
111181162|NCT03118232|Plasma Substitutes|plasma substitutes|mesh-ancestor
111181163|NCT03118232|Blood Substitutes|blood substitutes|mesh-ancestor
111181164|NCT03108846|Escitalopram|escitalopram|mesh-list
111181165|NCT03108846|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111181166|NCT03108846|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111181167|NCT03108846|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111181168|NCT03108846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111181169|NCT03108846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111181170|NCT03108846|Serotonin Agents|serotonin agents|mesh-ancestor
111181171|NCT03108846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111181172|NCT03103971|Cyclophosphamide|cyclophosphamide|mesh-list
111181173|NCT03103971|Fludarabine|fludarabine|mesh-list
111181174|NCT03103971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111181175|NCT03103971|Immunologic Factors|immunologic factors|mesh-ancestor
111181176|NCT03103971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111181177|NCT03103971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111181178|NCT03103971|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111181179|NCT03103971|Alkylating Agents|alkylating agents|mesh-ancestor
111181180|NCT03103971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111181181|NCT03103971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111181182|NCT03103971|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111181184|NCT03086343|Upadacitinib|upadacitinib|mesh-list
111181185|NCT03086343|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111181186|NCT03086343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111181187|NCT03086343|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111181188|NCT03086343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111181189|NCT03086343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111181190|NCT03086343|Immunologic Factors|immunologic factors|mesh-ancestor
111181191|NCT03086343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111181192|NCT03086343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111181193|NCT03086343|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
111181194|NCT03086343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111181195|NCT03086343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111181196|NCT02904226|Pembrolizumab|pembrolizumab|mesh-list
111181197|NCT02904226|Nivolumab|nivolumab|mesh-list
111181198|NCT02904226|Ipilimumab|ipilimumab|mesh-list
111181199|NCT02904226|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111181200|NCT02904226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111181201|NCT02904226|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111181202|NCT02904226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111181203|NCT02775695|Doxycycline|doxycycline|mesh-list
111181204|NCT02775695|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111181205|NCT02775695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111181206|NCT02775695|Antimalarials|antimalarials|mesh-ancestor
111181207|NCT02775695|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111181208|NCT02775695|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111181209|NCT02679040|Trastuzumab|trastuzumab|mesh-list
111181210|NCT02679040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111181211|NCT02679040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111181212|NCT02610075|Adavosertib|adavosertib|mesh-list
111181213|NCT02610075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111181214|NCT02610075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111181215|NCT02599454|Atezolizumab|atezolizumab|mesh-list
111181216|NCT02599454|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111181217|NCT02599454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111181218|NCT02599454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111181219|NCT02599454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111181220|NCT02559856|Rivaroxaban|rivaroxaban|mesh-list
111181221|NCT02559856|Apixaban|apixaban|mesh-list
111181222|NCT02559856|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111181223|NCT02559856|Antithrombins|antithrombins|mesh-ancestor
111181224|NCT02559856|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111181225|NCT02559856|Protease Inhibitors|protease inhibitors|mesh-ancestor
111181226|NCT02559856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111181227|NCT02559856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111181228|NCT02559856|Anticoagulants|anticoagulants|mesh-ancestor
111181229|NCT02482311|Adavosertib|adavosertib|mesh-list
111181230|NCT02482311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111181231|NCT02482311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111181232|NCT02437318|Fulvestrant|fulvestrant|mesh-list
111181233|NCT02437318|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111181234|NCT02437318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111181235|NCT02437318|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
111181236|NCT02437318|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111181237|NCT02437318|Hormone Antagonists|hormone antagonists|mesh-ancestor
111181238|NCT02437318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111181239|NCT02437318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111181240|NCT02344680|Anti-HIV Agents|anti-hiv agents|mesh-list
111181241|NCT02344680|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111181242|NCT02344680|Antiviral Agents|antiviral agents|mesh-ancestor
111181243|NCT02344680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111181244|NCT02338609|Everolimus|everolimus|mesh-list
111181245|NCT02338609|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111181246|NCT02338609|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111181247|NCT02338609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111181248|NCT02338609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111181249|NCT02338609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111181250|NCT02338609|Immunologic Factors|immunologic factors|mesh-ancestor
111181251|NCT02338609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111181252|NCT02338609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111181253|NCT02125461|Durvalumab|durvalumab|mesh-list
111181254|NCT02125461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111181255|NCT02125461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111181256|NCT01933932|Docetaxel|docetaxel|mesh-list
111181257|NCT01933932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111181258|NCT01933932|Tubulin Modulators|tubulin modulators|mesh-ancestor
111181259|NCT01933932|Antimitotic Agents|antimitotic agents|mesh-ancestor
111181260|NCT01933932|Mitosis Modulators|mitosis modulators|mesh-ancestor
111181261|NCT01933932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111181262|NCT01466686|Temozolomide|temozolomide|mesh-list
111181263|NCT01466686|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111181264|NCT01466686|Alkylating Agents|alkylating agents|mesh-ancestor
111181265|NCT01466686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111181266|NCT01466686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111181267|NCT01093196|Dexamethasone|dexamethasone|mesh-list
111181268|NCT01093196|Prednisone|prednisone|mesh-list
111181269|NCT01093196|Cyclophosphamide|cyclophosphamide|mesh-list
111181270|NCT01093196|Melphalan|melphalan|mesh-list
111181271|NCT01093196|Lenalidomide|lenalidomide|mesh-list
111181272|NCT01093196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111181273|NCT01093196|Immunologic Factors|immunologic factors|mesh-ancestor
111181274|NCT01093196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111181275|NCT01093196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111181276|NCT01093196|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111181277|NCT01093196|Alkylating Agents|alkylating agents|mesh-ancestor
111181278|NCT01093196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111181279|NCT01093196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111181280|NCT01093196|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111181281|NCT01093196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111181282|NCT01093196|Antiemetics|antiemetics|mesh-ancestor
111181283|NCT01093196|Autonomic Agents|autonomic agents|mesh-ancestor
111181284|NCT01093196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111181285|NCT01093196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111181286|NCT01093196|Glucocorticoids|glucocorticoids|mesh-ancestor
111181287|NCT01093196|Hormones|hormones|mesh-ancestor
111181288|NCT01093196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111181289|NCT01093196|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111181290|NCT01093196|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111181291|NCT01093196|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111181292|NCT01093196|Growth Substances|growth substances|mesh-ancestor
111181293|NCT01093196|Growth Inhibitors|growth inhibitors|mesh-ancestor
111181294|NCT01091831|Dexamethasone|dexamethasone|mesh-list
111181295|NCT01091831|Cyclophosphamide|cyclophosphamide|mesh-list
110898462|NCT02303431|Edoxaban|edoxaban|mesh-list
111181296|NCT01091831|Melphalan|melphalan|mesh-list
111181297|NCT01091831|Lenalidomide|lenalidomide|mesh-list
111181298|NCT01091831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111181299|NCT01091831|Immunologic Factors|immunologic factors|mesh-ancestor
111181300|NCT01091831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111181301|NCT01091831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111181302|NCT01091831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111181303|NCT01091831|Alkylating Agents|alkylating agents|mesh-ancestor
111181304|NCT01091831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111181305|NCT01091831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111181306|NCT01091831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111181307|NCT01091831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111181308|NCT01091831|Antiemetics|antiemetics|mesh-ancestor
111181309|NCT01091831|Autonomic Agents|autonomic agents|mesh-ancestor
111181310|NCT01091831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111181311|NCT01091831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111181312|NCT01091831|Glucocorticoids|glucocorticoids|mesh-ancestor
111181314|NCT01091831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111181315|NCT01091831|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111181316|NCT01091831|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111181317|NCT01091831|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111181318|NCT01091831|Growth Substances|growth substances|mesh-ancestor
111181319|NCT01091831|Growth Inhibitors|growth inhibitors|mesh-ancestor
111181320|NCT00093834|Cyclophosphamide|cyclophosphamide|mesh-list
111181321|NCT00093834|Doxorubicin|doxorubicin|mesh-list
111181322|NCT00093834|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111181323|NCT00093834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111181324|NCT00093834|Immunologic Factors|immunologic factors|mesh-ancestor
111181325|NCT00093834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111181326|NCT00093834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111181327|NCT00093834|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111181328|NCT00093834|Alkylating Agents|alkylating agents|mesh-ancestor
111181329|NCT00093834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111181330|NCT00093834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111181331|NCT00093834|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111181332|NCT00093834|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111181333|NCT00093834|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111181334|NCT00093834|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111181335|NCT00093834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111181336|NCT01550289|Vaccines|vaccines|mesh-list
111181337|NCT01550289|Immunologic Factors|immunologic factors|mesh-ancestor
111181338|NCT01550289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111181339|NCT01968031|Istradefylline|istradefylline|mesh-list
111181340|NCT01968031|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
111181341|NCT01968031|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
111181342|NCT01968031|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111181343|NCT01968031|Purinergic Agents|purinergic agents|mesh-ancestor
111181344|NCT01968031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111181345|NCT01968031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111181346|NCT01968031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111181347|NCT01684215|Letrozole|letrozole|mesh-list
111181348|NCT01684215|Palbociclib|palbociclib|mesh-list
111181349|NCT01684215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111181350|NCT01684215|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111181351|NCT01684215|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111181352|NCT01684215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111181353|NCT01684215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111181354|NCT01684215|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111181355|NCT01684215|Hormone Antagonists|hormone antagonists|mesh-ancestor
111181356|NCT01684215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111181357|NCT01684215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111181358|NCT01684215|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111181359|NCT01908205|Oxytocin|oxytocin|mesh-list
111181360|NCT01908205|Oxytocics|oxytocics|mesh-ancestor
111181361|NCT01908205|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111181362|NCT01908205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111181363|NCT01549041|Asenapine|asenapine|mesh-list
111181364|NCT01549041|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111181365|NCT01549041|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111181366|NCT01549041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111181367|NCT01549041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111181368|NCT01549041|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111181369|NCT01907815|Trametinib|trametinib|mesh-list
110898544|NCT02140268|Anesthetics|anesthetics|mesh-ancestor
111181370|NCT01907815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111181371|NCT01907815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111181372|NCT01907815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111181373|NCT01907815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111181374|NCT01548573|Thalidomide|thalidomide|mesh-list
111181375|NCT01548573|Dexamethasone|dexamethasone|mesh-list
111181376|NCT01548573|Cyclophosphamide|cyclophosphamide|mesh-list
111181377|NCT01548573|Melphalan|melphalan|mesh-list
111181378|NCT01548573|Doxorubicin|doxorubicin|mesh-list
111181379|NCT01548573|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111181380|NCT01548573|Etoposide|etoposide|mesh-list
111181381|NCT01548573|Etoposide phosphate|etoposide phosphate|mesh-list
111181382|NCT01548573|Bortezomib|bortezomib|mesh-list
111181383|NCT01548573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111181384|NCT01548573|Immunologic Factors|immunologic factors|mesh-ancestor
111181385|NCT01548573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111181386|NCT01548573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111181387|NCT01548573|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111181388|NCT01548573|Alkylating Agents|alkylating agents|mesh-ancestor
111181389|NCT01548573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111181390|NCT01548573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111181391|NCT01548573|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111181392|NCT01548573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111181393|NCT01548573|Antiemetics|antiemetics|mesh-ancestor
111181394|NCT01548573|Autonomic Agents|autonomic agents|mesh-ancestor
111181395|NCT01548573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111181396|NCT01548573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111181397|NCT01548573|Glucocorticoids|glucocorticoids|mesh-ancestor
111181398|NCT01548573|Hormones|hormones|mesh-ancestor
111181399|NCT01548573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111181400|NCT01548573|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111181401|NCT01548573|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111181402|NCT01548573|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111181403|NCT01548573|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111181404|NCT01548573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111181405|NCT01548573|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111181406|NCT01548573|Leprostatic Agents|leprostatic agents|mesh-ancestor
111181407|NCT01548573|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111181408|NCT01548573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111181409|NCT01548573|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111181410|NCT01548573|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111181411|NCT01548573|Growth Substances|growth substances|mesh-ancestor
111181412|NCT01548573|Growth Inhibitors|growth inhibitors|mesh-ancestor
111181413|NCT01570491|Anesthetics|anesthetics|mesh-list
111181414|NCT01570491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111181415|NCT01570491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111181416|NCT01518153|Methotrexate|methotrexate|mesh-list
111181417|NCT01518153|Fludarabine phosphate|fludarabine phosphate|mesh-list
111181418|NCT01518153|Fludarabine|fludarabine|mesh-list
111181419|NCT01518153|Melphalan|melphalan|mesh-list
111181420|NCT01518153|Alemtuzumab|alemtuzumab|mesh-list
111181421|NCT01518153|Tacrolimus|tacrolimus|mesh-list
111181422|NCT01518153|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111181423|NCT01518153|Abortifacient Agents|abortifacient agents|mesh-ancestor
111181424|NCT01518153|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111181425|NCT01518153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111181426|NCT01518153|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111181427|NCT01518153|Antimetabolites|antimetabolites|mesh-ancestor
111181428|NCT01518153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111181429|NCT01518153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111181430|NCT01518153|Dermatologic Agents|dermatologic agents|mesh-ancestor
111181431|NCT01518153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111181432|NCT01518153|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111181433|NCT01518153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111181434|NCT01518153|Immunologic Factors|immunologic factors|mesh-ancestor
111181435|NCT01518153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111181436|NCT01518153|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111181437|NCT01518153|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111181438|NCT01518153|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111181439|NCT01518153|Alkylating Agents|alkylating agents|mesh-ancestor
111181440|NCT01518153|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111181441|NCT01518153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111181442|NCT04620343|Anesthetics|anesthetics|mesh-list
111181443|NCT04620343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111181444|NCT04620343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111181445|NCT01517373|Glimepiride|glimepiride|mesh-list
111181446|NCT01517373|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111181448|NCT01517373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111181449|NCT01517373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111181450|NCT01517373|Immunologic Factors|immunologic factors|mesh-ancestor
111181451|NCT01517295|Hydrocodone|hydrocodone|mesh-list
111181452|NCT01517295|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111181453|NCT01517295|Narcotics|narcotics|mesh-ancestor
111181454|NCT01517295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111181455|NCT01517295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111181456|NCT01517295|Analgesics|analgesics|mesh-ancestor
111181457|NCT01517295|Sensory System Agents|sensory system agents|mesh-ancestor
111181458|NCT01517295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111181459|NCT01517295|Antitussive Agents|antitussive agents|mesh-ancestor
111181460|NCT01517295|Respiratory System Agents|respiratory system agents|mesh-ancestor
111181461|NCT01548417|Mifepristone|mifepristone|mesh-list
111181462|NCT01548417|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
111181463|NCT01548417|Abortifacient Agents|abortifacient agents|mesh-ancestor
111181464|NCT01548417|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111181465|NCT01548417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111181466|NCT01548417|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111181467|NCT01548417|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111181468|NCT01548417|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111181469|NCT01548417|Contraceptive Agents|contraceptive agents|mesh-ancestor
111181470|NCT01548417|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
111181471|NCT01548417|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
111181472|NCT01548417|Hormone Antagonists|hormone antagonists|mesh-ancestor
111181473|NCT01548417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111181474|NCT01548417|Luteolytic Agents|luteolytic agents|mesh-ancestor
111181475|NCT01548417|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111181476|NCT01548417|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
111181477|NCT01546857|Gabapentin|gabapentin|mesh-list
111181478|NCT01546857|Analgesics|analgesics|mesh-ancestor
111181479|NCT01546857|Sensory System Agents|sensory system agents|mesh-ancestor
111181480|NCT01546857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111181481|NCT01546857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111181482|NCT01546857|Anticonvulsants|anticonvulsants|mesh-ancestor
111181483|NCT01546857|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111181484|NCT01546857|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110843954|NCT03757715|Antiemetics|antiemetics|mesh-ancestor
111181485|NCT01546857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111181486|NCT01546857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111181487|NCT01546857|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111181488|NCT01546857|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111181489|NCT01546857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111181490|NCT01546857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111181491|NCT01546857|Antimanic Agents|antimanic agents|mesh-ancestor
111181492|NCT01516749|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
111181493|NCT01516749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111181494|NCT01515423|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
111181495|NCT01515423|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
111181496|NCT01515423|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
111181497|NCT01515423|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111181498|NCT00637000|Buprenorphine|buprenorphine|mesh-list
111181499|NCT00637000|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
111181500|NCT00637000|Naloxone|naloxone|mesh-list
111181501|NCT00637000|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111181502|NCT00637000|Narcotics|narcotics|mesh-ancestor
111181503|NCT00637000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111181504|NCT00637000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111181505|NCT00637000|Analgesics|analgesics|mesh-ancestor
111181506|NCT00637000|Sensory System Agents|sensory system agents|mesh-ancestor
111181507|NCT00637000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111181508|NCT00637000|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111181509|NCT01515189|Ipilimumab|ipilimumab|mesh-list
111181510|NCT01515189|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111181511|NCT01515189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111181512|NCT01515189|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111181513|NCT01515189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111181514|NCT01546623|Leuprolide|leuprolide|mesh-list
111181515|NCT01546623|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111181516|NCT01546623|Fertility Agents|fertility agents|mesh-ancestor
111181517|NCT01546623|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111181518|NCT01546623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111181519|NCT01546623|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111181520|NCT01546623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111181522|NCT00636610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111181523|NCT00636610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111181524|NCT00636610|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111181525|NCT00636610|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111181526|NCT00636610|Growth Substances|growth substances|mesh-ancestor
111181527|NCT00636610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111181528|NCT00636610|Growth Inhibitors|growth inhibitors|mesh-ancestor
111181529|NCT00635050|Paclitaxel|paclitaxel|mesh-list
111181530|NCT00635050|Cyclophosphamide|cyclophosphamide|mesh-list
111181531|NCT00635050|Bevacizumab|bevacizumab|mesh-list
111181532|NCT00635050|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111181533|NCT00635050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111181534|NCT00635050|Tubulin Modulators|tubulin modulators|mesh-ancestor
111181535|NCT00635050|Antimitotic Agents|antimitotic agents|mesh-ancestor
111181536|NCT00635050|Mitosis Modulators|mitosis modulators|mesh-ancestor
111181537|NCT00635050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111181538|NCT00635050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111181539|NCT00635050|Immunologic Factors|immunologic factors|mesh-ancestor
111181540|NCT00635050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111181541|NCT00635050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111181542|NCT00635050|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111181543|NCT00635050|Alkylating Agents|alkylating agents|mesh-ancestor
111181544|NCT00635050|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111181545|NCT00635050|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111181546|NCT00635050|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111181547|NCT00635050|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111181549|NCT00635050|Growth Inhibitors|growth inhibitors|mesh-ancestor
111181550|NCT05240404|Immunomodulating Agents|immunomodulating agents|mesh-list
111181551|NCT05240404|Immunologic Factors|immunologic factors|mesh-ancestor
111181552|NCT05240404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111181553|NCT01923376|Lactulose|lactulose|mesh-list
111181554|NCT01923376|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
111181555|NCT01923376|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111181556|NCT01923376|Laxatives|laxatives|mesh-ancestor
111181557|NCT05245786|Copper|copper|mesh-list
111181558|NCT05245786|Antibodies|antibodies|mesh-list
111181559|NCT05245786|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111181560|NCT05245786|Immunologic Factors|immunologic factors|mesh-ancestor
111181561|NCT05245786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111181562|NCT05245786|Trace Elements|trace elements|mesh-ancestor
111181563|NCT05245786|Micronutrients|micronutrients|mesh-ancestor
111181564|NCT00634504|Leucovorin|leucovorin|mesh-list
111181565|NCT00634504|Methotrexate|methotrexate|mesh-list
111181566|NCT00634504|Levoleucovorin|levoleucovorin|mesh-list
111181567|NCT00634504|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111181568|NCT00634504|Abortifacient Agents|abortifacient agents|mesh-ancestor
111181569|NCT00634504|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111181570|NCT00634504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111181571|NCT00634504|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111181572|NCT00634504|Antimetabolites|antimetabolites|mesh-ancestor
111181573|NCT00634504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111181574|NCT00634504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111181575|NCT00634504|Dermatologic Agents|dermatologic agents|mesh-ancestor
111181576|NCT00634504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111181577|NCT00634504|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111181578|NCT00634504|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111181579|NCT00634504|Immunologic Factors|immunologic factors|mesh-ancestor
111181580|NCT00634504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111181581|NCT00634504|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111181582|NCT00634504|Antidotes|antidotes|mesh-ancestor
111181583|NCT00634504|Protective Agents|protective agents|mesh-ancestor
111181584|NCT00634504|Vitamin B Complex|vitamin b complex|mesh-ancestor
111181585|NCT00634504|Vitamins|vitamins|mesh-ancestor
111181586|NCT00634504|Micronutrients|micronutrients|mesh-ancestor
111181587|NCT03101254|Vemurafenib|vemurafenib|mesh-list
111181588|NCT03101254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111181589|NCT03101254|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111181590|NCT03101254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111181591|NCT03101254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111181592|NCT00634114|Esomeprazole|esomeprazole|mesh-list
111181593|NCT00634114|Omeprazole|omeprazole|mesh-list
111181594|NCT00634114|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111181595|NCT00634114|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111181596|NCT00634114|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111181597|NCT00634114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111181598|NCT00634114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111181599|NCT00634036|Pioglitazone|pioglitazone|mesh-list
111181600|NCT00634036|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111181601|NCT00634036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111181602|NCT05241496|Lidocaine|lidocaine|mesh-list
111181603|NCT05241496|Anesthetics, Local|anesthetics, local|mesh-ancestor
111181604|NCT05241496|Anesthetics|anesthetics|mesh-ancestor
111181605|NCT05241496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110844000|NCT01164059|Antiemetics|antiemetics|mesh-ancestor
111181606|NCT05241496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111181607|NCT05241496|Sensory System Agents|sensory system agents|mesh-ancestor
111181608|NCT05241496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111181609|NCT05241496|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111181610|NCT05241496|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111181611|NCT05241496|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111181612|NCT05241496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111181613|NCT05241496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111181614|NCT01545375|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
111181615|NCT01545375|Immunologic Factors|immunologic factors|mesh-ancestor
111181616|NCT01545375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111181617|NCT01539837|Deferiprone|deferiprone|mesh-list
111181618|NCT01539837|Iron Chelating Agents|iron chelating agents|mesh-ancestor
111181619|NCT01539837|Chelating Agents|chelating agents|mesh-ancestor
111181620|NCT01539837|Sequestering Agents|sequestering agents|mesh-ancestor
111181621|NCT01539837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111181622|NCT03156790|Asparaginase|asparaginase|mesh-list
111181623|NCT03156790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111181624|NCT04410081|Lazertinib|lazertinib|mesh-list
111181625|NCT04410081|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111181626|NCT04410081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111181627|NCT04410081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111181628|NCT01923844|Pulmonary Surfactants|pulmonary surfactants|mesh-list
111181629|NCT01923844|Beractant|beractant|mesh-list
111181630|NCT01923844|Respiratory System Agents|respiratory system agents|mesh-ancestor
111181631|NCT01924000|Minoxidil|minoxidil|mesh-list
111181632|NCT01924000|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111181633|NCT01924000|Vasodilator Agents|vasodilator agents|mesh-ancestor
111181634|NCT01924078|Capecitabine|capecitabine|mesh-list
111181635|NCT01924078|Aromatase Inhibitors|aromatase inhibitors|mesh-list
111181636|NCT01924078|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111181637|NCT01924078|Antimetabolites|antimetabolites|mesh-ancestor
111181638|NCT01924078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111181639|NCT01924078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111181640|NCT01924078|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111181641|NCT01924078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111181642|NCT01924078|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111181643|NCT01924078|Hormone Antagonists|hormone antagonists|mesh-ancestor
111181644|NCT01924078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111181645|NCT01924078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111181646|NCT00630994|Decitabine|decitabine|mesh-list
111181647|NCT00630994|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111181648|NCT00630994|Antimetabolites|antimetabolites|mesh-ancestor
111181649|NCT00630994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111181650|NCT00630994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111181651|NCT00630994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111181652|NCT01924234|Morphine|morphine|mesh-list
111181653|NCT01924234|Remifentanil|remifentanil|mesh-list
111181654|NCT01924234|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111181655|NCT01924234|Narcotics|narcotics|mesh-ancestor
111181656|NCT01924234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111181657|NCT01924234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111181659|NCT01924234|Sensory System Agents|sensory system agents|mesh-ancestor
111181660|NCT01924234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111181661|NCT00630058|Interferon-alpha|interferon-alpha|mesh-list
111181662|NCT00630058|Interferon alpha-2|interferon alpha-2|mesh-list
111181663|NCT00630058|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
111181664|NCT00630058|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
111181665|NCT00630058|Antiviral Agents|antiviral agents|mesh-ancestor
111181666|NCT00630058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111181667|NCT00630058|Immunologic Factors|immunologic factors|mesh-ancestor
111181668|NCT00630058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111181669|NCT00630058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110898842|NCT02238288|Lidocaine|lidocaine|mesh-list
111181670|NCT01927198|Verinurad|verinurad|mesh-list
111181671|NCT01927198|Gout Suppressants|gout suppressants|mesh-ancestor
111181672|NCT01927198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111181673|NCT01924468|Haloperidol|haloperidol|mesh-list
111181674|NCT01924468|Haloperidol decanoate|haloperidol decanoate|mesh-list
111181675|NCT01924468|Methylphenidate|methylphenidate|mesh-list
111181676|NCT01924468|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111181677|NCT01924468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111181678|NCT01924468|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111181679|NCT01924468|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111181680|NCT01924468|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111181681|NCT01924468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111181682|NCT01924468|Dopamine Agents|dopamine agents|mesh-ancestor
111181683|NCT01924468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111181684|NCT01924468|Antiemetics|antiemetics|mesh-ancestor
111181685|NCT01924468|Autonomic Agents|autonomic agents|mesh-ancestor
111181686|NCT01924468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111181687|NCT01924468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111181688|NCT01924468|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111181689|NCT01924468|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111181690|NCT01924468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111181691|NCT01924468|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111181692|NCT01924468|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111181693|NCT01924468|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111181694|NCT01923064|Ethiodized Oil|ethiodized oil|mesh-list
111181695|NCT01923064|Polidocanol|polidocanol|mesh-list
111181696|NCT01923064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111181697|NCT01923064|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
111181698|NCT01923064|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111181699|NCT01924624|Thalidomide|thalidomide|mesh-list
111181700|NCT01924624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111181701|NCT01924624|Immunologic Factors|immunologic factors|mesh-ancestor
111181702|NCT01924624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111181703|NCT01924624|Leprostatic Agents|leprostatic agents|mesh-ancestor
111181704|NCT01924624|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111181705|NCT01924624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111181706|NCT01924624|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111181707|NCT01924624|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111181708|NCT01924624|Growth Substances|growth substances|mesh-ancestor
111181709|NCT01924624|Growth Inhibitors|growth inhibitors|mesh-ancestor
111181710|NCT01924624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111181711|NCT01929382|Interferons|interferons|mesh-list
111181712|NCT01929382|Interferon-gamma|interferon-gamma|mesh-list
111181713|NCT01929382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111181714|NCT01929382|Antiviral Agents|antiviral agents|mesh-ancestor
111181715|NCT01929382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111181716|NCT00989950|Methylphenidate|methylphenidate|mesh-list
111181717|NCT00989950|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111181718|NCT00989950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111181719|NCT00989950|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111181720|NCT00989950|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111181721|NCT00989950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111181722|NCT00989950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111181723|NCT00989950|Dopamine Agents|dopamine agents|mesh-ancestor
111181724|NCT00989950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111181725|NCT03121456|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
111181726|NCT03121456|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111181727|NCT03121456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111181728|NCT01925092|Mifepristone|mifepristone|mesh-list
111181729|NCT01925092|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
111181730|NCT01925092|Abortifacient Agents|abortifacient agents|mesh-ancestor
111181731|NCT01925092|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111181732|NCT01925092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111181733|NCT01925092|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111181734|NCT01925092|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111181735|NCT01925092|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111181736|NCT01925092|Contraceptive Agents|contraceptive agents|mesh-ancestor
111181737|NCT01925092|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
111181738|NCT01925092|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
111181739|NCT01925092|Hormone Antagonists|hormone antagonists|mesh-ancestor
111181740|NCT01925092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111181741|NCT01925092|Luteolytic Agents|luteolytic agents|mesh-ancestor
111181742|NCT01925092|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111181743|NCT01925092|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
111181744|NCT01905943|Cyclophosphamide|cyclophosphamide|mesh-list
111181745|NCT01905943|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
111181746|NCT01905943|Chlorambucil|chlorambucil|mesh-list
111181747|NCT01905943|Fludarabine|fludarabine|mesh-list
111181748|NCT01905943|Obinutuzumab|obinutuzumab|mesh-list
111181749|NCT01905943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111181750|NCT01905943|Immunologic Factors|immunologic factors|mesh-ancestor
111181751|NCT01905943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111181752|NCT01905943|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111181753|NCT01905943|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111181754|NCT01905943|Alkylating Agents|alkylating agents|mesh-ancestor
111181755|NCT01905943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111181756|NCT01905943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111181757|NCT01905943|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111181758|NCT01905943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111181759|NCT01929031|Ibuprofen|ibuprofen|mesh-list
111181760|NCT01929031|Caffeine|caffeine|mesh-list
111181761|NCT01929031|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111181762|NCT01929031|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111181763|NCT01929031|Analgesics|analgesics|mesh-ancestor
111181764|NCT01929031|Sensory System Agents|sensory system agents|mesh-ancestor
111181765|NCT01929031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111181766|NCT01929031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111181767|NCT01929031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111181768|NCT01929031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111181769|NCT01929031|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111181770|NCT01929031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111181771|NCT01929031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111181772|NCT01929031|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111181773|NCT01929031|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111181774|NCT01929031|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
111181775|NCT01929031|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111181776|NCT01929031|Purinergic Agents|purinergic agents|mesh-ancestor
111181777|NCT01929031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111181778|NCT00989092|Darbepoetin alfa|darbepoetin alfa|mesh-list
111181779|NCT00989092|Hematinics|hematinics|mesh-ancestor
111181780|NCT00988858|Pemetrexed|pemetrexed|mesh-list
111181781|NCT00988858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111181782|NCT00988858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111181783|NCT00988858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111181784|NCT00988858|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111181785|NCT00988858|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111181786|NCT01920334|Zolpidem|zolpidem|mesh-list
111181787|NCT01920334|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111181788|NCT01920334|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111181789|NCT01920334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111181790|NCT01920334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111181791|NCT01920334|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
111181793|NCT01920334|GABA Agents|gaba agents|mesh-ancestor
111181794|NCT01920334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111181795|NCT01920334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111181796|NCT03096418|Paclitaxel|paclitaxel|mesh-list
111181797|NCT03096418|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111181798|NCT03096418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111181799|NCT03096418|Tubulin Modulators|tubulin modulators|mesh-ancestor
111181800|NCT03096418|Antimitotic Agents|antimitotic agents|mesh-ancestor
111181801|NCT03096418|Mitosis Modulators|mitosis modulators|mesh-ancestor
111181802|NCT03096418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111181803|NCT00986986|Niacin|niacin|mesh-list
111181804|NCT00986986|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111181805|NCT00986986|Antimetabolites|antimetabolites|mesh-ancestor
111181806|NCT00986986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111181807|NCT00986986|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111181808|NCT00986986|Vasodilator Agents|vasodilator agents|mesh-ancestor
111181809|NCT00986986|Vitamin B Complex|vitamin b complex|mesh-ancestor
111181810|NCT00986986|Vitamins|vitamins|mesh-ancestor
111181811|NCT00986986|Micronutrients|micronutrients|mesh-ancestor
111181812|NCT00986986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111181813|NCT01928719|Nicotine|nicotine|mesh-list
111181814|NCT01928719|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111181815|NCT01928719|Autonomic Agents|autonomic agents|mesh-ancestor
110898990|NCT03577860|Sensory System Agents|sensory system agents|mesh-ancestor
111181816|NCT01928719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111181817|NCT01928719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111181818|NCT01928719|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111181819|NCT01928719|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111181820|NCT01928719|Cholinergic Agents|cholinergic agents|mesh-ancestor
111181821|NCT01928719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111181822|NCT01928719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111181823|NCT00986674|Paclitaxel|paclitaxel|mesh-list
111181824|NCT00986674|Carboplatin|carboplatin|mesh-list
111181825|NCT00986674|Cetuximab|cetuximab|mesh-list
111181826|NCT00986674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111181827|NCT00986674|Antibodies|antibodies|mesh-list
111181828|NCT00986674|Immunoglobulins|immunoglobulins|mesh-list
111181829|NCT00986674|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111181830|NCT00986674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111181831|NCT00986674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111181832|NCT00986674|Tubulin Modulators|tubulin modulators|mesh-ancestor
111181833|NCT00986674|Antimitotic Agents|antimitotic agents|mesh-ancestor
111181834|NCT00986674|Mitosis Modulators|mitosis modulators|mesh-ancestor
111181835|NCT00986674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111181836|NCT00986674|Immunologic Factors|immunologic factors|mesh-ancestor
111181837|NCT00986674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111181838|NCT00986440|Efatutazone|efatutazone|mesh-list
111181839|NCT00986440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111181840|NCT01904149|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
111181841|NCT01904149|Tramadol|tramadol|mesh-list
111181842|NCT01904149|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111181843|NCT01904149|Narcotics|narcotics|mesh-ancestor
111181844|NCT01904149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111181845|NCT01904149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111181846|NCT01904149|Analgesics|analgesics|mesh-ancestor
111181847|NCT01904149|Sensory System Agents|sensory system agents|mesh-ancestor
111181848|NCT01904149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111181849|NCT01904149|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111181850|NCT01904149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111181851|NCT01904149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111181852|NCT01904149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111181853|NCT01925638|Ketoconazole|ketoconazole|mesh-list
111181854|NCT01925638|Antifungal Agents|antifungal agents|mesh-ancestor
111181855|NCT01925638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111181856|NCT01925638|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111181857|NCT01925638|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111181858|NCT01925638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110844054|NCT01266707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
111181859|NCT01925638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111181860|NCT01925638|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111181861|NCT01925638|Hormone Antagonists|hormone antagonists|mesh-ancestor
111181862|NCT01925638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111181863|NCT01925638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111181864|NCT01925638|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111181866|NCT00985738|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
111181867|NCT00985738|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111181868|NCT00985738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111181869|NCT00985738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111181870|NCT00985738|Hormone Antagonists|hormone antagonists|mesh-ancestor
111181871|NCT00985738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111181872|NCT00985738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111181873|NCT00985504|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
111181874|NCT00985504|Escitalopram|escitalopram|mesh-list
111181875|NCT00985504|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111181876|NCT00985504|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111181877|NCT00985504|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111181878|NCT00985504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111181879|NCT00985504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111181880|NCT00985504|Serotonin Agents|serotonin agents|mesh-ancestor
111181881|NCT00985504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111181882|NCT00985504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111181883|NCT00985504|Antidepressive Agents|antidepressive agents|mesh-ancestor
111181884|NCT00985504|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111181885|NCT00985504|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111181886|NCT00985504|Analgesics|analgesics|mesh-ancestor
111181887|NCT00985504|Sensory System Agents|sensory system agents|mesh-ancestor
111181888|NCT00985504|Dopamine Agents|dopamine agents|mesh-ancestor
111181889|NCT01921192|Folic Acid|folic acid|mesh-list
111181890|NCT01921192|Hematinics|hematinics|mesh-ancestor
110844062|NCT03263442|Thiamine|thiamine|mesh-list
111181891|NCT01921192|Vitamin B Complex|vitamin b complex|mesh-ancestor
111181893|NCT01921192|Micronutrients|micronutrients|mesh-ancestor
111181894|NCT01921192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111181895|NCT04275388|Interferons|interferons|mesh-list
111181896|NCT04275388|Ritonavir|ritonavir|mesh-list
111181897|NCT04275388|Lopinavir|lopinavir|mesh-list
111181898|NCT04275388|Interferon-alpha|interferon-alpha|mesh-list
111181899|NCT04275388|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
111181900|NCT04275388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111181901|NCT04275388|Antiviral Agents|antiviral agents|mesh-ancestor
110489141|NCT04019782|Hylan|hylan|mesh-list
111181902|NCT04275388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111181903|NCT04275388|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111181904|NCT04275388|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111181905|NCT04275388|Protease Inhibitors|protease inhibitors|mesh-ancestor
111181906|NCT04275388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111181907|NCT04275388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111181908|NCT04275388|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111181909|NCT04275388|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111181910|NCT04275388|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111181911|NCT04275388|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111181912|NCT04275388|Immunologic Factors|immunologic factors|mesh-ancestor
111181913|NCT04275388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111181914|NCT01921426|Avasopasem manganese|avasopasem manganese|mesh-list
111181915|NCT01921426|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111181916|NCT01921426|Antioxidants|antioxidants|mesh-ancestor
111181917|NCT01921426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111181918|NCT01921426|Protective Agents|protective agents|mesh-ancestor
111181919|NCT01921426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111181920|NCT01921582|Methylphenidate|methylphenidate|mesh-list
111181921|NCT01921582|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111181922|NCT01921582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111181923|NCT01921582|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111181924|NCT01921582|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111181925|NCT01921582|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111181926|NCT01921582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111181927|NCT01921582|Dopamine Agents|dopamine agents|mesh-ancestor
111181928|NCT01921582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111181929|NCT00985426|Vaccines|vaccines|mesh-list
111181930|NCT00985426|Immunologic Factors|immunologic factors|mesh-ancestor
111181931|NCT00985426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111181932|NCT00985192|Everolimus|everolimus|mesh-list
111181933|NCT00985192|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111181934|NCT00985192|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111181935|NCT00985192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111181936|NCT00985192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111181937|NCT00985192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111181938|NCT00985192|Immunologic Factors|immunologic factors|mesh-ancestor
111181939|NCT00985192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111181940|NCT00985192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111181941|NCT03390010|Misoprostol|misoprostol|mesh-list
111181942|NCT03390010|Carboprost|carboprost|mesh-list
111181943|NCT03390010|Oxytocin|oxytocin|mesh-list
111181944|NCT03390010|Carboprost tromethamine|carboprost tromethamine|mesh-list
111181945|NCT03390010|Methylergonovine|methylergonovine|mesh-list
111181946|NCT03390010|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111181947|NCT03390010|Abortifacient Agents|abortifacient agents|mesh-ancestor
111181948|NCT03390010|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111181949|NCT03390010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111181950|NCT03390010|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111181951|NCT03390010|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111181952|NCT03390010|Oxytocics|oxytocics|mesh-ancestor
111181953|NCT00984568|Aminosalicylic Acid|aminosalicylic acid|mesh-list
111181954|NCT00984568|Prednisolone|prednisolone|mesh-list
111181955|NCT00984568|Infliximab|infliximab|mesh-list
111181956|NCT00984568|Mesalamine|mesalamine|mesh-list
111181957|NCT00984568|Azathioprine|azathioprine|mesh-list
111181958|NCT00984568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111181959|NCT00984568|Glucocorticoids|glucocorticoids|mesh-ancestor
111181960|NCT00984568|Hormones|hormones|mesh-ancestor
111181961|NCT00984568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111181962|NCT00984568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111181963|NCT00984568|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111181964|NCT00984568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111181965|NCT00984568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111181966|NCT00984568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111181967|NCT00984568|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111181968|NCT00984568|Dermatologic Agents|dermatologic agents|mesh-ancestor
111181969|NCT00984568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111181970|NCT00984568|Antimetabolites|antimetabolites|mesh-ancestor
111181971|NCT00984568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111181972|NCT00984568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111181973|NCT00984568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111181974|NCT00984568|Immunologic Factors|immunologic factors|mesh-ancestor
111181975|NCT00984568|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111181976|NCT00984568|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111181978|NCT00984568|Sensory System Agents|sensory system agents|mesh-ancestor
111181979|NCT00984568|Antitubercular Agents|antitubercular agents|mesh-ancestor
111181980|NCT00984568|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111181981|NCT00984568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111181982|NCT02984176|Simethicone|simethicone|mesh-list
111181983|NCT02984176|Antifoaming Agents|antifoaming agents|mesh-ancestor
111181984|NCT02984176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111181985|NCT02984176|Emollients|emollients|mesh-ancestor
111181986|NCT02984176|Dermatologic Agents|dermatologic agents|mesh-ancestor
111181987|NCT01921738|Azithromycin|azithromycin|mesh-list
111181988|NCT01921738|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111181989|NCT01921738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111181990|NCT01921816|Dialysis Solutions|dialysis solutions|mesh-list
111181991|NCT01921816|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111181992|NCT00984256|Atovaquone|atovaquone|mesh-list
111181993|NCT00984256|Proguanil|proguanil|mesh-list
111181994|NCT00984256|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
111181995|NCT00984256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111181996|NCT00984256|Antimalarials|antimalarials|mesh-ancestor
111181997|NCT00984256|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111181998|NCT00984256|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111181999|NCT00984256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111182000|NCT00984256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111182001|NCT00984256|Antimetabolites|antimetabolites|mesh-ancestor
111182002|NCT00984022|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
111182003|NCT00984022|Laxatives|laxatives|mesh-ancestor
111182004|NCT00984022|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111182005|NCT01890265|Pirfenidone|pirfenidone|mesh-list
111182006|NCT01890265|Nintedanib|nintedanib|mesh-list
111182007|NCT01890265|Immunoglobulins|immunoglobulins|mesh-list
111182008|NCT01890265|Antibodies|antibodies|mesh-list
111182009|NCT01890265|Immunoglobulin G|immunoglobulin g|mesh-list
111182010|NCT01890265|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111182011|NCT01890265|Immunologic Factors|immunologic factors|mesh-ancestor
111182012|NCT01890265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111182013|NCT01890265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111182014|NCT01890265|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111182015|NCT01890265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111182016|NCT01890265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111182017|NCT01890265|Analgesics|analgesics|mesh-ancestor
111182018|NCT01890265|Sensory System Agents|sensory system agents|mesh-ancestor
111182019|NCT01890265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111182020|NCT01890265|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111182021|NCT01890265|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111182022|NCT01890265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111182023|NCT01890265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111182024|NCT01926652|Amlodipine|amlodipine|mesh-list
111182025|NCT01926652|Candesartan|candesartan|mesh-list
111182026|NCT01926652|Candesartan cilexetil|candesartan cilexetil|mesh-list
111182027|NCT01926652|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111182028|NCT01926652|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111182029|NCT01926652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111182030|NCT01926652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111182031|NCT01926652|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111182032|NCT01926652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111182033|NCT01926652|Vasodilator Agents|vasodilator agents|mesh-ancestor
111182034|NCT01926652|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111182035|NCT01926652|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111182036|NCT01928329|Exenatide|exenatide|mesh-list
111182037|NCT01928329|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111182038|NCT01928329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111182039|NCT01928329|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111182040|NCT01928329|Incretins|incretins|mesh-ancestor
110899213|NCT01364987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111182041|NCT01928329|Hormones|hormones|mesh-ancestor
111182042|NCT01928329|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111182043|NCT01890109|Erenumab|erenumab|mesh-list
111182044|NCT01890109|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
111182045|NCT01890109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111182046|NCT01890109|Analgesics|analgesics|mesh-ancestor
111182047|NCT01890109|Sensory System Agents|sensory system agents|mesh-ancestor
111182048|NCT01890109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111182049|NCT01890109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111182050|NCT03069976|Metronidazole|metronidazole|mesh-list
111182051|NCT03069976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111182052|NCT03069976|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111182053|NCT03069976|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111182054|NCT03069976|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111182055|NCT00982930|Tobramycin|tobramycin|mesh-list
111182056|NCT00982930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111182057|NCT00982930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111182058|NCT03088540|Paclitaxel|paclitaxel|mesh-list
111182059|NCT03088540|Carboplatin|carboplatin|mesh-list
111182060|NCT03088540|Gemcitabine|gemcitabine|mesh-list
111182061|NCT03088540|Pemetrexed|pemetrexed|mesh-list
111182062|NCT03088540|Cemiplimab|cemiplimab|mesh-list
111182063|NCT03088540|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111182064|NCT03088540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111182065|NCT03088540|Tubulin Modulators|tubulin modulators|mesh-ancestor
111182066|NCT03088540|Antimitotic Agents|antimitotic agents|mesh-ancestor
111182067|NCT03088540|Mitosis Modulators|mitosis modulators|mesh-ancestor
110844115|NCT02527109|Vasodilator Agents|vasodilator agents|mesh-ancestor
111182068|NCT03088540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111182069|NCT03088540|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111182070|NCT03088540|Antimetabolites|antimetabolites|mesh-ancestor
111182071|NCT03088540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111182072|NCT03088540|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111182073|NCT03088540|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111182074|NCT03088540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111182075|NCT01903993|Docetaxel|docetaxel|mesh-list
111182076|NCT01903993|Atezolizumab|atezolizumab|mesh-list
111182077|NCT01903993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111182078|NCT01903993|Tubulin Modulators|tubulin modulators|mesh-ancestor
111182079|NCT01903993|Antimitotic Agents|antimitotic agents|mesh-ancestor
111182080|NCT01903993|Mitosis Modulators|mitosis modulators|mesh-ancestor
111182081|NCT01903993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111182082|NCT01903993|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111182083|NCT01903993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111182084|NCT00980044|Tramadol|tramadol|mesh-list
111182085|NCT00980044|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111182086|NCT00980044|Narcotics|narcotics|mesh-ancestor
111182087|NCT00980044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111182088|NCT00980044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111182089|NCT00980044|Analgesics|analgesics|mesh-ancestor
111182090|NCT00980044|Sensory System Agents|sensory system agents|mesh-ancestor
111182091|NCT00980044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111182092|NCT03049306|Propranolol|propranolol|mesh-list
111182093|NCT03049306|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111182094|NCT03049306|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111182095|NCT03049306|Adrenergic Agents|adrenergic agents|mesh-ancestor
111182096|NCT03049306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111182097|NCT03049306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111182098|NCT03049306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111182099|NCT03049306|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111182100|NCT03049306|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111182101|NCT03049306|Vasodilator Agents|vasodilator agents|mesh-ancestor
111182102|NCT01927588|Prednisone|prednisone|mesh-list
111182103|NCT01927588|Everolimus|everolimus|mesh-list
111182104|NCT01927588|Tacrolimus|tacrolimus|mesh-list
111182105|NCT01927588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111182106|NCT01927588|Glucocorticoids|glucocorticoids|mesh-ancestor
111182107|NCT01927588|Hormones|hormones|mesh-ancestor
111182108|NCT01927588|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111182109|NCT01927588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111182110|NCT01927588|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111182111|NCT01927588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111182112|NCT01927588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111182113|NCT01927588|Immunologic Factors|immunologic factors|mesh-ancestor
111182114|NCT01927588|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111182115|NCT01927588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111182116|NCT01927588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111182117|NCT01927588|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111182118|NCT01927588|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111182119|NCT05601466|Cytarabine|cytarabine|mesh-list
111182120|NCT05601466|Cyclophosphamide|cyclophosphamide|mesh-list
111182121|NCT05601466|Fludarabine|fludarabine|mesh-list
111182122|NCT05601466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111182123|NCT05601466|Immunologic Factors|immunologic factors|mesh-ancestor
111182124|NCT05601466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111182125|NCT05601466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111182126|NCT05601466|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111182127|NCT05601466|Alkylating Agents|alkylating agents|mesh-ancestor
111182128|NCT05601466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111182129|NCT05601466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111182130|NCT05601466|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110844154|NCT02472964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111182131|NCT05601466|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111182132|NCT05601466|Antimetabolites|antimetabolites|mesh-ancestor
111182133|NCT05601466|Antiviral Agents|antiviral agents|mesh-ancestor
111182134|NCT05601466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111182136|NCT01903837|Olanzapine|olanzapine|mesh-list
111182137|NCT01903837|ALKS-33|alks-33|mesh-list
111182138|NCT01903837|Antiemetics|antiemetics|mesh-ancestor
111182139|NCT01903837|Autonomic Agents|autonomic agents|mesh-ancestor
111182140|NCT01903837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111182141|NCT01903837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111182142|NCT01903837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111182143|NCT01903837|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111182144|NCT01903837|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111182145|NCT01903837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111182146|NCT01903837|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111182147|NCT01903837|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111182148|NCT01903837|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111182149|NCT01903837|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111182150|NCT01903837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111182151|NCT01903837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111182152|NCT01903837|Serotonin Agents|serotonin agents|mesh-ancestor
111182153|NCT01903837|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111182154|NCT01903837|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111182155|NCT01903837|Sensory System Agents|sensory system agents|mesh-ancestor
111182156|NCT00982696|Analgesics, Opioid|analgesics, opioid|mesh-list
111182157|NCT00982696|Mitogens|mitogens|mesh-list
111182158|NCT00982696|Enkephalins|enkephalins|mesh-list
111182159|NCT00982696|Opioid Peptides|opioid peptides|mesh-list
111182160|NCT00982696|Narcotics|narcotics|mesh-ancestor
111182161|NCT00982696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111182162|NCT00982696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111182163|NCT00982696|Analgesics|analgesics|mesh-ancestor
111182164|NCT00982696|Sensory System Agents|sensory system agents|mesh-ancestor
111182165|NCT00982696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111182166|NCT00982696|Mitosis Modulators|mitosis modulators|mesh-ancestor
111182167|NCT00982696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111182168|NCT00982696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111182169|NCT00981526|Telmisartan|telmisartan|mesh-list
111182170|NCT00981526|Olanzapine|olanzapine|mesh-list
111182171|NCT00981526|Clozapine|clozapine|mesh-list
111182172|NCT00981526|Antiemetics|antiemetics|mesh-ancestor
111182173|NCT00981526|Autonomic Agents|autonomic agents|mesh-ancestor
111182174|NCT00981526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111182175|NCT00981526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111182176|NCT00981526|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111182177|NCT00981526|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111182178|NCT00981526|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111182179|NCT00981526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111182180|NCT00981526|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111182181|NCT00981526|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111182182|NCT00981526|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111182183|NCT00981526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111182184|NCT00981526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111182185|NCT00981526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111182186|NCT00981526|Serotonin Agents|serotonin agents|mesh-ancestor
111182187|NCT00981526|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111182188|NCT00981526|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111182189|NCT00981526|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111182190|NCT00981526|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111182191|NCT00981526|GABA Antagonists|gaba antagonists|mesh-ancestor
111182192|NCT00981526|GABA Agents|gaba agents|mesh-ancestor
111182194|NCT04274920|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111182195|NCT04274920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111182196|NCT04274608|Botulinum Toxins|botulinum toxins|mesh-list
111182197|NCT04274608|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111182198|NCT04274608|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111182199|NCT04274608|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111182200|NCT04274608|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111182201|NCT04274608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111182202|NCT04274608|Cholinergic Agents|cholinergic agents|mesh-ancestor
111182203|NCT04274608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111182204|NCT04274608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111182205|NCT04274608|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111182206|NCT04274608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111182207|NCT05607940|Chrysarobin|chrysarobin|mesh-list
111182208|NCT05607940|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111182209|NCT05607940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111182210|NCT05607940|Analgesics|analgesics|mesh-ancestor
111182211|NCT05607940|Sensory System Agents|sensory system agents|mesh-ancestor
111182212|NCT05607940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111182213|NCT05607940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111182214|NCT05607940|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111182215|NCT05607940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111182216|NCT04394728|Trabectedin|trabectedin|mesh-list
111182217|NCT04394728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111182218|NCT04394728|Alkylating Agents|alkylating agents|mesh-ancestor
111182219|NCT04394728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111182220|NCT04394728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111182221|NCT05600608|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
111182222|NCT05600608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111182223|NCT01616173|Dexamethasone|dexamethasone|mesh-list
111182224|NCT01616173|Dexamethasone acetate|dexamethasone acetate|mesh-list
111182225|NCT01616173|BB 1101|bb 1101|mesh-list
111182226|NCT01616173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111182227|NCT01616173|Antiemetics|antiemetics|mesh-ancestor
111182228|NCT01616173|Autonomic Agents|autonomic agents|mesh-ancestor
111182229|NCT01616173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111182230|NCT01616173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111182231|NCT01616173|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111182232|NCT01616173|Glucocorticoids|glucocorticoids|mesh-ancestor
111182233|NCT01616173|Hormones|hormones|mesh-ancestor
111182234|NCT01616173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111182235|NCT01616173|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111182236|NCT01616173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111182237|NCT01616173|Protease Inhibitors|protease inhibitors|mesh-ancestor
111182238|NCT01616173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110489178|NCT00959894|Tenofovir|tenofovir|mesh-list
111182239|NCT01616173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111182240|NCT05609500|Warfarin|warfarin|mesh-list
111182241|NCT05609500|Anticoagulants|anticoagulants|mesh-ancestor
111182242|NCT03044314|Nitric Oxide|nitric oxide|mesh-list
111182243|NCT03044314|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111182244|NCT03044314|Autonomic Agents|autonomic agents|mesh-ancestor
111182245|NCT03044314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111182246|NCT03044314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111182247|NCT03044314|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111182248|NCT03044314|Respiratory System Agents|respiratory system agents|mesh-ancestor
111182249|NCT03044314|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111182250|NCT03044314|Antioxidants|antioxidants|mesh-ancestor
111182251|NCT03044314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111182252|NCT03044314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111182253|NCT03044314|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
111182254|NCT03044314|Vasodilator Agents|vasodilator agents|mesh-ancestor
111182255|NCT03044314|Gasotransmitters|gasotransmitters|mesh-ancestor
111182256|NCT03044314|Protective Agents|protective agents|mesh-ancestor
111182257|NCT05608642|Prednisolone|prednisolone|mesh-list
111182258|NCT05608642|Lidocaine|lidocaine|mesh-list
111182259|NCT05608642|Anesthetics, Local|anesthetics, local|mesh-ancestor
111182260|NCT05608642|Anesthetics|anesthetics|mesh-ancestor
111182261|NCT05608642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111182262|NCT05608642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111182263|NCT05608642|Sensory System Agents|sensory system agents|mesh-ancestor
111182264|NCT05608642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111182265|NCT05608642|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110899453|NCT02253602|Hematinics|hematinics|mesh-ancestor
111182266|NCT05608642|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111182267|NCT05608642|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111182268|NCT05608642|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111182269|NCT05608642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111182270|NCT05608642|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111182271|NCT05608642|Glucocorticoids|glucocorticoids|mesh-ancestor
111182272|NCT05608642|Hormones|hormones|mesh-ancestor
111182273|NCT05608642|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111182274|NCT05608642|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111182275|NCT05608642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111182276|NCT05608564|Amoxicillin|amoxicillin|mesh-list
111182277|NCT05608564|Metronidazole|metronidazole|mesh-list
111182278|NCT05608564|Tazobactam|tazobactam|mesh-list
111182279|NCT05608564|Piperacillin|piperacillin|mesh-list
111182280|NCT05608564|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111182281|NCT05608564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111182282|NCT05608564|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111182283|NCT05608564|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111182284|NCT05608564|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
111182285|NCT05608564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111182286|NCT05608564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111182287|NCT03036904|Prednisone|prednisone|mesh-list
111182288|NCT03036904|Cyclophosphamide|cyclophosphamide|mesh-list
111182289|NCT03036904|Rituximab|rituximab|mesh-list
111182290|NCT03036904|Doxorubicin|doxorubicin|mesh-list
111182291|NCT03036904|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111182292|NCT03036904|Etoposide|etoposide|mesh-list
111182293|NCT03036904|Vincristine|vincristine|mesh-list
111182294|NCT03036904|Venetoclax|venetoclax|mesh-list
111182295|NCT03036904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111182296|NCT03036904|Immunologic Factors|immunologic factors|mesh-ancestor
111182297|NCT03036904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111182298|NCT03036904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111182299|NCT03036904|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111182300|NCT03036904|Alkylating Agents|alkylating agents|mesh-ancestor
111182301|NCT03036904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111182302|NCT03036904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111182303|NCT03036904|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111182304|NCT03036904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111182305|NCT03036904|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111182306|NCT03036904|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111182307|NCT03036904|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111182308|NCT03036904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111182309|NCT03036904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111182310|NCT03036904|Glucocorticoids|glucocorticoids|mesh-ancestor
111182311|NCT03036904|Hormones|hormones|mesh-ancestor
110844202|NCT01164761|Protease Inhibitors|protease inhibitors|mesh-ancestor
111182312|NCT03036904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111182313|NCT03036904|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111182314|NCT03036904|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111182315|NCT03036904|Tubulin Modulators|tubulin modulators|mesh-ancestor
111182316|NCT03036904|Antimitotic Agents|antimitotic agents|mesh-ancestor
111182317|NCT03036904|Mitosis Modulators|mitosis modulators|mesh-ancestor
111182318|NCT05604898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111182319|NCT05604898|Antibodies|antibodies|mesh-list
111182320|NCT05604898|Immunoglobulins|immunoglobulins|mesh-list
111182321|NCT05604898|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111182322|NCT05604898|Immunologic Factors|immunologic factors|mesh-ancestor
111182323|NCT05604898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111182324|NCT05604898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111182325|NCT04392700|Tenofovir|tenofovir|mesh-list
111182326|NCT04392700|Entecavir|entecavir|mesh-list
111182327|NCT04392700|Antiviral Agents|antiviral agents|mesh-ancestor
111182328|NCT04392700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111182329|NCT04392700|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111182330|NCT04392700|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111182331|NCT04392700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111182332|NCT04392700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111182333|NCT04392700|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111182334|NCT04392700|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111182335|NCT03828058|Tacrolimus|tacrolimus|mesh-list
111182336|NCT03828058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111182337|NCT03828058|Immunologic Factors|immunologic factors|mesh-ancestor
111182338|NCT03828058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111182339|NCT03828058|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111182340|NCT03828058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111182341|NCT03828058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111182342|NCT01513551|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
111182343|NCT01513551|Immunologic Factors|immunologic factors|mesh-ancestor
111182344|NCT01513551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111182345|NCT03827122|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111182346|NCT03827122|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111182347|NCT03827122|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111182348|NCT03827122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111182349|NCT03827122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111182350|NCT03827122|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111182351|NCT03827122|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111182352|NCT03827122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111182353|NCT03827122|Cholinergic Agents|cholinergic agents|mesh-ancestor
111182354|NCT03827122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111182355|NCT03827200|Ambrisentan|ambrisentan|mesh-list
111182356|NCT03827200|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111182357|NCT02983630|Penicillins|penicillins|mesh-list
111182358|NCT02983630|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111182359|NCT02983630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111182360|NCT03827278|Itraconazole|itraconazole|mesh-list
111182361|NCT03827278|Voriconazole|voriconazole|mesh-list
111182362|NCT03827278|Amphotericin B|amphotericin b|mesh-list
111182363|NCT03827278|Antifungal Agents|antifungal agents|mesh-ancestor
111182364|NCT03827278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110489195|NCT02599168|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111182365|NCT03827278|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111182366|NCT03827278|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111182367|NCT03827278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111182368|NCT03827278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111182369|NCT03827278|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111182370|NCT03827278|Hormone Antagonists|hormone antagonists|mesh-ancestor
111182371|NCT03827278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111182372|NCT03827278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111182373|NCT03827278|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111182374|NCT03827278|Amebicides|amebicides|mesh-ancestor
111182375|NCT03827278|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111182376|NCT03827278|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111182377|NCT03827278|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111182378|NCT01513473|Insulin|insulin|mesh-list
111182379|NCT01513473|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111182380|NCT01513473|Insulin Aspart|insulin aspart|mesh-list
111182381|NCT01513473|Insulin Detemir|insulin detemir|mesh-list
111182382|NCT01513473|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111182383|NCT01513473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111182384|NCT03109990|Dexmedetomidine|dexmedetomidine|mesh-list
111182385|NCT03109990|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111182386|NCT03109990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111182387|NCT03109990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111182388|NCT03109990|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111182389|NCT03109990|Analgesics|analgesics|mesh-ancestor
111182390|NCT03109990|Sensory System Agents|sensory system agents|mesh-ancestor
111182391|NCT03109990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111182392|NCT03109990|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111182393|NCT03109990|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111182394|NCT03109990|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111182395|NCT03109990|Adrenergic Agents|adrenergic agents|mesh-ancestor
111182396|NCT03109990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111182397|NCT03109990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111182398|NCT03071536|Furosemide|furosemide|mesh-list
111182399|NCT03071536|Diuretics|diuretics|mesh-ancestor
111182400|NCT03071536|Natriuretic Agents|natriuretic agents|mesh-ancestor
111182401|NCT03071536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111182402|NCT03071536|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
111182403|NCT03071536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111182404|NCT03071536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111182405|NCT01513317|Siltuximab|siltuximab|mesh-list
111182406|NCT01513317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111182407|NCT03825250|Valproic Acid|valproic acid|mesh-list
111182408|NCT03825250|Anticonvulsants|anticonvulsants|mesh-ancestor
111182409|NCT03825250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111182410|NCT03825250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111182411|NCT03825250|GABA Agents|gaba agents|mesh-ancestor
111182412|NCT03825250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111182413|NCT03825250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111182414|NCT03825250|Antimanic Agents|antimanic agents|mesh-ancestor
111182415|NCT03825250|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111182416|NCT03825250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111182417|NCT03825250|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111182418|NCT03825328|Paclitaxel|paclitaxel|mesh-list
111182419|NCT03825328|Gemcitabine|gemcitabine|mesh-list
111182420|NCT03825328|Oxaliplatin|oxaliplatin|mesh-list
111182421|NCT03825328|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111182422|NCT03825328|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111182423|NCT03825328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111182424|NCT03825328|Tubulin Modulators|tubulin modulators|mesh-ancestor
111182425|NCT03825328|Antimitotic Agents|antimitotic agents|mesh-ancestor
111182426|NCT03825328|Mitosis Modulators|mitosis modulators|mesh-ancestor
111182427|NCT03825328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111182428|NCT03825328|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111182429|NCT03825328|Antimetabolites|antimetabolites|mesh-ancestor
111182430|NCT03825016|Diclofenac|diclofenac|mesh-list
111182431|NCT03825016|Lidocaine|lidocaine|mesh-list
111182432|NCT03825016|Anesthetics, Local|anesthetics, local|mesh-ancestor
111182433|NCT03825016|Anesthetics|anesthetics|mesh-ancestor
111182434|NCT03825016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111182435|NCT03825016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111182436|NCT03825016|Sensory System Agents|sensory system agents|mesh-ancestor
111182437|NCT03825016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111182438|NCT03825016|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111182439|NCT03825016|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111182440|NCT03825016|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111182441|NCT03825016|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111182442|NCT03825016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111182443|NCT03825016|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111182444|NCT03825016|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111182445|NCT03825016|Analgesics|analgesics|mesh-ancestor
111182446|NCT03825016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111182447|NCT03825016|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111182448|NCT03825016|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111182449|NCT03825016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111182450|NCT03043924|Cyproterone Acetate|cyproterone acetate|mesh-list
111182451|NCT03043924|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
111182452|NCT03043924|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
111182453|NCT03043924|Levonorgestrel|levonorgestrel|mesh-list
111182454|NCT03043924|Ethinyl Estradiol|ethinyl estradiol|mesh-list
111182456|NCT03043924|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
111182457|NCT03043924|Cyproterone|cyproterone|mesh-list
111182458|NCT03043924|Estrogens|estrogens|mesh-ancestor
111182459|NCT03043924|Hormones|hormones|mesh-ancestor
111182460|NCT03043924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111182461|NCT03043924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111182462|NCT03043924|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111182463|NCT03043924|Contraceptive Agents|contraceptive agents|mesh-ancestor
111182464|NCT03043924|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111182465|NCT03043924|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111182466|NCT03043924|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111182467|NCT03043924|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111182468|NCT03043924|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111182469|NCT03043924|Androgen Antagonists|androgen antagonists|mesh-ancestor
111182470|NCT03043924|Hormone Antagonists|hormone antagonists|mesh-ancestor
111182471|NCT03043924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111182472|NCT03043924|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
111182473|NCT03824314|Fentanyl|fentanyl|mesh-list
111182474|NCT03824314|Midazolam|midazolam|mesh-list
111182475|NCT03824314|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111182476|NCT03824314|Narcotics|narcotics|mesh-ancestor
111182477|NCT03824314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111182478|NCT03824314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111182479|NCT03824314|Analgesics|analgesics|mesh-ancestor
111182480|NCT03824314|Sensory System Agents|sensory system agents|mesh-ancestor
111182481|NCT03824314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111182482|NCT03824314|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111182483|NCT03824314|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111182484|NCT03824314|Anesthetics, General|anesthetics, general|mesh-ancestor
111182485|NCT03824314|Anesthetics|anesthetics|mesh-ancestor
111182486|NCT03824314|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111182487|NCT03824314|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111182488|NCT03824314|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111182489|NCT03824314|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111182490|NCT03824314|GABA Modulators|gaba modulators|mesh-ancestor
111182491|NCT03824314|GABA Agents|gaba agents|mesh-ancestor
111182492|NCT03824314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111182493|NCT03824314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111182495|NCT03824002|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111182496|NCT03824002|Metformin|metformin|mesh-list
111182497|NCT03824002|Insulin Glargine|insulin glargine|mesh-list
111182498|NCT03824002|Insulin Aspart|insulin aspart|mesh-list
111182499|NCT03824002|Dulaglutide|dulaglutide|mesh-list
111182500|NCT03824002|Repaglinide|repaglinide|mesh-list
111182501|NCT03824002|Insulin, Long-Acting|insulin, long-acting|mesh-list
111182502|NCT03824002|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
111182503|NCT03824002|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111182504|NCT03824002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111182505|NCT03823846|Flurbiprofen|flurbiprofen|mesh-list
111182506|NCT03823846|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
111182507|NCT03823846|Parecoxib|parecoxib|mesh-list
111182508|NCT03823846|Dezocine|dezocine|mesh-list
111182509|NCT03823846|Analgesics|analgesics|mesh-ancestor
111182510|NCT03823846|Sensory System Agents|sensory system agents|mesh-ancestor
110844217|NCT03385096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111182511|NCT03823846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111182512|NCT03823846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111182513|NCT03823846|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111182514|NCT03823846|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111182515|NCT03823846|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111182516|NCT03823846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111182517|NCT03823846|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111182518|NCT03823846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111182519|NCT03823846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111182520|NCT03823846|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111182521|NCT03823846|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111182523|NCT03823846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111182524|NCT02908750|Fexofenadine|fexofenadine|mesh-list
111182525|NCT02908750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111182526|NCT02908750|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111182527|NCT02908750|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
111182528|NCT02908750|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111182529|NCT02908750|Histamine Antagonists|histamine antagonists|mesh-ancestor
111182530|NCT02908750|Histamine Agents|histamine agents|mesh-ancestor
111182531|NCT02908750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111182532|NCT02908750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111182533|NCT03823612|Calcium|calcium|mesh-list
111182534|NCT03823612|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111182535|NCT03823612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111182536|NCT02810704|Aspirin|aspirin|mesh-list
111182537|NCT02810704|Warfarin|warfarin|mesh-list
111182538|NCT02810704|Rivaroxaban|rivaroxaban|mesh-list
111182539|NCT02810704|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111182540|NCT02810704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111182541|NCT02810704|Analgesics|analgesics|mesh-ancestor
111182542|NCT02810704|Sensory System Agents|sensory system agents|mesh-ancestor
111182543|NCT02810704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111182544|NCT02810704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110489248|NCT02598310|Trastuzumab|trastuzumab|mesh-list
111182545|NCT02810704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111182546|NCT02810704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111182547|NCT02810704|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111182548|NCT02810704|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111182549|NCT02810704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111182550|NCT02810704|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111182551|NCT02810704|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111182552|NCT02810704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111182553|NCT02810704|Antipyretics|antipyretics|mesh-ancestor
111182554|NCT02810704|Anticoagulants|anticoagulants|mesh-ancestor
111182555|NCT02810704|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111182556|NCT02810704|Antithrombins|antithrombins|mesh-ancestor
111182557|NCT02810704|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111182558|NCT02810704|Protease Inhibitors|protease inhibitors|mesh-ancestor
111182559|NCT02926222|Lomustine|lomustine|mesh-list
111182560|NCT02926222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111182561|NCT02926222|Alkylating Agents|alkylating agents|mesh-ancestor
111182562|NCT02926222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111182563|NCT02926222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111182564|NCT04273282|Moxifloxacin|moxifloxacin|mesh-list
111182565|NCT04273282|Dexamethasone|dexamethasone|mesh-list
111182566|NCT04273282|Prednisolone|prednisolone|mesh-list
111182567|NCT04273282|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111182568|NCT04273282|Methylprednisolone|methylprednisolone|mesh-list
111182569|NCT04273282|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111182570|NCT04273282|Prednisolone acetate|prednisolone acetate|mesh-list
111182571|NCT04273282|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111182572|NCT04273282|Prednisolone phosphate|prednisolone phosphate|mesh-list
111182573|NCT04273282|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111182574|NCT04273282|Antiemetics|antiemetics|mesh-ancestor
111182575|NCT04273282|Autonomic Agents|autonomic agents|mesh-ancestor
111182576|NCT04273282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111182577|NCT04273282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111182578|NCT04273282|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111182579|NCT04273282|Glucocorticoids|glucocorticoids|mesh-ancestor
111182580|NCT04273282|Hormones|hormones|mesh-ancestor
111182581|NCT04273282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111182582|NCT04273282|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111182583|NCT04273282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111182584|NCT04273282|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111182585|NCT04273282|Protective Agents|protective agents|mesh-ancestor
111182586|NCT04273282|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111182587|NCT04273282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111182588|NCT04273282|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111182589|NCT04273282|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111182590|NCT04273282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111182591|NCT04273282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111182592|NCT01454440|Eptifibatide|eptifibatide|mesh-list
111182593|NCT01454440|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111182594|NCT01454518|Anesthetics|anesthetics|mesh-list
111182595|NCT01454518|Anesthetics, Local|anesthetics, local|mesh-list
111182596|NCT01454518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111182597|NCT01454518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111182598|NCT01454518|Sensory System Agents|sensory system agents|mesh-ancestor
111182599|NCT01454518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111182601|NCT02983084|Nickel|nickel|mesh-list
111182602|NCT02983084|Trace Elements|trace elements|mesh-ancestor
111182603|NCT02983084|Micronutrients|micronutrients|mesh-ancestor
111182604|NCT02983084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111182605|NCT01455142|Insulin|insulin|mesh-list
111182606|NCT01455142|Insulin Aspart|insulin aspart|mesh-list
111182607|NCT01455142|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111182608|NCT01455142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111182609|NCT01455532|Carboplatin|carboplatin|mesh-list
111182610|NCT01455532|Gemcitabine|gemcitabine|mesh-list
111182611|NCT01455532|Doxorubicin|doxorubicin|mesh-list
111182612|NCT01455532|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111182613|NCT01455532|Iniparib|iniparib|mesh-list
111182614|NCT01455532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111182615|NCT01455532|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111182616|NCT01455532|Antimetabolites|antimetabolites|mesh-ancestor
111182617|NCT01455532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111182618|NCT01455532|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111182619|NCT01455532|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111182620|NCT01455532|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111182621|NCT01455532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111182622|NCT01455532|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111182623|NCT01455922|Glimepiride|glimepiride|mesh-list
111182624|NCT01455922|Exenatide|exenatide|mesh-list
111182625|NCT01455922|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111182626|NCT01455922|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111182627|NCT01455922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111182628|NCT01455922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111182629|NCT01455922|Immunologic Factors|immunologic factors|mesh-ancestor
111182630|NCT01455922|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111182631|NCT01455922|Incretins|incretins|mesh-ancestor
111182632|NCT01455922|Hormones|hormones|mesh-ancestor
111182633|NCT01455922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111182634|NCT01456234|Oseltamivir|oseltamivir|mesh-list
111182635|NCT01456234|Antiviral Agents|antiviral agents|mesh-ancestor
111182636|NCT01456234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111182637|NCT01456234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111182638|NCT01456234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111182639|NCT01456312|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
111182640|NCT01456312|Entecavir|entecavir|mesh-list
111182641|NCT01456312|Antiviral Agents|antiviral agents|mesh-ancestor
111182642|NCT01456312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111182643|NCT02542696|Apomorphine|apomorphine|mesh-list
111182644|NCT02542696|Emetics|emetics|mesh-ancestor
111182645|NCT02542696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111182646|NCT02542696|Autonomic Agents|autonomic agents|mesh-ancestor
111182647|NCT02542696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111182648|NCT02542696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111182649|NCT02542696|Dopamine Agonists|dopamine agonists|mesh-ancestor
111182650|NCT02542696|Dopamine Agents|dopamine agents|mesh-ancestor
111182651|NCT02542696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111182652|NCT02542696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111182654|NCT01456468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111182655|NCT01456468|Keratolytic Agents|keratolytic agents|mesh-ancestor
111182656|NCT01456468|Dermatologic Agents|dermatologic agents|mesh-ancestor
111182657|NCT01456546|Proguanil|proguanil|mesh-list
111182658|NCT01456546|Clopidogrel|clopidogrel|mesh-list
111182659|NCT01456546|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111182660|NCT01456546|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111182661|NCT01456546|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111182662|NCT01456546|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111182663|NCT01456546|Purinergic Agents|purinergic agents|mesh-ancestor
111182664|NCT01456546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111182665|NCT01456546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111182666|NCT01456546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111182667|NCT01456546|Antimalarials|antimalarials|mesh-ancestor
111182668|NCT01456546|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111182669|NCT01456546|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111182670|NCT01456546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111182671|NCT01456546|Antimetabolites|antimetabolites|mesh-ancestor
111182672|NCT01456624|Megestrol Acetate|megestrol acetate|mesh-list
111182673|NCT01456624|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111182674|NCT01456624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111182675|NCT01456624|Appetite Stimulants|appetite stimulants|mesh-ancestor
111182676|NCT01456624|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111182677|NCT01456624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111182678|NCT01457716|Budesonide|budesonide|mesh-list
111182679|NCT01457716|Formoterol Fumarate|formoterol fumarate|mesh-list
111182680|NCT01457716|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111182681|NCT01457716|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111182682|NCT01457716|Autonomic Agents|autonomic agents|mesh-ancestor
111182683|NCT01457716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111182684|NCT01457716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111182685|NCT01457716|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111182686|NCT01457716|Respiratory System Agents|respiratory system agents|mesh-ancestor
111182687|NCT01457716|Glucocorticoids|glucocorticoids|mesh-ancestor
111182688|NCT01457716|Hormones|hormones|mesh-ancestor
111182689|NCT01457716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111182690|NCT01457716|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111182691|NCT01457716|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111182692|NCT01457716|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111182693|NCT01457716|Adrenergic Agents|adrenergic agents|mesh-ancestor
111182694|NCT01457716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111182695|NCT01457716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111182696|NCT02880982|Vitamin D|vitamin d|mesh-list
111182697|NCT02880982|Cholecalciferol|cholecalciferol|mesh-list
111182698|NCT02880982|Vitamins|vitamins|mesh-ancestor
111182699|NCT02880982|Micronutrients|micronutrients|mesh-ancestor
111182700|NCT02880982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111182701|NCT02880982|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111182702|NCT02880982|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111182703|NCT01458964|Quetiapine Fumarate|quetiapine fumarate|mesh-list
111182704|NCT01458964|Antidepressive Agents|antidepressive agents|mesh-ancestor
111182705|NCT01458964|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111182706|NCT01458964|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111182707|NCT01458964|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111182708|NCT01458964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111182709|NCT01458964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111182710|NCT01459198|Vaccines|vaccines|mesh-list
111182711|NCT01459198|Immunologic Factors|immunologic factors|mesh-ancestor
111182712|NCT01459198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111182713|NCT02490904|Eplerenone|eplerenone|mesh-list
111182714|NCT02490904|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
111182715|NCT02490904|Hormone Antagonists|hormone antagonists|mesh-ancestor
111182716|NCT02490904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111182717|NCT02490904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111182718|NCT02490904|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
111182719|NCT02490904|Diuretics|diuretics|mesh-ancestor
111182720|NCT02490904|Natriuretic Agents|natriuretic agents|mesh-ancestor
111182721|NCT02490904|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111182723|NCT04390984|Gefitinib|gefitinib|mesh-list
111182724|NCT04390984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111182725|NCT04390984|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111182726|NCT04390984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111182727|NCT04390984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111182728|NCT02873806|Tobramycin|tobramycin|mesh-list
111182729|NCT02873806|Dexamethasone|dexamethasone|mesh-list
111182730|NCT02873806|Travoprost|travoprost|mesh-list
111182731|NCT02873806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111182732|NCT02873806|Antiemetics|antiemetics|mesh-ancestor
111182733|NCT02873806|Autonomic Agents|autonomic agents|mesh-ancestor
111182734|NCT02873806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111182735|NCT02873806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111182736|NCT02873806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111182737|NCT02873806|Glucocorticoids|glucocorticoids|mesh-ancestor
111182738|NCT02873806|Hormones|hormones|mesh-ancestor
111182739|NCT02873806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111182740|NCT02873806|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111182741|NCT02873806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111182742|NCT02873806|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111182743|NCT02873806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111182744|NCT02873806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111182745|NCT01890772|Vitamin D|vitamin d|mesh-list
111182746|NCT01890772|Ribavirin|ribavirin|mesh-list
111182747|NCT01890772|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
111182748|NCT01890772|Vitamins|vitamins|mesh-ancestor
111182749|NCT01890772|Micronutrients|micronutrients|mesh-ancestor
111182750|NCT01890772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111182751|NCT01890772|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111182752|NCT01890772|Antimetabolites|antimetabolites|mesh-ancestor
111182753|NCT01890772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111182754|NCT01890772|Antiviral Agents|antiviral agents|mesh-ancestor
111182755|NCT01890772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111182756|NCT01891084|Acetaminophen|acetaminophen|mesh-list
111182757|NCT01891084|Ibuprofen|ibuprofen|mesh-list
111182758|NCT01891084|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111182759|NCT01891084|Analgesics|analgesics|mesh-ancestor
111182760|NCT01891084|Sensory System Agents|sensory system agents|mesh-ancestor
111182761|NCT01891084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111182762|NCT01891084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111182763|NCT01891084|Antipyretics|antipyretics|mesh-ancestor
111182764|NCT01891084|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111182765|NCT01891084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111182766|NCT01891084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111182767|NCT01891084|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111182768|NCT01891084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111182769|NCT01891084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111182770|NCT01891708|Bevacizumab|bevacizumab|mesh-list
111182771|NCT01891708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111182772|NCT01891708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111182773|NCT01891708|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111182774|NCT01891708|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111182775|NCT01891708|Growth Substances|growth substances|mesh-ancestor
111182776|NCT01891708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111182777|NCT01891708|Growth Inhibitors|growth inhibitors|mesh-ancestor
111182778|NCT01892098|Zinc Sulfate|zinc sulfate|mesh-list
111182779|NCT01892098|Astringents|astringents|mesh-ancestor
111182780|NCT01892098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111182781|NCT01892098|Dermatologic Agents|dermatologic agents|mesh-ancestor
111182782|NCT01892176|Ubiquinone|ubiquinone|mesh-list
111182783|NCT01892176|Coenzyme Q10|coenzyme q10|mesh-list
111182784|NCT01892176|Micronutrients|micronutrients|mesh-ancestor
111182785|NCT01892176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111182786|NCT01892176|Vitamins|vitamins|mesh-ancestor
111182787|NCT01892254|Metformin|metformin|mesh-list
111182788|NCT01892254|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111182789|NCT01892254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111182790|NCT01892332|Lidocaine|lidocaine|mesh-list
111182791|NCT01892332|Fentanyl|fentanyl|mesh-list
111182792|NCT01892332|Anesthetics, Local|anesthetics, local|mesh-ancestor
111182793|NCT01892332|Anesthetics|anesthetics|mesh-ancestor
111182794|NCT01892332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111182795|NCT01892332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111182796|NCT01892332|Sensory System Agents|sensory system agents|mesh-ancestor
111182797|NCT01892332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111182798|NCT01892332|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111182799|NCT01892332|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111182800|NCT01892332|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111182801|NCT01892332|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111182802|NCT01892332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111182803|NCT01892332|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111182804|NCT01892332|Narcotics|narcotics|mesh-ancestor
111182805|NCT01892332|Analgesics|analgesics|mesh-ancestor
111182806|NCT01892332|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111182807|NCT01892332|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111182808|NCT01892332|Anesthetics, General|anesthetics, general|mesh-ancestor
111182809|NCT01892488|Sultamicillin|sultamicillin|mesh-list
111182810|NCT01892488|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-list
111182811|NCT01892488|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111182812|NCT01892488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111182813|NCT01892488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111182814|NCT01892488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111182815|NCT01892644|Deferasirox|deferasirox|mesh-list
111182816|NCT01892644|Iron Chelating Agents|iron chelating agents|mesh-ancestor
111182817|NCT01892644|Chelating Agents|chelating agents|mesh-ancestor
111182818|NCT01892644|Sequestering Agents|sequestering agents|mesh-ancestor
110219077|NCT00283621|Ifosfamide|ifosfamide|mesh-list
111182819|NCT01892644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111182820|NCT01901653|Rovalpituzumab tesirine|rovalpituzumab tesirine|mesh-list
111182821|NCT01901653|Immunoconjugates|immunoconjugates|mesh-ancestor
111182822|NCT01901653|Immunologic Factors|immunologic factors|mesh-ancestor
111182823|NCT01901653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111182824|NCT01925989|Insulin Glargine|insulin glargine|mesh-list
111182825|NCT01925989|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111182826|NCT01925989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111182827|NCT01901419|Nitroglycerin|nitroglycerin|mesh-list
111182828|NCT01901419|Vasodilator Agents|vasodilator agents|mesh-ancestor
111182830|NCT02798536|LMB-100|lmb-100|mesh-list
111182831|NCT02798536|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111182832|NCT02798536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111182833|NCT02798536|Tubulin Modulators|tubulin modulators|mesh-ancestor
111182834|NCT02798536|Antimitotic Agents|antimitotic agents|mesh-ancestor
111182835|NCT02798536|Mitosis Modulators|mitosis modulators|mesh-ancestor
111182836|NCT02798536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111182837|NCT02798536|Immunoconjugates|immunoconjugates|mesh-ancestor
111182838|NCT02798536|Immunologic Factors|immunologic factors|mesh-ancestor
111182839|NCT02798536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111182840|NCT04758286|Anesthetics|anesthetics|mesh-list
111182841|NCT04758286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111182842|NCT04758286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111182843|NCT01453660|Cisplatin|cisplatin|mesh-list
111182844|NCT01453660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111182845|NCT01615939|Bupivacaine|bupivacaine|mesh-list
111182846|NCT01615939|Ropivacaine|ropivacaine|mesh-list
111182847|NCT01615939|Anesthetics, Local|anesthetics, local|mesh-ancestor
111182848|NCT01615939|Anesthetics|anesthetics|mesh-ancestor
111182849|NCT01615939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111182850|NCT01615939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111182851|NCT01615939|Sensory System Agents|sensory system agents|mesh-ancestor
111182852|NCT01615939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111182853|NCT02789878|Prednisone|prednisone|mesh-list
111182854|NCT02789878|Goserelin|goserelin|mesh-list
111182855|NCT02789878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111182856|NCT02789878|Glucocorticoids|glucocorticoids|mesh-ancestor
111182857|NCT02789878|Hormones|hormones|mesh-ancestor
111182858|NCT02789878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111182859|NCT02789878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111182860|NCT02789878|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111182861|NCT02789878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111182863|NCT01901185|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111182864|NCT01901185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111182865|NCT01901185|Analgesics|analgesics|mesh-ancestor
111182866|NCT01901185|Sensory System Agents|sensory system agents|mesh-ancestor
111182867|NCT01901185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111182868|NCT01901185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111182869|NCT01901185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111182870|NCT01901185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111182871|NCT01901185|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111182872|NCT01901185|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111182873|NCT01901185|Immunologic Factors|immunologic factors|mesh-ancestor
111182874|NCT01893424|Dronabinol|dronabinol|mesh-list
110900047|NCT05324423|Colchicine|colchicine|mesh-list
111182875|NCT01893424|Nabiximols|nabiximols|mesh-list
111182876|NCT01893424|Cannabidiol|cannabidiol|mesh-list
111182877|NCT01893424|Piperine|piperine|mesh-list
111182878|NCT01893424|Anticonvulsants|anticonvulsants|mesh-ancestor
111182879|NCT01893424|Hallucinogens|hallucinogens|mesh-ancestor
111182880|NCT01893424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111182881|NCT01893424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111182882|NCT01893424|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111182883|NCT01893424|Analgesics|analgesics|mesh-ancestor
111182884|NCT01893424|Sensory System Agents|sensory system agents|mesh-ancestor
111182885|NCT01893424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111182886|NCT01893424|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
111182887|NCT01893424|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
111182888|NCT01893424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111182889|NCT01893424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111182890|NCT01893424|Hormones|hormones|mesh-ancestor
111182891|NCT01893424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111182892|NCT01893424|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111182893|NCT01893424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111182894|NCT02788708|Paclitaxel|paclitaxel|mesh-list
111182895|NCT02788708|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111182896|NCT02788708|Lenvatinib|lenvatinib|mesh-list
111182897|NCT02788708|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111182898|NCT02788708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111182899|NCT02788708|Tubulin Modulators|tubulin modulators|mesh-ancestor
111182900|NCT02788708|Antimitotic Agents|antimitotic agents|mesh-ancestor
111182901|NCT02788708|Mitosis Modulators|mitosis modulators|mesh-ancestor
111182902|NCT02788708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111182903|NCT02788708|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111182904|NCT02788708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111182905|NCT01888003|Epoetin Alfa|epoetin alfa|mesh-list
111182906|NCT01888003|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
111182907|NCT01888003|Hematinics|hematinics|mesh-ancestor
111182908|NCT02780128|Ceritinib|ceritinib|mesh-list
111182909|NCT02780128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111182910|NCT02780128|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111182911|NCT02780128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111182912|NCT02780128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111182913|NCT02773732|Ciprofloxacin|ciprofloxacin|mesh-list
111182914|NCT02773732|Etoposide|etoposide|mesh-list
111182915|NCT02773732|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111182916|NCT02773732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111182917|NCT02773732|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111182918|NCT02773732|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111182919|NCT02773732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111182920|NCT02773732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111182921|NCT02773732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111182922|NCT02773732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111182923|NCT02773732|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110844262|NCT01160627|Expectorants|expectorants|mesh-ancestor
111182924|NCT02773732|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111182925|NCT02769520|Pembrolizumab|pembrolizumab|mesh-list
111182926|NCT02769520|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111182927|NCT02769520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111182928|NCT02769520|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111182929|NCT02769520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111182930|NCT02735122|Acetaminophen|acetaminophen|mesh-list
111182931|NCT02735122|Ibuprofen|ibuprofen|mesh-list
111182932|NCT02735122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111182933|NCT02735122|Analgesics|analgesics|mesh-ancestor
111182934|NCT02735122|Sensory System Agents|sensory system agents|mesh-ancestor
111182935|NCT02735122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111182936|NCT02735122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111182937|NCT02735122|Antipyretics|antipyretics|mesh-ancestor
111182938|NCT02735122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111182939|NCT02735122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111182940|NCT02735122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111182941|NCT02735122|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111182942|NCT02735122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111182943|NCT02735122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111182944|NCT02718118|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111182945|NCT02718118|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111182946|NCT02718118|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111182947|NCT02718118|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111182948|NCT02718118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111182949|NCT02718118|Cholinergic Agents|cholinergic agents|mesh-ancestor
111182950|NCT02718118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111182951|NCT02718118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111182952|NCT02718118|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111182953|NCT02718118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111182954|NCT02717962|Dianhydrogalactitol|dianhydrogalactitol|mesh-list
111182955|NCT02717962|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111182956|NCT02717962|Alkylating Agents|alkylating agents|mesh-ancestor
111182957|NCT02717962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111182958|NCT02717962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111182959|NCT01893658|Omalizumab|omalizumab|mesh-list
111182960|NCT01893658|Prednisone|prednisone|mesh-list
111182961|NCT01893658|Prednisolone|prednisolone|mesh-list
111182962|NCT01893658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111182963|NCT01893658|Glucocorticoids|glucocorticoids|mesh-ancestor
111182964|NCT01893658|Hormones|hormones|mesh-ancestor
111182965|NCT01893658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111182966|NCT01893658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111182967|NCT01893658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111182968|NCT01893658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111182969|NCT01893658|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111182970|NCT01893658|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111182971|NCT01893658|Respiratory System Agents|respiratory system agents|mesh-ancestor
111182972|NCT02688556|Cyclosporine|cyclosporine|mesh-list
111182973|NCT02688556|Cyclosporins|cyclosporins|mesh-list
111182974|NCT02688556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111182975|NCT02688556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111182976|NCT02688556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111182977|NCT02688556|Immunologic Factors|immunologic factors|mesh-ancestor
111182978|NCT02688556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111182979|NCT02688556|Antifungal Agents|antifungal agents|mesh-ancestor
111182980|NCT02688556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111182981|NCT02688556|Dermatologic Agents|dermatologic agents|mesh-ancestor
111182982|NCT02688556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111182983|NCT02688556|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111182984|NCT02684032|Letrozole|letrozole|mesh-list
111182985|NCT02684032|Fulvestrant|fulvestrant|mesh-list
111182986|NCT02684032|Palbociclib|palbociclib|mesh-list
111182987|NCT02684032|Gedatolisib|gedatolisib|mesh-list
111182988|NCT02684032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111182989|NCT02684032|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111182990|NCT02684032|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111182991|NCT02684032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111182992|NCT02684032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111182993|NCT02684032|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111182994|NCT02684032|Hormone Antagonists|hormone antagonists|mesh-ancestor
111182995|NCT02684032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111182996|NCT02684032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111182997|NCT02684032|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111182998|NCT02684032|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
111182999|NCT02684032|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111183000|NCT02388178|Fluorides|fluorides|mesh-list
111183001|NCT02388178|Cariostatic Agents|cariostatic agents|mesh-ancestor
111183002|NCT02388178|Protective Agents|protective agents|mesh-ancestor
111183003|NCT02388178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111183004|NCT02384668|Vitamin D|vitamin d|mesh-list
111183005|NCT02384668|Cholecalciferol|cholecalciferol|mesh-list
111183006|NCT02384668|Vitamins|vitamins|mesh-ancestor
111183007|NCT02384668|Micronutrients|micronutrients|mesh-ancestor
111183008|NCT02384668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111183009|NCT02384668|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111183010|NCT02384668|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111183011|NCT01898923|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
111183012|NCT01898923|Laxatives|laxatives|mesh-ancestor
111183013|NCT01898923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111183014|NCT01924429|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
111183015|NCT01924429|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111183016|NCT01924429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111183017|NCT01924429|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111183018|NCT01924429|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111183019|NCT01924429|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111183020|NCT01924429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111183021|NCT01924429|Dopamine Agents|dopamine agents|mesh-ancestor
111183022|NCT01924429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111183023|NCT01886287|Octreotide|octreotide|mesh-list
111183024|NCT01886287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111183025|NCT01886287|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111183026|NCT01886287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111183027|NCT02707588|Pembrolizumab|pembrolizumab|mesh-list
111183028|NCT02707588|Cetuximab|cetuximab|mesh-list
111183029|NCT02707588|Antibodies|antibodies|mesh-list
111183030|NCT02707588|Immunoglobulins|immunoglobulins|mesh-list
111183031|NCT02707588|Immunologic Factors|immunologic factors|mesh-ancestor
111183032|NCT02707588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111183033|NCT02707588|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111183034|NCT02707588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111183035|NCT02707588|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111183036|NCT02707588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111183037|NCT05602480|Vaccines|vaccines|mesh-list
111183038|NCT05602480|Immunologic Factors|immunologic factors|mesh-ancestor
111183039|NCT05602480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111183040|NCT05600296|Levobupivacaine|levobupivacaine|mesh-list
111183041|NCT05600296|Anesthetics, Local|anesthetics, local|mesh-ancestor
111183042|NCT05600296|Anesthetics|anesthetics|mesh-ancestor
111183043|NCT05600296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111183044|NCT05600296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111183045|NCT05600296|Sensory System Agents|sensory system agents|mesh-ancestor
111183046|NCT05600296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111183047|NCT05604586|Acetylcysteine|acetylcysteine|mesh-list
111183048|NCT05604586|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111183049|NCT05604586|Antiviral Agents|antiviral agents|mesh-ancestor
111183050|NCT05604586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111183051|NCT05604586|Expectorants|expectorants|mesh-ancestor
111183052|NCT05604586|Respiratory System Agents|respiratory system agents|mesh-ancestor
111183053|NCT05604586|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111183054|NCT05604586|Antioxidants|antioxidants|mesh-ancestor
111183055|NCT05604586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111183056|NCT05604586|Protective Agents|protective agents|mesh-ancestor
111183057|NCT05604586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111183058|NCT05604586|Antidotes|antidotes|mesh-ancestor
111183059|NCT05604118|Aspirin|aspirin|mesh-list
110844283|NCT03877679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111183060|NCT05604118|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111183061|NCT05604118|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111183062|NCT05604118|Analgesics|analgesics|mesh-ancestor
111183063|NCT05604118|Sensory System Agents|sensory system agents|mesh-ancestor
111183064|NCT05604118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111183065|NCT05604118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111183066|NCT05604118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111183067|NCT05604118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111183068|NCT05604118|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111183069|NCT05604118|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111183070|NCT05604118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111183071|NCT05604118|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111183072|NCT05604118|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111183073|NCT05604118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111183074|NCT05604118|Antipyretics|antipyretics|mesh-ancestor
111183075|NCT05603884|Cytarabine|cytarabine|mesh-list
111183076|NCT05603884|Azacitidine|azacitidine|mesh-list
111183077|NCT05603884|Venetoclax|venetoclax|mesh-list
111183078|NCT05603884|Mitoxantrone|mitoxantrone|mesh-list
111183079|NCT05603884|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111183080|NCT05603884|Antimetabolites|antimetabolites|mesh-ancestor
111183081|NCT05603884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111183082|NCT05603884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111183083|NCT05603884|Antiviral Agents|antiviral agents|mesh-ancestor
111183084|NCT05603884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111183085|NCT05603884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111183086|NCT05603884|Immunologic Factors|immunologic factors|mesh-ancestor
111183087|NCT05603884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111183088|NCT05603884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111183089|NCT05603884|Analgesics|analgesics|mesh-ancestor
111183090|NCT05603884|Sensory System Agents|sensory system agents|mesh-ancestor
111183091|NCT05603884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111183092|NCT05603884|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111183093|NCT05603884|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111183094|NCT05603650|Listerine|listerine|mesh-list
111183095|NCT05603650|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111183096|NCT05603650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111183097|NCT03337594|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
111183098|NCT03337594|Chelating Agents|chelating agents|mesh-ancestor
111183099|NCT03337594|Sequestering Agents|sequestering agents|mesh-ancestor
111183100|NCT03337594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111183101|NCT03313804|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
111183102|NCT03313804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111183103|NCT03313804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111183104|NCT03313804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111183106|NCT04393792|Povidone|povidone|mesh-list
111183107|NCT04393792|Plasma Substitutes|plasma substitutes|mesh-ancestor
111183108|NCT04393792|Blood Substitutes|blood substitutes|mesh-ancestor
111183109|NCT04393792|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111183110|NCT04393792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111183111|NCT01896895|Botulinum Toxins|botulinum toxins|mesh-list
111183112|NCT01896895|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111183113|NCT01896895|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111183114|NCT01896895|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
111183115|NCT01896895|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111183116|NCT01896895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111183117|NCT01896895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111183118|NCT01896895|Cholinergic Agents|cholinergic agents|mesh-ancestor
111183119|NCT01896895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111183120|NCT01896895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111183121|NCT01896895|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111183122|NCT01896895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111183123|NCT02315872|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
111183125|NCT02315872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111183126|NCT02315872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111183127|NCT04127500|Dexmedetomidine|dexmedetomidine|mesh-list
111183128|NCT04127500|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111183129|NCT04127500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111183130|NCT04127500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111183131|NCT04127500|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111183132|NCT04127500|Analgesics|analgesics|mesh-ancestor
111183133|NCT04127500|Sensory System Agents|sensory system agents|mesh-ancestor
111183134|NCT04127500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110571898|NCT02554942|Epoetin Alfa|epoetin alfa|mesh-list
111183135|NCT04127500|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111183136|NCT04127500|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111183137|NCT04127500|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111183138|NCT04127500|Adrenergic Agents|adrenergic agents|mesh-ancestor
111183139|NCT04127500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111183140|NCT04127500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111183141|NCT03017326|Carboplatin|carboplatin|mesh-list
111183142|NCT03017326|Gemcitabine|gemcitabine|mesh-list
111183143|NCT03017326|Doxorubicin|doxorubicin|mesh-list
111183144|NCT03017326|Fluorouracil|fluorouracil|mesh-list
111183145|NCT03017326|Oxaliplatin|oxaliplatin|mesh-list
111183146|NCT03017326|Irinotecan|irinotecan|mesh-list
111183147|NCT03017326|Etoposide|etoposide|mesh-list
111183148|NCT03017326|Vincristine|vincristine|mesh-list
111183149|NCT03017326|Sorafenib|sorafenib|mesh-list
111183150|NCT03017326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111183151|NCT03017326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111183152|NCT03017326|Antimetabolites|antimetabolites|mesh-ancestor
111183153|NCT03017326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111183154|NCT03017326|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111183155|NCT03017326|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111183156|NCT03017326|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111183157|NCT03017326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111183158|NCT03017326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111183159|NCT03017326|Immunologic Factors|immunologic factors|mesh-ancestor
111183160|NCT03017326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111183161|NCT03017326|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111183162|NCT03017326|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111183163|NCT03017326|Tubulin Modulators|tubulin modulators|mesh-ancestor
111183164|NCT03017326|Antimitotic Agents|antimitotic agents|mesh-ancestor
111183165|NCT03017326|Mitosis Modulators|mitosis modulators|mesh-ancestor
111183166|NCT03017326|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111183167|NCT04126330|Vitamin D|vitamin d|mesh-list
111183168|NCT04126330|Vitamins|vitamins|mesh-ancestor
111183169|NCT04126330|Micronutrients|micronutrients|mesh-ancestor
111183170|NCT04126330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111183171|NCT04126330|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111183172|NCT04126720|Vitamin E|vitamin e|mesh-list
111183173|NCT04126720|Vitamins|vitamins|mesh-ancestor
111183174|NCT04126720|Micronutrients|micronutrients|mesh-ancestor
111183175|NCT04126720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111183176|NCT04126720|Antioxidants|antioxidants|mesh-ancestor
111183177|NCT04126720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111183178|NCT04126720|Protective Agents|protective agents|mesh-ancestor
111183179|NCT04126252|Sildenafil Citrate|sildenafil citrate|mesh-list
111183180|NCT04126252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111183181|NCT04126252|Vasodilator Agents|vasodilator agents|mesh-ancestor
111183182|NCT04126252|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111183183|NCT04126252|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111183184|NCT04126252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111183185|NCT04126252|Urological Agents|urological agents|mesh-ancestor
111183186|NCT03007732|Ascorbic Acid|ascorbic acid|mesh-list
111183187|NCT03007732|Prednisone|prednisone|mesh-list
111183188|NCT03007732|Pembrolizumab|pembrolizumab|mesh-list
111183189|NCT03007732|Leuprolide|leuprolide|mesh-list
111183190|NCT03007732|Abiraterone Acetate|abiraterone acetate|mesh-list
111183191|NCT03007732|Methyltestosterone|methyltestosterone|mesh-list
111183192|NCT03007732|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
111183193|NCT03007732|Androgens|androgens|mesh-list
110844298|NCT04652206|Tubulin Modulators|tubulin modulators|mesh-ancestor
111183194|NCT03007732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111183195|NCT03007732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111183196|NCT03007732|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111183197|NCT03007732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111183198|NCT03007732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111183199|NCT03007732|Glucocorticoids|glucocorticoids|mesh-ancestor
111183200|NCT03007732|Hormones|hormones|mesh-ancestor
111183201|NCT03007732|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111183202|NCT03007732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111183203|NCT03007732|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111183204|NCT03007732|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111183205|NCT03007732|Fertility Agents|fertility agents|mesh-ancestor
111183206|NCT03007732|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111183207|NCT03007732|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111183208|NCT03007732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111183209|NCT03007732|Hormone Antagonists|hormone antagonists|mesh-ancestor
111183210|NCT03007732|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111183211|NCT03007732|Antioxidants|antioxidants|mesh-ancestor
111183212|NCT03007732|Protective Agents|protective agents|mesh-ancestor
111183213|NCT03007732|Vitamins|vitamins|mesh-ancestor
111183214|NCT03007732|Micronutrients|micronutrients|mesh-ancestor
111183215|NCT03007732|Estrogens|estrogens|mesh-ancestor
111183216|NCT03007732|Anabolic Agents|anabolic agents|mesh-ancestor
111183217|NCT03007420|Lidocaine|lidocaine|mesh-list
111183218|NCT03007420|Anesthetics, Local|anesthetics, local|mesh-ancestor
111183219|NCT03007420|Anesthetics|anesthetics|mesh-ancestor
111183220|NCT03007420|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111183221|NCT03007420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111183222|NCT03007420|Sensory System Agents|sensory system agents|mesh-ancestor
111183223|NCT03007420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111183224|NCT03007420|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111183225|NCT03007420|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111183226|NCT03007420|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111183227|NCT03007420|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111183228|NCT03007420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111183229|NCT04125706|Metronidazole|metronidazole|mesh-list
111183230|NCT04125706|Minocycline|minocycline|mesh-list
111183231|NCT04125706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111183232|NCT04125706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111183233|NCT04125706|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111183234|NCT04125706|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111183235|NCT03005782|Cemiplimab|cemiplimab|mesh-list
111183236|NCT03005782|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111183237|NCT03005782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111183238|NCT04125394|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111183239|NCT04125394|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111183240|NCT04125082|Insulin|insulin|mesh-list
111183241|NCT04125082|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111183242|NCT04125082|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111183243|NCT04125082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111183244|NCT04393246|Dapagliflozin|dapagliflozin|mesh-list
111183245|NCT04393246|Ambrisentan|ambrisentan|mesh-list
111183246|NCT04393246|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111183247|NCT04393246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111183248|NCT04393246|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111183249|NCT04393246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111183250|NCT04393246|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111183251|NCT04124302|Insulin|insulin|mesh-list
111183252|NCT04124302|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111183253|NCT04124302|Insulin Aspart|insulin aspart|mesh-list
111183254|NCT04124302|Insulin Lispro|insulin lispro|mesh-list
111183255|NCT04124302|Insulin glulisine|insulin glulisine|mesh-list
111183256|NCT04124302|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111183257|NCT04124302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111183258|NCT04124068|Hydrogen Peroxide|hydrogen peroxide|mesh-list
111183259|NCT04124068|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111183260|NCT04124068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111183261|NCT04411069|Droperidol|droperidol|mesh-list
110844308|NCT01269281|Serotonin Agents|serotonin agents|mesh-ancestor
111183262|NCT04411069|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111183263|NCT04411069|Antiemetics|antiemetics|mesh-ancestor
111183264|NCT04411069|Autonomic Agents|autonomic agents|mesh-ancestor
111183265|NCT04411069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111183266|NCT04411069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110489358|NCT00745498|Bevacizumab|bevacizumab|mesh-list
111183267|NCT04411069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111183268|NCT04411069|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111183269|NCT04411069|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111183270|NCT04411069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111183271|NCT04411069|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111183272|NCT04411069|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111183273|NCT04411069|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111183274|NCT04411069|Dopamine Agents|dopamine agents|mesh-ancestor
111183275|NCT04411069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111183276|NCT04411069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111183277|NCT03003130|Hyaluronic Acid|hyaluronic acid|mesh-list
111183278|NCT03003130|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111183279|NCT03003130|Immunologic Factors|immunologic factors|mesh-ancestor
111183280|NCT03003130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111183281|NCT03003130|Viscosupplements|viscosupplements|mesh-ancestor
111183282|NCT03003130|Protective Agents|protective agents|mesh-ancestor
111183283|NCT01884571|Mycophenolic Acid|mycophenolic acid|mesh-list
111183284|NCT01884571|Prednisone|prednisone|mesh-list
111183285|NCT01884571|Methylprednisolone|methylprednisolone|mesh-list
111183286|NCT01884571|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111183287|NCT01884571|Tacrolimus|tacrolimus|mesh-list
111183288|NCT01884571|Basiliximab|basiliximab|mesh-list
111183289|NCT01884571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111183290|NCT01884571|Glucocorticoids|glucocorticoids|mesh-ancestor
111183291|NCT01884571|Hormones|hormones|mesh-ancestor
111183292|NCT01884571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111183293|NCT01884571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111183294|NCT01884571|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111183295|NCT01884571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111183296|NCT01884571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111183297|NCT01884571|Immunologic Factors|immunologic factors|mesh-ancestor
111183298|NCT01884571|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111183299|NCT01884571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111183300|NCT01884571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111183301|NCT01884571|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111183302|NCT01884571|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111183303|NCT01884571|Antitubercular Agents|antitubercular agents|mesh-ancestor
111183304|NCT01884571|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111183305|NCT01884571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111183306|NCT01884571|Antiemetics|antiemetics|mesh-ancestor
111183307|NCT01884571|Autonomic Agents|autonomic agents|mesh-ancestor
111183308|NCT01884571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111183309|NCT01884571|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111183310|NCT01884571|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111183311|NCT01884571|Protective Agents|protective agents|mesh-ancestor
111183312|NCT01884337|Apixaban|apixaban|mesh-list
111183313|NCT01884337|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111183314|NCT01884337|Antithrombins|antithrombins|mesh-ancestor
111183315|NCT01884337|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111183316|NCT01884337|Protease Inhibitors|protease inhibitors|mesh-ancestor
111183317|NCT01884337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111183318|NCT01884337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111183319|NCT01884337|Anticoagulants|anticoagulants|mesh-ancestor
111183320|NCT04123288|ACT-709478|act-709478|mesh-list
111183321|NCT04123288|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111183322|NCT04123288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111183323|NCT04123288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111183324|NCT04123288|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111183325|NCT04123288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111183326|NCT04123210|Vitamin A|vitamin a|mesh-list
111183327|NCT04123210|Vitamins|vitamins|mesh-ancestor
111183328|NCT04123210|Micronutrients|micronutrients|mesh-ancestor
111183329|NCT04123210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111183330|NCT01922089|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
111183331|NCT01922089|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111183332|NCT01922089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111183334|NCT04121416|Oxycodone|oxycodone|mesh-list
111183335|NCT04121416|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111183336|NCT04121416|Narcotics|narcotics|mesh-ancestor
111183337|NCT04121416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111183338|NCT04121416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111183339|NCT04121416|Analgesics|analgesics|mesh-ancestor
111183340|NCT04121416|Sensory System Agents|sensory system agents|mesh-ancestor
111183341|NCT04121416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111183342|NCT04121416|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111183343|NCT04121416|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111183344|NCT04121416|Anesthetics, General|anesthetics, general|mesh-ancestor
111183345|NCT04121416|Anesthetics|anesthetics|mesh-ancestor
111183346|NCT04121338|Bupivacaine|bupivacaine|mesh-list
111183347|NCT04121338|Anesthetics, Local|anesthetics, local|mesh-ancestor
111183348|NCT04121338|Anesthetics|anesthetics|mesh-ancestor
111183349|NCT04121338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111183350|NCT04121338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111183351|NCT04121338|Sensory System Agents|sensory system agents|mesh-ancestor
111183352|NCT04121338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111183353|NCT01896193|Sofosbuvir|sofosbuvir|mesh-list
111183354|NCT01896193|Antiviral Agents|antiviral agents|mesh-ancestor
111183355|NCT01896193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111183356|NCT01922011|Vancomycin|vancomycin|mesh-list
111183357|NCT01922011|Daptomycin|daptomycin|mesh-list
111183358|NCT01922011|Nafcillin|nafcillin|mesh-list
111183359|NCT01922011|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111183360|NCT01922011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111183361|NCT04127968|Vitamin A|vitamin a|mesh-list
111183362|NCT04127968|Vitamins|vitamins|mesh-ancestor
111183363|NCT04127968|Micronutrients|micronutrients|mesh-ancestor
111183364|NCT04127968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111183365|NCT01921387|Cytarabine|cytarabine|mesh-list
111183366|NCT01921387|Etoposide|etoposide|mesh-list
111183367|NCT01921387|Podophyllotoxin|podophyllotoxin|mesh-list
111183368|NCT01921387|Etoposide phosphate|etoposide phosphate|mesh-list
111183369|NCT01921387|Melphalan|melphalan|mesh-list
111183370|NCT01921387|Mechlorethamine|mechlorethamine|mesh-list
111183371|NCT01921387|Carmustine|carmustine|mesh-list
111183372|NCT01921387|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
111183373|NCT01921387|Antibodies|antibodies|mesh-list
111183374|NCT01921387|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111183375|NCT01921387|Immunologic Factors|immunologic factors|mesh-ancestor
111183376|NCT01921387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111183377|NCT01921387|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111183378|NCT01921387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111183379|NCT01921387|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111183380|NCT01921387|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111183381|NCT01921387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111183382|NCT01921387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111183383|NCT01921387|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111183384|NCT01921387|Antimetabolites|antimetabolites|mesh-ancestor
111183385|NCT01921387|Antiviral Agents|antiviral agents|mesh-ancestor
111183386|NCT01921387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111183387|NCT01921387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111183388|NCT01921387|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111183389|NCT01921387|Alkylating Agents|alkylating agents|mesh-ancestor
111183390|NCT01921387|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111183391|NCT01921387|Keratolytic Agents|keratolytic agents|mesh-ancestor
111183392|NCT01921387|Dermatologic Agents|dermatologic agents|mesh-ancestor
111183393|NCT01921387|Tubulin Modulators|tubulin modulators|mesh-ancestor
111183394|NCT01921387|Antimitotic Agents|antimitotic agents|mesh-ancestor
111183395|NCT01921387|Mitosis Modulators|mitosis modulators|mesh-ancestor
111183396|NCT04129996|Paclitaxel|paclitaxel|mesh-list
111183397|NCT04129996|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111183398|NCT04129996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111183399|NCT04129996|Tubulin Modulators|tubulin modulators|mesh-ancestor
111183400|NCT04129996|Antimitotic Agents|antimitotic agents|mesh-ancestor
111183401|NCT04129996|Mitosis Modulators|mitosis modulators|mesh-ancestor
110900570|NCT03110848|Antiemetics|antiemetics|mesh-ancestor
111183402|NCT04129996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111183403|NCT04129216|Tamoxifen|tamoxifen|mesh-list
111183404|NCT04129216|Letrozole|letrozole|mesh-list
111183405|NCT04129216|Exemestane|exemestane|mesh-list
111183406|NCT04129216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111183407|NCT04129216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111183408|NCT04129216|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111183409|NCT04129216|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111183410|NCT04129216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111183411|NCT04129216|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111183412|NCT04129216|Hormone Antagonists|hormone antagonists|mesh-ancestor
111183413|NCT04129216|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111183414|NCT04129216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111183415|NCT04129216|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111183416|NCT04129216|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111183417|NCT04129216|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111183418|NCT04129216|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111183419|NCT01895335|Teriflunomide|teriflunomide|mesh-list
111183420|NCT01895335|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111183421|NCT01895335|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111183422|NCT01895335|Analgesics|analgesics|mesh-ancestor
111183423|NCT01895335|Sensory System Agents|sensory system agents|mesh-ancestor
111183424|NCT01895335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111183425|NCT01895335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111183426|NCT01895335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111183427|NCT01895335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111183428|NCT01895335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111183429|NCT01895335|Immunologic Factors|immunologic factors|mesh-ancestor
111183430|NCT03829696|Misoprostol|misoprostol|mesh-list
111183431|NCT03829696|Mifepristone|mifepristone|mesh-list
111183432|NCT03829696|Ulipristal acetate|ulipristal acetate|mesh-list
111183433|NCT03829696|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111183434|NCT03829696|Abortifacient Agents|abortifacient agents|mesh-ancestor
111183435|NCT03829696|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111183436|NCT03829696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111183437|NCT03829696|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111183438|NCT03829696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111183439|NCT03829696|Oxytocics|oxytocics|mesh-ancestor
111183440|NCT03829696|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
111183441|NCT03829696|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111183442|NCT03829696|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111183443|NCT03829696|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111183444|NCT03829696|Contraceptive Agents|contraceptive agents|mesh-ancestor
111183445|NCT03829696|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
111183446|NCT03829696|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
111183447|NCT03829696|Hormone Antagonists|hormone antagonists|mesh-ancestor
111183448|NCT03829696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111183449|NCT03829696|Luteolytic Agents|luteolytic agents|mesh-ancestor
111183450|NCT03829696|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111183451|NCT03829696|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
111183452|NCT03829774|Acetaminophen|acetaminophen|mesh-list
111183453|NCT03829774|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111183454|NCT03829774|Analgesics|analgesics|mesh-ancestor
111183455|NCT03829774|Sensory System Agents|sensory system agents|mesh-ancestor
111183456|NCT03829774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111183457|NCT03829774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111183458|NCT03829774|Antipyretics|antipyretics|mesh-ancestor
111183460|NCT02974738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111183461|NCT02972398|Acetylcysteine|acetylcysteine|mesh-list
111183462|NCT02972398|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111183463|NCT02972398|Antiviral Agents|antiviral agents|mesh-ancestor
111183464|NCT02972398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111183465|NCT02972398|Expectorants|expectorants|mesh-ancestor
111183466|NCT02972398|Respiratory System Agents|respiratory system agents|mesh-ancestor
111183467|NCT02972398|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111183468|NCT02972398|Antioxidants|antioxidants|mesh-ancestor
111183469|NCT02972398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111183470|NCT02972398|Protective Agents|protective agents|mesh-ancestor
111183471|NCT02972398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111183472|NCT02972398|Antidotes|antidotes|mesh-ancestor
111183473|NCT01617655|Alirocumab|alirocumab|mesh-list
111183474|NCT01617655|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111183475|NCT01617655|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
111183476|NCT01617655|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111183477|NCT01617655|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111183478|NCT01617655|Antimetabolites|antimetabolites|mesh-ancestor
111183479|NCT01617655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111183480|NCT01617655|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111183481|NCT01617655|Protease Inhibitors|protease inhibitors|mesh-ancestor
111183482|NCT01617655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111183483|NCT01617655|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111183484|NCT01617655|Immunologic Factors|immunologic factors|mesh-ancestor
111183485|NCT01617655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111183486|NCT02965768|Naltrexone|naltrexone|mesh-list
111183487|NCT02965768|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111183488|NCT02965768|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111183489|NCT02965768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111183490|NCT02965768|Sensory System Agents|sensory system agents|mesh-ancestor
111183491|NCT02965768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111183492|NCT01895101|Tranexamic Acid|tranexamic acid|mesh-list
111183493|NCT01895101|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111183494|NCT01895101|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111183495|NCT01895101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111183496|NCT01895101|Hemostatics|hemostatics|mesh-ancestor
111183497|NCT01895101|Coagulants|coagulants|mesh-ancestor
111183498|NCT03828682|Mycophenolic Acid|mycophenolic acid|mesh-list
111183499|NCT03828682|Prednisone|prednisone|mesh-list
111183500|NCT03828682|Methylprednisolone|methylprednisolone|mesh-list
111183501|NCT03828682|Tacrolimus|tacrolimus|mesh-list
111183502|NCT03828682|Thymoglobulin|thymoglobulin|mesh-list
111183503|NCT03828682|Antilymphocyte Serum|antilymphocyte serum|mesh-list
111183504|NCT03828682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111183505|NCT03828682|Glucocorticoids|glucocorticoids|mesh-ancestor
111183506|NCT03828682|Hormones|hormones|mesh-ancestor
111183507|NCT03828682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111183508|NCT03828682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111183509|NCT03828682|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111183510|NCT03828682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111183511|NCT03828682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111183512|NCT03828682|Immunologic Factors|immunologic factors|mesh-ancestor
111183513|NCT03828682|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111183514|NCT03828682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111183515|NCT03828682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111183516|NCT03828682|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111183517|NCT03828682|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111183518|NCT03828682|Antitubercular Agents|antitubercular agents|mesh-ancestor
111183519|NCT03828682|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111183520|NCT03828682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111183521|NCT03828682|Antiemetics|antiemetics|mesh-ancestor
111183522|NCT03828682|Autonomic Agents|autonomic agents|mesh-ancestor
111183523|NCT03828682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111183524|NCT03828682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111183525|NCT03828682|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111183526|NCT03828682|Protective Agents|protective agents|mesh-ancestor
111183527|NCT03483649|Bevacizumab|bevacizumab|mesh-list
111183528|NCT03483649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111183529|NCT03483649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111183530|NCT03483649|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111183531|NCT03483649|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111183532|NCT03483649|Growth Substances|growth substances|mesh-ancestor
111183533|NCT03483649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111183534|NCT03483649|Growth Inhibitors|growth inhibitors|mesh-ancestor
111183535|NCT03822520|Moxifloxacin|moxifloxacin|mesh-list
111183536|NCT03822520|Celecoxib|celecoxib|mesh-list
111183537|NCT03822520|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111183538|NCT03822520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111183539|NCT03822520|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111183540|NCT03822520|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111183541|NCT03822520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111183542|NCT03822520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111183543|NCT03822520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111183544|NCT03822520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111183545|NCT03822520|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111183546|NCT03822520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111183547|NCT03822520|Analgesics|analgesics|mesh-ancestor
111183548|NCT03822520|Sensory System Agents|sensory system agents|mesh-ancestor
111183549|NCT03822520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111183550|NCT03822520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111183551|NCT03822520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111183552|NCT03822520|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111183553|NCT03822520|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111183554|NCT01894477|Fludarabine|fludarabine|mesh-list
110900717|NCT01369667|Vitamin D|vitamin d|mesh-list
111183556|NCT01894477|Treosulfan|treosulfan|mesh-list
111183557|NCT01894477|Busulfan|busulfan|mesh-list
111183558|NCT01894477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111183559|NCT01894477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111183560|NCT01894477|Antimetabolites|antimetabolites|mesh-ancestor
111183561|NCT01894477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111183562|NCT01894477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111183563|NCT01894477|Immunologic Factors|immunologic factors|mesh-ancestor
111183564|NCT01894477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111183565|NCT01894477|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111183566|NCT01894477|Alkylating Agents|alkylating agents|mesh-ancestor
111183567|NCT01894477|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111183568|NCT04391998|Metronidazole|metronidazole|mesh-list
111183569|NCT04391998|Albendazole|albendazole|mesh-list
111183570|NCT04391998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111183571|NCT04391998|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111183572|NCT04391998|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111183573|NCT04391998|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111183574|NCT04391998|Anthelmintics|anthelmintics|mesh-ancestor
111183575|NCT04391998|Anticestodal Agents|anticestodal agents|mesh-ancestor
111183576|NCT04391998|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
111183577|NCT04391998|Tubulin Modulators|tubulin modulators|mesh-ancestor
111183578|NCT04391998|Antimitotic Agents|antimitotic agents|mesh-ancestor
111183579|NCT04391998|Mitosis Modulators|mitosis modulators|mesh-ancestor
111183580|NCT04391998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111183581|NCT04391998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111183582|NCT03820180|Fluticasone|fluticasone|mesh-list
111183583|NCT03820180|Xhance|xhance|mesh-list
111183584|NCT03820180|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
111183585|NCT03820180|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
111183586|NCT03820180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111183587|NCT03820180|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111183588|NCT03820180|Autonomic Agents|autonomic agents|mesh-ancestor
111183589|NCT03820180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111183590|NCT03820180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111183591|NCT03820180|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111183592|NCT03820180|Respiratory System Agents|respiratory system agents|mesh-ancestor
111183593|NCT03820180|Dermatologic Agents|dermatologic agents|mesh-ancestor
111183594|NCT03820180|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111183595|NCT03820180|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111183596|NCT03820180|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111183597|NCT03820180|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111183598|NCT03820180|Adrenergic Agents|adrenergic agents|mesh-ancestor
111183599|NCT03820180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111183600|NCT03820180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111183601|NCT03820180|Glucocorticoids|glucocorticoids|mesh-ancestor
111183602|NCT03820180|Hormones|hormones|mesh-ancestor
111183603|NCT03820180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111183604|NCT03820180|Sympathomimetics|sympathomimetics|mesh-ancestor
111183605|NCT01894243|Olaparib|olaparib|mesh-list
111183606|NCT01894243|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111183607|NCT01894243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111183608|NCT01894243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111183609|NCT01894243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111183610|NCT01450384|Pemetrexed|pemetrexed|mesh-list
111183611|NCT01450384|Sorafenib|sorafenib|mesh-list
111183612|NCT01450384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111183613|NCT01450384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111183614|NCT01450384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111183615|NCT01450384|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111183616|NCT01450384|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111183617|NCT01450384|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111183618|NCT01450462|Vitamin D|vitamin d|mesh-list
111183619|NCT01450462|Cholecalciferol|cholecalciferol|mesh-list
111183620|NCT01450462|Vitamins|vitamins|mesh-ancestor
111183621|NCT01450462|Micronutrients|micronutrients|mesh-ancestor
111183622|NCT01450462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111183623|NCT01450462|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111183624|NCT01450462|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111183625|NCT01450774|Beclomethasone|beclomethasone|mesh-list
111183626|NCT01450774|Formoterol Fumarate|formoterol fumarate|mesh-list
111183627|NCT01450774|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111183628|NCT01450774|Autonomic Agents|autonomic agents|mesh-ancestor
111183629|NCT01450774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111183630|NCT01450774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111183631|NCT01450774|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111183632|NCT01450774|Respiratory System Agents|respiratory system agents|mesh-ancestor
111183633|NCT01450774|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111183634|NCT01450774|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111183635|NCT01450774|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111183636|NCT01450774|Adrenergic Agents|adrenergic agents|mesh-ancestor
111183637|NCT01450774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111183638|NCT01450774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111183639|NCT01450774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111183640|NCT01450774|Glucocorticoids|glucocorticoids|mesh-ancestor
111183641|NCT01450774|Hormones|hormones|mesh-ancestor
111183642|NCT01450774|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111183643|NCT01450930|Hydrocortisone|hydrocortisone|mesh-list
111183644|NCT01450930|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
111183645|NCT01450930|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
111183646|NCT01450930|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
111183647|NCT01450930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111183648|NCT01451086|Vaccines|vaccines|mesh-list
111183649|NCT01451086|Immunologic Factors|immunologic factors|mesh-ancestor
111183650|NCT01451086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111183651|NCT01451710|Prednisone|prednisone|mesh-list
111183652|NCT01451710|Prednisolone|prednisolone|mesh-list
111183653|NCT01451710|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111183654|NCT01451710|Methylprednisolone|methylprednisolone|mesh-list
111183655|NCT01451710|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111183656|NCT01451710|Prednisolone acetate|prednisolone acetate|mesh-list
111183657|NCT01451710|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111183658|NCT01451710|Prednisolone phosphate|prednisolone phosphate|mesh-list
111183659|NCT01451710|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111183660|NCT01451710|Glucocorticoids|glucocorticoids|mesh-ancestor
111183661|NCT01451710|Hormones|hormones|mesh-ancestor
111183662|NCT01451710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111183663|NCT01451710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111183664|NCT01451710|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111183665|NCT01451710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111183666|NCT01451710|Antiemetics|antiemetics|mesh-ancestor
111183667|NCT01451710|Autonomic Agents|autonomic agents|mesh-ancestor
111183668|NCT01451710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111183669|NCT01451710|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111183670|NCT01451710|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111183671|NCT01451710|Protective Agents|protective agents|mesh-ancestor
111183672|NCT01451788|Thrombin|thrombin|mesh-list
111183673|NCT01451788|Hemostatics|hemostatics|mesh-ancestor
111183674|NCT01451788|Coagulants|coagulants|mesh-ancestor
111183675|NCT01452100|Prednisone|prednisone|mesh-list
111183676|NCT01452100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111183677|NCT01452100|Glucocorticoids|glucocorticoids|mesh-ancestor
111183678|NCT01452100|Hormones|hormones|mesh-ancestor
111183679|NCT01452100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111183680|NCT01452100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111183681|NCT01452100|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111183682|NCT01452100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111183683|NCT01452334|BMS-936559|bms-936559|mesh-list
111183684|NCT01452334|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111183685|NCT01452334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111183686|NCT01452568|Aspirin|aspirin|mesh-list
111183687|NCT01452568|Salicylic Acid|salicylic acid|mesh-list
111183688|NCT01452568|Salicylates|salicylates|mesh-list
111183689|NCT01452568|Warfarin|warfarin|mesh-list
111183690|NCT01452568|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111183691|NCT01452568|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111183692|NCT01452568|Analgesics|analgesics|mesh-ancestor
111183693|NCT01452568|Sensory System Agents|sensory system agents|mesh-ancestor
111183694|NCT01452568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111183695|NCT01452568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111183696|NCT01452568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111183697|NCT01452568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111183698|NCT01452568|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111183699|NCT01452568|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111183700|NCT01452568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111183701|NCT01452568|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111183702|NCT01452568|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110900866|NCT02787239|Immunologic Factors|immunologic factors|mesh-ancestor
111183703|NCT01452568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111183704|NCT01452568|Antipyretics|antipyretics|mesh-ancestor
111183705|NCT01452568|Anticoagulants|anticoagulants|mesh-ancestor
111183706|NCT01452568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111183707|NCT01452568|Antifungal Agents|antifungal agents|mesh-ancestor
111183708|NCT01452568|Keratolytic Agents|keratolytic agents|mesh-ancestor
111183709|NCT01452568|Dermatologic Agents|dermatologic agents|mesh-ancestor
111183711|NCT01452724|Dexlansoprazole|dexlansoprazole|mesh-list
111183712|NCT01452724|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111183713|NCT01452724|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111183714|NCT01452724|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111183715|NCT01452724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111183716|NCT01452724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111183717|NCT01452880|Remifentanil|remifentanil|mesh-list
111183718|NCT01452880|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111183719|NCT01452880|Narcotics|narcotics|mesh-ancestor
111183720|NCT01452880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111183721|NCT01452880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111183722|NCT01452880|Analgesics|analgesics|mesh-ancestor
111183723|NCT01452880|Sensory System Agents|sensory system agents|mesh-ancestor
111183724|NCT01452880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111183725|NCT01453192|Raltegravir Potassium|raltegravir potassium|mesh-list
111183726|NCT01453192|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111183727|NCT01453192|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111183728|NCT01453192|Antiviral Agents|antiviral agents|mesh-ancestor
111183729|NCT01453192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111183730|NCT01453192|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111183731|NCT01453192|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111183732|NCT01453192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111183733|NCT01453192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111183734|NCT01453426|Dimethyl Fumarate|dimethyl fumarate|mesh-list
111183735|NCT01453426|Dermatologic Agents|dermatologic agents|mesh-ancestor
111183736|NCT01453426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111183737|NCT01453426|Immunologic Factors|immunologic factors|mesh-ancestor
111183738|NCT01453426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111183739|NCT01453504|Everolimus|everolimus|mesh-list
111183740|NCT01453504|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111183741|NCT01453504|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111183742|NCT01453504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111183743|NCT01453504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111183744|NCT01453504|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111183745|NCT01453504|Immunologic Factors|immunologic factors|mesh-ancestor
111183746|NCT01453504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111183747|NCT01453504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111183748|NCT01453582|Propolis|propolis|mesh-list
111183749|NCT01453582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111183750|NCT01453738|Plasma-lyte 148|plasma-lyte 148|mesh-list
111183751|NCT01453738|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
111183752|NCT01453738|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111183753|NCT04847752|Aspirin|aspirin|mesh-list
111183754|NCT04847752|Warfarin|warfarin|mesh-list
111183755|NCT04847752|Rivaroxaban|rivaroxaban|mesh-list
111183756|NCT04847752|Dabigatran|dabigatran|mesh-list
111183757|NCT04847752|Anticoagulants|anticoagulants|mesh-list
111183758|NCT04847752|Clopidogrel|clopidogrel|mesh-list
111183759|NCT04847752|Atorvastatin|atorvastatin|mesh-list
111183760|NCT04847752|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111183761|NCT04847752|Evolocumab|evolocumab|mesh-list
111183762|NCT04847752|Alirocumab|alirocumab|mesh-list
111183763|NCT04847752|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
111183764|NCT04847752|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-list
111183765|NCT04847752|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111183766|NCT04847752|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111183767|NCT04847752|Analgesics|analgesics|mesh-ancestor
111183768|NCT04847752|Sensory System Agents|sensory system agents|mesh-ancestor
111183769|NCT04847752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111183770|NCT04847752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111183771|NCT04847752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111183772|NCT04847752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111183773|NCT04847752|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111183774|NCT04847752|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111183775|NCT04847752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111183776|NCT04847752|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111183777|NCT04847752|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111183778|NCT04847752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111183779|NCT04847752|Antipyretics|antipyretics|mesh-ancestor
111183780|NCT04847752|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111183781|NCT04847752|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111183782|NCT04847752|Antimetabolites|antimetabolites|mesh-ancestor
111183783|NCT04847752|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111183784|NCT04847752|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111183785|NCT04847752|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111183786|NCT04847752|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111183787|NCT04847752|Purinergic Agents|purinergic agents|mesh-ancestor
111183788|NCT04847752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111183789|NCT04847752|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111183790|NCT04847752|Antithrombins|antithrombins|mesh-ancestor
111183791|NCT04847752|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111183792|NCT04847752|Protease Inhibitors|protease inhibitors|mesh-ancestor
111183793|NCT04847206|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
111183794|NCT04847206|3,4-Methylenedioxyamphetamine|3,4-methylenedioxyamphetamine|mesh-list
111183795|NCT04847206|Hallucinogens|hallucinogens|mesh-ancestor
111183796|NCT04847206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111183797|NCT04847206|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111183798|NCT04847206|Serotonin Agents|serotonin agents|mesh-ancestor
111183799|NCT04847206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111183800|NCT04847206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111183801|NCT04847206|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111183802|NCT04847206|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111183803|NCT04847206|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111183804|NCT04847206|Adrenergic Agents|adrenergic agents|mesh-ancestor
111183805|NCT02864914|Empagliflozin|empagliflozin|mesh-list
111183806|NCT02864914|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
111183807|NCT02864914|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111183808|NCT02864914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111183809|NCT02864914|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111183810|NCT02864914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111183811|NCT02864914|Protease Inhibitors|protease inhibitors|mesh-ancestor
111183812|NCT02864914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111183813|NCT02849470|Complement Factor H|complement factor h|mesh-list
111183814|NCT02849470|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
111183815|NCT02849470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111183816|NCT02849470|Immunologic Factors|immunologic factors|mesh-ancestor
111183817|NCT02849470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111183818|NCT05024188|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111183819|NCT05024188|Metronidazole|metronidazole|mesh-list
111183820|NCT05024188|Ciprofloxacin|ciprofloxacin|mesh-list
111183821|NCT05024188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111183822|NCT05024188|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111183823|NCT05024188|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111183824|NCT05024188|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111183825|NCT05024188|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111183826|NCT05024188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111183827|NCT05024188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111183828|NCT05024188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111183829|NCT05024188|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111183830|NCT05024188|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111183831|NCT04390594|Nafamostat|nafamostat|mesh-list
111183832|NCT04390594|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111183833|NCT04390594|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111183834|NCT04390594|Analgesics|analgesics|mesh-ancestor
111183835|NCT04390594|Sensory System Agents|sensory system agents|mesh-ancestor
111183836|NCT04390594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111183837|NCT04390594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111183838|NCT04390594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111183839|NCT04390594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111183840|NCT04390594|Anticoagulants|anticoagulants|mesh-ancestor
111183841|NCT04390594|Protease Inhibitors|protease inhibitors|mesh-ancestor
111183842|NCT04390594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111183843|NCT04390594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111183844|NCT04390594|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
110489465|NCT01023659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111183845|NCT04390594|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111183846|NCT04390594|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
111183847|NCT04390594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111183848|NCT04390594|Immunologic Factors|immunologic factors|mesh-ancestor
111183849|NCT05024422|Pyridoxine|pyridoxine|mesh-list
111183850|NCT05024422|Vitamin B 6|vitamin b 6|mesh-list
111183851|NCT05024422|Cabergoline|cabergoline|mesh-list
111183852|NCT05024422|Vitamins|vitamins|mesh-ancestor
111183853|NCT05024422|Micronutrients|micronutrients|mesh-ancestor
111183854|NCT05024422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111183855|NCT05024422|Vitamin B Complex|vitamin b complex|mesh-ancestor
111183856|NCT05024422|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111183857|NCT05024422|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111183858|NCT05024422|Dopamine Agonists|dopamine agonists|mesh-ancestor
111183859|NCT05024422|Dopamine Agents|dopamine agents|mesh-ancestor
111183860|NCT05024422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111183861|NCT05024422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111183862|NCT02819596|Durvalumab|durvalumab|mesh-list
111183863|NCT02819596|Tremelimumab|tremelimumab|mesh-list
111183864|NCT02819596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111183865|NCT02819596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111183866|NCT02818894|Lidocaine|lidocaine|mesh-list
111183867|NCT02818894|Bupivacaine|bupivacaine|mesh-list
111183868|NCT02818894|Anesthetics, Local|anesthetics, local|mesh-ancestor
111183869|NCT02818894|Anesthetics|anesthetics|mesh-ancestor
111183870|NCT02818894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111183871|NCT02818894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111183872|NCT02818894|Sensory System Agents|sensory system agents|mesh-ancestor
111183873|NCT02818894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111183874|NCT02818894|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111183875|NCT02818894|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111183876|NCT02818894|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111183877|NCT02818894|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111183878|NCT02818894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111183879|NCT05586568|Itraconazole|itraconazole|mesh-list
111183880|NCT05586568|Rifampin|rifampin|mesh-list
111183881|NCT05586568|Esomeprazole|esomeprazole|mesh-list
111183882|NCT05586568|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111183883|NCT05586568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111183884|NCT05586568|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111183885|NCT05586568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111183886|NCT05586568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111183887|NCT05586568|Antifungal Agents|antifungal agents|mesh-ancestor
110844362|NCT03384862|Vitamins|vitamins|mesh-ancestor
111183888|NCT05586568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111183889|NCT05586568|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111183890|NCT05586568|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111183891|NCT05586568|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111183892|NCT05586568|Hormone Antagonists|hormone antagonists|mesh-ancestor
111183893|NCT05586568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111183894|NCT05586568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111183895|NCT05586568|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111183896|NCT05586568|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111183897|NCT05586568|Antitubercular Agents|antitubercular agents|mesh-ancestor
111183898|NCT05586568|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111183899|NCT05586568|Leprostatic Agents|leprostatic agents|mesh-ancestor
111183900|NCT05586568|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111183901|NCT05586568|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111183902|NCT05586568|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111183903|NCT05586568|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
111183904|NCT05586568|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
111183905|NCT05586568|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
111183906|NCT05586568|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111183907|NCT02632708|Cytarabine|cytarabine|mesh-list
111183908|NCT02632708|Etoposide|etoposide|mesh-list
111183909|NCT02632708|Daunorubicin|daunorubicin|mesh-list
111183910|NCT02632708|Mitoxantrone|mitoxantrone|mesh-list
111183911|NCT02632708|Idarubicin|idarubicin|mesh-list
111183912|NCT02632708|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111183913|NCT02632708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111183914|NCT02632708|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111183915|NCT02632708|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111183916|NCT02632708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111183917|NCT02632708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111183918|NCT02632708|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111183919|NCT02632708|Antimetabolites|antimetabolites|mesh-ancestor
111183920|NCT02632708|Antiviral Agents|antiviral agents|mesh-ancestor
111183921|NCT02632708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111183922|NCT02632708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111183923|NCT02632708|Immunologic Factors|immunologic factors|mesh-ancestor
111183924|NCT02632708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111183925|NCT02632708|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111183926|NCT02632708|Analgesics|analgesics|mesh-ancestor
111183927|NCT02632708|Sensory System Agents|sensory system agents|mesh-ancestor
111183928|NCT02632708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111183929|NCT02624908|Canagliflozin|canagliflozin|mesh-list
110901097|NCT05385562|Triamcinolone|triamcinolone|mesh-list
111183930|NCT02624908|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111183931|NCT02624908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111183932|NCT02624908|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111183933|NCT02624908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111183934|NCT02587000|Ulipristal acetate|ulipristal acetate|mesh-list
111183935|NCT02587000|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111183936|NCT02587000|Contraceptive Agents|contraceptive agents|mesh-ancestor
111183937|NCT02587000|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111183938|NCT02587000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111183939|NCT02587000|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111183940|NCT04757818|Cetylpyridinium|cetylpyridinium|mesh-list
111183941|NCT04757818|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111183942|NCT04757818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111183943|NCT02556424|Dexamethasone|dexamethasone|mesh-list
111183944|NCT02556424|Triamcinolone|triamcinolone|mesh-list
111183945|NCT02556424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111183946|NCT02556424|Antiemetics|antiemetics|mesh-ancestor
111183947|NCT02556424|Autonomic Agents|autonomic agents|mesh-ancestor
111183948|NCT02556424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110844367|NCT01269437|Budesonide|budesonide|mesh-list
111183949|NCT02556424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111183950|NCT02556424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111183951|NCT02556424|Glucocorticoids|glucocorticoids|mesh-ancestor
111183953|NCT02556424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111183954|NCT02556424|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111183955|NCT02556424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111183957|NCT02543944|Naltrexone|naltrexone|mesh-list
111183958|NCT02543944|Buprenorphine|buprenorphine|mesh-list
111183959|NCT02543944|Gabapentin|gabapentin|mesh-list
111183960|NCT02543944|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111183961|NCT02543944|Narcotics|narcotics|mesh-ancestor
111183962|NCT02543944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111183963|NCT02543944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111183964|NCT02543944|Analgesics|analgesics|mesh-ancestor
111183965|NCT02543944|Sensory System Agents|sensory system agents|mesh-ancestor
111183966|NCT02543944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111183967|NCT02543944|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111183968|NCT02543944|Anticonvulsants|anticonvulsants|mesh-ancestor
111183969|NCT02543944|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111183970|NCT02543944|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111183971|NCT02543944|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111183972|NCT02543944|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111183973|NCT02543944|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110572728|NCT05757336|Paclitaxel|paclitaxel|mesh-list
111183974|NCT02543944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111183975|NCT02543944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111183976|NCT02543944|Antimanic Agents|antimanic agents|mesh-ancestor
111183977|NCT02543944|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111183978|NCT02543944|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111183979|NCT02543944|Sympatholytics|sympatholytics|mesh-ancestor
111183980|NCT02543944|Autonomic Agents|autonomic agents|mesh-ancestor
111183981|NCT02543944|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111183982|NCT02543944|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111183983|NCT02543944|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111183984|NCT02543944|Adrenergic Agents|adrenergic agents|mesh-ancestor
111183985|NCT02531308|Metformin|metformin|mesh-list
111183986|NCT02531308|Prednisone|prednisone|mesh-list
111183987|NCT02531308|Cyclophosphamide|cyclophosphamide|mesh-list
111183988|NCT02531308|Rituximab|rituximab|mesh-list
111183989|NCT02531308|Doxorubicin|doxorubicin|mesh-list
111183990|NCT02531308|Vincristine|vincristine|mesh-list
111183991|NCT02531308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111183992|NCT02531308|Immunologic Factors|immunologic factors|mesh-ancestor
111183993|NCT02531308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111183994|NCT02531308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111183995|NCT02531308|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111183996|NCT02531308|Alkylating Agents|alkylating agents|mesh-ancestor
111183997|NCT02531308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111183998|NCT02531308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111183999|NCT02531308|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111184000|NCT02531308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111184001|NCT02531308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111184002|NCT02531308|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111184003|NCT02531308|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110901164|NCT05087134|Lipotropic Agents|lipotropic agents|mesh-ancestor
111184004|NCT02531308|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111184005|NCT02531308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111184006|NCT02531308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111184007|NCT02531308|Glucocorticoids|glucocorticoids|mesh-ancestor
111184008|NCT02531308|Hormones|hormones|mesh-ancestor
111184009|NCT02531308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111184010|NCT02531308|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111184011|NCT02531308|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111184012|NCT02531308|Tubulin Modulators|tubulin modulators|mesh-ancestor
111184013|NCT02531308|Antimitotic Agents|antimitotic agents|mesh-ancestor
111184014|NCT02531308|Mitosis Modulators|mitosis modulators|mesh-ancestor
111184015|NCT02523976|Cytarabine|cytarabine|mesh-list
111184016|NCT02523976|Dexamethasone|dexamethasone|mesh-list
111184017|NCT02523976|Prednisone|prednisone|mesh-list
111184018|NCT02523976|Cyclophosphamide|cyclophosphamide|mesh-list
111184019|NCT02523976|Methotrexate|methotrexate|mesh-list
111184020|NCT02523976|Etoposide|etoposide|mesh-list
111184021|NCT02523976|Vincristine|vincristine|mesh-list
111184022|NCT02523976|Daunorubicin|daunorubicin|mesh-list
111184023|NCT02523976|Dasatinib|dasatinib|mesh-list
111184024|NCT02523976|Mitoxantrone|mitoxantrone|mesh-list
111184025|NCT02523976|Mercaptopurine|mercaptopurine|mesh-list
111184026|NCT02523976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111184027|NCT02523976|Immunologic Factors|immunologic factors|mesh-ancestor
111184028|NCT02523976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111184029|NCT02523976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111184030|NCT02523976|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111184031|NCT02523976|Alkylating Agents|alkylating agents|mesh-ancestor
111184032|NCT02523976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111184033|NCT02523976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111184034|NCT02523976|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111184035|NCT02523976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111184036|NCT02523976|Antiemetics|antiemetics|mesh-ancestor
111184037|NCT02523976|Autonomic Agents|autonomic agents|mesh-ancestor
111184038|NCT02523976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111184039|NCT02523976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111184040|NCT02523976|Glucocorticoids|glucocorticoids|mesh-ancestor
111184041|NCT02523976|Hormones|hormones|mesh-ancestor
111184042|NCT02523976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111184043|NCT02523976|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111184044|NCT02523976|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111184045|NCT02523976|Abortifacient Agents|abortifacient agents|mesh-ancestor
111184046|NCT02523976|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111184047|NCT02523976|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111184048|NCT02523976|Antimetabolites|antimetabolites|mesh-ancestor
111184049|NCT02523976|Dermatologic Agents|dermatologic agents|mesh-ancestor
111184050|NCT02523976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111184051|NCT02523976|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111184052|NCT02523976|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111184053|NCT02523976|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111184054|NCT02523976|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111184055|NCT02523976|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111184056|NCT02523976|Antiviral Agents|antiviral agents|mesh-ancestor
111184057|NCT02523976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111184058|NCT02523976|Tubulin Modulators|tubulin modulators|mesh-ancestor
111184059|NCT02523976|Antimitotic Agents|antimitotic agents|mesh-ancestor
111184060|NCT02523976|Mitosis Modulators|mitosis modulators|mesh-ancestor
111184061|NCT02523976|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111184062|NCT02523976|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111184063|NCT02523976|Analgesics|analgesics|mesh-ancestor
111184064|NCT02523976|Sensory System Agents|sensory system agents|mesh-ancestor
111184065|NCT02493322|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
111184066|NCT02493322|Olmesartan|olmesartan|mesh-list
111184067|NCT02493322|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
111184068|NCT02493322|Chlorthalidone|chlorthalidone|mesh-list
111184069|NCT02493322|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111184070|NCT02493322|Diuretics|diuretics|mesh-ancestor
111184071|NCT02493322|Natriuretic Agents|natriuretic agents|mesh-ancestor
111184072|NCT02493322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111184073|NCT02493322|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
111184074|NCT02493322|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111184075|NCT02493322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111184076|NCT02493322|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111184077|NCT02493322|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110901240|NCT05692245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111184078|NCT04757974|Fostemsavir|fostemsavir|mesh-list
111184079|NCT04757974|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111184080|NCT04757974|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111184081|NCT04757974|Antiviral Agents|antiviral agents|mesh-ancestor
111184082|NCT04757974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111184083|NCT04757974|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
111184084|NCT04757974|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
111184085|NCT04757974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111184087|NCT04757506|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111184088|NCT04757506|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111184089|NCT04757506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111184090|NCT04757506|Sensory System Agents|sensory system agents|mesh-ancestor
111184091|NCT04757506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111184092|NCT02477644|Olaparib|olaparib|mesh-list
110844384|NCT00462748|Atorvastatin|atorvastatin|mesh-list
111184093|NCT02477644|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111184094|NCT02477644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111184095|NCT02477644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111184096|NCT02477644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111184097|NCT02466334|Calcitonin|calcitonin|mesh-list
111184098|NCT02466334|Salmon calcitonin|salmon calcitonin|mesh-list
111184099|NCT02466334|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
111184100|NCT02466334|Katacalcin|katacalcin|mesh-list
111184101|NCT02466334|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111184102|NCT02466334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111184103|NCT02466334|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111184104|NCT02466334|Vasodilator Agents|vasodilator agents|mesh-ancestor
111184105|NCT02460874|Glyburide|glyburide|mesh-list
111184106|NCT02460874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111184107|NCT02460874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111184108|NCT02443324|Pembrolizumab|pembrolizumab|mesh-list
111184109|NCT02443324|Ramucirumab|ramucirumab|mesh-list
111184110|NCT02443324|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111184111|NCT02443324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111184112|NCT02443324|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111184113|NCT02443324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111184114|NCT01894048|Beclomethasone|beclomethasone|mesh-list
111184115|NCT01894048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111184116|NCT01894048|Glucocorticoids|glucocorticoids|mesh-ancestor
111184117|NCT01894048|Hormones|hormones|mesh-ancestor
111184118|NCT01894048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111184119|NCT01894048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111184120|NCT01894048|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111184121|NCT01894048|Respiratory System Agents|respiratory system agents|mesh-ancestor
111184122|NCT02420314|Ascorbic Acid|ascorbic acid|mesh-list
111184123|NCT02420314|Paclitaxel|paclitaxel|mesh-list
111184124|NCT02420314|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111184125|NCT02420314|Carboplatin|carboplatin|mesh-list
111184126|NCT02420314|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111184127|NCT02420314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111184128|NCT02420314|Tubulin Modulators|tubulin modulators|mesh-ancestor
111184129|NCT02420314|Antimitotic Agents|antimitotic agents|mesh-ancestor
111184130|NCT02420314|Mitosis Modulators|mitosis modulators|mesh-ancestor
111184131|NCT02420314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111184132|NCT02420314|Vitamins|vitamins|mesh-ancestor
111184133|NCT02420314|Micronutrients|micronutrients|mesh-ancestor
111184134|NCT02420314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111184135|NCT02420314|Antioxidants|antioxidants|mesh-ancestor
111184136|NCT02420314|Protective Agents|protective agents|mesh-ancestor
111184137|NCT01539291|Idelalisib|idelalisib|mesh-list
111184138|NCT01539291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111184139|NCT01539291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111184140|NCT01539291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111184141|NCT04746040|Fluticasone|fluticasone|mesh-list
111184142|NCT04746040|Xhance|xhance|mesh-list
111184143|NCT04746040|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
111184144|NCT04746040|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
111184145|NCT04746040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111184146|NCT04746040|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111184147|NCT04746040|Autonomic Agents|autonomic agents|mesh-ancestor
111184148|NCT04746040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111184149|NCT04746040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111184150|NCT04746040|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111184151|NCT04746040|Respiratory System Agents|respiratory system agents|mesh-ancestor
111184152|NCT04746040|Dermatologic Agents|dermatologic agents|mesh-ancestor
111184153|NCT04746040|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111184154|NCT04746040|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111184155|NCT04746040|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111184156|NCT04746040|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111184157|NCT04746040|Adrenergic Agents|adrenergic agents|mesh-ancestor
111184158|NCT04746040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111184159|NCT04746040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111184160|NCT04746040|Glucocorticoids|glucocorticoids|mesh-ancestor
111184161|NCT04746040|Hormones|hormones|mesh-ancestor
111184162|NCT04746040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111184163|NCT04746040|Sympathomimetics|sympathomimetics|mesh-ancestor
111184164|NCT02400814|Atezolizumab|atezolizumab|mesh-list
111184165|NCT02400814|Antibodies|antibodies|mesh-list
111184166|NCT02400814|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111184167|NCT02400814|Immunologic Factors|immunologic factors|mesh-ancestor
111184168|NCT02400814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111184169|NCT02400814|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111184170|NCT02400814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111184171|NCT02400814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111184172|NCT02400814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111184173|NCT02398240|Rituximab|rituximab|mesh-list
111184174|NCT02398240|Brentuximab Vedotin|brentuximab vedotin|mesh-list
111184175|NCT02398240|Doxorubicin|doxorubicin|mesh-list
111184176|NCT02398240|Vincristine|vincristine|mesh-list
111184177|NCT02398240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111184178|NCT02398240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111184179|NCT02398240|Immunologic Factors|immunologic factors|mesh-ancestor
111184180|NCT02398240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111184181|NCT02398240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111184182|NCT02398240|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111184183|NCT02398240|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111184184|NCT02398240|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111184185|NCT02398240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111184186|NCT02398240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111184187|NCT02398240|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111184188|NCT02398240|Tubulin Modulators|tubulin modulators|mesh-ancestor
111184189|NCT02398240|Antimitotic Agents|antimitotic agents|mesh-ancestor
111184190|NCT02398240|Mitosis Modulators|mitosis modulators|mesh-ancestor
111184191|NCT02398240|Immunotoxins|immunotoxins|mesh-ancestor
111184192|NCT02398240|Immunoconjugates|immunoconjugates|mesh-ancestor
111184193|NCT02022280|Lansoprazole|lansoprazole|mesh-list
111184194|NCT02022280|Dexlansoprazole|dexlansoprazole|mesh-list
111184195|NCT02022280|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111184196|NCT02022280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111184197|NCT02022280|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111184198|NCT02022280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111184199|NCT02022280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111184200|NCT02363374|Leucovorin|leucovorin|mesh-list
111184201|NCT02363374|Folic Acid|folic acid|mesh-list
111184202|NCT02363374|Fluorouracil|fluorouracil|mesh-list
111184203|NCT02363374|Oxaliplatin|oxaliplatin|mesh-list
111184204|NCT02363374|Levoleucovorin|levoleucovorin|mesh-list
111184205|NCT02363374|Antimetabolites|antimetabolites|mesh-ancestor
111184206|NCT02363374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111184207|NCT02363374|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111184208|NCT02363374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111184209|NCT02363374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111184210|NCT02363374|Immunologic Factors|immunologic factors|mesh-ancestor
111184211|NCT02363374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111184212|NCT02363374|Antidotes|antidotes|mesh-ancestor
111184213|NCT02363374|Protective Agents|protective agents|mesh-ancestor
111184214|NCT02363374|Vitamin B Complex|vitamin b complex|mesh-ancestor
111184215|NCT02363374|Vitamins|vitamins|mesh-ancestor
111184216|NCT02363374|Micronutrients|micronutrients|mesh-ancestor
111184217|NCT02363374|Hematinics|hematinics|mesh-ancestor
111184218|NCT01511445|Silicon|silicon|mesh-list
111184219|NCT01511445|Trace Elements|trace elements|mesh-ancestor
111184220|NCT01511445|Micronutrients|micronutrients|mesh-ancestor
111184221|NCT01511445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111184222|NCT02344186|Liraglutide|liraglutide|mesh-list
111184223|NCT02344186|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111184224|NCT02344186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111184225|NCT02344186|Incretins|incretins|mesh-ancestor
111184226|NCT02344186|Hormones|hormones|mesh-ancestor
111184227|NCT02344186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111184228|NCT01537887|Moxifloxacin|moxifloxacin|mesh-list
110901391|NCT05659563|Tamoxifen|tamoxifen|mesh-list
111184229|NCT01537887|Evacetrapib|evacetrapib|mesh-list
111184230|NCT01537887|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111184231|NCT01537887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111184232|NCT01537887|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111184233|NCT01537887|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111184234|NCT01537887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111184235|NCT01537887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111184236|NCT01537887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111184237|NCT01537887|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111184238|NCT01537887|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111184239|NCT01537887|Antimetabolites|antimetabolites|mesh-ancestor
111184240|NCT01537887|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111184241|NCT02305264|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
111184242|NCT02305264|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111184243|NCT02305264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111184244|NCT02297698|Trastuzumab|trastuzumab|mesh-list
111184245|NCT02297698|Sargramostim|sargramostim|mesh-list
111184246|NCT02297698|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111184247|NCT02297698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111184248|NCT02297698|Immunologic Factors|immunologic factors|mesh-ancestor
111184249|NCT02297698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111184250|NCT01487577|Mycophenolic Acid|mycophenolic acid|mesh-list
111184251|NCT01487577|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111184252|NCT01487577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111184253|NCT01487577|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111184254|NCT01487577|Antitubercular Agents|antitubercular agents|mesh-ancestor
111184255|NCT01487577|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111184256|NCT01487577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111184257|NCT01487577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111184258|NCT01487577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111184259|NCT01928056|Montelukast|montelukast|mesh-list
111184260|NCT01928056|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111184261|NCT01928056|Respiratory System Agents|respiratory system agents|mesh-ancestor
111184262|NCT01928056|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
111184263|NCT01928056|Hormone Antagonists|hormone antagonists|mesh-ancestor
111184264|NCT01928056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111184265|NCT01928056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111184266|NCT01928056|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
111184267|NCT01928056|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111184268|NCT01928056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111184269|NCT05585866|Anesthetics|anesthetics|mesh-list
111184270|NCT05585866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111184271|NCT05585866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111184272|NCT01992952|Fulvestrant|fulvestrant|mesh-list
111184273|NCT01992952|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111184274|NCT01992952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111184275|NCT01992952|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
111184276|NCT01992952|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111184277|NCT01992952|Hormone Antagonists|hormone antagonists|mesh-ancestor
111184278|NCT01992952|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111184279|NCT01992952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111184280|NCT01928134|Calcium Carbonate|calcium carbonate|mesh-list
111184281|NCT01928134|Calcium|calcium|mesh-list
111184282|NCT01928134|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111184283|NCT01928134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111184284|NCT01928134|Antacids|antacids|mesh-ancestor
111184285|NCT01928134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111184286|NCT01928134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111184287|NCT04756882|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111184288|NCT04756882|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111184289|NCT04756882|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111184290|NCT04756882|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111184291|NCT04756882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111184292|NCT04756882|Cholinergic Agents|cholinergic agents|mesh-ancestor
111184293|NCT04756882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111184294|NCT04756882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111184295|NCT04756882|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111184296|NCT04756882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111184297|NCT04756492|Cyclosporine|cyclosporine|mesh-list
111184298|NCT04756492|Antifungal Agents|antifungal agents|mesh-ancestor
111184299|NCT04756492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111184300|NCT04756492|Dermatologic Agents|dermatologic agents|mesh-ancestor
111184301|NCT04756492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111184302|NCT04756492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111184303|NCT04756492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111184304|NCT04756492|Immunologic Factors|immunologic factors|mesh-ancestor
111184305|NCT04756492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111184306|NCT04756492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111184307|NCT04756492|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111184308|NCT01536951|Moxifloxacin|moxifloxacin|mesh-list
111184309|NCT01536951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111184310|NCT01536951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111184311|NCT01536951|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111184312|NCT01536951|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111184313|NCT01536951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111184314|NCT01536951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111184315|NCT01536951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111184316|NCT04767633|Magnesium Sulfate|magnesium sulfate|mesh-list
111184317|NCT04767633|Analgesics|analgesics|mesh-ancestor
111184318|NCT04767633|Sensory System Agents|sensory system agents|mesh-ancestor
111184319|NCT04767633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111184320|NCT04767633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111184321|NCT04767633|Anesthetics|anesthetics|mesh-ancestor
111184322|NCT04767633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111184323|NCT04767633|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111184324|NCT04767633|Anticonvulsants|anticonvulsants|mesh-ancestor
111184325|NCT04767633|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111184326|NCT04767633|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111184327|NCT04767633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111184328|NCT04767633|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111184329|NCT04767633|Tocolytic Agents|tocolytic agents|mesh-ancestor
111184330|NCT04767633|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111184331|NCT01928914|Moxifloxacin|moxifloxacin|mesh-list
111184332|NCT01928914|Tafenoquine|tafenoquine|mesh-list
111184333|NCT01928914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111184334|NCT01928914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111184335|NCT01928914|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111184336|NCT01928914|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111184337|NCT01928914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111184338|NCT01928914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111184339|NCT01928914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111184340|NCT01928914|Antimalarials|antimalarials|mesh-ancestor
111184341|NCT01928914|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111184342|NCT01928914|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111184343|NCT02249104|Adapalene|adapalene|mesh-list
111184344|NCT02249104|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
111184345|NCT02249104|Benzoyl Peroxide|benzoyl peroxide|mesh-list
111184346|NCT02249104|Dermatologic Agents|dermatologic agents|mesh-ancestor
111184347|NCT02249104|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111184348|NCT02249104|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111184349|NCT02249104|Analgesics|analgesics|mesh-ancestor
111184350|NCT02249104|Sensory System Agents|sensory system agents|mesh-ancestor
111184351|NCT02249104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111184352|NCT02249104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111184353|NCT02249104|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111184354|NCT02249104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111184355|NCT01929070|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111184356|NCT01929070|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111184357|NCT01929070|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111184358|NCT01929070|Antimetabolites|antimetabolites|mesh-ancestor
111184359|NCT01929070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111184360|NCT01929070|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111184361|NCT01929070|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111184362|NCT01929070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111184363|NCT01536561|Tositumomab I-131|tositumomab i-131|mesh-list
111184364|NCT01536561|Antibodies|antibodies|mesh-list
111184365|NCT01536561|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111184366|NCT01536561|Antibodies, Anti-Idiotypic|antibodies, anti-idiotypic|mesh-list
111184367|NCT01536561|Immunologic Factors|immunologic factors|mesh-ancestor
111184368|NCT01536561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111184369|NCT01536561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111184370|NCT02236312|Botulinum Toxins|botulinum toxins|mesh-list
111184371|NCT02236312|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111184372|NCT02236312|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111184373|NCT02236312|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111184374|NCT02236312|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111184375|NCT02236312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111184376|NCT02236312|Cholinergic Agents|cholinergic agents|mesh-ancestor
111184377|NCT02236312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110901537|NCT03041181|Antimitotic Agents|antimitotic agents|mesh-ancestor
111184379|NCT02236312|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111184380|NCT02236312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111184381|NCT01916278|Lidocaine|lidocaine|mesh-list
111184382|NCT01916278|Anesthetics, Local|anesthetics, local|mesh-ancestor
111184383|NCT01916278|Anesthetics|anesthetics|mesh-ancestor
111184384|NCT01916278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111184385|NCT01916278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111184386|NCT01916278|Sensory System Agents|sensory system agents|mesh-ancestor
111184387|NCT01916278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111184388|NCT01916278|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111184389|NCT01916278|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111184390|NCT01916278|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111184391|NCT01916278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111184392|NCT01916278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111184393|NCT03084640|Pembrolizumab|pembrolizumab|mesh-list
111184394|NCT03084640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111184395|NCT03084640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111184396|NCT03084640|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111184397|NCT03084640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111184398|NCT04409691|Sirolimus|sirolimus|mesh-list
111184399|NCT04409691|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111184400|NCT04409691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111184401|NCT04409691|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111184402|NCT04409691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111184403|NCT04409691|Antifungal Agents|antifungal agents|mesh-ancestor
111184404|NCT04409691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111184405|NCT04409691|Immunologic Factors|immunologic factors|mesh-ancestor
111184406|NCT04409691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111184407|NCT02219776|Chlorhexidine|chlorhexidine|mesh-list
111184408|NCT02219776|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
111184409|NCT02219776|Benzoyl Peroxide|benzoyl peroxide|mesh-list
111184410|NCT02219776|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111184411|NCT02219776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111184412|NCT02219776|Disinfectants|disinfectants|mesh-ancestor
111184413|NCT02219776|Dermatologic Agents|dermatologic agents|mesh-ancestor
111184414|NCT01487265|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111184415|NCT01487265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111184416|NCT01487265|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111184417|NCT01487265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111184418|NCT01487265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111184419|NCT01516606|Clarithromycin|clarithromycin|mesh-list
111184420|NCT01516606|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111184421|NCT01516606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111184422|NCT01516606|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111184423|NCT01516606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111184424|NCT01516606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111184425|NCT01516606|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111184426|NCT01516606|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111184427|NCT02209636|Ascorbic Acid|ascorbic acid|mesh-list
111184428|NCT02209636|Nitroglycerin|nitroglycerin|mesh-list
111184429|NCT02209636|Vitamins|vitamins|mesh-ancestor
111184430|NCT02209636|Micronutrients|micronutrients|mesh-ancestor
111184431|NCT02209636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111184432|NCT02209636|Antioxidants|antioxidants|mesh-ancestor
111184433|NCT02209636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111184434|NCT02209636|Protective Agents|protective agents|mesh-ancestor
111184435|NCT02209636|Vasodilator Agents|vasodilator agents|mesh-ancestor
111184436|NCT01508325|Metoprolol|metoprolol|mesh-list
111184437|NCT01508325|Bisoprolol|bisoprolol|mesh-list
111184438|NCT01508325|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111184439|NCT01508325|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111184440|NCT01508325|Sympatholytics|sympatholytics|mesh-ancestor
111184441|NCT01508325|Autonomic Agents|autonomic agents|mesh-ancestor
111184442|NCT01508325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111184443|NCT01508325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111184444|NCT01508325|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
111184445|NCT01508325|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111184446|NCT01508325|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111184447|NCT01508325|Adrenergic Agents|adrenergic agents|mesh-ancestor
111184448|NCT01508325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111184449|NCT01508325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111184450|NCT01514344|Rituximab|rituximab|mesh-list
111184451|NCT01514344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111184452|NCT01514344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111184453|NCT01514344|Immunologic Factors|immunologic factors|mesh-ancestor
111184454|NCT01514344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111184455|NCT01514344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111184457|NCT02191930|Doxorubicin|doxorubicin|mesh-list
111184458|NCT02191930|Brentuximab Vedotin|brentuximab vedotin|mesh-list
111184459|NCT02191930|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111184460|NCT02191930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111184461|NCT02191930|Immunologic Factors|immunologic factors|mesh-ancestor
111184462|NCT02191930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111184463|NCT02191930|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111184464|NCT02191930|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111184465|NCT02191930|Alkylating Agents|alkylating agents|mesh-ancestor
111184466|NCT02191930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111184467|NCT02191930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111184468|NCT02191930|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111184469|NCT02191930|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111184470|NCT02191930|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111184471|NCT02191930|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111184472|NCT02191930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111184473|NCT02191930|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111184474|NCT02191930|Immunotoxins|immunotoxins|mesh-ancestor
111184475|NCT02191930|Immunoconjugates|immunoconjugates|mesh-ancestor
111184476|NCT01536015|Rotigotine|rotigotine|mesh-list
111184477|NCT01536015|Dopamine Agonists|dopamine agonists|mesh-ancestor
111184478|NCT01536015|Dopamine Agents|dopamine agents|mesh-ancestor
111184479|NCT01536015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111184480|NCT01536015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111184481|NCT01536015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111184482|NCT01484691|Budesonide|budesonide|mesh-list
111184483|NCT01484691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111184484|NCT01484691|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111184485|NCT01484691|Autonomic Agents|autonomic agents|mesh-ancestor
111184486|NCT01484691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111184487|NCT01484691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111184488|NCT01484691|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111184489|NCT01484691|Respiratory System Agents|respiratory system agents|mesh-ancestor
111184490|NCT01484691|Glucocorticoids|glucocorticoids|mesh-ancestor
111184491|NCT01484691|Hormones|hormones|mesh-ancestor
111184492|NCT01484691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111184493|NCT01464034|Dexamethasone|dexamethasone|mesh-list
111184494|NCT01464034|Pomalidomide|pomalidomide|mesh-list
111184495|NCT01464034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111184496|NCT01464034|Antiemetics|antiemetics|mesh-ancestor
111184497|NCT01464034|Autonomic Agents|autonomic agents|mesh-ancestor
111184498|NCT01464034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111184499|NCT01464034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111184500|NCT01464034|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111184501|NCT01464034|Glucocorticoids|glucocorticoids|mesh-ancestor
111184502|NCT01464034|Hormones|hormones|mesh-ancestor
111184503|NCT01464034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111184504|NCT01464034|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111184505|NCT01464034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111184506|NCT01464034|Immunologic Factors|immunologic factors|mesh-ancestor
111184507|NCT01464034|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111184508|NCT01464034|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111184509|NCT01464034|Growth Substances|growth substances|mesh-ancestor
111184510|NCT01464034|Growth Inhibitors|growth inhibitors|mesh-ancestor
111184511|NCT01535235|Lisinopril|lisinopril|mesh-list
110844413|NCT03935685|Mirtazapine|mirtazapine|mesh-list
111184512|NCT01535235|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
111184513|NCT01535235|Protease Inhibitors|protease inhibitors|mesh-ancestor
111184514|NCT01535235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111184515|NCT01535235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111184516|NCT01535235|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111184517|NCT01535235|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111184518|NCT01535235|Protective Agents|protective agents|mesh-ancestor
111184519|NCT01535235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111184520|NCT02317744|Naltrexone|naltrexone|mesh-list
111184521|NCT02317744|Bupropion|bupropion|mesh-list
111184522|NCT02317744|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111184523|NCT02317744|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111184524|NCT02317744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111184525|NCT02317744|Sensory System Agents|sensory system agents|mesh-ancestor
111184526|NCT02317744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111184527|NCT02317744|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111184528|NCT02317744|Antidepressive Agents|antidepressive agents|mesh-ancestor
111184530|NCT02317744|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111184531|NCT02317744|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111184532|NCT02317744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111184533|NCT02317744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111184534|NCT02317744|Dopamine Agents|dopamine agents|mesh-ancestor
111184535|NCT02317744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111184536|NCT02317744|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111184537|NCT02317744|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111184538|NCT02317744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111184539|NCT05577442|Trastuzumab|trastuzumab|mesh-list
111184540|NCT05577442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111184541|NCT05577442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111184542|NCT01895764|Adalimumab|adalimumab|mesh-list
111184543|NCT01895764|Methotrexate|methotrexate|mesh-list
111184544|NCT01895764|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111184545|NCT01895764|Abortifacient Agents|abortifacient agents|mesh-ancestor
111184546|NCT01895764|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111184547|NCT01895764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111184548|NCT01895764|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111184549|NCT01895764|Antimetabolites|antimetabolites|mesh-ancestor
111184550|NCT01895764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111184551|NCT01895764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111184552|NCT01895764|Dermatologic Agents|dermatologic agents|mesh-ancestor
111184553|NCT01895764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111184554|NCT01895764|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111184555|NCT01895764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111184556|NCT01895764|Immunologic Factors|immunologic factors|mesh-ancestor
111184557|NCT01895764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111184558|NCT01895764|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111184559|NCT01895764|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111184560|NCT01895764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111184561|NCT01894360|Belimumab|belimumab|mesh-list
111184562|NCT01894360|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111184563|NCT01894360|Immunologic Factors|immunologic factors|mesh-ancestor
111184564|NCT01894360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111184565|NCT01483599|Adalimumab|adalimumab|mesh-list
111184566|NCT01483599|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111184567|NCT01483599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111184568|NCT01483599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111184569|NCT01407562|Paclitaxel|paclitaxel|mesh-list
111184570|NCT01407562|Carboplatin|carboplatin|mesh-list
111184571|NCT01407562|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111184572|NCT01407562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111184573|NCT01407562|Tubulin Modulators|tubulin modulators|mesh-ancestor
111184574|NCT01407562|Antimitotic Agents|antimitotic agents|mesh-ancestor
111184575|NCT01407562|Mitosis Modulators|mitosis modulators|mesh-ancestor
111184576|NCT01407562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111184577|NCT01406548|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111184578|NCT01406548|Immunologic Factors|immunologic factors|mesh-ancestor
111184579|NCT01406548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111184580|NCT01393522|Milnacipran|milnacipran|mesh-list
111184581|NCT01393522|Levomilnacipran|levomilnacipran|mesh-list
111184582|NCT01393522|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111184583|NCT01393522|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111184584|NCT01393522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111184585|NCT01393522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111184586|NCT01393522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111184587|NCT01393522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111184588|NCT01393522|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111184589|NCT01393522|Analgesics|analgesics|mesh-ancestor
111184590|NCT01393522|Sensory System Agents|sensory system agents|mesh-ancestor
111184591|NCT01393522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111184592|NCT01393522|Antidepressive Agents|antidepressive agents|mesh-ancestor
111184593|NCT01393522|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111184594|NCT02086786|Risperidone|risperidone|mesh-list
111184595|NCT02086786|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111184596|NCT02086786|Serotonin Agents|serotonin agents|mesh-ancestor
111184597|NCT02086786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110901761|NCT05231460|Narcotics|narcotics|mesh-list
111184598|NCT02086786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111184599|NCT02086786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111184600|NCT02086786|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111184601|NCT02086786|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111184602|NCT02086786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111184603|NCT02086786|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111184604|NCT02086786|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111184605|NCT02086786|Dopamine Agents|dopamine agents|mesh-ancestor
111184606|NCT02108158|Botulinum Toxins|botulinum toxins|mesh-list
111184607|NCT02108158|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111184608|NCT02108158|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111184609|NCT02108158|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111184610|NCT02108158|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111184611|NCT02108158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111184612|NCT02108158|Cholinergic Agents|cholinergic agents|mesh-ancestor
111184613|NCT02108158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111184614|NCT02108158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111184615|NCT02108158|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111184616|NCT02108158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111184617|NCT01895218|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
111184618|NCT01895218|Hematinics|hematinics|mesh-ancestor
111184619|NCT01895998|Albuterol|albuterol|mesh-list
111184620|NCT01895998|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111184621|NCT01895998|Autonomic Agents|autonomic agents|mesh-ancestor
111184622|NCT01895998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111184623|NCT01895998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111184624|NCT01895998|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111184625|NCT01895998|Respiratory System Agents|respiratory system agents|mesh-ancestor
111184626|NCT01895998|Tocolytic Agents|tocolytic agents|mesh-ancestor
111184627|NCT01895998|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111184628|NCT01895998|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111184629|NCT01895998|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111184630|NCT01895998|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111184631|NCT01895998|Adrenergic Agents|adrenergic agents|mesh-ancestor
111184632|NCT01895998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111184633|NCT01895998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111184634|NCT01895296|Pasireotide|pasireotide|mesh-list
111184635|NCT01895296|Hormones|hormones|mesh-ancestor
111184636|NCT01895296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111184637|NCT01895296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111184638|NCT01276600|Tenofovir|tenofovir|mesh-list
111184639|NCT01276600|Emtricitabine|emtricitabine|mesh-list
111184640|NCT01276600|Antiviral Agents|antiviral agents|mesh-ancestor
111184641|NCT01276600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111184642|NCT01276600|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111184643|NCT01276600|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111184644|NCT01276600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111184645|NCT01276600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111184646|NCT01276600|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111184647|NCT01276600|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111184648|NCT02040376|Metformin|metformin|mesh-list
111184649|NCT02040376|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111184650|NCT02040376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111184651|NCT04755868|Talazoparib|talazoparib|mesh-list
111184652|NCT04755868|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111184653|NCT04755868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111184654|NCT04755868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111184655|NCT04755868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111184656|NCT01621906|Alovudine|alovudine|mesh-list
111184657|NCT01621906|Antiviral Agents|antiviral agents|mesh-ancestor
111184658|NCT01621906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111184659|NCT01615510|Tapentadol|tapentadol|mesh-list
111184660|NCT01615510|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111184661|NCT01615510|Narcotics|narcotics|mesh-ancestor
111184662|NCT01615510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111184663|NCT01615510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111184664|NCT01615510|Analgesics|analgesics|mesh-ancestor
111184665|NCT01615510|Sensory System Agents|sensory system agents|mesh-ancestor
111184666|NCT01615510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111184667|NCT01615510|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111184668|NCT01615510|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111184669|NCT01615510|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111184670|NCT01615510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111184671|NCT01615510|Adrenergic Agents|adrenergic agents|mesh-ancestor
111184672|NCT01615510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111184674|NCT00530062|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111184675|NCT00530062|Autonomic Agents|autonomic agents|mesh-ancestor
111184676|NCT00530062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111184677|NCT00530062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111184678|NCT00530062|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111184679|NCT00530062|Respiratory System Agents|respiratory system agents|mesh-ancestor
111184680|NCT00530062|Tocolytic Agents|tocolytic agents|mesh-ancestor
111184681|NCT00530062|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111184682|NCT00530062|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111184683|NCT00530062|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111184684|NCT00530062|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111184685|NCT00530062|Adrenergic Agents|adrenergic agents|mesh-ancestor
111184686|NCT00530062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111184687|NCT00530062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111184688|NCT01209364|Methylprednisolone|methylprednisolone|mesh-list
111184689|NCT01209364|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111184690|NCT01209364|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111184691|NCT01209364|Prednisolone|prednisolone|mesh-list
111184692|NCT01209364|Prednisolone acetate|prednisolone acetate|mesh-list
111184693|NCT01209364|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111184694|NCT01209364|Prednisolone phosphate|prednisolone phosphate|mesh-list
111184695|NCT01209364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111184696|NCT01209364|Antiemetics|antiemetics|mesh-ancestor
111184697|NCT01209364|Autonomic Agents|autonomic agents|mesh-ancestor
111184698|NCT01209364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111184699|NCT01209364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111184700|NCT01209364|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111184701|NCT01209364|Glucocorticoids|glucocorticoids|mesh-ancestor
111184702|NCT01209364|Hormones|hormones|mesh-ancestor
111184703|NCT01209364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111184704|NCT01209364|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111184705|NCT01209364|Protective Agents|protective agents|mesh-ancestor
111184706|NCT01209364|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111184707|NCT01209364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111184708|NCT05080192|Fenofibrate|fenofibrate|mesh-list
111184709|NCT05080192|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111184710|NCT05080192|Antimetabolites|antimetabolites|mesh-ancestor
111184711|NCT05080192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111184712|NCT05080192|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111184713|NCT00472966|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
111184714|NCT00472966|Tretinoin|tretinoin|mesh-list
111184715|NCT00472966|Glycolic acid|glycolic acid|mesh-list
111184716|NCT00472966|Hydroquinone|hydroquinone|mesh-list
111184717|NCT00472966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111184718|NCT00472966|Keratolytic Agents|keratolytic agents|mesh-ancestor
111184719|NCT00472966|Dermatologic Agents|dermatologic agents|mesh-ancestor
111184720|NCT00472966|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111184721|NCT00472966|Glucocorticoids|glucocorticoids|mesh-ancestor
111184722|NCT00472966|Hormones|hormones|mesh-ancestor
111184723|NCT00472966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111184724|NCT00472966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111184725|NCT00472966|Antioxidants|antioxidants|mesh-ancestor
111184726|NCT00472966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111184727|NCT00472966|Protective Agents|protective agents|mesh-ancestor
111184728|NCT00472966|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111184729|NCT01573780|Gemcitabine|gemcitabine|mesh-list
111184730|NCT01573780|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111184731|NCT01573780|Antimetabolites|antimetabolites|mesh-ancestor
111184732|NCT01573780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111184733|NCT01573780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111184734|NCT01547260|Gemcitabine|gemcitabine|mesh-list
111184735|NCT01547260|Lenalidomide|lenalidomide|mesh-list
111184736|NCT01547260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111184737|NCT01547260|Antimetabolites|antimetabolites|mesh-ancestor
111184738|NCT01547260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111184739|NCT01547260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111184740|NCT01547260|Immunologic Factors|immunologic factors|mesh-ancestor
111184741|NCT01547260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111184742|NCT01547260|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111184743|NCT01547260|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111184744|NCT01547260|Growth Substances|growth substances|mesh-ancestor
111184745|NCT01547260|Growth Inhibitors|growth inhibitors|mesh-ancestor
111184746|NCT04205266|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
111184748|NCT04205266|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
111184749|NCT04205266|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111184750|NCT01896388|Ifenprodil|ifenprodil|mesh-list
111184751|NCT01896388|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111184752|NCT01896388|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111184753|NCT01896388|Adrenergic Agents|adrenergic agents|mesh-ancestor
111184754|NCT01896388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111184755|NCT01896388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111184756|NCT01896388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111184757|NCT01896388|Vasodilator Agents|vasodilator agents|mesh-ancestor
111184758|NCT01896388|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111184759|NCT01896388|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111184760|NCT01125436|Vitamin D|vitamin d|mesh-list
111184761|NCT01125436|Cholecalciferol|cholecalciferol|mesh-list
111184762|NCT01125436|Vitamins|vitamins|mesh-ancestor
111184763|NCT01125436|Micronutrients|micronutrients|mesh-ancestor
111184764|NCT01125436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111184765|NCT01125436|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111184766|NCT01125436|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111184767|NCT04755322|Aspirin|aspirin|mesh-list
111184768|NCT04755322|Folic Acid|folic acid|mesh-list
111184769|NCT04755322|Hydroxychloroquine|hydroxychloroquine|mesh-list
110489583|NCT00739882|Antibodies|antibodies|mesh-list
111184770|NCT04755322|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111184771|NCT04755322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111184772|NCT04755322|Analgesics|analgesics|mesh-ancestor
111184773|NCT04755322|Sensory System Agents|sensory system agents|mesh-ancestor
111184774|NCT04755322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111184775|NCT04755322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111184776|NCT04755322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111184777|NCT04755322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111184778|NCT04755322|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111184779|NCT04755322|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111184780|NCT04755322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111184781|NCT04755322|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111184782|NCT04755322|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111184783|NCT04755322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111184784|NCT04755322|Antipyretics|antipyretics|mesh-ancestor
111184785|NCT04755322|Antimalarials|antimalarials|mesh-ancestor
111184786|NCT04755322|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111184787|NCT04755322|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110844431|NCT03935685|Serotonin Agents|serotonin agents|mesh-ancestor
111184788|NCT04755322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111184789|NCT04755322|Hematinics|hematinics|mesh-ancestor
111184790|NCT04755322|Vitamin B Complex|vitamin b complex|mesh-ancestor
111184791|NCT04755322|Vitamins|vitamins|mesh-ancestor
111184792|NCT04755322|Micronutrients|micronutrients|mesh-ancestor
111184793|NCT00436540|Clobetasol|clobetasol|mesh-list
111184794|NCT00436540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111184795|NCT00436540|Glucocorticoids|glucocorticoids|mesh-ancestor
111184796|NCT00436540|Hormones|hormones|mesh-ancestor
111184797|NCT00436540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111184798|NCT00436540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111184799|NCT00425230|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
111184800|NCT00425230|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111184801|NCT00425230|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111184802|NCT00425230|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111184803|NCT00425230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111184804|NCT00425230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111184805|NCT00425230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111184806|NCT00425230|Analgesics|analgesics|mesh-ancestor
111184807|NCT00425230|Sensory System Agents|sensory system agents|mesh-ancestor
111184808|NCT00425230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111184809|NCT00425230|Antidepressive Agents|antidepressive agents|mesh-ancestor
111184810|NCT00425230|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111184811|NCT00425230|Dopamine Agents|dopamine agents|mesh-ancestor
111184812|NCT04634578|Bevacizumab|bevacizumab|mesh-list
111184813|NCT04634578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111184814|NCT04634578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111184815|NCT04634578|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111184816|NCT04634578|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111184817|NCT04634578|Growth Substances|growth substances|mesh-ancestor
111184818|NCT04634578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111184819|NCT04634578|Growth Inhibitors|growth inhibitors|mesh-ancestor
111184820|NCT01066858|Tenofovir|tenofovir|mesh-list
111184821|NCT01066858|Antiviral Agents|antiviral agents|mesh-ancestor
111184822|NCT01066858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111184823|NCT01066858|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111184824|NCT01066858|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111184825|NCT01066858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111184826|NCT01066858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111184827|NCT01066858|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111184828|NCT01066858|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111184830|NCT04777552|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111184831|NCT04777552|Anticonvulsants|anticonvulsants|mesh-ancestor
111184832|NCT04777552|Antiemetics|antiemetics|mesh-ancestor
111184833|NCT04777552|Autonomic Agents|autonomic agents|mesh-ancestor
111184834|NCT04777552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111184835|NCT04777552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111184836|NCT04777552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111184837|NCT04777552|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111184838|NCT04777552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111184839|NCT04777552|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
111184840|NCT04777552|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111184841|NCT04777552|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111184842|NCT04777552|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111184843|NCT04777552|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111184844|NCT04777552|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111184845|NCT04777552|Anesthetics, General|anesthetics, general|mesh-ancestor
111184846|NCT04777552|Anesthetics|anesthetics|mesh-ancestor
111184847|NCT04777552|GABA Modulators|gaba modulators|mesh-ancestor
111184848|NCT04777552|GABA Agents|gaba agents|mesh-ancestor
111184849|NCT04777552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111184850|NCT04777552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111184851|NCT01506609|Paclitaxel|paclitaxel|mesh-list
111184852|NCT01506609|Carboplatin|carboplatin|mesh-list
111184853|NCT01506609|Temozolomide|temozolomide|mesh-list
111184854|NCT01506609|Veliparib|veliparib|mesh-list
111184855|NCT01506609|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111184856|NCT01506609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111184857|NCT01506609|Tubulin Modulators|tubulin modulators|mesh-ancestor
111184858|NCT01506609|Antimitotic Agents|antimitotic agents|mesh-ancestor
111184859|NCT01506609|Mitosis Modulators|mitosis modulators|mesh-ancestor
111184860|NCT01506609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111184861|NCT01506609|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111184862|NCT01506609|Alkylating Agents|alkylating agents|mesh-ancestor
111184863|NCT01506609|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111184864|NCT01506609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111184865|NCT04777162|Tislelizumab|tislelizumab|mesh-list
111184866|NCT04777162|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111184867|NCT04777162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111184868|NCT03027219|Alprostadil|alprostadil|mesh-list
111184869|NCT03027219|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111184870|NCT03027219|Vasodilator Agents|vasodilator agents|mesh-ancestor
111184871|NCT03027219|Urological Agents|urological agents|mesh-ancestor
111184872|NCT04776772|Complement System Proteins|complement system proteins|mesh-list
111184873|NCT04776772|Immunologic Factors|immunologic factors|mesh-ancestor
111184874|NCT04776772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111184875|NCT01506453|Gabapentin|gabapentin|mesh-list
111184876|NCT01506453|Analgesics|analgesics|mesh-ancestor
111184877|NCT01506453|Sensory System Agents|sensory system agents|mesh-ancestor
111184878|NCT01506453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111184879|NCT01506453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111184880|NCT01506453|Anticonvulsants|anticonvulsants|mesh-ancestor
111184881|NCT01506453|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111184882|NCT01506453|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111184883|NCT01506453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111184884|NCT01506453|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111184885|NCT01506453|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111184886|NCT01506453|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110489606|NCT04644289|Durvalumab|durvalumab|mesh-list
111184887|NCT01506453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111184888|NCT01506453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111184889|NCT01506453|Antimanic Agents|antimanic agents|mesh-ancestor
111184890|NCT04389580|Tamoxifen|tamoxifen|mesh-list
111184891|NCT04389580|Isotretinoin|isotretinoin|mesh-list
111184892|NCT04389580|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111184893|NCT04389580|Hormone Antagonists|hormone antagonists|mesh-ancestor
110902059|NCT05335655|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111184894|NCT04389580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111184895|NCT04389580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111184896|NCT04389580|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111184897|NCT04389580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111184898|NCT04389580|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111184899|NCT04389580|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111184900|NCT04389580|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111184901|NCT04389580|Dermatologic Agents|dermatologic agents|mesh-ancestor
111184902|NCT00199108|Dexamethasone|dexamethasone|mesh-list
111184903|NCT00199108|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111184904|NCT00199108|Antiemetics|antiemetics|mesh-ancestor
111184905|NCT00199108|Autonomic Agents|autonomic agents|mesh-ancestor
111184906|NCT00199108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111184907|NCT00199108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111184908|NCT00199108|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111184909|NCT00199108|Glucocorticoids|glucocorticoids|mesh-ancestor
111184910|NCT00199108|Hormones|hormones|mesh-ancestor
111184911|NCT00199108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111184912|NCT00199108|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111184913|NCT00199108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111184914|NCT01504971|Rabeprazole|rabeprazole|mesh-list
111184915|NCT01504971|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111184916|NCT01504971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111184917|NCT01504971|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111184918|NCT01504971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111184919|NCT01504971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111184920|NCT04753918|Ethiodized Oil|ethiodized oil|mesh-list
111184921|NCT04753918|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
111184922|NCT04753918|Trioxsalen|trioxsalen|mesh-list
111184923|NCT04753918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111184924|NCT04753918|Dermatologic Agents|dermatologic agents|mesh-ancestor
111184925|NCT04753918|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111184927|NCT04161664|Carboplatin|carboplatin|mesh-list
111184928|NCT04161664|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111184929|NCT04161664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111184930|NCT04161664|Tubulin Modulators|tubulin modulators|mesh-ancestor
111184931|NCT04161664|Antimitotic Agents|antimitotic agents|mesh-ancestor
111184932|NCT04161664|Mitosis Modulators|mitosis modulators|mesh-ancestor
111184933|NCT04161664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111184934|NCT00936832|Leucovorin|leucovorin|mesh-list
111184935|NCT00936832|Fluorouracil|fluorouracil|mesh-list
111184936|NCT00936832|Irinotecan|irinotecan|mesh-list
111184937|NCT00936832|Sunitinib|sunitinib|mesh-list
111184938|NCT00936832|Calcium|calcium|mesh-list
111184939|NCT00936832|Levoleucovorin|levoleucovorin|mesh-list
111184940|NCT00936832|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111184941|NCT00936832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111184942|NCT00936832|Antimetabolites|antimetabolites|mesh-ancestor
111184943|NCT00936832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111184944|NCT00936832|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111184945|NCT00936832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111184946|NCT00936832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111184947|NCT00936832|Immunologic Factors|immunologic factors|mesh-ancestor
111184948|NCT00936832|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111184949|NCT00936832|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111184950|NCT00936832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111184951|NCT00936832|Antidotes|antidotes|mesh-ancestor
111184952|NCT00936832|Protective Agents|protective agents|mesh-ancestor
111184953|NCT00936832|Vitamin B Complex|vitamin b complex|mesh-ancestor
111184954|NCT00936832|Vitamins|vitamins|mesh-ancestor
111184955|NCT00936832|Micronutrients|micronutrients|mesh-ancestor
111184956|NCT00936832|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111184957|NCT00936832|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111184958|NCT00936832|Growth Substances|growth substances|mesh-ancestor
111184959|NCT00936832|Growth Inhibitors|growth inhibitors|mesh-ancestor
111184960|NCT00936832|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111184961|NCT01479621|Fluticasone|fluticasone|mesh-list
111184962|NCT01479621|Xhance|xhance|mesh-list
111184963|NCT01479621|Albuterol|albuterol|mesh-list
111184964|NCT01479621|Adrenergic Agonists|adrenergic agonists|mesh-list
111184965|NCT01479621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111184966|NCT01479621|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111184967|NCT01479621|Autonomic Agents|autonomic agents|mesh-ancestor
111184968|NCT01479621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111184969|NCT01479621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111184970|NCT01479621|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111184971|NCT01479621|Respiratory System Agents|respiratory system agents|mesh-ancestor
111184972|NCT01479621|Dermatologic Agents|dermatologic agents|mesh-ancestor
111184973|NCT01479621|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111184974|NCT01479621|Tocolytic Agents|tocolytic agents|mesh-ancestor
111184975|NCT01479621|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111184976|NCT01479621|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111184977|NCT01479621|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111184978|NCT01479621|Adrenergic Agents|adrenergic agents|mesh-ancestor
111184979|NCT01479621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111184980|NCT01479621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111184981|NCT04776226|Citalopram|citalopram|mesh-list
111184982|NCT04776226|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111184983|NCT04776226|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111184984|NCT04776226|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111184985|NCT04776226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111184986|NCT04776226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111184987|NCT04776226|Serotonin Agents|serotonin agents|mesh-ancestor
111184988|NCT04776226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111184989|NCT04776226|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111184990|NCT04776226|Antidepressive Agents|antidepressive agents|mesh-ancestor
111184991|NCT04776226|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111184992|NCT02319304|Leucovorin|leucovorin|mesh-list
111184993|NCT02319304|Fluorouracil|fluorouracil|mesh-list
111184994|NCT02319304|Oxaliplatin|oxaliplatin|mesh-list
111184995|NCT02319304|Antimetabolites|antimetabolites|mesh-ancestor
111184996|NCT02319304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111184997|NCT02319304|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111184998|NCT02319304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111184999|NCT02319304|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111185000|NCT02319304|Immunologic Factors|immunologic factors|mesh-ancestor
111185001|NCT02319304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111185002|NCT02319304|Antidotes|antidotes|mesh-ancestor
111185003|NCT02319304|Protective Agents|protective agents|mesh-ancestor
111185004|NCT02319304|Vitamin B Complex|vitamin b complex|mesh-ancestor
111185005|NCT02319304|Vitamins|vitamins|mesh-ancestor
111185006|NCT02319304|Micronutrients|micronutrients|mesh-ancestor
111185007|NCT00885664|Ritonavir|ritonavir|mesh-list
111185008|NCT00885664|Lopinavir|lopinavir|mesh-list
111185009|NCT00885664|Tenofovir|tenofovir|mesh-list
111185010|NCT00885664|Emtricitabine|emtricitabine|mesh-list
111185011|NCT00885664|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
111185012|NCT00885664|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111185013|NCT00885664|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111185014|NCT00885664|Protease Inhibitors|protease inhibitors|mesh-ancestor
111185015|NCT00885664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111185016|NCT00885664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111185017|NCT00885664|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111185018|NCT00885664|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111185019|NCT00885664|Antiviral Agents|antiviral agents|mesh-ancestor
111185020|NCT00885664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111185021|NCT00885664|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111185022|NCT00885664|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111185023|NCT00885664|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111185024|NCT00885664|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111185025|NCT04784104|Epinephrine|epinephrine|mesh-list
111185026|NCT04784104|Racepinephrine|racepinephrine|mesh-list
111185027|NCT04784104|Bupivacaine|bupivacaine|mesh-list
111185028|NCT04784104|Prilocaine|prilocaine|mesh-list
111185029|NCT04784104|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111185030|NCT04784104|Epinephryl borate|epinephryl borate|mesh-list
111185031|NCT04784104|Anesthetics, Local|anesthetics, local|mesh-ancestor
111185032|NCT04784104|Anesthetics|anesthetics|mesh-ancestor
111185033|NCT04784104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111185034|NCT04784104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111185035|NCT04784104|Sensory System Agents|sensory system agents|mesh-ancestor
111185036|NCT04784104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111185037|NCT04784104|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111185038|NCT04784104|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111185039|NCT04784104|Adrenergic Agents|adrenergic agents|mesh-ancestor
111185040|NCT04784104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111185041|NCT04784104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111185042|NCT04784104|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111185043|NCT04784104|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111185044|NCT04784104|Autonomic Agents|autonomic agents|mesh-ancestor
111185045|NCT04784104|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111185046|NCT04784104|Respiratory System Agents|respiratory system agents|mesh-ancestor
111185047|NCT04784104|Mydriatics|mydriatics|mesh-ancestor
111185048|NCT04784104|Sympathomimetics|sympathomimetics|mesh-ancestor
111185049|NCT04784104|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111185050|NCT00880594|Desipramine|desipramine|mesh-list
111185051|NCT00880594|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
111185052|NCT00880594|Antidepressive Agents|antidepressive agents|mesh-ancestor
111185053|NCT00880594|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111185054|NCT00880594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111185055|NCT00880594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111185056|NCT00880594|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111185057|NCT00880594|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111185058|NCT00880594|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111185059|NCT00880594|Adrenergic Agents|adrenergic agents|mesh-ancestor
111185060|NCT00880594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111185061|NCT00880594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111185062|NCT04783870|Dapagliflozin|dapagliflozin|mesh-list
111185063|NCT04783870|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111185064|NCT04783870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111185065|NCT04783870|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111185066|NCT04783870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111185067|NCT04783636|Leuprolide|leuprolide|mesh-list
111185068|NCT04783636|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111185069|NCT04783636|Fertility Agents|fertility agents|mesh-ancestor
111185070|NCT04783636|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111185071|NCT04783636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111185072|NCT04783636|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111185073|NCT04783636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111185074|NCT00820846|Vaccines|vaccines|mesh-list
111185075|NCT00820846|Immunologic Factors|immunologic factors|mesh-ancestor
111185076|NCT00820846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111185077|NCT03364348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111185078|NCT03364348|Trastuzumab|trastuzumab|mesh-list
111185079|NCT03364348|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
111185080|NCT03364348|Maytansine|maytansine|mesh-list
111185081|NCT03364348|Antibodies|antibodies|mesh-list
111185082|NCT03364348|Immunoglobulins|immunoglobulins|mesh-list
111185083|NCT03364348|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111185084|NCT03364348|Immunoglobulin G|immunoglobulin g|mesh-list
111185085|NCT03364348|Immunoconjugates|immunoconjugates|mesh-list
111185086|NCT03364348|Immunologic Factors|immunologic factors|mesh-ancestor
111185087|NCT03364348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111185088|NCT03364348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111185089|NCT03364348|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111185090|NCT03364348|Tubulin Modulators|tubulin modulators|mesh-ancestor
111185091|NCT03364348|Antimitotic Agents|antimitotic agents|mesh-ancestor
111185092|NCT03364348|Mitosis Modulators|mitosis modulators|mesh-ancestor
111185093|NCT03364348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111185094|NCT03364348|Immunotoxins|immunotoxins|mesh-ancestor
111185095|NCT04782622|Apatinib|apatinib|mesh-list
111185096|NCT04782622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111185097|NCT04782622|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111185098|NCT04782622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111185099|NCT04782622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111185100|NCT04775212|Sevoflurane|sevoflurane|mesh-list
111185101|NCT04775212|Desflurane|desflurane|mesh-list
111185102|NCT04775212|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111185103|NCT04775212|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111185104|NCT04775212|Anesthetics, General|anesthetics, general|mesh-ancestor
111185105|NCT04775212|Anesthetics|anesthetics|mesh-ancestor
111185106|NCT04775212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111185107|NCT04775212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111185108|NCT04774822|Mydriatics|mydriatics|mesh-list
111185109|NCT04774822|Autonomic Agents|autonomic agents|mesh-ancestor
111185110|NCT04774822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111185111|NCT04774822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111185112|NCT04782388|Alprazolam|alprazolam|mesh-list
111185113|NCT04782388|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111185114|NCT04782388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111185115|NCT04782388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111185116|NCT04782388|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111185117|NCT04782388|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111185118|NCT04782388|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111185119|NCT04782388|GABA Modulators|gaba modulators|mesh-ancestor
111185120|NCT04782388|GABA Agents|gaba agents|mesh-ancestor
111185121|NCT04782388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110902281|NCT03632915|Anesthetics, General|anesthetics, general|mesh-ancestor
111185122|NCT04782388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111185123|NCT04782076|Dabigatran|dabigatran|mesh-list
111185124|NCT04782076|Antithrombins|antithrombins|mesh-ancestor
111185125|NCT04782076|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111185126|NCT04782076|Protease Inhibitors|protease inhibitors|mesh-ancestor
111185127|NCT04782076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111185128|NCT04782076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110489669|NCT02871713|Analgesics|analgesics|mesh-ancestor
111185129|NCT04782076|Anticoagulants|anticoagulants|mesh-ancestor
111185130|NCT04782310|Pregabalin|pregabalin|mesh-list
111185131|NCT04782310|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
111185132|NCT04782310|Analgesics|analgesics|mesh-ancestor
111185133|NCT04782310|Sensory System Agents|sensory system agents|mesh-ancestor
111185134|NCT04782310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111185135|NCT04782310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111185136|NCT04782310|Anticonvulsants|anticonvulsants|mesh-ancestor
111185137|NCT04782310|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111185138|NCT04782310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111185139|NCT04782310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111185140|NCT04782310|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111185142|NCT04782310|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111185143|NCT04782310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111185144|NCT04782310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111185145|NCT04782310|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111185146|NCT04782310|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111185147|NCT04782310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111185148|NCT04782310|Antidepressive Agents|antidepressive agents|mesh-ancestor
111185149|NCT04782310|Dopamine Agents|dopamine agents|mesh-ancestor
111185150|NCT03300544|Leucovorin|leucovorin|mesh-list
111185151|NCT03300544|Fluorouracil|fluorouracil|mesh-list
111185152|NCT03300544|Capecitabine|capecitabine|mesh-list
111185153|NCT03300544|Oxaliplatin|oxaliplatin|mesh-list
111185154|NCT03300544|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
111185155|NCT03300544|Antimetabolites|antimetabolites|mesh-ancestor
111185156|NCT03300544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111185157|NCT03300544|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111185158|NCT03300544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111185159|NCT03300544|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111185160|NCT03300544|Immunologic Factors|immunologic factors|mesh-ancestor
111185161|NCT03300544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111185162|NCT03300544|Antidotes|antidotes|mesh-ancestor
111185163|NCT03300544|Protective Agents|protective agents|mesh-ancestor
111185164|NCT03300544|Vitamin B Complex|vitamin b complex|mesh-ancestor
111185165|NCT03300544|Vitamins|vitamins|mesh-ancestor
111185166|NCT03300544|Micronutrients|micronutrients|mesh-ancestor
111185167|NCT03300544|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111185168|NCT03249844|Methylprednisolone|methylprednisolone|mesh-list
111185169|NCT03249844|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111185170|NCT03249844|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111185171|NCT03249844|Prednisolone|prednisolone|mesh-list
111185172|NCT03249844|Prednisolone acetate|prednisolone acetate|mesh-list
111185173|NCT03249844|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111185174|NCT03249844|Prednisolone phosphate|prednisolone phosphate|mesh-list
111185175|NCT03249844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111185176|NCT03249844|Antiemetics|antiemetics|mesh-ancestor
111185177|NCT03249844|Autonomic Agents|autonomic agents|mesh-ancestor
111185178|NCT03249844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111185179|NCT03249844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111185180|NCT03249844|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111185181|NCT03249844|Glucocorticoids|glucocorticoids|mesh-ancestor
111185182|NCT03249844|Hormones|hormones|mesh-ancestor
111185183|NCT03249844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111185184|NCT03249844|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111185185|NCT03249844|Protective Agents|protective agents|mesh-ancestor
111185186|NCT03249844|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111185187|NCT03249844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111185188|NCT00637624|Acetylcysteine|acetylcysteine|mesh-list
111185189|NCT00637624|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111185190|NCT00637624|Antiviral Agents|antiviral agents|mesh-ancestor
111185191|NCT00637624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111185192|NCT00637624|Expectorants|expectorants|mesh-ancestor
111185193|NCT00637624|Respiratory System Agents|respiratory system agents|mesh-ancestor
111185194|NCT00637624|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111185195|NCT00637624|Antioxidants|antioxidants|mesh-ancestor
110489678|NCT04342975|Vitamins|vitamins|mesh-ancestor
111185196|NCT00637624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111185197|NCT00637624|Protective Agents|protective agents|mesh-ancestor
111185198|NCT00637624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111185199|NCT00637624|Antidotes|antidotes|mesh-ancestor
111185201|NCT01479465|Fluorouracil|fluorouracil|mesh-list
111185202|NCT01479465|Irinotecan|irinotecan|mesh-list
111185203|NCT01479465|Antimetabolites|antimetabolites|mesh-ancestor
111185204|NCT01479465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111185205|NCT01479465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111185206|NCT01479465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111185207|NCT01479465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111185208|NCT01479465|Immunologic Factors|immunologic factors|mesh-ancestor
111185209|NCT01479465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111185210|NCT01479465|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111185211|NCT01479465|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111185212|NCT01479465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111185213|NCT01479465|Antidotes|antidotes|mesh-ancestor
111185214|NCT01479465|Protective Agents|protective agents|mesh-ancestor
111185215|NCT01479465|Vitamin B Complex|vitamin b complex|mesh-ancestor
111185216|NCT01479465|Vitamins|vitamins|mesh-ancestor
111185217|NCT01479465|Micronutrients|micronutrients|mesh-ancestor
111185218|NCT02428192|Nivolumab|nivolumab|mesh-list
111185219|NCT02428192|Ipilimumab|ipilimumab|mesh-list
111185220|NCT02428192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111185221|NCT02428192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111185222|NCT02428192|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111185223|NCT02428192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111185224|NCT04781686|Docetaxel|docetaxel|mesh-list
111185225|NCT04781686|Apatinib|apatinib|mesh-list
111185226|NCT04781686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111185227|NCT04781686|Tubulin Modulators|tubulin modulators|mesh-ancestor
111185228|NCT04781686|Antimitotic Agents|antimitotic agents|mesh-ancestor
111185229|NCT04781686|Mitosis Modulators|mitosis modulators|mesh-ancestor
111185230|NCT04781686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111185231|NCT04781686|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111185232|NCT04781686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111185233|NCT04780750|Docetaxel|docetaxel|mesh-list
111185234|NCT04780750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111185235|NCT04780750|Tubulin Modulators|tubulin modulators|mesh-ancestor
111185236|NCT04780750|Antimitotic Agents|antimitotic agents|mesh-ancestor
111185237|NCT04780750|Mitosis Modulators|mitosis modulators|mesh-ancestor
111185238|NCT04780750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111185239|NCT04780984|Bromides|bromides|mesh-list
111185240|NCT04780984|Tiotropium Bromide|tiotropium bromide|mesh-list
111185241|NCT04780984|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111185242|NCT04780984|Autonomic Agents|autonomic agents|mesh-ancestor
111185243|NCT04780984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111185244|NCT04780984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111185245|NCT04780984|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111185246|NCT04780984|Respiratory System Agents|respiratory system agents|mesh-ancestor
111185247|NCT04780984|Parasympatholytics|parasympatholytics|mesh-ancestor
111185248|NCT04780984|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111185249|NCT04780984|Cholinergic Agents|cholinergic agents|mesh-ancestor
111185250|NCT04780984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111185251|NCT04780984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111185252|NCT04780984|Anticonvulsants|anticonvulsants|mesh-ancestor
111185253|NCT02090374|Vitamin D|vitamin d|mesh-list
111185254|NCT02090374|Poly ICLC|poly iclc|mesh-list
111185255|NCT02090374|Vitamins|vitamins|mesh-ancestor
111185256|NCT02090374|Micronutrients|micronutrients|mesh-ancestor
111185257|NCT02090374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111185258|NCT02090374|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111185259|NCT02090374|Interferon Inducers|interferon inducers|mesh-ancestor
111185260|NCT02090374|Immunologic Factors|immunologic factors|mesh-ancestor
111185261|NCT02222740|Hydrocodone|hydrocodone|mesh-list
111185262|NCT02222740|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111185263|NCT02222740|Narcotics|narcotics|mesh-ancestor
110489689|NCT00734578|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111185264|NCT02222740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111185265|NCT02222740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111185266|NCT02222740|Analgesics|analgesics|mesh-ancestor
111185267|NCT02222740|Sensory System Agents|sensory system agents|mesh-ancestor
111185268|NCT02222740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111185269|NCT02222740|Antitussive Agents|antitussive agents|mesh-ancestor
111185270|NCT02222740|Respiratory System Agents|respiratory system agents|mesh-ancestor
111185271|NCT04780438|Dapagliflozin|dapagliflozin|mesh-list
111185272|NCT04780438|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111185273|NCT04780438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111185274|NCT04780438|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111185275|NCT04780438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111185277|NCT04779892|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111185278|NCT04779892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111185279|NCT04779892|Dermatologic Agents|dermatologic agents|mesh-ancestor
111185280|NCT04779892|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111185281|NCT04779892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111185282|NCT04389424|Tamoxifen|tamoxifen|mesh-list
111185283|NCT04389424|Anastrozole|anastrozole|mesh-list
111185284|NCT04389424|Exemestane|exemestane|mesh-list
111185285|NCT04389424|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111185286|NCT04389424|Hormone Antagonists|hormone antagonists|mesh-ancestor
111185287|NCT04389424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111185288|NCT04389424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111185289|NCT04389424|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111185290|NCT04389424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111185291|NCT04389424|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111185292|NCT04389424|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111185293|NCT04389424|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111185294|NCT04389424|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111185295|NCT04389424|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111185296|NCT04389424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111185297|NCT04389424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111185298|NCT04771390|Selitrectinib|selitrectinib|mesh-list
111185299|NCT04771390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111185300|NCT04771390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111185301|NCT04779502|Chlorhexidine|chlorhexidine|mesh-list
111185302|NCT04779502|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
111185303|NCT04779502|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111185304|NCT04779502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111185305|NCT04779502|Disinfectants|disinfectants|mesh-ancestor
111185306|NCT04779502|Dermatologic Agents|dermatologic agents|mesh-ancestor
111185307|NCT05411380|Capecitabine|capecitabine|mesh-list
111185308|NCT05411380|Letrozole|letrozole|mesh-list
111185309|NCT05411380|Fulvestrant|fulvestrant|mesh-list
111185310|NCT05411380|Anastrozole|anastrozole|mesh-list
111185311|NCT05411380|Exemestane|exemestane|mesh-list
111185312|NCT05411380|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111185313|NCT05411380|Antimetabolites|antimetabolites|mesh-ancestor
111185314|NCT05411380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111185315|NCT05411380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111185316|NCT05411380|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111185317|NCT05411380|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111185318|NCT05411380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111185319|NCT05411380|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111185320|NCT05411380|Hormone Antagonists|hormone antagonists|mesh-ancestor
111185321|NCT05411380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111185322|NCT05411380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111185323|NCT05411380|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111185324|NCT05411380|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
111185325|NCT04779580|Anesthetics|anesthetics|mesh-list
111185326|NCT04779580|Anesthetics, Local|anesthetics, local|mesh-list
111185327|NCT04779580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111185328|NCT04779580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111185329|NCT04779580|Sensory System Agents|sensory system agents|mesh-ancestor
111185330|NCT04779580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111185331|NCT04770688|Osimertinib|osimertinib|mesh-list
111185332|NCT04770688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111185333|NCT04770688|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111185334|NCT04770688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111185335|NCT04770688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111185336|NCT05390476|Capecitabine|capecitabine|mesh-list
111185337|NCT05390476|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111185338|NCT05390476|Antimetabolites|antimetabolites|mesh-ancestor
111185339|NCT05390476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111185340|NCT05390476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111185341|NCT05324332|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
111185342|NCT05324332|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111185343|NCT05324332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111185345|NCT04769908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111185346|NCT04769908|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111185347|NCT04769908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111185348|NCT04769908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111185349|NCT00054028|Suramin|suramin|mesh-list
111185350|NCT00054028|Paclitaxel|paclitaxel|mesh-list
111185351|NCT00054028|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111185352|NCT00054028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111185353|NCT00054028|Tubulin Modulators|tubulin modulators|mesh-ancestor
111185354|NCT00054028|Antimitotic Agents|antimitotic agents|mesh-ancestor
111185355|NCT00054028|Mitosis Modulators|mitosis modulators|mesh-ancestor
111185356|NCT00054028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111185357|NCT00054028|Antinematodal Agents|antinematodal agents|mesh-ancestor
111185358|NCT00054028|Anthelmintics|anthelmintics|mesh-ancestor
111185359|NCT00054028|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111185360|NCT00054028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111185361|NCT00054028|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
111185362|NCT00054028|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111185363|NCT00058240|Alvocidib|alvocidib|mesh-list
111185364|NCT00058240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111185365|NCT00058240|Growth Inhibitors|growth inhibitors|mesh-ancestor
111185366|NCT00058240|Growth Substances|growth substances|mesh-ancestor
111185367|NCT00058240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111185368|NCT00058240|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111185369|NCT00058240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111185370|NCT00058240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111185371|NCT03026907|Azathioprine|azathioprine|mesh-list
111185372|NCT03026907|Alitretinoin|alitretinoin|mesh-list
111185373|NCT03026907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111185374|NCT03026907|Dermatologic Agents|dermatologic agents|mesh-ancestor
111185375|NCT03026907|Antimetabolites|antimetabolites|mesh-ancestor
111185376|NCT03026907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111185377|NCT03026907|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111185378|NCT03026907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111185379|NCT03026907|Immunologic Factors|immunologic factors|mesh-ancestor
111185380|NCT03026907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111185381|NCT03026907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111185382|NCT00060424|Cyclosporine|cyclosporine|mesh-list
111185383|NCT00060424|Mycophenolic Acid|mycophenolic acid|mesh-list
111185384|NCT00060424|Fludarabine|fludarabine|mesh-list
111185385|NCT00060424|Fludarabine phosphate|fludarabine phosphate|mesh-list
111185386|NCT00060424|Cyclosporins|cyclosporins|mesh-list
111185387|NCT00060424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111185388|NCT00060424|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111185389|NCT00060424|Antimetabolites|antimetabolites|mesh-ancestor
111185390|NCT00060424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111185391|NCT00060424|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111185392|NCT00060424|Immunologic Factors|immunologic factors|mesh-ancestor
111185393|NCT00060424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111185394|NCT00060424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111185395|NCT00060424|Antifungal Agents|antifungal agents|mesh-ancestor
111185396|NCT00060424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111185397|NCT00060424|Dermatologic Agents|dermatologic agents|mesh-ancestor
111185398|NCT00060424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111185399|NCT00060424|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111185400|NCT00060424|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111185401|NCT00060424|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111185402|NCT00060424|Antitubercular Agents|antitubercular agents|mesh-ancestor
111185403|NCT00060424|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111185404|NCT00062764|Pioglitazone|pioglitazone|mesh-list
111185405|NCT00062764|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111185406|NCT00062764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111185407|NCT00063232|Metformin|metformin|mesh-list
111185408|NCT00063232|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111185409|NCT00063232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111185410|NCT00063622|Vitamin E|vitamin e|mesh-list
111185411|NCT00063622|Pioglitazone|pioglitazone|mesh-list
111185412|NCT00063622|Vitamins|vitamins|mesh-ancestor
111185413|NCT00063622|Micronutrients|micronutrients|mesh-ancestor
111185414|NCT00063622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111185415|NCT00063622|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111185416|NCT00063622|Antioxidants|antioxidants|mesh-ancestor
111185417|NCT00063622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111185418|NCT00063622|Protective Agents|protective agents|mesh-ancestor
111185419|NCT05605756|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111185420|NCT05605756|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111185421|NCT05605756|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111185422|NCT05605756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111185423|NCT05605756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111185424|NCT05605756|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111185425|NCT05605756|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111185426|NCT05605756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111185427|NCT05605756|Cholinergic Agents|cholinergic agents|mesh-ancestor
111185428|NCT05605756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111185430|NCT00153166|Atorvastatin|atorvastatin|mesh-list
111185431|NCT00153166|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111185432|NCT00153166|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111185433|NCT00153166|Antimetabolites|antimetabolites|mesh-ancestor
111185434|NCT00153166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111185435|NCT00153166|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111185436|NCT00153166|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111185437|NCT00153166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111185438|NCT00153166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111185439|NCT00153166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111185440|NCT00156910|Botulinum Toxins|botulinum toxins|mesh-list
111185441|NCT00156910|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111185442|NCT00156910|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111185443|NCT00156910|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111185444|NCT00156910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111185445|NCT00156910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111185446|NCT00156910|Cholinergic Agents|cholinergic agents|mesh-ancestor
111185447|NCT00156910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111185448|NCT00156910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111185449|NCT00156910|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111185450|NCT00156910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111185451|NCT01475721|Fluticasone|fluticasone|mesh-list
111185452|NCT01475721|Xhance|xhance|mesh-list
111185453|NCT01475721|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
111185454|NCT01475721|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111185455|NCT01475721|Autonomic Agents|autonomic agents|mesh-ancestor
111185456|NCT01475721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111185457|NCT01475721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111185458|NCT01475721|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111185459|NCT01475721|Respiratory System Agents|respiratory system agents|mesh-ancestor
111185460|NCT01475721|Glucocorticoids|glucocorticoids|mesh-ancestor
111185461|NCT01475721|Hormones|hormones|mesh-ancestor
111185462|NCT01475721|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111185463|NCT01475721|Sympathomimetics|sympathomimetics|mesh-ancestor
111185464|NCT01475721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111185465|NCT01475721|Dermatologic Agents|dermatologic agents|mesh-ancestor
111185466|NCT01475721|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111185467|NCT00065806|Atorvastatin|atorvastatin|mesh-list
111185468|NCT00065806|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111185469|NCT00065806|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111185470|NCT00065806|Antimetabolites|antimetabolites|mesh-ancestor
111185471|NCT00065806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111185472|NCT00065806|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111185473|NCT00065806|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111185474|NCT00065806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111185475|NCT00068770|Celecoxib|celecoxib|mesh-list
111185476|NCT00068770|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111185477|NCT00068770|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111185478|NCT00068770|Analgesics|analgesics|mesh-ancestor
111185479|NCT00068770|Sensory System Agents|sensory system agents|mesh-ancestor
111185480|NCT00068770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111185481|NCT00068770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111185482|NCT00068770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111185483|NCT00068770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111185484|NCT00068770|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111185485|NCT00068770|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111185486|NCT00068770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111185487|NCT00068770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111185488|NCT01475331|Ethanol|ethanol|mesh-list
111185489|NCT01475331|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111185490|NCT01475331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111185491|NCT01475331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111185492|NCT01475331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111185493|NCT01500213|Dexamethasone|dexamethasone|mesh-list
111185494|NCT01500213|Granisetron|granisetron|mesh-list
111185495|NCT01500213|Rolapitant|rolapitant|mesh-list
111185496|NCT01500213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110844552|NCT05173246|Paclitaxel|paclitaxel|mesh-list
111185497|NCT01500213|Antiemetics|antiemetics|mesh-ancestor
111185498|NCT01500213|Autonomic Agents|autonomic agents|mesh-ancestor
111185499|NCT01500213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111185500|NCT01500213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111185501|NCT01500213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111185502|NCT01500213|Glucocorticoids|glucocorticoids|mesh-ancestor
111185503|NCT01500213|Hormones|hormones|mesh-ancestor
111185504|NCT01500213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111185505|NCT01500213|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111185506|NCT01500213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111185507|NCT01500213|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111185508|NCT01500213|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111185509|NCT01500213|Serotonin Agents|serotonin agents|mesh-ancestor
111185510|NCT01500213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111185511|NCT01500213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111185512|NCT01500213|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
111185513|NCT00069160|Docetaxel|docetaxel|mesh-list
111185514|NCT00069160|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
111185515|NCT00069160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111185516|NCT00069160|Tubulin Modulators|tubulin modulators|mesh-ancestor
111185517|NCT00069160|Antimitotic Agents|antimitotic agents|mesh-ancestor
111185518|NCT00069160|Mitosis Modulators|mitosis modulators|mesh-ancestor
111185519|NCT00069160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111185520|NCT00069160|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111185521|NCT00071890|Aldesleukin|aldesleukin|mesh-list
111185522|NCT00071890|Interleukin-2|interleukin-2|mesh-list
111185523|NCT00071890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111185524|NCT00071890|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111185525|NCT00071890|Analgesics|analgesics|mesh-ancestor
111185526|NCT00071890|Sensory System Agents|sensory system agents|mesh-ancestor
111185527|NCT00071890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111185528|NCT00071890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111185529|NCT00071890|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111185530|NCT00071890|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111185531|NCT00071890|Antiviral Agents|antiviral agents|mesh-ancestor
111185532|NCT00071890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111185533|NCT01475253|Lidocaine|lidocaine|mesh-list
111185534|NCT01475253|Anesthetics, Local|anesthetics, local|mesh-ancestor
111185535|NCT01475253|Anesthetics|anesthetics|mesh-ancestor
111185536|NCT01475253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111185537|NCT01475253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111185538|NCT01475253|Sensory System Agents|sensory system agents|mesh-ancestor
111185539|NCT01475253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111185540|NCT01475253|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111185541|NCT01475253|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111185542|NCT01475253|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111185543|NCT01475253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111185544|NCT01475253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111185545|NCT00072514|Dexamethasone|dexamethasone|mesh-list
111185546|NCT00072514|Rituximab|rituximab|mesh-list
111185547|NCT00072514|Carboplatin|carboplatin|mesh-list
111185548|NCT00072514|Gemcitabine|gemcitabine|mesh-list
111185549|NCT00072514|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111185550|NCT00072514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111185551|NCT00072514|Immunologic Factors|immunologic factors|mesh-ancestor
111185552|NCT00072514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111185553|NCT00072514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111185554|NCT00072514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111185555|NCT00072514|Antiemetics|antiemetics|mesh-ancestor
111185556|NCT00072514|Autonomic Agents|autonomic agents|mesh-ancestor
111185557|NCT00072514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111185558|NCT00072514|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111185559|NCT00072514|Glucocorticoids|glucocorticoids|mesh-ancestor
111185560|NCT00072514|Hormones|hormones|mesh-ancestor
111185561|NCT00072514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111185562|NCT00072514|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111185563|NCT00072514|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111185564|NCT00072514|Antimetabolites|antimetabolites|mesh-ancestor
111185565|NCT00072514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111185566|NCT00074308|Bevacizumab|bevacizumab|mesh-list
110844557|NCT05173246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111185567|NCT00074308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111185569|NCT00074308|Antibodies|antibodies|mesh-list
111185570|NCT00074308|Immunoglobulins|immunoglobulins|mesh-list
111185571|NCT00074308|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111185572|NCT00074308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111185573|NCT00074308|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111185574|NCT00074308|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111185575|NCT00074308|Growth Substances|growth substances|mesh-ancestor
111185576|NCT00074308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111185577|NCT00074308|Growth Inhibitors|growth inhibitors|mesh-ancestor
111185578|NCT00074308|Immunologic Factors|immunologic factors|mesh-ancestor
111185579|NCT00074308|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111185580|NCT00074308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111185581|NCT00074308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111185582|NCT00166036|Atorvastatin|atorvastatin|mesh-list
111185583|NCT00166036|Pravastatin|pravastatin|mesh-list
111185584|NCT00166036|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111185585|NCT00166036|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111185586|NCT00166036|Antimetabolites|antimetabolites|mesh-ancestor
111185587|NCT00166036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111185588|NCT00166036|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111185589|NCT00166036|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111185590|NCT00166036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111185591|NCT00167206|Cyclophosphamide|cyclophosphamide|mesh-list
111185592|NCT00167206|Fludarabine|fludarabine|mesh-list
111185593|NCT00167206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111185594|NCT00167206|Immunologic Factors|immunologic factors|mesh-ancestor
111185595|NCT00167206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111185596|NCT00167206|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111185597|NCT00167206|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111185598|NCT00167206|Alkylating Agents|alkylating agents|mesh-ancestor
111185599|NCT00167206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111185600|NCT00167206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111185601|NCT00167206|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111185602|NCT01474551|Vemurafenib|vemurafenib|mesh-list
111185603|NCT01474551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111185604|NCT01474551|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111185605|NCT01474551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111185606|NCT01474551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111185607|NCT01499667|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
111185608|NCT01499667|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
111185609|NCT01499667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111185610|NCT01499667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111185611|NCT01499667|Immunologic Factors|immunologic factors|mesh-ancestor
111185612|NCT01499667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111185613|NCT00168298|Dexamethasone|dexamethasone|mesh-list
111185614|NCT00168298|Dexamethasone acetate|dexamethasone acetate|mesh-list
111185615|NCT00168298|BB 1101|bb 1101|mesh-list
111185616|NCT00168298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111185617|NCT00168298|Antiemetics|antiemetics|mesh-ancestor
111185618|NCT00168298|Autonomic Agents|autonomic agents|mesh-ancestor
111185619|NCT00168298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111185620|NCT00168298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111185621|NCT00168298|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111185622|NCT00168298|Glucocorticoids|glucocorticoids|mesh-ancestor
111185623|NCT00168298|Hormones|hormones|mesh-ancestor
111185624|NCT00168298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111185625|NCT00168298|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111185626|NCT00168298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111185627|NCT00168298|Protease Inhibitors|protease inhibitors|mesh-ancestor
111185628|NCT00168298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111185629|NCT00168298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111185630|NCT00076258|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
111185631|NCT00076258|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111185632|NCT00076258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111185633|NCT00076258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111185634|NCT00076258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111185635|NCT00076258|Serotonin Agents|serotonin agents|mesh-ancestor
111185636|NCT00076258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111185637|NCT00078286|Sertraline|sertraline|mesh-list
111185638|NCT00078286|Antidepressive Agents|antidepressive agents|mesh-ancestor
111185639|NCT00078286|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111185640|NCT00078286|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111185641|NCT00078286|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111185642|NCT00078286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111185643|NCT00078286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111185644|NCT00078286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111185645|NCT00078286|Serotonin Agents|serotonin agents|mesh-ancestor
111185646|NCT00078286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111185647|NCT00078754|Valproic Acid|valproic acid|mesh-list
111185648|NCT00078754|Fluoxetine|fluoxetine|mesh-list
111185649|NCT00078754|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111185650|NCT00078754|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111185651|NCT00078754|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111185652|NCT00078754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111185653|NCT00078754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111185654|NCT00078754|Serotonin Agents|serotonin agents|mesh-ancestor
111185655|NCT00078754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111185656|NCT00078754|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111185657|NCT00078754|Antidepressive Agents|antidepressive agents|mesh-ancestor
111185658|NCT00078754|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111185659|NCT00078754|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111185660|NCT00078754|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111185661|NCT00078754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111185662|NCT00078754|Anticonvulsants|anticonvulsants|mesh-ancestor
111185663|NCT00078754|GABA Agents|gaba agents|mesh-ancestor
111185664|NCT00078754|Antimanic Agents|antimanic agents|mesh-ancestor
111185665|NCT00078754|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111185666|NCT00078754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111185667|NCT00081328|Metformin|metformin|mesh-list
111185668|NCT00081328|Rosiglitazone|rosiglitazone|mesh-list
111185669|NCT00081328|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111185670|NCT00081328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111185671|NCT01499355|Mycophenolic Acid|mycophenolic acid|mesh-list
111185672|NCT01499355|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111185673|NCT01499355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111185674|NCT01499355|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111185675|NCT01499355|Antitubercular Agents|antitubercular agents|mesh-ancestor
111185676|NCT01499355|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111185677|NCT01499355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111185678|NCT01499355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111185679|NCT01499355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111185680|NCT00083122|Cisplatin|cisplatin|mesh-list
111185681|NCT00083122|Alvocidib|alvocidib|mesh-list
111185682|NCT00083122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111185683|NCT00083122|Growth Inhibitors|growth inhibitors|mesh-ancestor
111185684|NCT00083122|Growth Substances|growth substances|mesh-ancestor
111185685|NCT00083122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111185686|NCT00083122|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111185687|NCT00083122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111185688|NCT00083122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111185689|NCT01474239|Bevacizumab|bevacizumab|mesh-list
111185690|NCT01474239|Fotemustine|fotemustine|mesh-list
111185691|NCT01474239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111185692|NCT01474239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111185693|NCT01474239|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111185694|NCT01474239|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111185695|NCT01474239|Growth Substances|growth substances|mesh-ancestor
111185696|NCT01474239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111185697|NCT01474239|Growth Inhibitors|growth inhibitors|mesh-ancestor
111185698|NCT01473381|Dexetimide|dexetimide|mesh-list
111185699|NCT01473381|Citalopram|citalopram|mesh-list
111185700|NCT01473381|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
111185701|NCT01473381|Escitalopram|escitalopram|mesh-list
111185702|NCT01473381|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111185703|NCT01473381|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111185704|NCT01473381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111185705|NCT01473381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111185706|NCT01473381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111185707|NCT01473381|Serotonin Agents|serotonin agents|mesh-ancestor
111185708|NCT01473381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111185709|NCT01473381|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111185710|NCT01473381|Antidepressive Agents|antidepressive agents|mesh-ancestor
111185711|NCT01473381|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111185712|NCT01473381|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111185713|NCT01473381|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111185714|NCT01473381|Parasympatholytics|parasympatholytics|mesh-ancestor
111185715|NCT01473381|Autonomic Agents|autonomic agents|mesh-ancestor
111185716|NCT01473381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111185717|NCT01473381|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111185718|NCT01473381|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111185719|NCT01473381|Cholinergic Agents|cholinergic agents|mesh-ancestor
111185720|NCT01473381|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111185721|NCT01473381|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111185722|NCT00168454|Botulinum Toxins|botulinum toxins|mesh-list
111185723|NCT00168454|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111185724|NCT00168454|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111185725|NCT00168454|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111185726|NCT00168454|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111185727|NCT00168454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111185728|NCT00168454|Cholinergic Agents|cholinergic agents|mesh-ancestor
111185729|NCT00168454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111185730|NCT00168454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111185731|NCT00168454|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111185732|NCT00168454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111185733|NCT01499277|Vancomycin|vancomycin|mesh-list
111185734|NCT01499277|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
111185735|NCT01499277|Aztreonam|aztreonam|mesh-list
111185736|NCT01499277|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111185737|NCT01499277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111185738|NCT00176800|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
111185739|NCT00176800|Chelating Agents|chelating agents|mesh-ancestor
111185740|NCT00176800|Sequestering Agents|sequestering agents|mesh-ancestor
111185741|NCT00176800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111185742|NCT00176800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111185743|NCT00176800|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111185744|NCT00176800|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111185745|NCT00176800|Growth Substances|growth substances|mesh-ancestor
111185746|NCT00176800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111185747|NCT00176800|Growth Inhibitors|growth inhibitors|mesh-ancestor
111185748|NCT00176800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111185749|NCT00176878|Fludarabine|fludarabine|mesh-list
111185750|NCT00176878|Fludarabine phosphate|fludarabine phosphate|mesh-list
111185751|NCT00176878|Busulfan|busulfan|mesh-list
111185752|NCT00176878|Antilymphocyte Serum|antilymphocyte serum|mesh-list
111185753|NCT00176878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111185754|NCT00176878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111185755|NCT00176878|Antimetabolites|antimetabolites|mesh-ancestor
111185756|NCT00176878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111185757|NCT00176878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111185758|NCT00176878|Immunologic Factors|immunologic factors|mesh-ancestor
111185759|NCT00176878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111185760|NCT00176878|Alkylating Agents|alkylating agents|mesh-ancestor
111185761|NCT00176878|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111185762|NCT00176878|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111185763|NCT01898182|Kinetin|kinetin|mesh-list
111185764|NCT01898182|Plant Growth Regulators|plant growth regulators|mesh-ancestor
111185765|NCT01898182|Growth Substances|growth substances|mesh-ancestor
111185766|NCT01898182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111185767|NCT01499199|Dolutegravir|dolutegravir|mesh-list
111185768|NCT01499199|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111185769|NCT01499199|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111185770|NCT01499199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111185771|NCT01499199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111185772|NCT01499199|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111185773|NCT01499199|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111185774|NCT01499199|Antiviral Agents|antiviral agents|mesh-ancestor
111185775|NCT01499199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111185776|NCT00090844|Triptorelin Pamoate|triptorelin pamoate|mesh-list
111185777|NCT00090844|Luteolytic Agents|luteolytic agents|mesh-ancestor
111185778|NCT00090844|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111185779|NCT00090844|Contraceptive Agents|contraceptive agents|mesh-ancestor
111185780|NCT00090844|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111185781|NCT00090844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111185782|NCT00090844|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111185783|NCT00090844|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111185784|NCT00090844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111185785|NCT01897012|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111185786|NCT01897012|Romidepsin|romidepsin|mesh-list
111185787|NCT01897012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111185788|NCT01897012|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111185789|NCT01897012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111185790|NCT01897012|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111185791|NCT01897012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111185792|NCT01897012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111185793|NCT01498887|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
110489755|NCT00630110|Antimitotic Agents|antimitotic agents|mesh-ancestor
111185794|NCT01498887|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
110902960|NCT03544814|Cisplatin|cisplatin|mesh-list
111185795|NCT01498887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111185796|NCT01498887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111185797|NCT01498887|Immunologic Factors|immunologic factors|mesh-ancestor
111185798|NCT01498887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111185799|NCT01498185|Dapagliflozin|dapagliflozin|mesh-list
111185800|NCT01498185|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111185801|NCT01498185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111185802|NCT01498185|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111185803|NCT01498185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111185804|NCT01527357|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
111185805|NCT01527357|Fibrin Foam|fibrin foam|mesh-list
111185806|NCT01527357|Hemostatics|hemostatics|mesh-ancestor
111185807|NCT01527357|Coagulants|coagulants|mesh-ancestor
111185808|NCT00181714|Methylphenidate|methylphenidate|mesh-list
111185809|NCT00181714|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111185810|NCT00181714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111185811|NCT00181714|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111185812|NCT00181714|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111185813|NCT00181714|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111185814|NCT00181714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110844601|NCT03258762|Antidotes|antidotes|mesh-ancestor
111185815|NCT00181714|Dopamine Agents|dopamine agents|mesh-ancestor
111185816|NCT00181714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111185818|NCT01472835|Midazolam|midazolam|mesh-list
111185819|NCT01472835|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111185820|NCT01472835|Narcotics|narcotics|mesh-ancestor
111185821|NCT01472835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111185822|NCT01472835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111185823|NCT01472835|Analgesics|analgesics|mesh-ancestor
111185824|NCT01472835|Sensory System Agents|sensory system agents|mesh-ancestor
111185825|NCT01472835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111185826|NCT01472835|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111185827|NCT01472835|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111185828|NCT01472835|Anesthetics, General|anesthetics, general|mesh-ancestor
111185829|NCT01472835|Anesthetics|anesthetics|mesh-ancestor
111185830|NCT01472835|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111185831|NCT01472835|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111185832|NCT01472835|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111185833|NCT01472835|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111185834|NCT01472835|GABA Modulators|gaba modulators|mesh-ancestor
111185835|NCT01472835|GABA Agents|gaba agents|mesh-ancestor
111185836|NCT01472835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111185837|NCT01472835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111185838|NCT00185692|Acetaminophen|acetaminophen|mesh-list
111185839|NCT00185692|Cyclosporine|cyclosporine|mesh-list
111185840|NCT00185692|Mycophenolic Acid|mycophenolic acid|mesh-list
111185841|NCT00185692|Methylprednisolone|methylprednisolone|mesh-list
111185842|NCT00185692|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111185843|NCT00185692|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111185844|NCT00185692|Prednisolone|prednisolone|mesh-list
111185845|NCT00185692|Prednisolone acetate|prednisolone acetate|mesh-list
111185846|NCT00185692|Hydrocortisone|hydrocortisone|mesh-list
111185847|NCT00185692|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
111185848|NCT00185692|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
111185849|NCT00185692|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
111185850|NCT00185692|Cyclosporins|cyclosporins|mesh-list
111185851|NCT00185692|Antilymphocyte Serum|antilymphocyte serum|mesh-list
111185852|NCT00185692|Lenograstim|lenograstim|mesh-list
111185853|NCT00185692|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111185854|NCT00185692|Prednisolone phosphate|prednisolone phosphate|mesh-list
111185855|NCT00185692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111185856|NCT00185692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111185857|NCT00185692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111185858|NCT00185692|Immunologic Factors|immunologic factors|mesh-ancestor
111185859|NCT00185692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111185860|NCT00185692|Antifungal Agents|antifungal agents|mesh-ancestor
111185861|NCT00185692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111185862|NCT00185692|Dermatologic Agents|dermatologic agents|mesh-ancestor
111185863|NCT00185692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111185864|NCT00185692|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111185865|NCT00185692|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111185866|NCT00185692|Analgesics|analgesics|mesh-ancestor
111185867|NCT00185692|Sensory System Agents|sensory system agents|mesh-ancestor
111185868|NCT00185692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111185869|NCT00185692|Antipyretics|antipyretics|mesh-ancestor
111185870|NCT00185692|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111185871|NCT00185692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111185872|NCT00185692|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111185873|NCT00185692|Antitubercular Agents|antitubercular agents|mesh-ancestor
111185874|NCT00185692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111185875|NCT00185692|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111185876|NCT00185692|Antiemetics|antiemetics|mesh-ancestor
111185877|NCT00185692|Autonomic Agents|autonomic agents|mesh-ancestor
111185878|NCT00185692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111185879|NCT00185692|Glucocorticoids|glucocorticoids|mesh-ancestor
111185880|NCT00185692|Hormones|hormones|mesh-ancestor
111185881|NCT00185692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111185882|NCT00185692|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111185883|NCT00185692|Protective Agents|protective agents|mesh-ancestor
111185884|NCT00185692|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111185885|NCT00185692|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111185886|NCT01526733|Insulin|insulin|mesh-list
111185887|NCT01526733|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111185888|NCT01526733|Insulin Aspart|insulin aspart|mesh-list
111185889|NCT01526733|Insulin Lispro|insulin lispro|mesh-list
111185890|NCT01526733|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111185891|NCT01526733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111185892|NCT00094900|Rilonacept|rilonacept|mesh-list
111185893|NCT00094900|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111185894|NCT00096460|Cyclophosphamide|cyclophosphamide|mesh-list
111185895|NCT00096460|Carmustine|carmustine|mesh-list
111185896|NCT00096460|Rituximab|rituximab|mesh-list
111185897|NCT00096460|Methotrexate|methotrexate|mesh-list
111185898|NCT00096460|Fludarabine|fludarabine|mesh-list
111185899|NCT00096460|Etoposide|etoposide|mesh-list
111185900|NCT00096460|Tacrolimus|tacrolimus|mesh-list
111185901|NCT00096460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111185902|NCT00096460|Immunologic Factors|immunologic factors|mesh-ancestor
111185903|NCT00096460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111185904|NCT00096460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111185905|NCT00096460|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111185906|NCT00096460|Alkylating Agents|alkylating agents|mesh-ancestor
111185907|NCT00096460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111185908|NCT00096460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111185909|NCT00096460|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111185910|NCT00096460|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111185911|NCT00096460|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111185912|NCT00096460|Abortifacient Agents|abortifacient agents|mesh-ancestor
111185913|NCT00096460|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111185914|NCT00096460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111185915|NCT00096460|Antimetabolites|antimetabolites|mesh-ancestor
111185916|NCT00096460|Dermatologic Agents|dermatologic agents|mesh-ancestor
111185917|NCT00096460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111185918|NCT00096460|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111185919|NCT00096460|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111185920|NCT00096460|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111185921|NCT00096460|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111185922|NCT00096460|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111185923|NCT00096460|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111185924|NCT00006178|Sirolimus|sirolimus|mesh-list
111185925|NCT00006178|Thymoglobulin|thymoglobulin|mesh-list
111185926|NCT00006178|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111185927|NCT00006178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111185928|NCT00006178|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111185929|NCT00006178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111185930|NCT00006178|Antifungal Agents|antifungal agents|mesh-ancestor
111185931|NCT00006178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110489772|NCT04284098|Analgesics|analgesics|mesh-ancestor
111185932|NCT00006178|Immunologic Factors|immunologic factors|mesh-ancestor
111185933|NCT00006178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111185934|NCT00097708|Anti-Anxiety Agents|anti-anxiety agents|mesh-list
111185935|NCT00097708|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111185936|NCT00097708|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111185937|NCT00097708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111185938|NCT00097708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111185939|NCT00098956|Topotecan|topotecan|mesh-list
111185940|NCT00098956|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
111185941|NCT00098956|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111185942|NCT00098956|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111185943|NCT00098956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111185944|NCT00098956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110903109|NCT05960110|Fluorides|fluorides|mesh-list
111185945|NCT00098956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111185946|NCT00098956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111185947|NCT02197156|Acetaminophen|acetaminophen|mesh-list
111185948|NCT02197156|Hydrocodone|hydrocodone|mesh-list
111185949|NCT02197156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111185950|NCT02197156|Analgesics|analgesics|mesh-ancestor
111185951|NCT02197156|Sensory System Agents|sensory system agents|mesh-ancestor
111185952|NCT02197156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111185953|NCT02197156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111185954|NCT02197156|Antipyretics|antipyretics|mesh-ancestor
111185955|NCT02197156|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111185956|NCT02197156|Narcotics|narcotics|mesh-ancestor
111185957|NCT02197156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111185958|NCT02197156|Antitussive Agents|antitussive agents|mesh-ancestor
111185959|NCT02197156|Respiratory System Agents|respiratory system agents|mesh-ancestor
111185960|NCT00187720|Metformin|metformin|mesh-list
111185961|NCT00187720|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111185962|NCT00187720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111185963|NCT00006244|Interferons|interferons|mesh-list
111185964|NCT00006244|Interferon-alpha|interferon-alpha|mesh-list
111185965|NCT00006244|Aldesleukin|aldesleukin|mesh-list
111185966|NCT00006244|Interferon alpha-2|interferon alpha-2|mesh-list
111185967|NCT00006244|Melphalan|melphalan|mesh-list
111185968|NCT00006244|Interleukin-2|interleukin-2|mesh-list
111185969|NCT00006244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111185970|NCT00006244|Antiviral Agents|antiviral agents|mesh-ancestor
111185971|NCT00006244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111185972|NCT00006244|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111185973|NCT00006244|Alkylating Agents|alkylating agents|mesh-ancestor
111185974|NCT00006244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111185975|NCT00006244|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111185976|NCT00006244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111185977|NCT00006244|Immunologic Factors|immunologic factors|mesh-ancestor
111185978|NCT00006244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111185979|NCT00006244|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111185980|NCT00006244|Analgesics|analgesics|mesh-ancestor
111185981|NCT00006244|Sensory System Agents|sensory system agents|mesh-ancestor
111185982|NCT00006244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111185983|NCT00006244|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111185984|NCT00006244|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111185985|NCT01525875|Magnesium Oxide|magnesium oxide|mesh-list
111185986|NCT01525875|Antacids|antacids|mesh-ancestor
111185987|NCT01525875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111185988|NCT01525875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111185989|NCT01525641|Pramipexole|pramipexole|mesh-list
111185990|NCT01525641|Antioxidants|antioxidants|mesh-ancestor
111185991|NCT01525641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111185992|NCT01525641|Protective Agents|protective agents|mesh-ancestor
111185993|NCT01525641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111185994|NCT01525641|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111185995|NCT01525641|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111185996|NCT01525641|Dopamine Agonists|dopamine agonists|mesh-ancestor
111185997|NCT01525641|Dopamine Agents|dopamine agents|mesh-ancestor
111185998|NCT01525641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111185999|NCT00006400|Hydroxyurea|hydroxyurea|mesh-list
111186000|NCT00006400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111186001|NCT00006400|Antisickling Agents|antisickling agents|mesh-ancestor
111186002|NCT00006400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111186003|NCT00006400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111186004|NCT00006400|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111186005|NCT01496469|Febuxostat|febuxostat|mesh-list
111186006|NCT01496469|Gout Suppressants|gout suppressants|mesh-ancestor
111186007|NCT01496469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111186008|NCT00189436|Budesonide|budesonide|mesh-list
111186009|NCT00189436|Albuterol|albuterol|mesh-list
111186010|NCT00189436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111186011|NCT00189436|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111186012|NCT00189436|Autonomic Agents|autonomic agents|mesh-ancestor
111186013|NCT00189436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111186014|NCT00189436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111186015|NCT00189436|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111186016|NCT00189436|Respiratory System Agents|respiratory system agents|mesh-ancestor
111186017|NCT00189436|Glucocorticoids|glucocorticoids|mesh-ancestor
111186018|NCT00189436|Hormones|hormones|mesh-ancestor
111186019|NCT00189436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111186020|NCT00189436|Tocolytic Agents|tocolytic agents|mesh-ancestor
111186021|NCT00189436|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111186022|NCT00189436|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111186023|NCT00189436|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111186024|NCT00189436|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111186025|NCT00189436|Adrenergic Agents|adrenergic agents|mesh-ancestor
111186026|NCT00189436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111186027|NCT00189436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111186028|NCT01471353|Capecitabine|capecitabine|mesh-list
111186029|NCT01471353|Sorafenib|sorafenib|mesh-list
111186030|NCT01471353|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111186031|NCT01471353|Antimetabolites|antimetabolites|mesh-ancestor
111186032|NCT01471353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111186033|NCT01471353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111186034|NCT01471353|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111186035|NCT01471353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111186036|NCT01525407|Atorvastatin|atorvastatin|mesh-list
111186037|NCT01525407|Calcium|calcium|mesh-list
111186038|NCT01525407|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111186039|NCT01525407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111186040|NCT01525407|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111186041|NCT01525407|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111186042|NCT01525407|Antimetabolites|antimetabolites|mesh-ancestor
111186043|NCT01525407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111186044|NCT01525407|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111186045|NCT01525407|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111186046|NCT01525407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111186047|NCT01471197|Pemetrexed|pemetrexed|mesh-list
111186048|NCT01471197|Ipilimumab|ipilimumab|mesh-list
111186049|NCT01471197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111186050|NCT01471197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111186051|NCT01471197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111186052|NCT01471197|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111186053|NCT01471197|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111186054|NCT01471197|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111186055|NCT01471197|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111186056|NCT04408989|Bevacizumab|bevacizumab|mesh-list
111186057|NCT04408989|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111186058|NCT04408989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111186059|NCT04408989|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111186060|NCT04408989|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111186061|NCT04408989|Growth Substances|growth substances|mesh-ancestor
111186062|NCT04408989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111186063|NCT04408989|Growth Inhibitors|growth inhibitors|mesh-ancestor
111186064|NCT00011986|Paclitaxel|paclitaxel|mesh-list
111186065|NCT00011986|Carboplatin|carboplatin|mesh-list
111186066|NCT00011986|Gemcitabine|gemcitabine|mesh-list
111186067|NCT00011986|Doxorubicin|doxorubicin|mesh-list
111186068|NCT00011986|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111186069|NCT00011986|Topotecan|topotecan|mesh-list
111186070|NCT00011986|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111186071|NCT00011986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111186072|NCT00011986|Tubulin Modulators|tubulin modulators|mesh-ancestor
111186073|NCT00011986|Antimitotic Agents|antimitotic agents|mesh-ancestor
111186074|NCT00011986|Mitosis Modulators|mitosis modulators|mesh-ancestor
111186075|NCT00011986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111186076|NCT00011986|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111186077|NCT00011986|Antimetabolites|antimetabolites|mesh-ancestor
111186078|NCT00011986|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111186079|NCT00011986|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111186080|NCT00011986|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111186081|NCT00011986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111186082|NCT00011986|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111186083|NCT01898416|Aminolevulinic Acid|aminolevulinic acid|mesh-list
111186084|NCT01898416|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111186085|NCT01898416|Dermatologic Agents|dermatologic agents|mesh-ancestor
111186086|NCT01524783|Everolimus|everolimus|mesh-list
111186087|NCT01524783|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111186088|NCT01524783|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111186089|NCT01524783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111186090|NCT01524783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111186091|NCT01524783|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111186092|NCT01524783|Immunologic Factors|immunologic factors|mesh-ancestor
111186093|NCT01524783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111186094|NCT01524783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111186095|NCT01494987|Glimepiride|glimepiride|mesh-list
111186096|NCT01494987|Ranolazine|ranolazine|mesh-list
111186097|NCT01494987|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111186098|NCT01494987|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111186099|NCT01494987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111186100|NCT01494987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111186101|NCT01494987|Immunologic Factors|immunologic factors|mesh-ancestor
111186102|NCT01494987|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111186103|NCT01494987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111186104|NCT01494987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111186105|NCT04409769|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
111186106|NCT04409769|Ceftobiprole|ceftobiprole|mesh-list
111186107|NCT04409769|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
111186108|NCT04409769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111186109|NCT04409769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111186110|NCT01524627|Varenicline|varenicline|mesh-list
111186111|NCT01524627|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111186112|NCT01524627|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111186113|NCT01524627|Cholinergic Agents|cholinergic agents|mesh-ancestor
111186114|NCT01524627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111186115|NCT01524627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111186116|NCT01524627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111186117|NCT01469637|Sulfamethoxazole|sulfamethoxazole|mesh-list
111186118|NCT01469637|Mesalamine|mesalamine|mesh-list
111186119|NCT01469637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111186120|NCT01469637|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111186121|NCT01469637|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111186122|NCT01469637|Analgesics|analgesics|mesh-ancestor
111186123|NCT01469637|Sensory System Agents|sensory system agents|mesh-ancestor
111186124|NCT01469637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111186125|NCT01469637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111186126|NCT01469637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111186127|NCT01469637|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111186128|NCT04409223|Sunitinib|sunitinib|mesh-list
111186129|NCT04409223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111186130|NCT04409223|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111186131|NCT04409223|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111186132|NCT04409223|Growth Substances|growth substances|mesh-ancestor
111186133|NCT04409223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111186134|NCT04409223|Growth Inhibitors|growth inhibitors|mesh-ancestor
111186135|NCT04409223|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111186136|NCT04409223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111186137|NCT04409223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111186138|NCT00012298|Rituximab|rituximab|mesh-list
111186139|NCT00012298|Oprelvekin|oprelvekin|mesh-list
111186140|NCT00012298|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111186141|NCT00012298|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111186142|NCT00012298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111186143|NCT00012298|Immunologic Factors|immunologic factors|mesh-ancestor
111186144|NCT00012298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111186145|NCT00012298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111186146|NCT00193258|Bevacizumab|bevacizumab|mesh-list
111186147|NCT00193258|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111186148|NCT00193258|Imatinib Mesylate|imatinib mesylate|mesh-list
111186149|NCT00193258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111186150|NCT00193258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111186151|NCT00193258|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111186152|NCT00193258|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111186153|NCT00193258|Growth Substances|growth substances|mesh-ancestor
111186154|NCT00193258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111186155|NCT00193258|Growth Inhibitors|growth inhibitors|mesh-ancestor
111186156|NCT00193258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111186157|NCT00193258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111186158|NCT00193258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111186159|NCT00029536|Progesterone|progesterone|mesh-list
111186160|NCT00029536|Progestins|progestins|mesh-ancestor
111186161|NCT00029536|Hormones|hormones|mesh-ancestor
111186162|NCT00029536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111186163|NCT00029536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111186164|NCT00193492|Bevacizumab|bevacizumab|mesh-list
111186165|NCT00193492|Rituximab|rituximab|mesh-list
111186166|NCT00193492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111186167|NCT00193492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111186168|NCT00193492|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111186169|NCT00193492|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111186170|NCT00193492|Growth Substances|growth substances|mesh-ancestor
111186171|NCT00193492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111186172|NCT00193492|Growth Inhibitors|growth inhibitors|mesh-ancestor
111186173|NCT00193492|Immunologic Factors|immunologic factors|mesh-ancestor
110903335|NCT05789173|Narcotics|narcotics|mesh-ancestor
111186174|NCT00193492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111186175|NCT00194116|Valproic Acid|valproic acid|mesh-list
111186176|NCT00194116|Anticonvulsants|anticonvulsants|mesh-ancestor
111186177|NCT00194116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111186178|NCT00194116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111186179|NCT00194116|GABA Agents|gaba agents|mesh-ancestor
111186180|NCT00194116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111186181|NCT00194116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111186182|NCT00194116|Antimanic Agents|antimanic agents|mesh-ancestor
111186183|NCT00194116|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111186184|NCT00194116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111186185|NCT00194116|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111186186|NCT02096458|Dexlansoprazole|dexlansoprazole|mesh-list
111186187|NCT02096458|Lansoprazole|lansoprazole|mesh-list
111186188|NCT02096458|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111186189|NCT02096458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111186190|NCT02096458|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111186191|NCT02096458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111186192|NCT02096458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111186193|NCT00194896|Rosiglitazone|rosiglitazone|mesh-list
111186195|NCT00194896|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111186196|NCT00194896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111186197|NCT04348474|Azithromycin|azithromycin|mesh-list
111186198|NCT04348474|Hydroxychloroquine|hydroxychloroquine|mesh-list
111186199|NCT04348474|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111186200|NCT04348474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111186201|NCT04348474|Antimalarials|antimalarials|mesh-ancestor
111186202|NCT04348474|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111186203|NCT04348474|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111186204|NCT04348474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111186205|NCT04348474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111186206|NCT04348474|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111186207|NCT00107536|Lapatinib|lapatinib|mesh-list
111186208|NCT00107536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111186209|NCT00107536|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111186210|NCT00107536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111186211|NCT00107536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111186212|NCT00108550|Gabapentin|gabapentin|mesh-list
111186213|NCT00108550|Analgesics|analgesics|mesh-ancestor
111186214|NCT00108550|Sensory System Agents|sensory system agents|mesh-ancestor
111186215|NCT00108550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111186216|NCT00108550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111186217|NCT00108550|Anticonvulsants|anticonvulsants|mesh-ancestor
111186218|NCT00108550|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111186219|NCT00108550|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111186220|NCT00108550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111186221|NCT00108550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111186222|NCT00108550|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111186223|NCT00108550|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111186224|NCT00108550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111186225|NCT00108550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111186226|NCT00108550|Antimanic Agents|antimanic agents|mesh-ancestor
111186227|NCT02093962|Pemetrexed|pemetrexed|mesh-list
111186228|NCT02093962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111186229|NCT02093962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111186230|NCT02093962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111186231|NCT02093962|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111186232|NCT02093962|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111186233|NCT00200902|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
111186234|NCT00200902|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
111186235|NCT00200902|Escitalopram|escitalopram|mesh-list
111186236|NCT00200902|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111186237|NCT00200902|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111186238|NCT00200902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111186239|NCT00200902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111186240|NCT00200902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111186241|NCT00200902|Serotonin Agents|serotonin agents|mesh-ancestor
111186242|NCT00200902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111186243|NCT00200902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111186244|NCT00200902|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111186245|NCT00200902|Antidepressive Agents|antidepressive agents|mesh-ancestor
111186246|NCT00200902|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111186247|NCT00200902|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111186248|NCT00200902|Analgesics|analgesics|mesh-ancestor
111186249|NCT00200902|Sensory System Agents|sensory system agents|mesh-ancestor
111186250|NCT00200902|Dopamine Agents|dopamine agents|mesh-ancestor
111186252|NCT00201448|Immunologic Factors|immunologic factors|mesh-ancestor
111186253|NCT00201448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111186254|NCT00201760|Gemcitabine|gemcitabine|mesh-list
111186255|NCT00201760|Trastuzumab|trastuzumab|mesh-list
111186256|NCT00201760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111186257|NCT00201760|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111186258|NCT00201760|Antimetabolites|antimetabolites|mesh-ancestor
110489809|NCT04280588|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
111186259|NCT00201760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111186260|NCT00201760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111186261|NCT00201838|Etanercept|etanercept|mesh-list
111186262|NCT00201838|Gemcitabine|gemcitabine|mesh-list
111186263|NCT00201838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111186264|NCT00201838|Antimetabolites|antimetabolites|mesh-ancestor
111186265|NCT00201838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111186266|NCT00201838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111186267|NCT00201838|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111186268|NCT00201838|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111186269|NCT00201838|Analgesics|analgesics|mesh-ancestor
111186270|NCT00201838|Sensory System Agents|sensory system agents|mesh-ancestor
111186271|NCT00201838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111186272|NCT00201838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111186273|NCT00201838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111186274|NCT00201838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111186275|NCT00201838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111186276|NCT00201838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111186277|NCT00201838|Immunologic Factors|immunologic factors|mesh-ancestor
111186278|NCT00040846|Cyclosporine|cyclosporine|mesh-list
111186279|NCT00040846|Mycophenolic Acid|mycophenolic acid|mesh-list
111186280|NCT00040846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111186281|NCT00040846|Alemtuzumab|alemtuzumab|mesh-list
111186282|NCT00040846|Fludarabine|fludarabine|mesh-list
111186283|NCT00040846|Fludarabine phosphate|fludarabine phosphate|mesh-list
111186284|NCT00040846|Antibodies|antibodies|mesh-list
111186285|NCT00040846|Immunoglobulins|immunoglobulins|mesh-list
111186286|NCT00040846|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111186287|NCT00040846|Cyclosporins|cyclosporins|mesh-list
111186288|NCT00040846|Immunologic Factors|immunologic factors|mesh-ancestor
111186289|NCT00040846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111186290|NCT00040846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111186291|NCT00040846|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111186292|NCT00040846|Antimetabolites|antimetabolites|mesh-ancestor
111186293|NCT00040846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111186294|NCT00040846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111186295|NCT00040846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111186296|NCT00040846|Antifungal Agents|antifungal agents|mesh-ancestor
111186297|NCT00040846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111186298|NCT00040846|Dermatologic Agents|dermatologic agents|mesh-ancestor
111186299|NCT00040846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111186300|NCT00040846|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111186301|NCT00040846|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111186302|NCT00040846|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111186303|NCT00040846|Antitubercular Agents|antitubercular agents|mesh-ancestor
111186304|NCT00040846|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111186305|NCT00041938|Aspirin|aspirin|mesh-list
111186306|NCT00041938|Warfarin|warfarin|mesh-list
111186307|NCT00041938|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111186308|NCT00041938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111186309|NCT00041938|Analgesics|analgesics|mesh-ancestor
111186310|NCT00041938|Sensory System Agents|sensory system agents|mesh-ancestor
110844643|NCT01271231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111186311|NCT00041938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111186312|NCT00041938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111186313|NCT00041938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111186314|NCT00041938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111186315|NCT00041938|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111186316|NCT00041938|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111186317|NCT00041938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111186318|NCT00041938|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111186319|NCT00041938|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111186320|NCT00041938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111186321|NCT00041938|Antipyretics|antipyretics|mesh-ancestor
111186322|NCT00041938|Anticoagulants|anticoagulants|mesh-ancestor
111186323|NCT00202930|Rituximab|rituximab|mesh-list
111186324|NCT00202930|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111186325|NCT00202930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111186326|NCT00202930|Immunologic Factors|immunologic factors|mesh-ancestor
111186327|NCT00202930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111186328|NCT00202930|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111186329|NCT00044044|Haloperidol|haloperidol|mesh-list
111186330|NCT00044044|Haloperidol decanoate|haloperidol decanoate|mesh-list
111186331|NCT00044044|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
111186332|NCT00044044|Antiemetics|antiemetics|mesh-ancestor
111186333|NCT00044044|Autonomic Agents|autonomic agents|mesh-ancestor
111186334|NCT00044044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111186335|NCT00044044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111186336|NCT00044044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111186337|NCT00044044|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111186338|NCT00044044|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111186339|NCT00044044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111186340|NCT00044044|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111186341|NCT00044044|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111186342|NCT00044044|Dopamine Agents|dopamine agents|mesh-ancestor
111186343|NCT00044044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111186344|NCT00044044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111186345|NCT00044044|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111186346|NCT00044044|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
111186347|NCT00044044|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111186348|NCT00044044|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111186349|NCT00044044|Adrenergic Agents|adrenergic agents|mesh-ancestor
111186350|NCT00044044|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111186351|NCT00044044|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111186352|NCT00044044|Serotonin Agents|serotonin agents|mesh-ancestor
111186353|NCT00044044|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111186354|NCT00112918|Leucovorin|leucovorin|mesh-list
111186355|NCT00112918|Bevacizumab|bevacizumab|mesh-list
111186356|NCT00112918|Fluorouracil|fluorouracil|mesh-list
111186357|NCT00112918|Capecitabine|capecitabine|mesh-list
111186358|NCT00112918|Oxaliplatin|oxaliplatin|mesh-list
111186359|NCT00112918|Calcium|calcium|mesh-list
111186360|NCT00112918|Levoleucovorin|levoleucovorin|mesh-list
111186361|NCT00112918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111186362|NCT00112918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111186363|NCT00112918|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111186364|NCT00112918|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111186365|NCT00112918|Growth Substances|growth substances|mesh-ancestor
111186366|NCT00112918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111186367|NCT00112918|Growth Inhibitors|growth inhibitors|mesh-ancestor
111186368|NCT00112918|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111186369|NCT00112918|Antimetabolites|antimetabolites|mesh-ancestor
111186370|NCT00112918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111186371|NCT00112918|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111186372|NCT00112918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111186373|NCT00112918|Immunologic Factors|immunologic factors|mesh-ancestor
111186374|NCT00112918|Antidotes|antidotes|mesh-ancestor
111186375|NCT00112918|Protective Agents|protective agents|mesh-ancestor
111186376|NCT00112918|Vitamin B Complex|vitamin b complex|mesh-ancestor
111186377|NCT00112918|Vitamins|vitamins|mesh-ancestor
111186378|NCT00112918|Micronutrients|micronutrients|mesh-ancestor
111186379|NCT00046228|Reteplase|reteplase|mesh-list
111186380|NCT00046228|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
111186381|NCT00046228|Abciximab|abciximab|mesh-list
111186382|NCT00046228|Anticoagulants|anticoagulants|mesh-ancestor
111186383|NCT00046228|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111186384|NCT00046228|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111186385|NCT00046228|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111186386|NCT00046228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111186387|NCT00205504|Moxifloxacin|moxifloxacin|mesh-list
111186388|NCT00205504|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
111186389|NCT00205504|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111186390|NCT00205504|Contraceptive Agents|contraceptive agents|mesh-ancestor
111186391|NCT00205504|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110489832|NCT02595190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111186392|NCT00205504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111186393|NCT00205504|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
111186394|NCT00205504|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111186395|NCT00205504|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111186396|NCT00205504|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111186397|NCT00205504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111186398|NCT00205504|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111186399|NCT00205504|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111186400|NCT00205504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111186401|NCT00205504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111186402|NCT00205504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111186403|NCT00113230|Bevacizumab|bevacizumab|mesh-list
111186404|NCT00113230|Capecitabine|capecitabine|mesh-list
111186405|NCT00113230|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111186406|NCT00113230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111186407|NCT00113230|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111186408|NCT00113230|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111186409|NCT00113230|Growth Substances|growth substances|mesh-ancestor
111186410|NCT00113230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111186411|NCT00113230|Growth Inhibitors|growth inhibitors|mesh-ancestor
111186412|NCT00113230|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111186413|NCT00113230|Antimetabolites|antimetabolites|mesh-ancestor
111186414|NCT00113230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111186416|NCT00049036|Cyclophosphamide|cyclophosphamide|mesh-list
111186417|NCT00049036|Rituximab|rituximab|mesh-list
111186418|NCT00049036|Doxorubicin|doxorubicin|mesh-list
111186419|NCT00049036|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111186420|NCT00049036|Etoposide|etoposide|mesh-list
111186421|NCT00049036|Vincristine|vincristine|mesh-list
111186422|NCT00049036|Etoposide phosphate|etoposide phosphate|mesh-list
111186423|NCT00049036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111186424|NCT00049036|Immunologic Factors|immunologic factors|mesh-ancestor
111186425|NCT00049036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111186426|NCT00049036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111186427|NCT00049036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111186428|NCT00049036|Alkylating Agents|alkylating agents|mesh-ancestor
111186429|NCT00049036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111186430|NCT00049036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111186431|NCT00049036|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111186432|NCT00049036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111186433|NCT00049036|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111186434|NCT00049036|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111186435|NCT00049036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111186436|NCT00049036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111186437|NCT00049036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111186438|NCT00049036|Glucocorticoids|glucocorticoids|mesh-ancestor
111186439|NCT00049036|Hormones|hormones|mesh-ancestor
111186440|NCT00049036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111186441|NCT00049036|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111186442|NCT00049036|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111186443|NCT00049036|Tubulin Modulators|tubulin modulators|mesh-ancestor
111186444|NCT00049036|Antimitotic Agents|antimitotic agents|mesh-ancestor
111186445|NCT00049036|Mitosis Modulators|mitosis modulators|mesh-ancestor
111186446|NCT00049504|Mycophenolic Acid|mycophenolic acid|mesh-list
111186447|NCT00049504|Cyclophosphamide|cyclophosphamide|mesh-list
111186448|NCT00049504|Fludarabine|fludarabine|mesh-list
111186449|NCT00049504|Fludarabine phosphate|fludarabine phosphate|mesh-list
111186450|NCT00049504|Tacrolimus|tacrolimus|mesh-list
111186451|NCT00049504|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111186452|NCT00049504|Immunologic Factors|immunologic factors|mesh-ancestor
111186453|NCT00049504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111186454|NCT00049504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111186455|NCT00049504|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111186456|NCT00049504|Alkylating Agents|alkylating agents|mesh-ancestor
111186457|NCT00049504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111186458|NCT00049504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111186459|NCT00049504|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110489840|NCT04061473|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111186460|NCT00049504|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111186461|NCT00049504|Antimetabolites|antimetabolites|mesh-ancestor
111186462|NCT00049504|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111186463|NCT00049504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111186464|NCT00049504|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111186465|NCT00049504|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111186466|NCT00049504|Antitubercular Agents|antitubercular agents|mesh-ancestor
111186467|NCT00049504|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111186468|NCT00049504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111186469|NCT00050986|Temozolomide|temozolomide|mesh-list
111186470|NCT00050986|Tipifarnib|tipifarnib|mesh-list
111186471|NCT00050986|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111186472|NCT00050986|Alkylating Agents|alkylating agents|mesh-ancestor
111186473|NCT00050986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111186474|NCT00050986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111186475|NCT00118144|Bortezomib|bortezomib|mesh-list
111186476|NCT00118144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111186477|NCT00118378|Modafinil|modafinil|mesh-list
111186478|NCT00118378|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111186479|NCT00118378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111186480|NCT00118378|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
111186481|NCT00118378|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111186482|NCT00118378|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111186483|NCT00118378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111186484|NCT00217438|Melphalan|melphalan|mesh-list
111186485|NCT00217438|Amifostine|amifostine|mesh-list
111186486|NCT00217438|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111186487|NCT00217438|Alkylating Agents|alkylating agents|mesh-ancestor
111186488|NCT00217438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111186489|NCT00217438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111186490|NCT00217438|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111186491|NCT00217438|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111186492|NCT00217438|Immunologic Factors|immunologic factors|mesh-ancestor
111186493|NCT00217438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111186494|NCT00217438|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111186495|NCT00217438|Protective Agents|protective agents|mesh-ancestor
111186496|NCT04480450|Rituximab|rituximab|mesh-list
111186497|NCT04480450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111186498|NCT04480450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111186499|NCT04480450|Immunologic Factors|immunologic factors|mesh-ancestor
111186500|NCT04480450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111186501|NCT04480450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111186502|NCT00217594|Alemtuzumab|alemtuzumab|mesh-list
111186503|NCT00217594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111186504|NCT00217594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111186505|NCT00052078|Sertraline|sertraline|mesh-list
111186506|NCT00052078|Antidepressive Agents|antidepressive agents|mesh-ancestor
111186507|NCT00052078|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111186508|NCT00052078|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111186509|NCT00052078|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111186510|NCT00052078|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111186511|NCT00052078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111186512|NCT00052078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111186513|NCT00052078|Serotonin Agents|serotonin agents|mesh-ancestor
111186514|NCT00052078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111186515|NCT05820256|Caseins|caseins|mesh-list
111186516|NCT05820256|Chelating Agents|chelating agents|mesh-ancestor
111186517|NCT05820256|Sequestering Agents|sequestering agents|mesh-ancestor
111186518|NCT05820256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111186519|NCT05820048|Lansoprazole|lansoprazole|mesh-list
111186520|NCT05820048|Dexlansoprazole|dexlansoprazole|mesh-list
111186521|NCT05820048|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111186522|NCT05820048|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111186523|NCT05820048|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111186524|NCT05820048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111186525|NCT05820048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111186526|NCT05819983|Ivermectin|ivermectin|mesh-list
111186527|NCT05819983|Permethrin|permethrin|mesh-list
111186528|NCT05819983|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111186529|NCT05819983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111186530|NCT05819983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111186531|NCT05819983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111186532|NCT05819970|Allyl sulfide|allyl sulfide|mesh-list
111186533|NCT05819970|Antioxidants|antioxidants|mesh-ancestor
111186534|NCT05819970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111186535|NCT05819970|Protective Agents|protective agents|mesh-ancestor
111186536|NCT05819970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111186537|NCT05819970|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
111186538|NCT05819970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111186539|NCT05819970|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111186540|NCT05819970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111186541|NCT05819632|Curcumin|curcumin|mesh-list
111186542|NCT05819632|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111186543|NCT05819632|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111186544|NCT05819632|Analgesics|analgesics|mesh-ancestor
111186545|NCT05819632|Sensory System Agents|sensory system agents|mesh-ancestor
111186546|NCT05819632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111186547|NCT05819632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111186548|NCT05819632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110903709|NCT04654507|Dexamethasone|dexamethasone|mesh-list
111186549|NCT05819632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111186550|NCT05819632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111186551|NCT05819632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111186552|NCT05819632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111186553|NCT05819229|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111186554|NCT05819229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111186555|NCT05819060|Bevacizumab|bevacizumab|mesh-list
111186556|NCT05819060|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111186557|NCT05819060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111186558|NCT05819060|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111186559|NCT05819060|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111186560|NCT05819060|Growth Substances|growth substances|mesh-ancestor
111186561|NCT05819060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111186562|NCT05819060|Growth Inhibitors|growth inhibitors|mesh-ancestor
111186563|NCT05818995|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
111186564|NCT05818995|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
111186565|NCT05818995|Calcium Channel Blockers|calcium channel blockers|mesh-list
111186566|NCT05818995|Angiotensin II|angiotensin ii|mesh-list
111186567|NCT05818995|Giapreza|giapreza|mesh-list
111186568|NCT05818995|Enzyme Inhibitors|enzyme inhibitors|mesh-list
111186569|NCT05818995|Angiotensinogen|angiotensinogen|mesh-list
111186570|NCT05818995|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
111186571|NCT05818995|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
111186572|NCT05818995|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111186573|NCT05818995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111186574|NCT05818995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111186575|NCT05818995|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111186576|NCT05818995|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111186577|NCT05818995|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111186578|NCT05818995|Protease Inhibitors|protease inhibitors|mesh-ancestor
111186579|NCT05818995|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111186580|NCT05818982|Irinotecan|irinotecan|mesh-list
111186581|NCT05818982|Afatinib|afatinib|mesh-list
111186582|NCT05818982|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111186583|NCT05818982|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111186584|NCT05818982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111186585|NCT05818982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111186586|NCT05818982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111186587|NCT05818982|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111186588|NCT05818670|Tadalafil|tadalafil|mesh-list
111186589|NCT05818670|Tamsulosin|tamsulosin|mesh-list
111186590|NCT05818670|Vasodilator Agents|vasodilator agents|mesh-ancestor
111186591|NCT05818670|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111186592|NCT05818670|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111186593|NCT05818670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111186594|NCT05818670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111186595|NCT05818670|Urological Agents|urological agents|mesh-ancestor
111186596|NCT05818670|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111186597|NCT05818670|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111186598|NCT05818670|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111186599|NCT05818670|Adrenergic Agents|adrenergic agents|mesh-ancestor
111186600|NCT05818670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111186601|NCT05818670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111186602|NCT05816512|Chlorhexidine|chlorhexidine|mesh-list
111186603|NCT05816512|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
111186604|NCT05816512|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111186605|NCT05816512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111186606|NCT05816512|Disinfectants|disinfectants|mesh-ancestor
111186607|NCT05816512|Dermatologic Agents|dermatologic agents|mesh-ancestor
111186608|NCT05816499|Docetaxel|docetaxel|mesh-list
111186609|NCT05816499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111186610|NCT05816499|Tubulin Modulators|tubulin modulators|mesh-ancestor
111186611|NCT05816499|Antimitotic Agents|antimitotic agents|mesh-ancestor
111186612|NCT05816499|Mitosis Modulators|mitosis modulators|mesh-ancestor
111186613|NCT05816499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111186614|NCT05816343|Orlistat|orlistat|mesh-list
111186615|NCT05816343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111186616|NCT05816343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111186617|NCT05816343|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111186618|NCT05816343|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111186619|NCT05816226|Hydrocortisone|hydrocortisone|mesh-list
111186620|NCT05816226|Diclofenac|diclofenac|mesh-list
111186621|NCT05816226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110903787|NCT04540705|Nivolumab|nivolumab|mesh-list
111186622|NCT05816226|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111186623|NCT05816226|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111186624|NCT05816226|Analgesics|analgesics|mesh-ancestor
111186625|NCT05816226|Sensory System Agents|sensory system agents|mesh-ancestor
111186626|NCT05816226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111186627|NCT05816226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111186628|NCT05816226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111186629|NCT05816226|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111186630|NCT05816226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111186631|NCT05816226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111186632|NCT05816070|Ofloxacin|ofloxacin|mesh-list
111186633|NCT05816070|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111186634|NCT05816070|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111186635|NCT05816070|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111186636|NCT05816070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111186637|NCT05816070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111186638|NCT05816070|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111186639|NCT05816070|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111186640|NCT05816070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111186641|NCT05816070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111186642|NCT05816070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111186643|NCT05816070|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111186644|NCT05816070|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111186645|NCT05815927|Pembrolizumab|pembrolizumab|mesh-list
111186646|NCT05815927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111186647|NCT05815927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111186648|NCT05815927|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111186649|NCT05815927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111186650|NCT05815901|Febuxostat|febuxostat|mesh-list
111186651|NCT05815901|Gout Suppressants|gout suppressants|mesh-ancestor
111186652|NCT05815901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111186653|NCT05815784|Atropine|atropine|mesh-list
111186654|NCT05815784|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111186655|NCT05815784|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111186656|NCT05815784|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111186657|NCT05815784|Autonomic Agents|autonomic agents|mesh-ancestor
110489859|NCT00733408|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111186658|NCT05815784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111186659|NCT05815784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111186660|NCT05815784|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111186661|NCT05815784|Respiratory System Agents|respiratory system agents|mesh-ancestor
111186662|NCT05815784|Mydriatics|mydriatics|mesh-ancestor
111186663|NCT05815784|Parasympatholytics|parasympatholytics|mesh-ancestor
111186664|NCT05815784|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111186665|NCT05815784|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111186666|NCT05815784|Cholinergic Agents|cholinergic agents|mesh-ancestor
111186667|NCT05815784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111186668|NCT05815784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111186669|NCT05815719|Hormones|hormones|mesh-list
111186670|NCT05815719|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
111186671|NCT05815719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111186672|NCT05815719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111186673|NCT05815654|Analgesics|analgesics|mesh-list
111186674|NCT05815654|Sensory System Agents|sensory system agents|mesh-ancestor
111186675|NCT05815654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111186676|NCT05815654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111186677|NCT05815303|Capecitabine|capecitabine|mesh-list
111186678|NCT05815303|Oxaliplatin|oxaliplatin|mesh-list
111186679|NCT05815303|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111186680|NCT05815303|Antimetabolites|antimetabolites|mesh-ancestor
111186681|NCT05815303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111186682|NCT05815303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111186683|NCT05814874|Selenium|selenium|mesh-list
111186684|NCT05814874|Antioxidants|antioxidants|mesh-ancestor
111186685|NCT05814874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111186686|NCT05814874|Protective Agents|protective agents|mesh-ancestor
111186687|NCT05814874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111186688|NCT05814874|Trace Elements|trace elements|mesh-ancestor
111186689|NCT05814874|Micronutrients|micronutrients|mesh-ancestor
111186690|NCT05814770|Spironolactone|spironolactone|mesh-list
111186691|NCT05814770|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
111186692|NCT05814770|Hormone Antagonists|hormone antagonists|mesh-ancestor
111186693|NCT05814770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111186694|NCT05814770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111186695|NCT05814770|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
111186696|NCT05814770|Diuretics|diuretics|mesh-ancestor
111186697|NCT05814770|Natriuretic Agents|natriuretic agents|mesh-ancestor
111186698|NCT05814731|Cytarabine|cytarabine|mesh-list
111186699|NCT05814731|Cyclophosphamide|cyclophosphamide|mesh-list
111186700|NCT05814731|Busulfan|busulfan|mesh-list
111186701|NCT05814731|Semustine|semustine|mesh-list
111186702|NCT05814731|Mitoxantrone|mitoxantrone|mesh-list
111186703|NCT05814731|Thymoglobulin|thymoglobulin|mesh-list
111186704|NCT05814731|Antilymphocyte Serum|antilymphocyte serum|mesh-list
111186705|NCT05814731|Immunoglobulins|immunoglobulins|mesh-list
111186706|NCT05814731|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111186707|NCT05814731|Antibodies|antibodies|mesh-list
111186708|NCT05814731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111186709|NCT05814731|Immunologic Factors|immunologic factors|mesh-ancestor
111186710|NCT05814731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111186711|NCT05814731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111186712|NCT05814731|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111186713|NCT05814731|Alkylating Agents|alkylating agents|mesh-ancestor
111186714|NCT05814731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110844676|NCT01169909|Ranibizumab|ranibizumab|mesh-list
111186715|NCT05814731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111186716|NCT05814731|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111186717|NCT05814731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111186718|NCT05814731|Antimetabolites|antimetabolites|mesh-ancestor
111186719|NCT05814731|Antiviral Agents|antiviral agents|mesh-ancestor
111186720|NCT05814731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111186721|NCT05814731|Analgesics|analgesics|mesh-ancestor
111186722|NCT05814731|Sensory System Agents|sensory system agents|mesh-ancestor
111186723|NCT05814731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111186724|NCT05814731|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111186725|NCT05814731|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111186726|NCT05814731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111186727|NCT05814718|Cytarabine|cytarabine|mesh-list
111186728|NCT05814718|Etoposide|etoposide|mesh-list
111186729|NCT05814718|Mitoxantrone|mitoxantrone|mesh-list
111186730|NCT05814718|Etoposide phosphate|etoposide phosphate|mesh-list
111186731|NCT05814718|Melphalan|melphalan|mesh-list
111186732|NCT05814718|Carmustine|carmustine|mesh-list
111186733|NCT05814718|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111186734|NCT05814718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111186735|NCT05814718|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111186736|NCT05814718|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111186737|NCT05814718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111186738|NCT05814718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111186739|NCT05814718|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111186740|NCT05814718|Antimetabolites|antimetabolites|mesh-ancestor
111186741|NCT05814718|Antiviral Agents|antiviral agents|mesh-ancestor
111186742|NCT05814718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111186743|NCT05814718|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111186744|NCT05814718|Immunologic Factors|immunologic factors|mesh-ancestor
111186745|NCT05814718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111186746|NCT05814718|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111186747|NCT05814718|Alkylating Agents|alkylating agents|mesh-ancestor
111186748|NCT05814718|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111186749|NCT05814718|Analgesics|analgesics|mesh-ancestor
111186750|NCT05814718|Sensory System Agents|sensory system agents|mesh-ancestor
111186751|NCT05814718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111186752|NCT05814601|Norepinephrine|norepinephrine|mesh-list
111186753|NCT05814601|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111186754|NCT05814601|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111186755|NCT05814601|Adrenergic Agents|adrenergic agents|mesh-ancestor
111186756|NCT05814601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111186757|NCT05814601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111186758|NCT05814601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111186759|NCT05814601|Sympathomimetics|sympathomimetics|mesh-ancestor
111186760|NCT05814601|Autonomic Agents|autonomic agents|mesh-ancestor
111186761|NCT05814601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111186762|NCT05814601|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111186763|NCT05797662|Propranolol|propranolol|mesh-list
111186764|NCT05797662|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111186765|NCT05797662|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111186766|NCT05797662|Adrenergic Agents|adrenergic agents|mesh-ancestor
111186767|NCT05797662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111186768|NCT05797662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110903935|NCT03910452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111186769|NCT05797662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111186770|NCT05797662|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111186771|NCT05797662|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111186772|NCT05797662|Vasodilator Agents|vasodilator agents|mesh-ancestor
111186773|NCT05795257|Dimercaprol|dimercaprol|mesh-list
111186774|NCT05795257|Chelating Agents|chelating agents|mesh-ancestor
111186775|NCT05795257|Sequestering Agents|sequestering agents|mesh-ancestor
111186776|NCT05795257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111186777|NCT05786378|Anesthetics|anesthetics|mesh-list
111186778|NCT05786378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111186779|NCT05786378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111186780|NCT05779241|Risperidone|risperidone|mesh-list
111186781|NCT05779241|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111186782|NCT05779241|Serotonin Agents|serotonin agents|mesh-ancestor
111186783|NCT05779241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111186784|NCT05779241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111186785|NCT05779241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111186786|NCT05779241|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111186787|NCT05779241|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111186788|NCT05779241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111186789|NCT05779241|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111186790|NCT05779241|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111186791|NCT05779241|Dopamine Agents|dopamine agents|mesh-ancestor
111186792|NCT05766358|Tirzepatide|tirzepatide|mesh-list
111186793|NCT05766358|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111186794|NCT05766358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111186795|NCT05766358|Incretins|incretins|mesh-ancestor
111186796|NCT05766358|Hormones|hormones|mesh-ancestor
111186797|NCT05766358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111186798|NCT05757557|Nitric Oxide|nitric oxide|mesh-list
111186799|NCT05757557|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111186800|NCT05757557|Autonomic Agents|autonomic agents|mesh-ancestor
111186801|NCT05757557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111186802|NCT05757557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111186803|NCT05757557|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111186804|NCT05757557|Respiratory System Agents|respiratory system agents|mesh-ancestor
111186805|NCT05757557|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111186806|NCT05757557|Antioxidants|antioxidants|mesh-ancestor
111186807|NCT05757557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111186808|NCT05757557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111186809|NCT05757557|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
111186810|NCT05757557|Vasodilator Agents|vasodilator agents|mesh-ancestor
111186811|NCT05757557|Gasotransmitters|gasotransmitters|mesh-ancestor
111186812|NCT05757557|Protective Agents|protective agents|mesh-ancestor
111186813|NCT05751317|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111186814|NCT05751317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111186815|NCT05716984|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
111186816|NCT05716984|Natriuretic Agents|natriuretic agents|mesh-ancestor
111186817|NCT05716984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111186818|NCT05700344|Avelumab|avelumab|mesh-list
111186819|NCT05700344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111186820|NCT05700344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111186821|NCT05688904|Imipramine|imipramine|mesh-list
111186822|NCT05688904|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
111186823|NCT05688904|Antidepressive Agents|antidepressive agents|mesh-ancestor
111186824|NCT05688904|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111186825|NCT05688904|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111186826|NCT05688904|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111186827|NCT05688904|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111186828|NCT05688904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111186829|NCT05688904|Adrenergic Agents|adrenergic agents|mesh-ancestor
111186830|NCT05688904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111186831|NCT05688904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111186832|NCT05687357|Paclitaxel|paclitaxel|mesh-list
111186833|NCT05687357|Oxaliplatin|oxaliplatin|mesh-list
111186834|NCT05687357|Tislelizumab|tislelizumab|mesh-list
111186835|NCT05687357|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111186836|NCT05687357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111186837|NCT05687357|Tubulin Modulators|tubulin modulators|mesh-ancestor
111186838|NCT05687357|Antimitotic Agents|antimitotic agents|mesh-ancestor
111186839|NCT05687357|Mitosis Modulators|mitosis modulators|mesh-ancestor
111186840|NCT05687357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111186841|NCT05687357|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111186842|NCT05675943|Antibodies|antibodies|mesh-list
111186843|NCT05675943|Immunologic Factors|immunologic factors|mesh-ancestor
111186844|NCT05675943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111186845|NCT05619289|Vitamin D|vitamin d|mesh-list
111186846|NCT05619289|Ergocalciferols|ergocalciferols|mesh-list
111186847|NCT05619289|Vitamins|vitamins|mesh-ancestor
111186848|NCT05619289|Micronutrients|micronutrients|mesh-ancestor
111186849|NCT05619289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111186850|NCT05619289|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111186851|NCT05619289|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111186852|NCT05618002|Clonidine|clonidine|mesh-list
111186853|NCT05618002|Lemborexant|lemborexant|mesh-list
111186854|NCT05618002|Zopiclone|zopiclone|mesh-list
111186855|NCT05618002|Analgesics|analgesics|mesh-ancestor
111186856|NCT05618002|Sensory System Agents|sensory system agents|mesh-ancestor
111186857|NCT05618002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111186858|NCT05618002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111186859|NCT05618002|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111186860|NCT05618002|Sympatholytics|sympatholytics|mesh-ancestor
111186861|NCT05618002|Autonomic Agents|autonomic agents|mesh-ancestor
111186862|NCT05618002|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111186863|NCT05618002|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111186864|NCT05618002|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111186865|NCT05618002|Adrenergic Agents|adrenergic agents|mesh-ancestor
111186866|NCT05618002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111186867|NCT05618002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111186868|NCT05618002|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
111186869|NCT05618002|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111186870|NCT05618002|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111186871|NCT05618002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111186872|NCT05608005|MF59 oil emulsion|mf59 oil emulsion|mesh-list
111186873|NCT05608005|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111186874|NCT05608005|Immunologic Factors|immunologic factors|mesh-ancestor
111186875|NCT05608005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111186876|NCT05605470|Vaccines|vaccines|mesh-list
111186877|NCT05605470|Immunologic Factors|immunologic factors|mesh-ancestor
111186878|NCT05605470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111186879|NCT05604222|Mirabegron|mirabegron|mesh-list
111186880|NCT05604222|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
111186881|NCT05604222|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111186882|NCT05604222|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111186883|NCT05604222|Adrenergic Agents|adrenergic agents|mesh-ancestor
111186884|NCT05604222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111186885|NCT05604222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111186886|NCT05604222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111186887|NCT05604222|Urological Agents|urological agents|mesh-ancestor
111186888|NCT05603910|Pembrolizumab|pembrolizumab|mesh-list
111186889|NCT05603910|Lenvatinib|lenvatinib|mesh-list
111186890|NCT05603910|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111186891|NCT05603910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111186892|NCT05603910|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111186893|NCT05603910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111186894|NCT05603910|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111186895|NCT05603910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111186896|NCT05565222|Meropenem|meropenem|mesh-list
111186897|NCT05565222|Tazobactam|tazobactam|mesh-list
111186898|NCT05565222|Piperacillin|piperacillin|mesh-list
111186899|NCT05565222|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
111186900|NCT05565222|Temocillin|temocillin|mesh-list
111186901|NCT05565222|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111186902|NCT05565222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111186903|NCT05565222|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
111186904|NCT05565222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111186905|NCT05565222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111186906|NCT05562492|Insulin|insulin|mesh-list
111186907|NCT05562492|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111186908|NCT05562492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111186909|NCT05483491|Aldesleukin|aldesleukin|mesh-list
111186910|NCT05483491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111186911|NCT05483491|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111186912|NCT05483491|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111186913|NCT05483491|Antiviral Agents|antiviral agents|mesh-ancestor
111186914|NCT05483491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111186915|NCT05482789|Exenatide|exenatide|mesh-list
111186916|NCT05482789|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111186917|NCT05482789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111186918|NCT05482789|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111186919|NCT05482789|Incretins|incretins|mesh-ancestor
111186920|NCT05482789|Hormones|hormones|mesh-ancestor
110904085|NCT03182426|Antiviral Agents|antiviral agents|mesh-ancestor
111186921|NCT05482789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111186922|NCT05474950|Minocycline|minocycline|mesh-list
111186923|NCT05474950|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111186924|NCT05474950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111186925|NCT05664386|Propofol|propofol|mesh-list
111186926|NCT05664386|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111186927|NCT05664386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111186928|NCT05664386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111186929|NCT05664386|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111186930|NCT05664386|Anesthetics, General|anesthetics, general|mesh-ancestor
111186931|NCT05664386|Anesthetics|anesthetics|mesh-ancestor
111186932|NCT05461404|Emollients|emollients|mesh-list
111186933|NCT05461404|Dermatologic Agents|dermatologic agents|mesh-ancestor
111186934|NCT05449392|Bacitracin zinc, neomycin sulfate, polymyxin B, drug combination|bacitracin zinc, neomycin sulfate, polymyxin b, drug combination|mesh-list
111186935|NCT05449392|Petrolatum|petrolatum|mesh-list
111186936|NCT05449392|Emollients|emollients|mesh-ancestor
111186937|NCT05449392|Dermatologic Agents|dermatologic agents|mesh-ancestor
111186938|NCT05449392|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111186939|NCT05449392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111186940|NCT05449392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111186941|NCT05445076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111186942|NCT05445076|Antibodies|antibodies|mesh-list
111186943|NCT05445076|Immunoglobulins|immunoglobulins|mesh-list
111186944|NCT05445076|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111186945|NCT05445076|Immunologic Factors|immunologic factors|mesh-ancestor
111186946|NCT05445076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111186947|NCT05445076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111186948|NCT05405439|Prednisone|prednisone|mesh-list
111186949|NCT05405439|Abiraterone Acetate|abiraterone acetate|mesh-list
111186950|NCT05405439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111186951|NCT05405439|Glucocorticoids|glucocorticoids|mesh-ancestor
111186952|NCT05405439|Hormones|hormones|mesh-ancestor
111186953|NCT05405439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111186954|NCT05405439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111186955|NCT05405439|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111186956|NCT05405439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111186957|NCT05405439|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111186958|NCT05405439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111186959|NCT05405439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111186960|NCT05405439|Hormone Antagonists|hormone antagonists|mesh-ancestor
111186961|NCT05405439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111186962|NCT05389722|Itraconazole|itraconazole|mesh-list
111186963|NCT05389722|Rifampin|rifampin|mesh-list
111186964|NCT05389722|Digoxin|digoxin|mesh-list
111186965|NCT05389722|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111186966|NCT05389722|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111186967|NCT05389722|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111186968|NCT05389722|Antimetabolites|antimetabolites|mesh-ancestor
111186969|NCT05389722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111186970|NCT05389722|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111186971|NCT05389722|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111186972|NCT05389722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111186973|NCT05389722|Antifungal Agents|antifungal agents|mesh-ancestor
111186974|NCT05389722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111186975|NCT05389722|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111186976|NCT05389722|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111186977|NCT05389722|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111186978|NCT05389722|Hormone Antagonists|hormone antagonists|mesh-ancestor
111186979|NCT05389722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111186980|NCT05389722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111186981|NCT05389722|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111186982|NCT05389722|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111186983|NCT05389722|Antitubercular Agents|antitubercular agents|mesh-ancestor
111186984|NCT05389722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111186985|NCT05389722|Leprostatic Agents|leprostatic agents|mesh-ancestor
111186986|NCT05389722|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111186987|NCT05389722|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111186988|NCT05389722|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111186989|NCT05389722|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
111186990|NCT05389722|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
111186991|NCT05389722|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
111186992|NCT05389722|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111186994|NCT05389722|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111186995|NCT05389722|Protective Agents|protective agents|mesh-ancestor
111186997|NCT05383170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111186998|NCT05383170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111186999|NCT05383170|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111187000|NCT05383170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111187001|NCT05373680|Metformin|metformin|mesh-list
111187002|NCT05373680|Empagliflozin|empagliflozin|mesh-list
111187003|NCT05373680|Biguanides|biguanides|mesh-list
111187004|NCT05373680|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111187005|NCT05373680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111187006|NCT05373680|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111187007|NCT05373680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111187008|NCT05353348|Iron|iron|mesh-list
111187009|NCT05353348|Ascorbic Acid|ascorbic acid|mesh-list
111187010|NCT05353348|Epoetin Alfa|epoetin alfa|mesh-list
111187011|NCT05353348|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
111187012|NCT05353348|Trace Elements|trace elements|mesh-ancestor
111187013|NCT05353348|Micronutrients|micronutrients|mesh-ancestor
111187014|NCT05353348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111187015|NCT05353348|Antioxidants|antioxidants|mesh-ancestor
111187016|NCT05353348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111187017|NCT05353348|Protective Agents|protective agents|mesh-ancestor
111187018|NCT05353348|Vitamins|vitamins|mesh-ancestor
111187019|NCT05353348|Hematinics|hematinics|mesh-ancestor
111187020|NCT05304520|Natalizumab|natalizumab|mesh-list
111187021|NCT05304520|Immunologic Factors|immunologic factors|mesh-ancestor
111187022|NCT05304520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111187023|NCT05300152|Antibodies|antibodies|mesh-list
111187024|NCT05300152|Immunoglobulins|immunoglobulins|mesh-list
111187025|NCT05300152|Immunologic Factors|immunologic factors|mesh-ancestor
111187026|NCT05300152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111187027|NCT05294263|Varenicline|varenicline|mesh-list
111187028|NCT05294263|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111187029|NCT05294263|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111187030|NCT05294263|Cholinergic Agents|cholinergic agents|mesh-ancestor
111187031|NCT05294263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111187032|NCT05294263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111187033|NCT05294263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111187034|NCT05265728|Natalizumab|natalizumab|mesh-list
111187035|NCT05265728|Immunologic Factors|immunologic factors|mesh-ancestor
111187036|NCT05265728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111187037|NCT05261594|Caffeine|caffeine|mesh-list
111187038|NCT05261594|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111187039|NCT05261594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111187040|NCT05261594|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111187041|NCT05261594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111187042|NCT05261594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111187043|NCT05261594|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
111187044|NCT05261594|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111187045|NCT05261594|Purinergic Agents|purinergic agents|mesh-ancestor
111187046|NCT05261594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111187047|NCT05241288|Albuterol|albuterol|mesh-list
111187048|NCT05241288|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111187049|NCT05241288|Autonomic Agents|autonomic agents|mesh-ancestor
111187050|NCT05241288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111187051|NCT05241288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111187052|NCT05241288|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111187053|NCT05241288|Respiratory System Agents|respiratory system agents|mesh-ancestor
111187054|NCT05241288|Tocolytic Agents|tocolytic agents|mesh-ancestor
111187055|NCT05241288|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111187056|NCT05241288|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111187057|NCT05241288|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111187058|NCT05241288|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111187059|NCT05241288|Adrenergic Agents|adrenergic agents|mesh-ancestor
111187060|NCT05241288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111187061|NCT05241288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111187062|NCT05220748|Pembrolizumab|pembrolizumab|mesh-list
111187063|NCT05220748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111187064|NCT05220748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111187065|NCT05220748|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111187066|NCT05220748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111187068|NCT05180357|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111187069|NCT05180357|Respiratory System Agents|respiratory system agents|mesh-ancestor
111187071|NCT05144542|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111187072|NCT05144542|Autonomic Agents|autonomic agents|mesh-ancestor
111187073|NCT05144542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111187074|NCT05144542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111187075|NCT05144542|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111187076|NCT05144542|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111187077|NCT05144542|Cholinergic Agents|cholinergic agents|mesh-ancestor
111187078|NCT05144542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111187079|NCT05144542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111187080|NCT05141708|Talazoparib|talazoparib|mesh-list
111187081|NCT05141708|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111187082|NCT05141708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111187083|NCT05141708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111187084|NCT05141708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111187085|NCT05137119|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111187086|NCT05137119|Vancomycin|vancomycin|mesh-list
111187087|NCT05137119|Clindamycin|clindamycin|mesh-list
111187088|NCT05137119|Cefazolin|cefazolin|mesh-list
111187089|NCT05137119|Daptomycin|daptomycin|mesh-list
111187090|NCT05137119|Penicillins|penicillins|mesh-list
111187091|NCT05137119|Penicillin G|penicillin g|mesh-list
111187092|NCT05137119|Lincomycin|lincomycin|mesh-list
111187093|NCT05137119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111187094|NCT05137119|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111187095|NCT05137119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111187096|NCT05137119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111187097|NCT05117489|Cortisone|cortisone|mesh-list
111187098|NCT05117489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111187099|NCT05085808|Quetiapine Fumarate|quetiapine fumarate|mesh-list
111187100|NCT05085808|Trazodone|trazodone|mesh-list
111187101|NCT05085808|Antidepressive Agents|antidepressive agents|mesh-ancestor
111187102|NCT05085808|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111187103|NCT05085808|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111187104|NCT05085808|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111187105|NCT05085808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111187106|NCT05085808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111187107|NCT05085808|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111187108|NCT05085808|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111187109|NCT05085808|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111187110|NCT05085808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111187111|NCT05085808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111187112|NCT05085808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111187113|NCT05085808|Serotonin Agents|serotonin agents|mesh-ancestor
111187114|NCT05085808|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111187115|NCT05081609|Pembrolizumab|pembrolizumab|mesh-list
111187116|NCT05081609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111187117|NCT05081609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111187118|NCT05081609|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111187119|NCT05081609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111187120|NCT05078944|Donepezil|donepezil|mesh-list
111187121|NCT05078944|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111187122|NCT05078944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111187123|NCT05078944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111187124|NCT05078944|Cholinergic Agents|cholinergic agents|mesh-ancestor
111187125|NCT05078944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111187126|NCT05078944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111187127|NCT05078944|Nootropic Agents|nootropic agents|mesh-ancestor
111187128|NCT05076019|Atorvastatin|atorvastatin|mesh-list
111187129|NCT05076019|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111187130|NCT05076019|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111187131|NCT05076019|Antimetabolites|antimetabolites|mesh-ancestor
111187132|NCT05076019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111187133|NCT05076019|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110844710|NCT03291288|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111187134|NCT05076019|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111187135|NCT05076019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111187136|NCT05071937|Talazoparib|talazoparib|mesh-list
111187137|NCT05071937|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111187138|NCT05071937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111187139|NCT05071937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111187140|NCT05071937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111187141|NCT05063097|Carbon Monoxide|carbon monoxide|mesh-list
111187142|NCT05063097|Antimetabolites|antimetabolites|mesh-ancestor
111187143|NCT05063097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111187144|NCT05063097|Gasotransmitters|gasotransmitters|mesh-ancestor
111187145|NCT05063097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111187146|NCT05063097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111187147|NCT05059470|Pembrolizumab|pembrolizumab|mesh-list
111187148|NCT05059470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111187149|NCT05059470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111187150|NCT05059470|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111187151|NCT05059470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111187152|NCT05036005|Pertuzumab|pertuzumab|mesh-list
111187153|NCT05036005|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111187154|NCT05036005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111187155|NCT05033769|Paclitaxel|paclitaxel|mesh-list
111187156|NCT05033769|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111187157|NCT05033769|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111187158|NCT05033769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111187159|NCT05033769|Tubulin Modulators|tubulin modulators|mesh-ancestor
111187160|NCT05033769|Antimitotic Agents|antimitotic agents|mesh-ancestor
111187161|NCT05033769|Mitosis Modulators|mitosis modulators|mesh-ancestor
111187162|NCT05033769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111187163|NCT05019846|Bicalutamide|bicalutamide|mesh-list
111187164|NCT05019846|Triptorelin Pamoate|triptorelin pamoate|mesh-list
111187165|NCT05019846|Androgen Antagonists|androgen antagonists|mesh-ancestor
111187166|NCT05019846|Hormone Antagonists|hormone antagonists|mesh-ancestor
111187167|NCT05019846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111187168|NCT05019846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111187169|NCT05019846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111187170|NCT05019846|Luteolytic Agents|luteolytic agents|mesh-ancestor
111187171|NCT05019846|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111187172|NCT05019846|Contraceptive Agents|contraceptive agents|mesh-ancestor
111187173|NCT05019846|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111187174|NCT05019846|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111187175|NCT05019846|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111187176|NCT05004025|Nivolumab|nivolumab|mesh-list
111187177|NCT05004025|Ipilimumab|ipilimumab|mesh-list
111187178|NCT05004025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111187179|NCT05004025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111187180|NCT05004025|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111187181|NCT05004025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111187182|NCT04998240|Myeloma Proteins|myeloma proteins|mesh-list
111187183|NCT04998240|Paraproteins|paraproteins|mesh-list
111187184|NCT04998240|Immunologic Factors|immunologic factors|mesh-ancestor
111187185|NCT04998240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111187186|NCT04984759|Primaquine|primaquine|mesh-list
111187187|NCT04984759|Tafenoquine|tafenoquine|mesh-list
111187188|NCT04984759|Antimalarials|antimalarials|mesh-ancestor
111187189|NCT04984759|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111187190|NCT04984759|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111187191|NCT04984759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111187192|NCT04955743|Pembrolizumab|pembrolizumab|mesh-list
111187193|NCT04955743|Lenvatinib|lenvatinib|mesh-list
111187194|NCT04955743|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111187195|NCT04955743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111187196|NCT04955743|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111187197|NCT04955743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111187198|NCT04955743|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111187199|NCT04955743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111187200|NCT04952324|Folic Acid|folic acid|mesh-list
111187201|NCT04952324|Vitamin B 12|vitamin b 12|mesh-list
111187202|NCT04952324|Hydroxocobalamin|hydroxocobalamin|mesh-list
111187203|NCT04952324|Vitamins|vitamins|mesh-ancestor
111187204|NCT04952324|Micronutrients|micronutrients|mesh-ancestor
111187205|NCT04952324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111187206|NCT04952324|Hematinics|hematinics|mesh-ancestor
111187207|NCT04952324|Vitamin B Complex|vitamin b complex|mesh-ancestor
111187208|NCT04951726|Neostigmine|neostigmine|mesh-list
111187209|NCT04951726|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111187210|NCT04951726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111187211|NCT04951726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111187212|NCT04951726|Cholinergic Agents|cholinergic agents|mesh-ancestor
111187213|NCT04951726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111187214|NCT04951726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111187215|NCT04951726|Parasympathomimetics|parasympathomimetics|mesh-ancestor
111187216|NCT04951726|Autonomic Agents|autonomic agents|mesh-ancestor
111187217|NCT04951726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111187218|NCT04950764|Seladelpar|seladelpar|mesh-list
111187219|NCT04950764|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111187220|NCT04950764|Antimetabolites|antimetabolites|mesh-ancestor
111187221|NCT04950764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111187222|NCT04950764|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111187223|NCT04948892|Anesthetics|anesthetics|mesh-list
111187224|NCT04948892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111187225|NCT04948892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111187226|NCT04930562|Belumosudil|belumosudil|mesh-list
111187227|NCT04930562|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111187228|NCT04930562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111187229|NCT04930562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111187230|NCT04926571|Dexamethasone|dexamethasone|mesh-list
111187231|NCT04926571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111187232|NCT04926571|Antiemetics|antiemetics|mesh-ancestor
111187233|NCT04926571|Autonomic Agents|autonomic agents|mesh-ancestor
111187234|NCT04926571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111187235|NCT04926571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111187236|NCT04926571|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111187237|NCT04926571|Glucocorticoids|glucocorticoids|mesh-ancestor
111187239|NCT04926571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111187240|NCT04926571|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111187241|NCT04926571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111187242|NCT04919382|Temozolomide|temozolomide|mesh-list
111187243|NCT04919382|Atezolizumab|atezolizumab|mesh-list
111187244|NCT04919382|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111187245|NCT04919382|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111187246|NCT04919382|Alkylating Agents|alkylating agents|mesh-ancestor
111187247|NCT04919382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111187248|NCT04919382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111187249|NCT04919382|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111187250|NCT04919382|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111187251|NCT04919382|Immunologic Factors|immunologic factors|mesh-ancestor
111187252|NCT04919382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111187253|NCT04918823|Cyclosporine|cyclosporine|mesh-list
111187254|NCT04918823|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111187255|NCT04918823|Cyclosporins|cyclosporins|mesh-list
111187256|NCT04918823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111187257|NCT04918823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111187258|NCT04918823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111187259|NCT04918823|Immunologic Factors|immunologic factors|mesh-ancestor
111187260|NCT04918823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111187261|NCT04918823|Antifungal Agents|antifungal agents|mesh-ancestor
111187262|NCT04918823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111187263|NCT04918823|Dermatologic Agents|dermatologic agents|mesh-ancestor
111187264|NCT04918823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111187265|NCT04918823|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111187266|NCT04918823|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111187267|NCT04909073|Afatinib|afatinib|mesh-list
111187268|NCT04909073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111187269|NCT04909073|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111187270|NCT04909073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111187271|NCT04909073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111187272|NCT04792385|Drospirenone|drospirenone|mesh-list
111187273|NCT04792385|Contraceptive Agents|contraceptive agents|mesh-list
111187274|NCT04792385|Contraceptives, Oral|contraceptives, oral|mesh-list
111187275|NCT04792385|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
111187276|NCT04792385|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111187277|NCT04792385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111187278|NCT04792385|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111187279|NCT04792385|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
111187280|NCT04792385|Hormone Antagonists|hormone antagonists|mesh-ancestor
111187281|NCT04792385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111187282|NCT04792385|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
111187284|NCT04792385|Natriuretic Agents|natriuretic agents|mesh-ancestor
111187285|NCT04785651|Tranexamic Acid|tranexamic acid|mesh-list
111187286|NCT04785651|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111187287|NCT04785651|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111187288|NCT04785651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111187289|NCT04785651|Hemostatics|hemostatics|mesh-ancestor
111187290|NCT04785651|Coagulants|coagulants|mesh-ancestor
111187291|NCT04780204|Tenofovir|tenofovir|mesh-list
111187292|NCT04780204|Antiviral Agents|antiviral agents|mesh-ancestor
111187293|NCT04780204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111187294|NCT04780204|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111187295|NCT04780204|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111187296|NCT04780204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111187297|NCT04780204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111187298|NCT04780204|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111187299|NCT04780204|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111187300|NCT04763564|Liraglutide|liraglutide|mesh-list
111187301|NCT04763564|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111187302|NCT04763564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111187303|NCT04763564|Incretins|incretins|mesh-ancestor
111187304|NCT04763564|Hormones|hormones|mesh-ancestor
111187305|NCT04763564|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111187306|NCT04748588|Sotrovimab|sotrovimab|mesh-list
111187307|NCT04748588|Bamlanivimab|bamlanivimab|mesh-list
111187308|NCT04748588|Antiviral Agents|antiviral agents|mesh-ancestor
111187309|NCT04748588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111187310|NCT04735510|Cyclosporine|cyclosporine|mesh-list
111187311|NCT04735510|Cyclosporins|cyclosporins|mesh-list
111187312|NCT04735510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111187313|NCT04735510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111187314|NCT04735510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111187315|NCT04735510|Immunologic Factors|immunologic factors|mesh-ancestor
111187316|NCT04735510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111187317|NCT04735510|Antifungal Agents|antifungal agents|mesh-ancestor
111187318|NCT04735510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111187319|NCT04735510|Dermatologic Agents|dermatologic agents|mesh-ancestor
111187320|NCT04735510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111187321|NCT04735510|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111187322|NCT04696523|Xenon|xenon|mesh-list
111187323|NCT04696523|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111187324|NCT04696523|Anesthetics, General|anesthetics, general|mesh-ancestor
111187325|NCT04696523|Anesthetics|anesthetics|mesh-ancestor
111187326|NCT04696523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111187327|NCT04696523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111187328|NCT04655222|Interferons|interferons|mesh-list
111187329|NCT04655222|Interferon-beta|interferon-beta|mesh-list
111187330|NCT04655222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111187331|NCT04655222|Antiviral Agents|antiviral agents|mesh-ancestor
111187332|NCT04655222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111187333|NCT04655222|Immunologic Factors|immunologic factors|mesh-ancestor
111187334|NCT04655222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111187335|NCT04652440|Tislelizumab|tislelizumab|mesh-list
111187336|NCT04652440|Antibodies|antibodies|mesh-list
111187337|NCT04652440|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111187338|NCT04652440|Immunologic Factors|immunologic factors|mesh-ancestor
111187339|NCT04652440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111187340|NCT04652440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111187341|NCT04652440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111187342|NCT04612725|Benralizumab|benralizumab|mesh-list
111187343|NCT04612725|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111187344|NCT04612725|Respiratory System Agents|respiratory system agents|mesh-ancestor
111187346|NCT04604067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111187347|NCT04592744|Vasopressins|vasopressins|mesh-list
111187348|NCT04592744|Epinephrine|epinephrine|mesh-list
111187349|NCT04592744|Norepinephrine|norepinephrine|mesh-list
111187350|NCT04592744|Angiotensin II|angiotensin ii|mesh-list
111187351|NCT04592744|Giapreza|giapreza|mesh-list
111187352|NCT04592744|Angiotensinogen|angiotensinogen|mesh-list
111187353|NCT04592744|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111187354|NCT04592744|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111187355|NCT04592744|Adrenergic Agents|adrenergic agents|mesh-ancestor
111187356|NCT04592744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111187357|NCT04592744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111187358|NCT04592744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111187359|NCT04592744|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111187360|NCT04592744|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111187361|NCT04592744|Autonomic Agents|autonomic agents|mesh-ancestor
111187362|NCT04592744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111187363|NCT04592744|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111187364|NCT04592744|Respiratory System Agents|respiratory system agents|mesh-ancestor
111187365|NCT04592744|Mydriatics|mydriatics|mesh-ancestor
111187366|NCT04592744|Sympathomimetics|sympathomimetics|mesh-ancestor
111187367|NCT04592744|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111187368|NCT04592744|Hemostatics|hemostatics|mesh-ancestor
111187369|NCT04592744|Coagulants|coagulants|mesh-ancestor
111187370|NCT04592744|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
111187371|NCT04592744|Natriuretic Agents|natriuretic agents|mesh-ancestor
111187372|NCT04592744|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111187373|NCT04592744|Protease Inhibitors|protease inhibitors|mesh-ancestor
111187374|NCT04592744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111187375|NCT04585711|Etanercept|etanercept|mesh-list
111187376|NCT04585711|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111187377|NCT04585711|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111187378|NCT04585711|Analgesics|analgesics|mesh-ancestor
111187379|NCT04585711|Sensory System Agents|sensory system agents|mesh-ancestor
111187380|NCT04585711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111187381|NCT04585711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111187382|NCT04585711|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111187383|NCT04585711|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111187384|NCT04585711|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111187385|NCT04585711|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111187386|NCT04585711|Immunologic Factors|immunologic factors|mesh-ancestor
111187387|NCT04559334|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111187388|NCT04551495|Letrozole|letrozole|mesh-list
111187389|NCT04551495|Goserelin|goserelin|mesh-list
111187390|NCT04551495|Entrectinib|entrectinib|mesh-list
111187391|NCT04551495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111187392|NCT04551495|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111187393|NCT04551495|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111187394|NCT04551495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111187395|NCT04551495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111187396|NCT04551495|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111187397|NCT04551495|Hormone Antagonists|hormone antagonists|mesh-ancestor
111187398|NCT04551495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111187399|NCT04551495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110489953|NCT02595034|Clindamycin|clindamycin|mesh-list
111187400|NCT04551495|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111187401|NCT04551495|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111187402|NCT04545424|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
111187403|NCT04545424|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111187404|NCT04545424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111187405|NCT04545424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111187406|NCT04501718|Etoposide|etoposide|mesh-list
111187407|NCT04501718|Temozolomide|temozolomide|mesh-list
111187408|NCT04501718|Apatinib|apatinib|mesh-list
111187409|NCT04501718|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111187410|NCT04501718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111187411|NCT04501718|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111187412|NCT04501718|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111187413|NCT04501718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111187414|NCT04501718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111187415|NCT04501718|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111187416|NCT04501718|Alkylating Agents|alkylating agents|mesh-ancestor
111187417|NCT04501718|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111187418|NCT04501705|Apatinib|apatinib|mesh-list
111187419|NCT04501705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111187420|NCT04501705|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111187421|NCT04501705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111187422|NCT04501705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111187423|NCT04463394|Vasopressins|vasopressins|mesh-list
111187424|NCT04463394|Arginine Vasopressin|arginine vasopressin|mesh-list
111187425|NCT04463394|Hemostatics|hemostatics|mesh-ancestor
111187426|NCT04463394|Coagulants|coagulants|mesh-ancestor
111187427|NCT04463394|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111187428|NCT04463394|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
111187429|NCT04463394|Natriuretic Agents|natriuretic agents|mesh-ancestor
111187430|NCT04463394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111187431|NCT04454905|Apatinib|apatinib|mesh-list
111187432|NCT04454905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111187433|NCT04454905|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111187434|NCT04454905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111187435|NCT04454905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111187436|NCT04436601|Lactulose|lactulose|mesh-list
111187437|NCT04436601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111187438|NCT04373785|Temozolomide|temozolomide|mesh-list
111187439|NCT04373785|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111187440|NCT04373785|Alkylating Agents|alkylating agents|mesh-ancestor
111187441|NCT04373785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111187442|NCT04373785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111187443|NCT04312997|Pam2CSK4 acetate and ODN M362 combination|pam2csk4 acetate and odn m362 combination|mesh-list
111187444|NCT04312997|Respiratory System Agents|respiratory system agents|mesh-ancestor
111187445|NCT04309552|Alovudine|alovudine|mesh-list
111187446|NCT04309552|Antiviral Agents|antiviral agents|mesh-ancestor
111187447|NCT04309552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111187449|NCT04275180|Antithrombins|antithrombins|mesh-ancestor
111187450|NCT04275180|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111187451|NCT04275180|Protease Inhibitors|protease inhibitors|mesh-ancestor
111187452|NCT04275180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111187453|NCT04275180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111187454|NCT04275180|Anticoagulants|anticoagulants|mesh-ancestor
111187455|NCT04275180|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111187456|NCT04271332|Baclofen|baclofen|mesh-list
111187457|NCT04271332|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
111187458|NCT04271332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111187459|NCT04271332|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111187460|NCT04271332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111187461|NCT04271332|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
111187462|NCT04271332|GABA Agonists|gaba agonists|mesh-ancestor
111187463|NCT04271332|GABA Agents|gaba agents|mesh-ancestor
111187464|NCT04271332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111187465|NCT04271332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111187466|NCT04267978|Irinotecan|irinotecan|mesh-list
111187467|NCT04267978|Temozolomide|temozolomide|mesh-list
111187468|NCT04267978|Endostatins|endostatins|mesh-list
111187469|NCT04267978|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111187470|NCT04267978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111187471|NCT04267978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111187472|NCT04267978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111187473|NCT04267978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111187474|NCT04267978|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111187475|NCT04267978|Alkylating Agents|alkylating agents|mesh-ancestor
111187476|NCT04267978|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111187477|NCT04267978|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111187478|NCT04267978|Growth Substances|growth substances|mesh-ancestor
111187479|NCT04267978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111187480|NCT04267978|Growth Inhibitors|growth inhibitors|mesh-ancestor
111187481|NCT04230252|Acetaminophen|acetaminophen|mesh-list
111187482|NCT04230252|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111187483|NCT04230252|Analgesics|analgesics|mesh-ancestor
111187484|NCT04230252|Sensory System Agents|sensory system agents|mesh-ancestor
111187485|NCT04230252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111187486|NCT04230252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111187487|NCT04230252|Antipyretics|antipyretics|mesh-ancestor
111187488|NCT04217317|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
111187489|NCT04217317|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111187490|NCT04217317|Alkylating Agents|alkylating agents|mesh-ancestor
111187491|NCT04217317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111187492|NCT04217317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111187493|NCT04189263|Aromatase Inhibitors|aromatase inhibitors|mesh-list
111187494|NCT04189263|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111187495|NCT04189263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111187496|NCT04189263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111187497|NCT04189263|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111187498|NCT04189263|Hormone Antagonists|hormone antagonists|mesh-ancestor
111187499|NCT04189263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111187500|NCT04189263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111187501|NCT04140396|Lidocaine|lidocaine|mesh-list
111187502|NCT04140396|Anesthetics, Local|anesthetics, local|mesh-ancestor
111187503|NCT04140396|Anesthetics|anesthetics|mesh-ancestor
111187504|NCT04140396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111187505|NCT04140396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111187506|NCT04140396|Sensory System Agents|sensory system agents|mesh-ancestor
111187507|NCT04140396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111187508|NCT04140396|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111187509|NCT04140396|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111187510|NCT04140396|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111187511|NCT04140396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111187512|NCT04140396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111187513|NCT04117178|Memantine|memantine|mesh-list
111187514|NCT04117178|Donepezil|donepezil|mesh-list
111187515|NCT04117178|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111187516|NCT04117178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111187517|NCT04117178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111187518|NCT04117178|Cholinergic Agents|cholinergic agents|mesh-ancestor
111187519|NCT04117178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111187520|NCT04117178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111187521|NCT04117178|Nootropic Agents|nootropic agents|mesh-ancestor
111187522|NCT04117178|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111187523|NCT04117178|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111187524|NCT04117178|Dopamine Agents|dopamine agents|mesh-ancestor
111187525|NCT04117178|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111187526|NCT04117178|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111187527|NCT04099836|Bevacizumab|bevacizumab|mesh-list
111187528|NCT04099836|Atezolizumab|atezolizumab|mesh-list
111187529|NCT04099836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111187530|NCT04099836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111187531|NCT04099836|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111187532|NCT04099836|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111187533|NCT04099836|Growth Substances|growth substances|mesh-ancestor
111187534|NCT04099836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111187535|NCT04099836|Growth Inhibitors|growth inhibitors|mesh-ancestor
111187536|NCT04099836|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111187537|NCT04099836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111187538|NCT04094961|Dexamethasone|dexamethasone|mesh-list
111187539|NCT04094961|Dexamethasone acetate|dexamethasone acetate|mesh-list
111187540|NCT04094961|Pomalidomide|pomalidomide|mesh-list
111187541|NCT04094961|Ixazomib|ixazomib|mesh-list
111187542|NCT04094961|BB 1101|bb 1101|mesh-list
111187543|NCT04094961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111187544|NCT04094961|Antiemetics|antiemetics|mesh-ancestor
111187545|NCT04094961|Autonomic Agents|autonomic agents|mesh-ancestor
111187546|NCT04094961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111187547|NCT04094961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111187548|NCT04094961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111187549|NCT04094961|Glucocorticoids|glucocorticoids|mesh-ancestor
111187550|NCT04094961|Hormones|hormones|mesh-ancestor
111187551|NCT04094961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111187552|NCT04094961|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111187553|NCT04094961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111187554|NCT04094961|Protease Inhibitors|protease inhibitors|mesh-ancestor
111187555|NCT04094961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111187556|NCT04094961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111187557|NCT04094961|Immunologic Factors|immunologic factors|mesh-ancestor
111187558|NCT04094961|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111187559|NCT04094961|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111187560|NCT04094961|Growth Substances|growth substances|mesh-ancestor
111187561|NCT04094961|Growth Inhibitors|growth inhibitors|mesh-ancestor
111187562|NCT04025216|Cyclophosphamide|cyclophosphamide|mesh-list
111187563|NCT04025216|Fludarabine|fludarabine|mesh-list
111187564|NCT04025216|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111187565|NCT04025216|Immunologic Factors|immunologic factors|mesh-ancestor
111187566|NCT04025216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111187567|NCT04025216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111187568|NCT04025216|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111187569|NCT04025216|Alkylating Agents|alkylating agents|mesh-ancestor
111187570|NCT04025216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111187571|NCT04025216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111187572|NCT04025216|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111187573|NCT04020185|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
111187574|NCT04020185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111187575|NCT04020185|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111187576|NCT04020185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111187577|NCT03991936|Triamcinolone|triamcinolone|mesh-list
111187578|NCT03991936|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
111187579|NCT03991936|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
111187580|NCT03991936|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
111187581|NCT03991936|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111187582|NCT03991936|Glucocorticoids|glucocorticoids|mesh-ancestor
111187583|NCT03991936|Hormones|hormones|mesh-ancestor
111187584|NCT03991936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111187585|NCT03991936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111187586|NCT03991936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111187587|NCT03991936|Immunologic Factors|immunologic factors|mesh-ancestor
111187588|NCT03991936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111187589|NCT03991936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111187590|NCT03982082|Coal Tar|coal tar|mesh-list
111187591|NCT03982082|Keratolytic Agents|keratolytic agents|mesh-ancestor
111187592|NCT03982082|Dermatologic Agents|dermatologic agents|mesh-ancestor
111187593|NCT03979599|Magnesium Sulfate|magnesium sulfate|mesh-list
110904771|NCT03092375|Ribavirin|ribavirin|mesh-list
111187595|NCT03979599|Analgesics|analgesics|mesh-ancestor
111187596|NCT03979599|Sensory System Agents|sensory system agents|mesh-ancestor
111187597|NCT03979599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111187598|NCT03979599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111187599|NCT03979599|Anesthetics|anesthetics|mesh-ancestor
111187600|NCT03979599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111187601|NCT03979599|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111187602|NCT03979599|Anticonvulsants|anticonvulsants|mesh-ancestor
111187603|NCT03979599|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111187604|NCT03979599|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111187605|NCT03979599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111187606|NCT03979599|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111187607|NCT03979599|Tocolytic Agents|tocolytic agents|mesh-ancestor
111187608|NCT03979599|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111187609|NCT03979599|Anesthetics, Local|anesthetics, local|mesh-ancestor
111187610|NCT03966651|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
111187611|NCT03966651|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111187612|NCT03966651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111187613|NCT03946514|Losartan|losartan|mesh-list
111187614|NCT03946514|Amlodipine|amlodipine|mesh-list
111187615|NCT03946514|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
111187616|NCT03946514|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111187617|NCT03946514|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111187618|NCT03946514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111187619|NCT03946514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111187620|NCT03946514|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111187621|NCT03946514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111187622|NCT03946514|Vasodilator Agents|vasodilator agents|mesh-ancestor
111187623|NCT03946514|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111187624|NCT03946514|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111187625|NCT03946514|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111187626|NCT03946514|Diuretics|diuretics|mesh-ancestor
111187627|NCT03946514|Natriuretic Agents|natriuretic agents|mesh-ancestor
111187628|NCT03946514|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
111187630|NCT03935958|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111187631|NCT03935958|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111187632|NCT03935958|Analgesics|analgesics|mesh-ancestor
111187633|NCT03935958|Sensory System Agents|sensory system agents|mesh-ancestor
111187634|NCT03935958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111187635|NCT03935958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111187636|NCT03935958|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111187637|NCT03935958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111187638|NCT03935958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111187639|NCT03935958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111187640|NCT03935958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111187641|NCT03935295|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111187642|NCT03935295|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111187643|NCT03935295|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111187644|NCT03935295|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111187645|NCT03935295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111187646|NCT03935295|Cholinergic Agents|cholinergic agents|mesh-ancestor
111187647|NCT03935295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111187648|NCT03935295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111187649|NCT03935295|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111187650|NCT03935295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111187651|NCT03915444|Paclitaxel|paclitaxel|mesh-list
111187652|NCT03915444|Gemcitabine|gemcitabine|mesh-list
111187653|NCT03915444|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111187654|NCT03915444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111187655|NCT03915444|Tubulin Modulators|tubulin modulators|mesh-ancestor
111187656|NCT03915444|Antimitotic Agents|antimitotic agents|mesh-ancestor
111187657|NCT03915444|Mitosis Modulators|mitosis modulators|mesh-ancestor
111187658|NCT03915444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111187659|NCT03915444|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111187660|NCT03915444|Antimetabolites|antimetabolites|mesh-ancestor
111187661|NCT03892785|Prednisone|prednisone|mesh-list
111187662|NCT03892785|Methotrexate|methotrexate|mesh-list
111187663|NCT03892785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111187664|NCT03892785|Glucocorticoids|glucocorticoids|mesh-ancestor
111187665|NCT03892785|Hormones|hormones|mesh-ancestor
110904838|NCT02153762|Hydrocortisone|hydrocortisone|mesh-list
111187666|NCT03892785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111187667|NCT03892785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111187668|NCT03892785|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111187669|NCT03892785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111187670|NCT03892785|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111187671|NCT03892785|Abortifacient Agents|abortifacient agents|mesh-ancestor
111187672|NCT03892785|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111187673|NCT03892785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111187674|NCT03892785|Antimetabolites|antimetabolites|mesh-ancestor
111187675|NCT03892785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111187676|NCT03892785|Dermatologic Agents|dermatologic agents|mesh-ancestor
111187677|NCT03892785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111187678|NCT03892785|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111187679|NCT03892785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111187680|NCT03892785|Immunologic Factors|immunologic factors|mesh-ancestor
111187681|NCT03892785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111187682|NCT03892785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111187683|NCT03869034|Leucovorin|leucovorin|mesh-list
111187684|NCT03869034|Fluorouracil|fluorouracil|mesh-list
111187685|NCT03869034|Oxaliplatin|oxaliplatin|mesh-list
111187686|NCT03869034|Antimetabolites|antimetabolites|mesh-ancestor
111187687|NCT03869034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111187688|NCT03869034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111187689|NCT03869034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111187690|NCT03869034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111187691|NCT03869034|Immunologic Factors|immunologic factors|mesh-ancestor
111187692|NCT03869034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111187693|NCT03869034|Antidotes|antidotes|mesh-ancestor
111187694|NCT03869034|Protective Agents|protective agents|mesh-ancestor
111187695|NCT03869034|Vitamin B Complex|vitamin b complex|mesh-ancestor
111187696|NCT03869034|Vitamins|vitamins|mesh-ancestor
111187697|NCT03869034|Micronutrients|micronutrients|mesh-ancestor
111187698|NCT03841097|Tacrolimus|tacrolimus|mesh-list
111187700|NCT03841097|Immunologic Factors|immunologic factors|mesh-ancestor
111187701|NCT03841097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111187702|NCT03841097|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111187703|NCT03841097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111187704|NCT03841097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111187705|NCT03831425|Ubiquinone|ubiquinone|mesh-list
111187706|NCT03831425|Coenzyme Q10|coenzyme q10|mesh-list
111187707|NCT03831425|Micronutrients|micronutrients|mesh-ancestor
111187708|NCT03831425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111187709|NCT03831425|Vitamins|vitamins|mesh-ancestor
111187710|NCT03804944|Pembrolizumab|pembrolizumab|mesh-list
111187711|NCT03804944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111187712|NCT03804944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111187713|NCT03804944|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111187714|NCT03804944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111187715|NCT03790111|Cisplatin|cisplatin|mesh-list
111187716|NCT03790111|Gemcitabine|gemcitabine|mesh-list
111187717|NCT03790111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111187718|NCT03790111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111187719|NCT03790111|Antimetabolites|antimetabolites|mesh-ancestor
111187720|NCT03790111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111187721|NCT03780543|Tenofovir|tenofovir|mesh-list
111187722|NCT03780543|Entecavir|entecavir|mesh-list
111187723|NCT03780543|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
111187724|NCT03780543|Antiviral Agents|antiviral agents|mesh-ancestor
111187725|NCT03780543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111187726|NCT03780543|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111187727|NCT03780543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111187728|NCT03780543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111187729|NCT03780543|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111187730|NCT03780543|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111187731|NCT03772314|Modafinil|modafinil|mesh-list
111187732|NCT03772314|Amphetamine|amphetamine|mesh-list
111187733|NCT03772314|Adderall|adderall|mesh-list
111187734|NCT03772314|Dextroamphetamine|dextroamphetamine|mesh-list
111187735|NCT03772314|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111187736|NCT03772314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111187737|NCT03772314|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
111187738|NCT03772314|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111187739|NCT03772314|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111187740|NCT03772314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111187742|NCT03772314|Autonomic Agents|autonomic agents|mesh-ancestor
111187743|NCT03772314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111187744|NCT03772314|Dopamine Agents|dopamine agents|mesh-ancestor
111187745|NCT03772314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111187746|NCT03772314|Adrenergic Agents|adrenergic agents|mesh-ancestor
111187747|NCT03772314|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111187748|NCT03772314|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111187749|NCT03772314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111187750|NCT03772314|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111187751|NCT03760575|Pembrolizumab|pembrolizumab|mesh-list
111187752|NCT03760575|Pemetrexed|pemetrexed|mesh-list
111187753|NCT03760575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111187754|NCT03760575|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111187755|NCT03760575|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111187756|NCT03760575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111187757|NCT03760575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111187758|NCT03760575|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111187759|NCT03760575|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111187760|NCT03738579|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111187761|NCT03738579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111187762|NCT03720522|Adenosine|adenosine|mesh-list
111187763|NCT03720522|Analgesics|analgesics|mesh-ancestor
111187764|NCT03720522|Sensory System Agents|sensory system agents|mesh-ancestor
111187765|NCT03720522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111187766|NCT03720522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111187767|NCT03720522|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111187768|NCT03720522|Vasodilator Agents|vasodilator agents|mesh-ancestor
111187769|NCT03720522|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
111187770|NCT03720522|Purinergic Agonists|purinergic agonists|mesh-ancestor
111187771|NCT03720522|Purinergic Agents|purinergic agents|mesh-ancestor
110030066|NCT01850303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111187772|NCT03720522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111187773|NCT03720522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111187775|NCT03699631|Tacrolimus|tacrolimus|mesh-list
111187776|NCT03699631|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111187777|NCT03699631|Abortifacient Agents|abortifacient agents|mesh-ancestor
111187778|NCT03699631|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111187779|NCT03699631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111187780|NCT03699631|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111187781|NCT03699631|Antimetabolites|antimetabolites|mesh-ancestor
111187782|NCT03699631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111187783|NCT03699631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111187784|NCT03699631|Dermatologic Agents|dermatologic agents|mesh-ancestor
111187785|NCT03699631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111187786|NCT03699631|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111187787|NCT03699631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111187788|NCT03699631|Immunologic Factors|immunologic factors|mesh-ancestor
111187789|NCT03699631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111187790|NCT03699631|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111187791|NCT03699631|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111187792|NCT03686150|Vitamin D|vitamin d|mesh-list
111187793|NCT03686150|Cholecalciferol|cholecalciferol|mesh-list
111187794|NCT03686150|Vitamins|vitamins|mesh-ancestor
111187795|NCT03686150|Micronutrients|micronutrients|mesh-ancestor
111187796|NCT03686150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111187797|NCT03686150|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111187798|NCT03686150|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111187799|NCT03678233|Testosterone|testosterone|mesh-list
111187800|NCT03678233|Androgens|androgens|mesh-ancestor
111187801|NCT03678233|Hormones|hormones|mesh-ancestor
110799568|NCT03758235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111187802|NCT03678233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111187803|NCT03678233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111187804|NCT03629327|Aspirin|aspirin|mesh-list
111187805|NCT03629327|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111187806|NCT03629327|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111187807|NCT03629327|Analgesics|analgesics|mesh-ancestor
111187808|NCT03629327|Sensory System Agents|sensory system agents|mesh-ancestor
111187809|NCT03629327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111187810|NCT03629327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111187811|NCT03629327|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111187812|NCT03629327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111187813|NCT03629327|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111187814|NCT03629327|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111187815|NCT03629327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111187816|NCT03629327|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111187817|NCT03629327|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111187818|NCT03629327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111187819|NCT03629327|Antipyretics|antipyretics|mesh-ancestor
111187820|NCT03618641|Nivolumab|nivolumab|mesh-list
111187821|NCT03618641|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111187822|NCT03618641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111187823|NCT03618641|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111187824|NCT03618641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111187825|NCT03617718|Glycine|glycine|mesh-list
111187826|NCT03617718|Glycine Agents|glycine agents|mesh-ancestor
111187827|NCT03617718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111187828|NCT03617718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111187829|NCT03617718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111187830|NCT03610061|Durvalumab|durvalumab|mesh-list
111187831|NCT03610061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111187832|NCT03610061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111187833|NCT03606642|Clopidogrel|clopidogrel|mesh-list
111187834|NCT03606642|Ticagrelor|ticagrelor|mesh-list
111187835|NCT03606642|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
111187836|NCT03606642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111187837|NCT03606642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111187838|NCT03606642|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111187839|NCT03606642|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111187840|NCT03606642|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110844752|NCT03387592|Leucovorin|leucovorin|mesh-list
111187841|NCT03606642|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111187842|NCT03606642|Purinergic Agents|purinergic agents|mesh-ancestor
111187843|NCT03606642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111187845|NCT03530124|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
111187846|NCT03530124|Immunologic Factors|immunologic factors|mesh-ancestor
111187847|NCT03530124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111187848|NCT03527043|Escitalopram|escitalopram|mesh-list
111187849|NCT03527043|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111187850|NCT03527043|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111187851|NCT03527043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111187852|NCT03527043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111187853|NCT03527043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111187854|NCT03527043|Serotonin Agents|serotonin agents|mesh-ancestor
111187855|NCT03527043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111187856|NCT03458221|Itraconazole|itraconazole|mesh-list
111187857|NCT03458221|Everolimus|everolimus|mesh-list
111187858|NCT03458221|Letrozole|letrozole|mesh-list
111187859|NCT03458221|Bicalutamide|bicalutamide|mesh-list
111187860|NCT03458221|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111187861|NCT03458221|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111187862|NCT03458221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111187863|NCT03458221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111187864|NCT03458221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111187865|NCT03458221|Immunologic Factors|immunologic factors|mesh-ancestor
111187866|NCT03458221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111187867|NCT03458221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111187868|NCT03458221|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111187869|NCT03458221|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111187870|NCT03458221|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111187871|NCT03458221|Hormone Antagonists|hormone antagonists|mesh-ancestor
111187872|NCT03458221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111187873|NCT03458221|Antifungal Agents|antifungal agents|mesh-ancestor
111187874|NCT03458221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111187875|NCT03458221|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111187876|NCT03458221|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111187877|NCT03458221|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111187878|NCT03458221|Androgen Antagonists|androgen antagonists|mesh-ancestor
111187879|NCT03451487|Acetaminophen|acetaminophen|mesh-list
111187880|NCT03451487|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111187881|NCT03451487|Analgesics|analgesics|mesh-ancestor
111187882|NCT03451487|Sensory System Agents|sensory system agents|mesh-ancestor
111187883|NCT03451487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111187884|NCT03451487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111187885|NCT03451487|Antipyretics|antipyretics|mesh-ancestor
111187886|NCT03410030|Ascorbic Acid|ascorbic acid|mesh-list
111187887|NCT03410030|Paclitaxel|paclitaxel|mesh-list
110905067|NCT04113083|Provitamins|provitamins|mesh-ancestor
111187888|NCT03410030|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111187889|NCT03410030|Cisplatin|cisplatin|mesh-list
111187890|NCT03410030|Gemcitabine|gemcitabine|mesh-list
111187891|NCT03410030|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111187892|NCT03410030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111187893|NCT03410030|Tubulin Modulators|tubulin modulators|mesh-ancestor
111187894|NCT03410030|Antimitotic Agents|antimitotic agents|mesh-ancestor
111187895|NCT03410030|Mitosis Modulators|mitosis modulators|mesh-ancestor
111187896|NCT03410030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111187897|NCT03410030|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111187898|NCT03410030|Antimetabolites|antimetabolites|mesh-ancestor
111187899|NCT03410030|Antioxidants|antioxidants|mesh-ancestor
111187900|NCT03410030|Protective Agents|protective agents|mesh-ancestor
111187901|NCT03410030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111187902|NCT03410030|Vitamins|vitamins|mesh-ancestor
111187903|NCT03410030|Micronutrients|micronutrients|mesh-ancestor
111187904|NCT03382301|Cyclosporine|cyclosporine|mesh-list
111187905|NCT03382301|Cyclosporins|cyclosporins|mesh-list
111187906|NCT03382301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111187907|NCT03382301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111187908|NCT03382301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111187909|NCT03382301|Immunologic Factors|immunologic factors|mesh-ancestor
111187910|NCT03382301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111187911|NCT03382301|Antifungal Agents|antifungal agents|mesh-ancestor
111187912|NCT03382301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111187913|NCT03382301|Dermatologic Agents|dermatologic agents|mesh-ancestor
111187914|NCT03382301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111187915|NCT03382301|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111187916|NCT03290391|Naltrexone|naltrexone|mesh-list
111187917|NCT03290391|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111187918|NCT03290391|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111187919|NCT03290391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111187920|NCT03290391|Sensory System Agents|sensory system agents|mesh-ancestor
111187921|NCT03290391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111187922|NCT03280030|Midostaurin|midostaurin|mesh-list
111187923|NCT03280030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111187924|NCT03280030|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111187925|NCT03280030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111187926|NCT03280030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111187927|NCT03204188|Pembrolizumab|pembrolizumab|mesh-list
111187928|NCT03204188|Fludarabine|fludarabine|mesh-list
111187929|NCT03204188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111187930|NCT03204188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111187931|NCT03204188|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110490008|NCT02858804|Cytarabine|cytarabine|mesh-list
111187932|NCT03204188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111187933|NCT03194867|Cemiplimab|cemiplimab|mesh-list
111187934|NCT03194867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111187935|NCT03194867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111187936|NCT03138720|Paclitaxel|paclitaxel|mesh-list
111187937|NCT03138720|Cisplatin|cisplatin|mesh-list
111187938|NCT03138720|Gemcitabine|gemcitabine|mesh-list
111187939|NCT03138720|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111187940|NCT03138720|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111187941|NCT03138720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111187942|NCT03138720|Tubulin Modulators|tubulin modulators|mesh-ancestor
111187943|NCT03138720|Antimitotic Agents|antimitotic agents|mesh-ancestor
111187944|NCT03138720|Mitosis Modulators|mitosis modulators|mesh-ancestor
111187945|NCT03138720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111187946|NCT03138720|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111187947|NCT03138720|Antimetabolites|antimetabolites|mesh-ancestor
111187948|NCT03131726|Simvastatin|simvastatin|mesh-list
111187949|NCT03131726|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111187950|NCT03131726|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111187951|NCT03131726|Antimetabolites|antimetabolites|mesh-ancestor
111187952|NCT03131726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111187953|NCT03131726|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111187954|NCT03131726|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111187955|NCT03131726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111187956|NCT03112590|Interferons|interferons|mesh-list
111187957|NCT03112590|Interferon-gamma|interferon-gamma|mesh-list
111187958|NCT03112590|Paclitaxel|paclitaxel|mesh-list
111187959|NCT03112590|Trastuzumab|trastuzumab|mesh-list
111187960|NCT03112590|Pertuzumab|pertuzumab|mesh-list
111187961|NCT03112590|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110905133|NCT00974571|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111187962|NCT03112590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111187963|NCT03112590|Tubulin Modulators|tubulin modulators|mesh-ancestor
111187964|NCT03112590|Antimitotic Agents|antimitotic agents|mesh-ancestor
111187965|NCT03112590|Mitosis Modulators|mitosis modulators|mesh-ancestor
111187966|NCT03112590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111187967|NCT03112590|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111187968|NCT03112590|Antiviral Agents|antiviral agents|mesh-ancestor
111187969|NCT03112590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111187970|NCT03085394|Tranexamic Acid|tranexamic acid|mesh-list
111187971|NCT03085394|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111187972|NCT03085394|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111187973|NCT03085394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111187974|NCT03085394|Hemostatics|hemostatics|mesh-ancestor
111187975|NCT03085394|Coagulants|coagulants|mesh-ancestor
111187976|NCT03065621|Palbociclib|palbociclib|mesh-list
111187977|NCT03065621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111187978|NCT03065621|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111187979|NCT03065621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111187980|NCT03065621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111187982|NCT03060434|Ibuprofen|ibuprofen|mesh-list
111187983|NCT03060434|Pregabalin|pregabalin|mesh-list
111187984|NCT03060434|Pentoxifylline|pentoxifylline|mesh-list
111187985|NCT03060434|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111187986|NCT03060434|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111187987|NCT03060434|Analgesics|analgesics|mesh-ancestor
111187988|NCT03060434|Sensory System Agents|sensory system agents|mesh-ancestor
111187989|NCT03060434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111187990|NCT03060434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111187991|NCT03060434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111187992|NCT03060434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111187993|NCT03060434|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111187994|NCT03060434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111187995|NCT03060434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111187996|NCT03060434|Anticonvulsants|anticonvulsants|mesh-ancestor
111187997|NCT03060434|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111187998|NCT03060434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111187999|NCT03060434|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111188000|NCT03060434|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111188001|NCT03060434|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111188002|NCT03060434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111188003|NCT03060434|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111188004|NCT03060434|Antipyretics|antipyretics|mesh-ancestor
111188005|NCT03060434|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111188006|NCT03060434|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111188007|NCT03060434|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111188008|NCT03060434|Protective Agents|protective agents|mesh-ancestor
111188009|NCT03060434|Vasodilator Agents|vasodilator agents|mesh-ancestor
111188010|NCT03060434|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111188011|NCT03060434|Antioxidants|antioxidants|mesh-ancestor
111188012|NCT03021486|Haloperidol|haloperidol|mesh-list
111188013|NCT03021486|Chlorpromazine|chlorpromazine|mesh-list
111188014|NCT03021486|Haloperidol decanoate|haloperidol decanoate|mesh-list
111188015|NCT03021486|Antiemetics|antiemetics|mesh-ancestor
111188016|NCT03021486|Autonomic Agents|autonomic agents|mesh-ancestor
111188017|NCT03021486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111188018|NCT03021486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111188019|NCT03021486|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111188020|NCT03021486|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111188021|NCT03021486|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111188022|NCT03021486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111188023|NCT03021486|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111188024|NCT03021486|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111188025|NCT03021486|Dopamine Agents|dopamine agents|mesh-ancestor
111188026|NCT03021486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111188027|NCT03021486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111188028|NCT03021486|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111188029|NCT02949128|Ravulizumab|ravulizumab|mesh-list
111188030|NCT02949128|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
111188031|NCT02949128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111188032|NCT02949128|Immunologic Factors|immunologic factors|mesh-ancestor
111188033|NCT02949128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111188034|NCT02944617|Micronutrients|micronutrients|mesh-list
111188035|NCT02944617|Trace Elements|trace elements|mesh-list
111188036|NCT02944617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111188037|NCT02923115|Enoxaparin|enoxaparin|mesh-list
111188038|NCT02923115|Anticoagulants|anticoagulants|mesh-ancestor
111188039|NCT02923115|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111188041|NCT02923115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111188042|NCT02910583|Venetoclax|venetoclax|mesh-list
111188043|NCT02910583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111188044|NCT02820857|Bevacizumab|bevacizumab|mesh-list
111188045|NCT02820857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111188046|NCT02820857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111188047|NCT02820857|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111188048|NCT02820857|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111188049|NCT02820857|Growth Substances|growth substances|mesh-ancestor
111188050|NCT02820857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111188051|NCT02820857|Growth Inhibitors|growth inhibitors|mesh-ancestor
111188052|NCT02790710|Propranolol|propranolol|mesh-list
111188053|NCT02790710|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111188054|NCT02790710|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111188055|NCT02790710|Adrenergic Agents|adrenergic agents|mesh-ancestor
111188056|NCT02790710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111188057|NCT02790710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111188058|NCT02790710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111188059|NCT02790710|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111188060|NCT02790710|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111188061|NCT02790710|Vasodilator Agents|vasodilator agents|mesh-ancestor
111188062|NCT02648477|Doxorubicin|doxorubicin|mesh-list
111188063|NCT02648477|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111188064|NCT02648477|Pembrolizumab|pembrolizumab|mesh-list
111188065|NCT02648477|Letrozole|letrozole|mesh-list
111188066|NCT02648477|Anastrozole|anastrozole|mesh-list
111188067|NCT02648477|Exemestane|exemestane|mesh-list
111188068|NCT02648477|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111188069|NCT02648477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111188070|NCT02648477|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111188071|NCT02648477|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111188072|NCT02648477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111188073|NCT02648477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111188074|NCT02648477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111188075|NCT02648477|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111188076|NCT02648477|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111188077|NCT02648477|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111188078|NCT02648477|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111188079|NCT02648477|Hormone Antagonists|hormone antagonists|mesh-ancestor
111188080|NCT02648477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111188081|NCT02648477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111188082|NCT02648477|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111188083|NCT02604732|Aspirin|aspirin|mesh-list
111188084|NCT02604732|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111188085|NCT02604732|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111188086|NCT02604732|Analgesics|analgesics|mesh-ancestor
111188087|NCT02604732|Sensory System Agents|sensory system agents|mesh-ancestor
111188088|NCT02604732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111188089|NCT02604732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111188090|NCT02604732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111188091|NCT02604732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111188092|NCT02604732|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111188093|NCT02604732|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111188094|NCT02604732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111188095|NCT02604732|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111188096|NCT02604732|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111188097|NCT02604732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111188098|NCT02604732|Antipyretics|antipyretics|mesh-ancestor
111188099|NCT02444429|Methylprednisolone|methylprednisolone|mesh-list
111188100|NCT02444429|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111188101|NCT02444429|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111188102|NCT02444429|Prednisolone|prednisolone|mesh-list
111188103|NCT02444429|Prednisolone acetate|prednisolone acetate|mesh-list
111188104|NCT02444429|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111188105|NCT02444429|Prednisolone phosphate|prednisolone phosphate|mesh-list
111188106|NCT02444429|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111188107|NCT02444429|Antiemetics|antiemetics|mesh-ancestor
111188108|NCT02444429|Autonomic Agents|autonomic agents|mesh-ancestor
111188109|NCT02444429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111188110|NCT02444429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111188111|NCT02444429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111188112|NCT02444429|Glucocorticoids|glucocorticoids|mesh-ancestor
111188114|NCT02444429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111188115|NCT02444429|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111188116|NCT02444429|Protective Agents|protective agents|mesh-ancestor
111188117|NCT02444429|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111188118|NCT02444429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111188119|NCT02318342|Warfarin|warfarin|mesh-list
111188120|NCT02318342|Anticoagulants|anticoagulants|mesh-ancestor
111188121|NCT02134184|Vaccines|vaccines|mesh-list
111188122|NCT02134184|Immunologic Factors|immunologic factors|mesh-ancestor
111188123|NCT02134184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111188124|NCT02029846|Metformin|metformin|mesh-list
111188125|NCT02029846|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
111188126|NCT02029846|Incretins|incretins|mesh-list
111188127|NCT02029846|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111188128|NCT02029846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111188129|NCT02029846|Protease Inhibitors|protease inhibitors|mesh-ancestor
111188130|NCT02029846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111188131|NCT02029846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111188132|NCT02029846|Hormones|hormones|mesh-ancestor
111188133|NCT02029846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111188134|NCT06018623|Anesthetics|anesthetics|mesh-list
111188135|NCT06018623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111188136|NCT06018623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111188137|NCT06018597|Sevoflurane|sevoflurane|mesh-list
111188138|NCT06018597|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111188139|NCT06018597|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111188140|NCT06018597|Anesthetics, General|anesthetics, general|mesh-ancestor
111188141|NCT06018597|Anesthetics|anesthetics|mesh-ancestor
111188142|NCT06018597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111188143|NCT06018597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111188144|NCT06018467|Niacinamide|niacinamide|mesh-list
111188145|NCT06018467|Niacin|niacin|mesh-list
111188146|NCT06018467|Nicotinic Acids|nicotinic acids|mesh-list
111188147|NCT06018467|Dasatinib|dasatinib|mesh-list
111188148|NCT06018467|Quercetin|quercetin|mesh-list
111188149|NCT06018467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111188150|NCT06018467|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111188151|NCT06018467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111188152|NCT06018467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111188153|NCT06018467|Vitamin B Complex|vitamin b complex|mesh-ancestor
111188154|NCT06018467|Vitamins|vitamins|mesh-ancestor
111188155|NCT06018467|Micronutrients|micronutrients|mesh-ancestor
111188156|NCT06018467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111188157|NCT06018467|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111188158|NCT06018467|Antimetabolites|antimetabolites|mesh-ancestor
111188159|NCT06018467|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111188160|NCT06018467|Vasodilator Agents|vasodilator agents|mesh-ancestor
111188161|NCT06018467|Antioxidants|antioxidants|mesh-ancestor
111188162|NCT06018467|Protective Agents|protective agents|mesh-ancestor
111188163|NCT06018337|Paclitaxel|paclitaxel|mesh-list
111188164|NCT06018337|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111188165|NCT06018337|Capecitabine|capecitabine|mesh-list
111188166|NCT06018337|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111188167|NCT06018337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111188168|NCT06018337|Tubulin Modulators|tubulin modulators|mesh-ancestor
111188169|NCT06018337|Antimitotic Agents|antimitotic agents|mesh-ancestor
111188170|NCT06018337|Mitosis Modulators|mitosis modulators|mesh-ancestor
111188171|NCT06018337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110844790|NCT03379012|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111188172|NCT06018337|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111188174|NCT06018207|Midazolam|midazolam|mesh-list
111188175|NCT06018207|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111188176|NCT06018207|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111188177|NCT06018207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111188178|NCT06018207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111188179|NCT06018207|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111188180|NCT06018207|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111188181|NCT06018207|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111188182|NCT06018207|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111188183|NCT06018207|Anesthetics, General|anesthetics, general|mesh-ancestor
111188184|NCT06018207|Anesthetics|anesthetics|mesh-ancestor
111188185|NCT06018207|GABA Modulators|gaba modulators|mesh-ancestor
111188186|NCT06018207|GABA Agents|gaba agents|mesh-ancestor
110905356|NCT04326439|Antimetabolites|antimetabolites|mesh-ancestor
111188187|NCT06018207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111188188|NCT06018207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111188189|NCT06018025|Antibodies|antibodies|mesh-list
111188190|NCT06018025|Immunologic Factors|immunologic factors|mesh-ancestor
111188192|NCT06017921|Eszopiclone|eszopiclone|mesh-list
111188193|NCT06017921|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111188194|NCT06017921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111188195|NCT06017921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111188196|NCT06017895|Doxepin|doxepin|mesh-list
111188197|NCT06017895|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111188198|NCT06017895|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111188199|NCT06017895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111188200|NCT06017895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111188201|NCT06017895|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
111188202|NCT06017895|Antidepressive Agents|antidepressive agents|mesh-ancestor
111188203|NCT06017895|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111188204|NCT06017895|Histamine Antagonists|histamine antagonists|mesh-ancestor
111188205|NCT06017895|Histamine Agents|histamine agents|mesh-ancestor
111188206|NCT06017895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111188207|NCT06017895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111188208|NCT06017726|Insulin|insulin|mesh-list
111188209|NCT06017726|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111188210|NCT06017726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111188211|NCT06017583|Capecitabine|capecitabine|mesh-list
111188212|NCT06017583|Oxaliplatin|oxaliplatin|mesh-list
111188213|NCT06017583|Tislelizumab|tislelizumab|mesh-list
111188214|NCT06017583|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111188215|NCT06017583|Antimetabolites|antimetabolites|mesh-ancestor
111188216|NCT06017583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111188217|NCT06017583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111188218|NCT06017583|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111188219|NCT06017479|Levofloxacin|levofloxacin|mesh-list
111188220|NCT06017479|Fosfomycin|fosfomycin|mesh-list
111188221|NCT06017479|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111188222|NCT06017479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111188223|NCT06017479|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111188224|NCT06017479|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111188225|NCT06017479|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111188226|NCT06017479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111188227|NCT06017479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111188228|NCT06017479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111188229|NCT06017479|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111188230|NCT06017479|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111188231|NCT06017284|Thalidomide|thalidomide|mesh-list
111188232|NCT06017284|Paclitaxel|paclitaxel|mesh-list
111188233|NCT06017284|Gemcitabine|gemcitabine|mesh-list
111188234|NCT06017284|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111188235|NCT06017284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111188236|NCT06017284|Tubulin Modulators|tubulin modulators|mesh-ancestor
111188237|NCT06017284|Antimitotic Agents|antimitotic agents|mesh-ancestor
111188238|NCT06017284|Mitosis Modulators|mitosis modulators|mesh-ancestor
111188239|NCT06017284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111188240|NCT06017284|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111188242|NCT06017284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111188243|NCT06017284|Immunologic Factors|immunologic factors|mesh-ancestor
111188244|NCT06017284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111188245|NCT06017284|Leprostatic Agents|leprostatic agents|mesh-ancestor
111188246|NCT06017284|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111188247|NCT06017284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111188248|NCT06017284|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111188249|NCT06017284|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111188250|NCT06017284|Growth Substances|growth substances|mesh-ancestor
111188251|NCT06017284|Growth Inhibitors|growth inhibitors|mesh-ancestor
111188252|NCT06017167|Dexamethasone|dexamethasone|mesh-list
111188253|NCT06017167|Dexamethasone acetate|dexamethasone acetate|mesh-list
111188254|NCT06017167|Dexmedetomidine|dexmedetomidine|mesh-list
111188255|NCT06017167|Ondansetron|ondansetron|mesh-list
111188256|NCT06017167|BB 1101|bb 1101|mesh-list
111188257|NCT06017167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111188258|NCT06017167|Antiemetics|antiemetics|mesh-ancestor
111188259|NCT06017167|Autonomic Agents|autonomic agents|mesh-ancestor
111188260|NCT06017167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111188261|NCT06017167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111188262|NCT06017167|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111188263|NCT06017167|Glucocorticoids|glucocorticoids|mesh-ancestor
111188264|NCT06017167|Hormones|hormones|mesh-ancestor
110905432|NCT02770820|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111188265|NCT06017167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111188266|NCT06017167|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111188267|NCT06017167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111188268|NCT06017167|Protease Inhibitors|protease inhibitors|mesh-ancestor
111188269|NCT06017167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111188270|NCT06017167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111188271|NCT06017167|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111188272|NCT06017167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111188273|NCT06017167|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111188274|NCT06017167|Analgesics|analgesics|mesh-ancestor
111188275|NCT06017167|Sensory System Agents|sensory system agents|mesh-ancestor
111188276|NCT06017167|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111188277|NCT06017167|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111188278|NCT06017167|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111188279|NCT06017167|Adrenergic Agents|adrenergic agents|mesh-ancestor
111188280|NCT06017167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111188281|NCT06017167|Antipruritics|antipruritics|mesh-ancestor
111188282|NCT06017167|Dermatologic Agents|dermatologic agents|mesh-ancestor
111188283|NCT06017167|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111188284|NCT06017167|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111188285|NCT06017167|Serotonin Agents|serotonin agents|mesh-ancestor
111188287|NCT06017141|Propofol|propofol|mesh-list
111188288|NCT06017141|Sevoflurane|sevoflurane|mesh-list
111188289|NCT06017141|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111188290|NCT06017141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111188291|NCT06017141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111188292|NCT06017141|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111188293|NCT06017141|Anesthetics, General|anesthetics, general|mesh-ancestor
111188294|NCT06017141|Anesthetics|anesthetics|mesh-ancestor
111188295|NCT06017141|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111188296|NCT06017141|Narcotics|narcotics|mesh-ancestor
111188297|NCT06017141|Analgesics|analgesics|mesh-ancestor
111188298|NCT06017141|Sensory System Agents|sensory system agents|mesh-ancestor
111188299|NCT06017141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111188300|NCT06017141|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111188301|NCT06017141|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111188302|NCT06017141|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111188303|NCT06017037|Citalopram|citalopram|mesh-list
111188304|NCT06017037|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111188305|NCT06017037|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111188306|NCT06017037|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111188307|NCT06017037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111188308|NCT06017037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111188309|NCT06017037|Serotonin Agents|serotonin agents|mesh-ancestor
111188310|NCT06017037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111188311|NCT06017037|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111188312|NCT06017037|Antidepressive Agents|antidepressive agents|mesh-ancestor
111188313|NCT06017037|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111188314|NCT06016985|Caffeine|caffeine|mesh-list
111188315|NCT06016985|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111188316|NCT06016985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111188317|NCT06016985|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111188318|NCT06016985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111188319|NCT06016985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111188320|NCT06016985|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
111188321|NCT06016985|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111188322|NCT06016985|Purinergic Agents|purinergic agents|mesh-ancestor
111188323|NCT06016985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111188324|NCT06016920|Pembrolizumab|pembrolizumab|mesh-list
111188325|NCT06016920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111188326|NCT06016920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111188327|NCT06016920|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111188328|NCT06016920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111188329|NCT06016855|Copper|copper|mesh-list
111188330|NCT06016855|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
111188331|NCT06016855|Trace Elements|trace elements|mesh-ancestor
111188332|NCT06016855|Micronutrients|micronutrients|mesh-ancestor
111188333|NCT06016855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111188334|NCT06016855|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111188335|NCT06016855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111188336|NCT06011330|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
111188337|NCT06011330|Antibodies|antibodies|mesh-list
111188338|NCT06011330|Immunologic Factors|immunologic factors|mesh-ancestor
111188339|NCT06011330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111188340|NCT06011330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111188341|NCT06011330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111188342|NCT06011330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111188343|NCT06007391|Niacinamide|niacinamide|mesh-list
111188344|NCT06007391|Niacin|niacin|mesh-list
111188345|NCT06007391|Nicotinic Acids|nicotinic acids|mesh-list
111188346|NCT06007391|Vitamin B Complex|vitamin b complex|mesh-ancestor
111188347|NCT06007391|Vitamins|vitamins|mesh-ancestor
111188348|NCT06007391|Micronutrients|micronutrients|mesh-ancestor
111188349|NCT06007391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111188350|NCT06007391|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111188351|NCT06007391|Antimetabolites|antimetabolites|mesh-ancestor
111188352|NCT06007391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111188353|NCT06007391|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111188354|NCT06007391|Vasodilator Agents|vasodilator agents|mesh-ancestor
111188355|NCT05997563|Progesterone|progesterone|mesh-list
111188356|NCT05997563|Progestins|progestins|mesh-ancestor
111188357|NCT05997563|Hormones|hormones|mesh-ancestor
111188358|NCT05997563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111188359|NCT05997563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111188360|NCT05980572|Triamcinolone|triamcinolone|mesh-list
111188361|NCT05980572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
111188362|NCT05980572|Aceclofenac|aceclofenac|mesh-list
111188363|NCT05980572|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
111188364|NCT05980572|Glucocorticoids|glucocorticoids|mesh-ancestor
111188365|NCT05980572|Hormones|hormones|mesh-ancestor
111188366|NCT05980572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111188367|NCT05980572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111188368|NCT05980572|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111188369|NCT05980572|Analgesics|analgesics|mesh-ancestor
111188370|NCT05980572|Sensory System Agents|sensory system agents|mesh-ancestor
111188371|NCT05980572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111188372|NCT05980572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111188373|NCT05952453|Carboplatin|carboplatin|mesh-list
111188374|NCT05952453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111188375|NCT05936606|Clopidogrel|clopidogrel|mesh-list
111188376|NCT05936606|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111188377|NCT05936606|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111188378|NCT05936606|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111188379|NCT05936606|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111188380|NCT05936606|Purinergic Agents|purinergic agents|mesh-ancestor
111188381|NCT05936606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110844816|NCT03257358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111188382|NCT05936606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111188383|NCT05936606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111188385|NCT05936086|Dexamethasone|dexamethasone|mesh-list
111188386|NCT05936086|Etoposide|etoposide|mesh-list
111188387|NCT05936086|Cyclophosphamide|cyclophosphamide|mesh-list
111188388|NCT05936086|Cyclosporins|cyclosporins|mesh-list
111188389|NCT05936086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111188390|NCT05936086|Antiemetics|antiemetics|mesh-ancestor
111188391|NCT05936086|Autonomic Agents|autonomic agents|mesh-ancestor
111188392|NCT05936086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111188393|NCT05936086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111188394|NCT05936086|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111188395|NCT05936086|Glucocorticoids|glucocorticoids|mesh-ancestor
111188396|NCT05936086|Hormones|hormones|mesh-ancestor
111188397|NCT05936086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111188398|NCT05936086|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111188399|NCT05936086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111188400|NCT05936086|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111188401|NCT05936086|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111188402|NCT05936086|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111188403|NCT05936086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111188404|NCT05936086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111188405|NCT05936086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111188406|NCT05936086|Immunologic Factors|immunologic factors|mesh-ancestor
111188407|NCT05936086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111188408|NCT05936086|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111188409|NCT05936086|Alkylating Agents|alkylating agents|mesh-ancestor
111188410|NCT05936086|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111188411|NCT05936086|Antifungal Agents|antifungal agents|mesh-ancestor
111188412|NCT05936086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111188413|NCT05936086|Dermatologic Agents|dermatologic agents|mesh-ancestor
111188414|NCT05936086|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111188415|NCT05932511|Ascorbic Acid|ascorbic acid|mesh-list
111188416|NCT05932511|Antioxidants|antioxidants|mesh-ancestor
111188417|NCT05932511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111188418|NCT05932511|Protective Agents|protective agents|mesh-ancestor
111188419|NCT05932511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111188420|NCT05932511|Vitamins|vitamins|mesh-ancestor
111188421|NCT05932511|Micronutrients|micronutrients|mesh-ancestor
111188422|NCT05889013|Nitric Oxide|nitric oxide|mesh-list
111188423|NCT05889013|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111188424|NCT05889013|Autonomic Agents|autonomic agents|mesh-ancestor
111188425|NCT05889013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111188426|NCT05889013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111188427|NCT05889013|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111188428|NCT05889013|Respiratory System Agents|respiratory system agents|mesh-ancestor
111188429|NCT05889013|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111188430|NCT05889013|Antioxidants|antioxidants|mesh-ancestor
111188431|NCT05889013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111188432|NCT05889013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111188433|NCT05889013|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
111188434|NCT05889013|Vasodilator Agents|vasodilator agents|mesh-ancestor
111188435|NCT05889013|Gasotransmitters|gasotransmitters|mesh-ancestor
111188436|NCT05889013|Protective Agents|protective agents|mesh-ancestor
111188437|NCT05883644|Durvalumab|durvalumab|mesh-list
111188438|NCT05883644|Tremelimumab|tremelimumab|mesh-list
111188439|NCT05883644|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111188440|NCT05883644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111188441|NCT05882903|Betamethasone|betamethasone|mesh-list
111188442|NCT05882903|Betamethasone Valerate|betamethasone valerate|mesh-list
111188443|NCT05882903|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
111188444|NCT05882903|Betamethasone benzoate|betamethasone benzoate|mesh-list
111188445|NCT05882903|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
111188446|NCT05882903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111188447|NCT05882903|Glucocorticoids|glucocorticoids|mesh-ancestor
111188448|NCT05882903|Hormones|hormones|mesh-ancestor
111188449|NCT05882903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111188450|NCT05882903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111188451|NCT05882903|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111188452|NCT05882903|Respiratory System Agents|respiratory system agents|mesh-ancestor
111188453|NCT05873712|Cyclophosphamide|cyclophosphamide|mesh-list
111188455|NCT05873712|Zanubrutinib|zanubrutinib|mesh-list
111188456|NCT05873712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111188457|NCT05873712|Immunologic Factors|immunologic factors|mesh-ancestor
111188458|NCT05873712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111188459|NCT05873712|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111188460|NCT05873712|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111188461|NCT05873712|Alkylating Agents|alkylating agents|mesh-ancestor
111188462|NCT05873712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111188463|NCT05873712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111188464|NCT05873712|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111188465|NCT05873712|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111188466|NCT05873712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111188467|NCT05872451|Bromides|bromides|mesh-list
111188468|NCT05872451|Rocuronium|rocuronium|mesh-list
111188469|NCT05872451|Anticonvulsants|anticonvulsants|mesh-ancestor
111188470|NCT05872451|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
111188471|NCT05872451|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
111188472|NCT05872451|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111188473|NCT05872451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111188474|NCT05872451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111188475|NCT05871606|Nitrous Oxide|nitrous oxide|mesh-list
111188476|NCT05871606|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111188477|NCT05871606|Anesthetics, General|anesthetics, general|mesh-ancestor
111188478|NCT05871606|Anesthetics|anesthetics|mesh-ancestor
111188479|NCT05871606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111188480|NCT05871606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111188481|NCT05871606|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111188482|NCT05871606|Analgesics|analgesics|mesh-ancestor
111188483|NCT05871606|Sensory System Agents|sensory system agents|mesh-ancestor
111188484|NCT05871606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111188485|NCT05868577|Anesthetics|anesthetics|mesh-list
111188486|NCT05868577|Anesthetics, Local|anesthetics, local|mesh-list
110905654|NCT00102440|Allopurinol|allopurinol|mesh-list
111188487|NCT05868577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111188488|NCT05868577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111188489|NCT05868577|Sensory System Agents|sensory system agents|mesh-ancestor
111188490|NCT05868577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111188491|NCT05863312|Temazepam|temazepam|mesh-list
111188492|NCT05863312|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111188493|NCT05863312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111188494|NCT05863312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111188495|NCT05863312|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111188496|NCT05863312|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111188497|NCT05863312|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111188498|NCT05863312|GABA Modulators|gaba modulators|mesh-ancestor
111188499|NCT05863312|GABA Agents|gaba agents|mesh-ancestor
111188500|NCT05863312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111188501|NCT05863312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111188502|NCT05861921|Lithium Carbonate|lithium carbonate|mesh-list
111188503|NCT05861921|Antidepressive Agents|antidepressive agents|mesh-ancestor
111188504|NCT05861921|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111188505|NCT05861921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111188506|NCT05861921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111188507|NCT05861921|Antimanic Agents|antimanic agents|mesh-ancestor
111188508|NCT05861921|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111188509|NCT05861921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111188510|NCT05861921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111188511|NCT05854498|Bevacizumab|bevacizumab|mesh-list
111188512|NCT05854498|Irinotecan|irinotecan|mesh-list
111188513|NCT05854498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111188514|NCT05854498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111188515|NCT05854498|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111188516|NCT05854498|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111188517|NCT05854498|Growth Substances|growth substances|mesh-ancestor
111188518|NCT05854498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111188519|NCT05854498|Growth Inhibitors|growth inhibitors|mesh-ancestor
111188520|NCT05854498|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111188521|NCT05854498|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111188522|NCT05854498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111188523|NCT05854498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111188524|NCT05851898|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
111188525|NCT05851898|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111188526|NCT05851898|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111188527|NCT05851898|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111188528|NCT05851898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111188529|NCT05851898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111188530|NCT05851898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111188531|NCT05851898|Analgesics|analgesics|mesh-ancestor
111188532|NCT05851898|Sensory System Agents|sensory system agents|mesh-ancestor
111188533|NCT05851898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111188534|NCT05851898|Antidepressive Agents|antidepressive agents|mesh-ancestor
111188535|NCT05851898|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111188536|NCT05851898|Dopamine Agents|dopamine agents|mesh-ancestor
111188537|NCT05841472|Carboplatin|carboplatin|mesh-list
111188538|NCT05841472|Pemetrexed|pemetrexed|mesh-list
111188539|NCT05841472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111188540|NCT05841472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111188541|NCT05841472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111188542|NCT05841472|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111188543|NCT05841472|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111188544|NCT05831449|Ropivacaine|ropivacaine|mesh-list
111188545|NCT05831449|Anesthetics, Local|anesthetics, local|mesh-list
111188546|NCT05831449|Anesthetics|anesthetics|mesh-list
111188547|NCT05831449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111188548|NCT05831449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111188549|NCT05831449|Sensory System Agents|sensory system agents|mesh-ancestor
111188550|NCT05831449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111188551|NCT05829356|Vaccines|vaccines|mesh-list
111188552|NCT05829356|Immunologic Factors|immunologic factors|mesh-ancestor
111188553|NCT05829356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111188554|NCT05821725|Hyaluronic Acid|hyaluronic acid|mesh-list
111188555|NCT05821725|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111188556|NCT05821725|Immunologic Factors|immunologic factors|mesh-ancestor
111188557|NCT05821725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111188558|NCT05821725|Viscosupplements|viscosupplements|mesh-ancestor
111188559|NCT05821725|Protective Agents|protective agents|mesh-ancestor
111188560|NCT05818124|Oseltamivir|oseltamivir|mesh-list
111188561|NCT05818124|Molnupiravir|molnupiravir|mesh-list
111188562|NCT05818124|Antiviral Agents|antiviral agents|mesh-ancestor
111188563|NCT05818124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111188564|NCT05818124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111188565|NCT05818124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111188566|NCT05813847|Anesthetics|anesthetics|mesh-list
111188567|NCT05813847|Anesthetics, Local|anesthetics, local|mesh-list
111188568|NCT05813847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111188569|NCT05813847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111188570|NCT05813847|Sensory System Agents|sensory system agents|mesh-ancestor
111188571|NCT05813847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111188572|NCT05810233|Ascorbic Acid|ascorbic acid|mesh-list
111188573|NCT05810233|Vitamins|vitamins|mesh-ancestor
111188574|NCT05810233|Micronutrients|micronutrients|mesh-ancestor
111188575|NCT05810233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111188576|NCT05810233|Antioxidants|antioxidants|mesh-ancestor
111188577|NCT05810233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111188578|NCT05810233|Protective Agents|protective agents|mesh-ancestor
111188579|NCT05805891|Bortezomib|bortezomib|mesh-list
111188580|NCT05805891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111188581|NCT05803083|Hyaluronic Acid|hyaluronic acid|mesh-list
111188582|NCT05803083|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111188583|NCT05803083|Immunologic Factors|immunologic factors|mesh-ancestor
111188584|NCT05803083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111188585|NCT05803083|Viscosupplements|viscosupplements|mesh-ancestor
111188586|NCT05803083|Protective Agents|protective agents|mesh-ancestor
110618788|NCT00752414|Levofloxacin|levofloxacin|mesh-list
111188587|NCT05783648|Tranexamic Acid|tranexamic acid|mesh-list
111188588|NCT05783648|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111188589|NCT05783648|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111188590|NCT05783648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111188591|NCT05783648|Hemostatics|hemostatics|mesh-ancestor
111188592|NCT05783648|Coagulants|coagulants|mesh-ancestor
111188593|NCT05761951|Pembrolizumab|pembrolizumab|mesh-list
111188594|NCT05761951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111188595|NCT05761951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111188596|NCT05761951|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111188597|NCT05761951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111188598|NCT05761405|Ceftriaxone|ceftriaxone|mesh-list
111188599|NCT05761405|Amikacin|amikacin|mesh-list
111188600|NCT05761405|Mannitol|mannitol|mesh-list
111188601|NCT05761405|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
111188602|NCT05761405|Diuretics|diuretics|mesh-ancestor
111188603|NCT05761405|Natriuretic Agents|natriuretic agents|mesh-ancestor
111188604|NCT05761405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111188605|NCT05761405|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111188606|NCT05761405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111188607|NCT05739474|Vaccines|vaccines|mesh-list
111188608|NCT05739474|Immunologic Factors|immunologic factors|mesh-ancestor
111188609|NCT05739474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111188610|NCT05736562|Vitamins|vitamins|mesh-list
111188611|NCT05736562|Micronutrients|micronutrients|mesh-ancestor
111188612|NCT05736562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111188613|NCT05724134|Insulin|insulin|mesh-list
111188614|NCT05724134|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111188615|NCT05724134|Octreotide|octreotide|mesh-list
111188616|NCT05724134|Glucagon|glucagon|mesh-list
111188617|NCT05724134|Hormones|hormones|mesh-list
111188618|NCT05724134|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111188619|NCT05724134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111188620|NCT05724134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111188621|NCT05724134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111188622|NCT05724134|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111188623|NCT05724134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111188624|NCT05690698|Haloperidol|haloperidol|mesh-list
111188625|NCT05690698|Haloperidol decanoate|haloperidol decanoate|mesh-list
111188626|NCT05690698|Antiemetics|antiemetics|mesh-ancestor
111188627|NCT05690698|Autonomic Agents|autonomic agents|mesh-ancestor
111188628|NCT05690698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111188629|NCT05690698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111188630|NCT05690698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111188631|NCT05690698|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111188632|NCT05690698|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111188633|NCT05690698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111188634|NCT05690698|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111188635|NCT05690698|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111188636|NCT05690698|Dopamine Agents|dopamine agents|mesh-ancestor
111188637|NCT05690698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111188638|NCT05690698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111188639|NCT05690698|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111188640|NCT05687058|Empagliflozin|empagliflozin|mesh-list
111188641|NCT05687058|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111188642|NCT05687058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111188643|NCT05687058|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111188644|NCT05687058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111188645|NCT05665465|Nicotine|nicotine|mesh-list
111188646|NCT05665465|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111188647|NCT05665465|Autonomic Agents|autonomic agents|mesh-ancestor
111188648|NCT05665465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111188649|NCT05665465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111188650|NCT05665465|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111188651|NCT05665465|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111188652|NCT05665465|Cholinergic Agents|cholinergic agents|mesh-ancestor
111188653|NCT05665465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111188654|NCT05665465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111188655|NCT05658484|Dimethyl Fumarate|dimethyl fumarate|mesh-list
111188656|NCT05658484|Dermatologic Agents|dermatologic agents|mesh-ancestor
111188657|NCT05658484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111188658|NCT05658484|Immunologic Factors|immunologic factors|mesh-ancestor
111188659|NCT05658484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111188660|NCT05636189|Anesthetics|anesthetics|mesh-list
111188661|NCT05636189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111188662|NCT05636189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111188663|NCT05626998|Dexmedetomidine|dexmedetomidine|mesh-list
111188664|NCT05626998|Gabapentin|gabapentin|mesh-list
111188665|NCT05626998|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111188666|NCT05626998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111188667|NCT05626998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111188668|NCT05626998|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111188669|NCT05626998|Analgesics|analgesics|mesh-ancestor
111188670|NCT05626998|Sensory System Agents|sensory system agents|mesh-ancestor
111188671|NCT05626998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111188672|NCT05626998|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110799569|NCT03758235|Cholinergic Agents|cholinergic agents|mesh-ancestor
111188673|NCT05626998|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111188674|NCT05626998|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111188675|NCT05626998|Adrenergic Agents|adrenergic agents|mesh-ancestor
111188676|NCT05626998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111188677|NCT05626998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111188678|NCT05626998|Anticonvulsants|anticonvulsants|mesh-ancestor
111188679|NCT05626998|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111188680|NCT05626998|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111188681|NCT05626998|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111188682|NCT05626998|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111188683|NCT05626998|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111188684|NCT05626998|Antimanic Agents|antimanic agents|mesh-ancestor
111188685|NCT05605535|Paclitaxel|paclitaxel|mesh-list
111188686|NCT05605535|Carboplatin|carboplatin|mesh-list
111188687|NCT05605535|Oregovomab|oregovomab|mesh-list
111188688|NCT05605535|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111188689|NCT05605535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111188690|NCT05605535|Tubulin Modulators|tubulin modulators|mesh-ancestor
111188691|NCT05605535|Antimitotic Agents|antimitotic agents|mesh-ancestor
111188692|NCT05605535|Mitosis Modulators|mitosis modulators|mesh-ancestor
111188693|NCT05605535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111188694|NCT05605535|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111188695|NCT05597839|Nivolumab|nivolumab|mesh-list
111188696|NCT05597839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111188697|NCT05597839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111188698|NCT05597839|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111188699|NCT05597839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111188700|NCT05592223|Rifampin|rifampin|mesh-list
111188701|NCT05592223|Isoniazid|isoniazid|mesh-list
111188702|NCT05592223|BCG Vaccine|bcg vaccine|mesh-list
111188703|NCT05592223|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111188704|NCT05592223|Antitubercular Agents|antitubercular agents|mesh-ancestor
111188705|NCT05592223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111188706|NCT05592223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111188707|NCT05592223|Leprostatic Agents|leprostatic agents|mesh-ancestor
111188708|NCT05592223|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111188709|NCT05592223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111188710|NCT05592223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111188711|NCT05592223|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111188712|NCT05592223|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111188713|NCT05592223|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
111188714|NCT05592223|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
111188715|NCT05592223|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
111188716|NCT05592223|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111188717|NCT05592223|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
111188719|NCT05592223|Antimetabolites|antimetabolites|mesh-ancestor
111188720|NCT05592223|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111188721|NCT05592223|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111188722|NCT05592223|Immunologic Factors|immunologic factors|mesh-ancestor
111188723|NCT05592223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111188724|NCT05582174|Esomeprazole|esomeprazole|mesh-list
111188725|NCT05582174|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111188726|NCT05582174|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111188727|NCT05582174|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111188728|NCT05582174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111188729|NCT05582174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111188730|NCT05578664|Pembrolizumab|pembrolizumab|mesh-list
111188731|NCT05578664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111188732|NCT05578664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111188733|NCT05578664|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111188734|NCT05578664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111188735|NCT05555901|Bevacizumab|bevacizumab|mesh-list
111188736|NCT05555901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111188737|NCT05555901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111188738|NCT05555901|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111188739|NCT05555901|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111188740|NCT05555901|Growth Substances|growth substances|mesh-ancestor
111188741|NCT05555901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111188742|NCT05555901|Growth Inhibitors|growth inhibitors|mesh-ancestor
111188743|NCT05545969|Pembrolizumab|pembrolizumab|mesh-list
111188744|NCT05545969|Lenvatinib|lenvatinib|mesh-list
111188745|NCT05545969|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111188746|NCT05545969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111188747|NCT05545969|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111188748|NCT05545969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111188749|NCT05545969|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111188750|NCT05545969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111188751|NCT05538910|Nicotine|nicotine|mesh-list
111188752|NCT05538910|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111188753|NCT05538910|Autonomic Agents|autonomic agents|mesh-ancestor
111188754|NCT05538910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111188755|NCT05538910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111188756|NCT05538910|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111188757|NCT05538910|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111188758|NCT05538910|Cholinergic Agents|cholinergic agents|mesh-ancestor
111188759|NCT05538910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111188760|NCT05538910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111188761|NCT05538208|Mycophenolic Acid|mycophenolic acid|mesh-list
111188762|NCT05538208|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111188763|NCT05538208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111188764|NCT05538208|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111188765|NCT05538208|Antitubercular Agents|antitubercular agents|mesh-ancestor
111188766|NCT05538208|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111188767|NCT05538208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111188768|NCT05538208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111188769|NCT05538208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111188770|NCT05521828|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
111188771|NCT05521828|Dydrogesterone|dydrogesterone|mesh-list
111188772|NCT05521828|Hormones|hormones|mesh-ancestor
111188773|NCT05521828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111188774|NCT05521828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111188775|NCT05521828|Progestins|progestins|mesh-ancestor
111188776|NCT05514197|Ascorbic Acid|ascorbic acid|mesh-list
111188777|NCT05514197|Antioxidants|antioxidants|mesh-ancestor
111188778|NCT05514197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111188779|NCT05514197|Protective Agents|protective agents|mesh-ancestor
111188780|NCT05514197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111188781|NCT05514197|Vitamins|vitamins|mesh-ancestor
111188782|NCT05514197|Micronutrients|micronutrients|mesh-ancestor
111188783|NCT05447026|Anti-Infective Agents|anti-infective agents|mesh-list
111188784|NCT05447026|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111188785|NCT05421065|Ketamine|ketamine|mesh-list
111188786|NCT05421065|Psilocybin|psilocybin|mesh-list
111188787|NCT05421065|Analgesics|analgesics|mesh-ancestor
111188788|NCT05421065|Sensory System Agents|sensory system agents|mesh-ancestor
111188789|NCT05421065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111188790|NCT05421065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111188791|NCT05421065|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111188792|NCT05421065|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111188793|NCT05421065|Anesthetics, General|anesthetics, general|mesh-ancestor
111188794|NCT05421065|Anesthetics|anesthetics|mesh-ancestor
111188795|NCT05421065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111188796|NCT05421065|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111188797|NCT05421065|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111188798|NCT05421065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111188799|NCT05421065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111188801|NCT05421065|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111188802|NCT05418972|Nivolumab|nivolumab|mesh-list
111188803|NCT05418972|Relatlimab|relatlimab|mesh-list
111188804|NCT05418972|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111188805|NCT05418972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111188806|NCT05418972|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111188807|NCT05418972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111188808|NCT05416333|Azelaic acid|azelaic acid|mesh-list
111188809|NCT05416333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111188810|NCT05416333|Dermatologic Agents|dermatologic agents|mesh-ancestor
111188811|NCT05399173|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
111188812|NCT05399173|Hemostatics|hemostatics|mesh-ancestor
111188813|NCT05399173|Coagulants|coagulants|mesh-ancestor
111188814|NCT05399173|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
111188815|NCT05399173|Natriuretic Agents|natriuretic agents|mesh-ancestor
111188816|NCT05399173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111188817|NCT05388877|Dabrafenib|dabrafenib|mesh-list
111188818|NCT05388877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111188819|NCT05388877|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111188820|NCT05388877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111188821|NCT05388877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111188822|NCT05371899|Chiauranib|chiauranib|mesh-list
111188823|NCT05371899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111188824|NCT05371899|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111188825|NCT05371899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111188826|NCT05371899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111188827|NCT05339256|Buprenorphine|buprenorphine|mesh-list
111188828|NCT05339256|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111188829|NCT05339256|Narcotics|narcotics|mesh-ancestor
111188830|NCT05339256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111188831|NCT05339256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111188832|NCT05339256|Analgesics|analgesics|mesh-ancestor
111188833|NCT05339256|Sensory System Agents|sensory system agents|mesh-ancestor
111188834|NCT05339256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111188835|NCT05339256|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111188836|NCT05335993|Niraparib|niraparib|mesh-list
111188837|NCT05335993|Oregovomab|oregovomab|mesh-list
111188838|NCT05335993|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111188839|NCT05335993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111188840|NCT05335993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111188841|NCT05335993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111188842|NCT05335993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111188843|NCT05327023|Mycophenolic Acid|mycophenolic acid|mesh-list
111188844|NCT05327023|Sirolimus|sirolimus|mesh-list
111188845|NCT05327023|Cyclophosphamide|cyclophosphamide|mesh-list
111188846|NCT05327023|Busulfan|busulfan|mesh-list
111188847|NCT05327023|Fludarabine|fludarabine|mesh-list
111188848|NCT05327023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111188849|NCT05327023|Immunologic Factors|immunologic factors|mesh-ancestor
110844853|NCT02936037|Biotin|biotin|mesh-list
111188850|NCT05327023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111188851|NCT05327023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111188852|NCT05327023|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111188853|NCT05327023|Alkylating Agents|alkylating agents|mesh-ancestor
111188854|NCT05327023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111188855|NCT05327023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111188856|NCT05327023|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111188857|NCT05327023|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111188858|NCT05327023|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111188859|NCT05327023|Antitubercular Agents|antitubercular agents|mesh-ancestor
110906028|NCT04740008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111188860|NCT05327023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111188861|NCT05327023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111188862|NCT05327023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111188863|NCT05327023|Antifungal Agents|antifungal agents|mesh-ancestor
111188865|NCT05322707|Formoterol Fumarate|formoterol fumarate|mesh-list
111188866|NCT05322707|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
111188867|NCT05322707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111188868|NCT05322707|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111188869|NCT05322707|Autonomic Agents|autonomic agents|mesh-ancestor
111188870|NCT05322707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111188871|NCT05322707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111188872|NCT05322707|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111188873|NCT05322707|Respiratory System Agents|respiratory system agents|mesh-ancestor
111188874|NCT05322707|Glucocorticoids|glucocorticoids|mesh-ancestor
111188875|NCT05322707|Hormones|hormones|mesh-ancestor
111188876|NCT05322707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111188877|NCT05322707|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111188878|NCT05322707|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111188879|NCT05322707|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111188880|NCT05322707|Adrenergic Agents|adrenergic agents|mesh-ancestor
111188881|NCT05322707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111188882|NCT05322707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111188883|NCT05320887|Nicotine|nicotine|mesh-list
111188884|NCT05320887|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111188885|NCT05320887|Autonomic Agents|autonomic agents|mesh-ancestor
111188886|NCT05320887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111188887|NCT05320887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111188888|NCT05320887|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111188889|NCT05320887|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111188890|NCT05320887|Cholinergic Agents|cholinergic agents|mesh-ancestor
111188891|NCT05320887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111188892|NCT05320887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111188893|NCT05316233|Hyaluronic Acid|hyaluronic acid|mesh-list
111188894|NCT05316233|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111188895|NCT05316233|Immunologic Factors|immunologic factors|mesh-ancestor
111188896|NCT05316233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111188897|NCT05316233|Viscosupplements|viscosupplements|mesh-ancestor
111188898|NCT05316233|Protective Agents|protective agents|mesh-ancestor
111188899|NCT05251636|Aflibercept|aflibercept|mesh-list
111188900|NCT05251636|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111188901|NCT05251636|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111188902|NCT05251636|Growth Substances|growth substances|mesh-ancestor
111188903|NCT05251636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111188904|NCT05251636|Growth Inhibitors|growth inhibitors|mesh-ancestor
111188905|NCT05251636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111188906|NCT05226663|Fluorides|fluorides|mesh-list
111188907|NCT05226663|Cariostatic Agents|cariostatic agents|mesh-ancestor
111188908|NCT05226663|Protective Agents|protective agents|mesh-ancestor
111188909|NCT05226663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111188910|NCT05214820|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
111188911|NCT05214820|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
111188912|NCT05214820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111188913|NCT05191797|Atezolizumab|atezolizumab|mesh-list
111188914|NCT05191797|Immunoglobulins|immunoglobulins|mesh-list
111188915|NCT05191797|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111188916|NCT05191797|Immunoglobulin G|immunoglobulin g|mesh-list
111188917|NCT05191797|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111188918|NCT05191797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111188919|NCT05191797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111188920|NCT05191797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111188921|NCT05191797|Immunologic Factors|immunologic factors|mesh-ancestor
111188922|NCT05191797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111188923|NCT05163522|Midazolam|midazolam|mesh-list
111188924|NCT05163522|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111188925|NCT05163522|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111188926|NCT05163522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111188927|NCT05163522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111188928|NCT05163522|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111188929|NCT05163522|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111188930|NCT05163522|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111188931|NCT05163522|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111188932|NCT05163522|Anesthetics, General|anesthetics, general|mesh-ancestor
111188933|NCT05163522|Anesthetics|anesthetics|mesh-ancestor
111188934|NCT05163522|GABA Modulators|gaba modulators|mesh-ancestor
111188935|NCT05163522|GABA Agents|gaba agents|mesh-ancestor
110906101|NCT03540368|Hemostatics|hemostatics|mesh-ancestor
111188936|NCT05163522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111188937|NCT05163522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111188939|NCT05142735|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111188940|NCT05142735|Antiviral Agents|antiviral agents|mesh-ancestor
111188941|NCT05142735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111188942|NCT05142735|Expectorants|expectorants|mesh-ancestor
111188943|NCT05142735|Respiratory System Agents|respiratory system agents|mesh-ancestor
111188944|NCT05142735|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111188945|NCT05142735|Antioxidants|antioxidants|mesh-ancestor
111188946|NCT05142735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111188947|NCT05142735|Protective Agents|protective agents|mesh-ancestor
111188948|NCT05142735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111188949|NCT05142735|Antidotes|antidotes|mesh-ancestor
111188950|NCT05134363|Dexmedetomidine|dexmedetomidine|mesh-list
111188951|NCT05134363|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111188952|NCT05134363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111188953|NCT05134363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111188954|NCT05134363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111188955|NCT05134363|Analgesics|analgesics|mesh-ancestor
111188956|NCT05134363|Sensory System Agents|sensory system agents|mesh-ancestor
111188957|NCT05134363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111188958|NCT05134363|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111188959|NCT05134363|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111188960|NCT05134363|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111188961|NCT05134363|Adrenergic Agents|adrenergic agents|mesh-ancestor
111188962|NCT05134363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111188963|NCT05134363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111188964|NCT05107674|Paclitaxel|paclitaxel|mesh-list
111188965|NCT05107674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111188966|NCT05107674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111188967|NCT05107674|Tubulin Modulators|tubulin modulators|mesh-ancestor
111188968|NCT05107674|Antimitotic Agents|antimitotic agents|mesh-ancestor
110844900|NCT04094298|FX006|fx006|mesh-list
111188969|NCT05107674|Mitosis Modulators|mitosis modulators|mesh-ancestor
111188970|NCT05107674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111188971|NCT05049863|Mycophenolic Acid|mycophenolic acid|mesh-list
111188972|NCT05049863|Irinotecan|irinotecan|mesh-list
111188973|NCT05049863|Allopurinol|allopurinol|mesh-list
111188974|NCT05049863|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111188975|NCT05049863|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111188976|NCT05049863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111188977|NCT05049863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111188978|NCT05049863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111188979|NCT05049863|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111188980|NCT05049863|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111188981|NCT05049863|Antitubercular Agents|antitubercular agents|mesh-ancestor
111188982|NCT05049863|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111188983|NCT05049863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111188984|NCT05049863|Antimetabolites|antimetabolites|mesh-ancestor
111188985|NCT05049863|Gout Suppressants|gout suppressants|mesh-ancestor
111188986|NCT05049863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111188987|NCT05049863|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111188988|NCT05049863|Antioxidants|antioxidants|mesh-ancestor
111188989|NCT05049863|Protective Agents|protective agents|mesh-ancestor
111188990|NCT05049863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111188991|NCT05020899|Nicotine|nicotine|mesh-list
111188992|NCT05020899|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111188993|NCT05020899|Autonomic Agents|autonomic agents|mesh-ancestor
111188994|NCT05020899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111188995|NCT05020899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111188996|NCT05020899|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111188997|NCT05020899|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111188998|NCT05020899|Cholinergic Agents|cholinergic agents|mesh-ancestor
111188999|NCT05020899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111189000|NCT05020899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111189001|NCT04978493|Ustekinumab|ustekinumab|mesh-list
111189002|NCT04978493|Dermatologic Agents|dermatologic agents|mesh-ancestor
111189003|NCT04954287|Vaccines|vaccines|mesh-list
111189004|NCT04954287|Immunologic Factors|immunologic factors|mesh-ancestor
111189005|NCT04954287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111189006|NCT04934748|Phenylephrine|phenylephrine|mesh-list
111189007|NCT04934748|Oxymetazoline|oxymetazoline|mesh-list
111189008|NCT04934748|Norepinephrine|norepinephrine|mesh-list
111189009|NCT04934748|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111189010|NCT04934748|Mydriatics|mydriatics|mesh-ancestor
111189011|NCT04934748|Autonomic Agents|autonomic agents|mesh-ancestor
111189012|NCT04934748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111189013|NCT04934748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111189014|NCT04934748|Sympathomimetics|sympathomimetics|mesh-ancestor
111189015|NCT04934748|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111189016|NCT04934748|Nasal Decongestants|nasal decongestants|mesh-ancestor
111189017|NCT04934748|Respiratory System Agents|respiratory system agents|mesh-ancestor
111189018|NCT04934748|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111189019|NCT04934748|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111189020|NCT04934748|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111189021|NCT04934748|Adrenergic Agents|adrenergic agents|mesh-ancestor
111189022|NCT04934748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111189023|NCT04934748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111189024|NCT04934748|Protective Agents|protective agents|mesh-ancestor
111189025|NCT04856319|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111189026|NCT04856319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111189027|NCT04854499|Carboplatin|carboplatin|mesh-list
111189028|NCT04854499|Docetaxel|docetaxel|mesh-list
111189029|NCT04854499|Pembrolizumab|pembrolizumab|mesh-list
111189030|NCT04854499|Magrolimab|magrolimab|mesh-list
111189031|NCT04854499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111189032|NCT04854499|Tubulin Modulators|tubulin modulators|mesh-ancestor
111189033|NCT04854499|Antimitotic Agents|antimitotic agents|mesh-ancestor
111189034|NCT04854499|Mitosis Modulators|mitosis modulators|mesh-ancestor
111189035|NCT04854499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111189036|NCT04854499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111189037|NCT04854499|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111189038|NCT04830813|Chiauranib|chiauranib|mesh-list
111189039|NCT04830813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111189040|NCT04830813|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111189041|NCT04830813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111189042|NCT04830813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111189043|NCT04788108|Dydrogesterone|dydrogesterone|mesh-list
111189044|NCT04788108|Progestins|progestins|mesh-ancestor
111189045|NCT04788108|Hormones|hormones|mesh-ancestor
111189046|NCT04788108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111189047|NCT04788108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111189048|NCT04752696|Leucovorin|leucovorin|mesh-list
111189049|NCT04752696|Fluorouracil|fluorouracil|mesh-list
111189050|NCT04752696|Irinotecan|irinotecan|mesh-list
111189051|NCT04752696|Onvansertib|onvansertib|mesh-list
111189052|NCT04752696|Antimetabolites|antimetabolites|mesh-ancestor
111189053|NCT04752696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111189054|NCT04752696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111189055|NCT04752696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111189056|NCT04752696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111189057|NCT04752696|Immunologic Factors|immunologic factors|mesh-ancestor
111189058|NCT04752696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111189059|NCT04752696|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111189060|NCT04752696|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111189061|NCT04752696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111189062|NCT04752696|Antidotes|antidotes|mesh-ancestor
111189063|NCT04752696|Protective Agents|protective agents|mesh-ancestor
111189064|NCT04752696|Vitamin B Complex|vitamin b complex|mesh-ancestor
111189065|NCT04752696|Vitamins|vitamins|mesh-ancestor
111189066|NCT04752696|Micronutrients|micronutrients|mesh-ancestor
111189067|NCT04752696|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111189068|NCT04741438|Nivolumab|nivolumab|mesh-list
111189069|NCT04741438|Ipilimumab|ipilimumab|mesh-list
111189070|NCT04741438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111189071|NCT04741438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111189072|NCT04741438|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111189073|NCT04741438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111189074|NCT04731961|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111189075|NCT04731961|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111189076|NCT04731961|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111189077|NCT04731961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111189078|NCT04731961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111189079|NCT04731961|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111189080|NCT04731961|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111189081|NCT04731961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111189082|NCT04731961|Cholinergic Agents|cholinergic agents|mesh-ancestor
111189083|NCT04731961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111189084|NCT04662255|Acalabrutinib|acalabrutinib|mesh-list
111189085|NCT04662255|Zanubrutinib|zanubrutinib|mesh-list
111189086|NCT04662255|Pirtobrutinib|pirtobrutinib|mesh-list
111189087|NCT04662255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111189088|NCT04662255|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111189089|NCT04662255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111189090|NCT04662255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111189091|NCT04648540|Acetaminophen|acetaminophen|mesh-list
111189092|NCT04648540|Celecoxib|celecoxib|mesh-list
111189093|NCT04648540|Ketorolac|ketorolac|mesh-list
111189094|NCT04648540|Lidocaine|lidocaine|mesh-list
111189095|NCT04648540|Pregabalin|pregabalin|mesh-list
111189096|NCT04648540|Fentanyl|fentanyl|mesh-list
111189097|NCT04648540|Dexmedetomidine|dexmedetomidine|mesh-list
111189098|NCT04648540|Morphine|morphine|mesh-list
111189099|NCT04648540|Anesthetics, Local|anesthetics, local|mesh-ancestor
111189100|NCT04648540|Anesthetics|anesthetics|mesh-ancestor
111189101|NCT04648540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111189102|NCT04648540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111189103|NCT04648540|Sensory System Agents|sensory system agents|mesh-ancestor
111189104|NCT04648540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111189105|NCT04648540|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111189106|NCT04648540|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111189107|NCT04648540|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111189108|NCT04648540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111189109|NCT04648540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111189110|NCT04648540|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111189111|NCT04648540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111189112|NCT04648540|Analgesics|analgesics|mesh-ancestor
111189113|NCT04648540|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111189114|NCT04648540|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111189115|NCT04648540|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111189116|NCT04648540|Adrenergic Agents|adrenergic agents|mesh-ancestor
111189117|NCT04648540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111189118|NCT04648540|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111189119|NCT04648540|Narcotics|narcotics|mesh-ancestor
111189120|NCT04648540|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111189121|NCT04648540|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111189122|NCT04648540|Anesthetics, General|anesthetics, general|mesh-ancestor
111189123|NCT04648540|Antipyretics|antipyretics|mesh-ancestor
111189124|NCT04648540|Anticonvulsants|anticonvulsants|mesh-ancestor
111189125|NCT04648540|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111189126|NCT04648540|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111189127|NCT04648540|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111189128|NCT04648540|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111189129|NCT04648540|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111189130|NCT04648540|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111189131|NCT04648540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111189132|NCT04648540|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111189133|NCT04648540|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111189134|NCT04648540|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111189135|NCT04648540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111189136|NCT04645823|Lidocaine|lidocaine|mesh-list
111189137|NCT04645823|Fentanyl|fentanyl|mesh-list
111189138|NCT04645823|Citric Acid|citric acid|mesh-list
111189139|NCT04645823|Sodium Citrate|sodium citrate|mesh-list
111189140|NCT04645823|Anesthetics, Local|anesthetics, local|mesh-ancestor
111189141|NCT04645823|Anesthetics|anesthetics|mesh-ancestor
111189142|NCT04645823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111189143|NCT04645823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111189144|NCT04645823|Sensory System Agents|sensory system agents|mesh-ancestor
111189145|NCT04645823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111189146|NCT04645823|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111189147|NCT04645823|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111189148|NCT04645823|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111189149|NCT04645823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111189150|NCT04645823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111189151|NCT04645823|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111189152|NCT04645823|Narcotics|narcotics|mesh-ancestor
111189153|NCT04645823|Analgesics|analgesics|mesh-ancestor
111189154|NCT04645823|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111189155|NCT04645823|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111189156|NCT04645823|Anesthetics, General|anesthetics, general|mesh-ancestor
111189157|NCT04645823|Anticoagulants|anticoagulants|mesh-ancestor
111189158|NCT04645823|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
111189159|NCT04645823|Chelating Agents|chelating agents|mesh-ancestor
111189160|NCT04645823|Sequestering Agents|sequestering agents|mesh-ancestor
110906329|NCT01384253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111189161|NCT04594382|Analgesics, Opioid|analgesics, opioid|mesh-list
111189162|NCT04594382|Narcotics|narcotics|mesh-ancestor
111189163|NCT04594382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111189164|NCT04594382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111189165|NCT04594382|Analgesics|analgesics|mesh-ancestor
111189166|NCT04594382|Sensory System Agents|sensory system agents|mesh-ancestor
111189167|NCT04594382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111189168|NCT04558112|Levodopa|levodopa|mesh-list
111189169|NCT04558112|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111189170|NCT04558112|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111189171|NCT04558112|Dopamine Agents|dopamine agents|mesh-ancestor
111189172|NCT04558112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111189173|NCT04558112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111189174|NCT04558112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111189175|NCT04546230|Anesthetics|anesthetics|mesh-list
111189176|NCT04546230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111189177|NCT04546230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111189178|NCT04546178|Antipsychotic Agents|antipsychotic agents|mesh-list
111189179|NCT04546178|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111189180|NCT04546178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111189181|NCT04546178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111189182|NCT04546178|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111189183|NCT04495621|Cetuximab|cetuximab|mesh-list
110490192|NCT01005719|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111189184|NCT04495621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111189185|NCT04495621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111189186|NCT04473482|Ethanol|ethanol|mesh-list
111189187|NCT04473482|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111189188|NCT04473482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111189189|NCT04473482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111189190|NCT04473482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111189191|NCT04469686|Hydrocortisone|hydrocortisone|mesh-list
111189192|NCT04469686|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
111189193|NCT04469686|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
111189194|NCT04469686|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
111189195|NCT04469686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111189196|NCT04440735|Atezolizumab|atezolizumab|mesh-list
111189197|NCT04440735|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111189198|NCT04440735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111189199|NCT04440735|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111189200|NCT04440735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111189201|NCT04439318|Trametinib|trametinib|mesh-list
111189202|NCT04439318|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
111189203|NCT04439318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111189204|NCT04439318|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111189205|NCT04439318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111189206|NCT04439318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111189207|NCT04439318|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
111189208|NCT04439318|Protective Agents|protective agents|mesh-ancestor
111189209|NCT04439318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111189210|NCT04439318|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111189211|NCT04439318|Antioxidants|antioxidants|mesh-ancestor
111189212|NCT04438512|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
111189213|NCT04438512|Hallucinogens|hallucinogens|mesh-ancestor
111189214|NCT04438512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111189215|NCT04438512|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111189216|NCT04438512|Serotonin Agents|serotonin agents|mesh-ancestor
111189217|NCT04438512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111189218|NCT04438512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111189219|NCT04438512|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111189220|NCT04438512|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111189221|NCT04438512|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111189222|NCT04438512|Adrenergic Agents|adrenergic agents|mesh-ancestor
111189223|NCT04434092|Eculizumab|eculizumab|mesh-list
111189224|NCT04434092|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
111189225|NCT04434092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111189226|NCT04434092|Immunologic Factors|immunologic factors|mesh-ancestor
111189227|NCT04434092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111189228|NCT04422392|Paclitaxel|paclitaxel|mesh-list
111189229|NCT04422392|Carboplatin|carboplatin|mesh-list
111189230|NCT04422392|Pemetrexed|pemetrexed|mesh-list
111189231|NCT04422392|Antibodies|antibodies|mesh-list
111189232|NCT04422392|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111189233|NCT04422392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111189234|NCT04422392|Tubulin Modulators|tubulin modulators|mesh-ancestor
111189235|NCT04422392|Antimitotic Agents|antimitotic agents|mesh-ancestor
111189236|NCT04422392|Mitosis Modulators|mitosis modulators|mesh-ancestor
111189237|NCT04422392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111189238|NCT04422392|Immunologic Factors|immunologic factors|mesh-ancestor
111189239|NCT04422392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111189240|NCT04422392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111189241|NCT04422392|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111189242|NCT04422392|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111189243|NCT04414761|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
111189244|NCT04414761|Medroxyprogesterone|medroxyprogesterone|mesh-list
111189245|NCT04414761|Cetrorelix|cetrorelix|mesh-list
111189246|NCT04414761|Progesterone|progesterone|mesh-list
111189247|NCT04414761|Dydrogesterone|dydrogesterone|mesh-list
111189248|NCT04414761|Ganirelix|ganirelix|mesh-list
111189249|NCT04414761|Progestins|progestins|mesh-ancestor
111189250|NCT04414761|Hormones|hormones|mesh-ancestor
110490197|NCT02856854|Cocaine|cocaine|mesh-list
111189251|NCT04414761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111189252|NCT04414761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111189253|NCT04414761|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111189254|NCT04414761|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111189255|NCT04414761|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111189256|NCT04414761|Contraceptive Agents|contraceptive agents|mesh-ancestor
111189257|NCT04414761|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111189258|NCT04414761|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111189259|NCT04414761|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111189260|NCT04414761|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
111189261|NCT04414761|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111189262|NCT04414761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111189263|NCT04414761|Hormone Antagonists|hormone antagonists|mesh-ancestor
111189264|NCT04414761|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111189265|NCT04414761|Fertility Agents|fertility agents|mesh-ancestor
111189266|NCT04400994|Rituximab|rituximab|mesh-list
111189267|NCT04400994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111189268|NCT04400994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111189269|NCT04400994|Immunologic Factors|immunologic factors|mesh-ancestor
111189270|NCT04400994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111189271|NCT04400994|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111189272|NCT04367688|Tenofovir|tenofovir|mesh-list
111189273|NCT04367688|Emtricitabine|emtricitabine|mesh-list
111189274|NCT04367688|Antiviral Agents|antiviral agents|mesh-ancestor
111189275|NCT04367688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111189276|NCT04367688|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111189277|NCT04367688|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111189278|NCT04367688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111189279|NCT04367688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111189280|NCT04367688|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111189281|NCT04367688|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111189282|NCT04318678|Cyclophosphamide|cyclophosphamide|mesh-list
111189283|NCT04318678|Rituximab|rituximab|mesh-list
111189284|NCT04318678|Fludarabine|fludarabine|mesh-list
111189285|NCT04318678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111189286|NCT04318678|Immunologic Factors|immunologic factors|mesh-ancestor
111189287|NCT04318678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111189288|NCT04318678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111189289|NCT04318678|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111189290|NCT04318678|Alkylating Agents|alkylating agents|mesh-ancestor
110844944|NCT04446364|Disinfectants|disinfectants|mesh-list
111189291|NCT04318678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111189293|NCT04318678|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111189294|NCT04318678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111189295|NCT04307238|Anesthetics|anesthetics|mesh-list
111189296|NCT04307238|Propofol|propofol|mesh-list
111189297|NCT04307238|Sevoflurane|sevoflurane|mesh-list
111189298|NCT04307238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111189299|NCT04307238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111189300|NCT04307238|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111189301|NCT04307238|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111189302|NCT04307238|Anesthetics, General|anesthetics, general|mesh-ancestor
111189303|NCT04307238|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111189304|NCT04307238|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111189305|NCT04224571|Rituximab|rituximab|mesh-list
111189306|NCT04224571|Bortezomib|bortezomib|mesh-list
111189307|NCT04224571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111189308|NCT04224571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111189309|NCT04224571|Immunologic Factors|immunologic factors|mesh-ancestor
111189310|NCT04224571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111189311|NCT04224571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111189312|NCT04222062|Carmustine|carmustine|mesh-list
111189313|NCT04222062|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111189314|NCT04222062|Alkylating Agents|alkylating agents|mesh-ancestor
111189315|NCT04222062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111189316|NCT04222062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111189317|NCT04198766|Pembrolizumab|pembrolizumab|mesh-list
111189318|NCT04198766|Antibodies|antibodies|mesh-list
111189319|NCT04198766|Immunologic Factors|immunologic factors|mesh-ancestor
111189320|NCT04198766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111189321|NCT04198766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111189322|NCT04198766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111189323|NCT04198766|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111189324|NCT04198766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111189325|NCT04186598|Nifedipine|nifedipine|mesh-list
111189326|NCT04186598|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111189327|NCT04186598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111189328|NCT04186598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111189329|NCT04186598|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111189330|NCT04186598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111189331|NCT04186598|Vasodilator Agents|vasodilator agents|mesh-ancestor
111189332|NCT04186598|Tocolytic Agents|tocolytic agents|mesh-ancestor
111189333|NCT04186598|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111189334|NCT04151940|Immunomodulating Agents|immunomodulating agents|mesh-list
111189335|NCT04151940|Immunologic Factors|immunologic factors|mesh-ancestor
111189336|NCT04151940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111189337|NCT04103398|Sorafenib|sorafenib|mesh-list
111189338|NCT04103398|Chlorotrianisene|chlorotrianisene|mesh-list
111189339|NCT04103398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111189340|NCT04103398|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111189341|NCT04103398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111189342|NCT04103398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111189343|NCT04103398|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
111189344|NCT04103398|Estrogens|estrogens|mesh-ancestor
111189345|NCT04103398|Hormones|hormones|mesh-ancestor
111189346|NCT04103398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111189347|NCT04103398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111189348|NCT04103398|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111189349|NCT04067726|Vitamin D|vitamin d|mesh-list
111189350|NCT04067726|Cholecalciferol|cholecalciferol|mesh-list
111189351|NCT04067726|Denosumab|denosumab|mesh-list
111189352|NCT04067726|Calcium|calcium|mesh-list
111189353|NCT04067726|Vitamins|vitamins|mesh-ancestor
111189354|NCT04067726|Micronutrients|micronutrients|mesh-ancestor
111189355|NCT04067726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111189356|NCT04067726|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111189357|NCT04067726|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111189358|NCT04064840|Triptorelin Pamoate|triptorelin pamoate|mesh-list
111189359|NCT04064840|Luteolytic Agents|luteolytic agents|mesh-ancestor
111189360|NCT04064840|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111189361|NCT04064840|Contraceptive Agents|contraceptive agents|mesh-ancestor
111189362|NCT04064840|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111189363|NCT04064840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111189364|NCT04064840|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111189365|NCT04064840|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111189366|NCT04064840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111189367|NCT04050462|Nivolumab|nivolumab|mesh-list
111189368|NCT04050462|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111189369|NCT04050462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111189370|NCT04050462|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111189371|NCT04050462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111189372|NCT04048161|Mycophenolic Acid|mycophenolic acid|mesh-list
111189373|NCT04048161|Tacrolimus|tacrolimus|mesh-list
111189374|NCT04048161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111189375|NCT04048161|Immunologic Factors|immunologic factors|mesh-ancestor
111189376|NCT04048161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111189377|NCT04048161|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111189378|NCT04048161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111189379|NCT04048161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111189380|NCT04048161|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111189381|NCT04048161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111189382|NCT04048161|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111189383|NCT04048161|Antitubercular Agents|antitubercular agents|mesh-ancestor
111189384|NCT04048161|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111189385|NCT04048161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111189386|NCT04042740|Ribavirin|ribavirin|mesh-list
110906555|NCT02171546|Dabigatran|dabigatran|mesh-list
111189387|NCT04042740|Antimetabolites|antimetabolites|mesh-ancestor
111189388|NCT04042740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111189389|NCT04042740|Antiviral Agents|antiviral agents|mesh-ancestor
111189390|NCT04042740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111189391|NCT04007744|Pembrolizumab|pembrolizumab|mesh-list
111189392|NCT04007744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111189393|NCT04007744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111189394|NCT04007744|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111189395|NCT04007744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111189396|NCT03934814|Rituximab|rituximab|mesh-list
111189397|NCT03934814|Pembrolizumab|pembrolizumab|mesh-list
111189398|NCT03934814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111189399|NCT03934814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111189400|NCT03934814|Immunologic Factors|immunologic factors|mesh-ancestor
111189401|NCT03934814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111189402|NCT03934814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111189403|NCT03934814|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111189404|NCT03934814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111189405|NCT03924856|Gemcitabine|gemcitabine|mesh-list
111189406|NCT03924856|Pembrolizumab|pembrolizumab|mesh-list
111189407|NCT03924856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111189408|NCT03924856|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111189409|NCT03924856|Antimetabolites|antimetabolites|mesh-ancestor
111189410|NCT03924856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111189411|NCT03924856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111189412|NCT03924856|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111189413|NCT03919799|Belumosudil|belumosudil|mesh-list
111189414|NCT03919799|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111189415|NCT03919799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111189416|NCT03919799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111189417|NCT03866837|Micronutrients|micronutrients|mesh-list
111189418|NCT03866837|Trace Elements|trace elements|mesh-list
111189419|NCT03866837|Lactoferrin|lactoferrin|mesh-list
111189420|NCT03866837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111189421|NCT03866837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111189422|NCT03809624|Pembrolizumab|pembrolizumab|mesh-list
111189423|NCT03809624|Antibodies|antibodies|mesh-list
111189424|NCT03809624|Immunologic Factors|immunologic factors|mesh-ancestor
111189425|NCT03809624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111189426|NCT03809624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111189427|NCT03809624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111189428|NCT03809624|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110844962|NCT03441282|Sensory System Agents|sensory system agents|mesh-ancestor
111189429|NCT03809624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111189430|NCT03697811|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111189431|NCT03697811|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111189432|NCT03691649|Timolol|timolol|mesh-list
111189433|NCT03691649|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111189434|NCT03691649|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111189435|NCT03691649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111189436|NCT03691649|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111189437|NCT03691649|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111189438|NCT03691649|Adrenergic Agents|adrenergic agents|mesh-ancestor
111189439|NCT03691649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111189440|NCT03691649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111189441|NCT03691649|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111189442|NCT03691649|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111189443|NCT03689946|Listerine|listerine|mesh-list
111189444|NCT03689946|Evolocumab|evolocumab|mesh-list
111189445|NCT03689946|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-list
111189446|NCT03689946|Fluorides|fluorides|mesh-list
111189447|NCT03689946|Sodium Fluoride|sodium fluoride|mesh-list
111189448|NCT03689946|Cariostatic Agents|cariostatic agents|mesh-ancestor
111189449|NCT03689946|Protective Agents|protective agents|mesh-ancestor
111189450|NCT03689946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111189451|NCT03689946|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111189452|NCT03689946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111189453|NCT03689946|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111189454|NCT03689946|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111189455|NCT03689946|Antimetabolites|antimetabolites|mesh-ancestor
111189456|NCT03689946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111189457|NCT03689946|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111189458|NCT03689946|Protease Inhibitors|protease inhibitors|mesh-ancestor
111189459|NCT03689946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111189460|NCT03689946|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111189461|NCT03655002|Cyclophosphamide|cyclophosphamide|mesh-list
111189463|NCT03655002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111189464|NCT03655002|Immunologic Factors|immunologic factors|mesh-ancestor
111189465|NCT03655002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111189466|NCT03655002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111189467|NCT03655002|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111189468|NCT03655002|Alkylating Agents|alkylating agents|mesh-ancestor
111189469|NCT03655002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111189470|NCT03655002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111189471|NCT03655002|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111189472|NCT03655002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111189473|NCT03655002|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111189474|NCT03606980|Dexamethasone|dexamethasone|mesh-list
111189475|NCT03606980|Dexamethasone acetate|dexamethasone acetate|mesh-list
111189476|NCT03606980|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
111189477|NCT03606980|BB 1101|bb 1101|mesh-list
111189478|NCT03606980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111189479|NCT03606980|Antiemetics|antiemetics|mesh-ancestor
111189480|NCT03606980|Autonomic Agents|autonomic agents|mesh-ancestor
111189481|NCT03606980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111189482|NCT03606980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111189483|NCT03606980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111189484|NCT03606980|Glucocorticoids|glucocorticoids|mesh-ancestor
111189485|NCT03606980|Hormones|hormones|mesh-ancestor
111189486|NCT03606980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111189487|NCT03606980|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111189488|NCT03606980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111189489|NCT03606980|Protease Inhibitors|protease inhibitors|mesh-ancestor
111189490|NCT03606980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111189491|NCT03606980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111189492|NCT03596424|Dexmedetomidine|dexmedetomidine|mesh-list
111189493|NCT03596424|Ketamine|ketamine|mesh-list
111189494|NCT03596424|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111189495|NCT03596424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111189496|NCT03596424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111189497|NCT03596424|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111189498|NCT03596424|Analgesics|analgesics|mesh-ancestor
111189499|NCT03596424|Sensory System Agents|sensory system agents|mesh-ancestor
111189500|NCT03596424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111189501|NCT03596424|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111189502|NCT03596424|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111189503|NCT03596424|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111189504|NCT03596424|Adrenergic Agents|adrenergic agents|mesh-ancestor
111189505|NCT03596424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111189506|NCT03596424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111189507|NCT03596424|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111189508|NCT03596424|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111189509|NCT03596424|Anesthetics, General|anesthetics, general|mesh-ancestor
111189510|NCT03596424|Anesthetics|anesthetics|mesh-ancestor
111189511|NCT03596424|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111189512|NCT03596424|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111189513|NCT03547908|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
111189514|NCT03547908|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111189515|NCT03547908|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111189516|NCT03547908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111189517|NCT03547908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111189518|NCT03547908|Antiviral Agents|antiviral agents|mesh-ancestor
111189519|NCT03547908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111189520|NCT03547908|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111189521|NCT03547908|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111189522|NCT03546894|Ceritinib|ceritinib|mesh-list
111189523|NCT03546894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111189524|NCT03546894|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111189525|NCT03546894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111189526|NCT03546894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111189527|NCT03531918|Cytarabine|cytarabine|mesh-list
111189528|NCT03531918|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
111189529|NCT03531918|Mitoxantrone|mitoxantrone|mesh-list
111189530|NCT03531918|Cladribine|cladribine|mesh-list
111189531|NCT03531918|Gemtuzumab|gemtuzumab|mesh-list
111189532|NCT03531918|Calicheamicins|calicheamicins|mesh-list
111189533|NCT03531918|Lenograstim|lenograstim|mesh-list
111189534|NCT03531918|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111189535|NCT03531918|Antimetabolites|antimetabolites|mesh-ancestor
111189536|NCT03531918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111189537|NCT03531918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111189538|NCT03531918|Antiviral Agents|antiviral agents|mesh-ancestor
111189539|NCT03531918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111189540|NCT03531918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111189541|NCT03531918|Immunologic Factors|immunologic factors|mesh-ancestor
111189542|NCT03531918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111189543|NCT03531918|Analgesics|analgesics|mesh-ancestor
111189544|NCT03531918|Sensory System Agents|sensory system agents|mesh-ancestor
111189545|NCT03531918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111189546|NCT03531918|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111189547|NCT03531918|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111189548|NCT03531918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111189549|NCT03531918|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111189550|NCT03531918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111189551|NCT03531918|Immunotoxins|immunotoxins|mesh-ancestor
111189552|NCT03531918|Immunoconjugates|immunoconjugates|mesh-ancestor
111189553|NCT03531918|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111189554|NCT03531645|Fulvestrant|fulvestrant|mesh-list
111189555|NCT03531645|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111189556|NCT03531645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111189557|NCT03531645|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
111189558|NCT03531645|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111189559|NCT03531645|Hormone Antagonists|hormone antagonists|mesh-ancestor
111189560|NCT03531645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111189561|NCT03531645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111189562|NCT03509012|Paclitaxel|paclitaxel|mesh-list
111189563|NCT03509012|Etoposide|etoposide|mesh-list
111189564|NCT03509012|Cisplatin|cisplatin|mesh-list
111189565|NCT03509012|Carboplatin|carboplatin|mesh-list
111189566|NCT03509012|Etoposide phosphate|etoposide phosphate|mesh-list
111189567|NCT03509012|Pemetrexed|pemetrexed|mesh-list
111189568|NCT03509012|Durvalumab|durvalumab|mesh-list
111189569|NCT03509012|Tremelimumab|tremelimumab|mesh-list
111189570|NCT03509012|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111189571|NCT03509012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111189572|NCT03509012|Tubulin Modulators|tubulin modulators|mesh-ancestor
111189573|NCT03509012|Antimitotic Agents|antimitotic agents|mesh-ancestor
111189574|NCT03509012|Mitosis Modulators|mitosis modulators|mesh-ancestor
111189575|NCT03509012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111189576|NCT03509012|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111189577|NCT03509012|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111189578|NCT03509012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111189579|NCT03509012|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111189580|NCT03509012|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111189581|NCT03509012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111189582|NCT03499704|Metformin|metformin|mesh-list
111189583|NCT03499704|Pioglitazone|pioglitazone|mesh-list
111189584|NCT03499704|Dapagliflozin|dapagliflozin|mesh-list
111189585|NCT03499704|Alogliptin|alogliptin|mesh-list
111189586|NCT03499704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111189587|NCT03499704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111189588|NCT03499704|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111189589|NCT03499704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111189590|NCT03499704|Incretins|incretins|mesh-ancestor
111189591|NCT03499704|Hormones|hormones|mesh-ancestor
111189592|NCT03499704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111189593|NCT03499704|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111189594|NCT03499704|Protease Inhibitors|protease inhibitors|mesh-ancestor
111189595|NCT03499704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111189596|NCT03498612|Pembrolizumab|pembrolizumab|mesh-list
111189597|NCT03498612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111189598|NCT03498612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111189599|NCT03498612|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111189600|NCT03498612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111189601|NCT03462719|Venetoclax|venetoclax|mesh-list
111189602|NCT03462719|Obinutuzumab|obinutuzumab|mesh-list
111189603|NCT03462719|Chlorambucil|chlorambucil|mesh-list
111189604|NCT03462719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111189605|NCT03462719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111189606|NCT03462719|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111189607|NCT03462719|Alkylating Agents|alkylating agents|mesh-ancestor
111189608|NCT03462719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110906782|NCT02172248|Metformin|metformin|mesh-list
111189609|NCT03362515|Furosemide|furosemide|mesh-list
111189610|NCT03362515|Diuretics|diuretics|mesh-ancestor
111189612|NCT03362515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111189613|NCT03362515|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
111189614|NCT03362515|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111189615|NCT03362515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111189616|NCT03292926|Dexamethasone|dexamethasone|mesh-list
111189617|NCT03292926|Dexamethasone acetate|dexamethasone acetate|mesh-list
111189618|NCT03292926|Bupivacaine|bupivacaine|mesh-list
111189619|NCT03292926|BB 1101|bb 1101|mesh-list
111189620|NCT03292926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111189621|NCT03292926|Antiemetics|antiemetics|mesh-ancestor
111189622|NCT03292926|Autonomic Agents|autonomic agents|mesh-ancestor
111189623|NCT03292926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111189624|NCT03292926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111189625|NCT03292926|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111189626|NCT03292926|Glucocorticoids|glucocorticoids|mesh-ancestor
111189627|NCT03292926|Hormones|hormones|mesh-ancestor
111189628|NCT03292926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111189629|NCT03292926|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111189630|NCT03292926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111189631|NCT03292926|Protease Inhibitors|protease inhibitors|mesh-ancestor
111189632|NCT03292926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111189633|NCT03292926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111189634|NCT03292926|Anesthetics, Local|anesthetics, local|mesh-ancestor
111189635|NCT03292926|Anesthetics|anesthetics|mesh-ancestor
111189636|NCT03292926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111189637|NCT03292926|Sensory System Agents|sensory system agents|mesh-ancestor
111189638|NCT03288324|Tofacitinib|tofacitinib|mesh-list
111189639|NCT03288324|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
111189640|NCT03288324|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111189641|NCT03288324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111189642|NCT03288324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111189643|NCT03283878|Cefazolin|cefazolin|mesh-list
111189644|NCT03283878|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111189645|NCT03283878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111189646|NCT03245151|Everolimus|everolimus|mesh-list
111189647|NCT03245151|Lenvatinib|lenvatinib|mesh-list
111189648|NCT03245151|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111189649|NCT03245151|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111189650|NCT03245151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111189651|NCT03245151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111189652|NCT03245151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111189653|NCT03245151|Immunologic Factors|immunologic factors|mesh-ancestor
111189654|NCT03245151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111189655|NCT03245151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111189656|NCT03216343|Chiauranib|chiauranib|mesh-list
111189657|NCT03216343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111189658|NCT03216343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111189659|NCT03216343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111189660|NCT03216343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111189661|NCT03165734|Hydroxyurea|hydroxyurea|mesh-list
111189662|NCT03165734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111189663|NCT03165734|Antisickling Agents|antisickling agents|mesh-ancestor
111189664|NCT03165734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111189665|NCT03165734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111189666|NCT03165734|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111189667|NCT03099174|Letrozole|letrozole|mesh-list
111189668|NCT03099174|Fulvestrant|fulvestrant|mesh-list
111189669|NCT03099174|Anastrozole|anastrozole|mesh-list
111189670|NCT03099174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111189671|NCT03099174|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111189672|NCT03099174|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111189673|NCT03099174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111189674|NCT03099174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111189675|NCT03099174|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111189676|NCT03099174|Hormone Antagonists|hormone antagonists|mesh-ancestor
111189677|NCT03099174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111189678|NCT03099174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111189679|NCT03099174|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111189680|NCT03099174|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
111189681|NCT03096275|Glucocorticoids|glucocorticoids|mesh-list
111189682|NCT03096275|Hormones|hormones|mesh-ancestor
111189683|NCT03096275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111189684|NCT03096275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111189685|NCT03075527|Durvalumab|durvalumab|mesh-list
111189686|NCT03075527|Tremelimumab|tremelimumab|mesh-list
111189687|NCT03075527|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111189688|NCT03075527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111189689|NCT03070223|Pitavastatin|pitavastatin|mesh-list
111189690|NCT03070223|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111189691|NCT03070223|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111189692|NCT03070223|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111189693|NCT03070223|Antimetabolites|antimetabolites|mesh-ancestor
111189694|NCT03070223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111189695|NCT03070223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111189696|NCT03070223|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111189697|NCT03012321|Prednisone|prednisone|mesh-list
111189698|NCT03012321|Olaparib|olaparib|mesh-list
111189699|NCT03012321|Abiraterone Acetate|abiraterone acetate|mesh-list
111189700|NCT03012321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111189701|NCT03012321|Glucocorticoids|glucocorticoids|mesh-ancestor
111189702|NCT03012321|Hormones|hormones|mesh-ancestor
111189703|NCT03012321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111189704|NCT03012321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111189705|NCT03012321|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111189706|NCT03012321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111189707|NCT03012321|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111189709|NCT03012321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111189710|NCT03012321|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111189711|NCT03012321|Hormone Antagonists|hormone antagonists|mesh-ancestor
111189712|NCT03012321|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111189713|NCT02985593|KHK4083|khk4083|mesh-list
111189714|NCT02985593|Dermatologic Agents|dermatologic agents|mesh-ancestor
111189715|NCT02955082|Carboplatin|carboplatin|mesh-list
111189716|NCT02955082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111189717|NCT02858921|Pembrolizumab|pembrolizumab|mesh-list
111189718|NCT02858921|Trametinib|trametinib|mesh-list
111189719|NCT02858921|Dabrafenib|dabrafenib|mesh-list
111189720|NCT02858921|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111189721|NCT02858921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111189722|NCT02858921|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111189723|NCT02858921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111189724|NCT02858921|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111189725|NCT02858921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111189726|NCT02645149|Trametinib|trametinib|mesh-list
111189727|NCT02645149|Ceritinib|ceritinib|mesh-list
111189728|NCT02645149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111189729|NCT02645149|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111189730|NCT02645149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111189731|NCT02645149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111189732|NCT02588651|Brentuximab Vedotin|brentuximab vedotin|mesh-list
111189733|NCT02588651|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111189734|NCT02588651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111189735|NCT02588651|Immunotoxins|immunotoxins|mesh-ancestor
111189736|NCT02588651|Immunoconjugates|immunoconjugates|mesh-ancestor
111189737|NCT02588651|Immunologic Factors|immunologic factors|mesh-ancestor
111189738|NCT02588651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111189739|NCT02523859|Propofol|propofol|mesh-list
111189740|NCT02523859|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111189741|NCT02523859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111189742|NCT02523859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111189743|NCT02523859|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111189744|NCT02523859|Anesthetics, General|anesthetics, general|mesh-ancestor
111189745|NCT02523859|Anesthetics|anesthetics|mesh-ancestor
111189746|NCT02370329|Interferons|interferons|mesh-list
111189747|NCT02370329|Interferon-alpha|interferon-alpha|mesh-list
111189748|NCT02370329|Interferon alpha-2|interferon alpha-2|mesh-list
111189749|NCT02370329|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
111189750|NCT02370329|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
111189751|NCT02370329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111189752|NCT02370329|Antiviral Agents|antiviral agents|mesh-ancestor
111189753|NCT02370329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111189754|NCT02370329|Immunologic Factors|immunologic factors|mesh-ancestor
111189755|NCT02370329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111189756|NCT02229422|Obinutuzumab|obinutuzumab|mesh-list
111189757|NCT02229422|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111189758|NCT02229422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111189759|NCT02227199|Carboplatin|carboplatin|mesh-list
111189760|NCT02227199|Etoposide|etoposide|mesh-list
111189761|NCT02227199|Etoposide phosphate|etoposide phosphate|mesh-list
111189762|NCT02227199|Ifosfamide|ifosfamide|mesh-list
111189763|NCT02227199|Isophosphamide mustard|isophosphamide mustard|mesh-list
111189764|NCT02227199|Brentuximab Vedotin|brentuximab vedotin|mesh-list
111189765|NCT02227199|Podophyllotoxin|podophyllotoxin|mesh-list
111189766|NCT02227199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111189767|NCT02227199|Antibodies|antibodies|mesh-list
111189768|NCT02227199|Immunoglobulins|immunoglobulins|mesh-list
111189769|NCT02227199|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111189770|NCT02227199|Immunoconjugates|immunoconjugates|mesh-list
111189771|NCT02227199|Immunologic Factors|immunologic factors|mesh-ancestor
111189772|NCT02227199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111189773|NCT02227199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111189774|NCT02227199|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111189775|NCT02227199|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111189776|NCT02227199|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111189777|NCT02227199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110844988|NCT01274273|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111189778|NCT02227199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111189779|NCT02227199|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111189780|NCT02227199|Alkylating Agents|alkylating agents|mesh-ancestor
111189782|NCT02227199|Keratolytic Agents|keratolytic agents|mesh-ancestor
111189783|NCT02227199|Dermatologic Agents|dermatologic agents|mesh-ancestor
111189784|NCT02227199|Tubulin Modulators|tubulin modulators|mesh-ancestor
111189785|NCT02227199|Antimitotic Agents|antimitotic agents|mesh-ancestor
111189786|NCT02227199|Mitosis Modulators|mitosis modulators|mesh-ancestor
111189787|NCT02176148|Fluocinonide|fluocinonide|mesh-list
111189788|NCT02176148|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111189789|NCT02176148|Glucocorticoids|glucocorticoids|mesh-ancestor
111189790|NCT02176148|Hormones|hormones|mesh-ancestor
111189791|NCT02176148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111189792|NCT02176148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111189793|NCT02176148|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111189794|NCT02087865|Donepezil|donepezil|mesh-list
111189795|NCT02087865|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111189796|NCT02087865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111189797|NCT02087865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111189798|NCT02087865|Cholinergic Agents|cholinergic agents|mesh-ancestor
111189799|NCT02087865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111189800|NCT02087865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111189801|NCT02087865|Nootropic Agents|nootropic agents|mesh-ancestor
111189802|NCT01980823|Metformin|metformin|mesh-list
111189803|NCT01980823|Atorvastatin|atorvastatin|mesh-list
111189804|NCT01980823|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111189805|NCT01980823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111189806|NCT01980823|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111189807|NCT01980823|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111189808|NCT01980823|Antimetabolites|antimetabolites|mesh-ancestor
111189809|NCT01980823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111189810|NCT01980823|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111189811|NCT01980823|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111189812|NCT01980823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111189813|NCT01972347|Trametinib|trametinib|mesh-list
111189814|NCT01972347|Dabrafenib|dabrafenib|mesh-list
111189815|NCT01972347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111189816|NCT01972347|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111189817|NCT01972347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111189818|NCT01972347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111189819|NCT01889992|Sirolimus|sirolimus|mesh-list
111189820|NCT01889992|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111189821|NCT01889992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111189822|NCT01889992|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111189823|NCT01889992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111189824|NCT01889992|Antifungal Agents|antifungal agents|mesh-ancestor
111189825|NCT01889992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111189826|NCT01889992|Immunologic Factors|immunologic factors|mesh-ancestor
111189827|NCT01889992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111189828|NCT01858740|Methotrexate|methotrexate|mesh-list
111189829|NCT01858740|Fludarabine phosphate|fludarabine phosphate|mesh-list
111189830|NCT01858740|Fludarabine|fludarabine|mesh-list
111189831|NCT01858740|Thiotepa|thiotepa|mesh-list
111189832|NCT01858740|Tacrolimus|tacrolimus|mesh-list
111189833|NCT01858740|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111189834|NCT01858740|Abortifacient Agents|abortifacient agents|mesh-ancestor
111189835|NCT01858740|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111189836|NCT01858740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111189837|NCT01858740|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111189838|NCT01858740|Antimetabolites|antimetabolites|mesh-ancestor
111189839|NCT01858740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111189840|NCT01858740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111189841|NCT01858740|Dermatologic Agents|dermatologic agents|mesh-ancestor
111189842|NCT01858740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111189843|NCT01858740|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111189844|NCT01858740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111189845|NCT01858740|Immunologic Factors|immunologic factors|mesh-ancestor
111189846|NCT01858740|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111189847|NCT01858740|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111189848|NCT01858740|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111189849|NCT01858740|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111189850|NCT01858740|Alkylating Agents|alkylating agents|mesh-ancestor
111189851|NCT01858740|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111189852|NCT01848639|Spironolactone|spironolactone|mesh-list
111189853|NCT01848639|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
111189854|NCT01848639|Hormone Antagonists|hormone antagonists|mesh-ancestor
111189855|NCT01848639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111189856|NCT01848639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111189857|NCT01848639|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
111189858|NCT01848639|Diuretics|diuretics|mesh-ancestor
111189859|NCT01848639|Natriuretic Agents|natriuretic agents|mesh-ancestor
111189860|NCT01839734|Lubiprostone|lubiprostone|mesh-list
111189861|NCT01839734|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
111189862|NCT01839734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111189863|NCT01839734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111189864|NCT01682083|Trametinib|trametinib|mesh-list
111189865|NCT01682083|Dabrafenib|dabrafenib|mesh-list
111189866|NCT01682083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111189867|NCT01682083|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111189868|NCT01682083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111189869|NCT01682083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111189870|NCT01511068|Sargramostim|sargramostim|mesh-list
111189871|NCT01511068|Immunologic Factors|immunologic factors|mesh-ancestor
111189872|NCT01511068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111189873|NCT01180790|Interferons|interferons|mesh-list
111189874|NCT01180790|Ribavirin|ribavirin|mesh-list
111189875|NCT01180790|Interferon-alpha|interferon-alpha|mesh-list
111189876|NCT01180790|Interferon alpha-2|interferon alpha-2|mesh-list
111189877|NCT01180790|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
111189878|NCT01180790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111189879|NCT01180790|Antiviral Agents|antiviral agents|mesh-ancestor
111189880|NCT01180790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111189881|NCT01180790|Antimetabolites|antimetabolites|mesh-ancestor
111189882|NCT01180790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111189883|NCT01180790|Immunologic Factors|immunologic factors|mesh-ancestor
111189884|NCT01180790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111189885|NCT01112306|Selexipag|selexipag|mesh-list
111189886|NCT01112306|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111189887|NCT00721526|Disulfiram|disulfiram|mesh-list
111189888|NCT00721526|Lorazepam|lorazepam|mesh-list
111189889|NCT00721526|Anticonvulsants|anticonvulsants|mesh-ancestor
111189890|NCT00721526|Antiemetics|antiemetics|mesh-ancestor
111189891|NCT00721526|Autonomic Agents|autonomic agents|mesh-ancestor
111189892|NCT00721526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111189893|NCT00721526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111189894|NCT00721526|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111189895|NCT00721526|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111189896|NCT00721526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111189897|NCT00721526|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111189898|NCT00721526|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111189899|NCT00721526|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111189900|NCT00721526|GABA Modulators|gaba modulators|mesh-ancestor
111189901|NCT00721526|GABA Agents|gaba agents|mesh-ancestor
111189902|NCT00721526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111189903|NCT00721526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111189904|NCT00721526|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111189905|NCT00721526|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
111189906|NCT00721526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111189907|NCT00679042|Exenatide|exenatide|mesh-list
111189908|NCT00679042|Sirolimus|sirolimus|mesh-list
111189909|NCT00679042|Etanercept|etanercept|mesh-list
111189910|NCT00679042|Tacrolimus|tacrolimus|mesh-list
111189911|NCT00679042|Basiliximab|basiliximab|mesh-list
111189912|NCT00679042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111189913|NCT00679042|Immunologic Factors|immunologic factors|mesh-ancestor
111189914|NCT00679042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111189915|NCT00679042|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111189916|NCT00679042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111189917|NCT00679042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111189918|NCT00679042|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111189919|NCT00679042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111189920|NCT00679042|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111189921|NCT00679042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111189923|NCT00679042|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111189924|NCT00679042|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111189925|NCT00679042|Analgesics|analgesics|mesh-ancestor
111189926|NCT00679042|Sensory System Agents|sensory system agents|mesh-ancestor
111189927|NCT00679042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111189928|NCT00679042|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111189929|NCT00679042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111189930|NCT00679042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111189931|NCT00679042|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111189932|NCT00679042|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111189933|NCT00679042|Incretins|incretins|mesh-ancestor
111189934|NCT00679042|Hormones|hormones|mesh-ancestor
111189935|NCT00679042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111189936|NCT00670358|Prednisone|prednisone|mesh-list
111189937|NCT00670358|Cyclophosphamide|cyclophosphamide|mesh-list
111189938|NCT00670358|Rituximab|rituximab|mesh-list
111189939|NCT00670358|Doxorubicin|doxorubicin|mesh-list
111189940|NCT00670358|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111189941|NCT00670358|Vincristine|vincristine|mesh-list
111189942|NCT00670358|Lenalidomide|lenalidomide|mesh-list
111189943|NCT00670358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111189944|NCT00670358|Immunologic Factors|immunologic factors|mesh-ancestor
111189945|NCT00670358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111189946|NCT00670358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111189947|NCT00670358|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111189948|NCT00670358|Alkylating Agents|alkylating agents|mesh-ancestor
111189949|NCT00670358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111189950|NCT00670358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111189951|NCT00670358|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111189952|NCT00670358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111189953|NCT00670358|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111189954|NCT00670358|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111189955|NCT00670358|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111189956|NCT00670358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111189957|NCT00670358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111189958|NCT00670358|Glucocorticoids|glucocorticoids|mesh-ancestor
111189959|NCT00670358|Hormones|hormones|mesh-ancestor
111189960|NCT00670358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111189961|NCT00670358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111189962|NCT00670358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111189963|NCT00670358|Tubulin Modulators|tubulin modulators|mesh-ancestor
111189964|NCT00670358|Antimitotic Agents|antimitotic agents|mesh-ancestor
111189965|NCT00670358|Mitosis Modulators|mitosis modulators|mesh-ancestor
111189966|NCT00670358|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111189967|NCT00670358|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111189968|NCT00670358|Growth Substances|growth substances|mesh-ancestor
111189969|NCT00670358|Growth Inhibitors|growth inhibitors|mesh-ancestor
111189970|NCT00505063|Vaccines|vaccines|mesh-list
111189971|NCT00505063|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
111189972|NCT00505063|Immunologic Factors|immunologic factors|mesh-ancestor
111189973|NCT00505063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111189974|NCT00350272|Tenofovir|tenofovir|mesh-list
111189975|NCT00350272|Lamivudine|lamivudine|mesh-list
111189976|NCT00350272|Efavirenz|efavirenz|mesh-list
111189977|NCT00350272|Dexelvucitabine|dexelvucitabine|mesh-list
111189978|NCT00350272|Antiviral Agents|antiviral agents|mesh-ancestor
111189979|NCT00350272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111189980|NCT00350272|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111189981|NCT00350272|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111189982|NCT00350272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111189983|NCT00350272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111189984|NCT00350272|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111189985|NCT00350272|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111189986|NCT00350272|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111189987|NCT00350272|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111189988|NCT00350272|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111189989|NCT00350272|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111189990|NCT00350272|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111189991|NCT00350272|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111189992|NCT02020694|Vitamin D|vitamin d|mesh-list
111189993|NCT02020694|Ergocalciferols|ergocalciferols|mesh-list
111189994|NCT02020694|Cholecalciferol|cholecalciferol|mesh-list
111189995|NCT02020694|Vitamins|vitamins|mesh-list
111189996|NCT02020694|Micronutrients|micronutrients|mesh-ancestor
111189997|NCT02020694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111189998|NCT02020694|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111189999|NCT02020694|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111190000|NCT02019875|Clarithromycin|clarithromycin|mesh-list
111190001|NCT02019875|Rifampin|rifampin|mesh-list
111190002|NCT02019875|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110490345|NCT02858024|Dapivirine|dapivirine|mesh-list
111190003|NCT02019875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111190004|NCT02019875|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111190005|NCT02019875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111190006|NCT02019875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111190007|NCT02019875|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111190008|NCT02019875|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111190009|NCT02019875|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111190010|NCT02019875|Antitubercular Agents|antitubercular agents|mesh-ancestor
111190011|NCT02019875|Leprostatic Agents|leprostatic agents|mesh-ancestor
111190012|NCT02019875|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111190013|NCT02019875|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111190014|NCT02019875|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111190015|NCT02019875|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
111190016|NCT02019875|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
111190017|NCT02019875|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
111190018|NCT02019875|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111190019|NCT01907009|Melphalan|melphalan|mesh-list
111190020|NCT01907009|Lenograstim|lenograstim|mesh-list
111190021|NCT01907009|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111190022|NCT01907009|Alkylating Agents|alkylating agents|mesh-ancestor
111190023|NCT01907009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111190024|NCT01907009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111190025|NCT01907009|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111190026|NCT01907009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111190027|NCT01907009|Immunologic Factors|immunologic factors|mesh-ancestor
111190028|NCT01907009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111190029|NCT01907009|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111190030|NCT01882933|Oxaliplatin|oxaliplatin|mesh-list
111190031|NCT01882933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111190032|NCT01718743|Lenalidomide|lenalidomide|mesh-list
111190033|NCT01718743|Ixazomib|ixazomib|mesh-list
111190034|NCT01718743|Glycine|glycine|mesh-list
111190035|NCT01718743|Immunologic Factors|immunologic factors|mesh-ancestor
111190036|NCT01718743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111190037|NCT01718743|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111190038|NCT01718743|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111190039|NCT01718743|Growth Substances|growth substances|mesh-ancestor
111190040|NCT01718743|Growth Inhibitors|growth inhibitors|mesh-ancestor
111190041|NCT01718743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111190042|NCT01718743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111190043|NCT01718743|Protease Inhibitors|protease inhibitors|mesh-ancestor
111190044|NCT01718743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111190045|NCT01718743|Glycine Agents|glycine agents|mesh-ancestor
111190046|NCT01718743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111190047|NCT01686126|Metformin|metformin|mesh-list
111190048|NCT01686126|Levonorgestrel|levonorgestrel|mesh-list
111190049|NCT01686126|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111190050|NCT01686126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111190051|NCT01686126|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111190052|NCT01686126|Contraceptive Agents|contraceptive agents|mesh-ancestor
111190053|NCT01686126|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111190054|NCT01686126|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111190055|NCT01686126|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111190056|NCT01686126|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111190057|NCT01531582|Minocycline|minocycline|mesh-list
111190058|NCT01531582|Tetracycline|tetracycline|mesh-list
111190059|NCT01531582|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111190060|NCT01531582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111190061|NCT01531582|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111190062|NCT01531582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111190063|NCT01531582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111190064|NCT01512888|Busulfan|busulfan|mesh-list
111190065|NCT01512888|Alkylating Agents|alkylating agents|mesh-ancestor
111190066|NCT01512888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111190067|NCT01512888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111190068|NCT01512888|Immunologic Factors|immunologic factors|mesh-ancestor
111190069|NCT01512888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111190070|NCT01512888|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111190071|NCT01512888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111190072|NCT01512888|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111190073|NCT01493453|Cyclophosphamide|cyclophosphamide|mesh-list
111190074|NCT01493453|Fludarabine|fludarabine|mesh-list
111190075|NCT01493453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111190076|NCT01493453|Immunologic Factors|immunologic factors|mesh-ancestor
111190077|NCT01493453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111190078|NCT01493453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111190079|NCT01493453|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111190080|NCT01493453|Alkylating Agents|alkylating agents|mesh-ancestor
111190081|NCT01493453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111190082|NCT01493453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111190083|NCT01493453|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111190084|NCT01208662|Dexamethasone|dexamethasone|mesh-list
111190085|NCT01208662|Lenalidomide|lenalidomide|mesh-list
111190086|NCT01208662|Bortezomib|bortezomib|mesh-list
111190087|NCT01208662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111190088|NCT01208662|Antiemetics|antiemetics|mesh-ancestor
111190089|NCT01208662|Autonomic Agents|autonomic agents|mesh-ancestor
111190090|NCT01208662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111190091|NCT01208662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111190092|NCT01208662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111190093|NCT01208662|Glucocorticoids|glucocorticoids|mesh-ancestor
111190094|NCT01208662|Hormones|hormones|mesh-ancestor
111190095|NCT01208662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111190096|NCT01208662|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111190097|NCT01208662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111190098|NCT01208662|Immunologic Factors|immunologic factors|mesh-ancestor
111190099|NCT01208662|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111190100|NCT01208662|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111190101|NCT01208662|Growth Substances|growth substances|mesh-ancestor
111190102|NCT01208662|Growth Inhibitors|growth inhibitors|mesh-ancestor
111190103|NCT00667199|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
111190104|NCT00667199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111190105|NCT00460486|Formaldehyde|formaldehyde|mesh-list
111190106|NCT00460486|Disinfectants|disinfectants|mesh-ancestor
111190107|NCT00460486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111190108|NCT00378105|Dexamethasone|dexamethasone|mesh-list
111190109|NCT00378105|Lenalidomide|lenalidomide|mesh-list
111190110|NCT00378105|Bortezomib|bortezomib|mesh-list
111190111|NCT00378105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111190112|NCT00378105|Antiemetics|antiemetics|mesh-ancestor
111190113|NCT00378105|Autonomic Agents|autonomic agents|mesh-ancestor
111190114|NCT00378105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111190115|NCT00378105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111190116|NCT00378105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111190117|NCT00378105|Glucocorticoids|glucocorticoids|mesh-ancestor
111190118|NCT00378105|Hormones|hormones|mesh-ancestor
111190119|NCT00378105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111190120|NCT00378105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111190121|NCT00378105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111190122|NCT00378105|Immunologic Factors|immunologic factors|mesh-ancestor
111190123|NCT00378105|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111190124|NCT00378105|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111190125|NCT00378105|Growth Substances|growth substances|mesh-ancestor
111190126|NCT00378105|Growth Inhibitors|growth inhibitors|mesh-ancestor
111190127|NCT00139477|Metformin|metformin|mesh-list
111190128|NCT00139477|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111190129|NCT00139477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111190130|NCT00082706|Leucovorin|leucovorin|mesh-list
111190131|NCT00082706|Cisplatin|cisplatin|mesh-list
111190132|NCT00082706|Gemcitabine|gemcitabine|mesh-list
111190133|NCT00082706|Fluorouracil|fluorouracil|mesh-list
111190134|NCT00082706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111190135|NCT00082706|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111190136|NCT00082706|Antimetabolites|antimetabolites|mesh-ancestor
111190137|NCT00082706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111190138|NCT00082706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111190139|NCT00082706|Immunologic Factors|immunologic factors|mesh-ancestor
111190140|NCT00082706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111190141|NCT00082706|Antidotes|antidotes|mesh-ancestor
111190142|NCT00082706|Protective Agents|protective agents|mesh-ancestor
111190143|NCT00082706|Vitamin B Complex|vitamin b complex|mesh-ancestor
111190144|NCT00082706|Vitamins|vitamins|mesh-ancestor
111190145|NCT00082706|Micronutrients|micronutrients|mesh-ancestor
111190146|NCT00004935|Trastuzumab|trastuzumab|mesh-list
111190147|NCT00004935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111190148|NCT00004935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111190149|NCT00119158|Fluticasone|fluticasone|mesh-list
111190150|NCT00119158|Xhance|xhance|mesh-list
111190151|NCT00119158|Pimecrolimus|pimecrolimus|mesh-list
111190152|NCT00119158|Tacrolimus|tacrolimus|mesh-list
111190153|NCT00119158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111190154|NCT00119158|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111190155|NCT00119158|Autonomic Agents|autonomic agents|mesh-ancestor
111190156|NCT00119158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111190157|NCT00119158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111190158|NCT00119158|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111190159|NCT00119158|Respiratory System Agents|respiratory system agents|mesh-ancestor
111190160|NCT00119158|Dermatologic Agents|dermatologic agents|mesh-ancestor
111190161|NCT00119158|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111190162|NCT00119158|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111190163|NCT00119158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111190164|NCT00119158|Analgesics|analgesics|mesh-ancestor
111190165|NCT00119158|Sensory System Agents|sensory system agents|mesh-ancestor
111190166|NCT00119158|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111190167|NCT00119158|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111190168|NCT00119158|Immunologic Factors|immunologic factors|mesh-ancestor
111190169|NCT00119158|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111190170|NCT00119158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111190171|NCT00119158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111190172|NCT00119392|Cyclosporine|cyclosporine|mesh-list
111190173|NCT00119392|Mycophenolic Acid|mycophenolic acid|mesh-list
111190174|NCT00119392|Rituximab|rituximab|mesh-list
111190175|NCT00119392|Fludarabine|fludarabine|mesh-list
111190176|NCT00119392|Fludarabine phosphate|fludarabine phosphate|mesh-list
111190177|NCT00119392|Cyclosporins|cyclosporins|mesh-list
111190178|NCT00119392|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111190179|NCT00119392|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111190180|NCT00119392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111190181|NCT00119392|Immunologic Factors|immunologic factors|mesh-ancestor
111190182|NCT00119392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111190183|NCT00119392|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111190184|NCT00119392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111190185|NCT00119392|Antimetabolites|antimetabolites|mesh-ancestor
111190186|NCT00119392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111190187|NCT00119392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111190188|NCT00119392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111190189|NCT00119392|Antifungal Agents|antifungal agents|mesh-ancestor
111190190|NCT00119392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111190191|NCT00119392|Dermatologic Agents|dermatologic agents|mesh-ancestor
111190192|NCT00119392|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111190193|NCT00119392|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111190194|NCT00119392|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111190195|NCT00119392|Antitubercular Agents|antitubercular agents|mesh-ancestor
111190196|NCT00119392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111190197|NCT00218062|Modafinil|modafinil|mesh-list
111190198|NCT00218062|Amphetamine|amphetamine|mesh-list
111190199|NCT00218062|Dextroamphetamine|dextroamphetamine|mesh-list
111190200|NCT00218062|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111190201|NCT00218062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111190202|NCT00218062|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
111190203|NCT00218062|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111190204|NCT00218062|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111190205|NCT00218062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111190206|NCT00218062|Sympathomimetics|sympathomimetics|mesh-ancestor
111190207|NCT00218062|Autonomic Agents|autonomic agents|mesh-ancestor
111190208|NCT00218062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111190209|NCT00218062|Dopamine Agents|dopamine agents|mesh-ancestor
111190210|NCT00218062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111190211|NCT00218062|Adrenergic Agents|adrenergic agents|mesh-ancestor
111190212|NCT00218062|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111190213|NCT00218062|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111190214|NCT00218062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111190215|NCT00218062|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111190216|NCT00121186|Methotrexate|methotrexate|mesh-list
111190217|NCT00121186|Fludarabine phosphate|fludarabine phosphate|mesh-list
111190218|NCT00121186|Fludarabine|fludarabine|mesh-list
111190219|NCT00121186|Melphalan|melphalan|mesh-list
111190220|NCT00121186|Tacrolimus|tacrolimus|mesh-list
111190221|NCT00121186|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111190222|NCT00121186|Abortifacient Agents|abortifacient agents|mesh-ancestor
111190223|NCT00121186|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111190224|NCT00121186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111190225|NCT00121186|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111190226|NCT00121186|Antimetabolites|antimetabolites|mesh-ancestor
111190227|NCT00121186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111190228|NCT00121186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111190229|NCT00121186|Dermatologic Agents|dermatologic agents|mesh-ancestor
111190230|NCT00121186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111190231|NCT00121186|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111190232|NCT00121186|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111190233|NCT00121186|Immunologic Factors|immunologic factors|mesh-ancestor
111190234|NCT00121186|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111190235|NCT00121186|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111190236|NCT00121186|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111190237|NCT00121186|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111190238|NCT00121186|Alkylating Agents|alkylating agents|mesh-ancestor
111190239|NCT00121186|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111190240|NCT00121810|Mycophenolic Acid|mycophenolic acid|mesh-list
111190241|NCT00121810|Sirolimus|sirolimus|mesh-list
111190242|NCT00121810|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
111190243|NCT00121810|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111190244|NCT00121810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111190245|NCT00121810|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111190246|NCT00121810|Antitubercular Agents|antitubercular agents|mesh-ancestor
111190247|NCT00121810|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111190248|NCT00121810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111190249|NCT00121810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110845051|NCT03382756|Choline|choline|mesh-list
111190250|NCT00121810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111190251|NCT00121810|Antifungal Agents|antifungal agents|mesh-ancestor
111190252|NCT00121810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111190253|NCT00121810|Immunologic Factors|immunologic factors|mesh-ancestor
111190254|NCT00121810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111190255|NCT00053014|Cyclosporine|cyclosporine|mesh-list
111190256|NCT00053014|Mycophenolic Acid|mycophenolic acid|mesh-list
111190257|NCT00053014|Fludarabine|fludarabine|mesh-list
111190258|NCT00053014|Cyclosporins|cyclosporins|mesh-list
111190259|NCT00053014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111190260|NCT00053014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111190261|NCT00053014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111190262|NCT00053014|Immunologic Factors|immunologic factors|mesh-ancestor
111190263|NCT00053014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111190264|NCT00053014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111190265|NCT00053014|Antifungal Agents|antifungal agents|mesh-ancestor
111190266|NCT00053014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111190267|NCT00053014|Dermatologic Agents|dermatologic agents|mesh-ancestor
111190268|NCT00053014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111190269|NCT00053014|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110490386|NCT00689611|Dopamine Agents|dopamine agents|mesh-ancestor
111190270|NCT00053014|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111190271|NCT00053014|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111190272|NCT00053014|Antitubercular Agents|antitubercular agents|mesh-ancestor
111190273|NCT00053014|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111190274|NCT00123604|Metoprolol|metoprolol|mesh-list
111190275|NCT00123604|Carvedilol|carvedilol|mesh-list
111190276|NCT00123604|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111190277|NCT00123604|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111190278|NCT00123604|Sympatholytics|sympatholytics|mesh-ancestor
111190279|NCT00123604|Autonomic Agents|autonomic agents|mesh-ancestor
111190280|NCT00123604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111190281|NCT00123604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111190282|NCT00123604|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
111190283|NCT00123604|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111190284|NCT00123604|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111190285|NCT00123604|Adrenergic Agents|adrenergic agents|mesh-ancestor
111190286|NCT00123604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111190287|NCT00123604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111190288|NCT00123604|Antioxidants|antioxidants|mesh-ancestor
111190289|NCT00123604|Protective Agents|protective agents|mesh-ancestor
111190290|NCT00123604|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110907454|NCT02182856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111190291|NCT00123604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111190292|NCT00123604|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111190293|NCT00123604|Vasodilator Agents|vasodilator agents|mesh-ancestor
111190294|NCT00123604|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111190295|NCT00123604|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111190296|NCT00221338|Gabapentin|gabapentin|mesh-list
111190297|NCT00221338|Analgesics|analgesics|mesh-ancestor
111190298|NCT00221338|Sensory System Agents|sensory system agents|mesh-ancestor
111190299|NCT00221338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111190300|NCT00221338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111190301|NCT00221338|Anticonvulsants|anticonvulsants|mesh-ancestor
111190302|NCT00221338|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111190303|NCT00221338|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111190304|NCT00221338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111190305|NCT00221338|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111190306|NCT00221338|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111190307|NCT00221338|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111190308|NCT00221338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111190309|NCT00221338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111190310|NCT00221338|Antimanic Agents|antimanic agents|mesh-ancestor
111190311|NCT00223678|Sirolimus|sirolimus|mesh-list
111190312|NCT00223678|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111190313|NCT00223678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111190314|NCT00223678|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111190315|NCT00223678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111190316|NCT00223678|Antifungal Agents|antifungal agents|mesh-ancestor
111190317|NCT00223678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111190318|NCT00223678|Immunologic Factors|immunologic factors|mesh-ancestor
111190319|NCT00223678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111190320|NCT00053482|Vaccines|vaccines|mesh-list
111190321|NCT00053482|Immunologic Factors|immunologic factors|mesh-ancestor
111190322|NCT00053482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111190323|NCT00130780|Bevacizumab|bevacizumab|mesh-list
111190324|NCT00130780|Docetaxel|docetaxel|mesh-list
111190325|NCT00130780|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111190326|NCT00130780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111190327|NCT00130780|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111190328|NCT00130780|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111190329|NCT00130780|Growth Substances|growth substances|mesh-ancestor
111190330|NCT00130780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111190331|NCT00130780|Growth Inhibitors|growth inhibitors|mesh-ancestor
111190332|NCT00130780|Tubulin Modulators|tubulin modulators|mesh-ancestor
111190333|NCT00130780|Antimitotic Agents|antimitotic agents|mesh-ancestor
111190334|NCT00130780|Mitosis Modulators|mitosis modulators|mesh-ancestor
111190335|NCT00130780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111190336|NCT00225784|Gemcitabine|gemcitabine|mesh-list
111190337|NCT00225784|Cetuximab|cetuximab|mesh-list
111190338|NCT00225784|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111190339|NCT00225784|Antimetabolites|antimetabolites|mesh-ancestor
111190340|NCT00225784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111190341|NCT00225784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111190342|NCT00225784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111190343|NCT02092168|Opicapone|opicapone|mesh-list
111190344|NCT02092168|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
111190345|NCT02092168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111190346|NCT02092168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111190347|NCT02092168|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111190348|NCT02092168|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111190349|NCT00133978|Selenium|selenium|mesh-list
111190350|NCT00133978|Antioxidants|antioxidants|mesh-list
111190351|NCT00133978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111190352|NCT00133978|Protective Agents|protective agents|mesh-ancestor
111190353|NCT00133978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111190354|NCT00133978|Trace Elements|trace elements|mesh-ancestor
111190355|NCT00133978|Micronutrients|micronutrients|mesh-ancestor
111190356|NCT01897324|Hormones|hormones|mesh-list
111190357|NCT01897324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111190358|NCT01897324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111190359|NCT00254410|Cyclophosphamide|cyclophosphamide|mesh-list
111190360|NCT00254410|Rituximab|rituximab|mesh-list
111190361|NCT00254410|Fludarabine|fludarabine|mesh-list
111190362|NCT00254410|Mitoxantrone|mitoxantrone|mesh-list
111190363|NCT00254410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111190364|NCT00254410|Immunologic Factors|immunologic factors|mesh-ancestor
111190365|NCT00254410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111190366|NCT00254410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111190367|NCT00254410|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111190368|NCT00254410|Alkylating Agents|alkylating agents|mesh-ancestor
111190369|NCT00254410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111190370|NCT00254410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111190371|NCT00254410|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111190372|NCT00254410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111190373|NCT00254410|Analgesics|analgesics|mesh-ancestor
111190374|NCT00254410|Sensory System Agents|sensory system agents|mesh-ancestor
111190375|NCT00254410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111190376|NCT00254410|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111190377|NCT00254410|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111190378|NCT00254410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111190379|NCT00254488|Valproic Acid|valproic acid|mesh-list
111190380|NCT00254488|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111190381|NCT00254488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111190382|NCT00254488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111190383|NCT00254488|Antimanic Agents|antimanic agents|mesh-ancestor
111190384|NCT00254488|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111190385|NCT00254488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111190386|NCT00254488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111190387|NCT00254488|Anticonvulsants|anticonvulsants|mesh-ancestor
111190388|NCT00254488|GABA Agents|gaba agents|mesh-ancestor
111190389|NCT00254488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111190390|NCT01899118|Capecitabine|capecitabine|mesh-list
111190391|NCT01899118|Oxaliplatin|oxaliplatin|mesh-list
111190392|NCT01899118|Nimotuzumab|nimotuzumab|mesh-list
111190393|NCT01899118|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111190394|NCT01899118|Antimetabolites|antimetabolites|mesh-ancestor
111190395|NCT01899118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111190396|NCT01899118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111190397|NCT01899118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111190398|NCT00231868|Paclitaxel|paclitaxel|mesh-list
111190399|NCT00231868|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111190400|NCT00231868|Carboplatin|carboplatin|mesh-list
111190401|NCT00231868|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111190402|NCT00231868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111190403|NCT00231868|Tubulin Modulators|tubulin modulators|mesh-ancestor
111190404|NCT00231868|Antimitotic Agents|antimitotic agents|mesh-ancestor
111190405|NCT00231868|Mitosis Modulators|mitosis modulators|mesh-ancestor
111190406|NCT00231868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111190407|NCT00257686|Pravastatin|pravastatin|mesh-list
111190408|NCT00257686|Pitavastatin|pitavastatin|mesh-list
111190409|NCT00257686|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111190410|NCT00257686|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111190411|NCT00257686|Antimetabolites|antimetabolites|mesh-ancestor
111190412|NCT00257686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111190413|NCT00257686|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111190414|NCT00257686|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111190415|NCT00257686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111190416|NCT01469013|Methotrexate|methotrexate|mesh-list
111190417|NCT01469013|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111190418|NCT01469013|Abortifacient Agents|abortifacient agents|mesh-ancestor
111190419|NCT01469013|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111190420|NCT01469013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111190421|NCT01469013|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111190422|NCT01469013|Antimetabolites|antimetabolites|mesh-ancestor
111190423|NCT01469013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111190424|NCT01469013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111190425|NCT01469013|Dermatologic Agents|dermatologic agents|mesh-ancestor
111190426|NCT01469013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111190427|NCT01469013|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111190428|NCT01469013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111190429|NCT01469013|Immunologic Factors|immunologic factors|mesh-ancestor
111190430|NCT01469013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111190431|NCT01469013|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111190432|NCT01493427|Travoprost|travoprost|mesh-list
111190433|NCT01493427|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111190434|NCT01523457|Folfirinox|folfirinox|mesh-list
111190435|NCT01523457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111190436|NCT01523301|Rotigotine|rotigotine|mesh-list
111190437|NCT01523301|Dopamine Agonists|dopamine agonists|mesh-ancestor
111190438|NCT01523301|Dopamine Agents|dopamine agents|mesh-ancestor
111190439|NCT01523301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111190440|NCT01523301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111190441|NCT01523301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110907606|NCT02180516|Meloxicam|meloxicam|mesh-list
111190443|NCT01766336|Vitamin B Complex|vitamin b complex|mesh-ancestor
111190444|NCT01766336|Vitamins|vitamins|mesh-ancestor
111190445|NCT01766336|Micronutrients|micronutrients|mesh-ancestor
111190446|NCT01766336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111190447|NCT01797302|Vitamin D|vitamin d|mesh-list
111190448|NCT01797302|Cholecalciferol|cholecalciferol|mesh-list
111190449|NCT01797302|Vitamins|vitamins|mesh-ancestor
111190450|NCT01797302|Micronutrients|micronutrients|mesh-ancestor
111190451|NCT01797302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111190452|NCT01797302|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111190453|NCT01797302|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111190454|NCT01804946|Oseltamivir|oseltamivir|mesh-list
111190455|NCT01804946|Antiviral Agents|antiviral agents|mesh-ancestor
111190456|NCT01804946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111190457|NCT01804946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111190458|NCT01804946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111190459|NCT01795898|Fentanyl|fentanyl|mesh-list
111190460|NCT01795898|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111190461|NCT01795898|Narcotics|narcotics|mesh-ancestor
111190462|NCT01795898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111190463|NCT01795898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111190464|NCT01795898|Analgesics|analgesics|mesh-ancestor
111190465|NCT01795898|Sensory System Agents|sensory system agents|mesh-ancestor
111190466|NCT01795898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111190467|NCT01795898|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111190468|NCT01795898|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111190469|NCT01795898|Anesthetics, General|anesthetics, general|mesh-ancestor
111190470|NCT01795898|Anesthetics|anesthetics|mesh-ancestor
111190471|NCT01736696|Tofacitinib|tofacitinib|mesh-list
111190472|NCT01736696|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
111190473|NCT01736696|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111190474|NCT01736696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111190475|NCT01736696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111190476|NCT01609478|Mometasone Furoate|mometasone furoate|mesh-list
111190477|NCT01609478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111190478|NCT01609478|Dermatologic Agents|dermatologic agents|mesh-ancestor
111190479|NCT01609478|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111190480|NCT01764464|Gabapentin|gabapentin|mesh-list
111190481|NCT01764464|Analgesics|analgesics|mesh-ancestor
111190482|NCT01764464|Sensory System Agents|sensory system agents|mesh-ancestor
111190483|NCT01764464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111190484|NCT01764464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111190485|NCT01764464|Anticonvulsants|anticonvulsants|mesh-ancestor
111190486|NCT01764464|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111190487|NCT01764464|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111190488|NCT01764464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111190489|NCT01764464|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111190490|NCT01764464|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111190491|NCT01764464|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111190492|NCT01764464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111190493|NCT01764464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111190494|NCT01764464|Antimanic Agents|antimanic agents|mesh-ancestor
111190495|NCT01763918|Evolocumab|evolocumab|mesh-list
111190496|NCT01763918|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
111190497|NCT01763918|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111190498|NCT01763918|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111190499|NCT01763918|Antimetabolites|antimetabolites|mesh-ancestor
111190500|NCT01763918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111190501|NCT01763918|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111190502|NCT01763918|Protease Inhibitors|protease inhibitors|mesh-ancestor
111190503|NCT01763918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111190504|NCT01763918|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111190505|NCT01606748|Gemcitabine|gemcitabine|mesh-list
111190506|NCT01606748|Necitumumab|necitumumab|mesh-list
111190507|NCT01606748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111190508|NCT01606748|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111190509|NCT01606748|Antimetabolites|antimetabolites|mesh-ancestor
111190510|NCT01606748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111190511|NCT01606748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111190512|NCT01597622|Belimumab|belimumab|mesh-list
111190513|NCT01597622|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111190514|NCT01597622|Immunologic Factors|immunologic factors|mesh-ancestor
111190515|NCT01597622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111190516|NCT01761266|Sorafenib|sorafenib|mesh-list
111190517|NCT01761266|Lenvatinib|lenvatinib|mesh-list
111190518|NCT01761266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111190519|NCT01761266|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111190520|NCT01761266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111190521|NCT01761266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111190522|NCT01759862|Aminophylline|aminophylline|mesh-list
111190523|NCT01759862|Theophylline|theophylline|mesh-list
111190524|NCT01759862|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111190525|NCT01759862|Autonomic Agents|autonomic agents|mesh-ancestor
111190526|NCT01759862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111190527|NCT01759862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111190528|NCT01759862|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111190529|NCT01759862|Respiratory System Agents|respiratory system agents|mesh-ancestor
111190530|NCT01759862|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111190531|NCT01759862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111190532|NCT01759862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111190533|NCT01759862|Vasodilator Agents|vasodilator agents|mesh-ancestor
111190534|NCT01759862|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
111190535|NCT01759862|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111190536|NCT01759862|Purinergic Agents|purinergic agents|mesh-ancestor
111190537|NCT01759862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111190538|NCT01759862|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111190539|NCT01759862|Protective Agents|protective agents|mesh-ancestor
111190540|NCT01790828|Factor VIII|factor viii|mesh-list
111190541|NCT01790828|Coagulants|coagulants|mesh-ancestor
111190542|NCT01790594|Mycophenolic Acid|mycophenolic acid|mesh-list
111190543|NCT01790594|Methylprednisolone|methylprednisolone|mesh-list
111190544|NCT01790594|Abatacept|abatacept|mesh-list
111190545|NCT01790594|Tacrolimus|tacrolimus|mesh-list
111190546|NCT01790594|Thymoglobulin|thymoglobulin|mesh-list
111190547|NCT01790594|Antilymphocyte Serum|antilymphocyte serum|mesh-list
111190548|NCT01790594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111190549|NCT01790594|Immunologic Factors|immunologic factors|mesh-ancestor
111190550|NCT01790594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111190551|NCT01790594|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111190552|NCT01790594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111190553|NCT01790594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111190554|NCT01790594|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111190555|NCT01790594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111190556|NCT01790594|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111190557|NCT01790594|Antitubercular Agents|antitubercular agents|mesh-ancestor
111190558|NCT01790594|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111190559|NCT01790594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111190560|NCT01790594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111190561|NCT01790594|Antiemetics|antiemetics|mesh-ancestor
111190562|NCT01790594|Autonomic Agents|autonomic agents|mesh-ancestor
111190563|NCT01790594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111190564|NCT01790594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111190565|NCT01790594|Glucocorticoids|glucocorticoids|mesh-ancestor
111190566|NCT01790594|Hormones|hormones|mesh-ancestor
111190567|NCT01790594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111190568|NCT01790594|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111190569|NCT01790594|Protective Agents|protective agents|mesh-ancestor
111190570|NCT01790594|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111190571|NCT01790594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111190572|NCT01790594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111190573|NCT01790516|Cetuximab|cetuximab|mesh-list
111190574|NCT01790516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111190575|NCT01790516|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111190576|NCT01790438|Insulin|insulin|mesh-list
111190577|NCT01790438|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111190578|NCT01790438|Isophane Insulin, Human|isophane insulin, human|mesh-list
111190579|NCT01790438|Insulin, Isophane|insulin, isophane|mesh-list
111190580|NCT01790438|Isophane insulin, beef|isophane insulin, beef|mesh-list
111190581|NCT01790438|Hypoglycemic Agents|hypoglycemic agents|mesh-list
111190582|NCT01790438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111190583|NCT01790126|Triptorelin Pamoate|triptorelin pamoate|mesh-list
111190584|NCT01790126|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111190585|NCT01790126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111190586|NCT01790126|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111190587|NCT01790126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111190588|NCT01790126|Luteolytic Agents|luteolytic agents|mesh-ancestor
111190589|NCT01790126|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111190590|NCT01790126|Contraceptive Agents|contraceptive agents|mesh-ancestor
111190591|NCT01790126|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111190592|NCT01734902|Scopolamine|scopolamine|mesh-list
111190593|NCT01734902|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
111190594|NCT01734902|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111190595|NCT01734902|Antiemetics|antiemetics|mesh-ancestor
111190596|NCT01734902|Autonomic Agents|autonomic agents|mesh-ancestor
111190597|NCT01734902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110845078|NCT01170767|Bevacizumab|bevacizumab|mesh-list
111190598|NCT01734902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111190599|NCT01734902|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111190600|NCT01734902|Mydriatics|mydriatics|mesh-ancestor
111190601|NCT01734902|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111190602|NCT01734902|Cholinergic Agents|cholinergic agents|mesh-ancestor
111190603|NCT01734902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111190604|NCT01734902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111190605|NCT01734902|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111190606|NCT01734902|Parasympatholytics|parasympatholytics|mesh-ancestor
111190607|NCT01789970|Hydrocodone|hydrocodone|mesh-list
111190608|NCT01789970|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111190609|NCT01789970|Narcotics|narcotics|mesh-ancestor
111190610|NCT01789970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111190611|NCT01789970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111190612|NCT01789970|Analgesics|analgesics|mesh-ancestor
111190613|NCT01789970|Sensory System Agents|sensory system agents|mesh-ancestor
111190614|NCT01789970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111190615|NCT01789970|Antitussive Agents|antitussive agents|mesh-ancestor
111190616|NCT01789970|Respiratory System Agents|respiratory system agents|mesh-ancestor
111190617|NCT01788566|Gemcitabine|gemcitabine|mesh-list
111190618|NCT01788566|Necitumumab|necitumumab|mesh-list
111190619|NCT01788566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111190620|NCT01788566|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111190621|NCT01788566|Antimetabolites|antimetabolites|mesh-ancestor
111190622|NCT01788566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111190623|NCT01788566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111190624|NCT01733732|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111190625|NCT01733732|Lubricant Eye Drops|lubricant eye drops|mesh-list
111190626|NCT01733732|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111190627|NCT01732796|Ribavirin|ribavirin|mesh-list
111190628|NCT01732796|Antimetabolites|antimetabolites|mesh-ancestor
111190629|NCT01732796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111190630|NCT01732796|Antiviral Agents|antiviral agents|mesh-ancestor
111190631|NCT01732796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111190632|NCT01732640|Paclitaxel|paclitaxel|mesh-list
111190633|NCT01732640|Cisplatin|cisplatin|mesh-list
111190634|NCT01732640|Carboplatin|carboplatin|mesh-list
111190635|NCT01732640|Afatinib|afatinib|mesh-list
111190636|NCT01732640|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111190637|NCT01732640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111190638|NCT01732640|Tubulin Modulators|tubulin modulators|mesh-ancestor
111190639|NCT01732640|Antimitotic Agents|antimitotic agents|mesh-ancestor
111190640|NCT01732640|Mitosis Modulators|mitosis modulators|mesh-ancestor
111190641|NCT01732640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111190642|NCT01732640|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111190643|NCT01732640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111190644|NCT04560686|Atezolizumab|atezolizumab|mesh-list
111190645|NCT04560686|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111190646|NCT04560686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111190647|NCT04560686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111190648|NCT04560686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111190649|NCT01757288|Paclitaxel|paclitaxel|mesh-list
111190650|NCT01757288|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111190651|NCT01757288|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111190652|NCT01757288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111190653|NCT01757288|Tubulin Modulators|tubulin modulators|mesh-ancestor
111190654|NCT01757288|Antimitotic Agents|antimitotic agents|mesh-ancestor
111190655|NCT01757288|Mitosis Modulators|mitosis modulators|mesh-ancestor
111190656|NCT01757288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111190657|NCT01731938|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
111190658|NCT01731938|Hemostatics|hemostatics|mesh-ancestor
111190659|NCT01731938|Coagulants|coagulants|mesh-ancestor
111190660|NCT01731002|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111190661|NCT01731002|Latanoprost|latanoprost|mesh-list
111190662|NCT01731002|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111190663|NCT01783886|Aflibercept|aflibercept|mesh-list
111190664|NCT01783886|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111190665|NCT01783886|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111190666|NCT01783886|Growth Substances|growth substances|mesh-ancestor
111190667|NCT01783886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111190668|NCT01783886|Growth Inhibitors|growth inhibitors|mesh-ancestor
111190669|NCT01783886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111190670|NCT01609556|Maytansine|maytansine|mesh-list
111190671|NCT01609556|Mirvetuximab soravtansine|mirvetuximab soravtansine|mesh-list
111190672|NCT01609556|Immunoconjugates|immunoconjugates|mesh-ancestor
111190673|NCT01609556|Immunologic Factors|immunologic factors|mesh-ancestor
111190674|NCT01609556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111190675|NCT01609556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111190676|NCT01609556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111190677|NCT01609556|Tubulin Modulators|tubulin modulators|mesh-ancestor
111190678|NCT01609556|Antimitotic Agents|antimitotic agents|mesh-ancestor
111190679|NCT01609556|Mitosis Modulators|mitosis modulators|mesh-ancestor
111190680|NCT01609556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111190681|NCT00234832|Sibutramine|sibutramine|mesh-list
111190682|NCT00234832|Antidepressive Agents|antidepressive agents|mesh-ancestor
111190683|NCT00234832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111190684|NCT00234832|Appetite Depressants|appetite depressants|mesh-ancestor
111190685|NCT00234832|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111190686|NCT00259090|Fulvestrant|fulvestrant|mesh-list
111190687|NCT00259090|Anastrozole|anastrozole|mesh-list
111190688|NCT00259090|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111190689|NCT00259090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111190690|NCT00259090|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
111190691|NCT00259090|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111190692|NCT00259090|Hormone Antagonists|hormone antagonists|mesh-ancestor
111190693|NCT00259090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111190694|NCT00259090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111190695|NCT00259090|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111190696|NCT00259090|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111190697|NCT00259090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111190698|NCT00259090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111190699|NCT00236938|Epoetin Alfa|epoetin alfa|mesh-list
111190700|NCT00236938|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
111190701|NCT00236938|Hematinics|hematinics|mesh-ancestor
111190703|NCT01898728|Cadexomer iodine|cadexomer iodine|mesh-list
111190704|NCT01898728|Povidone-Iodine|povidone-iodine|mesh-list
111190705|NCT01898728|Povidone|povidone|mesh-list
111190706|NCT01898728|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111190707|NCT01898728|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111190708|NCT01898728|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111190709|NCT01898728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111190710|NCT01898728|Trace Elements|trace elements|mesh-ancestor
111190711|NCT01898728|Micronutrients|micronutrients|mesh-ancestor
111190712|NCT01898728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111190713|NCT01898728|Plasma Substitutes|plasma substitutes|mesh-ancestor
111190714|NCT01898728|Blood Substitutes|blood substitutes|mesh-ancestor
111190715|NCT00260962|Olanzapine|olanzapine|mesh-list
111190716|NCT00260962|Antiemetics|antiemetics|mesh-ancestor
111190717|NCT00260962|Autonomic Agents|autonomic agents|mesh-ancestor
111190718|NCT00260962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111190719|NCT00260962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111190720|NCT00260962|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111190721|NCT00260962|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111190722|NCT00260962|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111190723|NCT00260962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111190724|NCT00260962|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111190725|NCT00260962|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111190726|NCT00260962|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111190727|NCT00260962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111190728|NCT00260962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111190729|NCT00260962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111190730|NCT00260962|Serotonin Agents|serotonin agents|mesh-ancestor
111190731|NCT00237718|Vitamin E|vitamin e|mesh-list
111190732|NCT00237718|Tocopherols|tocopherols|mesh-list
111190733|NCT00237718|Tocotrienols|tocotrienols|mesh-list
111190734|NCT00237718|alpha-Tocopherol|alpha-tocopherol|mesh-list
111190735|NCT00237718|Thioctic Acid|thioctic acid|mesh-list
111190736|NCT00237718|Vitamins|vitamins|mesh-ancestor
111190737|NCT00237718|Micronutrients|micronutrients|mesh-ancestor
111190738|NCT00237718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111190739|NCT00237718|Antioxidants|antioxidants|mesh-ancestor
111190740|NCT00237718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111190741|NCT00237718|Protective Agents|protective agents|mesh-ancestor
111190742|NCT00237718|Vitamin B Complex|vitamin b complex|mesh-ancestor
111190743|NCT00238108|Melatonin|melatonin|mesh-list
110907920|NCT03561870|Olaparib|olaparib|mesh-list
111190744|NCT00238108|Antioxidants|antioxidants|mesh-ancestor
111190745|NCT00238108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111190746|NCT00238108|Protective Agents|protective agents|mesh-ancestor
111190747|NCT00238108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111190748|NCT00238108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111190750|NCT00266110|Vinorelbine|vinorelbine|mesh-list
111190751|NCT00266110|Sargramostim|sargramostim|mesh-list
111190752|NCT00266110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111190753|NCT00266110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111190754|NCT00266110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111190755|NCT00266110|Tubulin Modulators|tubulin modulators|mesh-ancestor
111190756|NCT00266110|Antimitotic Agents|antimitotic agents|mesh-ancestor
111190757|NCT00266110|Mitosis Modulators|mitosis modulators|mesh-ancestor
111190758|NCT00266110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111190759|NCT00266110|Immunologic Factors|immunologic factors|mesh-ancestor
111190760|NCT00266110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111190761|NCT00240526|Immunoglobulins|immunoglobulins|mesh-list
111190762|NCT00240526|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111190763|NCT00240526|Antibodies|antibodies|mesh-list
111190764|NCT00240526|Immunologic Factors|immunologic factors|mesh-ancestor
111190765|NCT00240526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111190766|NCT00242632|Memantine|memantine|mesh-list
111190767|NCT00242632|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111190768|NCT00242632|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111190769|NCT00242632|Dopamine Agents|dopamine agents|mesh-ancestor
111190770|NCT00242632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111190771|NCT00242632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111190772|NCT00242632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111190773|NCT00242632|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111190774|NCT00242632|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111190775|NCT01899430|Metformin|metformin|mesh-list
111190776|NCT01899430|Liraglutide|liraglutide|mesh-list
111190777|NCT01899430|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111190778|NCT01899430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111190779|NCT01899430|Incretins|incretins|mesh-ancestor
111190780|NCT01899430|Hormones|hormones|mesh-ancestor
111190781|NCT01899430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111190782|NCT00267670|Pentoxifylline|pentoxifylline|mesh-list
111190783|NCT00267670|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111190784|NCT00267670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111190785|NCT00267670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111190786|NCT00267670|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111190787|NCT00267670|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111190788|NCT00267670|Protective Agents|protective agents|mesh-ancestor
111190789|NCT00267670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111190790|NCT00267670|Vasodilator Agents|vasodilator agents|mesh-ancestor
111190791|NCT00267670|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111190792|NCT00267670|Antioxidants|antioxidants|mesh-ancestor
111190793|NCT00247624|Eszopiclone|eszopiclone|mesh-list
111190794|NCT00247624|Fluoxetine|fluoxetine|mesh-list
111190795|NCT00247624|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111190796|NCT00247624|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111190797|NCT00247624|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111190798|NCT00247624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111190799|NCT00247624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111190800|NCT00247624|Serotonin Agents|serotonin agents|mesh-ancestor
111190801|NCT00247624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111190802|NCT00247624|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111190803|NCT00247624|Antidepressive Agents|antidepressive agents|mesh-ancestor
111190804|NCT00247624|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111190805|NCT00247624|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111190806|NCT00247624|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111190807|NCT00247624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111190808|NCT00247624|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111190809|NCT00247624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111190810|NCT00248560|Gemcitabine|gemcitabine|mesh-list
111190811|NCT00248560|Docetaxel|docetaxel|mesh-list
111190812|NCT00248560|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111190813|NCT00248560|Antimetabolites|antimetabolites|mesh-ancestor
111190814|NCT00248560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111190815|NCT00248560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111190816|NCT00248560|Tubulin Modulators|tubulin modulators|mesh-ancestor
111190817|NCT00248560|Antimitotic Agents|antimitotic agents|mesh-ancestor
111190818|NCT00248560|Mitosis Modulators|mitosis modulators|mesh-ancestor
111190819|NCT00268762|Argatroban|argatroban|mesh-list
111190820|NCT00268762|Antithrombins|antithrombins|mesh-ancestor
110907986|NCT02054676|Ibuprofen|ibuprofen|mesh-list
111190821|NCT00268762|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111190822|NCT00268762|Protease Inhibitors|protease inhibitors|mesh-ancestor
111190823|NCT00268762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111190824|NCT00268762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111190825|NCT00268762|Anticoagulants|anticoagulants|mesh-ancestor
111190826|NCT00268762|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111190827|NCT00270634|Tacrolimus|tacrolimus|mesh-list
111190828|NCT00270634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111190829|NCT00270634|Immunologic Factors|immunologic factors|mesh-ancestor
111190830|NCT00270634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111190831|NCT00270634|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111190832|NCT00270634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111190833|NCT00270634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111190834|NCT04110340|Ciprofloxacin|ciprofloxacin|mesh-list
111190835|NCT04110340|Gentamicins|gentamicins|mesh-list
111190836|NCT04110340|Streptomycin|streptomycin|mesh-list
111190837|NCT04110340|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111190838|NCT04110340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111190839|NCT04110340|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111190840|NCT04110340|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111190841|NCT04110340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111190842|NCT04110340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111190843|NCT04110340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111190844|NCT04110340|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111190845|NCT04110340|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111190846|NCT04110340|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111190847|NCT00270790|Carboplatin|carboplatin|mesh-list
111190848|NCT00270790|Amifostine|amifostine|mesh-list
111190849|NCT00270790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111190850|NCT00270790|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111190851|NCT00270790|Protective Agents|protective agents|mesh-ancestor
111190852|NCT00270790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111190853|NCT00271570|Infliximab|infliximab|mesh-list
111190854|NCT00271570|Immunoglobulins|immunoglobulins|mesh-list
111190855|NCT00271570|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111190856|NCT00271570|Antibodies|antibodies|mesh-list
111190857|NCT00271570|gamma-Globulins|gamma-globulins|mesh-list
111190858|NCT00271570|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
111190859|NCT00271570|Immunologic Factors|immunologic factors|mesh-ancestor
111190860|NCT00271570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111190861|NCT00271570|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111190862|NCT00271570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111190863|NCT00271570|Dermatologic Agents|dermatologic agents|mesh-ancestor
111190864|NCT00271570|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111190865|NCT00271570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111190866|NCT05237596|Acetaminophen|acetaminophen|mesh-list
111190867|NCT05237596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
111190868|NCT05237596|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
111190869|NCT05237596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111190870|NCT05237596|Analgesics|analgesics|mesh-ancestor
111190871|NCT05237596|Sensory System Agents|sensory system agents|mesh-ancestor
111190872|NCT05237596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111190873|NCT05237596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111190874|NCT05237596|Antipyretics|antipyretics|mesh-ancestor
111190875|NCT05237596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111190876|NCT02102932|Metformin|metformin|mesh-list
111190877|NCT02102932|Empagliflozin|empagliflozin|mesh-list
111190878|NCT02102932|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111190879|NCT02102932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111190880|NCT02102932|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111190881|NCT02102932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111190882|NCT00273754|Caffeine|caffeine|mesh-list
111190883|NCT00273754|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111190884|NCT00273754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111190885|NCT00273754|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111190886|NCT00273754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111190887|NCT00273754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111190888|NCT00273754|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
111190889|NCT00273754|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111190890|NCT00273754|Purinergic Agents|purinergic agents|mesh-ancestor
111190891|NCT00273754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111190892|NCT04751344|Bupivacaine|bupivacaine|mesh-list
111190893|NCT04751344|Anesthetics, Local|anesthetics, local|mesh-ancestor
111190894|NCT04751344|Anesthetics|anesthetics|mesh-ancestor
111190895|NCT04751344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111190896|NCT04751344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111190897|NCT04751344|Sensory System Agents|sensory system agents|mesh-ancestor
111190898|NCT04751344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111190899|NCT05211232|Tislelizumab|tislelizumab|mesh-list
111190900|NCT05211232|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111190901|NCT05211232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111190902|NCT00273910|Imiquimod|imiquimod|mesh-list
111190903|NCT00273910|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
111190904|NCT00273910|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111190905|NCT00273910|Immunologic Factors|immunologic factors|mesh-ancestor
111190906|NCT00273910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111190907|NCT00273910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111190908|NCT00273910|Interferon Inducers|interferon inducers|mesh-ancestor
111190909|NCT00274768|Capecitabine|capecitabine|mesh-list
111190910|NCT00274768|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111190911|NCT00274768|Antimetabolites|antimetabolites|mesh-ancestor
111190912|NCT00274768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111190913|NCT00274768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111190914|NCT00280384|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
111190915|NCT00280384|Botulinum Toxins|botulinum toxins|mesh-list
111190916|NCT00280384|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111190917|NCT00280384|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111190918|NCT00280384|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111190919|NCT00280384|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111190920|NCT00280384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111190921|NCT00280384|Cholinergic Agents|cholinergic agents|mesh-ancestor
111190922|NCT00280384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111190923|NCT00280384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111190924|NCT00280384|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111190925|NCT00280384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111190926|NCT00280384|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111190927|NCT01763996|Febuxostat|febuxostat|mesh-list
111190928|NCT01763996|Gout Suppressants|gout suppressants|mesh-ancestor
111190929|NCT01763996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111190930|NCT01790464|Lidocaine|lidocaine|mesh-list
111190931|NCT01790464|Anesthetics, Local|anesthetics, local|mesh-ancestor
111190932|NCT01790464|Anesthetics|anesthetics|mesh-ancestor
111190933|NCT01790464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111190934|NCT01790464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111190935|NCT01790464|Sensory System Agents|sensory system agents|mesh-ancestor
111190936|NCT01790464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111190937|NCT01790464|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111190938|NCT01790464|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111190939|NCT01790464|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111190940|NCT01790464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111190941|NCT01790464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111190942|NCT01790542|Iron|iron|mesh-list
111190943|NCT01790542|Trace Elements|trace elements|mesh-ancestor
111190944|NCT01790542|Micronutrients|micronutrients|mesh-ancestor
111190945|NCT01790542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111190946|NCT01899820|Lumefantrine|lumefantrine|mesh-list
111190947|NCT01899820|Artemether|artemether|mesh-list
111190948|NCT01899820|Piperaquine|piperaquine|mesh-list
111190949|NCT01899820|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
111190950|NCT01899820|Artenimol|artenimol|mesh-list
111190951|NCT01899820|Antimalarials|antimalarials|mesh-ancestor
111190952|NCT01899820|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111190953|NCT01899820|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111190954|NCT01899820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111190955|NCT02100748|Morphine|morphine|mesh-list
111190956|NCT02100748|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111190957|NCT02100748|Narcotics|narcotics|mesh-ancestor
111190958|NCT02100748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111190959|NCT02100748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111190960|NCT02100748|Analgesics|analgesics|mesh-ancestor
111190961|NCT02100748|Sensory System Agents|sensory system agents|mesh-ancestor
111190962|NCT02100748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111190963|NCT00283504|Omalizumab|omalizumab|mesh-list
111190964|NCT00283504|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111190965|NCT00283504|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111190966|NCT00283504|Respiratory System Agents|respiratory system agents|mesh-ancestor
111190967|NCT00283816|Metformin|metformin|mesh-list
111190968|NCT00283816|Contraceptive Agents|contraceptive agents|mesh-list
111190969|NCT00283816|Contraceptives, Oral|contraceptives, oral|mesh-list
111190970|NCT00283816|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
111190971|NCT00283816|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111190972|NCT00283816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111190973|NCT00283816|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111190974|NCT00283816|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111190975|NCT00284518|Botulinum Toxins|botulinum toxins|mesh-list
111190976|NCT00284518|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111190977|NCT00284518|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111190978|NCT00284518|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111190979|NCT00284518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111190980|NCT00284518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111190981|NCT00284518|Cholinergic Agents|cholinergic agents|mesh-ancestor
111190982|NCT00284518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111190983|NCT00284518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111190984|NCT00284518|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110490573|NCT00948194|Antioxidants|antioxidants|mesh-ancestor
111190985|NCT00284518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111190986|NCT04339426|Azithromycin|azithromycin|mesh-list
111190987|NCT04339426|Atovaquone|atovaquone|mesh-list
111190988|NCT04339426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111190989|NCT04339426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111190990|NCT04339426|Antimalarials|antimalarials|mesh-ancestor
111190991|NCT04339426|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111190992|NCT04339426|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111190993|NCT04339426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111190994|NCT04339426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111190995|NCT01899898|Anticonvulsants|anticonvulsants|mesh-list
111190996|NCT00287716|Pirfenidone|pirfenidone|mesh-list
111190997|NCT00287716|Analgesics|analgesics|mesh-ancestor
111190998|NCT00287716|Sensory System Agents|sensory system agents|mesh-ancestor
111190999|NCT00287716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111191000|NCT00287716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111191001|NCT00287716|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111191002|NCT00287716|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111191003|NCT00287716|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111191004|NCT00287716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111191005|NCT00287716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111191006|NCT00287872|Thalidomide|thalidomide|mesh-list
111191007|NCT00287872|Bortezomib|bortezomib|mesh-list
111191008|NCT00287872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111191009|NCT00287872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111191010|NCT00287872|Immunologic Factors|immunologic factors|mesh-ancestor
111191011|NCT00287872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111191012|NCT00287872|Leprostatic Agents|leprostatic agents|mesh-ancestor
111191013|NCT00287872|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111191014|NCT00287872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111191015|NCT00287872|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111191016|NCT00287872|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111191017|NCT00287872|Growth Substances|growth substances|mesh-ancestor
111191018|NCT00287872|Growth Inhibitors|growth inhibitors|mesh-ancestor
111191019|NCT00288574|Fluoxetine|fluoxetine|mesh-list
111191020|NCT00288574|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111191021|NCT00288574|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111191022|NCT00288574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111191023|NCT00288574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111191024|NCT00288574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111191025|NCT00288574|Serotonin Agents|serotonin agents|mesh-ancestor
111191026|NCT00288574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111191027|NCT00288574|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111191028|NCT00288574|Antidepressive Agents|antidepressive agents|mesh-ancestor
111191029|NCT00288574|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111191030|NCT00288574|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111191031|NCT00288574|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111191032|NCT00288574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111191033|NCT04061590|Cisplatin|cisplatin|mesh-list
111191034|NCT04061590|Pembrolizumab|pembrolizumab|mesh-list
111191035|NCT04061590|Pemetrexed|pemetrexed|mesh-list
111191036|NCT04061590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111191037|NCT04061590|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111191038|NCT04061590|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111191039|NCT04061590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111191040|NCT04061590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111191041|NCT04061590|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111191042|NCT04061590|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111191043|NCT01791088|Sirolimus|sirolimus|mesh-list
111191044|NCT01791088|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111191045|NCT01791088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111191046|NCT01791088|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111191047|NCT01791088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111191048|NCT01791088|Antifungal Agents|antifungal agents|mesh-ancestor
111191049|NCT01791088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111191050|NCT01791088|Immunologic Factors|immunologic factors|mesh-ancestor
111191051|NCT01791088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111191052|NCT00291226|Glycine|glycine|mesh-list
111191053|NCT00291226|Glycine Agents|glycine agents|mesh-ancestor
111191054|NCT00291226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111191055|NCT00291226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111191056|NCT00291226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111191057|NCT01791166|Antibodies|antibodies|mesh-list
111191058|NCT01791166|Immunologic Factors|immunologic factors|mesh-ancestor
111191059|NCT01791166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111191060|NCT00291694|Celecoxib|celecoxib|mesh-list
111191061|NCT00291694|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111191062|NCT00291694|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111191063|NCT00291694|Analgesics|analgesics|mesh-ancestor
111191064|NCT00291694|Sensory System Agents|sensory system agents|mesh-ancestor
111191065|NCT00291694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111191066|NCT00291694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111191067|NCT00291694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111191068|NCT00291694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111191069|NCT00291694|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111191070|NCT00291694|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111191071|NCT00291694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111191072|NCT00291694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111191073|NCT00292162|Metoprolol|metoprolol|mesh-list
111191074|NCT00292162|Carvedilol|carvedilol|mesh-list
111191075|NCT00292162|Ramipril|ramipril|mesh-list
111191076|NCT00292162|Enalapril|enalapril|mesh-list
111191077|NCT00292162|Lisinopril|lisinopril|mesh-list
111191078|NCT00292162|Bisoprolol|bisoprolol|mesh-list
111191079|NCT00292162|Perindopril|perindopril|mesh-list
111191080|NCT00292162|Captopril|captopril|mesh-list
111191081|NCT00292162|Spironolactone|spironolactone|mesh-list
111191082|NCT00292162|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
111191083|NCT00292162|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
111191084|NCT00292162|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
111191085|NCT00292162|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111191086|NCT00292162|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111191087|NCT00292162|Sympatholytics|sympatholytics|mesh-ancestor
111191088|NCT00292162|Autonomic Agents|autonomic agents|mesh-ancestor
111191089|NCT00292162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111191090|NCT00292162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111191091|NCT00292162|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
111191092|NCT00292162|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111191093|NCT00292162|Adrenergic Agents|adrenergic agents|mesh-ancestor
111191094|NCT00292162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111191095|NCT00292162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111191096|NCT00292162|Hormone Antagonists|hormone antagonists|mesh-ancestor
111191097|NCT00292162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111191098|NCT00292162|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
111191099|NCT00292162|Diuretics|diuretics|mesh-ancestor
111191100|NCT00292162|Natriuretic Agents|natriuretic agents|mesh-ancestor
111191101|NCT00292162|Antioxidants|antioxidants|mesh-ancestor
111191102|NCT00292162|Protective Agents|protective agents|mesh-ancestor
111191103|NCT00292162|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111191104|NCT00292162|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111191105|NCT00292162|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111191106|NCT00292162|Vasodilator Agents|vasodilator agents|mesh-ancestor
111191107|NCT00292162|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111191108|NCT00292162|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111191109|NCT00292162|Protease Inhibitors|protease inhibitors|mesh-ancestor
111191110|NCT00292162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111191111|NCT00292162|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111191112|NCT00296296|Cyclosporine|cyclosporine|mesh-list
111191113|NCT00296296|Tacrolimus|tacrolimus|mesh-list
111191114|NCT00296296|Cyclosporins|cyclosporins|mesh-list
111191115|NCT00296296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111191116|NCT00296296|Immunologic Factors|immunologic factors|mesh-ancestor
111191117|NCT00296296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111191118|NCT00296296|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111191119|NCT00296296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111191120|NCT00296296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111191121|NCT00296296|Antifungal Agents|antifungal agents|mesh-ancestor
111191122|NCT00296296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111191123|NCT00296296|Dermatologic Agents|dermatologic agents|mesh-ancestor
111191124|NCT00296296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111191125|NCT01791400|Sumatriptan|sumatriptan|mesh-list
111191126|NCT01791400|Metoclopramide|metoclopramide|mesh-list
111191127|NCT01791400|Antiemetics|antiemetics|mesh-ancestor
111191128|NCT01791400|Autonomic Agents|autonomic agents|mesh-ancestor
111191129|NCT01791400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111191130|NCT01791400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111191131|NCT01791400|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111191132|NCT01791400|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111191133|NCT01791400|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111191134|NCT01791400|Dopamine Agents|dopamine agents|mesh-ancestor
111191135|NCT01791400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111191136|NCT01791400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111191137|NCT01791400|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111191138|NCT01791400|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111191139|NCT01791400|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111191140|NCT01791400|Serotonin Agents|serotonin agents|mesh-ancestor
111191141|NCT00300430|Calcium, Dietary|calcium, dietary|mesh-list
111191142|NCT00300430|Atorvastatin|atorvastatin|mesh-list
111191143|NCT00300430|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111191144|NCT00300430|Simvastatin|simvastatin|mesh-list
111191145|NCT00300430|Fenofibrate|fenofibrate|mesh-list
111191146|NCT00300430|Calcium|calcium|mesh-list
111191147|NCT00300430|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111191148|NCT00300430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111191149|NCT00300430|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111191150|NCT00300430|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111191151|NCT00300430|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111191152|NCT00300430|Antimetabolites|antimetabolites|mesh-ancestor
111191153|NCT00300430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111191154|NCT00300430|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111191155|NCT00300430|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111191156|NCT00300430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111191157|NCT02104414|Epinephrine|epinephrine|mesh-list
111191158|NCT02104414|Bupivacaine|bupivacaine|mesh-list
111191159|NCT02104414|Anesthetics, Local|anesthetics, local|mesh-ancestor
111191160|NCT02104414|Anesthetics|anesthetics|mesh-ancestor
111191161|NCT02104414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111191162|NCT02104414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111191163|NCT02104414|Sensory System Agents|sensory system agents|mesh-ancestor
111191164|NCT02104414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111191165|NCT02104414|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111191166|NCT02104414|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111191167|NCT02104414|Adrenergic Agents|adrenergic agents|mesh-ancestor
111191168|NCT02104414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111191169|NCT02104414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111191170|NCT02104414|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111191171|NCT02104414|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111191172|NCT02104414|Autonomic Agents|autonomic agents|mesh-ancestor
111191173|NCT02104414|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111191174|NCT02104414|Respiratory System Agents|respiratory system agents|mesh-ancestor
111191175|NCT02104414|Mydriatics|mydriatics|mesh-ancestor
111191176|NCT02104414|Sympathomimetics|sympathomimetics|mesh-ancestor
111191177|NCT02104414|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111191179|NCT02100826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111191180|NCT02100826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111191181|NCT03587272|Sirolimus|sirolimus|mesh-list
111191182|NCT03587272|Alemtuzumab|alemtuzumab|mesh-list
111191183|NCT03587272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111191184|NCT03587272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111191185|NCT03587272|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111191186|NCT03587272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111191187|NCT03587272|Antifungal Agents|antifungal agents|mesh-ancestor
111191188|NCT03587272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111191189|NCT03587272|Immunologic Factors|immunologic factors|mesh-ancestor
111191190|NCT03587272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111191191|NCT03587272|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111191192|NCT02101918|Aflibercept|aflibercept|mesh-list
111191193|NCT02101918|Endothelial Growth Factors|endothelial growth factors|mesh-list
111191194|NCT02101918|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111191195|NCT02101918|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111191196|NCT02101918|Growth Substances|growth substances|mesh-ancestor
111191197|NCT02101918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111191198|NCT02101918|Growth Inhibitors|growth inhibitors|mesh-ancestor
111191199|NCT02101918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111191200|NCT00300742|Topiramate|topiramate|mesh-list
111191201|NCT00300742|Anticonvulsants|anticonvulsants|mesh-ancestor
111191202|NCT00300742|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111191203|NCT00300742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111191204|NCT00301756|Belinostat|belinostat|mesh-list
111191205|NCT00301756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111191206|NCT00301756|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111191207|NCT00301756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111191208|NCT00301756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111191209|NCT00302068|Sertraline|sertraline|mesh-list
111191210|NCT00302068|Antidepressive Agents|antidepressive agents|mesh-ancestor
111191211|NCT00302068|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111191212|NCT00302068|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111191213|NCT00302068|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111191214|NCT00302068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111191215|NCT00302068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111191216|NCT00302068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111191217|NCT00302068|Serotonin Agents|serotonin agents|mesh-ancestor
111191218|NCT00302068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111191219|NCT00302848|Drospirenone|drospirenone|mesh-list
111191220|NCT00302848|Contraceptive Agents|contraceptive agents|mesh-list
111191221|NCT00302848|Levonorgestrel|levonorgestrel|mesh-list
111191222|NCT00302848|Contraceptives, Oral|contraceptives, oral|mesh-list
111191223|NCT00302848|Progestins|progestins|mesh-list
111191224|NCT00302848|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111191225|NCT00302848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111191226|NCT00302848|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111191227|NCT00302848|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111191228|NCT00302848|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111191229|NCT00302848|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
111191230|NCT00302848|Hormone Antagonists|hormone antagonists|mesh-ancestor
111191231|NCT00302848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111191232|NCT00302848|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
111191233|NCT00302848|Diuretics|diuretics|mesh-ancestor
111191234|NCT00302848|Natriuretic Agents|natriuretic agents|mesh-ancestor
111191235|NCT00302848|Hormones|hormones|mesh-ancestor
111191236|NCT00303862|Cediranib|cediranib|mesh-list
110845115|NCT01275911|Analgesics|analgesics|mesh-ancestor
111191237|NCT00303862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111191238|NCT00303862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111191239|NCT00303862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111191240|NCT00303862|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111191241|NCT00304096|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
111191242|NCT00304096|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111191243|NCT00304096|Immunologic Factors|immunologic factors|mesh-ancestor
111191244|NCT00304096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111191246|NCT05267392|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111191247|NCT05267392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111191248|NCT00142168|Rituximab|rituximab|mesh-list
111191249|NCT00142168|Lenalidomide|lenalidomide|mesh-list
111191250|NCT00142168|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111191251|NCT00142168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111191252|NCT00142168|Immunologic Factors|immunologic factors|mesh-ancestor
111191253|NCT00142168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111191254|NCT00142168|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111191255|NCT00142168|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111191256|NCT00142168|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111191257|NCT00142168|Growth Substances|growth substances|mesh-ancestor
111191258|NCT00142168|Growth Inhibitors|growth inhibitors|mesh-ancestor
111191259|NCT02501434|Heparin|heparin|mesh-list
111191260|NCT02501434|Calcium heparin|calcium heparin|mesh-list
111191261|NCT02501434|Anticoagulants|anticoagulants|mesh-ancestor
111191262|NCT02501434|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111191263|NCT02501434|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111191264|NCT02501434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111191265|NCT00147316|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
111191266|NCT00147316|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111191267|NCT00147316|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111191268|NCT00147316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111191269|NCT00148798|Cisplatin|cisplatin|mesh-list
111191270|NCT00148798|Cetuximab|cetuximab|mesh-list
111191271|NCT00148798|Vinorelbine|vinorelbine|mesh-list
111191272|NCT00148798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111191273|NCT00148798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111191274|NCT00148798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111191275|NCT00148798|Tubulin Modulators|tubulin modulators|mesh-ancestor
111191276|NCT00148798|Antimitotic Agents|antimitotic agents|mesh-ancestor
111191277|NCT00148798|Mitosis Modulators|mitosis modulators|mesh-ancestor
111191278|NCT00148798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111191279|NCT00149734|Ondansetron|ondansetron|mesh-list
111191280|NCT00149734|Antiemetics|antiemetics|mesh-ancestor
111191281|NCT00149734|Autonomic Agents|autonomic agents|mesh-ancestor
111191282|NCT00149734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111191283|NCT00149734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111191284|NCT00149734|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111191285|NCT00149734|Antipruritics|antipruritics|mesh-ancestor
111191286|NCT00149734|Dermatologic Agents|dermatologic agents|mesh-ancestor
111191287|NCT00149734|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111191288|NCT00149734|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111191289|NCT00149734|Serotonin Agents|serotonin agents|mesh-ancestor
111191290|NCT00149734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111191291|NCT00149734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111191293|NCT00198328|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111191294|NCT00198328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111191295|NCT00305578|Memantine|memantine|mesh-list
111191296|NCT00305578|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111191297|NCT00305578|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111191298|NCT00305578|Dopamine Agents|dopamine agents|mesh-ancestor
111191299|NCT00305578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111191300|NCT00305578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111191301|NCT00305578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111191302|NCT00305578|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111191303|NCT00305578|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111191304|NCT01492101|Etirinotecan pegol|etirinotecan pegol|mesh-list
111191305|NCT01492101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111191306|NCT01492101|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111191307|NCT01492101|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111191308|NCT01492101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111191309|NCT01492101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111191310|NCT01468311|Daclizumab|daclizumab|mesh-list
111191311|NCT01468311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111191312|NCT01468311|Immunologic Factors|immunologic factors|mesh-ancestor
111191313|NCT01468311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111191314|NCT00306202|Dasatinib|dasatinib|mesh-list
111191315|NCT00306202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111191316|NCT00306202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111191317|NCT00306202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110490615|NCT02856542|Dermatologic Agents|dermatologic agents|mesh-ancestor
111191318|NCT00306202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111191319|NCT00325078|Infliximab|infliximab|mesh-list
111191320|NCT00325078|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111191321|NCT00325078|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111191322|NCT00325078|Dermatologic Agents|dermatologic agents|mesh-ancestor
111191323|NCT00325078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111191324|NCT00325078|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111191325|NCT00325780|Pitavastatin|pitavastatin|mesh-list
111191326|NCT00325780|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111191327|NCT00325780|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111191328|NCT00325780|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111191329|NCT00325780|Antimetabolites|antimetabolites|mesh-ancestor
111191330|NCT00325780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111191331|NCT00325780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111191332|NCT00325780|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111191333|NCT00326170|Azacitidine|azacitidine|mesh-list
111191334|NCT00326170|Tretinoin|tretinoin|mesh-list
111191335|NCT00326170|Valproic Acid|valproic acid|mesh-list
111191336|NCT00326170|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111191337|NCT00326170|Antimetabolites|antimetabolites|mesh-ancestor
111191338|NCT00326170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111191339|NCT00326170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111191340|NCT00326170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111191341|NCT00326170|Keratolytic Agents|keratolytic agents|mesh-ancestor
111191342|NCT00326170|Dermatologic Agents|dermatologic agents|mesh-ancestor
111191343|NCT00326170|Anticonvulsants|anticonvulsants|mesh-ancestor
111191344|NCT00326170|GABA Agents|gaba agents|mesh-ancestor
111191345|NCT00326170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111191346|NCT00326170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111191347|NCT00326170|Antimanic Agents|antimanic agents|mesh-ancestor
111191348|NCT00326170|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111191349|NCT00326170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111191350|NCT00326170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111191352|NCT00326872|Maleic acid|maleic acid|mesh-list
111191353|NCT00326872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111191354|NCT00326872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111191355|NCT00326872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111191356|NCT00326872|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111191357|NCT05266690|Dextrans|dextrans|mesh-list
111191358|NCT05266690|Anticoagulants|anticoagulants|mesh-ancestor
111191359|NCT05266690|Plasma Substitutes|plasma substitutes|mesh-ancestor
111191360|NCT05266690|Blood Substitutes|blood substitutes|mesh-ancestor
111191361|NCT01730534|Dapagliflozin|dapagliflozin|mesh-list
111191362|NCT01730534|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111191363|NCT01730534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111191364|NCT01730534|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111191365|NCT01730534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111191366|NCT05266534|Terlipressin|terlipressin|mesh-list
111191367|NCT05266534|Carbetocin|carbetocin|mesh-list
111191368|NCT05266534|Oxytocics|oxytocics|mesh-ancestor
111191369|NCT05266534|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110845124|NCT01166165|Cholecalciferol|cholecalciferol|mesh-list
111191370|NCT05266534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111191371|NCT05266534|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111191372|NCT05266534|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111191373|NCT01730378|Vaccines|vaccines|mesh-list
111191374|NCT01730378|Immunologic Factors|immunologic factors|mesh-ancestor
111191375|NCT01730378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111191376|NCT00331162|Alemtuzumab|alemtuzumab|mesh-list
111191377|NCT00331162|Antilymphocyte Serum|antilymphocyte serum|mesh-list
111191378|NCT00331162|Immunologic Factors|immunologic factors|mesh-ancestor
111191379|NCT00331162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111191380|NCT00331162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111191381|NCT00331162|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111191382|NCT00331162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111191383|NCT01790308|Liraglutide|liraglutide|mesh-list
111191384|NCT01790308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111191385|NCT01790308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111191386|NCT01790308|Incretins|incretins|mesh-ancestor
111191387|NCT01790308|Hormones|hormones|mesh-ancestor
111191388|NCT01790308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111191389|NCT01609010|Interferons|interferons|mesh-list
111191390|NCT01609010|Interferon alpha-2|interferon alpha-2|mesh-list
111191391|NCT01609010|Rituximab|rituximab|mesh-list
111191392|NCT01609010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111191393|NCT01609010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111191394|NCT01609010|Immunologic Factors|immunologic factors|mesh-ancestor
111191395|NCT01609010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111191396|NCT01609010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111191397|NCT01609010|Antiviral Agents|antiviral agents|mesh-ancestor
111191398|NCT01609010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111191399|NCT01608308|Acetaminophen|acetaminophen|mesh-list
111191400|NCT01608308|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111191401|NCT01608308|Analgesics|analgesics|mesh-ancestor
111191402|NCT01608308|Sensory System Agents|sensory system agents|mesh-ancestor
111191403|NCT01608308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111191404|NCT01608308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111191405|NCT01608308|Antipyretics|antipyretics|mesh-ancestor
111191406|NCT00332644|Bupropion|bupropion|mesh-list
111191407|NCT00332644|Nicotine|nicotine|mesh-list
111191408|NCT00332644|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111191409|NCT00332644|Autonomic Agents|autonomic agents|mesh-ancestor
111191410|NCT00332644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111191411|NCT00332644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111191412|NCT00332644|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111191413|NCT00332644|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111191414|NCT00332644|Cholinergic Agents|cholinergic agents|mesh-ancestor
111191415|NCT00332644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111191416|NCT00332644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111191417|NCT00332644|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111191418|NCT00332644|Antidepressive Agents|antidepressive agents|mesh-ancestor
111191419|NCT00332644|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111191420|NCT00332644|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111191421|NCT00332644|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111191422|NCT00332644|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111191423|NCT00332644|Dopamine Agents|dopamine agents|mesh-ancestor
111191424|NCT00332644|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111191425|NCT00332644|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111191426|NCT00332644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111191427|NCT01755416|Insulin|insulin|mesh-list
111191428|NCT01755416|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111191429|NCT01755416|Liraglutide|liraglutide|mesh-list
111191430|NCT01755416|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111191431|NCT01755416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111191432|NCT01755416|Incretins|incretins|mesh-ancestor
111191433|NCT01755416|Hormones|hormones|mesh-ancestor
111191434|NCT01755416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111191435|NCT01755026|Cefazolin|cefazolin|mesh-list
111191436|NCT01755026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111191437|NCT01755026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111191438|NCT00333814|Dexamethasone|dexamethasone|mesh-list
111191439|NCT00333814|Dexamethasone acetate|dexamethasone acetate|mesh-list
111191440|NCT00333814|BB 1101|bb 1101|mesh-list
111191441|NCT00333814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111191442|NCT00333814|Antiemetics|antiemetics|mesh-ancestor
111191443|NCT00333814|Autonomic Agents|autonomic agents|mesh-ancestor
111191444|NCT00333814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111191445|NCT00333814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111191446|NCT00333814|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111191447|NCT00333814|Glucocorticoids|glucocorticoids|mesh-ancestor
111191448|NCT00333814|Hormones|hormones|mesh-ancestor
111191449|NCT00333814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111191450|NCT00333814|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111191451|NCT00333814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111191452|NCT00333814|Protease Inhibitors|protease inhibitors|mesh-ancestor
111191453|NCT00333814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111191454|NCT00333814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111191455|NCT01728584|Bromides|bromides|mesh-list
111191456|NCT01728584|Rocuronium|rocuronium|mesh-list
111191457|NCT01728584|Anticonvulsants|anticonvulsants|mesh-ancestor
111191458|NCT01728584|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
111191459|NCT01728584|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
111191460|NCT01728584|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111191461|NCT01728584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111191462|NCT01728584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111191463|NCT00315328|Atropine|atropine|mesh-list
111191464|NCT00315328|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111191465|NCT00315328|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111191466|NCT00315328|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111191467|NCT00315328|Autonomic Agents|autonomic agents|mesh-ancestor
111191468|NCT00315328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111191469|NCT00315328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111191470|NCT00315328|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111191471|NCT00315328|Respiratory System Agents|respiratory system agents|mesh-ancestor
111191472|NCT00315328|Mydriatics|mydriatics|mesh-ancestor
111191473|NCT00315328|Parasympatholytics|parasympatholytics|mesh-ancestor
111191474|NCT00315328|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111191475|NCT00315328|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111191476|NCT00315328|Cholinergic Agents|cholinergic agents|mesh-ancestor
111191477|NCT00315328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111191478|NCT00315328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111191479|NCT01522443|Prednisone|prednisone|mesh-list
111191480|NCT01522443|Mitoxantrone|mitoxantrone|mesh-list
111191481|NCT01522443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110676998|NCT03230734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110676999|NCT03229408|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
110677000|NCT03229408|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110677001|NCT03229408|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110677002|NCT03229408|Analgesics|analgesics|mesh-ancestor
110677003|NCT03229408|Sensory System Agents|sensory system agents|mesh-ancestor
110677004|NCT03229408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110677005|NCT03229408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110677006|NCT03229408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110677007|NCT03229408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110677008|NCT03174197|Temozolomide|temozolomide|mesh-list
110677009|NCT03174197|Atezolizumab|atezolizumab|mesh-list
110677010|NCT03174197|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110677011|NCT03174197|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110677012|NCT03174197|Alkylating Agents|alkylating agents|mesh-ancestor
110677013|NCT03174197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110677014|NCT03174197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111191482|NCT01522443|Glucocorticoids|glucocorticoids|mesh-ancestor
111191483|NCT01522443|Hormones|hormones|mesh-ancestor
111191484|NCT01522443|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111191485|NCT01522443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111191486|NCT01522443|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111191487|NCT01522443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111191489|NCT01522443|Sensory System Agents|sensory system agents|mesh-ancestor
111191490|NCT01522443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111191491|NCT01522443|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111191492|NCT01522443|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111191493|NCT01522443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111191494|NCT01522443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111191495|NCT00336232|Vitamin K|vitamin k|mesh-list
111191496|NCT00336232|Vitamin K 1|vitamin k 1|mesh-list
111191497|NCT00336232|Vitamins|vitamins|mesh-ancestor
111191498|NCT00336232|Micronutrients|micronutrients|mesh-ancestor
111191499|NCT00336232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111191500|NCT00336232|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111191501|NCT00336232|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111191502|NCT00336232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111191503|NCT00336232|Hemostatics|hemostatics|mesh-ancestor
111191504|NCT00336232|Coagulants|coagulants|mesh-ancestor
111191505|NCT00336700|Gemcitabine|gemcitabine|mesh-list
111191506|NCT00336700|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111191507|NCT00336700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111191508|NCT00336700|Antimetabolites|antimetabolites|mesh-ancestor
111191509|NCT00336700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111191510|NCT00336700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111191511|NCT00336700|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111191512|NCT00336700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111191513|NCT01468233|Adalimumab|adalimumab|mesh-list
111191514|NCT01468233|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111191515|NCT01468233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111191516|NCT01468233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111191517|NCT01754402|Dexamethasone|dexamethasone|mesh-list
111191518|NCT01754402|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
111191519|NCT01754402|Pomalidomide|pomalidomide|mesh-list
111191520|NCT01754402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111191521|NCT01754402|Antiemetics|antiemetics|mesh-ancestor
111191522|NCT01754402|Autonomic Agents|autonomic agents|mesh-ancestor
111191523|NCT01754402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111191524|NCT01754402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111191525|NCT01754402|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111191526|NCT01754402|Glucocorticoids|glucocorticoids|mesh-ancestor
111191527|NCT01754402|Hormones|hormones|mesh-ancestor
111191528|NCT01754402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111191529|NCT01754402|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111191530|NCT01754402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111191531|NCT01754402|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111191532|NCT01754402|Alkylating Agents|alkylating agents|mesh-ancestor
111191533|NCT01754402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111191534|NCT01754402|Immunologic Factors|immunologic factors|mesh-ancestor
111191535|NCT01754402|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111191536|NCT01754402|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111191537|NCT01754402|Growth Substances|growth substances|mesh-ancestor
111191538|NCT01754402|Growth Inhibitors|growth inhibitors|mesh-ancestor
111191539|NCT01521897|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
111191540|NCT01521897|Immunologic Factors|immunologic factors|mesh-ancestor
111191541|NCT01521897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111191542|NCT01782872|Ropivacaine|ropivacaine|mesh-list
111191543|NCT01782872|Anesthetics, Local|anesthetics, local|mesh-ancestor
111191544|NCT01782872|Anesthetics|anesthetics|mesh-ancestor
111191545|NCT01782872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111191546|NCT01782872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111191547|NCT01782872|Sensory System Agents|sensory system agents|mesh-ancestor
111191548|NCT01782872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111191549|NCT01490697|Cycloserine|cycloserine|mesh-list
111191550|NCT01490697|Mifepristone|mifepristone|mesh-list
111191551|NCT01490697|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
111191552|NCT01490697|Abortifacient Agents|abortifacient agents|mesh-ancestor
111191553|NCT01490697|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111191554|NCT01490697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111191555|NCT01490697|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111191556|NCT01490697|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111191557|NCT01490697|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111191558|NCT01490697|Contraceptive Agents|contraceptive agents|mesh-ancestor
111191559|NCT01490697|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
111191560|NCT01490697|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
111191561|NCT01490697|Hormone Antagonists|hormone antagonists|mesh-ancestor
111191562|NCT01490697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111191563|NCT01490697|Luteolytic Agents|luteolytic agents|mesh-ancestor
111191564|NCT01490697|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111191565|NCT01490697|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
111191566|NCT01490697|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111191567|NCT01490697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111191568|NCT01490697|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111191569|NCT01490697|Antitubercular Agents|antitubercular agents|mesh-ancestor
111191570|NCT01490697|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111191571|NCT01490697|Antimetabolites|antimetabolites|mesh-ancestor
111191572|NCT01490697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111191573|NCT01728194|Escitalopram|escitalopram|mesh-list
111191574|NCT01728194|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111191575|NCT01728194|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111191576|NCT01728194|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111191577|NCT01728194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111191578|NCT01728194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111191579|NCT01728194|Serotonin Agents|serotonin agents|mesh-ancestor
111191580|NCT01728194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111191581|NCT04408911|Midazolam|midazolam|mesh-list
111191582|NCT04408911|Lormetazepam|lormetazepam|mesh-list
111191583|NCT04408911|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111191584|NCT04408911|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111191585|NCT04408911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111191586|NCT04408911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111191587|NCT04408911|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111191588|NCT04408911|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111191589|NCT04408911|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111191590|NCT04408911|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111191591|NCT04408911|Anesthetics, General|anesthetics, general|mesh-ancestor
111191592|NCT04408911|Anesthetics|anesthetics|mesh-ancestor
111191593|NCT04408911|GABA Modulators|gaba modulators|mesh-ancestor
111191594|NCT04408911|GABA Agents|gaba agents|mesh-ancestor
111191595|NCT04408911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111191596|NCT04408911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111191598|NCT01466673|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
111191599|NCT01466673|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
111191600|NCT01466673|Ethinyl Estradiol|ethinyl estradiol|mesh-list
111191601|NCT01466673|Desogestrel|desogestrel|mesh-list
111191602|NCT01466673|Norgestimate|norgestimate|mesh-list
111191603|NCT01466673|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
111191604|NCT01466673|Estradiol|estradiol|mesh-list
111191605|NCT01466673|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
111191606|NCT01466673|Estrogens|estrogens|mesh-ancestor
111191607|NCT01466673|Hormones|hormones|mesh-ancestor
111191608|NCT01466673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111191609|NCT01466673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111191610|NCT01466673|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111191611|NCT01466673|Contraceptive Agents|contraceptive agents|mesh-ancestor
111191612|NCT01466673|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111191613|NCT01466673|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111191614|NCT01466673|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111191615|NCT01466673|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111191616|NCT01466673|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111191617|NCT01466673|Progestins|progestins|mesh-ancestor
111191618|NCT01466673|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111191619|NCT01466673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111191620|NCT01466673|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111191621|NCT01466673|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111191622|NCT01466673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111191623|NCT01466673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111191624|NCT01466673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111191625|NCT01466673|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
111191626|NCT01753856|Vitamin D|vitamin d|mesh-list
111191627|NCT01753856|Denosumab|denosumab|mesh-list
111191628|NCT01753856|Teriparatide|teriparatide|mesh-list
111191629|NCT01753856|Tetracycline|tetracycline|mesh-list
111191630|NCT01753856|Demeclocycline|demeclocycline|mesh-list
111191631|NCT01753856|Calcium|calcium|mesh-list
111191632|NCT01753856|Vitamins|vitamins|mesh-ancestor
111191633|NCT01753856|Micronutrients|micronutrients|mesh-ancestor
111191634|NCT01753856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111191635|NCT01753856|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111191636|NCT01753856|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111191637|NCT01753856|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111191638|NCT01753856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111191639|NCT01753856|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111191640|NCT01753856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111191641|NCT01753856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111191642|NCT01753310|Botulinum Toxins|botulinum toxins|mesh-list
111191643|NCT01753310|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111191644|NCT01753310|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111191645|NCT01753310|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111191646|NCT01753310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111191647|NCT01753310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111191648|NCT01753310|Cholinergic Agents|cholinergic agents|mesh-ancestor
111191649|NCT01753310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111191650|NCT01753310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111191651|NCT01753310|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111191652|NCT01753310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111191653|NCT01521117|Donepezil|donepezil|mesh-list
111191654|NCT01521117|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111191655|NCT01521117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111191656|NCT01521117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111191657|NCT01521117|Cholinergic Agents|cholinergic agents|mesh-ancestor
111191658|NCT01521117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111191659|NCT01521117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111191660|NCT01521117|Nootropic Agents|nootropic agents|mesh-ancestor
111191661|NCT01466595|Rifaximin|rifaximin|mesh-list
111191662|NCT01466595|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111191663|NCT01466595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111191664|NCT01466595|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111191665|NCT02073747|Albuterol|albuterol|mesh-list
111191666|NCT02073747|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111191667|NCT02073747|Autonomic Agents|autonomic agents|mesh-ancestor
111191668|NCT02073747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111191669|NCT02073747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111191670|NCT02073747|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111191671|NCT02073747|Respiratory System Agents|respiratory system agents|mesh-ancestor
111191672|NCT02073747|Tocolytic Agents|tocolytic agents|mesh-ancestor
111191673|NCT02073747|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111191674|NCT02073747|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111191675|NCT02073747|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111191676|NCT02073747|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111191677|NCT02073747|Adrenergic Agents|adrenergic agents|mesh-ancestor
111191678|NCT02073747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111191679|NCT02073747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111191680|NCT01465659|Temozolomide|temozolomide|mesh-list
111191681|NCT01465659|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111191682|NCT01465659|Alkylating Agents|alkylating agents|mesh-ancestor
111191683|NCT01465659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111191684|NCT01465659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111191685|NCT01462929|Bromides|bromides|mesh-list
111191686|NCT01462929|Tiotropium Bromide|tiotropium bromide|mesh-list
111191687|NCT01462929|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111191688|NCT01462929|Autonomic Agents|autonomic agents|mesh-ancestor
111191689|NCT01462929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111191690|NCT01462929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111191691|NCT01462929|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111191692|NCT01462929|Respiratory System Agents|respiratory system agents|mesh-ancestor
111191693|NCT01462929|Parasympatholytics|parasympatholytics|mesh-ancestor
111191694|NCT01462929|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111191695|NCT01462929|Cholinergic Agents|cholinergic agents|mesh-ancestor
111191696|NCT01462929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111191697|NCT01462929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111191698|NCT01462929|Anticonvulsants|anticonvulsants|mesh-ancestor
111191699|NCT01462695|Sunitinib|sunitinib|mesh-list
111191700|NCT01462695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111191701|NCT01462695|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111191702|NCT01462695|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111191703|NCT01462695|Growth Substances|growth substances|mesh-ancestor
111191704|NCT01462695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111191705|NCT01462695|Growth Inhibitors|growth inhibitors|mesh-ancestor
111191706|NCT01462695|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111191707|NCT01462695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111191708|NCT01462695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111191709|NCT01465347|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
111191710|NCT01465347|Antioxidants|antioxidants|mesh-ancestor
111191711|NCT01465347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111191712|NCT01465347|Protective Agents|protective agents|mesh-ancestor
111191713|NCT01465347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111191714|NCT01465347|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
111191715|NCT01465347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111191716|NCT01465191|Morphine|morphine|mesh-list
111191717|NCT01465191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111191718|NCT01465191|Narcotics|narcotics|mesh-ancestor
111191719|NCT01465191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111191720|NCT01465191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111191721|NCT01465191|Analgesics|analgesics|mesh-ancestor
111191722|NCT01465191|Sensory System Agents|sensory system agents|mesh-ancestor
111191723|NCT01465191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111191724|NCT01519947|Epoetin Alfa|epoetin alfa|mesh-list
111191725|NCT01519947|Hematinics|hematinics|mesh-ancestor
111191726|NCT01462227|Naltrexone|naltrexone|mesh-list
111191727|NCT01462227|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111191728|NCT01462227|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111191729|NCT01462227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111191730|NCT01462227|Sensory System Agents|sensory system agents|mesh-ancestor
111191731|NCT01462227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111191732|NCT01464879|Testosterone|testosterone|mesh-list
111191733|NCT01464879|Androgens|androgens|mesh-ancestor
111191734|NCT01464879|Hormones|hormones|mesh-ancestor
111191735|NCT01464879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111191736|NCT01464879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111191737|NCT03026205|Cetylpyridinium|cetylpyridinium|mesh-list
111191738|NCT03026205|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111191739|NCT03026205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111191740|NCT01519791|Certolizumab Pegol|certolizumab pegol|mesh-list
111191741|NCT01519791|Methotrexate|methotrexate|mesh-list
111191742|NCT01519791|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111191743|NCT01519791|Abortifacient Agents|abortifacient agents|mesh-ancestor
111191744|NCT01519791|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111191745|NCT01519791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111191746|NCT01519791|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111191747|NCT01519791|Antimetabolites|antimetabolites|mesh-ancestor
111191748|NCT01519791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111191749|NCT01519791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111191750|NCT01519791|Dermatologic Agents|dermatologic agents|mesh-ancestor
111191751|NCT01519791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111191752|NCT01519791|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111191753|NCT01519791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111191754|NCT01519791|Immunologic Factors|immunologic factors|mesh-ancestor
111191755|NCT01519791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111191756|NCT01519791|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111191757|NCT01519791|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111191758|NCT01519791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111191759|NCT01439373|Interferons|interferons|mesh-list
111191760|NCT01439373|Ribavirin|ribavirin|mesh-list
111191761|NCT01439373|Interferon-alpha|interferon-alpha|mesh-list
111191762|NCT01439373|Interferon alpha-2|interferon alpha-2|mesh-list
111191763|NCT01439373|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
111191764|NCT01439373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111191765|NCT01439373|Antiviral Agents|antiviral agents|mesh-ancestor
111191766|NCT01439373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111191767|NCT01439373|Antimetabolites|antimetabolites|mesh-ancestor
111191768|NCT01439373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111191769|NCT01439373|Immunologic Factors|immunologic factors|mesh-ancestor
111191770|NCT01439373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111191771|NCT01461369|Diclofenac|diclofenac|mesh-list
111191772|NCT01461369|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111191773|NCT01461369|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111191774|NCT01461369|Analgesics|analgesics|mesh-ancestor
111191775|NCT01461369|Sensory System Agents|sensory system agents|mesh-ancestor
111191776|NCT01461369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111191777|NCT01461369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111191778|NCT01461369|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111191779|NCT01461369|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111191780|NCT01461369|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111191781|NCT01461369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111191782|NCT01461369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111191783|NCT01727258|Fluorides|fluorides|mesh-list
111191784|NCT01727258|Cariostatic Agents|cariostatic agents|mesh-ancestor
111191785|NCT01727258|Protective Agents|protective agents|mesh-ancestor
111191786|NCT01727258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111191787|NCT01781234|Insulin|insulin|mesh-list
111191788|NCT01781234|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110562815|NCT00651443|Galiximab|galiximab|mesh-list
111191789|NCT01781234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111191791|NCT01752842|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111191792|NCT01752842|Antimetabolites|antimetabolites|mesh-ancestor
111191793|NCT01752842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111191794|NCT01752842|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111191795|NCT01461057|Capecitabine|capecitabine|mesh-list
111191796|NCT01461057|Trastuzumab|trastuzumab|mesh-list
111191797|NCT01461057|Pertuzumab|pertuzumab|mesh-list
111191798|NCT01461057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111191799|NCT01461057|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111191800|NCT01461057|Antimetabolites|antimetabolites|mesh-ancestor
111191801|NCT01461057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111191802|NCT01461057|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111191803|NCT04567407|Ropivacaine|ropivacaine|mesh-list
111191804|NCT04567407|Anesthetics, Local|anesthetics, local|mesh-ancestor
111191805|NCT04567407|Anesthetics|anesthetics|mesh-ancestor
111191806|NCT04567407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111191807|NCT04567407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111191808|NCT04567407|Sensory System Agents|sensory system agents|mesh-ancestor
111191809|NCT04567407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111191810|NCT01519635|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
111191811|NCT01519635|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111191812|NCT01519635|Diuretics|diuretics|mesh-ancestor
111191813|NCT01519635|Natriuretic Agents|natriuretic agents|mesh-ancestor
111191814|NCT01519635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111191815|NCT01519635|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
111191816|NCT01519635|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111191817|NCT01519635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111191818|NCT01519323|Vemurafenib|vemurafenib|mesh-list
111191819|NCT01519323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111191820|NCT01519323|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111191821|NCT01519323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111191822|NCT01519323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111191823|NCT01519245|Tranexamic Acid|tranexamic acid|mesh-list
111191824|NCT01519245|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111191825|NCT01519245|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111191826|NCT01519245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111191827|NCT01519245|Hemostatics|hemostatics|mesh-ancestor
111191828|NCT01519245|Coagulants|coagulants|mesh-ancestor
111191829|NCT01519167|Fentanyl|fentanyl|mesh-list
111191830|NCT01519167|Midazolam|midazolam|mesh-list
111191831|NCT01519167|Dexmedetomidine|dexmedetomidine|mesh-list
111191832|NCT01519167|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111191833|NCT01519167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111191834|NCT01519167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111191835|NCT01519167|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111191836|NCT01519167|Analgesics|analgesics|mesh-ancestor
111191837|NCT01519167|Sensory System Agents|sensory system agents|mesh-ancestor
111191838|NCT01519167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111191839|NCT01519167|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111191840|NCT01519167|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111191841|NCT01519167|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111191842|NCT01519167|Adrenergic Agents|adrenergic agents|mesh-ancestor
111191843|NCT01519167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111191844|NCT01519167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111191845|NCT01519167|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111191846|NCT01519167|Narcotics|narcotics|mesh-ancestor
111191847|NCT01519167|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110490672|NCT01667744|Serotonin Agents|serotonin agents|mesh-ancestor
111191848|NCT01519167|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111191849|NCT01519167|Anesthetics, General|anesthetics, general|mesh-ancestor
111191850|NCT01519167|Anesthetics|anesthetics|mesh-ancestor
110845231|NCT05666765|Silymarin|silymarin|mesh-list
111191851|NCT01519167|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111191852|NCT01519167|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111191853|NCT01519167|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111191854|NCT01519167|GABA Modulators|gaba modulators|mesh-ancestor
111191855|NCT01519167|GABA Agents|gaba agents|mesh-ancestor
111191857|NCT00318136|Bevacizumab|bevacizumab|mesh-list
111191858|NCT00318136|Carboplatin|carboplatin|mesh-list
111191859|NCT00318136|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111191860|NCT00318136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111191861|NCT00318136|Tubulin Modulators|tubulin modulators|mesh-ancestor
111191862|NCT00318136|Antimitotic Agents|antimitotic agents|mesh-ancestor
111191863|NCT00318136|Mitosis Modulators|mitosis modulators|mesh-ancestor
111191864|NCT00318136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111191865|NCT00318136|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111191866|NCT00318136|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111191867|NCT00318136|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111191868|NCT00318136|Growth Substances|growth substances|mesh-ancestor
111191869|NCT00318136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111191870|NCT00318136|Growth Inhibitors|growth inhibitors|mesh-ancestor
111191871|NCT00318292|Epinephrine|epinephrine|mesh-list
111191872|NCT00318292|Bupivacaine|bupivacaine|mesh-list
111191873|NCT00318292|Anesthetics, Local|anesthetics, local|mesh-ancestor
111191874|NCT00318292|Anesthetics|anesthetics|mesh-ancestor
111191875|NCT00318292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111191876|NCT00318292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111191877|NCT00318292|Sensory System Agents|sensory system agents|mesh-ancestor
111191878|NCT00318292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111191879|NCT00318292|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111191880|NCT00318292|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111191881|NCT00318292|Adrenergic Agents|adrenergic agents|mesh-ancestor
111191882|NCT00318292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111191883|NCT00318292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111191884|NCT00318292|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111191885|NCT00318292|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111191886|NCT00318292|Autonomic Agents|autonomic agents|mesh-ancestor
111191887|NCT00318292|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111191888|NCT00318292|Respiratory System Agents|respiratory system agents|mesh-ancestor
111191889|NCT00318292|Mydriatics|mydriatics|mesh-ancestor
111191890|NCT00318292|Sympathomimetics|sympathomimetics|mesh-ancestor
111191891|NCT00318292|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111191892|NCT01791868|Valproic Acid|valproic acid|mesh-list
111191893|NCT01791868|Anticonvulsants|anticonvulsants|mesh-ancestor
111191894|NCT01791868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111191895|NCT01791868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111191896|NCT01791868|GABA Agents|gaba agents|mesh-ancestor
111191897|NCT01791868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111191898|NCT01791868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111191899|NCT01791868|Antimanic Agents|antimanic agents|mesh-ancestor
111191900|NCT01791868|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111191901|NCT01791868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111191902|NCT01791868|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111191903|NCT03793114|Cosyntropin|cosyntropin|mesh-list
111191904|NCT03793114|Hormones|hormones|mesh-ancestor
111191905|NCT03793114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111191906|NCT03793114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111191907|NCT00348946|Androgens|androgens|mesh-list
111191908|NCT00348946|Oxandrolone|oxandrolone|mesh-list
111191909|NCT00348946|Hormones|hormones|mesh-ancestor
111191910|NCT00348946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111191911|NCT00348946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111191912|NCT00348946|Anabolic Agents|anabolic agents|mesh-ancestor
111191913|NCT00349336|Bevacizumab|bevacizumab|mesh-list
111191914|NCT00349336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111191915|NCT00349336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111191916|NCT00349336|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111191917|NCT00349336|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111191918|NCT00349336|Growth Substances|growth substances|mesh-ancestor
111191919|NCT00349336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111191920|NCT00349336|Growth Inhibitors|growth inhibitors|mesh-ancestor
110845246|NCT01127256|Analgesics|analgesics|mesh-ancestor
111191921|NCT04751188|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
111191922|NCT04751188|Bezafibrate|bezafibrate|mesh-list
111191923|NCT04751188|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
111191924|NCT04751188|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111191925|NCT04751188|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111191926|NCT04751188|Antimetabolites|antimetabolites|mesh-ancestor
111191927|NCT04751188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111191928|NCT04751188|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111191929|NCT00352612|Clindamycin|clindamycin|mesh-list
111191930|NCT00352612|Clindamycin palmitate|clindamycin palmitate|mesh-list
111191931|NCT00352612|Clindamycin phosphate|clindamycin phosphate|mesh-list
111191933|NCT00352612|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111191934|NCT00352612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111191935|NCT00352612|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111191936|NCT00352612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111191937|NCT00352612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111191938|NCT00323362|Gemcitabine|gemcitabine|mesh-list
111191939|NCT00323362|Imatinib Mesylate|imatinib mesylate|mesh-list
111191940|NCT00323362|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111191941|NCT00323362|Antimetabolites|antimetabolites|mesh-ancestor
111191942|NCT00323362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111191943|NCT00323362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111191944|NCT00323362|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111191945|NCT00323362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111191946|NCT00390364|Everolimus|everolimus|mesh-list
111191947|NCT00390364|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
111191948|NCT00390364|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111191949|NCT00390364|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111191950|NCT00390364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111191951|NCT00390364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111191952|NCT00390364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111191953|NCT00390364|Immunologic Factors|immunologic factors|mesh-ancestor
111191954|NCT00390364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111191955|NCT00390364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111191956|NCT00354640|Anastrozole|anastrozole|mesh-list
111191957|NCT00354640|Simvastatin|simvastatin|mesh-list
111191958|NCT00354640|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111191959|NCT00354640|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111191960|NCT00354640|Antimetabolites|antimetabolites|mesh-ancestor
111191961|NCT00354640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111191962|NCT00354640|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111191963|NCT00354640|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111191964|NCT00354640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111191965|NCT00354640|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111191966|NCT00354640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111191967|NCT00354640|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111191968|NCT00354640|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111191969|NCT00354640|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111191970|NCT00354640|Hormone Antagonists|hormone antagonists|mesh-ancestor
111191971|NCT00354640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111191972|NCT00354640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111191973|NCT00392392|Paclitaxel|paclitaxel|mesh-list
111191974|NCT00392392|Bevacizumab|bevacizumab|mesh-list
111191975|NCT00392392|Trastuzumab|trastuzumab|mesh-list
111191976|NCT00392392|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111191977|NCT00392392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111191978|NCT00392392|Tubulin Modulators|tubulin modulators|mesh-ancestor
111191979|NCT00392392|Antimitotic Agents|antimitotic agents|mesh-ancestor
111191980|NCT00392392|Mitosis Modulators|mitosis modulators|mesh-ancestor
111191981|NCT00392392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111191982|NCT00392392|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111191983|NCT00392392|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111191984|NCT00392392|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111191985|NCT00392392|Growth Substances|growth substances|mesh-ancestor
111191986|NCT00392392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111191987|NCT00392392|Growth Inhibitors|growth inhibitors|mesh-ancestor
111191988|NCT01519089|Tofacitinib|tofacitinib|mesh-list
110030295|NCT01385228|Mitosis Modulators|mitosis modulators|mesh-ancestor
111191989|NCT01519089|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
111191990|NCT01519089|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111191991|NCT01519089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111191992|NCT01519089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111191994|NCT00392704|Bevacizumab|bevacizumab|mesh-list
111191995|NCT00392704|Fluorouracil|fluorouracil|mesh-list
111191996|NCT00392704|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111191997|NCT00392704|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111191998|NCT00392704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111191999|NCT00392704|Tubulin Modulators|tubulin modulators|mesh-ancestor
111192000|NCT00392704|Antimitotic Agents|antimitotic agents|mesh-ancestor
111192001|NCT00392704|Mitosis Modulators|mitosis modulators|mesh-ancestor
111192002|NCT00392704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111192003|NCT00392704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111192004|NCT00392704|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111192005|NCT00392704|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111192006|NCT00392704|Growth Substances|growth substances|mesh-ancestor
111192007|NCT00392704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111192008|NCT00392704|Growth Inhibitors|growth inhibitors|mesh-ancestor
111192009|NCT00392704|Antimetabolites|antimetabolites|mesh-ancestor
111192010|NCT00392704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111192011|NCT00392704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111192012|NCT00392704|Immunologic Factors|immunologic factors|mesh-ancestor
111192013|NCT00392704|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111192014|NCT00392704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111192015|NCT00392782|Fludarabine|fludarabine|mesh-list
111192016|NCT00392782|Fludarabine phosphate|fludarabine phosphate|mesh-list
111192017|NCT00392782|Thiotepa|thiotepa|mesh-list
111192018|NCT00392782|Antilymphocyte Serum|antilymphocyte serum|mesh-list
111192019|NCT00392782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111192020|NCT00392782|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111192021|NCT00392782|Antimetabolites|antimetabolites|mesh-ancestor
111192022|NCT00392782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111192023|NCT00392782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111192024|NCT00392782|Immunologic Factors|immunologic factors|mesh-ancestor
111192025|NCT00392782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111192026|NCT00392782|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111192027|NCT00392782|Alkylating Agents|alkylating agents|mesh-ancestor
111192028|NCT00392782|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111192029|NCT01518699|Moxifloxacin|moxifloxacin|mesh-list
111192030|NCT01518699|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
111192031|NCT01518699|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111192032|NCT01518699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111192033|NCT01518699|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111192034|NCT01518699|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111192035|NCT01518699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111192036|NCT01518699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111192037|NCT01518699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111192038|NCT01518699|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111192039|NCT01518699|Contraceptive Agents|contraceptive agents|mesh-ancestor
111192040|NCT01518699|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111192041|NCT01518699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111192042|NCT01518699|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
111192043|NCT01518699|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111192044|NCT01518699|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111192045|NCT01518309|Pimavanserin|pimavanserin|mesh-list
111192046|NCT01518309|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111192047|NCT01518309|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111192048|NCT01518309|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111192049|NCT01518309|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111192050|NCT01518309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111192051|NCT01518309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111192052|NCT01518309|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111192053|NCT01518309|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111192054|NCT01518309|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111192055|NCT01518309|Serotonin Agents|serotonin agents|mesh-ancestor
111192056|NCT01518309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111192057|NCT01518309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111192058|NCT01419717|Denosumab|denosumab|mesh-list
111192059|NCT01419717|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111192060|NCT01419717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111192061|NCT01458951|Tofacitinib|tofacitinib|mesh-list
111192062|NCT01458951|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
111192063|NCT01458951|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111192064|NCT01458951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111192065|NCT01458951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111192066|NCT01458639|Xenon|xenon|mesh-list
111192067|NCT01458639|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111192068|NCT01458639|Anesthetics, General|anesthetics, general|mesh-ancestor
111192069|NCT01458639|Anesthetics|anesthetics|mesh-ancestor
111192070|NCT01458639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111192071|NCT01458639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111192072|NCT00393796|Sunitinib|sunitinib|mesh-list
111192073|NCT00393796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111192074|NCT00393796|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111192075|NCT00393796|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111192076|NCT00393796|Growth Substances|growth substances|mesh-ancestor
111192077|NCT00393796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111192078|NCT00393796|Growth Inhibitors|growth inhibitors|mesh-ancestor
111192079|NCT00393796|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111192080|NCT00393796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111192081|NCT00393796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111192082|NCT00393874|Prazosin|prazosin|mesh-list
111192083|NCT00393874|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111192084|NCT00393874|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111192085|NCT00393874|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111192086|NCT00393874|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111192087|NCT00393874|Adrenergic Agents|adrenergic agents|mesh-ancestor
111192088|NCT00393874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111192089|NCT00393874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111192090|NCT00393874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111192091|NCT00394888|Dermatologic Agents|dermatologic agents|mesh-list
111192092|NCT01458171|Immunoglobulins|immunoglobulins|mesh-list
111192093|NCT01458171|Antibodies|antibodies|mesh-list
111192094|NCT01458171|gamma-Globulins|gamma-globulins|mesh-list
111192095|NCT01458171|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111192096|NCT01458171|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
111192097|NCT01458171|Immunologic Factors|immunologic factors|mesh-ancestor
111192098|NCT01458171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111192099|NCT00395044|Gabapentin|gabapentin|mesh-list
111192100|NCT00395044|Analgesics|analgesics|mesh-ancestor
111192101|NCT00395044|Sensory System Agents|sensory system agents|mesh-ancestor
110490706|NCT00694369|Antipyretics|antipyretics|mesh-ancestor
111192102|NCT00395044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111192103|NCT00395044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111192104|NCT00395044|Anticonvulsants|anticonvulsants|mesh-ancestor
111192105|NCT00395044|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111192106|NCT00395044|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111192107|NCT00395044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111192108|NCT00395044|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111192109|NCT00395044|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111192110|NCT00395044|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110845272|NCT03377842|Vitamins|vitamins|mesh-ancestor
111192111|NCT00395044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111192112|NCT00395044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111192113|NCT00395044|Antimanic Agents|antimanic agents|mesh-ancestor
111192114|NCT01457703|Letrozole|letrozole|mesh-list
111192115|NCT01457703|Cetrorelix|cetrorelix|mesh-list
111192116|NCT01457703|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
111192117|NCT01457703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111192118|NCT01457703|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111192119|NCT01457703|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111192120|NCT01457703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111192121|NCT01457703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111192122|NCT01457703|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111192123|NCT01457703|Hormone Antagonists|hormone antagonists|mesh-ancestor
111192124|NCT01457703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111192125|NCT01457703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111192126|NCT01457703|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111192127|NCT01457703|Fertility Agents|fertility agents|mesh-ancestor
111192128|NCT01457703|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111192129|NCT01457703|Hormones|hormones|mesh-ancestor
111192130|NCT02076321|Acetaminophen|acetaminophen|mesh-list
111192131|NCT02076321|Ibuprofen|ibuprofen|mesh-list
111192132|NCT02076321|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111192133|NCT02076321|Analgesics|analgesics|mesh-ancestor
111192134|NCT02076321|Sensory System Agents|sensory system agents|mesh-ancestor
111192135|NCT02076321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111192136|NCT02076321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111192137|NCT02076321|Antipyretics|antipyretics|mesh-ancestor
111192138|NCT02076321|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111192139|NCT02076321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111192140|NCT02076321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111192141|NCT02076321|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111192142|NCT02076321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111192143|NCT02076321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111192144|NCT00358462|Azithromycin|azithromycin|mesh-list
110490720|NCT00745693|BQ 788|bq 788|mesh-list
111192145|NCT00358462|Doxycycline|doxycycline|mesh-list
111192146|NCT00358462|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111192147|NCT00358462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111192148|NCT00358462|Antimalarials|antimalarials|mesh-ancestor
111192149|NCT00358462|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111192150|NCT00358462|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111192151|NCT01437267|Vaccines|vaccines|mesh-list
111192152|NCT01437267|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
111192153|NCT01437267|Immunologic Factors|immunologic factors|mesh-ancestor
111192154|NCT01437267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111192155|NCT01437111|Vitamin D|vitamin d|mesh-list
111192156|NCT01437111|Cholecalciferol|cholecalciferol|mesh-list
111192157|NCT01437111|Alendronate|alendronate|mesh-list
111192158|NCT01437111|Vitamins|vitamins|mesh-ancestor
111192159|NCT01437111|Micronutrients|micronutrients|mesh-ancestor
111192160|NCT01437111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111192161|NCT01437111|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110845280|NCT04757337|Immunologic Factors|immunologic factors|mesh-ancestor
111192162|NCT01437111|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111192163|NCT04065555|Cetuximab|cetuximab|mesh-list
111192164|NCT04065555|Avelumab|avelumab|mesh-list
111192165|NCT04065555|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111192166|NCT04065555|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111192167|NCT04065555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111192168|NCT04065555|Immunologic Factors|immunologic factors|mesh-ancestor
111192169|NCT04065555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111192170|NCT00360724|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
111192171|NCT00360724|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111192172|NCT00360724|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111192173|NCT00360724|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111192174|NCT00360724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111192175|NCT00360724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111192176|NCT00360724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111192177|NCT00360724|Analgesics|analgesics|mesh-ancestor
111192178|NCT00360724|Sensory System Agents|sensory system agents|mesh-ancestor
111192179|NCT00360724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111192180|NCT00360724|Antidepressive Agents|antidepressive agents|mesh-ancestor
111192181|NCT00360724|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111192182|NCT00360724|Dopamine Agents|dopamine agents|mesh-ancestor
111192183|NCT00398398|Capecitabine|capecitabine|mesh-list
111192184|NCT00398398|Oxaliplatin|oxaliplatin|mesh-list
111192185|NCT00398398|Cetuximab|cetuximab|mesh-list
111192186|NCT00398398|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111192187|NCT00398398|Antimetabolites|antimetabolites|mesh-ancestor
111192188|NCT00398398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111192189|NCT00398398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110490763|NCT00954512|Leucovorin|leucovorin|mesh-list
111192190|NCT00398398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111192191|NCT00398476|Fluticasone|fluticasone|mesh-list
111192193|NCT00398476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111192194|NCT00398476|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111192195|NCT00398476|Autonomic Agents|autonomic agents|mesh-ancestor
111192196|NCT00398476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111192197|NCT00398476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111192198|NCT00398476|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111192199|NCT00398476|Respiratory System Agents|respiratory system agents|mesh-ancestor
111192200|NCT00398476|Dermatologic Agents|dermatologic agents|mesh-ancestor
111192201|NCT00398476|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111192202|NCT01436643|Fluoxetine|fluoxetine|mesh-list
111192203|NCT01436643|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
111192204|NCT01436643|Citalopram|citalopram|mesh-list
111192205|NCT01436643|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
111192206|NCT01436643|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111192207|NCT01436643|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111192208|NCT01436643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111192209|NCT01436643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111192210|NCT01436643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111192211|NCT01436643|Serotonin Agents|serotonin agents|mesh-ancestor
111192212|NCT01436643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111192213|NCT01436643|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111192214|NCT01436643|Antidepressive Agents|antidepressive agents|mesh-ancestor
111192215|NCT01436643|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111192216|NCT01436643|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111192217|NCT01436643|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111192218|NCT01436643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111192219|NCT01436643|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111192220|NCT01436643|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
111192221|NCT01436643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111192222|NCT01436643|Immunologic Factors|immunologic factors|mesh-ancestor
111192223|NCT00361972|Lansoprazole|lansoprazole|mesh-list
111192224|NCT00361972|Dexlansoprazole|dexlansoprazole|mesh-list
111192225|NCT00361972|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111192226|NCT00361972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111192227|NCT00361972|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111192228|NCT00361972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111192229|NCT00361972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111192230|NCT00362440|Metformin|metformin|mesh-list
111192231|NCT00362440|Pioglitazone|pioglitazone|mesh-list
111192232|NCT00362440|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111192233|NCT00362440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111192234|NCT02109640|Oxycodone|oxycodone|mesh-list
111192235|NCT02109640|Naloxone|naloxone|mesh-list
111192236|NCT02109640|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111192237|NCT02109640|Narcotics|narcotics|mesh-ancestor
111192238|NCT02109640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111192239|NCT02109640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111192240|NCT02109640|Analgesics|analgesics|mesh-ancestor
111192241|NCT02109640|Sensory System Agents|sensory system agents|mesh-ancestor
111192242|NCT02109640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111192243|NCT02109640|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111192244|NCT01454739|Factor VIII|factor viii|mesh-list
111192245|NCT01454739|Coagulants|coagulants|mesh-ancestor
111192246|NCT00366106|Dexamethasone|dexamethasone|mesh-list
111192247|NCT00366106|Doxorubicin|doxorubicin|mesh-list
111192248|NCT00366106|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111192249|NCT00366106|Bortezomib|bortezomib|mesh-list
111192250|NCT00366106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111192251|NCT00366106|Antiemetics|antiemetics|mesh-ancestor
111192252|NCT00366106|Autonomic Agents|autonomic agents|mesh-ancestor
111192253|NCT00366106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111192254|NCT00366106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111192255|NCT00366106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111192256|NCT00366106|Glucocorticoids|glucocorticoids|mesh-ancestor
111192257|NCT00366106|Hormones|hormones|mesh-ancestor
111192258|NCT00366106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111192259|NCT00366106|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111192260|NCT00366106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111192261|NCT00366106|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111192262|NCT00366106|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111192263|NCT00366106|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111192264|NCT00366106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111192265|NCT00366106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111192266|NCT00368290|Modafinil|modafinil|mesh-list
111192267|NCT00368290|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111192268|NCT00368290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111192269|NCT00368290|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
111192270|NCT00368290|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111192271|NCT00368290|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111192272|NCT00368290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111192273|NCT00369226|Methotrexate|methotrexate|mesh-list
111192274|NCT00369226|Bortezomib|bortezomib|mesh-list
111192275|NCT00369226|Tacrolimus|tacrolimus|mesh-list
111192276|NCT00369226|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111192277|NCT00369226|Abortifacient Agents|abortifacient agents|mesh-ancestor
111192278|NCT00369226|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111192279|NCT00369226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111192280|NCT00369226|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111192281|NCT00369226|Antimetabolites|antimetabolites|mesh-ancestor
111192282|NCT00369226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111192283|NCT00369226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111192284|NCT00369226|Dermatologic Agents|dermatologic agents|mesh-ancestor
111192285|NCT00369226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111192286|NCT00369226|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111192287|NCT00369226|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111192288|NCT00369226|Immunologic Factors|immunologic factors|mesh-ancestor
111192289|NCT00369226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110622502|NCT00537238|Pregabalin|pregabalin|mesh-list
111192290|NCT00369226|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111192291|NCT00369226|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111192293|NCT01416441|Antidepressive Agents|antidepressive agents|mesh-ancestor
111192294|NCT01416441|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111192295|NCT01416441|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111192296|NCT01416441|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111192297|NCT01416441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111192298|NCT01416441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111192299|NCT01416441|Dopamine Agonists|dopamine agonists|mesh-ancestor
111192300|NCT01416441|Dopamine Agents|dopamine agents|mesh-ancestor
111192301|NCT01416441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111192302|NCT01416441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111192303|NCT01416441|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111192304|NCT01416441|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111192305|NCT01416441|Serotonin Agents|serotonin agents|mesh-ancestor
111192306|NCT01416441|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111192307|NCT01416441|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111192308|NCT01416441|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111192309|NCT01416441|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111192311|NCT00406276|Everolimus|everolimus|mesh-list
111192312|NCT00406276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111192313|NCT00406276|Tubulin Modulators|tubulin modulators|mesh-ancestor
111192314|NCT00406276|Antimitotic Agents|antimitotic agents|mesh-ancestor
111192315|NCT00406276|Mitosis Modulators|mitosis modulators|mesh-ancestor
111192316|NCT00406276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111192317|NCT00406276|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111192318|NCT00406276|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111192319|NCT00406276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111192320|NCT00406276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111192321|NCT00406276|Immunologic Factors|immunologic factors|mesh-ancestor
111192322|NCT00406276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111192323|NCT00408070|Paclitaxel|paclitaxel|mesh-list
111192324|NCT00408070|Bevacizumab|bevacizumab|mesh-list
111192325|NCT00408070|Carboplatin|carboplatin|mesh-list
111192326|NCT00408070|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111192327|NCT00408070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111192328|NCT00408070|Tubulin Modulators|tubulin modulators|mesh-ancestor
111192329|NCT00408070|Antimitotic Agents|antimitotic agents|mesh-ancestor
111192330|NCT00408070|Mitosis Modulators|mitosis modulators|mesh-ancestor
111192331|NCT00408070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111192332|NCT00408070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111192333|NCT00408070|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111192334|NCT00408070|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111192335|NCT00408070|Growth Substances|growth substances|mesh-ancestor
111192336|NCT00408070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111192337|NCT00408070|Growth Inhibitors|growth inhibitors|mesh-ancestor
111192338|NCT00408460|Paclitaxel|paclitaxel|mesh-list
111192339|NCT00408460|Imatinib Mesylate|imatinib mesylate|mesh-list
111192340|NCT00408460|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111192341|NCT00408460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111192342|NCT00408460|Tubulin Modulators|tubulin modulators|mesh-ancestor
111192343|NCT00408460|Antimitotic Agents|antimitotic agents|mesh-ancestor
111192344|NCT00408460|Mitosis Modulators|mitosis modulators|mesh-ancestor
111192345|NCT00408460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111192346|NCT00408460|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111192347|NCT00408460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111192348|NCT02111200|Sodium Benzoate|sodium benzoate|mesh-list
111192349|NCT02111200|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
111192350|NCT02111200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111192351|NCT02111200|Antifungal Agents|antifungal agents|mesh-ancestor
111192352|NCT02111200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111192353|NCT02111746|Bupivacaine|bupivacaine|mesh-list
111192354|NCT02111746|Anesthetics, Local|anesthetics, local|mesh-ancestor
111192355|NCT02111746|Anesthetics|anesthetics|mesh-ancestor
111192356|NCT02111746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111192357|NCT02111746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111192358|NCT02111746|Sensory System Agents|sensory system agents|mesh-ancestor
111192359|NCT02111746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111192360|NCT01793272|Pentoxifylline|pentoxifylline|mesh-list
111192361|NCT01793272|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111192362|NCT01793272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111192363|NCT01793272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111192364|NCT01793272|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111192365|NCT01793272|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111192366|NCT01793272|Protective Agents|protective agents|mesh-ancestor
111192367|NCT01793272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111192368|NCT01793272|Vasodilator Agents|vasodilator agents|mesh-ancestor
111192369|NCT01793272|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111192371|NCT00410488|Dexamethasone|dexamethasone|mesh-list
111192372|NCT00410488|Dexamethasone acetate|dexamethasone acetate|mesh-list
111192373|NCT00410488|Doxorubicin|doxorubicin|mesh-list
111192374|NCT00410488|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111192375|NCT00410488|Vincristine|vincristine|mesh-list
111192376|NCT00410488|Ifosfamide|ifosfamide|mesh-list
111192377|NCT00410488|Dexrazoxane|dexrazoxane|mesh-list
111192378|NCT00410488|Palonosetron|palonosetron|mesh-list
111192379|NCT00410488|BB 1101|bb 1101|mesh-list
111192380|NCT00410488|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111192381|NCT00410488|Antiemetics|antiemetics|mesh-ancestor
111192382|NCT00410488|Autonomic Agents|autonomic agents|mesh-ancestor
111192383|NCT00410488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111192384|NCT00410488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111192385|NCT00410488|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111192386|NCT00410488|Glucocorticoids|glucocorticoids|mesh-ancestor
111192387|NCT00410488|Hormones|hormones|mesh-ancestor
111192388|NCT00410488|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111192389|NCT00410488|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111192390|NCT00410488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111192391|NCT00410488|Protease Inhibitors|protease inhibitors|mesh-ancestor
111192392|NCT00410488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111192393|NCT00410488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111192394|NCT00410488|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111192395|NCT00410488|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111192396|NCT00410488|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111192397|NCT00410488|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111192398|NCT00410488|Tubulin Modulators|tubulin modulators|mesh-ancestor
111192399|NCT00410488|Antimitotic Agents|antimitotic agents|mesh-ancestor
111192400|NCT00410488|Mitosis Modulators|mitosis modulators|mesh-ancestor
111192401|NCT00410488|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111192402|NCT00410488|Alkylating Agents|alkylating agents|mesh-ancestor
111192403|NCT00410488|Protective Agents|protective agents|mesh-ancestor
111192404|NCT00410488|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111192405|NCT00410488|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111192406|NCT00410488|Serotonin Agents|serotonin agents|mesh-ancestor
111192407|NCT00410488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111192408|NCT00410488|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111192409|NCT01793350|Benphothiamine|benphothiamine|mesh-list
111192410|NCT01793350|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111192411|NCT01793350|Immunologic Factors|immunologic factors|mesh-ancestor
111192412|NCT01793350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111192413|NCT01793350|Chelating Agents|chelating agents|mesh-ancestor
111192414|NCT01793350|Sequestering Agents|sequestering agents|mesh-ancestor
111192415|NCT01793350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111192416|NCT00416494|Bevacizumab|bevacizumab|mesh-list
111192417|NCT00416494|Capecitabine|capecitabine|mesh-list
111192418|NCT00416494|Oxaliplatin|oxaliplatin|mesh-list
111192419|NCT00416494|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111192420|NCT00416494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111192421|NCT00416494|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111192422|NCT00416494|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111192423|NCT00416494|Growth Substances|growth substances|mesh-ancestor
111192424|NCT00416494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111192425|NCT00416494|Growth Inhibitors|growth inhibitors|mesh-ancestor
111192426|NCT00416494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111192427|NCT00416494|Antimetabolites|antimetabolites|mesh-ancestor
111192428|NCT00416494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111192429|NCT00417274|Quinacrine|quinacrine|mesh-list
111192430|NCT00417274|Anticestodal Agents|anticestodal agents|mesh-ancestor
111192431|NCT00417274|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
111192432|NCT00417274|Anthelmintics|anthelmintics|mesh-ancestor
111192433|NCT00417274|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111192434|NCT00417274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111192435|NCT00417274|Antimalarials|antimalarials|mesh-ancestor
111192436|NCT00417274|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111192437|NCT00417274|Antinematodal Agents|antinematodal agents|mesh-ancestor
111192438|NCT00417274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111192439|NCT00417274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111192440|NCT00417274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111192441|NCT04749940|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
111192443|NCT04749940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111192444|NCT05286346|Tenofovir|tenofovir|mesh-list
111192445|NCT05286346|Antiviral Agents|antiviral agents|mesh-ancestor
111192446|NCT05286346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111192447|NCT05286346|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111192448|NCT05286346|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111192449|NCT05286346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111192450|NCT05286346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111192451|NCT05286346|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111192452|NCT05286346|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111192453|NCT05286268|Plasminogen|plasminogen|mesh-list
111192454|NCT05286268|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111192455|NCT05286268|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111192456|NCT05286268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111192457|NCT00422032|Clofarabine|clofarabine|mesh-list
111192458|NCT00422032|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111192459|NCT00422032|Antimetabolites|antimetabolites|mesh-ancestor
111192460|NCT00422032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111192461|NCT00422032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111192462|NCT01388920|Tesamorelin|tesamorelin|mesh-list
111192463|NCT01388920|Growth Substances|growth substances|mesh-ancestor
111192464|NCT01388920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111192465|NCT00423358|Vitamin D|vitamin d|mesh-list
111192466|NCT00423358|Ergocalciferols|ergocalciferols|mesh-list
111192467|NCT00423358|Vitamins|vitamins|mesh-ancestor
111192468|NCT00423358|Micronutrients|micronutrients|mesh-ancestor
111192469|NCT00423358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111192470|NCT00423358|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111192471|NCT00423358|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111192472|NCT00424840|Bevacizumab|bevacizumab|mesh-list
111192473|NCT00424840|Carboplatin|carboplatin|mesh-list
111192474|NCT00424840|Bortezomib|bortezomib|mesh-list
111192475|NCT00424840|Docetaxel|docetaxel|mesh-list
111192476|NCT00424840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111192477|NCT00424840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111192478|NCT00424840|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111192479|NCT00424840|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111192480|NCT00424840|Growth Substances|growth substances|mesh-ancestor
111192481|NCT00424840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111192482|NCT00424840|Growth Inhibitors|growth inhibitors|mesh-ancestor
111192483|NCT00424840|Tubulin Modulators|tubulin modulators|mesh-ancestor
111192484|NCT00424840|Antimitotic Agents|antimitotic agents|mesh-ancestor
111192485|NCT00424840|Mitosis Modulators|mitosis modulators|mesh-ancestor
111192486|NCT00424840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111192487|NCT00425386|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111192488|NCT00425386|Sunitinib|sunitinib|mesh-list
111192489|NCT00425386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111192490|NCT00425386|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111192491|NCT00425386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111192492|NCT00425386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111192493|NCT00425386|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111192494|NCT00425386|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111192495|NCT00425386|Growth Substances|growth substances|mesh-ancestor
111192496|NCT00425386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111192497|NCT00425386|Growth Inhibitors|growth inhibitors|mesh-ancestor
111192498|NCT01164202|Sunitinib|sunitinib|mesh-list
111192499|NCT01164202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111192500|NCT01164202|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111192501|NCT01164202|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111192502|NCT01164202|Growth Substances|growth substances|mesh-ancestor
111192503|NCT01164202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111192504|NCT01164202|Growth Inhibitors|growth inhibitors|mesh-ancestor
111192505|NCT01164202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111192506|NCT01164202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111192507|NCT01164202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111192509|NCT02112370|Racepinephrine|racepinephrine|mesh-list
111192510|NCT02112370|Ropivacaine|ropivacaine|mesh-list
111192511|NCT02112370|Epinephryl borate|epinephryl borate|mesh-list
111192512|NCT02112370|Anesthetics, Local|anesthetics, local|mesh-ancestor
111192513|NCT02112370|Anesthetics|anesthetics|mesh-ancestor
111192514|NCT02112370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111192515|NCT02112370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111192516|NCT02112370|Sensory System Agents|sensory system agents|mesh-ancestor
111192517|NCT02112370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111192518|NCT02112370|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111192519|NCT02112370|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111192520|NCT02112370|Adrenergic Agents|adrenergic agents|mesh-ancestor
111192521|NCT02112370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110490820|NCT00691015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111192522|NCT02112370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111192523|NCT02112370|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111192524|NCT02112370|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111192525|NCT02112370|Autonomic Agents|autonomic agents|mesh-ancestor
111192526|NCT02112370|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111192527|NCT02112370|Respiratory System Agents|respiratory system agents|mesh-ancestor
111192528|NCT02112370|Mydriatics|mydriatics|mesh-ancestor
111192529|NCT02112370|Sympathomimetics|sympathomimetics|mesh-ancestor
111192530|NCT02112370|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111192531|NCT00427336|Cyclophosphamide|cyclophosphamide|mesh-list
111192532|NCT00427336|Fludarabine|fludarabine|mesh-list
111192533|NCT00427336|Fludarabine phosphate|fludarabine phosphate|mesh-list
111192534|NCT00427336|Thymoglobulin|thymoglobulin|mesh-list
111192535|NCT00427336|Antilymphocyte Serum|antilymphocyte serum|mesh-list
111192536|NCT00427336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111192537|NCT00427336|Immunologic Factors|immunologic factors|mesh-ancestor
111192538|NCT00427336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111192539|NCT00427336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111192540|NCT00427336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111192541|NCT00427336|Alkylating Agents|alkylating agents|mesh-ancestor
111192542|NCT00427336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111192543|NCT00427336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111192544|NCT00427336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111192545|NCT00427336|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111192546|NCT00427336|Antimetabolites|antimetabolites|mesh-ancestor
111192547|NCT00371176|Cycloserine|cycloserine|mesh-list
111192548|NCT00371176|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111192549|NCT00371176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111192550|NCT00371176|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111192551|NCT00371176|Antitubercular Agents|antitubercular agents|mesh-ancestor
111192552|NCT00371176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111192553|NCT00371176|Antimetabolites|antimetabolites|mesh-ancestor
111192554|NCT00371176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111192555|NCT00428584|Interferons|interferons|mesh-list
111192557|NCT00428584|Interferon beta-1a|interferon beta-1a|mesh-list
111192558|NCT00428584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111192559|NCT00428584|Antiviral Agents|antiviral agents|mesh-ancestor
111192560|NCT00428584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111192561|NCT00428584|Immunologic Factors|immunologic factors|mesh-ancestor
111192562|NCT00428584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111192563|NCT00428584|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111192564|NCT05187286|Apixaban|apixaban|mesh-list
111192565|NCT05187286|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111192566|NCT05187286|Antithrombins|antithrombins|mesh-ancestor
111192567|NCT05187286|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111192568|NCT05187286|Protease Inhibitors|protease inhibitors|mesh-ancestor
111192569|NCT05187286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111192570|NCT05187286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111192571|NCT05187286|Anticoagulants|anticoagulants|mesh-ancestor
111192572|NCT00372970|Botulinum Toxins|botulinum toxins|mesh-list
111192573|NCT00372970|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111192574|NCT00372970|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111192575|NCT00372970|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111192576|NCT00372970|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111192577|NCT00372970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111192578|NCT00372970|Cholinergic Agents|cholinergic agents|mesh-ancestor
111192579|NCT00372970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111192580|NCT00372970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111192581|NCT00372970|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111192582|NCT00372970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111192583|NCT00373360|Treprostinil|treprostinil|mesh-list
111192584|NCT00373360|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111192585|NCT00455650|Mecamylamine|mecamylamine|mesh-list
111192586|NCT00455650|Varenicline|varenicline|mesh-list
111192587|NCT00455650|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111192588|NCT00455650|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111192589|NCT00455650|Cholinergic Agents|cholinergic agents|mesh-ancestor
111192590|NCT00455650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111192591|NCT00455650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111192592|NCT00455650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111192593|NCT00455650|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111192594|NCT00455650|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
111192595|NCT00455650|Autonomic Agents|autonomic agents|mesh-ancestor
111192596|NCT00455650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111192597|NCT00455650|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
111192598|NCT00455650|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111192599|NCT00431626|Dutasteride|dutasteride|mesh-list
111192600|NCT00431626|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
111192601|NCT00431626|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111192602|NCT00431626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111192603|NCT00431626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111192604|NCT00431626|Hormone Antagonists|hormone antagonists|mesh-ancestor
111192605|NCT00431626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111192606|NCT00431626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111192607|NCT00455962|Estradiol|estradiol|mesh-list
111192608|NCT00455962|Progesterone|progesterone|mesh-list
111192609|NCT00455962|Estrogens|estrogens|mesh-ancestor
111192610|NCT00455962|Hormones|hormones|mesh-ancestor
111192611|NCT00455962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111192612|NCT00455962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111192613|NCT00455962|Progestins|progestins|mesh-ancestor
111192614|NCT00434356|Paclitaxel|paclitaxel|mesh-list
111192615|NCT00434356|Bevacizumab|bevacizumab|mesh-list
111192616|NCT00434356|Sunitinib|sunitinib|mesh-list
111192617|NCT00434356|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111192618|NCT00434356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111192619|NCT00434356|Tubulin Modulators|tubulin modulators|mesh-ancestor
111192620|NCT00434356|Antimitotic Agents|antimitotic agents|mesh-ancestor
111192621|NCT00434356|Mitosis Modulators|mitosis modulators|mesh-ancestor
111192622|NCT00434356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111192623|NCT00434356|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111192624|NCT00434356|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111192625|NCT00434356|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111192626|NCT00434356|Growth Substances|growth substances|mesh-ancestor
111192627|NCT00434356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111192628|NCT00434356|Growth Inhibitors|growth inhibitors|mesh-ancestor
111192629|NCT00434356|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111192630|NCT00434356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111192631|NCT00376948|Gemcitabine|gemcitabine|mesh-list
111192632|NCT00376948|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111192633|NCT00376948|Genistein|genistein|mesh-list
111192634|NCT00376948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111192635|NCT00376948|Antimetabolites|antimetabolites|mesh-ancestor
111192636|NCT00376948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111192637|NCT00376948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111192638|NCT00376948|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111192639|NCT00376948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111192640|NCT00376948|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
111192641|NCT00376948|Protective Agents|protective agents|mesh-ancestor
111192642|NCT00376948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111192643|NCT00376948|Phytoestrogens|phytoestrogens|mesh-ancestor
111192644|NCT00376948|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
111192645|NCT00376948|Estrogens|estrogens|mesh-ancestor
111192646|NCT00376948|Hormones|hormones|mesh-ancestor
111192647|NCT00376948|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111192648|NCT03396874|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
111192649|NCT03396874|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111192650|NCT03396874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111192651|NCT00438100|Capecitabine|capecitabine|mesh-list
111192652|NCT00438100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111192653|NCT00438100|Antimetabolites|antimetabolites|mesh-ancestor
111192654|NCT00438100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111192655|NCT00438100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111192656|NCT00456508|Ecallantide|ecallantide|mesh-list
111192657|NCT00456508|Analgesics|analgesics|mesh-ancestor
111192658|NCT00456508|Sensory System Agents|sensory system agents|mesh-ancestor
111192659|NCT00456508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111192660|NCT00456508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111192661|NCT00456508|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111192662|NCT00456508|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111192663|NCT00456508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111192664|NCT00456508|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111192665|NCT00457366|Lorazepam|lorazepam|mesh-list
111192666|NCT00457366|Haloperidol|haloperidol|mesh-list
111192667|NCT00457366|Benztropine|benztropine|mesh-list
111192668|NCT00457366|Quetiapine Fumarate|quetiapine fumarate|mesh-list
111192669|NCT00457366|Haloperidol decanoate|haloperidol decanoate|mesh-list
111192670|NCT00457366|Antidepressive Agents|antidepressive agents|mesh-ancestor
111192671|NCT00457366|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111192672|NCT00457366|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111192673|NCT00457366|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111192674|NCT00457366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111192675|NCT00457366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111192676|NCT00457366|Antiemetics|antiemetics|mesh-ancestor
111192677|NCT00457366|Autonomic Agents|autonomic agents|mesh-ancestor
111192678|NCT00457366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111192679|NCT00457366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111192680|NCT00457366|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111192681|NCT00457366|Dopamine Agents|dopamine agents|mesh-ancestor
110909754|NCT02067078|Analgesics|analgesics|mesh-ancestor
111192682|NCT00457366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111192683|NCT00457366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111192684|NCT00457366|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111192685|NCT00457366|Anticonvulsants|anticonvulsants|mesh-ancestor
111192686|NCT00457366|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111192687|NCT00457366|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111192688|NCT00457366|GABA Modulators|gaba modulators|mesh-ancestor
111192689|NCT00457366|GABA Agents|gaba agents|mesh-ancestor
111192690|NCT00457366|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111192691|NCT00457366|Parasympatholytics|parasympatholytics|mesh-ancestor
111192692|NCT00457366|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111192693|NCT00457366|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111192694|NCT00457366|Cholinergic Agents|cholinergic agents|mesh-ancestor
111192695|NCT00457366|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111192696|NCT00457366|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111192697|NCT00457366|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111192698|NCT00458848|Prednisone|prednisone|mesh-list
111192699|NCT00458848|Methylprednisolone|methylprednisolone|mesh-list
111192700|NCT00458848|Methotrexate|methotrexate|mesh-list
111192701|NCT00458848|Etoposide|etoposide|mesh-list
111192702|NCT00458848|Vincristine|vincristine|mesh-list
111192703|NCT00458848|Imatinib Mesylate|imatinib mesylate|mesh-list
111192704|NCT00458848|Daunorubicin|daunorubicin|mesh-list
111192705|NCT00458848|Asparaginase|asparaginase|mesh-list
111192706|NCT00458848|Mitoxantrone|mitoxantrone|mesh-list
111192707|NCT00458848|Mercaptopurine|mercaptopurine|mesh-list
111192708|NCT00458848|Idarubicin|idarubicin|mesh-list
111192709|NCT00458848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111192710|NCT00458848|Glucocorticoids|glucocorticoids|mesh-ancestor
111192711|NCT00458848|Hormones|hormones|mesh-ancestor
111192712|NCT00458848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111192713|NCT00458848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111192714|NCT00458848|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111192715|NCT00458848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111192716|NCT00458848|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111192717|NCT00458848|Abortifacient Agents|abortifacient agents|mesh-ancestor
111192718|NCT00458848|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111192719|NCT00458848|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111192720|NCT00458848|Antimetabolites|antimetabolites|mesh-ancestor
111192721|NCT00458848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111192722|NCT00458848|Dermatologic Agents|dermatologic agents|mesh-ancestor
111192723|NCT00458848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111192724|NCT00458848|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110490847|NCT00949988|Rituximab|rituximab|mesh-list
111192725|NCT00458848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111192726|NCT00458848|Immunologic Factors|immunologic factors|mesh-ancestor
111192727|NCT00458848|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111192728|NCT00458848|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111192729|NCT00458848|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111192730|NCT00458848|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111192731|NCT00458848|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111192732|NCT00458848|Tubulin Modulators|tubulin modulators|mesh-ancestor
110845403|NCT02695992|Autonomic Agents|autonomic agents|mesh-ancestor
111192733|NCT00458848|Antimitotic Agents|antimitotic agents|mesh-ancestor
111192734|NCT00458848|Mitosis Modulators|mitosis modulators|mesh-ancestor
111192735|NCT00458848|Antiemetics|antiemetics|mesh-ancestor
111192736|NCT00458848|Autonomic Agents|autonomic agents|mesh-ancestor
111192737|NCT00458848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111192738|NCT00458848|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111192739|NCT00458848|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111192740|NCT00458848|Protective Agents|protective agents|mesh-ancestor
111192741|NCT00458848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111192742|NCT00458848|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111192743|NCT00458848|Analgesics|analgesics|mesh-ancestor
111192744|NCT00458848|Sensory System Agents|sensory system agents|mesh-ancestor
111192745|NCT00438802|Alefacept|alefacept|mesh-list
111192746|NCT00438802|Dermatologic Agents|dermatologic agents|mesh-ancestor
111192747|NCT00438802|Immunologic Factors|immunologic factors|mesh-ancestor
111192748|NCT00438802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111192749|NCT00377572|Omalizumab|omalizumab|mesh-list
111192750|NCT00377572|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111192751|NCT00377572|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111192752|NCT00377572|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111192753|NCT00377572|Respiratory System Agents|respiratory system agents|mesh-ancestor
111192754|NCT00377572|Immunologic Factors|immunologic factors|mesh-ancestor
111192755|NCT00377572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111192756|NCT00438880|Rituximab|rituximab|mesh-list
111192757|NCT00438880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111192758|NCT00438880|Antibodies|antibodies|mesh-list
111192759|NCT00438880|Immunoglobulins|immunoglobulins|mesh-list
111192760|NCT00438880|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111192761|NCT00438880|Immunologic Factors|immunologic factors|mesh-ancestor
111192762|NCT00438880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111192763|NCT00438880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111192764|NCT00438880|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111192765|NCT00378352|Epoetin Alfa|epoetin alfa|mesh-list
111192766|NCT00378352|Hematinics|hematinics|mesh-ancestor
111192767|NCT00462280|Lovastatin|lovastatin|mesh-list
111192768|NCT00462280|L 647318|l 647318|mesh-list
111192769|NCT00462280|Dihydromevinolin|dihydromevinolin|mesh-list
111192770|NCT00462280|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111192771|NCT00462280|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111192772|NCT00462280|Antimetabolites|antimetabolites|mesh-ancestor
111192773|NCT00462280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111192774|NCT00462280|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111192775|NCT00462280|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111192776|NCT00462280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111192777|NCT00381004|Cyclophosphamide|cyclophosphamide|mesh-list
111192778|NCT00381004|Rituximab|rituximab|mesh-list
111192779|NCT00381004|Fludarabine|fludarabine|mesh-list
111192780|NCT00381004|Fludarabine phosphate|fludarabine phosphate|mesh-list
111192781|NCT00381004|Sargramostim|sargramostim|mesh-list
111192782|NCT00381004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111192783|NCT00381004|Immunologic Factors|immunologic factors|mesh-ancestor
111192784|NCT00381004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111192785|NCT00381004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111192786|NCT00381004|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111192787|NCT00381004|Alkylating Agents|alkylating agents|mesh-ancestor
111192788|NCT00381004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111192789|NCT00381004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111192790|NCT00381004|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111192791|NCT00381004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111192792|NCT00381004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111192793|NCT00381004|Antimetabolites|antimetabolites|mesh-ancestor
111192794|NCT00381550|Fludarabine|fludarabine|mesh-list
111192795|NCT00381550|Fludarabine phosphate|fludarabine phosphate|mesh-list
111192796|NCT00381550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111192797|NCT00381550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111192798|NCT00381550|Antimetabolites|antimetabolites|mesh-ancestor
111192799|NCT00381550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111192800|NCT00381550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111192801|NCT00381550|Immunologic Factors|immunologic factors|mesh-ancestor
111192802|NCT00381550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111192803|NCT00440830|Nicotine|nicotine|mesh-list
111192804|NCT00440830|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111192805|NCT00440830|Autonomic Agents|autonomic agents|mesh-ancestor
111192806|NCT00440830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111192807|NCT00440830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111192808|NCT00440830|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111192809|NCT00440830|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111192810|NCT00440830|Cholinergic Agents|cholinergic agents|mesh-ancestor
111192811|NCT00440830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111192812|NCT00440830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111192813|NCT00427804|Calcitriol|calcitriol|mesh-list
111192814|NCT00427804|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111192815|NCT00427804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111192816|NCT00427804|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
111192817|NCT00427804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111192818|NCT00427804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111192819|NCT00427804|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111192820|NCT00427804|Vitamins|vitamins|mesh-ancestor
111192821|NCT00427804|Micronutrients|micronutrients|mesh-ancestor
111192822|NCT00427804|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111192823|NCT00381862|Leucovorin|leucovorin|mesh-list
111192824|NCT00381862|Dexamethasone|dexamethasone|mesh-list
111192825|NCT00381862|Fluorouracil|fluorouracil|mesh-list
111192826|NCT00381862|Oxaliplatin|oxaliplatin|mesh-list
111192827|NCT00381862|Irinotecan|irinotecan|mesh-list
111192828|NCT00381862|Camptothecin|camptothecin|mesh-list
111192829|NCT00381862|Aprepitant|aprepitant|mesh-list
111192830|NCT00381862|Palonosetron|palonosetron|mesh-list
111192831|NCT00381862|Levoleucovorin|levoleucovorin|mesh-list
111192832|NCT00381862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111192833|NCT00381862|Antiemetics|antiemetics|mesh-ancestor
111192834|NCT00381862|Autonomic Agents|autonomic agents|mesh-ancestor
111192835|NCT00381862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111192836|NCT00381862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111192837|NCT00381862|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111192838|NCT00381862|Glucocorticoids|glucocorticoids|mesh-ancestor
111192840|NCT00381862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111192841|NCT00381862|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111192842|NCT00381862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111192843|NCT00381862|Antimetabolites|antimetabolites|mesh-ancestor
111192844|NCT00381862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111192845|NCT00381862|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111192846|NCT00381862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111192847|NCT00381862|Immunologic Factors|immunologic factors|mesh-ancestor
111192848|NCT00381862|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111192849|NCT00381862|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111192850|NCT00381862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111192851|NCT00381862|Antidotes|antidotes|mesh-ancestor
111192852|NCT00381862|Protective Agents|protective agents|mesh-ancestor
111192853|NCT00381862|Vitamin B Complex|vitamin b complex|mesh-ancestor
111192854|NCT00381862|Vitamins|vitamins|mesh-ancestor
111192855|NCT00381862|Micronutrients|micronutrients|mesh-ancestor
111192856|NCT00381862|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
111192857|NCT00381862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111192858|NCT00381862|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111192859|NCT00381862|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111192860|NCT00381862|Serotonin Agents|serotonin agents|mesh-ancestor
111192861|NCT00381862|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111192862|NCT00464698|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
111192863|NCT00464698|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111192864|NCT00464698|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111192865|NCT00464698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110490863|NCT02593474|Naltrexone|naltrexone|mesh-list
111192866|NCT00464698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111192867|NCT00464698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111192868|NCT00464698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111192869|NCT00464698|Analgesics|analgesics|mesh-ancestor
111192870|NCT00464698|Sensory System Agents|sensory system agents|mesh-ancestor
111192871|NCT00464698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111192872|NCT00464698|Antidepressive Agents|antidepressive agents|mesh-ancestor
111192873|NCT00464698|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111192874|NCT00464698|Dopamine Agents|dopamine agents|mesh-ancestor
111192875|NCT00465088|Niacin|niacin|mesh-list
111192876|NCT00465088|Niacinamide|niacinamide|mesh-list
111192877|NCT00465088|Nicotinic Acids|nicotinic acids|mesh-list
111192878|NCT00465088|Atorvastatin|atorvastatin|mesh-list
111192879|NCT00465088|Simvastatin|simvastatin|mesh-list
111192880|NCT00465088|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111192881|NCT00465088|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111192882|NCT00465088|Antimetabolites|antimetabolites|mesh-ancestor
111192883|NCT00465088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111192884|NCT00465088|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111192885|NCT00465088|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111192886|NCT00465088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111192887|NCT00465088|Vasodilator Agents|vasodilator agents|mesh-ancestor
111192888|NCT00465088|Vitamin B Complex|vitamin b complex|mesh-ancestor
111192889|NCT00465088|Vitamins|vitamins|mesh-ancestor
111192890|NCT00465088|Micronutrients|micronutrients|mesh-ancestor
111192891|NCT00465088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111192892|NCT01796782|Capecitabine|capecitabine|mesh-list
111192893|NCT01796782|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111192894|NCT01796782|Antimetabolites|antimetabolites|mesh-ancestor
111192895|NCT01796782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111192896|NCT01796782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111192897|NCT00466960|Paclitaxel|paclitaxel|mesh-list
111192898|NCT00466960|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111192899|NCT00466960|Sargramostim|sargramostim|mesh-list
111192900|NCT00466960|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111192901|NCT00466960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111192902|NCT00466960|Tubulin Modulators|tubulin modulators|mesh-ancestor
111192903|NCT00466960|Antimitotic Agents|antimitotic agents|mesh-ancestor
111192904|NCT00466960|Mitosis Modulators|mitosis modulators|mesh-ancestor
111192905|NCT00466960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111192906|NCT00466960|Immunologic Factors|immunologic factors|mesh-ancestor
111192907|NCT00466960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111192908|NCT00383266|Carboplatin|carboplatin|mesh-list
111192909|NCT00383266|Pemetrexed|pemetrexed|mesh-list
111192910|NCT00383266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111192911|NCT00383266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111192912|NCT00383266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111192913|NCT00383266|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111192914|NCT00383266|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111192915|NCT00384670|Vaccines|vaccines|mesh-list
111192916|NCT00384670|Immunologic Factors|immunologic factors|mesh-ancestor
111192917|NCT00384670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111192918|NCT00467350|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
111192919|NCT00467350|Laxatives|laxatives|mesh-ancestor
111192920|NCT00467350|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111192921|NCT00444028|Loxapine|loxapine|mesh-list
111192922|NCT00444028|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111192923|NCT00444028|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111192924|NCT00444028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111192925|NCT00444028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111192926|NCT00444028|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111192927|NCT00444028|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111192928|NCT00444028|Dopamine Agents|dopamine agents|mesh-ancestor
111192929|NCT00444028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111192930|NCT00444028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111192931|NCT00444964|Hormones|hormones|mesh-list
110799570|NCT03758235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111192932|NCT00444964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111192933|NCT00444964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111192934|NCT00445588|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111192935|NCT00445588|Sorafenib|sorafenib|mesh-list
111192936|NCT00445588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111192937|NCT00445588|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111192938|NCT00445588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111192939|NCT00445588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111192940|NCT00445744|Cyclophosphamide|cyclophosphamide|mesh-list
111192941|NCT00445744|Busulfan|busulfan|mesh-list
111192942|NCT00445744|Methotrexate|methotrexate|mesh-list
111192943|NCT00445744|Tacrolimus|tacrolimus|mesh-list
111192944|NCT00445744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111192945|NCT00445744|Immunologic Factors|immunologic factors|mesh-ancestor
111192946|NCT00445744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111192947|NCT00445744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111192948|NCT00445744|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111192950|NCT00445744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111192951|NCT00445744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111192952|NCT00445744|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111192953|NCT00445744|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111192954|NCT00445744|Abortifacient Agents|abortifacient agents|mesh-ancestor
111192955|NCT00445744|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111192956|NCT00445744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111192957|NCT00445744|Antimetabolites|antimetabolites|mesh-ancestor
111192958|NCT00445744|Dermatologic Agents|dermatologic agents|mesh-ancestor
111192959|NCT00445744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111192960|NCT00445744|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111192961|NCT00445744|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111192962|NCT00445744|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111192963|NCT00468208|Abatacept|abatacept|mesh-list
111192964|NCT00468208|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111192965|NCT00468208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111192966|NCT00468208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111192967|NCT00468208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111192968|NCT00468208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111192969|NCT00468208|Immunologic Factors|immunologic factors|mesh-ancestor
111192970|NCT00468208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111192971|NCT00468208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111192972|NCT00385138|Clopidogrel|clopidogrel|mesh-list
111192973|NCT00385138|Cangrelor|cangrelor|mesh-list
111192974|NCT00385138|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111192975|NCT00385138|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111192976|NCT00385138|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111192977|NCT00385138|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111192978|NCT00385138|Purinergic Agents|purinergic agents|mesh-ancestor
111192979|NCT00385138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111192980|NCT00385138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111192981|NCT00385138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111192982|NCT00446290|Docetaxel|docetaxel|mesh-list
111192983|NCT00446290|Capecitabine|capecitabine|mesh-list
111192984|NCT00446290|Oxaliplatin|oxaliplatin|mesh-list
111192985|NCT00446290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111192986|NCT00446290|Tubulin Modulators|tubulin modulators|mesh-ancestor
111192987|NCT00446290|Antimitotic Agents|antimitotic agents|mesh-ancestor
111192988|NCT00446290|Mitosis Modulators|mitosis modulators|mesh-ancestor
111192989|NCT00446290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111192990|NCT00446290|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111192991|NCT00446290|Antimetabolites|antimetabolites|mesh-ancestor
111192993|NCT00385216|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111192994|NCT00385216|Autonomic Agents|autonomic agents|mesh-ancestor
111192995|NCT00385216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111192996|NCT00385216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111192997|NCT00385216|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111192998|NCT00385216|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111192999|NCT00385216|Cholinergic Agents|cholinergic agents|mesh-ancestor
111193000|NCT00385216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111193001|NCT00385216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111193002|NCT00385996|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111193003|NCT00385996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111193004|NCT00385996|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111193005|NCT00385996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111193006|NCT00385996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111193007|NCT00470392|Clobetasol|clobetasol|mesh-list
111193008|NCT00470392|Imiquimod|imiquimod|mesh-list
111193009|NCT00470392|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111193010|NCT00470392|Immunologic Factors|immunologic factors|mesh-ancestor
111193011|NCT00470392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111193012|NCT00470392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111193013|NCT00470392|Interferon Inducers|interferon inducers|mesh-ancestor
111193014|NCT00470392|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111193015|NCT00470392|Glucocorticoids|glucocorticoids|mesh-ancestor
111193016|NCT00470392|Hormones|hormones|mesh-ancestor
111193017|NCT00470392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111193018|NCT00470548|Paclitaxel|paclitaxel|mesh-list
111193019|NCT00470548|Pemetrexed|pemetrexed|mesh-list
111193020|NCT00470548|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111193021|NCT00470548|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111193022|NCT00470548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111193023|NCT00470548|Tubulin Modulators|tubulin modulators|mesh-ancestor
111193024|NCT00470548|Antimitotic Agents|antimitotic agents|mesh-ancestor
111193025|NCT00470548|Mitosis Modulators|mitosis modulators|mesh-ancestor
111193026|NCT00470548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111193027|NCT00470548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111193028|NCT00470548|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111193029|NCT00470548|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111193030|NCT00388414|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
111193031|NCT00388414|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111193032|NCT00388414|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111193033|NCT00388414|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111193034|NCT00388414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111193035|NCT00388414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111193036|NCT00388414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111193037|NCT00388414|Analgesics|analgesics|mesh-ancestor
111193038|NCT00388414|Sensory System Agents|sensory system agents|mesh-ancestor
111193039|NCT00388414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111193040|NCT00388414|Antidepressive Agents|antidepressive agents|mesh-ancestor
111193041|NCT00388414|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111193042|NCT00388414|Dopamine Agents|dopamine agents|mesh-ancestor
111193043|NCT00475150|Cediranib|cediranib|mesh-list
111193044|NCT00475150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111193045|NCT00475150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111193046|NCT00475150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111193047|NCT00475150|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111193048|NCT00451048|Sunitinib|sunitinib|mesh-list
111193049|NCT00451048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111193050|NCT00451048|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111193051|NCT00451048|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111193052|NCT00451048|Growth Substances|growth substances|mesh-ancestor
111193053|NCT00451048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111193054|NCT00451048|Growth Inhibitors|growth inhibitors|mesh-ancestor
111193055|NCT00451048|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111193056|NCT00451048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111193057|NCT00451048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111193058|NCT00388804|Leuprolide|leuprolide|mesh-list
111193059|NCT00388804|Goserelin|goserelin|mesh-list
110490889|NCT00730756|Xhance|xhance|mesh-list
111193060|NCT00388804|Flutamide|flutamide|mesh-list
111193061|NCT00388804|Bicalutamide|bicalutamide|mesh-list
111193062|NCT00388804|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111193063|NCT00388804|Fertility Agents|fertility agents|mesh-ancestor
111193064|NCT00388804|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111193065|NCT00388804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111193066|NCT00388804|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111193067|NCT00388804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111193068|NCT00388804|Androgen Antagonists|androgen antagonists|mesh-ancestor
111193069|NCT00388804|Hormone Antagonists|hormone antagonists|mesh-ancestor
111193070|NCT00388804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111193071|NCT00389818|Prednisone|prednisone|mesh-list
111193072|NCT00389818|Cyclophosphamide|cyclophosphamide|mesh-list
111193073|NCT00389818|Rituximab|rituximab|mesh-list
111193074|NCT00389818|Doxorubicin|doxorubicin|mesh-list
111193075|NCT00389818|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111193076|NCT00389818|Vincristine|vincristine|mesh-list
111193077|NCT00389818|Sargramostim|sargramostim|mesh-list
111193078|NCT00389818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111193079|NCT00389818|Immunologic Factors|immunologic factors|mesh-ancestor
111193080|NCT00389818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111193081|NCT00389818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111193082|NCT00389818|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111193083|NCT00389818|Alkylating Agents|alkylating agents|mesh-ancestor
111193084|NCT00389818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111193085|NCT00389818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111193086|NCT00389818|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111193087|NCT00389818|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111193088|NCT00389818|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111193089|NCT00389818|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111193090|NCT00389818|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111193091|NCT00389818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111193092|NCT00389818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111193093|NCT00389818|Glucocorticoids|glucocorticoids|mesh-ancestor
111193094|NCT00389818|Hormones|hormones|mesh-ancestor
111193095|NCT00389818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111193096|NCT00389818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111193097|NCT00389818|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111193098|NCT00389818|Tubulin Modulators|tubulin modulators|mesh-ancestor
111193099|NCT00389818|Antimitotic Agents|antimitotic agents|mesh-ancestor
111193100|NCT00389818|Mitosis Modulators|mitosis modulators|mesh-ancestor
111193101|NCT00452374|Cytarabine|cytarabine|mesh-list
111193102|NCT00452374|Rituximab|rituximab|mesh-list
111193103|NCT00452374|Oxaliplatin|oxaliplatin|mesh-list
111193104|NCT00452374|Fludarabine|fludarabine|mesh-list
111193105|NCT00452374|Fludarabine phosphate|fludarabine phosphate|mesh-list
111193106|NCT00452374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111193107|NCT00452374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111193108|NCT00452374|Immunologic Factors|immunologic factors|mesh-ancestor
111193109|NCT00452374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111193110|NCT00452374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111193111|NCT00452374|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111193112|NCT00452374|Antimetabolites|antimetabolites|mesh-ancestor
111193113|NCT00452374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111193114|NCT00452374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111193115|NCT00452374|Antiviral Agents|antiviral agents|mesh-ancestor
111193116|NCT00452374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111193117|NCT03286114|Pembrolizumab|pembrolizumab|mesh-list
111193118|NCT03286114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111193119|NCT03286114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111193120|NCT03286114|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111193121|NCT03286114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111193122|NCT00476242|Naltrexone|naltrexone|mesh-list
111193123|NCT00476242|Memantine|memantine|mesh-list
111193124|NCT00476242|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110490899|NCT00730132|Ezetimibe|ezetimibe|mesh-list
111193125|NCT00476242|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111193126|NCT00476242|Dopamine Agents|dopamine agents|mesh-ancestor
111193127|NCT00476242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111193128|NCT00476242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111193129|NCT00476242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111193130|NCT00476242|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111193131|NCT00476242|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111193132|NCT00476242|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111193133|NCT00476242|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111193134|NCT00476242|Sensory System Agents|sensory system agents|mesh-ancestor
111193135|NCT00476242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111193136|NCT00476788|Insulin|insulin|mesh-list
111193137|NCT00476788|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111193138|NCT00476788|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111193139|NCT00476788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111193140|NCT01795144|Glucagon|glucagon|mesh-list
111193141|NCT01795144|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
111193142|NCT01795144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111193143|NCT01795144|Hormones|hormones|mesh-ancestor
111193144|NCT01795144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111193145|NCT01795144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111193146|NCT01795144|Incretins|incretins|mesh-ancestor
110845436|NCT01171547|Daptomycin|daptomycin|mesh-list
111193147|NCT01436175|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
111193148|NCT01436175|Antidepressive Agents|antidepressive agents|mesh-list
111193149|NCT01436175|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111193150|NCT01436175|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111193151|NCT01436175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111193152|NCT01436175|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111193153|NCT01436175|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111193154|NCT01436175|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111193155|NCT01436175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111193156|NCT01436175|Dopamine Agents|dopamine agents|mesh-ancestor
111193157|NCT01436175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111193158|NCT00453388|Cyclosporine|cyclosporine|mesh-list
111193159|NCT00453388|Mycophenolic Acid|mycophenolic acid|mesh-list
111193160|NCT00453388|Cyclophosphamide|cyclophosphamide|mesh-list
111193161|NCT00453388|Fludarabine|fludarabine|mesh-list
111193162|NCT00453388|Fludarabine phosphate|fludarabine phosphate|mesh-list
111193163|NCT00453388|Cyclosporins|cyclosporins|mesh-list
111193164|NCT00453388|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111193165|NCT00453388|Immunologic Factors|immunologic factors|mesh-ancestor
111193166|NCT00453388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111193167|NCT00453388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111193168|NCT00453388|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111193169|NCT00453388|Alkylating Agents|alkylating agents|mesh-ancestor
111193170|NCT00453388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111193171|NCT00453388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111193172|NCT00453388|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111193173|NCT00453388|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111193174|NCT00453388|Antimetabolites|antimetabolites|mesh-ancestor
111193175|NCT00453388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111193176|NCT00453388|Antifungal Agents|antifungal agents|mesh-ancestor
111193177|NCT00453388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111193178|NCT00453388|Dermatologic Agents|dermatologic agents|mesh-ancestor
111193179|NCT00453388|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111193180|NCT00453388|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111193181|NCT00453388|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111193182|NCT00453388|Antitubercular Agents|antitubercular agents|mesh-ancestor
111193183|NCT00453388|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111193184|NCT00389974|Sunitinib|sunitinib|mesh-list
111193185|NCT00389974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111193186|NCT00389974|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111193187|NCT00389974|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111193188|NCT00389974|Growth Substances|growth substances|mesh-ancestor
111193189|NCT00389974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111193190|NCT00389974|Growth Inhibitors|growth inhibitors|mesh-ancestor
111193191|NCT00389974|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111193192|NCT00389974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111193193|NCT00389974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111193194|NCT01453725|Golimumab|golimumab|mesh-list
111193195|NCT01453725|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111193196|NCT01453725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111193197|NCT01453725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111193198|NCT01453725|Immunologic Factors|immunologic factors|mesh-ancestor
111193199|NCT01453725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111193200|NCT00454324|Paclitaxel|paclitaxel|mesh-list
111193201|NCT00454324|Carboplatin|carboplatin|mesh-list
111193202|NCT00454324|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111193203|NCT00454324|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111193204|NCT00454324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111193205|NCT00454324|Tubulin Modulators|tubulin modulators|mesh-ancestor
111193206|NCT00454324|Antimitotic Agents|antimitotic agents|mesh-ancestor
111193207|NCT00454324|Mitosis Modulators|mitosis modulators|mesh-ancestor
111193208|NCT00454324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111193209|NCT02110264|Naltrexone|naltrexone|mesh-list
111193210|NCT02110264|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111193211|NCT02110264|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111193212|NCT02110264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111193213|NCT02110264|Sensory System Agents|sensory system agents|mesh-ancestor
111193214|NCT02110264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111193215|NCT01795222|Midazolam|midazolam|mesh-list
111193216|NCT01795222|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111193217|NCT01795222|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111193218|NCT01795222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111193219|NCT01795222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111193220|NCT01795222|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111193221|NCT01795222|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111193222|NCT01795222|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111193223|NCT01795222|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111193224|NCT01795222|Anesthetics, General|anesthetics, general|mesh-ancestor
111193226|NCT01795222|GABA Modulators|gaba modulators|mesh-ancestor
111193227|NCT01795222|GABA Agents|gaba agents|mesh-ancestor
111193228|NCT01795222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111193229|NCT01795222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111193230|NCT01415349|Omeprazole|omeprazole|mesh-list
111193231|NCT01415349|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111193232|NCT01415349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111193233|NCT01415349|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111193234|NCT01415349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111193235|NCT01415349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111193236|NCT00528190|Itraconazole|itraconazole|mesh-list
111193237|NCT00528190|Antifungal Agents|antifungal agents|mesh-ancestor
111193238|NCT00528190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111193239|NCT00528190|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111193240|NCT00528190|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111193241|NCT00528190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111193242|NCT00528190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111193243|NCT00528190|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111193244|NCT00528190|Hormone Antagonists|hormone antagonists|mesh-ancestor
111193245|NCT00528190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111193246|NCT00528190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111193247|NCT00528190|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111193248|NCT02334813|Dexamethasone|dexamethasone|mesh-list
111193249|NCT02334813|Prednisone|prednisone|mesh-list
111193250|NCT02334813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111193251|NCT02334813|Antiemetics|antiemetics|mesh-ancestor
111193252|NCT02334813|Autonomic Agents|autonomic agents|mesh-ancestor
111193253|NCT02334813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111193254|NCT02334813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111193255|NCT02334813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111193256|NCT02334813|Glucocorticoids|glucocorticoids|mesh-ancestor
111193257|NCT02334813|Hormones|hormones|mesh-ancestor
111193258|NCT02334813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111193259|NCT02334813|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111193260|NCT02334813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111193261|NCT00478036|Prednisolone|prednisolone|mesh-list
111193262|NCT00478036|Prednisolone acetate|prednisolone acetate|mesh-list
111193263|NCT00478036|Ketorolac|ketorolac|mesh-list
111193264|NCT00478036|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
111193265|NCT00478036|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
111193266|NCT00478036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111193267|NCT00478036|Glucocorticoids|glucocorticoids|mesh-ancestor
111193268|NCT00478036|Hormones|hormones|mesh-ancestor
111193269|NCT00478036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111193270|NCT00478036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111193271|NCT00478036|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111193272|NCT00478036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111193273|NCT00478036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111193274|NCT00478036|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111193275|NCT00478036|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111193276|NCT00478036|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111193277|NCT00478036|Analgesics|analgesics|mesh-ancestor
111193278|NCT00478036|Sensory System Agents|sensory system agents|mesh-ancestor
111193279|NCT00478036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111193280|NCT00478036|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111193281|NCT00478036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111193282|NCT00478036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111193283|NCT00478036|Laxatives|laxatives|mesh-ancestor
111193284|NCT04048863|Imidacloprid|imidacloprid|mesh-list
111193285|NCT04048863|Cholinergic Agents|cholinergic agents|mesh-ancestor
111193286|NCT04048863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111193287|NCT04048863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111193288|NCT04048863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111193289|NCT04522557|Interferon alpha-2|interferon alpha-2|mesh-list
111193290|NCT04522557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111193291|NCT04522557|Antiviral Agents|antiviral agents|mesh-ancestor
111193292|NCT04522557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111193293|NCT01453023|Fluticasone|fluticasone|mesh-list
111193295|NCT01453023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111193296|NCT01453023|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111193297|NCT01453023|Autonomic Agents|autonomic agents|mesh-ancestor
111193298|NCT01453023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111193299|NCT01453023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111193300|NCT01453023|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111193301|NCT01453023|Respiratory System Agents|respiratory system agents|mesh-ancestor
111193302|NCT01453023|Dermatologic Agents|dermatologic agents|mesh-ancestor
111193303|NCT01453023|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111193304|NCT01452789|Morphine|morphine|mesh-list
111193305|NCT01452789|Buprenorphine|buprenorphine|mesh-list
111193306|NCT01452789|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111193307|NCT01452789|Narcotics|narcotics|mesh-ancestor
111193308|NCT01452789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111193309|NCT01452789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111193310|NCT01452789|Analgesics|analgesics|mesh-ancestor
111193311|NCT01452789|Sensory System Agents|sensory system agents|mesh-ancestor
111193312|NCT01452789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111193313|NCT01452789|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111193314|NCT00478192|Conivaptan|conivaptan|mesh-list
111193315|NCT00478192|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
110799571|NCT02066350|Pancrelipase|pancrelipase|mesh-list
111193316|NCT00478192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111193317|NCT00478192|Natriuretic Agents|natriuretic agents|mesh-ancestor
111193318|NCT00478192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111193319|NCT01414257|Methotrexate|methotrexate|mesh-list
111193320|NCT01414257|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111193321|NCT01414257|Abortifacient Agents|abortifacient agents|mesh-ancestor
111193322|NCT01414257|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111193323|NCT01414257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111193324|NCT01414257|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111193325|NCT01414257|Antimetabolites|antimetabolites|mesh-ancestor
111193326|NCT01414257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111193327|NCT01414257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111193328|NCT01414257|Dermatologic Agents|dermatologic agents|mesh-ancestor
111193329|NCT01414257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111193330|NCT01414257|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111193331|NCT01414257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111193332|NCT01414257|Immunologic Factors|immunologic factors|mesh-ancestor
111193333|NCT01414257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111193334|NCT01414257|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111193335|NCT00528268|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
111193336|NCT00528268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111193337|NCT00528580|Simvastatin|simvastatin|mesh-list
111193338|NCT00528580|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111193339|NCT00528580|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111193340|NCT00528580|Antimetabolites|antimetabolites|mesh-ancestor
111193341|NCT00528580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111193342|NCT00528580|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111193343|NCT00528580|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111193344|NCT00528580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111193345|NCT00529126|Epinephrine|epinephrine|mesh-list
111193346|NCT00529126|Bupivacaine|bupivacaine|mesh-list
111193347|NCT00529126|Anesthetics, Local|anesthetics, local|mesh-ancestor
111193348|NCT00529126|Anesthetics|anesthetics|mesh-ancestor
111193349|NCT00529126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111193350|NCT00529126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111193351|NCT00529126|Sensory System Agents|sensory system agents|mesh-ancestor
111193352|NCT00529126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111193353|NCT00529126|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111193354|NCT00529126|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111193355|NCT00529126|Adrenergic Agents|adrenergic agents|mesh-ancestor
111193356|NCT00529126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111193357|NCT00529126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111193358|NCT00529126|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111193359|NCT00529126|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110910444|NCT02220218|Metformin|metformin|mesh-list
111193361|NCT00529126|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111193362|NCT00529126|Respiratory System Agents|respiratory system agents|mesh-ancestor
111193363|NCT00529126|Mydriatics|mydriatics|mesh-ancestor
111193364|NCT00529126|Sympathomimetics|sympathomimetics|mesh-ancestor
111193365|NCT00529126|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111193366|NCT00529204|Exenatide|exenatide|mesh-list
111193367|NCT00529204|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111193368|NCT00529204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111193369|NCT00529204|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111193370|NCT00529204|Incretins|incretins|mesh-ancestor
111193371|NCT00529204|Hormones|hormones|mesh-ancestor
111193372|NCT00529204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111193373|NCT01451541|Ciclesonide|ciclesonide|mesh-list
111193374|NCT01451541|Glucocorticoids|glucocorticoids|mesh-ancestor
111193375|NCT01451541|Hormones|hormones|mesh-ancestor
111193376|NCT01451541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111193377|NCT01451541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111193378|NCT01451541|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111193379|NCT00530764|Nabiximols|nabiximols|mesh-list
111193380|NCT00530764|Dronabinol|dronabinol|mesh-list
111193381|NCT00530764|Cannabidiol|cannabidiol|mesh-list
111193382|NCT00530764|Analgesics|analgesics|mesh-ancestor
111193383|NCT00530764|Sensory System Agents|sensory system agents|mesh-ancestor
111193384|NCT00530764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111193385|NCT00530764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111193386|NCT00530764|Anticonvulsants|anticonvulsants|mesh-ancestor
111193387|NCT00530764|Hallucinogens|hallucinogens|mesh-ancestor
111193388|NCT00530764|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111193389|NCT00530764|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111193390|NCT00530764|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
111193391|NCT00530764|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
111193392|NCT00530764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111193393|NCT00530764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111193394|NCT00530764|Hormones|hormones|mesh-ancestor
111193395|NCT00530764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111193396|NCT00532480|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
111193397|NCT00532480|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111193398|NCT00532480|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111193399|NCT00532480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111193400|NCT00532480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111193401|NCT00532480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111193402|NCT00532480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111193403|NCT00532480|Analgesics|analgesics|mesh-ancestor
111193404|NCT00532480|Sensory System Agents|sensory system agents|mesh-ancestor
111193405|NCT00532480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111193406|NCT00532480|Antidepressive Agents|antidepressive agents|mesh-ancestor
111193407|NCT00532480|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111193408|NCT00532480|Dopamine Agents|dopamine agents|mesh-ancestor
111193409|NCT00483262|Bortezomib|bortezomib|mesh-list
111193410|NCT00483262|Temsirolimus|temsirolimus|mesh-list
111193411|NCT00483262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111193412|NCT00483262|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111193413|NCT00483262|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111193414|NCT00483262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111193415|NCT00483262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111193416|NCT00483262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111193417|NCT00483262|Immunologic Factors|immunologic factors|mesh-ancestor
111193418|NCT00483262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111193419|NCT00483496|Titanium dioxide|titanium dioxide|mesh-list
111193420|NCT00483496|Sunscreening Agents|sunscreening agents|mesh-ancestor
111193421|NCT00483496|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111193422|NCT00483496|Protective Agents|protective agents|mesh-ancestor
111193423|NCT00483496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111193424|NCT00483496|Dermatologic Agents|dermatologic agents|mesh-ancestor
111193425|NCT00483496|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111193426|NCT00485836|Ranibizumab|ranibizumab|mesh-list
111193427|NCT00485836|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111193428|NCT00485836|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111193429|NCT00485836|Growth Substances|growth substances|mesh-ancestor
111193430|NCT00485836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111193431|NCT00485836|Growth Inhibitors|growth inhibitors|mesh-ancestor
111193432|NCT00485836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111193433|NCT00488488|Tigecycline|tigecycline|mesh-list
111193434|NCT00488488|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111193435|NCT00488488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111193436|NCT00488488|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111193437|NCT00488488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111193438|NCT00488488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111193439|NCT01450761|Carboplatin|carboplatin|mesh-list
111193440|NCT01450761|Etoposide|etoposide|mesh-list
111193441|NCT01450761|Ipilimumab|ipilimumab|mesh-list
111193442|NCT01450761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111193443|NCT01450761|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111193444|NCT01450761|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111193445|NCT01450761|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111193446|NCT01450761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111193447|NCT01450761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111193448|NCT01450761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111193449|NCT01450761|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111193450|NCT00491374|Mometasone Furoate|mometasone furoate|mesh-list
111193451|NCT00491374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111193452|NCT00491374|Dermatologic Agents|dermatologic agents|mesh-ancestor
111193453|NCT00491374|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111193454|NCT00538642|Ziprasidone|ziprasidone|mesh-list
110490943|NCT00949910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111193455|NCT00538642|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111193456|NCT00538642|Serotonin Agents|serotonin agents|mesh-ancestor
111193457|NCT00538642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111193458|NCT00538642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111193459|NCT00538642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111193460|NCT00538642|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111193461|NCT00538642|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111193462|NCT00538642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111193463|NCT00538642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111193464|NCT00538642|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111193465|NCT00538642|Dopamine Agents|dopamine agents|mesh-ancestor
111193466|NCT01433991|Lenvatinib|lenvatinib|mesh-list
111193467|NCT01433991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111193468|NCT01433991|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111193469|NCT01433991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111193470|NCT01433991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111193471|NCT01450683|Itraconazole|itraconazole|mesh-list
111193472|NCT01450683|Antifungal Agents|antifungal agents|mesh-ancestor
111193473|NCT01450683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111193474|NCT01450683|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111193475|NCT01450683|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111193476|NCT01450683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111193477|NCT01450683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111193478|NCT01450683|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111193479|NCT01450683|Hormone Antagonists|hormone antagonists|mesh-ancestor
111193480|NCT01450683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110845473|NCT01168739|Quercetin|quercetin|mesh-list
111193481|NCT01450683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111193482|NCT01450683|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111193483|NCT01433055|Minocycline|minocycline|mesh-list
110490948|NCT02594800|Antimetabolites|antimetabolites|mesh-ancestor
111193484|NCT01433055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111193485|NCT01433055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111193486|NCT01450137|Glucocorticoids|glucocorticoids|mesh-list
111193487|NCT01450137|Hormones|hormones|mesh-ancestor
111193488|NCT01450137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111193489|NCT01450137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111193490|NCT04075149|Spironolactone|spironolactone|mesh-list
111193491|NCT04075149|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
111193492|NCT04075149|Hormone Antagonists|hormone antagonists|mesh-ancestor
111193493|NCT04075149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111193494|NCT04075149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111193495|NCT04075149|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
111193496|NCT04075149|Diuretics|diuretics|mesh-ancestor
111193497|NCT04075149|Natriuretic Agents|natriuretic agents|mesh-ancestor
111193498|NCT01412229|Paclitaxel|paclitaxel|mesh-list
111193499|NCT01412229|Carboplatin|carboplatin|mesh-list
111193500|NCT01412229|Cetuximab|cetuximab|mesh-list
111193501|NCT01412229|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111193502|NCT01412229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111193503|NCT01412229|Tubulin Modulators|tubulin modulators|mesh-ancestor
111193504|NCT01412229|Antimitotic Agents|antimitotic agents|mesh-ancestor
111193505|NCT01412229|Mitosis Modulators|mitosis modulators|mesh-ancestor
111193506|NCT01412229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111193507|NCT01412229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111193508|NCT01432275|Insulin|insulin|mesh-list
111193509|NCT01432275|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111193510|NCT01432275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111193511|NCT01411995|Lidocaine|lidocaine|mesh-list
111193512|NCT01411995|Anesthetics, Local|anesthetics, local|mesh-ancestor
111193513|NCT01411995|Anesthetics|anesthetics|mesh-ancestor
111193514|NCT01411995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111193515|NCT01411995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111193516|NCT01411995|Sensory System Agents|sensory system agents|mesh-ancestor
111193517|NCT01411995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111193518|NCT01411995|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111193519|NCT01411995|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111193520|NCT01411995|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111193521|NCT01411995|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111193522|NCT01411995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111193523|NCT01411215|Etanercept|etanercept|mesh-list
111193524|NCT01411215|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111193525|NCT01411215|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111193526|NCT01411215|Analgesics|analgesics|mesh-ancestor
111193527|NCT01411215|Sensory System Agents|sensory system agents|mesh-ancestor
111193528|NCT01411215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111193529|NCT01411215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111193530|NCT01411215|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111193531|NCT01411215|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111193532|NCT01411215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111193533|NCT01411215|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111193534|NCT01411215|Immunologic Factors|immunologic factors|mesh-ancestor
111193535|NCT01449279|Ipilimumab|ipilimumab|mesh-list
111193536|NCT01449279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111193537|NCT01449279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111193538|NCT01449279|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111193539|NCT01449279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111193540|NCT01431963|Lamotrigine|lamotrigine|mesh-list
111193541|NCT01431963|Anticonvulsants|anticonvulsants|mesh-ancestor
111193542|NCT01431963|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111193543|NCT01431963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111193544|NCT01431963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111193545|NCT01431963|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111193546|NCT01431963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111193547|NCT01431963|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111193548|NCT01431963|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111193549|NCT01431963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111193550|NCT01431963|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111193551|NCT01431963|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111193552|NCT01447407|Vaccines|vaccines|mesh-list
111193553|NCT01447407|Aluminum sulfate|aluminum sulfate|mesh-list
111193554|NCT01447407|Immunologic Factors|immunologic factors|mesh-ancestor
111193555|NCT01447407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111193556|NCT01447407|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111193557|NCT01446237|Benzoyl Peroxide|benzoyl peroxide|mesh-list
111193558|NCT01446237|Dermatologic Agents|dermatologic agents|mesh-ancestor
111193559|NCT00540982|Vinorelbine|vinorelbine|mesh-list
111193560|NCT00540982|Lidocaine|lidocaine|mesh-list
111193561|NCT00540982|Anesthetics, Local|anesthetics, local|mesh-ancestor
111193562|NCT00540982|Anesthetics|anesthetics|mesh-ancestor
111193563|NCT00540982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111193564|NCT00540982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111193565|NCT00540982|Sensory System Agents|sensory system agents|mesh-ancestor
111193566|NCT00540982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111193567|NCT00540982|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111193568|NCT00540982|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111193569|NCT00540982|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111193570|NCT00540982|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111193571|NCT00540982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111193572|NCT00540982|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111193573|NCT00540982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111193574|NCT00540982|Tubulin Modulators|tubulin modulators|mesh-ancestor
111193575|NCT00540982|Antimitotic Agents|antimitotic agents|mesh-ancestor
111193576|NCT00540982|Mitosis Modulators|mitosis modulators|mesh-ancestor
111193577|NCT00542620|Insulin|insulin|mesh-list
111193578|NCT00542620|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111193579|NCT00542620|Insulin Aspart|insulin aspart|mesh-list
111193580|NCT00542620|Insulin, Long-Acting|insulin, long-acting|mesh-list
111193581|NCT00542620|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
111193582|NCT00542620|Insulin Detemir|insulin detemir|mesh-list
111193583|NCT00542620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111193584|NCT00542620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111193585|NCT00543400|Heparin|heparin|mesh-list
111193586|NCT00543400|Calcium heparin|calcium heparin|mesh-list
111193587|NCT00543400|Anticoagulants|anticoagulants|mesh-ancestor
111193588|NCT00543400|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111193589|NCT00543400|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111193590|NCT00543400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111193591|NCT01796938|Lacosamide|lacosamide|mesh-list
111193592|NCT01796938|Anticonvulsants|anticonvulsants|mesh-ancestor
111193593|NCT01796938|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111193594|NCT01796938|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111193595|NCT01796938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111193596|NCT01796938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111193597|NCT00492544|Vaccines|vaccines|mesh-list
111193598|NCT00492544|Immunologic Factors|immunologic factors|mesh-ancestor
111193599|NCT00492544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111193600|NCT00492622|Omeprazole|omeprazole|mesh-list
111193601|NCT00492622|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111193602|NCT00492622|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111193603|NCT00492622|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111193604|NCT00492622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111193605|NCT00492622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111193606|NCT00494494|Nepafenac|nepafenac|mesh-list
111193607|NCT00494494|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111193608|NCT00494494|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111193609|NCT00494494|Analgesics|analgesics|mesh-ancestor
111193610|NCT00494494|Sensory System Agents|sensory system agents|mesh-ancestor
111193611|NCT00494494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111193612|NCT00494494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111193613|NCT00494494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111193614|NCT00494494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111193615|NCT03145558|Doxorubicin|doxorubicin|mesh-list
111193616|NCT03145558|Tirapazamine|tirapazamine|mesh-list
111193617|NCT03145558|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110845493|NCT02652468|Mycophenolic Acid|mycophenolic acid|mesh-list
111193619|NCT03145558|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111193620|NCT03145558|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111193621|NCT03145558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111193622|NCT03145558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111193623|NCT00497770|Pemetrexed|pemetrexed|mesh-list
111193624|NCT00497770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111193625|NCT00497770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111193626|NCT00497770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111193627|NCT00497770|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111193628|NCT00497770|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111193629|NCT00498550|Clozapine|clozapine|mesh-list
111193630|NCT00498550|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111193631|NCT00498550|Serotonin Agents|serotonin agents|mesh-ancestor
111193632|NCT00498550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111193633|NCT00498550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111193634|NCT00498550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111193635|NCT00498550|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111193636|NCT00498550|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111193637|NCT00498550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111193638|NCT00498550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111193639|NCT00498550|GABA Antagonists|gaba antagonists|mesh-ancestor
111193640|NCT00498550|GABA Agents|gaba agents|mesh-ancestor
111193641|NCT00498628|Quetiapine Fumarate|quetiapine fumarate|mesh-list
111193642|NCT00498628|Antidepressive Agents|antidepressive agents|mesh-ancestor
111193643|NCT00498628|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111193644|NCT00498628|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111193645|NCT00498628|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111193646|NCT00498628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111193647|NCT00498628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111193648|NCT01446159|Aromatase Inhibitors|aromatase inhibitors|mesh-list
111193649|NCT01446159|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111193650|NCT01446159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111193651|NCT01446159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111193652|NCT01446159|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111193653|NCT01446159|Hormone Antagonists|hormone antagonists|mesh-ancestor
111193654|NCT01446159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110910729|NCT02226926|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111193655|NCT01446159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111193656|NCT00499408|Vitamin D|vitamin d|mesh-list
111193657|NCT00499408|Cholecalciferol|cholecalciferol|mesh-list
111193658|NCT00499408|Vitamins|vitamins|mesh-ancestor
111193659|NCT00499408|Micronutrients|micronutrients|mesh-ancestor
111193660|NCT00499408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111193661|NCT00499408|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111193662|NCT00499408|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111193663|NCT03019666|Niacinamide|niacinamide|mesh-list
111193665|NCT03019666|Nicotinic Acids|nicotinic acids|mesh-list
111193666|NCT03019666|Vitamin B Complex|vitamin b complex|mesh-ancestor
111193667|NCT03019666|Vitamins|vitamins|mesh-ancestor
111193668|NCT03019666|Micronutrients|micronutrients|mesh-ancestor
111193669|NCT03019666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111193670|NCT03019666|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111193671|NCT03019666|Antimetabolites|antimetabolites|mesh-ancestor
111193672|NCT03019666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111193673|NCT03019666|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111193674|NCT03019666|Vasodilator Agents|vasodilator agents|mesh-ancestor
111193675|NCT00500578|Ribavirin|ribavirin|mesh-list
111193676|NCT00500578|Antimetabolites|antimetabolites|mesh-ancestor
111193677|NCT00500578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111193678|NCT00500578|Antiviral Agents|antiviral agents|mesh-ancestor
111193679|NCT00500578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111193680|NCT01430559|Meloxicam|meloxicam|mesh-list
111193681|NCT01430559|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111193682|NCT01430559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111193683|NCT01430559|Analgesics|analgesics|mesh-ancestor
111193684|NCT01430559|Sensory System Agents|sensory system agents|mesh-ancestor
111193685|NCT01430559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110845498|NCT02652468|Tacrolimus|tacrolimus|mesh-list
111193686|NCT01430559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111193687|NCT01430559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111193688|NCT01430559|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111193689|NCT01430559|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111193690|NCT01430559|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111193691|NCT01430559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111193692|NCT01430559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111193694|NCT00500656|Tranexamic Acid|tranexamic acid|mesh-list
111193695|NCT00500656|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111193696|NCT00500656|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111193697|NCT00500656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111193698|NCT00500656|Hemostatics|hemostatics|mesh-ancestor
111193699|NCT00500656|Coagulants|coagulants|mesh-ancestor
111193700|NCT00500656|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111193701|NCT00500656|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111193702|NCT00500656|Analgesics|analgesics|mesh-ancestor
111193703|NCT00500656|Sensory System Agents|sensory system agents|mesh-ancestor
111193704|NCT00500656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111193705|NCT00500656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111193706|NCT00500656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111193707|NCT00500656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111193708|NCT00500656|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
111193709|NCT00500656|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
111193710|NCT00500656|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
111193711|NCT00500656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111193712|NCT00500656|Immunologic Factors|immunologic factors|mesh-ancestor
111193713|NCT01409811|Zoledronic Acid|zoledronic acid|mesh-list
111193714|NCT01409811|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111193715|NCT01409811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111193716|NCT01445847|Lidocaine|lidocaine|mesh-list
111193717|NCT01445847|Anesthetics, Local|anesthetics, local|mesh-ancestor
111193718|NCT01445847|Anesthetics|anesthetics|mesh-ancestor
111193719|NCT01445847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111193720|NCT01445847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111193721|NCT01445847|Sensory System Agents|sensory system agents|mesh-ancestor
111193722|NCT01445847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111193723|NCT01445847|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111193724|NCT01445847|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111193725|NCT01445847|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111193726|NCT01445847|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111193727|NCT01445847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111193728|NCT00502216|Naltrexone|naltrexone|mesh-list
110910802|NCT01377961|Lycopene|lycopene|mesh-list
111193729|NCT00502216|Varenicline|varenicline|mesh-list
111193730|NCT00502216|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111193731|NCT00502216|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111193732|NCT00502216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111193733|NCT00502216|Sensory System Agents|sensory system agents|mesh-ancestor
111193734|NCT00502216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111193735|NCT00502216|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111193736|NCT00502216|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111193737|NCT00502216|Cholinergic Agents|cholinergic agents|mesh-ancestor
111193738|NCT00502216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111193739|NCT00502216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111193740|NCT00545662|Choline|choline|mesh-list
111193741|NCT00545662|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
111193742|NCT00545662|Lipotropic Agents|lipotropic agents|mesh-ancestor
111193743|NCT00545662|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111193744|NCT00545662|Antimetabolites|antimetabolites|mesh-ancestor
111193745|NCT00545662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111193746|NCT00545662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111193747|NCT00545662|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111193748|NCT00545662|Nootropic Agents|nootropic agents|mesh-ancestor
111193749|NCT00545974|Memantine|memantine|mesh-list
111193750|NCT00545974|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111193751|NCT00545974|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111193752|NCT00545974|Dopamine Agents|dopamine agents|mesh-ancestor
111193753|NCT00545974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111193754|NCT00545974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111193755|NCT00545974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111193756|NCT00545974|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111193757|NCT00545974|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111193758|NCT00548470|Varenicline|varenicline|mesh-list
111193759|NCT00548470|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111193760|NCT00548470|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111193761|NCT00548470|Cholinergic Agents|cholinergic agents|mesh-ancestor
111193762|NCT00548470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111193763|NCT00548470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111193764|NCT00548470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111193765|NCT02675452|Itraconazole|itraconazole|mesh-list
111193766|NCT02675452|Azacitidine|azacitidine|mesh-list
111193767|NCT02675452|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111193768|NCT02675452|Antimetabolites|antimetabolites|mesh-ancestor
111193769|NCT02675452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111193770|NCT02675452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111193771|NCT02675452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111193772|NCT02675452|Antifungal Agents|antifungal agents|mesh-ancestor
111193773|NCT02675452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111193774|NCT02675452|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111193775|NCT02675452|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111193776|NCT02675452|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111193777|NCT02675452|Hormone Antagonists|hormone antagonists|mesh-ancestor
111193778|NCT02675452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111193779|NCT02675452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111193780|NCT02675452|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111193781|NCT00509002|Gefitinib|gefitinib|mesh-list
111193782|NCT00509002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111193783|NCT00509002|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111193784|NCT00509002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111193785|NCT00509002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111193786|NCT00887380|Anastrozole|anastrozole|mesh-list
111193787|NCT00887380|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111193788|NCT00887380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111193789|NCT00887380|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111193790|NCT00887380|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111193791|NCT00887380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111193792|NCT00887380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111193793|NCT00887380|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111193794|NCT00887380|Hormone Antagonists|hormone antagonists|mesh-ancestor
111193795|NCT00887380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111193796|NCT00887380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111193797|NCT00551200|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
111193798|NCT00551200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111193799|NCT00557284|Montelukast|montelukast|mesh-list
111193800|NCT00557284|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110910878|NCT02227550|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111193801|NCT00557284|Respiratory System Agents|respiratory system agents|mesh-ancestor
111193802|NCT00557284|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
111193803|NCT00557284|Hormone Antagonists|hormone antagonists|mesh-ancestor
111193804|NCT00557284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111193805|NCT00557284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111193806|NCT00557284|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
111193807|NCT00557284|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111193808|NCT00557284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111193809|NCT00557362|Voriconazole|voriconazole|mesh-list
111193810|NCT00557362|Natamycin|natamycin|mesh-list
110845510|NCT02652468|Antimetabolites|antimetabolites|mesh-ancestor
111193811|NCT00557362|Antifungal Agents|antifungal agents|mesh-ancestor
111193812|NCT00557362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111193813|NCT00557362|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111193814|NCT00557362|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111193815|NCT00557362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111193816|NCT00557362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111193817|NCT00557362|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111193818|NCT00557362|Hormone Antagonists|hormone antagonists|mesh-ancestor
111193819|NCT00557362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111193820|NCT00557362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111193821|NCT00557362|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111193822|NCT00557362|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111193823|NCT00557362|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111193824|NCT00512278|Infliximab|infliximab|mesh-list
111193825|NCT00512278|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111193826|NCT00512278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111193827|NCT00512278|Dermatologic Agents|dermatologic agents|mesh-ancestor
111193828|NCT00512278|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111193829|NCT00512278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111193830|NCT01445535|Prednisone|prednisone|mesh-list
111193831|NCT01445535|Cyclophosphamide|cyclophosphamide|mesh-list
111193832|NCT01445535|Rituximab|rituximab|mesh-list
111193833|NCT01445535|Doxorubicin|doxorubicin|mesh-list
111193834|NCT01445535|Etoposide|etoposide|mesh-list
111193835|NCT01445535|Vincristine|vincristine|mesh-list
111193836|NCT01445535|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111193837|NCT01445535|Immunologic Factors|immunologic factors|mesh-ancestor
111193838|NCT01445535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111193839|NCT01445535|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111193840|NCT01445535|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111193841|NCT01445535|Alkylating Agents|alkylating agents|mesh-ancestor
111193842|NCT01445535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111193843|NCT01445535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111193844|NCT01445535|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111193845|NCT01445535|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111193846|NCT01445535|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111193847|NCT01445535|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111193848|NCT01445535|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111193849|NCT01445535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111193850|NCT01445535|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111193851|NCT01445535|Glucocorticoids|glucocorticoids|mesh-ancestor
111193852|NCT01445535|Hormones|hormones|mesh-ancestor
111193853|NCT01445535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111193854|NCT01445535|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111193855|NCT01445535|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111193856|NCT01445535|Tubulin Modulators|tubulin modulators|mesh-ancestor
111193857|NCT01445535|Antimitotic Agents|antimitotic agents|mesh-ancestor
111193858|NCT01445535|Mitosis Modulators|mitosis modulators|mesh-ancestor
111193859|NCT01409031|Sildenafil Citrate|sildenafil citrate|mesh-list
111193860|NCT01409031|Vasodilator Agents|vasodilator agents|mesh-ancestor
111193861|NCT01409031|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111193862|NCT01409031|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111193863|NCT01409031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111193864|NCT01409031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111193865|NCT01409031|Urological Agents|urological agents|mesh-ancestor
111193866|NCT01430403|Fluticasone|fluticasone|mesh-list
111193867|NCT01430403|Xhance|xhance|mesh-list
111193868|NCT01430403|Omalizumab|omalizumab|mesh-list
111193869|NCT01430403|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111193870|NCT01430403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111193871|NCT01430403|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111193872|NCT01430403|Autonomic Agents|autonomic agents|mesh-ancestor
111193873|NCT01430403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111193874|NCT01430403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111193875|NCT01430403|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111193876|NCT01430403|Respiratory System Agents|respiratory system agents|mesh-ancestor
111193878|NCT01430403|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111193879|NCT01430403|Immunologic Factors|immunologic factors|mesh-ancestor
111193880|NCT01408641|Topiramate|topiramate|mesh-list
111193881|NCT01408641|Anticonvulsants|anticonvulsants|mesh-ancestor
111193882|NCT01408641|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111193883|NCT01408641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111193884|NCT01429077|Levodopa|levodopa|mesh-list
111193885|NCT01429077|Carbidopa|carbidopa|mesh-list
111193886|NCT01429077|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111193887|NCT01429077|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111193888|NCT01429077|Dopamine Agents|dopamine agents|mesh-ancestor
111193889|NCT01429077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111193890|NCT01429077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111193891|NCT01429077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111193892|NCT01429077|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
111193893|NCT01429077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111193894|NCT01408563|Fludarabine|fludarabine|mesh-list
111193895|NCT01408563|Melphalan|melphalan|mesh-list
111193896|NCT01408563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111193897|NCT01408563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111193898|NCT01408563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111193899|NCT01408563|Immunologic Factors|immunologic factors|mesh-ancestor
111193900|NCT01408563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111193901|NCT01408563|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111193902|NCT01408563|Alkylating Agents|alkylating agents|mesh-ancestor
111193903|NCT01408563|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111193904|NCT01442493|Methadone|methadone|mesh-list
111193905|NCT01442493|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111193906|NCT01442493|Narcotics|narcotics|mesh-ancestor
111193907|NCT01442493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111193908|NCT01442493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111193909|NCT01442493|Analgesics|analgesics|mesh-ancestor
111193910|NCT01442493|Sensory System Agents|sensory system agents|mesh-ancestor
111193911|NCT01442493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111193912|NCT01442493|Antitussive Agents|antitussive agents|mesh-ancestor
111193913|NCT01442493|Respiratory System Agents|respiratory system agents|mesh-ancestor
111193914|NCT04407975|Betamethasone|betamethasone|mesh-list
111193915|NCT04407975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111193916|NCT04407975|Glucocorticoids|glucocorticoids|mesh-ancestor
111193917|NCT04407975|Hormones|hormones|mesh-ancestor
111193918|NCT04407975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111193919|NCT04407975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111193920|NCT04407975|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111193921|NCT04407975|Respiratory System Agents|respiratory system agents|mesh-ancestor
111193922|NCT01428063|Interferons|interferons|mesh-list
111193923|NCT01428063|Ribavirin|ribavirin|mesh-list
110491042|NCT00741949|Propofol|propofol|mesh-list
111193924|NCT01428063|Interferon-alpha|interferon-alpha|mesh-list
111193925|NCT01428063|Interferon alpha-2|interferon alpha-2|mesh-list
111193926|NCT01428063|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
111193927|NCT01428063|Asunaprevir|asunaprevir|mesh-list
111193928|NCT01428063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111193929|NCT01428063|Antiviral Agents|antiviral agents|mesh-ancestor
111193930|NCT01428063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111193931|NCT01428063|Antimetabolites|antimetabolites|mesh-ancestor
111193932|NCT01428063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111193933|NCT01428063|Immunologic Factors|immunologic factors|mesh-ancestor
111193934|NCT01428063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111193935|NCT01428063|Protease Inhibitors|protease inhibitors|mesh-ancestor
111193936|NCT01428063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111193937|NCT00513292|Paclitaxel|paclitaxel|mesh-list
111193938|NCT00513292|Cyclophosphamide|cyclophosphamide|mesh-list
111193939|NCT00513292|Trastuzumab|trastuzumab|mesh-list
111193940|NCT00513292|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111193941|NCT00513292|Epirubicin|epirubicin|mesh-list
111193942|NCT00513292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111193943|NCT00513292|Antibodies|antibodies|mesh-list
111193944|NCT00513292|Immunoglobulins|immunoglobulins|mesh-list
111193945|NCT00513292|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111193946|NCT00513292|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111193947|NCT00513292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111193948|NCT00513292|Tubulin Modulators|tubulin modulators|mesh-ancestor
111193949|NCT00513292|Antimitotic Agents|antimitotic agents|mesh-ancestor
111193950|NCT00513292|Mitosis Modulators|mitosis modulators|mesh-ancestor
111193951|NCT00513292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111193952|NCT00513292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111193953|NCT00513292|Immunologic Factors|immunologic factors|mesh-ancestor
110845528|NCT01314339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111193954|NCT00513292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111193955|NCT00513292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111193956|NCT00513292|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111193957|NCT00513292|Alkylating Agents|alkylating agents|mesh-ancestor
111193958|NCT00513292|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111193959|NCT00513292|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111193960|NCT00513292|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111193961|NCT00513292|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111193962|NCT00513292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111193964|NCT00513370|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111193965|NCT00513370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111193966|NCT00513370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111193968|NCT00559468|Propofol|propofol|mesh-list
111193969|NCT00559468|Sevoflurane|sevoflurane|mesh-list
111193970|NCT00559468|Rocuronium|rocuronium|mesh-list
111193971|NCT00559468|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111193972|NCT00559468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111193973|NCT00559468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111193974|NCT00559468|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111193975|NCT00559468|Anesthetics, General|anesthetics, general|mesh-ancestor
111193976|NCT00559468|Anesthetics|anesthetics|mesh-ancestor
111193977|NCT00559468|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111193978|NCT00559468|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111193979|NCT00559468|Anticonvulsants|anticonvulsants|mesh-ancestor
111193980|NCT00559468|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
111193981|NCT00559468|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
111193982|NCT00559468|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111193983|NCT00559468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111193984|NCT00513526|Vaccines|vaccines|mesh-list
111193985|NCT00513526|Immunologic Factors|immunologic factors|mesh-ancestor
111193986|NCT00513526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111193987|NCT00561418|Vorinostat|vorinostat|mesh-list
111193988|NCT00561418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111193989|NCT00561418|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111193990|NCT00561418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111193991|NCT00561418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111193992|NCT00514852|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
111193993|NCT00514852|Lubricant Eye Drops|lubricant eye drops|mesh-list
111193994|NCT00514852|Glycerol|glycerol|mesh-list
111193995|NCT00514852|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
111193996|NCT00514852|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111193997|NCT00514852|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
111193998|NCT00514852|Protective Agents|protective agents|mesh-ancestor
111193999|NCT00514852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111194000|NCT00514852|Laxatives|laxatives|mesh-ancestor
111194001|NCT00514852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111194002|NCT00555880|Midodrine|midodrine|mesh-list
111194003|NCT00555880|Sympathomimetics|sympathomimetics|mesh-ancestor
111194004|NCT00555880|Autonomic Agents|autonomic agents|mesh-ancestor
111194005|NCT00555880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111194006|NCT00555880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111194007|NCT00555880|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111194008|NCT00555880|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111194009|NCT00555880|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111194010|NCT00555880|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111194011|NCT00555880|Adrenergic Agents|adrenergic agents|mesh-ancestor
111194012|NCT00555880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111194013|NCT00555880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111194014|NCT00563290|Dasatinib|dasatinib|mesh-list
111194015|NCT00563290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111194016|NCT00563290|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111194017|NCT00563290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111194018|NCT00563290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111194019|NCT00556504|Ribavirin|ribavirin|mesh-list
111194020|NCT00556504|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
111194021|NCT00556504|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
111194022|NCT00556504|Antimetabolites|antimetabolites|mesh-ancestor
111194023|NCT00556504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111194024|NCT00556504|Antiviral Agents|antiviral agents|mesh-ancestor
111194025|NCT00556504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111194026|NCT02128828|Cenicriviroc|cenicriviroc|mesh-list
111194027|NCT02128828|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
111194028|NCT02128828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111194029|NCT02128828|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111194030|NCT02128828|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111194031|NCT02128828|Antiviral Agents|antiviral agents|mesh-ancestor
111194032|NCT02128828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111194033|NCT00520234|Caspofungin|caspofungin|mesh-list
111194034|NCT00520234|Antifungal Agents|antifungal agents|mesh-ancestor
111194035|NCT00520234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111194036|NCT00520234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111194037|NCT00520234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111194038|NCT00520468|Cyclosporine|cyclosporine|mesh-list
111194039|NCT00520468|Prednisone|prednisone|mesh-list
111194040|NCT00520468|Epoetin Alfa|epoetin alfa|mesh-list
111194041|NCT00520468|Darbepoetin alfa|darbepoetin alfa|mesh-list
111194042|NCT00520468|Cyclosporins|cyclosporins|mesh-list
111194043|NCT00520468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111194044|NCT00520468|Glucocorticoids|glucocorticoids|mesh-ancestor
111194045|NCT00520468|Hormones|hormones|mesh-ancestor
111194046|NCT00520468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111194047|NCT00520468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111194048|NCT00520468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111194049|NCT00520468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111194050|NCT00520468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111194051|NCT00520468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111194052|NCT00520468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111194053|NCT00520468|Immunologic Factors|immunologic factors|mesh-ancestor
111194054|NCT00520468|Antifungal Agents|antifungal agents|mesh-ancestor
111194055|NCT00520468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111194056|NCT00520468|Dermatologic Agents|dermatologic agents|mesh-ancestor
111194057|NCT00520468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111194058|NCT00520468|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111194059|NCT00520468|Hematinics|hematinics|mesh-ancestor
111194060|NCT05560516|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
111194061|NCT05560516|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111194062|NCT05560516|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111194063|NCT05560516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111194064|NCT05560516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111194065|NCT05560516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111194066|NCT05560516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111194067|NCT05560516|Analgesics|analgesics|mesh-ancestor
111194068|NCT05560516|Sensory System Agents|sensory system agents|mesh-ancestor
111194069|NCT05560516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111194070|NCT05560516|Antidepressive Agents|antidepressive agents|mesh-ancestor
111194071|NCT05560516|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111194072|NCT05560516|Dopamine Agents|dopamine agents|mesh-ancestor
111194073|NCT05559268|Denosumab|denosumab|mesh-list
111194074|NCT05559268|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111194075|NCT05559268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111194076|NCT02121418|Cytarabine|cytarabine|mesh-list
111194077|NCT02121418|Decitabine|decitabine|mesh-list
111194078|NCT02121418|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111194079|NCT02121418|Antimetabolites|antimetabolites|mesh-ancestor
111194080|NCT02121418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111194081|NCT02121418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111194082|NCT02121418|Antiviral Agents|antiviral agents|mesh-ancestor
111194083|NCT02121418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111194084|NCT02121418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111194085|NCT02121418|Immunologic Factors|immunologic factors|mesh-ancestor
111194086|NCT02121418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111194087|NCT02121418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111194088|NCT01441635|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
111194089|NCT01441635|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
111194090|NCT01441635|Norethindrone|norethindrone|mesh-list
111194091|NCT01441635|Norethindrone Acetate|norethindrone acetate|mesh-list
111194092|NCT01441635|Estradiol|estradiol|mesh-list
111194093|NCT01441635|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
111194094|NCT01441635|Progesterone|progesterone|mesh-list
111194095|NCT01441635|Estrogens|estrogens|mesh-ancestor
111194096|NCT01441635|Hormones|hormones|mesh-ancestor
111194097|NCT01441635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111194098|NCT01441635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111194099|NCT01441635|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111194100|NCT01441635|Contraceptive Agents|contraceptive agents|mesh-ancestor
111194101|NCT01441635|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111194102|NCT01441635|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111194103|NCT01441635|Progestins|progestins|mesh-ancestor
111194104|NCT01441635|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111194106|NCT01441635|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111194107|NCT01427907|Calcium|calcium|mesh-list
111194108|NCT01427907|Sevelamer|sevelamer|mesh-list
111194109|NCT01427907|Calcium acetate|calcium acetate|mesh-list
110799572|NCT02066350|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111194110|NCT01427907|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111194111|NCT01427907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111194112|NCT01427907|Chelating Agents|chelating agents|mesh-ancestor
111194113|NCT01427907|Sequestering Agents|sequestering agents|mesh-ancestor
111194114|NCT01427907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111194115|NCT02985333|Dexamethasone|dexamethasone|mesh-list
111194116|NCT02985333|Paclitaxel|paclitaxel|mesh-list
111194117|NCT02985333|Cyclophosphamide|cyclophosphamide|mesh-list
111194118|NCT02985333|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111194119|NCT02985333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111194120|NCT02985333|Tubulin Modulators|tubulin modulators|mesh-ancestor
111194121|NCT02985333|Antimitotic Agents|antimitotic agents|mesh-ancestor
111194122|NCT02985333|Mitosis Modulators|mitosis modulators|mesh-ancestor
111194123|NCT02985333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111194124|NCT02985333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111194125|NCT02985333|Immunologic Factors|immunologic factors|mesh-ancestor
111194126|NCT02985333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111194127|NCT02985333|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111194128|NCT02985333|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111194129|NCT02985333|Alkylating Agents|alkylating agents|mesh-ancestor
111194130|NCT02985333|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111194131|NCT02985333|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111194132|NCT02985333|Antiemetics|antiemetics|mesh-ancestor
111194133|NCT02985333|Autonomic Agents|autonomic agents|mesh-ancestor
111194134|NCT02985333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111194135|NCT02985333|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111194136|NCT02985333|Glucocorticoids|glucocorticoids|mesh-ancestor
111194137|NCT02985333|Hormones|hormones|mesh-ancestor
111194138|NCT02985333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111194139|NCT02985333|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111194140|NCT01427751|Dexamethasone|dexamethasone|mesh-list
111194141|NCT01427751|Ranibizumab|ranibizumab|mesh-list
111194142|NCT01427751|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111194143|NCT01427751|Antiemetics|antiemetics|mesh-ancestor
111194144|NCT01427751|Autonomic Agents|autonomic agents|mesh-ancestor
111194145|NCT01427751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111194146|NCT01427751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111194147|NCT01427751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111194148|NCT01427751|Glucocorticoids|glucocorticoids|mesh-ancestor
111194149|NCT01427751|Hormones|hormones|mesh-ancestor
111194150|NCT01427751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111194151|NCT01427751|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111194152|NCT01427751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111194153|NCT01427751|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111194154|NCT01427751|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111194155|NCT01427751|Growth Substances|growth substances|mesh-ancestor
111194156|NCT01427751|Growth Inhibitors|growth inhibitors|mesh-ancestor
111194157|NCT01920061|Docetaxel|docetaxel|mesh-list
111194158|NCT01920061|Gedatolisib|gedatolisib|mesh-list
111194159|NCT01920061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111194160|NCT01920061|Tubulin Modulators|tubulin modulators|mesh-ancestor
111194161|NCT01920061|Antimitotic Agents|antimitotic agents|mesh-ancestor
111194162|NCT01920061|Mitosis Modulators|mitosis modulators|mesh-ancestor
111194163|NCT01920061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111194164|NCT01920061|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111194165|NCT01920061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111194167|NCT01426347|Ergocalciferols|ergocalciferols|mesh-list
111194168|NCT01426347|Vitamins|vitamins|mesh-ancestor
111194169|NCT01426347|Micronutrients|micronutrients|mesh-ancestor
111194170|NCT01426347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111194171|NCT01426347|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111194172|NCT01426347|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111194173|NCT04612309|Immunomodulating Agents|immunomodulating agents|mesh-list
111194174|NCT04612309|Immunologic Factors|immunologic factors|mesh-ancestor
111194175|NCT04612309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111194176|NCT04415983|Metronidazole|metronidazole|mesh-list
111194177|NCT04415983|Clarithromycin|clarithromycin|mesh-list
111194178|NCT04415983|Nitazoxanide|nitazoxanide|mesh-list
111194179|NCT04415983|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
111194180|NCT04415983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111194181|NCT04415983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111194182|NCT04415983|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111194183|NCT04415983|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111194184|NCT04415983|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111194185|NCT04415983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111194186|NCT04415983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111194187|NCT04415983|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111194188|NCT04415983|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111194189|NCT01426269|Metronidazole|metronidazole|mesh-list
111194190|NCT01426269|Doxycycline|doxycycline|mesh-list
111194191|NCT01426269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111194192|NCT01426269|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111194193|NCT01426269|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111194194|NCT01426269|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111194195|NCT01426269|Antimalarials|antimalarials|mesh-ancestor
111194196|NCT01426113|Timolol|timolol|mesh-list
111194197|NCT01426113|Bimatoprost|bimatoprost|mesh-list
111194198|NCT01426113|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111194199|NCT01426113|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111194200|NCT01426113|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111194201|NCT01426113|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111194202|NCT01426113|Adrenergic Agents|adrenergic agents|mesh-ancestor
111194203|NCT01426113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111194204|NCT01426113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111194205|NCT01426113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111194206|NCT01426113|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111194207|NCT01426113|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111194208|NCT01393899|Tofacitinib|tofacitinib|mesh-list
111194209|NCT01393899|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
111194210|NCT01393899|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111194211|NCT01393899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111194212|NCT01393899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111194213|NCT02078193|Abatacept|abatacept|mesh-list
111194214|NCT02078193|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111194215|NCT02078193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111194216|NCT02078193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111194217|NCT02078193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111194218|NCT02078193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111194219|NCT02078193|Immunologic Factors|immunologic factors|mesh-ancestor
111194220|NCT02078193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111194221|NCT02078193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111194222|NCT01405911|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111194223|NCT01405911|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111194224|NCT01405911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111194225|NCT01405911|Incretins|incretins|mesh-ancestor
111194226|NCT01405911|Hormones|hormones|mesh-ancestor
111194227|NCT01405911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111194228|NCT01405911|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111194229|NCT01405911|Protease Inhibitors|protease inhibitors|mesh-ancestor
111194230|NCT01405911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111194231|NCT01405911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111194232|NCT01425801|Albuterol|albuterol|mesh-list
111194233|NCT01425801|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111194234|NCT01425801|Autonomic Agents|autonomic agents|mesh-ancestor
111194235|NCT01425801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111194236|NCT01425801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111194237|NCT01425801|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111194238|NCT01425801|Respiratory System Agents|respiratory system agents|mesh-ancestor
111194239|NCT01425801|Tocolytic Agents|tocolytic agents|mesh-ancestor
111194240|NCT01425801|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111194241|NCT01425801|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111194242|NCT01425801|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111194243|NCT01425801|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111194244|NCT01425801|Adrenergic Agents|adrenergic agents|mesh-ancestor
111194245|NCT01425801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111194246|NCT01425801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111194247|NCT02335125|Psychotropic Drugs|psychotropic drugs|mesh-list
111194248|NCT02076243|Paclitaxel|paclitaxel|mesh-list
111194249|NCT02076243|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111194250|NCT02076243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111194251|NCT02076243|Tubulin Modulators|tubulin modulators|mesh-ancestor
111194252|NCT02076243|Antimitotic Agents|antimitotic agents|mesh-ancestor
111194253|NCT02076243|Mitosis Modulators|mitosis modulators|mesh-ancestor
111194254|NCT02076243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111194255|NCT01392963|Botulinum Toxins|botulinum toxins|mesh-list
111194256|NCT01392963|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111194257|NCT01392963|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111194258|NCT01392963|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111194259|NCT01392963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111194260|NCT01392963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111194261|NCT01392963|Cholinergic Agents|cholinergic agents|mesh-ancestor
111194262|NCT01392963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111194263|NCT01392963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111194264|NCT01392963|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111194265|NCT01392963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111194266|NCT01392573|Insulin|insulin|mesh-list
111194267|NCT01392573|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111194268|NCT01392573|Liraglutide|liraglutide|mesh-list
111194269|NCT01392573|Insulin, Long-Acting|insulin, long-acting|mesh-list
111194270|NCT01392573|Xultophy|xultophy|mesh-list
111194271|NCT01392573|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111194272|NCT01392573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111194273|NCT01392573|Incretins|incretins|mesh-ancestor
111194274|NCT01392573|Hormones|hormones|mesh-ancestor
111194275|NCT01392573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111194276|NCT01392495|Imatinib Mesylate|imatinib mesylate|mesh-list
111194277|NCT01392495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111194278|NCT01392495|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111194279|NCT01392495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111194280|NCT01392495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111194281|NCT01405053|Rufinamide|rufinamide|mesh-list
111194282|NCT01405053|Anticonvulsants|anticonvulsants|mesh-list
111194283|NCT01405053|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111194284|NCT01405053|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111194285|NCT01405053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111194286|NCT01405053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111194287|NCT01403805|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
111194288|NCT01403805|Immunologic Factors|immunologic factors|mesh-ancestor
111194289|NCT01403805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111194290|NCT01392183|Diphenhydramine|diphenhydramine|mesh-list
111194291|NCT01392183|Sirolimus|sirolimus|mesh-list
111194292|NCT01392183|Temsirolimus|temsirolimus|mesh-list
111194293|NCT01392183|MTOR Inhibitors|mtor inhibitors|mesh-list
111194294|NCT01392183|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111194295|NCT01392183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111194296|NCT01392183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111194297|NCT01392183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111194298|NCT01392183|Immunologic Factors|immunologic factors|mesh-ancestor
110845555|NCT01279811|Dopamine Agents|dopamine agents|mesh-ancestor
111194299|NCT01392183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111194300|NCT01392183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111194301|NCT01392183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111194302|NCT01392183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111194303|NCT01392183|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111194304|NCT01392183|Antifungal Agents|antifungal agents|mesh-ancestor
111194305|NCT01392183|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111194306|NCT01392183|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111194307|NCT01392183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111194308|NCT01392183|Anesthetics, Local|anesthetics, local|mesh-ancestor
111194309|NCT01392183|Anesthetics|anesthetics|mesh-ancestor
111194310|NCT01392183|Sensory System Agents|sensory system agents|mesh-ancestor
111194311|NCT01392183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111194312|NCT01392183|Antiemetics|antiemetics|mesh-ancestor
111194313|NCT01392183|Autonomic Agents|autonomic agents|mesh-ancestor
111194314|NCT01392183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111194315|NCT01392183|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111194316|NCT01392183|Histamine Antagonists|histamine antagonists|mesh-ancestor
111194317|NCT01392183|Histamine Agents|histamine agents|mesh-ancestor
111194318|NCT01392183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111194319|NCT01392183|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111194320|NCT01402947|Ciprofloxacin|ciprofloxacin|mesh-list
111194321|NCT01402947|Mesalamine|mesalamine|mesh-list
111194322|NCT01402947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111194323|NCT01402947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111194324|NCT01402947|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111194325|NCT01402947|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111194326|NCT01402947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111194327|NCT01402947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111194328|NCT01402947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111194329|NCT01402947|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111194330|NCT01402947|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111194331|NCT01402947|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111194332|NCT01402947|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111194333|NCT01402947|Analgesics|analgesics|mesh-ancestor
111194334|NCT01402947|Sensory System Agents|sensory system agents|mesh-ancestor
111194335|NCT01402947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111194336|NCT01402947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111194337|NCT01402947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111194338|NCT01402947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111194339|NCT03025893|Sunitinib|sunitinib|mesh-list
111194340|NCT03025893|Lomustine|lomustine|mesh-list
111194341|NCT03025893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111194342|NCT03025893|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111194343|NCT03025893|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111194344|NCT03025893|Growth Substances|growth substances|mesh-ancestor
111194345|NCT03025893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111194346|NCT03025893|Growth Inhibitors|growth inhibitors|mesh-ancestor
111194347|NCT03025893|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111194348|NCT03025893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111194349|NCT03025893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111194350|NCT03025893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111194351|NCT03025893|Alkylating Agents|alkylating agents|mesh-ancestor
111194352|NCT01402869|Lidocaine|lidocaine|mesh-list
111194353|NCT01402869|Epinephrine|epinephrine|mesh-list
111194354|NCT01402869|Prilocaine|prilocaine|mesh-list
111194355|NCT01402869|Anesthetics, Local|anesthetics, local|mesh-ancestor
111194356|NCT01402869|Anesthetics|anesthetics|mesh-ancestor
111194357|NCT01402869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111194358|NCT01402869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111194359|NCT01402869|Sensory System Agents|sensory system agents|mesh-ancestor
111194360|NCT01402869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111194361|NCT01402869|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111194362|NCT01402869|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111194363|NCT01402869|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111194364|NCT01402869|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111194365|NCT01402869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111194366|NCT01402869|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111194367|NCT01402869|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111194368|NCT01402869|Adrenergic Agents|adrenergic agents|mesh-ancestor
111194369|NCT01402869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111194370|NCT01402869|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111194371|NCT01402869|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111194372|NCT01402869|Autonomic Agents|autonomic agents|mesh-ancestor
111194373|NCT01402869|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111194374|NCT01402869|Respiratory System Agents|respiratory system agents|mesh-ancestor
111194375|NCT01402869|Mydriatics|mydriatics|mesh-ancestor
111194376|NCT01402869|Sympathomimetics|sympathomimetics|mesh-ancestor
111194377|NCT01402869|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111194378|NCT01391793|Dexamethasone|dexamethasone|mesh-list
111194379|NCT01391793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111194380|NCT01391793|Antiemetics|antiemetics|mesh-ancestor
111194381|NCT01391793|Autonomic Agents|autonomic agents|mesh-ancestor
111194382|NCT01391793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111194383|NCT01391793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111194384|NCT01391793|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111194385|NCT01391793|Glucocorticoids|glucocorticoids|mesh-ancestor
111194387|NCT01391793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111194388|NCT01391793|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111194389|NCT01391793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111194390|NCT01422915|Colestipol|colestipol|mesh-list
111194391|NCT01422915|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111194392|NCT01422915|Antimetabolites|antimetabolites|mesh-ancestor
111194393|NCT01422915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111194394|NCT01422915|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111194395|NCT01422915|Sequestering Agents|sequestering agents|mesh-ancestor
111194396|NCT01727024|Tiotropium Bromide|tiotropium bromide|mesh-list
111194397|NCT01727024|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111194398|NCT01727024|Autonomic Agents|autonomic agents|mesh-ancestor
111194399|NCT01727024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111194400|NCT01727024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111194401|NCT01727024|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111194402|NCT01727024|Respiratory System Agents|respiratory system agents|mesh-ancestor
111194403|NCT01727024|Parasympatholytics|parasympatholytics|mesh-ancestor
111194404|NCT01727024|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111194405|NCT01727024|Cholinergic Agents|cholinergic agents|mesh-ancestor
111194406|NCT01727024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111194407|NCT01727024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111194408|NCT01422213|Vortioxetine|vortioxetine|mesh-list
111194409|NCT01422213|Antidepressive Agents|antidepressive agents|mesh-ancestor
111194410|NCT01422213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111194411|NCT01422213|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111194412|NCT01422213|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111194413|NCT01422213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111194414|NCT01422213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111194415|NCT01422213|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111194416|NCT01422213|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111194417|NCT01422213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111194418|NCT01422213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111194419|NCT01422213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111194420|NCT01422213|Serotonin Agents|serotonin agents|mesh-ancestor
111194421|NCT01422213|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111194422|NCT01422213|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111194423|NCT01422213|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111194424|NCT01422213|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111194425|NCT01390857|Valacyclovir|valacyclovir|mesh-list
111194426|NCT01390857|Antiviral Agents|antiviral agents|mesh-ancestor
111194427|NCT01390857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111194428|NCT01725386|Capecitabine|capecitabine|mesh-list
111194429|NCT01725386|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111194430|NCT01725386|Antimetabolites|antimetabolites|mesh-ancestor
111194431|NCT01725386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111194432|NCT01725386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111194433|NCT01402011|Lidocaine|lidocaine|mesh-list
111194434|NCT01402011|Anesthetics, Local|anesthetics, local|mesh-ancestor
111194435|NCT01402011|Anesthetics|anesthetics|mesh-ancestor
111194436|NCT01402011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111194437|NCT01402011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111194438|NCT01402011|Sensory System Agents|sensory system agents|mesh-ancestor
111194439|NCT01402011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111194440|NCT01402011|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111194441|NCT01402011|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111194442|NCT01402011|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111194443|NCT01402011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111194444|NCT01402011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111194445|NCT01421667|Rituximab|rituximab|mesh-list
111194446|NCT01421667|Brentuximab Vedotin|brentuximab vedotin|mesh-list
111194447|NCT01421667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111194448|NCT01421667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111194449|NCT01421667|Immunologic Factors|immunologic factors|mesh-ancestor
111194450|NCT01421667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111194451|NCT01421667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111194452|NCT01421667|Immunotoxins|immunotoxins|mesh-ancestor
111194453|NCT01421667|Immunoconjugates|immunoconjugates|mesh-ancestor
111194454|NCT01891669|PF-06263507|pf-06263507|mesh-list
111194455|NCT01891669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111194456|NCT01891669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111194457|NCT01891669|Antimitotic Agents|antimitotic agents|mesh-ancestor
111194458|NCT01891669|Mitosis Modulators|mitosis modulators|mesh-ancestor
111194459|NCT01891669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111194460|NCT01421511|Linezolid|linezolid|mesh-list
111194461|NCT01421511|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111194462|NCT01421511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111194463|NCT01421511|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111194464|NCT01421511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111194465|NCT01421511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111194466|NCT01891357|Paclitaxel|paclitaxel|mesh-list
111194467|NCT01891357|Trastuzumab|trastuzumab|mesh-list
111194468|NCT01891357|Lapatinib|lapatinib|mesh-list
111194469|NCT01891357|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111194470|NCT01891357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111194471|NCT01891357|Tubulin Modulators|tubulin modulators|mesh-ancestor
111194472|NCT01891357|Antimitotic Agents|antimitotic agents|mesh-ancestor
111194473|NCT01891357|Mitosis Modulators|mitosis modulators|mesh-ancestor
111194474|NCT01891357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111194475|NCT01891357|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111194476|NCT01891357|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111194477|NCT01891357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111194478|NCT01420965|Cyclophosphamide|cyclophosphamide|mesh-list
111194479|NCT01420965|Antibodies|antibodies|mesh-list
111194480|NCT01420965|Immunoglobulins|immunoglobulins|mesh-list
111194481|NCT01420965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111194482|NCT01420965|Immunologic Factors|immunologic factors|mesh-ancestor
111194483|NCT01420965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111194484|NCT01420965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111194485|NCT01420965|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111194486|NCT01420965|Alkylating Agents|alkylating agents|mesh-ancestor
111194487|NCT01420965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111194488|NCT01420965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111194489|NCT01420965|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111194490|NCT04033575|Listerine|listerine|mesh-list
111194491|NCT04033575|Fluorides|fluorides|mesh-list
111194492|NCT04033575|Sodium Fluoride|sodium fluoride|mesh-list
111194493|NCT04033575|Tin Fluorides|tin fluorides|mesh-list
111194494|NCT04033575|Cariostatic Agents|cariostatic agents|mesh-ancestor
111194495|NCT04033575|Protective Agents|protective agents|mesh-ancestor
111194496|NCT04033575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111194497|NCT04033575|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111194498|NCT04033575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111194499|NCT03842085|Antibodies|antibodies|mesh-list
111194500|NCT03842085|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111194501|NCT03842085|Antibodies, Bispecific|antibodies, bispecific|mesh-list
111194502|NCT03842085|Immunologic Factors|immunologic factors|mesh-ancestor
111194503|NCT03842085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111194504|NCT01390389|Ubiquinone|ubiquinone|mesh-list
111194505|NCT01390389|Coenzyme Q10|coenzyme q10|mesh-list
111194506|NCT01390389|Micronutrients|micronutrients|mesh-ancestor
111194507|NCT01390389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111194509|NCT03835533|Nivolumab|nivolumab|mesh-list
111194510|NCT03835533|Poly ICLC|poly iclc|mesh-list
111194511|NCT03835533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111194512|NCT03835533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111194513|NCT03835533|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111194514|NCT03835533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111194515|NCT03835533|Interferon Inducers|interferon inducers|mesh-ancestor
111194516|NCT03835533|Immunologic Factors|immunologic factors|mesh-ancestor
111194517|NCT03835533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111194518|NCT01401465|Mometasone Furoate|mometasone furoate|mesh-list
111194519|NCT01401465|Ciclesonide|ciclesonide|mesh-list
111194520|NCT01401465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111194521|NCT01401465|Dermatologic Agents|dermatologic agents|mesh-ancestor
111194522|NCT01401465|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111194523|NCT01401465|Glucocorticoids|glucocorticoids|mesh-ancestor
111194524|NCT01401465|Hormones|hormones|mesh-ancestor
111194525|NCT01401465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111194526|NCT01401465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111194527|NCT01890967|Atorvastatin|atorvastatin|mesh-list
111194528|NCT01890967|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111194529|NCT01890967|Simvastatin|simvastatin|mesh-list
111194530|NCT01890967|Ezetimibe|ezetimibe|mesh-list
111194531|NCT01890967|Pravastatin|pravastatin|mesh-list
111194532|NCT01890967|Pitavastatin|pitavastatin|mesh-list
111194533|NCT01890967|Lovastatin|lovastatin|mesh-list
111194534|NCT01890967|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111194535|NCT01890967|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111194536|NCT01890967|Antimetabolites|antimetabolites|mesh-ancestor
111194537|NCT01890967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111194538|NCT01890967|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111194539|NCT01890967|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111194540|NCT01890967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111194541|NCT01863667|Glimepiride|glimepiride|mesh-list
111194542|NCT01863667|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111194543|NCT01863667|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111194544|NCT01863667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111194545|NCT01863667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111194546|NCT01863667|Immunologic Factors|immunologic factors|mesh-ancestor
111194547|NCT01614769|Glimepiride|glimepiride|mesh-list
111194548|NCT01614769|Hypoglycemic Agents|hypoglycemic agents|mesh-list
111194549|NCT01614769|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111194550|NCT01614769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111194551|NCT01614769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111194552|NCT01614769|Immunologic Factors|immunologic factors|mesh-ancestor
111194553|NCT01614457|Ivacaftor|ivacaftor|mesh-list
111194554|NCT01614457|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
111194555|NCT01614457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111194556|NCT01614457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111194557|NCT01835431|Insulin|insulin|mesh-list
111194558|NCT01835431|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111194559|NCT01835431|Insulin Aspart|insulin aspart|mesh-list
111194560|NCT01835431|Insulin, Long-Acting|insulin, long-acting|mesh-list
111194561|NCT01835431|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
111194562|NCT01835431|Insulin Detemir|insulin detemir|mesh-list
111194563|NCT01835431|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111194564|NCT01835431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111194565|NCT01880593|Ketamine|ketamine|mesh-list
111194566|NCT01880593|Lithium Carbonate|lithium carbonate|mesh-list
111194567|NCT01880593|Analgesics|analgesics|mesh-ancestor
111194568|NCT01880593|Sensory System Agents|sensory system agents|mesh-ancestor
111194569|NCT01880593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111194570|NCT01880593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111194571|NCT01880593|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111194572|NCT01880593|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111194573|NCT01880593|Anesthetics, General|anesthetics, general|mesh-ancestor
111194574|NCT01880593|Anesthetics|anesthetics|mesh-ancestor
111194575|NCT01880593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111194576|NCT01880593|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111194577|NCT01880593|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111194578|NCT01880593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111194579|NCT01880593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111194580|NCT01880593|Antidepressive Agents|antidepressive agents|mesh-ancestor
111194581|NCT01880593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111194582|NCT01880593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111194583|NCT01880593|Antimanic Agents|antimanic agents|mesh-ancestor
111194584|NCT01880593|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111194585|NCT01400451|Ipilimumab|ipilimumab|mesh-list
111194586|NCT01400451|Vemurafenib|vemurafenib|mesh-list
111194587|NCT01400451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111194588|NCT01400451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111194589|NCT01400451|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111194590|NCT01400451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111194591|NCT01400451|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111194592|NCT01400451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111194593|NCT01400139|Hydrocodone|hydrocodone|mesh-list
111194594|NCT01400139|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111194595|NCT01400139|Narcotics|narcotics|mesh-ancestor
111194596|NCT01400139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111194597|NCT01400139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111194598|NCT01400139|Analgesics|analgesics|mesh-ancestor
111194599|NCT01400139|Sensory System Agents|sensory system agents|mesh-ancestor
111194600|NCT01400139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111194601|NCT01400139|Antitussive Agents|antitussive agents|mesh-ancestor
111194602|NCT01400139|Respiratory System Agents|respiratory system agents|mesh-ancestor
111194603|NCT01399905|Carbidopa|carbidopa|mesh-list
111194604|NCT01399905|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111194605|NCT01399905|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111194606|NCT01399905|Dopamine Agents|dopamine agents|mesh-ancestor
111194607|NCT01399905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111194608|NCT01399905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111194609|NCT01399905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111194610|NCT01399905|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
111194611|NCT01399905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111194612|NCT01725308|Quetiapine Fumarate|quetiapine fumarate|mesh-list
111194613|NCT01725308|Antidepressive Agents|antidepressive agents|mesh-ancestor
111194614|NCT01725308|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111194615|NCT01725308|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111194616|NCT01725308|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111194617|NCT01725308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111194618|NCT01725308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111194619|NCT01724528|Allopurinol|allopurinol|mesh-list
111194620|NCT01724528|Febuxostat|febuxostat|mesh-list
111194621|NCT01724528|Antimetabolites|antimetabolites|mesh-ancestor
111194622|NCT01724528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111194623|NCT01724528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111194624|NCT01724528|Gout Suppressants|gout suppressants|mesh-ancestor
111194625|NCT01724528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111194626|NCT01724528|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111194627|NCT01724528|Antioxidants|antioxidants|mesh-ancestor
111194628|NCT01724528|Protective Agents|protective agents|mesh-ancestor
111194629|NCT01724528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111194630|NCT01750268|Topiramate|topiramate|mesh-list
110911705|NCT04539808|Antidotes|antidotes|mesh-ancestor
111194631|NCT01750268|Anticonvulsants|anticonvulsants|mesh-ancestor
111194632|NCT01750268|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111194633|NCT01750268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111194634|NCT01880437|Cytarabine|cytarabine|mesh-list
111194635|NCT01880437|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111194636|NCT01880437|Antimetabolites|antimetabolites|mesh-ancestor
111194637|NCT01880437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111194638|NCT01880437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111194639|NCT01880437|Antiviral Agents|antiviral agents|mesh-ancestor
111194640|NCT01880437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111194641|NCT01880437|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111194642|NCT01880437|Immunologic Factors|immunologic factors|mesh-ancestor
111194643|NCT01880437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111194644|NCT01861717|Lanreotide|lanreotide|mesh-list
111194645|NCT01861717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111194646|NCT01834729|Alfuzosin|alfuzosin|mesh-list
111194647|NCT01834729|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111194648|NCT01834729|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111194649|NCT01834729|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111194650|NCT01834729|Adrenergic Agents|adrenergic agents|mesh-ancestor
111194651|NCT01834729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111194652|NCT01834729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111194653|NCT01834729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111194654|NCT01834729|Urological Agents|urological agents|mesh-ancestor
111194655|NCT01860703|Moxifloxacin|moxifloxacin|mesh-list
111194656|NCT01860703|Deferiprone|deferiprone|mesh-list
111194657|NCT01860703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111194658|NCT01860703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111194659|NCT01860703|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111194660|NCT01860703|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111194661|NCT01860703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111194662|NCT01860703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111194663|NCT01860703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111194664|NCT01860703|Iron Chelating Agents|iron chelating agents|mesh-ancestor
111194665|NCT01860703|Chelating Agents|chelating agents|mesh-ancestor
111194666|NCT01860703|Sequestering Agents|sequestering agents|mesh-ancestor
111194667|NCT01399593|Eculizumab|eculizumab|mesh-list
111194668|NCT01399593|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
111194669|NCT01399593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111194670|NCT01399593|Immunologic Factors|immunologic factors|mesh-ancestor
111194671|NCT01399593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111194672|NCT01388985|Vaccines|vaccines|mesh-list
111194673|NCT01388985|Immunologic Factors|immunologic factors|mesh-ancestor
111194674|NCT01388985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111194675|NCT01388361|Insulin|insulin|mesh-list
111194676|NCT01388361|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111194677|NCT01388361|Insulin Aspart|insulin aspart|mesh-list
111194678|NCT01388361|Liraglutide|liraglutide|mesh-list
111194679|NCT01388361|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111194680|NCT01388361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111194681|NCT01388361|Incretins|incretins|mesh-ancestor
111194682|NCT01388361|Hormones|hormones|mesh-ancestor
111194683|NCT01388361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111194684|NCT05368935|Nitazoxanide|nitazoxanide|mesh-list
111194685|NCT05368935|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111194686|NCT05368935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111194687|NCT01399125|Rivastigmine|rivastigmine|mesh-list
111194688|NCT01399125|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111194689|NCT01399125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111194690|NCT01399125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111194691|NCT01399125|Cholinergic Agents|cholinergic agents|mesh-ancestor
111194692|NCT01399125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111194693|NCT01399125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111194694|NCT01399125|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111194695|NCT01399125|Protective Agents|protective agents|mesh-ancestor
111194696|NCT01399047|Mycophenolic Acid|mycophenolic acid|mesh-list
111194697|NCT01399047|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111194698|NCT01399047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111194699|NCT01399047|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111194700|NCT01399047|Antitubercular Agents|antitubercular agents|mesh-ancestor
111194701|NCT01399047|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111194702|NCT01399047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111194703|NCT01399047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111194704|NCT01399047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111194705|NCT01387347|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111194706|NCT01387347|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111194707|NCT04040439|Dexmedetomidine|dexmedetomidine|mesh-list
111194708|NCT04040439|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111194709|NCT04040439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111194710|NCT04040439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111194711|NCT04040439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111194712|NCT04040439|Analgesics|analgesics|mesh-ancestor
111194713|NCT04040439|Sensory System Agents|sensory system agents|mesh-ancestor
111194714|NCT04040439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111194715|NCT04040439|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111194716|NCT04040439|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111194717|NCT04040439|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111194718|NCT04040439|Adrenergic Agents|adrenergic agents|mesh-ancestor
111194719|NCT04040439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111194720|NCT04040439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111194721|NCT04012827|Doxorubicin|doxorubicin|mesh-list
111194722|NCT04012827|Apatinib|apatinib|mesh-list
111194723|NCT04012827|Ifosfamide|ifosfamide|mesh-list
111194724|NCT04012827|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111194725|NCT04012827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111194726|NCT04012827|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111194727|NCT04012827|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111194728|NCT04012827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111194729|NCT04012827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111194730|NCT04012827|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111194731|NCT04012827|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111194732|NCT04012827|Alkylating Agents|alkylating agents|mesh-ancestor
111194733|NCT01879579|Insulin|insulin|mesh-list
111194734|NCT01879579|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111194735|NCT01879579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111194736|NCT01386645|Acetylcysteine|acetylcysteine|mesh-list
111194737|NCT01386645|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111194738|NCT01386645|Antiviral Agents|antiviral agents|mesh-ancestor
111194739|NCT01386645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111194740|NCT01386645|Expectorants|expectorants|mesh-ancestor
111194741|NCT01386645|Respiratory System Agents|respiratory system agents|mesh-ancestor
111194742|NCT01386645|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111194743|NCT01386645|Antioxidants|antioxidants|mesh-ancestor
111194744|NCT01386645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111194745|NCT01386645|Protective Agents|protective agents|mesh-ancestor
111194746|NCT01386645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111194747|NCT01386645|Antidotes|antidotes|mesh-ancestor
111194748|NCT01831765|Insulin|insulin|mesh-list
111194749|NCT01831765|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111194750|NCT01831765|Insulin Aspart|insulin aspart|mesh-list
111194751|NCT01831765|Insulin, Long-Acting|insulin, long-acting|mesh-list
111194752|NCT01831765|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
111194753|NCT01831765|Insulin Detemir|insulin detemir|mesh-list
111194754|NCT01831765|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111194755|NCT01831765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111194756|NCT01830595|Lactoferrin|lactoferrin|mesh-list
111194757|NCT01830595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111194758|NCT01748162|Fluticasone|fluticasone|mesh-list
111194759|NCT01748162|Prednisolone|prednisolone|mesh-list
111194760|NCT01748162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111194761|NCT01748162|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111194762|NCT01748162|Autonomic Agents|autonomic agents|mesh-ancestor
111194763|NCT01748162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111194764|NCT01748162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111194765|NCT01748162|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111194766|NCT01748162|Respiratory System Agents|respiratory system agents|mesh-ancestor
111194767|NCT01748162|Dermatologic Agents|dermatologic agents|mesh-ancestor
111194768|NCT01748162|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111194769|NCT01748162|Glucocorticoids|glucocorticoids|mesh-ancestor
111194770|NCT01748162|Hormones|hormones|mesh-ancestor
111194771|NCT01748162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111194772|NCT01748162|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111194773|NCT01748162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111194774|NCT01723904|Rotigotine|rotigotine|mesh-list
111194775|NCT01723904|Dopamine Agonists|dopamine agonists|mesh-ancestor
111194776|NCT01723904|Dopamine Agents|dopamine agents|mesh-ancestor
111194777|NCT01723904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111194778|NCT01723904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111194779|NCT01723904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111194780|NCT01830127|Ribavirin|ribavirin|mesh-list
111194781|NCT01830127|Antimetabolites|antimetabolites|mesh-ancestor
111194782|NCT01830127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111194783|NCT01830127|Antiviral Agents|antiviral agents|mesh-ancestor
111194784|NCT01830127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111194785|NCT01614067|Ganirelix|ganirelix|mesh-list
111194786|NCT01614067|Hormone Antagonists|hormone antagonists|mesh-ancestor
111194787|NCT01614067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111194788|NCT01614067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111194789|NCT01397409|Ranibizumab|ranibizumab|mesh-list
111194790|NCT01397409|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111194791|NCT01397409|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111194792|NCT01397409|Growth Substances|growth substances|mesh-ancestor
111194793|NCT01397409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111194794|NCT01397409|Growth Inhibitors|growth inhibitors|mesh-ancestor
111194795|NCT01397409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111194796|NCT04766775|Fluorides|fluorides|mesh-list
111194797|NCT04766775|Cariostatic Agents|cariostatic agents|mesh-ancestor
111194798|NCT04766775|Protective Agents|protective agents|mesh-ancestor
111194799|NCT04766775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111194800|NCT01777334|Tiotropium Bromide|tiotropium bromide|mesh-list
111194801|NCT01777334|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111194802|NCT01777334|Autonomic Agents|autonomic agents|mesh-ancestor
111194803|NCT01777334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111194804|NCT01777334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111194805|NCT01777334|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111194806|NCT01777334|Respiratory System Agents|respiratory system agents|mesh-ancestor
111194807|NCT01777334|Parasympatholytics|parasympatholytics|mesh-ancestor
111194808|NCT01777334|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111194809|NCT01777334|Cholinergic Agents|cholinergic agents|mesh-ancestor
111194810|NCT01777334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111194811|NCT01777334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111194812|NCT03024879|Erythromycin|erythromycin|mesh-list
111194813|NCT03024879|Erythromycin Estolate|erythromycin estolate|mesh-list
111194814|NCT03024879|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
111194815|NCT03024879|Erythromycin stearate|erythromycin stearate|mesh-list
111194816|NCT03024879|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111194817|NCT03024879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111194818|NCT03024879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111194819|NCT03024879|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111194820|NCT03024879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111194821|NCT03024879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111194822|NCT01383993|Voriconazole|voriconazole|mesh-list
111194823|NCT01383993|Antifungal Agents|antifungal agents|mesh-ancestor
111194824|NCT01383993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111194825|NCT01383993|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111194826|NCT01383993|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111194827|NCT01383993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111194828|NCT01383993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111194829|NCT01383993|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111194830|NCT01383993|Hormone Antagonists|hormone antagonists|mesh-ancestor
111194831|NCT01383993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111194832|NCT01383993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111194833|NCT01383993|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111194835|NCT01396395|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111194836|NCT01396395|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111194837|NCT01396395|Vasodilator Agents|vasodilator agents|mesh-ancestor
111194838|NCT01396395|Vitamin B Complex|vitamin b complex|mesh-ancestor
111194839|NCT01396395|Vitamins|vitamins|mesh-ancestor
111194840|NCT01396395|Micronutrients|micronutrients|mesh-ancestor
111194841|NCT01396395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111194842|NCT01396083|Dexamethasone|dexamethasone|mesh-list
111194843|NCT01396083|Ranibizumab|ranibizumab|mesh-list
111194844|NCT01396083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111194845|NCT01396083|Antiemetics|antiemetics|mesh-ancestor
111194846|NCT01396083|Autonomic Agents|autonomic agents|mesh-ancestor
111194847|NCT01396083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111194848|NCT01396083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111194849|NCT01396083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111194850|NCT01396083|Glucocorticoids|glucocorticoids|mesh-ancestor
111194851|NCT01396083|Hormones|hormones|mesh-ancestor
111194852|NCT01396083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111194853|NCT01396083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111194854|NCT01396083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111194855|NCT01396083|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111194856|NCT01396083|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111194857|NCT01396083|Growth Substances|growth substances|mesh-ancestor
111194858|NCT01396083|Growth Inhibitors|growth inhibitors|mesh-ancestor
111194859|NCT01776008|Anastrozole|anastrozole|mesh-list
111194860|NCT01776008|Goserelin|goserelin|mesh-list
111194861|NCT01776008|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111194862|NCT01776008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111194863|NCT01776008|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111194864|NCT01776008|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111194865|NCT01776008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111194866|NCT01776008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111194867|NCT01776008|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111194868|NCT01776008|Hormone Antagonists|hormone antagonists|mesh-ancestor
111194869|NCT01776008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111194870|NCT01776008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111194871|NCT01858363|Paclitaxel|paclitaxel|mesh-list
111194872|NCT01858363|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111194873|NCT01858363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111194874|NCT01858363|Tubulin Modulators|tubulin modulators|mesh-ancestor
111194875|NCT01858363|Antimitotic Agents|antimitotic agents|mesh-ancestor
111194876|NCT01858363|Mitosis Modulators|mitosis modulators|mesh-ancestor
111194877|NCT01858363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111194878|NCT01877551|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
111194879|NCT01877551|Antiviral Agents|antiviral agents|mesh-ancestor
111194880|NCT01877551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111194881|NCT01877551|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
111194882|NCT01877551|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111194883|NCT01396005|Buprenorphine|buprenorphine|mesh-list
111194884|NCT01396005|Methadone|methadone|mesh-list
111194885|NCT01396005|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
111194886|NCT01396005|Naloxone|naloxone|mesh-list
111194887|NCT01396005|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111194888|NCT01396005|Narcotics|narcotics|mesh-ancestor
111194889|NCT01396005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111194890|NCT01396005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111194891|NCT01396005|Analgesics|analgesics|mesh-ancestor
111194892|NCT01396005|Sensory System Agents|sensory system agents|mesh-ancestor
111194893|NCT01396005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111194894|NCT01396005|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111194895|NCT01396005|Antitussive Agents|antitussive agents|mesh-ancestor
111194896|NCT01396005|Respiratory System Agents|respiratory system agents|mesh-ancestor
111194897|NCT03024957|Dexmedetomidine|dexmedetomidine|mesh-list
111194898|NCT03024957|Morphine|morphine|mesh-list
111194899|NCT03024957|Bupivacaine|bupivacaine|mesh-list
111194900|NCT03024957|Anesthetics, Local|anesthetics, local|mesh-ancestor
111194901|NCT03024957|Anesthetics|anesthetics|mesh-ancestor
111194902|NCT03024957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111194903|NCT03024957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111194904|NCT03024957|Sensory System Agents|sensory system agents|mesh-ancestor
111194905|NCT03024957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111194906|NCT03024957|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111194907|NCT03024957|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111194908|NCT03024957|Analgesics|analgesics|mesh-ancestor
111194909|NCT03024957|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111194910|NCT03024957|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111194911|NCT03024957|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111194912|NCT03024957|Adrenergic Agents|adrenergic agents|mesh-ancestor
111194913|NCT03024957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111194914|NCT03024957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111194915|NCT03024957|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111194916|NCT03024957|Narcotics|narcotics|mesh-ancestor
111194917|NCT03025113|Ketoprofen|ketoprofen|mesh-list
111194918|NCT03025113|Amitriptyline|amitriptyline|mesh-list
111194919|NCT03025113|Cyclobenzaprine|cyclobenzaprine|mesh-list
111194920|NCT03025113|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111194921|NCT03025113|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111194922|NCT03025113|Analgesics|analgesics|mesh-ancestor
111194923|NCT03025113|Sensory System Agents|sensory system agents|mesh-ancestor
111194924|NCT03025113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111194925|NCT03025113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111194926|NCT03025113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111194927|NCT03025113|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111194928|NCT03025113|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111194929|NCT03025113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111194930|NCT03025113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111194931|NCT03025113|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
111194932|NCT03025113|Antidepressive Agents|antidepressive agents|mesh-ancestor
111194934|NCT03025113|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
111194935|NCT03025113|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111194936|NCT03025113|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111194937|NCT03025113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111194938|NCT03025113|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111194939|NCT03025113|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111194940|NCT03025113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111194941|NCT03025113|Adrenergic Agents|adrenergic agents|mesh-ancestor
111194942|NCT03025113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111194943|NCT01877083|Lenvatinib|lenvatinib|mesh-list
111194944|NCT01877083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111194945|NCT01877083|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111194946|NCT01877083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111194947|NCT01877083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111194948|NCT01380327|Immunomodulating Agents|immunomodulating agents|mesh-list
111194949|NCT01380327|Immunologic Factors|immunologic factors|mesh-list
111194950|NCT01380327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111194951|NCT01829425|Tolterodine Tartrate|tolterodine tartrate|mesh-list
111194952|NCT01829425|Oxybutynin|oxybutynin|mesh-list
111194953|NCT01829425|Cholinergic Antagonists|cholinergic antagonists|mesh-list
111194954|NCT01829425|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111194955|NCT01829425|Cholinergic Agents|cholinergic agents|mesh-ancestor
111194956|NCT01829425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111194957|NCT01829425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111194958|NCT01829425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111194959|NCT01829425|Urological Agents|urological agents|mesh-ancestor
111194960|NCT01829425|Parasympatholytics|parasympatholytics|mesh-ancestor
111194961|NCT01829425|Autonomic Agents|autonomic agents|mesh-ancestor
111194962|NCT01829425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111194963|NCT01394991|Epoetin Alfa|epoetin alfa|mesh-list
111194964|NCT01394991|Hematinics|hematinics|mesh-ancestor
111194965|NCT01394523|Bupivacaine|bupivacaine|mesh-list
111194966|NCT01394523|Anesthetics, Local|anesthetics, local|mesh-ancestor
111194967|NCT01394523|Anesthetics|anesthetics|mesh-ancestor
111194968|NCT01394523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111194969|NCT01394523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111194970|NCT01394523|Sensory System Agents|sensory system agents|mesh-ancestor
111194971|NCT01394523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111194972|NCT01857583|PENTA|penta|mesh-list
111194973|NCT01857583|Edoxaban|edoxaban|mesh-list
111194974|NCT01857583|Fondaparinux|fondaparinux|mesh-list
111194975|NCT01857583|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111194976|NCT01857583|Antithrombins|antithrombins|mesh-ancestor
111194977|NCT01857583|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111194978|NCT01857583|Protease Inhibitors|protease inhibitors|mesh-ancestor
111194979|NCT01857583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111194980|NCT01857583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111194981|NCT01857583|Anticoagulants|anticoagulants|mesh-ancestor
111194982|NCT01857583|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111194983|NCT01857583|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111194984|NCT04000347|Benzoyl Peroxide|benzoyl peroxide|mesh-list
111194985|NCT04000347|Dermatologic Agents|dermatologic agents|mesh-ancestor
111194986|NCT00211185|Prednisone|prednisone|mesh-list
111194987|NCT00211185|Cyclophosphamide|cyclophosphamide|mesh-list
111194988|NCT00211185|Doxorubicin|doxorubicin|mesh-list
111194989|NCT00211185|Vincristine|vincristine|mesh-list
111194990|NCT00211185|Denileukin diftitox|denileukin diftitox|mesh-list
111194991|NCT00211185|Lenograstim|lenograstim|mesh-list
111194992|NCT00211185|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111194993|NCT00211185|Immunologic Factors|immunologic factors|mesh-ancestor
111194994|NCT00211185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111194995|NCT00211185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111194996|NCT00211185|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111194997|NCT00211185|Alkylating Agents|alkylating agents|mesh-ancestor
111194998|NCT00211185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111194999|NCT00211185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111195001|NCT00211185|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111195002|NCT00211185|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111195003|NCT00211185|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111195004|NCT00211185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111195005|NCT00211185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111195006|NCT00211185|Glucocorticoids|glucocorticoids|mesh-ancestor
111195007|NCT00211185|Hormones|hormones|mesh-ancestor
111195008|NCT00211185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111195009|NCT00211185|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111195010|NCT00211185|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111195011|NCT00211185|Tubulin Modulators|tubulin modulators|mesh-ancestor
111195012|NCT00211185|Antimitotic Agents|antimitotic agents|mesh-ancestor
111195013|NCT00211185|Mitosis Modulators|mitosis modulators|mesh-ancestor
111195014|NCT00211185|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111195015|NCT00219297|Epothilone B|epothilone b|mesh-list
111195016|NCT00219297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111195017|NCT00219297|Tubulin Modulators|tubulin modulators|mesh-ancestor
111195018|NCT00219297|Antimitotic Agents|antimitotic agents|mesh-ancestor
111195019|NCT00219297|Mitosis Modulators|mitosis modulators|mesh-ancestor
111195020|NCT00219297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111195021|NCT01857271|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111195022|NCT01857271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111195023|NCT01857271|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111195024|NCT01857271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111195025|NCT01857271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111195026|NCT01721486|Acetaminophen|acetaminophen|mesh-list
111195027|NCT01721486|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111195028|NCT01721486|Analgesics|analgesics|mesh-ancestor
111195029|NCT01721486|Sensory System Agents|sensory system agents|mesh-ancestor
111195030|NCT01721486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111195031|NCT01721486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111195032|NCT01721486|Antipyretics|antipyretics|mesh-ancestor
111195033|NCT01721408|Imipenem|imipenem|mesh-list
111195034|NCT01721408|Tigecycline|tigecycline|mesh-list
111195035|NCT01721408|Cilastatin|cilastatin|mesh-list
111195036|NCT01721408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111195037|NCT01721408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111195038|NCT01721408|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111195039|NCT01721408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111195040|NCT01721408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111195041|NCT01721408|Protease Inhibitors|protease inhibitors|mesh-ancestor
111195042|NCT03998709|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
111195043|NCT03998709|Somatostatin|somatostatin|mesh-list
111195044|NCT03998709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111195045|NCT03998709|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
111195046|NCT03998709|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
111195047|NCT03998709|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111195048|NCT03998709|Hormones|hormones|mesh-ancestor
111195049|NCT03998709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111195050|NCT01744496|Rotigotine|rotigotine|mesh-list
111195051|NCT01744496|Dopamine Agonists|dopamine agonists|mesh-ancestor
111195052|NCT01744496|Dopamine Agents|dopamine agents|mesh-ancestor
111195053|NCT01744496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111195054|NCT01744496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111195055|NCT01744496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111195056|NCT04007055|Ticagrelor|ticagrelor|mesh-list
111195057|NCT04007055|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111195058|NCT04007055|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111195059|NCT04007055|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111195060|NCT04007055|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111195061|NCT04007055|Purinergic Agents|purinergic agents|mesh-ancestor
111195062|NCT04007055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111195063|NCT04007055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111195064|NCT04007055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111195065|NCT01721330|Naltrexone|naltrexone|mesh-list
111195066|NCT01721330|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111195067|NCT01721330|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111195068|NCT01721330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111195069|NCT01721330|Sensory System Agents|sensory system agents|mesh-ancestor
111195070|NCT01721330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111195072|NCT03592407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111195073|NCT03592407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111195074|NCT03592407|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111195075|NCT03592407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111195076|NCT03595371|Dapansutrile|dapansutrile|mesh-list
111195077|NCT03595371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111195078|NCT05634057|Anisodamine|anisodamine|mesh-list
111195079|NCT05634057|Heparin|heparin|mesh-list
111195080|NCT05634057|Calcium heparin|calcium heparin|mesh-list
111195081|NCT05634057|Anticoagulants|anticoagulants|mesh-ancestor
111195082|NCT05634057|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111195083|NCT05634057|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111195084|NCT05634057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111195085|NCT05634057|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111195086|NCT05634057|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111195087|NCT05634057|Adrenergic Agents|adrenergic agents|mesh-ancestor
111195088|NCT05634057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111195089|NCT05634057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111195090|NCT05634057|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111195091|NCT05634057|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111195092|NCT05634057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111195093|NCT05634057|Analgesics|analgesics|mesh-ancestor
111195094|NCT05634057|Sensory System Agents|sensory system agents|mesh-ancestor
111195095|NCT05634057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111195096|NCT05634057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111195097|NCT05634057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111195098|NCT05634057|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111195099|NCT05634057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111195100|NCT05634057|Parasympatholytics|parasympatholytics|mesh-ancestor
111195101|NCT05634057|Autonomic Agents|autonomic agents|mesh-ancestor
111195102|NCT05634057|Vasodilator Agents|vasodilator agents|mesh-ancestor
111195103|NCT05634057|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111195104|NCT05634057|Antioxidants|antioxidants|mesh-ancestor
111195105|NCT05634057|Protective Agents|protective agents|mesh-ancestor
111195106|NCT03596385|Metoprolol|metoprolol|mesh-list
111195107|NCT03596385|Atenolol|atenolol|mesh-list
111195108|NCT03596385|Carvedilol|carvedilol|mesh-list
111195109|NCT03596385|Bisoprolol|bisoprolol|mesh-list
111195110|NCT03596385|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
111195111|NCT03596385|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111195112|NCT03596385|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111195113|NCT03596385|Sympatholytics|sympatholytics|mesh-ancestor
111195114|NCT03596385|Autonomic Agents|autonomic agents|mesh-ancestor
111195115|NCT03596385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111195116|NCT03596385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111195117|NCT03596385|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
111195118|NCT03596385|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111195119|NCT03596385|Adrenergic Agents|adrenergic agents|mesh-ancestor
111195120|NCT03596385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111195121|NCT03596385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111195122|NCT03596385|Antioxidants|antioxidants|mesh-ancestor
111195123|NCT03596385|Protective Agents|protective agents|mesh-ancestor
111195124|NCT03596385|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111195125|NCT03596385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111195126|NCT03596385|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111195127|NCT03596385|Vasodilator Agents|vasodilator agents|mesh-ancestor
111195128|NCT03596385|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111195129|NCT03596385|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111195130|NCT01828021|Margetuximab|margetuximab|mesh-list
111195131|NCT01828021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111195132|NCT03784599|Trastuzumab|trastuzumab|mesh-list
111195133|NCT03784599|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
111195134|NCT03784599|Osimertinib|osimertinib|mesh-list
111195135|NCT03784599|Maytansine|maytansine|mesh-list
111195136|NCT03784599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111195137|NCT03784599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111195138|NCT03784599|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111195139|NCT03784599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111195140|NCT03784599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111195141|NCT03784599|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111195142|NCT03784599|Tubulin Modulators|tubulin modulators|mesh-ancestor
111195143|NCT03784599|Antimitotic Agents|antimitotic agents|mesh-ancestor
111195144|NCT03784599|Mitosis Modulators|mitosis modulators|mesh-ancestor
111195145|NCT03784599|Immunotoxins|immunotoxins|mesh-ancestor
111195146|NCT03784599|Immunoconjugates|immunoconjugates|mesh-ancestor
111195147|NCT03784599|Immunologic Factors|immunologic factors|mesh-ancestor
111195148|NCT03784599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111195149|NCT01827943|Sirolimus|sirolimus|mesh-list
111195150|NCT01827943|Temsirolimus|temsirolimus|mesh-list
111195151|NCT01827943|MTOR Inhibitors|mtor inhibitors|mesh-list
111195152|NCT01827943|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111195153|NCT01827943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111195154|NCT01827943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111195155|NCT01827943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111195156|NCT01827943|Immunologic Factors|immunologic factors|mesh-ancestor
111195157|NCT01827943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111195158|NCT01827943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111195159|NCT01827943|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111195160|NCT01827943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111195161|NCT01827943|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111195162|NCT01827943|Antifungal Agents|antifungal agents|mesh-ancestor
111195164|NCT02985255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111195165|NCT02985255|Tubulin Modulators|tubulin modulators|mesh-ancestor
111195166|NCT02985255|Antimitotic Agents|antimitotic agents|mesh-ancestor
111195167|NCT02985255|Mitosis Modulators|mitosis modulators|mesh-ancestor
111195168|NCT02985255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111195169|NCT00214851|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
111195170|NCT00214851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111195171|NCT00217971|Dronabinol|dronabinol|mesh-list
111195172|NCT00217971|Hallucinogens|hallucinogens|mesh-ancestor
111195173|NCT00217971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111195174|NCT00217971|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111195175|NCT00217971|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111195176|NCT00217971|Analgesics|analgesics|mesh-ancestor
111195177|NCT00217971|Sensory System Agents|sensory system agents|mesh-ancestor
111195178|NCT00217971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111195179|NCT00217971|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
111195180|NCT00217971|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
111195181|NCT00217971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111195182|NCT00217971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111195183|NCT00217971|Hormones|hormones|mesh-ancestor
111195184|NCT00217971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111195185|NCT00217581|Bevacizumab|bevacizumab|mesh-list
111195186|NCT00217581|Docetaxel|docetaxel|mesh-list
111195187|NCT00217581|Oxaliplatin|oxaliplatin|mesh-list
111195188|NCT00217581|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111195189|NCT00217581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111195190|NCT00217581|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111195191|NCT00217581|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111195192|NCT00217581|Growth Substances|growth substances|mesh-ancestor
111195193|NCT00217581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111195194|NCT00217581|Growth Inhibitors|growth inhibitors|mesh-ancestor
111195195|NCT00217581|Tubulin Modulators|tubulin modulators|mesh-ancestor
111195196|NCT00217581|Antimitotic Agents|antimitotic agents|mesh-ancestor
111195197|NCT00217581|Mitosis Modulators|mitosis modulators|mesh-ancestor
111195198|NCT00217581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111195199|NCT01856257|Mycophenolic Acid|mycophenolic acid|mesh-list
111195200|NCT01856257|Methylprednisolone|methylprednisolone|mesh-list
111195201|NCT01856257|Abatacept|abatacept|mesh-list
111195202|NCT01856257|Tacrolimus|tacrolimus|mesh-list
111195203|NCT01856257|Thymoglobulin|thymoglobulin|mesh-list
111195204|NCT01856257|Antilymphocyte Serum|antilymphocyte serum|mesh-list
111195205|NCT01856257|Basiliximab|basiliximab|mesh-list
111195206|NCT01856257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111195207|NCT01856257|Immunologic Factors|immunologic factors|mesh-ancestor
111195208|NCT01856257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111195209|NCT01856257|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111195210|NCT01856257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111195211|NCT01856257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111195212|NCT01856257|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111195213|NCT01856257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111195214|NCT01856257|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111195215|NCT01856257|Antitubercular Agents|antitubercular agents|mesh-ancestor
111195216|NCT01856257|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111195217|NCT01856257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111195218|NCT01856257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111195219|NCT01856257|Antiemetics|antiemetics|mesh-ancestor
111195220|NCT01856257|Autonomic Agents|autonomic agents|mesh-ancestor
111195221|NCT01856257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111195222|NCT01856257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111195223|NCT01856257|Glucocorticoids|glucocorticoids|mesh-ancestor
111195224|NCT01856257|Hormones|hormones|mesh-ancestor
111195225|NCT01856257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111195226|NCT01856257|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111195227|NCT01856257|Protective Agents|protective agents|mesh-ancestor
111195228|NCT01856257|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111195229|NCT01856257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111195230|NCT01856257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111195231|NCT00215943|Zoledronic Acid|zoledronic acid|mesh-list
111195232|NCT00215943|Thalidomide|thalidomide|mesh-list
111195233|NCT00215943|Dexamethasone|dexamethasone|mesh-list
111195234|NCT00215943|Doxorubicin|doxorubicin|mesh-list
111195235|NCT00215943|Vincristine|vincristine|mesh-list
111195236|NCT00215943|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111195237|NCT00215943|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111195238|NCT00215943|Antiemetics|antiemetics|mesh-ancestor
111195239|NCT00215943|Autonomic Agents|autonomic agents|mesh-ancestor
111195240|NCT00215943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111195241|NCT00215943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111195242|NCT00215943|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111195243|NCT00215943|Glucocorticoids|glucocorticoids|mesh-ancestor
111195244|NCT00215943|Hormones|hormones|mesh-ancestor
111195245|NCT00215943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111195246|NCT00215943|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111195247|NCT00215943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111195248|NCT00215943|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111195249|NCT00215943|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111195250|NCT00215943|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111195251|NCT00215943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111195252|NCT00215943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111195253|NCT00215943|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111195254|NCT00215943|Tubulin Modulators|tubulin modulators|mesh-ancestor
111195255|NCT00215943|Antimitotic Agents|antimitotic agents|mesh-ancestor
111195256|NCT00215943|Mitosis Modulators|mitosis modulators|mesh-ancestor
111195257|NCT00215943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111195258|NCT00215943|Immunologic Factors|immunologic factors|mesh-ancestor
111195259|NCT00215943|Leprostatic Agents|leprostatic agents|mesh-ancestor
111195260|NCT00215943|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111195261|NCT00215943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111195262|NCT00215943|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111195263|NCT00215943|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111195264|NCT00215943|Growth Substances|growth substances|mesh-ancestor
111195265|NCT00215943|Growth Inhibitors|growth inhibitors|mesh-ancestor
111195266|NCT00215943|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111195267|NCT01827163|Paclitaxel|paclitaxel|mesh-list
111195268|NCT01827163|Trastuzumab|trastuzumab|mesh-list
111195269|NCT01827163|Lapatinib|lapatinib|mesh-list
111195270|NCT01827163|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111195271|NCT01827163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111195272|NCT01827163|Tubulin Modulators|tubulin modulators|mesh-ancestor
111195273|NCT01827163|Antimitotic Agents|antimitotic agents|mesh-ancestor
111195274|NCT01827163|Mitosis Modulators|mitosis modulators|mesh-ancestor
111195275|NCT01827163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111195276|NCT01827163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111195277|NCT01827163|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111195278|NCT01827163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111195279|NCT00215553|Pulmonary Surfactants|pulmonary surfactants|mesh-list
111195280|NCT00215553|Respiratory System Agents|respiratory system agents|mesh-ancestor
111195281|NCT00214461|Vaccines|vaccines|mesh-list
111195282|NCT00214461|Immunologic Factors|immunologic factors|mesh-ancestor
111195283|NCT00214461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111195284|NCT03599973|Plasma-lyte 148|plasma-lyte 148|mesh-list
111195285|NCT03599973|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
111195286|NCT03599973|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111195287|NCT00211887|Interferons|interferons|mesh-list
111195288|NCT00211887|Interferon-beta|interferon-beta|mesh-list
111195289|NCT00211887|Interferon beta-1a|interferon beta-1a|mesh-list
111195290|NCT00211887|Glatiramer Acetate|glatiramer acetate|mesh-list
111195291|NCT00211887|(T,G)-A-L|(t,g)-a-l|mesh-list
111195292|NCT00211887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111195293|NCT00211887|Antiviral Agents|antiviral agents|mesh-ancestor
111195294|NCT00211887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111195295|NCT00211887|Immunologic Factors|immunologic factors|mesh-ancestor
111195296|NCT00211887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111195297|NCT00211887|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111195298|NCT00211887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111195299|NCT00211887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111195300|NCT04002453|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111195301|NCT04002453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111195302|NCT03592485|Acetaminophen|acetaminophen|mesh-list
111195303|NCT03592485|Oxycodone|oxycodone|mesh-list
111195304|NCT03592485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111195305|NCT03592485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111195306|NCT03592485|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111195307|NCT03592485|Analgesics|analgesics|mesh-ancestor
111195308|NCT03592485|Sensory System Agents|sensory system agents|mesh-ancestor
111195309|NCT03592485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111195310|NCT03592485|Antipyretics|antipyretics|mesh-ancestor
111195311|NCT03592485|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111195312|NCT03592485|Narcotics|narcotics|mesh-ancestor
111195313|NCT04199013|Fentanyl|fentanyl|mesh-list
111195314|NCT04199013|Ropivacaine|ropivacaine|mesh-list
111195315|NCT04199013|Anesthetics, Local|anesthetics, local|mesh-ancestor
111195316|NCT04199013|Anesthetics|anesthetics|mesh-ancestor
111195317|NCT04199013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111195318|NCT04199013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111195319|NCT04199013|Sensory System Agents|sensory system agents|mesh-ancestor
111195320|NCT04199013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111195321|NCT04199013|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111195322|NCT04199013|Narcotics|narcotics|mesh-ancestor
111195323|NCT04199013|Analgesics|analgesics|mesh-ancestor
111195324|NCT04199013|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111195325|NCT04199013|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111195326|NCT04199013|Anesthetics, General|anesthetics, general|mesh-ancestor
111195327|NCT04198467|Hyaluronic Acid|hyaluronic acid|mesh-list
111195328|NCT04198467|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111195329|NCT04198467|Immunologic Factors|immunologic factors|mesh-ancestor
111195330|NCT04198467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111195331|NCT04198467|Viscosupplements|viscosupplements|mesh-ancestor
111195332|NCT04198467|Protective Agents|protective agents|mesh-ancestor
111195333|NCT03599427|Lidocaine|lidocaine|mesh-list
111195334|NCT03599427|Anesthetics, Local|anesthetics, local|mesh-ancestor
111195335|NCT03599427|Anesthetics|anesthetics|mesh-ancestor
111195336|NCT03599427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111195337|NCT03599427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111195338|NCT03599427|Sensory System Agents|sensory system agents|mesh-ancestor
111195339|NCT03599427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111195340|NCT03599427|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111195341|NCT03599427|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111195342|NCT03599427|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111195343|NCT03599427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111195344|NCT03599427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111195346|NCT01855789|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111195347|NCT01855789|Abortifacient Agents|abortifacient agents|mesh-ancestor
111195348|NCT01855789|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111195349|NCT01855789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111195350|NCT01855789|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111195351|NCT01855789|Antimetabolites|antimetabolites|mesh-ancestor
110799573|NCT02064946|Vitamin D|vitamin d|mesh-list
111195352|NCT01855789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111195353|NCT01855789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111195354|NCT01855789|Dermatologic Agents|dermatologic agents|mesh-ancestor
111195355|NCT01855789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111195356|NCT01855789|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111195357|NCT01855789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111195358|NCT01855789|Immunologic Factors|immunologic factors|mesh-ancestor
111195359|NCT01855789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111195360|NCT01855789|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111195361|NCT04198233|Diazepam|diazepam|mesh-list
111195362|NCT04198233|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111195363|NCT04198233|Anticonvulsants|anticonvulsants|mesh-ancestor
111195364|NCT04198233|Antiemetics|antiemetics|mesh-ancestor
111195365|NCT04198233|Autonomic Agents|autonomic agents|mesh-ancestor
111195366|NCT04198233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111195367|NCT04198233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111195368|NCT04198233|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111195369|NCT04198233|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111195370|NCT04198233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111195371|NCT04198233|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
111195372|NCT04198233|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111195373|NCT04198233|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111195374|NCT04198233|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111195375|NCT04198233|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111195376|NCT04198233|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111195377|NCT04198233|Anesthetics, General|anesthetics, general|mesh-ancestor
111195378|NCT04198233|Anesthetics|anesthetics|mesh-ancestor
111195379|NCT04198233|GABA Modulators|gaba modulators|mesh-ancestor
111195380|NCT04198233|GABA Agents|gaba agents|mesh-ancestor
111195381|NCT04198233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111195382|NCT04198233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111195383|NCT03591471|Prednisone|prednisone|mesh-list
111195384|NCT03591471|Benazepril|benazepril|mesh-list
111195385|NCT03591471|Heparin|heparin|mesh-list
111195386|NCT03591471|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
111195387|NCT03591471|Tinzaparin|tinzaparin|mesh-list
110677015|NCT03174197|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111195388|NCT03591471|Dalteparin|dalteparin|mesh-list
111195389|NCT03591471|Calcium heparin|calcium heparin|mesh-list
111195391|NCT03591471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111195392|NCT03591471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111195393|NCT03591471|Glucocorticoids|glucocorticoids|mesh-ancestor
111195394|NCT03591471|Hormones|hormones|mesh-ancestor
111195395|NCT03591471|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111195396|NCT03591471|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111195397|NCT03591471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111195398|NCT03591471|Anticoagulants|anticoagulants|mesh-ancestor
111195399|NCT03591471|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111195400|NCT03591471|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111195401|NCT03591471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111195402|NCT03591471|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111195403|NCT03591471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111195404|NCT03591471|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111195405|NCT03591471|Vasodilator Agents|vasodilator agents|mesh-ancestor
111195406|NCT03591471|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
111195407|NCT03591471|Protease Inhibitors|protease inhibitors|mesh-ancestor
111195408|NCT03591471|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111195409|NCT04406805|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
111195410|NCT04406805|Natriuretic Agents|natriuretic agents|mesh-ancestor
111195411|NCT04406805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111195412|NCT01876381|Tolvaptan|tolvaptan|mesh-list
111195413|NCT01876381|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
110845654|NCT05331911|Propofol|propofol|mesh-list
111195414|NCT01876381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111195416|NCT01876381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111195417|NCT03591003|Antibodies|antibodies|mesh-list
111195418|NCT03591003|Antibodies, Blocking|antibodies, blocking|mesh-list
111195419|NCT03591003|Immunologic Factors|immunologic factors|mesh-ancestor
111195420|NCT03591003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111195421|NCT01875991|Etanercept|etanercept|mesh-list
111195422|NCT01875991|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111195423|NCT01875991|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111195424|NCT01875991|Analgesics|analgesics|mesh-ancestor
111195425|NCT01875991|Sensory System Agents|sensory system agents|mesh-ancestor
111195426|NCT01875991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111195427|NCT01875991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111195428|NCT01875991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111195429|NCT01875991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111195430|NCT01875991|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111195431|NCT01875991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111195432|NCT01875991|Immunologic Factors|immunologic factors|mesh-ancestor
111195433|NCT04203927|Empagliflozin|empagliflozin|mesh-list
111195434|NCT04203927|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111195435|NCT04203927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111195436|NCT04203927|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111195437|NCT04203927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111195438|NCT01855243|Insulin|insulin|mesh-list
111195439|NCT01855243|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111195440|NCT01855243|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111195441|NCT01855243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111195442|NCT04196829|Fluorides|fluorides|mesh-list
111195443|NCT04196829|Cariostatic Agents|cariostatic agents|mesh-ancestor
111195444|NCT04196829|Protective Agents|protective agents|mesh-ancestor
111195445|NCT04196829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111195446|NCT01825837|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
111195447|NCT01825837|Anticonvulsants|anticonvulsants|mesh-ancestor
111195448|NCT01825837|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111195449|NCT01825837|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111195450|NCT01825837|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111195451|NCT01825837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111195452|NCT01854697|Interferons|interferons|mesh-list
111195453|NCT01854697|Ribavirin|ribavirin|mesh-list
111195454|NCT01854697|Interferon-alpha|interferon-alpha|mesh-list
111195455|NCT01854697|Interferon alpha-2|interferon alpha-2|mesh-list
111195456|NCT01854697|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
111195457|NCT01854697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111195458|NCT01854697|Antiviral Agents|antiviral agents|mesh-ancestor
111195459|NCT01854697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111195460|NCT01854697|Antimetabolites|antimetabolites|mesh-ancestor
111195461|NCT01854697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111195462|NCT01854697|Immunologic Factors|immunologic factors|mesh-ancestor
111195463|NCT01854697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111195464|NCT03594123|Brexpiprazole|brexpiprazole|mesh-list
111195465|NCT03594123|Serotonin Agents|serotonin agents|mesh-ancestor
111195466|NCT03594123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111195467|NCT03594123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111195468|NCT03594123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111195469|NCT03594123|Dopamine Agonists|dopamine agonists|mesh-ancestor
111195470|NCT03594123|Dopamine Agents|dopamine agents|mesh-ancestor
111195471|NCT01824823|Afatinib|afatinib|mesh-list
111195472|NCT01824823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111195473|NCT01824823|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111195474|NCT01824823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111195475|NCT01824823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111195476|NCT03598725|Prednisone|prednisone|mesh-list
111195477|NCT03598725|Rituximab|rituximab|mesh-list
111195478|NCT03598725|Factor VIII|factor viii|mesh-list
111195479|NCT03598725|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111195480|NCT03598725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111195481|NCT03598725|Immunologic Factors|immunologic factors|mesh-ancestor
111195482|NCT03598725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111195483|NCT03598725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111195484|NCT03598725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111195485|NCT03598725|Glucocorticoids|glucocorticoids|mesh-ancestor
111195486|NCT03598725|Hormones|hormones|mesh-ancestor
110845656|NCT05331911|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111195487|NCT03598725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111195488|NCT03598725|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111195489|NCT03598725|Coagulants|coagulants|mesh-ancestor
111195490|NCT04766307|Interleukin-2|interleukin-2|mesh-list
111195491|NCT04766307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111195492|NCT04766307|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111195493|NCT04766307|Analgesics|analgesics|mesh-ancestor
111195494|NCT04766307|Sensory System Agents|sensory system agents|mesh-ancestor
111195495|NCT04766307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111195496|NCT04766307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111195497|NCT01875367|Trastuzumab|trastuzumab|mesh-list
111195498|NCT01875367|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111195499|NCT01875367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111195500|NCT04194957|Fluorouracil|fluorouracil|mesh-list
111195501|NCT04194957|Capecitabine|capecitabine|mesh-list
111195502|NCT04194957|Antimetabolites|antimetabolites|mesh-ancestor
111195503|NCT04194957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111195504|NCT04194957|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111195505|NCT04194957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111195506|NCT04194957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111195507|NCT04194957|Immunologic Factors|immunologic factors|mesh-ancestor
111195508|NCT04194957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111195509|NCT04194255|Ferrous fumarate|ferrous fumarate|mesh-list
111195510|NCT04194255|Trace Elements|trace elements|mesh-ancestor
111195511|NCT04194255|Micronutrients|micronutrients|mesh-ancestor
111195512|NCT04194255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111195513|NCT04406883|Simvastatin|simvastatin|mesh-list
111195514|NCT04406883|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111195515|NCT04406883|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111195516|NCT04406883|Antimetabolites|antimetabolites|mesh-ancestor
111195517|NCT04406883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111195518|NCT04406883|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111195519|NCT04406883|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111195520|NCT04406883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111195522|NCT03597867|Indomethacin|indomethacin|mesh-list
111195523|NCT03597867|Nepafenac|nepafenac|mesh-list
111195524|NCT03597867|Bromfenac|bromfenac|mesh-list
111195525|NCT03597867|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111195526|NCT03597867|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111195527|NCT03597867|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111195528|NCT03597867|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111195529|NCT03597867|Analgesics|analgesics|mesh-ancestor
111195530|NCT03597867|Sensory System Agents|sensory system agents|mesh-ancestor
111195531|NCT03597867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111195532|NCT03597867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111195533|NCT03597867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111195534|NCT03597867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111195535|NCT03597867|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111195536|NCT03597867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111195537|NCT03597867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111195538|NCT03597867|Gout Suppressants|gout suppressants|mesh-ancestor
111195539|NCT03597867|Tocolytic Agents|tocolytic agents|mesh-ancestor
111195540|NCT03597867|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111195541|NCT03597477|Dexmedetomidine|dexmedetomidine|mesh-list
111195542|NCT03597477|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111195543|NCT03597477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111195544|NCT03597477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111195545|NCT03597477|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111195546|NCT03597477|Analgesics|analgesics|mesh-ancestor
111195547|NCT03597477|Sensory System Agents|sensory system agents|mesh-ancestor
111195548|NCT03597477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111195549|NCT03597477|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111195550|NCT03597477|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111195551|NCT03597477|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111195552|NCT03597477|Adrenergic Agents|adrenergic agents|mesh-ancestor
111195553|NCT03597477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110845658|NCT05331911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111195554|NCT03597477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111195555|NCT04193319|Fluconazole|fluconazole|mesh-list
111195557|NCT04193319|Antifungal Agents|antifungal agents|mesh-ancestor
111195558|NCT04193319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111195559|NCT04193319|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111195560|NCT04193319|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111195561|NCT04193319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111195562|NCT04193319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111195563|NCT04193319|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111195564|NCT04193319|Hormone Antagonists|hormone antagonists|mesh-ancestor
111195565|NCT04193319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111195566|NCT04193319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111195567|NCT04193319|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111195568|NCT04193319|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111195569|NCT04193319|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111195570|NCT04193319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111195571|NCT04192617|Methotrexate|methotrexate|mesh-list
111195572|NCT04192617|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111195573|NCT04192617|Abortifacient Agents|abortifacient agents|mesh-ancestor
111195574|NCT04192617|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111195575|NCT04192617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111195576|NCT04192617|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111195577|NCT04192617|Antimetabolites|antimetabolites|mesh-ancestor
111195578|NCT04192617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111195579|NCT04192617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111195580|NCT04192617|Dermatologic Agents|dermatologic agents|mesh-ancestor
111195581|NCT04192617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111195582|NCT04192617|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111195583|NCT04192617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111195584|NCT04192617|Immunologic Factors|immunologic factors|mesh-ancestor
111195585|NCT04192617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111195586|NCT04192617|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111195587|NCT04026009|Vaccines|vaccines|mesh-list
111195588|NCT04026009|Immunologic Factors|immunologic factors|mesh-ancestor
111195589|NCT04026009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111195590|NCT01874665|Ponatinib|ponatinib|mesh-list
111195591|NCT01874665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111195592|NCT01874665|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111195593|NCT01874665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111195594|NCT01874665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111195595|NCT04766151|Nitroglycerin|nitroglycerin|mesh-list
111195596|NCT04766151|Vasodilator Agents|vasodilator agents|mesh-ancestor
111195597|NCT04028739|Curcumin|curcumin|mesh-list
111195598|NCT04028739|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111195599|NCT04028739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111195600|NCT04028739|Analgesics|analgesics|mesh-ancestor
111195601|NCT04028739|Sensory System Agents|sensory system agents|mesh-ancestor
111195602|NCT04028739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111195603|NCT04028739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111195604|NCT04028739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111195605|NCT04028739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111195606|NCT04028739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111195607|NCT04028739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111195608|NCT04028739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111195609|NCT04028505|Terlipressin|terlipressin|mesh-list
111195610|NCT04028505|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111195611|NCT04028505|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111195613|NCT04190745|Apatinib|apatinib|mesh-list
111195614|NCT04190745|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111195615|NCT04190745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111195616|NCT04190745|Tubulin Modulators|tubulin modulators|mesh-ancestor
110491324|NCT00742339|Sympathomimetics|sympathomimetics|mesh-ancestor
111195617|NCT04190745|Antimitotic Agents|antimitotic agents|mesh-ancestor
111195618|NCT04190745|Mitosis Modulators|mitosis modulators|mesh-ancestor
111195619|NCT04190745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111195620|NCT04190745|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111195621|NCT04190745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111195622|NCT04028349|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
111195623|NCT04028349|Antiviral Agents|antiviral agents|mesh-ancestor
110845667|NCT03857542|Miotics|miotics|mesh-ancestor
111195624|NCT04028349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111195625|NCT04198623|Montelukast|montelukast|mesh-list
111195626|NCT04198623|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111195627|NCT04198623|Respiratory System Agents|respiratory system agents|mesh-ancestor
111195628|NCT04198623|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
111195629|NCT04198623|Hormone Antagonists|hormone antagonists|mesh-ancestor
111195630|NCT04198623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111195631|NCT04198623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111195632|NCT04198623|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
111195633|NCT04198623|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111195634|NCT04198623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111195635|NCT01873729|Naltrexone|naltrexone|mesh-list
111195636|NCT01873729|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111195637|NCT01873729|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111195638|NCT01873729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111195639|NCT01873729|Sensory System Agents|sensory system agents|mesh-ancestor
111195640|NCT01873729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111195641|NCT01873495|Homoharringtonine|homoharringtonine|mesh-list
111195642|NCT01873495|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111195643|NCT01873495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111195644|NCT01873495|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111195645|NCT01873495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111195646|NCT01873495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111195647|NCT04027959|Vitamin B 12|vitamin b 12|mesh-list
111195648|NCT04027959|Hydroxocobalamin|hydroxocobalamin|mesh-list
111195649|NCT04027959|Vitamins|vitamins|mesh-ancestor
111195650|NCT04027959|Micronutrients|micronutrients|mesh-ancestor
111195651|NCT04027959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111195652|NCT04027959|Vitamin B Complex|vitamin b complex|mesh-ancestor
111195653|NCT04027959|Hematinics|hematinics|mesh-ancestor
111195654|NCT04344951|Chloroquine|chloroquine|mesh-list
111195655|NCT04344951|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
111195656|NCT04344951|Amebicides|amebicides|mesh-ancestor
111195657|NCT04344951|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111195658|NCT04344951|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111195659|NCT04344951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111195660|NCT04344951|Antimalarials|antimalarials|mesh-ancestor
111195661|NCT04344951|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111195662|NCT04344951|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111195663|NCT04344951|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111195664|NCT04344951|Analgesics|analgesics|mesh-ancestor
111195665|NCT04344951|Sensory System Agents|sensory system agents|mesh-ancestor
111195666|NCT04344951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111195667|NCT04344951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111195668|NCT04344951|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111195669|NCT04344951|Filaricides|filaricides|mesh-ancestor
111195670|NCT04344951|Antinematodal Agents|antinematodal agents|mesh-ancestor
111195671|NCT04344951|Anthelmintics|anthelmintics|mesh-ancestor
111195672|NCT01822561|Eplerenone|eplerenone|mesh-list
111195673|NCT01822561|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
111195674|NCT01822561|Hormone Antagonists|hormone antagonists|mesh-ancestor
111195675|NCT01822561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111195676|NCT01822561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111195677|NCT01822561|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
111195678|NCT01822561|Diuretics|diuretics|mesh-ancestor
111195679|NCT01822561|Natriuretic Agents|natriuretic agents|mesh-ancestor
111195680|NCT01822561|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111195681|NCT02080455|Atorvastatin|atorvastatin|mesh-list
111195682|NCT02080455|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111195683|NCT02080455|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111195684|NCT02080455|Antimetabolites|antimetabolites|mesh-ancestor
111195685|NCT02080455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111195686|NCT02080455|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111195687|NCT02080455|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111195688|NCT02080455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111195689|NCT01852591|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
111195690|NCT01852591|Immunologic Factors|immunologic factors|mesh-ancestor
111195691|NCT01852591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111195692|NCT04021173|Fibrinolysin|fibrinolysin|mesh-list
110845668|NCT03857542|Autonomic Agents|autonomic agents|mesh-ancestor
111195693|NCT04021173|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111195694|NCT04021173|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111195695|NCT04021173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111195696|NCT01852045|Botulinum Toxins|botulinum toxins|mesh-list
111195697|NCT01852045|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111195698|NCT01852045|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111195699|NCT01852045|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111195700|NCT01852045|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111195701|NCT01852045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111195702|NCT01852045|Cholinergic Agents|cholinergic agents|mesh-ancestor
111195703|NCT01852045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111195704|NCT01852045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111195705|NCT01852045|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111195706|NCT01852045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111195707|NCT03960957|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111195708|NCT03960957|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111195709|NCT03960957|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111195710|NCT03960957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111195711|NCT03960957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111195712|NCT03960957|Cholinergic Agents|cholinergic agents|mesh-ancestor
111195713|NCT03960957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111195714|NCT03960957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111195715|NCT03960957|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111195716|NCT03960957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111195717|NCT04027179|Chlorhexidine|chlorhexidine|mesh-list
111195718|NCT04027179|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
111195719|NCT04027179|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111195720|NCT04027179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111195721|NCT04027179|Disinfectants|disinfectants|mesh-ancestor
111195722|NCT04027179|Dermatologic Agents|dermatologic agents|mesh-ancestor
111195723|NCT04199169|Vaccines|vaccines|mesh-list
111195724|NCT04199169|Immunologic Factors|immunologic factors|mesh-ancestor
111195725|NCT04199169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111195726|NCT03022929|Anti-Infective Agents|anti-infective agents|mesh-list
111195727|NCT03022929|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111195728|NCT01821391|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
111195729|NCT01821391|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111195730|NCT01821391|Dermatologic Agents|dermatologic agents|mesh-ancestor
111195731|NCT04020705|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
111195732|NCT04020705|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111195733|NCT04020705|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111195734|NCT04020705|Nootropic Agents|nootropic agents|mesh-ancestor
111195735|NCT01873417|Dimethyl Fumarate|dimethyl fumarate|mesh-list
111195736|NCT01873417|Dermatologic Agents|dermatologic agents|mesh-ancestor
111195737|NCT01873417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111195738|NCT01873417|Immunologic Factors|immunologic factors|mesh-ancestor
111195739|NCT01873417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111195740|NCT01872715|Doxycycline|doxycycline|mesh-list
111195741|NCT01872715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111195742|NCT01872715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111195743|NCT01872715|Antimalarials|antimalarials|mesh-ancestor
111195744|NCT01872715|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111195745|NCT01872715|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111195746|NCT01613599|Rituximab|rituximab|mesh-list
110799574|NCT02064946|Vitamins|vitamins|mesh-ancestor
111195747|NCT01613599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111195748|NCT01613599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111195749|NCT01613599|Immunologic Factors|immunologic factors|mesh-ancestor
111195750|NCT01613599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111195751|NCT01613599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111195752|NCT03930771|Capecitabine|capecitabine|mesh-list
111195753|NCT03930771|Temozolomide|temozolomide|mesh-list
111195754|NCT03930771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111195755|NCT03930771|Antimetabolites|antimetabolites|mesh-ancestor
111195756|NCT03930771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111195757|NCT03930771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111195758|NCT03930771|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111195759|NCT03930771|Alkylating Agents|alkylating agents|mesh-ancestor
111195760|NCT04024683|Ropivacaine|ropivacaine|mesh-list
111195762|NCT04024683|Anesthetics|anesthetics|mesh-ancestor
111195763|NCT04024683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111195764|NCT04024683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111195765|NCT04024683|Sensory System Agents|sensory system agents|mesh-ancestor
111195766|NCT04024683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111195767|NCT04024527|Amoxicillin|amoxicillin|mesh-list
111195768|NCT04024527|Metronidazole|metronidazole|mesh-list
111195769|NCT04024527|Esomeprazole|esomeprazole|mesh-list
111195770|NCT04024527|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111195771|NCT04024527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111195772|NCT04024527|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111195773|NCT04024527|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111195774|NCT04024527|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111195775|NCT04024527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111195776|NCT04024527|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111195777|NCT04024527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111195778|NCT04024527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111195779|NCT06061926|Magnesium Oxide|magnesium oxide|mesh-list
111195780|NCT06061926|Antacids|antacids|mesh-ancestor
111195781|NCT06061926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111195782|NCT06061926|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111195783|NCT06061848|Vitamin D|vitamin d|mesh-list
111195784|NCT06061848|Vitamins|vitamins|mesh-ancestor
111195785|NCT06061848|Micronutrients|micronutrients|mesh-ancestor
111195786|NCT06061848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111195787|NCT06061848|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111195788|NCT06061835|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
111195789|NCT06061835|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111195790|NCT06061835|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111195791|NCT06061835|Analgesics|analgesics|mesh-ancestor
111195792|NCT06061835|Sensory System Agents|sensory system agents|mesh-ancestor
111195793|NCT06061835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111195794|NCT06061835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111195795|NCT06061835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111195796|NCT06061835|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111195797|NCT06061809|Bevacizumab|bevacizumab|mesh-list
111195798|NCT06061809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111195799|NCT06061809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111195800|NCT06061809|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111195801|NCT06061809|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111195802|NCT06061809|Growth Substances|growth substances|mesh-ancestor
111195803|NCT06061809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111195804|NCT06061809|Growth Inhibitors|growth inhibitors|mesh-ancestor
111195805|NCT06061718|Travoprost|travoprost|mesh-list
111195806|NCT06061718|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111195807|NCT06061666|Glycerol|glycerol|mesh-list
111195808|NCT06061666|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
111195809|NCT06061666|Protective Agents|protective agents|mesh-ancestor
111195810|NCT06061666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111195811|NCT06061575|Acetaminophen|acetaminophen|mesh-list
111195812|NCT06061575|Ibuprofen|ibuprofen|mesh-list
111195813|NCT06061575|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111195814|NCT06061575|Analgesics|analgesics|mesh-ancestor
111195815|NCT06061575|Sensory System Agents|sensory system agents|mesh-ancestor
111195816|NCT06061575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110491347|NCT02592772|Antipruritics|antipruritics|mesh-ancestor
111195817|NCT06061575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111195818|NCT06061575|Antipyretics|antipyretics|mesh-ancestor
111195819|NCT06061575|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111195820|NCT06061575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111195821|NCT06061575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111195822|NCT06061575|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111195823|NCT06061575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111195824|NCT06061575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111195825|NCT06061536|Lamivudine|lamivudine|mesh-list
111195826|NCT06061536|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111195827|NCT06061536|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111195828|NCT06061536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111195829|NCT06061536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111195830|NCT06061536|Antiviral Agents|antiviral agents|mesh-ancestor
111195831|NCT06061536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111195832|NCT06061536|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111195833|NCT06061536|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111195834|NCT06061523|Sotorasib|sotorasib|mesh-list
111195835|NCT06061523|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111195836|NCT06061523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111195837|NCT06061523|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111195838|NCT06061523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111195839|NCT06061484|Amoxicillin|amoxicillin|mesh-list
111195840|NCT06061484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111195841|NCT06061484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111195842|NCT06061445|Antibodies|antibodies|mesh-list
111195843|NCT06061445|Immunologic Factors|immunologic factors|mesh-ancestor
111195844|NCT06061445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111195845|NCT06061393|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
111195846|NCT06061393|Hematinics|hematinics|mesh-ancestor
111195847|NCT06061354|Teriparatide|teriparatide|mesh-list
111195848|NCT06061354|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111195849|NCT06061354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111195850|NCT06061354|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111195851|NCT06061315|Silicon|silicon|mesh-list
111195852|NCT06061315|Trace Elements|trace elements|mesh-ancestor
111195853|NCT06061315|Micronutrients|micronutrients|mesh-ancestor
111195854|NCT06061315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111195855|NCT06061276|Lenvatinib|lenvatinib|mesh-list
111195856|NCT06061276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111195857|NCT06061276|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111195858|NCT06061276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111195859|NCT06061276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111195860|NCT06061094|Imatinib Mesylate|imatinib mesylate|mesh-list
111195861|NCT06061094|Blinatumomab|blinatumomab|mesh-list
111195862|NCT06061094|Ponatinib|ponatinib|mesh-list
111195863|NCT06061094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111195864|NCT06061094|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111195865|NCT06061094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111195866|NCT06061094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111195867|NCT06060990|Trace Elements|trace elements|mesh-list
111195868|NCT06060990|Micronutrients|micronutrients|mesh-list
111195869|NCT06060990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111195870|NCT06060886|Aripiprazole|aripiprazole|mesh-list
111195871|NCT06060886|Paliperidone Palmitate|paliperidone palmitate|mesh-list
111195872|NCT06060886|Antidepressive Agents|antidepressive agents|mesh-ancestor
111195873|NCT06060886|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111195874|NCT06060886|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111195875|NCT06060886|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111195876|NCT06060886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111195877|NCT06060886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111195878|NCT06060886|Dopamine Agonists|dopamine agonists|mesh-ancestor
111195879|NCT06060886|Dopamine Agents|dopamine agents|mesh-ancestor
111195880|NCT06060886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111195881|NCT06060886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111195882|NCT06060886|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111195883|NCT06060886|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111195884|NCT06060886|Serotonin Agents|serotonin agents|mesh-ancestor
111195885|NCT06060886|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111195886|NCT06060886|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111195887|NCT06060886|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111195888|NCT06060886|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111195889|NCT06060847|Liver Extracts|liver extracts|mesh-list
111195890|NCT06060847|Hematinics|hematinics|mesh-ancestor
111195891|NCT06060782|Cytarabine|cytarabine|mesh-list
111195892|NCT06060782|Cyclophosphamide|cyclophosphamide|mesh-list
111195893|NCT06060782|Thiotepa|thiotepa|mesh-list
111195894|NCT06060782|Cladribine|cladribine|mesh-list
111195895|NCT06060782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111195896|NCT06060782|Immunologic Factors|immunologic factors|mesh-ancestor
111195897|NCT06060782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111195898|NCT06060782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111195899|NCT06060782|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111195900|NCT06060782|Alkylating Agents|alkylating agents|mesh-ancestor
111195901|NCT06060782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111195902|NCT06060782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111195903|NCT06060782|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111195904|NCT06060782|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111195905|NCT06060782|Antimetabolites|antimetabolites|mesh-ancestor
111195906|NCT06060782|Antiviral Agents|antiviral agents|mesh-ancestor
111195907|NCT06060782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111195908|NCT06060743|Insulin|insulin|mesh-list
111195909|NCT06060743|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111195910|NCT06060743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111195911|NCT06060704|Trifluridine|trifluridine|mesh-list
111195912|NCT06060704|Bevacizumab|bevacizumab|mesh-list
111195913|NCT06060704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111195914|NCT06060704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111195915|NCT06060704|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111195916|NCT06060704|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111195917|NCT06060704|Growth Substances|growth substances|mesh-ancestor
111195918|NCT06060704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111195919|NCT06060704|Growth Inhibitors|growth inhibitors|mesh-ancestor
111195920|NCT06060704|Antimetabolites|antimetabolites|mesh-ancestor
111195921|NCT06060704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111195922|NCT06060704|Antiviral Agents|antiviral agents|mesh-ancestor
111195923|NCT06060704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111195924|NCT06060665|Seladelpar|seladelpar|mesh-list
111195925|NCT06060665|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111195926|NCT06060665|Antimetabolites|antimetabolites|mesh-ancestor
111195927|NCT06060665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111195928|NCT06060665|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111195929|NCT06060626|Fentanyl|fentanyl|mesh-list
111195930|NCT06060626|Propofol|propofol|mesh-list
111195931|NCT06060626|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111195932|NCT06060626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111195933|NCT06060626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111195934|NCT06060626|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111195935|NCT06060626|Anesthetics, General|anesthetics, general|mesh-ancestor
111195936|NCT06060626|Anesthetics|anesthetics|mesh-ancestor
111195937|NCT06060626|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111195938|NCT06060626|Narcotics|narcotics|mesh-ancestor
111195939|NCT06060626|Analgesics|analgesics|mesh-ancestor
111195940|NCT06060626|Sensory System Agents|sensory system agents|mesh-ancestor
111195941|NCT06060626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111195942|NCT06060626|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111195943|NCT06060587|Docetaxel|docetaxel|mesh-list
111195944|NCT06060587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111195945|NCT06060587|Tubulin Modulators|tubulin modulators|mesh-ancestor
111195946|NCT06060587|Antimitotic Agents|antimitotic agents|mesh-ancestor
111195947|NCT06060587|Mitosis Modulators|mitosis modulators|mesh-ancestor
111195948|NCT06060587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111195949|NCT06060405|Durvalumab|durvalumab|mesh-list
111195950|NCT06060405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111195951|NCT06060405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111195952|NCT06060340|Propolis|propolis|mesh-list
111195953|NCT06060340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111195954|NCT06060327|Misoprostol|misoprostol|mesh-list
111195955|NCT06060327|Tranexamic Acid|tranexamic acid|mesh-list
111195956|NCT06060327|Oxytocin|oxytocin|mesh-list
111195957|NCT06060327|Carbetocin|carbetocin|mesh-list
111195958|NCT06060327|Oxytocics|oxytocics|mesh-ancestor
111195959|NCT06060327|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111195960|NCT06060327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111195961|NCT06060327|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111195962|NCT06060327|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111195963|NCT06060327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111195964|NCT06060327|Hemostatics|hemostatics|mesh-ancestor
111195965|NCT06060327|Coagulants|coagulants|mesh-ancestor
111195966|NCT06060327|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111195967|NCT06060327|Abortifacient Agents|abortifacient agents|mesh-ancestor
111195968|NCT06060327|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111195969|NCT06060327|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111195970|NCT06060301|Sulfasalazine|sulfasalazine|mesh-list
111195971|NCT06060301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111195972|NCT06060301|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111195973|NCT06060301|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111195974|NCT06060301|Analgesics|analgesics|mesh-ancestor
111195975|NCT06060301|Sensory System Agents|sensory system agents|mesh-ancestor
111195976|NCT06060301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111195977|NCT06060301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111195978|NCT06060301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111195979|NCT06060301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111195980|NCT06060301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111195981|NCT06060236|Ibuprofen|ibuprofen|mesh-list
111195982|NCT06060236|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
111195983|NCT06060236|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111195984|NCT06060236|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111195985|NCT06060236|Analgesics|analgesics|mesh-ancestor
111195986|NCT06060236|Sensory System Agents|sensory system agents|mesh-ancestor
111195987|NCT06060236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111195988|NCT06060236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111195989|NCT06060236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111195990|NCT06060236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111195991|NCT06060236|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111195992|NCT06060236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111195993|NCT06060236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111195994|NCT06060210|Ketamine|ketamine|mesh-list
111195995|NCT06060210|Analgesics|analgesics|mesh-ancestor
111195996|NCT06060210|Sensory System Agents|sensory system agents|mesh-ancestor
111195997|NCT06060210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111195998|NCT06060210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111195999|NCT06060210|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111196000|NCT06060210|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111196001|NCT06060210|Anesthetics, General|anesthetics, general|mesh-ancestor
111196002|NCT06060210|Anesthetics|anesthetics|mesh-ancestor
111196003|NCT06060210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111196004|NCT06060210|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111196005|NCT06060210|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111196006|NCT06060210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111196007|NCT06060210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111196008|NCT06060132|Arsenic Trioxide|arsenic trioxide|mesh-list
111196009|NCT06060132|Sodium arsenite|sodium arsenite|mesh-list
111196010|NCT06060132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111196011|NCT06060132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111196012|NCT06060132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111196013|NCT06060080|Lenograstim|lenograstim|mesh-list
111196014|NCT06060080|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111196015|NCT06060080|Immunologic Factors|immunologic factors|mesh-ancestor
111196016|NCT06060080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111196017|NCT06060015|Bupivacaine|bupivacaine|mesh-list
111196018|NCT06060015|Anesthetics, Local|anesthetics, local|mesh-ancestor
111196019|NCT06060015|Anesthetics|anesthetics|mesh-ancestor
110491367|NCT04055623|Aldesleukin|aldesleukin|mesh-list
111196020|NCT06060015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111196021|NCT06060015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111196022|NCT06060015|Sensory System Agents|sensory system agents|mesh-ancestor
111196023|NCT06060015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111196024|NCT06059989|Folic Acid|folic acid|mesh-list
111196025|NCT06059989|Infliximab|infliximab|mesh-list
111196026|NCT06059989|Methotrexate|methotrexate|mesh-list
111196027|NCT06059989|Mercaptopurine|mercaptopurine|mesh-list
111196028|NCT06059989|Azathioprine|azathioprine|mesh-list
111196029|NCT06059989|Thioguanine|thioguanine|mesh-list
111196030|NCT06059989|Immunosuppressive Agents|immunosuppressive agents|mesh-list
111196031|NCT06059989|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111196032|NCT06059989|Abortifacient Agents|abortifacient agents|mesh-ancestor
111196033|NCT06059989|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111196034|NCT06059989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111196035|NCT06059989|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111196036|NCT06059989|Antimetabolites|antimetabolites|mesh-ancestor
111196037|NCT06059989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111196038|NCT06059989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111196039|NCT06059989|Dermatologic Agents|dermatologic agents|mesh-ancestor
111196040|NCT06059989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111196041|NCT06059989|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111196042|NCT06059989|Immunologic Factors|immunologic factors|mesh-ancestor
111196043|NCT06059989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111196044|NCT06059989|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111196045|NCT06059989|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111196046|NCT06059989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111196047|NCT06059989|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111196048|NCT06059989|Hematinics|hematinics|mesh-ancestor
111196049|NCT06059989|Vitamin B Complex|vitamin b complex|mesh-ancestor
111196050|NCT06059989|Vitamins|vitamins|mesh-ancestor
111196051|NCT06059989|Micronutrients|micronutrients|mesh-ancestor
111196052|NCT06059911|Caffeine|caffeine|mesh-list
111196053|NCT06059911|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111196054|NCT06059911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111196055|NCT06059911|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111196056|NCT06059911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111196057|NCT06059911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111196058|NCT06059911|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
111196059|NCT06059911|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111196060|NCT06059911|Purinergic Agents|purinergic agents|mesh-ancestor
111196061|NCT06059911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111196062|NCT06059885|Tislelizumab|tislelizumab|mesh-list
111196063|NCT06059885|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
111196064|NCT06059885|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111196065|NCT06059885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111196066|NCT06059885|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111196068|NCT06059885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111196069|NCT06059846|Imipenem|imipenem|mesh-list
111196070|NCT06059846|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
111196071|NCT06059846|Cilastatin|cilastatin|mesh-list
111196072|NCT06059846|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111196073|NCT06059846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111196074|NCT06059846|Protease Inhibitors|protease inhibitors|mesh-ancestor
111196075|NCT06059846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111196076|NCT06059846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111196077|NCT06058884|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
111196078|NCT06058884|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111196079|NCT06058884|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111196080|NCT06058884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111196081|NCT06057896|Inositol|inositol|mesh-list
111196082|NCT06057896|Phytoestrogens|phytoestrogens|mesh-list
111196083|NCT06057896|Vitamin B Complex|vitamin b complex|mesh-ancestor
111196084|NCT06057896|Vitamins|vitamins|mesh-ancestor
111196085|NCT06057896|Micronutrients|micronutrients|mesh-ancestor
111196086|NCT06057896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111196087|NCT06057896|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
111196088|NCT06057896|Estrogens|estrogens|mesh-ancestor
111196089|NCT06057896|Hormones|hormones|mesh-ancestor
111196090|NCT06057896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111196091|NCT06057675|Lidocaine|lidocaine|mesh-list
111196092|NCT06057675|Epinephrine|epinephrine|mesh-list
111196093|NCT06057675|Racepinephrine|racepinephrine|mesh-list
111196094|NCT06057675|Tranexamic Acid|tranexamic acid|mesh-list
111196095|NCT06057675|Epinephryl borate|epinephryl borate|mesh-list
111196096|NCT06057675|Anesthetics, Local|anesthetics, local|mesh-ancestor
111196097|NCT06057675|Anesthetics|anesthetics|mesh-ancestor
111196098|NCT06057675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111196099|NCT06057675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111196100|NCT06057675|Sensory System Agents|sensory system agents|mesh-ancestor
111196101|NCT06057675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111196102|NCT06057675|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111196103|NCT06057675|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111196104|NCT06057675|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111196105|NCT06057675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111196106|NCT06057675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111196107|NCT06057675|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111196108|NCT06057675|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111196109|NCT06057675|Hemostatics|hemostatics|mesh-ancestor
111196111|NCT06057675|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111196112|NCT06057675|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111196113|NCT06057675|Adrenergic Agents|adrenergic agents|mesh-ancestor
111196114|NCT06057675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111196115|NCT06057675|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111196116|NCT06057675|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111196117|NCT06057675|Autonomic Agents|autonomic agents|mesh-ancestor
111196118|NCT06057675|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111196119|NCT06057675|Respiratory System Agents|respiratory system agents|mesh-ancestor
111196120|NCT06057675|Mydriatics|mydriatics|mesh-ancestor
111196121|NCT06057675|Sympathomimetics|sympathomimetics|mesh-ancestor
111196122|NCT06057675|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111196123|NCT06057610|Docetaxel|docetaxel|mesh-list
111196124|NCT06057610|Trastuzumab|trastuzumab|mesh-list
111196125|NCT06057610|Pertuzumab|pertuzumab|mesh-list
111196126|NCT06057610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111196127|NCT06057610|Tubulin Modulators|tubulin modulators|mesh-ancestor
111196128|NCT06057610|Antimitotic Agents|antimitotic agents|mesh-ancestor
111196129|NCT06057610|Mitosis Modulators|mitosis modulators|mesh-ancestor
111196130|NCT06057610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111196131|NCT06057610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111196132|NCT06057545|Tacrolimus|tacrolimus|mesh-list
111196133|NCT06057545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111196134|NCT06057545|Immunologic Factors|immunologic factors|mesh-ancestor
111196135|NCT06057545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111196136|NCT06057545|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111196137|NCT06057545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111196138|NCT06057545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111196139|NCT06057519|Rifampin|rifampin|mesh-list
111196140|NCT06057519|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111196141|NCT06057519|Antitubercular Agents|antitubercular agents|mesh-ancestor
111196142|NCT06057519|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111196143|NCT06057519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111196144|NCT06057519|Leprostatic Agents|leprostatic agents|mesh-ancestor
111196145|NCT06057519|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111196146|NCT06057519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111196147|NCT06057519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111196148|NCT06057519|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111196149|NCT06057519|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111196150|NCT06057519|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
111196151|NCT06057519|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
111196152|NCT06057519|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
111196153|NCT06057519|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111196155|NCT06057194|Letermovir|letermovir|mesh-list
111196156|NCT06057194|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111196157|NCT06057194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111196158|NCT06057194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111196159|NCT06057194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111196160|NCT06057194|Antiviral Agents|antiviral agents|mesh-ancestor
111196161|NCT06057194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110799575|NCT02064946|Micronutrients|micronutrients|mesh-ancestor
111196162|NCT06057168|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
111196163|NCT06057168|Chelating Agents|chelating agents|mesh-ancestor
111196164|NCT06057168|Sequestering Agents|sequestering agents|mesh-ancestor
111196165|NCT06057168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111196166|NCT06057103|Oseltamivir|oseltamivir|mesh-list
111196167|NCT06057103|Antiviral Agents|antiviral agents|mesh-ancestor
111196168|NCT06057103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110845716|NCT03866681|Anticoagulants|anticoagulants|mesh-ancestor
111196170|NCT06057103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111196171|NCT06057038|Carboplatin|carboplatin|mesh-list
111196172|NCT06057038|Pembrolizumab|pembrolizumab|mesh-list
111196173|NCT06057038|Fluorouracil|fluorouracil|mesh-list
111196174|NCT06057038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111196175|NCT06057038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111196176|NCT06057038|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111196177|NCT06057038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111196178|NCT06057038|Antimetabolites|antimetabolites|mesh-ancestor
111196179|NCT06057038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111196180|NCT06057038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111196181|NCT06057038|Immunologic Factors|immunologic factors|mesh-ancestor
111196182|NCT06057038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111196183|NCT06056869|Scopolamine|scopolamine|mesh-list
111196184|NCT06056869|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
111196185|NCT06056869|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111196186|NCT06056869|Antiemetics|antiemetics|mesh-ancestor
111196187|NCT06056869|Autonomic Agents|autonomic agents|mesh-ancestor
111196188|NCT06056869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111196189|NCT06056869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111196190|NCT06056869|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111196191|NCT06056869|Mydriatics|mydriatics|mesh-ancestor
111196192|NCT06056869|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111196193|NCT06056869|Cholinergic Agents|cholinergic agents|mesh-ancestor
111196194|NCT06056869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111196195|NCT06056869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111196196|NCT06056869|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111196197|NCT06056869|Parasympatholytics|parasympatholytics|mesh-ancestor
111196198|NCT06056804|Capecitabine|capecitabine|mesh-list
111196199|NCT06056804|Tislelizumab|tislelizumab|mesh-list
111196200|NCT06056804|Thymalfasin|thymalfasin|mesh-list
111196201|NCT06056804|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111196202|NCT06056804|Antimetabolites|antimetabolites|mesh-ancestor
111196203|NCT06056804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111196204|NCT06056804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111196205|NCT06056804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111196206|NCT06056804|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111196207|NCT06056804|Immunologic Factors|immunologic factors|mesh-ancestor
111196208|NCT06056804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111196209|NCT06056752|Cyclophosphamide|cyclophosphamide|mesh-list
111196210|NCT06056752|Fludarabine|fludarabine|mesh-list
111196211|NCT06056752|Fludarabine phosphate|fludarabine phosphate|mesh-list
111196212|NCT06056752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110913283|NCT05617508|Niacin|niacin|mesh-list
111196213|NCT06056752|Immunologic Factors|immunologic factors|mesh-ancestor
111196214|NCT06056752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111196215|NCT06056752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111196216|NCT06056752|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111196217|NCT06056752|Alkylating Agents|alkylating agents|mesh-ancestor
111196218|NCT06056752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111196219|NCT06056752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111196220|NCT06056752|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111196221|NCT06056752|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111196222|NCT06056752|Antimetabolites|antimetabolites|mesh-ancestor
111196223|NCT06056596|Lamivudine|lamivudine|mesh-list
111196224|NCT06056596|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111196225|NCT06056596|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111196226|NCT06056596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111196227|NCT06056596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111196228|NCT06056596|Antiviral Agents|antiviral agents|mesh-ancestor
111196229|NCT06056596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111196230|NCT06056596|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111196231|NCT06056596|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111196232|NCT06056583|Cimetidine|cimetidine|mesh-list
111196233|NCT06056583|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111196234|NCT06056583|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111196235|NCT06056583|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
111196236|NCT06056583|Histamine Antagonists|histamine antagonists|mesh-ancestor
111196237|NCT06056583|Histamine Agents|histamine agents|mesh-ancestor
111196238|NCT06056583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111196239|NCT06056583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111196240|NCT06056583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111196241|NCT06056583|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111196242|NCT06056583|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111196243|NCT06056583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111196244|NCT06056570|Allopurinol|allopurinol|mesh-list
111196245|NCT06056570|Dotinurad|dotinurad|mesh-list
111196246|NCT06056570|Antimetabolites|antimetabolites|mesh-ancestor
111196247|NCT06056570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111196248|NCT06056570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111196249|NCT06056570|Gout Suppressants|gout suppressants|mesh-ancestor
111196250|NCT06056570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111196251|NCT06056570|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111196252|NCT06056570|Antioxidants|antioxidants|mesh-ancestor
111196253|NCT06056570|Protective Agents|protective agents|mesh-ancestor
111196254|NCT06056570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111196255|NCT06056570|Uricosuric Agents|uricosuric agents|mesh-ancestor
111196256|NCT06056492|Nitrous Oxide|nitrous oxide|mesh-list
111196257|NCT06056492|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111196258|NCT06056492|Anesthetics, General|anesthetics, general|mesh-ancestor
111196259|NCT06056492|Anesthetics|anesthetics|mesh-ancestor
111196260|NCT06056492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111196261|NCT06056492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111196262|NCT06056492|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111196263|NCT06056492|Analgesics|analgesics|mesh-ancestor
111196264|NCT06056492|Sensory System Agents|sensory system agents|mesh-ancestor
111196265|NCT06056492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111196266|NCT06056336|Paclitaxel|paclitaxel|mesh-list
111196267|NCT06056336|Carboplatin|carboplatin|mesh-list
111196268|NCT06056336|Tislelizumab|tislelizumab|mesh-list
111196269|NCT06056336|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111196270|NCT06056336|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111196271|NCT06056336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111196272|NCT06056336|Tubulin Modulators|tubulin modulators|mesh-ancestor
111196273|NCT06056336|Antimitotic Agents|antimitotic agents|mesh-ancestor
111196274|NCT06056336|Mitosis Modulators|mitosis modulators|mesh-ancestor
111196275|NCT06056336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111196276|NCT06056336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111196277|NCT06056310|Cisplatin|cisplatin|mesh-list
111196278|NCT06056310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111196279|NCT06056245|Methadone|methadone|mesh-list
111196280|NCT06056245|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111196281|NCT06056245|Narcotics|narcotics|mesh-ancestor
111196282|NCT06056245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111196283|NCT06056245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111196284|NCT06056245|Analgesics|analgesics|mesh-ancestor
111196285|NCT06056245|Sensory System Agents|sensory system agents|mesh-ancestor
111196286|NCT06056245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111196287|NCT06056245|Antitussive Agents|antitussive agents|mesh-ancestor
111196288|NCT06056245|Respiratory System Agents|respiratory system agents|mesh-ancestor
111196289|NCT06056167|Insulin|insulin|mesh-list
111196290|NCT06056167|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111196291|NCT06056167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111196292|NCT06056141|Misoprostol|misoprostol|mesh-list
111196293|NCT06056141|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111196294|NCT06056141|Abortifacient Agents|abortifacient agents|mesh-ancestor
111196295|NCT06056141|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110491395|NCT00727246|Nootropic Agents|nootropic agents|mesh-ancestor
111196296|NCT06056141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111196297|NCT06056141|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111196298|NCT06056141|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111196299|NCT06056141|Oxytocics|oxytocics|mesh-ancestor
111196300|NCT06056115|Tislelizumab|tislelizumab|mesh-list
111196301|NCT06056115|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111196302|NCT06056115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111196303|NCT06056102|Cyclophosphamide|cyclophosphamide|mesh-list
111196304|NCT06056102|Fludarabine|fludarabine|mesh-list
111196305|NCT06056102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111196306|NCT06056102|Immunologic Factors|immunologic factors|mesh-ancestor
111196307|NCT06056102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111196308|NCT06056102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111196309|NCT06056102|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111196310|NCT06056102|Alkylating Agents|alkylating agents|mesh-ancestor
111196311|NCT06056102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111196312|NCT06056102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111196313|NCT06056102|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111196314|NCT06056089|Amoxicillin|amoxicillin|mesh-list
111196315|NCT06056089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111196316|NCT06056089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111196317|NCT06056050|Vaccines|vaccines|mesh-list
111196318|NCT06056050|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
111196319|NCT06056050|Immunologic Factors|immunologic factors|mesh-ancestor
111196320|NCT06056050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111196321|NCT06055920|Anticoagulants|anticoagulants|mesh-list
111196322|NCT06055907|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
111196323|NCT06055907|Dalteparin|dalteparin|mesh-list
111196324|NCT06055907|Anticoagulants|anticoagulants|mesh-ancestor
111196325|NCT06055907|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111196326|NCT06055907|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111196327|NCT06055907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111196328|NCT06055894|Curcumin|curcumin|mesh-list
111196329|NCT06055894|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111196330|NCT06055894|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111196331|NCT06055894|Analgesics|analgesics|mesh-ancestor
111196332|NCT06055894|Sensory System Agents|sensory system agents|mesh-ancestor
111196333|NCT06055894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111196334|NCT06055894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111196335|NCT06055894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111196336|NCT06055894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111196337|NCT06055894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111196338|NCT06055894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111196339|NCT06055894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111196340|NCT06055829|Insulin|insulin|mesh-list
111196341|NCT06055829|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111196342|NCT06055829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111196343|NCT06055816|Endostar protein|endostar protein|mesh-list
111196344|NCT06055816|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111196345|NCT06055816|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111196346|NCT06055816|Growth Substances|growth substances|mesh-ancestor
111196347|NCT06055816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111196348|NCT06055816|Growth Inhibitors|growth inhibitors|mesh-ancestor
111196349|NCT06055816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111196350|NCT06055777|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111196351|NCT06055777|beta-Lactams|beta-lactams|mesh-list
111196352|NCT06055777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111196353|NCT06055738|Paclitaxel|paclitaxel|mesh-list
111196354|NCT06055738|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111196355|NCT06055738|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111196356|NCT06055738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110491402|NCT04055233|Biguanides|biguanides|mesh-list
111196357|NCT06055738|Tubulin Modulators|tubulin modulators|mesh-ancestor
111196358|NCT06055738|Antimitotic Agents|antimitotic agents|mesh-ancestor
111196359|NCT06055738|Mitosis Modulators|mitosis modulators|mesh-ancestor
111196360|NCT06055738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111196361|NCT06055712|Cefazolin|cefazolin|mesh-list
111196362|NCT06055712|Cephalexin|cephalexin|mesh-list
111196363|NCT06055712|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111196364|NCT06055712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111196365|NCT06055621|Dasatinib|dasatinib|mesh-list
111196366|NCT06055621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111196367|NCT06055621|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111196368|NCT06055621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111196369|NCT06055621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111196370|NCT06055608|Mycophenolic Acid|mycophenolic acid|mesh-list
111196371|NCT06055608|Sirolimus|sirolimus|mesh-list
111196372|NCT06055608|Abatacept|abatacept|mesh-list
111196373|NCT06055608|Tacrolimus|tacrolimus|mesh-list
111196374|NCT06055608|Antilymphocyte Serum|antilymphocyte serum|mesh-list
111196375|NCT06055608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111196376|NCT06055608|Immunologic Factors|immunologic factors|mesh-ancestor
111196377|NCT06055608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111196378|NCT06055608|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111196379|NCT06055608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111196380|NCT06055608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111196381|NCT06055608|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111196382|NCT06055608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111196383|NCT06055608|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111196384|NCT06055608|Antitubercular Agents|antitubercular agents|mesh-ancestor
111196385|NCT06055608|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111196386|NCT06055608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111196388|NCT06055608|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111196389|NCT06055608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111196390|NCT06055608|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111196391|NCT06053411|Diclofenac|diclofenac|mesh-list
111196392|NCT06053411|Curcumin|curcumin|mesh-list
111196393|NCT06053411|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111196394|NCT06053411|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111196395|NCT06053411|Analgesics|analgesics|mesh-ancestor
111196396|NCT06053411|Sensory System Agents|sensory system agents|mesh-ancestor
111196397|NCT06053411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111196398|NCT06053411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111196399|NCT06053411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111196400|NCT06053411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111196401|NCT06053411|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111196402|NCT06053411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111196403|NCT06053411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111196404|NCT06053411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111196405|NCT06053385|Melatonin|melatonin|mesh-list
111196406|NCT06053385|Antioxidants|antioxidants|mesh-ancestor
111196407|NCT06053385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111196408|NCT06053385|Protective Agents|protective agents|mesh-ancestor
111196409|NCT06053385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111196410|NCT06053385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111196411|NCT06052956|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
111196412|NCT06052956|Methylene Blue|methylene blue|mesh-list
111196413|NCT06052956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111196414|NCT06052956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111196415|NCT06052956|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
111196416|NCT06052956|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
111196417|NCT06052956|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111196418|NCT06052787|Amantadine|amantadine|mesh-list
111196419|NCT06052787|Cerebrolysin|cerebrolysin|mesh-list
111196420|NCT06052787|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111196421|NCT06052787|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111196422|NCT06052787|Antiviral Agents|antiviral agents|mesh-ancestor
111196423|NCT06052787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111196424|NCT06052787|Dopamine Agents|dopamine agents|mesh-ancestor
111196425|NCT06052787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110799576|NCT02064946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111196426|NCT06052787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111196427|NCT06052787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111196428|NCT06052787|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111196429|NCT06052787|Analgesics|analgesics|mesh-ancestor
111196430|NCT06052787|Sensory System Agents|sensory system agents|mesh-ancestor
111196431|NCT06052787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111196432|NCT06052787|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111196433|NCT06052787|Protective Agents|protective agents|mesh-ancestor
111196434|NCT06052787|Nootropic Agents|nootropic agents|mesh-ancestor
111196435|NCT06052267|Albuterol|albuterol|mesh-list
111196436|NCT06052267|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111196437|NCT06052267|Autonomic Agents|autonomic agents|mesh-ancestor
111196438|NCT06052267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111196439|NCT06052267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111196440|NCT06052267|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111196441|NCT06052267|Respiratory System Agents|respiratory system agents|mesh-ancestor
111196442|NCT06052267|Tocolytic Agents|tocolytic agents|mesh-ancestor
111196443|NCT06052267|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111196444|NCT06052267|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111196445|NCT06052267|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111196446|NCT06052267|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111196447|NCT06052267|Adrenergic Agents|adrenergic agents|mesh-ancestor
111196448|NCT06052267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111196449|NCT06052267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111196450|NCT06052020|Atorvastatin|atorvastatin|mesh-list
111196451|NCT06052020|Alirocumab|alirocumab|mesh-list
111196452|NCT06052020|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111196453|NCT06052020|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111196454|NCT06052020|Antimetabolites|antimetabolites|mesh-ancestor
111196455|NCT06052020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111196456|NCT06052020|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111196457|NCT06052020|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111196458|NCT06052020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111196459|NCT06052020|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
111196460|NCT06052020|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111196461|NCT06052020|Protease Inhibitors|protease inhibitors|mesh-ancestor
111196462|NCT06051617|Seladelpar|seladelpar|mesh-list
111196463|NCT06051617|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111196464|NCT06051617|Antimetabolites|antimetabolites|mesh-ancestor
111196465|NCT06051617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111196466|NCT06051617|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111196467|NCT06051487|Titanium dioxide|titanium dioxide|mesh-list
111196468|NCT06051487|Sunscreening Agents|sunscreening agents|mesh-ancestor
111196469|NCT06051487|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111196470|NCT06051487|Protective Agents|protective agents|mesh-ancestor
111196471|NCT06051487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111196472|NCT06051487|Dermatologic Agents|dermatologic agents|mesh-ancestor
111196473|NCT06051487|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111196474|NCT06051253|Infliximab|infliximab|mesh-list
111196475|NCT06051253|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111196476|NCT06051253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111196477|NCT06051253|Dermatologic Agents|dermatologic agents|mesh-ancestor
111196478|NCT06051253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111196479|NCT06051253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111196480|NCT06047977|Cyclophosphamide|cyclophosphamide|mesh-list
111196481|NCT06047977|Fludarabine|fludarabine|mesh-list
111196482|NCT06047977|Interleukin-2|interleukin-2|mesh-list
111196483|NCT06047977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111196484|NCT06047977|Immunologic Factors|immunologic factors|mesh-ancestor
111196485|NCT06047977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111196486|NCT06047977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111196487|NCT06047977|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111196488|NCT06047977|Alkylating Agents|alkylating agents|mesh-ancestor
111196489|NCT06047977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111196490|NCT06047977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111196491|NCT06047977|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111196492|NCT06047977|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111196493|NCT06047977|Analgesics|analgesics|mesh-ancestor
111196494|NCT06047977|Sensory System Agents|sensory system agents|mesh-ancestor
111196495|NCT06047977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111196496|NCT06047457|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110491425|NCT02853578|Budesonide|budesonide|mesh-list
111196497|NCT06047457|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111196498|NCT06047457|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111196499|NCT06047457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111196500|NCT06047457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111196501|NCT06047457|Cholinergic Agents|cholinergic agents|mesh-ancestor
111196502|NCT06047457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111196503|NCT06047457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111196504|NCT06047457|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111196505|NCT06047457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111196506|NCT06047444|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111196507|NCT06047444|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111196508|NCT06047444|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111196509|NCT06047444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111196510|NCT06047444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111196511|NCT06047444|Cholinergic Agents|cholinergic agents|mesh-ancestor
111196512|NCT06047444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111196513|NCT06047444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111196514|NCT06047444|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111196515|NCT06047444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111196516|NCT06046287|Daratumumab|daratumumab|mesh-list
111196517|NCT06046287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111196518|NCT06045806|Cyclophosphamide|cyclophosphamide|mesh-list
111196519|NCT06045806|Fludarabine|fludarabine|mesh-list
111196520|NCT06045806|Lenalidomide|lenalidomide|mesh-list
111196521|NCT06045806|Idecabtagene vicleucel|idecabtagene vicleucel|mesh-list
111196522|NCT06045806|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111196523|NCT06045806|Immunologic Factors|immunologic factors|mesh-ancestor
111196524|NCT06045806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111196525|NCT06045806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111196526|NCT06045806|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111196527|NCT06045806|Alkylating Agents|alkylating agents|mesh-ancestor
111196528|NCT06045806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111196529|NCT06045806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111196530|NCT06045806|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111196531|NCT06045806|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111196532|NCT06045806|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111196533|NCT06045806|Growth Substances|growth substances|mesh-ancestor
111196534|NCT06045806|Growth Inhibitors|growth inhibitors|mesh-ancestor
111196535|NCT06045806|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111196536|NCT06045351|Vitamin D|vitamin d|mesh-list
111196537|NCT06045351|Vitamins|vitamins|mesh-ancestor
111196538|NCT06045351|Micronutrients|micronutrients|mesh-ancestor
111196539|NCT06045351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111196540|NCT06045351|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111196541|NCT06044558|Mycophenolic Acid|mycophenolic acid|mesh-list
111196542|NCT06044558|Voriconazole|voriconazole|mesh-list
111196543|NCT06044558|Caspofungin|caspofungin|mesh-list
111196544|NCT06044558|Methylprednisolone|methylprednisolone|mesh-list
111196545|NCT06044558|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111196546|NCT06044558|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111196547|NCT06044558|Prednisolone|prednisolone|mesh-list
111196548|NCT06044558|Prednisolone acetate|prednisolone acetate|mesh-list
111196549|NCT06044558|Tacrolimus|tacrolimus|mesh-list
111196550|NCT06044558|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111196551|NCT06044558|Prednisolone phosphate|prednisolone phosphate|mesh-list
111196552|NCT06044558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111196553|NCT06044558|Immunologic Factors|immunologic factors|mesh-ancestor
111196554|NCT06044558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111196555|NCT06044558|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111196556|NCT06044558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111196557|NCT06044558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111196558|NCT06044558|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111196559|NCT06044558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111196560|NCT06044558|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111196561|NCT06044558|Antitubercular Agents|antitubercular agents|mesh-ancestor
111196562|NCT06044558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111196563|NCT06044558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111196564|NCT06044558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111196565|NCT06044558|Antiemetics|antiemetics|mesh-ancestor
111196566|NCT06044558|Autonomic Agents|autonomic agents|mesh-ancestor
111196567|NCT06044558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110585378|NCT00754052|Donepezil|donepezil|mesh-list
111196568|NCT06044558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111196569|NCT06044558|Glucocorticoids|glucocorticoids|mesh-ancestor
111196570|NCT06044558|Hormones|hormones|mesh-ancestor
111196571|NCT06044558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111196572|NCT06044558|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111196573|NCT06044558|Protective Agents|protective agents|mesh-ancestor
111196574|NCT06044558|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111196575|NCT06044558|Antifungal Agents|antifungal agents|mesh-ancestor
111196576|NCT06044558|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111196577|NCT06044558|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111196578|NCT06044558|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111196579|NCT06044558|Hormone Antagonists|hormone antagonists|mesh-ancestor
111196580|NCT06044558|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111196581|NCT06043713|Cyclophosphamide|cyclophosphamide|mesh-list
111196582|NCT06043713|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
111196583|NCT06043713|Fludarabine|fludarabine|mesh-list
111196584|NCT06043713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111196585|NCT06043713|Immunologic Factors|immunologic factors|mesh-ancestor
111196586|NCT06043713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111196587|NCT06043713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110845755|NCT03867071|Epoetin Alfa|epoetin alfa|mesh-list
111196588|NCT06043713|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110913646|NCT00992732|Valganciclovir|valganciclovir|mesh-list
111196589|NCT06043713|Alkylating Agents|alkylating agents|mesh-ancestor
111196590|NCT06043713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111196591|NCT06043713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111196592|NCT06043713|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111196593|NCT06043063|Lidocaine|lidocaine|mesh-list
111196594|NCT06043063|Bupivacaine|bupivacaine|mesh-list
111196595|NCT06043063|Anesthetics, Local|anesthetics, local|mesh-list
111196596|NCT06043063|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
111196597|NCT06043063|Anesthetics|anesthetics|mesh-list
111196598|NCT06043063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111196599|NCT06043063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111196600|NCT06043063|Sensory System Agents|sensory system agents|mesh-ancestor
111196601|NCT06043063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111196602|NCT06043063|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111196603|NCT06043063|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111196604|NCT06043063|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111196605|NCT06043063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111196606|NCT06043063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111196607|NCT06043063|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
111196608|NCT06041503|Pembrolizumab|pembrolizumab|mesh-list
111196609|NCT06041503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111196610|NCT06041503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111196611|NCT06041503|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111196612|NCT06041503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111196613|NCT06039384|Adagrasib|adagrasib|mesh-list
111196614|NCT06039384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111196615|NCT06039371|Carboplatin|carboplatin|mesh-list
111196616|NCT06039371|Etoposide|etoposide|mesh-list
111196617|NCT06039371|Etoposide phosphate|etoposide phosphate|mesh-list
111196618|NCT06039371|Methyltestosterone|methyltestosterone|mesh-list
111196619|NCT06039371|Podophyllotoxin|podophyllotoxin|mesh-list
111196620|NCT06039371|Testosterone|testosterone|mesh-list
111196621|NCT06039371|Testosterone undecanoate|testosterone undecanoate|mesh-list
111196622|NCT06039371|Testosterone enanthate|testosterone enanthate|mesh-list
111196623|NCT06039371|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
111196624|NCT06039371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111196625|NCT06039371|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111196626|NCT06039371|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111196627|NCT06039371|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111196628|NCT06039371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111196629|NCT06039371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111196630|NCT06039371|Androgens|androgens|mesh-ancestor
111196631|NCT06039371|Hormones|hormones|mesh-ancestor
111196632|NCT06039371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111196633|NCT06039371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111196634|NCT06039371|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111196635|NCT06039371|Anabolic Agents|anabolic agents|mesh-ancestor
111196636|NCT06039371|Keratolytic Agents|keratolytic agents|mesh-ancestor
111196637|NCT06039371|Dermatologic Agents|dermatologic agents|mesh-ancestor
111196638|NCT06039371|Tubulin Modulators|tubulin modulators|mesh-ancestor
111196639|NCT06039371|Antimitotic Agents|antimitotic agents|mesh-ancestor
111196640|NCT06039371|Mitosis Modulators|mitosis modulators|mesh-ancestor
111196641|NCT06038578|Paclitaxel|paclitaxel|mesh-list
111196642|NCT06038578|Ramucirumab|ramucirumab|mesh-list
111196643|NCT06038578|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111196644|NCT06038578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111196645|NCT06038578|Tubulin Modulators|tubulin modulators|mesh-ancestor
111196646|NCT06038578|Antimitotic Agents|antimitotic agents|mesh-ancestor
111196647|NCT06038578|Mitosis Modulators|mitosis modulators|mesh-ancestor
111196648|NCT06038578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111196649|NCT06037590|Levodopa|levodopa|mesh-list
111196650|NCT06037590|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111196651|NCT06037590|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111196652|NCT06037590|Dopamine Agents|dopamine agents|mesh-ancestor
111196653|NCT06037590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110845761|NCT01284413|Antimetabolites|antimetabolites|mesh-ancestor
111196654|NCT06037590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111196655|NCT06037590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111196657|NCT06036511|Analgesics|analgesics|mesh-ancestor
111196658|NCT06036511|Sensory System Agents|sensory system agents|mesh-ancestor
111196659|NCT06036511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111196660|NCT06036511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111196661|NCT06036511|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111196662|NCT06036511|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111196663|NCT06036511|Anesthetics, General|anesthetics, general|mesh-ancestor
111196664|NCT06036511|Anesthetics|anesthetics|mesh-ancestor
111196665|NCT06036511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111196666|NCT06036511|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111196667|NCT06036511|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111196668|NCT06036511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111196669|NCT06036511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111196670|NCT06035536|Calcium|calcium|mesh-list
111196671|NCT06035536|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111196672|NCT06035536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111196673|NCT06034821|Ketamine|ketamine|mesh-list
111196674|NCT06034821|Analgesics|analgesics|mesh-ancestor
111196675|NCT06034821|Sensory System Agents|sensory system agents|mesh-ancestor
111196676|NCT06034821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111196677|NCT06034821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111196678|NCT06034821|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111196679|NCT06034821|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111196680|NCT06034821|Anesthetics, General|anesthetics, general|mesh-ancestor
111196681|NCT06034821|Anesthetics|anesthetics|mesh-ancestor
111196682|NCT06034821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111196683|NCT06034821|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111196684|NCT06034821|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111196685|NCT06034821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111196686|NCT06034821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111196687|NCT06032923|Niacinamide|niacinamide|mesh-list
111196689|NCT06032923|Nicotinic Acids|nicotinic acids|mesh-list
111196690|NCT06032923|Vitamin B Complex|vitamin b complex|mesh-ancestor
111196691|NCT06032923|Vitamins|vitamins|mesh-ancestor
111196692|NCT06032923|Micronutrients|micronutrients|mesh-ancestor
111196693|NCT06032923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111196694|NCT06032923|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111196695|NCT06032923|Antimetabolites|antimetabolites|mesh-ancestor
111196696|NCT06032923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111196697|NCT06032923|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111196698|NCT06032923|Vasodilator Agents|vasodilator agents|mesh-ancestor
111196699|NCT06030622|Metformin|metformin|mesh-list
111196700|NCT06030622|Digoxin|digoxin|mesh-list
111196701|NCT06030622|Simvastatin|simvastatin|mesh-list
111196702|NCT06030622|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111196703|NCT06030622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111196704|NCT06030622|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111196705|NCT06030622|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111196706|NCT06030622|Antimetabolites|antimetabolites|mesh-ancestor
111196707|NCT06030622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111196708|NCT06030622|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111196709|NCT06030622|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111196710|NCT06030622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111196711|NCT06030622|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111196712|NCT06030622|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111196713|NCT06030622|Protective Agents|protective agents|mesh-ancestor
111196714|NCT06027268|Carboplatin|carboplatin|mesh-list
111196715|NCT06027268|Gemcitabine|gemcitabine|mesh-list
111196716|NCT06027268|Pembrolizumab|pembrolizumab|mesh-list
111196717|NCT06027268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111196718|NCT06027268|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111196719|NCT06027268|Antimetabolites|antimetabolites|mesh-ancestor
110845767|NCT03866993|Carboplatin|carboplatin|mesh-list
111196720|NCT06027268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111196721|NCT06027268|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111196722|NCT06027268|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111196723|NCT06027229|Vaccines|vaccines|mesh-list
111196724|NCT06027229|Immunologic Factors|immunologic factors|mesh-ancestor
111196725|NCT06027229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111196726|NCT06016465|Dexamethasone|dexamethasone|mesh-list
111196727|NCT06016465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111196728|NCT06016465|Antiemetics|antiemetics|mesh-ancestor
111196729|NCT06016465|Autonomic Agents|autonomic agents|mesh-ancestor
111196730|NCT06016465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111196731|NCT06016465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111196732|NCT06016465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111196733|NCT06016465|Glucocorticoids|glucocorticoids|mesh-ancestor
111196734|NCT06016465|Hormones|hormones|mesh-ancestor
111196735|NCT06016465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111196736|NCT06016465|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111196737|NCT06016465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111196738|NCT06012240|Upadacitinib|upadacitinib|mesh-list
111196739|NCT06012240|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
111196740|NCT06012240|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111196741|NCT06012240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111196742|NCT06012240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111196743|NCT06012240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111196744|NCT06007911|Cytarabine|cytarabine|mesh-list
111196745|NCT06007911|Venetoclax|venetoclax|mesh-list
111196746|NCT06007911|Mitoxantrone|mitoxantrone|mesh-list
111196747|NCT06007911|Cladribine|cladribine|mesh-list
111196748|NCT06007911|Navitoclax|navitoclax|mesh-list
111196749|NCT06007911|Lenograstim|lenograstim|mesh-list
111196750|NCT06007911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111196751|NCT06007911|Antimetabolites|antimetabolites|mesh-ancestor
111196752|NCT06007911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111196753|NCT06007911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111196754|NCT06007911|Antiviral Agents|antiviral agents|mesh-ancestor
111196755|NCT06007911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111196756|NCT06007911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111196757|NCT06007911|Immunologic Factors|immunologic factors|mesh-ancestor
111196758|NCT06007911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111196759|NCT06007911|Analgesics|analgesics|mesh-ancestor
111196760|NCT06007911|Sensory System Agents|sensory system agents|mesh-ancestor
111196761|NCT06007911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111196762|NCT06007911|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111196763|NCT06007911|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111196764|NCT06007911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111196765|NCT06007911|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111196766|NCT06007547|Poractant alfa|poractant alfa|mesh-list
111196767|NCT06007547|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
110491444|NCT02592694|Anticoagulants|anticoagulants|mesh-ancestor
111196768|NCT06007547|Respiratory System Agents|respiratory system agents|mesh-ancestor
111196769|NCT06006117|Rituximab|rituximab|mesh-list
111196770|NCT06006117|Lenalidomide|lenalidomide|mesh-list
111196771|NCT06006117|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
111196772|NCT06006117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111196773|NCT06006117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111196774|NCT06006117|Immunologic Factors|immunologic factors|mesh-ancestor
111196775|NCT06006117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111196776|NCT06006117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111196777|NCT06006117|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111196778|NCT06006117|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111196779|NCT06006117|Growth Substances|growth substances|mesh-ancestor
111196780|NCT06006117|Growth Inhibitors|growth inhibitors|mesh-ancestor
111196781|NCT06006117|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111196782|NCT06006117|Alkylating Agents|alkylating agents|mesh-ancestor
111196783|NCT06006117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111196784|NCT06005662|Buprenorphine|buprenorphine|mesh-list
111196785|NCT06005662|Psilocybin|psilocybin|mesh-list
111196786|NCT06005662|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111196787|NCT06005662|Narcotics|narcotics|mesh-ancestor
111196788|NCT06005662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111196789|NCT06005662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111196790|NCT06005662|Analgesics|analgesics|mesh-ancestor
111196791|NCT06005662|Sensory System Agents|sensory system agents|mesh-ancestor
111196792|NCT06005662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111196793|NCT06005662|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111196794|NCT06005662|Hallucinogens|hallucinogens|mesh-ancestor
111196795|NCT06005662|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111196796|NCT06004674|Enoxaparin|enoxaparin|mesh-list
111196797|NCT06004674|Anticoagulants|anticoagulants|mesh-ancestor
111196798|NCT06004674|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111196799|NCT06004674|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111196800|NCT06004674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111196801|NCT06002490|Aspirin|aspirin|mesh-list
111196802|NCT06002490|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111196803|NCT06002490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111196804|NCT06002490|Analgesics|analgesics|mesh-ancestor
111196805|NCT06002490|Sensory System Agents|sensory system agents|mesh-ancestor
111196806|NCT06002490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111196807|NCT06002490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111196808|NCT06002490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111196809|NCT06002490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111196810|NCT06002490|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111196811|NCT06002490|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111196812|NCT06002490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111196813|NCT06002490|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110913871|NCT00860288|Hormones|hormones|mesh-ancestor
111196814|NCT06002490|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111196815|NCT06002490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111196817|NCT05999955|Neomycin|neomycin|mesh-list
111196818|NCT05999955|Dexamethasone|dexamethasone|mesh-list
111196819|NCT05999955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111196820|NCT05999955|Antiemetics|antiemetics|mesh-ancestor
111196821|NCT05999955|Autonomic Agents|autonomic agents|mesh-ancestor
111196822|NCT05999955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111196823|NCT05999955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111196824|NCT05999955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111196825|NCT05999955|Glucocorticoids|glucocorticoids|mesh-ancestor
111196826|NCT05999955|Hormones|hormones|mesh-ancestor
111196827|NCT05999955|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111196828|NCT05999955|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111196829|NCT05999955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111196830|NCT05999955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111196831|NCT05999955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111196832|NCT05999955|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111196833|NCT05999955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111196834|NCT05999955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111196835|NCT05997732|Propranolol|propranolol|mesh-list
111196836|NCT05997732|Phentolamine|phentolamine|mesh-list
111196837|NCT05997732|Phenylephrine|phenylephrine|mesh-list
111196838|NCT05997732|Isoproterenol|isoproterenol|mesh-list
111196839|NCT05997732|Oxymetazoline|oxymetazoline|mesh-list
111196840|NCT05997732|Norepinephrine|norepinephrine|mesh-list
111196841|NCT05997732|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111196842|NCT05997732|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111196843|NCT05997732|Adrenergic Agents|adrenergic agents|mesh-ancestor
111196844|NCT05997732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111196845|NCT05997732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111196846|NCT05997732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111196847|NCT05997732|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111196848|NCT05997732|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111196849|NCT05997732|Vasodilator Agents|vasodilator agents|mesh-ancestor
111196850|NCT05997732|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111196851|NCT05997732|Mydriatics|mydriatics|mesh-ancestor
111196852|NCT05997732|Autonomic Agents|autonomic agents|mesh-ancestor
111196853|NCT05997732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111196854|NCT05997732|Sympathomimetics|sympathomimetics|mesh-ancestor
111196855|NCT05997732|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111196856|NCT05997732|Nasal Decongestants|nasal decongestants|mesh-ancestor
111196857|NCT05997732|Respiratory System Agents|respiratory system agents|mesh-ancestor
111196858|NCT05997732|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111196859|NCT05997732|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111196860|NCT05997732|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111196861|NCT05997732|Protective Agents|protective agents|mesh-ancestor
111196862|NCT05997732|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111196863|NCT05997732|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111196864|NCT05997732|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111196865|NCT05997732|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111196866|NCT05996523|Pembrolizumab|pembrolizumab|mesh-list
111196867|NCT05996523|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111196868|NCT05996523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111196869|NCT05996523|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111196870|NCT05996523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111196871|NCT05987332|Pembrolizumab|pembrolizumab|mesh-list
111196872|NCT05987332|Nivolumab|nivolumab|mesh-list
111196873|NCT05987332|Ipilimumab|ipilimumab|mesh-list
111196874|NCT05987332|Dacarbazine|dacarbazine|mesh-list
111196875|NCT05987332|Crizotinib|crizotinib|mesh-list
111196876|NCT05987332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111196877|NCT05987332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111196878|NCT05987332|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111196879|NCT05987332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111196880|NCT05987332|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111196881|NCT05987332|Alkylating Agents|alkylating agents|mesh-ancestor
111196882|NCT05987332|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111196883|NCT05987332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111196884|NCT05986773|Metolazone|metolazone|mesh-list
111196885|NCT05986773|Furosemide|furosemide|mesh-list
111196886|NCT05986773|Acetazolamide|acetazolamide|mesh-list
111196887|NCT05986773|Diuretics|diuretics|mesh-ancestor
111196888|NCT05986773|Natriuretic Agents|natriuretic agents|mesh-ancestor
111196889|NCT05986773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111196890|NCT05986773|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
111196891|NCT05986773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111196892|NCT05986773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111196893|NCT05986773|Anticonvulsants|anticonvulsants|mesh-ancestor
111196894|NCT05986773|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
111196895|NCT05986773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111196896|NCT05986773|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111196897|NCT05986773|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
111196898|NCT05985681|Vaccines|vaccines|mesh-list
111196899|NCT05985681|Immunologic Factors|immunologic factors|mesh-ancestor
111196900|NCT05985681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111196901|NCT05985590|Drospirenone|drospirenone|mesh-list
111196902|NCT05985590|Ethinyl Estradiol|ethinyl estradiol|mesh-list
111196903|NCT05985590|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
111196904|NCT05985590|Estradiol|estradiol|mesh-list
111196905|NCT05985590|Estrogens|estrogens|mesh-ancestor
111196906|NCT05985590|Hormones|hormones|mesh-ancestor
111196907|NCT05985590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111196908|NCT05985590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111196909|NCT05985590|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111196910|NCT05985590|Contraceptive Agents|contraceptive agents|mesh-ancestor
111196911|NCT05985590|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111196912|NCT05985590|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111196913|NCT05985590|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111196914|NCT05985590|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111196915|NCT05985590|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
111196916|NCT05985590|Hormone Antagonists|hormone antagonists|mesh-ancestor
111196917|NCT05985590|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
111196918|NCT05985590|Diuretics|diuretics|mesh-ancestor
111196919|NCT05985590|Natriuretic Agents|natriuretic agents|mesh-ancestor
111196920|NCT05981703|Tislelizumab|tislelizumab|mesh-list
111196921|NCT05981703|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111196922|NCT05981703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111196923|NCT05981118|Betamethasone|betamethasone|mesh-list
111196924|NCT05981118|Betamethasone Valerate|betamethasone valerate|mesh-list
111196925|NCT05981118|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
111196926|NCT05981118|Betamethasone benzoate|betamethasone benzoate|mesh-list
111196927|NCT05981118|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
111196928|NCT05981118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111196929|NCT05981118|Glucocorticoids|glucocorticoids|mesh-ancestor
111196931|NCT05981118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111196932|NCT05981118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111196933|NCT05981118|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111196934|NCT05981118|Respiratory System Agents|respiratory system agents|mesh-ancestor
111196935|NCT05979493|Bupivacaine|bupivacaine|mesh-list
111196936|NCT05979493|Anesthetics, Local|anesthetics, local|mesh-ancestor
111196937|NCT05979493|Anesthetics|anesthetics|mesh-ancestor
111196938|NCT05979493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111196939|NCT05979493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111196940|NCT05979493|Sensory System Agents|sensory system agents|mesh-ancestor
111196941|NCT05979493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111196942|NCT05976828|Vaccines|vaccines|mesh-list
111196943|NCT05976828|Immunologic Factors|immunologic factors|mesh-ancestor
111196944|NCT05976828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111196945|NCT05971602|Rifampin|rifampin|mesh-list
111196946|NCT05971602|Isoniazid|isoniazid|mesh-list
111196947|NCT05971602|Pyrazinamide|pyrazinamide|mesh-list
111196948|NCT05971602|Ethambutol|ethambutol|mesh-list
111196949|NCT05971602|Bedaquiline|bedaquiline|mesh-list
111196950|NCT05971602|Diarylquinolines|diarylquinolines|mesh-list
111196951|NCT05971602|Oxazolidinones|oxazolidinones|mesh-list
111196952|NCT05971602|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111196953|NCT05971602|Antitubercular Agents|antitubercular agents|mesh-ancestor
111196954|NCT05971602|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111196955|NCT05971602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111196956|NCT05971602|Leprostatic Agents|leprostatic agents|mesh-ancestor
111196957|NCT05971602|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111196958|NCT05971602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111196959|NCT05971602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111196960|NCT05971602|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111196961|NCT05971602|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111196962|NCT05971602|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
111196963|NCT05971602|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
111196964|NCT05971602|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
111196965|NCT05971602|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110914014|NCT00771134|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111196966|NCT05971602|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
111196967|NCT05971602|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111196968|NCT05971602|Antimetabolites|antimetabolites|mesh-ancestor
111196969|NCT05971602|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111196970|NCT05971602|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111196971|NCT05969496|Pembrolizumab|pembrolizumab|mesh-list
111196972|NCT05969496|Axitinib|axitinib|mesh-list
111196973|NCT05969496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111196974|NCT05969496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111196975|NCT05969496|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111196976|NCT05969496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111196977|NCT05969496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111196978|NCT05969496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111196980|NCT05965492|Celecoxib|celecoxib|mesh-list
111196981|NCT05965492|Oxycodone|oxycodone|mesh-list
111196982|NCT05965492|Gabapentin|gabapentin|mesh-list
111196983|NCT05965492|Famotidine|famotidine|mesh-list
111196984|NCT05965492|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111196985|NCT05965492|Analgesics|analgesics|mesh-ancestor
111196986|NCT05965492|Sensory System Agents|sensory system agents|mesh-ancestor
111196987|NCT05965492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111196988|NCT05965492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111196989|NCT05965492|Antipyretics|antipyretics|mesh-ancestor
111196990|NCT05965492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111196991|NCT05965492|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111196992|NCT05965492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111196993|NCT05965492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111196994|NCT05965492|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111196995|NCT05965492|Narcotics|narcotics|mesh-ancestor
111196996|NCT05965492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111196997|NCT05965492|Anticonvulsants|anticonvulsants|mesh-ancestor
111196998|NCT05965492|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111196999|NCT05965492|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111197000|NCT05965492|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111197001|NCT05965492|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111197002|NCT05965492|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111197003|NCT05965492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111197004|NCT05965492|Antimanic Agents|antimanic agents|mesh-ancestor
111197005|NCT05965492|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111197006|NCT05965492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111197007|NCT05965492|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111197008|NCT05965492|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111197009|NCT05965492|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111197010|NCT05965492|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
111197011|NCT05965492|Histamine Antagonists|histamine antagonists|mesh-ancestor
111197012|NCT05965492|Histamine Agents|histamine agents|mesh-ancestor
111197013|NCT05960773|Decitabine|decitabine|mesh-list
111197014|NCT05960773|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111197015|NCT05960773|Antimetabolites|antimetabolites|mesh-ancestor
111197016|NCT05960773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111197017|NCT05960773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111197018|NCT05960773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111197019|NCT05956821|Bevacizumab|bevacizumab|mesh-list
111197020|NCT05956821|Cetuximab|cetuximab|mesh-list
111197021|NCT05956821|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111197022|NCT05956821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111197023|NCT05956821|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111197024|NCT05956821|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111197025|NCT05956821|Growth Substances|growth substances|mesh-ancestor
111197026|NCT05956821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111197027|NCT05956821|Growth Inhibitors|growth inhibitors|mesh-ancestor
111197028|NCT05953428|Analgesics, Opioid|analgesics, opioid|mesh-list
111197029|NCT05953428|Anesthetics|anesthetics|mesh-list
111197030|NCT05953428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111197031|NCT05953428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111197032|NCT05953428|Narcotics|narcotics|mesh-ancestor
111197033|NCT05953428|Analgesics|analgesics|mesh-ancestor
111197034|NCT05953428|Sensory System Agents|sensory system agents|mesh-ancestor
111197035|NCT05953428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111197036|NCT05945160|Thioctic Acid|thioctic acid|mesh-list
111197037|NCT05945160|Ubiquinone|ubiquinone|mesh-list
111197038|NCT05945160|Coenzyme Q10|coenzyme q10|mesh-list
111197039|NCT05945160|Antioxidants|antioxidants|mesh-ancestor
111197040|NCT05945160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111197041|NCT05945160|Protective Agents|protective agents|mesh-ancestor
111197042|NCT05945160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111197043|NCT05945160|Vitamin B Complex|vitamin b complex|mesh-ancestor
111197044|NCT05945160|Vitamins|vitamins|mesh-ancestor
111197045|NCT05945160|Micronutrients|micronutrients|mesh-ancestor
111197046|NCT05940324|Naltrexone|naltrexone|mesh-list
111197047|NCT05940324|Ketamine|ketamine|mesh-list
111197048|NCT05940324|Analgesics|analgesics|mesh-ancestor
111197049|NCT05940324|Sensory System Agents|sensory system agents|mesh-ancestor
111197050|NCT05940324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111197051|NCT05940324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111197052|NCT05940324|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111197053|NCT05940324|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111197054|NCT05940324|Anesthetics, General|anesthetics, general|mesh-ancestor
111197056|NCT05940324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111197057|NCT05940324|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111197058|NCT05940324|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111197059|NCT05940324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111197060|NCT05940324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111197061|NCT05940324|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111197062|NCT05940324|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111197063|NCT05939765|Antipsychotic Agents|antipsychotic agents|mesh-list
111197064|NCT05939765|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111197065|NCT05939765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111197066|NCT05939765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111197067|NCT05939765|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111197068|NCT05928806|Nivolumab|nivolumab|mesh-list
111197069|NCT05928806|Ipilimumab|ipilimumab|mesh-list
111197070|NCT05928806|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111197071|NCT05928806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111197072|NCT05928806|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111197073|NCT05928806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111197074|NCT05926336|Anesthetics|anesthetics|mesh-list
111197075|NCT05926336|Propofol|propofol|mesh-list
111197076|NCT05926336|Sevoflurane|sevoflurane|mesh-list
111197077|NCT05926336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111197078|NCT05926336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111197079|NCT05926336|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111197080|NCT05926336|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111197081|NCT05926336|Anesthetics, General|anesthetics, general|mesh-ancestor
111197082|NCT05926336|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111197083|NCT05926336|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111197084|NCT05918055|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
111197085|NCT05918055|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111197086|NCT05918055|Antimetabolites|antimetabolites|mesh-ancestor
111197087|NCT05918055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111197088|NCT05918055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111197089|NCT05912062|Paclitaxel|paclitaxel|mesh-list
111197090|NCT05912062|Trastuzumab|trastuzumab|mesh-list
111197091|NCT05912062|Pertuzumab|pertuzumab|mesh-list
111197092|NCT05912062|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111197093|NCT05912062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111197094|NCT05912062|Tubulin Modulators|tubulin modulators|mesh-ancestor
111197095|NCT05912062|Antimitotic Agents|antimitotic agents|mesh-ancestor
111197096|NCT05912062|Mitosis Modulators|mitosis modulators|mesh-ancestor
111197097|NCT05912062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111197098|NCT05912062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111197099|NCT05909904|Tislelizumab|tislelizumab|mesh-list
111197100|NCT05909904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111197101|NCT05909904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111197102|NCT05907759|Daratumumab|daratumumab|mesh-list
111197103|NCT05907759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111197104|NCT05907746|Mycophenolic Acid|mycophenolic acid|mesh-list
111197105|NCT05907746|Cyclophosphamide|cyclophosphamide|mesh-list
111197106|NCT05907746|Fludarabine|fludarabine|mesh-list
111197107|NCT05907746|Tacrolimus|tacrolimus|mesh-list
111197108|NCT05907746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111197109|NCT05907746|Immunologic Factors|immunologic factors|mesh-ancestor
111197110|NCT05907746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111197111|NCT05907746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111197112|NCT05907746|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111197113|NCT05907746|Alkylating Agents|alkylating agents|mesh-ancestor
111197114|NCT05907746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111197115|NCT05907746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110677016|NCT03174197|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111197116|NCT05907746|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111197117|NCT05907746|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111197118|NCT05907746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111197119|NCT05907746|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111197120|NCT05907746|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111197121|NCT05907746|Antitubercular Agents|antitubercular agents|mesh-ancestor
111197122|NCT05907746|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111197123|NCT05907746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111197125|NCT05904028|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111197126|NCT05904028|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111197127|NCT05904028|Growth Substances|growth substances|mesh-ancestor
111197128|NCT05904028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111197129|NCT05904028|Growth Inhibitors|growth inhibitors|mesh-ancestor
111197130|NCT05904028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111197131|NCT05898828|Nivolumab|nivolumab|mesh-list
111197132|NCT05898828|Entinostat|entinostat|mesh-list
111197133|NCT05898828|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
111197134|NCT05898828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111197135|NCT05898828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111197136|NCT05898828|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111197137|NCT05898828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111197138|NCT05898828|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111197139|NCT05898828|Immunologic Factors|immunologic factors|mesh-ancestor
111197140|NCT05898828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111197141|NCT05898828|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111197142|NCT05898828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111197143|NCT05898646|Daratumumab|daratumumab|mesh-list
111197144|NCT05898646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111197145|NCT05894538|Ivermectin|ivermectin|mesh-list
111197146|NCT05894538|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111197147|NCT05894538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111197148|NCT05889741|Ropivacaine|ropivacaine|mesh-list
111197149|NCT05889741|Anesthetics, Local|anesthetics, local|mesh-ancestor
111197150|NCT05889741|Anesthetics|anesthetics|mesh-ancestor
111197151|NCT05889741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111197152|NCT05889741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111197153|NCT05889741|Sensory System Agents|sensory system agents|mesh-ancestor
111197154|NCT05889741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111197155|NCT05886335|Cyclophosphamide|cyclophosphamide|mesh-list
111197156|NCT05886335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111197157|NCT05886335|Immunologic Factors|immunologic factors|mesh-ancestor
111197158|NCT05886335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111197159|NCT05886335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110491491|NCT00687973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111197160|NCT05886335|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111197161|NCT05886335|Alkylating Agents|alkylating agents|mesh-ancestor
111197162|NCT05886335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111197163|NCT05886335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111197164|NCT05886335|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111197165|NCT05880394|Copper|copper|mesh-list
111197166|NCT05880394|Trace Elements|trace elements|mesh-ancestor
111197167|NCT05880394|Micronutrients|micronutrients|mesh-ancestor
111197168|NCT05880394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111197169|NCT05879484|Pembrolizumab|pembrolizumab|mesh-list
111197170|NCT05879484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111197171|NCT05879484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111197172|NCT05879484|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111197173|NCT05879484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111197174|NCT05878717|Belimumab|belimumab|mesh-list
111197175|NCT05878717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111197176|NCT05878717|Immunologic Factors|immunologic factors|mesh-ancestor
111197177|NCT05878717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111197178|NCT05877846|Vitamin D|vitamin d|mesh-list
111197179|NCT05877846|Ergocalciferols|ergocalciferols|mesh-list
111197180|NCT05877846|Cholecalciferol|cholecalciferol|mesh-list
111197181|NCT05877846|Vitamins|vitamins|mesh-list
111197182|NCT05877846|Micronutrients|micronutrients|mesh-ancestor
111197183|NCT05877846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111197184|NCT05877846|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111197185|NCT05877846|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111197186|NCT05876572|Naloxone|naloxone|mesh-list
111197187|NCT05876572|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111197188|NCT05876572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111197189|NCT05876572|Sensory System Agents|sensory system agents|mesh-ancestor
111197190|NCT05876572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111197191|NCT05867849|Cannabidiol|cannabidiol|mesh-list
111197192|NCT05867849|Anticonvulsants|anticonvulsants|mesh-ancestor
111197193|NCT05867056|Cysteamine|cysteamine|mesh-list
111197194|NCT05867056|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
111197195|NCT05867056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111197196|NCT05866471|Psilocybin|psilocybin|mesh-list
111197198|NCT05866471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111197199|NCT05866471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111197200|NCT05857007|Glucocorticoids|glucocorticoids|mesh-list
111197201|NCT05857007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111197202|NCT05857007|Hormones|hormones|mesh-ancestor
111197203|NCT05857007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111197204|NCT05854992|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-list
111197205|NCT05854992|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111197206|NCT05854992|Serotonin Agents|serotonin agents|mesh-ancestor
111197207|NCT05854992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111197208|NCT05854992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111197209|NCT05854992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111197210|NCT05849480|Capecitabine|capecitabine|mesh-list
111197211|NCT05849480|Oxaliplatin|oxaliplatin|mesh-list
111197212|NCT05849480|Pembrolizumab|pembrolizumab|mesh-list
111197213|NCT05849480|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111197214|NCT05849480|Antimetabolites|antimetabolites|mesh-ancestor
111197215|NCT05849480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111197216|NCT05849480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111197217|NCT05849480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111197218|NCT05849480|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111197219|NCT05845671|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
111197220|NCT05845671|Antibodies, Bispecific|antibodies, bispecific|mesh-list
111197221|NCT05845671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111197222|NCT05845671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111197223|NCT05845671|Immunologic Factors|immunologic factors|mesh-ancestor
111197224|NCT05845671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111197225|NCT05844982|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
111197226|NCT05844982|Faricimab|faricimab|mesh-list
111197227|NCT05844982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111197228|NCT05844982|Glucocorticoids|glucocorticoids|mesh-ancestor
111197229|NCT05844982|Hormones|hormones|mesh-ancestor
111197230|NCT05844982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111197231|NCT05844982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111197232|NCT05844982|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111197233|NCT05844982|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111197234|NCT05844982|Growth Substances|growth substances|mesh-ancestor
111197235|NCT05844982|Growth Inhibitors|growth inhibitors|mesh-ancestor
111197236|NCT05844982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111197237|NCT05837897|Vedolizumab|vedolizumab|mesh-list
111197238|NCT05837897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111197239|NCT05836584|Calcium, Dietary|calcium, dietary|mesh-list
111197240|NCT05836584|Leucovorin|leucovorin|mesh-list
111197241|NCT05836584|Folic Acid|folic acid|mesh-list
111197242|NCT05836584|Docetaxel|docetaxel|mesh-list
111197243|NCT05836584|Fluorouracil|fluorouracil|mesh-list
111197244|NCT05836584|Capecitabine|capecitabine|mesh-list
111197245|NCT05836584|Oxaliplatin|oxaliplatin|mesh-list
111197246|NCT05836584|Atezolizumab|atezolizumab|mesh-list
111197247|NCT05836584|Calcium|calcium|mesh-list
111197248|NCT05836584|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111197249|NCT05836584|Levoleucovorin|levoleucovorin|mesh-list
111197250|NCT05836584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111197251|NCT05836584|Tubulin Modulators|tubulin modulators|mesh-ancestor
111197252|NCT05836584|Antimitotic Agents|antimitotic agents|mesh-ancestor
111197253|NCT05836584|Mitosis Modulators|mitosis modulators|mesh-ancestor
111197254|NCT05836584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111197255|NCT05836584|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111197256|NCT05836584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111197257|NCT05836584|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111197258|NCT05836584|Antimetabolites|antimetabolites|mesh-ancestor
111197259|NCT05836584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111197260|NCT05836584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111197261|NCT05836584|Immunologic Factors|immunologic factors|mesh-ancestor
111197262|NCT05836584|Antidotes|antidotes|mesh-ancestor
111197263|NCT05836584|Protective Agents|protective agents|mesh-ancestor
111197264|NCT05836584|Vitamin B Complex|vitamin b complex|mesh-ancestor
111197265|NCT05836584|Vitamins|vitamins|mesh-ancestor
111197266|NCT05836584|Micronutrients|micronutrients|mesh-ancestor
111197267|NCT05836584|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111197268|NCT05836584|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111197269|NCT05836584|Hematinics|hematinics|mesh-ancestor
111197270|NCT05827978|Vaccines|vaccines|mesh-list
111197271|NCT05827978|Immunologic Factors|immunologic factors|mesh-ancestor
110845827|NCT01284725|Azathioprine|azathioprine|mesh-list
111197272|NCT05827978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111197273|NCT05814627|Adalimumab|adalimumab|mesh-list
111197274|NCT05814627|Upadacitinib|upadacitinib|mesh-list
111197275|NCT05814627|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111197276|NCT05814627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111197277|NCT05814627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111197278|NCT05814627|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
111197279|NCT05814627|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111197280|NCT05814627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111197281|NCT05814627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111197282|NCT05813132|Cytarabine|cytarabine|mesh-list
111197283|NCT05813132|Carboplatin|carboplatin|mesh-list
111197284|NCT05813132|Etoposide|etoposide|mesh-list
111197285|NCT05813132|Etoposide phosphate|etoposide phosphate|mesh-list
111197286|NCT05813132|Melphalan|melphalan|mesh-list
111197287|NCT05813132|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
111197288|NCT05813132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111197289|NCT05813132|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111197290|NCT05813132|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111197291|NCT05813132|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111197292|NCT05813132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111197293|NCT05813132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111197294|NCT05813132|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111197295|NCT05813132|Antimetabolites|antimetabolites|mesh-ancestor
111197296|NCT05813132|Antiviral Agents|antiviral agents|mesh-ancestor
111197297|NCT05813132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111197298|NCT05813132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111197299|NCT05813132|Immunologic Factors|immunologic factors|mesh-ancestor
111197300|NCT05813132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111197301|NCT05813132|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111197302|NCT05813132|Alkylating Agents|alkylating agents|mesh-ancestor
111197303|NCT05813132|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111197304|NCT05800834|Lidocaine|lidocaine|mesh-list
111197305|NCT05800834|Morphine|morphine|mesh-list
111197306|NCT05800834|Anesthetics, Local|anesthetics, local|mesh-ancestor
111197307|NCT05800834|Anesthetics|anesthetics|mesh-ancestor
111197308|NCT05800834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111197309|NCT05800834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111197310|NCT05800834|Sensory System Agents|sensory system agents|mesh-ancestor
111197311|NCT05800834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111197312|NCT05800834|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111197313|NCT05800834|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111197314|NCT05800834|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111197315|NCT05800834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111197316|NCT05800834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111197317|NCT05800834|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111197318|NCT05800834|Narcotics|narcotics|mesh-ancestor
111197319|NCT05800834|Analgesics|analgesics|mesh-ancestor
111197320|NCT05793905|Lidocaine|lidocaine|mesh-list
111197321|NCT05793905|Anesthetics, Local|anesthetics, local|mesh-ancestor
111197322|NCT05793905|Anesthetics|anesthetics|mesh-ancestor
111197323|NCT05793905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111197324|NCT05793905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111197325|NCT05793905|Sensory System Agents|sensory system agents|mesh-ancestor
110491556|NCT02851394|Narcotics|narcotics|mesh-ancestor
111197326|NCT05793905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111197327|NCT05793905|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111197328|NCT05793905|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111197329|NCT05793905|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111197330|NCT05793905|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111197331|NCT05793905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111197332|NCT05793099|Propolis|propolis|mesh-list
111197333|NCT05793099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111197334|NCT05789537|Protein C|protein c|mesh-list
111197335|NCT05789537|Anticoagulants|anticoagulants|mesh-ancestor
111197336|NCT05789537|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111197337|NCT05789537|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111197338|NCT05789537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111197339|NCT05785819|Enzyme Inhibitors|enzyme inhibitors|mesh-list
111197340|NCT05785819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111197341|NCT05784844|Meropenem|meropenem|mesh-list
111197342|NCT05784844|Micafungin|micafungin|mesh-list
111197343|NCT05784844|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111197344|NCT05784844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111197345|NCT05784844|Antifungal Agents|antifungal agents|mesh-ancestor
111197346|NCT05783661|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111197347|NCT05783661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111197349|NCT05781711|Levodopa|levodopa|mesh-list
111197350|NCT05781711|Carbidopa|carbidopa|mesh-list
111197351|NCT05781711|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
111197352|NCT05781711|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111197353|NCT05781711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111197354|NCT05781711|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111197355|NCT05781711|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111197356|NCT05781711|Dopamine Agents|dopamine agents|mesh-ancestor
111197357|NCT05781711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111197358|NCT05781711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111197359|NCT05781711|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
111197360|NCT05781711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111197361|NCT05781711|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111197362|NCT05781711|Immunologic Factors|immunologic factors|mesh-ancestor
111197363|NCT05781711|Dopamine Agonists|dopamine agonists|mesh-ancestor
111197364|NCT05778591|Buprenorphine|buprenorphine|mesh-list
111197365|NCT05778591|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111197366|NCT05778591|Narcotics|narcotics|mesh-ancestor
111197367|NCT05778591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111197368|NCT05778591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111197369|NCT05778591|Analgesics|analgesics|mesh-ancestor
111197370|NCT05778591|Sensory System Agents|sensory system agents|mesh-ancestor
111197371|NCT05778591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111197372|NCT05778591|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111197373|NCT05777603|Vancomycin|vancomycin|mesh-list
111197374|NCT05777603|Aztreonam|aztreonam|mesh-list
111197375|NCT05777603|Pembrolizumab|pembrolizumab|mesh-list
111197376|NCT05777603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111197377|NCT05777603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111197378|NCT05777603|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111197379|NCT05777603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111197380|NCT05777603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111197381|NCT05777603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111197382|NCT05774626|Contraceptive Agents|contraceptive agents|mesh-list
111197383|NCT05774626|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111197384|NCT05774626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111197385|NCT05773274|Everolimus|everolimus|mesh-list
111197386|NCT05773274|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
111197387|NCT05773274|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111197388|NCT05773274|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111197389|NCT05773274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111197390|NCT05773274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111197391|NCT05773274|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111197392|NCT05773274|Immunologic Factors|immunologic factors|mesh-ancestor
111197393|NCT05773274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111197394|NCT05773274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111197395|NCT05773274|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111197396|NCT05766683|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111197397|NCT05766683|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111197398|NCT05766683|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111197399|NCT05766683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111197400|NCT05766683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111197401|NCT05766683|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111197402|NCT05766683|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111197403|NCT05766683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111197404|NCT05766683|Cholinergic Agents|cholinergic agents|mesh-ancestor
111197405|NCT05766683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111197406|NCT05755997|Cerebrolysin|cerebrolysin|mesh-list
111197407|NCT05755997|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111197408|NCT05755997|Protective Agents|protective agents|mesh-ancestor
111197409|NCT05755997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111197410|NCT05755997|Nootropic Agents|nootropic agents|mesh-ancestor
111197411|NCT05753787|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111197412|NCT05753787|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111197413|NCT05746559|Ravulizumab|ravulizumab|mesh-list
111197414|NCT05746559|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
111197415|NCT05746559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111197416|NCT05746559|Immunologic Factors|immunologic factors|mesh-ancestor
111197417|NCT05746559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111197419|NCT05743400|Immunologic Factors|immunologic factors|mesh-ancestor
111197420|NCT05743400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110677017|NCT03174197|Immunologic Factors|immunologic factors|mesh-ancestor
111197421|NCT05743400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111197422|NCT05735639|Enoxaparin|enoxaparin|mesh-list
111197423|NCT05735639|Dalteparin|dalteparin|mesh-list
111197424|NCT05735639|Tinzaparin|tinzaparin|mesh-list
111197425|NCT05735639|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
111197426|NCT05735639|Rivaroxaban|rivaroxaban|mesh-list
111197427|NCT05735639|Apixaban|apixaban|mesh-list
111197428|NCT05735639|Enoxaparin sodium|enoxaparin sodium|mesh-list
111197429|NCT05735639|Dabigatran|dabigatran|mesh-list
111197430|NCT05735639|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111197431|NCT05735639|Antithrombins|antithrombins|mesh-ancestor
111197432|NCT05735639|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111197433|NCT05735639|Protease Inhibitors|protease inhibitors|mesh-ancestor
111197434|NCT05735639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111197435|NCT05735639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111197436|NCT05735639|Anticoagulants|anticoagulants|mesh-ancestor
111197437|NCT05735639|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111197438|NCT05735639|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111197439|NCT05735184|Cytarabine|cytarabine|mesh-list
111197440|NCT05735184|Azacitidine|azacitidine|mesh-list
111197441|NCT05735184|Daunorubicin|daunorubicin|mesh-list
111197442|NCT05735184|Venetoclax|venetoclax|mesh-list
111197443|NCT05735184|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111197444|NCT05735184|Antimetabolites|antimetabolites|mesh-ancestor
111197445|NCT05735184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111197446|NCT05735184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111197447|NCT05735184|Antiviral Agents|antiviral agents|mesh-ancestor
111197448|NCT05735184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111197449|NCT05735184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111197450|NCT05735184|Immunologic Factors|immunologic factors|mesh-ancestor
111197451|NCT05735184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111197452|NCT05735184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111197453|NCT05735184|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111197454|NCT05735184|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111197455|NCT05735184|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111197456|NCT05734807|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
111197457|NCT05734807|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111197458|NCT05734807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111197459|NCT05734807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111197460|NCT05734807|Antiviral Agents|antiviral agents|mesh-ancestor
111197461|NCT05734807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111197462|NCT05732077|Dopamine|dopamine|mesh-list
111197463|NCT05732077|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111197464|NCT05732077|Sympathomimetics|sympathomimetics|mesh-ancestor
111197465|NCT05732077|Autonomic Agents|autonomic agents|mesh-ancestor
111197466|NCT05732077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111197467|NCT05732077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111197468|NCT05732077|Dopamine Agents|dopamine agents|mesh-ancestor
111197469|NCT05732077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111197470|NCT05732077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111197471|NCT05732077|Protective Agents|protective agents|mesh-ancestor
111197472|NCT05724589|Mitogens|mitogens|mesh-list
111197473|NCT05724589|Mitosis Modulators|mitosis modulators|mesh-ancestor
111197474|NCT05724589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111197475|NCT05723601|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
111197476|NCT05723601|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
111197477|NCT05723601|Estradiol|estradiol|mesh-list
111197478|NCT05723601|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
111197479|NCT05723601|Estrogens|estrogens|mesh-ancestor
111197480|NCT05723601|Hormones|hormones|mesh-ancestor
111197481|NCT05723601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111197482|NCT05723601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111197483|NCT05723601|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111197484|NCT05723601|Contraceptive Agents|contraceptive agents|mesh-ancestor
111197485|NCT05723601|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111197486|NCT05723601|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111197488|NCT05723588|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111197489|NCT05723588|Autonomic Agents|autonomic agents|mesh-ancestor
111197490|NCT05723588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111197491|NCT05723588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111197492|NCT05723588|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111197493|NCT05723588|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111197494|NCT05723588|Cholinergic Agents|cholinergic agents|mesh-ancestor
111197495|NCT05723588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111197496|NCT05723588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111197497|NCT05717062|Varespladib methyl|varespladib methyl|mesh-list
111197498|NCT05717062|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
111197499|NCT05717062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111197500|NCT05717062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111197501|NCT05713799|Thioctic Acid|thioctic acid|mesh-list
111197502|NCT05713799|Mirabegron|mirabegron|mesh-list
111197503|NCT05713799|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
111197504|NCT05713799|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111197505|NCT05713799|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111197506|NCT05713799|Adrenergic Agents|adrenergic agents|mesh-ancestor
111197507|NCT05713799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111197508|NCT05713799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111197509|NCT05713799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111197510|NCT05713799|Urological Agents|urological agents|mesh-ancestor
111197511|NCT05713799|Antioxidants|antioxidants|mesh-ancestor
111197512|NCT05713799|Protective Agents|protective agents|mesh-ancestor
111197513|NCT05713799|Vitamin B Complex|vitamin b complex|mesh-ancestor
111197514|NCT05713799|Vitamins|vitamins|mesh-ancestor
111197515|NCT05713799|Micronutrients|micronutrients|mesh-ancestor
111197516|NCT05709301|Donepezil|donepezil|mesh-list
111197517|NCT05709301|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111197518|NCT05709301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111197519|NCT05709301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111197520|NCT05709301|Cholinergic Agents|cholinergic agents|mesh-ancestor
111197521|NCT05709301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111197522|NCT05709301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111197523|NCT05709301|Nootropic Agents|nootropic agents|mesh-ancestor
111197524|NCT05707377|Zanubrutinib|zanubrutinib|mesh-list
111197525|NCT05707377|Tacrolimus|tacrolimus|mesh-list
111197526|NCT05707377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111197527|NCT05707377|Immunologic Factors|immunologic factors|mesh-ancestor
111197528|NCT05707377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111197529|NCT05707377|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111197530|NCT05707377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111197531|NCT05707377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111197532|NCT05707377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111197533|NCT05707377|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111197534|NCT05691465|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
111197535|NCT05691465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111197536|NCT05691465|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111197537|NCT05685602|Paclitaxel|paclitaxel|mesh-list
111197538|NCT05685602|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111197539|NCT05685602|Gemcitabine|gemcitabine|mesh-list
111197540|NCT05685602|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111197541|NCT05685602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111197542|NCT05685602|Tubulin Modulators|tubulin modulators|mesh-ancestor
111197543|NCT05685602|Antimitotic Agents|antimitotic agents|mesh-ancestor
111197544|NCT05685602|Mitosis Modulators|mitosis modulators|mesh-ancestor
111197545|NCT05685602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111197546|NCT05685602|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111197547|NCT05685602|Antimetabolites|antimetabolites|mesh-ancestor
111197548|NCT05685004|Temozolomide|temozolomide|mesh-list
111197549|NCT05685004|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111197550|NCT05685004|Alkylating Agents|alkylating agents|mesh-ancestor
111197551|NCT05685004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111197552|NCT05685004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111197553|NCT05681780|Cyclophosphamide|cyclophosphamide|mesh-list
111197554|NCT05681780|Nivolumab|nivolumab|mesh-list
111197555|NCT05681780|Fludarabine|fludarabine|mesh-list
111197556|NCT05681780|Interleukin-2|interleukin-2|mesh-list
111197557|NCT05681780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111197558|NCT05681780|Immunologic Factors|immunologic factors|mesh-ancestor
111197559|NCT05681780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111197560|NCT05681780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111197561|NCT05681780|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111197562|NCT05681780|Alkylating Agents|alkylating agents|mesh-ancestor
111197563|NCT05681780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111197564|NCT05681780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111197565|NCT05681780|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111197566|NCT05681780|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111197567|NCT05681780|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111197568|NCT05681780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111197569|NCT05681780|Analgesics|analgesics|mesh-ancestor
111197570|NCT05681780|Sensory System Agents|sensory system agents|mesh-ancestor
111197571|NCT05681780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110677018|NCT03174197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111197572|NCT05678959|Antibodies, Anti-Idiotypic|antibodies, anti-idiotypic|mesh-list
111197573|NCT05678959|Immunologic Factors|immunologic factors|mesh-ancestor
111197574|NCT05678959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111197575|NCT05675410|Deoxyglucose|deoxyglucose|mesh-list
111197576|NCT05675410|Prednisone|prednisone|mesh-list
111197577|NCT05675410|Prednisolone|prednisolone|mesh-list
111197578|NCT05675410|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111197579|NCT05675410|Methylprednisolone|methylprednisolone|mesh-list
111197580|NCT05675410|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111197581|NCT05675410|Prednisolone acetate|prednisolone acetate|mesh-list
111197582|NCT05675410|Hydrocortisone|hydrocortisone|mesh-list
111197583|NCT05675410|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
111197584|NCT05675410|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
111197585|NCT05675410|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
111197586|NCT05675410|Cortisone|cortisone|mesh-list
111197587|NCT05675410|Cyclophosphamide|cyclophosphamide|mesh-list
111197588|NCT05675410|Dacarbazine|dacarbazine|mesh-list
111197589|NCT05675410|Doxorubicin|doxorubicin|mesh-list
111197590|NCT05675410|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111197591|NCT05675410|Nivolumab|nivolumab|mesh-list
111197592|NCT05675410|Etoposide|etoposide|mesh-list
111197593|NCT05675410|Etoposide phosphate|etoposide phosphate|mesh-list
111197594|NCT05675410|Vincristine|vincristine|mesh-list
111197595|NCT05675410|Brentuximab Vedotin|brentuximab vedotin|mesh-list
111197596|NCT05675410|Bleomycin|bleomycin|mesh-list
111197597|NCT05675410|Vinblastine|vinblastine|mesh-list
111197598|NCT05675410|Podophyllotoxin|podophyllotoxin|mesh-list
111197599|NCT05675410|Procarbazine|procarbazine|mesh-list
111197600|NCT05675410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111197601|NCT05675410|Antibodies|antibodies|mesh-list
111197602|NCT05675410|Immunoglobulins|immunoglobulins|mesh-list
111197603|NCT05675410|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111197604|NCT05675410|Imidazole|imidazole|mesh-list
111197605|NCT05675410|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110491579|NCT00943670|Trastuzumab|trastuzumab|mesh-list
111197606|NCT05675410|Prednisolone phosphate|prednisolone phosphate|mesh-list
111197607|NCT05675410|Immunoconjugates|immunoconjugates|mesh-list
111197608|NCT05675410|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
111197609|NCT05675410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111197610|NCT05675410|Immunologic Factors|immunologic factors|mesh-ancestor
111197611|NCT05675410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111197612|NCT05675410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111197613|NCT05675410|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111197614|NCT05675410|Alkylating Agents|alkylating agents|mesh-ancestor
111197615|NCT05675410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111197616|NCT05675410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111197617|NCT05675410|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111197618|NCT05675410|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111197619|NCT05675410|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111197620|NCT05675410|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111197621|NCT05675410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111197622|NCT05675410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111197623|NCT05675410|Glucocorticoids|glucocorticoids|mesh-ancestor
111197624|NCT05675410|Hormones|hormones|mesh-ancestor
111197625|NCT05675410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111197626|NCT05675410|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111197627|NCT05675410|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111197628|NCT05675410|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111197629|NCT05675410|Tubulin Modulators|tubulin modulators|mesh-ancestor
111197630|NCT05675410|Antimitotic Agents|antimitotic agents|mesh-ancestor
111197631|NCT05675410|Mitosis Modulators|mitosis modulators|mesh-ancestor
111197632|NCT05675410|Antiemetics|antiemetics|mesh-ancestor
111197633|NCT05675410|Autonomic Agents|autonomic agents|mesh-ancestor
111197634|NCT05675410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111197635|NCT05675410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111197636|NCT05675410|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111197637|NCT05675410|Protective Agents|protective agents|mesh-ancestor
111197638|NCT05675410|Immunotoxins|immunotoxins|mesh-ancestor
111197639|NCT05675410|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111197640|NCT05675410|Keratolytic Agents|keratolytic agents|mesh-ancestor
111197641|NCT05675410|Dermatologic Agents|dermatologic agents|mesh-ancestor
111197642|NCT05675410|Antimetabolites|antimetabolites|mesh-ancestor
111197643|NCT05675410|Antiviral Agents|antiviral agents|mesh-ancestor
111197644|NCT05675410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110914686|NCT03134612|Lidocaine|lidocaine|mesh-list
111197646|NCT05673200|Pembrolizumab|pembrolizumab|mesh-list
111197647|NCT05673200|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111197648|NCT05673200|Decitabine|decitabine|mesh-list
111197649|NCT05673200|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
111197650|NCT05673200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111197651|NCT05673200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111197652|NCT05673200|Tubulin Modulators|tubulin modulators|mesh-ancestor
111197653|NCT05673200|Antimitotic Agents|antimitotic agents|mesh-ancestor
111197654|NCT05673200|Mitosis Modulators|mitosis modulators|mesh-ancestor
111197655|NCT05673200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111197656|NCT05673200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111197657|NCT05673200|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111197658|NCT05673200|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111197659|NCT05673200|Antimetabolites|antimetabolites|mesh-ancestor
111197660|NCT05673200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111197661|NCT05669339|Irinotecan|irinotecan|mesh-list
111197662|NCT05669339|Sorafenib|sorafenib|mesh-list
111197663|NCT05669339|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111197664|NCT05669339|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111197665|NCT05669339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111197666|NCT05669339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111197667|NCT05669339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111197668|NCT05669339|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111197669|NCT05664737|Luspatercept|luspatercept|mesh-list
111197670|NCT05664737|Hematinics|hematinics|mesh-ancestor
111197671|NCT05662202|Aminolevulinic Acid|aminolevulinic acid|mesh-list
111197672|NCT05662202|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111197673|NCT05662202|Dermatologic Agents|dermatologic agents|mesh-ancestor
111197674|NCT05661357|Disitamab vedotin|disitamab vedotin|mesh-list
111197675|NCT05661357|Immunoconjugates|immunoconjugates|mesh-ancestor
111197676|NCT05661357|Immunologic Factors|immunologic factors|mesh-ancestor
111197677|NCT05661357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111197678|NCT05658510|Dexmedetomidine|dexmedetomidine|mesh-list
111197679|NCT05658510|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111197680|NCT05658510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111197681|NCT05658510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111197682|NCT05658510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111197683|NCT05658510|Analgesics|analgesics|mesh-ancestor
111197684|NCT05658510|Sensory System Agents|sensory system agents|mesh-ancestor
111197685|NCT05658510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111197686|NCT05658510|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111197687|NCT05658510|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111197688|NCT05658510|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111197689|NCT05658510|Adrenergic Agents|adrenergic agents|mesh-ancestor
111197690|NCT05658510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111197691|NCT05658510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111197692|NCT05658003|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
111197693|NCT05658003|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111197694|NCT05658003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111197695|NCT05654454|Paclitaxel|paclitaxel|mesh-list
111197696|NCT05654454|Bevacizumab|bevacizumab|mesh-list
111197697|NCT05654454|Carboplatin|carboplatin|mesh-list
111197698|NCT05654454|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110845853|NCT03744091|Dronabinol|dronabinol|mesh-list
111197699|NCT05654454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111197700|NCT05654454|Tubulin Modulators|tubulin modulators|mesh-ancestor
111197701|NCT05654454|Antimitotic Agents|antimitotic agents|mesh-ancestor
111197702|NCT05654454|Mitosis Modulators|mitosis modulators|mesh-ancestor
111197703|NCT05654454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111197704|NCT05654454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111197705|NCT05654454|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111197706|NCT05654454|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111197707|NCT05654454|Growth Substances|growth substances|mesh-ancestor
111197708|NCT05654454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111197709|NCT05654454|Growth Inhibitors|growth inhibitors|mesh-ancestor
111197710|NCT05652478|Tenofovir|tenofovir|mesh-list
111197711|NCT05652478|Dolutegravir|dolutegravir|mesh-list
111197712|NCT05652478|Antiviral Agents|antiviral agents|mesh-ancestor
111197713|NCT05652478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111197714|NCT05652478|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111197715|NCT05652478|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111197716|NCT05652478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111197717|NCT05652478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111197718|NCT05652478|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111197719|NCT05652478|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111197720|NCT05652478|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111197721|NCT05652478|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111197722|NCT05651711|KHK4083|khk4083|mesh-list
111197723|NCT05651711|Dermatologic Agents|dermatologic agents|mesh-ancestor
111197724|NCT05649059|Cannabidiol|cannabidiol|mesh-list
110677019|NCT03146962|Ascorbic Acid|ascorbic acid|mesh-list
111197725|NCT05649059|Anticonvulsants|anticonvulsants|mesh-ancestor
111197726|NCT05642195|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
111197727|NCT05642195|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111197728|NCT05642195|Immunologic Factors|immunologic factors|mesh-ancestor
111197729|NCT05642195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111197731|NCT05640102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111197732|NCT05640102|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111197733|NCT05640102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111197734|NCT05640102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111197735|NCT05638620|Bupivacaine|bupivacaine|mesh-list
111197736|NCT05638620|Anesthetics, Local|anesthetics, local|mesh-ancestor
111197737|NCT05638620|Anesthetics|anesthetics|mesh-ancestor
111197738|NCT05638620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111197739|NCT05638620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111197740|NCT05638620|Sensory System Agents|sensory system agents|mesh-ancestor
111197741|NCT05638620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111197742|NCT05637606|Etilefrine|etilefrine|mesh-list
111197743|NCT05637606|Norepinephrine|norepinephrine|mesh-list
111197744|NCT05637606|Ephedrine|ephedrine|mesh-list
111197745|NCT05637606|Pseudoephedrine|pseudoephedrine|mesh-list
111197746|NCT05637606|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111197747|NCT05637606|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111197748|NCT05637606|Adrenergic Agents|adrenergic agents|mesh-ancestor
111197749|NCT05637606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111197750|NCT05637606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111197751|NCT05637606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111197752|NCT05637606|Sympathomimetics|sympathomimetics|mesh-ancestor
111197753|NCT05637606|Autonomic Agents|autonomic agents|mesh-ancestor
111197754|NCT05637606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111197755|NCT05637606|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111197756|NCT05637606|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111197757|NCT05637606|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111197758|NCT05637606|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111197759|NCT05637606|Respiratory System Agents|respiratory system agents|mesh-ancestor
111197760|NCT05637606|Nasal Decongestants|nasal decongestants|mesh-ancestor
111197761|NCT05637606|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111197762|NCT05637606|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
111197763|NCT05637606|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111197764|NCT05637606|Protective Agents|protective agents|mesh-ancestor
111197765|NCT05627245|Belinostat|belinostat|mesh-list
111197766|NCT05627245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111197767|NCT05627245|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111197768|NCT05627245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110845858|NCT03744091|Analgesics|analgesics|mesh-ancestor
111197769|NCT05627245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111197770|NCT05625932|Tinzaparin|tinzaparin|mesh-list
111197771|NCT05625932|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
111197772|NCT05625932|Dalteparin|dalteparin|mesh-list
111197773|NCT05625932|Anticoagulants|anticoagulants|mesh-ancestor
111197774|NCT05625932|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111197775|NCT05625932|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111197776|NCT05625932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111197777|NCT05623774|Imatinib Mesylate|imatinib mesylate|mesh-list
111197778|NCT05623774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111197779|NCT05623774|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111197780|NCT05623774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111197781|NCT05623774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111197782|NCT05623059|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
111197783|NCT05623059|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111197784|NCT05623059|Immunologic Factors|immunologic factors|mesh-ancestor
111197785|NCT05623059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111197786|NCT05622708|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111197787|NCT05622708|Immunologic Factors|immunologic factors|mesh-ancestor
111197788|NCT05622708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111197789|NCT05621616|Mirabegron|mirabegron|mesh-list
111197790|NCT05621616|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
111197791|NCT05621616|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111197792|NCT05621616|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111197793|NCT05621616|Adrenergic Agents|adrenergic agents|mesh-ancestor
111197794|NCT05621616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111197795|NCT05621616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111197796|NCT05621616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111197797|NCT05621616|Urological Agents|urological agents|mesh-ancestor
111197798|NCT05618925|Cyclophosphamide|cyclophosphamide|mesh-list
111197799|NCT05618925|Rituximab|rituximab|mesh-list
111197800|NCT05618925|Fludarabine|fludarabine|mesh-list
111197801|NCT05618925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111197802|NCT05618925|Immunologic Factors|immunologic factors|mesh-ancestor
111197803|NCT05618925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111197804|NCT05618925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111197805|NCT05618925|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111197806|NCT05618925|Alkylating Agents|alkylating agents|mesh-ancestor
111197807|NCT05618925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111197808|NCT05618925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111197809|NCT05618925|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111197810|NCT05618925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111197811|NCT05617625|Fludarabine|fludarabine|mesh-list
111197812|NCT05617625|Melphalan|melphalan|mesh-list
111197813|NCT05617625|Busulfan|busulfan|mesh-list
111197814|NCT05617625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111197815|NCT05617625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111197816|NCT05617625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111197817|NCT05617625|Immunologic Factors|immunologic factors|mesh-ancestor
111197818|NCT05617625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111197819|NCT05617625|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111197820|NCT05617625|Alkylating Agents|alkylating agents|mesh-ancestor
111197821|NCT05617625|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111197822|NCT05613088|Paclitaxel|paclitaxel|mesh-list
111197823|NCT05613088|Doxorubicin|doxorubicin|mesh-list
111197824|NCT05613088|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111197825|NCT05613088|Topotecan|topotecan|mesh-list
111197826|NCT05613088|Farletuzumab|farletuzumab|mesh-list
111197827|NCT05613088|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111197828|NCT05613088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111197829|NCT05613088|Tubulin Modulators|tubulin modulators|mesh-ancestor
111197830|NCT05613088|Antimitotic Agents|antimitotic agents|mesh-ancestor
111197831|NCT05613088|Mitosis Modulators|mitosis modulators|mesh-ancestor
111197832|NCT05613088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111197833|NCT05613088|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111197834|NCT05613088|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111197835|NCT05613088|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111197836|NCT05613088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111197837|NCT05613088|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111197838|NCT05608291|Pembrolizumab|pembrolizumab|mesh-list
111197839|NCT05608291|Cemiplimab|cemiplimab|mesh-list
111197840|NCT05608291|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111197841|NCT05608291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111197842|NCT05608291|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111197843|NCT05608291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111197844|NCT05601882|Upadacitinib|upadacitinib|mesh-list
111197845|NCT05601882|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
111197846|NCT05601882|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111197847|NCT05601882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111197848|NCT05601882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111197849|NCT05601882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111197850|NCT05600894|Decitabine|decitabine|mesh-list
111197851|NCT05600894|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
111197852|NCT05600894|Venetoclax|venetoclax|mesh-list
111197853|NCT05600894|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111197854|NCT05600894|Antimetabolites|antimetabolites|mesh-ancestor
111197855|NCT05600894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111197856|NCT05600894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111197857|NCT05600894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111197858|NCT05590728|Apramycin|apramycin|mesh-list
111197859|NCT05590728|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111197860|NCT05590728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111197861|NCT05582538|Paclitaxel|paclitaxel|mesh-list
111197862|NCT05582538|Durvalumab|durvalumab|mesh-list
111197863|NCT05582538|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111197864|NCT05582538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111197865|NCT05582538|Tubulin Modulators|tubulin modulators|mesh-ancestor
111197866|NCT05582538|Antimitotic Agents|antimitotic agents|mesh-ancestor
111197867|NCT05582538|Mitosis Modulators|mitosis modulators|mesh-ancestor
111197868|NCT05582538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111197869|NCT05582538|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111197870|NCT05570305|Dapagliflozin|dapagliflozin|mesh-list
111197871|NCT05570305|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111197872|NCT05570305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111197873|NCT05570305|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111197874|NCT05570305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111197875|NCT05568888|Thrombin|thrombin|mesh-list
111197876|NCT05568888|Hemostatics|hemostatics|mesh-ancestor
111197877|NCT05568888|Coagulants|coagulants|mesh-ancestor
111197878|NCT05565105|Cyclophosphamide|cyclophosphamide|mesh-list
111197879|NCT05565105|Melphalan|melphalan|mesh-list
111197880|NCT05565105|Busulfan|busulfan|mesh-list
111197881|NCT05565105|Thiotepa|thiotepa|mesh-list
111197882|NCT05565105|Fludarabine|fludarabine|mesh-list
111197883|NCT05565105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111197884|NCT05565105|Immunologic Factors|immunologic factors|mesh-ancestor
111197885|NCT05565105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111197886|NCT05565105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111197887|NCT05565105|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111197888|NCT05565105|Alkylating Agents|alkylating agents|mesh-ancestor
111197889|NCT05565105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111197890|NCT05565105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111197891|NCT05565105|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111197892|NCT05564377|Leucovorin|leucovorin|mesh-list
111197893|NCT05564377|Paclitaxel|paclitaxel|mesh-list
111197894|NCT05564377|Fluorouracil|fluorouracil|mesh-list
111197895|NCT05564377|Oxaliplatin|oxaliplatin|mesh-list
111197896|NCT05564377|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111197897|NCT05564377|Fulvestrant|fulvestrant|mesh-list
111197898|NCT05564377|Olaparib|olaparib|mesh-list
111197899|NCT05564377|Palbociclib|palbociclib|mesh-list
111197900|NCT05564377|Panitumumab|panitumumab|mesh-list
111197901|NCT05564377|Ipatasertib|ipatasertib|mesh-list
111197902|NCT05564377|Sotorasib|sotorasib|mesh-list
111197903|NCT05564377|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111197904|NCT05564377|Antibodies|antibodies|mesh-list
111197905|NCT05564377|Immunoglobulins|immunoglobulins|mesh-list
111197906|NCT05564377|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111197907|NCT05564377|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-list
111197908|NCT05564377|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111197909|NCT05564377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111197910|NCT05564377|Tubulin Modulators|tubulin modulators|mesh-ancestor
111197911|NCT05564377|Antimitotic Agents|antimitotic agents|mesh-ancestor
111197912|NCT05564377|Mitosis Modulators|mitosis modulators|mesh-ancestor
111197913|NCT05564377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111197914|NCT05564377|Immunologic Factors|immunologic factors|mesh-ancestor
111197915|NCT05564377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111197916|NCT05564377|Antimetabolites|antimetabolites|mesh-ancestor
111197917|NCT05564377|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111197918|NCT05564377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111197919|NCT05564377|Antidotes|antidotes|mesh-ancestor
111197920|NCT05564377|Protective Agents|protective agents|mesh-ancestor
111197921|NCT05564377|Vitamin B Complex|vitamin b complex|mesh-ancestor
111197922|NCT05564377|Vitamins|vitamins|mesh-ancestor
111197923|NCT05564377|Micronutrients|micronutrients|mesh-ancestor
111197924|NCT05564377|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111197925|NCT05564377|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
111197926|NCT05564377|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111197927|NCT05564377|Hormone Antagonists|hormone antagonists|mesh-ancestor
111197928|NCT05564377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111197929|NCT05564377|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111197930|NCT05564377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111197931|NCT05564377|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111197932|NCT05564377|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111197933|NCT05562947|Ranibizumab|ranibizumab|mesh-list
111197934|NCT05562947|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111197935|NCT05562947|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111197936|NCT05562947|Growth Substances|growth substances|mesh-ancestor
111197937|NCT05562947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111197938|NCT05562947|Growth Inhibitors|growth inhibitors|mesh-ancestor
111197939|NCT05562947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111197940|NCT05562518|Estrogens|estrogens|mesh-list
111197941|NCT05562518|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
111197942|NCT05562518|Hormones|hormones|mesh-ancestor
111197943|NCT05562518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111197944|NCT05562518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111197945|NCT05562518|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111197946|NCT05562518|Immunologic Factors|immunologic factors|mesh-ancestor
111197947|NCT05556356|Acetaminophen|acetaminophen|mesh-list
111197948|NCT05556356|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111197949|NCT05556356|Analgesics|analgesics|mesh-ancestor
111197950|NCT05556356|Sensory System Agents|sensory system agents|mesh-ancestor
111197951|NCT05556356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111197952|NCT05556356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111197953|NCT05556356|Antipyretics|antipyretics|mesh-ancestor
111197955|NCT05554341|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111197956|NCT05554341|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111197957|NCT05554341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111197958|NCT05554341|Tubulin Modulators|tubulin modulators|mesh-ancestor
111197959|NCT05554341|Antimitotic Agents|antimitotic agents|mesh-ancestor
111197960|NCT05554341|Mitosis Modulators|mitosis modulators|mesh-ancestor
111197961|NCT05554341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111197962|NCT05553522|Capecitabine|capecitabine|mesh-list
111197963|NCT05553522|Trastuzumab|trastuzumab|mesh-list
111197964|NCT05553522|Tucatinib|tucatinib|mesh-list
111197965|NCT05553522|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111197966|NCT05553522|Antimetabolites|antimetabolites|mesh-ancestor
111197967|NCT05553522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111197968|NCT05553522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111197969|NCT05553522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111197970|NCT05553522|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111197971|NCT05553522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111197972|NCT05553132|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
111197973|NCT05553132|Hemostatics|hemostatics|mesh-ancestor
111197974|NCT05553132|Coagulants|coagulants|mesh-ancestor
111197975|NCT05549297|Pembrolizumab|pembrolizumab|mesh-list
111197976|NCT05549297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111197977|NCT05549297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111197978|NCT05549297|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111197979|NCT05549297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111197980|NCT05544734|Acetaminophen|acetaminophen|mesh-list
111197981|NCT05544734|Ibuprofen|ibuprofen|mesh-list
111197982|NCT05544734|Hydrocodone|hydrocodone|mesh-list
111197983|NCT05544734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111197984|NCT05544734|Analgesics|analgesics|mesh-ancestor
111197985|NCT05544734|Sensory System Agents|sensory system agents|mesh-ancestor
111197986|NCT05544734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111197987|NCT05544734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111197988|NCT05544734|Antipyretics|antipyretics|mesh-ancestor
111197989|NCT05544734|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111197990|NCT05544734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111197991|NCT05544734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111197992|NCT05544734|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111197993|NCT05544734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111197994|NCT05544734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111197995|NCT05544734|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111197996|NCT05544734|Narcotics|narcotics|mesh-ancestor
111197997|NCT05544734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111197998|NCT05544734|Antitussive Agents|antitussive agents|mesh-ancestor
111197999|NCT05544734|Respiratory System Agents|respiratory system agents|mesh-ancestor
111198000|NCT05538897|Megestrol|megestrol|mesh-list
111198001|NCT05538897|Megestrol Acetate|megestrol acetate|mesh-list
111198002|NCT05538897|Ipatasertib|ipatasertib|mesh-list
111198003|NCT05538897|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111198004|NCT05538897|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111198005|NCT05538897|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111198006|NCT05538897|Contraceptive Agents|contraceptive agents|mesh-ancestor
111198007|NCT05538897|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111198008|NCT05538897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111198009|NCT05538897|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111198010|NCT05538897|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111198011|NCT05538897|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111198012|NCT05538897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111198013|NCT05538897|Appetite Stimulants|appetite stimulants|mesh-ancestor
111198014|NCT05538897|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111198015|NCT05538897|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111198016|NCT05538897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111198017|NCT05538897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111198018|NCT05536804|Tirzepatide|tirzepatide|mesh-list
111198019|NCT05536804|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111198020|NCT05536804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111198021|NCT05536804|Incretins|incretins|mesh-ancestor
111198022|NCT05536804|Hormones|hormones|mesh-ancestor
111198023|NCT05536804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111198024|NCT05533775|Rituximab|rituximab|mesh-list
111198025|NCT05533775|Obinutuzumab|obinutuzumab|mesh-list
111198026|NCT05533775|Carboplatin|carboplatin|mesh-list
111198027|NCT05533775|Etoposide|etoposide|mesh-list
110677020|NCT03146962|Vitamins|vitamins|mesh-ancestor
111198028|NCT05533775|Ifosfamide|ifosfamide|mesh-list
111198029|NCT05533775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111198030|NCT05533775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111198031|NCT05533775|Immunologic Factors|immunologic factors|mesh-ancestor
111198032|NCT05533775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111198033|NCT05533775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111198034|NCT05533775|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111198035|NCT05533775|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111198036|NCT05533775|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111198037|NCT05533775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111198038|NCT05533775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111198039|NCT05533775|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111198040|NCT05533775|Alkylating Agents|alkylating agents|mesh-ancestor
111198041|NCT05520567|Azacitidine|azacitidine|mesh-list
111198042|NCT05520567|Venetoclax|venetoclax|mesh-list
111198043|NCT05520567|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111198044|NCT05520567|Antimetabolites|antimetabolites|mesh-ancestor
111198045|NCT05520567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111198046|NCT05520567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111198047|NCT05520567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111198048|NCT05515939|Insulin|insulin|mesh-list
111198049|NCT05515939|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111198050|NCT05515939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111198051|NCT05515029|Cyclophosphamide|cyclophosphamide|mesh-list
111198052|NCT05515029|Abatacept|abatacept|mesh-list
111198053|NCT05515029|Vedolizumab|vedolizumab|mesh-list
111198054|NCT05515029|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
111198055|NCT05515029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111198056|NCT05515029|Immunologic Factors|immunologic factors|mesh-ancestor
111198057|NCT05515029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111198058|NCT05515029|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111198059|NCT05515029|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111198060|NCT05515029|Alkylating Agents|alkylating agents|mesh-ancestor
111198061|NCT05515029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111198062|NCT05515029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111198063|NCT05515029|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111198064|NCT05515029|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111198065|NCT05515029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110491637|NCT00943124|Vitamins|vitamins|mesh-ancestor
111198066|NCT05515029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111198067|NCT05515029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111198068|NCT05514483|Ondansetron|ondansetron|mesh-list
111198069|NCT05514483|Antiemetics|antiemetics|mesh-ancestor
111198070|NCT05514483|Autonomic Agents|autonomic agents|mesh-ancestor
111198071|NCT05514483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111198072|NCT05514483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111198073|NCT05514483|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111198074|NCT05514483|Antipruritics|antipruritics|mesh-ancestor
111198075|NCT05514483|Dermatologic Agents|dermatologic agents|mesh-ancestor
111198076|NCT05514483|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111198077|NCT05514483|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111198078|NCT05514483|Serotonin Agents|serotonin agents|mesh-ancestor
111198079|NCT05514483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111198080|NCT05514483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111198081|NCT05513001|Remibrutinib|remibrutinib|mesh-list
111198082|NCT05513001|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111198083|NCT05513001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111198084|NCT05513001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111198085|NCT05509777|Mirikizumab|mirikizumab|mesh-list
111198086|NCT05509777|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111198087|NCT05509777|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111198088|NCT05509777|Analgesics|analgesics|mesh-ancestor
111198089|NCT05509777|Sensory System Agents|sensory system agents|mesh-ancestor
111198090|NCT05509777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111198091|NCT05509777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111198092|NCT05509777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111198093|NCT05509777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111198094|NCT05509777|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111198095|NCT05509777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111198096|NCT05506943|Paclitaxel|paclitaxel|mesh-list
111198097|NCT05506943|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111198098|NCT05506943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111198099|NCT05506943|Tubulin Modulators|tubulin modulators|mesh-ancestor
111198100|NCT05506943|Antimitotic Agents|antimitotic agents|mesh-ancestor
111198101|NCT05506943|Mitosis Modulators|mitosis modulators|mesh-ancestor
111198102|NCT05506943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111198103|NCT05502315|Nivolumab|nivolumab|mesh-list
111198104|NCT05502315|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111198105|NCT05502315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111198106|NCT05502315|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111198107|NCT05502315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111198108|NCT05499052|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
111198109|NCT05499052|Hormones|hormones|mesh-ancestor
111198110|NCT05499052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111198111|NCT05499052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111198112|NCT05484557|Enoxaparin|enoxaparin|mesh-list
111198113|NCT05484557|Enoxaparin sodium|enoxaparin sodium|mesh-list
111198114|NCT05484557|Apixaban|apixaban|mesh-list
111198115|NCT05484557|Anticoagulants|anticoagulants|mesh-ancestor
111198116|NCT05484557|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111198117|NCT05484557|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110845886|NCT03381664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111198118|NCT05484557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111198119|NCT05484557|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111198120|NCT05484557|Antithrombins|antithrombins|mesh-ancestor
111198121|NCT05484557|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111198122|NCT05484557|Protease Inhibitors|protease inhibitors|mesh-ancestor
111198123|NCT05484557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111198124|NCT05480800|Vaccines|vaccines|mesh-list
111198125|NCT05480800|Immunologic Factors|immunologic factors|mesh-ancestor
111198126|NCT05480800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111198127|NCT05480306|Bevacizumab|bevacizumab|mesh-list
111198128|NCT05480306|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111198129|NCT05480306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111198130|NCT05480306|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111198131|NCT05480306|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111198132|NCT05480306|Growth Substances|growth substances|mesh-ancestor
111198133|NCT05480306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111198134|NCT05480306|Growth Inhibitors|growth inhibitors|mesh-ancestor
111198135|NCT05477823|Androgens|androgens|mesh-list
111198136|NCT05477823|Hormones|hormones|mesh-ancestor
110491650|NCT02850848|Entecavir|entecavir|mesh-list
111198137|NCT05477823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111198138|NCT05477823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111198139|NCT05473520|Doxycycline|doxycycline|mesh-list
111198140|NCT05473520|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111198141|NCT05473520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111198142|NCT05473520|Antimalarials|antimalarials|mesh-ancestor
111198143|NCT05473520|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111198144|NCT05473520|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111198145|NCT05468619|Valacyclovir|valacyclovir|mesh-list
111198146|NCT05468619|Antiviral Agents|antiviral agents|mesh-ancestor
111198147|NCT05468619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111198148|NCT05459701|Dapagliflozin|dapagliflozin|mesh-list
111198149|NCT05459701|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111198150|NCT05459701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111198151|NCT05459701|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111198152|NCT05459701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111198153|NCT05459389|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111198154|NCT05459389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111198155|NCT05452772|Niacin|niacin|mesh-list
111198156|NCT05452772|Psilocybin|psilocybin|mesh-list
111198157|NCT05452772|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111198158|NCT05452772|Antimetabolites|antimetabolites|mesh-ancestor
111198159|NCT05452772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111198160|NCT05452772|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111198161|NCT05452772|Vasodilator Agents|vasodilator agents|mesh-ancestor
111198162|NCT05452772|Vitamin B Complex|vitamin b complex|mesh-ancestor
111198163|NCT05452772|Vitamins|vitamins|mesh-ancestor
111198164|NCT05452772|Micronutrients|micronutrients|mesh-ancestor
111198165|NCT05452772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111198166|NCT05452772|Hallucinogens|hallucinogens|mesh-ancestor
111198167|NCT05452772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111198168|NCT05445778|Bevacizumab|bevacizumab|mesh-list
111198169|NCT05445778|Maytansine|maytansine|mesh-list
111198170|NCT05445778|Mirvetuximab soravtansine|mirvetuximab soravtansine|mesh-list
111198171|NCT05445778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111198172|NCT05445778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111198173|NCT05445778|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111198174|NCT05445778|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111198175|NCT05445778|Growth Substances|growth substances|mesh-ancestor
111198176|NCT05445778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110677021|NCT03146962|Micronutrients|micronutrients|mesh-ancestor
111198177|NCT05445778|Growth Inhibitors|growth inhibitors|mesh-ancestor
111198178|NCT05445778|Immunoconjugates|immunoconjugates|mesh-ancestor
111198179|NCT05445778|Immunologic Factors|immunologic factors|mesh-ancestor
111198180|NCT05445778|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111198181|NCT05445778|Tubulin Modulators|tubulin modulators|mesh-ancestor
111198182|NCT05445778|Antimitotic Agents|antimitotic agents|mesh-ancestor
111198183|NCT05445778|Mitosis Modulators|mitosis modulators|mesh-ancestor
111198184|NCT05445778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111198185|NCT05436418|Sirolimus|sirolimus|mesh-list
111198186|NCT05436418|Cyclophosphamide|cyclophosphamide|mesh-list
111198187|NCT05436418|Melphalan|melphalan|mesh-list
111198188|NCT05436418|Fludarabine|fludarabine|mesh-list
111198189|NCT05436418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111198190|NCT05436418|Immunologic Factors|immunologic factors|mesh-ancestor
111198191|NCT05436418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111198192|NCT05436418|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111198193|NCT05436418|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111198194|NCT05436418|Alkylating Agents|alkylating agents|mesh-ancestor
111198195|NCT05436418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111198196|NCT05436418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111198197|NCT05436418|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111198198|NCT05436418|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111198199|NCT05436418|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111198200|NCT05436418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111198201|NCT05436418|Antifungal Agents|antifungal agents|mesh-ancestor
111198202|NCT05430828|Evolocumab|evolocumab|mesh-list
111198203|NCT05430828|Alirocumab|alirocumab|mesh-list
111198204|NCT05430828|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
111198205|NCT05430828|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111198206|NCT05430828|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111198207|NCT05430828|Antimetabolites|antimetabolites|mesh-ancestor
111198208|NCT05430828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111198209|NCT05430828|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111198210|NCT05430828|Protease Inhibitors|protease inhibitors|mesh-ancestor
111198211|NCT05430828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111198212|NCT05430828|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111198213|NCT05429268|Lenalidomide|lenalidomide|mesh-list
111198214|NCT05429268|Immunologic Factors|immunologic factors|mesh-ancestor
111198215|NCT05429268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111198216|NCT05429268|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111198217|NCT05429268|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111198218|NCT05429268|Growth Substances|growth substances|mesh-ancestor
111198219|NCT05429268|Growth Inhibitors|growth inhibitors|mesh-ancestor
111198220|NCT05429268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111198221|NCT05428488|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
111198222|NCT05428488|Abatacept|abatacept|mesh-list
111198223|NCT05428488|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111198224|NCT05428488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111198225|NCT05428488|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111198226|NCT05428488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111198227|NCT05428488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111198228|NCT05428488|Immunologic Factors|immunologic factors|mesh-ancestor
111198229|NCT05428488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111198230|NCT05428488|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111198231|NCT05428488|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111198232|NCT05428007|Nivolumab|nivolumab|mesh-list
111198233|NCT05428007|Ipilimumab|ipilimumab|mesh-list
111198234|NCT05428007|Relatlimab|relatlimab|mesh-list
111198235|NCT05428007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111198236|NCT05428007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111198237|NCT05428007|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111198238|NCT05428007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111198239|NCT05422794|Paclitaxel|paclitaxel|mesh-list
111198240|NCT05422794|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111198241|NCT05422794|Pembrolizumab|pembrolizumab|mesh-list
111198242|NCT05422794|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111198243|NCT05422794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111198244|NCT05422794|Tubulin Modulators|tubulin modulators|mesh-ancestor
111198245|NCT05422794|Antimitotic Agents|antimitotic agents|mesh-ancestor
111198246|NCT05422794|Mitosis Modulators|mitosis modulators|mesh-ancestor
111198247|NCT05422794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111198248|NCT05422794|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111198249|NCT05422794|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111198250|NCT05412004|Tirzepatide|tirzepatide|mesh-list
111198251|NCT05412004|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111198252|NCT05412004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111198253|NCT05412004|Incretins|incretins|mesh-ancestor
111198254|NCT05412004|Hormones|hormones|mesh-ancestor
111198255|NCT05412004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111198256|NCT05411081|Atezolizumab|atezolizumab|mesh-list
111198257|NCT05411081|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111198258|NCT05411081|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111198259|NCT05411081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111198260|NCT05411081|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111198261|NCT05411081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111198262|NCT05411081|Immunologic Factors|immunologic factors|mesh-ancestor
111198263|NCT05411081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111198264|NCT05409066|Rituximab|rituximab|mesh-list
111198265|NCT05409066|Lenalidomide|lenalidomide|mesh-list
111198266|NCT05409066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111198267|NCT05409066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111198268|NCT05409066|Immunologic Factors|immunologic factors|mesh-ancestor
111198269|NCT05409066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111198270|NCT05409066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111198271|NCT05409066|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111198272|NCT05409066|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111198273|NCT05409066|Growth Substances|growth substances|mesh-ancestor
111198274|NCT05409066|Growth Inhibitors|growth inhibitors|mesh-ancestor
111198275|NCT05408910|Rifaximin|rifaximin|mesh-list
111198276|NCT05408910|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111198277|NCT05408910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111198278|NCT05408910|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111198279|NCT05407961|Dulaglutide|dulaglutide|mesh-list
111198280|NCT05407961|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111198281|NCT05407961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111198282|NCT05405114|Decitabine|decitabine|mesh-list
111198283|NCT05405114|Hydroxyurea|hydroxyurea|mesh-list
111198284|NCT05405114|Tetrahydrouridine|tetrahydrouridine|mesh-list
111198285|NCT05405114|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111198286|NCT05405114|Antimetabolites|antimetabolites|mesh-ancestor
111198287|NCT05405114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111198288|NCT05405114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111198289|NCT05405114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111198290|NCT05405114|Antisickling Agents|antisickling agents|mesh-ancestor
111198291|NCT05405114|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111198292|NCT05400031|Propolis|propolis|mesh-list
111198293|NCT05400031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111198294|NCT05393674|Nivolumab|nivolumab|mesh-list
111198295|NCT05393674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111198296|NCT05393674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111198297|NCT05393674|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111198298|NCT05393674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111198299|NCT05392946|Dexamethasone|dexamethasone|mesh-list
111198300|NCT05392946|Dexamethasone acetate|dexamethasone acetate|mesh-list
111198301|NCT05392946|Bortezomib|bortezomib|mesh-list
111198302|NCT05392946|Daratumumab|daratumumab|mesh-list
111198303|NCT05392946|Ichthammol|ichthammol|mesh-list
111198304|NCT05392946|BB 1101|bb 1101|mesh-list
111198305|NCT05392946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111198306|NCT05392946|Antiemetics|antiemetics|mesh-ancestor
111198307|NCT05392946|Autonomic Agents|autonomic agents|mesh-ancestor
111198308|NCT05392946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111198309|NCT05392946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111198310|NCT05392946|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111198311|NCT05392946|Glucocorticoids|glucocorticoids|mesh-ancestor
111198312|NCT05392946|Hormones|hormones|mesh-ancestor
111198313|NCT05392946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111198314|NCT05392946|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111198315|NCT05392946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111198316|NCT05392946|Protease Inhibitors|protease inhibitors|mesh-ancestor
111198317|NCT05392946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111198318|NCT05392946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111198319|NCT05392946|Dermatologic Agents|dermatologic agents|mesh-ancestor
111198320|NCT05383352|Leucovorin|leucovorin|mesh-list
111198321|NCT05383352|Folic Acid|folic acid|mesh-list
111198322|NCT05383352|Fluorouracil|fluorouracil|mesh-list
111198323|NCT05383352|Irinotecan|irinotecan|mesh-list
111198324|NCT05383352|Camptothecin|camptothecin|mesh-list
111198325|NCT05383352|Levoleucovorin|levoleucovorin|mesh-list
111198326|NCT05383352|Antimetabolites|antimetabolites|mesh-ancestor
111198327|NCT05383352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111198328|NCT05383352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111198329|NCT05383352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111198330|NCT05383352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110915362|NCT00680342|Silymarin|silymarin|mesh-list
111198331|NCT05383352|Immunologic Factors|immunologic factors|mesh-ancestor
111198332|NCT05383352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111198333|NCT05383352|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111198334|NCT05383352|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111198335|NCT05383352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111198336|NCT05383352|Antidotes|antidotes|mesh-ancestor
111198337|NCT05383352|Protective Agents|protective agents|mesh-ancestor
111198338|NCT05383352|Vitamin B Complex|vitamin b complex|mesh-ancestor
111198339|NCT05383352|Vitamins|vitamins|mesh-ancestor
111198340|NCT05383352|Micronutrients|micronutrients|mesh-ancestor
111198341|NCT05383352|Hematinics|hematinics|mesh-ancestor
111198342|NCT05383352|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111198343|NCT05382299|Paclitaxel|paclitaxel|mesh-list
111198344|NCT05382299|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111198345|NCT05382299|Carboplatin|carboplatin|mesh-list
111198346|NCT05382299|Gemcitabine|gemcitabine|mesh-list
111198347|NCT05382299|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
111198348|NCT05382299|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111198349|NCT05382299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111198350|NCT05382299|Tubulin Modulators|tubulin modulators|mesh-ancestor
111198351|NCT05382299|Antimitotic Agents|antimitotic agents|mesh-ancestor
111198352|NCT05382299|Mitosis Modulators|mitosis modulators|mesh-ancestor
111198353|NCT05382299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111198354|NCT05382299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111198355|NCT05382299|Antimetabolites|antimetabolites|mesh-ancestor
111198356|NCT05382299|Immunoconjugates|immunoconjugates|mesh-ancestor
111198357|NCT05382299|Immunologic Factors|immunologic factors|mesh-ancestor
111198358|NCT05382299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111198359|NCT05379790|Irinotecan|irinotecan|mesh-list
111198360|NCT05379790|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111198361|NCT05379790|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111198362|NCT05379790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111198363|NCT05379790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111198364|NCT05379790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111198365|NCT05377333|Dulaglutide|dulaglutide|mesh-list
111198366|NCT05377333|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111198367|NCT05377333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111198368|NCT05375825|LMB-100|lmb-100|mesh-list
111198369|NCT05375825|Immunoconjugates|immunoconjugates|mesh-ancestor
111198370|NCT05375825|Immunologic Factors|immunologic factors|mesh-ancestor
111198371|NCT05375825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111198372|NCT05374538|Sotorasib|sotorasib|mesh-list
111198373|NCT05374538|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111198374|NCT05374538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111198375|NCT05374538|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111198376|NCT05374538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111198377|NCT05373264|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
111198378|NCT05373264|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111198379|NCT05373264|Diuretics|diuretics|mesh-ancestor
111198380|NCT05373264|Natriuretic Agents|natriuretic agents|mesh-ancestor
111198381|NCT05373264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111198382|NCT05373264|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
111198383|NCT05373264|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111198384|NCT05373264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111198385|NCT05370040|Vaccines|vaccines|mesh-list
111198386|NCT05370040|Immunologic Factors|immunologic factors|mesh-ancestor
111198387|NCT05370040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111198388|NCT05368376|Metoprolol|metoprolol|mesh-list
111198389|NCT05368376|Labetalol|labetalol|mesh-list
111198390|NCT05368376|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111198391|NCT05368376|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111198392|NCT05368376|Sympatholytics|sympatholytics|mesh-ancestor
111198393|NCT05368376|Autonomic Agents|autonomic agents|mesh-ancestor
111198394|NCT05368376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111198395|NCT05368376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111198396|NCT05368376|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
111198397|NCT05368376|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111198398|NCT05368376|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111198399|NCT05368376|Adrenergic Agents|adrenergic agents|mesh-ancestor
111198400|NCT05368376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111198401|NCT05368376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111198402|NCT05368376|Sympathomimetics|sympathomimetics|mesh-ancestor
111198403|NCT05368376|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110915430|NCT00479258|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111198404|NCT05368376|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111198405|NCT05362058|Insulin|insulin|mesh-list
111198406|NCT05362058|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110628586|NCT00961857|Metformin|metformin|mesh-list
111198407|NCT05362058|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111198408|NCT05362058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111198410|NCT05353439|Topotecan|topotecan|mesh-list
111198411|NCT05353439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111198412|NCT05353439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111198413|NCT05353439|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111198414|NCT05353439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111198415|NCT05353439|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111198416|NCT05353439|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111198417|NCT05353439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111198418|NCT05334004|Ritonavir|ritonavir|mesh-list
111198419|NCT05334004|Lopinavir|lopinavir|mesh-list
111198420|NCT05334004|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111198421|NCT05334004|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111198422|NCT05334004|Protease Inhibitors|protease inhibitors|mesh-ancestor
111198423|NCT05334004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111198424|NCT05334004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111198425|NCT05334004|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111198426|NCT05334004|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111198427|NCT05334004|Antiviral Agents|antiviral agents|mesh-ancestor
111198428|NCT05334004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111198429|NCT05334004|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111198430|NCT05334004|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111198431|NCT05333458|Atezolizumab|atezolizumab|mesh-list
111198432|NCT05333458|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111198433|NCT05333458|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111198434|NCT05333458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111198435|NCT05333458|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111198436|NCT05333458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111198437|NCT05333458|Immunologic Factors|immunologic factors|mesh-ancestor
111198438|NCT05333458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111198439|NCT05327270|Nivolumab|nivolumab|mesh-list
111198440|NCT05327270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111198441|NCT05327270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111198442|NCT05327270|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111198443|NCT05327270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111198444|NCT05327010|Talazoparib|talazoparib|mesh-list
111198445|NCT05327010|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111198446|NCT05327010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111198447|NCT05327010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111198448|NCT05327010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111198449|NCT05319353|Maribavir|maribavir|mesh-list
111198450|NCT05319353|Antiviral Agents|antiviral agents|mesh-ancestor
111198451|NCT05319353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111198452|NCT05317806|Metformin|metformin|mesh-list
111198453|NCT05317806|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111198454|NCT05317806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111198455|NCT05309928|Amoxicillin|amoxicillin|mesh-list
111198456|NCT05309928|Probenecid|probenecid|mesh-list
111198457|NCT05309928|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111198458|NCT05309928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111198459|NCT05309928|Uricosuric Agents|uricosuric agents|mesh-ancestor
111198460|NCT05309928|Gout Suppressants|gout suppressants|mesh-ancestor
111198461|NCT05309928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111198462|NCT05309421|Pembrolizumab|pembrolizumab|mesh-list
111198463|NCT05309421|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111198464|NCT05309421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111198465|NCT05309421|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111198466|NCT05309421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111198467|NCT05308446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111198468|NCT05308446|Nivolumab|nivolumab|mesh-list
111198469|NCT05308446|Cetuximab|cetuximab|mesh-list
111198470|NCT05308446|Antibodies|antibodies|mesh-list
111198471|NCT05308446|Immunoglobulins|immunoglobulins|mesh-list
110491688|NCT00685945|Isosorbide|isosorbide|mesh-list
111198472|NCT05308446|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111198473|NCT05308446|Immunologic Factors|immunologic factors|mesh-ancestor
110845908|NCT03863405|Metformin|metformin|mesh-list
111198474|NCT05308446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111198476|NCT05308446|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111198477|NCT05308446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111198478|NCT05298423|Paclitaxel|paclitaxel|mesh-list
111198479|NCT05298423|Etoposide|etoposide|mesh-list
111198480|NCT05298423|Carboplatin|carboplatin|mesh-list
110915509|NCT02996097|Hormones|hormones|mesh-ancestor
111198481|NCT05298423|Pembrolizumab|pembrolizumab|mesh-list
111198482|NCT05298423|Pemetrexed|pemetrexed|mesh-list
111198483|NCT05298423|Durvalumab|durvalumab|mesh-list
111198484|NCT05298423|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111198485|NCT05298423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111198486|NCT05298423|Tubulin Modulators|tubulin modulators|mesh-ancestor
111198487|NCT05298423|Antimitotic Agents|antimitotic agents|mesh-ancestor
111198488|NCT05298423|Mitosis Modulators|mitosis modulators|mesh-ancestor
111198489|NCT05298423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111198490|NCT05298423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111198491|NCT05298423|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111198492|NCT05298423|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111198493|NCT05298423|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111198494|NCT05298423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111198495|NCT05298423|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111198496|NCT05298423|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111198497|NCT05292664|Leucovorin|leucovorin|mesh-list
111198498|NCT05292664|Cytarabine|cytarabine|mesh-list
111198499|NCT05292664|Dexamethasone|dexamethasone|mesh-list
111198500|NCT05292664|Dexamethasone acetate|dexamethasone acetate|mesh-list
111198501|NCT05292664|Hydrocortisone|hydrocortisone|mesh-list
111198502|NCT05292664|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
111198503|NCT05292664|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
111198504|NCT05292664|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
111198505|NCT05292664|Cortisone|cortisone|mesh-list
111198506|NCT05292664|Doxorubicin|doxorubicin|mesh-list
111198507|NCT05292664|Methotrexate|methotrexate|mesh-list
111198508|NCT05292664|Vincristine|vincristine|mesh-list
111198509|NCT05292664|Azacitidine|azacitidine|mesh-list
111198510|NCT05292664|Venetoclax|venetoclax|mesh-list
111198511|NCT05292664|Asparaginase|asparaginase|mesh-list
111198512|NCT05292664|Dexrazoxane|dexrazoxane|mesh-list
111198513|NCT05292664|Razoxane|razoxane|mesh-list
111198514|NCT05292664|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
111198515|NCT05292664|BB 1101|bb 1101|mesh-list
111198516|NCT05292664|Levoleucovorin|levoleucovorin|mesh-list
111198517|NCT05292664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111198518|NCT05292664|Antiemetics|antiemetics|mesh-ancestor
111198519|NCT05292664|Autonomic Agents|autonomic agents|mesh-ancestor
111198520|NCT05292664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111198521|NCT05292664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111198522|NCT05292664|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111198523|NCT05292664|Glucocorticoids|glucocorticoids|mesh-ancestor
111198524|NCT05292664|Hormones|hormones|mesh-ancestor
111198525|NCT05292664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111198526|NCT05292664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111198527|NCT05292664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111198528|NCT05292664|Protease Inhibitors|protease inhibitors|mesh-ancestor
111198529|NCT05292664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111198530|NCT05292664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111198531|NCT05292664|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111198532|NCT05292664|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111198533|NCT05292664|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111198534|NCT05292664|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111198535|NCT05292664|Abortifacient Agents|abortifacient agents|mesh-ancestor
111198536|NCT05292664|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111198537|NCT05292664|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111198538|NCT05292664|Antimetabolites|antimetabolites|mesh-ancestor
111198539|NCT05292664|Dermatologic Agents|dermatologic agents|mesh-ancestor
111198540|NCT05292664|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110491695|NCT00685945|Vasodilator Agents|vasodilator agents|mesh-ancestor
111198541|NCT05292664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111198543|NCT05292664|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111198544|NCT05292664|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111198545|NCT05292664|Antiviral Agents|antiviral agents|mesh-ancestor
111198546|NCT05292664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111198547|NCT05292664|Antidotes|antidotes|mesh-ancestor
111198548|NCT05292664|Protective Agents|protective agents|mesh-ancestor
111198549|NCT05292664|Vitamin B Complex|vitamin b complex|mesh-ancestor
111198550|NCT05292664|Vitamins|vitamins|mesh-ancestor
111198551|NCT05292664|Micronutrients|micronutrients|mesh-ancestor
111198552|NCT05292664|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111198553|NCT05292664|Tubulin Modulators|tubulin modulators|mesh-ancestor
111198554|NCT05292664|Antimitotic Agents|antimitotic agents|mesh-ancestor
111198555|NCT05292664|Mitosis Modulators|mitosis modulators|mesh-ancestor
111198556|NCT05292664|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111198557|NCT05290727|Hyaluronic Acid|hyaluronic acid|mesh-list
111198558|NCT05290727|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111198559|NCT05290727|Immunologic Factors|immunologic factors|mesh-ancestor
111198560|NCT05290727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111198561|NCT05290727|Viscosupplements|viscosupplements|mesh-ancestor
111198562|NCT05290727|Protective Agents|protective agents|mesh-ancestor
111198563|NCT05286827|Olaparib|olaparib|mesh-list
111198564|NCT05286827|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111198565|NCT05286827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111198566|NCT05286827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111198567|NCT05286827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111198568|NCT05286801|Deoxyglucose|deoxyglucose|mesh-list
111198569|NCT05286801|Atezolizumab|atezolizumab|mesh-list
111198570|NCT05286801|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111198571|NCT05286801|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
111198572|NCT05286801|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111198573|NCT05286801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111198574|NCT05286801|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111198575|NCT05286801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111198576|NCT05286801|Immunologic Factors|immunologic factors|mesh-ancestor
111198577|NCT05286801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111198578|NCT05286801|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111198579|NCT05286801|Antimetabolites|antimetabolites|mesh-ancestor
111198580|NCT05286801|Antiviral Agents|antiviral agents|mesh-ancestor
111198581|NCT05286801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111198582|NCT05276973|Paclitaxel|paclitaxel|mesh-list
111198583|NCT05276973|Carboplatin|carboplatin|mesh-list
111198584|NCT05276973|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111198585|NCT05276973|Ipatasertib|ipatasertib|mesh-list
111198586|NCT05276973|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111198587|NCT05276973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111198588|NCT05276973|Tubulin Modulators|tubulin modulators|mesh-ancestor
111198589|NCT05276973|Antimitotic Agents|antimitotic agents|mesh-ancestor
111198590|NCT05276973|Mitosis Modulators|mitosis modulators|mesh-ancestor
111198591|NCT05276973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111198592|NCT05276973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111198593|NCT05276973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111198594|NCT05271604|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
111198595|NCT05271604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111198596|NCT05271604|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111198597|NCT05271604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111198598|NCT05260021|Tirzepatide|tirzepatide|mesh-list
111198599|NCT05260021|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111198600|NCT05260021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111198601|NCT05260021|Incretins|incretins|mesh-ancestor
111198602|NCT05260021|Hormones|hormones|mesh-ancestor
111198603|NCT05260021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111198604|NCT05256225|Paclitaxel|paclitaxel|mesh-list
111198605|NCT05256225|Carboplatin|carboplatin|mesh-list
111198606|NCT05256225|Trastuzumab|trastuzumab|mesh-list
111198607|NCT05256225|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111198608|NCT05256225|Pertuzumab|pertuzumab|mesh-list
111198609|NCT05256225|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111198610|NCT05256225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111198611|NCT05256225|Tubulin Modulators|tubulin modulators|mesh-ancestor
111198612|NCT05256225|Antimitotic Agents|antimitotic agents|mesh-ancestor
111198613|NCT05256225|Mitosis Modulators|mitosis modulators|mesh-ancestor
111198614|NCT05256225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111198615|NCT05256225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111198616|NCT05255302|Pembrolizumab|pembrolizumab|mesh-list
111198617|NCT05255302|Pemetrexed|pemetrexed|mesh-list
111198618|NCT05255302|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111198619|NCT05255302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111198620|NCT05255302|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111198621|NCT05255302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111198622|NCT05255302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111198623|NCT05255302|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111198624|NCT05255302|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111198625|NCT05243550|Mitomycins|mitomycins|mesh-list
111198626|NCT05243550|Mitomycin|mitomycin|mesh-list
111198627|NCT05243550|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111198628|NCT05243550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111198629|NCT05243550|Alkylating Agents|alkylating agents|mesh-ancestor
111198630|NCT05243550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110915656|NCT04520074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111198631|NCT05243550|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111198632|NCT05243550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111198633|NCT05243290|Niacinamide|niacinamide|mesh-list
111198634|NCT05243290|Niacin|niacin|mesh-list
111198635|NCT05243290|Nicotinic Acids|nicotinic acids|mesh-list
111198636|NCT05243290|Vitamin B Complex|vitamin b complex|mesh-ancestor
111198637|NCT05243290|Vitamins|vitamins|mesh-ancestor
111198638|NCT05243290|Micronutrients|micronutrients|mesh-ancestor
111198639|NCT05243290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111198640|NCT05243290|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111198641|NCT05243290|Antimetabolites|antimetabolites|mesh-ancestor
111198642|NCT05243290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111198643|NCT05243290|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111198644|NCT05243290|Vasodilator Agents|vasodilator agents|mesh-ancestor
111198645|NCT05239546|Dostarlimab|dostarlimab|mesh-list
111198646|NCT05239546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111198647|NCT05226871|Cetuximab|cetuximab|mesh-list
111198648|NCT05226871|Letrozole|letrozole|mesh-list
111198649|NCT05226871|Fulvestrant|fulvestrant|mesh-list
111198650|NCT05226871|Palbociclib|palbociclib|mesh-list
111198651|NCT05226871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111198652|NCT05226871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111198653|NCT05226871|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111198654|NCT05226871|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111198655|NCT05226871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111198656|NCT05226871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111198657|NCT05226871|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111198658|NCT05226871|Hormone Antagonists|hormone antagonists|mesh-ancestor
111198659|NCT05226871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111198660|NCT05226871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111198661|NCT05226871|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111198662|NCT05226871|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
111198663|NCT05226871|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111198664|NCT05222555|Lenalidomide|lenalidomide|mesh-list
111198665|NCT05222555|Immunologic Factors|immunologic factors|mesh-ancestor
111198666|NCT05222555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111198667|NCT05222555|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111198668|NCT05222555|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111198669|NCT05222555|Growth Substances|growth substances|mesh-ancestor
111198670|NCT05222555|Growth Inhibitors|growth inhibitors|mesh-ancestor
111198671|NCT05222555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111198672|NCT05220722|Pembrolizumab|pembrolizumab|mesh-list
111198673|NCT05220722|Nivolumab|nivolumab|mesh-list
111198674|NCT05220722|Ipilimumab|ipilimumab|mesh-list
111198675|NCT05220722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111198676|NCT05220722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111198677|NCT05220722|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111198678|NCT05220722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111198679|NCT05218499|Doxorubicin|doxorubicin|mesh-list
111198680|NCT05218499|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110491708|NCT00747487|Idebenone|idebenone|mesh-list
111198681|NCT05218499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111198682|NCT05218499|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111198683|NCT05218499|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111198684|NCT05218499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111198685|NCT05218499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111198686|NCT05208047|Sunitinib|sunitinib|mesh-list
111198687|NCT05208047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111198688|NCT05208047|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111198689|NCT05208047|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111198690|NCT05208047|Growth Substances|growth substances|mesh-ancestor
111198691|NCT05208047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111198692|NCT05208047|Growth Inhibitors|growth inhibitors|mesh-ancestor
111198693|NCT05208047|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111198694|NCT05208047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111198695|NCT05208047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111198696|NCT05198830|Cisplatin|cisplatin|mesh-list
111198697|NCT05198830|Pemetrexed|pemetrexed|mesh-list
111198698|NCT05198830|Durvalumab|durvalumab|mesh-list
111198699|NCT05198830|Immunoglobulins|immunoglobulins|mesh-list
111198700|NCT05198830|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111198701|NCT05198830|Immunoglobulin G|immunoglobulin g|mesh-list
111198702|NCT05198830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111198703|NCT05198830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111198704|NCT05198830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111198705|NCT05198830|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111198706|NCT05198830|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111198707|NCT05198830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111198708|NCT05198830|Immunologic Factors|immunologic factors|mesh-ancestor
111198709|NCT05198830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111198710|NCT05193552|gamma-Globulins|gamma-globulins|mesh-list
111198711|NCT05193552|Immunologic Factors|immunologic factors|mesh-ancestor
111198712|NCT05193552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111198713|NCT05177263|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111198714|NCT05174832|Paclitaxel|paclitaxel|mesh-list
111198715|NCT05174832|Pembrolizumab|pembrolizumab|mesh-list
111198716|NCT05174832|Olaparib|olaparib|mesh-list
111198717|NCT05174832|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111198718|NCT05174832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111198719|NCT05174832|Tubulin Modulators|tubulin modulators|mesh-ancestor
111198720|NCT05174832|Antimitotic Agents|antimitotic agents|mesh-ancestor
111198721|NCT05174832|Mitosis Modulators|mitosis modulators|mesh-ancestor
111198722|NCT05174832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111198723|NCT05174832|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111198724|NCT05174832|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111198725|NCT05174832|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111198726|NCT05174832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111198727|NCT05172245|Cisplatin|cisplatin|mesh-list
111198728|NCT05172245|Ipatasertib|ipatasertib|mesh-list
111198729|NCT05172245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111198730|NCT05172245|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111198731|NCT05172245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111198732|NCT05172245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111198733|NCT05169437|Niraparib|niraparib|mesh-list
111198734|NCT05169437|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111198735|NCT05169437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111198736|NCT05169437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111198737|NCT05169437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111198738|NCT05168202|Azacitidine|azacitidine|mesh-list
111198739|NCT05168202|Venetoclax|venetoclax|mesh-list
110491715|NCT00750217|Narcotics|narcotics|mesh-ancestor
111198740|NCT05168202|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111198741|NCT05168202|Antimetabolites|antimetabolites|mesh-ancestor
111198742|NCT05168202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111198743|NCT05168202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111198744|NCT05168202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111198745|NCT05158140|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
111198746|NCT05158140|Immunologic Factors|immunologic factors|mesh-ancestor
111198747|NCT05158140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111198748|NCT05157243|Nitazoxanide|nitazoxanide|mesh-list
111198749|NCT05157243|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111198750|NCT05157243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111198751|NCT05144945|Vaccines|vaccines|mesh-list
111198752|NCT05144945|Immunologic Factors|immunologic factors|mesh-ancestor
111198753|NCT05144945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111198754|NCT05142241|Temozolomide|temozolomide|mesh-list
111198755|NCT05142241|Talazoparib|talazoparib|mesh-list
111198756|NCT05142241|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111198757|NCT05142241|Alkylating Agents|alkylating agents|mesh-ancestor
111198758|NCT05142241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111198759|NCT05142241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111198760|NCT05142241|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111198761|NCT05142241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111198762|NCT05136196|Nivolumab|nivolumab|mesh-list
111198763|NCT05136196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111198764|NCT05136196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111198765|NCT05136196|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111198766|NCT05136196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111198767|NCT05128630|Durvalumab|durvalumab|mesh-list
111198768|NCT05128630|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111198769|NCT05128630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111198770|NCT05115110|Risdiplam|risdiplam|mesh-list
111198771|NCT05115110|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111198772|NCT05115110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111198773|NCT05115110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111198774|NCT05112965|Atezolizumab|atezolizumab|mesh-list
111198775|NCT05112965|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111198776|NCT05112965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111198777|NCT05112965|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111198778|NCT05112965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111198779|NCT05112601|Nivolumab|nivolumab|mesh-list
111198780|NCT05112601|Ipilimumab|ipilimumab|mesh-list
111198781|NCT05112601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111198782|NCT05112601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111198783|NCT05112601|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111198784|NCT05112601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111198785|NCT05111574|Nivolumab|nivolumab|mesh-list
111198786|NCT05111574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111198787|NCT05111574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111198788|NCT05111574|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111198789|NCT05111574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111198790|NCT05109429|Analgesics, Opioid|analgesics, opioid|mesh-list
111198791|NCT05109429|Narcotics|narcotics|mesh-ancestor
111198792|NCT05109429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111198793|NCT05109429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111198794|NCT05109429|Analgesics|analgesics|mesh-ancestor
111198795|NCT05109429|Sensory System Agents|sensory system agents|mesh-ancestor
111198796|NCT05109429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111198797|NCT05100862|Rituximab|rituximab|mesh-list
111198798|NCT05100862|Obinutuzumab|obinutuzumab|mesh-list
111198799|NCT05100862|Lenalidomide|lenalidomide|mesh-list
111198800|NCT05100862|Zanubrutinib|zanubrutinib|mesh-list
111198801|NCT05100862|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111198802|NCT05100862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111198803|NCT05100862|Immunologic Factors|immunologic factors|mesh-ancestor
111198804|NCT05100862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111198805|NCT05100862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111198806|NCT05100862|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111198807|NCT05100862|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111198808|NCT05100862|Growth Substances|growth substances|mesh-ancestor
111198809|NCT05100862|Growth Inhibitors|growth inhibitors|mesh-ancestor
111198810|NCT05100862|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111198811|NCT05100862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111198812|NCT05100862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111198813|NCT05092958|Avelumab|avelumab|mesh-list
111198814|NCT05092958|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111198815|NCT05092958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111198816|NCT05092958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111198817|NCT05092958|Immunologic Factors|immunologic factors|mesh-ancestor
111198818|NCT05092958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111198819|NCT05082142|Tranexamic Acid|tranexamic acid|mesh-list
111198820|NCT05082142|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111198821|NCT05082142|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111198822|NCT05082142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111198823|NCT05082142|Hemostatics|hemostatics|mesh-ancestor
111198824|NCT05082142|Coagulants|coagulants|mesh-ancestor
111198825|NCT05080803|Bevacizumab|bevacizumab|mesh-list
111198826|NCT05080803|Ranibizumab|ranibizumab|mesh-list
111198827|NCT05080803|Aflibercept|aflibercept|mesh-list
111198828|NCT05080803|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111198829|NCT05080803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111198830|NCT05080803|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110845925|NCT04024891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111198831|NCT05080803|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111198832|NCT05080803|Growth Substances|growth substances|mesh-ancestor
111198833|NCT05080803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111198834|NCT05080803|Growth Inhibitors|growth inhibitors|mesh-ancestor
111198835|NCT05077904|Alprazolam|alprazolam|mesh-list
111198836|NCT05077904|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111198837|NCT05077904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111198838|NCT05077904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111198839|NCT05077904|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110491741|NCT00750451|Enoxaparin|enoxaparin|mesh-list
111198840|NCT05077904|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111198841|NCT05077904|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111198842|NCT05077904|GABA Modulators|gaba modulators|mesh-ancestor
111198843|NCT05077904|GABA Agents|gaba agents|mesh-ancestor
111198844|NCT05077904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111198845|NCT05077904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111198846|NCT05076617|Alprazolam|alprazolam|mesh-list
111198847|NCT05076617|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111198848|NCT05076617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111198849|NCT05076617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111198850|NCT05076617|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111198851|NCT05076617|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111198852|NCT05076617|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111198853|NCT05076617|GABA Modulators|gaba modulators|mesh-ancestor
111198854|NCT05076617|GABA Agents|gaba agents|mesh-ancestor
111198855|NCT05076617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111198856|NCT05076617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111198857|NCT05075993|Paclitaxel|paclitaxel|mesh-list
111198858|NCT05075993|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111198859|NCT05075993|Cyclophosphamide|cyclophosphamide|mesh-list
111198860|NCT05075993|Bevacizumab|bevacizumab|mesh-list
111198861|NCT05075993|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111198862|NCT05075993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111198863|NCT05075993|Tubulin Modulators|tubulin modulators|mesh-ancestor
111198864|NCT05075993|Antimitotic Agents|antimitotic agents|mesh-ancestor
111198865|NCT05075993|Mitosis Modulators|mitosis modulators|mesh-ancestor
111198866|NCT05075993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111198867|NCT05075993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111198868|NCT05075993|Immunologic Factors|immunologic factors|mesh-ancestor
111198869|NCT05075993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111198870|NCT05075993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111198871|NCT05075993|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111198872|NCT05075993|Alkylating Agents|alkylating agents|mesh-ancestor
111198873|NCT05075993|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111198874|NCT05075993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111198875|NCT05075993|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111198876|NCT05075993|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111198877|NCT05075993|Growth Substances|growth substances|mesh-ancestor
111198878|NCT05075993|Growth Inhibitors|growth inhibitors|mesh-ancestor
111198879|NCT05065970|Felzartamab|felzartamab|mesh-list
111198880|NCT05065970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111198881|NCT05065970|Immunologic Factors|immunologic factors|mesh-ancestor
111198882|NCT05065970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111198883|NCT05065801|Folfirinox|folfirinox|mesh-list
111198884|NCT05065801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111198885|NCT05063552|Bevacizumab|bevacizumab|mesh-list
111198886|NCT05063552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111198887|NCT05063552|Cetuximab|cetuximab|mesh-list
111198888|NCT05063552|Atezolizumab|atezolizumab|mesh-list
111198889|NCT05063552|Cisplatin|cisplatin|mesh-list
111198890|NCT05063552|Carboplatin|carboplatin|mesh-list
111198891|NCT05063552|Docetaxel|docetaxel|mesh-list
111198892|NCT05063552|Endothelial Growth Factors|endothelial growth factors|mesh-list
111198893|NCT05063552|Antibodies|antibodies|mesh-list
111198894|NCT05063552|Immunoglobulins|immunoglobulins|mesh-list
111198895|NCT05063552|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111198896|NCT05063552|Immunoglobulin G|immunoglobulin g|mesh-list
111198897|NCT05063552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111198898|NCT05063552|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111198899|NCT05063552|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111198900|NCT05063552|Growth Substances|growth substances|mesh-ancestor
111198901|NCT05063552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111198902|NCT05063552|Growth Inhibitors|growth inhibitors|mesh-ancestor
111198903|NCT05063552|Immunologic Factors|immunologic factors|mesh-ancestor
111198904|NCT05063552|Tubulin Modulators|tubulin modulators|mesh-ancestor
111198905|NCT05063552|Antimitotic Agents|antimitotic agents|mesh-ancestor
111198906|NCT05063552|Mitosis Modulators|mitosis modulators|mesh-ancestor
111198907|NCT05063552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111198908|NCT05063552|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111198909|NCT05063162|Rozanolixizumab|rozanolixizumab|mesh-list
111198910|NCT05063162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111198911|NCT05063162|Immunologic Factors|immunologic factors|mesh-ancestor
111198912|NCT05063162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111198913|NCT05058651|Cisplatin|cisplatin|mesh-list
111198914|NCT05058651|Carboplatin|carboplatin|mesh-list
111198915|NCT05058651|Etoposide|etoposide|mesh-list
111198916|NCT05058651|Etoposide phosphate|etoposide phosphate|mesh-list
111198917|NCT05058651|Atezolizumab|atezolizumab|mesh-list
111198918|NCT05058651|Podophyllotoxin|podophyllotoxin|mesh-list
111198919|NCT05058651|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111198920|NCT05058651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111198921|NCT05058651|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111198922|NCT05058651|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111198923|NCT05058651|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111198924|NCT05058651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111198925|NCT05058651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111198926|NCT05058651|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111198927|NCT05058651|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111198928|NCT05058651|Immunologic Factors|immunologic factors|mesh-ancestor
111198929|NCT05058651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111198930|NCT05058651|Keratolytic Agents|keratolytic agents|mesh-ancestor
111198931|NCT05058651|Dermatologic Agents|dermatologic agents|mesh-ancestor
111198932|NCT05058651|Tubulin Modulators|tubulin modulators|mesh-ancestor
111198933|NCT05058651|Antimitotic Agents|antimitotic agents|mesh-ancestor
111198934|NCT05058651|Mitosis Modulators|mitosis modulators|mesh-ancestor
111198935|NCT05055830|Acetaminophen|acetaminophen|mesh-list
111198936|NCT05055830|Milrinone|milrinone|mesh-list
111198937|NCT05055830|Methadone|methadone|mesh-list
111198938|NCT05055830|Caffeine|caffeine|mesh-list
111198939|NCT05055830|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111198940|NCT05055830|Analgesics|analgesics|mesh-ancestor
111198941|NCT05055830|Sensory System Agents|sensory system agents|mesh-ancestor
111198942|NCT05055830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111198943|NCT05055830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111198944|NCT05055830|Antipyretics|antipyretics|mesh-ancestor
111198945|NCT05055830|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111198946|NCT05055830|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111198947|NCT05055830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111198948|NCT05055830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111198949|NCT05055830|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
111198950|NCT05055830|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111198951|NCT05055830|Purinergic Agents|purinergic agents|mesh-ancestor
111198952|NCT05055830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111198953|NCT05055830|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111198954|NCT05055830|Narcotics|narcotics|mesh-ancestor
110845945|NCT01178021|Filaricides|filaricides|mesh-ancestor
111198955|NCT05055830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111198956|NCT05055830|Antitussive Agents|antitussive agents|mesh-ancestor
111198957|NCT05055830|Respiratory System Agents|respiratory system agents|mesh-ancestor
111198958|NCT05055830|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111198959|NCT05055830|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111198960|NCT05055830|Vasodilator Agents|vasodilator agents|mesh-ancestor
111198961|NCT05055830|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
111198962|NCT05055830|Protective Agents|protective agents|mesh-ancestor
111198964|NCT05053971|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
111198965|NCT05053971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111198966|NCT05053971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111198967|NCT05053971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111198968|NCT05048069|Rebamipide|rebamipide|mesh-list
111198969|NCT05048069|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111198970|NCT05048069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111198971|NCT05048069|Antioxidants|antioxidants|mesh-ancestor
111198972|NCT05048069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111198973|NCT05048069|Protective Agents|protective agents|mesh-ancestor
111198974|NCT05048069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111198975|NCT05048069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111198976|NCT05041257|Maytansine|maytansine|mesh-list
111198977|NCT05041257|Mirvetuximab soravtansine|mirvetuximab soravtansine|mesh-list
111198978|NCT05041257|Immunoconjugates|immunoconjugates|mesh-ancestor
111198979|NCT05041257|Immunologic Factors|immunologic factors|mesh-ancestor
111198980|NCT05041257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111198981|NCT05041257|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111198982|NCT05041257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111198983|NCT05041257|Tubulin Modulators|tubulin modulators|mesh-ancestor
111198984|NCT05041257|Antimitotic Agents|antimitotic agents|mesh-ancestor
111198985|NCT05041257|Mitosis Modulators|mitosis modulators|mesh-ancestor
111198986|NCT05041257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111198987|NCT05032157|Remibrutinib|remibrutinib|mesh-list
111198988|NCT05032157|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111198989|NCT05032157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111198990|NCT05032157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111198991|NCT05030311|Remibrutinib|remibrutinib|mesh-list
111198992|NCT05030311|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111198993|NCT05030311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111198994|NCT05030311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111198995|NCT05029063|Rivaroxaban|rivaroxaban|mesh-list
111198996|NCT05029063|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111198997|NCT05029063|Antithrombins|antithrombins|mesh-ancestor
111198998|NCT05029063|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111198999|NCT05029063|Protease Inhibitors|protease inhibitors|mesh-ancestor
111199000|NCT05029063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111199001|NCT05029063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111199002|NCT05029063|Anticoagulants|anticoagulants|mesh-ancestor
111199003|NCT05024773|Paclitaxel|paclitaxel|mesh-list
111199004|NCT05024773|Hyaluronic Acid|hyaluronic acid|mesh-list
111199005|NCT05024773|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111199006|NCT05024773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111199007|NCT05024773|Tubulin Modulators|tubulin modulators|mesh-ancestor
111199008|NCT05024773|Antimitotic Agents|antimitotic agents|mesh-ancestor
111199009|NCT05024773|Mitosis Modulators|mitosis modulators|mesh-ancestor
111199010|NCT05024773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111199011|NCT05024773|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111199012|NCT05024773|Immunologic Factors|immunologic factors|mesh-ancestor
111199013|NCT05024773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111199014|NCT05024773|Viscosupplements|viscosupplements|mesh-ancestor
111199015|NCT05024773|Protective Agents|protective agents|mesh-ancestor
111199016|NCT05009979|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
111199017|NCT05009979|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111199018|NCT05009979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111199019|NCT05007821|Linezolid|linezolid|mesh-list
111199020|NCT05007821|Bedaquiline|bedaquiline|mesh-list
111199021|NCT05007821|Diarylquinolines|diarylquinolines|mesh-list
111199022|NCT05007821|Clofazimine|clofazimine|mesh-list
111199023|NCT05007821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111199024|NCT05007821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111199025|NCT05007821|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111199026|NCT05007821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111199027|NCT05007821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111199028|NCT05007821|Antitubercular Agents|antitubercular agents|mesh-ancestor
111199029|NCT05007821|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111199030|NCT05007821|Leprostatic Agents|leprostatic agents|mesh-ancestor
111199031|NCT05001880|Bevacizumab|bevacizumab|mesh-list
111199032|NCT05001880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111199033|NCT05001880|Atezolizumab|atezolizumab|mesh-list
111199034|NCT05001880|Carboplatin|carboplatin|mesh-list
111199035|NCT05001880|Pemetrexed|pemetrexed|mesh-list
111199036|NCT05001880|Endothelial Growth Factors|endothelial growth factors|mesh-list
111199037|NCT05001880|Antibodies|antibodies|mesh-list
111199038|NCT05001880|Immunoglobulins|immunoglobulins|mesh-list
111199039|NCT05001880|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111199040|NCT05001880|Immunoglobulin G|immunoglobulin g|mesh-list
111199041|NCT05001880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111199042|NCT05001880|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111199043|NCT05001880|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111199044|NCT05001880|Growth Substances|growth substances|mesh-ancestor
111199045|NCT05001880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111199046|NCT05001880|Growth Inhibitors|growth inhibitors|mesh-ancestor
111199047|NCT05001880|Immunologic Factors|immunologic factors|mesh-ancestor
111199048|NCT05001880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111199049|NCT05001880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111199050|NCT05001880|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111199051|NCT05001880|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111199052|NCT05001880|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111199053|NCT04998851|Ocrelizumab|ocrelizumab|mesh-list
111199054|NCT04998851|Immunologic Factors|immunologic factors|mesh-ancestor
111199055|NCT04998851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111199056|NCT04994808|Fludarabine|fludarabine|mesh-list
111199057|NCT04994808|Clofarabine|clofarabine|mesh-list
111199058|NCT04994808|Treosulfan|treosulfan|mesh-list
111199059|NCT04994808|Busulfan|busulfan|mesh-list
111199060|NCT04994808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111199061|NCT04994808|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111199062|NCT04994808|Antimetabolites|antimetabolites|mesh-ancestor
111199063|NCT04994808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111199064|NCT04994808|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111199065|NCT04994808|Immunologic Factors|immunologic factors|mesh-ancestor
111199066|NCT04994808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111199067|NCT04994808|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111199068|NCT04994808|Alkylating Agents|alkylating agents|mesh-ancestor
111199069|NCT04994808|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111199070|NCT04991402|Dolutegravir|dolutegravir|mesh-list
111199071|NCT04991402|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
111199072|NCT04991402|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111199073|NCT04991402|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111199074|NCT04991402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111199075|NCT04991402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111199076|NCT04991402|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111199077|NCT04991402|Antiviral Agents|antiviral agents|mesh-ancestor
111199078|NCT04991402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111199079|NCT04981509|Listerine|listerine|mesh-list
111199080|NCT04981509|Bevacizumab|bevacizumab|mesh-list
111199081|NCT04981509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111199082|NCT04981509|Atezolizumab|atezolizumab|mesh-list
111199083|NCT04981509|Endothelial Growth Factors|endothelial growth factors|mesh-list
111199084|NCT04981509|Antibodies|antibodies|mesh-list
111199085|NCT04981509|Immunoglobulins|immunoglobulins|mesh-list
111199086|NCT04981509|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111199087|NCT04981509|Immunoglobulin G|immunoglobulin g|mesh-list
111199088|NCT04981509|Fluorides|fluorides|mesh-list
111199089|NCT04981509|Sodium Fluoride|sodium fluoride|mesh-list
111199090|NCT04981509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111199091|NCT04981509|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111199092|NCT04981509|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111199094|NCT04981509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111199095|NCT04981509|Growth Inhibitors|growth inhibitors|mesh-ancestor
111199096|NCT04981509|Immunologic Factors|immunologic factors|mesh-ancestor
111199097|NCT04981509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111199098|NCT04981509|Cariostatic Agents|cariostatic agents|mesh-ancestor
111199099|NCT04981509|Protective Agents|protective agents|mesh-ancestor
111199100|NCT04981509|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111199101|NCT04981509|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111199102|NCT04981509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111199103|NCT04974528|Insulin|insulin|mesh-list
111199104|NCT04974528|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111199105|NCT04974528|Insulin Glargine|insulin glargine|mesh-list
111199106|NCT04974528|Insulin Aspart|insulin aspart|mesh-list
111199107|NCT04974528|Insulin Lispro|insulin lispro|mesh-list
111199108|NCT04974528|Insulin Detemir|insulin detemir|mesh-list
111199109|NCT04974528|Insulin glulisine|insulin glulisine|mesh-list
111199110|NCT04974528|Insulin, Short-Acting|insulin, short-acting|mesh-list
111199111|NCT04974528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111199112|NCT04974528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111199113|NCT04973605|Dexamethasone|dexamethasone|mesh-list
111199114|NCT04973605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111199115|NCT04973605|Antiemetics|antiemetics|mesh-ancestor
111199116|NCT04973605|Autonomic Agents|autonomic agents|mesh-ancestor
111199117|NCT04973605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111199118|NCT04973605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111199119|NCT04973605|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111199120|NCT04973605|Glucocorticoids|glucocorticoids|mesh-ancestor
111199121|NCT04973605|Hormones|hormones|mesh-ancestor
111199122|NCT04973605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111199123|NCT04973605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111199124|NCT04973605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111199125|NCT04972123|Phenylephrine|phenylephrine|mesh-list
111199126|NCT04972123|Oxymetazoline|oxymetazoline|mesh-list
111199127|NCT04972123|Caffeine|caffeine|mesh-list
111199128|NCT04972123|Capsaicin|capsaicin|mesh-list
111199129|NCT04972123|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111199130|NCT04972123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111199131|NCT04972123|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111199132|NCT04972123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111199133|NCT04972123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111199134|NCT04972123|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
111199135|NCT04972123|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111199136|NCT04972123|Purinergic Agents|purinergic agents|mesh-ancestor
111199137|NCT04972123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111199138|NCT04972123|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111199139|NCT04972123|Mydriatics|mydriatics|mesh-ancestor
111199140|NCT04972123|Autonomic Agents|autonomic agents|mesh-ancestor
111199141|NCT04972123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111199142|NCT04972123|Sympathomimetics|sympathomimetics|mesh-ancestor
111199143|NCT04972123|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111199144|NCT04972123|Nasal Decongestants|nasal decongestants|mesh-ancestor
111199145|NCT04972123|Respiratory System Agents|respiratory system agents|mesh-ancestor
111199146|NCT04972123|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111199147|NCT04972123|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111199148|NCT04972123|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111199149|NCT04972123|Adrenergic Agents|adrenergic agents|mesh-ancestor
111199150|NCT04972123|Protective Agents|protective agents|mesh-ancestor
111199151|NCT04972123|Antipruritics|antipruritics|mesh-ancestor
111199152|NCT04972123|Dermatologic Agents|dermatologic agents|mesh-ancestor
111199153|NCT04972123|Sensory System Agents|sensory system agents|mesh-ancestor
111199154|NCT04954781|Tislelizumab|tislelizumab|mesh-list
111199155|NCT04954781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111199156|NCT04954781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111199157|NCT04949256|Calcium, Dietary|calcium, dietary|mesh-list
111199158|NCT04949256|Leucovorin|leucovorin|mesh-list
111199159|NCT04949256|Paclitaxel|paclitaxel|mesh-list
111199160|NCT04949256|Pembrolizumab|pembrolizumab|mesh-list
111199161|NCT04949256|Oxaliplatin|oxaliplatin|mesh-list
111199162|NCT04949256|Lenvatinib|lenvatinib|mesh-list
111199163|NCT04949256|Calcium|calcium|mesh-list
111199164|NCT04949256|Levoleucovorin|levoleucovorin|mesh-list
111199165|NCT04949256|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111199166|NCT04949256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111199167|NCT04949256|Tubulin Modulators|tubulin modulators|mesh-ancestor
111199168|NCT04949256|Antimitotic Agents|antimitotic agents|mesh-ancestor
111199169|NCT04949256|Mitosis Modulators|mitosis modulators|mesh-ancestor
111199170|NCT04949256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111199171|NCT04949256|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111199172|NCT04949256|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110845969|NCT03250182|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111199173|NCT04949256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111199174|NCT04949256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111199175|NCT04949256|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111199176|NCT04949256|Antidotes|antidotes|mesh-ancestor
111199177|NCT04949256|Protective Agents|protective agents|mesh-ancestor
111199178|NCT04949256|Vitamin B Complex|vitamin b complex|mesh-ancestor
111199179|NCT04949256|Vitamins|vitamins|mesh-ancestor
111199180|NCT04949256|Micronutrients|micronutrients|mesh-ancestor
111199181|NCT04949256|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111199182|NCT04949256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111199183|NCT04949191|Pembrolizumab|pembrolizumab|mesh-list
111199184|NCT04949191|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111199185|NCT04949191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111199186|NCT04949191|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111199187|NCT04949191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111199188|NCT04936685|Vaccines|vaccines|mesh-list
111199189|NCT04936685|Immunologic Factors|immunologic factors|mesh-ancestor
111199190|NCT04936685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111199191|NCT04936230|Atezolizumab|atezolizumab|mesh-list
111199192|NCT04936230|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111199193|NCT04936230|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111199194|NCT04936230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111199195|NCT04936230|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111199196|NCT04936230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111199197|NCT04936230|Immunologic Factors|immunologic factors|mesh-ancestor
111199198|NCT04936230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111199199|NCT04935177|Antibodies|antibodies|mesh-list
111199200|NCT04935177|Immunoglobulins|immunoglobulins|mesh-list
111199201|NCT04935177|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111199202|NCT04935177|gamma-Globulins|gamma-globulins|mesh-list
111199203|NCT04935177|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
111199204|NCT04935177|Eculizumab|eculizumab|mesh-list
111199205|NCT04935177|Immunologic Factors|immunologic factors|mesh-ancestor
111199206|NCT04935177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111199207|NCT04935177|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
111199208|NCT04935177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111199209|NCT04933539|Dexamethasone|dexamethasone|mesh-list
111199210|NCT04933539|Daratumumab|daratumumab|mesh-list
111199211|NCT04933539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111199212|NCT04933539|Antiemetics|antiemetics|mesh-ancestor
111199213|NCT04933539|Autonomic Agents|autonomic agents|mesh-ancestor
111199214|NCT04933539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111199215|NCT04933539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111199216|NCT04933539|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111199217|NCT04933539|Glucocorticoids|glucocorticoids|mesh-ancestor
111199218|NCT04933539|Hormones|hormones|mesh-ancestor
111199219|NCT04933539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111199220|NCT04933539|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111199221|NCT04933539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111199222|NCT04932135|Hormones|hormones|mesh-list
111199223|NCT04932135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111199224|NCT04932135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111199225|NCT04929041|Paclitaxel|paclitaxel|mesh-list
111199226|NCT04929041|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111199227|NCT04929041|Carboplatin|carboplatin|mesh-list
111199228|NCT04929041|Pembrolizumab|pembrolizumab|mesh-list
111199229|NCT04929041|Nivolumab|nivolumab|mesh-list
111199230|NCT04929041|Pemetrexed|pemetrexed|mesh-list
111199231|NCT04929041|Ipilimumab|ipilimumab|mesh-list
111199232|NCT04929041|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111199233|NCT04929041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111199234|NCT04929041|Tubulin Modulators|tubulin modulators|mesh-ancestor
111199235|NCT04929041|Antimitotic Agents|antimitotic agents|mesh-ancestor
111199236|NCT04929041|Mitosis Modulators|mitosis modulators|mesh-ancestor
111199237|NCT04929041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111199238|NCT04929041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111199239|NCT04929041|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111199240|NCT04929041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111199241|NCT04929041|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111199242|NCT04929041|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110916256|NCT04450498|Vaccines|vaccines|mesh-list
111199243|NCT04925284|Bevacizumab|bevacizumab|mesh-list
111199244|NCT04925284|Nivolumab|nivolumab|mesh-list
111199245|NCT04925284|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111199246|NCT04925284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111199247|NCT04925284|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111199248|NCT04925284|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111199249|NCT04925284|Growth Substances|growth substances|mesh-ancestor
111199250|NCT04925284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111199251|NCT04925284|Growth Inhibitors|growth inhibitors|mesh-ancestor
111199252|NCT04925284|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111199253|NCT04925284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111199254|NCT04924660|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
111199255|NCT04924660|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111199256|NCT04924660|Vasodilator Agents|vasodilator agents|mesh-ancestor
111199257|NCT04921371|Listerine|listerine|mesh-list
111199258|NCT04921371|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111199259|NCT04921371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111199260|NCT04915183|Atorvastatin|atorvastatin|mesh-list
111199261|NCT04915183|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111199262|NCT04915183|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111199263|NCT04915183|Antimetabolites|antimetabolites|mesh-ancestor
111199264|NCT04915183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111199265|NCT04915183|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111199266|NCT04915183|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111199267|NCT04915183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111199268|NCT04907721|Glucagon|glucagon|mesh-list
111199269|NCT04907721|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
111199270|NCT04907721|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111199271|NCT04907721|Hormones|hormones|mesh-ancestor
111199272|NCT04907721|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111199273|NCT04907721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111199274|NCT04907721|Incretins|incretins|mesh-ancestor
111199275|NCT04906395|Tamoxifen|tamoxifen|mesh-list
111199276|NCT04906395|Letrozole|letrozole|mesh-list
111199277|NCT04906395|Anastrozole|anastrozole|mesh-list
111199278|NCT04906395|Exemestane|exemestane|mesh-list
111199279|NCT04906395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111199280|NCT04906395|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111199281|NCT04906395|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111199282|NCT04906395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111199283|NCT04906395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111199284|NCT04906395|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111199285|NCT04906395|Hormone Antagonists|hormone antagonists|mesh-ancestor
111199286|NCT04906395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111199287|NCT04906395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111199288|NCT04906395|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111199289|NCT04906395|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111199290|NCT04906395|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111199291|NCT04906395|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111199292|NCT04902703|Molgramostim|molgramostim|mesh-list
111199293|NCT04902703|Sargramostim|sargramostim|mesh-list
111199294|NCT04902703|Immunologic Factors|immunologic factors|mesh-ancestor
111199295|NCT04902703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111199296|NCT04902703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111199297|NCT04898894|Cytarabine|cytarabine|mesh-list
111199298|NCT04898894|Hydrocortisone|hydrocortisone|mesh-list
111199299|NCT04898894|Methotrexate|methotrexate|mesh-list
111199300|NCT04898894|Fludarabine phosphate|fludarabine phosphate|mesh-list
111199301|NCT04898894|Fludarabine|fludarabine|mesh-list
111199302|NCT04898894|Venetoclax|venetoclax|mesh-list
111199303|NCT04898894|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111199304|NCT04898894|Abortifacient Agents|abortifacient agents|mesh-ancestor
111199305|NCT04898894|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111199306|NCT04898894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111199307|NCT04898894|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111199308|NCT04898894|Antimetabolites|antimetabolites|mesh-ancestor
111199309|NCT04898894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111199310|NCT04898894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111199311|NCT04898894|Dermatologic Agents|dermatologic agents|mesh-ancestor
111199312|NCT04898894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111199313|NCT04898894|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110845977|NCT01173263|Anesthetics|anesthetics|mesh-ancestor
111199315|NCT04898894|Immunologic Factors|immunologic factors|mesh-ancestor
111199316|NCT04898894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111199317|NCT04898894|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111199318|NCT04898894|Antiviral Agents|antiviral agents|mesh-ancestor
110916326|NCT02090322|Bevacizumab|bevacizumab|mesh-list
110491823|NCT01001429|Anesthetics, General|anesthetics, general|mesh-ancestor
111199319|NCT04898894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111199320|NCT04898894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111199322|NCT04893096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111199323|NCT04893096|Immunologic Factors|immunologic factors|mesh-ancestor
111199324|NCT04893096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111199325|NCT04892875|Cisplatin|cisplatin|mesh-list
111199326|NCT04892875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111199327|NCT04890093|Vincristine|vincristine|mesh-list
111199328|NCT04890093|Temozolomide|temozolomide|mesh-list
111199329|NCT04890093|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111199330|NCT04890093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111199331|NCT04890093|Tubulin Modulators|tubulin modulators|mesh-ancestor
111199332|NCT04890093|Antimitotic Agents|antimitotic agents|mesh-ancestor
111199333|NCT04890093|Mitosis Modulators|mitosis modulators|mesh-ancestor
111199334|NCT04890093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111199335|NCT04890093|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111199336|NCT04890093|Alkylating Agents|alkylating agents|mesh-ancestor
111199337|NCT04888741|Cyclosporine|cyclosporine|mesh-list
111199338|NCT04888741|Sirolimus|sirolimus|mesh-list
111199339|NCT04888741|Mycophenolic Acid|mycophenolic acid|mesh-list
111199340|NCT04888741|Cyclophosphamide|cyclophosphamide|mesh-list
111199341|NCT04888741|Cyclosporins|cyclosporins|mesh-list
111199342|NCT04888741|Thymoglobulin|thymoglobulin|mesh-list
111199343|NCT04888741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111199344|NCT04888741|Immunologic Factors|immunologic factors|mesh-ancestor
111199345|NCT04888741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111199346|NCT04888741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111199347|NCT04888741|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111199348|NCT04888741|Alkylating Agents|alkylating agents|mesh-ancestor
111199349|NCT04888741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111199350|NCT04888741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111199351|NCT04888741|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111199352|NCT04888741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111199353|NCT04888741|Antifungal Agents|antifungal agents|mesh-ancestor
111199354|NCT04888741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111199355|NCT04888741|Dermatologic Agents|dermatologic agents|mesh-ancestor
111199356|NCT04888741|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111199357|NCT04888741|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111199358|NCT04888741|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111199359|NCT04888741|Antitubercular Agents|antitubercular agents|mesh-ancestor
111199360|NCT04888741|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111199361|NCT04875975|Rozanolixizumab|rozanolixizumab|mesh-list
111199362|NCT04875975|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111199363|NCT04875975|Immunologic Factors|immunologic factors|mesh-ancestor
111199364|NCT04875975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111199365|NCT04870112|Carboplatin|carboplatin|mesh-list
111199366|NCT04870112|Etoposide|etoposide|mesh-list
111199367|NCT04870112|Durvalumab|durvalumab|mesh-list
111199368|NCT04870112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111199369|NCT04870112|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111199370|NCT04870112|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111199371|NCT04870112|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111199372|NCT04870112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111199373|NCT04870112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111199374|NCT04870112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111199375|NCT04869358|Ofatumumab|ofatumumab|mesh-list
111199376|NCT04869358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111199377|NCT04860960|Betadex|betadex|mesh-list
111199378|NCT04860960|Sequestering Agents|sequestering agents|mesh-ancestor
111199379|NCT04860960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111199380|NCT04847063|Sodium thiosulfate|sodium thiosulfate|mesh-list
111199381|NCT04847063|Doxorubicin|doxorubicin|mesh-list
111199382|NCT04847063|Fluorouracil|fluorouracil|mesh-list
111199383|NCT04847063|Oxaliplatin|oxaliplatin|mesh-list
111199384|NCT04847063|Mitomycins|mitomycins|mesh-list
111199385|NCT04847063|Mitomycin|mitomycin|mesh-list
111199386|NCT04847063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111199387|NCT04847063|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111199388|NCT04847063|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111199389|NCT04847063|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111199390|NCT04847063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111199391|NCT04847063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111199392|NCT04847063|Antimetabolites|antimetabolites|mesh-ancestor
111199393|NCT04847063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111199394|NCT04847063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111199395|NCT04847063|Immunologic Factors|immunologic factors|mesh-ancestor
111199396|NCT04847063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111199397|NCT04847063|Alkylating Agents|alkylating agents|mesh-ancestor
111199398|NCT04847063|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111199399|NCT04847063|Antidotes|antidotes|mesh-ancestor
111199400|NCT04847063|Protective Agents|protective agents|mesh-ancestor
111199401|NCT04847063|Antioxidants|antioxidants|mesh-ancestor
111199402|NCT04847063|Antitubercular Agents|antitubercular agents|mesh-ancestor
111199403|NCT04847063|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111199404|NCT04847063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111199405|NCT04847063|Chelating Agents|chelating agents|mesh-ancestor
111199406|NCT04847063|Sequestering Agents|sequestering agents|mesh-ancestor
111199408|NCT04840602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111199409|NCT04840602|Venetoclax|venetoclax|mesh-list
111199410|NCT04840602|Antibodies|antibodies|mesh-list
111199411|NCT04840602|Immunoglobulins|immunoglobulins|mesh-list
111199412|NCT04840602|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111199413|NCT04840602|Immunologic Factors|immunologic factors|mesh-ancestor
111199414|NCT04840602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111199415|NCT04840602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111199416|NCT04840602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111199417|NCT04840589|Nivolumab|nivolumab|mesh-list
111199418|NCT04840589|Ipilimumab|ipilimumab|mesh-list
111199419|NCT04840589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111199420|NCT04840589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111199421|NCT04840589|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111199422|NCT04840589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111199423|NCT04826341|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
111199424|NCT04826341|Immunoconjugates|immunoconjugates|mesh-ancestor
111199425|NCT04826341|Immunologic Factors|immunologic factors|mesh-ancestor
111199426|NCT04826341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111199427|NCT04825223|Vaccines|vaccines|mesh-list
111199428|NCT04825223|Immunologic Factors|immunologic factors|mesh-ancestor
111199429|NCT04825223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111199430|NCT04822649|Adenosine|adenosine|mesh-list
111199431|NCT04822649|Analgesics|analgesics|mesh-ancestor
111199432|NCT04822649|Sensory System Agents|sensory system agents|mesh-ancestor
111199433|NCT04822649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111199434|NCT04822649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111199435|NCT04822649|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111199436|NCT04822649|Vasodilator Agents|vasodilator agents|mesh-ancestor
111199437|NCT04822649|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
111199438|NCT04822649|Purinergic Agonists|purinergic agonists|mesh-ancestor
111199439|NCT04822649|Purinergic Agents|purinergic agents|mesh-ancestor
111199440|NCT04822649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111199441|NCT04822649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111199442|NCT04821089|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111199443|NCT04821089|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111199444|NCT04821089|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111199445|NCT04821089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111199446|NCT04821089|Cholinergic Agents|cholinergic agents|mesh-ancestor
111199447|NCT04821089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111199448|NCT04821089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111199449|NCT04799275|Prednisone|prednisone|mesh-list
111199450|NCT04799275|Cortisone|cortisone|mesh-list
111199451|NCT04799275|Cyclophosphamide|cyclophosphamide|mesh-list
111199452|NCT04799275|Rituximab|rituximab|mesh-list
111199453|NCT04799275|Doxorubicin|doxorubicin|mesh-list
111199454|NCT04799275|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111199455|NCT04799275|Vincristine|vincristine|mesh-list
111199456|NCT04799275|Azacitidine|azacitidine|mesh-list
111199457|NCT04799275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111199459|NCT04799275|Immunoglobulins|immunoglobulins|mesh-list
111199460|NCT04799275|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111199461|NCT04799275|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111199462|NCT04799275|Immunologic Factors|immunologic factors|mesh-ancestor
111199463|NCT04799275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111199464|NCT04799275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111199465|NCT04799275|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111199466|NCT04799275|Alkylating Agents|alkylating agents|mesh-ancestor
111199467|NCT04799275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111199468|NCT04799275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111199469|NCT04799275|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111199470|NCT04799275|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111199471|NCT04799275|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111199472|NCT04799275|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111199473|NCT04799275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111199474|NCT04799275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111199476|NCT04799275|Hormones|hormones|mesh-ancestor
111199477|NCT04799275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111199478|NCT04799275|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111199479|NCT04799275|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111199480|NCT04799275|Tubulin Modulators|tubulin modulators|mesh-ancestor
111199481|NCT04799275|Antimitotic Agents|antimitotic agents|mesh-ancestor
111199482|NCT04799275|Mitosis Modulators|mitosis modulators|mesh-ancestor
111199483|NCT04799275|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111199484|NCT04799275|Antimetabolites|antimetabolites|mesh-ancestor
111199485|NCT04786548|Celecoxib|celecoxib|mesh-list
111199486|NCT04786548|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111199487|NCT04786548|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111199488|NCT04786548|Analgesics|analgesics|mesh-ancestor
111199489|NCT04786548|Sensory System Agents|sensory system agents|mesh-ancestor
111199490|NCT04786548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111199491|NCT04786548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111199492|NCT04786548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111199493|NCT04786548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111199494|NCT04786548|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111199495|NCT04786548|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111199496|NCT04786548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111199497|NCT04786548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111199498|NCT04775953|Vancomycin|vancomycin|mesh-list
111199499|NCT04775953|Cefazolin|cefazolin|mesh-list
111199500|NCT04775953|Daptomycin|daptomycin|mesh-list
111199501|NCT04775953|Dalbavancin|dalbavancin|mesh-list
111199502|NCT04775953|Oxacillin|oxacillin|mesh-list
111199503|NCT04775953|Nafcillin|nafcillin|mesh-list
111199504|NCT04775953|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111199505|NCT04775953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111199506|NCT04771130|Posaconazole|posaconazole|mesh-list
111199507|NCT04771130|Azacitidine|azacitidine|mesh-list
111199508|NCT04771130|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111199509|NCT04771130|Antimetabolites|antimetabolites|mesh-ancestor
111199510|NCT04771130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111199511|NCT04771130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111199512|NCT04771130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111199513|NCT04771130|Antifungal Agents|antifungal agents|mesh-ancestor
111199514|NCT04771130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111199515|NCT04771130|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
111199516|NCT04771130|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111199517|NCT04771130|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111199518|NCT04771130|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111199519|NCT04771130|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111199520|NCT04771130|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111199521|NCT04771130|Hormone Antagonists|hormone antagonists|mesh-ancestor
111199522|NCT04771130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111199523|NCT04771130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111199524|NCT04759586|Prednisone|prednisone|mesh-list
111199525|NCT04759586|Prednisolone|prednisolone|mesh-list
111199526|NCT04759586|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111199527|NCT04759586|Methylprednisolone|methylprednisolone|mesh-list
111199528|NCT04759586|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111199529|NCT04759586|Prednisolone acetate|prednisolone acetate|mesh-list
111199530|NCT04759586|Hydrocortisone|hydrocortisone|mesh-list
111199531|NCT04759586|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
111199532|NCT04759586|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
111199533|NCT04759586|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
111199534|NCT04759586|Cortisone|cortisone|mesh-list
111199535|NCT04759586|Cyclophosphamide|cyclophosphamide|mesh-list
111199536|NCT04759586|Rituximab|rituximab|mesh-list
111199537|NCT04759586|Doxorubicin|doxorubicin|mesh-list
111199538|NCT04759586|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111199539|NCT04759586|Nivolumab|nivolumab|mesh-list
111199540|NCT04759586|Etoposide|etoposide|mesh-list
111199541|NCT04759586|Vincristine|vincristine|mesh-list
111199542|NCT04759586|Etoposide phosphate|etoposide phosphate|mesh-list
111199543|NCT04759586|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111199544|NCT04759586|Antibodies|antibodies|mesh-list
111199545|NCT04759586|Immunoglobulins|immunoglobulins|mesh-list
111199546|NCT04759586|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111199547|NCT04759586|Lenograstim|lenograstim|mesh-list
111199548|NCT04759586|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111199549|NCT04759586|Prednisolone phosphate|prednisolone phosphate|mesh-list
111199550|NCT04759586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111199552|NCT04759586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111199553|NCT04759586|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111199554|NCT04759586|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111199555|NCT04759586|Alkylating Agents|alkylating agents|mesh-ancestor
111199556|NCT04759586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111199557|NCT04759586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111199558|NCT04759586|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111199559|NCT04759586|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111199560|NCT04759586|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111199561|NCT04759586|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111199562|NCT04759586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111199563|NCT04759586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111199564|NCT04759586|Glucocorticoids|glucocorticoids|mesh-ancestor
111199565|NCT04759586|Hormones|hormones|mesh-ancestor
111199566|NCT04759586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111199567|NCT04759586|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111199568|NCT04759586|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111199569|NCT04759586|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111199570|NCT04759586|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111199571|NCT04759586|Tubulin Modulators|tubulin modulators|mesh-ancestor
111199572|NCT04759586|Antimitotic Agents|antimitotic agents|mesh-ancestor
111199573|NCT04759586|Mitosis Modulators|mitosis modulators|mesh-ancestor
111199574|NCT04759586|Antiemetics|antiemetics|mesh-ancestor
111199575|NCT04759586|Autonomic Agents|autonomic agents|mesh-ancestor
111199576|NCT04759586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111199577|NCT04759586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111199578|NCT04759586|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111199579|NCT04759586|Protective Agents|protective agents|mesh-ancestor
111199580|NCT04753372|Aspirin|aspirin|mesh-list
111199581|NCT04753372|Rivaroxaban|rivaroxaban|mesh-list
111199582|NCT04753372|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111199583|NCT04753372|Antithrombins|antithrombins|mesh-ancestor
111199584|NCT04753372|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111199585|NCT04753372|Protease Inhibitors|protease inhibitors|mesh-ancestor
111199586|NCT04753372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111199587|NCT04753372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111199588|NCT04753372|Anticoagulants|anticoagulants|mesh-ancestor
111199589|NCT04753372|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111199590|NCT04753372|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111199591|NCT04753372|Analgesics|analgesics|mesh-ancestor
111199592|NCT04753372|Sensory System Agents|sensory system agents|mesh-ancestor
111199593|NCT04753372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111199594|NCT04753372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111199595|NCT04753372|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111199596|NCT04753372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111199597|NCT04753372|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111199598|NCT04753372|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111199599|NCT04753372|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111199600|NCT04753372|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111199601|NCT04753372|Antipyretics|antipyretics|mesh-ancestor
111199602|NCT04752774|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111199603|NCT04752774|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111199604|NCT04752774|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111199605|NCT04752774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111199606|NCT04752774|Cholinergic Agents|cholinergic agents|mesh-ancestor
111199607|NCT04752774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111199608|NCT04752774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111199609|NCT04748042|Prednisone|prednisone|mesh-list
111199610|NCT04748042|Olaparib|olaparib|mesh-list
111199611|NCT04748042|Androgens|androgens|mesh-list
111199612|NCT04748042|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111199613|NCT04748042|Glucocorticoids|glucocorticoids|mesh-ancestor
111199614|NCT04748042|Hormones|hormones|mesh-ancestor
111199615|NCT04748042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111199616|NCT04748042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111199617|NCT04748042|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111199618|NCT04748042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111199619|NCT04748042|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111199620|NCT04748042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111199621|NCT04748042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111199622|NCT04736706|Pembrolizumab|pembrolizumab|mesh-list
111199623|NCT04736706|Lenvatinib|lenvatinib|mesh-list
111199624|NCT04736706|Belzutifan|belzutifan|mesh-list
111199625|NCT04736706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111199626|NCT04736706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111199627|NCT04736706|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111199628|NCT04736706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111199629|NCT04736706|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111199630|NCT04736706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111199631|NCT04733040|Felzartamab|felzartamab|mesh-list
111199632|NCT04733040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111199633|NCT04733040|Immunologic Factors|immunologic factors|mesh-ancestor
111199634|NCT04733040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111199635|NCT04730609|Dexmedetomidine|dexmedetomidine|mesh-list
111199636|NCT04730609|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111199637|NCT04730609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111199638|NCT04730609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111199639|NCT04730609|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111199640|NCT04730609|Analgesics|analgesics|mesh-ancestor
111199641|NCT04730609|Sensory System Agents|sensory system agents|mesh-ancestor
111199642|NCT04730609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111199643|NCT04730609|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111199644|NCT04730609|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111199645|NCT04730609|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111199646|NCT04730609|Adrenergic Agents|adrenergic agents|mesh-ancestor
111199647|NCT04730609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111199648|NCT04730609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111199649|NCT04722887|Protease Inhibitors|protease inhibitors|mesh-list
111199650|NCT04722887|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
111199651|NCT04722887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111199652|NCT04722887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111199653|NCT04722887|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
111199654|NCT04722887|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111199655|NCT04713176|Remdesivir|remdesivir|mesh-list
111199656|NCT04713176|Antimetabolites|antimetabolites|mesh-ancestor
111199657|NCT04713176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111199658|NCT04713176|Antiviral Agents|antiviral agents|mesh-ancestor
111199659|NCT04713176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111199660|NCT04713098|Coal Tar|coal tar|mesh-list
110491860|NCT00750529|Galantamine|galantamine|mesh-list
111199661|NCT04713098|Keratolytic Agents|keratolytic agents|mesh-ancestor
111199662|NCT04713098|Dermatologic Agents|dermatologic agents|mesh-ancestor
111199663|NCT04710030|Valacyclovir|valacyclovir|mesh-list
111199664|NCT04710030|Antiviral Agents|antiviral agents|mesh-ancestor
111199665|NCT04710030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111199666|NCT04708418|Pembrolizumab|pembrolizumab|mesh-list
111199667|NCT04708418|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111199668|NCT04708418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111199669|NCT04708418|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110846007|NCT03866447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111199670|NCT04708418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111199672|NCT04704661|Camptothecin|camptothecin|mesh-list
111199673|NCT04704661|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
111199674|NCT04704661|Immunoconjugates|immunoconjugates|mesh-list
111199675|NCT04704661|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111199676|NCT04704661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111199677|NCT04704661|Immunologic Factors|immunologic factors|mesh-ancestor
111199678|NCT04704661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111199679|NCT04704661|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111199680|NCT04704661|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111199681|NCT04704661|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111199682|NCT04704661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111199683|NCT04704661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111199684|NCT04704154|Nivolumab|nivolumab|mesh-list
111199685|NCT04704154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111199686|NCT04704154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111199687|NCT04704154|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111199688|NCT04704154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111199689|NCT04703621|Daratumumab|daratumumab|mesh-list
111199690|NCT04703621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111199691|NCT04696146|Complement C1s|complement c1s|mesh-list
111199692|NCT04696146|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
111199693|NCT04696146|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
111199694|NCT04696146|Immunologic Factors|immunologic factors|mesh-ancestor
111199695|NCT04696146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111199696|NCT04696146|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
111199697|NCT04696146|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111199698|NCT04669665|Ketamine|ketamine|mesh-list
111199699|NCT04669665|Analgesics|analgesics|mesh-ancestor
111199700|NCT04669665|Sensory System Agents|sensory system agents|mesh-ancestor
111199701|NCT04669665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111199702|NCT04669665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111199703|NCT04669665|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111199704|NCT04669665|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111199705|NCT04669665|Anesthetics, General|anesthetics, general|mesh-ancestor
111199706|NCT04669665|Anesthetics|anesthetics|mesh-ancestor
111199707|NCT04669665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111199708|NCT04669665|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111199709|NCT04669665|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111199710|NCT04669665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111199711|NCT04669665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111199712|NCT04665856|Carboplatin|carboplatin|mesh-list
111199713|NCT04665856|Etoposide|etoposide|mesh-list
111199714|NCT04665856|Atezolizumab|atezolizumab|mesh-list
111199715|NCT04665856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111199716|NCT04665856|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111199717|NCT04665856|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111199718|NCT04665856|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111199719|NCT04665856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111199720|NCT04665856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111199721|NCT04665856|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111199722|NCT04665856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111199723|NCT04665739|Everolimus|everolimus|mesh-list
111199724|NCT04665739|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
111199725|NCT04665739|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110311691|NCT00290108|Anesthetics|anesthetics|mesh-ancestor
111199726|NCT04665739|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111199727|NCT04665739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111199728|NCT04665739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111199729|NCT04665739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111199730|NCT04665739|Immunologic Factors|immunologic factors|mesh-ancestor
111199731|NCT04665739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111199732|NCT04665739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111199733|NCT04665739|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111199734|NCT04661007|Lenalidomide|lenalidomide|mesh-list
111199735|NCT04661007|Immunologic Factors|immunologic factors|mesh-ancestor
111199736|NCT04661007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111199737|NCT04661007|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111199738|NCT04661007|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111199739|NCT04661007|Growth Substances|growth substances|mesh-ancestor
111199740|NCT04661007|Growth Inhibitors|growth inhibitors|mesh-ancestor
111199741|NCT04661007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111199743|NCT04633252|Docetaxel|docetaxel|mesh-list
111199744|NCT04633252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111199745|NCT04633252|Tubulin Modulators|tubulin modulators|mesh-ancestor
111199746|NCT04633252|Antimitotic Agents|antimitotic agents|mesh-ancestor
111199747|NCT04633252|Mitosis Modulators|mitosis modulators|mesh-ancestor
111199748|NCT04633252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111199749|NCT04633252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111199750|NCT04633252|Glucocorticoids|glucocorticoids|mesh-ancestor
111199751|NCT04633252|Hormones|hormones|mesh-ancestor
111199752|NCT04633252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111199753|NCT04633252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111199754|NCT04633252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111199755|NCT04628767|Cisplatin|cisplatin|mesh-list
111199756|NCT04628767|Gemcitabine|gemcitabine|mesh-list
111199757|NCT04628767|Doxorubicin|doxorubicin|mesh-list
111199758|NCT04628767|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111199759|NCT04628767|Methotrexate|methotrexate|mesh-list
111199760|NCT04628767|Durvalumab|durvalumab|mesh-list
111199761|NCT04628767|Vinblastine|vinblastine|mesh-list
111199762|NCT04628767|Lenograstim|lenograstim|mesh-list
111199763|NCT04628767|Immunoglobulins|immunoglobulins|mesh-list
111199764|NCT04628767|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111199765|NCT04628767|Immunoglobulin G|immunoglobulin g|mesh-list
111199766|NCT04628767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111199767|NCT04628767|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111199768|NCT04628767|Antimetabolites|antimetabolites|mesh-ancestor
111199769|NCT04628767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111199770|NCT04628767|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111199771|NCT04628767|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111199772|NCT04628767|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111199773|NCT04628767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111199774|NCT04628767|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111199775|NCT04628767|Abortifacient Agents|abortifacient agents|mesh-ancestor
111199776|NCT04628767|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111199777|NCT04628767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111199778|NCT04628767|Dermatologic Agents|dermatologic agents|mesh-ancestor
111199779|NCT04628767|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111199780|NCT04628767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111199781|NCT04628767|Immunologic Factors|immunologic factors|mesh-ancestor
111199782|NCT04628767|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111199783|NCT04628767|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111199784|NCT04628767|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111199785|NCT04628767|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111199786|NCT04628767|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111199787|NCT04628767|Tubulin Modulators|tubulin modulators|mesh-ancestor
111199788|NCT04628767|Antimitotic Agents|antimitotic agents|mesh-ancestor
111199789|NCT04628767|Mitosis Modulators|mitosis modulators|mesh-ancestor
111199791|NCT04622228|Etoposide|etoposide|mesh-list
111199792|NCT04622228|Atezolizumab|atezolizumab|mesh-list
111199793|NCT04622228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111199794|NCT04622228|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111199795|NCT04622228|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111199796|NCT04622228|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111199797|NCT04622228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111199798|NCT04622228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111199799|NCT04622228|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111199800|NCT04622228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111199801|NCT04616560|Trastuzumab|trastuzumab|mesh-list
111199802|NCT04616560|Camptothecin|camptothecin|mesh-list
111199803|NCT04616560|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
111199804|NCT04616560|Immunoconjugates|immunoconjugates|mesh-list
111199805|NCT04616560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111199806|NCT04616560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111199807|NCT04616560|Immunologic Factors|immunologic factors|mesh-ancestor
111199808|NCT04616560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111199809|NCT04616560|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111199810|NCT04616560|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111199811|NCT04616560|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111199812|NCT04616560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111199813|NCT04616560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111199814|NCT04613518|Deucravacitinib|deucravacitinib|mesh-list
111199815|NCT04613518|Dermatologic Agents|dermatologic agents|mesh-ancestor
111199816|NCT04613518|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111199817|NCT04613518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111199818|NCT04613518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111199819|NCT04610866|Mitapivat|mitapivat|mesh-list
111199820|NCT04610866|Enzyme Activators|enzyme activators|mesh-ancestor
111199821|NCT04610866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111199822|NCT04609046|Rituximab|rituximab|mesh-list
111199823|NCT04609046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111199824|NCT04609046|Nivolumab|nivolumab|mesh-list
111199825|NCT04609046|Methotrexate|methotrexate|mesh-list
111199826|NCT04609046|Lenalidomide|lenalidomide|mesh-list
111199827|NCT04609046|Antibodies|antibodies|mesh-list
111199828|NCT04609046|Immunoglobulins|immunoglobulins|mesh-list
111199829|NCT04609046|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111199830|NCT04609046|Immunologic Factors|immunologic factors|mesh-ancestor
111199831|NCT04609046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111199832|NCT04609046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111199833|NCT04609046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111199834|NCT04609046|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111199835|NCT04609046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111199836|NCT04609046|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111199837|NCT04609046|Abortifacient Agents|abortifacient agents|mesh-ancestor
111199838|NCT04609046|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111199839|NCT04609046|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111199840|NCT04609046|Antimetabolites|antimetabolites|mesh-ancestor
111199841|NCT04609046|Dermatologic Agents|dermatologic agents|mesh-ancestor
111199842|NCT04609046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111199843|NCT04609046|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111199844|NCT04609046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111199845|NCT04609046|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111199846|NCT04609046|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111199847|NCT04609046|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111199848|NCT04609046|Growth Substances|growth substances|mesh-ancestor
111199849|NCT04609046|Growth Inhibitors|growth inhibitors|mesh-ancestor
111199850|NCT04588233|Melatonin|melatonin|mesh-list
111199851|NCT04588233|Antioxidants|antioxidants|mesh-ancestor
111199852|NCT04588233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111199853|NCT04588233|Protective Agents|protective agents|mesh-ancestor
111199854|NCT04588233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111199855|NCT04588233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111199856|NCT04579224|Paclitaxel|paclitaxel|mesh-list
111199857|NCT04579224|Docetaxel|docetaxel|mesh-list
111199858|NCT04579224|Halichondrin B|halichondrin b|mesh-list
111199859|NCT04579224|Gemcitabine|gemcitabine|mesh-list
111199860|NCT04579224|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111199861|NCT04579224|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111199862|NCT04579224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111199863|NCT04579224|Tubulin Modulators|tubulin modulators|mesh-ancestor
111199864|NCT04579224|Antimitotic Agents|antimitotic agents|mesh-ancestor
111199865|NCT04579224|Mitosis Modulators|mitosis modulators|mesh-ancestor
111199866|NCT04579224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111199867|NCT04579224|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111199868|NCT04579224|Antimetabolites|antimetabolites|mesh-ancestor
111199869|NCT04576117|Vinblastine|vinblastine|mesh-list
111199870|NCT04576117|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111199871|NCT04576117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111199872|NCT04576117|Tubulin Modulators|tubulin modulators|mesh-ancestor
111199873|NCT04576117|Antimitotic Agents|antimitotic agents|mesh-ancestor
111199875|NCT04576117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111199876|NCT04569461|Pembrolizumab|pembrolizumab|mesh-list
111199877|NCT04569461|Androgens|androgens|mesh-list
111199878|NCT04569461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111199879|NCT04569461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111199880|NCT04569461|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111199881|NCT04569461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111199882|NCT04569461|Hormones|hormones|mesh-ancestor
111199883|NCT04569461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111199884|NCT04569461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111199885|NCT04567615|Nivolumab|nivolumab|mesh-list
111199886|NCT04567615|Relatlimab|relatlimab|mesh-list
111199887|NCT04567615|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111199888|NCT04567615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111199889|NCT04567615|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111199890|NCT04567615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111199891|NCT04566692|Immunoglobulins|immunoglobulins|mesh-list
111199892|NCT04566692|gamma-Globulins|gamma-globulins|mesh-list
111199893|NCT04566692|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111199894|NCT04566692|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
111199895|NCT04566692|Immunologic Factors|immunologic factors|mesh-ancestor
111199896|NCT04566692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111199897|NCT04563325|Ceftriaxone|ceftriaxone|mesh-list
111199898|NCT04563325|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
111199899|NCT04563325|Dicloxacillin|dicloxacillin|mesh-list
111199900|NCT04563325|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111199901|NCT04563325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111199902|NCT04563325|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
111199903|NCT04563325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111199904|NCT04563325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111199905|NCT04557956|Trametinib|trametinib|mesh-list
111199906|NCT04557956|Dabrafenib|dabrafenib|mesh-list
111199907|NCT04557956|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
111199908|NCT04557956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111199909|NCT04557956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111199910|NCT04557956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111199911|NCT04557956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111199912|NCT04557956|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
111199913|NCT04557956|Protective Agents|protective agents|mesh-ancestor
111199914|NCT04557956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111199915|NCT04557956|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111199916|NCT04557956|Antioxidants|antioxidants|mesh-ancestor
111199917|NCT04553692|Leucovorin|leucovorin|mesh-list
111199918|NCT04553692|Bevacizumab|bevacizumab|mesh-list
111199919|NCT04553692|Gemcitabine|gemcitabine|mesh-list
111199920|NCT04553692|Docetaxel|docetaxel|mesh-list
111199921|NCT04553692|Fluorouracil|fluorouracil|mesh-list
111199922|NCT04553692|Irinotecan|irinotecan|mesh-list
111199923|NCT04553692|Azacitidine|azacitidine|mesh-list
111199924|NCT04553692|Venetoclax|venetoclax|mesh-list
111199925|NCT04553692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111199926|NCT04553692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111199927|NCT04553692|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111199928|NCT04553692|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111199930|NCT04553692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111199931|NCT04553692|Growth Inhibitors|growth inhibitors|mesh-ancestor
111199932|NCT04553692|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111199933|NCT04553692|Antimetabolites|antimetabolites|mesh-ancestor
111199934|NCT04553692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111199935|NCT04553692|Tubulin Modulators|tubulin modulators|mesh-ancestor
111199936|NCT04553692|Antimitotic Agents|antimitotic agents|mesh-ancestor
111199937|NCT04553692|Mitosis Modulators|mitosis modulators|mesh-ancestor
111199938|NCT04553692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111199939|NCT04553692|Immunologic Factors|immunologic factors|mesh-ancestor
111199940|NCT04553692|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111199941|NCT04553692|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111199942|NCT04553692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111199943|NCT04553692|Antidotes|antidotes|mesh-ancestor
111199944|NCT04553692|Protective Agents|protective agents|mesh-ancestor
111199945|NCT04553692|Vitamin B Complex|vitamin b complex|mesh-ancestor
111199947|NCT04553692|Micronutrients|micronutrients|mesh-ancestor
111199948|NCT04543617|Atezolizumab|atezolizumab|mesh-list
111199949|NCT04543617|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111199950|NCT04543617|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111199951|NCT04543617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111199952|NCT04543617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111199953|NCT04543617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111199954|NCT04543617|Immunologic Factors|immunologic factors|mesh-ancestor
111199955|NCT04543617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111199956|NCT04538378|Durvalumab|durvalumab|mesh-list
111199957|NCT04538378|Olaparib|olaparib|mesh-list
111199958|NCT04538378|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111199959|NCT04538378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111199960|NCT04538378|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111199961|NCT04538378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111199962|NCT04538378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111199963|NCT04534153|Fexofenadine|fexofenadine|mesh-list
111199964|NCT04534153|Terfenadine|terfenadine|mesh-list
111199965|NCT04534153|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111199966|NCT04534153|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
111199967|NCT04534153|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111199968|NCT04534153|Histamine Antagonists|histamine antagonists|mesh-ancestor
111199969|NCT04534153|Histamine Agents|histamine agents|mesh-ancestor
111199970|NCT04534153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111199971|NCT04534153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111199972|NCT04534153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111199973|NCT04533750|Peposertib|peposertib|mesh-list
111199974|NCT04533750|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111199975|NCT04533750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111199976|NCT04533750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111199977|NCT04530565|Cytarabine|cytarabine|mesh-list
111199978|NCT04530565|Dexamethasone|dexamethasone|mesh-list
111199979|NCT04530565|Dexamethasone acetate|dexamethasone acetate|mesh-list
111199980|NCT04530565|Prednisone|prednisone|mesh-list
111199981|NCT04530565|Cortisone|cortisone|mesh-list
111199982|NCT04530565|Cyclophosphamide|cyclophosphamide|mesh-list
111199983|NCT04530565|Doxorubicin|doxorubicin|mesh-list
111199984|NCT04530565|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111199985|NCT04530565|Methotrexate|methotrexate|mesh-list
111199986|NCT04530565|Vincristine|vincristine|mesh-list
111199987|NCT04530565|Dasatinib|dasatinib|mesh-list
111199988|NCT04530565|Blinatumomab|blinatumomab|mesh-list
111199989|NCT04530565|Ponatinib|ponatinib|mesh-list
111199990|NCT04530565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111199991|NCT04530565|Muromonab-CD3|muromonab-cd3|mesh-list
111199992|NCT04530565|Antibodies|antibodies|mesh-list
111199993|NCT04530565|Immunoglobulins|immunoglobulins|mesh-list
111199994|NCT04530565|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111199995|NCT04530565|Antibodies, Bispecific|antibodies, bispecific|mesh-list
111199996|NCT04530565|BB 1101|bb 1101|mesh-list
111199997|NCT04530565|Mesna|mesna|mesh-list
111199998|NCT04530565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111199999|NCT04530565|Immunologic Factors|immunologic factors|mesh-ancestor
111200000|NCT04530565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111200001|NCT04530565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111200002|NCT04530565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111200003|NCT04530565|Alkylating Agents|alkylating agents|mesh-ancestor
111200004|NCT04530565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111200005|NCT04530565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110491904|NCT00752479|Dermatologic Agents|dermatologic agents|mesh-ancestor
111200006|NCT04530565|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111200007|NCT04530565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111200008|NCT04530565|Antiemetics|antiemetics|mesh-ancestor
111200009|NCT04530565|Autonomic Agents|autonomic agents|mesh-ancestor
111200010|NCT04530565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111200011|NCT04530565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111200012|NCT04530565|Glucocorticoids|glucocorticoids|mesh-ancestor
111200013|NCT04530565|Hormones|hormones|mesh-ancestor
111200014|NCT04530565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111200015|NCT04530565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111200016|NCT04530565|Protease Inhibitors|protease inhibitors|mesh-ancestor
111200017|NCT04530565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111200018|NCT04530565|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111200019|NCT04530565|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111200020|NCT04530565|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111200021|NCT04530565|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111200022|NCT04530565|Abortifacient Agents|abortifacient agents|mesh-ancestor
111200023|NCT04530565|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111200024|NCT04530565|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111200025|NCT04530565|Antimetabolites|antimetabolites|mesh-ancestor
111200026|NCT04530565|Dermatologic Agents|dermatologic agents|mesh-ancestor
111200027|NCT04530565|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111200028|NCT04530565|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111200029|NCT04530565|Antiviral Agents|antiviral agents|mesh-ancestor
111200030|NCT04530565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111200031|NCT04530565|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111200032|NCT04530565|Tubulin Modulators|tubulin modulators|mesh-ancestor
111200033|NCT04530565|Antimitotic Agents|antimitotic agents|mesh-ancestor
111200034|NCT04530565|Mitosis Modulators|mitosis modulators|mesh-ancestor
111200035|NCT04530565|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111200036|NCT04530565|Protective Agents|protective agents|mesh-ancestor
111200037|NCT04525014|Irinotecan|irinotecan|mesh-list
111200038|NCT04525014|Temozolomide|temozolomide|mesh-list
111200039|NCT04525014|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111200040|NCT04525014|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111200041|NCT04525014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111200042|NCT04525014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111200043|NCT04525014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111200044|NCT04525014|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111200045|NCT04525014|Alkylating Agents|alkylating agents|mesh-ancestor
111200046|NCT04524611|Ustekinumab|ustekinumab|mesh-list
111200047|NCT04524611|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111200048|NCT04524611|Dermatologic Agents|dermatologic agents|mesh-ancestor
111200049|NCT04524611|Immunologic Factors|immunologic factors|mesh-ancestor
111200050|NCT04524611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111200051|NCT04515147|Vaccines|vaccines|mesh-list
111200052|NCT04515147|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
111200053|NCT04515147|Immunologic Factors|immunologic factors|mesh-ancestor
111200054|NCT04515147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111200055|NCT04514497|Irinotecan|irinotecan|mesh-list
111200056|NCT04514497|Topotecan|topotecan|mesh-list
111200057|NCT04514497|Camptothecin|camptothecin|mesh-list
111200058|NCT04514497|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111200059|NCT04514497|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111200060|NCT04514497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111200061|NCT04514497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111200062|NCT04514497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111200063|NCT04514497|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111200064|NCT04514484|Nivolumab|nivolumab|mesh-list
111200065|NCT04514484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111200066|NCT04514484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111200067|NCT04514484|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111200068|NCT04514484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111200069|NCT04491942|Cisplatin|cisplatin|mesh-list
111200070|NCT04491942|Gemcitabine|gemcitabine|mesh-list
111200071|NCT04491942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111200072|NCT04491942|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111200073|NCT04491942|Antimetabolites|antimetabolites|mesh-ancestor
111200074|NCT04491942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111200075|NCT04491877|Vaccines|vaccines|mesh-list
111200076|NCT04491877|Immunologic Factors|immunologic factors|mesh-ancestor
111200077|NCT04491877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110917084|NCT04441424|Azithromycin|azithromycin|mesh-list
111200078|NCT04490018|Vaccines|vaccines|mesh-list
111200079|NCT04490018|Immunologic Factors|immunologic factors|mesh-ancestor
111200080|NCT04490018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111200081|NCT04471818|Ketamine|ketamine|mesh-list
111200082|NCT04471818|Analgesics|analgesics|mesh-ancestor
111200083|NCT04471818|Sensory System Agents|sensory system agents|mesh-ancestor
111200084|NCT04471818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111200085|NCT04471818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111200086|NCT04471818|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111200087|NCT04471818|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111200088|NCT04471818|Anesthetics, General|anesthetics, general|mesh-ancestor
111200089|NCT04471818|Anesthetics|anesthetics|mesh-ancestor
111200090|NCT04471818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111200091|NCT04471818|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111200092|NCT04471818|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111200093|NCT04471818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111200094|NCT04471818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111200095|NCT04468984|Navitoclax|navitoclax|mesh-list
111200096|NCT04468984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111200097|NCT04454658|Navitoclax|navitoclax|mesh-list
111200098|NCT04454658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111200099|NCT04444921|Paclitaxel|paclitaxel|mesh-list
111200100|NCT04444921|Carboplatin|carboplatin|mesh-list
111200101|NCT04444921|Nivolumab|nivolumab|mesh-list
111200102|NCT04444921|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111200103|NCT04444921|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111200104|NCT04444921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111200105|NCT04444921|Tubulin Modulators|tubulin modulators|mesh-ancestor
111200106|NCT04444921|Antimitotic Agents|antimitotic agents|mesh-ancestor
111200107|NCT04444921|Mitosis Modulators|mitosis modulators|mesh-ancestor
111200108|NCT04444921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111200109|NCT04444921|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111200110|NCT04444921|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111200111|NCT04434482|Temozolomide|temozolomide|mesh-list
111200112|NCT04434482|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111200113|NCT04434482|Alkylating Agents|alkylating agents|mesh-ancestor
111200114|NCT04434482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111200115|NCT04434482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111200116|NCT04431518|Dolutegravir, rilpivirine drug combination|dolutegravir, rilpivirine drug combination|mesh-list
111200117|NCT04431518|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111200118|NCT04431518|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111200119|NCT04431518|Antiviral Agents|antiviral agents|mesh-ancestor
111200120|NCT04431518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111200121|NCT04419909|Tisagenlecleucel|tisagenlecleucel|mesh-list
111200122|NCT04419909|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111200123|NCT04419909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111200124|NCT04418167|Dabrafenib|dabrafenib|mesh-list
111200125|NCT04418167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111200126|NCT04418167|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111200127|NCT04418167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111200128|NCT04418167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111200129|NCT04402788|Atezolizumab|atezolizumab|mesh-list
111200130|NCT04402788|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111200131|NCT04402788|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111200132|NCT04402788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111200133|NCT04402788|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111200134|NCT04402788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111200135|NCT04402788|Immunologic Factors|immunologic factors|mesh-ancestor
111200136|NCT04402788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111200137|NCT04387227|Carboplatin|carboplatin|mesh-list
111200138|NCT04387227|Pembrolizumab|pembrolizumab|mesh-list
111200139|NCT04387227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111200140|NCT04387227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111200141|NCT04387227|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111200142|NCT04387227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111200143|NCT04370795|Sirolimus|sirolimus|mesh-list
111200144|NCT04370795|Busulfan|busulfan|mesh-list
111200145|NCT04370795|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111200146|NCT04370795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111200147|NCT04370795|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111200148|NCT04370795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111200149|NCT04370795|Antifungal Agents|antifungal agents|mesh-ancestor
111200150|NCT04370795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111200151|NCT04370795|Immunologic Factors|immunologic factors|mesh-ancestor
110917160|NCT00005918|Antimetabolites|antimetabolites|mesh-ancestor
111200152|NCT04370795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110846046|NCT03732469|Narcotics|narcotics|mesh-ancestor
111200153|NCT04370795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111200154|NCT04370795|Alkylating Agents|alkylating agents|mesh-ancestor
111200155|NCT04370795|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111200156|NCT04370795|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111200158|NCT04370054|Coagulants|coagulants|mesh-ancestor
111200159|NCT04364776|Durvalumab|durvalumab|mesh-list
111200160|NCT04364776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111200161|NCT04364776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111200162|NCT04363801|Leucovorin|leucovorin|mesh-list
111200163|NCT04363801|Fluorouracil|fluorouracil|mesh-list
111200164|NCT04363801|Capecitabine|capecitabine|mesh-list
111200165|NCT04363801|Oxaliplatin|oxaliplatin|mesh-list
111200166|NCT04363801|Tislelizumab|tislelizumab|mesh-list
111200167|NCT04363801|Calcium|calcium|mesh-list
111200168|NCT04363801|Levoleucovorin|levoleucovorin|mesh-list
111200169|NCT04363801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111200170|NCT04363801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111200171|NCT04363801|Antimetabolites|antimetabolites|mesh-ancestor
111200172|NCT04363801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111200173|NCT04363801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111200174|NCT04363801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111200175|NCT04363801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111200176|NCT04363801|Immunologic Factors|immunologic factors|mesh-ancestor
111200177|NCT04363801|Antidotes|antidotes|mesh-ancestor
111200178|NCT04363801|Protective Agents|protective agents|mesh-ancestor
111200179|NCT04363801|Vitamin B Complex|vitamin b complex|mesh-ancestor
111200180|NCT04363801|Vitamins|vitamins|mesh-ancestor
111200181|NCT04363801|Micronutrients|micronutrients|mesh-ancestor
111200182|NCT04363801|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111200183|NCT04349267|Nivolumab|nivolumab|mesh-list
111200184|NCT04349267|Cetuximab|cetuximab|mesh-list
111200185|NCT04349267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111200186|NCT04349267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111200187|NCT04349267|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111200188|NCT04349267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111200189|NCT04345913|Halichondrin B|halichondrin b|mesh-list
111200190|NCT04345913|Tubulin Modulators|tubulin modulators|mesh-ancestor
111200191|NCT04345913|Antimitotic Agents|antimitotic agents|mesh-ancestor
111200192|NCT04345913|Mitosis Modulators|mitosis modulators|mesh-ancestor
111200193|NCT04345913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111200194|NCT04345913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111200195|NCT04344795|Pembrolizumab|pembrolizumab|mesh-list
111200196|NCT04344795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111200197|NCT04344795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111200198|NCT04344795|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111200199|NCT04344795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111200200|NCT04340843|Decitabine|decitabine|mesh-list
111200201|NCT04340843|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
111200202|NCT04340843|Azacitidine|azacitidine|mesh-list
111200203|NCT04340843|Belinostat|belinostat|mesh-list
111200204|NCT04340843|Guadecitabine|guadecitabine|mesh-list
111200205|NCT04340843|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111200206|NCT04340843|Antimetabolites|antimetabolites|mesh-ancestor
111200207|NCT04340843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111200208|NCT04340843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111200209|NCT04340843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111200210|NCT04340843|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111200211|NCT04339751|Vorinostat|vorinostat|mesh-list
111200212|NCT04339751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111200213|NCT04339751|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111200214|NCT04339751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111200215|NCT04339751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111200216|NCT04339738|Paclitaxel|paclitaxel|mesh-list
111200217|NCT04339738|Nivolumab|nivolumab|mesh-list
111200218|NCT04339738|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111200219|NCT04339738|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111200220|NCT04339738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111200221|NCT04339738|Tubulin Modulators|tubulin modulators|mesh-ancestor
111200222|NCT04339738|Antimitotic Agents|antimitotic agents|mesh-ancestor
111200223|NCT04339738|Mitosis Modulators|mitosis modulators|mesh-ancestor
111200224|NCT04339738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111200225|NCT04339738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111200226|NCT04339738|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110917232|NCT03878368|Sulforaphane|sulforaphane|mesh-list
111200227|NCT04338529|Cholecalciferol|cholecalciferol|mesh-list
111200228|NCT04338529|Calcium Carbonate|calcium carbonate|mesh-list
111200229|NCT04338529|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111200230|NCT04338529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111200231|NCT04338529|Vitamins|vitamins|mesh-ancestor
111200232|NCT04338529|Micronutrients|micronutrients|mesh-ancestor
111200233|NCT04338529|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111200234|NCT04338529|Antacids|antacids|mesh-ancestor
111200235|NCT04338529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111200236|NCT04338529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111200237|NCT04338269|Atezolizumab|atezolizumab|mesh-list
111200238|NCT04338269|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111200239|NCT04338269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111200240|NCT04338269|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111200241|NCT04338269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111200242|NCT04310020|Atezolizumab|atezolizumab|mesh-list
111200243|NCT04310020|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111200244|NCT04310020|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111200245|NCT04310020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111200246|NCT04310020|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111200247|NCT04310020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111200248|NCT04310020|Immunologic Factors|immunologic factors|mesh-ancestor
111200249|NCT04310020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111200250|NCT04304820|Cyclosporine|cyclosporine|mesh-list
111200251|NCT04304820|Cyclosporins|cyclosporins|mesh-list
111200252|NCT04304820|Antilymphocyte Serum|antilymphocyte serum|mesh-list
111200253|NCT04304820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111200254|NCT04304820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111200255|NCT04304820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111200256|NCT04304820|Immunologic Factors|immunologic factors|mesh-ancestor
111200257|NCT04304820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111200258|NCT04304820|Antifungal Agents|antifungal agents|mesh-ancestor
111200259|NCT04304820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111200260|NCT04304820|Dermatologic Agents|dermatologic agents|mesh-ancestor
111200261|NCT04304820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111200262|NCT04304820|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111200263|NCT04303858|Atezolizumab|atezolizumab|mesh-list
111200264|NCT04303858|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111200265|NCT04303858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111200266|NCT04303858|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111200267|NCT04303858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111200268|NCT04301076|Prednisone|prednisone|mesh-list
111200269|NCT04301076|Cortisone|cortisone|mesh-list
111200270|NCT04301076|Cyclophosphamide|cyclophosphamide|mesh-list
111200271|NCT04301076|Doxorubicin|doxorubicin|mesh-list
111200272|NCT04301076|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111200273|NCT04301076|Etoposide|etoposide|mesh-list
111200274|NCT04301076|Vincristine|vincristine|mesh-list
111200275|NCT04301076|Lenalidomide|lenalidomide|mesh-list
111200276|NCT04301076|Etoposide phosphate|etoposide phosphate|mesh-list
111200277|NCT04301076|Podophyllotoxin|podophyllotoxin|mesh-list
111200278|NCT04301076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111200279|NCT04301076|Immunologic Factors|immunologic factors|mesh-ancestor
111200280|NCT04301076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111200281|NCT04301076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111200282|NCT04301076|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111200283|NCT04301076|Alkylating Agents|alkylating agents|mesh-ancestor
111200284|NCT04301076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111200285|NCT04301076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111200286|NCT04301076|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111200287|NCT04301076|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111200288|NCT04301076|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111200289|NCT04301076|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111200290|NCT04301076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111200291|NCT04301076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111200292|NCT04301076|Glucocorticoids|glucocorticoids|mesh-ancestor
111200293|NCT04301076|Hormones|hormones|mesh-ancestor
110630463|NCT02597231|Antioxidants|antioxidants|mesh-ancestor
111200294|NCT04301076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111200295|NCT04301076|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111200296|NCT04301076|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111200297|NCT04301076|Tubulin Modulators|tubulin modulators|mesh-ancestor
111200298|NCT04301076|Antimitotic Agents|antimitotic agents|mesh-ancestor
111200299|NCT04301076|Mitosis Modulators|mitosis modulators|mesh-ancestor
111200300|NCT04301076|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111200301|NCT04301076|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111200302|NCT04301076|Growth Substances|growth substances|mesh-ancestor
111200303|NCT04301076|Growth Inhibitors|growth inhibitors|mesh-ancestor
111200304|NCT04301076|Keratolytic Agents|keratolytic agents|mesh-ancestor
111200305|NCT04301076|Dermatologic Agents|dermatologic agents|mesh-ancestor
111200306|NCT04294160|Tislelizumab|tislelizumab|mesh-list
111200307|NCT04294160|Spartalizumab|spartalizumab|mesh-list
111200308|NCT04294160|Trametinib|trametinib|mesh-list
111200309|NCT04294160|Dabrafenib|dabrafenib|mesh-list
111200310|NCT04294160|Naporafenib|naporafenib|mesh-list
111200311|NCT04294160|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111200312|NCT04294160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111200313|NCT04294160|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111200314|NCT04294160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111200315|NCT04294160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111200316|NCT04294160|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111200317|NCT04284774|Tipifarnib|tipifarnib|mesh-list
111200318|NCT04284774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111200319|NCT04282018|Tislelizumab|tislelizumab|mesh-list
111200320|NCT04282018|Zanubrutinib|zanubrutinib|mesh-list
111200321|NCT04282018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111200322|NCT04282018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111200323|NCT04282018|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111200324|NCT04282018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111200325|NCT04282018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111200326|NCT04279847|INCB057643|incb057643|mesh-list
111200327|NCT04279847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111200328|NCT04279392|Zoledronic Acid|zoledronic acid|mesh-list
111200329|NCT04279392|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111200330|NCT04279392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111200331|NCT04277637|Obinutuzumab|obinutuzumab|mesh-list
111200332|NCT04277637|Zanubrutinib|zanubrutinib|mesh-list
111200333|NCT04277637|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111200334|NCT04277637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111200335|NCT04277637|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111200336|NCT04277637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111200337|NCT04277637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111200338|NCT04270747|Aflibercept|aflibercept|mesh-list
111200339|NCT04270747|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111200340|NCT04270747|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111200341|NCT04270747|Growth Substances|growth substances|mesh-ancestor
110491943|NCT00752635|Androgen Antagonists|androgen antagonists|mesh-ancestor
111200342|NCT04270747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111200343|NCT04270747|Growth Inhibitors|growth inhibitors|mesh-ancestor
111200344|NCT04270747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111200345|NCT04270682|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
111200346|NCT04270682|Cathartics|cathartics|mesh-ancestor
111200347|NCT04270682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111200348|NCT04269902|Venetoclax|venetoclax|mesh-list
111200349|NCT04269902|Obinutuzumab|obinutuzumab|mesh-list
111200350|NCT04269902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111200351|NCT04269902|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111200352|NCT04267848|Paclitaxel|paclitaxel|mesh-list
111200353|NCT04267848|Cisplatin|cisplatin|mesh-list
111200354|NCT04267848|Carboplatin|carboplatin|mesh-list
111200355|NCT04267848|Gemcitabine|gemcitabine|mesh-list
111200356|NCT04267848|Pembrolizumab|pembrolizumab|mesh-list
111200357|NCT04267848|Pemetrexed|pemetrexed|mesh-list
111200358|NCT04267848|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111200359|NCT04267848|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111200360|NCT04267848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111200361|NCT04267848|Tubulin Modulators|tubulin modulators|mesh-ancestor
111200362|NCT04267848|Antimitotic Agents|antimitotic agents|mesh-ancestor
111200363|NCT04267848|Mitosis Modulators|mitosis modulators|mesh-ancestor
111200364|NCT04267848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111200365|NCT04267848|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111200366|NCT04267848|Antimetabolites|antimetabolites|mesh-ancestor
111200367|NCT04267848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111200368|NCT04267848|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111200369|NCT04267848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111200370|NCT04267848|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111200371|NCT04267848|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111200372|NCT04266795|Azacitidine|azacitidine|mesh-list
111200373|NCT04266795|Venetoclax|venetoclax|mesh-list
111200374|NCT04266795|Pevonedistat|pevonedistat|mesh-list
111200375|NCT04266795|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111200376|NCT04266795|Antimetabolites|antimetabolites|mesh-ancestor
111200377|NCT04266795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111200378|NCT04266795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111200379|NCT04266795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111200380|NCT04262466|Pembrolizumab|pembrolizumab|mesh-list
111200381|NCT04262466|Atezolizumab|atezolizumab|mesh-list
111200382|NCT04262466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111200383|NCT04262466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111200384|NCT04262466|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111200385|NCT04262466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111200386|NCT04259944|Capecitabine|capecitabine|mesh-list
111200387|NCT04259944|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111200388|NCT04259944|Antimetabolites|antimetabolites|mesh-ancestor
111200389|NCT04259944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111200390|NCT04259944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111200391|NCT04256941|Letrozole|letrozole|mesh-list
111200392|NCT04256941|Fulvestrant|fulvestrant|mesh-list
111200393|NCT04256941|Palbociclib|palbociclib|mesh-list
111200394|NCT04256941|Anastrozole|anastrozole|mesh-list
111200395|NCT04256941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111200396|NCT04256941|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111200397|NCT04256941|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111200398|NCT04256941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111200399|NCT04256941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111200400|NCT04256941|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111200401|NCT04256941|Hormone Antagonists|hormone antagonists|mesh-ancestor
111200402|NCT04256941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111200403|NCT04256941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111200404|NCT04256941|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111200405|NCT04256941|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
111200406|NCT04256941|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111200407|NCT04254692|Bupivacaine|bupivacaine|mesh-list
111200408|NCT04254692|Anesthetics, Local|anesthetics, local|mesh-ancestor
111200409|NCT04254692|Anesthetics|anesthetics|mesh-ancestor
111200410|NCT04254692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111200411|NCT04254692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111200412|NCT04254692|Sensory System Agents|sensory system agents|mesh-ancestor
111200413|NCT04254692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111200414|NCT04246086|Lenalidomide|lenalidomide|mesh-list
111200415|NCT04246086|Immunologic Factors|immunologic factors|mesh-ancestor
111200416|NCT04246086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111200417|NCT04246086|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111200418|NCT04246086|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111200419|NCT04246086|Growth Substances|growth substances|mesh-ancestor
111200420|NCT04246086|Growth Inhibitors|growth inhibitors|mesh-ancestor
111200421|NCT04246086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111200422|NCT04234113|Pembrolizumab|pembrolizumab|mesh-list
111200423|NCT04234113|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111200424|NCT04234113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111200425|NCT04234113|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111200426|NCT04234113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111200427|NCT04224493|Rituximab|rituximab|mesh-list
111200428|NCT04224493|Lenalidomide|lenalidomide|mesh-list
111200429|NCT04224493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111200430|NCT04224493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111200431|NCT04224493|Immunologic Factors|immunologic factors|mesh-ancestor
111200432|NCT04224493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111200433|NCT04224493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111200434|NCT04224493|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111200435|NCT04224493|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111200436|NCT04224493|Growth Substances|growth substances|mesh-ancestor
110846064|NCT01175525|Cromolyn Sodium|cromolyn sodium|mesh-list
111200437|NCT04224493|Growth Inhibitors|growth inhibitors|mesh-ancestor
111200438|NCT04222257|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111200439|NCT04222257|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
111200440|NCT04222257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111200441|NCT04222257|Antitubercular Agents|antitubercular agents|mesh-ancestor
111200442|NCT04216472|Paclitaxel|paclitaxel|mesh-list
111200443|NCT04216472|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111200444|NCT04216472|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-list
111200445|NCT04216472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111200446|NCT04216472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111200447|NCT04216472|Tubulin Modulators|tubulin modulators|mesh-ancestor
111200448|NCT04216472|Antimitotic Agents|antimitotic agents|mesh-ancestor
111200449|NCT04216472|Mitosis Modulators|mitosis modulators|mesh-ancestor
111200450|NCT04216472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111200451|NCT04216472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111200452|NCT04216329|Temozolomide|temozolomide|mesh-list
111200453|NCT04216329|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111200454|NCT04216329|Alkylating Agents|alkylating agents|mesh-ancestor
111200455|NCT04216329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111200456|NCT04216329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111200457|NCT04216316|Carboplatin|carboplatin|mesh-list
111200458|NCT04216316|Gemcitabine|gemcitabine|mesh-list
111200459|NCT04216316|Pembrolizumab|pembrolizumab|mesh-list
111200460|NCT04216316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111200461|NCT04216316|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111200462|NCT04216316|Antimetabolites|antimetabolites|mesh-ancestor
111200463|NCT04216316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111200464|NCT04216316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111200465|NCT04216316|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111200466|NCT04216290|Cisplatin|cisplatin|mesh-list
111200467|NCT04216290|Gemcitabine|gemcitabine|mesh-list
111200468|NCT04216290|Fluorouracil|fluorouracil|mesh-list
111200469|NCT04216290|Durvalumab|durvalumab|mesh-list
111200470|NCT04216290|Mitomycins|mitomycins|mesh-list
111200471|NCT04216290|Mitomycin|mitomycin|mesh-list
111200472|NCT04216290|Immunoglobulins|immunoglobulins|mesh-list
111200473|NCT04216290|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111200474|NCT04216290|Immunoglobulin G|immunoglobulin g|mesh-list
111200475|NCT04216290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111200476|NCT04216290|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111200477|NCT04216290|Antimetabolites|antimetabolites|mesh-ancestor
111200478|NCT04216290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111200479|NCT04216290|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111200480|NCT04216290|Immunologic Factors|immunologic factors|mesh-ancestor
111200481|NCT04216290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111200482|NCT04216290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111200483|NCT04216290|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111200484|NCT04216290|Alkylating Agents|alkylating agents|mesh-ancestor
111200485|NCT04216290|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111200486|NCT04216290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111200488|NCT04214262|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111200489|NCT04214262|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111200490|NCT04214262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111200491|NCT04214262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111200492|NCT04214262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111200493|NCT04214262|Immunologic Factors|immunologic factors|mesh-ancestor
111200494|NCT04214262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111200495|NCT04214249|Cytarabine|cytarabine|mesh-list
111200496|NCT04214249|Pembrolizumab|pembrolizumab|mesh-list
111200497|NCT04214249|Daunorubicin|daunorubicin|mesh-list
111200498|NCT04214249|Idarubicin|idarubicin|mesh-list
111200499|NCT04214249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111200500|NCT04214249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111200501|NCT04214249|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111200502|NCT04214249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111200503|NCT04214249|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111200504|NCT04214249|Antimetabolites|antimetabolites|mesh-ancestor
111200505|NCT04214249|Antiviral Agents|antiviral agents|mesh-ancestor
111200506|NCT04214249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111200507|NCT04214249|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111200508|NCT04214249|Immunologic Factors|immunologic factors|mesh-ancestor
111200509|NCT04214249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111200510|NCT04214249|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111200511|NCT04214249|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111200512|NCT04214249|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111200513|NCT04214249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111200514|NCT04212364|Naloxone|naloxone|mesh-list
111200515|NCT04212364|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111200516|NCT04212364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111200517|NCT04212364|Sensory System Agents|sensory system agents|mesh-ancestor
111200518|NCT04212364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111200519|NCT04205643|Infliximab|infliximab|mesh-list
111200520|NCT04205643|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111200521|NCT04205643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111200522|NCT04205643|Dermatologic Agents|dermatologic agents|mesh-ancestor
111200523|NCT04205643|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111200524|NCT04205643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111200525|NCT04195945|Cytarabine|cytarabine|mesh-list
111200526|NCT04195945|Daunorubicin|daunorubicin|mesh-list
111200527|NCT04195945|Mitoxantrone|mitoxantrone|mesh-list
111200528|NCT04195945|Cladribine|cladribine|mesh-list
111200529|NCT04195945|Lenograstim|lenograstim|mesh-list
111200530|NCT04195945|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111200531|NCT04195945|Antimetabolites|antimetabolites|mesh-ancestor
111200532|NCT04195945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111200533|NCT04195945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111200534|NCT04195945|Antiviral Agents|antiviral agents|mesh-ancestor
111200535|NCT04195945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111200536|NCT04195945|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111200537|NCT04195945|Immunologic Factors|immunologic factors|mesh-ancestor
111200538|NCT04195945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111200539|NCT04195945|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111200540|NCT04195945|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111200541|NCT04195945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111200542|NCT04195945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111200543|NCT04195945|Analgesics|analgesics|mesh-ancestor
111200544|NCT04195945|Sensory System Agents|sensory system agents|mesh-ancestor
111200545|NCT04195945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111200546|NCT04195945|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111200547|NCT04195555|Ivosidenib|ivosidenib|mesh-list
111200548|NCT04195555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111200549|NCT04195555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111200550|NCT04195555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111200551|NCT04181060|Bevacizumab|bevacizumab|mesh-list
111200552|NCT04181060|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111200553|NCT04181060|Osimertinib|osimertinib|mesh-list
111200554|NCT04181060|Endothelial Growth Factors|endothelial growth factors|mesh-list
111200555|NCT04181060|Antibodies|antibodies|mesh-list
111200556|NCT04181060|Immunoglobulins|immunoglobulins|mesh-list
111200557|NCT04181060|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111200558|NCT04181060|Immunoglobulin G|immunoglobulin g|mesh-list
111200559|NCT04181060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111200560|NCT04181060|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111200561|NCT04181060|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111200562|NCT04181060|Growth Substances|growth substances|mesh-ancestor
111200563|NCT04181060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111200564|NCT04181060|Growth Inhibitors|growth inhibitors|mesh-ancestor
111200565|NCT04181060|Immunologic Factors|immunologic factors|mesh-ancestor
111200566|NCT04181060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111200567|NCT04181060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111200568|NCT04181060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111200569|NCT04176705|Triamcinolone|triamcinolone|mesh-list
111200570|NCT04176705|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
111200571|NCT04176705|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
111200572|NCT04176705|Lidocaine|lidocaine|mesh-list
111200573|NCT04176705|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
111200574|NCT04176705|Anesthetics, Local|anesthetics, local|mesh-ancestor
111200575|NCT04176705|Anesthetics|anesthetics|mesh-ancestor
111200576|NCT04176705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111200577|NCT04176705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111200578|NCT04176705|Sensory System Agents|sensory system agents|mesh-ancestor
111200579|NCT04176705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111200580|NCT04176705|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111200581|NCT04176705|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111200582|NCT04176705|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111200583|NCT04176705|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111200584|NCT04176705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111200585|NCT04176705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111200586|NCT04176705|Glucocorticoids|glucocorticoids|mesh-ancestor
111200587|NCT04176705|Hormones|hormones|mesh-ancestor
111200588|NCT04176705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111200589|NCT04176705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111200590|NCT04176705|Immunologic Factors|immunologic factors|mesh-ancestor
111200591|NCT04176705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111200592|NCT04172532|Peposertib|peposertib|mesh-list
111200593|NCT04172532|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111200594|NCT04172532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111200595|NCT04172532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111200596|NCT04166604|Trifluridine|trifluridine|mesh-list
111200597|NCT04166604|Antimetabolites|antimetabolites|mesh-ancestor
111200598|NCT04166604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111200599|NCT04166604|Antiviral Agents|antiviral agents|mesh-ancestor
111200600|NCT04166604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111200601|NCT04166409|Carboplatin|carboplatin|mesh-list
111200602|NCT04166409|Vincristine|vincristine|mesh-list
111200603|NCT04166409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111200604|NCT04166409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111200605|NCT04166409|Tubulin Modulators|tubulin modulators|mesh-ancestor
111200606|NCT04166409|Antimitotic Agents|antimitotic agents|mesh-ancestor
111200607|NCT04166409|Mitosis Modulators|mitosis modulators|mesh-ancestor
111200608|NCT04166409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111200609|NCT04164199|Capecitabine|capecitabine|mesh-list
111200610|NCT04164199|Pemetrexed|pemetrexed|mesh-list
111200611|NCT04164199|Temozolomide|temozolomide|mesh-list
111200612|NCT04164199|Tislelizumab|tislelizumab|mesh-list
111200613|NCT04164199|Pamiparib|pamiparib|mesh-list
111200614|NCT04164199|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111200615|NCT04164199|Antimetabolites|antimetabolites|mesh-ancestor
111200616|NCT04164199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111200617|NCT04164199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111200618|NCT04164199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111200619|NCT04164199|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111200620|NCT04164199|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111200621|NCT04164199|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111200622|NCT04164199|Alkylating Agents|alkylating agents|mesh-ancestor
111200623|NCT04164199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111200624|NCT04164199|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111200625|NCT04164082|Gemcitabine|gemcitabine|mesh-list
111200626|NCT04164082|Pembrolizumab|pembrolizumab|mesh-list
111200627|NCT04164082|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111200628|NCT04164082|Antimetabolites|antimetabolites|mesh-ancestor
111200629|NCT04164082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111200630|NCT04164082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111200631|NCT04164082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111200632|NCT04164082|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111200633|NCT04145440|Felzartamab|felzartamab|mesh-list
111200634|NCT04145440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111200635|NCT04145440|Immunologic Factors|immunologic factors|mesh-ancestor
111200636|NCT04145440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111200637|NCT04145115|Nivolumab|nivolumab|mesh-list
111200638|NCT04145115|Ipilimumab|ipilimumab|mesh-list
111200639|NCT04145115|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111200640|NCT04145115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111200641|NCT04145115|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111200642|NCT04145115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111200643|NCT04127227|Gemcitabine|gemcitabine|mesh-list
111200644|NCT04127227|Oxaliplatin|oxaliplatin|mesh-list
111200645|NCT04127227|Pegaspargase|pegaspargase|mesh-list
111200646|NCT04127227|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111200647|NCT04127227|Antimetabolites|antimetabolites|mesh-ancestor
111200648|NCT04127227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111200649|NCT04127227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111200650|NCT04106219|Cyclophosphamide|cyclophosphamide|mesh-list
111200651|NCT04106219|Topotecan|topotecan|mesh-list
111200652|NCT04106219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111200653|NCT04106219|Immunologic Factors|immunologic factors|mesh-ancestor
111200654|NCT04106219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111200655|NCT04106219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111200656|NCT04106219|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111200657|NCT04106219|Alkylating Agents|alkylating agents|mesh-ancestor
111200658|NCT04106219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111200659|NCT04106219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111200660|NCT04106219|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111200661|NCT04106219|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111200662|NCT04106219|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111200663|NCT04106219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111200664|NCT04102436|Aldesleukin|aldesleukin|mesh-list
111200665|NCT04102436|Cyclophosphamide|cyclophosphamide|mesh-list
111200666|NCT04102436|Fludarabine|fludarabine|mesh-list
111200667|NCT04102436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111200668|NCT04102436|Immunologic Factors|immunologic factors|mesh-ancestor
111200669|NCT04102436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111200670|NCT04102436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111200671|NCT04102436|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111200672|NCT04102436|Alkylating Agents|alkylating agents|mesh-ancestor
111200673|NCT04102436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111200674|NCT04102436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111200675|NCT04102436|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111200676|NCT04102436|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111200677|NCT04102436|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111200678|NCT04102436|Antiviral Agents|antiviral agents|mesh-ancestor
111200679|NCT04102436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111200680|NCT04092283|Paclitaxel|paclitaxel|mesh-list
111200681|NCT04092283|Etoposide|etoposide|mesh-list
111200682|NCT04092283|Podophyllotoxin|podophyllotoxin|mesh-list
111200685|NCT04092283|Pemetrexed|pemetrexed|mesh-list
111200686|NCT04092283|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111200687|NCT04092283|Etoposide phosphate|etoposide phosphate|mesh-list
111200688|NCT04092283|Durvalumab|durvalumab|mesh-list
111200689|NCT04092283|Immunoglobulins|immunoglobulins|mesh-list
111200690|NCT04092283|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111200691|NCT04092283|Immunoglobulin G|immunoglobulin g|mesh-list
111200692|NCT04092283|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111200693|NCT04092283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111200694|NCT04092283|Tubulin Modulators|tubulin modulators|mesh-ancestor
111200695|NCT04092283|Antimitotic Agents|antimitotic agents|mesh-ancestor
111200696|NCT04092283|Mitosis Modulators|mitosis modulators|mesh-ancestor
111200697|NCT04092283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111200698|NCT04092283|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111200699|NCT04092283|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111200700|NCT04092283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111200701|NCT04092283|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111200702|NCT04092283|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111200703|NCT04092283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111200704|NCT04092283|Immunologic Factors|immunologic factors|mesh-ancestor
111200705|NCT04092283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111200706|NCT04092283|Keratolytic Agents|keratolytic agents|mesh-ancestor
111200707|NCT04092283|Dermatologic Agents|dermatologic agents|mesh-ancestor
111200708|NCT04089865|Tranexamic Acid|tranexamic acid|mesh-list
111200709|NCT04089865|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111200710|NCT04089865|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111200711|NCT04089865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111200712|NCT04089865|Hemostatics|hemostatics|mesh-ancestor
111200713|NCT04089865|Coagulants|coagulants|mesh-ancestor
111200714|NCT04086485|Olaparib|olaparib|mesh-list
111200715|NCT04086485|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111200716|NCT04086485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111200717|NCT04086485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111200718|NCT04086485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111200719|NCT04074512|Copper|copper|mesh-list
111200720|NCT04074512|Trace Elements|trace elements|mesh-ancestor
111200721|NCT04074512|Micronutrients|micronutrients|mesh-ancestor
111200722|NCT04074512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111200723|NCT04071236|Avelumab|avelumab|mesh-list
111200724|NCT04071236|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
111200725|NCT04071236|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111200726|NCT04071236|Peposertib|peposertib|mesh-list
111200727|NCT04071236|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111200728|NCT04071236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111200729|NCT04071236|Immunologic Factors|immunologic factors|mesh-ancestor
111200730|NCT04071236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111200731|NCT04071236|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111200732|NCT04071236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111200733|NCT04071236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111200734|NCT04071223|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
111200735|NCT04071223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111200736|NCT04068194|Avelumab|avelumab|mesh-list
111200737|NCT04068194|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111200738|NCT04068194|Peposertib|peposertib|mesh-list
111200739|NCT04068194|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111200740|NCT04068194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111200741|NCT04068194|Immunologic Factors|immunologic factors|mesh-ancestor
111200742|NCT04068194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111200743|NCT04068194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111200744|NCT04068194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111200745|NCT04068194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111200746|NCT04062708|Durvalumab|durvalumab|mesh-list
111200747|NCT04062708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111200748|NCT04062708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111200749|NCT04059484|Tamoxifen|tamoxifen|mesh-list
111200750|NCT04059484|Letrozole|letrozole|mesh-list
111200751|NCT04059484|Fulvestrant|fulvestrant|mesh-list
111200752|NCT04059484|Anastrozole|anastrozole|mesh-list
111200753|NCT04059484|Exemestane|exemestane|mesh-list
111200754|NCT04059484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111200755|NCT04059484|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111200756|NCT04059484|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111200757|NCT04059484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111200758|NCT04059484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111200759|NCT04059484|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111200760|NCT04059484|Hormone Antagonists|hormone antagonists|mesh-ancestor
111200761|NCT04059484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111200762|NCT04059484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111200763|NCT04059484|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111200764|NCT04059484|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111200765|NCT04059484|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111200766|NCT04059484|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111200767|NCT04059484|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
111200768|NCT04057131|Icatibant|icatibant|mesh-list
111200769|NCT04057131|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111200770|NCT04057131|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111200771|NCT04057131|Analgesics|analgesics|mesh-ancestor
111200772|NCT04057131|Sensory System Agents|sensory system agents|mesh-ancestor
111200773|NCT04057131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111200774|NCT04057131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111200775|NCT04057131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111200776|NCT04057131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111200777|NCT04057131|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
111200778|NCT04057131|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
111200779|NCT04057131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111200780|NCT04057131|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
111200781|NCT04057131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111200782|NCT04057131|Immunologic Factors|immunologic factors|mesh-ancestor
111200783|NCT04047641|Cytarabine|cytarabine|mesh-list
111200784|NCT04047641|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
111200785|NCT04047641|Idarubicin|idarubicin|mesh-list
111200786|NCT04047641|Cladribine|cladribine|mesh-list
111200787|NCT04047641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111200788|NCT04047641|Antimetabolites|antimetabolites|mesh-ancestor
111200789|NCT04047641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111200790|NCT04047641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111200791|NCT04047641|Antiviral Agents|antiviral agents|mesh-ancestor
111200792|NCT04047641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111200793|NCT04047641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111200794|NCT04047641|Immunologic Factors|immunologic factors|mesh-ancestor
111200795|NCT04047641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111200796|NCT04047641|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111200797|NCT04047641|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111200798|NCT04047641|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111200799|NCT04047641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111200800|NCT04039464|Bosentan|bosentan|mesh-list
111200801|NCT04039464|Sildenafil Citrate|sildenafil citrate|mesh-list
111200802|NCT04039464|Vasodilator Agents|vasodilator agents|mesh-ancestor
111200803|NCT04039464|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111200804|NCT04039464|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111200805|NCT04039464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111200806|NCT04039464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111200807|NCT04039464|Urological Agents|urological agents|mesh-ancestor
111200808|NCT04039464|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111200809|NCT04039464|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
111200810|NCT04036435|Deucravacitinib|deucravacitinib|mesh-list
111200811|NCT04036435|Dermatologic Agents|dermatologic agents|mesh-ancestor
111200812|NCT04036435|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111200813|NCT04036435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111200814|NCT04036435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111200815|NCT04033107|Ascorbic Acid|ascorbic acid|mesh-list
111200816|NCT04033107|Metformin|metformin|mesh-list
111200817|NCT04033107|Vitamins|vitamins|mesh-ancestor
111200819|NCT04033107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111200820|NCT04033107|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111200821|NCT04033107|Antioxidants|antioxidants|mesh-ancestor
111200822|NCT04033107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111200823|NCT04033107|Protective Agents|protective agents|mesh-ancestor
111200824|NCT04017832|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111200825|NCT04017832|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111200826|NCT04017832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111200827|NCT04017832|Incretins|incretins|mesh-ancestor
111200828|NCT04017832|Hormones|hormones|mesh-ancestor
111200829|NCT04017832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111200830|NCT04017832|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111200831|NCT04017832|Protease Inhibitors|protease inhibitors|mesh-ancestor
111200832|NCT04017832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111200833|NCT04017832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111200835|NCT04006262|Ipilimumab|ipilimumab|mesh-list
111200836|NCT04006262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111200837|NCT04006262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111200838|NCT04006262|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111200839|NCT04006262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111200840|NCT03999515|Abiraterone Acetate|abiraterone acetate|mesh-list
111200841|NCT03999515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111200842|NCT03999515|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111200843|NCT03999515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111200844|NCT03999515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111200845|NCT03999515|Hormone Antagonists|hormone antagonists|mesh-ancestor
111200846|NCT03999515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111200847|NCT03999515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111200848|NCT03999515|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111200849|NCT03994627|Olaratumab|olaratumab|mesh-list
111200850|NCT03994627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111200851|NCT03984448|Prednisone|prednisone|mesh-list
111200852|NCT03984448|Cortisone|cortisone|mesh-list
111200853|NCT03984448|Cyclophosphamide|cyclophosphamide|mesh-list
111200854|NCT03984448|Rituximab|rituximab|mesh-list
111200855|NCT03984448|Doxorubicin|doxorubicin|mesh-list
111200856|NCT03984448|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111200857|NCT03984448|Etoposide|etoposide|mesh-list
111200858|NCT03984448|Vincristine|vincristine|mesh-list
111200859|NCT03984448|Etoposide phosphate|etoposide phosphate|mesh-list
111200860|NCT03984448|Venetoclax|venetoclax|mesh-list
111200861|NCT03984448|Podophyllotoxin|podophyllotoxin|mesh-list
111200862|NCT03984448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111200863|NCT03984448|Antibodies|antibodies|mesh-list
111200864|NCT03984448|Immunoglobulins|immunoglobulins|mesh-list
111200865|NCT03984448|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111200866|NCT03984448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111200867|NCT03984448|Immunologic Factors|immunologic factors|mesh-ancestor
111200868|NCT03984448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111200869|NCT03984448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111200870|NCT03984448|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111200871|NCT03984448|Alkylating Agents|alkylating agents|mesh-ancestor
111200872|NCT03984448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111200873|NCT03984448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111200874|NCT03984448|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111200875|NCT03984448|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111200876|NCT03984448|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111200877|NCT03984448|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111200878|NCT03984448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111200879|NCT03984448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111200880|NCT03984448|Glucocorticoids|glucocorticoids|mesh-ancestor
111200881|NCT03984448|Hormones|hormones|mesh-ancestor
111200882|NCT03984448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111200883|NCT03984448|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111200884|NCT03984448|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111200885|NCT03984448|Tubulin Modulators|tubulin modulators|mesh-ancestor
111200886|NCT03984448|Antimitotic Agents|antimitotic agents|mesh-ancestor
111200887|NCT03984448|Mitosis Modulators|mitosis modulators|mesh-ancestor
111200888|NCT03984448|Keratolytic Agents|keratolytic agents|mesh-ancestor
110631063|NCT00864240|Clobetasol|clobetasol|mesh-list
111200889|NCT03984448|Dermatologic Agents|dermatologic agents|mesh-ancestor
111200890|NCT03983824|Cytarabine|cytarabine|mesh-list
111200891|NCT03983824|Etoposide|etoposide|mesh-list
111200892|NCT03983824|Mitoxantrone|mitoxantrone|mesh-list
111200893|NCT03983824|Etoposide phosphate|etoposide phosphate|mesh-list
111200894|NCT03983824|Peposertib|peposertib|mesh-list
111200895|NCT03983824|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111200896|NCT03983824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111200897|NCT03983824|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111200898|NCT03983824|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111200899|NCT03983824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111200900|NCT03983824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111200901|NCT03983824|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111200902|NCT03983824|Antimetabolites|antimetabolites|mesh-ancestor
111200903|NCT03983824|Antiviral Agents|antiviral agents|mesh-ancestor
111200904|NCT03983824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111200905|NCT03983824|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111200906|NCT03983824|Immunologic Factors|immunologic factors|mesh-ancestor
111200907|NCT03983824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111200908|NCT03983824|Analgesics|analgesics|mesh-ancestor
111200909|NCT03983824|Sensory System Agents|sensory system agents|mesh-ancestor
111200910|NCT03983824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111200911|NCT03983824|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111200912|NCT03978611|Ipilimumab|ipilimumab|mesh-list
111200913|NCT03978611|Relatlimab|relatlimab|mesh-list
111200914|NCT03978611|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111200915|NCT03978611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111200916|NCT03978611|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111200917|NCT03978611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111200918|NCT03973333|Atezolizumab|atezolizumab|mesh-list
111200919|NCT03973333|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111200920|NCT03973333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111200921|NCT03973333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111200922|NCT03973333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111200923|NCT03970447|Temozolomide|temozolomide|mesh-list
111200924|NCT03970447|Lomustine|lomustine|mesh-list
111200925|NCT03970447|Dianhydrogalactitol|dianhydrogalactitol|mesh-list
111200926|NCT03970447|GDC-0084|gdc-0084|mesh-list
111200927|NCT03970447|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111200928|NCT03970447|Alkylating Agents|alkylating agents|mesh-ancestor
111200929|NCT03970447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111200930|NCT03970447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111200931|NCT03970447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111200932|NCT03965468|Paclitaxel|paclitaxel|mesh-list
111200933|NCT03965468|Carboplatin|carboplatin|mesh-list
111200934|NCT03965468|Durvalumab|durvalumab|mesh-list
111200935|NCT03965468|Tremelimumab|tremelimumab|mesh-list
111200936|NCT03965468|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111200937|NCT03965468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111200938|NCT03965468|Tubulin Modulators|tubulin modulators|mesh-ancestor
111200939|NCT03965468|Antimitotic Agents|antimitotic agents|mesh-ancestor
111200940|NCT03965468|Mitosis Modulators|mitosis modulators|mesh-ancestor
111200941|NCT03965468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111200942|NCT03965468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111200943|NCT03964090|Cytarabine|cytarabine|mesh-list
111200944|NCT03964090|Isavuconazole|isavuconazole|mesh-list
111200945|NCT03964090|Methotrexate|methotrexate|mesh-list
110492017|NCT00752947|Metronidazole|metronidazole|mesh-list
111200946|NCT03964090|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111200947|NCT03964090|Abortifacient Agents|abortifacient agents|mesh-ancestor
111200948|NCT03964090|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111200949|NCT03964090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111200950|NCT03964090|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111200951|NCT03964090|Antimetabolites|antimetabolites|mesh-ancestor
111200952|NCT03964090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111200953|NCT03964090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111200954|NCT03964090|Dermatologic Agents|dermatologic agents|mesh-ancestor
111200955|NCT03964090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111200956|NCT03964090|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111200957|NCT03964090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111200958|NCT03964090|Immunologic Factors|immunologic factors|mesh-ancestor
111200959|NCT03964090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111200960|NCT03964090|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111200961|NCT03964090|Antiviral Agents|antiviral agents|mesh-ancestor
111200962|NCT03964090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111200963|NCT03964090|Antifungal Agents|antifungal agents|mesh-ancestor
111200964|NCT03944902|Niraparib|niraparib|mesh-list
111200965|NCT03944902|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111200966|NCT03944902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111200967|NCT03944902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111200968|NCT03944902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111200969|NCT03944876|Botulinum Toxins|botulinum toxins|mesh-list
111200970|NCT03944876|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111200971|NCT03944876|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111200972|NCT03944876|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111200973|NCT03944876|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111200974|NCT03944876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111200975|NCT03944876|Cholinergic Agents|cholinergic agents|mesh-ancestor
111200976|NCT03944876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111200977|NCT03944876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111200978|NCT03944876|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111200979|NCT03944876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111200980|NCT03944577|Evolocumab|evolocumab|mesh-list
111200981|NCT03944577|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
111200982|NCT03944577|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111200983|NCT03944577|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111200984|NCT03944577|Antimetabolites|antimetabolites|mesh-ancestor
111200985|NCT03944577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111200986|NCT03944577|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111200987|NCT03944577|Protease Inhibitors|protease inhibitors|mesh-ancestor
111200988|NCT03944577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111200989|NCT03944577|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111200990|NCT03939897|Fulvestrant|fulvestrant|mesh-list
111200991|NCT03939897|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111200992|NCT03939897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111200993|NCT03939897|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
111200994|NCT03939897|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111200995|NCT03939897|Hormone Antagonists|hormone antagonists|mesh-ancestor
111200996|NCT03939897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111200997|NCT03939897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111200998|NCT03936777|Fenfluramine|fenfluramine|mesh-list
111200999|NCT03936777|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111201000|NCT03936777|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111201001|NCT03936777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111201002|NCT03936777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111201003|NCT03936777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111201004|NCT03936777|Serotonin Agents|serotonin agents|mesh-ancestor
111201005|NCT03936777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111201006|NCT03925025|Magnesium Sulfate|magnesium sulfate|mesh-list
111201007|NCT03925025|Nimodipine|nimodipine|mesh-list
111201008|NCT03925025|Analgesics|analgesics|mesh-ancestor
111201009|NCT03925025|Sensory System Agents|sensory system agents|mesh-ancestor
111201010|NCT03925025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111201011|NCT03925025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111201012|NCT03925025|Anesthetics|anesthetics|mesh-ancestor
111201013|NCT03925025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111201014|NCT03925025|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111201015|NCT03925025|Anticonvulsants|anticonvulsants|mesh-ancestor
111201016|NCT03925025|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111201017|NCT03925025|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111201018|NCT03925025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111201019|NCT03925025|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111201020|NCT03925025|Tocolytic Agents|tocolytic agents|mesh-ancestor
111201021|NCT03925025|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111201022|NCT03925025|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111201023|NCT03925025|Vasodilator Agents|vasodilator agents|mesh-ancestor
111201024|NCT03924947|Pancrelipase|pancrelipase|mesh-list
111201025|NCT03924947|Pancreatin|pancreatin|mesh-list
111201026|NCT03924947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111201027|NCT03920267|Deucravacitinib|deucravacitinib|mesh-list
111201028|NCT03920267|Dermatologic Agents|dermatologic agents|mesh-ancestor
111201029|NCT03920267|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111201030|NCT03920267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111201031|NCT03920267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111201032|NCT03919292|Valproic Acid|valproic acid|mesh-list
111201033|NCT03919292|Anticonvulsants|anticonvulsants|mesh-ancestor
111201034|NCT03919292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111201035|NCT03919292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111201036|NCT03919292|GABA Agents|gaba agents|mesh-ancestor
111201037|NCT03919292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111201038|NCT03919292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111201039|NCT03919292|Antimanic Agents|antimanic agents|mesh-ancestor
111201040|NCT03919292|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111201041|NCT03919292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111201042|NCT03919292|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111201043|NCT03919071|Trametinib|trametinib|mesh-list
111201044|NCT03919071|Dabrafenib|dabrafenib|mesh-list
111201045|NCT03919071|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
111201046|NCT03919071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111201047|NCT03919071|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111201048|NCT03919071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111201049|NCT03919071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111201050|NCT03919071|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
111201051|NCT03919071|Protective Agents|protective agents|mesh-ancestor
111201052|NCT03919071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111201053|NCT03919071|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111201054|NCT03919071|Antioxidants|antioxidants|mesh-ancestor
111201055|NCT03914625|Calcium, Dietary|calcium, dietary|mesh-list
111201056|NCT03914625|Leucovorin|leucovorin|mesh-list
111201057|NCT03914625|Folic Acid|folic acid|mesh-list
111201058|NCT03914625|Cytarabine|cytarabine|mesh-list
111201059|NCT03914625|Dexamethasone|dexamethasone|mesh-list
111201060|NCT03914625|Dexamethasone acetate|dexamethasone acetate|mesh-list
111201061|NCT03914625|Prednisone|prednisone|mesh-list
111201062|NCT03914625|Prednisolone|prednisolone|mesh-list
111201063|NCT03914625|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111201064|NCT03914625|Methylprednisolone|methylprednisolone|mesh-list
111201065|NCT03914625|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111201066|NCT03914625|Prednisolone acetate|prednisolone acetate|mesh-list
111201067|NCT03914625|Hydrocortisone|hydrocortisone|mesh-list
111201068|NCT03914625|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
111201069|NCT03914625|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
111201070|NCT03914625|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
111201071|NCT03914625|Cortisone|cortisone|mesh-list
111201072|NCT03914625|Cyclophosphamide|cyclophosphamide|mesh-list
111201073|NCT03914625|Doxorubicin|doxorubicin|mesh-list
111201074|NCT03914625|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111201075|NCT03914625|Methotrexate|methotrexate|mesh-list
111201076|NCT03914625|Vincristine|vincristine|mesh-list
111201077|NCT03914625|Asparaginase|asparaginase|mesh-list
111201078|NCT03914625|Mercaptopurine|mercaptopurine|mesh-list
111201079|NCT03914625|Pegaspargase|pegaspargase|mesh-list
111201080|NCT03914625|Thioguanine|thioguanine|mesh-list
111201081|NCT03914625|Blinatumomab|blinatumomab|mesh-list
111201082|NCT03914625|Asparaginase erwinia chrysanthemi, recombinant-rywn|asparaginase erwinia chrysanthemi, recombinant-rywn|mesh-list
111201083|NCT03914625|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111201084|NCT03914625|Muromonab-CD3|muromonab-cd3|mesh-list
111201085|NCT03914625|Antibodies|antibodies|mesh-list
111201086|NCT03914625|Immunoglobulins|immunoglobulins|mesh-list
111201087|NCT03914625|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111201088|NCT03914625|Antibodies, Bispecific|antibodies, bispecific|mesh-list
111201089|NCT03914625|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111201090|NCT03914625|Prednisolone phosphate|prednisolone phosphate|mesh-list
111201091|NCT03914625|BB 1101|bb 1101|mesh-list
111201092|NCT03914625|Calcium|calcium|mesh-list
111201093|NCT03914625|2-Aminopurine|2-aminopurine|mesh-list
111201094|NCT03914625|Levoleucovorin|levoleucovorin|mesh-list
111201095|NCT03914625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111201096|NCT03914625|Immunologic Factors|immunologic factors|mesh-ancestor
111201097|NCT03914625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111201098|NCT03914625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111201099|NCT03914625|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111201100|NCT03914625|Alkylating Agents|alkylating agents|mesh-ancestor
111201101|NCT03914625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111201102|NCT03914625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111201103|NCT03914625|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111201104|NCT03914625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111201105|NCT03914625|Antiemetics|antiemetics|mesh-ancestor
111201106|NCT03914625|Autonomic Agents|autonomic agents|mesh-ancestor
111201107|NCT03914625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111201108|NCT03914625|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111201109|NCT03914625|Glucocorticoids|glucocorticoids|mesh-ancestor
111201110|NCT03914625|Hormones|hormones|mesh-ancestor
111201111|NCT03914625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111201112|NCT03914625|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111201113|NCT03914625|Protease Inhibitors|protease inhibitors|mesh-ancestor
111201114|NCT03914625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111201115|NCT03914625|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111201116|NCT03914625|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111201117|NCT03914625|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111201118|NCT03914625|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111201119|NCT03914625|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111201120|NCT03914625|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111201121|NCT03914625|Abortifacient Agents|abortifacient agents|mesh-ancestor
111201122|NCT03914625|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111201123|NCT03914625|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111201124|NCT03914625|Antimetabolites|antimetabolites|mesh-ancestor
111201125|NCT03914625|Dermatologic Agents|dermatologic agents|mesh-ancestor
111201126|NCT03914625|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111201127|NCT03914625|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111201128|NCT03914625|Antiviral Agents|antiviral agents|mesh-ancestor
111201129|NCT03914625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111201130|NCT03914625|Antidotes|antidotes|mesh-ancestor
111201131|NCT03914625|Protective Agents|protective agents|mesh-ancestor
111201132|NCT03914625|Vitamin B Complex|vitamin b complex|mesh-ancestor
111201133|NCT03914625|Vitamins|vitamins|mesh-ancestor
111201134|NCT03914625|Micronutrients|micronutrients|mesh-ancestor
111201135|NCT03914625|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111201136|NCT03914625|Tubulin Modulators|tubulin modulators|mesh-ancestor
111201137|NCT03914625|Antimitotic Agents|antimitotic agents|mesh-ancestor
111201138|NCT03914625|Mitosis Modulators|mitosis modulators|mesh-ancestor
111201139|NCT03914625|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111201140|NCT03914625|Hematinics|hematinics|mesh-ancestor
111201141|NCT03914118|Modafinil|modafinil|mesh-list
111201142|NCT03914118|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111201143|NCT03914118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111201144|NCT03914118|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
111201145|NCT03914118|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111201146|NCT03914118|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111201147|NCT03914118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111201148|NCT03911973|Talazoparib|talazoparib|mesh-list
111201149|NCT03911973|Gedatolisib|gedatolisib|mesh-list
110492035|NCT04614545|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111201150|NCT03911973|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111201151|NCT03911973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111201152|NCT03911973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111201153|NCT03911973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111201154|NCT03911973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111201155|NCT03907488|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111201156|NCT03907488|Nivolumab|nivolumab|mesh-list
111201157|NCT03907488|Brentuximab Vedotin|brentuximab vedotin|mesh-list
111201158|NCT03907488|Doxorubicin|doxorubicin|mesh-list
111201159|NCT03907488|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111201160|NCT03907488|Dacarbazine|dacarbazine|mesh-list
111201161|NCT03907488|Vinblastine|vinblastine|mesh-list
111201162|NCT03907488|Antibodies|antibodies|mesh-list
111201163|NCT03907488|Immunoglobulins|immunoglobulins|mesh-list
111201164|NCT03907488|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111201165|NCT03907488|Lenograstim|lenograstim|mesh-list
111201166|NCT03907488|Imidazole|imidazole|mesh-list
111201167|NCT03907488|Immunoconjugates|immunoconjugates|mesh-list
111201168|NCT03907488|Immunologic Factors|immunologic factors|mesh-ancestor
111201169|NCT03907488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111201170|NCT03907488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111201171|NCT03907488|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111201172|NCT03907488|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111201173|NCT03907488|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111201174|NCT03907488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110846158|NCT03207243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111201175|NCT03907488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111201176|NCT03907488|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111201177|NCT03907488|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111201178|NCT03907488|Immunotoxins|immunotoxins|mesh-ancestor
111201179|NCT03907488|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111201180|NCT03907488|Alkylating Agents|alkylating agents|mesh-ancestor
111201181|NCT03907488|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111201182|NCT03907488|Tubulin Modulators|tubulin modulators|mesh-ancestor
111201183|NCT03907488|Antimitotic Agents|antimitotic agents|mesh-ancestor
111201184|NCT03907488|Mitosis Modulators|mitosis modulators|mesh-ancestor
111201185|NCT03907475|Paclitaxel|paclitaxel|mesh-list
111201186|NCT03907475|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111201187|NCT03907475|Carboplatin|carboplatin|mesh-list
111201188|NCT03907475|Gemcitabine|gemcitabine|mesh-list
111201189|NCT03907475|Doxorubicin|doxorubicin|mesh-list
111201190|NCT03907475|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111201191|NCT03907475|Capecitabine|capecitabine|mesh-list
111201192|NCT03907475|Durvalumab|durvalumab|mesh-list
111201193|NCT03907475|Immunoglobulins|immunoglobulins|mesh-list
111201194|NCT03907475|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111201195|NCT03907475|Immunoglobulin G|immunoglobulin g|mesh-list
111201196|NCT03907475|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111201197|NCT03907475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111201198|NCT03907475|Tubulin Modulators|tubulin modulators|mesh-ancestor
111201199|NCT03907475|Antimitotic Agents|antimitotic agents|mesh-ancestor
111201200|NCT03907475|Mitosis Modulators|mitosis modulators|mesh-ancestor
111201201|NCT03907475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111201202|NCT03907475|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111201203|NCT03907475|Antimetabolites|antimetabolites|mesh-ancestor
111201204|NCT03907475|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111201205|NCT03907475|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111201206|NCT03907475|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111201207|NCT03907475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111201208|NCT03907475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111201209|NCT03907475|Immunologic Factors|immunologic factors|mesh-ancestor
111201210|NCT03907475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111201211|NCT03903653|Botulinum Toxins|botulinum toxins|mesh-list
111201212|NCT03903653|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111201213|NCT03903653|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111201214|NCT03903653|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111201215|NCT03903653|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111201216|NCT03903653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111201217|NCT03903653|Cholinergic Agents|cholinergic agents|mesh-ancestor
111201218|NCT03903653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111201219|NCT03903653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111201220|NCT03903653|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111201221|NCT03903653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111201223|NCT03899155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111201224|NCT03899155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111201225|NCT03899155|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111201226|NCT03899155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111201227|NCT03892928|Dexmedetomidine|dexmedetomidine|mesh-list
111201228|NCT03892928|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111201229|NCT03892928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111201230|NCT03892928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111201231|NCT03892928|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111201232|NCT03892928|Analgesics|analgesics|mesh-ancestor
111201233|NCT03892928|Sensory System Agents|sensory system agents|mesh-ancestor
111201234|NCT03892928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111201235|NCT03892928|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111201236|NCT03892928|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111201237|NCT03892928|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111201238|NCT03892928|Adrenergic Agents|adrenergic agents|mesh-ancestor
111201239|NCT03892928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111201240|NCT03892928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111201241|NCT03891901|Isoniazid|isoniazid|mesh-list
111201242|NCT03891901|Rifabutin|rifabutin|mesh-list
111201243|NCT03891901|Imatinib Mesylate|imatinib mesylate|mesh-list
111201244|NCT03891901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111201245|NCT03891901|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111201246|NCT03891901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111201247|NCT03891901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111201248|NCT03891901|Antitubercular Agents|antitubercular agents|mesh-ancestor
111201249|NCT03891901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111201250|NCT03891901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111201251|NCT03891901|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
111201252|NCT03891901|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111201253|NCT03891901|Antimetabolites|antimetabolites|mesh-ancestor
111201254|NCT03891901|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111201255|NCT03891901|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111201256|NCT03873883|Pembrolizumab|pembrolizumab|mesh-list
111201257|NCT03873883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111201258|NCT03873883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111201259|NCT03873883|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111201260|NCT03873883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111201261|NCT03873402|Nivolumab|nivolumab|mesh-list
111201262|NCT03873402|Ipilimumab|ipilimumab|mesh-list
111201263|NCT03873402|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111201264|NCT03873402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111201265|NCT03873402|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111201266|NCT03873402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111201267|NCT03871257|Carboplatin|carboplatin|mesh-list
111201268|NCT03871257|Vincristine|vincristine|mesh-list
111201269|NCT03871257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111201270|NCT03871257|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111201271|NCT03871257|Tubulin Modulators|tubulin modulators|mesh-ancestor
111201272|NCT03871257|Antimitotic Agents|antimitotic agents|mesh-ancestor
111201273|NCT03871257|Mitosis Modulators|mitosis modulators|mesh-ancestor
110799577|NCT02064946|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111201274|NCT03871257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111201275|NCT03866382|Nivolumab|nivolumab|mesh-list
111201276|NCT03866382|Ipilimumab|ipilimumab|mesh-list
111201277|NCT03866382|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111201278|NCT03866382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111201279|NCT03866382|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111201280|NCT03866382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111201281|NCT03864094|Phenylephrine|phenylephrine|mesh-list
111201282|NCT03864094|Oxymetazoline|oxymetazoline|mesh-list
111201283|NCT03864094|Norepinephrine|norepinephrine|mesh-list
111201284|NCT03864094|Ephedrine|ephedrine|mesh-list
111201285|NCT03864094|Pseudoephedrine|pseudoephedrine|mesh-list
111201286|NCT03864094|Remifentanil|remifentanil|mesh-list
111201287|NCT03864094|Propofol|propofol|mesh-list
111201288|NCT03864094|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111201289|NCT03864094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111201290|NCT03864094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111201291|NCT03864094|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111201292|NCT03864094|Anesthetics, General|anesthetics, general|mesh-ancestor
111201293|NCT03864094|Anesthetics|anesthetics|mesh-ancestor
111201294|NCT03864094|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111201295|NCT03864094|Narcotics|narcotics|mesh-ancestor
111201296|NCT03864094|Analgesics|analgesics|mesh-ancestor
111201297|NCT03864094|Sensory System Agents|sensory system agents|mesh-ancestor
111201298|NCT03864094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111201299|NCT03864094|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111201300|NCT03864094|Mydriatics|mydriatics|mesh-ancestor
111201301|NCT03864094|Autonomic Agents|autonomic agents|mesh-ancestor
111201302|NCT03864094|Sympathomimetics|sympathomimetics|mesh-ancestor
111201303|NCT03864094|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111201304|NCT03864094|Nasal Decongestants|nasal decongestants|mesh-ancestor
111201305|NCT03864094|Respiratory System Agents|respiratory system agents|mesh-ancestor
111201306|NCT03864094|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111201307|NCT03864094|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111201308|NCT03864094|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111201309|NCT03864094|Adrenergic Agents|adrenergic agents|mesh-ancestor
111201310|NCT03864094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111201311|NCT03864094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111201312|NCT03864094|Protective Agents|protective agents|mesh-ancestor
111201313|NCT03864094|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111201314|NCT03864094|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111201315|NCT03864094|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111201316|NCT03863184|Rituximab|rituximab|mesh-list
111201317|NCT03863184|Lenalidomide|lenalidomide|mesh-list
111201318|NCT03863184|Acalabrutinib|acalabrutinib|mesh-list
111201319|NCT03863184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111201320|NCT03863184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111201321|NCT03863184|Immunologic Factors|immunologic factors|mesh-ancestor
111201322|NCT03863184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111201323|NCT03863184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111201324|NCT03863184|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111201325|NCT03863184|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111201326|NCT03863184|Growth Substances|growth substances|mesh-ancestor
111201327|NCT03863184|Growth Inhibitors|growth inhibitors|mesh-ancestor
111201328|NCT03845270|Docetaxel|docetaxel|mesh-list
111201329|NCT03845270|Trastuzumab|trastuzumab|mesh-list
111201330|NCT03845270|Pertuzumab|pertuzumab|mesh-list
111201331|NCT03845270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111201332|NCT03845270|Tubulin Modulators|tubulin modulators|mesh-ancestor
111201333|NCT03845270|Antimitotic Agents|antimitotic agents|mesh-ancestor
111201334|NCT03845270|Mitosis Modulators|mitosis modulators|mesh-ancestor
111201335|NCT03845270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111201336|NCT03845270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111201337|NCT03826693|Nitrous Oxide|nitrous oxide|mesh-list
111201338|NCT03826693|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111201339|NCT03826693|Anesthetics, General|anesthetics, general|mesh-ancestor
111201340|NCT03826693|Anesthetics|anesthetics|mesh-ancestor
111201341|NCT03826693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111201342|NCT03826693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111201343|NCT03826693|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111201344|NCT03826693|Analgesics|analgesics|mesh-ancestor
111201345|NCT03826693|Sensory System Agents|sensory system agents|mesh-ancestor
111201346|NCT03826693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111201347|NCT03816358|Gemcitabine|gemcitabine|mesh-list
111201348|NCT03816358|Nivolumab|nivolumab|mesh-list
111201349|NCT03816358|Ipilimumab|ipilimumab|mesh-list
111201350|NCT03816358|Maytansine|maytansine|mesh-list
111201351|NCT03816358|Anetumab ravtansine|anetumab ravtansine|mesh-list
111201352|NCT03816358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111201353|NCT03816358|Antimetabolites|antimetabolites|mesh-ancestor
111201354|NCT03816358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111201355|NCT03816358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111201356|NCT03816358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111201357|NCT03816358|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111201358|NCT03816358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111201359|NCT03816358|Tubulin Modulators|tubulin modulators|mesh-ancestor
111201360|NCT03816358|Antimitotic Agents|antimitotic agents|mesh-ancestor
111201361|NCT03816358|Mitosis Modulators|mitosis modulators|mesh-ancestor
111201362|NCT03816358|Immunoconjugates|immunoconjugates|mesh-ancestor
111201363|NCT03816358|Immunologic Factors|immunologic factors|mesh-ancestor
111201364|NCT03816358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111201365|NCT03811015|Deoxyglucose|deoxyglucose|mesh-list
111201366|NCT03811015|Cisplatin|cisplatin|mesh-list
111201367|NCT03811015|Nivolumab|nivolumab|mesh-list
111201368|NCT03811015|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
111201369|NCT03811015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111201370|NCT03811015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111201371|NCT03811015|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111201372|NCT03811015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111201373|NCT03811015|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111201374|NCT03811015|Antimetabolites|antimetabolites|mesh-ancestor
111201375|NCT03811015|Antiviral Agents|antiviral agents|mesh-ancestor
111201376|NCT03811015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111201377|NCT03811002|Cisplatin|cisplatin|mesh-list
111201378|NCT03811002|Carboplatin|carboplatin|mesh-list
111201379|NCT03811002|Etoposide|etoposide|mesh-list
111201380|NCT03811002|Etoposide phosphate|etoposide phosphate|mesh-list
111201381|NCT03811002|Atezolizumab|atezolizumab|mesh-list
111201382|NCT03811002|Podophyllotoxin|podophyllotoxin|mesh-list
111201383|NCT03811002|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111201384|NCT03811002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111201385|NCT03811002|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111201386|NCT03811002|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111201387|NCT03811002|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111201388|NCT03811002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111201389|NCT03811002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111201390|NCT03811002|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111201391|NCT03811002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111201392|NCT03811002|Immunologic Factors|immunologic factors|mesh-ancestor
111201393|NCT03811002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111201394|NCT03811002|Keratolytic Agents|keratolytic agents|mesh-ancestor
111201395|NCT03811002|Dermatologic Agents|dermatologic agents|mesh-ancestor
111201396|NCT03811002|Tubulin Modulators|tubulin modulators|mesh-ancestor
111201397|NCT03811002|Antimitotic Agents|antimitotic agents|mesh-ancestor
111201398|NCT03811002|Mitosis Modulators|mitosis modulators|mesh-ancestor
111201399|NCT03801902|Durvalumab|durvalumab|mesh-list
111201400|NCT03801902|Immunoglobulins|immunoglobulins|mesh-list
111201401|NCT03801902|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111201402|NCT03801902|Immunoglobulin G|immunoglobulin g|mesh-list
111201403|NCT03801902|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111201404|NCT03801902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111201405|NCT03801902|Immunologic Factors|immunologic factors|mesh-ancestor
111201406|NCT03801902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111201407|NCT03798691|Vaccines|vaccines|mesh-list
111201408|NCT03798691|Immunologic Factors|immunologic factors|mesh-ancestor
111201409|NCT03798691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111201410|NCT03793166|Nivolumab|nivolumab|mesh-list
111201411|NCT03793166|Ipilimumab|ipilimumab|mesh-list
111201412|NCT03793166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111201413|NCT03793166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111201414|NCT03793166|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111201415|NCT03793166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111201416|NCT03789240|Rituximab|rituximab|mesh-list
111201417|NCT03789240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111201418|NCT03789240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111201419|NCT03789240|Immunologic Factors|immunologic factors|mesh-ancestor
111201420|NCT03789240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111201421|NCT03789240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111201422|NCT03775265|Cisplatin|cisplatin|mesh-list
111201423|NCT03775265|Gemcitabine|gemcitabine|mesh-list
111201424|NCT03775265|Fluorouracil|fluorouracil|mesh-list
111201425|NCT03775265|Atezolizumab|atezolizumab|mesh-list
111201426|NCT03775265|Mitomycins|mitomycins|mesh-list
111201427|NCT03775265|Mitomycin|mitomycin|mesh-list
111201428|NCT03775265|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111201429|NCT03775265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111201430|NCT03775265|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111201431|NCT03775265|Antimetabolites|antimetabolites|mesh-ancestor
111201432|NCT03775265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111201433|NCT03775265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111201434|NCT03775265|Immunologic Factors|immunologic factors|mesh-ancestor
111201435|NCT03775265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111201436|NCT03775265|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111201437|NCT03775265|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111201438|NCT03775265|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111201439|NCT03775265|Alkylating Agents|alkylating agents|mesh-ancestor
111201440|NCT03775265|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111201441|NCT03775265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111201442|NCT03768349|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
111201443|NCT03768349|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111201444|NCT03768349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111201445|NCT03768063|Atezolizumab|atezolizumab|mesh-list
111201446|NCT03768063|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111201447|NCT03768063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111201448|NCT03768063|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111201449|NCT03768063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111201450|NCT03765983|Trastuzumab|trastuzumab|mesh-list
111201451|NCT03765983|GDC-0084|gdc-0084|mesh-list
111201452|NCT03765983|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111201453|NCT03765983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111201454|NCT03765983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111201455|NCT03765983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111201457|NCT03761225|Docetaxel|docetaxel|mesh-list
111201458|NCT03761225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111201459|NCT03761225|Tubulin Modulators|tubulin modulators|mesh-ancestor
111201460|NCT03761225|Antimitotic Agents|antimitotic agents|mesh-ancestor
111201461|NCT03761225|Mitosis Modulators|mitosis modulators|mesh-ancestor
111201462|NCT03761225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111201463|NCT03761225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111201464|NCT03761225|Glucocorticoids|glucocorticoids|mesh-ancestor
111201465|NCT03761225|Hormones|hormones|mesh-ancestor
111201466|NCT03761225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111201467|NCT03761225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111201468|NCT03761225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111201469|NCT03755804|Prednisone|prednisone|mesh-list
111201470|NCT03755804|Prednisolone|prednisolone|mesh-list
111201471|NCT03755804|Cyclophosphamide|cyclophosphamide|mesh-list
111201472|NCT03755804|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
111201473|NCT03755804|Dacarbazine|dacarbazine|mesh-list
111201474|NCT03755804|Doxorubicin|doxorubicin|mesh-list
111201475|NCT03755804|Etoposide|etoposide|mesh-list
111201476|NCT03755804|Vincristine|vincristine|mesh-list
111201477|NCT03755804|Bleomycin|bleomycin|mesh-list
111201478|NCT03755804|Brentuximab Vedotin|brentuximab vedotin|mesh-list
111201479|NCT03755804|Vinblastine|vinblastine|mesh-list
111201480|NCT03755804|Imidazole|imidazole|mesh-list
111201481|NCT03755804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111201482|NCT03755804|Immunologic Factors|immunologic factors|mesh-ancestor
111201483|NCT03755804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111201484|NCT03755804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111201485|NCT03755804|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111201486|NCT03755804|Alkylating Agents|alkylating agents|mesh-ancestor
111201487|NCT03755804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111201488|NCT03755804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111201489|NCT03755804|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111201490|NCT03755804|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111201491|NCT03755804|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111201492|NCT03755804|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111201493|NCT03755804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111201494|NCT03755804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111201495|NCT03755804|Glucocorticoids|glucocorticoids|mesh-ancestor
111201496|NCT03755804|Hormones|hormones|mesh-ancestor
111201497|NCT03755804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111201498|NCT03755804|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111201499|NCT03755804|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111201500|NCT03755804|Tubulin Modulators|tubulin modulators|mesh-ancestor
111201501|NCT03755804|Antimitotic Agents|antimitotic agents|mesh-ancestor
111201502|NCT03755804|Mitosis Modulators|mitosis modulators|mesh-ancestor
111201503|NCT03755804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111201504|NCT03755804|Immunotoxins|immunotoxins|mesh-ancestor
111201505|NCT03755804|Immunoconjugates|immunoconjugates|mesh-ancestor
111201506|NCT03744468|Tislelizumab|tislelizumab|mesh-list
111201507|NCT03744468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111201508|NCT03744468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111201509|NCT03739814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111201510|NCT03739814|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
111201511|NCT03739814|Blinatumomab|blinatumomab|mesh-list
111201512|NCT03739814|Antibodies|antibodies|mesh-list
111201513|NCT03739814|Immunoglobulins|immunoglobulins|mesh-list
111201514|NCT03739814|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111201515|NCT03739814|Muromonab-CD3|muromonab-cd3|mesh-list
111201516|NCT03739814|Antibodies, Bispecific|antibodies, bispecific|mesh-list
111201517|NCT03739814|Immunologic Factors|immunologic factors|mesh-ancestor
111201518|NCT03739814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111201519|NCT03739814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111201520|NCT03739814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111201521|NCT03739814|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111201523|NCT03739814|Immunoconjugates|immunoconjugates|mesh-ancestor
111201524|NCT03737643|Paclitaxel|paclitaxel|mesh-list
111201525|NCT03737643|Bevacizumab|bevacizumab|mesh-list
111201526|NCT03737643|Carboplatin|carboplatin|mesh-list
111201527|NCT03737643|Durvalumab|durvalumab|mesh-list
111201528|NCT03737643|Olaparib|olaparib|mesh-list
111201529|NCT03737643|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111201530|NCT03737643|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111201531|NCT03737643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111201532|NCT03737643|Tubulin Modulators|tubulin modulators|mesh-ancestor
111201533|NCT03737643|Antimitotic Agents|antimitotic agents|mesh-ancestor
111201534|NCT03737643|Mitosis Modulators|mitosis modulators|mesh-ancestor
111201535|NCT03737643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111201536|NCT03737643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111201537|NCT03737643|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111201538|NCT03737643|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111201539|NCT03737643|Growth Substances|growth substances|mesh-ancestor
111201540|NCT03737643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111201541|NCT03737643|Growth Inhibitors|growth inhibitors|mesh-ancestor
111201542|NCT03737643|Immunologic Factors|immunologic factors|mesh-ancestor
111201543|NCT03737643|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111201544|NCT03737643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111201545|NCT03733067|Abatacept|abatacept|mesh-list
111201546|NCT03733067|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111201547|NCT03733067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111201548|NCT03733067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111201549|NCT03733067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111201550|NCT03733067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111201551|NCT03733067|Immunologic Factors|immunologic factors|mesh-ancestor
111201552|NCT03733067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111201553|NCT03733067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111201554|NCT03712605|Pembrolizumab|pembrolizumab|mesh-list
111201555|NCT03712605|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111201556|NCT03712605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111201557|NCT03712605|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111201558|NCT03712605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111201559|NCT03704363|Infliximab|infliximab|mesh-list
111201560|NCT03704363|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111201561|NCT03704363|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111201562|NCT03704363|Dermatologic Agents|dermatologic agents|mesh-ancestor
111201563|NCT03704363|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111201564|NCT03704363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111201565|NCT03701308|Cytarabine|cytarabine|mesh-list
111201566|NCT03701308|Daunorubicin|daunorubicin|mesh-list
111201567|NCT03701308|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111201568|NCT03701308|Antimetabolites|antimetabolites|mesh-ancestor
111201569|NCT03701308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111201570|NCT03701308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111201571|NCT03701308|Antiviral Agents|antiviral agents|mesh-ancestor
111201572|NCT03701308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111201573|NCT03701308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111201574|NCT03701308|Immunologic Factors|immunologic factors|mesh-ancestor
111201575|NCT03701308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111201576|NCT03701308|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111201577|NCT03701308|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111201578|NCT03701308|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111201579|NCT03701308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111201580|NCT03700541|Morphine|morphine|mesh-list
111201581|NCT03700541|Pirinitramide|pirinitramide|mesh-list
111201582|NCT03700541|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111201583|NCT03700541|Narcotics|narcotics|mesh-ancestor
111201584|NCT03700541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111201585|NCT03700541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111201586|NCT03700541|Analgesics|analgesics|mesh-ancestor
111201587|NCT03700541|Sensory System Agents|sensory system agents|mesh-ancestor
111201588|NCT03700541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111201589|NCT03700411|Morphine|morphine|mesh-list
111201590|NCT03700411|Pirinitramide|pirinitramide|mesh-list
111201591|NCT03700411|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111201592|NCT03700411|Narcotics|narcotics|mesh-ancestor
111201593|NCT03700411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111201594|NCT03700411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111201595|NCT03700411|Analgesics|analgesics|mesh-ancestor
111201596|NCT03700411|Sensory System Agents|sensory system agents|mesh-ancestor
111201597|NCT03700411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111201598|NCT03699475|Cyclophosphamide|cyclophosphamide|mesh-list
111201599|NCT03699475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111201600|NCT03699475|Immunologic Factors|immunologic factors|mesh-ancestor
111201601|NCT03699475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111201602|NCT03699475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111201603|NCT03699475|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111201604|NCT03699475|Alkylating Agents|alkylating agents|mesh-ancestor
111201605|NCT03699475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111201606|NCT03699475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111201607|NCT03699475|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111201608|NCT03683251|Ranibizumab|ranibizumab|mesh-list
111201609|NCT03683251|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111201610|NCT03683251|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111201611|NCT03683251|Growth Substances|growth substances|mesh-ancestor
111201612|NCT03683251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111201613|NCT03683251|Growth Inhibitors|growth inhibitors|mesh-ancestor
111201614|NCT03683251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111201616|NCT03674424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111201617|NCT03674424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111201618|NCT03672630|Azithromycin|azithromycin|mesh-list
111201619|NCT03672630|Rifampin|rifampin|mesh-list
111201620|NCT03672630|Ethambutol|ethambutol|mesh-list
111201621|NCT03672630|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111201622|NCT03672630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111201623|NCT03672630|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111201624|NCT03672630|Antitubercular Agents|antitubercular agents|mesh-ancestor
111201625|NCT03672630|Leprostatic Agents|leprostatic agents|mesh-ancestor
111201626|NCT03672630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111201627|NCT03672630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111201628|NCT03672630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111201629|NCT03672630|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111201630|NCT03672630|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111201631|NCT03672630|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
111201632|NCT03672630|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
111201633|NCT03672630|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
111201634|NCT03672630|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111201635|NCT03668613|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111201636|NCT03668613|Immunologic Factors|immunologic factors|mesh-ancestor
111201637|NCT03668613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111201638|NCT03643510|Fulvestrant|fulvestrant|mesh-list
111201639|NCT03643510|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111201640|NCT03643510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111201641|NCT03643510|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
111201642|NCT03643510|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111201643|NCT03643510|Hormone Antagonists|hormone antagonists|mesh-ancestor
111201644|NCT03643510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111201645|NCT03643510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111201646|NCT03606967|Poly I-C|poly i-c|mesh-list
111201647|NCT03606967|Paclitaxel|paclitaxel|mesh-list
111201648|NCT03606967|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111201649|NCT03606967|Carboplatin|carboplatin|mesh-list
111201650|NCT03606967|Gemcitabine|gemcitabine|mesh-list
111201651|NCT03606967|Durvalumab|durvalumab|mesh-list
111201652|NCT03606967|Tremelimumab|tremelimumab|mesh-list
111201653|NCT03606967|Ipilimumab|ipilimumab|mesh-list
111201654|NCT03606967|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
111201655|NCT03606967|Vaccines|vaccines|mesh-list
111201656|NCT03606967|Immunoglobulins|immunoglobulins|mesh-list
111201657|NCT03606967|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111201658|NCT03606967|Immunoglobulin G|immunoglobulin g|mesh-list
111201659|NCT03606967|Poly ICLC|poly iclc|mesh-list
111201660|NCT03606967|Immunologic Factors|immunologic factors|mesh-ancestor
111201661|NCT03606967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111201662|NCT03606967|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111201663|NCT03606967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111201664|NCT03606967|Tubulin Modulators|tubulin modulators|mesh-ancestor
111201665|NCT03606967|Antimitotic Agents|antimitotic agents|mesh-ancestor
111201666|NCT03606967|Mitosis Modulators|mitosis modulators|mesh-ancestor
111201667|NCT03606967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111201668|NCT03606967|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111201669|NCT03606967|Antimetabolites|antimetabolites|mesh-ancestor
111201670|NCT03606967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111201671|NCT03606967|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111201672|NCT03606967|Interferon Inducers|interferon inducers|mesh-ancestor
111201673|NCT03606967|Laxatives|laxatives|mesh-ancestor
111201674|NCT03606967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111201675|NCT03606967|Antiviral Agents|antiviral agents|mesh-ancestor
111201676|NCT03606967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111201677|NCT03604991|Paclitaxel|paclitaxel|mesh-list
111201678|NCT03604991|Carboplatin|carboplatin|mesh-list
111201679|NCT03604991|Nivolumab|nivolumab|mesh-list
111201680|NCT03604991|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111201681|NCT03604991|Ipilimumab|ipilimumab|mesh-list
111201682|NCT03604991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111201683|NCT03604991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111201684|NCT03604991|Tubulin Modulators|tubulin modulators|mesh-ancestor
111201685|NCT03604991|Antimitotic Agents|antimitotic agents|mesh-ancestor
111201686|NCT03604991|Mitosis Modulators|mitosis modulators|mesh-ancestor
111201687|NCT03604991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111201688|NCT03604991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111201689|NCT03604991|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111201690|NCT03604978|Nivolumab|nivolumab|mesh-list
111201691|NCT03604978|Ipilimumab|ipilimumab|mesh-list
111201692|NCT03604978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111201693|NCT03604978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111201694|NCT03604978|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111201695|NCT03604978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111201696|NCT03600701|Atezolizumab|atezolizumab|mesh-list
111201697|NCT03600701|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111201698|NCT03600701|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111201699|NCT03600701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111201700|NCT03600701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111201701|NCT03600701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111201702|NCT03600701|Immunologic Factors|immunologic factors|mesh-ancestor
111201703|NCT03600701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111201704|NCT03599245|Ocrelizumab|ocrelizumab|mesh-list
111201705|NCT03599245|Immunologic Factors|immunologic factors|mesh-ancestor
111201706|NCT03599245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111201707|NCT03597555|Sodium Oxybate|sodium oxybate|mesh-list
111201708|NCT03597555|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111201709|NCT03597555|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111201710|NCT03597555|Anesthetics, General|anesthetics, general|mesh-ancestor
111201711|NCT03597555|Anesthetics|anesthetics|mesh-ancestor
111201712|NCT03597555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111201713|NCT03597555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111201714|NCT03595124|Nivolumab|nivolumab|mesh-list
111201715|NCT03595124|Axitinib|axitinib|mesh-list
111201716|NCT03595124|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111201717|NCT03595124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111201718|NCT03595124|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111201719|NCT03595124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111201720|NCT03595124|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111201721|NCT03595124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111201722|NCT03581292|Temozolomide|temozolomide|mesh-list
111201723|NCT03581292|Veliparib|veliparib|mesh-list
111201724|NCT03581292|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111201725|NCT03581292|Alkylating Agents|alkylating agents|mesh-ancestor
111201726|NCT03581292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111201727|NCT03581292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111201728|NCT03581292|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111201729|NCT03581292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111201730|NCT03571308|Prednisolone|prednisolone|mesh-list
111201731|NCT03571308|Cyclophosphamide|cyclophosphamide|mesh-list
111201732|NCT03571308|Doxorubicin|doxorubicin|mesh-list
111201733|NCT03571308|Vincristine|vincristine|mesh-list
111201734|NCT03571308|Acalabrutinib|acalabrutinib|mesh-list
111201735|NCT03571308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111201736|NCT03571308|Immunologic Factors|immunologic factors|mesh-ancestor
111201737|NCT03571308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111201738|NCT03571308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111201739|NCT03571308|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111201740|NCT03571308|Alkylating Agents|alkylating agents|mesh-ancestor
111201741|NCT03571308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111201742|NCT03571308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111201743|NCT03571308|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111201744|NCT03571308|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111201745|NCT03571308|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111201746|NCT03571308|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111201747|NCT03571308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111201748|NCT03571308|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111201749|NCT03571308|Tubulin Modulators|tubulin modulators|mesh-ancestor
111201750|NCT03571308|Antimitotic Agents|antimitotic agents|mesh-ancestor
111201751|NCT03571308|Mitosis Modulators|mitosis modulators|mesh-ancestor
111201752|NCT03571308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111201753|NCT03571308|Glucocorticoids|glucocorticoids|mesh-ancestor
111201754|NCT03571308|Hormones|hormones|mesh-ancestor
111201755|NCT03571308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110492126|NCT00753493|Topiramate|topiramate|mesh-list
111201756|NCT03571308|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111201757|NCT03568968|Niacinamide|niacinamide|mesh-list
111201758|NCT03568968|Niacin|niacin|mesh-list
111201759|NCT03568968|Nicotinic Acids|nicotinic acids|mesh-list
111201760|NCT03568968|Vitamin B Complex|vitamin b complex|mesh-ancestor
111201761|NCT03568968|Vitamins|vitamins|mesh-ancestor
111201762|NCT03568968|Micronutrients|micronutrients|mesh-ancestor
111201763|NCT03568968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111201764|NCT03568968|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111201765|NCT03568968|Antimetabolites|antimetabolites|mesh-ancestor
111201766|NCT03568968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111201767|NCT03568968|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111201768|NCT03568968|Vasodilator Agents|vasodilator agents|mesh-ancestor
111201769|NCT03554473|Temozolomide|temozolomide|mesh-list
111201770|NCT03554473|Topotecan|topotecan|mesh-list
111201771|NCT03554473|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110846221|NCT03375580|Simvastatin|simvastatin|mesh-list
111201772|NCT03554473|Alkylating Agents|alkylating agents|mesh-ancestor
111201773|NCT03554473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111201774|NCT03554473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111201775|NCT03554473|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111201776|NCT03554473|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111201777|NCT03554473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111201779|NCT03539731|Antinematodal Agents|antinematodal agents|mesh-ancestor
111201780|NCT03539731|Anthelmintics|anthelmintics|mesh-ancestor
111201781|NCT03539731|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111201782|NCT03539731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111201783|NCT03529448|Temozolomide|temozolomide|mesh-list
111201784|NCT03529448|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111201785|NCT03529448|Alkylating Agents|alkylating agents|mesh-ancestor
111201786|NCT03529448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111201787|NCT03529448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111201788|NCT03526250|Palbociclib|palbociclib|mesh-list
111201789|NCT03526250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111201790|NCT03526250|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111201791|NCT03526250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111201792|NCT03526250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111201793|NCT03520660|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
111201794|NCT03520660|Antiviral Agents|antiviral agents|mesh-ancestor
111201795|NCT03520660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111201796|NCT03519412|Pembrolizumab|pembrolizumab|mesh-list
111201797|NCT03519412|Temozolomide|temozolomide|mesh-list
111201798|NCT03519412|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111201799|NCT03519412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111201800|NCT03519412|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111201801|NCT03519412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111201802|NCT03519412|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111201803|NCT03519412|Alkylating Agents|alkylating agents|mesh-ancestor
111201804|NCT03514017|Pembrolizumab|pembrolizumab|mesh-list
111201805|NCT03514017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111201806|NCT03514017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111201807|NCT03514017|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111201808|NCT03514017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111201809|NCT03513406|Glycopyrrolate|glycopyrrolate|mesh-list
111201810|NCT03513406|Neostigmine|neostigmine|mesh-list
111201811|NCT03513406|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111201812|NCT03513406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111201813|NCT03513406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111201814|NCT03513406|Cholinergic Agents|cholinergic agents|mesh-ancestor
111201815|NCT03513406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111201816|NCT03513406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111201817|NCT03513406|Parasympathomimetics|parasympathomimetics|mesh-ancestor
111201818|NCT03513406|Autonomic Agents|autonomic agents|mesh-ancestor
111201819|NCT03513406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111201820|NCT03513406|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111201821|NCT03513406|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111201822|NCT03513406|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111201823|NCT03504163|Pembrolizumab|pembrolizumab|mesh-list
111201824|NCT03504163|BCG Vaccine|bcg vaccine|mesh-list
111201825|NCT03504163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111201826|NCT03504163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111201827|NCT03504163|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111201828|NCT03504163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111201829|NCT03504163|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111201830|NCT03504163|Immunologic Factors|immunologic factors|mesh-ancestor
111201831|NCT03504163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111201832|NCT03493945|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
111201833|NCT03493945|Antiviral Agents|antiviral agents|mesh-ancestor
111201834|NCT03493945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111201835|NCT03484819|Nivolumab|nivolumab|mesh-list
111201836|NCT03484819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111201837|NCT03484819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111201838|NCT03484819|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111201839|NCT03484819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111201840|NCT03478878|Vitamin A|vitamin a|mesh-list
111201841|NCT03478878|Retinol palmitate|retinol palmitate|mesh-list
111201842|NCT03478878|Vitamins|vitamins|mesh-ancestor
111201843|NCT03478878|Micronutrients|micronutrients|mesh-ancestor
111201844|NCT03478878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111201845|NCT03478878|Antioxidants|antioxidants|mesh-ancestor
111201846|NCT03478878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111201847|NCT03478878|Protective Agents|protective agents|mesh-ancestor
111201848|NCT03478878|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
111201849|NCT03478878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111201850|NCT03478865|Vitamin A|vitamin a|mesh-list
111201851|NCT03478865|Retinol palmitate|retinol palmitate|mesh-list
111201852|NCT03478865|Vitamins|vitamins|mesh-ancestor
111201853|NCT03478865|Micronutrients|micronutrients|mesh-ancestor
111201854|NCT03478865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111201855|NCT03478865|Antioxidants|antioxidants|mesh-ancestor
111201856|NCT03478865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111201857|NCT03478865|Protective Agents|protective agents|mesh-ancestor
111201858|NCT03478865|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
111201859|NCT03478865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111201860|NCT03469960|Nivolumab|nivolumab|mesh-list
111201861|NCT03469960|Ipilimumab|ipilimumab|mesh-list
111201862|NCT03469960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111201863|NCT03469960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111201864|NCT03469960|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111201865|NCT03469960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111201866|NCT03450343|Azacitidine|azacitidine|mesh-list
111201867|NCT03450343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111201868|NCT03450343|Antimetabolites|antimetabolites|mesh-ancestor
111201869|NCT03450343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111201870|NCT03450343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111201871|NCT03450343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111201872|NCT03448393|Cyclophosphamide|cyclophosphamide|mesh-list
111201873|NCT03448393|Fludarabine|fludarabine|mesh-list
111201874|NCT03448393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111201875|NCT03448393|Immunologic Factors|immunologic factors|mesh-ancestor
111201876|NCT03448393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111201877|NCT03448393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111201878|NCT03448393|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111201879|NCT03448393|Alkylating Agents|alkylating agents|mesh-ancestor
111201880|NCT03448393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111201881|NCT03448393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111201882|NCT03448393|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111201883|NCT03435952|Doxycycline|doxycycline|mesh-list
111201884|NCT03435952|Pembrolizumab|pembrolizumab|mesh-list
111201885|NCT03435952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111201886|NCT03435952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111201887|NCT03435952|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111201888|NCT03435952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111201889|NCT03435952|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111201890|NCT03435952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111201891|NCT03435952|Antimalarials|antimalarials|mesh-ancestor
111201892|NCT03435952|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111201893|NCT03435952|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111201894|NCT03420963|Cyclophosphamide|cyclophosphamide|mesh-list
111201895|NCT03420963|Etoposide|etoposide|mesh-list
111201896|NCT03420963|Etoposide phosphate|etoposide phosphate|mesh-list
111201897|NCT03420963|Podophyllotoxin|podophyllotoxin|mesh-list
111201898|NCT03420963|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111201899|NCT03420963|Immunologic Factors|immunologic factors|mesh-ancestor
111201900|NCT03420963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111201901|NCT03420963|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111201902|NCT03420963|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111201903|NCT03420963|Alkylating Agents|alkylating agents|mesh-ancestor
111201904|NCT03420963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111201905|NCT03420963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111201906|NCT03420963|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110846259|NCT02525237|Apatinib|apatinib|mesh-list
111201907|NCT03420963|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111201908|NCT03420963|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111201909|NCT03420963|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111201910|NCT03420963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111201911|NCT03420963|Keratolytic Agents|keratolytic agents|mesh-ancestor
111201912|NCT03420963|Dermatologic Agents|dermatologic agents|mesh-ancestor
111201913|NCT03420963|Tubulin Modulators|tubulin modulators|mesh-ancestor
111201914|NCT03420963|Antimitotic Agents|antimitotic agents|mesh-ancestor
111201915|NCT03420963|Mitosis Modulators|mitosis modulators|mesh-ancestor
111201916|NCT03418779|Prednisolone|prednisolone|mesh-list
111201917|NCT03418779|Cyclophosphamide|cyclophosphamide|mesh-list
111201918|NCT03418779|Immunosuppressive Agents|immunosuppressive agents|mesh-list
111201919|NCT03418779|Immunologic Factors|immunologic factors|mesh-ancestor
111201920|NCT03418779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111201921|NCT03418779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111201922|NCT03418779|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111201923|NCT03418779|Alkylating Agents|alkylating agents|mesh-ancestor
111201924|NCT03418779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111201925|NCT03418779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111201926|NCT03418779|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111201927|NCT03418779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111201928|NCT03418779|Glucocorticoids|glucocorticoids|mesh-ancestor
111201929|NCT03418779|Hormones|hormones|mesh-ancestor
111201930|NCT03418779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110799578|NCT02064556|Amlodipine|amlodipine|mesh-list
111201931|NCT03418779|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111201932|NCT03418038|Vitamins|vitamins|mesh-list
111201933|NCT03418038|Ascorbic Acid|ascorbic acid|mesh-list
111201934|NCT03418038|Cytarabine|cytarabine|mesh-list
111201935|NCT03418038|Dexamethasone|dexamethasone|mesh-list
111201936|NCT03418038|Dexamethasone acetate|dexamethasone acetate|mesh-list
111201937|NCT03418038|Rituximab|rituximab|mesh-list
111201938|NCT03418038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111201939|NCT03418038|Cisplatin|cisplatin|mesh-list
111201940|NCT03418038|Carboplatin|carboplatin|mesh-list
111201941|NCT03418038|Gemcitabine|gemcitabine|mesh-list
111201942|NCT03418038|Oxaliplatin|oxaliplatin|mesh-list
111201943|NCT03418038|Etoposide|etoposide|mesh-list
111201944|NCT03418038|Etoposide phosphate|etoposide phosphate|mesh-list
111201945|NCT03418038|Ifosfamide|ifosfamide|mesh-list
111201946|NCT03418038|Isophosphamide mustard|isophosphamide mustard|mesh-list
111201947|NCT03418038|Podophyllotoxin|podophyllotoxin|mesh-list
111201948|NCT03418038|Antibodies|antibodies|mesh-list
111201949|NCT03418038|Immunoglobulins|immunoglobulins|mesh-list
111201950|NCT03418038|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111201951|NCT03418038|BB 1101|bb 1101|mesh-list
111201952|NCT03418038|Micronutrients|micronutrients|mesh-ancestor
111201953|NCT03418038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111201954|NCT03418038|Immunologic Factors|immunologic factors|mesh-ancestor
111201955|NCT03418038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111201956|NCT03418038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111201957|NCT03418038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111201958|NCT03418038|Antiemetics|antiemetics|mesh-ancestor
111201959|NCT03418038|Autonomic Agents|autonomic agents|mesh-ancestor
111201960|NCT03418038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111201961|NCT03418038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111201962|NCT03418038|Glucocorticoids|glucocorticoids|mesh-ancestor
111201963|NCT03418038|Hormones|hormones|mesh-ancestor
111201964|NCT03418038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111201965|NCT03418038|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111201966|NCT03418038|Protease Inhibitors|protease inhibitors|mesh-ancestor
111201967|NCT03418038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111201968|NCT03418038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111201969|NCT03418038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111201970|NCT03418038|Antimetabolites|antimetabolites|mesh-ancestor
111201971|NCT03418038|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111201972|NCT03418038|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111201973|NCT03418038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111201974|NCT03418038|Antiviral Agents|antiviral agents|mesh-ancestor
111201975|NCT03418038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111201976|NCT03418038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111201977|NCT03418038|Antioxidants|antioxidants|mesh-ancestor
111201978|NCT03418038|Protective Agents|protective agents|mesh-ancestor
111201979|NCT03418038|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111201980|NCT03418038|Alkylating Agents|alkylating agents|mesh-ancestor
111201981|NCT03418038|Keratolytic Agents|keratolytic agents|mesh-ancestor
111201982|NCT03418038|Dermatologic Agents|dermatologic agents|mesh-ancestor
111201983|NCT03418038|Tubulin Modulators|tubulin modulators|mesh-ancestor
111201984|NCT03418038|Antimitotic Agents|antimitotic agents|mesh-ancestor
111201985|NCT03418038|Mitosis Modulators|mitosis modulators|mesh-ancestor
111201987|NCT03412877|Cyclophosphamide|cyclophosphamide|mesh-list
111201988|NCT03412877|Pembrolizumab|pembrolizumab|mesh-list
111201989|NCT03412877|Fludarabine|fludarabine|mesh-list
111201990|NCT03412877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111201991|NCT03412877|Immunologic Factors|immunologic factors|mesh-ancestor
111201992|NCT03412877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111201993|NCT03412877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111201994|NCT03412877|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111201995|NCT03412877|Alkylating Agents|alkylating agents|mesh-ancestor
111201996|NCT03412877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111201997|NCT03412877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111201998|NCT03412877|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111201999|NCT03412877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111202000|NCT03412877|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111202001|NCT03412877|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111202002|NCT03412877|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111202003|NCT03412877|Antiviral Agents|antiviral agents|mesh-ancestor
110492176|NCT00753883|Simvastatin|simvastatin|mesh-list
111202004|NCT03412877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111202005|NCT03409588|Riociguat|riociguat|mesh-list
111202006|NCT03409588|Enzyme Activators|enzyme activators|mesh-ancestor
111202007|NCT03409588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111202008|NCT03387085|Leucovorin|leucovorin|mesh-list
111202009|NCT03387085|Paclitaxel|paclitaxel|mesh-list
111202010|NCT03387085|Cyclophosphamide|cyclophosphamide|mesh-list
111202011|NCT03387085|Bevacizumab|bevacizumab|mesh-list
111202012|NCT03387085|Fluorouracil|fluorouracil|mesh-list
111202013|NCT03387085|Capecitabine|capecitabine|mesh-list
111202014|NCT03387085|Avelumab|avelumab|mesh-list
111202015|NCT03387085|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111202016|NCT03387085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111202017|NCT03387085|Tubulin Modulators|tubulin modulators|mesh-ancestor
111202018|NCT03387085|Antimitotic Agents|antimitotic agents|mesh-ancestor
111202019|NCT03387085|Mitosis Modulators|mitosis modulators|mesh-ancestor
111202020|NCT03387085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111202021|NCT03387085|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111202022|NCT03387085|Immunologic Factors|immunologic factors|mesh-ancestor
111202023|NCT03387085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111202024|NCT03387085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111202025|NCT03387085|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111202026|NCT03387085|Alkylating Agents|alkylating agents|mesh-ancestor
111202027|NCT03387085|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111202028|NCT03387085|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111202029|NCT03387085|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111202030|NCT03387085|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111202031|NCT03387085|Growth Substances|growth substances|mesh-ancestor
111202032|NCT03387085|Growth Inhibitors|growth inhibitors|mesh-ancestor
111202033|NCT03387085|Antimetabolites|antimetabolites|mesh-ancestor
111202034|NCT03387085|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111202035|NCT03387085|Antidotes|antidotes|mesh-ancestor
111202036|NCT03387085|Protective Agents|protective agents|mesh-ancestor
111202037|NCT03387085|Vitamin B Complex|vitamin b complex|mesh-ancestor
111202038|NCT03387085|Vitamins|vitamins|mesh-ancestor
111202039|NCT03387085|Micronutrients|micronutrients|mesh-ancestor
111202040|NCT03385928|Tranexamic Acid|tranexamic acid|mesh-list
111202041|NCT03385928|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111202042|NCT03385928|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111202043|NCT03385928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111202044|NCT03385928|Hemostatics|hemostatics|mesh-ancestor
111202045|NCT03385928|Coagulants|coagulants|mesh-ancestor
111202046|NCT03377361|Nivolumab|nivolumab|mesh-list
111202047|NCT03377361|Ipilimumab|ipilimumab|mesh-list
111202048|NCT03377361|Trametinib|trametinib|mesh-list
111202049|NCT03377361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111202050|NCT03377361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111202051|NCT03377361|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111202052|NCT03377361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111202053|NCT03377361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111202056|NCT03375307|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
111202057|NCT03375307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111202058|NCT03375307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111202059|NCT03375307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111202060|NCT03374254|Leucovorin|leucovorin|mesh-list
111202061|NCT03374254|Pembrolizumab|pembrolizumab|mesh-list
111202062|NCT03374254|Fluorouracil|fluorouracil|mesh-list
111202063|NCT03374254|Oxaliplatin|oxaliplatin|mesh-list
111202064|NCT03374254|Irinotecan|irinotecan|mesh-list
111202065|NCT03374254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111202066|NCT03374254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111202067|NCT03374254|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111202068|NCT03374254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111202069|NCT03374254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111202070|NCT03374254|Antimetabolites|antimetabolites|mesh-ancestor
111202071|NCT03374254|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111202072|NCT03374254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111202073|NCT03374254|Immunologic Factors|immunologic factors|mesh-ancestor
110492186|NCT00720382|Azelastine|azelastine|mesh-list
111202074|NCT03374254|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111202075|NCT03374254|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111202076|NCT03374254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111202077|NCT03374254|Antidotes|antidotes|mesh-ancestor
111202078|NCT03374254|Protective Agents|protective agents|mesh-ancestor
111202079|NCT03374254|Vitamin B Complex|vitamin b complex|mesh-ancestor
111202080|NCT03374254|Vitamins|vitamins|mesh-ancestor
111202081|NCT03374254|Micronutrients|micronutrients|mesh-ancestor
111202082|NCT03354728|Vaccines|vaccines|mesh-list
111202083|NCT03354728|Immunologic Factors|immunologic factors|mesh-ancestor
111202084|NCT03354728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111202085|NCT03350126|Nivolumab|nivolumab|mesh-list
111202086|NCT03350126|Ipilimumab|ipilimumab|mesh-list
111202087|NCT03350126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111202088|NCT03350126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111202089|NCT03350126|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111202090|NCT03350126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111202091|NCT03347929|Naproxen|naproxen|mesh-list
111202092|NCT03347929|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111202093|NCT03347929|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111202094|NCT03347929|Analgesics|analgesics|mesh-ancestor
111202095|NCT03347929|Sensory System Agents|sensory system agents|mesh-ancestor
111202096|NCT03347929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111202097|NCT03347929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111202098|NCT03347929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111202099|NCT03347929|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111202100|NCT03347929|Gout Suppressants|gout suppressants|mesh-ancestor
111202101|NCT03347929|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111202102|NCT03347929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111202103|NCT03347929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111202104|NCT03273023|Chromium|chromium|mesh-list
111202105|NCT03273023|Everolimus|everolimus|mesh-list
111202106|NCT03273023|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111202107|NCT03273023|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111202108|NCT03273023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111202109|NCT03273023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111202110|NCT03273023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111202111|NCT03273023|Immunologic Factors|immunologic factors|mesh-ancestor
111202112|NCT03273023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111202113|NCT03273023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111202114|NCT03273023|Trace Elements|trace elements|mesh-ancestor
111202115|NCT03273023|Micronutrients|micronutrients|mesh-ancestor
111202116|NCT03269669|Prednisone|prednisone|mesh-list
111202117|NCT03269669|Cortisone|cortisone|mesh-list
111202118|NCT03269669|Cyclophosphamide|cyclophosphamide|mesh-list
111202119|NCT03269669|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
111202120|NCT03269669|Doxorubicin|doxorubicin|mesh-list
111202121|NCT03269669|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111202122|NCT03269669|Vincristine|vincristine|mesh-list
111202123|NCT03269669|Lenalidomide|lenalidomide|mesh-list
111202124|NCT03269669|Obinutuzumab|obinutuzumab|mesh-list
111202125|NCT03269669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111202126|NCT03269669|Immunologic Factors|immunologic factors|mesh-ancestor
111202127|NCT03269669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111202128|NCT03269669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111202129|NCT03269669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111202130|NCT03269669|Alkylating Agents|alkylating agents|mesh-ancestor
110919120|NCT05723900|Castor Oil|castor oil|mesh-list
111202131|NCT03269669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111202132|NCT03269669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111202133|NCT03269669|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111202134|NCT03269669|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111202135|NCT03269669|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111202136|NCT03269669|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111202137|NCT03269669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111202138|NCT03269669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111202139|NCT03269669|Glucocorticoids|glucocorticoids|mesh-ancestor
111202140|NCT03269669|Hormones|hormones|mesh-ancestor
111202141|NCT03269669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111202142|NCT03269669|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111202143|NCT03269669|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111202144|NCT03269669|Tubulin Modulators|tubulin modulators|mesh-ancestor
111202145|NCT03269669|Antimitotic Agents|antimitotic agents|mesh-ancestor
111202146|NCT03269669|Mitosis Modulators|mitosis modulators|mesh-ancestor
111202147|NCT03269669|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111202148|NCT03269669|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111202149|NCT03269669|Growth Substances|growth substances|mesh-ancestor
111202150|NCT03269669|Growth Inhibitors|growth inhibitors|mesh-ancestor
111202151|NCT03269669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111202152|NCT03248570|Pembrolizumab|pembrolizumab|mesh-list
111202153|NCT03248570|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111202154|NCT03248570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111202155|NCT03248570|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111202156|NCT03248570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111202157|NCT03237689|Hydrocortisone|hydrocortisone|mesh-list
111202158|NCT03237689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111202159|NCT03233204|Olaparib|olaparib|mesh-list
111202160|NCT03233204|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
111202161|NCT03233204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111202162|NCT03233204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111202163|NCT03233204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111202164|NCT03216525|Alvimopan|alvimopan|mesh-list
111202165|NCT03216525|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111202166|NCT03213652|Ensartinib|ensartinib|mesh-list
111202167|NCT03213652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111202168|NCT03213652|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111202169|NCT03213652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111202170|NCT03213652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111202171|NCT03206060|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
111202172|NCT03206060|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111202173|NCT03206060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111202174|NCT03193190|Leucovorin|leucovorin|mesh-list
111202175|NCT03193190|Paclitaxel|paclitaxel|mesh-list
111202176|NCT03193190|Bevacizumab|bevacizumab|mesh-list
111202177|NCT03193190|Gemcitabine|gemcitabine|mesh-list
111202178|NCT03193190|Fluorouracil|fluorouracil|mesh-list
111202179|NCT03193190|Oxaliplatin|oxaliplatin|mesh-list
111202180|NCT03193190|Atezolizumab|atezolizumab|mesh-list
111202181|NCT03193190|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111202182|NCT03193190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111202183|NCT03193190|Tubulin Modulators|tubulin modulators|mesh-ancestor
111202184|NCT03193190|Antimitotic Agents|antimitotic agents|mesh-ancestor
111202185|NCT03193190|Mitosis Modulators|mitosis modulators|mesh-ancestor
111202186|NCT03193190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111202187|NCT03193190|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111202188|NCT03193190|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111202189|NCT03193190|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111202190|NCT03193190|Growth Substances|growth substances|mesh-ancestor
111202191|NCT03193190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111202192|NCT03193190|Growth Inhibitors|growth inhibitors|mesh-ancestor
111202193|NCT03193190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111202194|NCT03193190|Antimetabolites|antimetabolites|mesh-ancestor
111202195|NCT03193190|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111202196|NCT03193190|Immunologic Factors|immunologic factors|mesh-ancestor
111202197|NCT03193190|Antidotes|antidotes|mesh-ancestor
111202198|NCT03193190|Protective Agents|protective agents|mesh-ancestor
111202199|NCT03193190|Vitamin B Complex|vitamin b complex|mesh-ancestor
111202200|NCT03193190|Vitamins|vitamins|mesh-ancestor
111202201|NCT03193190|Micronutrients|micronutrients|mesh-ancestor
111202202|NCT03193190|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111202203|NCT03191149|Osimertinib|osimertinib|mesh-list
110919190|NCT04328506|Vorolanib|vorolanib|mesh-list
111202204|NCT03191149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111202205|NCT03191149|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111202206|NCT03191149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111202207|NCT03191149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111202208|NCT03190915|Trametinib|trametinib|mesh-list
111202209|NCT03190915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111202210|NCT03190915|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111202211|NCT03190915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111202212|NCT03190915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111202213|NCT03181867|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
111202214|NCT03181867|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111202215|NCT03181867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111202216|NCT03173924|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
111202217|NCT03173924|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111202218|NCT03173924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111202219|NCT03155620|Olaparib|olaparib|mesh-list
111202220|NCT03155620|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
111202221|NCT03155620|Palbociclib|palbociclib|mesh-list
111202222|NCT03155620|Vemurafenib|vemurafenib|mesh-list
111202223|NCT03155620|Tipifarnib|tipifarnib|mesh-list
111202224|NCT03155620|Ensartinib|ensartinib|mesh-list
111202225|NCT03155620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111202226|NCT03155620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111202227|NCT03155620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111202228|NCT03155620|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111202229|NCT03143270|Nivolumab|nivolumab|mesh-list
111202230|NCT03143270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111202231|NCT03143270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111202232|NCT03143270|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111202233|NCT03143270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111202234|NCT03143153|Fluorouracil|fluorouracil|mesh-list
111202235|NCT03143153|Nivolumab|nivolumab|mesh-list
111202236|NCT03143153|Ipilimumab|ipilimumab|mesh-list
111202237|NCT03143153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111202238|NCT03143153|Antimetabolites|antimetabolites|mesh-ancestor
111202239|NCT03143153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111202240|NCT03143153|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111202241|NCT03143153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111202242|NCT03143153|Immunologic Factors|immunologic factors|mesh-ancestor
111202243|NCT03143153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111202244|NCT03143153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111202245|NCT03143153|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111202246|NCT03141684|Bevacizumab|bevacizumab|mesh-list
111202247|NCT03141684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111202248|NCT03141684|Atezolizumab|atezolizumab|mesh-list
111202249|NCT03141684|Endothelial Growth Factors|endothelial growth factors|mesh-list
111202250|NCT03141684|Antibodies|antibodies|mesh-list
111202251|NCT03141684|Immunoglobulins|immunoglobulins|mesh-list
111202252|NCT03141684|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111202253|NCT03141684|Immunoglobulin G|immunoglobulin g|mesh-list
111202254|NCT03141684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111202255|NCT03141684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111202256|NCT03141684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111202257|NCT03141684|Growth Substances|growth substances|mesh-ancestor
111202258|NCT03141684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111202259|NCT03141684|Growth Inhibitors|growth inhibitors|mesh-ancestor
111202260|NCT03141684|Immunologic Factors|immunologic factors|mesh-ancestor
111202261|NCT03141684|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111202262|NCT03141684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111202263|NCT03117751|Cytarabine|cytarabine|mesh-list
111202264|NCT03117751|Dexamethasone|dexamethasone|mesh-list
111202265|NCT03117751|Prednisone|prednisone|mesh-list
111202266|NCT03117751|Prednisolone|prednisolone|mesh-list
111202267|NCT03117751|Cyclophosphamide|cyclophosphamide|mesh-list
111202268|NCT03117751|Doxorubicin|doxorubicin|mesh-list
111202269|NCT03117751|Methotrexate|methotrexate|mesh-list
111202270|NCT03117751|Etoposide|etoposide|mesh-list
111202271|NCT03117751|Etoposide phosphate|etoposide phosphate|mesh-list
111202272|NCT03117751|Vincristine|vincristine|mesh-list
111202273|NCT03117751|Bortezomib|bortezomib|mesh-list
111202274|NCT03117751|Daunorubicin|daunorubicin|mesh-list
111202275|NCT03117751|Asparaginase|asparaginase|mesh-list
111202276|NCT03117751|Dasatinib|dasatinib|mesh-list
111202277|NCT03117751|Mercaptopurine|mercaptopurine|mesh-list
111202278|NCT03117751|Vorinostat|vorinostat|mesh-list
111202279|NCT03117751|Idarubicin|idarubicin|mesh-list
111202280|NCT03117751|Clofarabine|clofarabine|mesh-list
111202281|NCT03117751|Pegaspargase|pegaspargase|mesh-list
111202282|NCT03117751|Thioguanine|thioguanine|mesh-list
111202283|NCT03117751|Blinatumomab|blinatumomab|mesh-list
111202284|NCT03117751|Asparaginase erwinia chrysanthemi, recombinant-rywn|asparaginase erwinia chrysanthemi, recombinant-rywn|mesh-list
111202285|NCT03117751|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111202286|NCT03117751|Immunologic Factors|immunologic factors|mesh-ancestor
111202287|NCT03117751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111202288|NCT03117751|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111202289|NCT03117751|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111202290|NCT03117751|Alkylating Agents|alkylating agents|mesh-ancestor
111202291|NCT03117751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111202292|NCT03117751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111202293|NCT03117751|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111202294|NCT03117751|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111202295|NCT03117751|Antiemetics|antiemetics|mesh-ancestor
111202296|NCT03117751|Autonomic Agents|autonomic agents|mesh-ancestor
111202297|NCT03117751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111202298|NCT03117751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111202299|NCT03117751|Glucocorticoids|glucocorticoids|mesh-ancestor
111202301|NCT03117751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111202302|NCT03117751|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111202303|NCT03117751|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111202304|NCT03117751|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111202305|NCT03117751|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111202306|NCT03117751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111202307|NCT03117751|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111202308|NCT03117751|Abortifacient Agents|abortifacient agents|mesh-ancestor
111202309|NCT03117751|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111202310|NCT03117751|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111202311|NCT03117751|Antimetabolites|antimetabolites|mesh-ancestor
111202312|NCT03117751|Dermatologic Agents|dermatologic agents|mesh-ancestor
111202313|NCT03117751|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111202314|NCT03117751|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111202315|NCT03117751|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111202316|NCT03117751|Antiviral Agents|antiviral agents|mesh-ancestor
111202317|NCT03117751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111202318|NCT03117751|Tubulin Modulators|tubulin modulators|mesh-ancestor
111202319|NCT03117751|Antimitotic Agents|antimitotic agents|mesh-ancestor
111202320|NCT03117751|Mitosis Modulators|mitosis modulators|mesh-ancestor
111202321|NCT03117751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111202322|NCT03117751|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111202323|NCT03113968|Ketamine|ketamine|mesh-list
111202324|NCT03113968|Analgesics|analgesics|mesh-ancestor
111202325|NCT03113968|Sensory System Agents|sensory system agents|mesh-ancestor
111202326|NCT03113968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111202327|NCT03113968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111202328|NCT03113968|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111202329|NCT03113968|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111202330|NCT03113968|Anesthetics, General|anesthetics, general|mesh-ancestor
111202331|NCT03113968|Anesthetics|anesthetics|mesh-ancestor
111202332|NCT03113968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111202333|NCT03113968|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111202334|NCT03113968|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111202335|NCT03113968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111202336|NCT03113968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111202337|NCT03112174|Venetoclax|venetoclax|mesh-list
111202338|NCT03112174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111202339|NCT03064126|Paclitaxel|paclitaxel|mesh-list
111202340|NCT03064126|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111202341|NCT03064126|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111202342|NCT03064126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111202343|NCT03064126|Tubulin Modulators|tubulin modulators|mesh-ancestor
111202344|NCT03064126|Antimitotic Agents|antimitotic agents|mesh-ancestor
111202345|NCT03064126|Mitosis Modulators|mitosis modulators|mesh-ancestor
111202346|NCT03064126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111202347|NCT03047135|Olaparib|olaparib|mesh-list
111202348|NCT03047135|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111202349|NCT03047135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111202350|NCT03047135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111202351|NCT03047135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111202352|NCT03036098|Carboplatin|carboplatin|mesh-list
111202353|NCT03036098|Gemcitabine|gemcitabine|mesh-list
111202354|NCT03036098|Nivolumab|nivolumab|mesh-list
111202355|NCT03036098|Ipilimumab|ipilimumab|mesh-list
111202356|NCT03036098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111202357|NCT03036098|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111202358|NCT03036098|Antimetabolites|antimetabolites|mesh-ancestor
111202359|NCT03036098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111202360|NCT03036098|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111202361|NCT03036098|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111202362|NCT03031730|Dexamethasone|dexamethasone|mesh-list
111202363|NCT03031730|Dexamethasone acetate|dexamethasone acetate|mesh-list
111202364|NCT03031730|Lenalidomide|lenalidomide|mesh-list
111202365|NCT03031730|Ichthammol|ichthammol|mesh-list
111202366|NCT03031730|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
111202367|NCT03031730|BB 1101|bb 1101|mesh-list
111202368|NCT03031730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111202369|NCT03031730|Antiemetics|antiemetics|mesh-ancestor
111202370|NCT03031730|Autonomic Agents|autonomic agents|mesh-ancestor
111202371|NCT03031730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111202372|NCT03031730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111202373|NCT03031730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111202374|NCT03031730|Glucocorticoids|glucocorticoids|mesh-ancestor
111202375|NCT03031730|Hormones|hormones|mesh-ancestor
111202376|NCT03031730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111202377|NCT03031730|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111202378|NCT03031730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111202379|NCT03031730|Protease Inhibitors|protease inhibitors|mesh-ancestor
111202380|NCT03031730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111202381|NCT03031730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111202382|NCT03031730|Immunologic Factors|immunologic factors|mesh-ancestor
111202383|NCT03031730|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111202384|NCT03031730|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111202385|NCT03031730|Growth Substances|growth substances|mesh-ancestor
111202386|NCT03031730|Growth Inhibitors|growth inhibitors|mesh-ancestor
111202387|NCT03031730|Dermatologic Agents|dermatologic agents|mesh-ancestor
111202388|NCT03030378|Pembrolizumab|pembrolizumab|mesh-list
111202389|NCT03030378|Interleukin-12|interleukin-12|mesh-list
111202390|NCT03030378|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111202391|NCT03030378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111202392|NCT03030378|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111202393|NCT03030378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111202394|NCT03030378|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111202395|NCT03030378|Immunologic Factors|immunologic factors|mesh-ancestor
111202396|NCT03030378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111202397|NCT03030378|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110799579|NCT02064556|Candesartan|candesartan|mesh-list
111202398|NCT03030378|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111202399|NCT03030378|Growth Substances|growth substances|mesh-ancestor
111202400|NCT03030378|Growth Inhibitors|growth inhibitors|mesh-ancestor
111202401|NCT03028857|Choline|choline|mesh-list
111202402|NCT03028857|Lipotropic Agents|lipotropic agents|mesh-ancestor
111202403|NCT03028857|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111202404|NCT03028857|Antimetabolites|antimetabolites|mesh-ancestor
111202405|NCT03028857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111202406|NCT03028857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111202407|NCT03028857|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111202408|NCT03028857|Nootropic Agents|nootropic agents|mesh-ancestor
111202409|NCT02997228|Leucovorin|leucovorin|mesh-list
111202410|NCT02997228|Bevacizumab|bevacizumab|mesh-list
111202411|NCT02997228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111202412|NCT02997228|Atezolizumab|atezolizumab|mesh-list
111202413|NCT02997228|Fluorouracil|fluorouracil|mesh-list
111202414|NCT02997228|Oxaliplatin|oxaliplatin|mesh-list
111202415|NCT02997228|Endothelial Growth Factors|endothelial growth factors|mesh-list
111202416|NCT02997228|Antibodies|antibodies|mesh-list
111202417|NCT02997228|Immunoglobulins|immunoglobulins|mesh-list
111202418|NCT02997228|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111202419|NCT02997228|Immunoglobulin G|immunoglobulin g|mesh-list
111202420|NCT02997228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111202421|NCT02997228|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111202422|NCT02997228|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111202423|NCT02997228|Growth Substances|growth substances|mesh-ancestor
111202424|NCT02997228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111202425|NCT02997228|Growth Inhibitors|growth inhibitors|mesh-ancestor
111202426|NCT02997228|Immunologic Factors|immunologic factors|mesh-ancestor
111202427|NCT02997228|Antimetabolites|antimetabolites|mesh-ancestor
111202428|NCT02997228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111202429|NCT02997228|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111202430|NCT02997228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111202431|NCT02997228|Antidotes|antidotes|mesh-ancestor
111202432|NCT02997228|Protective Agents|protective agents|mesh-ancestor
111202433|NCT02997228|Vitamin B Complex|vitamin b complex|mesh-ancestor
111202434|NCT02997228|Vitamins|vitamins|mesh-ancestor
111202435|NCT02997228|Micronutrients|micronutrients|mesh-ancestor
111202436|NCT02997228|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111202437|NCT02994576|Atezolizumab|atezolizumab|mesh-list
111202438|NCT02994576|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111202439|NCT02994576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111202440|NCT02994576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111202441|NCT02994576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111202442|NCT02985957|Prednisone|prednisone|mesh-list
111202443|NCT02985957|Nivolumab|nivolumab|mesh-list
111202444|NCT02985957|Ipilimumab|ipilimumab|mesh-list
111202445|NCT02985957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111202446|NCT02985957|Glucocorticoids|glucocorticoids|mesh-ancestor
111202447|NCT02985957|Hormones|hormones|mesh-ancestor
111202448|NCT02985957|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111202449|NCT02985957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111202450|NCT02985957|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111202451|NCT02985957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111202452|NCT02985957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111202453|NCT02985957|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111202454|NCT02985957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111202455|NCT02973789|Docetaxel|docetaxel|mesh-list
111202456|NCT02973789|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
111202457|NCT02973789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111202458|NCT02973789|Tubulin Modulators|tubulin modulators|mesh-ancestor
111202459|NCT02973789|Antimitotic Agents|antimitotic agents|mesh-ancestor
111202460|NCT02973789|Mitosis Modulators|mitosis modulators|mesh-ancestor
111202461|NCT02973789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111202462|NCT02973789|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111202463|NCT02915198|Metformin|metformin|mesh-list
111202464|NCT02915198|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111202465|NCT02915198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111202466|NCT02906007|Bedaquiline|bedaquiline|mesh-list
111202467|NCT02906007|Antitubercular Agents|antitubercular agents|mesh-ancestor
111202468|NCT02906007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111202469|NCT02906007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111202470|NCT02883049|Calcium, Dietary|calcium, dietary|mesh-list
111202471|NCT02883049|Leucovorin|leucovorin|mesh-list
111202472|NCT02883049|Folic Acid|folic acid|mesh-list
111202473|NCT02883049|Cytarabine|cytarabine|mesh-list
111202474|NCT02883049|Dexamethasone|dexamethasone|mesh-list
111202475|NCT02883049|Dexamethasone acetate|dexamethasone acetate|mesh-list
111202477|NCT02883049|Hydrocortisone|hydrocortisone|mesh-list
111202478|NCT02883049|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
111202479|NCT02883049|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
111202480|NCT02883049|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
111202481|NCT02883049|Cortisone|cortisone|mesh-list
111202482|NCT02883049|Cyclophosphamide|cyclophosphamide|mesh-list
111202483|NCT02883049|Doxorubicin|doxorubicin|mesh-list
111202484|NCT02883049|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111202485|NCT02883049|Methotrexate|methotrexate|mesh-list
111202486|NCT02883049|Etoposide|etoposide|mesh-list
111202487|NCT02883049|Vincristine|vincristine|mesh-list
111202488|NCT02883049|Etoposide phosphate|etoposide phosphate|mesh-list
111202489|NCT02883049|Daunorubicin|daunorubicin|mesh-list
111202490|NCT02883049|Asparaginase|asparaginase|mesh-list
111202491|NCT02883049|Dasatinib|dasatinib|mesh-list
111202492|NCT02883049|Mercaptopurine|mercaptopurine|mesh-list
111202493|NCT02883049|Clofarabine|clofarabine|mesh-list
111202494|NCT02883049|Podophyllotoxin|podophyllotoxin|mesh-list
111202495|NCT02883049|Pegaspargase|pegaspargase|mesh-list
111202496|NCT02883049|Thioguanine|thioguanine|mesh-list
111202497|NCT02883049|BB 1101|bb 1101|mesh-list
111202498|NCT02883049|Calcium|calcium|mesh-list
111202499|NCT02883049|2-Aminopurine|2-aminopurine|mesh-list
111202500|NCT02883049|Levoleucovorin|levoleucovorin|mesh-list
111202501|NCT02883049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111202502|NCT02883049|Immunologic Factors|immunologic factors|mesh-ancestor
111202503|NCT02883049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111202504|NCT02883049|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111202505|NCT02883049|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111202506|NCT02883049|Alkylating Agents|alkylating agents|mesh-ancestor
111202507|NCT02883049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111202508|NCT02883049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111202509|NCT02883049|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111202510|NCT02883049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111202511|NCT02883049|Antiemetics|antiemetics|mesh-ancestor
111202512|NCT02883049|Autonomic Agents|autonomic agents|mesh-ancestor
111202513|NCT02883049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111202514|NCT02883049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111202515|NCT02883049|Glucocorticoids|glucocorticoids|mesh-ancestor
111202517|NCT02883049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111202518|NCT02883049|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111202519|NCT02883049|Protease Inhibitors|protease inhibitors|mesh-ancestor
111202520|NCT02883049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111202521|NCT02883049|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111202522|NCT02883049|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111202523|NCT02883049|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111202524|NCT02883049|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111202525|NCT02883049|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111202526|NCT02883049|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111202527|NCT02883049|Abortifacient Agents|abortifacient agents|mesh-ancestor
111202528|NCT02883049|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111202529|NCT02883049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111202530|NCT02883049|Antimetabolites|antimetabolites|mesh-ancestor
111202531|NCT02883049|Dermatologic Agents|dermatologic agents|mesh-ancestor
111202532|NCT02883049|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111202533|NCT02883049|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111202534|NCT02883049|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111202535|NCT02883049|Antiviral Agents|antiviral agents|mesh-ancestor
111202536|NCT02883049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111202537|NCT02883049|Antidotes|antidotes|mesh-ancestor
111202538|NCT02883049|Protective Agents|protective agents|mesh-ancestor
111202539|NCT02883049|Vitamin B Complex|vitamin b complex|mesh-ancestor
111202540|NCT02883049|Vitamins|vitamins|mesh-ancestor
111202541|NCT02883049|Micronutrients|micronutrients|mesh-ancestor
111202542|NCT02883049|Tubulin Modulators|tubulin modulators|mesh-ancestor
111202543|NCT02883049|Antimitotic Agents|antimitotic agents|mesh-ancestor
111202544|NCT02883049|Mitosis Modulators|mitosis modulators|mesh-ancestor
111202545|NCT02883049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111202546|NCT02883049|Hematinics|hematinics|mesh-ancestor
111202547|NCT02883049|Keratolytic Agents|keratolytic agents|mesh-ancestor
111202548|NCT02864251|Carboplatin|carboplatin|mesh-list
111202549|NCT02864251|Nivolumab|nivolumab|mesh-list
111202550|NCT02864251|Pemetrexed|pemetrexed|mesh-list
111202551|NCT02864251|Ipilimumab|ipilimumab|mesh-list
111202552|NCT02864251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111202553|NCT02864251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111202554|NCT02864251|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111202555|NCT02864251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111202556|NCT02864251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111202557|NCT02864251|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111202558|NCT02864251|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111202559|NCT02834013|Nivolumab|nivolumab|mesh-list
111202560|NCT02834013|Ipilimumab|ipilimumab|mesh-list
111202561|NCT02834013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111202562|NCT02834013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111202563|NCT02834013|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111202564|NCT02834013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111202565|NCT02822092|Risperidone|risperidone|mesh-list
111202566|NCT02822092|Aripiprazole|aripiprazole|mesh-list
111202567|NCT02822092|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111202568|NCT02822092|Serotonin Agents|serotonin agents|mesh-ancestor
111202569|NCT02822092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111202570|NCT02822092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111202571|NCT02822092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111202572|NCT02822092|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111202573|NCT02822092|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111202574|NCT02822092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111202575|NCT02822092|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111202576|NCT02822092|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111202577|NCT02822092|Dopamine Agents|dopamine agents|mesh-ancestor
111202578|NCT02822092|Antidepressive Agents|antidepressive agents|mesh-ancestor
111202579|NCT02822092|Dopamine Agonists|dopamine agonists|mesh-ancestor
111202580|NCT02822092|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111202581|NCT02822092|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111202582|NCT02822092|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111202583|NCT02822092|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111202584|NCT02816021|Pembrolizumab|pembrolizumab|mesh-list
111202585|NCT02816021|Azacitidine|azacitidine|mesh-list
111202586|NCT02816021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111202587|NCT02816021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111202588|NCT02816021|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111202589|NCT02816021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111202590|NCT02816021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111202591|NCT02816021|Antimetabolites|antimetabolites|mesh-ancestor
111202592|NCT02816021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111202593|NCT02779751|Pembrolizumab|pembrolizumab|mesh-list
111202594|NCT02779751|Anastrozole|anastrozole|mesh-list
111202595|NCT02779751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111202596|NCT02779751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111202597|NCT02779751|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111202598|NCT02779751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111202599|NCT02779751|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111202600|NCT02779751|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111202601|NCT02779751|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111202602|NCT02779751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111202603|NCT02779751|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111202604|NCT02779751|Hormone Antagonists|hormone antagonists|mesh-ancestor
111202605|NCT02779751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111202606|NCT02779751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111202607|NCT02774148|Acetaminophen|acetaminophen|mesh-list
111202608|NCT02774148|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111202609|NCT02774148|Analgesics|analgesics|mesh-ancestor
111202610|NCT02774148|Sensory System Agents|sensory system agents|mesh-ancestor
111202611|NCT02774148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111202612|NCT02774148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111202613|NCT02774148|Antipyretics|antipyretics|mesh-ancestor
111202614|NCT02771197|Pembrolizumab|pembrolizumab|mesh-list
111202615|NCT02771197|Fludarabine|fludarabine|mesh-list
111202616|NCT02771197|Melphalan|melphalan|mesh-list
111202617|NCT02771197|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111202618|NCT02771197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111202619|NCT02771197|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111202620|NCT02771197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111202621|NCT02771197|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111202622|NCT02771197|Immunologic Factors|immunologic factors|mesh-ancestor
111202623|NCT02771197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111202624|NCT02771197|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111202625|NCT02771197|Alkylating Agents|alkylating agents|mesh-ancestor
111202626|NCT02771197|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111202627|NCT02769962|Olaparib|olaparib|mesh-list
111202628|NCT02769962|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111202629|NCT02769962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111202630|NCT02769962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111202631|NCT02769962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111202632|NCT02722421|Efavirenz|efavirenz|mesh-list
111202633|NCT02722421|Levonorgestrel|levonorgestrel|mesh-list
111202634|NCT02722421|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111202635|NCT02722421|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111202636|NCT02722421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111202637|NCT02722421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111202638|NCT02722421|Antiviral Agents|antiviral agents|mesh-ancestor
111202639|NCT02722421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111202640|NCT02722421|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111202641|NCT02722421|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111202642|NCT02722421|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111202643|NCT02722421|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111202644|NCT02722421|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111202645|NCT02722421|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111202646|NCT02722421|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111202647|NCT02722421|Contraceptive Agents|contraceptive agents|mesh-ancestor
111202648|NCT02722421|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111202649|NCT02722421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111202650|NCT02722421|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111202651|NCT02722421|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111202652|NCT02722421|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111202653|NCT02693535|Pembrolizumab|pembrolizumab|mesh-list
111202654|NCT02693535|Nivolumab|nivolumab|mesh-list
111202655|NCT02693535|Trastuzumab|trastuzumab|mesh-list
111202656|NCT02693535|Ipilimumab|ipilimumab|mesh-list
111202657|NCT02693535|Atezolizumab|atezolizumab|mesh-list
111202658|NCT02693535|Pertuzumab|pertuzumab|mesh-list
111202659|NCT02693535|Sunitinib|sunitinib|mesh-list
111202660|NCT02693535|Olaparib|olaparib|mesh-list
111202661|NCT02693535|Palbociclib|palbociclib|mesh-list
111202662|NCT02693535|Temsirolimus|temsirolimus|mesh-list
111202663|NCT02693535|Vemurafenib|vemurafenib|mesh-list
111202664|NCT02693535|Talazoparib|talazoparib|mesh-list
111202665|NCT02693535|Tucatinib|tucatinib|mesh-list
111202666|NCT02693535|Futibatinib|futibatinib|mesh-list
111202667|NCT02693535|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111202668|NCT02693535|Entrectinib|entrectinib|mesh-list
111202669|NCT02693535|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111202670|NCT02693535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111202671|NCT02693535|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111202672|NCT02693535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111202673|NCT02693535|Immunologic Factors|immunologic factors|mesh-ancestor
111202674|NCT02693535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111202675|NCT02693535|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111202676|NCT02693535|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111202677|NCT02693535|Growth Substances|growth substances|mesh-ancestor
111202678|NCT02693535|Growth Inhibitors|growth inhibitors|mesh-ancestor
111202679|NCT02693535|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111202680|NCT02693535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111202681|NCT02693535|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111202682|NCT02693535|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111202683|NCT02693535|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111202684|NCT02693184|Vitamin D|vitamin d|mesh-list
111202685|NCT02693184|Calcium|calcium|mesh-list
111202686|NCT02693184|Vitamins|vitamins|mesh-ancestor
111202687|NCT02693184|Micronutrients|micronutrients|mesh-ancestor
111202688|NCT02693184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111202689|NCT02693184|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111202690|NCT02693184|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111202691|NCT02689427|Paclitaxel|paclitaxel|mesh-list
111202692|NCT02689427|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111202693|NCT02689427|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111202694|NCT02689427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111202695|NCT02689427|Tubulin Modulators|tubulin modulators|mesh-ancestor
111202696|NCT02689427|Antimitotic Agents|antimitotic agents|mesh-ancestor
111202697|NCT02689427|Mitosis Modulators|mitosis modulators|mesh-ancestor
111202698|NCT02689427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111202699|NCT02667587|Nivolumab|nivolumab|mesh-list
111202700|NCT02667587|Temozolomide|temozolomide|mesh-list
111202701|NCT02667587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111202702|NCT02667587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111202703|NCT02667587|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111202704|NCT02667587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111202705|NCT02667587|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111202706|NCT02667587|Alkylating Agents|alkylating agents|mesh-ancestor
111202707|NCT02659241|Adavosertib|adavosertib|mesh-list
111202708|NCT02659241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111202709|NCT02659241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111202710|NCT02658487|Cytarabine|cytarabine|mesh-list
111202711|NCT02658487|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111202712|NCT02658487|Antimetabolites|antimetabolites|mesh-ancestor
111202713|NCT02658487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111202714|NCT02658487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111202715|NCT02658487|Antiviral Agents|antiviral agents|mesh-ancestor
111202716|NCT02658487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111202717|NCT02658487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111202718|NCT02658487|Immunologic Factors|immunologic factors|mesh-ancestor
111202719|NCT02658487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111202720|NCT02647385|Lidocaine|lidocaine|mesh-list
111202721|NCT02647385|Anesthetics, Local|anesthetics, local|mesh-ancestor
111202722|NCT02647385|Anesthetics|anesthetics|mesh-ancestor
111202723|NCT02647385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111202724|NCT02647385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111202725|NCT02647385|Sensory System Agents|sensory system agents|mesh-ancestor
111202726|NCT02647385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111202727|NCT02647385|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111202728|NCT02647385|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111202729|NCT02647385|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111202730|NCT02647385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111202731|NCT02647385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111202732|NCT02632409|Nivolumab|nivolumab|mesh-list
111202733|NCT02632409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111202734|NCT02632409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111202735|NCT02632409|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111202736|NCT02632409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111202737|NCT02613507|Docetaxel|docetaxel|mesh-list
111202738|NCT02613507|Nivolumab|nivolumab|mesh-list
111202739|NCT02613507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111202740|NCT02613507|Tubulin Modulators|tubulin modulators|mesh-ancestor
111202741|NCT02613507|Antimitotic Agents|antimitotic agents|mesh-ancestor
111202742|NCT02613507|Mitosis Modulators|mitosis modulators|mesh-ancestor
111202743|NCT02613507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111202744|NCT02613507|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111202745|NCT02613507|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111202747|NCT02598661|Motesanib diphosphate|motesanib diphosphate|mesh-list
111202748|NCT02598661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111202749|NCT02598661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111202750|NCT02598661|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111202751|NCT02588677|Riluzole|riluzole|mesh-list
111202752|NCT02588677|Anticonvulsants|anticonvulsants|mesh-ancestor
111202753|NCT02588677|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111202754|NCT02588677|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111202755|NCT02588677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111202756|NCT02588677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111202757|NCT02588677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111202758|NCT02588677|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111202759|NCT02588677|Protective Agents|protective agents|mesh-ancestor
111202761|NCT02565914|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
111202762|NCT02565914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111202763|NCT02565914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111202764|NCT02535078|Durvalumab|durvalumab|mesh-list
111202765|NCT02535078|Tremelimumab|tremelimumab|mesh-list
111202766|NCT02535078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111202767|NCT02535078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111202768|NCT02520791|Antibodies|antibodies|mesh-list
111202769|NCT02520791|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111202770|NCT02520791|Immunologic Factors|immunologic factors|mesh-ancestor
111202771|NCT02520791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111202772|NCT02465060|Nivolumab|nivolumab|mesh-list
111202773|NCT02465060|Trastuzumab|trastuzumab|mesh-list
111202774|NCT02465060|Pertuzumab|pertuzumab|mesh-list
111202775|NCT02465060|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
111202776|NCT02465060|Relatlimab|relatlimab|mesh-list
111202777|NCT02465060|Sunitinib|sunitinib|mesh-list
111202778|NCT02465060|Dasatinib|dasatinib|mesh-list
111202779|NCT02465060|Palbociclib|palbociclib|mesh-list
111202780|NCT02465060|Trametinib|trametinib|mesh-list
111202781|NCT02465060|Osimertinib|osimertinib|mesh-list
111202782|NCT02465060|Afatinib|afatinib|mesh-list
111202783|NCT02465060|Dabrafenib|dabrafenib|mesh-list
111202784|NCT02465060|Crizotinib|crizotinib|mesh-list
111202785|NCT02465060|Maytansine|maytansine|mesh-list
111202786|NCT02465060|Ipatasertib|ipatasertib|mesh-list
111202787|NCT02465060|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
111202788|NCT02465060|GSK2636771|gsk2636771|mesh-list
111202789|NCT02465060|Antibodies|antibodies|mesh-list
111202790|NCT02465060|Immunoglobulins|immunoglobulins|mesh-list
111202791|NCT02465060|Immunoglobulin G|immunoglobulin g|mesh-list
111202792|NCT02465060|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111202793|NCT02465060|Adavosertib|adavosertib|mesh-list
111202794|NCT02465060|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
111202795|NCT02465060|Immunoconjugates|immunoconjugates|mesh-list
111202796|NCT02465060|Immunologic Factors|immunologic factors|mesh-ancestor
111202797|NCT02465060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111202798|NCT02465060|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111202799|NCT02465060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111202800|NCT02465060|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111202801|NCT02465060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111202802|NCT02465060|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111202803|NCT02465060|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111202804|NCT02465060|Growth Substances|growth substances|mesh-ancestor
111202805|NCT02465060|Growth Inhibitors|growth inhibitors|mesh-ancestor
111202806|NCT02465060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111202807|NCT02465060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111202808|NCT02465060|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111202809|NCT02465060|Tubulin Modulators|tubulin modulators|mesh-ancestor
111202810|NCT02465060|Antimitotic Agents|antimitotic agents|mesh-ancestor
111202811|NCT02465060|Mitosis Modulators|mitosis modulators|mesh-ancestor
111202812|NCT02465060|Immunotoxins|immunotoxins|mesh-ancestor
111202813|NCT02435849|Tisagenlecleucel|tisagenlecleucel|mesh-list
111202814|NCT02435849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111202815|NCT02435849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110919811|NCT02137434|Calcium|calcium|mesh-list
111202816|NCT02426658|Pemetrexed|pemetrexed|mesh-list
111202817|NCT02426658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111202818|NCT02426658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111202819|NCT02426658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111202820|NCT02426658|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111202821|NCT02426658|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111202822|NCT02359565|Pembrolizumab|pembrolizumab|mesh-list
111202823|NCT02359565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111202824|NCT02359565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111202825|NCT02359565|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111202826|NCT02359565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111202827|NCT02339571|Nivolumab|nivolumab|mesh-list
111202828|NCT02339571|Ipilimumab|ipilimumab|mesh-list
111202829|NCT02339571|Sargramostim|sargramostim|mesh-list
111202830|NCT02339571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111202831|NCT02339571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111202832|NCT02339571|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111202833|NCT02339571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111202834|NCT02339571|Immunologic Factors|immunologic factors|mesh-ancestor
111202835|NCT02339571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111202836|NCT02338518|Oxaliplatin|oxaliplatin|mesh-list
111202837|NCT02338518|Etoposide|etoposide|mesh-list
111202838|NCT02338518|Epirubicin|epirubicin|mesh-list
111202839|NCT02338518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111202840|NCT02338518|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111202841|NCT02338518|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111202842|NCT02338518|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111202843|NCT02338518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111202844|NCT02338518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111202845|NCT02338518|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111202846|NCT02286687|Talazoparib|talazoparib|mesh-list
111202847|NCT02286687|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111202848|NCT02286687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111202849|NCT02286687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111202850|NCT02286687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111202851|NCT02264678|Carboplatin|carboplatin|mesh-list
111202852|NCT02264678|Durvalumab|durvalumab|mesh-list
111202853|NCT02264678|Olaparib|olaparib|mesh-list
111202854|NCT02264678|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111202855|NCT02264678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111202856|NCT02264678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111202857|NCT02264678|Immunologic Factors|immunologic factors|mesh-ancestor
111202858|NCT02264678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111202859|NCT02264678|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111202860|NCT02264678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111202861|NCT02264678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111202862|NCT02248701|Methyltestosterone|methyltestosterone|mesh-list
111202863|NCT02248701|Finasteride|finasteride|mesh-list
111202864|NCT02248701|Testosterone|testosterone|mesh-list
111202865|NCT02248701|Testosterone undecanoate|testosterone undecanoate|mesh-list
111202866|NCT02248701|Testosterone enanthate|testosterone enanthate|mesh-list
111202867|NCT02248701|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
111202868|NCT02248701|Androgens|androgens|mesh-ancestor
111202869|NCT02248701|Hormones|hormones|mesh-ancestor
111202870|NCT02248701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111202871|NCT02248701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111202872|NCT02248701|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111202873|NCT02248701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111202874|NCT02248701|Anabolic Agents|anabolic agents|mesh-ancestor
111202875|NCT02248701|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
111202876|NCT02248701|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111202877|NCT02248701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111202878|NCT02248701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111202879|NCT02248701|Hormone Antagonists|hormone antagonists|mesh-ancestor
111202880|NCT02248701|Urological Agents|urological agents|mesh-ancestor
111202881|NCT02204982|Rituximab|rituximab|mesh-list
111202882|NCT02204982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111202883|NCT02204982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111202884|NCT02204982|Immunologic Factors|immunologic factors|mesh-ancestor
111202885|NCT02204982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111202886|NCT02204982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111202887|NCT02194738|Paclitaxel|paclitaxel|mesh-list
111202888|NCT02194738|Cisplatin|cisplatin|mesh-list
111202889|NCT02194738|Carboplatin|carboplatin|mesh-list
111202890|NCT02194738|Gemcitabine|gemcitabine|mesh-list
110919860|NCT01062399|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111202891|NCT02194738|Pembrolizumab|pembrolizumab|mesh-list
111202893|NCT02194738|Pemetrexed|pemetrexed|mesh-list
111202894|NCT02194738|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111202895|NCT02194738|Crizotinib|crizotinib|mesh-list
111202896|NCT02194738|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
111202897|NCT02194738|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111202898|NCT02194738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111202899|NCT02194738|Tubulin Modulators|tubulin modulators|mesh-ancestor
111202900|NCT02194738|Antimitotic Agents|antimitotic agents|mesh-ancestor
111202901|NCT02194738|Mitosis Modulators|mitosis modulators|mesh-ancestor
111202902|NCT02194738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111202903|NCT02194738|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111202904|NCT02194738|Antimetabolites|antimetabolites|mesh-ancestor
111202905|NCT02194738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111202906|NCT02194738|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111202907|NCT02194738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111202908|NCT02194738|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111202909|NCT02194738|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111202910|NCT02194738|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111202911|NCT02185560|Sorafenib|sorafenib|mesh-list
111202912|NCT02185560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111202913|NCT02185560|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111202914|NCT02185560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111202915|NCT02185560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111202916|NCT02086175|Rituximab|rituximab|mesh-list
111202917|NCT02086175|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111202918|NCT02086175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111202919|NCT02086175|Immunologic Factors|immunologic factors|mesh-ancestor
111202920|NCT02086175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111202921|NCT02086175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111202922|NCT02073838|Ribavirin|ribavirin|mesh-list
111202923|NCT02073838|Decitabine|decitabine|mesh-list
111202924|NCT02073838|Antimetabolites|antimetabolites|mesh-ancestor
111202925|NCT02073838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111202926|NCT02073838|Antiviral Agents|antiviral agents|mesh-ancestor
111202927|NCT02073838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111202928|NCT02073838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111202929|NCT02073838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111202930|NCT02073838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111202931|NCT02068443|Metformin|metformin|mesh-list
111202932|NCT02068443|Alogliptin|alogliptin|mesh-list
111202933|NCT02068443|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111202934|NCT02068443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111202935|NCT02068443|Incretins|incretins|mesh-ancestor
111202936|NCT02068443|Hormones|hormones|mesh-ancestor
111202937|NCT02068443|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111202938|NCT02068443|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111202939|NCT02068443|Protease Inhibitors|protease inhibitors|mesh-ancestor
111202940|NCT02068443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111202941|NCT02068443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111202942|NCT02021006|Amoxicillin|amoxicillin|mesh-list
111202943|NCT02021006|Clavulanic Acid|clavulanic acid|mesh-list
111202944|NCT02021006|Clavulanic Acids|clavulanic acids|mesh-list
111202945|NCT02021006|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
111202946|NCT02021006|Nitrofurantoin|nitrofurantoin|mesh-list
111202947|NCT02021006|Cefixime|cefixime|mesh-list
111202948|NCT02021006|Trimethoprim|trimethoprim|mesh-list
111202949|NCT02021006|Sulfamethoxazole|sulfamethoxazole|mesh-list
111202950|NCT02021006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111202951|NCT02021006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111202952|NCT02021006|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111202953|NCT02021006|Antimalarials|antimalarials|mesh-ancestor
111202954|NCT02021006|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111202955|NCT02021006|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111202956|NCT02021006|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111202957|NCT02021006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111202958|NCT02021006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111202959|NCT02021006|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111202960|NCT02021006|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
111202961|NCT02021006|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111202962|NCT02021006|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
111202963|NCT02019706|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
111202964|NCT02019706|Dopamine Agents|dopamine agents|mesh-ancestor
111202965|NCT02019706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111202966|NCT02019706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111202967|NCT02019706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111202968|NCT02018861|Rituximab|rituximab|mesh-list
111202969|NCT02018861|Carboplatin|carboplatin|mesh-list
111202970|NCT02018861|Etoposide|etoposide|mesh-list
111202971|NCT02018861|Ifosfamide|ifosfamide|mesh-list
111202972|NCT02018861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111202973|NCT02018861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111202974|NCT02018861|Immunologic Factors|immunologic factors|mesh-ancestor
111202975|NCT02018861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111202976|NCT02018861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111202977|NCT02018861|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111202978|NCT02018861|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111202979|NCT02018861|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111202980|NCT02018861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111202981|NCT02018861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111202982|NCT02018861|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111202983|NCT02018861|Alkylating Agents|alkylating agents|mesh-ancestor
111202985|NCT02017717|Nivolumab|nivolumab|mesh-list
111202986|NCT02017717|Ipilimumab|ipilimumab|mesh-list
111202987|NCT02017717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111202988|NCT02017717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111202989|NCT02017717|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111202990|NCT02017717|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111202991|NCT02017717|Growth Substances|growth substances|mesh-ancestor
111202992|NCT02017717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111202993|NCT02017717|Growth Inhibitors|growth inhibitors|mesh-ancestor
111202994|NCT02017717|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111202995|NCT02017717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111202996|NCT01995578|Azacitidine|azacitidine|mesh-list
111202997|NCT01995578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111202998|NCT01995578|Antimetabolites|antimetabolites|mesh-ancestor
111202999|NCT01995578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111203000|NCT01995578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111203001|NCT01995578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111203002|NCT01949337|Prednisone|prednisone|mesh-list
111203003|NCT01949337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111203004|NCT01949337|Glucocorticoids|glucocorticoids|mesh-ancestor
111203005|NCT01949337|Hormones|hormones|mesh-ancestor
111203006|NCT01949337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111203007|NCT01949337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111203008|NCT01949337|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111203009|NCT01949337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111203010|NCT01922076|Adavosertib|adavosertib|mesh-list
111203011|NCT01922076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111203012|NCT01922076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111203013|NCT01827384|Carboplatin|carboplatin|mesh-list
111203014|NCT01827384|Everolimus|everolimus|mesh-list
111203015|NCT01827384|Temozolomide|temozolomide|mesh-list
111203016|NCT01827384|Trametinib|trametinib|mesh-list
111203017|NCT01827384|Veliparib|veliparib|mesh-list
111203018|NCT01827384|Adavosertib|adavosertib|mesh-list
111203019|NCT01827384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111203020|NCT01827384|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111203021|NCT01827384|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111203022|NCT01827384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111203023|NCT01827384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111203024|NCT01827384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111203025|NCT01827384|Immunologic Factors|immunologic factors|mesh-ancestor
111203026|NCT01827384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111203027|NCT01827384|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111203028|NCT01827384|Alkylating Agents|alkylating agents|mesh-ancestor
111203029|NCT01827384|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111203030|NCT01810913|Cisplatin|cisplatin|mesh-list
111203031|NCT01810913|Docetaxel|docetaxel|mesh-list
111203032|NCT01810913|Cetuximab|cetuximab|mesh-list
111203033|NCT01810913|Atezolizumab|atezolizumab|mesh-list
111203034|NCT01810913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111203035|NCT01810913|Antibodies|antibodies|mesh-list
111203036|NCT01810913|Immunoglobulins|immunoglobulins|mesh-list
111203037|NCT01810913|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111203038|NCT01810913|Immunologic Factors|immunologic factors|mesh-ancestor
111203039|NCT01810913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111203040|NCT01810913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111203041|NCT01810913|Tubulin Modulators|tubulin modulators|mesh-ancestor
110920009|NCT02260908|Enoxaparin|enoxaparin|mesh-list
111203042|NCT01810913|Antimitotic Agents|antimitotic agents|mesh-ancestor
111203043|NCT01810913|Mitosis Modulators|mitosis modulators|mesh-ancestor
111203044|NCT01810913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111203045|NCT01810913|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111203046|NCT01585194|Nivolumab|nivolumab|mesh-list
111203047|NCT01585194|Ipilimumab|ipilimumab|mesh-list
111203048|NCT01585194|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111203049|NCT01585194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111203050|NCT01585194|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111203051|NCT01585194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111203052|NCT01560663|Carboplatin|carboplatin|mesh-list
111203053|NCT01560663|Docetaxel|docetaxel|mesh-list
111203054|NCT01560663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111203055|NCT01560663|Tubulin Modulators|tubulin modulators|mesh-ancestor
111203056|NCT01560663|Antimitotic Agents|antimitotic agents|mesh-ancestor
111203057|NCT01560663|Mitosis Modulators|mitosis modulators|mesh-ancestor
111203058|NCT01560663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111203059|NCT01500473|Desogestrel|desogestrel|mesh-list
111203060|NCT01500473|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111203061|NCT01500473|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111203062|NCT01500473|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111203063|NCT01500473|Contraceptive Agents|contraceptive agents|mesh-ancestor
111203064|NCT01500473|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111203065|NCT01500473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111203066|NCT01500473|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111203067|NCT01500473|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111203068|NCT01500473|Progestins|progestins|mesh-ancestor
111203069|NCT01500473|Hormones|hormones|mesh-ancestor
111203070|NCT01500473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111203071|NCT01463371|Azithromycin|azithromycin|mesh-list
111203072|NCT01463371|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111203073|NCT01463371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111203074|NCT01419067|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
111203075|NCT01419067|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111203076|NCT01419067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111203077|NCT01377389|Ipilimumab|ipilimumab|mesh-list
111203078|NCT01377389|Leuprolide|leuprolide|mesh-list
111203079|NCT01377389|Goserelin|goserelin|mesh-list
111203080|NCT01377389|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111203081|NCT01377389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111203082|NCT01377389|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111203083|NCT01377389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111203084|NCT01377389|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111203085|NCT01377389|Fertility Agents|fertility agents|mesh-ancestor
111203086|NCT01377389|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111203087|NCT01377389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111203088|NCT01377389|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111203089|NCT01300962|Capecitabine|capecitabine|mesh-list
111203090|NCT01300962|Trastuzumab|trastuzumab|mesh-list
111203091|NCT01300962|Lapatinib|lapatinib|mesh-list
111203092|NCT01300962|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111203093|NCT01300962|Antimetabolites|antimetabolites|mesh-ancestor
111203094|NCT01300962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111203095|NCT01300962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111203096|NCT01300962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111203097|NCT01300962|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111203098|NCT01300962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111203099|NCT01194271|Ipilimumab|ipilimumab|mesh-list
111203100|NCT01194271|Leuprolide|leuprolide|mesh-list
111203101|NCT01194271|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111203102|NCT01194271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111203103|NCT01194271|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111203104|NCT01194271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111203105|NCT01194271|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111203106|NCT01194271|Fertility Agents|fertility agents|mesh-ancestor
111203107|NCT01194271|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111203108|NCT01194271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111203109|NCT01194271|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111203110|NCT01172418|Alemtuzumab|alemtuzumab|mesh-list
111203111|NCT01172418|Thymoglobulin|thymoglobulin|mesh-list
111203112|NCT01172418|Antilymphocyte Serum|antilymphocyte serum|mesh-list
111203113|NCT01172418|Daclizumab|daclizumab|mesh-list
111203114|NCT01172418|Immunologic Factors|immunologic factors|mesh-ancestor
111203115|NCT01172418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111203116|NCT01172418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111203117|NCT01172418|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111203118|NCT01172418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111203119|NCT01119508|Temozolomide|temozolomide|mesh-list
111203120|NCT01119508|Ipilimumab|ipilimumab|mesh-list
111203121|NCT01119508|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111203122|NCT01119508|Alkylating Agents|alkylating agents|mesh-ancestor
111203123|NCT01119508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111203124|NCT01119508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111203125|NCT01119508|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111203126|NCT01119508|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111203127|NCT00958737|Fluorouracil|fluorouracil|mesh-list
111203128|NCT00958737|Capecitabine|capecitabine|mesh-list
111203129|NCT00958737|Oxaliplatin|oxaliplatin|mesh-list
111203130|NCT00958737|Antimetabolites|antimetabolites|mesh-ancestor
111203131|NCT00958737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111203132|NCT00958737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111203133|NCT00958737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110492341|NCT00754429|Losartan|losartan|mesh-list
111203134|NCT00958737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111203135|NCT00958737|Immunologic Factors|immunologic factors|mesh-ancestor
111203136|NCT00958737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111203137|NCT00917592|Amoxicillin|amoxicillin|mesh-list
111203138|NCT00917592|Clavulanic Acids|clavulanic acids|mesh-list
111203139|NCT00917592|Clavulanic Acid|clavulanic acid|mesh-list
111203140|NCT00917592|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111203141|NCT00917592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111203142|NCT00917592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111203143|NCT00917592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111203144|NCT00917592|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
111203145|NCT00862433|Vitamins|vitamins|mesh-list
111203146|NCT00862433|Vitamin E|vitamin e|mesh-list
111203147|NCT00862433|Tocopherols|tocopherols|mesh-list
111203148|NCT00862433|Tocotrienols|tocotrienols|mesh-list
111203149|NCT00862433|alpha-Tocopherol|alpha-tocopherol|mesh-list
111203150|NCT00862433|Micronutrients|micronutrients|mesh-ancestor
111203151|NCT00862433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111203152|NCT00862433|Antioxidants|antioxidants|mesh-ancestor
111203153|NCT00862433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111203154|NCT00862433|Protective Agents|protective agents|mesh-ancestor
111203155|NCT00828919|Axitinib|axitinib|mesh-list
111203156|NCT00828919|Crizotinib|crizotinib|mesh-list
111203157|NCT00828919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111203158|NCT00828919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111203159|NCT00828919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111203160|NCT00828919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111203161|NCT00754338|Dipivefrin|dipivefrin|mesh-list
111203162|NCT00754338|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111203163|NCT00754338|Adrenergic Agents|adrenergic agents|mesh-ancestor
111203164|NCT00754338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111203165|NCT00754338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111203166|NCT00754338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111203167|NCT00752154|Curcumin|curcumin|mesh-list
111203168|NCT00752154|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111203169|NCT00752154|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111203170|NCT00752154|Analgesics|analgesics|mesh-ancestor
111203171|NCT00752154|Sensory System Agents|sensory system agents|mesh-ancestor
111203172|NCT00752154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111203173|NCT00752154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111203174|NCT00752154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111203175|NCT00752154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111203176|NCT00752154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111203177|NCT00752154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111203178|NCT00752154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111203179|NCT00745134|Curcumin|curcumin|mesh-list
111203180|NCT00745134|Capecitabine|capecitabine|mesh-list
111203181|NCT00745134|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111203182|NCT00745134|Antimetabolites|antimetabolites|mesh-ancestor
110846351|NCT03373708|Tamoxifen|tamoxifen|mesh-list
111203183|NCT00745134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111203184|NCT00745134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111203185|NCT00745134|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111203186|NCT00745134|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111203187|NCT00745134|Analgesics|analgesics|mesh-ancestor
111203188|NCT00745134|Sensory System Agents|sensory system agents|mesh-ancestor
111203189|NCT00745134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111203190|NCT00745134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111203191|NCT00745134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111203192|NCT00745134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111203193|NCT00745134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111203194|NCT00673010|Iodine|iodine|mesh-list
111203195|NCT00673010|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111203196|NCT00673010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111203197|NCT00673010|Trace Elements|trace elements|mesh-ancestor
111203198|NCT00673010|Micronutrients|micronutrients|mesh-ancestor
111203199|NCT00673010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111203200|NCT00610883|Cyclophosphamide|cyclophosphamide|mesh-list
111203201|NCT00610883|Methotrexate|methotrexate|mesh-list
111203202|NCT00610883|Asparaginase|asparaginase|mesh-list
111203203|NCT00610883|Daunorubicin|daunorubicin|mesh-list
111203204|NCT00610883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111203205|NCT00610883|Immunologic Factors|immunologic factors|mesh-ancestor
111203206|NCT00610883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111203207|NCT00610883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111203208|NCT00610883|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111203209|NCT00610883|Alkylating Agents|alkylating agents|mesh-ancestor
111203210|NCT00610883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111203211|NCT00610883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111203212|NCT00610883|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111203213|NCT00610883|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111203214|NCT00610883|Abortifacient Agents|abortifacient agents|mesh-ancestor
111203215|NCT00610883|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111203216|NCT00610883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111203217|NCT00610883|Antimetabolites|antimetabolites|mesh-ancestor
111203218|NCT00610883|Dermatologic Agents|dermatologic agents|mesh-ancestor
111203219|NCT00610883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111203220|NCT00610883|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111203221|NCT00610883|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111203222|NCT00610883|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111203223|NCT00610883|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111203224|NCT00610883|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111203225|NCT00574496|Cyclosporine|cyclosporine|mesh-list
111203226|NCT00574496|Mycophenolic Acid|mycophenolic acid|mesh-list
111203227|NCT00574496|Prednisone|prednisone|mesh-list
111203228|NCT00574496|Cyclophosphamide|cyclophosphamide|mesh-list
111203229|NCT00574496|Melphalan|melphalan|mesh-list
111203230|NCT00574496|Ifosfamide|ifosfamide|mesh-list
111203231|NCT00574496|Mechlorethamine|mechlorethamine|mesh-list
111203232|NCT00574496|Gemcitabine|gemcitabine|mesh-list
111203233|NCT00574496|Methotrexate|methotrexate|mesh-list
111203234|NCT00574496|Fludarabine|fludarabine|mesh-list
111203235|NCT00574496|Fludarabine phosphate|fludarabine phosphate|mesh-list
111203236|NCT00574496|Vincristine|vincristine|mesh-list
111203237|NCT00574496|Vinorelbine|vinorelbine|mesh-list
111203238|NCT00574496|Procarbazine|procarbazine|mesh-list
111203239|NCT00574496|Cyclosporins|cyclosporins|mesh-list
111203240|NCT00574496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111203241|NCT00574496|Immunologic Factors|immunologic factors|mesh-ancestor
111203242|NCT00574496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111203243|NCT00574496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111203244|NCT00574496|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111203245|NCT00574496|Alkylating Agents|alkylating agents|mesh-ancestor
111203246|NCT00574496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111203247|NCT00574496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111203248|NCT00574496|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111203249|NCT00574496|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111203250|NCT00574496|Antimetabolites|antimetabolites|mesh-ancestor
111203251|NCT00574496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111203252|NCT00574496|Glucocorticoids|glucocorticoids|mesh-ancestor
111203253|NCT00574496|Hormones|hormones|mesh-ancestor
111203254|NCT00574496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111203255|NCT00574496|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111203256|NCT00574496|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111203257|NCT00574496|Abortifacient Agents|abortifacient agents|mesh-ancestor
111203258|NCT00574496|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111203259|NCT00574496|Dermatologic Agents|dermatologic agents|mesh-ancestor
111203260|NCT00574496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111203261|NCT00574496|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111203262|NCT00574496|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111203263|NCT00574496|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111203264|NCT00574496|Tubulin Modulators|tubulin modulators|mesh-ancestor
111203265|NCT00574496|Antimitotic Agents|antimitotic agents|mesh-ancestor
111203266|NCT00574496|Mitosis Modulators|mitosis modulators|mesh-ancestor
111203267|NCT00574496|Antifungal Agents|antifungal agents|mesh-ancestor
111203268|NCT00574496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111203269|NCT00574496|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111203270|NCT00574496|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111203271|NCT00574496|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111203272|NCT00574496|Antitubercular Agents|antitubercular agents|mesh-ancestor
111203273|NCT00574496|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111203274|NCT00542451|Paclitaxel|paclitaxel|mesh-list
111203275|NCT00542451|Trastuzumab|trastuzumab|mesh-list
111203276|NCT00542451|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111203277|NCT00542451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111203278|NCT00542451|Tubulin Modulators|tubulin modulators|mesh-ancestor
111203279|NCT00542451|Antimitotic Agents|antimitotic agents|mesh-ancestor
111203280|NCT00542451|Mitosis Modulators|mitosis modulators|mesh-ancestor
111203281|NCT00542451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111203282|NCT00542451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111203283|NCT00533624|Mycophenolic Acid|mycophenolic acid|mesh-list
111203284|NCT00533624|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111203285|NCT00533624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111203286|NCT00533624|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111203287|NCT00533624|Antitubercular Agents|antitubercular agents|mesh-ancestor
111203288|NCT00533624|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111203289|NCT00533624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111203290|NCT00533624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111203291|NCT00533624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111203292|NCT00499083|Tamoxifen|tamoxifen|mesh-list
111203293|NCT00499083|Paclitaxel|paclitaxel|mesh-list
111203294|NCT00499083|Cyclophosphamide|cyclophosphamide|mesh-list
111203295|NCT00499083|Doxorubicin|doxorubicin|mesh-list
111203296|NCT00499083|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111203297|NCT00499083|Aromatase Inhibitors|aromatase inhibitors|mesh-list
111203298|NCT00499083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111203299|NCT00499083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111203300|NCT00499083|Tubulin Modulators|tubulin modulators|mesh-ancestor
111203301|NCT00499083|Antimitotic Agents|antimitotic agents|mesh-ancestor
111203302|NCT00499083|Mitosis Modulators|mitosis modulators|mesh-ancestor
111203303|NCT00499083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111203304|NCT00499083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111203305|NCT00499083|Immunologic Factors|immunologic factors|mesh-ancestor
111203306|NCT00499083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111203307|NCT00499083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111203308|NCT00499083|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111203309|NCT00499083|Alkylating Agents|alkylating agents|mesh-ancestor
111203310|NCT00499083|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111203311|NCT00499083|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111203312|NCT00499083|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111203313|NCT00499083|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111203314|NCT00499083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111203315|NCT00499083|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111203316|NCT00499083|Hormone Antagonists|hormone antagonists|mesh-ancestor
111203317|NCT00499083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111203318|NCT00499083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111203319|NCT00499083|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111203320|NCT00499083|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111203321|NCT00499083|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111203322|NCT00499083|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111203323|NCT00418886|Pemetrexed|pemetrexed|mesh-list
111203324|NCT00418886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111203325|NCT00418886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110846364|NCT03373708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111203326|NCT00418886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111203327|NCT00418886|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111203328|NCT00418886|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111203329|NCT00089024|Leucovorin|leucovorin|mesh-list
111203330|NCT00089024|Folic Acid|folic acid|mesh-list
111203331|NCT00089024|Gemcitabine|gemcitabine|mesh-list
111203332|NCT00089024|Fluorouracil|fluorouracil|mesh-list
111203333|NCT00089024|Oxaliplatin|oxaliplatin|mesh-list
111203334|NCT00089024|Calcium|calcium|mesh-list
111203335|NCT00089024|Levoleucovorin|levoleucovorin|mesh-list
111203336|NCT00089024|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111203337|NCT00089024|Antimetabolites|antimetabolites|mesh-ancestor
111203338|NCT00089024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110492362|NCT00725608|Buprenorphine|buprenorphine|mesh-list
111203339|NCT00089024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111203340|NCT00089024|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111203341|NCT00089024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111203342|NCT00089024|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111203343|NCT00089024|Immunologic Factors|immunologic factors|mesh-ancestor
111203344|NCT00089024|Antidotes|antidotes|mesh-ancestor
111203345|NCT00089024|Protective Agents|protective agents|mesh-ancestor
111203346|NCT00089024|Vitamin B Complex|vitamin b complex|mesh-ancestor
111203348|NCT00089024|Micronutrients|micronutrients|mesh-ancestor
111203349|NCT00089024|Hematinics|hematinics|mesh-ancestor
111203350|NCT00065676|Quercetin|quercetin|mesh-list
111203351|NCT00065676|Antioxidants|antioxidants|mesh-ancestor
111203352|NCT00065676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111203353|NCT00065676|Protective Agents|protective agents|mesh-ancestor
111203354|NCT00065676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111203355|NCT00026312|Vitamin A|vitamin a|mesh-list
111203356|NCT00026312|Aldesleukin|aldesleukin|mesh-list
111203357|NCT00026312|Interleukin-2|interleukin-2|mesh-list
111203358|NCT00026312|Tretinoin|tretinoin|mesh-list
111203359|NCT00026312|Dinutuximab|dinutuximab|mesh-list
111203360|NCT00026312|Isotretinoin|isotretinoin|mesh-list
111203361|NCT00026312|Sargramostim|sargramostim|mesh-list
111203362|NCT00026312|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111203363|NCT00026312|Vitamins|vitamins|mesh-ancestor
111203364|NCT00026312|Micronutrients|micronutrients|mesh-ancestor
111203365|NCT00026312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111203366|NCT00026312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111203367|NCT00026312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111203368|NCT00026312|Analgesics|analgesics|mesh-ancestor
111203369|NCT00026312|Sensory System Agents|sensory system agents|mesh-ancestor
111203370|NCT00026312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111203371|NCT00026312|Immunologic Factors|immunologic factors|mesh-ancestor
111203372|NCT00026312|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111203373|NCT00026312|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111203374|NCT00026312|Antiviral Agents|antiviral agents|mesh-ancestor
111203375|NCT00026312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111203376|NCT00026312|Keratolytic Agents|keratolytic agents|mesh-ancestor
111203377|NCT00026312|Dermatologic Agents|dermatologic agents|mesh-ancestor
111203378|NCT00006421|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
111203379|NCT00006421|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111203380|NCT00006421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111203381|NCT00001521|Hydrocortisone|hydrocortisone|mesh-list
111203382|NCT00001521|Fludrocortisone|fludrocortisone|mesh-list
111203383|NCT00001521|Letrozole|letrozole|mesh-list
111203384|NCT00001521|Flutamide|flutamide|mesh-list
111203385|NCT00001521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111203386|NCT00001521|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111203387|NCT00001521|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111203388|NCT00001521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111203389|NCT00001521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111203390|NCT00001521|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111203391|NCT00001521|Hormone Antagonists|hormone antagonists|mesh-ancestor
111203392|NCT00001521|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111203393|NCT00001521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111203394|NCT00001521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111203395|NCT00001521|Androgen Antagonists|androgen antagonists|mesh-ancestor
111203396|NCT00001521|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111203397|NCT00001230|Diethylcarbamazine|diethylcarbamazine|mesh-list
111203398|NCT00001230|Filaricides|filaricides|mesh-ancestor
111203399|NCT00001230|Antinematodal Agents|antinematodal agents|mesh-ancestor
111203400|NCT00001230|Anthelmintics|anthelmintics|mesh-ancestor
111203401|NCT00001230|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111203402|NCT00001230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111203403|NCT00001230|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
111203404|NCT00001230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111203405|NCT00001230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110677022|NCT03146962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110324153|NCT01055834|Eszopiclone|eszopiclone|mesh-list
110677023|NCT03146962|Antioxidants|antioxidants|mesh-ancestor
110922260|NCT02027935|Analgesics|analgesics|mesh-ancestor
110922396|NCT03517748|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110922471|NCT05430802|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110922617|NCT02293148|Glycine|glycine|mesh-list
110922765|NCT01597258|Crizotinib|crizotinib|mesh-list
110923373|NCT04752813|Hemostatics|hemostatics|mesh-ancestor
110923667|NCT03657160|Vedolizumab|vedolizumab|mesh-list
110924052|NCT03656926|Cyclosporine|cyclosporine|mesh-list
110924117|NCT03507374|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110924118|NCT02639650|Dactinomycin|dactinomycin|mesh-list
110924340|NCT03509168|Abortifacient Agents|abortifacient agents|mesh-ancestor
110924418|NCT03504566|Incretins|incretins|mesh-ancestor
110924643|NCT00389896|Nasal Decongestants|nasal decongestants|mesh-ancestor
110924725|NCT03501680|Insulin|insulin|mesh-list
110924799|NCT03098680|Mydriatics|mydriatics|mesh-ancestor
110924959|NCT02317640|Hormones|hormones|mesh-ancestor
110925164|NCT02639338|Velpatasvir|velpatasvir|mesh-list
110925392|NCT02318888|Icodextrin|icodextrin|mesh-list
110925618|NCT02146638|Sensory System Agents|sensory system agents|mesh-ancestor
110925702|NCT02780700|Capecitabine|capecitabine|mesh-list
110925772|NCT03492866|Gentamicins|gentamicins|mesh-list
110925846|NCT02224573|Cannabidiol|cannabidiol|mesh-list
110926070|NCT02155530|Atorvastatin|atorvastatin|mesh-list
110926982|NCT04737109|Androgens|androgens|mesh-list
110927121|NCT03088072|Aspirin|aspirin|mesh-list
110927938|NCT04991584|Levofloxacin|levofloxacin|mesh-list
110928016|NCT03072082|Analgesics|analgesics|mesh-ancestor
110928532|NCT04994626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110929130|NCT02169882|Antiemetics|antiemetics|mesh-ancestor
110929654|NCT02171754|Ritonavir|ritonavir|mesh-list
110930334|NCT02174094|Clobazam|clobazam|mesh-list
110930409|NCT02174328|Aspirin|aspirin|mesh-list
110930619|NCT02238639|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110930845|NCT03571815|Listerine|listerine|mesh-list
110930920|NCT03062800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110930995|NCT03572517|Morphine|morphine|mesh-list
110931222|NCT03704077|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110931821|NCT03694873|Narcotics|narcotics|mesh-ancestor
110931891|NCT02191332|Nevirapine|nevirapine|mesh-list
110932038|NCT04412707|Antiemetics|antiemetics|mesh-ancestor
110932628|NCT02207010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110932711|NCT03532698|Antipyretics|antipyretics|mesh-ancestor
110932781|NCT03026257|Hydrogen Peroxide|hydrogen peroxide|mesh-list
110933084|NCT02831673|Tenofovir|tenofovir|mesh-list
110934288|NCT05008809|Irinotecan|irinotecan|mesh-list
110934364|NCT04848753|Paclitaxel|paclitaxel|mesh-list
110934741|NCT03333395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110934975|NCT02215265|Cisplatin|cisplatin|mesh-list
110935274|NCT04946734|Clopidogrel|clopidogrel|mesh-list
110935351|NCT02587598|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110935435|NCT01291004|Diuretics|diuretics|mesh-ancestor
110935885|NCT03473210|Hormones|hormones|mesh-ancestor
110936057|NCT04931524|Mitogens|mitogens|mesh-list
110936337|NCT04967326|GABA Agents|gaba agents|mesh-ancestor
110936483|NCT06016413|Antimitotic Agents|antimitotic agents|mesh-ancestor
110936705|NCT05887843|Dermatologic Agents|dermatologic agents|mesh-ancestor
110937076|NCT05363267|Curcumin|curcumin|mesh-list
110937160|NCT05143840|Dasatinib|dasatinib|mesh-list
110937227|NCT05070650|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110938072|NCT02112916|Hematinics|hematinics|mesh-ancestor
110938150|NCT01245179|Panobinostat|panobinostat|mesh-list
110938892|NCT04456712|Levofloxacin|levofloxacin|mesh-list
110938968|NCT04883164|Antibodies|antibodies|mesh-list
110939042|NCT04887844|Glucocorticoids|glucocorticoids|mesh-ancestor
110939189|NCT04895800|Purinergic Agents|purinergic agents|mesh-ancestor
110939349|NCT04870372|Selegiline|selegiline|mesh-list
110939492|NCT02049411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110939651|NCT02052687|Imiquimod|imiquimod|mesh-list
110939882|NCT04383574|Vaccines|vaccines|mesh-list
110940627|NCT01329978|Sofosbuvir|sofosbuvir|mesh-list
110941139|NCT04850950|Tenofovir|tenofovir|mesh-list
110941535|NCT06056687|Vitamins|vitamins|mesh-ancestor
110941838|NCT06047366|Mydriatics|mydriatics|mesh-ancestor
110942351|NCT05848011|Prednisone|prednisone|mesh-list
110773448|NCT01302756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110773450|NCT04893252|Vactosertib|vactosertib|mesh-list
110773451|NCT04893252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110773452|NCT04893252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110773453|NCT04893252|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110773454|NCT04893252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110773455|NCT04893252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110773456|NCT03797508|Progesterone|progesterone|mesh-list
110773457|NCT03797508|Progestins|progestins|mesh-ancestor
110773458|NCT03797508|Hormones|hormones|mesh-ancestor
110773459|NCT03797508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110773460|NCT03797508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110773461|NCT01380496|Doxycycline|doxycycline|mesh-list
110773462|NCT01380496|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110773463|NCT01380496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110773464|NCT01380496|Antimalarials|antimalarials|mesh-ancestor
110773465|NCT01380496|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110773466|NCT01380496|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110773467|NCT01304316|Phenylephrine|phenylephrine|mesh-list
110773468|NCT01304316|Oxymetazoline|oxymetazoline|mesh-list
110773469|NCT01304316|Tetracaine|tetracaine|mesh-list
110773470|NCT01304316|Anesthetics, Local|anesthetics, local|mesh-ancestor
110773471|NCT01304316|Anesthetics|anesthetics|mesh-ancestor
110773472|NCT01304316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110773473|NCT01304316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110773474|NCT01304316|Sensory System Agents|sensory system agents|mesh-ancestor
110773475|NCT01304316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110773476|NCT01304316|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110773477|NCT01304316|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110773478|NCT01304316|Adrenergic Agents|adrenergic agents|mesh-ancestor
110773479|NCT01304316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110773480|NCT01304316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110773481|NCT01304316|Sympathomimetics|sympathomimetics|mesh-ancestor
110773482|NCT01304316|Autonomic Agents|autonomic agents|mesh-ancestor
110773483|NCT01304316|Nasal Decongestants|nasal decongestants|mesh-ancestor
110773484|NCT01304316|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110773485|NCT01304316|Respiratory System Agents|respiratory system agents|mesh-ancestor
110773486|NCT01304316|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110773487|NCT01304316|Mydriatics|mydriatics|mesh-ancestor
110773488|NCT01304316|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110773489|NCT01304316|Protective Agents|protective agents|mesh-ancestor
110773490|NCT03792828|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110773491|NCT03792828|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110773492|NCT03792828|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110773493|NCT03792828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110773494|NCT03792828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110773495|NCT03792828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110773496|NCT03792828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110773497|NCT03792828|Analgesics|analgesics|mesh-ancestor
110773498|NCT03792828|Sensory System Agents|sensory system agents|mesh-ancestor
110773499|NCT03792828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110773500|NCT03792828|Antidepressive Agents|antidepressive agents|mesh-ancestor
110846391|NCT02519608|Analgesics|analgesics|mesh-ancestor
110773501|NCT03792828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110773502|NCT03792828|Dopamine Agents|dopamine agents|mesh-ancestor
110773503|NCT01379326|Mebendazole|mebendazole|mesh-list
110773504|NCT01379326|Piperazine|piperazine|mesh-list
110773505|NCT01379326|Piperazine citrate|piperazine citrate|mesh-list
110773506|NCT01379326|DMP 777|dmp 777|mesh-list
110773507|NCT01379326|Antinematodal Agents|antinematodal agents|mesh-ancestor
110773508|NCT01379326|Anthelmintics|anthelmintics|mesh-ancestor
110773509|NCT01379326|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110773510|NCT01379326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110773511|NCT01379326|Tubulin Modulators|tubulin modulators|mesh-ancestor
110773512|NCT01379326|Antimitotic Agents|antimitotic agents|mesh-ancestor
110773513|NCT01379326|Mitosis Modulators|mitosis modulators|mesh-ancestor
110773514|NCT01379326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110773515|NCT01379326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110773516|NCT01379326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110773517|NCT01560546|Testosterone|testosterone|mesh-list
110773518|NCT01560546|Androgens|androgens|mesh-ancestor
110773519|NCT01560546|Hormones|hormones|mesh-ancestor
110773520|NCT01560546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110773521|NCT01560546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110773522|NCT03792984|Vitamin D|vitamin d|mesh-list
110773523|NCT03792984|Cholecalciferol|cholecalciferol|mesh-list
110773524|NCT03792984|Metformin|metformin|mesh-list
110773525|NCT03792984|Calcium Carbonate|calcium carbonate|mesh-list
110773526|NCT03792984|Calcium|calcium|mesh-list
110773527|NCT03792984|Vitamins|vitamins|mesh-ancestor
110773528|NCT03792984|Micronutrients|micronutrients|mesh-ancestor
110773529|NCT03792984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110773530|NCT03792984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110773531|NCT03792984|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110773532|NCT03792984|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110773533|NCT03792984|Antacids|antacids|mesh-ancestor
110773534|NCT03792984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110773535|NCT03792984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110773536|NCT03792906|Norepinephrine|norepinephrine|mesh-list
110773537|NCT03792906|Bupivacaine|bupivacaine|mesh-list
110773538|NCT03792906|Anesthetics, Local|anesthetics, local|mesh-ancestor
110773539|NCT03792906|Anesthetics|anesthetics|mesh-ancestor
110773540|NCT03792906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110773541|NCT03792906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110773542|NCT03792906|Sensory System Agents|sensory system agents|mesh-ancestor
110773543|NCT03792906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110773544|NCT03792906|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110773545|NCT03792906|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110773546|NCT03792906|Adrenergic Agents|adrenergic agents|mesh-ancestor
110773547|NCT03792906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110773548|NCT03792906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110773549|NCT03792906|Sympathomimetics|sympathomimetics|mesh-ancestor
110773550|NCT03792906|Autonomic Agents|autonomic agents|mesh-ancestor
110773551|NCT03792906|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110773552|NCT03078556|Lamivudine|lamivudine|mesh-list
110773553|NCT03078556|Dolutegravir|dolutegravir|mesh-list
110773554|NCT03078556|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110773555|NCT03078556|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110773556|NCT03078556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110773557|NCT03078556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110773558|NCT03078556|Antiviral Agents|antiviral agents|mesh-ancestor
110773559|NCT03078556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110773560|NCT03078556|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110773561|NCT03078556|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110773562|NCT03078556|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110773563|NCT03078556|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110773564|NCT03949894|Tolvaptan|tolvaptan|mesh-list
110773565|NCT03949894|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
110773566|NCT03949894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110773567|NCT03949894|Natriuretic Agents|natriuretic agents|mesh-ancestor
110773568|NCT03949894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110773569|NCT03714672|Diclofenac|diclofenac|mesh-list
110773570|NCT03714672|Tramadol|tramadol|mesh-list
110773571|NCT03714672|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110773572|NCT03714672|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110773573|NCT03714672|Analgesics|analgesics|mesh-ancestor
110773574|NCT03714672|Sensory System Agents|sensory system agents|mesh-ancestor
110773575|NCT03714672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110773576|NCT03714672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110773577|NCT03714672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110773578|NCT03714672|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110773579|NCT03714672|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110773580|NCT03714672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110773581|NCT03714672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110773582|NCT03714672|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110773583|NCT03714672|Narcotics|narcotics|mesh-ancestor
110773584|NCT03714672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110773585|NCT03083470|Paclitaxel|paclitaxel|mesh-list
110773586|NCT03083470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110773587|NCT03083470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110773588|NCT03083470|Tubulin Modulators|tubulin modulators|mesh-ancestor
110773589|NCT03083470|Antimitotic Agents|antimitotic agents|mesh-ancestor
110773590|NCT03083470|Mitosis Modulators|mitosis modulators|mesh-ancestor
110773591|NCT03083470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110773592|NCT01377610|Naltrexone|naltrexone|mesh-list
110773593|NCT01377610|Buprenorphine|buprenorphine|mesh-list
110773594|NCT01377610|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110773595|NCT01377610|Narcotics|narcotics|mesh-ancestor
110773596|NCT01377610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110773597|NCT01377610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110773598|NCT01377610|Analgesics|analgesics|mesh-ancestor
110773599|NCT01377610|Sensory System Agents|sensory system agents|mesh-ancestor
110773600|NCT01377610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110773601|NCT01377610|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110773602|NCT01377610|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110773603|NCT03811080|Fexuprazan|fexuprazan|mesh-list
110773604|NCT03811080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110773605|NCT01377532|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
110773606|NCT01377532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110773607|NCT01377532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110773608|NCT01377532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110846410|NCT05181852|Analgesics|analgesics|mesh-ancestor
110773609|NCT01377532|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110773610|NCT03810976|Gemcitabine|gemcitabine|mesh-list
110773611|NCT03810976|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110773612|NCT03810976|Antimetabolites|antimetabolites|mesh-ancestor
110773613|NCT03810976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110773614|NCT03810976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110773615|NCT05405244|Bromocriptine|bromocriptine|mesh-list
110773616|NCT05405244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110773617|NCT05405244|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110773618|NCT05405244|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110773619|NCT05405244|Hormone Antagonists|hormone antagonists|mesh-ancestor
110773620|NCT05405244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110773621|NCT05405244|Dopamine Agonists|dopamine agonists|mesh-ancestor
110773622|NCT05405244|Dopamine Agents|dopamine agents|mesh-ancestor
110773623|NCT05405244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110773624|NCT05405244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110773625|NCT03789006|Interleukin-2|interleukin-2|mesh-list
110773626|NCT03789006|Immunoglobulins|immunoglobulins|mesh-list
110773627|NCT03789006|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110773628|NCT03789006|Antibodies|antibodies|mesh-list
110773629|NCT03789006|Basiliximab|basiliximab|mesh-list
110773630|NCT03789006|Thymoglobulin|thymoglobulin|mesh-list
110773631|NCT03789006|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110773632|NCT03789006|Immunologic Factors|immunologic factors|mesh-ancestor
110773633|NCT03789006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110773634|NCT03789006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110773635|NCT03789006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110773636|NCT03789006|Analgesics|analgesics|mesh-ancestor
110773637|NCT03789006|Sensory System Agents|sensory system agents|mesh-ancestor
110773638|NCT03789006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110773639|NCT03789006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110773640|NCT01306266|Rizatriptan|rizatriptan|mesh-list
110773641|NCT01306266|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110773642|NCT01306266|Serotonin Agents|serotonin agents|mesh-ancestor
110773643|NCT01306266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110773644|NCT01306266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110773645|NCT01306266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110773646|NCT03516214|Trametinib|trametinib|mesh-list
110773647|NCT03516214|Nazartinib|nazartinib|mesh-list
110773648|NCT03516214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110773649|NCT03516214|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110773650|NCT03516214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110773651|NCT03516214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110773652|NCT03630796|Sevoflurane|sevoflurane|mesh-list
110773653|NCT03630796|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110773654|NCT03630796|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110773655|NCT03630796|Anesthetics, General|anesthetics, general|mesh-ancestor
110773656|NCT03630796|Anesthetics|anesthetics|mesh-ancestor
110773657|NCT03630796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110773658|NCT03630796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110773659|NCT05202964|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110773660|NCT05202964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110773661|NCT01096966|Bupivacaine|bupivacaine|mesh-list
110773662|NCT01096966|Anesthetics, Local|anesthetics, local|mesh-ancestor
110773663|NCT01096966|Anesthetics|anesthetics|mesh-ancestor
110773664|NCT01096966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110773665|NCT01096966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110773666|NCT01096966|Sensory System Agents|sensory system agents|mesh-ancestor
110773667|NCT01096966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110773668|NCT01379560|Isopropyl unoprostone|isopropyl unoprostone|mesh-list
110773669|NCT01379560|Dinoprost|dinoprost|mesh-list
110773670|NCT01379560|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110773671|NCT01379560|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110773672|NCT01379560|Abortifacient Agents|abortifacient agents|mesh-ancestor
110773673|NCT01379560|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110773674|NCT01379560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110773676|NCT01379482|Paclitaxel|paclitaxel|mesh-list
110773677|NCT01379482|Docetaxel|docetaxel|mesh-list
110773679|NCT01379482|Doxorubicin|doxorubicin|mesh-list
110773680|NCT01379482|Oxaliplatin|oxaliplatin|mesh-list
110773681|NCT01379482|Irinotecan|irinotecan|mesh-list
110773682|NCT01379482|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110773683|NCT01379482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110773684|NCT01379482|Tubulin Modulators|tubulin modulators|mesh-ancestor
110773685|NCT01379482|Antimitotic Agents|antimitotic agents|mesh-ancestor
110773686|NCT01379482|Mitosis Modulators|mitosis modulators|mesh-ancestor
110773687|NCT01379482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110773688|NCT01379482|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110773689|NCT01379482|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110773690|NCT01379482|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110773691|NCT01379482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110773692|NCT01379482|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110773693|NCT05624424|Sufentanil|sufentanil|mesh-list
110773694|NCT05624424|Remifentanil|remifentanil|mesh-list
110773695|NCT05624424|Propofol|propofol|mesh-list
110773696|NCT05624424|Sevoflurane|sevoflurane|mesh-list
110773697|NCT05624424|Cisatracurium|cisatracurium|mesh-list
110773698|NCT05624424|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110773699|NCT05624424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110773700|NCT05624424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110773701|NCT05624424|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110773702|NCT05624424|Anesthetics, General|anesthetics, general|mesh-ancestor
110773703|NCT05624424|Anesthetics|anesthetics|mesh-ancestor
110773704|NCT05624424|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110773705|NCT05624424|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110773706|NCT05624424|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110773707|NCT05624424|Narcotics|narcotics|mesh-ancestor
110773708|NCT05624424|Analgesics|analgesics|mesh-ancestor
110773709|NCT05624424|Sensory System Agents|sensory system agents|mesh-ancestor
110773710|NCT05624424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110773711|NCT05624424|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110773712|NCT05624424|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110773713|NCT05624424|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110773714|NCT05461690|Niraparib|niraparib|mesh-list
110773715|NCT05461690|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110773716|NCT05461690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110773717|NCT05461690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110773718|NCT05461690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110773719|NCT05456230|Midazolam|midazolam|mesh-list
110773720|NCT05456230|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110773721|NCT05456230|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110773722|NCT05456230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110773723|NCT05456230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110773724|NCT05456230|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110773725|NCT05456230|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110773726|NCT05456230|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110773727|NCT05456230|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110773728|NCT05456230|Anesthetics, General|anesthetics, general|mesh-ancestor
110773729|NCT05456230|Anesthetics|anesthetics|mesh-ancestor
110773730|NCT05456230|GABA Modulators|gaba modulators|mesh-ancestor
110773731|NCT05456230|GABA Agents|gaba agents|mesh-ancestor
110773732|NCT05456230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110773733|NCT05456230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110773734|NCT03791814|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
110773735|NCT03791814|Antiviral Agents|antiviral agents|mesh-ancestor
110773736|NCT03791814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110773737|NCT05404048|Atezolizumab|atezolizumab|mesh-list
110773738|NCT05404048|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110773739|NCT05404048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110773740|NCT05404048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110773741|NCT05404048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110773742|NCT01377376|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110773743|NCT01377376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110846452|NCT03231228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110773744|NCT01377376|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110773745|NCT01377376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110773746|NCT01377376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110773747|NCT03788538|Dexmedetomidine|dexmedetomidine|mesh-list
110773748|NCT03788538|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110773749|NCT03788538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110773750|NCT03788538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110773751|NCT03788538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110773752|NCT03788538|Analgesics|analgesics|mesh-ancestor
110773753|NCT03788538|Sensory System Agents|sensory system agents|mesh-ancestor
110773754|NCT03788538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110773755|NCT03788538|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110773756|NCT03788538|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110773757|NCT03788538|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110773758|NCT03788538|Adrenergic Agents|adrenergic agents|mesh-ancestor
110773759|NCT03788538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110773760|NCT03788538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110682903|NCT02539979|Analgesics|analgesics|mesh-ancestor
110773761|NCT05320120|Esketamine|esketamine|mesh-list
110773762|NCT05320120|Antidepressive Agents|antidepressive agents|mesh-ancestor
110773763|NCT05320120|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110773764|NCT03077698|Megestrol|megestrol|mesh-list
110773765|NCT03077698|Megestrol Acetate|megestrol acetate|mesh-list
110773766|NCT03077698|Progestins|progestins|mesh-list
110773767|NCT03077698|10-carboxymethyl-9-acridanone|10-carboxymethyl-9-acridanone|mesh-list
110773768|NCT03077698|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110773769|NCT03077698|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110773770|NCT03077698|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110773771|NCT03077698|Contraceptive Agents|contraceptive agents|mesh-ancestor
110773772|NCT03077698|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110773773|NCT03077698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110773774|NCT03077698|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110773775|NCT03077698|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110773776|NCT03077698|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110773777|NCT03077698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110773778|NCT03077698|Appetite Stimulants|appetite stimulants|mesh-ancestor
110773779|NCT03077698|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110773781|NCT03077698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110773782|NCT03077698|Interferon Inducers|interferon inducers|mesh-ancestor
110773783|NCT03077698|Immunologic Factors|immunologic factors|mesh-ancestor
110773784|NCT01377220|Choline|choline|mesh-list
110773785|NCT01377220|Lipotropic Agents|lipotropic agents|mesh-ancestor
110773786|NCT01377220|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110773787|NCT01377220|Antimetabolites|antimetabolites|mesh-ancestor
110773788|NCT01377220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110773789|NCT01377220|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110773790|NCT01377220|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110773791|NCT01377220|Nootropic Agents|nootropic agents|mesh-ancestor
110773792|NCT03079102|Nitric Oxide|nitric oxide|mesh-list
110773793|NCT03079102|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110773794|NCT03079102|Autonomic Agents|autonomic agents|mesh-ancestor
110773795|NCT03079102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110773796|NCT03079102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110773797|NCT03079102|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110773798|NCT03079102|Respiratory System Agents|respiratory system agents|mesh-ancestor
110773799|NCT03079102|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110773800|NCT03079102|Antioxidants|antioxidants|mesh-ancestor
110773801|NCT03079102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110773802|NCT03079102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110773803|NCT03079102|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
110773804|NCT03079102|Vasodilator Agents|vasodilator agents|mesh-ancestor
110773805|NCT03079102|Gasotransmitters|gasotransmitters|mesh-ancestor
110773806|NCT03079102|Protective Agents|protective agents|mesh-ancestor
110773807|NCT03791424|Midazolam|midazolam|mesh-list
110773808|NCT03791424|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110773809|NCT03791424|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110773810|NCT03791424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110773811|NCT03791424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110773812|NCT03791424|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110773813|NCT03791424|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110773814|NCT03791424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110773815|NCT03791424|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110773816|NCT03791424|Anesthetics, General|anesthetics, general|mesh-ancestor
110773817|NCT03791424|Anesthetics|anesthetics|mesh-ancestor
110773818|NCT03791424|GABA Modulators|gaba modulators|mesh-ancestor
110773819|NCT03791424|GABA Agents|gaba agents|mesh-ancestor
110773820|NCT03791424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110846507|NCT04525066|Hyaluronic Acid|hyaluronic acid|mesh-list
110773821|NCT03791424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110773823|NCT03787992|Aflutinib|aflutinib|mesh-list
110773824|NCT03787992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110773825|NCT03787992|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110773826|NCT03787992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110773827|NCT03787992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110773828|NCT02434354|Pembrolizumab|pembrolizumab|mesh-list
110773829|NCT02434354|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110773830|NCT02434354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110773831|NCT02434354|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110773832|NCT02434354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110773833|NCT05764018|Caffeine|caffeine|mesh-list
110773834|NCT05764018|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110773835|NCT05764018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110773836|NCT05764018|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110773837|NCT05764018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110773838|NCT05764018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110773839|NCT05764018|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110773840|NCT05764018|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110773841|NCT05764018|Purinergic Agents|purinergic agents|mesh-ancestor
110773842|NCT05764018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110773843|NCT01308528|Enoxaparin|enoxaparin|mesh-list
110773844|NCT01308528|Enoxaparin sodium|enoxaparin sodium|mesh-list
110773845|NCT01308528|Anticoagulants|anticoagulants|mesh-ancestor
110773846|NCT01308528|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110773847|NCT01308528|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110773848|NCT01308528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110773849|NCT04839328|Hemay005|hemay005|mesh-list
110773850|NCT04839328|Dermatologic Agents|dermatologic agents|mesh-ancestor
110773851|NCT04839328|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
110773852|NCT04839328|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110773853|NCT04839328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110773854|NCT04839328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110773855|NCT03785496|Spartalizumab|spartalizumab|mesh-list
110773856|NCT03785496|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110773857|NCT03785496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110773858|NCT03785496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110773859|NCT03785496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110773860|NCT01307202|Gabapentin|gabapentin|mesh-list
110773861|NCT01307202|Analgesics|analgesics|mesh-ancestor
110773862|NCT01307202|Sensory System Agents|sensory system agents|mesh-ancestor
110773863|NCT01307202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110773864|NCT01307202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110773865|NCT01307202|Anticonvulsants|anticonvulsants|mesh-ancestor
110773866|NCT01307202|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110773867|NCT01307202|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110773868|NCT01307202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110773869|NCT01307202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110773870|NCT01307202|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110773871|NCT01307202|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110773872|NCT01307202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110773873|NCT01307202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110773874|NCT01307202|Antimanic Agents|antimanic agents|mesh-ancestor
110773875|NCT01308606|Simeprevir|simeprevir|mesh-list
110773876|NCT01308606|Antiviral Agents|antiviral agents|mesh-ancestor
110773877|NCT01308606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110773878|NCT01308606|Protease Inhibitors|protease inhibitors|mesh-ancestor
110773879|NCT01308606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110773880|NCT01308606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110773881|NCT04637386|Anesthetics|anesthetics|mesh-list
110773882|NCT04637386|Anesthetics, Local|anesthetics, local|mesh-list
110773883|NCT04637386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110773884|NCT04637386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110773885|NCT04637386|Sensory System Agents|sensory system agents|mesh-ancestor
110773886|NCT04637386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110773887|NCT01308684|Bevacizumab|bevacizumab|mesh-list
110773888|NCT01308684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110773889|NCT01308684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110773891|NCT01308684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110773892|NCT01308684|Growth Substances|growth substances|mesh-ancestor
110773893|NCT01308684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110773894|NCT01308684|Growth Inhibitors|growth inhibitors|mesh-ancestor
110773895|NCT05613114|4-Aminopyridine|4-aminopyridine|mesh-list
110773896|NCT05613114|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
110773897|NCT05613114|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110773898|NCT05613114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110773899|NCT03790566|Bupivacaine|bupivacaine|mesh-list
110773900|NCT03790566|Anesthetics, Local|anesthetics, local|mesh-ancestor
110773901|NCT03790566|Anesthetics|anesthetics|mesh-ancestor
110773902|NCT03790566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110773903|NCT03790566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110773904|NCT03790566|Sensory System Agents|sensory system agents|mesh-ancestor
110773905|NCT03790566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110773906|NCT04436224|Fentanyl|fentanyl|mesh-list
110773907|NCT04436224|Hydromorphone|hydromorphone|mesh-list
110773908|NCT04436224|Butorphanol|butorphanol|mesh-list
110773909|NCT04436224|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110773910|NCT04436224|Narcotics|narcotics|mesh-ancestor
110491624|NCT00943124|Niacin|niacin|mesh-list
110773911|NCT04436224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110773912|NCT04436224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110773913|NCT04436224|Analgesics|analgesics|mesh-ancestor
110773914|NCT04436224|Sensory System Agents|sensory system agents|mesh-ancestor
110773915|NCT04436224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110773916|NCT04436224|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110773917|NCT04436224|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110773918|NCT04436224|Anesthetics, General|anesthetics, general|mesh-ancestor
110773920|NCT04436224|Antitussive Agents|antitussive agents|mesh-ancestor
110773921|NCT04436224|Respiratory System Agents|respiratory system agents|mesh-ancestor
110773922|NCT04436224|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110773923|NCT03785184|Dexamethasone|dexamethasone|mesh-list
110773924|NCT03785184|Lenalidomide|lenalidomide|mesh-list
110773925|NCT03785184|Venetoclax|venetoclax|mesh-list
110773926|NCT03785184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110773927|NCT03785184|Antiemetics|antiemetics|mesh-ancestor
110773928|NCT03785184|Autonomic Agents|autonomic agents|mesh-ancestor
110773929|NCT03785184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110773930|NCT03785184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110773931|NCT03785184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110773932|NCT03785184|Glucocorticoids|glucocorticoids|mesh-ancestor
110773933|NCT03785184|Hormones|hormones|mesh-ancestor
110773934|NCT03785184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110773935|NCT03785184|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110773936|NCT03785184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110773937|NCT03785184|Immunologic Factors|immunologic factors|mesh-ancestor
110773938|NCT03785184|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110773939|NCT03785184|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110773940|NCT03785184|Growth Substances|growth substances|mesh-ancestor
110773941|NCT03785184|Growth Inhibitors|growth inhibitors|mesh-ancestor
110773942|NCT03784794|Thrombin|thrombin|mesh-list
110773943|NCT03784794|Hemostatics|hemostatics|mesh-ancestor
110773944|NCT03784794|Coagulants|coagulants|mesh-ancestor
110773945|NCT01378546|Amifampridine|amifampridine|mesh-list
110773946|NCT01378546|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110773947|NCT01378546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110773948|NCT01378546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110773949|NCT01378546|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
110773950|NCT01378546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110773951|NCT01378546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110773952|NCT05688384|Alfentanil|alfentanil|mesh-list
110773953|NCT05688384|Propofol|propofol|mesh-list
110773954|NCT05688384|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110773955|NCT05688384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110773956|NCT05688384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110773957|NCT05688384|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110773958|NCT05688384|Anesthetics, General|anesthetics, general|mesh-ancestor
110773959|NCT05688384|Anesthetics|anesthetics|mesh-ancestor
110773960|NCT05688384|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110773961|NCT05688384|Narcotics|narcotics|mesh-ancestor
110773962|NCT05688384|Analgesics|analgesics|mesh-ancestor
110773963|NCT05688384|Sensory System Agents|sensory system agents|mesh-ancestor
110773964|NCT05688384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110773965|NCT01307592|Rituximab|rituximab|mesh-list
110773967|NCT01307592|Oxaliplatin|oxaliplatin|mesh-list
110773968|NCT01307592|Lenalidomide|lenalidomide|mesh-list
110773969|NCT01307592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110773970|NCT01307592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110773971|NCT01307592|Immunologic Factors|immunologic factors|mesh-ancestor
110773972|NCT01307592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110773973|NCT01307592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110773974|NCT01307592|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110773975|NCT01307592|Antimetabolites|antimetabolites|mesh-ancestor
110773976|NCT01307592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110773977|NCT01307592|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110773978|NCT01307592|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110773979|NCT01307592|Growth Substances|growth substances|mesh-ancestor
110773980|NCT01307592|Growth Inhibitors|growth inhibitors|mesh-ancestor
110773981|NCT03790020|Bupivacaine|bupivacaine|mesh-list
110773982|NCT03790020|Anesthetics, Local|anesthetics, local|mesh-ancestor
110773983|NCT03790020|Anesthetics|anesthetics|mesh-ancestor
110773984|NCT03790020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110773985|NCT03790020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110773986|NCT03790020|Sensory System Agents|sensory system agents|mesh-ancestor
110773987|NCT03790020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110773988|NCT03075826|Guadecitabine|guadecitabine|mesh-list
110773989|NCT03075826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110773990|NCT01378156|Vaccines|vaccines|mesh-list
110773991|NCT01378156|Immunologic Factors|immunologic factors|mesh-ancestor
110773992|NCT01378156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110773993|NCT04108234|Ketamine|ketamine|mesh-list
110773994|NCT04108234|Analgesics|analgesics|mesh-ancestor
110773995|NCT04108234|Sensory System Agents|sensory system agents|mesh-ancestor
110773997|NCT04108234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110773998|NCT04108234|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110773999|NCT04108234|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110774000|NCT04108234|Anesthetics, General|anesthetics, general|mesh-ancestor
110774001|NCT04108234|Anesthetics|anesthetics|mesh-ancestor
110774002|NCT04108234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110774003|NCT04108234|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110774004|NCT04108234|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110774005|NCT04108234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110774006|NCT04108234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110774007|NCT03687814|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
110774008|NCT03687814|Laxatives|laxatives|mesh-ancestor
110774009|NCT03687814|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110774010|NCT05763550|Pregabalin|pregabalin|mesh-list
110774011|NCT05763550|Analgesics|analgesics|mesh-ancestor
110774012|NCT05763550|Sensory System Agents|sensory system agents|mesh-ancestor
110774013|NCT05763550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110774014|NCT05763550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110774015|NCT05763550|Anticonvulsants|anticonvulsants|mesh-ancestor
110774016|NCT05763550|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110774017|NCT05763550|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110774018|NCT05763550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110774019|NCT05763550|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110774020|NCT05763550|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110774021|NCT05763550|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110774022|NCT05763550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110774023|NCT05763550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110774024|NCT03783936|Leucovorin|leucovorin|mesh-list
110774025|NCT03783936|Fluorouracil|fluorouracil|mesh-list
110774026|NCT03783936|Oxaliplatin|oxaliplatin|mesh-list
110774027|NCT03783936|Trastuzumab|trastuzumab|mesh-list
110774028|NCT03783936|Avelumab|avelumab|mesh-list
110774029|NCT03783936|Antimetabolites|antimetabolites|mesh-ancestor
110774030|NCT03783936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110774031|NCT03783936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110774032|NCT03783936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110774033|NCT03783936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110774034|NCT03783936|Immunologic Factors|immunologic factors|mesh-ancestor
110774035|NCT03783936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110774036|NCT03783936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110774037|NCT03783936|Antidotes|antidotes|mesh-ancestor
110774038|NCT03783936|Protective Agents|protective agents|mesh-ancestor
110774039|NCT03783936|Vitamin B Complex|vitamin b complex|mesh-ancestor
110774040|NCT03783936|Vitamins|vitamins|mesh-ancestor
110774041|NCT03783936|Micronutrients|micronutrients|mesh-ancestor
110774042|NCT03781908|Silver Nitrate|silver nitrate|mesh-list
110774043|NCT03781908|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110774044|NCT03781908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110774045|NCT03781596|Fluticasone|fluticasone|mesh-list
110774046|NCT03781596|Omeprazole|omeprazole|mesh-list
110774047|NCT03781596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110774048|NCT03781596|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110774049|NCT03781596|Autonomic Agents|autonomic agents|mesh-ancestor
110774050|NCT03781596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110774051|NCT03781596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110774052|NCT03781596|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110774053|NCT03781596|Respiratory System Agents|respiratory system agents|mesh-ancestor
110774054|NCT03781596|Dermatologic Agents|dermatologic agents|mesh-ancestor
110774055|NCT03781596|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110774056|NCT03781596|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110774057|NCT03781596|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110774058|NCT03781596|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110774059|NCT03781596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110774060|NCT03781596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110774061|NCT03781674|Progesterone|progesterone|mesh-list
110774062|NCT03781674|Progestins|progestins|mesh-ancestor
110774063|NCT03781674|Hormones|hormones|mesh-ancestor
110774064|NCT03781674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110774065|NCT03781674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110774066|NCT03786120|Zolpidem|zolpidem|mesh-list
110774067|NCT03786120|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110774068|NCT03786120|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110774069|NCT03786120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110774070|NCT03786120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110774071|NCT03786120|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
110774072|NCT03786120|GABA Agonists|gaba agonists|mesh-ancestor
110774073|NCT03786120|GABA Agents|gaba agents|mesh-ancestor
110774074|NCT03786120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110774075|NCT03786120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110774076|NCT01561014|Fluorouracil|fluorouracil|mesh-list
110774077|NCT01561014|Oxaliplatin|oxaliplatin|mesh-list
110774078|NCT01561014|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110774079|NCT01561014|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110774080|NCT01561014|Antimetabolites|antimetabolites|mesh-ancestor
110774081|NCT01561014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110774082|NCT01561014|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110774083|NCT01561014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110774084|NCT01561014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110774085|NCT01561014|Immunologic Factors|immunologic factors|mesh-ancestor
110774086|NCT01561014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110774087|NCT01561014|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110774088|NCT01561014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110774089|NCT01561014|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110774090|NCT01561092|Escitalopram|escitalopram|mesh-list
110774091|NCT01561092|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110774092|NCT01561092|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110774093|NCT01561092|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110774094|NCT01561092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110774095|NCT01561092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110774096|NCT01561092|Serotonin Agents|serotonin agents|mesh-ancestor
110774097|NCT01561092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110774098|NCT05494866|Cobicistat|cobicistat|mesh-list
110774099|NCT05494866|Paclitaxel|paclitaxel|mesh-list
110774100|NCT05494866|Gemcitabine|gemcitabine|mesh-list
110774101|NCT05494866|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110774102|NCT05494866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110774103|NCT05494866|Tubulin Modulators|tubulin modulators|mesh-ancestor
110774104|NCT05494866|Antimitotic Agents|antimitotic agents|mesh-ancestor
110774105|NCT05494866|Mitosis Modulators|mitosis modulators|mesh-ancestor
110774106|NCT05494866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110774107|NCT05494866|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110774108|NCT05494866|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110774109|NCT05494866|Antiviral Agents|antiviral agents|mesh-ancestor
110774110|NCT05494866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110774111|NCT05494866|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110774112|NCT05494866|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110774113|NCT05494866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110774114|NCT05494866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110774115|NCT05494866|Antimetabolites|antimetabolites|mesh-ancestor
110774117|NCT01316874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110774118|NCT01316874|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110774119|NCT01316874|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110774120|NCT01316874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110774121|NCT01316874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110774122|NCT01309542|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
110774123|NCT01309542|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110774124|NCT01309542|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110774125|NCT01309542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110774126|NCT01309542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110774127|NCT01309542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110846719|NCT03179787|Aripiprazole|aripiprazole|mesh-list
110774128|NCT01309542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110774129|NCT01309542|Antidepressive Agents|antidepressive agents|mesh-ancestor
110774130|NCT01309542|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110774131|NCT01309620|Zinc|zinc|mesh-list
110774132|NCT01309620|Trace Elements|trace elements|mesh-ancestor
110774133|NCT01309620|Micronutrients|micronutrients|mesh-ancestor
110774134|NCT01309620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110774135|NCT03783312|Acetaminophen|acetaminophen|mesh-list
110774136|NCT03783312|Ibuprofen|ibuprofen|mesh-list
110774137|NCT03783312|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110491801|NCT04294823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110774138|NCT03783312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110774140|NCT03783312|Sensory System Agents|sensory system agents|mesh-ancestor
110774141|NCT03783312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110774142|NCT03783312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110774143|NCT03783312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110774144|NCT03783312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110774145|NCT03783312|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110774146|NCT03783312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110774147|NCT03783312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110774148|NCT03783312|Antipyretics|antipyretics|mesh-ancestor
110774149|NCT03776916|Simethicone|simethicone|mesh-list
110774150|NCT03776916|Antifoaming Agents|antifoaming agents|mesh-ancestor
110774151|NCT03776916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110774152|NCT03776916|Emollients|emollients|mesh-ancestor
110774153|NCT03776916|Dermatologic Agents|dermatologic agents|mesh-ancestor
110774154|NCT01560702|Epinephrine|epinephrine|mesh-list
110774155|NCT01560702|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110774156|NCT01560702|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110774157|NCT01560702|Adrenergic Agents|adrenergic agents|mesh-ancestor
110774158|NCT01560702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110774159|NCT01560702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110774160|NCT01560702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110774161|NCT01560702|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110774162|NCT01560702|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110774163|NCT01560702|Autonomic Agents|autonomic agents|mesh-ancestor
110774164|NCT01560702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110774165|NCT01560702|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110774166|NCT01560702|Respiratory System Agents|respiratory system agents|mesh-ancestor
110774167|NCT01560702|Mydriatics|mydriatics|mesh-ancestor
110774168|NCT01560702|Sympathomimetics|sympathomimetics|mesh-ancestor
110774169|NCT01560702|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110774170|NCT03776838|Fentanyl|fentanyl|mesh-list
110846758|NCT01176851|Glycopyrrolate|glycopyrrolate|mesh-list
110774171|NCT03776838|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110774172|NCT03776838|Narcotics|narcotics|mesh-ancestor
110774173|NCT03776838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110774174|NCT03776838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110774175|NCT03776838|Analgesics|analgesics|mesh-ancestor
110774176|NCT03776838|Sensory System Agents|sensory system agents|mesh-ancestor
110774177|NCT03776838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110774178|NCT03776838|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110774179|NCT03776838|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110774180|NCT03776838|Anesthetics, General|anesthetics, general|mesh-ancestor
110774181|NCT03776838|Anesthetics|anesthetics|mesh-ancestor
110774182|NCT03781050|Sirolimus|sirolimus|mesh-list
110774183|NCT03781050|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110774184|NCT03781050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110774185|NCT03781050|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110774186|NCT03781050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110774187|NCT03781050|Antifungal Agents|antifungal agents|mesh-ancestor
110774188|NCT03781050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110774189|NCT03781050|Immunologic Factors|immunologic factors|mesh-ancestor
110099268|NCT01747226|Fluorides|fluorides|mesh-list
110774190|NCT03781050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110774192|NCT02865850|Hematinics|hematinics|mesh-ancestor
110774193|NCT01309698|Inositol|inositol|mesh-list
110774194|NCT01309698|Vildagliptin|vildagliptin|mesh-list
110774195|NCT01309698|Voglibose|voglibose|mesh-list
110774196|NCT01309698|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110774197|NCT01309698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110774198|NCT01309698|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110774199|NCT01309698|Protease Inhibitors|protease inhibitors|mesh-ancestor
110774200|NCT01309698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110774201|NCT01309698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110774202|NCT01309698|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
110774203|NCT01309698|Vitamin B Complex|vitamin b complex|mesh-ancestor
110774204|NCT01309698|Vitamins|vitamins|mesh-ancestor
110774205|NCT01309698|Micronutrients|micronutrients|mesh-ancestor
110774206|NCT01142284|Cilostazol|cilostazol|mesh-list
110774207|NCT01142284|Probucol|probucol|mesh-list
110774208|NCT01142284|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110774209|NCT01142284|Autonomic Agents|autonomic agents|mesh-ancestor
110774210|NCT01142284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110774211|NCT01142284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110774212|NCT01142284|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110774213|NCT01142284|Respiratory System Agents|respiratory system agents|mesh-ancestor
110774214|NCT01142284|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110774215|NCT01142284|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110774216|NCT01142284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110774217|NCT01142284|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110774218|NCT01142284|Vasodilator Agents|vasodilator agents|mesh-ancestor
110774219|NCT01142284|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110774220|NCT01142284|Protective Agents|protective agents|mesh-ancestor
110774221|NCT01142284|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110774222|NCT01142284|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110774223|NCT01142284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110774224|NCT01142284|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110774225|NCT01142284|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110774226|NCT01142284|Antimetabolites|antimetabolites|mesh-ancestor
110774227|NCT01142284|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110774228|NCT01142284|Antioxidants|antioxidants|mesh-ancestor
110774229|NCT01309776|Tianeptine|tianeptine|mesh-list
110774230|NCT01309776|Escitalopram|escitalopram|mesh-list
110774231|NCT01309776|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110774232|NCT01309776|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110774233|NCT01309776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110774234|NCT01309776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110846789|NCT01179971|Dermatologic Agents|dermatologic agents|mesh-ancestor
110774235|NCT01309776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110774236|NCT01309776|Serotonin Agents|serotonin agents|mesh-ancestor
110774237|NCT01309776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110774238|NCT01309776|Antidepressive Agents|antidepressive agents|mesh-ancestor
110774239|NCT01309776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110774240|NCT01309776|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110774241|NCT03783000|BI 425809|bi 425809|mesh-list
110774242|NCT03783000|Nootropic Agents|nootropic agents|mesh-ancestor
110774243|NCT01309854|Pioglitazone|pioglitazone|mesh-list
110774244|NCT01309854|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110774245|NCT01309854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110774246|NCT03780192|Sirolimus|sirolimus|mesh-list
110774247|NCT03780192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110774248|NCT03780192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110774249|NCT03780192|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110774250|NCT03780192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110774251|NCT03780192|Antifungal Agents|antifungal agents|mesh-ancestor
110774252|NCT03780192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110774253|NCT03780192|Immunologic Factors|immunologic factors|mesh-ancestor
110774254|NCT03780192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110774255|NCT05305560|Ivermectin|ivermectin|mesh-list
110774256|NCT05305560|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110774257|NCT05305560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110774258|NCT03776448|Charcoal|charcoal|mesh-list
110774259|NCT03776448|Antidotes|antidotes|mesh-ancestor
110774260|NCT03776448|Protective Agents|protective agents|mesh-ancestor
110774261|NCT03776448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110774262|NCT03780270|Fluorides|fluorides|mesh-list
110774263|NCT03780270|Fluorides, Topical|fluorides, topical|mesh-list
110774264|NCT03780270|Cariostatic Agents|cariostatic agents|mesh-ancestor
110774265|NCT03780270|Protective Agents|protective agents|mesh-ancestor
110774266|NCT03780270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110774268|NCT03072160|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110774269|NCT03072160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110774270|NCT03072160|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110774271|NCT03072160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110774272|NCT05517486|Bupivacaine|bupivacaine|mesh-list
110774273|NCT05517486|Anesthetics, Local|anesthetics, local|mesh-ancestor
110774274|NCT05517486|Anesthetics|anesthetics|mesh-ancestor
110774275|NCT05517486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110774276|NCT05517486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110774277|NCT05517486|Sensory System Agents|sensory system agents|mesh-ancestor
110774278|NCT05517486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110774279|NCT01019356|Rosiglitazone|rosiglitazone|mesh-list
110774280|NCT01019356|Acarbose|acarbose|mesh-list
110774281|NCT01019356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110774282|NCT01019356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110774283|NCT01019356|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
110774284|NCT01019356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110774285|NCT01019356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110774286|NCT01314066|Bevacizumab|bevacizumab|mesh-list
110774287|NCT01314066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110682904|NCT02539979|Sensory System Agents|sensory system agents|mesh-ancestor
110774288|NCT01314066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110774289|NCT01314066|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110774290|NCT01314066|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110774291|NCT01314066|Growth Substances|growth substances|mesh-ancestor
110774292|NCT01314066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110774293|NCT01314066|Growth Inhibitors|growth inhibitors|mesh-ancestor
110774294|NCT01314300|Lidocaine|lidocaine|mesh-list
110774295|NCT01314300|Anesthetics, Local|anesthetics, local|mesh-ancestor
110774296|NCT01314300|Anesthetics|anesthetics|mesh-ancestor
110774297|NCT01314300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110774298|NCT01314300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110774299|NCT01314300|Sensory System Agents|sensory system agents|mesh-ancestor
110774300|NCT01314300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110774301|NCT01314300|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110774302|NCT01314300|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110774303|NCT01314300|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110774304|NCT01314300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110774305|NCT01314300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110774306|NCT05762536|Docetaxel|docetaxel|mesh-list
110774307|NCT05762536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110774308|NCT05762536|Tubulin Modulators|tubulin modulators|mesh-ancestor
110774309|NCT05762536|Antimitotic Agents|antimitotic agents|mesh-ancestor
110774310|NCT05762536|Mitosis Modulators|mitosis modulators|mesh-ancestor
110774311|NCT05762536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110774312|NCT03776058|Cinacalcet|cinacalcet|mesh-list
110774313|NCT03776058|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110774314|NCT03776058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110774315|NCT03776058|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
110774316|NCT03776058|Hormone Antagonists|hormone antagonists|mesh-ancestor
110774317|NCT03776058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110774318|NCT05202496|Calcitriol|calcitriol|mesh-list
110774319|NCT05202496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110846822|NCT01285661|Warfarin|warfarin|mesh-list
110774320|NCT05202496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110774321|NCT05202496|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
110774322|NCT05202496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110774323|NCT05202496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110774324|NCT05202496|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110774325|NCT05202496|Vitamins|vitamins|mesh-ancestor
110774326|NCT05202496|Micronutrients|micronutrients|mesh-ancestor
110774327|NCT05202496|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110774328|NCT03779568|Bupivacaine|bupivacaine|mesh-list
110774329|NCT03779568|Anesthetics, Local|anesthetics, local|mesh-ancestor
110774330|NCT03779568|Anesthetics|anesthetics|mesh-ancestor
110774331|NCT03779568|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110774332|NCT03779568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110774333|NCT03779568|Sensory System Agents|sensory system agents|mesh-ancestor
110774334|NCT03779568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110774335|NCT05201560|Fentanyl|fentanyl|mesh-list
110774336|NCT05201560|Butorphanol|butorphanol|mesh-list
110774337|NCT05201560|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110774338|NCT05201560|Narcotics|narcotics|mesh-ancestor
110774340|NCT05201560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110774341|NCT05201560|Analgesics|analgesics|mesh-ancestor
110774342|NCT05201560|Sensory System Agents|sensory system agents|mesh-ancestor
110774343|NCT05201560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110774344|NCT05201560|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110774345|NCT05201560|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110774346|NCT05201560|Anesthetics, General|anesthetics, general|mesh-ancestor
110774347|NCT05201560|Anesthetics|anesthetics|mesh-ancestor
110774348|NCT05201560|Antitussive Agents|antitussive agents|mesh-ancestor
110774349|NCT05201560|Respiratory System Agents|respiratory system agents|mesh-ancestor
110774350|NCT05201560|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110774351|NCT05201326|Bevacizumab|bevacizumab|mesh-list
110774352|NCT05201326|Irinotecan|irinotecan|mesh-list
110774353|NCT05201326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110774354|NCT05201326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110774355|NCT05201326|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110774356|NCT05201326|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110774357|NCT05201326|Growth Substances|growth substances|mesh-ancestor
110774358|NCT05201326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110774359|NCT05201326|Growth Inhibitors|growth inhibitors|mesh-ancestor
110774360|NCT05201326|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110774361|NCT05201326|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110774362|NCT05201326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110774363|NCT05201326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110774364|NCT03775668|Enmetazobactam|enmetazobactam|mesh-list
110774365|NCT03775668|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110774366|NCT03775668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110774367|NCT03775668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110774368|NCT03775668|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110774369|NCT03775668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110774370|NCT01561404|Everolimus|everolimus|mesh-list
110774371|NCT01561404|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110774372|NCT01561404|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110774373|NCT01561404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110774374|NCT01561404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110774375|NCT01561404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110774376|NCT01561404|Immunologic Factors|immunologic factors|mesh-ancestor
110846868|NCT04523506|Cholinergic Agents|cholinergic agents|mesh-ancestor
110774377|NCT01561404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110774378|NCT01561404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110774379|NCT03775590|Acetic Acid|acetic acid|mesh-list
110774380|NCT03775590|Retinol acetate|retinol acetate|mesh-list
110774381|NCT03775590|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110774382|NCT03775590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110774383|NCT03775590|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110774384|NCT03775590|Immunologic Factors|immunologic factors|mesh-ancestor
110774385|NCT03775590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110774386|NCT03775590|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110774387|NCT03775590|Protective Agents|protective agents|mesh-ancestor
110774388|NCT03775590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110774389|NCT03775746|Rivaroxaban|rivaroxaban|mesh-list
110774390|NCT03775746|Clopidogrel|clopidogrel|mesh-list
110774391|NCT03775746|Ticagrelor|ticagrelor|mesh-list
110774392|NCT03775746|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110774393|NCT03775746|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110774394|NCT03775746|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110774395|NCT03775746|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110774396|NCT03775746|Purinergic Agents|purinergic agents|mesh-ancestor
110774397|NCT03775746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110774398|NCT03775746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110774399|NCT03775746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110774400|NCT03775746|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110774401|NCT03775746|Antithrombins|antithrombins|mesh-ancestor
110774402|NCT03775746|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110774403|NCT03775746|Protease Inhibitors|protease inhibitors|mesh-ancestor
110774404|NCT03775746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110774405|NCT03775746|Anticoagulants|anticoagulants|mesh-ancestor
110774406|NCT03779178|Landiolol|landiolol|mesh-list
110774407|NCT03779178|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110846898|NCT01064479|Cisplatin|cisplatin|mesh-list
110774408|NCT03779178|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110774409|NCT03779178|Adrenergic Agents|adrenergic agents|mesh-ancestor
110774410|NCT03779178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110774411|NCT03779178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110774412|NCT03779178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110774413|NCT03779178|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110774415|NCT03779100|Antibodies|antibodies|mesh-list
110774416|NCT03779100|Immunoglobulins|immunoglobulins|mesh-list
110774417|NCT03779100|Immunologic Factors|immunologic factors|mesh-ancestor
110774418|NCT03779100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110774419|NCT03779100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110774420|NCT03779100|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110774421|NCT03779100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110774422|NCT03779100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110774423|NCT05711212|Xanthohumol|xanthohumol|mesh-list
110774424|NCT05711212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110774425|NCT05711212|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110774426|NCT05711212|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110774427|NCT05711212|Growth Substances|growth substances|mesh-ancestor
110774428|NCT05711212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110774429|NCT05711212|Growth Inhibitors|growth inhibitors|mesh-ancestor
110774430|NCT05212636|Antidepressive Agents|antidepressive agents|mesh-list
110774431|NCT05212636|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110774432|NCT03773094|Chlorhexidine|chlorhexidine|mesh-list
110774433|NCT03773094|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110774434|NCT03773094|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110774435|NCT03773094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110774436|NCT03773094|Disinfectants|disinfectants|mesh-ancestor
110774437|NCT03773094|Dermatologic Agents|dermatologic agents|mesh-ancestor
110774438|NCT03775356|Anesthetics|anesthetics|mesh-list
110774439|NCT03775356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110774440|NCT03775356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110774441|NCT05211622|Thioctic Acid|thioctic acid|mesh-list
110774442|NCT05211622|Chlorhexidine|chlorhexidine|mesh-list
110774443|NCT05211622|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110774444|NCT05211622|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110774445|NCT05211622|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110774446|NCT05211622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110774447|NCT05211622|Disinfectants|disinfectants|mesh-ancestor
110774448|NCT05211622|Dermatologic Agents|dermatologic agents|mesh-ancestor
110774449|NCT05211622|Antioxidants|antioxidants|mesh-ancestor
110774450|NCT05211622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110774451|NCT05211622|Protective Agents|protective agents|mesh-ancestor
110774452|NCT05211622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110774453|NCT05211622|Vitamin B Complex|vitamin b complex|mesh-ancestor
110774455|NCT05211622|Micronutrients|micronutrients|mesh-ancestor
110774456|NCT05705518|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110774457|NCT05705518|Lubricant Eye Drops|lubricant eye drops|mesh-list
110774458|NCT05705518|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110774459|NCT05191264|Analgesics|analgesics|mesh-list
110774460|NCT05191264|Sensory System Agents|sensory system agents|mesh-ancestor
110774461|NCT05191264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110774462|NCT05191264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110774463|NCT03778008|Vitamin B 12|vitamin b 12|mesh-list
110774464|NCT03778008|Gentamicins|gentamicins|mesh-list
110774465|NCT03778008|Dexamethasone|dexamethasone|mesh-list
110774466|NCT03778008|Lidocaine|lidocaine|mesh-list
110774467|NCT03778008|Mitogens|mitogens|mesh-list
110774468|NCT03778008|Vitamins|vitamins|mesh-ancestor
110774469|NCT03778008|Micronutrients|micronutrients|mesh-ancestor
110774470|NCT03778008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110774471|NCT03778008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110774472|NCT03778008|Antiemetics|antiemetics|mesh-ancestor
110774473|NCT03778008|Autonomic Agents|autonomic agents|mesh-ancestor
110774474|NCT03778008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110774475|NCT03778008|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110774476|NCT03778008|Glucocorticoids|glucocorticoids|mesh-ancestor
110774477|NCT03778008|Hormones|hormones|mesh-ancestor
110774478|NCT03778008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110774479|NCT03778008|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110774480|NCT03778008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110774481|NCT03778008|Anesthetics, Local|anesthetics, local|mesh-ancestor
110774482|NCT03778008|Anesthetics|anesthetics|mesh-ancestor
110774483|NCT03778008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110774484|NCT03778008|Sensory System Agents|sensory system agents|mesh-ancestor
110774485|NCT03778008|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110774486|NCT03778008|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110774487|NCT03778008|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110774488|NCT03778008|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110774489|NCT03778008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110774490|NCT03778008|Mitosis Modulators|mitosis modulators|mesh-ancestor
110774491|NCT03778008|Vitamin B Complex|vitamin b complex|mesh-ancestor
110774492|NCT03778008|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110774493|NCT03778008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110774494|NCT03778008|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110774495|NCT03778008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110774496|NCT05697328|Pseudoephedrine|pseudoephedrine|mesh-list
110774497|NCT05697328|Ephedrine|ephedrine|mesh-list
110774498|NCT05697328|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110774499|NCT05697328|Autonomic Agents|autonomic agents|mesh-ancestor
110774500|NCT05697328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110774501|NCT05697328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110774502|NCT05697328|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110774503|NCT05697328|Respiratory System Agents|respiratory system agents|mesh-ancestor
110774504|NCT05697328|Nasal Decongestants|nasal decongestants|mesh-ancestor
110774505|NCT05697328|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110774506|NCT05697328|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110774507|NCT05697328|Sympathomimetics|sympathomimetics|mesh-ancestor
110774508|NCT05697328|Adrenergic Agents|adrenergic agents|mesh-ancestor
110774509|NCT05697328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110774510|NCT05697328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110774511|NCT03777930|Thalidomide|thalidomide|mesh-list
110774512|NCT03777930|Megestrol|megestrol|mesh-list
110774513|NCT03777930|Megestrol Acetate|megestrol acetate|mesh-list
110774514|NCT03777930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110774515|NCT03777930|Immunologic Factors|immunologic factors|mesh-ancestor
110774516|NCT03777930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110774517|NCT03777930|Leprostatic Agents|leprostatic agents|mesh-ancestor
110774518|NCT03777930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110774519|NCT03777930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110774520|NCT03777930|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110774521|NCT03777930|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110774522|NCT03777930|Growth Substances|growth substances|mesh-ancestor
110774523|NCT03777930|Growth Inhibitors|growth inhibitors|mesh-ancestor
110774524|NCT03777930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110774525|NCT03777930|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110774526|NCT03777930|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110774527|NCT03777930|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110774528|NCT03777930|Contraceptive Agents|contraceptive agents|mesh-ancestor
110774529|NCT03777930|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110774530|NCT03777930|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110774531|NCT03777930|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110774532|NCT03777930|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110774533|NCT03777930|Appetite Stimulants|appetite stimulants|mesh-ancestor
110774534|NCT03777930|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110774535|NCT03777696|Misoprostol|misoprostol|mesh-list
110774536|NCT03777696|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110774537|NCT03777696|Abortifacient Agents|abortifacient agents|mesh-ancestor
110774538|NCT03777696|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110774539|NCT03777696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110774540|NCT03777696|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110774541|NCT03777696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110774542|NCT03777696|Oxytocics|oxytocics|mesh-ancestor
110774543|NCT04581148|Antibodies|antibodies|mesh-list
110774544|NCT04581148|Immunoglobulins|immunoglobulins|mesh-list
110774545|NCT04581148|Immunologic Factors|immunologic factors|mesh-ancestor
110774546|NCT04581148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110774547|NCT03708744|Oxazolidinones|oxazolidinones|mesh-list
110774548|NCT03708744|Zolmitriptan|zolmitriptan|mesh-list
110774549|NCT03708744|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110774550|NCT03708744|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110774551|NCT03708744|Serotonin Agents|serotonin agents|mesh-ancestor
110774552|NCT03708744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110774553|NCT03708744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110774554|NCT03708744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110774555|NCT03708744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110774556|NCT03708744|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110774557|NCT03708744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110774558|NCT03774108|Metformin|metformin|mesh-list
110774559|NCT03774108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110774560|NCT03774108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110774561|NCT03438526|Melatonin|melatonin|mesh-list
110774562|NCT03438526|Antioxidants|antioxidants|mesh-ancestor
110774563|NCT03438526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110774564|NCT03438526|Protective Agents|protective agents|mesh-ancestor
110774565|NCT03438526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110774566|NCT03438526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110774567|NCT02575144|Clarithromycin|clarithromycin|mesh-list
110774568|NCT02575144|Dexamethasone|dexamethasone|mesh-list
110774569|NCT02575144|Lenalidomide|lenalidomide|mesh-list
110774570|NCT02575144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110774571|NCT02575144|Antiemetics|antiemetics|mesh-ancestor
110774572|NCT02575144|Autonomic Agents|autonomic agents|mesh-ancestor
110774573|NCT02575144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110774574|NCT02575144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110774575|NCT02575144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110774576|NCT02575144|Glucocorticoids|glucocorticoids|mesh-ancestor
110774577|NCT02575144|Hormones|hormones|mesh-ancestor
110774578|NCT02575144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110774579|NCT02575144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110774580|NCT02575144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110774581|NCT02575144|Immunologic Factors|immunologic factors|mesh-ancestor
110774582|NCT02575144|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110774583|NCT02575144|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110774584|NCT02575144|Growth Substances|growth substances|mesh-ancestor
110774585|NCT02575144|Growth Inhibitors|growth inhibitors|mesh-ancestor
110774586|NCT02575144|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110774587|NCT02575144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110774588|NCT02575144|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110774589|NCT02575144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110492249|NCT00725842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110774590|NCT02575144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110774591|NCT02575144|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110774592|NCT02575144|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110774593|NCT03768882|Acetaminophen|acetaminophen|mesh-list
110774594|NCT03768882|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
110774595|NCT03768882|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110774596|NCT03768882|Analgesics|analgesics|mesh-ancestor
110774597|NCT03768882|Sensory System Agents|sensory system agents|mesh-ancestor
110774598|NCT03768882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110774599|NCT03768882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110774600|NCT03768882|Antipyretics|antipyretics|mesh-ancestor
110774601|NCT03768882|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110774602|NCT03768882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110774603|NCT03768882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110774604|NCT02574286|Vitamin D|vitamin d|mesh-list
110774605|NCT02574286|Vitamins|vitamins|mesh-ancestor
110774606|NCT02574286|Micronutrients|micronutrients|mesh-ancestor
110774607|NCT02574286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110774608|NCT02574286|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110774609|NCT01321944|Nicotine|nicotine|mesh-list
110774610|NCT01321944|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110774611|NCT01321944|Autonomic Agents|autonomic agents|mesh-ancestor
110774612|NCT01321944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110774613|NCT01321944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110774614|NCT01321944|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110774615|NCT01321944|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110774616|NCT01321944|Cholinergic Agents|cholinergic agents|mesh-ancestor
110774617|NCT01321944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110774618|NCT01321944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110774619|NCT03771846|Leucovorin|leucovorin|mesh-list
110774620|NCT03771846|Gemcitabine|gemcitabine|mesh-list
110774621|NCT03771846|Fluorouracil|fluorouracil|mesh-list
110774622|NCT03771846|Oxaliplatin|oxaliplatin|mesh-list
110774623|NCT03771846|Irinotecan|irinotecan|mesh-list
110774624|NCT03771846|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110774625|NCT03771846|Antimetabolites|antimetabolites|mesh-ancestor
110774626|NCT03771846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110774627|NCT03771846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110774628|NCT03771846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110774629|NCT03771846|Immunologic Factors|immunologic factors|mesh-ancestor
110774630|NCT03771846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110774631|NCT03771846|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110774632|NCT03771846|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110774633|NCT03771846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110774634|NCT03771846|Antidotes|antidotes|mesh-ancestor
110774635|NCT03771846|Protective Agents|protective agents|mesh-ancestor
110774636|NCT03771846|Vitamin B Complex|vitamin b complex|mesh-ancestor
110774637|NCT03771846|Vitamins|vitamins|mesh-ancestor
110774638|NCT03771846|Micronutrients|micronutrients|mesh-ancestor
110774639|NCT03763110|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110774640|NCT03763110|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
110774641|NCT03763110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110492625|NCT05684692|Siltuximab|siltuximab|mesh-list
110774642|NCT03763110|Antitubercular Agents|antitubercular agents|mesh-ancestor
110774643|NCT03771768|Triamcinolone|triamcinolone|mesh-list
110774644|NCT03771768|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110774645|NCT03771768|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110774646|NCT03771768|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110774647|NCT03771768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110774648|NCT03771768|Glucocorticoids|glucocorticoids|mesh-ancestor
110774649|NCT03771768|Hormones|hormones|mesh-ancestor
110774650|NCT03771768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110774651|NCT03771768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110774652|NCT03771768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110774653|NCT03771768|Immunologic Factors|immunologic factors|mesh-ancestor
110774654|NCT03771768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110774655|NCT03771768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110774656|NCT04393350|Pembrolizumab|pembrolizumab|mesh-list
110774657|NCT04393350|Lenvatinib|lenvatinib|mesh-list
110774658|NCT04393350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110774659|NCT04393350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110774660|NCT04393350|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110774661|NCT04393350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110774662|NCT04393350|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110774663|NCT04393350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110774664|NCT03768258|Methyltestosterone|methyltestosterone|mesh-list
110774665|NCT03768258|Anastrozole|anastrozole|mesh-list
110492325|NCT00754351|Bevacizumab|bevacizumab|mesh-list
110774666|NCT03768258|Testosterone|testosterone|mesh-list
110774667|NCT03768258|Testosterone undecanoate|testosterone undecanoate|mesh-list
110774668|NCT03768258|Testosterone enanthate|testosterone enanthate|mesh-list
110774669|NCT03768258|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
110774670|NCT03768258|Androgens|androgens|mesh-ancestor
110774671|NCT03768258|Hormones|hormones|mesh-ancestor
110774672|NCT03768258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110774673|NCT03768258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110774674|NCT03768258|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110774675|NCT03768258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110774676|NCT03768258|Anabolic Agents|anabolic agents|mesh-ancestor
110774677|NCT03768258|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110774678|NCT03768258|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110774679|NCT03768258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110774680|NCT03768258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110774681|NCT03768258|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110774682|NCT03768258|Hormone Antagonists|hormone antagonists|mesh-ancestor
110774683|NCT03771222|Decitabine|decitabine|mesh-list
110774684|NCT03771222|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110774685|NCT03771222|Antimetabolites|antimetabolites|mesh-ancestor
110774686|NCT03771222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110774687|NCT03771222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110774688|NCT03771222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110774689|NCT03771066|Bisphenol A|bisphenol a|mesh-list
110774690|NCT03771066|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
110774691|NCT03771066|Estrogens|estrogens|mesh-ancestor
110774692|NCT03771066|Hormones|hormones|mesh-ancestor
110774693|NCT03771066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110774694|NCT03771066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110774695|NCT03771066|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110774696|NCT03771066|Antioxidants|antioxidants|mesh-ancestor
110774697|NCT03771066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110774698|NCT03771066|Protective Agents|protective agents|mesh-ancestor
110774699|NCT03768024|Hydromorphone|hydromorphone|mesh-list
110774700|NCT03768024|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110774701|NCT03768024|Narcotics|narcotics|mesh-ancestor
110774702|NCT03768024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110774703|NCT03768024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110774704|NCT03768024|Analgesics|analgesics|mesh-ancestor
110774705|NCT03768024|Sensory System Agents|sensory system agents|mesh-ancestor
110774706|NCT03768024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110774707|NCT03999684|Tretinoin|tretinoin|mesh-list
110774708|NCT03999684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110774709|NCT03999684|Keratolytic Agents|keratolytic agents|mesh-ancestor
110774710|NCT03999684|Dermatologic Agents|dermatologic agents|mesh-ancestor
110774711|NCT02083354|Trametinib|trametinib|mesh-list
110774712|NCT02083354|Dabrafenib|dabrafenib|mesh-list
110774713|NCT02083354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110774714|NCT02083354|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110774715|NCT02083354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110774716|NCT02083354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110774718|NCT01399918|Everolimus|everolimus|mesh-list
110774719|NCT01399918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110774720|NCT01399918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110774721|NCT01399918|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110774722|NCT01399918|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110774723|NCT01399918|Growth Substances|growth substances|mesh-ancestor
110774724|NCT01399918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110774725|NCT01399918|Growth Inhibitors|growth inhibitors|mesh-ancestor
110774726|NCT01399918|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110774727|NCT01399918|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110774728|NCT01399918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110774729|NCT01399918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110774730|NCT01399918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110774731|NCT01399918|Immunologic Factors|immunologic factors|mesh-ancestor
110774732|NCT03761472|Hyaluronic Acid|hyaluronic acid|mesh-list
110774733|NCT03761472|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110774734|NCT03761472|Immunologic Factors|immunologic factors|mesh-ancestor
110774735|NCT03761472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110774736|NCT03761472|Viscosupplements|viscosupplements|mesh-ancestor
110774737|NCT03761472|Protective Agents|protective agents|mesh-ancestor
110774738|NCT03767322|Allopurinol|allopurinol|mesh-list
110774739|NCT03767322|Febuxostat|febuxostat|mesh-list
110774740|NCT03767322|Antimetabolites|antimetabolites|mesh-ancestor
110774741|NCT03767322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110774742|NCT03767322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110774743|NCT03767322|Gout Suppressants|gout suppressants|mesh-ancestor
110774744|NCT03767322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110774745|NCT03767322|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110774746|NCT03767322|Antioxidants|antioxidants|mesh-ancestor
110774747|NCT03767322|Protective Agents|protective agents|mesh-ancestor
110774748|NCT03767322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110774749|NCT03761004|Levodopa|levodopa|mesh-list
110774750|NCT03761004|Carbidopa|carbidopa|mesh-list
110847184|NCT03357718|Midazolam|midazolam|mesh-list
110774751|NCT03761004|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
110774752|NCT03761004|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110774753|NCT03761004|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110774754|NCT03761004|Dopamine Agents|dopamine agents|mesh-ancestor
110774755|NCT03761004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110774756|NCT03761004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110774757|NCT03761004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110774758|NCT03761004|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
110774759|NCT03761004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110774760|NCT03761004|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110774761|NCT03761004|Immunologic Factors|immunologic factors|mesh-ancestor
110774762|NCT03761004|Dopamine Agonists|dopamine agonists|mesh-ancestor
110774763|NCT03770208|Lidocaine|lidocaine|mesh-list
110774764|NCT03770208|Anesthetics, Local|anesthetics, local|mesh-ancestor
110774765|NCT03770208|Anesthetics|anesthetics|mesh-ancestor
110774766|NCT03770208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110774767|NCT03770208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110774768|NCT03770208|Sensory System Agents|sensory system agents|mesh-ancestor
110774769|NCT03770208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110774770|NCT03770208|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110774771|NCT03770208|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110774772|NCT03770208|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110492639|NCT02589652|Entecavir|entecavir|mesh-list
110774773|NCT03770208|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110774774|NCT03770208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110774775|NCT03766854|Insulin|insulin|mesh-list
110774776|NCT03766854|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110774777|NCT03766854|Insulin Glargine|insulin glargine|mesh-list
110774778|NCT03766854|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110774779|NCT03766854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110774780|NCT01322100|Bleomycin|bleomycin|mesh-list
110774781|NCT01322100|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110774782|NCT01322100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110774783|NCT03760848|Midazolam|midazolam|mesh-list
110774784|NCT03760848|Atorvastatin|atorvastatin|mesh-list
110774785|NCT03760848|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110774786|NCT03760848|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110774787|NCT03760848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110774788|NCT03760848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110774789|NCT03760848|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110774790|NCT03760848|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110774791|NCT03760848|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110774792|NCT03760848|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110774793|NCT03760848|Anesthetics, General|anesthetics, general|mesh-ancestor
110774794|NCT03760848|Anesthetics|anesthetics|mesh-ancestor
110774795|NCT03760848|GABA Modulators|gaba modulators|mesh-ancestor
110774796|NCT03760848|GABA Agents|gaba agents|mesh-ancestor
110774797|NCT03760848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110774798|NCT03760848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110774799|NCT03760848|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110774800|NCT03760848|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110774801|NCT03760848|Antimetabolites|antimetabolites|mesh-ancestor
110774802|NCT03760848|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110774803|NCT03760848|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110774804|NCT03760848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110774805|NCT01567488|Everolimus|everolimus|mesh-list
110774806|NCT01567488|Octreotide|octreotide|mesh-list
110774807|NCT01567488|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110774808|NCT01567488|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110774809|NCT01567488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110774810|NCT01567488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110774811|NCT01567488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110774812|NCT01567488|Immunologic Factors|immunologic factors|mesh-ancestor
110774813|NCT01567488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110774814|NCT01567488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110774815|NCT01567488|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110774816|NCT01567488|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110774817|NCT03760770|Riboflavin|riboflavin|mesh-list
110774818|NCT03760770|Vitamin B Complex|vitamin b complex|mesh-ancestor
110774819|NCT03760770|Vitamins|vitamins|mesh-ancestor
110774820|NCT03760770|Micronutrients|micronutrients|mesh-ancestor
110774821|NCT03760770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110774822|NCT03760770|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110774823|NCT03760770|Dermatologic Agents|dermatologic agents|mesh-ancestor
110774824|NCT01561794|Ciprofloxacin|ciprofloxacin|mesh-list
110774825|NCT01561794|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110774826|NCT01561794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110774827|NCT01561794|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110774828|NCT01561794|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110774829|NCT01561794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110774830|NCT01561794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110774831|NCT01561794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110774832|NCT01561794|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110774833|NCT01561794|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110774834|NCT01322178|Cetuximab|cetuximab|mesh-list
110774835|NCT01322178|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110774836|NCT01322178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110774837|NCT03760614|Entinostat|entinostat|mesh-list
110774838|NCT03760614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110774839|NCT03760614|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110774840|NCT03760614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110774841|NCT03760614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110774842|NCT00112840|Bevacizumab|bevacizumab|mesh-list
110774843|NCT00112840|Temsirolimus|temsirolimus|mesh-list
110774844|NCT00112840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110774845|NCT00112840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110774846|NCT00112840|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110774847|NCT00112840|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110774848|NCT00112840|Growth Substances|growth substances|mesh-ancestor
110774849|NCT00112840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110774850|NCT00112840|Growth Inhibitors|growth inhibitors|mesh-ancestor
110774851|NCT00112840|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110774852|NCT00112840|Immunologic Factors|immunologic factors|mesh-ancestor
110774853|NCT00112840|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110774854|NCT00112840|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110774855|NCT00112840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110774856|NCT00112840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110774857|NCT03769818|Dexamethasone|dexamethasone|mesh-list
110774858|NCT03769818|Dexamethasone acetate|dexamethasone acetate|mesh-list
110774859|NCT03769818|Bupivacaine|bupivacaine|mesh-list
110774860|NCT03769818|BB 1101|bb 1101|mesh-list
110774861|NCT03769818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110774862|NCT03769818|Antiemetics|antiemetics|mesh-ancestor
110774863|NCT03769818|Autonomic Agents|autonomic agents|mesh-ancestor
110774864|NCT03769818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110774865|NCT03769818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110774866|NCT03769818|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110774867|NCT03769818|Glucocorticoids|glucocorticoids|mesh-ancestor
110774868|NCT03769818|Hormones|hormones|mesh-ancestor
110774869|NCT03769818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110774870|NCT03769818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110774871|NCT03769818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110774872|NCT03769818|Protease Inhibitors|protease inhibitors|mesh-ancestor
110774873|NCT03769818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110774874|NCT03769818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110774875|NCT03769818|Anesthetics, Local|anesthetics, local|mesh-ancestor
110774876|NCT03769818|Anesthetics|anesthetics|mesh-ancestor
110774877|NCT03769818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110774878|NCT03769818|Sensory System Agents|sensory system agents|mesh-ancestor
110774879|NCT05223244|Triamcinolone|triamcinolone|mesh-list
110774880|NCT05223244|Heparin|heparin|mesh-list
110774881|NCT05223244|Bupivacaine|bupivacaine|mesh-list
110774882|NCT05223244|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
110774883|NCT05223244|Anesthetics, Local|anesthetics, local|mesh-ancestor
110774884|NCT05223244|Anesthetics|anesthetics|mesh-ancestor
110774885|NCT05223244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110774886|NCT05223244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110774887|NCT05223244|Sensory System Agents|sensory system agents|mesh-ancestor
110774888|NCT05223244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110774889|NCT05223244|Anticoagulants|anticoagulants|mesh-ancestor
110774890|NCT05223244|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110774891|NCT05223244|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110774892|NCT05223244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110774893|NCT05223244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110774894|NCT05223244|Glucocorticoids|glucocorticoids|mesh-ancestor
110774896|NCT05223244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110774897|NCT05223244|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
110774898|NCT05223244|Protective Agents|protective agents|mesh-ancestor
110774899|NCT05223244|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110774900|NCT05223244|Antioxidants|antioxidants|mesh-ancestor
110774901|NCT05223010|Sevoflurane|sevoflurane|mesh-list
110774902|NCT05223010|Melatonin|melatonin|mesh-list
110774903|NCT05223010|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110774904|NCT05223010|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110774905|NCT05223010|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110774906|NCT05223010|Anesthetics, General|anesthetics, general|mesh-ancestor
110774907|NCT05223010|Anesthetics|anesthetics|mesh-ancestor
110774908|NCT05223010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110774909|NCT05223010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110774910|NCT05223010|Antioxidants|antioxidants|mesh-ancestor
110774911|NCT05223010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110774913|NCT03760302|Analgesics|analgesics|mesh-list
110774914|NCT03760302|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
110774915|NCT03760302|Sensory System Agents|sensory system agents|mesh-ancestor
110774916|NCT03760302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110774917|NCT03760302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110774918|NCT03760302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110774919|NCT03766074|Vitamin D|vitamin d|mesh-list
110774920|NCT03766074|Vitamins|vitamins|mesh-ancestor
110774921|NCT03766074|Micronutrients|micronutrients|mesh-ancestor
110774922|NCT03766074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110774923|NCT03766074|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110774924|NCT05219656|Cyclosporine|cyclosporine|mesh-list
110774925|NCT05219656|Cyclosporins|cyclosporins|mesh-list
110774926|NCT05219656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110774927|NCT05219656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110774928|NCT05219656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110774929|NCT05219656|Immunologic Factors|immunologic factors|mesh-ancestor
110774930|NCT05219656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110774931|NCT05219656|Antifungal Agents|antifungal agents|mesh-ancestor
110774932|NCT05219656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110774933|NCT05219656|Dermatologic Agents|dermatologic agents|mesh-ancestor
110774934|NCT05219656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110774935|NCT05219656|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110774936|NCT05168644|Niclosamide|niclosamide|mesh-list
110774937|NCT05168644|Anticestodal Agents|anticestodal agents|mesh-ancestor
110774938|NCT05168644|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110774939|NCT05168644|Anthelmintics|anthelmintics|mesh-ancestor
110774940|NCT05168644|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110774941|NCT05168644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110774942|NCT05168644|Antinematodal Agents|antinematodal agents|mesh-ancestor
110774943|NCT05412888|Coenzyme Q10|coenzyme q10|mesh-list
110774944|NCT05412888|Ubiquinone|ubiquinone|mesh-list
110774945|NCT05412888|Vitamins|vitamins|mesh-ancestor
110774946|NCT05412888|Micronutrients|micronutrients|mesh-ancestor
110774947|NCT05412888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110774948|NCT05087212|Plerixafor|plerixafor|mesh-list
110774949|NCT05087212|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110774950|NCT05087212|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110774951|NCT05087212|Antiviral Agents|antiviral agents|mesh-ancestor
110774952|NCT05087212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110774953|NCT01532310|Belimumab|belimumab|mesh-list
110774954|NCT01532310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110774955|NCT01532310|Immunologic Factors|immunologic factors|mesh-ancestor
110774956|NCT01532310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110774957|NCT01321788|Tinzaparin|tinzaparin|mesh-list
110774958|NCT01321788|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
110774959|NCT01321788|Dalteparin|dalteparin|mesh-list
110774960|NCT01321788|Anticoagulants|anticoagulants|mesh-ancestor
110774961|NCT01321788|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110774962|NCT01321788|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110774963|NCT01321788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110774964|NCT05053828|Clopidogrel|clopidogrel|mesh-list
110774965|NCT05053828|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
110774966|NCT05053828|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110774967|NCT05053828|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110774968|NCT05053828|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110774969|NCT05053828|Purinergic Agents|purinergic agents|mesh-ancestor
110492624|NCT00754819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110774970|NCT05053828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110774971|NCT05053828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110774972|NCT05053828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110774974|NCT03120780|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110774975|NCT03120780|Narcotics|narcotics|mesh-ancestor
110774976|NCT03120780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110774977|NCT03120780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110774978|NCT03120780|Analgesics|analgesics|mesh-ancestor
110774979|NCT03120780|Sensory System Agents|sensory system agents|mesh-ancestor
110774980|NCT03120780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110774981|NCT03120780|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110774982|NCT03120780|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110774983|NCT03120780|Anesthetics, General|anesthetics, general|mesh-ancestor
110774984|NCT03120780|Anesthetics|anesthetics|mesh-ancestor
110774985|NCT04920838|Acetaminophen|acetaminophen|mesh-list
110774986|NCT04920838|Ciclesonide|ciclesonide|mesh-list
110774987|NCT04920838|Nitazoxanide|nitazoxanide|mesh-list
110774988|NCT04920838|Budesonide|budesonide|mesh-list
110774989|NCT04920838|Telmisartan|telmisartan|mesh-list
110774990|NCT04920838|Fluoxetine|fluoxetine|mesh-list
110774991|NCT04920838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110774992|NCT04920838|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110774993|NCT04920838|Autonomic Agents|autonomic agents|mesh-ancestor
110774994|NCT04920838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110774995|NCT04920838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110774996|NCT04920838|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110774997|NCT04920838|Respiratory System Agents|respiratory system agents|mesh-ancestor
110774998|NCT04920838|Glucocorticoids|glucocorticoids|mesh-ancestor
110774999|NCT04920838|Hormones|hormones|mesh-ancestor
110775000|NCT04920838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110775001|NCT04920838|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110775002|NCT04920838|Analgesics|analgesics|mesh-ancestor
110775003|NCT04920838|Sensory System Agents|sensory system agents|mesh-ancestor
110775004|NCT04920838|Antipyretics|antipyretics|mesh-ancestor
110775005|NCT04920838|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110775006|NCT04920838|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110775007|NCT04920838|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110775008|NCT04920838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110775009|NCT04920838|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110775010|NCT04920838|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110775011|NCT04920838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110775012|NCT04920838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110775013|NCT04920838|Serotonin Agents|serotonin agents|mesh-ancestor
110775014|NCT04920838|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110775015|NCT04920838|Antidepressive Agents|antidepressive agents|mesh-ancestor
110775016|NCT04920838|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110775017|NCT04920838|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110775018|NCT04920838|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110775019|NCT04920838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110775020|NCT04920838|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110775021|NCT04920838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110775022|NCT04920838|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110775023|NCT03764280|Insulin|insulin|mesh-list
110775024|NCT03764280|Insulin, Short-Acting|insulin, short-acting|mesh-list
110775025|NCT03764280|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110775026|NCT03764280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110775027|NCT05133804|Methylphenidate|methylphenidate|mesh-list
110775028|NCT05133804|Reboxetine|reboxetine|mesh-list
110775029|NCT05133804|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110775030|NCT05133804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110775031|NCT05133804|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110775032|NCT05133804|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110775033|NCT05133804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110775034|NCT05133804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110775035|NCT05133804|Dopamine Agents|dopamine agents|mesh-ancestor
110775036|NCT05133804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110775037|NCT05133804|Antidepressive Agents|antidepressive agents|mesh-ancestor
110775038|NCT05133804|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110775039|NCT05133804|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110775040|NCT05133804|Adrenergic Agents|adrenergic agents|mesh-ancestor
110775041|NCT03764202|Sufentanil|sufentanil|mesh-list
110775042|NCT03764202|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110775043|NCT03764202|Narcotics|narcotics|mesh-ancestor
110775044|NCT03764202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110492703|NCT04084912|Hormones|hormones|mesh-ancestor
110775045|NCT03764202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110775046|NCT03764202|Analgesics|analgesics|mesh-ancestor
110775047|NCT03764202|Sensory System Agents|sensory system agents|mesh-ancestor
110775048|NCT03764202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110775049|NCT03764202|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110775050|NCT03764202|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110847314|NCT01185743|Olanzapine|olanzapine|mesh-list
110775051|NCT03764202|Anesthetics, General|anesthetics, general|mesh-ancestor
110775052|NCT03764202|Anesthetics|anesthetics|mesh-ancestor
110775053|NCT04678492|Amoxicillin|amoxicillin|mesh-list
110775054|NCT04678492|Tetracycline|tetracycline|mesh-list
110775055|NCT04678492|Furazolidone|furazolidone|mesh-list
110775056|NCT04678492|Esomeprazole|esomeprazole|mesh-list
110775057|NCT04678492|Bismuth|bismuth|mesh-list
110775058|NCT04678492|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110775059|NCT04678492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110775060|NCT04678492|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110775061|NCT04678492|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110775062|NCT04678492|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110775063|NCT04678492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110775064|NCT04678492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110775065|NCT04678492|Antacids|antacids|mesh-ancestor
110775066|NCT04678492|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110775067|NCT04678492|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110775068|NCT04678492|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110775069|NCT04678492|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
110775070|NCT04678492|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110775071|NCT04678492|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110775072|NCT04678492|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
110775073|NCT03176784|Nicotine|nicotine|mesh-list
110775074|NCT03176784|Varenicline|varenicline|mesh-list
110775075|NCT03176784|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110775076|NCT03176784|Autonomic Agents|autonomic agents|mesh-ancestor
110775077|NCT03176784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110775078|NCT03176784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110775079|NCT03176784|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110775080|NCT03176784|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110775081|NCT03176784|Cholinergic Agents|cholinergic agents|mesh-ancestor
110775082|NCT03176784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110775083|NCT03176784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110775084|NCT05091528|Capecitabine|capecitabine|mesh-list
110775085|NCT05091528|Trastuzumab|trastuzumab|mesh-list
110775086|NCT05091528|Tucatinib|tucatinib|mesh-list
110775087|NCT05091528|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
110775088|NCT05091528|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110775089|NCT05091528|Antimetabolites|antimetabolites|mesh-ancestor
110775090|NCT05091528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110775091|NCT05091528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110775092|NCT05091528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110775093|NCT05091528|Immunoconjugates|immunoconjugates|mesh-ancestor
110775094|NCT05091528|Immunologic Factors|immunologic factors|mesh-ancestor
110775095|NCT05091528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110775096|NCT05091528|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110775097|NCT05091528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110775099|NCT04236258|Nifedipine|nifedipine|mesh-list
110775100|NCT04236258|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110775101|NCT04236258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110847342|NCT01188005|Antioxidants|antioxidants|mesh-ancestor
110775102|NCT04236258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110775103|NCT04236258|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110775104|NCT04236258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110775105|NCT04236258|Vasodilator Agents|vasodilator agents|mesh-ancestor
110775106|NCT04236258|Tocolytic Agents|tocolytic agents|mesh-ancestor
110775107|NCT04236258|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110775108|NCT04236258|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110775109|NCT04236258|Protease Inhibitors|protease inhibitors|mesh-ancestor
110775110|NCT04236258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110775111|NCT04236258|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110775112|NCT01317004|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
110775113|NCT01317004|Interferon beta-1b|interferon beta-1b|mesh-list
110775114|NCT01317004|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
110775115|NCT01317004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110775116|NCT01317004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110775117|NCT01317004|Immunologic Factors|immunologic factors|mesh-ancestor
110775118|NCT01317004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110775119|NCT01317004|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110775120|NCT03049618|Pembrolizumab|pembrolizumab|mesh-list
110775121|NCT03049618|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110775122|NCT03049618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110775123|NCT03049618|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110775124|NCT03049618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110775125|NCT05536102|Doxorubicin|doxorubicin|mesh-list
110775126|NCT05536102|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110775127|NCT05536102|Capecitabine|capecitabine|mesh-list
110775128|NCT05536102|Oxaliplatin|oxaliplatin|mesh-list
110775129|NCT05536102|Tislelizumab|tislelizumab|mesh-list
110775130|NCT05536102|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110775131|NCT05536102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110775132|NCT05536102|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110775133|NCT05536102|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110775134|NCT05536102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110775135|NCT05536102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110775136|NCT05536102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110775137|NCT05536102|Antimetabolites|antimetabolites|mesh-ancestor
110775138|NCT05536102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110775139|NCT05524714|Xanthohumol|xanthohumol|mesh-list
110775140|NCT05524714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110775141|NCT05524714|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110775142|NCT05524714|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110492729|NCT00755209|Hemostatics|hemostatics|mesh-ancestor
110775143|NCT05524714|Growth Substances|growth substances|mesh-ancestor
110847370|NCT04444726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110775144|NCT05524714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110775145|NCT05524714|Growth Inhibitors|growth inhibitors|mesh-ancestor
110775147|NCT05692804|Anticoagulants|anticoagulants|mesh-ancestor
110775148|NCT01316380|Tiotropium Bromide|tiotropium bromide|mesh-list
110775149|NCT01316380|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110775150|NCT01316380|Autonomic Agents|autonomic agents|mesh-ancestor
110775151|NCT01316380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110775152|NCT01316380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110775153|NCT01316380|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110775154|NCT01316380|Respiratory System Agents|respiratory system agents|mesh-ancestor
110775155|NCT01316380|Parasympatholytics|parasympatholytics|mesh-ancestor
110775156|NCT01316380|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110775157|NCT01316380|Cholinergic Agents|cholinergic agents|mesh-ancestor
110775158|NCT01316380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110775159|NCT01316380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110775160|NCT05692570|Ritonavir|ritonavir|mesh-list
110775161|NCT05692570|Cobicistat|cobicistat|mesh-list
110775162|NCT05692570|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110775163|NCT05692570|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110775164|NCT05692570|Protease Inhibitors|protease inhibitors|mesh-ancestor
110775165|NCT05692570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110775166|NCT05692570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110775167|NCT05692570|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110775168|NCT05692570|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110775169|NCT05692570|Antiviral Agents|antiviral agents|mesh-ancestor
110775170|NCT05692570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110775171|NCT05692570|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110775172|NCT05692570|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110775173|NCT05691556|Botulinum Toxins|botulinum toxins|mesh-list
110775174|NCT05691556|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110775175|NCT05691556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110775176|NCT05691556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110775177|NCT05691556|Cholinergic Agents|cholinergic agents|mesh-ancestor
110775178|NCT05691556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110775179|NCT05691556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110775180|NCT05689450|Amikacin|amikacin|mesh-list
110775181|NCT05689450|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110775182|NCT05689450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110775183|NCT05417308|Minoxidil|minoxidil|mesh-list
110775184|NCT05417308|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110775185|NCT05417308|Vasodilator Agents|vasodilator agents|mesh-ancestor
110775186|NCT04650542|Paroxetine|paroxetine|mesh-list
110775187|NCT04650542|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110775188|NCT04650542|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110775189|NCT04650542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110775190|NCT04650542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110775191|NCT04650542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110775193|NCT04650542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110775194|NCT04650542|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110775195|NCT04650542|Antidepressive Agents|antidepressive agents|mesh-ancestor
110775196|NCT04650542|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110775197|NCT04650542|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110775198|NCT04650542|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110775199|NCT04650542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110775200|NCT04621058|Vitamin D|vitamin d|mesh-list
110775201|NCT04621058|Vitamins|vitamins|mesh-list
110775202|NCT04621058|Micronutrients|micronutrients|mesh-ancestor
110775203|NCT04621058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110775204|NCT04621058|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110775205|NCT04308668|Hydroxychloroquine|hydroxychloroquine|mesh-list
110775206|NCT04308668|Antimalarials|antimalarials|mesh-ancestor
110775207|NCT04308668|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110775208|NCT04308668|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110775209|NCT04308668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110775210|NCT04308668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110775211|NCT04308668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110775212|NCT04308668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110775213|NCT04451330|Doxycycline|doxycycline|mesh-list
110775214|NCT04451330|Trifarotene|trifarotene|mesh-list
110775215|NCT04451330|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110775216|NCT04451330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110775217|NCT04451330|Antimalarials|antimalarials|mesh-ancestor
110775218|NCT04451330|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110775219|NCT04451330|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110775220|NCT04451330|Dermatologic Agents|dermatologic agents|mesh-ancestor
110775221|NCT02493426|Oxytocin|oxytocin|mesh-list
110775222|NCT02493426|Oxytocics|oxytocics|mesh-ancestor
110775223|NCT02493426|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110775224|NCT02493426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110775225|NCT03763734|Dexamethasone|dexamethasone|mesh-list
110775226|NCT03763734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110775227|NCT03763734|Antiemetics|antiemetics|mesh-ancestor
110775228|NCT03763734|Autonomic Agents|autonomic agents|mesh-ancestor
110847425|NCT01185977|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110775229|NCT03763734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110775230|NCT03763734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110775231|NCT03763734|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110775232|NCT03763734|Glucocorticoids|glucocorticoids|mesh-ancestor
110775233|NCT03763734|Hormones|hormones|mesh-ancestor
110775234|NCT03763734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110775235|NCT03763734|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110775236|NCT03763734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110775237|NCT05063136|Capecitabine|capecitabine|mesh-list
110775238|NCT05063136|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110775239|NCT05063136|Antimetabolites|antimetabolites|mesh-ancestor
110775240|NCT05063136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110775241|NCT05063136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110775242|NCT03756324|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110775243|NCT03756324|Cefdinir|cefdinir|mesh-list
110775244|NCT03756324|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
110775245|NCT03756324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110775246|NCT03756324|Antitubercular Agents|antitubercular agents|mesh-ancestor
110775247|NCT03751202|Fluticasone|fluticasone|mesh-list
110775248|NCT03751202|Xhance|xhance|mesh-list
110775249|NCT03751202|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110775250|NCT03751202|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
110775251|NCT03751202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110775252|NCT03751202|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110775253|NCT03751202|Autonomic Agents|autonomic agents|mesh-ancestor
110775254|NCT03751202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110775255|NCT03751202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110775256|NCT03751202|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110775257|NCT03751202|Respiratory System Agents|respiratory system agents|mesh-ancestor
110775258|NCT03751202|Dermatologic Agents|dermatologic agents|mesh-ancestor
110775259|NCT03751202|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110775260|NCT03751202|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110775261|NCT03751202|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110775262|NCT03751202|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110775263|NCT03751202|Adrenergic Agents|adrenergic agents|mesh-ancestor
110775264|NCT03751202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110775265|NCT03751202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110775266|NCT03751202|Glucocorticoids|glucocorticoids|mesh-ancestor
110775267|NCT03751202|Hormones|hormones|mesh-ancestor
110775268|NCT03751202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110775269|NCT03751202|Sympathomimetics|sympathomimetics|mesh-ancestor
110775270|NCT03749408|Mannitol|mannitol|mesh-list
110775271|NCT03749408|Bupivacaine|bupivacaine|mesh-list
110775272|NCT03749408|Anesthetics, Local|anesthetics, local|mesh-ancestor
110775274|NCT03749408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110775275|NCT03749408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110775276|NCT03749408|Sensory System Agents|sensory system agents|mesh-ancestor
110775277|NCT03749408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110775278|NCT03749408|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110775279|NCT03749408|Diuretics|diuretics|mesh-ancestor
110775280|NCT03749408|Natriuretic Agents|natriuretic agents|mesh-ancestor
110775281|NCT04387136|Sufentanil|sufentanil|mesh-list
110775282|NCT04387136|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110775283|NCT04387136|Narcotics|narcotics|mesh-ancestor
110775284|NCT04387136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110775285|NCT04387136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110775286|NCT04387136|Analgesics|analgesics|mesh-ancestor
110775287|NCT04387136|Sensory System Agents|sensory system agents|mesh-ancestor
110775288|NCT04387136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110775289|NCT04387136|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110775290|NCT04387136|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110775291|NCT04387136|Anesthetics, General|anesthetics, general|mesh-ancestor
110775292|NCT04387136|Anesthetics|anesthetics|mesh-ancestor
110775293|NCT04252586|Cannabidiol|cannabidiol|mesh-list
110775294|NCT04252586|Anticonvulsants|anticonvulsants|mesh-ancestor
110775295|NCT04507776|Etanercept|etanercept|mesh-list
110775296|NCT04507776|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110775297|NCT04507776|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110775298|NCT04507776|Analgesics|analgesics|mesh-ancestor
110775299|NCT04507776|Sensory System Agents|sensory system agents|mesh-ancestor
110775300|NCT04507776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110775301|NCT04507776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110775302|NCT04507776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110775303|NCT04507776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110775304|NCT04507776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110775305|NCT04507776|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110775306|NCT04507776|Immunologic Factors|immunologic factors|mesh-ancestor
110775307|NCT04504032|Rivaroxaban|rivaroxaban|mesh-list
110775308|NCT04504032|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110775309|NCT04504032|Antithrombins|antithrombins|mesh-ancestor
110775310|NCT04504032|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110775311|NCT04504032|Protease Inhibitors|protease inhibitors|mesh-ancestor
110775312|NCT04504032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110775313|NCT04504032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110775314|NCT04504032|Anticoagulants|anticoagulants|mesh-ancestor
110775315|NCT03756246|Vaccines|vaccines|mesh-list
110775316|NCT03756246|Immunologic Factors|immunologic factors|mesh-ancestor
110775317|NCT03756246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110775318|NCT05460858|Acetylcysteine|acetylcysteine|mesh-list
110775319|NCT05460858|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110775320|NCT05460858|Antiviral Agents|antiviral agents|mesh-ancestor
110775321|NCT05460858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110775322|NCT05460858|Expectorants|expectorants|mesh-ancestor
110775323|NCT05460858|Respiratory System Agents|respiratory system agents|mesh-ancestor
110775324|NCT05460858|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110775325|NCT05460858|Antioxidants|antioxidants|mesh-ancestor
110775326|NCT05460858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110775327|NCT05460858|Protective Agents|protective agents|mesh-ancestor
110775328|NCT05460858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110775329|NCT05460858|Antidotes|antidotes|mesh-ancestor
110775330|NCT05359224|Clopidogrel|clopidogrel|mesh-list
110775331|NCT05359224|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
110775332|NCT05359224|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110775333|NCT05359224|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110775334|NCT05359224|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110775335|NCT05359224|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110775336|NCT05359224|Purinergic Agents|purinergic agents|mesh-ancestor
110775337|NCT05359224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110775338|NCT05359224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110775339|NCT05359224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110775340|NCT03758118|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
110775341|NCT03758118|Nootropic Agents|nootropic agents|mesh-ancestor
110775342|NCT03756090|Paclitaxel|paclitaxel|mesh-list
110775343|NCT03756090|Cyclophosphamide|cyclophosphamide|mesh-list
110775344|NCT03756090|Epirubicin|epirubicin|mesh-list
110775345|NCT03756090|Palbociclib|palbociclib|mesh-list
110775346|NCT03756090|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110775347|NCT03756090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110775348|NCT03756090|Tubulin Modulators|tubulin modulators|mesh-ancestor
110775349|NCT03756090|Antimitotic Agents|antimitotic agents|mesh-ancestor
110775350|NCT03756090|Mitosis Modulators|mitosis modulators|mesh-ancestor
110775351|NCT03756090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110775352|NCT03756090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110775353|NCT03756090|Immunologic Factors|immunologic factors|mesh-ancestor
110775354|NCT03756090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110775355|NCT03756090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110775356|NCT03756090|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110775357|NCT03756090|Alkylating Agents|alkylating agents|mesh-ancestor
110775358|NCT03756090|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110775359|NCT03756090|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110775360|NCT03756090|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110775361|NCT03756090|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110775362|NCT03756090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110775363|NCT03756090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110775364|NCT04605588|Ribavirin|ribavirin|mesh-list
110775365|NCT04605588|Hydroxychloroquine|hydroxychloroquine|mesh-list
110775366|NCT04605588|Nitazoxanide|nitazoxanide|mesh-list
110775367|NCT04605588|Antimetabolites|antimetabolites|mesh-ancestor
110775368|NCT04605588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110775369|NCT04605588|Antiviral Agents|antiviral agents|mesh-ancestor
110775370|NCT04605588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110775371|NCT04605588|Antimalarials|antimalarials|mesh-ancestor
110775372|NCT04605588|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110775373|NCT04605588|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110775374|NCT04605588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110775375|NCT04605588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110775376|NCT03752736|Sunscreening Agents|sunscreening agents|mesh-list
110775377|NCT03752736|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110775378|NCT03752736|Protective Agents|protective agents|mesh-ancestor
110775379|NCT03752736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110775380|NCT03752736|Dermatologic Agents|dermatologic agents|mesh-ancestor
110775381|NCT03752658|Tenofovir|tenofovir|mesh-list
110775382|NCT03752658|Antiviral Agents|antiviral agents|mesh-ancestor
110775383|NCT03752658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110775384|NCT03752658|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110775385|NCT03752658|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110775386|NCT03752658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110775387|NCT03752658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110775388|NCT03752658|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110775389|NCT03752658|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110775390|NCT03752424|Anti-Infective Agents|anti-infective agents|mesh-list
110775391|NCT03752424|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110775393|NCT03755778|Rifampin|rifampin|mesh-list
110775394|NCT03755778|Quinidine|quinidine|mesh-list
110775395|NCT03755778|Antifungal Agents|antifungal agents|mesh-ancestor
110775396|NCT03755778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110775397|NCT03755778|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110775398|NCT03755778|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110775399|NCT03755778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110775400|NCT03755778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110775401|NCT03755778|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110775402|NCT03755778|Hormone Antagonists|hormone antagonists|mesh-ancestor
110775403|NCT03755778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110775404|NCT03755778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110775405|NCT03755778|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110775406|NCT03755778|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110775407|NCT03755778|Antitubercular Agents|antitubercular agents|mesh-ancestor
110775408|NCT03755778|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110847559|NCT03738943|Pyridoxine|pyridoxine|mesh-list
110775409|NCT03755778|Leprostatic Agents|leprostatic agents|mesh-ancestor
110775410|NCT03755778|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110775411|NCT03755778|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110775412|NCT03755778|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110775413|NCT03755778|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110775414|NCT03755778|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110775415|NCT03755778|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110775416|NCT03755778|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110775417|NCT03755778|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110775418|NCT03755778|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110492758|NCT05340205|Hemostatics|hemostatics|mesh-ancestor
110775419|NCT03755778|Adrenergic Agents|adrenergic agents|mesh-ancestor
110775420|NCT03755778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110775421|NCT03755778|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110775422|NCT03755778|Antimalarials|antimalarials|mesh-ancestor
110775423|NCT03755778|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110775424|NCT03755778|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110775425|NCT03755778|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110775426|NCT03755778|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110775427|NCT03755778|Cholinergic Agents|cholinergic agents|mesh-ancestor
110775428|NCT03755778|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110775429|NCT03755778|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110775430|NCT03755778|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110775431|NCT03755778|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110775432|NCT03779074|Amoxicillin|amoxicillin|mesh-list
110775433|NCT03779074|Metronidazole|metronidazole|mesh-list
110775434|NCT03779074|Clarithromycin|clarithromycin|mesh-list
110775435|NCT03779074|Tetracycline|tetracycline|mesh-list
110775436|NCT03779074|Rabeprazole|rabeprazole|mesh-list
110775437|NCT03779074|Bismuth|bismuth|mesh-list
110775438|NCT03779074|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110775439|NCT03779074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110775440|NCT03779074|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110775441|NCT03779074|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110775442|NCT03779074|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110775443|NCT03779074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110775444|NCT03779074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110775445|NCT03779074|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110775446|NCT03779074|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110775447|NCT03779074|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110775448|NCT03779074|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110775449|NCT03779074|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110775450|NCT03779074|Antacids|antacids|mesh-ancestor
110775451|NCT03755700|Vitamin E|vitamin e|mesh-list
110775452|NCT03755700|Acetylcysteine|acetylcysteine|mesh-list
110775453|NCT03755700|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110775454|NCT03755700|Vitamins|vitamins|mesh-ancestor
110775455|NCT03755700|Micronutrients|micronutrients|mesh-ancestor
110775456|NCT03755700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110775457|NCT03755700|Antioxidants|antioxidants|mesh-ancestor
110775458|NCT03755700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110775459|NCT03755700|Protective Agents|protective agents|mesh-ancestor
110775460|NCT03755700|Antiviral Agents|antiviral agents|mesh-ancestor
110775461|NCT03755700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110775462|NCT03755700|Expectorants|expectorants|mesh-ancestor
110775463|NCT03755700|Respiratory System Agents|respiratory system agents|mesh-ancestor
110775464|NCT03755700|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110775465|NCT03755700|Antidotes|antidotes|mesh-ancestor
110775466|NCT03757650|Amoxicillin|amoxicillin|mesh-list
110775467|NCT03757650|Clarithromycin|clarithromycin|mesh-list
110775468|NCT03757650|Omeprazole|omeprazole|mesh-list
110775469|NCT03757650|Bismuth|bismuth|mesh-list
110775470|NCT03757650|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
110775471|NCT03757650|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110775472|NCT03757650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110775473|NCT03757650|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110775474|NCT03757650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110775475|NCT03757650|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110775476|NCT03757650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110775477|NCT03757650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110775478|NCT03757650|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110775479|NCT03757650|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110775480|NCT03757650|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110775481|NCT03757650|Antacids|antacids|mesh-ancestor
110775482|NCT03757650|Antidiarrheals|antidiarrheals|mesh-ancestor
110775483|NCT04432376|Miconazole|miconazole|mesh-list
110775484|NCT04432376|Antifungal Agents|antifungal agents|mesh-ancestor
110775485|NCT04432376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110775486|NCT04432376|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110775487|NCT04432376|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110775488|NCT04432376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110775489|NCT04432376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110775490|NCT04432376|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110775491|NCT04432376|Hormone Antagonists|hormone antagonists|mesh-ancestor
110492764|NCT00713830|Metformin|metformin|mesh-list
110775492|NCT04432376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110775493|NCT04432376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110775494|NCT04432376|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110775495|NCT04432376|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110775496|NCT05180968|Dronabinol|dronabinol|mesh-list
110775497|NCT05180968|Nabilone|nabilone|mesh-list
110775498|NCT05180968|Antiemetics|antiemetics|mesh-ancestor
110493143|NCT00678379|Adrenergic Agents|adrenergic agents|mesh-ancestor
110775499|NCT05180968|Autonomic Agents|autonomic agents|mesh-ancestor
110775500|NCT05180968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110775501|NCT05180968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110775502|NCT05180968|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110775503|NCT05180968|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110775504|NCT05180968|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110775505|NCT05180968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110775506|NCT05180968|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110775507|NCT05180968|Hallucinogens|hallucinogens|mesh-ancestor
110775508|NCT05180968|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110775509|NCT05180968|Analgesics|analgesics|mesh-ancestor
110775510|NCT05180968|Sensory System Agents|sensory system agents|mesh-ancestor
110775511|NCT05180968|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
110775512|NCT05180968|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110775513|NCT05180968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110775514|NCT05180968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110775515|NCT05180968|Hormones|hormones|mesh-ancestor
110775516|NCT05180968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110775517|NCT03693404|Ketorolac|ketorolac|mesh-list
110775518|NCT03693404|Morphine|morphine|mesh-list
110775519|NCT03693404|Bupivacaine|bupivacaine|mesh-list
110775520|NCT03693404|Anesthetics|anesthetics|mesh-list
110775521|NCT03693404|Anesthetics, General|anesthetics, general|mesh-list
110775522|NCT03693404|Anesthetics, Local|anesthetics, local|mesh-ancestor
110775523|NCT03693404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110775524|NCT03693404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110775525|NCT03693404|Sensory System Agents|sensory system agents|mesh-ancestor
110775526|NCT03693404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110775527|NCT03693404|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110775528|NCT03693404|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110775529|NCT03693404|Analgesics|analgesics|mesh-ancestor
110775530|NCT03693404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110775531|NCT03693404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110775532|NCT03693404|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110775533|NCT03693404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110775534|NCT03693404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110775535|NCT03693404|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110775536|NCT03693404|Narcotics|narcotics|mesh-ancestor
110775537|NCT04219358|Imiquimod|imiquimod|mesh-list
110775538|NCT04219358|Sunscreening Agents|sunscreening agents|mesh-list
110775539|NCT04219358|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110775540|NCT04219358|Immunologic Factors|immunologic factors|mesh-ancestor
110775541|NCT04219358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110775542|NCT04219358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110775543|NCT04219358|Interferon Inducers|interferon inducers|mesh-ancestor
110775544|NCT04219358|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110847635|NCT03205566|Antiviral Agents|antiviral agents|mesh-ancestor
110775546|NCT04219358|Dermatologic Agents|dermatologic agents|mesh-ancestor
110775547|NCT04218110|Ethanol|ethanol|mesh-list
110775548|NCT04218110|Chlorhexidine|chlorhexidine|mesh-list
110775549|NCT04218110|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110775550|NCT04218110|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
110775551|NCT04218110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110775552|NCT04218110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110775553|NCT04218110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110775554|NCT04218110|Disinfectants|disinfectants|mesh-ancestor
110775555|NCT04218110|Dermatologic Agents|dermatologic agents|mesh-ancestor
110775556|NCT05154994|Durvalumab|durvalumab|mesh-list
110775557|NCT05154994|Ipilimumab|ipilimumab|mesh-list
110775558|NCT05154994|Tremelimumab|tremelimumab|mesh-list
110775559|NCT05154994|Belinostat|belinostat|mesh-list
110775560|NCT05154994|Immunoglobulins|immunoglobulins|mesh-list
110775561|NCT05154994|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110775562|NCT05154994|Immunoglobulin G|immunoglobulin g|mesh-list
110775563|NCT05154994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110775564|NCT05154994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110775565|NCT05154994|Immunologic Factors|immunologic factors|mesh-ancestor
110775566|NCT05154994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110775567|NCT05154994|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110775568|NCT05154994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110775569|NCT05154994|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110775570|NCT05154994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110775571|NCT03752190|Cosyntropin|cosyntropin|mesh-list
110775572|NCT03752190|Hormones|hormones|mesh-ancestor
110775573|NCT03752190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110775574|NCT03752190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110775575|NCT04210310|Oxytocin|oxytocin|mesh-list
110775576|NCT04210310|Oxytocics|oxytocics|mesh-ancestor
110775577|NCT04210310|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110775578|NCT04210310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110775579|NCT03755466|Tofacitinib|tofacitinib|mesh-list
110775580|NCT03755466|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
110775581|NCT03755466|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110775582|NCT03755466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110775583|NCT03755466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110775584|NCT03755310|Suvorexant|suvorexant|mesh-list
110775585|NCT03755310|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110775586|NCT03755310|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110775587|NCT03755310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110775588|NCT03755310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110775589|NCT03755310|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
110775590|NCT03755310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110775591|NCT03755310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110775592|NCT04381988|Hydroxychloroquine|hydroxychloroquine|mesh-list
110775593|NCT04381988|Antimalarials|antimalarials|mesh-ancestor
110775594|NCT04381988|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110775595|NCT04381988|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110775596|NCT04381988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110775597|NCT04381988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110775598|NCT04381988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110775599|NCT04381988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110775600|NCT03668392|Asparaginase|asparaginase|mesh-list
110775601|NCT03668392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110775602|NCT04176016|Edetic Acid|edetic acid|mesh-list
110775603|NCT04176016|Pentetic Acid|pentetic acid|mesh-list
110775604|NCT04176016|Antidotes|antidotes|mesh-ancestor
110775605|NCT04176016|Protective Agents|protective agents|mesh-ancestor
110775606|NCT04176016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110775607|NCT04176016|Chelating Agents|chelating agents|mesh-ancestor
110775608|NCT04176016|Sequestering Agents|sequestering agents|mesh-ancestor
110775609|NCT04176016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110775610|NCT04176016|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110775611|NCT04176016|Anticoagulants|anticoagulants|mesh-ancestor
110775612|NCT04176016|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110775613|NCT03695094|Lamotrigine|lamotrigine|mesh-list
110775614|NCT03695094|Oxcarbazepine|oxcarbazepine|mesh-list
110775615|NCT03695094|Levetiracetam|levetiracetam|mesh-list
110775616|NCT03695094|Brivaracetam|brivaracetam|mesh-list
110775617|NCT03695094|Padsevonil|padsevonil|mesh-list
110775618|NCT03695094|Anticonvulsants|anticonvulsants|mesh-ancestor
110775619|NCT03695094|Nootropic Agents|nootropic agents|mesh-ancestor
110775620|NCT03695094|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110775621|NCT03695094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110775622|NCT03695094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110775623|NCT03695094|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110775624|NCT03695094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110775625|NCT03695094|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110775626|NCT03695094|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110775627|NCT03695094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110775628|NCT03695094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110775629|NCT03695094|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110775630|NCT03695094|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110775631|NCT03695094|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110775632|NCT03695094|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110775633|NCT04497948|Acalabrutinib|acalabrutinib|mesh-list
110775634|NCT04497948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110775635|NCT04495374|Pregabalin|pregabalin|mesh-list
110775636|NCT04495374|Analgesics|analgesics|mesh-ancestor
110775637|NCT04495374|Sensory System Agents|sensory system agents|mesh-ancestor
110775638|NCT04495374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110775639|NCT04495374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110775640|NCT04495374|Anticonvulsants|anticonvulsants|mesh-ancestor
110775641|NCT04495374|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110775642|NCT04495374|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110775643|NCT04495374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110775644|NCT04495374|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110775645|NCT04495374|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110775646|NCT04495374|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110775647|NCT04495374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110775648|NCT04495374|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110775649|NCT03752112|Penicillins|penicillins|mesh-list
110493343|NCT00603824|PENTA|penta|mesh-list
110775650|NCT03752112|Cefixime|cefixime|mesh-list
110775651|NCT03752112|Penicillin G Benzathine|penicillin g benzathine|mesh-list
110775652|NCT03752112|Penicillin G|penicillin g|mesh-list
110775653|NCT03752112|Penicillin G Procaine|penicillin g procaine|mesh-list
110775654|NCT03752112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110775655|NCT03752112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110775656|NCT03757338|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
110775657|NCT03757338|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
110775658|NCT03757338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110775659|NCT03757338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110775660|NCT03757338|Immunologic Factors|immunologic factors|mesh-ancestor
110775661|NCT03757338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110775662|NCT03757260|Anti-Infective Agents|anti-infective agents|mesh-list
110775663|NCT03757260|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110775664|NCT04168190|Vaccines|vaccines|mesh-list
110775665|NCT04168190|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110775666|NCT04168190|Immunologic Factors|immunologic factors|mesh-ancestor
110775667|NCT04168190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110775668|NCT03529942|FX006|fx006|mesh-list
110775669|NCT03529942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110775670|NCT03529942|Glucocorticoids|glucocorticoids|mesh-ancestor
110775671|NCT03529942|Hormones|hormones|mesh-ancestor
110775672|NCT03529942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110775673|NCT03529942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110775674|NCT03529942|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110775675|NCT03529942|Immunologic Factors|immunologic factors|mesh-ancestor
110775676|NCT03501940|Fluorides|fluorides|mesh-list
110775677|NCT03501940|Cariostatic Agents|cariostatic agents|mesh-ancestor
110775678|NCT03501940|Protective Agents|protective agents|mesh-ancestor
110775679|NCT03501940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110775680|NCT03754842|Niacinamide|niacinamide|mesh-list
110775681|NCT03754842|Niacin|niacin|mesh-list
110775682|NCT03754842|Nicotinic Acids|nicotinic acids|mesh-list
110775683|NCT03754842|Vitamin B Complex|vitamin b complex|mesh-ancestor
110775684|NCT03754842|Vitamins|vitamins|mesh-ancestor
110775685|NCT03754842|Micronutrients|micronutrients|mesh-ancestor
110775686|NCT03754842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110775687|NCT03754842|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110775688|NCT03754842|Antimetabolites|antimetabolites|mesh-ancestor
110775689|NCT03754842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110775690|NCT03754842|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110775691|NCT03754842|Vasodilator Agents|vasodilator agents|mesh-ancestor
110775692|NCT01562210|Olaparib|olaparib|mesh-list
110775693|NCT01562210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110775694|NCT01562210|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110775695|NCT01562210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110775696|NCT01562210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110775697|NCT04189952|Rituximab|rituximab|mesh-list
110775698|NCT04189952|Carboplatin|carboplatin|mesh-list
110775699|NCT04189952|Etoposide|etoposide|mesh-list
110775700|NCT04189952|Ifosfamide|ifosfamide|mesh-list
110775701|NCT04189952|Acalabrutinib|acalabrutinib|mesh-list
110775702|NCT04189952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110775703|NCT04189952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110775704|NCT04189952|Immunologic Factors|immunologic factors|mesh-ancestor
110775705|NCT04189952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110775706|NCT04189952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110775707|NCT04189952|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110775708|NCT04189952|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110775709|NCT04189952|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110775710|NCT04189952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110775711|NCT04189952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110775712|NCT04189952|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110775713|NCT04189952|Alkylating Agents|alkylating agents|mesh-ancestor
110775714|NCT04716426|Tetracycline|tetracycline|mesh-list
110775715|NCT04716426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110775716|NCT04716426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110775717|NCT04716426|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110775718|NCT04716426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110775719|NCT04716426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110775720|NCT05761756|Caffeine|caffeine|mesh-list
110775721|NCT05761756|Methylphenidate|methylphenidate|mesh-list
110775722|NCT05761756|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110775723|NCT05761756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110775724|NCT05761756|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110775725|NCT05761756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110775726|NCT05761756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110775727|NCT05761756|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110775728|NCT05761756|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110775729|NCT05761756|Purinergic Agents|purinergic agents|mesh-ancestor
110775730|NCT05761756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110775731|NCT05761756|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110775732|NCT05761756|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110847764|NCT02518516|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110775733|NCT05761756|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110775734|NCT05761756|Dopamine Agents|dopamine agents|mesh-ancestor
110775735|NCT04164758|Pimavanserin|pimavanserin|mesh-list
110775736|NCT04164758|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110775737|NCT04164758|Antidepressive Agents|antidepressive agents|mesh-ancestor
110775738|NCT04164758|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110775739|NCT04164758|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110775740|NCT04164758|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110775741|NCT04164758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110775742|NCT04164758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110775743|NCT04164758|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110775744|NCT04164758|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110775745|NCT04164758|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110775746|NCT04164758|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110775747|NCT04164758|Serotonin Agents|serotonin agents|mesh-ancestor
110775748|NCT04164758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110775749|NCT04164758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110775750|NCT03754686|Acetaminophen|acetaminophen|mesh-list
110775751|NCT03754686|Oseltamivir|oseltamivir|mesh-list
110775752|NCT03754686|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110775753|NCT03754686|Analgesics|analgesics|mesh-ancestor
110775754|NCT03754686|Sensory System Agents|sensory system agents|mesh-ancestor
110775755|NCT03754686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110775756|NCT03754686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110775757|NCT03754686|Antipyretics|antipyretics|mesh-ancestor
110775758|NCT03754686|Antiviral Agents|antiviral agents|mesh-ancestor
110775759|NCT03754686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110775760|NCT03754686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110775761|NCT03754686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110775762|NCT05200884|Lidocaine|lidocaine|mesh-list
110775763|NCT05200884|Carticaine|carticaine|mesh-list
110775764|NCT05200884|Anesthetics, Local|anesthetics, local|mesh-ancestor
110775765|NCT05200884|Anesthetics|anesthetics|mesh-ancestor
110775766|NCT05200884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110775767|NCT05200884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110775768|NCT05200884|Sensory System Agents|sensory system agents|mesh-ancestor
110775769|NCT05200884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110775770|NCT05200884|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110775771|NCT05200884|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110775772|NCT05200884|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110775773|NCT05200884|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110775774|NCT05200884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110775776|NCT03746444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110775777|NCT03746444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110775778|NCT03749096|Immunoglobulins|immunoglobulins|mesh-list
110775779|NCT03749096|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110775780|NCT03749096|Antibodies|antibodies|mesh-list
110775781|NCT03749096|gamma-Globulins|gamma-globulins|mesh-list
110775782|NCT03749096|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110775783|NCT03749096|Immunologic Factors|immunologic factors|mesh-ancestor
110775784|NCT03749096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110775785|NCT03748940|Mirikizumab|mirikizumab|mesh-list
110775786|NCT03748940|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110775787|NCT03748940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110775788|NCT03748940|Analgesics|analgesics|mesh-ancestor
110775789|NCT03748940|Sensory System Agents|sensory system agents|mesh-ancestor
110775790|NCT03748940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110775791|NCT03748940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110775792|NCT03748940|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110775793|NCT03748940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110775794|NCT03748940|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110775795|NCT03748940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110775796|NCT04177862|Fentanyl|fentanyl|mesh-list
110775797|NCT04177862|Sufentanil|sufentanil|mesh-list
110493450|NCT00604682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110775798|NCT04177862|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110775799|NCT04177862|Narcotics|narcotics|mesh-ancestor
110775800|NCT04177862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110775802|NCT04177862|Analgesics|analgesics|mesh-ancestor
110775803|NCT04177862|Sensory System Agents|sensory system agents|mesh-ancestor
110775804|NCT04177862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110775805|NCT04177862|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110775806|NCT04177862|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110775807|NCT04177862|Anesthetics, General|anesthetics, general|mesh-ancestor
110775808|NCT04177862|Anesthetics|anesthetics|mesh-ancestor
110775809|NCT03746366|Corticosterone|corticosterone|mesh-list
110775810|NCT03746366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110775811|NCT04157738|Insulin|insulin|mesh-list
110775812|NCT04157738|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110775813|NCT04157738|Insulin, Short-Acting|insulin, short-acting|mesh-list
110775814|NCT04157738|Insulin, Long-Acting|insulin, long-acting|mesh-list
110775815|NCT04157738|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110775816|NCT04157738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110775817|NCT04156646|Balovaptan|balovaptan|mesh-list
110775818|NCT04156646|Esomeprazole|esomeprazole|mesh-list
110775819|NCT04156646|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110775820|NCT04156646|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110775821|NCT04156646|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110775822|NCT04156646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110775823|NCT04156646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110775824|NCT04156646|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
110775825|NCT04156646|Natriuretic Agents|natriuretic agents|mesh-ancestor
110775826|NCT04156646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110775827|NCT04676412|Pembrolizumab|pembrolizumab|mesh-list
110775828|NCT04676412|Lenvatinib|lenvatinib|mesh-list
110775829|NCT04676412|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110775830|NCT04676412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110775831|NCT04676412|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110775832|NCT04676412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110775833|NCT04676412|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110775834|NCT04676412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110775835|NCT03751488|Paliperidone Palmitate|paliperidone palmitate|mesh-list
110775836|NCT03751488|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110775837|NCT03751488|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110847827|NCT01291433|Vasodilator Agents|vasodilator agents|mesh-ancestor
110775838|NCT03751488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110775839|NCT03751488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110775840|NCT03751488|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110775841|NCT03751488|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110775842|NCT03751488|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110775843|NCT03751488|Serotonin Agents|serotonin agents|mesh-ancestor
110775844|NCT03751488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110775845|NCT03751488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110775846|NCT03751488|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110775847|NCT03751488|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110775848|NCT03751488|Dopamine Agents|dopamine agents|mesh-ancestor
110775849|NCT04150250|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110775850|NCT04150250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110775852|NCT04537806|Brexanolone|brexanolone|mesh-list
110775853|NCT04537806|Anesthetics|anesthetics|mesh-ancestor
110775854|NCT04537806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110775855|NCT04537806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110775856|NCT04537806|Neurosteroids|neurosteroids|mesh-ancestor
110775857|NCT04537806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110775858|NCT04537806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110775859|NCT04537806|GABA Modulators|gaba modulators|mesh-ancestor
110775860|NCT04537806|GABA Agents|gaba agents|mesh-ancestor
110775861|NCT03744806|Bevacizumab|bevacizumab|mesh-list
110775862|NCT03744806|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110775863|NCT03744806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110775864|NCT03744806|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110775865|NCT03744806|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110775866|NCT03744806|Growth Substances|growth substances|mesh-ancestor
110775867|NCT03744806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110775868|NCT03744806|Growth Inhibitors|growth inhibitors|mesh-ancestor
110775869|NCT04531098|Vaccines|vaccines|mesh-list
110775870|NCT04531098|Immunologic Factors|immunologic factors|mesh-ancestor
110775871|NCT04531098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110775872|NCT04529850|Avasopasem manganese|avasopasem manganese|mesh-list
110775873|NCT04529850|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110775874|NCT04529850|Antioxidants|antioxidants|mesh-ancestor
110775875|NCT04529850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110775876|NCT04529850|Protective Agents|protective agents|mesh-ancestor
110775877|NCT04529850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110775878|NCT04225676|Tisagenlecleucel|tisagenlecleucel|mesh-list
110775879|NCT04225676|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110775880|NCT04225676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110775881|NCT01561950|Clopidogrel|clopidogrel|mesh-list
110775882|NCT01561950|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110775883|NCT01561950|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110775884|NCT01561950|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110775885|NCT01561950|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110775886|NCT01561950|Purinergic Agents|purinergic agents|mesh-ancestor
110775887|NCT01561950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110847833|NCT01314144|Bupivacaine|bupivacaine|mesh-list
110775888|NCT01561950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110775889|NCT01561950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110775890|NCT04139018|Timolol|timolol|mesh-list
110775891|NCT04139018|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110775892|NCT04139018|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110775893|NCT04139018|Adrenergic Agents|adrenergic agents|mesh-ancestor
110775894|NCT04139018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110775895|NCT04139018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110775896|NCT04139018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110775897|NCT04139018|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110775898|NCT04139018|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110775899|NCT05206318|Cysteamine|cysteamine|mesh-list
110775900|NCT05206318|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
110775901|NCT05206318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110775902|NCT04136444|Padsevonil|padsevonil|mesh-list
110775903|NCT04136444|Anticonvulsants|anticonvulsants|mesh-ancestor
110775904|NCT03751332|Tacrolimus|tacrolimus|mesh-list
110775905|NCT03751332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110775906|NCT03751332|Immunologic Factors|immunologic factors|mesh-ancestor
110775907|NCT03751332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110775908|NCT03751332|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110775909|NCT03751332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110775910|NCT03751332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110775911|NCT04425252|Brequinar|brequinar|mesh-list
110775912|NCT04425252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110775913|NCT04425252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110775914|NCT04425252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110775915|NCT04425252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110775916|NCT04425252|Immunologic Factors|immunologic factors|mesh-ancestor
110775917|NCT04425252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110775918|NCT04003610|Carboplatin|carboplatin|mesh-list
110775919|NCT04003610|Gemcitabine|gemcitabine|mesh-list
110775920|NCT04003610|Pembrolizumab|pembrolizumab|mesh-list
110775921|NCT04003610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110775922|NCT04003610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110775923|NCT04003610|Antimetabolites|antimetabolites|mesh-ancestor
110775924|NCT04003610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110775925|NCT04003610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110775926|NCT04003610|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110775927|NCT03744104|Vaccines|vaccines|mesh-list
110775928|NCT03744104|Immunologic Factors|immunologic factors|mesh-ancestor
110775929|NCT03744104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110775930|NCT03999554|Vaccines|vaccines|mesh-list
110775931|NCT03999554|Immunologic Factors|immunologic factors|mesh-ancestor
110775932|NCT03999554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110775933|NCT05280626|Prednisolone|prednisolone|mesh-list
110775934|NCT05280626|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110775935|NCT05280626|Methylprednisolone|methylprednisolone|mesh-list
110775936|NCT05280626|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110775937|NCT05280626|Prednisolone acetate|prednisolone acetate|mesh-list
110775938|NCT05280626|Cyclophosphamide|cyclophosphamide|mesh-list
110775939|NCT05280626|Rituximab|rituximab|mesh-list
110775940|NCT05280626|Doxorubicin|doxorubicin|mesh-list
110775941|NCT05280626|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110775942|NCT05280626|Vincristine|vincristine|mesh-list
110775943|NCT05280626|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110775944|NCT05280626|Prednisolone phosphate|prednisolone phosphate|mesh-list
110775945|NCT05280626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110775946|NCT05280626|Immunologic Factors|immunologic factors|mesh-ancestor
110775947|NCT05280626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110775948|NCT05280626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110775949|NCT05280626|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110775950|NCT05280626|Alkylating Agents|alkylating agents|mesh-ancestor
110847858|NCT04508452|Capecitabine|capecitabine|mesh-list
110775951|NCT05280626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110775953|NCT05280626|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110775954|NCT05280626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110775955|NCT05280626|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110775956|NCT05280626|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110775957|NCT05280626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110775958|NCT05280626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110775959|NCT05280626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110775960|NCT05280626|Glucocorticoids|glucocorticoids|mesh-ancestor
110775961|NCT05280626|Hormones|hormones|mesh-ancestor
110775962|NCT05280626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110775963|NCT05280626|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110775964|NCT05280626|Antiemetics|antiemetics|mesh-ancestor
110775965|NCT05280626|Autonomic Agents|autonomic agents|mesh-ancestor
110775966|NCT05280626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110775967|NCT05280626|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110775968|NCT05280626|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110775969|NCT05280626|Protective Agents|protective agents|mesh-ancestor
110775970|NCT05280626|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110775971|NCT05280626|Tubulin Modulators|tubulin modulators|mesh-ancestor
110775972|NCT05280626|Antimitotic Agents|antimitotic agents|mesh-ancestor
110775973|NCT05280626|Mitosis Modulators|mitosis modulators|mesh-ancestor
110775974|NCT04526574|Vaccines|vaccines|mesh-list
110775975|NCT04526574|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110775976|NCT04526574|Immunologic Factors|immunologic factors|mesh-ancestor
110775977|NCT04526574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110775978|NCT03993392|Buprenorphine|buprenorphine|mesh-list
110775979|NCT03993392|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110775980|NCT03993392|Narcotics|narcotics|mesh-ancestor
110775981|NCT03993392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110775982|NCT03993392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110775983|NCT03993392|Analgesics|analgesics|mesh-ancestor
110775984|NCT03993392|Sensory System Agents|sensory system agents|mesh-ancestor
110775985|NCT03993392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110775986|NCT03993392|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110775987|NCT03751176|Leucovorin|leucovorin|mesh-list
110775988|NCT03751176|Folic Acid|folic acid|mesh-list
110775989|NCT03751176|Fluorouracil|fluorouracil|mesh-list
110775990|NCT03751176|Irinotecan|irinotecan|mesh-list
110775991|NCT03751176|Panitumumab|panitumumab|mesh-list
110775992|NCT03751176|Levoleucovorin|levoleucovorin|mesh-list
110775993|NCT03751176|Antimetabolites|antimetabolites|mesh-ancestor
110775994|NCT03751176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110775995|NCT03751176|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110775996|NCT03751176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110775997|NCT03751176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110847874|NCT03856853|Pirfenidone|pirfenidone|mesh-list
110775998|NCT03751176|Immunologic Factors|immunologic factors|mesh-ancestor
110775999|NCT03751176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110776000|NCT03751176|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110776001|NCT03751176|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110776002|NCT03751176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110776003|NCT03751176|Antidotes|antidotes|mesh-ancestor
110776004|NCT03751176|Protective Agents|protective agents|mesh-ancestor
110776005|NCT03751176|Vitamin B Complex|vitamin b complex|mesh-ancestor
110776006|NCT03751176|Vitamins|vitamins|mesh-ancestor
110776007|NCT03751176|Micronutrients|micronutrients|mesh-ancestor
110776008|NCT03751176|Hematinics|hematinics|mesh-ancestor
110776009|NCT03751176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110776010|NCT04377308|Fluoxetine|fluoxetine|mesh-list
110776011|NCT04377308|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110776012|NCT04377308|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110776013|NCT04377308|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110776014|NCT04377308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110776015|NCT04377308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110776016|NCT04377308|Serotonin Agents|serotonin agents|mesh-ancestor
110776017|NCT04377308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110776018|NCT04377308|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110776019|NCT04377308|Antidepressive Agents|antidepressive agents|mesh-ancestor
110776020|NCT04377308|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110776021|NCT04377308|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110776022|NCT04377308|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110776023|NCT04377308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110776024|NCT03743870|Bupivacaine|bupivacaine|mesh-list
110776025|NCT03743870|Levobupivacaine|levobupivacaine|mesh-list
110776026|NCT03743870|Anesthetics, Local|anesthetics, local|mesh-ancestor
110776028|NCT03743870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110776029|NCT03743870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110776030|NCT03743870|Sensory System Agents|sensory system agents|mesh-ancestor
110776031|NCT03743870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110776032|NCT03988088|Lasmiditan|lasmiditan|mesh-list
110776033|NCT03988088|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110776034|NCT03988088|Serotonin Agents|serotonin agents|mesh-ancestor
110776035|NCT03988088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110776036|NCT03988088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110776037|NCT03988088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110776038|NCT03987620|Ibrexafungerp|ibrexafungerp|mesh-list
110776039|NCT03987620|Antifungal Agents|antifungal agents|mesh-ancestor
110776040|NCT03987620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110776041|NCT05204524|Temozolomide|temozolomide|mesh-list
110776042|NCT05204524|Epirubicin|epirubicin|mesh-list
110776043|NCT05204524|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110776044|NCT05204524|Alkylating Agents|alkylating agents|mesh-ancestor
110776045|NCT05204524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110776046|NCT05204524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110776047|NCT05204524|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110776048|NCT05204524|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110776049|NCT05204524|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110776050|NCT05204524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110776051|NCT05204056|Epinephrine|epinephrine|mesh-list
110776052|NCT05204056|Morphine|morphine|mesh-list
110776053|NCT05204056|Ropivacaine|ropivacaine|mesh-list
110776054|NCT05204056|Tranexamic Acid|tranexamic acid|mesh-list
110776055|NCT05204056|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110776056|NCT05204056|Narcotics|narcotics|mesh-ancestor
110776057|NCT05204056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110776058|NCT05204056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110776059|NCT05204056|Analgesics|analgesics|mesh-ancestor
110776060|NCT05204056|Sensory System Agents|sensory system agents|mesh-ancestor
110776061|NCT05204056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110776062|NCT05204056|Anesthetics, Local|anesthetics, local|mesh-ancestor
110776063|NCT05204056|Anesthetics|anesthetics|mesh-ancestor
110776064|NCT05204056|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110776065|NCT05204056|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110101138|NCT01758666|Antidotes|antidotes|mesh-ancestor
110776066|NCT05204056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110776067|NCT05204056|Hemostatics|hemostatics|mesh-ancestor
110776068|NCT05204056|Coagulants|coagulants|mesh-ancestor
110776069|NCT05204056|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110776070|NCT05204056|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110776071|NCT05204056|Adrenergic Agents|adrenergic agents|mesh-ancestor
110776072|NCT05204056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110776073|NCT05204056|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110776074|NCT05204056|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110776075|NCT05204056|Autonomic Agents|autonomic agents|mesh-ancestor
110776076|NCT05204056|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110776077|NCT05204056|Respiratory System Agents|respiratory system agents|mesh-ancestor
110776078|NCT05204056|Mydriatics|mydriatics|mesh-ancestor
110776079|NCT05204056|Sympathomimetics|sympathomimetics|mesh-ancestor
110776080|NCT05204056|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110776081|NCT05203744|Tafenoquine|tafenoquine|mesh-list
110776082|NCT05203744|Antimalarials|antimalarials|mesh-ancestor
110776083|NCT05203744|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110776084|NCT05203744|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110776085|NCT05203744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110776086|NCT03987074|Firsocostat|firsocostat|mesh-list
110776087|NCT03987074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110776088|NCT03987074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110776089|NCT05761366|PSMA-BCH|psma-bch|mesh-list
110776090|NCT05761366|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110776091|NCT05761366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110776092|NCT05302466|Silicon|silicon|mesh-list
110776093|NCT05302466|Trace Elements|trace elements|mesh-ancestor
110776094|NCT05302466|Micronutrients|micronutrients|mesh-ancestor
110776095|NCT05302466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110776096|NCT05203588|Vitamin D|vitamin d|mesh-list
110776097|NCT05203588|Denosumab|denosumab|mesh-list
110776098|NCT05203588|Calcium|calcium|mesh-list
110493747|NCT05721755|Fluorouracil|fluorouracil|mesh-list
110776099|NCT05203588|Vitamins|vitamins|mesh-ancestor
110776100|NCT05203588|Micronutrients|micronutrients|mesh-ancestor
110776101|NCT05203588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110776102|NCT05203588|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110776103|NCT05203588|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110776104|NCT05203354|Acitretin|acitretin|mesh-list
110776105|NCT05203354|Keratolytic Agents|keratolytic agents|mesh-ancestor
110776106|NCT05203354|Dermatologic Agents|dermatologic agents|mesh-ancestor
110776107|NCT04439214|Nivolumab|nivolumab|mesh-list
110776108|NCT04439214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110776109|NCT04439214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110776110|NCT04439214|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110776111|NCT04439214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110776112|NCT03754062|Haloperidol|haloperidol|mesh-list
110776113|NCT03754062|Haloperidol decanoate|haloperidol decanoate|mesh-list
110776114|NCT03754062|Antiemetics|antiemetics|mesh-ancestor
110776115|NCT03754062|Autonomic Agents|autonomic agents|mesh-ancestor
110776116|NCT03754062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110776117|NCT03754062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110776118|NCT03754062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110776119|NCT03754062|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110776120|NCT03754062|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110776121|NCT03754062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110776122|NCT03754062|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110776123|NCT03754062|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110776124|NCT03754062|Dopamine Agents|dopamine agents|mesh-ancestor
110776125|NCT03754062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110776126|NCT03754062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110776127|NCT03754062|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110776128|NCT03696342|Gatifloxacin|gatifloxacin|mesh-list
110776129|NCT03696342|Pazufloxacin|pazufloxacin|mesh-list
110776130|NCT03696342|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110776131|NCT03696342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110776132|NCT03696342|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110776133|NCT03696342|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110776134|NCT03696342|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110776135|NCT03696342|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110776136|NCT03696342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110776137|NCT03696342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110776138|NCT03696342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110776139|NCT03696342|Antitubercular Agents|antitubercular agents|mesh-ancestor
110776140|NCT05180032|Denosumab|denosumab|mesh-list
110776141|NCT05180032|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110776142|NCT05180032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110776144|NCT05761132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110776145|NCT05761132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110776146|NCT05761132|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110776147|NCT05761132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110776148|NCT04411680|Sargramostim|sargramostim|mesh-list
110776149|NCT04411680|Immunologic Factors|immunologic factors|mesh-ancestor
110776150|NCT04411680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110776151|NCT05760976|Cisatracurium|cisatracurium|mesh-list
110776152|NCT05760976|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110776153|NCT05760976|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110776154|NCT05760976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110776155|NCT05760976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110776156|NCT05324358|Ketorolac|ketorolac|mesh-list
110776157|NCT05324358|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
110776158|NCT05324358|Morphine|morphine|mesh-list
110776159|NCT05324358|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110776160|NCT05324358|Narcotics|narcotics|mesh-ancestor
110776161|NCT05324358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110776162|NCT05324358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110776163|NCT05324358|Analgesics|analgesics|mesh-ancestor
110776164|NCT05324358|Sensory System Agents|sensory system agents|mesh-ancestor
110776165|NCT05324358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110776166|NCT05324358|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110776167|NCT05324358|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110776168|NCT05324358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110776169|NCT05324358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110776170|NCT05324358|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110776171|NCT05324358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110776172|NCT05324358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110776173|NCT03747978|Amlodipine|amlodipine|mesh-list
110776174|NCT03747978|Perindopril|perindopril|mesh-list
110776175|NCT03747978|Indapamide|indapamide|mesh-list
110493830|NCT05419089|Cisplatin|cisplatin|mesh-list
110776176|NCT03747978|Indapamide, perindopril drug combination|indapamide, perindopril drug combination|mesh-list
110776177|NCT03747978|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110776178|NCT03747978|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110776179|NCT03747978|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110776180|NCT03747978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110776181|NCT03747978|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110776182|NCT03747978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110776183|NCT03747978|Vasodilator Agents|vasodilator agents|mesh-ancestor
110776184|NCT03747978|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110776185|NCT03747978|Protease Inhibitors|protease inhibitors|mesh-ancestor
110776186|NCT03747978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110776187|NCT03747978|Diuretics|diuretics|mesh-ancestor
110776188|NCT03747978|Natriuretic Agents|natriuretic agents|mesh-ancestor
110776189|NCT03747978|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110776190|NCT04603846|Paclitaxel|paclitaxel|mesh-list
110776191|NCT04603846|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110776192|NCT04603846|Antibodies|antibodies|mesh-list
110776193|NCT04603846|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110776194|NCT04603846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110776195|NCT04603846|Tubulin Modulators|tubulin modulators|mesh-ancestor
110776196|NCT04603846|Antimitotic Agents|antimitotic agents|mesh-ancestor
110776197|NCT04603846|Mitosis Modulators|mitosis modulators|mesh-ancestor
110776198|NCT04603846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110776199|NCT04603846|Immunologic Factors|immunologic factors|mesh-ancestor
110776200|NCT04603846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110776201|NCT03747900|Botulinum Toxins|botulinum toxins|mesh-list
110776202|NCT03747900|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110776203|NCT03747900|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110776204|NCT03747900|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110776205|NCT03747900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110776206|NCT03747900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110776207|NCT03747900|Cholinergic Agents|cholinergic agents|mesh-ancestor
110776208|NCT03747900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110776209|NCT03747900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110776210|NCT03747900|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110776211|NCT03747900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110776212|NCT04578106|Trastuzumab|trastuzumab|mesh-list
110776213|NCT04578106|Pertuzumab|pertuzumab|mesh-list
110776214|NCT04578106|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110101289|NCT01759719|Chromium|chromium|mesh-list
110776215|NCT04578106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110776216|NCT04472182|Calcium|calcium|mesh-list
110776217|NCT04472182|Fluorides|fluorides|mesh-list
110776218|NCT04472182|Fluorides, Topical|fluorides, topical|mesh-list
110492859|NCT00676663|Exemestane|exemestane|mesh-list
110776219|NCT04472182|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110776220|NCT04472182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110776221|NCT04472182|Cariostatic Agents|cariostatic agents|mesh-ancestor
110776222|NCT04472182|Protective Agents|protective agents|mesh-ancestor
110776223|NCT04423744|Moxifloxacin|moxifloxacin|mesh-list
110776224|NCT04423744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110776225|NCT04423744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110776226|NCT04423744|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110776227|NCT04423744|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110776228|NCT04423744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110776229|NCT04423744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110776230|NCT04423744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110776231|NCT05759416|Melatonin|melatonin|mesh-list
110776232|NCT05759416|Antioxidants|antioxidants|mesh-ancestor
110776233|NCT05759416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110776234|NCT05759416|Protective Agents|protective agents|mesh-ancestor
110776235|NCT05759416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110776236|NCT05759416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110776237|NCT03746340|Propofol|propofol|mesh-list
110776238|NCT03746340|Sevoflurane|sevoflurane|mesh-list
110776239|NCT03746340|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110776240|NCT03746340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110776241|NCT03746340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110776242|NCT03746340|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110776243|NCT03746340|Anesthetics, General|anesthetics, general|mesh-ancestor
110776244|NCT03746340|Anesthetics|anesthetics|mesh-ancestor
110776245|NCT03746340|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110776246|NCT03746340|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110776247|NCT04222816|Lithium Carbonate|lithium carbonate|mesh-list
110776248|NCT04222816|Antidepressive Agents|antidepressive agents|mesh-ancestor
110776249|NCT04222816|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110776250|NCT04222816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110776251|NCT04222816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110776252|NCT04222816|Antimanic Agents|antimanic agents|mesh-ancestor
110776253|NCT04222816|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110776254|NCT04222816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110776255|NCT04222816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110776256|NCT04161144|Sirolimus|sirolimus|mesh-list
110776257|NCT04161144|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110776258|NCT04161144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110776259|NCT04161144|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110776260|NCT04161144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110776261|NCT04161144|Antifungal Agents|antifungal agents|mesh-ancestor
110776262|NCT04161144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110776263|NCT04161144|Immunologic Factors|immunologic factors|mesh-ancestor
110776264|NCT04161144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110776265|NCT03747744|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
110776266|NCT03747744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110776267|NCT03747744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110776268|NCT04823364|Neurotransmitter Agents|neurotransmitter agents|mesh-list
110776269|NCT04823364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110776270|NCT04823364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110776271|NCT04764630|Naloxone|naloxone|mesh-list
110776272|NCT04764630|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110776273|NCT04764630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110776274|NCT04764630|Sensory System Agents|sensory system agents|mesh-ancestor
110776275|NCT04764630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110776276|NCT04153188|Phenylephrine|phenylephrine|mesh-list
110776277|NCT04153188|Oxymetazoline|oxymetazoline|mesh-list
110776278|NCT04153188|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110776279|NCT04153188|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110776280|NCT04153188|Adrenergic Agents|adrenergic agents|mesh-ancestor
110776281|NCT04153188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110776282|NCT04153188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110492871|NCT02560207|Cefotaxime|cefotaxime|mesh-list
110776283|NCT04153188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110776284|NCT04153188|Sympathomimetics|sympathomimetics|mesh-ancestor
110776285|NCT04153188|Autonomic Agents|autonomic agents|mesh-ancestor
110776286|NCT04153188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110776287|NCT04153188|Nasal Decongestants|nasal decongestants|mesh-ancestor
110776288|NCT04153188|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110776289|NCT04153188|Respiratory System Agents|respiratory system agents|mesh-ancestor
110776290|NCT04153188|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110776291|NCT04153188|Mydriatics|mydriatics|mesh-ancestor
110776292|NCT04153188|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110776293|NCT04153188|Protective Agents|protective agents|mesh-ancestor
110776294|NCT03611010|Atorvastatin|atorvastatin|mesh-list
110776295|NCT03611010|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110776296|NCT03611010|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110776297|NCT03611010|Antimetabolites|antimetabolites|mesh-ancestor
110776298|NCT03611010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110776299|NCT03611010|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110776300|NCT03611010|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110776301|NCT03611010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110776302|NCT03749850|Cyclophosphamide|cyclophosphamide|mesh-list
110776303|NCT03749850|Doxorubicin|doxorubicin|mesh-list
110776304|NCT03749850|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110776305|NCT03749850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110776306|NCT03749850|Immunologic Factors|immunologic factors|mesh-ancestor
110776307|NCT03749850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110776308|NCT03749850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110776309|NCT03749850|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110776310|NCT03749850|Alkylating Agents|alkylating agents|mesh-ancestor
110776311|NCT03749850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110776312|NCT03749850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110776313|NCT03749850|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110776314|NCT03749850|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110776315|NCT03749850|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110776316|NCT03749850|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110776317|NCT03749850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110776318|NCT04357782|Ascorbic Acid|ascorbic acid|mesh-list
110776319|NCT04357782|Vitamins|vitamins|mesh-ancestor
110776320|NCT04357782|Micronutrients|micronutrients|mesh-ancestor
110776321|NCT04357782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110776322|NCT04357782|Antioxidants|antioxidants|mesh-ancestor
110776323|NCT04357782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110776324|NCT04357782|Protective Agents|protective agents|mesh-ancestor
110493969|NCT04983940|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110776325|NCT03980522|Rilonacept|rilonacept|mesh-list
110776326|NCT03980522|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110776328|NCT04400682|Antiviral Agents|antiviral agents|mesh-ancestor
110776329|NCT04400682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110776330|NCT03066778|Carboplatin|carboplatin|mesh-list
110776331|NCT03066778|Pembrolizumab|pembrolizumab|mesh-list
110776332|NCT03066778|Etoposide|etoposide|mesh-list
110776333|NCT03066778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110776334|NCT03066778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110776335|NCT03066778|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110776336|NCT03066778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110776337|NCT03066778|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110776338|NCT03066778|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110776339|NCT03066778|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110776340|NCT03066778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110776341|NCT04136548|Fentanyl|fentanyl|mesh-list
110776342|NCT04136548|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110776343|NCT04136548|Narcotics|narcotics|mesh-ancestor
110776344|NCT04136548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110776345|NCT04136548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110776346|NCT04136548|Analgesics|analgesics|mesh-ancestor
110776347|NCT04136548|Sensory System Agents|sensory system agents|mesh-ancestor
110776348|NCT04136548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110776349|NCT04136548|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110776350|NCT04136548|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110776351|NCT04136548|Anesthetics, General|anesthetics, general|mesh-ancestor
110776352|NCT04136548|Anesthetics|anesthetics|mesh-ancestor
110776353|NCT04347954|Iodine|iodine|mesh-list
110776354|NCT04347954|Cadexomer iodine|cadexomer iodine|mesh-list
110776355|NCT04347954|Povidone-Iodine|povidone-iodine|mesh-list
110776356|NCT04347954|Povidone|povidone|mesh-list
110776357|NCT04347954|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110776359|NCT04347954|Trace Elements|trace elements|mesh-ancestor
110776360|NCT04347954|Micronutrients|micronutrients|mesh-ancestor
110776361|NCT04347954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110776362|NCT04347954|Plasma Substitutes|plasma substitutes|mesh-ancestor
110776363|NCT04347954|Blood Substitutes|blood substitutes|mesh-ancestor
110776364|NCT03065530|Dexmedetomidine|dexmedetomidine|mesh-list
110776365|NCT03065530|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110776366|NCT03065530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110776367|NCT03065530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110776368|NCT03065530|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110776369|NCT03065530|Analgesics|analgesics|mesh-ancestor
110776370|NCT03065530|Sensory System Agents|sensory system agents|mesh-ancestor
110776371|NCT03065530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110776372|NCT03065530|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110776373|NCT03065530|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110776374|NCT03065530|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110776375|NCT03065530|Adrenergic Agents|adrenergic agents|mesh-ancestor
110776376|NCT03065530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110776377|NCT03065530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110776378|NCT03979820|Phenelzine|phenelzine|mesh-list
110776379|NCT03979820|Tyramine|tyramine|mesh-list
110776380|NCT03979820|Antidepressive Agents|antidepressive agents|mesh-ancestor
110776381|NCT03979820|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110776382|NCT03979820|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
110776383|NCT03979820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110776384|NCT03979820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110776385|NCT03979820|Sympathomimetics|sympathomimetics|mesh-ancestor
110776386|NCT03979820|Autonomic Agents|autonomic agents|mesh-ancestor
110776387|NCT03979820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110776388|NCT03979820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110776389|NCT03979820|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110776390|NCT03979820|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110776391|NCT03979820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110776392|NCT03979820|Adrenergic Agents|adrenergic agents|mesh-ancestor
110776393|NCT03979820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110776394|NCT03647488|Docetaxel|docetaxel|mesh-list
110776395|NCT03647488|Spartalizumab|spartalizumab|mesh-list
110776396|NCT03647488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110776397|NCT03647488|Tubulin Modulators|tubulin modulators|mesh-ancestor
110776398|NCT03647488|Antimitotic Agents|antimitotic agents|mesh-ancestor
110776399|NCT03647488|Mitosis Modulators|mitosis modulators|mesh-ancestor
110776400|NCT03647488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110776401|NCT03647488|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110776405|NCT03579160|Timolol|timolol|mesh-list
110776407|NCT03579160|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110776408|NCT03579160|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110776409|NCT03579160|Adrenergic Agents|adrenergic agents|mesh-ancestor
110776410|NCT03579160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110776411|NCT03579160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110776412|NCT03579160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110776413|NCT03579160|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110776414|NCT03579160|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110776415|NCT03579160|Emollients|emollients|mesh-ancestor
110776416|NCT03579160|Dermatologic Agents|dermatologic agents|mesh-ancestor
110776417|NCT04109456|Atezolizumab|atezolizumab|mesh-list
110776418|NCT04109456|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110776419|NCT04109456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110776420|NCT04109456|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110776421|NCT04109456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110776425|NCT03745664|Methylprednisolone|methylprednisolone|mesh-list
110776426|NCT03745664|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110776427|NCT03745664|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110776428|NCT03745664|Prednisolone|prednisolone|mesh-list
110776429|NCT03745664|Prednisolone acetate|prednisolone acetate|mesh-list
110776430|NCT03745664|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110776432|NCT03745664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110776433|NCT03745664|Antiemetics|antiemetics|mesh-ancestor
110776434|NCT03745664|Autonomic Agents|autonomic agents|mesh-ancestor
110776435|NCT03745664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110776436|NCT03745664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110776437|NCT03745664|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110776438|NCT03745664|Glucocorticoids|glucocorticoids|mesh-ancestor
110776439|NCT03745664|Hormones|hormones|mesh-ancestor
110776440|NCT03745664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110776441|NCT03745664|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110776442|NCT03745664|Protective Agents|protective agents|mesh-ancestor
110776443|NCT03745664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110776444|NCT03745664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110776445|NCT03447262|Ivacaftor|ivacaftor|mesh-list
110776448|NCT03447262|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110776449|NCT03447262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110776450|NCT04094870|Sertraline|sertraline|mesh-list
110776451|NCT04094870|Antidepressive Agents|antidepressive agents|mesh-ancestor
110776452|NCT04094870|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110776453|NCT04094870|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110776454|NCT04094870|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110776455|NCT04094870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110776456|NCT04094870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110776457|NCT04094870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110776458|NCT04094870|Serotonin Agents|serotonin agents|mesh-ancestor
110776459|NCT04094870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110776460|NCT04399356|Niclosamide|niclosamide|mesh-list
110776461|NCT04399356|Anticestodal Agents|anticestodal agents|mesh-ancestor
110776462|NCT04399356|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110776463|NCT04399356|Anthelmintics|anthelmintics|mesh-ancestor
110776464|NCT04399356|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110776465|NCT04399356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110776466|NCT04399356|Antinematodal Agents|antinematodal agents|mesh-ancestor
110776467|NCT03692676|Tiotropium Bromide|tiotropium bromide|mesh-list
110776468|NCT03692676|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110776469|NCT03692676|Autonomic Agents|autonomic agents|mesh-ancestor
110776470|NCT03692676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110776471|NCT03692676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110776472|NCT03692676|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110776473|NCT03692676|Respiratory System Agents|respiratory system agents|mesh-ancestor
110776474|NCT03692676|Parasympatholytics|parasympatholytics|mesh-ancestor
110776475|NCT03692676|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110776476|NCT03692676|Cholinergic Agents|cholinergic agents|mesh-ancestor
110776477|NCT03692676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110776478|NCT03692676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110776479|NCT04118166|Nivolumab|nivolumab|mesh-list
110776480|NCT04118166|Ipilimumab|ipilimumab|mesh-list
110776481|NCT04118166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110776482|NCT04118166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110776483|NCT04118166|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110776484|NCT04118166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110776485|NCT04346628|Favipiravir|favipiravir|mesh-list
110776486|NCT04346628|Antiviral Agents|antiviral agents|mesh-ancestor
110776487|NCT04346628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110776488|NCT03681470|Dapsone|dapsone|mesh-list
110776489|NCT03681470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110776490|NCT03681470|Antimalarials|antimalarials|mesh-ancestor
110776491|NCT03681470|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110776492|NCT03681470|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110776493|NCT03681470|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110776494|NCT03681470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110776495|NCT03681470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110776496|NCT03681470|Leprostatic Agents|leprostatic agents|mesh-ancestor
110776497|NCT03681470|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110776499|NCT02414750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110776500|NCT02414750|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110776501|NCT02414750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110776502|NCT02414750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110776503|NCT04343976|Interferons|interferons|mesh-list
110776504|NCT04343976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110776505|NCT04343976|Antiviral Agents|antiviral agents|mesh-ancestor
110776506|NCT04343976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110776507|NCT03322540|Pembrolizumab|pembrolizumab|mesh-list
110776508|NCT03322540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110776509|NCT03322540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110776510|NCT03322540|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110776511|NCT03322540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110776512|NCT02909452|Pembrolizumab|pembrolizumab|mesh-list
110776513|NCT02909452|Entinostat|entinostat|mesh-list
110776514|NCT02909452|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110776515|NCT02909452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110776516|NCT02909452|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110776517|NCT02909452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110776518|NCT02909452|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110595326|NCT00718484|Ifosfamide|ifosfamide|mesh-list
110776519|NCT02909452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110776520|NCT02025556|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110776521|NCT02025556|Immunologic Factors|immunologic factors|mesh-ancestor
110776522|NCT02025556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110776523|NCT01935466|Pioglitazone|pioglitazone|mesh-list
110776524|NCT01935466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110776525|NCT01935466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110776526|NCT04334148|Hydroxychloroquine|hydroxychloroquine|mesh-list
110776527|NCT04334148|Antimalarials|antimalarials|mesh-ancestor
110776528|NCT04334148|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110776529|NCT04334148|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110776530|NCT04334148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110776531|NCT04334148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110776532|NCT04334148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110776533|NCT04334148|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110776534|NCT04399122|Acetaminophen|acetaminophen|mesh-list
110776535|NCT04399122|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
110776536|NCT04399122|Oxycodone|oxycodone|mesh-list
110776537|NCT04399122|Codeine|codeine|mesh-list
110776538|NCT04399122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110776539|NCT04399122|Analgesics|analgesics|mesh-ancestor
110776540|NCT04399122|Sensory System Agents|sensory system agents|mesh-ancestor
110776541|NCT04399122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110776542|NCT04399122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110776543|NCT04399122|Antipyretics|antipyretics|mesh-ancestor
110776544|NCT04399122|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110776545|NCT04399122|Narcotics|narcotics|mesh-ancestor
110776546|NCT04399122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110776547|NCT04399122|Antitussive Agents|antitussive agents|mesh-ancestor
110776548|NCT04399122|Respiratory System Agents|respiratory system agents|mesh-ancestor
110776549|NCT04399122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110776550|NCT04399122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110776551|NCT04399122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110776552|NCT00826462|Triamcinolone|triamcinolone|mesh-list
110776553|NCT00826462|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110776554|NCT00826462|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110776556|NCT00826462|Lidocaine|lidocaine|mesh-list
110776557|NCT00826462|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110776558|NCT00826462|Anesthetics, Local|anesthetics, local|mesh-ancestor
110776559|NCT00826462|Anesthetics|anesthetics|mesh-ancestor
110776560|NCT00826462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110776561|NCT00826462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110776562|NCT00826462|Sensory System Agents|sensory system agents|mesh-ancestor
110776563|NCT00826462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110776564|NCT00826462|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110776565|NCT00826462|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110776566|NCT00826462|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110776567|NCT00826462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110776568|NCT00826462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110776569|NCT00826462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110776571|NCT00826462|Hormones|hormones|mesh-ancestor
110776572|NCT00826462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110776573|NCT00826462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110776574|NCT00826462|Immunologic Factors|immunologic factors|mesh-ancestor
110776575|NCT00826462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110776576|NCT00826462|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110776577|NCT00826462|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110776578|NCT00826462|Analgesics|analgesics|mesh-ancestor
110776579|NCT00826462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110776580|NCT00826462|Gout Suppressants|gout suppressants|mesh-ancestor
110776581|NCT00826462|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110776582|NCT04398732|Etanercept|etanercept|mesh-list
110776583|NCT04398732|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110776584|NCT04398732|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110776585|NCT04398732|Analgesics|analgesics|mesh-ancestor
110776586|NCT04398732|Sensory System Agents|sensory system agents|mesh-ancestor
110776587|NCT04398732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110776588|NCT04398732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110776589|NCT04398732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110776590|NCT04398732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110776591|NCT04398732|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110776592|NCT04398732|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110776593|NCT04398732|Immunologic Factors|immunologic factors|mesh-ancestor
110776594|NCT04322682|Colchicine|colchicine|mesh-list
110776595|NCT04322682|Gout Suppressants|gout suppressants|mesh-ancestor
110776596|NCT04322682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110776597|NCT04322682|Tubulin Modulators|tubulin modulators|mesh-ancestor
110776598|NCT04322682|Antimitotic Agents|antimitotic agents|mesh-ancestor
110848175|NCT01189097|Dextromethorphan|dextromethorphan|mesh-list
110776599|NCT04322682|Mitosis Modulators|mitosis modulators|mesh-ancestor
110776600|NCT04322682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110776601|NCT04322682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110776603|NCT04322526|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110776604|NCT04322526|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110776605|NCT04322526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110776606|NCT04322526|Sensory System Agents|sensory system agents|mesh-ancestor
110776607|NCT04322526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110776608|NCT04115358|Hyaluronic Acid|hyaluronic acid|mesh-list
110776609|NCT04115358|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110776610|NCT04115358|Immunologic Factors|immunologic factors|mesh-ancestor
110776611|NCT04115358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110776612|NCT04115358|Viscosupplements|viscosupplements|mesh-ancestor
110776613|NCT04115358|Protective Agents|protective agents|mesh-ancestor
110776614|NCT05668884|Gemcitabine|gemcitabine|mesh-list
110776615|NCT05668884|Oxaliplatin|oxaliplatin|mesh-list
110776616|NCT05668884|Tislelizumab|tislelizumab|mesh-list
110776617|NCT05668884|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110776618|NCT05668884|Antimetabolites|antimetabolites|mesh-ancestor
110776619|NCT05668884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110776620|NCT05668884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110776621|NCT05668884|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110776622|NCT05187208|Niraparib|niraparib|mesh-list
110776623|NCT05187208|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110776624|NCT05187208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110776625|NCT05187208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110776626|NCT05187208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110776627|NCT05081206|Propofol|propofol|mesh-list
110776628|NCT05081206|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110776629|NCT05081206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110776630|NCT05081206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110776631|NCT05081206|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110776632|NCT05081206|Anesthetics, General|anesthetics, general|mesh-ancestor
110776634|NCT04105998|Oxytocin|oxytocin|mesh-list
110776635|NCT04105998|Oxytocics|oxytocics|mesh-ancestor
110776636|NCT04105998|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110776637|NCT04105998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110776638|NCT04543968|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
110776639|NCT04543968|Phenylethyl Alcohol|phenylethyl alcohol|mesh-list
110776640|NCT04543968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110776641|NCT04543968|Antioxidants|antioxidants|mesh-ancestor
110776642|NCT04543968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110776643|NCT04543968|Protective Agents|protective agents|mesh-ancestor
110776644|NCT04543968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110776645|NCT04543968|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110776646|NCT04543968|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110776647|NCT04543968|Disinfectants|disinfectants|mesh-ancestor
110776648|NCT04368910|Artesunate|artesunate|mesh-list
110776649|NCT04368910|Chloroquine|chloroquine|mesh-list
110776651|NCT04368910|Antimalarials|antimalarials|mesh-ancestor
110776652|NCT04368910|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110776653|NCT04368910|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110776654|NCT04368910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110776655|NCT04368910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110776656|NCT04368910|Antiviral Agents|antiviral agents|mesh-ancestor
110776657|NCT04368910|Schistosomicides|schistosomicides|mesh-ancestor
110776658|NCT04368910|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110776659|NCT04368910|Anthelmintics|anthelmintics|mesh-ancestor
110776660|NCT04368910|Amebicides|amebicides|mesh-ancestor
110776661|NCT04368910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110776662|NCT04249258|Dobutamine|dobutamine|mesh-list
110776663|NCT04249258|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110776664|NCT04249258|Sympathomimetics|sympathomimetics|mesh-ancestor
110776665|NCT04249258|Autonomic Agents|autonomic agents|mesh-ancestor
110776666|NCT04249258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110776667|NCT04249258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110776668|NCT04249258|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
110776669|NCT04249258|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110776670|NCT04249258|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110776671|NCT04249258|Adrenergic Agents|adrenergic agents|mesh-ancestor
110776672|NCT04249258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110101751|NCT01761669|Vitamin D|vitamin d|mesh-list
110776673|NCT04249258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110776674|NCT04249258|Protective Agents|protective agents|mesh-ancestor
110776675|NCT03938584|Ascorbic Acid|ascorbic acid|mesh-list
110776676|NCT03938584|Vitamins|vitamins|mesh-ancestor
110776677|NCT03938584|Micronutrients|micronutrients|mesh-ancestor
110776678|NCT03938584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110776679|NCT03938584|Antioxidants|antioxidants|mesh-ancestor
110776680|NCT03938584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110776681|NCT03938584|Protective Agents|protective agents|mesh-ancestor
110776682|NCT03269344|Gabapentin|gabapentin|mesh-list
110776683|NCT03269344|Analgesics|analgesics|mesh-ancestor
110776684|NCT03269344|Sensory System Agents|sensory system agents|mesh-ancestor
110776685|NCT03269344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110776686|NCT03269344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110776687|NCT03269344|Anticonvulsants|anticonvulsants|mesh-ancestor
110776688|NCT03269344|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110776689|NCT03269344|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110776690|NCT03269344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110776691|NCT03269344|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110776692|NCT03269344|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110776693|NCT03269344|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110776694|NCT03269344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110776695|NCT03269344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110776696|NCT03269344|Antimanic Agents|antimanic agents|mesh-ancestor
110776697|NCT04389840|Heparin|heparin|mesh-list
110776698|NCT04389840|Anticoagulants|anticoagulants|mesh-ancestor
110776699|NCT04389840|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110776700|NCT04389840|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110776701|NCT04389840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110776702|NCT03747198|Dimethyl sulfone|dimethyl sulfone|mesh-list
110776703|NCT03747198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110776704|NCT02933944|Pembrolizumab|pembrolizumab|mesh-list
110776705|NCT02933944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110776706|NCT02933944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110776707|NCT02933944|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110776708|NCT02933944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110776709|NCT04307940|Acetaminophen|acetaminophen|mesh-list
110776710|NCT04307940|Naproxen|naproxen|mesh-list
110776711|NCT04307940|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
110776712|NCT04307940|Hydrocodone|hydrocodone|mesh-list
110776713|NCT04307940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110776714|NCT04307940|Analgesics|analgesics|mesh-ancestor
110776715|NCT04307940|Sensory System Agents|sensory system agents|mesh-ancestor
110776716|NCT04307940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110776717|NCT04307940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110776718|NCT04307940|Antipyretics|antipyretics|mesh-ancestor
110776719|NCT04307940|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110776720|NCT04307940|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110776721|NCT04307940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110776722|NCT04307940|Gout Suppressants|gout suppressants|mesh-ancestor
110848302|NCT04443556|Tramadol|tramadol|mesh-list
110776723|NCT04307940|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110776724|NCT04307940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110492976|NCT04935034|Vitamin D|vitamin d|mesh-list
110776725|NCT04307940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110776726|NCT04307940|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110776727|NCT04307940|Narcotics|narcotics|mesh-ancestor
110776728|NCT04307940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110776729|NCT04307940|Antitussive Agents|antitussive agents|mesh-ancestor
110776730|NCT04307940|Respiratory System Agents|respiratory system agents|mesh-ancestor
110776731|NCT02717416|Hemostatics|hemostatics|mesh-list
110776732|NCT02717416|Coagulants|coagulants|mesh-ancestor
110776733|NCT02054104|Celecoxib|celecoxib|mesh-list
110776734|NCT02054104|Cyclophosphamide|cyclophosphamide|mesh-list
110776735|NCT02054104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110776736|NCT02054104|Immunologic Factors|immunologic factors|mesh-ancestor
110776737|NCT02054104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110776738|NCT02054104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110776739|NCT02054104|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110776740|NCT02054104|Alkylating Agents|alkylating agents|mesh-ancestor
110776741|NCT02054104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110776742|NCT02054104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110776743|NCT02054104|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110776744|NCT02054104|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110776745|NCT02054104|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110776746|NCT02054104|Analgesics|analgesics|mesh-ancestor
110776748|NCT02054104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110776749|NCT02054104|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110776750|NCT02054104|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110776751|NCT02054104|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110776752|NCT02054104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110776753|NCT04331704|Tenofovir|tenofovir|mesh-list
110776754|NCT04331704|Emtricitabine|emtricitabine|mesh-list
110776755|NCT04331704|Antiviral Agents|antiviral agents|mesh-ancestor
110776756|NCT04331704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110848312|NCT01187615|Cisplatin|cisplatin|mesh-list
110776758|NCT04331704|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110776759|NCT04331704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110776760|NCT04331704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110776761|NCT04331704|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110776762|NCT04331704|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110776763|NCT04229290|Dolutegravir|dolutegravir|mesh-list
110776764|NCT04229290|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110776765|NCT04229290|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110776766|NCT04229290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110776767|NCT04229290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110776768|NCT04229290|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110776769|NCT04229290|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110776770|NCT04229290|Antiviral Agents|antiviral agents|mesh-ancestor
110776771|NCT04229290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110776772|NCT04181476|Sunscreening Agents|sunscreening agents|mesh-list
110776773|NCT04181476|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110776774|NCT04181476|Protective Agents|protective agents|mesh-ancestor
110776775|NCT04181476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110776776|NCT04181476|Dermatologic Agents|dermatologic agents|mesh-ancestor
110776777|NCT03855046|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
110776778|NCT03855046|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110776779|NCT03855046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110776785|NCT03855046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110776791|NCT04292730|Remdesivir|remdesivir|mesh-list
110776792|NCT04292730|Antimetabolites|antimetabolites|mesh-ancestor
110776793|NCT04292730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110776794|NCT04292730|Antiviral Agents|antiviral agents|mesh-ancestor
110776795|NCT04292730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110776796|NCT02861014|Ocrelizumab|ocrelizumab|mesh-list
110776797|NCT02861014|Immunologic Factors|immunologic factors|mesh-ancestor
110776798|NCT02861014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110776799|NCT04382586|Zanubrutinib|zanubrutinib|mesh-list
110776800|NCT04382586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110776801|NCT04382586|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110776802|NCT04382586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110776803|NCT04382586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110776804|NCT02737306|Leronlimab|leronlimab|mesh-list
110776805|NCT02737306|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110492977|NCT04935034|Vitamins|vitamins|mesh-ancestor
110776806|NCT02737306|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110776807|NCT02737306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110776808|NCT02737306|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110776809|NCT02737306|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110776810|NCT02737306|Antiviral Agents|antiviral agents|mesh-ancestor
110776811|NCT02737306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110776812|NCT02728648|Oxycodone|oxycodone|mesh-list
110776813|NCT02728648|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110776814|NCT02728648|Narcotics|narcotics|mesh-ancestor
110776815|NCT02728648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110776816|NCT02728648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110776817|NCT02728648|Analgesics|analgesics|mesh-ancestor
110776818|NCT02728648|Sensory System Agents|sensory system agents|mesh-ancestor
110848354|NCT05352321|Gemcitabine|gemcitabine|mesh-list
110776819|NCT02728648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110776820|NCT01971970|Adalimumab|adalimumab|mesh-list
110776821|NCT01971970|Infliximab|infliximab|mesh-list
110776822|NCT01971970|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110776823|NCT01971970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110776824|NCT01971970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110776825|NCT01971970|Dermatologic Agents|dermatologic agents|mesh-ancestor
110776826|NCT01971970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110776827|NCT01161394|Pioglitazone|pioglitazone|mesh-list
110776828|NCT01161394|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110776829|NCT01161394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110776830|NCT04079790|Gepotidacin|gepotidacin|mesh-list
110776831|NCT04079790|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110776832|NCT04079790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110776833|NCT04079790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110776834|NCT04079790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110776835|NCT03749226|Aztreonam|aztreonam|mesh-list
110776836|NCT03749226|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110776837|NCT03749226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110776838|NCT04259346|Ixekizumab|ixekizumab|mesh-list
110776839|NCT04259346|Dermatologic Agents|dermatologic agents|mesh-ancestor
110776840|NCT03748836|ALPN-101|alpn-101|mesh-list
110776841|NCT03748836|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110776842|NCT03748836|Immunologic Factors|immunologic factors|mesh-ancestor
110776843|NCT03748836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110776844|NCT01348100|Iloperidone|iloperidone|mesh-list
110776845|NCT01348100|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110776846|NCT01348100|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110776847|NCT01348100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110776848|NCT01348100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110776849|NCT01348100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110776850|NCT03673670|Tiotropium Bromide|tiotropium bromide|mesh-list
110776851|NCT03673670|Olodaterol|olodaterol|mesh-list
110776852|NCT03673670|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110776853|NCT03673670|Autonomic Agents|autonomic agents|mesh-ancestor
110776854|NCT03673670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110776855|NCT03673670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110776856|NCT03673670|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110776857|NCT03673670|Respiratory System Agents|respiratory system agents|mesh-ancestor
110776858|NCT03673670|Parasympatholytics|parasympatholytics|mesh-ancestor
110776859|NCT03673670|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110776860|NCT03673670|Cholinergic Agents|cholinergic agents|mesh-ancestor
110776861|NCT03673670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110776862|NCT03673670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110776863|NCT04369742|Hydroxychloroquine|hydroxychloroquine|mesh-list
110776865|NCT04369742|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110776866|NCT04369742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110776867|NCT04369742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110776868|NCT04369742|Antimalarials|antimalarials|mesh-ancestor
110776869|NCT04369742|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110776870|NCT04369742|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110776871|NCT04369742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110776872|NCT04369742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110776873|NCT04369742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110776874|NCT03745586|Glucocorticoids|glucocorticoids|mesh-list
110776875|NCT03745586|Hormones|hormones|mesh-ancestor
110776876|NCT03745586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110776877|NCT03745586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110776878|NCT03055936|Levodopa|levodopa|mesh-list
110776879|NCT03055936|Carbidopa|carbidopa|mesh-list
110776880|NCT03055936|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110776881|NCT03055936|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110776882|NCT03055936|Dopamine Agents|dopamine agents|mesh-ancestor
110776883|NCT03055936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110776884|NCT03055936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110776885|NCT03055936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110776886|NCT03055936|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
110776887|NCT03055936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110776888|NCT05215366|Arginine Vasopressin|arginine vasopressin|mesh-list
110776889|NCT05215366|Hemostatics|hemostatics|mesh-ancestor
110776890|NCT05215366|Coagulants|coagulants|mesh-ancestor
110776891|NCT05215366|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110776892|NCT05215366|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
110776893|NCT05215366|Natriuretic Agents|natriuretic agents|mesh-ancestor
110776894|NCT05215366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110776895|NCT05201170|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110776896|NCT03891524|Enoxaparin|enoxaparin|mesh-list
110776897|NCT03891524|Anticoagulants|anticoagulants|mesh-ancestor
110776898|NCT03891524|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110776899|NCT03891524|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110776900|NCT03891524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110776901|NCT04695652|Somatomedin B|somatomedin b|mesh-list
110776902|NCT04695652|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
110776903|NCT04695652|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110776904|NCT04695652|Protease Inhibitors|protease inhibitors|mesh-ancestor
110776905|NCT04695652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110776906|NCT04695652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110776907|NCT04489108|Tranexamic Acid|tranexamic acid|mesh-list
110776908|NCT04489108|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110776909|NCT04489108|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110776910|NCT04489108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110776911|NCT04489108|Hemostatics|hemostatics|mesh-ancestor
110776912|NCT04489108|Coagulants|coagulants|mesh-ancestor
110776914|NCT03771586|Analgesics|analgesics|mesh-ancestor
110776915|NCT03771586|Sensory System Agents|sensory system agents|mesh-ancestor
110776916|NCT03771586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110776917|NCT03771586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110776918|NCT03771586|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110776919|NCT03771586|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110776920|NCT03771586|Anesthetics, General|anesthetics, general|mesh-ancestor
110776921|NCT03771586|Anesthetics|anesthetics|mesh-ancestor
110776922|NCT03771586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110776923|NCT03771586|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110776924|NCT03771586|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110776925|NCT03771586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110776926|NCT03771586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110776927|NCT02335060|Acetylcysteine|acetylcysteine|mesh-list
110776928|NCT02335060|Dronabinol|dronabinol|mesh-list
110776929|NCT02335060|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110776930|NCT02335060|Antiviral Agents|antiviral agents|mesh-ancestor
110776931|NCT02335060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110776932|NCT02335060|Expectorants|expectorants|mesh-ancestor
110776933|NCT02335060|Respiratory System Agents|respiratory system agents|mesh-ancestor
110776934|NCT02335060|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110776935|NCT02335060|Antioxidants|antioxidants|mesh-ancestor
110776936|NCT02335060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110776937|NCT02335060|Protective Agents|protective agents|mesh-ancestor
110776938|NCT02335060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110776939|NCT02335060|Antidotes|antidotes|mesh-ancestor
110776940|NCT02335060|Hallucinogens|hallucinogens|mesh-ancestor
110776941|NCT02335060|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110776942|NCT02335060|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110776944|NCT02335060|Sensory System Agents|sensory system agents|mesh-ancestor
110776945|NCT02335060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110776946|NCT02335060|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
110776947|NCT02335060|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110776948|NCT02335060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110776949|NCT02335060|Hormones|hormones|mesh-ancestor
110776950|NCT02335060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110776951|NCT00284986|Remestemcel-l|remestemcel-l|mesh-list
110776952|NCT00284986|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110776953|NCT00284986|Antiviral Agents|antiviral agents|mesh-ancestor
110776954|NCT00284986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110776955|NCT04075604|Nivolumab|nivolumab|mesh-list
110776956|NCT04075604|Palbociclib|palbociclib|mesh-list
110776957|NCT04075604|Anastrozole|anastrozole|mesh-list
110776958|NCT04075604|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110776959|NCT04075604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110776960|NCT04075604|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110776961|NCT04075604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110776962|NCT04075604|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110776963|NCT04075604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110776964|NCT04075604|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110776965|NCT04075604|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110776966|NCT04075604|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110776967|NCT04075604|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110776968|NCT04075604|Hormone Antagonists|hormone antagonists|mesh-ancestor
110776969|NCT04075604|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110776970|NCT04075604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110776971|NCT01765400|Clopidogrel|clopidogrel|mesh-list
110776972|NCT01765400|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
110776973|NCT01765400|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110776974|NCT01765400|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110776975|NCT01765400|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110776976|NCT01765400|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110776977|NCT01765400|Purinergic Agents|purinergic agents|mesh-ancestor
110776978|NCT01765400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110776979|NCT01765400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110776980|NCT01765400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110776981|NCT05217238|Remifentanil|remifentanil|mesh-list
110776982|NCT05217238|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110776983|NCT05217238|Narcotics|narcotics|mesh-ancestor
110776984|NCT05217238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110776985|NCT05217238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110776986|NCT05217238|Analgesics|analgesics|mesh-ancestor
110776987|NCT05217238|Sensory System Agents|sensory system agents|mesh-ancestor
110776988|NCT05217238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110776989|NCT05217160|Morphine|morphine|mesh-list
110776990|NCT05217160|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110776991|NCT05217160|Narcotics|narcotics|mesh-ancestor
110776992|NCT05217160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110776993|NCT05217160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110776994|NCT05217160|Analgesics|analgesics|mesh-ancestor
110776995|NCT05217160|Sensory System Agents|sensory system agents|mesh-ancestor
110776996|NCT05217160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110776997|NCT01495676|Cisplatin|cisplatin|mesh-list
110776998|NCT01495676|Gemcitabine|gemcitabine|mesh-list
110776999|NCT01495676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110777000|NCT01495676|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110777001|NCT01495676|Antimetabolites|antimetabolites|mesh-ancestor
110777002|NCT01495676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110777003|NCT05052970|Dexamethasone|dexamethasone|mesh-list
110777004|NCT05052970|Dexamethasone acetate|dexamethasone acetate|mesh-list
110777005|NCT05052970|Bortezomib|bortezomib|mesh-list
110777007|NCT05052970|BB 1101|bb 1101|mesh-list
110777008|NCT05052970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110777009|NCT05052970|Antiemetics|antiemetics|mesh-ancestor
110777010|NCT05052970|Autonomic Agents|autonomic agents|mesh-ancestor
110777011|NCT05052970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110777012|NCT05052970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110777013|NCT05052970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110777014|NCT05052970|Glucocorticoids|glucocorticoids|mesh-ancestor
110777015|NCT05052970|Hormones|hormones|mesh-ancestor
110777016|NCT05052970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110777017|NCT05052970|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110777018|NCT05052970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110777019|NCT05052970|Protease Inhibitors|protease inhibitors|mesh-ancestor
110777020|NCT05052970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110777021|NCT05052970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110777022|NCT05052970|Analgesics|analgesics|mesh-ancestor
110777023|NCT05052970|Sensory System Agents|sensory system agents|mesh-ancestor
110777024|NCT05052970|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110777025|NCT05052970|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110777026|NCT04903210|Niacinamide|niacinamide|mesh-list
110777027|NCT04903210|Niacin|niacin|mesh-list
110777028|NCT04903210|Nicotinic Acids|nicotinic acids|mesh-list
110777029|NCT04903210|Vitamin B Complex|vitamin b complex|mesh-ancestor
110777030|NCT04903210|Vitamins|vitamins|mesh-ancestor
110777031|NCT04903210|Micronutrients|micronutrients|mesh-ancestor
110777032|NCT04903210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110777033|NCT04903210|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110777034|NCT04903210|Antimetabolites|antimetabolites|mesh-ancestor
110777035|NCT04903210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110777036|NCT04903210|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110777037|NCT04903210|Vasodilator Agents|vasodilator agents|mesh-ancestor
110777038|NCT04719208|Chlorhexidine|chlorhexidine|mesh-list
110777039|NCT04719208|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110777040|NCT04719208|Hydrogen Peroxide|hydrogen peroxide|mesh-list
110777041|NCT04719208|Povidone-Iodine|povidone-iodine|mesh-list
110777042|NCT04719208|Listerine|listerine|mesh-list
110777043|NCT04719208|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110777044|NCT04719208|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110777045|NCT04719208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110777046|NCT04719208|Disinfectants|disinfectants|mesh-ancestor
110777047|NCT04719208|Dermatologic Agents|dermatologic agents|mesh-ancestor
110777048|NCT04701190|Norepinephrine|norepinephrine|mesh-list
110777049|NCT04701190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110777050|NCT04701190|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110777051|NCT04701190|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110777052|NCT04701190|Adrenergic Agents|adrenergic agents|mesh-ancestor
110777053|NCT04701190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110777054|NCT04701190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110777055|NCT04701190|Sympathomimetics|sympathomimetics|mesh-ancestor
110777056|NCT04701190|Autonomic Agents|autonomic agents|mesh-ancestor
110777057|NCT04701190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110777058|NCT04701190|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110777059|NCT04496362|Heparin|heparin|mesh-list
110777060|NCT04496362|Anticoagulants|anticoagulants|mesh-ancestor
110777061|NCT04496362|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110777062|NCT04496362|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110777063|NCT04496362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110777064|NCT04423588|Dexlansoprazole|dexlansoprazole|mesh-list
110777065|NCT04423588|Lansoprazole|lansoprazole|mesh-list
110777066|NCT04423588|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110777067|NCT04423588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110777068|NCT04423588|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110777069|NCT04423588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110777070|NCT04423588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110777071|NCT04090684|Ciprofloxacin|ciprofloxacin|mesh-list
110777072|NCT04090684|Celecoxib|celecoxib|mesh-list
110777073|NCT04090684|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110777074|NCT04090684|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110777075|NCT04090684|Analgesics|analgesics|mesh-ancestor
110777076|NCT04090684|Sensory System Agents|sensory system agents|mesh-ancestor
110777077|NCT04090684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110777078|NCT04090684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110777079|NCT04090684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110777080|NCT04090684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110777081|NCT04090684|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110777082|NCT04090684|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110777083|NCT04090684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110777084|NCT04090684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110777085|NCT04090684|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110777086|NCT04090684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110777087|NCT04090684|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110777088|NCT04090684|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110777089|NCT04090684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110777090|NCT04090684|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110777091|NCT04090684|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110848550|NCT03729505|Magnesium Sulfate|magnesium sulfate|mesh-list
110777093|NCT04963816|Dexamethasone acetate|dexamethasone acetate|mesh-list
110777094|NCT04963816|Bupivacaine|bupivacaine|mesh-list
110777095|NCT04963816|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110777096|NCT04963816|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
110777097|NCT04963816|BB 1101|bb 1101|mesh-list
110777098|NCT04963816|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110777099|NCT04963816|Antiemetics|antiemetics|mesh-ancestor
110777100|NCT04963816|Autonomic Agents|autonomic agents|mesh-ancestor
110777101|NCT04963816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110777102|NCT04963816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110777103|NCT04963816|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110777104|NCT04963816|Glucocorticoids|glucocorticoids|mesh-ancestor
110777105|NCT04963816|Hormones|hormones|mesh-ancestor
110777106|NCT04963816|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110777107|NCT04963816|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110777108|NCT04963816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110777109|NCT04963816|Protease Inhibitors|protease inhibitors|mesh-ancestor
110777110|NCT04963816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110777111|NCT04963816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110777112|NCT04963816|Anesthetics, Local|anesthetics, local|mesh-ancestor
110777113|NCT04963816|Anesthetics|anesthetics|mesh-ancestor
110777114|NCT04963816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110777115|NCT04963816|Sensory System Agents|sensory system agents|mesh-ancestor
110777116|NCT04933240|Tamoxifen|tamoxifen|mesh-list
110777117|NCT04933240|Estradiol|estradiol|mesh-list
110777118|NCT04933240|Estrogens|estrogens|mesh-ancestor
110777119|NCT04933240|Hormones|hormones|mesh-ancestor
110777120|NCT04933240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110777121|NCT04933240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110777122|NCT04933240|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110777123|NCT04933240|Hormone Antagonists|hormone antagonists|mesh-ancestor
110777124|NCT04933240|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110777125|NCT04933240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110777126|NCT04933240|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110777127|NCT04933240|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110777128|NCT04933240|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110777129|NCT01317940|Calcium, Dietary|calcium, dietary|mesh-list
110777130|NCT01317940|Vitamin D|vitamin d|mesh-list
110777131|NCT01317940|Calcitriol|calcitriol|mesh-list
110777132|NCT01317940|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
110777133|NCT01317940|Calcium Carbonate|calcium carbonate|mesh-list
110777134|NCT01317940|Calcium|calcium|mesh-list
110777135|NCT01317940|Vitamins|vitamins|mesh-ancestor
110777136|NCT01317940|Micronutrients|micronutrients|mesh-ancestor
110777137|NCT01317940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110777138|NCT01317940|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110777139|NCT01317940|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110777140|NCT01317940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110777141|NCT01317940|Antacids|antacids|mesh-ancestor
110777142|NCT01317940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110777143|NCT01317940|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
110777144|NCT01317940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110777145|NCT01317940|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110777146|NCT05706688|Anesthetics|anesthetics|mesh-list
110777147|NCT05706688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110777148|NCT05706688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110777149|NCT05706454|Ramatroban|ramatroban|mesh-list
110777150|NCT05706454|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110777151|NCT01317550|Minocycline|minocycline|mesh-list
110777152|NCT01317550|Modafinil|modafinil|mesh-list
110777153|NCT01317550|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110777154|NCT01317550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110777155|NCT01317550|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110777156|NCT01317550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110777157|NCT01317550|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
110777158|NCT01317550|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110777159|NCT01317550|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110777160|NCT01317550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110777162|NCT01317472|Lansoprazole|lansoprazole|mesh-list
110777163|NCT01317472|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110777164|NCT01317472|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110777165|NCT01317472|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110777166|NCT01317472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110777167|NCT01317472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110777168|NCT01345630|Ritonavir|ritonavir|mesh-list
110777169|NCT01345630|Darunavir|darunavir|mesh-list
110777170|NCT01345630|Tenofovir|tenofovir|mesh-list
110777171|NCT01345630|Emtricitabine|emtricitabine|mesh-list
110777172|NCT01345630|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110777173|NCT01345630|Maraviroc|maraviroc|mesh-list
110777174|NCT01345630|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110777175|NCT01345630|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110777176|NCT01345630|Protease Inhibitors|protease inhibitors|mesh-ancestor
110777177|NCT01345630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110777178|NCT01345630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110777179|NCT01345630|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110777180|NCT01345630|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110848594|NCT01193855|Dutasteride|dutasteride|mesh-list
110777181|NCT01345630|Antiviral Agents|antiviral agents|mesh-ancestor
110777182|NCT01345630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110777183|NCT01345630|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110777184|NCT01345630|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110777185|NCT01345630|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110777186|NCT01345630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110777187|NCT01345630|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110777188|NCT01345630|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110777189|NCT01345630|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
110777190|NCT03693612|Paclitaxel|paclitaxel|mesh-list
110777191|NCT03693612|Docetaxel|docetaxel|mesh-list
110777192|NCT03693612|Cetuximab|cetuximab|mesh-list
110777193|NCT03693612|Tremelimumab|tremelimumab|mesh-list
110777194|NCT03693612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110777195|NCT03693612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110777196|NCT03693612|Tubulin Modulators|tubulin modulators|mesh-ancestor
110777197|NCT03693612|Antimitotic Agents|antimitotic agents|mesh-ancestor
110777198|NCT03693612|Mitosis Modulators|mitosis modulators|mesh-ancestor
110777199|NCT03693612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110777200|NCT03693612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110777201|NCT03746652|Dexamethasone|dexamethasone|mesh-list
110777202|NCT03746652|Daratumumab|daratumumab|mesh-list
110777203|NCT03746652|Ixazomib|ixazomib|mesh-list
110777204|NCT03746652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110777205|NCT03746652|Antiemetics|antiemetics|mesh-ancestor
110777206|NCT03746652|Autonomic Agents|autonomic agents|mesh-ancestor
110777207|NCT03746652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110777208|NCT03746652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110777209|NCT03746652|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110777210|NCT03746652|Glucocorticoids|glucocorticoids|mesh-ancestor
110777211|NCT03746652|Hormones|hormones|mesh-ancestor
110445891|NCT02770378|Hormone Antagonists|hormone antagonists|mesh-ancestor
110777212|NCT03746652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110777213|NCT03746652|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110777214|NCT03746652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110777215|NCT03746652|Protease Inhibitors|protease inhibitors|mesh-ancestor
110777216|NCT03746652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110777217|NCT03746652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110777218|NCT01562808|Aripiprazole|aripiprazole|mesh-list
110777219|NCT01562808|Antidepressive Agents|antidepressive agents|mesh-ancestor
110777220|NCT01562808|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110777221|NCT01562808|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110777222|NCT01562808|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110777223|NCT01562808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110777224|NCT01562808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110777225|NCT01562808|Dopamine Agonists|dopamine agonists|mesh-ancestor
110777226|NCT01562808|Dopamine Agents|dopamine agents|mesh-ancestor
110777227|NCT01562808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110777228|NCT01562808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110777229|NCT01562808|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110777230|NCT01562808|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110777231|NCT01562808|Serotonin Agents|serotonin agents|mesh-ancestor
110777232|NCT01562808|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110777233|NCT01562808|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110777234|NCT01562808|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110777235|NCT01562808|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110777236|NCT04051944|Rozanolixizumab|rozanolixizumab|mesh-list
110777237|NCT04051944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110777238|NCT04051944|Immunologic Factors|immunologic factors|mesh-ancestor
110777239|NCT04051944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110777240|NCT04067492|Diclofenac|diclofenac|mesh-list
110848621|NCT02729896|Immunoconjugates|immunoconjugates|mesh-ancestor
110777241|NCT04067492|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110777242|NCT04067492|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110777243|NCT04067492|Analgesics|analgesics|mesh-ancestor
110777244|NCT04067492|Sensory System Agents|sensory system agents|mesh-ancestor
110777245|NCT04067492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110777246|NCT04067492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110777247|NCT04067492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110777248|NCT04067492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110777249|NCT04067492|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110777250|NCT04067492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110777251|NCT04067492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110777252|NCT04186806|Muramidase|muramidase|mesh-list
110777253|NCT04186806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110777254|NCT03748446|Xenon|xenon|mesh-list
110777255|NCT03748446|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110777256|NCT03748446|Anesthetics, General|anesthetics, general|mesh-ancestor
110777257|NCT03748446|Anesthetics|anesthetics|mesh-ancestor
110777258|NCT03748446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110777259|NCT03748446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110777260|NCT04036110|Vitamins|vitamins|mesh-list
110777261|NCT04036110|Ascorbic Acid|ascorbic acid|mesh-list
110777262|NCT04036110|Micronutrients|micronutrients|mesh-ancestor
110777263|NCT04036110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110777264|NCT04036110|Antioxidants|antioxidants|mesh-ancestor
110777265|NCT04036110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110777266|NCT04036110|Protective Agents|protective agents|mesh-ancestor
110777267|NCT03053050|Selonsertib|selonsertib|mesh-list
110777268|NCT03053050|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110777269|NCT03053050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110777270|NCT03053050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110777271|NCT04369950|Lidocaine|lidocaine|mesh-list
110777272|NCT04369950|Epinephrine|epinephrine|mesh-list
110777273|NCT04369950|Morphine|morphine|mesh-list
110777274|NCT04369950|Chloroprocaine|chloroprocaine|mesh-list
110777275|NCT04369950|Anesthetics, Local|anesthetics, local|mesh-ancestor
110777276|NCT04369950|Anesthetics|anesthetics|mesh-ancestor
110777277|NCT04369950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110777278|NCT04369950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110777279|NCT04369950|Sensory System Agents|sensory system agents|mesh-ancestor
110777280|NCT04369950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110777281|NCT04369950|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110777282|NCT04369950|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110777283|NCT04369950|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110777284|NCT04369950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110777285|NCT04369950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110777286|NCT04369950|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110777288|NCT04369950|Analgesics|analgesics|mesh-ancestor
110777289|NCT04369950|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110777290|NCT04369950|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110777291|NCT04369950|Adrenergic Agents|adrenergic agents|mesh-ancestor
110777292|NCT04369950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110777293|NCT04369950|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110777294|NCT04369950|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110777295|NCT04369950|Autonomic Agents|autonomic agents|mesh-ancestor
110777296|NCT04369950|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110777297|NCT04369950|Respiratory System Agents|respiratory system agents|mesh-ancestor
110777298|NCT04369950|Mydriatics|mydriatics|mesh-ancestor
110777299|NCT04369950|Sympathomimetics|sympathomimetics|mesh-ancestor
110777300|NCT04369950|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110777301|NCT02955602|Seladelpar|seladelpar|mesh-list
110777302|NCT02955602|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110777303|NCT02955602|Antimetabolites|antimetabolites|mesh-ancestor
110777304|NCT02955602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110777305|NCT02955602|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110777306|NCT03748290|Pregabalin|pregabalin|mesh-list
110777307|NCT03748290|Analgesics|analgesics|mesh-ancestor
110777308|NCT03748290|Sensory System Agents|sensory system agents|mesh-ancestor
110777309|NCT03748290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110777310|NCT03748290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110777311|NCT03748290|Anticonvulsants|anticonvulsants|mesh-ancestor
110777312|NCT03748290|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110777313|NCT03748290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110777314|NCT03748290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110777315|NCT03748290|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110777316|NCT03748290|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110777317|NCT03748290|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110777318|NCT03748290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110777319|NCT03748290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110777320|NCT05651074|Omeprazole|omeprazole|mesh-list
110777321|NCT05651074|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110777322|NCT05651074|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110777323|NCT05651074|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110777324|NCT05651074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110777325|NCT05651074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110777326|NCT03738956|Tofacitinib|tofacitinib|mesh-list
110777327|NCT03738956|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
110777328|NCT03738956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110777329|NCT03738956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110777330|NCT03738956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110777331|NCT05609656|Pembrolizumab|pembrolizumab|mesh-list
110777332|NCT05609656|Calcium|calcium|mesh-list
110777333|NCT05609656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110777334|NCT05609656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110777335|NCT05609656|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110777336|NCT05609656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110777337|NCT05609656|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110777338|NCT05609656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110777339|NCT04175808|Moxifloxacin|moxifloxacin|mesh-list
110777340|NCT04175808|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110777341|NCT04175808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110777342|NCT04175808|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110777343|NCT04175808|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110777344|NCT04175808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110777345|NCT04175808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110777346|NCT04175808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110777347|NCT05598424|Methylprednisolone|methylprednisolone|mesh-list
110777348|NCT05598424|Glucocorticoids|glucocorticoids|mesh-list
110777349|NCT05598424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110777350|NCT05598424|Antiemetics|antiemetics|mesh-ancestor
110777351|NCT05598424|Autonomic Agents|autonomic agents|mesh-ancestor
110777352|NCT05598424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110777353|NCT05598424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110777354|NCT05598424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110777355|NCT05598424|Hormones|hormones|mesh-ancestor
110777356|NCT05598424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110777357|NCT05598424|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110777358|NCT05598424|Protective Agents|protective agents|mesh-ancestor
110777359|NCT05501860|Carticaine|carticaine|mesh-list
110777360|NCT05501860|Anesthetics, Local|anesthetics, local|mesh-ancestor
110777361|NCT05501860|Anesthetics|anesthetics|mesh-ancestor
110777362|NCT05501860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110777363|NCT05501860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110777364|NCT05501860|Sensory System Agents|sensory system agents|mesh-ancestor
110777365|NCT05501860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110777366|NCT03738176|Triamcinolone|triamcinolone|mesh-list
110777367|NCT03738176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110777368|NCT03738176|Glucocorticoids|glucocorticoids|mesh-ancestor
110777369|NCT03738176|Hormones|hormones|mesh-ancestor
110848675|NCT03847571|Natriuretic Agents|natriuretic agents|mesh-ancestor
110777370|NCT03738176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110777371|NCT03738176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110777372|NCT03051100|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
110777373|NCT03051100|Atorvastatin|atorvastatin|mesh-list
110777374|NCT03051100|Ezetimibe|ezetimibe|mesh-list
110777375|NCT03051100|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110777376|NCT03051100|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110777377|NCT03051100|Antimetabolites|antimetabolites|mesh-ancestor
110777378|NCT03051100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110777379|NCT03051100|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110777380|NCT03051100|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110777381|NCT03051100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110777382|NCT03051100|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110777383|NCT03051100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110777384|NCT05280028|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
110777386|NCT05280028|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110777387|NCT05280028|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110777388|NCT05280028|Medroxyprogesterone|medroxyprogesterone|mesh-list
110777389|NCT05280028|Estradiol|estradiol|mesh-list
110777390|NCT05280028|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110777391|NCT05280028|Estrogens|estrogens|mesh-ancestor
110777392|NCT05280028|Hormones|hormones|mesh-ancestor
110777393|NCT05280028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110777394|NCT05280028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110777395|NCT05280028|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110777396|NCT05280028|Contraceptive Agents|contraceptive agents|mesh-ancestor
110777397|NCT05280028|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110777398|NCT05280028|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110777399|NCT05280028|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110777400|NCT05280028|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110777401|NCT05280028|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110777402|NCT05280028|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110777403|NCT05280028|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110777404|NCT05280028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110777405|NCT05280028|Androgen Antagonists|androgen antagonists|mesh-ancestor
110777406|NCT05280028|Hormone Antagonists|hormone antagonists|mesh-ancestor
110777407|NCT05280028|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110777408|NCT05280028|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110777409|NCT05280028|Anabolic Agents|anabolic agents|mesh-ancestor
110777410|NCT05569876|Hypoglycemic Agents|hypoglycemic agents|mesh-list
110777411|NCT05569876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110777412|NCT01343368|Leuprolide|leuprolide|mesh-list
110777413|NCT01343368|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110777414|NCT01343368|Fertility Agents|fertility agents|mesh-ancestor
110777415|NCT01343368|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110777416|NCT01343368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110777417|NCT01343368|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110777418|NCT01343368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110777419|NCT02955212|Upadacitinib|upadacitinib|mesh-list
110777420|NCT02955212|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
110777421|NCT02955212|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110777422|NCT02955212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110777423|NCT02955212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110777424|NCT02955212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110777425|NCT03050398|Letrozole|letrozole|mesh-list
110777426|NCT03050398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110777427|NCT03050398|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110777428|NCT03050398|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110777429|NCT03050398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110777430|NCT03050398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110777431|NCT03050398|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110777432|NCT03050398|Hormone Antagonists|hormone antagonists|mesh-ancestor
110777433|NCT03050398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110777434|NCT03050398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110777436|NCT03626506|Indapamide|indapamide|mesh-list
110777437|NCT03626506|Spironolactone|spironolactone|mesh-list
110777438|NCT03626506|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110777439|NCT03626506|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110777440|NCT03626506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110777441|NCT03626506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110777442|NCT03626506|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110777443|NCT03626506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110777444|NCT03626506|Vasodilator Agents|vasodilator agents|mesh-ancestor
110777445|NCT03626506|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110777446|NCT03626506|Hormone Antagonists|hormone antagonists|mesh-ancestor
110777447|NCT03626506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110777448|NCT03626506|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110777449|NCT03626506|Diuretics|diuretics|mesh-ancestor
110777450|NCT03626506|Natriuretic Agents|natriuretic agents|mesh-ancestor
110777451|NCT03626506|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110777452|NCT03737708|Adalimumab|adalimumab|mesh-list
110777453|NCT03737708|Methotrexate|methotrexate|mesh-list
110777454|NCT03737708|Abatacept|abatacept|mesh-list
110777455|NCT03737708|Tacrolimus|tacrolimus|mesh-list
110777456|NCT03737708|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110777457|NCT03737708|Abortifacient Agents|abortifacient agents|mesh-ancestor
110777458|NCT03737708|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110777459|NCT03737708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110777460|NCT03737708|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110777461|NCT03737708|Antimetabolites|antimetabolites|mesh-ancestor
110777462|NCT03737708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110777463|NCT03737708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110777464|NCT03737708|Dermatologic Agents|dermatologic agents|mesh-ancestor
110777465|NCT03737708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110777466|NCT03737708|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110777467|NCT03737708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110777468|NCT03737708|Immunologic Factors|immunologic factors|mesh-ancestor
110777469|NCT03737708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110777470|NCT03737708|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110777471|NCT03737708|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110777472|NCT03737708|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110777473|NCT03737708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110777474|NCT03737708|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110777475|NCT03737708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110777477|NCT05517928|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110777478|NCT05517928|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110777479|NCT05517928|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110777480|NCT05517928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110777481|NCT05517928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110777483|NCT04052204|Talazoparib|talazoparib|mesh-list
110777484|NCT04052204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110777485|NCT04052204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110777486|NCT04052204|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110777487|NCT04052204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110777488|NCT04052204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110777489|NCT04050722|Listerine|listerine|mesh-list
110777490|NCT04050722|Sodium Fluoride|sodium fluoride|mesh-list
110777491|NCT04050722|Cariostatic Agents|cariostatic agents|mesh-ancestor
110777492|NCT04050722|Protective Agents|protective agents|mesh-ancestor
110777493|NCT04050722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110777494|NCT04050722|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110777495|NCT04050722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110777496|NCT04049552|Sirolimus|sirolimus|mesh-list
110777497|NCT04049552|Temsirolimus|temsirolimus|mesh-list
110777498|NCT04049552|MTOR Inhibitors|mtor inhibitors|mesh-list
110777499|NCT04049552|Petrolatum|petrolatum|mesh-list
110777500|NCT04049552|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110777501|NCT04049552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110777502|NCT04049552|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110777503|NCT04049552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110777504|NCT04049552|Antifungal Agents|antifungal agents|mesh-ancestor
110777505|NCT04049552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110777506|NCT04049552|Immunologic Factors|immunologic factors|mesh-ancestor
110848778|NCT01296503|Glucocorticoids|glucocorticoids|mesh-ancestor
110777507|NCT04049552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110777508|NCT04049552|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110777509|NCT04049552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110777510|NCT04049552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110777511|NCT04049552|Emollients|emollients|mesh-ancestor
110777512|NCT04049552|Dermatologic Agents|dermatologic agents|mesh-ancestor
110777513|NCT03737474|Brexpiprazole|brexpiprazole|mesh-list
110777514|NCT03737474|Serotonin Agents|serotonin agents|mesh-ancestor
110777515|NCT03737474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110777516|NCT03737474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110777517|NCT03737474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110777518|NCT03737474|Dopamine Agonists|dopamine agonists|mesh-ancestor
110777519|NCT03737474|Dopamine Agents|dopamine agents|mesh-ancestor
110777520|NCT03048058|Brimonidine Tartrate|brimonidine tartrate|mesh-list
110777521|NCT03048058|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110777522|NCT03048058|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110777523|NCT03048058|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110777524|NCT03048058|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110777525|NCT03048058|Adrenergic Agents|adrenergic agents|mesh-ancestor
110777526|NCT03048058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110777527|NCT03048058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110777528|NCT03048058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110777529|NCT03047980|Sirolimus|sirolimus|mesh-list
110777530|NCT03047980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110777531|NCT03047980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110777532|NCT03047980|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110777533|NCT03047980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110777534|NCT03047980|Antifungal Agents|antifungal agents|mesh-ancestor
110777535|NCT03047980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110777536|NCT03047980|Immunologic Factors|immunologic factors|mesh-ancestor
110777537|NCT03047980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110777538|NCT03876028|Tisagenlecleucel|tisagenlecleucel|mesh-list
110777539|NCT03876028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110777540|NCT03876028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110777541|NCT03732482|Temozolomide|temozolomide|mesh-list
110848815|NCT01426529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110777542|NCT03732482|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110777543|NCT03732482|Alkylating Agents|alkylating agents|mesh-ancestor
110777544|NCT03732482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110777545|NCT03732482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110777546|NCT04047446|Dexamethasone|dexamethasone|mesh-list
110777547|NCT04047446|Bupivacaine|bupivacaine|mesh-list
110777548|NCT04047446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110777549|NCT04047446|Antiemetics|antiemetics|mesh-ancestor
110777550|NCT04047446|Autonomic Agents|autonomic agents|mesh-ancestor
110777551|NCT04047446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110777552|NCT04047446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110777553|NCT04047446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110777554|NCT04047446|Glucocorticoids|glucocorticoids|mesh-ancestor
110777556|NCT04047446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110777557|NCT04047446|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110777558|NCT04047446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110777559|NCT04047446|Anesthetics, Local|anesthetics, local|mesh-ancestor
110777560|NCT04047446|Anesthetics|anesthetics|mesh-ancestor
110777561|NCT04047446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110777562|NCT04047446|Sensory System Agents|sensory system agents|mesh-ancestor
110777564|NCT03629054|Empagliflozin|empagliflozin|mesh-list
110777565|NCT03629054|Linagliptin|linagliptin|mesh-list
110777566|NCT03629054|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110777567|NCT03629054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110777568|NCT03629054|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110777569|NCT03629054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110777570|NCT03629054|Incretins|incretins|mesh-ancestor
110777571|NCT03629054|Hormones|hormones|mesh-ancestor
110777572|NCT03629054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110777573|NCT03629054|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110777574|NCT03629054|Protease Inhibitors|protease inhibitors|mesh-ancestor
110777575|NCT03629054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110777576|NCT02754856|Durvalumab|durvalumab|mesh-list
110777577|NCT02754856|Ipilimumab|ipilimumab|mesh-list
110777578|NCT02754856|Tremelimumab|tremelimumab|mesh-list
110777579|NCT02754856|Immunoglobulins|immunoglobulins|mesh-list
110777580|NCT02754856|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110777581|NCT02754856|Immunoglobulin G|immunoglobulin g|mesh-list
110777582|NCT02754856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110777583|NCT02754856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110777584|NCT02754856|Immunologic Factors|immunologic factors|mesh-ancestor
110777585|NCT02754856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110777586|NCT02754856|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110777587|NCT02754856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110777589|NCT02573896|Dinutuximab|dinutuximab|mesh-list
110777590|NCT02573896|Immunologic Factors|immunologic factors|mesh-ancestor
110777591|NCT02573896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110777592|NCT02573896|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110777593|NCT02573896|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110777594|NCT02573896|Growth Substances|growth substances|mesh-ancestor
110777595|NCT02573896|Growth Inhibitors|growth inhibitors|mesh-ancestor
110777596|NCT02573896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110777597|NCT03045328|Venetoclax|venetoclax|mesh-list
110777598|NCT03045328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110777599|NCT02154490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110777600|NCT02154490|Nivolumab|nivolumab|mesh-list
110777601|NCT02154490|Ipilimumab|ipilimumab|mesh-list
110777602|NCT02154490|Durvalumab|durvalumab|mesh-list
110777603|NCT02154490|Rilotumumab|rilotumumab|mesh-list
110495249|NCT00767221|Hormones|hormones|mesh-ancestor
110777604|NCT02154490|Docetaxel|docetaxel|mesh-list
110777606|NCT02154490|Palbociclib|palbociclib|mesh-list
110777607|NCT02154490|Tremelimumab|tremelimumab|mesh-list
110777608|NCT02154490|Talazoparib|talazoparib|mesh-list
110777609|NCT02154490|Antibodies|antibodies|mesh-list
110777610|NCT02154490|Immunoglobulins|immunoglobulins|mesh-list
110777611|NCT02154490|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110777612|NCT02154490|Immunoglobulin G|immunoglobulin g|mesh-list
110777613|NCT02154490|Immunologic Factors|immunologic factors|mesh-ancestor
110777614|NCT02154490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110777615|NCT02154490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110777616|NCT02154490|Tubulin Modulators|tubulin modulators|mesh-ancestor
110777617|NCT02154490|Antimitotic Agents|antimitotic agents|mesh-ancestor
110777618|NCT02154490|Mitosis Modulators|mitosis modulators|mesh-ancestor
110777619|NCT02154490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110777620|NCT02154490|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110777621|NCT02154490|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110777622|NCT02154490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110777623|NCT02154490|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110777624|NCT01512316|Cycloserine|cycloserine|mesh-list
110777625|NCT01512316|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110777626|NCT01512316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110777627|NCT01512316|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110777628|NCT01512316|Antitubercular Agents|antitubercular agents|mesh-ancestor
110777629|NCT01512316|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110777630|NCT01512316|Antimetabolites|antimetabolites|mesh-ancestor
110777631|NCT01512316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110777632|NCT03639740|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110777633|NCT03639740|Immunologic Factors|immunologic factors|mesh-ancestor
110777634|NCT03639740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110777635|NCT01048138|Biperiden|biperiden|mesh-list
110777636|NCT01048138|Biperiden lactate|biperiden lactate|mesh-list
110777637|NCT01048138|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110777638|NCT01048138|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110777639|NCT01048138|Parasympatholytics|parasympatholytics|mesh-ancestor
110777640|NCT01048138|Autonomic Agents|autonomic agents|mesh-ancestor
110777641|NCT01048138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110777642|NCT01048138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110777643|NCT01048138|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110777644|NCT01048138|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110777645|NCT01048138|Cholinergic Agents|cholinergic agents|mesh-ancestor
110777646|NCT01048138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110777647|NCT01048138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110777648|NCT00972478|Prednisone|prednisone|mesh-list
110777649|NCT00972478|Cortisone|cortisone|mesh-list
110777650|NCT00972478|Cyclophosphamide|cyclophosphamide|mesh-list
110777651|NCT00972478|Rituximab|rituximab|mesh-list
110777652|NCT00972478|Doxorubicin|doxorubicin|mesh-list
110777653|NCT00972478|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110777654|NCT00972478|Vincristine|vincristine|mesh-list
110777655|NCT00972478|Vorinostat|vorinostat|mesh-list
110777656|NCT00972478|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110777657|NCT00972478|Antibodies|antibodies|mesh-list
110777658|NCT00972478|Immunoglobulins|immunoglobulins|mesh-list
110777659|NCT00972478|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110777660|NCT00972478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110777661|NCT00972478|Immunologic Factors|immunologic factors|mesh-ancestor
110777662|NCT00972478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110777664|NCT00972478|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110777665|NCT00972478|Alkylating Agents|alkylating agents|mesh-ancestor
110777666|NCT00972478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110493101|NCT04049227|Letrozole|letrozole|mesh-list
110777667|NCT00972478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110777668|NCT00972478|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110777669|NCT00972478|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110777670|NCT00972478|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110777671|NCT00972478|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110777672|NCT00972478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110777673|NCT00972478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110777674|NCT00972478|Glucocorticoids|glucocorticoids|mesh-ancestor
110777676|NCT00972478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110777677|NCT00972478|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110777678|NCT00972478|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110777679|NCT00972478|Tubulin Modulators|tubulin modulators|mesh-ancestor
110777680|NCT00972478|Antimitotic Agents|antimitotic agents|mesh-ancestor
110777681|NCT00972478|Mitosis Modulators|mitosis modulators|mesh-ancestor
110777682|NCT00972478|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110777683|NCT00823342|Tenofovir|tenofovir|mesh-list
110777684|NCT00823342|Clevudine|clevudine|mesh-list
110777685|NCT00823342|Antiviral Agents|antiviral agents|mesh-ancestor
110777686|NCT00823342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110777687|NCT00823342|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110777688|NCT00823342|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110777689|NCT00823342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110777690|NCT00823342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110777691|NCT00823342|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110777692|NCT00823342|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110777693|NCT01082445|Acetylcysteine|acetylcysteine|mesh-list
110777694|NCT01082445|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110777695|NCT01082445|Antiviral Agents|antiviral agents|mesh-ancestor
110777696|NCT01082445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110777697|NCT01082445|Expectorants|expectorants|mesh-ancestor
110777698|NCT01082445|Respiratory System Agents|respiratory system agents|mesh-ancestor
110777699|NCT01082445|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110777700|NCT01082445|Antioxidants|antioxidants|mesh-ancestor
110777701|NCT01082445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110777702|NCT01082445|Protective Agents|protective agents|mesh-ancestor
110777703|NCT01082445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110777704|NCT01082445|Antidotes|antidotes|mesh-ancestor
110777705|NCT01085877|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110777706|NCT01085877|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110777707|NCT01085877|Estradiol|estradiol|mesh-list
110777708|NCT01085877|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110777709|NCT01085877|Estrogens|estrogens|mesh-ancestor
110777710|NCT01085877|Hormones|hormones|mesh-ancestor
110777711|NCT01085877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110777712|NCT01085877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110777713|NCT01085877|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110777714|NCT01085877|Contraceptive Agents|contraceptive agents|mesh-ancestor
110777715|NCT01085877|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110777716|NCT01085877|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110777717|NCT01089855|Carbamazepine|carbamazepine|mesh-list
110777718|NCT01089855|Anticonvulsants|anticonvulsants|mesh-ancestor
110777719|NCT01089855|Antimanic Agents|antimanic agents|mesh-ancestor
110777720|NCT01089855|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110777721|NCT01089855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110777722|NCT01089855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110777723|NCT01089855|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110777724|NCT01089855|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110777726|NCT01089855|Sensory System Agents|sensory system agents|mesh-ancestor
110777727|NCT01089855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110777728|NCT01089855|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110777729|NCT01089855|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110777730|NCT01089855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110777731|NCT01089855|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110777732|NCT01089855|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110777733|NCT04132960|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
110777734|NCT04132960|Immunoconjugates|immunoconjugates|mesh-ancestor
110777735|NCT04132960|Immunologic Factors|immunologic factors|mesh-ancestor
110102783|NCT01767610|Infliximab|infliximab|mesh-list
110777736|NCT04132960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110777737|NCT03980314|Nivolumab|nivolumab|mesh-list
110777738|NCT03980314|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110777739|NCT03980314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110777740|NCT03980314|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110777741|NCT03980314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110777742|NCT03674320|Methyltestosterone|methyltestosterone|mesh-list
110777743|NCT03674320|Testosterone|testosterone|mesh-list
110777744|NCT03674320|Testosterone undecanoate|testosterone undecanoate|mesh-list
110777745|NCT03674320|Testosterone enanthate|testosterone enanthate|mesh-list
110777746|NCT03674320|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
110777747|NCT03674320|Androgens|androgens|mesh-ancestor
110777748|NCT03674320|Hormones|hormones|mesh-ancestor
110777749|NCT03674320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110777750|NCT03674320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110777751|NCT03674320|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110777752|NCT03674320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110777753|NCT03674320|Anabolic Agents|anabolic agents|mesh-ancestor
110777754|NCT05457946|Vaccines|vaccines|mesh-list
110777755|NCT05457946|Immunologic Factors|immunologic factors|mesh-ancestor
110777756|NCT05457946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110777757|NCT03625960|Cantharidin|cantharidin|mesh-list
110777758|NCT03625960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110777759|NCT03625960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110777760|NCT03042910|Talazoparib|talazoparib|mesh-list
110777761|NCT03042910|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110777762|NCT03042910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110777763|NCT03042910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110777764|NCT03042910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110777766|NCT03243838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110777767|NCT03243838|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110777768|NCT03243838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110777769|NCT03243838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110777770|NCT03059446|Cenicriviroc|cenicriviroc|mesh-list
110777771|NCT03059446|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
110777772|NCT03059446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110777773|NCT03059446|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110777774|NCT03059446|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110777775|NCT03059446|Antiviral Agents|antiviral agents|mesh-ancestor
110777776|NCT03059446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110777777|NCT00090519|Ruboxistaurin|ruboxistaurin|mesh-list
110777778|NCT00090519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110777779|NCT00090519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110777780|NCT02980666|Teduglutide|teduglutide|mesh-list
110777781|NCT02980666|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110777782|NCT02980666|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110777783|NCT02980666|Protective Agents|protective agents|mesh-ancestor
110777784|NCT02980666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110777785|NCT02962102|Calcitriol|calcitriol|mesh-list
110777786|NCT02962102|Calcifediol|calcifediol|mesh-list
110777787|NCT02962102|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110777788|NCT02962102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110777789|NCT02962102|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
110777790|NCT02962102|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110777791|NCT02962102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110777792|NCT02962102|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110777793|NCT02962102|Vitamins|vitamins|mesh-ancestor
110777794|NCT02962102|Micronutrients|micronutrients|mesh-ancestor
110777795|NCT02962102|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110777796|NCT02947750|Folic Acid|folic acid|mesh-list
110777797|NCT02947750|Hematinics|hematinics|mesh-ancestor
110777798|NCT02947750|Vitamin B Complex|vitamin b complex|mesh-ancestor
110777799|NCT02947750|Vitamins|vitamins|mesh-ancestor
110777800|NCT02947750|Micronutrients|micronutrients|mesh-ancestor
110777801|NCT02947750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110777802|NCT02630368|Cyclophosphamide|cyclophosphamide|mesh-list
110777803|NCT02630368|Avelumab|avelumab|mesh-list
110777804|NCT02630368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110777805|NCT02630368|Immunologic Factors|immunologic factors|mesh-ancestor
110777806|NCT02630368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110777807|NCT02630368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110777808|NCT02630368|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110777809|NCT02630368|Alkylating Agents|alkylating agents|mesh-ancestor
110777810|NCT02630368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110777811|NCT02630368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110777812|NCT02630368|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110777813|NCT02630368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110777814|NCT05244460|Diphenhydramine|diphenhydramine|mesh-list
110777815|NCT05244460|Promethazine|promethazine|mesh-list
110777816|NCT05244460|Droperidol|droperidol|mesh-list
110777817|NCT05244460|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110777818|NCT05244460|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110777819|NCT05244460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110777820|NCT05244460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110777821|NCT05244460|Anesthetics, Local|anesthetics, local|mesh-ancestor
110777822|NCT05244460|Anesthetics|anesthetics|mesh-ancestor
110777823|NCT05244460|Sensory System Agents|sensory system agents|mesh-ancestor
110777824|NCT05244460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110777825|NCT05244460|Antiemetics|antiemetics|mesh-ancestor
110777826|NCT05244460|Autonomic Agents|autonomic agents|mesh-ancestor
110777827|NCT05244460|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110777828|NCT05244460|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110777829|NCT05244460|Histamine Antagonists|histamine antagonists|mesh-ancestor
110777830|NCT05244460|Histamine Agents|histamine agents|mesh-ancestor
110777831|NCT05244460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110777832|NCT05244460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110777833|NCT05244460|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110777834|NCT05244460|Antipruritics|antipruritics|mesh-ancestor
110777835|NCT05244460|Dermatologic Agents|dermatologic agents|mesh-ancestor
110777836|NCT05244460|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110777837|NCT05244460|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110777838|NCT05244460|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110777839|NCT05244460|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110777840|NCT05244460|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110777841|NCT05244460|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110777842|NCT05244460|Dopamine Agents|dopamine agents|mesh-ancestor
110777843|NCT00096993|Gemcitabine|gemcitabine|mesh-list
110777844|NCT00096993|Pertuzumab|pertuzumab|mesh-list
110777845|NCT00096993|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110777846|NCT00096993|Antimetabolites|antimetabolites|mesh-ancestor
110777847|NCT00096993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110777848|NCT00096993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110777849|NCT00096993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110777850|NCT05172700|Pirtobrutinib|pirtobrutinib|mesh-list
110777851|NCT05172700|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110777852|NCT05172700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110777853|NCT05172700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110777854|NCT00072189|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
110777855|NCT00072189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110777856|NCT00072189|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110777857|NCT00072189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110777858|NCT00072189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110777859|NCT03040024|Ketamine|ketamine|mesh-list
110777860|NCT03040024|Analgesics|analgesics|mesh-ancestor
110777861|NCT03040024|Sensory System Agents|sensory system agents|mesh-ancestor
110777862|NCT03040024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110777863|NCT03040024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110777864|NCT03040024|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110777865|NCT03040024|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110777866|NCT03040024|Anesthetics, General|anesthetics, general|mesh-ancestor
110777867|NCT03040024|Anesthetics|anesthetics|mesh-ancestor
110777868|NCT03040024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110777869|NCT03040024|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110596657|NCT05808946|Vitamins|vitamins|mesh-ancestor
110777870|NCT03040024|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110777871|NCT03040024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110777872|NCT03040024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110777873|NCT04716946|Durvalumab|durvalumab|mesh-list
110777874|NCT04716946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110777875|NCT04716946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110777876|NCT03038620|Liraglutide|liraglutide|mesh-list
110777877|NCT03038620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110777878|NCT03038620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110777879|NCT03038620|Incretins|incretins|mesh-ancestor
110777880|NCT03038620|Hormones|hormones|mesh-ancestor
110777881|NCT03038620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110777882|NCT02032810|Ipilimumab|ipilimumab|mesh-list
110777884|NCT02032810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110777885|NCT02032810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110777886|NCT02032810|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110777887|NCT02032810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110777888|NCT02032810|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110777889|NCT02032810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110777890|NCT01415674|Afatinib|afatinib|mesh-list
110777891|NCT01415674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110777892|NCT01415674|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110777893|NCT01415674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110777894|NCT01415674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110777895|NCT01350934|Vitamin D|vitamin d|mesh-list
110777896|NCT01350934|Cholecalciferol|cholecalciferol|mesh-list
110777897|NCT01350934|Alendronate|alendronate|mesh-list
110777898|NCT01350934|Calcitriol|calcitriol|mesh-list
110777899|NCT01350934|Calcium|calcium|mesh-list
110777900|NCT01350934|Vitamins|vitamins|mesh-ancestor
110777901|NCT01350934|Micronutrients|micronutrients|mesh-ancestor
110777902|NCT01350934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110777903|NCT01350934|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110777904|NCT01350934|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110777905|NCT01350934|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
110777906|NCT01350934|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110777907|NCT01350934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110495545|NCT00669877|Cytarabine|cytarabine|mesh-list
110777908|NCT01350934|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110777909|NCT01146418|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
110777910|NCT01146418|Hormones|hormones|mesh-ancestor
110777911|NCT01146418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110777912|NCT01146418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110777913|NCT05654896|Ceftriaxone|ceftriaxone|mesh-list
110777914|NCT05654896|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110777915|NCT05654896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110777916|NCT00745108|Tibolone|tibolone|mesh-list
110777917|NCT00745108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110777918|NCT00745108|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110777919|NCT00745108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110777921|NCT00745108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110777922|NCT00745108|Androgen Antagonists|androgen antagonists|mesh-ancestor
110777923|NCT00745108|Hormone Antagonists|hormone antagonists|mesh-ancestor
110777924|NCT00745108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110777925|NCT00745108|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110777926|NCT00745108|Anabolic Agents|anabolic agents|mesh-ancestor
110777927|NCT00725374|Tibolone|tibolone|mesh-list
110777928|NCT00725374|Androgen Antagonists|androgen antagonists|mesh-ancestor
110777929|NCT00725374|Hormone Antagonists|hormone antagonists|mesh-ancestor
110777930|NCT00725374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110777931|NCT00725374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110777932|NCT00725374|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110777933|NCT00725374|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110777934|NCT00725374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110777935|NCT00725374|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110777936|NCT00725374|Anabolic Agents|anabolic agents|mesh-ancestor
110777937|NCT00725374|Hormones|hormones|mesh-ancestor
110777938|NCT03622580|Aflibercept|aflibercept|mesh-list
110777939|NCT03622580|Faricimab|faricimab|mesh-list
110777940|NCT03622580|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110777941|NCT03622580|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110777942|NCT03622580|Growth Substances|growth substances|mesh-ancestor
110777943|NCT03622580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110777944|NCT03622580|Growth Inhibitors|growth inhibitors|mesh-ancestor
110777945|NCT03622580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110777946|NCT00461032|Montelukast|montelukast|mesh-list
110777947|NCT00461032|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110777948|NCT00461032|Respiratory System Agents|respiratory system agents|mesh-ancestor
110777949|NCT00461032|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110777950|NCT00461032|Hormone Antagonists|hormone antagonists|mesh-ancestor
110777951|NCT00461032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110777952|NCT00461032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110777953|NCT00461032|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110777954|NCT00461032|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110777955|NCT00461032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110777956|NCT00446056|Ketotifen|ketotifen|mesh-list
110777957|NCT00446056|Montelukast|montelukast|mesh-list
110777958|NCT00446056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110777959|NCT00446056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110777960|NCT00446056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110777961|NCT00446056|Respiratory System Agents|respiratory system agents|mesh-ancestor
110777962|NCT00446056|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110777963|NCT00446056|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110777964|NCT00446056|Hormone Antagonists|hormone antagonists|mesh-ancestor
110777965|NCT00446056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110777966|NCT00446056|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110777967|NCT00446056|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110777968|NCT00446056|Antipruritics|antipruritics|mesh-ancestor
110777969|NCT00446056|Dermatologic Agents|dermatologic agents|mesh-ancestor
110777970|NCT00446056|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110777971|NCT00446056|Histamine Antagonists|histamine antagonists|mesh-ancestor
110777972|NCT00446056|Histamine Agents|histamine agents|mesh-ancestor
110777973|NCT00446056|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110777974|NCT00389740|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
110777975|NCT00389740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110777976|NCT00389740|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110777977|NCT00389740|Hormone Antagonists|hormone antagonists|mesh-ancestor
110777978|NCT00389740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110777979|NCT00389740|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110495622|NCT00773149|Alemtuzumab|alemtuzumab|mesh-list
110777980|NCT00389740|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110777981|NCT00389740|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110777982|NCT00092092|Budesonide|budesonide|mesh-list
110777983|NCT00092092|Montelukast|montelukast|mesh-list
110777984|NCT00092092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110777985|NCT00092092|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110777986|NCT00092092|Autonomic Agents|autonomic agents|mesh-ancestor
110777987|NCT00092092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110777988|NCT00092092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110777989|NCT00092092|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110777990|NCT00092092|Respiratory System Agents|respiratory system agents|mesh-ancestor
110777991|NCT00092092|Glucocorticoids|glucocorticoids|mesh-ancestor
110777992|NCT00092092|Hormones|hormones|mesh-ancestor
110777993|NCT00092092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110777994|NCT00092092|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110777995|NCT00092092|Hormone Antagonists|hormone antagonists|mesh-ancestor
110777996|NCT00092092|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110777997|NCT00092092|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110777998|NCT00092092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110777999|NCT00092014|Vitamin D|vitamin d|mesh-list
110778000|NCT00092014|Alendronate|alendronate|mesh-list
110778001|NCT00092014|Risedronic Acid|risedronic acid|mesh-list
110778002|NCT00092014|Calcium|calcium|mesh-list
110778003|NCT00092014|Vitamins|vitamins|mesh-ancestor
110778004|NCT00092014|Micronutrients|micronutrients|mesh-ancestor
110778005|NCT00092014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110778006|NCT00092014|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110778007|NCT00092014|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110778008|NCT00092014|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110778009|NCT00092014|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110778010|NCT00092014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110778011|NCT00090142|Montelukast|montelukast|mesh-list
110778013|NCT00090142|Respiratory System Agents|respiratory system agents|mesh-ancestor
110778014|NCT00090142|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110778015|NCT00090142|Hormone Antagonists|hormone antagonists|mesh-ancestor
110778016|NCT00090142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110778017|NCT00090142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110778018|NCT00090142|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110778019|NCT00090142|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110778020|NCT00090142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110778021|NCT00043108|Paclitaxel|paclitaxel|mesh-list
110778022|NCT00043108|Carboplatin|carboplatin|mesh-list
110778023|NCT00043108|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110778024|NCT00043108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110778025|NCT00043108|Tubulin Modulators|tubulin modulators|mesh-ancestor
110778026|NCT00043108|Antimitotic Agents|antimitotic agents|mesh-ancestor
110778027|NCT00043108|Mitosis Modulators|mitosis modulators|mesh-ancestor
110778028|NCT00043108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110778029|NCT03619408|Antacids|antacids|mesh-list
110778030|NCT03619408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110778031|NCT03619408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110778032|NCT04032158|Interferon beta-1a|interferon beta-1a|mesh-list
110778033|NCT04032158|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110778034|NCT04032158|Immunologic Factors|immunologic factors|mesh-ancestor
110778035|NCT04032158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110778036|NCT04032158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110778037|NCT04032158|Antiviral Agents|antiviral agents|mesh-ancestor
110778038|NCT04032158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110778039|NCT03620708|Nicotine|nicotine|mesh-list
110778040|NCT03620708|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110778041|NCT03620708|Autonomic Agents|autonomic agents|mesh-ancestor
110778042|NCT03620708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110778043|NCT03620708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110778044|NCT03620708|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110778045|NCT03620708|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110778046|NCT03620708|Cholinergic Agents|cholinergic agents|mesh-ancestor
110778047|NCT03620708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110778048|NCT03620708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110778049|NCT03654326|Naproxen|naproxen|mesh-list
110778050|NCT03654326|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110778051|NCT03654326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110778052|NCT03654326|Analgesics|analgesics|mesh-ancestor
110778053|NCT03654326|Sensory System Agents|sensory system agents|mesh-ancestor
110778054|NCT03654326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110778055|NCT03654326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110778056|NCT03654326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110778057|NCT03654326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110778058|NCT03654326|Gout Suppressants|gout suppressants|mesh-ancestor
110778059|NCT03654326|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110778060|NCT03654326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110778061|NCT03654326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110778062|NCT03735446|Cytarabine|cytarabine|mesh-list
110778063|NCT03735446|Etoposide|etoposide|mesh-list
110778064|NCT03735446|Mitoxantrone|mitoxantrone|mesh-list
110778065|NCT03735446|Prexasertib|prexasertib|mesh-list
110778066|NCT03735446|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110778067|NCT03735446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110778068|NCT03735446|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110778069|NCT03735446|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110778070|NCT03735446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110778071|NCT03735446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110778072|NCT03735446|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110778073|NCT03735446|Antimetabolites|antimetabolites|mesh-ancestor
110778074|NCT03735446|Antiviral Agents|antiviral agents|mesh-ancestor
110778075|NCT03735446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110778076|NCT03735446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110778077|NCT03735446|Immunologic Factors|immunologic factors|mesh-ancestor
110778078|NCT03735446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110778079|NCT03735446|Analgesics|analgesics|mesh-ancestor
110778080|NCT03735446|Sensory System Agents|sensory system agents|mesh-ancestor
110778081|NCT03735446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110778082|NCT03735446|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110778083|NCT03735368|Pregabalin|pregabalin|mesh-list
110778084|NCT03735368|Dexmedetomidine|dexmedetomidine|mesh-list
110778085|NCT03735368|Benoxinate|benoxinate|mesh-list
110778086|NCT03735368|Anesthetics|anesthetics|mesh-ancestor
110778087|NCT03735368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110778088|NCT03735368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110778089|NCT03735368|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110778090|NCT03735368|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110778091|NCT03735368|Analgesics|analgesics|mesh-ancestor
110778092|NCT03735368|Sensory System Agents|sensory system agents|mesh-ancestor
110778093|NCT03735368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110778094|NCT03735368|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110778095|NCT03735368|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110778096|NCT03735368|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110778097|NCT03735368|Adrenergic Agents|adrenergic agents|mesh-ancestor
110778098|NCT03735368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110778099|NCT03735368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110778100|NCT03735368|Anticonvulsants|anticonvulsants|mesh-ancestor
110778101|NCT03735368|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110778102|NCT03735368|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110778103|NCT03735368|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110778104|NCT03735368|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110778105|NCT03735368|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110778106|NCT03735368|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110778107|NCT03735368|Anesthetics, Local|anesthetics, local|mesh-ancestor
110778108|NCT00071799|Cytarabine|cytarabine|mesh-list
110778109|NCT00071799|Azacitidine|azacitidine|mesh-list
110778110|NCT00071799|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110778111|NCT00071799|Antimetabolites|antimetabolites|mesh-ancestor
110778112|NCT00071799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110778113|NCT00071799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110778115|NCT00071799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110778116|NCT00071799|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110778117|NCT00071799|Immunologic Factors|immunologic factors|mesh-ancestor
110778118|NCT00071799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110778119|NCT00071799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110778120|NCT03615482|Vaccines|vaccines|mesh-list
110778121|NCT03615482|Immunologic Factors|immunologic factors|mesh-ancestor
110778122|NCT03615482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110778123|NCT03652610|Vaccines|vaccines|mesh-list
110778124|NCT03652610|Immunologic Factors|immunologic factors|mesh-ancestor
110778125|NCT03652610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110778126|NCT03615404|Molgramostim|molgramostim|mesh-list
110778127|NCT03615404|Sargramostim|sargramostim|mesh-list
110778128|NCT03615404|Immunologic Factors|immunologic factors|mesh-ancestor
110778129|NCT03615404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110778130|NCT03615404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110778131|NCT03730064|Acetylcysteine|acetylcysteine|mesh-list
110778132|NCT03730064|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110778133|NCT03730064|Antiviral Agents|antiviral agents|mesh-ancestor
110778134|NCT03730064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110778135|NCT03730064|Expectorants|expectorants|mesh-ancestor
110778136|NCT03730064|Respiratory System Agents|respiratory system agents|mesh-ancestor
110778137|NCT03730064|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110778138|NCT03730064|Antioxidants|antioxidants|mesh-ancestor
110778139|NCT03730064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110778140|NCT03730064|Protective Agents|protective agents|mesh-ancestor
110778141|NCT03730064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110778142|NCT03730064|Antidotes|antidotes|mesh-ancestor
110778143|NCT03580382|Trametinib|trametinib|mesh-list
110778144|NCT03580382|Antibodies|antibodies|mesh-list
110778145|NCT03580382|Immunologic Factors|immunologic factors|mesh-ancestor
110778146|NCT03580382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110778147|NCT03580382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110778148|NCT03580382|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110778149|NCT03580382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110778150|NCT03580382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110778151|NCT03577730|Caffeine|caffeine|mesh-list
110778152|NCT03577730|Caffeine citrate|caffeine citrate|mesh-list
110778153|NCT03577730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110778154|NCT03577730|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110778155|NCT03577730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110778156|NCT03577730|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110778157|NCT03577730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110778158|NCT03577730|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110778159|NCT03577730|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110778160|NCT03577730|Purinergic Agents|purinergic agents|mesh-ancestor
110778161|NCT03577730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110778162|NCT03731780|Chlorhexidine|chlorhexidine|mesh-list
110778163|NCT03731780|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110778164|NCT03731780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110778165|NCT03731780|Disinfectants|disinfectants|mesh-ancestor
110778166|NCT03735134|Colchicine|colchicine|mesh-list
110778167|NCT03735134|Gout Suppressants|gout suppressants|mesh-ancestor
110778168|NCT03735134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110778169|NCT03735134|Tubulin Modulators|tubulin modulators|mesh-ancestor
110778170|NCT03735134|Antimitotic Agents|antimitotic agents|mesh-ancestor
110778171|NCT03735134|Mitosis Modulators|mitosis modulators|mesh-ancestor
110778172|NCT03735134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110778173|NCT03735134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110778174|NCT03608774|Azithromycin|azithromycin|mesh-list
110778175|NCT03608774|Doxycycline|doxycycline|mesh-list
110778176|NCT03608774|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110778177|NCT03608774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110778178|NCT03608774|Antimalarials|antimalarials|mesh-ancestor
110778179|NCT03608774|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110778180|NCT03608774|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110778181|NCT04021524|Chlorhexidine|chlorhexidine|mesh-list
110778182|NCT04021524|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110778183|NCT04021524|Benzoyl Peroxide|benzoyl peroxide|mesh-list
110778184|NCT04021524|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110778185|NCT04021524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110778186|NCT04021524|Disinfectants|disinfectants|mesh-ancestor
110778187|NCT04021524|Dermatologic Agents|dermatologic agents|mesh-ancestor
110778188|NCT03729674|Infliximab|infliximab|mesh-list
110778189|NCT03729674|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110778190|NCT03729674|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110778191|NCT03729674|Dermatologic Agents|dermatologic agents|mesh-ancestor
110778192|NCT03729674|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110778193|NCT03729674|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110778194|NCT03731468|Dexamethasone|dexamethasone|mesh-list
110778195|NCT03731468|Anesthetics|anesthetics|mesh-list
110778196|NCT03731468|Anesthetics, Local|anesthetics, local|mesh-list
110778197|NCT03731468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110778198|NCT03731468|Antiemetics|antiemetics|mesh-ancestor
110778199|NCT03731468|Autonomic Agents|autonomic agents|mesh-ancestor
110778200|NCT03731468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110778201|NCT03731468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110778202|NCT03731468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110778203|NCT03731468|Glucocorticoids|glucocorticoids|mesh-ancestor
110778204|NCT03731468|Hormones|hormones|mesh-ancestor
110778205|NCT03731468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110778206|NCT03731468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110495849|NCT00582790|Zoledronic Acid|zoledronic acid|mesh-list
110778207|NCT03731468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110778208|NCT03731468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110778209|NCT03731468|Sensory System Agents|sensory system agents|mesh-ancestor
110778210|NCT03600428|Vaccines|vaccines|mesh-list
110778211|NCT03600428|Immunologic Factors|immunologic factors|mesh-ancestor
110778212|NCT03600428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110778213|NCT03575702|Tolterodine Tartrate|tolterodine tartrate|mesh-list
110778214|NCT03575702|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110778215|NCT03575702|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110778216|NCT03575702|Cholinergic Agents|cholinergic agents|mesh-ancestor
110778217|NCT03575702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110778218|NCT03575702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110778219|NCT03575702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110778220|NCT03575702|Urological Agents|urological agents|mesh-ancestor
110778221|NCT03639896|Dexmedetomidine|dexmedetomidine|mesh-list
110778222|NCT03639896|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110778223|NCT03639896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110778224|NCT03639896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110778225|NCT03639896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110778226|NCT03639896|Analgesics|analgesics|mesh-ancestor
110778227|NCT03639896|Sensory System Agents|sensory system agents|mesh-ancestor
110778228|NCT03639896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110778229|NCT03639896|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110778230|NCT03639896|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110778231|NCT03639896|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110778232|NCT03639896|Adrenergic Agents|adrenergic agents|mesh-ancestor
110778233|NCT03639896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110778234|NCT03639896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110778235|NCT03573908|Linaclotide|linaclotide|mesh-list
110778236|NCT03573908|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
110778237|NCT03573908|Enzyme Activators|enzyme activators|mesh-ancestor
110778238|NCT03573908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110778239|NCT03573908|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110778240|NCT03729284|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110778241|NCT03729284|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110778242|NCT03729284|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110778243|NCT03729284|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110778244|NCT03729284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110778245|NCT03729284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110778246|NCT03729284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110778247|NCT03729284|Analgesics|analgesics|mesh-ancestor
110103305|NCT01770132|Trioxsalen|trioxsalen|mesh-list
110778248|NCT03729284|Sensory System Agents|sensory system agents|mesh-ancestor
110778249|NCT03729284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110778250|NCT03729284|Antidepressive Agents|antidepressive agents|mesh-ancestor
110778251|NCT03729284|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110778252|NCT03729284|Dopamine Agents|dopamine agents|mesh-ancestor
110778253|NCT03729128|Memantine|memantine|mesh-list
110778254|NCT03729128|Dextromethorphan|dextromethorphan|mesh-list
110778255|NCT03729128|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110778256|NCT03729128|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110778257|NCT03729128|Dopamine Agents|dopamine agents|mesh-ancestor
110778258|NCT03729128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110778259|NCT03729128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110778260|NCT03729128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110778261|NCT03729128|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110778262|NCT03729128|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110778263|NCT03729128|Antitussive Agents|antitussive agents|mesh-ancestor
110778264|NCT03729128|Respiratory System Agents|respiratory system agents|mesh-ancestor
110778265|NCT03734354|Brexpiprazole|brexpiprazole|mesh-list
110778266|NCT03734354|Serotonin Agents|serotonin agents|mesh-ancestor
110778267|NCT03734354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110778268|NCT03734354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110778269|NCT03734354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110778270|NCT03734354|Dopamine Agonists|dopamine agonists|mesh-ancestor
110778271|NCT03734354|Dopamine Agents|dopamine agents|mesh-ancestor
110778272|NCT03728894|Midazolam|midazolam|mesh-list
110778273|NCT03728894|Hydroxyzine|hydroxyzine|mesh-list
110778274|NCT03728894|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110778275|NCT03728894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110778276|NCT03728894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110778277|NCT03728894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110778278|NCT03728894|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110778279|NCT03728894|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110778280|NCT03728894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110778281|NCT03728894|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110778282|NCT03728894|Anesthetics, General|anesthetics, general|mesh-ancestor
110778283|NCT03728894|Anesthetics|anesthetics|mesh-ancestor
110778284|NCT03728894|GABA Modulators|gaba modulators|mesh-ancestor
110778285|NCT03728894|GABA Agents|gaba agents|mesh-ancestor
110778286|NCT03728894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110778287|NCT03728894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110778288|NCT03728894|Antipruritics|antipruritics|mesh-ancestor
110778289|NCT03728894|Dermatologic Agents|dermatologic agents|mesh-ancestor
110778290|NCT03728894|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110778291|NCT03728894|Histamine Antagonists|histamine antagonists|mesh-ancestor
110778292|NCT03728894|Histamine Agents|histamine agents|mesh-ancestor
110778293|NCT03730766|Amoxicillin|amoxicillin|mesh-list
110778294|NCT03730766|Metronidazole|metronidazole|mesh-list
110778295|NCT03730766|Potassium Citrate|potassium citrate|mesh-list
110778296|NCT03730766|Esomeprazole|esomeprazole|mesh-list
110778297|NCT03730766|Bismuth|bismuth|mesh-list
110778298|NCT03730766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110778299|NCT03730766|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110778300|NCT03730766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110778301|NCT03730766|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110778302|NCT03730766|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110778303|NCT03730766|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110778304|NCT03730766|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110778305|NCT03730766|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110778306|NCT03730766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110778308|NCT03730766|Diuretics|diuretics|mesh-ancestor
110778309|NCT03730766|Natriuretic Agents|natriuretic agents|mesh-ancestor
110493218|NCT02558569|Anesthetics|anesthetics|mesh-ancestor
110778310|NCT03730766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110778311|NCT03730766|Expectorants|expectorants|mesh-ancestor
110778312|NCT03730766|Respiratory System Agents|respiratory system agents|mesh-ancestor
110778313|NCT00071487|Belimumab|belimumab|mesh-list
110778314|NCT00071487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110778315|NCT00071487|Immunologic Factors|immunologic factors|mesh-ancestor
110778316|NCT00071487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110778317|NCT03962283|Rifaximin|rifaximin|mesh-list
110778318|NCT03962283|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110778319|NCT03962283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110778320|NCT03962283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110778321|NCT03591146|Ropivacaine|ropivacaine|mesh-list
110778322|NCT03591146|Anesthetics, Local|anesthetics, local|mesh-ancestor
110778323|NCT03591146|Anesthetics|anesthetics|mesh-ancestor
110778324|NCT03591146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110778325|NCT03591146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110778326|NCT03591146|Sensory System Agents|sensory system agents|mesh-ancestor
110778327|NCT03591146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110778328|NCT00096447|Lapatinib|lapatinib|mesh-list
110778329|NCT00096447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110778330|NCT00096447|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110778331|NCT00096447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110778332|NCT00096447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110778333|NCT03588572|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
110778334|NCT03588572|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110778335|NCT03588572|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110778336|NCT03588572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110778337|NCT03588572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110778338|NCT03588572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110778339|NCT03588572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110778340|NCT03588572|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110778342|NCT03588572|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110778343|NCT00070941|Escitalopram|escitalopram|mesh-list
110778344|NCT00070941|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110778345|NCT00070941|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110778346|NCT00070941|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110778347|NCT00070941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110778348|NCT00070941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110778349|NCT00070941|Serotonin Agents|serotonin agents|mesh-ancestor
110778350|NCT00070941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110778351|NCT00070707|Mometasone Furoate|mometasone furoate|mesh-list
110778352|NCT00070707|Albuterol|albuterol|mesh-list
110778353|NCT00070707|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110778354|NCT00070707|Autonomic Agents|autonomic agents|mesh-ancestor
110778355|NCT00070707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110778356|NCT00070707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110778357|NCT00070707|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110778358|NCT00070707|Respiratory System Agents|respiratory system agents|mesh-ancestor
110778359|NCT00070707|Tocolytic Agents|tocolytic agents|mesh-ancestor
110778360|NCT00070707|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110778361|NCT00070707|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110778362|NCT00070707|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110778363|NCT00070707|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110778364|NCT00070707|Adrenergic Agents|adrenergic agents|mesh-ancestor
110778365|NCT00070707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110778366|NCT00070707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110778367|NCT00070707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110778368|NCT00070707|Dermatologic Agents|dermatologic agents|mesh-ancestor
110778369|NCT00070707|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110778371|NCT03036124|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110778372|NCT03036124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110778373|NCT03036124|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110778374|NCT03036124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110778375|NCT00070317|Methylene Blue|methylene blue|mesh-list
110493223|NCT00939692|Topiramate|topiramate|mesh-list
110778376|NCT00070317|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
110778377|NCT00070317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110778378|NCT00070317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110778379|NCT00070317|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110778380|NCT01086345|Bevacizumab|bevacizumab|mesh-list
110778381|NCT01086345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110778382|NCT01086345|Irinotecan|irinotecan|mesh-list
110778383|NCT01086345|Camptothecin|camptothecin|mesh-list
110778384|NCT01086345|Antibodies|antibodies|mesh-list
110778385|NCT01086345|Immunoglobulins|immunoglobulins|mesh-list
110778386|NCT01086345|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110778387|NCT01086345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110778388|NCT01086345|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110778389|NCT01086345|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110778390|NCT01086345|Growth Substances|growth substances|mesh-ancestor
110778391|NCT01086345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110778392|NCT01086345|Growth Inhibitors|growth inhibitors|mesh-ancestor
110778393|NCT01086345|Immunologic Factors|immunologic factors|mesh-ancestor
110778394|NCT01086345|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110778395|NCT01086345|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110778396|NCT01086345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110778397|NCT01086345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110778398|NCT01086345|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110778399|NCT01089933|Anesthetics|anesthetics|mesh-list
110778400|NCT01089933|Anesthetics, Local|anesthetics, local|mesh-list
110778401|NCT01089933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110778402|NCT01089933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110778403|NCT01089933|Sensory System Agents|sensory system agents|mesh-ancestor
110778404|NCT01089933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110778405|NCT03960411|Doxycycline|doxycycline|mesh-list
110778406|NCT03960411|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110778407|NCT03960411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110778408|NCT03960411|Antimalarials|antimalarials|mesh-ancestor
110778409|NCT03960411|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110778410|NCT03960411|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110778411|NCT01090167|Clofarabine|clofarabine|mesh-list
110778412|NCT01090167|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110778413|NCT01090167|Antimetabolites|antimetabolites|mesh-ancestor
110778414|NCT01090167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110778415|NCT01090167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110778416|NCT03587636|Bupivacaine|bupivacaine|mesh-list
110778417|NCT03587636|Anesthetics, Local|anesthetics, local|mesh-ancestor
110778418|NCT03587636|Anesthetics|anesthetics|mesh-ancestor
110778419|NCT03587636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110778420|NCT03587636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110778421|NCT03587636|Sensory System Agents|sensory system agents|mesh-ancestor
110778422|NCT03587636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110778423|NCT03053362|Vortioxetine|vortioxetine|mesh-list
110778424|NCT03053362|Antidepressive Agents|antidepressive agents|mesh-ancestor
110778425|NCT03053362|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110778426|NCT03053362|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110778427|NCT03053362|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110778428|NCT03053362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110778429|NCT03053362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110778430|NCT03053362|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110778431|NCT03053362|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110778432|NCT03053362|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110778433|NCT03053362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110493233|NCT00920608|Antimetabolites|antimetabolites|mesh-ancestor
110778434|NCT03053362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110778435|NCT03053362|Serotonin Agents|serotonin agents|mesh-ancestor
110778436|NCT03053362|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110778437|NCT03053362|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110778438|NCT03053362|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110778439|NCT03053362|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110778440|NCT03733652|Interferons|interferons|mesh-list
110778441|NCT03733652|Interferon-alpha|interferon-alpha|mesh-list
110778442|NCT03733652|Interferon alpha-2|interferon alpha-2|mesh-list
110778443|NCT03733652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110778444|NCT03733652|Antiviral Agents|antiviral agents|mesh-ancestor
110778445|NCT03733652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110778446|NCT03733652|Immunologic Factors|immunologic factors|mesh-ancestor
110778447|NCT03733652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110778448|NCT03586544|Albuterol|albuterol|mesh-list
110778449|NCT03586544|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110778450|NCT03586544|Autonomic Agents|autonomic agents|mesh-ancestor
110778451|NCT03586544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110778452|NCT03586544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110778453|NCT03586544|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110778454|NCT03586544|Respiratory System Agents|respiratory system agents|mesh-ancestor
110778455|NCT03586544|Tocolytic Agents|tocolytic agents|mesh-ancestor
110778456|NCT03586544|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110778457|NCT03586544|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110778458|NCT03586544|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110778459|NCT03586544|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110778460|NCT03586544|Adrenergic Agents|adrenergic agents|mesh-ancestor
110778461|NCT03586544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110778462|NCT03586544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110778463|NCT03737448|Trimetazidine|trimetazidine|mesh-list
110778464|NCT03737448|Vasodilator Agents|vasodilator agents|mesh-ancestor
110778465|NCT03733574|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
110778466|NCT03733574|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110778467|NCT03733574|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110778468|NCT03733574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110778469|NCT03733574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110778470|NCT03733574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110778471|NCT03733574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110778472|NCT03733574|Antidepressive Agents|antidepressive agents|mesh-ancestor
110778473|NCT03733574|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110778474|NCT03728192|Camptothecin|camptothecin|mesh-list
110778475|NCT03728192|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110778476|NCT03728192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110778477|NCT03728192|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110778478|NCT03728192|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110778479|NCT03728192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110849394|NCT01198223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110778480|NCT03728192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110778481|NCT03589768|Aluminum Hydroxide|aluminum hydroxide|mesh-list
110778482|NCT03589768|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110778483|NCT03589768|Immunologic Factors|immunologic factors|mesh-ancestor
110778484|NCT03589768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110778486|NCT03589768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110778487|NCT03589768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110778488|NCT03733340|Imipenem|imipenem|mesh-list
110778489|NCT03733340|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110778490|NCT03733340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110778491|NCT05183308|Clodronic Acid|clodronic acid|mesh-list
110778492|NCT05183308|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110778493|NCT05183308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110778494|NCT05137600|Clarithromycin|clarithromycin|mesh-list
110778495|NCT05137600|Midazolam|midazolam|mesh-list
110778496|NCT05137600|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110778497|NCT05137600|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110778498|NCT05137600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110778499|NCT05137600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110778500|NCT05137600|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110778501|NCT05137600|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110778502|NCT05137600|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110778503|NCT05137600|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110778504|NCT05137600|Anesthetics, General|anesthetics, general|mesh-ancestor
110778505|NCT05137600|Anesthetics|anesthetics|mesh-ancestor
110778506|NCT05137600|GABA Modulators|gaba modulators|mesh-ancestor
110778507|NCT05137600|GABA Agents|gaba agents|mesh-ancestor
110778508|NCT05137600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110778509|NCT05137600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110778510|NCT05137600|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110778511|NCT05137600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110778512|NCT05137600|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110778513|NCT05137600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110778514|NCT05137600|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110778515|NCT05137600|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110778516|NCT00089505|Ritonavir|ritonavir|mesh-list
110778517|NCT00089505|Lopinavir|lopinavir|mesh-list
110778518|NCT00089505|Tenofovir|tenofovir|mesh-list
110778519|NCT00089505|Emtricitabine|emtricitabine|mesh-list
110778520|NCT00089505|Nevirapine|nevirapine|mesh-list
110778521|NCT00089505|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110778522|NCT00089505|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110778523|NCT00089505|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110778524|NCT00089505|Protease Inhibitors|protease inhibitors|mesh-ancestor
110778525|NCT00089505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110778526|NCT00089505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110778527|NCT00089505|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110778528|NCT00089505|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110778529|NCT00089505|Antiviral Agents|antiviral agents|mesh-ancestor
110778530|NCT00089505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110778531|NCT00089505|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110778532|NCT00089505|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110778533|NCT00089505|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110778534|NCT00089505|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110778535|NCT00089505|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110849412|NCT04220866|Pembrolizumab|pembrolizumab|mesh-list
110778536|NCT00089505|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110778537|NCT04009824|Aluminum Hydroxide|aluminum hydroxide|mesh-list
110778538|NCT04009824|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
110778539|NCT04009824|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110778540|NCT04009824|Immunologic Factors|immunologic factors|mesh-ancestor
110778541|NCT04009824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110778542|NCT04009824|Antacids|antacids|mesh-ancestor
110778543|NCT04009824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110778544|NCT04009824|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110778545|NCT05041426|Valganciclovir|valganciclovir|mesh-list
110778546|NCT05041426|Letermovir|letermovir|mesh-list
110778547|NCT05041426|Antiviral Agents|antiviral agents|mesh-ancestor
110778548|NCT05041426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110778549|NCT05041426|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110778550|NCT05041426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110778551|NCT05041426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110778552|NCT05041426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110778553|NCT04987372|Lidocaine|lidocaine|mesh-list
110778554|NCT04987372|Magnesium Sulfate|magnesium sulfate|mesh-list
110778555|NCT04987372|Pregabalin|pregabalin|mesh-list
110778556|NCT04987372|Dexmedetomidine|dexmedetomidine|mesh-list
110778557|NCT04987372|Ketamine|ketamine|mesh-list
110778558|NCT04987372|Anesthetics, Local|anesthetics, local|mesh-ancestor
110778559|NCT04987372|Anesthetics|anesthetics|mesh-ancestor
110778560|NCT04987372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110778561|NCT04987372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110778562|NCT04987372|Sensory System Agents|sensory system agents|mesh-ancestor
110778563|NCT04987372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110778564|NCT04987372|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110778565|NCT04987372|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110778566|NCT04987372|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110778567|NCT04987372|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110778568|NCT04987372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110778569|NCT04987372|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110778570|NCT04987372|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110778571|NCT04987372|Analgesics|analgesics|mesh-ancestor
110778572|NCT04987372|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110778573|NCT04987372|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110778574|NCT04987372|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110778575|NCT04987372|Adrenergic Agents|adrenergic agents|mesh-ancestor
110778576|NCT04987372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110778577|NCT04987372|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110778578|NCT04987372|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110778580|NCT04987372|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110778581|NCT04987372|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110778582|NCT04987372|Anticonvulsants|anticonvulsants|mesh-ancestor
110778583|NCT04987372|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110778584|NCT04987372|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110778585|NCT04987372|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110778586|NCT04987372|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110778587|NCT04987372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110778588|NCT04987372|Tocolytic Agents|tocolytic agents|mesh-ancestor
110778589|NCT04987372|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110778590|NCT03555890|Cetirizine|cetirizine|mesh-list
110778591|NCT03555890|Levocetirizine|levocetirizine|mesh-list
110778592|NCT03555890|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110778593|NCT03555890|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110778594|NCT03555890|Histamine Antagonists|histamine antagonists|mesh-ancestor
110778595|NCT03555890|Histamine Agents|histamine agents|mesh-ancestor
110778596|NCT03555890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110778597|NCT03555890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110778598|NCT03555890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110778599|NCT03555890|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110778600|NCT04905862|Antipyretics|antipyretics|mesh-list
110778601|NCT04905862|Analgesics|analgesics|mesh-list
110778602|NCT04905862|Sensory System Agents|sensory system agents|mesh-ancestor
110778603|NCT04905862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110778604|NCT04905862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110778605|NCT03630120|Sorafenib|sorafenib|mesh-list
110778606|NCT03630120|Lenvatinib|lenvatinib|mesh-list
110778607|NCT03630120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110778608|NCT03630120|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110778609|NCT03630120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110778610|NCT03630120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110778611|NCT03744702|Ascorbic Acid|ascorbic acid|mesh-list
110778612|NCT03744702|Antioxidants|antioxidants|mesh-ancestor
110778613|NCT03744702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110778614|NCT03744702|Protective Agents|protective agents|mesh-ancestor
110778615|NCT03744702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110778616|NCT03744702|Vitamins|vitamins|mesh-ancestor
110778617|NCT03744702|Micronutrients|micronutrients|mesh-ancestor
110778618|NCT03736980|Psilocybin|psilocybin|mesh-list
110778619|NCT03736980|Hallucinogens|hallucinogens|mesh-ancestor
110778620|NCT03736980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110778621|NCT03736980|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110778624|NCT03727646|Nicotinic Acids|nicotinic acids|mesh-list
110778625|NCT03727646|Vitamin B Complex|vitamin b complex|mesh-ancestor
110778626|NCT03727646|Vitamins|vitamins|mesh-ancestor
110778627|NCT03727646|Micronutrients|micronutrients|mesh-ancestor
110778628|NCT03727646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110778629|NCT03727646|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110778630|NCT03727646|Antimetabolites|antimetabolites|mesh-ancestor
110778631|NCT03727646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110778632|NCT03727646|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110778633|NCT03727646|Vasodilator Agents|vasodilator agents|mesh-ancestor
110778634|NCT05666336|Mycophenolic Acid|mycophenolic acid|mesh-list
110778635|NCT05666336|Hydroxychloroquine|hydroxychloroquine|mesh-list
110778636|NCT05666336|Prednisone|prednisone|mesh-list
110778637|NCT05666336|Methylprednisolone|methylprednisolone|mesh-list
110778638|NCT05666336|Cyclophosphamide|cyclophosphamide|mesh-list
110778639|NCT05666336|Tacrolimus|tacrolimus|mesh-list
110778640|NCT05666336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110778641|NCT05666336|Immunologic Factors|immunologic factors|mesh-ancestor
110778642|NCT05666336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110778643|NCT05666336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110778644|NCT05666336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110778645|NCT05666336|Alkylating Agents|alkylating agents|mesh-ancestor
110778646|NCT05666336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110778647|NCT05666336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110778648|NCT05666336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110778649|NCT05666336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110778650|NCT05666336|Glucocorticoids|glucocorticoids|mesh-ancestor
110778651|NCT05666336|Hormones|hormones|mesh-ancestor
110778652|NCT05666336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110496300|NCT02631603|Glucocorticoids|glucocorticoids|mesh-ancestor
110778653|NCT05666336|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110778654|NCT05666336|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110778655|NCT05666336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110778656|NCT05666336|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110778657|NCT05666336|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110778658|NCT05666336|Antitubercular Agents|antitubercular agents|mesh-ancestor
110778659|NCT05666336|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110778660|NCT05666336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110778661|NCT05666336|Antiemetics|antiemetics|mesh-ancestor
110778662|NCT05666336|Autonomic Agents|autonomic agents|mesh-ancestor
110778663|NCT05666336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110778664|NCT05666336|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110778665|NCT05666336|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110778666|NCT05666336|Protective Agents|protective agents|mesh-ancestor
110778667|NCT05666336|Antimalarials|antimalarials|mesh-ancestor
110778668|NCT05666336|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110778669|NCT05666336|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110778670|NCT03554486|Insulin|insulin|mesh-list
110778671|NCT03554486|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110778672|NCT03554486|Insulin Aspart|insulin aspart|mesh-list
110778673|NCT03554486|Insulin, Long-Acting|insulin, long-acting|mesh-list
110778674|NCT03554486|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
110778675|NCT03554486|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110778676|NCT03554486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110778677|NCT03554018|Acetaminophen|acetaminophen|mesh-list
110778678|NCT03554018|Ibuprofen|ibuprofen|mesh-list
110778679|NCT03554018|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110778680|NCT03554018|Analgesics|analgesics|mesh-ancestor
110778681|NCT03554018|Sensory System Agents|sensory system agents|mesh-ancestor
110778682|NCT03554018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110778683|NCT03554018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110778684|NCT03554018|Antipyretics|antipyretics|mesh-ancestor
110778685|NCT03554018|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110778686|NCT03554018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110778687|NCT03554018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110778688|NCT03554018|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110778689|NCT03554018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110778690|NCT03554018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110778691|NCT05462938|Dexmedetomidine|dexmedetomidine|mesh-list
110778692|NCT05462938|Propofol|propofol|mesh-list
110778693|NCT05462938|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110778694|NCT05462938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110778695|NCT05462938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110103751|NCT01773408|Immunologic Factors|immunologic factors|mesh-ancestor
110778696|NCT05462938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110778697|NCT05462938|Analgesics|analgesics|mesh-ancestor
110778698|NCT05462938|Sensory System Agents|sensory system agents|mesh-ancestor
110778699|NCT05462938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110778700|NCT05462938|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110778701|NCT05462938|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110778702|NCT05462938|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110778703|NCT05462938|Adrenergic Agents|adrenergic agents|mesh-ancestor
110778704|NCT05462938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110778705|NCT05462938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110778706|NCT05462938|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110778707|NCT05462938|Anesthetics, General|anesthetics, general|mesh-ancestor
110778708|NCT05462938|Anesthetics|anesthetics|mesh-ancestor
110778709|NCT04787692|Analgesics, Opioid|analgesics, opioid|mesh-list
110778710|NCT04787692|Narcotics|narcotics|mesh-ancestor
110778711|NCT04787692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110778712|NCT04787692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110778713|NCT04787692|Analgesics|analgesics|mesh-ancestor
110778714|NCT04787692|Sensory System Agents|sensory system agents|mesh-ancestor
110778715|NCT04787692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110778716|NCT05462548|Luspatercept|luspatercept|mesh-list
110778717|NCT05462548|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
110778718|NCT05462548|Hematinics|hematinics|mesh-ancestor
110778719|NCT05462548|Immunologic Factors|immunologic factors|mesh-ancestor
110778720|NCT05462548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110778721|NCT03408340|Fentanyl|fentanyl|mesh-list
110778722|NCT03408340|Ketamine|ketamine|mesh-list
110778723|NCT03408340|Propofol|propofol|mesh-list
110778724|NCT03408340|Sevoflurane|sevoflurane|mesh-list
110778725|NCT03408340|Rocuronium|rocuronium|mesh-list
110778726|NCT03408340|Anesthetics|anesthetics|mesh-ancestor
110778727|NCT03408340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110778728|NCT03408340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110778729|NCT03408340|Sensory System Agents|sensory system agents|mesh-ancestor
110778730|NCT03408340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110778731|NCT03408340|Analgesics|analgesics|mesh-ancestor
110778732|NCT03408340|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110778733|NCT03408340|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110778734|NCT03408340|Anesthetics, General|anesthetics, general|mesh-ancestor
110778735|NCT03408340|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110778736|NCT03408340|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110778737|NCT03408340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110778738|NCT03408340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110778739|NCT03408340|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110778740|NCT03408340|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110778741|NCT03408340|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110778742|NCT03408340|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110778743|NCT03408340|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110778744|NCT03408340|Narcotics|narcotics|mesh-ancestor
110778745|NCT03408340|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110778746|NCT03408340|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110778747|NCT03408340|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110778748|NCT03570554|Acetaminophen|acetaminophen|mesh-list
110778749|NCT03570554|Celecoxib|celecoxib|mesh-list
110778750|NCT03570554|Naproxen|naproxen|mesh-list
110778751|NCT03570554|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110778752|NCT03570554|Analgesics|analgesics|mesh-ancestor
110778753|NCT03570554|Sensory System Agents|sensory system agents|mesh-ancestor
110778754|NCT03570554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110778755|NCT03570554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110778756|NCT03570554|Antipyretics|antipyretics|mesh-ancestor
110799580|NCT02064556|Candesartan cilexetil|candesartan cilexetil|mesh-list
110778757|NCT03570554|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110778758|NCT03570554|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110778759|NCT03570554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110778760|NCT03570554|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110778761|NCT03570554|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110778762|NCT03570554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110778763|NCT03570554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110778764|NCT03570554|Gout Suppressants|gout suppressants|mesh-ancestor
110778765|NCT04004208|Aflibercept|aflibercept|mesh-list
110778766|NCT04004208|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110778767|NCT04004208|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110778768|NCT04004208|Growth Substances|growth substances|mesh-ancestor
110778769|NCT04004208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110778770|NCT04004208|Growth Inhibitors|growth inhibitors|mesh-ancestor
110778771|NCT04004208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110778772|NCT03727412|Naproxen|naproxen|mesh-list
110778773|NCT03727412|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110778774|NCT03727412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110778775|NCT03727412|Analgesics|analgesics|mesh-ancestor
110778776|NCT03727412|Sensory System Agents|sensory system agents|mesh-ancestor
110778777|NCT03727412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110778778|NCT03727412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110778779|NCT03727412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110778780|NCT03727412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110778781|NCT03727412|Gout Suppressants|gout suppressants|mesh-ancestor
110778782|NCT03727412|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110778783|NCT03727412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110778784|NCT03727412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110778785|NCT03643952|Daptomycin|daptomycin|mesh-list
110778786|NCT03643952|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110778787|NCT03643952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110778788|NCT03035032|Leuprolide|leuprolide|mesh-list
110778789|NCT03035032|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110778790|NCT03035032|Fertility Agents|fertility agents|mesh-ancestor
110778791|NCT03035032|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110778792|NCT03035032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110778793|NCT03035032|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110778794|NCT03035032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110778795|NCT03629184|Oseltamivir|oseltamivir|mesh-list
110778796|NCT03629184|Baloxavir|baloxavir|mesh-list
110778797|NCT03629184|Antiviral Agents|antiviral agents|mesh-ancestor
110778798|NCT03629184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110778799|NCT03629184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110778800|NCT03629184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110778801|NCT03725228|Lidocaine|lidocaine|mesh-list
110778802|NCT03725228|Magnesium Sulfate|magnesium sulfate|mesh-list
110778803|NCT03725228|Anesthetics, Local|anesthetics, local|mesh-ancestor
110778804|NCT03725228|Anesthetics|anesthetics|mesh-ancestor
110778805|NCT03725228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110778806|NCT03725228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110778808|NCT03725228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110778809|NCT03725228|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110778810|NCT03725228|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110778811|NCT03725228|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110778812|NCT03725228|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110778813|NCT03725228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110778814|NCT03725228|Analgesics|analgesics|mesh-ancestor
110778815|NCT03725228|Anticonvulsants|anticonvulsants|mesh-ancestor
110778816|NCT03725228|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110778817|NCT03725228|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110778818|NCT03725228|Tocolytic Agents|tocolytic agents|mesh-ancestor
110778819|NCT03725228|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110778820|NCT03724838|Sildenafil Citrate|sildenafil citrate|mesh-list
110778821|NCT03724838|Esomeprazole|esomeprazole|mesh-list
110778822|NCT03724838|Citric Acid|citric acid|mesh-list
110778823|NCT03724838|Sodium Citrate|sodium citrate|mesh-list
110778824|NCT03724838|Anticoagulants|anticoagulants|mesh-ancestor
110778825|NCT03724838|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110778826|NCT03724838|Chelating Agents|chelating agents|mesh-ancestor
110778827|NCT03724838|Sequestering Agents|sequestering agents|mesh-ancestor
110778828|NCT03724838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110778829|NCT03724838|Vasodilator Agents|vasodilator agents|mesh-ancestor
110778830|NCT03724838|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110778831|NCT03724838|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110778832|NCT03724838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110778833|NCT03724838|Urological Agents|urological agents|mesh-ancestor
110778834|NCT03724838|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110778835|NCT03724838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110778836|NCT03724838|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110778837|NCT02892344|Mometasone Furoate|mometasone furoate|mesh-list
110778838|NCT02892344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110778839|NCT02892344|Dermatologic Agents|dermatologic agents|mesh-ancestor
110778840|NCT02892344|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110778841|NCT03727100|Clonidine|clonidine|mesh-list
110778842|NCT03727100|Analgesics|analgesics|mesh-ancestor
110778843|NCT03727100|Sensory System Agents|sensory system agents|mesh-ancestor
110778844|NCT03727100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110778845|NCT03727100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110778846|NCT03727100|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110778847|NCT03727100|Sympatholytics|sympatholytics|mesh-ancestor
110778848|NCT03727100|Autonomic Agents|autonomic agents|mesh-ancestor
110778849|NCT03727100|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110778850|NCT03727100|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110778851|NCT03727100|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110778852|NCT03727100|Adrenergic Agents|adrenergic agents|mesh-ancestor
110778853|NCT03727100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110778854|NCT03727100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110778855|NCT03358030|Riboflavin|riboflavin|mesh-list
110778856|NCT03358030|Vitamin B Complex|vitamin b complex|mesh-ancestor
110778857|NCT03358030|Vitamins|vitamins|mesh-ancestor
110778858|NCT03358030|Micronutrients|micronutrients|mesh-ancestor
110778859|NCT03358030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110778860|NCT03358030|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110778861|NCT03358030|Dermatologic Agents|dermatologic agents|mesh-ancestor
110778862|NCT03566810|Metformin|metformin|mesh-list
110778863|NCT03566810|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110778864|NCT03566810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110778865|NCT03628716|Atezolizumab|atezolizumab|mesh-list
110778866|NCT03628716|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110778867|NCT03628716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110778868|NCT03628716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110778869|NCT03628716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110778870|NCT03840616|Fluconazole|fluconazole|mesh-list
110778871|NCT03840616|Antifungal Agents|antifungal agents|mesh-ancestor
110778872|NCT03840616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110778873|NCT03840616|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110778874|NCT03840616|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110778875|NCT03840616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110778876|NCT03840616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110778877|NCT03840616|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110778878|NCT03840616|Hormone Antagonists|hormone antagonists|mesh-ancestor
110778879|NCT03840616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110778880|NCT03840616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110778881|NCT03840616|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110778882|NCT03840616|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110778883|NCT00088413|Molgramostim|molgramostim|mesh-list
110778884|NCT00088413|Sargramostim|sargramostim|mesh-list
110778885|NCT00088413|Immunologic Factors|immunologic factors|mesh-ancestor
110778886|NCT00088413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110778887|NCT00088413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110778888|NCT03787654|Solifenacin Succinate|solifenacin succinate|mesh-list
110778889|NCT03787654|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110778890|NCT03787654|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110778891|NCT03787654|Cholinergic Agents|cholinergic agents|mesh-ancestor
110778892|NCT03787654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110778893|NCT03787654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110778894|NCT03787654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110778895|NCT03787654|Urological Agents|urological agents|mesh-ancestor
110778896|NCT00086385|Bupropion|bupropion|mesh-list
110778897|NCT00086385|Nicotine|nicotine|mesh-list
110778898|NCT00086385|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110778899|NCT00086385|Autonomic Agents|autonomic agents|mesh-ancestor
110778900|NCT00086385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110778901|NCT00086385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110778902|NCT00086385|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110778903|NCT00086385|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110778904|NCT00086385|Cholinergic Agents|cholinergic agents|mesh-ancestor
110778905|NCT00086385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110778906|NCT00086385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110778907|NCT00086385|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110778908|NCT00086385|Antidepressive Agents|antidepressive agents|mesh-ancestor
110778909|NCT00086385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110778910|NCT00086385|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110778911|NCT00086385|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110778912|NCT00086385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110778913|NCT00086385|Dopamine Agents|dopamine agents|mesh-ancestor
110778914|NCT00086385|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110778915|NCT00086385|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110778916|NCT00086385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110778917|NCT03993288|Iron|iron|mesh-list
110778918|NCT03993288|Trace Elements|trace elements|mesh-ancestor
110778919|NCT03993288|Micronutrients|micronutrients|mesh-ancestor
110778920|NCT03993288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110778921|NCT05093608|Bevacizumab|bevacizumab|mesh-list
110778922|NCT05093608|Atezolizumab|atezolizumab|mesh-list
110778923|NCT05093608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110778924|NCT05093608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110493310|NCT00919984|Paclitaxel|paclitaxel|mesh-list
110778925|NCT05093608|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110778926|NCT05093608|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110778927|NCT05093608|Growth Substances|growth substances|mesh-ancestor
110778928|NCT05093608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110778929|NCT05093608|Growth Inhibitors|growth inhibitors|mesh-ancestor
110778930|NCT05093608|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110778931|NCT05093608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110778932|NCT03991494|Pamiparib|pamiparib|mesh-list
110778933|NCT03991494|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110778934|NCT03991494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110778935|NCT03991494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110778936|NCT03991494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110778937|NCT03736044|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
110778938|NCT03736044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110778939|NCT03383770|Anesthetics|anesthetics|mesh-list
110778940|NCT03383770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110778941|NCT03383770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110778942|NCT00086307|Pramipexole|pramipexole|mesh-list
110778943|NCT00086307|Escitalopram|escitalopram|mesh-list
110778944|NCT00086307|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110778945|NCT00086307|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110778946|NCT00086307|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110778947|NCT00086307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110778948|NCT00086307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110778949|NCT00086307|Serotonin Agents|serotonin agents|mesh-ancestor
110778950|NCT00086307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110778951|NCT00086307|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110778952|NCT00086307|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110778953|NCT00086307|Antioxidants|antioxidants|mesh-ancestor
110778954|NCT00086307|Protective Agents|protective agents|mesh-ancestor
110778955|NCT00086307|Dopamine Agonists|dopamine agonists|mesh-ancestor
110778956|NCT00086307|Dopamine Agents|dopamine agents|mesh-ancestor
110778957|NCT01086579|Paclitaxel|paclitaxel|mesh-list
110778958|NCT01086579|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110778959|NCT01086579|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110778960|NCT01086579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110778961|NCT01086579|Tubulin Modulators|tubulin modulators|mesh-ancestor
110778962|NCT01086579|Antimitotic Agents|antimitotic agents|mesh-ancestor
110778963|NCT01086579|Mitosis Modulators|mitosis modulators|mesh-ancestor
110778964|NCT01086579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110778965|NCT03743922|Ergocalciferols|ergocalciferols|mesh-list
110778966|NCT03743922|Cholecalciferol|cholecalciferol|mesh-list
110778967|NCT03743922|Vitamin D|vitamin d|mesh-list
110778968|NCT03743922|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110778969|NCT03743922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110778970|NCT03743922|Vitamins|vitamins|mesh-ancestor
110778971|NCT03743922|Micronutrients|micronutrients|mesh-ancestor
110778972|NCT03743922|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110778973|NCT03988842|Heparin|heparin|mesh-list
110778974|NCT03988842|Calcium heparin|calcium heparin|mesh-list
110778975|NCT03988842|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
110778976|NCT03988842|Plasminogen|plasminogen|mesh-list
110778977|NCT03988842|Apixaban|apixaban|mesh-list
110778978|NCT03988842|Anticoagulants|anticoagulants|mesh-ancestor
110778979|NCT03988842|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110778980|NCT03988842|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110778981|NCT03988842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110778982|NCT03988842|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110778983|NCT03988842|Antithrombins|antithrombins|mesh-ancestor
110778984|NCT03988842|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110778985|NCT03988842|Protease Inhibitors|protease inhibitors|mesh-ancestor
110778986|NCT03988842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110778987|NCT02668822|Ibuprofen|ibuprofen|mesh-list
110778988|NCT02668822|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110778989|NCT02668822|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110778990|NCT02668822|Analgesics|analgesics|mesh-ancestor
110778991|NCT02668822|Sensory System Agents|sensory system agents|mesh-ancestor
110778992|NCT02668822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110778993|NCT02668822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110778994|NCT02668822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110778995|NCT02668822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110778996|NCT02668822|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110778997|NCT02668822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110778998|NCT02668822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110778999|NCT04112589|Cytarabine|cytarabine|mesh-list
110779000|NCT04112589|Fludarabine|fludarabine|mesh-list
110779001|NCT04112589|Idarubicin|idarubicin|mesh-list
110779002|NCT04112589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110779003|NCT04112589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110779004|NCT04112589|Antimetabolites|antimetabolites|mesh-ancestor
110779005|NCT04112589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110779006|NCT04112589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110779007|NCT04112589|Immunologic Factors|immunologic factors|mesh-ancestor
110779008|NCT04112589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110779009|NCT04112589|Antiviral Agents|antiviral agents|mesh-ancestor
110779010|NCT04112589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110779011|NCT04112589|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110779012|NCT04112589|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110779013|NCT04112589|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110779014|NCT04112589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110779015|NCT03547154|Interferons|interferons|mesh-list
110779016|NCT03547154|Interferon-alpha|interferon-alpha|mesh-list
110779017|NCT03547154|Interferon alpha-2|interferon alpha-2|mesh-list
110779018|NCT03547154|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110779019|NCT03547154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110779020|NCT03547154|Antiviral Agents|antiviral agents|mesh-ancestor
110779021|NCT03547154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110779022|NCT03547154|Immunologic Factors|immunologic factors|mesh-ancestor
110779023|NCT03547154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110779024|NCT02275546|NuvaRing|nuvaring|mesh-list
110779025|NCT02275546|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110779026|NCT02275546|Desogestrel|desogestrel|mesh-list
110779027|NCT02275546|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110779028|NCT02275546|Contraceptive Agents|contraceptive agents|mesh-ancestor
110779029|NCT02275546|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110779030|NCT02275546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110779031|NCT02275546|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110779032|NCT02275546|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110779033|NCT02275546|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110779034|NCT02275546|Estrogens|estrogens|mesh-ancestor
110779035|NCT02275546|Hormones|hormones|mesh-ancestor
110779036|NCT02275546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110779037|NCT02275546|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110779038|NCT02275546|Progestins|progestins|mesh-ancestor
110779039|NCT01090713|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
110779040|NCT01090713|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110779041|NCT01090713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110779042|NCT01090713|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110779043|NCT01090713|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110779044|NCT01090713|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110779045|NCT01090713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110779046|NCT01090713|Dopamine Agents|dopamine agents|mesh-ancestor
110779047|NCT01090713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110779048|NCT01096797|Sevoflurane|sevoflurane|mesh-list
110779049|NCT01096797|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110779050|NCT01096797|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110779051|NCT01096797|Anesthetics, General|anesthetics, general|mesh-ancestor
110779052|NCT01096797|Anesthetics|anesthetics|mesh-ancestor
110779053|NCT01096797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110779054|NCT01096797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110779055|NCT00068601|Cyclophosphamide|cyclophosphamide|mesh-list
110779056|NCT00068601|Goserelin|goserelin|mesh-list
110779057|NCT00068601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110779058|NCT00068601|Immunologic Factors|immunologic factors|mesh-ancestor
110779059|NCT00068601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110779060|NCT00068601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110779061|NCT00068601|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110779062|NCT00068601|Alkylating Agents|alkylating agents|mesh-ancestor
110779063|NCT00068601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110779064|NCT00068601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110779065|NCT00068601|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110779066|NCT00068601|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110779067|NCT01670656|Ibuprofen|ibuprofen|mesh-list
110779068|NCT01670656|Contraceptive Agents|contraceptive agents|mesh-list
110779069|NCT01670656|Etonogestrel|etonogestrel|mesh-list
110779070|NCT01670656|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110779071|NCT01670656|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110779072|NCT01670656|Analgesics|analgesics|mesh-ancestor
110779073|NCT01670656|Sensory System Agents|sensory system agents|mesh-ancestor
110779074|NCT01670656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110779075|NCT01670656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110779076|NCT01670656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110779077|NCT01670656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110779078|NCT01670656|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110779079|NCT01670656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110779080|NCT01670656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110779081|NCT01670656|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110779082|NCT01670656|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110779083|NCT01670656|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110779084|NCT03621696|Cisplatin|cisplatin|mesh-list
110779085|NCT03621696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110779086|NCT00068445|Lamotrigine|lamotrigine|mesh-list
110779087|NCT00068445|Anticonvulsants|anticonvulsants|mesh-ancestor
110779088|NCT00068445|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110779089|NCT00068445|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110779090|NCT00068445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110779091|NCT00068445|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110779092|NCT00068445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110779093|NCT00068445|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110779094|NCT00068445|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110779095|NCT00068445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110779096|NCT00068445|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110779097|NCT00068445|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110779098|NCT03033784|Oxytocin|oxytocin|mesh-list
110779099|NCT03033784|Oxytocics|oxytocics|mesh-ancestor
110493391|NCT00942266|Immunologic Factors|immunologic factors|mesh-ancestor
110779100|NCT03033784|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110779101|NCT03033784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110779102|NCT00038649|Imatinib Mesylate|imatinib mesylate|mesh-list
110779103|NCT00038649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110496753|NCT00671697|Decitabine|decitabine|mesh-list
110779104|NCT00038649|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110779105|NCT00038649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110779106|NCT00038649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110779108|NCT02926690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110779109|NCT02926690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110779110|NCT02926690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110779111|NCT03652818|Acetaminophen|acetaminophen|mesh-list
110779112|NCT03652818|Pregabalin|pregabalin|mesh-list
110779113|NCT03652818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110779114|NCT03652818|Analgesics|analgesics|mesh-ancestor
110779115|NCT03652818|Sensory System Agents|sensory system agents|mesh-ancestor
110779116|NCT03652818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110779117|NCT03652818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110779118|NCT03652818|Antipyretics|antipyretics|mesh-ancestor
110779119|NCT03652818|Anticonvulsants|anticonvulsants|mesh-ancestor
110779120|NCT03652818|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110779121|NCT03652818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110779122|NCT03652818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110779123|NCT03652818|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110779124|NCT03652818|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110779125|NCT03652818|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110779126|NCT03652818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110779127|NCT03652818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110779128|NCT03723824|Grazoprevir|grazoprevir|mesh-list
110779129|NCT03723824|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
110779130|NCT03723824|Antiviral Agents|antiviral agents|mesh-ancestor
110779131|NCT03723824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110779132|NCT00620464|Etonogestrel|etonogestrel|mesh-list
110779133|NCT00620464|Desogestrel|desogestrel|mesh-list
110779134|NCT00620464|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110779135|NCT00620464|Contraceptive Agents|contraceptive agents|mesh-ancestor
110779136|NCT00620464|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110779137|NCT00620464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110779138|NCT00620464|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110779139|NCT00620464|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110779140|NCT00620464|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110560307|NCT00859898|Metformin|metformin|mesh-list
110779141|NCT00620464|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110779142|NCT00620464|Progestins|progestins|mesh-ancestor
110779143|NCT00620464|Hormones|hormones|mesh-ancestor
110779144|NCT00620464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110779145|NCT00541684|Atenolol|atenolol|mesh-list
110779146|NCT00541684|Adrenergic Agents|adrenergic agents|mesh-ancestor
110779147|NCT00541684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110779148|NCT00541684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110779149|NCT00541684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110779150|NCT00541684|Autonomic Agents|autonomic agents|mesh-ancestor
110779151|NCT00541684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110779152|NCT00541684|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110779153|NCT00541684|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110779154|NCT00541684|Sympatholytics|sympatholytics|mesh-ancestor
110779155|NCT00541684|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110779156|NCT00541684|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110779157|NCT00541684|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110779158|NCT00413764|Tibolone|tibolone|mesh-list
110779159|NCT00413764|Norethindrone|norethindrone|mesh-list
110779160|NCT00413764|Norethindrone Acetate|norethindrone acetate|mesh-list
110779161|NCT00413764|Estradiol|estradiol|mesh-list
110779162|NCT00413764|Estrogens|estrogens|mesh-ancestor
110779163|NCT00413764|Hormones|hormones|mesh-ancestor
110779164|NCT00413764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110779165|NCT00413764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110779166|NCT00413764|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110779167|NCT00413764|Contraceptive Agents|contraceptive agents|mesh-ancestor
110779168|NCT00413764|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110779169|NCT00413764|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110779170|NCT00413764|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110779171|NCT00413764|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110779172|NCT00413764|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110779173|NCT00413764|Androgen Antagonists|androgen antagonists|mesh-ancestor
110779174|NCT00413764|Hormone Antagonists|hormone antagonists|mesh-ancestor
110779175|NCT00413764|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110779176|NCT00413764|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110779177|NCT00413764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110779178|NCT00413764|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110779179|NCT00413764|Anabolic Agents|anabolic agents|mesh-ancestor
110779180|NCT03726788|Triamcinolone|triamcinolone|mesh-list
110779181|NCT03726788|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110779182|NCT03726788|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110779183|NCT03726788|Botulinum Toxins|botulinum toxins|mesh-list
110779184|NCT03726788|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110779185|NCT03726788|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110779186|NCT03726788|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110779187|NCT03726788|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110779188|NCT03726788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110779189|NCT03726788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110779190|NCT03726788|Cholinergic Agents|cholinergic agents|mesh-ancestor
110779191|NCT03726788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110779192|NCT03726788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110779193|NCT03726788|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110779194|NCT03726788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110779195|NCT03726788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110779196|NCT03726788|Glucocorticoids|glucocorticoids|mesh-ancestor
110779197|NCT03726788|Hormones|hormones|mesh-ancestor
110779198|NCT03726788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110779199|NCT03726788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110779200|NCT03726788|Immunologic Factors|immunologic factors|mesh-ancestor
110779201|NCT03726788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110779202|NCT03735264|Docetaxel|docetaxel|mesh-list
110779203|NCT03735264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110779204|NCT03735264|Tubulin Modulators|tubulin modulators|mesh-ancestor
110779205|NCT03735264|Antimitotic Agents|antimitotic agents|mesh-ancestor
110779206|NCT03735264|Mitosis Modulators|mitosis modulators|mesh-ancestor
110779207|NCT03735264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110779208|NCT03560258|Vaccines|vaccines|mesh-list
110779209|NCT03560258|Immunologic Factors|immunologic factors|mesh-ancestor
110779210|NCT03560258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110779211|NCT02759380|Phytoestrogens|phytoestrogens|mesh-list
110779212|NCT02759380|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
110779213|NCT02759380|Estrogens|estrogens|mesh-ancestor
110779214|NCT02759380|Hormones|hormones|mesh-ancestor
110779215|NCT02759380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110779216|NCT02759380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110779217|NCT03539432|Gemfibrozil|gemfibrozil|mesh-list
110779218|NCT03539432|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110779219|NCT03539432|Antimetabolites|antimetabolites|mesh-ancestor
110779220|NCT03539432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110779221|NCT03539432|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110779222|NCT03539432|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
110779223|NCT03539432|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110779224|NCT03539432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110779225|NCT03615924|Ticagrelor|ticagrelor|mesh-list
110779226|NCT03615924|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110779227|NCT03615924|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110779228|NCT03615924|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110779229|NCT03615924|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110779230|NCT03615924|Purinergic Agents|purinergic agents|mesh-ancestor
110779231|NCT03615924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110779232|NCT03615924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110779233|NCT03615924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110779234|NCT05576038|Tryptophan|tryptophan|mesh-list
110779235|NCT05576038|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110779236|NCT05576038|Antidepressive Agents|antidepressive agents|mesh-ancestor
110779237|NCT05576038|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110779238|NCT04660240|Sirolimus|sirolimus|mesh-list
110779239|NCT04660240|Temsirolimus|temsirolimus|mesh-list
110779240|NCT04660240|MTOR Inhibitors|mtor inhibitors|mesh-list
110779241|NCT04660240|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110779242|NCT04660240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110779243|NCT04660240|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110779244|NCT04660240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110779245|NCT04660240|Antifungal Agents|antifungal agents|mesh-ancestor
110779246|NCT04660240|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110779247|NCT04660240|Immunologic Factors|immunologic factors|mesh-ancestor
110779248|NCT04660240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110779249|NCT04660240|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110779250|NCT04660240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110779251|NCT04660240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110682905|NCT02539979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110779252|NCT03033394|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110779253|NCT03033394|Penicillins|penicillins|mesh-list
110779254|NCT03033394|Lactams|lactams|mesh-list
110779255|NCT03033394|beta-Lactams|beta-lactams|mesh-list
110779256|NCT03033394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110779257|NCT03639428|Midazolam|midazolam|mesh-list
110779258|NCT03639428|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110779259|NCT03639428|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110779260|NCT03639428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110779261|NCT03639428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110779262|NCT03639428|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110779263|NCT03639428|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110779264|NCT03639428|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110779265|NCT03639428|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110779266|NCT03639428|Anesthetics, General|anesthetics, general|mesh-ancestor
110779267|NCT03639428|Anesthetics|anesthetics|mesh-ancestor
110779268|NCT03639428|GABA Modulators|gaba modulators|mesh-ancestor
110779269|NCT03639428|GABA Agents|gaba agents|mesh-ancestor
110779270|NCT03639428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110779271|NCT03639428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110779272|NCT04575688|Bupivacaine|bupivacaine|mesh-list
110779273|NCT04575688|Anesthetics, Local|anesthetics, local|mesh-ancestor
110779274|NCT04575688|Anesthetics|anesthetics|mesh-ancestor
110779275|NCT04575688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110779276|NCT04575688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110779277|NCT04575688|Sensory System Agents|sensory system agents|mesh-ancestor
110779278|NCT04575688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110779279|NCT04561648|Heparin|heparin|mesh-list
110779280|NCT04561648|Calcium heparin|calcium heparin|mesh-list
110779281|NCT04561648|Anticoagulants|anticoagulants|mesh-ancestor
110779282|NCT04561648|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110779283|NCT04561648|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110779284|NCT04561648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110779285|NCT03981822|Cantharidin|cantharidin|mesh-list
110779286|NCT03981822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110779287|NCT03981822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110779288|NCT03704818|Dapagliflozin|dapagliflozin|mesh-list
110104349|NCT01779271|Analgesics|analgesics|mesh-ancestor
110779289|NCT03704818|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110779290|NCT03704818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110779291|NCT03704818|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110779292|NCT03704818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110779293|NCT05506930|Morphine|morphine|mesh-list
110779294|NCT05506930|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110779295|NCT05506930|Narcotics|narcotics|mesh-ancestor
110779296|NCT05506930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110779297|NCT05506930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110779298|NCT05506930|Analgesics|analgesics|mesh-ancestor
110779299|NCT05506930|Sensory System Agents|sensory system agents|mesh-ancestor
110779300|NCT05506930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110779301|NCT05464264|Ketamine|ketamine|mesh-list
110779302|NCT05464264|Analgesics|analgesics|mesh-ancestor
110779303|NCT05464264|Sensory System Agents|sensory system agents|mesh-ancestor
110779304|NCT05464264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110779305|NCT05464264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110779306|NCT05464264|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110779307|NCT05464264|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110779308|NCT05464264|Anesthetics, General|anesthetics, general|mesh-ancestor
110779309|NCT05464264|Anesthetics|anesthetics|mesh-ancestor
110779310|NCT05464264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110779311|NCT05464264|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110779312|NCT05464264|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110779313|NCT05464264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110779314|NCT05464264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110779315|NCT01310738|Amphotericin B|amphotericin b|mesh-list
110779316|NCT01310738|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
110779317|NCT01310738|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
110779318|NCT01310738|Meglumine Antimoniate|meglumine antimoniate|mesh-list
110779319|NCT01310738|Deoxycholic Acid|deoxycholic acid|mesh-list
110779320|NCT01310738|Amebicides|amebicides|mesh-ancestor
110779321|NCT01310738|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110779322|NCT01310738|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110779323|NCT01310738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110779324|NCT01310738|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110779325|NCT01310738|Antifungal Agents|antifungal agents|mesh-ancestor
110779326|NCT01310738|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
110779327|NCT01310738|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110779328|NCT03704506|Amoxicillin|amoxicillin|mesh-list
110779329|NCT03704506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110779330|NCT03704506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110779331|NCT03615144|Fludarabine|fludarabine|mesh-list
110779332|NCT03615144|Melphalan|melphalan|mesh-list
110779333|NCT03615144|Thiotepa|thiotepa|mesh-list
110779334|NCT03615144|Clofarabine|clofarabine|mesh-list
110779335|NCT03615144|Thymoglobulin|thymoglobulin|mesh-list
110779336|NCT03615144|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110779337|NCT03615144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110779338|NCT03615144|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110779339|NCT03615144|Antimetabolites|antimetabolites|mesh-ancestor
110779340|NCT03615144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110779341|NCT03615144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110779342|NCT03615144|Immunologic Factors|immunologic factors|mesh-ancestor
110779343|NCT03615144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110779344|NCT03615144|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110779345|NCT03615144|Alkylating Agents|alkylating agents|mesh-ancestor
110779346|NCT03615144|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110779347|NCT05340790|Anti-Infective Agents|anti-infective agents|mesh-list
110779348|NCT05340790|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110779349|NCT03682302|Bupivacaine|bupivacaine|mesh-list
110779350|NCT03682302|Anesthetics, Local|anesthetics, local|mesh-ancestor
110779351|NCT03682302|Anesthetics|anesthetics|mesh-ancestor
110779352|NCT03682302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110779353|NCT03682302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110779354|NCT03682302|Sensory System Agents|sensory system agents|mesh-ancestor
110779355|NCT03682302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110779356|NCT03522506|Modafinil|modafinil|mesh-list
110779357|NCT03522506|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110779358|NCT03522506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110779359|NCT03522506|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
110779360|NCT03522506|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110779361|NCT03522506|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110779362|NCT03522506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110779363|NCT03320434|Prednisolone acetate|prednisolone acetate|mesh-list
110779364|NCT03320434|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110779365|NCT03320434|Methylprednisolone|methylprednisolone|mesh-list
110779366|NCT03320434|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110779367|NCT03320434|Prednisolone|prednisolone|mesh-list
110779368|NCT03320434|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110779369|NCT03320434|Prednisolone phosphate|prednisolone phosphate|mesh-list
110779370|NCT03320434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110779371|NCT03320434|Antiemetics|antiemetics|mesh-ancestor
110779372|NCT03320434|Autonomic Agents|autonomic agents|mesh-ancestor
110493414|NCT04079374|Immunologic Factors|immunologic factors|mesh-ancestor
110779373|NCT03320434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110779374|NCT03320434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110779375|NCT03320434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110779376|NCT03320434|Glucocorticoids|glucocorticoids|mesh-ancestor
110779377|NCT03320434|Hormones|hormones|mesh-ancestor
110779378|NCT03320434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110779379|NCT03320434|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110779380|NCT03320434|Protective Agents|protective agents|mesh-ancestor
110779381|NCT03320434|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110779382|NCT03320434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110779383|NCT02892734|Nivolumab|nivolumab|mesh-list
110779384|NCT02892734|Ipilimumab|ipilimumab|mesh-list
110779385|NCT02892734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110779386|NCT02892734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110779387|NCT02892734|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110779388|NCT02892734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110779389|NCT05231590|Myeloma Proteins|myeloma proteins|mesh-list
110779390|NCT05231590|Paraproteins|paraproteins|mesh-list
110779391|NCT05231590|Immunologic Factors|immunologic factors|mesh-ancestor
110779392|NCT05231590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110779393|NCT00055497|Adalimumab|adalimumab|mesh-list
110779394|NCT00055497|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110779395|NCT00055497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110779396|NCT00055497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110779397|NCT03726398|Macitentan|macitentan|mesh-list
110779398|NCT03726398|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
110779399|NCT03726398|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
110779400|NCT03726398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110779401|NCT03726398|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
110779402|NCT04050592|Estradiol|estradiol|mesh-list
110497042|NCT00996593|Iodine|iodine|mesh-list
110779403|NCT04050592|Estrogens|estrogens|mesh-ancestor
110779404|NCT04050592|Hormones|hormones|mesh-ancestor
110779405|NCT04050592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110779406|NCT04050592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110779407|NCT03726242|Cromakalim|cromakalim|mesh-list
110779408|NCT03726242|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110779409|NCT03726242|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110779410|NCT03726242|Autonomic Agents|autonomic agents|mesh-ancestor
110779411|NCT03726242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110779412|NCT03726242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110779413|NCT03726242|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110779414|NCT03726242|Respiratory System Agents|respiratory system agents|mesh-ancestor
110779415|NCT03726242|Parasympatholytics|parasympatholytics|mesh-ancestor
110779416|NCT03726242|Vasodilator Agents|vasodilator agents|mesh-ancestor
110779417|NCT03731988|Lidocaine|lidocaine|mesh-list
110779418|NCT03731988|Prilocaine|prilocaine|mesh-list
110779419|NCT03731988|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
110779420|NCT03731988|Anesthetics, Local|anesthetics, local|mesh-ancestor
110779421|NCT03731988|Anesthetics|anesthetics|mesh-ancestor
110779422|NCT03731988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110779423|NCT03731988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110779424|NCT03731988|Sensory System Agents|sensory system agents|mesh-ancestor
110779425|NCT03731988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110779426|NCT03731988|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110779427|NCT03731988|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110779428|NCT03731988|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110779429|NCT03731988|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110779430|NCT03731988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110779431|NCT03731988|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
110779432|NCT01094457|Aspirin|aspirin|mesh-list
110779433|NCT01094457|Cilostazol|cilostazol|mesh-list
110779434|NCT01094457|Clopidogrel|clopidogrel|mesh-list
110779435|NCT01094457|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110779436|NCT01094457|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110779437|NCT01094457|Analgesics|analgesics|mesh-ancestor
110779438|NCT01094457|Sensory System Agents|sensory system agents|mesh-ancestor
110779439|NCT01094457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110779440|NCT01094457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110779441|NCT01094457|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110779442|NCT01094457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110779443|NCT01094457|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110779444|NCT01094457|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110849627|NCT03844763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110779445|NCT01094457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110779446|NCT01094457|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110779447|NCT01094457|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110779448|NCT01094457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110779450|NCT01094457|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110779451|NCT01094457|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110779452|NCT01094457|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110779453|NCT01094457|Purinergic Agents|purinergic agents|mesh-ancestor
110779454|NCT01094457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110779455|NCT01094457|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110779456|NCT01094457|Autonomic Agents|autonomic agents|mesh-ancestor
110779457|NCT01094457|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110779458|NCT01094457|Respiratory System Agents|respiratory system agents|mesh-ancestor
110779459|NCT01094457|Vasodilator Agents|vasodilator agents|mesh-ancestor
110779460|NCT01094457|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110779461|NCT01094457|Protective Agents|protective agents|mesh-ancestor
110779462|NCT01094457|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110779463|NCT01094457|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110779464|NCT03701698|Methylprednisolone|methylprednisolone|mesh-list
110779465|NCT03701698|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110779466|NCT03701698|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110779467|NCT03701698|Prednisolone|prednisolone|mesh-list
110779468|NCT03701698|Prednisolone acetate|prednisolone acetate|mesh-list
110779469|NCT03701698|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110779470|NCT03701698|Prednisolone phosphate|prednisolone phosphate|mesh-list
110779471|NCT03701698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110779472|NCT03701698|Antiemetics|antiemetics|mesh-ancestor
110779473|NCT03701698|Autonomic Agents|autonomic agents|mesh-ancestor
110779474|NCT03701698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110779475|NCT03701698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110779476|NCT03701698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110497129|NCT00927758|Hormones|hormones|mesh-ancestor
110779482|NCT03701698|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110779483|NCT03701698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110779484|NCT03734562|Amiodarone|amiodarone|mesh-list
110779485|NCT03734562|Sotalol|sotalol|mesh-list
110779486|NCT03734562|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
110779487|NCT03734562|Vasodilator Agents|vasodilator agents|mesh-ancestor
110779488|NCT03734562|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
110779489|NCT03734562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110779490|NCT03734562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110779491|NCT03734562|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110779492|NCT03734562|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110779493|NCT03734562|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110779494|NCT03734562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110779495|NCT03734562|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110779496|NCT03734562|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110779497|NCT03734562|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110779498|NCT03734562|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110779499|NCT03734562|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110779500|NCT03734562|Adrenergic Agents|adrenergic agents|mesh-ancestor
110779501|NCT03734562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110779502|NCT03734562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110779503|NCT03734562|Sympatholytics|sympatholytics|mesh-ancestor
110779504|NCT03734562|Autonomic Agents|autonomic agents|mesh-ancestor
110779505|NCT03734562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110779506|NCT03034096|Propofol|propofol|mesh-list
110779507|NCT03034096|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110779508|NCT03034096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110779509|NCT03034096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110779510|NCT03034096|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110779511|NCT03034096|Anesthetics, General|anesthetics, general|mesh-ancestor
110779512|NCT03034096|Anesthetics|anesthetics|mesh-ancestor
110779518|NCT03721874|Dapagliflozin|dapagliflozin|mesh-list
110779519|NCT03721874|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110779520|NCT03721874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110779521|NCT03721874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110779522|NCT03721874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110779523|NCT03807843|Vaccines|vaccines|mesh-list
110849637|NCT04500496|Isoniazid|isoniazid|mesh-list
110779524|NCT03807843|Immunologic Factors|immunologic factors|mesh-ancestor
110779525|NCT03807843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110779526|NCT01094535|Secretin|secretin|mesh-list
110779527|NCT01094535|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110779528|NCT01094535|Hormones|hormones|mesh-ancestor
110779529|NCT01094535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110779530|NCT01094535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110779531|NCT02843074|Dexamethasone|dexamethasone|mesh-list
110779532|NCT02843074|Lenalidomide|lenalidomide|mesh-list
110779533|NCT02843074|Elotuzumab|elotuzumab|mesh-list
110779534|NCT02843074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110779535|NCT02843074|Antiemetics|antiemetics|mesh-ancestor
110779536|NCT02843074|Autonomic Agents|autonomic agents|mesh-ancestor
110779537|NCT02843074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110779538|NCT02843074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110779539|NCT02843074|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110779540|NCT02843074|Glucocorticoids|glucocorticoids|mesh-ancestor
110779541|NCT02843074|Hormones|hormones|mesh-ancestor
110779542|NCT02843074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110779543|NCT02843074|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110779544|NCT02843074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110779545|NCT02843074|Immunologic Factors|immunologic factors|mesh-ancestor
110779546|NCT02843074|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110779547|NCT02843074|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110779548|NCT02843074|Growth Substances|growth substances|mesh-ancestor
110779549|NCT02843074|Growth Inhibitors|growth inhibitors|mesh-ancestor
110682906|NCT02539979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110779554|NCT00038103|Analgesics|analgesics|mesh-ancestor
110779555|NCT00038103|Sensory System Agents|sensory system agents|mesh-ancestor
110779556|NCT00038103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110779557|NCT00038103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110779558|NCT00038103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110779559|NCT00038103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110779560|NCT00038103|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110779561|NCT00038103|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110779562|NCT00038103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110779563|NCT00038103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110779564|NCT00038103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110779565|NCT00038103|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110779566|NCT00038103|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110779567|NCT00038103|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110779568|NCT00038103|Hormone Antagonists|hormone antagonists|mesh-ancestor
110779569|NCT00038103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110779570|NCT03678870|Analgesics, Opioid|analgesics, opioid|mesh-list
110779571|NCT03678870|Narcotics|narcotics|mesh-ancestor
110779572|NCT03678870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110779573|NCT03678870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110779574|NCT03678870|Analgesics|analgesics|mesh-ancestor
110779575|NCT03678870|Sensory System Agents|sensory system agents|mesh-ancestor
110779576|NCT03678870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110779577|NCT03032380|Meropenem|meropenem|mesh-list
110779578|NCT03032380|Linezolid|linezolid|mesh-list
110779579|NCT03032380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110779580|NCT03032380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110779581|NCT03032380|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110779582|NCT03032380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110779583|NCT03032380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110779584|NCT03519854|Bromides|bromides|mesh-list
110779585|NCT03519854|Rocuronium|rocuronium|mesh-list
110779586|NCT03519854|Anticonvulsants|anticonvulsants|mesh-ancestor
110779587|NCT03519854|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110779588|NCT03519854|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110779589|NCT03519854|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110779590|NCT03519854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110779591|NCT03519854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110779595|NCT03479216|Magnesium Sulfate|magnesium sulfate|mesh-list
110779596|NCT03479216|Dexmedetomidine|dexmedetomidine|mesh-list
110779597|NCT03479216|Bupivacaine|bupivacaine|mesh-list
110779598|NCT03479216|Anesthetics, Local|anesthetics, local|mesh-ancestor
110779599|NCT03479216|Anesthetics|anesthetics|mesh-ancestor
110779600|NCT03479216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110779601|NCT03479216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110779602|NCT03479216|Sensory System Agents|sensory system agents|mesh-ancestor
110779603|NCT03479216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110779604|NCT03479216|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110779605|NCT03479216|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110779607|NCT03479216|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110779608|NCT03479216|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110779609|NCT03479216|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110779610|NCT03479216|Adrenergic Agents|adrenergic agents|mesh-ancestor
110779611|NCT03479216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110779612|NCT03479216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110779613|NCT03479216|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110779614|NCT03479216|Anticonvulsants|anticonvulsants|mesh-ancestor
110779615|NCT03479216|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110779616|NCT03479216|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110779617|NCT03479216|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110779618|NCT03479216|Tocolytic Agents|tocolytic agents|mesh-ancestor
110779619|NCT03479216|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110779620|NCT03717116|Parathyroid Hormone|parathyroid hormone|mesh-list
110779621|NCT03717116|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110779622|NCT03717116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110779623|NCT03717038|Trifluridine|trifluridine|mesh-list
110779624|NCT03717038|Antimetabolites|antimetabolites|mesh-ancestor
110779625|NCT03717038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110779626|NCT03717038|Antiviral Agents|antiviral agents|mesh-ancestor
110779627|NCT03717038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110779628|NCT00143182|Olanzapine|olanzapine|mesh-list
110779629|NCT00143182|Asenapine|asenapine|mesh-list
110779630|NCT00143182|Antiemetics|antiemetics|mesh-ancestor
110779631|NCT00143182|Autonomic Agents|autonomic agents|mesh-ancestor
110779632|NCT00143182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110779633|NCT00143182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110779634|NCT00143182|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110779635|NCT00143182|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110779636|NCT00143182|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110779637|NCT00143182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110779638|NCT00143182|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110779639|NCT00143182|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110779640|NCT00143182|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110779641|NCT00143182|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110779642|NCT00143182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110779643|NCT00143182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110779644|NCT00143182|Serotonin Agents|serotonin agents|mesh-ancestor
110779645|NCT03677934|Ranibizumab|ranibizumab|mesh-list
110779646|NCT03677934|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110779647|NCT03677934|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110779648|NCT03677934|Growth Substances|growth substances|mesh-ancestor
110779649|NCT03677934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110779650|NCT03677934|Growth Inhibitors|growth inhibitors|mesh-ancestor
110779651|NCT03677934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110779652|NCT03435692|Acetaminophen|acetaminophen|mesh-list
110779653|NCT03435692|Diphenhydramine|diphenhydramine|mesh-list
110779654|NCT03435692|Promethazine|promethazine|mesh-list
110779655|NCT03435692|Fentanyl|fentanyl|mesh-list
110779656|NCT03435692|Morphine|morphine|mesh-list
110779657|NCT03435692|Oxycodone|oxycodone|mesh-list
110779658|NCT03435692|Lorazepam|lorazepam|mesh-list
110779659|NCT03435692|Ondansetron|ondansetron|mesh-list
110779660|NCT03435692|Ropivacaine|ropivacaine|mesh-list
110779661|NCT03435692|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110779662|NCT03435692|Narcotics|narcotics|mesh-ancestor
110779663|NCT03435692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110849642|NCT04500496|Antitubercular Agents|antitubercular agents|mesh-ancestor
110779664|NCT03435692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110779665|NCT03435692|Analgesics|analgesics|mesh-ancestor
110779666|NCT03435692|Sensory System Agents|sensory system agents|mesh-ancestor
110779667|NCT03435692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110779668|NCT03435692|Anesthetics, Local|anesthetics, local|mesh-ancestor
110779669|NCT03435692|Anesthetics|anesthetics|mesh-ancestor
110779670|NCT03435692|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110779671|NCT03435692|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110779672|NCT03435692|Anesthetics, General|anesthetics, general|mesh-ancestor
110779673|NCT03435692|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110779674|NCT03435692|Antipyretics|antipyretics|mesh-ancestor
110779675|NCT03435692|Antiemetics|antiemetics|mesh-ancestor
110779677|NCT03435692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110779678|NCT03435692|Antipruritics|antipruritics|mesh-ancestor
110779679|NCT03435692|Dermatologic Agents|dermatologic agents|mesh-ancestor
110779680|NCT03435692|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110779681|NCT03435692|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110779682|NCT03435692|Serotonin Agents|serotonin agents|mesh-ancestor
110779683|NCT03435692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110779684|NCT03435692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110779685|NCT03435692|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110779686|NCT03435692|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110779687|NCT03435692|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110779688|NCT03435692|Histamine Antagonists|histamine antagonists|mesh-ancestor
110779689|NCT03435692|Histamine Agents|histamine agents|mesh-ancestor
110779690|NCT03435692|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110779691|NCT03435692|Anticonvulsants|anticonvulsants|mesh-ancestor
110779692|NCT03435692|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110779693|NCT03435692|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110779694|NCT03435692|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110779695|NCT03435692|GABA Modulators|gaba modulators|mesh-ancestor
110779696|NCT03435692|GABA Agents|gaba agents|mesh-ancestor
110779697|NCT03705442|Loperamide|loperamide|mesh-list
110682907|NCT02539979|Antipyretics|antipyretics|mesh-ancestor
110779698|NCT03705442|Antidiarrheals|antidiarrheals|mesh-list
110779699|NCT03705442|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110779700|NCT04817410|Naltrexone|naltrexone|mesh-list
110779701|NCT04817410|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110779703|NCT04817410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110779704|NCT04817410|Sensory System Agents|sensory system agents|mesh-ancestor
110779705|NCT04817410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110779706|NCT03673956|Vancomycin|vancomycin|mesh-list
110779707|NCT03673956|Levofloxacin|levofloxacin|mesh-list
110779708|NCT03673956|Tobramycin|tobramycin|mesh-list
110779709|NCT03673956|Mupirocin|mupirocin|mesh-list
110779710|NCT03673956|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110779711|NCT03673956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110779712|NCT03673956|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110779713|NCT03673956|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110779714|NCT03673956|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110779715|NCT03673956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110779716|NCT03673956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110779717|NCT03673956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110779718|NCT03673956|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110779719|NCT03673956|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110779720|NCT03673956|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110779721|NCT03716804|Ciprofloxacin|ciprofloxacin|mesh-list
110779722|NCT03716804|Cefuroxime|cefuroxime|mesh-list
110779723|NCT03716804|Cefuroxime axetil|cefuroxime axetil|mesh-list
110779724|NCT03716804|Nitrofurantoin|nitrofurantoin|mesh-list
110779725|NCT03716804|Cefixime|cefixime|mesh-list
110779726|NCT03716804|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110779727|NCT03716804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110779728|NCT03716804|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110779729|NCT03716804|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110779730|NCT03716804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110779731|NCT03716804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110779732|NCT03716804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110779733|NCT03716804|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110779734|NCT03716804|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110779735|NCT03716804|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110779736|NCT01310166|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
110779737|NCT01310166|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
110779738|NCT01310166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110779739|NCT01310166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110779740|NCT01310166|Immunologic Factors|immunologic factors|mesh-ancestor
110779741|NCT01310166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110779742|NCT03733860|Alprostadil|alprostadil|mesh-list
110779743|NCT03733860|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110779744|NCT03733860|Vasodilator Agents|vasodilator agents|mesh-ancestor
110779745|NCT03733860|Urological Agents|urological agents|mesh-ancestor
110779746|NCT03605862|Nitazoxanide|nitazoxanide|mesh-list
110779747|NCT03605862|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110779748|NCT03605862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110779749|NCT01310244|Paclitaxel|paclitaxel|mesh-list
110779750|NCT01310244|Carboplatin|carboplatin|mesh-list
110779751|NCT01310244|Belinostat|belinostat|mesh-list
110104804|NCT01782508|Imatinib Mesylate|imatinib mesylate|mesh-list
110779752|NCT01310244|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110779753|NCT01310244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110779754|NCT01310244|Tubulin Modulators|tubulin modulators|mesh-ancestor
110779755|NCT01310244|Antimitotic Agents|antimitotic agents|mesh-ancestor
110779756|NCT01310244|Mitosis Modulators|mitosis modulators|mesh-ancestor
110779757|NCT01310244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110779758|NCT01310244|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110779759|NCT01310244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110779760|NCT03672006|Heparin|heparin|mesh-list
110779761|NCT03672006|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
110779762|NCT03672006|Anticoagulants|anticoagulants|mesh-ancestor
110779763|NCT03672006|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110779764|NCT03672006|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110779765|NCT03672006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110779766|NCT03621072|Fluconazole|fluconazole|mesh-list
110779767|NCT03621072|Antifungal Agents|antifungal agents|mesh-ancestor
110779768|NCT03621072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110779769|NCT03621072|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110779770|NCT03621072|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110779771|NCT03621072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110779772|NCT03621072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110779773|NCT03621072|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110779774|NCT03621072|Hormone Antagonists|hormone antagonists|mesh-ancestor
110682908|NCT05277701|Lazertinib|lazertinib|mesh-list
110779775|NCT03621072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110779776|NCT03621072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110779777|NCT03621072|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110779778|NCT03621072|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110779779|NCT03512288|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110779780|NCT03512288|Immunologic Factors|immunologic factors|mesh-ancestor
110779781|NCT03512288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110779782|NCT01311050|Bevacizumab|bevacizumab|mesh-list
110779783|NCT01311050|Capecitabine|capecitabine|mesh-list
110779784|NCT01311050|Oxaliplatin|oxaliplatin|mesh-list
110779785|NCT01311050|Irinotecan|irinotecan|mesh-list
110849672|NCT01199159|Vitamin B 6|vitamin b 6|mesh-list
110779786|NCT01311050|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110779787|NCT01311050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110779788|NCT01311050|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110779789|NCT01311050|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110779790|NCT01311050|Growth Substances|growth substances|mesh-ancestor
110598586|NCT00720590|Lopinavir|lopinavir|mesh-list
110779791|NCT01311050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110779792|NCT01311050|Growth Inhibitors|growth inhibitors|mesh-ancestor
110779793|NCT01311050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110779794|NCT01311050|Antimetabolites|antimetabolites|mesh-ancestor
110779795|NCT01311050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110779796|NCT01311050|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110779797|NCT01311050|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110779798|NCT01311050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110779799|NCT03700450|Cyclophosphamide|cyclophosphamide|mesh-list
110779800|NCT03700450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110779801|NCT03700450|Immunologic Factors|immunologic factors|mesh-ancestor
110779802|NCT03700450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110779803|NCT03700450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110779804|NCT03700450|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110779805|NCT03700450|Alkylating Agents|alkylating agents|mesh-ancestor
110779806|NCT03700450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110779807|NCT03700450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110779808|NCT03700450|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110779809|NCT03702946|Oxytocin|oxytocin|mesh-list
110779810|NCT03702946|Oxytocics|oxytocics|mesh-ancestor
110779811|NCT03702946|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110779812|NCT03702946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110779813|NCT04491526|Tamsulosin|tamsulosin|mesh-list
110779814|NCT04491526|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110779815|NCT04491526|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110779816|NCT04491526|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110779817|NCT04491526|Adrenergic Agents|adrenergic agents|mesh-ancestor
110779818|NCT04491526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110779819|NCT04491526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110779820|NCT04491526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110779821|NCT04491526|Urological Agents|urological agents|mesh-ancestor
110779822|NCT04484350|Enalapril|enalapril|mesh-list
110779823|NCT04484350|Labetalol|labetalol|mesh-list
110779824|NCT04484350|Hydralazine|hydralazine|mesh-list
110779825|NCT04484350|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110779826|NCT04484350|Protease Inhibitors|protease inhibitors|mesh-ancestor
110779827|NCT04484350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110779828|NCT04484350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110779829|NCT04484350|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110779830|NCT04484350|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110779831|NCT04484350|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110779832|NCT04484350|Adrenergic Agents|adrenergic agents|mesh-ancestor
110779833|NCT04484350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110779834|NCT04484350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110779835|NCT04484350|Sympathomimetics|sympathomimetics|mesh-ancestor
110779836|NCT04484350|Autonomic Agents|autonomic agents|mesh-ancestor
110779837|NCT04484350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110779838|NCT04484350|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110779839|NCT04484350|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110779840|NCT04484350|Vasodilator Agents|vasodilator agents|mesh-ancestor
110779841|NCT03699904|Valacyclovir|valacyclovir|mesh-list
110779842|NCT03699904|Antiviral Agents|antiviral agents|mesh-ancestor
110779843|NCT03699904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110779844|NCT03697018|Lithium Carbonate|lithium carbonate|mesh-list
110779845|NCT03697018|Antidepressive Agents|antidepressive agents|mesh-ancestor
110779846|NCT03697018|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110779847|NCT03697018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110497490|NCT00795613|Tubulin Modulators|tubulin modulators|mesh-ancestor
110779848|NCT03697018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110779849|NCT03697018|Antimanic Agents|antimanic agents|mesh-ancestor
110779850|NCT03697018|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110849688|NCT02507440|Lidocaine|lidocaine|mesh-list
110779851|NCT03697018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110779852|NCT03697018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110779853|NCT03696940|Atorvastatin|atorvastatin|mesh-list
110779854|NCT03696940|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110779855|NCT03696940|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110779856|NCT03696940|Antimetabolites|antimetabolites|mesh-ancestor
110493466|NCT00672841|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110779857|NCT03696940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110779858|NCT03696940|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110779859|NCT03696940|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110779860|NCT03696940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110779862|NCT03731442|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110779863|NCT03731442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110779864|NCT03731442|Tubulin Modulators|tubulin modulators|mesh-ancestor
110779865|NCT03731442|Antimitotic Agents|antimitotic agents|mesh-ancestor
110779866|NCT03731442|Mitosis Modulators|mitosis modulators|mesh-ancestor
110779867|NCT03731442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110779868|NCT03702400|Phenylephrine|phenylephrine|mesh-list
110779869|NCT03702400|Oxymetazoline|oxymetazoline|mesh-list
110779870|NCT03702400|Norepinephrine|norepinephrine|mesh-list
110779871|NCT03702400|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110779872|NCT03702400|Mydriatics|mydriatics|mesh-ancestor
110779873|NCT03702400|Autonomic Agents|autonomic agents|mesh-ancestor
110779874|NCT03702400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110779875|NCT03702400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110779876|NCT03702400|Sympathomimetics|sympathomimetics|mesh-ancestor
110779877|NCT03702400|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110779878|NCT03702400|Nasal Decongestants|nasal decongestants|mesh-ancestor
110779879|NCT03702400|Respiratory System Agents|respiratory system agents|mesh-ancestor
110779880|NCT03702400|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110779881|NCT03702400|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110779882|NCT03702400|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110779883|NCT03702400|Adrenergic Agents|adrenergic agents|mesh-ancestor
110779884|NCT03702400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110779885|NCT03702400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110779886|NCT03702400|Protective Agents|protective agents|mesh-ancestor
110779887|NCT03699202|Ziresovir|ziresovir|mesh-list
110779888|NCT03699202|Antiviral Agents|antiviral agents|mesh-ancestor
110779889|NCT03699202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110779890|NCT03598140|Sildenafil Citrate|sildenafil citrate|mesh-list
110779891|NCT03598140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110779892|NCT03598140|Vasodilator Agents|vasodilator agents|mesh-ancestor
110779893|NCT03598140|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110779894|NCT03598140|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110779895|NCT03598140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110779896|NCT03598140|Urological Agents|urological agents|mesh-ancestor
110779897|NCT03644550|Pembrolizumab|pembrolizumab|mesh-list
110779898|NCT03644550|LMB-100|lmb-100|mesh-list
110779899|NCT03644550|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110779900|NCT03644550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110779901|NCT03644550|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110779902|NCT03644550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110779903|NCT03644550|Immunoconjugates|immunoconjugates|mesh-ancestor
110779904|NCT03644550|Immunologic Factors|immunologic factors|mesh-ancestor
110779905|NCT03644550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110779906|NCT00054717|Ritonavir|ritonavir|mesh-list
110779907|NCT00054717|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
110779908|NCT00054717|Tipranavir|tipranavir|mesh-list
110779909|NCT00054717|Protease Inhibitors|protease inhibitors|mesh-list
110779910|NCT00054717|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110779911|NCT00054717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110779912|NCT00054717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110779913|NCT00054717|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110779914|NCT00054717|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110779915|NCT00054717|Antiviral Agents|antiviral agents|mesh-ancestor
110779916|NCT00054717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110779917|NCT00054717|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110779918|NCT00054717|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110779919|NCT03430856|Insulin|insulin|mesh-list
110779920|NCT03430856|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110779921|NCT03430856|Insulin Aspart|insulin aspart|mesh-list
110779922|NCT03430856|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110779923|NCT03430856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110779924|NCT01097265|Capecitabine|capecitabine|mesh-list
110779925|NCT01097265|Oxaliplatin|oxaliplatin|mesh-list
110779926|NCT01097265|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110779927|NCT01097265|Antimetabolites|antimetabolites|mesh-ancestor
110779928|NCT01097265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110779929|NCT01097265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110779930|NCT03731286|Caffeine|caffeine|mesh-list
110779931|NCT03731286|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110779932|NCT03731286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110779933|NCT03731286|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110779934|NCT03731286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110779935|NCT03731286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110779936|NCT03731286|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110779937|NCT03731286|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110779938|NCT03731286|Purinergic Agents|purinergic agents|mesh-ancestor
110779939|NCT03731286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110779940|NCT00066807|Tamoxifen|tamoxifen|mesh-list
110779941|NCT00066807|Epirubicin|epirubicin|mesh-list
110779942|NCT00066807|Exemestane|exemestane|mesh-list
110779943|NCT00066807|Triptorelin Pamoate|triptorelin pamoate|mesh-list
110779944|NCT00066807|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110779945|NCT00066807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110779946|NCT00066807|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110779947|NCT00066807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110779948|NCT00066807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110779949|NCT00066807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110779950|NCT00066807|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110779951|NCT00066807|Hormone Antagonists|hormone antagonists|mesh-ancestor
110779952|NCT00066807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110779953|NCT00066807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110779954|NCT00066807|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110779955|NCT00066807|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110779956|NCT00066807|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110779957|NCT00066807|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110779958|NCT00066807|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110779959|NCT00066807|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110779960|NCT00066807|Luteolytic Agents|luteolytic agents|mesh-ancestor
110779961|NCT00066807|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110779962|NCT00066807|Contraceptive Agents|contraceptive agents|mesh-ancestor
110779963|NCT00066807|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110779964|NCT00066807|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110779965|NCT03619330|Liraglutide|liraglutide|mesh-list
110779966|NCT03619330|Testosterone|testosterone|mesh-list
110779967|NCT03619330|Androgens|androgens|mesh-ancestor
110779968|NCT03619330|Hormones|hormones|mesh-ancestor
110779969|NCT03619330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110779970|NCT03619330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110779971|NCT03619330|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110779972|NCT03619330|Incretins|incretins|mesh-ancestor
110779973|NCT04457284|Nivolumab|nivolumab|mesh-list
110779974|NCT04457284|Temozolomide|temozolomide|mesh-list
110779975|NCT04457284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110779976|NCT04457284|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110779977|NCT04457284|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110779978|NCT04457284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110779979|NCT04457284|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110779980|NCT04457284|Alkylating Agents|alkylating agents|mesh-ancestor
110779981|NCT00054639|Rituximab|rituximab|mesh-list
110779982|NCT00054639|Oblimersen|oblimersen|mesh-list
110779983|NCT00054639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110779984|NCT00054639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110779985|NCT00054639|Immunologic Factors|immunologic factors|mesh-ancestor
110779986|NCT00054639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110779987|NCT00054639|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110779988|NCT02530359|Pirfenidone|pirfenidone|mesh-list
110779989|NCT02530359|Analgesics|analgesics|mesh-ancestor
110779990|NCT02530359|Sensory System Agents|sensory system agents|mesh-ancestor
110779991|NCT02530359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110849764|NCT03345004|Micronutrients|micronutrients|mesh-ancestor
110779992|NCT02530359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110779993|NCT02530359|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110779994|NCT02530359|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110779995|NCT02530359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110779996|NCT02530359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110779997|NCT02530359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110779998|NCT03428360|Diazepam|diazepam|mesh-list
110779999|NCT03428360|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110780000|NCT03428360|Anticonvulsants|anticonvulsants|mesh-ancestor
110780001|NCT03428360|Antiemetics|antiemetics|mesh-ancestor
110780002|NCT03428360|Autonomic Agents|autonomic agents|mesh-ancestor
110780003|NCT03428360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110780004|NCT03428360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110780005|NCT03428360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110780006|NCT03428360|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110780007|NCT03428360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110780008|NCT03428360|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110780009|NCT03428360|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110780010|NCT03428360|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110780011|NCT03428360|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110780012|NCT03428360|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110780013|NCT03428360|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110780014|NCT03428360|Anesthetics, General|anesthetics, general|mesh-ancestor
110780015|NCT03428360|Anesthetics|anesthetics|mesh-ancestor
110780016|NCT03428360|GABA Modulators|gaba modulators|mesh-ancestor
110780017|NCT03428360|GABA Agents|gaba agents|mesh-ancestor
110780018|NCT03428360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110780019|NCT03428360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110780020|NCT03427892|Brexpiprazole|brexpiprazole|mesh-list
110780021|NCT03427892|Serotonin Agents|serotonin agents|mesh-ancestor
110780022|NCT03427892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110780023|NCT03427892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110780024|NCT03427892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110780025|NCT03427892|Dopamine Agonists|dopamine agonists|mesh-ancestor
110780026|NCT03427892|Dopamine Agents|dopamine agents|mesh-ancestor
110780027|NCT03466658|Anti-Infective Agents|anti-infective agents|mesh-list
110780028|NCT03466658|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110780029|NCT04867928|Azacitidine|azacitidine|mesh-list
110780030|NCT04867928|Venetoclax|venetoclax|mesh-list
110780031|NCT04867928|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110780032|NCT04867928|Antimetabolites|antimetabolites|mesh-ancestor
110780033|NCT04867928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110780034|NCT04867928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110780035|NCT04867928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110780036|NCT03425396|Nitrofurantoin|nitrofurantoin|mesh-list
110780037|NCT03425396|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110780038|NCT03425396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110780039|NCT03425396|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110780040|NCT03698734|Evening primrose oil|evening primrose oil|mesh-list
110780041|NCT03698734|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110780042|NCT03698734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110780043|NCT03698734|Analgesics|analgesics|mesh-ancestor
110780044|NCT03698734|Sensory System Agents|sensory system agents|mesh-ancestor
110493496|NCT04080622|Trace Elements|trace elements|mesh-ancestor
110780045|NCT03698734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110780046|NCT03698734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110780047|NCT03698734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110780048|NCT03698734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110780049|NCT03698734|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110780050|NCT03698734|Antimetabolites|antimetabolites|mesh-ancestor
110780051|NCT03698734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110780052|NCT03698734|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110780053|NCT03698734|Dermatologic Agents|dermatologic agents|mesh-ancestor
110780054|NCT04070157|Lofexidine|lofexidine|mesh-list
110780055|NCT04070157|Clonidine|clonidine|mesh-list
110780056|NCT04070157|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110780057|NCT04070157|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110780058|NCT04070157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110780059|NCT04070157|Sensory System Agents|sensory system agents|mesh-ancestor
110780060|NCT04070157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110780061|NCT04070157|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110780062|NCT04070157|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110780063|NCT04070157|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110780064|NCT04070157|Adrenergic Agents|adrenergic agents|mesh-ancestor
110780065|NCT04070157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110780066|NCT04070157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110780067|NCT04070157|Analgesics|analgesics|mesh-ancestor
110780068|NCT04070157|Sympatholytics|sympatholytics|mesh-ancestor
110780069|NCT04070157|Autonomic Agents|autonomic agents|mesh-ancestor
110780070|NCT01091337|Albuterol|albuterol|mesh-list
110780071|NCT01091337|Procaterol|procaterol|mesh-list
110780072|NCT01091337|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110780073|NCT01091337|Autonomic Agents|autonomic agents|mesh-ancestor
110780074|NCT01091337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110780075|NCT01091337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110780076|NCT01091337|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110780077|NCT01091337|Respiratory System Agents|respiratory system agents|mesh-ancestor
110780078|NCT01091337|Tocolytic Agents|tocolytic agents|mesh-ancestor
110780079|NCT01091337|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110780080|NCT01091337|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110780081|NCT01091337|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110780082|NCT01091337|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110780083|NCT01091337|Adrenergic Agents|adrenergic agents|mesh-ancestor
110780084|NCT01091337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110780085|NCT01091337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110780086|NCT01091337|Sympathomimetics|sympathomimetics|mesh-ancestor
110780088|NCT03955809|Analgesics|analgesics|mesh-ancestor
110780089|NCT03955809|Sensory System Agents|sensory system agents|mesh-ancestor
110780090|NCT03955809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110780091|NCT03955809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110780092|NCT03955809|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110780093|NCT03955809|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110780094|NCT03955809|Anesthetics, General|anesthetics, general|mesh-ancestor
110780095|NCT03955809|Anesthetics|anesthetics|mesh-ancestor
110780096|NCT03955809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110780097|NCT03955809|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110780098|NCT03955809|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110780099|NCT03955809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110780100|NCT03955809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110780101|NCT01094613|Mercaptopurine|mercaptopurine|mesh-list
110780102|NCT01094613|Antimetabolites|antimetabolites|mesh-ancestor
110780103|NCT01094613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110780104|NCT01094613|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110780105|NCT01094613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110780106|NCT01094613|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110780107|NCT01094613|Immunologic Factors|immunologic factors|mesh-ancestor
110780108|NCT01094613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110780109|NCT01094613|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110780110|NCT01094613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110780112|NCT03953001|Epinephrine|epinephrine|mesh-list
110780113|NCT03953001|Anesthetics, Local|anesthetics, local|mesh-list
110780114|NCT03953001|Anesthetics|anesthetics|mesh-list
110780115|NCT03953001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110493502|NCT00673465|Metformin|metformin|mesh-list
110780116|NCT03953001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110780117|NCT03953001|Sensory System Agents|sensory system agents|mesh-ancestor
110780118|NCT03953001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110780119|NCT03953001|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110780120|NCT03953001|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110780121|NCT03953001|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110780122|NCT03953001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110780123|NCT03953001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110780124|NCT03953001|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110780125|NCT03953001|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110780126|NCT03953001|Adrenergic Agents|adrenergic agents|mesh-ancestor
110780127|NCT03953001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110780128|NCT03953001|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110780129|NCT03953001|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110780130|NCT03953001|Autonomic Agents|autonomic agents|mesh-ancestor
110780131|NCT03953001|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110780132|NCT03953001|Respiratory System Agents|respiratory system agents|mesh-ancestor
110780133|NCT03953001|Mydriatics|mydriatics|mesh-ancestor
110780134|NCT03953001|Sympathomimetics|sympathomimetics|mesh-ancestor
110780135|NCT03953001|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110780136|NCT01091415|Calcium|calcium|mesh-list
110780137|NCT01091415|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110780138|NCT01091415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110780139|NCT00032487|Metformin|metformin|mesh-list
110780140|NCT00032487|Glimepiride|glimepiride|mesh-list
110780141|NCT00032487|Rosiglitazone|rosiglitazone|mesh-list
110780142|NCT00032487|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110780143|NCT00032487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110780144|NCT00032487|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110780145|NCT00032487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110780146|NCT00032487|Immunologic Factors|immunologic factors|mesh-ancestor
110780147|NCT01091493|Moxifloxacin|moxifloxacin|mesh-list
110780148|NCT01091493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110780149|NCT01091493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110780150|NCT01091493|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110780151|NCT01091493|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110780152|NCT01091493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110780153|NCT01091493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110780154|NCT01091493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110780155|NCT03692416|Prednisone|prednisone|mesh-list
110780156|NCT03692416|Ibuprofen|ibuprofen|mesh-list
110849812|NCT02515864|Contraceptive Agents|contraceptive agents|mesh-ancestor
110780157|NCT03692416|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110780158|NCT03692416|Methotrexate|methotrexate|mesh-list
110780159|NCT03692416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110780160|NCT03692416|Glucocorticoids|glucocorticoids|mesh-ancestor
110780162|NCT03692416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110780163|NCT03692416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110780164|NCT03692416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110780165|NCT03692416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110780166|NCT03692416|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110780167|NCT03692416|Abortifacient Agents|abortifacient agents|mesh-ancestor
110780168|NCT03692416|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110780169|NCT03692416|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110780170|NCT03692416|Antimetabolites|antimetabolites|mesh-ancestor
110780171|NCT03692416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110780172|NCT03692416|Dermatologic Agents|dermatologic agents|mesh-ancestor
110780173|NCT03692416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110780174|NCT03692416|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110780175|NCT03692416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110780176|NCT03692416|Immunologic Factors|immunologic factors|mesh-ancestor
110780177|NCT03692416|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110780178|NCT03692416|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110780179|NCT03692416|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110780180|NCT03692416|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110780181|NCT03692416|Analgesics|analgesics|mesh-ancestor
110780182|NCT03692416|Sensory System Agents|sensory system agents|mesh-ancestor
110780183|NCT03692416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110780184|NCT03692416|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110780185|NCT03692416|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110780186|NCT03692416|Protective Agents|protective agents|mesh-ancestor
110780187|NCT03594552|Baclofen|baclofen|mesh-list
110780188|NCT03594552|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110780189|NCT03594552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110780190|NCT03594552|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110780191|NCT03594552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110780192|NCT03594552|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
110780193|NCT03594552|GABA Agonists|gaba agonists|mesh-ancestor
110780194|NCT03594552|GABA Agents|gaba agents|mesh-ancestor
110780195|NCT03594552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110849842|NCT02892409|Antacids|antacids|mesh-ancestor
110780196|NCT03594552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110780197|NCT03641508|Dexamethasone|dexamethasone|mesh-list
110780199|NCT03641508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110780200|NCT03641508|Antiemetics|antiemetics|mesh-ancestor
110780201|NCT03641508|Autonomic Agents|autonomic agents|mesh-ancestor
110780202|NCT03641508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110780203|NCT03641508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110780204|NCT03641508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110780205|NCT03641508|Glucocorticoids|glucocorticoids|mesh-ancestor
110780206|NCT03641508|Hormones|hormones|mesh-ancestor
110780207|NCT03641508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110780208|NCT03641508|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110780209|NCT03641508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110780210|NCT03465878|Insulin Lispro|insulin lispro|mesh-list
110780211|NCT03465878|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110780212|NCT03465878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110780213|NCT01091571|Dipyridamole|dipyridamole|mesh-list
110780214|NCT01091571|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110780215|NCT01091571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110780216|NCT01091571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110780217|NCT01091571|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110780218|NCT01091571|Vasodilator Agents|vasodilator agents|mesh-ancestor
110780219|NCT01091649|Ritonavir|ritonavir|mesh-list
110780220|NCT01091649|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110780221|NCT01091649|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110780222|NCT01091649|Protease Inhibitors|protease inhibitors|mesh-ancestor
110780223|NCT01091649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110780224|NCT01091649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110780225|NCT01091649|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110780226|NCT01091649|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110780227|NCT01091649|Antiviral Agents|antiviral agents|mesh-ancestor
110780228|NCT01091649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110780229|NCT01091649|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110780230|NCT01091649|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110780231|NCT01091727|Botulinum Toxins|botulinum toxins|mesh-list
110780232|NCT01091727|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110780233|NCT01091727|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110780234|NCT01091727|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110780235|NCT01091727|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110780236|NCT01091727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110780237|NCT01091727|Cholinergic Agents|cholinergic agents|mesh-ancestor
110780238|NCT01091727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110780239|NCT01091727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110780240|NCT01091727|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110780241|NCT01091727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110780242|NCT03421730|Budesonide|budesonide|mesh-list
110780243|NCT03421730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110780244|NCT03421730|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110780245|NCT03421730|Autonomic Agents|autonomic agents|mesh-ancestor
110780246|NCT03421730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110780247|NCT03421730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110780248|NCT03421730|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110780249|NCT03421730|Respiratory System Agents|respiratory system agents|mesh-ancestor
110780250|NCT03421730|Glucocorticoids|glucocorticoids|mesh-ancestor
110780251|NCT03421730|Hormones|hormones|mesh-ancestor
110780252|NCT03421730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110780253|NCT01094925|Gabapentin|gabapentin|mesh-list
110780254|NCT01094925|Analgesics|analgesics|mesh-ancestor
110780255|NCT01094925|Sensory System Agents|sensory system agents|mesh-ancestor
110780256|NCT01094925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110780257|NCT01094925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110780258|NCT01094925|Anticonvulsants|anticonvulsants|mesh-ancestor
110780259|NCT01094925|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110780260|NCT01094925|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110780261|NCT01094925|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110780262|NCT01094925|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110780263|NCT01094925|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110780264|NCT01094925|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110780265|NCT01094925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110780266|NCT01094925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110780267|NCT01094925|Antimanic Agents|antimanic agents|mesh-ancestor
110780268|NCT03718676|Pemetrexed|pemetrexed|mesh-list
110780269|NCT03718676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110780270|NCT03718676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110105341|NCT01785979|Hormones|hormones|mesh-ancestor
110780271|NCT03718676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110780272|NCT03718676|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110780273|NCT03718676|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110780274|NCT00054327|Cytarabine|cytarabine|mesh-list
110780275|NCT00054327|Cyclophosphamide|cyclophosphamide|mesh-list
110780276|NCT00054327|Busulfan|busulfan|mesh-list
110780277|NCT00054327|Etoposide|etoposide|mesh-list
110780278|NCT00054327|Etoposide phosphate|etoposide phosphate|mesh-list
110780279|NCT00054327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110780280|NCT00054327|Immunologic Factors|immunologic factors|mesh-ancestor
110780281|NCT00054327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110780282|NCT00054327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110780283|NCT00054327|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110780284|NCT00054327|Alkylating Agents|alkylating agents|mesh-ancestor
110780285|NCT00054327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110780286|NCT00054327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110780287|NCT00054327|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110780288|NCT00054327|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110780289|NCT00054327|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110780290|NCT00054327|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110780291|NCT00054327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110780292|NCT00054327|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110780293|NCT00054327|Antimetabolites|antimetabolites|mesh-ancestor
110780294|NCT00054327|Antiviral Agents|antiviral agents|mesh-ancestor
110780295|NCT00054327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110780296|NCT03029650|Scopolamine|scopolamine|mesh-list
110780297|NCT03029650|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
110780298|NCT03029650|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110780299|NCT03029650|Antiemetics|antiemetics|mesh-ancestor
110780300|NCT03029650|Autonomic Agents|autonomic agents|mesh-ancestor
110780301|NCT03029650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110780302|NCT03029650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110493529|NCT00583102|Cytarabine|cytarabine|mesh-list
110780303|NCT03029650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110780304|NCT03029650|Mydriatics|mydriatics|mesh-ancestor
110780305|NCT03029650|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110780306|NCT03029650|Cholinergic Agents|cholinergic agents|mesh-ancestor
110780307|NCT03029650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110780308|NCT03029650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110780310|NCT03029650|Parasympatholytics|parasympatholytics|mesh-ancestor
110780311|NCT03462680|Niacin|niacin|mesh-list
110780312|NCT03462680|Vitamins|vitamins|mesh-ancestor
110780313|NCT03462680|Micronutrients|micronutrients|mesh-ancestor
110780314|NCT03462680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110780315|NCT03462680|Vitamin B Complex|vitamin b complex|mesh-ancestor
110780316|NCT03462680|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110780317|NCT03462680|Antimetabolites|antimetabolites|mesh-ancestor
110780318|NCT03462680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110780319|NCT03462680|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110780320|NCT03462680|Vasodilator Agents|vasodilator agents|mesh-ancestor
110780321|NCT03692026|Melatonin|melatonin|mesh-list
110780322|NCT03692026|Hyaluronic Acid|hyaluronic acid|mesh-list
110780323|NCT03692026|Antioxidants|antioxidants|mesh-ancestor
110780324|NCT03692026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110780325|NCT03692026|Protective Agents|protective agents|mesh-ancestor
110780326|NCT03692026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110780327|NCT03692026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110780328|NCT03692026|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110780329|NCT03692026|Immunologic Factors|immunologic factors|mesh-ancestor
110780330|NCT03692026|Viscosupplements|viscosupplements|mesh-ancestor
110780331|NCT03624322|Olanzapine|olanzapine|mesh-list
110780332|NCT03624322|Antiemetics|antiemetics|mesh-ancestor
110780333|NCT03624322|Autonomic Agents|autonomic agents|mesh-ancestor
110780334|NCT03624322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110780335|NCT03624322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110780336|NCT03624322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110780337|NCT03624322|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110780338|NCT03624322|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110780339|NCT03624322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110780340|NCT03624322|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110780341|NCT03624322|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110780342|NCT03624322|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110780343|NCT03624322|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110780344|NCT03624322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110780345|NCT03624322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110780346|NCT03624322|Serotonin Agents|serotonin agents|mesh-ancestor
110780347|NCT01097811|Erythromycin|erythromycin|mesh-list
110780348|NCT01097811|Erythromycin Estolate|erythromycin estolate|mesh-list
110780349|NCT01097811|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
110780350|NCT01097811|Erythromycin stearate|erythromycin stearate|mesh-list
110780351|NCT01097811|Neomycin|neomycin|mesh-list
110780352|NCT01097811|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110780353|NCT01097811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110780354|NCT01097811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110780355|NCT01097811|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110780356|NCT01097811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110780357|NCT01097811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110780358|NCT03957291|Chlorhexidine|chlorhexidine|mesh-list
110780359|NCT03957291|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110780360|NCT03957291|Povidone-Iodine|povidone-iodine|mesh-list
110780361|NCT03957291|Povidone|povidone|mesh-list
110780362|NCT03957291|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110780363|NCT03957291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110780364|NCT03957291|Disinfectants|disinfectants|mesh-ancestor
110780365|NCT03957291|Dermatologic Agents|dermatologic agents|mesh-ancestor
110780366|NCT03957291|Plasma Substitutes|plasma substitutes|mesh-ancestor
110780367|NCT03957291|Blood Substitutes|blood substitutes|mesh-ancestor
110498007|NCT00610610|Paroxetine|paroxetine|mesh-list
110780368|NCT04044976|Caffeine|caffeine|mesh-list
110780369|NCT04044976|Caffeine citrate|caffeine citrate|mesh-list
110780370|NCT04044976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110780371|NCT04044976|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110493542|NCT00583102|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110780372|NCT04044976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110780373|NCT04044976|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110780374|NCT04044976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110780375|NCT04044976|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110780376|NCT04044976|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110780377|NCT04044976|Purinergic Agents|purinergic agents|mesh-ancestor
110780378|NCT04044976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110780379|NCT03691636|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110780380|NCT03691636|Lifitegrast|lifitegrast|mesh-list
110780381|NCT03691636|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110780382|NCT04295902|Pyrithione zinc|pyrithione zinc|mesh-list
110780383|NCT04295902|Keratolytic Agents|keratolytic agents|mesh-ancestor
110780384|NCT04295902|Dermatologic Agents|dermatologic agents|mesh-ancestor
110780385|NCT03956121|Magnesium Sulfate|magnesium sulfate|mesh-list
110780386|NCT03956121|Analgesics|analgesics|mesh-ancestor
110780387|NCT03956121|Sensory System Agents|sensory system agents|mesh-ancestor
110780388|NCT03956121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110780389|NCT03956121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110780390|NCT03956121|Anesthetics|anesthetics|mesh-ancestor
110780391|NCT03956121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110780392|NCT03956121|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110780393|NCT03956121|Anticonvulsants|anticonvulsants|mesh-ancestor
110780394|NCT03956121|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110780395|NCT03956121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110780396|NCT03956121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110780397|NCT03956121|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110780398|NCT03956121|Tocolytic Agents|tocolytic agents|mesh-ancestor
110780399|NCT03956121|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110780400|NCT03636906|Vaccines|vaccines|mesh-list
110780401|NCT03636906|Immunologic Factors|immunologic factors|mesh-ancestor
110780402|NCT03636906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110780403|NCT03028870|Naproxen|naproxen|mesh-list
110780404|NCT03028870|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110780405|NCT03028870|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110780406|NCT03028870|Analgesics|analgesics|mesh-ancestor
110780407|NCT03028870|Sensory System Agents|sensory system agents|mesh-ancestor
110780408|NCT03028870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110780409|NCT03028870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110780410|NCT03028870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110780411|NCT03028870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110780412|NCT03028870|Gout Suppressants|gout suppressants|mesh-ancestor
110780413|NCT03028870|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110780414|NCT03028870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110780415|NCT03028870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110780416|NCT01098201|Certolizumab Pegol|certolizumab pegol|mesh-list
110780417|NCT01098201|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110780418|NCT01098201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110780419|NCT01098201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110780420|NCT01098201|Immunologic Factors|immunologic factors|mesh-ancestor
110780421|NCT01098201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110780423|NCT01092039|Lactoferrin|lactoferrin|mesh-list
110780424|NCT01092039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110780425|NCT03663582|Teduglutide|teduglutide|mesh-list
110780426|NCT03663582|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110780427|NCT03663582|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110780428|NCT03663582|Protective Agents|protective agents|mesh-ancestor
110780429|NCT03663582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110780430|NCT01098357|Becaplermin|becaplermin|mesh-list
110780431|NCT01098357|Anticoagulants|anticoagulants|mesh-ancestor
110780432|NCT01098357|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
110780433|NCT01098357|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110780434|NCT01098357|Growth Substances|growth substances|mesh-ancestor
110780435|NCT01098357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110780437|NCT03730740|Immunologic Factors|immunologic factors|mesh-ancestor
110780438|NCT03730740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110780439|NCT03730740|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110493548|NCT02585440|Antiviral Agents|antiviral agents|mesh-ancestor
110780440|NCT03730740|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110780441|NCT03730740|Growth Substances|growth substances|mesh-ancestor
110780442|NCT03730740|Growth Inhibitors|growth inhibitors|mesh-ancestor
110780443|NCT03730740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110780444|NCT01098513|Dolutegravir|dolutegravir|mesh-list
110780445|NCT01098513|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110780446|NCT01098513|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110498082|NCT04046029|Antithrombins|antithrombins|mesh-ancestor
110780447|NCT01098513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110780448|NCT01098513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110780449|NCT01098513|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110780450|NCT01098513|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110780451|NCT01098513|Antiviral Agents|antiviral agents|mesh-ancestor
110780452|NCT01098513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110780453|NCT03693976|Xylometazoline|xylometazoline|mesh-list
110780454|NCT03693976|Nasal Decongestants|nasal decongestants|mesh-ancestor
110780455|NCT03693976|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110780456|NCT03693976|Respiratory System Agents|respiratory system agents|mesh-ancestor
110780457|NCT03730584|Ropivacaine|ropivacaine|mesh-list
110780458|NCT03730584|Anesthetics, Local|anesthetics, local|mesh-ancestor
110780459|NCT03730584|Anesthetics|anesthetics|mesh-ancestor
110780460|NCT03730584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110780461|NCT03730584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110780462|NCT03730584|Sensory System Agents|sensory system agents|mesh-ancestor
110780463|NCT03730584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110780464|NCT03502616|Tofacitinib|tofacitinib|mesh-list
110780465|NCT03502616|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
110780466|NCT03502616|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110780467|NCT03502616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110780468|NCT03502616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110780469|NCT04003012|Lidocaine|lidocaine|mesh-list
110780470|NCT04003012|Anesthetics, Local|anesthetics, local|mesh-ancestor
110780471|NCT04003012|Anesthetics|anesthetics|mesh-ancestor
110780472|NCT04003012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110780473|NCT04003012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110780474|NCT04003012|Sensory System Agents|sensory system agents|mesh-ancestor
110780475|NCT04003012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110780476|NCT04003012|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110780477|NCT04003012|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110780478|NCT04003012|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110780479|NCT04003012|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110780480|NCT04003012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110780481|NCT05666076|Bupivacaine|bupivacaine|mesh-list
110780482|NCT05666076|Prilocaine|prilocaine|mesh-list
110780483|NCT05666076|Anesthetics, Local|anesthetics, local|mesh-ancestor
110780484|NCT05666076|Anesthetics|anesthetics|mesh-ancestor
110780485|NCT05666076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110780486|NCT05666076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110780487|NCT05666076|Sensory System Agents|sensory system agents|mesh-ancestor
110780488|NCT05666076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110780489|NCT03028012|Dexamethasone|dexamethasone|mesh-list
110780490|NCT03028012|Ketorolac|ketorolac|mesh-list
110780491|NCT03028012|Lidocaine|lidocaine|mesh-list
110780492|NCT03028012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110780493|NCT03028012|Antiemetics|antiemetics|mesh-ancestor
110780494|NCT03028012|Autonomic Agents|autonomic agents|mesh-ancestor
110780495|NCT03028012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110780496|NCT03028012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110780497|NCT03028012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110780498|NCT03028012|Glucocorticoids|glucocorticoids|mesh-ancestor
110780499|NCT03028012|Hormones|hormones|mesh-ancestor
110780500|NCT03028012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110849933|NCT03216954|Acetylcysteine|acetylcysteine|mesh-list
110780501|NCT03028012|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110780502|NCT03028012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110780503|NCT03028012|Anesthetics, Local|anesthetics, local|mesh-ancestor
110780504|NCT03028012|Anesthetics|anesthetics|mesh-ancestor
110780505|NCT03028012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110780506|NCT03028012|Sensory System Agents|sensory system agents|mesh-ancestor
110780507|NCT03028012|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110780508|NCT03028012|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110780509|NCT03028012|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110780510|NCT03028012|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110780511|NCT03028012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110780512|NCT03028012|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110780513|NCT03028012|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110780514|NCT03028012|Analgesics|analgesics|mesh-ancestor
110780515|NCT03028012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110780516|NCT03028012|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110780517|NCT03028012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110780518|NCT03634800|Nivolumab|nivolumab|mesh-list
110780519|NCT03634800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110780520|NCT03634800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110498158|NCT00990821|Midazolam|midazolam|mesh-list
110780521|NCT03634800|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110780522|NCT03634800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110780523|NCT03662334|Insulin, Short-Acting|insulin, short-acting|mesh-list
110780524|NCT03662334|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110780525|NCT03662334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110780527|NCT02955186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110780528|NCT02955186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110780529|NCT02955186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110780530|NCT03693508|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110780531|NCT03693508|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110780532|NCT03693508|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110780533|NCT03693508|Antiviral Agents|antiviral agents|mesh-ancestor
110780534|NCT03693508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110780535|NCT03690778|Metformin|metformin|mesh-list
110780536|NCT03690778|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110780537|NCT03690778|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110780538|NCT03690778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110780539|NCT03690778|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110780540|NCT03690778|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110780541|NCT03690778|Antimetabolites|antimetabolites|mesh-ancestor
110780542|NCT03690778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110780543|NCT03690778|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110780544|NCT03690778|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110780545|NCT03690778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110780546|NCT03715634|Buprenorphine|buprenorphine|mesh-list
110780547|NCT03715634|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110780548|NCT03715634|Narcotics|narcotics|mesh-ancestor
110780549|NCT03715634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110780550|NCT03715634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110780551|NCT03715634|Analgesics|analgesics|mesh-ancestor
110780552|NCT03715634|Sensory System Agents|sensory system agents|mesh-ancestor
110780553|NCT03715634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110780554|NCT03715634|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110780555|NCT03502070|Tobramycin|tobramycin|mesh-list
110780556|NCT03502070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110780557|NCT03502070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110780558|NCT04158934|Factor VIII|factor viii|mesh-list
110780559|NCT04158934|BAX 855|bax 855|mesh-list
110780560|NCT04158934|Coagulants|coagulants|mesh-ancestor
110780561|NCT03715556|Amiodarone|amiodarone|mesh-list
110780562|NCT03715556|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110780563|NCT03715556|Vasodilator Agents|vasodilator agents|mesh-ancestor
110780564|NCT03715556|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
110780565|NCT03715556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110780566|NCT03715556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110780567|NCT03715556|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110780568|NCT03715556|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110780569|NCT03715556|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110780570|NCT03715556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110780571|NCT03715556|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110780572|NCT03715556|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110780573|NCT03715556|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110780574|NCT03730038|Pitavastatin|pitavastatin|mesh-list
110780575|NCT03730038|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110780576|NCT03730038|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110780577|NCT03730038|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110780578|NCT03730038|Antimetabolites|antimetabolites|mesh-ancestor
110780579|NCT03730038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110780580|NCT03730038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110780581|NCT03730038|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110780582|NCT03725904|Progesterone|progesterone|mesh-list
110780583|NCT03725904|Progestins|progestins|mesh-ancestor
110780584|NCT03725904|Hormones|hormones|mesh-ancestor
110780585|NCT03725904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110780586|NCT03725904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110780587|NCT03730272|Analgesics|analgesics|mesh-list
110780588|NCT03730272|Sensory System Agents|sensory system agents|mesh-ancestor
110780589|NCT03730272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110780590|NCT03730272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110780591|NCT03585504|Contraceptive Agents|contraceptive agents|mesh-list
110780592|NCT03585504|Etonogestrel|etonogestrel|mesh-list
110498240|NCT00985985|Nicotine|nicotine|mesh-list
110780593|NCT03585504|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110780594|NCT03585504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110780595|NCT03585504|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110780596|NCT03585504|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110780597|NCT03690622|Dexmedetomidine|dexmedetomidine|mesh-list
110780598|NCT03690622|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110780599|NCT03690622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110780600|NCT03690622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110780601|NCT03690622|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110780603|NCT03690622|Sensory System Agents|sensory system agents|mesh-ancestor
110780604|NCT03690622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110780605|NCT03690622|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110780606|NCT03690622|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110780607|NCT03690622|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110780608|NCT03690622|Adrenergic Agents|adrenergic agents|mesh-ancestor
110780609|NCT03690622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110780610|NCT03690622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110780611|NCT03715322|Tobramycin|tobramycin|mesh-list
110780612|NCT03715322|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110780613|NCT03715322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110780614|NCT03687268|Naloxone|naloxone|mesh-list
110780615|NCT03687268|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110780616|NCT03687268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110780617|NCT03687268|Sensory System Agents|sensory system agents|mesh-ancestor
110780618|NCT03687268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110780619|NCT03576066|Tenofovir|tenofovir|mesh-list
110780620|NCT03576066|Entecavir|entecavir|mesh-list
110780621|NCT03576066|Antiviral Agents|antiviral agents|mesh-ancestor
110780622|NCT03576066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110780623|NCT03576066|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110780624|NCT03576066|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110780625|NCT03576066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110780626|NCT03576066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110780627|NCT03576066|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110780628|NCT03576066|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110780629|NCT03639480|Amlodipine|amlodipine|mesh-list
110780630|NCT03639480|Valsartan|valsartan|mesh-list
110780631|NCT03639480|Atorvastatin|atorvastatin|mesh-list
110780632|NCT03639480|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110780633|NCT03639480|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110780634|NCT03639480|Antimetabolites|antimetabolites|mesh-ancestor
110493579|NCT02852720|Levobupivacaine|levobupivacaine|mesh-list
110780635|NCT03639480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110780636|NCT03639480|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110780637|NCT03639480|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110780638|NCT03639480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110780639|NCT03639480|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110780640|NCT03639480|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110780641|NCT03639480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110780642|NCT03639480|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110780643|NCT03639480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110780644|NCT03639480|Vasodilator Agents|vasodilator agents|mesh-ancestor
110780645|NCT03639480|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110780646|NCT03639480|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110780647|NCT03689998|Melatonin|melatonin|mesh-list
110780648|NCT03689998|Antioxidants|antioxidants|mesh-ancestor
110780649|NCT03689998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110780650|NCT03689998|Protective Agents|protective agents|mesh-ancestor
110780651|NCT03689998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110780652|NCT03689998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110780653|NCT03948178|Simendan|simendan|mesh-list
110780654|NCT03948178|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110780655|NCT03948178|Vasodilator Agents|vasodilator agents|mesh-ancestor
110780656|NCT03948178|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110780657|NCT03948178|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110780658|NCT03948178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110780659|NCT03948178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110780660|NCT03948178|Protective Agents|protective agents|mesh-ancestor
110780661|NCT03948178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110780662|NCT03687034|Temozolomide|temozolomide|mesh-list
110780663|NCT03687034|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110780664|NCT03687034|Alkylating Agents|alkylating agents|mesh-ancestor
110498306|NCT00802009|Sensory System Agents|sensory system agents|mesh-ancestor
110780665|NCT03687034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110780666|NCT03687034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110780667|NCT03520920|Rituximab|rituximab|mesh-list
110780668|NCT03520920|Zanubrutinib|zanubrutinib|mesh-list
110780669|NCT03520920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110780670|NCT03520920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110780671|NCT03520920|Immunologic Factors|immunologic factors|mesh-ancestor
110780672|NCT03520920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110780673|NCT03520920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110780674|NCT03520920|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110780675|NCT03520920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110849976|NCT03599089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110780676|NCT03520920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110780677|NCT03686878|Lifitegrast|lifitegrast|mesh-list
110780678|NCT03686878|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110780679|NCT03686878|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110780680|NCT03682198|Phenylephrine|phenylephrine|mesh-list
110780681|NCT03682198|Oxymetazoline|oxymetazoline|mesh-list
110780682|NCT03682198|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110780683|NCT03682198|Mydriatics|mydriatics|mesh-ancestor
110780684|NCT03682198|Autonomic Agents|autonomic agents|mesh-ancestor
110780685|NCT03682198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110780686|NCT03682198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110780687|NCT03682198|Sympathomimetics|sympathomimetics|mesh-ancestor
110780688|NCT03682198|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110780689|NCT03682198|Nasal Decongestants|nasal decongestants|mesh-ancestor
110780690|NCT03682198|Respiratory System Agents|respiratory system agents|mesh-ancestor
110780691|NCT03682198|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110780692|NCT03682198|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110780693|NCT03682198|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110780694|NCT03682198|Adrenergic Agents|adrenergic agents|mesh-ancestor
110780695|NCT03682198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110780696|NCT03682198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110780697|NCT03682198|Protective Agents|protective agents|mesh-ancestor
110780698|NCT02953340|Cyclophosphamide|cyclophosphamide|mesh-list
110780699|NCT02953340|Docetaxel|docetaxel|mesh-list
110493585|NCT05857631|Cisplatin|cisplatin|mesh-list
110780700|NCT02953340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110780701|NCT02953340|Immunologic Factors|immunologic factors|mesh-ancestor
110780702|NCT02953340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110780703|NCT02953340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110780704|NCT02953340|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110780705|NCT02953340|Alkylating Agents|alkylating agents|mesh-ancestor
110780706|NCT02953340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110780707|NCT02953340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110780708|NCT02953340|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110780709|NCT02953340|Tubulin Modulators|tubulin modulators|mesh-ancestor
110780710|NCT02953340|Antimitotic Agents|antimitotic agents|mesh-ancestor
110780711|NCT02953340|Mitosis Modulators|mitosis modulators|mesh-ancestor
110780712|NCT03554772|Celecoxib|celecoxib|mesh-list
110780713|NCT03554772|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110780714|NCT03554772|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110780715|NCT03554772|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110780716|NCT03554772|Analgesics|analgesics|mesh-ancestor
110780717|NCT03554772|Sensory System Agents|sensory system agents|mesh-ancestor
110780718|NCT03554772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110780719|NCT03554772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110780720|NCT03554772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110780721|NCT03554772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110780722|NCT03554772|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110780723|NCT03554772|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110780724|NCT03554772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110780725|NCT03554772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110780726|NCT03624010|Simendan|simendan|mesh-list
110780727|NCT03624010|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110780728|NCT03624010|Vasodilator Agents|vasodilator agents|mesh-ancestor
110780729|NCT03624010|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110780730|NCT03624010|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110780731|NCT03624010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110780732|NCT03624010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110780733|NCT03624010|Protective Agents|protective agents|mesh-ancestor
110780734|NCT03624010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110780735|NCT03686722|Metformin|metformin|mesh-list
110780736|NCT03686722|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110780737|NCT03686722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110780738|NCT04629976|Tenofovir|tenofovir|mesh-list
110498382|NCT00924950|Vitamins|vitamins|mesh-ancestor
110780739|NCT04629976|Antiviral Agents|antiviral agents|mesh-ancestor
110780740|NCT04629976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110780741|NCT04629976|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110780742|NCT04629976|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110780743|NCT04629976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110780744|NCT04629976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110780745|NCT04629976|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110780746|NCT04629976|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110780748|NCT03728946|Anesthetics, Local|anesthetics, local|mesh-ancestor
110780749|NCT03728946|Anesthetics|anesthetics|mesh-ancestor
110780750|NCT03728946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110780751|NCT03728946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110780752|NCT03728946|Sensory System Agents|sensory system agents|mesh-ancestor
110780753|NCT03728946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110780754|NCT03553758|Ketamine|ketamine|mesh-list
110780755|NCT03553758|Analgesics|analgesics|mesh-ancestor
110780756|NCT03553758|Sensory System Agents|sensory system agents|mesh-ancestor
110780757|NCT03553758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110780758|NCT03553758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110780759|NCT03553758|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110780760|NCT03553758|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110780761|NCT03553758|Anesthetics, General|anesthetics, general|mesh-ancestor
110780762|NCT03553758|Anesthetics|anesthetics|mesh-ancestor
110780763|NCT03553758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110780764|NCT03553758|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110780765|NCT03553758|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110780766|NCT03553758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110780767|NCT03553758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110780768|NCT02954354|Oseltamivir|oseltamivir|mesh-list
110780769|NCT02954354|Baloxavir|baloxavir|mesh-list
110780770|NCT02954354|Antiviral Agents|antiviral agents|mesh-ancestor
110780771|NCT02954354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110780772|NCT02954354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110780773|NCT02954354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110780774|NCT03519516|Ciprofloxacin|ciprofloxacin|mesh-list
110780775|NCT03519516|Levofloxacin|levofloxacin|mesh-list
110780776|NCT03519516|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110780777|NCT03519516|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110780778|NCT03519516|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110780779|NCT03519516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110780780|NCT03519516|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110780781|NCT03519516|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110780782|NCT03519516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110780783|NCT03519516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110780784|NCT03519516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110780785|NCT03519516|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110780786|NCT03519516|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110780787|NCT03519516|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110780788|NCT03681574|gamma-Aminobutyric Acid|gamma-aminobutyric acid|mesh-list
110780789|NCT03681574|GABA Agents|gaba agents|mesh-ancestor
110780790|NCT03681574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110780791|NCT03681574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110780792|NCT03681574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110780793|NCT03519204|Lidocaine|lidocaine|mesh-list
110780794|NCT03519204|Anesthetics, Local|anesthetics, local|mesh-ancestor
110780795|NCT03519204|Anesthetics|anesthetics|mesh-ancestor
110780796|NCT03519204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110780797|NCT03519204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110780798|NCT03519204|Sensory System Agents|sensory system agents|mesh-ancestor
110780799|NCT03519204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110780800|NCT03519204|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110780801|NCT03519204|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110780802|NCT03519204|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110780803|NCT03519204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110780804|NCT03519204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110780805|NCT03624166|Ketamine|ketamine|mesh-list
110780806|NCT03624166|Anesthetics|anesthetics|mesh-list
110780807|NCT03624166|Anesthetics, General|anesthetics, general|mesh-list
110780808|NCT03624166|Analgesics|analgesics|mesh-ancestor
110780809|NCT03624166|Sensory System Agents|sensory system agents|mesh-ancestor
110780810|NCT03624166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110780811|NCT03624166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110780812|NCT03624166|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110780813|NCT03624166|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110780814|NCT03624166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110780815|NCT03624166|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110780816|NCT03624166|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110780817|NCT03624166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110780818|NCT03624166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110780819|NCT03518112|Calcium, Dietary|calcium, dietary|mesh-list
110780820|NCT03518112|Leucovorin|leucovorin|mesh-list
110780821|NCT03518112|Folic Acid|folic acid|mesh-list
110780822|NCT03518112|Cytarabine|cytarabine|mesh-list
110780823|NCT03518112|Dexamethasone|dexamethasone|mesh-list
110780824|NCT03518112|Dexamethasone acetate|dexamethasone acetate|mesh-list
110780825|NCT03518112|Cyclophosphamide|cyclophosphamide|mesh-list
110780826|NCT03518112|Rituximab|rituximab|mesh-list
110780827|NCT03518112|Methotrexate|methotrexate|mesh-list
110780828|NCT03518112|Vincristine|vincristine|mesh-list
110780829|NCT03518112|Mercaptopurine|mercaptopurine|mesh-list
110780830|NCT03518112|Blinatumomab|blinatumomab|mesh-list
110780831|NCT03518112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110780832|NCT03518112|Muromonab-CD3|muromonab-cd3|mesh-list
110780833|NCT03518112|Antibodies|antibodies|mesh-list
110780834|NCT03518112|Immunoglobulins|immunoglobulins|mesh-list
110780835|NCT03518112|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110780836|NCT03518112|Lenograstim|lenograstim|mesh-list
110780837|NCT03518112|Antibodies, Bispecific|antibodies, bispecific|mesh-list
110780838|NCT03518112|BB 1101|bb 1101|mesh-list
110780839|NCT03518112|Calcium|calcium|mesh-list
110780840|NCT03518112|Levoleucovorin|levoleucovorin|mesh-list
110493596|NCT05857267|Timolol|timolol|mesh-list
110780841|NCT03518112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110780842|NCT03518112|Immunologic Factors|immunologic factors|mesh-ancestor
110780843|NCT03518112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110780844|NCT03518112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110780845|NCT03518112|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110780846|NCT03518112|Alkylating Agents|alkylating agents|mesh-ancestor
110780847|NCT03518112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110780848|NCT03518112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110780849|NCT03518112|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110780850|NCT03518112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110780851|NCT03518112|Antiemetics|antiemetics|mesh-ancestor
110780852|NCT03518112|Autonomic Agents|autonomic agents|mesh-ancestor
110780853|NCT03518112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110780854|NCT03518112|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110780855|NCT03518112|Glucocorticoids|glucocorticoids|mesh-ancestor
110780856|NCT03518112|Hormones|hormones|mesh-ancestor
110780857|NCT03518112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110780858|NCT03518112|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110780859|NCT03518112|Protease Inhibitors|protease inhibitors|mesh-ancestor
110780860|NCT03518112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110780861|NCT03518112|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110780862|NCT03518112|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110780863|NCT03518112|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110780864|NCT03518112|Abortifacient Agents|abortifacient agents|mesh-ancestor
110780865|NCT03518112|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110780866|NCT03518112|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110780867|NCT03518112|Antimetabolites|antimetabolites|mesh-ancestor
110780868|NCT03518112|Dermatologic Agents|dermatologic agents|mesh-ancestor
110780869|NCT03518112|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110780870|NCT03518112|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110780871|NCT03518112|Antiviral Agents|antiviral agents|mesh-ancestor
110780872|NCT03518112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110780873|NCT03518112|Antidotes|antidotes|mesh-ancestor
110780874|NCT03518112|Protective Agents|protective agents|mesh-ancestor
110780875|NCT03518112|Vitamin B Complex|vitamin b complex|mesh-ancestor
110780877|NCT03518112|Micronutrients|micronutrients|mesh-ancestor
110780878|NCT03518112|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110780879|NCT03518112|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110780880|NCT03518112|Tubulin Modulators|tubulin modulators|mesh-ancestor
110780881|NCT03518112|Antimitotic Agents|antimitotic agents|mesh-ancestor
110780882|NCT03518112|Mitosis Modulators|mitosis modulators|mesh-ancestor
110780883|NCT03518112|Hematinics|hematinics|mesh-ancestor
110780884|NCT03686254|Bevacizumab|bevacizumab|mesh-list
110780885|NCT03686254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110780886|NCT03686254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110498533|NCT00687999|Immunologic Factors|immunologic factors|mesh-ancestor
110780887|NCT03686254|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110780888|NCT03686254|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110780889|NCT03686254|Growth Substances|growth substances|mesh-ancestor
110780890|NCT03686254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110780891|NCT03686254|Growth Inhibitors|growth inhibitors|mesh-ancestor
110780892|NCT03679780|Nitroprusside|nitroprusside|mesh-list
110780893|NCT03679780|BQ 788|bq 788|mesh-list
110780894|NCT03679780|Nitroarginine|nitroarginine|mesh-list
110780895|NCT03679780|NG-Nitroarginine Methyl Ester|ng-nitroarginine methyl ester|mesh-list
110780896|NCT03679780|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110780897|NCT03679780|Vasodilator Agents|vasodilator agents|mesh-ancestor
110780898|NCT03679780|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
110780899|NCT03679780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110780900|NCT03679780|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
110780901|NCT03679780|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
110780902|NCT03679780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110780903|NCT03659734|Analgesics, Opioid|analgesics, opioid|mesh-list
110780904|NCT03659734|Narcotics|narcotics|mesh-ancestor
110780905|NCT03659734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110780906|NCT03659734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110780907|NCT03659734|Analgesics|analgesics|mesh-ancestor
110780908|NCT03659734|Sensory System Agents|sensory system agents|mesh-ancestor
110780909|NCT03659734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110780910|NCT03680716|Ropivacaine|ropivacaine|mesh-list
110780911|NCT03680716|Anesthetics, Local|anesthetics, local|mesh-ancestor
110780912|NCT03680716|Anesthetics|anesthetics|mesh-ancestor
110780913|NCT03680716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110780914|NCT03680716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110780915|NCT03680716|Sensory System Agents|sensory system agents|mesh-ancestor
110780916|NCT03680716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110780917|NCT03680638|Allopurinol|allopurinol|mesh-list
110780918|NCT03680638|Tempol|tempol|mesh-list
110780919|NCT03680638|Antimetabolites|antimetabolites|mesh-ancestor
110780920|NCT03680638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110780921|NCT03680638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110780922|NCT03680638|Gout Suppressants|gout suppressants|mesh-ancestor
110780923|NCT03680638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110780924|NCT03680638|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110780925|NCT03680638|Antioxidants|antioxidants|mesh-ancestor
110780926|NCT03680638|Protective Agents|protective agents|mesh-ancestor
110780927|NCT03680638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110780928|NCT03680638|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110780929|NCT03680638|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110780930|NCT03680638|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110780931|NCT03680560|Trastuzumab|trastuzumab|mesh-list
110780932|NCT03680560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110780933|NCT03680560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110780935|NCT03444298|Tocopherols|tocopherols|mesh-list
110780936|NCT03444298|Tocotrienols|tocotrienols|mesh-list
110780937|NCT03444298|alpha-Tocopherol|alpha-tocopherol|mesh-list
110780938|NCT03444298|gamma-Tocopherol|gamma-tocopherol|mesh-list
110780939|NCT03444298|Vitamins|vitamins|mesh-ancestor
110780940|NCT03444298|Micronutrients|micronutrients|mesh-ancestor
110780941|NCT03444298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110780943|NCT03444298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110780944|NCT03444298|Protective Agents|protective agents|mesh-ancestor
110780945|NCT03639610|Dexamethasone|dexamethasone|mesh-list
110780946|NCT03639610|Melphalan|melphalan|mesh-list
110780947|NCT03639610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110780948|NCT03639610|Antiemetics|antiemetics|mesh-ancestor
110780949|NCT03639610|Autonomic Agents|autonomic agents|mesh-ancestor
110780950|NCT03639610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110780951|NCT03639610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110780952|NCT03639610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110780953|NCT03639610|Glucocorticoids|glucocorticoids|mesh-ancestor
110780954|NCT03639610|Hormones|hormones|mesh-ancestor
110780955|NCT03639610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110780956|NCT03639610|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110780957|NCT03639610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110780958|NCT03639610|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110780959|NCT03639610|Alkylating Agents|alkylating agents|mesh-ancestor
110780960|NCT03639610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110780961|NCT03639610|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110780962|NCT03639610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110780963|NCT03639610|Immunologic Factors|immunologic factors|mesh-ancestor
110498615|NCT02625519|Hormones|hormones|mesh-list
110780964|NCT03680404|Allopurinol|allopurinol|mesh-list
110780965|NCT03680404|Phenylephrine|phenylephrine|mesh-list
110780966|NCT03680404|Oxymetazoline|oxymetazoline|mesh-list
110780968|NCT03680404|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110780969|NCT03680404|Mydriatics|mydriatics|mesh-ancestor
110780970|NCT03680404|Autonomic Agents|autonomic agents|mesh-ancestor
110780971|NCT03680404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110780972|NCT03680404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110780973|NCT03680404|Sympathomimetics|sympathomimetics|mesh-ancestor
110780974|NCT03680404|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110780975|NCT03680404|Nasal Decongestants|nasal decongestants|mesh-ancestor
110780976|NCT03680404|Respiratory System Agents|respiratory system agents|mesh-ancestor
110780977|NCT03680404|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110780978|NCT03680404|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110780979|NCT03680404|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110780980|NCT03680404|Adrenergic Agents|adrenergic agents|mesh-ancestor
110780981|NCT03680404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110850037|NCT03597139|Dermatologic Agents|dermatologic agents|mesh-ancestor
110780982|NCT03680404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110780983|NCT03680404|Protective Agents|protective agents|mesh-ancestor
110780984|NCT03680404|Antimetabolites|antimetabolites|mesh-ancestor
110780985|NCT03680404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110780986|NCT03680404|Gout Suppressants|gout suppressants|mesh-ancestor
110780987|NCT03680404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110780988|NCT03680404|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110780989|NCT03680404|Antioxidants|antioxidants|mesh-ancestor
110780990|NCT03680404|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110780991|NCT03680404|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110780992|NCT03680404|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110780993|NCT03685630|Brivaracetam|brivaracetam|mesh-list
110780994|NCT03685630|Anticonvulsants|anticonvulsants|mesh-ancestor
110780995|NCT02954406|Rituximab|rituximab|mesh-list
110780996|NCT02954406|Gemcitabine|gemcitabine|mesh-list
110780997|NCT02954406|Lenalidomide|lenalidomide|mesh-list
110780998|NCT02954406|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110780999|NCT02954406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110781000|NCT02954406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110781001|NCT02954406|Immunologic Factors|immunologic factors|mesh-ancestor
110781002|NCT02954406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110781003|NCT02954406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110781004|NCT02954406|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110781005|NCT02954406|Antimetabolites|antimetabolites|mesh-ancestor
110781006|NCT02954406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110781007|NCT02954406|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110781008|NCT02954406|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110781009|NCT02954406|Growth Substances|growth substances|mesh-ancestor
110781010|NCT02954406|Growth Inhibitors|growth inhibitors|mesh-ancestor
110781011|NCT02954406|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110781012|NCT02954406|Alkylating Agents|alkylating agents|mesh-ancestor
110781013|NCT01310478|Endostatins|endostatins|mesh-list
110781014|NCT01310478|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110781015|NCT01310478|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110781016|NCT01310478|Growth Substances|growth substances|mesh-ancestor
110781017|NCT01310478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110781018|NCT01310478|Growth Inhibitors|growth inhibitors|mesh-ancestor
110781019|NCT01310478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110781020|NCT03728244|Hyaluronic Acid|hyaluronic acid|mesh-list
110781021|NCT03728244|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110781022|NCT03728244|Immunologic Factors|immunologic factors|mesh-ancestor
110781023|NCT03728244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110781024|NCT03728244|Viscosupplements|viscosupplements|mesh-ancestor
110781025|NCT03728244|Protective Agents|protective agents|mesh-ancestor
110781026|NCT03511326|Aminolevulinic Acid|aminolevulinic acid|mesh-list
110781027|NCT03511326|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
110781028|NCT03511326|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110781029|NCT03511326|Dermatologic Agents|dermatologic agents|mesh-ancestor
110781030|NCT03721614|Sirolimus|sirolimus|mesh-list
110781031|NCT03721614|Everolimus|everolimus|mesh-list
110781032|NCT03721614|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110781033|NCT03721614|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110781034|NCT03721614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110781035|NCT03721614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110781036|NCT03721614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110781037|NCT03721614|Immunologic Factors|immunologic factors|mesh-ancestor
110781038|NCT03721614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110781039|NCT03721614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110781040|NCT03721614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110781041|NCT03721614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110498688|NCT00689949|Folic Acid|folic acid|mesh-list
110781042|NCT03721614|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110781043|NCT03721614|Antifungal Agents|antifungal agents|mesh-ancestor
110781044|NCT03727620|Amoxicillin|amoxicillin|mesh-list
110781045|NCT03727620|Metronidazole|metronidazole|mesh-list
110781046|NCT03727620|Doxycycline|doxycycline|mesh-list
110781047|NCT03727620|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110781048|NCT03727620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110781049|NCT03727620|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110781050|NCT03727620|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110781051|NCT03727620|Antimalarials|antimalarials|mesh-ancestor
110781052|NCT03727464|Propofol|propofol|mesh-list
110781053|NCT03727464|Sevoflurane|sevoflurane|mesh-list
110781054|NCT03727464|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110781055|NCT03727464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110781056|NCT03727464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110781057|NCT03727464|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110781058|NCT03727464|Anesthetics, General|anesthetics, general|mesh-ancestor
110781059|NCT03727464|Anesthetics|anesthetics|mesh-ancestor
110781060|NCT03727464|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110781061|NCT03727464|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110781062|NCT03508830|Bupivacaine|bupivacaine|mesh-list
110781063|NCT03508830|Anesthetics, Local|anesthetics, local|mesh-ancestor
110781064|NCT03508830|Anesthetics|anesthetics|mesh-ancestor
110781065|NCT03508830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110781066|NCT03508830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110781067|NCT03508830|Sensory System Agents|sensory system agents|mesh-ancestor
110781068|NCT03508830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110781069|NCT03569202|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110781070|NCT03569202|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110781071|NCT03724578|Anti-Infective Agents|anti-infective agents|mesh-list
110781072|NCT03724578|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110781073|NCT03724578|Grape Seed Extract|grape seed extract|mesh-list
110781074|NCT03724578|Fluorides|fluorides|mesh-list
110781075|NCT03724578|Cariostatic Agents|cariostatic agents|mesh-ancestor
110781076|NCT03724578|Protective Agents|protective agents|mesh-ancestor
110781077|NCT03724578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110781078|NCT03724578|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110781079|NCT03724578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110781080|NCT03724578|Antioxidants|antioxidants|mesh-ancestor
110781081|NCT03724578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110781082|NCT03721380|Methadone|methadone|mesh-list
110781083|NCT03721380|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110781084|NCT03721380|Narcotics|narcotics|mesh-ancestor
110781085|NCT03721380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110781086|NCT03721380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110781087|NCT03721380|Analgesics|analgesics|mesh-ancestor
110781088|NCT03721380|Sensory System Agents|sensory system agents|mesh-ancestor
110781089|NCT03721380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110781090|NCT03721380|Antitussive Agents|antitussive agents|mesh-ancestor
110781091|NCT03721380|Respiratory System Agents|respiratory system agents|mesh-ancestor
110781092|NCT03568500|Olanzapine|olanzapine|mesh-list
110781094|NCT03568500|Aripiprazole|aripiprazole|mesh-list
110781095|NCT03568500|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110781096|NCT03568500|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110781097|NCT03568500|Serotonin Agents|serotonin agents|mesh-ancestor
110781098|NCT03568500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110781099|NCT03568500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110781100|NCT03568500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110781101|NCT03568500|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110781102|NCT03568500|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110781103|NCT03568500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110781104|NCT03568500|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110781105|NCT03568500|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110781106|NCT03568500|Dopamine Agents|dopamine agents|mesh-ancestor
110781107|NCT03568500|Antiemetics|antiemetics|mesh-ancestor
110781108|NCT03568500|Autonomic Agents|autonomic agents|mesh-ancestor
110781109|NCT03568500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110781110|NCT03568500|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110781111|NCT03568500|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110781112|NCT03568500|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110781113|NCT03568500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110781114|NCT03568500|Antidepressive Agents|antidepressive agents|mesh-ancestor
110781115|NCT03568500|Dopamine Agonists|dopamine agonists|mesh-ancestor
110781116|NCT03568500|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110781117|NCT03568500|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110498767|NCT00912639|Paclitaxel|paclitaxel|mesh-list
110781118|NCT03568500|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110781119|NCT03568500|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110781120|NCT03910738|Methyltestosterone|methyltestosterone|mesh-list
110781121|NCT03910738|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110781122|NCT03910738|Testosterone|testosterone|mesh-list
110781123|NCT03910738|Testosterone undecanoate|testosterone undecanoate|mesh-list
110781124|NCT03910738|Testosterone enanthate|testosterone enanthate|mesh-list
110781125|NCT03910738|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
110781126|NCT03910738|Androgens|androgens|mesh-ancestor
110781127|NCT03910738|Hormones|hormones|mesh-ancestor
110781128|NCT03910738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110781129|NCT03910738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110781130|NCT03910738|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110781131|NCT03910738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110781132|NCT03910738|Anabolic Agents|anabolic agents|mesh-ancestor
110781133|NCT03685084|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110781134|NCT03685084|Piperacillin|piperacillin|mesh-list
110781135|NCT03685084|Cefepime|cefepime|mesh-list
110781136|NCT03685084|Lactams|lactams|mesh-list
110781137|NCT03685084|beta-Lactams|beta-lactams|mesh-list
110781138|NCT03685084|Enmetazobactam|enmetazobactam|mesh-list
110781139|NCT03685084|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
110781140|NCT03685084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110781141|NCT03685084|Antitubercular Agents|antitubercular agents|mesh-ancestor
110781142|NCT03685084|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110781143|NCT03685084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110781144|NCT03685084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110781145|NCT03724266|Chitosan|chitosan|mesh-list
110781146|NCT03724266|Calcium|calcium|mesh-list
110781147|NCT03724266|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110781148|NCT03724266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110781149|NCT03724266|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110781150|NCT03724266|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110781151|NCT03724266|Antimetabolites|antimetabolites|mesh-ancestor
110781152|NCT03724266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110781153|NCT03724266|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110781154|NCT03724266|Chelating Agents|chelating agents|mesh-ancestor
110781155|NCT03724266|Sequestering Agents|sequestering agents|mesh-ancestor
110781156|NCT03724266|Hemostatics|hemostatics|mesh-ancestor
110781157|NCT03724266|Coagulants|coagulants|mesh-ancestor
110781158|NCT03679390|Ketamine|ketamine|mesh-list
110781159|NCT03679390|Analgesics|analgesics|mesh-ancestor
110781160|NCT03679390|Sensory System Agents|sensory system agents|mesh-ancestor
110781161|NCT03679390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110781162|NCT03679390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110781163|NCT03679390|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110493641|NCT05856578|Hypoglycemic Agents|hypoglycemic agents|mesh-list
110781164|NCT03679390|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110781165|NCT03679390|Anesthetics, General|anesthetics, general|mesh-ancestor
110781166|NCT03679390|Anesthetics|anesthetics|mesh-ancestor
110781167|NCT03679390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110781168|NCT03679390|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110781170|NCT03679390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110781171|NCT03679390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110781172|NCT03684772|Digoxin|digoxin|mesh-list
110781173|NCT03684772|Furosemide|furosemide|mesh-list
110781174|NCT03684772|Diuretics|diuretics|mesh-ancestor
110781175|NCT03684772|Natriuretic Agents|natriuretic agents|mesh-ancestor
110781176|NCT03684772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110781177|NCT03684772|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110781178|NCT03684772|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110781179|NCT03684772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110781180|NCT03684772|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110781181|NCT03684772|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110781182|NCT03684772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110781183|NCT03684772|Protective Agents|protective agents|mesh-ancestor
110781184|NCT03676114|Ketamine|ketamine|mesh-list
110781185|NCT03676114|Analgesics|analgesics|mesh-ancestor
110781186|NCT03676114|Sensory System Agents|sensory system agents|mesh-ancestor
110781187|NCT03676114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110781188|NCT03676114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110781189|NCT03676114|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110781190|NCT03676114|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110781191|NCT03676114|Anesthetics, General|anesthetics, general|mesh-ancestor
110781192|NCT03676114|Anesthetics|anesthetics|mesh-ancestor
110781193|NCT03676114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110781194|NCT03676114|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110781195|NCT03676114|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110781196|NCT03676114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110781197|NCT03676114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110781198|NCT03676036|Mometasone Furoate|mometasone furoate|mesh-list
110781199|NCT03676036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110781200|NCT03676036|Dermatologic Agents|dermatologic agents|mesh-ancestor
110781201|NCT03676036|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110781202|NCT03025828|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
110781203|NCT03025828|Hormones|hormones|mesh-ancestor
110781204|NCT03025828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110781205|NCT03025828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110781206|NCT03546816|Serlopitant|serlopitant|mesh-list
110781207|NCT03546816|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110781208|NCT03546816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110781209|NCT03546816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110781210|NCT03546816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110781211|NCT03675802|Misoprostol|misoprostol|mesh-list
110781212|NCT03675802|Dinoprostone|dinoprostone|mesh-list
110781213|NCT03675802|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110781214|NCT03675802|Abortifacient Agents|abortifacient agents|mesh-ancestor
110781215|NCT03675802|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110781216|NCT03675802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110781217|NCT03675802|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110781218|NCT03675802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110781219|NCT03675802|Oxytocics|oxytocics|mesh-ancestor
110781220|NCT03678610|Ionomycin|ionomycin|mesh-list
110781221|NCT03678610|Calcium Ionophores|calcium ionophores|mesh-ancestor
110781222|NCT03678610|Ionophores|ionophores|mesh-ancestor
110781223|NCT03678610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110781224|NCT03678610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110781225|NCT03675646|Morphine|morphine|mesh-list
110781226|NCT03675646|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110781227|NCT03675646|Narcotics|narcotics|mesh-ancestor
110781228|NCT03675646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110781229|NCT03675646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110781230|NCT03675646|Analgesics|analgesics|mesh-ancestor
110781231|NCT03675646|Sensory System Agents|sensory system agents|mesh-ancestor
110781232|NCT03675646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110781233|NCT03678532|Midazolam|midazolam|mesh-list
110781234|NCT03678532|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110781235|NCT03678532|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110781236|NCT03678532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110781237|NCT03678532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110781238|NCT03678532|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110781239|NCT03678532|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110781240|NCT03678532|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110781241|NCT03678532|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110781242|NCT03678532|Anesthetics, General|anesthetics, general|mesh-ancestor
110781243|NCT03678532|Anesthetics|anesthetics|mesh-ancestor
110781244|NCT03678532|GABA Modulators|gaba modulators|mesh-ancestor
110781245|NCT03678532|GABA Agents|gaba agents|mesh-ancestor
110781246|NCT03678532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110781247|NCT03678532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110781248|NCT03675178|Ceftriaxone|ceftriaxone|mesh-list
110781249|NCT03675178|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110781250|NCT03675178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110781251|NCT03678142|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110781252|NCT03678142|Vancomycin|vancomycin|mesh-list
110781253|NCT03678142|Imipenem|imipenem|mesh-list
110781254|NCT03678142|Floxacillin|floxacillin|mesh-list
110781255|NCT03678142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110781256|NCT03522298|GDC-0084|gdc-0084|mesh-list
110781257|NCT03522298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110781258|NCT03522298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110781259|NCT03674866|Insulin|insulin|mesh-list
110781260|NCT03674866|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110781261|NCT03674866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110781262|NCT03623776|Carboplatin|carboplatin|mesh-list
110781263|NCT03623776|Pemetrexed|pemetrexed|mesh-list
110781264|NCT03623776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110781265|NCT03623776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110781266|NCT03623776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110781267|NCT03623776|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110781268|NCT03623776|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110781269|NCT03683914|Dinoprostone|dinoprostone|mesh-list
110781270|NCT03683914|Oxytocics|oxytocics|mesh-ancestor
110781271|NCT03683914|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110781272|NCT03683914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110781273|NCT03448406|Empagliflozin|empagliflozin|mesh-list
110781274|NCT03448406|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110781275|NCT03448406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110781276|NCT03448406|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110781277|NCT03448406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110781278|NCT00064701|Cyclosporine|cyclosporine|mesh-list
110781279|NCT00064701|Mycophenolic Acid|mycophenolic acid|mesh-list
110781280|NCT00064701|Tacrolimus|tacrolimus|mesh-list
110781281|NCT00064701|Cyclosporins|cyclosporins|mesh-list
110781282|NCT00064701|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110781283|NCT00064701|Immunologic Factors|immunologic factors|mesh-ancestor
110781284|NCT00064701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110781285|NCT00064701|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110781286|NCT00064701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110781287|NCT00064701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110781288|NCT00064701|Antifungal Agents|antifungal agents|mesh-ancestor
110781289|NCT00064701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110781290|NCT00064701|Dermatologic Agents|dermatologic agents|mesh-ancestor
110781291|NCT00064701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110781292|NCT00064701|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110781293|NCT00064701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110781294|NCT00064701|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110781295|NCT00064701|Antitubercular Agents|antitubercular agents|mesh-ancestor
110781296|NCT00064701|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110781297|NCT00064077|Paclitaxel|paclitaxel|mesh-list
110781298|NCT00064077|Vinorelbine|vinorelbine|mesh-list
110781299|NCT00064077|Cisplatin|cisplatin|mesh-list
110781300|NCT00064077|Gemcitabine|gemcitabine|mesh-list
110781301|NCT00064077|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110781302|NCT00064077|Topotecan|topotecan|mesh-list
110781303|NCT00064077|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110781304|NCT00064077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110781305|NCT00064077|Tubulin Modulators|tubulin modulators|mesh-ancestor
110781306|NCT00064077|Antimitotic Agents|antimitotic agents|mesh-ancestor
110781307|NCT00064077|Mitosis Modulators|mitosis modulators|mesh-ancestor
110781308|NCT00064077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110781309|NCT00064077|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110781310|NCT00064077|Antimetabolites|antimetabolites|mesh-ancestor
110781311|NCT00064077|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110781312|NCT00064077|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110781313|NCT00064077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110781314|NCT03674008|Propofol|propofol|mesh-list
110781315|NCT03674008|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110781316|NCT03674008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110781317|NCT03674008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110781318|NCT03674008|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110781319|NCT03674008|Anesthetics, General|anesthetics, general|mesh-ancestor
110781320|NCT03674008|Anesthetics|anesthetics|mesh-ancestor
110781321|NCT00063999|Paclitaxel|paclitaxel|mesh-list
110781322|NCT00063999|Cisplatin|cisplatin|mesh-list
110781323|NCT00063999|Carboplatin|carboplatin|mesh-list
110781324|NCT00063999|Doxorubicin|doxorubicin|mesh-list
110781325|NCT00063999|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110781326|NCT00063999|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110781327|NCT00063999|Lenograstim|lenograstim|mesh-list
110781328|NCT00063999|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110781329|NCT00063999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110781330|NCT00063999|Tubulin Modulators|tubulin modulators|mesh-ancestor
110781331|NCT00063999|Antimitotic Agents|antimitotic agents|mesh-ancestor
110781332|NCT00063999|Mitosis Modulators|mitosis modulators|mesh-ancestor
110781333|NCT00063999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110781334|NCT00063999|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110781335|NCT00063999|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110781336|NCT00063999|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110781337|NCT00063999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110781338|NCT00063999|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110781339|NCT00063999|Immunologic Factors|immunologic factors|mesh-ancestor
110781340|NCT00063999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110781341|NCT01092351|Nitrofurantoin|nitrofurantoin|mesh-list
110781342|NCT01092351|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110781343|NCT01092351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110781344|NCT01092351|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110781345|NCT02878798|Topiramate|topiramate|mesh-list
110498984|NCT05813912|Insulin|insulin|mesh-list
110781346|NCT02878798|Anticonvulsants|anticonvulsants|mesh-ancestor
110781347|NCT02878798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110781348|NCT02878798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110781349|NCT03673384|Fluticasone|fluticasone|mesh-list
110781351|NCT03673384|Histamine|histamine|mesh-list
110781352|NCT03673384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110781353|NCT03673384|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110781354|NCT03673384|Autonomic Agents|autonomic agents|mesh-ancestor
110781355|NCT03673384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110781356|NCT03673384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110781357|NCT03673384|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110781358|NCT03673384|Respiratory System Agents|respiratory system agents|mesh-ancestor
110781359|NCT03673384|Dermatologic Agents|dermatologic agents|mesh-ancestor
110781360|NCT03673384|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110781361|NCT03673384|Histamine Agonists|histamine agonists|mesh-ancestor
110781362|NCT03673384|Histamine Agents|histamine agents|mesh-ancestor
110781363|NCT03673384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110781364|NCT03673384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110781365|NCT02915302|Vaccines|vaccines|mesh-list
110781366|NCT02915302|Immunologic Factors|immunologic factors|mesh-ancestor
110781367|NCT02915302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110781368|NCT03023878|Dexamethasone|dexamethasone|mesh-list
110781369|NCT03023878|Blinatumomab|blinatumomab|mesh-list
110781370|NCT03023878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110781371|NCT03023878|Antiemetics|antiemetics|mesh-ancestor
110781372|NCT03023878|Autonomic Agents|autonomic agents|mesh-ancestor
110781373|NCT03023878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110781374|NCT03023878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110781375|NCT03023878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110781376|NCT03023878|Glucocorticoids|glucocorticoids|mesh-ancestor
110781377|NCT03023878|Hormones|hormones|mesh-ancestor
110781378|NCT03023878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110781379|NCT03023878|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110781380|NCT03023878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110781382|NCT03670888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110781383|NCT03670888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110781384|NCT03670888|Immunologic Factors|immunologic factors|mesh-ancestor
110781385|NCT03670888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110781386|NCT03670888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110781387|NCT03023722|Maytansine|maytansine|mesh-list
110781388|NCT03023722|Anetumab ravtansine|anetumab ravtansine|mesh-list
110781389|NCT03023722|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110781390|NCT03023722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110781391|NCT03023722|Tubulin Modulators|tubulin modulators|mesh-ancestor
110781393|NCT03023722|Mitosis Modulators|mitosis modulators|mesh-ancestor
110781394|NCT03023722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110781395|NCT03023722|Immunoconjugates|immunoconjugates|mesh-ancestor
110781396|NCT03023722|Immunologic Factors|immunologic factors|mesh-ancestor
110781397|NCT03023722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110781398|NCT03623230|Bupivacaine|bupivacaine|mesh-list
110781399|NCT03623230|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110781400|NCT03623230|Anesthetics, Local|anesthetics, local|mesh-ancestor
110781401|NCT03623230|Anesthetics|anesthetics|mesh-ancestor
110781402|NCT03623230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110781403|NCT03623230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110781404|NCT03623230|Sensory System Agents|sensory system agents|mesh-ancestor
110781405|NCT03623230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110781406|NCT02624596|Midazolam|midazolam|mesh-list
110781407|NCT02624596|Ketamine|ketamine|mesh-list
110781408|NCT02624596|Analgesics|analgesics|mesh-ancestor
110781409|NCT02624596|Sensory System Agents|sensory system agents|mesh-ancestor
110781410|NCT02624596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110781411|NCT02624596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110781412|NCT02624596|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110781413|NCT02624596|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110781414|NCT02624596|Anesthetics, General|anesthetics, general|mesh-ancestor
110781415|NCT02624596|Anesthetics|anesthetics|mesh-ancestor
110781416|NCT02624596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110781417|NCT02624596|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110781418|NCT02624596|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110781419|NCT02624596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110781420|NCT02624596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110781421|NCT02624596|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110499063|NCT05709483|Aspirin|aspirin|mesh-list
110781422|NCT02624596|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110781423|NCT02624596|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110781424|NCT02624596|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110781425|NCT02624596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110781426|NCT02624596|GABA Modulators|gaba modulators|mesh-ancestor
110781427|NCT02624596|GABA Agents|gaba agents|mesh-ancestor
110781428|NCT03669562|Alprostadil|alprostadil|mesh-list
110781429|NCT03669562|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110781430|NCT03669562|Vasodilator Agents|vasodilator agents|mesh-ancestor
110781431|NCT03669562|Urological Agents|urological agents|mesh-ancestor
110781432|NCT03669484|Fentanyl|fentanyl|mesh-list
110781433|NCT03669484|Bromides|bromides|mesh-list
110781434|NCT03669484|Propofol|propofol|mesh-list
110781435|NCT03669484|Rocuronium|rocuronium|mesh-list
110781436|NCT03669484|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110781437|NCT03669484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110781438|NCT03669484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110781439|NCT03669484|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110781440|NCT03669484|Anesthetics, General|anesthetics, general|mesh-ancestor
110781441|NCT03669484|Anesthetics|anesthetics|mesh-ancestor
110781442|NCT03669484|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110781443|NCT03669484|Narcotics|narcotics|mesh-ancestor
110781444|NCT03669484|Analgesics|analgesics|mesh-ancestor
110781445|NCT03669484|Sensory System Agents|sensory system agents|mesh-ancestor
110781446|NCT03669484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110781447|NCT03669484|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110781448|NCT03669484|Anticonvulsants|anticonvulsants|mesh-ancestor
110781449|NCT03669484|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110781450|NCT03669484|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110781451|NCT03669484|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110781452|NCT02159404|Immunomodulating Agents|immunomodulating agents|mesh-list
110781453|NCT02159404|Immunologic Factors|immunologic factors|mesh-ancestor
110781454|NCT02159404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110781455|NCT01979536|Cytarabine|cytarabine|mesh-list
110781456|NCT01979536|Dexamethasone|dexamethasone|mesh-list
110781457|NCT01979536|Dexamethasone acetate|dexamethasone acetate|mesh-list
110781458|NCT01979536|Cyclophosphamide|cyclophosphamide|mesh-list
110781459|NCT01979536|Ifosfamide|ifosfamide|mesh-list
110781460|NCT01979536|Isophosphamide mustard|isophosphamide mustard|mesh-list
110781461|NCT01979536|Doxorubicin|doxorubicin|mesh-list
110781462|NCT01979536|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110781463|NCT01979536|Methotrexate|methotrexate|mesh-list
110781464|NCT01979536|Etoposide|etoposide|mesh-list
110781465|NCT01979536|Etoposide phosphate|etoposide phosphate|mesh-list
110781466|NCT01979536|Brentuximab Vedotin|brentuximab vedotin|mesh-list
110781467|NCT01979536|Podophyllotoxin|podophyllotoxin|mesh-list
110781468|NCT01979536|Crizotinib|crizotinib|mesh-list
110781469|NCT01979536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110781470|NCT01979536|Antibodies|antibodies|mesh-list
110781471|NCT01979536|Immunoglobulins|immunoglobulins|mesh-list
110781472|NCT01979536|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110781473|NCT01979536|BB 1101|bb 1101|mesh-list
110781474|NCT01979536|Immunoconjugates|immunoconjugates|mesh-list
110781475|NCT01979536|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
110781476|NCT01979536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110781477|NCT01979536|Immunologic Factors|immunologic factors|mesh-ancestor
110781478|NCT01979536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110781479|NCT01979536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110781480|NCT01979536|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110781481|NCT01979536|Alkylating Agents|alkylating agents|mesh-ancestor
110781482|NCT01979536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110781483|NCT01979536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110781484|NCT01979536|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110781485|NCT01979536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110781486|NCT01979536|Antiemetics|antiemetics|mesh-ancestor
110781487|NCT01979536|Autonomic Agents|autonomic agents|mesh-ancestor
110781488|NCT01979536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110781489|NCT01979536|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110781490|NCT01979536|Glucocorticoids|glucocorticoids|mesh-ancestor
110781491|NCT01979536|Hormones|hormones|mesh-ancestor
110781492|NCT01979536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110781493|NCT01979536|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110781494|NCT01979536|Protease Inhibitors|protease inhibitors|mesh-ancestor
110781495|NCT01979536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110781496|NCT01979536|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110781497|NCT01979536|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110499168|NCT05590260|Iron|iron|mesh-list
110781498|NCT01979536|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110781499|NCT01979536|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110781500|NCT01979536|Abortifacient Agents|abortifacient agents|mesh-ancestor
110781501|NCT01979536|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110781502|NCT01979536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110781503|NCT01979536|Antimetabolites|antimetabolites|mesh-ancestor
110781504|NCT01979536|Dermatologic Agents|dermatologic agents|mesh-ancestor
110781505|NCT01979536|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110781506|NCT01979536|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110781507|NCT01979536|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110781508|NCT01979536|Antiviral Agents|antiviral agents|mesh-ancestor
110781509|NCT01979536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110781510|NCT01979536|Immunotoxins|immunotoxins|mesh-ancestor
110781511|NCT01979536|Keratolytic Agents|keratolytic agents|mesh-ancestor
110781512|NCT01979536|Tubulin Modulators|tubulin modulators|mesh-ancestor
110781513|NCT01979536|Antimitotic Agents|antimitotic agents|mesh-ancestor
110781514|NCT01979536|Mitosis Modulators|mitosis modulators|mesh-ancestor
110781515|NCT01979536|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110781516|NCT03496298|Efpeglenatide|efpeglenatide|mesh-list
110781517|NCT03496298|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110781518|NCT03496298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110781519|NCT03668860|Dexamethasone|dexamethasone|mesh-list
110781520|NCT03668860|Dexamethasone acetate|dexamethasone acetate|mesh-list
110781521|NCT03668860|Betamethasone|betamethasone|mesh-list
110781522|NCT03668860|Betamethasone Valerate|betamethasone valerate|mesh-list
110781523|NCT03668860|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
110781524|NCT03668860|Betamethasone benzoate|betamethasone benzoate|mesh-list
110781525|NCT03668860|Betamethasone acetate phosphate|betamethasone acetate phosphate|mesh-list
110781526|NCT03668860|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
110781527|NCT03668860|BB 1101|bb 1101|mesh-list
110781528|NCT03668860|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110781529|NCT03668860|Antiemetics|antiemetics|mesh-ancestor
110781530|NCT03668860|Autonomic Agents|autonomic agents|mesh-ancestor
110781531|NCT03668860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110781532|NCT03668860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110781533|NCT03668860|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110781534|NCT03668860|Glucocorticoids|glucocorticoids|mesh-ancestor
110781535|NCT03668860|Hormones|hormones|mesh-ancestor
110781536|NCT03668860|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110781537|NCT03668860|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110781539|NCT03668860|Protease Inhibitors|protease inhibitors|mesh-ancestor
110781540|NCT03668860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110781541|NCT03668860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110781542|NCT03668860|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110781543|NCT03668860|Respiratory System Agents|respiratory system agents|mesh-ancestor
110781544|NCT03668860|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110781545|NCT00062751|Sirolimus|sirolimus|mesh-list
110781546|NCT00062751|Letrozole|letrozole|mesh-list
110781547|NCT00062751|Temsirolimus|temsirolimus|mesh-list
110781548|NCT00062751|MTOR Inhibitors|mtor inhibitors|mesh-list
110781549|NCT00062751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110781550|NCT00062751|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110781551|NCT00062751|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110781552|NCT00062751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110781553|NCT00062751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110781554|NCT00062751|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110781555|NCT00062751|Hormone Antagonists|hormone antagonists|mesh-ancestor
110781556|NCT00062751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110781557|NCT00062751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110781558|NCT00062751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110781559|NCT00062751|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110781560|NCT00062751|Immunologic Factors|immunologic factors|mesh-ancestor
110781561|NCT00062751|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110781562|NCT00062751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110781563|NCT00062751|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110781564|NCT00062751|Antifungal Agents|antifungal agents|mesh-ancestor
110781565|NCT00945724|Cytarabine|cytarabine|mesh-list
110781566|NCT00945724|Prednisolone|prednisolone|mesh-list
110781567|NCT00945724|Cyclophosphamide|cyclophosphamide|mesh-list
110781568|NCT00945724|Rituximab|rituximab|mesh-list
110781569|NCT00945724|Doxorubicin|doxorubicin|mesh-list
110781570|NCT00945724|Methotrexate|methotrexate|mesh-list
110781571|NCT00945724|Vincristine|vincristine|mesh-list
110781572|NCT00945724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110781573|NCT00945724|Immunologic Factors|immunologic factors|mesh-ancestor
110781574|NCT00945724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110781575|NCT00945724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110781576|NCT00945724|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110781577|NCT00945724|Alkylating Agents|alkylating agents|mesh-ancestor
110781578|NCT00945724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110781579|NCT00945724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110781580|NCT00945724|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110781581|NCT00945724|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110781582|NCT00945724|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110781583|NCT00945724|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110781584|NCT00945724|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110781585|NCT00945724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110781586|NCT00945724|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110781587|NCT00945724|Abortifacient Agents|abortifacient agents|mesh-ancestor
110781588|NCT00945724|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110781589|NCT00945724|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110781590|NCT00945724|Antimetabolites|antimetabolites|mesh-ancestor
110781591|NCT00945724|Dermatologic Agents|dermatologic agents|mesh-ancestor
110781592|NCT00945724|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110781593|NCT00945724|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110781594|NCT00945724|Antiviral Agents|antiviral agents|mesh-ancestor
110781595|NCT00945724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110850123|NCT01200641|Analgesics|analgesics|mesh-ancestor
110781596|NCT00945724|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110781597|NCT00945724|Tubulin Modulators|tubulin modulators|mesh-ancestor
110781598|NCT00945724|Antimitotic Agents|antimitotic agents|mesh-ancestor
110781599|NCT00945724|Mitosis Modulators|mitosis modulators|mesh-ancestor
110781600|NCT00945724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110781601|NCT00945724|Glucocorticoids|glucocorticoids|mesh-ancestor
110781602|NCT00945724|Hormones|hormones|mesh-ancestor
110781603|NCT00945724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110781604|NCT00945724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110781605|NCT00258310|Capecitabine|capecitabine|mesh-list
110781606|NCT00258310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110781607|NCT00258310|Antimetabolites|antimetabolites|mesh-ancestor
110781608|NCT00258310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110781609|NCT00258310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110781610|NCT00062439|Docetaxel|docetaxel|mesh-list
110781611|NCT00062439|Etoposide|etoposide|mesh-list
110781612|NCT00062439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110781613|NCT00062439|Tubulin Modulators|tubulin modulators|mesh-ancestor
110781614|NCT00062439|Antimitotic Agents|antimitotic agents|mesh-ancestor
110781615|NCT00062439|Mitosis Modulators|mitosis modulators|mesh-ancestor
110781616|NCT00062439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110781617|NCT00062439|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110781618|NCT00062439|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110781619|NCT00062439|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110781620|NCT00062439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110781621|NCT01099059|Amantadine|amantadine|mesh-list
110781622|NCT01099059|Methylphenidate|methylphenidate|mesh-list
110781623|NCT01099059|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110781624|NCT01099059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110781625|NCT01099059|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110781626|NCT01099059|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110781627|NCT01099059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110781628|NCT01099059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110781629|NCT01099059|Dopamine Agents|dopamine agents|mesh-ancestor
110781630|NCT01099059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110781631|NCT01099059|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110781632|NCT01099059|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110781633|NCT01099059|Antiviral Agents|antiviral agents|mesh-ancestor
110781634|NCT01099059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110781635|NCT01099059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110781636|NCT01099059|Analgesics|analgesics|mesh-ancestor
110781637|NCT01099059|Sensory System Agents|sensory system agents|mesh-ancestor
110781638|NCT01099059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110781639|NCT01092741|Imatinib Mesylate|imatinib mesylate|mesh-list
110781640|NCT01092741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110781641|NCT01092741|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110781642|NCT01092741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110781643|NCT01092741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110781644|NCT01095471|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110781645|NCT01095471|Immunologic Factors|immunologic factors|mesh-ancestor
110781646|NCT01095471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110781647|NCT03955341|Chlorhexidine|chlorhexidine|mesh-list
110781648|NCT03955341|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110781649|NCT03955341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110781650|NCT03955341|Disinfectants|disinfectants|mesh-ancestor
110781651|NCT00031551|Etanercept|etanercept|mesh-list
110493697|NCT05766540|Metformin|metformin|mesh-list
110781652|NCT00031551|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110781653|NCT00031551|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110781655|NCT00031551|Sensory System Agents|sensory system agents|mesh-ancestor
110781656|NCT00031551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110781657|NCT00031551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110781658|NCT00031551|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110781659|NCT00031551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110781660|NCT00031551|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110781661|NCT00031551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110781662|NCT00031551|Immunologic Factors|immunologic factors|mesh-ancestor
110781663|NCT01099137|Vildagliptin|vildagliptin|mesh-list
110781664|NCT01099137|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110781665|NCT01099137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110781666|NCT01099137|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110781667|NCT01099137|Protease Inhibitors|protease inhibitors|mesh-ancestor
110781668|NCT01099137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110781669|NCT01099137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110781670|NCT01092975|Phenylephrine|phenylephrine|mesh-list
110781671|NCT01092975|Oxymetazoline|oxymetazoline|mesh-list
110781672|NCT01092975|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110781673|NCT01092975|Mydriatics|mydriatics|mesh-ancestor
110781674|NCT01092975|Autonomic Agents|autonomic agents|mesh-ancestor
110781675|NCT01092975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110781676|NCT01092975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110781677|NCT01092975|Sympathomimetics|sympathomimetics|mesh-ancestor
110781678|NCT01092975|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110781679|NCT01092975|Nasal Decongestants|nasal decongestants|mesh-ancestor
110781680|NCT01092975|Respiratory System Agents|respiratory system agents|mesh-ancestor
110781681|NCT01092975|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110781683|NCT01092975|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110781684|NCT01092975|Adrenergic Agents|adrenergic agents|mesh-ancestor
110781685|NCT01092975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110781686|NCT01092975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110781687|NCT01092975|Protective Agents|protective agents|mesh-ancestor
110781688|NCT01584297|Ketoconazole|ketoconazole|mesh-list
110781689|NCT01584297|Antifungal Agents|antifungal agents|mesh-ancestor
110781690|NCT01584297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110781691|NCT01584297|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110781692|NCT01584297|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110781693|NCT01584297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110781694|NCT01584297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110781695|NCT01584297|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110781696|NCT01584297|Hormone Antagonists|hormone antagonists|mesh-ancestor
110781697|NCT01584297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110781698|NCT01584297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110781699|NCT01584297|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110781700|NCT00049257|Paclitaxel|paclitaxel|mesh-list
110781701|NCT00049257|Carboplatin|carboplatin|mesh-list
110781702|NCT00049257|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110781703|NCT00049257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110781704|NCT00049257|Tubulin Modulators|tubulin modulators|mesh-ancestor
110781705|NCT00049257|Antimitotic Agents|antimitotic agents|mesh-ancestor
110781706|NCT00049257|Mitosis Modulators|mitosis modulators|mesh-ancestor
110781707|NCT00049257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110781708|NCT03951987|Charcoal|charcoal|mesh-list
110781709|NCT03951987|Antidotes|antidotes|mesh-ancestor
110781710|NCT03951987|Protective Agents|protective agents|mesh-ancestor
110781711|NCT03951987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110781712|NCT03668470|Dulaglutide|dulaglutide|mesh-list
110781713|NCT03668470|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110781714|NCT03668470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110781715|NCT03020992|Certolizumab Pegol|certolizumab pegol|mesh-list
110781716|NCT03020992|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110781717|NCT03020992|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110781718|NCT03020992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110781719|NCT03020992|Immunologic Factors|immunologic factors|mesh-ancestor
110781720|NCT03020992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110781721|NCT03020992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110781722|NCT03020914|Methamphetamine|methamphetamine|mesh-list
110781723|NCT03020914|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110781724|NCT03020914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110781726|NCT03020914|Autonomic Agents|autonomic agents|mesh-ancestor
110781727|NCT03020914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110781728|NCT03020914|Dopamine Agents|dopamine agents|mesh-ancestor
110781729|NCT03020914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110781730|NCT03020914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110781731|NCT03020914|Adrenergic Agents|adrenergic agents|mesh-ancestor
110781732|NCT03020914|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110781733|NCT03020914|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110781734|NCT03020914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110781735|NCT03020914|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110781736|NCT03018340|Pimavanserin|pimavanserin|mesh-list
110781737|NCT03018340|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110781738|NCT03018340|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110781739|NCT03018340|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110781740|NCT03018340|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110781741|NCT03018340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110781742|NCT03018340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110781743|NCT03018340|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110781744|NCT03018340|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110781745|NCT03018340|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110781746|NCT03018340|Serotonin Agents|serotonin agents|mesh-ancestor
110781747|NCT03018340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110781748|NCT03018340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110781749|NCT00048165|Cyclosporine|cyclosporine|mesh-list
110781750|NCT00048165|Mycophenolic Acid|mycophenolic acid|mesh-list
110781751|NCT00048165|Methylprednisolone|methylprednisolone|mesh-list
110781752|NCT00048165|Cyclosporins|cyclosporins|mesh-list
110781753|NCT00048165|Daclizumab|daclizumab|mesh-list
110781754|NCT00048165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110781755|NCT00048165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110781756|NCT00048165|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110781757|NCT00048165|Immunologic Factors|immunologic factors|mesh-ancestor
110781758|NCT00048165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110781759|NCT00048165|Antifungal Agents|antifungal agents|mesh-ancestor
110781760|NCT00048165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110781761|NCT00048165|Dermatologic Agents|dermatologic agents|mesh-ancestor
110781762|NCT00048165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110781763|NCT00048165|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110781764|NCT00048165|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110781765|NCT00048165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110781766|NCT00048165|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110781767|NCT00048165|Antitubercular Agents|antitubercular agents|mesh-ancestor
110781768|NCT00048165|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110781769|NCT00048165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110781770|NCT00048165|Antiemetics|antiemetics|mesh-ancestor
110781771|NCT00048165|Autonomic Agents|autonomic agents|mesh-ancestor
110781772|NCT00048165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110781773|NCT00048165|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110781774|NCT00048165|Glucocorticoids|glucocorticoids|mesh-ancestor
110781775|NCT00048165|Hormones|hormones|mesh-ancestor
110781776|NCT00048165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110781777|NCT00048165|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110781778|NCT00048165|Protective Agents|protective agents|mesh-ancestor
110781779|NCT01099527|Capecitabine|capecitabine|mesh-list
110781780|NCT01099527|Everolimus|everolimus|mesh-list
110781781|NCT01099527|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110781782|NCT01099527|Antimetabolites|antimetabolites|mesh-ancestor
110781783|NCT01099527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110781784|NCT01099527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110781785|NCT01099527|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110493718|NCT05766540|GABA Antagonists|gaba antagonists|mesh-ancestor
110781786|NCT01099527|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110781787|NCT01099527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110781788|NCT01099527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110781789|NCT01099527|Immunologic Factors|immunologic factors|mesh-ancestor
110781790|NCT01099527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110781792|NCT01093365|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110781793|NCT01093365|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110781794|NCT01093365|Cholinergic Agents|cholinergic agents|mesh-ancestor
110781795|NCT01093365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110781796|NCT01093365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110781797|NCT01093365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110781798|NCT03955497|Hyaluronic Acid|hyaluronic acid|mesh-list
110499471|NCT03842696|Vorinostat|vorinostat|mesh-list
110781799|NCT03955497|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110781800|NCT03955497|Immunologic Factors|immunologic factors|mesh-ancestor
110781801|NCT03955497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110781803|NCT03955497|Protective Agents|protective agents|mesh-ancestor
110781804|NCT01099605|Bupivacaine|bupivacaine|mesh-list
110781805|NCT01099605|Anesthetics, Local|anesthetics, local|mesh-ancestor
110781806|NCT01099605|Anesthetics|anesthetics|mesh-ancestor
110781807|NCT01099605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110781808|NCT01099605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110781809|NCT01099605|Sensory System Agents|sensory system agents|mesh-ancestor
110781810|NCT01099605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110781811|NCT00059787|Paclitaxel|paclitaxel|mesh-list
110781812|NCT00059787|Carboplatin|carboplatin|mesh-list
110781813|NCT00059787|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110781814|NCT00059787|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110781815|NCT00059787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110781816|NCT00059787|Tubulin Modulators|tubulin modulators|mesh-ancestor
110781817|NCT00059787|Antimitotic Agents|antimitotic agents|mesh-ancestor
110781818|NCT00059787|Mitosis Modulators|mitosis modulators|mesh-ancestor
110781819|NCT00059787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110781820|NCT00059787|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110781821|NCT00059787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110781822|NCT01099839|Ipragliflozin|ipragliflozin|mesh-list
110781823|NCT01099839|Miglitol|miglitol|mesh-list
110781824|NCT01099839|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110781825|NCT01099839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110781826|NCT01099839|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110781827|NCT01099839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110781828|NCT01099839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110781829|NCT01099839|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
110781831|NCT00058539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110781832|NCT00058539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110781833|NCT03956823|Amlodipine|amlodipine|mesh-list
110781834|NCT03956823|Telmisartan|telmisartan|mesh-list
110781835|NCT03956823|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110781836|NCT03956823|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110781837|NCT03956823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110781838|NCT03956823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110781839|NCT03956823|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110781840|NCT03956823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110781841|NCT03956823|Vasodilator Agents|vasodilator agents|mesh-ancestor
110781842|NCT03956823|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110781843|NCT03956823|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110781844|NCT03015532|Bupivacaine|bupivacaine|mesh-list
110781845|NCT03015532|Ropivacaine|ropivacaine|mesh-list
110781846|NCT03015532|Anesthetics, Local|anesthetics, local|mesh-ancestor
110781847|NCT03015532|Anesthetics|anesthetics|mesh-ancestor
110781848|NCT03015532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110781849|NCT03015532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110781850|NCT03015532|Sensory System Agents|sensory system agents|mesh-ancestor
110781851|NCT03015532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110781852|NCT03954873|Glucagon|glucagon|mesh-list
110781853|NCT03954873|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
110781854|NCT03954873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110781855|NCT03954873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110781856|NCT03954873|Hormones|hormones|mesh-ancestor
110781857|NCT03954873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110781858|NCT03954873|Incretins|incretins|mesh-ancestor
110781859|NCT03954639|Bupivacaine|bupivacaine|mesh-list
110781860|NCT03954639|Anesthetics, Local|anesthetics, local|mesh-ancestor
110781861|NCT03954639|Anesthetics|anesthetics|mesh-ancestor
110781862|NCT03954639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110781863|NCT03954639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110781864|NCT03954639|Sensory System Agents|sensory system agents|mesh-ancestor
110781865|NCT03954639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110781866|NCT01095939|Benazepril|benazepril|mesh-list
110781867|NCT01095939|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110781868|NCT01095939|Protease Inhibitors|protease inhibitors|mesh-ancestor
110781869|NCT01095939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110781870|NCT01095939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110781871|NCT01095939|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110781872|NCT03015220|Dulaglutide|dulaglutide|mesh-list
110781873|NCT03015220|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110781874|NCT03015220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110781875|NCT00022659|Bevacizumab|bevacizumab|mesh-list
110781876|NCT00022659|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110781877|NCT00022659|Antibodies|antibodies|mesh-list
110781878|NCT00022659|Immunoglobulins|immunoglobulins|mesh-list
110781879|NCT00022659|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110781880|NCT00022659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110781881|NCT00022659|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110781882|NCT00022659|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110781883|NCT00022659|Growth Substances|growth substances|mesh-ancestor
110781884|NCT00022659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110781885|NCT00022659|Growth Inhibitors|growth inhibitors|mesh-ancestor
110781886|NCT00022659|Immunologic Factors|immunologic factors|mesh-ancestor
110781887|NCT03018106|Estrogens|estrogens|mesh-list
110781888|NCT03018106|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
110781889|NCT03018106|Hormones|hormones|mesh-ancestor
110781890|NCT03018106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110781891|NCT03018106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110781892|NCT03018028|Liraglutide|liraglutide|mesh-list
110781893|NCT03018028|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110781894|NCT03018028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110781895|NCT03018028|Incretins|incretins|mesh-ancestor
110781896|NCT03018028|Hormones|hormones|mesh-ancestor
110781897|NCT03018028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110781898|NCT03667222|Minocycline|minocycline|mesh-list
110781899|NCT03667222|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110781900|NCT03667222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110781901|NCT03667300|Linagliptin|linagliptin|mesh-list
110781902|NCT03667300|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110781903|NCT03667300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110781904|NCT03667300|Incretins|incretins|mesh-ancestor
110781906|NCT03667300|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110781907|NCT03667300|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110781908|NCT03667300|Protease Inhibitors|protease inhibitors|mesh-ancestor
110781909|NCT03667300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110781910|NCT03667300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110781911|NCT03667066|Clopidogrel|clopidogrel|mesh-list
110781912|NCT03667066|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110781913|NCT03667066|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110850171|NCT01318070|Pioglitazone|pioglitazone|mesh-list
110781914|NCT03667066|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110781915|NCT03667066|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110493729|NCT05746806|Androgens|androgens|mesh-list
110781916|NCT03667066|Purinergic Agents|purinergic agents|mesh-ancestor
110781917|NCT03667066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110781918|NCT03667066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110781919|NCT03667066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110781920|NCT00021255|Cyclophosphamide|cyclophosphamide|mesh-list
110781921|NCT00021255|Carboplatin|carboplatin|mesh-list
110781923|NCT00021255|Doxorubicin|doxorubicin|mesh-list
110781924|NCT00021255|Trastuzumab|trastuzumab|mesh-list
110781925|NCT00021255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110781926|NCT00021255|Immunologic Factors|immunologic factors|mesh-ancestor
110781927|NCT00021255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110781928|NCT00021255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110781929|NCT00021255|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110781930|NCT00021255|Alkylating Agents|alkylating agents|mesh-ancestor
110781931|NCT00021255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110781932|NCT00021255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110781933|NCT00021255|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110781934|NCT00021255|Tubulin Modulators|tubulin modulators|mesh-ancestor
110781935|NCT00021255|Antimitotic Agents|antimitotic agents|mesh-ancestor
110781936|NCT00021255|Mitosis Modulators|mitosis modulators|mesh-ancestor
110781937|NCT00021255|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110781938|NCT00021255|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110781939|NCT00021255|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110781940|NCT00021255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110781941|NCT00021255|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110781942|NCT03012334|Alprazolam|alprazolam|mesh-list
110781943|NCT03012334|Lasmiditan|lasmiditan|mesh-list
110781944|NCT03012334|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110781945|NCT03012334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110781946|NCT03012334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110781947|NCT03012334|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110781948|NCT03012334|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110781949|NCT03012334|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110781950|NCT03012334|GABA Modulators|gaba modulators|mesh-ancestor
110781952|NCT03012334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110781953|NCT03012334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110781954|NCT03012334|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110781955|NCT03012334|Serotonin Agents|serotonin agents|mesh-ancestor
110781956|NCT03951285|Niacinamide|niacinamide|mesh-list
110781957|NCT03951285|Vitamin B Complex|vitamin b complex|mesh-ancestor
110781958|NCT03951285|Vitamins|vitamins|mesh-ancestor
110781959|NCT03951285|Micronutrients|micronutrients|mesh-ancestor
110781960|NCT03951285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110781961|NCT04571944|Suvorexant|suvorexant|mesh-list
110781962|NCT04571944|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110781963|NCT04571944|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110781964|NCT04571944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110781965|NCT04571944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110781966|NCT04571944|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
110781967|NCT04571944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110781968|NCT04571944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110781969|NCT04052932|Allopurinol|allopurinol|mesh-list
110781970|NCT04052932|Antimetabolites|antimetabolites|mesh-ancestor
110781971|NCT04052932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110781972|NCT04052932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110781973|NCT04052932|Gout Suppressants|gout suppressants|mesh-ancestor
110850198|NCT03835715|Serotonin Agents|serotonin agents|mesh-ancestor
110781974|NCT04052932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110781975|NCT04052932|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110781977|NCT04052932|Protective Agents|protective agents|mesh-ancestor
110781978|NCT04052932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110781979|NCT03006562|Heparin|heparin|mesh-list
110781981|NCT03006562|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110781982|NCT03006562|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110781983|NCT03006562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110781984|NCT03666208|Sirolimus|sirolimus|mesh-list
110781985|NCT03666208|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110781986|NCT03666208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110781987|NCT03666208|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110781988|NCT03666208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110781989|NCT03666208|Antifungal Agents|antifungal agents|mesh-ancestor
110781990|NCT03666208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110781991|NCT03666208|Immunologic Factors|immunologic factors|mesh-ancestor
110781992|NCT03666208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110781993|NCT03007966|Clonidine|clonidine|mesh-list
110781994|NCT03007966|Epinephrine|epinephrine|mesh-list
110781995|NCT03007966|Bupivacaine|bupivacaine|mesh-list
110781996|NCT03007966|Anesthetics, Local|anesthetics, local|mesh-ancestor
110781997|NCT03007966|Anesthetics|anesthetics|mesh-ancestor
110781998|NCT03007966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110781999|NCT03007966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110782000|NCT03007966|Sensory System Agents|sensory system agents|mesh-ancestor
110782001|NCT03007966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110782002|NCT03007966|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110782003|NCT03007966|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110782004|NCT03007966|Adrenergic Agents|adrenergic agents|mesh-ancestor
110782005|NCT03007966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110782006|NCT03007966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110782007|NCT03007966|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110782008|NCT03007966|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110782009|NCT03007966|Autonomic Agents|autonomic agents|mesh-ancestor
110782010|NCT03007966|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110782011|NCT03007966|Respiratory System Agents|respiratory system agents|mesh-ancestor
110782012|NCT03007966|Mydriatics|mydriatics|mesh-ancestor
110782013|NCT03007966|Sympathomimetics|sympathomimetics|mesh-ancestor
110782014|NCT03007966|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110782015|NCT03007966|Analgesics|analgesics|mesh-ancestor
110782016|NCT03007966|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110782017|NCT03007966|Sympatholytics|sympatholytics|mesh-ancestor
110782018|NCT03007966|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110782019|NCT03007888|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
110782020|NCT03007888|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110782021|NCT03007888|Immunologic Factors|immunologic factors|mesh-ancestor
110782022|NCT03007888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110782023|NCT03007888|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110782024|NCT03007888|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110782025|NCT03007888|Dopamine Agonists|dopamine agonists|mesh-ancestor
110782026|NCT03007888|Dopamine Agents|dopamine agents|mesh-ancestor
110782027|NCT03007888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110782028|NCT03007888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110782029|NCT03541044|Nicotine|nicotine|mesh-list
110782030|NCT03541044|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110782031|NCT03541044|Autonomic Agents|autonomic agents|mesh-ancestor
110782032|NCT03541044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110782033|NCT03541044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110782034|NCT03541044|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110782035|NCT03541044|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110782036|NCT03541044|Cholinergic Agents|cholinergic agents|mesh-ancestor
110782037|NCT03541044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110782038|NCT03541044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110782039|NCT00009945|Clodronic Acid|clodronic acid|mesh-list
110782040|NCT00009945|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110782041|NCT00009945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110782042|NCT03540030|Acetaminophen|acetaminophen|mesh-list
110782043|NCT03540030|Celecoxib|celecoxib|mesh-list
110782044|NCT03540030|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
110782045|NCT03540030|Lidocaine|lidocaine|mesh-list
110782046|NCT03540030|Gabapentin|gabapentin|mesh-list
110782047|NCT03540030|Propofol|propofol|mesh-list
110782048|NCT03540030|Sevoflurane|sevoflurane|mesh-list
110782049|NCT03540030|Desflurane|desflurane|mesh-list
110782050|NCT03540030|Rocuronium|rocuronium|mesh-list
110782051|NCT03540030|Vecuronium Bromide|vecuronium bromide|mesh-list
110782052|NCT03540030|Anesthetics, Local|anesthetics, local|mesh-ancestor
110782053|NCT03540030|Anesthetics|anesthetics|mesh-ancestor
110782054|NCT03540030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110782055|NCT03540030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110782056|NCT03540030|Sensory System Agents|sensory system agents|mesh-ancestor
110782057|NCT03540030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110493802|NCT05604794|Ketamine|ketamine|mesh-list
110782058|NCT03540030|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110782059|NCT03540030|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110782060|NCT03540030|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110782061|NCT03540030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110782062|NCT03540030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110782063|NCT03540030|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110782064|NCT03540030|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110782065|NCT03540030|Anesthetics, General|anesthetics, general|mesh-ancestor
110782066|NCT03540030|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110782067|NCT03540030|Analgesics|analgesics|mesh-ancestor
110782068|NCT03540030|Antipyretics|antipyretics|mesh-ancestor
110782069|NCT03540030|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110782070|NCT03540030|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110782071|NCT03540030|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110782072|NCT03540030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110782073|NCT03540030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110782074|NCT03540030|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110782075|NCT03540030|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110782076|NCT03540030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110782077|NCT03540030|Anticonvulsants|anticonvulsants|mesh-ancestor
110782078|NCT03540030|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110782079|NCT03540030|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110782080|NCT03540030|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110782081|NCT03540030|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110782082|NCT03540030|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110782083|NCT03540030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110782084|NCT03540030|Antimanic Agents|antimanic agents|mesh-ancestor
110782085|NCT03540030|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110782086|NCT03540030|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110782087|NCT03540030|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110782088|NCT03540030|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
110782089|NCT03540030|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110782090|NCT03540030|Cholinergic Agents|cholinergic agents|mesh-ancestor
110782091|NCT03003676|Cyclophosphamide|cyclophosphamide|mesh-list
110782092|NCT03003676|Pembrolizumab|pembrolizumab|mesh-list
110782093|NCT03003676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110782094|NCT03003676|Immunologic Factors|immunologic factors|mesh-ancestor
110782095|NCT03003676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110782096|NCT03003676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110782097|NCT03003676|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110782098|NCT03003676|Alkylating Agents|alkylating agents|mesh-ancestor
110493835|NCT05305248|Dexmedetomidine|dexmedetomidine|mesh-list
110782099|NCT03003676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110782100|NCT03003676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110782101|NCT03003676|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110782102|NCT03003676|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110782103|NCT03003676|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110782104|NCT03665740|Resveratrol|resveratrol|mesh-list
110782105|NCT03665740|Antioxidants|antioxidants|mesh-ancestor
110782106|NCT03665740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110782107|NCT03665740|Protective Agents|protective agents|mesh-ancestor
110782108|NCT03665740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110782109|NCT03665740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110782110|NCT03665740|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110782111|NCT03665350|Insulin|insulin|mesh-list
110782112|NCT03665350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110782113|NCT03665350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110782114|NCT03665428|Bismuth|bismuth|mesh-list
110782115|NCT03665428|Antacids|antacids|mesh-ancestor
110782116|NCT03665428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110782117|NCT03665428|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110782118|NCT03669328|Anesthetics|anesthetics|mesh-list
110782119|NCT03669328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110782120|NCT03669328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110782122|NCT02912650|Ibuprofen|ibuprofen|mesh-list
110782123|NCT02912650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110782124|NCT02912650|Analgesics|analgesics|mesh-ancestor
110782125|NCT02912650|Sensory System Agents|sensory system agents|mesh-ancestor
110782126|NCT02912650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110782127|NCT02912650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110782128|NCT02912650|Antipyretics|antipyretics|mesh-ancestor
110782129|NCT02912650|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110782130|NCT02912650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110782131|NCT02912650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110782132|NCT02912650|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110782133|NCT02912650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110782134|NCT02912650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110782136|NCT03002038|Azathioprine|azathioprine|mesh-list
110782137|NCT03002038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110782138|NCT03002038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110782139|NCT03002038|Immunologic Factors|immunologic factors|mesh-ancestor
110782140|NCT03002038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110782141|NCT03002038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110782142|NCT03002038|Antimetabolites|antimetabolites|mesh-ancestor
110782143|NCT03002038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110782144|NCT03002038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110782145|NCT03002038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110782146|NCT03664414|Pentoxifylline|pentoxifylline|mesh-list
110782147|NCT03664414|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110782148|NCT03664414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110782149|NCT03664414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110782150|NCT03664414|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110782151|NCT03664414|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110782152|NCT03664414|Protective Agents|protective agents|mesh-ancestor
110782153|NCT03664414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110782154|NCT03664414|Vasodilator Agents|vasodilator agents|mesh-ancestor
110782155|NCT03664414|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110782156|NCT03664414|Antioxidants|antioxidants|mesh-ancestor
110782157|NCT02911948|Insulin|insulin|mesh-list
110782158|NCT02911948|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110782159|NCT02911948|Liraglutide|liraglutide|mesh-list
110782160|NCT02911948|Insulin, Long-Acting|insulin, long-acting|mesh-list
110782161|NCT02911948|Xultophy|xultophy|mesh-list
110782162|NCT02911948|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110782163|NCT02911948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110782164|NCT02911948|Incretins|incretins|mesh-ancestor
110782165|NCT02911948|Hormones|hormones|mesh-ancestor
110782166|NCT02911948|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110782167|NCT03622918|Rifampin|rifampin|mesh-list
110782168|NCT03622918|Colistin|colistin|mesh-list
110782169|NCT03622918|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110782170|NCT03622918|Antitubercular Agents|antitubercular agents|mesh-ancestor
110782171|NCT03622918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110782172|NCT03622918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110782173|NCT03622918|Leprostatic Agents|leprostatic agents|mesh-ancestor
110782174|NCT03622918|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110782175|NCT03622918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110782176|NCT03622918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110782177|NCT03622918|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110782178|NCT03622918|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110782179|NCT03622918|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110782180|NCT03622918|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110493907|NCT05110001|Natamycin|natamycin|mesh-list
110782181|NCT03622918|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110782182|NCT03622918|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110782184|NCT03487666|Nivolumab|nivolumab|mesh-list
110782185|NCT03487666|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110782186|NCT03487666|Antimetabolites|antimetabolites|mesh-ancestor
110782187|NCT03487666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110782188|NCT03487666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110782189|NCT03487666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110850214|NCT03843281|Acetaminophen|acetaminophen|mesh-list
110782191|NCT03367312|Xenon|xenon|mesh-list
110782192|NCT03367312|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110782193|NCT03367312|Anesthetics, General|anesthetics, general|mesh-ancestor
110782194|NCT03367312|Anesthetics|anesthetics|mesh-ancestor
110782195|NCT03367312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110782196|NCT03367312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110782197|NCT00027027|Pertuzumab|pertuzumab|mesh-list
110782198|NCT00027027|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110782199|NCT00027027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110782200|NCT00046839|Celecoxib|celecoxib|mesh-list
110782201|NCT00046839|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
110782202|NCT00046839|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110782203|NCT00046839|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110782204|NCT00046839|Analgesics|analgesics|mesh-ancestor
110782205|NCT00046839|Sensory System Agents|sensory system agents|mesh-ancestor
110782206|NCT00046839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110782207|NCT00046839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110782208|NCT00046839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110782209|NCT00046839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110782210|NCT00046839|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110782211|NCT00046839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110782212|NCT00046839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110782213|NCT00006903|Fulvestrant|fulvestrant|mesh-list
110782214|NCT00006903|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110782215|NCT00006903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110782216|NCT00006903|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110782217|NCT00006903|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110782218|NCT00006903|Hormone Antagonists|hormone antagonists|mesh-ancestor
110782219|NCT00006903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110782220|NCT00006903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110782221|NCT03951597|Gemcitabine|gemcitabine|mesh-list
110782222|NCT03951597|Oxaliplatin|oxaliplatin|mesh-list
110782223|NCT03951597|Lenvatinib|lenvatinib|mesh-list
110782224|NCT03951597|Antibodies|antibodies|mesh-list
110782225|NCT03951597|Immunologic Factors|immunologic factors|mesh-ancestor
110782226|NCT03951597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110782227|NCT03951597|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110782228|NCT03951597|Antimetabolites|antimetabolites|mesh-ancestor
110782229|NCT03951597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110782230|NCT03951597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110782231|NCT03951597|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110782232|NCT03951597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110782233|NCT03539484|Obinutuzumab|obinutuzumab|mesh-list
110782234|NCT03539484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110782235|NCT03539484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110782236|NCT01101009|Amlodipine|amlodipine|mesh-list
110782237|NCT01101009|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110782238|NCT01101009|Olmesartan|olmesartan|mesh-list
110782239|NCT01101009|Perindopril|perindopril|mesh-list
110782240|NCT01101009|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110782241|NCT01101009|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110782242|NCT01101009|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110850219|NCT03843281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110782243|NCT01101009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110782244|NCT01101009|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110782245|NCT01101009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110782246|NCT01101009|Vasodilator Agents|vasodilator agents|mesh-ancestor
110782247|NCT01101009|Diuretics|diuretics|mesh-ancestor
110782248|NCT01101009|Natriuretic Agents|natriuretic agents|mesh-ancestor
110782249|NCT01101009|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110782250|NCT01101009|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110782251|NCT01101009|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110782252|NCT01101009|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110782253|NCT01101009|Protease Inhibitors|protease inhibitors|mesh-ancestor
110782254|NCT01101009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110782255|NCT02996500|Tofacitinib|tofacitinib|mesh-list
110782256|NCT02996500|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
110782257|NCT02996500|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110782258|NCT02996500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110782259|NCT02996500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110782260|NCT00006489|Naltrexone|naltrexone|mesh-list
110782261|NCT00006489|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110782262|NCT00006489|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110782263|NCT00006489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110782264|NCT00006489|Sensory System Agents|sensory system agents|mesh-ancestor
110782265|NCT00006489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110782266|NCT01096095|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
110782267|NCT01096095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110782268|NCT03720756|Nickel|nickel|mesh-list
110782269|NCT03720756|Trace Elements|trace elements|mesh-ancestor
110782270|NCT03720756|Micronutrients|micronutrients|mesh-ancestor
110782271|NCT03720756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110782272|NCT00025233|Bevacizumab|bevacizumab|mesh-list
110782273|NCT00025233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110782274|NCT00025233|Antibodies|antibodies|mesh-list
110782275|NCT00025233|Immunoglobulins|immunoglobulins|mesh-list
110782276|NCT00025233|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110782277|NCT00025233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110782278|NCT00025233|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110782279|NCT00025233|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110782280|NCT00025233|Growth Substances|growth substances|mesh-ancestor
110782281|NCT00025233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110782282|NCT00025233|Growth Inhibitors|growth inhibitors|mesh-ancestor
110782283|NCT00025233|Immunologic Factors|immunologic factors|mesh-ancestor
110782285|NCT00025155|Epothilone B|epothilone b|mesh-list
110782286|NCT00025155|Tubulin Modulators|tubulin modulators|mesh-ancestor
110782287|NCT00025155|Antimitotic Agents|antimitotic agents|mesh-ancestor
110782288|NCT00025155|Mitosis Modulators|mitosis modulators|mesh-ancestor
110782289|NCT00025155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110782290|NCT00025155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110782291|NCT02998996|Endocine|endocine|mesh-list
110782292|NCT02998996|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110782293|NCT02998996|Immunologic Factors|immunologic factors|mesh-ancestor
110782294|NCT02998996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110782295|NCT03663478|Ropivacaine|ropivacaine|mesh-list
110850245|NCT04443322|Durvalumab|durvalumab|mesh-list
110782296|NCT03663478|Anesthetics, Local|anesthetics, local|mesh-ancestor
110782297|NCT03663478|Anesthetics|anesthetics|mesh-ancestor
110782298|NCT03663478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110782299|NCT03663478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110782300|NCT03663478|Sensory System Agents|sensory system agents|mesh-ancestor
110782301|NCT03663478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110782302|NCT02994940|Acetaminophen|acetaminophen|mesh-list
110782303|NCT02994940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110782304|NCT02994940|Analgesics|analgesics|mesh-ancestor
110782305|NCT02994940|Sensory System Agents|sensory system agents|mesh-ancestor
110782306|NCT02994940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110782307|NCT02994940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110782308|NCT02994940|Antipyretics|antipyretics|mesh-ancestor
110782309|NCT02994394|Tolvaptan|tolvaptan|mesh-list
110782310|NCT02994394|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
110782311|NCT02994394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110782312|NCT02994394|Natriuretic Agents|natriuretic agents|mesh-ancestor
110493998|NCT04939090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110782313|NCT02994394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110782314|NCT01063270|Rifampin|rifampin|mesh-list
110782315|NCT01063270|Clindamycin|clindamycin|mesh-list
110782316|NCT01063270|Clindamycin palmitate|clindamycin palmitate|mesh-list
110782317|NCT01063270|Clindamycin phosphate|clindamycin phosphate|mesh-list
110782318|NCT01063270|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110782319|NCT01063270|Antitubercular Agents|antitubercular agents|mesh-ancestor
110782320|NCT01063270|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110782321|NCT01063270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110782322|NCT01063270|Leprostatic Agents|leprostatic agents|mesh-ancestor
110782323|NCT01063270|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110782324|NCT01063270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110782325|NCT01063270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110782326|NCT01063270|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110782327|NCT01063270|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110782328|NCT01063270|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110782329|NCT01063270|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110782330|NCT01063270|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110782331|NCT01063270|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110782332|NCT01063270|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110782333|NCT00023673|Paclitaxel|paclitaxel|mesh-list
110782334|NCT00023673|Carboplatin|carboplatin|mesh-list
110782335|NCT00023673|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110782336|NCT00023673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110782337|NCT00023673|Tubulin Modulators|tubulin modulators|mesh-ancestor
110782338|NCT00023673|Antimitotic Agents|antimitotic agents|mesh-ancestor
110782339|NCT00023673|Mitosis Modulators|mitosis modulators|mesh-ancestor
110782340|NCT00023673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110782341|NCT01069900|Amoxicillin|amoxicillin|mesh-list
110782342|NCT01069900|Moxifloxacin|moxifloxacin|mesh-list
110782343|NCT01069900|Clavulanic Acid|clavulanic acid|mesh-list
110782344|NCT01069900|Clavulanic Acids|clavulanic acids|mesh-list
110782345|NCT01069900|Ertapenem|ertapenem|mesh-list
110782346|NCT01069900|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
110782347|NCT01069900|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
110782348|NCT01069900|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110782349|NCT01069900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110782350|NCT01069900|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110782351|NCT01069900|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110782352|NCT01069900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110782353|NCT01069900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110782354|NCT01069900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110782355|NCT01069900|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110494026|NCT04806906|Cc-486|cc-486|mesh-list
110782356|NCT01069900|Contraceptive Agents|contraceptive agents|mesh-ancestor
110782357|NCT01069900|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110782358|NCT01069900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110782359|NCT01069900|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110782360|NCT01069900|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110782361|NCT01069900|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110782362|NCT01069900|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110782363|NCT00006237|Interferons|interferons|mesh-list
110782364|NCT00006237|Interferon-alpha|interferon-alpha|mesh-list
110782365|NCT00006237|Aldesleukin|aldesleukin|mesh-list
110782366|NCT00006237|Interleukin-2|interleukin-2|mesh-list
110782367|NCT00006237|Dacarbazine|dacarbazine|mesh-list
110782368|NCT00006237|Vinblastine|vinblastine|mesh-list
110782369|NCT00006237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110782370|NCT00006237|Antiviral Agents|antiviral agents|mesh-ancestor
110782371|NCT00006237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110782372|NCT00006237|Immunologic Factors|immunologic factors|mesh-ancestor
110782373|NCT00006237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110782374|NCT00006237|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110782375|NCT00006237|Analgesics|analgesics|mesh-ancestor
110782376|NCT00006237|Sensory System Agents|sensory system agents|mesh-ancestor
110782377|NCT00006237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110782378|NCT00006237|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110782379|NCT00006237|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110782380|NCT00006237|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110782381|NCT00006237|Alkylating Agents|alkylating agents|mesh-ancestor
110782382|NCT00006237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110782383|NCT00006237|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110782384|NCT00006237|Tubulin Modulators|tubulin modulators|mesh-ancestor
110782385|NCT00006237|Antimitotic Agents|antimitotic agents|mesh-ancestor
110782386|NCT00006237|Mitosis Modulators|mitosis modulators|mesh-ancestor
110782388|NCT04056754|Abiraterone Acetate|abiraterone acetate|mesh-list
110782389|NCT04056754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110782390|NCT04056754|Glucocorticoids|glucocorticoids|mesh-ancestor
110782391|NCT04056754|Hormones|hormones|mesh-ancestor
110782392|NCT04056754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110782393|NCT04056754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110782394|NCT04056754|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110782395|NCT04056754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110782396|NCT04056754|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110782397|NCT04056754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110500073|NCT02621385|Midazolam|midazolam|mesh-list
110782398|NCT04056754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110782399|NCT04056754|Hormone Antagonists|hormone antagonists|mesh-ancestor
110782400|NCT04056754|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110782401|NCT04056442|Cannabidiol|cannabidiol|mesh-list
110782402|NCT04056442|Anticonvulsants|anticonvulsants|mesh-ancestor
110782403|NCT02993926|Leuprolide|leuprolide|mesh-list
110782404|NCT02993926|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110782405|NCT02993926|Fertility Agents|fertility agents|mesh-ancestor
110782406|NCT02993926|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110782407|NCT02993926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110782408|NCT02993926|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110782409|NCT02993926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110782410|NCT04055506|Ritonavir|ritonavir|mesh-list
110782411|NCT04055506|Deucravacitinib|deucravacitinib|mesh-list
110782412|NCT04055506|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110782413|NCT04055506|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110782414|NCT04055506|Protease Inhibitors|protease inhibitors|mesh-ancestor
110782415|NCT04055506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110782416|NCT04055506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110782417|NCT04055506|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110782418|NCT04055506|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110782419|NCT04055506|Antiviral Agents|antiviral agents|mesh-ancestor
110782420|NCT04055506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110782421|NCT04055506|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110782422|NCT04055506|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110782423|NCT04055506|Dermatologic Agents|dermatologic agents|mesh-ancestor
110782424|NCT04055506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110782425|NCT02993224|Deferasirox|deferasirox|mesh-list
110782426|NCT02993224|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110782427|NCT02993224|Chelating Agents|chelating agents|mesh-ancestor
110107516|NCT01812720|Hormones|hormones|mesh-ancestor
110782428|NCT02993224|Sequestering Agents|sequestering agents|mesh-ancestor
110782429|NCT02993224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110782430|NCT02992132|Pimavanserin|pimavanserin|mesh-list
110782431|NCT02992132|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110782432|NCT02992132|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110782433|NCT02992132|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110782434|NCT02992132|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110782435|NCT02992132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110782436|NCT02992132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110782437|NCT02992132|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110782438|NCT02992132|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110782439|NCT02992132|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110782440|NCT02992132|Serotonin Agents|serotonin agents|mesh-ancestor
110782441|NCT02992132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110782442|NCT02992132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110782443|NCT03444584|Metformin|metformin|mesh-list
110782444|NCT03444584|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110782445|NCT03444584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110782446|NCT03717740|Esomeprazole|esomeprazole|mesh-list
110782447|NCT03717740|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110782448|NCT03717740|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110782449|NCT03717740|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110782450|NCT03717740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110782451|NCT03717740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110782452|NCT03411902|Risedronic Acid|risedronic acid|mesh-list
110782453|NCT03411902|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110782454|NCT03411902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110782455|NCT03411902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110782456|NCT03411902|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110782457|NCT03411902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110782458|NCT03411902|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110782459|NCT03717662|Nicotine|nicotine|mesh-list
110782460|NCT03717662|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110782461|NCT03717662|Autonomic Agents|autonomic agents|mesh-ancestor
110782462|NCT03717662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110782463|NCT03717662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110782464|NCT03717662|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110782465|NCT03717662|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110782466|NCT03717662|Cholinergic Agents|cholinergic agents|mesh-ancestor
110782467|NCT03717662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110782468|NCT03717662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110782469|NCT03494816|Axitinib|axitinib|mesh-list
110782470|NCT03494816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110500108|NCT02620839|Cisplatin|cisplatin|mesh-list
110782471|NCT03494816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110782472|NCT03494816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110782473|NCT03494816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110782474|NCT03713918|Lithium Carbonate|lithium carbonate|mesh-list
110782475|NCT03713918|Antidepressive Agents|antidepressive agents|mesh-ancestor
110782476|NCT03713918|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110782477|NCT03713918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110782478|NCT03713918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110782479|NCT03713918|Antimanic Agents|antimanic agents|mesh-ancestor
110782480|NCT03713918|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110782481|NCT03713918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110782482|NCT03713918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110782483|NCT03713762|Lidocaine|lidocaine|mesh-list
110782484|NCT03713762|Fentanyl|fentanyl|mesh-list
110782485|NCT03713762|Bupivacaine|bupivacaine|mesh-list
110782486|NCT03713762|Anesthetics, Local|anesthetics, local|mesh-ancestor
110782487|NCT03713762|Anesthetics|anesthetics|mesh-ancestor
110782488|NCT03713762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110782489|NCT03713762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110782490|NCT03713762|Sensory System Agents|sensory system agents|mesh-ancestor
110782491|NCT03713762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110782492|NCT03713762|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110782493|NCT03713762|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110782494|NCT03713762|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110782495|NCT03713762|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110782496|NCT03713762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110782497|NCT03713762|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110782498|NCT03713762|Narcotics|narcotics|mesh-ancestor
110782499|NCT03713762|Analgesics|analgesics|mesh-ancestor
110782500|NCT03713762|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110782501|NCT03713762|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110782502|NCT03713762|Anesthetics, General|anesthetics, general|mesh-ancestor
110782503|NCT05975450|Abatacept|abatacept|mesh-list
110782504|NCT05975450|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110782505|NCT05975450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110782506|NCT05975450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110782507|NCT05975450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110782508|NCT05975450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110782509|NCT05975450|Immunologic Factors|immunologic factors|mesh-ancestor
110782510|NCT05975450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110782511|NCT05975450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110782512|NCT05975411|Anesthetics|anesthetics|mesh-list
110782513|NCT05975411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110782514|NCT05975411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110782515|NCT05975346|Ketamine|ketamine|mesh-list
110782516|NCT05975346|Analgesics|analgesics|mesh-ancestor
110782517|NCT05975346|Sensory System Agents|sensory system agents|mesh-ancestor
110782518|NCT05975346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110782519|NCT05975346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110782520|NCT05975346|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110782521|NCT05975346|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110782522|NCT05975346|Anesthetics, General|anesthetics, general|mesh-ancestor
110782523|NCT05975346|Anesthetics|anesthetics|mesh-ancestor
110782524|NCT05975346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110782525|NCT05975346|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110782526|NCT05975346|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110782527|NCT05975346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110782528|NCT05975346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110782529|NCT05975320|Warfarin|warfarin|mesh-list
110782530|NCT05975320|Apixaban|apixaban|mesh-list
110782531|NCT05975320|Anticoagulants|anticoagulants|mesh-ancestor
110782532|NCT05975320|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110782533|NCT05975320|Antithrombins|antithrombins|mesh-ancestor
110782534|NCT05975320|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110782535|NCT05975320|Protease Inhibitors|protease inhibitors|mesh-ancestor
110782536|NCT05975320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110782537|NCT05975320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110782538|NCT05975294|Dexamethasone|dexamethasone|mesh-list
110782539|NCT05975294|Ketorolac|ketorolac|mesh-list
110782540|NCT05975294|Fentanyl|fentanyl|mesh-list
110782541|NCT05975294|Nalbuphine|nalbuphine|mesh-list
110782542|NCT05975294|Bupivacaine|bupivacaine|mesh-list
110782543|NCT05975294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110782544|NCT05975294|Antiemetics|antiemetics|mesh-ancestor
110782545|NCT05975294|Autonomic Agents|autonomic agents|mesh-ancestor
110782546|NCT05975294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110782547|NCT05975294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110782548|NCT05975294|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110782549|NCT05975294|Glucocorticoids|glucocorticoids|mesh-ancestor
110782550|NCT05975294|Hormones|hormones|mesh-ancestor
110782551|NCT05975294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110494131|NCT04197687|Sargramostim|sargramostim|mesh-list
110782552|NCT05975294|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110782553|NCT05975294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110782554|NCT05975294|Anesthetics, Local|anesthetics, local|mesh-ancestor
110782555|NCT05975294|Anesthetics|anesthetics|mesh-ancestor
110782556|NCT05975294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110782557|NCT05975294|Sensory System Agents|sensory system agents|mesh-ancestor
110782558|NCT05975294|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110782559|NCT05975294|Narcotics|narcotics|mesh-ancestor
110782560|NCT05975294|Analgesics|analgesics|mesh-ancestor
110782561|NCT05975294|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110782562|NCT05975294|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110782563|NCT05975294|Anesthetics, General|anesthetics, general|mesh-ancestor
110782564|NCT05975294|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110782565|NCT05975294|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110782566|NCT05975294|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110782567|NCT05975294|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110782568|NCT05975294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110782569|NCT05975294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110782570|NCT05975112|Plasminogen|plasminogen|mesh-list
110782571|NCT05975112|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110850282|NCT05218616|Sunitinib|sunitinib|mesh-list
110782572|NCT05975112|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110782573|NCT05975112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110782574|NCT05974969|Daratumumab|daratumumab|mesh-list
110782575|NCT05974969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110782576|NCT05974852|Ocrelizumab|ocrelizumab|mesh-list
110782577|NCT05974852|Immunologic Factors|immunologic factors|mesh-ancestor
110782578|NCT05974852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110782579|NCT05974839|Ocrelizumab|ocrelizumab|mesh-list
110782580|NCT05974839|Immunologic Factors|immunologic factors|mesh-ancestor
110782581|NCT05974839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110782582|NCT05974774|Ascorbic Acid|ascorbic acid|mesh-list
110782583|NCT05974774|Methyltestosterone|methyltestosterone|mesh-list
110782584|NCT05974774|Androgens|androgens|mesh-list
110782585|NCT05974774|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
110782586|NCT05974774|Micronutrients|micronutrients|mesh-ancestor
110782587|NCT05974774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110782588|NCT05974774|Hormones|hormones|mesh-ancestor
110782589|NCT05974774|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110782590|NCT05974774|Antioxidants|antioxidants|mesh-ancestor
110782591|NCT05974774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110782592|NCT05974774|Protective Agents|protective agents|mesh-ancestor
110782593|NCT05974774|Vitamins|vitamins|mesh-ancestor
110782594|NCT05974774|Estrogens|estrogens|mesh-ancestor
110782595|NCT05974774|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110782596|NCT05974774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110782597|NCT05974774|Anabolic Agents|anabolic agents|mesh-ancestor
110782598|NCT05974683|Mycophenolic Acid|mycophenolic acid|mesh-list
110782599|NCT05974683|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110782600|NCT05974683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110782601|NCT05974683|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110782602|NCT05974683|Antitubercular Agents|antitubercular agents|mesh-ancestor
110782603|NCT05974683|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110782604|NCT05974683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110782605|NCT05974683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110782606|NCT05974683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110782607|NCT05974527|Dexmedetomidine|dexmedetomidine|mesh-list
110782608|NCT05974527|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110782609|NCT05974527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110782610|NCT05974527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110782611|NCT05974527|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110782612|NCT05974527|Analgesics|analgesics|mesh-ancestor
110782613|NCT05974527|Sensory System Agents|sensory system agents|mesh-ancestor
110782614|NCT05974527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110782615|NCT05974527|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110782616|NCT05974527|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110782617|NCT05974527|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110782618|NCT05974527|Adrenergic Agents|adrenergic agents|mesh-ancestor
110782619|NCT05974527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110782620|NCT05974527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110782621|NCT05974501|Acetaminophen|acetaminophen|mesh-list
110782622|NCT05974501|Dexamethasone|dexamethasone|mesh-list
110782623|NCT05974501|Celecoxib|celecoxib|mesh-list
110782624|NCT05974501|Meloxicam|meloxicam|mesh-list
110782625|NCT05974501|Oxycodone|oxycodone|mesh-list
110782626|NCT05974501|Ropivacaine|ropivacaine|mesh-list
110782627|NCT05974501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110782628|NCT05974501|Antiemetics|antiemetics|mesh-ancestor
110782629|NCT05974501|Autonomic Agents|autonomic agents|mesh-ancestor
110782630|NCT05974501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110782631|NCT05974501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110782632|NCT05974501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110782633|NCT05974501|Glucocorticoids|glucocorticoids|mesh-ancestor
110782634|NCT05974501|Hormones|hormones|mesh-ancestor
110782635|NCT05974501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110782636|NCT05974501|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110782637|NCT05974501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110782638|NCT05974501|Anesthetics, Local|anesthetics, local|mesh-ancestor
110782639|NCT05974501|Anesthetics|anesthetics|mesh-ancestor
110782640|NCT05974501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110782641|NCT05974501|Sensory System Agents|sensory system agents|mesh-ancestor
110782642|NCT05974501|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110782644|NCT05974501|Antipyretics|antipyretics|mesh-ancestor
110782645|NCT05974501|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110782646|NCT05974501|Narcotics|narcotics|mesh-ancestor
110782647|NCT05974501|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110782648|NCT05974501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110782649|NCT05974501|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110782650|NCT05974501|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110782651|NCT05974501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110782652|NCT05974501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110782653|NCT05974436|Dialysis Solutions|dialysis solutions|mesh-list
110782654|NCT05974436|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110782655|NCT05974423|Acetaminophen|acetaminophen|mesh-list
110782656|NCT05974423|Ibuprofen|ibuprofen|mesh-list
110782657|NCT05974423|Oxycodone|oxycodone|mesh-list
110782658|NCT05974423|Narcotics|narcotics|mesh-list
110782659|NCT05974423|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110782660|NCT05974423|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110782661|NCT05974423|Analgesics|analgesics|mesh-ancestor
110782662|NCT05974423|Sensory System Agents|sensory system agents|mesh-ancestor
110782663|NCT05974423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110782664|NCT05974423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110782665|NCT05974423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110782666|NCT05974423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110782667|NCT05974423|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110782668|NCT05974423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110782669|NCT05974423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110782670|NCT05974423|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110782671|NCT05974423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110782672|NCT05974423|Antipyretics|antipyretics|mesh-ancestor
110782673|NCT05974410|Hydrocortisone|hydrocortisone|mesh-list
110782674|NCT05974410|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
110782675|NCT05974410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110782676|NCT05974410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110782677|NCT05974410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110782678|NCT05974345|Ezetimibe|ezetimibe|mesh-list
110782679|NCT05974345|Evolocumab|evolocumab|mesh-list
110782680|NCT05974345|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110782681|NCT05974345|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110782682|NCT05974345|Antimetabolites|antimetabolites|mesh-ancestor
110782683|NCT05974345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110782684|NCT05974345|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110782685|NCT05974345|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
110782686|NCT05974345|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110782687|NCT05974345|Protease Inhibitors|protease inhibitors|mesh-ancestor
110782688|NCT05974345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110782689|NCT05974332|Oncostatin M|oncostatin m|mesh-list
110782690|NCT05974332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110782691|NCT05974332|Growth Inhibitors|growth inhibitors|mesh-ancestor
110494208|NCT03841201|Nivolumab|nivolumab|mesh-list
110782692|NCT05974332|Growth Substances|growth substances|mesh-ancestor
110782693|NCT05974332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110782694|NCT05974293|Nabiximols|nabiximols|mesh-list
110782695|NCT05974293|Analgesics|analgesics|mesh-ancestor
110782696|NCT05974293|Sensory System Agents|sensory system agents|mesh-ancestor
110782697|NCT05974293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110782698|NCT05974293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110782699|NCT05974267|Atovaquone|atovaquone|mesh-list
110782700|NCT05974267|Pyronaridine|pyronaridine|mesh-list
110782701|NCT05974267|Proguanil|proguanil|mesh-list
110782702|NCT05974267|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
110782703|NCT05974267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110782704|NCT05974267|Antimalarials|antimalarials|mesh-ancestor
110782705|NCT05974267|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110782706|NCT05974267|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110782707|NCT05974267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110782708|NCT05974267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110782709|NCT05974267|Antimetabolites|antimetabolites|mesh-ancestor
110782710|NCT05974059|Capecitabine|capecitabine|mesh-list
110782711|NCT05974059|Oxaliplatin|oxaliplatin|mesh-list
110782712|NCT05974059|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110782713|NCT05974059|Antimetabolites|antimetabolites|mesh-ancestor
110850288|NCT05218616|Growth Inhibitors|growth inhibitors|mesh-ancestor
110782714|NCT05974059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110782715|NCT05974059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110782716|NCT05974007|Immunomodulating Agents|immunomodulating agents|mesh-list
110782717|NCT05974007|Immunologic Factors|immunologic factors|mesh-ancestor
110782718|NCT05974007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110782719|NCT05973903|Pembrolizumab|pembrolizumab|mesh-list
110782720|NCT05973903|Lenvatinib|lenvatinib|mesh-list
110782721|NCT05973903|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110782722|NCT05973903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110782723|NCT05973903|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110782724|NCT05973903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110782725|NCT05973903|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110782726|NCT05973903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110782728|NCT05973864|Capecitabine|capecitabine|mesh-list
110782729|NCT05973864|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110782730|NCT05973864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110782731|NCT05973864|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110782732|NCT05973864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110782733|NCT05973864|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110782734|NCT05973864|Antimetabolites|antimetabolites|mesh-ancestor
110782735|NCT05973747|Calcium, Dietary|calcium, dietary|mesh-list
110782736|NCT05973747|Calcium|calcium|mesh-list
110782737|NCT05973747|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110782738|NCT05973747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110494256|NCT03617731|Bortezomib|bortezomib|mesh-list
110782739|NCT05973747|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110782741|NCT05973552|Trace Elements|trace elements|mesh-ancestor
110782742|NCT05973552|Micronutrients|micronutrients|mesh-ancestor
110782743|NCT05973552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110782744|NCT05973487|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
110782745|NCT05973487|Antioxidants|antioxidants|mesh-ancestor
110782746|NCT05973487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110782747|NCT05973487|Protective Agents|protective agents|mesh-ancestor
110782748|NCT05973487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110782749|NCT05973487|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110782750|NCT05973487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110782751|NCT05971667|Sildenafil Citrate|sildenafil citrate|mesh-list
110782752|NCT05971667|Tadalafil|tadalafil|mesh-list
110782753|NCT05971667|Pentoxifylline|pentoxifylline|mesh-list
110782754|NCT05971667|Vasodilator Agents|vasodilator agents|mesh-ancestor
110782755|NCT05971667|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110782756|NCT05971667|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110782757|NCT05971667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110782758|NCT05971667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110782759|NCT05971667|Urological Agents|urological agents|mesh-ancestor
110782760|NCT05971667|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110782761|NCT05971667|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110782762|NCT05971667|Protective Agents|protective agents|mesh-ancestor
110782763|NCT05971667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110782764|NCT05971667|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110782765|NCT05971667|Antioxidants|antioxidants|mesh-ancestor
110782766|NCT05970770|Norepinephrine|norepinephrine|mesh-list
110782767|NCT05970770|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110782768|NCT05970770|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110782769|NCT05970770|Adrenergic Agents|adrenergic agents|mesh-ancestor
110782770|NCT05970770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110782771|NCT05970770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110782772|NCT05970770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110782773|NCT05970770|Sympathomimetics|sympathomimetics|mesh-ancestor
110782774|NCT05970770|Autonomic Agents|autonomic agents|mesh-ancestor
110782775|NCT05970770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110782776|NCT05970770|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110782777|NCT05957367|Cetuximab|cetuximab|mesh-list
110782778|NCT05957367|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110782779|NCT05957367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110782780|NCT05953766|Ropivacaine|ropivacaine|mesh-list
110782781|NCT05953766|Anesthetics, Local|anesthetics, local|mesh-ancestor
110782782|NCT05953766|Anesthetics|anesthetics|mesh-ancestor
110782783|NCT05953766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110782784|NCT05953766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110850293|NCT02505880|Anesthetics, Local|anesthetics, local|mesh-list
110782785|NCT05953766|Sensory System Agents|sensory system agents|mesh-ancestor
110782786|NCT05953766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110782787|NCT05951400|Cetrorelix|cetrorelix|mesh-list
110782788|NCT05951400|Dydrogesterone|dydrogesterone|mesh-list
110782789|NCT05951400|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110782790|NCT05951400|Fertility Agents|fertility agents|mesh-ancestor
110782791|NCT05951400|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110782792|NCT05951400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110782793|NCT05951400|Hormone Antagonists|hormone antagonists|mesh-ancestor
110782794|NCT05951400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110782795|NCT05951400|Progestins|progestins|mesh-ancestor
110782796|NCT05951400|Hormones|hormones|mesh-ancestor
110782797|NCT05905341|Fulvestrant|fulvestrant|mesh-list
110782798|NCT05905341|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110782799|NCT05905341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110782800|NCT05905341|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110782801|NCT05905341|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110107887|NCT01814501|Leucovorin|leucovorin|mesh-list
110782802|NCT05905341|Hormone Antagonists|hormone antagonists|mesh-ancestor
110782803|NCT05905341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110782804|NCT05905341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110782806|NCT05853458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110782807|NCT05853458|Antisickling Agents|antisickling agents|mesh-ancestor
110782808|NCT05853458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110782809|NCT05853458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110782810|NCT05853458|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110782811|NCT05826015|Paclitaxel|paclitaxel|mesh-list
110782812|NCT05826015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110782813|NCT05826015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110782814|NCT05826015|Tubulin Modulators|tubulin modulators|mesh-ancestor
110782815|NCT05826015|Antimitotic Agents|antimitotic agents|mesh-ancestor
110782816|NCT05826015|Mitosis Modulators|mitosis modulators|mesh-ancestor
110782817|NCT05826015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110782818|NCT05812807|Pembrolizumab|pembrolizumab|mesh-list
110782819|NCT05812807|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110494300|NCT03493789|Deoxyglucose|deoxyglucose|mesh-list
110782820|NCT05812807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110782821|NCT05812807|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110782822|NCT05812807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110782823|NCT05806164|Mirabegron|mirabegron|mesh-list
110782824|NCT05806164|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110782825|NCT05806164|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110782826|NCT05806164|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-list
110782827|NCT05806164|Adrenergic Agents|adrenergic agents|mesh-list
110782828|NCT05806164|Adrenergic Agonists|adrenergic agonists|mesh-list
110782829|NCT05806164|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110782830|NCT05806164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110782831|NCT05806164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110782832|NCT05806164|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110782833|NCT05806164|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110782834|NCT05806164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110782835|NCT05806164|Cholinergic Agents|cholinergic agents|mesh-ancestor
110782836|NCT05806164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110782837|NCT05806164|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110782838|NCT05806164|Urological Agents|urological agents|mesh-ancestor
110782839|NCT05805761|Anti-Infective Agents|anti-infective agents|mesh-list
110782840|NCT05805761|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110782841|NCT05701540|Esomeprazole|esomeprazole|mesh-list
110782842|NCT05701540|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110782843|NCT05701540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110782844|NCT05701540|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110782845|NCT05701540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110782846|NCT05701540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110782847|NCT05688371|Dexmedetomidine|dexmedetomidine|mesh-list
110782849|NCT05688371|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110782850|NCT05688371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110782851|NCT05688371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110782852|NCT05688371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110782853|NCT05688371|Analgesics|analgesics|mesh-ancestor
110782854|NCT05688371|Sensory System Agents|sensory system agents|mesh-ancestor
110782855|NCT05688371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110782856|NCT05688371|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110782857|NCT05688371|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110782858|NCT05688371|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110782859|NCT05688371|Adrenergic Agents|adrenergic agents|mesh-ancestor
110782860|NCT05688371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110782861|NCT05688371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110782862|NCT05688371|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110782863|NCT05688371|Narcotics|narcotics|mesh-ancestor
110782864|NCT05668949|Pembrolizumab|pembrolizumab|mesh-list
110782865|NCT05668949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110782866|NCT05668949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110782867|NCT05668949|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110782868|NCT05668949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110782869|NCT05662332|Insulin|insulin|mesh-list
110782870|NCT05662332|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110782871|NCT05662332|Insulin Glargine|insulin glargine|mesh-list
110782872|NCT05662332|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110782873|NCT05662332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110782874|NCT05618353|Colchicine|colchicine|mesh-list
110782875|NCT05618353|Gout Suppressants|gout suppressants|mesh-ancestor
110494353|NCT03232918|Oxytocin|oxytocin|mesh-list
110782876|NCT05618353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110782877|NCT05618353|Tubulin Modulators|tubulin modulators|mesh-ancestor
110782878|NCT05618353|Antimitotic Agents|antimitotic agents|mesh-ancestor
110782879|NCT05618353|Mitosis Modulators|mitosis modulators|mesh-ancestor
110782880|NCT05618353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110782881|NCT05618353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110782883|NCT05595044|Vitamins|vitamins|mesh-ancestor
110782884|NCT05595044|Micronutrients|micronutrients|mesh-ancestor
110782885|NCT05595044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110782886|NCT05595044|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110782887|NCT05563766|Itraconazole|itraconazole|mesh-list
110782888|NCT05563766|Antifungal Agents|antifungal agents|mesh-ancestor
110782889|NCT05563766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110782890|NCT05563766|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110782891|NCT05563766|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110782892|NCT05563766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110782893|NCT05563766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110782894|NCT05563766|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110782895|NCT05563766|Hormone Antagonists|hormone antagonists|mesh-ancestor
110782896|NCT05563766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110782897|NCT05563766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110782898|NCT05563766|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110782899|NCT05556265|Deucravacitinib|deucravacitinib|mesh-list
110782900|NCT05556265|Dermatologic Agents|dermatologic agents|mesh-ancestor
110782901|NCT05556265|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110782902|NCT05556265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110782903|NCT05556265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110782904|NCT05545280|Glycopyrrolate|glycopyrrolate|mesh-list
110782905|NCT05545280|Neostigmine|neostigmine|mesh-list
110782906|NCT05545280|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110782907|NCT05545280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110782908|NCT05545280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110782909|NCT05545280|Cholinergic Agents|cholinergic agents|mesh-ancestor
110782910|NCT05545280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110782911|NCT05545280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110782912|NCT05545280|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110782913|NCT05545280|Autonomic Agents|autonomic agents|mesh-ancestor
110782914|NCT05545280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110782915|NCT05545280|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110782916|NCT05545280|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110782917|NCT05545280|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110782918|NCT05535764|Interferons|interferons|mesh-list
110782919|NCT05535764|Interferon-alpha|interferon-alpha|mesh-list
110782920|NCT05535764|Interferon alpha-2|interferon alpha-2|mesh-list
110782921|NCT05535764|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110500566|NCT00803335|Estrogens|estrogens|mesh-list
110782922|NCT05535764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110782923|NCT05535764|Antiviral Agents|antiviral agents|mesh-ancestor
110782924|NCT05535764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110782925|NCT05535764|Immunologic Factors|immunologic factors|mesh-ancestor
110782926|NCT05535764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110782927|NCT05416125|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
110782928|NCT05416125|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110782929|NCT05416125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110782930|NCT05416125|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110782931|NCT05416125|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110782932|NCT05416125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110782933|NCT05416125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110782934|NCT05416125|Dopamine Agents|dopamine agents|mesh-ancestor
110782935|NCT05416125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110782936|NCT05377905|Doxorubicin|doxorubicin|mesh-list
110782937|NCT05377905|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110782938|NCT05377905|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110782939|NCT05377905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110782940|NCT05377905|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110782941|NCT05377905|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110782942|NCT05377905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110782943|NCT05377905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110782944|NCT05372133|Morphine|morphine|mesh-list
110782945|NCT05372133|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110782946|NCT05372133|Narcotics|narcotics|mesh-ancestor
110782947|NCT05372133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110782948|NCT05372133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110782950|NCT05372133|Sensory System Agents|sensory system agents|mesh-ancestor
110782951|NCT05372133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110782952|NCT05347212|Nivolumab|nivolumab|mesh-list
110782953|NCT05347212|Relatlimab|relatlimab|mesh-list
110782954|NCT05347212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110494387|NCT03107988|Cyclophosphamide|cyclophosphamide|mesh-list
110782955|NCT05347212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110782956|NCT05347212|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110782957|NCT05347212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110782958|NCT05250011|Dapagliflozin|dapagliflozin|mesh-list
110782959|NCT05250011|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110782960|NCT05250011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110782961|NCT05250011|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110782962|NCT05250011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110782963|NCT05144009|Rituximab|rituximab|mesh-list
110782964|NCT05144009|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
110782965|NCT05144009|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110782966|NCT05144009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110782967|NCT05144009|Immunologic Factors|immunologic factors|mesh-ancestor
110782968|NCT05144009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110782969|NCT05144009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110782970|NCT05110742|Cyclophosphamide|cyclophosphamide|mesh-list
110782971|NCT05110742|Fludarabine|fludarabine|mesh-list
110782972|NCT05110742|Fludarabine phosphate|fludarabine phosphate|mesh-list
110782973|NCT05110742|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110782974|NCT05110742|Immunologic Factors|immunologic factors|mesh-ancestor
110782975|NCT05110742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110782976|NCT05110742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110782978|NCT05110742|Alkylating Agents|alkylating agents|mesh-ancestor
110782979|NCT05110742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110782980|NCT05110742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110782981|NCT05110742|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110782982|NCT05110742|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110782983|NCT05110742|Antimetabolites|antimetabolites|mesh-ancestor
110782984|NCT05076006|PF-06700841|pf-06700841|mesh-list
110782985|NCT05076006|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110782986|NCT05076006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110782987|NCT05076006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110782988|NCT05064631|Broncho-Vaxom|broncho-vaxom|mesh-list
110782989|NCT05064631|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110782990|NCT05064631|Immunologic Factors|immunologic factors|mesh-ancestor
110782991|NCT05064631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110782992|NCT05042440|Factor VIII|factor viii|mesh-list
110782993|NCT05042440|BAX 855|bax 855|mesh-list
110782994|NCT05042440|Coagulants|coagulants|mesh-ancestor
110500628|NCT00659269|Docetaxel|docetaxel|mesh-list
110782995|NCT05022563|Warfarin|warfarin|mesh-list
110782996|NCT05022563|Rivaroxaban|rivaroxaban|mesh-list
110782997|NCT05022563|Dabigatran|dabigatran|mesh-list
110782998|NCT05022563|Apixaban|apixaban|mesh-list
110782999|NCT05022563|Anticoagulants|anticoagulants|mesh-list
110783000|NCT05022563|Edoxaban|edoxaban|mesh-list
110783001|NCT05022563|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110494434|NCT02723513|Xenon|xenon|mesh-list
110783002|NCT05022563|Antithrombins|antithrombins|mesh-ancestor
110783003|NCT05022563|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110783004|NCT05022563|Protease Inhibitors|protease inhibitors|mesh-ancestor
110783005|NCT05022563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110783006|NCT05022563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110783007|NCT05009069|Fluorouracil|fluorouracil|mesh-list
110783008|NCT05009069|Capecitabine|capecitabine|mesh-list
110783009|NCT05009069|Atezolizumab|atezolizumab|mesh-list
110783010|NCT05009069|Antimetabolites|antimetabolites|mesh-ancestor
110783011|NCT05009069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110783012|NCT05009069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110783013|NCT05009069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110783014|NCT05009069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110783015|NCT05009069|Immunologic Factors|immunologic factors|mesh-ancestor
110783016|NCT05009069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110783017|NCT05009069|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110783018|NCT05009069|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110783019|NCT04972110|Olaparib|olaparib|mesh-list
110783020|NCT04972110|Niraparib|niraparib|mesh-list
110783021|NCT04972110|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110783022|NCT04972110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110799581|NCT02064556|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110783023|NCT04972110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110783024|NCT04972110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110783025|NCT04968951|Metronidazole|metronidazole|mesh-list
110783026|NCT04968951|Vancomycin|vancomycin|mesh-list
110783027|NCT04968951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110783028|NCT04968951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110783029|NCT04968951|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110783030|NCT04968951|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110783031|NCT04950426|Propranolol|propranolol|mesh-list
110783032|NCT04950426|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110783033|NCT04950426|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110850334|NCT05217836|Hepcidins|hepcidins|mesh-list
110783034|NCT04950426|Adrenergic Agents|adrenergic agents|mesh-ancestor
110783035|NCT04950426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110783036|NCT04950426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110783037|NCT04950426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110783038|NCT04950426|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110783039|NCT04950426|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110783040|NCT04950426|Vasodilator Agents|vasodilator agents|mesh-ancestor
110783041|NCT04940546|Bevacizumab|bevacizumab|mesh-list
110783042|NCT04940546|Capecitabine|capecitabine|mesh-list
110783043|NCT04940546|Oxaliplatin|oxaliplatin|mesh-list
110783044|NCT04940546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110783045|NCT04940546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110783046|NCT04940546|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110783047|NCT04940546|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110783048|NCT04940546|Growth Substances|growth substances|mesh-ancestor
110783049|NCT04940546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110783050|NCT04940546|Growth Inhibitors|growth inhibitors|mesh-ancestor
110783051|NCT04940546|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110783052|NCT04940546|Antimetabolites|antimetabolites|mesh-ancestor
110783053|NCT04940546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110783054|NCT04936334|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
110783055|NCT04936334|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110783056|NCT04936334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110783057|NCT04892017|Trametinib|trametinib|mesh-list
110783058|NCT04892017|Sotorasib|sotorasib|mesh-list
110783059|NCT04892017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110783060|NCT04892017|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110783061|NCT04892017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110783062|NCT04892017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110783063|NCT04892017|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110783064|NCT04892017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110783065|NCT04884412|Anesthetics|anesthetics|mesh-list
110783066|NCT04884412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110783067|NCT04884412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110783068|NCT04863950|Lomustine|lomustine|mesh-list
110783069|NCT04863950|Imipramine|imipramine|mesh-list
110783070|NCT04863950|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110783071|NCT04863950|Alkylating Agents|alkylating agents|mesh-ancestor
110783077|NCT04863950|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110783078|NCT04863950|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110783079|NCT04863950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110783081|NCT04863950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110783082|NCT04863950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110783083|NCT04826393|Cemiplimab|cemiplimab|mesh-list
110783084|NCT04826393|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110783085|NCT04826393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110783086|NCT04824391|Vaccines|vaccines|mesh-list
110783087|NCT04824391|Immunologic Factors|immunologic factors|mesh-ancestor
110783088|NCT04824391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110783089|NCT04822597|Lidocaine|lidocaine|mesh-list
110783090|NCT04822597|Anesthetics, Local|anesthetics, local|mesh-ancestor
110783091|NCT04822597|Anesthetics|anesthetics|mesh-ancestor
110783092|NCT04822597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110783093|NCT04822597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110783094|NCT04822597|Sensory System Agents|sensory system agents|mesh-ancestor
110783095|NCT04822597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110783096|NCT04822597|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110783097|NCT04822597|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110783098|NCT04822597|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110783099|NCT04822597|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110783100|NCT04822597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110783101|NCT04821856|Cannabidiol|cannabidiol|mesh-list
110783102|NCT04821856|Anticonvulsants|anticonvulsants|mesh-ancestor
110783103|NCT04808999|Pembrolizumab|pembrolizumab|mesh-list
110783104|NCT04808999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110783105|NCT04808999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110783106|NCT04808999|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110783107|NCT04808999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110783108|NCT04764227|Paclitaxel|paclitaxel|mesh-list
110783109|NCT04764227|Carboplatin|carboplatin|mesh-list
110783110|NCT04764227|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110783111|NCT04764227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110783112|NCT04764227|Tubulin Modulators|tubulin modulators|mesh-ancestor
110783113|NCT04764227|Antimitotic Agents|antimitotic agents|mesh-ancestor
110783114|NCT04764227|Mitosis Modulators|mitosis modulators|mesh-ancestor
110783115|NCT04764227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110783117|NCT04733092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110783124|NCT04706026|Anesthetics|anesthetics|mesh-list
110783125|NCT04706026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110783126|NCT04706026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110783127|NCT04695340|Psyllium|psyllium|mesh-list
110783128|NCT04695340|Cathartics|cathartics|mesh-ancestor
110783129|NCT04695340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110783130|NCT04639245|Cyclophosphamide|cyclophosphamide|mesh-list
110783131|NCT04639245|Fludarabine|fludarabine|mesh-list
110783132|NCT04639245|Atezolizumab|atezolizumab|mesh-list
110783133|NCT04639245|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
110783134|NCT04639245|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110783135|NCT04639245|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110783136|NCT04639245|Immunologic Factors|immunologic factors|mesh-ancestor
110783137|NCT04639245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110783138|NCT04639245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110783139|NCT04639245|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110783140|NCT04639245|Alkylating Agents|alkylating agents|mesh-ancestor
110783141|NCT04639245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110783142|NCT04639245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110783143|NCT04639245|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110783144|NCT04639245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110783145|NCT04599465|Ivacaftor|ivacaftor|mesh-list
110783146|NCT04599465|Elexacaftor|elexacaftor|mesh-list
110783147|NCT04599465|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
110783148|NCT04599465|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110783149|NCT04599465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110494533|NCT01613118|Irbesartan|irbesartan|mesh-list
110783150|NCT04589130|Bupropion hydrochloride, naltrexone hydrochoride drug combination|bupropion hydrochloride, naltrexone hydrochoride drug combination|mesh-list
110783151|NCT04589130|Naltrexone|naltrexone|mesh-list
110783152|NCT04589130|Bupropion|bupropion|mesh-list
110783153|NCT04589130|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110783154|NCT04589130|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110783155|NCT04589130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110783156|NCT04589130|Sensory System Agents|sensory system agents|mesh-ancestor
110783157|NCT04589130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110783158|NCT04589130|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110783159|NCT04589130|Antidepressive Agents|antidepressive agents|mesh-ancestor
110783160|NCT04589130|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110783161|NCT04589130|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110783162|NCT04589130|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110783163|NCT04589130|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110783164|NCT04589130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110783165|NCT04589130|Dopamine Agents|dopamine agents|mesh-ancestor
110783166|NCT04589130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110783167|NCT04589130|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110783168|NCT04589130|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110783169|NCT04589130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110783170|NCT04589130|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110783171|NCT04587843|Bupropion hydrochloride, naltrexone hydrochoride drug combination|bupropion hydrochloride, naltrexone hydrochoride drug combination|mesh-list
110783172|NCT04587843|Naltrexone|naltrexone|mesh-list
110783173|NCT04587843|Bupropion|bupropion|mesh-list
110783174|NCT04587843|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110783175|NCT04587843|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110783176|NCT04587843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110783177|NCT04587843|Sensory System Agents|sensory system agents|mesh-ancestor
110783178|NCT04587843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110783179|NCT04587843|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110783180|NCT04587843|Antidepressive Agents|antidepressive agents|mesh-ancestor
110783181|NCT04587843|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110783182|NCT04587843|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110783183|NCT04587843|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110783184|NCT04587843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110850349|NCT02514538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110783185|NCT04587843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110783186|NCT04587843|Dopamine Agents|dopamine agents|mesh-ancestor
110783187|NCT04587843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110783188|NCT04587843|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110783189|NCT04587843|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110783190|NCT04587843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110783191|NCT04587843|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110783192|NCT04562441|Avelumab|avelumab|mesh-list
110783193|NCT04562441|Axitinib|axitinib|mesh-list
110783194|NCT04562441|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110783195|NCT04562441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110783196|NCT04562441|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110783197|NCT04562441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110783198|NCT04562441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110783199|NCT04497116|Gemcitabine|gemcitabine|mesh-list
110783200|NCT04497116|Talazoparib|talazoparib|mesh-list
110783201|NCT04497116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110783202|NCT04497116|Antimetabolites|antimetabolites|mesh-ancestor
110783203|NCT04497116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110783204|NCT04497116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110783205|NCT04497116|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110783206|NCT04497116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110783207|NCT04433780|Tenofovir|tenofovir|mesh-list
110783208|NCT04433780|Lamivudine|lamivudine|mesh-list
110783209|NCT04433780|Antiviral Agents|antiviral agents|mesh-ancestor
110783210|NCT04433780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110783211|NCT04433780|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110783212|NCT04433780|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110783213|NCT04433780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110783214|NCT04433780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110783215|NCT04433780|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110783216|NCT04433780|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110783217|NCT04408664|Cromolyn Sodium|cromolyn sodium|mesh-list
110783218|NCT04408664|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
110783219|NCT04408664|Immunologic Factors|immunologic factors|mesh-ancestor
110783220|NCT04408664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110783221|NCT04408664|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110783222|NCT04408664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110783223|NCT04408664|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110783224|NCT04408664|Respiratory System Agents|respiratory system agents|mesh-ancestor
110783225|NCT04373265|Pembrolizumab|pembrolizumab|mesh-list
110783226|NCT04373265|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110783227|NCT04373265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110783228|NCT04373265|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110783229|NCT04373265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110783230|NCT04362293|Sirolimus|sirolimus|mesh-list
110783231|NCT04362293|Plerixafor|plerixafor|mesh-list
110783232|NCT04362293|Cyclophosphamide|cyclophosphamide|mesh-list
110783233|NCT04362293|Thiotepa|thiotepa|mesh-list
110783234|NCT04362293|Temsirolimus|temsirolimus|mesh-list
110783235|NCT04362293|Alemtuzumab|alemtuzumab|mesh-list
110783236|NCT04362293|Hydroxyurea|hydroxyurea|mesh-list
110783237|NCT04362293|Azathioprine|azathioprine|mesh-list
110783238|NCT04362293|MTOR Inhibitors|mtor inhibitors|mesh-list
110783239|NCT04362293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110783240|NCT04362293|Immunologic Factors|immunologic factors|mesh-ancestor
110783241|NCT04362293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110783242|NCT04362293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110783243|NCT04362293|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110783244|NCT04362293|Alkylating Agents|alkylating agents|mesh-ancestor
110783245|NCT04362293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110783246|NCT04362293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110783247|NCT04362293|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110783248|NCT04362293|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110783249|NCT04362293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110783250|NCT04362293|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110783251|NCT04362293|Antifungal Agents|antifungal agents|mesh-ancestor
110783252|NCT04362293|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110783253|NCT04362293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110783254|NCT04362293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110850354|NCT02514538|Antipyretics|antipyretics|mesh-ancestor
110783255|NCT04362293|Antisickling Agents|antisickling agents|mesh-ancestor
110783256|NCT04362293|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110783257|NCT04362293|Antimetabolites|antimetabolites|mesh-ancestor
110783258|NCT04362293|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110783259|NCT04362293|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110783260|NCT04362293|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110783261|NCT04362293|Antiviral Agents|antiviral agents|mesh-ancestor
110783262|NCT04332367|Paclitaxel|paclitaxel|mesh-list
110783263|NCT04332367|Carboplatin|carboplatin|mesh-list
110783264|NCT04332367|Ramucirumab|ramucirumab|mesh-list
110783265|NCT04332367|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110783266|NCT04332367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110783267|NCT04332367|Tubulin Modulators|tubulin modulators|mesh-ancestor
110783268|NCT04332367|Antimitotic Agents|antimitotic agents|mesh-ancestor
110783269|NCT04332367|Mitosis Modulators|mitosis modulators|mesh-ancestor
110783270|NCT04332367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110783271|NCT04290546|Cetuximab|cetuximab|mesh-list
110783272|NCT04290546|Ipilimumab|ipilimumab|mesh-list
110783273|NCT04290546|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
110783274|NCT04290546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110783275|NCT04290546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110783276|NCT04290546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110783277|NCT04212013|Rituximab|rituximab|mesh-list
110783278|NCT04212013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110783279|NCT04212013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110783280|NCT04212013|Immunologic Factors|immunologic factors|mesh-ancestor
110783281|NCT04212013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110783282|NCT04212013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110783283|NCT04209595|Rucaparib|rucaparib|mesh-list
110783284|NCT04209595|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110783285|NCT04209595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110494603|NCT02852564|Natriuretic Agents|natriuretic agents|mesh-ancestor
110783286|NCT04209595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110783287|NCT04209595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110783288|NCT04186559|Pentoxifylline|pentoxifylline|mesh-list
110783289|NCT04186559|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110783290|NCT04186559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110783291|NCT04186559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110500938|NCT00862719|Incretins|incretins|mesh-ancestor
110783292|NCT04186559|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110783293|NCT04186559|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110783294|NCT04186559|Protective Agents|protective agents|mesh-ancestor
110783295|NCT04186559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110783296|NCT04186559|Vasodilator Agents|vasodilator agents|mesh-ancestor
110783297|NCT04186559|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110783299|NCT04183452|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
110783300|NCT04183452|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
110783301|NCT04183452|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110783302|NCT04183452|Hormone Antagonists|hormone antagonists|mesh-ancestor
110783303|NCT04183452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110783304|NCT04183452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110783305|NCT04183452|Progestins|progestins|mesh-ancestor
110783306|NCT04183452|Hormones|hormones|mesh-ancestor
110783307|NCT04104646|Morphine|morphine|mesh-list
110783308|NCT04104646|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110783309|NCT04104646|Narcotics|narcotics|mesh-ancestor
110783310|NCT04104646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110783311|NCT04104646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110783312|NCT04104646|Analgesics|analgesics|mesh-ancestor
110783313|NCT04104646|Sensory System Agents|sensory system agents|mesh-ancestor
110783314|NCT04104646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110783315|NCT04098874|Bupropion|bupropion|mesh-list
110783316|NCT04098874|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110783317|NCT04098874|Antidepressive Agents|antidepressive agents|mesh-ancestor
110783318|NCT04098874|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110783319|NCT04098874|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110783320|NCT04098874|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110783321|NCT04098874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110783322|NCT04098874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110783323|NCT04098874|Dopamine Agents|dopamine agents|mesh-ancestor
110783324|NCT04098874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110783325|NCT04098874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110783326|NCT04098874|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110783327|NCT04098874|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110783328|NCT04098874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110783329|NCT03841357|Abatacept|abatacept|mesh-list
110783330|NCT03841357|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110783331|NCT03841357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110783332|NCT03841357|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110783333|NCT03841357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110783334|NCT03841357|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110783335|NCT03841357|Immunologic Factors|immunologic factors|mesh-ancestor
110783336|NCT03841357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110783337|NCT03841357|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110783338|NCT03818191|Acamprosate|acamprosate|mesh-list
110783339|NCT03818191|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110783340|NCT03640481|Belumosudil|belumosudil|mesh-list
110783341|NCT03640481|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110783342|NCT03640481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110783343|NCT03640481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110783344|NCT03622788|Cyclophosphamide|cyclophosphamide|mesh-list
110783345|NCT03622788|Fludarabine|fludarabine|mesh-list
110783346|NCT03622788|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110783347|NCT03622788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110783348|NCT03622788|Immunologic Factors|immunologic factors|mesh-ancestor
110783349|NCT03622788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110783350|NCT03622788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110783351|NCT03622788|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110783352|NCT03622788|Alkylating Agents|alkylating agents|mesh-ancestor
110783353|NCT03622788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110783354|NCT03622788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110783355|NCT03622788|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110783356|NCT03594110|Empagliflozin|empagliflozin|mesh-list
110783357|NCT03594110|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110783358|NCT03594110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110783359|NCT03594110|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110783360|NCT03594110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110783361|NCT03580824|Adjuvants, Vaccine|adjuvants, vaccine|mesh-list
110783362|NCT03580824|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110783363|NCT03580824|Immunologic Factors|immunologic factors|mesh-ancestor
110783364|NCT03580824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110783365|NCT03532295|Bevacizumab|bevacizumab|mesh-list
110783366|NCT03532295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110783367|NCT03532295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110783368|NCT03532295|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110783369|NCT03532295|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110783370|NCT03532295|Growth Substances|growth substances|mesh-ancestor
110783371|NCT03532295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110783372|NCT03532295|Growth Inhibitors|growth inhibitors|mesh-ancestor
110783373|NCT03497676|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
110783374|NCT03497676|Rilpivirine|rilpivirine|mesh-list
110783375|NCT03497676|Cabotegravir|cabotegravir|mesh-list
110783376|NCT03497676|Antiviral Agents|antiviral agents|mesh-ancestor
110783377|NCT03497676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110783378|NCT03497676|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110783379|NCT03497676|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110783380|NCT03497676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110783381|NCT03497676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110783382|NCT03497676|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110783383|NCT03497676|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110783384|NCT03497676|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110783385|NCT03403205|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
110783386|NCT03403205|Choline|choline|mesh-list
110783387|NCT03403205|Lipotropic Agents|lipotropic agents|mesh-ancestor
110783388|NCT03403205|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110783389|NCT03403205|Antimetabolites|antimetabolites|mesh-ancestor
110783390|NCT03403205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110783391|NCT03403205|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110783392|NCT03403205|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110783393|NCT03403205|Nootropic Agents|nootropic agents|mesh-ancestor
110783394|NCT03403205|Chelating Agents|chelating agents|mesh-ancestor
110783395|NCT03403205|Sequestering Agents|sequestering agents|mesh-ancestor
110783396|NCT03403205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110783397|NCT03403205|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110783398|NCT03403205|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110783399|NCT03403205|Growth Substances|growth substances|mesh-ancestor
110783400|NCT03403205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110783401|NCT03403205|Growth Inhibitors|growth inhibitors|mesh-ancestor
110783402|NCT03403205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110783403|NCT03366142|Ustekinumab|ustekinumab|mesh-list
110783404|NCT03366142|Dermatologic Agents|dermatologic agents|mesh-ancestor
110783405|NCT03311126|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110783406|NCT03311126|Obinutuzumab|obinutuzumab|mesh-list
110783407|NCT03311126|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110783408|NCT03311126|Alkylating Agents|alkylating agents|mesh-ancestor
110783409|NCT03311126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110783410|NCT03311126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110783411|NCT03311126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110783412|NCT03304418|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
110783413|NCT03304418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110783414|NCT03300947|Lorazepam|lorazepam|mesh-list
110783415|NCT03300947|Psilocybin|psilocybin|mesh-list
110783416|NCT03300947|Hallucinogens|hallucinogens|mesh-ancestor
110783417|NCT03300947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110783418|NCT03300947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110783419|NCT03300947|Anticonvulsants|anticonvulsants|mesh-ancestor
110783420|NCT03300947|Antiemetics|antiemetics|mesh-ancestor
110783421|NCT03300947|Autonomic Agents|autonomic agents|mesh-ancestor
110783422|NCT03300947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110783423|NCT03300947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110783424|NCT03300947|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110783425|NCT03300947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110783426|NCT03300947|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110783427|NCT03300947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110783428|NCT03300947|GABA Modulators|gaba modulators|mesh-ancestor
110783429|NCT03300947|GABA Agents|gaba agents|mesh-ancestor
110783430|NCT03300947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110783431|NCT03300947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110783432|NCT03278925|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
110783433|NCT03278925|Antioxidants|antioxidants|mesh-ancestor
110783434|NCT03278925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110783435|NCT03278925|Protective Agents|protective agents|mesh-ancestor
110783436|NCT03278925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110783437|NCT03278925|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
110783438|NCT03278925|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110783439|NCT03278925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110783440|NCT03278925|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110682909|NCT05277701|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110783441|NCT03238326|Brexpiprazole|brexpiprazole|mesh-list
110783442|NCT03238326|Serotonin Agents|serotonin agents|mesh-ancestor
110783443|NCT03238326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110783444|NCT03238326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110783445|NCT03238326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110783446|NCT03238326|Dopamine Agonists|dopamine agonists|mesh-ancestor
110783447|NCT03238326|Dopamine Agents|dopamine agents|mesh-ancestor
110783448|NCT03107884|Metformin|metformin|mesh-list
110783449|NCT03107884|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110783450|NCT03107884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110783451|NCT03106415|Pembrolizumab|pembrolizumab|mesh-list
110783452|NCT03106415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110783453|NCT03106415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110783454|NCT03106415|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110783455|NCT03106415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110783456|NCT03024996|Atezolizumab|atezolizumab|mesh-list
110783457|NCT03024996|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110783458|NCT03024996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110783459|NCT03024996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110783460|NCT03024996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110783461|NCT03003325|Aspirin|aspirin|mesh-list
110783462|NCT03003325|Interferons|interferons|mesh-list
110783463|NCT03003325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110783464|NCT03003325|Antiviral Agents|antiviral agents|mesh-ancestor
110783465|NCT03003325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110783466|NCT03003325|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110783467|NCT03003325|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110783468|NCT03003325|Analgesics|analgesics|mesh-ancestor
110783469|NCT03003325|Sensory System Agents|sensory system agents|mesh-ancestor
110783470|NCT03003325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110783471|NCT03003325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110783472|NCT03003325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110783473|NCT03003325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110783474|NCT03003325|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110783475|NCT03003325|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110445913|NCT02770222|Antitubercular Agents|antitubercular agents|mesh-ancestor
110783476|NCT03003325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110783477|NCT03003325|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110783478|NCT03003325|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110783479|NCT03003325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110783480|NCT03003325|Antipyretics|antipyretics|mesh-ancestor
110783481|NCT02969798|Metformin|metformin|mesh-list
110783482|NCT02969798|Pioglitazone|pioglitazone|mesh-list
110783483|NCT02969798|Dapagliflozin|dapagliflozin|mesh-list
110783484|NCT02969798|Saxagliptin|saxagliptin|mesh-list
110783485|NCT02969798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110783486|NCT02969798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110783487|NCT02969798|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110783488|NCT02969798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110783489|NCT02969798|Incretins|incretins|mesh-ancestor
110783490|NCT02969798|Hormones|hormones|mesh-ancestor
110783491|NCT02969798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110783492|NCT02969798|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110783493|NCT02969798|Protease Inhibitors|protease inhibitors|mesh-ancestor
110783494|NCT02969798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110783495|NCT02967692|Trametinib|trametinib|mesh-list
110783496|NCT02967692|Dabrafenib|dabrafenib|mesh-list
110783497|NCT02967692|Spartalizumab|spartalizumab|mesh-list
110783498|NCT02967692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110783499|NCT02967692|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110783500|NCT02967692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110783501|NCT02967692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110783502|NCT02967692|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110783503|NCT02967692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110783504|NCT02917993|Osimertinib|osimertinib|mesh-list
110783505|NCT02917993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110783506|NCT02917993|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110783507|NCT02917993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110783508|NCT02917993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110783509|NCT02855203|Pembrolizumab|pembrolizumab|mesh-list
110783510|NCT02855203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110783511|NCT02855203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110783512|NCT02855203|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110783513|NCT02855203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110783514|NCT02753283|Vitamin D|vitamin d|mesh-list
110783515|NCT02753283|Zoledronic Acid|zoledronic acid|mesh-list
110783516|NCT02753283|Denosumab|denosumab|mesh-list
110783517|NCT02753283|Calcium|calcium|mesh-list
110783518|NCT02753283|Vitamins|vitamins|mesh-ancestor
110783520|NCT02753283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110783521|NCT02753283|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110783522|NCT02753283|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110783523|NCT02748564|Aldesleukin|aldesleukin|mesh-list
110783524|NCT02748564|Pembrolizumab|pembrolizumab|mesh-list
110783525|NCT02748564|Interleukin-2|interleukin-2|mesh-list
110783526|NCT02748564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110783527|NCT02748564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110783528|NCT02748564|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110783529|NCT02748564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110783530|NCT02748564|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110783531|NCT02748564|Analgesics|analgesics|mesh-ancestor
110783532|NCT02748564|Sensory System Agents|sensory system agents|mesh-ancestor
110783533|NCT02748564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110783534|NCT02748564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110783535|NCT02748564|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110783536|NCT02748564|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110783537|NCT02748564|Antiviral Agents|antiviral agents|mesh-ancestor
110783538|NCT02748564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110783539|NCT02642965|Cytarabine|cytarabine|mesh-list
110783540|NCT02642965|Fludarabine|fludarabine|mesh-list
110783541|NCT02642965|Fludarabine phosphate|fludarabine phosphate|mesh-list
110783542|NCT02642965|Daunorubicin|daunorubicin|mesh-list
110783543|NCT02642965|Lenograstim|lenograstim|mesh-list
110783544|NCT02642965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110783545|NCT02642965|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110783546|NCT02642965|Antimetabolites|antimetabolites|mesh-ancestor
110783547|NCT02642965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110783548|NCT02642965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110783549|NCT02642965|Immunologic Factors|immunologic factors|mesh-ancestor
110783550|NCT02642965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110783551|NCT02642965|Antiviral Agents|antiviral agents|mesh-ancestor
110783552|NCT02642965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110783553|NCT02642965|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110783554|NCT02642965|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110783555|NCT02642965|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110494777|NCT00764725|Infliximab|infliximab|mesh-list
110783556|NCT02642965|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110783557|NCT02642965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110783558|NCT02595892|Gemcitabine|gemcitabine|mesh-list
110783559|NCT02595892|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110783560|NCT02595892|Antimetabolites|antimetabolites|mesh-ancestor
110783561|NCT02595892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110783562|NCT02595892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110783563|NCT02520362|Denosumab|denosumab|mesh-list
110783564|NCT02520362|Diphosphonates|diphosphonates|mesh-list
110783565|NCT02520362|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110783566|NCT02520362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110783567|NCT02461927|Midazolam|midazolam|mesh-list
110783568|NCT02461927|Naltrexone|naltrexone|mesh-list
110783569|NCT02461927|Ketamine|ketamine|mesh-list
110783570|NCT02461927|Analgesics|analgesics|mesh-ancestor
110783571|NCT02461927|Sensory System Agents|sensory system agents|mesh-ancestor
110783572|NCT02461927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110783573|NCT02461927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110783574|NCT02461927|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110783575|NCT02461927|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110783576|NCT02461927|Anesthetics, General|anesthetics, general|mesh-ancestor
110783577|NCT02461927|Anesthetics|anesthetics|mesh-ancestor
110783578|NCT02461927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110783579|NCT02461927|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110783580|NCT02461927|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110783581|NCT02461927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110783582|NCT02461927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110850387|NCT01201499|Morphine|morphine|mesh-list
110783583|NCT02461927|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110783584|NCT02461927|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110783585|NCT02461927|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110783586|NCT02461927|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110783587|NCT02461927|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110783588|NCT02461927|GABA Modulators|gaba modulators|mesh-ancestor
110783589|NCT02461927|GABA Agents|gaba agents|mesh-ancestor
110783590|NCT02461927|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110783591|NCT02461927|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110783592|NCT01936532|Dexamethasone|dexamethasone|mesh-list
110494808|NCT04077892|Budesonide|budesonide|mesh-list
110783652|NCT01038778|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
110783653|NCT01038778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110783654|NCT01038778|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110783655|NCT01038778|Analgesics|analgesics|mesh-ancestor
110783656|NCT01038778|Sensory System Agents|sensory system agents|mesh-ancestor
110783657|NCT01038778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110783658|NCT01038778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110783659|NCT01038778|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110783660|NCT01038778|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110783661|NCT01038778|Antiviral Agents|antiviral agents|mesh-ancestor
110783662|NCT01038778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110783663|NCT01038778|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110783664|NCT01038778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110783665|NCT01038778|Antimetabolites|antimetabolites|mesh-ancestor
110783666|NCT01038778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110783667|NCT00707655|Zalutumumab|zalutumumab|mesh-list
110783668|NCT00707655|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110783669|NCT00707655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110783671|NCT00542308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110783672|NCT00542308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110783673|NCT00488605|Leucovorin|leucovorin|mesh-list
110783674|NCT00488605|Prednisone|prednisone|mesh-list
110783675|NCT00488605|Methotrexate|methotrexate|mesh-list
110783676|NCT00488605|Vinblastine|vinblastine|mesh-list
110783677|NCT00488605|Levoleucovorin|levoleucovorin|mesh-list
110783678|NCT00488605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110783679|NCT00488605|Glucocorticoids|glucocorticoids|mesh-ancestor
110783680|NCT00488605|Hormones|hormones|mesh-ancestor
110783681|NCT00488605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110783682|NCT00488605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110783683|NCT00488605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110783684|NCT00488605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110783685|NCT00488605|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110783686|NCT00488605|Abortifacient Agents|abortifacient agents|mesh-ancestor
110783687|NCT00488605|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110783688|NCT00488605|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110783689|NCT00488605|Antimetabolites|antimetabolites|mesh-ancestor
110783690|NCT00488605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110783691|NCT00488605|Dermatologic Agents|dermatologic agents|mesh-ancestor
110783692|NCT00488605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110783693|NCT00488605|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110783694|NCT00488605|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110783695|NCT00488605|Immunologic Factors|immunologic factors|mesh-ancestor
110783696|NCT00488605|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110783697|NCT00488605|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110783698|NCT00488605|Antidotes|antidotes|mesh-ancestor
110783699|NCT00488605|Protective Agents|protective agents|mesh-ancestor
110783700|NCT00488605|Vitamin B Complex|vitamin b complex|mesh-ancestor
110783701|NCT00488605|Vitamins|vitamins|mesh-ancestor
110783702|NCT00488605|Micronutrients|micronutrients|mesh-ancestor
110783703|NCT00488605|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110783704|NCT00488605|Tubulin Modulators|tubulin modulators|mesh-ancestor
110783705|NCT00488605|Antimitotic Agents|antimitotic agents|mesh-ancestor
110783706|NCT00488605|Mitosis Modulators|mitosis modulators|mesh-ancestor
110783707|NCT00006734|Cyclophosphamide|cyclophosphamide|mesh-list
110783708|NCT00006734|Ifosfamide|ifosfamide|mesh-list
110783709|NCT00006734|Doxorubicin|doxorubicin|mesh-list
110783710|NCT00006734|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110783711|NCT00006734|Etoposide|etoposide|mesh-list
110783712|NCT00006734|Vincristine|vincristine|mesh-list
110783713|NCT00006734|Lenograstim|lenograstim|mesh-list
110783714|NCT00006734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110783715|NCT00006734|Immunologic Factors|immunologic factors|mesh-ancestor
110783716|NCT00006734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110783717|NCT00006734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110783718|NCT00006734|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110783719|NCT00006734|Alkylating Agents|alkylating agents|mesh-ancestor
110783720|NCT00006734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110783721|NCT00006734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110783722|NCT00006734|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110783723|NCT00006734|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110783724|NCT00006734|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110783725|NCT00006734|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110783726|NCT00006734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110783727|NCT00006734|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110783728|NCT00006734|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110783729|NCT00006734|Tubulin Modulators|tubulin modulators|mesh-ancestor
110783730|NCT00006734|Antimitotic Agents|antimitotic agents|mesh-ancestor
110783731|NCT00006734|Mitosis Modulators|mitosis modulators|mesh-ancestor
110783732|NCT02991118|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
110783733|NCT02991118|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110783734|NCT02991118|Antimetabolites|antimetabolites|mesh-ancestor
110783735|NCT02991118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110783736|NCT02991118|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110783737|NCT02991118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110783738|NCT02991118|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110783739|NCT02991118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110783740|NCT02991040|Lidocaine|lidocaine|mesh-list
110783741|NCT02991040|Anesthetics, Local|anesthetics, local|mesh-ancestor
110783742|NCT02991040|Anesthetics|anesthetics|mesh-ancestor
110783743|NCT02991040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110783744|NCT02991040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110783745|NCT02991040|Sensory System Agents|sensory system agents|mesh-ancestor
110783746|NCT02991040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110783747|NCT02991040|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110783748|NCT02991040|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110783749|NCT02991040|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110783750|NCT02991040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110783751|NCT02991040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110783753|NCT03660436|Deucravacitinib|deucravacitinib|mesh-list
110783754|NCT03660436|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110783755|NCT03660436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110783756|NCT03660436|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110783757|NCT03660436|Antitubercular Agents|antitubercular agents|mesh-ancestor
110783758|NCT03660436|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110783759|NCT03660436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110783760|NCT03660436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110783761|NCT03660436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110783762|NCT03660436|Dermatologic Agents|dermatologic agents|mesh-ancestor
110783763|NCT03660436|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110783764|NCT03662620|Amlodipine|amlodipine|mesh-list
110783765|NCT03662620|Telmisartan|telmisartan|mesh-list
110783766|NCT03662620|Chlorthalidone|chlorthalidone|mesh-list
110783767|NCT03662620|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110783768|NCT03662620|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110783769|NCT03662620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110494923|NCT00607958|Protease Inhibitors|protease inhibitors|mesh-ancestor
110783770|NCT03662620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110783771|NCT03662620|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110783772|NCT03662620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110783773|NCT03662620|Vasodilator Agents|vasodilator agents|mesh-ancestor
110783774|NCT03662620|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110783775|NCT03662620|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110783776|NCT03662620|Diuretics|diuretics|mesh-ancestor
110783777|NCT03662620|Natriuretic Agents|natriuretic agents|mesh-ancestor
110783778|NCT03662620|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110783779|NCT03415178|Atorvastatin|atorvastatin|mesh-list
110783780|NCT03415178|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110783781|NCT03415178|Alirocumab|alirocumab|mesh-list
110783782|NCT03415178|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110783783|NCT03415178|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110783784|NCT03415178|Antimetabolites|antimetabolites|mesh-ancestor
110783785|NCT03415178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110783786|NCT03415178|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110783787|NCT03415178|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110783788|NCT03415178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110783789|NCT03415178|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
110783790|NCT03415178|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110783791|NCT03415178|Protease Inhibitors|protease inhibitors|mesh-ancestor
110783792|NCT01068730|Metformin|metformin|mesh-list
110783793|NCT01068730|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110783794|NCT01068730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110783795|NCT01068652|Insulin|insulin|mesh-list
110783796|NCT01068652|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110783797|NCT01068652|Metformin|metformin|mesh-list
110783798|NCT01068652|Insulin Aspart|insulin aspart|mesh-list
110783799|NCT01068652|Insulin, Long-Acting|insulin, long-acting|mesh-list
110783800|NCT01068652|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
110783801|NCT01068652|Insulin Detemir|insulin detemir|mesh-list
110494961|NCT00775255|Clarithromycin|clarithromycin|mesh-list
110783802|NCT01068652|Biphasic Insulins|biphasic insulins|mesh-list
110783803|NCT01068652|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
110783804|NCT01068652|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110783805|NCT01068652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110783806|NCT03658720|Ibuprofen|ibuprofen|mesh-list
110783807|NCT03658720|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110783808|NCT03658720|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110783809|NCT03658720|Analgesics|analgesics|mesh-ancestor
110783810|NCT03658720|Sensory System Agents|sensory system agents|mesh-ancestor
110783811|NCT03658720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110783812|NCT03658720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110783813|NCT03658720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110783814|NCT03658720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110783815|NCT03658720|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110783816|NCT03658720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110783817|NCT03658720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110783818|NCT03658408|4-Aminopyridine|4-aminopyridine|mesh-list
110783819|NCT03658408|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
110783820|NCT03658408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110783821|NCT03658408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110783822|NCT03658330|Naltrexone|naltrexone|mesh-list
110783823|NCT03658330|Ketamine|ketamine|mesh-list
110783824|NCT03658330|Analgesics|analgesics|mesh-ancestor
110783825|NCT03658330|Sensory System Agents|sensory system agents|mesh-ancestor
110783826|NCT03658330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110783827|NCT03658330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110783828|NCT03658330|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110783829|NCT03658330|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110783830|NCT03658330|Anesthetics, General|anesthetics, general|mesh-ancestor
110783831|NCT03658330|Anesthetics|anesthetics|mesh-ancestor
110783832|NCT03658330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110783833|NCT03658330|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110783834|NCT03658330|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110783835|NCT03658330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110783836|NCT03658330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110783837|NCT03658330|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110783838|NCT03658330|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110783839|NCT02920528|Ketamine|ketamine|mesh-list
110783840|NCT02920528|Analgesics|analgesics|mesh-ancestor
110783841|NCT02920528|Sensory System Agents|sensory system agents|mesh-ancestor
110783842|NCT02920528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110783843|NCT02920528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110783844|NCT02920528|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110783845|NCT02920528|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110783846|NCT02920528|Anesthetics, General|anesthetics, general|mesh-ancestor
110783847|NCT02920528|Anesthetics|anesthetics|mesh-ancestor
110783848|NCT02920528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110783849|NCT02920528|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110783850|NCT02920528|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110783851|NCT02920528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110783852|NCT02920528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110783853|NCT01068418|Vitamin D|vitamin d|mesh-list
110783854|NCT01068418|Cholecalciferol|cholecalciferol|mesh-list
110783855|NCT01068418|Vitamins|vitamins|mesh-ancestor
110783856|NCT01068418|Micronutrients|micronutrients|mesh-ancestor
110783857|NCT01068418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110783858|NCT01068418|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110783859|NCT01068418|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110783860|NCT01100619|Rosiglitazone|rosiglitazone|mesh-list
110783861|NCT01100619|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110783862|NCT01100619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110783863|NCT03657550|Niacin|niacin|mesh-list
110783864|NCT03657550|Amlodipine|amlodipine|mesh-list
110783865|NCT03657550|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110783866|NCT03657550|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110783867|NCT03657550|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110783868|NCT03657550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110783869|NCT03657550|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110783870|NCT03657550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110783871|NCT03657550|Vasodilator Agents|vasodilator agents|mesh-ancestor
110783872|NCT03657550|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110783873|NCT03657550|Antimetabolites|antimetabolites|mesh-ancestor
110783874|NCT03657550|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110783875|NCT03657550|Vitamin B Complex|vitamin b complex|mesh-ancestor
110783876|NCT03657550|Vitamins|vitamins|mesh-ancestor
110783877|NCT03657550|Micronutrients|micronutrients|mesh-ancestor
110783878|NCT02920450|Paclitaxel|paclitaxel|mesh-list
110783879|NCT02920450|Carboplatin|carboplatin|mesh-list
110783880|NCT02920450|Gedatolisib|gedatolisib|mesh-list
110783881|NCT02920450|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110783882|NCT02920450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110783883|NCT02920450|Tubulin Modulators|tubulin modulators|mesh-ancestor
110783884|NCT02920450|Antimitotic Agents|antimitotic agents|mesh-ancestor
110783885|NCT02920450|Mitosis Modulators|mitosis modulators|mesh-ancestor
110783886|NCT02920450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110783887|NCT02920450|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110783888|NCT02920450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110783889|NCT03622450|Ciprofloxacin|ciprofloxacin|mesh-list
110783890|NCT03622450|Levofloxacin|levofloxacin|mesh-list
110783891|NCT03622450|Gentamicins|gentamicins|mesh-list
110783892|NCT03622450|Meropenem|meropenem|mesh-list
110783893|NCT03622450|Amikacin|amikacin|mesh-list
110783894|NCT03622450|Colistin|colistin|mesh-list
110783895|NCT03622450|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110783896|NCT03622450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110783897|NCT03622450|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110783898|NCT03622450|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110783899|NCT03622450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110783900|NCT03622450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110783901|NCT03622450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110783902|NCT03622450|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110783903|NCT03622450|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110783904|NCT03622450|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110783905|NCT03622450|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110783906|NCT03657862|Fluorides|fluorides|mesh-list
110783907|NCT03657862|Cariostatic Agents|cariostatic agents|mesh-ancestor
110783908|NCT03657862|Protective Agents|protective agents|mesh-ancestor
110783909|NCT03657862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110783910|NCT02730130|Pembrolizumab|pembrolizumab|mesh-list
110783911|NCT02730130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110783912|NCT02730130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110783913|NCT02730130|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110783914|NCT02730130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110783915|NCT02919436|Tamsulosin|tamsulosin|mesh-list
110783916|NCT02919436|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110783917|NCT02919436|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110783918|NCT02919436|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110783919|NCT02919436|Adrenergic Agents|adrenergic agents|mesh-ancestor
110783920|NCT02919436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110495069|NCT00766441|Hormones|hormones|mesh-ancestor
110783921|NCT02919436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110783922|NCT02919436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110783923|NCT02919436|Urological Agents|urological agents|mesh-ancestor
110783924|NCT03657472|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
110783925|NCT03657472|Atorvastatin|atorvastatin|mesh-list
110783926|NCT03657472|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110783927|NCT03657472|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110783928|NCT03657472|Antimetabolites|antimetabolites|mesh-ancestor
110783929|NCT03657472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110783930|NCT03657472|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110783931|NCT03657472|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110783932|NCT03657472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110783933|NCT03657472|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110783934|NCT04440358|Carboplatin|carboplatin|mesh-list
110783935|NCT04440358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110783937|NCT04438330|Trace Elements|trace elements|mesh-ancestor
110783938|NCT04438330|Micronutrients|micronutrients|mesh-ancestor
110783939|NCT04438330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110783940|NCT03803475|Edetic Acid|edetic acid|mesh-list
110783941|NCT03803475|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
110783942|NCT03803475|Chelating Agents|chelating agents|mesh-ancestor
110783943|NCT03803475|Sequestering Agents|sequestering agents|mesh-ancestor
110783944|NCT03803475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110783945|NCT03803475|Anticoagulants|anticoagulants|mesh-ancestor
110783946|NCT03803475|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110783947|NCT03803475|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110495097|NCT00775489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110783949|NCT02682004|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110783950|NCT02682004|Serotonin Agents|serotonin agents|mesh-ancestor
110783951|NCT02682004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110783952|NCT02682004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110783953|NCT02682004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110783954|NCT00005937|Cyclosporine|cyclosporine|mesh-list
110783955|NCT00005937|Cyclosporins|cyclosporins|mesh-list
110783956|NCT00005937|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110783957|NCT00005937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110783958|NCT00005937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110783959|NCT00005937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110783960|NCT00005937|Immunologic Factors|immunologic factors|mesh-ancestor
110783961|NCT00005937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110783962|NCT00005937|Antifungal Agents|antifungal agents|mesh-ancestor
110783963|NCT00005937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110783964|NCT00005937|Dermatologic Agents|dermatologic agents|mesh-ancestor
110783965|NCT00005937|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110783966|NCT00005937|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110783967|NCT01096329|Methyltestosterone|methyltestosterone|mesh-list
110783968|NCT01096329|Testosterone|testosterone|mesh-list
110682910|NCT05277701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110783969|NCT01096329|Testosterone undecanoate|testosterone undecanoate|mesh-list
110783970|NCT01096329|Testosterone enanthate|testosterone enanthate|mesh-list
110783971|NCT01096329|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
110783972|NCT01096329|Androgens|androgens|mesh-ancestor
110783973|NCT01096329|Hormones|hormones|mesh-ancestor
110783974|NCT01096329|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110783975|NCT01096329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110783976|NCT01096329|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110783977|NCT01096329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110783978|NCT01096329|Anabolic Agents|anabolic agents|mesh-ancestor
110783979|NCT02908516|Tranexamic Acid|tranexamic acid|mesh-list
110783980|NCT02908516|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110783981|NCT02908516|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110783982|NCT02908516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110783983|NCT02908516|Hemostatics|hemostatics|mesh-ancestor
110783985|NCT03717350|Meropenem|meropenem|mesh-list
110783986|NCT03717350|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110783987|NCT03717350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110783988|NCT03713372|Antibodies|antibodies|mesh-list
110783989|NCT03713372|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110783990|NCT03713372|Immunologic Factors|immunologic factors|mesh-ancestor
110783991|NCT03713372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110783992|NCT03656614|Neostigmine|neostigmine|mesh-list
110783993|NCT03656614|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110783994|NCT03656614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110783995|NCT03656614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110783996|NCT03656614|Cholinergic Agents|cholinergic agents|mesh-ancestor
110783997|NCT03656614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110783998|NCT03656614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110783999|NCT03656614|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110784000|NCT03656614|Autonomic Agents|autonomic agents|mesh-ancestor
110784001|NCT03656614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110784002|NCT02906644|Nicotine|nicotine|mesh-list
110784003|NCT02906644|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110784004|NCT02906644|Autonomic Agents|autonomic agents|mesh-ancestor
110784005|NCT02906644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110784006|NCT02906644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110784007|NCT02906644|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110784008|NCT02906644|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110784009|NCT02906644|Cholinergic Agents|cholinergic agents|mesh-ancestor
110784010|NCT02906644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110784011|NCT02906644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110784012|NCT02982772|Nicotine|nicotine|mesh-list
110784013|NCT02982772|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110784014|NCT02982772|Autonomic Agents|autonomic agents|mesh-ancestor
110784015|NCT02982772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110784016|NCT02982772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110784017|NCT02982772|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110784018|NCT02982772|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110784019|NCT02982772|Cholinergic Agents|cholinergic agents|mesh-ancestor
110784020|NCT02982772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110784021|NCT02982772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110784022|NCT03713216|Morphine|morphine|mesh-list
110784023|NCT03713216|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110784024|NCT03713216|Narcotics|narcotics|mesh-ancestor
110784025|NCT03713216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110784026|NCT03713216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110784027|NCT03713216|Analgesics|analgesics|mesh-ancestor
110784028|NCT03713216|Sensory System Agents|sensory system agents|mesh-ancestor
110784029|NCT03713216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110784030|NCT02098954|Gemcitabine|gemcitabine|mesh-list
110784031|NCT02098954|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110784032|NCT02098954|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110784033|NCT02098954|Antimetabolites|antimetabolites|mesh-ancestor
110784034|NCT02098954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110784035|NCT02098954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110784036|NCT02098954|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110784037|NCT02098954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110784038|NCT03655834|Pemetrexed|pemetrexed|mesh-list
110784039|NCT03655834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110784040|NCT03655834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110784041|NCT03655834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110784042|NCT03655834|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110784043|NCT03655834|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110784044|NCT03488108|Minoxidil|minoxidil|mesh-list
110784045|NCT03488108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110784046|NCT03488108|Vasodilator Agents|vasodilator agents|mesh-ancestor
110784047|NCT03712670|Pyranoprofen|pyranoprofen|mesh-list
110784048|NCT03712670|Aflibercept|aflibercept|mesh-list
110784049|NCT03712670|Carotenoids|carotenoids|mesh-list
110784050|NCT03712670|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110784051|NCT03712670|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110784052|NCT03712670|Growth Substances|growth substances|mesh-ancestor
110784053|NCT03712670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110784054|NCT03712670|Growth Inhibitors|growth inhibitors|mesh-ancestor
110784055|NCT03712670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110784056|NCT03712670|Antioxidants|antioxidants|mesh-ancestor
110784057|NCT03712670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110784058|NCT03712670|Protective Agents|protective agents|mesh-ancestor
110784059|NCT03712670|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110784060|NCT03712670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110784061|NCT03712670|Analgesics|analgesics|mesh-ancestor
110784062|NCT03712670|Sensory System Agents|sensory system agents|mesh-ancestor
110784063|NCT03712670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110784064|NCT03712670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110784065|NCT03712670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110784066|NCT03712670|Gout Suppressants|gout suppressants|mesh-ancestor
110784067|NCT03440918|Anti-Infective Agents|anti-infective agents|mesh-list
110784068|NCT03440918|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110784069|NCT03486392|Liraglutide|liraglutide|mesh-list
110784070|NCT03486392|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110784071|NCT03486392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110784072|NCT03486392|Incretins|incretins|mesh-ancestor
110784073|NCT03486392|Hormones|hormones|mesh-ancestor
110784074|NCT03486392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110784075|NCT02981524|Cyclophosphamide|cyclophosphamide|mesh-list
110784076|NCT02981524|Pembrolizumab|pembrolizumab|mesh-list
110784077|NCT02981524|Immunologic Factors|immunologic factors|mesh-ancestor
110784078|NCT02981524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110784079|NCT02981524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110784080|NCT02981524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110784081|NCT02981524|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110784082|NCT02981524|Alkylating Agents|alkylating agents|mesh-ancestor
110784083|NCT02981524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110784084|NCT02981524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110784085|NCT02981524|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110784086|NCT02981524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110784087|NCT02981524|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110784088|NCT04297150|Rivaroxaban|rivaroxaban|mesh-list
110784089|NCT04297150|Apixaban|apixaban|mesh-list
110784090|NCT04297150|Edoxaban|edoxaban|mesh-list
110784091|NCT04297150|Dabigatran|dabigatran|mesh-list
110784092|NCT04297150|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110784093|NCT04297150|Antithrombins|antithrombins|mesh-ancestor
110784094|NCT04297150|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110784095|NCT04297150|Protease Inhibitors|protease inhibitors|mesh-ancestor
110784096|NCT04297150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110784097|NCT04297150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110784098|NCT04297150|Anticoagulants|anticoagulants|mesh-ancestor
110784099|NCT03486314|Rifampin|rifampin|mesh-list
110784100|NCT03486314|Paclitaxel|paclitaxel|mesh-list
110784101|NCT03486314|Docetaxel|docetaxel|mesh-list
110784102|NCT03486314|Carboplatin|carboplatin|mesh-list
110784103|NCT03486314|Pevonedistat|pevonedistat|mesh-list
110784104|NCT03486314|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110784105|NCT03486314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110784106|NCT03486314|Tubulin Modulators|tubulin modulators|mesh-ancestor
110784107|NCT03486314|Antimitotic Agents|antimitotic agents|mesh-ancestor
110784108|NCT03486314|Mitosis Modulators|mitosis modulators|mesh-ancestor
110784109|NCT03486314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110784110|NCT03486314|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110784111|NCT03486314|Antitubercular Agents|antitubercular agents|mesh-ancestor
110784112|NCT03486314|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110784113|NCT03486314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110784114|NCT03486314|Leprostatic Agents|leprostatic agents|mesh-ancestor
110784115|NCT03486314|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110501752|NCT00642811|Antipyretics|antipyretics|mesh-ancestor
110784116|NCT03486314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110784117|NCT03486314|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110784118|NCT03486314|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110784119|NCT03486314|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110784120|NCT03486314|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110784121|NCT03486314|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110784122|NCT03486314|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110784123|NCT02975206|Serlopitant|serlopitant|mesh-list
110784124|NCT02975206|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110784125|NCT02975206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110784126|NCT02975206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110784127|NCT02975206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110784128|NCT03654820|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110784129|NCT01066156|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110784130|NCT01066156|Antidepressive Agents|antidepressive agents|mesh-ancestor
110784131|NCT01066156|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110784132|NCT01066156|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110784133|NCT01066156|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110784134|NCT01066156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110784135|NCT01066156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110784136|NCT02980042|Rituximab|rituximab|mesh-list
110784137|NCT02980042|Ocrelizumab|ocrelizumab|mesh-list
110495228|NCT00668317|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110784138|NCT02980042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110784139|NCT02980042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110784140|NCT02980042|Immunologic Factors|immunologic factors|mesh-ancestor
110784141|NCT02980042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110784142|NCT02980042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110784143|NCT01066000|Epoetin Alfa|epoetin alfa|mesh-list
110784144|NCT01066000|Hematinics|hematinics|mesh-ancestor
110784145|NCT01065844|Nelfinavir|nelfinavir|mesh-list
110784146|NCT01065844|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110784147|NCT01065844|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110784148|NCT01065844|Protease Inhibitors|protease inhibitors|mesh-ancestor
110784149|NCT01065844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110784150|NCT01065844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110784151|NCT01065844|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110784152|NCT01065844|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110784153|NCT01065844|Antiviral Agents|antiviral agents|mesh-ancestor
110784154|NCT01065844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110784155|NCT00004635|Thalidomide|thalidomide|mesh-list
110784156|NCT00004635|Leuprolide|leuprolide|mesh-list
110784157|NCT00004635|Goserelin|goserelin|mesh-list
110784158|NCT00004635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110784159|NCT00004635|Immunologic Factors|immunologic factors|mesh-ancestor
110784160|NCT00004635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110784161|NCT00004635|Leprostatic Agents|leprostatic agents|mesh-ancestor
110784162|NCT00004635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110784163|NCT00004635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110784164|NCT00004635|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110784165|NCT00004635|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110784166|NCT00004635|Growth Substances|growth substances|mesh-ancestor
110784167|NCT00004635|Growth Inhibitors|growth inhibitors|mesh-ancestor
110784168|NCT00004635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110784169|NCT00004635|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110784170|NCT00004635|Fertility Agents|fertility agents|mesh-ancestor
110784171|NCT00004635|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110784172|NCT00004635|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110784173|NCT00004563|Cyclophosphamide|cyclophosphamide|mesh-list
110784174|NCT00004563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110784175|NCT00004563|Immunologic Factors|immunologic factors|mesh-ancestor
110784176|NCT00004563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110784177|NCT00004563|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110784178|NCT00004563|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110784179|NCT00004563|Alkylating Agents|alkylating agents|mesh-ancestor
110784180|NCT00004563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110784181|NCT00004563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110784182|NCT00004563|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110784183|NCT03951051|Olmesartan|olmesartan|mesh-list
110784184|NCT03951051|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
110495255|NCT00771511|Capsaicin|capsaicin|mesh-list
110784185|NCT03951051|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110784186|NCT03951051|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110784187|NCT03951051|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110784188|NCT03951051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110784189|NCT01103115|Calcium, Dietary|calcium, dietary|mesh-list
110784190|NCT01103115|Vitamin D|vitamin d|mesh-list
110784191|NCT01103115|Calcium Carbonate|calcium carbonate|mesh-list
110784192|NCT01103115|Calcium|calcium|mesh-list
110784193|NCT01103115|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110784194|NCT01103115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110784195|NCT01103115|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110784197|NCT01103115|Micronutrients|micronutrients|mesh-ancestor
110784198|NCT01103115|Antacids|antacids|mesh-ancestor
110784199|NCT01103115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110784200|NCT01103115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110784201|NCT01103193|Remifentanil|remifentanil|mesh-list
110784202|NCT01103193|Sevoflurane|sevoflurane|mesh-list
110784203|NCT01103193|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110784204|NCT01103193|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110784205|NCT01103193|Anesthetics, General|anesthetics, general|mesh-ancestor
110784206|NCT01103193|Anesthetics|anesthetics|mesh-ancestor
110784207|NCT01103193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110784208|NCT01103193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110784209|NCT01103193|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110784210|NCT01103193|Narcotics|narcotics|mesh-ancestor
110784211|NCT01103193|Analgesics|analgesics|mesh-ancestor
110784212|NCT01103193|Sensory System Agents|sensory system agents|mesh-ancestor
110784213|NCT01103193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110784214|NCT03949101|Atropine|atropine|mesh-list
110784215|NCT03949101|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110784216|NCT03949101|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110784217|NCT03949101|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110784218|NCT03949101|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110784219|NCT03949101|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110784220|NCT03949101|Autonomic Agents|autonomic agents|mesh-ancestor
110784221|NCT03949101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110784222|NCT03949101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110784223|NCT03949101|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110784224|NCT03949101|Respiratory System Agents|respiratory system agents|mesh-ancestor
110784225|NCT03949101|Mydriatics|mydriatics|mesh-ancestor
110784226|NCT03949101|Parasympatholytics|parasympatholytics|mesh-ancestor
110784227|NCT03949101|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110784228|NCT03949101|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110784229|NCT03949101|Cholinergic Agents|cholinergic agents|mesh-ancestor
110784230|NCT03949101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110784231|NCT03949101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110784232|NCT01096485|Levonorgestrel|levonorgestrel|mesh-list
110784233|NCT01096485|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110784234|NCT01096485|Contraceptive Agents|contraceptive agents|mesh-ancestor
110784235|NCT01096485|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110784236|NCT01096485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110784237|NCT01096485|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110784238|NCT01096485|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110784239|NCT01096485|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110784240|NCT00003645|Leuprolide|leuprolide|mesh-list
110784241|NCT00003645|Goserelin|goserelin|mesh-list
110784242|NCT00003645|Flutamide|flutamide|mesh-list
110784243|NCT00003645|Bicalutamide|bicalutamide|mesh-list
110784244|NCT00003645|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110784245|NCT00003645|Fertility Agents|fertility agents|mesh-ancestor
110784246|NCT00003645|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110784247|NCT00003645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110784248|NCT00003645|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110784249|NCT00003645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110784250|NCT00003645|Androgen Antagonists|androgen antagonists|mesh-ancestor
110784251|NCT00003645|Hormone Antagonists|hormone antagonists|mesh-ancestor
110784252|NCT00003645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110784253|NCT02918968|Flutamide|flutamide|mesh-list
110784254|NCT02918968|Androgens|androgens|mesh-list
110784255|NCT02918968|Hormones|hormones|mesh-ancestor
110784256|NCT02918968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110784257|NCT02918968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110784258|NCT02918968|Androgen Antagonists|androgen antagonists|mesh-ancestor
110784259|NCT02918968|Hormone Antagonists|hormone antagonists|mesh-ancestor
110784260|NCT02918968|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110784261|NCT02918968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110784262|NCT01065766|Metformin|metformin|mesh-list
110784263|NCT01065766|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110784264|NCT01065766|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110850447|NCT03830489|Ascorbic Acid|ascorbic acid|mesh-list
110784265|NCT01065766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110784266|NCT01065766|Incretins|incretins|mesh-ancestor
110784267|NCT01065766|Hormones|hormones|mesh-ancestor
110784268|NCT01065766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110784269|NCT01065766|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110784270|NCT01065766|Protease Inhibitors|protease inhibitors|mesh-ancestor
110784271|NCT01065766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110784272|NCT01065766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110784273|NCT03653260|Lidocaine|lidocaine|mesh-list
110784274|NCT03653260|Anesthetics, Local|anesthetics, local|mesh-ancestor
110784275|NCT03653260|Anesthetics|anesthetics|mesh-ancestor
110784276|NCT03653260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110784277|NCT03653260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110784278|NCT03653260|Sensory System Agents|sensory system agents|mesh-ancestor
110784279|NCT03653260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110784280|NCT03653260|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110784281|NCT03653260|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110784282|NCT03653260|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110784283|NCT03653260|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110784284|NCT03653260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110784285|NCT03652792|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
110784286|NCT03652792|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110784287|NCT03652792|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110784288|NCT03652792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110784289|NCT04054960|Levodopa|levodopa|mesh-list
110784290|NCT04054960|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110784291|NCT04054960|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110784292|NCT04054960|Dopamine Agents|dopamine agents|mesh-ancestor
110784293|NCT04054960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110784294|NCT04054960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110784295|NCT04054960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110784296|NCT04055194|Tranexamic Acid|tranexamic acid|mesh-list
110784297|NCT04055194|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110784298|NCT04055194|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110784299|NCT04055194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110784300|NCT04055194|Hemostatics|hemostatics|mesh-ancestor
110784301|NCT04055194|Coagulants|coagulants|mesh-ancestor
110784302|NCT01103583|Hydroxyurea|hydroxyurea|mesh-list
110784303|NCT01103583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110784304|NCT01103583|Antisickling Agents|antisickling agents|mesh-ancestor
110784305|NCT01103583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110784306|NCT01103583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110784307|NCT01103583|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110784308|NCT02530047|Interferons|interferons|mesh-list
110784309|NCT02530047|Interferon-beta|interferon-beta|mesh-list
110784310|NCT02530047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110784311|NCT02530047|Antiviral Agents|antiviral agents|mesh-ancestor
110784312|NCT02530047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110784313|NCT02530047|Immunologic Factors|immunologic factors|mesh-ancestor
110784314|NCT02530047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110784315|NCT02529969|Curcumin|curcumin|mesh-list
110784316|NCT02529969|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110784317|NCT02529969|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110784318|NCT02529969|Analgesics|analgesics|mesh-ancestor
110784319|NCT02529969|Sensory System Agents|sensory system agents|mesh-ancestor
110784320|NCT02529969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110784321|NCT02529969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110784322|NCT02529969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110784323|NCT02529969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110784324|NCT02529969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110784325|NCT02529969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110784326|NCT02529969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110784327|NCT01584687|Omalizumab|omalizumab|mesh-list
110784328|NCT01584687|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110784329|NCT01584687|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110784330|NCT01584687|Respiratory System Agents|respiratory system agents|mesh-ancestor
110784331|NCT01101789|Triclosan|triclosan|mesh-list
110784332|NCT01101789|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110784333|NCT01101789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110784334|NCT01101789|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
110784335|NCT01101789|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110784336|NCT01101789|Antimetabolites|antimetabolites|mesh-ancestor
110784337|NCT01101789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110784338|NCT01101789|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110784339|NCT04185220|Mogamulizumab|mogamulizumab|mesh-list
110784340|NCT04185220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110784341|NCT01103739|Simvastatin|simvastatin|mesh-list
110784342|NCT01103739|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110784343|NCT01103739|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110784344|NCT01103739|Antimetabolites|antimetabolites|mesh-ancestor
110784345|NCT01103739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110784346|NCT01103739|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110784347|NCT01103739|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110784348|NCT01103739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110784349|NCT04054024|Erenumab|erenumab|mesh-list
110784350|NCT04054024|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
110784351|NCT04054024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110784352|NCT04054024|Analgesics|analgesics|mesh-ancestor
110784353|NCT04054024|Sensory System Agents|sensory system agents|mesh-ancestor
110784354|NCT04054024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110784355|NCT04054024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110784356|NCT00002931|Paclitaxel|paclitaxel|mesh-list
110784357|NCT00002931|Etoposide|etoposide|mesh-list
110784358|NCT00002931|Carboplatin|carboplatin|mesh-list
110784359|NCT00002931|Ifosfamide|ifosfamide|mesh-list
110784360|NCT00002931|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110784361|NCT00002931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110784362|NCT00002931|Tubulin Modulators|tubulin modulators|mesh-ancestor
110784363|NCT00002931|Antimitotic Agents|antimitotic agents|mesh-ancestor
110784364|NCT00002931|Mitosis Modulators|mitosis modulators|mesh-ancestor
110784365|NCT00002931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110784366|NCT00002931|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110784367|NCT00002931|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110784368|NCT00002931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110784369|NCT00002931|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110784370|NCT00002931|Alkylating Agents|alkylating agents|mesh-ancestor
110784371|NCT02918266|Scopolamine|scopolamine|mesh-list
110784372|NCT02918266|Donepezil|donepezil|mesh-list
110784373|NCT02918266|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
110784374|NCT02918266|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110784375|NCT02918266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110784376|NCT02918266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110784377|NCT02918266|Cholinergic Agents|cholinergic agents|mesh-ancestor
110784378|NCT02918266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110784379|NCT02918266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110784380|NCT02918266|Nootropic Agents|nootropic agents|mesh-ancestor
110784381|NCT02918266|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110784382|NCT02918266|Antiemetics|antiemetics|mesh-ancestor
110784383|NCT02918266|Autonomic Agents|autonomic agents|mesh-ancestor
110784384|NCT02918266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110784385|NCT02918266|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110784386|NCT02918266|Mydriatics|mydriatics|mesh-ancestor
110784387|NCT02918266|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110784388|NCT02918266|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110784389|NCT02918266|Parasympatholytics|parasympatholytics|mesh-ancestor
110784390|NCT00041067|Docetaxel|docetaxel|mesh-list
110784391|NCT00041067|Trastuzumab|trastuzumab|mesh-list
110784392|NCT00041067|Vinorelbine|vinorelbine|mesh-list
110784393|NCT00041067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110784394|NCT00041067|Tubulin Modulators|tubulin modulators|mesh-ancestor
110784395|NCT00041067|Antimitotic Agents|antimitotic agents|mesh-ancestor
110784396|NCT00041067|Mitosis Modulators|mitosis modulators|mesh-ancestor
110784397|NCT00041067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110784398|NCT00041067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110784399|NCT00041067|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110784400|NCT01063036|Tenofovir|tenofovir|mesh-list
110784401|NCT01063036|Entecavir|entecavir|mesh-list
110850463|NCT03344614|Apatinib|apatinib|mesh-list
110784402|NCT01063036|Antiviral Agents|antiviral agents|mesh-ancestor
110784403|NCT01063036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110784404|NCT01063036|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110784405|NCT01063036|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110784406|NCT01063036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110784407|NCT01063036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110784408|NCT01063036|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110784409|NCT01063036|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110784410|NCT03652480|Methylprednisolone|methylprednisolone|mesh-list
110784411|NCT03652480|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110784412|NCT03652480|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110784413|NCT03652480|Prednisolone|prednisolone|mesh-list
110784414|NCT03652480|Prednisolone acetate|prednisolone acetate|mesh-list
110784415|NCT03652480|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110784416|NCT03652480|Prednisolone phosphate|prednisolone phosphate|mesh-list
110784417|NCT03652480|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110502052|NCT00811993|Growth Inhibitors|growth inhibitors|mesh-ancestor
110784418|NCT03652480|Antiemetics|antiemetics|mesh-ancestor
110784419|NCT03652480|Autonomic Agents|autonomic agents|mesh-ancestor
110784420|NCT03652480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110784421|NCT03652480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110784422|NCT03652480|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110784424|NCT03652480|Hormones|hormones|mesh-ancestor
110784425|NCT03652480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110784426|NCT03652480|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110784427|NCT03652480|Protective Agents|protective agents|mesh-ancestor
110784428|NCT03652480|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110784429|NCT03652480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110784430|NCT03622060|Nicardipine|nicardipine|mesh-list
110784431|NCT03622060|Nitroglycerin|nitroglycerin|mesh-list
110784432|NCT03622060|Vasodilator Agents|vasodilator agents|mesh-ancestor
110784433|NCT03622060|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110784434|NCT03622060|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110784435|NCT03622060|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110784436|NCT03622060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110784437|NCT03622060|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110784438|NCT03622060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110784439|NCT00040365|Amifostine|amifostine|mesh-list
110784440|NCT00040365|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110784441|NCT00040365|Protective Agents|protective agents|mesh-ancestor
110784442|NCT00040365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110784443|NCT02974114|Acetaminophen|acetaminophen|mesh-list
110784444|NCT02974114|Caffeine|caffeine|mesh-list
110784445|NCT02974114|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110784446|NCT02974114|Analgesics|analgesics|mesh-ancestor
110784447|NCT02974114|Sensory System Agents|sensory system agents|mesh-ancestor
110784448|NCT02974114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110784449|NCT02974114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110784450|NCT02974114|Antipyretics|antipyretics|mesh-ancestor
110784451|NCT02974114|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110784452|NCT02974114|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110784453|NCT02974114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110784454|NCT02974114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110784455|NCT02974114|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110784456|NCT02974114|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110784457|NCT02974114|Purinergic Agents|purinergic agents|mesh-ancestor
110784458|NCT02974114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110784459|NCT00001959|Pirfenidone|pirfenidone|mesh-list
110784460|NCT00001959|Analgesics|analgesics|mesh-ancestor
110784461|NCT00001959|Sensory System Agents|sensory system agents|mesh-ancestor
110784462|NCT00001959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110784463|NCT00001959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110784464|NCT00001959|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110784465|NCT00001959|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110784466|NCT00001959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110784467|NCT00001959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110784468|NCT00001959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110784469|NCT03950505|Pioglitazone|pioglitazone|mesh-list
110784470|NCT03950505|Alogliptin|alogliptin|mesh-list
110784471|NCT03950505|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110784472|NCT03950505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110784473|NCT03950505|Incretins|incretins|mesh-ancestor
110784474|NCT03950505|Hormones|hormones|mesh-ancestor
110784475|NCT03950505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110784476|NCT03950505|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110784477|NCT03950505|Protease Inhibitors|protease inhibitors|mesh-ancestor
110784478|NCT03950505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110495475|NCT00772291|Pregabalin|pregabalin|mesh-list
110784479|NCT03950505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110784480|NCT00001941|Daclizumab|daclizumab|mesh-list
110784481|NCT00001941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110784482|NCT00001941|Immunologic Factors|immunologic factors|mesh-ancestor
110784483|NCT00001941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110784484|NCT01061866|Thalidomide|thalidomide|mesh-list
110784485|NCT01061866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110784486|NCT01061866|Immunologic Factors|immunologic factors|mesh-ancestor
110784487|NCT01061866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110784488|NCT01061866|Leprostatic Agents|leprostatic agents|mesh-ancestor
110784489|NCT01061866|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110784490|NCT01061866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110784491|NCT01061866|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110784492|NCT01061866|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110502134|NCT04515134|Ubiquinone|ubiquinone|mesh-list
110784493|NCT01061866|Growth Substances|growth substances|mesh-ancestor
110784494|NCT01061866|Growth Inhibitors|growth inhibitors|mesh-ancestor
110784495|NCT01061866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110784497|NCT03652714|Anesthetics, Local|anesthetics, local|mesh-list
110784498|NCT03652714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110784499|NCT03652714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110784500|NCT03652714|Sensory System Agents|sensory system agents|mesh-ancestor
110784501|NCT03652714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110784502|NCT03948477|Pantoprazole|pantoprazole|mesh-list
110784503|NCT03948477|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110784504|NCT03948477|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110784505|NCT03948477|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110784506|NCT03948477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110784507|NCT03948477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110784508|NCT03953781|Levetiracetam|levetiracetam|mesh-list
110784509|NCT03953781|Anticonvulsants|anticonvulsants|mesh-ancestor
110784510|NCT03953781|Nootropic Agents|nootropic agents|mesh-ancestor
110784511|NCT01103817|Vitamin D|vitamin d|mesh-list
110784512|NCT01103817|Vitamins|vitamins|mesh-ancestor
110784513|NCT01103817|Micronutrients|micronutrients|mesh-ancestor
110784514|NCT01103817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110784515|NCT01103817|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110784516|NCT01102101|Remifentanil|remifentanil|mesh-list
110784517|NCT01102101|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110784518|NCT01102101|Narcotics|narcotics|mesh-ancestor
110784519|NCT01102101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110784520|NCT01102101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110784521|NCT01102101|Analgesics|analgesics|mesh-ancestor
110784522|NCT01102101|Sensory System Agents|sensory system agents|mesh-ancestor
110784523|NCT01102101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110784524|NCT03950271|Capecitabine|capecitabine|mesh-list
110784525|NCT03950271|Oxaliplatin|oxaliplatin|mesh-list
110784526|NCT03950271|Trastuzumab|trastuzumab|mesh-list
110784527|NCT03950271|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110784528|NCT03950271|Antimetabolites|antimetabolites|mesh-ancestor
110784529|NCT03950271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110784530|NCT03950271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110784531|NCT03950271|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110784533|NCT01102335|Antiviral Agents|antiviral agents|mesh-ancestor
110784534|NCT01102335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110784535|NCT01102335|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110784536|NCT01102335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110784537|NCT01102335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110784538|NCT02973100|Dulaglutide|dulaglutide|mesh-list
110784539|NCT02973100|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110784540|NCT02973100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110784541|NCT01105611|Ritonavir|ritonavir|mesh-list
110784542|NCT01105611|Atazanavir Sulfate|atazanavir sulfate|mesh-list
110784543|NCT01105611|Raltegravir Potassium|raltegravir potassium|mesh-list
110784544|NCT01105611|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110784545|NCT01105611|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110784546|NCT01105611|Protease Inhibitors|protease inhibitors|mesh-ancestor
110784547|NCT01105611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110784548|NCT01105611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110784549|NCT01105611|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110784550|NCT01105611|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110784551|NCT01105611|Antiviral Agents|antiviral agents|mesh-ancestor
110784552|NCT01105611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110784553|NCT01105611|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110784554|NCT01105611|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110784555|NCT01105611|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110784556|NCT01105611|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110784557|NCT05497557|Sotorasib|sotorasib|mesh-list
110784558|NCT05497557|Omeprazole|omeprazole|mesh-list
110784559|NCT05497557|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110784560|NCT05497557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110784561|NCT05497557|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110784562|NCT05497557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110784563|NCT05497557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110784564|NCT05497557|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110784565|NCT05497557|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110784566|NCT05497557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110784567|NCT03948321|Aminolevulinic Acid|aminolevulinic acid|mesh-list
110784568|NCT03948321|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110784569|NCT03948321|Dermatologic Agents|dermatologic agents|mesh-ancestor
110784570|NCT05415267|Vaccines|vaccines|mesh-list
110784571|NCT05415267|Immunologic Factors|immunologic factors|mesh-ancestor
110784572|NCT05415267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110784573|NCT01482286|Metformin|metformin|mesh-list
110784574|NCT01482286|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110784575|NCT01482286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110784576|NCT03651934|Iron|iron|mesh-list
110784577|NCT03651934|Selenium|selenium|mesh-list
110784578|NCT03651934|Trace Elements|trace elements|mesh-ancestor
110784579|NCT03651934|Micronutrients|micronutrients|mesh-ancestor
110784580|NCT03651934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110784581|NCT03651934|Antioxidants|antioxidants|mesh-ancestor
110784582|NCT03651934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110784583|NCT03651934|Protective Agents|protective agents|mesh-ancestor
110784584|NCT02972632|Vortioxetine|vortioxetine|mesh-list
110784585|NCT02972632|Antidepressive Agents|antidepressive agents|mesh-ancestor
110784586|NCT02972632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110784587|NCT02972632|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110784588|NCT02972632|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110784589|NCT02972632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110784590|NCT02972632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110784591|NCT02972632|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110784592|NCT02972632|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110784593|NCT02972632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110784594|NCT02972632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110784595|NCT02972632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110784596|NCT02972632|Serotonin Agents|serotonin agents|mesh-ancestor
110784597|NCT02972632|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110784598|NCT02972632|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110784599|NCT02972632|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110784600|NCT02972632|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110784601|NCT01106001|Levobupivacaine|levobupivacaine|mesh-list
110784602|NCT01106001|Anesthetics, Local|anesthetics, local|mesh-ancestor
110784603|NCT01106001|Anesthetics|anesthetics|mesh-ancestor
110784604|NCT01106001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110784605|NCT01106001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110784606|NCT01106001|Sensory System Agents|sensory system agents|mesh-ancestor
110784607|NCT01106001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110784608|NCT01327521|Cisplatin|cisplatin|mesh-list
110784609|NCT01327521|Gemcitabine|gemcitabine|mesh-list
110784610|NCT01327521|Doxorubicin|doxorubicin|mesh-list
110784611|NCT01327521|Fluorouracil|fluorouracil|mesh-list
110784612|NCT01327521|Epirubicin|epirubicin|mesh-list
110784613|NCT01327521|Mitomycins|mitomycins|mesh-list
110784614|NCT01327521|Mitomycin|mitomycin|mesh-list
110784615|NCT01327521|Maleic acid|maleic acid|mesh-list
110784616|NCT01327521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110784617|NCT01327521|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110784618|NCT01327521|Antimetabolites|antimetabolites|mesh-ancestor
110784619|NCT01327521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110784620|NCT01327521|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110784621|NCT01327521|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110784622|NCT01327521|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110784623|NCT01327521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110784624|NCT01327521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110784625|NCT01327521|Immunologic Factors|immunologic factors|mesh-ancestor
110784626|NCT01327521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110784627|NCT01327521|Alkylating Agents|alkylating agents|mesh-ancestor
110784628|NCT01327521|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110784629|NCT04899921|Nivolumab|nivolumab|mesh-list
110784630|NCT04899921|Ipilimumab|ipilimumab|mesh-list
110784631|NCT04899921|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110784632|NCT04899921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110784633|NCT04899921|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110784634|NCT04899921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110784635|NCT01104519|Niacin|niacin|mesh-list
110784636|NCT01104519|Nicotinic Acids|nicotinic acids|mesh-list
110784637|NCT01104519|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110784638|NCT01104519|Antimetabolites|antimetabolites|mesh-ancestor
110784639|NCT01104519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110502277|NCT00643201|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110784640|NCT01104519|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110784641|NCT01104519|Vasodilator Agents|vasodilator agents|mesh-ancestor
110784642|NCT01104519|Vitamin B Complex|vitamin b complex|mesh-ancestor
110784643|NCT01104519|Vitamins|vitamins|mesh-ancestor
110784644|NCT01104519|Micronutrients|micronutrients|mesh-ancestor
110784645|NCT01104519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110784646|NCT03944733|Iron|iron|mesh-list
110784647|NCT03944733|Trace Elements|trace elements|mesh-ancestor
110784648|NCT03944733|Micronutrients|micronutrients|mesh-ancestor
110784649|NCT03944733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110784650|NCT01060384|Lenalidomide|lenalidomide|mesh-list
110784651|NCT01060384|Ofatumumab|ofatumumab|mesh-list
110784652|NCT01060384|Immunologic Factors|immunologic factors|mesh-ancestor
110784653|NCT01060384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110784654|NCT01060384|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110784655|NCT01060384|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110784656|NCT01060384|Growth Substances|growth substances|mesh-ancestor
110784657|NCT01060384|Growth Inhibitors|growth inhibitors|mesh-ancestor
110784658|NCT01060384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110784659|NCT01060150|Methylphenidate|methylphenidate|mesh-list
110784660|NCT01060150|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110784661|NCT01060150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110784662|NCT01060150|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110784663|NCT01060150|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110784664|NCT01060150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110784665|NCT01060150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110784666|NCT01060150|Dopamine Agents|dopamine agents|mesh-ancestor
110784667|NCT01060150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110784668|NCT03863223|Docetaxel|docetaxel|mesh-list
110784669|NCT03863223|Trastuzumab|trastuzumab|mesh-list
110784670|NCT03863223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110784671|NCT03863223|Tubulin Modulators|tubulin modulators|mesh-ancestor
110784672|NCT03863223|Antimitotic Agents|antimitotic agents|mesh-ancestor
110784673|NCT03863223|Mitosis Modulators|mitosis modulators|mesh-ancestor
110784674|NCT03863223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110784675|NCT03863223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110784676|NCT01104597|Nitroglycerin|nitroglycerin|mesh-list
110784677|NCT01104597|Vasodilator Agents|vasodilator agents|mesh-ancestor
110784678|NCT02970292|Pimavanserin|pimavanserin|mesh-list
110784679|NCT02970292|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110784680|NCT02970292|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110784681|NCT02970292|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110784682|NCT02970292|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110784683|NCT02970292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110784684|NCT02970292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110784685|NCT02970292|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110784686|NCT02970292|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110784687|NCT02970292|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110784688|NCT02970292|Serotonin Agents|serotonin agents|mesh-ancestor
110784689|NCT02970292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110784690|NCT02970292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110784691|NCT03944655|Anesthetics|anesthetics|mesh-list
110784692|NCT03944655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110784693|NCT03944655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110784694|NCT05276895|Glycyrrhizic Acid|glycyrrhizic acid|mesh-list
110784695|NCT05276895|Quercetin|quercetin|mesh-list
110784696|NCT05276895|Antioxidants|antioxidants|mesh-ancestor
110784697|NCT05276895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110784698|NCT05276895|Protective Agents|protective agents|mesh-ancestor
110784699|NCT05276895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110784700|NCT05276895|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110784701|NCT02971228|Insulin Lispro|insulin lispro|mesh-list
110784702|NCT02971228|Glucagon|glucagon|mesh-list
110784703|NCT02971228|Pancrelipase|pancrelipase|mesh-list
110784704|NCT02971228|Pancreatin|pancreatin|mesh-list
110784705|NCT02971228|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
110784706|NCT02971228|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110784707|NCT02971228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110784708|NCT02971228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110784709|NCT02971228|Hormones|hormones|mesh-ancestor
110784710|NCT02971228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110784711|NCT02971228|Incretins|incretins|mesh-ancestor
110784712|NCT01060072|Loteprednol Etabonate|loteprednol etabonate|mesh-list
110784713|NCT01060072|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110784714|NCT03741075|Tranexamic Acid|tranexamic acid|mesh-list
110784715|NCT03741075|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110784716|NCT03741075|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110784717|NCT03741075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110784718|NCT03741075|Hemostatics|hemostatics|mesh-ancestor
110784719|NCT03741075|Coagulants|coagulants|mesh-ancestor
110502354|NCT02863679|Tetracaine|tetracaine|mesh-list
110784720|NCT01328223|Sorafenib|sorafenib|mesh-list
110784721|NCT01328223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110784722|NCT01328223|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110784723|NCT01328223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110784724|NCT01328223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110784726|NCT01104987|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110784727|NCT01104987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110784728|NCT01106235|Aldesleukin|aldesleukin|mesh-list
110784729|NCT01106235|Cyclophosphamide|cyclophosphamide|mesh-list
110784730|NCT01106235|Interleukin-2|interleukin-2|mesh-list
110784731|NCT01106235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110784732|NCT01106235|Immunologic Factors|immunologic factors|mesh-ancestor
110784733|NCT01106235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110784734|NCT01106235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110784735|NCT01106235|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110784736|NCT01106235|Alkylating Agents|alkylating agents|mesh-ancestor
110784737|NCT01106235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110784739|NCT01106235|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110784740|NCT01106235|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110784741|NCT01106235|Analgesics|analgesics|mesh-ancestor
110784742|NCT01106235|Sensory System Agents|sensory system agents|mesh-ancestor
110784743|NCT01106235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110784744|NCT01106235|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110784745|NCT01106235|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110784746|NCT01106235|Antiviral Agents|antiviral agents|mesh-ancestor
110784747|NCT01106235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110784748|NCT02969590|Leuprolide|leuprolide|mesh-list
110784749|NCT02969590|Norethindrone|norethindrone|mesh-list
110784750|NCT02969590|Estradiol|estradiol|mesh-list
110784751|NCT02969590|Estrogens|estrogens|mesh-list
110784752|NCT02969590|Progesterone|progesterone|mesh-list
110784753|NCT02969590|Progestins|progestins|mesh-list
110784754|NCT02969590|Hormones|hormones|mesh-ancestor
110784755|NCT02969590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110784756|NCT02969590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110784757|NCT02969590|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110784758|NCT02969590|Contraceptive Agents|contraceptive agents|mesh-ancestor
110784759|NCT02969590|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110784760|NCT02969590|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110784761|NCT02969590|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110784762|NCT02969590|Fertility Agents|fertility agents|mesh-ancestor
110784763|NCT02969590|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110784764|NCT02969590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110784765|NCT02969590|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110784766|NCT02969590|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110784767|NCT02969590|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110784768|NCT03650998|Ropivacaine|ropivacaine|mesh-list
110784769|NCT03650998|Anesthetics, Local|anesthetics, local|mesh-ancestor
110784770|NCT03650998|Anesthetics|anesthetics|mesh-ancestor
110784771|NCT03650998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110784772|NCT03650998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110784773|NCT03650998|Sensory System Agents|sensory system agents|mesh-ancestor
110784774|NCT03650998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110784775|NCT04053400|Ketamine|ketamine|mesh-list
110784776|NCT04053400|Analgesics|analgesics|mesh-ancestor
110784777|NCT04053400|Sensory System Agents|sensory system agents|mesh-ancestor
110784778|NCT04053400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110784779|NCT04053400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110784780|NCT04053400|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110784781|NCT04053400|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110784782|NCT04053400|Anesthetics, General|anesthetics, general|mesh-ancestor
110784783|NCT04053400|Anesthetics|anesthetics|mesh-ancestor
110784784|NCT04053400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110784785|NCT04053400|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110784786|NCT04053400|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110784787|NCT04053400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110784788|NCT04053400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110784789|NCT03345849|Upadacitinib|upadacitinib|mesh-list
110784790|NCT03345849|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
110784791|NCT03345849|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110784792|NCT03345849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110784793|NCT03345849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110784794|NCT03345849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110784795|NCT01109043|Bisoprolol|bisoprolol|mesh-list
110784796|NCT01109043|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110784797|NCT01109043|Sympatholytics|sympatholytics|mesh-ancestor
110784798|NCT01109043|Autonomic Agents|autonomic agents|mesh-ancestor
110784799|NCT01109043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110784800|NCT01109043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110784801|NCT01109043|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110784802|NCT01109043|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110784803|NCT01109043|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110784804|NCT01109043|Adrenergic Agents|adrenergic agents|mesh-ancestor
110784805|NCT01109043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110784806|NCT01109043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110784807|NCT01109121|Allopurinol|allopurinol|mesh-list
110784808|NCT01109121|Antimetabolites|antimetabolites|mesh-ancestor
110784809|NCT01109121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110784810|NCT01109121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110784811|NCT01109121|Gout Suppressants|gout suppressants|mesh-ancestor
110784812|NCT01109121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110784813|NCT01109121|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110784814|NCT01109121|Antioxidants|antioxidants|mesh-ancestor
110784815|NCT01109121|Protective Agents|protective agents|mesh-ancestor
110784816|NCT01109121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110784817|NCT01106547|Methylprednisolone|methylprednisolone|mesh-list
110784818|NCT01106547|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110784819|NCT01106547|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110784820|NCT01106547|Prednisolone|prednisolone|mesh-list
110784821|NCT01106547|Prednisolone acetate|prednisolone acetate|mesh-list
110784822|NCT01106547|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110784823|NCT01106547|Prednisolone phosphate|prednisolone phosphate|mesh-list
110784824|NCT01106547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110784825|NCT01106547|Antiemetics|antiemetics|mesh-ancestor
110784826|NCT01106547|Autonomic Agents|autonomic agents|mesh-ancestor
110784827|NCT01106547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110784828|NCT01106547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110784829|NCT01106547|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110784830|NCT01106547|Glucocorticoids|glucocorticoids|mesh-ancestor
110784832|NCT01106547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110784833|NCT01106547|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110784834|NCT01106547|Protective Agents|protective agents|mesh-ancestor
110603579|NCT00610168|Vaccines|vaccines|mesh-list
110784835|NCT01106547|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110784836|NCT01106547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110784837|NCT01105299|Anastrozole|anastrozole|mesh-list
110784838|NCT01105299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110784839|NCT01105299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110784840|NCT01105299|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110784841|NCT01105299|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110784842|NCT01105299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110784843|NCT01105299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110784844|NCT01105299|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110784845|NCT01105299|Hormone Antagonists|hormone antagonists|mesh-ancestor
110784846|NCT01105299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110784847|NCT01105299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110784848|NCT03947229|Clopidogrel|clopidogrel|mesh-list
110784849|NCT03947229|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110784850|NCT03947229|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110784851|NCT03947229|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110784852|NCT03947229|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110784853|NCT03947229|Purinergic Agents|purinergic agents|mesh-ancestor
110784854|NCT03947229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110784855|NCT03947229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110784856|NCT03947229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110784857|NCT03011307|Oxytocin|oxytocin|mesh-list
110784858|NCT03011307|Oxytocics|oxytocics|mesh-ancestor
110784859|NCT03011307|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110784860|NCT03011307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110784861|NCT01327755|Selenium|selenium|mesh-list
110784862|NCT01327755|Antioxidants|antioxidants|mesh-ancestor
110784863|NCT01327755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110784864|NCT01327755|Protective Agents|protective agents|mesh-ancestor
110784865|NCT01327755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110784866|NCT01327755|Trace Elements|trace elements|mesh-ancestor
110784867|NCT01327755|Micronutrients|micronutrients|mesh-ancestor
110784868|NCT04537923|Insulin|insulin|mesh-list
110784869|NCT04537923|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110784870|NCT04537923|Insulin Glargine|insulin glargine|mesh-list
110784872|NCT04537923|Tirzepatide|tirzepatide|mesh-list
110784873|NCT04537923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110784874|NCT04537923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110784875|NCT04537923|Incretins|incretins|mesh-ancestor
110784876|NCT04537923|Hormones|hormones|mesh-ancestor
110784877|NCT04537923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110784878|NCT01107093|Ulipristal acetate|ulipristal acetate|mesh-list
110784879|NCT01107093|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110784880|NCT01107093|Contraceptive Agents|contraceptive agents|mesh-ancestor
110784881|NCT01107093|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110784882|NCT01107093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110784883|NCT01107093|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110784884|NCT01118793|Clopidogrel|clopidogrel|mesh-list
110784885|NCT01118793|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110784886|NCT01118793|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110784887|NCT01118793|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110784888|NCT01118793|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110784889|NCT01118793|Purinergic Agents|purinergic agents|mesh-ancestor
110784890|NCT01118793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110784891|NCT01118793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110784892|NCT01118793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110784894|NCT00127335|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110784895|NCT00127335|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110784896|NCT00127335|Antimetabolites|antimetabolites|mesh-ancestor
110784897|NCT00127335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110784898|NCT00127335|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110784899|NCT00127335|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110784900|NCT00127335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110784901|NCT01109511|Oxycodone|oxycodone|mesh-list
110784902|NCT01109511|Naloxone|naloxone|mesh-list
110784903|NCT01109511|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110784904|NCT01109511|Narcotics|narcotics|mesh-ancestor
110784905|NCT01109511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110784906|NCT01109511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110784907|NCT01109511|Analgesics|analgesics|mesh-ancestor
110784908|NCT01109511|Sensory System Agents|sensory system agents|mesh-ancestor
110784909|NCT01109511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110495725|NCT02829502|Incretins|incretins|mesh-ancestor
110784910|NCT01109511|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110784911|NCT01112085|Ranibizumab|ranibizumab|mesh-list
110784912|NCT01112085|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110784913|NCT01112085|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110784914|NCT01112085|Growth Substances|growth substances|mesh-ancestor
110784915|NCT01112085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110784916|NCT01112085|Growth Inhibitors|growth inhibitors|mesh-ancestor
110784917|NCT01112085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110784918|NCT01328301|Methamphetamine|methamphetamine|mesh-list
110784919|NCT01328301|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110784920|NCT01328301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110784921|NCT01328301|Sympathomimetics|sympathomimetics|mesh-ancestor
110784922|NCT01328301|Autonomic Agents|autonomic agents|mesh-ancestor
110784923|NCT01328301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110784924|NCT01328301|Dopamine Agents|dopamine agents|mesh-ancestor
110784925|NCT01328301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110784926|NCT01328301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110784927|NCT01328301|Adrenergic Agents|adrenergic agents|mesh-ancestor
110784928|NCT01328301|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110784929|NCT01328301|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110784930|NCT01328301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110784931|NCT01328301|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110784932|NCT01328457|Paromomycin|paromomycin|mesh-list
110784933|NCT01328457|Neomycin|neomycin|mesh-list
110784934|NCT01328457|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110784935|NCT01328457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110784936|NCT01328457|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110784937|NCT01328457|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110784938|NCT01328457|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110784939|NCT01328457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110784940|NCT01328457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110784941|NCT01109823|Levofloxacin|levofloxacin|mesh-list
110850512|NCT01205321|Bombesin|bombesin|mesh-list
110784942|NCT01109823|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110784943|NCT01109823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110784944|NCT01109823|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110784945|NCT01109823|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110784946|NCT01109823|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110784947|NCT01109823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110784948|NCT01109823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110784949|NCT01109823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110784950|NCT01109823|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110784951|NCT01109823|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110784952|NCT03943407|Imiquimod|imiquimod|mesh-list
110784953|NCT03943407|Cinnamaldehyde|cinnamaldehyde|mesh-list
110784954|NCT03943407|Doxepin|doxepin|mesh-list
110784955|NCT03943407|Menthol|menthol|mesh-list
110784956|NCT03943407|Histamine|histamine|mesh-list
110784957|NCT03943407|Antipruritics|antipruritics|mesh-ancestor
110784958|NCT03943407|Dermatologic Agents|dermatologic agents|mesh-ancestor
110784959|NCT03943407|Histamine Agonists|histamine agonists|mesh-ancestor
110784960|NCT03943407|Histamine Agents|histamine agents|mesh-ancestor
110784961|NCT03943407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110784962|NCT03943407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110784963|NCT03943407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110784964|NCT03943407|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110784965|NCT03943407|Immunologic Factors|immunologic factors|mesh-ancestor
110784966|NCT03943407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110784967|NCT03943407|Interferon Inducers|interferon inducers|mesh-ancestor
110784968|NCT03943407|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110784969|NCT03943407|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
110784970|NCT03943407|Protective Agents|protective agents|mesh-ancestor
110784971|NCT03943407|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110784972|NCT03943407|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110784973|NCT03943407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110784974|NCT03943407|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110784975|NCT03943407|Antidepressive Agents|antidepressive agents|mesh-ancestor
110784976|NCT03943407|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110784977|NCT03943407|Histamine Antagonists|histamine antagonists|mesh-ancestor
110784979|NCT01209351|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110784980|NCT01209351|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110784981|NCT01209351|Protective Agents|protective agents|mesh-ancestor
110784982|NCT01209351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110784983|NCT02529579|Gemcitabine|gemcitabine|mesh-list
110784984|NCT02529579|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110784985|NCT02529579|Antimetabolites|antimetabolites|mesh-ancestor
110784986|NCT02529579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110784987|NCT02529579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110784988|NCT01209429|Hormones|hormones|mesh-list
110784989|NCT01209429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110784990|NCT01209429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110784991|NCT01110291|Docetaxel|docetaxel|mesh-list
110784992|NCT01110291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110784993|NCT01110291|Tubulin Modulators|tubulin modulators|mesh-ancestor
110784994|NCT01110291|Antimitotic Agents|antimitotic agents|mesh-ancestor
110784995|NCT01110291|Mitosis Modulators|mitosis modulators|mesh-ancestor
110784996|NCT01110291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110784997|NCT01207947|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
110784998|NCT01207947|Vasodilator Agents|vasodilator agents|mesh-ancestor
110784999|NCT01207947|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110785000|NCT01207947|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110785001|NCT01207947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110785002|NCT01207947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110785003|NCT01207947|Urological Agents|urological agents|mesh-ancestor
110785004|NCT01107639|Docetaxel|docetaxel|mesh-list
110785005|NCT01107639|Cetuximab|cetuximab|mesh-list
110785006|NCT01107639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110785007|NCT01107639|Tubulin Modulators|tubulin modulators|mesh-ancestor
110785008|NCT01107639|Antimitotic Agents|antimitotic agents|mesh-ancestor
110785009|NCT01107639|Mitosis Modulators|mitosis modulators|mesh-ancestor
110785010|NCT01107639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110850525|NCT02513290|Loratadine|loratadine|mesh-list
110785011|NCT01107639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110785012|NCT03942861|Methylprednisolone|methylprednisolone|mesh-list
110785013|NCT03942861|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110785014|NCT03942861|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110785015|NCT03942861|Prednisolone|prednisolone|mesh-list
110785016|NCT03942861|Prednisolone acetate|prednisolone acetate|mesh-list
110785017|NCT03942861|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110502645|NCT00625183|Selenium|selenium|mesh-list
110785018|NCT03942861|Prednisolone phosphate|prednisolone phosphate|mesh-list
110785019|NCT03942861|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110785021|NCT03942861|Autonomic Agents|autonomic agents|mesh-ancestor
110785022|NCT03942861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110785023|NCT03942861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110785024|NCT03942861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110785025|NCT03942861|Glucocorticoids|glucocorticoids|mesh-ancestor
110785026|NCT03942861|Hormones|hormones|mesh-ancestor
110785027|NCT03942861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110785028|NCT03942861|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110785029|NCT03942861|Protective Agents|protective agents|mesh-ancestor
110785030|NCT03942861|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110785031|NCT03942861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110785032|NCT01107951|Dexamethasone|dexamethasone|mesh-list
110785033|NCT01107951|Rituximab|rituximab|mesh-list
110785034|NCT01107951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110785035|NCT01107951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110785036|NCT01107951|Immunologic Factors|immunologic factors|mesh-ancestor
110785037|NCT01107951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110785038|NCT01107951|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110785039|NCT01107951|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110785040|NCT01107951|Antiemetics|antiemetics|mesh-ancestor
110785041|NCT01107951|Autonomic Agents|autonomic agents|mesh-ancestor
110785042|NCT01107951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110785043|NCT01107951|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110785044|NCT01107951|Glucocorticoids|glucocorticoids|mesh-ancestor
110785045|NCT01107951|Hormones|hormones|mesh-ancestor
110785046|NCT01107951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110785047|NCT01107951|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110785048|NCT01108029|Memantine|memantine|mesh-list
110785049|NCT01108029|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110785050|NCT01108029|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110785051|NCT01108029|Dopamine Agents|dopamine agents|mesh-ancestor
110785052|NCT01108029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110785053|NCT01108029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110785054|NCT01108029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110785055|NCT01108029|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110785056|NCT01108029|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110785057|NCT03941925|Levan|levan|mesh-list
110785058|NCT03941925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110785059|NCT01110603|Paclitaxel|paclitaxel|mesh-list
110785060|NCT01110603|Carboplatin|carboplatin|mesh-list
110785061|NCT01110603|Doxorubicin|doxorubicin|mesh-list
110785062|NCT01110603|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110785063|NCT01110603|Niraparib|niraparib|mesh-list
110785064|NCT01110603|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110785065|NCT01110603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110785066|NCT01110603|Tubulin Modulators|tubulin modulators|mesh-ancestor
110785067|NCT01110603|Antimitotic Agents|antimitotic agents|mesh-ancestor
110785068|NCT01110603|Mitosis Modulators|mitosis modulators|mesh-ancestor
110785069|NCT01110603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110785070|NCT01110603|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110785071|NCT01110603|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110785072|NCT01110603|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110785073|NCT01110603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110785074|NCT01110603|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110785075|NCT04258683|Pembrolizumab|pembrolizumab|mesh-list
110785076|NCT04258683|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110785077|NCT04258683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110785078|NCT04258683|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110785079|NCT04258683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110785080|NCT01112787|Tazarotene|tazarotene|mesh-list
110785081|NCT01112787|Dermatologic Agents|dermatologic agents|mesh-ancestor
110785082|NCT01112787|Keratolytic Agents|keratolytic agents|mesh-ancestor
110785083|NCT01108107|Capecitabine|capecitabine|mesh-list
110785084|NCT01108107|Oxaliplatin|oxaliplatin|mesh-list
110785085|NCT01108107|Panitumumab|panitumumab|mesh-list
110785086|NCT01108107|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110785087|NCT01108107|Antimetabolites|antimetabolites|mesh-ancestor
110785088|NCT01108107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110785089|NCT01108107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110785090|NCT01108107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110502729|NCT04400383|Antibodies|antibodies|mesh-list
110785091|NCT01111227|Propofol|propofol|mesh-list
110785092|NCT01111227|Isoflurane|isoflurane|mesh-list
110785093|NCT01111227|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110785094|NCT01111227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110785095|NCT01111227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110785096|NCT01111227|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110785097|NCT01111227|Anesthetics, General|anesthetics, general|mesh-ancestor
110785098|NCT01111227|Anesthetics|anesthetics|mesh-ancestor
110785099|NCT01111227|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110785100|NCT01111383|Tobramycin|tobramycin|mesh-list
110785101|NCT01111383|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110785102|NCT01111383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110785103|NCT01208649|Exenatide|exenatide|mesh-list
110785104|NCT01208649|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110785105|NCT01208649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110785106|NCT01208649|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110785107|NCT01208649|Incretins|incretins|mesh-ancestor
110785108|NCT01208649|Hormones|hormones|mesh-ancestor
110785109|NCT01208649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110785110|NCT01211847|Diazoxide|diazoxide|mesh-list
110785111|NCT01211847|Choline|choline|mesh-list
110785112|NCT01211847|Lipotropic Agents|lipotropic agents|mesh-ancestor
110785113|NCT01211847|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110785114|NCT01211847|Antimetabolites|antimetabolites|mesh-ancestor
110785115|NCT01211847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110785116|NCT01211847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110785117|NCT01211847|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110785118|NCT01211847|Nootropic Agents|nootropic agents|mesh-ancestor
110785119|NCT01211847|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110785120|NCT01211847|Vasodilator Agents|vasodilator agents|mesh-ancestor
110785121|NCT01210287|Lamivudine|lamivudine|mesh-list
110785122|NCT01210287|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
110785123|NCT01210287|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110785124|NCT01210287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110785125|NCT01210287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110785126|NCT01210287|Antiviral Agents|antiviral agents|mesh-ancestor
110785127|NCT01210287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110495885|NCT00774241|Bevacizumab|bevacizumab|mesh-list
110785128|NCT01210287|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110785129|NCT01210287|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110785130|NCT01211925|Aspirin|aspirin|mesh-list
110785131|NCT01211925|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110785132|NCT01211925|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110785133|NCT01211925|Analgesics|analgesics|mesh-ancestor
110785134|NCT01211925|Sensory System Agents|sensory system agents|mesh-ancestor
110785135|NCT01211925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110785136|NCT01211925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110785137|NCT01211925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110785138|NCT01211925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110785139|NCT01211925|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110785140|NCT01211925|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110785141|NCT01211925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110785142|NCT01211925|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110785143|NCT01211925|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110785144|NCT01211925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110785145|NCT01211925|Antipyretics|antipyretics|mesh-ancestor
110785146|NCT01114425|Raltegravir Potassium|raltegravir potassium|mesh-list
110785147|NCT01114425|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110785148|NCT01114425|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110785149|NCT01114425|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110785150|NCT01114425|Antiviral Agents|antiviral agents|mesh-ancestor
110785151|NCT01114425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110785152|NCT01114425|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110785153|NCT01114425|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110785154|NCT01114425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110785155|NCT01114425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110785156|NCT01114425|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110785157|NCT01114425|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110785158|NCT01328145|Aspirin|aspirin|mesh-list
110785159|NCT01328145|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110785160|NCT01328145|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110785161|NCT01328145|Analgesics|analgesics|mesh-ancestor
110785162|NCT01328145|Sensory System Agents|sensory system agents|mesh-ancestor
110785163|NCT01328145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110785164|NCT01328145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110785165|NCT01328145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110495931|NCT02634021|Midazolam|midazolam|mesh-list
110785166|NCT01328145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110785167|NCT01328145|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110785168|NCT01328145|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110785169|NCT01328145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110785170|NCT01328145|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110785171|NCT01328145|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110785172|NCT01328145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110785173|NCT01328145|Antipyretics|antipyretics|mesh-ancestor
110785174|NCT01210521|Vitamin D|vitamin d|mesh-list
110785175|NCT01210521|Vitamins|vitamins|mesh-ancestor
110785176|NCT01210521|Micronutrients|micronutrients|mesh-ancestor
110785177|NCT01210521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110785178|NCT01210521|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110785179|NCT01210599|Pamidronate|pamidronate|mesh-list
110785180|NCT01210599|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110785181|NCT01210599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110785182|NCT03944889|Capsaicin|capsaicin|mesh-list
110785183|NCT03944889|Antipruritics|antipruritics|mesh-ancestor
110785184|NCT03944889|Dermatologic Agents|dermatologic agents|mesh-ancestor
110785185|NCT03944889|Sensory System Agents|sensory system agents|mesh-ancestor
110785186|NCT03944889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110785187|NCT03944889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110785189|NCT01210677|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110785190|NCT01210677|Glucocorticoids|glucocorticoids|mesh-ancestor
110785191|NCT01210677|Hormones|hormones|mesh-ancestor
110785192|NCT01210677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110785193|NCT01210677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110785194|NCT01210677|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110785195|NCT01210677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110785196|NCT01210755|Rivaroxaban|rivaroxaban|mesh-list
110785197|NCT01210755|Dabigatran|dabigatran|mesh-list
110785198|NCT01210755|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110785199|NCT01210755|Antithrombins|antithrombins|mesh-ancestor
110785200|NCT01210755|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110785201|NCT01210755|Protease Inhibitors|protease inhibitors|mesh-ancestor
110785202|NCT01210755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110785203|NCT01210755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110785204|NCT01210755|Anticoagulants|anticoagulants|mesh-ancestor
110785205|NCT01210911|Metformin|metformin|mesh-list
110785206|NCT01210911|Gemcitabine|gemcitabine|mesh-list
110785207|NCT01210911|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110785208|NCT01210911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110785209|NCT01210911|Antimetabolites|antimetabolites|mesh-ancestor
110785210|NCT01210911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110785211|NCT01210911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110785212|NCT01210911|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110785213|NCT01210911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110785214|NCT01210911|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110785215|NCT01210911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110785216|NCT01115049|Chlorhexidine|chlorhexidine|mesh-list
110785217|NCT01115049|Hexetidine|hexetidine|mesh-list
110785218|NCT01115049|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110785219|NCT01115049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110785220|NCT01115049|Disinfectants|disinfectants|mesh-ancestor
110785221|NCT01115049|Antifungal Agents|antifungal agents|mesh-ancestor
110785222|NCT03941535|Vitamin K|vitamin k|mesh-list
110785223|NCT03941535|Vitamins|vitamins|mesh-ancestor
110785224|NCT03941535|Micronutrients|micronutrients|mesh-ancestor
110785225|NCT03941535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110785226|NCT03941535|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110785227|NCT03941535|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110785228|NCT03941535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110785229|NCT03941535|Hemostatics|hemostatics|mesh-ancestor
110785230|NCT03941535|Coagulants|coagulants|mesh-ancestor
110785231|NCT01115127|Inositol|inositol|mesh-list
110785232|NCT01115127|Melatonin|melatonin|mesh-list
110785233|NCT01115127|Antioxidants|antioxidants|mesh-ancestor
110785234|NCT01115127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110785235|NCT01115127|Protective Agents|protective agents|mesh-ancestor
110785236|NCT01115127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110785237|NCT01115127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110785238|NCT01115127|Vitamin B Complex|vitamin b complex|mesh-ancestor
110785239|NCT01115127|Vitamins|vitamins|mesh-ancestor
110785240|NCT01115127|Micronutrients|micronutrients|mesh-ancestor
110785241|NCT01211223|Amoxicillin|amoxicillin|mesh-list
110785242|NCT01211223|Metronidazole|metronidazole|mesh-list
110785243|NCT01211223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110785244|NCT01211223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110785245|NCT01211223|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110785246|NCT01211223|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110785248|NCT01113489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110785249|NCT01113489|Glucocorticoids|glucocorticoids|mesh-ancestor
110785250|NCT01113489|Hormones|hormones|mesh-ancestor
110785251|NCT01113489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110785252|NCT01113489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110785253|NCT01113489|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110785254|NCT01113489|Respiratory System Agents|respiratory system agents|mesh-ancestor
110785255|NCT01115439|Artesunate|artesunate|mesh-list
110785256|NCT01115439|Pyrimethamine|pyrimethamine|mesh-list
110785257|NCT01115439|Sulfadoxine|sulfadoxine|mesh-list
110785258|NCT01115439|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
110785259|NCT01115439|Antimalarials|antimalarials|mesh-ancestor
110785260|NCT01115439|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110785261|NCT01115439|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110785262|NCT01115439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110785263|NCT01115439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110785264|NCT01115439|Antiviral Agents|antiviral agents|mesh-ancestor
110785265|NCT01115439|Schistosomicides|schistosomicides|mesh-ancestor
110785266|NCT01115439|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110785267|NCT01115439|Anthelmintics|anthelmintics|mesh-ancestor
110785268|NCT01115439|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110785269|NCT01115439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110785270|NCT01115439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110785271|NCT01115439|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110785272|NCT01212315|Triclosan|triclosan|mesh-list
110496035|NCT00607178|Vaccines|vaccines|mesh-list
110785273|NCT01212315|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110785274|NCT01212315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110785275|NCT01212315|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
110785276|NCT01212315|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110785277|NCT01212315|Antimetabolites|antimetabolites|mesh-ancestor
110785278|NCT01212315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110785279|NCT01212315|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110785280|NCT03938259|Fentanyl|fentanyl|mesh-list
110785281|NCT03938259|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110785282|NCT03938259|Narcotics|narcotics|mesh-ancestor
110785283|NCT03938259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110785284|NCT03938259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110785285|NCT03938259|Analgesics|analgesics|mesh-ancestor
110785286|NCT03938259|Sensory System Agents|sensory system agents|mesh-ancestor
110785287|NCT03938259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110785288|NCT03938259|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110785289|NCT03938259|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110785290|NCT03938259|Anesthetics, General|anesthetics, general|mesh-ancestor
110785291|NCT03938259|Anesthetics|anesthetics|mesh-ancestor
110785292|NCT03939663|Misoprostol|misoprostol|mesh-list
110785293|NCT03939663|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110785294|NCT03939663|Abortifacient Agents|abortifacient agents|mesh-ancestor
110785295|NCT03939663|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110785296|NCT03939663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110785297|NCT03939663|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110785298|NCT03939663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110785299|NCT03939663|Oxytocics|oxytocics|mesh-ancestor
110785300|NCT01213407|Temozolomide|temozolomide|mesh-list
110785301|NCT01213407|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110785302|NCT01213407|Alkylating Agents|alkylating agents|mesh-ancestor
110785303|NCT01213407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110785304|NCT01213407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110785305|NCT01211457|Decitabine|decitabine|mesh-list
110785306|NCT01211457|Venetoclax|venetoclax|mesh-list
110785307|NCT01211457|Sapacitabine|sapacitabine|mesh-list
110785308|NCT01211457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110785309|NCT01211457|Antimetabolites|antimetabolites|mesh-ancestor
110785310|NCT01211457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110785311|NCT01211457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110785312|NCT01211457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110785313|NCT01213563|Insulin|insulin|mesh-list
110785314|NCT01213563|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110785315|NCT01213563|Insulin, neutral|insulin, neutral|mesh-list
110785316|NCT01213563|Insulin, Regular, Pork|insulin, regular, pork|mesh-list
110785317|NCT01213563|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110785318|NCT01213563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110785319|NCT01115985|Atorvastatin|atorvastatin|mesh-list
110785320|NCT01115985|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110785321|NCT01115985|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110785322|NCT01115985|Antimetabolites|antimetabolites|mesh-ancestor
110785323|NCT01115985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110785324|NCT01115985|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110785325|NCT01115985|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110785326|NCT01115985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110785327|NCT01116063|Iloprost|iloprost|mesh-list
110785328|NCT01116063|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110785329|NCT01116063|Vasodilator Agents|vasodilator agents|mesh-ancestor
110785330|NCT01116219|Bevacizumab|bevacizumab|mesh-list
110785331|NCT01116219|Pemetrexed|pemetrexed|mesh-list
110785332|NCT01116219|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110785333|NCT01116219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110785334|NCT01116219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110785335|NCT01116219|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110785336|NCT01116219|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110785337|NCT01116219|Growth Substances|growth substances|mesh-ancestor
110785338|NCT01116219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110785339|NCT01116219|Growth Inhibitors|growth inhibitors|mesh-ancestor
110785340|NCT01116219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110785341|NCT01116219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110785342|NCT01116219|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110785343|NCT01116219|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110785344|NCT01116219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110785345|NCT01213719|Betaine|betaine|mesh-list
110785346|NCT01213719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110785347|NCT01213719|Lipotropic Agents|lipotropic agents|mesh-ancestor
110785348|NCT01213719|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110785349|NCT01213719|Antimetabolites|antimetabolites|mesh-ancestor
110645438|NCT05248919|Sofosbuvir|sofosbuvir|mesh-list
110785350|NCT01213719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110785351|NCT01213719|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110785352|NCT01114191|Ketoconazole|ketoconazole|mesh-list
110785353|NCT01114191|Antifungal Agents|antifungal agents|mesh-ancestor
110785354|NCT01114191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110785355|NCT01114191|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110785356|NCT01114191|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110785357|NCT01114191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110785358|NCT01114191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110785359|NCT01114191|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110785360|NCT01114191|Hormone Antagonists|hormone antagonists|mesh-ancestor
110785361|NCT01114191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110785362|NCT01114191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110785363|NCT01114191|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110785364|NCT01211691|Antibodies|antibodies|mesh-list
110785365|NCT01211691|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110785366|NCT01211691|Immunologic Factors|immunologic factors|mesh-ancestor
110785367|NCT01211691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110785368|NCT03937869|Secnidazole|secnidazole|mesh-list
110785369|NCT03937869|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110785370|NCT03937869|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110785371|NCT03937869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110785372|NCT01116531|Pregabalin|pregabalin|mesh-list
110785373|NCT01116531|Tramadol|tramadol|mesh-list
110785374|NCT01116531|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110785375|NCT01116531|Analgesics|analgesics|mesh-ancestor
110785376|NCT01116531|Sensory System Agents|sensory system agents|mesh-ancestor
110785377|NCT01116531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110785378|NCT01116531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110785379|NCT01116531|Anticonvulsants|anticonvulsants|mesh-ancestor
110785380|NCT01116531|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110785381|NCT01116531|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110785382|NCT01116531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110785383|NCT01116531|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110785384|NCT01116531|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110785385|NCT01116531|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110785386|NCT01116531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110785387|NCT01116531|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110785388|NCT01116531|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110785389|NCT01116531|Narcotics|narcotics|mesh-ancestor
110785390|NCT01116531|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110785391|NCT01116531|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110785392|NCT01116531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110785393|NCT01116531|Antidepressive Agents|antidepressive agents|mesh-ancestor
110785394|NCT01116531|Dopamine Agents|dopamine agents|mesh-ancestor
110785395|NCT03939975|Pembrolizumab|pembrolizumab|mesh-list
110785396|NCT03939975|Nivolumab|nivolumab|mesh-list
110785397|NCT03939975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110785398|NCT03939975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110785399|NCT03939975|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110785400|NCT03939975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110785401|NCT01116609|Epinephrine|epinephrine|mesh-list
110785402|NCT01116609|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110785403|NCT01116609|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110785404|NCT01116609|Adrenergic Agents|adrenergic agents|mesh-ancestor
110785405|NCT01116609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110785406|NCT01116609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110785407|NCT01116609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110785408|NCT01116609|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110785409|NCT01116609|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110785410|NCT01116609|Autonomic Agents|autonomic agents|mesh-ancestor
110785411|NCT01116609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110785412|NCT01116609|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110785413|NCT01116609|Respiratory System Agents|respiratory system agents|mesh-ancestor
110785414|NCT01116609|Mydriatics|mydriatics|mesh-ancestor
110785415|NCT01116609|Sympathomimetics|sympathomimetics|mesh-ancestor
110785416|NCT01116609|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110785417|NCT01118403|Ampicillin|ampicillin|mesh-list
110785418|NCT01118403|Sulbactam|sulbactam|mesh-list
110785419|NCT01118403|Sultamicillin|sultamicillin|mesh-list
110785420|NCT01118403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110785421|NCT01118403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110785422|NCT01118403|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110785423|NCT01118403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110785424|NCT01118403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110785425|NCT01121835|Insulin|insulin|mesh-list
110785426|NCT01121835|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110785427|NCT01121835|Insulin Glargine|insulin glargine|mesh-list
110785428|NCT01121835|Insulin glulisine|insulin glulisine|mesh-list
110785429|NCT01121835|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110785430|NCT01121835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110785431|NCT03788967|Ertapenem|ertapenem|mesh-list
110785432|NCT03788967|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110785433|NCT03788967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110785434|NCT01118559|Darexaban|darexaban|mesh-list
110785435|NCT01118559|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110785436|NCT01118559|Antithrombins|antithrombins|mesh-ancestor
110785437|NCT01118559|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110785438|NCT01118559|Protease Inhibitors|protease inhibitors|mesh-ancestor
110785439|NCT01118559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110785440|NCT01118559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110785441|NCT01118559|Anticoagulants|anticoagulants|mesh-ancestor
110785442|NCT01216293|Esomeprazole|esomeprazole|mesh-list
110785443|NCT01216293|Dexlansoprazole|dexlansoprazole|mesh-list
110785444|NCT01216293|Lansoprazole|lansoprazole|mesh-list
110785445|NCT01216293|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110785446|NCT01216293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110785447|NCT01216293|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110785448|NCT01216293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110785449|NCT01216293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110785450|NCT01216371|Sunitinib|sunitinib|mesh-list
110785451|NCT01216371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110785452|NCT01216371|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110785453|NCT01216371|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110785454|NCT01216371|Growth Substances|growth substances|mesh-ancestor
110785455|NCT01216371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110785456|NCT01216371|Growth Inhibitors|growth inhibitors|mesh-ancestor
110785457|NCT01216371|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110785458|NCT01216371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110785459|NCT01216371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110785460|NCT01118871|Ritonavir|ritonavir|mesh-list
110785461|NCT01118871|Darunavir|darunavir|mesh-list
110785462|NCT01118871|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110785463|NCT01118871|Etravirine|etravirine|mesh-list
110785464|NCT01118871|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110785465|NCT01118871|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110785466|NCT01118871|Protease Inhibitors|protease inhibitors|mesh-ancestor
110785467|NCT01118871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110785468|NCT01118871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110785469|NCT01118871|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110785470|NCT01118871|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110785471|NCT01118871|Antiviral Agents|antiviral agents|mesh-ancestor
110785472|NCT01118871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110785473|NCT01118871|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110785474|NCT01118871|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110785475|NCT01118871|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110785476|NCT01118871|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110785477|NCT01216449|Citalopram|citalopram|mesh-list
110785478|NCT01216449|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110785479|NCT01216449|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110785480|NCT01216449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110785481|NCT01216449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110785482|NCT01216449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110785483|NCT01216449|Serotonin Agents|serotonin agents|mesh-ancestor
110785484|NCT01216449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110785485|NCT01216449|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110785486|NCT01216449|Antidepressive Agents|antidepressive agents|mesh-ancestor
110785487|NCT01216449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110785488|NCT03937401|Oxytocin|oxytocin|mesh-list
110785489|NCT03937401|Oxytocics|oxytocics|mesh-ancestor
110785490|NCT03937401|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110785491|NCT03937401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110785492|NCT03939273|Metronidazole|metronidazole|mesh-list
110785493|NCT03939273|Vancomycin|vancomycin|mesh-list
110785494|NCT03939273|Ciprofloxacin|ciprofloxacin|mesh-list
110785495|NCT03939273|Fluconazole|fluconazole|mesh-list
110785496|NCT03939273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110785497|NCT03939273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110785498|NCT03939273|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110785499|NCT03939273|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110785500|NCT03939273|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110785501|NCT03939273|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110785502|NCT03939273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110785503|NCT03939273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110785504|NCT03939273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110785505|NCT03939273|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110785506|NCT03939273|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110785507|NCT03939273|Antifungal Agents|antifungal agents|mesh-ancestor
110785508|NCT03939273|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110785509|NCT03939273|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110785510|NCT03939273|Hormone Antagonists|hormone antagonists|mesh-ancestor
110785511|NCT03939273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110785512|NCT03939273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110785513|NCT03939273|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110785514|NCT03939273|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110785515|NCT01213017|Certolizumab Pegol|certolizumab pegol|mesh-list
110785516|NCT01213017|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110785517|NCT01213017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110785518|NCT01213017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110785519|NCT01213017|Immunologic Factors|immunologic factors|mesh-ancestor
110785520|NCT01213017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110785521|NCT01213017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110785522|NCT01119417|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
110785523|NCT01119417|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110785524|NCT01119417|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
110785525|NCT01119417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110785526|NCT01216605|Oxytocin|oxytocin|mesh-list
110785527|NCT01216605|Oxytocics|oxytocics|mesh-ancestor
110785528|NCT01216605|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110785529|NCT01216605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110785530|NCT01213095|Rituximab|rituximab|mesh-list
110785531|NCT01213095|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110785532|NCT01213095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110785533|NCT01213095|Immunologic Factors|immunologic factors|mesh-ancestor
110785534|NCT01213095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110785535|NCT01213095|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110785536|NCT03938883|Hyaluronic Acid|hyaluronic acid|mesh-list
110785537|NCT03938883|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110785538|NCT03938883|Immunologic Factors|immunologic factors|mesh-ancestor
110785539|NCT03938883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110785540|NCT03938883|Viscosupplements|viscosupplements|mesh-ancestor
110785541|NCT03938883|Protective Agents|protective agents|mesh-ancestor
110785542|NCT01216839|Everolimus|everolimus|mesh-list
110785543|NCT01216839|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110785544|NCT01216839|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110785545|NCT01216839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110785546|NCT01216839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110785547|NCT01216839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110785548|NCT01216839|Immunologic Factors|immunologic factors|mesh-ancestor
110785549|NCT01216839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110785550|NCT01216839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110785551|NCT01119651|Tazarotene|tazarotene|mesh-list
110785552|NCT01119651|Dermatologic Agents|dermatologic agents|mesh-ancestor
110785553|NCT01119651|Keratolytic Agents|keratolytic agents|mesh-ancestor
110785554|NCT03971877|Polymyxins|polymyxins|mesh-list
110785555|NCT03971877|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110785556|NCT03971877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110785557|NCT01328925|Nitazoxanide|nitazoxanide|mesh-list
110785558|NCT01328925|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110785559|NCT01328925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110785560|NCT01119885|Fentanyl|fentanyl|mesh-list
110785561|NCT01119885|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110785562|NCT01119885|Narcotics|narcotics|mesh-ancestor
110785563|NCT01119885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110785564|NCT01119885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110785565|NCT01119885|Analgesics|analgesics|mesh-ancestor
110785566|NCT01119885|Sensory System Agents|sensory system agents|mesh-ancestor
110785567|NCT01119885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110785568|NCT01119885|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110785569|NCT01119885|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110785570|NCT01119885|Anesthetics, General|anesthetics, general|mesh-ancestor
110785571|NCT01119885|Anesthetics|anesthetics|mesh-ancestor
110785572|NCT03935217|Secnidazole|secnidazole|mesh-list
110785573|NCT03935217|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110785574|NCT03935217|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110785575|NCT03935217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110785576|NCT01219023|Sildenafil Citrate|sildenafil citrate|mesh-list
110785577|NCT01219023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110785578|NCT01219023|Vasodilator Agents|vasodilator agents|mesh-ancestor
110785579|NCT01219023|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110785580|NCT01219023|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110785581|NCT01219023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110785582|NCT01219023|Urological Agents|urological agents|mesh-ancestor
110785583|NCT01124487|Insulin|insulin|mesh-list
110785584|NCT01124487|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110785585|NCT01124487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110785586|NCT01120119|Calcitriol|calcitriol|mesh-list
110785587|NCT01120119|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110785588|NCT01120119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110785589|NCT01120119|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
110785590|NCT01120119|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110785591|NCT01120119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110785592|NCT01120119|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110785594|NCT01120119|Micronutrients|micronutrients|mesh-ancestor
110785595|NCT01120119|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110785596|NCT01219101|Citric Acid|citric acid|mesh-list
110785597|NCT01219101|Sodium Citrate|sodium citrate|mesh-list
110785598|NCT01219101|Clomiphene|clomiphene|mesh-list
110785599|NCT01219101|Enclomiphene|enclomiphene|mesh-list
110785600|NCT01219101|Zuclomiphene|zuclomiphene|mesh-list
110785601|NCT01219101|Anticoagulants|anticoagulants|mesh-ancestor
110785602|NCT01219101|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110785603|NCT01219101|Chelating Agents|chelating agents|mesh-ancestor
110785604|NCT01219101|Sequestering Agents|sequestering agents|mesh-ancestor
110785605|NCT01219101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110785606|NCT01219101|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110785607|NCT01219101|Hormone Antagonists|hormone antagonists|mesh-ancestor
110785608|NCT01219101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110785609|NCT01219101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110785610|NCT01219101|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110785611|NCT01219101|Fertility Agents|fertility agents|mesh-ancestor
110496453|NCT00785551|Quinine|quinine|mesh-list
110785612|NCT01219101|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110785613|NCT01219101|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110785614|NCT01219101|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110785615|NCT01217619|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110785616|NCT01217619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110785617|NCT01217619|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110785618|NCT01217619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110785619|NCT01217619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110785620|NCT01122615|Sirolimus|sirolimus|mesh-list
110785621|NCT01122615|Sunitinib|sunitinib|mesh-list
110785622|NCT01122615|Temsirolimus|temsirolimus|mesh-list
110785623|NCT01122615|MTOR Inhibitors|mtor inhibitors|mesh-list
110785624|NCT01122615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110785625|NCT01122615|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110785626|NCT01122615|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110785627|NCT01122615|Growth Substances|growth substances|mesh-ancestor
110785628|NCT01122615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110785629|NCT01122615|Growth Inhibitors|growth inhibitors|mesh-ancestor
110785630|NCT01122615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110785631|NCT01122615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110785632|NCT01122615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110785633|NCT01122615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110785634|NCT01122615|Immunologic Factors|immunologic factors|mesh-ancestor
110785635|NCT01122615|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110785636|NCT01122615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110785637|NCT01122615|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110785638|NCT01122615|Antifungal Agents|antifungal agents|mesh-ancestor
110785639|NCT01217697|Prednisone|prednisone|mesh-list
110785640|NCT01217697|Prednisolone|prednisolone|mesh-list
110785641|NCT01217697|Abiraterone Acetate|abiraterone acetate|mesh-list
110785642|NCT01217697|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110785643|NCT01217697|Glucocorticoids|glucocorticoids|mesh-ancestor
110785644|NCT01217697|Hormones|hormones|mesh-ancestor
110785645|NCT01217697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110785646|NCT01217697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110785647|NCT01217697|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110785648|NCT01217697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110785649|NCT01217697|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110785650|NCT01217697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110785651|NCT01217697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110785652|NCT01217697|Hormone Antagonists|hormone antagonists|mesh-ancestor
110785653|NCT01217697|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110785654|NCT01214343|Sorafenib|sorafenib|mesh-list
110785655|NCT01214343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110785656|NCT01214343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110785657|NCT01214343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110785658|NCT01214343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110850609|NCT01345682|Methotrexate|methotrexate|mesh-list
110785659|NCT01120431|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110785660|NCT01124799|Ciprofloxacin|ciprofloxacin|mesh-list
110785661|NCT01124799|Simeprevir|simeprevir|mesh-list
110785662|NCT01124799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110785663|NCT01124799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110785664|NCT01124799|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110496561|NCT00663741|Sorafenib|sorafenib|mesh-list
110785665|NCT01124799|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110785666|NCT01124799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110785667|NCT01124799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110785668|NCT01124799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110785669|NCT01124799|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110785670|NCT01124799|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110785671|NCT01124799|Antiviral Agents|antiviral agents|mesh-ancestor
110785672|NCT01124799|Protease Inhibitors|protease inhibitors|mesh-ancestor
110785673|NCT01124877|Ziprasidone|ziprasidone|mesh-list
110785674|NCT01124877|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110785675|NCT01124877|Serotonin Agents|serotonin agents|mesh-ancestor
110785676|NCT01124877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110785677|NCT01124877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110785678|NCT01124877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110785679|NCT01124877|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110785680|NCT01124877|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110785681|NCT01124877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110785682|NCT01124877|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110785683|NCT01124877|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110785684|NCT01124877|Dopamine Agents|dopamine agents|mesh-ancestor
110785685|NCT01219413|Perindopril|perindopril|mesh-list
110785686|NCT01219413|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110785687|NCT01219413|Protease Inhibitors|protease inhibitors|mesh-ancestor
110785688|NCT01219413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110785689|NCT01219413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110785690|NCT01219413|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110785691|NCT03783039|Cellulose, Oxidized|cellulose, oxidized|mesh-list
110785692|NCT03783039|Hemostatics|hemostatics|mesh-ancestor
110785693|NCT03783039|Coagulants|coagulants|mesh-ancestor
110785694|NCT03933501|Amoxicillin|amoxicillin|mesh-list
110785695|NCT03933501|Metronidazole|metronidazole|mesh-list
110785696|NCT03933501|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110143866|NCT02028026|Citalopram|citalopram|mesh-list
110785697|NCT03933501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110785698|NCT03933501|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110785699|NCT03933501|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110785700|NCT01122771|Amphotericin B|amphotericin b|mesh-list
110785701|NCT01122771|Paromomycin|paromomycin|mesh-list
110785702|NCT01122771|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
110785703|NCT01122771|Miltefosine|miltefosine|mesh-list
110785704|NCT01122771|Amebicides|amebicides|mesh-ancestor
110785705|NCT01122771|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110785706|NCT01122771|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110785707|NCT01122771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110785708|NCT01122771|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110785709|NCT01122771|Antifungal Agents|antifungal agents|mesh-ancestor
110785710|NCT01122771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110785712|NCT01125033|Ascorbic Acid|ascorbic acid|mesh-list
110785713|NCT01125033|Vitamin E|vitamin e|mesh-list
110785714|NCT01125033|Tocopherols|tocopherols|mesh-list
110785716|NCT01125033|alpha-Tocopherol|alpha-tocopherol|mesh-list
110785717|NCT01125033|Micronutrients|micronutrients|mesh-ancestor
110785718|NCT01125033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110785719|NCT01125033|Antioxidants|antioxidants|mesh-ancestor
110785720|NCT01125033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110785721|NCT01125033|Protective Agents|protective agents|mesh-ancestor
110785722|NCT01120665|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110785723|NCT01120665|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110785724|NCT01120665|Estradiol|estradiol|mesh-list
110785725|NCT01120665|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110785726|NCT01120665|Hormones|hormones|mesh-ancestor
110785727|NCT01120665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110785728|NCT01120665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110785729|NCT01120665|Estrogens|estrogens|mesh-ancestor
110785730|NCT01120665|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110785731|NCT01120665|Contraceptive Agents|contraceptive agents|mesh-ancestor
110785732|NCT01120665|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110785733|NCT01120665|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110785734|NCT01120821|Imatinib Mesylate|imatinib mesylate|mesh-list
110785735|NCT01120821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110785736|NCT01120821|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110785737|NCT01120821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110785738|NCT01120821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110785739|NCT01125423|Milnacipran|milnacipran|mesh-list
110785740|NCT01125423|Levomilnacipran|levomilnacipran|mesh-list
110785741|NCT01125423|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110785742|NCT01125423|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110785743|NCT01125423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110785744|NCT01125423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110785745|NCT01125423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110785746|NCT01125423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110785747|NCT01125423|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110785748|NCT01125423|Analgesics|analgesics|mesh-ancestor
110785749|NCT01125423|Sensory System Agents|sensory system agents|mesh-ancestor
110785750|NCT01125423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110785751|NCT01125423|Antidepressive Agents|antidepressive agents|mesh-ancestor
110785752|NCT01125423|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110785754|NCT01219569|Sevoflurane|sevoflurane|mesh-list
110785755|NCT01219569|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110785756|NCT01219569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110785757|NCT01219569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110785758|NCT01219569|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110785759|NCT01219569|Anesthetics, General|anesthetics, general|mesh-ancestor
110785760|NCT01219569|Anesthetics|anesthetics|mesh-ancestor
110785761|NCT01219569|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110785762|NCT01219569|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110785763|NCT03933345|Naloxone|naloxone|mesh-list
110785764|NCT03933345|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110785765|NCT03933345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110785766|NCT03933345|Sensory System Agents|sensory system agents|mesh-ancestor
110785767|NCT03933345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110785768|NCT01121055|Lorazepam|lorazepam|mesh-list
110785769|NCT01121055|Anticonvulsants|anticonvulsants|mesh-ancestor
110785770|NCT01121055|Antiemetics|antiemetics|mesh-ancestor
110785771|NCT01121055|Autonomic Agents|autonomic agents|mesh-ancestor
110785772|NCT01121055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110785773|NCT01121055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110785774|NCT01121055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110785775|NCT01121055|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110785776|NCT01121055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110785777|NCT01121055|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110785778|NCT01121055|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110785779|NCT01121055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110785781|NCT01121055|GABA Agents|gaba agents|mesh-ancestor
110785782|NCT01121055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110785783|NCT01121055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110785784|NCT01121133|Rifampin|rifampin|mesh-list
110785785|NCT01121133|Navitoclax|navitoclax|mesh-list
110785786|NCT01121133|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110785787|NCT01121133|Antitubercular Agents|antitubercular agents|mesh-ancestor
110785788|NCT01121133|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110785789|NCT01121133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110785790|NCT01121133|Leprostatic Agents|leprostatic agents|mesh-ancestor
110785791|NCT01121133|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110785792|NCT01121133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110785793|NCT01121133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110785794|NCT01121133|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110785795|NCT01121133|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110785796|NCT01121133|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110785797|NCT01121133|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110785798|NCT01121133|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110785799|NCT01121133|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110785800|NCT01121133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110785801|NCT01218321|Anticonvulsants|anticonvulsants|mesh-list
110785802|NCT01214889|Vaccines|vaccines|mesh-list
110785803|NCT01214889|Immunologic Factors|immunologic factors|mesh-ancestor
110785804|NCT01214889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110785805|NCT01123317|Oxytocin|oxytocin|mesh-list
110785806|NCT01123317|Oxytocics|oxytocics|mesh-ancestor
110785807|NCT01123317|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110785808|NCT01123317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110785809|NCT01121289|Insulin Aspart|insulin aspart|mesh-list
110785810|NCT01121289|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110785811|NCT01121289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110785812|NCT01123473|Fluorouracil|fluorouracil|mesh-list
110785813|NCT01123473|Capecitabine|capecitabine|mesh-list
110785814|NCT01123473|Epirubicin|epirubicin|mesh-list
110785815|NCT01123473|Lapatinib|lapatinib|mesh-list
110785816|NCT01123473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110785817|NCT01123473|Antimetabolites|antimetabolites|mesh-ancestor
110785818|NCT01123473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110785819|NCT01123473|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110785820|NCT01123473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110785821|NCT01123473|Immunologic Factors|immunologic factors|mesh-ancestor
110785822|NCT01123473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110785823|NCT01123473|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110785824|NCT01123473|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110785825|NCT01123473|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110785826|NCT01123473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110785827|NCT01123473|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110785828|NCT01123551|Morphine|morphine|mesh-list
110785829|NCT01123551|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110785830|NCT01123551|Narcotics|narcotics|mesh-ancestor
110785831|NCT01123551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110785832|NCT01123551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110785833|NCT01123551|Analgesics|analgesics|mesh-ancestor
110785834|NCT01123551|Sensory System Agents|sensory system agents|mesh-ancestor
110785835|NCT01123551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110785836|NCT01125657|Darexaban|darexaban|mesh-list
110785837|NCT01125657|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110785838|NCT01125657|Antithrombins|antithrombins|mesh-ancestor
110785839|NCT01125657|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110785840|NCT01125657|Protease Inhibitors|protease inhibitors|mesh-ancestor
110785841|NCT01125657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110850625|NCT01345682|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110496692|NCT00671151|Autonomic Agents|autonomic agents|mesh-ancestor
110785842|NCT01125657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110785843|NCT01125657|Anticoagulants|anticoagulants|mesh-ancestor
110785844|NCT03934203|Moxifloxacin|moxifloxacin|mesh-list
110785845|NCT03934203|BI 409306|bi 409306|mesh-list
110785846|NCT03934203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110785847|NCT03934203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110785848|NCT03934203|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110785849|NCT03934203|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110785850|NCT03934203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110785851|NCT03934203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110785853|NCT03934203|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110785854|NCT03934047|Tranexamic Acid|tranexamic acid|mesh-list
110785855|NCT03934047|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110785856|NCT03934047|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110785857|NCT03934047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110785858|NCT03934047|Hemostatics|hemostatics|mesh-ancestor
110785859|NCT03934047|Coagulants|coagulants|mesh-ancestor
110785860|NCT01218711|Losartan|losartan|mesh-list
110785861|NCT01218711|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110785862|NCT01218711|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110785863|NCT01218711|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110785864|NCT01218711|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110785865|NCT01218711|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110785866|NCT01218711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110785867|NCT01218711|Diuretics|diuretics|mesh-ancestor
110785868|NCT01218711|Natriuretic Agents|natriuretic agents|mesh-ancestor
110785869|NCT01218711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110785870|NCT01218711|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110785871|NCT01218711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110785872|NCT01125891|Gemcitabine|gemcitabine|mesh-list
110785873|NCT01125891|ON 01910|on 01910|mesh-list
110785874|NCT01125891|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110785875|NCT01125891|Antimetabolites|antimetabolites|mesh-ancestor
110785876|NCT01125891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110785877|NCT01125891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110785878|NCT01125891|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110785879|NCT01125891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110785880|NCT01124253|Endostatins|endostatins|mesh-list
110785881|NCT01124253|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110785882|NCT01124253|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110785883|NCT01124253|Growth Substances|growth substances|mesh-ancestor
110785884|NCT01124253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110785885|NCT01124253|Growth Inhibitors|growth inhibitors|mesh-ancestor
110785886|NCT01124253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110785887|NCT01215669|Vaccines|vaccines|mesh-list
110785888|NCT01215669|Immunologic Factors|immunologic factors|mesh-ancestor
110785889|NCT01215669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110785890|NCT01222221|Temozolomide|temozolomide|mesh-list
110785891|NCT01222221|Sargramostim|sargramostim|mesh-list
110785892|NCT01222221|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110785893|NCT01222221|Alkylating Agents|alkylating agents|mesh-ancestor
110785894|NCT01222221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110785895|NCT01222221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110785896|NCT01222221|Immunologic Factors|immunologic factors|mesh-ancestor
110785897|NCT01222221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110785898|NCT01220661|Cefotetan|cefotetan|mesh-list
110785899|NCT01220661|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110785900|NCT01220661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110785901|NCT02903914|Pembrolizumab|pembrolizumab|mesh-list
110785902|NCT02903914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110785903|NCT02903914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110785904|NCT02903914|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110785905|NCT02903914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110785906|NCT01222611|Fosamprenavir|fosamprenavir|mesh-list
110785907|NCT01222611|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110785908|NCT01222611|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110785909|NCT01222611|Protease Inhibitors|protease inhibitors|mesh-ancestor
110785910|NCT01222611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110850640|NCT02503462|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110785911|NCT01222611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110785913|NCT01222611|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110785914|NCT01222611|Antiviral Agents|antiviral agents|mesh-ancestor
110785915|NCT01222611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110785916|NCT03928353|Ticagrelor|ticagrelor|mesh-list
110785917|NCT03928353|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110785918|NCT03928353|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110785919|NCT03928353|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110785920|NCT03928353|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110785921|NCT03928353|Purinergic Agents|purinergic agents|mesh-ancestor
110503545|NCT00902174|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110785922|NCT03928353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110785923|NCT03928353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110785924|NCT03928353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110785925|NCT03931863|Ondansetron|ondansetron|mesh-list
110785926|NCT03931863|Antiemetics|antiemetics|mesh-ancestor
110785927|NCT03931863|Autonomic Agents|autonomic agents|mesh-ancestor
110785928|NCT03931863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110785929|NCT03931863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110785930|NCT03931863|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110785931|NCT03931863|Antipruritics|antipruritics|mesh-ancestor
110785932|NCT03931863|Dermatologic Agents|dermatologic agents|mesh-ancestor
110785933|NCT03931863|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110785934|NCT03931863|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110785935|NCT03931863|Serotonin Agents|serotonin agents|mesh-ancestor
110785936|NCT03931863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110785937|NCT03931863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110785938|NCT03650608|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110785939|NCT03650608|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110785940|NCT01226355|Sirolimus|sirolimus|mesh-list
110785941|NCT01226355|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110785942|NCT01226355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110785943|NCT01226355|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110785944|NCT01226355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110785945|NCT01226355|Antifungal Agents|antifungal agents|mesh-ancestor
110785946|NCT01226355|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110785947|NCT01226355|Immunologic Factors|immunologic factors|mesh-ancestor
110785948|NCT01226355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110785949|NCT01129089|Micronutrients|micronutrients|mesh-list
110785950|NCT01129089|Trace Elements|trace elements|mesh-list
110785951|NCT01129089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110785952|NCT01129323|Cyclophosphamide|cyclophosphamide|mesh-list
110785953|NCT01129323|Fludarabine|fludarabine|mesh-list
110785954|NCT01129323|Thymoglobulin|thymoglobulin|mesh-list
110785955|NCT01129323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110785956|NCT01129323|Immunologic Factors|immunologic factors|mesh-ancestor
110785957|NCT01129323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110785958|NCT01129323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110785959|NCT01129323|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110785960|NCT01129323|Alkylating Agents|alkylating agents|mesh-ancestor
110785961|NCT01129323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110785962|NCT01129323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110785963|NCT01129323|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110785964|NCT01221129|Zinc|zinc|mesh-list
110785965|NCT01221129|Trace Elements|trace elements|mesh-ancestor
110785966|NCT01221129|Micronutrients|micronutrients|mesh-ancestor
110785967|NCT01221129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110785968|NCT01222923|Risperidone|risperidone|mesh-list
110785969|NCT01222923|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110785970|NCT01222923|Serotonin Agents|serotonin agents|mesh-ancestor
110785971|NCT01222923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110785972|NCT01222923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110785973|NCT01222923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110785974|NCT01222923|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110785975|NCT01222923|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110785976|NCT01222923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110785977|NCT01222923|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110785978|NCT01222923|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110785979|NCT01222923|Dopamine Agents|dopamine agents|mesh-ancestor
110785980|NCT01223079|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
110785981|NCT01223079|Hormones|hormones|mesh-ancestor
110785982|NCT01223079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110785983|NCT01223079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110785984|NCT03648970|Pravastatin|pravastatin|mesh-list
110785985|NCT03648970|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110785986|NCT03648970|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110785987|NCT03648970|Antimetabolites|antimetabolites|mesh-ancestor
110785988|NCT03648970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110785989|NCT03648970|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110785990|NCT03648970|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110785991|NCT03648970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110785992|NCT03927963|Dexmedetomidine|dexmedetomidine|mesh-list
110785993|NCT03927963|Propofol|propofol|mesh-list
110785994|NCT03927963|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110785995|NCT03927963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110785996|NCT03927963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110785997|NCT03927963|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110785998|NCT03927963|Analgesics|analgesics|mesh-ancestor
110785999|NCT03927963|Sensory System Agents|sensory system agents|mesh-ancestor
110786000|NCT03927963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110786001|NCT03927963|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110786002|NCT03927963|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110786003|NCT03927963|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110786004|NCT03927963|Adrenergic Agents|adrenergic agents|mesh-ancestor
110786005|NCT03927963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110786006|NCT03927963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110786007|NCT03927963|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110786008|NCT03927963|Anesthetics, General|anesthetics, general|mesh-ancestor
110786009|NCT03927963|Anesthetics|anesthetics|mesh-ancestor
110786010|NCT03648346|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110786011|NCT01127529|Protein C|protein c|mesh-list
110786012|NCT01127529|Anticoagulants|anticoagulants|mesh-ancestor
110786013|NCT01127529|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110786015|NCT01127529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110786016|NCT01226667|Pregabalin|pregabalin|mesh-list
110786017|NCT01226667|Analgesics|analgesics|mesh-ancestor
110786018|NCT01226667|Sensory System Agents|sensory system agents|mesh-ancestor
110786019|NCT01226667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110786020|NCT01226667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110786021|NCT01226667|Anticonvulsants|anticonvulsants|mesh-ancestor
110786022|NCT01226667|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110786023|NCT01226667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110786024|NCT01226667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110786025|NCT01226667|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110786026|NCT01226667|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110786027|NCT01226667|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110786028|NCT01226667|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110786029|NCT01226667|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110786030|NCT03927807|Misoprostol|misoprostol|mesh-list
110786031|NCT03927807|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110786032|NCT03927807|Abortifacient Agents|abortifacient agents|mesh-ancestor
110786033|NCT03927807|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110786034|NCT03927807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110786035|NCT03927807|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110786036|NCT03927807|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110786037|NCT03927807|Oxytocics|oxytocics|mesh-ancestor
110786038|NCT05284942|Mycophenolic Acid|mycophenolic acid|mesh-list
110786039|NCT05284942|Prednisone|prednisone|mesh-list
110786040|NCT05284942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110786042|NCT05284942|Hormones|hormones|mesh-ancestor
110786043|NCT05284942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110786044|NCT05284942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110786045|NCT05284942|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110786046|NCT05284942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110786047|NCT05284942|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110786048|NCT05284942|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110786049|NCT05284942|Antitubercular Agents|antitubercular agents|mesh-ancestor
110786050|NCT05284942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110786051|NCT05284942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110786052|NCT05284942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110786053|NCT05284942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110786054|NCT03648034|Ropivacaine|ropivacaine|mesh-list
110786055|NCT03648034|Anesthetics, Local|anesthetics, local|mesh-ancestor
110786056|NCT03648034|Anesthetics|anesthetics|mesh-ancestor
110786057|NCT03648034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110786058|NCT03648034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110786059|NCT03648034|Sensory System Agents|sensory system agents|mesh-ancestor
110786060|NCT03648034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110786061|NCT01129479|Galantamine|galantamine|mesh-list
110786062|NCT01129479|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110786063|NCT01129479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110786064|NCT01129479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110786065|NCT01129479|Cholinergic Agents|cholinergic agents|mesh-ancestor
110786066|NCT01129479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110786067|NCT01129479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110786068|NCT01129479|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110786069|NCT01129479|Autonomic Agents|autonomic agents|mesh-ancestor
110786070|NCT01129479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110786071|NCT01129479|Nootropic Agents|nootropic agents|mesh-ancestor
110786072|NCT03647956|Bevacizumab|bevacizumab|mesh-list
110786073|NCT03647956|Atezolizumab|atezolizumab|mesh-list
110786074|NCT03647956|Carboplatin|carboplatin|mesh-list
110786075|NCT03647956|Pemetrexed|pemetrexed|mesh-list
110786076|NCT03647956|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110786077|NCT03647956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110786078|NCT03647956|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110786079|NCT03647956|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110786080|NCT03647956|Growth Substances|growth substances|mesh-ancestor
110786081|NCT03647956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110786082|NCT03647956|Growth Inhibitors|growth inhibitors|mesh-ancestor
110786083|NCT03647956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110786084|NCT03647956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110786085|NCT03647956|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110786086|NCT03647956|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110786087|NCT03647956|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110786088|NCT01221675|Antibodies|antibodies|mesh-list
110786089|NCT01221675|Immunologic Factors|immunologic factors|mesh-ancestor
110786090|NCT01221675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110786091|NCT03927729|Methoxyflurane|methoxyflurane|mesh-list
110786092|NCT03927729|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110786093|NCT03927729|Anesthetics, General|anesthetics, general|mesh-ancestor
110786094|NCT03927729|Anesthetics|anesthetics|mesh-ancestor
110786095|NCT03927729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110786096|NCT03927729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110786097|NCT01226823|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
110786098|NCT01226823|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
110786099|NCT01226823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110786100|NCT02968576|Tenofovir|tenofovir|mesh-list
110786101|NCT02968576|Emtricitabine|emtricitabine|mesh-list
110786102|NCT02968576|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110786103|NCT02968576|Antiviral Agents|antiviral agents|mesh-ancestor
110786104|NCT02968576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110786105|NCT02968576|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110786106|NCT02968576|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110786107|NCT02968576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110786108|NCT02968576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110786109|NCT02968576|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110786110|NCT02968576|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110786111|NCT01127217|Losartan|losartan|mesh-list
110786112|NCT01127217|Amlodipine|amlodipine|mesh-list
110786113|NCT01127217|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110786114|NCT01127217|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110786115|NCT01127217|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110786116|NCT01127217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110786117|NCT01127217|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110786118|NCT01127217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110786119|NCT01127217|Vasodilator Agents|vasodilator agents|mesh-ancestor
110786120|NCT01127217|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110786121|NCT01127217|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110786122|NCT01127217|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110786123|NCT01226901|Niraparib|niraparib|mesh-list
110786124|NCT01226901|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110786125|NCT01226901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110786126|NCT01226901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110786127|NCT01226901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110786128|NCT03648658|Acetaminophen|acetaminophen|mesh-list
110786129|NCT03648658|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110786130|NCT03648658|Analgesics|analgesics|mesh-ancestor
110786131|NCT03648658|Sensory System Agents|sensory system agents|mesh-ancestor
110786132|NCT03648658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110786133|NCT03648658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110786134|NCT03648658|Antipyretics|antipyretics|mesh-ancestor
110786135|NCT03931239|Vaccines|vaccines|mesh-list
110496861|NCT04293809|Anesthetics|anesthetics|mesh-ancestor
110786136|NCT03931239|Immunologic Factors|immunologic factors|mesh-ancestor
110786137|NCT03931239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110786138|NCT03927495|Paclitaxel|paclitaxel|mesh-list
110786139|NCT03927495|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110786140|NCT03927495|Cisplatin|cisplatin|mesh-list
110786141|NCT03927495|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110786142|NCT03927495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110786143|NCT03927495|Tubulin Modulators|tubulin modulators|mesh-ancestor
110786144|NCT03927495|Antimitotic Agents|antimitotic agents|mesh-ancestor
110786145|NCT03927495|Mitosis Modulators|mitosis modulators|mesh-ancestor
110503785|NCT02342444|Enoxaparin|enoxaparin|mesh-list
110786146|NCT03927495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110786147|NCT02966002|Aspirin|aspirin|mesh-list
110786148|NCT02966002|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110786149|NCT02966002|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110786150|NCT02966002|Analgesics|analgesics|mesh-ancestor
110786151|NCT02966002|Sensory System Agents|sensory system agents|mesh-ancestor
110786152|NCT02966002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110786153|NCT02966002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110786154|NCT02966002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110786155|NCT02966002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110786156|NCT02966002|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110786157|NCT02966002|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110786158|NCT02966002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110786159|NCT02966002|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110786160|NCT02966002|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110786161|NCT02966002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110786162|NCT02966002|Antipyretics|antipyretics|mesh-ancestor
110786163|NCT01127295|Tamoxifen|tamoxifen|mesh-list
110786164|NCT01127295|Letrozole|letrozole|mesh-list
110786165|NCT01127295|Anastrozole|anastrozole|mesh-list
110786166|NCT01127295|Exemestane|exemestane|mesh-list
110786167|NCT01127295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110786168|NCT01127295|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110786169|NCT01127295|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110786170|NCT01127295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110786171|NCT01127295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110786172|NCT01127295|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110786173|NCT01127295|Hormone Antagonists|hormone antagonists|mesh-ancestor
110786174|NCT01127295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110786175|NCT01127295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110786176|NCT01127295|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110786177|NCT01127295|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110786178|NCT01127295|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110786179|NCT01127295|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110786180|NCT01129713|Esomeprazole|esomeprazole|mesh-list
110786181|NCT01129713|Omeprazole|omeprazole|mesh-list
110786182|NCT01129713|Lansoprazole|lansoprazole|mesh-list
110786183|NCT01129713|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110786184|NCT01129713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110786185|NCT01129713|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110786186|NCT01129713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110786187|NCT01129713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110786188|NCT01221831|Dienogest|dienogest|mesh-list
110786189|NCT01221831|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110786190|NCT01221831|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110786191|NCT01221831|Estradiol|estradiol|mesh-list
110786192|NCT01221831|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110786193|NCT01221831|Estrogens|estrogens|mesh-ancestor
110786194|NCT01221831|Hormones|hormones|mesh-ancestor
110786195|NCT01221831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110786196|NCT01221831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110786197|NCT01221831|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110786198|NCT01221831|Contraceptive Agents|contraceptive agents|mesh-ancestor
110786199|NCT01221831|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110786200|NCT01221831|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110786201|NCT01221831|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110786202|NCT01221831|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110786203|NCT01221831|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110786204|NCT01221831|Hormone Antagonists|hormone antagonists|mesh-ancestor
110786205|NCT01221831|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110786206|NCT01221831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110786207|NCT03931317|Timolol|timolol|mesh-list
110786208|NCT03931317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110786209|NCT03931317|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110786210|NCT03931317|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110786211|NCT03931317|Adrenergic Agents|adrenergic agents|mesh-ancestor
110786212|NCT03931317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110786213|NCT03931317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110786214|NCT03931317|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110786215|NCT03931317|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110786216|NCT01221909|Tranexamic Acid|tranexamic acid|mesh-list
110786217|NCT01221909|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110786218|NCT01221909|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110786219|NCT01221909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110786220|NCT01221909|Hemostatics|hemostatics|mesh-ancestor
110786221|NCT01221909|Coagulants|coagulants|mesh-ancestor
110786222|NCT02900092|Ganaxolone|ganaxolone|mesh-list
110786223|NCT02900092|Neurosteroids|neurosteroids|mesh-ancestor
110786224|NCT02900092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110786225|NCT02900092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110786226|NCT02900092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110786227|NCT02900092|GABA Modulators|gaba modulators|mesh-ancestor
110786228|NCT02900092|GABA Agents|gaba agents|mesh-ancestor
110786229|NCT01130025|Tinzaparin|tinzaparin|mesh-list
110786230|NCT01130025|Warfarin|warfarin|mesh-list
110786231|NCT01130025|Anticoagulants|anticoagulants|mesh-ancestor
110786232|NCT01130025|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110786233|NCT01130025|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110786234|NCT01130025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110786235|NCT03925155|Iodine|iodine|mesh-list
110786236|NCT03925155|Chlorhexidine|chlorhexidine|mesh-list
110786237|NCT03925155|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110786238|NCT03925155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110786239|NCT03925155|Disinfectants|disinfectants|mesh-ancestor
110786240|NCT03925155|Trace Elements|trace elements|mesh-ancestor
110786241|NCT03925155|Micronutrients|micronutrients|mesh-ancestor
110786242|NCT03925155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110786243|NCT01131195|Paclitaxel|paclitaxel|mesh-list
110786244|NCT01131195|Cyclophosphamide|cyclophosphamide|mesh-list
110786245|NCT01131195|Bevacizumab|bevacizumab|mesh-list
110786246|NCT01131195|Capecitabine|capecitabine|mesh-list
110786247|NCT01131195|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110786248|NCT01131195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110786249|NCT01131195|Tubulin Modulators|tubulin modulators|mesh-ancestor
110786250|NCT01131195|Antimitotic Agents|antimitotic agents|mesh-ancestor
110786251|NCT01131195|Mitosis Modulators|mitosis modulators|mesh-ancestor
110786252|NCT01131195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110786253|NCT01131195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110786254|NCT01131195|Immunologic Factors|immunologic factors|mesh-ancestor
110786255|NCT01131195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110786256|NCT01131195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110786257|NCT01131195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110786258|NCT01131195|Alkylating Agents|alkylating agents|mesh-ancestor
110786259|NCT01131195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110786260|NCT01131195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110786261|NCT01131195|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110786262|NCT01131195|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110786263|NCT01131195|Growth Substances|growth substances|mesh-ancestor
110786264|NCT01131195|Growth Inhibitors|growth inhibitors|mesh-ancestor
110786265|NCT01131195|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110786266|NCT01131195|Antimetabolites|antimetabolites|mesh-ancestor
110786267|NCT01227135|Hydroxychloroquine|hydroxychloroquine|mesh-list
110786268|NCT01227135|Imatinib Mesylate|imatinib mesylate|mesh-list
110786269|NCT01227135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110786270|NCT01227135|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110786271|NCT01227135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110786272|NCT01227135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110786273|NCT01227135|Antimalarials|antimalarials|mesh-ancestor
110786274|NCT01227135|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110786275|NCT01227135|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110786276|NCT01227135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110786277|NCT01227135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110786278|NCT01223625|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110786279|NCT01223625|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110786280|NCT01223625|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110786281|NCT01223625|Antimetabolites|antimetabolites|mesh-ancestor
110786282|NCT01223625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110786283|NCT01223625|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110786284|NCT01223625|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110786285|NCT01223625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110786286|NCT01228227|Atorvastatin|atorvastatin|mesh-list
110786287|NCT01228227|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110786288|NCT01228227|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110786289|NCT01228227|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110786290|NCT01228227|Antimetabolites|antimetabolites|mesh-ancestor
110786291|NCT01228227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110786292|NCT01228227|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110786293|NCT01228227|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110786294|NCT01228227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110786295|NCT04052854|Zanubrutinib|zanubrutinib|mesh-list
110786296|NCT04052854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110786297|NCT04052854|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110786298|NCT04052854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110786299|NCT04052854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110786301|NCT03740373|Glycopyrrolate|glycopyrrolate|mesh-list
110786302|NCT03740373|Formoterol Fumarate|formoterol fumarate|mesh-list
110786303|NCT03740373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110786304|NCT03740373|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110786305|NCT03740373|Autonomic Agents|autonomic agents|mesh-ancestor
110786306|NCT03740373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110786307|NCT03740373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110786308|NCT03740373|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110786309|NCT03740373|Respiratory System Agents|respiratory system agents|mesh-ancestor
110786310|NCT03740373|Glucocorticoids|glucocorticoids|mesh-ancestor
110786311|NCT03740373|Hormones|hormones|mesh-ancestor
110786312|NCT03740373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110786313|NCT03740373|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110786314|NCT03740373|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110786315|NCT03740373|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110786316|NCT03740373|Adrenergic Agents|adrenergic agents|mesh-ancestor
110786317|NCT03740373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110786318|NCT03740373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110786319|NCT03740373|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110786320|NCT03740373|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110786321|NCT03740373|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110786322|NCT03740373|Cholinergic Agents|cholinergic agents|mesh-ancestor
110786323|NCT01228305|Acetaminophen|acetaminophen|mesh-list
110786324|NCT01228305|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110786325|NCT01228305|Analgesics|analgesics|mesh-ancestor
110786326|NCT01228305|Sensory System Agents|sensory system agents|mesh-ancestor
110786327|NCT01228305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110786328|NCT01228305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110786329|NCT01228305|Antipyretics|antipyretics|mesh-ancestor
110786330|NCT02902120|Grazoprevir|grazoprevir|mesh-list
110786331|NCT02902120|Antiviral Agents|antiviral agents|mesh-ancestor
110786332|NCT02902120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110786333|NCT03646396|Sofosbuvir|sofosbuvir|mesh-list
110786334|NCT03646396|Antiviral Agents|antiviral agents|mesh-ancestor
110786335|NCT03646396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110786336|NCT01131273|Buprenorphine|buprenorphine|mesh-list
110786337|NCT01131273|Methadone|methadone|mesh-list
110786338|NCT01131273|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
110786339|NCT01131273|Naloxone|naloxone|mesh-list
110786340|NCT01131273|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110786341|NCT01131273|Narcotics|narcotics|mesh-ancestor
110786342|NCT01131273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110786343|NCT01131273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110786344|NCT01131273|Analgesics|analgesics|mesh-ancestor
110786345|NCT01131273|Sensory System Agents|sensory system agents|mesh-ancestor
110786346|NCT01131273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110786347|NCT01131273|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110786348|NCT01131273|Antitussive Agents|antitussive agents|mesh-ancestor
110786349|NCT01131273|Respiratory System Agents|respiratory system agents|mesh-ancestor
110786350|NCT03646318|Ketanserin|ketanserin|mesh-list
110786351|NCT03646318|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110786352|NCT03646318|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110786353|NCT03646318|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110786354|NCT03646318|Serotonin Agents|serotonin agents|mesh-ancestor
110786355|NCT03646318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110786356|NCT03646318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110786357|NCT03646318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110786358|NCT01130181|Cholecalciferol|cholecalciferol|mesh-list
110786359|NCT01130181|Vitamin D|vitamin d|mesh-list
110786360|NCT01130181|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110786361|NCT01130181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110786362|NCT01130181|Vitamins|vitamins|mesh-ancestor
110786363|NCT01130181|Micronutrients|micronutrients|mesh-ancestor
110786364|NCT01130181|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110786365|NCT03621514|Lidocaine|lidocaine|mesh-list
110786366|NCT03621514|Anesthetics, Local|anesthetics, local|mesh-ancestor
110786367|NCT03621514|Anesthetics|anesthetics|mesh-ancestor
110786368|NCT03621514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110786369|NCT03621514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110786370|NCT03621514|Sensory System Agents|sensory system agents|mesh-ancestor
110786371|NCT03621514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110786372|NCT03621514|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110786373|NCT03621514|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110786374|NCT03621514|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110786375|NCT03621514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110786376|NCT03621514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110786377|NCT01127841|Rituximab|rituximab|mesh-list
110786378|NCT01127841|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110786379|NCT01127841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110786380|NCT01127841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110786381|NCT01127841|Immunologic Factors|immunologic factors|mesh-ancestor
110786382|NCT01127841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110786383|NCT01127841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110786384|NCT01127841|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110786385|NCT01127841|Alkylating Agents|alkylating agents|mesh-ancestor
110786386|NCT01127841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110786388|NCT01227603|Candesartan cilexetil|candesartan cilexetil|mesh-list
110786389|NCT01227603|Nifedipine|nifedipine|mesh-list
110786390|NCT01227603|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110786391|NCT01227603|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110786392|NCT01227603|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110786393|NCT01227603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110786394|NCT01227603|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110786395|NCT01227603|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110786396|NCT01227603|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110786397|NCT01227603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110786398|NCT01227603|Vasodilator Agents|vasodilator agents|mesh-ancestor
110786399|NCT01227603|Tocolytic Agents|tocolytic agents|mesh-ancestor
110786400|NCT01227603|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110786401|NCT01130259|Iniparib|iniparib|mesh-list
110786402|NCT01130259|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110786403|NCT01130259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110786404|NCT01130259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110786405|NCT01130259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110786407|NCT01585623|Midazolam|midazolam|mesh-list
110786408|NCT01585623|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110786409|NCT01585623|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110786410|NCT01585623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110786411|NCT01585623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110786412|NCT01585623|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110786413|NCT01585623|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110786414|NCT01585623|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110786415|NCT01585623|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110786416|NCT01585623|Anesthetics, General|anesthetics, general|mesh-ancestor
110786417|NCT01585623|Anesthetics|anesthetics|mesh-ancestor
110786418|NCT01585623|GABA Modulators|gaba modulators|mesh-ancestor
110786419|NCT01585623|GABA Agents|gaba agents|mesh-ancestor
110786420|NCT01585623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110786421|NCT01585623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110786422|NCT01585623|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110786423|NCT01585623|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110786424|NCT01585623|Sympatholytics|sympatholytics|mesh-ancestor
110786425|NCT01585623|Autonomic Agents|autonomic agents|mesh-ancestor
110786426|NCT01585623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110786427|NCT01585623|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110786428|NCT01585623|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110786429|NCT01585623|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110786430|NCT01585623|Adrenergic Agents|adrenergic agents|mesh-ancestor
110786431|NCT03926559|Morphine|morphine|mesh-list
110786432|NCT03926559|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110786433|NCT03926559|Narcotics|narcotics|mesh-ancestor
110786434|NCT03926559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110786435|NCT03926559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110786436|NCT03926559|Analgesics|analgesics|mesh-ancestor
110786437|NCT03926559|Sensory System Agents|sensory system agents|mesh-ancestor
110786438|NCT03926559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110786439|NCT01228617|Nicotine|nicotine|mesh-list
110786440|NCT01228617|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110786441|NCT01228617|Autonomic Agents|autonomic agents|mesh-ancestor
110786442|NCT01228617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110786443|NCT01228617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110786444|NCT01228617|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110786445|NCT01228617|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110786446|NCT01228617|Cholinergic Agents|cholinergic agents|mesh-ancestor
110786448|NCT01228617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110786449|NCT01227759|Tyrothricin|tyrothricin|mesh-list
110786450|NCT01227759|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110786451|NCT01227759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110786452|NCT01227759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110786453|NCT03923829|Zinc|zinc|mesh-list
110786454|NCT03923829|Zinc Sulfate|zinc sulfate|mesh-list
110786455|NCT03923829|Trace Elements|trace elements|mesh-ancestor
110786456|NCT03923829|Micronutrients|micronutrients|mesh-ancestor
110786457|NCT03923829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110786458|NCT03923829|Astringents|astringents|mesh-ancestor
110786459|NCT03923829|Dermatologic Agents|dermatologic agents|mesh-ancestor
110786461|NCT01128075|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110786462|NCT01128075|Immunologic Factors|immunologic factors|mesh-ancestor
110786463|NCT01128075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110786464|NCT01128075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110786465|NCT01128075|Antiviral Agents|antiviral agents|mesh-ancestor
110786466|NCT01128075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110786467|NCT03923751|Anesthetics|anesthetics|mesh-list
110786468|NCT03923751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110786469|NCT03923751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110786470|NCT03923361|Propofol|propofol|mesh-list
110786471|NCT03923361|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110786472|NCT03923361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110786473|NCT03923361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110786474|NCT03923361|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110786475|NCT03923361|Anesthetics, General|anesthetics, general|mesh-ancestor
110786476|NCT03923361|Anesthetics|anesthetics|mesh-ancestor
110786477|NCT03740295|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
110786478|NCT03740295|Antioxidants|antioxidants|mesh-ancestor
110786479|NCT03740295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110786481|NCT03740295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110786482|NCT03740295|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
110786483|NCT03740295|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110786484|NCT03740295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110786485|NCT03740295|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110786486|NCT02965378|Docetaxel|docetaxel|mesh-list
110786487|NCT02965378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110786488|NCT02965378|Tubulin Modulators|tubulin modulators|mesh-ancestor
110786489|NCT02965378|Antimitotic Agents|antimitotic agents|mesh-ancestor
110786490|NCT02965378|Mitosis Modulators|mitosis modulators|mesh-ancestor
110786491|NCT02965378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110786492|NCT01224093|Rituximab|rituximab|mesh-list
110786493|NCT01224093|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110786494|NCT01224093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110786495|NCT01224093|Immunologic Factors|immunologic factors|mesh-ancestor
110786496|NCT01224093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110786497|NCT01224093|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110786498|NCT03772041|Tolvaptan|tolvaptan|mesh-list
110786499|NCT03772041|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
110786500|NCT03772041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110786501|NCT03772041|Natriuretic Agents|natriuretic agents|mesh-ancestor
110786502|NCT03772041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110786503|NCT03922815|Fentanyl|fentanyl|mesh-list
110786504|NCT03922815|Propofol|propofol|mesh-list
110786505|NCT03922815|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110786506|NCT03922815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110786507|NCT03922815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110786508|NCT03922815|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110786509|NCT03922815|Anesthetics, General|anesthetics, general|mesh-ancestor
110786510|NCT03922815|Anesthetics|anesthetics|mesh-ancestor
110786511|NCT03922815|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110786512|NCT03922815|Narcotics|narcotics|mesh-ancestor
110786513|NCT03922815|Analgesics|analgesics|mesh-ancestor
110786514|NCT03922815|Sensory System Agents|sensory system agents|mesh-ancestor
110786515|NCT03922815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110786516|NCT03922815|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110786517|NCT01227915|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
110786518|NCT01227915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110786519|NCT01227915|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110786520|NCT01227915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110786521|NCT01227915|Glucocorticoids|glucocorticoids|mesh-ancestor
110786522|NCT01227915|Hormones|hormones|mesh-ancestor
110786523|NCT01227915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110786524|NCT01227915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110786525|NCT01227915|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110786526|NCT01227915|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110786527|NCT01224405|Docetaxel|docetaxel|mesh-list
110786528|NCT01224405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110786529|NCT01224405|Tubulin Modulators|tubulin modulators|mesh-ancestor
110786530|NCT01224405|Antimitotic Agents|antimitotic agents|mesh-ancestor
110786531|NCT01224405|Mitosis Modulators|mitosis modulators|mesh-ancestor
110786532|NCT01224405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110786533|NCT02899156|Flumazenil|flumazenil|mesh-list
110786534|NCT02899156|Antidotes|antidotes|mesh-ancestor
110497128|NCT00927758|Glucocorticoids|glucocorticoids|mesh-ancestor
110786536|NCT02899156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110786537|NCT02899156|GABA Modulators|gaba modulators|mesh-ancestor
110786538|NCT02899156|GABA Agents|gaba agents|mesh-ancestor
110786539|NCT02899156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110850727|NCT03121222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110786540|NCT02899156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110786542|NCT01131429|Docetaxel|docetaxel|mesh-list
110786543|NCT01131429|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110786544|NCT01131429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110786545|NCT01131429|Tubulin Modulators|tubulin modulators|mesh-ancestor
110786546|NCT01131429|Antimitotic Agents|antimitotic agents|mesh-ancestor
110786547|NCT01131429|Mitosis Modulators|mitosis modulators|mesh-ancestor
110786548|NCT01131429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110786549|NCT01131429|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110786550|NCT01131429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110786551|NCT03645304|Ropivacaine|ropivacaine|mesh-list
110786552|NCT03645304|Anesthetics, Local|anesthetics, local|mesh-ancestor
110786553|NCT03645304|Anesthetics|anesthetics|mesh-ancestor
110786554|NCT03645304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110786555|NCT03645304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110786556|NCT03645304|Sensory System Agents|sensory system agents|mesh-ancestor
110786557|NCT03645304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110786558|NCT03773133|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
110786559|NCT03773133|Chelating Agents|chelating agents|mesh-ancestor
110786560|NCT03773133|Sequestering Agents|sequestering agents|mesh-ancestor
110786561|NCT03773133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110786562|NCT02969356|Botulinum Toxins|botulinum toxins|mesh-list
110786563|NCT02969356|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110786564|NCT02969356|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110786565|NCT02969356|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110786566|NCT02969356|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110786567|NCT02969356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110786568|NCT02969356|Cholinergic Agents|cholinergic agents|mesh-ancestor
110786569|NCT02969356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110786570|NCT02969356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110786571|NCT02969356|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110786572|NCT02969356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110786573|NCT03646006|Bupivacaine|bupivacaine|mesh-list
110786574|NCT03646006|Anesthetics, Local|anesthetics, local|mesh-ancestor
110786575|NCT03646006|Anesthetics|anesthetics|mesh-ancestor
110786576|NCT03646006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110786577|NCT03646006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110497166|NCT00787969|Cladribine|cladribine|mesh-list
110786578|NCT03646006|Sensory System Agents|sensory system agents|mesh-ancestor
110786579|NCT03646006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110786580|NCT03854344|Lidocaine|lidocaine|mesh-list
110786581|NCT03854344|Bupivacaine|bupivacaine|mesh-list
110786582|NCT03854344|Anesthetics, Local|anesthetics, local|mesh-ancestor
110786583|NCT03854344|Anesthetics|anesthetics|mesh-ancestor
110786584|NCT03854344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110786585|NCT03854344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110786586|NCT03854344|Sensory System Agents|sensory system agents|mesh-ancestor
110786587|NCT03854344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110786588|NCT03854344|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110786589|NCT03854344|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110786590|NCT03854344|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110786591|NCT03854344|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110786592|NCT03854344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110786593|NCT05284318|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110786594|NCT05284318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110786595|NCT03609424|Imatinib Mesylate|imatinib mesylate|mesh-list
110786596|NCT03609424|Spartalizumab|spartalizumab|mesh-list
110786597|NCT03609424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110786598|NCT03609424|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110786599|NCT03609424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110786600|NCT03609424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110786601|NCT03609424|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110786602|NCT03609424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110786603|NCT03645850|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110786604|NCT03645850|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110786605|NCT03644446|Bisoprolol|bisoprolol|mesh-list
110786606|NCT03644446|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110786607|NCT03644446|Sympatholytics|sympatholytics|mesh-ancestor
110786608|NCT03644446|Autonomic Agents|autonomic agents|mesh-ancestor
110786609|NCT03644446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110786610|NCT03644446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110786611|NCT03644446|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110786612|NCT03644446|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110786613|NCT03644446|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110786614|NCT03644446|Adrenergic Agents|adrenergic agents|mesh-ancestor
110786615|NCT03644446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110786616|NCT03644446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110786617|NCT02898454|Mometasone Furoate|mometasone furoate|mesh-list
110786618|NCT02898454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110786619|NCT02898454|Dermatologic Agents|dermatologic agents|mesh-ancestor
110786620|NCT02898454|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110786621|NCT05283850|Calcium, Dietary|calcium, dietary|mesh-list
110786622|NCT05283850|Calcium|calcium|mesh-list
110786623|NCT05283850|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110786624|NCT05283850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110786625|NCT05283850|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110786626|NCT03925779|Dexmedetomidine|dexmedetomidine|mesh-list
110786627|NCT03925779|Remifentanil|remifentanil|mesh-list
110786628|NCT03925779|Propofol|propofol|mesh-list
110786629|NCT03925779|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110786630|NCT03925779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110786631|NCT03925779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110786632|NCT03925779|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110786633|NCT03925779|Analgesics|analgesics|mesh-ancestor
110786634|NCT03925779|Sensory System Agents|sensory system agents|mesh-ancestor
110786635|NCT03925779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110786636|NCT03925779|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110786637|NCT03925779|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110786638|NCT03925779|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110786639|NCT03925779|Adrenergic Agents|adrenergic agents|mesh-ancestor
110786640|NCT03925779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110786641|NCT03925779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110786642|NCT03925779|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110786643|NCT03925779|Anesthetics, General|anesthetics, general|mesh-ancestor
110786644|NCT03925779|Anesthetics|anesthetics|mesh-ancestor
110786645|NCT03925779|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110786646|NCT03925779|Narcotics|narcotics|mesh-ancestor
110786647|NCT05283694|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110497238|NCT04259684|Nitric Oxide|nitric oxide|mesh-list
110786648|NCT05283694|Immunologic Factors|immunologic factors|mesh-ancestor
110786649|NCT05283694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110786650|NCT03925701|Metformin|metformin|mesh-list
110786651|NCT03925701|Vildagliptin|vildagliptin|mesh-list
110786652|NCT03925701|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110786653|NCT03925701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110786654|NCT03925701|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110786655|NCT03925701|Protease Inhibitors|protease inhibitors|mesh-ancestor
110786656|NCT03925701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110786657|NCT03925701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110786658|NCT01224717|Teriparatide|teriparatide|mesh-list
110786659|NCT01224717|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110786660|NCT01224717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110786661|NCT01224717|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110786662|NCT03925233|Tamoxifen|tamoxifen|mesh-list
110786663|NCT03925233|Toremifene|toremifene|mesh-list
110786665|NCT03925233|Cyclophosphamide|cyclophosphamide|mesh-list
110786666|NCT03925233|Bevacizumab|bevacizumab|mesh-list
110786667|NCT03925233|Carboplatin|carboplatin|mesh-list
110786668|NCT03925233|Gemcitabine|gemcitabine|mesh-list
110786669|NCT03925233|Doxorubicin|doxorubicin|mesh-list
110786670|NCT03925233|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110786671|NCT03925233|Fluorouracil|fluorouracil|mesh-list
110786672|NCT03925233|Capecitabine|capecitabine|mesh-list
110786673|NCT03925233|Methotrexate|methotrexate|mesh-list
110786674|NCT03925233|Trastuzumab|trastuzumab|mesh-list
110786676|NCT03925233|Apatinib|apatinib|mesh-list
110786677|NCT03925233|Epirubicin|epirubicin|mesh-list
110786678|NCT03925233|Fulvestrant|fulvestrant|mesh-list
110786679|NCT03925233|Olaparib|olaparib|mesh-list
110786680|NCT03925233|Anastrozole|anastrozole|mesh-list
110786681|NCT03925233|Exemestane|exemestane|mesh-list
110786682|NCT03925233|Endostatins|endostatins|mesh-list
110786683|NCT03925233|Pirarubicin|pirarubicin|mesh-list
110786684|NCT03925233|Citric Acid|citric acid|mesh-list
110786685|NCT03925233|Sodium Citrate|sodium citrate|mesh-list
110786686|NCT03925233|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110786687|NCT03925233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110786688|NCT03925233|Tubulin Modulators|tubulin modulators|mesh-ancestor
110786689|NCT03925233|Antimitotic Agents|antimitotic agents|mesh-ancestor
110786690|NCT03925233|Mitosis Modulators|mitosis modulators|mesh-ancestor
110786691|NCT03925233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110786692|NCT03925233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110786693|NCT03925233|Immunologic Factors|immunologic factors|mesh-ancestor
110497278|NCT00788749|Glucocorticoids|glucocorticoids|mesh-ancestor
110786694|NCT03925233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110786695|NCT03925233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110786696|NCT03925233|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110786697|NCT03925233|Alkylating Agents|alkylating agents|mesh-ancestor
110786698|NCT03925233|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110786699|NCT03925233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110786700|NCT03925233|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110786701|NCT03925233|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110786702|NCT03925233|Growth Substances|growth substances|mesh-ancestor
110786703|NCT03925233|Growth Inhibitors|growth inhibitors|mesh-ancestor
110786704|NCT03925233|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110786705|NCT03925233|Antimetabolites|antimetabolites|mesh-ancestor
110786706|NCT03925233|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110786707|NCT03925233|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110786708|NCT03925233|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110786709|NCT03925233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110786710|NCT03925233|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110786711|NCT03925233|Abortifacient Agents|abortifacient agents|mesh-ancestor
110786712|NCT03925233|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110786713|NCT03925233|Dermatologic Agents|dermatologic agents|mesh-ancestor
110786714|NCT03925233|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110786715|NCT03925233|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110786716|NCT03925233|Anticoagulants|anticoagulants|mesh-ancestor
110786717|NCT03925233|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110786718|NCT03925233|Chelating Agents|chelating agents|mesh-ancestor
110786719|NCT03925233|Sequestering Agents|sequestering agents|mesh-ancestor
110786720|NCT03925233|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110786721|NCT03925233|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110786722|NCT03925233|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110786723|NCT03925233|Hormone Antagonists|hormone antagonists|mesh-ancestor
110786724|NCT03925233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110786725|NCT03925233|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110786726|NCT03925233|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110786727|NCT03925233|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110786728|NCT03925233|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110786729|NCT03925233|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110786730|NCT03925233|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110786731|NCT03925233|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110786732|NCT01130805|Capecitabine|capecitabine|mesh-list
110786733|NCT01130805|Oxaliplatin|oxaliplatin|mesh-list
110786734|NCT01130805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110786735|NCT01130805|Antimetabolites|antimetabolites|mesh-ancestor
110786736|NCT01130805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110786737|NCT01130805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110786739|NCT01345162|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
110786740|NCT01345162|Tramadol|tramadol|mesh-list
110786741|NCT01345162|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110786742|NCT01345162|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110786743|NCT01345162|Analgesics|analgesics|mesh-ancestor
110786744|NCT01345162|Sensory System Agents|sensory system agents|mesh-ancestor
110786745|NCT01345162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110497322|NCT02628951|Paclitaxel|paclitaxel|mesh-list
110786746|NCT01345162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110504375|NCT05307770|Antioxidants|antioxidants|mesh-ancestor
110786747|NCT01345162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110786748|NCT01345162|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110786749|NCT01345162|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110786750|NCT01345162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110786751|NCT01345162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110786752|NCT01345162|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110786754|NCT01345162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110786755|NCT01131039|Bevacizumab|bevacizumab|mesh-list
110786756|NCT01131039|Gemcitabine|gemcitabine|mesh-list
110786757|NCT01131039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110786758|NCT01131039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110786759|NCT01131039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110786760|NCT01131039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110786761|NCT01131039|Growth Substances|growth substances|mesh-ancestor
110786762|NCT01131039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110786763|NCT01131039|Growth Inhibitors|growth inhibitors|mesh-ancestor
110786764|NCT01131039|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110786765|NCT01131039|Antimetabolites|antimetabolites|mesh-ancestor
110786766|NCT01131039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110786767|NCT01229085|Salicylic Acid|salicylic acid|mesh-list
110786768|NCT01229085|Salicylates|salicylates|mesh-list
110786769|NCT01229085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110786770|NCT01229085|Antifungal Agents|antifungal agents|mesh-ancestor
110786771|NCT01229085|Keratolytic Agents|keratolytic agents|mesh-ancestor
110786772|NCT01229085|Dermatologic Agents|dermatologic agents|mesh-ancestor
110786773|NCT01229085|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110786774|NCT01229085|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110786775|NCT01229085|Analgesics|analgesics|mesh-ancestor
110786776|NCT01229085|Sensory System Agents|sensory system agents|mesh-ancestor
110786777|NCT01229085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110786778|NCT01229085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110786779|NCT01229085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110786780|NCT01229085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110786781|NCT01229085|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110786782|NCT01229085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110786783|NCT01229085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110786784|NCT03921645|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110786785|NCT03921645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110786786|NCT03643666|Dexamethasone|dexamethasone|mesh-list
110786787|NCT03643666|Magnesium Sulfate|magnesium sulfate|mesh-list
110786788|NCT03643666|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110786789|NCT03643666|Antiemetics|antiemetics|mesh-ancestor
110786790|NCT03643666|Autonomic Agents|autonomic agents|mesh-ancestor
110786791|NCT03643666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110786792|NCT03643666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110786793|NCT03643666|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110786794|NCT03643666|Glucocorticoids|glucocorticoids|mesh-ancestor
110786795|NCT03643666|Hormones|hormones|mesh-ancestor
110786796|NCT03643666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110786797|NCT03643666|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110786798|NCT03643666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110786799|NCT03643666|Analgesics|analgesics|mesh-ancestor
110786800|NCT03643666|Sensory System Agents|sensory system agents|mesh-ancestor
110786801|NCT03643666|Anesthetics|anesthetics|mesh-ancestor
110786802|NCT03643666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110786803|NCT03643666|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110786804|NCT03643666|Anticonvulsants|anticonvulsants|mesh-ancestor
110786805|NCT03643666|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110786806|NCT03643666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110786807|NCT03643666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110786808|NCT03643666|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110786809|NCT03643666|Tocolytic Agents|tocolytic agents|mesh-ancestor
110786810|NCT03643666|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110786811|NCT03643588|Hyaluronic Acid|hyaluronic acid|mesh-list
110786812|NCT03643588|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110786813|NCT03643588|Immunologic Factors|immunologic factors|mesh-ancestor
110786814|NCT03643588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110786815|NCT03643588|Viscosupplements|viscosupplements|mesh-ancestor
110786816|NCT03643588|Protective Agents|protective agents|mesh-ancestor
110786817|NCT01224951|Beclomethasone|beclomethasone|mesh-list
110786818|NCT01224951|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110786819|NCT01224951|Glucocorticoids|glucocorticoids|mesh-ancestor
110786820|NCT01224951|Hormones|hormones|mesh-ancestor
110786821|NCT01224951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110786822|NCT01224951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110786823|NCT01224951|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110786824|NCT01224951|Respiratory System Agents|respiratory system agents|mesh-ancestor
110786825|NCT03641404|Ergothioneine|ergothioneine|mesh-list
110786826|NCT03641404|Antioxidants|antioxidants|mesh-ancestor
110786827|NCT03641404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110786828|NCT03641404|Protective Agents|protective agents|mesh-ancestor
110786829|NCT03641404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110786830|NCT01131741|Epinephrine|epinephrine|mesh-list
110786831|NCT01131741|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110497390|NCT00795223|Morphine|morphine|mesh-list
110786832|NCT01131741|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110786833|NCT01131741|Adrenergic Agents|adrenergic agents|mesh-ancestor
110786834|NCT01131741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110786835|NCT01131741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110786836|NCT01131741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110786837|NCT01131741|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110786838|NCT01131741|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110786839|NCT01131741|Autonomic Agents|autonomic agents|mesh-ancestor
110786840|NCT01131741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110786841|NCT01131741|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110786842|NCT01131741|Respiratory System Agents|respiratory system agents|mesh-ancestor
110786843|NCT01131741|Mydriatics|mydriatics|mesh-ancestor
110786844|NCT01131741|Sympathomimetics|sympathomimetics|mesh-ancestor
110786845|NCT01131741|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110786846|NCT03919851|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110786847|NCT03919851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110786848|NCT03921567|Lidocaine|lidocaine|mesh-list
110786849|NCT03921567|Ketamine|ketamine|mesh-list
110786850|NCT03921567|Anesthetics, Local|anesthetics, local|mesh-ancestor
110786851|NCT03921567|Anesthetics|anesthetics|mesh-ancestor
110786852|NCT03921567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110786853|NCT03921567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110786854|NCT03921567|Sensory System Agents|sensory system agents|mesh-ancestor
110786855|NCT03921567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110786856|NCT03921567|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110786857|NCT03921567|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110786858|NCT03921567|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110786859|NCT03921567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110786860|NCT03921567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110786861|NCT03921567|Analgesics|analgesics|mesh-ancestor
110786862|NCT03921567|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110786863|NCT03921567|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110786864|NCT03921567|Anesthetics, General|anesthetics, general|mesh-ancestor
110786865|NCT03921567|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110786866|NCT03921567|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110786867|NCT03921567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110786868|NCT01229241|Anesthetics|anesthetics|mesh-list
110497403|NCT00795301|Cetuximab|cetuximab|mesh-list
110786869|NCT01229241|Anesthetics, Local|anesthetics, local|mesh-list
110786870|NCT01229241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110786871|NCT01229241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110786872|NCT01229241|Sensory System Agents|sensory system agents|mesh-ancestor
110786873|NCT01229241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110786874|NCT05252884|Calcium, Dietary|calcium, dietary|mesh-list
110786875|NCT05252884|Calcitriol|calcitriol|mesh-list
110786876|NCT05252884|Calcium Carbonate|calcium carbonate|mesh-list
110786877|NCT05252884|Calcium|calcium|mesh-list
110850759|NCT01297829|Ibuprofen|ibuprofen|mesh-list
110786878|NCT05252884|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110786879|NCT05252884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110786880|NCT05252884|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110786881|NCT05252884|Antacids|antacids|mesh-ancestor
110786882|NCT05252884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110786883|NCT05252884|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110786884|NCT05252884|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
110786885|NCT05252884|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110786886|NCT05252884|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110786887|NCT05252884|Vitamins|vitamins|mesh-ancestor
110786888|NCT05252884|Micronutrients|micronutrients|mesh-ancestor
110786889|NCT03921177|Micronutrients|micronutrients|mesh-list
110786890|NCT03921177|Trace Elements|trace elements|mesh-list
110786891|NCT03921177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110786892|NCT01229319|Imiquimod|imiquimod|mesh-list
110786893|NCT01229319|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110786894|NCT01229319|Immunologic Factors|immunologic factors|mesh-ancestor
110786895|NCT01229319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110786896|NCT01229319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110786897|NCT01229319|Interferon Inducers|interferon inducers|mesh-ancestor
110786898|NCT03921099|Ascorbic Acid|ascorbic acid|mesh-list
110786899|NCT03921099|Vitamins|vitamins|mesh-ancestor
110786900|NCT03921099|Micronutrients|micronutrients|mesh-ancestor
110786901|NCT03921099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110786902|NCT03921099|Antioxidants|antioxidants|mesh-ancestor
110786903|NCT03921099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110786904|NCT03921099|Protective Agents|protective agents|mesh-ancestor
110786905|NCT02962648|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
110786906|NCT02962648|Hematinics|hematinics|mesh-ancestor
110786907|NCT03920631|Nivolumab|nivolumab|mesh-list
110786908|NCT03920631|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110786909|NCT03920631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110786910|NCT03920631|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110786911|NCT03920631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110786913|NCT03930069|Arginine Vasopressin|arginine vasopressin|mesh-list
110786914|NCT03930069|Misoprostol|misoprostol|mesh-list
110786915|NCT03930069|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110786916|NCT03930069|Abortifacient Agents|abortifacient agents|mesh-ancestor
110786917|NCT03930069|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110786918|NCT03930069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110786919|NCT03930069|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110786920|NCT03930069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110786921|NCT03930069|Oxytocics|oxytocics|mesh-ancestor
110786922|NCT03930069|Hemostatics|hemostatics|mesh-ancestor
110786923|NCT03930069|Coagulants|coagulants|mesh-ancestor
110786924|NCT03930069|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110786925|NCT03930069|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
110786926|NCT03930069|Natriuretic Agents|natriuretic agents|mesh-ancestor
110786927|NCT01132443|Clindamycin|clindamycin|mesh-list
110786928|NCT01132443|Clindamycin palmitate|clindamycin palmitate|mesh-list
110786929|NCT01132443|Clindamycin phosphate|clindamycin phosphate|mesh-list
110786930|NCT01132443|Benzoyl Peroxide|benzoyl peroxide|mesh-list
110786931|NCT01132443|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110786932|NCT01132443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110786933|NCT01132443|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110786934|NCT01132443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110786935|NCT01132443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110786936|NCT01132443|Dermatologic Agents|dermatologic agents|mesh-ancestor
110786937|NCT01132521|Urinastatin|urinastatin|mesh-list
110786938|NCT01132521|Trypsin Inhibitors|trypsin inhibitors|mesh-list
110786939|NCT01132521|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110786940|NCT01132521|Protease Inhibitors|protease inhibitors|mesh-ancestor
110786941|NCT01132521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110799582|NCT02064556|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110786942|NCT01132521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110786943|NCT01132599|Choline|choline|mesh-list
110786944|NCT01132599|Lipotropic Agents|lipotropic agents|mesh-ancestor
110786945|NCT01132599|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110786946|NCT01132599|Antimetabolites|antimetabolites|mesh-ancestor
110786947|NCT01132599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110786948|NCT01132599|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110786949|NCT01132599|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110786950|NCT01132599|Nootropic Agents|nootropic agents|mesh-ancestor
110786951|NCT03929835|Chlorophyllin|chlorophyllin|mesh-list
110786952|NCT03929835|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
110786953|NCT03929835|Protective Agents|protective agents|mesh-ancestor
110786954|NCT03929835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110786956|NCT01132677|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110786957|NCT01132677|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110786958|NCT01132677|Prednisolone|prednisolone|mesh-list
110786959|NCT01132677|Prednisolone acetate|prednisolone acetate|mesh-list
110786960|NCT01132677|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110786961|NCT01132677|Prednisolone phosphate|prednisolone phosphate|mesh-list
110786962|NCT01132677|Hylan|hylan|mesh-list
110786963|NCT01132677|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110786964|NCT01132677|Antiemetics|antiemetics|mesh-ancestor
110786965|NCT01132677|Autonomic Agents|autonomic agents|mesh-ancestor
110786966|NCT01132677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110786967|NCT01132677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110786968|NCT01132677|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110786969|NCT01132677|Glucocorticoids|glucocorticoids|mesh-ancestor
110786970|NCT01132677|Hormones|hormones|mesh-ancestor
110786971|NCT01132677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110786972|NCT01132677|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110786973|NCT01132677|Protective Agents|protective agents|mesh-ancestor
110786974|NCT01132677|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110786975|NCT01132677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110786976|NCT01132677|Viscosupplements|viscosupplements|mesh-ancestor
110786977|NCT02961790|Mandelic Acids|mandelic acids|mesh-list
110786978|NCT02961790|Oxybutynin|oxybutynin|mesh-list
110786979|NCT02961790|Parasympatholytics|parasympatholytics|mesh-ancestor
110786980|NCT02961790|Autonomic Agents|autonomic agents|mesh-ancestor
110786981|NCT02961790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110786982|NCT02961790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110786983|NCT02961790|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110786984|NCT02961790|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110786985|NCT02961790|Cholinergic Agents|cholinergic agents|mesh-ancestor
110786986|NCT02961790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110786987|NCT02961790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110786989|NCT02961790|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110786990|NCT02961790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110786991|NCT01225341|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110786992|NCT01225341|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110786993|NCT01225341|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110786994|NCT01225341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110786995|NCT01225341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110786996|NCT01225341|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110786997|NCT01225341|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110786998|NCT01225341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110786999|NCT01225341|Cholinergic Agents|cholinergic agents|mesh-ancestor
110787000|NCT01225341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110787001|NCT03920553|Hyaluronic Acid|hyaluronic acid|mesh-list
110787002|NCT03920553|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110787003|NCT03920553|Immunologic Factors|immunologic factors|mesh-ancestor
110787004|NCT03920553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110787005|NCT03920553|Viscosupplements|viscosupplements|mesh-ancestor
110787006|NCT03920553|Protective Agents|protective agents|mesh-ancestor
110787007|NCT03643900|Indomethacin|indomethacin|mesh-list
110787008|NCT03643900|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110787009|NCT03643900|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110787010|NCT03643900|Analgesics|analgesics|mesh-ancestor
110787011|NCT03643900|Sensory System Agents|sensory system agents|mesh-ancestor
110787012|NCT03643900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110787013|NCT03643900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110787014|NCT03643900|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110787015|NCT03643900|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110787016|NCT03643900|Gout Suppressants|gout suppressants|mesh-ancestor
110787017|NCT03643900|Tocolytic Agents|tocolytic agents|mesh-ancestor
110787018|NCT03643900|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110787019|NCT03643900|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110787020|NCT03643900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110787021|NCT03643900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110787022|NCT03919383|Lenvatinib|lenvatinib|mesh-list
110787023|NCT03919383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110787024|NCT03919383|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110787025|NCT03919383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110787026|NCT03919383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110787027|NCT01131897|Levetiracetam|levetiracetam|mesh-list
110787028|NCT01131897|Anticonvulsants|anticonvulsants|mesh-ancestor
110787029|NCT01131897|Nootropic Agents|nootropic agents|mesh-ancestor
110787030|NCT01225419|Plerixafor|plerixafor|mesh-list
110787031|NCT01225419|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110787032|NCT01225419|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110787033|NCT01225419|Antiviral Agents|antiviral agents|mesh-ancestor
110787034|NCT01225419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110787035|NCT03919461|Etodolac|etodolac|mesh-list
110787036|NCT03919461|Propranolol|propranolol|mesh-list
110787037|NCT03919461|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110787038|NCT03919461|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110787039|NCT03919461|Adrenergic Agents|adrenergic agents|mesh-ancestor
110787040|NCT03919461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110787041|NCT03919461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110787042|NCT03919461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110787043|NCT03919461|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110787044|NCT03919461|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110787045|NCT03919461|Vasodilator Agents|vasodilator agents|mesh-ancestor
110787046|NCT03919461|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110497549|NCT05003102|Anesthetics|anesthetics|mesh-ancestor
110787047|NCT03919461|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110787048|NCT03919461|Analgesics|analgesics|mesh-ancestor
110787049|NCT03919461|Sensory System Agents|sensory system agents|mesh-ancestor
110787050|NCT03919461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110787051|NCT03919461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110787052|NCT03919461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110787053|NCT03919461|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110787054|NCT03919461|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110787055|NCT03919461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110787056|NCT02528877|Sirolimus|sirolimus|mesh-list
110787057|NCT02528877|Fludarabine|fludarabine|mesh-list
110787058|NCT02528877|Fludarabine phosphate|fludarabine phosphate|mesh-list
110787059|NCT02528877|Melphalan|melphalan|mesh-list
110787060|NCT02528877|Mechlorethamine|mechlorethamine|mesh-list
110787061|NCT02528877|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
110787062|NCT02528877|Tacrolimus|tacrolimus|mesh-list
110787063|NCT02528877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110787064|NCT02528877|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110787065|NCT02528877|Antimetabolites|antimetabolites|mesh-ancestor
110787066|NCT02528877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110787067|NCT02528877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110787068|NCT02528877|Immunologic Factors|immunologic factors|mesh-ancestor
110787069|NCT02528877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110787070|NCT02528877|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110787071|NCT02528877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110787072|NCT02528877|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110787073|NCT02528877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110787074|NCT02528877|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110787075|NCT02528877|Antifungal Agents|antifungal agents|mesh-ancestor
110787076|NCT02528877|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110787077|NCT02528877|Alkylating Agents|alkylating agents|mesh-ancestor
110787078|NCT02528877|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110787079|NCT03918993|Tadalafil|tadalafil|mesh-list
110787080|NCT03918993|Vasodilator Agents|vasodilator agents|mesh-ancestor
110787081|NCT03918993|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110787082|NCT03918993|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110787083|NCT03918993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110850782|NCT02508142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110787084|NCT03918993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110787085|NCT03918993|Urological Agents|urological agents|mesh-ancestor
110787087|NCT03920475|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
110787088|NCT03920475|Antidepressive Agents|antidepressive agents|mesh-ancestor
110787089|NCT03920475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110787090|NCT03920475|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110787091|NCT03920475|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110787092|NCT03920475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110787093|NCT03920475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110787094|NCT03920475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110787095|NCT03920475|Serotonin Agents|serotonin agents|mesh-ancestor
110787096|NCT03920475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110787097|NCT03920475|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110787098|NCT03920475|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110787099|NCT03920319|Bupropion|bupropion|mesh-list
110497560|NCT00676533|Ciprofloxacin|ciprofloxacin|mesh-list
110787100|NCT03920319|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110787101|NCT03920319|Antidepressive Agents|antidepressive agents|mesh-ancestor
110787102|NCT03920319|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110787103|NCT03920319|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110787104|NCT03920319|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110787105|NCT03920319|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110787106|NCT03920319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110787107|NCT03920319|Dopamine Agents|dopamine agents|mesh-ancestor
110787108|NCT03920319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110787109|NCT03920319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110787110|NCT03920319|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110787111|NCT03920319|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110787112|NCT03920319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110787113|NCT03920397|Cholecalciferol|cholecalciferol|mesh-list
110787114|NCT03920397|Vitamin D|vitamin d|mesh-list
110787115|NCT03920397|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110787116|NCT03920397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110787117|NCT03920397|Vitamins|vitamins|mesh-ancestor
110787118|NCT03920397|Micronutrients|micronutrients|mesh-ancestor
110787119|NCT03920397|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110787120|NCT01131975|Lamotrigine|lamotrigine|mesh-list
110787121|NCT01131975|Anticonvulsants|anticonvulsants|mesh-ancestor
110787122|NCT01131975|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110787123|NCT01131975|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110787124|NCT01131975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110787125|NCT01131975|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110787126|NCT01131975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110787127|NCT01131975|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110787128|NCT01131975|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110787129|NCT01131975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110787130|NCT01131975|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110787131|NCT01131975|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110787132|NCT01231737|Prulifloxacin|prulifloxacin|mesh-list
110787133|NCT01231737|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110787134|NCT01231737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110787135|NCT01231737|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110787136|NCT01231737|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110787137|NCT01231737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110787138|NCT01231737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110787139|NCT01231737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110787140|NCT01128699|Bevacizumab|bevacizumab|mesh-list
110787141|NCT01128699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110787142|NCT01128699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110787143|NCT01128699|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110787144|NCT01128699|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110787145|NCT01128699|Growth Substances|growth substances|mesh-ancestor
110787146|NCT01128699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110787147|NCT01128699|Growth Inhibitors|growth inhibitors|mesh-ancestor
110787148|NCT01329627|Paclitaxel|paclitaxel|mesh-list
110787149|NCT01329627|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110787150|NCT01329627|Cyclophosphamide|cyclophosphamide|mesh-list
110787151|NCT01329627|Doxorubicin|doxorubicin|mesh-list
110787152|NCT01329627|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110787153|NCT01329627|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110787154|NCT01329627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110787155|NCT01329627|Tubulin Modulators|tubulin modulators|mesh-ancestor
110787156|NCT01329627|Antimitotic Agents|antimitotic agents|mesh-ancestor
110787157|NCT01329627|Mitosis Modulators|mitosis modulators|mesh-ancestor
110787158|NCT01329627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110787159|NCT01329627|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110787160|NCT01329627|Immunologic Factors|immunologic factors|mesh-ancestor
110787161|NCT01329627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110787162|NCT01329627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110787163|NCT01329627|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110787164|NCT01329627|Alkylating Agents|alkylating agents|mesh-ancestor
110787165|NCT01329627|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110787166|NCT01329627|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110787167|NCT01329627|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110787168|NCT01329627|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110787169|NCT01329627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110787170|NCT03929211|Hydroxychloroquine|hydroxychloroquine|mesh-list
110787171|NCT03929211|Antimalarials|antimalarials|mesh-ancestor
110787172|NCT03929211|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110787173|NCT03929211|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110787174|NCT03929211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110787175|NCT03929211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110787176|NCT03929211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110787177|NCT03929211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110787178|NCT01132911|Bortezomib|bortezomib|mesh-list
110787179|NCT01132911|Vorinostat|vorinostat|mesh-list
110787180|NCT01132911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110787181|NCT01132911|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110787182|NCT01132911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110787183|NCT01132911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110787184|NCT01132989|Lenalidomide|lenalidomide|mesh-list
110787185|NCT01132989|Immunologic Factors|immunologic factors|mesh-ancestor
110787186|NCT01132989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110787187|NCT01132989|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110787188|NCT01132989|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110787189|NCT01132989|Growth Substances|growth substances|mesh-ancestor
110787190|NCT01132989|Growth Inhibitors|growth inhibitors|mesh-ancestor
110787191|NCT01132989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110787192|NCT01225653|Latanoprost|latanoprost|mesh-list
110787193|NCT01225653|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110787194|NCT01225653|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110787195|NCT01134861|Cisplatin|cisplatin|mesh-list
110787196|NCT01134861|Etoposide|etoposide|mesh-list
110787197|NCT01134861|Vinblastine|vinblastine|mesh-list
110787198|NCT01134861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110787199|NCT01134861|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110787200|NCT01134861|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110787201|NCT01134861|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110787202|NCT01134861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110787203|NCT01134861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110787204|NCT01134861|Tubulin Modulators|tubulin modulators|mesh-ancestor
110787205|NCT01134861|Antimitotic Agents|antimitotic agents|mesh-ancestor
110787206|NCT01134861|Mitosis Modulators|mitosis modulators|mesh-ancestor
110787207|NCT01133223|Plasminogen|plasminogen|mesh-list
110787208|NCT01133223|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
110787209|NCT01133223|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110787210|NCT01133223|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110787211|NCT01133223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110787212|NCT01233219|Morphine|morphine|mesh-list
110787213|NCT01233219|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110787214|NCT01233219|Narcotics|narcotics|mesh-ancestor
110787215|NCT01233219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110787216|NCT01233219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110787217|NCT01233219|Analgesics|analgesics|mesh-ancestor
110787218|NCT01233219|Sensory System Agents|sensory system agents|mesh-ancestor
110787219|NCT01233219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110787220|NCT02960854|Nivolumab|nivolumab|mesh-list
110850796|NCT01297907|Miotics|miotics|mesh-ancestor
110787221|NCT02960854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110787223|NCT02960854|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110787224|NCT02960854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110787225|NCT01133301|Naltrexone|naltrexone|mesh-list
110787226|NCT01133301|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110787227|NCT01133301|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110787228|NCT01133301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110787229|NCT01133301|Sensory System Agents|sensory system agents|mesh-ancestor
110787230|NCT01133301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110787231|NCT03918135|Acetaminophen|acetaminophen|mesh-list
110787232|NCT03918135|Ibuprofen|ibuprofen|mesh-list
110787233|NCT03918135|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110787234|NCT03918135|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110787235|NCT03918135|Analgesics|analgesics|mesh-ancestor
110787236|NCT03918135|Sensory System Agents|sensory system agents|mesh-ancestor
110787237|NCT03918135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110787238|NCT03918135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110787239|NCT03918135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110787240|NCT03918135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110787241|NCT03918135|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110787242|NCT03918135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110787243|NCT03918135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110787244|NCT03918135|Antipyretics|antipyretics|mesh-ancestor
110787245|NCT05480475|Dabigatran|dabigatran|mesh-list
110787246|NCT05480475|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110787247|NCT05480475|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110787248|NCT05480475|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110787249|NCT05480475|Antimetabolites|antimetabolites|mesh-ancestor
110787250|NCT05480475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110787251|NCT05480475|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110787252|NCT05480475|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110787253|NCT05480475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110787254|NCT05480475|Antithrombins|antithrombins|mesh-ancestor
110787255|NCT05480475|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110787256|NCT05480475|Protease Inhibitors|protease inhibitors|mesh-ancestor
110787257|NCT05480475|Anticoagulants|anticoagulants|mesh-ancestor
110787258|NCT03642184|Empagliflozin|empagliflozin|mesh-list
110787259|NCT03642184|Linagliptin|linagliptin|mesh-list
110787260|NCT03642184|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110787261|NCT03642184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110787262|NCT03642184|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110787263|NCT03642184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110787264|NCT03642184|Incretins|incretins|mesh-ancestor
110787265|NCT03642184|Hormones|hormones|mesh-ancestor
110787266|NCT03642184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110787267|NCT03642184|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110787268|NCT03642184|Protease Inhibitors|protease inhibitors|mesh-ancestor
110787269|NCT03642184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110787270|NCT01137591|Acetaminophen|acetaminophen|mesh-list
110787271|NCT01137591|Acetylcysteine|acetylcysteine|mesh-list
110787272|NCT01137591|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110787273|NCT01137591|Analgesics|analgesics|mesh-ancestor
110787274|NCT01137591|Sensory System Agents|sensory system agents|mesh-ancestor
110787275|NCT01137591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110787276|NCT01137591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110787277|NCT01137591|Antipyretics|antipyretics|mesh-ancestor
110787278|NCT01137591|Antiviral Agents|antiviral agents|mesh-ancestor
110787279|NCT01137591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110787280|NCT01137591|Expectorants|expectorants|mesh-ancestor
110787281|NCT01137591|Respiratory System Agents|respiratory system agents|mesh-ancestor
110787282|NCT01137591|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110787284|NCT01137591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110787285|NCT01137591|Protective Agents|protective agents|mesh-ancestor
110787286|NCT01133457|Finasteride|finasteride|mesh-list
110787287|NCT01133457|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
110787288|NCT01133457|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110787289|NCT01133457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110787290|NCT01133457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110787291|NCT01133457|Hormone Antagonists|hormone antagonists|mesh-ancestor
110787292|NCT01133457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110787293|NCT01133457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110787294|NCT01133457|Urological Agents|urological agents|mesh-ancestor
110787296|NCT01135563|Vinblastine|vinblastine|mesh-list
110787297|NCT01135563|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110787298|NCT01135563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110787299|NCT01135563|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110787300|NCT01135563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110787301|NCT01135563|Antifungal Agents|antifungal agents|mesh-ancestor
110787302|NCT01135563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110787303|NCT01135563|Immunologic Factors|immunologic factors|mesh-ancestor
110787304|NCT01135563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110787305|NCT01135563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110787306|NCT01135563|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110787307|NCT01135563|Tubulin Modulators|tubulin modulators|mesh-ancestor
110787308|NCT01135563|Antimitotic Agents|antimitotic agents|mesh-ancestor
110787309|NCT01135563|Mitosis Modulators|mitosis modulators|mesh-ancestor
110787310|NCT03641950|Botulinum Toxins|botulinum toxins|mesh-list
110787311|NCT03641950|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110787312|NCT03641950|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110787313|NCT03641950|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110787314|NCT03641950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110787315|NCT03641950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110787316|NCT03641950|Cholinergic Agents|cholinergic agents|mesh-ancestor
110787317|NCT03641950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110787318|NCT03641950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110787319|NCT03641950|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110787320|NCT03641950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110787321|NCT03764631|Empagliflozin|empagliflozin|mesh-list
110787322|NCT03764631|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
110787323|NCT03764631|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110787324|NCT03764631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110787325|NCT03764631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110787326|NCT03764631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110787327|NCT03764631|Protease Inhibitors|protease inhibitors|mesh-ancestor
110787328|NCT03764631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110787329|NCT01135641|Cyclosporine|cyclosporine|mesh-list
110787330|NCT01135641|Rituximab|rituximab|mesh-list
110787331|NCT01135641|Cyclosporins|cyclosporins|mesh-list
110787332|NCT01135641|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110787333|NCT01135641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110787334|NCT01135641|Immunologic Factors|immunologic factors|mesh-ancestor
110787335|NCT01135641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110787336|NCT01135641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110787337|NCT01135641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110787338|NCT01135641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110787339|NCT01135641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110787340|NCT01135641|Antifungal Agents|antifungal agents|mesh-ancestor
110787341|NCT01135641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110787342|NCT01135641|Dermatologic Agents|dermatologic agents|mesh-ancestor
110787343|NCT01135641|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110787344|NCT03640156|Oxytocin|oxytocin|mesh-list
110787345|NCT03640156|Oxytocics|oxytocics|mesh-ancestor
110787346|NCT03640156|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110787347|NCT03640156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110787348|NCT01230723|Everolimus|everolimus|mesh-list
110504976|NCT00890149|Serotonin Agents|serotonin agents|mesh-ancestor
110787349|NCT01230723|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110787350|NCT01230723|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110787351|NCT01230723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110787352|NCT01230723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110787353|NCT01230723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110787354|NCT01230723|Immunologic Factors|immunologic factors|mesh-ancestor
110112374|NCT01854762|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110787355|NCT01230723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110787356|NCT01230723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110497690|NCT00994643|Rituximab|rituximab|mesh-list
110787357|NCT05401071|Rifapentine|rifapentine|mesh-list
110787358|NCT05401071|Rifampin|rifampin|mesh-list
110850808|NCT02508064|Fostemsavir|fostemsavir|mesh-list
110787359|NCT05401071|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110787360|NCT05401071|Antitubercular Agents|antitubercular agents|mesh-ancestor
110787361|NCT05401071|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110787362|NCT05401071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110787363|NCT05401071|Leprostatic Agents|leprostatic agents|mesh-ancestor
110787364|NCT05401071|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110787365|NCT05401071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110787366|NCT05401071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110787367|NCT05401071|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110787368|NCT05401071|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110787369|NCT05401071|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110787370|NCT05401071|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110787371|NCT05401071|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110787372|NCT05401071|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110787374|NCT01135953|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110787375|NCT01135953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110787376|NCT01135953|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110787377|NCT01135953|Antitubercular Agents|antitubercular agents|mesh-ancestor
110787378|NCT01135953|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110787379|NCT01135953|Antimetabolites|antimetabolites|mesh-ancestor
110787380|NCT01135953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110787381|NCT01136031|Paclitaxel|paclitaxel|mesh-list
110787382|NCT01136031|Irinotecan|irinotecan|mesh-list
110787383|NCT01136031|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110787384|NCT01136031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110787385|NCT01136031|Tubulin Modulators|tubulin modulators|mesh-ancestor
110787386|NCT01136031|Antimitotic Agents|antimitotic agents|mesh-ancestor
110787387|NCT01136031|Mitosis Modulators|mitosis modulators|mesh-ancestor
110787388|NCT01136031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110787389|NCT01136031|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110787390|NCT01136031|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110787391|NCT01136031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110787392|NCT05400915|Paclitaxel|paclitaxel|mesh-list
110787393|NCT05400915|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110787394|NCT05400915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110787395|NCT05400915|Tubulin Modulators|tubulin modulators|mesh-ancestor
110787396|NCT05400915|Antimitotic Agents|antimitotic agents|mesh-ancestor
110787397|NCT05400915|Mitosis Modulators|mitosis modulators|mesh-ancestor
110787398|NCT05400915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110787399|NCT01137903|Amoxicillin|amoxicillin|mesh-list
110787400|NCT01137903|Ciprofloxacin|ciprofloxacin|mesh-list
110787401|NCT01137903|Clavulanic Acid|clavulanic acid|mesh-list
110787402|NCT01137903|Clavulanic Acids|clavulanic acids|mesh-list
110787403|NCT01137903|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
110787404|NCT01137903|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
110787405|NCT01137903|Trimethoprim|trimethoprim|mesh-list
110787406|NCT01137903|Sulfamethoxazole|sulfamethoxazole|mesh-list
110787407|NCT01137903|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110787408|NCT01137903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110787409|NCT01137903|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110787410|NCT01137903|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110787411|NCT01137903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110787412|NCT01137903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110787413|NCT01137903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110787414|NCT01137903|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110787415|NCT01137903|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110787416|NCT01137903|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110787417|NCT01137903|Antimalarials|antimalarials|mesh-ancestor
110787418|NCT01137903|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110787419|NCT01137903|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110787420|NCT01137903|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110505049|NCT00703755|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110787421|NCT01137903|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110787422|NCT01137903|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
110787423|NCT01137903|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110787425|NCT03739671|Ergocalciferols|ergocalciferols|mesh-list
110787426|NCT03739671|Cholecalciferol|cholecalciferol|mesh-list
110787427|NCT03739671|Vitamins|vitamins|mesh-list
110787428|NCT03739671|Micronutrients|micronutrients|mesh-ancestor
110787429|NCT03739671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110787430|NCT03739671|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110787431|NCT03739671|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110787432|NCT01233453|Umirolimus|umirolimus|mesh-list
110787433|NCT01233453|Everolimus|everolimus|mesh-list
110787434|NCT01233453|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110787435|NCT01233453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110787436|NCT01233453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110787437|NCT01233453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110787438|NCT01233453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110787439|NCT01233453|Immunologic Factors|immunologic factors|mesh-ancestor
110787440|NCT01233453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110787441|NCT01233453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110787442|NCT01233453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110787443|NCT01133925|Sirolimus|sirolimus|mesh-list
110787444|NCT01133925|Paclitaxel|paclitaxel|mesh-list
110787445|NCT01133925|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110787446|NCT01133925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110787447|NCT01133925|Tubulin Modulators|tubulin modulators|mesh-ancestor
110787448|NCT01133925|Antimitotic Agents|antimitotic agents|mesh-ancestor
110787449|NCT01133925|Mitosis Modulators|mitosis modulators|mesh-ancestor
110787450|NCT01133925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110787451|NCT01133925|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110787452|NCT01133925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110787453|NCT01133925|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110787454|NCT01133925|Antifungal Agents|antifungal agents|mesh-ancestor
110787455|NCT01133925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110787456|NCT01133925|Immunologic Factors|immunologic factors|mesh-ancestor
110787457|NCT01133925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110787458|NCT01232439|Aticaprant|aticaprant|mesh-list
110787459|NCT01232439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110787460|NCT01232439|Sensory System Agents|sensory system agents|mesh-ancestor
110787461|NCT01232439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110787462|NCT01232439|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110787463|NCT01138137|Acetylcysteine|acetylcysteine|mesh-list
110787464|NCT01138137|Paclitaxel|paclitaxel|mesh-list
110787465|NCT01138137|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110787466|NCT01138137|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110787467|NCT01138137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110787468|NCT01138137|Tubulin Modulators|tubulin modulators|mesh-ancestor
110787469|NCT01138137|Antimitotic Agents|antimitotic agents|mesh-ancestor
110787470|NCT01138137|Mitosis Modulators|mitosis modulators|mesh-ancestor
110787471|NCT01138137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110787472|NCT01138137|Antiviral Agents|antiviral agents|mesh-ancestor
110787473|NCT01138137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110787474|NCT01138137|Expectorants|expectorants|mesh-ancestor
110787475|NCT01138137|Respiratory System Agents|respiratory system agents|mesh-ancestor
110787476|NCT01138137|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110787477|NCT01138137|Antioxidants|antioxidants|mesh-ancestor
110787478|NCT01138137|Protective Agents|protective agents|mesh-ancestor
110787479|NCT01138137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110787480|NCT01138137|Antidotes|antidotes|mesh-ancestor
110787481|NCT01231113|Artesunate|artesunate|mesh-list
110787482|NCT01231113|Piperaquine|piperaquine|mesh-list
110787483|NCT01231113|Amodiaquine|amodiaquine|mesh-list
110787484|NCT01231113|Artenimol|artenimol|mesh-list
110787485|NCT01231113|Antimalarials|antimalarials|mesh-ancestor
110787486|NCT01231113|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110787487|NCT01231113|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110787488|NCT01231113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110787489|NCT01231113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110787490|NCT01231113|Antiviral Agents|antiviral agents|mesh-ancestor
110787491|NCT01231113|Schistosomicides|schistosomicides|mesh-ancestor
110787492|NCT01231113|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110787493|NCT01231113|Anthelmintics|anthelmintics|mesh-ancestor
110787494|NCT01136421|Magnesium Sulfate|magnesium sulfate|mesh-list
110787495|NCT01136421|Bromides|bromides|mesh-list
110787496|NCT01136421|Ipratropium|ipratropium|mesh-list
110787497|NCT01136421|Anticonvulsants|anticonvulsants|mesh-ancestor
110787498|NCT01136421|Analgesics|analgesics|mesh-ancestor
110787499|NCT01136421|Sensory System Agents|sensory system agents|mesh-ancestor
110787500|NCT01136421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110850816|NCT05705570|Cyclophosphamide|cyclophosphamide|mesh-list
110787501|NCT01136421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110787503|NCT01136421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110787504|NCT01136421|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110787505|NCT01136421|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110787506|NCT01136421|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110787507|NCT01136421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110497741|NCT00660829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110787508|NCT01136421|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110787509|NCT01136421|Tocolytic Agents|tocolytic agents|mesh-ancestor
110787510|NCT01136421|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110787511|NCT01136421|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110787512|NCT01136421|Autonomic Agents|autonomic agents|mesh-ancestor
110787513|NCT01136421|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110787514|NCT01136421|Respiratory System Agents|respiratory system agents|mesh-ancestor
110787515|NCT01136421|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110787516|NCT01136421|Cholinergic Agents|cholinergic agents|mesh-ancestor
110787517|NCT01136421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110787518|NCT01136499|Panobinostat|panobinostat|mesh-list
110787519|NCT01136499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110787520|NCT01136499|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110787521|NCT01136499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110787522|NCT01136499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110787523|NCT01231191|Acetaminophen|acetaminophen|mesh-list
110787524|NCT01231191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110787525|NCT01231191|Analgesics|analgesics|mesh-ancestor
110787526|NCT01231191|Sensory System Agents|sensory system agents|mesh-ancestor
110787527|NCT01231191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110787528|NCT01231191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110787529|NCT01231191|Antipyretics|antipyretics|mesh-ancestor
110787530|NCT01138449|Vitamin A|vitamin a|mesh-list
110787531|NCT01138449|Vitamins|vitamins|mesh-ancestor
110787532|NCT01138449|Micronutrients|micronutrients|mesh-ancestor
110787533|NCT01138449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110787534|NCT05402865|Denosumab|denosumab|mesh-list
110787535|NCT05402865|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110787536|NCT05402865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110787537|NCT01138605|Ritonavir|ritonavir|mesh-list
110787538|NCT01138605|Darunavir|darunavir|mesh-list
110787539|NCT01138605|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110787540|NCT01138605|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110787541|NCT01138605|Protease Inhibitors|protease inhibitors|mesh-ancestor
110787542|NCT01138605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110787543|NCT01138605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110787544|NCT01138605|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110787545|NCT01138605|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110787546|NCT01138605|Antiviral Agents|antiviral agents|mesh-ancestor
110787547|NCT01138605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110787548|NCT01138605|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110787549|NCT01138605|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110787550|NCT01138683|Diuretics|diuretics|mesh-list
110787551|NCT01138683|Natriuretic Agents|natriuretic agents|mesh-ancestor
110787552|NCT01138683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110787553|NCT04767243|Methamphetamine|methamphetamine|mesh-list
110787554|NCT04767243|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110787555|NCT04767243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110787556|NCT04767243|Sympathomimetics|sympathomimetics|mesh-ancestor
110787557|NCT04767243|Autonomic Agents|autonomic agents|mesh-ancestor
110787558|NCT04767243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110787559|NCT04767243|Dopamine Agents|dopamine agents|mesh-ancestor
110787560|NCT04767243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110787561|NCT04767243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110787562|NCT04767243|Adrenergic Agents|adrenergic agents|mesh-ancestor
110787563|NCT04767243|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110787564|NCT04767243|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110787565|NCT04767243|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110787566|NCT04767243|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110787567|NCT01138839|Dexamethasone|dexamethasone|mesh-list
110787568|NCT01138839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110787569|NCT01138839|Antiemetics|antiemetics|mesh-ancestor
110787570|NCT01138839|Autonomic Agents|autonomic agents|mesh-ancestor
110647760|NCT00555906|Hormones|hormones|mesh-ancestor
110787571|NCT01138839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110787572|NCT01138839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110787573|NCT01138839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110505208|NCT00835731|Vitamins|vitamins|mesh-ancestor
110787574|NCT01138839|Glucocorticoids|glucocorticoids|mesh-ancestor
110787576|NCT01138839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110787577|NCT01138839|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110787578|NCT01138839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110787579|NCT01234623|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110787580|NCT01234623|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110787581|NCT01234701|Liver Extracts|liver extracts|mesh-list
110787582|NCT01234701|Hematinics|hematinics|mesh-ancestor
110787583|NCT05280717|Sotrovimab|sotrovimab|mesh-list
110787584|NCT05280717|Antiviral Agents|antiviral agents|mesh-ancestor
110787585|NCT05280717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110787586|NCT04721613|Melatonin|melatonin|mesh-list
110787587|NCT04721613|Antioxidants|antioxidants|mesh-ancestor
110787588|NCT04721613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110787589|NCT04721613|Protective Agents|protective agents|mesh-ancestor
110787590|NCT04721613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110787591|NCT04721613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110787592|NCT05275179|Posaconazole|posaconazole|mesh-list
110787593|NCT05275179|Antifungal Agents|antifungal agents|mesh-ancestor
110787594|NCT05275179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110787595|NCT05275179|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
110787596|NCT05275179|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110787597|NCT05275179|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110787598|NCT05275179|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110787599|NCT05275179|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110787600|NCT05275179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110787601|NCT05275179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110787602|NCT05275179|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110787603|NCT05275179|Hormone Antagonists|hormone antagonists|mesh-ancestor
110787604|NCT05275179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110787605|NCT05275179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110787606|NCT01139151|Cytarabine|cytarabine|mesh-list
110787607|NCT01139151|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110787608|NCT01139151|Antimetabolites|antimetabolites|mesh-ancestor
110787609|NCT01139151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110787610|NCT01139151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110787611|NCT01139151|Antiviral Agents|antiviral agents|mesh-ancestor
110787612|NCT01139151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110787613|NCT01139151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110787614|NCT01139151|Immunologic Factors|immunologic factors|mesh-ancestor
110787615|NCT01139151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110787616|NCT01234857|Sirolimus|sirolimus|mesh-list
110787617|NCT01234857|Exemestane|exemestane|mesh-list
110787618|NCT01234857|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110787619|NCT01234857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110787620|NCT01234857|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110787621|NCT01234857|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110787622|NCT01234857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110787623|NCT01234857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110787624|NCT01234857|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110787625|NCT01234857|Hormone Antagonists|hormone antagonists|mesh-ancestor
110787626|NCT01234857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110787627|NCT01234857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110787628|NCT01234857|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110787629|NCT01234857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110787630|NCT01234857|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110787631|NCT01234857|Antifungal Agents|antifungal agents|mesh-ancestor
110787632|NCT01234857|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110787633|NCT01234857|Immunologic Factors|immunologic factors|mesh-ancestor
110787634|NCT01233843|Carboplatin|carboplatin|mesh-list
110787635|NCT01233843|Fluorouracil|fluorouracil|mesh-list
110787636|NCT01233843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110787637|NCT01233843|Antimetabolites|antimetabolites|mesh-ancestor
110787638|NCT01233843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110787639|NCT01233843|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110787640|NCT01233843|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110787641|NCT01233843|Immunologic Factors|immunologic factors|mesh-ancestor
110787642|NCT01233843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110787644|NCT01234935|Dasatinib|dasatinib|mesh-list
110787645|NCT01234935|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110787646|NCT01234935|Antimetabolites|antimetabolites|mesh-ancestor
110787647|NCT01234935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110787649|NCT01234935|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110787650|NCT01234935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110787651|NCT03674541|Bromides|bromides|mesh-list
110787652|NCT03674541|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
110787653|NCT03674541|Anticonvulsants|anticonvulsants|mesh-ancestor
110787654|NCT03674541|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110787655|NCT03674541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110787656|NCT03674541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110787657|NCT03674541|Cholinergic Agents|cholinergic agents|mesh-ancestor
110787658|NCT03674541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110787659|NCT03674541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110787661|NCT01235013|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110787662|NCT01235013|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110787663|NCT01235013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110787664|NCT01235013|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110787665|NCT01235013|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110787666|NCT01235013|Antiviral Agents|antiviral agents|mesh-ancestor
110787667|NCT01235013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110787668|NCT01235013|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
110787669|NCT01236495|Morphine|morphine|mesh-list
110787670|NCT01236495|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110787671|NCT01236495|Narcotics|narcotics|mesh-ancestor
110787672|NCT01236495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110787673|NCT01236495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110787674|NCT01236495|Analgesics|analgesics|mesh-ancestor
110787675|NCT01236495|Sensory System Agents|sensory system agents|mesh-ancestor
110787676|NCT01236495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110787677|NCT01143129|Dexamethasone|dexamethasone|mesh-list
110787678|NCT01143129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110787679|NCT01143129|Antiemetics|antiemetics|mesh-ancestor
110787680|NCT01143129|Autonomic Agents|autonomic agents|mesh-ancestor
110787681|NCT01143129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110787682|NCT01143129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110787683|NCT01143129|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110787684|NCT01143129|Glucocorticoids|glucocorticoids|mesh-ancestor
110787685|NCT01143129|Hormones|hormones|mesh-ancestor
110787686|NCT01143129|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110787687|NCT01143129|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110787688|NCT01143129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110787689|NCT01139463|Haloperidol|haloperidol|mesh-list
110787690|NCT01139463|Olanzapine|olanzapine|mesh-list
110787691|NCT01139463|Haloperidol decanoate|haloperidol decanoate|mesh-list
110787692|NCT01139463|Antiemetics|antiemetics|mesh-ancestor
110787693|NCT01139463|Autonomic Agents|autonomic agents|mesh-ancestor
110787694|NCT01139463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110787695|NCT01139463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110787696|NCT01139463|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110787697|NCT01139463|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110787698|NCT01139463|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110787699|NCT01139463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110787700|NCT01139463|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110787701|NCT01139463|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110787702|NCT01139463|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110787703|NCT01139463|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110787704|NCT01139463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110787705|NCT01139463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110787706|NCT01139463|Serotonin Agents|serotonin agents|mesh-ancestor
110787707|NCT01139463|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110787708|NCT01139463|Dopamine Agents|dopamine agents|mesh-ancestor
110787709|NCT01139463|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110787710|NCT03640468|Lidocaine|lidocaine|mesh-list
110787711|NCT03640468|Midazolam|midazolam|mesh-list
110787712|NCT03640468|Ketamine|ketamine|mesh-list
110787713|NCT03640468|Anesthetics, Local|anesthetics, local|mesh-ancestor
110787714|NCT03640468|Anesthetics|anesthetics|mesh-ancestor
110787715|NCT03640468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110787716|NCT03640468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110787717|NCT03640468|Sensory System Agents|sensory system agents|mesh-ancestor
110787718|NCT03640468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110787719|NCT03640468|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110787720|NCT03640468|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110787721|NCT03640468|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110787722|NCT03640468|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110787723|NCT03640468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110787724|NCT03640468|Analgesics|analgesics|mesh-ancestor
110787725|NCT03640468|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110787726|NCT03640468|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110787727|NCT03640468|Anesthetics, General|anesthetics, general|mesh-ancestor
110787728|NCT03640468|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110787729|NCT03640468|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110787730|NCT03640468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110787731|NCT03640468|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110787732|NCT03640468|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110787733|NCT03640468|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110787734|NCT03640468|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110787735|NCT03640468|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110787736|NCT03640468|GABA Modulators|gaba modulators|mesh-ancestor
110787737|NCT03640468|GABA Agents|gaba agents|mesh-ancestor
110787738|NCT03640390|Magnesium Sulfate|magnesium sulfate|mesh-list
110787739|NCT03640390|Dexmedetomidine|dexmedetomidine|mesh-list
110787740|NCT03640390|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110787741|NCT03640390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110787742|NCT03640390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110787743|NCT03640390|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110787744|NCT03640390|Analgesics|analgesics|mesh-ancestor
110787745|NCT03640390|Sensory System Agents|sensory system agents|mesh-ancestor
110787746|NCT03640390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110787747|NCT03640390|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110787748|NCT03640390|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110787749|NCT03640390|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110787750|NCT03640390|Adrenergic Agents|adrenergic agents|mesh-ancestor
110787751|NCT03640390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110787752|NCT03640390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110787753|NCT03640390|Anesthetics|anesthetics|mesh-ancestor
110787754|NCT03640390|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110787755|NCT03640390|Anticonvulsants|anticonvulsants|mesh-ancestor
110787756|NCT03640390|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110787757|NCT03640390|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110787758|NCT03640390|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110787759|NCT03640390|Tocolytic Agents|tocolytic agents|mesh-ancestor
110787760|NCT03640390|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110787761|NCT03618472|Metformin|metformin|mesh-list
110787762|NCT03618472|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110787763|NCT03618472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110787764|NCT00001984|Alemtuzumab|alemtuzumab|mesh-list
110787765|NCT00001984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110787766|NCT00001984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110787767|NCT03618316|Cimetidine|cimetidine|mesh-list
110787768|NCT03618316|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110787769|NCT03618316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110787770|NCT03618316|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110787771|NCT03618316|Histamine Antagonists|histamine antagonists|mesh-ancestor
110787772|NCT03618316|Histamine Agents|histamine agents|mesh-ancestor
110787773|NCT03618316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110787774|NCT03618316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110787775|NCT03618316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110787776|NCT03618316|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110787777|NCT03618316|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110787778|NCT03618316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110787779|NCT03445533|Ipilimumab|ipilimumab|mesh-list
110787780|NCT03445533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110787781|NCT03445533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110787782|NCT03445533|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110787783|NCT03445533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110787784|NCT01336972|Tolvaptan|tolvaptan|mesh-list
110850829|NCT05670236|Anesthetics|anesthetics|mesh-ancestor
110787785|NCT01336972|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
110787786|NCT01336972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110787787|NCT01336972|Natriuretic Agents|natriuretic agents|mesh-ancestor
110787788|NCT01336972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110787789|NCT03537508|Vaccines|vaccines|mesh-list
110787790|NCT03537508|Immunologic Factors|immunologic factors|mesh-ancestor
110787791|NCT03537508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110787792|NCT03618082|Desflurane|desflurane|mesh-list
110787793|NCT03618082|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110787794|NCT03618082|Anesthetics, General|anesthetics, general|mesh-ancestor
110787795|NCT03618082|Anesthetics|anesthetics|mesh-ancestor
110787796|NCT03618082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110787797|NCT03618082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110787798|NCT01236651|Drotaverin|drotaverin|mesh-list
110787799|NCT01236651|Meperidine|meperidine|mesh-list
110787800|NCT01236651|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110787801|NCT01236651|Narcotics|narcotics|mesh-ancestor
110787802|NCT01236651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110787803|NCT01236651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110787804|NCT01236651|Analgesics|analgesics|mesh-ancestor
110497889|NCT00793663|Anesthetics|anesthetics|mesh-ancestor
110787805|NCT01236651|Sensory System Agents|sensory system agents|mesh-ancestor
110787806|NCT01236651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110787807|NCT01236651|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110787808|NCT01236651|Parasympatholytics|parasympatholytics|mesh-ancestor
110787809|NCT01236651|Autonomic Agents|autonomic agents|mesh-ancestor
110787810|NCT01236651|Vasodilator Agents|vasodilator agents|mesh-ancestor
110787812|NCT04484025|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110787813|NCT04484025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110787814|NCT04484025|Analgesics|analgesics|mesh-ancestor
110787815|NCT04484025|Sensory System Agents|sensory system agents|mesh-ancestor
110787816|NCT04484025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110787817|NCT04484025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110787818|NCT04484025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110787819|NCT04484025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110787820|NCT04484025|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110787821|NCT04484025|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110787822|NCT04484025|Antioxidants|antioxidants|mesh-ancestor
110787823|NCT04484025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110787824|NCT04484025|Protective Agents|protective agents|mesh-ancestor
110787825|NCT04484025|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110787826|NCT04484025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110787827|NCT04484025|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110787828|NCT01064518|Botulinum Toxins|botulinum toxins|mesh-list
110787829|NCT01064518|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110787830|NCT01064518|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110787831|NCT01064518|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110787832|NCT01064518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110787833|NCT01064518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110787834|NCT01064518|Cholinergic Agents|cholinergic agents|mesh-ancestor
110787835|NCT01064518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110787836|NCT01064518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110787837|NCT01064518|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110787838|NCT01064518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110787839|NCT03616288|Thiamine|thiamine|mesh-list
110787840|NCT03616288|Vitamin B Complex|vitamin b complex|mesh-ancestor
110787841|NCT03616288|Vitamins|vitamins|mesh-ancestor
110787842|NCT03616288|Micronutrients|micronutrients|mesh-ancestor
110787843|NCT03616288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110787844|NCT03616132|Sirolimus|sirolimus|mesh-list
110787845|NCT03616132|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110787846|NCT03616132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110787847|NCT03616132|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110787848|NCT03616132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110787849|NCT03616132|Antifungal Agents|antifungal agents|mesh-ancestor
110787850|NCT03616132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110787851|NCT03616132|Immunologic Factors|immunologic factors|mesh-ancestor
110787852|NCT03616132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110787854|NCT02872012|Anesthetics, Local|anesthetics, local|mesh-ancestor
110787855|NCT02872012|Anesthetics|anesthetics|mesh-ancestor
110787856|NCT02872012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110787857|NCT02872012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110787858|NCT02872012|Sensory System Agents|sensory system agents|mesh-ancestor
110787859|NCT02872012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110787860|NCT02872012|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110787861|NCT02872012|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110787862|NCT02872012|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110787863|NCT02872012|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110787864|NCT02872012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110787865|NCT03617224|Pembrolizumab|pembrolizumab|mesh-list
110787866|NCT03617224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110787867|NCT03617224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110787868|NCT03617224|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110787869|NCT03617224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110787870|NCT03615430|Anesthetics|anesthetics|mesh-list
110787871|NCT03615430|Anesthetics, Local|anesthetics, local|mesh-list
110787872|NCT03615430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110787873|NCT03615430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110787874|NCT03615430|Sensory System Agents|sensory system agents|mesh-ancestor
110787875|NCT03615430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110787876|NCT01344226|Loteprednol Etabonate|loteprednol etabonate|mesh-list
110787877|NCT01344226|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110787878|NCT01344226|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110787879|NCT01344226|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110787880|NCT03615196|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110787882|NCT04837768|Progesterone|progesterone|mesh-list
110787883|NCT04837768|Progestins|progestins|mesh-ancestor
110787884|NCT04837768|Hormones|hormones|mesh-ancestor
110787885|NCT04837768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110787886|NCT04837768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110787887|NCT02869438|Benralizumab|benralizumab|mesh-list
110787888|NCT02869438|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110787889|NCT02869438|Respiratory System Agents|respiratory system agents|mesh-ancestor
110787890|NCT02868892|Pemetrexed|pemetrexed|mesh-list
110787891|NCT02868892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110787892|NCT02868892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110787893|NCT02868892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110787894|NCT02868892|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110787895|NCT02868892|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110787896|NCT03613558|Dexmedetomidine|dexmedetomidine|mesh-list
110787897|NCT03613558|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110787898|NCT03613558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110787899|NCT03613558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110787900|NCT03613558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110787901|NCT03613558|Analgesics|analgesics|mesh-ancestor
110787902|NCT03613558|Sensory System Agents|sensory system agents|mesh-ancestor
110787903|NCT03613558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110787904|NCT03613558|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110787905|NCT03613558|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110787906|NCT03613558|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110787907|NCT03613558|Adrenergic Agents|adrenergic agents|mesh-ancestor
110787908|NCT03613558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110787909|NCT03613558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110787910|NCT03613168|Trastuzumab|trastuzumab|mesh-list
110787911|NCT03613168|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110787912|NCT03613168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110787913|NCT01141881|Bevacizumab|bevacizumab|mesh-list
110787914|NCT01141881|Plasminogen|plasminogen|mesh-list
110787915|NCT01141881|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
110787916|NCT01141881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110787917|NCT01141881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110787918|NCT01141881|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110787919|NCT01141881|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110787920|NCT01141881|Growth Substances|growth substances|mesh-ancestor
110787921|NCT01141881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110787922|NCT01141881|Growth Inhibitors|growth inhibitors|mesh-ancestor
110787923|NCT01141881|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110787924|NCT01141881|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110787925|NCT01141881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110787926|NCT04707430|Progesterone|progesterone|mesh-list
110787927|NCT04707430|Progestins|progestins|mesh-ancestor
110787928|NCT04707430|Hormones|hormones|mesh-ancestor
110787929|NCT04707430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110787930|NCT04707430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110787931|NCT03611920|Tetracycline|tetracycline|mesh-list
110787932|NCT03611920|Dexamethasone|dexamethasone|mesh-list
110787933|NCT03611920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110787934|NCT03611920|Antiemetics|antiemetics|mesh-ancestor
110787935|NCT03611920|Autonomic Agents|autonomic agents|mesh-ancestor
110787936|NCT03611920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110787937|NCT03611920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110787938|NCT03611920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110787939|NCT03611920|Glucocorticoids|glucocorticoids|mesh-ancestor
110787940|NCT03611920|Hormones|hormones|mesh-ancestor
110787941|NCT03611920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110787942|NCT03611920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110787943|NCT03611920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110787944|NCT03611920|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110505589|NCT00838357|Plerixafor|plerixafor|mesh-list
110787946|NCT03611920|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110787947|NCT03611920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110787948|NCT03611920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110787949|NCT03611530|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110787950|NCT03611530|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110787951|NCT02936752|Pembrolizumab|pembrolizumab|mesh-list
110787952|NCT02936752|Entinostat|entinostat|mesh-list
110787953|NCT02936752|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
110787954|NCT02936752|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110787955|NCT02936752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110787956|NCT02936752|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110787957|NCT02936752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110787958|NCT02936752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110787959|NCT05383534|Propofol|propofol|mesh-list
110787960|NCT05383534|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110787961|NCT05383534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110787962|NCT05383534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110787963|NCT05383534|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110787964|NCT05383534|Anesthetics, General|anesthetics, general|mesh-ancestor
110787965|NCT05383534|Anesthetics|anesthetics|mesh-ancestor
110787966|NCT01235325|Vitamin K|vitamin k|mesh-list
110787967|NCT01235325|Vitamin K 1|vitamin k 1|mesh-list
110787968|NCT01235325|Vitamins|vitamins|mesh-ancestor
110787969|NCT01235325|Micronutrients|micronutrients|mesh-ancestor
110787970|NCT01235325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110787971|NCT01235325|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110787972|NCT01235325|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110787973|NCT01235325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110787974|NCT01235325|Hemostatics|hemostatics|mesh-ancestor
110787975|NCT01235325|Coagulants|coagulants|mesh-ancestor
110787976|NCT01140009|Vaccines|vaccines|mesh-list
110787977|NCT01140009|Immunologic Factors|immunologic factors|mesh-ancestor
110787978|NCT01140009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110787979|NCT01235637|Sufentanil|sufentanil|mesh-list
110787980|NCT01235637|Alfentanil|alfentanil|mesh-list
110787981|NCT01235637|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110787982|NCT01235637|Narcotics|narcotics|mesh-ancestor
110787983|NCT01235637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110787984|NCT01235637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110787985|NCT01235637|Analgesics|analgesics|mesh-ancestor
110787986|NCT01235637|Sensory System Agents|sensory system agents|mesh-ancestor
110787987|NCT01235637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110787988|NCT01235637|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110787989|NCT01235637|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110787990|NCT01235637|Anesthetics, General|anesthetics, general|mesh-ancestor
110787991|NCT01235637|Anesthetics|anesthetics|mesh-ancestor
110787992|NCT01143831|Vitamins|vitamins|mesh-list
110787993|NCT01143831|Vitamin K|vitamin k|mesh-list
110787994|NCT01143831|Vitamin K 2|vitamin k 2|mesh-list
110787995|NCT01143831|Menatetrenone|menatetrenone|mesh-list
110787996|NCT01143831|Micronutrients|micronutrients|mesh-ancestor
110787997|NCT01143831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110787998|NCT01143831|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110787999|NCT01143831|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110788000|NCT01143831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110788001|NCT01143831|Hemostatics|hemostatics|mesh-ancestor
110788002|NCT01143831|Coagulants|coagulants|mesh-ancestor
110788003|NCT01143987|Cinacalcet|cinacalcet|mesh-list
110788004|NCT01143987|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110788005|NCT01143987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110788006|NCT01143987|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
110788007|NCT01143987|Hormone Antagonists|hormone antagonists|mesh-ancestor
110788008|NCT01143987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110788009|NCT01144065|Hydrocortisone|hydrocortisone|mesh-list
110788010|NCT01144065|Testosterone|testosterone|mesh-list
110788011|NCT01144065|Androgens|androgens|mesh-ancestor
110788012|NCT01144065|Hormones|hormones|mesh-ancestor
110788013|NCT01144065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110788014|NCT01144065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110788015|NCT01144065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110788016|NCT01142505|Mannitol|mannitol|mesh-list
110788017|NCT01142505|Montelukast|montelukast|mesh-list
110788018|NCT01142505|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110788019|NCT01142505|Respiratory System Agents|respiratory system agents|mesh-ancestor
110788020|NCT01142505|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110788021|NCT01142505|Hormone Antagonists|hormone antagonists|mesh-ancestor
110788022|NCT01142505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110788023|NCT01142505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110788024|NCT01142505|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110788025|NCT01142505|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110788026|NCT01142505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110788027|NCT01142505|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110788028|NCT01142505|Diuretics|diuretics|mesh-ancestor
110788029|NCT01142505|Natriuretic Agents|natriuretic agents|mesh-ancestor
110788030|NCT01236963|Listerine|listerine|mesh-list
110788031|NCT01236963|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110788032|NCT01236963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110788033|NCT02908672|Atezolizumab|atezolizumab|mesh-list
110788034|NCT02908672|Vemurafenib|vemurafenib|mesh-list
110788035|NCT02908672|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110788036|NCT02908672|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110788037|NCT02908672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110498038|NCT02868749|Protective Agents|protective agents|mesh-ancestor
110788038|NCT02908672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110788039|NCT02908672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110788040|NCT02908672|Immunologic Factors|immunologic factors|mesh-ancestor
110788041|NCT02908672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110788042|NCT02908672|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110788043|NCT02908672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110788044|NCT02572167|Nivolumab|nivolumab|mesh-list
110788045|NCT02572167|Brentuximab Vedotin|brentuximab vedotin|mesh-list
110788046|NCT02572167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110788047|NCT02572167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110788048|NCT02572167|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110788049|NCT02572167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110788050|NCT02572167|Immunotoxins|immunotoxins|mesh-ancestor
110788051|NCT02572167|Immunoconjugates|immunoconjugates|mesh-ancestor
110788052|NCT02572167|Immunologic Factors|immunologic factors|mesh-ancestor
110788053|NCT02572167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110788054|NCT01336738|Nicotinic Acids|nicotinic acids|mesh-list
110788055|NCT01336738|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110788056|NCT01336738|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1h-imidazol-1-yl)propanamido)nicotinic acid|mesh-list
110788057|NCT01336738|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110788058|NCT01336738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110788059|NCT01336738|Incretins|incretins|mesh-ancestor
110788060|NCT01336738|Hormones|hormones|mesh-ancestor
110788061|NCT01336738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110788062|NCT01336738|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110788063|NCT01336738|Protease Inhibitors|protease inhibitors|mesh-ancestor
110788064|NCT01336738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110788065|NCT01336738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110788066|NCT01336738|Vitamin B Complex|vitamin b complex|mesh-ancestor
110788067|NCT01336738|Vitamins|vitamins|mesh-ancestor
110788068|NCT01336738|Micronutrients|micronutrients|mesh-ancestor
110788069|NCT01140399|Dopamine|dopamine|mesh-list
110788070|NCT01140399|Furosemide|furosemide|mesh-list
110788071|NCT01140399|Diuretics|diuretics|mesh-ancestor
110788072|NCT01140399|Natriuretic Agents|natriuretic agents|mesh-ancestor
110788073|NCT01140399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110788074|NCT01140399|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110788075|NCT01140399|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110788076|NCT01140399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110788077|NCT01140399|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110788078|NCT01140399|Sympathomimetics|sympathomimetics|mesh-ancestor
110788079|NCT01140399|Autonomic Agents|autonomic agents|mesh-ancestor
110788080|NCT01140399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110788081|NCT01140399|Dopamine Agents|dopamine agents|mesh-ancestor
110788082|NCT01140399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110788083|NCT01140399|Protective Agents|protective agents|mesh-ancestor
110788084|NCT02410317|Morphine|morphine|mesh-list
110788085|NCT02410317|Ropivacaine|ropivacaine|mesh-list
110788086|NCT02410317|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110788087|NCT02410317|Narcotics|narcotics|mesh-ancestor
110788088|NCT02410317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110788089|NCT02410317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110788090|NCT02410317|Analgesics|analgesics|mesh-ancestor
110788091|NCT02410317|Sensory System Agents|sensory system agents|mesh-ancestor
110788092|NCT02410317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110788093|NCT02410317|Anesthetics, Local|anesthetics, local|mesh-ancestor
110788094|NCT02410317|Anesthetics|anesthetics|mesh-ancestor
110788095|NCT01237119|Liraglutide|liraglutide|mesh-list
110788097|NCT01237119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110788098|NCT01237119|Incretins|incretins|mesh-ancestor
110788099|NCT01237119|Hormones|hormones|mesh-ancestor
110788100|NCT01237119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110788101|NCT03760263|Tacrolimus|tacrolimus|mesh-list
110788102|NCT03760263|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110788103|NCT03760263|Immunologic Factors|immunologic factors|mesh-ancestor
110788104|NCT03760263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110788105|NCT03760263|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110788106|NCT03760263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110788107|NCT03760263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110788108|NCT01237275|Sertraline|sertraline|mesh-list
110788109|NCT01237275|Fluoxetine|fluoxetine|mesh-list
110788110|NCT01237275|Paroxetine|paroxetine|mesh-list
110788111|NCT01237275|Antidepressive Agents|antidepressive agents|mesh-ancestor
110788112|NCT01237275|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110788113|NCT01237275|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110788114|NCT01237275|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110788115|NCT01237275|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110788116|NCT01237275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110788117|NCT01237275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110788118|NCT01237275|Serotonin Agents|serotonin agents|mesh-ancestor
110788119|NCT01237275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110788120|NCT01237275|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110788121|NCT01237275|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110788122|NCT01237275|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110788123|NCT01237275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110788124|NCT01237977|Botulinum Toxins|botulinum toxins|mesh-list
110788125|NCT01237977|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110788126|NCT01237977|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110788127|NCT01237977|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110788128|NCT01237977|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110788129|NCT01237977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110788130|NCT01237977|Cholinergic Agents|cholinergic agents|mesh-ancestor
110788131|NCT01237977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110788132|NCT01237977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110788133|NCT01237977|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110788134|NCT01237977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110788135|NCT02033434|Ketamine|ketamine|mesh-list
110788136|NCT02033434|Analgesics|analgesics|mesh-ancestor
110788137|NCT02033434|Sensory System Agents|sensory system agents|mesh-ancestor
110788138|NCT02033434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110788139|NCT02033434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110788140|NCT02033434|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110788141|NCT02033434|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110788142|NCT02033434|Anesthetics, General|anesthetics, general|mesh-ancestor
110788143|NCT02033434|Anesthetics|anesthetics|mesh-ancestor
110788144|NCT02033434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110788145|NCT02033434|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110788146|NCT02033434|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110788147|NCT02033434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110788148|NCT02033434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110788149|NCT02033512|Hormones|hormones|mesh-list
110788150|NCT02033512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110788151|NCT02033512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110788152|NCT02712112|Imatinib Mesylate|imatinib mesylate|mesh-list
110788153|NCT02712112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110788154|NCT02712112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110788155|NCT02712112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110788156|NCT02712112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110788157|NCT02860546|Nivolumab|nivolumab|mesh-list
110788158|NCT02860546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110788159|NCT02860546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110788160|NCT02860546|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110788161|NCT02860546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110788162|NCT01982955|Carboplatin|carboplatin|mesh-list
110788163|NCT01982955|Pemetrexed|pemetrexed|mesh-list
110788164|NCT01982955|Gefitinib|gefitinib|mesh-list
110788165|NCT01982955|Tepotinib|tepotinib|mesh-list
110788166|NCT01982955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110788167|NCT01982955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110788168|NCT01982955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110788169|NCT01982955|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110788170|NCT01982955|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110788171|NCT01982955|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110788172|NCT01144533|Hyaluronic Acid|hyaluronic acid|mesh-list
110788173|NCT01144533|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110788174|NCT01144533|Immunologic Factors|immunologic factors|mesh-ancestor
110788175|NCT01144533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110788176|NCT01144533|Viscosupplements|viscosupplements|mesh-ancestor
110788177|NCT01144533|Protective Agents|protective agents|mesh-ancestor
110788178|NCT01238055|Docetaxel|docetaxel|mesh-list
110788180|NCT01238055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110788181|NCT01238055|Tubulin Modulators|tubulin modulators|mesh-ancestor
110788182|NCT01238055|Antimitotic Agents|antimitotic agents|mesh-ancestor
110788183|NCT01238055|Mitosis Modulators|mitosis modulators|mesh-ancestor
110788184|NCT01238055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110788185|NCT01238055|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110498111|NCT00679653|Antidepressive Agents|antidepressive agents|mesh-ancestor
110788186|NCT01238055|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110788187|NCT01238055|Growth Substances|growth substances|mesh-ancestor
110788188|NCT01238055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110788189|NCT01238055|Growth Inhibitors|growth inhibitors|mesh-ancestor
110788190|NCT01238055|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110788191|NCT01238055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110788192|NCT01144923|Gabapentin|gabapentin|mesh-list
110788193|NCT01144923|Nortriptyline|nortriptyline|mesh-list
110788194|NCT01144923|Analgesics|analgesics|mesh-ancestor
110788195|NCT01144923|Sensory System Agents|sensory system agents|mesh-ancestor
110788196|NCT01144923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110788197|NCT01144923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110788198|NCT01144923|Anticonvulsants|anticonvulsants|mesh-ancestor
110788199|NCT01144923|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110788200|NCT01144923|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110788201|NCT01144923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110788202|NCT01144923|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110788203|NCT01144923|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110788204|NCT01144923|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110788205|NCT01144923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110788206|NCT01144923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110788207|NCT01144923|Antimanic Agents|antimanic agents|mesh-ancestor
110788208|NCT01144923|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110788209|NCT01144923|Antidepressive Agents|antidepressive agents|mesh-ancestor
110788210|NCT01144923|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110788211|NCT01144923|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110788212|NCT01144923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110788213|NCT01144923|Adrenergic Agents|adrenergic agents|mesh-ancestor
110788214|NCT01329783|Maraviroc|maraviroc|mesh-list
110788215|NCT01329783|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110788216|NCT01329783|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110788217|NCT01329783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110788218|NCT01329783|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110788219|NCT01329783|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110788220|NCT01329783|Antiviral Agents|antiviral agents|mesh-ancestor
110788221|NCT01329783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110788222|NCT01329783|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
110788223|NCT01238133|Paclitaxel|paclitaxel|mesh-list
110788224|NCT01238133|Carboplatin|carboplatin|mesh-list
110788225|NCT01238133|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110788226|NCT01238133|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
110788227|NCT01238133|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-list
110788228|NCT01238133|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110788229|NCT01238133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110788230|NCT01238133|Tubulin Modulators|tubulin modulators|mesh-ancestor
110788231|NCT01238133|Antimitotic Agents|antimitotic agents|mesh-ancestor
110788232|NCT01238133|Mitosis Modulators|mitosis modulators|mesh-ancestor
110788233|NCT01238133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110788234|NCT01238133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110788235|NCT01145079|Sirolimus|sirolimus|mesh-list
110788236|NCT01145079|Everolimus|everolimus|mesh-list
110788237|NCT01145079|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110788238|NCT01145079|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110788239|NCT01145079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110788240|NCT01145079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110788241|NCT01145079|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110788242|NCT01145079|Immunologic Factors|immunologic factors|mesh-ancestor
110788243|NCT01145079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110788244|NCT01145079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110788245|NCT01145079|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110788246|NCT01145079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110788247|NCT01145079|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110788248|NCT01145079|Antifungal Agents|antifungal agents|mesh-ancestor
110788249|NCT01146483|Pantoprazole|pantoprazole|mesh-list
110788250|NCT01146483|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110788251|NCT01146483|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110788252|NCT01146483|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110788253|NCT01146483|Antimetabolites|antimetabolites|mesh-ancestor
110788254|NCT01146483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110788255|NCT01146483|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110788256|NCT01146483|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110788257|NCT01146483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110788258|NCT01146483|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110788259|NCT01146483|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110788260|NCT01146483|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110788261|NCT00396279|Vitamin D|vitamin d|mesh-list
110788262|NCT00396279|Denosumab|denosumab|mesh-list
110788263|NCT00396279|Calcium|calcium|mesh-list
110788264|NCT00396279|Vitamins|vitamins|mesh-ancestor
110788265|NCT00396279|Micronutrients|micronutrients|mesh-ancestor
110788266|NCT00396279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110788267|NCT00396279|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110788268|NCT00396279|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110788269|NCT01238367|Factor VIII|factor viii|mesh-list
110788270|NCT01238367|Coagulants|coagulants|mesh-ancestor
110788272|NCT01347866|Gedatolisib|gedatolisib|mesh-list
110788273|NCT01347866|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110788274|NCT01347866|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110788275|NCT01347866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110788276|NCT01347866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110788277|NCT01347866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110788278|NCT01347866|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110788279|NCT01347710|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
110788280|NCT01347710|Technetium tc-99m tetrofosmin|technetium tc-99m tetrofosmin|mesh-list
110788281|NCT01347710|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110788282|NCT01347710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110788283|NCT05470868|Naphazoline|naphazoline|mesh-list
110788284|NCT05470868|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110788285|NCT05470868|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110788286|NCT05470868|Adrenergic Agents|adrenergic agents|mesh-ancestor
110788287|NCT05470868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110788288|NCT05470868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110788289|NCT05470868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110788290|NCT05470868|Nasal Decongestants|nasal decongestants|mesh-ancestor
110788291|NCT05470868|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110788292|NCT05470868|Respiratory System Agents|respiratory system agents|mesh-ancestor
110788293|NCT03485222|Empagliflozin|empagliflozin|mesh-list
110788294|NCT03485222|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110788295|NCT03485222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110788296|NCT03485222|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110788297|NCT03485222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110788298|NCT01347554|Everolimus|everolimus|mesh-list
110788299|NCT01347554|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110788300|NCT01347554|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110788301|NCT01347554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110788302|NCT01347554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110788303|NCT01347554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110788304|NCT01347554|Immunologic Factors|immunologic factors|mesh-ancestor
110788305|NCT01347554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110788306|NCT01347554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110788307|NCT05567354|Oxycodone|oxycodone|mesh-list
110788308|NCT05567354|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110788309|NCT05567354|Narcotics|narcotics|mesh-ancestor
110788310|NCT05567354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110788311|NCT05567354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110788312|NCT05567354|Analgesics|analgesics|mesh-ancestor
110788313|NCT05567354|Sensory System Agents|sensory system agents|mesh-ancestor
110788314|NCT05567354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110788315|NCT03482882|Pimavanserin|pimavanserin|mesh-list
110788316|NCT03482882|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110788317|NCT03482882|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110788318|NCT03482882|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110788319|NCT03482882|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110788320|NCT03482882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110788321|NCT03482882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110788322|NCT03482882|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110788323|NCT03482882|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110788324|NCT03482882|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110788325|NCT03482882|Serotonin Agents|serotonin agents|mesh-ancestor
110788326|NCT03482882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110788327|NCT03482882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110788329|NCT03480932|Interferon-alpha|interferon-alpha|mesh-list
110788330|NCT03480932|Interferon alpha-2|interferon alpha-2|mesh-list
110788331|NCT03480932|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110788332|NCT03480932|Sofosbuvir|sofosbuvir|mesh-list
110788333|NCT03480932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110788334|NCT03480932|Antiviral Agents|antiviral agents|mesh-ancestor
110788335|NCT03480932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110788336|NCT03480932|Immunologic Factors|immunologic factors|mesh-ancestor
110788337|NCT03480932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110788338|NCT03387020|Everolimus|everolimus|mesh-list
110788339|NCT03387020|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110788340|NCT03387020|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110788341|NCT03387020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110788342|NCT03387020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110788343|NCT03387020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110788344|NCT03387020|Immunologic Factors|immunologic factors|mesh-ancestor
110788345|NCT03387020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110788346|NCT03387020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110788347|NCT03386474|Aflibercept|aflibercept|mesh-list
110788348|NCT03386474|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110788349|NCT03386474|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110788350|NCT03386474|Growth Substances|growth substances|mesh-ancestor
110788351|NCT03386474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110788352|NCT03386474|Growth Inhibitors|growth inhibitors|mesh-ancestor
110788353|NCT03386474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110788354|NCT03405818|Tavaborole|tavaborole|mesh-list
110788355|NCT03405818|Antifungal Agents|antifungal agents|mesh-ancestor
110788356|NCT03405818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110788357|NCT03403634|Interferons|interferons|mesh-list
110788358|NCT03403634|Interferon-alpha|interferon-alpha|mesh-list
110788359|NCT03403634|Interferon alpha-2|interferon alpha-2|mesh-list
110788360|NCT03403634|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
110788361|NCT03403634|Celecoxib|celecoxib|mesh-list
110788362|NCT03403634|Benzenesulfonamide|benzenesulfonamide|mesh-list
110788363|NCT03403634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110788364|NCT03403634|Antiviral Agents|antiviral agents|mesh-ancestor
110788365|NCT03403634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110788366|NCT03403634|Immunologic Factors|immunologic factors|mesh-ancestor
110788367|NCT03403634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110788368|NCT03403634|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110788369|NCT03403634|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110788370|NCT03403634|Analgesics|analgesics|mesh-ancestor
110788371|NCT03403634|Sensory System Agents|sensory system agents|mesh-ancestor
110498250|NCT00685347|Albuterol|albuterol|mesh-list
110788372|NCT03403634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110788373|NCT03403634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110788374|NCT03403634|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110788375|NCT03403634|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110788376|NCT03403634|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110788377|NCT03403634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110788378|NCT03403634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110788379|NCT03403634|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110788380|NCT02863354|Aflibercept|aflibercept|mesh-list
110788381|NCT02863354|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110788382|NCT02863354|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110788383|NCT02863354|Growth Substances|growth substances|mesh-ancestor
110788384|NCT02863354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110788385|NCT02863354|Growth Inhibitors|growth inhibitors|mesh-ancestor
110788386|NCT02863354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110788387|NCT02859454|Avelumab|avelumab|mesh-list
110788388|NCT02859454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110788389|NCT02859454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110506008|NCT02826252|Iloprost|iloprost|mesh-list
110788390|NCT02862730|Pancrelipase|pancrelipase|mesh-list
110788391|NCT02862730|Pancreatin|pancreatin|mesh-list
110788392|NCT02862730|Hormones|hormones|mesh-list
110788393|NCT02862730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110788394|NCT02862730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110788395|NCT02862730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110788396|NCT03609970|Vitamin D|vitamin d|mesh-list
110788397|NCT03609970|Vitamins|vitamins|mesh-ancestor
110788398|NCT03609970|Micronutrients|micronutrients|mesh-ancestor
110788399|NCT03609970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110788400|NCT03609970|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110788401|NCT03610282|Propofol|propofol|mesh-list
110788402|NCT03610282|Methylphenidate|methylphenidate|mesh-list
110788404|NCT03610282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110788405|NCT03610282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110788406|NCT03610282|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110788407|NCT03610282|Anesthetics, General|anesthetics, general|mesh-ancestor
110788408|NCT03610282|Anesthetics|anesthetics|mesh-ancestor
110850880|NCT03819101|Antipyretics|antipyretics|mesh-ancestor
110788409|NCT03610282|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110788410|NCT03610282|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110788411|NCT03610282|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110788412|NCT03610282|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110788413|NCT03610282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110788414|NCT03610282|Dopamine Agents|dopamine agents|mesh-ancestor
110788415|NCT03610282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110788416|NCT02862574|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
110788417|NCT02862574|Methotrexate|methotrexate|mesh-list
110498255|NCT00685347|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110788418|NCT02862574|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110788419|NCT02862574|Abortifacient Agents|abortifacient agents|mesh-ancestor
110788420|NCT02862574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110788421|NCT02862574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110788422|NCT02862574|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110788423|NCT02862574|Antimetabolites|antimetabolites|mesh-ancestor
110788424|NCT02862574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110788425|NCT02862574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110788426|NCT02862574|Dermatologic Agents|dermatologic agents|mesh-ancestor
110788427|NCT02862574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110788428|NCT02862574|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110788429|NCT02862574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110788430|NCT02862574|Immunologic Factors|immunologic factors|mesh-ancestor
110788431|NCT02862574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110788432|NCT02862574|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110788433|NCT02862574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110788434|NCT05383300|Oxytocin|oxytocin|mesh-list
110788435|NCT05383300|Oxytocics|oxytocics|mesh-ancestor
110788436|NCT05383300|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110788437|NCT05383300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110788438|NCT03712046|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110788439|NCT03712046|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110788440|NCT03712046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110788441|NCT02862106|Vaccines|vaccines|mesh-list
110788442|NCT02862106|Immunologic Factors|immunologic factors|mesh-ancestor
110788443|NCT02862106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110788444|NCT03609892|Amoxicillin|amoxicillin|mesh-list
110788445|NCT03609892|Tetracycline|tetracycline|mesh-list
110788446|NCT03609892|Furazolidone|furazolidone|mesh-list
110788447|NCT03609892|Esomeprazole|esomeprazole|mesh-list
110788448|NCT03609892|Bismuth|bismuth|mesh-list
110788449|NCT03609892|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110788450|NCT03609892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110788451|NCT03609892|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110788452|NCT03609892|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110788453|NCT03609892|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110788454|NCT03609892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110788455|NCT03609892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110788456|NCT03609892|Antacids|antacids|mesh-ancestor
110788457|NCT03609892|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110788458|NCT03609892|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110788459|NCT03609892|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110788460|NCT03609892|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
110788461|NCT03609892|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110788462|NCT03609892|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110788463|NCT03609892|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
110788464|NCT03609814|Fludarabine|fludarabine|mesh-list
110788465|NCT03609814|Clofarabine|clofarabine|mesh-list
110788466|NCT03609814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110506083|NCT02839694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110788467|NCT03609814|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110788468|NCT03609814|Antimetabolites|antimetabolites|mesh-ancestor
110788469|NCT03609814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110788470|NCT02457598|Obinutuzumab|obinutuzumab|mesh-list
110788471|NCT02457598|Idelalisib|idelalisib|mesh-list
110788472|NCT02457598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110788473|NCT02457598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110788474|NCT02457598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110788475|NCT02457598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110788476|NCT02859142|Nicotine|nicotine|mesh-list
110788477|NCT02859142|Varenicline|varenicline|mesh-list
110788478|NCT02859142|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110788479|NCT02859142|Autonomic Agents|autonomic agents|mesh-ancestor
110788480|NCT02859142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110788481|NCT02859142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110788482|NCT02859142|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110788483|NCT02859142|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110788484|NCT02859142|Cholinergic Agents|cholinergic agents|mesh-ancestor
110788485|NCT02859142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110788486|NCT02859142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110788487|NCT03351608|Atropine|atropine|mesh-list
110788488|NCT03351608|Glycopyrrolate|glycopyrrolate|mesh-list
110788489|NCT03351608|Neostigmine|neostigmine|mesh-list
110788490|NCT03351608|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110788491|NCT03351608|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110788492|NCT03351608|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110788493|NCT03351608|Autonomic Agents|autonomic agents|mesh-ancestor
110788494|NCT03351608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110788495|NCT03351608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110788496|NCT03351608|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110788497|NCT03351608|Respiratory System Agents|respiratory system agents|mesh-ancestor
110788498|NCT03351608|Mydriatics|mydriatics|mesh-ancestor
110788499|NCT03351608|Parasympatholytics|parasympatholytics|mesh-ancestor
110788500|NCT03351608|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110788501|NCT03351608|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110788502|NCT03351608|Cholinergic Agents|cholinergic agents|mesh-ancestor
110788503|NCT03351608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110788504|NCT03351608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110788505|NCT03351608|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110788506|NCT03351608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110788507|NCT03351608|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110788508|NCT03382418|Aluminum Hydroxide|aluminum hydroxide|mesh-list
110788509|NCT03382418|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110788510|NCT03382418|Immunologic Factors|immunologic factors|mesh-ancestor
110788511|NCT03382418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110788512|NCT03382418|Antacids|antacids|mesh-ancestor
110788513|NCT03382418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110788514|NCT03382418|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110788515|NCT03382262|Triamcinolone|triamcinolone|mesh-list
110788516|NCT03382262|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110788517|NCT03382262|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110788518|NCT03382262|FX006|fx006|mesh-list
110788519|NCT03382262|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110788520|NCT03382262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110788521|NCT03382262|Glucocorticoids|glucocorticoids|mesh-ancestor
110788522|NCT03382262|Hormones|hormones|mesh-ancestor
110788523|NCT03382262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110788524|NCT03382262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110788525|NCT03382262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110788526|NCT03382262|Immunologic Factors|immunologic factors|mesh-ancestor
110788527|NCT03382262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110788528|NCT03382262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110788529|NCT02236936|Cetuximab|cetuximab|mesh-list
110788530|NCT02236936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110788531|NCT02236936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110788532|NCT03638960|Bupivacaine|bupivacaine|mesh-list
110788533|NCT03638960|Anesthetics, Local|anesthetics, local|mesh-ancestor
110788534|NCT03638960|Anesthetics|anesthetics|mesh-ancestor
110788535|NCT03638960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110788536|NCT03638960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110788537|NCT03638960|Sensory System Agents|sensory system agents|mesh-ancestor
110788538|NCT03638960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110788539|NCT02259790|Amlodipine|amlodipine|mesh-list
110506154|NCT02826174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
110788540|NCT02259790|Telmisartan|telmisartan|mesh-list
110788541|NCT02259790|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
110788542|NCT02259790|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110788543|NCT02259790|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110788544|NCT02259790|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110788545|NCT02259790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110788546|NCT02259790|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110788547|NCT02259790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110788548|NCT02259790|Vasodilator Agents|vasodilator agents|mesh-ancestor
110788549|NCT02259790|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110788550|NCT02259790|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110788551|NCT02857270|Paclitaxel|paclitaxel|mesh-list
110788552|NCT02857270|Gemcitabine|gemcitabine|mesh-list
110788553|NCT02857270|Cetuximab|cetuximab|mesh-list
110788554|NCT02857270|Midazolam|midazolam|mesh-list
110788555|NCT02857270|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110788556|NCT02857270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110788557|NCT02857270|Tubulin Modulators|tubulin modulators|mesh-ancestor
110788558|NCT02857270|Antimitotic Agents|antimitotic agents|mesh-ancestor
110788559|NCT02857270|Mitosis Modulators|mitosis modulators|mesh-ancestor
110788560|NCT02857270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110788561|NCT02857270|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110788562|NCT02857270|Antimetabolites|antimetabolites|mesh-ancestor
110788563|NCT02857270|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110788564|NCT02857270|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110788565|NCT02857270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110788566|NCT02857270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110788567|NCT02857270|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110788568|NCT02857270|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110788569|NCT02857270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110788570|NCT02857270|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110788571|NCT02857270|Anesthetics, General|anesthetics, general|mesh-ancestor
110788572|NCT02857270|Anesthetics|anesthetics|mesh-ancestor
110788573|NCT02857270|GABA Modulators|gaba modulators|mesh-ancestor
110788574|NCT02857270|GABA Agents|gaba agents|mesh-ancestor
110788575|NCT02857270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110788576|NCT02857270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110788577|NCT03609190|Ketamine|ketamine|mesh-list
110788578|NCT03609190|Analgesics|analgesics|mesh-ancestor
110788579|NCT03609190|Sensory System Agents|sensory system agents|mesh-ancestor
110788580|NCT03609190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110788581|NCT03609190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110788582|NCT03609190|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110788583|NCT03609190|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110788584|NCT03609190|Anesthetics, General|anesthetics, general|mesh-ancestor
110788585|NCT03609190|Anesthetics|anesthetics|mesh-ancestor
110788586|NCT03609190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110788587|NCT03609190|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110788588|NCT03609190|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110788589|NCT03609190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110788590|NCT03609190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110788591|NCT02856880|Zinc|zinc|mesh-list
110788592|NCT02856880|Trace Elements|trace elements|mesh-ancestor
110788593|NCT02856880|Micronutrients|micronutrients|mesh-ancestor
110788594|NCT02856880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110788595|NCT02856802|Sumatriptan|sumatriptan|mesh-list
110788596|NCT02856802|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110788597|NCT02856802|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110788598|NCT02856802|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110788599|NCT02856802|Serotonin Agents|serotonin agents|mesh-ancestor
110788600|NCT02856802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110788601|NCT02856802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110788602|NCT02856802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110788603|NCT03381248|Hyaluronic Acid|hyaluronic acid|mesh-list
110788604|NCT03381248|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110788605|NCT03381248|Immunologic Factors|immunologic factors|mesh-ancestor
110788606|NCT03381248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110498369|NCT00924950|Betamethasone|betamethasone|mesh-list
110788607|NCT03381248|Viscosupplements|viscosupplements|mesh-ancestor
110788608|NCT03381248|Protective Agents|protective agents|mesh-ancestor
110788609|NCT02024230|Warfarin|warfarin|mesh-list
110788610|NCT02024230|Rivaroxaban|rivaroxaban|mesh-list
110788611|NCT02024230|Anticoagulants|anticoagulants|mesh-ancestor
110788612|NCT02024230|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110788613|NCT02024230|Antithrombins|antithrombins|mesh-ancestor
110788614|NCT02024230|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110788615|NCT02024230|Protease Inhibitors|protease inhibitors|mesh-ancestor
110506230|NCT05660382|Miconazole|miconazole|mesh-list
110788616|NCT02024230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110788617|NCT02024230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110788618|NCT03380390|Phenylephrine|phenylephrine|mesh-list
110788619|NCT03380390|Oxymetazoline|oxymetazoline|mesh-list
110788620|NCT03380390|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110788621|NCT03380390|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110788622|NCT03380390|Adrenergic Agents|adrenergic agents|mesh-ancestor
110788623|NCT03380390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110788624|NCT03380390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110788625|NCT03380390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110788626|NCT03380390|Sympathomimetics|sympathomimetics|mesh-ancestor
110788627|NCT03380390|Autonomic Agents|autonomic agents|mesh-ancestor
110788628|NCT03380390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110788629|NCT03380390|Nasal Decongestants|nasal decongestants|mesh-ancestor
110788630|NCT03380390|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110788631|NCT03380390|Respiratory System Agents|respiratory system agents|mesh-ancestor
110788632|NCT03380390|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110788633|NCT03380390|Mydriatics|mydriatics|mesh-ancestor
110788634|NCT03380390|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110788635|NCT03380390|Protective Agents|protective agents|mesh-ancestor
110788636|NCT01935778|Docetaxel|docetaxel|mesh-list
110788637|NCT01935778|Capecitabine|capecitabine|mesh-list
110788638|NCT01935778|Oxaliplatin|oxaliplatin|mesh-list
110788639|NCT01935778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110788640|NCT01935778|Tubulin Modulators|tubulin modulators|mesh-ancestor
110788641|NCT01935778|Antimitotic Agents|antimitotic agents|mesh-ancestor
110788642|NCT01935778|Mitosis Modulators|mitosis modulators|mesh-ancestor
110788643|NCT01935778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110788644|NCT01935778|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110788645|NCT01935778|Antimetabolites|antimetabolites|mesh-ancestor
110788646|NCT02034292|Aspirin|aspirin|mesh-list
110788647|NCT02034292|Clopidogrel|clopidogrel|mesh-list
110788648|NCT02034292|APD791|apd791|mesh-list
110788649|NCT02034292|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110788650|NCT02034292|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110788651|NCT02034292|Analgesics|analgesics|mesh-ancestor
110788652|NCT02034292|Sensory System Agents|sensory system agents|mesh-ancestor
110788653|NCT02034292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110788654|NCT02034292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110788655|NCT02034292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110788656|NCT02034292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110788657|NCT02034292|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110788658|NCT02034292|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110788659|NCT02034292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110788660|NCT02034292|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110788661|NCT02034292|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110788662|NCT02034292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110788663|NCT02034292|Antipyretics|antipyretics|mesh-ancestor
110788664|NCT02034292|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110788665|NCT02034292|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110788666|NCT02034292|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110788667|NCT02034292|Purinergic Agents|purinergic agents|mesh-ancestor
110788668|NCT02034292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110788669|NCT02034292|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110788670|NCT02034292|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110788671|NCT02034292|Serotonin Agents|serotonin agents|mesh-ancestor
110788672|NCT01758328|Fludarabine|fludarabine|mesh-list
110788673|NCT01758328|Melphalan|melphalan|mesh-list
110788674|NCT01758328|Busulfan|busulfan|mesh-list
110788675|NCT01758328|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110788676|NCT01758328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110788677|NCT01758328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110788678|NCT01758328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110788679|NCT01758328|Immunologic Factors|immunologic factors|mesh-ancestor
110788680|NCT01758328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110788681|NCT01758328|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110788682|NCT01758328|Alkylating Agents|alkylating agents|mesh-ancestor
110788683|NCT01758328|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110788684|NCT04125550|Propofol|propofol|mesh-list
110788685|NCT04125550|Sevoflurane|sevoflurane|mesh-list
110788686|NCT04125550|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110788687|NCT04125550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110788688|NCT04125550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110850898|NCT05199324|Antimalarials|antimalarials|mesh-ancestor
110788689|NCT04125550|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110788690|NCT04125550|Anesthetics, General|anesthetics, general|mesh-ancestor
110788692|NCT04125550|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110788693|NCT04125550|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110788694|NCT02237326|Acetic Acid|acetic acid|mesh-list
110788695|NCT02237326|Retinol acetate|retinol acetate|mesh-list
110788696|NCT02237326|Lugol's solution|lugol's solution|mesh-list
110788697|NCT02237326|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110788698|NCT02237326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110788699|NCT02237326|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110788700|NCT02237326|Immunologic Factors|immunologic factors|mesh-ancestor
110788701|NCT02237326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110788702|NCT02237326|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110788703|NCT02237326|Protective Agents|protective agents|mesh-ancestor
110788704|NCT02237326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110788705|NCT02237326|Hemostatics|hemostatics|mesh-ancestor
110788706|NCT02237326|Coagulants|coagulants|mesh-ancestor
110788707|NCT02034604|Tamsulosin|tamsulosin|mesh-list
110788708|NCT02034604|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110788709|NCT02034604|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110788710|NCT02034604|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110788711|NCT02034604|Adrenergic Agents|adrenergic agents|mesh-ancestor
110788712|NCT02034604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110788713|NCT02034604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110788714|NCT02034604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110788715|NCT02034604|Urological Agents|urological agents|mesh-ancestor
110788716|NCT03608098|Oxymetazoline|oxymetazoline|mesh-list
110788717|NCT03608098|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110788718|NCT03608098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110788719|NCT03608098|Adrenergic Agents|adrenergic agents|mesh-ancestor
110788720|NCT03608098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110788721|NCT03608098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110498407|NCT00802243|Leflunomide|leflunomide|mesh-list
110788722|NCT03608098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110788723|NCT03608098|Sympathomimetics|sympathomimetics|mesh-ancestor
110788724|NCT03608098|Autonomic Agents|autonomic agents|mesh-ancestor
110788725|NCT03608098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110788726|NCT03608098|Nasal Decongestants|nasal decongestants|mesh-ancestor
110788727|NCT03608098|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110788728|NCT03608098|Respiratory System Agents|respiratory system agents|mesh-ancestor
110788729|NCT02035072|Gemcitabine|gemcitabine|mesh-list
110788730|NCT02035072|Oxaliplatin|oxaliplatin|mesh-list
110788731|NCT02035072|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110788732|NCT02035072|Antimetabolites|antimetabolites|mesh-ancestor
110788733|NCT02035072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110788734|NCT02035072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110788735|NCT00358215|Darbepoetin alfa|darbepoetin alfa|mesh-list
110788736|NCT00358215|Hematinics|hematinics|mesh-ancestor
110788737|NCT03605758|Ivermectin|ivermectin|mesh-list
110788738|NCT03605758|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110788739|NCT03605758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110788740|NCT03605056|Dexamethasone|dexamethasone|mesh-list
110788741|NCT03605056|Lenalidomide|lenalidomide|mesh-list
110788742|NCT03605056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110788743|NCT03605056|Antiemetics|antiemetics|mesh-ancestor
110788744|NCT03605056|Autonomic Agents|autonomic agents|mesh-ancestor
110788745|NCT03605056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110788746|NCT03605056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110788747|NCT03605056|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110788748|NCT03605056|Glucocorticoids|glucocorticoids|mesh-ancestor
110788749|NCT03605056|Hormones|hormones|mesh-ancestor
110788750|NCT03605056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110788751|NCT03605056|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110788752|NCT03605056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110788753|NCT03605056|Immunologic Factors|immunologic factors|mesh-ancestor
110788754|NCT03605056|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110788755|NCT03605056|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110788756|NCT03605056|Growth Substances|growth substances|mesh-ancestor
110788757|NCT03605056|Growth Inhibitors|growth inhibitors|mesh-ancestor
110788758|NCT01002742|Mycophenolic Acid|mycophenolic acid|mesh-list
110788759|NCT01002742|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110788760|NCT01002742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110788761|NCT01002742|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110788762|NCT01002742|Antitubercular Agents|antitubercular agents|mesh-ancestor
110788763|NCT01002742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110788764|NCT01002742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110788765|NCT01002742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110788766|NCT01002742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110506377|NCT00845689|Sensory System Agents|sensory system agents|mesh-ancestor
110788767|NCT03604744|Psilocybin|psilocybin|mesh-list
110788768|NCT03604744|Hallucinogens|hallucinogens|mesh-ancestor
110788769|NCT03604744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110788770|NCT03604744|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110788771|NCT03604354|Pregabalin|pregabalin|mesh-list
110788772|NCT03604354|Tapentadol|tapentadol|mesh-list
110788773|NCT03604354|Analgesics|analgesics|mesh-ancestor
110788774|NCT03604354|Sensory System Agents|sensory system agents|mesh-ancestor
110788775|NCT03604354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110788776|NCT03604354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110788777|NCT03604354|Anticonvulsants|anticonvulsants|mesh-ancestor
110788778|NCT03604354|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110788779|NCT03604354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110788780|NCT03604354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110788781|NCT03604354|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110788782|NCT03604354|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110788783|NCT03604354|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110788784|NCT03604354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110788785|NCT03604354|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110788786|NCT03604354|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110788787|NCT03604354|Narcotics|narcotics|mesh-ancestor
110788788|NCT03604354|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110788789|NCT03604354|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110788790|NCT03604354|Adrenergic Agents|adrenergic agents|mesh-ancestor
110788791|NCT03604354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110788792|NCT03603418|Dexamethasone|dexamethasone|mesh-list
110788793|NCT03603418|Dexamethasone acetate|dexamethasone acetate|mesh-list
110788794|NCT03603418|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
110788795|NCT03603418|BB 1101|bb 1101|mesh-list
110498463|NCT00797485|Antimetabolites|antimetabolites|mesh-ancestor
110788796|NCT03603418|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110788797|NCT03603418|Antiemetics|antiemetics|mesh-ancestor
110788798|NCT03603418|Autonomic Agents|autonomic agents|mesh-ancestor
110788799|NCT03603418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110788800|NCT03603418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110788801|NCT03603418|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110788802|NCT03603418|Glucocorticoids|glucocorticoids|mesh-ancestor
110788803|NCT03603418|Hormones|hormones|mesh-ancestor
110788804|NCT03603418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110788805|NCT03603418|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110788806|NCT03603418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110788807|NCT03603418|Protease Inhibitors|protease inhibitors|mesh-ancestor
110788808|NCT03603418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110788809|NCT03603418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110788810|NCT02034838|Ritonavir|ritonavir|mesh-list
110788811|NCT02034838|Atazanavir Sulfate|atazanavir sulfate|mesh-list
110788812|NCT02034838|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110788813|NCT02034838|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110788814|NCT02034838|Protease Inhibitors|protease inhibitors|mesh-ancestor
110788815|NCT02034838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110788816|NCT02034838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110788817|NCT02034838|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110788818|NCT02034838|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110788819|NCT02034838|Antiviral Agents|antiviral agents|mesh-ancestor
110788820|NCT02034838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110788821|NCT02034838|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110788822|NCT02034838|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110788823|NCT02852434|Lidocaine|lidocaine|mesh-list
110788824|NCT02852434|Anesthetics, Local|anesthetics, local|mesh-ancestor
110788825|NCT02852434|Anesthetics|anesthetics|mesh-ancestor
110788826|NCT02852434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110788827|NCT02852434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110788828|NCT02852434|Sensory System Agents|sensory system agents|mesh-ancestor
110788829|NCT02852434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110850906|NCT03343366|Metronidazole|metronidazole|mesh-list
110788831|NCT02852434|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110788832|NCT02852434|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110788833|NCT02852434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110788834|NCT02852434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110788835|NCT03606928|Leucovorin|leucovorin|mesh-list
110788836|NCT03606928|Docetaxel|docetaxel|mesh-list
110788837|NCT03606928|Oxaliplatin|oxaliplatin|mesh-list
110788838|NCT03606928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110788839|NCT03606928|Tubulin Modulators|tubulin modulators|mesh-ancestor
110788840|NCT03606928|Antimitotic Agents|antimitotic agents|mesh-ancestor
110788841|NCT03606928|Mitosis Modulators|mitosis modulators|mesh-ancestor
110788842|NCT03606928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110788843|NCT03606928|Antidotes|antidotes|mesh-ancestor
110788844|NCT03606928|Protective Agents|protective agents|mesh-ancestor
110788845|NCT03606928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110788846|NCT03606928|Vitamin B Complex|vitamin b complex|mesh-ancestor
110788847|NCT03606928|Vitamins|vitamins|mesh-ancestor
110788848|NCT03606928|Micronutrients|micronutrients|mesh-ancestor
110788849|NCT03602248|Methamphetamine|methamphetamine|mesh-list
110788850|NCT03602248|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110788851|NCT03602248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110788852|NCT03602248|Sympathomimetics|sympathomimetics|mesh-ancestor
110788853|NCT03602248|Autonomic Agents|autonomic agents|mesh-ancestor
110788854|NCT03602248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110788855|NCT03602248|Dopamine Agents|dopamine agents|mesh-ancestor
110788856|NCT03602248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110788857|NCT03602248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110788858|NCT03602248|Adrenergic Agents|adrenergic agents|mesh-ancestor
110788859|NCT03602248|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110788860|NCT03602248|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110788861|NCT03602248|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110788862|NCT03602248|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110788863|NCT03602638|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110788864|NCT03602638|Acarbose|acarbose|mesh-list
110788865|NCT03602638|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110788866|NCT03602638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110788867|NCT03602638|Incretins|incretins|mesh-ancestor
110788868|NCT03602638|Hormones|hormones|mesh-ancestor
110788869|NCT03602638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110788870|NCT03602638|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110788871|NCT03602638|Protease Inhibitors|protease inhibitors|mesh-ancestor
110788872|NCT03602638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110788873|NCT03602638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110788874|NCT03602638|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
110788875|NCT02237560|Camphor|camphor|mesh-list
110788876|NCT02237560|Salicylates|salicylates|mesh-list
110788877|NCT02237560|Methyl salicylate|methyl salicylate|mesh-list
110788878|NCT02237560|Menthol|menthol|mesh-list
110788879|NCT02237560|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110788880|NCT02237560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110788881|NCT02237560|Antipruritics|antipruritics|mesh-ancestor
110788882|NCT02237560|Dermatologic Agents|dermatologic agents|mesh-ancestor
110788883|NCT02237560|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110788884|NCT02237560|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110788885|NCT02237560|Analgesics|analgesics|mesh-ancestor
110788886|NCT02237560|Sensory System Agents|sensory system agents|mesh-ancestor
110788887|NCT02237560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110788888|NCT02237560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110788889|NCT02237560|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110788890|NCT02237560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110788891|NCT02237560|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110788892|NCT02237560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110788893|NCT02237560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110788894|NCT03601624|Dexamethasone|dexamethasone|mesh-list
110788895|NCT03601624|Cyclophosphamide|cyclophosphamide|mesh-list
110788896|NCT03601624|Pomalidomide|pomalidomide|mesh-list
110788897|NCT03601624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110788898|NCT03601624|Immunologic Factors|immunologic factors|mesh-ancestor
110788899|NCT03601624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110788900|NCT03601624|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110788901|NCT03601624|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110788902|NCT03601624|Alkylating Agents|alkylating agents|mesh-ancestor
110498525|NCT00687999|Interferons|interferons|mesh-list
110788903|NCT03601624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110788904|NCT03601624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110788905|NCT03601624|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110788906|NCT03601624|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110788907|NCT03601624|Antiemetics|antiemetics|mesh-ancestor
110788908|NCT03601624|Autonomic Agents|autonomic agents|mesh-ancestor
110788909|NCT03601624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110788910|NCT03601624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110788911|NCT03601624|Glucocorticoids|glucocorticoids|mesh-ancestor
110788913|NCT03601624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110788914|NCT03601624|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110788915|NCT03601624|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110788916|NCT03601624|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110788917|NCT03601624|Growth Substances|growth substances|mesh-ancestor
110788918|NCT03601624|Growth Inhibitors|growth inhibitors|mesh-ancestor
110788920|NCT03899428|Durvalumab|durvalumab|mesh-list
110788921|NCT03899428|Lenvatinib|lenvatinib|mesh-list
110788922|NCT03899428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110788923|NCT03899428|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110788924|NCT03899428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110788925|NCT03899428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110788926|NCT03899428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110788928|NCT02238418|Vitamin D|vitamin d|mesh-list
110788929|NCT02238418|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110788930|NCT02238418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110788931|NCT02238418|Vitamins|vitamins|mesh-ancestor
110788932|NCT02238418|Micronutrients|micronutrients|mesh-ancestor
110788933|NCT02238418|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110788934|NCT02850016|Romidepsin|romidepsin|mesh-list
110788935|NCT02850016|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
110788936|NCT02850016|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110788937|NCT02850016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110788938|NCT02850016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110788939|NCT02850016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110788940|NCT02849704|Pancrelipase|pancrelipase|mesh-list
110788941|NCT02849704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110788942|NCT03600766|Mirabegron|mirabegron|mesh-list
110788943|NCT03600766|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
110788944|NCT03600766|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110788945|NCT03600766|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110788946|NCT03600766|Adrenergic Agents|adrenergic agents|mesh-ancestor
110788947|NCT03600766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110788948|NCT03600766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110788949|NCT03600766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110788950|NCT03600766|Urological Agents|urological agents|mesh-ancestor
110788951|NCT03600454|Anesthetics|anesthetics|mesh-list
110788952|NCT03600454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110788953|NCT03600454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110788954|NCT03594604|Contraceptive Agents|contraceptive agents|mesh-list
110788955|NCT03594604|Norethindrone|norethindrone|mesh-list
110788956|NCT03594604|Norethindrone Acetate|norethindrone acetate|mesh-list
110788957|NCT03594604|Contraceptives, Oral|contraceptives, oral|mesh-list
110788958|NCT03594604|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
110788959|NCT03594604|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110788960|NCT03594604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110788961|NCT03594604|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110788962|NCT03594604|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110788963|NCT03594604|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110788964|NCT03594604|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110788965|NCT02689258|Bupivacaine|bupivacaine|mesh-list
110788966|NCT02689258|Anesthetics, Local|anesthetics, local|mesh-ancestor
110788967|NCT02689258|Anesthetics|anesthetics|mesh-ancestor
110788968|NCT02689258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110788969|NCT02689258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110788970|NCT02689258|Sensory System Agents|sensory system agents|mesh-ancestor
110788971|NCT02689258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110788972|NCT02238184|Ipratropium|ipratropium|mesh-list
110788973|NCT02238184|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110788975|NCT02238184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110788976|NCT02238184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110788977|NCT02238184|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110788978|NCT02238184|Respiratory System Agents|respiratory system agents|mesh-ancestor
110788979|NCT02238184|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110788980|NCT02238184|Cholinergic Agents|cholinergic agents|mesh-ancestor
110788981|NCT02238184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110788982|NCT02238184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110788983|NCT03592498|Sulfadiazine|sulfadiazine|mesh-list
110788984|NCT03592498|Silver Sulfadiazine|silver sulfadiazine|mesh-list
110788985|NCT03592498|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110788986|NCT03592498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110788987|NCT03592498|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110788988|NCT03592498|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110788989|NCT03592498|Coccidiostats|coccidiostats|mesh-ancestor
110788990|NCT03592498|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110788991|NCT03600064|Misoprostol|misoprostol|mesh-list
110788992|NCT03600064|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110506610|NCT00620113|Antacids|antacids|mesh-ancestor
110788993|NCT03600064|Abortifacient Agents|abortifacient agents|mesh-ancestor
110788994|NCT03600064|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110788995|NCT03600064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110788996|NCT03600064|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110788997|NCT03600064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110788998|NCT03600064|Oxytocics|oxytocics|mesh-ancestor
110788999|NCT02721082|Nicotine|nicotine|mesh-list
110498574|NCT00687843|Antiviral Agents|antiviral agents|mesh-ancestor
110789000|NCT02721082|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110789001|NCT02721082|Autonomic Agents|autonomic agents|mesh-ancestor
110789002|NCT02721082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110789003|NCT02721082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110789004|NCT02721082|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110789005|NCT02721082|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110789006|NCT02721082|Cholinergic Agents|cholinergic agents|mesh-ancestor
110789007|NCT02721082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110789008|NCT02721082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110789009|NCT02238106|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110789010|NCT02238106|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110789011|NCT02238106|Autonomic Agents|autonomic agents|mesh-ancestor
110789012|NCT02238106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110789013|NCT02238106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110789014|NCT02238106|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110789015|NCT02238106|Respiratory System Agents|respiratory system agents|mesh-ancestor
110789016|NCT02238106|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110789017|NCT02238106|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110789018|NCT02238106|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110789019|NCT02238106|Adrenergic Agents|adrenergic agents|mesh-ancestor
110789020|NCT02238106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110789021|NCT02238106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110789022|NCT03577912|Anesthetics|anesthetics|mesh-list
110789023|NCT03577912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110789024|NCT03577912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110789025|NCT02238262|Telmisartan|telmisartan|mesh-list
110789026|NCT02238262|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110789027|NCT02238262|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110789028|NCT02238262|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110789029|NCT02238262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110789030|NCT03577834|Acetic Acid|acetic acid|mesh-list
110789031|NCT03577834|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110789032|NCT03577834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110789033|NCT03707678|Albuterol|albuterol|mesh-list
110789034|NCT03707678|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110789035|NCT03707678|Autonomic Agents|autonomic agents|mesh-ancestor
110789036|NCT03707678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110789037|NCT03707678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110789038|NCT03707678|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110789039|NCT03707678|Respiratory System Agents|respiratory system agents|mesh-ancestor
110789040|NCT03707678|Tocolytic Agents|tocolytic agents|mesh-ancestor
110850919|NCT01298297|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110789041|NCT03707678|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110789042|NCT03707678|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110789043|NCT03707678|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110789044|NCT03707678|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110789045|NCT03707678|Adrenergic Agents|adrenergic agents|mesh-ancestor
110789046|NCT03707678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110789047|NCT03707678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110789049|NCT03334448|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110789050|NCT03334448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110789051|NCT04773002|Anesthetics|anesthetics|mesh-list
110789052|NCT04773002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110789053|NCT04773002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110789054|NCT02849080|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110789055|NCT02849080|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110789056|NCT02849080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110789057|NCT02849080|Incretins|incretins|mesh-ancestor
110789058|NCT02849080|Hormones|hormones|mesh-ancestor
110789059|NCT02849080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110789060|NCT02849080|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110789061|NCT02849080|Protease Inhibitors|protease inhibitors|mesh-ancestor
110789062|NCT02849080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110789063|NCT02849080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110789064|NCT03346070|Glycopyrrolate|glycopyrrolate|mesh-list
110789065|NCT03346070|Rocuronium|rocuronium|mesh-list
110789066|NCT03346070|Vecuronium Bromide|vecuronium bromide|mesh-list
110789067|NCT03346070|Neostigmine|neostigmine|mesh-list
110789068|NCT03346070|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110789069|NCT03346070|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110789070|NCT03346070|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110789071|NCT03346070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110789072|NCT03346070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110789073|NCT03346070|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110789074|NCT03346070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110789075|NCT03346070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110789076|NCT03346070|Cholinergic Agents|cholinergic agents|mesh-ancestor
110789077|NCT03346070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110789078|NCT03346070|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110789079|NCT03346070|Autonomic Agents|autonomic agents|mesh-ancestor
110789080|NCT03346070|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110789081|NCT03346070|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110789082|NCT03346070|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110789083|NCT03346070|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
110789085|NCT03590626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110789086|NCT03590626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110789087|NCT02238340|Ketoprofen|ketoprofen|mesh-list
110789088|NCT02238340|Morphine|morphine|mesh-list
110789089|NCT02238340|Oxycodone|oxycodone|mesh-list
110789090|NCT02238340|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110789091|NCT02238340|Narcotics|narcotics|mesh-ancestor
110789092|NCT02238340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110789093|NCT02238340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110789094|NCT02238340|Analgesics|analgesics|mesh-ancestor
110789095|NCT02238340|Sensory System Agents|sensory system agents|mesh-ancestor
110789096|NCT02238340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110789097|NCT02238340|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110789098|NCT02238340|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110789099|NCT02238340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110789100|NCT02238340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110789101|NCT02238340|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110789102|NCT02238340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110789103|NCT02238340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110789104|NCT03577132|Atezolizumab|atezolizumab|mesh-list
110789105|NCT03577132|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110789106|NCT03577132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110789107|NCT03577132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110789108|NCT03577132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110789109|NCT02250664|Nicotine|nicotine|mesh-list
110789110|NCT02250664|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110789111|NCT02250664|Autonomic Agents|autonomic agents|mesh-ancestor
110789112|NCT02250664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110789113|NCT02250664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110789114|NCT02250664|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110498668|NCT00689559|Serotonin Agents|serotonin agents|mesh-ancestor
110789115|NCT02250664|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110789116|NCT02250664|Cholinergic Agents|cholinergic agents|mesh-ancestor
110789117|NCT02250664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110789118|NCT02250664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110789119|NCT02239276|Stiripentol|stiripentol|mesh-list
110789120|NCT02239276|Anticonvulsants|anticonvulsants|mesh-ancestor
110789121|NCT03576820|Lidocaine|lidocaine|mesh-list
110789122|NCT03576820|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110789123|NCT03576820|Anesthetics, Local|anesthetics, local|mesh-ancestor
110789124|NCT03576820|Anesthetics|anesthetics|mesh-ancestor
110789125|NCT03576820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110789126|NCT03576820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110789127|NCT03576820|Sensory System Agents|sensory system agents|mesh-ancestor
110789128|NCT03576820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110789129|NCT03576820|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110789130|NCT03576820|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110789131|NCT03576820|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110789132|NCT03576820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110789133|NCT03576820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110789134|NCT03579082|Decitabine|decitabine|mesh-list
110789135|NCT03579082|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110789136|NCT03579082|Antimetabolites|antimetabolites|mesh-ancestor
110789137|NCT03579082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110789138|NCT03579082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110789139|NCT03579082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110789140|NCT03579004|Paclitaxel|paclitaxel|mesh-list
110789141|NCT03579004|Fluorouracil|fluorouracil|mesh-list
110789142|NCT03579004|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110789143|NCT03579004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110789144|NCT03579004|Tubulin Modulators|tubulin modulators|mesh-ancestor
110789145|NCT03579004|Antimitotic Agents|antimitotic agents|mesh-ancestor
110789146|NCT03579004|Mitosis Modulators|mitosis modulators|mesh-ancestor
110789147|NCT03579004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110789148|NCT03579004|Antimetabolites|antimetabolites|mesh-ancestor
110789149|NCT03579004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110789150|NCT03579004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110789151|NCT03579004|Immunologic Factors|immunologic factors|mesh-ancestor
110789152|NCT03579004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110789153|NCT03576508|Lidocaine|lidocaine|mesh-list
110789154|NCT03576508|Epinephrine|epinephrine|mesh-list
110789155|NCT03576508|Capsaicin|capsaicin|mesh-list
110789156|NCT03576508|Anesthetics, Local|anesthetics, local|mesh-ancestor
110789157|NCT03576508|Anesthetics|anesthetics|mesh-ancestor
110789158|NCT03576508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110789159|NCT03576508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110789160|NCT03576508|Sensory System Agents|sensory system agents|mesh-ancestor
110789161|NCT03576508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110789162|NCT03576508|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110789163|NCT03576508|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110789164|NCT03576508|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110789165|NCT03576508|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110789166|NCT03576508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110789167|NCT03576508|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110789168|NCT03576508|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110789169|NCT03576508|Adrenergic Agents|adrenergic agents|mesh-ancestor
110789170|NCT03576508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110789171|NCT03576508|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110789172|NCT03576508|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110789173|NCT03576508|Autonomic Agents|autonomic agents|mesh-ancestor
110789174|NCT03576508|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110789175|NCT03576508|Respiratory System Agents|respiratory system agents|mesh-ancestor
110789176|NCT03576508|Mydriatics|mydriatics|mesh-ancestor
110789177|NCT03576508|Sympathomimetics|sympathomimetics|mesh-ancestor
110789178|NCT03576508|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110789179|NCT03576508|Antipruritics|antipruritics|mesh-ancestor
110789180|NCT03576508|Dermatologic Agents|dermatologic agents|mesh-ancestor
110789182|NCT02646982|Candesartan cilexetil|candesartan cilexetil|mesh-list
110789183|NCT02646982|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110789184|NCT02646982|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110789185|NCT02646982|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110789186|NCT02646982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110789187|NCT03576040|Edotreotide|edotreotide|mesh-list
110789188|NCT03576040|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110789189|NCT03576040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110789190|NCT03574246|Chlorhexidine|chlorhexidine|mesh-list
110789191|NCT03574246|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110789192|NCT03574246|Benzydamine|benzydamine|mesh-list
110789193|NCT03574246|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110789194|NCT03574246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110498768|NCT00912639|genexol-PM|genexol-pm|mesh-list
110789195|NCT03574246|Disinfectants|disinfectants|mesh-ancestor
110789196|NCT03574246|Dermatologic Agents|dermatologic agents|mesh-ancestor
110789197|NCT03574246|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110789198|NCT02239900|Ipilimumab|ipilimumab|mesh-list
110789199|NCT02239900|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110789200|NCT02239900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110789201|NCT02239900|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110789202|NCT02239900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110789203|NCT03573934|Glucagon|glucagon|mesh-list
110789204|NCT03573934|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
110789205|NCT03573934|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110789206|NCT03573934|Hormones|hormones|mesh-ancestor
110789207|NCT03573934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110789208|NCT03573934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110789209|NCT03573934|Incretins|incretins|mesh-ancestor
110789210|NCT02229136|Prednisolone|prednisolone|mesh-list
110789211|NCT02229136|Hydrocortisone|hydrocortisone|mesh-list
110789212|NCT02229136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110789213|NCT02229136|Glucocorticoids|glucocorticoids|mesh-ancestor
110789214|NCT02229136|Hormones|hormones|mesh-ancestor
110789215|NCT02229136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110789216|NCT02229136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110789217|NCT02229136|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110789218|NCT02229136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110789219|NCT02523898|Metformin|metformin|mesh-list
110789220|NCT02523898|Clomiphene|clomiphene|mesh-list
110789221|NCT02523898|Enclomiphene|enclomiphene|mesh-list
110789222|NCT02523898|Zuclomiphene|zuclomiphene|mesh-list
110789223|NCT02523898|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110789224|NCT02523898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110789225|NCT02523898|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110789226|NCT02523898|Hormone Antagonists|hormone antagonists|mesh-ancestor
110789227|NCT02523898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110789228|NCT02523898|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110789229|NCT02523898|Fertility Agents|fertility agents|mesh-ancestor
110789230|NCT02523898|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110789231|NCT02523898|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110789232|NCT02523898|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110789233|NCT02845336|Celecoxib|celecoxib|mesh-list
110789234|NCT02845336|Lubricant Eye Drops|lubricant eye drops|mesh-list
110789235|NCT02845336|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110789236|NCT02845336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110789237|NCT02845336|Analgesics|analgesics|mesh-ancestor
110789238|NCT02845336|Sensory System Agents|sensory system agents|mesh-ancestor
110789239|NCT02845336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110789240|NCT02845336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110789241|NCT02845336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110789242|NCT02845336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110789243|NCT02845336|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110789244|NCT02845336|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110789245|NCT02845336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110789246|NCT02845336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110789247|NCT02845336|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110789248|NCT02845336|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110789249|NCT02244502|Paclitaxel|paclitaxel|mesh-list
110789250|NCT02244502|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110789251|NCT02244502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110789252|NCT02244502|Tubulin Modulators|tubulin modulators|mesh-ancestor
110789253|NCT02244502|Antimitotic Agents|antimitotic agents|mesh-ancestor
110789254|NCT02244502|Mitosis Modulators|mitosis modulators|mesh-ancestor
110789255|NCT02244502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110789256|NCT03573622|Sarpogrelate|sarpogrelate|mesh-list
110789257|NCT03573622|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110789258|NCT03573622|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110789259|NCT03573622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110789260|NCT03573622|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110789261|NCT03573622|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110789262|NCT03573622|Serotonin Agents|serotonin agents|mesh-ancestor
110789263|NCT03573622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110789264|NCT03573622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110789265|NCT02951156|Rituximab|rituximab|mesh-list
110789266|NCT02951156|Avelumab|avelumab|mesh-list
110789267|NCT02951156|Gemcitabine|gemcitabine|mesh-list
110789268|NCT02951156|Oxaliplatin|oxaliplatin|mesh-list
110789269|NCT02951156|Azacitidine|azacitidine|mesh-list
110789270|NCT02951156|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110789271|NCT02951156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110789272|NCT02951156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110789273|NCT02951156|Immunologic Factors|immunologic factors|mesh-ancestor
110789274|NCT02951156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110789275|NCT02951156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110789276|NCT02951156|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110789277|NCT02951156|Antimetabolites|antimetabolites|mesh-ancestor
110789278|NCT02951156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110789279|NCT02951156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110789280|NCT02951156|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110789281|NCT02951156|Alkylating Agents|alkylating agents|mesh-ancestor
110789282|NCT03571594|Octreotide|octreotide|mesh-list
110789283|NCT03571594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110789284|NCT03571594|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110789285|NCT03571594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110789286|NCT03571438|Sirolimus|sirolimus|mesh-list
110789287|NCT03571438|Sunitinib|sunitinib|mesh-list
110789288|NCT03571438|Temsirolimus|temsirolimus|mesh-list
110789289|NCT03571438|MTOR Inhibitors|mtor inhibitors|mesh-list
110789290|NCT03571438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110789291|NCT03571438|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110789292|NCT03571438|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110789293|NCT03571438|Growth Substances|growth substances|mesh-ancestor
110789294|NCT03571438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110789295|NCT03571438|Growth Inhibitors|growth inhibitors|mesh-ancestor
110789296|NCT03571438|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110789297|NCT03571438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110789298|NCT03571438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110789299|NCT03571438|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110789300|NCT03571438|Immunologic Factors|immunologic factors|mesh-ancestor
110789301|NCT03571438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110789302|NCT03571438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110789303|NCT03571438|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110789304|NCT03571438|Antifungal Agents|antifungal agents|mesh-ancestor
110789305|NCT01874860|Doxycycline|doxycycline|mesh-list
110789306|NCT01874860|Clindamycin|clindamycin|mesh-list
110789307|NCT01874860|Clindamycin palmitate|clindamycin palmitate|mesh-list
110789308|NCT01874860|Clindamycin phosphate|clindamycin phosphate|mesh-list
110789309|NCT01874860|Hydrocortisone|hydrocortisone|mesh-list
110789310|NCT01874860|Methylprednisolone|methylprednisolone|mesh-list
110789311|NCT01874860|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110789312|NCT01874860|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110789313|NCT01874860|Prednisolone|prednisolone|mesh-list
110789314|NCT01874860|Prednisolone acetate|prednisolone acetate|mesh-list
110789315|NCT01874860|Sunscreening Agents|sunscreening agents|mesh-list
110789316|NCT01874860|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110789317|NCT01874860|Prednisolone phosphate|prednisolone phosphate|mesh-list
110850943|NCT03172026|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110789318|NCT01874860|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110789319|NCT01874860|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110789320|NCT01874860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110789321|NCT01874860|Antimalarials|antimalarials|mesh-ancestor
110789322|NCT01874860|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110789323|NCT01874860|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110789324|NCT01874860|Antiemetics|antiemetics|mesh-ancestor
110789325|NCT01874860|Autonomic Agents|autonomic agents|mesh-ancestor
110789326|NCT01874860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110789327|NCT01874860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110789328|NCT01874860|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110789329|NCT01874860|Glucocorticoids|glucocorticoids|mesh-ancestor
110789330|NCT01874860|Hormones|hormones|mesh-ancestor
110789331|NCT01874860|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110789332|NCT01874860|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110789333|NCT01874860|Protective Agents|protective agents|mesh-ancestor
110789334|NCT01874860|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110789335|NCT01874860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110789336|NCT01874860|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110789337|NCT01874860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110789338|NCT01874860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110789339|NCT01874860|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110789340|NCT01874860|Dermatologic Agents|dermatologic agents|mesh-ancestor
110789341|NCT03570346|Hemay005|hemay005|mesh-list
110789342|NCT03570346|Dermatologic Agents|dermatologic agents|mesh-ancestor
110789343|NCT03570346|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
110789344|NCT03570346|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110789345|NCT03570346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110789346|NCT03570346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110789347|NCT03571126|Olanzapine|olanzapine|mesh-list
110789348|NCT03571126|Antiemetics|antiemetics|mesh-ancestor
110789349|NCT03571126|Autonomic Agents|autonomic agents|mesh-ancestor
110789350|NCT03571126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110498902|NCT05832515|Fludarabine phosphate|fludarabine phosphate|mesh-list
110789351|NCT03571126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110789352|NCT03571126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110789353|NCT03571126|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110789354|NCT03571126|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110789355|NCT03571126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110789356|NCT03571126|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110789357|NCT03571126|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110789358|NCT03571126|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110789359|NCT03571126|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110789360|NCT03571126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110789361|NCT03571126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110789362|NCT03571126|Serotonin Agents|serotonin agents|mesh-ancestor
110789363|NCT03570112|Sofosbuvir|sofosbuvir|mesh-list
110789364|NCT03570112|Velpatasvir|velpatasvir|mesh-list
110789365|NCT03570112|Antiviral Agents|antiviral agents|mesh-ancestor
110789366|NCT03570112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110789367|NCT03572686|Dexamethasone|dexamethasone|mesh-list
110789368|NCT03572686|Dexamethasone acetate|dexamethasone acetate|mesh-list
110789369|NCT03572686|Ropivacaine|ropivacaine|mesh-list
110789371|NCT03572686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110789372|NCT03572686|Antiemetics|antiemetics|mesh-ancestor
110789373|NCT03572686|Autonomic Agents|autonomic agents|mesh-ancestor
110789374|NCT03572686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110789375|NCT03572686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110789376|NCT03572686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110789377|NCT03572686|Glucocorticoids|glucocorticoids|mesh-ancestor
110789378|NCT03572686|Hormones|hormones|mesh-ancestor
110789379|NCT03572686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110789380|NCT03572686|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110789381|NCT03572686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110789382|NCT03572686|Protease Inhibitors|protease inhibitors|mesh-ancestor
110789383|NCT03572686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110789384|NCT03572686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110789385|NCT03572686|Anesthetics, Local|anesthetics, local|mesh-ancestor
110789386|NCT03572686|Anesthetics|anesthetics|mesh-ancestor
110789387|NCT03572686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110789388|NCT03572686|Sensory System Agents|sensory system agents|mesh-ancestor
110789389|NCT02523820|Fluticasone|fluticasone|mesh-list
110789390|NCT02523820|Xhance|xhance|mesh-list
110789391|NCT02523820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110789392|NCT02523820|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110789393|NCT02523820|Autonomic Agents|autonomic agents|mesh-ancestor
110789394|NCT02523820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110789395|NCT02523820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110789396|NCT02523820|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110789397|NCT02523820|Respiratory System Agents|respiratory system agents|mesh-ancestor
110789398|NCT02523820|Dermatologic Agents|dermatologic agents|mesh-ancestor
110789399|NCT02523820|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110789401|NCT03369704|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110789402|NCT03369704|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110789403|NCT03369704|Respiratory System Agents|respiratory system agents|mesh-ancestor
110789404|NCT03709160|Bumetanide|bumetanide|mesh-list
110789405|NCT03709160|Diuretics|diuretics|mesh-ancestor
110789406|NCT03709160|Natriuretic Agents|natriuretic agents|mesh-ancestor
110789407|NCT03709160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110789408|NCT03709160|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110789409|NCT03709160|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110789410|NCT03709160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110789411|NCT05332496|Bevacizumab|bevacizumab|mesh-list
110789412|NCT05332496|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
110498934|NCT05832216|Daratumumab|daratumumab|mesh-list
110789413|NCT05332496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110789414|NCT05332496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110789415|NCT05332496|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110789416|NCT05332496|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110789417|NCT05332496|Growth Substances|growth substances|mesh-ancestor
110789418|NCT05332496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110789419|NCT05332496|Growth Inhibitors|growth inhibitors|mesh-ancestor
110789420|NCT05332496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110789421|NCT03567304|Rilpivirine|rilpivirine|mesh-list
110789422|NCT03567304|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110789423|NCT03567304|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110789424|NCT03567304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110789425|NCT03567304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110789426|NCT03567304|Antiviral Agents|antiviral agents|mesh-ancestor
110789427|NCT03567304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110789428|NCT03567304|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110789429|NCT03567304|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110789430|NCT05356858|Zanubrutinib|zanubrutinib|mesh-list
110789431|NCT05356858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110789432|NCT05356858|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110789433|NCT05356858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110789434|NCT05356858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110789435|NCT03566914|Tadalafil|tadalafil|mesh-list
110789436|NCT03566914|Vasodilator Agents|vasodilator agents|mesh-ancestor
110789437|NCT03566914|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110789438|NCT03566914|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110789439|NCT03566914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110789440|NCT03566914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110789441|NCT03566914|Urological Agents|urological agents|mesh-ancestor
110789442|NCT03366428|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
110789443|NCT03366428|Immunoconjugates|immunoconjugates|mesh-ancestor
110789444|NCT03366428|Immunologic Factors|immunologic factors|mesh-ancestor
110789445|NCT03366428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110789447|NCT03709082|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
110789448|NCT03709082|Letrozole|letrozole|mesh-list
110789449|NCT03709082|Palbociclib|palbociclib|mesh-list
110789450|NCT03709082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110789451|NCT03709082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110789452|NCT03709082|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110789453|NCT03709082|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110789454|NCT03709082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110799583|NCT02064556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110789455|NCT03709082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110789456|NCT03709082|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110789457|NCT03709082|Hormone Antagonists|hormone antagonists|mesh-ancestor
110789458|NCT03709082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110789459|NCT03709082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110789460|NCT03709082|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110789461|NCT03709082|Tubulin Modulators|tubulin modulators|mesh-ancestor
110789462|NCT03709082|Antimitotic Agents|antimitotic agents|mesh-ancestor
110789463|NCT03709082|Mitosis Modulators|mitosis modulators|mesh-ancestor
110789464|NCT03709082|Immunotoxins|immunotoxins|mesh-ancestor
110789465|NCT03709082|Immunoconjugates|immunoconjugates|mesh-ancestor
110789466|NCT03709082|Immunologic Factors|immunologic factors|mesh-ancestor
110789467|NCT02839876|Acetaminophen|acetaminophen|mesh-list
110789468|NCT02839876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110789469|NCT02839876|Analgesics|analgesics|mesh-ancestor
110789470|NCT02839876|Sensory System Agents|sensory system agents|mesh-ancestor
110789471|NCT02839876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110789472|NCT02839876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110789473|NCT02839876|Antipyretics|antipyretics|mesh-ancestor
110789474|NCT01312064|Rituximab|rituximab|mesh-list
110789475|NCT01312064|Everolimus|everolimus|mesh-list
110789476|NCT01312064|Tacrolimus|tacrolimus|mesh-list
110789477|NCT01312064|Thymoglobulin|thymoglobulin|mesh-list
110789478|NCT01312064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110789479|NCT01312064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110789480|NCT01312064|Immunologic Factors|immunologic factors|mesh-ancestor
110789481|NCT01312064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110789482|NCT01312064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110789483|NCT01312064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110789484|NCT01312064|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110789485|NCT01312064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110789486|NCT01312064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110789487|NCT01312064|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110789488|NCT01312064|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110789489|NCT05682716|Nitroglycerin|nitroglycerin|mesh-list
110789490|NCT05682716|Vasodilator Agents|vasodilator agents|mesh-ancestor
110789491|NCT03566134|Solifenacin Succinate|solifenacin succinate|mesh-list
110789492|NCT03566134|DA-8010|da-8010|mesh-list
110789493|NCT03566134|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110789494|NCT03566134|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110789495|NCT03566134|Cholinergic Agents|cholinergic agents|mesh-ancestor
110789496|NCT03566134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110789497|NCT03566134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110789498|NCT03566134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110789499|NCT03566134|Urological Agents|urological agents|mesh-ancestor
110789500|NCT03101722|Huperzine A|huperzine a|mesh-list
110789501|NCT03101722|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
110789502|NCT03101722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110789503|NCT03101722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110789504|NCT03101722|Cholinergic Agents|cholinergic agents|mesh-ancestor
110789505|NCT03101722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110789506|NCT03101722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110789507|NCT03101722|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110789508|NCT03101722|Protective Agents|protective agents|mesh-ancestor
110789509|NCT03088852|Magnesium citrate|magnesium citrate|mesh-list
110789510|NCT03088852|Cathartics|cathartics|mesh-ancestor
110789511|NCT03088852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110789513|NCT03568474|Cariostatic Agents|cariostatic agents|mesh-ancestor
110789514|NCT03568474|Protective Agents|protective agents|mesh-ancestor
110789515|NCT03568474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110789516|NCT03345836|Upadacitinib|upadacitinib|mesh-list
110789517|NCT03345836|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
110789518|NCT03345836|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110789519|NCT03345836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110789520|NCT03345836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110789521|NCT03345836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110789522|NCT03708926|Abaloparatide|abaloparatide|mesh-list
110789523|NCT03708926|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110850953|NCT01201577|Antimalarials|antimalarials|mesh-ancestor
110789525|NCT03567928|Propofol|propofol|mesh-list
110789526|NCT03567928|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110789527|NCT03567928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110789528|NCT03567928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110789529|NCT03567928|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110789530|NCT03567928|Anesthetics, General|anesthetics, general|mesh-ancestor
110789531|NCT03567928|Anesthetics|anesthetics|mesh-ancestor
110789532|NCT03565354|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
110789533|NCT03565354|Hematinics|hematinics|mesh-ancestor
110789534|NCT03363776|Nivolumab|nivolumab|mesh-list
110789535|NCT03363776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110789536|NCT03363776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110789537|NCT03363776|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110789538|NCT03363776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110789539|NCT03565276|Tranexamic Acid|tranexamic acid|mesh-list
110789540|NCT03565276|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110789541|NCT03565276|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110789542|NCT03565276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110789543|NCT03565276|Hemostatics|hemostatics|mesh-ancestor
110789544|NCT03565276|Coagulants|coagulants|mesh-ancestor
110789545|NCT03564964|1-((2-bromophenyl)sulfonyl)-5-methoxy-3-((4-methyl-1-piperazinyl)methyl)-1H-indole dimesylate monohydrate|1-((2-bromophenyl)sulfonyl)-5-methoxy-3-((4-methyl-1-piperazinyl)methyl)-1h-indole dimesylate monohydrate|mesh-list
110789546|NCT03564964|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110789547|NCT03564964|Serotonin Agents|serotonin agents|mesh-ancestor
110789548|NCT03564964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110789549|NCT03564964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110789550|NCT03564964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110789551|NCT03708848|Metronidazole|metronidazole|mesh-list
110789552|NCT03708848|Clarithromycin|clarithromycin|mesh-list
110789553|NCT03708848|Levofloxacin|levofloxacin|mesh-list
110789554|NCT03708848|Tetracycline|tetracycline|mesh-list
110789555|NCT03708848|Potassium Citrate|potassium citrate|mesh-list
110789556|NCT03708848|Esomeprazole|esomeprazole|mesh-list
110789557|NCT03708848|Bismuth|bismuth|mesh-list
110789558|NCT03708848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110789559|NCT03708848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110789560|NCT03708848|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110789561|NCT03708848|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110789562|NCT03708848|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110789563|NCT03708848|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110789564|NCT03708848|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110789565|NCT03708848|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110789566|NCT03708848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110789567|NCT03708848|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110789568|NCT03708848|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110789569|NCT03708848|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110789570|NCT03708848|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110789571|NCT03708848|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110789572|NCT03708848|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110789573|NCT03708848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110789574|NCT03708848|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110789575|NCT03708848|Antacids|antacids|mesh-ancestor
110499050|NCT05737069|Ibuprofen|ibuprofen|mesh-list
110789576|NCT03708848|Diuretics|diuretics|mesh-ancestor
110789577|NCT03708848|Natriuretic Agents|natriuretic agents|mesh-ancestor
110789578|NCT03708848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110789579|NCT03708848|Expectorants|expectorants|mesh-ancestor
110789580|NCT03708848|Respiratory System Agents|respiratory system agents|mesh-ancestor
110789581|NCT03564652|Azithromycin|azithromycin|mesh-list
110789582|NCT03564652|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110789583|NCT03564652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110789584|NCT03564574|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
110789585|NCT03564574|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
110789586|NCT03564574|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
110789587|NCT03564574|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110789588|NCT03710330|Tranexamic Acid|tranexamic acid|mesh-list
110789589|NCT03710330|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110789590|NCT03710330|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110789591|NCT03710330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110789594|NCT03710252|Ritonavir|ritonavir|mesh-list
110789595|NCT03710252|Ribavirin|ribavirin|mesh-list
110789596|NCT03710252|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110789597|NCT03710252|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110789598|NCT03710252|Protease Inhibitors|protease inhibitors|mesh-ancestor
110789599|NCT03710252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110789600|NCT03710252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110789601|NCT03710252|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110789602|NCT03710252|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110789603|NCT03710252|Antiviral Agents|antiviral agents|mesh-ancestor
110789604|NCT03710252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110789605|NCT03710252|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110789606|NCT03710252|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110789607|NCT03710252|Antimetabolites|antimetabolites|mesh-ancestor
110789608|NCT02838628|Tirbanibulin|tirbanibulin|mesh-list
110789609|NCT02838628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110789610|NCT02838628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110789611|NCT03705884|Prednisolone|prednisolone|mesh-list
110789612|NCT03705884|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110789613|NCT03705884|Glucocorticoids|glucocorticoids|mesh-ancestor
110789614|NCT03705884|Hormones|hormones|mesh-ancestor
110789615|NCT03705884|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110789616|NCT03705884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110789617|NCT03705884|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110789618|NCT03705884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110789619|NCT03359174|Tretinoin|tretinoin|mesh-list
110789620|NCT03359174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110789621|NCT03359174|Keratolytic Agents|keratolytic agents|mesh-ancestor
110789622|NCT03359174|Dermatologic Agents|dermatologic agents|mesh-ancestor
110789623|NCT03564106|Methylprednisolone|methylprednisolone|mesh-list
110789624|NCT03564106|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110789625|NCT03564106|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110789626|NCT03564106|Prednisolone|prednisolone|mesh-list
110789627|NCT03564106|Prednisolone acetate|prednisolone acetate|mesh-list
110789628|NCT03564106|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110789629|NCT03564106|Prednisolone phosphate|prednisolone phosphate|mesh-list
110789630|NCT03564106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110789631|NCT03564106|Antiemetics|antiemetics|mesh-ancestor
110789632|NCT03564106|Autonomic Agents|autonomic agents|mesh-ancestor
110789633|NCT03564106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110789634|NCT03564106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110789635|NCT03564106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110789636|NCT03564106|Glucocorticoids|glucocorticoids|mesh-ancestor
110789637|NCT03564106|Hormones|hormones|mesh-ancestor
110789638|NCT03564106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110789639|NCT03564106|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110789640|NCT03564106|Protective Agents|protective agents|mesh-ancestor
110789641|NCT03564106|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110789642|NCT03564106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110789643|NCT03710174|Salicylic Acid|salicylic acid|mesh-list
110789644|NCT03710174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110789645|NCT03710174|Antifungal Agents|antifungal agents|mesh-ancestor
110789646|NCT03710174|Keratolytic Agents|keratolytic agents|mesh-ancestor
110789647|NCT03710174|Dermatologic Agents|dermatologic agents|mesh-ancestor
110789648|NCT00093015|Darbepoetin alfa|darbepoetin alfa|mesh-list
110789649|NCT00093015|Hematinics|hematinics|mesh-ancestor
110789650|NCT01145703|Vitamin D|vitamin d|mesh-list
110789651|NCT01145703|Ergocalciferols|ergocalciferols|mesh-list
110789652|NCT01145703|Cholecalciferol|cholecalciferol|mesh-list
110789653|NCT01145703|Vitamins|vitamins|mesh-list
110789654|NCT01145703|Micronutrients|micronutrients|mesh-ancestor
110789655|NCT01145703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110789656|NCT01145703|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110789657|NCT01145703|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110789658|NCT05137587|Ketamine|ketamine|mesh-list
110789659|NCT05137587|Propofol|propofol|mesh-list
110789660|NCT05137587|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110789661|NCT05137587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110789662|NCT05137587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110789663|NCT05137587|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110789664|NCT05137587|Anesthetics, General|anesthetics, general|mesh-ancestor
110789665|NCT05137587|Anesthetics|anesthetics|mesh-ancestor
110789666|NCT05137587|Analgesics|analgesics|mesh-ancestor
110789667|NCT05137587|Sensory System Agents|sensory system agents|mesh-ancestor
110789668|NCT05137587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110789669|NCT05137587|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110789670|NCT05137587|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110789671|NCT05137587|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110789672|NCT05137587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110789673|NCT05137587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110789675|NCT01145859|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110789676|NCT01145859|Antithrombins|antithrombins|mesh-ancestor
110789677|NCT01145859|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110789678|NCT01145859|Protease Inhibitors|protease inhibitors|mesh-ancestor
110789679|NCT01145859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110789680|NCT01145859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110789681|NCT01145859|Anticoagulants|anticoagulants|mesh-ancestor
110789682|NCT01250847|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110789683|NCT01250847|Antidepressive Agents|antidepressive agents|mesh-ancestor
110789684|NCT01250847|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110789685|NCT01250847|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110789686|NCT01250847|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110789687|NCT01250847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110789688|NCT01250847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110789689|NCT03913455|Carboplatin|carboplatin|mesh-list
110789690|NCT03913455|Guadecitabine|guadecitabine|mesh-list
110789691|NCT03913455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110789692|NCT01238523|Calpastatin|calpastatin|mesh-list
110789693|NCT01238523|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
110789694|NCT01238523|Protease Inhibitors|protease inhibitors|mesh-ancestor
110789695|NCT01238523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110789696|NCT01238523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110789697|NCT03708536|Bevacizumab|bevacizumab|mesh-list
110789698|NCT03708536|Capecitabine|capecitabine|mesh-list
110789699|NCT03708536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110789700|NCT03708536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110789701|NCT03708536|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110789702|NCT03708536|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110789703|NCT03708536|Growth Substances|growth substances|mesh-ancestor
110789704|NCT03708536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110789705|NCT03708536|Growth Inhibitors|growth inhibitors|mesh-ancestor
110789706|NCT03708536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110789707|NCT03708536|Antimetabolites|antimetabolites|mesh-ancestor
110789708|NCT03708536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110789709|NCT03705728|Remifentanil|remifentanil|mesh-list
110789710|NCT03705728|Propofol|propofol|mesh-list
110789711|NCT03705728|Sevoflurane|sevoflurane|mesh-list
110789712|NCT03705728|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110789713|NCT03705728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110789714|NCT03705728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110789715|NCT03705728|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110789716|NCT03705728|Anesthetics, General|anesthetics, general|mesh-ancestor
110789717|NCT03705728|Anesthetics|anesthetics|mesh-ancestor
110789718|NCT03705728|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110499127|NCT05594615|Purinergic Agents|purinergic agents|mesh-ancestor
110789719|NCT03705728|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110789720|NCT03705728|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110789721|NCT03705728|Narcotics|narcotics|mesh-ancestor
110789722|NCT03705728|Analgesics|analgesics|mesh-ancestor
110789723|NCT03705728|Sensory System Agents|sensory system agents|mesh-ancestor
110789724|NCT03705728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110789725|NCT01147419|Blood Substitutes|blood substitutes|mesh-list
110789726|NCT05177666|Trastuzumab|trastuzumab|mesh-list
110789727|NCT05177666|Pertuzumab|pertuzumab|mesh-list
110789728|NCT05177666|Vemurafenib|vemurafenib|mesh-list
110789729|NCT05177666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110789730|NCT05177666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110789731|NCT05177666|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110789732|NCT05177666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110789733|NCT05177666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110789734|NCT03342638|Methylprednisolone|methylprednisolone|mesh-list
110789735|NCT03342638|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110789736|NCT03342638|Cyclophosphamide|cyclophosphamide|mesh-list
110789737|NCT03342638|Thymoglobulin|thymoglobulin|mesh-list
110789738|NCT03342638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110789739|NCT03342638|Immunologic Factors|immunologic factors|mesh-ancestor
110789740|NCT03342638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110789741|NCT03342638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110789742|NCT03342638|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110789743|NCT03342638|Alkylating Agents|alkylating agents|mesh-ancestor
110789744|NCT03342638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110789745|NCT03342638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110789746|NCT03342638|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110789747|NCT03342638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110789748|NCT03342638|Antiemetics|antiemetics|mesh-ancestor
110789749|NCT03342638|Autonomic Agents|autonomic agents|mesh-ancestor
110789750|NCT03342638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110789751|NCT03342638|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110789752|NCT03342638|Glucocorticoids|glucocorticoids|mesh-ancestor
110789753|NCT03342638|Hormones|hormones|mesh-ancestor
110789754|NCT03342638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110789755|NCT03342638|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110789756|NCT03342638|Protective Agents|protective agents|mesh-ancestor
110789757|NCT03342638|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110789758|NCT01246323|Fentanyl|fentanyl|mesh-list
110789759|NCT01246323|Morphine|morphine|mesh-list
110789760|NCT01246323|Anesthetics|anesthetics|mesh-ancestor
110789761|NCT01246323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110789762|NCT01246323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110789763|NCT01246323|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110789764|NCT01246323|Narcotics|narcotics|mesh-ancestor
110789765|NCT01246323|Analgesics|analgesics|mesh-ancestor
110789766|NCT01246323|Sensory System Agents|sensory system agents|mesh-ancestor
110789767|NCT01246323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110789768|NCT01246323|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110789769|NCT01246323|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110789770|NCT01246323|Anesthetics, General|anesthetics, general|mesh-ancestor
110789771|NCT05160363|Piperaquine|piperaquine|mesh-list
110789772|NCT05160363|Pyronaridine|pyronaridine|mesh-list
110789773|NCT05160363|Antimalarials|antimalarials|mesh-ancestor
110789774|NCT05160363|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110789775|NCT05160363|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110789776|NCT05160363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110789777|NCT05177276|Irinotecan|irinotecan|mesh-list
110789778|NCT05177276|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110789779|NCT05177276|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110789780|NCT05177276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110789781|NCT05177276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110789782|NCT05177276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110789783|NCT02528175|Capecitabine|capecitabine|mesh-list
110789784|NCT02528175|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110789785|NCT02528175|Antimetabolites|antimetabolites|mesh-ancestor
110789786|NCT02528175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110789787|NCT02528175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110789788|NCT03708458|Acetylcysteine|acetylcysteine|mesh-list
110789789|NCT03708458|Indomethacin|indomethacin|mesh-list
110789790|NCT03708458|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110789791|NCT03708458|Antiviral Agents|antiviral agents|mesh-ancestor
110789792|NCT03708458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110789793|NCT03708458|Expectorants|expectorants|mesh-ancestor
110789794|NCT03708458|Respiratory System Agents|respiratory system agents|mesh-ancestor
110789795|NCT03708458|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110789796|NCT03708458|Antioxidants|antioxidants|mesh-ancestor
110789797|NCT03708458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110789798|NCT03708458|Protective Agents|protective agents|mesh-ancestor
110789799|NCT03708458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110789800|NCT03708458|Antidotes|antidotes|mesh-ancestor
110789801|NCT03708458|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110789802|NCT03708458|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110789803|NCT03708458|Analgesics|analgesics|mesh-ancestor
110850989|NCT03336970|Calcium|calcium|mesh-list
110789804|NCT03708458|Sensory System Agents|sensory system agents|mesh-ancestor
110789805|NCT03708458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110789806|NCT03708458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110789807|NCT03708458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110789808|NCT03708458|Gout Suppressants|gout suppressants|mesh-ancestor
110789809|NCT03708458|Tocolytic Agents|tocolytic agents|mesh-ancestor
110789810|NCT03708458|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110789811|NCT03708458|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110789812|NCT03708458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110789814|NCT05625555|Ketamine|ketamine|mesh-list
110789815|NCT05625555|Analgesics|analgesics|mesh-ancestor
110789816|NCT05625555|Sensory System Agents|sensory system agents|mesh-ancestor
110789817|NCT05625555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110789818|NCT05625555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110789819|NCT05625555|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110789820|NCT05625555|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110789821|NCT05625555|Anesthetics, General|anesthetics, general|mesh-ancestor
110789822|NCT05625555|Anesthetics|anesthetics|mesh-ancestor
110789823|NCT05625555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110789824|NCT05625555|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110789825|NCT05625555|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110789826|NCT05625555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110789827|NCT05625555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110789828|NCT05625555|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110789829|NCT05625555|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110789830|NCT05625555|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110789831|NCT05625555|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110789832|NCT05625555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110789833|NCT05625555|GABA Modulators|gaba modulators|mesh-ancestor
110789834|NCT05625555|GABA Agents|gaba agents|mesh-ancestor
110789835|NCT01251471|Escitalopram|escitalopram|mesh-list
110789836|NCT01251471|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110789837|NCT01251471|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110789838|NCT01251471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110789839|NCT01251471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110789840|NCT01251471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110789841|NCT01251471|Serotonin Agents|serotonin agents|mesh-ancestor
110789842|NCT01251471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110789843|NCT01247805|Sildenafil Citrate|sildenafil citrate|mesh-list
110789844|NCT01247805|Citric Acid|citric acid|mesh-list
110789845|NCT01247805|Sodium Citrate|sodium citrate|mesh-list
110789846|NCT01247805|Anticoagulants|anticoagulants|mesh-ancestor
110789847|NCT01247805|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110789848|NCT01247805|Chelating Agents|chelating agents|mesh-ancestor
110789849|NCT01247805|Sequestering Agents|sequestering agents|mesh-ancestor
110789850|NCT01247805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110789851|NCT01247805|Vasodilator Agents|vasodilator agents|mesh-ancestor
110789852|NCT01247805|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110789853|NCT01247805|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110789854|NCT01247805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110789855|NCT01247805|Urological Agents|urological agents|mesh-ancestor
110789856|NCT05631717|Aldesleukin|aldesleukin|mesh-list
110789857|NCT05631717|Interleukin-2|interleukin-2|mesh-list
110789858|NCT05631717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110789859|NCT05631717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110789860|NCT05631717|Analgesics|analgesics|mesh-ancestor
110789861|NCT05631717|Sensory System Agents|sensory system agents|mesh-ancestor
110789862|NCT05631717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110789863|NCT05631717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110789864|NCT05631717|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110789865|NCT05631717|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110789866|NCT05631717|Antiviral Agents|antiviral agents|mesh-ancestor
110789867|NCT05631717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110789868|NCT01147731|Warfarin|warfarin|mesh-list
110789869|NCT01147731|rGLP-1 protein|rglp-1 protein|mesh-list
110789870|NCT01147731|Anticoagulants|anticoagulants|mesh-ancestor
110789871|NCT01147731|Incretins|incretins|mesh-ancestor
110789872|NCT01147731|Hormones|hormones|mesh-ancestor
110789873|NCT01147731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110789874|NCT01147731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110789875|NCT03912285|Losartan|losartan|mesh-list
110789876|NCT03912285|Amlodipine|amlodipine|mesh-list
110789877|NCT03912285|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110850995|NCT02495584|Vitamin D|vitamin d|mesh-list
110789878|NCT03912285|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110789879|NCT03912285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110789880|NCT03912285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110789881|NCT03912285|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110789882|NCT03912285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110789883|NCT03912285|Vasodilator Agents|vasodilator agents|mesh-ancestor
110789884|NCT03912285|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110789885|NCT03912285|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110789886|NCT03912285|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110789887|NCT01251627|Decitabine|decitabine|mesh-list
110789888|NCT01251627|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110789889|NCT01251627|Antimetabolites|antimetabolites|mesh-ancestor
110789890|NCT01251627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110789891|NCT01251627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110789892|NCT01251627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110789893|NCT01146093|Pravastatin|pravastatin|mesh-list
110789894|NCT01146093|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110789895|NCT01146093|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110789896|NCT01146093|Antimetabolites|antimetabolites|mesh-ancestor
110789897|NCT01146093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110789898|NCT01146093|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110789899|NCT01146093|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110789900|NCT01146093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110789901|NCT02452983|Sertraline|sertraline|mesh-list
110789902|NCT02452983|Antidepressive Agents|antidepressive agents|mesh-ancestor
110789903|NCT02452983|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110789904|NCT02452983|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110789905|NCT02452983|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110789906|NCT02452983|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110789907|NCT02452983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110789908|NCT02452983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110789909|NCT02452983|Serotonin Agents|serotonin agents|mesh-ancestor
110789910|NCT02452983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110789911|NCT03911817|Midodrine|midodrine|mesh-list
110789912|NCT03911817|Sympathomimetics|sympathomimetics|mesh-ancestor
110789913|NCT03911817|Autonomic Agents|autonomic agents|mesh-ancestor
110789914|NCT03911817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110789915|NCT03911817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110789916|NCT03911817|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110789917|NCT03911817|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110789918|NCT03911817|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110789919|NCT03911817|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110789920|NCT03911817|Adrenergic Agents|adrenergic agents|mesh-ancestor
110789921|NCT03911817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110789922|NCT03911817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110789923|NCT01239849|Atorvastatin|atorvastatin|mesh-list
110789924|NCT01239849|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110789925|NCT01239849|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110789926|NCT01239849|Antimetabolites|antimetabolites|mesh-ancestor
110789927|NCT01239849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110789928|NCT01239849|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110789929|NCT01239849|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110789930|NCT01239849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110789931|NCT04896489|Hydrocortisone|hydrocortisone|mesh-list
110789932|NCT04896489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110789933|NCT01148043|Hydroxychloroquine|hydroxychloroquine|mesh-list
110789934|NCT01148043|Antimalarials|antimalarials|mesh-ancestor
110789935|NCT01148043|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110789936|NCT01148043|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110789937|NCT01148043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110789938|NCT01148043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110789939|NCT01148043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110789940|NCT01148043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110789941|NCT04880655|Bacitracin|bacitracin|mesh-list
110789942|NCT04880655|Petrolatum|petrolatum|mesh-list
110789943|NCT04880655|Emollients|emollients|mesh-ancestor
110789944|NCT04880655|Dermatologic Agents|dermatologic agents|mesh-ancestor
110789945|NCT04880655|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110789946|NCT04880655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110789947|NCT04880655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110789949|NCT04865835|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110789950|NCT04865835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110789951|NCT03911271|Atropine|atropine|mesh-list
110789952|NCT03911271|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110789953|NCT03911271|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110789954|NCT03911271|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110789955|NCT03911271|Autonomic Agents|autonomic agents|mesh-ancestor
110789956|NCT03911271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110789957|NCT03911271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110789958|NCT03911271|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110789959|NCT03911271|Respiratory System Agents|respiratory system agents|mesh-ancestor
110789960|NCT03911271|Mydriatics|mydriatics|mesh-ancestor
110789961|NCT03911271|Parasympatholytics|parasympatholytics|mesh-ancestor
110789962|NCT03911271|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110789963|NCT03911271|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110789964|NCT03911271|Cholinergic Agents|cholinergic agents|mesh-ancestor
110789965|NCT03911271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110789966|NCT03911271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110789967|NCT01248195|Olanzapine|olanzapine|mesh-list
110789968|NCT01248195|Clozapine|clozapine|mesh-list
110789969|NCT01248195|Amisulpride|amisulpride|mesh-list
110789970|NCT01248195|Antiemetics|antiemetics|mesh-ancestor
110789971|NCT01248195|Autonomic Agents|autonomic agents|mesh-ancestor
110789972|NCT01248195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110789973|NCT01248195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110789974|NCT01248195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110789975|NCT01248195|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110789976|NCT01248195|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110789977|NCT01248195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110789978|NCT01248195|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110789979|NCT01248195|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110789980|NCT01248195|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110789981|NCT01248195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110789982|NCT01248195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110789983|NCT01248195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110789984|NCT01248195|Serotonin Agents|serotonin agents|mesh-ancestor
110789985|NCT01248195|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110789986|NCT01248195|GABA Antagonists|gaba antagonists|mesh-ancestor
110789987|NCT01248195|GABA Agents|gaba agents|mesh-ancestor
110789988|NCT01248195|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110789989|NCT01248195|Dopamine Agents|dopamine agents|mesh-ancestor
110789990|NCT01248195|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110789991|NCT01248195|Antidepressive Agents|antidepressive agents|mesh-ancestor
110789993|NCT03910803|Dermatologic Agents|dermatologic agents|mesh-ancestor
110789994|NCT03910647|Pantoprazole|pantoprazole|mesh-list
110789995|NCT03910647|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110789996|NCT03910647|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110789997|NCT03910647|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110789998|NCT03910647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110789999|NCT03910647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110790000|NCT03709940|Methylphenidate|methylphenidate|mesh-list
110790001|NCT03709940|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110790002|NCT03709940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110790003|NCT03709940|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110790004|NCT03709940|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110790005|NCT03709940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110790006|NCT03709940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110790007|NCT03709940|Dopamine Agents|dopamine agents|mesh-ancestor
110790008|NCT03709940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110790009|NCT03341312|Insulin Lispro|insulin lispro|mesh-list
110790010|NCT03341312|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110790011|NCT03341312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110790012|NCT01147029|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
110790013|NCT01147029|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110790014|NCT01147029|Growth Substances|growth substances|mesh-ancestor
110851003|NCT02495818|Lidocaine|lidocaine|mesh-list
110790016|NCT01147029|Growth Inhibitors|growth inhibitors|mesh-ancestor
110790017|NCT01147029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110790018|NCT01239459|Teriflunomide|teriflunomide|mesh-list
110790019|NCT01239459|Cholestyramine Resin|cholestyramine resin|mesh-list
110790020|NCT01239459|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110790021|NCT01239459|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110790022|NCT01239459|Analgesics|analgesics|mesh-ancestor
110790023|NCT01239459|Sensory System Agents|sensory system agents|mesh-ancestor
110790024|NCT01239459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110790025|NCT01239459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110499422|NCT04004611|Analgesics|analgesics|mesh-ancestor
110790026|NCT01239459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110790027|NCT01239459|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110790028|NCT01239459|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110790029|NCT01239459|Immunologic Factors|immunologic factors|mesh-ancestor
110790030|NCT01239459|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110790031|NCT01239459|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110790032|NCT01239459|Antimetabolites|antimetabolites|mesh-ancestor
110790033|NCT01239459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110790034|NCT01239459|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110790035|NCT03915561|Parecoxib|parecoxib|mesh-list
110790036|NCT03915561|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110790037|NCT03915561|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110790039|NCT03915561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110790040|NCT03915561|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110790041|NCT03915561|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110790042|NCT03915561|Analgesics|analgesics|mesh-ancestor
110790043|NCT03915561|Sensory System Agents|sensory system agents|mesh-ancestor
110790044|NCT03915561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110790045|NCT03915561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110507662|NCT00817479|Hormones|hormones|mesh-ancestor
110790046|NCT03915561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110790047|NCT03915561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110790048|NCT01148277|Fentanyl|fentanyl|mesh-list
110790049|NCT01148277|Midazolam|midazolam|mesh-list
110790050|NCT01148277|Propofol|propofol|mesh-list
110790051|NCT01148277|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110790052|NCT01148277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110790053|NCT01148277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110790054|NCT01148277|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110790055|NCT01148277|Anesthetics, General|anesthetics, general|mesh-ancestor
110790056|NCT01148277|Anesthetics|anesthetics|mesh-ancestor
110790057|NCT01148277|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110790058|NCT01148277|Narcotics|narcotics|mesh-ancestor
110790059|NCT01148277|Analgesics|analgesics|mesh-ancestor
110790060|NCT01148277|Sensory System Agents|sensory system agents|mesh-ancestor
110790061|NCT01148277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110790062|NCT01148277|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110790063|NCT01148277|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110790064|NCT01148277|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110790065|NCT01148277|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110790066|NCT01148277|GABA Modulators|gaba modulators|mesh-ancestor
110790067|NCT01148277|GABA Agents|gaba agents|mesh-ancestor
110790068|NCT01148277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110790069|NCT01148277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110790070|NCT03907371|Donepezil|donepezil|mesh-list
110790071|NCT03907371|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110790072|NCT03907371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110790073|NCT03907371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110790074|NCT03907371|Cholinergic Agents|cholinergic agents|mesh-ancestor
110790075|NCT03907371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110790076|NCT03907371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110790077|NCT03907371|Nootropic Agents|nootropic agents|mesh-ancestor
110790078|NCT03908619|Esomeprazole|esomeprazole|mesh-list
110790079|NCT03908619|Omeprazole|omeprazole|mesh-list
110790080|NCT03908619|Rabeprazole|rabeprazole|mesh-list
110790081|NCT03908619|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110790082|NCT03908619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110790083|NCT03908619|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110790084|NCT03908619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110790085|NCT03908619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110790086|NCT01358734|Lenalidomide|lenalidomide|mesh-list
110790087|NCT01358734|Azacitidine|azacitidine|mesh-list
110790088|NCT01358734|Immunologic Factors|immunologic factors|mesh-ancestor
110790089|NCT01358734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110790090|NCT01358734|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110790091|NCT01358734|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110790092|NCT01358734|Growth Substances|growth substances|mesh-ancestor
110790093|NCT01358734|Growth Inhibitors|growth inhibitors|mesh-ancestor
110790094|NCT01358734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110790095|NCT01358734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110790096|NCT01358734|Antimetabolites|antimetabolites|mesh-ancestor
110790097|NCT01358734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110790098|NCT01358734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110790099|NCT03907215|Citalopram|citalopram|mesh-list
110790100|NCT03907215|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110790101|NCT03907215|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110790102|NCT03907215|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110790103|NCT03907215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110790104|NCT03907215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110790105|NCT03907215|Serotonin Agents|serotonin agents|mesh-ancestor
110790106|NCT03907215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110790107|NCT03907215|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110790108|NCT03907215|Antidepressive Agents|antidepressive agents|mesh-ancestor
110790109|NCT03907215|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110790110|NCT05335954|Norepinephrine|norepinephrine|mesh-list
110790111|NCT05335954|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110790112|NCT05335954|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110790113|NCT05335954|Adrenergic Agents|adrenergic agents|mesh-ancestor
110790114|NCT05335954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110790115|NCT05335954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110790116|NCT05335954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110790117|NCT05335954|Sympathomimetics|sympathomimetics|mesh-ancestor
110790118|NCT05335954|Autonomic Agents|autonomic agents|mesh-ancestor
110790119|NCT05335954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110790120|NCT05335954|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110790122|NCT01250457|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110790123|NCT01250457|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110790124|NCT01250457|Adrenergic Agents|adrenergic agents|mesh-ancestor
110790125|NCT01250457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110499550|NCT03013998|Antiviral Agents|antiviral agents|mesh-ancestor
110790126|NCT01250457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110790127|NCT01250457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110790128|NCT01250457|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110790129|NCT01250457|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110790131|NCT03902925|Ropivacaine|ropivacaine|mesh-list
110790132|NCT03902925|Anesthetics, Local|anesthetics, local|mesh-ancestor
110790133|NCT03902925|Anesthetics|anesthetics|mesh-ancestor
110790134|NCT03902925|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110790135|NCT03902925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110790136|NCT03902925|Sensory System Agents|sensory system agents|mesh-ancestor
110790137|NCT03902925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110790138|NCT03902925|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110790139|NCT03902925|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110790140|NCT03902925|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110790141|NCT03902925|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110790142|NCT03902925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110790143|NCT01250535|Warfarin|warfarin|mesh-list
110790144|NCT01250535|Lovastatin|lovastatin|mesh-list
110790145|NCT01250535|L 647318|l 647318|mesh-list
110790146|NCT01250535|Dihydromevinolin|dihydromevinolin|mesh-list
110790147|NCT01250535|Anticoagulants|anticoagulants|mesh-ancestor
110790148|NCT01250535|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110790149|NCT01250535|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110790150|NCT01250535|Antimetabolites|antimetabolites|mesh-ancestor
110790151|NCT01250535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110790152|NCT01250535|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110790153|NCT01250535|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110790154|NCT01250535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110790155|NCT02527941|Metronidazole|metronidazole|mesh-list
110790156|NCT02527941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110790157|NCT02527941|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110790158|NCT02527941|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110790159|NCT02527941|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110790160|NCT03906669|Tamoxifen|tamoxifen|mesh-list
110790161|NCT03906669|Letrozole|letrozole|mesh-list
110790162|NCT03906669|Progesterone|progesterone|mesh-list
110790163|NCT03906669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110790164|NCT03906669|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110790165|NCT03906669|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110790166|NCT03906669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110790167|NCT03906669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110790168|NCT03906669|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110790169|NCT03906669|Hormone Antagonists|hormone antagonists|mesh-ancestor
110499589|NCT02859896|Vitamins|vitamins|mesh-ancestor
110790170|NCT03906669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110790171|NCT03906669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110790172|NCT03906669|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110790173|NCT03906669|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110790174|NCT03906669|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110790175|NCT03906669|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110790176|NCT03906669|Progestins|progestins|mesh-ancestor
110790177|NCT03906669|Hormones|hormones|mesh-ancestor
110790178|NCT01254825|Ropivacaine|ropivacaine|mesh-list
110790179|NCT01254825|Anesthetics, Local|anesthetics, local|mesh-ancestor
110790180|NCT01254825|Anesthetics|anesthetics|mesh-ancestor
110790181|NCT01254825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110790182|NCT01254825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110790183|NCT01254825|Sensory System Agents|sensory system agents|mesh-ancestor
110790184|NCT01254825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110790185|NCT03906123|3-n-butylphthalide|3-n-butylphthalide|mesh-list
110790186|NCT03906123|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110790187|NCT03906123|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110790188|NCT03906123|Protective Agents|protective agents|mesh-ancestor
110790189|NCT03906123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110790190|NCT01341652|Molgramostim|molgramostim|mesh-list
110790191|NCT01341652|Sargramostim|sargramostim|mesh-list
110790192|NCT01341652|Immunologic Factors|immunologic factors|mesh-ancestor
110790193|NCT01341652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110790194|NCT01341652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110790195|NCT03563794|Insulin Lispro|insulin lispro|mesh-list
110790196|NCT03563794|Vildagliptin|vildagliptin|mesh-list
110790197|NCT03563794|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110790198|NCT03563794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110790199|NCT03563794|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110790200|NCT03563794|Protease Inhibitors|protease inhibitors|mesh-ancestor
110790201|NCT03563794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110790202|NCT03563794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110790204|NCT03905967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110790205|NCT03905967|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110790206|NCT03905967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110790207|NCT03905967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110790208|NCT03563950|Rifampin|rifampin|mesh-list
110790209|NCT03563950|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110790210|NCT03563950|Antitubercular Agents|antitubercular agents|mesh-ancestor
110790211|NCT03563950|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110790212|NCT03563950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110790213|NCT03563950|Leprostatic Agents|leprostatic agents|mesh-ancestor
110790214|NCT03563950|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110790215|NCT03563950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110790216|NCT03563950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110790217|NCT03563950|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110790218|NCT03563950|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110790219|NCT03563950|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110790220|NCT03563950|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110790221|NCT03563950|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110790222|NCT03563950|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110790223|NCT03905655|Nitazoxanide|nitazoxanide|mesh-list
110790224|NCT03905655|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110790225|NCT03905655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110790226|NCT03914235|Lidocaine|lidocaine|mesh-list
110790227|NCT03914235|Anesthetics, Local|anesthetics, local|mesh-ancestor
110790228|NCT03914235|Anesthetics|anesthetics|mesh-ancestor
110790229|NCT03914235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110790230|NCT03914235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110790231|NCT03914235|Sensory System Agents|sensory system agents|mesh-ancestor
110790232|NCT03914235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110790233|NCT03914235|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110790234|NCT03914235|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110790235|NCT03914235|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110790236|NCT03914235|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110790237|NCT03914235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110790238|NCT01148667|Caseins|caseins|mesh-list
110790239|NCT01148667|Chelating Agents|chelating agents|mesh-ancestor
110790240|NCT01148667|Sequestering Agents|sequestering agents|mesh-ancestor
110790241|NCT01148667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110790242|NCT01254123|Exenatide|exenatide|mesh-list
110790243|NCT01254123|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110790244|NCT01254123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110790245|NCT01254123|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110790246|NCT01254123|Incretins|incretins|mesh-ancestor
110790247|NCT01254123|Hormones|hormones|mesh-ancestor
110790248|NCT01254123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110790249|NCT03898635|Linezolid|linezolid|mesh-list
110790250|NCT03898635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110790251|NCT03898635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110790252|NCT03898635|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110790253|NCT03898635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110790254|NCT03898635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110790255|NCT02528019|Glimepiride|glimepiride|mesh-list
110790256|NCT02528019|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
110790257|NCT02528019|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110790258|NCT02528019|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110790259|NCT02528019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110790260|NCT02528019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110790261|NCT02528019|Immunologic Factors|immunologic factors|mesh-ancestor
110790262|NCT02528019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110790263|NCT01255215|Nitric Oxide|nitric oxide|mesh-list
110790264|NCT01255215|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110790265|NCT01255215|Autonomic Agents|autonomic agents|mesh-ancestor
110790266|NCT01255215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110790267|NCT01255215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110790268|NCT01255215|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110790269|NCT01255215|Respiratory System Agents|respiratory system agents|mesh-ancestor
110790270|NCT01255215|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110790271|NCT01255215|Antioxidants|antioxidants|mesh-ancestor
110790272|NCT01255215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110790273|NCT01255215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110790274|NCT01255215|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
110790275|NCT01255215|Vasodilator Agents|vasodilator agents|mesh-ancestor
110790276|NCT01255215|Gasotransmitters|gasotransmitters|mesh-ancestor
110790277|NCT01255215|Protective Agents|protective agents|mesh-ancestor
110790278|NCT02527785|Oxaliplatin|oxaliplatin|mesh-list
110790279|NCT02527785|Irinotecan|irinotecan|mesh-list
110790280|NCT02527785|Tegafur|tegafur|mesh-list
110790281|NCT02527785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110790282|NCT02527785|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110790283|NCT02527785|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110790284|NCT02527785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110790285|NCT02527785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110790286|NCT02527785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110790287|NCT02527785|Antimetabolites|antimetabolites|mesh-ancestor
110790288|NCT02527863|Tolvaptan|tolvaptan|mesh-list
110790289|NCT02527863|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
110790290|NCT02527863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110790291|NCT02527863|Natriuretic Agents|natriuretic agents|mesh-ancestor
110790292|NCT02527863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110790293|NCT01256541|Lactulose|lactulose|mesh-list
110790294|NCT01256541|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110790295|NCT03904719|Vorolanib|vorolanib|mesh-list
110790296|NCT03904719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110790297|NCT03904719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110790298|NCT03904719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110790299|NCT01148901|Infliximab|infliximab|mesh-list
110790300|NCT01148901|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110790301|NCT01148901|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110790302|NCT01148901|Dermatologic Agents|dermatologic agents|mesh-ancestor
110790303|NCT01148901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110790304|NCT01148901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110790305|NCT01150617|Insulin|insulin|mesh-list
110790306|NCT01150617|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110790307|NCT01150617|Insulin Glargine|insulin glargine|mesh-list
110790308|NCT01150617|Hypoglycemic Agents|hypoglycemic agents|mesh-list
110790309|NCT01150617|Insulin, Short-Acting|insulin, short-acting|mesh-list
110790310|NCT01150617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110790311|NCT01256619|Desogestrel|desogestrel|mesh-list
110790312|NCT01256619|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110790313|NCT01256619|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110790314|NCT01256619|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110790315|NCT01256619|Contraceptive Agents|contraceptive agents|mesh-ancestor
110790316|NCT01256619|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110790317|NCT01256619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110790318|NCT01256619|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110790319|NCT01256619|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110790320|NCT01256619|Progestins|progestins|mesh-ancestor
110790321|NCT01256619|Hormones|hormones|mesh-ancestor
110790322|NCT01256619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110790323|NCT03898011|Lamotrigine|lamotrigine|mesh-list
110790324|NCT03898011|Anticonvulsants|anticonvulsants|mesh-ancestor
110790325|NCT03898011|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110790326|NCT03898011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110790327|NCT03898011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110790328|NCT03898011|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110790329|NCT03898011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110790330|NCT03898011|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110790331|NCT03898011|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110790332|NCT03898011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110790333|NCT03898011|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110790334|NCT03898011|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110790335|NCT01254513|Prednisone|prednisone|mesh-list
110790336|NCT01254513|Docetaxel|docetaxel|mesh-list
110790337|NCT01254513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110790338|NCT01254513|Tubulin Modulators|tubulin modulators|mesh-ancestor
110790339|NCT01254513|Antimitotic Agents|antimitotic agents|mesh-ancestor
110790340|NCT01254513|Mitosis Modulators|mitosis modulators|mesh-ancestor
110790341|NCT01254513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110790342|NCT01254513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110790343|NCT01254513|Glucocorticoids|glucocorticoids|mesh-ancestor
110790344|NCT01254513|Hormones|hormones|mesh-ancestor
110790345|NCT01254513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110790346|NCT01254513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110790347|NCT01254513|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110790348|NCT01254591|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110790349|NCT01254591|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110790350|NCT01254591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110790351|NCT01149993|Mycophenolic Acid|mycophenolic acid|mesh-list
110790352|NCT01149993|Thymoglobulin|thymoglobulin|mesh-list
110790353|NCT01149993|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110790354|NCT01149993|Immunologic Factors|immunologic factors|mesh-ancestor
110790355|NCT01149993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110790356|NCT01149993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110790357|NCT01149993|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110790358|NCT01149993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110790359|NCT01149993|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110790360|NCT01149993|Antitubercular Agents|antitubercular agents|mesh-ancestor
110790361|NCT01149993|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110790362|NCT01149993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110790363|NCT01149993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110790364|NCT01149993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110790365|NCT01255371|Lopinavir|lopinavir|mesh-list
110790366|NCT01255371|Atazanavir Sulfate|atazanavir sulfate|mesh-list
110790367|NCT01255371|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110790368|NCT01255371|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110790369|NCT01255371|Protease Inhibitors|protease inhibitors|mesh-ancestor
110790370|NCT01255371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110790371|NCT01255371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110790372|NCT01255371|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110790373|NCT01255371|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110790374|NCT01255371|Antiviral Agents|antiviral agents|mesh-ancestor
110790375|NCT01255371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110790376|NCT01255371|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110790377|NCT01255371|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110790378|NCT03903783|Ceftriaxone|ceftriaxone|mesh-list
110790379|NCT03903783|Cefotaxime|cefotaxime|mesh-list
110790380|NCT03903783|Cefoxitin|cefoxitin|mesh-list
110790381|NCT03903783|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110790382|NCT03903783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110790383|NCT03899337|Prednisolone|prednisolone|mesh-list
110790384|NCT03899337|Cyclophosphamide|cyclophosphamide|mesh-list
110790385|NCT03899337|Rituximab|rituximab|mesh-list
110790386|NCT03899337|Doxorubicin|doxorubicin|mesh-list
110790387|NCT03899337|Vincristine|vincristine|mesh-list
110790388|NCT03899337|Acalabrutinib|acalabrutinib|mesh-list
110790389|NCT03899337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110790390|NCT03899337|Immunologic Factors|immunologic factors|mesh-ancestor
110790391|NCT03899337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110790392|NCT03899337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110790393|NCT03899337|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110790394|NCT03899337|Alkylating Agents|alkylating agents|mesh-ancestor
110790395|NCT03899337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110790396|NCT03899337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110790397|NCT03899337|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110790398|NCT03899337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110790399|NCT03899337|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110790400|NCT03899337|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110790401|NCT03899337|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110790402|NCT03899337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110790403|NCT03899337|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110790404|NCT03899337|Tubulin Modulators|tubulin modulators|mesh-ancestor
110790405|NCT03899337|Antimitotic Agents|antimitotic agents|mesh-ancestor
110790406|NCT03899337|Mitosis Modulators|mitosis modulators|mesh-ancestor
110790407|NCT03899337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110790408|NCT03899337|Glucocorticoids|glucocorticoids|mesh-ancestor
110790409|NCT03899337|Hormones|hormones|mesh-ancestor
110790410|NCT03899337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110790411|NCT03899337|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110790412|NCT01586169|Azithromycin|azithromycin|mesh-list
110790413|NCT01586169|Ivermectin|ivermectin|mesh-list
110790414|NCT01586169|Albendazole|albendazole|mesh-list
110790415|NCT01586169|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110790416|NCT01586169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110790417|NCT01586169|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110790418|NCT01586169|Anthelmintics|anthelmintics|mesh-ancestor
110790419|NCT01586169|Anticestodal Agents|anticestodal agents|mesh-ancestor
110790420|NCT01586169|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110790421|NCT01586169|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110790422|NCT01586169|Tubulin Modulators|tubulin modulators|mesh-ancestor
110790423|NCT01586169|Antimitotic Agents|antimitotic agents|mesh-ancestor
110790424|NCT01586169|Mitosis Modulators|mitosis modulators|mesh-ancestor
110790425|NCT01586169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110790426|NCT01586169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110790427|NCT01256775|Aspirin|aspirin|mesh-list
110790428|NCT01256775|Nitroaspirin|nitroaspirin|mesh-list
110790429|NCT01256775|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110790430|NCT01256775|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110790431|NCT01256775|Analgesics|analgesics|mesh-ancestor
110790432|NCT01256775|Sensory System Agents|sensory system agents|mesh-ancestor
110790433|NCT01256775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110790434|NCT01256775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110790435|NCT01256775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110790436|NCT01256775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110790437|NCT01256775|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110790438|NCT01256775|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110790439|NCT01256775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110790440|NCT01256775|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110790441|NCT01256775|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
110790442|NCT01256775|Protease Inhibitors|protease inhibitors|mesh-ancestor
110790443|NCT01256775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110790444|NCT01256775|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110790445|NCT01256775|Antipyretics|antipyretics|mesh-ancestor
110790446|NCT03899571|Oseltamivir|oseltamivir|mesh-list
110790447|NCT03899571|Antiviral Agents|antiviral agents|mesh-ancestor
110790448|NCT03899571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110790449|NCT03899571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110790450|NCT03899571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110790451|NCT01257009|Atorvastatin|atorvastatin|mesh-list
110790452|NCT01257009|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110790453|NCT01257009|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110790454|NCT01257009|Antimetabolites|antimetabolites|mesh-ancestor
110790455|NCT01257009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110790456|NCT01257009|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110790457|NCT01257009|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110790458|NCT01257009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110790459|NCT01255527|Bortezomib|bortezomib|mesh-list
110790460|NCT01255527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110790461|NCT01151787|Amitriptyline|amitriptyline|mesh-list
110790462|NCT01151787|Cyclobenzaprine|cyclobenzaprine|mesh-list
110790463|NCT01151787|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110790464|NCT01151787|Antidepressive Agents|antidepressive agents|mesh-ancestor
110790465|NCT01151787|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110790466|NCT01151787|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110790467|NCT01151787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110790468|NCT01151787|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110790469|NCT01151787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110790470|NCT01151787|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110790471|NCT01151787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110790472|NCT01151787|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110790473|NCT01151787|Analgesics|analgesics|mesh-ancestor
110790474|NCT01151787|Sensory System Agents|sensory system agents|mesh-ancestor
110790475|NCT01151787|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110790476|NCT01151787|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110790477|NCT01151787|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110790478|NCT01151787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110790479|NCT01151787|Adrenergic Agents|adrenergic agents|mesh-ancestor
110790480|NCT01151787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110790481|NCT01151865|Dexmedetomidine|dexmedetomidine|mesh-list
110790482|NCT01151865|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110790483|NCT01151865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110790484|NCT01151865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110790485|NCT01151865|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110790486|NCT01151865|Analgesics|analgesics|mesh-ancestor
110790487|NCT01151865|Sensory System Agents|sensory system agents|mesh-ancestor
110790488|NCT01151865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110790489|NCT01151865|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110790490|NCT01151865|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110790491|NCT01151865|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110790492|NCT01151865|Adrenergic Agents|adrenergic agents|mesh-ancestor
110790493|NCT01151865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110790494|NCT01151865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110790495|NCT03893097|Artesunate|artesunate|mesh-list
110790496|NCT03893097|Mefloquine|mefloquine|mesh-list
110790497|NCT03893097|Praziquantel|praziquantel|mesh-list
110790498|NCT03893097|Antimalarials|antimalarials|mesh-ancestor
110790499|NCT03893097|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110790500|NCT03893097|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110790501|NCT03893097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110790502|NCT03893097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110790503|NCT03893097|Antiviral Agents|antiviral agents|mesh-ancestor
110790504|NCT03893097|Schistosomicides|schistosomicides|mesh-ancestor
110790505|NCT03893097|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110790506|NCT03893097|Anthelmintics|anthelmintics|mesh-ancestor
110790507|NCT01258491|Nicotinic Acids|nicotinic acids|mesh-list
110790508|NCT01258491|Niacin|niacin|mesh-list
110790509|NCT01258491|Niacinamide|niacinamide|mesh-list
110790510|NCT01258491|Vitamin B Complex|vitamin b complex|mesh-ancestor
110790511|NCT01258491|Vitamins|vitamins|mesh-ancestor
110790512|NCT01258491|Micronutrients|micronutrients|mesh-ancestor
110790513|NCT01258491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110790514|NCT01258491|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110790515|NCT01258491|Antimetabolites|antimetabolites|mesh-ancestor
110790516|NCT01258491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110790517|NCT01258491|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110790518|NCT01258491|Vasodilator Agents|vasodilator agents|mesh-ancestor
110790519|NCT01257165|Ethanol|ethanol|mesh-list
110790520|NCT01257165|Zopiclone|zopiclone|mesh-list
110790521|NCT01257165|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110790522|NCT01257165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110790523|NCT01257165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110790524|NCT01257165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110790525|NCT01257165|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110790526|NCT01151943|Anesthetics|anesthetics|mesh-list
110790527|NCT01151943|Anesthetics, Local|anesthetics, local|mesh-list
110790528|NCT01151943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110790529|NCT01151943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110790530|NCT01151943|Sensory System Agents|sensory system agents|mesh-ancestor
110790531|NCT01151943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110790532|NCT01256151|Alprazolam|alprazolam|mesh-list
110790533|NCT01256151|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110790534|NCT01256151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110790535|NCT01256151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110790536|NCT01256151|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110790537|NCT01256151|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110790538|NCT01256151|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110790539|NCT01256151|GABA Modulators|gaba modulators|mesh-ancestor
110790540|NCT01256151|GABA Agents|gaba agents|mesh-ancestor
110790541|NCT01256151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110790542|NCT01256151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110790543|NCT01259973|Haloperidol|haloperidol|mesh-list
110790544|NCT01259973|Risperidone|risperidone|mesh-list
110790545|NCT01259973|Haloperidol decanoate|haloperidol decanoate|mesh-list
110790546|NCT01259973|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110790547|NCT01259973|Serotonin Agents|serotonin agents|mesh-ancestor
110790548|NCT01259973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110790549|NCT01259973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110790550|NCT01259973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110790551|NCT01259973|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110790552|NCT01259973|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110790553|NCT01259973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110790554|NCT01259973|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110790555|NCT01259973|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110790556|NCT01259973|Dopamine Agents|dopamine agents|mesh-ancestor
110790557|NCT01259973|Antiemetics|antiemetics|mesh-ancestor
110790558|NCT01259973|Autonomic Agents|autonomic agents|mesh-ancestor
110790559|NCT01259973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110790560|NCT01259973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110790561|NCT01259973|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110790562|NCT01257243|Potassium iodate|potassium iodate|mesh-list
110790563|NCT01257243|Phenylpropanolamine|phenylpropanolamine|mesh-list
110790564|NCT01257243|Guaifenesin|guaifenesin|mesh-list
110790565|NCT01257243|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
110790566|NCT01257243|Expectorants|expectorants|mesh-ancestor
110790567|NCT01257243|Respiratory System Agents|respiratory system agents|mesh-ancestor
110790568|NCT01257243|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110790569|NCT01257243|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110790570|NCT01257243|Adrenergic Agents|adrenergic agents|mesh-ancestor
110790571|NCT01257243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110790572|NCT01257243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110790573|NCT01257243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110790574|NCT01257243|Appetite Depressants|appetite depressants|mesh-ancestor
110790575|NCT01257243|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110790576|NCT01257243|Sympathomimetics|sympathomimetics|mesh-ancestor
110790577|NCT01257243|Autonomic Agents|autonomic agents|mesh-ancestor
110790578|NCT01257243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110790579|NCT01257243|Nasal Decongestants|nasal decongestants|mesh-ancestor
110790580|NCT01257243|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110790581|NCT01257243|Antifungal Agents|antifungal agents|mesh-ancestor
110790582|NCT01257243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110790583|NCT01258569|Alvimopan|alvimopan|mesh-list
110790584|NCT01258569|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110790585|NCT01257399|Mesalamine|mesalamine|mesh-list
110790586|NCT01257399|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110790587|NCT01257399|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110790588|NCT01257399|Analgesics|analgesics|mesh-ancestor
110790589|NCT01257399|Sensory System Agents|sensory system agents|mesh-ancestor
110790590|NCT01257399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110790591|NCT01257399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110790592|NCT01257399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110790593|NCT01257399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110790594|NCT01258959|Anesthetics|anesthetics|mesh-list
110790595|NCT01258959|Anesthetics, Local|anesthetics, local|mesh-list
110790596|NCT01258959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110790597|NCT01258959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110790598|NCT01258959|Sensory System Agents|sensory system agents|mesh-ancestor
110790599|NCT01258959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110790600|NCT01153659|Esomeprazole|esomeprazole|mesh-list
110790601|NCT01153659|Rabeprazole|rabeprazole|mesh-list
110790602|NCT01153659|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110790603|NCT01153659|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110790604|NCT01153659|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110790605|NCT01153659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110790606|NCT01153659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110790607|NCT01260129|Silodosin|silodosin|mesh-list
110790608|NCT01260129|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110790609|NCT01260129|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110790610|NCT01260129|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110790611|NCT01260129|Adrenergic Agents|adrenergic agents|mesh-ancestor
110790612|NCT01260129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110790613|NCT01260129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110790614|NCT01260129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110790615|NCT01260129|Urological Agents|urological agents|mesh-ancestor
110790616|NCT01260285|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
110790617|NCT01260285|Vasodilator Agents|vasodilator agents|mesh-ancestor
110790618|NCT01260285|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110790619|NCT01260285|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110790620|NCT01260285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110790621|NCT01260285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110790622|NCT01260285|Urological Agents|urological agents|mesh-ancestor
110790623|NCT03888729|Velpatasvir|velpatasvir|mesh-list
110790624|NCT03888729|Antiviral Agents|antiviral agents|mesh-ancestor
110790625|NCT03888729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110790626|NCT01151241|Anesthetics|anesthetics|mesh-list
110790627|NCT01151241|Anesthetics, Local|anesthetics, local|mesh-list
110790628|NCT01151241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110790629|NCT01151241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110790630|NCT01151241|Sensory System Agents|sensory system agents|mesh-ancestor
110790631|NCT01151241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110790632|NCT02949362|Teduglutide|teduglutide|mesh-list
110790633|NCT02949362|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110790634|NCT02949362|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110790635|NCT02949362|Protective Agents|protective agents|mesh-ancestor
110499857|NCT00696033|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110790636|NCT02949362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110790637|NCT03896217|Simvastatin|simvastatin|mesh-list
110790638|NCT03896217|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110790639|NCT03896217|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110790640|NCT03896217|Antimetabolites|antimetabolites|mesh-ancestor
110790641|NCT03896217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110790642|NCT03896217|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110790643|NCT03896217|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110790644|NCT03896217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110790645|NCT05220410|Psilocybin|psilocybin|mesh-list
110790646|NCT05220410|Hallucinogens|hallucinogens|mesh-ancestor
110790647|NCT05220410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110790648|NCT05220410|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110790649|NCT03892161|Ritonavir|ritonavir|mesh-list
110790650|NCT03892161|Darunavir|darunavir|mesh-list
110790651|NCT03892161|Rifampin|rifampin|mesh-list
110790652|NCT03892161|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110790653|NCT03892161|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110790655|NCT03892161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110790656|NCT03892161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110790657|NCT03892161|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110790658|NCT03892161|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110790659|NCT03892161|Antiviral Agents|antiviral agents|mesh-ancestor
110790660|NCT03892161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110790661|NCT03892161|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110790662|NCT03892161|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110790663|NCT03892161|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110790664|NCT03892161|Antitubercular Agents|antitubercular agents|mesh-ancestor
110790665|NCT03892161|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110790666|NCT03892161|Leprostatic Agents|leprostatic agents|mesh-ancestor
110790667|NCT03892161|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110790668|NCT03892161|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110790669|NCT03892161|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110790670|NCT03892161|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110790671|NCT03892161|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110499893|NCT04291313|Vitamin D|vitamin d|mesh-list
110790672|NCT03892161|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110790673|NCT03892161|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110790674|NCT01154361|Cortisone|cortisone|mesh-list
110790675|NCT01154361|Icatibant|icatibant|mesh-list
110790676|NCT01154361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110790677|NCT01154361|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110790678|NCT01154361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110790679|NCT01154361|Analgesics|analgesics|mesh-ancestor
110790680|NCT01154361|Sensory System Agents|sensory system agents|mesh-ancestor
110790681|NCT01154361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110790682|NCT01154361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110790683|NCT01154361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110790684|NCT01154361|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
110790685|NCT01154361|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
110790686|NCT01154361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110790687|NCT01154361|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
110790688|NCT01154361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110790689|NCT01154361|Immunologic Factors|immunologic factors|mesh-ancestor
110790690|NCT01260519|Heparin|heparin|mesh-list
110790691|NCT01260519|Calcium heparin|calcium heparin|mesh-list
110790692|NCT01260519|Anticoagulants|anticoagulants|mesh-ancestor
110790693|NCT01260519|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110790694|NCT01260519|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110790695|NCT01260519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110790696|NCT03888183|Lubricant Eye Drops|lubricant eye drops|mesh-list
110790697|NCT03888183|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110790698|NCT03888183|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110790699|NCT03891615|Niraparib|niraparib|mesh-list
110790700|NCT03891615|Osimertinib|osimertinib|mesh-list
110790701|NCT03891615|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110790702|NCT03891615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110790703|NCT03891615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110790704|NCT03891615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110790705|NCT03891615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110790706|NCT02947022|Calcium, Dietary|calcium, dietary|mesh-list
110790707|NCT02947022|Zinc|zinc|mesh-list
110790708|NCT02947022|Edetic Acid|edetic acid|mesh-list
110790709|NCT02947022|Calcium|calcium|mesh-list
110790710|NCT02947022|Pentetic Acid|pentetic acid|mesh-list
110790711|NCT02947022|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110790712|NCT02947022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110790713|NCT02947022|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110790714|NCT02947022|Trace Elements|trace elements|mesh-ancestor
110790715|NCT02947022|Micronutrients|micronutrients|mesh-ancestor
110790716|NCT02947022|Antidotes|antidotes|mesh-ancestor
110790717|NCT02947022|Protective Agents|protective agents|mesh-ancestor
110790718|NCT02947022|Chelating Agents|chelating agents|mesh-ancestor
110790719|NCT02947022|Sequestering Agents|sequestering agents|mesh-ancestor
110790720|NCT02947022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110790721|NCT02947022|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110790722|NCT02947022|Anticoagulants|anticoagulants|mesh-ancestor
110790723|NCT02947022|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110790724|NCT01259193|Zoledronic Acid|zoledronic acid|mesh-list
110790725|NCT01259193|Sorafenib|sorafenib|mesh-list
110790726|NCT01259193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110790727|NCT01259193|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110790728|NCT01259193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110790729|NCT01259193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110790730|NCT01259193|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110790731|NCT01259193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110790732|NCT05182892|Dopamine|dopamine|mesh-list
110790733|NCT05182892|Dopamine Agonists|dopamine agonists|mesh-list
110790734|NCT05182892|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110790735|NCT05182892|Sympathomimetics|sympathomimetics|mesh-ancestor
110790736|NCT05182892|Autonomic Agents|autonomic agents|mesh-ancestor
110790737|NCT05182892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110790738|NCT05182892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110790739|NCT05182892|Dopamine Agents|dopamine agents|mesh-ancestor
110790740|NCT05182892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110790741|NCT05182892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110790742|NCT05182892|Protective Agents|protective agents|mesh-ancestor
110790743|NCT01312376|Cyclophosphamide|cyclophosphamide|mesh-list
110790744|NCT01312376|Bevacizumab|bevacizumab|mesh-list
110790745|NCT01312376|Fludarabine|fludarabine|mesh-list
110790746|NCT01312376|Vaccines|vaccines|mesh-list
110790747|NCT01312376|Immunologic Factors|immunologic factors|mesh-ancestor
110790748|NCT01312376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110790749|NCT01312376|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110790750|NCT01312376|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110790751|NCT01312376|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110790752|NCT01312376|Alkylating Agents|alkylating agents|mesh-ancestor
110790753|NCT01312376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110790754|NCT01312376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110790755|NCT01312376|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110790756|NCT01312376|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110790757|NCT01312376|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110790758|NCT01312376|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110790759|NCT01312376|Growth Substances|growth substances|mesh-ancestor
110790760|NCT01312376|Growth Inhibitors|growth inhibitors|mesh-ancestor
110790761|NCT01260675|Buprenorphine|buprenorphine|mesh-list
110790762|NCT01260675|Naloxone|naloxone|mesh-list
110499960|NCT02622555|Mirabegron|mirabegron|mesh-list
110790763|NCT01260675|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110790764|NCT01260675|Narcotics|narcotics|mesh-ancestor
110790765|NCT01260675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110790766|NCT01260675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110790767|NCT01260675|Analgesics|analgesics|mesh-ancestor
110790768|NCT01260675|Sensory System Agents|sensory system agents|mesh-ancestor
110790769|NCT01260675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110790770|NCT01260675|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110790771|NCT03887871|Tamsulosin|tamsulosin|mesh-list
110790772|NCT03887871|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110790773|NCT03887871|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110790774|NCT03887871|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110790775|NCT03887871|Adrenergic Agents|adrenergic agents|mesh-ancestor
110790776|NCT03887871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110790777|NCT03887871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110790778|NCT03887871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110790779|NCT03887871|Urological Agents|urological agents|mesh-ancestor
110790780|NCT03708146|Zamicastat|zamicastat|mesh-list
110790781|NCT03708146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110790782|NCT03708146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110790783|NCT01260753|Fluticasone|fluticasone|mesh-list
110790784|NCT01260753|Xhance|xhance|mesh-list
110790785|NCT01260753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110790786|NCT01260753|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110790787|NCT01260753|Autonomic Agents|autonomic agents|mesh-ancestor
110790788|NCT01260753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110790789|NCT01260753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110790790|NCT01260753|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110790791|NCT01260753|Respiratory System Agents|respiratory system agents|mesh-ancestor
110790792|NCT01260753|Dermatologic Agents|dermatologic agents|mesh-ancestor
110790793|NCT01260753|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110508466|NCT05969587|Cysteamine|cysteamine|mesh-list
110790794|NCT03895671|Azacitidine|azacitidine|mesh-list
110790795|NCT03895671|Ponatinib|ponatinib|mesh-list
110790796|NCT03895671|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110790797|NCT03895671|Antimetabolites|antimetabolites|mesh-ancestor
110790798|NCT03895671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110790799|NCT03895671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110790800|NCT03895671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110790801|NCT03895671|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110790802|NCT01152723|Nicotine|nicotine|mesh-list
110499986|NCT02622477|Pirfenidone|pirfenidone|mesh-list
110790803|NCT01152723|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110790804|NCT01152723|Autonomic Agents|autonomic agents|mesh-ancestor
110790805|NCT01152723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110790806|NCT01152723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110790807|NCT01152723|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110790808|NCT01152723|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110790809|NCT01152723|Cholinergic Agents|cholinergic agents|mesh-ancestor
110790810|NCT01152723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110790811|NCT01152723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110790812|NCT01261065|Carvedilol|carvedilol|mesh-list
110790813|NCT01261065|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110790814|NCT01261065|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110790815|NCT01261065|Adrenergic Agents|adrenergic agents|mesh-ancestor
110790816|NCT01261065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110790817|NCT01261065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110790818|NCT01261065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110790819|NCT01261065|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110790820|NCT01261065|Antioxidants|antioxidants|mesh-ancestor
110790821|NCT01261065|Protective Agents|protective agents|mesh-ancestor
110790822|NCT01261065|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110790823|NCT01261065|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110790824|NCT01261065|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110790825|NCT01261065|Vasodilator Agents|vasodilator agents|mesh-ancestor
110790826|NCT01261065|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110790827|NCT01261065|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110790828|NCT01257867|Lithium Carbonate|lithium carbonate|mesh-list
110790829|NCT01257867|Antidepressive Agents|antidepressive agents|mesh-ancestor
110790830|NCT01257867|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110790831|NCT01257867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110790832|NCT01257867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110790833|NCT01257867|Antimanic Agents|antimanic agents|mesh-ancestor
110790834|NCT01257867|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110790835|NCT01257867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110790836|NCT01257867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110790837|NCT03338972|Cyclophosphamide|cyclophosphamide|mesh-list
110790838|NCT03338972|Fludarabine|fludarabine|mesh-list
110790839|NCT03338972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110790840|NCT03338972|Immunologic Factors|immunologic factors|mesh-ancestor
110790841|NCT03338972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110790842|NCT03338972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110790843|NCT03338972|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110790844|NCT03338972|Alkylating Agents|alkylating agents|mesh-ancestor
110790845|NCT03338972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110790846|NCT03338972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110790847|NCT03338972|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110790848|NCT01151397|Vitamin D|vitamin d|mesh-list
110790849|NCT01151397|Ribavirin|ribavirin|mesh-list
110790850|NCT01151397|Vitamins|vitamins|mesh-ancestor
110790851|NCT01151397|Micronutrients|micronutrients|mesh-ancestor
110790852|NCT01151397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110790853|NCT01151397|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110790854|NCT01151397|Antimetabolites|antimetabolites|mesh-ancestor
110790855|NCT01151397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110790856|NCT01151397|Antiviral Agents|antiviral agents|mesh-ancestor
110790857|NCT01151397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110790858|NCT01152801|Everolimus|everolimus|mesh-list
110790859|NCT01152801|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110790860|NCT01152801|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110790861|NCT01152801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110790862|NCT01152801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110790863|NCT01152801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110790864|NCT01152801|Immunologic Factors|immunologic factors|mesh-ancestor
110790865|NCT01152801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110790866|NCT01152801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110790867|NCT03887169|Vitamin B 12|vitamin b 12|mesh-list
110790868|NCT03887169|Hydroxocobalamin|hydroxocobalamin|mesh-list
110790869|NCT03887169|Vitamins|vitamins|mesh-ancestor
110790870|NCT03887169|Micronutrients|micronutrients|mesh-ancestor
110790871|NCT03887169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110790872|NCT03887169|Vitamin B Complex|vitamin b complex|mesh-ancestor
110790873|NCT03887169|Hematinics|hematinics|mesh-ancestor
110790874|NCT03886779|Nepafenac|nepafenac|mesh-list
110790875|NCT03886779|Bromfenac|bromfenac|mesh-list
110790876|NCT03886779|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110790877|NCT03886779|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110790878|NCT03886779|Analgesics|analgesics|mesh-ancestor
110790879|NCT03886779|Sensory System Agents|sensory system agents|mesh-ancestor
110790880|NCT03886779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110790881|NCT03886779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110790882|NCT03886779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110790883|NCT03886779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110790884|NCT03887013|Trimetazidine|trimetazidine|mesh-list
110790885|NCT03887013|Vasodilator Agents|vasodilator agents|mesh-ancestor
110790886|NCT01261299|Carboplatin|carboplatin|mesh-list
110790887|NCT01261299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110790888|NCT01154829|Aripiprazole|aripiprazole|mesh-list
110790889|NCT01154829|Amisulpride|amisulpride|mesh-list
110790890|NCT01154829|Antidepressive Agents|antidepressive agents|mesh-ancestor
110790891|NCT01154829|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110790892|NCT01154829|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110790893|NCT01154829|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110790894|NCT01154829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110790895|NCT01154829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110790896|NCT01154829|Dopamine Agonists|dopamine agonists|mesh-ancestor
110790897|NCT01154829|Dopamine Agents|dopamine agents|mesh-ancestor
110790898|NCT01154829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110790899|NCT01154829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110790900|NCT01154829|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110790901|NCT01154829|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110790902|NCT01154829|Serotonin Agents|serotonin agents|mesh-ancestor
110790903|NCT01154829|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110790904|NCT01154829|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110790905|NCT01154829|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110790906|NCT01154829|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110790907|NCT01154829|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110790908|NCT01153191|Gentamicins|gentamicins|mesh-list
110790909|NCT01153191|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110790910|NCT01153191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110790911|NCT01153191|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110790912|NCT01153191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110790913|NCT01153191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110790914|NCT01259817|Aspirin|aspirin|mesh-list
110790915|NCT01259817|Interferons|interferons|mesh-list
110790916|NCT01259817|Interferon-alpha|interferon-alpha|mesh-list
110790917|NCT01259817|Interferon alpha-2|interferon alpha-2|mesh-list
110790918|NCT01259817|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110790919|NCT01259817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110790920|NCT01259817|Antiviral Agents|antiviral agents|mesh-ancestor
110790921|NCT01259817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110790922|NCT01259817|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110790923|NCT01259817|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110790924|NCT01259817|Analgesics|analgesics|mesh-ancestor
110790925|NCT01259817|Sensory System Agents|sensory system agents|mesh-ancestor
110500083|NCT02621385|Anesthetics|anesthetics|mesh-ancestor
110790926|NCT01259817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110790927|NCT01259817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110790928|NCT01259817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110790929|NCT01259817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110790930|NCT01259817|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110790931|NCT01259817|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110790932|NCT01259817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110790933|NCT01259817|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110790934|NCT01259817|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110790935|NCT01259817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110790937|NCT01259817|Immunologic Factors|immunologic factors|mesh-ancestor
110790939|NCT01261689|Dsuvia|dsuvia|mesh-list
110790940|NCT01261689|Ropivacaine|ropivacaine|mesh-list
110790941|NCT01261689|Anesthetics, Local|anesthetics, local|mesh-ancestor
110790942|NCT01261689|Anesthetics|anesthetics|mesh-ancestor
110790943|NCT01261689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110790944|NCT01261689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110790945|NCT01261689|Sensory System Agents|sensory system agents|mesh-ancestor
110790946|NCT01261689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110790947|NCT01261689|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110790948|NCT01261689|Narcotics|narcotics|mesh-ancestor
110508555|NCT05825430|Anesthetics|anesthetics|mesh-list
110790949|NCT01261689|Analgesics|analgesics|mesh-ancestor
110790950|NCT01261689|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110790951|NCT01261689|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110790952|NCT01261689|Anesthetics, General|anesthetics, general|mesh-ancestor
110790953|NCT01154907|Praziquantel|praziquantel|mesh-list
110790954|NCT01154907|Anthelmintics|anthelmintics|mesh-ancestor
110790955|NCT01154907|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110790956|NCT01154907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110790957|NCT01261923|Alitretinoin|alitretinoin|mesh-list
110790958|NCT01261923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110790959|NCT01261923|Dermatologic Agents|dermatologic agents|mesh-ancestor
110790960|NCT01157247|Fentanyl|fentanyl|mesh-list
110790961|NCT01157247|Anesthetics|anesthetics|mesh-list
110790962|NCT01157247|Anesthetics, Local|anesthetics, local|mesh-list
110790963|NCT01157247|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110790964|NCT01157247|Narcotics|narcotics|mesh-ancestor
110790965|NCT01157247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110790966|NCT01157247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110790967|NCT01157247|Analgesics|analgesics|mesh-ancestor
110790968|NCT01157247|Sensory System Agents|sensory system agents|mesh-ancestor
110790969|NCT01157247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110790970|NCT01157247|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110790971|NCT01157247|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110790972|NCT01157247|Anesthetics, General|anesthetics, general|mesh-ancestor
110790973|NCT03881787|Cetuximab|cetuximab|mesh-list
110790974|NCT03881787|Antibodies|antibodies|mesh-list
110790975|NCT03881787|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110790976|NCT03881787|Immunologic Factors|immunologic factors|mesh-ancestor
110790977|NCT03881787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110790978|NCT03881787|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110790979|NCT03881787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110790980|NCT01157481|Nifedipine|nifedipine|mesh-list
110790981|NCT01157481|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110790982|NCT01157481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110790983|NCT01157481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110790984|NCT01157481|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110790985|NCT01157481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110790986|NCT01157481|Vasodilator Agents|vasodilator agents|mesh-ancestor
110790987|NCT01157481|Tocolytic Agents|tocolytic agents|mesh-ancestor
110790988|NCT01157481|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110790989|NCT03894189|Theophylline|theophylline|mesh-list
110790990|NCT03894189|Doxapram|doxapram|mesh-list
110790991|NCT03894189|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110790992|NCT03894189|Autonomic Agents|autonomic agents|mesh-ancestor
110790993|NCT03894189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110790994|NCT03894189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110790995|NCT03894189|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110790996|NCT03894189|Respiratory System Agents|respiratory system agents|mesh-ancestor
110790997|NCT03894189|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110790998|NCT03894189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110790999|NCT03894189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110791000|NCT03894189|Vasodilator Agents|vasodilator agents|mesh-ancestor
110791001|NCT03894189|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110791002|NCT03894189|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110791003|NCT03894189|Purinergic Agents|purinergic agents|mesh-ancestor
110791004|NCT03894189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110791005|NCT03894189|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110791006|NCT03886311|Nivolumab|nivolumab|mesh-list
110791007|NCT03886311|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
110791008|NCT03886311|Trabectedin|trabectedin|mesh-list
110791009|NCT03886311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110791010|NCT03886311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110791011|NCT03886311|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110791012|NCT03886311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110791013|NCT03886311|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110791015|NCT01155453|Trametinib|trametinib|mesh-list
110791016|NCT01155453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110791017|NCT01155453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110791018|NCT01155453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110791019|NCT01155453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110791020|NCT03886233|Immunosuppressive Agents|immunosuppressive agents|mesh-list
110791021|NCT03886233|Immunologic Factors|immunologic factors|mesh-ancestor
110508633|NCT05602519|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110791022|NCT03886233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110791023|NCT03885219|Paclitaxel|paclitaxel|mesh-list
110791024|NCT03885219|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110791025|NCT03885219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110791026|NCT03885219|Tubulin Modulators|tubulin modulators|mesh-ancestor
110791027|NCT03885219|Antimitotic Agents|antimitotic agents|mesh-ancestor
110791028|NCT03885219|Mitosis Modulators|mitosis modulators|mesh-ancestor
110791029|NCT03885219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110791030|NCT01157559|Ziprasidone|ziprasidone|mesh-list
110791031|NCT01157559|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110791032|NCT01157559|Serotonin Agents|serotonin agents|mesh-ancestor
110791033|NCT01157559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110791034|NCT01157559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110791035|NCT01157559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110791036|NCT01157559|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110791037|NCT01157559|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110791038|NCT01157559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110791039|NCT01157559|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110791040|NCT01157559|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110791041|NCT01157559|Dopamine Agents|dopamine agents|mesh-ancestor
110791042|NCT01263951|Everolimus|everolimus|mesh-list
110791043|NCT01263951|Sorafenib|sorafenib|mesh-list
110791044|NCT01263951|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110791045|NCT01263951|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110791046|NCT01263951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110791047|NCT01263951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110791048|NCT01263951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110791049|NCT01263951|Immunologic Factors|immunologic factors|mesh-ancestor
110791050|NCT01263951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110791051|NCT01263951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110791052|NCT01265433|Molgramostim|molgramostim|mesh-list
110791053|NCT01265433|Sargramostim|sargramostim|mesh-list
110791054|NCT01265433|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
110791055|NCT01265433|Immunologic Factors|immunologic factors|mesh-ancestor
110791056|NCT01265433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110791057|NCT01265433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110791058|NCT01265433|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110791059|NCT01265589|Vitamin A|vitamin a|mesh-list
110791060|NCT01265589|Pulmonary Surfactants|pulmonary surfactants|mesh-list
110791061|NCT01265589|Vitamins|vitamins|mesh-ancestor
110791062|NCT01265589|Micronutrients|micronutrients|mesh-ancestor
110791063|NCT01265589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110791064|NCT01265589|Respiratory System Agents|respiratory system agents|mesh-ancestor
110791065|NCT01159587|Factor VIII|factor viii|mesh-list
110791066|NCT01159587|Coagulants|coagulants|mesh-ancestor
110791067|NCT03885297|Liraglutide|liraglutide|mesh-list
110791068|NCT03885297|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110791069|NCT03885297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110791070|NCT03885297|Incretins|incretins|mesh-ancestor
110791071|NCT03885297|Hormones|hormones|mesh-ancestor
110791072|NCT03885297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110791073|NCT01159821|Paroxetine|paroxetine|mesh-list
110791074|NCT01159821|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110791075|NCT01159821|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110791076|NCT01159821|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110791077|NCT01159821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110791078|NCT01159821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110791079|NCT01159821|Serotonin Agents|serotonin agents|mesh-ancestor
110791080|NCT01159821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110791081|NCT01159821|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110791082|NCT01159821|Antidepressive Agents|antidepressive agents|mesh-ancestor
110791083|NCT01159821|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110791084|NCT01159821|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110791085|NCT01159821|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110791086|NCT01159821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110791087|NCT03881319|Contraceptive Agents|contraceptive agents|mesh-list
110791088|NCT03881319|Contraceptives, Oral|contraceptives, oral|mesh-list
110791089|NCT03881319|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110791090|NCT03881319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110791091|NCT03881319|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110791092|NCT03885141|Zolpidem|zolpidem|mesh-list
110791093|NCT03885141|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110791094|NCT03885141|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110791095|NCT03885141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110791096|NCT03885141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110791097|NCT03885141|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
110791098|NCT03885141|GABA Agonists|gaba agonists|mesh-ancestor
110791100|NCT03885141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110791101|NCT03885141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110791102|NCT03879057|Antibodies|antibodies|mesh-list
110791103|NCT03879057|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110791104|NCT03879057|Immunologic Factors|immunologic factors|mesh-ancestor
110791105|NCT03879057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110791106|NCT01266057|Sirolimus|sirolimus|mesh-list
110791107|NCT01266057|Hydroxychloroquine|hydroxychloroquine|mesh-list
110791108|NCT01266057|Vorinostat|vorinostat|mesh-list
110791109|NCT01266057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110791110|NCT01266057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110791111|NCT01266057|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110791112|NCT01266057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110791113|NCT01266057|Antifungal Agents|antifungal agents|mesh-ancestor
110791114|NCT01266057|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110791115|NCT01266057|Immunologic Factors|immunologic factors|mesh-ancestor
110791116|NCT01266057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110791117|NCT01266057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110791118|NCT01266057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110791119|NCT01266057|Antimalarials|antimalarials|mesh-ancestor
110791120|NCT01266057|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110791121|NCT01266057|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110791122|NCT01266057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110791123|NCT01266057|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110791124|NCT01266213|Fulvestrant|fulvestrant|mesh-list
110791125|NCT01266213|Anastrozole|anastrozole|mesh-list
110791126|NCT01266213|Goserelin|goserelin|mesh-list
110791127|NCT01266213|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110791128|NCT01266213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110791129|NCT01266213|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110791130|NCT01266213|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110791131|NCT01266213|Hormone Antagonists|hormone antagonists|mesh-ancestor
110791132|NCT01266213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110791133|NCT01266213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110791134|NCT01266213|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110791135|NCT01266213|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110791136|NCT01266213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110791137|NCT01266213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110791138|NCT01262391|Solifenacin Succinate|solifenacin succinate|mesh-list
110791139|NCT01262391|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110791140|NCT01262391|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110791141|NCT01262391|Cholinergic Agents|cholinergic agents|mesh-ancestor
110791142|NCT01262391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110791143|NCT01262391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110791144|NCT01262391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110791145|NCT01262391|Urological Agents|urological agents|mesh-ancestor
110791146|NCT03880695|Doxorubicin|doxorubicin|mesh-list
110791147|NCT03880695|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110791148|NCT03880695|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110791149|NCT03880695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110791150|NCT03880695|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110851067|NCT03341884|Ipatasertib|ipatasertib|mesh-list
110791151|NCT03880695|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110791152|NCT03880695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110791153|NCT03880695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110791154|NCT01155765|Clopidogrel|clopidogrel|mesh-list
110791155|NCT01155765|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
110791156|NCT01155765|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110791157|NCT01155765|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110791158|NCT01155765|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110791159|NCT01155765|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110791161|NCT01155765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110791162|NCT01155765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110791163|NCT01155765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110791164|NCT01264341|Sirolimus|sirolimus|mesh-list
110791165|NCT01264341|Bevacizumab|bevacizumab|mesh-list
110791166|NCT01264341|Temsirolimus|temsirolimus|mesh-list
110791167|NCT01264341|MTOR Inhibitors|mtor inhibitors|mesh-list
110791168|NCT01264341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110791169|NCT01264341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110791170|NCT01264341|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110791171|NCT01264341|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110791172|NCT01264341|Growth Substances|growth substances|mesh-ancestor
110791173|NCT01264341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110791174|NCT01264341|Growth Inhibitors|growth inhibitors|mesh-ancestor
110791175|NCT01264341|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110791176|NCT01264341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110791177|NCT01264341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110791178|NCT01264341|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110791179|NCT01264341|Immunologic Factors|immunologic factors|mesh-ancestor
110791180|NCT01264341|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110791181|NCT01264341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110791182|NCT01264341|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110791183|NCT01264341|Antifungal Agents|antifungal agents|mesh-ancestor
110791185|NCT01264497|Growth Substances|growth substances|mesh-ancestor
110791186|NCT01264497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110791187|NCT01157949|Thymoglobulin|thymoglobulin|mesh-list
110791188|NCT01157949|Immunologic Factors|immunologic factors|mesh-ancestor
110791189|NCT01157949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110791190|NCT01157949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110791191|NCT01262469|Capecitabine|capecitabine|mesh-list
110791192|NCT01262469|Lapatinib|lapatinib|mesh-list
110791193|NCT01262469|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110791194|NCT01262469|Antimetabolites|antimetabolites|mesh-ancestor
110791195|NCT01262469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110791196|NCT01262469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110791197|NCT01262469|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110791198|NCT01262469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110791199|NCT01155921|Risperidone|risperidone|mesh-list
110791200|NCT01155921|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110791201|NCT01155921|Serotonin Agents|serotonin agents|mesh-ancestor
110791202|NCT01155921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110791203|NCT01155921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110791204|NCT01155921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110791205|NCT01155921|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110791206|NCT01155921|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110791207|NCT01155921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110791208|NCT01155921|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110791209|NCT01155921|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110791210|NCT01155921|Dopamine Agents|dopamine agents|mesh-ancestor
110791211|NCT03884127|Orlistat|orlistat|mesh-list
110791212|NCT03884127|Ezetimibe|ezetimibe|mesh-list
110791213|NCT03884127|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110791214|NCT03884127|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110791215|NCT03884127|Antimetabolites|antimetabolites|mesh-ancestor
110791216|NCT03884127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110791217|NCT03884127|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110791218|NCT03884127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110791219|NCT03884127|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110791220|NCT01158105|Bortezomib|bortezomib|mesh-list
110791221|NCT01158105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110791222|NCT03337490|Ivermectin|ivermectin|mesh-list
110791223|NCT03337490|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110791224|NCT03337490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110791225|NCT01158183|Interferons|interferons|mesh-list
110791226|NCT01158183|Interferon-beta|interferon-beta|mesh-list
110791227|NCT01158183|Interferon beta-1b|interferon beta-1b|mesh-list
110791228|NCT01158183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110791229|NCT01158183|Antiviral Agents|antiviral agents|mesh-ancestor
110791230|NCT01158183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110791231|NCT01158183|Immunologic Factors|immunologic factors|mesh-ancestor
110791232|NCT01158183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110791233|NCT01158183|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110791234|NCT01264575|Epinephrine|epinephrine|mesh-list
110791235|NCT01264575|Racepinephrine|racepinephrine|mesh-list
110791236|NCT01264575|Bupivacaine|bupivacaine|mesh-list
110791237|NCT01264575|Epinephryl borate|epinephryl borate|mesh-list
110791238|NCT01264575|Anesthetics, Local|anesthetics, local|mesh-ancestor
110791239|NCT01264575|Anesthetics|anesthetics|mesh-ancestor
110791240|NCT01264575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110791241|NCT01264575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110791242|NCT01264575|Sensory System Agents|sensory system agents|mesh-ancestor
110791243|NCT01264575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110791244|NCT01264575|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110791245|NCT01264575|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110791246|NCT01264575|Adrenergic Agents|adrenergic agents|mesh-ancestor
110791247|NCT01264575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110508861|NCT04900792|Ascorbic Acid|ascorbic acid|mesh-list
110791248|NCT01264575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110791249|NCT01264575|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110791250|NCT01264575|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110791251|NCT01264575|Autonomic Agents|autonomic agents|mesh-ancestor
110791252|NCT01264575|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110791253|NCT01264575|Respiratory System Agents|respiratory system agents|mesh-ancestor
110791254|NCT01264575|Mydriatics|mydriatics|mesh-ancestor
110791255|NCT01264575|Sympathomimetics|sympathomimetics|mesh-ancestor
110791256|NCT01264575|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110791257|NCT04992260|Vaccines|vaccines|mesh-list
110791258|NCT04992260|Immunologic Factors|immunologic factors|mesh-ancestor
110791259|NCT04992260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110791260|NCT01266681|Amiodarone|amiodarone|mesh-list
110791261|NCT01266681|Dronedarone|dronedarone|mesh-list
110791262|NCT01266681|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110791263|NCT01266681|Vasodilator Agents|vasodilator agents|mesh-ancestor
110791264|NCT01266681|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
110791265|NCT01266681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110791266|NCT01266681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110791267|NCT01266681|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110791268|NCT01266681|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110791269|NCT01266681|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110791270|NCT01266681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110791271|NCT01266681|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110791272|NCT01266681|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110791273|NCT01266681|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110791274|NCT03638648|Capecitabine|capecitabine|mesh-list
110791275|NCT03638648|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110791276|NCT03638648|Antimetabolites|antimetabolites|mesh-ancestor
110791277|NCT03638648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110791278|NCT03638648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110791279|NCT01266759|NuvaRing|nuvaring|mesh-list
110791280|NCT01266759|Norethindrone|norethindrone|mesh-list
110791281|NCT01266759|Norethindrone Acetate|norethindrone acetate|mesh-list
110791282|NCT01266759|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110791283|NCT01266759|Contraceptive Agents|contraceptive agents|mesh-ancestor
110791284|NCT01266759|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110791285|NCT01266759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110791286|NCT01266759|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110791287|NCT01266759|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110791288|NCT01266759|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110791289|NCT01266759|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110791290|NCT03512223|Dexamethasone|dexamethasone|mesh-list
110791291|NCT03512223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110791292|NCT03512223|Antiemetics|antiemetics|mesh-ancestor
110791293|NCT03512223|Autonomic Agents|autonomic agents|mesh-ancestor
110791294|NCT03512223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110791295|NCT03512223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110791296|NCT03512223|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110791297|NCT03512223|Glucocorticoids|glucocorticoids|mesh-ancestor
110791298|NCT03512223|Hormones|hormones|mesh-ancestor
110791299|NCT03512223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110791300|NCT03512223|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110791301|NCT03512223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110791302|NCT03878667|Calcium, Dietary|calcium, dietary|mesh-list
110791303|NCT03878667|Calcium Carbonate|calcium carbonate|mesh-list
110791304|NCT03878667|Calcium|calcium|mesh-list
110791305|NCT03878667|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110791306|NCT03878667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110791307|NCT03878667|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110791308|NCT03878667|Antacids|antacids|mesh-ancestor
110791309|NCT03878667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110791310|NCT03878667|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110791311|NCT01264653|Epinephrine|epinephrine|mesh-list
110791312|NCT01264653|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110791313|NCT01264653|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110791314|NCT01264653|Adrenergic Agents|adrenergic agents|mesh-ancestor
110791315|NCT01264653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110791316|NCT01264653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110791317|NCT01264653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110791318|NCT01264653|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110791319|NCT01264653|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110791320|NCT01264653|Autonomic Agents|autonomic agents|mesh-ancestor
110791321|NCT01264653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110791322|NCT01264653|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110791323|NCT01264653|Respiratory System Agents|respiratory system agents|mesh-ancestor
110791324|NCT01264653|Mydriatics|mydriatics|mesh-ancestor
110791325|NCT01264653|Sympathomimetics|sympathomimetics|mesh-ancestor
110791326|NCT01264653|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110791327|NCT01266837|Everolimus|everolimus|mesh-list
110791328|NCT01266837|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110791329|NCT01266837|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110791330|NCT01266837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110791331|NCT01266837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110791332|NCT01266837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110791333|NCT01266837|Immunologic Factors|immunologic factors|mesh-ancestor
110791334|NCT01266837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110791335|NCT01266837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110791336|NCT01264731|Imiquimod|imiquimod|mesh-list
110791337|NCT01264731|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110791338|NCT01264731|Immunologic Factors|immunologic factors|mesh-ancestor
110791339|NCT01264731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110791340|NCT01264731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110791341|NCT01264731|Interferon Inducers|interferon inducers|mesh-ancestor
110791342|NCT03879837|Fluticasone|fluticasone|mesh-list
110791343|NCT03879837|Xhance|xhance|mesh-list
110791344|NCT03879837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110791345|NCT03879837|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110791346|NCT03879837|Autonomic Agents|autonomic agents|mesh-ancestor
110791347|NCT03879837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110791348|NCT03879837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110791349|NCT03879837|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110791350|NCT03879837|Respiratory System Agents|respiratory system agents|mesh-ancestor
110791351|NCT03879837|Dermatologic Agents|dermatologic agents|mesh-ancestor
110791352|NCT03879837|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110791353|NCT05308628|Complement C3|complement c3|mesh-list
110791354|NCT05308628|Immunologic Factors|immunologic factors|mesh-ancestor
110791355|NCT05308628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110791356|NCT01156077|Tedizolid phosphate|tedizolid phosphate|mesh-list
110791357|NCT01156077|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110791358|NCT01156077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110791359|NCT01158729|Antithrombins|antithrombins|mesh-list
110791360|NCT01158729|Antithrombin III|antithrombin iii|mesh-list
110791361|NCT01158729|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110791362|NCT01158729|Protease Inhibitors|protease inhibitors|mesh-ancestor
110791363|NCT01158729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110791364|NCT01158729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110791365|NCT01158729|Anticoagulants|anticoagulants|mesh-ancestor
110791366|NCT01262859|Bevacizumab|bevacizumab|mesh-list
110791367|NCT01262859|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110500479|NCT04252274|Darunavir|darunavir|mesh-list
110791368|NCT01262859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110791369|NCT01262859|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110791370|NCT01262859|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110791371|NCT01262859|Growth Substances|growth substances|mesh-ancestor
110791372|NCT01262859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110791373|NCT01262859|Growth Inhibitors|growth inhibitors|mesh-ancestor
110791374|NCT02527083|Ketamine|ketamine|mesh-list
110791375|NCT02527083|Remifentanil|remifentanil|mesh-list
110791376|NCT02527083|Propofol|propofol|mesh-list
110791377|NCT02527083|Sevoflurane|sevoflurane|mesh-list
110791378|NCT02527083|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110791379|NCT02527083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110791380|NCT02527083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110791381|NCT02527083|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110791382|NCT02527083|Anesthetics, General|anesthetics, general|mesh-ancestor
110791383|NCT02527083|Anesthetics|anesthetics|mesh-ancestor
110791384|NCT02527083|Analgesics|analgesics|mesh-ancestor
110791385|NCT02527083|Sensory System Agents|sensory system agents|mesh-ancestor
110791386|NCT02527083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110791387|NCT02527083|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110791388|NCT02527083|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110791389|NCT02527083|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110791390|NCT02527083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110791391|NCT02527083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110791392|NCT02527083|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110791393|NCT02527083|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110791394|NCT02527083|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110791395|NCT02527083|Narcotics|narcotics|mesh-ancestor
110791396|NCT05156684|Zinc|zinc|mesh-list
110791397|NCT05156684|Pentoxifylline|pentoxifylline|mesh-list
110791398|NCT05156684|Zinc Sulfate|zinc sulfate|mesh-list
110791399|NCT05156684|Trace Elements|trace elements|mesh-ancestor
110791400|NCT05156684|Micronutrients|micronutrients|mesh-ancestor
110791401|NCT05156684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110791402|NCT05156684|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110791403|NCT05156684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110791404|NCT05156684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110791405|NCT05156684|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110791406|NCT05156684|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110791407|NCT05156684|Protective Agents|protective agents|mesh-ancestor
110791408|NCT05156684|Vasodilator Agents|vasodilator agents|mesh-ancestor
110791409|NCT05156684|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110791410|NCT05156684|Antioxidants|antioxidants|mesh-ancestor
110791411|NCT05156684|Astringents|astringents|mesh-ancestor
110791412|NCT05156684|Dermatologic Agents|dermatologic agents|mesh-ancestor
110791413|NCT03883347|Dexmedetomidine|dexmedetomidine|mesh-list
110791414|NCT03883347|Remifentanil|remifentanil|mesh-list
110791415|NCT03883347|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110791416|NCT03883347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110791417|NCT03883347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110791418|NCT03883347|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110791419|NCT03883347|Analgesics|analgesics|mesh-ancestor
110791420|NCT03883347|Sensory System Agents|sensory system agents|mesh-ancestor
110791421|NCT03883347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110791422|NCT03883347|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110791423|NCT03883347|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110791424|NCT03883347|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110791425|NCT03883347|Adrenergic Agents|adrenergic agents|mesh-ancestor
110791426|NCT03883347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110791427|NCT03883347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110791428|NCT03883347|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110791429|NCT03883347|Narcotics|narcotics|mesh-ancestor
110791430|NCT01159275|Lopinavir|lopinavir|mesh-list
110791431|NCT01159275|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110791432|NCT01159275|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110791434|NCT01159275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110791435|NCT01159275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110791436|NCT01159275|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110791437|NCT01159275|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110791438|NCT01159275|Antiviral Agents|antiviral agents|mesh-ancestor
110791439|NCT01159275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110791440|NCT01159275|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110791441|NCT01159275|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110791442|NCT01159353|Insulin|insulin|mesh-list
110791443|NCT01159353|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110791444|NCT01159353|Insulin Aspart|insulin aspart|mesh-list
110791445|NCT01159353|Insulin glulisine|insulin glulisine|mesh-list
110791446|NCT01159353|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110791447|NCT01159353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110791448|NCT02943668|Deferasirox|deferasirox|mesh-list
110791449|NCT02943668|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110791450|NCT02943668|Chelating Agents|chelating agents|mesh-ancestor
110791451|NCT02943668|Sequestering Agents|sequestering agents|mesh-ancestor
110791452|NCT02943668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110791453|NCT01265199|Cytarabine|cytarabine|mesh-list
110791454|NCT01265199|Daunorubicin|daunorubicin|mesh-list
110791455|NCT01265199|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110791456|NCT01265199|Antimetabolites|antimetabolites|mesh-ancestor
110791457|NCT01265199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110791458|NCT01265199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110500604|NCT00803725|Anesthetics|anesthetics|mesh-ancestor
110791459|NCT01265199|Antiviral Agents|antiviral agents|mesh-ancestor
110791460|NCT01265199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110791461|NCT01265199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110791462|NCT01265199|Immunologic Factors|immunologic factors|mesh-ancestor
110791463|NCT01265199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110791464|NCT01265199|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110791465|NCT01265199|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110791466|NCT01265199|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110791467|NCT01265199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110791468|NCT01263171|Leucovorin|leucovorin|mesh-list
110791469|NCT01263171|Fluorouracil|fluorouracil|mesh-list
110791470|NCT01263171|Oxaliplatin|oxaliplatin|mesh-list
110791471|NCT01263171|Calcium|calcium|mesh-list
110791472|NCT01263171|Levoleucovorin|levoleucovorin|mesh-list
110791473|NCT01263171|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110791474|NCT01263171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110791475|NCT01263171|Antimetabolites|antimetabolites|mesh-ancestor
110791476|NCT01263171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110791477|NCT01263171|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110791478|NCT01263171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110791479|NCT01263171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110791480|NCT01263171|Immunologic Factors|immunologic factors|mesh-ancestor
110791481|NCT01263171|Antidotes|antidotes|mesh-ancestor
110791482|NCT01263171|Protective Agents|protective agents|mesh-ancestor
110791483|NCT01263171|Vitamin B Complex|vitamin b complex|mesh-ancestor
110791484|NCT01263171|Vitamins|vitamins|mesh-ancestor
110791485|NCT01263171|Micronutrients|micronutrients|mesh-ancestor
110791486|NCT01156233|Anesthetics|anesthetics|mesh-list
110791487|NCT01156233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110791488|NCT01156233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110791489|NCT03883269|Ethanol|ethanol|mesh-list
110791490|NCT03883269|Clindamycin|clindamycin|mesh-list
110791491|NCT03883269|Clindamycin palmitate|clindamycin palmitate|mesh-list
110791492|NCT03883269|Clindamycin phosphate|clindamycin phosphate|mesh-list
110791493|NCT03883269|Erythromycin|erythromycin|mesh-list
110791494|NCT03883269|Erythromycin Estolate|erythromycin estolate|mesh-list
110791495|NCT03883269|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
110791496|NCT03883269|Erythromycin stearate|erythromycin stearate|mesh-list
110791497|NCT03883269|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110791498|NCT03883269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110791499|NCT03883269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110791500|NCT03883269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110791501|NCT03883269|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110791502|NCT03883269|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110791503|NCT03883269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110791504|NCT03883269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110791505|NCT03883269|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110791506|NCT01267305|Calcium, Dietary|calcium, dietary|mesh-list
110791507|NCT01267305|PENTA|penta|mesh-list
110791508|NCT01267305|Nadroparin|nadroparin|mesh-list
110791509|NCT01267305|Fondaparinux|fondaparinux|mesh-list
110791510|NCT01267305|Calcium|calcium|mesh-list
110500653|NCT00922129|Dermatologic Agents|dermatologic agents|mesh-ancestor
110791511|NCT01267305|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110791512|NCT01267305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110791513|NCT01267305|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110791514|NCT01267305|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110791515|NCT01267305|Antithrombins|antithrombins|mesh-ancestor
110791516|NCT01267305|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110791517|NCT01267305|Protease Inhibitors|protease inhibitors|mesh-ancestor
110791518|NCT01267305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110791519|NCT01267305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110791520|NCT01267305|Anticoagulants|anticoagulants|mesh-ancestor
110791521|NCT01267305|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110791522|NCT01267305|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110791523|NCT02891408|Fenofibrate|fenofibrate|mesh-list
110791524|NCT02891408|Firsocostat|firsocostat|mesh-list
110791525|NCT02891408|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110791526|NCT02891408|Antimetabolites|antimetabolites|mesh-ancestor
110791527|NCT02891408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110791528|NCT02891408|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110791529|NCT02891408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110791530|NCT01160991|Olanzapine|olanzapine|mesh-list
110791531|NCT01160991|Amisulpride|amisulpride|mesh-list
110791532|NCT01160991|Antiemetics|antiemetics|mesh-ancestor
110791533|NCT01160991|Autonomic Agents|autonomic agents|mesh-ancestor
110791534|NCT01160991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110791535|NCT01160991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110791536|NCT01160991|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110791537|NCT01160991|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110791538|NCT01160991|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110791539|NCT01160991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110791540|NCT01160991|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110791541|NCT01160991|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110791542|NCT01160991|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110791543|NCT01160991|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110791544|NCT01160991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110791545|NCT01160991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110791546|NCT01160991|Serotonin Agents|serotonin agents|mesh-ancestor
110791547|NCT01160991|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110791548|NCT01160991|Dopamine Agents|dopamine agents|mesh-ancestor
110791549|NCT01160991|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110791550|NCT01160991|Antidepressive Agents|antidepressive agents|mesh-ancestor
110791551|NCT05498480|Nivolumab|nivolumab|mesh-list
110791552|NCT05498480|Relatlimab|relatlimab|mesh-list
110791553|NCT05498480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110791554|NCT05498480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110500681|NCT02554123|Vitamin E|vitamin e|mesh-list
110791555|NCT05498480|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110791556|NCT05498480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110791557|NCT01161069|3-(4-(2-hydroxyethyl)piperazin-1-yl)-7-(6-methoxypyridin-3-yl)-1-(2-propoxyethyl)pyrido(3,4-b)pyrazin-2(1H)-one|3-(4-(2-hydroxyethyl)piperazin-1-yl)-7-(6-methoxypyridin-3-yl)-1-(2-propoxyethyl)pyrido(3,4-b)pyrazin-2(1h)-one|mesh-list
110791558|NCT01161069|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110791559|NCT01161069|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110791560|NCT01161069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110791561|NCT01161069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110791562|NCT01161147|Meloxicam|meloxicam|mesh-list
110791563|NCT01161147|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110791564|NCT01161147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110791565|NCT01161147|Analgesics|analgesics|mesh-ancestor
110791566|NCT01161147|Sensory System Agents|sensory system agents|mesh-ancestor
110791567|NCT01161147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110791568|NCT01161147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110791569|NCT01161147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110791570|NCT01161147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110791571|NCT01161147|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110791572|NCT01161147|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110791573|NCT01161147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110791574|NCT01161147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110791575|NCT01161927|Nizatidine|nizatidine|mesh-list
110791576|NCT01161927|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110791577|NCT01161927|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110791578|NCT01161927|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110791579|NCT01161927|Histamine Antagonists|histamine antagonists|mesh-ancestor
110791580|NCT01161927|Histamine Agents|histamine agents|mesh-ancestor
110791581|NCT01161927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110791582|NCT01161927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110791583|NCT01161927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110791584|NCT01267383|Sertraline|sertraline|mesh-list
110791585|NCT01267383|Antidepressive Agents|antidepressive agents|mesh-ancestor
110791586|NCT01267383|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110791587|NCT01267383|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110791588|NCT01267383|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110791589|NCT01267383|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110791590|NCT01267383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110791591|NCT01267383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110791592|NCT01267383|Serotonin Agents|serotonin agents|mesh-ancestor
110791593|NCT01267383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110791594|NCT03283670|Nitrous Oxide|nitrous oxide|mesh-list
110791595|NCT03283670|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110791596|NCT03283670|Anesthetics, General|anesthetics, general|mesh-ancestor
110791597|NCT03283670|Anesthetics|anesthetics|mesh-ancestor
110791598|NCT03283670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110791599|NCT03283670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110791600|NCT03283670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110791601|NCT03283670|Analgesics|analgesics|mesh-ancestor
110791602|NCT03283670|Sensory System Agents|sensory system agents|mesh-ancestor
110791603|NCT03283670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110791604|NCT03110432|Nicotinic Acids|nicotinic acids|mesh-list
110791605|NCT03110432|Niacin|niacin|mesh-list
110791606|NCT03110432|Ezetimibe|ezetimibe|mesh-list
110791607|NCT03110432|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
110791608|NCT03110432|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-list
110791609|NCT03110432|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110791611|NCT03110432|Antimetabolites|antimetabolites|mesh-ancestor
110791612|NCT03110432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110791613|NCT03110432|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110791614|NCT03110432|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110791615|NCT03110432|Protease Inhibitors|protease inhibitors|mesh-ancestor
110791616|NCT03110432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110791617|NCT03110432|Vitamin B Complex|vitamin b complex|mesh-ancestor
110791618|NCT03110432|Vitamins|vitamins|mesh-ancestor
110791619|NCT03110432|Micronutrients|micronutrients|mesh-ancestor
110791620|NCT03110432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110791621|NCT03110432|Vasodilator Agents|vasodilator agents|mesh-ancestor
110791622|NCT03205358|Vaccines|vaccines|mesh-list
110791623|NCT03205358|Immunologic Factors|immunologic factors|mesh-ancestor
110791624|NCT03205358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110791625|NCT01358578|Etanercept|etanercept|mesh-list
110791626|NCT01358578|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110791627|NCT01358578|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110791628|NCT01358578|Analgesics|analgesics|mesh-ancestor
110791629|NCT01358578|Sensory System Agents|sensory system agents|mesh-ancestor
110791630|NCT01358578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110791631|NCT01358578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110791632|NCT01358578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110791633|NCT01358578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110791634|NCT01358578|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110791635|NCT01358578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110791636|NCT01358578|Immunologic Factors|immunologic factors|mesh-ancestor
110791637|NCT01161459|Prednisone|prednisone|mesh-list
110791638|NCT01161459|Tacrolimus|tacrolimus|mesh-list
110791639|NCT01161459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110791640|NCT01161459|Glucocorticoids|glucocorticoids|mesh-ancestor
110791641|NCT01161459|Hormones|hormones|mesh-ancestor
110791642|NCT01161459|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110791643|NCT01161459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110791644|NCT01161459|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110791645|NCT01161459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110791646|NCT01161459|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110791647|NCT01161459|Immunologic Factors|immunologic factors|mesh-ancestor
110791648|NCT01161459|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110791649|NCT01161459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110791650|NCT01161459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110791651|NCT03882489|Chloroprocaine|chloroprocaine|mesh-list
110791652|NCT03882489|Anesthetics, Local|anesthetics, local|mesh-ancestor
110791653|NCT03882489|Anesthetics|anesthetics|mesh-ancestor
110791654|NCT03882489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110791655|NCT03882489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110791656|NCT03882489|Sensory System Agents|sensory system agents|mesh-ancestor
110791657|NCT03882489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110791658|NCT03882099|Vitamin D|vitamin d|mesh-list
110791659|NCT03882099|Vitamins|vitamins|mesh-ancestor
110791660|NCT03882099|Micronutrients|micronutrients|mesh-ancestor
110791661|NCT03882099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110791662|NCT03882099|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110791663|NCT01268163|Docetaxel|docetaxel|mesh-list
110791664|NCT01268163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110791665|NCT01268163|Tubulin Modulators|tubulin modulators|mesh-ancestor
110791666|NCT01268163|Antimitotic Agents|antimitotic agents|mesh-ancestor
110791667|NCT01268163|Mitosis Modulators|mitosis modulators|mesh-ancestor
110791668|NCT01268163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110791669|NCT04745780|Inositol|inositol|mesh-list
110791670|NCT04745780|Vitamin B Complex|vitamin b complex|mesh-ancestor
110791671|NCT04745780|Vitamins|vitamins|mesh-ancestor
110791672|NCT04745780|Micronutrients|micronutrients|mesh-ancestor
110791673|NCT04745780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110791674|NCT02833948|Aspirin|aspirin|mesh-list
110791675|NCT02833948|Rivaroxaban|rivaroxaban|mesh-list
110791676|NCT02833948|Clopidogrel|clopidogrel|mesh-list
110791677|NCT02833948|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110791678|NCT02833948|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110791679|NCT02833948|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110791680|NCT02833948|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110791681|NCT02833948|Purinergic Agents|purinergic agents|mesh-ancestor
110791682|NCT02833948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110500764|NCT00863655|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110791683|NCT02833948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110791684|NCT02833948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110791685|NCT02833948|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110791686|NCT02833948|Antithrombins|antithrombins|mesh-ancestor
110791687|NCT02833948|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110791688|NCT02833948|Protease Inhibitors|protease inhibitors|mesh-ancestor
110791689|NCT02833948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110791690|NCT02833948|Anticoagulants|anticoagulants|mesh-ancestor
110791691|NCT02833948|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110791692|NCT02833948|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110791693|NCT02833948|Analgesics|analgesics|mesh-ancestor
110791694|NCT02833948|Sensory System Agents|sensory system agents|mesh-ancestor
110791695|NCT02833948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110791696|NCT02833948|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110791697|NCT02833948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110791698|NCT02833948|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110791699|NCT02833948|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110791700|NCT02833948|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110791701|NCT02833948|Antipyretics|antipyretics|mesh-ancestor
110791702|NCT02527005|Azithromycin|azithromycin|mesh-list
110791703|NCT02527005|Pyrimethamine|pyrimethamine|mesh-list
110791705|NCT02527005|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
110791706|NCT02527005|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110791707|NCT02527005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110791708|NCT02527005|Antimalarials|antimalarials|mesh-ancestor
110791709|NCT02527005|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110791710|NCT02527005|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110791711|NCT02527005|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110791712|NCT02527005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110791713|NCT02527005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110791714|NCT02527005|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110791715|NCT01267695|Imatinib Mesylate|imatinib mesylate|mesh-list
110791716|NCT01267695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110791717|NCT01267695|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110791718|NCT01267695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110791719|NCT01267695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110791720|NCT02404688|Ethanol|ethanol|mesh-list
110791721|NCT02404688|Dronabinol|dronabinol|mesh-list
110791722|NCT02404688|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110791723|NCT02404688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110791724|NCT02404688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110791725|NCT02404688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110791726|NCT02404688|Hallucinogens|hallucinogens|mesh-ancestor
110791727|NCT02404688|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110791728|NCT02404688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110791729|NCT02404688|Analgesics|analgesics|mesh-ancestor
110791730|NCT02404688|Sensory System Agents|sensory system agents|mesh-ancestor
110791731|NCT02404688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110791732|NCT02404688|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
110791733|NCT02404688|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110791734|NCT02404688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110791735|NCT02404688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110791736|NCT02404688|Hormones|hormones|mesh-ancestor
110791737|NCT02404688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110791738|NCT04704518|Hyaluronic Acid|hyaluronic acid|mesh-list
110791739|NCT04704518|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110791740|NCT04704518|Immunologic Factors|immunologic factors|mesh-ancestor
110791741|NCT04704518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110791742|NCT04704518|Viscosupplements|viscosupplements|mesh-ancestor
110791743|NCT04704518|Protective Agents|protective agents|mesh-ancestor
110791744|NCT02624102|Antidepressive Agents|antidepressive agents|mesh-list
110791745|NCT02624102|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110791746|NCT01162941|Prednisolone|prednisolone|mesh-list
110791747|NCT01162941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110791748|NCT01162941|Glucocorticoids|glucocorticoids|mesh-ancestor
110791749|NCT01162941|Hormones|hormones|mesh-ancestor
110791750|NCT01162941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110791751|NCT01162941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110791752|NCT01162941|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110791753|NCT01162941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110791754|NCT00161044|Galantamine|galantamine|mesh-list
110791755|NCT00161044|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110791756|NCT00161044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110791757|NCT00161044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110791758|NCT00161044|Cholinergic Agents|cholinergic agents|mesh-ancestor
110791759|NCT00161044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110791760|NCT00161044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110791761|NCT00161044|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110791762|NCT00161044|Autonomic Agents|autonomic agents|mesh-ancestor
110791763|NCT00161044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110791764|NCT00161044|Nootropic Agents|nootropic agents|mesh-ancestor
110791765|NCT01156779|Exenatide|exenatide|mesh-list
110791766|NCT01156779|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110791767|NCT01156779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110791768|NCT01156779|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110791769|NCT01156779|Incretins|incretins|mesh-ancestor
110791770|NCT01156779|Hormones|hormones|mesh-ancestor
110791771|NCT01156779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110791772|NCT01156857|Ulipristal acetate|ulipristal acetate|mesh-list
110791773|NCT01156857|Progestins|progestins|mesh-list
110791774|NCT01156857|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110791775|NCT01156857|Contraceptive Agents|contraceptive agents|mesh-ancestor
110791776|NCT01156857|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110791777|NCT01156857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110791778|NCT01156857|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110791779|NCT01156857|Hormones|hormones|mesh-ancestor
110500830|NCT00804895|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110791780|NCT01156857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110791781|NCT01269333|Fluvoxamine|fluvoxamine|mesh-list
110791782|NCT01269333|Omeprazole|omeprazole|mesh-list
110791783|NCT01269333|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110791784|NCT01269333|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110791785|NCT01269333|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110791786|NCT01269333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110791787|NCT01269333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110791788|NCT01269333|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110791789|NCT01269333|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110791790|NCT01269333|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110791791|NCT01269333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110791792|NCT01269333|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110791793|NCT01269333|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110791794|NCT01269333|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110791795|NCT01269333|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110791796|NCT01269333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110791797|NCT01269333|Serotonin Agents|serotonin agents|mesh-ancestor
110791798|NCT01269333|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110791799|NCT01269333|Antidepressive Agents|antidepressive agents|mesh-ancestor
110791800|NCT01269333|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110791801|NCT01269333|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110791802|NCT01269333|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110791803|NCT01269411|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
110791804|NCT01269411|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
110791805|NCT01269411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110791806|NCT01269411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110791808|NCT03882255|Ponesimod|ponesimod|mesh-list
110791809|NCT03882255|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110791810|NCT03882255|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110791811|NCT03882255|Adrenergic Agents|adrenergic agents|mesh-ancestor
110791812|NCT03882255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110791813|NCT03882255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110791814|NCT03882255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110791815|NCT03882255|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110791816|NCT03882255|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110791817|NCT03882255|Vasodilator Agents|vasodilator agents|mesh-ancestor
110791818|NCT03882255|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
110791819|NCT03882255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110791820|NCT03882255|Immunologic Factors|immunologic factors|mesh-ancestor
110791821|NCT05433272|Vaccines|vaccines|mesh-list
110791822|NCT05433272|Immunologic Factors|immunologic factors|mesh-ancestor
110791823|NCT05433272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110791824|NCT01268631|Pregabalin|pregabalin|mesh-list
110791825|NCT01268631|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110791826|NCT01268631|Analgesics|analgesics|mesh-ancestor
110791827|NCT01268631|Sensory System Agents|sensory system agents|mesh-ancestor
110791828|NCT01268631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110791829|NCT01268631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110791830|NCT01268631|Anticonvulsants|anticonvulsants|mesh-ancestor
110791831|NCT01268631|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110791832|NCT01268631|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110791833|NCT01268631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110791834|NCT01268631|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110791835|NCT01268631|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110791836|NCT01268631|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110791837|NCT01268631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110791838|NCT01268631|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110791839|NCT01268631|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110791840|NCT01268631|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110791841|NCT01268631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110791842|NCT01268631|Antidepressive Agents|antidepressive agents|mesh-ancestor
110791843|NCT01268631|Dopamine Agents|dopamine agents|mesh-ancestor
110791844|NCT05430230|Naproxen|naproxen|mesh-list
110791845|NCT05430230|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
110791846|NCT05430230|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
110791847|NCT05430230|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110791848|NCT05430230|Analgesics|analgesics|mesh-ancestor
110791849|NCT05430230|Sensory System Agents|sensory system agents|mesh-ancestor
110791850|NCT05430230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110791851|NCT05430230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110791852|NCT05430230|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110791853|NCT05430230|Gout Suppressants|gout suppressants|mesh-ancestor
110791854|NCT05430230|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110791855|NCT05430230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110791856|NCT05430230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110791857|NCT01268709|Doxepin|doxepin|mesh-list
110791858|NCT01268709|Nortriptyline|nortriptyline|mesh-list
110500888|NCT05251610|Propranolol|propranolol|mesh-list
110791859|NCT01268709|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110791860|NCT01268709|Antidepressive Agents|antidepressive agents|mesh-ancestor
110791861|NCT01268709|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110791862|NCT01268709|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110791863|NCT01268709|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110791864|NCT01268709|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110791865|NCT01268709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110791866|NCT01268709|Adrenergic Agents|adrenergic agents|mesh-ancestor
110791867|NCT01268709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110791868|NCT01268709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110791869|NCT01268709|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110791870|NCT01268709|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110791871|NCT01268709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110791872|NCT01268709|Histamine Antagonists|histamine antagonists|mesh-ancestor
110791873|NCT01268709|Histamine Agents|histamine agents|mesh-ancestor
110791874|NCT03881943|Aspirin|aspirin|mesh-list
110791875|NCT03881943|Ticagrelor|ticagrelor|mesh-list
110791876|NCT03881943|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110791877|NCT03881943|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110791878|NCT03881943|Analgesics|analgesics|mesh-ancestor
110791879|NCT03881943|Sensory System Agents|sensory system agents|mesh-ancestor
110791880|NCT03881943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110791881|NCT03881943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110791882|NCT03881943|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110791883|NCT03881943|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110791884|NCT03881943|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110791885|NCT03881943|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110791886|NCT03881943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110791887|NCT03881943|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110791888|NCT03881943|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110791889|NCT03881943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110791890|NCT03881943|Antipyretics|antipyretics|mesh-ancestor
110791891|NCT03881943|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110791892|NCT03881943|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110791893|NCT03881943|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110791894|NCT03881943|Purinergic Agents|purinergic agents|mesh-ancestor
110791895|NCT03881943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110791896|NCT03760185|Brimonidine Tartrate|brimonidine tartrate|mesh-list
110791897|NCT03760185|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110791898|NCT03760185|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110791899|NCT03760185|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110791900|NCT03760185|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110500939|NCT00862719|Hormones|hormones|mesh-ancestor
110791901|NCT03760185|Adrenergic Agents|adrenergic agents|mesh-ancestor
110791902|NCT03760185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110791903|NCT03760185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110791904|NCT03760185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110791905|NCT01164969|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110791906|NCT01164969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110791907|NCT04722848|Imatinib Mesylate|imatinib mesylate|mesh-list
110791908|NCT04722848|Blinatumomab|blinatumomab|mesh-list
110791909|NCT04722848|Ponatinib|ponatinib|mesh-list
110791910|NCT04722848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110791911|NCT04722848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110791912|NCT04722848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110791913|NCT04722848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110791914|NCT01157013|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110791915|NCT01157013|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110791916|NCT01157013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110791917|NCT01584466|Paliperidone Palmitate|paliperidone palmitate|mesh-list
110791918|NCT01584466|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110791919|NCT01584466|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110791920|NCT01584466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110851116|NCT03730363|Pentamidine|pentamidine|mesh-list
110791921|NCT01584466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110791922|NCT01584466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110791923|NCT01584466|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110791924|NCT01584466|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110791925|NCT01584466|Serotonin Agents|serotonin agents|mesh-ancestor
110791926|NCT01584466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110791927|NCT01584466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110791928|NCT01584466|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110791929|NCT01584466|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110791930|NCT01584466|Dopamine Agents|dopamine agents|mesh-ancestor
110791931|NCT05363384|Metformin|metformin|mesh-list
110791932|NCT05363384|Alogliptin|alogliptin|mesh-list
110791933|NCT05363384|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110791934|NCT05363384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110791935|NCT05363384|Incretins|incretins|mesh-ancestor
110791936|NCT05363384|Hormones|hormones|mesh-ancestor
110791937|NCT05363384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110791938|NCT05363384|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110791939|NCT05363384|Protease Inhibitors|protease inhibitors|mesh-ancestor
110791940|NCT05363384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110791941|NCT05363384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110791942|NCT01165125|Ketoconazole|ketoconazole|mesh-list
110791943|NCT01165125|Antifungal Agents|antifungal agents|mesh-ancestor
110791944|NCT01165125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110791945|NCT01165125|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110791946|NCT01165125|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110791947|NCT01165125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110791948|NCT01165125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110791949|NCT01165125|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110791950|NCT01165125|Hormone Antagonists|hormone antagonists|mesh-ancestor
110791951|NCT01165125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110791952|NCT01165125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110791953|NCT01165125|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110791954|NCT01163799|Alefacept|alefacept|mesh-list
110791955|NCT01163799|Dermatologic Agents|dermatologic agents|mesh-ancestor
110791956|NCT01163799|Immunologic Factors|immunologic factors|mesh-ancestor
110791957|NCT01163799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110791958|NCT02274662|Cyclosporine|cyclosporine|mesh-list
110791959|NCT02274662|Tacrolimus|tacrolimus|mesh-list
110791960|NCT02274662|Cyclosporins|cyclosporins|mesh-list
110791961|NCT02274662|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110791962|NCT02274662|Thymoglobulin|thymoglobulin|mesh-list
110791963|NCT02274662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110791964|NCT02274662|Immunologic Factors|immunologic factors|mesh-ancestor
110791965|NCT02274662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110791966|NCT02274662|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110791967|NCT02274662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110791968|NCT02274662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110791969|NCT02274662|Antifungal Agents|antifungal agents|mesh-ancestor
110791970|NCT02274662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110791971|NCT02274662|Dermatologic Agents|dermatologic agents|mesh-ancestor
110791972|NCT02274662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110791973|NCT02891174|Acetaminophen|acetaminophen|mesh-list
110791974|NCT02891174|Ibuprofen|ibuprofen|mesh-list
110791975|NCT02891174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110791976|NCT02891174|Analgesics|analgesics|mesh-ancestor
110791977|NCT02891174|Sensory System Agents|sensory system agents|mesh-ancestor
110791978|NCT02891174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110791979|NCT02891174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110791980|NCT02891174|Antipyretics|antipyretics|mesh-ancestor
110791981|NCT02891174|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110791982|NCT02891174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110791983|NCT02891174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110791984|NCT02891174|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110791985|NCT02891174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110791986|NCT02891174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110791987|NCT01280175|Charcoal|charcoal|mesh-list
110791988|NCT01280175|Antidotes|antidotes|mesh-ancestor
110791989|NCT01280175|Protective Agents|protective agents|mesh-ancestor
110791990|NCT01280175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110791991|NCT01588431|Bevacizumab|bevacizumab|mesh-list
110791992|NCT01588431|Cetuximab|cetuximab|mesh-list
110791993|NCT01588431|Cisplatin|cisplatin|mesh-list
110791994|NCT01588431|Docetaxel|docetaxel|mesh-list
110791995|NCT01588431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110791996|NCT01588431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110791997|NCT01588431|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110791998|NCT01588431|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110791999|NCT01588431|Growth Substances|growth substances|mesh-ancestor
110792000|NCT01588431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110792001|NCT01588431|Growth Inhibitors|growth inhibitors|mesh-ancestor
110792002|NCT01588431|Tubulin Modulators|tubulin modulators|mesh-ancestor
110792003|NCT01588431|Antimitotic Agents|antimitotic agents|mesh-ancestor
110792004|NCT01588431|Mitosis Modulators|mitosis modulators|mesh-ancestor
110792005|NCT01588431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110792006|NCT01583283|Dexamethasone|dexamethasone|mesh-list
110792007|NCT01583283|Lenalidomide|lenalidomide|mesh-list
110792008|NCT01583283|Ricolinostat|ricolinostat|mesh-list
110792009|NCT01583283|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
110792010|NCT01583283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110792011|NCT01583283|Antiemetics|antiemetics|mesh-ancestor
110792012|NCT01583283|Autonomic Agents|autonomic agents|mesh-ancestor
110792013|NCT01583283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110792014|NCT01583283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110792015|NCT01583283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110792016|NCT01583283|Glucocorticoids|glucocorticoids|mesh-ancestor
110792017|NCT01583283|Hormones|hormones|mesh-ancestor
110792018|NCT01583283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110792019|NCT01583283|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110792020|NCT01583283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110792021|NCT01583283|Immunologic Factors|immunologic factors|mesh-ancestor
110792022|NCT01583283|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110792023|NCT01583283|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110792024|NCT01583283|Growth Substances|growth substances|mesh-ancestor
110792025|NCT01583283|Growth Inhibitors|growth inhibitors|mesh-ancestor
110792026|NCT01583283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110792027|NCT01583283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110792028|NCT02076620|Doxorubicin|doxorubicin|mesh-list
110792029|NCT02076620|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110792030|NCT02076620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110792031|NCT02076620|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110792032|NCT02076620|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110792033|NCT02076620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110792034|NCT02076620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110792035|NCT01270737|Daidzein|daidzein|mesh-list
110792036|NCT01270737|Phytoestrogens|phytoestrogens|mesh-ancestor
110792037|NCT01270737|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
110792038|NCT01270737|Estrogens|estrogens|mesh-ancestor
110792039|NCT01270737|Hormones|hormones|mesh-ancestor
110792040|NCT01270737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110792041|NCT01270737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110792042|NCT01270815|Pregabalin|pregabalin|mesh-list
110792043|NCT01270815|Analgesics|analgesics|mesh-ancestor
110792044|NCT01270815|Sensory System Agents|sensory system agents|mesh-ancestor
110792045|NCT01270815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110792046|NCT01270815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110792047|NCT01270815|Anticonvulsants|anticonvulsants|mesh-ancestor
110792048|NCT01270815|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110792049|NCT01270815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110792050|NCT01270815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110792051|NCT01270815|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110792052|NCT01270815|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110792053|NCT01270815|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110792054|NCT01270815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110792055|NCT01270815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110792056|NCT01751984|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
110792057|NCT01751984|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110792058|NCT01751984|Antimetabolites|antimetabolites|mesh-ancestor
110792059|NCT01751984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110792060|NCT01751984|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110792061|NCT01751984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110792062|NCT01751984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110792063|NCT01751984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110792064|NCT03330236|Anesthetics|anesthetics|mesh-list
110792065|NCT03330236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110792066|NCT03330236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110792067|NCT01271361|Sirolimus|sirolimus|mesh-list
110792068|NCT01271361|Umirolimus|umirolimus|mesh-list
110792069|NCT01271361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110792070|NCT01271361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110792071|NCT01271361|Immunologic Factors|immunologic factors|mesh-ancestor
110792072|NCT01271361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110792073|NCT01271361|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110792074|NCT01271361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110792075|NCT01271361|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110792076|NCT01271361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110792077|NCT01271361|Antifungal Agents|antifungal agents|mesh-ancestor
110792078|NCT03638726|Atropine|atropine|mesh-list
110792079|NCT03638726|Phenylephrine|phenylephrine|mesh-list
110792080|NCT03638726|Epinephrine|epinephrine|mesh-list
110792081|NCT03638726|Racepinephrine|racepinephrine|mesh-list
110792082|NCT03638726|Oxymetazoline|oxymetazoline|mesh-list
110792083|NCT03638726|Cyclopentolate|cyclopentolate|mesh-list
110792084|NCT03638726|Epinephryl borate|epinephryl borate|mesh-list
110792085|NCT03638726|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110792086|NCT03638726|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110792087|NCT03638726|Adrenergic Agents|adrenergic agents|mesh-ancestor
110792088|NCT03638726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110792089|NCT03638726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110792090|NCT03638726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110792091|NCT03638726|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110792092|NCT03638726|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110792093|NCT03638726|Autonomic Agents|autonomic agents|mesh-ancestor
110792094|NCT03638726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110792095|NCT03638726|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110792096|NCT03638726|Respiratory System Agents|respiratory system agents|mesh-ancestor
110792097|NCT03638726|Mydriatics|mydriatics|mesh-ancestor
110792098|NCT03638726|Sympathomimetics|sympathomimetics|mesh-ancestor
110792099|NCT03638726|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110792100|NCT03638726|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110792101|NCT03638726|Nasal Decongestants|nasal decongestants|mesh-ancestor
110792102|NCT03638726|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110792103|NCT03638726|Protective Agents|protective agents|mesh-ancestor
110792104|NCT03638726|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110792105|NCT03638726|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110792106|NCT03638726|Parasympatholytics|parasympatholytics|mesh-ancestor
110792107|NCT03638726|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110792108|NCT03638726|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110792109|NCT03638726|Cholinergic Agents|cholinergic agents|mesh-ancestor
110792110|NCT01164189|Bevacizumab|bevacizumab|mesh-list
110792111|NCT01164189|Temozolomide|temozolomide|mesh-list
110792112|NCT01164189|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110792113|NCT01164189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110792114|NCT01164189|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110792115|NCT01164189|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110792116|NCT01164189|Growth Substances|growth substances|mesh-ancestor
110792117|NCT01164189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110792118|NCT01164189|Growth Inhibitors|growth inhibitors|mesh-ancestor
110792119|NCT01164189|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110792120|NCT01164189|Alkylating Agents|alkylating agents|mesh-ancestor
110792121|NCT01164189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110792122|NCT01164267|Everolimus|everolimus|mesh-list
110792123|NCT01164267|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110792124|NCT01164267|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110792125|NCT01164267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110792126|NCT01164267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110792127|NCT01164267|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110792128|NCT01164267|Immunologic Factors|immunologic factors|mesh-ancestor
110792129|NCT01164267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110792131|NCT01164345|Plerixafor|plerixafor|mesh-list
110792132|NCT01164345|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110792133|NCT01164345|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110792134|NCT01164345|Antiviral Agents|antiviral agents|mesh-ancestor
110792135|NCT01164345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110792136|NCT02948582|Glycopyrrolate|glycopyrrolate|mesh-list
110792137|NCT02948582|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110792138|NCT02948582|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110792139|NCT02948582|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110792140|NCT02948582|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110792141|NCT02948582|Cholinergic Agents|cholinergic agents|mesh-ancestor
110792142|NCT02948582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110509765|NCT00855361|Rabeprazole|rabeprazole|mesh-list
110792143|NCT02948582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110792144|NCT02948582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110792145|NCT02259868|Ritonavir|ritonavir|mesh-list
110792146|NCT02259868|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110792147|NCT02259868|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110792148|NCT02259868|Protease Inhibitors|protease inhibitors|mesh-ancestor
110792149|NCT02259868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110792150|NCT02259868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110792151|NCT02259868|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110792152|NCT02259868|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110792153|NCT02259868|Antiviral Agents|antiviral agents|mesh-ancestor
110792154|NCT02259868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110792155|NCT02259868|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110792156|NCT02259868|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110792157|NCT01167231|Acarbose|acarbose|mesh-list
110792158|NCT01167231|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
110792159|NCT01167231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110792160|NCT01167231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110792161|NCT01167231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110792162|NCT01167231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110792163|NCT03871803|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
110792164|NCT03871803|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110792165|NCT03871803|Adrenergic Agents|adrenergic agents|mesh-ancestor
110792166|NCT03871803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110792167|NCT03871803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110792168|NCT03871803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110792169|NCT00135226|Aspirin|aspirin|mesh-list
110792170|NCT00135226|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110792171|NCT00135226|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110792172|NCT00135226|Analgesics|analgesics|mesh-ancestor
110792173|NCT00135226|Sensory System Agents|sensory system agents|mesh-ancestor
110792174|NCT00135226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110792175|NCT00135226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110792176|NCT00135226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110792177|NCT00135226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110792178|NCT00135226|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110792179|NCT00135226|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110792180|NCT00135226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110792181|NCT00135226|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110792182|NCT00135226|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110792183|NCT00135226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110792184|NCT00135226|Antipyretics|antipyretics|mesh-ancestor
110792185|NCT01587261|Ascorbic Acid|ascorbic acid|mesh-list
110792186|NCT01587261|Vitamins|vitamins|mesh-ancestor
110792187|NCT01587261|Micronutrients|micronutrients|mesh-ancestor
110792188|NCT01587261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110792189|NCT01587261|Antioxidants|antioxidants|mesh-ancestor
110792190|NCT01587261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110792191|NCT01587261|Protective Agents|protective agents|mesh-ancestor
110792192|NCT01269021|Mycophenolic Acid|mycophenolic acid|mesh-list
110792193|NCT01269021|Prednisone|prednisone|mesh-list
110792194|NCT01269021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110792195|NCT01269021|Glucocorticoids|glucocorticoids|mesh-ancestor
110792196|NCT01269021|Hormones|hormones|mesh-ancestor
110792197|NCT01269021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110792198|NCT01269021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110792199|NCT01269021|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110792200|NCT01269021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110792201|NCT01269021|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110792202|NCT01269021|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110792203|NCT01269021|Antitubercular Agents|antitubercular agents|mesh-ancestor
110792204|NCT01269021|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110792205|NCT01269021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110792206|NCT01269021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110792207|NCT01269021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110792208|NCT01269099|Fentanyl|fentanyl|mesh-list
110792209|NCT01269099|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110792210|NCT01269099|Narcotics|narcotics|mesh-ancestor
110792211|NCT01269099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110792212|NCT01269099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110792213|NCT01269099|Analgesics|analgesics|mesh-ancestor
110792214|NCT01269099|Sensory System Agents|sensory system agents|mesh-ancestor
110792215|NCT01269099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110792216|NCT01269099|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110792217|NCT01269099|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110792218|NCT01269099|Anesthetics, General|anesthetics, general|mesh-ancestor
110792219|NCT01269099|Anesthetics|anesthetics|mesh-ancestor
110792220|NCT01164813|Nabumetone|nabumetone|mesh-list
110792221|NCT01164813|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110792222|NCT01164813|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110792223|NCT01164813|Analgesics|analgesics|mesh-ancestor
110792224|NCT01164813|Sensory System Agents|sensory system agents|mesh-ancestor
110792225|NCT01164813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110792226|NCT01164813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110792227|NCT01164813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110792228|NCT01164813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110792229|NCT01164813|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110792230|NCT01164813|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110792231|NCT01164813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110792232|NCT01164813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110792233|NCT01165905|Gemcitabine|gemcitabine|mesh-list
110792234|NCT01165905|ON 01910|on 01910|mesh-list
110792235|NCT01165905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110792236|NCT01165905|Antimetabolites|antimetabolites|mesh-ancestor
110792237|NCT01165905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110792238|NCT01165905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110792239|NCT01165905|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110792240|NCT01165905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110792241|NCT01339000|Vaccines|vaccines|mesh-list
110792242|NCT01339000|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110792243|NCT01339000|Immunologic Factors|immunologic factors|mesh-ancestor
110792244|NCT01339000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110792245|NCT01269255|Cisplatin|cisplatin|mesh-list
110792246|NCT01269255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110792247|NCT03563170|Leucovorin|leucovorin|mesh-list
110792248|NCT03563170|Paclitaxel|paclitaxel|mesh-list
110792249|NCT03563170|Cyclophosphamide|cyclophosphamide|mesh-list
110792250|NCT03563170|Fluorouracil|fluorouracil|mesh-list
110792251|NCT03563170|Capecitabine|capecitabine|mesh-list
110792252|NCT03563170|Cetuximab|cetuximab|mesh-list
110792253|NCT03563170|Sorafenib|sorafenib|mesh-list
110792254|NCT03563170|Avelumab|avelumab|mesh-list
110792255|NCT03563170|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110792256|NCT03563170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110792257|NCT03563170|Tubulin Modulators|tubulin modulators|mesh-ancestor
110792258|NCT03563170|Antimitotic Agents|antimitotic agents|mesh-ancestor
110792259|NCT03563170|Mitosis Modulators|mitosis modulators|mesh-ancestor
110792260|NCT03563170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110792261|NCT03563170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110792262|NCT03563170|Immunologic Factors|immunologic factors|mesh-ancestor
110792263|NCT03563170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110792264|NCT03563170|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110792265|NCT03563170|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110851151|NCT01206881|Docetaxel|docetaxel|mesh-list
110792266|NCT03563170|Alkylating Agents|alkylating agents|mesh-ancestor
110792267|NCT03563170|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110792268|NCT03563170|Antimetabolites|antimetabolites|mesh-ancestor
110792269|NCT03563170|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110792270|NCT03563170|Antidotes|antidotes|mesh-ancestor
110792271|NCT03563170|Protective Agents|protective agents|mesh-ancestor
110792272|NCT03563170|Vitamin B Complex|vitamin b complex|mesh-ancestor
110792273|NCT03563170|Vitamins|vitamins|mesh-ancestor
110792274|NCT03563170|Micronutrients|micronutrients|mesh-ancestor
110792275|NCT03563170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110792276|NCT03563170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110792277|NCT03563170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110792278|NCT01281111|Aspirin|aspirin|mesh-list
110792279|NCT01281111|Dimethyl Fumarate|dimethyl fumarate|mesh-list
110792280|NCT01281111|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110792281|NCT01281111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110792282|NCT01281111|Analgesics|analgesics|mesh-ancestor
110792283|NCT01281111|Sensory System Agents|sensory system agents|mesh-ancestor
110792284|NCT01281111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110501224|NCT00652327|Ezetimibe|ezetimibe|mesh-list
110792285|NCT01281111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110792286|NCT01281111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110792287|NCT01281111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110792288|NCT01281111|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110792289|NCT01281111|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110792290|NCT01281111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110792291|NCT01281111|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110792292|NCT01281111|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110792293|NCT01281111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110792294|NCT01281111|Antipyretics|antipyretics|mesh-ancestor
110792295|NCT01281111|Dermatologic Agents|dermatologic agents|mesh-ancestor
110792296|NCT01281111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110792297|NCT01281111|Immunologic Factors|immunologic factors|mesh-ancestor
110792298|NCT03869931|Fenofibrate|fenofibrate|mesh-list
110792299|NCT03869931|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110792300|NCT03869931|Antimetabolites|antimetabolites|mesh-ancestor
110792301|NCT03869931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110792302|NCT03869931|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110792303|NCT04876066|Ketamine|ketamine|mesh-list
110792304|NCT04876066|Analgesics|analgesics|mesh-ancestor
110792305|NCT04876066|Sensory System Agents|sensory system agents|mesh-ancestor
110792306|NCT04876066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110792307|NCT04876066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110792308|NCT04876066|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110792309|NCT04876066|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110792310|NCT04876066|Anesthetics, General|anesthetics, general|mesh-ancestor
110792311|NCT04876066|Anesthetics|anesthetics|mesh-ancestor
110792312|NCT04876066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110792313|NCT04876066|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110792314|NCT04876066|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110792315|NCT04876066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110792316|NCT04876066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110792317|NCT01169805|Ondansetron|ondansetron|mesh-list
110792318|NCT01169805|Palonosetron|palonosetron|mesh-list
110792319|NCT01169805|Ramosetron|ramosetron|mesh-list
110792320|NCT01169805|Antiemetics|antiemetics|mesh-ancestor
110792321|NCT01169805|Autonomic Agents|autonomic agents|mesh-ancestor
110792322|NCT01169805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110792323|NCT01169805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110792324|NCT01169805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110792325|NCT01169805|Antipruritics|antipruritics|mesh-ancestor
110792326|NCT01169805|Dermatologic Agents|dermatologic agents|mesh-ancestor
110792327|NCT01169805|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110792328|NCT01169805|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110792329|NCT01169805|Serotonin Agents|serotonin agents|mesh-ancestor
110851152|NCT01206881|Doxorubicin|doxorubicin|mesh-list
110792330|NCT01169805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110792331|NCT01169805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110792332|NCT01283061|Zafirlukast|zafirlukast|mesh-list
110792333|NCT01283061|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110792334|NCT01283061|Respiratory System Agents|respiratory system agents|mesh-ancestor
110792335|NCT01283061|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110792336|NCT01283061|Hormone Antagonists|hormone antagonists|mesh-ancestor
110792337|NCT01283061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110792338|NCT01283061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110792339|NCT03563014|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
110792340|NCT03563014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110792341|NCT01167465|Zinc Oxide|zinc oxide|mesh-list
110792342|NCT01167465|Dermatologic Agents|dermatologic agents|mesh-ancestor
110792343|NCT01167465|Sunscreening Agents|sunscreening agents|mesh-ancestor
110792344|NCT01167465|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110792345|NCT01167465|Protective Agents|protective agents|mesh-ancestor
110792346|NCT01167465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110792347|NCT01283217|Cisplatin|cisplatin|mesh-list
110792348|NCT01283217|Docetaxel|docetaxel|mesh-list
110792349|NCT01283217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110792350|NCT01283217|Tubulin Modulators|tubulin modulators|mesh-ancestor
110792351|NCT01283217|Antimitotic Agents|antimitotic agents|mesh-ancestor
110792352|NCT01283217|Mitosis Modulators|mitosis modulators|mesh-ancestor
110445941|NCT02876250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110792353|NCT01283217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110792355|NCT01276431|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110792356|NCT01276431|Narcotics|narcotics|mesh-ancestor
110792357|NCT01276431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110792358|NCT01276431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110792359|NCT01276431|Analgesics|analgesics|mesh-ancestor
110792360|NCT01276431|Sensory System Agents|sensory system agents|mesh-ancestor
110792361|NCT01276431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110792362|NCT01276431|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110792363|NCT01281579|Canagliflozin|canagliflozin|mesh-list
110792364|NCT01281579|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110792365|NCT01281579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110792366|NCT01281579|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110792367|NCT01281579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110792368|NCT01281657|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
110792369|NCT01281657|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
110792370|NCT01281657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110792371|NCT01281657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110792372|NCT01281657|Immunologic Factors|immunologic factors|mesh-ancestor
110792373|NCT01281657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110792375|NCT01166451|Trace Elements|trace elements|mesh-ancestor
110792376|NCT01166451|Micronutrients|micronutrients|mesh-ancestor
110792377|NCT01166451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110792378|NCT02526615|Metformin|metformin|mesh-list
110792379|NCT02526615|Rosiglitazone|rosiglitazone|mesh-list
110792380|NCT02526615|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110792381|NCT02526615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110792382|NCT01283763|Imiquimod|imiquimod|mesh-list
110792383|NCT01283763|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110792384|NCT01283763|Immunologic Factors|immunologic factors|mesh-ancestor
110792385|NCT01283763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110792386|NCT01283763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110792387|NCT01283763|Interferon Inducers|interferon inducers|mesh-ancestor
110792388|NCT01283841|Mycophenolic Acid|mycophenolic acid|mesh-list
110792389|NCT01283841|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110792390|NCT01283841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110792391|NCT01283841|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110792392|NCT01283841|Antitubercular Agents|antitubercular agents|mesh-ancestor
110792393|NCT01283841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110792394|NCT01283841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110792395|NCT01283841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110792396|NCT01283841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110792397|NCT03872661|Bevacizumab|bevacizumab|mesh-list
110792398|NCT03872661|Carboplatin|carboplatin|mesh-list
110792399|NCT03872661|Pemetrexed|pemetrexed|mesh-list
110792400|NCT03872661|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110792401|NCT03872661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110792402|NCT03872661|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110792403|NCT03872661|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110792404|NCT03872661|Growth Substances|growth substances|mesh-ancestor
110792405|NCT03872661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110792406|NCT03872661|Growth Inhibitors|growth inhibitors|mesh-ancestor
110792407|NCT03872661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110792408|NCT03872661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110792409|NCT03872661|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110792410|NCT03872661|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110792411|NCT01167699|Oxycodone|oxycodone|mesh-list
110792412|NCT01167699|Naloxone|naloxone|mesh-list
110792413|NCT01167699|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110792414|NCT01167699|Narcotics|narcotics|mesh-ancestor
110792415|NCT01167699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110792416|NCT01167699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110792417|NCT01167699|Analgesics|analgesics|mesh-ancestor
110792418|NCT01167699|Sensory System Agents|sensory system agents|mesh-ancestor
110792419|NCT01167699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110792420|NCT01167699|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110792421|NCT02526303|Nadroparin|nadroparin|mesh-list
110792422|NCT02526303|Warfarin|warfarin|mesh-list
110792423|NCT02526303|Calcium|calcium|mesh-list
110792424|NCT02526303|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110792425|NCT02526303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110792426|NCT02526303|Anticoagulants|anticoagulants|mesh-ancestor
110792427|NCT02526303|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110117509|NCT01877954|Fluticasone|fluticasone|mesh-list
110792428|NCT02526303|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110792429|NCT02526303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110792430|NCT03869073|Evolocumab|evolocumab|mesh-list
110792431|NCT03869073|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
110792432|NCT03869073|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110792433|NCT03869073|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110792434|NCT03869073|Antimetabolites|antimetabolites|mesh-ancestor
110792435|NCT03869073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110792436|NCT03869073|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110792437|NCT03869073|Protease Inhibitors|protease inhibitors|mesh-ancestor
110792438|NCT03869073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110792439|NCT03869073|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110792440|NCT01587495|Ertapenem|ertapenem|mesh-list
110792441|NCT01587495|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110792442|NCT01587495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110792443|NCT01170351|Cyclosporine|cyclosporine|mesh-list
110792444|NCT01170351|Cyclosporins|cyclosporins|mesh-list
110792445|NCT01170351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110792446|NCT01170351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110792447|NCT01170351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110792448|NCT01170351|Immunologic Factors|immunologic factors|mesh-ancestor
110792449|NCT01170351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110792450|NCT01170351|Antifungal Agents|antifungal agents|mesh-ancestor
110792451|NCT01170351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110792452|NCT01170351|Dermatologic Agents|dermatologic agents|mesh-ancestor
110792453|NCT01170351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110792454|NCT01170351|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110792455|NCT01170429|Procaterol|procaterol|mesh-list
110792456|NCT01170429|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110792457|NCT01170429|Autonomic Agents|autonomic agents|mesh-ancestor
110792458|NCT01170429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110792459|NCT01170429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110792460|NCT01170429|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110792461|NCT01170429|Respiratory System Agents|respiratory system agents|mesh-ancestor
110792462|NCT01170429|Sympathomimetics|sympathomimetics|mesh-ancestor
110792463|NCT01170429|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110792464|NCT01170429|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110792465|NCT01170429|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110792466|NCT01170429|Adrenergic Agents|adrenergic agents|mesh-ancestor
110792467|NCT01170429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110792468|NCT01170429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110792469|NCT01170507|Vitamin D|vitamin d|mesh-list
110792470|NCT01170507|Ergocalciferols|ergocalciferols|mesh-list
110792471|NCT01170507|Cholecalciferol|cholecalciferol|mesh-list
110792472|NCT01170507|Vitamins|vitamins|mesh-list
110792473|NCT01170507|Micronutrients|micronutrients|mesh-ancestor
110792474|NCT01170507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110792475|NCT01170507|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110792476|NCT01170507|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110792477|NCT01170585|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110792478|NCT01170585|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110792479|NCT01170585|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110792480|NCT01170585|Antimetabolites|antimetabolites|mesh-ancestor
110792481|NCT01170585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110792482|NCT01170585|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110792483|NCT01170585|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110792484|NCT01170585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110792485|NCT01170819|Dinoprostone|dinoprostone|mesh-list
110792486|NCT01170819|Oxytocics|oxytocics|mesh-ancestor
110792487|NCT01170819|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110792488|NCT01170819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110792489|NCT03868137|Ibuprofen|ibuprofen|mesh-list
110792490|NCT03868137|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110792491|NCT03868137|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110792492|NCT03868137|Analgesics|analgesics|mesh-ancestor
110792493|NCT03868137|Sensory System Agents|sensory system agents|mesh-ancestor
110792494|NCT03868137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110792495|NCT03868137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110792496|NCT03868137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110792497|NCT03868137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110792498|NCT03868137|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110792499|NCT03868137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110792500|NCT03868137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110792501|NCT01283919|Pantoprazole|pantoprazole|mesh-list
110792502|NCT01283919|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110792503|NCT01283919|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110792504|NCT01283919|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110792505|NCT01283919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110792506|NCT01283919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110792507|NCT01167933|Simvastatin|simvastatin|mesh-list
110792508|NCT01167933|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110792509|NCT01167933|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110792510|NCT01167933|Antimetabolites|antimetabolites|mesh-ancestor
110792511|NCT01167933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110792512|NCT01167933|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110792513|NCT01167933|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110792514|NCT01167933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110792515|NCT01168011|ON 01910|on 01910|mesh-list
110792516|NCT01168011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110792517|NCT01168011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110792518|NCT01168011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110792519|NCT01168011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110792520|NCT01171209|Interferons|interferons|mesh-list
110792521|NCT01171209|Interferon-beta|interferon-beta|mesh-list
110510136|NCT03853044|Hormones|hormones|mesh-ancestor
110792522|NCT01171209|Interferon-alpha|interferon-alpha|mesh-list
110792523|NCT01171209|Interferon beta-1b|interferon beta-1b|mesh-list
110792524|NCT01171209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110792525|NCT01171209|Antiviral Agents|antiviral agents|mesh-ancestor
110792526|NCT01171209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110792527|NCT01171209|Immunologic Factors|immunologic factors|mesh-ancestor
110792528|NCT01171209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110792529|NCT01171209|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110792530|NCT01166685|Everolimus|everolimus|mesh-list
110792531|NCT01166685|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110792532|NCT01166685|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110792533|NCT01166685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110792534|NCT01166685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110792535|NCT01166685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110792536|NCT01166685|Immunologic Factors|immunologic factors|mesh-ancestor
110792537|NCT01166685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110792538|NCT01166685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110792539|NCT03870711|Lidocaine|lidocaine|mesh-list
110792540|NCT03870711|Anesthetics, Local|anesthetics, local|mesh-ancestor
110792541|NCT03870711|Anesthetics|anesthetics|mesh-ancestor
110792542|NCT03870711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110792543|NCT03870711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110792544|NCT03870711|Sensory System Agents|sensory system agents|mesh-ancestor
110792545|NCT03870711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110792546|NCT03870711|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110792547|NCT03870711|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110792548|NCT03870711|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110792549|NCT03870711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110792550|NCT03870711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110792551|NCT03872505|Paclitaxel|paclitaxel|mesh-list
110792552|NCT03872505|Carboplatin|carboplatin|mesh-list
110792553|NCT03872505|Durvalumab|durvalumab|mesh-list
110792554|NCT03872505|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110792555|NCT03872505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110792556|NCT03872505|Tubulin Modulators|tubulin modulators|mesh-ancestor
110792557|NCT03872505|Antimitotic Agents|antimitotic agents|mesh-ancestor
110792558|NCT03872505|Mitosis Modulators|mitosis modulators|mesh-ancestor
110792559|NCT03872505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110792560|NCT03872505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110792561|NCT01171365|Ciclesonide|ciclesonide|mesh-list
110792562|NCT01171365|Glucocorticoids|glucocorticoids|mesh-ancestor
110792563|NCT01171365|Hormones|hormones|mesh-ancestor
110792564|NCT01171365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110501396|NCT02612649|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110792565|NCT01171365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110792566|NCT01171365|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110792567|NCT01281891|Morphine|morphine|mesh-list
110792568|NCT01281891|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110792569|NCT01281891|Narcotics|narcotics|mesh-ancestor
110792570|NCT01281891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110792571|NCT01281891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110792572|NCT01281891|Analgesics|analgesics|mesh-ancestor
110792573|NCT01281891|Sensory System Agents|sensory system agents|mesh-ancestor
110792574|NCT01281891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110792575|NCT01282047|Lenalidomide|lenalidomide|mesh-list
110792576|NCT01282047|Immunologic Factors|immunologic factors|mesh-ancestor
110792577|NCT01282047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110792578|NCT01282047|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110792579|NCT01282047|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110792580|NCT01282047|Growth Substances|growth substances|mesh-ancestor
110792581|NCT01282047|Growth Inhibitors|growth inhibitors|mesh-ancestor
110792582|NCT01282047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110792584|NCT02525991|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110792585|NCT02525991|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110792586|NCT02525991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110792587|NCT02525991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110792588|NCT02525991|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110792589|NCT02525991|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110792590|NCT02525991|Dopamine Agents|dopamine agents|mesh-ancestor
110792591|NCT02525991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110792592|NCT02525991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110792593|NCT01171755|Gemcitabine|gemcitabine|mesh-list
110792594|NCT01171755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110792595|NCT01171755|Antimetabolites|antimetabolites|mesh-ancestor
110510206|NCT02795754|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110792596|NCT01171755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110792597|NCT01171755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110792598|NCT01172691|Nitric Oxide|nitric oxide|mesh-list
110792599|NCT01172691|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110792600|NCT01172691|Autonomic Agents|autonomic agents|mesh-ancestor
110792601|NCT01172691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110792602|NCT01172691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110792603|NCT01172691|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110792604|NCT01172691|Respiratory System Agents|respiratory system agents|mesh-ancestor
110792605|NCT01172691|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110792606|NCT01172691|Antioxidants|antioxidants|mesh-ancestor
110792607|NCT01172691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110792608|NCT01172691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110792609|NCT01172691|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
110792610|NCT01172691|Vasodilator Agents|vasodilator agents|mesh-ancestor
110792611|NCT01172691|Gasotransmitters|gasotransmitters|mesh-ancestor
110792612|NCT01172691|Protective Agents|protective agents|mesh-ancestor
110792613|NCT01171833|Sevoflurane|sevoflurane|mesh-list
110792614|NCT01171833|Desflurane|desflurane|mesh-list
110792615|NCT01171833|Isoflurane|isoflurane|mesh-list
110792616|NCT01171833|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110792617|NCT01171833|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110792618|NCT01171833|Anesthetics, General|anesthetics, general|mesh-ancestor
110792619|NCT01171833|Anesthetics|anesthetics|mesh-ancestor
110792620|NCT01171833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110792621|NCT01171833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110792622|NCT01172769|Sirolimus|sirolimus|mesh-list
110792623|NCT01172769|Temsirolimus|temsirolimus|mesh-list
110792624|NCT01172769|MTOR Inhibitors|mtor inhibitors|mesh-list
110792625|NCT01172769|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-list
110792626|NCT01172769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110792627|NCT01172769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110792628|NCT01172769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110792629|NCT01172769|Immunologic Factors|immunologic factors|mesh-ancestor
110792630|NCT01172769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110792631|NCT01172769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110792632|NCT01172769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110792633|NCT01172769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110501451|NCT00913107|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110792634|NCT01172769|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110792635|NCT01172769|Antifungal Agents|antifungal agents|mesh-ancestor
110792636|NCT01584531|ON 01910|on 01910|mesh-list
110792637|NCT01584531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110792638|NCT01584531|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110792639|NCT01584531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110792640|NCT01584531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110792641|NCT01171911|Nicardipine|nicardipine|mesh-list
110792642|NCT01171911|Calcium Channel Blockers|calcium channel blockers|mesh-list
110792643|NCT01171911|Esmolol|esmolol|mesh-list
110792644|NCT01171911|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110792645|NCT01171911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110792646|NCT01171911|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110792647|NCT01171911|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110792648|NCT01171911|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110117731|NCT01879514|Hormones|hormones|mesh-ancestor
110792649|NCT01171911|Adrenergic Agents|adrenergic agents|mesh-ancestor
110792650|NCT01171911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110792651|NCT01171911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110792652|NCT01171911|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110792653|NCT01171911|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110792654|NCT01171911|Vasodilator Agents|vasodilator agents|mesh-ancestor
110792655|NCT01172925|Tiotropium Bromide|tiotropium bromide|mesh-list
110792656|NCT01172925|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110792657|NCT01172925|Autonomic Agents|autonomic agents|mesh-ancestor
110792658|NCT01172925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110792659|NCT01172925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110792660|NCT01172925|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110792661|NCT01172925|Respiratory System Agents|respiratory system agents|mesh-ancestor
110851201|NCT03817541|Anesthetics|anesthetics|mesh-ancestor
110792662|NCT01172925|Parasympatholytics|parasympatholytics|mesh-ancestor
110792663|NCT01172925|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110792664|NCT01172925|Cholinergic Agents|cholinergic agents|mesh-ancestor
110792665|NCT01172925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110792666|NCT01172925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110792668|NCT01173003|Mifepristone|mifepristone|mesh-list
110792669|NCT01173003|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110792670|NCT01173003|Abortifacient Agents|abortifacient agents|mesh-ancestor
110792671|NCT01173003|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110792672|NCT01173003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110792673|NCT01173003|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110792674|NCT01173003|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110792676|NCT01173003|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
110792677|NCT01173003|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110792678|NCT01173003|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110792679|NCT01173003|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110792680|NCT01173003|Contraceptive Agents|contraceptive agents|mesh-ancestor
110792681|NCT01173003|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
110792682|NCT01173003|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
110792683|NCT01173003|Hormone Antagonists|hormone antagonists|mesh-ancestor
110792684|NCT01173003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110792685|NCT01173003|Luteolytic Agents|luteolytic agents|mesh-ancestor
110792686|NCT01173003|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110792687|NCT01173003|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
110792688|NCT03435003|Dexamethasone|dexamethasone|mesh-list
110792690|NCT03435003|Scopolamine|scopolamine|mesh-list
110792691|NCT03435003|Dexmedetomidine|dexmedetomidine|mesh-list
110792692|NCT03435003|Ondansetron|ondansetron|mesh-list
110792693|NCT03435003|Aprepitant|aprepitant|mesh-list
110792694|NCT03435003|Metoclopramide|metoclopramide|mesh-list
110792695|NCT03435003|Prochlorperazine|prochlorperazine|mesh-list
110792696|NCT03435003|Propofol|propofol|mesh-list
110792697|NCT03435003|Sevoflurane|sevoflurane|mesh-list
110792698|NCT03435003|Desflurane|desflurane|mesh-list
110792699|NCT03435003|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
110792700|NCT03435003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110792701|NCT03435003|Antiemetics|antiemetics|mesh-ancestor
110792702|NCT03435003|Autonomic Agents|autonomic agents|mesh-ancestor
110792703|NCT03435003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110792704|NCT03435003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110792705|NCT03435003|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110792706|NCT03435003|Glucocorticoids|glucocorticoids|mesh-ancestor
110792707|NCT03435003|Hormones|hormones|mesh-ancestor
110792708|NCT03435003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110792709|NCT03435003|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110792710|NCT03435003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110792711|NCT03435003|Anesthetics|anesthetics|mesh-ancestor
110792712|NCT03435003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110792713|NCT03435003|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110792714|NCT03435003|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110792715|NCT03435003|Analgesics|analgesics|mesh-ancestor
110792716|NCT03435003|Sensory System Agents|sensory system agents|mesh-ancestor
110792717|NCT03435003|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110792718|NCT03435003|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110792719|NCT03435003|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110792720|NCT03435003|Adrenergic Agents|adrenergic agents|mesh-ancestor
110792721|NCT03435003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110792722|NCT03435003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110851214|NCT03586609|Cytarabine|cytarabine|mesh-list
110792723|NCT03435003|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110792724|NCT03435003|Anesthetics, General|anesthetics, general|mesh-ancestor
110792725|NCT03435003|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110792726|NCT03435003|Narcotics|narcotics|mesh-ancestor
110792727|NCT03435003|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110792728|NCT03435003|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110792729|NCT03435003|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110792730|NCT03435003|Antipruritics|antipruritics|mesh-ancestor
110792731|NCT03435003|Dermatologic Agents|dermatologic agents|mesh-ancestor
110792732|NCT03435003|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110792733|NCT03435003|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110792734|NCT03435003|Serotonin Agents|serotonin agents|mesh-ancestor
110792735|NCT03435003|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110792736|NCT03435003|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110792737|NCT03435003|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110792738|NCT03435003|Dopamine Agents|dopamine agents|mesh-ancestor
110792739|NCT03435003|Mydriatics|mydriatics|mesh-ancestor
110792740|NCT03435003|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110792741|NCT03435003|Cholinergic Agents|cholinergic agents|mesh-ancestor
110792742|NCT03435003|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110792743|NCT03435003|Parasympatholytics|parasympatholytics|mesh-ancestor
110792744|NCT03435003|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110792745|NCT03435003|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110792746|NCT03435003|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110792748|NCT01172223|Doxorubicin|doxorubicin|mesh-list
110792749|NCT01172223|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110792750|NCT01172223|Lapatinib|lapatinib|mesh-list
110792751|NCT01172223|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110792752|NCT01172223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110792753|NCT01172223|Tubulin Modulators|tubulin modulators|mesh-ancestor
110792754|NCT01172223|Antimitotic Agents|antimitotic agents|mesh-ancestor
110792755|NCT01172223|Mitosis Modulators|mitosis modulators|mesh-ancestor
110792756|NCT01172223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110792757|NCT01172223|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110792758|NCT01172223|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110792759|NCT01172223|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110792760|NCT01172223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110792761|NCT01172223|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110792762|NCT01173081|Teriparatide|teriparatide|mesh-list
110792763|NCT01173081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110792764|NCT01173081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110792765|NCT01173081|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110792766|NCT03866733|Narcotics|narcotics|mesh-list
110792767|NCT03866733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110792768|NCT03866733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110792769|NCT03866733|Analgesics|analgesics|mesh-ancestor
110792770|NCT03866733|Sensory System Agents|sensory system agents|mesh-ancestor
110792771|NCT03866733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110792772|NCT01168791|Doxorubicin|doxorubicin|mesh-list
110792773|NCT01168791|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110792774|NCT01168791|Isophosphamide mustard|isophosphamide mustard|mesh-list
110792775|NCT01168791|Ifosfamide|ifosfamide|mesh-list
110792776|NCT01168791|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110792777|NCT01168791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110792778|NCT01168791|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110792779|NCT01168791|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110792780|NCT01168791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110792781|NCT01168791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110792782|NCT01168791|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110792783|NCT01168791|Alkylating Agents|alkylating agents|mesh-ancestor
110792784|NCT01284309|Mirabegron|mirabegron|mesh-list
110792785|NCT01284309|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
110792786|NCT01284309|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110792787|NCT01284309|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110792788|NCT01284309|Adrenergic Agents|adrenergic agents|mesh-ancestor
110792789|NCT01284309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110792790|NCT01284309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110792791|NCT01284309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110792792|NCT01284309|Urological Agents|urological agents|mesh-ancestor
110792793|NCT01173237|Pulmonary Surfactants|pulmonary surfactants|mesh-list
110792794|NCT01173237|Respiratory System Agents|respiratory system agents|mesh-ancestor
110792795|NCT01169025|Fentanyl|fentanyl|mesh-list
110792796|NCT01169025|Ketamine|ketamine|mesh-list
110792797|NCT01169025|Analgesics|analgesics|mesh-ancestor
110792798|NCT01169025|Sensory System Agents|sensory system agents|mesh-ancestor
110792799|NCT01169025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110792800|NCT01169025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110792802|NCT01169025|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110792803|NCT01169025|Anesthetics, General|anesthetics, general|mesh-ancestor
110792804|NCT01169025|Anesthetics|anesthetics|mesh-ancestor
110792805|NCT01169025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110792806|NCT01169025|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110792807|NCT01169025|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110792808|NCT01169025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110792809|NCT01169025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110792810|NCT01169025|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110792811|NCT01169025|Narcotics|narcotics|mesh-ancestor
110792812|NCT01169025|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110792813|NCT01582347|Buprenorphine|buprenorphine|mesh-list
110792814|NCT01582347|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
110792815|NCT01582347|Naloxone|naloxone|mesh-list
110792816|NCT01582347|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110792817|NCT01582347|Narcotics|narcotics|mesh-ancestor
110792818|NCT01582347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110792819|NCT01582347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110792820|NCT01582347|Analgesics|analgesics|mesh-ancestor
110792821|NCT01582347|Sensory System Agents|sensory system agents|mesh-ancestor
110792822|NCT01582347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110792823|NCT01582347|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110792824|NCT01336634|Trametinib|trametinib|mesh-list
110792825|NCT01336634|Dabrafenib|dabrafenib|mesh-list
110792826|NCT01336634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110792827|NCT01336634|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110792828|NCT01336634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110792829|NCT01336634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110792830|NCT01284855|Antivenins|antivenins|mesh-list
110792831|NCT01284855|Immunologic Factors|immunologic factors|mesh-ancestor
110792832|NCT01284855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110792833|NCT00785798|Doxorubicin|doxorubicin|mesh-list
110792834|NCT00785798|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110792835|NCT00785798|Vorinostat|vorinostat|mesh-list
110792836|NCT00785798|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110792837|NCT00785798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110792838|NCT00785798|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110792839|NCT00785798|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110792840|NCT00785798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110501650|NCT04045093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110792841|NCT00785798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110792842|NCT00785798|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110792843|NCT01175109|Imatinib Mesylate|imatinib mesylate|mesh-list
110792844|NCT01175109|Panobinostat|panobinostat|mesh-list
110792845|NCT01175109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110792846|NCT01175109|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110792847|NCT01175109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110792848|NCT01175109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110792849|NCT01175109|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110792850|NCT01282515|Clobetasol|clobetasol|mesh-list
110792851|NCT01282515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110792852|NCT01282515|Glucocorticoids|glucocorticoids|mesh-ancestor
110792853|NCT01282515|Hormones|hormones|mesh-ancestor
110792854|NCT01282515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110792855|NCT01282515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110792856|NCT04732910|Ivacaftor|ivacaftor|mesh-list
110792857|NCT04732910|Elexacaftor|elexacaftor|mesh-list
110792858|NCT04732910|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
110792859|NCT04732910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110792860|NCT04732910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110792861|NCT03329846|Nivolumab|nivolumab|mesh-list
110792862|NCT03329846|Linrodostat|linrodostat|mesh-list
110792863|NCT03329846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110792864|NCT03329846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110792865|NCT03329846|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110792866|NCT03329846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110792867|NCT03329846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110792868|NCT04020848|Melatonin|melatonin|mesh-list
110792869|NCT04020848|Antioxidants|antioxidants|mesh-ancestor
110792870|NCT04020848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110792871|NCT04020848|Protective Agents|protective agents|mesh-ancestor
110792872|NCT04020848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110792873|NCT04020848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110792874|NCT01338610|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110792875|NCT01338610|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110792876|NCT01355302|Capecitabine|capecitabine|mesh-list
110792877|NCT01355302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110792878|NCT01355302|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110792879|NCT01355302|Antimetabolites|antimetabolites|mesh-ancestor
110792880|NCT01355302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110792881|NCT01355068|Phenytoin|phenytoin|mesh-list
110792882|NCT01355068|Anticonvulsants|anticonvulsants|mesh-ancestor
110792883|NCT01355068|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110792884|NCT01355068|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110792885|NCT01355068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110792886|NCT01355068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110792887|NCT01355068|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110792888|NCT01355068|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110792889|NCT03562780|Acetaminophen|acetaminophen|mesh-list
110792890|NCT03562780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110792891|NCT03562780|Analgesics|analgesics|mesh-ancestor
110792892|NCT03562780|Sensory System Agents|sensory system agents|mesh-ancestor
110792893|NCT03562780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110792894|NCT03562780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110792895|NCT03562780|Antipyretics|antipyretics|mesh-ancestor
110792896|NCT02259946|Bromides|bromides|mesh-list
110792897|NCT02259946|Tiotropium Bromide|tiotropium bromide|mesh-list
110510506|NCT02789592|GABA Modulators|gaba modulators|mesh-ancestor
110792898|NCT02259946|Olodaterol|olodaterol|mesh-list
110792899|NCT02259946|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110792900|NCT02259946|Autonomic Agents|autonomic agents|mesh-ancestor
110792901|NCT02259946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110792902|NCT02259946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110792903|NCT02259946|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110792904|NCT02259946|Respiratory System Agents|respiratory system agents|mesh-ancestor
110792905|NCT02259946|Parasympatholytics|parasympatholytics|mesh-ancestor
110792906|NCT02259946|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110792907|NCT02259946|Cholinergic Agents|cholinergic agents|mesh-ancestor
110792908|NCT02259946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110792909|NCT02259946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110792910|NCT02259946|Anticonvulsants|anticonvulsants|mesh-ancestor
110792911|NCT03756129|Ketamine|ketamine|mesh-list
110792912|NCT03756129|Analgesics|analgesics|mesh-ancestor
110792913|NCT03756129|Sensory System Agents|sensory system agents|mesh-ancestor
110792914|NCT03756129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110792915|NCT03756129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110792916|NCT03756129|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110792917|NCT03756129|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110792918|NCT03756129|Anesthetics, General|anesthetics, general|mesh-ancestor
110792919|NCT03756129|Anesthetics|anesthetics|mesh-ancestor
110792920|NCT03756129|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110792921|NCT03756129|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110792922|NCT03756129|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110792923|NCT03756129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110792924|NCT03756129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110792925|NCT03863691|Amisulpride|amisulpride|mesh-list
110501717|NCT02612181|Analgesics|analgesics|mesh-ancestor
110792926|NCT03863691|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110792927|NCT03863691|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110792928|NCT03863691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110792929|NCT03863691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110792930|NCT03863691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110792931|NCT03863691|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110792932|NCT03863691|Dopamine Agents|dopamine agents|mesh-ancestor
110792933|NCT03863691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110792934|NCT03863691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110792935|NCT03863691|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110792936|NCT03863691|Antidepressive Agents|antidepressive agents|mesh-ancestor
110792937|NCT02822794|Ribavirin|ribavirin|mesh-list
110792938|NCT02822794|Sofosbuvir|sofosbuvir|mesh-list
110792939|NCT02822794|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
110792940|NCT02822794|Velpatasvir|velpatasvir|mesh-list
110792941|NCT02822794|Antimetabolites|antimetabolites|mesh-ancestor
110792942|NCT02822794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110792943|NCT02822794|Antiviral Agents|antiviral agents|mesh-ancestor
110792944|NCT02822794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110792945|NCT01173315|Vitamins|vitamins|mesh-list
110792946|NCT01173315|Micronutrients|micronutrients|mesh-ancestor
110792947|NCT01173315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110792948|NCT01173549|Canagliflozin|canagliflozin|mesh-list
110792949|NCT01173549|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110792950|NCT01173549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110792951|NCT01173549|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110792952|NCT01173549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110792953|NCT01338298|Aripiprazole|aripiprazole|mesh-list
110792954|NCT01338298|Antidepressive Agents|antidepressive agents|mesh-ancestor
110792955|NCT01338298|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110501735|NCT00642811|Aspirin|aspirin|mesh-list
110792956|NCT01338298|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110792957|NCT01338298|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110792958|NCT01338298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110792959|NCT01338298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110792960|NCT01338298|Dopamine Agonists|dopamine agonists|mesh-ancestor
110792961|NCT01338298|Dopamine Agents|dopamine agents|mesh-ancestor
110792962|NCT01338298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110792963|NCT01338298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110792964|NCT01338298|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110792965|NCT01338298|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110792966|NCT01338298|Serotonin Agents|serotonin agents|mesh-ancestor
110792967|NCT01338298|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110792968|NCT01338298|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110792969|NCT01338298|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110792970|NCT01338298|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110792971|NCT01169415|Dexamethasone|dexamethasone|mesh-list
110792972|NCT01169415|Dexamethasone acetate|dexamethasone acetate|mesh-list
110792974|NCT01169415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110792975|NCT01169415|Antiemetics|antiemetics|mesh-ancestor
110792976|NCT01169415|Autonomic Agents|autonomic agents|mesh-ancestor
110792977|NCT01169415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110792978|NCT01169415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110792979|NCT01169415|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110792980|NCT01169415|Glucocorticoids|glucocorticoids|mesh-ancestor
110792981|NCT01169415|Hormones|hormones|mesh-ancestor
110792982|NCT01169415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110792983|NCT01169415|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110792984|NCT01169415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110792985|NCT01169415|Protease Inhibitors|protease inhibitors|mesh-ancestor
110792986|NCT01169415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110792987|NCT01169415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110792988|NCT01173627|Fentanyl|fentanyl|mesh-list
110792989|NCT01173627|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110792990|NCT01173627|Narcotics|narcotics|mesh-ancestor
110792991|NCT01173627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110792992|NCT01173627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110792993|NCT01173627|Analgesics|analgesics|mesh-ancestor
110792994|NCT01173627|Sensory System Agents|sensory system agents|mesh-ancestor
110792995|NCT01173627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110792996|NCT01173627|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110792997|NCT01173627|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110792998|NCT01173627|Anesthetics, General|anesthetics, general|mesh-ancestor
110792999|NCT01173627|Anesthetics|anesthetics|mesh-ancestor
110793000|NCT01169571|Dexmedetomidine|dexmedetomidine|mesh-list
110793001|NCT01169571|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110793002|NCT01169571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110793003|NCT01169571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110793004|NCT01169571|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110793005|NCT01169571|Analgesics|analgesics|mesh-ancestor
110793006|NCT01169571|Sensory System Agents|sensory system agents|mesh-ancestor
110793007|NCT01169571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110793008|NCT01169571|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110793009|NCT01169571|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110793010|NCT01169571|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110793011|NCT01169571|Adrenergic Agents|adrenergic agents|mesh-ancestor
110793012|NCT01169571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110793013|NCT01169571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110793014|NCT01354132|Acetylcysteine|acetylcysteine|mesh-list
110793015|NCT01354132|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110793016|NCT01354132|Antiviral Agents|antiviral agents|mesh-ancestor
110793017|NCT01354132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110793018|NCT01354132|Expectorants|expectorants|mesh-ancestor
110793019|NCT01354132|Respiratory System Agents|respiratory system agents|mesh-ancestor
110793020|NCT01354132|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110793021|NCT01354132|Antioxidants|antioxidants|mesh-ancestor
110793022|NCT01354132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110793023|NCT01354132|Protective Agents|protective agents|mesh-ancestor
110793024|NCT01354132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110793025|NCT01354132|Antidotes|antidotes|mesh-ancestor
110793026|NCT05707936|Heparin|heparin|mesh-list
110793027|NCT05707936|Anticoagulants|anticoagulants|mesh-ancestor
110793028|NCT05707936|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110793029|NCT05707936|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110793030|NCT05707936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110793031|NCT03863613|Progesterone|progesterone|mesh-list
110793032|NCT03863613|Progestins|progestins|mesh-ancestor
110793033|NCT03863613|Hormones|hormones|mesh-ancestor
110793034|NCT03863613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110793035|NCT03863613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110793036|NCT01372150|Fluoxetine|fluoxetine|mesh-list
110793037|NCT01372150|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
110793038|NCT01372150|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110793039|NCT01372150|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110793040|NCT01372150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110793041|NCT01372150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110793042|NCT01372150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110793043|NCT01372150|Serotonin Agents|serotonin agents|mesh-ancestor
110793044|NCT01372150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110793045|NCT01372150|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110793046|NCT01372150|Antidepressive Agents|antidepressive agents|mesh-ancestor
110793047|NCT01372150|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110793048|NCT01372150|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110793049|NCT01372150|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110793050|NCT01372150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110793051|NCT01372150|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110793052|NCT01285245|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
110793053|NCT01285245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110793054|NCT01175577|Carotenoids|carotenoids|mesh-list
110793055|NCT01175577|Antioxidants|antioxidants|mesh-ancestor
110793056|NCT01175577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110793057|NCT01175577|Protective Agents|protective agents|mesh-ancestor
110793058|NCT01175577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110793059|NCT01175733|Panitumumab|panitumumab|mesh-list
110793060|NCT01175733|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110793061|NCT01175733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110793062|NCT02035930|Dexmedetomidine|dexmedetomidine|mesh-list
110793063|NCT02035930|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110793064|NCT02035930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110793065|NCT02035930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110793066|NCT02035930|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110793067|NCT02035930|Analgesics|analgesics|mesh-ancestor
110793068|NCT02035930|Sensory System Agents|sensory system agents|mesh-ancestor
110793069|NCT02035930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110793070|NCT02035930|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110793071|NCT02035930|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110793072|NCT02035930|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110793073|NCT02035930|Adrenergic Agents|adrenergic agents|mesh-ancestor
110793074|NCT02035930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110793075|NCT02035930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110793076|NCT01173939|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110793077|NCT01173939|Pravastatin|pravastatin|mesh-list
110793078|NCT01173939|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110793079|NCT01173939|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110793080|NCT01173939|Antimetabolites|antimetabolites|mesh-ancestor
110793081|NCT01173939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110793082|NCT01173939|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110793083|NCT01173939|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110793084|NCT01173939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110793085|NCT01174017|Iodine|iodine|mesh-list
110793086|NCT01174017|Cadexomer iodine|cadexomer iodine|mesh-list
110793087|NCT01174017|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110793088|NCT01174017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110793089|NCT01174017|Trace Elements|trace elements|mesh-ancestor
110793090|NCT01174017|Micronutrients|micronutrients|mesh-ancestor
110793091|NCT01174017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110793092|NCT01288131|Cyclosporine|cyclosporine|mesh-list
110793093|NCT01288131|Mycophenolic Acid|mycophenolic acid|mesh-list
110793094|NCT01288131|Cyclophosphamide|cyclophosphamide|mesh-list
110793095|NCT01288131|Cyclosporins|cyclosporins|mesh-list
110793096|NCT01288131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110793097|NCT01288131|Immunologic Factors|immunologic factors|mesh-ancestor
110793098|NCT01288131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110793099|NCT01288131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110793100|NCT01288131|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110793101|NCT01288131|Alkylating Agents|alkylating agents|mesh-ancestor
110793102|NCT01288131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110793103|NCT01288131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110793104|NCT01288131|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110793105|NCT01288131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110793106|NCT01288131|Antifungal Agents|antifungal agents|mesh-ancestor
110793107|NCT01288131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110793108|NCT01288131|Dermatologic Agents|dermatologic agents|mesh-ancestor
110793109|NCT01288131|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110793110|NCT01288131|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110793111|NCT01288131|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110793112|NCT01288131|Antitubercular Agents|antitubercular agents|mesh-ancestor
110793113|NCT01288131|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110793114|NCT02525211|Ropivacaine|ropivacaine|mesh-list
110793115|NCT02525211|Anesthetics, Local|anesthetics, local|mesh-ancestor
110793116|NCT02525211|Anesthetics|anesthetics|mesh-ancestor
110793117|NCT02525211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110793118|NCT02525211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110510732|NCT00913887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110793119|NCT02525211|Sensory System Agents|sensory system agents|mesh-ancestor
110793120|NCT02525211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110793121|NCT03865563|Gemcitabine|gemcitabine|mesh-list
110793122|NCT03865563|Ethiodized Oil|ethiodized oil|mesh-list
110793123|NCT03865563|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110793124|NCT03865563|Antimetabolites|antimetabolites|mesh-ancestor
110793125|NCT03865563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110793126|NCT03865563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110793128|NCT01178151|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110793129|NCT01178151|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110793130|NCT01178151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110793131|NCT01178151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110793132|NCT01178151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110793133|NCT01178151|Immunologic Factors|immunologic factors|mesh-ancestor
110793134|NCT01178151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110793135|NCT01178151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110793136|NCT03862287|Lidocaine|lidocaine|mesh-list
110793137|NCT03862287|Bupivacaine|bupivacaine|mesh-list
110793138|NCT03862287|Anesthetics, Local|anesthetics, local|mesh-ancestor
110793139|NCT03862287|Anesthetics|anesthetics|mesh-ancestor
110793140|NCT03862287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110793141|NCT03862287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110793142|NCT03862287|Sensory System Agents|sensory system agents|mesh-ancestor
110793143|NCT03862287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110793144|NCT03862287|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110793145|NCT03862287|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110793146|NCT03862287|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110793147|NCT03862287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110793148|NCT03862287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110793149|NCT03862053|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110501916|NCT04133948|Ipilimumab|ipilimumab|mesh-list
110793150|NCT03862053|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110793151|NCT01287351|Fluticasone|fluticasone|mesh-list
110793152|NCT01287351|Xhance|xhance|mesh-list
110793153|NCT01287351|Beclomethasone|beclomethasone|mesh-list
110793154|NCT01287351|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110793155|NCT01287351|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110793156|NCT01287351|Autonomic Agents|autonomic agents|mesh-ancestor
110793157|NCT01287351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110793158|NCT01287351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110793159|NCT01287351|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110793160|NCT01287351|Respiratory System Agents|respiratory system agents|mesh-ancestor
110793161|NCT01287351|Dermatologic Agents|dermatologic agents|mesh-ancestor
110793162|NCT01287351|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110793163|NCT01287351|Glucocorticoids|glucocorticoids|mesh-ancestor
110793164|NCT01287351|Hormones|hormones|mesh-ancestor
110793165|NCT01287351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110793166|NCT03864783|Curcumin|curcumin|mesh-list
110793167|NCT03864783|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110793168|NCT03864783|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110793169|NCT03864783|Analgesics|analgesics|mesh-ancestor
110793170|NCT03864783|Sensory System Agents|sensory system agents|mesh-ancestor
110793171|NCT03864783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110793172|NCT03864783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110793173|NCT03864783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110793174|NCT03864783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110793175|NCT03864783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110793176|NCT03864783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110793177|NCT03864783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110793178|NCT01287507|Lactoferrin|lactoferrin|mesh-list
110793179|NCT01287507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110793181|NCT03864705|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110793182|NCT03864705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110793183|NCT01287663|Permethrin|permethrin|mesh-list
110793184|NCT01287663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110793185|NCT01287663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110793186|NCT01176669|Apatinib|apatinib|mesh-list
110793187|NCT01176669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110793188|NCT01176669|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110793189|NCT01176669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110793190|NCT01176669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110793191|NCT01176747|Formoterol Fumarate|formoterol fumarate|mesh-list
110793192|NCT01176747|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110793193|NCT01176747|Autonomic Agents|autonomic agents|mesh-ancestor
110793194|NCT01176747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110793195|NCT01176747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110793196|NCT01176747|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110793197|NCT01176747|Respiratory System Agents|respiratory system agents|mesh-ancestor
110793198|NCT01176747|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110793199|NCT01176747|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110793200|NCT01176747|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110793201|NCT01176747|Adrenergic Agents|adrenergic agents|mesh-ancestor
110793202|NCT01176747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110793203|NCT01176747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110793204|NCT01174953|Finasteride|finasteride|mesh-list
110793205|NCT01174953|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
110793206|NCT01174953|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110793207|NCT01174953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110793208|NCT01174953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110793209|NCT01174953|Hormone Antagonists|hormone antagonists|mesh-ancestor
110793210|NCT01174953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110793211|NCT01174953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110793212|NCT01174953|Urological Agents|urological agents|mesh-ancestor
110793213|NCT01286103|Canagliflozin|canagliflozin|mesh-list
110793214|NCT01286103|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110793215|NCT01286103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110793216|NCT01286103|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110793217|NCT01286103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110793218|NCT01176903|Glycopyrrolate|glycopyrrolate|mesh-list
110793219|NCT01176903|Tiotropium Bromide|tiotropium bromide|mesh-list
110793220|NCT01176903|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110793221|NCT01176903|Autonomic Agents|autonomic agents|mesh-ancestor
110793222|NCT01176903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110793223|NCT01176903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110793224|NCT01176903|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110793225|NCT01176903|Respiratory System Agents|respiratory system agents|mesh-ancestor
110793226|NCT01176903|Parasympatholytics|parasympatholytics|mesh-ancestor
110793227|NCT01176903|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110793228|NCT01176903|Cholinergic Agents|cholinergic agents|mesh-ancestor
110793229|NCT01176903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110793230|NCT01176903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110793231|NCT01176903|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110793232|NCT01176903|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110793233|NCT03863925|Propofol|propofol|mesh-list
110793234|NCT03863925|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110793235|NCT03863925|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110793236|NCT03863925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110793237|NCT03863925|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110793238|NCT03863925|Anesthetics, General|anesthetics, general|mesh-ancestor
110793239|NCT03863925|Anesthetics|anesthetics|mesh-ancestor
110793240|NCT01178697|Triamcinolone|triamcinolone|mesh-list
110793241|NCT01178697|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110793242|NCT01178697|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110793243|NCT01178697|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110793244|NCT01178697|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110793245|NCT01178697|Glucocorticoids|glucocorticoids|mesh-ancestor
110793246|NCT01178697|Hormones|hormones|mesh-ancestor
110793247|NCT01178697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110793248|NCT01178697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110793249|NCT01178697|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110793250|NCT01178697|Immunologic Factors|immunologic factors|mesh-ancestor
110793251|NCT01178697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110793252|NCT01178697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110793253|NCT03329690|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
110793254|NCT03329690|Immunoconjugates|immunoconjugates|mesh-ancestor
110793255|NCT03329690|Immunologic Factors|immunologic factors|mesh-ancestor
110793256|NCT03329690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110793257|NCT03328832|Tranylcypromine|tranylcypromine|mesh-list
110793258|NCT03328832|Rivaroxaban|rivaroxaban|mesh-list
110793259|NCT03328832|Tranexamic Acid|tranexamic acid|mesh-list
110793260|NCT03328832|Thrombin|thrombin|mesh-list
110793261|NCT03328832|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110793262|NCT03328832|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110793263|NCT03328832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110793264|NCT03328832|Hemostatics|hemostatics|mesh-ancestor
110793265|NCT03328832|Coagulants|coagulants|mesh-ancestor
110793266|NCT03328832|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110793267|NCT03328832|Antithrombins|antithrombins|mesh-ancestor
110793268|NCT03328832|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110793269|NCT03328832|Protease Inhibitors|protease inhibitors|mesh-ancestor
110793270|NCT03328832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110793271|NCT03328832|Anticoagulants|anticoagulants|mesh-ancestor
110793272|NCT03328832|Antidepressive Agents|antidepressive agents|mesh-ancestor
110793273|NCT03328832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110793274|NCT03328832|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
110793275|NCT03328832|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110793276|NCT03328832|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110793277|NCT03328832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110793278|NCT03328832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110793279|NCT02820844|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110793280|NCT02820844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110793281|NCT02942576|Warfarin|warfarin|mesh-list
110793282|NCT02942576|Edoxaban|edoxaban|mesh-list
110793283|NCT02942576|Acenocoumarol|acenocoumarol|mesh-list
110793284|NCT02942576|Phenprocoumon|phenprocoumon|mesh-list
110793285|NCT02942576|Fluindione|fluindione|mesh-list
110793286|NCT02942576|Anticoagulants|anticoagulants|mesh-ancestor
110793287|NCT02942576|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110793288|NCT02942576|Antithrombins|antithrombins|mesh-ancestor
110793289|NCT02942576|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110793290|NCT02942576|Protease Inhibitors|protease inhibitors|mesh-ancestor
110793291|NCT02942576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110793292|NCT02942576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110793293|NCT02820298|Bexagliflozin|bexagliflozin|mesh-list
110793294|NCT02820298|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110502073|NCT00817765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110793295|NCT02820298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110793296|NCT02036008|Liver Extracts|liver extracts|mesh-list
110793297|NCT02036008|Hematinics|hematinics|mesh-ancestor
110793298|NCT02819440|Tadalafil|tadalafil|mesh-list
110793299|NCT02819440|Vasodilator Agents|vasodilator agents|mesh-ancestor
110793300|NCT02819440|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110793301|NCT02819440|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110793302|NCT02819440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110793303|NCT02819440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110793304|NCT02819440|Urological Agents|urological agents|mesh-ancestor
110793305|NCT03562468|Niacinamide|niacinamide|mesh-list
110793307|NCT03562468|Nicotinic Acids|nicotinic acids|mesh-list
110793308|NCT03562468|Vitamin B Complex|vitamin b complex|mesh-ancestor
110793309|NCT03562468|Vitamins|vitamins|mesh-ancestor
110793310|NCT03562468|Micronutrients|micronutrients|mesh-ancestor
110793311|NCT03562468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110793312|NCT03562468|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110793313|NCT03562468|Antimetabolites|antimetabolites|mesh-ancestor
110793314|NCT03562468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110793315|NCT03562468|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110793316|NCT03562468|Vasodilator Agents|vasodilator agents|mesh-ancestor
110793317|NCT02036164|Paclitaxel|paclitaxel|mesh-list
110793319|NCT02036164|Carboplatin|carboplatin|mesh-list
110793320|NCT02036164|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110793321|NCT02036164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110793322|NCT02036164|Tubulin Modulators|tubulin modulators|mesh-ancestor
110793323|NCT02036164|Antimitotic Agents|antimitotic agents|mesh-ancestor
110793324|NCT02036164|Mitosis Modulators|mitosis modulators|mesh-ancestor
110793325|NCT02036164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110793326|NCT02818036|Naltrexone|naltrexone|mesh-list
110793327|NCT02818036|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110793328|NCT02818036|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110793329|NCT02818036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110793330|NCT02818036|Sensory System Agents|sensory system agents|mesh-ancestor
110793331|NCT02818036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110793332|NCT01287741|Prednisone|prednisone|mesh-list
110793333|NCT01287741|Cyclophosphamide|cyclophosphamide|mesh-list
110793334|NCT01287741|Rituximab|rituximab|mesh-list
110793335|NCT01287741|Doxorubicin|doxorubicin|mesh-list
110793336|NCT01287741|Vincristine|vincristine|mesh-list
110793338|NCT01287741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110793339|NCT01287741|Immunologic Factors|immunologic factors|mesh-ancestor
110793340|NCT01287741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110793341|NCT01287741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110793342|NCT01287741|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110793343|NCT01287741|Alkylating Agents|alkylating agents|mesh-ancestor
110793344|NCT01287741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110510956|NCT02787018|Dexamethasone|dexamethasone|mesh-list
110793345|NCT01287741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110793346|NCT01287741|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110793347|NCT01287741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110793348|NCT01287741|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110793349|NCT01287741|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110793350|NCT01287741|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110793351|NCT01287741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110793352|NCT01287741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110793353|NCT01287741|Glucocorticoids|glucocorticoids|mesh-ancestor
110793354|NCT01287741|Hormones|hormones|mesh-ancestor
110793355|NCT01287741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110793356|NCT01287741|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110793357|NCT01287741|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110793358|NCT01287741|Tubulin Modulators|tubulin modulators|mesh-ancestor
110793359|NCT01287741|Antimitotic Agents|antimitotic agents|mesh-ancestor
110793360|NCT01287741|Mitosis Modulators|mitosis modulators|mesh-ancestor
110793361|NCT01180959|Bevacizumab|bevacizumab|mesh-list
110793362|NCT01180959|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110793363|NCT01180959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110793364|NCT01180959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110793365|NCT01180959|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110793366|NCT01180959|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110793367|NCT01180959|Growth Substances|growth substances|mesh-ancestor
110793368|NCT01180959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110793369|NCT01180959|Growth Inhibitors|growth inhibitors|mesh-ancestor
110502159|NCT00637910|Tubulin Modulators|tubulin modulators|mesh-ancestor
110793370|NCT01180959|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110793371|NCT01180959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110793372|NCT01180959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110793373|NCT01177371|Cyclosporine|cyclosporine|mesh-list
110793374|NCT01177371|Methylprednisolone|methylprednisolone|mesh-list
110793375|NCT01177371|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110793376|NCT01177371|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110793377|NCT01177371|Prednisolone|prednisolone|mesh-list
110793378|NCT01177371|Prednisolone acetate|prednisolone acetate|mesh-list
110793379|NCT01177371|Cyclophosphamide|cyclophosphamide|mesh-list
110793380|NCT01177371|Busulfan|busulfan|mesh-list
110793381|NCT01177371|Methotrexate|methotrexate|mesh-list
110793382|NCT01177371|Cyclosporins|cyclosporins|mesh-list
110793383|NCT01177371|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110793384|NCT01177371|Prednisolone phosphate|prednisolone phosphate|mesh-list
110793385|NCT01177371|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110793386|NCT01177371|Immunologic Factors|immunologic factors|mesh-ancestor
110793387|NCT01177371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110793388|NCT01177371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110793389|NCT01177371|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110793390|NCT01177371|Alkylating Agents|alkylating agents|mesh-ancestor
110793391|NCT01177371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110118495|NCT01885988|Nebivolol|nebivolol|mesh-list
110793393|NCT01177371|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110793394|NCT01177371|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110793395|NCT01177371|Abortifacient Agents|abortifacient agents|mesh-ancestor
110793396|NCT01177371|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110793397|NCT01177371|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110793398|NCT01177371|Antimetabolites|antimetabolites|mesh-ancestor
110793399|NCT01177371|Dermatologic Agents|dermatologic agents|mesh-ancestor
110793400|NCT01177371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110793401|NCT01177371|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110793402|NCT01177371|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110793403|NCT01177371|Antifungal Agents|antifungal agents|mesh-ancestor
110793404|NCT01177371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110793405|NCT01177371|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110793406|NCT01177371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110793407|NCT01177371|Antiemetics|antiemetics|mesh-ancestor
110793408|NCT01177371|Autonomic Agents|autonomic agents|mesh-ancestor
110793409|NCT01177371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110793410|NCT01177371|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110793411|NCT01177371|Glucocorticoids|glucocorticoids|mesh-ancestor
110793412|NCT01177371|Hormones|hormones|mesh-ancestor
110793413|NCT01177371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110793414|NCT01177371|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110793415|NCT01177371|Protective Agents|protective agents|mesh-ancestor
110793416|NCT01177371|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110793417|NCT01178931|Dydrogesterone|dydrogesterone|mesh-list
110793418|NCT01178931|Progesterone|progesterone|mesh-list
110793419|NCT01178931|Progestins|progestins|mesh-ancestor
110793420|NCT01178931|Hormones|hormones|mesh-ancestor
110793421|NCT01178931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110793422|NCT01178931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110793423|NCT01181115|Interferon beta-1a|interferon beta-1a|mesh-list
110793424|NCT01181115|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110793425|NCT01181115|Immunologic Factors|immunologic factors|mesh-ancestor
110793426|NCT01181115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110793427|NCT01181115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110793428|NCT01181115|Antiviral Agents|antiviral agents|mesh-ancestor
110793429|NCT01181115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110793430|NCT01181193|Vitamin D|vitamin d|mesh-list
110793431|NCT01181193|Cholecalciferol|cholecalciferol|mesh-list
110793432|NCT01181193|Temozolomide|temozolomide|mesh-list
110793433|NCT01181193|Vitamins|vitamins|mesh-ancestor
110793434|NCT01181193|Micronutrients|micronutrients|mesh-ancestor
110793435|NCT01181193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110793436|NCT01181193|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110793437|NCT01181193|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110793438|NCT01181193|Alkylating Agents|alkylating agents|mesh-ancestor
110793439|NCT01181193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110793440|NCT01181193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110793441|NCT01181193|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110793442|NCT01177683|Doxorubicin|doxorubicin|mesh-list
110793443|NCT01177683|Bortezomib|bortezomib|mesh-list
110793444|NCT01177683|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110793445|NCT01177683|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110793446|NCT01177683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110793447|NCT01177683|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110793448|NCT01177683|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110793449|NCT01177683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110793450|NCT01177683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110793451|NCT01177683|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110793452|NCT01177683|Alkylating Agents|alkylating agents|mesh-ancestor
110793453|NCT01181427|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-list
110793454|NCT01181427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110793455|NCT01181427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110793456|NCT03855579|Simendan|simendan|mesh-list
110793457|NCT03855579|Milrinone|milrinone|mesh-list
110793458|NCT03855579|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110793459|NCT03855579|Vasodilator Agents|vasodilator agents|mesh-ancestor
110793460|NCT03855579|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110793461|NCT03855579|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110793462|NCT03855579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110502222|NCT05332106|Dienogest|dienogest|mesh-list
110793463|NCT03855579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110793464|NCT03855579|Protective Agents|protective agents|mesh-ancestor
110793465|NCT03855579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110793466|NCT03855579|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110793467|NCT03855423|Tocotrienols|tocotrienols|mesh-list
110793468|NCT03855423|Vitamin E|vitamin e|mesh-list
110793469|NCT03855423|Tocopherols|tocopherols|mesh-list
110793470|NCT03855423|Tocovid|tocovid|mesh-list
110793471|NCT03855423|Antioxidants|antioxidants|mesh-ancestor
110793472|NCT03855423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110793473|NCT03855423|Protective Agents|protective agents|mesh-ancestor
110793474|NCT03855423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110793475|NCT03855423|Vitamins|vitamins|mesh-ancestor
110793476|NCT03855423|Micronutrients|micronutrients|mesh-ancestor
110793477|NCT01181505|Tolterodine Tartrate|tolterodine tartrate|mesh-list
110793478|NCT01181505|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110793479|NCT01181505|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110793480|NCT01181505|Cholinergic Agents|cholinergic agents|mesh-ancestor
110793481|NCT01181505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110793482|NCT01181505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110793483|NCT01181505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110793484|NCT01181505|Urological Agents|urological agents|mesh-ancestor
110793485|NCT01290783|Irinotecan|irinotecan|mesh-list
110793486|NCT01290783|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110793487|NCT01290783|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110793488|NCT01290783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110793489|NCT01290783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110793490|NCT01290783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110793491|NCT03857763|Paclitaxel|paclitaxel|mesh-list
110793492|NCT03857763|Apatinib|apatinib|mesh-list
110793493|NCT03857763|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110793494|NCT03857763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110793495|NCT03857763|Tubulin Modulators|tubulin modulators|mesh-ancestor
110793496|NCT03857763|Antimitotic Agents|antimitotic agents|mesh-ancestor
110511108|NCT05753865|Paclitaxel|paclitaxel|mesh-list
110793497|NCT03857763|Mitosis Modulators|mitosis modulators|mesh-ancestor
110793498|NCT03857763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110793499|NCT03857763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110793500|NCT03857763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110793501|NCT06008522|Bevacizumab|bevacizumab|mesh-list
110793502|NCT06008522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110793503|NCT06008522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110793504|NCT06008522|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110793505|NCT06008522|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110793506|NCT06008522|Growth Substances|growth substances|mesh-ancestor
110793507|NCT06008522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110793508|NCT06008522|Growth Inhibitors|growth inhibitors|mesh-ancestor
110793509|NCT06008327|Tretinoin|tretinoin|mesh-list
110793510|NCT06008327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110793511|NCT06008327|Keratolytic Agents|keratolytic agents|mesh-ancestor
110793512|NCT06008327|Dermatologic Agents|dermatologic agents|mesh-ancestor
110793513|NCT06008249|Lithium Carbonate|lithium carbonate|mesh-list
110793514|NCT06008249|Antidepressive Agents|antidepressive agents|mesh-ancestor
110793515|NCT06008249|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110793516|NCT06008249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110793517|NCT06008249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110793518|NCT06008249|Antimanic Agents|antimanic agents|mesh-ancestor
110793519|NCT06008249|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110793520|NCT06008249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110793521|NCT06008249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110793523|NCT06008223|Pyridoxal|pyridoxal|mesh-list
110793524|NCT06008223|Pyridoxine|pyridoxine|mesh-list
110793525|NCT06008223|Vitamins|vitamins|mesh-ancestor
110793526|NCT06008223|Micronutrients|micronutrients|mesh-ancestor
110793527|NCT06008223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110793528|NCT06008223|Vitamin B Complex|vitamin b complex|mesh-ancestor
110793529|NCT06008119|Bevacizumab|bevacizumab|mesh-list
110793530|NCT06008119|Cetuximab|cetuximab|mesh-list
110793531|NCT06008119|Vemurafenib|vemurafenib|mesh-list
110793532|NCT06008119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110793533|NCT06008119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110793534|NCT06008119|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110793535|NCT06008119|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110793536|NCT06008119|Growth Substances|growth substances|mesh-ancestor
110793537|NCT06008119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110793538|NCT06008119|Growth Inhibitors|growth inhibitors|mesh-ancestor
110793539|NCT06008119|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110793540|NCT06008119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110793541|NCT06008119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110793542|NCT06008106|Paclitaxel|paclitaxel|mesh-list
110793567|NCT06007937|Ramucirumab|ramucirumab|mesh-list
110793568|NCT06007937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110793591|NCT06007573|Nimodipine|nimodipine|mesh-list
110793592|NCT06007573|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110793593|NCT06007573|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110793594|NCT06007573|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110793595|NCT06007573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110793596|NCT06007573|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110793597|NCT06007573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110793598|NCT06007573|Vasodilator Agents|vasodilator agents|mesh-ancestor
110793602|NCT06007508|Insulin Glargine|insulin glargine|mesh-list
110793603|NCT06007508|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110793604|NCT06007508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110793605|NCT06007352|Gentamicins|gentamicins|mesh-list
110793606|NCT06007352|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110793607|NCT06007352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110793608|NCT06007352|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110793609|NCT06007352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110793610|NCT06007352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110793611|NCT06007222|Aspirin|aspirin|mesh-list
110793612|NCT06007222|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110793613|NCT06007222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110793614|NCT06007222|Analgesics|analgesics|mesh-ancestor
110793615|NCT06007222|Sensory System Agents|sensory system agents|mesh-ancestor
110793616|NCT06007222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110793617|NCT06007222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110793618|NCT06007222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110793620|NCT06007222|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110793621|NCT06007222|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110793622|NCT06007222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110793623|NCT06007222|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110793624|NCT06007222|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110793625|NCT06007222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110793626|NCT06007222|Antipyretics|antipyretics|mesh-ancestor
110793627|NCT06006949|Luspatercept|luspatercept|mesh-list
110793628|NCT06006949|Hematinics|hematinics|mesh-ancestor
110793629|NCT06006923|Pembrolizumab|pembrolizumab|mesh-list
110793630|NCT06006923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110793631|NCT06006923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110793632|NCT06006923|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110793633|NCT06006923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110793634|NCT06006663|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110793635|NCT06006663|Metronidazole|metronidazole|mesh-list
110793637|NCT06006663|Clindamycin|clindamycin|mesh-list
110793638|NCT06006663|Ibuprofen|ibuprofen|mesh-list
110793639|NCT06006663|Curcumin|curcumin|mesh-list
110793640|NCT06006663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110793641|NCT06006663|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110793642|NCT06006663|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110793643|NCT06006663|Analgesics|analgesics|mesh-ancestor
110793644|NCT06006663|Sensory System Agents|sensory system agents|mesh-ancestor
110793645|NCT06006663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110793646|NCT06006663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110793647|NCT06006663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110793648|NCT06006663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110793649|NCT06006663|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110793650|NCT06006663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110793651|NCT06006663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110793652|NCT06006663|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110793653|NCT06006663|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110793654|NCT06006663|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110793655|NCT06006663|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110793656|NCT06006663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110793657|NCT06006663|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110502305|NCT00818155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110793658|NCT06006663|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110793659|NCT06006663|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110793660|NCT06006650|Paclitaxel|paclitaxel|mesh-list
110793661|NCT06006650|Pembrolizumab|pembrolizumab|mesh-list
110793662|NCT06006650|Fluorouracil|fluorouracil|mesh-list
110793663|NCT06006650|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110793664|NCT06006650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110793665|NCT06006650|Tubulin Modulators|tubulin modulators|mesh-ancestor
110793666|NCT06006650|Antimitotic Agents|antimitotic agents|mesh-ancestor
110793667|NCT06006650|Mitosis Modulators|mitosis modulators|mesh-ancestor
110793668|NCT06006650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110793669|NCT06006650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110793670|NCT06006650|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110793671|NCT06006650|Antimetabolites|antimetabolites|mesh-ancestor
110793672|NCT06006650|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110793673|NCT06006650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110793674|NCT06006650|Immunologic Factors|immunologic factors|mesh-ancestor
110793675|NCT06006650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110793676|NCT06006624|Dexamethasone|dexamethasone|mesh-list
110793677|NCT06006624|Bupivacaine|bupivacaine|mesh-list
110793678|NCT06006624|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110793679|NCT06006624|Antiemetics|antiemetics|mesh-ancestor
110793680|NCT06006624|Autonomic Agents|autonomic agents|mesh-ancestor
110793681|NCT06006624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110793682|NCT06006624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110793683|NCT06006624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110793684|NCT06006624|Glucocorticoids|glucocorticoids|mesh-ancestor
110793685|NCT06006624|Hormones|hormones|mesh-ancestor
110793686|NCT06006624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110793687|NCT06006624|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110793688|NCT06006624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110793689|NCT06006624|Anesthetics, Local|anesthetics, local|mesh-ancestor
110793690|NCT06006624|Anesthetics|anesthetics|mesh-ancestor
110793691|NCT06006624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110793692|NCT06006624|Sensory System Agents|sensory system agents|mesh-ancestor
110793693|NCT06006598|Midazolam|midazolam|mesh-list
110793694|NCT06006598|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110793695|NCT06006598|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110793696|NCT06006598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110793697|NCT06006598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110793698|NCT06006598|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110793699|NCT06006598|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110793700|NCT06006598|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110793701|NCT06006598|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110793702|NCT06006598|Anesthetics, General|anesthetics, general|mesh-ancestor
110793703|NCT06006598|Anesthetics|anesthetics|mesh-ancestor
110793704|NCT06006598|GABA Modulators|gaba modulators|mesh-ancestor
110793705|NCT06006598|GABA Agents|gaba agents|mesh-ancestor
110793706|NCT06006598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110793707|NCT06006598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110793708|NCT06006143|Varenicline|varenicline|mesh-list
110793709|NCT06006143|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110793710|NCT06006143|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110793711|NCT06006143|Cholinergic Agents|cholinergic agents|mesh-ancestor
110793712|NCT06006143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110793713|NCT06006143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110793714|NCT06006143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110793730|NCT06006091|Letrozole|letrozole|mesh-list
110793731|NCT06006091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110793732|NCT06006091|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110793733|NCT06006091|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110793734|NCT06006091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110793735|NCT06006091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110793736|NCT06006091|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110793737|NCT06006091|Hormone Antagonists|hormone antagonists|mesh-ancestor
110793738|NCT06006091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110793739|NCT06006091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110793740|NCT06006026|Ropivacaine|ropivacaine|mesh-list
110793741|NCT06006026|Anesthetics, Local|anesthetics, local|mesh-ancestor
110793742|NCT06006026|Anesthetics|anesthetics|mesh-ancestor
110793743|NCT06006026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110793744|NCT06006026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110793745|NCT06006026|Sensory System Agents|sensory system agents|mesh-ancestor
110793746|NCT06006026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110793747|NCT06006013|Atezolizumab|atezolizumab|mesh-list
110793748|NCT06006013|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110793749|NCT06006013|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110793750|NCT06006013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110793751|NCT06006013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110793752|NCT06006013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110793753|NCT06006013|Immunologic Factors|immunologic factors|mesh-ancestor
110793754|NCT06006013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110793755|NCT06005870|Zanubrutinib|zanubrutinib|mesh-list
110793756|NCT06005870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110793757|NCT06005870|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110793758|NCT06005870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110793759|NCT06005870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110793760|NCT06004037|Delpazolid|delpazolid|mesh-list
110793761|NCT06004037|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110793762|NCT06004037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110793763|NCT06004037|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110793764|NCT06004037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110793765|NCT06004037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110793766|NCT06002789|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110793767|NCT06002789|Antibodies|antibodies|mesh-list
110793768|NCT06002789|Immunoglobulins|immunoglobulins|mesh-list
110793769|NCT06002789|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110793770|NCT06002789|Immunologic Factors|immunologic factors|mesh-ancestor
110793771|NCT06002789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110793772|NCT06002789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110793773|NCT06002295|Chlorhexidine|chlorhexidine|mesh-list
110793774|NCT06002295|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110793775|NCT06002295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110793776|NCT06002295|Disinfectants|disinfectants|mesh-ancestor
110793777|NCT06002152|Bupivacaine|bupivacaine|mesh-list
110793778|NCT06002152|Anesthetics, Local|anesthetics, local|mesh-ancestor
110793779|NCT06002152|Anesthetics|anesthetics|mesh-ancestor
110793780|NCT06002152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110793781|NCT06002152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110793782|NCT06002152|Sensory System Agents|sensory system agents|mesh-ancestor
110793783|NCT06002152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110793784|NCT05995457|Haloperidol|haloperidol|mesh-list
110793785|NCT05995457|Haloperidol decanoate|haloperidol decanoate|mesh-list
110793786|NCT05995457|Antiemetics|antiemetics|mesh-ancestor
110793787|NCT05995457|Autonomic Agents|autonomic agents|mesh-ancestor
110653934|NCT00956696|Topiramate|topiramate|mesh-list
110793788|NCT05995457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110793789|NCT05995457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110793790|NCT05995457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110793791|NCT05995457|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110793792|NCT05995457|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110793793|NCT05995457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110793794|NCT05995457|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110793795|NCT05995457|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110793796|NCT05995457|Dopamine Agents|dopamine agents|mesh-ancestor
110793797|NCT05995457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110793798|NCT05995457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110511409|NCT04230330|Dexamethasone|dexamethasone|mesh-list
110793799|NCT05995457|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110793800|NCT05988528|Nifuroxazide|nifuroxazide|mesh-list
110793801|NCT05988528|Mesalamine|mesalamine|mesh-list
110793802|NCT05988528|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110793803|NCT05988528|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110793804|NCT05988528|Analgesics|analgesics|mesh-ancestor
110793805|NCT05988528|Sensory System Agents|sensory system agents|mesh-ancestor
110793806|NCT05988528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110793807|NCT05988528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110793808|NCT05988528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110793809|NCT05988528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110793810|NCT05988528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110793811|NCT05987293|Salicylic Acid|salicylic acid|mesh-list
110793812|NCT05987293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110793813|NCT05987293|Antifungal Agents|antifungal agents|mesh-ancestor
110793814|NCT05987293|Keratolytic Agents|keratolytic agents|mesh-ancestor
110793815|NCT05987293|Dermatologic Agents|dermatologic agents|mesh-ancestor
110793816|NCT05986318|Acetylcysteine|acetylcysteine|mesh-list
110793817|NCT05986318|Dexamethasone|dexamethasone|mesh-list
110793818|NCT05986318|Dexamethasone acetate|dexamethasone acetate|mesh-list
110793819|NCT05986318|BB 1101|bb 1101|mesh-list
110793820|NCT05986318|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110793821|NCT05986318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110793822|NCT05986318|Antiemetics|antiemetics|mesh-ancestor
110793823|NCT05986318|Autonomic Agents|autonomic agents|mesh-ancestor
110793824|NCT05986318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110793825|NCT05986318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110793826|NCT05986318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110793827|NCT05986318|Glucocorticoids|glucocorticoids|mesh-ancestor
110793828|NCT05986318|Hormones|hormones|mesh-ancestor
110793829|NCT05986318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110793830|NCT05986318|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110793831|NCT05986318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110793832|NCT05986318|Protease Inhibitors|protease inhibitors|mesh-ancestor
110793833|NCT05986318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110793834|NCT05986318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110793835|NCT05986318|Antiviral Agents|antiviral agents|mesh-ancestor
110793836|NCT05986318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110793837|NCT05986318|Expectorants|expectorants|mesh-ancestor
110793838|NCT05986318|Respiratory System Agents|respiratory system agents|mesh-ancestor
110793839|NCT05986318|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110793840|NCT05986318|Antioxidants|antioxidants|mesh-ancestor
110793841|NCT05986318|Protective Agents|protective agents|mesh-ancestor
110793842|NCT05986318|Antidotes|antidotes|mesh-ancestor
110793844|NCT05981573|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110793845|NCT05981573|Narcotics|narcotics|mesh-ancestor
110793846|NCT05981573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110793847|NCT05981573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110793848|NCT05981573|Analgesics|analgesics|mesh-ancestor
110793849|NCT05981573|Sensory System Agents|sensory system agents|mesh-ancestor
110793850|NCT05981573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110793851|NCT05981573|Antitussive Agents|antitussive agents|mesh-ancestor
110793852|NCT05981573|Respiratory System Agents|respiratory system agents|mesh-ancestor
110793853|NCT05962957|Pentoxifylline|pentoxifylline|mesh-list
110793855|NCT05962957|Carbidopa|carbidopa|mesh-list
110793856|NCT05962957|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
110793857|NCT05962957|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110793858|NCT05962957|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110793859|NCT05962957|Dopamine Agents|dopamine agents|mesh-ancestor
110793860|NCT05962957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110793861|NCT05962957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110793862|NCT05962957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110793863|NCT05962957|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
110793864|NCT05962957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110793865|NCT05962957|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110793866|NCT05962957|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110793867|NCT05962957|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110793868|NCT05962957|Protective Agents|protective agents|mesh-ancestor
110793869|NCT05962957|Vasodilator Agents|vasodilator agents|mesh-ancestor
110793870|NCT05962957|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110793871|NCT05962957|Antioxidants|antioxidants|mesh-ancestor
110793872|NCT05962957|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110793873|NCT05962957|Immunologic Factors|immunologic factors|mesh-ancestor
110511486|NCT02783040|Anesthetics|anesthetics|mesh-ancestor
110793874|NCT05962957|Dopamine Agonists|dopamine agonists|mesh-ancestor
110793875|NCT05957848|Guanfacine|guanfacine|mesh-list
110793876|NCT05957848|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110793877|NCT05957848|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110793878|NCT05957848|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110793879|NCT05957848|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110793880|NCT05957848|Adrenergic Agents|adrenergic agents|mesh-ancestor
110793881|NCT05957848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110793882|NCT05957848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110793883|NCT05957848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110793884|NCT05928871|Misoprostol|misoprostol|mesh-list
110793885|NCT05928871|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110793886|NCT05928871|Abortifacient Agents|abortifacient agents|mesh-ancestor
110793887|NCT05928871|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110793888|NCT05928871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110793889|NCT05928871|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110793890|NCT05928871|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110793891|NCT05928871|Oxytocics|oxytocics|mesh-ancestor
110793892|NCT05925127|Vaccines|vaccines|mesh-list
110793893|NCT05925127|Immunologic Factors|immunologic factors|mesh-ancestor
110793894|NCT05925127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110793895|NCT05906914|Cytarabine|cytarabine|mesh-list
110793896|NCT05906914|Cladribine|cladribine|mesh-list
110793897|NCT05906914|Homoharringtonine|homoharringtonine|mesh-list
110793898|NCT05906914|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110793899|NCT05906914|Antimetabolites|antimetabolites|mesh-ancestor
110793900|NCT05906914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110793901|NCT05906914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110793902|NCT05906914|Antiviral Agents|antiviral agents|mesh-ancestor
110793903|NCT05906914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110793904|NCT05906914|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110793905|NCT05906914|Immunologic Factors|immunologic factors|mesh-ancestor
110793906|NCT05906914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110793907|NCT05906914|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110793908|NCT05906914|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110793909|NCT05906914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110793910|NCT05902533|Capecitabine|capecitabine|mesh-list
110793911|NCT05902533|Mitomycins|mitomycins|mesh-list
110793912|NCT05902533|Mitomycin|mitomycin|mesh-list
110851367|NCT05255159|Furosemide|furosemide|mesh-list
110793913|NCT05902533|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110793914|NCT05902533|Antimetabolites|antimetabolites|mesh-ancestor
110793915|NCT05902533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110793916|NCT05902533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110793918|NCT05902533|Alkylating Agents|alkylating agents|mesh-ancestor
110793919|NCT05902533|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110793920|NCT05902533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110793921|NCT05892237|Immunomodulating Agents|immunomodulating agents|mesh-list
110793922|NCT05892237|Immunologic Factors|immunologic factors|mesh-ancestor
110793923|NCT05892237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110793924|NCT05864118|Antibodies|antibodies|mesh-list
110793925|NCT05864118|Immunologic Factors|immunologic factors|mesh-ancestor
110793926|NCT05864118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110793927|NCT05855200|Dostarlimab|dostarlimab|mesh-list
110793928|NCT05855200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110793929|NCT05840016|Carboplatin|carboplatin|mesh-list
110793930|NCT05840016|Tislelizumab|tislelizumab|mesh-list
110793931|NCT05840016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110793932|NCT05840016|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110793933|NCT05819541|Albuterol|albuterol|mesh-list
110793934|NCT05819541|Montelukast|montelukast|mesh-list
110793935|NCT05819541|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110793936|NCT05819541|Respiratory System Agents|respiratory system agents|mesh-ancestor
110793937|NCT05819541|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110793938|NCT05819541|Hormone Antagonists|hormone antagonists|mesh-ancestor
110793939|NCT05819541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110793940|NCT05819541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110793941|NCT05819541|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110793942|NCT05819541|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110793943|NCT05819541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110793944|NCT05819541|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110793945|NCT05819541|Autonomic Agents|autonomic agents|mesh-ancestor
110793946|NCT05819541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110793947|NCT05819541|Tocolytic Agents|tocolytic agents|mesh-ancestor
110793948|NCT05819541|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110793949|NCT05819541|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110793950|NCT05819541|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110793951|NCT05819541|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110793952|NCT05819541|Adrenergic Agents|adrenergic agents|mesh-ancestor
110793953|NCT05819541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110793954|NCT05803941|177Lu-PSMA-617|177lu-psma-617|mesh-list
110793955|NCT05803941|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110793956|NCT05803941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110793957|NCT05802264|Amphotericin B|amphotericin b|mesh-list
110793958|NCT05802264|Amebicides|amebicides|mesh-ancestor
110793959|NCT05802264|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110793960|NCT05802264|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110793961|NCT05802264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110793962|NCT05802264|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110793963|NCT05802264|Antifungal Agents|antifungal agents|mesh-ancestor
110793964|NCT05799144|Pembrolizumab|pembrolizumab|mesh-list
110793965|NCT05799144|Vaccines|vaccines|mesh-list
110793966|NCT05799144|Immunologic Factors|immunologic factors|mesh-ancestor
110793967|NCT05799144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110793968|NCT05799144|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110793969|NCT05799144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110793970|NCT05799144|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110793971|NCT05799144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110793972|NCT05797870|Ethiodized Oil|ethiodized oil|mesh-list
110793973|NCT05797870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110793974|NCT05790213|Androgens|androgens|mesh-list
110793975|NCT05790213|Hormones|hormones|mesh-ancestor
110793976|NCT05790213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110793977|NCT05790213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110793978|NCT05777733|Acetylcysteine|acetylcysteine|mesh-list
110793979|NCT05777733|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110793980|NCT05777733|Antidotes|antidotes|mesh-ancestor
110793981|NCT05777733|Protective Agents|protective agents|mesh-ancestor
110793982|NCT05777733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110793983|NCT05777733|Antioxidants|antioxidants|mesh-ancestor
110793984|NCT05777733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110793985|NCT05777733|Antiviral Agents|antiviral agents|mesh-ancestor
110793986|NCT05777733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110793987|NCT05777733|Expectorants|expectorants|mesh-ancestor
110793988|NCT05777733|Respiratory System Agents|respiratory system agents|mesh-ancestor
110793989|NCT05777733|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110793990|NCT05777109|Denosumab|denosumab|mesh-list
110793991|NCT05777109|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110793998|NCT05773365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110794004|NCT05683223|Sertraline|sertraline|mesh-list
110794005|NCT05683223|Antidepressive Agents|antidepressive agents|mesh-ancestor
110794006|NCT05683223|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110794007|NCT05683223|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110794008|NCT05683223|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110794009|NCT05683223|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110794010|NCT05683223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110794011|NCT05683223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110794012|NCT05683223|Serotonin Agents|serotonin agents|mesh-ancestor
110794013|NCT05683223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110794014|NCT05665387|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110794015|NCT05665387|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110794016|NCT05525455|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
110794017|NCT05525455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110794018|NCT05525455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110794019|NCT05525455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110794020|NCT05503030|Nintedanib|nintedanib|mesh-list
110794021|NCT05503030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110794022|NCT05503030|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110794023|NCT05503030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110794024|NCT05503030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110794025|NCT05471609|Levodopa|levodopa|mesh-list
110794026|NCT05471609|Carbidopa|carbidopa|mesh-list
110794027|NCT05471609|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110794028|NCT05471609|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110794029|NCT05471609|Dopamine Agents|dopamine agents|mesh-ancestor
110794030|NCT05471609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110794031|NCT05471609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110794032|NCT05471609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110794033|NCT05471609|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
110794034|NCT05471609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110794035|NCT05410782|Vitamins|vitamins|mesh-list
110794036|NCT05410782|Micronutrients|micronutrients|mesh-ancestor
110794037|NCT05410782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110794038|NCT05383482|Paclitaxel|paclitaxel|mesh-list
110794039|NCT05383482|Docetaxel|docetaxel|mesh-list
110794040|NCT05383482|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110794041|NCT05383482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110794042|NCT05383482|Tubulin Modulators|tubulin modulators|mesh-ancestor
110794043|NCT05383482|Antimitotic Agents|antimitotic agents|mesh-ancestor
110794044|NCT05383482|Mitosis Modulators|mitosis modulators|mesh-ancestor
110851379|NCT04905108|Riboflavin|riboflavin|mesh-list
110794045|NCT05383482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110794046|NCT05372315|Dexamethasone|dexamethasone|mesh-list
110794047|NCT05372315|Dexamethasone acetate|dexamethasone acetate|mesh-list
110794048|NCT05372315|BB 1101|bb 1101|mesh-list
110794049|NCT05372315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110794050|NCT05372315|Antiemetics|antiemetics|mesh-ancestor
110794051|NCT05372315|Autonomic Agents|autonomic agents|mesh-ancestor
110794052|NCT05372315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110794053|NCT05372315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110794054|NCT05372315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110794055|NCT05372315|Glucocorticoids|glucocorticoids|mesh-ancestor
110794056|NCT05372315|Hormones|hormones|mesh-ancestor
110794057|NCT05372315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110794058|NCT05372315|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110794059|NCT05372315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110794060|NCT05372315|Protease Inhibitors|protease inhibitors|mesh-ancestor
110794061|NCT05372315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110794062|NCT05372315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110794063|NCT05359133|Tetrodotoxin|tetrodotoxin|mesh-list
110794064|NCT05359133|Anesthetics, Local|anesthetics, local|mesh-ancestor
110794065|NCT05359133|Anesthetics|anesthetics|mesh-ancestor
110794066|NCT05359133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110794067|NCT05359133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110794068|NCT05359133|Sensory System Agents|sensory system agents|mesh-ancestor
110794069|NCT05359133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110794070|NCT05359133|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110794071|NCT05359133|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110794072|NCT05359133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110794073|NCT05265208|Capecitabine|capecitabine|mesh-list
110794074|NCT05265208|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110794075|NCT05265208|Antimetabolites|antimetabolites|mesh-ancestor
110794076|NCT05265208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110794077|NCT05265208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110794078|NCT05252416|Carboplatin|carboplatin|mesh-list
110794079|NCT05252416|Fulvestrant|fulvestrant|mesh-list
110794080|NCT05252416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110794081|NCT05252416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110794082|NCT05252416|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110794083|NCT05252416|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110794084|NCT05252416|Hormone Antagonists|hormone antagonists|mesh-ancestor
110794085|NCT05252416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110794086|NCT05252416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110794087|NCT05242315|Tacrolimus|tacrolimus|mesh-list
110794088|NCT05242315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110794089|NCT05242315|Immunologic Factors|immunologic factors|mesh-ancestor
110794090|NCT05242315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110794091|NCT05242315|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110794092|NCT05242315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110794093|NCT05242315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110794094|NCT05190770|Triamcinolone|triamcinolone|mesh-list
110794095|NCT05190770|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110794096|NCT05190770|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110794097|NCT05190770|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110794098|NCT05190770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110511713|NCT05340192|Octreotide|octreotide|mesh-list
110794099|NCT05190770|Glucocorticoids|glucocorticoids|mesh-ancestor
110794100|NCT05190770|Hormones|hormones|mesh-ancestor
110851401|NCT01560221|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110794101|NCT05190770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110794102|NCT05190770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110794103|NCT05190770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110794104|NCT05190770|Immunologic Factors|immunologic factors|mesh-ancestor
110794105|NCT05190770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110794106|NCT05190770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110794107|NCT05178862|Fluconazole|fluconazole|mesh-list
110794108|NCT05178862|Caspofungin|caspofungin|mesh-list
110794109|NCT05178862|Micafungin|micafungin|mesh-list
110794110|NCT05178862|Anidulafungin|anidulafungin|mesh-list
110794111|NCT05178862|Ibrexafungerp|ibrexafungerp|mesh-list
110794112|NCT05178862|Echinocandins|echinocandins|mesh-list
110794113|NCT05178862|Antifungal Agents|antifungal agents|mesh-ancestor
110794114|NCT05178862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110794115|NCT05178862|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110794116|NCT05178862|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110794117|NCT05178862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110794118|NCT05178862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110794119|NCT05178862|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110794120|NCT05178862|Hormone Antagonists|hormone antagonists|mesh-ancestor
110794121|NCT05178862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110794122|NCT05178862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110794123|NCT05178862|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110794124|NCT05178862|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110794125|NCT05121883|Edaravone|edaravone|mesh-list
110794126|NCT05121883|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110794127|NCT05121883|Antioxidants|antioxidants|mesh-ancestor
110794128|NCT05121883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110794129|NCT05121883|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110794130|NCT05121883|Protective Agents|protective agents|mesh-ancestor
110794131|NCT05121883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110794132|NCT05104983|Sirolimus|sirolimus|mesh-list
110794133|NCT05104983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110794134|NCT05104983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110794135|NCT05104983|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110794136|NCT05104983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110794137|NCT05104983|Antifungal Agents|antifungal agents|mesh-ancestor
110794138|NCT05104983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110794139|NCT05104983|Immunologic Factors|immunologic factors|mesh-ancestor
110794140|NCT05104983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110794141|NCT05062044|Folic Acid|folic acid|mesh-list
110794142|NCT05062044|Hematinics|hematinics|mesh-ancestor
110794143|NCT05062044|Vitamin B Complex|vitamin b complex|mesh-ancestor
110794144|NCT05062044|Vitamins|vitamins|mesh-ancestor
110794145|NCT05062044|Micronutrients|micronutrients|mesh-ancestor
110794146|NCT05062044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110794147|NCT05030194|Nicotine|nicotine|mesh-list
110794148|NCT05030194|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110794149|NCT05030194|Autonomic Agents|autonomic agents|mesh-ancestor
110794150|NCT05030194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110794151|NCT05030194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110794152|NCT05030194|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110794153|NCT05030194|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110794154|NCT05030194|Cholinergic Agents|cholinergic agents|mesh-ancestor
110794155|NCT05030194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110794156|NCT05030194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110794157|NCT04929028|Fluorouracil|fluorouracil|mesh-list
110794158|NCT04929028|Capecitabine|capecitabine|mesh-list
110794159|NCT04929028|Nivolumab|nivolumab|mesh-list
110794160|NCT04929028|Mitomycins|mitomycins|mesh-list
110794161|NCT04929028|Mitomycin|mitomycin|mesh-list
110794162|NCT04929028|Antimetabolites|antimetabolites|mesh-ancestor
110794163|NCT04929028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110794164|NCT04929028|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110794165|NCT04929028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110794166|NCT04929028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110794167|NCT04929028|Immunologic Factors|immunologic factors|mesh-ancestor
110794168|NCT04929028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110794169|NCT04929028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110794170|NCT04929028|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110794171|NCT04929028|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110794172|NCT04929028|Alkylating Agents|alkylating agents|mesh-ancestor
110794173|NCT04929028|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110794174|NCT04929028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110794175|NCT04914741|Prednisolone|prednisolone|mesh-list
110794176|NCT04914741|Cyclophosphamide|cyclophosphamide|mesh-list
110794177|NCT04914741|Rituximab|rituximab|mesh-list
110794178|NCT04914741|Doxorubicin|doxorubicin|mesh-list
110794179|NCT04914741|Vincristine|vincristine|mesh-list
110794180|NCT04914741|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
110794181|NCT04914741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110794182|NCT04914741|Immunologic Factors|immunologic factors|mesh-ancestor
110794183|NCT04914741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110794184|NCT04914741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110794185|NCT04914741|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110794186|NCT04914741|Alkylating Agents|alkylating agents|mesh-ancestor
110794187|NCT04914741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110794188|NCT04914741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110794189|NCT04914741|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110502682|NCT04044547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110794190|NCT04914741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110794191|NCT04914741|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110794192|NCT04914741|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110794193|NCT04914741|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110794194|NCT04914741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110794195|NCT04914741|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110794196|NCT04914741|Tubulin Modulators|tubulin modulators|mesh-ancestor
110794197|NCT04914741|Antimitotic Agents|antimitotic agents|mesh-ancestor
110794198|NCT04914741|Mitosis Modulators|mitosis modulators|mesh-ancestor
110794199|NCT04914741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110794200|NCT04914741|Glucocorticoids|glucocorticoids|mesh-ancestor
110794201|NCT04914741|Hormones|hormones|mesh-ancestor
110794202|NCT04914741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110794203|NCT04914741|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110794204|NCT04914741|Immunoconjugates|immunoconjugates|mesh-ancestor
110794205|NCT04913675|Sotrovimab|sotrovimab|mesh-list
110794206|NCT04913675|Antiviral Agents|antiviral agents|mesh-ancestor
110794207|NCT04913675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110794208|NCT04862260|Atorvastatin|atorvastatin|mesh-list
110794209|NCT04862260|Ezetimibe|ezetimibe|mesh-list
110794210|NCT04862260|Evolocumab|evolocumab|mesh-list
110794211|NCT04862260|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-list
110794212|NCT04862260|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110794213|NCT04862260|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110794214|NCT04862260|Antimetabolites|antimetabolites|mesh-ancestor
110794215|NCT04862260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110794216|NCT04862260|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110794217|NCT04862260|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110794218|NCT04862260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110794219|NCT04862260|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110794220|NCT04862260|Protease Inhibitors|protease inhibitors|mesh-ancestor
110794221|NCT04862221|Diphenhydramine|diphenhydramine|mesh-list
110794222|NCT04862221|Promethazine|promethazine|mesh-list
110794223|NCT04862221|Methylprednisolone|methylprednisolone|mesh-list
110794224|NCT04862221|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110794225|NCT04862221|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110794226|NCT04862221|Prednisolone|prednisolone|mesh-list
110794227|NCT04862221|Prednisolone acetate|prednisolone acetate|mesh-list
110794228|NCT04862221|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110794229|NCT04862221|Prednisolone phosphate|prednisolone phosphate|mesh-list
110794230|NCT04862221|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110794231|NCT04862221|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110794232|NCT04862221|Antiemetics|antiemetics|mesh-ancestor
110794233|NCT04862221|Autonomic Agents|autonomic agents|mesh-ancestor
110794234|NCT04862221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110794235|NCT04862221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110794236|NCT04862221|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110794237|NCT04862221|Glucocorticoids|glucocorticoids|mesh-ancestor
110794238|NCT04862221|Hormones|hormones|mesh-ancestor
110794239|NCT04862221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110794240|NCT04862221|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110794241|NCT04862221|Protective Agents|protective agents|mesh-ancestor
110794242|NCT04862221|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110794243|NCT04862221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110794244|NCT04862221|Immunologic Factors|immunologic factors|mesh-ancestor
110794245|NCT04862221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110511863|NCT05339646|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110794246|NCT04862221|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110794247|NCT04862221|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110794248|NCT04862221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110794249|NCT04862221|Anesthetics, Local|anesthetics, local|mesh-ancestor
110794250|NCT04862221|Anesthetics|anesthetics|mesh-ancestor
110794251|NCT04862221|Sensory System Agents|sensory system agents|mesh-ancestor
110794252|NCT04862221|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110794253|NCT04862221|Histamine Antagonists|histamine antagonists|mesh-ancestor
110794254|NCT04862221|Histamine Agents|histamine agents|mesh-ancestor
110794255|NCT04862221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110794256|NCT04862221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110794257|NCT04862221|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110794258|NCT04862221|Antipruritics|antipruritics|mesh-ancestor
110794259|NCT04862221|Dermatologic Agents|dermatologic agents|mesh-ancestor
110794260|NCT04821310|Pantoprazole|pantoprazole|mesh-list
110794261|NCT04821310|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110794262|NCT04821310|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110794263|NCT04821310|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110794264|NCT04821310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110794265|NCT04821310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110794267|NCT04795336|Antioxidants|antioxidants|mesh-ancestor
110794268|NCT04795336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110794269|NCT04795336|Protective Agents|protective agents|mesh-ancestor
110794270|NCT04795336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110794271|NCT04795336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110794272|NCT04793958|Cetuximab|cetuximab|mesh-list
110794273|NCT04793958|Adagrasib|adagrasib|mesh-list
110794274|NCT04793958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110794275|NCT04793958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110794276|NCT04788615|Interferons|interferons|mesh-list
110794277|NCT04788615|Interferon-beta|interferon-beta|mesh-list
110794278|NCT04788615|Interferon beta-1a|interferon beta-1a|mesh-list
110794279|NCT04788615|Teriflunomide|teriflunomide|mesh-list
110794280|NCT04788615|Ofatumumab|ofatumumab|mesh-list
110794281|NCT04788615|Glatiramer Acetate|glatiramer acetate|mesh-list
110794282|NCT04788615|Dimethyl Fumarate|dimethyl fumarate|mesh-list
110794283|NCT04788615|(T,G)-A-L|(t,g)-a-l|mesh-list
110794284|NCT04788615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110794285|NCT04788615|Antiviral Agents|antiviral agents|mesh-ancestor
110794286|NCT04788615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110794287|NCT04788615|Immunologic Factors|immunologic factors|mesh-ancestor
110794288|NCT04788615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110794289|NCT04788615|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110794290|NCT04788615|Dermatologic Agents|dermatologic agents|mesh-ancestor
110794291|NCT04788615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110794292|NCT04788615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110794293|NCT04788615|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110794294|NCT04788615|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110794295|NCT04788615|Analgesics|analgesics|mesh-ancestor
110794296|NCT04788615|Sensory System Agents|sensory system agents|mesh-ancestor
110794297|NCT04788615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110794298|NCT04788615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110794300|NCT04739813|Lenalidomide|lenalidomide|mesh-list
110794301|NCT04739813|Venetoclax|venetoclax|mesh-list
110794302|NCT04739813|Obinutuzumab|obinutuzumab|mesh-list
110794303|NCT04739813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110794304|NCT04739813|Glucocorticoids|glucocorticoids|mesh-ancestor
110794305|NCT04739813|Hormones|hormones|mesh-ancestor
110794306|NCT04739813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110794307|NCT04739813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110794308|NCT04739813|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110794309|NCT04739813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110794310|NCT04739813|Immunologic Factors|immunologic factors|mesh-ancestor
110794311|NCT04739813|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110794312|NCT04739813|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110794313|NCT04739813|Growth Substances|growth substances|mesh-ancestor
110794314|NCT04739813|Growth Inhibitors|growth inhibitors|mesh-ancestor
110794315|NCT04739813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110794316|NCT04738318|Dexamethasone|dexamethasone|mesh-list
110794317|NCT04738318|Methylprednisolone|methylprednisolone|mesh-list
110794318|NCT04738318|Glucocorticoids|glucocorticoids|mesh-list
110851428|NCT03340168|Bisphenol A|bisphenol a|mesh-list
110794319|NCT04738318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110794320|NCT04738318|Antiemetics|antiemetics|mesh-ancestor
110794321|NCT04738318|Autonomic Agents|autonomic agents|mesh-ancestor
110794322|NCT04738318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110794323|NCT04738318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110794324|NCT04738318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110511942|NCT02859077|Pemetrexed|pemetrexed|mesh-list
110794325|NCT04738318|Hormones|hormones|mesh-ancestor
110794326|NCT04738318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110794327|NCT04738318|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110794328|NCT04738318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110794329|NCT04738318|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110794330|NCT04738318|Protective Agents|protective agents|mesh-ancestor
110794331|NCT04725032|Propofol|propofol|mesh-list
110794332|NCT04725032|Sevoflurane|sevoflurane|mesh-list
110794333|NCT04725032|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110794334|NCT04725032|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110794335|NCT04725032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110794336|NCT04725032|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110794337|NCT04725032|Anesthetics, General|anesthetics, general|mesh-ancestor
110794338|NCT04725032|Anesthetics|anesthetics|mesh-ancestor
110794339|NCT04725032|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110794340|NCT04725032|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110794341|NCT04699838|Carboplatin|carboplatin|mesh-list
110794342|NCT04699838|Etoposide|etoposide|mesh-list
110794343|NCT04699838|Durvalumab|durvalumab|mesh-list
110794344|NCT04699838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110794345|NCT04699838|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110794346|NCT04699838|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110794347|NCT04699838|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110794348|NCT04699838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110794349|NCT04699838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110794350|NCT04699838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110794351|NCT04686786|PF-06372865|pf-06372865|mesh-list
110794352|NCT04686786|GABA Modulators|gaba modulators|mesh-ancestor
110794353|NCT04686786|GABA Agents|gaba agents|mesh-ancestor
110794354|NCT04686786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110794355|NCT04686786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110794356|NCT04686786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110794357|NCT04678895|Naltrexone|naltrexone|mesh-list
110794358|NCT04678895|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110794359|NCT04678895|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110794360|NCT04678895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110794361|NCT04678895|Sensory System Agents|sensory system agents|mesh-ancestor
110794362|NCT04678895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110794363|NCT04677569|Azithromycin|azithromycin|mesh-list
110794364|NCT04677569|Amikacin|amikacin|mesh-list
110794365|NCT04677569|Ethambutol|ethambutol|mesh-list
110794366|NCT04677569|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110794367|NCT04677569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110794368|NCT04677569|Antitubercular Agents|antitubercular agents|mesh-ancestor
110794369|NCT04648930|Omalizumab|omalizumab|mesh-list
110794370|NCT04648930|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110794371|NCT04648930|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110794372|NCT04648930|Respiratory System Agents|respiratory system agents|mesh-ancestor
110794373|NCT04633148|Cyclophosphamide|cyclophosphamide|mesh-list
110794374|NCT04633148|Fludarabine|fludarabine|mesh-list
110794375|NCT04633148|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110794376|NCT04633148|Immunologic Factors|immunologic factors|mesh-ancestor
110794377|NCT04633148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110794378|NCT04633148|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110794379|NCT04633148|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110794380|NCT04633148|Alkylating Agents|alkylating agents|mesh-ancestor
110794381|NCT04633148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110794382|NCT04633148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110794383|NCT04633148|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110794384|NCT04630730|Gemcitabine|gemcitabine|mesh-list
110794385|NCT04630730|Atezolizumab|atezolizumab|mesh-list
110794386|NCT04630730|BCG Vaccine|bcg vaccine|mesh-list
110794387|NCT04630730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110794388|NCT04630730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110794389|NCT04630730|Antimetabolites|antimetabolites|mesh-ancestor
110794390|NCT04630730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110794391|NCT04630730|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110794392|NCT04630730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110794393|NCT04630730|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110794394|NCT04630730|Immunologic Factors|immunologic factors|mesh-ancestor
110794395|NCT04630730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110794396|NCT04624633|Acalabrutinib|acalabrutinib|mesh-list
110794397|NCT04624633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110794398|NCT04597125|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
110794399|NCT04597125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110794400|NCT04576455|Fulvestrant|fulvestrant|mesh-list
110794401|NCT04576455|Aromatase Inhibitors|aromatase inhibitors|mesh-list
110794402|NCT04576455|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110794403|NCT04576455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110794404|NCT04576455|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110794405|NCT04576455|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110794406|NCT04576455|Hormone Antagonists|hormone antagonists|mesh-ancestor
110794407|NCT04576455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110794408|NCT04576455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110794409|NCT04576455|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110794410|NCT04576455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110794411|NCT04576455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110794412|NCT04565236|Factor VIII|factor viii|mesh-list
110794413|NCT04565236|Coagulants|coagulants|mesh-ancestor
110794414|NCT04550260|Cisplatin|cisplatin|mesh-list
110794415|NCT04550260|Fluorouracil|fluorouracil|mesh-list
110794416|NCT04550260|Capecitabine|capecitabine|mesh-list
110794417|NCT04550260|Durvalumab|durvalumab|mesh-list
110794418|NCT04550260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110794419|NCT04550260|Antimetabolites|antimetabolites|mesh-ancestor
110794420|NCT04550260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110794421|NCT04550260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110794422|NCT04550260|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110794423|NCT04550260|Immunologic Factors|immunologic factors|mesh-ancestor
110794424|NCT04550260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110794425|NCT04550260|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110794426|NCT04501861|Vasopressins|vasopressins|mesh-list
110794427|NCT04501861|Arginine Vasopressin|arginine vasopressin|mesh-list
110794428|NCT04501861|Norepinephrine|norepinephrine|mesh-list
110794429|NCT04501861|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110794430|NCT04501861|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110794431|NCT04501861|Adrenergic Agents|adrenergic agents|mesh-ancestor
110794432|NCT04501861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110794433|NCT04501861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110794434|NCT04501861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110794435|NCT04501861|Sympathomimetics|sympathomimetics|mesh-ancestor
110794436|NCT04501861|Autonomic Agents|autonomic agents|mesh-ancestor
110794437|NCT04501861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110794438|NCT04501861|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110794439|NCT04501861|Hemostatics|hemostatics|mesh-ancestor
110794440|NCT04501861|Coagulants|coagulants|mesh-ancestor
110794441|NCT04501861|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
110794443|NCT04494529|Betamethasone|betamethasone|mesh-list
110794444|NCT04494529|Betamethasone Valerate|betamethasone valerate|mesh-list
110794445|NCT04494529|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
110794446|NCT04494529|Betamethasone benzoate|betamethasone benzoate|mesh-list
110794447|NCT04494529|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
110794448|NCT04494529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110794449|NCT04494529|Glucocorticoids|glucocorticoids|mesh-ancestor
110794450|NCT04494529|Hormones|hormones|mesh-ancestor
110794451|NCT04494529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110502877|NCT00634933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110794452|NCT04494529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110794453|NCT04494529|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110794454|NCT04494529|Respiratory System Agents|respiratory system agents|mesh-ancestor
110794455|NCT04447768|Venetoclax|venetoclax|mesh-list
110794456|NCT04447768|Obinutuzumab|obinutuzumab|mesh-list
110794457|NCT04447768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110794458|NCT04447768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110794459|NCT04442022|Dexamethasone|dexamethasone|mesh-list
110794460|NCT04442022|Rituximab|rituximab|mesh-list
110794461|NCT04442022|Gemcitabine|gemcitabine|mesh-list
110794462|NCT04442022|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110794463|NCT04442022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110794464|NCT04442022|Immunologic Factors|immunologic factors|mesh-ancestor
110794465|NCT04442022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110794466|NCT04442022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110794467|NCT04442022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110794468|NCT04442022|Antiemetics|antiemetics|mesh-ancestor
110794469|NCT04442022|Autonomic Agents|autonomic agents|mesh-ancestor
110794470|NCT04442022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110794471|NCT04442022|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110794472|NCT04442022|Glucocorticoids|glucocorticoids|mesh-ancestor
110794473|NCT04442022|Hormones|hormones|mesh-ancestor
110794474|NCT04442022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110794475|NCT04442022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110794476|NCT04442022|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110794477|NCT04442022|Antimetabolites|antimetabolites|mesh-ancestor
110794478|NCT04442022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110794479|NCT04401774|Nivolumab|nivolumab|mesh-list
110794480|NCT04401774|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110794481|NCT04401774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110794482|NCT04401774|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110794483|NCT04401774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110794484|NCT04356209|Pravastatin|pravastatin|mesh-list
110794485|NCT04356209|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110794486|NCT04356209|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110794487|NCT04356209|Antimetabolites|antimetabolites|mesh-ancestor
110794488|NCT04356209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110794489|NCT04356209|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110794490|NCT04356209|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110794491|NCT04356209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110794492|NCT04346394|Yohimbine|yohimbine|mesh-list
110794493|NCT04346394|Mydriatics|mydriatics|mesh-ancestor
110794494|NCT04346394|Autonomic Agents|autonomic agents|mesh-ancestor
110794495|NCT04346394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110794496|NCT04346394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110794497|NCT04346394|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
110794498|NCT04346394|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110794499|NCT04346394|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110794500|NCT04346394|Adrenergic Agents|adrenergic agents|mesh-ancestor
110794501|NCT04346394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110794502|NCT04346394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110794503|NCT04346394|Urological Agents|urological agents|mesh-ancestor
110794504|NCT04344873|Abatacept|abatacept|mesh-list
110794505|NCT04344873|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110794506|NCT04344873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110794507|NCT04344873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110794508|NCT04344873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110794509|NCT04344873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110794510|NCT04344873|Immunologic Factors|immunologic factors|mesh-ancestor
110794511|NCT04344873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110794512|NCT04344873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110794513|NCT04310397|Trametinib|trametinib|mesh-list
110794514|NCT04310397|Dabrafenib|dabrafenib|mesh-list
110794515|NCT04310397|Spartalizumab|spartalizumab|mesh-list
110794516|NCT04310397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110794517|NCT04310397|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110794518|NCT04310397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110794519|NCT04310397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110794520|NCT04310397|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110794521|NCT04310397|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110794522|NCT04299490|Analgesics|analgesics|mesh-list
110794523|NCT04299490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110794524|NCT04299490|Sensory System Agents|sensory system agents|mesh-ancestor
110794525|NCT04299490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110794526|NCT04299438|Propranolol|propranolol|mesh-list
110794527|NCT04299438|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110794528|NCT04299438|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110794529|NCT04299438|Adrenergic Agents|adrenergic agents|mesh-ancestor
110794530|NCT04299438|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110794531|NCT04299438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110794532|NCT04299438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110794533|NCT04299438|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110794534|NCT04299438|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110794535|NCT04299438|Vasodilator Agents|vasodilator agents|mesh-ancestor
110794536|NCT04265872|Pembrolizumab|pembrolizumab|mesh-list
110794537|NCT04265872|Bortezomib|bortezomib|mesh-list
110794538|NCT04265872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110794539|NCT04265872|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110794540|NCT04265872|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110794541|NCT04265872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110794542|NCT04249362|Durvalumab|durvalumab|mesh-list
110794543|NCT04249362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110794544|NCT04249362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110794545|NCT04245514|Durvalumab|durvalumab|mesh-list
110794546|NCT04245514|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110794547|NCT04245514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110794548|NCT04240821|Theophylline|theophylline|mesh-list
110794549|NCT04240821|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110794550|NCT04240821|Autonomic Agents|autonomic agents|mesh-ancestor
110794551|NCT04240821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110794552|NCT04240821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110794553|NCT04240821|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110512164|NCT02837198|Dotinurad|dotinurad|mesh-list
110794555|NCT04240821|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110794556|NCT04240821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110794557|NCT04240821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110794558|NCT04240821|Vasodilator Agents|vasodilator agents|mesh-ancestor
110794559|NCT04240821|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110794560|NCT04240821|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110794561|NCT04240821|Purinergic Agents|purinergic agents|mesh-ancestor
110794562|NCT04240821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110794563|NCT04214678|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
110794564|NCT04214678|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
110794565|NCT04214678|beta-Endorphin|beta-endorphin|mesh-list
110794566|NCT04214678|Hormones|hormones|mesh-ancestor
110794567|NCT04214678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110794568|NCT04214678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110794569|NCT04214678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110794570|NCT04214678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110794571|NCT04207619|Hypoglycemic Agents|hypoglycemic agents|mesh-list
110794572|NCT04207619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110794573|NCT04196491|Cyclophosphamide|cyclophosphamide|mesh-list
110794574|NCT04196491|Fludarabine|fludarabine|mesh-list
110794575|NCT04196491|Lenalidomide|lenalidomide|mesh-list
110794576|NCT04196491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110794577|NCT04196491|Immunologic Factors|immunologic factors|mesh-ancestor
110794578|NCT04196491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110794579|NCT04196491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110794580|NCT04196491|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110794581|NCT04196491|Alkylating Agents|alkylating agents|mesh-ancestor
110794582|NCT04196491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110794583|NCT04196491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110794584|NCT04196491|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110794585|NCT04196491|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110794586|NCT04196491|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110794587|NCT04196491|Growth Substances|growth substances|mesh-ancestor
110794593|NCT04165967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110794595|NCT04064359|Immunoconjugates|immunoconjugates|mesh-list
110794596|NCT04064359|Immunologic Factors|immunologic factors|mesh-ancestor
110794597|NCT04064359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110794598|NCT04044859|Pembrolizumab|pembrolizumab|mesh-list
110794599|NCT04044859|Nivolumab|nivolumab|mesh-list
110794600|NCT04044859|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110794601|NCT04044859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110794602|NCT04044859|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110794603|NCT04044859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110794604|NCT04007224|Oxytocin|oxytocin|mesh-list
110794605|NCT04007224|Oxytocics|oxytocics|mesh-ancestor
110794606|NCT04007224|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110794607|NCT04007224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110794608|NCT03995628|Dexamethasone|dexamethasone|mesh-list
110794609|NCT03995628|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110794610|NCT03995628|Antiemetics|antiemetics|mesh-ancestor
110794611|NCT03995628|Autonomic Agents|autonomic agents|mesh-ancestor
110794612|NCT03995628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110794613|NCT03995628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110794614|NCT03995628|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110794615|NCT03995628|Glucocorticoids|glucocorticoids|mesh-ancestor
110794616|NCT03995628|Hormones|hormones|mesh-ancestor
110794617|NCT03995628|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110794618|NCT03995628|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110794619|NCT03995628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110794620|NCT03923556|Neostigmine|neostigmine|mesh-list
110794621|NCT03923556|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110794622|NCT03923556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110794623|NCT03923556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110794624|NCT03923556|Cholinergic Agents|cholinergic agents|mesh-ancestor
110794625|NCT03923556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110512231|NCT04250246|Guadecitabine|guadecitabine|mesh-list
110794626|NCT03923556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110794627|NCT03923556|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110794628|NCT03923556|Autonomic Agents|autonomic agents|mesh-ancestor
110794629|NCT03923556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110794630|NCT03913247|Metronidazole|metronidazole|mesh-list
110794631|NCT03913247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110794632|NCT03913247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110794633|NCT03913247|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110794634|NCT03913247|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110794635|NCT03816982|Bupivacaine|bupivacaine|mesh-list
110794636|NCT03816982|Anesthetics, Local|anesthetics, local|mesh-ancestor
110794637|NCT03816982|Anesthetics|anesthetics|mesh-ancestor
110794638|NCT03816982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110794639|NCT03816982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110794640|NCT03816982|Sensory System Agents|sensory system agents|mesh-ancestor
110794641|NCT03816982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110794642|NCT03816397|Adalimumab|adalimumab|mesh-list
110794643|NCT03816397|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110794644|NCT03816397|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110794645|NCT03816397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110794646|NCT03751436|Venetoclax|venetoclax|mesh-list
110794647|NCT03751436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110794648|NCT03736629|Azithromycin|azithromycin|mesh-list
110794649|NCT03736629|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110794650|NCT03736629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110794657|NCT03686124|Nivolumab|nivolumab|mesh-list
110794658|NCT03686124|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110794659|NCT03686124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110794660|NCT03686124|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110794661|NCT03686124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110794662|NCT03681639|Cobalt|cobalt|mesh-list
110794663|NCT03681639|Chromium|chromium|mesh-list
110794664|NCT03681639|Trace Elements|trace elements|mesh-ancestor
110794665|NCT03681639|Micronutrients|micronutrients|mesh-ancestor
110794666|NCT03681639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110794667|NCT03645928|Pembrolizumab|pembrolizumab|mesh-list
110794668|NCT03645928|Nivolumab|nivolumab|mesh-list
110794669|NCT03645928|Ipilimumab|ipilimumab|mesh-list
110794670|NCT03645928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110794671|NCT03645928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110794672|NCT03645928|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110794673|NCT03645928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110794674|NCT03482115|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
110794675|NCT03482115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110794676|NCT03476798|Bevacizumab|bevacizumab|mesh-list
110794677|NCT03476798|Rucaparib|rucaparib|mesh-list
110794678|NCT03476798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110794679|NCT03476798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110794680|NCT03476798|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110794681|NCT03476798|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110794682|NCT03476798|Growth Substances|growth substances|mesh-ancestor
110794683|NCT03476798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110794684|NCT03476798|Growth Inhibitors|growth inhibitors|mesh-ancestor
110794685|NCT03476798|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110794686|NCT03476798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110794687|NCT03476798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110794688|NCT03453632|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110794689|NCT03453632|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110794690|NCT03453632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110794691|NCT03453632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110794692|NCT03453632|Cholinergic Agents|cholinergic agents|mesh-ancestor
110794693|NCT03453632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110794694|NCT03453632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110794695|NCT03351348|Bupivacaine|bupivacaine|mesh-list
110794696|NCT03351348|Anesthetics, Local|anesthetics, local|mesh-ancestor
110794697|NCT03351348|Anesthetics|anesthetics|mesh-ancestor
110794698|NCT03351348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110794699|NCT03351348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110794700|NCT03351348|Sensory System Agents|sensory system agents|mesh-ancestor
110512308|NCT02232737|Nicotine|nicotine|mesh-list
110794701|NCT03351348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110794702|NCT03217201|Methamphetamine|methamphetamine|mesh-list
110794703|NCT03217201|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110794704|NCT03217201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110794705|NCT03217201|Sympathomimetics|sympathomimetics|mesh-ancestor
110794706|NCT03217201|Autonomic Agents|autonomic agents|mesh-ancestor
110794707|NCT03217201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110794708|NCT03217201|Dopamine Agents|dopamine agents|mesh-ancestor
110794709|NCT03217201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110794710|NCT03217201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110794711|NCT03217201|Adrenergic Agents|adrenergic agents|mesh-ancestor
110794712|NCT03217201|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110794713|NCT03217201|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110503217|NCT00623779|Antipyretics|antipyretics|mesh-ancestor
110794714|NCT03217201|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110794715|NCT03217201|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110794716|NCT03199053|Dapagliflozin|dapagliflozin|mesh-list
110794717|NCT03199053|Saxagliptin|saxagliptin|mesh-list
110851483|NCT02500498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110794718|NCT03199053|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110794719|NCT03199053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110794720|NCT03199053|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110794721|NCT03199053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110794722|NCT03199053|Incretins|incretins|mesh-ancestor
110794723|NCT03199053|Hormones|hormones|mesh-ancestor
110794724|NCT03199053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110794725|NCT03199053|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110794726|NCT03199053|Protease Inhibitors|protease inhibitors|mesh-ancestor
110794727|NCT03199053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110794728|NCT03029429|Theophylline|theophylline|mesh-list
110794729|NCT03029429|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110794730|NCT03029429|Autonomic Agents|autonomic agents|mesh-ancestor
110794731|NCT03029429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110794732|NCT03029429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110794733|NCT03029429|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110794734|NCT03029429|Respiratory System Agents|respiratory system agents|mesh-ancestor
110794735|NCT03029429|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110794736|NCT03029429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110794737|NCT03029429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110794738|NCT03029429|Vasodilator Agents|vasodilator agents|mesh-ancestor
110794739|NCT03029429|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110794740|NCT03029429|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110794741|NCT03029429|Purinergic Agents|purinergic agents|mesh-ancestor
110794742|NCT03029429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110794744|NCT03012529|Rifampin|rifampin|mesh-list
110794745|NCT03012529|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110794746|NCT03012529|Antitubercular Agents|antitubercular agents|mesh-ancestor
110794747|NCT03012529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110794748|NCT03012529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110794749|NCT03012529|Leprostatic Agents|leprostatic agents|mesh-ancestor
110794750|NCT03012529|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110794751|NCT03012529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110794752|NCT03012529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110794753|NCT03012529|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110794754|NCT03012529|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110794755|NCT03012529|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110794756|NCT03012529|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110794757|NCT03012529|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110794758|NCT03012529|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110794759|NCT03012529|Vitamin B Complex|vitamin b complex|mesh-ancestor
110794760|NCT03012529|Vitamins|vitamins|mesh-ancestor
110794761|NCT03012529|Micronutrients|micronutrients|mesh-ancestor
110794762|NCT03012529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110794763|NCT03012529|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110794764|NCT03012529|Dermatologic Agents|dermatologic agents|mesh-ancestor
110794765|NCT02959463|Pembrolizumab|pembrolizumab|mesh-list
110794766|NCT02959463|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110794767|NCT02959463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110794768|NCT02959463|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110794769|NCT02959463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110794770|NCT02830594|Pembrolizumab|pembrolizumab|mesh-list
110794771|NCT02830594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110794772|NCT02830594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110794773|NCT02830594|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110794774|NCT02830594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110794775|NCT02754765|Moxifloxacin|moxifloxacin|mesh-list
110794776|NCT02754765|Levofloxacin|levofloxacin|mesh-list
110794778|NCT02754765|Pyrazinamide|pyrazinamide|mesh-list
110794779|NCT02754765|Bedaquiline|bedaquiline|mesh-list
110794780|NCT02754765|Clofazimine|clofazimine|mesh-list
110794781|NCT02754765|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110794782|NCT02754765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110794783|NCT02754765|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110794784|NCT02754765|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110794785|NCT02754765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110794786|NCT02754765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110794787|NCT02754765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110794788|NCT02754765|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110851492|NCT02500108|Dopamine Agents|dopamine agents|mesh-ancestor
110794789|NCT02754765|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110794790|NCT02754765|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110794791|NCT02754765|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110794792|NCT02754765|Antitubercular Agents|antitubercular agents|mesh-ancestor
110794793|NCT02754765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110794794|NCT02754765|Leprostatic Agents|leprostatic agents|mesh-ancestor
110794795|NCT02620007|Ciprofloxacin|ciprofloxacin|mesh-list
110794796|NCT02620007|Rifaximin|rifaximin|mesh-list
110794797|NCT02620007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110794798|NCT02620007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110794799|NCT02620007|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110794800|NCT02620007|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110794801|NCT02620007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110794802|NCT02620007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110794803|NCT02620007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110794804|NCT02620007|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110794805|NCT02620007|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110794806|NCT02620007|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110794807|NCT02586623|Droxidopa|droxidopa|mesh-list
110794808|NCT02586623|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110119913|NCT01901861|Incretins|incretins|mesh-ancestor
110794809|NCT02586623|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110794811|NCT02537613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110794812|NCT02537613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110794813|NCT01622543|Leucovorin|leucovorin|mesh-list
110794814|NCT01622543|Bevacizumab|bevacizumab|mesh-list
110794815|NCT01622543|Fluorouracil|fluorouracil|mesh-list
110794816|NCT01622543|Oxaliplatin|oxaliplatin|mesh-list
110794817|NCT01622543|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110794818|NCT01622543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110794819|NCT01622543|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110794820|NCT01622543|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110794821|NCT01622543|Growth Substances|growth substances|mesh-ancestor
110794822|NCT01622543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110794823|NCT01622543|Growth Inhibitors|growth inhibitors|mesh-ancestor
110794824|NCT01622543|Antimetabolites|antimetabolites|mesh-ancestor
110794825|NCT01622543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110794826|NCT01622543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110794827|NCT01622543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110794828|NCT01622543|Immunologic Factors|immunologic factors|mesh-ancestor
110794829|NCT01622543|Antidotes|antidotes|mesh-ancestor
110794830|NCT01622543|Protective Agents|protective agents|mesh-ancestor
110794831|NCT01622543|Vitamin B Complex|vitamin b complex|mesh-ancestor
110794832|NCT01622543|Vitamins|vitamins|mesh-ancestor
110794833|NCT01622543|Micronutrients|micronutrients|mesh-ancestor
110794834|NCT01618357|Veliparib|veliparib|mesh-list
110794835|NCT01618357|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110794836|NCT01618357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110794837|NCT01618357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110794838|NCT01618357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110794839|NCT01176006|Cyclophosphamide|cyclophosphamide|mesh-list
110794840|NCT01176006|Busulfan|busulfan|mesh-list
110794841|NCT01176006|Fludarabine|fludarabine|mesh-list
110794842|NCT01176006|Fludarabine phosphate|fludarabine phosphate|mesh-list
110794843|NCT01176006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110794844|NCT01176006|Immunologic Factors|immunologic factors|mesh-ancestor
110794845|NCT01176006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110794846|NCT01176006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110794847|NCT01176006|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110794848|NCT01176006|Alkylating Agents|alkylating agents|mesh-ancestor
110794849|NCT01176006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110794850|NCT01176006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110794851|NCT01176006|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110794852|NCT01176006|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110794853|NCT01176006|Antimetabolites|antimetabolites|mesh-ancestor
110794854|NCT00882193|Ribavirin|ribavirin|mesh-list
110794855|NCT00882193|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110794856|NCT00882193|Betaine|betaine|mesh-list
110794857|NCT00882193|Antimetabolites|antimetabolites|mesh-ancestor
110794858|NCT00882193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110794859|NCT00882193|Antiviral Agents|antiviral agents|mesh-ancestor
110794860|NCT00882193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110794861|NCT00882193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110794862|NCT00882193|Lipotropic Agents|lipotropic agents|mesh-ancestor
110794863|NCT00882193|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110794864|NCT00882193|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110794865|NCT00662740|Tiotropium Bromide|tiotropium bromide|mesh-list
110794866|NCT00662740|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110794867|NCT00662740|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110794868|NCT00662740|Autonomic Agents|autonomic agents|mesh-ancestor
110794869|NCT00662740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110794870|NCT00662740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110794871|NCT00662740|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110794872|NCT00662740|Respiratory System Agents|respiratory system agents|mesh-ancestor
110794873|NCT00662740|Parasympatholytics|parasympatholytics|mesh-ancestor
110794874|NCT00662740|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110794875|NCT00662740|Cholinergic Agents|cholinergic agents|mesh-ancestor
110794876|NCT00662740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110794877|NCT00662740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110794878|NCT00662740|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110794879|NCT00662740|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110794880|NCT00662740|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110794881|NCT00662740|Adrenergic Agents|adrenergic agents|mesh-ancestor
110794882|NCT00451815|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3H-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3h-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|mesh-list
110445952|NCT02769910|Antipruritics|antipruritics|mesh-ancestor
110794883|NCT00451815|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
110794884|NCT00451815|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110794885|NCT00451815|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110794886|NCT00451815|Purinergic Agents|purinergic agents|mesh-ancestor
110794887|NCT00451815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110794888|NCT00451815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110794889|NCT00451815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110794891|NCT00233662|Dermatologic Agents|dermatologic agents|mesh-ancestor
110794892|NCT00233662|Immunologic Factors|immunologic factors|mesh-ancestor
110794893|NCT00233662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110794894|NCT00078949|Cytarabine|cytarabine|mesh-list
110794895|NCT00078949|Dexamethasone|dexamethasone|mesh-list
110794896|NCT00078949|Rituximab|rituximab|mesh-list
110794897|NCT00078949|Gemcitabine|gemcitabine|mesh-list
110794898|NCT00078949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110794899|NCT00078949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110794900|NCT00078949|Immunologic Factors|immunologic factors|mesh-ancestor
110794901|NCT00078949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110794902|NCT00078949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110794903|NCT00078949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110794904|NCT00078949|Antiemetics|antiemetics|mesh-ancestor
110794905|NCT00078949|Autonomic Agents|autonomic agents|mesh-ancestor
110794906|NCT00078949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110794907|NCT00078949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110794908|NCT00078949|Glucocorticoids|glucocorticoids|mesh-ancestor
110794909|NCT00078949|Hormones|hormones|mesh-ancestor
110794910|NCT00078949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110794911|NCT00078949|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110794912|NCT00078949|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110794913|NCT00078949|Antimetabolites|antimetabolites|mesh-ancestor
110503371|NCT02844530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110794914|NCT00078949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110794915|NCT00078949|Antiviral Agents|antiviral agents|mesh-ancestor
110794916|NCT00078949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110794917|NCT00078949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110794918|NCT01289769|Dexmedetomidine|dexmedetomidine|mesh-list
110794919|NCT01289769|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110794920|NCT01289769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110794921|NCT01289769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110794922|NCT01289769|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110794923|NCT01289769|Analgesics|analgesics|mesh-ancestor
110794924|NCT01289769|Sensory System Agents|sensory system agents|mesh-ancestor
110794925|NCT01289769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110794926|NCT01289769|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110794927|NCT01289769|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110794928|NCT01289769|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110794929|NCT01289769|Adrenergic Agents|adrenergic agents|mesh-ancestor
110794930|NCT01289769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110794931|NCT01289769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110794933|NCT01185015|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110794934|NCT01185015|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110794935|NCT01185015|Vasodilator Agents|vasodilator agents|mesh-ancestor
110794936|NCT01185015|Vitamin B Complex|vitamin b complex|mesh-ancestor
110794937|NCT01185015|Vitamins|vitamins|mesh-ancestor
110794938|NCT01185015|Micronutrients|micronutrients|mesh-ancestor
110794939|NCT01185015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110794940|NCT01289925|Selenium|selenium|mesh-list
110794941|NCT01289925|Antioxidants|antioxidants|mesh-ancestor
110794942|NCT01289925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110794943|NCT01289925|Protective Agents|protective agents|mesh-ancestor
110794944|NCT01289925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110794945|NCT01289925|Trace Elements|trace elements|mesh-ancestor
110794946|NCT01289925|Micronutrients|micronutrients|mesh-ancestor
110794947|NCT01290939|Bevacizumab|bevacizumab|mesh-list
110794948|NCT01290939|Lomustine|lomustine|mesh-list
110794949|NCT01290939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110794950|NCT01290939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110794951|NCT01290939|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110794952|NCT01290939|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110794953|NCT01290939|Growth Substances|growth substances|mesh-ancestor
110794954|NCT01290939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110794955|NCT01290939|Growth Inhibitors|growth inhibitors|mesh-ancestor
110794956|NCT01290939|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110794957|NCT01290939|Alkylating Agents|alkylating agents|mesh-ancestor
110794958|NCT01290939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110794959|NCT01288755|Raltegravir Potassium|raltegravir potassium|mesh-list
110794960|NCT01288755|Rilpivirine|rilpivirine|mesh-list
110794961|NCT01288755|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110794962|NCT01288755|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110794963|NCT01288755|Antiviral Agents|antiviral agents|mesh-ancestor
110794964|NCT01288755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110794965|NCT01288755|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110794966|NCT01288755|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110794967|NCT01288755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110794968|NCT01288755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110794969|NCT01288755|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110794970|NCT01288755|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110794971|NCT01290003|Tazobactam|tazobactam|mesh-list
110794972|NCT01290003|Piperacillin|piperacillin|mesh-list
110794973|NCT01290003|Amikacin|amikacin|mesh-list
110794974|NCT01290003|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
110794975|NCT01290003|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110503489|NCT05337332|Hormones|hormones|mesh-ancestor
110794976|NCT01290003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110794977|NCT01290003|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110794978|NCT01290003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110794979|NCT01290003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110794980|NCT01291095|Cisplatin|cisplatin|mesh-list
110794981|NCT01291095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110794982|NCT03739203|Cariprazine|cariprazine|mesh-list
110794983|NCT03739203|Antidepressive Agents|antidepressive agents|mesh-list
110794984|NCT03739203|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110794985|NCT03739203|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110794986|NCT03739203|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110794987|NCT03739203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110794988|NCT03739203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110794989|NCT01185405|Voriconazole|voriconazole|mesh-list
110794990|NCT01185405|Antifungal Agents|antifungal agents|mesh-ancestor
110794991|NCT01185405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110794992|NCT01185405|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110794993|NCT01185405|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110794994|NCT01185405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110794995|NCT01185405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110794996|NCT01185405|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110794997|NCT01185405|Hormone Antagonists|hormone antagonists|mesh-ancestor
110794998|NCT01185405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110794999|NCT01185405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110795000|NCT01185405|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110795001|NCT01182129|Nicotine|nicotine|mesh-list
110795002|NCT01182129|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110795003|NCT01182129|Autonomic Agents|autonomic agents|mesh-ancestor
110795004|NCT01182129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110795005|NCT01182129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110795006|NCT01182129|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110795007|NCT01182129|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110795008|NCT01182129|Cholinergic Agents|cholinergic agents|mesh-ancestor
110795009|NCT01182129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110795010|NCT01182129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110795011|NCT01587729|Antidepressive Agents|antidepressive agents|mesh-list
110795012|NCT01587729|Serotonin|serotonin|mesh-list
110795013|NCT01587729|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
110795014|NCT01587729|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110795015|NCT01587729|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110795016|NCT01587729|Serotonin Agents|serotonin agents|mesh-ancestor
110795017|NCT01587729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110795018|NCT01587729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110795019|NCT01587729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110795020|NCT01587729|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110795021|NCT01587729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110795022|NCT03855267|Propofol|propofol|mesh-list
110795023|NCT03855267|Etomidate|etomidate|mesh-list
110795024|NCT03855267|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110795025|NCT03855267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110795026|NCT03855267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110795027|NCT03855267|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110795028|NCT03855267|Anesthetics, General|anesthetics, general|mesh-ancestor
110795029|NCT03855267|Anesthetics|anesthetics|mesh-ancestor
110795030|NCT01185873|Ritonavir|ritonavir|mesh-list
110795031|NCT01185873|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110795032|NCT01185873|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110795033|NCT01185873|Protease Inhibitors|protease inhibitors|mesh-ancestor
110795034|NCT01185873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110795035|NCT01185873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110795036|NCT01185873|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110795037|NCT01185873|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110795038|NCT01185873|Antiviral Agents|antiviral agents|mesh-ancestor
110795039|NCT01185873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110795040|NCT01185873|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110795041|NCT01185873|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110795042|NCT01182597|Pantoprazole|pantoprazole|mesh-list
110795043|NCT01182597|Lansoprazole|lansoprazole|mesh-list
110795044|NCT01182597|Dexlansoprazole|dexlansoprazole|mesh-list
110795045|NCT01182597|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110795046|NCT01182597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110795047|NCT01182597|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110795048|NCT01182597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110795049|NCT01182597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110795050|NCT01185951|Polidocanol|polidocanol|mesh-list
110503574|NCT02845388|Estradiol|estradiol|mesh-list
110795051|NCT01185951|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
110795052|NCT01185951|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110795053|NCT01587807|Dimercaprol|dimercaprol|mesh-list
110795054|NCT01587807|Chelating Agents|chelating agents|mesh-ancestor
110795055|NCT01587807|Sequestering Agents|sequestering agents|mesh-ancestor
110795056|NCT01587807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110795057|NCT01186185|Fludrocortisone|fludrocortisone|mesh-list
110795058|NCT01186185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110795059|NCT01180179|Lansoprazole|lansoprazole|mesh-list
110795060|NCT01180179|Dexlansoprazole|dexlansoprazole|mesh-list
110795061|NCT01180179|Famotidine|famotidine|mesh-list
110795062|NCT01180179|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110795063|NCT01180179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110795064|NCT01180179|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110795065|NCT01180179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110795066|NCT01180179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110795067|NCT01180179|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110795068|NCT01180179|Histamine Antagonists|histamine antagonists|mesh-ancestor
110795069|NCT01180179|Histamine Agents|histamine agents|mesh-ancestor
110795070|NCT01180179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110795071|NCT01180179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110795072|NCT01289223|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110795073|NCT01289223|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110795074|NCT01289223|Alkylating Agents|alkylating agents|mesh-ancestor
110795075|NCT01289223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110795076|NCT01289223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110795077|NCT01186497|Rabeprazole|rabeprazole|mesh-list
110795078|NCT01186497|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110795079|NCT01186497|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110795080|NCT01186497|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110795081|NCT01186497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110795082|NCT01186497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110795083|NCT03854409|Aripiprazole|aripiprazole|mesh-list
110795084|NCT03854409|Antidepressive Agents|antidepressive agents|mesh-ancestor
110795085|NCT03854409|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110795086|NCT03854409|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110795087|NCT03854409|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110795088|NCT03854409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110795089|NCT03854409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110795090|NCT03854409|Dopamine Agonists|dopamine agonists|mesh-ancestor
110795091|NCT03854409|Dopamine Agents|dopamine agents|mesh-ancestor
110795092|NCT03854409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110795093|NCT03854409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110795094|NCT03854409|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110795095|NCT03854409|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110795096|NCT03854409|Serotonin Agents|serotonin agents|mesh-ancestor
110795097|NCT03854409|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110795098|NCT03854409|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110795099|NCT03854409|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110795100|NCT03854409|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110795101|NCT01186653|Fluticasone|fluticasone|mesh-list
110795102|NCT01186653|Budesonide|budesonide|mesh-list
110795103|NCT01186653|Formoterol Fumarate|formoterol fumarate|mesh-list
110795104|NCT01186653|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110795105|NCT01186653|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
110795106|NCT01186653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110795107|NCT01186653|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110795108|NCT01186653|Autonomic Agents|autonomic agents|mesh-ancestor
110795109|NCT01186653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110795110|NCT01186653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110795111|NCT01186653|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110795112|NCT01186653|Respiratory System Agents|respiratory system agents|mesh-ancestor
110795113|NCT01186653|Dermatologic Agents|dermatologic agents|mesh-ancestor
110795114|NCT01186653|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110795115|NCT01186653|Glucocorticoids|glucocorticoids|mesh-ancestor
110795116|NCT01186653|Hormones|hormones|mesh-ancestor
110795117|NCT01186653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110795118|NCT01186653|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110795119|NCT01186653|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110795120|NCT01186653|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110795121|NCT01186653|Adrenergic Agents|adrenergic agents|mesh-ancestor
110795122|NCT01186653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110795123|NCT01186653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110795124|NCT01186653|Sympathomimetics|sympathomimetics|mesh-ancestor
110795125|NCT01186731|Docetaxel|docetaxel|mesh-list
110795126|NCT01186731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110795127|NCT01186731|Tubulin Modulators|tubulin modulators|mesh-ancestor
110795128|NCT01186731|Antimitotic Agents|antimitotic agents|mesh-ancestor
110795129|NCT01186731|Mitosis Modulators|mitosis modulators|mesh-ancestor
110795130|NCT01186731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110795131|NCT01186887|Celecoxib|celecoxib|mesh-list
110795132|NCT01186887|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110795133|NCT01186887|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110795134|NCT01186887|Analgesics|analgesics|mesh-ancestor
110795135|NCT01186887|Sensory System Agents|sensory system agents|mesh-ancestor
110795136|NCT01186887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110795137|NCT01186887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110795138|NCT01186887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110795139|NCT01186887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110795140|NCT01186887|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110795141|NCT01186887|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110795142|NCT01186887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110795143|NCT01186887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110795144|NCT01180413|Losartan|losartan|mesh-list
110795145|NCT01180413|Amlodipine|amlodipine|mesh-list
110795146|NCT01180413|Ramipril|ramipril|mesh-list
110795147|NCT01180413|Lercanidipine|lercanidipine|mesh-list
110795148|NCT01180413|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110795149|NCT01180413|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110795150|NCT01180413|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110503667|NCT00901628|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110795151|NCT01180413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110795152|NCT01180413|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110795153|NCT01180413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110795154|NCT01180413|Vasodilator Agents|vasodilator agents|mesh-ancestor
110795155|NCT01180413|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110795156|NCT01180413|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110795157|NCT01180413|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110851562|NCT05864664|Anesthetics|anesthetics|mesh-list
110795158|NCT01180413|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110795159|NCT01180413|Protease Inhibitors|protease inhibitors|mesh-ancestor
110795160|NCT01180413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110795161|NCT03858387|Meropenem|meropenem|mesh-list
110795162|NCT03858387|Imipenem|imipenem|mesh-list
110795163|NCT03858387|Cilastatin|cilastatin|mesh-list
110795164|NCT03858387|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110795165|NCT03858387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110795166|NCT03858387|Protease Inhibitors|protease inhibitors|mesh-ancestor
110795167|NCT03858387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110795168|NCT03858387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110795169|NCT01289301|Cyclosporine|cyclosporine|mesh-list
110795170|NCT01289301|Sirolimus|sirolimus|mesh-list
110795171|NCT01289301|Everolimus|everolimus|mesh-list
110795172|NCT01289301|MTOR Inhibitors|mtor inhibitors|mesh-list
110795173|NCT01289301|Temsirolimus|temsirolimus|mesh-list
110795174|NCT01289301|Tacrolimus|tacrolimus|mesh-list
110795175|NCT01289301|Cyclosporins|cyclosporins|mesh-list
110795176|NCT01289301|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
110795177|NCT01289301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110795178|NCT01289301|Immunologic Factors|immunologic factors|mesh-ancestor
110795179|NCT01289301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110795180|NCT01289301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110795181|NCT01289301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110795183|NCT01289301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110795184|NCT01289301|Dermatologic Agents|dermatologic agents|mesh-ancestor
110795185|NCT01289301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110795186|NCT01289301|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110795187|NCT01289301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110795188|NCT01289301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110795189|NCT01289301|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110795190|NCT02524899|Guanfacine|guanfacine|mesh-list
110795191|NCT02524899|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110795192|NCT02524899|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110795193|NCT02524899|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110795194|NCT02524899|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110795195|NCT02524899|Adrenergic Agents|adrenergic agents|mesh-ancestor
110795196|NCT02524899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110795197|NCT02524899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110795198|NCT02524899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110795199|NCT02524821|Metformin|metformin|mesh-list
110795200|NCT02524821|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110795201|NCT02524821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110795202|NCT01183455|Protease Inhibitors|protease inhibitors|mesh-list
110795203|NCT01183455|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
110795204|NCT01183455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110795205|NCT01183455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110795206|NCT01183455|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
110795207|NCT01183455|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110795208|NCT03854175|Sildenafil Citrate|sildenafil citrate|mesh-list
110795209|NCT03854175|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110795210|NCT03854175|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110795211|NCT03854175|Estradiol|estradiol|mesh-list
110795212|NCT03854175|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110851574|NCT05864053|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110795213|NCT03854175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110795214|NCT03854175|Estrogens|estrogens|mesh-ancestor
110795215|NCT03854175|Hormones|hormones|mesh-ancestor
110795216|NCT03854175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110795217|NCT03854175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110795218|NCT03854175|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110795219|NCT03854175|Contraceptive Agents|contraceptive agents|mesh-ancestor
110795220|NCT03854175|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110795221|NCT03854175|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110795222|NCT03854175|Vasodilator Agents|vasodilator agents|mesh-ancestor
110795223|NCT03854175|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110795224|NCT03854175|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110795225|NCT03854175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110795226|NCT03854175|Urological Agents|urological agents|mesh-ancestor
110795227|NCT01183611|Vaccines|vaccines|mesh-list
110795228|NCT01183611|Immunologic Factors|immunologic factors|mesh-ancestor
110795229|NCT01183611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110795230|NCT01180569|Lenalidomide|lenalidomide|mesh-list
110795231|NCT01180569|Immunologic Factors|immunologic factors|mesh-ancestor
110795232|NCT01180569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110795233|NCT01180569|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110795234|NCT01180569|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110795235|NCT01180569|Growth Substances|growth substances|mesh-ancestor
110795236|NCT01180569|Growth Inhibitors|growth inhibitors|mesh-ancestor
110503745|NCT02839356|Epinephrine|epinephrine|mesh-list
110795237|NCT01180569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110795238|NCT02942264|Temozolomide|temozolomide|mesh-list
110795239|NCT02942264|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110795240|NCT02942264|Alkylating Agents|alkylating agents|mesh-ancestor
110795241|NCT02942264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110795242|NCT02942264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110795243|NCT01180725|Psyllium|psyllium|mesh-list
110795244|NCT01180725|Cathartics|cathartics|mesh-ancestor
110795245|NCT01180725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110795246|NCT01183767|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
110795247|NCT01183767|Antioxidants|antioxidants|mesh-ancestor
110795248|NCT01183767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110795249|NCT01183767|Protective Agents|protective agents|mesh-ancestor
110795250|NCT01183767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110795251|NCT01183767|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
110795252|NCT01183767|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110795253|NCT01183767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110120367|NCT01905150|Leucovorin|leucovorin|mesh-list
110795254|NCT01183767|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110795255|NCT03853785|Podophyllin|podophyllin|mesh-list
110795256|NCT03853785|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110795257|NCT03853785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110795258|NCT03853785|Keratolytic Agents|keratolytic agents|mesh-ancestor
110795259|NCT03853785|Dermatologic Agents|dermatologic agents|mesh-ancestor
110795260|NCT01290471|U3-1565|u3-1565|mesh-list
110795261|NCT01290471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110795262|NCT01290471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110795263|NCT01291563|Moxifloxacin|moxifloxacin|mesh-list
110795264|NCT01291563|Bedaquiline|bedaquiline|mesh-list
110795265|NCT01291563|Diarylquinolines|diarylquinolines|mesh-list
110795266|NCT01291563|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
110795267|NCT01291563|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110795268|NCT01291563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110795269|NCT01291563|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110795270|NCT01291563|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110795271|NCT01291563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110851597|NCT05863949|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110795272|NCT01291563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110795273|NCT01291563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110795274|NCT01291563|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110795275|NCT01291563|Contraceptive Agents|contraceptive agents|mesh-ancestor
110795276|NCT01291563|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110795277|NCT01291563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110795278|NCT01291563|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110795279|NCT01291563|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110795280|NCT01291563|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110795281|NCT01291563|Antitubercular Agents|antitubercular agents|mesh-ancestor
110795282|NCT01187589|Albuterol|albuterol|mesh-list
110795283|NCT01187589|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110795284|NCT01187589|Autonomic Agents|autonomic agents|mesh-ancestor
110795285|NCT01187589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110503774|NCT02840526|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110795286|NCT01187589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110795287|NCT01187589|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110795288|NCT01187589|Respiratory System Agents|respiratory system agents|mesh-ancestor
110795289|NCT01187589|Tocolytic Agents|tocolytic agents|mesh-ancestor
110795290|NCT01187589|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110795291|NCT01187589|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110795292|NCT01187589|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110795293|NCT01187589|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110795294|NCT01187589|Adrenergic Agents|adrenergic agents|mesh-ancestor
110795295|NCT01187589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110795296|NCT01187589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110795297|NCT01290549|Rituximab|rituximab|mesh-list
110795298|NCT01290549|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
110795299|NCT01290549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110795300|NCT01290549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110503798|NCT00820885|Teduglutide|teduglutide|mesh-list
110795301|NCT01290549|Immunologic Factors|immunologic factors|mesh-ancestor
110795302|NCT01290549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110795303|NCT01290549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110795304|NCT01290549|Immunoconjugates|immunoconjugates|mesh-ancestor
110795305|NCT01184235|Antipsychotic Agents|antipsychotic agents|mesh-list
110795306|NCT01184235|Antidepressive Agents|antidepressive agents|mesh-list
110795307|NCT01184235|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110795308|NCT01184235|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110795309|NCT01184235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110795310|NCT01184235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110795311|NCT04951947|Lenvatinib|lenvatinib|mesh-list
110795312|NCT04951947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110795313|NCT04951947|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110795314|NCT04951947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110795315|NCT04951947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110795316|NCT01184391|Valproic Acid|valproic acid|mesh-list
110795317|NCT01184391|Anticonvulsants|anticonvulsants|mesh-ancestor
110795318|NCT01184391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110795319|NCT01184391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110795320|NCT01184391|GABA Agents|gaba agents|mesh-ancestor
110795321|NCT01184391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110795322|NCT01184391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110795323|NCT01184391|Antimanic Agents|antimanic agents|mesh-ancestor
110795324|NCT01184391|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110795325|NCT01184391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110795326|NCT01184391|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110795327|NCT02524743|Acetaminophen|acetaminophen|mesh-list
110795328|NCT02524743|Lidocaine|lidocaine|mesh-list
110795330|NCT02524743|Anesthetics|anesthetics|mesh-ancestor
110795331|NCT02524743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110795332|NCT02524743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110795333|NCT02524743|Sensory System Agents|sensory system agents|mesh-ancestor
110795334|NCT02524743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110795335|NCT02524743|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110795336|NCT02524743|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110795337|NCT02524743|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110795338|NCT02524743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110795339|NCT02524743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110795340|NCT02524743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110795341|NCT02524743|Analgesics|analgesics|mesh-ancestor
110795342|NCT02524743|Antipyretics|antipyretics|mesh-ancestor
110795343|NCT01188057|Alprazolam|alprazolam|mesh-list
110795344|NCT01188057|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110795345|NCT01188057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110795346|NCT01188057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110795347|NCT01188057|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110795348|NCT01188057|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110795349|NCT01188057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110795350|NCT01188057|GABA Modulators|gaba modulators|mesh-ancestor
110795351|NCT01188057|GABA Agents|gaba agents|mesh-ancestor
110795352|NCT01188057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110795353|NCT01188057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110795354|NCT01291641|Cilostazol|cilostazol|mesh-list
110795355|NCT01291641|Probucol|probucol|mesh-list
110795356|NCT01291641|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
110503858|NCT00633282|Pioglitazone|pioglitazone|mesh-list
110795357|NCT01291641|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110795358|NCT01291641|Autonomic Agents|autonomic agents|mesh-ancestor
110795359|NCT01291641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110795360|NCT01291641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110795361|NCT01291641|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110795362|NCT01291641|Respiratory System Agents|respiratory system agents|mesh-ancestor
110795363|NCT01291641|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110795364|NCT01291641|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110795365|NCT01291641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110795366|NCT01291641|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110795367|NCT01291641|Vasodilator Agents|vasodilator agents|mesh-ancestor
110795368|NCT01291641|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110795369|NCT01291641|Protective Agents|protective agents|mesh-ancestor
110795370|NCT01291641|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110795371|NCT01291641|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110795372|NCT01291641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110795373|NCT01291641|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110795374|NCT01291641|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110795375|NCT01291641|Antimetabolites|antimetabolites|mesh-ancestor
110795376|NCT01291641|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110795377|NCT01291641|Antioxidants|antioxidants|mesh-ancestor
110795378|NCT03855501|Calcium|calcium|mesh-list
110795379|NCT03855501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110795380|NCT03855501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110795381|NCT01588587|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110795382|NCT01588587|Vildagliptin|vildagliptin|mesh-list
110795383|NCT01588587|Alogliptin|alogliptin|mesh-list
110795384|NCT01588587|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110503875|NCT02837874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110795385|NCT01588587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110795386|NCT01588587|Incretins|incretins|mesh-ancestor
110795387|NCT01588587|Hormones|hormones|mesh-ancestor
110795388|NCT01588587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110795389|NCT01588587|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110795390|NCT01588587|Protease Inhibitors|protease inhibitors|mesh-ancestor
110795391|NCT01588587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110795392|NCT01588587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110795393|NCT03325712|Midazolam|midazolam|mesh-list
110795394|NCT03325712|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110795395|NCT03325712|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110795396|NCT03325712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110795397|NCT03325712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110795398|NCT03325712|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110795399|NCT03325712|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110795400|NCT03325712|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110795401|NCT03325712|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110795402|NCT03325712|Anesthetics, General|anesthetics, general|mesh-ancestor
110795403|NCT03325712|Anesthetics|anesthetics|mesh-ancestor
110795404|NCT03325712|GABA Modulators|gaba modulators|mesh-ancestor
110795405|NCT03325712|GABA Agents|gaba agents|mesh-ancestor
110795406|NCT03325712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110795407|NCT03325712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110795408|NCT01293747|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110795409|NCT01293747|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110795410|NCT01293747|Estradiol|estradiol|mesh-list
110795411|NCT01293747|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110795412|NCT01293747|Progesterone|progesterone|mesh-list
110795413|NCT01293747|Estrogens|estrogens|mesh-ancestor
110795415|NCT01293747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110795416|NCT01293747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110795417|NCT01293747|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110795418|NCT01293747|Contraceptive Agents|contraceptive agents|mesh-ancestor
110795419|NCT01293747|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110795420|NCT01293747|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110795421|NCT01293747|Progestins|progestins|mesh-ancestor
110795422|NCT03849729|Phentermine|phentermine|mesh-list
110795423|NCT03849729|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110795424|NCT03849729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110795425|NCT03849729|Appetite Depressants|appetite depressants|mesh-ancestor
110795426|NCT03849729|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110795427|NCT03849729|Sympathomimetics|sympathomimetics|mesh-ancestor
110795428|NCT03849729|Autonomic Agents|autonomic agents|mesh-ancestor
110795429|NCT03849729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110795430|NCT03849729|Adrenergic Agents|adrenergic agents|mesh-ancestor
110795431|NCT03849729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110795432|NCT03849729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110795433|NCT03325556|Pimavanserin|pimavanserin|mesh-list
110795434|NCT03325556|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110795435|NCT03325556|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110795436|NCT03325556|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110795437|NCT03325556|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110795438|NCT03325556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110795439|NCT03325556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110795440|NCT03325556|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110795441|NCT03325556|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110795442|NCT03325556|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110795443|NCT03325556|Serotonin Agents|serotonin agents|mesh-ancestor
110795444|NCT03325556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110795445|NCT03325556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110795446|NCT01188213|Dimethyl sulfone|dimethyl sulfone|mesh-list
110795447|NCT01188213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110795448|NCT03320564|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110795449|NCT03320564|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110795450|NCT03320564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110795451|NCT03852303|Ivermectin|ivermectin|mesh-list
110795452|NCT03852303|Anticonvulsants|anticonvulsants|mesh-list
110795453|NCT03852303|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110795454|NCT03852303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110795455|NCT03325166|Pembrolizumab|pembrolizumab|mesh-list
110795456|NCT03325166|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
110795457|NCT03325166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110795458|NCT03325166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110795459|NCT03325166|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110795460|NCT03325166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110795461|NCT03325166|Hematinics|hematinics|mesh-ancestor
110795462|NCT03325166|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
110795463|NCT03325166|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110795464|NCT03847623|Curcumin|curcumin|mesh-list
110795465|NCT03847623|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110795466|NCT03847623|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110795467|NCT03847623|Analgesics|analgesics|mesh-ancestor
110795468|NCT03847623|Sensory System Agents|sensory system agents|mesh-ancestor
110795469|NCT03847623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110795470|NCT03847623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110795471|NCT03847623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110795472|NCT03847623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110795473|NCT03847623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110795474|NCT03847623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110795475|NCT03847623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110795476|NCT01294059|Milnacipran|milnacipran|mesh-list
110795477|NCT01294059|Levomilnacipran|levomilnacipran|mesh-list
110795478|NCT01294059|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110795479|NCT01294059|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110795480|NCT01294059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110851621|NCT05863858|Amoxicillin|amoxicillin|mesh-list
110795481|NCT01294059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110795482|NCT01294059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110795483|NCT01294059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110795484|NCT01294059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110795486|NCT01294059|Sensory System Agents|sensory system agents|mesh-ancestor
110795487|NCT01294059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110795488|NCT01294059|Antidepressive Agents|antidepressive agents|mesh-ancestor
110795489|NCT01294059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110795491|NCT03847155|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110795492|NCT03847155|Autonomic Agents|autonomic agents|mesh-ancestor
110795493|NCT03847155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110795494|NCT03847155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110795495|NCT03847155|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110795496|NCT03847155|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110795497|NCT03847155|Cholinergic Agents|cholinergic agents|mesh-ancestor
110795498|NCT03847155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110795499|NCT03847155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110795500|NCT01294215|Nifedipine|nifedipine|mesh-list
110795501|NCT01294215|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110795502|NCT01294215|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110795503|NCT01294215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110795504|NCT01294215|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110795505|NCT01294215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110795506|NCT01294215|Vasodilator Agents|vasodilator agents|mesh-ancestor
110795507|NCT01294215|Tocolytic Agents|tocolytic agents|mesh-ancestor
110795508|NCT01294215|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110795509|NCT01296555|Letrozole|letrozole|mesh-list
110795510|NCT01296555|Fulvestrant|fulvestrant|mesh-list
110795511|NCT01296555|Midazolam|midazolam|mesh-list
110795512|NCT01296555|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110795513|NCT01296555|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110795514|NCT01296555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110795515|NCT01296555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110795516|NCT01296555|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110795517|NCT01296555|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110795518|NCT01296555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110795519|NCT01296555|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110795520|NCT01296555|Anesthetics, General|anesthetics, general|mesh-ancestor
110795521|NCT01296555|Anesthetics|anesthetics|mesh-ancestor
110795522|NCT01296555|GABA Modulators|gaba modulators|mesh-ancestor
110795523|NCT01296555|GABA Agents|gaba agents|mesh-ancestor
110795524|NCT01296555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110503929|NCT00825721|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110795525|NCT01296555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110795526|NCT01296555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110795527|NCT01296555|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110795528|NCT01296555|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110795529|NCT01296555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110795530|NCT01296555|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110795531|NCT01296555|Hormone Antagonists|hormone antagonists|mesh-ancestor
110795532|NCT01296555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110795533|NCT01296555|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110795534|NCT01296555|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110795535|NCT01294293|Paclitaxel|paclitaxel|mesh-list
110795536|NCT01294293|Doxorubicin|doxorubicin|mesh-list
110795537|NCT01294293|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110795538|NCT01294293|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110795539|NCT01294293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110795540|NCT01294293|Tubulin Modulators|tubulin modulators|mesh-ancestor
110795541|NCT01294293|Antimitotic Agents|antimitotic agents|mesh-ancestor
110795542|NCT01294293|Mitosis Modulators|mitosis modulators|mesh-ancestor
110795543|NCT01294293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110795544|NCT01294293|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110795545|NCT01294293|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110795546|NCT01294293|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110795547|NCT01294293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110795548|NCT01294605|Edetic Acid|edetic acid|mesh-list
110795549|NCT01294605|Pentetic Acid|pentetic acid|mesh-list
110795550|NCT01294605|Antidotes|antidotes|mesh-ancestor
110795551|NCT01294605|Protective Agents|protective agents|mesh-ancestor
110795552|NCT01294605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110795553|NCT01294605|Chelating Agents|chelating agents|mesh-ancestor
110795554|NCT01294605|Sequestering Agents|sequestering agents|mesh-ancestor
110795555|NCT01294605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110795556|NCT01294605|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110795557|NCT01294605|Anticoagulants|anticoagulants|mesh-ancestor
110795558|NCT01294605|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110795559|NCT01294761|Raltegravir Potassium|raltegravir potassium|mesh-list
110795561|NCT01294761|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110795562|NCT01294761|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110795563|NCT01294761|Antiviral Agents|antiviral agents|mesh-ancestor
110795564|NCT01294761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110795565|NCT01294761|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110795566|NCT01294761|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110795567|NCT01294761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110503934|NCT02837640|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110795568|NCT01294761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110795569|NCT01294761|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110795570|NCT01294761|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110795571|NCT01294761|Protease Inhibitors|protease inhibitors|mesh-ancestor
110795572|NCT03849183|Nitroglycerin|nitroglycerin|mesh-list
110795573|NCT03849183|Vasodilator Agents|vasodilator agents|mesh-ancestor
110795574|NCT03305666|Bupivacaine|bupivacaine|mesh-list
110795575|NCT03305666|Anesthetics, Local|anesthetics, local|mesh-ancestor
110795576|NCT03305666|Anesthetics|anesthetics|mesh-ancestor
110795577|NCT03305666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110795578|NCT03305666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110795579|NCT03305666|Sensory System Agents|sensory system agents|mesh-ancestor
110795580|NCT03305666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110795581|NCT01194843|Ropivacaine|ropivacaine|mesh-list
110795582|NCT01194843|Anesthetics, Local|anesthetics, local|mesh-ancestor
110795583|NCT01194843|Anesthetics|anesthetics|mesh-ancestor
110795584|NCT01194843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110795585|NCT01194843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110795586|NCT01194843|Sensory System Agents|sensory system agents|mesh-ancestor
110795587|NCT01194843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110795588|NCT01297023|Calcium, Dietary|calcium, dietary|mesh-list
110795589|NCT01297023|Vitamin D|vitamin d|mesh-list
110795590|NCT01297023|Ergocalciferols|ergocalciferols|mesh-list
110795591|NCT01297023|Cholecalciferol|cholecalciferol|mesh-list
110795592|NCT01297023|Vitamins|vitamins|mesh-list
110795593|NCT01297023|Calcium|calcium|mesh-list
110795594|NCT01297023|Micronutrients|micronutrients|mesh-ancestor
110795595|NCT01297023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110513216|NCT04243850|Empagliflozin|empagliflozin|mesh-list
110795596|NCT01297023|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110795597|NCT01297023|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110795598|NCT03846843|Phenylacetic acid|phenylacetic acid|mesh-list
110795599|NCT03846843|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110795600|NCT03846843|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110795601|NCT03846843|Antimetabolites|antimetabolites|mesh-ancestor
110795602|NCT03846843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110795603|NCT03846843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110795604|NCT01297101|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110795605|NCT01297101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110795606|NCT01297101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110795607|NCT01297101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110795608|NCT01297101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110795609|NCT04781426|Tenofovir|tenofovir|mesh-list
110795610|NCT04781426|Lamivudine|lamivudine|mesh-list
110795611|NCT04781426|Antiviral Agents|antiviral agents|mesh-ancestor
110795612|NCT04781426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110795613|NCT04781426|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110795614|NCT04781426|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110795615|NCT04781426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110795616|NCT04781426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110795617|NCT04781426|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110795618|NCT04781426|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110795619|NCT01292031|Meropenem|meropenem|mesh-list
110795620|NCT01292031|Colistin|colistin|mesh-list
110795621|NCT01292031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110795622|NCT01292031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110795623|NCT04633226|Vaccines|vaccines|mesh-list
110795624|NCT04633226|Immunologic Factors|immunologic factors|mesh-ancestor
110795625|NCT04633226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110795626|NCT03849027|Methoxyflurane|methoxyflurane|mesh-list
110795627|NCT03849027|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110795628|NCT03849027|Anesthetics, General|anesthetics, general|mesh-ancestor
110795629|NCT03849027|Anesthetics|anesthetics|mesh-ancestor
110795630|NCT03849027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110795631|NCT03849027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110795632|NCT01188759|Voriconazole|voriconazole|mesh-list
110795633|NCT01188759|Anidulafungin|anidulafungin|mesh-list
110795634|NCT01188759|Antifungal Agents|antifungal agents|mesh-ancestor
110795635|NCT01188759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110795636|NCT01188759|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110795637|NCT01188759|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110795638|NCT01188759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110795639|NCT01188759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110795640|NCT01188759|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110795641|NCT01188759|Hormone Antagonists|hormone antagonists|mesh-ancestor
110795642|NCT01188759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110795643|NCT01188759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110795644|NCT01188759|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110795645|NCT01295073|Trientine|trientine|mesh-list
110795646|NCT01295073|Chelating Agents|chelating agents|mesh-ancestor
110795647|NCT01295073|Sequestering Agents|sequestering agents|mesh-ancestor
110795648|NCT01295073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110795649|NCT01292109|Picosulfate sodium|picosulfate sodium|mesh-list
110795650|NCT01292109|Cathartics|cathartics|mesh-ancestor
110795651|NCT01292109|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110795652|NCT01191645|Remifentanil|remifentanil|mesh-list
110795653|NCT01191645|Metoclopramide|metoclopramide|mesh-list
110795654|NCT01191645|Naloxone|naloxone|mesh-list
110795655|NCT01191645|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110795656|NCT01191645|Narcotics|narcotics|mesh-ancestor
110795657|NCT01191645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110795658|NCT01191645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110795659|NCT01191645|Analgesics|analgesics|mesh-ancestor
110795660|NCT01191645|Sensory System Agents|sensory system agents|mesh-ancestor
110795661|NCT01191645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110795662|NCT01191645|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110795663|NCT01191645|Antiemetics|antiemetics|mesh-ancestor
110795664|NCT01191645|Autonomic Agents|autonomic agents|mesh-ancestor
110795665|NCT01191645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110795666|NCT01191645|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110795667|NCT01191645|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110795668|NCT01191645|Dopamine Agents|dopamine agents|mesh-ancestor
110795669|NCT01191645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110795670|NCT01191645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110795671|NCT03736785|Insulin|insulin|mesh-list
110795672|NCT03736785|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110513286|NCT02769936|Cycloserine|cycloserine|mesh-list
110795673|NCT03736785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110795674|NCT03734991|Ibrexafungerp|ibrexafungerp|mesh-list
110795675|NCT03734991|Antifungal Agents|antifungal agents|mesh-ancestor
110795676|NCT03734991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110795677|NCT01295151|Adalimumab|adalimumab|mesh-list
110795678|NCT01295151|Infliximab|infliximab|mesh-list
110795679|NCT01295151|Golimumab|golimumab|mesh-list
110795680|NCT01295151|Certolizumab Pegol|certolizumab pegol|mesh-list
110795681|NCT01295151|Etanercept|etanercept|mesh-list
110795682|NCT01295151|Rituximab|rituximab|mesh-list
110795683|NCT01295151|Abatacept|abatacept|mesh-list
110795684|NCT01295151|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110795685|NCT01295151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110795686|NCT01295151|Immunologic Factors|immunologic factors|mesh-ancestor
110795687|NCT01295151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110795688|NCT01295151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110795689|NCT01295151|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110795690|NCT01295151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110795691|NCT01295151|Dermatologic Agents|dermatologic agents|mesh-ancestor
110795692|NCT01295151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110795693|NCT01295151|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110795694|NCT01295151|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110795695|NCT01295151|Analgesics|analgesics|mesh-ancestor
110795696|NCT01295151|Sensory System Agents|sensory system agents|mesh-ancestor
110795697|NCT01295151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110795698|NCT01295151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110795699|NCT01295151|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110795700|NCT01295151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110795701|NCT01295307|Clofarabine|clofarabine|mesh-list
110795702|NCT01295307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110795703|NCT01295307|Antimetabolites|antimetabolites|mesh-ancestor
110795704|NCT01295307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110795705|NCT01295307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110795707|NCT01292343|Triclosan|triclosan|mesh-list
110795708|NCT01292343|Fluorides|fluorides|mesh-list
110795709|NCT01292343|Sodium Fluoride|sodium fluoride|mesh-list
110795710|NCT01292343|Cariostatic Agents|cariostatic agents|mesh-ancestor
110795711|NCT01292343|Protective Agents|protective agents|mesh-ancestor
110795712|NCT01292343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110795713|NCT01292343|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110795714|NCT01292343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110795715|NCT01292343|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
110795716|NCT01292343|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110795717|NCT01292343|Antimetabolites|antimetabolites|mesh-ancestor
110795718|NCT01292343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110795719|NCT01292343|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110795720|NCT01192113|Vitamin B 12|vitamin b 12|mesh-list
110795721|NCT01192113|Vitamin B Complex|vitamin b complex|mesh-ancestor
110795722|NCT01192113|Vitamins|vitamins|mesh-ancestor
110795723|NCT01192113|Micronutrients|micronutrients|mesh-ancestor
110795724|NCT01192113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110795725|NCT03303092|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110795726|NCT03303092|Immunologic Factors|immunologic factors|mesh-ancestor
110795727|NCT03303092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110795728|NCT03851679|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
110795729|NCT03851679|Natriuretic Agents|natriuretic agents|mesh-ancestor
110795730|NCT03851679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110795731|NCT01192503|Rasagiline|rasagiline|mesh-list
110795732|NCT01192503|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
110795733|NCT01192503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110795734|NCT01192503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110795735|NCT01192503|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110795736|NCT01192503|Protective Agents|protective agents|mesh-ancestor
110795737|NCT01192503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110795738|NCT01192581|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
110795739|NCT01192581|Plasma Substitutes|plasma substitutes|mesh-ancestor
110795740|NCT01192581|Blood Substitutes|blood substitutes|mesh-ancestor
110795741|NCT03851289|Calcium|calcium|mesh-list
110795742|NCT03851289|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110795743|NCT03851289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110795744|NCT03733899|Anesthetics|anesthetics|mesh-list
110513359|NCT02769390|Anesthetics, General|anesthetics, general|mesh-ancestor
110795745|NCT03733899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110795746|NCT03733899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110795747|NCT01196013|Clofarabine|clofarabine|mesh-list
110795748|NCT01196013|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110795749|NCT01196013|Antimetabolites|antimetabolites|mesh-ancestor
110795750|NCT01196013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110795751|NCT01196013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110795752|NCT01196169|Vancomycin|vancomycin|mesh-list
110795753|NCT01196169|Daptomycin|daptomycin|mesh-list
110795754|NCT01196169|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110795755|NCT01196169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110795756|NCT01196481|Carvedilol|carvedilol|mesh-list
110795757|NCT01196481|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110795758|NCT01196481|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110795759|NCT01196481|Adrenergic Agents|adrenergic agents|mesh-ancestor
110795760|NCT01196481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110795761|NCT01196481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110795762|NCT01196481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110795763|NCT01196481|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110795764|NCT01196481|Antioxidants|antioxidants|mesh-ancestor
110795765|NCT01196481|Protective Agents|protective agents|mesh-ancestor
110795766|NCT01196481|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110795767|NCT01196481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110795768|NCT01196481|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110795769|NCT01196481|Vasodilator Agents|vasodilator agents|mesh-ancestor
110504064|NCT05878379|Iron|iron|mesh-list
110795770|NCT01196481|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110795771|NCT01196481|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110795772|NCT05283057|Empagliflozin|empagliflozin|mesh-list
110795773|NCT05283057|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110795774|NCT05283057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110795775|NCT05283057|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110795776|NCT05283057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110795778|NCT01193595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110795779|NCT01193595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110795780|NCT01193595|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110795781|NCT01193595|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110795782|NCT01193595|Growth Substances|growth substances|mesh-ancestor
110795783|NCT01193595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110795784|NCT01193595|Growth Inhibitors|growth inhibitors|mesh-ancestor
110795785|NCT01196559|Gemcitabine|gemcitabine|mesh-list
110795786|NCT01196559|Vinorelbine|vinorelbine|mesh-list
110795787|NCT01196559|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110795788|NCT01196559|Antimetabolites|antimetabolites|mesh-ancestor
110795789|NCT01196559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110795790|NCT01196559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110795791|NCT01196559|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110795792|NCT01196559|Tubulin Modulators|tubulin modulators|mesh-ancestor
110795793|NCT01196559|Antimitotic Agents|antimitotic agents|mesh-ancestor
110795794|NCT01196559|Mitosis Modulators|mitosis modulators|mesh-ancestor
110795795|NCT01295775|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
110795796|NCT01295775|Anticoagulants|anticoagulants|mesh-ancestor
110795797|NCT01295775|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110795798|NCT01295775|Antimetabolites|antimetabolites|mesh-ancestor
110795799|NCT01295775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110795800|NCT01295775|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110795801|NCT01295775|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110795802|NCT01295775|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110795803|NCT01295775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110795804|NCT01295775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110795805|NCT01581177|Albuterol|albuterol|mesh-list
110504090|NCT05878249|Eusol|eusol|mesh-list
110795806|NCT01581177|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110795807|NCT01581177|Autonomic Agents|autonomic agents|mesh-ancestor
110795808|NCT01581177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110795809|NCT01581177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110795810|NCT01581177|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110795811|NCT01581177|Respiratory System Agents|respiratory system agents|mesh-ancestor
110795812|NCT01581177|Tocolytic Agents|tocolytic agents|mesh-ancestor
110795813|NCT01581177|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110795814|NCT01581177|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110795815|NCT01581177|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110795816|NCT01581177|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110795817|NCT01581177|Adrenergic Agents|adrenergic agents|mesh-ancestor
110795818|NCT01581177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110795819|NCT01581177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110795820|NCT01580007|Cholecalciferol|cholecalciferol|mesh-list
110795821|NCT01580007|Vitamin D|vitamin d|mesh-list
110795822|NCT01580007|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
110795823|NCT01580007|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110795824|NCT01580007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110795825|NCT01580007|Vitamins|vitamins|mesh-ancestor
110795826|NCT01580007|Micronutrients|micronutrients|mesh-ancestor
110851650|NCT05863858|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110795827|NCT01580007|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110795828|NCT01580007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110795829|NCT01189695|Ritonavir|ritonavir|mesh-list
110795830|NCT01189695|Lopinavir|lopinavir|mesh-list
110795831|NCT01189695|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110795832|NCT01189695|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110795833|NCT01189695|Protease Inhibitors|protease inhibitors|mesh-ancestor
110795834|NCT01189695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110795835|NCT01189695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110795836|NCT01189695|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110795837|NCT01189695|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110795838|NCT01189695|Antiviral Agents|antiviral agents|mesh-ancestor
110795839|NCT01189695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110795840|NCT01189695|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110795841|NCT01189695|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110795842|NCT01196715|Darbepoetin alfa|darbepoetin alfa|mesh-list
110795843|NCT01196715|Hematinics|hematinics|mesh-ancestor
110795844|NCT03848091|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110795845|NCT03848091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110795846|NCT01189773|Ibuprofen|ibuprofen|mesh-list
110795847|NCT01189773|Codeine|codeine|mesh-list
110795848|NCT01189773|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110795849|NCT01189773|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110795850|NCT01189773|Analgesics|analgesics|mesh-ancestor
110795851|NCT01189773|Sensory System Agents|sensory system agents|mesh-ancestor
110795852|NCT01189773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110795853|NCT01189773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110795854|NCT01189773|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110795855|NCT01189773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110795856|NCT01189773|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110795857|NCT01189773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110795858|NCT01189773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110795859|NCT01189773|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110795860|NCT01189773|Narcotics|narcotics|mesh-ancestor
110795861|NCT01189773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110795862|NCT01189773|Antitussive Agents|antitussive agents|mesh-ancestor
110795863|NCT01189773|Respiratory System Agents|respiratory system agents|mesh-ancestor
110795864|NCT01189929|Gemcitabine|gemcitabine|mesh-list
110795865|NCT01189929|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110795866|NCT01189929|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110795867|NCT01189929|Antimetabolites|antimetabolites|mesh-ancestor
110795868|NCT01189929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110795869|NCT01189929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110795870|NCT03845673|Psyllium|psyllium|mesh-list
110795871|NCT03845673|Cathartics|cathartics|mesh-ancestor
110795872|NCT03845673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110795873|NCT01190163|Oxytocin|oxytocin|mesh-list
110795874|NCT01190163|Dinoprostone|dinoprostone|mesh-list
110795875|NCT01190163|Oxytocics|oxytocics|mesh-ancestor
110795876|NCT01190163|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110795877|NCT01190163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110795878|NCT01199445|Vitamin A|vitamin a|mesh-list
110795879|NCT01199445|Vitamins|vitamins|mesh-ancestor
110795880|NCT01199445|Micronutrients|micronutrients|mesh-ancestor
110795881|NCT01199445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110795882|NCT01199523|Moxifloxacin|moxifloxacin|mesh-list
110795883|NCT01199523|Mirabegron|mirabegron|mesh-list
110795884|NCT01199523|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110795885|NCT01199523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110795886|NCT01199523|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110795887|NCT01199523|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110795888|NCT01199523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110795889|NCT01199523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110795890|NCT01199523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110795891|NCT01199523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110795892|NCT01199523|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
110795893|NCT01199523|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110795894|NCT01199523|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110795895|NCT01199523|Adrenergic Agents|adrenergic agents|mesh-ancestor
110795896|NCT01199523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110795897|NCT01199523|Urological Agents|urological agents|mesh-ancestor
110795898|NCT01190241|Everolimus|everolimus|mesh-list
110795899|NCT01190241|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110795901|NCT01190241|Sunitinib|sunitinib|mesh-list
110795902|NCT01190241|Lapatinib|lapatinib|mesh-list
110795903|NCT01190241|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110795904|NCT01190241|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110795905|NCT01190241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110795906|NCT01190241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110795907|NCT01190241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110504150|NCT05877781|Antiviral Agents|antiviral agents|mesh-ancestor
110795908|NCT01190241|Immunologic Factors|immunologic factors|mesh-ancestor
110795909|NCT01190241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110795910|NCT01190241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110795911|NCT01190241|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110795912|NCT01190241|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110795913|NCT01190241|Growth Substances|growth substances|mesh-ancestor
110795914|NCT01190241|Growth Inhibitors|growth inhibitors|mesh-ancestor
110795915|NCT01197261|Oxycodone|oxycodone|mesh-list
110795916|NCT01197261|Naloxone|naloxone|mesh-list
110795917|NCT01197261|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110795918|NCT01197261|Narcotics|narcotics|mesh-ancestor
110795919|NCT01197261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110795920|NCT01197261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110795921|NCT01197261|Analgesics|analgesics|mesh-ancestor
110795922|NCT01197261|Sensory System Agents|sensory system agents|mesh-ancestor
110795923|NCT01197261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110795924|NCT01197261|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110795925|NCT01190553|Amantadine|amantadine|mesh-list
110795926|NCT01190553|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110795927|NCT01190553|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110795928|NCT01190553|Antiviral Agents|antiviral agents|mesh-ancestor
110795929|NCT01190553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110795930|NCT01190553|Dopamine Agents|dopamine agents|mesh-ancestor
110795931|NCT01190553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110795932|NCT01190553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110795933|NCT01190553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110795934|NCT01190553|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110795935|NCT01190553|Analgesics|analgesics|mesh-ancestor
110795936|NCT01190553|Sensory System Agents|sensory system agents|mesh-ancestor
110795937|NCT01190553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110795938|NCT01199757|Fluticasone|fluticasone|mesh-list
110795940|NCT01199757|Mometasone Furoate|mometasone furoate|mesh-list
110795941|NCT01199757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110795942|NCT01199757|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110795943|NCT01199757|Autonomic Agents|autonomic agents|mesh-ancestor
110795944|NCT01199757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110795945|NCT01199757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110795946|NCT01199757|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110795947|NCT01199757|Respiratory System Agents|respiratory system agents|mesh-ancestor
110795948|NCT01199757|Dermatologic Agents|dermatologic agents|mesh-ancestor
110795949|NCT01199757|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110795950|NCT03843879|Lidocaine|lidocaine|mesh-list
110795951|NCT03843879|Anesthetics, Local|anesthetics, local|mesh-ancestor
110795952|NCT03843879|Anesthetics|anesthetics|mesh-ancestor
110795953|NCT03843879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110795954|NCT03843879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110795955|NCT03843879|Sensory System Agents|sensory system agents|mesh-ancestor
110795956|NCT03843879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110795957|NCT03843879|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110795958|NCT03843879|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110795959|NCT03843879|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110795960|NCT03843879|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110795961|NCT03843879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110795962|NCT03850587|Celecoxib|celecoxib|mesh-list
110795963|NCT03850587|Tramadol|tramadol|mesh-list
110795964|NCT03850587|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110795965|NCT03850587|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110795966|NCT03850587|Analgesics|analgesics|mesh-ancestor
110795967|NCT03850587|Sensory System Agents|sensory system agents|mesh-ancestor
110795968|NCT03850587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110795969|NCT03850587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110795970|NCT03850587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110795971|NCT03850587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110795972|NCT03850587|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110795973|NCT03850587|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110513584|NCT02768610|Dexmedetomidine|dexmedetomidine|mesh-list
110795974|NCT03850587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110795975|NCT03850587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110795976|NCT03850587|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110795978|NCT03850587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110795979|NCT01199835|Calcium|calcium|mesh-list
110795980|NCT01199835|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110795981|NCT01199835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110795982|NCT05671497|Antirheumatic Agents|antirheumatic agents|mesh-list
110795983|NCT05671497|Cilostazol|cilostazol|mesh-list
110795984|NCT05671497|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110795985|NCT05671497|Autonomic Agents|autonomic agents|mesh-ancestor
110795986|NCT05671497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110795987|NCT05671497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110795988|NCT05671497|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110795989|NCT05671497|Respiratory System Agents|respiratory system agents|mesh-ancestor
110795990|NCT05671497|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110795991|NCT05671497|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110795992|NCT05671497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110795993|NCT05671497|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110795994|NCT05671497|Vasodilator Agents|vasodilator agents|mesh-ancestor
110795995|NCT05671497|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110795996|NCT05671497|Protective Agents|protective agents|mesh-ancestor
110795997|NCT05671497|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110795998|NCT05671497|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110795999|NCT05671497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110796000|NCT03915626|Rivastigmine|rivastigmine|mesh-list
110796001|NCT03915626|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110796002|NCT03915626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110796003|NCT03915626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110796004|NCT03915626|Cholinergic Agents|cholinergic agents|mesh-ancestor
110796005|NCT03915626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110796006|NCT03915626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110796007|NCT03915626|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110796008|NCT03915626|Protective Agents|protective agents|mesh-ancestor
110796010|NCT04491968|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110796011|NCT04491968|Narcotics|narcotics|mesh-ancestor
110796012|NCT04491968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110796013|NCT04491968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110796014|NCT04491968|Analgesics|analgesics|mesh-ancestor
110796015|NCT04491968|Sensory System Agents|sensory system agents|mesh-ancestor
110796016|NCT04491968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110796017|NCT04491968|Antitussive Agents|antitussive agents|mesh-ancestor
110796018|NCT04491968|Respiratory System Agents|respiratory system agents|mesh-ancestor
110796019|NCT03313076|Vitamin D|vitamin d|mesh-list
110796020|NCT03313076|Ergocalciferols|ergocalciferols|mesh-list
110796021|NCT03313076|Cholecalciferol|cholecalciferol|mesh-list
110796022|NCT03313076|Vitamins|vitamins|mesh-list
110796023|NCT03313076|Micronutrients|micronutrients|mesh-ancestor
110796024|NCT03313076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110796025|NCT03313076|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110796026|NCT03313076|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110796027|NCT01191021|Propofol|propofol|mesh-list
110796028|NCT01191021|Anesthetics|anesthetics|mesh-ancestor
110796029|NCT01191021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110796030|NCT01191021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110796031|NCT01191021|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110796032|NCT01191021|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110796033|NCT01191021|Anesthetics, General|anesthetics, general|mesh-ancestor
110796034|NCT01200537|Norinyl|norinyl|mesh-list
110796035|NCT01200537|Contraceptive Agents|contraceptive agents|mesh-list
110796036|NCT01200537|Contraceptives, Oral|contraceptives, oral|mesh-list
110796037|NCT01200537|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
110796038|NCT01200537|Estradiol|estradiol|mesh-list
110796039|NCT01200537|Estrogens|estrogens|mesh-ancestor
110796040|NCT01200537|Hormones|hormones|mesh-ancestor
110796041|NCT01200537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110796042|NCT01200537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110796043|NCT01200537|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110796044|NCT01200537|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110796045|NCT01200537|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110796046|NCT01200537|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110796048|NCT01198353|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110796049|NCT01198353|Serotonin Agents|serotonin agents|mesh-ancestor
110796050|NCT01198353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110796051|NCT01198353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110796052|NCT01198353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110796053|NCT01198353|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110796054|NCT01198353|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110796055|NCT01198353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110796056|NCT01198353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110796057|NCT01198353|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110796058|NCT01198353|Dopamine Agents|dopamine agents|mesh-ancestor
110796059|NCT01200693|Sirolimus|sirolimus|mesh-list
110796060|NCT01200693|Everolimus|everolimus|mesh-list
110796061|NCT01200693|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110796062|NCT01200693|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110796063|NCT01200693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110796064|NCT01200693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110796065|NCT01200693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110796066|NCT01200693|Immunologic Factors|immunologic factors|mesh-ancestor
110796067|NCT01200693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110796068|NCT01200693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110796069|NCT01200693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110796070|NCT01200693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110796071|NCT01200693|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110796072|NCT01200693|Antifungal Agents|antifungal agents|mesh-ancestor
110796073|NCT03844581|Propiverine|propiverine|mesh-list
110796074|NCT03844581|Parasympatholytics|parasympatholytics|mesh-ancestor
110796075|NCT03844581|Autonomic Agents|autonomic agents|mesh-ancestor
110796076|NCT03844581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110796077|NCT03844581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110796078|NCT03844581|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110796079|NCT03844581|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110796080|NCT03844581|Cholinergic Agents|cholinergic agents|mesh-ancestor
110796081|NCT03844581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110796082|NCT03844581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110796083|NCT03844581|Urological Agents|urological agents|mesh-ancestor
110796084|NCT01202097|Fluticasone|fluticasone|mesh-list
110796085|NCT01202097|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110796086|NCT01202097|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
110796087|NCT01202097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110796088|NCT01202097|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110796089|NCT01202097|Autonomic Agents|autonomic agents|mesh-ancestor
110796090|NCT01202097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110796091|NCT01202097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110796092|NCT01202097|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110796093|NCT01202097|Respiratory System Agents|respiratory system agents|mesh-ancestor
110796094|NCT01202097|Dermatologic Agents|dermatologic agents|mesh-ancestor
110796095|NCT01202097|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110796096|NCT01202097|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110796097|NCT01202097|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110796098|NCT01202097|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110796099|NCT01202097|Adrenergic Agents|adrenergic agents|mesh-ancestor
110796100|NCT01202097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110796101|NCT01202097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110796102|NCT01202097|Glucocorticoids|glucocorticoids|mesh-ancestor
110796103|NCT01202097|Hormones|hormones|mesh-ancestor
110796104|NCT01202097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110796105|NCT01202097|Sympathomimetics|sympathomimetics|mesh-ancestor
110796106|NCT05670015|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110796107|NCT05670015|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110796108|NCT01201005|Hydroxocobalamin|hydroxocobalamin|mesh-list
110796109|NCT01201005|Vitamin B 12|vitamin b 12|mesh-list
110796110|NCT01201005|Hematinics|hematinics|mesh-ancestor
110796111|NCT01201005|Vitamin B Complex|vitamin b complex|mesh-ancestor
110796112|NCT01201005|Vitamins|vitamins|mesh-ancestor
110796113|NCT01201005|Micronutrients|micronutrients|mesh-ancestor
110796114|NCT01201005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110796115|NCT01198665|Prednisolone|prednisolone|mesh-list
110796116|NCT01198665|Doxorubicin|doxorubicin|mesh-list
110796117|NCT01198665|Vincristine|vincristine|mesh-list
110796118|NCT01198665|Everolimus|everolimus|mesh-list
110796119|NCT01198665|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110796120|NCT01198665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110796121|NCT01198665|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110504310|NCT05555667|Anesthetics|anesthetics|mesh-ancestor
110796122|NCT01198665|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110796123|NCT01198665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110796124|NCT01198665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110513729|NCT00887588|Valsartan|valsartan|mesh-list
110796125|NCT01198665|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110796126|NCT01198665|Tubulin Modulators|tubulin modulators|mesh-ancestor
110796127|NCT01198665|Antimitotic Agents|antimitotic agents|mesh-ancestor
110796128|NCT01198665|Mitosis Modulators|mitosis modulators|mesh-ancestor
110796129|NCT01198665|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110796130|NCT01198665|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110796131|NCT01198665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110796132|NCT01198665|Immunologic Factors|immunologic factors|mesh-ancestor
110796133|NCT01198665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110796134|NCT01198665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110796135|NCT01198665|Glucocorticoids|glucocorticoids|mesh-ancestor
110796136|NCT01198665|Hormones|hormones|mesh-ancestor
110169068|NCT00037141|Ethanol|ethanol|mesh-list
110504347|NCT05398081|Ceftriaxone|ceftriaxone|mesh-list
110796137|NCT01198665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110796138|NCT01198665|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110796139|NCT05030415|Ixekizumab|ixekizumab|mesh-list
110796140|NCT05030415|Dermatologic Agents|dermatologic agents|mesh-ancestor
110796141|NCT01198821|Gemcitabine|gemcitabine|mesh-list
110796142|NCT01198821|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110796143|NCT01198821|Antimetabolites|antimetabolites|mesh-ancestor
110796144|NCT01198821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110796145|NCT01198821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110796146|NCT05013801|Hydroquinone|hydroquinone|mesh-list
110796147|NCT05013801|Antioxidants|antioxidants|mesh-ancestor
110796148|NCT05013801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110796149|NCT05013801|Protective Agents|protective agents|mesh-ancestor
110796150|NCT05013801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110796151|NCT05013801|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110796153|NCT01566669|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110796154|NCT01566669|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110796155|NCT01566669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110796156|NCT01566669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110796157|NCT01566669|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110796158|NCT01566669|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110504404|NCT05060744|Antacids|antacids|mesh-list
110796159|NCT01566669|Analgesics|analgesics|mesh-ancestor
110796160|NCT01566669|Sensory System Agents|sensory system agents|mesh-ancestor
110796161|NCT01566669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110796162|NCT01566669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110796163|NCT01566669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110796164|NCT01566669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110796165|NCT03841773|Cyclobenzaprine|cyclobenzaprine|mesh-list
110796166|NCT03841773|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110796167|NCT03841773|Antidepressive Agents|antidepressive agents|mesh-ancestor
110796168|NCT03841773|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110796169|NCT03841773|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110796170|NCT03841773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110796171|NCT03841773|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110796172|NCT03841773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110796173|NCT03841773|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110796174|NCT03841773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110796175|NCT01201161|Ranibizumab|ranibizumab|mesh-list
110796176|NCT01201161|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110796177|NCT01201161|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110796178|NCT01201161|Growth Substances|growth substances|mesh-ancestor
110796179|NCT01201161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110796180|NCT01201161|Growth Inhibitors|growth inhibitors|mesh-ancestor
110796181|NCT01201161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110796182|NCT03841383|Dipyridamole|dipyridamole|mesh-list
110796183|NCT03841383|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110796184|NCT03841383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110796185|NCT03841383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110796186|NCT03841383|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110796187|NCT03841383|Vasodilator Agents|vasodilator agents|mesh-ancestor
110796188|NCT05667987|Lidocaine|lidocaine|mesh-list
110796189|NCT05667987|Anesthetics, Local|anesthetics, local|mesh-ancestor
110796190|NCT05667987|Anesthetics|anesthetics|mesh-ancestor
110796191|NCT05667987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110796192|NCT05667987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110796193|NCT05667987|Sensory System Agents|sensory system agents|mesh-ancestor
110796194|NCT05667987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110796195|NCT05667987|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110796196|NCT05667987|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110796197|NCT05667987|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110513808|NCT00887432|Vitamin D|vitamin d|mesh-list
110796198|NCT05667987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110796199|NCT05667987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110796201|NCT01201239|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110796202|NCT01201239|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110796203|NCT01201239|Antiviral Agents|antiviral agents|mesh-ancestor
110796204|NCT01201239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110796205|NCT01201239|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110796206|NCT01201239|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110796207|NCT01201239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110796208|NCT01201239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110796209|NCT01199367|Letrozole|letrozole|mesh-list
110796210|NCT01199367|Lapatinib|lapatinib|mesh-list
110796211|NCT01199367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110796212|NCT01199367|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110796213|NCT01199367|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110796214|NCT01199367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110796215|NCT01199367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110796216|NCT01199367|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110796217|NCT01199367|Hormone Antagonists|hormone antagonists|mesh-ancestor
110796218|NCT01199367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110796219|NCT01199367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110796220|NCT01199367|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110796221|NCT01203735|Valproic Acid|valproic acid|mesh-list
110796222|NCT01203735|Anticonvulsants|anticonvulsants|mesh-ancestor
110796235|NCT03842631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110796236|NCT03842631|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110796237|NCT03842631|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110796238|NCT03842631|Adrenergic Agents|adrenergic agents|mesh-ancestor
110796239|NCT03842631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110796240|NCT03842631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110796241|NCT03842631|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110796242|NCT03842631|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110796243|NCT05669781|Metoclopramide|metoclopramide|mesh-list
110796244|NCT05669781|Antiemetics|antiemetics|mesh-ancestor
110796245|NCT05669781|Autonomic Agents|autonomic agents|mesh-ancestor
110796246|NCT05669781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110796247|NCT05669781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110796248|NCT05669781|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110796249|NCT05669781|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110796250|NCT05669781|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110796251|NCT05669781|Dopamine Agents|dopamine agents|mesh-ancestor
110796252|NCT05669781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110796253|NCT05669781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110796254|NCT01202331|Azithromycin|azithromycin|mesh-list
110796255|NCT01202331|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110796256|NCT01202331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110796257|NCT01201551|Brimonidine Tartrate|brimonidine tartrate|mesh-list
110796258|NCT01201551|Latanoprost|latanoprost|mesh-list
110796259|NCT01201551|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110796260|NCT01201551|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110796261|NCT01201551|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110796262|NCT01201551|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110796263|NCT01201551|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110796264|NCT01201551|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110796265|NCT01201551|Adrenergic Agents|adrenergic agents|mesh-ancestor
110796266|NCT01201551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110796267|NCT01201551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110796268|NCT01201551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110796269|NCT01204125|Paclitaxel|paclitaxel|mesh-list
110796270|NCT01204125|Iniparib|iniparib|mesh-list
110796271|NCT01204125|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110796272|NCT01204125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110796273|NCT01204125|Tubulin Modulators|tubulin modulators|mesh-ancestor
110851673|NCT05863832|Metronidazole|metronidazole|mesh-list
110796274|NCT01204125|Antimitotic Agents|antimitotic agents|mesh-ancestor
110796275|NCT01204125|Mitosis Modulators|mitosis modulators|mesh-ancestor
110796276|NCT01204125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110796277|NCT01204125|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110796278|NCT01204125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110796280|NCT03074240|Anesthetics, General|anesthetics, general|mesh-list
110796281|NCT03074240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110796282|NCT03074240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110796283|NCT03725085|Guaifenesin|guaifenesin|mesh-list
110796284|NCT03725085|Expectorants|expectorants|mesh-ancestor
110796285|NCT03725085|Respiratory System Agents|respiratory system agents|mesh-ancestor
110796323|NCT01566825|Amitriptyline|amitriptyline|mesh-list
110796324|NCT01566825|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110796325|NCT01566825|Antidepressive Agents|antidepressive agents|mesh-ancestor
110796326|NCT01566825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110796327|NCT01566825|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110796328|NCT01566825|Analgesics|analgesics|mesh-ancestor
110796329|NCT01566825|Sensory System Agents|sensory system agents|mesh-ancestor
110796330|NCT01566825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110796331|NCT01566825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110796332|NCT01566825|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110796333|NCT01566825|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110796334|NCT01566825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110796335|NCT01566825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110796336|NCT01566825|Adrenergic Agents|adrenergic agents|mesh-ancestor
110796337|NCT01566825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110796339|NCT03559010|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110796340|NCT03559010|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110796341|NCT03559010|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110796342|NCT03559010|Contraceptive Agents|contraceptive agents|mesh-ancestor
110796343|NCT03559010|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110796344|NCT03559010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110796345|NCT03559010|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110796346|NCT03559010|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110796347|NCT03298412|Blinatumomab|blinatumomab|mesh-list
110796348|NCT03298412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110796349|NCT03297398|Ascorbic Acid|ascorbic acid|mesh-list
110796350|NCT03297398|Methyltestosterone|methyltestosterone|mesh-list
110796351|NCT03297398|Androgens|androgens|mesh-list
110796352|NCT03297398|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
110796353|NCT03297398|Hormones|hormones|mesh-ancestor
110796354|NCT03297398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110796355|NCT03297398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110796356|NCT03297398|Antioxidants|antioxidants|mesh-ancestor
110796357|NCT03297398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110796358|NCT03297398|Protective Agents|protective agents|mesh-ancestor
110796359|NCT03297398|Vitamins|vitamins|mesh-ancestor
110796360|NCT03297398|Micronutrients|micronutrients|mesh-ancestor
110796361|NCT03297398|Estrogens|estrogens|mesh-ancestor
110796362|NCT03297398|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110796363|NCT03297398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110796364|NCT03297398|Anabolic Agents|anabolic agents|mesh-ancestor
110796365|NCT03293654|Bevacizumab|bevacizumab|mesh-list
110796366|NCT03293654|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110796367|NCT03293654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110796368|NCT03293654|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110796369|NCT03293654|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110796370|NCT03293654|Growth Substances|growth substances|mesh-ancestor
110796371|NCT03293654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110796372|NCT03293654|Growth Inhibitors|growth inhibitors|mesh-ancestor
110796374|NCT03930615|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110796375|NCT03930615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110796376|NCT03930615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110796377|NCT03930615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110796378|NCT03930615|Antiviral Agents|antiviral agents|mesh-ancestor
110796379|NCT03930615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110796380|NCT03838029|Etodolac|etodolac|mesh-list
110796381|NCT03838029|Propranolol|propranolol|mesh-list
110796382|NCT03838029|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110796383|NCT03838029|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110796384|NCT03838029|Adrenergic Agents|adrenergic agents|mesh-ancestor
110796385|NCT03838029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110796386|NCT03838029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110796387|NCT03838029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110796388|NCT03838029|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110796389|NCT03838029|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110796390|NCT03838029|Vasodilator Agents|vasodilator agents|mesh-ancestor
110796391|NCT03838029|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110796392|NCT03838029|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110796394|NCT03838029|Sensory System Agents|sensory system agents|mesh-ancestor
110796395|NCT03838029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110796396|NCT03838029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110796397|NCT03838029|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110796398|NCT03838029|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110796399|NCT03838029|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110796400|NCT03838029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110796401|NCT04708340|Ascorbic acid, magnesium sulfate heptahydrate, cyanocobalamin, thiamine hydrochloride, riboflavin 5' phosphate, niacinamide, pyridoxine hydrochloride, and calcium D-pantothenate drug combination|ascorbic acid, magnesium sulfate heptahydrate, cyanocobalamin, thiamine hydrochloride, riboflavin 5' phosphate, niacinamide, pyridoxine hydrochloride, and calcium d-pantothenate drug combination|mesh-list
110796402|NCT04708340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110796403|NCT04708340|Antioxidants|antioxidants|mesh-ancestor
110796404|NCT04708340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110796405|NCT04708340|Protective Agents|protective agents|mesh-ancestor
110796406|NCT04708340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110796407|NCT03292640|Nicotinic Acids|nicotinic acids|mesh-list
110796408|NCT03292640|Tazarotene|tazarotene|mesh-list
110796409|NCT03292640|Dermatologic Agents|dermatologic agents|mesh-ancestor
110796410|NCT03292640|Keratolytic Agents|keratolytic agents|mesh-ancestor
110796411|NCT03292640|Vitamin B Complex|vitamin b complex|mesh-ancestor
110796412|NCT03292640|Vitamins|vitamins|mesh-ancestor
110796413|NCT03292640|Micronutrients|micronutrients|mesh-ancestor
110796414|NCT03292640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110796415|NCT01567215|Ethanol|ethanol|mesh-list
110796416|NCT01567215|Silver Nitrate|silver nitrate|mesh-list
110796417|NCT01567215|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110796418|NCT01567215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110796419|NCT01567215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110796420|NCT01567215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110796421|NCT02871141|Antidepressive Agents|antidepressive agents|mesh-list
110796422|NCT02871141|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110796423|NCT01202487|Lidocaine|lidocaine|mesh-list
110796424|NCT01202487|Epinephrine|epinephrine|mesh-list
110796425|NCT01202487|Tetracaine|tetracaine|mesh-list
110796426|NCT01202487|Anesthetics, Local|anesthetics, local|mesh-ancestor
110796427|NCT01202487|Anesthetics|anesthetics|mesh-ancestor
110796428|NCT01202487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110796429|NCT01202487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110796430|NCT01202487|Sensory System Agents|sensory system agents|mesh-ancestor
110796431|NCT01202487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110796432|NCT01202487|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110796433|NCT01202487|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110796434|NCT01202487|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110796435|NCT01202487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110796436|NCT01202487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110796437|NCT01202487|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110796438|NCT01202487|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110796439|NCT01202487|Adrenergic Agents|adrenergic agents|mesh-ancestor
110796440|NCT01202487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110796441|NCT01202487|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110796442|NCT01202487|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110796443|NCT01202487|Autonomic Agents|autonomic agents|mesh-ancestor
110121564|NCT01913002|Moxifloxacin|moxifloxacin|mesh-list
110796444|NCT01202487|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110796445|NCT01202487|Respiratory System Agents|respiratory system agents|mesh-ancestor
110796447|NCT01202487|Sympathomimetics|sympathomimetics|mesh-ancestor
110796448|NCT01202487|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110796449|NCT01204437|Paclitaxel|paclitaxel|mesh-list
110796450|NCT01204437|Cyclophosphamide|cyclophosphamide|mesh-list
110796451|NCT01204437|Capecitabine|capecitabine|mesh-list
110796452|NCT01204437|Methotrexate|methotrexate|mesh-list
110796453|NCT01204437|Epirubicin|epirubicin|mesh-list
110796454|NCT01204437|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110796455|NCT01204437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110796456|NCT01204437|Tubulin Modulators|tubulin modulators|mesh-ancestor
110796457|NCT01204437|Antimitotic Agents|antimitotic agents|mesh-ancestor
110796458|NCT01204437|Mitosis Modulators|mitosis modulators|mesh-ancestor
110796459|NCT01204437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110796460|NCT01204437|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110796461|NCT01204437|Immunologic Factors|immunologic factors|mesh-ancestor
110796462|NCT01204437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110796463|NCT01204437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110796464|NCT01204437|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110796465|NCT01204437|Alkylating Agents|alkylating agents|mesh-ancestor
110796466|NCT01204437|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110796467|NCT01204437|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110796468|NCT01204437|Antimetabolites|antimetabolites|mesh-ancestor
110796469|NCT01204437|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110796470|NCT01204437|Abortifacient Agents|abortifacient agents|mesh-ancestor
110617882|NCT00691028|Infliximab|infliximab|mesh-list
110796471|NCT01204437|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110796472|NCT01204437|Dermatologic Agents|dermatologic agents|mesh-ancestor
110796473|NCT01204437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110796474|NCT01204437|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110796475|NCT01204437|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110796476|NCT01204437|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110796477|NCT01204437|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110796478|NCT01204437|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110796479|NCT02633241|Dexmedetomidine|dexmedetomidine|mesh-list
110796480|NCT02633241|Propofol|propofol|mesh-list
110796481|NCT02633241|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110796482|NCT02633241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110796483|NCT02633241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110796484|NCT02633241|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110796485|NCT02633241|Analgesics|analgesics|mesh-ancestor
110796486|NCT02633241|Sensory System Agents|sensory system agents|mesh-ancestor
110796487|NCT02633241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110796488|NCT02633241|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110796489|NCT02633241|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110796490|NCT02633241|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110796491|NCT02633241|Adrenergic Agents|adrenergic agents|mesh-ancestor
110796492|NCT02633241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110796493|NCT02633241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110796494|NCT02633241|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110796495|NCT02633241|Anesthetics, General|anesthetics, general|mesh-ancestor
110796496|NCT02633241|Anesthetics|anesthetics|mesh-ancestor
110796498|NCT03292016|Emetics|emetics|mesh-ancestor
110796499|NCT03292016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110796500|NCT03292016|Autonomic Agents|autonomic agents|mesh-ancestor
110796501|NCT03292016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110796502|NCT03292016|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110796503|NCT03292016|Dopamine Agonists|dopamine agonists|mesh-ancestor
110796504|NCT03292016|Dopamine Agents|dopamine agents|mesh-ancestor
110796505|NCT03292016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110796506|NCT03292016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110796507|NCT05669391|Antidepressive Agents|antidepressive agents|mesh-list
110796508|NCT05669391|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110796509|NCT01206075|Plerixafor|plerixafor|mesh-list
110796510|NCT01206075|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110796511|NCT01206075|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110796512|NCT01206075|Antiviral Agents|antiviral agents|mesh-ancestor
110796513|NCT01206075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110796514|NCT03289676|Nicotine|nicotine|mesh-list
110796515|NCT03289676|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110796516|NCT03289676|Autonomic Agents|autonomic agents|mesh-ancestor
110796517|NCT03289676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110796518|NCT03289676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110121635|NCT01913691|Ipilimumab|ipilimumab|mesh-list
110796520|NCT03289676|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110796521|NCT03289676|Cholinergic Agents|cholinergic agents|mesh-ancestor
110796522|NCT03289676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110851686|NCT05863585|MEDI9197|medi9197|mesh-list
110796523|NCT03289676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110796524|NCT03834831|Selenium|selenium|mesh-list
110796525|NCT03834831|Ubiquinone|ubiquinone|mesh-list
110796526|NCT03834831|Coenzyme Q10|coenzyme q10|mesh-list
110796527|NCT03834831|Antioxidants|antioxidants|mesh-ancestor
110796528|NCT03834831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110796529|NCT03834831|Protective Agents|protective agents|mesh-ancestor
110796530|NCT03834831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110796531|NCT03834831|Trace Elements|trace elements|mesh-ancestor
110796532|NCT03834831|Micronutrients|micronutrients|mesh-ancestor
110796533|NCT03834831|Vitamins|vitamins|mesh-ancestor
110796534|NCT01206153|Metformin|metformin|mesh-list
110796535|NCT01206153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110796536|NCT01206153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110796537|NCT01298271|Propranolol|propranolol|mesh-list
110796538|NCT01298271|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110796539|NCT01298271|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110796540|NCT01298271|Adrenergic Agents|adrenergic agents|mesh-ancestor
110796541|NCT01298271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110796542|NCT01298271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110796543|NCT01298271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110796544|NCT01298271|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110796545|NCT01298271|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110796546|NCT01298271|Vasodilator Agents|vasodilator agents|mesh-ancestor
110796547|NCT05281965|Tretinoin|tretinoin|mesh-list
110796548|NCT05281965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110796549|NCT05281965|Keratolytic Agents|keratolytic agents|mesh-ancestor
110796550|NCT05281965|Dermatologic Agents|dermatologic agents|mesh-ancestor
110796551|NCT04251884|Ropivacaine|ropivacaine|mesh-list
110796552|NCT04251884|Anesthetics, Local|anesthetics, local|mesh-list
110796553|NCT04251884|Anesthetics|anesthetics|mesh-list
110796554|NCT04251884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110796555|NCT04251884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110796556|NCT04251884|Sensory System Agents|sensory system agents|mesh-ancestor
110796557|NCT04251884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110796558|NCT01202799|Diclofenac|diclofenac|mesh-list
110796559|NCT01202799|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110796560|NCT01202799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110796561|NCT01202799|Analgesics|analgesics|mesh-ancestor
110796562|NCT01202799|Sensory System Agents|sensory system agents|mesh-ancestor
110796563|NCT01202799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110796564|NCT01202799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110796565|NCT01202799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110796566|NCT01202799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110796567|NCT01202799|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110796568|NCT01202799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110796569|NCT01202799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110796570|NCT03829605|Hydrogen Sulfide|hydrogen sulfide|mesh-list
110796571|NCT03829605|Gasotransmitters|gasotransmitters|mesh-ancestor
110796572|NCT03829605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110514178|NCT04221906|Hormones|hormones|mesh-ancestor
110796573|NCT03829605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110796574|NCT03829605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110796576|NCT01298505|Terfenadine|terfenadine|mesh-list
110796577|NCT01298505|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110617943|NCT00744536|Growth Substances|growth substances|mesh-ancestor
110796578|NCT01298505|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110796579|NCT01298505|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110796580|NCT01298505|Histamine Antagonists|histamine antagonists|mesh-ancestor
110796581|NCT01298505|Histamine Agents|histamine agents|mesh-ancestor
110796582|NCT01298505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110796583|NCT01298505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110796584|NCT01298505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110796585|NCT01204593|Insulin|insulin|mesh-list
110796586|NCT01204593|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110796587|NCT01204593|Insulin Glargine|insulin glargine|mesh-list
110796588|NCT01204593|Insulin glulisine|insulin glulisine|mesh-list
110796589|NCT01204593|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110796590|NCT01204593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110796591|NCT03310970|Lidocaine|lidocaine|mesh-list
110796592|NCT03310970|Anesthetics, Local|anesthetics, local|mesh-ancestor
110851690|NCT05863455|Midazolam|midazolam|mesh-list
110796594|NCT03310970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110796595|NCT03310970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110796596|NCT03310970|Sensory System Agents|sensory system agents|mesh-ancestor
110796597|NCT03310970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110796598|NCT03310970|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110796599|NCT03310970|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110796600|NCT03310970|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110796601|NCT03310970|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110796602|NCT03310970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110796603|NCT05281419|Triamcinolone|triamcinolone|mesh-list
110796604|NCT05281419|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110796605|NCT05281419|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110796606|NCT05281419|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110796607|NCT05281419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110796608|NCT05281419|Glucocorticoids|glucocorticoids|mesh-ancestor
110796609|NCT05281419|Hormones|hormones|mesh-ancestor
110796610|NCT05281419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110796611|NCT05281419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110796612|NCT05281419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110796613|NCT05281419|Immunologic Factors|immunologic factors|mesh-ancestor
110796614|NCT05281419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110617985|NCT02556840|Insulin|insulin|mesh-list
110796615|NCT05281419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110796616|NCT04427072|Docetaxel|docetaxel|mesh-list
110796617|NCT04427072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110796618|NCT04427072|Tubulin Modulators|tubulin modulators|mesh-ancestor
110796619|NCT04427072|Antimitotic Agents|antimitotic agents|mesh-ancestor
110796620|NCT04427072|Mitosis Modulators|mitosis modulators|mesh-ancestor
110796621|NCT04427072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110796622|NCT03537651|Ivacaftor|ivacaftor|mesh-list
110796623|NCT03537651|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
110796624|NCT03537651|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110796625|NCT03537651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110796626|NCT01203111|Insulin|insulin|mesh-list
110796627|NCT01203111|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110796628|NCT01203111|Insulin Glargine|insulin glargine|mesh-list
110796629|NCT01203111|Insulin glulisine|insulin glulisine|mesh-list
110796630|NCT01203111|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110796631|NCT01203111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110796632|NCT02722941|Panobinostat|panobinostat|mesh-list
110796633|NCT02722941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110796634|NCT02722941|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110796635|NCT02722941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110796636|NCT02722941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110796637|NCT03420339|Adderall|adderall|mesh-list
110796638|NCT03420339|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110796639|NCT03420339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110796640|NCT01297179|Levonorgestrel|levonorgestrel|mesh-list
110796641|NCT01297179|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110796642|NCT01297179|Mirabegron|mirabegron|mesh-list
110796643|NCT01297179|Estradiol|estradiol|mesh-list
110796644|NCT01297179|Estrogens|estrogens|mesh-ancestor
110796645|NCT01297179|Hormones|hormones|mesh-ancestor
110796646|NCT01297179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110796647|NCT01297179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110796648|NCT01297179|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110796649|NCT01297179|Contraceptive Agents|contraceptive agents|mesh-ancestor
110796650|NCT01297179|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110796651|NCT01297179|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110796652|NCT01297179|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110796653|NCT01297179|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110796654|NCT01297179|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110796655|NCT01297179|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
110796656|NCT01297179|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110796657|NCT01297179|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110796658|NCT01297179|Adrenergic Agents|adrenergic agents|mesh-ancestor
110796659|NCT01297179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110796660|NCT01297179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110796661|NCT01297179|Urological Agents|urological agents|mesh-ancestor
110796662|NCT01205139|Simeprevir|simeprevir|mesh-list
110796663|NCT01205139|Rilpivirine|rilpivirine|mesh-list
110796664|NCT01205139|Antiviral Agents|antiviral agents|mesh-ancestor
110121776|NCT01914627|Analgesics|analgesics|mesh-ancestor
110796665|NCT01205139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110796667|NCT01205139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110796668|NCT01205139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110796669|NCT01205139|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110796670|NCT01205139|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110796671|NCT01205139|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110796672|NCT01205139|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110796673|NCT01205217|Paclitaxel|paclitaxel|mesh-list
110796674|NCT01205217|Cyclophosphamide|cyclophosphamide|mesh-list
110796675|NCT01205217|Trastuzumab|trastuzumab|mesh-list
110796676|NCT01205217|Epirubicin|epirubicin|mesh-list
110796677|NCT01205217|Lapatinib|lapatinib|mesh-list
110796678|NCT01205217|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110796679|NCT01205217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110796680|NCT01205217|Tubulin Modulators|tubulin modulators|mesh-ancestor
110796681|NCT01205217|Antimitotic Agents|antimitotic agents|mesh-ancestor
110796682|NCT01205217|Mitosis Modulators|mitosis modulators|mesh-ancestor
110796683|NCT01205217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110796684|NCT01205217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110796685|NCT01205217|Immunologic Factors|immunologic factors|mesh-ancestor
110796686|NCT01205217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110796687|NCT01205217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110796688|NCT01205217|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110796689|NCT01205217|Alkylating Agents|alkylating agents|mesh-ancestor
110796690|NCT01205217|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110796691|NCT01205217|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110796692|NCT01205217|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110796693|NCT01205217|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110796694|NCT01205217|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110796695|NCT01205217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110796696|NCT01205217|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110796697|NCT01203267|Paclitaxel|paclitaxel|mesh-list
110796698|NCT01203267|Carboplatin|carboplatin|mesh-list
110796699|NCT01203267|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110796700|NCT01203267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110796701|NCT01203267|Tubulin Modulators|tubulin modulators|mesh-ancestor
110796702|NCT01203267|Antimitotic Agents|antimitotic agents|mesh-ancestor
110796703|NCT01203267|Mitosis Modulators|mitosis modulators|mesh-ancestor
110796704|NCT01203267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110796705|NCT01207245|Tobramycin|tobramycin|mesh-list
110796706|NCT01207245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110796707|NCT01207245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110796708|NCT01297569|Ranibizumab|ranibizumab|mesh-list
110796709|NCT01297569|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110796710|NCT01297569|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110796711|NCT01297569|Growth Substances|growth substances|mesh-ancestor
110796712|NCT01297569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110796713|NCT01297569|Growth Inhibitors|growth inhibitors|mesh-ancestor
110796714|NCT01297569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110796715|NCT01203345|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110796716|NCT01203345|Immunologic Factors|immunologic factors|mesh-ancestor
110796717|NCT01203345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110796718|NCT01299597|Atorvastatin|atorvastatin|mesh-list
110796719|NCT01299597|Simvastatin|simvastatin|mesh-list
110796720|NCT01299597|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110796721|NCT01299597|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110796722|NCT01299597|Antimetabolites|antimetabolites|mesh-ancestor
110796723|NCT01299597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110796724|NCT01299597|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110796725|NCT01299597|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110796726|NCT01299597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110796727|NCT03723915|Pembrolizumab|pembrolizumab|mesh-list
110796728|NCT03723915|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110796729|NCT03723915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110796730|NCT03723915|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110796731|NCT03723915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110796732|NCT03840057|Azithromycin|azithromycin|mesh-list
110796733|NCT03840057|Metoclopramide|metoclopramide|mesh-list
110796734|NCT03840057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110796735|NCT03840057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110796736|NCT03840057|Antiemetics|antiemetics|mesh-ancestor
110796737|NCT03840057|Autonomic Agents|autonomic agents|mesh-ancestor
110796738|NCT03840057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110121848|NCT01915069|Cilostazol|cilostazol|mesh-list
110796739|NCT03840057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110796740|NCT03840057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110796741|NCT03840057|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110796742|NCT03840057|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110796743|NCT03840057|Dopamine Agents|dopamine agents|mesh-ancestor
110796744|NCT03840057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110796745|NCT03840057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110796746|NCT01297803|Mitomycins|mitomycins|mesh-list
110796747|NCT01297803|Mitomycin|mitomycin|mesh-list
110796748|NCT01297803|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110796749|NCT01297803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110796750|NCT01297803|Alkylating Agents|alkylating agents|mesh-ancestor
110796751|NCT01297803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110796752|NCT01297803|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110796753|NCT01297803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110796754|NCT03824691|Durvalumab|durvalumab|mesh-list
110796755|NCT03824691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110796756|NCT03824691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110796757|NCT01299831|Hormones|hormones|mesh-list
110796758|NCT01299831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110796759|NCT01299831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110796760|NCT01205997|Magnesium Sulfate|magnesium sulfate|mesh-list
110796761|NCT01205997|Fentanyl|fentanyl|mesh-list
110796762|NCT01205997|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110796763|NCT01205997|Narcotics|narcotics|mesh-ancestor
110796764|NCT01205997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110796765|NCT01205997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110796766|NCT01205997|Analgesics|analgesics|mesh-ancestor
110796767|NCT01205997|Sensory System Agents|sensory system agents|mesh-ancestor
110796768|NCT01205997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110796769|NCT01205997|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110796770|NCT01205997|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110796771|NCT01205997|Anesthetics, General|anesthetics, general|mesh-ancestor
110796772|NCT01205997|Anesthetics|anesthetics|mesh-ancestor
110796773|NCT01205997|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110796774|NCT01205997|Anticonvulsants|anticonvulsants|mesh-ancestor
110796775|NCT01205997|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110796776|NCT01205997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110796777|NCT01205997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110796778|NCT01205997|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110796779|NCT01205997|Tocolytic Agents|tocolytic agents|mesh-ancestor
110796780|NCT01205997|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110796781|NCT03818997|Paclitaxel|paclitaxel|mesh-list
110796782|NCT03818997|Atezolizumab|atezolizumab|mesh-list
110796783|NCT03818997|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110796784|NCT03818997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110796785|NCT03818997|Tubulin Modulators|tubulin modulators|mesh-ancestor
110796786|NCT03818997|Antimitotic Agents|antimitotic agents|mesh-ancestor
110796787|NCT03818997|Mitosis Modulators|mitosis modulators|mesh-ancestor
110796788|NCT03818997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110796789|NCT03818997|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110796790|NCT03818997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110796791|NCT03818919|Acetaminophen|acetaminophen|mesh-list
110796792|NCT03818919|Celecoxib|celecoxib|mesh-list
110796793|NCT03818919|Ketorolac|ketorolac|mesh-list
110796794|NCT03818919|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
110796795|NCT03818919|Diazepam|diazepam|mesh-list
110796796|NCT03818919|Gabapentin|gabapentin|mesh-list
110796797|NCT03818919|Hydrocodone|hydrocodone|mesh-list
110796798|NCT03818919|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110796799|NCT03818919|Analgesics|analgesics|mesh-ancestor
110796800|NCT03818919|Sensory System Agents|sensory system agents|mesh-ancestor
110796801|NCT03818919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110796802|NCT03818919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110796803|NCT03818919|Antipyretics|antipyretics|mesh-ancestor
110796804|NCT03818919|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110796805|NCT03818919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110796806|NCT03818919|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110796807|NCT03818919|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110796808|NCT03818919|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110796809|NCT03818919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110796810|NCT03818919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110796811|NCT03818919|Anticonvulsants|anticonvulsants|mesh-ancestor
110796812|NCT03818919|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110796813|NCT03818919|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110796814|NCT03818919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110618174|NCT00785382|Pregabalin|pregabalin|mesh-list
110796815|NCT03818919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110796816|NCT03818919|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110796817|NCT03818919|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110796818|NCT03818919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110796819|NCT03818919|Antimanic Agents|antimanic agents|mesh-ancestor
110796820|NCT03818919|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110796821|NCT03818919|Narcotics|narcotics|mesh-ancestor
110796822|NCT03818919|Antitussive Agents|antitussive agents|mesh-ancestor
110796823|NCT03818919|Respiratory System Agents|respiratory system agents|mesh-ancestor
110796824|NCT03818919|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110796825|NCT03818919|Antiemetics|antiemetics|mesh-ancestor
110796826|NCT03818919|Autonomic Agents|autonomic agents|mesh-ancestor
110796827|NCT03818919|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110796828|NCT03818919|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110796829|NCT03818919|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110796830|NCT03818919|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110796831|NCT03818919|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110796832|NCT03818919|Anesthetics, General|anesthetics, general|mesh-ancestor
110796833|NCT03818919|Anesthetics|anesthetics|mesh-ancestor
110796834|NCT03818919|GABA Modulators|gaba modulators|mesh-ancestor
110796835|NCT03818919|GABA Agents|gaba agents|mesh-ancestor
110796836|NCT03821493|Itraconazole|itraconazole|mesh-list
110796837|NCT03821493|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110796838|NCT03821493|Antifungal Agents|antifungal agents|mesh-ancestor
110796839|NCT03821493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110796840|NCT03821493|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110796841|NCT03821493|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110796842|NCT03821493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110796843|NCT03821493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110796844|NCT03821493|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110796845|NCT03821493|Hormone Antagonists|hormone antagonists|mesh-ancestor
110796846|NCT03821493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110796847|NCT03821493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110796848|NCT03821493|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110796849|NCT01301937|Meglumine Antimoniate|meglumine antimoniate|mesh-list
110796850|NCT01301937|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110796851|NCT01301937|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110796852|NCT01301937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110796853|NCT05618223|Dapagliflozin|dapagliflozin|mesh-list
110796854|NCT05618223|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110796855|NCT05618223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110796856|NCT05618223|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110796857|NCT05618223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110796858|NCT03814629|Vitamins|vitamins|mesh-list
110796859|NCT03814629|Micronutrients|micronutrients|mesh-ancestor
110796860|NCT03814629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110796861|NCT01585935|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
110796862|NCT01585935|SMOFlipid|smoflipid|mesh-list
110796863|NCT01585935|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
110796864|NCT01585935|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
110796865|NCT01585935|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110796866|NCT01300377|Lidocaine|lidocaine|mesh-list
110796867|NCT01300377|Bupivacaine|bupivacaine|mesh-list
110796868|NCT01300377|Anesthetics, Local|anesthetics, local|mesh-ancestor
110796870|NCT01300377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110796871|NCT01300377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110514478|NCT00602303|Torsemide|torsemide|mesh-list
110796872|NCT01300377|Sensory System Agents|sensory system agents|mesh-ancestor
110796873|NCT01300377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110796874|NCT01300377|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110796875|NCT01300377|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110796876|NCT01300377|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110796877|NCT01300377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110796878|NCT01300377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110796879|NCT03814707|Hyaluronic Acid|hyaluronic acid|mesh-list
110796880|NCT03814707|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110796881|NCT03814707|Immunologic Factors|immunologic factors|mesh-ancestor
110796882|NCT03814707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110796883|NCT03814707|Viscosupplements|viscosupplements|mesh-ancestor
110796884|NCT03814707|Protective Agents|protective agents|mesh-ancestor
110796885|NCT03818295|Praliciguat|praliciguat|mesh-list
110796886|NCT03818295|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
110796888|NCT03818295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110796889|NCT03818295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110796890|NCT01300611|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
110796891|NCT01300611|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110796892|NCT01300611|Vasodilator Agents|vasodilator agents|mesh-ancestor
110796893|NCT01301313|Simendan|simendan|mesh-list
110796894|NCT01301313|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110796895|NCT01301313|Vasodilator Agents|vasodilator agents|mesh-ancestor
110796896|NCT01301313|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110796897|NCT01301313|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110796898|NCT01301313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110796899|NCT01301313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110796900|NCT01301313|Protective Agents|protective agents|mesh-ancestor
110796901|NCT01301313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110796902|NCT03817359|Remifentanil|remifentanil|mesh-list
110796903|NCT03817359|Propofol|propofol|mesh-list
110796904|NCT03817359|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110796905|NCT03817359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110796906|NCT03817359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110796907|NCT03817359|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110796908|NCT03817359|Anesthetics, General|anesthetics, general|mesh-ancestor
110796909|NCT03817359|Anesthetics|anesthetics|mesh-ancestor
110796910|NCT03817359|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110796911|NCT03817359|Narcotics|narcotics|mesh-ancestor
110796912|NCT03817359|Analgesics|analgesics|mesh-ancestor
110796913|NCT03817359|Sensory System Agents|sensory system agents|mesh-ancestor
110796914|NCT03817359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110796915|NCT03813927|Vitamin D|vitamin d|mesh-list
110796917|NCT03813927|Micronutrients|micronutrients|mesh-ancestor
110796918|NCT03813927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110796919|NCT03813927|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110796920|NCT02819518|Paclitaxel|paclitaxel|mesh-list
110796921|NCT02819518|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110796922|NCT02819518|Carboplatin|carboplatin|mesh-list
110796923|NCT02819518|Gemcitabine|gemcitabine|mesh-list
110796924|NCT02819518|Pembrolizumab|pembrolizumab|mesh-list
110796925|NCT02819518|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110796926|NCT02819518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110796927|NCT02819518|Tubulin Modulators|tubulin modulators|mesh-ancestor
110796928|NCT02819518|Antimitotic Agents|antimitotic agents|mesh-ancestor
110796929|NCT02819518|Mitosis Modulators|mitosis modulators|mesh-ancestor
110796930|NCT02819518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110796931|NCT02819518|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110796932|NCT02819518|Antimetabolites|antimetabolites|mesh-ancestor
110796933|NCT02819518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110796934|NCT02819518|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110796935|NCT03310580|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110796936|NCT03310580|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110796937|NCT03813771|Hydroxychloroquine|hydroxychloroquine|mesh-list
110796938|NCT03813771|Sulfasalazine|sulfasalazine|mesh-list
110796939|NCT03813771|Etanercept|etanercept|mesh-list
110796940|NCT03813771|Methotrexate|methotrexate|mesh-list
110796941|NCT03813771|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110796942|NCT03813771|Abortifacient Agents|abortifacient agents|mesh-ancestor
110796943|NCT03813771|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110796944|NCT03813771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110796945|NCT03813771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110796946|NCT03813771|Antimetabolites|antimetabolites|mesh-ancestor
110796947|NCT03813771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110796948|NCT03813771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110796949|NCT03813771|Dermatologic Agents|dermatologic agents|mesh-ancestor
110796950|NCT03813771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110796951|NCT03813771|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110796952|NCT03813771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110796953|NCT03813771|Immunologic Factors|immunologic factors|mesh-ancestor
110796954|NCT03813771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110796955|NCT03813771|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110796956|NCT03813771|Antimalarials|antimalarials|mesh-ancestor
110796957|NCT03813771|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110796958|NCT03813771|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110796959|NCT03813771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110796960|NCT03813771|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110796961|NCT03813771|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110796963|NCT03813771|Sensory System Agents|sensory system agents|mesh-ancestor
110796964|NCT03813771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110796965|NCT03813771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110796966|NCT03813771|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110796967|NCT03813693|Chlorhexidine|chlorhexidine|mesh-list
110796968|NCT03813693|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110796969|NCT03813693|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110796970|NCT03813693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110796971|NCT03813693|Disinfectants|disinfectants|mesh-ancestor
110796972|NCT03813693|Dermatologic Agents|dermatologic agents|mesh-ancestor
110796973|NCT02036242|Sufentanil|sufentanil|mesh-list
110796974|NCT02036242|Ropivacaine|ropivacaine|mesh-list
110796975|NCT02036242|Anesthetics, Local|anesthetics, local|mesh-list
110796976|NCT02036242|Anesthetics|anesthetics|mesh-list
110796977|NCT02036242|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110796978|NCT02036242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110796979|NCT02036242|Sensory System Agents|sensory system agents|mesh-ancestor
110618268|NCT00778752|Lenalidomide|lenalidomide|mesh-list
110796980|NCT02036242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110796981|NCT02036242|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110796982|NCT02036242|Narcotics|narcotics|mesh-ancestor
110796983|NCT02036242|Analgesics|analgesics|mesh-ancestor
110796984|NCT02036242|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110796985|NCT02036242|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110796986|NCT02036242|Anesthetics, General|anesthetics, general|mesh-ancestor
110796987|NCT05281107|Calcium, Dietary|calcium, dietary|mesh-list
110796988|NCT05281107|Vitamin D|vitamin d|mesh-list
110657047|NCT05914506|Xenon|xenon|mesh-list
110796989|NCT05281107|Ergocalciferols|ergocalciferols|mesh-list
110796990|NCT05281107|Cholecalciferol|cholecalciferol|mesh-list
110796991|NCT05281107|Vitamins|vitamins|mesh-list
110796992|NCT05281107|Calcium|calcium|mesh-list
110796993|NCT05281107|Micronutrients|micronutrients|mesh-ancestor
110796994|NCT05281107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110796995|NCT05281107|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110796996|NCT05281107|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110796997|NCT02812186|Rocuronium|rocuronium|mesh-list
110796998|NCT02812186|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110796999|NCT02812186|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110797000|NCT02812186|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110797001|NCT02812186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110797002|NCT02812186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110797003|NCT03310268|Listerine|listerine|mesh-list
110797004|NCT03310268|Fluorides|fluorides|mesh-list
110797005|NCT03310268|Sodium Fluoride|sodium fluoride|mesh-list
110797006|NCT03310268|Tin Fluorides|tin fluorides|mesh-list
110797007|NCT03310268|Fluorophosphate|fluorophosphate|mesh-list
110797008|NCT03310268|Cariostatic Agents|cariostatic agents|mesh-ancestor
110797009|NCT03310268|Protective Agents|protective agents|mesh-ancestor
110797010|NCT03310268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110797011|NCT03310268|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110797012|NCT03310268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110797013|NCT01301469|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110797014|NCT02810392|Insulin|insulin|mesh-list
110797015|NCT02810392|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110797016|NCT02810392|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110797017|NCT02810392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110797018|NCT03805035|Chlorpheniramine|chlorpheniramine|mesh-list
110797019|NCT03805035|Maleic acid|maleic acid|mesh-list
110797020|NCT03805035|Histamine Antagonists|histamine antagonists|mesh-list
110797021|NCT03805035|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
110797022|NCT03805035|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
110797023|NCT03805035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110797024|NCT03805035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110797025|NCT03805035|Histamine Agents|histamine agents|mesh-ancestor
110797026|NCT03805035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110797027|NCT03805035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110797029|NCT03805035|Dermatologic Agents|dermatologic agents|mesh-ancestor
110797030|NCT03805035|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110797031|NCT02815540|Cannabidiol|cannabidiol|mesh-list
110797032|NCT02815540|Anticonvulsants|anticonvulsants|mesh-ancestor
110797033|NCT03816267|Albuterol|albuterol|mesh-list
110797034|NCT03816267|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110797035|NCT03816267|Autonomic Agents|autonomic agents|mesh-ancestor
110797036|NCT03816267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110797037|NCT03816267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110797038|NCT03816267|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110797039|NCT03816267|Respiratory System Agents|respiratory system agents|mesh-ancestor
110797040|NCT03816267|Tocolytic Agents|tocolytic agents|mesh-ancestor
110797041|NCT03816267|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110797042|NCT03816267|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110797043|NCT03816267|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110797044|NCT03816267|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110797045|NCT03816267|Adrenergic Agents|adrenergic agents|mesh-ancestor
110797046|NCT03816267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110797047|NCT03816267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110797049|NCT03280550|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110797050|NCT03280550|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110797051|NCT03280550|Respiratory System Agents|respiratory system agents|mesh-ancestor
110797052|NCT02036554|Mycophenolic Acid|mycophenolic acid|mesh-list
110797053|NCT02036554|Everolimus|everolimus|mesh-list
110797054|NCT02036554|Tacrolimus|tacrolimus|mesh-list
110797055|NCT02036554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110797056|NCT02036554|Immunologic Factors|immunologic factors|mesh-ancestor
110797057|NCT02036554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110797058|NCT02036554|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110797059|NCT02036554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110797060|NCT02036554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110797061|NCT02036554|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110797062|NCT02036554|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110797063|NCT02036554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110797064|NCT02036554|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110797065|NCT02036554|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110797066|NCT02036554|Antitubercular Agents|antitubercular agents|mesh-ancestor
110797067|NCT02036554|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110797068|NCT02036554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110797070|NCT05577117|Dexmedetomidine|dexmedetomidine|mesh-list
110797071|NCT05577117|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110797072|NCT05577117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110797073|NCT05577117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110797074|NCT05577117|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110797075|NCT05577117|Analgesics|analgesics|mesh-ancestor
110797076|NCT05577117|Sensory System Agents|sensory system agents|mesh-ancestor
110797077|NCT05577117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110797078|NCT05577117|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110797079|NCT05577117|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110797080|NCT05577117|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110797081|NCT05577117|Adrenergic Agents|adrenergic agents|mesh-ancestor
110797082|NCT05577117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110797083|NCT05577117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110797084|NCT05577117|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110797085|NCT05577117|Narcotics|narcotics|mesh-ancestor
110797086|NCT05577117|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110797087|NCT05577117|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110797088|NCT05577117|Anesthetics, General|anesthetics, general|mesh-ancestor
110797089|NCT05577117|Anesthetics|anesthetics|mesh-ancestor
110797090|NCT03813303|Fentanyl|fentanyl|mesh-list
110797091|NCT03813303|Midazolam|midazolam|mesh-list
110797092|NCT03813303|Propofol|propofol|mesh-list
110797093|NCT03813303|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110797094|NCT03813303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110797095|NCT03813303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110797096|NCT03813303|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110797097|NCT03813303|Anesthetics, General|anesthetics, general|mesh-ancestor
110797098|NCT03813303|Anesthetics|anesthetics|mesh-ancestor
110514702|NCT00901849|Sirolimus|sirolimus|mesh-list
110797099|NCT03813303|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110797100|NCT03813303|Narcotics|narcotics|mesh-ancestor
110797101|NCT03813303|Analgesics|analgesics|mesh-ancestor
110797102|NCT03813303|Sensory System Agents|sensory system agents|mesh-ancestor
110797103|NCT03813303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110797104|NCT03813303|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110797105|NCT03813303|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110797106|NCT03813303|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110797107|NCT03813303|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110797108|NCT03813303|GABA Modulators|gaba modulators|mesh-ancestor
110797109|NCT03813303|GABA Agents|gaba agents|mesh-ancestor
110797110|NCT03813303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110797111|NCT03813303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110797112|NCT03637790|Rifampin|rifampin|mesh-list
110797113|NCT03637790|Abrocitinib|abrocitinib|mesh-list
110797114|NCT03637790|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110797115|NCT03637790|Antitubercular Agents|antitubercular agents|mesh-ancestor
110797116|NCT03637790|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110797118|NCT03637790|Leprostatic Agents|leprostatic agents|mesh-ancestor
110797119|NCT03637790|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110797120|NCT03637790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110797121|NCT03637790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110797122|NCT03637790|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110618384|NCT00930189|Growth Inhibitors|growth inhibitors|mesh-ancestor
110797123|NCT03637790|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110797124|NCT03637790|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110797125|NCT03637790|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110797126|NCT03637790|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110797127|NCT03637790|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110797128|NCT03637790|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110797129|NCT03813069|Permethrin|permethrin|mesh-list
110797130|NCT03813069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110797131|NCT03813069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110797132|NCT03276026|Neostigmine|neostigmine|mesh-list
110797133|NCT03276026|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110797134|NCT03276026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110797135|NCT03276026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110797136|NCT03276026|Cholinergic Agents|cholinergic agents|mesh-ancestor
110797137|NCT03276026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110797138|NCT03276026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110797139|NCT03276026|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110797140|NCT03276026|Autonomic Agents|autonomic agents|mesh-ancestor
110797141|NCT03276026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110797142|NCT01303497|Paclitaxel|paclitaxel|mesh-list
110797143|NCT01303497|Bevacizumab|bevacizumab|mesh-list
110797144|NCT01303497|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110797145|NCT01303497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110797146|NCT01303497|Tubulin Modulators|tubulin modulators|mesh-ancestor
110797147|NCT01303497|Antimitotic Agents|antimitotic agents|mesh-ancestor
110797148|NCT01303497|Mitosis Modulators|mitosis modulators|mesh-ancestor
110797149|NCT01303497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110618433|NCT00746720|Etoricoxib|etoricoxib|mesh-list
110797150|NCT01303497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110797151|NCT01303497|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110797152|NCT01303497|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110797153|NCT01303497|Growth Substances|growth substances|mesh-ancestor
110797154|NCT01303497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110797155|NCT01303497|Growth Inhibitors|growth inhibitors|mesh-ancestor
110797156|NCT01589523|Cholic Acids|cholic acids|mesh-list
110797157|NCT01589523|Glycocholic Acid|glycocholic acid|mesh-list
110797158|NCT01589523|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110797159|NCT01589523|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
110797160|NCT03804177|Ascorbic Acid|ascorbic acid|mesh-list
110797161|NCT03804177|Melatonin|melatonin|mesh-list
110797162|NCT03804177|Hyaluronic Acid|hyaluronic acid|mesh-list
110797163|NCT03804177|Antioxidants|antioxidants|mesh-ancestor
110797164|NCT03804177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110797165|NCT03804177|Protective Agents|protective agents|mesh-ancestor
110797166|NCT03804177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110797167|NCT03804177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110797168|NCT03804177|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110797169|NCT03804177|Immunologic Factors|immunologic factors|mesh-ancestor
110797170|NCT03804177|Viscosupplements|viscosupplements|mesh-ancestor
110797171|NCT03804177|Vitamins|vitamins|mesh-ancestor
110797172|NCT03804177|Micronutrients|micronutrients|mesh-ancestor
110797173|NCT03277352|Pembrolizumab|pembrolizumab|mesh-list
110797174|NCT03277352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110797175|NCT03277352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110797176|NCT03277352|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110514776|NCT00939029|Nicotine|nicotine|mesh-list
110797177|NCT03277352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110797178|NCT01302093|Racecadotril|racecadotril|mesh-list
110797179|NCT01302093|Thiorphan|thiorphan|mesh-list
110797180|NCT01302093|Antidiarrheals|antidiarrheals|mesh-ancestor
110797181|NCT01302093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110797182|NCT01302093|Protease Inhibitors|protease inhibitors|mesh-ancestor
110797183|NCT01302093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110797184|NCT01302093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110797185|NCT03803007|Glenzocimab|glenzocimab|mesh-list
110797186|NCT03803007|Anticoagulants|anticoagulants|mesh-ancestor
110797187|NCT03802149|Ulipristal acetate|ulipristal acetate|mesh-list
110797188|NCT03802149|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110797189|NCT03802149|Contraceptive Agents|contraceptive agents|mesh-ancestor
110797190|NCT03802149|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110797191|NCT03802149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110797192|NCT03802149|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110797193|NCT02047552|Iron|iron|mesh-list
110851760|NCT05860452|Anesthetics|anesthetics|mesh-ancestor
110797194|NCT02047552|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
110797196|NCT02047552|Trace Elements|trace elements|mesh-ancestor
110797197|NCT02047552|Micronutrients|micronutrients|mesh-ancestor
110797198|NCT02047552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110797199|NCT02047552|Hematinics|hematinics|mesh-ancestor
110797200|NCT02047552|Androgens|androgens|mesh-ancestor
110797201|NCT02047552|Hormones|hormones|mesh-ancestor
110797202|NCT02047552|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110797203|NCT02047552|Anabolic Agents|anabolic agents|mesh-ancestor
110797204|NCT01303731|Fentanyl|fentanyl|mesh-list
110797205|NCT01303731|Bupivacaine|bupivacaine|mesh-list
110797206|NCT01303731|Anesthetics, Local|anesthetics, local|mesh-ancestor
110797207|NCT01303731|Anesthetics|anesthetics|mesh-ancestor
110797208|NCT01303731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110797209|NCT01303731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110797210|NCT01303731|Sensory System Agents|sensory system agents|mesh-ancestor
110797211|NCT01303731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110797212|NCT01303731|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110797213|NCT01303731|Narcotics|narcotics|mesh-ancestor
110797214|NCT01303731|Analgesics|analgesics|mesh-ancestor
110797215|NCT01303731|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110797216|NCT01303731|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110797217|NCT01303731|Anesthetics, General|anesthetics, general|mesh-ancestor
110797218|NCT03815487|Insulin|insulin|mesh-list
110797219|NCT03815487|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110797220|NCT03815487|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110797221|NCT03815487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110797222|NCT03815422|Anesthetics|anesthetics|mesh-list
110797223|NCT03815422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110797224|NCT03815422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110797225|NCT02260024|Pramipexole|pramipexole|mesh-list
110797226|NCT02260024|Antioxidants|antioxidants|mesh-ancestor
110797227|NCT02260024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110797228|NCT02260024|Protective Agents|protective agents|mesh-ancestor
110797229|NCT02260024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110797230|NCT02260024|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110797231|NCT02260024|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110797232|NCT02260024|Dopamine Agonists|dopamine agonists|mesh-ancestor
110797233|NCT02260024|Dopamine Agents|dopamine agents|mesh-ancestor
110797234|NCT02260024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110797235|NCT03800667|Ascorbic Acid|ascorbic acid|mesh-list
110797236|NCT03800667|Antioxidants|antioxidants|mesh-ancestor
110797237|NCT03800667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110797238|NCT03800667|Protective Agents|protective agents|mesh-ancestor
110797239|NCT03800667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110797240|NCT03800667|Vitamins|vitamins|mesh-ancestor
110797241|NCT03800667|Micronutrients|micronutrients|mesh-ancestor
110797242|NCT01302171|Lenograstim|lenograstim|mesh-list
110797243|NCT01302171|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110797244|NCT01302171|Immunologic Factors|immunologic factors|mesh-ancestor
110797245|NCT01302171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110797246|NCT02047630|Latanoprost|latanoprost|mesh-list
110797247|NCT02047630|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110797248|NCT02047630|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110797249|NCT04305470|Aminolevulinic Acid|aminolevulinic acid|mesh-list
110797250|NCT04305470|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110797251|NCT04305470|Dermatologic Agents|dermatologic agents|mesh-ancestor
110514854|NCT05565729|Levocetirizine|levocetirizine|mesh-list
110797252|NCT03799809|Voriconazole|voriconazole|mesh-list
110797253|NCT03799809|Antifungal Agents|antifungal agents|mesh-ancestor
110797254|NCT03799809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110797255|NCT03799809|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110797256|NCT03799809|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110797257|NCT03799809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110797258|NCT03799809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110797259|NCT03799809|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110797260|NCT03799809|Hormone Antagonists|hormone antagonists|mesh-ancestor
110797261|NCT03799809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110797262|NCT03799809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110797263|NCT03799809|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110797264|NCT03812523|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110797265|NCT03812523|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110797266|NCT03812523|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110797267|NCT03812523|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110797268|NCT03812523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110797269|NCT03812523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110797270|NCT03812523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110797272|NCT03812523|Sensory System Agents|sensory system agents|mesh-ancestor
110797273|NCT03812523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110797274|NCT03812523|Antidepressive Agents|antidepressive agents|mesh-ancestor
110797275|NCT03812523|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110797276|NCT03812523|Dopamine Agents|dopamine agents|mesh-ancestor
110797277|NCT04216251|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
110797278|NCT04216251|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110797279|NCT04216251|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110797280|NCT02049970|Dexmedetomidine|dexmedetomidine|mesh-list
110797281|NCT02049970|Bupivacaine|bupivacaine|mesh-list
110797282|NCT02049970|Anesthetics, Local|anesthetics, local|mesh-ancestor
110797283|NCT02049970|Anesthetics|anesthetics|mesh-ancestor
110797284|NCT02049970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110797285|NCT02049970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110797286|NCT02049970|Sensory System Agents|sensory system agents|mesh-ancestor
110797287|NCT02049970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110797288|NCT02049970|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110797289|NCT02049970|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110797290|NCT02049970|Analgesics|analgesics|mesh-ancestor
110797291|NCT02049970|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110797292|NCT02049970|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110797293|NCT02049970|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110797294|NCT02049970|Adrenergic Agents|adrenergic agents|mesh-ancestor
110797295|NCT02049970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110797296|NCT02049970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110797297|NCT02048020|Paclitaxel|paclitaxel|mesh-list
110797298|NCT02048020|Carboplatin|carboplatin|mesh-list
110797299|NCT02048020|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110797300|NCT02048020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110797301|NCT02048020|Tubulin Modulators|tubulin modulators|mesh-ancestor
110797302|NCT02048020|Antimitotic Agents|antimitotic agents|mesh-ancestor
110797303|NCT02048020|Mitosis Modulators|mitosis modulators|mesh-ancestor
110797304|NCT02048020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110797305|NCT03562390|Irinotecan|irinotecan|mesh-list
110797306|NCT03562390|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110797307|NCT03562390|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110797308|NCT03562390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110797309|NCT03562390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110797310|NCT03562390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110797311|NCT02048098|Misoprostol|misoprostol|mesh-list
110797312|NCT02048098|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110797313|NCT02048098|Abortifacient Agents|abortifacient agents|mesh-ancestor
110797314|NCT02048098|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110797315|NCT02048098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110797316|NCT02048098|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110797317|NCT02048098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110797318|NCT02048098|Oxytocics|oxytocics|mesh-ancestor
110797319|NCT02050360|Sildenafil Citrate|sildenafil citrate|mesh-list
110797320|NCT02050360|Vasodilator Agents|vasodilator agents|mesh-ancestor
110797321|NCT02050360|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110797322|NCT02050360|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110797323|NCT02050360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110797324|NCT02050360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110797325|NCT02050360|Urological Agents|urological agents|mesh-ancestor
110797327|NCT02940860|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
110797328|NCT02940860|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
110797329|NCT02940860|Trace Elements|trace elements|mesh-ancestor
110797330|NCT02940860|Micronutrients|micronutrients|mesh-ancestor
110797331|NCT02940860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110797332|NCT02940860|Hematinics|hematinics|mesh-ancestor
110797333|NCT01303887|Prednisolone|prednisolone|mesh-list
110797334|NCT01303887|Cyclophosphamide|cyclophosphamide|mesh-list
110797335|NCT01303887|Rituximab|rituximab|mesh-list
110797336|NCT01303887|Fludarabine|fludarabine|mesh-list
110797337|NCT01303887|Vincristine|vincristine|mesh-list
110797338|NCT01303887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110797339|NCT01303887|Immunologic Factors|immunologic factors|mesh-ancestor
110797340|NCT01303887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110797341|NCT01303887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110797342|NCT01303887|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110797343|NCT01303887|Alkylating Agents|alkylating agents|mesh-ancestor
110797344|NCT01303887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110797345|NCT01303887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110797346|NCT01303887|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110797347|NCT01303887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110797348|NCT01303887|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110797349|NCT01303887|Tubulin Modulators|tubulin modulators|mesh-ancestor
110797350|NCT01303887|Antimitotic Agents|antimitotic agents|mesh-ancestor
110797351|NCT01303887|Mitosis Modulators|mitosis modulators|mesh-ancestor
110797352|NCT01303887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110797353|NCT01303887|Glucocorticoids|glucocorticoids|mesh-ancestor
110797355|NCT01303887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110797356|NCT01303887|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110797357|NCT02050594|Ipilimumab|ipilimumab|mesh-list
110797358|NCT02050594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110797359|NCT02050594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110797360|NCT02050594|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110797361|NCT02050594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110797362|NCT02806960|Glucagon|glucagon|mesh-list
110797363|NCT02806960|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110797364|NCT02806960|Hormones|hormones|mesh-ancestor
110797365|NCT02806960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110797366|NCT02806960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110797367|NCT03718143|Adavosertib|adavosertib|mesh-list
110797368|NCT03718143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110797369|NCT03718143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110797370|NCT02955134|Hydrotalcite|hydrotalcite|mesh-list
110797371|NCT02955134|Antacids|antacids|mesh-ancestor
110797372|NCT02955134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110797373|NCT02955134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110797374|NCT02048488|Belizatinib|belizatinib|mesh-list
110797375|NCT02048488|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110797376|NCT02048488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110797377|NCT02048488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110797378|NCT02050672|Inositol|inositol|mesh-list
110797379|NCT02050672|Vitamin B Complex|vitamin b complex|mesh-ancestor
110797380|NCT02050672|Vitamins|vitamins|mesh-ancestor
110797381|NCT02050672|Micronutrients|micronutrients|mesh-ancestor
110797382|NCT02050672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110797383|NCT03811366|Prednisone|prednisone|mesh-list
110797384|NCT03811366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110797385|NCT03811366|Glucocorticoids|glucocorticoids|mesh-ancestor
110797386|NCT03811366|Hormones|hormones|mesh-ancestor
110797387|NCT03811366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110797388|NCT03811366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110797389|NCT03811366|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110797390|NCT03811366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110797391|NCT03274466|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
110797392|NCT03274466|Laxatives|laxatives|mesh-ancestor
110797393|NCT03274466|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110797394|NCT02037802|Fentanyl|fentanyl|mesh-list
110797395|NCT02037802|Meperidine|meperidine|mesh-list
110797396|NCT02037802|Bupivacaine|bupivacaine|mesh-list
110797397|NCT02037802|Propofol|propofol|mesh-list
110797398|NCT02037802|Anesthetics, Local|anesthetics, local|mesh-ancestor
110797399|NCT02037802|Anesthetics|anesthetics|mesh-ancestor
110797400|NCT02037802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110797401|NCT02037802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110515012|NCT02852837|Daratumumab|daratumumab|mesh-list
110797402|NCT02037802|Sensory System Agents|sensory system agents|mesh-ancestor
110797403|NCT02037802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110797404|NCT02037802|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110797405|NCT02037802|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110797406|NCT02037802|Anesthetics, General|anesthetics, general|mesh-ancestor
110797407|NCT02037802|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110797408|NCT02037802|Narcotics|narcotics|mesh-ancestor
110797409|NCT02037802|Analgesics|analgesics|mesh-ancestor
110797410|NCT02037802|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110797412|NCT02051530|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110797413|NCT02051530|Antidepressive Agents|antidepressive agents|mesh-ancestor
110797415|NCT03797703|Lidocaine|lidocaine|mesh-list
110797416|NCT03797703|Anesthetics, Local|anesthetics, local|mesh-ancestor
110797417|NCT03797703|Anesthetics|anesthetics|mesh-ancestor
110797418|NCT03797703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110797419|NCT03797703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110797420|NCT03797703|Sensory System Agents|sensory system agents|mesh-ancestor
110797421|NCT03797703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110797422|NCT03797703|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110797423|NCT03797703|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110618700|NCT00565773|Abatacept|abatacept|mesh-list
110797424|NCT03797703|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110797425|NCT03797703|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110797426|NCT03797703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110797427|NCT02048644|Beclomethasone|beclomethasone|mesh-list
110797428|NCT02048644|Formoterol Fumarate|formoterol fumarate|mesh-list
110797429|NCT02048644|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110797430|NCT02048644|Autonomic Agents|autonomic agents|mesh-ancestor
110797431|NCT02048644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110797432|NCT02048644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110797433|NCT02048644|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110797434|NCT02048644|Respiratory System Agents|respiratory system agents|mesh-ancestor
110797435|NCT02048644|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110797436|NCT02048644|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110797437|NCT02048644|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110797438|NCT02048644|Adrenergic Agents|adrenergic agents|mesh-ancestor
110797439|NCT02048644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110797440|NCT02048644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110797441|NCT02048644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110797442|NCT02048644|Glucocorticoids|glucocorticoids|mesh-ancestor
110797443|NCT02048644|Hormones|hormones|mesh-ancestor
110797444|NCT02048644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110797445|NCT02048800|Treosulfan|treosulfan|mesh-list
110797446|NCT02048800|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110797447|NCT02048800|Alkylating Agents|alkylating agents|mesh-ancestor
110797448|NCT02048800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110797449|NCT02048800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110797450|NCT03797625|Cisplatin|cisplatin|mesh-list
110797451|NCT03797625|Irinotecan|irinotecan|mesh-list
110797452|NCT03797625|Endostar protein|endostar protein|mesh-list
110797453|NCT03797625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110797454|NCT03797625|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110797455|NCT03797625|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110797456|NCT03797625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110797457|NCT03797625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110797458|NCT03797625|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110797459|NCT03797625|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110797460|NCT03797625|Growth Substances|growth substances|mesh-ancestor
110797461|NCT03797625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110797462|NCT03797625|Growth Inhibitors|growth inhibitors|mesh-ancestor
110797464|NCT02051842|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110797465|NCT02806414|Ivermectin|ivermectin|mesh-list
110797466|NCT02806414|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110797467|NCT02806414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110797468|NCT02049034|Lixisenatide|lixisenatide|mesh-list
110797469|NCT02049034|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110797470|NCT02049034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110797471|NCT02049190|Onapristone|onapristone|mesh-list
110797472|NCT02049190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110797473|NCT02049190|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110515079|NCT00906295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110797474|NCT02049190|Fertility Agents|fertility agents|mesh-ancestor
110797475|NCT02049190|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110797476|NCT02049190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110797477|NCT02049190|Hormone Antagonists|hormone antagonists|mesh-ancestor
110797478|NCT02049190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110797479|NCT03811509|Denosumab|denosumab|mesh-list
110797480|NCT03811509|Diphosphonates|diphosphonates|mesh-list
110797481|NCT03811509|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110797482|NCT03811509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110797483|NCT02037412|Clopidogrel|clopidogrel|mesh-list
110797484|NCT02037412|Ticagrelor|ticagrelor|mesh-list
110797485|NCT02037412|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110797486|NCT02037412|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110797487|NCT02037412|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110797488|NCT02037412|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110797489|NCT02037412|Purinergic Agents|purinergic agents|mesh-ancestor
110797490|NCT02037412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110797491|NCT02037412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110797492|NCT02037412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110797493|NCT02052154|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110797494|NCT02052154|Immunologic Factors|immunologic factors|mesh-ancestor
110797495|NCT02052154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110797496|NCT03797079|Bupivacaine|bupivacaine|mesh-list
110618780|NCT00752180|Insulin|insulin|mesh-list
110797497|NCT03797079|Anesthetics, Local|anesthetics, local|mesh-ancestor
110797498|NCT03797079|Anesthetics|anesthetics|mesh-ancestor
110797499|NCT03797079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110797500|NCT03797079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110797501|NCT03797079|Sensory System Agents|sensory system agents|mesh-ancestor
110797502|NCT03797079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110797503|NCT02049268|Ethanol|ethanol|mesh-list
110797504|NCT02049268|Nicotine|nicotine|mesh-list
110797505|NCT02049268|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110797506|NCT02049268|Autonomic Agents|autonomic agents|mesh-ancestor
110797507|NCT02049268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110797508|NCT02049268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110797509|NCT02049268|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110797510|NCT02049268|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110797511|NCT02049268|Cholinergic Agents|cholinergic agents|mesh-ancestor
110797512|NCT02049268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110797513|NCT02049268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110797514|NCT02049268|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110797515|NCT02049268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110797516|NCT02049268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110797517|NCT02049346|Epoetin Alfa|epoetin alfa|mesh-list
110797518|NCT02049346|Darbepoetin alfa|darbepoetin alfa|mesh-list
110797519|NCT02049346|Hematinics|hematinics|mesh-ancestor
110797520|NCT03564873|Azacitidine|azacitidine|mesh-list
110797521|NCT03564873|Homoharringtonine|homoharringtonine|mesh-list
110797522|NCT03564873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110797523|NCT03564873|Antimetabolites|antimetabolites|mesh-ancestor
110797524|NCT03564873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110797525|NCT03564873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110797526|NCT03564873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110797527|NCT03564873|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110797528|NCT03564873|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110797529|NCT02806024|Tranexamic Acid|tranexamic acid|mesh-list
110797530|NCT02806024|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110797531|NCT02806024|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110797532|NCT02806024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110797533|NCT02806024|Hemostatics|hemostatics|mesh-ancestor
110797534|NCT02806024|Coagulants|coagulants|mesh-ancestor
110797535|NCT03811197|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
110797536|NCT03811197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110797537|NCT03811197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110797538|NCT02049580|Cyclophosphamide|cyclophosphamide|mesh-list
110797539|NCT02049580|Thiotepa|thiotepa|mesh-list
110797540|NCT02049580|Fludarabine|fludarabine|mesh-list
110797541|NCT02049580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110797542|NCT02049580|Immunologic Factors|immunologic factors|mesh-ancestor
110797543|NCT02049580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110797544|NCT02049580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110797545|NCT02049580|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110797546|NCT02049580|Alkylating Agents|alkylating agents|mesh-ancestor
110797547|NCT02049580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110797548|NCT02049580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110797549|NCT02049580|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110797550|NCT01302951|Moxifloxacin|moxifloxacin|mesh-list
110797551|NCT01302951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110797552|NCT01302951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110797553|NCT01302951|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110797554|NCT01302951|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110797555|NCT01302951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110797556|NCT01302951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110797557|NCT01302951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110797559|NCT03796533|Antifungal Agents|antifungal agents|mesh-ancestor
110797560|NCT03796533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110797561|NCT03796533|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
110797562|NCT03796533|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110797563|NCT03796533|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110797564|NCT03796533|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110797565|NCT03796533|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110797566|NCT03796533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110797567|NCT03796533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110797568|NCT03796533|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110797569|NCT03796533|Hormone Antagonists|hormone antagonists|mesh-ancestor
110797570|NCT03796533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110797571|NCT03796533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110797572|NCT03796377|Rivaroxaban|rivaroxaban|mesh-list
110797573|NCT03796377|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110797574|NCT03796377|Antithrombins|antithrombins|mesh-ancestor
110797575|NCT03796377|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110797576|NCT03796377|Protease Inhibitors|protease inhibitors|mesh-ancestor
110797577|NCT03796377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110797578|NCT03796377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110797579|NCT03796377|Anticoagulants|anticoagulants|mesh-ancestor
110797580|NCT02049736|Telbivudine|telbivudine|mesh-list
110797581|NCT02049736|Antiviral Agents|antiviral agents|mesh-ancestor
110797582|NCT02049736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110797583|NCT02049736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110797584|NCT02049736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110797585|NCT02049736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110797587|NCT01303029|Capecitabine|capecitabine|mesh-list
110797588|NCT01303029|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110797589|NCT01303029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110797590|NCT01303029|Antimetabolites|antimetabolites|mesh-ancestor
110797591|NCT01303029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110797592|NCT01303029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110797593|NCT01303029|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110797594|NCT01303029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110797596|NCT02052388|Brilacidin|brilacidin|mesh-list
110797597|NCT02052388|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110797598|NCT02052388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110797599|NCT01303107|Bupivacaine|bupivacaine|mesh-list
110797600|NCT01303107|Anesthetics, Local|anesthetics, local|mesh-ancestor
110797601|NCT01303107|Anesthetics|anesthetics|mesh-ancestor
110618844|NCT00790608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110797602|NCT01303107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110797603|NCT01303107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110797604|NCT01303107|Sensory System Agents|sensory system agents|mesh-ancestor
110797605|NCT01303107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110797606|NCT03795909|Dexamethasone|dexamethasone|mesh-list
110797607|NCT03795909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110797608|NCT03795909|Antiemetics|antiemetics|mesh-ancestor
110797609|NCT03795909|Autonomic Agents|autonomic agents|mesh-ancestor
110797610|NCT03795909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110797611|NCT03795909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110797612|NCT03795909|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110797613|NCT03795909|Glucocorticoids|glucocorticoids|mesh-ancestor
110797614|NCT03795909|Hormones|hormones|mesh-ancestor
110797615|NCT03795909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110797616|NCT03795909|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110797617|NCT03795909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110797618|NCT03795597|Melphalan|melphalan|mesh-list
110797619|NCT03795597|Busulfan|busulfan|mesh-list
110797620|NCT03795597|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110797621|NCT03795597|Alkylating Agents|alkylating agents|mesh-ancestor
110797622|NCT03795597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110797623|NCT03795597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110797624|NCT03795597|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110797625|NCT03795597|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110797626|NCT03795597|Immunologic Factors|immunologic factors|mesh-ancestor
110797627|NCT03795597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110797628|NCT02802592|Epoetin Alfa|epoetin alfa|mesh-list
110797629|NCT02802592|Hematinics|hematinics|mesh-ancestor
110797630|NCT03637972|Nicotine|nicotine|mesh-list
110797631|NCT03637972|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110797632|NCT03637972|Autonomic Agents|autonomic agents|mesh-ancestor
110797633|NCT03637972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110797634|NCT03637972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110122764|NCT01921972|Memantine|memantine|mesh-list
110797635|NCT03637972|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110797636|NCT03637972|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110797637|NCT03637972|Cholinergic Agents|cholinergic agents|mesh-ancestor
110797638|NCT03637972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110797639|NCT03637972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110797640|NCT03383679|Capecitabine|capecitabine|mesh-list
110797641|NCT03383679|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110797642|NCT03383679|Antimetabolites|antimetabolites|mesh-ancestor
110797643|NCT03383679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110797644|NCT03383679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110797645|NCT02037958|Chlorhexidine|chlorhexidine|mesh-list
110797646|NCT02037958|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110797647|NCT02037958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110797648|NCT02037958|Disinfectants|disinfectants|mesh-ancestor
110797649|NCT02053402|Vitamin D|vitamin d|mesh-list
110797650|NCT02053402|Cholecalciferol|cholecalciferol|mesh-list
110797651|NCT02053402|Vitamins|vitamins|mesh-ancestor
110797652|NCT02053402|Micronutrients|micronutrients|mesh-ancestor
110797653|NCT02053402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110797654|NCT02053402|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110797655|NCT02053402|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110797656|NCT04639011|Norepinephrine|norepinephrine|mesh-list
110797657|NCT04639011|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110797658|NCT04639011|Serotonin|serotonin|mesh-list
110797659|NCT04639011|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110797660|NCT04639011|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110797661|NCT04639011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110797662|NCT04639011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110797663|NCT04639011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110797664|NCT04639011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110797665|NCT04639011|Analgesics|analgesics|mesh-ancestor
110797666|NCT04639011|Sensory System Agents|sensory system agents|mesh-ancestor
110797667|NCT04639011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110797668|NCT04639011|Antidepressive Agents|antidepressive agents|mesh-ancestor
110797669|NCT04639011|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110797670|NCT04639011|Dopamine Agents|dopamine agents|mesh-ancestor
110797671|NCT04639011|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110797672|NCT04639011|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110797673|NCT04639011|Adrenergic Agents|adrenergic agents|mesh-ancestor
110797674|NCT04639011|Sympathomimetics|sympathomimetics|mesh-ancestor
110797675|NCT04639011|Autonomic Agents|autonomic agents|mesh-ancestor
110618908|NCT00787410|Gefitinib|gefitinib|mesh-list
110797676|NCT04639011|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110797677|NCT04639011|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110797678|NCT04639011|Serotonin Agents|serotonin agents|mesh-ancestor
110797679|NCT02053558|Lidocaine|lidocaine|mesh-list
110797680|NCT02053558|Ropivacaine|ropivacaine|mesh-list
110797681|NCT02053558|Anesthetics, Local|anesthetics, local|mesh-ancestor
110797682|NCT02053558|Anesthetics|anesthetics|mesh-ancestor
110797683|NCT02053558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110797684|NCT02053558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110797685|NCT02053558|Sensory System Agents|sensory system agents|mesh-ancestor
110797686|NCT02053558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110797687|NCT02053558|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110797688|NCT02053558|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110797689|NCT02053558|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110797690|NCT02053558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110797691|NCT02053558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110797692|NCT03809949|Fentanyl|fentanyl|mesh-list
110797693|NCT03809949|Anesthetics|anesthetics|mesh-list
110797694|NCT03809949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110797695|NCT03809949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110797696|NCT03809949|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110797697|NCT03809949|Narcotics|narcotics|mesh-ancestor
110515299|NCT02750904|Nicotine|nicotine|mesh-list
110797698|NCT03809949|Analgesics|analgesics|mesh-ancestor
110797699|NCT03809949|Sensory System Agents|sensory system agents|mesh-ancestor
110797700|NCT03809949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110797701|NCT03809949|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110797702|NCT03809949|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110797703|NCT03809949|Anesthetics, General|anesthetics, general|mesh-ancestor
110797704|NCT02052934|Vaccines|vaccines|mesh-list
110797705|NCT02052934|Immunologic Factors|immunologic factors|mesh-ancestor
110797706|NCT02052934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110797707|NCT03810261|Vitamin D|vitamin d|mesh-list
110797708|NCT03810261|Ergocalciferols|ergocalciferols|mesh-list
110797709|NCT03810261|Cholecalciferol|cholecalciferol|mesh-list
110797710|NCT03810261|Vitamins|vitamins|mesh-list
110797712|NCT03810261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110797713|NCT03810261|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110797714|NCT03810261|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110797715|NCT02037724|Iron|iron|mesh-list
110797716|NCT02037724|Trace Elements|trace elements|mesh-ancestor
110797717|NCT02037724|Micronutrients|micronutrients|mesh-ancestor
110797718|NCT02037724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110797719|NCT03327675|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
110797720|NCT03327675|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110797721|NCT03327675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110797722|NCT01569633|Erythromycin|erythromycin|mesh-list
110797723|NCT01569633|Erythromycin Estolate|erythromycin estolate|mesh-list
110797724|NCT01569633|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
110797725|NCT01569633|Erythromycin stearate|erythromycin stearate|mesh-list
110797726|NCT01569633|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110797727|NCT01569633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110797728|NCT01569633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110797729|NCT01569633|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110797730|NCT01569633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110797731|NCT01569633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110797732|NCT02054182|Vitamin D|vitamin d|mesh-list
110797733|NCT02054182|Cholecalciferol|cholecalciferol|mesh-list
110797734|NCT02054182|Vitamins|vitamins|mesh-ancestor
110797735|NCT02054182|Micronutrients|micronutrients|mesh-ancestor
110797736|NCT02054182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110797737|NCT02054182|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110797738|NCT02054182|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110797739|NCT03323151|Ixazomib|ixazomib|mesh-list
110797740|NCT03323151|Glycine|glycine|mesh-list
110797741|NCT03323151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110797742|NCT03323151|Protease Inhibitors|protease inhibitors|mesh-ancestor
110797743|NCT03323151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110797744|NCT03323151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110797745|NCT03323151|Glycine Agents|glycine agents|mesh-ancestor
110797746|NCT03323151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110797747|NCT03323151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110797748|NCT02803138|Ritonavir|ritonavir|mesh-list
110797749|NCT02803138|Ribavirin|ribavirin|mesh-list
110797750|NCT02803138|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110797751|NCT02803138|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110797752|NCT02803138|Protease Inhibitors|protease inhibitors|mesh-ancestor
110797753|NCT02803138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110797754|NCT02803138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110797755|NCT02803138|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110797756|NCT02803138|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110797757|NCT02803138|Antiviral Agents|antiviral agents|mesh-ancestor
110797758|NCT02803138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110797759|NCT02803138|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110797760|NCT02803138|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110797761|NCT02803138|Antimetabolites|antimetabolites|mesh-ancestor
110797762|NCT03795207|Durvalumab|durvalumab|mesh-list
110797763|NCT03795207|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110797764|NCT03795207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110797765|NCT02056210|Plerixafor|plerixafor|mesh-list
110797766|NCT02056210|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110797767|NCT02056210|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110797768|NCT02056210|Antiviral Agents|antiviral agents|mesh-ancestor
110797769|NCT02056210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110797770|NCT00131235|Azithromycin|azithromycin|mesh-list
110797771|NCT00131235|Pyrimethamine|pyrimethamine|mesh-list
110797772|NCT00131235|Sulfadoxine|sulfadoxine|mesh-list
110619002|NCT00795678|Vinorelbine|vinorelbine|mesh-list
110797773|NCT00131235|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
110797774|NCT00131235|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110797775|NCT00131235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110797776|NCT00131235|Antimalarials|antimalarials|mesh-ancestor
110797777|NCT00131235|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110797778|NCT00131235|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110797779|NCT00131235|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110797780|NCT00131235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110797781|NCT00131235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110797782|NCT00131235|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110797783|NCT03794505|Methylprednisolone|methylprednisolone|mesh-list
110797784|NCT03794505|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110797785|NCT03794505|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110797786|NCT03794505|Prednisolone|prednisolone|mesh-list
110797787|NCT03794505|Prednisolone acetate|prednisolone acetate|mesh-list
110797788|NCT03794505|Lidocaine|lidocaine|mesh-list
110797789|NCT03794505|Ropivacaine|ropivacaine|mesh-list
110797790|NCT03794505|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110797791|NCT03794505|Prednisolone phosphate|prednisolone phosphate|mesh-list
110797792|NCT03794505|Anesthetics, Local|anesthetics, local|mesh-ancestor
110797793|NCT03794505|Anesthetics|anesthetics|mesh-ancestor
110797794|NCT03794505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110797795|NCT03794505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110797796|NCT03794505|Sensory System Agents|sensory system agents|mesh-ancestor
110797797|NCT03794505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110797798|NCT03794505|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110797799|NCT03794505|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110797800|NCT03794505|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110797801|NCT03794505|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110797802|NCT03794505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110797803|NCT03794505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110797804|NCT03794505|Antiemetics|antiemetics|mesh-ancestor
110797805|NCT03794505|Autonomic Agents|autonomic agents|mesh-ancestor
110797806|NCT03794505|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110797807|NCT03794505|Glucocorticoids|glucocorticoids|mesh-ancestor
110797808|NCT03794505|Hormones|hormones|mesh-ancestor
110797809|NCT03794505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110797810|NCT03794505|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110797811|NCT03794505|Protective Agents|protective agents|mesh-ancestor
110797812|NCT03794505|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110797813|NCT03794505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110797814|NCT05625243|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
110797815|NCT05625243|Vasodilator Agents|vasodilator agents|mesh-ancestor
110797816|NCT05625243|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
110797817|NCT05625243|Protective Agents|protective agents|mesh-ancestor
110797818|NCT05625243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110797819|NCT03023007|Anesthetics|anesthetics|mesh-list
110797820|NCT03023007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110797821|NCT03023007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110797822|NCT01304901|Montelukast|montelukast|mesh-list
110797823|NCT01304901|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110797824|NCT01304901|Respiratory System Agents|respiratory system agents|mesh-ancestor
110797825|NCT01304901|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110797826|NCT01304901|Hormone Antagonists|hormone antagonists|mesh-ancestor
110797827|NCT01304901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110797828|NCT01304901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110797829|NCT01304901|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110797830|NCT01304901|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110797831|NCT01304901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110797832|NCT05624853|Pregabalin|pregabalin|mesh-list
110797833|NCT05624853|Analgesics|analgesics|mesh-ancestor
110797834|NCT05624853|Sensory System Agents|sensory system agents|mesh-ancestor
110797835|NCT05624853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110797836|NCT05624853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110797837|NCT05624853|Anticonvulsants|anticonvulsants|mesh-ancestor
110797838|NCT05624853|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110797839|NCT05624853|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110797840|NCT05624853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110797841|NCT05624853|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110797842|NCT05624853|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110797843|NCT05624853|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110797844|NCT05624853|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110797845|NCT05624853|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110797846|NCT03794271|Anesthetics|anesthetics|mesh-list
110797847|NCT03794271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110797848|NCT03794271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110797849|NCT03792321|Methyltestosterone|methyltestosterone|mesh-list
110797850|NCT03792321|Testosterone|testosterone|mesh-list
110797851|NCT03792321|Testosterone undecanoate|testosterone undecanoate|mesh-list
110797852|NCT03792321|Testosterone enanthate|testosterone enanthate|mesh-list
110797853|NCT03792321|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
110797854|NCT03792321|Androgens|androgens|mesh-ancestor
110797855|NCT03792321|Hormones|hormones|mesh-ancestor
110797856|NCT03792321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110797857|NCT03792321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110797858|NCT03792321|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110797859|NCT03792321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110851850|NCT05676203|Docetaxel|docetaxel|mesh-list
110797861|NCT01305057|Pyridoxine|pyridoxine|mesh-list
110797862|NCT01305057|Vitamin B Complex|vitamin b complex|mesh-ancestor
110797863|NCT01305057|Vitamins|vitamins|mesh-ancestor
110797864|NCT01305057|Micronutrients|micronutrients|mesh-ancestor
110797865|NCT01305057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110797866|NCT03792009|Bupivacaine|bupivacaine|mesh-list
110797867|NCT03792009|Anesthetics, Local|anesthetics, local|mesh-ancestor
110797868|NCT03792009|Anesthetics|anesthetics|mesh-ancestor
110797869|NCT03792009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110797870|NCT03792009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110797871|NCT03792009|Sensory System Agents|sensory system agents|mesh-ancestor
110797872|NCT03792009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110797873|NCT01305135|Azacitidine|azacitidine|mesh-list
110797874|NCT01305135|Idarubicin|idarubicin|mesh-list
110797875|NCT01305135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110797876|NCT01305135|Antimetabolites|antimetabolites|mesh-ancestor
110797877|NCT01305135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110797878|NCT01305135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110797879|NCT01305135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110797880|NCT01305135|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110797881|NCT01305135|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110797882|NCT01305135|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110797883|NCT01305603|Bupivacaine|bupivacaine|mesh-list
110797884|NCT01305603|Anesthetics, Local|anesthetics, local|mesh-list
110797885|NCT01305603|Anesthetics|anesthetics|mesh-list
110797886|NCT01305603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110797887|NCT01305603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110797888|NCT01305603|Sensory System Agents|sensory system agents|mesh-ancestor
110797889|NCT01305603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110797890|NCT03793725|Apatinib|apatinib|mesh-list
110797891|NCT03793725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110797892|NCT03793725|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110797893|NCT03793725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110797894|NCT03793725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110797895|NCT01305369|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
110797896|NCT01305369|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110797897|NCT02056366|Thioctic Acid|thioctic acid|mesh-list
110797898|NCT02056366|Antioxidants|antioxidants|mesh-ancestor
110797899|NCT02056366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110797900|NCT02056366|Protective Agents|protective agents|mesh-ancestor
110797901|NCT02056366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110797902|NCT02056366|Vitamin B Complex|vitamin b complex|mesh-ancestor
110797903|NCT02056366|Vitamins|vitamins|mesh-ancestor
110797904|NCT02056366|Micronutrients|micronutrients|mesh-ancestor
110797905|NCT02056444|Tranexamic Acid|tranexamic acid|mesh-list
110797906|NCT02056444|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110797907|NCT02056444|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110797908|NCT02056444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110797909|NCT02056444|Hemostatics|hemostatics|mesh-ancestor
110797910|NCT02056444|Coagulants|coagulants|mesh-ancestor
110797911|NCT02665234|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110797912|NCT02665234|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110797913|NCT05624229|Esomeprazole|esomeprazole|mesh-list
110797914|NCT05624229|Omeprazole|omeprazole|mesh-list
110797915|NCT05624229|Rabeprazole|rabeprazole|mesh-list
110797916|NCT05624229|Pantoprazole|pantoprazole|mesh-list
110797917|NCT05624229|Lansoprazole|lansoprazole|mesh-list
110797918|NCT05624229|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
110797919|NCT05624229|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110797920|NCT05624229|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110797921|NCT05624229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110797922|NCT05624229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110797923|NCT05622370|Brivaracetam|brivaracetam|mesh-list
110797924|NCT05622370|Anticonvulsants|anticonvulsants|mesh-ancestor
110797925|NCT03791775|Polidocanol|polidocanol|mesh-list
110797926|NCT03791775|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
110797927|NCT03791775|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110797928|NCT03789123|Dienogest|dienogest|mesh-list
110797929|NCT03789123|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110797930|NCT03789123|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110797931|NCT03789123|Estradiol|estradiol|mesh-list
110797932|NCT03789123|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110797933|NCT03789123|Nandrolone|nandrolone|mesh-list
110797934|NCT03789123|Estrogens|estrogens|mesh-ancestor
110797935|NCT03789123|Hormones|hormones|mesh-ancestor
110797936|NCT03789123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110797937|NCT03789123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110797938|NCT03789123|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110797940|NCT03789123|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110797941|NCT03789123|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110797942|NCT03789123|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110797943|NCT03789123|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110797944|NCT03789123|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110797945|NCT03789123|Hormone Antagonists|hormone antagonists|mesh-ancestor
110797946|NCT03789123|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110797947|NCT03789123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110797948|NCT03789123|Androgens|androgens|mesh-ancestor
110797949|NCT03789123|Anabolic Agents|anabolic agents|mesh-ancestor
110797950|NCT05471817|Dabigatran|dabigatran|mesh-list
110797951|NCT05471817|Antithrombins|antithrombins|mesh-ancestor
110619136|NCT00688064|Dermatologic Agents|dermatologic agents|mesh-ancestor
110797952|NCT05471817|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110797953|NCT05471817|Protease Inhibitors|protease inhibitors|mesh-ancestor
110797954|NCT05471817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110797955|NCT05471817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110797956|NCT05471817|Anticoagulants|anticoagulants|mesh-ancestor
110797957|NCT03788889|Ketamine|ketamine|mesh-list
110797958|NCT03788889|Lorazepam|lorazepam|mesh-list
110797959|NCT03788889|Phenobarbital|phenobarbital|mesh-list
110797960|NCT03788889|Analgesics|analgesics|mesh-ancestor
110797961|NCT03788889|Sensory System Agents|sensory system agents|mesh-ancestor
110797962|NCT03788889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110797963|NCT03788889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110797964|NCT03788889|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110797965|NCT03788889|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110797966|NCT03788889|Anesthetics, General|anesthetics, general|mesh-ancestor
110797967|NCT03788889|Anesthetics|anesthetics|mesh-ancestor
110797968|NCT03788889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110797969|NCT03788889|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110797970|NCT03788889|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110797971|NCT03788889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110797972|NCT03788889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110797973|NCT03788889|Anticonvulsants|anticonvulsants|mesh-ancestor
110797974|NCT03788889|Antiemetics|antiemetics|mesh-ancestor
110797975|NCT03788889|Autonomic Agents|autonomic agents|mesh-ancestor
110797976|NCT03788889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110797977|NCT03788889|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110797978|NCT03788889|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110797979|NCT03788889|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110797980|NCT03788889|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110797981|NCT03788889|GABA Modulators|gaba modulators|mesh-ancestor
110797982|NCT03788889|GABA Agents|gaba agents|mesh-ancestor
110797983|NCT03788889|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110797984|NCT03788889|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110797985|NCT03788889|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110797986|NCT03788733|Melatonin|melatonin|mesh-list
110797987|NCT03788733|Antioxidants|antioxidants|mesh-ancestor
110797988|NCT03788733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110797989|NCT03788733|Protective Agents|protective agents|mesh-ancestor
110797990|NCT03788733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110797991|NCT03788733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110797992|NCT03791463|Salvianolic acid A|salvianolic acid a|mesh-list
110797993|NCT03791463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110797994|NCT03791463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110797995|NCT03791463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110797996|NCT03791463|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110797997|NCT04753515|Midazolam|midazolam|mesh-list
110797998|NCT04753515|Dexmedetomidine|dexmedetomidine|mesh-list
110797999|NCT04753515|Remifentanil|remifentanil|mesh-list
110798000|NCT04753515|Propofol|propofol|mesh-list
110798001|NCT04753515|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110798002|NCT04753515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110619185|NCT00663234|Atorvastatin|atorvastatin|mesh-list
110798003|NCT04753515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110798004|NCT04753515|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110798006|NCT04753515|Sensory System Agents|sensory system agents|mesh-ancestor
110798007|NCT04753515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110798008|NCT04753515|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110798009|NCT04753515|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110798010|NCT04753515|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110798011|NCT04753515|Adrenergic Agents|adrenergic agents|mesh-ancestor
110798012|NCT04753515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110798013|NCT04753515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110798015|NCT04753515|Anesthetics, General|anesthetics, general|mesh-ancestor
110798016|NCT04753515|Anesthetics|anesthetics|mesh-ancestor
110798017|NCT04753515|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110798018|NCT04753515|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110798019|NCT04753515|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110798020|NCT04753515|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110798021|NCT04753515|GABA Modulators|gaba modulators|mesh-ancestor
110798022|NCT04753515|GABA Agents|gaba agents|mesh-ancestor
110798023|NCT04753515|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110798024|NCT04753515|Narcotics|narcotics|mesh-ancestor
110798025|NCT01306461|Timolol|timolol|mesh-list
110798026|NCT01306461|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110798027|NCT01306461|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110798028|NCT01306461|Adrenergic Agents|adrenergic agents|mesh-ancestor
110798029|NCT01306461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110798030|NCT01306461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110798031|NCT01306461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110798032|NCT01306461|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110798033|NCT01306461|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110798034|NCT01305837|Methylprednisolone|methylprednisolone|mesh-list
110798035|NCT01305837|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110798036|NCT01305837|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110798037|NCT01305837|Prednisolone|prednisolone|mesh-list
110798038|NCT01305837|Prednisolone acetate|prednisolone acetate|mesh-list
110798039|NCT01305837|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110798040|NCT01305837|Prednisolone phosphate|prednisolone phosphate|mesh-list
110798041|NCT01305837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110798042|NCT01305837|Antiemetics|antiemetics|mesh-ancestor
110798043|NCT01305837|Autonomic Agents|autonomic agents|mesh-ancestor
110798044|NCT01305837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110798045|NCT01305837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110798046|NCT01305837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110798047|NCT01305837|Glucocorticoids|glucocorticoids|mesh-ancestor
110798048|NCT01305837|Hormones|hormones|mesh-ancestor
110798049|NCT01305837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110798050|NCT01305837|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110798051|NCT01305837|Protective Agents|protective agents|mesh-ancestor
110798052|NCT01305837|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110798053|NCT01305837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110798054|NCT01306773|Oseltamivir|oseltamivir|mesh-list
110798055|NCT01306773|Antiviral Agents|antiviral agents|mesh-ancestor
110798056|NCT01306773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110798057|NCT01306773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110798058|NCT01306773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110798059|NCT03790605|Curcumin|curcumin|mesh-list
110798060|NCT03790605|Iproplatin|iproplatin|mesh-list
110798061|NCT03790605|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110798062|NCT03790605|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110798063|NCT03790605|Analgesics|analgesics|mesh-ancestor
110798064|NCT03790605|Sensory System Agents|sensory system agents|mesh-ancestor
110798065|NCT03790605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110798066|NCT03790605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110798067|NCT03790605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110798068|NCT03790605|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110798069|NCT03790605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110798070|NCT03790605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110798071|NCT03790605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110798072|NCT03787953|Antibodies|antibodies|mesh-list
110798073|NCT03787953|Immunologic Factors|immunologic factors|mesh-ancestor
110798074|NCT03787953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110798075|NCT05590689|Aminolevulinic Acid|aminolevulinic acid|mesh-list
110798077|NCT05590689|Dermatologic Agents|dermatologic agents|mesh-ancestor
110798078|NCT01306851|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
110798079|NCT01306851|Hemostatics|hemostatics|mesh-ancestor
110798080|NCT01306851|Coagulants|coagulants|mesh-ancestor
110798081|NCT03790215|Dydrogesterone|dydrogesterone|mesh-list
110798082|NCT03790215|Progestins|progestins|mesh-ancestor
110798084|NCT03790215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110798085|NCT03790215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110798086|NCT03790371|Misoprostol|misoprostol|mesh-list
110798087|NCT03790371|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110798088|NCT03790371|Abortifacient Agents|abortifacient agents|mesh-ancestor
110798089|NCT03790371|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110798090|NCT03790371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110798091|NCT03790371|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110798092|NCT03790371|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110798093|NCT03790371|Oxytocics|oxytocics|mesh-ancestor
110798094|NCT01307475|Adenosine|adenosine|mesh-list
110798095|NCT01307475|Analgesics|analgesics|mesh-ancestor
110798096|NCT01307475|Sensory System Agents|sensory system agents|mesh-ancestor
110798097|NCT01307475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110798098|NCT01307475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110798099|NCT01307475|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110798100|NCT01307475|Vasodilator Agents|vasodilator agents|mesh-ancestor
110798101|NCT01307475|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
110798102|NCT01307475|Purinergic Agonists|purinergic agonists|mesh-ancestor
110798103|NCT01307475|Purinergic Agents|purinergic agents|mesh-ancestor
110798104|NCT01307475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110798105|NCT01307475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110798106|NCT03787641|Protamines|protamines|mesh-list
110798107|NCT03787641|Heparin Antagonists|heparin antagonists|mesh-ancestor
110798108|NCT03787641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110798109|NCT03787641|Coagulants|coagulants|mesh-ancestor
110798110|NCT03790293|Rituximab|rituximab|mesh-list
110798111|NCT03790293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110798112|NCT03790293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110798113|NCT03790293|Immunologic Factors|immunologic factors|mesh-ancestor
110798114|NCT03790293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110798115|NCT03790293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110798116|NCT03245450|Irinotecan|irinotecan|mesh-list
110798117|NCT03245450|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110798118|NCT03245450|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110798119|NCT03245450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110798120|NCT03245450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110798121|NCT03245450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110798122|NCT05694585|Esmolol|esmolol|mesh-list
110798123|NCT05694585|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110798124|NCT05694585|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110798125|NCT05694585|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110798126|NCT05694585|Adrenergic Agents|adrenergic agents|mesh-ancestor
110798127|NCT05694585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110798128|NCT05694585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110798129|NCT05694585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110798130|NCT03712917|Topiramate|topiramate|mesh-list
110798131|NCT03712917|Flunarizine|flunarizine|mesh-list
110798132|NCT03712917|Anticonvulsants|anticonvulsants|mesh-ancestor
110798133|NCT03712917|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110798134|NCT03712917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110798135|NCT03712917|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110798136|NCT03712917|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110798137|NCT03712917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110798138|NCT03712917|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110798139|NCT03712917|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110798140|NCT03712917|Histamine Antagonists|histamine antagonists|mesh-ancestor
110798141|NCT03712917|Histamine Agents|histamine agents|mesh-ancestor
110798142|NCT03712917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110798143|NCT03712917|Vasodilator Agents|vasodilator agents|mesh-ancestor
110798144|NCT03787017|Metformin|metformin|mesh-list
110798145|NCT03787017|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110798146|NCT03787017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110798148|NCT01307865|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110798149|NCT01307865|Diuretics|diuretics|mesh-ancestor
110798150|NCT01307865|Natriuretic Agents|natriuretic agents|mesh-ancestor
110798151|NCT01307865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110798152|NCT01308177|Ecabet|ecabet|mesh-list
110798153|NCT01308177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110798154|NCT01308177|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110798155|NCT01308177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110798156|NCT01308177|Protease Inhibitors|protease inhibitors|mesh-ancestor
110798157|NCT01308177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110798158|NCT01308177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110798159|NCT01308177|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110798160|NCT01308177|Protective Agents|protective agents|mesh-ancestor
110798161|NCT01308177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110798162|NCT01308177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110798163|NCT01308255|Vitamins|vitamins|mesh-list
110798164|NCT01308255|Folic Acid|folic acid|mesh-list
110798165|NCT01308255|Methylprednisolone|methylprednisolone|mesh-list
110798166|NCT01308255|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110798168|NCT01308255|Methotrexate|methotrexate|mesh-list
110798169|NCT01308255|Micronutrients|micronutrients|mesh-ancestor
110798170|NCT01308255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110619249|NCT00747110|Hormones|hormones|mesh-ancestor
110798171|NCT01308255|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110798172|NCT01308255|Abortifacient Agents|abortifacient agents|mesh-ancestor
110798173|NCT01308255|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110798174|NCT01308255|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110798175|NCT01308255|Antimetabolites|antimetabolites|mesh-ancestor
110798176|NCT01308255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110798177|NCT01308255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110798178|NCT01308255|Dermatologic Agents|dermatologic agents|mesh-ancestor
110798179|NCT01308255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110798180|NCT01308255|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110798181|NCT01308255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110798182|NCT01308255|Immunologic Factors|immunologic factors|mesh-ancestor
110798183|NCT01308255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110798184|NCT01308255|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110798185|NCT01308255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110798186|NCT01308255|Antiemetics|antiemetics|mesh-ancestor
110798187|NCT01308255|Autonomic Agents|autonomic agents|mesh-ancestor
110798188|NCT01308255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110798189|NCT01308255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110798190|NCT01308255|Glucocorticoids|glucocorticoids|mesh-ancestor
110798191|NCT01308255|Hormones|hormones|mesh-ancestor
110798192|NCT01308255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110798193|NCT01308255|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110798194|NCT01308255|Protective Agents|protective agents|mesh-ancestor
110798195|NCT01308255|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110798196|NCT01308255|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110798197|NCT01308255|Hematinics|hematinics|mesh-ancestor
110798198|NCT01308255|Vitamin B Complex|vitamin b complex|mesh-ancestor
110798199|NCT03782025|Vitamin K 1|vitamin k 1|mesh-list
110798200|NCT03782025|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110798201|NCT03782025|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110798202|NCT03782025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110798203|NCT03782025|Hemostatics|hemostatics|mesh-ancestor
110798204|NCT03782025|Coagulants|coagulants|mesh-ancestor
110798205|NCT03782025|Vitamins|vitamins|mesh-ancestor
110798206|NCT03782025|Micronutrients|micronutrients|mesh-ancestor
110798207|NCT03782025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110798208|NCT03781947|Antarelix|antarelix|mesh-list
110798209|NCT03781947|Hormone Antagonists|hormone antagonists|mesh-ancestor
110851877|NCT05615779|Levan|levan|mesh-list
110798210|NCT03781947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110798211|NCT03781947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110798213|NCT03781869|Etoposide|etoposide|mesh-list
110798214|NCT03781869|Etoposide phosphate|etoposide phosphate|mesh-list
110798215|NCT03781869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110619268|NCT04046016|Tubulin Modulators|tubulin modulators|mesh-ancestor
110798216|NCT03781869|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110798217|NCT03781869|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110798218|NCT03781869|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110798219|NCT03781869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110798220|NCT03781869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110798221|NCT01311765|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110798222|NCT01311765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110798223|NCT03781635|Ketamine|ketamine|mesh-list
110798224|NCT03781635|Analgesics|analgesics|mesh-ancestor
110798225|NCT03781635|Sensory System Agents|sensory system agents|mesh-ancestor
110798226|NCT03781635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110798227|NCT03781635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110798228|NCT03781635|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110798229|NCT03781635|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110798230|NCT03781635|Anesthetics, General|anesthetics, general|mesh-ancestor
110798231|NCT03781635|Anesthetics|anesthetics|mesh-ancestor
110798232|NCT03781635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110798233|NCT03781635|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110798234|NCT03781635|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110798235|NCT03781635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110798236|NCT03781635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110798237|NCT03781713|Anti-Infective Agents|anti-infective agents|mesh-list
110798238|NCT03781713|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110798239|NCT03781011|Choline|choline|mesh-list
110798240|NCT03781011|Lipotropic Agents|lipotropic agents|mesh-ancestor
110798241|NCT03781011|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110798242|NCT03781011|Antimetabolites|antimetabolites|mesh-ancestor
110798243|NCT03781011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110798244|NCT03781011|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110798245|NCT03781011|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110798246|NCT03781011|Nootropic Agents|nootropic agents|mesh-ancestor
110798247|NCT03785613|Buprenorphine|buprenorphine|mesh-list
110798248|NCT03785613|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110798249|NCT03785613|Narcotics|narcotics|mesh-ancestor
110798250|NCT03785613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110798251|NCT03785613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110798252|NCT03785613|Analgesics|analgesics|mesh-ancestor
110798253|NCT03785613|Sensory System Agents|sensory system agents|mesh-ancestor
110798254|NCT03785613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110798255|NCT03785613|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110619332|NCT00990418|Fentanyl|fentanyl|mesh-list
110798256|NCT03785223|Methylphenidate|methylphenidate|mesh-list
110798257|NCT03785223|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110798258|NCT03785223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110798259|NCT03785223|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110798260|NCT03785223|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110798261|NCT03785223|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110798262|NCT03785223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110798263|NCT03785223|Dopamine Agents|dopamine agents|mesh-ancestor
110798264|NCT03785223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110798265|NCT01308723|Sorafenib|sorafenib|mesh-list
110798266|NCT01308723|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110798267|NCT01308723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110798268|NCT01308723|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110798269|NCT01308723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110798270|NCT01308723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110798271|NCT01308723|Immunologic Factors|immunologic factors|mesh-ancestor
110798272|NCT01308723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110798273|NCT01561131|Calcium|calcium|mesh-list
110798274|NCT01561131|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110798275|NCT01561131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110798276|NCT01313403|Antidepressive Agents|antidepressive agents|mesh-list
110798277|NCT01313403|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110798278|NCT03780621|Andrographolide|andrographolide|mesh-list
110798279|NCT03780621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110798280|NCT03780621|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110798281|NCT03780621|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110798282|NCT03780621|Analgesics|analgesics|mesh-ancestor
110798283|NCT03780621|Sensory System Agents|sensory system agents|mesh-ancestor
110798284|NCT03780621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110798285|NCT03780621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110798286|NCT03780621|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110798287|NCT03780621|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110798288|NCT03780621|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110798289|NCT03780621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110798290|NCT03780621|Antiviral Agents|antiviral agents|mesh-ancestor
110798291|NCT03780621|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110798292|NCT03785067|Amlodipine|amlodipine|mesh-list
110798293|NCT03785067|Telmisartan|telmisartan|mesh-list
110798294|NCT03785067|Indapamide|indapamide|mesh-list
110798295|NCT03785067|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110798296|NCT03785067|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110798297|NCT03785067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110798298|NCT03785067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110798299|NCT03785067|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110798300|NCT03785067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110798301|NCT03785067|Vasodilator Agents|vasodilator agents|mesh-ancestor
110798302|NCT03785067|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110798303|NCT03785067|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110798304|NCT03785067|Diuretics|diuretics|mesh-ancestor
110798305|NCT03785067|Natriuretic Agents|natriuretic agents|mesh-ancestor
110798306|NCT03785067|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110798307|NCT05688111|Tranexamic Acid|tranexamic acid|mesh-list
110798308|NCT05688111|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110798309|NCT05688111|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110798310|NCT05688111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110798311|NCT05688111|Hemostatics|hemostatics|mesh-ancestor
110798312|NCT05688111|Coagulants|coagulants|mesh-ancestor
110798313|NCT02059018|Diclofenac|diclofenac|mesh-list
110798314|NCT02059018|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-list
110798316|NCT02059018|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110798317|NCT02059018|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110798318|NCT02059018|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110798319|NCT02059018|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110798320|NCT02059018|Analgesics|analgesics|mesh-ancestor
110798321|NCT02059018|Sensory System Agents|sensory system agents|mesh-ancestor
110798322|NCT02059018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110798323|NCT02059018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110798324|NCT02059018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110798325|NCT02059018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110798326|NCT02059018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110798327|NCT02059018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110798328|NCT02059018|Vasodilator Agents|vasodilator agents|mesh-ancestor
110798329|NCT01561209|Amitriptyline|amitriptyline|mesh-list
110798330|NCT01561209|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110798331|NCT01561209|Antidepressive Agents|antidepressive agents|mesh-ancestor
110798332|NCT01561209|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110798333|NCT01561209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110798334|NCT01561209|Analgesics|analgesics|mesh-ancestor
110798335|NCT01561209|Sensory System Agents|sensory system agents|mesh-ancestor
110798336|NCT01561209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110798337|NCT01561209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110798338|NCT01561209|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110798339|NCT01561209|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110798340|NCT01561209|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110798341|NCT01561209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110798342|NCT01561209|Adrenergic Agents|adrenergic agents|mesh-ancestor
110798343|NCT01561209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110798344|NCT02800642|Aflibercept|aflibercept|mesh-list
110798345|NCT02800642|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110798346|NCT02800642|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110798347|NCT02800642|Growth Substances|growth substances|mesh-ancestor
110798348|NCT02800642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110798349|NCT02800642|Growth Inhibitors|growth inhibitors|mesh-ancestor
110798350|NCT02800642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110798351|NCT02056600|Metformin|metformin|mesh-list
110798352|NCT02056600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110798353|NCT02056600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110798354|NCT02056678|Acetaminophen|acetaminophen|mesh-list
110798355|NCT02056678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110798356|NCT02056678|Analgesics|analgesics|mesh-ancestor
110798357|NCT02056678|Sensory System Agents|sensory system agents|mesh-ancestor
110798358|NCT02056678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110798359|NCT02056678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110798360|NCT02056678|Antipyretics|antipyretics|mesh-ancestor
110798361|NCT04662567|Acetaminophen|acetaminophen|mesh-list
110798362|NCT04662567|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110798363|NCT04662567|Analgesics|analgesics|mesh-ancestor
110798364|NCT04662567|Sensory System Agents|sensory system agents|mesh-ancestor
110798365|NCT04662567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110798366|NCT04662567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110798367|NCT04662567|Antipyretics|antipyretics|mesh-ancestor
110798368|NCT02799784|Albuterol|albuterol|mesh-list
110798369|NCT02799784|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110798370|NCT02799784|Autonomic Agents|autonomic agents|mesh-ancestor
110798371|NCT02799784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110798372|NCT02799784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110798373|NCT02799784|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110798374|NCT02799784|Respiratory System Agents|respiratory system agents|mesh-ancestor
110798375|NCT02799784|Tocolytic Agents|tocolytic agents|mesh-ancestor
110798376|NCT02799784|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110798377|NCT02799784|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110798378|NCT02799784|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110798379|NCT02799784|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110619450|NCT00539500|Carboplatin|carboplatin|mesh-list
110798380|NCT02799784|Adrenergic Agents|adrenergic agents|mesh-ancestor
110798381|NCT02799784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110798382|NCT02799784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110798383|NCT03779685|Anesthetics|anesthetics|mesh-list
110798384|NCT03779685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110798385|NCT03779685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110798386|NCT03779451|Progesterone|progesterone|mesh-list
110798387|NCT03779451|Progestins|progestins|mesh-ancestor
110798389|NCT03779451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110798390|NCT03779451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110798391|NCT02059330|Palbociclib|palbociclib|mesh-list
110798392|NCT02059330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110798393|NCT02059330|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110798394|NCT02059330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110798395|NCT02059330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110798396|NCT03784443|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
110798397|NCT03784443|Ranibizumab|ranibizumab|mesh-list
110798398|NCT03784443|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110798399|NCT03784443|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110798400|NCT03784443|Growth Substances|growth substances|mesh-ancestor
110798401|NCT03784443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110798403|NCT03784443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110798404|NCT03784443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110798405|NCT03784443|Glucocorticoids|glucocorticoids|mesh-ancestor
110798406|NCT03784443|Hormones|hormones|mesh-ancestor
110798407|NCT03784443|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110798408|NCT02054806|Pembrolizumab|pembrolizumab|mesh-list
110798409|NCT02054806|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110798410|NCT02054806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110798411|NCT02054806|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110798412|NCT02054806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110798413|NCT02054884|Paclitaxel|paclitaxel|mesh-list
110798414|NCT02054884|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110798415|NCT02054884|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110798416|NCT02054884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110798417|NCT02054884|Tubulin Modulators|tubulin modulators|mesh-ancestor
110798418|NCT02054884|Antimitotic Agents|antimitotic agents|mesh-ancestor
110798419|NCT02054884|Mitosis Modulators|mitosis modulators|mesh-ancestor
110798420|NCT02054884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110798421|NCT01333072|Risperidone|risperidone|mesh-list
110798422|NCT01333072|Aripiprazole|aripiprazole|mesh-list
110798423|NCT01333072|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110798424|NCT01333072|Serotonin Agents|serotonin agents|mesh-ancestor
110798425|NCT01333072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110798426|NCT01333072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110798427|NCT01333072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110798428|NCT01333072|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110798429|NCT01333072|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110798430|NCT01333072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110798431|NCT01333072|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110798432|NCT01333072|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110798433|NCT01333072|Dopamine Agents|dopamine agents|mesh-ancestor
110798434|NCT01333072|Antidepressive Agents|antidepressive agents|mesh-ancestor
110798435|NCT01333072|Dopamine Agonists|dopamine agonists|mesh-ancestor
110798436|NCT01333072|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110798437|NCT01333072|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110798438|NCT01333072|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110798439|NCT01333072|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110798447|NCT02059564|Liraglutide|liraglutide|mesh-list
110798448|NCT02059564|Exenatide|exenatide|mesh-list
110798449|NCT02059564|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110798450|NCT02059564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110798451|NCT02059564|Incretins|incretins|mesh-ancestor
110798452|NCT02059564|Hormones|hormones|mesh-ancestor
110798453|NCT02059564|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110798454|NCT02059564|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110798455|NCT05622058|Cyclophosphamide|cyclophosphamide|mesh-list
110798456|NCT05622058|Docetaxel|docetaxel|mesh-list
110798457|NCT05622058|Doxorubicin|doxorubicin|mesh-list
110798458|NCT05622058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110798459|NCT05622058|Immunologic Factors|immunologic factors|mesh-ancestor
110798460|NCT05622058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110798461|NCT05622058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110798462|NCT05622058|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110798463|NCT05622058|Alkylating Agents|alkylating agents|mesh-ancestor
110798464|NCT05622058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110798465|NCT05622058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110798466|NCT05622058|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110798467|NCT05622058|Tubulin Modulators|tubulin modulators|mesh-ancestor
110851920|NCT05489796|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110798468|NCT05622058|Antimitotic Agents|antimitotic agents|mesh-ancestor
110798469|NCT05622058|Mitosis Modulators|mitosis modulators|mesh-ancestor
110798470|NCT05622058|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110798471|NCT05622058|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110798472|NCT05622058|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110798473|NCT05622058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110798474|NCT02055196|Irinotecan|irinotecan|mesh-list
110798475|NCT02055196|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110798476|NCT02055196|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110798477|NCT02055196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110798478|NCT02055196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110798479|NCT02055196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110798480|NCT02055274|Rotigotine|rotigotine|mesh-list
110798481|NCT02055274|Dopamine Agonists|dopamine agonists|mesh-ancestor
110798482|NCT02055274|Dopamine Agents|dopamine agents|mesh-ancestor
110798483|NCT02055274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110798484|NCT02055274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110798485|NCT02055274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110798486|NCT03783897|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110798487|NCT03783897|Norgestimate|norgestimate|mesh-list
110798488|NCT03783897|Contraceptive Agents|contraceptive agents|mesh-list
110798489|NCT03783897|Contraceptives, Oral|contraceptives, oral|mesh-list
110798490|NCT03783897|Estradiol|estradiol|mesh-list
110798491|NCT03783897|Estrogens|estrogens|mesh-ancestor
110798492|NCT03783897|Hormones|hormones|mesh-ancestor
110798493|NCT03783897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110798494|NCT03783897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110798495|NCT03783897|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110798496|NCT03783897|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110798497|NCT03783897|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110798498|NCT03783897|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110798499|NCT03783897|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110798500|NCT03779061|Propofol|propofol|mesh-list
110798501|NCT03779061|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110798502|NCT03779061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110798503|NCT03779061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110798504|NCT03779061|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110798505|NCT03779061|Anesthetics, General|anesthetics, general|mesh-ancestor
110798506|NCT03779061|Anesthetics|anesthetics|mesh-ancestor
110798507|NCT01316445|Midazolam|midazolam|mesh-list
110798508|NCT01316445|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110798509|NCT01316445|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110798510|NCT01316445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110798511|NCT01316445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110798512|NCT01316445|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110798513|NCT01316445|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110798514|NCT01316445|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110798515|NCT01316445|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110798516|NCT01316445|Anesthetics, General|anesthetics, general|mesh-ancestor
110798517|NCT01316445|Anesthetics|anesthetics|mesh-ancestor
110798518|NCT01316445|GABA Modulators|gaba modulators|mesh-ancestor
110798519|NCT01316445|GABA Agents|gaba agents|mesh-ancestor
110798520|NCT01316445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110798521|NCT01316445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110798522|NCT03712449|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110798523|NCT03712449|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110798524|NCT03712449|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110798525|NCT03712449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110798526|NCT03712449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110798527|NCT03712449|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110798528|NCT03712449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110798529|NCT03712449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110798530|NCT03712449|Cholinergic Agents|cholinergic agents|mesh-ancestor
110798531|NCT03712449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110798532|NCT03517540|Cenicriviroc|cenicriviroc|mesh-list
110798533|NCT03517540|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
110798534|NCT03517540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110798535|NCT03517540|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110798536|NCT03517540|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110798537|NCT03517540|Antiviral Agents|antiviral agents|mesh-ancestor
110798538|NCT03517540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110798540|NCT03778359|Dienogest|dienogest|mesh-list
110798541|NCT03778359|Levonorgestrel|levonorgestrel|mesh-list
110798542|NCT03778359|Progestins|progestins|mesh-list
110798543|NCT03778359|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110798544|NCT03778359|Contraceptive Agents|contraceptive agents|mesh-ancestor
110798545|NCT03778359|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110798546|NCT03778359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110798547|NCT03778359|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110798548|NCT03778359|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110798549|NCT03778359|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110798550|NCT03778359|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110798551|NCT03778359|Fertility Agents|fertility agents|mesh-ancestor
110798552|NCT03778359|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110798553|NCT03778359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110798554|NCT03778359|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110798555|NCT03778359|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110798556|NCT03778359|Hormone Antagonists|hormone antagonists|mesh-ancestor
110798557|NCT03778359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110798558|NCT03778359|Hormones|hormones|mesh-ancestor
110798559|NCT03560908|Dasatinib|dasatinib|mesh-list
110798560|NCT03560908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110798561|NCT03560908|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110798562|NCT03560908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110798563|NCT03560908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110798564|NCT02057770|Cyclophosphamide|cyclophosphamide|mesh-list
110798565|NCT02057770|Busulfan|busulfan|mesh-list
110798566|NCT02057770|Fludarabine|fludarabine|mesh-list
110798567|NCT02057770|Fludarabine phosphate|fludarabine phosphate|mesh-list
110798568|NCT02057770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110798569|NCT02057770|Immunologic Factors|immunologic factors|mesh-ancestor
110798570|NCT02057770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110798571|NCT02057770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110798572|NCT02057770|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110798573|NCT02057770|Alkylating Agents|alkylating agents|mesh-ancestor
110798574|NCT02057770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110798575|NCT02057770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110798576|NCT02057770|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110798577|NCT02057770|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110798578|NCT02057770|Antimetabolites|antimetabolites|mesh-ancestor
110798579|NCT03778281|Baclofen|baclofen|mesh-list
110798580|NCT03778281|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110798581|NCT03778281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110798582|NCT03778281|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110798583|NCT03778281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110798584|NCT03778281|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
110798585|NCT03778281|GABA Agonists|gaba agonists|mesh-ancestor
110798586|NCT03778281|GABA Agents|gaba agents|mesh-ancestor
110798587|NCT03778281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110798588|NCT03778281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110798589|NCT02055586|Alovudine|alovudine|mesh-list
110798590|NCT02055586|Fluorides|fluorides|mesh-list
110798591|NCT02055586|Cariostatic Agents|cariostatic agents|mesh-ancestor
110798592|NCT02055586|Protective Agents|protective agents|mesh-ancestor
110798593|NCT02055586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110798594|NCT02055586|Antiviral Agents|antiviral agents|mesh-ancestor
110798595|NCT02055586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110798596|NCT03778593|Leucovorin|leucovorin|mesh-list
110798597|NCT03778593|Fluorouracil|fluorouracil|mesh-list
110798598|NCT03778593|Oxaliplatin|oxaliplatin|mesh-list
110798599|NCT03778593|Irinotecan|irinotecan|mesh-list
110798600|NCT03778593|Antimetabolites|antimetabolites|mesh-ancestor
110798601|NCT03778593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110798602|NCT03778593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110798603|NCT03778593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110798604|NCT03778593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110798605|NCT03778593|Immunologic Factors|immunologic factors|mesh-ancestor
110798606|NCT03778593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110798607|NCT03778593|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110798608|NCT03778593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110798609|NCT03778593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110798610|NCT03778593|Antidotes|antidotes|mesh-ancestor
110798611|NCT03778593|Protective Agents|protective agents|mesh-ancestor
110798612|NCT03778593|Vitamin B Complex|vitamin b complex|mesh-ancestor
110798614|NCT03778593|Micronutrients|micronutrients|mesh-ancestor
110798615|NCT02055664|Ropivacaine|ropivacaine|mesh-list
110798616|NCT02055664|Anesthetics, Local|anesthetics, local|mesh-ancestor
110798617|NCT02055664|Anesthetics|anesthetics|mesh-ancestor
110798618|NCT02055664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110798619|NCT02055664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110798620|NCT02055664|Sensory System Agents|sensory system agents|mesh-ancestor
110798621|NCT02055664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110798622|NCT01309425|Tapentadol|tapentadol|mesh-list
110798623|NCT01309425|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110798624|NCT01309425|Narcotics|narcotics|mesh-ancestor
110798625|NCT01309425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110798626|NCT01309425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110798627|NCT01309425|Analgesics|analgesics|mesh-ancestor
110798628|NCT01309425|Sensory System Agents|sensory system agents|mesh-ancestor
110798629|NCT01309425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110619705|NCT03827473|Antioxidants|antioxidants|mesh-ancestor
110798630|NCT01309425|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110798631|NCT01309425|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110798632|NCT01309425|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110798633|NCT01309425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110798634|NCT01309425|Adrenergic Agents|adrenergic agents|mesh-ancestor
110798635|NCT01309425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110798636|NCT03561298|Zanubrutinib|zanubrutinib|mesh-list
110798637|NCT03561298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110798638|NCT03561298|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110798639|NCT03561298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110798640|NCT03561298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110798641|NCT05648422|Nitazoxanide|nitazoxanide|mesh-list
110798642|NCT05648422|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110798643|NCT05648422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110798644|NCT02057926|Tetracycline|tetracycline|mesh-list
110798645|NCT02057926|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110798646|NCT02057926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110798647|NCT02057926|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110798648|NCT02057926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110798649|NCT02057926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110798650|NCT03777579|Paclitaxel|paclitaxel|mesh-list
110798651|NCT03777579|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110798652|NCT03777579|Antibodies|antibodies|mesh-list
110798653|NCT03777579|Immunoglobulins|immunoglobulins|mesh-list
110798654|NCT03777579|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110798655|NCT03777579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110798656|NCT03777579|Tubulin Modulators|tubulin modulators|mesh-ancestor
110798657|NCT03777579|Antimitotic Agents|antimitotic agents|mesh-ancestor
110798658|NCT03777579|Mitosis Modulators|mitosis modulators|mesh-ancestor
110798659|NCT03777579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110798660|NCT03777579|Immunologic Factors|immunologic factors|mesh-ancestor
110798661|NCT03777579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110798662|NCT02059876|Paclitaxel|paclitaxel|mesh-list
110798663|NCT02059876|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110798664|NCT02059876|Carboplatin|carboplatin|mesh-list
110798665|NCT02059876|Trastuzumab|trastuzumab|mesh-list
110798666|NCT02059876|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110798667|NCT02059876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110798668|NCT02059876|Tubulin Modulators|tubulin modulators|mesh-ancestor
110798669|NCT02059876|Antimitotic Agents|antimitotic agents|mesh-ancestor
110798670|NCT02059876|Mitosis Modulators|mitosis modulators|mesh-ancestor
110798671|NCT02059876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110798672|NCT02059876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110798673|NCT03777423|Cobalt|cobalt|mesh-list
110798674|NCT03777423|Chromium|chromium|mesh-list
110798675|NCT03777423|Trace Elements|trace elements|mesh-ancestor
110798676|NCT03777423|Micronutrients|micronutrients|mesh-ancestor
110798677|NCT03777423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110798679|NCT05654662|Chlorhexidine|chlorhexidine|mesh-list
110798680|NCT05654662|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110798681|NCT05654662|Sodium Fluoride|sodium fluoride|mesh-list
110798682|NCT05654662|Cariostatic Agents|cariostatic agents|mesh-ancestor
110798683|NCT05654662|Protective Agents|protective agents|mesh-ancestor
110798684|NCT05654662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110798685|NCT05654662|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110798686|NCT05654662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110798687|NCT05654662|Disinfectants|disinfectants|mesh-ancestor
110798688|NCT05654662|Dermatologic Agents|dermatologic agents|mesh-ancestor
110798689|NCT03777033|Alfacalcidol|alfacalcidol|mesh-list
110798691|NCT03777033|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110798692|NCT03777033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110798693|NCT03777033|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110798694|NCT02060032|Atorvastatin|atorvastatin|mesh-list
110798695|NCT02060032|Simvastatin|simvastatin|mesh-list
110798696|NCT02060032|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110798697|NCT02060032|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110798698|NCT02060032|Antimetabolites|antimetabolites|mesh-ancestor
110798699|NCT02060032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110798700|NCT02060032|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110798701|NCT02060032|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110798702|NCT02060032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110798703|NCT03783273|Vitamin D|vitamin d|mesh-list
110798704|NCT03783273|Cholecalciferol|cholecalciferol|mesh-list
110798705|NCT03783273|Vitamins|vitamins|mesh-ancestor
110798706|NCT03783273|Micronutrients|micronutrients|mesh-ancestor
110798707|NCT03783273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110798708|NCT03783273|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110798709|NCT03783273|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110798710|NCT03777345|Cobalt|cobalt|mesh-list
110798711|NCT03777345|Chromium|chromium|mesh-list
110798712|NCT03777345|Trace Elements|trace elements|mesh-ancestor
110798713|NCT03777345|Micronutrients|micronutrients|mesh-ancestor
110798714|NCT03777345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110798715|NCT01318005|Contraceptive Agents|contraceptive agents|mesh-list
110798716|NCT01318005|Norinyl|norinyl|mesh-list
110798717|NCT01318005|Contraceptives, Oral|contraceptives, oral|mesh-list
110798718|NCT01318005|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110798719|NCT01318005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110798720|NCT01318005|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110798721|NCT01318005|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110798722|NCT01318005|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110619779|NCT00537940|Anticonvulsants|anticonvulsants|mesh-ancestor
110798723|NCT01318005|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110798724|NCT02799082|Aminolevulinic Acid|aminolevulinic acid|mesh-list
110798725|NCT02799082|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110798726|NCT02799082|Dermatologic Agents|dermatologic agents|mesh-ancestor
110798727|NCT03710889|Abaloparatide|abaloparatide|mesh-list
110798728|NCT03710889|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110798729|NCT03710889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110798730|NCT02061124|Sevelamer|sevelamer|mesh-list
110798731|NCT02061124|Chelating Agents|chelating agents|mesh-ancestor
110798732|NCT02061124|Sequestering Agents|sequestering agents|mesh-ancestor
110798733|NCT02061124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110798734|NCT01318941|Ranibizumab|ranibizumab|mesh-list
110798735|NCT01318941|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110798736|NCT01318941|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110798737|NCT01318941|Growth Substances|growth substances|mesh-ancestor
110798738|NCT01318941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110798739|NCT01318941|Growth Inhibitors|growth inhibitors|mesh-ancestor
110798740|NCT01318941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110798741|NCT03560440|Vancomycin|vancomycin|mesh-list
110798742|NCT03560440|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110798743|NCT03560440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110798744|NCT03776955|Carvedilol|carvedilol|mesh-list
110798745|NCT03776955|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110798746|NCT03776955|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110798747|NCT03776955|Adrenergic Agents|adrenergic agents|mesh-ancestor
110798748|NCT03776955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110798749|NCT03776955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110798750|NCT03776955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110798751|NCT03776955|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110798752|NCT03776955|Antioxidants|antioxidants|mesh-ancestor
110798753|NCT03776955|Protective Agents|protective agents|mesh-ancestor
110798754|NCT03776955|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110798755|NCT03776955|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110798756|NCT03776955|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110798757|NCT03776955|Vasodilator Agents|vasodilator agents|mesh-ancestor
110798758|NCT03776955|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110798759|NCT03776955|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110798760|NCT03308942|Pembrolizumab|pembrolizumab|mesh-list
110798761|NCT03308942|Niraparib|niraparib|mesh-list
110798762|NCT03308942|Dostarlimab|dostarlimab|mesh-list
110798763|NCT03308942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110798764|NCT03308942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110798765|NCT03308942|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110798766|NCT03308942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110798767|NCT03308942|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110798768|NCT03308942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110798769|NCT01319019|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110798770|NCT01319019|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110798771|NCT01319019|Autonomic Agents|autonomic agents|mesh-ancestor
110798772|NCT01319019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110798773|NCT01319019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110798774|NCT01319019|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110798775|NCT01319019|Respiratory System Agents|respiratory system agents|mesh-ancestor
110798776|NCT01319019|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110798777|NCT01319019|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110798778|NCT01319019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110798779|NCT01319019|Adrenergic Agents|adrenergic agents|mesh-ancestor
110798780|NCT01319019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110798781|NCT01319019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110798782|NCT03308786|Aldesleukin|aldesleukin|mesh-list
110798783|NCT03308786|Interleukin-2|interleukin-2|mesh-list
110798784|NCT03308786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110798785|NCT03308786|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110798786|NCT03308786|Analgesics|analgesics|mesh-ancestor
110798787|NCT03308786|Sensory System Agents|sensory system agents|mesh-ancestor
110798788|NCT03308786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110798789|NCT03308786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110798790|NCT03308786|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110798791|NCT03308786|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110798792|NCT03308786|Antiviral Agents|antiviral agents|mesh-ancestor
110798793|NCT03308786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110798794|NCT03776409|Vancomycin|vancomycin|mesh-list
110798795|NCT03776409|Tazobactam|tazobactam|mesh-list
110798796|NCT03776409|Piperacillin|piperacillin|mesh-list
110798797|NCT03776409|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
110798798|NCT03776409|Lactams|lactams|mesh-list
110798799|NCT03776409|beta-Lactams|beta-lactams|mesh-list
110798800|NCT03776409|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110798801|NCT03776409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110798802|NCT03776409|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110798803|NCT03776409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110798804|NCT03776409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110798805|NCT03782805|Cholecalciferol|cholecalciferol|mesh-list
110798806|NCT03782805|Vitamin D|vitamin d|mesh-list
110619872|NCT01055041|Hormone Antagonists|hormone antagonists|mesh-ancestor
110798807|NCT03782805|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110798808|NCT03782805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110798809|NCT03782805|Vitamins|vitamins|mesh-ancestor
110798810|NCT03782805|Micronutrients|micronutrients|mesh-ancestor
110798811|NCT03782805|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110798812|NCT03775863|Liver Extracts|liver extracts|mesh-list
110798813|NCT03775863|Hematinics|hematinics|mesh-ancestor
110798814|NCT03274076|Tofacitinib|tofacitinib|mesh-list
110798815|NCT03274076|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
110798816|NCT03274076|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110798817|NCT03274076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110851959|NCT05357079|Hemostatics|hemostatics|mesh-ancestor
110798818|NCT03274076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110798819|NCT03775707|Lenvatinib|lenvatinib|mesh-list
110798820|NCT03775707|Antibodies|antibodies|mesh-list
110798821|NCT03775707|Immunologic Factors|immunologic factors|mesh-ancestor
110798822|NCT03775707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110798823|NCT03775707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110798824|NCT03775707|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110798825|NCT03775707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110798826|NCT03775707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110798827|NCT01320501|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110798828|NCT01320501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110798829|NCT01320501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110798830|NCT01320501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110798831|NCT01320501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110798832|NCT02764268|Apatinib|apatinib|mesh-list
110798833|NCT02764268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110798834|NCT02764268|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110798835|NCT02764268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110798836|NCT02764268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110798838|NCT01320111|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110798839|NCT01320111|Sorafenib|sorafenib|mesh-list
110798840|NCT01320111|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110798841|NCT01320111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110798842|NCT01320111|Tubulin Modulators|tubulin modulators|mesh-ancestor
110798843|NCT01320111|Antimitotic Agents|antimitotic agents|mesh-ancestor
110798844|NCT01320111|Mitosis Modulators|mitosis modulators|mesh-ancestor
110798845|NCT01320111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110798846|NCT01320111|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110798847|NCT01320111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110798848|NCT01320579|Tacrolimus|tacrolimus|mesh-list
110798849|NCT01320579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110798850|NCT01320579|Immunologic Factors|immunologic factors|mesh-ancestor
110798851|NCT01320579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110798852|NCT01320579|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110798853|NCT01320579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110798854|NCT01320579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110798855|NCT05669001|Mycophenolic Acid|mycophenolic acid|mesh-list
110798856|NCT05669001|Abatacept|abatacept|mesh-list
110798857|NCT05669001|Tacrolimus|tacrolimus|mesh-list
110798858|NCT05669001|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110798859|NCT05669001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110798860|NCT05669001|Immunologic Factors|immunologic factors|mesh-ancestor
110798861|NCT05669001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110798862|NCT05669001|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110798863|NCT05669001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110798864|NCT05669001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110798865|NCT05669001|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110798866|NCT05669001|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110798867|NCT05669001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110798868|NCT05669001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110798869|NCT05669001|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110798870|NCT05669001|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110798871|NCT05669001|Antitubercular Agents|antitubercular agents|mesh-ancestor
110798872|NCT05669001|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110798873|NCT05669001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110798874|NCT03775395|Sorafenib|sorafenib|mesh-list
110798875|NCT03775395|Lenvatinib|lenvatinib|mesh-list
110798876|NCT03775395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110798877|NCT03775395|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110798878|NCT03775395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110798879|NCT03775395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110798880|NCT02797522|Acetaminophen|acetaminophen|mesh-list
110798881|NCT02797522|Tenofovir|tenofovir|mesh-list
110798882|NCT02797522|Entecavir|entecavir|mesh-list
110798883|NCT02797522|Histamine Antagonists|histamine antagonists|mesh-list
110798884|NCT02797522|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
110798885|NCT02797522|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110798886|NCT02797522|Analgesics|analgesics|mesh-ancestor
110798887|NCT02797522|Sensory System Agents|sensory system agents|mesh-ancestor
110798888|NCT02797522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110798889|NCT02797522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110798890|NCT02797522|Antipyretics|antipyretics|mesh-ancestor
110798891|NCT02797522|Antiviral Agents|antiviral agents|mesh-ancestor
110798892|NCT02797522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110798893|NCT02797522|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110798894|NCT02797522|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110798895|NCT02797522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110798896|NCT02797522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110798897|NCT02797522|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110798898|NCT02797522|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110798899|NCT02797522|Histamine Agents|histamine agents|mesh-ancestor
110798900|NCT02797522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110798901|NCT03773367|Fluorouracil|fluorouracil|mesh-list
110798902|NCT03773367|Oxaliplatin|oxaliplatin|mesh-list
110798903|NCT03773367|Irinotecan|irinotecan|mesh-list
110798904|NCT03773367|Antimetabolites|antimetabolites|mesh-ancestor
110798905|NCT03773367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110798906|NCT03773367|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110798907|NCT03773367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110516495|NCT05658692|Antimetabolites|antimetabolites|mesh-ancestor
110798908|NCT03773367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110798909|NCT03773367|Immunologic Factors|immunologic factors|mesh-ancestor
110798910|NCT03773367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110798911|NCT03773367|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110798912|NCT03773367|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110798913|NCT03773367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110798914|NCT02060656|Methylprednisolone|methylprednisolone|mesh-list
110798915|NCT02060656|Rituximab|rituximab|mesh-list
110798916|NCT02060656|Gemcitabine|gemcitabine|mesh-list
110798917|NCT02060656|Lenalidomide|lenalidomide|mesh-list
110798918|NCT02060656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110798919|NCT02060656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110798920|NCT02060656|Immunologic Factors|immunologic factors|mesh-ancestor
110798921|NCT02060656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110798922|NCT02060656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110798923|NCT02060656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110798924|NCT02060656|Antimetabolites|antimetabolites|mesh-ancestor
110798925|NCT02060656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110798926|NCT02060656|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110798927|NCT02060656|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110798928|NCT02060656|Growth Substances|growth substances|mesh-ancestor
110798929|NCT02060656|Growth Inhibitors|growth inhibitors|mesh-ancestor
110798930|NCT02060656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110798931|NCT02060656|Antiemetics|antiemetics|mesh-ancestor
110798932|NCT02060656|Autonomic Agents|autonomic agents|mesh-ancestor
110798933|NCT02060656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110798934|NCT02060656|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110798935|NCT02060656|Glucocorticoids|glucocorticoids|mesh-ancestor
110798936|NCT02060656|Hormones|hormones|mesh-ancestor
110798937|NCT02060656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110798938|NCT02060656|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110798939|NCT02060656|Protective Agents|protective agents|mesh-ancestor
110798940|NCT03774771|Cinacalcet|cinacalcet|mesh-list
110798941|NCT03774771|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110798942|NCT03774771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110798943|NCT03774771|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
110798944|NCT03774771|Hormone Antagonists|hormone antagonists|mesh-ancestor
110798945|NCT03774771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110798946|NCT03774693|Fentanyl|fentanyl|mesh-list
110798947|NCT03774693|Anesthetics|anesthetics|mesh-ancestor
110798948|NCT03774693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110798949|NCT03774693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110798950|NCT03774693|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110798951|NCT03774693|Narcotics|narcotics|mesh-ancestor
110798952|NCT03774693|Analgesics|analgesics|mesh-ancestor
110798953|NCT03774693|Sensory System Agents|sensory system agents|mesh-ancestor
110798954|NCT03774693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110798955|NCT03774693|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110798956|NCT03774693|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110798957|NCT03774693|Anesthetics, General|anesthetics, general|mesh-ancestor
110798958|NCT03774615|Ferric maltol|ferric maltol|mesh-list
110798959|NCT03774615|Hematinics|hematinics|mesh-ancestor
110798960|NCT01321047|Propofol|propofol|mesh-list
110798961|NCT01321047|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110798962|NCT01321047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110798963|NCT01321047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110798964|NCT01321047|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110798965|NCT01321047|Anesthetics, General|anesthetics, general|mesh-ancestor
110798966|NCT01321047|Anesthetics|anesthetics|mesh-ancestor
110798967|NCT01321125|Chlorhexidine|chlorhexidine|mesh-list
110798968|NCT01321125|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110798969|NCT01321125|Povidone-Iodine|povidone-iodine|mesh-list
110798970|NCT01321125|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
110798971|NCT01321125|Povidone|povidone|mesh-list
110798972|NCT01321125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110798973|NCT01321125|Disinfectants|disinfectants|mesh-ancestor
110798974|NCT01321125|Dermatologic Agents|dermatologic agents|mesh-ancestor
110798975|NCT01321125|Plasma Substitutes|plasma substitutes|mesh-ancestor
110798976|NCT01321125|Blood Substitutes|blood substitutes|mesh-ancestor
110798977|NCT03773991|Nitric Oxide|nitric oxide|mesh-list
110798978|NCT03773991|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110798979|NCT03773991|Autonomic Agents|autonomic agents|mesh-ancestor
110798980|NCT03773991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110798981|NCT03773991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110798982|NCT03773991|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110798983|NCT03773991|Respiratory System Agents|respiratory system agents|mesh-ancestor
110798984|NCT03773991|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110798985|NCT03773991|Antioxidants|antioxidants|mesh-ancestor
110798986|NCT03773991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110798987|NCT03773991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110798988|NCT03773991|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
110798989|NCT03773991|Vasodilator Agents|vasodilator agents|mesh-ancestor
110798990|NCT03773991|Gasotransmitters|gasotransmitters|mesh-ancestor
110798992|NCT05435313|Oxaliplatin|oxaliplatin|mesh-list
110798993|NCT05435313|Irinotecan|irinotecan|mesh-list
110798994|NCT05435313|Tislelizumab|tislelizumab|mesh-list
110798995|NCT05435313|Raltitrexed|raltitrexed|mesh-list
110798996|NCT05435313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110798997|NCT05435313|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110798998|NCT05435313|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110798999|NCT05435313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110799000|NCT05435313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110852048|NCT04968054|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110799001|NCT05435313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110799002|NCT05435313|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110799003|NCT05435313|Antimetabolites|antimetabolites|mesh-ancestor
110799004|NCT05435313|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110799005|NCT05472675|Bupivacaine|bupivacaine|mesh-list
110799006|NCT05472675|Botulinum Toxins|botulinum toxins|mesh-list
110799007|NCT05472675|Anesthetics, Local|anesthetics, local|mesh-ancestor
110799008|NCT05472675|Anesthetics|anesthetics|mesh-ancestor
110799009|NCT05472675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110799010|NCT05472675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110799011|NCT05472675|Sensory System Agents|sensory system agents|mesh-ancestor
110799012|NCT05472675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110799013|NCT05472675|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110799014|NCT05472675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110799015|NCT05472675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110799016|NCT05472675|Cholinergic Agents|cholinergic agents|mesh-ancestor
110799017|NCT05472675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110799018|NCT01321905|Vitamin D|vitamin d|mesh-list
110799019|NCT01321905|Ergocalciferols|ergocalciferols|mesh-list
110799020|NCT01321905|Vitamins|vitamins|mesh-ancestor
110799021|NCT01321905|Micronutrients|micronutrients|mesh-ancestor
110799022|NCT01321905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110799023|NCT01321905|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110799024|NCT01321905|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110799025|NCT04570670|Dimethyl Fumarate|dimethyl fumarate|mesh-list
110799026|NCT04570670|Dermatologic Agents|dermatologic agents|mesh-ancestor
110799027|NCT04570670|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110799028|NCT04570670|Immunologic Factors|immunologic factors|mesh-ancestor
110799029|NCT04570670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110799030|NCT03763227|Ranibizumab|ranibizumab|mesh-list
110799031|NCT03763227|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-list
110799032|NCT03763227|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110799033|NCT03763227|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110799034|NCT03763227|Growth Substances|growth substances|mesh-ancestor
110799035|NCT03763227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110799036|NCT03763227|Growth Inhibitors|growth inhibitors|mesh-ancestor
110799037|NCT03763227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110799038|NCT03763227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110799039|NCT03763227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110799040|NCT04929548|Maleic acid|maleic acid|mesh-list
110799041|NCT04929548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110799042|NCT04929548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110799043|NCT04150029|Azacitidine|azacitidine|mesh-list
110799044|NCT04150029|Venetoclax|venetoclax|mesh-list
110799045|NCT04150029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110799046|NCT04150029|Antimetabolites|antimetabolites|mesh-ancestor
110799047|NCT04150029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110799048|NCT04150029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110799049|NCT04150029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110799050|NCT02060734|Lidocaine|lidocaine|mesh-list
110799051|NCT02060734|Anesthetics, Local|anesthetics, local|mesh-ancestor
110799052|NCT02060734|Anesthetics|anesthetics|mesh-ancestor
110799053|NCT02060734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110799054|NCT02060734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110799055|NCT02060734|Sensory System Agents|sensory system agents|mesh-ancestor
110799056|NCT02060734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110799057|NCT02060734|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110799058|NCT02060734|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110799059|NCT02060734|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110799060|NCT02060734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110799061|NCT02060734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110799062|NCT03270644|Propranolol|propranolol|mesh-list
110516659|NCT05657678|Vitamin D|vitamin d|mesh-list
110799064|NCT03270644|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110799065|NCT03270644|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110799066|NCT03270644|Adrenergic Agents|adrenergic agents|mesh-ancestor
110799067|NCT03270644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110799068|NCT03270644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110799069|NCT03270644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110799070|NCT03270644|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110799071|NCT03270644|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110799072|NCT03270644|Vasodilator Agents|vasodilator agents|mesh-ancestor
110799073|NCT03270644|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110799074|NCT03270644|Serotonin Agents|serotonin agents|mesh-ancestor
110799075|NCT04535102|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
110799076|NCT04535102|Immunoconjugates|immunoconjugates|mesh-ancestor
110799077|NCT04535102|Immunologic Factors|immunologic factors|mesh-ancestor
110799078|NCT04535102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110799079|NCT04529720|Vaccines|vaccines|mesh-list
110799080|NCT04529720|Immunologic Factors|immunologic factors|mesh-ancestor
110799081|NCT04529720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110799082|NCT03768609|Cyclosporine|cyclosporine|mesh-list
110799083|NCT03768609|Cyclosporins|cyclosporins|mesh-list
110799084|NCT03768609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110799085|NCT03768609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110799086|NCT03768609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110799087|NCT03768609|Immunologic Factors|immunologic factors|mesh-ancestor
110799088|NCT03768609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110799089|NCT03768609|Antifungal Agents|antifungal agents|mesh-ancestor
110799090|NCT03768609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110799091|NCT03768609|Dermatologic Agents|dermatologic agents|mesh-ancestor
110799092|NCT03768609|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110799093|NCT03768609|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110799094|NCT03269552|Rituximab|rituximab|mesh-list
110799095|NCT03269552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110799096|NCT03269552|Antibodies|antibodies|mesh-list
110799097|NCT03269552|Immunoglobulins|immunoglobulins|mesh-list
110799098|NCT03269552|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110799099|NCT03269552|Immunologic Factors|immunologic factors|mesh-ancestor
110799100|NCT03269552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110620077|NCT02560766|Antimanic Agents|antimanic agents|mesh-ancestor
110799101|NCT03269552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110799102|NCT03269552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110799103|NCT03771729|Valsartan|valsartan|mesh-list
110799104|NCT03771729|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
110799105|NCT03771729|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110799106|NCT03771729|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110799107|NCT03771729|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110799108|NCT03771729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110799109|NCT03560362|Epinephrine|epinephrine|mesh-list
110799110|NCT03560362|Bupivacaine|bupivacaine|mesh-list
110799111|NCT03560362|Anesthetics, Local|anesthetics, local|mesh-ancestor
110799112|NCT03560362|Anesthetics|anesthetics|mesh-ancestor
110799113|NCT03560362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110799114|NCT03560362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110799115|NCT03560362|Sensory System Agents|sensory system agents|mesh-ancestor
110799116|NCT03560362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110799117|NCT03560362|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110799118|NCT03560362|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110799119|NCT03560362|Adrenergic Agents|adrenergic agents|mesh-ancestor
110799120|NCT03560362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110799121|NCT03560362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110799122|NCT03560362|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110799123|NCT03560362|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110799124|NCT03560362|Autonomic Agents|autonomic agents|mesh-ancestor
110799125|NCT03560362|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110799126|NCT03560362|Respiratory System Agents|respiratory system agents|mesh-ancestor
110799127|NCT03560362|Mydriatics|mydriatics|mesh-ancestor
110799129|NCT03560362|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110799130|NCT03768531|Nivolumab|nivolumab|mesh-list
110799131|NCT03768531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110799132|NCT03768531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110799133|NCT03768531|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110799134|NCT03768531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110799135|NCT01322061|Ascorbic Acid|ascorbic acid|mesh-list
110799136|NCT01322061|Vitamins|vitamins|mesh-ancestor
110799137|NCT01322061|Micronutrients|micronutrients|mesh-ancestor
110799138|NCT01322061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110799139|NCT01322061|Antioxidants|antioxidants|mesh-ancestor
110799140|NCT01322061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110799141|NCT01322061|Protective Agents|protective agents|mesh-ancestor
110799142|NCT02062996|Phenylephrine|phenylephrine|mesh-list
110799143|NCT02062996|Oxymetazoline|oxymetazoline|mesh-list
110799144|NCT02062996|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110799145|NCT02062996|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110799146|NCT02062996|Adrenergic Agents|adrenergic agents|mesh-ancestor
110799147|NCT02062996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110799148|NCT02062996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110799149|NCT02062996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110799150|NCT02062996|Sympathomimetics|sympathomimetics|mesh-ancestor
110799151|NCT02062996|Autonomic Agents|autonomic agents|mesh-ancestor
110799152|NCT02062996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110799153|NCT02062996|Nasal Decongestants|nasal decongestants|mesh-ancestor
110799154|NCT02062996|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110799155|NCT02062996|Respiratory System Agents|respiratory system agents|mesh-ancestor
110799156|NCT02062996|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110799157|NCT02062996|Mydriatics|mydriatics|mesh-ancestor
110799158|NCT02062996|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110799159|NCT02062996|Protective Agents|protective agents|mesh-ancestor
110799160|NCT03762369|Latanoprost|latanoprost|mesh-list
110799161|NCT03762369|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110620119|NCT00660816|Docetaxel|docetaxel|mesh-list
110799162|NCT03762369|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110799163|NCT01321515|Famciclovir|famciclovir|mesh-list
110799164|NCT01321515|Antiviral Agents|antiviral agents|mesh-ancestor
110799165|NCT01321515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110799166|NCT01321515|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110799167|NCT01321515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110799168|NCT01321515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110799169|NCT02065414|Chlorhexidine|chlorhexidine|mesh-list
110799170|NCT02065414|Listerine|listerine|mesh-list
110799171|NCT02065414|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110799172|NCT02065414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110799173|NCT02065414|Disinfectants|disinfectants|mesh-ancestor
110799174|NCT04233879|Tenofovir|tenofovir|mesh-list
110799175|NCT04233879|Emtricitabine|emtricitabine|mesh-list
110799176|NCT04233879|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
110799177|NCT04233879|Islatravir|islatravir|mesh-list
110799178|NCT04233879|Antiviral Agents|antiviral agents|mesh-ancestor
110799179|NCT04233879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110799180|NCT04233879|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110799181|NCT04233879|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110799182|NCT04233879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110799183|NCT04233879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110799184|NCT04233879|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110799185|NCT04233879|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110799186|NCT01370356|Varenicline|varenicline|mesh-list
110799187|NCT01370356|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110799188|NCT01370356|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110799189|NCT01370356|Cholinergic Agents|cholinergic agents|mesh-ancestor
110799190|NCT01370356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110799191|NCT01370356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110852102|NCT04765111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110799192|NCT01370356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110799193|NCT03792334|Anesthetics|anesthetics|mesh-list
110799194|NCT03792334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110799195|NCT03792334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110799196|NCT04545411|Dapagliflozin|dapagliflozin|mesh-list
110799197|NCT04545411|Volagidemab|volagidemab|mesh-list
110799198|NCT04545411|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110799199|NCT04545411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110799200|NCT04545411|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110799201|NCT04545411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110799202|NCT02065492|Amlodipine|amlodipine|mesh-list
110799203|NCT02065492|Calcium Channel Blockers|calcium channel blockers|mesh-list
110799204|NCT02065492|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110799205|NCT02065492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110799206|NCT02065492|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110799207|NCT02065492|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110799208|NCT02065492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110799209|NCT02065492|Vasodilator Agents|vasodilator agents|mesh-ancestor
110799210|NCT02063620|Ketamine|ketamine|mesh-list
110799211|NCT02063620|Analgesics|analgesics|mesh-ancestor
110799212|NCT02063620|Sensory System Agents|sensory system agents|mesh-ancestor
110799213|NCT02063620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110799214|NCT02063620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110799215|NCT02063620|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110799216|NCT02063620|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110799217|NCT02063620|Anesthetics, General|anesthetics, general|mesh-ancestor
110799218|NCT02063620|Anesthetics|anesthetics|mesh-ancestor
110799219|NCT02063620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110799220|NCT02063620|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110799221|NCT02063620|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110799222|NCT02063620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110799223|NCT02063620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110799224|NCT03767439|Nivolumab|nivolumab|mesh-list
110799225|NCT03767439|Ipilimumab|ipilimumab|mesh-list
110799226|NCT03767439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110799227|NCT03767439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110799228|NCT03767439|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110799229|NCT03767439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110799230|NCT04539405|Sevoflurane|sevoflurane|mesh-list
110799231|NCT04539405|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110799232|NCT04539405|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110799233|NCT04539405|Anesthetics, General|anesthetics, general|mesh-ancestor
110799234|NCT04539405|Anesthetics|anesthetics|mesh-ancestor
110799235|NCT04539405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110799236|NCT04539405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110799237|NCT02065804|Bupivacaine|bupivacaine|mesh-list
110799238|NCT02065804|Anesthetics, Local|anesthetics, local|mesh-ancestor
110799239|NCT02065804|Anesthetics|anesthetics|mesh-ancestor
110799240|NCT02065804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110799241|NCT02065804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110799242|NCT02065804|Sensory System Agents|sensory system agents|mesh-ancestor
110799243|NCT02065804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110799244|NCT02064010|Calcium, Dietary|calcium, dietary|mesh-list
110799245|NCT02064010|Acamprosate|acamprosate|mesh-list
110799246|NCT02064010|Calcium|calcium|mesh-list
110799247|NCT02064010|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110799248|NCT02064010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110799249|NCT02064010|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110620174|NCT05360602|Vitamins|vitamins|mesh-ancestor
110799250|NCT02064010|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110799251|NCT02064088|Levobupivacaine|levobupivacaine|mesh-list
110799252|NCT02064088|Anesthetics, Local|anesthetics, local|mesh-ancestor
110799253|NCT02064088|Anesthetics|anesthetics|mesh-ancestor
110799254|NCT02064088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110799255|NCT02064088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110799256|NCT02064088|Sensory System Agents|sensory system agents|mesh-ancestor
110799257|NCT02064088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110799258|NCT02066038|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110799259|NCT02066038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110799260|NCT02066038|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110799261|NCT02066038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110799262|NCT02066038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110799263|NCT03766893|Naltrexone|naltrexone|mesh-list
110799264|NCT03766893|Buprenorphine|buprenorphine|mesh-list
110799265|NCT03766893|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
110799266|NCT03766893|Naloxone|naloxone|mesh-list
110799267|NCT03766893|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110799268|NCT03766893|Narcotics|narcotics|mesh-ancestor
110799269|NCT03766893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110799270|NCT03766893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110799271|NCT03766893|Analgesics|analgesics|mesh-ancestor
110799272|NCT03766893|Sensory System Agents|sensory system agents|mesh-ancestor
110799273|NCT03766893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110799274|NCT03766893|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110799275|NCT03766893|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110799276|NCT03760809|Dexmedetomidine|dexmedetomidine|mesh-list
110799277|NCT03760809|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110799278|NCT03760809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110799279|NCT03760809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110799280|NCT03760809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110799281|NCT03760809|Analgesics|analgesics|mesh-ancestor
110799282|NCT03760809|Sensory System Agents|sensory system agents|mesh-ancestor
110799283|NCT03760809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110799284|NCT03760809|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110799285|NCT03760809|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110799286|NCT03760809|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110799287|NCT03760809|Adrenergic Agents|adrenergic agents|mesh-ancestor
110799288|NCT03760809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110799289|NCT03760809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110799290|NCT01370590|Atorvastatin|atorvastatin|mesh-list
110799291|NCT01370590|Ezetimibe|ezetimibe|mesh-list
110799292|NCT01370590|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110799293|NCT01370590|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110799294|NCT01370590|Antimetabolites|antimetabolites|mesh-ancestor
110799295|NCT01370590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110799296|NCT01370590|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110799297|NCT01370590|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110799298|NCT01370590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110799299|NCT01567683|Imiquimod|imiquimod|mesh-list
110799300|NCT01567683|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110799301|NCT01567683|Immunologic Factors|immunologic factors|mesh-ancestor
110799302|NCT01567683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110799303|NCT01567683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110799304|NCT01567683|Interferon Inducers|interferon inducers|mesh-ancestor
110799305|NCT03766425|Aflibercept|aflibercept|mesh-list
110799306|NCT03766425|Mitomycins|mitomycins|mesh-list
110799307|NCT03766425|Mitomycin|mitomycin|mesh-list
110620195|NCT00991744|Glucocorticoids|glucocorticoids|mesh-ancestor
110799308|NCT03766425|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110799309|NCT03766425|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110799310|NCT03766425|Growth Substances|growth substances|mesh-ancestor
110799311|NCT03766425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110799312|NCT03766425|Growth Inhibitors|growth inhibitors|mesh-ancestor
110852130|NCT04735354|Valsartan|valsartan|mesh-list
110799313|NCT03766425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110799314|NCT03766425|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110799315|NCT03766425|Alkylating Agents|alkylating agents|mesh-ancestor
110799316|NCT03766425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110799317|NCT03766425|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110799318|NCT03766425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110799319|NCT01561911|Antibodies|antibodies|mesh-list
110799320|NCT01561911|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110799321|NCT01561911|Immunologic Factors|immunologic factors|mesh-ancestor
110799322|NCT01561911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110799323|NCT03770637|Glucagon|glucagon|mesh-list
110799324|NCT03770637|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
110799325|NCT03770637|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110799326|NCT03770637|Hormones|hormones|mesh-ancestor
110799327|NCT03770637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110799328|NCT03770637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110799329|NCT03770637|Incretins|incretins|mesh-ancestor
110799330|NCT03766269|Dronabinol|dronabinol|mesh-list
110799331|NCT03766269|Hallucinogens|hallucinogens|mesh-ancestor
110799332|NCT03766269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110799333|NCT03766269|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110799334|NCT03766269|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110799335|NCT03766269|Analgesics|analgesics|mesh-ancestor
110799336|NCT03766269|Sensory System Agents|sensory system agents|mesh-ancestor
110799337|NCT03766269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110799338|NCT03766269|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
110799339|NCT03766269|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110799340|NCT03766269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110799341|NCT03766269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110799342|NCT03766269|Hormones|hormones|mesh-ancestor
110799343|NCT03766269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110799344|NCT03894891|Docetaxel|docetaxel|mesh-list
110799345|NCT03894891|Nivolumab|nivolumab|mesh-list
110799346|NCT03894891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110799347|NCT03894891|Tubulin Modulators|tubulin modulators|mesh-ancestor
110799348|NCT03894891|Antimitotic Agents|antimitotic agents|mesh-ancestor
110799349|NCT03894891|Mitosis Modulators|mitosis modulators|mesh-ancestor
110799350|NCT03894891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110799351|NCT03894891|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110799352|NCT03894891|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110799353|NCT03878979|Nivolumab|nivolumab|mesh-list
110799354|NCT03878979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110799355|NCT03878979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110799356|NCT03878979|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110799357|NCT03878979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110799358|NCT03765645|Tazobactam|tazobactam|mesh-list
110799359|NCT03765645|Piperacillin|piperacillin|mesh-list
110799360|NCT03765645|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
110799361|NCT03765645|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110799362|NCT03765645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110799363|NCT03765645|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110799364|NCT03765645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110799365|NCT03765645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110799366|NCT01321671|Pregabalin|pregabalin|mesh-list
110799367|NCT01321671|Analgesics|analgesics|mesh-ancestor
110799368|NCT01321671|Sensory System Agents|sensory system agents|mesh-ancestor
110799369|NCT01321671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110799370|NCT01321671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110799371|NCT01321671|Anticonvulsants|anticonvulsants|mesh-ancestor
110799372|NCT01321671|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110799373|NCT01321671|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110799374|NCT01321671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110799375|NCT01321671|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110799376|NCT01321671|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110799377|NCT01321671|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110799378|NCT01321671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110799379|NCT01321671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110799380|NCT03770013|Clonidine|clonidine|mesh-list
110799381|NCT03770013|Dexmedetomidine|dexmedetomidine|mesh-list
110799382|NCT03770013|Bupivacaine|bupivacaine|mesh-list
110799383|NCT03770013|Anesthetics, Local|anesthetics, local|mesh-ancestor
110799384|NCT03770013|Anesthetics|anesthetics|mesh-ancestor
110799385|NCT03770013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110799386|NCT03770013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110799387|NCT03770013|Sensory System Agents|sensory system agents|mesh-ancestor
110799388|NCT03770013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110799389|NCT03770013|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110799390|NCT03770013|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110799391|NCT03770013|Analgesics|analgesics|mesh-ancestor
110799392|NCT03770013|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110799393|NCT03770013|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110799394|NCT03770013|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110799395|NCT03770013|Adrenergic Agents|adrenergic agents|mesh-ancestor
110799396|NCT03770013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110799397|NCT03770013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110799398|NCT03770013|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110799399|NCT03770013|Sympatholytics|sympatholytics|mesh-ancestor
110799400|NCT03770013|Autonomic Agents|autonomic agents|mesh-ancestor
110799401|NCT03769935|Etoposide|etoposide|mesh-list
110799402|NCT03769935|Cisplatin|cisplatin|mesh-list
110799403|NCT03769935|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110799404|NCT03769935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110799405|NCT03769935|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110799406|NCT03769935|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110799407|NCT03769935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110799408|NCT03769935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110799409|NCT03765021|Tranexamic Acid|tranexamic acid|mesh-list
110799410|NCT03765021|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110799411|NCT03765021|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110799412|NCT03765021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110799413|NCT03765021|Hemostatics|hemostatics|mesh-ancestor
110799414|NCT03765021|Coagulants|coagulants|mesh-ancestor
110799415|NCT05418699|Insulin|insulin|mesh-list
110799416|NCT05418699|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110799417|NCT05418699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110799418|NCT03758859|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110799419|NCT03758859|Hyaluronic Acid|hyaluronic acid|mesh-list
110799420|NCT03758859|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110799421|NCT03758859|Immunologic Factors|immunologic factors|mesh-ancestor
110799422|NCT03758859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110799423|NCT03758859|Viscosupplements|viscosupplements|mesh-ancestor
110799424|NCT03758859|Protective Agents|protective agents|mesh-ancestor
110799425|NCT03758859|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110799426|NCT03764241|Vitamin K|vitamin k|mesh-list
110799427|NCT03764241|Rivaroxaban|rivaroxaban|mesh-list
110799428|NCT03764241|Vitamins|vitamins|mesh-ancestor
110799429|NCT03764241|Micronutrients|micronutrients|mesh-ancestor
110799430|NCT03764241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110799431|NCT03764241|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110799432|NCT03764241|Antithrombins|antithrombins|mesh-ancestor
110799433|NCT03764241|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110799434|NCT03764241|Protease Inhibitors|protease inhibitors|mesh-ancestor
110799435|NCT03764241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110799436|NCT03764241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110799437|NCT03764241|Anticoagulants|anticoagulants|mesh-ancestor
110799438|NCT03764241|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110799439|NCT03764241|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110799441|NCT03764241|Coagulants|coagulants|mesh-ancestor
110799442|NCT03764163|Xenon|xenon|mesh-list
110799443|NCT03764163|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110799444|NCT03764163|Anesthetics, General|anesthetics, general|mesh-ancestor
110799445|NCT03764163|Anesthetics|anesthetics|mesh-ancestor
110799446|NCT03764163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110799447|NCT03764163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110799448|NCT02556099|Hydroxyurea|hydroxyurea|mesh-list
110799449|NCT02556099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110799450|NCT02556099|Antisickling Agents|antisickling agents|mesh-ancestor
110799451|NCT02556099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110799452|NCT02556099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110799453|NCT02556099|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110799454|NCT01321827|Itraconazole|itraconazole|mesh-list
110799455|NCT01321827|Prednisolone|prednisolone|mesh-list
110799456|NCT01321827|Glucocorticoids|glucocorticoids|mesh-list
110799457|NCT01321827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110799458|NCT01321827|Hormones|hormones|mesh-ancestor
110799459|NCT01321827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110799460|NCT01321827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110799461|NCT01321827|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110799462|NCT01321827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110799463|NCT01321827|Antifungal Agents|antifungal agents|mesh-ancestor
110620304|NCT00575666|Insulin|insulin|mesh-list
110799464|NCT01321827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110799465|NCT01321827|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110799466|NCT01321827|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110799467|NCT01321827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110799468|NCT01321827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110799469|NCT01321827|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110799470|NCT01321827|Hormone Antagonists|hormone antagonists|mesh-ancestor
110799471|NCT01321827|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110799472|NCT03753477|Amlodipine|amlodipine|mesh-list
110799473|NCT03753477|Olmesartan|olmesartan|mesh-list
110799474|NCT03753477|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
110799475|NCT03753477|Amlodipine Besylate, Olmesartan Medoxomil Drug Combination|amlodipine besylate, olmesartan medoxomil drug combination|mesh-list
110799476|NCT03753477|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110799477|NCT03753477|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110799478|NCT03753477|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110799479|NCT03753477|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110799480|NCT03753477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110799481|NCT03753477|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110799482|NCT03753477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110799483|NCT03753477|Vasodilator Agents|vasodilator agents|mesh-ancestor
110799484|NCT03753477|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110799485|NCT03753477|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110799486|NCT03753477|Antimetabolites|antimetabolites|mesh-ancestor
110799487|NCT03753477|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110799488|NCT03753477|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110799489|NCT03753477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110799490|NCT03753477|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110799491|NCT03753477|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110799492|NCT05236647|Morphine|morphine|mesh-list
110799493|NCT05236647|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110799494|NCT05236647|Narcotics|narcotics|mesh-ancestor
110799495|NCT05236647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110799496|NCT05236647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110799497|NCT05236647|Analgesics|analgesics|mesh-ancestor
110799498|NCT05236647|Sensory System Agents|sensory system agents|mesh-ancestor
110799499|NCT05236647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110799500|NCT03758469|Rifampin|rifampin|mesh-list
110799501|NCT03758469|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110799502|NCT03758469|Antitubercular Agents|antitubercular agents|mesh-ancestor
110799503|NCT03758469|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110799504|NCT03758469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110799505|NCT03758469|Leprostatic Agents|leprostatic agents|mesh-ancestor
110799506|NCT03758469|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110799507|NCT03758469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110799508|NCT03758469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110799509|NCT03758469|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110517094|NCT00928213|Progesterone|progesterone|mesh-list
110799511|NCT03758469|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110799512|NCT03758469|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110799513|NCT03758469|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110799514|NCT03758469|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110799515|NCT04646109|Azithromycin|azithromycin|mesh-list
110799516|NCT04646109|Hydroxychloroquine|hydroxychloroquine|mesh-list
110799517|NCT04646109|Ivermectin|ivermectin|mesh-list
110799518|NCT04646109|Favipiravir|favipiravir|mesh-list
110799519|NCT04646109|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110799520|NCT04646109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110799521|NCT04646109|Antimalarials|antimalarials|mesh-ancestor
110799522|NCT04646109|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110799523|NCT04646109|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110799524|NCT04646109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110799525|NCT04646109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110799526|NCT04646109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110799527|NCT04646109|Antiviral Agents|antiviral agents|mesh-ancestor
110799528|NCT05320107|Ketamine|ketamine|mesh-list
110799529|NCT05320107|Analgesics|analgesics|mesh-ancestor
110799530|NCT05320107|Sensory System Agents|sensory system agents|mesh-ancestor
110799531|NCT05320107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110620366|NCT00801918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110799584|NCT02064556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110799585|NCT02064556|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110799586|NCT02064556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110799587|NCT02064556|Vasodilator Agents|vasodilator agents|mesh-ancestor
110799588|NCT02064556|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110799589|NCT02064556|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110799590|NCT03752229|Diazepam|diazepam|mesh-list
110799591|NCT03752229|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110799592|NCT03752229|Anticonvulsants|anticonvulsants|mesh-ancestor
110799593|NCT03752229|Antiemetics|antiemetics|mesh-ancestor
110799594|NCT03752229|Autonomic Agents|autonomic agents|mesh-ancestor
110799595|NCT03752229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110799596|NCT03752229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110799597|NCT03752229|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110799598|NCT03752229|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110799599|NCT03752229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110799600|NCT03752229|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110799601|NCT03752229|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110799602|NCT03752229|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110799603|NCT03752229|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110799604|NCT03752229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110799605|NCT03752229|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110799606|NCT03752229|Anesthetics, General|anesthetics, general|mesh-ancestor
110799607|NCT03752229|Anesthetics|anesthetics|mesh-ancestor
110799608|NCT03752229|GABA Modulators|gaba modulators|mesh-ancestor
110799609|NCT03752229|GABA Agents|gaba agents|mesh-ancestor
110799610|NCT03752229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110799611|NCT03752229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110799612|NCT05359731|Dexamethasone|dexamethasone|mesh-list
110799613|NCT05359731|Bupivacaine|bupivacaine|mesh-list
110799614|NCT05359731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110799615|NCT05359731|Antiemetics|antiemetics|mesh-ancestor
110799616|NCT05359731|Autonomic Agents|autonomic agents|mesh-ancestor
110799617|NCT05359731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110799618|NCT05359731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110799619|NCT05359731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110799620|NCT05359731|Glucocorticoids|glucocorticoids|mesh-ancestor
110799621|NCT05359731|Hormones|hormones|mesh-ancestor
110799622|NCT05359731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110799623|NCT05359731|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110799624|NCT05359731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110799625|NCT05359731|Anesthetics, Local|anesthetics, local|mesh-ancestor
110799626|NCT05359731|Anesthetics|anesthetics|mesh-ancestor
110799627|NCT05359731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110799628|NCT05359731|Sensory System Agents|sensory system agents|mesh-ancestor
110799629|NCT03695367|Acetaminophen|acetaminophen|mesh-list
110799630|NCT03695367|Ibuprofen|ibuprofen|mesh-list
110799631|NCT03695367|Ketorolac|ketorolac|mesh-list
110799632|NCT03695367|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110799633|NCT03695367|Analgesics|analgesics|mesh-ancestor
110799634|NCT03695367|Sensory System Agents|sensory system agents|mesh-ancestor
110799635|NCT03695367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110799636|NCT03695367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110799637|NCT03695367|Antipyretics|antipyretics|mesh-ancestor
110799638|NCT03695367|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110799639|NCT03695367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110799640|NCT03695367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110799641|NCT03695367|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110799642|NCT03695367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110799643|NCT03695367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110799644|NCT03755427|Aluminum Hydroxide|aluminum hydroxide|mesh-list
110799645|NCT03755427|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110799646|NCT03755427|Immunologic Factors|immunologic factors|mesh-ancestor
110799647|NCT03755427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110799648|NCT03755427|Antacids|antacids|mesh-ancestor
110339849|NCT02951897|Pemetrexed|pemetrexed|mesh-list
110799649|NCT03755427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110799650|NCT03755427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110799651|NCT03758079|Gabapentin|gabapentin|mesh-list
110799652|NCT03758079|Doxepin|doxepin|mesh-list
110799653|NCT03758079|Analgesics|analgesics|mesh-ancestor
110799654|NCT03758079|Sensory System Agents|sensory system agents|mesh-ancestor
110799655|NCT03758079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110799656|NCT03758079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110799657|NCT03758079|Anticonvulsants|anticonvulsants|mesh-ancestor
110517241|NCT00925093|Vancomycin|vancomycin|mesh-list
110799658|NCT03758079|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110799659|NCT03758079|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110799660|NCT03758079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110799661|NCT03758079|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110799662|NCT03758079|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110799663|NCT03758079|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110799665|NCT03758079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110799667|NCT03758079|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110799668|NCT03758079|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110799669|NCT03758079|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110799670|NCT03758079|Antidepressive Agents|antidepressive agents|mesh-ancestor
110799671|NCT03758079|Histamine Antagonists|histamine antagonists|mesh-ancestor
110799672|NCT03758079|Histamine Agents|histamine agents|mesh-ancestor
110799673|NCT02067910|Abatacept|abatacept|mesh-list
110799674|NCT02067910|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110799675|NCT02067910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110799676|NCT02067910|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110799677|NCT02067910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110799678|NCT02067910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110799679|NCT02067910|Immunologic Factors|immunologic factors|mesh-ancestor
110799680|NCT02067910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110799681|NCT02067910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110799682|NCT02066662|Rivaroxaban|rivaroxaban|mesh-list
110799683|NCT02066662|Phenprocoumon|phenprocoumon|mesh-list
110799684|NCT02066662|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110799685|NCT02066662|Antithrombins|antithrombins|mesh-ancestor
110799686|NCT02066662|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110799687|NCT02066662|Protease Inhibitors|protease inhibitors|mesh-ancestor
110799688|NCT02066662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110799689|NCT02066662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110799690|NCT02066662|Anticoagulants|anticoagulants|mesh-ancestor
110799691|NCT05280873|Methylprednisolone|methylprednisolone|mesh-list
110799692|NCT05280873|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110799693|NCT05280873|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110799694|NCT05280873|Prednisolone|prednisolone|mesh-list
110799695|NCT05280873|Prednisolone acetate|prednisolone acetate|mesh-list
110799696|NCT05280873|Pirfenidone|pirfenidone|mesh-list
110799697|NCT05280873|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110799698|NCT05280873|Prednisolone phosphate|prednisolone phosphate|mesh-list
110799699|NCT05280873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110799700|NCT05280873|Antiemetics|antiemetics|mesh-ancestor
110799701|NCT05280873|Autonomic Agents|autonomic agents|mesh-ancestor
110799702|NCT05280873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110799703|NCT05280873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110799704|NCT05280873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110799705|NCT05280873|Glucocorticoids|glucocorticoids|mesh-ancestor
110799706|NCT05280873|Hormones|hormones|mesh-ancestor
110799707|NCT05280873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110799708|NCT05280873|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110799709|NCT05280873|Protective Agents|protective agents|mesh-ancestor
110799710|NCT05280873|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110799711|NCT05280873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110799712|NCT05280873|Analgesics|analgesics|mesh-ancestor
110799713|NCT05280873|Sensory System Agents|sensory system agents|mesh-ancestor
110799714|NCT05280873|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110799715|NCT05280873|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110799716|NCT05280873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110799717|NCT02066818|Lidocaine|lidocaine|mesh-list
110799718|NCT02066818|Tetracaine|tetracaine|mesh-list
110799719|NCT02066818|Anesthetics, Local|anesthetics, local|mesh-ancestor
110799720|NCT02066818|Anesthetics|anesthetics|mesh-ancestor
110799721|NCT02066818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110799722|NCT02066818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110799723|NCT02066818|Sensory System Agents|sensory system agents|mesh-ancestor
110799724|NCT02066818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110799725|NCT02066818|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110799726|NCT02066818|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110799727|NCT02066818|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110799728|NCT02066818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110799729|NCT02066818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110799730|NCT04558125|Heparin|heparin|mesh-list
110799731|NCT04558125|Calcium heparin|calcium heparin|mesh-list
110799732|NCT04558125|Enoxaparin|enoxaparin|mesh-list
110517318|NCT00925327|Riboflavin|riboflavin|mesh-list
110799733|NCT04558125|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
110799735|NCT04558125|Dalteparin|dalteparin|mesh-list
110799736|NCT04558125|Tenecteplase|tenecteplase|mesh-list
110799737|NCT04558125|Enoxaparin sodium|enoxaparin sodium|mesh-list
110799738|NCT04558125|Anticoagulants|anticoagulants|mesh-ancestor
110799739|NCT04558125|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110799740|NCT04558125|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110799741|NCT04558125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110799742|NCT05460195|Immunomodulating Agents|immunomodulating agents|mesh-list
110799743|NCT05460195|Immunologic Factors|immunologic factors|mesh-list
110799744|NCT05460195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110799745|NCT02793622|Pyrimethamine|pyrimethamine|mesh-list
110799746|NCT02793622|Piperaquine|piperaquine|mesh-list
110799747|NCT02793622|Sulfadoxine|sulfadoxine|mesh-list
110799748|NCT02793622|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
110799749|NCT02793622|Artenimol|artenimol|mesh-list
110799750|NCT02793622|Antimalarials|antimalarials|mesh-ancestor
110799751|NCT02793622|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110799752|NCT02793622|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110799753|NCT02793622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110799754|NCT02793622|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110799755|NCT02793622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110799756|NCT02793622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110799757|NCT02793622|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110799758|NCT04493931|Rifampin|rifampin|mesh-list
110799759|NCT04493931|Gepotidacin|gepotidacin|mesh-list
110799760|NCT04493931|Digoxin|digoxin|mesh-list
110799761|NCT04493931|Midazolam|midazolam|mesh-list
110799762|NCT04493931|Cimetidine|cimetidine|mesh-list
110799763|NCT04493931|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110799764|NCT04493931|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110799765|NCT04493931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110799766|NCT04493931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110799767|NCT04493931|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110799768|NCT04493931|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110799769|NCT04493931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110799770|NCT04493931|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110799771|NCT04493931|Anesthetics, General|anesthetics, general|mesh-ancestor
110799772|NCT04493931|Anesthetics|anesthetics|mesh-ancestor
110799773|NCT04493931|GABA Modulators|gaba modulators|mesh-ancestor
110799774|NCT04493931|GABA Agents|gaba agents|mesh-ancestor
110799775|NCT04493931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110799776|NCT04493931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110799777|NCT04493931|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110799778|NCT04493931|Antitubercular Agents|antitubercular agents|mesh-ancestor
110799779|NCT04493931|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110799780|NCT04493931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110799781|NCT04493931|Leprostatic Agents|leprostatic agents|mesh-ancestor
110799782|NCT04493931|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110799783|NCT04493931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110799784|NCT04493931|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110799785|NCT04493931|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110799786|NCT04493931|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110799787|NCT04493931|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110799788|NCT04493931|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110799789|NCT04493931|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110799790|NCT04493931|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110799791|NCT04493931|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110799792|NCT04493931|Protective Agents|protective agents|mesh-ancestor
110799793|NCT04493931|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110799794|NCT04493931|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110799795|NCT04493931|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110799796|NCT04493931|Histamine Antagonists|histamine antagonists|mesh-ancestor
110799797|NCT04493931|Histamine Agents|histamine agents|mesh-ancestor
110799798|NCT04493931|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110799799|NCT04493931|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110799800|NCT04493931|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110799801|NCT04493931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110799802|NCT02260336|Celecoxib|celecoxib|mesh-list
110799803|NCT02260336|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110799804|NCT02260336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110799805|NCT02260336|Analgesics|analgesics|mesh-ancestor
110799806|NCT02260336|Sensory System Agents|sensory system agents|mesh-ancestor
110799807|NCT02260336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110799808|NCT02260336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110799809|NCT02260336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110339867|NCT00511823|Serotonin Agents|serotonin agents|mesh-ancestor
110799811|NCT02260336|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110799812|NCT02260336|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110799814|NCT02260336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110799815|NCT04948203|Sirolimus|sirolimus|mesh-list
110799816|NCT04948203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110799817|NCT04948203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110799818|NCT04948203|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110799819|NCT04948203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110799820|NCT04948203|Antifungal Agents|antifungal agents|mesh-ancestor
110799821|NCT04948203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110799822|NCT04948203|Immunologic Factors|immunologic factors|mesh-ancestor
110799823|NCT04948203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110799824|NCT03755193|Diphosphonates|diphosphonates|mesh-list
110799825|NCT03755193|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110799826|NCT03755193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110799827|NCT03755115|Epirubicin|epirubicin|mesh-list
110799828|NCT03755115|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110799829|NCT03755115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110799830|NCT03755115|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110799831|NCT03755115|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110799832|NCT03755115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110799833|NCT03755115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110799834|NCT03755037|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110799835|NCT03755037|Estradiol|estradiol|mesh-list
110799836|NCT03755037|Estrogens|estrogens|mesh-ancestor
110799837|NCT03755037|Hormones|hormones|mesh-ancestor
110799838|NCT03755037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110799839|NCT03755037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110799840|NCT03755037|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110799841|NCT03755037|Contraceptive Agents|contraceptive agents|mesh-ancestor
110799842|NCT03755037|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110799843|NCT03755037|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110799844|NCT03755037|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110799845|NCT03755037|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110799846|NCT03751917|Arsenic Trioxide|arsenic trioxide|mesh-list
110799847|NCT03751917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110799848|NCT04490499|Vaccines|vaccines|mesh-list
110799849|NCT04490499|Immunologic Factors|immunologic factors|mesh-ancestor
110799850|NCT04490499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110799851|NCT01332994|Rituximab|rituximab|mesh-list
110799852|NCT01332994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110799853|NCT01332994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110799854|NCT01332994|Immunologic Factors|immunologic factors|mesh-ancestor
110799855|NCT01332994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110799856|NCT01332994|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110799857|NCT03754959|Midazolam|midazolam|mesh-list
110799858|NCT03754959|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110799859|NCT03754959|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110799860|NCT03754959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110799861|NCT03754959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110799862|NCT03754959|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110799863|NCT03754959|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110799864|NCT03754959|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110799865|NCT03754959|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110799866|NCT03754959|Anesthetics, General|anesthetics, general|mesh-ancestor
110799867|NCT03754959|Anesthetics|anesthetics|mesh-ancestor
110799868|NCT03754959|GABA Modulators|gaba modulators|mesh-ancestor
110799869|NCT03754959|GABA Agents|gaba agents|mesh-ancestor
110799870|NCT03754959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110340040|NCT00512057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110799871|NCT03754959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110799872|NCT02068690|BI 425809|bi 425809|mesh-list
110799873|NCT02068690|Nootropic Agents|nootropic agents|mesh-ancestor
110799874|NCT02067442|Acetaminophen|acetaminophen|mesh-list
110799875|NCT02067442|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110799876|NCT02067442|Analgesics|analgesics|mesh-ancestor
110799877|NCT02067442|Sensory System Agents|sensory system agents|mesh-ancestor
110799878|NCT02067442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110799879|NCT02067442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110799880|NCT02067442|Antipyretics|antipyretics|mesh-ancestor
110799881|NCT02067520|Hydromorphone|hydromorphone|mesh-list
110799882|NCT02067520|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110799883|NCT02067520|Narcotics|narcotics|mesh-ancestor
110799884|NCT02067520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110799885|NCT02067520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110799886|NCT02067520|Analgesics|analgesics|mesh-ancestor
110799887|NCT02067520|Sensory System Agents|sensory system agents|mesh-ancestor
110799888|NCT02067520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110799889|NCT03757923|Metformin|metformin|mesh-list
110799890|NCT03757923|Pioglitazone|pioglitazone|mesh-list
110799891|NCT03757923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110799892|NCT03757923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110799893|NCT02071888|Dexamethasone|dexamethasone|mesh-list
110799894|NCT02071888|Dexamethasone acetate|dexamethasone acetate|mesh-list
110799895|NCT02071888|Pomalidomide|pomalidomide|mesh-list
110799896|NCT02071888|BB 1101|bb 1101|mesh-list
110799897|NCT02071888|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110799898|NCT02071888|Antiemetics|antiemetics|mesh-ancestor
110799899|NCT02071888|Autonomic Agents|autonomic agents|mesh-ancestor
110799900|NCT02071888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110799901|NCT02071888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110799902|NCT02071888|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110799903|NCT02071888|Glucocorticoids|glucocorticoids|mesh-ancestor
110799904|NCT02071888|Hormones|hormones|mesh-ancestor
110799905|NCT02071888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110799906|NCT02071888|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110799907|NCT02071888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110799908|NCT02071888|Protease Inhibitors|protease inhibitors|mesh-ancestor
110799909|NCT02071888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110799910|NCT02071888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110799911|NCT02071888|Immunologic Factors|immunologic factors|mesh-ancestor
110799912|NCT02071888|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110799913|NCT02071888|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110799914|NCT02071888|Growth Substances|growth substances|mesh-ancestor
110799915|NCT02071888|Growth Inhibitors|growth inhibitors|mesh-ancestor
110799916|NCT02071966|Clopidogrel|clopidogrel|mesh-list
110799917|NCT02071966|Ticagrelor|ticagrelor|mesh-list
110799918|NCT02071966|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110799919|NCT02071966|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110799920|NCT02071966|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110799921|NCT02071966|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110799922|NCT02071966|Purinergic Agents|purinergic agents|mesh-ancestor
110799923|NCT02071966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110340370|NCT00531999|Lopinavir|lopinavir|mesh-list
110799924|NCT02071966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110799925|NCT02071966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110799926|NCT02072278|Vortioxetine|vortioxetine|mesh-list
110799927|NCT02072278|Escitalopram|escitalopram|mesh-list
110799928|NCT02072278|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110799929|NCT02072278|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110799930|NCT02072278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110799931|NCT02072278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110799932|NCT02072278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110799933|NCT02072278|Serotonin Agents|serotonin agents|mesh-ancestor
110799934|NCT02072278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110799935|NCT02072278|Antidepressive Agents|antidepressive agents|mesh-ancestor
110799936|NCT02072278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110799937|NCT02072278|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110799938|NCT02072278|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110799939|NCT02072278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110799940|NCT02072278|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110799941|NCT02072278|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110799942|NCT02072278|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110799943|NCT02072278|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110799944|NCT02072512|Fulvestrant|fulvestrant|mesh-list
110799945|NCT02072512|Anastrozole|anastrozole|mesh-list
110799946|NCT02072512|Goserelin|goserelin|mesh-list
110799947|NCT02072512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110799948|NCT02072512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110799949|NCT02072512|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110799950|NCT02072512|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110799951|NCT02072512|Hormone Antagonists|hormone antagonists|mesh-ancestor
110799952|NCT02072512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110799953|NCT02072512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110799954|NCT02072512|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110799955|NCT02072512|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110799956|NCT02072512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110799957|NCT02072512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110799958|NCT04534491|Oxybutynin|oxybutynin|mesh-list
110799959|NCT04534491|Parasympatholytics|parasympatholytics|mesh-ancestor
110799960|NCT04534491|Autonomic Agents|autonomic agents|mesh-ancestor
110799961|NCT04534491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110799962|NCT04534491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110799963|NCT04534491|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110799964|NCT04534491|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110799965|NCT04534491|Cholinergic Agents|cholinergic agents|mesh-ancestor
110799966|NCT04534491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110799967|NCT04534491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110799968|NCT04534491|Urological Agents|urological agents|mesh-ancestor
110799969|NCT02069080|Plerixafor|plerixafor|mesh-list
110799970|NCT02069080|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110799971|NCT02069080|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110799972|NCT02069080|Antiviral Agents|antiviral agents|mesh-ancestor
110799973|NCT02069080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110799974|NCT02077348|Hormones|hormones|mesh-list
110799975|NCT02077348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110799976|NCT02077348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110799977|NCT03694821|Methylprednisolone|methylprednisolone|mesh-list
110799978|NCT03694821|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110799979|NCT03694821|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110799980|NCT03694821|Prednisolone|prednisolone|mesh-list
110799981|NCT03694821|Prednisolone acetate|prednisolone acetate|mesh-list
110799982|NCT03694821|Ketorolac|ketorolac|mesh-list
110799983|NCT03694821|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
110799984|NCT03694821|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110799985|NCT03694821|Prednisolone phosphate|prednisolone phosphate|mesh-list
110799986|NCT03694821|Hylan|hylan|mesh-list
110799987|NCT03694821|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110799988|NCT03694821|Antiemetics|antiemetics|mesh-ancestor
110799989|NCT03694821|Autonomic Agents|autonomic agents|mesh-ancestor
110799990|NCT03694821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110799991|NCT03694821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110799992|NCT03694821|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110799993|NCT03694821|Glucocorticoids|glucocorticoids|mesh-ancestor
110799994|NCT03694821|Hormones|hormones|mesh-ancestor
110799995|NCT03694821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110799996|NCT03694821|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110799997|NCT03694821|Protective Agents|protective agents|mesh-ancestor
110799998|NCT03694821|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110799999|NCT03694821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110800000|NCT03694821|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110800001|NCT03694821|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110800002|NCT03694821|Analgesics|analgesics|mesh-ancestor
110800003|NCT03694821|Sensory System Agents|sensory system agents|mesh-ancestor
110800004|NCT03694821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110800005|NCT03694821|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110800006|NCT03694821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110800007|NCT03694821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110800008|NCT03694821|Viscosupplements|viscosupplements|mesh-ancestor
110800009|NCT02069158|Paclitaxel|paclitaxel|mesh-list
110800010|NCT02069158|Carboplatin|carboplatin|mesh-list
110800011|NCT02069158|Gedatolisib|gedatolisib|mesh-list
110800012|NCT02069158|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110800013|NCT02069158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110800014|NCT02069158|Tubulin Modulators|tubulin modulators|mesh-ancestor
110800015|NCT02069158|Antimitotic Agents|antimitotic agents|mesh-ancestor
110800016|NCT02069158|Mitosis Modulators|mitosis modulators|mesh-ancestor
110800017|NCT02069158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110800018|NCT02069158|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110800019|NCT02069158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110800020|NCT04531527|Butenafine|butenafine|mesh-list
110340709|NCT00516854|GABA Agents|gaba agents|mesh-ancestor
110800021|NCT04531527|Antifungal Agents|antifungal agents|mesh-ancestor
110800022|NCT04531527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110800023|NCT02078440|Bromocriptine|bromocriptine|mesh-list
110800024|NCT02078440|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110800025|NCT02078440|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110800026|NCT02078440|Hormone Antagonists|hormone antagonists|mesh-ancestor
110340779|NCT00518570|Levetiracetam|levetiracetam|mesh-list
110800027|NCT02078440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110800028|NCT02078440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110800029|NCT02078440|Dopamine Agonists|dopamine agonists|mesh-ancestor
110800030|NCT02078440|Dopamine Agents|dopamine agents|mesh-ancestor
110800031|NCT02078440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110800032|NCT02078440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110517613|NCT05702827|Sensory System Agents|sensory system agents|mesh-ancestor
110800033|NCT02070406|Aldesleukin|aldesleukin|mesh-list
110800034|NCT02070406|Cyclophosphamide|cyclophosphamide|mesh-list
110800035|NCT02070406|Fludarabine|fludarabine|mesh-list
110800036|NCT02070406|Fludarabine phosphate|fludarabine phosphate|mesh-list
110800037|NCT02070406|Interleukin-2|interleukin-2|mesh-list
110800038|NCT02070406|Vaccines|vaccines|mesh-list
110800039|NCT02070406|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110800040|NCT02070406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110800041|NCT02070406|Immunologic Factors|immunologic factors|mesh-ancestor
110800042|NCT02070406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110800043|NCT02070406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110340918|NCT04988685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110800044|NCT02070406|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110800045|NCT02070406|Alkylating Agents|alkylating agents|mesh-ancestor
110800046|NCT02070406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110800047|NCT02070406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110800048|NCT02070406|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110800049|NCT02070406|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110800050|NCT02070406|Antimetabolites|antimetabolites|mesh-ancestor
110800051|NCT02070406|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110800052|NCT02070406|Analgesics|analgesics|mesh-ancestor
110800053|NCT02070406|Sensory System Agents|sensory system agents|mesh-ancestor
110800054|NCT02070406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110800055|NCT02070406|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110800056|NCT02070406|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110800057|NCT02070406|Antiviral Agents|antiviral agents|mesh-ancestor
110800058|NCT02070406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110800059|NCT02070406|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110800060|NCT02078596|Valproic Acid|valproic acid|mesh-list
110800061|NCT02078596|Anticonvulsants|anticonvulsants|mesh-ancestor
110800062|NCT02078596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110800063|NCT02078596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110800064|NCT02078596|GABA Agents|gaba agents|mesh-ancestor
110800065|NCT02078596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110800066|NCT02078596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110800067|NCT02078596|Antimanic Agents|antimanic agents|mesh-ancestor
110800068|NCT02078596|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110800069|NCT02078596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110800070|NCT02078596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110800071|NCT02070718|Pentazocine|pentazocine|mesh-list
110800072|NCT02070718|Naloxone|naloxone|mesh-list
110800073|NCT02070718|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110800074|NCT02070718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110800075|NCT02070718|Sensory System Agents|sensory system agents|mesh-ancestor
110800076|NCT02070718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110800077|NCT02070718|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110800078|NCT02070718|Narcotics|narcotics|mesh-ancestor
110800079|NCT02070718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110800080|NCT02070718|Analgesics|analgesics|mesh-ancestor
110800081|NCT02070718|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110800082|NCT02070796|Rotigotine|rotigotine|mesh-list
110800083|NCT02070796|Dopamine Agonists|dopamine agonists|mesh-ancestor
110800084|NCT02070796|Dopamine Agents|dopamine agents|mesh-ancestor
110800085|NCT02070796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110800086|NCT02070796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110800087|NCT02070796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110800088|NCT02079064|Propofol|propofol|mesh-list
110800089|NCT02079064|Desflurane|desflurane|mesh-list
110800090|NCT02079064|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110800091|NCT02079064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110800092|NCT02079064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110800093|NCT02079064|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110800094|NCT02079064|Anesthetics, General|anesthetics, general|mesh-ancestor
110800095|NCT02079064|Anesthetics|anesthetics|mesh-ancestor
110800096|NCT02079064|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110800097|NCT02079220|Capecitabine|capecitabine|mesh-list
110800098|NCT02079220|Oxaliplatin|oxaliplatin|mesh-list
110800099|NCT02079220|Aflibercept|aflibercept|mesh-list
110800100|NCT02079220|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110800101|NCT02079220|Antimetabolites|antimetabolites|mesh-ancestor
110800102|NCT02079220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110800103|NCT02079220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110800104|NCT02079220|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110800105|NCT02079220|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110800106|NCT02079220|Growth Substances|growth substances|mesh-ancestor
110800107|NCT02079220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110800108|NCT02079220|Growth Inhibitors|growth inhibitors|mesh-ancestor
110800109|NCT02079298|Fluconazole|fluconazole|mesh-list
110800110|NCT02079298|Ibuprofen|ibuprofen|mesh-list
110800111|NCT02079298|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110800112|NCT02079298|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110800115|NCT02079298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110800116|NCT02079298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110800117|NCT02079298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110800118|NCT02079298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110800119|NCT02079298|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110800120|NCT02079298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110800121|NCT02079298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110800122|NCT02079298|Antifungal Agents|antifungal agents|mesh-ancestor
110800123|NCT02079298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110800124|NCT02079298|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110800125|NCT02079298|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110800126|NCT02079298|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110800127|NCT02079298|Hormone Antagonists|hormone antagonists|mesh-ancestor
110800128|NCT02079298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110800129|NCT02079298|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110800130|NCT02079298|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110800131|NCT02071342|Everolimus|everolimus|mesh-list
110800132|NCT02071342|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110800133|NCT02071342|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110800134|NCT02071342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110800135|NCT02071342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110800136|NCT02071342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110800137|NCT02071342|Immunologic Factors|immunologic factors|mesh-ancestor
110800138|NCT02071342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110800139|NCT02071342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110800140|NCT02080078|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110800141|NCT02080078|Theophylline|theophylline|mesh-list
110800142|NCT02080078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110800143|NCT02080078|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110800144|NCT02080078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110800145|NCT02080078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110800146|NCT02080078|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110800147|NCT02080078|Autonomic Agents|autonomic agents|mesh-ancestor
110800148|NCT02080078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110800149|NCT02080078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110800150|NCT02080078|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110800151|NCT02080078|Respiratory System Agents|respiratory system agents|mesh-ancestor
110800152|NCT02080078|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110800153|NCT02080078|Vasodilator Agents|vasodilator agents|mesh-ancestor
110800154|NCT02080078|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110800155|NCT02080078|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110800156|NCT02080078|Purinergic Agents|purinergic agents|mesh-ancestor
110800157|NCT02080078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110800158|NCT02083276|Amdinocillin Pivoxil|amdinocillin pivoxil|mesh-list
110800159|NCT02083276|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110800160|NCT02083276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110800161|NCT02083276|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110800162|NCT03559504|Sevoflurane|sevoflurane|mesh-list
110800163|NCT03559504|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110800164|NCT03559504|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110800165|NCT03559504|Anesthetics, General|anesthetics, general|mesh-ancestor
110800166|NCT03559504|Anesthetics|anesthetics|mesh-ancestor
110800167|NCT03559504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110800168|NCT03559504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110800169|NCT02080234|Gemcitabine|gemcitabine|mesh-list
110800170|NCT02080234|Oxaliplatin|oxaliplatin|mesh-list
110800171|NCT02080234|Asparaginase|asparaginase|mesh-list
110800172|NCT02080234|Pegaspargase|pegaspargase|mesh-list
110800173|NCT02080234|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110800174|NCT02080234|Antimetabolites|antimetabolites|mesh-ancestor
110800175|NCT02080234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110800176|NCT02080234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110800177|NCT05070039|Antibodies|antibodies|mesh-list
110800178|NCT05070039|Immunologic Factors|immunologic factors|mesh-ancestor
110800179|NCT05070039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110800180|NCT05459649|Cyclosporine|cyclosporine|mesh-list
110800181|NCT05459649|Prednisone|prednisone|mesh-list
110800182|NCT05459649|Cyclosporins|cyclosporins|mesh-list
110800183|NCT05459649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110800184|NCT05459649|Glucocorticoids|glucocorticoids|mesh-ancestor
110800185|NCT05459649|Hormones|hormones|mesh-ancestor
110800186|NCT05459649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110800187|NCT05459649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110800188|NCT05459649|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110800189|NCT05459649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110800190|NCT05459649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110800191|NCT05459649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110800192|NCT05459649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110800193|NCT05459649|Immunologic Factors|immunologic factors|mesh-ancestor
110800194|NCT05459649|Antifungal Agents|antifungal agents|mesh-ancestor
110800195|NCT05459649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110800196|NCT05459649|Dermatologic Agents|dermatologic agents|mesh-ancestor
110800197|NCT05459649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110800198|NCT05459649|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110800199|NCT04461795|Erenumab|erenumab|mesh-list
110800200|NCT04461795|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110800201|NCT04461795|Immunologic Factors|immunologic factors|mesh-ancestor
110800202|NCT04461795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110800203|NCT04461795|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
110800204|NCT04461795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110800205|NCT04461795|Analgesics|analgesics|mesh-ancestor
110800206|NCT04461795|Sensory System Agents|sensory system agents|mesh-ancestor
110800207|NCT04461795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110800208|NCT04461015|Insulin|insulin|mesh-list
110800209|NCT04461015|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110800210|NCT04461015|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110800211|NCT04461015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110800212|NCT03754179|Hydroxychloroquine|hydroxychloroquine|mesh-list
110800213|NCT03754179|Trametinib|trametinib|mesh-list
110800214|NCT03754179|Dabrafenib|dabrafenib|mesh-list
110800215|NCT03754179|Antimalarials|antimalarials|mesh-ancestor
110800216|NCT03754179|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110800217|NCT03754179|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110800218|NCT03754179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110800219|NCT03754179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110800220|NCT03754179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110800221|NCT03754179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110800222|NCT03754179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110800223|NCT03754179|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110800225|NCT03753867|Keratolytic Agents|keratolytic agents|mesh-ancestor
110800226|NCT03753867|Dermatologic Agents|dermatologic agents|mesh-ancestor
110800227|NCT04439253|Crizotinib|crizotinib|mesh-list
110800228|NCT04439253|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
110800229|NCT04439253|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110800230|NCT04439253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110800231|NCT04439253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110800232|NCT04439253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110800233|NCT03750669|Folic Acid|folic acid|mesh-list
110800234|NCT03750669|Paclitaxel|paclitaxel|mesh-list
110800235|NCT03750669|Gemcitabine|gemcitabine|mesh-list
110800236|NCT03750669|Fluorouracil|fluorouracil|mesh-list
110800237|NCT03750669|Oxaliplatin|oxaliplatin|mesh-list
110800238|NCT03750669|Irinotecan|irinotecan|mesh-list
110800239|NCT03750669|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110800240|NCT03750669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110800241|NCT03750669|Tubulin Modulators|tubulin modulators|mesh-ancestor
110800242|NCT03750669|Antimitotic Agents|antimitotic agents|mesh-ancestor
110800243|NCT03750669|Mitosis Modulators|mitosis modulators|mesh-ancestor
110800244|NCT03750669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110800245|NCT03750669|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110800246|NCT03750669|Antimetabolites|antimetabolites|mesh-ancestor
110800247|NCT03750669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110800248|NCT03750669|Immunologic Factors|immunologic factors|mesh-ancestor
110800249|NCT03750669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110800250|NCT03750669|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110800251|NCT03750669|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110800252|NCT03750669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110800253|NCT03750669|Hematinics|hematinics|mesh-ancestor
110800254|NCT03750669|Vitamin B Complex|vitamin b complex|mesh-ancestor
110800255|NCT03750669|Vitamins|vitamins|mesh-ancestor
110800256|NCT03750669|Micronutrients|micronutrients|mesh-ancestor
110800257|NCT03757221|Daratumumab|daratumumab|mesh-list
110800258|NCT03757221|Ixazomib|ixazomib|mesh-list
110800259|NCT03757221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110800260|NCT03757221|Protease Inhibitors|protease inhibitors|mesh-ancestor
110800261|NCT03757221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110863851|NCT01365312|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110800262|NCT03757221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110800263|NCT03757143|Ethanol|ethanol|mesh-list
110800264|NCT03757143|Chlorhexidine|chlorhexidine|mesh-list
110800265|NCT03757143|Povidone-Iodine|povidone-iodine|mesh-list
110800266|NCT03757143|Povidone|povidone|mesh-list
110800267|NCT03757143|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110800268|NCT03757143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110800269|NCT03757143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110800270|NCT03757143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110800271|NCT03757143|Disinfectants|disinfectants|mesh-ancestor
110800272|NCT03757143|Plasma Substitutes|plasma substitutes|mesh-ancestor
110800273|NCT03757143|Blood Substitutes|blood substitutes|mesh-ancestor
110800274|NCT04428411|Etanercept|etanercept|mesh-list
110800275|NCT04428411|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110800276|NCT04428411|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110800277|NCT04428411|Analgesics|analgesics|mesh-ancestor
110800278|NCT04428411|Sensory System Agents|sensory system agents|mesh-ancestor
110800279|NCT04428411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110800280|NCT04428411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110800281|NCT04428411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110800282|NCT04428411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110800283|NCT04428411|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110800284|NCT04428411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110341836|NCT00525239|Ritonavir|ritonavir|mesh-list
110800285|NCT04428411|Immunologic Factors|immunologic factors|mesh-ancestor
110800286|NCT03751059|Dexamethasone|dexamethasone|mesh-list
110800287|NCT03751059|Bromfenac|bromfenac|mesh-list
110800288|NCT03751059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110800289|NCT03751059|Antiemetics|antiemetics|mesh-ancestor
110800290|NCT03751059|Autonomic Agents|autonomic agents|mesh-ancestor
110800291|NCT03751059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110800292|NCT03751059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110800293|NCT03751059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110800294|NCT03751059|Glucocorticoids|glucocorticoids|mesh-ancestor
110800295|NCT03751059|Hormones|hormones|mesh-ancestor
110800296|NCT03751059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110800297|NCT03751059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110800298|NCT03751059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110800299|NCT03751059|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110800300|NCT03751059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110800301|NCT03751059|Analgesics|analgesics|mesh-ancestor
110800302|NCT03751059|Sensory System Agents|sensory system agents|mesh-ancestor
110800303|NCT03751059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110800304|NCT04422561|Ivermectin|ivermectin|mesh-list
110800305|NCT04422561|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110800306|NCT04422561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110800307|NCT03756987|Ropivacaine|ropivacaine|mesh-list
110800308|NCT03756987|Anesthetics, Local|anesthetics, local|mesh-ancestor
110800309|NCT03756987|Anesthetics|anesthetics|mesh-ancestor
110800310|NCT03756987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110800311|NCT03756987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110800312|NCT03756987|Sensory System Agents|sensory system agents|mesh-ancestor
110800313|NCT03756987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110800315|NCT02072746|Zinc Sulfate|zinc sulfate|mesh-list
110800316|NCT02072746|Trace Elements|trace elements|mesh-ancestor
110800317|NCT02072746|Micronutrients|micronutrients|mesh-ancestor
110800318|NCT02072746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110800319|NCT02072746|Astringents|astringents|mesh-ancestor
110800320|NCT02072746|Dermatologic Agents|dermatologic agents|mesh-ancestor
110800321|NCT04940338|Dexamethasone|dexamethasone|mesh-list
110800322|NCT04940338|Dexamethasone acetate|dexamethasone acetate|mesh-list
110800323|NCT04940338|Bromfenac|bromfenac|mesh-list
110800324|NCT04940338|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110800325|NCT04940338|BB 1101|bb 1101|mesh-list
110800326|NCT04940338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110800327|NCT04940338|Antiemetics|antiemetics|mesh-ancestor
110800328|NCT04940338|Autonomic Agents|autonomic agents|mesh-ancestor
110800329|NCT04940338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110800330|NCT04940338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110800331|NCT04940338|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110800332|NCT04940338|Glucocorticoids|glucocorticoids|mesh-ancestor
110800333|NCT04940338|Hormones|hormones|mesh-ancestor
110800334|NCT04940338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110800335|NCT04940338|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110517934|NCT04759664|LUT014|lut014|mesh-list
110800336|NCT04940338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110800337|NCT04940338|Protease Inhibitors|protease inhibitors|mesh-ancestor
110800338|NCT04940338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110800339|NCT04940338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110800340|NCT04940338|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110800341|NCT04940338|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110800342|NCT04940338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110800344|NCT04940338|Sensory System Agents|sensory system agents|mesh-ancestor
110800345|NCT04940338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110800346|NCT02083510|Colchicine|colchicine|mesh-list
110800347|NCT02083510|Gout Suppressants|gout suppressants|mesh-ancestor
110800348|NCT02083510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110800349|NCT02083510|Tubulin Modulators|tubulin modulators|mesh-ancestor
110800350|NCT02083510|Antimitotic Agents|antimitotic agents|mesh-ancestor
110800351|NCT02083510|Mitosis Modulators|mitosis modulators|mesh-ancestor
110800352|NCT02083510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110342147|NCT02928315|Anticonvulsants|anticonvulsants|mesh-ancestor
110800353|NCT02083510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110800354|NCT04407507|Ivermectin|ivermectin|mesh-list
110800355|NCT04407507|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110800356|NCT04407507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110800357|NCT02080624|Sirolimus|sirolimus|mesh-list
110800358|NCT02080624|Temsirolimus|temsirolimus|mesh-list
110800359|NCT02080624|MTOR Inhibitors|mtor inhibitors|mesh-list
110800360|NCT02080624|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110800361|NCT02080624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110800362|NCT02080624|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110800363|NCT02080624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110800364|NCT02080624|Antifungal Agents|antifungal agents|mesh-ancestor
110800365|NCT02080624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110800366|NCT02080624|Immunologic Factors|immunologic factors|mesh-ancestor
110800367|NCT02080624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110800368|NCT02080624|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110800369|NCT02080624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110800370|NCT02080624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110800371|NCT02080858|Apixaban|apixaban|mesh-list
110800372|NCT02080858|Ticagrelor|ticagrelor|mesh-list
110800373|NCT02080858|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110800374|NCT02080858|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110800375|NCT02080858|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110800376|NCT02080858|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110800377|NCT02080858|Purinergic Agents|purinergic agents|mesh-ancestor
110800378|NCT02080858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110342284|NCT02927379|Anesthetics, General|anesthetics, general|mesh-ancestor
110800379|NCT02080858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110800380|NCT02080858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110800381|NCT02080858|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110800382|NCT02080858|Antithrombins|antithrombins|mesh-ancestor
110800383|NCT02080858|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110800384|NCT02080858|Protease Inhibitors|protease inhibitors|mesh-ancestor
110800385|NCT02080858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110800386|NCT02080858|Anticoagulants|anticoagulants|mesh-ancestor
110800387|NCT02073526|Adalimumab|adalimumab|mesh-list
110800388|NCT02073526|Infliximab|infliximab|mesh-list
110800389|NCT02073526|Certolizumab Pegol|certolizumab pegol|mesh-list
110800390|NCT02073526|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110800391|NCT02073526|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110800392|NCT02073526|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110800393|NCT02073526|Dermatologic Agents|dermatologic agents|mesh-ancestor
110800394|NCT02073526|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110800395|NCT02073526|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110800396|NCT02073526|Immunologic Factors|immunologic factors|mesh-ancestor
110800397|NCT02073526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110800398|NCT02073916|Paclitaxel|paclitaxel|mesh-list
110800399|NCT02073916|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
110800400|NCT02073916|Trastuzumab|trastuzumab|mesh-list
110800401|NCT02073916|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110800402|NCT02073916|Lapatinib|lapatinib|mesh-list
110800403|NCT02073916|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110800404|NCT02073916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110800405|NCT02073916|Tubulin Modulators|tubulin modulators|mesh-ancestor
110800406|NCT02073916|Antimitotic Agents|antimitotic agents|mesh-ancestor
110800407|NCT02073916|Mitosis Modulators|mitosis modulators|mesh-ancestor
110800408|NCT02073916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110800409|NCT02073916|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110800410|NCT02073916|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110800411|NCT02073916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110800412|NCT02073916|Immunotoxins|immunotoxins|mesh-ancestor
110800413|NCT02073916|Immunoconjugates|immunoconjugates|mesh-ancestor
110800414|NCT02073916|Immunologic Factors|immunologic factors|mesh-ancestor
110800415|NCT02073916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110800416|NCT02084368|Bupivacaine|bupivacaine|mesh-list
110800417|NCT02084368|Ropivacaine|ropivacaine|mesh-list
110800418|NCT02084368|Anesthetics, Local|anesthetics, local|mesh-ancestor
110800419|NCT02084368|Anesthetics|anesthetics|mesh-ancestor
110800420|NCT02084368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110800421|NCT02084368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110800422|NCT02084368|Sensory System Agents|sensory system agents|mesh-ancestor
110800423|NCT02084368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110800424|NCT02084446|Mycophenolic Acid|mycophenolic acid|mesh-list
110800425|NCT02084446|Prednisone|prednisone|mesh-list
110800426|NCT02084446|Methylprednisolone|methylprednisolone|mesh-list
110800428|NCT02084446|Tacrolimus|tacrolimus|mesh-list
110800429|NCT02084446|Thymoglobulin|thymoglobulin|mesh-list
110800430|NCT02084446|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110800431|NCT02084446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110800432|NCT02084446|Glucocorticoids|glucocorticoids|mesh-ancestor
110800433|NCT02084446|Hormones|hormones|mesh-ancestor
110800434|NCT02084446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110800435|NCT02084446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110800436|NCT02084446|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110800437|NCT02084446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110800438|NCT02084446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110800439|NCT02084446|Immunologic Factors|immunologic factors|mesh-ancestor
110800440|NCT02084446|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110800441|NCT02084446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110800442|NCT02084446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110800443|NCT02084446|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110800444|NCT02084446|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110800445|NCT02084446|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110800446|NCT02084446|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110800447|NCT02084446|Antitubercular Agents|antitubercular agents|mesh-ancestor
110800448|NCT02084446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110800449|NCT02084446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110800450|NCT02084446|Antiemetics|antiemetics|mesh-ancestor
110800451|NCT02084446|Autonomic Agents|autonomic agents|mesh-ancestor
110800452|NCT02084446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110800453|NCT02084446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110800454|NCT02084446|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110800455|NCT02084446|Protective Agents|protective agents|mesh-ancestor
110800456|NCT02801656|Vancomycin|vancomycin|mesh-list
110800457|NCT02801656|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110800458|NCT02801656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110800459|NCT02081482|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110800460|NCT02081482|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110800461|NCT02081482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110800462|NCT02084602|Artesunate|artesunate|mesh-list
110800463|NCT02084602|Mefloquine|mefloquine|mesh-list
110800464|NCT02084602|Antimalarials|antimalarials|mesh-ancestor
110800465|NCT02084602|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110800466|NCT02084602|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110800467|NCT02084602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110800468|NCT02084602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110800469|NCT02084602|Antiviral Agents|antiviral agents|mesh-ancestor
110800470|NCT02084602|Schistosomicides|schistosomicides|mesh-ancestor
110800471|NCT02084602|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110800472|NCT02084602|Anthelmintics|anthelmintics|mesh-ancestor
110800473|NCT02081560|Colistin|colistin|mesh-list
110800474|NCT02081560|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110800475|NCT02081560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110800476|NCT02074150|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110800477|NCT02074150|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110800478|NCT02074150|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110800479|NCT02074150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110800480|NCT02074150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110800481|NCT02074150|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110800482|NCT02074150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110173734|NCT05038410|Wobenzym|wobenzym|mesh-list
110800483|NCT02074150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110800484|NCT02074150|Cholinergic Agents|cholinergic agents|mesh-ancestor
110800485|NCT02074150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110800486|NCT02074228|Methylphenidate|methylphenidate|mesh-list
110800487|NCT02074228|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110800488|NCT02074228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110800489|NCT02074228|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110800490|NCT02074228|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110800491|NCT02074228|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110518061|NCT04339062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110800492|NCT02074228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110800493|NCT02074228|Dopamine Agents|dopamine agents|mesh-ancestor
110800494|NCT02074228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110800495|NCT04346199|Acalabrutinib|acalabrutinib|mesh-list
110800496|NCT04346199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110800497|NCT03558490|Immunomodulating Agents|immunomodulating agents|mesh-list
110800498|NCT03558490|Immunologic Factors|immunologic factors|mesh-ancestor
110800499|NCT03558490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110800500|NCT04345653|Hydroxychloroquine|hydroxychloroquine|mesh-list
110800501|NCT04345653|Antimalarials|antimalarials|mesh-ancestor
110800502|NCT04345653|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110800503|NCT04345653|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110800504|NCT04345653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110800505|NCT04345653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110800506|NCT04345653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110800507|NCT04345653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110800508|NCT02085304|Temozolomide|temozolomide|mesh-list
110800509|NCT02085304|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110800510|NCT02085304|Alkylating Agents|alkylating agents|mesh-ancestor
110800511|NCT02085304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110800512|NCT02085304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110800513|NCT02260414|Tinzaparin|tinzaparin|mesh-list
110800514|NCT02260414|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
110800515|NCT02260414|Dalteparin|dalteparin|mesh-list
110800516|NCT02260414|Anticoagulants|anticoagulants|mesh-ancestor
110800517|NCT02260414|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110800518|NCT02260414|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110800519|NCT02260414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110800520|NCT02085538|Palbociclib|palbociclib|mesh-list
110800521|NCT02085538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110800522|NCT02085538|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110800523|NCT02085538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110800524|NCT02085538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110800525|NCT04169061|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
110800526|NCT04169061|Hormones|hormones|mesh-ancestor
110800527|NCT04169061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110800528|NCT04169061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110800529|NCT01562691|Petrolatum|petrolatum|mesh-list
110800530|NCT01562691|Emollients|emollients|mesh-ancestor
110800531|NCT01562691|Dermatologic Agents|dermatologic agents|mesh-ancestor
110800532|NCT04681677|Bevacizumab|bevacizumab|mesh-list
110800533|NCT04681677|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110800534|NCT04681677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110800535|NCT04681677|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110800536|NCT04681677|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110800537|NCT04681677|Growth Substances|growth substances|mesh-ancestor
110800538|NCT04681677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110800539|NCT04681677|Growth Inhibitors|growth inhibitors|mesh-ancestor
110800540|NCT02792218|Teriflunomide|teriflunomide|mesh-list
110800541|NCT02792218|Ofatumumab|ofatumumab|mesh-list
110800542|NCT02792218|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110800543|NCT02792218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110800544|NCT02792218|Immunologic Factors|immunologic factors|mesh-ancestor
110800545|NCT02792218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110800546|NCT02792218|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110800547|NCT02792218|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110800548|NCT02792218|Analgesics|analgesics|mesh-ancestor
110800549|NCT02792218|Sensory System Agents|sensory system agents|mesh-ancestor
110800550|NCT02792218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110800551|NCT02792218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110800552|NCT02792218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110800553|NCT02792218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110800554|NCT02075086|Bevacizumab|bevacizumab|mesh-list
110800555|NCT02075086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110800556|NCT02075086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110800557|NCT02075086|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110800558|NCT02075086|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110800559|NCT02075086|Growth Substances|growth substances|mesh-ancestor
110800560|NCT02075086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110800561|NCT02075086|Growth Inhibitors|growth inhibitors|mesh-ancestor
110800563|NCT02082418|Chelating Agents|chelating agents|mesh-ancestor
110800564|NCT02082418|Sequestering Agents|sequestering agents|mesh-ancestor
110800565|NCT02082418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110800566|NCT02082496|Liraglutide|liraglutide|mesh-list
110800567|NCT02082496|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110800568|NCT02082496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110800569|NCT02082496|Incretins|incretins|mesh-ancestor
110800571|NCT02082496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110800572|NCT02075242|Mycophenolic Acid|mycophenolic acid|mesh-list
110800573|NCT02075242|Tacrolimus|tacrolimus|mesh-list
110800574|NCT02075242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110800575|NCT02075242|Immunologic Factors|immunologic factors|mesh-ancestor
110800576|NCT02075242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110800577|NCT02075242|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110800578|NCT02075242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110800579|NCT02075242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110800580|NCT02075242|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110800581|NCT02075242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110800582|NCT02075242|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110800583|NCT02075242|Antitubercular Agents|antitubercular agents|mesh-ancestor
110800584|NCT02075242|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110800585|NCT02075242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110800586|NCT02082652|Etonogestrel|etonogestrel|mesh-list
110800587|NCT02082652|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110800588|NCT02082652|Contraceptive Agents|contraceptive agents|mesh-ancestor
110800589|NCT02082652|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110800590|NCT02082652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110800591|NCT02082652|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110800592|NCT00153101|Telmisartan|telmisartan|mesh-list
110800593|NCT00153101|Ramipril|ramipril|mesh-list
110800594|NCT00153101|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110800595|NCT00153101|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110800596|NCT00153101|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110800597|NCT00153101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110800598|NCT00153101|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110800599|NCT00153101|Protease Inhibitors|protease inhibitors|mesh-ancestor
110800600|NCT00153101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110800601|NCT03558412|Decitabine|decitabine|mesh-list
110800602|NCT03558412|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110800603|NCT03558412|Antimetabolites|antimetabolites|mesh-ancestor
110800604|NCT03558412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110800605|NCT03558412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110800606|NCT03558412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110800607|NCT04401579|Remdesivir|remdesivir|mesh-list
110800608|NCT04401579|Antimetabolites|antimetabolites|mesh-ancestor
110800609|NCT04401579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110800610|NCT04401579|Antiviral Agents|antiviral agents|mesh-ancestor
110800611|NCT04401579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110800612|NCT03558880|Anesthetics|anesthetics|mesh-list
110800613|NCT03558880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110800614|NCT03558880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110800615|NCT04401423|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
110800616|NCT04401423|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110800617|NCT04401423|Vasodilator Agents|vasodilator agents|mesh-ancestor
110800618|NCT03749733|Megestrol|megestrol|mesh-list
110800619|NCT03749733|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110800620|NCT03749733|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110800621|NCT03749733|Estradiol|estradiol|mesh-list
110800622|NCT03749733|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110800623|NCT03749733|Estrogens|estrogens|mesh-ancestor
110800624|NCT03749733|Hormones|hormones|mesh-ancestor
110800625|NCT03749733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110800626|NCT03749733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110800627|NCT03749733|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110800628|NCT03749733|Contraceptive Agents|contraceptive agents|mesh-ancestor
110800629|NCT03749733|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110800630|NCT03749733|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110800631|NCT03749733|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110800633|NCT03749733|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110800634|NCT03749733|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110800635|NCT03749733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110800636|NCT04399161|Chlorhexidine|chlorhexidine|mesh-list
110800637|NCT04399161|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110800638|NCT04399161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110800639|NCT04399161|Disinfectants|disinfectants|mesh-ancestor
110800640|NCT04160091|FX006|fx006|mesh-list
110800641|NCT04160091|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110800642|NCT04160091|Glucocorticoids|glucocorticoids|mesh-ancestor
110800643|NCT04160091|Hormones|hormones|mesh-ancestor
110800644|NCT04160091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110800645|NCT04160091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110800646|NCT04160091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110800647|NCT04160091|Immunologic Factors|immunologic factors|mesh-ancestor
110800648|NCT01582607|Fentanyl|fentanyl|mesh-list
110800649|NCT01582607|Bupivacaine|bupivacaine|mesh-list
110800650|NCT01582607|Ropivacaine|ropivacaine|mesh-list
110800651|NCT01582607|Levobupivacaine|levobupivacaine|mesh-list
110800652|NCT01582607|Anesthetics, Local|anesthetics, local|mesh-ancestor
110800653|NCT01582607|Anesthetics|anesthetics|mesh-ancestor
110800654|NCT01582607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110800655|NCT01582607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110800656|NCT01582607|Sensory System Agents|sensory system agents|mesh-ancestor
110800657|NCT01582607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110800658|NCT01582607|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110800659|NCT01582607|Narcotics|narcotics|mesh-ancestor
110800660|NCT01582607|Analgesics|analgesics|mesh-ancestor
110800661|NCT01582607|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110800662|NCT01582607|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110800663|NCT01582607|Anesthetics, General|anesthetics, general|mesh-ancestor
110800664|NCT00149825|Dexetimide|dexetimide|mesh-list
110800665|NCT00149825|Citalopram|citalopram|mesh-list
110800666|NCT00149825|Escitalopram|escitalopram|mesh-list
110800667|NCT00149825|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110800668|NCT00149825|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110800669|NCT00149825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110800670|NCT00149825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110800671|NCT00149825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110800672|NCT00149825|Serotonin Agents|serotonin agents|mesh-ancestor
110800673|NCT00149825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110800674|NCT00149825|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110800675|NCT00149825|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110800676|NCT00149825|Parasympatholytics|parasympatholytics|mesh-ancestor
110800677|NCT00149825|Autonomic Agents|autonomic agents|mesh-ancestor
110800678|NCT00149825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110800679|NCT00149825|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110800680|NCT00149825|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110800681|NCT00149825|Cholinergic Agents|cholinergic agents|mesh-ancestor
110800682|NCT00149825|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110800683|NCT00149825|Antidepressive Agents|antidepressive agents|mesh-ancestor
110800684|NCT00149825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110800685|NCT02792062|Relugolix|relugolix|mesh-list
110800686|NCT02792062|Androgen Antagonists|androgen antagonists|mesh-ancestor
110800687|NCT02792062|Hormone Antagonists|hormone antagonists|mesh-ancestor
110800688|NCT02792062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110800689|NCT02792062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110800690|NCT05027295|Riboflavin|riboflavin|mesh-list
110800691|NCT05027295|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110800692|NCT05027295|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110800693|NCT05027295|Vitamin B Complex|vitamin b complex|mesh-ancestor
110800694|NCT05027295|Vitamins|vitamins|mesh-ancestor
110800695|NCT05027295|Micronutrients|micronutrients|mesh-ancestor
110800696|NCT05027295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110800697|NCT05027295|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110800698|NCT05027295|Dermatologic Agents|dermatologic agents|mesh-ancestor
110800699|NCT02090920|Nifedipine|nifedipine|mesh-list
110800700|NCT02090920|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110800701|NCT02090920|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110800702|NCT02090920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110800703|NCT02090920|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110800704|NCT02090920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110800705|NCT02090920|Vasodilator Agents|vasodilator agents|mesh-ancestor
110800706|NCT02090920|Tocolytic Agents|tocolytic agents|mesh-ancestor
110125811|NCT02330562|Bevacizumab|bevacizumab|mesh-list
110800707|NCT02090920|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110800708|NCT02086474|Bupivacaine|bupivacaine|mesh-list
110800709|NCT02086474|Hyaluronic Acid|hyaluronic acid|mesh-list
110800710|NCT02086474|Anesthetics, Local|anesthetics, local|mesh-ancestor
110800711|NCT02086474|Anesthetics|anesthetics|mesh-ancestor
110800712|NCT02086474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110800713|NCT02086474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110800714|NCT02086474|Sensory System Agents|sensory system agents|mesh-ancestor
110800715|NCT02086474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110800716|NCT02086474|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110800717|NCT02086474|Immunologic Factors|immunologic factors|mesh-ancestor
110518285|NCT03070886|Hormone Antagonists|hormone antagonists|mesh-ancestor
110800718|NCT02086474|Viscosupplements|viscosupplements|mesh-ancestor
110800719|NCT02086474|Protective Agents|protective agents|mesh-ancestor
110800720|NCT02091310|Moxifloxacin|moxifloxacin|mesh-list
110800721|NCT02091310|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110800722|NCT02091310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110800723|NCT02091310|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110800724|NCT02091310|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110800725|NCT02091310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110800726|NCT02091310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110800727|NCT02091310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110800728|NCT02621398|Paclitaxel|paclitaxel|mesh-list
110800729|NCT02621398|Carboplatin|carboplatin|mesh-list
110800730|NCT02621398|Pembrolizumab|pembrolizumab|mesh-list
110800731|NCT02621398|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110800732|NCT02621398|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110800733|NCT02621398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110800734|NCT02621398|Tubulin Modulators|tubulin modulators|mesh-ancestor
110800735|NCT02621398|Antimitotic Agents|antimitotic agents|mesh-ancestor
110800736|NCT02621398|Mitosis Modulators|mitosis modulators|mesh-ancestor
110800737|NCT02621398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110343006|NCT02917512|Cyclosporine|cyclosporine|mesh-list
110800738|NCT02621398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110800739|NCT02621398|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110800740|NCT04397445|Ranitidine|ranitidine|mesh-list
110800741|NCT04397445|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
110800742|NCT04397445|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110800743|NCT04397445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110800744|NCT04397445|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110800745|NCT04397445|Histamine Antagonists|histamine antagonists|mesh-ancestor
110800746|NCT04397445|Histamine Agents|histamine agents|mesh-ancestor
110800747|NCT04397445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110800748|NCT04397445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110800749|NCT04397445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110800750|NCT02091388|Risperidone|risperidone|mesh-list
110800751|NCT02091388|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110800752|NCT02091388|Serotonin Agents|serotonin agents|mesh-ancestor
110800753|NCT02091388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110800754|NCT02091388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110800755|NCT02091388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110800756|NCT02091388|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110800757|NCT02091388|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110800758|NCT02091388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110800759|NCT02091388|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110800760|NCT02091388|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110800761|NCT02091388|Dopamine Agents|dopamine agents|mesh-ancestor
110800762|NCT02086942|Dexamethasone|dexamethasone|mesh-list
110800763|NCT02086942|Cyclophosphamide|cyclophosphamide|mesh-list
110800764|NCT02086942|Bortezomib|bortezomib|mesh-list
110800765|NCT02086942|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110800766|NCT02086942|Immunologic Factors|immunologic factors|mesh-ancestor
110800767|NCT02086942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110800768|NCT02086942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110800769|NCT02086942|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110800770|NCT02086942|Alkylating Agents|alkylating agents|mesh-ancestor
110800771|NCT02086942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110800772|NCT02086942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110800773|NCT02086942|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110800774|NCT02086942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110800775|NCT02086942|Antiemetics|antiemetics|mesh-ancestor
110800776|NCT02086942|Autonomic Agents|autonomic agents|mesh-ancestor
110852260|NCT04258488|Coagulants|coagulants|mesh-ancestor
110800777|NCT02086942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110800778|NCT02086942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110800779|NCT02086942|Glucocorticoids|glucocorticoids|mesh-ancestor
110800781|NCT02086942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110800782|NCT02086942|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110800784|NCT02088424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110800785|NCT02088424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110800786|NCT00191945|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
110800787|NCT00191945|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110800788|NCT00191945|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110800789|NCT00191945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110800790|NCT00191945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110800791|NCT00191945|Adrenergic Agents|adrenergic agents|mesh-ancestor
110800792|NCT00191945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110518363|NCT02540707|Mirabegron|mirabegron|mesh-list
110800793|NCT00191945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110800795|NCT02087020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110800796|NCT02088502|Acetylcysteine|acetylcysteine|mesh-list
110800797|NCT02088502|Theophylline|theophylline|mesh-list
110800798|NCT02088502|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110800799|NCT02088502|Antiviral Agents|antiviral agents|mesh-ancestor
110800800|NCT02088502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110800801|NCT02088502|Expectorants|expectorants|mesh-ancestor
110800802|NCT02088502|Respiratory System Agents|respiratory system agents|mesh-ancestor
110800803|NCT02088502|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110800804|NCT02088502|Antioxidants|antioxidants|mesh-ancestor
110800805|NCT02088502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110800806|NCT02088502|Protective Agents|protective agents|mesh-ancestor
110800807|NCT02088502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110800808|NCT02088502|Antidotes|antidotes|mesh-ancestor
110800809|NCT02088502|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110800810|NCT02088502|Autonomic Agents|autonomic agents|mesh-ancestor
110800811|NCT02088502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110800812|NCT02088502|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110800813|NCT02088502|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110800814|NCT02088502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110800815|NCT02088502|Vasodilator Agents|vasodilator agents|mesh-ancestor
110800816|NCT02088502|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110800817|NCT02088502|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110800818|NCT02088502|Purinergic Agents|purinergic agents|mesh-ancestor
110800819|NCT02088502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110800820|NCT02087098|Solifenacin Succinate|solifenacin succinate|mesh-list
110800821|NCT02087098|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110800822|NCT02087098|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110800823|NCT02087098|Cholinergic Agents|cholinergic agents|mesh-ancestor
110800824|NCT02087098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110800825|NCT02087098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110800826|NCT02087098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110800827|NCT02087098|Urological Agents|urological agents|mesh-ancestor
110800828|NCT01369342|Ustekinumab|ustekinumab|mesh-list
110800829|NCT01369342|Dermatologic Agents|dermatologic agents|mesh-ancestor
110800830|NCT00191477|Gemcitabine|gemcitabine|mesh-list
110800831|NCT00191477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110800832|NCT00191477|Antimetabolites|antimetabolites|mesh-ancestor
110800833|NCT00191477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110800834|NCT00191477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110800835|NCT02087332|Torsemide|torsemide|mesh-list
110800836|NCT02087332|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110800837|NCT02087332|Diuretics|diuretics|mesh-ancestor
110800838|NCT02087332|Natriuretic Agents|natriuretic agents|mesh-ancestor
110800839|NCT02087332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110800840|NCT02087332|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110800841|NCT02087332|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110800842|NCT02087332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110800843|NCT02092012|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
110852273|NCT04214626|Prednisone|prednisone|mesh-list
110800844|NCT02092012|Dexmedetomidine|dexmedetomidine|mesh-list
110800845|NCT02092012|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110800846|NCT02092012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110800847|NCT02092012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110800848|NCT02092012|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110800849|NCT02092012|Analgesics|analgesics|mesh-ancestor
110800850|NCT02092012|Sensory System Agents|sensory system agents|mesh-ancestor
110800851|NCT02092012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110800852|NCT02092012|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110800853|NCT02092012|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110800854|NCT02092012|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110343106|NCT02917005|Exemestane|exemestane|mesh-list
110800855|NCT02092012|Adrenergic Agents|adrenergic agents|mesh-ancestor
110800856|NCT02092012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110800857|NCT02092012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110800858|NCT02092012|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110800859|NCT02092012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110800860|NCT02092012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110800861|NCT00187889|Eplerenone|eplerenone|mesh-list
110800862|NCT00187889|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110800863|NCT00187889|Hormone Antagonists|hormone antagonists|mesh-ancestor
110800864|NCT00187889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110518437|NCT01572480|Hormones|hormones|mesh-ancestor
110800865|NCT00187889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110800866|NCT00187889|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110800867|NCT00187889|Diuretics|diuretics|mesh-ancestor
110800868|NCT00187889|Natriuretic Agents|natriuretic agents|mesh-ancestor
110800869|NCT00187889|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110800870|NCT02087488|Eszopiclone|eszopiclone|mesh-list
110800871|NCT02087488|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110800872|NCT02087488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110800873|NCT02087488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110800874|NCT02087566|Linezolid|linezolid|mesh-list
110800875|NCT02087566|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110800876|NCT02087566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110800877|NCT02087566|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110800878|NCT02087566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110800879|NCT02087566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110800880|NCT00148109|Cetuximab|cetuximab|mesh-list
110800881|NCT00148109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110800882|NCT00148109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110800883|NCT03746223|Rituximab|rituximab|mesh-list
110800884|NCT03746223|Methotrexate|methotrexate|mesh-list
110800885|NCT03746223|Lenalidomide|lenalidomide|mesh-list
110800886|NCT03746223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110800887|NCT03746223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110800888|NCT03746223|Immunologic Factors|immunologic factors|mesh-ancestor
110800889|NCT03746223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110800890|NCT03746223|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110800891|NCT03746223|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110800892|NCT03746223|Abortifacient Agents|abortifacient agents|mesh-ancestor
110800893|NCT03746223|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110800894|NCT03746223|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110800895|NCT03746223|Antimetabolites|antimetabolites|mesh-ancestor
110800896|NCT03746223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110800897|NCT03746223|Dermatologic Agents|dermatologic agents|mesh-ancestor
110800898|NCT03746223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110800899|NCT03746223|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110800900|NCT03746223|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110800901|NCT03746223|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110800902|NCT03746223|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110800903|NCT03746223|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110800904|NCT03746223|Growth Substances|growth substances|mesh-ancestor
110800905|NCT03746223|Growth Inhibitors|growth inhibitors|mesh-ancestor
110800906|NCT03969017|Interferons|interferons|mesh-list
110800907|NCT03969017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110800908|NCT03969017|Antiviral Agents|antiviral agents|mesh-ancestor
110800909|NCT03969017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110800910|NCT04596033|Cyclophosphamide|cyclophosphamide|mesh-list
110800911|NCT04596033|Fludarabine|fludarabine|mesh-list
110800912|NCT04596033|Interleukin-2|interleukin-2|mesh-list
110800913|NCT04596033|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110800914|NCT04596033|Immunologic Factors|immunologic factors|mesh-ancestor
110800915|NCT04596033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110800917|NCT04596033|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110800918|NCT04596033|Alkylating Agents|alkylating agents|mesh-ancestor
110800919|NCT04596033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110800920|NCT04596033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110800921|NCT04596033|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110800922|NCT04596033|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110800923|NCT04596033|Analgesics|analgesics|mesh-ancestor
110800924|NCT04596033|Sensory System Agents|sensory system agents|mesh-ancestor
110800925|NCT04596033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110800926|NCT02092558|Nitrofurantoin|nitrofurantoin|mesh-list
110800927|NCT02092558|Cephalosporins|cephalosporins|mesh-list
110800928|NCT02092558|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110800929|NCT02092558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110800930|NCT02092558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110800931|NCT01074359|Tocopherylquinone|tocopherylquinone|mesh-list
110800932|NCT01074359|Anticoagulants|anticoagulants|mesh-ancestor
110800933|NCT01074359|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110800934|NCT01074359|Antioxidants|antioxidants|mesh-ancestor
110800935|NCT01074359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110800936|NCT01074359|Protective Agents|protective agents|mesh-ancestor
110800937|NCT01074359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110800938|NCT02087722|Melatonin|melatonin|mesh-list
110800939|NCT02087722|Antioxidants|antioxidants|mesh-ancestor
110800940|NCT02087722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110800941|NCT02087722|Protective Agents|protective agents|mesh-ancestor
110800942|NCT02087722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110800943|NCT02087722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110800944|NCT01326221|Tenofovir|tenofovir|mesh-list
110800945|NCT01326221|Emtricitabine|emtricitabine|mesh-list
110800946|NCT01326221|Antiviral Agents|antiviral agents|mesh-ancestor
110800947|NCT01326221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110800948|NCT01326221|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110800949|NCT01326221|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110800950|NCT01326221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110800951|NCT01326221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110800952|NCT01326221|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110800953|NCT01326221|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110800954|NCT04311177|Losartan|losartan|mesh-list
110800955|NCT04311177|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110343250|NCT02920047|Amlodipine|amlodipine|mesh-list
110800956|NCT04311177|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110800957|NCT04311177|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110800958|NCT04311177|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110800959|NCT04311177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110800960|NCT02088892|BCG Vaccine|bcg vaccine|mesh-list
110800961|NCT02088892|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110800962|NCT02088892|Immunologic Factors|immunologic factors|mesh-ancestor
110800963|NCT02088892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110800964|NCT01074593|Interferons|interferons|mesh-list
110800965|NCT01074593|Interferon-beta|interferon-beta|mesh-list
110800966|NCT01074593|Interferon beta-1a|interferon beta-1a|mesh-list
110343283|NCT02919501|Vortioxetine|vortioxetine|mesh-list
110800967|NCT01074593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110800968|NCT01074593|Antiviral Agents|antiviral agents|mesh-ancestor
110800969|NCT01074593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110800970|NCT01074593|Immunologic Factors|immunologic factors|mesh-ancestor
110800971|NCT01074593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110800972|NCT01074593|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110800973|NCT02088970|Riboflavin|riboflavin|mesh-list
110800974|NCT02088970|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110800975|NCT02088970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110800976|NCT02088970|Vitamin B Complex|vitamin b complex|mesh-ancestor
110800977|NCT02088970|Vitamins|vitamins|mesh-ancestor
110800978|NCT02088970|Micronutrients|micronutrients|mesh-ancestor
110800979|NCT02088970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110800980|NCT02088970|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110800981|NCT02088970|Dermatologic Agents|dermatologic agents|mesh-ancestor
110800982|NCT03968861|Xenon|xenon|mesh-list
110800983|NCT03968861|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110800984|NCT03968861|Anesthetics, General|anesthetics, general|mesh-ancestor
110800985|NCT03968861|Anesthetics|anesthetics|mesh-ancestor
110800986|NCT03968861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110800987|NCT03968861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110800988|NCT04292535|Insulin|insulin|mesh-list
110800989|NCT04292535|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110800990|NCT04292535|Insulin Aspart|insulin aspart|mesh-list
110800991|NCT04292535|Insulin, Long-Acting|insulin, long-acting|mesh-list
110800992|NCT04292535|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
110800993|NCT04292535|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110800994|NCT04292535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110800995|NCT03747081|Warfarin|warfarin|mesh-list
110800996|NCT03747081|Rivaroxaban|rivaroxaban|mesh-list
110800997|NCT03747081|Anticoagulants|anticoagulants|mesh-ancestor
110800998|NCT03747081|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110800999|NCT03747081|Antithrombins|antithrombins|mesh-ancestor
110801000|NCT03747081|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110801001|NCT03747081|Protease Inhibitors|protease inhibitors|mesh-ancestor
110801002|NCT03747081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110801003|NCT03747081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110801004|NCT01075841|Cetuximab|cetuximab|mesh-list
110801005|NCT01075841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110801006|NCT01075841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110801007|NCT01313390|Docetaxel|docetaxel|mesh-list
110801008|NCT01313390|Everolimus|everolimus|mesh-list
110801009|NCT01313390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110801010|NCT01313390|Tubulin Modulators|tubulin modulators|mesh-ancestor
110801011|NCT01313390|Antimitotic Agents|antimitotic agents|mesh-ancestor
110801012|NCT01313390|Mitosis Modulators|mitosis modulators|mesh-ancestor
110343469|NCT06025773|Antacids|antacids|mesh-ancestor
110801013|NCT01313390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110801014|NCT01313390|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110801015|NCT01313390|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110801016|NCT01313390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110801017|NCT01313390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110801018|NCT01313390|Immunologic Factors|immunologic factors|mesh-ancestor
110801019|NCT01313390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110801020|NCT05571332|Cyclosporine|cyclosporine|mesh-list
110801021|NCT05571332|Cyclosporins|cyclosporins|mesh-list
110801022|NCT05571332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110801023|NCT05571332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110801024|NCT05571332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110801025|NCT05571332|Immunologic Factors|immunologic factors|mesh-ancestor
110801026|NCT05571332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110801027|NCT05571332|Antifungal Agents|antifungal agents|mesh-ancestor
110801028|NCT05571332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110801029|NCT05571332|Dermatologic Agents|dermatologic agents|mesh-ancestor
110801030|NCT05571332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110801031|NCT05571332|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110801032|NCT02791438|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
110801033|NCT02791438|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110801034|NCT02791438|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110801035|NCT02791438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110801036|NCT02089048|Auranofin|auranofin|mesh-list
110801037|NCT02089048|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110801038|NCT02089126|Glimepiride|glimepiride|mesh-list
110801039|NCT02089126|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110801040|NCT02089126|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110801041|NCT02089126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110801042|NCT02089126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110801043|NCT02089126|Immunologic Factors|immunologic factors|mesh-ancestor
110801044|NCT05571176|Ketamine|ketamine|mesh-list
110801045|NCT05571176|Esketamine|esketamine|mesh-list
110801046|NCT05571176|Analgesics|analgesics|mesh-ancestor
110801047|NCT05571176|Sensory System Agents|sensory system agents|mesh-ancestor
110343599|NCT06024746|Empagliflozin|empagliflozin|mesh-list
110801048|NCT05571176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110801049|NCT05571176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110801050|NCT05571176|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110801051|NCT05571176|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110801052|NCT05571176|Anesthetics, General|anesthetics, general|mesh-ancestor
110801053|NCT05571176|Anesthetics|anesthetics|mesh-ancestor
110801054|NCT05571176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110801055|NCT05571176|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110801056|NCT05571176|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110801057|NCT05571176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110801058|NCT05571176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110801059|NCT05571176|Antidepressive Agents|antidepressive agents|mesh-ancestor
110801060|NCT05571176|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110801061|NCT03689582|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
110801062|NCT03689582|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110801063|NCT03689582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110801064|NCT02095834|Dexamethasone|dexamethasone|mesh-list
110801065|NCT02095834|Dexamethasone acetate|dexamethasone acetate|mesh-list
110801066|NCT02095834|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110801067|NCT02095834|Ichthammol|ichthammol|mesh-list
110801068|NCT02095834|BB 1101|bb 1101|mesh-list
110801069|NCT02095834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110801070|NCT02095834|Antiemetics|antiemetics|mesh-ancestor
110801071|NCT02095834|Autonomic Agents|autonomic agents|mesh-ancestor
110801072|NCT02095834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110801073|NCT02095834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110801074|NCT02095834|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110801075|NCT02095834|Glucocorticoids|glucocorticoids|mesh-ancestor
110801076|NCT02095834|Hormones|hormones|mesh-ancestor
110801077|NCT02095834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110801078|NCT02095834|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110801079|NCT02095834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110801080|NCT02095834|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110801081|NCT02095834|Alkylating Agents|alkylating agents|mesh-ancestor
110801082|NCT02095834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110801083|NCT02095834|Protease Inhibitors|protease inhibitors|mesh-ancestor
110801084|NCT02095834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110801085|NCT02095834|Dermatologic Agents|dermatologic agents|mesh-ancestor
110801086|NCT03556852|Misoprostol|misoprostol|mesh-list
110801087|NCT03556852|Carbetocin|carbetocin|mesh-list
110801088|NCT03556852|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110801089|NCT03556852|Abortifacient Agents|abortifacient agents|mesh-ancestor
110801090|NCT03556852|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110801091|NCT03556852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110801092|NCT03556852|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110801093|NCT03556852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110801094|NCT03556852|Oxytocics|oxytocics|mesh-ancestor
110801095|NCT02808572|Mitogens|mitogens|mesh-list
110801096|NCT02808572|Mitosis Modulators|mitosis modulators|mesh-ancestor
110801097|NCT02808572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110801098|NCT02093728|Itraconazole|itraconazole|mesh-list
110801099|NCT02093728|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
110801100|NCT02093728|Fluconazole|fluconazole|mesh-list
110801101|NCT02093728|Antifungal Agents|antifungal agents|mesh-ancestor
110801102|NCT02093728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110801103|NCT02093728|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110801104|NCT02093728|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110801105|NCT02093728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110801106|NCT02093728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110343754|NCT06022939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110801107|NCT02093728|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110801108|NCT02093728|Hormone Antagonists|hormone antagonists|mesh-ancestor
110801109|NCT02093728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110801110|NCT02093728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110801111|NCT02093728|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110801112|NCT02093728|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110801113|NCT02093728|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110801114|NCT02089204|Deoxyglucose|deoxyglucose|mesh-list
110801115|NCT02089204|Fluorides|fluorides|mesh-list
110801116|NCT02089204|Cariostatic Agents|cariostatic agents|mesh-ancestor
110801117|NCT02089204|Protective Agents|protective agents|mesh-ancestor
110801118|NCT02089204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110801119|NCT02089204|Antimetabolites|antimetabolites|mesh-ancestor
110801120|NCT02089204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110801121|NCT02089204|Antiviral Agents|antiviral agents|mesh-ancestor
110801122|NCT02089204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110801123|NCT02095990|Hydroquinone|hydroquinone|mesh-list
110801124|NCT02095990|Antioxidants|antioxidants|mesh-ancestor
110801125|NCT02095990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110801126|NCT02095990|Protective Agents|protective agents|mesh-ancestor
110801127|NCT02095990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110801128|NCT02095990|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110801130|NCT02096068|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110801131|NCT02096068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110801132|NCT02096068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110801133|NCT02096068|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110801134|NCT02096068|Analgesics|analgesics|mesh-ancestor
110801135|NCT02096068|Sensory System Agents|sensory system agents|mesh-ancestor
110801136|NCT02096068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110801137|NCT02096068|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110801138|NCT02096068|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110801139|NCT02096068|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110801140|NCT02096068|Adrenergic Agents|adrenergic agents|mesh-ancestor
110801141|NCT02096068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110801142|NCT02096068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110801143|NCT02089438|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110801144|NCT02089438|Vildagliptin|vildagliptin|mesh-list
110801145|NCT02089438|Saxagliptin|saxagliptin|mesh-list
110801146|NCT02089438|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110801147|NCT02089438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110801148|NCT02089438|Incretins|incretins|mesh-ancestor
110801149|NCT02089438|Hormones|hormones|mesh-ancestor
110801150|NCT02089438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110801151|NCT02089438|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110801152|NCT02089438|Protease Inhibitors|protease inhibitors|mesh-ancestor
110801153|NCT02089438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110801154|NCT02089438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110801156|NCT05471674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110801157|NCT05471674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110801158|NCT05471674|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110801159|NCT05471674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110801160|NCT02096224|Sevoflurane|sevoflurane|mesh-list
110801161|NCT02096224|Desflurane|desflurane|mesh-list
110801162|NCT02096224|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110801163|NCT02096224|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110801164|NCT02096224|Anesthetics, General|anesthetics, general|mesh-ancestor
110801165|NCT02096224|Anesthetics|anesthetics|mesh-ancestor
110801166|NCT02096224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110801167|NCT02096224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110801168|NCT02096380|Cisplatin|cisplatin|mesh-list
110801169|NCT02096380|Docetaxel|docetaxel|mesh-list
110801170|NCT02096380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110801171|NCT02096380|Tubulin Modulators|tubulin modulators|mesh-ancestor
110801172|NCT02096380|Antimitotic Agents|antimitotic agents|mesh-ancestor
110801173|NCT02096380|Mitosis Modulators|mitosis modulators|mesh-ancestor
110801174|NCT02096380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110801175|NCT02250118|Bevacizumab|bevacizumab|mesh-list
110801176|NCT02250118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110801177|NCT02250118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110801178|NCT02250118|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110801179|NCT02250118|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110801180|NCT02250118|Growth Substances|growth substances|mesh-ancestor
110801181|NCT02250118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110801182|NCT02250118|Growth Inhibitors|growth inhibitors|mesh-ancestor
110801183|NCT03060772|Pioglitazone|pioglitazone|mesh-list
110801184|NCT03060772|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110801185|NCT03060772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110801186|NCT02096536|Vancomycin|vancomycin|mesh-list
110801187|NCT02096536|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110801188|NCT02096536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110801189|NCT02096614|Cyclophosphamide|cyclophosphamide|mesh-list
110801190|NCT02096614|Fludarabine|fludarabine|mesh-list
110801191|NCT02096614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110801192|NCT02096614|Immunologic Factors|immunologic factors|mesh-ancestor
110801193|NCT02096614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110801194|NCT02096614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110801195|NCT02096614|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110801196|NCT02096614|Alkylating Agents|alkylating agents|mesh-ancestor
110852291|NCT04214626|Glucocorticoids|glucocorticoids|mesh-ancestor
110801197|NCT02096614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110534764|NCT02672202|Pregabalin|pregabalin|mesh-list
110801198|NCT02096614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110801199|NCT02096614|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110801200|NCT02094196|Ethanol|ethanol|mesh-list
110801201|NCT02094196|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110801202|NCT02094196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110801203|NCT02094196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110801204|NCT02094196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110801205|NCT02094274|Fluticasone|fluticasone|mesh-list
110801207|NCT02094274|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110801208|NCT02094274|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110801209|NCT02094274|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110801210|NCT02094274|Autonomic Agents|autonomic agents|mesh-ancestor
110801211|NCT02094274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110801212|NCT02094274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110801213|NCT02094274|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110801214|NCT02094274|Respiratory System Agents|respiratory system agents|mesh-ancestor
110801215|NCT02094274|Dermatologic Agents|dermatologic agents|mesh-ancestor
110801216|NCT02094274|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110801217|NCT02094274|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110801218|NCT02094274|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110801219|NCT02094274|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110801220|NCT02094274|Adrenergic Agents|adrenergic agents|mesh-ancestor
110801221|NCT02094274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110801222|NCT02094274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110801223|NCT02096926|Ibuprofen|ibuprofen|mesh-list
110801224|NCT02096926|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110801225|NCT02096926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110801226|NCT02096926|Analgesics|analgesics|mesh-ancestor
110801227|NCT02096926|Sensory System Agents|sensory system agents|mesh-ancestor
110801228|NCT02096926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110801229|NCT02096926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110801230|NCT02096926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110801231|NCT02096926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110801232|NCT02096926|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110801233|NCT02096926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110801234|NCT02096926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110801235|NCT02097004|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110801236|NCT02097004|Entecavir|entecavir|mesh-list
110801237|NCT02097004|Antiviral Agents|antiviral agents|mesh-ancestor
110801238|NCT02097004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110801239|NCT02090296|Hydroxyurea|hydroxyurea|mesh-list
110801240|NCT02090296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110801241|NCT02090296|Antisickling Agents|antisickling agents|mesh-ancestor
110801242|NCT02090296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110801243|NCT02090296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110801244|NCT02090296|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110801245|NCT03691779|Ivacaftor|ivacaftor|mesh-list
110801246|NCT03691779|Elexacaftor|elexacaftor|mesh-list
110801247|NCT03691779|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
110801248|NCT03691779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110801249|NCT03691779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110801250|NCT02095054|Cetuximab|cetuximab|mesh-list
110801251|NCT02095054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110801252|NCT02095054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110801253|NCT03555994|Liraglutide|liraglutide|mesh-list
110801254|NCT03555994|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110801255|NCT03555994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110801256|NCT03555994|Incretins|incretins|mesh-ancestor
110801257|NCT03555994|Hormones|hormones|mesh-ancestor
110801258|NCT03555994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110801259|NCT02095366|Sufentanil|sufentanil|mesh-list
110801260|NCT02095366|Morphine|morphine|mesh-list
110801261|NCT02095366|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110801262|NCT02095366|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110801263|NCT02095366|Narcotics|narcotics|mesh-ancestor
110801264|NCT02095366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110801265|NCT02095366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110801266|NCT02095366|Analgesics|analgesics|mesh-ancestor
110801267|NCT02095366|Sensory System Agents|sensory system agents|mesh-ancestor
110801268|NCT02095366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110801269|NCT02095366|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110801270|NCT02095366|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110801271|NCT02095366|Anesthetics, General|anesthetics, general|mesh-ancestor
110801272|NCT02095366|Anesthetics|anesthetics|mesh-ancestor
110801273|NCT02097082|Paclitaxel|paclitaxel|mesh-list
110801274|NCT02097082|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110801275|NCT02097082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110801276|NCT02097082|Tubulin Modulators|tubulin modulators|mesh-ancestor
110801277|NCT02097082|Antimitotic Agents|antimitotic agents|mesh-ancestor
110801278|NCT02097082|Mitosis Modulators|mitosis modulators|mesh-ancestor
110801279|NCT02097082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110801280|NCT02097160|Vitamin D|vitamin d|mesh-list
110801281|NCT02097160|Vitamins|vitamins|mesh-ancestor
110801282|NCT02097160|Micronutrients|micronutrients|mesh-ancestor
110801283|NCT02097160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110801284|NCT02097160|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110801285|NCT01562223|Motexafin gadolinium|motexafin gadolinium|mesh-list
110801286|NCT01562223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110801287|NCT01562223|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110801288|NCT01562223|Dermatologic Agents|dermatologic agents|mesh-ancestor
110801289|NCT02097316|Insulin|insulin|mesh-list
110801290|NCT02097316|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110801291|NCT02097316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110801292|NCT02095522|Colchicine|colchicine|mesh-list
110801293|NCT02095522|Gout Suppressants|gout suppressants|mesh-ancestor
110801294|NCT02095522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110801295|NCT02095522|Tubulin Modulators|tubulin modulators|mesh-ancestor
110801296|NCT02095522|Antimitotic Agents|antimitotic agents|mesh-ancestor
110801297|NCT02095522|Mitosis Modulators|mitosis modulators|mesh-ancestor
110801298|NCT02095522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110801299|NCT02095522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110801300|NCT02097394|Pancreatin|pancreatin|mesh-list
110801301|NCT02097394|Pancrelipase|pancrelipase|mesh-list
110801302|NCT02097394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110801303|NCT04123665|Fluorides|fluorides|mesh-list
110801304|NCT04123665|Tin Fluorides|tin fluorides|mesh-list
110801305|NCT04123665|Fluorophosphate|fluorophosphate|mesh-list
110801306|NCT04123665|Cariostatic Agents|cariostatic agents|mesh-ancestor
110801307|NCT04123665|Protective Agents|protective agents|mesh-ancestor
110801308|NCT04123665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110801309|NCT02250508|Factor VIII|factor viii|mesh-list
110801310|NCT02250508|Coagulants|coagulants|mesh-ancestor
110801311|NCT03555526|Amoxicillin|amoxicillin|mesh-list
110801312|NCT03555526|Metronidazole|metronidazole|mesh-list
110801313|NCT03555526|Clarithromycin|clarithromycin|mesh-list
110801314|NCT03555526|Levofloxacin|levofloxacin|mesh-list
110518876|NCT00926809|Dexlansoprazole|dexlansoprazole|mesh-list
110801315|NCT03555526|Tetracycline|tetracycline|mesh-list
110801316|NCT03555526|Esomeprazole|esomeprazole|mesh-list
110801317|NCT03555526|Bismuth|bismuth|mesh-list
110801318|NCT03555526|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110801319|NCT03555526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110801320|NCT03555526|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110801321|NCT03555526|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110801322|NCT03555526|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110801323|NCT03555526|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110801324|NCT03555526|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110801325|NCT03555526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110801326|NCT03555526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110801327|NCT03555526|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110801328|NCT03555526|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110801329|NCT03555526|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110801330|NCT03555526|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110801331|NCT03555526|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110801332|NCT03555526|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110801333|NCT03555526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110801334|NCT03555526|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110801335|NCT03555526|Antacids|antacids|mesh-ancestor
110801336|NCT02102620|Lidocaine|lidocaine|mesh-list
110801337|NCT02102620|Anesthetics, Local|anesthetics, local|mesh-ancestor
110801338|NCT02102620|Anesthetics|anesthetics|mesh-ancestor
110801339|NCT02102620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110801340|NCT02102620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110801341|NCT02102620|Sensory System Agents|sensory system agents|mesh-ancestor
110801342|NCT02102620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110801343|NCT02102620|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110801344|NCT02102620|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110801345|NCT02102620|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110801346|NCT02102620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110801347|NCT02102620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110801348|NCT02102698|Ecopipam|ecopipam|mesh-list
110801349|NCT02102698|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110801350|NCT02102698|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110801351|NCT02102698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110801352|NCT02102698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110801353|NCT02102698|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110801354|NCT02102698|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110801355|NCT02102698|Dopamine Agents|dopamine agents|mesh-ancestor
110801356|NCT02102698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110801357|NCT02102698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110801358|NCT02102776|Mitomycins|mitomycins|mesh-list
110801359|NCT02102776|Mitomycin|mitomycin|mesh-list
110801360|NCT02102776|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110801361|NCT02102776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110801362|NCT02102776|Alkylating Agents|alkylating agents|mesh-ancestor
110801363|NCT02102776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110801364|NCT02102776|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110801365|NCT02102776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110801366|NCT02102854|Thymoglobulin|thymoglobulin|mesh-list
110801367|NCT02102854|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110801368|NCT02102854|Immunologic Factors|immunologic factors|mesh-ancestor
110801369|NCT02102854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110801370|NCT02102854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110801371|NCT02670044|Venetoclax|venetoclax|mesh-list
110801372|NCT02670044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110801373|NCT02307656|Atazanavir Sulfate|atazanavir sulfate|mesh-list
110801374|NCT02307656|Cobicistat|cobicistat|mesh-list
110801375|NCT02307656|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110801376|NCT02307656|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110801377|NCT02307656|Protease Inhibitors|protease inhibitors|mesh-ancestor
110801378|NCT02307656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110801379|NCT02307656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110801380|NCT02307656|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110801381|NCT02307656|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110801382|NCT02307656|Antiviral Agents|antiviral agents|mesh-ancestor
110801383|NCT02307656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110801384|NCT02307656|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110801385|NCT02307656|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110801386|NCT04232943|Vaccines|vaccines|mesh-list
110801387|NCT04232943|Immunologic Factors|immunologic factors|mesh-ancestor
110801388|NCT04232943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110801389|NCT02098330|Methylprednisolone|methylprednisolone|mesh-list
110801390|NCT02098330|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110801391|NCT02098330|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110801392|NCT02098330|Prednisolone|prednisolone|mesh-list
110801393|NCT02098330|Prednisolone acetate|prednisolone acetate|mesh-list
110801394|NCT02098330|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110801395|NCT02098330|Prednisolone phosphate|prednisolone phosphate|mesh-list
110518950|NCT00926965|Olanzapine|olanzapine|mesh-list
110535006|NCT04173858|Naloxegol|naloxegol|mesh-list
110801396|NCT02098330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110801397|NCT02098330|Antiemetics|antiemetics|mesh-ancestor
110801398|NCT02098330|Autonomic Agents|autonomic agents|mesh-ancestor
110801399|NCT02098330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110801400|NCT02098330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110801401|NCT02098330|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110801402|NCT02098330|Glucocorticoids|glucocorticoids|mesh-ancestor
110801403|NCT02098330|Hormones|hormones|mesh-ancestor
110801404|NCT02098330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110801405|NCT02098330|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110801406|NCT02098330|Protective Agents|protective agents|mesh-ancestor
110801407|NCT02098330|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110801408|NCT02098330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110801409|NCT02103166|Scopolamine|scopolamine|mesh-list
110801410|NCT02103166|Bromides|bromides|mesh-list
110801411|NCT02103166|Anticonvulsants|anticonvulsants|mesh-ancestor
110801412|NCT02103166|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110801413|NCT02103166|Antiemetics|antiemetics|mesh-ancestor
110801414|NCT02103166|Autonomic Agents|autonomic agents|mesh-ancestor
110099767|NCT01749566|Maraviroc|maraviroc|mesh-list
110801415|NCT02103166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110801416|NCT02103166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110801417|NCT02103166|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110801418|NCT02103166|Mydriatics|mydriatics|mesh-ancestor
110801419|NCT02103166|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110801420|NCT02103166|Cholinergic Agents|cholinergic agents|mesh-ancestor
110801421|NCT02103166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110801422|NCT02103166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110801423|NCT02103166|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110801424|NCT02103244|Carboplatin|carboplatin|mesh-list
110801425|NCT02103244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110801426|NCT02098486|Moxifloxacin|moxifloxacin|mesh-list
110801427|NCT02098486|Ceftriaxone|ceftriaxone|mesh-list
110801428|NCT02098486|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110801429|NCT02098486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110801430|NCT02098486|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110801431|NCT02098486|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110801432|NCT02098486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110801433|NCT02098486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110801434|NCT02098486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110801435|NCT02250820|Pentobarbital|pentobarbital|mesh-list
110801436|NCT02250820|Dexmedetomidine|dexmedetomidine|mesh-list
110801437|NCT02250820|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110801438|NCT02250820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110801439|NCT02250820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110801440|NCT02250820|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110801441|NCT02250820|Analgesics|analgesics|mesh-ancestor
110801442|NCT02250820|Sensory System Agents|sensory system agents|mesh-ancestor
110535187|NCT04173390|Pregabalin|pregabalin|mesh-list
110801443|NCT02250820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110801444|NCT02250820|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110801445|NCT02250820|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110801446|NCT02250820|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110535251|NCT00646620|Hormones|hormones|mesh-ancestor
110801447|NCT02250820|Adrenergic Agents|adrenergic agents|mesh-ancestor
110801448|NCT02250820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110801449|NCT02250820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110801450|NCT02250820|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110801451|NCT02250820|GABA Modulators|gaba modulators|mesh-ancestor
110801452|NCT02250820|GABA Agents|gaba agents|mesh-ancestor
110801453|NCT02100046|Ethosuximide|ethosuximide|mesh-list
110801454|NCT02100046|Anticonvulsants|anticonvulsants|mesh-ancestor
110801455|NCT02100202|Turmeric extract|turmeric extract|mesh-list
110801457|NCT02100202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110801458|NCT02100202|Protective Agents|protective agents|mesh-ancestor
110801459|NCT02100202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110801460|NCT05423392|Lidocaine|lidocaine|mesh-list
110801461|NCT05423392|Carticaine|carticaine|mesh-list
110801462|NCT05423392|Anesthetics|anesthetics|mesh-list
110801463|NCT05423392|Anesthetics, Local|anesthetics, local|mesh-ancestor
110801464|NCT05423392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110801465|NCT05423392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110801466|NCT05423392|Sensory System Agents|sensory system agents|mesh-ancestor
110801467|NCT05423392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110801468|NCT05423392|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110519023|NCT00933985|Mitosis Modulators|mitosis modulators|mesh-ancestor
110801469|NCT05423392|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110801470|NCT05423392|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110801472|NCT05423392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110801473|NCT02103556|Mineral Oil|mineral oil|mesh-list
110801474|NCT02103556|Emollients|emollients|mesh-ancestor
110801475|NCT02103556|Dermatologic Agents|dermatologic agents|mesh-ancestor
110801476|NCT02099890|Curcumin|curcumin|mesh-list
110801477|NCT02099890|Antioxidants|antioxidants|mesh-list
110801478|NCT02099890|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110801479|NCT02099890|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110801480|NCT02099890|Analgesics|analgesics|mesh-ancestor
110801481|NCT02099890|Sensory System Agents|sensory system agents|mesh-ancestor
110801482|NCT02099890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110801483|NCT02099890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110801484|NCT02099890|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110801485|NCT02099890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110801486|NCT02099890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110801487|NCT02099890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110863852|NCT01365312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110801488|NCT02099890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110801489|NCT02099890|Protective Agents|protective agents|mesh-ancestor
110801490|NCT03555136|Vortioxetine|vortioxetine|mesh-list
110801491|NCT03555136|Antidepressive Agents|antidepressive agents|mesh-ancestor
110801492|NCT03555136|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110801493|NCT03555136|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110801494|NCT03555136|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110535574|NCT04437329|Cisplatin|cisplatin|mesh-list
110801495|NCT03555136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110801496|NCT03555136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110801497|NCT03555136|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110801498|NCT03555136|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110801499|NCT03555136|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110801500|NCT03555136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110801501|NCT03555136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110801502|NCT03555136|Serotonin Agents|serotonin agents|mesh-ancestor
110801503|NCT03555136|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110801504|NCT03555136|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110801505|NCT03555136|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110801506|NCT03555136|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110801507|NCT03554980|Listerine|listerine|mesh-list
110801508|NCT03554980|Fluorides|fluorides|mesh-list
110801509|NCT03554980|Sodium Fluoride|sodium fluoride|mesh-list
110801510|NCT03554980|Fluorides, Topical|fluorides, topical|mesh-list
110801511|NCT03554980|Cariostatic Agents|cariostatic agents|mesh-ancestor
110801512|NCT03554980|Protective Agents|protective agents|mesh-ancestor
110801513|NCT03554980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110801514|NCT03554980|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110801515|NCT03554980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110801516|NCT04230213|Adalimumab|adalimumab|mesh-list
110801517|NCT04230213|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110801518|NCT04230213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110801519|NCT04230213|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110801520|NCT03746691|Citalopram|citalopram|mesh-list
110801521|NCT03746691|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110801522|NCT03746691|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110535701|NCT02660736|Hormones|hormones|mesh-ancestor
110801523|NCT03746691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110801524|NCT03746691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110801525|NCT03746691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110801526|NCT03746691|Serotonin Agents|serotonin agents|mesh-ancestor
110801527|NCT03746691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110801528|NCT03746691|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110801529|NCT03746691|Antidepressive Agents|antidepressive agents|mesh-ancestor
110801530|NCT03746691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110801531|NCT04222725|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110801532|NCT04222725|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110801533|NCT03745911|Paclitaxel|paclitaxel|mesh-list
110535763|NCT02831231|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110801534|NCT03745911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110801535|NCT03745911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110801536|NCT03745911|Tubulin Modulators|tubulin modulators|mesh-ancestor
110801537|NCT03745911|Antimitotic Agents|antimitotic agents|mesh-ancestor
110801538|NCT03745911|Mitosis Modulators|mitosis modulators|mesh-ancestor
110801539|NCT03745911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110801540|NCT03242252|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
110801541|NCT03242252|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110801542|NCT03242252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110801543|NCT03242252|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110801544|NCT03242252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110801545|NCT03554590|Insulin|insulin|mesh-list
110801546|NCT03554590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110801547|NCT03554590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110801548|NCT02106286|Bisoprolol|bisoprolol|mesh-list
110852317|NCT04180371|Nivolumab|nivolumab|mesh-list
110801549|NCT02106286|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110801550|NCT02106286|Sympatholytics|sympatholytics|mesh-ancestor
110801551|NCT02106286|Autonomic Agents|autonomic agents|mesh-ancestor
110801552|NCT02106286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110801553|NCT02106286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110801554|NCT02106286|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110801555|NCT02106286|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110801556|NCT02106286|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110801557|NCT02106286|Adrenergic Agents|adrenergic agents|mesh-ancestor
110801558|NCT02106286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110801559|NCT02106286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110801560|NCT04109391|Trastuzumab|trastuzumab|mesh-list
110801561|NCT04109391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110801562|NCT04109391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110801563|NCT02106364|Insulin|insulin|mesh-list
110801564|NCT02106364|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110801565|NCT02106364|Insulin Glargine|insulin glargine|mesh-list
110801566|NCT02106364|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110801567|NCT02106364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110801568|NCT04077866|Temozolomide|temozolomide|mesh-list
110801569|NCT04077866|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110801570|NCT04077866|Alkylating Agents|alkylating agents|mesh-ancestor
110801571|NCT04077866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110801572|NCT04077866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110801573|NCT02101138|Pramipexole|pramipexole|mesh-list
110801574|NCT02101138|Antioxidants|antioxidants|mesh-ancestor
110801575|NCT02101138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110801576|NCT02101138|Protective Agents|protective agents|mesh-ancestor
110801577|NCT02101138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110801578|NCT02101138|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110801579|NCT02101138|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110801580|NCT02101138|Dopamine Agonists|dopamine agonists|mesh-ancestor
110801581|NCT02101138|Dopamine Agents|dopamine agents|mesh-ancestor
110536226|NCT02832635|Alkylating Agents|alkylating agents|mesh-ancestor
110801582|NCT02101138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110801583|NCT02106520|Bevacizumab|bevacizumab|mesh-list
110801584|NCT02106520|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110801585|NCT02106520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110801586|NCT02106520|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110801587|NCT02106520|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110801588|NCT02106520|Growth Substances|growth substances|mesh-ancestor
110801589|NCT02106520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110801590|NCT02106520|Growth Inhibitors|growth inhibitors|mesh-ancestor
110801591|NCT02101216|Abacavir|abacavir|mesh-list
110801592|NCT02101216|Dideoxynucleosides|dideoxynucleosides|mesh-list
110801593|NCT02101216|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110801594|NCT02101216|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110801595|NCT02101216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110801596|NCT02101216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110801597|NCT02101216|Antiviral Agents|antiviral agents|mesh-ancestor
110801598|NCT02101216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110801599|NCT02101216|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110801600|NCT02101216|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110801601|NCT02101216|Antimetabolites|antimetabolites|mesh-ancestor
110801602|NCT04097925|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
110801603|NCT04097925|Antiviral Agents|antiviral agents|mesh-ancestor
110801604|NCT04097925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110801605|NCT04097925|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110801606|NCT04097925|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110801607|NCT04097925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110801608|NCT04097925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110801609|NCT04097925|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110801610|NCT04097925|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110801611|NCT02104648|Moxifloxacin|moxifloxacin|mesh-list
110801612|NCT02104648|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
110801613|NCT02104648|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110801614|NCT02104648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110801615|NCT02104648|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110801616|NCT02104648|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110801617|NCT02104648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110030617|NCT01387048|Analgesics|analgesics|mesh-ancestor
110801618|NCT02104648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110801620|NCT02104648|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110801621|NCT02104648|Contraceptive Agents|contraceptive agents|mesh-ancestor
110801622|NCT02104648|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110801623|NCT02104648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110801624|NCT02104648|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110801625|NCT02104648|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110801626|NCT02104648|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110801627|NCT01562301|Carboplatin|carboplatin|mesh-list
110801628|NCT01562301|Docetaxel|docetaxel|mesh-list
110801629|NCT01562301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110801630|NCT01562301|Tubulin Modulators|tubulin modulators|mesh-ancestor
110801631|NCT01562301|Antimitotic Agents|antimitotic agents|mesh-ancestor
110801632|NCT01562301|Mitosis Modulators|mitosis modulators|mesh-ancestor
110801633|NCT01562301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110801634|NCT02104960|Dermatologic Agents|dermatologic agents|mesh-list
110801635|NCT04094883|Vaccines|vaccines|mesh-list
110801636|NCT04094883|Immunologic Factors|immunologic factors|mesh-ancestor
110536621|NCT02827487|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110801637|NCT04094883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110801638|NCT02101606|Tenecteplase|tenecteplase|mesh-list
110801639|NCT02101606|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110801640|NCT02101606|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110801641|NCT02101606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110801642|NCT02101840|Oxycodone|oxycodone|mesh-list
110801643|NCT02101840|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110801644|NCT02101840|Narcotics|narcotics|mesh-ancestor
110801645|NCT02101840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110801646|NCT02101840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110801647|NCT02101840|Analgesics|analgesics|mesh-ancestor
110801648|NCT02101840|Sensory System Agents|sensory system agents|mesh-ancestor
110801649|NCT02101840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110801650|NCT02107378|Paclitaxel|paclitaxel|mesh-list
110801651|NCT02107378|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110801652|NCT02107378|Doxorubicin|doxorubicin|mesh-list
110801653|NCT02107378|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110801654|NCT02107378|Topotecan|topotecan|mesh-list
110801655|NCT02107378|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110801656|NCT02107378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110801657|NCT02107378|Tubulin Modulators|tubulin modulators|mesh-ancestor
110801658|NCT02107378|Antimitotic Agents|antimitotic agents|mesh-ancestor
110801659|NCT02107378|Mitosis Modulators|mitosis modulators|mesh-ancestor
110801660|NCT02107378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110801661|NCT02107378|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110801662|NCT02107378|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110801663|NCT02107378|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110536904|NCT00652392|Hormones|hormones|mesh-ancestor
110801664|NCT02107378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110801665|NCT02107378|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110801666|NCT02105350|Gemcitabine|gemcitabine|mesh-list
110801667|NCT02105350|Oxaliplatin|oxaliplatin|mesh-list
110801668|NCT02105350|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110801669|NCT02105350|Antimetabolites|antimetabolites|mesh-ancestor
110801670|NCT02105350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110537045|NCT02536014|Dexmedetomidine|dexmedetomidine|mesh-list
110801671|NCT02105350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110801672|NCT02102152|Tobramycin|tobramycin|mesh-list
110801673|NCT02102152|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110801674|NCT02102152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110801675|NCT01368562|Methylnaltrexone|methylnaltrexone|mesh-list
110801676|NCT01368562|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110801677|NCT01368562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110801678|NCT01368562|Sensory System Agents|sensory system agents|mesh-ancestor
110801679|NCT01368562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110801680|NCT03242018|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
110801681|NCT03242018|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110801682|NCT03242018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110801683|NCT03242018|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110801684|NCT03242018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110801685|NCT02107690|Lidocaine|lidocaine|mesh-list
110801686|NCT02107690|Anesthetics, Local|anesthetics, local|mesh-ancestor
110801687|NCT02107690|Anesthetics|anesthetics|mesh-ancestor
110852322|NCT04160910|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
110801688|NCT02107690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110801689|NCT02107690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110801690|NCT02107690|Sensory System Agents|sensory system agents|mesh-ancestor
110801691|NCT02107690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110801692|NCT02107690|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110801693|NCT02107690|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110801694|NCT02107690|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110801695|NCT02107690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110801696|NCT02107690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110801697|NCT05568836|Vitamin D|vitamin d|mesh-list
110801698|NCT05568836|Vitamins|vitamins|mesh-ancestor
110801699|NCT05568836|Micronutrients|micronutrients|mesh-ancestor
110801700|NCT05568836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110801701|NCT05568836|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110801702|NCT03259490|Metformin|metformin|mesh-list
110537156|NCT00599196|Rotigotine|rotigotine|mesh-list
110801703|NCT03259490|Empagliflozin|empagliflozin|mesh-list
110801704|NCT03259490|Linagliptin|linagliptin|mesh-list
110801705|NCT03259490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110801706|NCT03259490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110801707|NCT03259490|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110801708|NCT03259490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110801709|NCT03259490|Incretins|incretins|mesh-ancestor
110801710|NCT03259490|Hormones|hormones|mesh-ancestor
110801711|NCT03259490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110801712|NCT03259490|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110801713|NCT03259490|Protease Inhibitors|protease inhibitors|mesh-ancestor
110801714|NCT03259490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110801715|NCT02106130|Rebamipide|rebamipide|mesh-list
110801716|NCT02106130|Mosapride|mosapride|mesh-list
110801717|NCT02106130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110801718|NCT02106130|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110801719|NCT02106130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110801720|NCT02106130|Antioxidants|antioxidants|mesh-ancestor
110801721|NCT02106130|Protective Agents|protective agents|mesh-ancestor
110801722|NCT02106130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110801723|NCT02106130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110801724|NCT02106130|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110801725|NCT02106130|Serotonin Agents|serotonin agents|mesh-ancestor
110801726|NCT02106130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110801727|NCT02251132|Ritonavir|ritonavir|mesh-list
110801728|NCT02251132|Erythromycin|erythromycin|mesh-list
110801729|NCT02251132|Erythromycin Estolate|erythromycin estolate|mesh-list
110801730|NCT02251132|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
110801731|NCT02251132|Erythromycin stearate|erythromycin stearate|mesh-list
110537231|NCT04243109|Hormones|hormones|mesh-ancestor
110801732|NCT02251132|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110801733|NCT02251132|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110801734|NCT02251132|Protease Inhibitors|protease inhibitors|mesh-ancestor
110801735|NCT02251132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110801736|NCT02251132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110801737|NCT02251132|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110801738|NCT02251132|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110801739|NCT02251132|Antiviral Agents|antiviral agents|mesh-ancestor
110801740|NCT02251132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110801741|NCT02251132|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110801742|NCT02251132|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110537266|NCT02640300|GABA Antagonists|gaba antagonists|mesh-ancestor
110801743|NCT02251132|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110801744|NCT02251132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110801745|NCT02251132|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110801746|NCT01331824|Amrubicin|amrubicin|mesh-list
110801747|NCT01331824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110801748|NCT02113774|Anti-Infective Agents|anti-infective agents|mesh-list
110801749|NCT02113774|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110801750|NCT05571722|Vancomycin|vancomycin|mesh-list
110801751|NCT05571722|Linezolid|linezolid|mesh-list
110801752|NCT05571722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110801753|NCT05571722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110801754|NCT05571722|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110801755|NCT05571722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110801756|NCT05571722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110801757|NCT02110654|Mometasone Furoate|mometasone furoate|mesh-list
110801758|NCT02110654|Montelukast|montelukast|mesh-list
110801759|NCT02110654|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110801760|NCT02110654|Respiratory System Agents|respiratory system agents|mesh-ancestor
110801761|NCT02110654|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110801762|NCT02110654|Hormone Antagonists|hormone antagonists|mesh-ancestor
110801763|NCT02110654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110801764|NCT02110654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110801765|NCT02110654|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110801766|NCT02110654|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110863853|NCT01365312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110801767|NCT02110654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110801768|NCT02110654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110801769|NCT02110654|Dermatologic Agents|dermatologic agents|mesh-ancestor
110801770|NCT02110654|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110801771|NCT03258710|Tenofovir|tenofovir|mesh-list
110801772|NCT03258710|Antiviral Agents|antiviral agents|mesh-ancestor
110537458|NCT02642484|Analgesics|analgesics|mesh-ancestor
110801773|NCT03258710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110801774|NCT03258710|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110801775|NCT03258710|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110801776|NCT03258710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110801777|NCT03258710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110801778|NCT03258710|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110801779|NCT03258710|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110801780|NCT02110810|Indomethacin|indomethacin|mesh-list
110801781|NCT02110810|Glycerol|glycerol|mesh-list
110801782|NCT02110810|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110801783|NCT02110810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110801784|NCT02110810|Analgesics|analgesics|mesh-ancestor
110801785|NCT02110810|Sensory System Agents|sensory system agents|mesh-ancestor
110801786|NCT02110810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110801787|NCT02110810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110801788|NCT02110810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110801789|NCT02110810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110801790|NCT02110810|Gout Suppressants|gout suppressants|mesh-ancestor
110801791|NCT02110810|Tocolytic Agents|tocolytic agents|mesh-ancestor
110801792|NCT02110810|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110801793|NCT02110810|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110801794|NCT02110810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110801795|NCT02110810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110801796|NCT02110810|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
110537746|NCT00681213|Sirolimus|sirolimus|mesh-list
110801797|NCT02110810|Protective Agents|protective agents|mesh-ancestor
110801798|NCT02107924|Vancomycin|vancomycin|mesh-list
110801799|NCT02107924|Tobramycin|tobramycin|mesh-list
110801800|NCT02107924|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110801801|NCT02107924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110801802|NCT02108002|Vorinostat|vorinostat|mesh-list
110801803|NCT02108002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110801804|NCT02108002|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110801805|NCT02108002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110801806|NCT02108002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110801807|NCT02114476|Progestins|progestins|mesh-list
110801808|NCT02114476|Hormones|hormones|mesh-ancestor
110801809|NCT02114476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110801810|NCT02114476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110801811|NCT02110966|Tramadol|tramadol|mesh-list
110801812|NCT02110966|Mepivacaine|mepivacaine|mesh-list
110801813|NCT02110966|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110801814|NCT02110966|Narcotics|narcotics|mesh-ancestor
110801815|NCT02110966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110801816|NCT02110966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110801817|NCT02110966|Analgesics|analgesics|mesh-ancestor
110801818|NCT02110966|Sensory System Agents|sensory system agents|mesh-ancestor
110801819|NCT02110966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110801820|NCT02110966|Anesthetics, Local|anesthetics, local|mesh-ancestor
110801821|NCT02110966|Anesthetics|anesthetics|mesh-ancestor
110801822|NCT02937740|Methyltestosterone|methyltestosterone|mesh-list
110801823|NCT02937740|Testosterone|testosterone|mesh-list
110801824|NCT02937740|Testosterone undecanoate|testosterone undecanoate|mesh-list
110801825|NCT02937740|Testosterone enanthate|testosterone enanthate|mesh-list
110801826|NCT02937740|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
110801828|NCT02937740|Hormones|hormones|mesh-ancestor
110801829|NCT02937740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110801830|NCT02937740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110801831|NCT02937740|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110801832|NCT02937740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110801833|NCT02937740|Anabolic Agents|anabolic agents|mesh-ancestor
110801834|NCT02111044|Octreotide|octreotide|mesh-list
110801835|NCT02111044|Somatostatin|somatostatin|mesh-list
110801836|NCT02111044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110801837|NCT02111044|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110801838|NCT02111044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110801839|NCT02111044|Hormones|hormones|mesh-ancestor
110801840|NCT02111044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110801841|NCT02111044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110801842|NCT02114710|Hydrocortisone|hydrocortisone|mesh-list
110801843|NCT02114710|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110801844|NCT02108548|Naproxen|naproxen|mesh-list
110801845|NCT02108548|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110801846|NCT02108548|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110801847|NCT02108548|Analgesics|analgesics|mesh-ancestor
110801848|NCT02108548|Sensory System Agents|sensory system agents|mesh-ancestor
110801849|NCT02108548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110801850|NCT02108548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110801851|NCT02108548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110801852|NCT02108548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110801853|NCT02108548|Gout Suppressants|gout suppressants|mesh-ancestor
110801854|NCT02108548|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110801855|NCT02108548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110801856|NCT02108548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110801857|NCT02111122|Sodium Oxybate|sodium oxybate|mesh-list
110801858|NCT02111122|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110801859|NCT02111122|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110801860|NCT02111122|Anesthetics, General|anesthetics, general|mesh-ancestor
110801861|NCT02111122|Anesthetics|anesthetics|mesh-ancestor
110801862|NCT02111122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110801863|NCT02111122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110801864|NCT02108626|Nicotine|nicotine|mesh-list
110801865|NCT02108626|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110801866|NCT02108626|Autonomic Agents|autonomic agents|mesh-ancestor
110801867|NCT02108626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110801868|NCT02108626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110801869|NCT02108626|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110801870|NCT02108626|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110801871|NCT02108626|Cholinergic Agents|cholinergic agents|mesh-ancestor
110801872|NCT02108626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110801873|NCT02108626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110801874|NCT05431322|Dexmedetomidine|dexmedetomidine|mesh-list
110801875|NCT05431322|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110801876|NCT05431322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110801877|NCT05431322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110801878|NCT05431322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110801879|NCT05431322|Analgesics|analgesics|mesh-ancestor
110801880|NCT05431322|Sensory System Agents|sensory system agents|mesh-ancestor
110801881|NCT05431322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110538043|NCT02819375|Ketamine|ketamine|mesh-list
110801882|NCT05431322|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110801883|NCT05431322|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110801884|NCT05431322|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110801885|NCT05431322|Adrenergic Agents|adrenergic agents|mesh-ancestor
110801886|NCT05431322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110801887|NCT05431322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110801888|NCT03745599|Diclofenac|diclofenac|mesh-list
110801889|NCT03745599|Flurbiprofen|flurbiprofen|mesh-list
110801890|NCT03745599|Benzydamine|benzydamine|mesh-list
110801891|NCT03745599|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110801892|NCT03745599|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110801893|NCT03745599|Analgesics|analgesics|mesh-ancestor
110801894|NCT03745599|Sensory System Agents|sensory system agents|mesh-ancestor
110801895|NCT03745599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110801896|NCT03745599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110801897|NCT03745599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110852330|NCT04067037|Dacarbazine|dacarbazine|mesh-list
110801899|NCT03745599|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110801900|NCT03745599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110801901|NCT03745599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110801902|NCT02108782|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
110801903|NCT02108782|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110801904|NCT02108782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110801905|NCT02108782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110801906|NCT02111434|Testosterone|testosterone|mesh-list
110801907|NCT02111434|Androgens|androgens|mesh-ancestor
110801908|NCT02111434|Hormones|hormones|mesh-ancestor
110801909|NCT02111434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110801910|NCT02111434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110801911|NCT03230864|Olanzapine|olanzapine|mesh-list
110801912|NCT03230864|Risperidone|risperidone|mesh-list
110801913|NCT03230864|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110801914|NCT03230864|Serotonin Agents|serotonin agents|mesh-ancestor
110538086|NCT03362060|Pembrolizumab|pembrolizumab|mesh-list
110801915|NCT03230864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110801916|NCT03230864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110801917|NCT03230864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110801918|NCT03230864|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110801919|NCT03230864|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110801920|NCT03230864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110801921|NCT03230864|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110801922|NCT03230864|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110801923|NCT03230864|Dopamine Agents|dopamine agents|mesh-ancestor
110801924|NCT03230864|Antiemetics|antiemetics|mesh-ancestor
110801925|NCT03230864|Autonomic Agents|autonomic agents|mesh-ancestor
110801926|NCT03230864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110801927|NCT03230864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110801928|NCT03230864|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110801929|NCT03230864|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110801930|NCT03230864|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110801931|NCT02111590|Immunoglobulins|immunoglobulins|mesh-list
110801932|NCT02111590|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110801933|NCT02111590|Antibodies|antibodies|mesh-list
110801934|NCT02111590|Immunologic Factors|immunologic factors|mesh-ancestor
110801935|NCT02111590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110801936|NCT02937350|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
110801937|NCT02937350|Calcifediol|calcifediol|mesh-list
110801938|NCT02937350|Vitamins|vitamins|mesh-ancestor
110801939|NCT02937350|Micronutrients|micronutrients|mesh-ancestor
110801940|NCT02937350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110801941|NCT02937350|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110801942|NCT02109328|Paclitaxel|paclitaxel|mesh-list
110801943|NCT02109328|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110801944|NCT02109328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110801945|NCT02109328|Tubulin Modulators|tubulin modulators|mesh-ancestor
110801946|NCT02109328|Antimitotic Agents|antimitotic agents|mesh-ancestor
110801947|NCT02109328|Mitosis Modulators|mitosis modulators|mesh-ancestor
110801948|NCT02109328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110801949|NCT02115490|Diphosphonates|diphosphonates|mesh-list
110801950|NCT02115490|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110801951|NCT02115490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110801952|NCT02251288|Vaccines|vaccines|mesh-list
110801953|NCT02251288|Immunologic Factors|immunologic factors|mesh-ancestor
110801954|NCT02251288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110801955|NCT02109718|Sulfadiazine|sulfadiazine|mesh-list
110801956|NCT02109718|Silver Sulfadiazine|silver sulfadiazine|mesh-list
110801957|NCT02109718|Petrolatum|petrolatum|mesh-list
110801958|NCT02109718|Emollients|emollients|mesh-ancestor
110801959|NCT02109718|Dermatologic Agents|dermatologic agents|mesh-ancestor
110801960|NCT02109718|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110801961|NCT02109718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110801962|NCT02109718|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110801963|NCT02109718|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110801964|NCT02109718|Coccidiostats|coccidiostats|mesh-ancestor
110801965|NCT02109718|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110801966|NCT03744897|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
110801967|NCT03744897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110801968|NCT03744897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110801969|NCT02112214|Bismuth|bismuth|mesh-list
110801970|NCT02112214|Antacids|antacids|mesh-ancestor
110801971|NCT02112214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110801972|NCT02112214|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110801973|NCT02112292|Dronabinol|dronabinol|mesh-list
110801974|NCT02112292|Cannabidiol|cannabidiol|mesh-list
110801975|NCT02112292|Anticonvulsants|anticonvulsants|mesh-ancestor
110801976|NCT02112292|Hallucinogens|hallucinogens|mesh-ancestor
110801977|NCT02112292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110801978|NCT02112292|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110801979|NCT02112292|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110801980|NCT02112292|Analgesics|analgesics|mesh-ancestor
110801981|NCT02112292|Sensory System Agents|sensory system agents|mesh-ancestor
110801982|NCT02112292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110801983|NCT02112292|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
110801984|NCT02112292|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110538240|NCT00634205|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110801985|NCT02112292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110801986|NCT02112292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110801987|NCT02112292|Hormones|hormones|mesh-ancestor
110801988|NCT02112292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110801989|NCT02116036|Rivaroxaban|rivaroxaban|mesh-list
110801990|NCT02116036|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110801991|NCT02116036|Antithrombins|antithrombins|mesh-ancestor
110801992|NCT02116036|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110538288|NCT02817503|Hematinics|hematinics|mesh-ancestor
110801993|NCT02116036|Protease Inhibitors|protease inhibitors|mesh-ancestor
110801994|NCT02116036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110801995|NCT02116036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110801996|NCT02116036|Anticoagulants|anticoagulants|mesh-ancestor
110801997|NCT04011735|Tiotropium Bromide|tiotropium bromide|mesh-list
110801998|NCT04011735|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110801999|NCT04011735|Autonomic Agents|autonomic agents|mesh-ancestor
110802000|NCT04011735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110802001|NCT04011735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110802002|NCT04011735|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110802003|NCT04011735|Respiratory System Agents|respiratory system agents|mesh-ancestor
110802004|NCT04011735|Parasympatholytics|parasympatholytics|mesh-ancestor
110802005|NCT04011735|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110802006|NCT04011735|Cholinergic Agents|cholinergic agents|mesh-ancestor
110802007|NCT04011735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110802008|NCT04011735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110802009|NCT02118844|Rocuronium|rocuronium|mesh-list
110802010|NCT02118844|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110802011|NCT02118844|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110802012|NCT02118844|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110802013|NCT02118844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110802014|NCT02118844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110802015|NCT02116348|Cerebrolysin|cerebrolysin|mesh-list
110802016|NCT02116348|Mitogens|mitogens|mesh-list
110802017|NCT02116348|Mitosis Modulators|mitosis modulators|mesh-ancestor
110802018|NCT02116348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110802019|NCT02116348|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110802020|NCT02116348|Protective Agents|protective agents|mesh-ancestor
110802021|NCT02116348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110802022|NCT02116348|Nootropic Agents|nootropic agents|mesh-ancestor
110802023|NCT02119000|Bisacodyl|bisacodyl|mesh-list
110802024|NCT02119000|Cathartics|cathartics|mesh-ancestor
110802025|NCT02119000|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110802026|NCT02119000|Laxatives|laxatives|mesh-ancestor
110802027|NCT02119234|Beclomethasone|beclomethasone|mesh-list
110802028|NCT02119234|Glycopyrrolate|glycopyrrolate|mesh-list
110802029|NCT02119234|Formoterol Fumarate|formoterol fumarate|mesh-list
110802030|NCT02119234|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110802031|NCT02119234|Autonomic Agents|autonomic agents|mesh-ancestor
110802032|NCT02119234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110802033|NCT02119234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110802034|NCT02119234|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110802035|NCT02119234|Respiratory System Agents|respiratory system agents|mesh-ancestor
110802036|NCT02119234|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110802037|NCT02119234|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110802038|NCT02119234|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110802039|NCT02119234|Adrenergic Agents|adrenergic agents|mesh-ancestor
110802040|NCT02119234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110802041|NCT02119234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110802042|NCT02119234|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110802043|NCT02119234|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110802044|NCT02119234|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110802045|NCT02119234|Cholinergic Agents|cholinergic agents|mesh-ancestor
110802046|NCT02119234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110802047|NCT02119234|Glucocorticoids|glucocorticoids|mesh-ancestor
110802049|NCT02119234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110538521|NCT02812199|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110802050|NCT02112604|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
110802051|NCT02112604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110802052|NCT02112604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110802053|NCT03694197|Alirocumab|alirocumab|mesh-list
110802054|NCT03694197|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
110802055|NCT03694197|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110802056|NCT03694197|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110802057|NCT03694197|Antimetabolites|antimetabolites|mesh-ancestor
110802058|NCT03694197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110802059|NCT03694197|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110802060|NCT03694197|Protease Inhibitors|protease inhibitors|mesh-ancestor
110802061|NCT03694197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110802062|NCT03694197|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110802063|NCT04480424|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110802064|NCT04480424|Immunologic Factors|immunologic factors|mesh-ancestor
110802065|NCT04480424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110802067|NCT04473716|Cisplatin|cisplatin|mesh-list
110802068|NCT04473716|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110802069|NCT04473716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110802070|NCT04473716|Tubulin Modulators|tubulin modulators|mesh-ancestor
110802071|NCT04473716|Antimitotic Agents|antimitotic agents|mesh-ancestor
110802072|NCT04473716|Mitosis Modulators|mitosis modulators|mesh-ancestor
110802073|NCT04473716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110802074|NCT04000815|Natriuretic Peptide, C-Type|natriuretic peptide, c-type|mesh-list
110802075|NCT04000815|Natriuretic Agents|natriuretic agents|mesh-ancestor
110802076|NCT04000815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110802077|NCT03919617|Volagidemab|volagidemab|mesh-list
110802078|NCT03919617|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110802079|NCT03919617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110802080|NCT03748173|Calfactant|calfactant|mesh-list
110802081|NCT03748173|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
110802082|NCT03748173|Respiratory System Agents|respiratory system agents|mesh-ancestor
110802083|NCT03848403|Ixekizumab|ixekizumab|mesh-list
110802084|NCT03848403|Dermatologic Agents|dermatologic agents|mesh-ancestor
110802085|NCT04054011|Deoxycholic Acid|deoxycholic acid|mesh-list
110802086|NCT04054011|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
110802087|NCT04054011|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110802088|NCT03743883|Aspirin|aspirin|mesh-list
110802089|NCT03743883|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110802090|NCT03743883|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110802091|NCT03743883|Analgesics|analgesics|mesh-ancestor
110802092|NCT03743883|Sensory System Agents|sensory system agents|mesh-ancestor
110802093|NCT03743883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110802094|NCT03743883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110802095|NCT03743883|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110802096|NCT03743883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110802097|NCT03743883|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110802098|NCT03743883|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110802099|NCT03743883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110538783|NCT02680808|Olorofim|olorofim|mesh-list
110802100|NCT03743883|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110802101|NCT03743883|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110802102|NCT03743883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110802103|NCT03743883|Antipyretics|antipyretics|mesh-ancestor
110802104|NCT03988803|Memantine|memantine|mesh-list
110802105|NCT03988803|BI 425809|bi 425809|mesh-list
110802106|NCT03988803|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110802107|NCT03988803|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110802108|NCT03988803|Dopamine Agents|dopamine agents|mesh-ancestor
110802109|NCT03988803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110802110|NCT03988803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110852349|NCT03601507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110802111|NCT03988803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110802112|NCT03988803|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110802113|NCT03988803|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110802114|NCT03988803|Nootropic Agents|nootropic agents|mesh-ancestor
110802115|NCT00181883|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110802116|NCT00181883|Antidepressive Agents|antidepressive agents|mesh-ancestor
110802117|NCT00181883|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110802118|NCT00181883|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110802119|NCT00181883|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110802120|NCT00181883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110802121|NCT00181883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110802122|NCT00180713|Simvastatin|simvastatin|mesh-list
110802123|NCT00180713|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110802124|NCT00180713|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110802125|NCT00180713|Antimetabolites|antimetabolites|mesh-ancestor
110538970|NCT03973177|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110802126|NCT00180713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110802127|NCT00180713|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110802128|NCT00180713|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110802129|NCT00180713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110802130|NCT02531477|Propofol|propofol|mesh-list
110802131|NCT02531477|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110539112|NCT02677532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110802132|NCT02531477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110802133|NCT02531477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110802134|NCT02531477|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110802135|NCT02531477|Anesthetics, General|anesthetics, general|mesh-ancestor
110802136|NCT02531477|Anesthetics|anesthetics|mesh-ancestor
110802137|NCT04052139|Naltrexone|naltrexone|mesh-list
110802138|NCT04052139|Gabapentin|gabapentin|mesh-list
110802139|NCT04052139|Analgesics|analgesics|mesh-ancestor
110519719|NCT04548999|Hormones|hormones|mesh-ancestor
110802140|NCT04052139|Sensory System Agents|sensory system agents|mesh-ancestor
110802141|NCT04052139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110802142|NCT04052139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110802143|NCT04052139|Anticonvulsants|anticonvulsants|mesh-ancestor
110802144|NCT04052139|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110539187|NCT00642512|Dronabinol|dronabinol|mesh-list
110802145|NCT04052139|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110802146|NCT04052139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110802147|NCT04052139|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110802148|NCT04052139|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110802149|NCT04052139|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110802150|NCT04052139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110802151|NCT04052139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110802152|NCT04052139|Antimanic Agents|antimanic agents|mesh-ancestor
110539339|NCT04032834|Hormones|hormones|mesh-ancestor
110802153|NCT04052139|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110802154|NCT04052139|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110802155|NCT03743805|Naloxone|naloxone|mesh-list
110802156|NCT03743805|Flumazenil|flumazenil|mesh-list
110802157|NCT03743805|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110802158|NCT03743805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110802159|NCT03743805|Sensory System Agents|sensory system agents|mesh-ancestor
110802160|NCT03743805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110802161|NCT03743805|Antidotes|antidotes|mesh-ancestor
110802162|NCT03743805|Protective Agents|protective agents|mesh-ancestor
110802163|NCT03743805|GABA Modulators|gaba modulators|mesh-ancestor
110802164|NCT03743805|GABA Agents|gaba agents|mesh-ancestor
110802165|NCT03743805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110802166|NCT03743805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110802167|NCT03743727|Sofosbuvir|sofosbuvir|mesh-list
110802168|NCT03743727|Ledipasvir|ledipasvir|mesh-list
110802169|NCT03743727|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
110802170|NCT03743727|Antiviral Agents|antiviral agents|mesh-ancestor
110802171|NCT03743727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110802172|NCT03981861|Metformin|metformin|mesh-list
110802173|NCT03981861|Spironolactone|spironolactone|mesh-list
110802174|NCT03981861|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110802175|NCT03981861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110802176|NCT03981861|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110802177|NCT03981861|Hormone Antagonists|hormone antagonists|mesh-ancestor
110539393|NCT02801357|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110802178|NCT03981861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110802179|NCT03981861|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110802180|NCT03981861|Diuretics|diuretics|mesh-ancestor
110802181|NCT03981861|Natriuretic Agents|natriuretic agents|mesh-ancestor
110802183|NCT03743649|Haloperidol|haloperidol|mesh-list
110802184|NCT03743649|Haloperidol decanoate|haloperidol decanoate|mesh-list
110802185|NCT03743649|Antiemetics|antiemetics|mesh-ancestor
110802186|NCT03743649|Autonomic Agents|autonomic agents|mesh-ancestor
110802187|NCT03743649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110539444|NCT04183088|Tislelizumab|tislelizumab|mesh-list
110802188|NCT03743649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110802189|NCT03743649|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110802190|NCT03743649|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110802191|NCT03743649|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110802192|NCT03743649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110802193|NCT03743649|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110802194|NCT03743649|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110802195|NCT03743649|Dopamine Agents|dopamine agents|mesh-ancestor
110802196|NCT03743649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110802197|NCT03743649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110802198|NCT03743649|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110802199|NCT03743649|Anticonvulsants|anticonvulsants|mesh-ancestor
110802200|NCT03743649|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110802201|NCT03743649|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110802202|NCT03743649|GABA Modulators|gaba modulators|mesh-ancestor
110802203|NCT03743649|GABA Agents|gaba agents|mesh-ancestor
110802204|NCT01332266|Cetuximab|cetuximab|mesh-list
110802205|NCT01332266|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110539582|NCT02797145|Digoxin|digoxin|mesh-list
110802206|NCT01332266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110802207|NCT03255824|Fentanyl|fentanyl|mesh-list
110802208|NCT03255824|Midazolam|midazolam|mesh-list
110802209|NCT03255824|Dexmedetomidine|dexmedetomidine|mesh-list
110802210|NCT03255824|Propofol|propofol|mesh-list
110802211|NCT03255824|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110802212|NCT03255824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110802213|NCT03255824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110802214|NCT03255824|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110802215|NCT03255824|Analgesics|analgesics|mesh-ancestor
110519783|NCT04395079|Immunologic Factors|immunologic factors|mesh-ancestor
110802216|NCT03255824|Sensory System Agents|sensory system agents|mesh-ancestor
110539641|NCT00963703|Immunologic Factors|immunologic factors|mesh-ancestor
110802217|NCT03255824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110802218|NCT03255824|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110802219|NCT03255824|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110802220|NCT03255824|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110802221|NCT03255824|Adrenergic Agents|adrenergic agents|mesh-ancestor
110802222|NCT03255824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110802223|NCT03255824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110539780|NCT02635074|Cytarabine|cytarabine|mesh-list
110802224|NCT03255824|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110802225|NCT03255824|Anesthetics, General|anesthetics, general|mesh-ancestor
110802226|NCT03255824|Anesthetics|anesthetics|mesh-ancestor
110802227|NCT03255824|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110802228|NCT03255824|Narcotics|narcotics|mesh-ancestor
110802229|NCT03255824|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110802230|NCT03255824|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110802231|NCT03255824|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110802232|NCT03255824|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110802233|NCT03255824|GABA Modulators|gaba modulators|mesh-ancestor
110802234|NCT03255824|GABA Agents|gaba agents|mesh-ancestor
110802235|NCT03238352|Listerine|listerine|mesh-list
110802236|NCT03238352|Fluorides|fluorides|mesh-list
110802237|NCT03238352|Sodium Fluoride|sodium fluoride|mesh-list
110802238|NCT03238352|Cariostatic Agents|cariostatic agents|mesh-ancestor
110802239|NCT03238352|Protective Agents|protective agents|mesh-ancestor
110539863|NCT02816567|Sufentanil|sufentanil|mesh-list
110802240|NCT03238352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110802241|NCT03238352|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110802242|NCT03238352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110802243|NCT01222754|Lenalidomide|lenalidomide|mesh-list
110802244|NCT01222754|Immunologic Factors|immunologic factors|mesh-ancestor
110802245|NCT01222754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110802246|NCT01222754|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110802247|NCT01222754|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110802248|NCT01222754|Growth Substances|growth substances|mesh-ancestor
110802249|NCT01222754|Growth Inhibitors|growth inhibitors|mesh-ancestor
110802250|NCT01222754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110802251|NCT03850418|Azacitidine|azacitidine|mesh-list
110802252|NCT03850418|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110802253|NCT03850418|Antimetabolites|antimetabolites|mesh-ancestor
110540059|NCT00959101|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110802254|NCT03850418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110802255|NCT03850418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110802256|NCT03850418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110802257|NCT05256914|Chlorhexidine|chlorhexidine|mesh-list
110802258|NCT05256914|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110802259|NCT05256914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110802260|NCT05256914|Disinfectants|disinfectants|mesh-ancestor
110802261|NCT00180479|Paclitaxel|paclitaxel|mesh-list
110802262|NCT00180479|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110802263|NCT00180479|Everolimus|everolimus|mesh-list
110802264|NCT00180479|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110802265|NCT00180479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110802266|NCT00180479|Tubulin Modulators|tubulin modulators|mesh-ancestor
110540191|NCT00881868|Hormones|hormones|mesh-ancestor
110802267|NCT00180479|Antimitotic Agents|antimitotic agents|mesh-ancestor
110802268|NCT00180479|Mitosis Modulators|mitosis modulators|mesh-ancestor
110802269|NCT00180479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110802270|NCT00180479|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110802271|NCT00180479|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110802272|NCT00180479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110802273|NCT00180479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110802274|NCT00180479|Immunologic Factors|immunologic factors|mesh-ancestor
110802275|NCT00180479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110802276|NCT05169944|Magrolimab|magrolimab|mesh-list
110540265|NCT00965107|Anesthetics|anesthetics|mesh-ancestor
110802277|NCT05169944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110802278|NCT05169944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110802279|NCT02955069|Spartalizumab|spartalizumab|mesh-list
110802280|NCT02955069|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110802281|NCT02955069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110802282|NCT02955069|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110802283|NCT02955069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110802284|NCT03254108|Tolvaptan|tolvaptan|mesh-list
110802285|NCT03254108|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
110540397|NCT00644696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110802286|NCT03254108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110802287|NCT03254108|Natriuretic Agents|natriuretic agents|mesh-ancestor
110802288|NCT03254108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110519867|NCT04249622|Rifaximin|rifaximin|mesh-list
110802289|NCT02585895|Evolocumab|evolocumab|mesh-list
110802290|NCT02585895|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
110802291|NCT02585895|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110802292|NCT02585895|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110802293|NCT02585895|Antimetabolites|antimetabolites|mesh-ancestor
110802294|NCT02585895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110802295|NCT02585895|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110802296|NCT02585895|Protease Inhibitors|protease inhibitors|mesh-ancestor
110802297|NCT02585895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110802298|NCT02585895|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110802299|NCT03736161|Methotrexate|methotrexate|mesh-list
110802300|NCT03736161|Tofacitinib|tofacitinib|mesh-list
110802301|NCT03736161|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110802302|NCT03736161|Abortifacient Agents|abortifacient agents|mesh-ancestor
110802303|NCT03736161|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110802304|NCT03736161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110802305|NCT03736161|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110802306|NCT03736161|Antimetabolites|antimetabolites|mesh-ancestor
110802307|NCT03736161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110802308|NCT03736161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110802309|NCT03736161|Dermatologic Agents|dermatologic agents|mesh-ancestor
110802310|NCT03736161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110802311|NCT03736161|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110802312|NCT03736161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110802313|NCT03736161|Immunologic Factors|immunologic factors|mesh-ancestor
110802314|NCT03736161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110802315|NCT03736161|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110802316|NCT03736161|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
110802317|NCT03736161|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110802318|NCT02956005|Tacrolimus|tacrolimus|mesh-list
110802319|NCT02956005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110802320|NCT02956005|Immunologic Factors|immunologic factors|mesh-ancestor
110802321|NCT02956005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110802322|NCT02956005|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110802323|NCT02956005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110802324|NCT02956005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110802325|NCT02579499|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
110540665|NCT04176224|Edaravone|edaravone|mesh-list
110802326|NCT02579499|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110802327|NCT02579499|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110802328|NCT02579499|Antimetabolites|antimetabolites|mesh-ancestor
110802329|NCT02579499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110802330|NCT02579499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110802331|NCT02579499|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110802332|NCT03253094|Fluconazole|fluconazole|mesh-list
110802333|NCT03253094|Ibrexafungerp|ibrexafungerp|mesh-list
110802334|NCT03253094|Antifungal Agents|antifungal agents|mesh-ancestor
110802335|NCT03253094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110802336|NCT03253094|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110802337|NCT03253094|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110802338|NCT03253094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110802339|NCT03253094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110540794|NCT03102047|Durvalumab|durvalumab|mesh-list
110802340|NCT03253094|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110802341|NCT03253094|Hormone Antagonists|hormone antagonists|mesh-ancestor
110802342|NCT03253094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110802343|NCT03253094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110802344|NCT03253094|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110802345|NCT03253094|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110802346|NCT05179070|Carvedilol|carvedilol|mesh-list
110802347|NCT05179070|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110802348|NCT05179070|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110802349|NCT05179070|Adrenergic Agents|adrenergic agents|mesh-ancestor
110802350|NCT05179070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110802351|NCT05179070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110802352|NCT05179070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110802353|NCT05179070|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110802355|NCT05179070|Protective Agents|protective agents|mesh-ancestor
110802356|NCT05179070|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110802357|NCT05179070|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110802358|NCT05179070|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110802359|NCT05179070|Vasodilator Agents|vasodilator agents|mesh-ancestor
110802360|NCT05179070|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110802361|NCT05179070|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110802362|NCT00179621|Lenalidomide|lenalidomide|mesh-list
110540924|NCT00967057|Dexamethasone|dexamethasone|mesh-list
110802363|NCT00179621|Immunologic Factors|immunologic factors|mesh-ancestor
110802364|NCT00179621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110802365|NCT00179621|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110802366|NCT00179621|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110802367|NCT00179621|Growth Substances|growth substances|mesh-ancestor
110802368|NCT00179621|Growth Inhibitors|growth inhibitors|mesh-ancestor
110802369|NCT00179621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110802370|NCT00179309|Docetaxel|docetaxel|mesh-list
110802371|NCT00179309|Sargramostim|sargramostim|mesh-list
110802372|NCT00179309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110802373|NCT00179309|Tubulin Modulators|tubulin modulators|mesh-ancestor
110802374|NCT00179309|Antimitotic Agents|antimitotic agents|mesh-ancestor
110802375|NCT00179309|Mitosis Modulators|mitosis modulators|mesh-ancestor
110802376|NCT00179309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110802377|NCT00179309|Immunologic Factors|immunologic factors|mesh-ancestor
110802378|NCT00179309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110802379|NCT00177671|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110802380|NCT00177671|Donepezil|donepezil|mesh-list
110802381|NCT00177671|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
110802382|NCT00177671|Escitalopram|escitalopram|mesh-list
110802383|NCT00177671|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110802384|NCT00177671|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110802385|NCT00177671|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110802386|NCT00177671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110802387|NCT00177671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110802388|NCT00177671|Serotonin Agents|serotonin agents|mesh-ancestor
110802389|NCT00177671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110802390|NCT00177671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110802391|NCT00177671|Cholinergic Agents|cholinergic agents|mesh-ancestor
110100741|NCT01756612|Hematinics|hematinics|mesh-ancestor
110802392|NCT00177671|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110802393|NCT00177671|Antidepressive Agents|antidepressive agents|mesh-ancestor
110802395|NCT00177671|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110802396|NCT00177671|Analgesics|analgesics|mesh-ancestor
110802397|NCT00177671|Sensory System Agents|sensory system agents|mesh-ancestor
110802398|NCT00177671|Dopamine Agents|dopamine agents|mesh-ancestor
110802399|NCT00177671|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110802400|NCT00177671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110802401|NCT00177671|Nootropic Agents|nootropic agents|mesh-ancestor
110802402|NCT03235154|Sofosbuvir|sofosbuvir|mesh-list
110802403|NCT03235154|Velpatasvir|velpatasvir|mesh-list
110802404|NCT03235154|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
110802405|NCT03235154|Antiviral Agents|antiviral agents|mesh-ancestor
110802406|NCT03235154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110802407|NCT03233438|Dalbavancin|dalbavancin|mesh-list
110802408|NCT03233438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110802409|NCT03233438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110802410|NCT02251600|Deflazacort|deflazacort|mesh-list
110802411|NCT02251600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110802412|NCT02251600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110802413|NCT02251600|Immunologic Factors|immunologic factors|mesh-ancestor
110541135|NCT00657228|Heparin|heparin|mesh-list
110802414|NCT02251600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110802415|NCT02113072|Beclomethasone|beclomethasone|mesh-list
110802416|NCT02113072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110802417|NCT02113072|Glucocorticoids|glucocorticoids|mesh-ancestor
110802418|NCT02113072|Hormones|hormones|mesh-ancestor
110802419|NCT02113072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110802420|NCT02113072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110802421|NCT02113072|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110802422|NCT02113072|Respiratory System Agents|respiratory system agents|mesh-ancestor
110802423|NCT02113150|Ketamine|ketamine|mesh-list
110802424|NCT02113150|Remifentanil|remifentanil|mesh-list
110802425|NCT02113150|Analgesics|analgesics|mesh-ancestor
110802426|NCT02113150|Sensory System Agents|sensory system agents|mesh-ancestor
110802427|NCT02113150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110802428|NCT02113150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110802429|NCT02113150|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110802430|NCT02113150|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110802431|NCT02113150|Anesthetics, General|anesthetics, general|mesh-ancestor
110802432|NCT02113150|Anesthetics|anesthetics|mesh-ancestor
110802433|NCT02113150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110802434|NCT02113150|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110802435|NCT02113150|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110802436|NCT02113150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110802437|NCT02113150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110802438|NCT02113150|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110802439|NCT02113150|Narcotics|narcotics|mesh-ancestor
110802441|NCT04647500|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110802442|NCT04647500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110802443|NCT04647500|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110802444|NCT04647500|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110802445|NCT04647500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110802446|NCT04647500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110802447|NCT04647500|Dopamine Agents|dopamine agents|mesh-ancestor
110802448|NCT04647500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110802449|NCT03553108|Olaparib|olaparib|mesh-list
110541232|NCT02632032|Insulin|insulin|mesh-list
110802450|NCT03553108|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110802451|NCT03553108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110802452|NCT03553108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110802453|NCT03553108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110802454|NCT02119858|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110802455|NCT02117128|Tranexamic Acid|tranexamic acid|mesh-list
110802456|NCT02117128|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110802457|NCT02117128|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110802458|NCT02117128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110802459|NCT02117128|Hemostatics|hemostatics|mesh-ancestor
110802460|NCT02117128|Coagulants|coagulants|mesh-ancestor
110802461|NCT00175877|Certolizumab Pegol|certolizumab pegol|mesh-list
110802462|NCT00175877|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110802463|NCT00175877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110802464|NCT00175877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110802465|NCT00175877|Immunologic Factors|immunologic factors|mesh-ancestor
110802466|NCT00175877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110802467|NCT00175877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110802469|NCT02117362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110802470|NCT02117362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110802471|NCT02117362|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110802472|NCT02117362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110802473|NCT02113540|Atorvastatin|atorvastatin|mesh-list
110802474|NCT02113540|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110802475|NCT02113540|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110802476|NCT02113540|Antimetabolites|antimetabolites|mesh-ancestor
110541276|NCT02785757|Hemostatics|hemostatics|mesh-ancestor
110802477|NCT02113540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110802478|NCT02113540|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110802479|NCT02113540|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110802480|NCT02113540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110802481|NCT02123056|Metoprolol|metoprolol|mesh-list
110802482|NCT02123056|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110802483|NCT02123056|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110802484|NCT02123056|Sympatholytics|sympatholytics|mesh-ancestor
110802485|NCT02123056|Autonomic Agents|autonomic agents|mesh-ancestor
110802486|NCT02123056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110802487|NCT02123056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110802488|NCT02123056|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110802489|NCT02123056|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110802490|NCT02123056|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110802491|NCT02123056|Adrenergic Agents|adrenergic agents|mesh-ancestor
110802492|NCT02123056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110802493|NCT02123056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110802494|NCT02120092|Clopidogrel|clopidogrel|mesh-list
110802495|NCT02120092|Ticagrelor|ticagrelor|mesh-list
110802496|NCT02120092|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110802497|NCT02120092|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110802498|NCT02120092|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110802499|NCT02120092|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110802500|NCT02120092|Purinergic Agents|purinergic agents|mesh-ancestor
110802501|NCT02120092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110802502|NCT02120092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110802503|NCT02120092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110802504|NCT02117596|Sirolimus|sirolimus|mesh-list
110802505|NCT02117596|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110802506|NCT02117596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110802507|NCT02117596|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110802508|NCT02117596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110802509|NCT02117596|Antifungal Agents|antifungal agents|mesh-ancestor
110802510|NCT02117596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110802511|NCT02117596|Immunologic Factors|immunologic factors|mesh-ancestor
110802512|NCT02117596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110802513|NCT02117752|Dapsone|dapsone|mesh-list
110802514|NCT02117752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110802515|NCT02117752|Antimalarials|antimalarials|mesh-ancestor
110802516|NCT02117752|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110802517|NCT02117752|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110802518|NCT02117752|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110802519|NCT02117752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110802520|NCT02117752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110802521|NCT02117752|Leprostatic Agents|leprostatic agents|mesh-ancestor
110802522|NCT02117752|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110802523|NCT02117830|Moxifloxacin|moxifloxacin|mesh-list
110802524|NCT02117830|Enclomiphene|enclomiphene|mesh-list
110802525|NCT02117830|Clomiphene|clomiphene|mesh-list
110802526|NCT02117830|Zuclomiphene|zuclomiphene|mesh-list
110802527|NCT02117830|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110802528|NCT02117830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110802529|NCT02117830|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110802530|NCT02117830|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110802531|NCT02117830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110802532|NCT02117830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110802533|NCT02117830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110802534|NCT02117830|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110802535|NCT02117830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110802536|NCT02117830|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110802537|NCT02117830|Hormone Antagonists|hormone antagonists|mesh-ancestor
110802538|NCT02117830|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110802539|NCT02117830|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110802540|NCT02117830|Fertility Agents|fertility agents|mesh-ancestor
110802541|NCT02117830|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110802542|NCT02117830|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110802543|NCT02120638|Pyrazinamide|pyrazinamide|mesh-list
110802544|NCT02120638|Antitubercular Agents|antitubercular agents|mesh-ancestor
110802545|NCT02120638|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110802546|NCT02120638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110802547|NCT03552406|Cetuximab|cetuximab|mesh-list
110802548|NCT03552406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110802549|NCT03552406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110802550|NCT02123368|Hyaluronic Acid|hyaluronic acid|mesh-list
110802551|NCT02123368|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110802552|NCT02123368|Immunologic Factors|immunologic factors|mesh-ancestor
110802553|NCT02123368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110802554|NCT02123368|Viscosupplements|viscosupplements|mesh-ancestor
110802555|NCT02123368|Protective Agents|protective agents|mesh-ancestor
110802556|NCT02123524|Rivaroxaban|rivaroxaban|mesh-list
110802557|NCT02123524|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110802558|NCT02123524|Antithrombins|antithrombins|mesh-ancestor
110802559|NCT02123524|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110802560|NCT02123524|Protease Inhibitors|protease inhibitors|mesh-ancestor
110802561|NCT02123524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110802562|NCT02123524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110802563|NCT02123524|Anticoagulants|anticoagulants|mesh-ancestor
110802564|NCT02117986|Colistin|colistin|mesh-list
110802565|NCT02117986|Polymyxins|polymyxins|mesh-list
110802566|NCT02117986|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110802567|NCT02117986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110802568|NCT02118064|Irinotecan|irinotecan|mesh-list
110802569|NCT02118064|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110802570|NCT02118064|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110802572|NCT02118064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110802573|NCT02118064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110802574|NCT02120872|Simvastatin|simvastatin|mesh-list
110802575|NCT02120872|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110802576|NCT02120872|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110802577|NCT02120872|Antimetabolites|antimetabolites|mesh-ancestor
110802578|NCT02120872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110802579|NCT02120872|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110802580|NCT02120872|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110189079|NCT00039858|Argatroban|argatroban|mesh-list
110802581|NCT02120872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110802582|NCT03552016|Riboflavin|riboflavin|mesh-list
110802583|NCT03552016|Vitamins|vitamins|mesh-ancestor
110802584|NCT03552016|Micronutrients|micronutrients|mesh-ancestor
110802585|NCT03552016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110520156|NCT03370367|Tretinoin|tretinoin|mesh-list
110802586|NCT03552016|Vitamin B Complex|vitamin b complex|mesh-ancestor
110802587|NCT03552016|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110802588|NCT03552016|Dermatologic Agents|dermatologic agents|mesh-ancestor
110802589|NCT02788474|Nintedanib|nintedanib|mesh-list
110802590|NCT02788474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110802591|NCT02788474|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110802592|NCT02788474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110802593|NCT02788474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110802594|NCT02118142|Betaine|betaine|mesh-list
110802595|NCT02118142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110802596|NCT02118142|Lipotropic Agents|lipotropic agents|mesh-ancestor
110802597|NCT02118142|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110802598|NCT02118142|Antimetabolites|antimetabolites|mesh-ancestor
110100954|NCT01757860|Vitamin D|vitamin d|mesh-list
110802599|NCT02118142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110802600|NCT02118142|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110802602|NCT02118376|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110802603|NCT02118376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110802604|NCT02118376|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110802605|NCT02118376|Incretins|incretins|mesh-ancestor
110802606|NCT02118376|Hormones|hormones|mesh-ancestor
110802607|NCT02118376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110802608|NCT02124070|Hormones|hormones|mesh-list
110863854|NCT01365312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110802609|NCT02124070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110802610|NCT02124070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110802611|NCT02118532|Paclitaxel|paclitaxel|mesh-list
110802612|NCT02118532|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110802613|NCT02118532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110802614|NCT02118532|Tubulin Modulators|tubulin modulators|mesh-ancestor
110802615|NCT02118532|Antimitotic Agents|antimitotic agents|mesh-ancestor
110802616|NCT02118532|Mitosis Modulators|mitosis modulators|mesh-ancestor
110802617|NCT02118532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110802618|NCT02118688|Risperidone|risperidone|mesh-list
110802619|NCT02118688|Trazodone|trazodone|mesh-list
110802620|NCT02118688|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110802621|NCT02118688|Serotonin Agents|serotonin agents|mesh-ancestor
110802622|NCT02118688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110802623|NCT02118688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110802624|NCT02118688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110802625|NCT02118688|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110802626|NCT02118688|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110802627|NCT02118688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110802628|NCT02118688|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110802629|NCT02118688|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110802630|NCT02118688|Dopamine Agents|dopamine agents|mesh-ancestor
110802631|NCT02118688|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110802632|NCT02118688|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110802633|NCT02118688|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110802634|NCT02118688|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110802635|NCT02118688|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110802636|NCT02118688|Antidepressive Agents|antidepressive agents|mesh-ancestor
110802637|NCT03248492|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
110802638|NCT03248492|Immunoconjugates|immunoconjugates|mesh-ancestor
110802639|NCT03248492|Immunologic Factors|immunologic factors|mesh-ancestor
110802640|NCT03248492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110802641|NCT02126956|Ponesimod|ponesimod|mesh-list
110802642|NCT02126956|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
110127757|NCT05876598|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110802656|NCT02124148|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110802657|NCT02124148|Immunologic Factors|immunologic factors|mesh-ancestor
110802658|NCT02124148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110802659|NCT02124148|Antidotes|antidotes|mesh-ancestor
110802660|NCT02124148|Protective Agents|protective agents|mesh-ancestor
110802661|NCT02124148|Vitamin B Complex|vitamin b complex|mesh-ancestor
110802662|NCT02124148|Vitamins|vitamins|mesh-ancestor
110520232|NCT03003546|Paclitaxel|paclitaxel|mesh-list
110802663|NCT02124148|Micronutrients|micronutrients|mesh-ancestor
110802664|NCT02124148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110802665|NCT02124148|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110802666|NCT02124148|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110802667|NCT02124148|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110802668|NCT02124148|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110802669|NCT02124226|Methotrexate|methotrexate|mesh-list
110802670|NCT02124226|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110802671|NCT02124226|Abortifacient Agents|abortifacient agents|mesh-ancestor
110802672|NCT02124226|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110802673|NCT02124226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110802674|NCT02124226|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110802675|NCT02124226|Antimetabolites|antimetabolites|mesh-ancestor
110852385|NCT03495960|Growth Inhibitors|growth inhibitors|mesh-ancestor
110802676|NCT02124226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110802677|NCT02124226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110802679|NCT02124226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110802680|NCT02124226|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110802681|NCT02124226|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110802682|NCT02124226|Immunologic Factors|immunologic factors|mesh-ancestor
110541769|NCT00646178|Adalimumab|adalimumab|mesh-list
110802683|NCT02124226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110802684|NCT02124226|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110802685|NCT02127034|Digoxin|digoxin|mesh-list
110802686|NCT02127034|Solifenacin Succinate|solifenacin succinate|mesh-list
110802687|NCT02127034|Mirabegron|mirabegron|mesh-list
110802688|NCT02127034|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110802689|NCT02127034|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110802690|NCT02127034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110802691|NCT02127034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110802692|NCT02127034|Protective Agents|protective agents|mesh-ancestor
110802693|NCT02127034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110802694|NCT02127034|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110802695|NCT02127034|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110802696|NCT02127034|Cholinergic Agents|cholinergic agents|mesh-ancestor
110802697|NCT02127034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110802698|NCT02127034|Urological Agents|urological agents|mesh-ancestor
110802699|NCT02127034|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
110802700|NCT02127034|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110802701|NCT02127034|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110802702|NCT02127034|Adrenergic Agents|adrenergic agents|mesh-ancestor
110802703|NCT02787304|Volixibat|volixibat|mesh-list
110802704|NCT02787304|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110802787|NCT02127736|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110802788|NCT02127736|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110802789|NCT02127736|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110802790|NCT02127736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110802791|NCT02127736|Adrenergic Agents|adrenergic agents|mesh-ancestor
110127910|NCT05874882|Chlorhexidine|chlorhexidine|mesh-list
110802792|NCT02127736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110802793|NCT02124850|Nivolumab|nivolumab|mesh-list
110802794|NCT02124850|Cetuximab|cetuximab|mesh-list
110802795|NCT02124850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110802796|NCT02124850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110802797|NCT02124850|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110802798|NCT02124850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110802799|NCT02125084|Everolimus|everolimus|mesh-list
110802800|NCT02125084|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110802801|NCT02125084|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110802802|NCT02125084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110863855|NCT04495283|Acetaminophen|acetaminophen|mesh-list
110802803|NCT02125084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110802804|NCT02125084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110802805|NCT02125084|Immunologic Factors|immunologic factors|mesh-ancestor
110802806|NCT02125084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110802807|NCT02125084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110802808|NCT02122510|Dexmedetomidine|dexmedetomidine|mesh-list
110802809|NCT02122510|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110802810|NCT02122510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110802811|NCT02122510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110802812|NCT02122510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110802813|NCT02122510|Analgesics|analgesics|mesh-ancestor
110802814|NCT02122510|Sensory System Agents|sensory system agents|mesh-ancestor
110802815|NCT02122510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110802816|NCT02122510|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110802817|NCT02122510|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110802818|NCT02122510|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110802819|NCT02122510|Adrenergic Agents|adrenergic agents|mesh-ancestor
110802820|NCT02122510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110802821|NCT02122510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110802822|NCT02125318|Anagrelide|anagrelide|mesh-list
110802823|NCT02125318|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110802824|NCT02125318|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110802825|NCT02125318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110802826|NCT02125318|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110802827|NCT02128126|Vaccines|vaccines|mesh-list
110802828|NCT02128126|Immunologic Factors|immunologic factors|mesh-ancestor
110802829|NCT02128126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110802830|NCT02128204|Lidocaine|lidocaine|mesh-list
110802831|NCT02128204|Anesthetics, Local|anesthetics, local|mesh-ancestor
110802832|NCT02128204|Anesthetics|anesthetics|mesh-ancestor
110802833|NCT02128204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110802834|NCT02128204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110802835|NCT02128204|Sensory System Agents|sensory system agents|mesh-ancestor
110802836|NCT02128204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110802837|NCT02128204|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110541965|NCT04008043|Hydrocodone|hydrocodone|mesh-list
110802838|NCT02128204|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110802839|NCT02128204|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110802840|NCT02128204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110802841|NCT02128204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110802842|NCT02128282|Gemcitabine|gemcitabine|mesh-list
110802843|NCT02128282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110802844|NCT02128282|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110802845|NCT02128282|Antimetabolites|antimetabolites|mesh-ancestor
110802846|NCT02128282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110802847|NCT02125630|Hormones|hormones|mesh-list
110802848|NCT02125630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110802849|NCT02125630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110802850|NCT03551548|Spironolactone|spironolactone|mesh-list
110802851|NCT03551548|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110802852|NCT03551548|Hormone Antagonists|hormone antagonists|mesh-ancestor
110802853|NCT03551548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110802854|NCT03551548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110802855|NCT03551548|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110802856|NCT03551548|Diuretics|diuretics|mesh-ancestor
110802857|NCT03551548|Natriuretic Agents|natriuretic agents|mesh-ancestor
110802858|NCT02128360|Letrozole|letrozole|mesh-list
110802859|NCT02128360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110802860|NCT02128360|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110802861|NCT02128360|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110802862|NCT02128360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110802863|NCT02128360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110802864|NCT02128360|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110802865|NCT02128360|Hormone Antagonists|hormone antagonists|mesh-ancestor
110802866|NCT02128360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110802867|NCT02128360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110802868|NCT02126020|Infliximab|infliximab|mesh-list
110802869|NCT02126020|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110802870|NCT02126020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110802871|NCT02126020|Dermatologic Agents|dermatologic agents|mesh-ancestor
110802872|NCT02126020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110802873|NCT02126020|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110802874|NCT00688376|Donepezil|donepezil|mesh-list
110802875|NCT00688376|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110802876|NCT00688376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110802877|NCT00688376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110802878|NCT00688376|Cholinergic Agents|cholinergic agents|mesh-ancestor
110802879|NCT00688376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110802880|NCT00688376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110802881|NCT00688376|Nootropic Agents|nootropic agents|mesh-ancestor
110802882|NCT02126332|Acetaminophen|acetaminophen|mesh-list
110802883|NCT02126332|Sufentanil|sufentanil|mesh-list
110802884|NCT02126332|Nefopam|nefopam|mesh-list
110802885|NCT02126332|Tramadol|tramadol|mesh-list
110802886|NCT02126332|Ropivacaine|ropivacaine|mesh-list
110802887|NCT02126332|Anesthetics, Local|anesthetics, local|mesh-ancestor
110802888|NCT02126332|Anesthetics|anesthetics|mesh-ancestor
110802889|NCT02126332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110802890|NCT02126332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110802891|NCT02126332|Sensory System Agents|sensory system agents|mesh-ancestor
110802892|NCT02126332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110802893|NCT02126332|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110802895|NCT02126332|Antipyretics|antipyretics|mesh-ancestor
110802896|NCT02126332|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110802897|NCT02126332|Narcotics|narcotics|mesh-ancestor
110802898|NCT02126332|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110802899|NCT02126332|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110802900|NCT02126332|Anesthetics, General|anesthetics, general|mesh-ancestor
110802901|NCT02131246|Insulin|insulin|mesh-list
110802902|NCT02131246|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110802903|NCT02131246|Insulin Aspart|insulin aspart|mesh-list
110802904|NCT02131246|Insulin, Long-Acting|insulin, long-acting|mesh-list
110802905|NCT02131246|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
110802906|NCT02131246|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110802907|NCT02131246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110802908|NCT02126644|Glycolic acid|glycolic acid|mesh-list
110802909|NCT02126644|Keratolytic Agents|keratolytic agents|mesh-ancestor
110802910|NCT02126644|Dermatologic Agents|dermatologic agents|mesh-ancestor
110802911|NCT03550534|Calcium Carbonate|calcium carbonate|mesh-list
110802912|NCT03550534|Calcium|calcium|mesh-list
110802913|NCT03550534|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110802914|NCT03550534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110802915|NCT03550534|Antacids|antacids|mesh-ancestor
110863856|NCT04495283|Pregabalin|pregabalin|mesh-list
110802916|NCT03550534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110802917|NCT03550534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110802918|NCT02131480|Doxorubicin|doxorubicin|mesh-list
110802919|NCT02131480|Trabectedin|trabectedin|mesh-list
110802920|NCT02131480|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110802921|NCT02131480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110802922|NCT02131480|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110802923|NCT02131480|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110802924|NCT02131480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110802925|NCT02131480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110802926|NCT02131480|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110802927|NCT02131480|Alkylating Agents|alkylating agents|mesh-ancestor
110802928|NCT02128906|Docetaxel|docetaxel|mesh-list
110802929|NCT02128906|Cetuximab|cetuximab|mesh-list
110802930|NCT02128906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110802931|NCT02128906|Tubulin Modulators|tubulin modulators|mesh-ancestor
110802932|NCT02128906|Antimitotic Agents|antimitotic agents|mesh-ancestor
110802933|NCT02128906|Mitosis Modulators|mitosis modulators|mesh-ancestor
110802934|NCT02128906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110802935|NCT02128906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110802936|NCT02128984|Antioxidants|antioxidants|mesh-list
110802937|NCT02128984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110802938|NCT02128984|Protective Agents|protective agents|mesh-ancestor
110802939|NCT02128984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110802940|NCT02252302|Albuterol|albuterol|mesh-list
110802941|NCT02252302|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110802942|NCT02252302|Autonomic Agents|autonomic agents|mesh-ancestor
110802943|NCT02252302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110802944|NCT02252302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110802945|NCT02252302|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110802946|NCT02252302|Respiratory System Agents|respiratory system agents|mesh-ancestor
110802947|NCT02252302|Tocolytic Agents|tocolytic agents|mesh-ancestor
110802948|NCT02252302|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110802949|NCT02252302|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110802950|NCT02252302|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110802951|NCT02252302|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110802952|NCT02252302|Adrenergic Agents|adrenergic agents|mesh-ancestor
110802953|NCT02252302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110802954|NCT02252302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110802955|NCT02252614|Acetaminophen|acetaminophen|mesh-list
110802956|NCT02252614|Naproxen|naproxen|mesh-list
110802957|NCT02252614|Codeine|codeine|mesh-list
110802958|NCT02252614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110802959|NCT02252614|Analgesics|analgesics|mesh-ancestor
110802960|NCT02252614|Sensory System Agents|sensory system agents|mesh-ancestor
110520530|NCT00329043|Fertility Agents|fertility agents|mesh-ancestor
110802961|NCT02252614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110802962|NCT02252614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110802964|NCT02252614|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110802965|NCT02252614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110802966|NCT02252614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110802967|NCT02252614|Gout Suppressants|gout suppressants|mesh-ancestor
110802968|NCT02252614|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110802969|NCT02252614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110802970|NCT02252614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110802971|NCT02252614|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110802972|NCT02252614|Narcotics|narcotics|mesh-ancestor
110802973|NCT02252614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110802974|NCT02252614|Antitussive Agents|antitussive agents|mesh-ancestor
110802975|NCT02252614|Respiratory System Agents|respiratory system agents|mesh-ancestor
110802976|NCT02260570|Tolcapone|tolcapone|mesh-list
110802977|NCT02260570|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110802978|NCT02260570|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110802979|NCT02260570|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
110802980|NCT02260570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110802981|NCT02260570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110802982|NCT03681951|Pembrolizumab|pembrolizumab|mesh-list
110802983|NCT03681951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110802984|NCT03681951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110802985|NCT03681951|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110802986|NCT03681951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110802987|NCT02131948|Insulin|insulin|mesh-list
110802988|NCT02131948|Insulin Lispro|insulin lispro|mesh-list
110802989|NCT02131948|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110802990|NCT02131948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110802991|NCT02132026|Denosumab|denosumab|mesh-list
110802992|NCT02132026|Alendronate|alendronate|mesh-list
110802993|NCT02132026|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110802994|NCT02132026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110802995|NCT03735771|Bupivacaine|bupivacaine|mesh-list
110802996|NCT03735771|Anesthetics, Local|anesthetics, local|mesh-ancestor
110802997|NCT03735771|Anesthetics|anesthetics|mesh-ancestor
110802998|NCT03735771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110802999|NCT03735771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110803000|NCT03735771|Sensory System Agents|sensory system agents|mesh-ancestor
110803001|NCT03735771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110803002|NCT02132104|Hormones|hormones|mesh-list
110803003|NCT02132104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110803004|NCT02132104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110803005|NCT00174785|Dronedarone|dronedarone|mesh-list
110803006|NCT00174785|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110803007|NCT03681093|Indoleacetic Acids|indoleacetic acids|mesh-list
110803008|NCT03681093|Plant Growth Regulators|plant growth regulators|mesh-ancestor
110803009|NCT03681093|Growth Substances|growth substances|mesh-ancestor
110803010|NCT03681093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110803011|NCT00166439|Cytarabine|cytarabine|mesh-list
110803012|NCT00166439|Dexamethasone|dexamethasone|mesh-list
110803013|NCT00166439|Oxaliplatin|oxaliplatin|mesh-list
110803014|NCT00166439|Rituximab|rituximab|mesh-list
110803015|NCT00166439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110803016|NCT00166439|Antiemetics|antiemetics|mesh-ancestor
110803017|NCT00166439|Autonomic Agents|autonomic agents|mesh-ancestor
110803018|NCT00166439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110803019|NCT00166439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110803020|NCT00166439|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110803021|NCT00166439|Glucocorticoids|glucocorticoids|mesh-ancestor
110803022|NCT00166439|Hormones|hormones|mesh-ancestor
110803023|NCT00166439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110803024|NCT00166439|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110803025|NCT00166439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110542389|NCT05340803|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110803026|NCT00166439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110803027|NCT00166439|Immunologic Factors|immunologic factors|mesh-ancestor
110803028|NCT00166439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110803029|NCT00166439|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110803030|NCT00166439|Antimetabolites|antimetabolites|mesh-ancestor
110803031|NCT00166439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110803032|NCT00166439|Antiviral Agents|antiviral agents|mesh-ancestor
110803033|NCT00166439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110520609|NCT00049517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110803034|NCT00166439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110803036|NCT01074905|Chloroquine|chloroquine|mesh-list
110803037|NCT01074905|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
110803038|NCT01074905|Primaquine|primaquine|mesh-list
110803039|NCT01074905|Antimalarials|antimalarials|mesh-ancestor
110803040|NCT01074905|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110803041|NCT01074905|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110542435|NCT05340725|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110803042|NCT01074905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110803043|NCT01074905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110803044|NCT01074905|Antiviral Agents|antiviral agents|mesh-ancestor
110803045|NCT01074905|Schistosomicides|schistosomicides|mesh-ancestor
110803046|NCT01074905|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110803047|NCT01074905|Anthelmintics|anthelmintics|mesh-ancestor
110803048|NCT01074905|Amebicides|amebicides|mesh-ancestor
110803049|NCT01074905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110803050|NCT01074905|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110803051|NCT01074905|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110803052|NCT01074905|Analgesics|analgesics|mesh-ancestor
110803053|NCT01074905|Sensory System Agents|sensory system agents|mesh-ancestor
110803054|NCT01074905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110803055|NCT01074905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110803056|NCT01074905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110803057|NCT01074905|Filaricides|filaricides|mesh-ancestor
110803058|NCT01074905|Antinematodal Agents|antinematodal agents|mesh-ancestor
110803059|NCT03968237|Buprenorphine|buprenorphine|mesh-list
110803060|NCT03968237|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
110803061|NCT03968237|Naloxone|naloxone|mesh-list
110803062|NCT03968237|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110803063|NCT03968237|Narcotics|narcotics|mesh-ancestor
110803064|NCT03968237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110803065|NCT03968237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110803066|NCT03968237|Analgesics|analgesics|mesh-ancestor
110803067|NCT03968237|Sensory System Agents|sensory system agents|mesh-ancestor
110803068|NCT03968237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110803069|NCT03968237|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110803070|NCT00138671|Insulin|insulin|mesh-list
110803071|NCT00138671|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110803072|NCT00138671|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110803073|NCT00138671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110803074|NCT01367158|Vaccines|vaccines|mesh-list
110803075|NCT01367158|Immunologic Factors|immunologic factors|mesh-ancestor
110803076|NCT01367158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110803077|NCT00130637|Daclizumab|daclizumab|mesh-list
110803078|NCT00130637|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110803079|NCT00130637|Immunologic Factors|immunologic factors|mesh-ancestor
110803080|NCT00130637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110803081|NCT01077479|Metformin|metformin|mesh-list
110803082|NCT01077479|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110803083|NCT01077479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110803084|NCT02136784|Morphine|morphine|mesh-list
110803085|NCT02136784|Oxycodone|oxycodone|mesh-list
110803086|NCT02136784|Buprenorphine|buprenorphine|mesh-list
110803087|NCT02136784|Hydromorphone|hydromorphone|mesh-list
110803088|NCT02136784|Hydrocodone|hydrocodone|mesh-list
110803089|NCT02136784|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110803090|NCT02136784|Narcotics|narcotics|mesh-ancestor
110803091|NCT02136784|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110803092|NCT02136784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110803093|NCT02136784|Analgesics|analgesics|mesh-ancestor
110803094|NCT02136784|Sensory System Agents|sensory system agents|mesh-ancestor
110803095|NCT02136784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110803096|NCT02136784|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110803097|NCT02136784|Antitussive Agents|antitussive agents|mesh-ancestor
110803098|NCT02136784|Respiratory System Agents|respiratory system agents|mesh-ancestor
110803099|NCT02129764|Prednisone|prednisone|mesh-list
110803100|NCT02129764|Allopurinol|allopurinol|mesh-list
110803101|NCT02129764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110803102|NCT02129764|Glucocorticoids|glucocorticoids|mesh-ancestor
110803103|NCT02129764|Hormones|hormones|mesh-ancestor
110803104|NCT02129764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110803105|NCT02129764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110803106|NCT02129764|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110803107|NCT02129764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110803108|NCT02129764|Antimetabolites|antimetabolites|mesh-ancestor
110803109|NCT02129764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110803110|NCT02129764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110803111|NCT02129764|Gout Suppressants|gout suppressants|mesh-ancestor
110520683|NCT00026286|Estrogens|estrogens|mesh-list
110803112|NCT02129764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110803113|NCT02129764|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110803114|NCT02129764|Antioxidants|antioxidants|mesh-ancestor
110803115|NCT02129764|Protective Agents|protective agents|mesh-ancestor
110803117|NCT00130247|Isoniazid|isoniazid|mesh-list
110803118|NCT00130247|Pyrazinamide|pyrazinamide|mesh-list
110803119|NCT00130247|Ethambutol|ethambutol|mesh-list
110803120|NCT00130247|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110803121|NCT00130247|Antitubercular Agents|antitubercular agents|mesh-ancestor
110803122|NCT00130247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110803123|NCT00130247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110803124|NCT00130247|Leprostatic Agents|leprostatic agents|mesh-ancestor
110803125|NCT00130247|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110803126|NCT00130247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110803127|NCT00130247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110803128|NCT00130247|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110803129|NCT00130247|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110803130|NCT00130247|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110803131|NCT00130247|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110803132|NCT00130247|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110803133|NCT00130247|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110803134|NCT00130247|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
110803135|NCT00130247|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110803136|NCT00130247|Antimetabolites|antimetabolites|mesh-ancestor
110803137|NCT00130247|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110803138|NCT02252926|Acetaminophen|acetaminophen|mesh-list
110803139|NCT02252926|Lidocaine|lidocaine|mesh-list
110803140|NCT02252926|Morphine|morphine|mesh-list
110803141|NCT02252926|Gabapentin|gabapentin|mesh-list
110803142|NCT02252926|Bupivacaine|bupivacaine|mesh-list
110803143|NCT02252926|Anesthetics, Local|anesthetics, local|mesh-ancestor
110803144|NCT02252926|Anesthetics|anesthetics|mesh-ancestor
110803145|NCT02252926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110803146|NCT02252926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110803147|NCT02252926|Sensory System Agents|sensory system agents|mesh-ancestor
110803148|NCT02252926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110803149|NCT02252926|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110803150|NCT02252926|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110803151|NCT02252926|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110803152|NCT02252926|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110803153|NCT02252926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110803154|NCT02252926|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110803155|NCT02252926|Narcotics|narcotics|mesh-ancestor
110803156|NCT02252926|Analgesics|analgesics|mesh-ancestor
110803157|NCT02252926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110803158|NCT02252926|Antipyretics|antipyretics|mesh-ancestor
110803159|NCT02252926|Anticonvulsants|anticonvulsants|mesh-ancestor
110803160|NCT02252926|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110803161|NCT02252926|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110803162|NCT02252926|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110803163|NCT02252926|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110803164|NCT02252926|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110803165|NCT02252926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110803166|NCT02252926|Antimanic Agents|antimanic agents|mesh-ancestor
110803167|NCT02253004|Cilostazol|cilostazol|mesh-list
110803168|NCT02253004|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110803169|NCT02253004|Autonomic Agents|autonomic agents|mesh-ancestor
110803170|NCT02253004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110803171|NCT02253004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110803172|NCT02253004|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110803173|NCT02253004|Respiratory System Agents|respiratory system agents|mesh-ancestor
110803174|NCT02253004|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110803175|NCT02253004|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110852418|NCT03203850|Deferasirox|deferasirox|mesh-list
110803176|NCT02253004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110803177|NCT02253004|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110803178|NCT02253004|Vasodilator Agents|vasodilator agents|mesh-ancestor
110803179|NCT02253004|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110803180|NCT02253004|Protective Agents|protective agents|mesh-ancestor
110803181|NCT02253004|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110803182|NCT02253004|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110803183|NCT02253004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110803184|NCT02252458|Fentanyl|fentanyl|mesh-list
110803185|NCT02252458|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110803186|NCT02252458|Narcotics|narcotics|mesh-ancestor
110803187|NCT02252458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110803188|NCT02252458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110803189|NCT02252458|Analgesics|analgesics|mesh-ancestor
110803190|NCT02252458|Sensory System Agents|sensory system agents|mesh-ancestor
110803191|NCT02252458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110803192|NCT02252458|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110803193|NCT02252458|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110803194|NCT02252458|Anesthetics, General|anesthetics, general|mesh-ancestor
110803195|NCT02252458|Anesthetics|anesthetics|mesh-ancestor
110803196|NCT04032171|Interferon beta-1a|interferon beta-1a|mesh-list
110803197|NCT04032171|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110803198|NCT04032171|Immunologic Factors|immunologic factors|mesh-ancestor
110803199|NCT04032171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110803200|NCT04032171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110803201|NCT04032171|Antiviral Agents|antiviral agents|mesh-ancestor
110803202|NCT04032171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110803203|NCT02130154|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110803204|NCT02130154|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110803205|NCT02130154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110803206|NCT02132260|Naftifine|naftifine|mesh-list
110803207|NCT02132260|Antifungal Agents|antifungal agents|mesh-ancestor
110803208|NCT02132260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110803209|NCT02137564|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-list
110803210|NCT02137564|Nirogacestat|nirogacestat|mesh-list
110803211|NCT02137564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110803212|NCT02137564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110803213|NCT02132416|Acetaminophen|acetaminophen|mesh-list
110803214|NCT02132416|Ibuprofen|ibuprofen|mesh-list
110803215|NCT02132416|Diclofenac|diclofenac|mesh-list
110803216|NCT02132416|Morphine|morphine|mesh-list
110803217|NCT02132416|Oxycodone|oxycodone|mesh-list
110803218|NCT02132416|Tramadol|tramadol|mesh-list
110803219|NCT02132416|Anesthetics|anesthetics|mesh-list
110803220|NCT02132416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110803221|NCT02132416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110803222|NCT02132416|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110803223|NCT02132416|Narcotics|narcotics|mesh-ancestor
110803224|NCT02132416|Analgesics|analgesics|mesh-ancestor
110803225|NCT02132416|Sensory System Agents|sensory system agents|mesh-ancestor
110803226|NCT02132416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110803227|NCT02132416|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110803228|NCT02132416|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110803229|NCT02132416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110803230|NCT02132416|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110803231|NCT02132416|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110803232|NCT02132416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110803233|NCT02132416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110803234|NCT02132416|Antipyretics|antipyretics|mesh-ancestor
110803235|NCT00137423|Sunitinib|sunitinib|mesh-list
110803236|NCT00137423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110803237|NCT00137423|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110803238|NCT00137423|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110803239|NCT00137423|Growth Substances|growth substances|mesh-ancestor
110803240|NCT00137423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110803241|NCT00137423|Growth Inhibitors|growth inhibitors|mesh-ancestor
110803242|NCT00137423|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110803243|NCT00137423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110803244|NCT00137423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110803245|NCT01077557|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
110803246|NCT01077557|Antiviral Agents|antiviral agents|mesh-ancestor
110803247|NCT01077557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110803248|NCT02130700|Seviteronel|seviteronel|mesh-list
110803249|NCT02130700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110803250|NCT02130700|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110803251|NCT02130700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110803252|NCT02130700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110803253|NCT02137954|Lidocaine|lidocaine|mesh-list
110803254|NCT02137954|Anesthetics, Local|anesthetics, local|mesh-ancestor
110803255|NCT02137954|Anesthetics|anesthetics|mesh-ancestor
110803256|NCT02137954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110803257|NCT02137954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110803258|NCT02137954|Sensory System Agents|sensory system agents|mesh-ancestor
110803259|NCT02137954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110803260|NCT02137954|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110803261|NCT02137954|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110803262|NCT02137954|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110803263|NCT02137954|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110803264|NCT02137954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110803265|NCT02131012|Celecoxib|celecoxib|mesh-list
110803266|NCT02131012|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110803267|NCT02131012|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110803268|NCT02131012|Analgesics|analgesics|mesh-ancestor
110803269|NCT02131012|Sensory System Agents|sensory system agents|mesh-ancestor
110803270|NCT02131012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110803271|NCT02131012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110803272|NCT02131012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110803273|NCT02131012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110803274|NCT02131012|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110803275|NCT02131012|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110803276|NCT02131012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110803277|NCT02131012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110803278|NCT02138500|PF-06372865|pf-06372865|mesh-list
110803279|NCT02138500|GABA Modulators|gaba modulators|mesh-ancestor
110803280|NCT02138500|GABA Agents|gaba agents|mesh-ancestor
110803281|NCT02138500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110803282|NCT02138500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110803283|NCT02138500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110803284|NCT01561768|Vaccines|vaccines|mesh-list
110803285|NCT01561768|Immunologic Factors|immunologic factors|mesh-ancestor
110803286|NCT01561768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110803287|NCT00137111|Cytarabine|cytarabine|mesh-list
110803288|NCT00137111|Dexamethasone|dexamethasone|mesh-list
110803289|NCT00137111|Prednisone|prednisone|mesh-list
110803290|NCT00137111|Cyclophosphamide|cyclophosphamide|mesh-list
110803291|NCT00137111|Doxorubicin|doxorubicin|mesh-list
110803292|NCT00137111|Methotrexate|methotrexate|mesh-list
110803293|NCT00137111|Etoposide|etoposide|mesh-list
110803294|NCT00137111|Vincristine|vincristine|mesh-list
110803295|NCT00137111|Daunorubicin|daunorubicin|mesh-list
110803296|NCT00137111|Asparaginase|asparaginase|mesh-list
110803297|NCT00137111|Mercaptopurine|mercaptopurine|mesh-list
110803298|NCT00137111|Pegaspargase|pegaspargase|mesh-list
110803299|NCT00137111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110803300|NCT00137111|Immunologic Factors|immunologic factors|mesh-ancestor
110803301|NCT00137111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110803302|NCT00137111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110803303|NCT00137111|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110803304|NCT00137111|Alkylating Agents|alkylating agents|mesh-ancestor
110803305|NCT00137111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110803306|NCT00137111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110803307|NCT00137111|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110803308|NCT00137111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110803309|NCT00137111|Antiemetics|antiemetics|mesh-ancestor
110803310|NCT00137111|Autonomic Agents|autonomic agents|mesh-ancestor
110803311|NCT00137111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110803312|NCT00137111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110803313|NCT00137111|Glucocorticoids|glucocorticoids|mesh-ancestor
110803315|NCT00137111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110803316|NCT00137111|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110803317|NCT00137111|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110803318|NCT00137111|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110803319|NCT00137111|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110803320|NCT00137111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110803321|NCT00137111|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110803322|NCT00137111|Abortifacient Agents|abortifacient agents|mesh-ancestor
110803323|NCT00137111|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110803324|NCT00137111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110803325|NCT00137111|Antimetabolites|antimetabolites|mesh-ancestor
110803326|NCT00137111|Dermatologic Agents|dermatologic agents|mesh-ancestor
110803327|NCT00137111|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110803328|NCT00137111|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110803329|NCT00137111|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110803330|NCT00137111|Antiviral Agents|antiviral agents|mesh-ancestor
110803331|NCT00137111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110803332|NCT00137111|Tubulin Modulators|tubulin modulators|mesh-ancestor
110803333|NCT00137111|Antimitotic Agents|antimitotic agents|mesh-ancestor
110803334|NCT00137111|Mitosis Modulators|mitosis modulators|mesh-ancestor
110803335|NCT02133118|Pioglitazone|pioglitazone|mesh-list
110803336|NCT02133118|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110803337|NCT02133118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110803338|NCT02138812|Paclitaxel|paclitaxel|mesh-list
110803339|NCT02138812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110520920|NCT05122481|Vitamins|vitamins|mesh-ancestor
110803340|NCT02138812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110803341|NCT02138812|Tubulin Modulators|tubulin modulators|mesh-ancestor
110803342|NCT02138812|Antimitotic Agents|antimitotic agents|mesh-ancestor
110803343|NCT02138812|Mitosis Modulators|mitosis modulators|mesh-ancestor
110803344|NCT02138812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110803345|NCT00136955|Irinotecan|irinotecan|mesh-list
110803346|NCT00136955|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110543056|NCT02660840|Flupenthixol|flupenthixol|mesh-list
110803347|NCT00136955|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110803348|NCT00136955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110803349|NCT00136955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110803350|NCT00136955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110803351|NCT00135707|Vitamins|vitamins|mesh-list
110803352|NCT00135707|Ascorbic Acid|ascorbic acid|mesh-list
110803353|NCT00135707|Vitamin E|vitamin e|mesh-list
110803354|NCT00135707|alpha-Tocopherol|alpha-tocopherol|mesh-list
110803355|NCT00135707|Micronutrients|micronutrients|mesh-ancestor
110803356|NCT00135707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110803357|NCT00135707|Antioxidants|antioxidants|mesh-ancestor
110803358|NCT00135707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110803359|NCT00135707|Protective Agents|protective agents|mesh-ancestor
110803360|NCT03548818|Interferons|interferons|mesh-list
110803361|NCT03548818|Interferon-gamma|interferon-gamma|mesh-list
110803362|NCT03548818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110803363|NCT03548818|Antiviral Agents|antiviral agents|mesh-ancestor
110803364|NCT03548818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110803365|NCT02252692|Enalapril|enalapril|mesh-list
110803366|NCT02252692|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110803367|NCT02252692|Protease Inhibitors|protease inhibitors|mesh-ancestor
110803368|NCT02252692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110803369|NCT02252692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110543190|NCT02660762|Cytarabine|cytarabine|mesh-list
110803370|NCT02252692|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110803371|NCT03548662|Hyaluronic Acid|hyaluronic acid|mesh-list
110803372|NCT03548662|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110803373|NCT03548662|Immunologic Factors|immunologic factors|mesh-ancestor
110803374|NCT03548662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110803375|NCT03548662|Viscosupplements|viscosupplements|mesh-ancestor
110803376|NCT03548662|Protective Agents|protective agents|mesh-ancestor
110803377|NCT03966209|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
110803378|NCT03966209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110803379|NCT03966209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110803380|NCT03966209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110803381|NCT02252770|Nitric Oxide|nitric oxide|mesh-list
110803382|NCT02252770|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110803383|NCT02252770|Autonomic Agents|autonomic agents|mesh-ancestor
110543249|NCT02660684|Antimetabolites|antimetabolites|mesh-ancestor
110803384|NCT02252770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110803385|NCT02252770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110803386|NCT02252770|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110803387|NCT02252770|Respiratory System Agents|respiratory system agents|mesh-ancestor
110803388|NCT02252770|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110803389|NCT02252770|Antioxidants|antioxidants|mesh-ancestor
110128528|NCT04262024|Dopamine Agonists|dopamine agonists|mesh-ancestor
110803390|NCT02252770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110803391|NCT02252770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110803392|NCT02252770|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
110803393|NCT02252770|Vasodilator Agents|vasodilator agents|mesh-ancestor
110803394|NCT02252770|Gasotransmitters|gasotransmitters|mesh-ancestor
110803395|NCT02252770|Protective Agents|protective agents|mesh-ancestor
110803396|NCT05578456|Aspirin|aspirin|mesh-list
110803397|NCT05578456|Prednisone|prednisone|mesh-list
110803398|NCT05578456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110803399|NCT05578456|Glucocorticoids|glucocorticoids|mesh-ancestor
110803400|NCT05578456|Hormones|hormones|mesh-ancestor
110803401|NCT05578456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110803402|NCT05578456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110803403|NCT05578456|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110803404|NCT05578456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110803405|NCT05578456|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110803406|NCT05578456|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110803407|NCT05578456|Analgesics|analgesics|mesh-ancestor
110803408|NCT05578456|Sensory System Agents|sensory system agents|mesh-ancestor
110803409|NCT05578456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110803410|NCT05578456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110803411|NCT05578456|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110803412|NCT05578456|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110803413|NCT05578456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110803414|NCT05578456|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110803415|NCT05578456|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110803416|NCT05578456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110803417|NCT05578456|Antipyretics|antipyretics|mesh-ancestor
110803418|NCT02133820|Analgesics|analgesics|mesh-list
110803419|NCT02133820|Sensory System Agents|sensory system agents|mesh-ancestor
110803420|NCT02133820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110803421|NCT02133820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110803422|NCT05578378|Cytarabine|cytarabine|mesh-list
110803423|NCT05578378|Methotrexate|methotrexate|mesh-list
110803424|NCT05578378|Fludarabine|fludarabine|mesh-list
110803425|NCT05578378|Cladribine|cladribine|mesh-list
110803426|NCT05578378|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110803427|NCT05578378|Abortifacient Agents|abortifacient agents|mesh-ancestor
110803428|NCT05578378|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110803429|NCT05578378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110803430|NCT05578378|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110803431|NCT05578378|Antimetabolites|antimetabolites|mesh-ancestor
110803432|NCT05578378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110803433|NCT05578378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110803434|NCT05578378|Dermatologic Agents|dermatologic agents|mesh-ancestor
110803435|NCT05578378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110803436|NCT05578378|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110803437|NCT05578378|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110803438|NCT05578378|Immunologic Factors|immunologic factors|mesh-ancestor
110803439|NCT05578378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110803440|NCT05578378|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110803441|NCT05578378|Antiviral Agents|antiviral agents|mesh-ancestor
110803442|NCT05578378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110803443|NCT00129623|Ibandronic Acid|ibandronic acid|mesh-list
110803444|NCT00129623|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110803445|NCT00129623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110803446|NCT02139904|Vinorelbine|vinorelbine|mesh-list
110803447|NCT02139904|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110803448|NCT02139904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110803449|NCT02139904|Tubulin Modulators|tubulin modulators|mesh-ancestor
110803450|NCT02139904|Antimitotic Agents|antimitotic agents|mesh-ancestor
110803451|NCT02139904|Mitosis Modulators|mitosis modulators|mesh-ancestor
110803452|NCT02139904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110803453|NCT05578222|Pembrolizumab|pembrolizumab|mesh-list
110803454|NCT05578222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110803455|NCT05578222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110803456|NCT05578222|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110803457|NCT05578222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110803458|NCT05201638|Calcium, Dietary|calcium, dietary|mesh-list
110803459|NCT05201638|Calcium|calcium|mesh-list
110803460|NCT05201638|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110803461|NCT05201638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110803462|NCT05201638|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110803464|NCT00129545|Anticoagulants|anticoagulants|mesh-ancestor
110803465|NCT02134288|Everolimus|everolimus|mesh-list
110803466|NCT02134288|Abatacept|abatacept|mesh-list
110803467|NCT02134288|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110803468|NCT02134288|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110543485|NCT04654351|Icatibant|icatibant|mesh-list
110803469|NCT02134288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110803470|NCT02134288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110803471|NCT02134288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110803472|NCT02134288|Immunologic Factors|immunologic factors|mesh-ancestor
110803473|NCT02134288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110803474|NCT02134288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110803475|NCT02134288|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110803476|NCT02134288|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110803477|NCT02134288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110803478|NCT00129467|Methylphenidate|methylphenidate|mesh-list
110803479|NCT00129467|Serotonin|serotonin|mesh-list
110803480|NCT00129467|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
110803481|NCT00129467|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110803482|NCT00129467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110803483|NCT00129467|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110803484|NCT00129467|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110803485|NCT00129467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110803486|NCT00129467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110803487|NCT00129467|Dopamine Agents|dopamine agents|mesh-ancestor
110803488|NCT00129467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110803489|NCT00129467|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110803490|NCT00129467|Serotonin Agents|serotonin agents|mesh-ancestor
110803491|NCT00129311|Selegiline|selegiline|mesh-list
110543528|NCT01563601|Etoposide|etoposide|mesh-list
110803492|NCT00129311|Antidepressive Agents|antidepressive agents|mesh-ancestor
110803493|NCT00129311|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110803494|NCT00129311|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110803495|NCT00129311|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110803496|NCT00129311|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
110803497|NCT00129311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110803498|NCT00129311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110803499|NCT00129311|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110803500|NCT00129311|Protective Agents|protective agents|mesh-ancestor
110803501|NCT00129311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110803502|NCT01076621|Norethindrone|norethindrone|mesh-list
110803503|NCT01076621|Norethindrone Acetate|norethindrone acetate|mesh-list
110803504|NCT01076621|Estradiol|estradiol|mesh-list
110803505|NCT01076621|Estrogens|estrogens|mesh-ancestor
110803506|NCT01076621|Hormones|hormones|mesh-ancestor
110803507|NCT01076621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110803508|NCT01076621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110803509|NCT01076621|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110803510|NCT01076621|Contraceptive Agents|contraceptive agents|mesh-ancestor
110803511|NCT01076621|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110803512|NCT01076621|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110803513|NCT01076621|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110803514|NCT01076621|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110803515|NCT01076621|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110803516|NCT03965819|Acetaminophen|acetaminophen|mesh-list
110803517|NCT03965819|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110803518|NCT03965819|Analgesics|analgesics|mesh-ancestor
110803519|NCT03965819|Sensory System Agents|sensory system agents|mesh-ancestor
110803520|NCT03965819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110803521|NCT03965819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110803522|NCT03965819|Antipyretics|antipyretics|mesh-ancestor
110803523|NCT02134366|Lorazepam|lorazepam|mesh-list
110803524|NCT02134366|Clonazepam|clonazepam|mesh-list
110803525|NCT02134366|Clobazam|clobazam|mesh-list
110803526|NCT02134366|Anticonvulsants|anticonvulsants|mesh-ancestor
110803527|NCT02134366|Antiemetics|antiemetics|mesh-ancestor
110803528|NCT02134366|Autonomic Agents|autonomic agents|mesh-ancestor
110803529|NCT02134366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110803530|NCT02134366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110803531|NCT02134366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110803532|NCT02134366|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110543695|NCT00582166|Rituximab|rituximab|mesh-list
110803533|NCT02134366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110803534|NCT02134366|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110803535|NCT02134366|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110803536|NCT02134366|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110803537|NCT02134366|GABA Modulators|gaba modulators|mesh-ancestor
110803538|NCT02134366|GABA Agents|gaba agents|mesh-ancestor
110803539|NCT02134366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110803540|NCT02134366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110803541|NCT02134366|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
110803542|NCT02134366|GABA Agonists|gaba agonists|mesh-ancestor
110803543|NCT01077947|Anesthetics|anesthetics|mesh-list
110803544|NCT01077947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110803545|NCT01077947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110803547|NCT00133991|Cytarabine|cytarabine|mesh-list
110803548|NCT00133991|Prednisone|prednisone|mesh-list
110803549|NCT00133991|Hydrocortisone|hydrocortisone|mesh-list
110803550|NCT00133991|Cyclophosphamide|cyclophosphamide|mesh-list
110803551|NCT00133991|Rituximab|rituximab|mesh-list
110803552|NCT00133991|Methotrexate|methotrexate|mesh-list
110803553|NCT00133991|Vincristine|vincristine|mesh-list
110803554|NCT00133991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110803555|NCT00133991|Immunologic Factors|immunologic factors|mesh-ancestor
110803556|NCT00133991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110803557|NCT00133991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110803558|NCT00133991|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110803559|NCT00133991|Alkylating Agents|alkylating agents|mesh-ancestor
110803560|NCT00133991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110803561|NCT00133991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110803562|NCT00133991|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110803563|NCT00133991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110803564|NCT00133991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110803565|NCT00133991|Glucocorticoids|glucocorticoids|mesh-ancestor
110803566|NCT00133991|Hormones|hormones|mesh-ancestor
110803567|NCT00133991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110852481|NCT02329080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110803568|NCT00133991|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110803569|NCT00133991|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110803570|NCT00133991|Abortifacient Agents|abortifacient agents|mesh-ancestor
110803571|NCT00133991|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110803572|NCT00133991|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110803573|NCT00133991|Antimetabolites|antimetabolites|mesh-ancestor
110803574|NCT00133991|Dermatologic Agents|dermatologic agents|mesh-ancestor
110803575|NCT00133991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110803576|NCT00133991|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110803577|NCT00133991|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110803578|NCT00133991|Antiviral Agents|antiviral agents|mesh-ancestor
110803579|NCT00133991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110803580|NCT00133991|Antidotes|antidotes|mesh-ancestor
110803581|NCT00133991|Protective Agents|protective agents|mesh-ancestor
110803582|NCT00133991|Vitamin B Complex|vitamin b complex|mesh-ancestor
110803583|NCT00133991|Vitamins|vitamins|mesh-ancestor
110803584|NCT00133991|Micronutrients|micronutrients|mesh-ancestor
110803585|NCT00133991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110803586|NCT00133991|Tubulin Modulators|tubulin modulators|mesh-ancestor
110803587|NCT00133991|Antimitotic Agents|antimitotic agents|mesh-ancestor
110803588|NCT00133991|Mitosis Modulators|mitosis modulators|mesh-ancestor
110803589|NCT03549208|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110803590|NCT03549208|Immunologic Factors|immunologic factors|mesh-ancestor
110543932|NCT03920215|Cholinergic Agents|cholinergic agents|mesh-ancestor
110803591|NCT03549208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110803592|NCT02140450|Timolol|timolol|mesh-list
110803593|NCT02140450|Brimonidine Tartrate|brimonidine tartrate|mesh-list
110803594|NCT02140450|Mannitol|mannitol|mesh-list
110803595|NCT02140450|Acetazolamide|acetazolamide|mesh-list
110803596|NCT02140450|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110803597|NCT02140450|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110803598|NCT02140450|Adrenergic Agents|adrenergic agents|mesh-ancestor
110803599|NCT02140450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110803600|NCT02140450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110803601|NCT02140450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110803602|NCT02140450|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110803603|NCT02140450|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110803604|NCT02140450|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110803605|NCT02140450|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110803606|NCT02140450|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110803607|NCT02140450|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110803608|NCT02140450|Diuretics|diuretics|mesh-ancestor
110803609|NCT02140450|Natriuretic Agents|natriuretic agents|mesh-ancestor
110803610|NCT02140450|Anticonvulsants|anticonvulsants|mesh-ancestor
110803611|NCT02140450|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110803612|NCT02140450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110803613|NCT05577676|Triamcinolone|triamcinolone|mesh-list
110803614|NCT05577676|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110803615|NCT05577676|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110803616|NCT05577676|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110803617|NCT05577676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110803618|NCT05577676|Glucocorticoids|glucocorticoids|mesh-ancestor
110803619|NCT05577676|Hormones|hormones|mesh-ancestor
110803620|NCT05577676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110803621|NCT05577676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110803622|NCT05577676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110803623|NCT05577676|Immunologic Factors|immunologic factors|mesh-ancestor
110803624|NCT05577676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110803625|NCT05577676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110803626|NCT03549832|Ritonavir|ritonavir|mesh-list
110803627|NCT03549832|Ribavirin|ribavirin|mesh-list
110803628|NCT03549832|Sofosbuvir|sofosbuvir|mesh-list
110803629|NCT03549832|Simeprevir|simeprevir|mesh-list
110803630|NCT03549832|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110803631|NCT03549832|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110803632|NCT03549832|Protease Inhibitors|protease inhibitors|mesh-ancestor
110803633|NCT03549832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110544137|NCT02774837|Tenofovir|tenofovir|mesh-list
110803634|NCT03549832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110803635|NCT03549832|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110803636|NCT03549832|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110803637|NCT03549832|Antiviral Agents|antiviral agents|mesh-ancestor
110803638|NCT03549832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110803639|NCT03549832|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110803640|NCT03549832|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110803642|NCT02134990|Docetaxel|docetaxel|mesh-list
110803643|NCT02134990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110803644|NCT02134990|Tubulin Modulators|tubulin modulators|mesh-ancestor
110803645|NCT02134990|Antimitotic Agents|antimitotic agents|mesh-ancestor
110803646|NCT02134990|Mitosis Modulators|mitosis modulators|mesh-ancestor
110803647|NCT02134990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110803648|NCT02135224|Fentanyl|fentanyl|mesh-list
110803649|NCT02135224|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110803650|NCT02135224|Narcotics|narcotics|mesh-ancestor
110803651|NCT02135224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110803652|NCT02135224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110803653|NCT02135224|Analgesics|analgesics|mesh-ancestor
110803654|NCT02135224|Sensory System Agents|sensory system agents|mesh-ancestor
110803655|NCT02135224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110803656|NCT02135224|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110803657|NCT02135224|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110803658|NCT02135224|Anesthetics, General|anesthetics, general|mesh-ancestor
110803659|NCT02135224|Anesthetics|anesthetics|mesh-ancestor
110803660|NCT02785900|Azacitidine|azacitidine|mesh-list
110803661|NCT02785900|Decitabine|decitabine|mesh-list
110803662|NCT02785900|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110803663|NCT02785900|Antimetabolites|antimetabolites|mesh-ancestor
110803664|NCT02785900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110803665|NCT02785900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110803666|NCT02785900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110803667|NCT00127205|Zoledronic Acid|zoledronic acid|mesh-list
110803668|NCT00127205|Ibandronic Acid|ibandronic acid|mesh-list
110803669|NCT00127205|Clodronic Acid|clodronic acid|mesh-list
110803670|NCT00127205|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110803671|NCT00127205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110803672|NCT02135770|Heparin|heparin|mesh-list
110803673|NCT02135770|Calcium heparin|calcium heparin|mesh-list
110803674|NCT02135770|Anticoagulants|anticoagulants|mesh-ancestor
110803675|NCT02135770|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110803676|NCT02135770|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110863857|NCT04495283|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110803677|NCT02135770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110803678|NCT05478850|Anesthetics|anesthetics|mesh-list
110803679|NCT05478850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110803680|NCT05478850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110803681|NCT01560754|Nicotine|nicotine|mesh-list
110803682|NCT01560754|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110803683|NCT01560754|Autonomic Agents|autonomic agents|mesh-ancestor
110803684|NCT01560754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110803685|NCT01560754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110803686|NCT01560754|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110803687|NCT01560754|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110803688|NCT01560754|Cholinergic Agents|cholinergic agents|mesh-ancestor
110803689|NCT01560754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110803690|NCT01560754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110803691|NCT03547804|Apatinib|apatinib|mesh-list
110803692|NCT03547804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110803693|NCT03547804|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110803694|NCT03547804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110803695|NCT03547804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110803696|NCT02217267|Lidocaine|lidocaine|mesh-list
110803697|NCT02217267|Anesthetics, Local|anesthetics, local|mesh-ancestor
110803698|NCT02217267|Anesthetics|anesthetics|mesh-ancestor
110803699|NCT02217267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110803700|NCT02217267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110803701|NCT02217267|Sensory System Agents|sensory system agents|mesh-ancestor
110803702|NCT02217267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110803703|NCT02217267|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110803704|NCT02217267|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110803705|NCT02217267|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110803706|NCT02217267|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110803707|NCT02217267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110803708|NCT03670641|Insulin Glargine|insulin glargine|mesh-list
110803709|NCT03670641|Insulin Lispro|insulin lispro|mesh-list
110803710|NCT03670641|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110803711|NCT03670641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110803712|NCT03546400|Methylphenidate|methylphenidate|mesh-list
110803713|NCT03546400|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110803714|NCT03546400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110803715|NCT03546400|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110803716|NCT03546400|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110803717|NCT03546400|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110803718|NCT03546400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110803719|NCT03546400|Dopamine Agents|dopamine agents|mesh-ancestor
110803720|NCT03546400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110803721|NCT03669861|Abatacept|abatacept|mesh-list
110803722|NCT03669861|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110803723|NCT03669861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110803724|NCT03669861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110803725|NCT03669861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110803726|NCT03669861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110803727|NCT03669861|Immunologic Factors|immunologic factors|mesh-ancestor
110803728|NCT03669861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110803729|NCT03669861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110803730|NCT00127127|Vorinostat|vorinostat|mesh-list
110803731|NCT00127127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110803732|NCT00127127|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110803733|NCT00127127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110803734|NCT00127127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110803735|NCT00126659|Sorafenib|sorafenib|mesh-list
110544463|NCT00650624|Valdecoxib|valdecoxib|mesh-list
110803736|NCT00126659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110803737|NCT00126659|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110803738|NCT00126659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110803739|NCT00126659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110803740|NCT03669081|Ketorolac|ketorolac|mesh-list
110803741|NCT03669081|Pregabalin|pregabalin|mesh-list
110803742|NCT03669081|Analgesics|analgesics|mesh-ancestor
110803743|NCT03669081|Sensory System Agents|sensory system agents|mesh-ancestor
110803744|NCT03669081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110803745|NCT03669081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110803746|NCT03669081|Anticonvulsants|anticonvulsants|mesh-ancestor
110544530|NCT02650544|Serotonin Agents|serotonin agents|mesh-ancestor
110803747|NCT03669081|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110803748|NCT03669081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110803749|NCT03669081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110803750|NCT03669081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110803751|NCT03669081|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110803752|NCT03669081|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110803753|NCT03669081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110803754|NCT03669081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110803755|NCT03669081|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110803756|NCT03669081|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110803757|NCT03669081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110803758|NCT03669081|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110803759|NCT03669081|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110803760|NCT03669081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110803761|NCT02253940|Ritonavir|ritonavir|mesh-list
110803762|NCT02253940|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110803763|NCT02253940|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110803764|NCT02253940|Protease Inhibitors|protease inhibitors|mesh-ancestor
110803765|NCT02253940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110803766|NCT02253940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110803767|NCT02253940|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110803768|NCT02253940|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110803769|NCT02253940|Antiviral Agents|antiviral agents|mesh-ancestor
110803770|NCT02253940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110803771|NCT02253940|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110803772|NCT02253940|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110803773|NCT02253550|Sofosbuvir|sofosbuvir|mesh-list
110803774|NCT02253550|Simeprevir|simeprevir|mesh-list
110803775|NCT02253550|Antiviral Agents|antiviral agents|mesh-ancestor
110803776|NCT02253550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110803777|NCT02253550|Protease Inhibitors|protease inhibitors|mesh-ancestor
110803778|NCT02253550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110803779|NCT02253550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110803781|NCT05203432|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110803782|NCT05203432|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110803783|NCT05203432|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110803784|NCT05203432|Autonomic Agents|autonomic agents|mesh-ancestor
110803785|NCT05203432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110544718|NCT00667758|Fertility Agents|fertility agents|mesh-ancestor
110803786|NCT05203432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110803787|NCT05203432|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110803788|NCT05203432|Respiratory System Agents|respiratory system agents|mesh-ancestor
110803789|NCT05203432|Mydriatics|mydriatics|mesh-ancestor
110803790|NCT05203432|Parasympatholytics|parasympatholytics|mesh-ancestor
110803791|NCT05203432|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110803792|NCT05203432|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110803793|NCT05203432|Cholinergic Agents|cholinergic agents|mesh-ancestor
110521357|NCT00610493|Immunologic Factors|immunologic factors|mesh-ancestor
110803794|NCT05203432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110803795|NCT05203432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110803796|NCT03667053|Glucagon|glucagon|mesh-list
110803797|NCT03667053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110803798|NCT03667053|Hormones|hormones|mesh-ancestor
110544791|NCT02630160|Mydriatics|mydriatics|mesh-ancestor
110803799|NCT03667053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110803800|NCT03667053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110803801|NCT04589728|Venetoclax|venetoclax|mesh-list
110803802|NCT04589728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110803803|NCT05557240|Poly I-C|poly i-c|mesh-list
110803804|NCT05557240|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
110803805|NCT05557240|Vaccines|vaccines|mesh-list
110803806|NCT05557240|Poly ICLC|poly iclc|mesh-list
110803807|NCT05557240|Immunologic Factors|immunologic factors|mesh-ancestor
110803808|NCT05557240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110803809|NCT05557240|Interferon Inducers|interferon inducers|mesh-ancestor
110803810|NCT05557240|Laxatives|laxatives|mesh-ancestor
110803811|NCT05557240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110803812|NCT05557240|Antiviral Agents|antiviral agents|mesh-ancestor
110803813|NCT05557240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110803814|NCT03631407|Pembrolizumab|pembrolizumab|mesh-list
110803815|NCT03631407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110803816|NCT03631407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110803817|NCT03631407|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110803818|NCT03631407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110803819|NCT03547024|Midazolam|midazolam|mesh-list
110803820|NCT03547024|Dextromethorphan|dextromethorphan|mesh-list
110803821|NCT03547024|Omeprazole|omeprazole|mesh-list
110803822|NCT03547024|Levonorgestrel|levonorgestrel|mesh-list
110803823|NCT03547024|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110803824|NCT03547024|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
110803825|NCT03547024|JNJ-55308942|jnj-55308942|mesh-list
110803826|NCT03547024|Estradiol|estradiol|mesh-list
110803827|NCT03547024|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110803828|NCT03547024|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110803829|NCT03547024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110803830|NCT03547024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110803831|NCT03547024|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110803832|NCT03547024|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110803833|NCT03547024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110544899|NCT00541099|Docetaxel|docetaxel|mesh-list
110803834|NCT03547024|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110803835|NCT03547024|Anesthetics, General|anesthetics, general|mesh-ancestor
110803836|NCT03547024|Anesthetics|anesthetics|mesh-ancestor
110803837|NCT03547024|GABA Modulators|gaba modulators|mesh-ancestor
110803838|NCT03547024|GABA Agents|gaba agents|mesh-ancestor
110803839|NCT03547024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110803840|NCT03547024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110803841|NCT03547024|Estrogens|estrogens|mesh-ancestor
110803842|NCT03547024|Hormones|hormones|mesh-ancestor
110803843|NCT03547024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110544957|NCT02577250|Ketamine|ketamine|mesh-list
110803844|NCT03547024|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110803845|NCT03547024|Contraceptive Agents|contraceptive agents|mesh-ancestor
110803846|NCT03547024|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110803847|NCT03547024|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110803848|NCT03547024|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110803849|NCT03547024|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110803850|NCT03547024|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110803851|NCT03547024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110803852|NCT03547024|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110803853|NCT03547024|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110803854|NCT03547024|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110803855|NCT03547024|Antitussive Agents|antitussive agents|mesh-ancestor
110803856|NCT03547024|Respiratory System Agents|respiratory system agents|mesh-ancestor
110803857|NCT03547024|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110803858|NCT03547024|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110803859|NCT03547024|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110803860|NCT03547024|Purinergic P2X Receptor Antagonists|purinergic p2x receptor antagonists|mesh-ancestor
110803861|NCT03547024|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110803862|NCT03547024|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110803863|NCT03547024|Purinergic Agents|purinergic agents|mesh-ancestor
110803864|NCT05115994|Antihypertensive Agents|antihypertensive agents|mesh-list
110803865|NCT04012996|Meloxicam|meloxicam|mesh-list
110803866|NCT04012996|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110803867|NCT04012996|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110803868|NCT04012996|Analgesics|analgesics|mesh-ancestor
110803869|NCT04012996|Sensory System Agents|sensory system agents|mesh-ancestor
110803870|NCT04012996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110803871|NCT04012996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110803872|NCT04012996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110803873|NCT04012996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110803874|NCT04012996|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110803875|NCT04012996|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110803876|NCT04012996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110803877|NCT04012996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110803878|NCT02253784|Dexamethasone|dexamethasone|mesh-list
110803879|NCT02253784|Bupivacaine|bupivacaine|mesh-list
110803880|NCT02253784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110803881|NCT02253784|Antiemetics|antiemetics|mesh-ancestor
110803882|NCT02253784|Autonomic Agents|autonomic agents|mesh-ancestor
110803883|NCT02253784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110803884|NCT02253784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110803885|NCT02253784|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110803886|NCT02253784|Glucocorticoids|glucocorticoids|mesh-ancestor
110803888|NCT02253784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110803889|NCT02253784|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110803890|NCT02253784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110803891|NCT02253784|Anesthetics, Local|anesthetics, local|mesh-ancestor
110803892|NCT02253784|Anesthetics|anesthetics|mesh-ancestor
110803893|NCT02253784|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110803894|NCT02253784|Sensory System Agents|sensory system agents|mesh-ancestor
110803895|NCT03734445|Vitamins|vitamins|mesh-list
110803896|NCT03734445|Micronutrients|micronutrients|mesh-ancestor
110803897|NCT03734445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110803898|NCT04538092|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110803899|NCT04538092|Analgesics|analgesics|mesh-list
110803900|NCT04538092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110803901|NCT04538092|Sensory System Agents|sensory system agents|mesh-ancestor
110803902|NCT04538092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110803903|NCT04538092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110803904|NCT03546088|Anesthetics|anesthetics|mesh-list
110863858|NCT04495283|Analgesics|analgesics|mesh-ancestor
110803905|NCT03546088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110803906|NCT03546088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110803907|NCT03866980|Carboplatin|carboplatin|mesh-list
110803908|NCT03866980|Pemetrexed|pemetrexed|mesh-list
110803909|NCT03866980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110803910|NCT03866980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110803911|NCT03866980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110803912|NCT03866980|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110803913|NCT03866980|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110803914|NCT02253862|Ritonavir|ritonavir|mesh-list
110803915|NCT02253862|Tipranavir|tipranavir|mesh-list
110803916|NCT02253862|Tadalafil|tadalafil|mesh-list
110803917|NCT02253862|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110803918|NCT02253862|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110803919|NCT02253862|Protease Inhibitors|protease inhibitors|mesh-ancestor
110803920|NCT02253862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110803921|NCT02253862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110803922|NCT02253862|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110803923|NCT02253862|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110803924|NCT02253862|Antiviral Agents|antiviral agents|mesh-ancestor
110803925|NCT02253862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110803926|NCT02253862|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110803927|NCT02253862|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110803928|NCT02253862|Vasodilator Agents|vasodilator agents|mesh-ancestor
110803929|NCT02253862|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110803930|NCT02253862|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110803931|NCT02253862|Urological Agents|urological agents|mesh-ancestor
110803932|NCT03627195|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
110803933|NCT03627195|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110803934|NCT03627195|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110803935|NCT03627195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110803936|NCT03627195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110803937|NCT03627195|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110803938|NCT03627195|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
110803939|NCT03627195|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110803940|NCT03627195|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110803941|NCT03627195|Adrenergic Agents|adrenergic agents|mesh-ancestor
110803942|NCT03627195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110803943|NCT03627195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110803944|NCT03627195|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110803945|NCT03627195|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110803946|NCT03627195|Serotonin Agents|serotonin agents|mesh-ancestor
110803947|NCT03627195|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110803948|NCT03627195|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110803949|NCT03627195|Dopamine Agents|dopamine agents|mesh-ancestor
110803950|NCT03776656|Allopurinol|allopurinol|mesh-list
110803951|NCT03776656|Antimetabolites|antimetabolites|mesh-ancestor
110863859|NCT04495283|Sensory System Agents|sensory system agents|mesh-ancestor
110803952|NCT03776656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110803953|NCT03776656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110803954|NCT03776656|Gout Suppressants|gout suppressants|mesh-ancestor
110803955|NCT03776656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110803956|NCT03776656|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110803957|NCT03776656|Antioxidants|antioxidants|mesh-ancestor
110803958|NCT03776656|Protective Agents|protective agents|mesh-ancestor
110803959|NCT03776656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110803960|NCT03733587|Cyclophosphamide|cyclophosphamide|mesh-list
110803961|NCT03733587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110803962|NCT03733587|Immunologic Factors|immunologic factors|mesh-ancestor
110803963|NCT03733587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110803964|NCT03733587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110803965|NCT03733587|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110803966|NCT03733587|Alkylating Agents|alkylating agents|mesh-ancestor
110803967|NCT03733587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110803968|NCT03733587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110803969|NCT03733587|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110803970|NCT00126581|Paclitaxel|paclitaxel|mesh-list
110803971|NCT00126581|Carboplatin|carboplatin|mesh-list
110803972|NCT00126581|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110803973|NCT00126581|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110803974|NCT00126581|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110803975|NCT00126581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110803976|NCT00126581|Tubulin Modulators|tubulin modulators|mesh-ancestor
110803977|NCT00126581|Antimitotic Agents|antimitotic agents|mesh-ancestor
110803978|NCT00126581|Mitosis Modulators|mitosis modulators|mesh-ancestor
110863860|NCT04495283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110803979|NCT00126581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110803980|NCT00126581|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110803981|NCT00126581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110803982|NCT03704584|Methylprednisolone|methylprednisolone|mesh-list
110803983|NCT03704584|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110803984|NCT03704584|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110803985|NCT03704584|Prednisolone|prednisolone|mesh-list
110803986|NCT03704584|Prednisolone acetate|prednisolone acetate|mesh-list
110803988|NCT03704584|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110803989|NCT03704584|Prednisolone phosphate|prednisolone phosphate|mesh-list
110803990|NCT03704584|Anesthetics, Local|anesthetics, local|mesh-ancestor
110803991|NCT03704584|Anesthetics|anesthetics|mesh-ancestor
110803992|NCT03704584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110803993|NCT03704584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110803994|NCT03704584|Sensory System Agents|sensory system agents|mesh-ancestor
110803995|NCT03704584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110803996|NCT03704584|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110803997|NCT03704584|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110803998|NCT03704584|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110803999|NCT03704584|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110804000|NCT03704584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110804001|NCT03704584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110804002|NCT03704584|Antiemetics|antiemetics|mesh-ancestor
110804003|NCT03704584|Autonomic Agents|autonomic agents|mesh-ancestor
110804004|NCT03704584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110804005|NCT03704584|Glucocorticoids|glucocorticoids|mesh-ancestor
110804007|NCT03704584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110804008|NCT03704584|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110804009|NCT03704584|Protective Agents|protective agents|mesh-ancestor
110804010|NCT03704584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110804011|NCT03704584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110804012|NCT03737721|Avelumab|avelumab|mesh-list
110804013|NCT03737721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110804014|NCT03737721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110804015|NCT03647709|Analgesics, Opioid|analgesics, opioid|mesh-list
110804016|NCT03647709|Narcotics|narcotics|mesh-ancestor
110804017|NCT03647709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110804018|NCT03647709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110804019|NCT03647709|Analgesics|analgesics|mesh-ancestor
110804020|NCT03647709|Sensory System Agents|sensory system agents|mesh-ancestor
110804021|NCT03647709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110804022|NCT03546634|Vaccines|vaccines|mesh-list
110804023|NCT03546634|Immunologic Factors|immunologic factors|mesh-ancestor
110804024|NCT03546634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110804025|NCT03661983|Aripiprazole|aripiprazole|mesh-list
110804026|NCT03661983|Antidepressive Agents|antidepressive agents|mesh-ancestor
110804027|NCT03661983|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110804028|NCT03661983|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110804029|NCT03661983|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110804030|NCT03661983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110804031|NCT03661983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110804032|NCT03661983|Dopamine Agonists|dopamine agonists|mesh-ancestor
110804033|NCT03661983|Dopamine Agents|dopamine agents|mesh-ancestor
110804034|NCT03661983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110804035|NCT03661983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110804036|NCT03661983|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110804037|NCT03661983|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110804038|NCT03661983|Serotonin Agents|serotonin agents|mesh-ancestor
110804039|NCT03661983|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110804040|NCT03661983|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110804041|NCT03661983|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110804042|NCT03661983|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110804043|NCT02783170|Vaccines|vaccines|mesh-list
110804044|NCT02783170|Immunologic Factors|immunologic factors|mesh-ancestor
110804045|NCT02783170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110804046|NCT02254018|Maytansine|maytansine|mesh-list
110804047|NCT02254018|Bivatuzumab mertansine|bivatuzumab mertansine|mesh-list
110804048|NCT02254018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110804049|NCT02254018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110804050|NCT02254018|Tubulin Modulators|tubulin modulators|mesh-ancestor
110804051|NCT02254018|Antimitotic Agents|antimitotic agents|mesh-ancestor
110804052|NCT02254018|Mitosis Modulators|mitosis modulators|mesh-ancestor
110852518|NCT00071071|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110804053|NCT02254018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110804054|NCT02254018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110804055|NCT02254018|Immunotoxins|immunotoxins|mesh-ancestor
110804056|NCT02254018|Immunoconjugates|immunoconjugates|mesh-ancestor
110804057|NCT02254018|Immunologic Factors|immunologic factors|mesh-ancestor
110545733|NCT02653742|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110804058|NCT02254018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110804059|NCT03396952|Aspirin|aspirin|mesh-list
110804060|NCT03396952|Pembrolizumab|pembrolizumab|mesh-list
110804061|NCT03396952|Ipilimumab|ipilimumab|mesh-list
110804063|NCT03396952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110804064|NCT03396952|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110804065|NCT03396952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110804066|NCT03396952|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110804067|NCT03396952|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110804068|NCT03396952|Analgesics|analgesics|mesh-ancestor
110804069|NCT03396952|Sensory System Agents|sensory system agents|mesh-ancestor
110804070|NCT03396952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110804071|NCT03396952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110804072|NCT03396952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110804073|NCT03396952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110804074|NCT03396952|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110804075|NCT03396952|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110804076|NCT03396952|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110804077|NCT03396952|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110804078|NCT03396952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110804079|NCT03396952|Antipyretics|antipyretics|mesh-ancestor
110804080|NCT03378934|Aspirin|aspirin|mesh-list
110804081|NCT03378934|Clopidogrel|clopidogrel|mesh-list
110804082|NCT03378934|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110804083|NCT03378934|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110804084|NCT03378934|Analgesics|analgesics|mesh-ancestor
110804085|NCT03378934|Sensory System Agents|sensory system agents|mesh-ancestor
110804086|NCT03378934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110804087|NCT03378934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110804088|NCT03378934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110804089|NCT03378934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110804090|NCT03378934|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110804091|NCT03378934|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110804092|NCT03378934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110804093|NCT03378934|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110804094|NCT03378934|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110804095|NCT03378934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110804096|NCT03378934|Antipyretics|antipyretics|mesh-ancestor
110804097|NCT03378934|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110804098|NCT03378934|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110804099|NCT03378934|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110804100|NCT03378934|Purinergic Agents|purinergic agents|mesh-ancestor
110804101|NCT03378934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110804102|NCT00126503|Bevacizumab|bevacizumab|mesh-list
110804103|NCT00126503|Sorafenib|sorafenib|mesh-list
110804104|NCT00126503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110804105|NCT00126503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110804106|NCT00126503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110804107|NCT00126503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110804108|NCT00126503|Growth Substances|growth substances|mesh-ancestor
110804109|NCT00126503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110804110|NCT00126503|Growth Inhibitors|growth inhibitors|mesh-ancestor
110804111|NCT00126503|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110804112|NCT00126503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110804113|NCT00126503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110545855|NCT02644616|Torsemide|torsemide|mesh-list
110804114|NCT00126425|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
110804115|NCT00126425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110804116|NCT00126425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110804117|NCT00126425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110804118|NCT00126425|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110804119|NCT00126191|Leucovorin|leucovorin|mesh-list
110804120|NCT00126191|Cytarabine|cytarabine|mesh-list
110804121|NCT00126191|Cyclophosphamide|cyclophosphamide|mesh-list
110804122|NCT00126191|Ifosfamide|ifosfamide|mesh-list
110804123|NCT00126191|Rituximab|rituximab|mesh-list
110804124|NCT00126191|Doxorubicin|doxorubicin|mesh-list
110804125|NCT00126191|Methotrexate|methotrexate|mesh-list
110804126|NCT00126191|Etoposide|etoposide|mesh-list
110804127|NCT00126191|Vincristine|vincristine|mesh-list
110804128|NCT00126191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110804129|NCT00126191|Immunologic Factors|immunologic factors|mesh-ancestor
110804130|NCT00126191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110804131|NCT00126191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110804132|NCT00126191|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110804133|NCT00126191|Alkylating Agents|alkylating agents|mesh-ancestor
110804134|NCT00126191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110804135|NCT00126191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110804137|NCT00126191|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110804138|NCT00126191|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110804139|NCT00126191|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110804140|NCT00126191|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110804141|NCT00126191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110804142|NCT00126191|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110804143|NCT00126191|Abortifacient Agents|abortifacient agents|mesh-ancestor
110804144|NCT00126191|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110804145|NCT00126191|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110804146|NCT00126191|Antimetabolites|antimetabolites|mesh-ancestor
110804147|NCT00126191|Dermatologic Agents|dermatologic agents|mesh-ancestor
110804148|NCT00126191|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110545881|NCT00676416|Anesthetics|anesthetics|mesh-ancestor
110804149|NCT00126191|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110804150|NCT00126191|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110804151|NCT00126191|Antiviral Agents|antiviral agents|mesh-ancestor
110804152|NCT00126191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110804153|NCT00126191|Antidotes|antidotes|mesh-ancestor
110804154|NCT00126191|Protective Agents|protective agents|mesh-ancestor
110804155|NCT00126191|Vitamin B Complex|vitamin b complex|mesh-ancestor
110804156|NCT00126191|Vitamins|vitamins|mesh-ancestor
110804157|NCT00126191|Micronutrients|micronutrients|mesh-ancestor
110804158|NCT00126191|Tubulin Modulators|tubulin modulators|mesh-ancestor
110804159|NCT00126191|Antimitotic Agents|antimitotic agents|mesh-ancestor
110804160|NCT00126191|Mitosis Modulators|mitosis modulators|mesh-ancestor
110804161|NCT03207958|Belimumab|belimumab|mesh-list
110804162|NCT03207958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110804163|NCT03207958|Immunologic Factors|immunologic factors|mesh-ancestor
110804164|NCT03207958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110804165|NCT00124943|Paclitaxel|paclitaxel|mesh-list
110804166|NCT00124943|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110521730|NCT02715336|Leuprolide|leuprolide|mesh-list
110804167|NCT00124943|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110804168|NCT00124943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110804169|NCT00124943|Tubulin Modulators|tubulin modulators|mesh-ancestor
110804170|NCT00124943|Antimitotic Agents|antimitotic agents|mesh-ancestor
110804171|NCT00124943|Mitosis Modulators|mitosis modulators|mesh-ancestor
110804172|NCT00124943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110804173|NCT00124709|Pimecrolimus|pimecrolimus|mesh-list
110804174|NCT00124709|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110804175|NCT00124709|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110804176|NCT00124709|Analgesics|analgesics|mesh-ancestor
110804177|NCT00124709|Sensory System Agents|sensory system agents|mesh-ancestor
110804178|NCT00124709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110545985|NCT00652808|Naproxen|naproxen|mesh-list
110804179|NCT00124709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110804180|NCT00124709|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110804181|NCT00124709|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110804182|NCT00124709|Dermatologic Agents|dermatologic agents|mesh-ancestor
110804183|NCT00124709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110804184|NCT00124709|Immunologic Factors|immunologic factors|mesh-ancestor
110804185|NCT00124709|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110804186|NCT00124709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110804187|NCT00124709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110804188|NCT04139434|Azacitidine|azacitidine|mesh-list
110804189|NCT04139434|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110804190|NCT04139434|Antimetabolites|antimetabolites|mesh-ancestor
110804191|NCT04139434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110804192|NCT04139434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110852533|NCT01302275|Oxcarbazepine|oxcarbazepine|mesh-list
110804193|NCT04139434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110804195|NCT04130464|Ropivacaine|ropivacaine|mesh-list
110804196|NCT04130464|Anesthetics, Local|anesthetics, local|mesh-ancestor
110804197|NCT04130464|Anesthetics|anesthetics|mesh-ancestor
110804198|NCT04130464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110804199|NCT04130464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110546079|NCT02653196|Etoposide|etoposide|mesh-list
110804200|NCT04130464|Sensory System Agents|sensory system agents|mesh-ancestor
110804201|NCT04130464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110804202|NCT04130464|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110804203|NCT04130464|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110804204|NCT04130464|Analgesics|analgesics|mesh-ancestor
110804205|NCT04130464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110804206|NCT04130464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110804207|NCT04130464|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110804208|NCT04130464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110804209|NCT04130464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110804211|NCT03058354|Anesthetics|anesthetics|mesh-ancestor
110804212|NCT03058354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110804213|NCT03058354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110804214|NCT03058354|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110804215|NCT03058354|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110804216|NCT03058354|Anesthetics, General|anesthetics, general|mesh-ancestor
110804218|NCT02911792|Dapagliflozin|dapagliflozin|mesh-list
110804219|NCT02911792|Glipizide|glipizide|mesh-list
110804220|NCT02911792|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110804221|NCT02911792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110804222|NCT02911792|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110804223|NCT02911792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110804224|NCT02143570|Darifenacin|darifenacin|mesh-list
110804225|NCT02143570|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110804226|NCT02143570|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110804227|NCT02143570|Cholinergic Agents|cholinergic agents|mesh-ancestor
110804228|NCT02143570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110804229|NCT02143570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110804230|NCT02143570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110804231|NCT02143570|Urological Agents|urological agents|mesh-ancestor
110804232|NCT02143804|Molgramostim|molgramostim|mesh-list
110804233|NCT02143804|Sargramostim|sargramostim|mesh-list
110804234|NCT02143804|Immunologic Factors|immunologic factors|mesh-ancestor
110804235|NCT02143804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110804236|NCT02143804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110804237|NCT03544996|Insulin|insulin|mesh-list
110804238|NCT03544996|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110804239|NCT03544996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110804240|NCT00564850|Triptorelin Pamoate|triptorelin pamoate|mesh-list
110804241|NCT00564850|Luteolytic Agents|luteolytic agents|mesh-ancestor
110804242|NCT00564850|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110804243|NCT00564850|Contraceptive Agents|contraceptive agents|mesh-ancestor
110521805|NCT00939757|Mirabegron|mirabegron|mesh-list
110804244|NCT00564850|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110804245|NCT00564850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110804246|NCT00564850|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110804247|NCT00564850|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110804248|NCT00564850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110804249|NCT02144194|Docetaxel|docetaxel|mesh-list
110804250|NCT02144194|Vinorelbine|vinorelbine|mesh-list
110804251|NCT02144194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110804252|NCT02144194|Tubulin Modulators|tubulin modulators|mesh-ancestor
110804253|NCT02144194|Antimitotic Agents|antimitotic agents|mesh-ancestor
110804254|NCT02144194|Mitosis Modulators|mitosis modulators|mesh-ancestor
110852536|NCT01302275|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110546156|NCT04725695|Lidocaine|lidocaine|mesh-list
110804255|NCT02144194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110804256|NCT02144194|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110804258|NCT02140840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110804259|NCT02140840|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110804260|NCT02140840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110804261|NCT02140840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110804262|NCT02140918|Fludrocortisone|fludrocortisone|mesh-list
110804263|NCT02140918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110804264|NCT00108160|Mupirocin|mupirocin|mesh-list
110804265|NCT00108160|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110804266|NCT00108160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110804267|NCT00108160|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110804268|NCT00108160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110804269|NCT00108160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110804270|NCT02254174|Tiotropium Bromide|tiotropium bromide|mesh-list
110804271|NCT02254174|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110804272|NCT02254174|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110804273|NCT02254174|Autonomic Agents|autonomic agents|mesh-ancestor
110804274|NCT02254174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110804275|NCT02254174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110804276|NCT02254174|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110804277|NCT02254174|Respiratory System Agents|respiratory system agents|mesh-ancestor
110804278|NCT02254174|Parasympatholytics|parasympatholytics|mesh-ancestor
110804279|NCT02254174|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110804280|NCT02254174|Cholinergic Agents|cholinergic agents|mesh-ancestor
110804281|NCT02254174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110804282|NCT02254174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110129435|NCT01954368|Sufentanil|sufentanil|mesh-list
110804283|NCT02254174|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110546262|NCT04330690|Dermatologic Agents|dermatologic agents|mesh-ancestor
110804284|NCT02254174|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110804285|NCT02254174|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110804286|NCT02254174|Adrenergic Agents|adrenergic agents|mesh-ancestor
110804287|NCT03545308|Rocuronium|rocuronium|mesh-list
110804288|NCT03545308|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110804289|NCT03545308|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110804290|NCT03545308|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110804291|NCT03545308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110804292|NCT03545308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110804293|NCT00108082|Atenolol|atenolol|mesh-list
110804294|NCT00108082|Carvedilol|carvedilol|mesh-list
110804295|NCT00108082|Lisinopril|lisinopril|mesh-list
110804296|NCT00108082|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110804297|NCT00108082|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110804298|NCT00108082|Adrenergic Agents|adrenergic agents|mesh-ancestor
110804299|NCT00108082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110804300|NCT00108082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110804301|NCT00108082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110804302|NCT00108082|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110804303|NCT00108082|Antioxidants|antioxidants|mesh-ancestor
110804304|NCT00108082|Protective Agents|protective agents|mesh-ancestor
110804305|NCT00108082|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110804306|NCT00108082|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110804307|NCT00108082|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110804308|NCT00108082|Vasodilator Agents|vasodilator agents|mesh-ancestor
110804309|NCT00108082|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110804310|NCT00108082|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110804311|NCT00108082|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110804312|NCT00108082|Protease Inhibitors|protease inhibitors|mesh-ancestor
110804313|NCT00108082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110804314|NCT00108082|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110804315|NCT00108082|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110804316|NCT00108082|Sympatholytics|sympatholytics|mesh-ancestor
110804317|NCT00108082|Autonomic Agents|autonomic agents|mesh-ancestor
110804318|NCT00108082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110804319|NCT00108082|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110804320|NCT02144662|Ranibizumab|ranibizumab|mesh-list
110804321|NCT02144662|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110804322|NCT02144662|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110804323|NCT02144662|Growth Substances|growth substances|mesh-ancestor
110804324|NCT02144662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110804325|NCT02144662|Growth Inhibitors|growth inhibitors|mesh-ancestor
110804326|NCT02144662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110804327|NCT02141698|Esomeprazole|esomeprazole|mesh-list
110804328|NCT02141698|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110804329|NCT02141698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110804330|NCT02141698|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110804331|NCT02141698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110804332|NCT02141698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110804333|NCT02144818|Triptorelin Pamoate|triptorelin pamoate|mesh-list
110804334|NCT02144818|Luteolytic Agents|luteolytic agents|mesh-ancestor
110546432|NCT00710086|Narcotics|narcotics|mesh-ancestor
110804335|NCT02144818|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110804336|NCT02144818|Contraceptive Agents|contraceptive agents|mesh-ancestor
110804337|NCT02144818|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110804338|NCT02144818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110804339|NCT02144818|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110804340|NCT02144818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110804341|NCT02144818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110804342|NCT02147938|Tacrolimus|tacrolimus|mesh-list
110804343|NCT02147938|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110804344|NCT02147938|Immunologic Factors|immunologic factors|mesh-ancestor
110804345|NCT02147938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110804346|NCT02147938|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110804347|NCT02147938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110804348|NCT02147938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110804349|NCT02148016|Levofloxacin|levofloxacin|mesh-list
110804350|NCT02148016|Betamethasone|betamethasone|mesh-list
110804351|NCT02148016|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110804352|NCT02148016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110804353|NCT02148016|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110804354|NCT02148016|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110804355|NCT02148016|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110804356|NCT02148016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110804357|NCT02148016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110804358|NCT02148016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110546548|NCT05360953|Doxazosin|doxazosin|mesh-list
110804359|NCT02148016|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110804360|NCT02148016|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110804361|NCT02148016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110804362|NCT02148016|Glucocorticoids|glucocorticoids|mesh-ancestor
110804363|NCT02148016|Hormones|hormones|mesh-ancestor
110804364|NCT02148016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110804365|NCT02148016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110804366|NCT02148016|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110804367|NCT02148016|Respiratory System Agents|respiratory system agents|mesh-ancestor
110804368|NCT02148094|Tenofovir|tenofovir|mesh-list
110804369|NCT02148094|Emtricitabine|emtricitabine|mesh-list
110804370|NCT02148094|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110804371|NCT02148094|Antiviral Agents|antiviral agents|mesh-ancestor
110804372|NCT02148094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110804373|NCT02148094|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110804374|NCT02148094|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110804375|NCT02148094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110804376|NCT02148094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110804377|NCT02148094|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110804378|NCT02148094|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110804379|NCT02148328|Vaccines|vaccines|mesh-list
110804380|NCT02148328|Immunologic Factors|immunologic factors|mesh-ancestor
110804381|NCT02148328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110804382|NCT02142010|Paclitaxel|paclitaxel|mesh-list
110804383|NCT02142010|Cisplatin|cisplatin|mesh-list
110546691|NCT00719758|Beraprost|beraprost|mesh-list
110804384|NCT02142010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110804385|NCT02142010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110804386|NCT02142010|Tubulin Modulators|tubulin modulators|mesh-ancestor
110804387|NCT02142010|Antimitotic Agents|antimitotic agents|mesh-ancestor
110804388|NCT02142010|Mitosis Modulators|mitosis modulators|mesh-ancestor
110804389|NCT02142010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110804390|NCT02142166|Dialysis Solutions|dialysis solutions|mesh-list
110804392|NCT05054140|Calcium|calcium|mesh-list
110804393|NCT05054140|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110804394|NCT05054140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110804395|NCT03543826|Rocuronium|rocuronium|mesh-list
110804396|NCT03543826|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110804397|NCT03543826|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110804398|NCT03543826|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110804399|NCT03543826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110804400|NCT03543826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110804401|NCT02148640|Infliximab|infliximab|mesh-list
110804402|NCT02148640|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110804403|NCT02148640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110804404|NCT02148640|Dermatologic Agents|dermatologic agents|mesh-ancestor
110804405|NCT02148640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110804406|NCT02148640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110804407|NCT02142556|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110804408|NCT02142556|Antidepressive Agents|antidepressive agents|mesh-ancestor
110804409|NCT02142556|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110804410|NCT02142556|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110804411|NCT02142556|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110804412|NCT02142556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110804413|NCT02142556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110804414|NCT02142634|Budesonide|budesonide|mesh-list
110804415|NCT02142634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110804416|NCT02142634|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110804417|NCT02142634|Autonomic Agents|autonomic agents|mesh-ancestor
110804418|NCT02142634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110804419|NCT02142634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110804420|NCT02142634|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110804421|NCT02142634|Respiratory System Agents|respiratory system agents|mesh-ancestor
110804422|NCT02142634|Glucocorticoids|glucocorticoids|mesh-ancestor
110804423|NCT02142634|Hormones|hormones|mesh-ancestor
110804424|NCT02142634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110804425|NCT02142790|Paclitaxel|paclitaxel|mesh-list
110546861|NCT00681720|Flumazenil|flumazenil|mesh-list
110804426|NCT02142790|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110804427|NCT02142790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110804428|NCT02142790|Tubulin Modulators|tubulin modulators|mesh-ancestor
110804429|NCT02142790|Antimitotic Agents|antimitotic agents|mesh-ancestor
110804430|NCT02142790|Mitosis Modulators|mitosis modulators|mesh-ancestor
110804431|NCT02142790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110804433|NCT02142868|Palbociclib|palbociclib|mesh-list
110804434|NCT02142868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110804435|NCT02142868|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110804436|NCT02142868|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110804437|NCT02142868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110804438|NCT02142868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110804439|NCT02142868|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110804440|NCT02142868|Hormone Antagonists|hormone antagonists|mesh-ancestor
110804441|NCT02142868|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110804442|NCT02142868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110804443|NCT02142868|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110804444|NCT02145520|Magnesium Sulfate|magnesium sulfate|mesh-list
110804445|NCT02145520|Analgesics|analgesics|mesh-ancestor
110804446|NCT02145520|Sensory System Agents|sensory system agents|mesh-ancestor
110804447|NCT02145520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110804448|NCT02145520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110804449|NCT02145520|Anesthetics|anesthetics|mesh-ancestor
110804450|NCT02145520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110804451|NCT02145520|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110804452|NCT02145520|Anticonvulsants|anticonvulsants|mesh-ancestor
110804453|NCT02145520|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110852568|NCT03332602|Antioxidants|antioxidants|mesh-ancestor
110804454|NCT02145520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110804455|NCT02145520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110804456|NCT02145520|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110804458|NCT02145520|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110804459|NCT02145598|Lenalidomide|lenalidomide|mesh-list
110804460|NCT02145598|Immunologic Factors|immunologic factors|mesh-ancestor
110804461|NCT02145598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110804462|NCT02145598|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110522029|NCT00925769|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110804463|NCT02145598|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110804464|NCT02145598|Growth Substances|growth substances|mesh-ancestor
110804465|NCT02145598|Growth Inhibitors|growth inhibitors|mesh-ancestor
110804466|NCT02145598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110804468|NCT02145832|Micafungin|micafungin|mesh-list
110804469|NCT02145832|Antifungal Agents|antifungal agents|mesh-list
110804470|NCT02145832|Clotrimazole|clotrimazole|mesh-list
110804471|NCT02145832|Miconazole|miconazole|mesh-list
110804472|NCT02145832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110804473|NCT02145832|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110804474|NCT02145832|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110804475|NCT02145832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110804476|NCT02145832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110804477|NCT02145832|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110804478|NCT02145832|Hormone Antagonists|hormone antagonists|mesh-ancestor
110863861|NCT04495283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110804479|NCT02145832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110804480|NCT02145832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110804481|NCT02145832|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110804482|NCT02145832|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110804483|NCT02145832|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110804484|NCT02145832|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110804485|NCT00104728|Gefitinib|gefitinib|mesh-list
110804486|NCT00104728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110804487|NCT00104728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110804488|NCT00104728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110804489|NCT00104728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110804490|NCT02145910|Vemurafenib|vemurafenib|mesh-list
110804491|NCT02145910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110804492|NCT02145910|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110804493|NCT02145910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110547168|NCT00594516|Tapentadol|tapentadol|mesh-list
110804494|NCT02145910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110804495|NCT02146222|Docetaxel|docetaxel|mesh-list
110804496|NCT02146222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110804497|NCT02146222|Tubulin Modulators|tubulin modulators|mesh-ancestor
110804498|NCT02146222|Antimitotic Agents|antimitotic agents|mesh-ancestor
110804499|NCT02146222|Mitosis Modulators|mitosis modulators|mesh-ancestor
110804500|NCT02146222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110804501|NCT02146300|Xylometazoline|xylometazoline|mesh-list
110804502|NCT02146300|Nasal Decongestants|nasal decongestants|mesh-ancestor
110804503|NCT02146300|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110804504|NCT02146300|Respiratory System Agents|respiratory system agents|mesh-ancestor
110804505|NCT02146456|Tranexamic Acid|tranexamic acid|mesh-list
110804506|NCT02146456|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110804507|NCT02146456|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110804508|NCT02146456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110804509|NCT02146456|Hemostatics|hemostatics|mesh-ancestor
110804510|NCT02146456|Coagulants|coagulants|mesh-ancestor
110804511|NCT02146534|4-Aminopyridine|4-aminopyridine|mesh-list
110804512|NCT02146534|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
110804513|NCT02146534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110804514|NCT02146534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110804515|NCT02151916|Fluorides|fluorides|mesh-list
110804516|NCT02151916|Fluorides, Topical|fluorides, topical|mesh-list
110804517|NCT02151916|Cariostatic Agents|cariostatic agents|mesh-ancestor
110804518|NCT02151916|Protective Agents|protective agents|mesh-ancestor
110804519|NCT02151916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110804520|NCT02146846|Imatinib Mesylate|imatinib mesylate|mesh-list
110804521|NCT02146846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110804522|NCT02146846|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110804523|NCT02146846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110804524|NCT02146846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110804525|NCT02152228|Teriparatide|teriparatide|mesh-list
110804527|NCT02152228|Parathyroid Hormone|parathyroid hormone|mesh-list
110804528|NCT02152228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110804529|NCT02152228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110804530|NCT02152228|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110804531|NCT02152228|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110804532|NCT02152306|Amlodipine|amlodipine|mesh-list
110804533|NCT02152306|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110804534|NCT02152306|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110804535|NCT02152306|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110804536|NCT02152306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110804537|NCT02152306|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110804538|NCT02152306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110804539|NCT02152306|Vasodilator Agents|vasodilator agents|mesh-ancestor
110804540|NCT02261116|Telmisartan|telmisartan|mesh-list
110804541|NCT02261116|Candesartan|candesartan|mesh-list
110804542|NCT02261116|Candesartan cilexetil|candesartan cilexetil|mesh-list
110804543|NCT02261116|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110804544|NCT02261116|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110804545|NCT02261116|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110804546|NCT02261116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110804547|NCT02254720|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110804548|NCT02147548|Lorazepam|lorazepam|mesh-list
110804549|NCT02147548|Etifoxine|etifoxine|mesh-list
110804550|NCT02147548|Anticonvulsants|anticonvulsants|mesh-ancestor
110804551|NCT02147548|Antiemetics|antiemetics|mesh-ancestor
110804552|NCT02147548|Autonomic Agents|autonomic agents|mesh-ancestor
110804553|NCT02147548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110804554|NCT02147548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110804555|NCT02147548|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110804556|NCT02147548|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110804557|NCT02147548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110804558|NCT02147548|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110804559|NCT02147548|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110804560|NCT02147548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110804561|NCT02147548|GABA Modulators|gaba modulators|mesh-ancestor
110804562|NCT02147548|GABA Agents|gaba agents|mesh-ancestor
110804563|NCT02147548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110804564|NCT02147548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110804565|NCT00122681|Vaccines|vaccines|mesh-list
110804566|NCT00122681|Immunologic Factors|immunologic factors|mesh-ancestor
110804567|NCT00122681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110804568|NCT02774278|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110804569|NCT02774278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110863862|NCT04495283|Antipyretics|antipyretics|mesh-ancestor
110804570|NCT02774278|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110804571|NCT02774278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110804572|NCT02774278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110804573|NCT05666349|Niraparib|niraparib|mesh-list
110804574|NCT05666349|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110804575|NCT05666349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110804576|NCT05666349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110804577|NCT05666349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110804578|NCT03733275|Lidocaine|lidocaine|mesh-list
110804579|NCT03733275|Bupivacaine|bupivacaine|mesh-list
110804580|NCT03733275|Anesthetics, Local|anesthetics, local|mesh-ancestor
110804581|NCT03733275|Anesthetics|anesthetics|mesh-ancestor
110804582|NCT03733275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110804583|NCT03733275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110804584|NCT03733275|Sensory System Agents|sensory system agents|mesh-ancestor
110804585|NCT03733275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110804586|NCT03733275|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110804587|NCT03733275|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110804588|NCT03733275|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110804589|NCT03733275|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110804590|NCT03733275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110804591|NCT03542422|Apatinib|apatinib|mesh-list
110804592|NCT03542422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110804593|NCT03542422|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110804594|NCT03542422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110804595|NCT03542422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110804596|NCT01077011|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110804597|NCT01077011|Lubricant Eye Drops|lubricant eye drops|mesh-list
110804598|NCT01077011|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110804599|NCT02153866|Vaccines|vaccines|mesh-list
110804600|NCT02153866|Immunologic Factors|immunologic factors|mesh-ancestor
110804601|NCT02153866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110804602|NCT03645057|Tacrolimus|tacrolimus|mesh-list
110804603|NCT03645057|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110804604|NCT03645057|Immunologic Factors|immunologic factors|mesh-ancestor
110804605|NCT03645057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110804606|NCT03645057|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110804607|NCT03645057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110804608|NCT03645057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110522188|NCT00637988|Aspirin|aspirin|mesh-list
110804609|NCT04863430|Oxaliplatin|oxaliplatin|mesh-list
110804610|NCT04863430|Apatinib|apatinib|mesh-list
110804611|NCT04863430|Tegafur|tegafur|mesh-list
110804612|NCT04863430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110804613|NCT04863430|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110804614|NCT04863430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110804615|NCT04863430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110804616|NCT04863430|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110804617|NCT04863430|Antimetabolites|antimetabolites|mesh-ancestor
110804618|NCT05665881|Phenylephrine|phenylephrine|mesh-list
110804619|NCT05665881|Oxymetazoline|oxymetazoline|mesh-list
110804620|NCT05665881|Norepinephrine|norepinephrine|mesh-list
110804621|NCT05665881|Ephedrine|ephedrine|mesh-list
110804622|NCT05665881|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110804623|NCT05665881|Mydriatics|mydriatics|mesh-ancestor
110804624|NCT05665881|Autonomic Agents|autonomic agents|mesh-ancestor
110804625|NCT05665881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110804626|NCT05665881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110804627|NCT05665881|Sympathomimetics|sympathomimetics|mesh-ancestor
110804628|NCT05665881|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110804629|NCT05665881|Nasal Decongestants|nasal decongestants|mesh-ancestor
110804630|NCT05665881|Respiratory System Agents|respiratory system agents|mesh-ancestor
110804631|NCT05665881|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110804632|NCT05665881|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110804633|NCT05665881|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110804634|NCT05665881|Adrenergic Agents|adrenergic agents|mesh-ancestor
110804635|NCT05665881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110804636|NCT05665881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110804637|NCT05665881|Protective Agents|protective agents|mesh-ancestor
110804638|NCT05665881|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110804639|NCT03643575|Phenylpropanolamine|phenylpropanolamine|mesh-list
110804640|NCT03643575|Guaifenesin|guaifenesin|mesh-list
110804641|NCT03643575|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
110804642|NCT03643575|Expectorants|expectorants|mesh-ancestor
110804643|NCT03643575|Respiratory System Agents|respiratory system agents|mesh-ancestor
110804644|NCT03643575|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110804645|NCT03643575|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110804646|NCT03643575|Adrenergic Agents|adrenergic agents|mesh-ancestor
110804647|NCT03643575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110129798|NCT01956786|Vasodilator Agents|vasodilator agents|mesh-ancestor
110804648|NCT03643575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110804649|NCT03643575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110804650|NCT03643575|Appetite Depressants|appetite depressants|mesh-ancestor
110804651|NCT03643575|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110804652|NCT03643575|Sympathomimetics|sympathomimetics|mesh-ancestor
110804653|NCT03643575|Autonomic Agents|autonomic agents|mesh-ancestor
110852589|NCT03332524|Analgesics|analgesics|mesh-ancestor
110804654|NCT03643575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110804655|NCT03643575|Nasal Decongestants|nasal decongestants|mesh-ancestor
110804656|NCT03643575|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110804657|NCT02768194|Fluorides|fluorides|mesh-list
110804658|NCT02768194|Tin Fluorides|tin fluorides|mesh-list
110804659|NCT02768194|Fluorophosphate|fluorophosphate|mesh-list
110804660|NCT02768194|Cariostatic Agents|cariostatic agents|mesh-ancestor
110804661|NCT02768194|Protective Agents|protective agents|mesh-ancestor
110804662|NCT02768194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110804663|NCT02254954|Temozolomide|temozolomide|mesh-list
110804664|NCT02254954|Macitentan|macitentan|mesh-list
110804665|NCT02254954|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110804666|NCT02254954|Alkylating Agents|alkylating agents|mesh-ancestor
110804667|NCT02254954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110804668|NCT02254954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110804669|NCT02254954|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
110804670|NCT02254954|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
110804671|NCT02254954|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
110804672|NCT00130793|Vaccines|vaccines|mesh-list
110804673|NCT00130793|Immunologic Factors|immunologic factors|mesh-ancestor
110804674|NCT00130793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110804675|NCT03732105|Apatinib|apatinib|mesh-list
110804676|NCT03732105|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
110804677|NCT03732105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110804678|NCT03732105|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110804679|NCT03732105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110804680|NCT03732105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110804681|NCT03732105|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110804682|NCT03732105|Growth Substances|growth substances|mesh-ancestor
110804683|NCT03732105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110804684|NCT03732105|Growth Inhibitors|growth inhibitors|mesh-ancestor
110804685|NCT02154334|Mometasone Furoate|mometasone furoate|mesh-list
110804686|NCT02154334|Phenylephrine|phenylephrine|mesh-list
110804687|NCT02154334|Oxymetazoline|oxymetazoline|mesh-list
110804688|NCT02154334|Esketamine|esketamine|mesh-list
110863863|NCT04495283|Anticonvulsants|anticonvulsants|mesh-ancestor
110804689|NCT02154334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110804690|NCT02154334|Dermatologic Agents|dermatologic agents|mesh-ancestor
110804691|NCT02154334|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110804692|NCT02154334|Antidepressive Agents|antidepressive agents|mesh-ancestor
110804693|NCT02154334|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110804694|NCT02154334|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110804695|NCT02154334|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110804696|NCT02154334|Adrenergic Agents|adrenergic agents|mesh-ancestor
110804697|NCT02154334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110804698|NCT02154334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110804699|NCT02154334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110804700|NCT02154334|Sympathomimetics|sympathomimetics|mesh-ancestor
110804701|NCT02154334|Autonomic Agents|autonomic agents|mesh-ancestor
110804702|NCT02154334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110804703|NCT02154334|Nasal Decongestants|nasal decongestants|mesh-ancestor
110804704|NCT02154334|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110804705|NCT02154334|Respiratory System Agents|respiratory system agents|mesh-ancestor
110804706|NCT02154334|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110804707|NCT02154334|Mydriatics|mydriatics|mesh-ancestor
110804708|NCT02154334|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110804709|NCT02154334|Protective Agents|protective agents|mesh-ancestor
110804710|NCT01078961|Bortezomib|bortezomib|mesh-list
110804711|NCT01078961|Sorafenib|sorafenib|mesh-list
110804712|NCT01078961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110804713|NCT01078961|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110804714|NCT01078961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110804715|NCT01078961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110804716|NCT03818399|Buprenorphine|buprenorphine|mesh-list
110804717|NCT03818399|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110804718|NCT03818399|Narcotics|narcotics|mesh-ancestor
110804719|NCT03818399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110804720|NCT03818399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110804721|NCT03818399|Analgesics|analgesics|mesh-ancestor
110804722|NCT03818399|Sensory System Agents|sensory system agents|mesh-ancestor
110804723|NCT03818399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110103003|NCT01768741|Liver Extracts|liver extracts|mesh-list
110804724|NCT03818399|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110804726|NCT02154646|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110804727|NCT02154646|Antimetabolites|antimetabolites|mesh-ancestor
110804728|NCT02154646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110804729|NCT02154646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110804730|NCT03642873|Phenylpropanolamine|phenylpropanolamine|mesh-list
110804731|NCT03642873|Hydrocodone|hydrocodone|mesh-list
110804732|NCT03642873|Guaifenesin|guaifenesin|mesh-list
110804733|NCT03642873|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
110804734|NCT03642873|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110804735|NCT03642873|Narcotics|narcotics|mesh-ancestor
110804736|NCT03642873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110804737|NCT03642873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110804738|NCT03642873|Analgesics|analgesics|mesh-ancestor
110804739|NCT03642873|Sensory System Agents|sensory system agents|mesh-ancestor
110804740|NCT03642873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110804741|NCT03642873|Antitussive Agents|antitussive agents|mesh-ancestor
110804742|NCT03642873|Respiratory System Agents|respiratory system agents|mesh-ancestor
110804743|NCT03642873|Expectorants|expectorants|mesh-ancestor
110804744|NCT03642873|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110804745|NCT03642873|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110804746|NCT03642873|Adrenergic Agents|adrenergic agents|mesh-ancestor
110804747|NCT03642873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110804748|NCT03642873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110804749|NCT03642873|Appetite Depressants|appetite depressants|mesh-ancestor
110804750|NCT03642873|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110804751|NCT03642873|Sympathomimetics|sympathomimetics|mesh-ancestor
110804752|NCT03642873|Autonomic Agents|autonomic agents|mesh-ancestor
110804753|NCT03642873|Nasal Decongestants|nasal decongestants|mesh-ancestor
110804754|NCT03642873|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110804755|NCT01079819|BMS 708163|bms 708163|mesh-list
110804756|NCT01079819|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
110804757|NCT01079819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110804758|NCT01079819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110804759|NCT02156596|Ketoprofen|ketoprofen|mesh-list
110804760|NCT02156596|Morphine|morphine|mesh-list
110804761|NCT02156596|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110804762|NCT02156596|Narcotics|narcotics|mesh-ancestor
110804763|NCT02156596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110804764|NCT02156596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110804765|NCT02156596|Analgesics|analgesics|mesh-ancestor
110804766|NCT02156596|Sensory System Agents|sensory system agents|mesh-ancestor
110804767|NCT02156596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110804768|NCT02156596|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110804769|NCT02156596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110804770|NCT02156596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110804771|NCT02156596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110804772|NCT02156596|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110804773|NCT02156596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110804774|NCT02156596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110804775|NCT01079117|Morphine|morphine|mesh-list
110804776|NCT01079117|Methadone|methadone|mesh-list
110804777|NCT01079117|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110804778|NCT01079117|Narcotics|narcotics|mesh-ancestor
110804779|NCT01079117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110804780|NCT01079117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110804781|NCT01079117|Analgesics|analgesics|mesh-ancestor
110804782|NCT01079117|Sensory System Agents|sensory system agents|mesh-ancestor
110804783|NCT01079117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110804784|NCT01079117|Antitussive Agents|antitussive agents|mesh-ancestor
110804785|NCT01079117|Respiratory System Agents|respiratory system agents|mesh-ancestor
110804786|NCT03732963|Melatonin|melatonin|mesh-list
110804787|NCT03732963|Antioxidants|antioxidants|mesh-ancestor
110804788|NCT03732963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110804789|NCT03732963|Protective Agents|protective agents|mesh-ancestor
110804790|NCT03732963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110852605|NCT02499484|Nitroglycerin|nitroglycerin|mesh-list
110548086|NCT00717730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110804791|NCT03732963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110804792|NCT03729687|Capecitabine|capecitabine|mesh-list
110804793|NCT03729687|Oxaliplatin|oxaliplatin|mesh-list
110804794|NCT03729687|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110804795|NCT03729687|Antimetabolites|antimetabolites|mesh-ancestor
110804796|NCT03729687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110804797|NCT03729687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110804798|NCT03818321|Methenamine|methenamine|mesh-list
110804799|NCT03818321|Methenamine hippurate|methenamine hippurate|mesh-list
110804800|NCT03818321|Methenamine mandelate|methenamine mandelate|mesh-list
110804801|NCT03818321|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110804802|NCT03818321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110804803|NCT03818321|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110804804|NCT03616977|Insulin Lispro|insulin lispro|mesh-list
110804805|NCT03616977|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110804806|NCT03616977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110804807|NCT04996719|Sirolimus|sirolimus|mesh-list
110804808|NCT04996719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110804809|NCT04996719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110804810|NCT04996719|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110804811|NCT04996719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110804812|NCT04996719|Antifungal Agents|antifungal agents|mesh-ancestor
110804813|NCT04996719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110804814|NCT04996719|Immunologic Factors|immunologic factors|mesh-ancestor
110804815|NCT04996719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110804816|NCT03816761|Insulin Aspart|insulin aspart|mesh-list
110804817|NCT03816761|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110804818|NCT03816761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110804819|NCT02770612|Analgesics, Opioid|analgesics, opioid|mesh-list
110804820|NCT02770612|Narcotics|narcotics|mesh-ancestor
110804821|NCT02770612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110804822|NCT02770612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110804823|NCT02770612|Analgesics|analgesics|mesh-ancestor
110804824|NCT02770612|Sensory System Agents|sensory system agents|mesh-ancestor
110804825|NCT02770612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110804826|NCT03542110|Alirocumab|alirocumab|mesh-list
110804827|NCT03542110|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
110804828|NCT03542110|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110804829|NCT03542110|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110804830|NCT03542110|Antimetabolites|antimetabolites|mesh-ancestor
110548262|NCT02732249|Bismuth|bismuth|mesh-list
110804831|NCT03542110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110804832|NCT03542110|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110804833|NCT03542110|Protease Inhibitors|protease inhibitors|mesh-ancestor
110804834|NCT03542110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110804835|NCT03542110|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110804836|NCT03575871|Abrocitinib|abrocitinib|mesh-list
110804837|NCT03575871|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110804838|NCT03575871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110804839|NCT03575871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110804841|NCT02155504|Antifungal Agents|antifungal agents|mesh-ancestor
110804842|NCT02155504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110804843|NCT02155504|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110548326|NCT00536809|Capecitabine|capecitabine|mesh-list
110804844|NCT02155504|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110804845|NCT02155504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110804846|NCT02155504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110804847|NCT02155504|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110804848|NCT02155504|Hormone Antagonists|hormone antagonists|mesh-ancestor
110804849|NCT02155504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110804850|NCT02155504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110804851|NCT02155504|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110804852|NCT03642717|Empagliflozin|empagliflozin|mesh-list
110804853|NCT03642717|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110548387|NCT02730689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110804854|NCT03642717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110804855|NCT03642717|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110804856|NCT03642717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110804857|NCT02766478|Genistein|genistein|mesh-list
110804858|NCT02766478|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110804859|NCT02766478|Protective Agents|protective agents|mesh-ancestor
110804860|NCT02766478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110804861|NCT02766478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110804862|NCT02766478|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110804863|NCT02766478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110804864|NCT02766478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110804865|NCT02766478|Phytoestrogens|phytoestrogens|mesh-ancestor
110804866|NCT02766478|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
110804867|NCT02766478|Estrogens|estrogens|mesh-ancestor
110804868|NCT02766478|Hormones|hormones|mesh-ancestor
110804869|NCT02766478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110804870|NCT03729375|Bupivacaine|bupivacaine|mesh-list
110804872|NCT03729375|Anesthetics|anesthetics|mesh-ancestor
110804873|NCT03729375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110804874|NCT03729375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110804875|NCT03729375|Sensory System Agents|sensory system agents|mesh-ancestor
110804876|NCT03729375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110804877|NCT02159326|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
110804878|NCT02159326|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
110804879|NCT02159326|Riociguat|riociguat|mesh-list
110804880|NCT02159326|Enzyme Activators|enzyme activators|mesh-ancestor
110804881|NCT02159326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110804882|NCT02159326|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110804883|NCT02159326|Contraceptive Agents|contraceptive agents|mesh-ancestor
110804884|NCT02159326|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110804885|NCT02159326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110804886|NCT02159326|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110804887|NCT02159326|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110804888|NCT02159326|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110804889|NCT02159326|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110548572|NCT00723268|Colchicine|colchicine|mesh-list
110804890|NCT02159326|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110804891|NCT02159326|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
110804892|NCT02159326|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
110804893|NCT02159326|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
110804894|NCT02255266|Liraglutide|liraglutide|mesh-list
110804895|NCT02255266|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110804896|NCT02255266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110804897|NCT02255266|Incretins|incretins|mesh-ancestor
110804898|NCT02255266|Hormones|hormones|mesh-ancestor
110804899|NCT02255266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110804900|NCT00104650|Diphosphonates|diphosphonates|mesh-list
110804901|NCT00104650|Denosumab|denosumab|mesh-list
110804902|NCT00104650|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110804903|NCT00104650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110804904|NCT02158078|Insulin|insulin|mesh-list
110804905|NCT02158078|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110804906|NCT02158078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110804907|NCT00104416|Lamotrigine|lamotrigine|mesh-list
110804908|NCT00104416|Anticonvulsants|anticonvulsants|mesh-ancestor
110804909|NCT00104416|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110804910|NCT00104416|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110804911|NCT00104416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110804912|NCT00104416|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110804913|NCT00104416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110804914|NCT00104416|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110804915|NCT00104416|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110804916|NCT00104416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110804917|NCT00104416|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110804918|NCT00104416|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110804919|NCT02149888|Tenofovir|tenofovir|mesh-list
110804920|NCT02149888|Emtricitabine|emtricitabine|mesh-list
110804921|NCT02149888|Antiviral Agents|antiviral agents|mesh-ancestor
110804922|NCT02149888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110804923|NCT02149888|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110804924|NCT02149888|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110804925|NCT02149888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110804926|NCT02149888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110804927|NCT02149888|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110804928|NCT02149888|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110804929|NCT03639675|Aflibercept|aflibercept|mesh-list
110804930|NCT03639675|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110804931|NCT03639675|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110804932|NCT03639675|Growth Substances|growth substances|mesh-ancestor
110804933|NCT03639675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110804934|NCT03639675|Growth Inhibitors|growth inhibitors|mesh-ancestor
110804935|NCT03639675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110804936|NCT03543436|Meropenem|meropenem|mesh-list
110804937|NCT03543436|Imipenem|imipenem|mesh-list
110804938|NCT03543436|Temocillin|temocillin|mesh-list
110804939|NCT03543436|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110804940|NCT03543436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110804941|NCT02149966|Mitapivat|mitapivat|mesh-list
110804942|NCT02149966|Enzyme Activators|enzyme activators|mesh-ancestor
110804943|NCT02149966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110804944|NCT03729063|Carbon Monoxide|carbon monoxide|mesh-list
110804945|NCT03729063|Antimetabolites|antimetabolites|mesh-ancestor
110804946|NCT03729063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110804947|NCT03729063|Gasotransmitters|gasotransmitters|mesh-ancestor
110804948|NCT03729063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110804949|NCT03729063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110804950|NCT01310361|Amoxicillin|amoxicillin|mesh-list
110804951|NCT01310361|Penicillins|penicillins|mesh-list
110804952|NCT01310361|Penicillin G|penicillin g|mesh-list
110804953|NCT01310361|Penicillin G Benzathine|penicillin g benzathine|mesh-list
110804954|NCT01310361|Penicillin G Procaine|penicillin g procaine|mesh-list
110804955|NCT01310361|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110804956|NCT01310361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110804957|NCT03541798|Anesthetics|anesthetics|mesh-list
110804958|NCT03541798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110804959|NCT03541798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110804960|NCT02150122|Vitamin D|vitamin d|mesh-list
110804961|NCT02150122|Cholecalciferol|cholecalciferol|mesh-list
110804962|NCT02150122|Vitamins|vitamins|mesh-ancestor
110804963|NCT02150122|Micronutrients|micronutrients|mesh-ancestor
110804964|NCT02150122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110804965|NCT02150122|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110804966|NCT02150122|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110804967|NCT03728829|Carboplatin|carboplatin|mesh-list
110804968|NCT03728829|Docetaxel|docetaxel|mesh-list
110804969|NCT03728829|Trastuzumab|trastuzumab|mesh-list
110548798|NCT01564381|Resveratrol|resveratrol|mesh-list
110804970|NCT03728829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110804971|NCT03728829|Tubulin Modulators|tubulin modulators|mesh-ancestor
110804972|NCT03728829|Antimitotic Agents|antimitotic agents|mesh-ancestor
110804973|NCT03728829|Mitosis Modulators|mitosis modulators|mesh-ancestor
110804974|NCT03728829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110804975|NCT03728829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110804976|NCT00121667|Metformin|metformin|mesh-list
110804977|NCT00121667|Pioglitazone|pioglitazone|mesh-list
110804978|NCT00121667|Saxagliptin|saxagliptin|mesh-list
110804979|NCT00121667|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110804980|NCT00121667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110804981|NCT00121667|Incretins|incretins|mesh-ancestor
110804982|NCT00121667|Hormones|hormones|mesh-ancestor
110804983|NCT00121667|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110804984|NCT00121667|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110804985|NCT00121667|Protease Inhibitors|protease inhibitors|mesh-ancestor
110804986|NCT00121667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110804987|NCT00121667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110804988|NCT02954601|Insulin|insulin|mesh-list
110548858|NCT02638142|Furosemide|furosemide|mesh-list
110804989|NCT02954601|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110804990|NCT02954601|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110804991|NCT02954601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110804992|NCT00121199|Prednisone|prednisone|mesh-list
110804993|NCT00121199|Cyclophosphamide|cyclophosphamide|mesh-list
110804994|NCT00121199|Bevacizumab|bevacizumab|mesh-list
110804995|NCT00121199|Rituximab|rituximab|mesh-list
110804996|NCT00121199|Doxorubicin|doxorubicin|mesh-list
110804997|NCT00121199|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110804998|NCT00121199|Vincristine|vincristine|mesh-list
110804999|NCT00121199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110805000|NCT00121199|Antibodies|antibodies|mesh-list
110805001|NCT00121199|Immunoglobulins|immunoglobulins|mesh-list
110805002|NCT00121199|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110805003|NCT00121199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110805004|NCT00121199|Immunologic Factors|immunologic factors|mesh-ancestor
110852618|NCT04874610|Prednisolone|prednisolone|mesh-list
110805005|NCT00121199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110805006|NCT00121199|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110805007|NCT00121199|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110805008|NCT00121199|Alkylating Agents|alkylating agents|mesh-ancestor
110805009|NCT00121199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110805010|NCT00121199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110805011|NCT00121199|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110805012|NCT00121199|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110805013|NCT00121199|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110805014|NCT00121199|Growth Substances|growth substances|mesh-ancestor
110805015|NCT00121199|Growth Inhibitors|growth inhibitors|mesh-ancestor
110805016|NCT00121199|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110805017|NCT00121199|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110805018|NCT00121199|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110805019|NCT00121199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110805020|NCT00121199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110805022|NCT00121199|Hormones|hormones|mesh-ancestor
110805023|NCT00121199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110805024|NCT00121199|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110805025|NCT00121199|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110805026|NCT00121199|Tubulin Modulators|tubulin modulators|mesh-ancestor
110805027|NCT00121199|Antimitotic Agents|antimitotic agents|mesh-ancestor
110805028|NCT00121199|Mitosis Modulators|mitosis modulators|mesh-ancestor
110805029|NCT01079897|Glycyrrhetinic Acid|glycyrrhetinic acid|mesh-list
110805030|NCT01079897|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110805031|NCT00119015|Fluticasone|fluticasone|mesh-list
110805032|NCT00119015|Xhance|xhance|mesh-list
110805033|NCT00119015|Montelukast|montelukast|mesh-list
110805034|NCT00119015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110805035|NCT00119015|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110805036|NCT00119015|Autonomic Agents|autonomic agents|mesh-ancestor
110805037|NCT00119015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110805038|NCT00119015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110805039|NCT00119015|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110805040|NCT00119015|Respiratory System Agents|respiratory system agents|mesh-ancestor
110805041|NCT00119015|Dermatologic Agents|dermatologic agents|mesh-ancestor
110805042|NCT00119015|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110805043|NCT00119015|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110805044|NCT00119015|Hormone Antagonists|hormone antagonists|mesh-ancestor
110805045|NCT00119015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110805046|NCT00119015|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110805047|NCT00119015|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110805048|NCT00119015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110805049|NCT03557307|Benralizumab|benralizumab|mesh-list
110805050|NCT03557307|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110805051|NCT03557307|Respiratory System Agents|respiratory system agents|mesh-ancestor
110805052|NCT01079351|Carbamazepine|carbamazepine|mesh-list
110805053|NCT01079351|Anticonvulsants|anticonvulsants|mesh-ancestor
110805054|NCT01079351|Antimanic Agents|antimanic agents|mesh-ancestor
110805055|NCT01079351|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110805056|NCT01079351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110805057|NCT01079351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110805058|NCT01079351|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110805059|NCT01079351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110805060|NCT01079351|Analgesics|analgesics|mesh-ancestor
110805061|NCT01079351|Sensory System Agents|sensory system agents|mesh-ancestor
110805062|NCT01079351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110805063|NCT01079351|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110805064|NCT01079351|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110805065|NCT01079351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110805066|NCT01079351|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110805067|NCT01079351|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110805068|NCT00104104|Zoledronic Acid|zoledronic acid|mesh-list
110805069|NCT00104104|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110805070|NCT00104104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110805071|NCT02158624|Ranibizumab|ranibizumab|mesh-list
110805072|NCT02158624|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110805073|NCT02158624|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110805074|NCT02158624|Growth Substances|growth substances|mesh-ancestor
110805075|NCT02158624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110805076|NCT02158624|Growth Inhibitors|growth inhibitors|mesh-ancestor
110805077|NCT02158624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110805078|NCT00115739|Imatinib Mesylate|imatinib mesylate|mesh-list
110805079|NCT00115739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110805080|NCT00115739|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110805081|NCT00115739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110805082|NCT00115739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110805083|NCT03639519|Ascorbic Acid|ascorbic acid|mesh-list
110805084|NCT03639519|Antioxidants|antioxidants|mesh-ancestor
110805085|NCT03639519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110805086|NCT03639519|Protective Agents|protective agents|mesh-ancestor
110805087|NCT03639519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110805088|NCT03639519|Vitamins|vitamins|mesh-ancestor
110805089|NCT03639519|Micronutrients|micronutrients|mesh-ancestor
110805090|NCT02158702|Dexamethasone|dexamethasone|mesh-list
110805091|NCT02158702|Pomalidomide|pomalidomide|mesh-list
110805092|NCT02158702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110805093|NCT02158702|Antiemetics|antiemetics|mesh-ancestor
110805094|NCT02158702|Autonomic Agents|autonomic agents|mesh-ancestor
110805095|NCT02158702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110805096|NCT02158702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110805097|NCT02158702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110805098|NCT02158702|Glucocorticoids|glucocorticoids|mesh-ancestor
110805099|NCT02158702|Hormones|hormones|mesh-ancestor
110805100|NCT02158702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110805101|NCT02158702|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110805102|NCT02158702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110805103|NCT02158702|Immunologic Factors|immunologic factors|mesh-ancestor
110805104|NCT02158702|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110805105|NCT02158702|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110805106|NCT02158702|Growth Substances|growth substances|mesh-ancestor
110805107|NCT02158702|Growth Inhibitors|growth inhibitors|mesh-ancestor
110805108|NCT03725709|Anesthetics|anesthetics|mesh-list
110805109|NCT03725709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110805110|NCT03725709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110805111|NCT01761890|Dasatinib|dasatinib|mesh-list
110805112|NCT01761890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110805113|NCT01761890|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110805114|NCT01761890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110805115|NCT01761890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110805116|NCT02160028|Anesthetics|anesthetics|mesh-list
110805117|NCT02160028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110805118|NCT02160028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110805119|NCT03246152|Bevacizumab|bevacizumab|mesh-list
110805120|NCT03246152|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110805121|NCT03246152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110805122|NCT03246152|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110805123|NCT03246152|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110805124|NCT03246152|Growth Substances|growth substances|mesh-ancestor
110805125|NCT03246152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110805126|NCT03246152|Growth Inhibitors|growth inhibitors|mesh-ancestor
110805127|NCT03541564|Moxifloxacin|moxifloxacin|mesh-list
110805128|NCT03541564|Deucravacitinib|deucravacitinib|mesh-list
110805129|NCT03541564|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110805130|NCT03541564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110549271|NCT00687648|Exemestane|exemestane|mesh-list
110805131|NCT03541564|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110805132|NCT03541564|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110805133|NCT03541564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110805134|NCT03541564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110805135|NCT03541564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110805136|NCT03541564|Dermatologic Agents|dermatologic agents|mesh-ancestor
110805137|NCT03541564|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110805138|NCT00115349|Deferiprone|deferiprone|mesh-list
110805139|NCT00115349|Deferoxamine|deferoxamine|mesh-list
110805140|NCT00115349|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110805141|NCT00115349|Chelating Agents|chelating agents|mesh-ancestor
110805142|NCT00115349|Sequestering Agents|sequestering agents|mesh-ancestor
110805143|NCT00115349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110805144|NCT00115349|Siderophores|siderophores|mesh-ancestor
110805147|NCT04804696|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110805148|NCT04804696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110805149|NCT04804696|Tubulin Modulators|tubulin modulators|mesh-ancestor
110805150|NCT04804696|Antimitotic Agents|antimitotic agents|mesh-ancestor
110805151|NCT04804696|Mitosis Modulators|mitosis modulators|mesh-ancestor
110805152|NCT04804696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110805153|NCT00115037|Naltrexone|naltrexone|mesh-list
110805154|NCT00115037|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110805155|NCT00115037|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110805156|NCT00115037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110805157|NCT00115037|Sensory System Agents|sensory system agents|mesh-ancestor
110805158|NCT00115037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110805159|NCT02160106|Vactosertib|vactosertib|mesh-list
110805160|NCT02160106|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110805161|NCT02160106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110549295|NCT00687648|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110805162|NCT02160106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110805163|NCT02160184|Pancrelipase|pancrelipase|mesh-list
110805164|NCT02160184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110805165|NCT03725553|Vasopressins|vasopressins|mesh-list
110805166|NCT03725553|Arginine Vasopressin|arginine vasopressin|mesh-list
110805167|NCT03725553|Hemostatics|hemostatics|mesh-ancestor
110805168|NCT03725553|Coagulants|coagulants|mesh-ancestor
110805169|NCT03725553|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110805170|NCT03725553|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
110805171|NCT03725553|Natriuretic Agents|natriuretic agents|mesh-ancestor
110805172|NCT03725553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110805173|NCT03213626|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110805174|NCT03213626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110805175|NCT03213626|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110805176|NCT03213626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110805177|NCT03213626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110805178|NCT03604341|Dronabinol|dronabinol|mesh-list
110805179|NCT03604341|Hallucinogens|hallucinogens|mesh-ancestor
110805180|NCT03604341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110805181|NCT03604341|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110805182|NCT03604341|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110805183|NCT03604341|Analgesics|analgesics|mesh-ancestor
110805184|NCT03604341|Sensory System Agents|sensory system agents|mesh-ancestor
110805185|NCT03604341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110805186|NCT03604341|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
110805187|NCT03604341|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110805188|NCT03604341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110805189|NCT03604341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110805190|NCT03604341|Hormones|hormones|mesh-ancestor
110805191|NCT03604341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110805192|NCT02160574|Chlorhexidine|chlorhexidine|mesh-list
110805193|NCT02160574|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110852645|NCT02440230|Anastrozole|anastrozole|mesh-list
110805194|NCT02160574|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110805195|NCT02160574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110805196|NCT02160574|Disinfectants|disinfectants|mesh-ancestor
110805197|NCT02160574|Dermatologic Agents|dermatologic agents|mesh-ancestor
110805198|NCT01186640|Cyclophosphamide|cyclophosphamide|mesh-list
110805199|NCT01186640|Fludarabine|fludarabine|mesh-list
110805200|NCT01186640|Fludarabine phosphate|fludarabine phosphate|mesh-list
110805201|NCT01186640|Mitoxantrone|mitoxantrone|mesh-list
110805202|NCT01186640|Alemtuzumab|alemtuzumab|mesh-list
110805203|NCT01186640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110805204|NCT01186640|Immunologic Factors|immunologic factors|mesh-ancestor
110805205|NCT01186640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110805206|NCT01186640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110805207|NCT01186640|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110805208|NCT01186640|Alkylating Agents|alkylating agents|mesh-ancestor
110805209|NCT01186640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110805210|NCT01186640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110805211|NCT01186640|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110805212|NCT01186640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110805213|NCT01186640|Antimetabolites|antimetabolites|mesh-ancestor
110805214|NCT01186640|Analgesics|analgesics|mesh-ancestor
110805215|NCT01186640|Sensory System Agents|sensory system agents|mesh-ancestor
110805216|NCT01186640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110805217|NCT01186640|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110805218|NCT01186640|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110805219|NCT01186640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110805220|NCT01186640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110805221|NCT04949516|Aspirin|aspirin|mesh-list
110805222|NCT04949516|Colchicine|colchicine|mesh-list
110805223|NCT04949516|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110805224|NCT04949516|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110805225|NCT04949516|Analgesics|analgesics|mesh-ancestor
110805226|NCT04949516|Sensory System Agents|sensory system agents|mesh-ancestor
110805227|NCT04949516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110805228|NCT04949516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110805229|NCT04949516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110805230|NCT04949516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110805231|NCT04949516|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110805232|NCT04949516|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110805233|NCT04949516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110805234|NCT04949516|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110805235|NCT04949516|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110805236|NCT04949516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110805237|NCT04949516|Antipyretics|antipyretics|mesh-ancestor
110805238|NCT04949516|Gout Suppressants|gout suppressants|mesh-ancestor
110805239|NCT04949516|Tubulin Modulators|tubulin modulators|mesh-ancestor
110805240|NCT04949516|Antimitotic Agents|antimitotic agents|mesh-ancestor
110805241|NCT04949516|Mitosis Modulators|mitosis modulators|mesh-ancestor
110805242|NCT04949516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110805243|NCT00114959|Imatinib Mesylate|imatinib mesylate|mesh-list
110805244|NCT00114959|Homoharringtonine|homoharringtonine|mesh-list
110805245|NCT00114959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110805246|NCT00114959|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110805247|NCT00114959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110805248|NCT00114959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110805249|NCT00114959|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110805250|NCT00114959|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110805251|NCT02778100|Phenylephrine|phenylephrine|mesh-list
110805252|NCT02778100|Oxymetazoline|oxymetazoline|mesh-list
110805253|NCT02778100|Glucagon|glucagon|mesh-list
110805254|NCT02778100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110805255|NCT02778100|Hormones|hormones|mesh-ancestor
110805256|NCT02778100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110805257|NCT02778100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110805258|NCT02778100|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110805259|NCT02778100|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110805260|NCT02778100|Adrenergic Agents|adrenergic agents|mesh-ancestor
110805261|NCT02778100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110805262|NCT02778100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110805263|NCT02778100|Sympathomimetics|sympathomimetics|mesh-ancestor
110805264|NCT02778100|Autonomic Agents|autonomic agents|mesh-ancestor
110805265|NCT02778100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110805266|NCT02778100|Nasal Decongestants|nasal decongestants|mesh-ancestor
110805267|NCT02778100|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110805268|NCT02778100|Respiratory System Agents|respiratory system agents|mesh-ancestor
110805269|NCT02778100|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110805270|NCT02778100|Mydriatics|mydriatics|mesh-ancestor
110805271|NCT02778100|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110805272|NCT02778100|Protective Agents|protective agents|mesh-ancestor
110805273|NCT02159248|Tolfenamic acid|tolfenamic acid|mesh-list
110805274|NCT02159248|Gemcitabine|gemcitabine|mesh-list
110805275|NCT02159248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110805276|NCT02159248|Antimetabolites|antimetabolites|mesh-ancestor
110805277|NCT02159248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110805278|NCT02159248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110805279|NCT02159248|Analgesics|analgesics|mesh-ancestor
110805280|NCT02159248|Sensory System Agents|sensory system agents|mesh-ancestor
110805281|NCT02159248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110805282|NCT02159248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110805283|NCT02159248|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110805284|NCT02159248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110805285|NCT02159248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110805286|NCT02159248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110805287|NCT02159248|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110805288|NCT02159248|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110805289|NCT02159248|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110805290|NCT02159248|Prostaglandin Antagonists|prostaglandin antagonists|mesh-ancestor
110805291|NCT02159248|Hormone Antagonists|hormone antagonists|mesh-ancestor
110805292|NCT02159248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110805293|NCT02159248|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110805294|NCT02159248|Serotonin Agents|serotonin agents|mesh-ancestor
110805295|NCT02159248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110805296|NCT00118157|Tamoxifen|tamoxifen|mesh-list
110805297|NCT00118157|Lapatinib|lapatinib|mesh-list
110805298|NCT00118157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110805299|NCT00118157|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110805300|NCT00118157|Hormone Antagonists|hormone antagonists|mesh-ancestor
110805301|NCT00118157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110805302|NCT00118157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110805303|NCT00118157|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110805304|NCT00118157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110805305|NCT00118157|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110805306|NCT00118157|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110805307|NCT00118157|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110805308|NCT00118157|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110805309|NCT00118157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110805310|NCT03543202|Anesthetics|anesthetics|mesh-list
110805311|NCT03543202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110805312|NCT03543202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110805313|NCT03552549|Interferons|interferons|mesh-list
110805314|NCT03552549|Interferon-alpha|interferon-alpha|mesh-list
110805315|NCT03552549|Interferon alpha-2|interferon alpha-2|mesh-list
110549728|NCT05342467|Oxytocics|oxytocics|mesh-ancestor
110805316|NCT03552549|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110805317|NCT03552549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110805318|NCT03552549|Antiviral Agents|antiviral agents|mesh-ancestor
110805319|NCT03552549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110805320|NCT03552549|Immunologic Factors|immunologic factors|mesh-ancestor
110805321|NCT03552549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110805322|NCT00117845|Denileukin diftitox|denileukin diftitox|mesh-list
110805323|NCT00117845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110805324|NCT02761642|Epoetin Alfa|epoetin alfa|mesh-list
110805325|NCT02761642|Hematinics|hematinics|mesh-ancestor
110805326|NCT03731403|Fluorides|fluorides|mesh-list
110805327|NCT03731403|Cariostatic Agents|cariostatic agents|mesh-ancestor
110805328|NCT03731403|Protective Agents|protective agents|mesh-ancestor
110805329|NCT03731403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110805330|NCT03189524|Zanubrutinib|zanubrutinib|mesh-list
110805331|NCT03189524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110805332|NCT03189524|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110805333|NCT03189524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110805334|NCT03189524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110805335|NCT03600909|Cyclophosphamide|cyclophosphamide|mesh-list
110805336|NCT03600909|Busulfan|busulfan|mesh-list
110805337|NCT03600909|Fludarabine|fludarabine|mesh-list
110805338|NCT03600909|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110805339|NCT03600909|Thymoglobulin|thymoglobulin|mesh-list
110805340|NCT03600909|Lenograstim|lenograstim|mesh-list
110805341|NCT03600909|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110805342|NCT03600909|Immunologic Factors|immunologic factors|mesh-ancestor
110805343|NCT03600909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110805344|NCT03600909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110805345|NCT03600909|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110805346|NCT03600909|Alkylating Agents|alkylating agents|mesh-ancestor
110805347|NCT03600909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110805348|NCT03600909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110805349|NCT03600909|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110805350|NCT03600909|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110805351|NCT03189446|Paclitaxel|paclitaxel|mesh-list
110805352|NCT03189446|Carboplatin|carboplatin|mesh-list
110805353|NCT03189446|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110549848|NCT00692952|Nonoxynol|nonoxynol|mesh-list
110805354|NCT03189446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110805355|NCT03189446|Tubulin Modulators|tubulin modulators|mesh-ancestor
110805356|NCT03189446|Antimitotic Agents|antimitotic agents|mesh-ancestor
110805357|NCT03189446|Mitosis Modulators|mitosis modulators|mesh-ancestor
110805358|NCT03189446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110805359|NCT01314482|Minocycline|minocycline|mesh-list
110805360|NCT01314482|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110805361|NCT01314482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110805362|NCT03188120|Tiotropium Bromide|tiotropium bromide|mesh-list
110805363|NCT03188120|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110805364|NCT03188120|Autonomic Agents|autonomic agents|mesh-ancestor
110805365|NCT03188120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110805366|NCT03188120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110805367|NCT03188120|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110805368|NCT03188120|Respiratory System Agents|respiratory system agents|mesh-ancestor
110805369|NCT03188120|Parasympatholytics|parasympatholytics|mesh-ancestor
110805370|NCT03188120|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110805371|NCT03188120|Cholinergic Agents|cholinergic agents|mesh-ancestor
110805372|NCT03188120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110805373|NCT03188120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110805374|NCT02895945|Factor VIII|factor viii|mesh-list
110805375|NCT02895945|Coagulants|coagulants|mesh-ancestor
110805376|NCT02777554|Thalidomide|thalidomide|mesh-list
110805377|NCT02777554|Apremilast|apremilast|mesh-list
110805378|NCT02777554|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110805379|NCT02777554|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110805380|NCT02777554|Analgesics|analgesics|mesh-ancestor
110805381|NCT02777554|Sensory System Agents|sensory system agents|mesh-ancestor
110805382|NCT02777554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110805383|NCT02777554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110805384|NCT02777554|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110805385|NCT02777554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110852665|NCT00706966|Hormone Antagonists|hormone antagonists|mesh-ancestor
110549972|NCT00912444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110805386|NCT02777554|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
110805387|NCT02777554|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110805388|NCT02777554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110805389|NCT02777554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110805390|NCT02777554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110805391|NCT02777554|Immunologic Factors|immunologic factors|mesh-ancestor
110805392|NCT02777554|Leprostatic Agents|leprostatic agents|mesh-ancestor
110805393|NCT02777554|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110805394|NCT02777554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110805395|NCT02777554|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110805396|NCT02777554|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110805397|NCT02777554|Growth Substances|growth substances|mesh-ancestor
110805398|NCT02777554|Growth Inhibitors|growth inhibitors|mesh-ancestor
110805399|NCT02777554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110805401|NCT03220178|Fulvestrant|fulvestrant|mesh-list
110805402|NCT03220178|Palbociclib|palbociclib|mesh-list
110805403|NCT03220178|Anastrozole|anastrozole|mesh-list
110805404|NCT03220178|Exemestane|exemestane|mesh-list
110805405|NCT03220178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110805406|NCT03220178|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110805407|NCT03220178|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110805408|NCT03220178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110805409|NCT03220178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110805410|NCT03220178|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110805411|NCT03220178|Hormone Antagonists|hormone antagonists|mesh-ancestor
110805412|NCT03220178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110805413|NCT03220178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110805414|NCT03220178|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110805415|NCT03220178|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110805416|NCT03220178|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110805417|NCT03032510|Levofloxacin|levofloxacin|mesh-list
110805418|NCT03032510|Ertapenem|ertapenem|mesh-list
110805419|NCT03032510|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110805420|NCT03032510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110805421|NCT03032510|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110805422|NCT03032510|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110805423|NCT03032510|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110805424|NCT03032510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110805425|NCT03032510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110805426|NCT03032510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110805427|NCT03032510|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110805428|NCT03032510|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110805429|NCT03022292|Aflibercept|aflibercept|mesh-list
110805430|NCT03022292|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110805431|NCT03022292|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110805432|NCT03022292|Growth Substances|growth substances|mesh-ancestor
110805433|NCT03022292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110805434|NCT03022292|Growth Inhibitors|growth inhibitors|mesh-ancestor
110523007|NCT05766553|Nicotine|nicotine|mesh-list
110805435|NCT03022292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110805436|NCT03599193|Nicotinic Acids|nicotinic acids|mesh-list
110805437|NCT03599193|Tazarotene|tazarotene|mesh-list
110805438|NCT03599193|Dermatologic Agents|dermatologic agents|mesh-ancestor
110805439|NCT03599193|Keratolytic Agents|keratolytic agents|mesh-ancestor
110805440|NCT03599193|Vitamin B Complex|vitamin b complex|mesh-ancestor
110805441|NCT03599193|Vitamins|vitamins|mesh-ancestor
110805442|NCT03599193|Micronutrients|micronutrients|mesh-ancestor
110805443|NCT03599193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110805444|NCT02161354|Buprenorphine|buprenorphine|mesh-list
110805445|NCT02161354|Naloxone|naloxone|mesh-list
110805446|NCT02161354|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110805447|NCT02161354|Narcotics|narcotics|mesh-ancestor
110805448|NCT02161354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110805449|NCT02161354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110805450|NCT02161354|Analgesics|analgesics|mesh-ancestor
110805451|NCT02161354|Sensory System Agents|sensory system agents|mesh-ancestor
110805452|NCT02161354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110805453|NCT02161354|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110805454|NCT03166124|Insulin Lispro|insulin lispro|mesh-list
110805455|NCT03166124|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110805456|NCT03166124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110805457|NCT02777242|Methyltestosterone|methyltestosterone|mesh-list
110805458|NCT02777242|Testosterone|testosterone|mesh-list
110805459|NCT02777242|Testosterone undecanoate|testosterone undecanoate|mesh-list
110805460|NCT02777242|Testosterone enanthate|testosterone enanthate|mesh-list
110805461|NCT02777242|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
110805462|NCT02777242|Androgens|androgens|mesh-ancestor
110805463|NCT02777242|Hormones|hormones|mesh-ancestor
110805464|NCT02777242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110805465|NCT02777242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110805466|NCT02777242|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110805467|NCT02777242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110805468|NCT02777242|Anabolic Agents|anabolic agents|mesh-ancestor
110805469|NCT02163070|Vitamins|vitamins|mesh-list
110805470|NCT02163070|Vitamin E|vitamin e|mesh-list
110805471|NCT02163070|Micronutrients|micronutrients|mesh-ancestor
110805472|NCT02163070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110805473|NCT02163070|Antioxidants|antioxidants|mesh-ancestor
110805474|NCT02163070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110805475|NCT02163070|Protective Agents|protective agents|mesh-ancestor
110805476|NCT03484520|Venetoclax|venetoclax|mesh-list
110805477|NCT03484520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110805478|NCT03566979|Naproxen|naproxen|mesh-list
110805479|NCT03566979|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110805480|NCT03566979|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110805481|NCT03566979|Analgesics|analgesics|mesh-ancestor
110805482|NCT03566979|Sensory System Agents|sensory system agents|mesh-ancestor
110805483|NCT03566979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110550123|NCT00884390|Factor VIII|factor viii|mesh-list
110805484|NCT03566979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110805485|NCT03566979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110805486|NCT03566979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110805487|NCT03566979|Gout Suppressants|gout suppressants|mesh-ancestor
110805488|NCT03566979|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110805489|NCT03566979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110805490|NCT03566979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110805491|NCT00116831|Rosiglitazone|rosiglitazone|mesh-list
110805492|NCT00116831|Glipizide|glipizide|mesh-list
110805493|NCT00116831|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110805494|NCT00116831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110805495|NCT02784704|Meropenem|meropenem|mesh-list
110805496|NCT02784704|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110805497|NCT02784704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110805498|NCT03540472|Tacrolimus|tacrolimus|mesh-list
110805499|NCT03540472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110805500|NCT03540472|Immunologic Factors|immunologic factors|mesh-ancestor
110805501|NCT03540472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110805502|NCT03540472|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110805503|NCT03540472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110805504|NCT03540472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110805505|NCT02166814|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110805506|NCT02166814|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110805507|NCT02166814|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110805508|NCT02166814|Antimetabolites|antimetabolites|mesh-ancestor
110805509|NCT02166814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110805510|NCT02166814|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110805511|NCT02166814|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110805512|NCT02166814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110805513|NCT01310283|Fluorides|fluorides|mesh-list
110805515|NCT01310283|Cariostatic Agents|cariostatic agents|mesh-ancestor
110805516|NCT01310283|Protective Agents|protective agents|mesh-ancestor
110805517|NCT01310283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110805518|NCT02161822|Simvastatin|simvastatin|mesh-list
110805519|NCT02161822|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110805520|NCT02161822|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110805521|NCT02161822|Antimetabolites|antimetabolites|mesh-ancestor
110805522|NCT02161822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110805523|NCT02161822|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110805524|NCT02161822|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110852695|NCT01302587|Tocolytic Agents|tocolytic agents|mesh-ancestor
110805525|NCT02161822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110805527|NCT03183908|Immunologic Factors|immunologic factors|mesh-ancestor
110805528|NCT03183908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110805529|NCT03724851|Vactosertib|vactosertib|mesh-list
110805530|NCT03724851|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110805531|NCT03724851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110805532|NCT03724851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110805533|NCT03565887|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110805534|NCT03565887|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110805535|NCT00113399|Paclitaxel|paclitaxel|mesh-list
110805536|NCT00113399|Docetaxel|docetaxel|mesh-list
110805537|NCT00113399|Fluorouracil|fluorouracil|mesh-list
110805538|NCT00113399|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110805539|NCT00113399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110805540|NCT00113399|Tubulin Modulators|tubulin modulators|mesh-ancestor
110805541|NCT00113399|Antimitotic Agents|antimitotic agents|mesh-ancestor
110805542|NCT00113399|Mitosis Modulators|mitosis modulators|mesh-ancestor
110805543|NCT00113399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110805544|NCT00113399|Antimetabolites|antimetabolites|mesh-ancestor
110805545|NCT00113399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110805546|NCT00113399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110805547|NCT00113399|Immunologic Factors|immunologic factors|mesh-ancestor
110805548|NCT00113399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110805549|NCT01326611|Clarithromycin|clarithromycin|mesh-list
110805550|NCT01326611|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110805551|NCT01326611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110805552|NCT01326611|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110805553|NCT01326611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110805554|NCT01326611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110805555|NCT01326611|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110805556|NCT01326611|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110805557|NCT00113087|Enalapril|enalapril|mesh-list
110805558|NCT00113087|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110805559|NCT00113087|Protease Inhibitors|protease inhibitors|mesh-ancestor
110805560|NCT00113087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110805561|NCT00113087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110805562|NCT00113087|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110805563|NCT00112463|Romidepsin|romidepsin|mesh-list
110805564|NCT00112463|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110805565|NCT00112463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110805566|NCT00112463|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110805567|NCT00112463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110805568|NCT00112463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110805569|NCT01083017|Chlorthalidone|chlorthalidone|mesh-list
110805570|NCT01083017|Antihypertensive Agents|antihypertensive agents|mesh-list
110805571|NCT01083017|Diuretics|diuretics|mesh-ancestor
110805572|NCT01083017|Natriuretic Agents|natriuretic agents|mesh-ancestor
110805573|NCT01083017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110805574|NCT01083017|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110805575|NCT01083017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110805576|NCT01083017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110805577|NCT00112385|Etanercept|etanercept|mesh-list
110805578|NCT00112385|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110805579|NCT00112385|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110805580|NCT00112385|Analgesics|analgesics|mesh-ancestor
110805581|NCT00112385|Sensory System Agents|sensory system agents|mesh-ancestor
110805582|NCT00112385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110805583|NCT00112385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110805584|NCT00112385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110805585|NCT00112385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110523157|NCT05435677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110805586|NCT00112385|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110805587|NCT00112385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110805588|NCT00112385|Immunologic Factors|immunologic factors|mesh-ancestor
110805589|NCT03731169|Voriconazole|voriconazole|mesh-list
110805590|NCT03731169|Antifungal Agents|antifungal agents|mesh-ancestor
110805591|NCT03731169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110805592|NCT03731169|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110805593|NCT03731169|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110805594|NCT03731169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110805595|NCT03731169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110805596|NCT03731169|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110805597|NCT03731169|Hormone Antagonists|hormone antagonists|mesh-ancestor
110805598|NCT03731169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110805599|NCT03731169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110805600|NCT03731169|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110805601|NCT03731091|Calcitriol|calcitriol|mesh-list
110805602|NCT03731091|Betamethasone|betamethasone|mesh-list
110805603|NCT03731091|Betamethasone Valerate|betamethasone valerate|mesh-list
110805604|NCT03731091|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
110805605|NCT03731091|Betamethasone benzoate|betamethasone benzoate|mesh-list
110805606|NCT03731091|Calcipotriene|calcipotriene|mesh-list
110805607|NCT03731091|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
110805608|NCT03731091|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110805609|NCT03731091|Glucocorticoids|glucocorticoids|mesh-ancestor
110805610|NCT03731091|Hormones|hormones|mesh-ancestor
110805611|NCT03731091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110805612|NCT03731091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110805613|NCT03731091|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110805614|NCT03731091|Respiratory System Agents|respiratory system agents|mesh-ancestor
110805615|NCT03731091|Dermatologic Agents|dermatologic agents|mesh-ancestor
110805616|NCT03731091|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110805617|NCT03731091|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
110805618|NCT03731091|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110805619|NCT03731091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110805620|NCT03731091|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110805621|NCT03731091|Vitamins|vitamins|mesh-ancestor
110805622|NCT03731091|Micronutrients|micronutrients|mesh-ancestor
110805623|NCT03731091|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110805624|NCT03547167|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110805625|NCT03547167|Immunologic Factors|immunologic factors|mesh-ancestor
110805626|NCT03547167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110805627|NCT03560739|Ofatumumab|ofatumumab|mesh-list
110805628|NCT03560739|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110805629|NCT03560739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110805630|NCT03560739|Immunologic Factors|immunologic factors|mesh-ancestor
110805631|NCT03560739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110805632|NCT01310673|Allopurinol|allopurinol|mesh-list
110805633|NCT01310673|Antimetabolites|antimetabolites|mesh-ancestor
110805634|NCT01310673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110805635|NCT01310673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110805636|NCT01310673|Gout Suppressants|gout suppressants|mesh-ancestor
110805637|NCT01310673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110805638|NCT01310673|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110805639|NCT01310673|Antioxidants|antioxidants|mesh-ancestor
110805640|NCT01310673|Protective Agents|protective agents|mesh-ancestor
110805641|NCT01310673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110805642|NCT00101686|Bevacizumab|bevacizumab|mesh-list
110805643|NCT00101686|Capecitabine|capecitabine|mesh-list
110805644|NCT00101686|Irinotecan|irinotecan|mesh-list
110805645|NCT00101686|Fluorouracil|fluorouracil|mesh-list
110805646|NCT00101686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110805647|NCT00101686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110805648|NCT00101686|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110805649|NCT00101686|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110805650|NCT00101686|Growth Substances|growth substances|mesh-ancestor
110805651|NCT00101686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110805652|NCT00101686|Growth Inhibitors|growth inhibitors|mesh-ancestor
110805653|NCT00101686|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110805654|NCT00101686|Antimetabolites|antimetabolites|mesh-ancestor
110805655|NCT00101686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110805656|NCT00101686|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110805657|NCT00101686|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110805658|NCT00101686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110805659|NCT00101686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110805660|NCT00101686|Immunologic Factors|immunologic factors|mesh-ancestor
110805661|NCT02163616|Misoprostol|misoprostol|mesh-list
110805662|NCT02163616|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110805663|NCT02163616|Abortifacient Agents|abortifacient agents|mesh-ancestor
110805664|NCT02163616|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110805665|NCT02163616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110805666|NCT02163616|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110805667|NCT02163616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110805668|NCT02163616|Oxytocics|oxytocics|mesh-ancestor
110805669|NCT00101452|Escitalopram|escitalopram|mesh-list
110805670|NCT00101452|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110805671|NCT00101452|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110805672|NCT00101452|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110805673|NCT00101452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110805674|NCT00101452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110805675|NCT00101452|Serotonin Agents|serotonin agents|mesh-ancestor
110805676|NCT00101452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110805677|NCT02162134|Cefuroxime|cefuroxime|mesh-list
110805678|NCT02162134|Cefuroxime axetil|cefuroxime axetil|mesh-list
110805679|NCT02162134|Ketorolac|ketorolac|mesh-list
110805680|NCT02162134|Midazolam|midazolam|mesh-list
110805681|NCT02162134|Propofol|propofol|mesh-list
110805682|NCT02162134|Sevoflurane|sevoflurane|mesh-list
110805683|NCT02162134|Atracurium|atracurium|mesh-list
110805684|NCT02162134|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110805685|NCT02162134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110805686|NCT02162134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110805687|NCT02162134|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110805688|NCT02162134|Anesthetics, General|anesthetics, general|mesh-ancestor
110805689|NCT02162134|Anesthetics|anesthetics|mesh-ancestor
110805690|NCT02162134|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110805691|NCT02162134|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110805692|NCT02162134|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110805693|NCT02162134|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110805694|NCT02162134|GABA Modulators|gaba modulators|mesh-ancestor
110805695|NCT02162134|GABA Agents|gaba agents|mesh-ancestor
110805696|NCT02162134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110805697|NCT02162134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110805698|NCT02162134|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110805699|NCT02162134|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110805700|NCT02162134|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110805701|NCT02162134|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110805702|NCT02162134|Analgesics|analgesics|mesh-ancestor
110805703|NCT02162134|Sensory System Agents|sensory system agents|mesh-ancestor
110805704|NCT02162134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110805705|NCT02162134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110805706|NCT02162134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110805707|NCT02162134|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110805708|NCT02162134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110805709|NCT02162134|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110805710|NCT02162134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110805711|NCT02162134|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110805712|NCT02162134|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110805713|NCT02162134|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110805714|NCT02162134|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
110805715|NCT02162134|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110805716|NCT02162134|Cholinergic Agents|cholinergic agents|mesh-ancestor
110805717|NCT02164006|Brentuximab Vedotin|brentuximab vedotin|mesh-list
110805718|NCT02164006|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110805719|NCT02164006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110805720|NCT02164006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110805721|NCT02164006|Immunotoxins|immunotoxins|mesh-ancestor
110805722|NCT02164006|Immunoconjugates|immunoconjugates|mesh-ancestor
110805723|NCT02164006|Immunologic Factors|immunologic factors|mesh-ancestor
110805724|NCT02164006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110805725|NCT02167360|Tisagenlecleucel|tisagenlecleucel|mesh-list
110805726|NCT02167360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110805727|NCT02167360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110805728|NCT03546621|Tenofovir|tenofovir|mesh-list
110805729|NCT03546621|Antiviral Agents|antiviral agents|mesh-ancestor
110805730|NCT03546621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110805731|NCT03546621|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110805732|NCT03546621|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110805733|NCT03546621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110805734|NCT03546621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110805735|NCT03546621|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110805737|NCT02761330|Ketamine|ketamine|mesh-list
110805738|NCT02761330|Analgesics|analgesics|mesh-ancestor
110805739|NCT02761330|Sensory System Agents|sensory system agents|mesh-ancestor
110805740|NCT02761330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110805741|NCT02761330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110805742|NCT02761330|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110805743|NCT02761330|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110805744|NCT02761330|Anesthetics, General|anesthetics, general|mesh-ancestor
110805745|NCT02761330|Anesthetics|anesthetics|mesh-ancestor
110805746|NCT02761330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110805747|NCT02761330|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110805748|NCT02761330|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110805749|NCT02761330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110805750|NCT02761330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110805751|NCT03730857|Olanzapine|olanzapine|mesh-list
110805752|NCT03730857|Risperidone|risperidone|mesh-list
110805753|NCT03730857|Paliperidone Palmitate|paliperidone palmitate|mesh-list
110805754|NCT03730857|Antipsychotic Agents|antipsychotic agents|mesh-list
110805755|NCT03730857|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110805756|NCT03730857|Serotonin Agents|serotonin agents|mesh-ancestor
110805757|NCT03730857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110805758|NCT03730857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110805759|NCT03730857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110805760|NCT03730857|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110805761|NCT03730857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110805762|NCT03730857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110805763|NCT03730857|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110805764|NCT03730857|Dopamine Agents|dopamine agents|mesh-ancestor
110805765|NCT03730857|Antiemetics|antiemetics|mesh-ancestor
110805767|NCT03730857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110805768|NCT03730857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110805769|NCT03730857|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110805770|NCT03730857|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110805771|NCT03730857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110805772|NCT03730857|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110805773|NCT03730857|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110805774|NCT03726177|Aspirin|aspirin|mesh-list
110805775|NCT03726177|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110805776|NCT03726177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110805777|NCT03726177|Analgesics|analgesics|mesh-ancestor
110805778|NCT03726177|Sensory System Agents|sensory system agents|mesh-ancestor
110805779|NCT03726177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110805780|NCT03726177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110805781|NCT03726177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110805782|NCT03726177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110805783|NCT03726177|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110805784|NCT03726177|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110805785|NCT03726177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110805786|NCT03726177|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110805787|NCT03726177|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110805788|NCT03726177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110805789|NCT03726177|Antipyretics|antipyretics|mesh-ancestor
110805790|NCT03726099|Amoxicillin|amoxicillin|mesh-list
110805791|NCT03726099|Tetracycline|tetracycline|mesh-list
110805792|NCT03726099|Furazolidone|furazolidone|mesh-list
110805793|NCT03726099|Esomeprazole|esomeprazole|mesh-list
110805794|NCT03726099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110805795|NCT03726099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110805796|NCT03726099|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110852725|NCT03515941|Antidotes|antidotes|mesh-ancestor
110805797|NCT03726099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110805798|NCT03726099|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110805800|NCT03726099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110805801|NCT03726099|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110805802|NCT03726099|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110805803|NCT03726099|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110805804|NCT03726099|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
110805805|NCT03726099|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110805806|NCT03726099|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110805807|NCT03726099|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
110805808|NCT03723759|Insulin Aspart|insulin aspart|mesh-list
110805809|NCT03723759|Insulin, Long-Acting|insulin, long-acting|mesh-list
110805810|NCT03723759|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
110805811|NCT03723759|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110805812|NCT03723759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110805813|NCT03558555|Acetaminophen|acetaminophen|mesh-list
110805814|NCT03558555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110805815|NCT03558555|Analgesics|analgesics|mesh-ancestor
110805816|NCT03558555|Sensory System Agents|sensory system agents|mesh-ancestor
110805817|NCT03558555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110805818|NCT03558555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110805819|NCT03558555|Antipyretics|antipyretics|mesh-ancestor
110805820|NCT03726021|Oxaliplatin|oxaliplatin|mesh-list
110805821|NCT03726021|Irinotecan|irinotecan|mesh-list
110805822|NCT03726021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110805823|NCT03726021|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110805824|NCT03726021|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110805825|NCT03726021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110805826|NCT03726021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110805827|NCT05665023|Bevacizumab|bevacizumab|mesh-list
110805828|NCT05665023|Folfirinox|folfirinox|mesh-list
110805829|NCT05665023|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110805830|NCT05665023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110805831|NCT05665023|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110805832|NCT05665023|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110805833|NCT05665023|Growth Substances|growth substances|mesh-ancestor
110805834|NCT05665023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110805835|NCT05665023|Growth Inhibitors|growth inhibitors|mesh-ancestor
110805836|NCT03557931|Olanzapine|olanzapine|mesh-list
110805837|NCT03557931|Risperidone|risperidone|mesh-list
110805838|NCT03557931|Aripiprazole|aripiprazole|mesh-list
110805839|NCT03557931|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110805840|NCT03557931|Paliperidone Palmitate|paliperidone palmitate|mesh-list
110805842|NCT03557931|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
110805843|NCT03557931|Brexpiprazole|brexpiprazole|mesh-list
110805844|NCT03557931|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110805845|NCT03557931|Serotonin Agents|serotonin agents|mesh-ancestor
110805846|NCT03557931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110805847|NCT03557931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110805848|NCT03557931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110805849|NCT03557931|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110805850|NCT03557931|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110805851|NCT03557931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110805852|NCT03557931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110805853|NCT03557931|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110805854|NCT03557931|Dopamine Agents|dopamine agents|mesh-ancestor
110805855|NCT03557931|Antiemetics|antiemetics|mesh-ancestor
110805856|NCT03557931|Autonomic Agents|autonomic agents|mesh-ancestor
110805857|NCT03557931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110805858|NCT03557931|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110805859|NCT03557931|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110805860|NCT03557931|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110805861|NCT03557931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110805862|NCT03557931|Antidepressive Agents|antidepressive agents|mesh-ancestor
110805863|NCT03557931|Dopamine Agonists|dopamine agonists|mesh-ancestor
110805864|NCT03557931|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110805865|NCT03557931|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110805866|NCT03557931|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110805867|NCT03557931|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110805868|NCT03557931|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
110805869|NCT03557931|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110805870|NCT03557931|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110805871|NCT03557931|Adrenergic Agents|adrenergic agents|mesh-ancestor
110805872|NCT03977675|Ketamine|ketamine|mesh-list
110805873|NCT03977675|Analgesics|analgesics|mesh-ancestor
110805874|NCT03977675|Sensory System Agents|sensory system agents|mesh-ancestor
110805875|NCT03977675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110805876|NCT03977675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110805877|NCT03977675|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110805878|NCT03977675|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110805879|NCT03977675|Anesthetics, General|anesthetics, general|mesh-ancestor
110805880|NCT03977675|Anesthetics|anesthetics|mesh-ancestor
110805881|NCT03977675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110805882|NCT03977675|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110805883|NCT03977675|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110805884|NCT03977675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110805885|NCT03977675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110805886|NCT01066559|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
110805887|NCT01066559|Vasodilator Agents|vasodilator agents|mesh-ancestor
110805888|NCT01066559|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
110805889|NCT01066559|Protective Agents|protective agents|mesh-ancestor
110805890|NCT01066559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110805892|NCT00293813|Alendronate|alendronate|mesh-list
110805893|NCT00293813|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110805894|NCT00293813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110805895|NCT00293579|Pemetrexed|pemetrexed|mesh-list
110805896|NCT00293579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110805897|NCT00293579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110805898|NCT00293579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110805899|NCT00293579|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110805900|NCT00293579|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110805901|NCT00293423|polysaccharide-K|polysaccharide-k|mesh-list
110805902|NCT00293423|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110805903|NCT00293423|Immunologic Factors|immunologic factors|mesh-ancestor
110805904|NCT00293423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110805905|NCT00293423|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110805906|NCT00293423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110805907|NCT00293423|Antiviral Agents|antiviral agents|mesh-ancestor
110805908|NCT00293423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110805909|NCT00293423|Interferon Inducers|interferon inducers|mesh-ancestor
110805910|NCT00293423|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110805911|NCT00293423|Protective Agents|protective agents|mesh-ancestor
110805912|NCT03521817|Ethanol|ethanol|mesh-list
110805913|NCT03521817|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110805914|NCT03521817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110805915|NCT03521817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110805916|NCT03521817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110805917|NCT03538431|Buspirone|buspirone|mesh-list
110805918|NCT03538431|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110805919|NCT03538431|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110805920|NCT03538431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110805921|NCT03538431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110805922|NCT03538431|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110805923|NCT03538431|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110805924|NCT03538431|Serotonin Agents|serotonin agents|mesh-ancestor
110805925|NCT03538431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110805926|NCT03538431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110805927|NCT03521193|Aspirin|aspirin|mesh-list
110805928|NCT03521193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110805929|NCT03521193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110805930|NCT03521193|Analgesics|analgesics|mesh-ancestor
110805931|NCT03521193|Sensory System Agents|sensory system agents|mesh-ancestor
110805932|NCT03521193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110805933|NCT03521193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110805934|NCT03521193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110805935|NCT03521193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110805936|NCT03521193|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110805937|NCT03521193|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110805938|NCT03521193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110805939|NCT03521193|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110805940|NCT03521193|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110805941|NCT03521193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110805943|NCT00293267|Raltegravir Potassium|raltegravir potassium|mesh-list
110805944|NCT00293267|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110805945|NCT00293267|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110805946|NCT00293267|Antiviral Agents|antiviral agents|mesh-ancestor
110805947|NCT00293267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110805948|NCT00293267|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110805949|NCT00293267|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110805950|NCT00293267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110805951|NCT00293267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110805952|NCT03977441|Pramipexole|pramipexole|mesh-list
110805953|NCT03977441|Agomelatine|agomelatine|mesh-list
110805954|NCT03977441|Antioxidants|antioxidants|mesh-ancestor
110805955|NCT03977441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110805956|NCT03977441|Protective Agents|protective agents|mesh-ancestor
110805957|NCT03977441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110523525|NCT04376268|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110805958|NCT03977441|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110805959|NCT03977441|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110805960|NCT03977441|Dopamine Agonists|dopamine agonists|mesh-ancestor
110805961|NCT03977441|Dopamine Agents|dopamine agents|mesh-ancestor
110805962|NCT03977441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110805963|NCT03977441|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110805964|NCT03977441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110805965|NCT03536949|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110805966|NCT03536949|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110805967|NCT01080443|Mycophenolic Acid|mycophenolic acid|mesh-list
110805968|NCT01080443|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110805969|NCT01080443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110805970|NCT01080443|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110805971|NCT01080443|Antitubercular Agents|antitubercular agents|mesh-ancestor
110805972|NCT01080443|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110805973|NCT01080443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110805974|NCT01080443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110805975|NCT01080443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110805976|NCT00111917|Infliximab|infliximab|mesh-list
110805977|NCT00111917|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110805978|NCT00111917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110805979|NCT00111917|Dermatologic Agents|dermatologic agents|mesh-ancestor
110805980|NCT00111917|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110805981|NCT00111917|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110805982|NCT01067417|Hydroxychloroquine|hydroxychloroquine|mesh-list
110805983|NCT01067417|Antimalarials|antimalarials|mesh-ancestor
110805984|NCT01067417|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110805985|NCT01067417|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110805986|NCT01067417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110805987|NCT01067417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110805988|NCT01067417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110805989|NCT01067417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110805990|NCT03520569|Octreotide|octreotide|mesh-list
110805991|NCT03520569|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110805992|NCT03520569|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110805993|NCT03520569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110805994|NCT00111839|Pemetrexed|pemetrexed|mesh-list
110805995|NCT00111839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110805996|NCT00111839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110805997|NCT00111839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110805998|NCT00111839|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110805999|NCT00111839|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110806000|NCT03723291|Tocopherols|tocopherols|mesh-list
110806001|NCT03723291|Vitamin E|vitamin e|mesh-list
110806002|NCT03723291|Tocotrienols|tocotrienols|mesh-list
110806003|NCT03723291|alpha-Tocopherol|alpha-tocopherol|mesh-list
110806004|NCT03723291|Pentoxifylline|pentoxifylline|mesh-list
110806005|NCT03723291|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110806006|NCT03723291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110806007|NCT03723291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110806008|NCT03723291|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110806009|NCT03723291|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110806010|NCT03723291|Protective Agents|protective agents|mesh-ancestor
110806011|NCT03723291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110806012|NCT03723291|Vasodilator Agents|vasodilator agents|mesh-ancestor
110806013|NCT03723291|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110806014|NCT03723291|Antioxidants|antioxidants|mesh-ancestor
110806015|NCT03723291|Vitamins|vitamins|mesh-ancestor
110806016|NCT03723291|Micronutrients|micronutrients|mesh-ancestor
110806017|NCT00111761|Leucovorin|leucovorin|mesh-list
110806018|NCT00111761|Fluorouracil|fluorouracil|mesh-list
110806019|NCT00111761|Irinotecan|irinotecan|mesh-list
110806020|NCT00111761|Panitumumab|panitumumab|mesh-list
110806021|NCT00111761|Antimetabolites|antimetabolites|mesh-ancestor
110806022|NCT00111761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110806023|NCT00111761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110806024|NCT00111761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110806025|NCT00111761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110806026|NCT00111761|Immunologic Factors|immunologic factors|mesh-ancestor
110806027|NCT00111761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110806028|NCT00111761|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110806029|NCT00111761|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110806030|NCT00111761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110806031|NCT00111761|Antidotes|antidotes|mesh-ancestor
110806032|NCT00111761|Protective Agents|protective agents|mesh-ancestor
110806033|NCT00111761|Vitamin B Complex|vitamin b complex|mesh-ancestor
110806034|NCT00111761|Vitamins|vitamins|mesh-ancestor
110806035|NCT00111761|Micronutrients|micronutrients|mesh-ancestor
110806036|NCT00111761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110806037|NCT03519867|Bromides|bromides|mesh-list
110806038|NCT03519867|Rocuronium|rocuronium|mesh-list
110806039|NCT03519867|Anticonvulsants|anticonvulsants|mesh-ancestor
110806040|NCT03519867|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110806041|NCT03519867|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110806042|NCT03519867|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110806043|NCT03519867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110806044|NCT03519867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110806045|NCT03977285|Chlorhexidine|chlorhexidine|mesh-list
110806046|NCT03977285|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110806047|NCT03977285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110806048|NCT03977285|Disinfectants|disinfectants|mesh-ancestor
110806049|NCT03730311|Elsulfavirine|elsulfavirine|mesh-list
110806050|NCT03730311|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110806051|NCT03730311|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110806052|NCT03730311|Antiviral Agents|antiviral agents|mesh-ancestor
110806053|NCT03730311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110806054|NCT02763046|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110806055|NCT02763046|Immunologic Factors|immunologic factors|mesh-ancestor
110806056|NCT02763046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110806057|NCT02164552|Vitamin D|vitamin d|mesh-list
110806058|NCT02164552|Ergocalciferols|ergocalciferols|mesh-list
110806059|NCT02164552|Cholecalciferol|cholecalciferol|mesh-list
110806060|NCT02164552|Vitamins|vitamins|mesh-list
110806061|NCT02164552|Micronutrients|micronutrients|mesh-ancestor
110806062|NCT02164552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110806063|NCT02164552|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110806064|NCT02164552|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110806065|NCT03723135|Azacitidine|azacitidine|mesh-list
110806067|NCT03723135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110806068|NCT03723135|Antimetabolites|antimetabolites|mesh-ancestor
110806069|NCT03723135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110806070|NCT03723135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110806071|NCT03723135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110806073|NCT02762578|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110806074|NCT02762578|Insulin Aspart|insulin aspart|mesh-list
110806075|NCT02762578|Insulin, Long-Acting|insulin, long-acting|mesh-list
110806076|NCT02762578|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
110806077|NCT02762578|Biphasic Insulins|biphasic insulins|mesh-list
110806078|NCT02762578|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110806079|NCT02762578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110806080|NCT03540628|Thiamine|thiamine|mesh-list
110806081|NCT03540628|Vitamins|vitamins|mesh-ancestor
110806082|NCT03540628|Micronutrients|micronutrients|mesh-ancestor
110806083|NCT03540628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110806084|NCT03540628|Vitamin B Complex|vitamin b complex|mesh-ancestor
110806085|NCT02170948|Dexmedetomidine|dexmedetomidine|mesh-list
110806086|NCT02170948|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110806087|NCT02170948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110806088|NCT02170948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110806089|NCT02170948|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110806090|NCT02170948|Analgesics|analgesics|mesh-ancestor
110806091|NCT02170948|Sensory System Agents|sensory system agents|mesh-ancestor
110806092|NCT02170948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110806093|NCT02170948|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110806094|NCT02170948|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110806095|NCT02170948|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110806096|NCT02170948|Adrenergic Agents|adrenergic agents|mesh-ancestor
110806097|NCT02170948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110806098|NCT02170948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110806099|NCT02171026|Amiodarone|amiodarone|mesh-list
110806100|NCT02171026|Dabigatran|dabigatran|mesh-list
110806101|NCT02171026|Antithrombins|antithrombins|mesh-ancestor
110806102|NCT02171026|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110806103|NCT02171026|Protease Inhibitors|protease inhibitors|mesh-ancestor
110806104|NCT02171026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110806105|NCT02171026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110806106|NCT02171026|Anticoagulants|anticoagulants|mesh-ancestor
110806107|NCT02171026|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110806108|NCT02171026|Vasodilator Agents|vasodilator agents|mesh-ancestor
110806109|NCT02171026|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
110806110|NCT02171026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110806111|NCT02171026|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110806112|NCT02171026|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110806113|NCT02171026|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110806114|NCT02171026|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110806115|NCT02171026|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110806116|NCT02171026|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110806117|NCT02165020|Hyaluronic Acid|hyaluronic acid|mesh-list
110806118|NCT02165020|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110806119|NCT02165020|Immunologic Factors|immunologic factors|mesh-ancestor
110806120|NCT02165020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110806121|NCT02165020|Viscosupplements|viscosupplements|mesh-ancestor
110806122|NCT02165020|Protective Agents|protective agents|mesh-ancestor
110806123|NCT03514641|Bexagliflozin|bexagliflozin|mesh-list
110806124|NCT03514641|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110806125|NCT03514641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110806126|NCT03539224|Lamivudine|lamivudine|mesh-list
110806127|NCT03539224|Dolutegravir|dolutegravir|mesh-list
110806128|NCT03539224|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110806129|NCT03539224|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110806130|NCT03539224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110806131|NCT03539224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110806132|NCT03539224|Antiviral Agents|antiviral agents|mesh-ancestor
110806133|NCT03539224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110806134|NCT03539224|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110806135|NCT03539224|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110806136|NCT03539224|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110806137|NCT03539224|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110806138|NCT02171182|Capsaicin|capsaicin|mesh-list
110806139|NCT02171182|Antipruritics|antipruritics|mesh-ancestor
110806140|NCT02171182|Dermatologic Agents|dermatologic agents|mesh-ancestor
110806141|NCT02171182|Sensory System Agents|sensory system agents|mesh-ancestor
110806142|NCT02171182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110806143|NCT02171182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110806144|NCT00100828|Irinotecan|irinotecan|mesh-list
110806145|NCT00100828|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110806146|NCT00100828|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110806147|NCT00100828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110806148|NCT00100828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110806149|NCT00100828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110806150|NCT02165098|Cariprazine|cariprazine|mesh-list
110806151|NCT02165098|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110806152|NCT02165098|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110806153|NCT02165098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110806154|NCT02165098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110806155|NCT02165098|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110806156|NCT02171338|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110806157|NCT02171338|Azithromycin|azithromycin|mesh-list
110806158|NCT02171338|Clarithromycin|clarithromycin|mesh-list
110806159|NCT02171338|Ciprofloxacin|ciprofloxacin|mesh-list
110806160|NCT02171338|Tazobactam|tazobactam|mesh-list
110806161|NCT02171338|Piperacillin|piperacillin|mesh-list
110806162|NCT02171338|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
110806163|NCT02171338|Penicillin G|penicillin g|mesh-list
110806164|NCT02171338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110806165|NCT02171338|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110806166|NCT02171338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110806167|NCT02171338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110806168|NCT02171338|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110806169|NCT02171338|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110806170|NCT02171338|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110806171|NCT02171338|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110806172|NCT02171338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110806173|NCT02171338|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110806174|NCT02171338|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110806175|NCT02171416|Rilonacept|rilonacept|mesh-list
110806176|NCT02171416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110806177|NCT02171494|Warfarin|warfarin|mesh-list
110806178|NCT02171494|Anticoagulants|anticoagulants|mesh-ancestor
110806179|NCT02165332|Moxifloxacin|moxifloxacin|mesh-list
110806180|NCT02165332|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
110806181|NCT02165332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110806182|NCT02165332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110806183|NCT02165332|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110806184|NCT02165332|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110550926|NCT00532441|Docetaxel|docetaxel|mesh-list
110806185|NCT02165332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110806186|NCT02165332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110806187|NCT02165332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110806188|NCT02165332|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110806189|NCT02165332|Contraceptive Agents|contraceptive agents|mesh-ancestor
110806190|NCT02165332|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110806191|NCT02165332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110806192|NCT02165332|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110806193|NCT02165332|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110806194|NCT02165332|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110806195|NCT02171572|Dabigatran|dabigatran|mesh-list
110806196|NCT02171572|Antithrombins|antithrombins|mesh-ancestor
110806197|NCT02171572|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110806198|NCT02171572|Protease Inhibitors|protease inhibitors|mesh-ancestor
110806199|NCT02171572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110806200|NCT02171572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110806201|NCT02171572|Anticoagulants|anticoagulants|mesh-ancestor
110806202|NCT02255578|Clomiphene|clomiphene|mesh-list
110806203|NCT02255578|Enclomiphene|enclomiphene|mesh-list
110806204|NCT02255578|Zuclomiphene|zuclomiphene|mesh-list
110806205|NCT02255578|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110806206|NCT02255578|Hormone Antagonists|hormone antagonists|mesh-ancestor
110806207|NCT02255578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110806208|NCT02255578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110806209|NCT02255578|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110806210|NCT02255578|Fertility Agents|fertility agents|mesh-ancestor
110806211|NCT02255578|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110852746|NCT03819647|Stiripentol|stiripentol|mesh-list
110806212|NCT02255578|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110806213|NCT02255578|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110806214|NCT02169154|Diclofenac|diclofenac|mesh-list
110806215|NCT02169154|Menthol|menthol|mesh-list
110806216|NCT02169154|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110806217|NCT02169154|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110806218|NCT02169154|Analgesics|analgesics|mesh-ancestor
110806219|NCT02169154|Sensory System Agents|sensory system agents|mesh-ancestor
110806220|NCT02169154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110806221|NCT02169154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110806222|NCT02169154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110806223|NCT02169154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110806224|NCT02169154|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110806225|NCT02169154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110806226|NCT02169154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110806227|NCT02169154|Antipruritics|antipruritics|mesh-ancestor
110806228|NCT02169154|Dermatologic Agents|dermatologic agents|mesh-ancestor
110806229|NCT00100048|Tenofovir|tenofovir|mesh-list
110806230|NCT00100048|Lamivudine|lamivudine|mesh-list
110806231|NCT00100048|Efavirenz|efavirenz|mesh-list
110806232|NCT00100048|Raltegravir Potassium|raltegravir potassium|mesh-list
110806233|NCT00100048|Antiviral Agents|antiviral agents|mesh-ancestor
110806234|NCT00100048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110806235|NCT00100048|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110551098|NCT02715947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110806236|NCT00100048|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110806237|NCT00100048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110806238|NCT00100048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110806239|NCT00100048|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110806240|NCT00100048|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110806241|NCT00100048|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110806242|NCT00100048|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110806243|NCT00100048|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110806244|NCT00100048|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110806245|NCT00100048|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110806246|NCT00100048|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110806247|NCT00100048|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110806248|NCT00100048|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110806249|NCT02171650|Afatinib|afatinib|mesh-list
110806250|NCT02171650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110806251|NCT02171650|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110806252|NCT02171650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110806253|NCT02171650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110806254|NCT02165566|Insulin|insulin|mesh-list
110806255|NCT02165566|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110806256|NCT02165566|Insulin Lispro|insulin lispro|mesh-list
110806257|NCT02165566|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110806258|NCT02165566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110806259|NCT02171728|Afatinib|afatinib|mesh-list
110806260|NCT02171728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110806261|NCT02171728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110806262|NCT02171728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110806263|NCT02171728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110806265|NCT02165644|Acetazolamide|acetazolamide|mesh-list
110806266|NCT02165644|Anticonvulsants|anticonvulsants|mesh-ancestor
110806267|NCT02165644|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110806268|NCT02165644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110806269|NCT02165644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110806270|NCT02165644|Diuretics|diuretics|mesh-ancestor
110806271|NCT02165644|Natriuretic Agents|natriuretic agents|mesh-ancestor
110806272|NCT02165644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110806273|NCT02165644|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110806274|NCT02165644|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110806275|NCT02165644|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110806276|NCT02165644|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110806277|NCT02165644|Vasodilator Agents|vasodilator agents|mesh-ancestor
110806278|NCT02171806|Olodaterol|olodaterol|mesh-list
110806279|NCT02171806|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110806280|NCT02171806|Autonomic Agents|autonomic agents|mesh-ancestor
110852768|NCT01302821|Tryptophan|tryptophan|mesh-list
110806281|NCT02171806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110806282|NCT02171806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110806283|NCT02171806|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110806284|NCT02171806|Respiratory System Agents|respiratory system agents|mesh-ancestor
110806285|NCT02169544|Abatacept|abatacept|mesh-list
110806286|NCT02169544|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110806287|NCT02169544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110806288|NCT02169544|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110806289|NCT02169544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110806290|NCT02169544|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110806291|NCT02169544|Immunologic Factors|immunologic factors|mesh-ancestor
110806292|NCT02169544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110806293|NCT02169544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110806294|NCT02169856|Cefuroxime|cefuroxime|mesh-list
110806295|NCT02169856|Cefuroxime axetil|cefuroxime axetil|mesh-list
110806296|NCT02169856|Ketorolac|ketorolac|mesh-list
110806297|NCT02169856|Midazolam|midazolam|mesh-list
110806298|NCT02169856|Propofol|propofol|mesh-list
110806299|NCT02169856|Sevoflurane|sevoflurane|mesh-list
110806300|NCT02169856|Atracurium|atracurium|mesh-list
110806301|NCT02169856|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110806302|NCT02169856|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110806303|NCT02169856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110806304|NCT02169856|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110806305|NCT02169856|Anesthetics, General|anesthetics, general|mesh-ancestor
110806306|NCT02169856|Anesthetics|anesthetics|mesh-ancestor
110551322|NCT02714699|Diclofenac|diclofenac|mesh-list
110806307|NCT02169856|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110806308|NCT02169856|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110806309|NCT02169856|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110806310|NCT02169856|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110806311|NCT02169856|GABA Modulators|gaba modulators|mesh-ancestor
110806312|NCT02169856|GABA Agents|gaba agents|mesh-ancestor
110806313|NCT02169856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110806314|NCT02169856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110806315|NCT02169856|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110806316|NCT02169856|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110806317|NCT02169856|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110806318|NCT02169856|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110806319|NCT02169856|Analgesics|analgesics|mesh-ancestor
110806320|NCT02169856|Sensory System Agents|sensory system agents|mesh-ancestor
110806321|NCT02169856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110806322|NCT02169856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110806323|NCT02169856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110806324|NCT02169856|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110806325|NCT02169856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110806326|NCT02169856|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110806327|NCT02169856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110806328|NCT02169856|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110806329|NCT02169856|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110806330|NCT02169856|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110806331|NCT02169856|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
110806332|NCT02169856|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110806333|NCT02169856|Cholinergic Agents|cholinergic agents|mesh-ancestor
110806334|NCT02170246|Telmisartan|telmisartan|mesh-list
110806335|NCT02170246|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110806336|NCT02170246|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110806337|NCT02170246|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110806338|NCT02170246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110806339|NCT02170324|Exenatide|exenatide|mesh-list
110806340|NCT02170324|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110806341|NCT02170324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110806342|NCT02170324|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110806343|NCT02170324|Incretins|incretins|mesh-ancestor
110806344|NCT02170324|Hormones|hormones|mesh-ancestor
110806345|NCT02170324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110806346|NCT02170402|Factor VIII|factor viii|mesh-list
110806347|NCT02170402|Coagulants|coagulants|mesh-ancestor
110806348|NCT02172196|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110806349|NCT02172196|Empagliflozin|empagliflozin|mesh-list
110806350|NCT02172196|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110806351|NCT02172196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110806352|NCT02172196|Incretins|incretins|mesh-ancestor
110806353|NCT02172196|Hormones|hormones|mesh-ancestor
110806354|NCT02172196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110806355|NCT02172196|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110806356|NCT02172196|Protease Inhibitors|protease inhibitors|mesh-ancestor
110806357|NCT02172196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110806358|NCT02172196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110806359|NCT02172196|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110806360|NCT02172274|Empagliflozin|empagliflozin|mesh-list
110806361|NCT02172274|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110806362|NCT02172274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110806363|NCT02172274|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110806364|NCT02172274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110806365|NCT02172352|Tiotropium Bromide|tiotropium bromide|mesh-list
110806366|NCT02172352|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110806367|NCT02172352|Autonomic Agents|autonomic agents|mesh-ancestor
110806368|NCT02172352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110806369|NCT02172352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110806371|NCT02172352|Respiratory System Agents|respiratory system agents|mesh-ancestor
110806372|NCT02172352|Parasympatholytics|parasympatholytics|mesh-ancestor
110806373|NCT02172352|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110806374|NCT02172352|Cholinergic Agents|cholinergic agents|mesh-ancestor
110806375|NCT02172352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110806376|NCT02172352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110806377|NCT02757352|Ixekizumab|ixekizumab|mesh-list
110806378|NCT02757352|Dermatologic Agents|dermatologic agents|mesh-ancestor
110806379|NCT02172430|Tiotropium Bromide|tiotropium bromide|mesh-list
110806380|NCT02172430|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110806381|NCT02172430|Autonomic Agents|autonomic agents|mesh-ancestor
110806382|NCT02172430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110806383|NCT02172430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110806384|NCT02172430|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110806385|NCT02172430|Respiratory System Agents|respiratory system agents|mesh-ancestor
110806386|NCT02172430|Parasympatholytics|parasympatholytics|mesh-ancestor
110806387|NCT02172430|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110806388|NCT02172430|Cholinergic Agents|cholinergic agents|mesh-ancestor
110806389|NCT02172430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110806390|NCT02172430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110806391|NCT02172508|Tiotropium Bromide|tiotropium bromide|mesh-list
110806392|NCT02172508|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110806393|NCT02172508|Autonomic Agents|autonomic agents|mesh-ancestor
110806394|NCT02172508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110806395|NCT02172508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110806396|NCT02172508|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110806397|NCT02172508|Respiratory System Agents|respiratory system agents|mesh-ancestor
110806398|NCT02172508|Parasympatholytics|parasympatholytics|mesh-ancestor
110806399|NCT02172508|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110806400|NCT02172508|Cholinergic Agents|cholinergic agents|mesh-ancestor
110806401|NCT02172508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110806402|NCT02172508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110806403|NCT02172586|Losartan|losartan|mesh-list
110806404|NCT02172586|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110806405|NCT02172586|Telmisartan|telmisartan|mesh-list
110806406|NCT02172586|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110806407|NCT02172586|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110806408|NCT02172586|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110806409|NCT02172586|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110806410|NCT02172586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110806412|NCT02172586|Natriuretic Agents|natriuretic agents|mesh-ancestor
110806413|NCT02172586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110806414|NCT02172586|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110806415|NCT02172586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110806416|NCT02170636|Pantoprazole|pantoprazole|mesh-list
110806417|NCT02170636|Dabigatran|dabigatran|mesh-list
110806418|NCT02170636|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110806419|NCT02170636|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110806420|NCT02170636|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110806421|NCT02170636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110551633|NCT02714075|Zinc|zinc|mesh-list
110806422|NCT02170636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110806423|NCT02170636|Antithrombins|antithrombins|mesh-ancestor
110806424|NCT02170636|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110806425|NCT02170636|Protease Inhibitors|protease inhibitors|mesh-ancestor
110806426|NCT02170636|Anticoagulants|anticoagulants|mesh-ancestor
110806428|NCT02255734|Antiviral Agents|antiviral agents|mesh-ancestor
110806429|NCT02255734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110806430|NCT02170792|Ranitidine|ranitidine|mesh-list
110806431|NCT02170792|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
110806432|NCT02170792|Dabigatran|dabigatran|mesh-list
110806433|NCT02170792|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110806434|NCT02170792|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110806435|NCT02170792|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110806436|NCT02170792|Histamine Antagonists|histamine antagonists|mesh-ancestor
110806437|NCT02170792|Histamine Agents|histamine agents|mesh-ancestor
110806438|NCT02170792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110806439|NCT02170792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110806440|NCT02170792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110806441|NCT02170792|Antithrombins|antithrombins|mesh-ancestor
110806442|NCT02170792|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110806444|NCT02170792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110806445|NCT02170792|Anticoagulants|anticoagulants|mesh-ancestor
110806446|NCT02172976|Gemcitabine|gemcitabine|mesh-list
110806447|NCT02172976|Fluorouracil|fluorouracil|mesh-list
110806448|NCT02172976|Oxaliplatin|oxaliplatin|mesh-list
110806449|NCT02172976|Irinotecan|irinotecan|mesh-list
110806450|NCT02172976|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110806451|NCT02172976|Antimetabolites|antimetabolites|mesh-ancestor
110806452|NCT02172976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110806453|NCT02172976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110806454|NCT02172976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110806455|NCT02172976|Immunologic Factors|immunologic factors|mesh-ancestor
110806456|NCT02172976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110551779|NCT02713139|Metronidazole|metronidazole|mesh-list
110806457|NCT02172976|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110806458|NCT02172976|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110806459|NCT02172976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110806460|NCT02173132|Acetylcarnitine|acetylcarnitine|mesh-list
110806461|NCT02173132|Vitamin B Complex|vitamin b complex|mesh-ancestor
110806462|NCT02173132|Vitamins|vitamins|mesh-ancestor
110806463|NCT02173132|Micronutrients|micronutrients|mesh-ancestor
110806464|NCT02173132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110806465|NCT02173132|Nootropic Agents|nootropic agents|mesh-ancestor
110806466|NCT02173288|Furosemide|furosemide|mesh-list
110806467|NCT02173288|Spironolactone|spironolactone|mesh-list
110806468|NCT02173288|Tolvaptan|tolvaptan|mesh-list
110806469|NCT02173288|Midodrine|midodrine|mesh-list
110806470|NCT02173288|Diuretics|diuretics|mesh-ancestor
110806471|NCT02173288|Natriuretic Agents|natriuretic agents|mesh-ancestor
110806472|NCT02173288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110806473|NCT02173288|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110806474|NCT02173288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110806475|NCT02173288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110806476|NCT02173288|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110806477|NCT02173288|Hormone Antagonists|hormone antagonists|mesh-ancestor
110806478|NCT02173288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110806479|NCT02173288|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110806480|NCT02173288|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
110806481|NCT02173288|Sympathomimetics|sympathomimetics|mesh-ancestor
110806482|NCT02173288|Autonomic Agents|autonomic agents|mesh-ancestor
110806483|NCT02173288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110806484|NCT02173288|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110806485|NCT02173288|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110806486|NCT02173288|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110551900|NCT01005199|Everolimus|everolimus|mesh-list
110806487|NCT02173288|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110806488|NCT02173288|Adrenergic Agents|adrenergic agents|mesh-ancestor
110806489|NCT02173288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110806490|NCT02175394|Linagliptin|linagliptin|mesh-list
110806491|NCT02175394|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
110806492|NCT02175394|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
110806493|NCT02175394|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110806494|NCT02175394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110806495|NCT02175394|Incretins|incretins|mesh-ancestor
110806496|NCT02175394|Hormones|hormones|mesh-ancestor
110806497|NCT02175394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110806498|NCT02175394|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110806499|NCT02175394|Protease Inhibitors|protease inhibitors|mesh-ancestor
110806500|NCT02175394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110863864|NCT04495283|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110806501|NCT02175394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110806502|NCT02175394|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110806503|NCT02175394|Contraceptive Agents|contraceptive agents|mesh-ancestor
110806504|NCT02175394|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110806505|NCT02175394|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110806506|NCT02175394|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110806507|NCT02175394|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110806508|NCT02175394|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110806509|NCT02175394|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110806510|NCT02175394|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
110806511|NCT02175394|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
110806512|NCT02175394|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
110806513|NCT02256124|Lamotrigine|lamotrigine|mesh-list
110806514|NCT02256124|Anticonvulsants|anticonvulsants|mesh-ancestor
110806515|NCT02256124|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110806516|NCT02256124|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110806517|NCT02256124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110806518|NCT02256124|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110806519|NCT02256124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110806520|NCT02256124|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110806521|NCT02256124|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110806522|NCT02256124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110806523|NCT02256124|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110806524|NCT02256124|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110806526|NCT02173756|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110806527|NCT02173756|Narcotics|narcotics|mesh-ancestor
110806528|NCT02173756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110806529|NCT02173756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110806530|NCT02173756|Analgesics|analgesics|mesh-ancestor
110806531|NCT02173756|Sensory System Agents|sensory system agents|mesh-ancestor
110806532|NCT02173756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110806533|NCT00102466|Metformin|metformin|mesh-list
110806534|NCT00102466|Vildagliptin|vildagliptin|mesh-list
110806535|NCT00102466|Gliclazide|gliclazide|mesh-list
110806536|NCT00102466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110806537|NCT00102466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110806538|NCT00102466|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110806539|NCT00102466|Protease Inhibitors|protease inhibitors|mesh-ancestor
110806540|NCT00102466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110806541|NCT00102466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110806542|NCT02173834|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
110806543|NCT02173834|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110806544|NCT02173834|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110806545|NCT02173834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110806546|NCT02173834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110806547|NCT02173834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110806548|NCT02173912|Amlodipine|amlodipine|mesh-list
110806549|NCT02173912|Candesartan|candesartan|mesh-list
110806550|NCT02173912|Candesartan cilexetil|candesartan cilexetil|mesh-list
110806551|NCT02173912|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110806552|NCT02173912|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110806553|NCT02173912|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110806554|NCT02173912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110806555|NCT02173912|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110806556|NCT02173912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110806557|NCT02173912|Vasodilator Agents|vasodilator agents|mesh-ancestor
110806558|NCT02173912|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110806559|NCT02173912|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110806561|NCT02173990|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110806562|NCT02173990|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110806563|NCT02173990|Growth Substances|growth substances|mesh-ancestor
110806564|NCT02173990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110806565|NCT02173990|Growth Inhibitors|growth inhibitors|mesh-ancestor
110806566|NCT02173990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110806567|NCT02255812|Quinine|quinine|mesh-list
110806568|NCT02255812|Citric Acid|citric acid|mesh-list
110806569|NCT02255812|Sodium Citrate|sodium citrate|mesh-list
110806570|NCT02255812|Antimalarials|antimalarials|mesh-ancestor
110806571|NCT02255812|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110806572|NCT02255812|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110806573|NCT02255812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110806574|NCT02255812|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110552052|NCT01005979|Growth Substances|growth substances|mesh-ancestor
110806575|NCT02255812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110806576|NCT02255812|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110806577|NCT02255812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110806578|NCT02255812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110806579|NCT02255812|Analgesics|analgesics|mesh-ancestor
110806580|NCT02255812|Sensory System Agents|sensory system agents|mesh-ancestor
110806581|NCT02255812|Anticoagulants|anticoagulants|mesh-ancestor
110806582|NCT02255812|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110806583|NCT02255812|Chelating Agents|chelating agents|mesh-ancestor
110806584|NCT02255812|Sequestering Agents|sequestering agents|mesh-ancestor
110806585|NCT02255812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110806586|NCT02175784|Ipragliflozin|ipragliflozin|mesh-list
110806587|NCT02175784|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110806588|NCT02175784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110806589|NCT02175784|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110131738|NCT01970072|Midazolam|midazolam|mesh-list
110806590|NCT02175784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110806592|NCT02256280|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110806593|NCT02256280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110552099|NCT02710877|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110806594|NCT02256280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110806595|NCT02256280|Cholinergic Agents|cholinergic agents|mesh-ancestor
110806596|NCT02256280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110806597|NCT02256280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110806598|NCT02256280|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110806599|NCT02256280|Autonomic Agents|autonomic agents|mesh-ancestor
110806600|NCT02256280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110806601|NCT02174068|Acetaminophen|acetaminophen|mesh-list
110806602|NCT02174068|Nefopam|nefopam|mesh-list
110806603|NCT02174068|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110806604|NCT02174068|Analgesics|analgesics|mesh-ancestor
110806605|NCT02174068|Sensory System Agents|sensory system agents|mesh-ancestor
110806606|NCT02174068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110806607|NCT02174068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110806608|NCT02174068|Antipyretics|antipyretics|mesh-ancestor
110806609|NCT02179294|Meperidine|meperidine|mesh-list
110806610|NCT02179294|Remifentanil|remifentanil|mesh-list
110806611|NCT02179294|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110806612|NCT02179294|Narcotics|narcotics|mesh-ancestor
110806613|NCT02179294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110806614|NCT02179294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110806615|NCT02179294|Analgesics|analgesics|mesh-ancestor
110806616|NCT02179294|Sensory System Agents|sensory system agents|mesh-ancestor
110806617|NCT02179294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110806618|NCT02179294|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110806619|NCT02179528|Etoposide|etoposide|mesh-list
110806620|NCT02179528|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110806621|NCT02179528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110806622|NCT02179528|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110806623|NCT02179528|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110806624|NCT02179528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110806625|NCT02179528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110806626|NCT02176564|Bronchodilator Agents|bronchodilator agents|mesh-list
110806627|NCT02176564|Autonomic Agents|autonomic agents|mesh-ancestor
110806628|NCT02176564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110806629|NCT02176564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110806630|NCT02176564|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110806631|NCT02176564|Respiratory System Agents|respiratory system agents|mesh-ancestor
110806632|NCT02182102|Pemetrexed|pemetrexed|mesh-list
110806633|NCT02182102|Nintedanib|nintedanib|mesh-list
110806634|NCT02182102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110806636|NCT02182102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110806637|NCT02182102|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110806638|NCT02182102|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110806639|NCT02182102|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110806640|NCT02176720|Fluorides|fluorides|mesh-list
110806641|NCT02176720|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
110806642|NCT02176720|Cariostatic Agents|cariostatic agents|mesh-ancestor
110806643|NCT02176720|Protective Agents|protective agents|mesh-ancestor
110806644|NCT02176720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110806645|NCT02176720|Dopamine Agents|dopamine agents|mesh-ancestor
110806646|NCT02176720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110806647|NCT02176720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110806648|NCT02176876|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110552269|NCT02619786|Colistin|colistin|mesh-list
110806649|NCT02176876|Immunologic Factors|immunologic factors|mesh-ancestor
110806650|NCT02176876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110806651|NCT02182258|Nintedanib|nintedanib|mesh-list
110806652|NCT02182258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110806653|NCT02182258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110806654|NCT02182258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110806655|NCT02182258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110806656|NCT02182336|Vitamin K|vitamin k|mesh-list
110806657|NCT02182336|Digoxin|digoxin|mesh-list
110806658|NCT02182336|Midazolam|midazolam|mesh-list
110806659|NCT02182336|Dextromethorphan|dextromethorphan|mesh-list
110806660|NCT02182336|Caffeine|caffeine|mesh-list
110806661|NCT02182336|Omeprazole|omeprazole|mesh-list
110806662|NCT02182336|Warfarin|warfarin|mesh-list
110806663|NCT02182336|Vitamins|vitamins|mesh-ancestor
110806664|NCT02182336|Micronutrients|micronutrients|mesh-ancestor
110806665|NCT02182336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110806666|NCT02182336|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110806667|NCT02182336|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110806668|NCT02182336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110806669|NCT02182336|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110806670|NCT02182336|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110806671|NCT02182336|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110806672|NCT02182336|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110806673|NCT02182336|Anesthetics, General|anesthetics, general|mesh-ancestor
110806674|NCT02182336|Anesthetics|anesthetics|mesh-ancestor
110806675|NCT02182336|GABA Modulators|gaba modulators|mesh-ancestor
110806676|NCT02182336|GABA Agents|gaba agents|mesh-ancestor
110806677|NCT02182336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110852828|NCT03337828|Ethanol|ethanol|mesh-list
110552389|NCT00577642|Zoledronic Acid|zoledronic acid|mesh-list
110806678|NCT02182336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110806679|NCT02182336|Anticoagulants|anticoagulants|mesh-ancestor
110806680|NCT02182336|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110806681|NCT02182336|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110806682|NCT02182336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110806683|NCT02182336|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110806684|NCT02182336|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110806685|NCT02182336|Purinergic Agents|purinergic agents|mesh-ancestor
110806686|NCT02182336|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110806687|NCT02182336|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110806688|NCT02182336|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110806689|NCT02182336|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110806690|NCT02182336|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110806691|NCT02182336|Protective Agents|protective agents|mesh-ancestor
110806692|NCT02182336|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110806693|NCT02182336|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110806694|NCT02182336|Hemostatics|hemostatics|mesh-ancestor
110806695|NCT02182336|Coagulants|coagulants|mesh-ancestor
110806696|NCT02182336|Antitussive Agents|antitussive agents|mesh-ancestor
110806697|NCT02182336|Respiratory System Agents|respiratory system agents|mesh-ancestor
110806698|NCT02182336|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110806699|NCT02182336|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110806700|NCT02182570|Epinastine|epinastine|mesh-list
110806701|NCT02182570|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110806702|NCT02182570|Histamine Antagonists|histamine antagonists|mesh-ancestor
110806703|NCT02182570|Histamine Agents|histamine agents|mesh-ancestor
110806704|NCT02182570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110806705|NCT02182570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110806706|NCT02182570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110806707|NCT02182648|Propofol|propofol|mesh-list
110806708|NCT02182648|Etomidate|etomidate|mesh-list
110806709|NCT02182648|Sevoflurane|sevoflurane|mesh-list
110806710|NCT02182648|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110552515|NCT02615106|Growth Substances|growth substances|mesh-ancestor
110806711|NCT02182648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110806712|NCT02182648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110806714|NCT02182648|Anesthetics, General|anesthetics, general|mesh-ancestor
110806715|NCT02182648|Anesthetics|anesthetics|mesh-ancestor
110806716|NCT02182648|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110806717|NCT02182648|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110806718|NCT02179996|Vaccines|vaccines|mesh-list
110806719|NCT02179996|Immunologic Factors|immunologic factors|mesh-ancestor
110806720|NCT02179996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110806721|NCT02177344|Bromides|bromides|mesh-list
110806722|NCT02177344|Ipratropium|ipratropium|mesh-list
110806723|NCT02177344|Anticonvulsants|anticonvulsants|mesh-ancestor
110806724|NCT02177344|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110806725|NCT02177344|Autonomic Agents|autonomic agents|mesh-ancestor
110806726|NCT02177344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110806727|NCT02177344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110806728|NCT02177344|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110806729|NCT02177344|Respiratory System Agents|respiratory system agents|mesh-ancestor
110806730|NCT02177344|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110806731|NCT02177344|Cholinergic Agents|cholinergic agents|mesh-ancestor
110806732|NCT02177344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110806733|NCT02177344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110806734|NCT03536494|Mirabegron|mirabegron|mesh-list
110806735|NCT03536494|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
110806736|NCT03536494|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110806737|NCT03536494|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110806738|NCT03536494|Adrenergic Agents|adrenergic agents|mesh-ancestor
110806739|NCT03536494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110806740|NCT03536494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110806741|NCT03536494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110806742|NCT03536494|Urological Agents|urological agents|mesh-ancestor
110806743|NCT02177422|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110806744|NCT02177422|Telmisartan|telmisartan|mesh-list
110806745|NCT02177422|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110806747|NCT02177422|Natriuretic Agents|natriuretic agents|mesh-ancestor
110806748|NCT02177422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110806749|NCT02177422|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110806750|NCT02177422|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110806751|NCT02177422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110806752|NCT02177422|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110806753|NCT02177422|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110806754|NCT02182960|Ibuprofen|ibuprofen|mesh-list
110806755|NCT02182960|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110806756|NCT02182960|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110806757|NCT02182960|Analgesics|analgesics|mesh-ancestor
110806758|NCT02182960|Sensory System Agents|sensory system agents|mesh-ancestor
110806759|NCT02182960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110806760|NCT02182960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110806761|NCT02182960|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110806762|NCT02182960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110806763|NCT02182960|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110806764|NCT02182960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110806765|NCT02182960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110806766|NCT05141968|Vitamin D|vitamin d|mesh-list
110806767|NCT05141968|Vitamins|vitamins|mesh-ancestor
110806768|NCT05141968|Micronutrients|micronutrients|mesh-ancestor
110806769|NCT05141968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110806770|NCT05141968|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110806771|NCT00110357|Irinotecan|irinotecan|mesh-list
110806772|NCT00110357|Cetuximab|cetuximab|mesh-list
110806773|NCT00110357|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110806774|NCT00110357|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110806775|NCT00110357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110806776|NCT00110357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110806777|NCT00110357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110806778|NCT00110357|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110806779|NCT02183038|Naproxen|naproxen|mesh-list
110806780|NCT02183038|Meloxicam|meloxicam|mesh-list
110806781|NCT02183038|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110806782|NCT02183038|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110552809|NCT00869778|Vaccines|vaccines|mesh-list
110806783|NCT02183038|Analgesics|analgesics|mesh-ancestor
110806784|NCT02183038|Sensory System Agents|sensory system agents|mesh-ancestor
110806785|NCT02183038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110806786|NCT02183038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110806787|NCT02183038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110806788|NCT02183038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110806789|NCT02183038|Gout Suppressants|gout suppressants|mesh-ancestor
110806790|NCT02183038|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110806791|NCT02183038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110806792|NCT02183038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110806793|NCT02183038|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110806794|NCT02752906|Vaccines|vaccines|mesh-list
110806795|NCT02752906|Immunologic Factors|immunologic factors|mesh-ancestor
110806796|NCT02752906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110806797|NCT00293033|Fentanyl|fentanyl|mesh-list
110806798|NCT00293033|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110806799|NCT00293033|Narcotics|narcotics|mesh-ancestor
110806800|NCT00293033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110806801|NCT00293033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110806802|NCT00293033|Analgesics|analgesics|mesh-ancestor
110806803|NCT00293033|Sensory System Agents|sensory system agents|mesh-ancestor
110806804|NCT00293033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110806805|NCT00293033|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110806806|NCT00293033|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110806807|NCT00293033|Anesthetics, General|anesthetics, general|mesh-ancestor
110806808|NCT00293033|Anesthetics|anesthetics|mesh-ancestor
110806809|NCT02183116|Meloxicam|meloxicam|mesh-list
110852840|NCT03510715|Pravastatin|pravastatin|mesh-list
110806810|NCT02183116|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110806811|NCT02183116|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110806812|NCT02183116|Analgesics|analgesics|mesh-ancestor
110806813|NCT02183116|Sensory System Agents|sensory system agents|mesh-ancestor
110806814|NCT02183116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110806815|NCT02183116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110806816|NCT02183116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110806817|NCT02183116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110806818|NCT02183116|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110806819|NCT02183116|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110806820|NCT02183116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110806821|NCT02183116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110806822|NCT02183194|Paclitaxel|paclitaxel|mesh-list
110806823|NCT02183194|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110806824|NCT02183194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110806825|NCT02183194|Tubulin Modulators|tubulin modulators|mesh-ancestor
110806826|NCT02183194|Antimitotic Agents|antimitotic agents|mesh-ancestor
110552986|NCT04873063|Beclomethasone|beclomethasone|mesh-list
110806827|NCT02183194|Mitosis Modulators|mitosis modulators|mesh-ancestor
110806828|NCT02183194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110806829|NCT02183272|Ketamine|ketamine|mesh-list
110806830|NCT02183272|Analgesics|analgesics|mesh-ancestor
110806831|NCT02183272|Sensory System Agents|sensory system agents|mesh-ancestor
110806832|NCT02183272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110806833|NCT02183272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110806834|NCT02183272|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110806835|NCT02183272|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110806836|NCT02183272|Anesthetics, General|anesthetics, general|mesh-ancestor
110806837|NCT02183272|Anesthetics|anesthetics|mesh-ancestor
110806838|NCT02183272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110553046|NCT00613145|Antimetabolites|antimetabolites|mesh-ancestor
110806839|NCT02183272|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110806840|NCT02183272|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110806841|NCT02183272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110806842|NCT02183272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110806843|NCT02177500|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110806844|NCT02177500|Telmisartan|telmisartan|mesh-list
110806845|NCT02177500|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
110806846|NCT02177500|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110806847|NCT02177500|Diuretics|diuretics|mesh-ancestor
110806848|NCT02177500|Natriuretic Agents|natriuretic agents|mesh-ancestor
110806849|NCT02177500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110806850|NCT02177500|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110806851|NCT02177500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110806852|NCT02177500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110806853|NCT02177500|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110806854|NCT02177500|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110806855|NCT02183350|Linagliptin|linagliptin|mesh-list
110806856|NCT02183350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110806857|NCT02183350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110806858|NCT02183350|Incretins|incretins|mesh-ancestor
110806859|NCT02183350|Hormones|hormones|mesh-ancestor
110806860|NCT02183350|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110806861|NCT02183350|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110806862|NCT02183350|Protease Inhibitors|protease inhibitors|mesh-ancestor
110553179|NCT00613223|Etoposide|etoposide|mesh-list
110806863|NCT02183350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110806864|NCT02183350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110806865|NCT03537898|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110806866|NCT03537898|Plasma-lyte 148|plasma-lyte 148|mesh-list
110806867|NCT03537898|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110806868|NCT02183428|Glyburide|glyburide|mesh-list
110806869|NCT02183428|Linagliptin|linagliptin|mesh-list
110806870|NCT02183428|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110806871|NCT02183428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110806872|NCT02183428|Incretins|incretins|mesh-ancestor
110806873|NCT02183428|Hormones|hormones|mesh-ancestor
110806874|NCT02183428|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110806875|NCT02183428|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110806876|NCT02183428|Protease Inhibitors|protease inhibitors|mesh-ancestor
110806878|NCT02183428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110806879|NCT01080911|Morphine|morphine|mesh-list
110806880|NCT01080911|Analgesics, Opioid|analgesics, opioid|mesh-list
110806881|NCT01080911|Narcotics|narcotics|mesh-ancestor
110806882|NCT01080911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110806883|NCT01080911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110806884|NCT01080911|Analgesics|analgesics|mesh-ancestor
110806885|NCT01080911|Sensory System Agents|sensory system agents|mesh-ancestor
110806886|NCT01080911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110806887|NCT02183506|Metformin|metformin|mesh-list
110806888|NCT02183506|Linagliptin|linagliptin|mesh-list
110806889|NCT02183506|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110806890|NCT02183506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110806891|NCT02183506|Incretins|incretins|mesh-ancestor
110806892|NCT02183506|Hormones|hormones|mesh-ancestor
110806893|NCT02183506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110806894|NCT02183506|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110806895|NCT02183506|Protease Inhibitors|protease inhibitors|mesh-ancestor
110806896|NCT02183506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110806897|NCT02183506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110806899|NCT02177734|Immunologic Factors|immunologic factors|mesh-ancestor
110806900|NCT02177734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110806901|NCT02183584|Linagliptin|linagliptin|mesh-list
110806902|NCT02183584|Rifampin|rifampin|mesh-list
110806903|NCT02183584|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110806904|NCT02183584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110806905|NCT02183584|Incretins|incretins|mesh-ancestor
110806906|NCT02183584|Hormones|hormones|mesh-ancestor
110806907|NCT02183584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110806908|NCT02183584|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110806909|NCT02183584|Protease Inhibitors|protease inhibitors|mesh-ancestor
110806910|NCT02183584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110806911|NCT02183584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110806912|NCT02183584|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110806913|NCT02183584|Antitubercular Agents|antitubercular agents|mesh-ancestor
110806914|NCT02183584|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110806915|NCT02183584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110806916|NCT02183584|Leprostatic Agents|leprostatic agents|mesh-ancestor
110806917|NCT02183584|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110806918|NCT02183584|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110806919|NCT02183584|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110806920|NCT02183584|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110806921|NCT02183584|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110806922|NCT02183584|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110806923|NCT02183584|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110806924|NCT03964493|Vancomycin|vancomycin|mesh-list
110806925|NCT03964493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110806926|NCT03964493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110806927|NCT01068353|Etanercept|etanercept|mesh-list
110806928|NCT01068353|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110806929|NCT01068353|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110806930|NCT01068353|Analgesics|analgesics|mesh-ancestor
110806931|NCT01068353|Sensory System Agents|sensory system agents|mesh-ancestor
110806932|NCT01068353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110524516|NCT02787356|Lidocaine|lidocaine|mesh-list
110806933|NCT01068353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110806934|NCT01068353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110806935|NCT01068353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110806936|NCT01068353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110806937|NCT01068353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110806938|NCT01068353|Immunologic Factors|immunologic factors|mesh-ancestor
110806939|NCT01083251|Vitamin D|vitamin d|mesh-list
110806940|NCT01083251|Ergocalciferols|ergocalciferols|mesh-list
110806941|NCT01083251|Cholecalciferol|cholecalciferol|mesh-list
110806942|NCT01083251|Vitamins|vitamins|mesh-list
110806943|NCT01083251|Entecavir|entecavir|mesh-list
110806944|NCT01083251|Micronutrients|micronutrients|mesh-ancestor
110806945|NCT01083251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110806946|NCT01083251|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110806947|NCT01083251|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110806948|NCT01083251|Antiviral Agents|antiviral agents|mesh-ancestor
110806949|NCT01083251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110806950|NCT02184052|Meloxicam|meloxicam|mesh-list
110806951|NCT02184052|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110806952|NCT02184052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110806953|NCT02184052|Analgesics|analgesics|mesh-ancestor
110806954|NCT02184052|Sensory System Agents|sensory system agents|mesh-ancestor
110806955|NCT02184052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110806956|NCT02184052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110806957|NCT02184052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110806958|NCT02184052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110553449|NCT00636935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110806959|NCT02184052|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110806960|NCT02184052|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110806961|NCT02184052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110806962|NCT02184052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110806963|NCT01083329|Nicotinic Acids|nicotinic acids|mesh-list
110806965|NCT01083329|Niacinamide|niacinamide|mesh-list
110806966|NCT01083329|Vitamin B Complex|vitamin b complex|mesh-ancestor
110806967|NCT01083329|Vitamins|vitamins|mesh-ancestor
110806968|NCT01083329|Micronutrients|micronutrients|mesh-ancestor
110806969|NCT01083329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110806970|NCT01083329|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110806971|NCT01083329|Antimetabolites|antimetabolites|mesh-ancestor
110806972|NCT01083329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110806973|NCT01083329|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110806974|NCT01083329|Vasodilator Agents|vasodilator agents|mesh-ancestor
110806975|NCT01083407|Chlorhexidine|chlorhexidine|mesh-list
110806976|NCT01083407|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110806977|NCT01083407|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110806978|NCT01083407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110806979|NCT01083407|Disinfectants|disinfectants|mesh-ancestor
110806980|NCT01083407|Dermatologic Agents|dermatologic agents|mesh-ancestor
110806981|NCT02181322|Meloxicam|meloxicam|mesh-list
110806982|NCT02181322|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110806983|NCT02181322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110806984|NCT02181322|Analgesics|analgesics|mesh-ancestor
110806985|NCT02181322|Sensory System Agents|sensory system agents|mesh-ancestor
110806986|NCT02181322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110806987|NCT02181322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110806988|NCT02181322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110806989|NCT02181322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110806990|NCT02181322|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110806991|NCT02181322|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110806992|NCT02181322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110806993|NCT02181322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110806994|NCT02184286|Nevirapine|nevirapine|mesh-list
110806995|NCT02184286|Saquinavir|saquinavir|mesh-list
110806996|NCT02184286|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110806997|NCT02184286|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110806998|NCT02184286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110806999|NCT02184286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110807000|NCT02184286|Antiviral Agents|antiviral agents|mesh-ancestor
110807001|NCT02184286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110807002|NCT02184286|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110807003|NCT02184286|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110807004|NCT02184286|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110807005|NCT02184286|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110807006|NCT02184286|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110807007|NCT02184286|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110807008|NCT02184286|Protease Inhibitors|protease inhibitors|mesh-ancestor
110807009|NCT02184286|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110807010|NCT02184286|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110807011|NCT02178124|Donepezil|donepezil|mesh-list
110807012|NCT02178124|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110807013|NCT02178124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110807014|NCT02178124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110807015|NCT02178124|Cholinergic Agents|cholinergic agents|mesh-ancestor
110807016|NCT02178124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110807017|NCT02178124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110807018|NCT02178124|Nootropic Agents|nootropic agents|mesh-ancestor
110807019|NCT02030314|Chlorthalidone|chlorthalidone|mesh-list
110807020|NCT02030314|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110807021|NCT02030314|Diuretics|diuretics|mesh-ancestor
110807022|NCT02030314|Natriuretic Agents|natriuretic agents|mesh-ancestor
110807023|NCT02030314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110807024|NCT02030314|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110807025|NCT02030314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110807026|NCT02030314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110807027|NCT02184364|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
110807028|NCT02184364|Estrogens|estrogens|mesh-ancestor
110807029|NCT02184364|Hormones|hormones|mesh-ancestor
110807030|NCT02184364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110807031|NCT02184364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110807032|NCT02181478|Cyclosporine|cyclosporine|mesh-list
110807033|NCT02181478|Mycophenolic Acid|mycophenolic acid|mesh-list
110807034|NCT02181478|Cyclophosphamide|cyclophosphamide|mesh-list
110807035|NCT02181478|Fludarabine|fludarabine|mesh-list
110807036|NCT02181478|Fludarabine phosphate|fludarabine phosphate|mesh-list
110807037|NCT02181478|Cyclosporins|cyclosporins|mesh-list
110807038|NCT02181478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110807039|NCT02181478|Immunologic Factors|immunologic factors|mesh-ancestor
110807040|NCT02181478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110807041|NCT02181478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110807042|NCT02181478|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110807043|NCT02181478|Alkylating Agents|alkylating agents|mesh-ancestor
110807044|NCT02181478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110807045|NCT02181478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110807046|NCT02181478|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110807047|NCT02181478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110807048|NCT02181478|Antimetabolites|antimetabolites|mesh-ancestor
110807049|NCT02181478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110807050|NCT02181478|Antifungal Agents|antifungal agents|mesh-ancestor
110807051|NCT02181478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110807052|NCT02181478|Dermatologic Agents|dermatologic agents|mesh-ancestor
110807053|NCT02181478|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110807054|NCT02181478|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110807055|NCT02181478|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110807056|NCT02181478|Antitubercular Agents|antitubercular agents|mesh-ancestor
110807057|NCT02181478|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110807058|NCT02755090|Nitrous Oxide|nitrous oxide|mesh-list
110807059|NCT02755090|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110807060|NCT02755090|Anesthetics, General|anesthetics, general|mesh-ancestor
110807061|NCT02755090|Anesthetics|anesthetics|mesh-ancestor
110807062|NCT02755090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110807063|NCT02755090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110807064|NCT02755090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110807065|NCT02755090|Analgesics|analgesics|mesh-ancestor
110807066|NCT02755090|Sensory System Agents|sensory system agents|mesh-ancestor
110807067|NCT02755090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110807068|NCT00109343|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110807069|NCT00109343|Immunologic Factors|immunologic factors|mesh-ancestor
110807070|NCT00109343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110807071|NCT02185690|Carboplatin|carboplatin|mesh-list
110807072|NCT02185690|Pemetrexed|pemetrexed|mesh-list
110807073|NCT02185690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110807074|NCT02185690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110807075|NCT02185690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110807076|NCT02185690|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110807077|NCT02185690|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110807078|NCT03536806|Canrenone|canrenone|mesh-list
110807079|NCT03536806|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110807080|NCT03536806|Hormone Antagonists|hormone antagonists|mesh-ancestor
110807081|NCT03536806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110807082|NCT03536806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110852872|NCT03815279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110807083|NCT03536806|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110807085|NCT03536806|Natriuretic Agents|natriuretic agents|mesh-ancestor
110807087|NCT00108485|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110807088|NCT00108485|Antimetabolites|antimetabolites|mesh-ancestor
110807089|NCT00108485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110807090|NCT00108485|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110807091|NCT00108485|Vasodilator Agents|vasodilator agents|mesh-ancestor
110807092|NCT00108485|Vitamin B Complex|vitamin b complex|mesh-ancestor
110807093|NCT00108485|Vitamins|vitamins|mesh-ancestor
110807094|NCT00108485|Micronutrients|micronutrients|mesh-ancestor
110807095|NCT00108485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110807096|NCT02181946|Fluconazole|fluconazole|mesh-list
110807097|NCT02181946|Nevirapine|nevirapine|mesh-list
110807098|NCT02181946|Antifungal Agents|antifungal agents|mesh-ancestor
110807099|NCT02181946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110807100|NCT02181946|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110807101|NCT02181946|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110807102|NCT02181946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110807103|NCT02181946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110807104|NCT02181946|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110807105|NCT02181946|Hormone Antagonists|hormone antagonists|mesh-ancestor
110807106|NCT02181946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110807107|NCT02181946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110807108|NCT02181946|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110807109|NCT02181946|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110807110|NCT02181946|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110807111|NCT02181946|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110807112|NCT02181946|Antiviral Agents|antiviral agents|mesh-ancestor
110807113|NCT02181946|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110807114|NCT02181946|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110807115|NCT02181946|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110807116|NCT02181946|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110807117|NCT00107783|Nitisinone|nitisinone|mesh-list
110807118|NCT00107783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110807119|NCT00107783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110807120|NCT02185768|Idarubicin|idarubicin|mesh-list
110807121|NCT02185768|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110807122|NCT02185768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110807123|NCT02185768|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110807124|NCT02185768|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110807125|NCT02185768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110807126|NCT02185768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110807127|NCT02182024|Dabigatran|dabigatran|mesh-list
110807128|NCT02182024|Antithrombins|antithrombins|mesh-ancestor
110807129|NCT02182024|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110807130|NCT02182024|Protease Inhibitors|protease inhibitors|mesh-ancestor
110807131|NCT02182024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110807132|NCT02182024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110852878|NCT03814733|Ketamine|ketamine|mesh-list
110807133|NCT02182024|Anticoagulants|anticoagulants|mesh-ancestor
110807134|NCT02185846|Dirithromycin|dirithromycin|mesh-list
110807135|NCT02185846|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110807136|NCT02185846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110807137|NCT02184832|Metformin|metformin|mesh-list
110807138|NCT02184832|Tryptophan|tryptophan|mesh-list
110807139|NCT02184832|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110807140|NCT02184832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110807141|NCT02184832|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110807142|NCT02184832|Antidepressive Agents|antidepressive agents|mesh-ancestor
110807143|NCT02184832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110807144|NCT01083797|Dexmedetomidine|dexmedetomidine|mesh-list
110807145|NCT01083797|Chloral Hydrate|chloral hydrate|mesh-list
110807146|NCT01083797|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110807147|NCT01083797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110807148|NCT01083797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110807149|NCT01083797|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110807150|NCT01083797|Analgesics|analgesics|mesh-ancestor
110807151|NCT01083797|Sensory System Agents|sensory system agents|mesh-ancestor
110807152|NCT01083797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110807153|NCT01083797|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110553996|NCT00659048|Ciclesonide|ciclesonide|mesh-list
110807154|NCT01083797|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110807155|NCT01083797|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110807156|NCT01083797|Adrenergic Agents|adrenergic agents|mesh-ancestor
110807157|NCT01083797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110807158|NCT01083797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110807159|NCT01083875|Amlexanox|amlexanox|mesh-list
110807160|NCT01083875|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110807161|NCT01068977|Bevacizumab|bevacizumab|mesh-list
110807162|NCT01068977|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110807163|NCT01068977|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110807164|NCT01068977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110807165|NCT01068977|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110807166|NCT01068977|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110807167|NCT01068977|Growth Substances|growth substances|mesh-ancestor
110807168|NCT01068977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110807169|NCT01068977|Growth Inhibitors|growth inhibitors|mesh-ancestor
110807170|NCT01068977|Immunologic Factors|immunologic factors|mesh-ancestor
110807171|NCT02184910|Gastrins|gastrins|mesh-list
110807172|NCT02184910|Hormones|hormones|mesh-ancestor
110807173|NCT02184910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110807174|NCT02184910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110807175|NCT02185924|Parecoxib|parecoxib|mesh-list
110807176|NCT02185924|Ropivacaine|ropivacaine|mesh-list
110807177|NCT02185924|Anesthetics, Local|anesthetics, local|mesh-ancestor
110807178|NCT02185924|Anesthetics|anesthetics|mesh-ancestor
110807179|NCT02185924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110807180|NCT02185924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110807181|NCT02185924|Sensory System Agents|sensory system agents|mesh-ancestor
110807182|NCT02185924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110807183|NCT02185924|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110807184|NCT02185924|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110807185|NCT02185924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110807186|NCT02185924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110807187|NCT02185924|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110807188|NCT02185924|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110807189|NCT02185924|Analgesics|analgesics|mesh-ancestor
110807190|NCT02185924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110807191|NCT02185924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110807192|NCT02185066|Metformin|metformin|mesh-list
110807193|NCT02185066|Atorvastatin|atorvastatin|mesh-list
110807194|NCT02185066|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110807195|NCT02185066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110807196|NCT02185066|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110807197|NCT02185066|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110807198|NCT02185066|Antimetabolites|antimetabolites|mesh-ancestor
110807199|NCT02185066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110807200|NCT02185066|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110807201|NCT02185066|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110807202|NCT02185066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110807203|NCT01081223|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
110807204|NCT01081223|Immunologic Factors|immunologic factors|mesh-ancestor
110807205|NCT01081223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110807206|NCT01069055|Acetaminophen|acetaminophen|mesh-list
110807207|NCT01069055|Lornoxicam|lornoxicam|mesh-list
110807208|NCT01069055|Piroxicam|piroxicam|mesh-list
110807209|NCT01069055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110807210|NCT01069055|Analgesics|analgesics|mesh-ancestor
110807211|NCT01069055|Sensory System Agents|sensory system agents|mesh-ancestor
110807212|NCT01069055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110807213|NCT01069055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110807214|NCT01069055|Antipyretics|antipyretics|mesh-ancestor
110807215|NCT01069055|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110807216|NCT01069055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110807217|NCT01069055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110807218|NCT01069055|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110807219|NCT01069055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110807220|NCT01069055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110807221|NCT01083953|Sevoflurane|sevoflurane|mesh-list
110807222|NCT01083953|Desflurane|desflurane|mesh-list
110807223|NCT01083953|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110807224|NCT01083953|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110807225|NCT01083953|Anesthetics, General|anesthetics, general|mesh-ancestor
110807226|NCT01083953|Anesthetics|anesthetics|mesh-ancestor
110807227|NCT01083953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110807228|NCT01083953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110807229|NCT02190526|Mesalamine|mesalamine|mesh-list
110807230|NCT02190526|Amitriptyline|amitriptyline|mesh-list
110807231|NCT02190526|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110807232|NCT02190526|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110807233|NCT02190526|Analgesics|analgesics|mesh-ancestor
110807234|NCT02190526|Sensory System Agents|sensory system agents|mesh-ancestor
110807235|NCT02190526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110807236|NCT02190526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110807237|NCT02190526|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110807238|NCT02190526|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110554288|NCT02633384|Sorbitol|sorbitol|mesh-list
110807239|NCT02190526|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110807240|NCT02190526|Antidepressive Agents|antidepressive agents|mesh-ancestor
110807241|NCT02190526|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110807242|NCT02190526|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110807243|NCT02190526|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110807244|NCT02190526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110807245|NCT02190526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110807246|NCT02190526|Adrenergic Agents|adrenergic agents|mesh-ancestor
110807247|NCT02190526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110807249|NCT01084031|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110807250|NCT01084031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110807251|NCT01084031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110807252|NCT01084031|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110807253|NCT01084031|Anesthetics, General|anesthetics, general|mesh-ancestor
110807254|NCT01084031|Anesthetics|anesthetics|mesh-ancestor
110807255|NCT02185222|Cholecalciferol|cholecalciferol|mesh-list
110807256|NCT02185222|Vitamin D|vitamin d|mesh-list
110807257|NCT02185222|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110807258|NCT02185222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110807259|NCT02185222|Vitamins|vitamins|mesh-ancestor
110807260|NCT02185222|Micronutrients|micronutrients|mesh-ancestor
110807261|NCT02185222|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110807262|NCT01084187|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
110807263|NCT01084187|Vasodilator Agents|vasodilator agents|mesh-ancestor
110807264|NCT01084187|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110807265|NCT01084187|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110807266|NCT01084187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110807267|NCT01084187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110807268|NCT01084187|Urological Agents|urological agents|mesh-ancestor
110807269|NCT02185300|Dolutegravir|dolutegravir|mesh-list
110807270|NCT02185300|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110807271|NCT02185300|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110807272|NCT02185300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110807273|NCT02185300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110807274|NCT02185300|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110852904|NCT03811223|Evolocumab|evolocumab|mesh-list
110807276|NCT02185300|Antiviral Agents|antiviral agents|mesh-ancestor
110807277|NCT02185300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110807278|NCT02190760|Dexamethasone|dexamethasone|mesh-list
110807279|NCT02190760|Bupivacaine|bupivacaine|mesh-list
110807280|NCT02190760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110807281|NCT02190760|Antiemetics|antiemetics|mesh-ancestor
110807282|NCT02190760|Autonomic Agents|autonomic agents|mesh-ancestor
110807283|NCT02190760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110807284|NCT02190760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110807285|NCT02190760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110807286|NCT02190760|Glucocorticoids|glucocorticoids|mesh-ancestor
110807287|NCT02190760|Hormones|hormones|mesh-ancestor
110554472|NCT02704481|Contraceptive Agents|contraceptive agents|mesh-ancestor
110807288|NCT02190760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110807289|NCT02190760|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110807290|NCT02190760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110807291|NCT02190760|Anesthetics, Local|anesthetics, local|mesh-ancestor
110807292|NCT02190760|Anesthetics|anesthetics|mesh-ancestor
110807293|NCT02190760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110807294|NCT02190760|Sensory System Agents|sensory system agents|mesh-ancestor
110807295|NCT02190838|Metformin|metformin|mesh-list
110807296|NCT02190838|Dacarbazine|dacarbazine|mesh-list
110807297|NCT02190838|Melatonin|melatonin|mesh-list
110807298|NCT02190838|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110807299|NCT02190838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110807300|NCT02190838|Antioxidants|antioxidants|mesh-ancestor
110807301|NCT02190838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110807302|NCT02190838|Protective Agents|protective agents|mesh-ancestor
110807303|NCT02190838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110807304|NCT02190838|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110807305|NCT02190838|Alkylating Agents|alkylating agents|mesh-ancestor
110807306|NCT02190838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110807307|NCT02185456|Metronidazole|metronidazole|mesh-list
110807308|NCT02185456|Miconazole|miconazole|mesh-list
110807309|NCT02185456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110807310|NCT02185456|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110807311|NCT02185456|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110807312|NCT02185456|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110807313|NCT02185456|Antifungal Agents|antifungal agents|mesh-ancestor
110807314|NCT02185456|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110807315|NCT02185456|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110807316|NCT02185456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110807317|NCT02185456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110807318|NCT02185456|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110807319|NCT02185456|Hormone Antagonists|hormone antagonists|mesh-ancestor
110807320|NCT02185456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110807321|NCT02185456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110807322|NCT02185456|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110807323|NCT02185456|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110807324|NCT02190994|Prednisone|prednisone|mesh-list
110807325|NCT02190994|Hydrocortisone|hydrocortisone|mesh-list
110807326|NCT02190994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110807327|NCT02190994|Glucocorticoids|glucocorticoids|mesh-ancestor
110807328|NCT02190994|Hormones|hormones|mesh-ancestor
110807329|NCT02190994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110807330|NCT02190994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110807331|NCT02190994|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110807332|NCT02190994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110807333|NCT02193568|Anesthetics|anesthetics|mesh-list
110807334|NCT02193568|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110807335|NCT02193568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110807336|NCT02191072|Omalizumab|omalizumab|mesh-list
110807337|NCT02191072|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110807338|NCT02191072|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110807339|NCT02191072|Respiratory System Agents|respiratory system agents|mesh-ancestor
110807340|NCT02191228|Linagliptin|linagliptin|mesh-list
110807341|NCT02191228|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110807342|NCT02191228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110807343|NCT02191228|Incretins|incretins|mesh-ancestor
110807344|NCT02191228|Hormones|hormones|mesh-ancestor
110852911|NCT03811223|Protease Inhibitors|protease inhibitors|mesh-ancestor
110807345|NCT02191228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110554624|NCT02632136|Bupivacaine|bupivacaine|mesh-list
110807346|NCT02191228|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110807348|NCT02191228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110807349|NCT02191228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110807350|NCT02186782|Citric Acid|citric acid|mesh-list
110807351|NCT02186782|Sodium Citrate|sodium citrate|mesh-list
110807352|NCT02186782|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110807353|NCT02186782|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110807354|NCT02186782|Clomiphene|clomiphene|mesh-list
110807355|NCT02186782|Enclomiphene|enclomiphene|mesh-list
110807356|NCT02186782|Zuclomiphene|zuclomiphene|mesh-list
110807357|NCT02186782|Estradiol|estradiol|mesh-list
110807358|NCT02186782|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110807359|NCT02186782|Anticoagulants|anticoagulants|mesh-ancestor
110807360|NCT02186782|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110807361|NCT02186782|Chelating Agents|chelating agents|mesh-ancestor
110807362|NCT02186782|Sequestering Agents|sequestering agents|mesh-ancestor
110807363|NCT02186782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110807364|NCT02186782|Estrogens|estrogens|mesh-ancestor
110807365|NCT02186782|Hormones|hormones|mesh-ancestor
110807366|NCT02186782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110807367|NCT02186782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110807368|NCT02186782|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110807369|NCT02186782|Contraceptive Agents|contraceptive agents|mesh-ancestor
110807370|NCT02186782|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110807371|NCT02186782|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110807372|NCT02186782|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110807373|NCT02186782|Hormone Antagonists|hormone antagonists|mesh-ancestor
110807374|NCT02186782|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110807375|NCT02186782|Fertility Agents|fertility agents|mesh-ancestor
110807376|NCT02186782|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110807377|NCT02186782|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110807378|NCT02187250|Metformin|metformin|mesh-list
110807379|NCT02187250|Liraglutide|liraglutide|mesh-list
110807380|NCT02187250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110807381|NCT02187250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110807382|NCT02187250|Incretins|incretins|mesh-ancestor
110524967|NCT00923195|Aldesleukin|aldesleukin|mesh-list
110807383|NCT02187250|Hormones|hormones|mesh-ancestor
110807384|NCT02187250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110807385|NCT03535480|Lenograstim|lenograstim|mesh-list
110807386|NCT03535480|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110807387|NCT03535480|Immunologic Factors|immunologic factors|mesh-ancestor
110554811|NCT00665756|Mitomycins|mitomycins|mesh-list
110807388|NCT03535480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110807389|NCT02187484|Telmisartan|telmisartan|mesh-list
110807390|NCT02187484|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110807391|NCT02187484|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110807392|NCT02187484|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110807393|NCT02187484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110807394|NCT02256748|Midazolam|midazolam|mesh-list
110807395|NCT02256748|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110807396|NCT02256748|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110807397|NCT02256748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110807398|NCT02256748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110807399|NCT02256748|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110807400|NCT02256748|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110807401|NCT02256748|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110852914|NCT03723031|Misoprostol|misoprostol|mesh-list
110807402|NCT02256748|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110807403|NCT02256748|Anesthetics, General|anesthetics, general|mesh-ancestor
110807404|NCT02256748|Anesthetics|anesthetics|mesh-ancestor
110807405|NCT02256748|GABA Modulators|gaba modulators|mesh-ancestor
110807406|NCT02256748|GABA Agents|gaba agents|mesh-ancestor
110807407|NCT02256748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110807408|NCT02256748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110807409|NCT02187562|Aspirin|aspirin|mesh-list
110807410|NCT02187562|Meloxicam|meloxicam|mesh-list
110807411|NCT02187562|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110807412|NCT02187562|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110807413|NCT02187562|Analgesics|analgesics|mesh-ancestor
110807414|NCT02187562|Sensory System Agents|sensory system agents|mesh-ancestor
110807415|NCT02187562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110807416|NCT02187562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110807418|NCT02187562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110807419|NCT02187562|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110807420|NCT02187562|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110807421|NCT02187562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110807422|NCT02187562|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110807423|NCT02187562|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110807424|NCT02187562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110807425|NCT02187562|Antipyretics|antipyretics|mesh-ancestor
110807426|NCT02187562|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110807427|NCT02187718|Anesthetics|anesthetics|mesh-list
110807428|NCT02187718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110807429|NCT02187718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110807430|NCT03535168|Midazolam|midazolam|mesh-list
110807431|NCT03535168|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110807432|NCT03535168|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110807433|NCT03535168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110807434|NCT03535168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110807435|NCT03535168|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110807436|NCT03535168|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110807437|NCT03535168|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110807438|NCT03535168|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110807439|NCT03535168|Anesthetics, General|anesthetics, general|mesh-ancestor
110807440|NCT03535168|Anesthetics|anesthetics|mesh-ancestor
110807441|NCT03535168|GABA Modulators|gaba modulators|mesh-ancestor
110807442|NCT03535168|GABA Agents|gaba agents|mesh-ancestor
110807443|NCT03535168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110807444|NCT03535168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110807445|NCT02192320|Dexamethasone|dexamethasone|mesh-list
110807446|NCT02192320|Atorvastatin|atorvastatin|mesh-list
110807447|NCT02192320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110807448|NCT02192320|Antiemetics|antiemetics|mesh-ancestor
110807449|NCT02192320|Autonomic Agents|autonomic agents|mesh-ancestor
110555058|NCT00666302|Tacrolimus|tacrolimus|mesh-list
110807450|NCT02192320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110807451|NCT02192320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110807452|NCT02192320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110807453|NCT02192320|Glucocorticoids|glucocorticoids|mesh-ancestor
110807454|NCT02192320|Hormones|hormones|mesh-ancestor
110807455|NCT02192320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110807456|NCT02192320|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110807457|NCT02192320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110807458|NCT02192320|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110807459|NCT02192320|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110807460|NCT02192320|Antimetabolites|antimetabolites|mesh-ancestor
110807461|NCT02192320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110807462|NCT02192320|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110807463|NCT02192320|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110807464|NCT02192320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110807465|NCT02187874|Oxytocin|oxytocin|mesh-list
110807467|NCT02187874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110807468|NCT02187874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110807469|NCT04870138|Azithromycin|azithromycin|mesh-list
110807470|NCT04870138|Ciprofloxacin|ciprofloxacin|mesh-list
110807471|NCT04870138|Ceftriaxone|ceftriaxone|mesh-list
110807472|NCT04870138|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110807473|NCT04870138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110807474|NCT04870138|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110807475|NCT04870138|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110807476|NCT04870138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110807477|NCT04870138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110807478|NCT04870138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110807479|NCT04870138|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110807480|NCT04870138|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110807481|NCT02188186|Metformin|metformin|mesh-list
110807482|NCT02188186|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110807483|NCT02188186|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110807484|NCT02188186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110807485|NCT02188186|Incretins|incretins|mesh-ancestor
110807486|NCT02188186|Hormones|hormones|mesh-ancestor
110807487|NCT02188186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110807488|NCT02188186|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110807489|NCT02188186|Protease Inhibitors|protease inhibitors|mesh-ancestor
110807490|NCT02188186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110807491|NCT02188186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110807492|NCT02192632|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
110807493|NCT02192632|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110807494|NCT02192632|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110807495|NCT02192632|Analgesics|analgesics|mesh-ancestor
110807496|NCT02192632|Sensory System Agents|sensory system agents|mesh-ancestor
110807497|NCT02192632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110807498|NCT02192632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110807499|NCT02192632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110807500|NCT02192632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110807501|NCT02192632|Dermatologic Agents|dermatologic agents|mesh-ancestor
110807502|NCT03535090|Methylprednisolone|methylprednisolone|mesh-list
110807503|NCT03535090|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110807504|NCT03535090|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110807505|NCT03535090|Prednisolone|prednisolone|mesh-list
110807506|NCT03535090|Prednisolone acetate|prednisolone acetate|mesh-list
110807507|NCT03535090|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110807508|NCT03535090|Prednisolone phosphate|prednisolone phosphate|mesh-list
110807509|NCT03535090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110807510|NCT03535090|Antiemetics|antiemetics|mesh-ancestor
110807511|NCT03535090|Autonomic Agents|autonomic agents|mesh-ancestor
110807512|NCT03535090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110807513|NCT03535090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110807514|NCT03535090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110807515|NCT03535090|Glucocorticoids|glucocorticoids|mesh-ancestor
110807516|NCT03535090|Hormones|hormones|mesh-ancestor
110807517|NCT03535090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110807518|NCT03535090|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110807519|NCT03535090|Protective Agents|protective agents|mesh-ancestor
110807520|NCT03535090|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110807521|NCT03535090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110807522|NCT03535870|Fluticasone|fluticasone|mesh-list
110807524|NCT03535870|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110807525|NCT03535870|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
110807526|NCT03535870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110807527|NCT03535870|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110807528|NCT03535870|Autonomic Agents|autonomic agents|mesh-ancestor
110807529|NCT03535870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110807530|NCT03535870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110807531|NCT03535870|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110807532|NCT03535870|Respiratory System Agents|respiratory system agents|mesh-ancestor
110807533|NCT03535870|Dermatologic Agents|dermatologic agents|mesh-ancestor
110807534|NCT03535870|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110807535|NCT03535870|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110807536|NCT03535870|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110807537|NCT03535870|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110807538|NCT03535870|Adrenergic Agents|adrenergic agents|mesh-ancestor
110807539|NCT03535870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110807540|NCT03535870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110807541|NCT03535870|Glucocorticoids|glucocorticoids|mesh-ancestor
110807542|NCT03535870|Hormones|hormones|mesh-ancestor
110807543|NCT03535870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110807544|NCT03535870|Sympathomimetics|sympathomimetics|mesh-ancestor
110807545|NCT02192710|Midazolam|midazolam|mesh-list
110807546|NCT02192710|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110807547|NCT02192710|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110807548|NCT02192710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110807549|NCT02192710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110807550|NCT02192710|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110807551|NCT02192710|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110807552|NCT02192710|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110807553|NCT02192710|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110807554|NCT02192710|Anesthetics, General|anesthetics, general|mesh-ancestor
110807555|NCT02192710|Anesthetics|anesthetics|mesh-ancestor
110807556|NCT02192710|GABA Modulators|gaba modulators|mesh-ancestor
110807557|NCT02192710|GABA Agents|gaba agents|mesh-ancestor
110807558|NCT02192710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110807559|NCT02192710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110807560|NCT02188654|Metformin|metformin|mesh-list
110807561|NCT02188654|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110807562|NCT02188654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110807563|NCT02192944|Chloroquine|chloroquine|mesh-list
110807564|NCT02192944|Piperaquine|piperaquine|mesh-list
110807565|NCT02192944|Artenimol|artenimol|mesh-list
110807566|NCT02192944|Amebicides|amebicides|mesh-ancestor
110807567|NCT02192944|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110807568|NCT02192944|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110807569|NCT02192944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110807570|NCT02192944|Antimalarials|antimalarials|mesh-ancestor
110807571|NCT02192944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110807572|NCT02193022|Miltefosine|miltefosine|mesh-list
110807573|NCT02193022|Antifungal Agents|antifungal agents|mesh-ancestor
110807574|NCT02193022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110807575|NCT02193022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110807576|NCT02193022|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110807577|NCT02193022|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110807578|NCT02188810|Vaccines|vaccines|mesh-list
110807579|NCT02188810|Immunologic Factors|immunologic factors|mesh-ancestor
110807580|NCT02188810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110807581|NCT02188888|Esmolol|esmolol|mesh-list
110807582|NCT02188888|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110807583|NCT02188888|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110807584|NCT02188888|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110807585|NCT02188888|Adrenergic Agents|adrenergic agents|mesh-ancestor
110807586|NCT02188888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110807587|NCT02188888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110807588|NCT02188888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110807589|NCT02256826|Ritonavir|ritonavir|mesh-list
110807590|NCT02256826|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110807591|NCT02256826|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110807592|NCT02256826|Protease Inhibitors|protease inhibitors|mesh-ancestor
110807593|NCT02256826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110807594|NCT02256826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110807595|NCT02256826|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110807596|NCT02256826|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110807597|NCT02256826|Antiviral Agents|antiviral agents|mesh-ancestor
110807598|NCT02256826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110807599|NCT02256826|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110807600|NCT02256826|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110807601|NCT03535792|Fentanyl|fentanyl|mesh-list
110807602|NCT03535792|Nalbuphine|nalbuphine|mesh-list
110807603|NCT03535792|Bupivacaine|bupivacaine|mesh-list
110807604|NCT03535792|Anesthetics, Local|anesthetics, local|mesh-ancestor
110525192|NCT02708628|Heparin|heparin|mesh-list
110807605|NCT03535792|Anesthetics|anesthetics|mesh-ancestor
110807606|NCT03535792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110807607|NCT03535792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110807608|NCT03535792|Sensory System Agents|sensory system agents|mesh-ancestor
110807609|NCT03535792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110807610|NCT03535792|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110807611|NCT03535792|Narcotics|narcotics|mesh-ancestor
110807612|NCT03535792|Analgesics|analgesics|mesh-ancestor
110807613|NCT03535792|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110807614|NCT03535792|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110807615|NCT03535792|Anesthetics, General|anesthetics, general|mesh-ancestor
110807616|NCT02193256|Prazosin|prazosin|mesh-list
110807617|NCT02193256|Varenicline|varenicline|mesh-list
110807618|NCT02193256|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110807619|NCT02193256|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110807620|NCT02193256|Cholinergic Agents|cholinergic agents|mesh-ancestor
110807621|NCT02193256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110807622|NCT02193256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110807623|NCT02193256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110807624|NCT02193256|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110807625|NCT02193256|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110807626|NCT02193256|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110807627|NCT02193256|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110807628|NCT02193256|Adrenergic Agents|adrenergic agents|mesh-ancestor
110807629|NCT03535558|Azithromycin|azithromycin|mesh-list
110555555|NCT04213781|Narcotics|narcotics|mesh-ancestor
110807630|NCT03535558|Fluoroquinolones|fluoroquinolones|mesh-list
110807631|NCT03535558|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
110807632|NCT03535558|Trimethoprim|trimethoprim|mesh-list
110807633|NCT03535558|Sulfamethoxazole|sulfamethoxazole|mesh-list
110807634|NCT03535558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110807635|NCT03535558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110807636|NCT03535558|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110807637|NCT03535558|Antimalarials|antimalarials|mesh-ancestor
110807638|NCT03535558|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110807639|NCT03535558|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110807640|NCT03535558|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110807641|NCT03535558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110807642|NCT03535558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110807643|NCT03535558|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110807644|NCT03535558|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
110807645|NCT03535558|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110807646|NCT03535558|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110807647|NCT02193334|Mitogens|mitogens|mesh-list
110807648|NCT02193334|Mitosis Modulators|mitosis modulators|mesh-ancestor
110807649|NCT02193334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110807650|NCT02194192|Ephedrine|ephedrine|mesh-list
110807651|NCT02194192|Ondansetron|ondansetron|mesh-list
110807652|NCT02194192|Antiemetics|antiemetics|mesh-ancestor
110807653|NCT02194192|Autonomic Agents|autonomic agents|mesh-ancestor
110807654|NCT02194192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110807655|NCT02194192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110807656|NCT02194192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110807657|NCT02194192|Antipruritics|antipruritics|mesh-ancestor
110807658|NCT02194192|Dermatologic Agents|dermatologic agents|mesh-ancestor
110807659|NCT02194192|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110807660|NCT02194192|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110807661|NCT02194192|Serotonin Agents|serotonin agents|mesh-ancestor
110807662|NCT02194192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110807663|NCT02194192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110807664|NCT02194192|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110807665|NCT02194192|Sympathomimetics|sympathomimetics|mesh-ancestor
110807666|NCT02194192|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110807667|NCT02194192|Adrenergic Agents|adrenergic agents|mesh-ancestor
110807668|NCT02194270|Ambroxol|ambroxol|mesh-list
110807669|NCT02194270|Expectorants|expectorants|mesh-ancestor
110807670|NCT02194270|Respiratory System Agents|respiratory system agents|mesh-ancestor
110807671|NCT02190058|DS-1971a|ds-1971a|mesh-list
110807672|NCT02190058|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110807673|NCT02190058|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110807674|NCT02190058|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110807675|NCT02190058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110807676|NCT02194348|Olcegepant|olcegepant|mesh-list
110807677|NCT02194348|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
110807678|NCT02194348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110807679|NCT02194348|Analgesics|analgesics|mesh-ancestor
110807680|NCT02194348|Sensory System Agents|sensory system agents|mesh-ancestor
110807681|NCT02194348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110807682|NCT02194348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110807683|NCT02195908|Antiemetics|antiemetics|mesh-list
110807684|NCT02195908|Autonomic Agents|autonomic agents|mesh-ancestor
110807685|NCT02195908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110807686|NCT02195908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110807687|NCT02195908|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110807688|NCT02197000|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
110807689|NCT02197000|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110807690|NCT02197000|Protective Agents|protective agents|mesh-ancestor
110807691|NCT02197000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110807692|NCT02197000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110807693|NCT02196142|Hydrocortisone|hydrocortisone|mesh-list
110807694|NCT02196142|Mannitol|mannitol|mesh-list
110807695|NCT02196142|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110807696|NCT02196142|Diuretics|diuretics|mesh-ancestor
110807697|NCT02196142|Natriuretic Agents|natriuretic agents|mesh-ancestor
110807698|NCT02196142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110807699|NCT02196142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110807700|NCT02257294|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
110807701|NCT02257294|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110807702|NCT02257294|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110807703|NCT02257294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110807704|NCT03534388|Sodium Hypochlorite|sodium hypochlorite|mesh-list
110807705|NCT03534388|Eusol|eusol|mesh-list
110807706|NCT03534388|Disinfectants|disinfectants|mesh-ancestor
110807707|NCT03534388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110807708|NCT04308694|Methadone|methadone|mesh-list
110807709|NCT04308694|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110807710|NCT04308694|Narcotics|narcotics|mesh-ancestor
110807711|NCT04308694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110807712|NCT04308694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110807713|NCT04308694|Analgesics|analgesics|mesh-ancestor
110807714|NCT04308694|Sensory System Agents|sensory system agents|mesh-ancestor
110807715|NCT04308694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110555845|NCT02699879|Pirfenidone|pirfenidone|mesh-list
110807716|NCT04308694|Antitussive Agents|antitussive agents|mesh-ancestor
110807717|NCT04308694|Respiratory System Agents|respiratory system agents|mesh-ancestor
110807718|NCT03534310|Liraglutide|liraglutide|mesh-list
110807719|NCT03534310|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110807720|NCT03534310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110807721|NCT03534310|Incretins|incretins|mesh-ancestor
110807722|NCT03534310|Hormones|hormones|mesh-ancestor
110807723|NCT03534310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110807724|NCT02194894|Acetaminophen|acetaminophen|mesh-list
110807725|NCT02194894|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110807726|NCT02194894|Analgesics|analgesics|mesh-ancestor
110807727|NCT02194894|Sensory System Agents|sensory system agents|mesh-ancestor
110807728|NCT02194894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110807729|NCT02194894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110807730|NCT02194894|Antipyretics|antipyretics|mesh-ancestor
110807731|NCT03534622|Delafloxacin|delafloxacin|mesh-list
110807732|NCT03534622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110807733|NCT02197702|Vitamin D|vitamin d|mesh-list
110807734|NCT02197702|Cholecalciferol|cholecalciferol|mesh-list
110807735|NCT02197702|Vitamins|vitamins|mesh-ancestor
110807736|NCT02197702|Micronutrients|micronutrients|mesh-ancestor
110807737|NCT02197702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110807738|NCT02197702|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110807739|NCT02197702|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110807740|NCT02031016|Fentanyl|fentanyl|mesh-list
110807741|NCT02031016|Remifentanil|remifentanil|mesh-list
110807742|NCT02031016|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110807743|NCT02031016|Narcotics|narcotics|mesh-ancestor
110807744|NCT02031016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110807745|NCT02031016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110807746|NCT02031016|Analgesics|analgesics|mesh-ancestor
110807747|NCT02031016|Sensory System Agents|sensory system agents|mesh-ancestor
110807748|NCT02031016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110807749|NCT02031016|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110807750|NCT02031016|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110807751|NCT02031016|Anesthetics, General|anesthetics, general|mesh-ancestor
110807753|NCT00095147|Infliximab|infliximab|mesh-list
110807754|NCT00095147|Methotrexate|methotrexate|mesh-list
110807755|NCT00095147|Abatacept|abatacept|mesh-list
110525332|NCT02693808|Protective Agents|protective agents|mesh-ancestor
110807756|NCT00095147|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110807757|NCT00095147|Abortifacient Agents|abortifacient agents|mesh-ancestor
110807758|NCT00095147|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110807759|NCT00095147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110807760|NCT00095147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110807762|NCT00095147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110807763|NCT00095147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110807764|NCT00095147|Dermatologic Agents|dermatologic agents|mesh-ancestor
110807765|NCT00095147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110807766|NCT00095147|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110807767|NCT00095147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110807768|NCT00095147|Immunologic Factors|immunologic factors|mesh-ancestor
110807769|NCT00095147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110807770|NCT00095147|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110807771|NCT00095147|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110807772|NCT00095147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110807773|NCT00095147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110807774|NCT00095147|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110807775|NCT00095147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110807776|NCT02198170|Ketoconazole|ketoconazole|mesh-list
110807777|NCT02198170|Lenvatinib|lenvatinib|mesh-list
110807778|NCT02198170|Antifungal Agents|antifungal agents|mesh-ancestor
110807779|NCT02198170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110556085|NCT00673556|Dermatologic Agents|dermatologic agents|mesh-ancestor
110807780|NCT02198170|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110807781|NCT02198170|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110807782|NCT02198170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110807783|NCT02198170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110807784|NCT02198170|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110807785|NCT02198170|Hormone Antagonists|hormone antagonists|mesh-ancestor
110807786|NCT02198170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110807787|NCT02198170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110807788|NCT02198170|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110807789|NCT02198170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110807790|NCT02198170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110807791|NCT02198248|Prednisolone|prednisolone|mesh-list
110807792|NCT02198248|Rituximab|rituximab|mesh-list
110807793|NCT02198248|Glucocorticoids|glucocorticoids|mesh-list
110807794|NCT02198248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110807795|NCT02198248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110807796|NCT02198248|Immunologic Factors|immunologic factors|mesh-ancestor
110807797|NCT02198248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110807798|NCT02198248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110807799|NCT02198248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110807800|NCT02198248|Hormones|hormones|mesh-ancestor
110807801|NCT02198248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110807802|NCT02198248|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110807803|NCT01069133|Rifaximin|rifaximin|mesh-list
110807804|NCT01069133|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110807805|NCT01069133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110807806|NCT01069133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110807807|NCT02198326|Olcegepant|olcegepant|mesh-list
110807808|NCT02198326|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
110807809|NCT02198326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110807810|NCT02198326|Analgesics|analgesics|mesh-ancestor
110807811|NCT02198326|Sensory System Agents|sensory system agents|mesh-ancestor
110807812|NCT02198326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110807813|NCT02198326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110807814|NCT02198404|Propofol|propofol|mesh-list
110807815|NCT02198404|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110807816|NCT02198404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110807817|NCT02198404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110807818|NCT02198404|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110807820|NCT02198404|Anesthetics|anesthetics|mesh-ancestor
110807821|NCT02198482|Cytarabine|cytarabine|mesh-list
110807822|NCT02198482|Daunorubicin|daunorubicin|mesh-list
110807823|NCT02198482|Mitoxantrone|mitoxantrone|mesh-list
110807824|NCT02198482|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110807825|NCT02198482|Antimetabolites|antimetabolites|mesh-ancestor
110807826|NCT02198482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110807827|NCT02198482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110807828|NCT02198482|Antiviral Agents|antiviral agents|mesh-ancestor
110807829|NCT02198482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110807830|NCT02198482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110807831|NCT02198482|Immunologic Factors|immunologic factors|mesh-ancestor
110807832|NCT02198482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110807833|NCT02198482|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110807834|NCT02198482|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110807835|NCT02198482|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110807836|NCT02198482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110807837|NCT02198482|Analgesics|analgesics|mesh-ancestor
110807838|NCT02198482|Sensory System Agents|sensory system agents|mesh-ancestor
110807839|NCT02198482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110807840|NCT03961841|Oxaliplatin|oxaliplatin|mesh-list
110807841|NCT03961841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110807842|NCT02201134|Sevoflurane|sevoflurane|mesh-list
110807843|NCT02201134|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110807844|NCT02201134|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110807845|NCT02201134|Anesthetics, General|anesthetics, general|mesh-ancestor
110807846|NCT02201134|Anesthetics|anesthetics|mesh-ancestor
110807847|NCT02201134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110807848|NCT02201134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110807850|NCT02201602|Glyburide|glyburide|mesh-list
110807851|NCT02201602|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110807852|NCT02201602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110807853|NCT02201914|Triptorelin Pamoate|triptorelin pamoate|mesh-list
110807854|NCT02201914|Clomiphene|clomiphene|mesh-list
110807855|NCT02201914|Enclomiphene|enclomiphene|mesh-list
110807856|NCT02201914|Zuclomiphene|zuclomiphene|mesh-list
110807857|NCT02201914|Cetrorelix|cetrorelix|mesh-list
110807858|NCT02201914|Luteolytic Agents|luteolytic agents|mesh-ancestor
110807859|NCT02201914|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110807860|NCT02201914|Contraceptive Agents|contraceptive agents|mesh-ancestor
110807861|NCT02201914|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110807862|NCT02201914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110807863|NCT02201914|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110807864|NCT02201914|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110807865|NCT02201914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110807866|NCT02201914|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110807867|NCT02201914|Hormone Antagonists|hormone antagonists|mesh-ancestor
110807868|NCT02201914|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110807869|NCT02201914|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110807870|NCT02201914|Fertility Agents|fertility agents|mesh-ancestor
110807871|NCT02201914|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110807872|NCT02201914|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110807873|NCT02202070|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110807874|NCT02202070|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110807875|NCT02202070|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110807876|NCT02202070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110807877|NCT02202070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110807878|NCT02202070|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110807879|NCT02202070|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110852966|NCT03528577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110807880|NCT02202070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110807881|NCT02202070|Cholinergic Agents|cholinergic agents|mesh-ancestor
110807882|NCT02202070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110807883|NCT02202304|Chlorhexidine|chlorhexidine|mesh-list
110807884|NCT02202304|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110807885|NCT02202304|Thymol|thymol|mesh-list
110807886|NCT02202304|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110807887|NCT02202304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110807888|NCT02202304|Disinfectants|disinfectants|mesh-ancestor
110807889|NCT02202304|Dermatologic Agents|dermatologic agents|mesh-ancestor
110807890|NCT02202304|Antifungal Agents|antifungal agents|mesh-ancestor
110807891|NCT02207452|Albuterol|albuterol|mesh-list
110807892|NCT02207452|Ipratropium|ipratropium|mesh-list
110807893|NCT02207452|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110807894|NCT02207452|Autonomic Agents|autonomic agents|mesh-ancestor
110807895|NCT02207452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110807896|NCT02207452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110807897|NCT02207452|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110807898|NCT02207452|Respiratory System Agents|respiratory system agents|mesh-ancestor
110807899|NCT02207452|Tocolytic Agents|tocolytic agents|mesh-ancestor
110807900|NCT02207452|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110807901|NCT02207452|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110807902|NCT02207452|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110807903|NCT02207452|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110807904|NCT02207452|Adrenergic Agents|adrenergic agents|mesh-ancestor
110807905|NCT02207452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110807906|NCT02207452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110807907|NCT02207452|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110525500|NCT04229264|Apixaban|apixaban|mesh-list
110807908|NCT02207452|Cholinergic Agents|cholinergic agents|mesh-ancestor
110807909|NCT03533062|Botulinum Toxins|botulinum toxins|mesh-list
110807910|NCT03533062|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110807911|NCT03533062|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110807912|NCT03533062|Cholinergic Antagonists|cholinergic antagonists|mesh-list
110807913|NCT03533062|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110852983|NCT05432414|Immunologic Factors|immunologic factors|mesh-ancestor
110807915|NCT03533062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110807916|NCT03533062|Cholinergic Agents|cholinergic agents|mesh-ancestor
110807917|NCT03533062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110807918|NCT03533062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110807919|NCT03533062|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110807920|NCT03533062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110807921|NCT02207920|Vaccines|vaccines|mesh-list
110807922|NCT02207920|Immunologic Factors|immunologic factors|mesh-ancestor
110807923|NCT02207920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110807924|NCT02208154|Chlorhexidine|chlorhexidine|mesh-list
110807925|NCT02208154|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110807926|NCT02208154|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110807927|NCT02208154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110807928|NCT02208154|Disinfectants|disinfectants|mesh-ancestor
110807929|NCT02208154|Dermatologic Agents|dermatologic agents|mesh-ancestor
110807930|NCT03532906|Bupivacaine|bupivacaine|mesh-list
110807931|NCT03532906|Anesthetics, Local|anesthetics, local|mesh-ancestor
110807932|NCT03532906|Anesthetics|anesthetics|mesh-ancestor
110807933|NCT03532906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110807934|NCT03532906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110807935|NCT03532906|Sensory System Agents|sensory system agents|mesh-ancestor
110807936|NCT03532906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110807938|NCT02199418|Cisplatin|cisplatin|mesh-list
110807939|NCT02199418|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110807940|NCT02199418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110807941|NCT02199418|Tubulin Modulators|tubulin modulators|mesh-ancestor
110807942|NCT02199418|Antimitotic Agents|antimitotic agents|mesh-ancestor
110807943|NCT02199418|Mitosis Modulators|mitosis modulators|mesh-ancestor
110807944|NCT02199418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110807945|NCT02208778|Remifentanil|remifentanil|mesh-list
110807946|NCT02208778|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110807947|NCT02208778|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110807948|NCT02208778|Narcotics|narcotics|mesh-ancestor
110807949|NCT02208778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110556673|NCT00878072|Famciclovir|famciclovir|mesh-list
110807950|NCT02208778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110807951|NCT02208778|Analgesics|analgesics|mesh-ancestor
110807952|NCT02208778|Sensory System Agents|sensory system agents|mesh-ancestor
110807953|NCT02208778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110807954|NCT02208778|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110807955|NCT02208778|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110807956|NCT02208778|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110807957|NCT02208778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110807958|NCT02208778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110807959|NCT02208778|Antidepressive Agents|antidepressive agents|mesh-ancestor
110807960|NCT02208778|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110807961|NCT02208778|Dopamine Agents|dopamine agents|mesh-ancestor
110807962|NCT02203396|Cyclosporine|cyclosporine|mesh-list
110807963|NCT02203396|Levamisole|levamisole|mesh-list
110807964|NCT02203396|Cyclosporins|cyclosporins|mesh-list
110807965|NCT02203396|Thymoglobulin|thymoglobulin|mesh-list
110807966|NCT02203396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110807967|NCT02203396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110807968|NCT02203396|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110807969|NCT02203396|Immunologic Factors|immunologic factors|mesh-ancestor
110807970|NCT02203396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110807971|NCT02203396|Antifungal Agents|antifungal agents|mesh-ancestor
110807972|NCT02203396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110807973|NCT02203396|Dermatologic Agents|dermatologic agents|mesh-ancestor
110807974|NCT02203396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110807975|NCT02203396|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110807976|NCT02203396|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110807977|NCT02203396|Antinematodal Agents|antinematodal agents|mesh-ancestor
110807978|NCT02203396|Anthelmintics|anthelmintics|mesh-ancestor
110807979|NCT02203396|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110807980|NCT02203552|Minocycline|minocycline|mesh-list
110807981|NCT02203552|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110807982|NCT02203552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110525558|NCT02711358|Tocolytic Agents|tocolytic agents|mesh-ancestor
110807983|NCT02209012|Aminolevulinic Acid|aminolevulinic acid|mesh-list
110807984|NCT02209012|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110807985|NCT02209012|Dermatologic Agents|dermatologic agents|mesh-ancestor
110807986|NCT02200354|Bevacizumab|bevacizumab|mesh-list
110807987|NCT02200354|Pemetrexed|pemetrexed|mesh-list
110807988|NCT02200354|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110807989|NCT02200354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110807990|NCT02200354|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110807991|NCT02200354|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110807992|NCT02200354|Growth Substances|growth substances|mesh-ancestor
110807993|NCT02200354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110807994|NCT02200354|Growth Inhibitors|growth inhibitors|mesh-ancestor
110807995|NCT02200354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110807996|NCT02200354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110807997|NCT02200354|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110807998|NCT02200354|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110807999|NCT02204020|Azacitidine|azacitidine|mesh-list
110808000|NCT02204020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110808001|NCT02204020|Antimetabolites|antimetabolites|mesh-ancestor
110808002|NCT02204020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110808003|NCT02204020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110808004|NCT02204020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110808005|NCT02200822|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
110808006|NCT02200822|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110808007|NCT02200822|Adrenergic Agents|adrenergic agents|mesh-ancestor
110808008|NCT02200822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110808009|NCT02200822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110808010|NCT02200822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110808011|NCT02220634|Regadenoson|regadenoson|mesh-list
110808012|NCT02220634|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
110808013|NCT02220634|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
110808014|NCT02220634|Purinergic Agonists|purinergic agonists|mesh-ancestor
110808015|NCT02220634|Purinergic Agents|purinergic agents|mesh-ancestor
110808016|NCT02220634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110808017|NCT02220634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110808018|NCT02220634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110808019|NCT02204644|Imatinib Mesylate|imatinib mesylate|mesh-list
110808020|NCT02204644|Flumatinib|flumatinib|mesh-list
110808021|NCT02204644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110808022|NCT02204644|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110808023|NCT02204644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110808024|NCT02204644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110808025|NCT02204722|Imatinib Mesylate|imatinib mesylate|mesh-list
110808026|NCT02204722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110808027|NCT02204722|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110808028|NCT02204722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110808029|NCT02204722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110808030|NCT02204878|Parecoxib|parecoxib|mesh-list
110808031|NCT02204878|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110808032|NCT02204878|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110808033|NCT02204878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110808034|NCT02204878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110808035|NCT02204878|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110808036|NCT02204878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110808037|NCT02204878|Analgesics|analgesics|mesh-ancestor
110808038|NCT02204878|Sensory System Agents|sensory system agents|mesh-ancestor
110808039|NCT02204878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110808040|NCT02204878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110808041|NCT02204878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110808042|NCT02204878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110808043|NCT02205034|Oxytocin|oxytocin|mesh-list
110808044|NCT02205034|Oxytocics|oxytocics|mesh-ancestor
110808045|NCT02205034|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110808046|NCT02205034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110808047|NCT02210728|Methylphenidate|methylphenidate|mesh-list
110808048|NCT02210728|Amphetamine|amphetamine|mesh-list
110808049|NCT02210728|Adderall|adderall|mesh-list
110808050|NCT02210728|Dextroamphetamine|dextroamphetamine|mesh-list
110808051|NCT02210728|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110808052|NCT02210728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110808053|NCT02210728|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110808054|NCT02210728|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110808055|NCT02210728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110808056|NCT02210728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110808057|NCT02210728|Dopamine Agents|dopamine agents|mesh-ancestor
110808058|NCT02210728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110808059|NCT02210728|Sympathomimetics|sympathomimetics|mesh-ancestor
110808060|NCT02210728|Autonomic Agents|autonomic agents|mesh-ancestor
110808061|NCT02210728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110808062|NCT02210728|Adrenergic Agents|adrenergic agents|mesh-ancestor
110808063|NCT02210728|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110808064|NCT02220868|Ribavirin|ribavirin|mesh-list
110808065|NCT02220868|Sofosbuvir|sofosbuvir|mesh-list
110557090|NCT00577096|Antiemetics|antiemetics|mesh-ancestor
110808066|NCT02220868|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110808067|NCT02220868|Antimetabolites|antimetabolites|mesh-ancestor
110808068|NCT02220868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110808069|NCT02220868|Antiviral Agents|antiviral agents|mesh-ancestor
110808070|NCT02220868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110808071|NCT02220868|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110808072|NCT02220868|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110808073|NCT02221024|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110808074|NCT02221102|Aspirin|aspirin|mesh-list
110808075|NCT02221102|Edoxaban|edoxaban|mesh-list
110808076|NCT02221102|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110808077|NCT02221102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110808078|NCT02221102|Analgesics|analgesics|mesh-ancestor
110808079|NCT02221102|Sensory System Agents|sensory system agents|mesh-ancestor
110808080|NCT02221102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110808081|NCT02221102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110808082|NCT02221102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110808083|NCT02221102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110808084|NCT02221102|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110808085|NCT02221102|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110863865|NCT04495283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110808086|NCT02221102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110808087|NCT02221102|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110808088|NCT02221102|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110557359|NCT00685568|Celecoxib|celecoxib|mesh-list
110808089|NCT02221102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110808091|NCT02221102|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110808092|NCT02221102|Antithrombins|antithrombins|mesh-ancestor
110808093|NCT02221102|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110808095|NCT02221102|Anticoagulants|anticoagulants|mesh-ancestor
110808096|NCT02213302|Midazolam|midazolam|mesh-list
110808097|NCT02213302|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110808098|NCT02213302|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110808099|NCT02213302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110808100|NCT02213302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110808101|NCT02213302|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110808102|NCT02213302|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110557565|NCT00698724|Antiemetics|antiemetics|mesh-ancestor
110808103|NCT02213302|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110808104|NCT02213302|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110808105|NCT02213302|Anesthetics, General|anesthetics, general|mesh-ancestor
110808106|NCT02213302|Anesthetics|anesthetics|mesh-ancestor
110808107|NCT02213302|GABA Modulators|gaba modulators|mesh-ancestor
110808108|NCT02213302|GABA Agents|gaba agents|mesh-ancestor
110808109|NCT02213302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110557778|NCT01010581|Hematinics|hematinics|mesh-ancestor
110808110|NCT02213302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110808111|NCT02221180|Metformin|metformin|mesh-list
110808112|NCT02221180|Canagliflozin|canagliflozin|mesh-list
110808113|NCT02221180|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110808114|NCT02221180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110808115|NCT02221180|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110808116|NCT02221180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110808117|NCT02205112|Levofloxacin|levofloxacin|mesh-list
110808118|NCT02205112|Nemonoxacin|nemonoxacin|mesh-list
110808119|NCT02205112|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110808120|NCT02205112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110808121|NCT02205112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110808122|NCT02205112|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110808123|NCT02205112|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110808124|NCT02205112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110808125|NCT02205112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110558073|NCT02624726|Leucovorin|leucovorin|mesh-list
110808126|NCT02205112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110808127|NCT02205112|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110808128|NCT02205112|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110808129|NCT02205190|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110808130|NCT02205190|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110808131|NCT02205190|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110808132|NCT02205190|Antimetabolites|antimetabolites|mesh-ancestor
110808133|NCT02205190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110808134|NCT02205190|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110808135|NCT02205190|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110808136|NCT02205190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110808137|NCT02257918|Ceftriaxone|ceftriaxone|mesh-list
110808138|NCT02257918|Zoliflodacin|zoliflodacin|mesh-list
110808139|NCT02257918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110808140|NCT02257918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110808141|NCT02257918|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110808142|NCT02257918|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110808143|NCT02257918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110808144|NCT02257918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110558215|NCT02167763|Contraceptive Agents|contraceptive agents|mesh-list
110808145|NCT02257918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110808146|NCT02221414|Metformin|metformin|mesh-list
110808147|NCT02221414|Linagliptin|linagliptin|mesh-list
110808148|NCT02221414|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110808149|NCT02221414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110808150|NCT02221414|Incretins|incretins|mesh-ancestor
110808151|NCT02221414|Hormones|hormones|mesh-ancestor
110808152|NCT02221414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110808153|NCT02221414|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110808154|NCT02221414|Protease Inhibitors|protease inhibitors|mesh-ancestor
110808155|NCT02221414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110808156|NCT02221414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110808157|NCT02221492|Plerixafor|plerixafor|mesh-list
110808158|NCT02221492|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110808159|NCT02221492|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110808160|NCT02221492|Antiviral Agents|antiviral agents|mesh-ancestor
110808161|NCT02221492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110808162|NCT05164978|Antibodies|antibodies|mesh-list
110808163|NCT05164978|Immunologic Factors|immunologic factors|mesh-ancestor
110808164|NCT05164978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110808165|NCT02221570|Baclofen|baclofen|mesh-list
110808166|NCT02221570|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110808167|NCT02221570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110808168|NCT02221570|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110808169|NCT02221570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110808170|NCT02221570|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
110808171|NCT02221570|GABA Agonists|gaba agonists|mesh-ancestor
110808172|NCT02221570|GABA Agents|gaba agents|mesh-ancestor
110808173|NCT02221570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110808174|NCT02221570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110808175|NCT02205502|Lidocaine|lidocaine|mesh-list
110808176|NCT02205502|Anesthetics, Local|anesthetics, local|mesh-ancestor
110808177|NCT02205502|Anesthetics|anesthetics|mesh-ancestor
110558398|NCT04145336|Analgesics|analgesics|mesh-ancestor
110808178|NCT02205502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110808179|NCT02205502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110808180|NCT02205502|Sensory System Agents|sensory system agents|mesh-ancestor
110808181|NCT02205502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110808182|NCT02205502|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110808183|NCT02205502|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110808184|NCT02205502|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110558469|NCT01946711|Budesonide|budesonide|mesh-list
110808185|NCT02205502|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110558531|NCT04137380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110808186|NCT02205502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110808187|NCT02219698|Acetaminophen|acetaminophen|mesh-list
110808188|NCT02219698|Ibuprofen|ibuprofen|mesh-list
110808189|NCT02219698|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110808190|NCT02219698|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110808191|NCT02219698|Analgesics|analgesics|mesh-ancestor
110808192|NCT02219698|Sensory System Agents|sensory system agents|mesh-ancestor
110808193|NCT02219698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110808194|NCT02219698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110808195|NCT02219698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110808196|NCT02219698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110808197|NCT02219698|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110808198|NCT02219698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110558678|NCT01011205|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110808199|NCT02219698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110808200|NCT02219698|Antipyretics|antipyretics|mesh-ancestor
110808201|NCT02205580|Sufentanil|sufentanil|mesh-list
110808202|NCT02205580|Dsuvia|dsuvia|mesh-list
110808203|NCT02205580|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110808204|NCT02205580|Narcotics|narcotics|mesh-ancestor
110808205|NCT02205580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110808206|NCT02205580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110808207|NCT02205580|Analgesics|analgesics|mesh-ancestor
110808208|NCT02205580|Sensory System Agents|sensory system agents|mesh-ancestor
110808209|NCT02205580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110808210|NCT02205580|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110808211|NCT02205580|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110808212|NCT02205580|Anesthetics, General|anesthetics, general|mesh-ancestor
110808213|NCT02205580|Anesthetics|anesthetics|mesh-ancestor
110808214|NCT02221960|Durvalumab|durvalumab|mesh-list
110808215|NCT02221960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110808216|NCT02221960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110808217|NCT02220088|Leucovorin|leucovorin|mesh-list
110808218|NCT02220088|Fluorouracil|fluorouracil|mesh-list
110808219|NCT02220088|Oxaliplatin|oxaliplatin|mesh-list
110808220|NCT02220088|Sorafenib|sorafenib|mesh-list
110558966|NCT00689624|Antidotes|antidotes|mesh-ancestor
110808221|NCT02220088|Antimetabolites|antimetabolites|mesh-ancestor
110808222|NCT02220088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110559025|NCT02616692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110808223|NCT02220088|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110808224|NCT02220088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110106519|NCT01802645|Leucovorin|leucovorin|mesh-list
110559109|NCT00696956|Paclitaxel|paclitaxel|mesh-list
110808226|NCT02220088|Immunologic Factors|immunologic factors|mesh-ancestor
110808227|NCT02220088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110808228|NCT02220088|Antidotes|antidotes|mesh-ancestor
110808229|NCT02220088|Protective Agents|protective agents|mesh-ancestor
110808230|NCT02220088|Vitamin B Complex|vitamin b complex|mesh-ancestor
110808231|NCT02220088|Vitamins|vitamins|mesh-ancestor
110808232|NCT02220088|Micronutrients|micronutrients|mesh-ancestor
110808233|NCT02220088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110808234|NCT02220088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110808236|NCT02220400|Analgesics|analgesics|mesh-ancestor
110808237|NCT02220400|Sensory System Agents|sensory system agents|mesh-ancestor
110808238|NCT02220400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110808239|NCT02220400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110808240|NCT02220400|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110808241|NCT02220400|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110808242|NCT02220400|Anesthetics, General|anesthetics, general|mesh-ancestor
110808243|NCT02220400|Anesthetics|anesthetics|mesh-ancestor
110808244|NCT02220400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110808245|NCT02220400|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110808246|NCT02220400|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110808247|NCT02220400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110808248|NCT02220400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110808250|NCT02205892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110808251|NCT02224768|Ipilimumab|ipilimumab|mesh-list
110808252|NCT02224768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110808253|NCT02224768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110808254|NCT02224768|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110808255|NCT02224768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110808256|NCT05262166|Dexmedetomidine|dexmedetomidine|mesh-list
110808257|NCT05262166|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110808258|NCT05262166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110808259|NCT05262166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110808260|NCT05262166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110808261|NCT05262166|Analgesics|analgesics|mesh-ancestor
110808262|NCT05262166|Sensory System Agents|sensory system agents|mesh-ancestor
110808263|NCT05262166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110808264|NCT05262166|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110808265|NCT05262166|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110808266|NCT05262166|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110808267|NCT05262166|Adrenergic Agents|adrenergic agents|mesh-ancestor
110808268|NCT05262166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110808269|NCT05262166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110808270|NCT02206204|Moxifloxacin|moxifloxacin|mesh-list
110808271|NCT02206204|Selexipag|selexipag|mesh-list
110808272|NCT02206204|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
110808273|NCT02206204|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110808274|NCT02206204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110808275|NCT02206204|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110808276|NCT02206204|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110808277|NCT02206204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110808278|NCT02206204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110808279|NCT02206204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110808280|NCT02206204|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110808281|NCT02206204|Contraceptive Agents|contraceptive agents|mesh-ancestor
110808282|NCT02206204|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110808283|NCT02206204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110808284|NCT02206204|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110808285|NCT02206204|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110808286|NCT02206204|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110808287|NCT02206204|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110808288|NCT02230930|Hydrocortisone|hydrocortisone|mesh-list
110808289|NCT02230930|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
110808290|NCT02230930|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
110808291|NCT02230930|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
110808292|NCT02230930|Apomorphine|apomorphine|mesh-list
110808293|NCT02230930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110808294|NCT02230930|Emetics|emetics|mesh-ancestor
110808295|NCT02230930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110808296|NCT02230930|Autonomic Agents|autonomic agents|mesh-ancestor
110808297|NCT02230930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110808298|NCT02230930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110808299|NCT02230930|Dopamine Agonists|dopamine agonists|mesh-ancestor
110559733|NCT00699426|Esomeprazole|esomeprazole|mesh-list
110808300|NCT02230930|Dopamine Agents|dopamine agents|mesh-ancestor
110808301|NCT02230930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110559779|NCT02614508|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110808302|NCT02230930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110808303|NCT02222350|Firuglipel|firuglipel|mesh-list
110808304|NCT02222350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110446012|NCT00580047|Zoledronic Acid|zoledronic acid|mesh-list
110808305|NCT02222350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110808307|NCT02222428|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110808308|NCT02222428|Autonomic Agents|autonomic agents|mesh-ancestor
110808309|NCT02222428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110808310|NCT02222428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110808311|NCT02222428|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110808312|NCT02222428|Respiratory System Agents|respiratory system agents|mesh-ancestor
110808313|NCT02231320|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
110808314|NCT02231320|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110808315|NCT02231320|Autonomic Agents|autonomic agents|mesh-ancestor
110808316|NCT02231320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110808317|NCT02231320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110808318|NCT02231320|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110808319|NCT02231320|Respiratory System Agents|respiratory system agents|mesh-ancestor
110808320|NCT02225470|Vinorelbine|vinorelbine|mesh-list
110808321|NCT02225470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110808322|NCT02225470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110808323|NCT02225470|Tubulin Modulators|tubulin modulators|mesh-ancestor
110808324|NCT02225470|Antimitotic Agents|antimitotic agents|mesh-ancestor
110808325|NCT02225470|Mitosis Modulators|mitosis modulators|mesh-ancestor
110808326|NCT02225470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110808327|NCT02225548|Tadalafil|tadalafil|mesh-list
110808328|NCT02225548|Selegiline|selegiline|mesh-list
110559996|NCT00849186|Sunitinib|sunitinib|mesh-list
110808329|NCT02225548|Vasodilator Agents|vasodilator agents|mesh-ancestor
110560080|NCT00861692|Argatroban|argatroban|mesh-list
110808330|NCT02225548|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110808331|NCT02225548|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110808332|NCT02225548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110808333|NCT02225548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110808334|NCT02225548|Urological Agents|urological agents|mesh-ancestor
110808335|NCT02225548|Antidepressive Agents|antidepressive agents|mesh-ancestor
110808336|NCT02225548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110808337|NCT02225548|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110808338|NCT02225548|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110808339|NCT02225548|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
110808340|NCT02225548|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110808341|NCT02225548|Protective Agents|protective agents|mesh-ancestor
110808342|NCT02225548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110808343|NCT02223052|Azacitidine|azacitidine|mesh-list
110808344|NCT02223052|Cc-486|cc-486|mesh-list
110808345|NCT02223052|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110683019|NCT00909077|Dexamethasone|dexamethasone|mesh-list
110808346|NCT02223052|Antimetabolites|antimetabolites|mesh-ancestor
110808347|NCT02223052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110808348|NCT02223052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110808349|NCT02223052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110808350|NCT02231632|Vaccines|vaccines|mesh-list
110808351|NCT02231632|Immunologic Factors|immunologic factors|mesh-ancestor
110808352|NCT02231632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110808353|NCT02225782|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
110808354|NCT02225782|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110808355|NCT02225782|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110808356|NCT02225782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110808357|NCT02231788|Amlodipine|amlodipine|mesh-list
110808358|NCT02231788|Telmisartan|telmisartan|mesh-list
110808359|NCT02231788|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110808360|NCT02231788|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110808361|NCT02231788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110808362|NCT02231788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110808363|NCT02231788|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110683220|NCT00908297|Ubiquinone|ubiquinone|mesh-list
110808364|NCT02231788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110808365|NCT02231788|Vasodilator Agents|vasodilator agents|mesh-ancestor
110808366|NCT02231788|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110808367|NCT02231788|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110808368|NCT02258620|Isosorbide|isosorbide|mesh-list
110808369|NCT02258620|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
110808370|NCT02258620|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
110808371|NCT02258620|Nitroglycerin|nitroglycerin|mesh-list
110808372|NCT02258620|Vasodilator Agents|vasodilator agents|mesh-ancestor
110808373|NCT02258620|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110808374|NCT02258620|Diuretics|diuretics|mesh-ancestor
110808375|NCT02258620|Natriuretic Agents|natriuretic agents|mesh-ancestor
110808376|NCT02258620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110808377|NCT02258620|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
110683291|NCT00927875|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110808378|NCT02258620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110808379|NCT02223598|Dexamethasone|dexamethasone|mesh-list
110808380|NCT02223598|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110808381|NCT02223598|Antiemetics|antiemetics|mesh-ancestor
110808382|NCT02223598|Autonomic Agents|autonomic agents|mesh-ancestor
110808383|NCT02223598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110808384|NCT02223598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110808385|NCT02223598|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110808386|NCT02223598|Glucocorticoids|glucocorticoids|mesh-ancestor
110808387|NCT02223598|Hormones|hormones|mesh-ancestor
110808388|NCT02223598|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110808389|NCT02223598|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110808390|NCT02223598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110808391|NCT00094835|Paclitaxel|paclitaxel|mesh-list
110808392|NCT00094835|Carboplatin|carboplatin|mesh-list
110808393|NCT00094835|Panitumumab|panitumumab|mesh-list
110808394|NCT00094835|Motesanib diphosphate|motesanib diphosphate|mesh-list
110808395|NCT00094835|Imetelstat|imetelstat|mesh-list
110808396|NCT00094835|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110808397|NCT00094835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110808398|NCT00094835|Tubulin Modulators|tubulin modulators|mesh-ancestor
110808399|NCT00094835|Antimitotic Agents|antimitotic agents|mesh-ancestor
110808400|NCT00094835|Mitosis Modulators|mitosis modulators|mesh-ancestor
110808401|NCT00094835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110808402|NCT00094835|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110808403|NCT00094835|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110808404|NCT00094835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110808405|NCT02226328|Fentanyl|fentanyl|mesh-list
110808406|NCT02226328|Midazolam|midazolam|mesh-list
110808407|NCT02226328|Propofol|propofol|mesh-list
110808408|NCT02226328|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110808409|NCT02226328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110808410|NCT02226328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110808411|NCT02226328|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110808412|NCT02226328|Anesthetics, General|anesthetics, general|mesh-ancestor
110808413|NCT02226328|Anesthetics|anesthetics|mesh-ancestor
110808414|NCT02226328|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110808415|NCT02226328|Narcotics|narcotics|mesh-ancestor
110808416|NCT02226328|Analgesics|analgesics|mesh-ancestor
110808417|NCT02226328|Sensory System Agents|sensory system agents|mesh-ancestor
110808418|NCT02226328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110808419|NCT02226328|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110808420|NCT02226328|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110683630|NCT01015248|Rituximab|rituximab|mesh-list
110808421|NCT02226328|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110808422|NCT02226328|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110808423|NCT02226328|GABA Modulators|gaba modulators|mesh-ancestor
110808424|NCT02226328|GABA Agents|gaba agents|mesh-ancestor
110808425|NCT02226328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110808426|NCT02226328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110808427|NCT03962777|Chlorhexidine|chlorhexidine|mesh-list
110808428|NCT03962777|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110808429|NCT03962777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110808430|NCT03962777|Disinfectants|disinfectants|mesh-ancestor
110808431|NCT02226484|Quercetin|quercetin|mesh-list
110808432|NCT02226484|Antioxidants|antioxidants|mesh-ancestor
110683681|NCT00492024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110808433|NCT02226484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110683748|NCT00934739|Analgesics|analgesics|mesh-ancestor
110808434|NCT02226484|Protective Agents|protective agents|mesh-ancestor
110808435|NCT02226484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110808436|NCT04453852|Vaccines|vaccines|mesh-list
110808437|NCT04453852|Immunologic Factors|immunologic factors|mesh-ancestor
110808438|NCT04453852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110808439|NCT00094757|Pioglitazone|pioglitazone|mesh-list
110808440|NCT00094757|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110808441|NCT00094757|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110808442|NCT00094757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110808443|NCT00094757|Incretins|incretins|mesh-ancestor
110808444|NCT00094757|Hormones|hormones|mesh-ancestor
110808445|NCT00094757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110808446|NCT00094757|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110808447|NCT00094757|Protease Inhibitors|protease inhibitors|mesh-ancestor
110808448|NCT00094757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110808449|NCT00094757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110808450|NCT02223832|Ponesimod|ponesimod|mesh-list
110808451|NCT02223832|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
110683888|NCT00491322|Vitamins|vitamins|mesh-ancestor
110808452|NCT02223832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110808453|NCT02223832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110808454|NCT02223832|Immunologic Factors|immunologic factors|mesh-ancestor
110808455|NCT02223832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110808456|NCT02224066|Aspirin|aspirin|mesh-list
110808457|NCT02224066|Clopidogrel|clopidogrel|mesh-list
110808458|NCT02224066|Ticagrelor|ticagrelor|mesh-list
110808459|NCT02224066|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110808460|NCT02224066|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110808461|NCT02224066|Analgesics|analgesics|mesh-ancestor
110853137|NCT02861183|Viscosupplements|viscosupplements|mesh-ancestor
110808462|NCT02224066|Sensory System Agents|sensory system agents|mesh-ancestor
110808463|NCT02224066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110808464|NCT02224066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110808465|NCT02224066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110808466|NCT02224066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110808467|NCT02224066|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110808468|NCT02224066|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110808469|NCT02224066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110808470|NCT02224066|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110808471|NCT02224066|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110808472|NCT02224066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110808473|NCT02224066|Antipyretics|antipyretics|mesh-ancestor
110808474|NCT02224066|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110808475|NCT02224066|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110808476|NCT02224066|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110808477|NCT02224066|Purinergic Agents|purinergic agents|mesh-ancestor
110808478|NCT02224066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110808479|NCT02227030|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110808480|NCT04378114|Acetaminophen|acetaminophen|mesh-list
110808481|NCT04378114|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110808482|NCT04378114|Analgesics|analgesics|mesh-ancestor
110808483|NCT04378114|Sensory System Agents|sensory system agents|mesh-ancestor
110808484|NCT04378114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110808485|NCT04378114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110808486|NCT04378114|Antipyretics|antipyretics|mesh-ancestor
110808487|NCT00082433|Capecitabine|capecitabine|mesh-list
110808488|NCT00082433|Epothilones|epothilones|mesh-list
110808489|NCT00082433|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110808490|NCT00082433|Antimetabolites|antimetabolites|mesh-ancestor
110808491|NCT00082433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110808492|NCT00082433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110808493|NCT00082433|Tubulin Modulators|tubulin modulators|mesh-ancestor
110808494|NCT00082433|Antimitotic Agents|antimitotic agents|mesh-ancestor
110808495|NCT00082433|Mitosis Modulators|mitosis modulators|mesh-ancestor
110808496|NCT00094445|Curcumin|curcumin|mesh-list
110808497|NCT00094445|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110808498|NCT00094445|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110808499|NCT00094445|Analgesics|analgesics|mesh-ancestor
110808500|NCT00094445|Sensory System Agents|sensory system agents|mesh-ancestor
110808501|NCT00094445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110808502|NCT00094445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110808503|NCT00094445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110808504|NCT00094445|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110808505|NCT00094445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110808506|NCT00094445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110808507|NCT00094445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110808508|NCT01081535|Ketorolac|ketorolac|mesh-list
110808509|NCT01081535|Fentanyl|fentanyl|mesh-list
110808510|NCT01081535|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110808511|NCT01081535|Narcotics|narcotics|mesh-ancestor
110808512|NCT01081535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110808513|NCT01081535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110808514|NCT01081535|Analgesics|analgesics|mesh-ancestor
110808515|NCT01081535|Sensory System Agents|sensory system agents|mesh-ancestor
110808516|NCT01081535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110808517|NCT01081535|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110808518|NCT01081535|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110808519|NCT01081535|Anesthetics, General|anesthetics, general|mesh-ancestor
110808520|NCT01081535|Anesthetics|anesthetics|mesh-ancestor
110808521|NCT01081535|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110808522|NCT01081535|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110808523|NCT01081535|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110808524|NCT01081535|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110808525|NCT01081535|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110808526|NCT01081535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110808527|NCT01081535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110808528|NCT01087229|Nitrous Oxide|nitrous oxide|mesh-list
110684405|NCT03684044|Baloxavir|baloxavir|mesh-list
110808529|NCT01087229|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110808531|NCT01087229|Anesthetics|anesthetics|mesh-ancestor
110808532|NCT01087229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110808533|NCT01087229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110808534|NCT01087229|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110808535|NCT01087229|Analgesics|analgesics|mesh-ancestor
110808536|NCT01087229|Sensory System Agents|sensory system agents|mesh-ancestor
110808537|NCT01087229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110808538|NCT00082355|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
110808539|NCT00082355|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110808540|NCT00082355|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110808541|NCT00082355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110808542|NCT01084577|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
110808543|NCT01084577|Laxatives|laxatives|mesh-ancestor
110808544|NCT01084577|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110808545|NCT00094055|Axitinib|axitinib|mesh-list
110808546|NCT00094055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110808547|NCT00094055|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110808548|NCT00094055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110808549|NCT00094055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110808550|NCT02531165|Aspirin|aspirin|mesh-list
110808551|NCT02531165|Heparin|heparin|mesh-list
110808552|NCT02531165|Fentanyl|fentanyl|mesh-list
110808553|NCT02531165|Morphine|morphine|mesh-list
110808554|NCT02531165|Ticagrelor|ticagrelor|mesh-list
110808555|NCT02531165|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110808556|NCT02531165|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110808557|NCT02531165|Analgesics|analgesics|mesh-ancestor
110808558|NCT02531165|Sensory System Agents|sensory system agents|mesh-ancestor
110808559|NCT02531165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110808560|NCT02531165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110808561|NCT02531165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110808562|NCT02531165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110808563|NCT02531165|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110808564|NCT02531165|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110808565|NCT02531165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110808566|NCT02531165|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110808567|NCT02531165|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110808568|NCT02531165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110808569|NCT02531165|Antipyretics|antipyretics|mesh-ancestor
110808570|NCT02531165|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110808571|NCT02531165|Narcotics|narcotics|mesh-ancestor
110808572|NCT02531165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110808573|NCT02531165|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110808574|NCT02531165|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110808575|NCT02531165|Anesthetics, General|anesthetics, general|mesh-ancestor
110808576|NCT02531165|Anesthetics|anesthetics|mesh-ancestor
110808577|NCT02531165|Anticoagulants|anticoagulants|mesh-ancestor
110808578|NCT02531165|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110808579|NCT02531165|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110808580|NCT02531165|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110808581|NCT02531165|Purinergic Agents|purinergic agents|mesh-ancestor
110808582|NCT02531165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110808583|NCT00099983|Risperidone|risperidone|mesh-list
110808584|NCT00099983|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110808585|NCT00099983|Serotonin Agents|serotonin agents|mesh-ancestor
110808586|NCT00099983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110853158|NCT03810209|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110808587|NCT00099983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110808588|NCT00099983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110808589|NCT00099983|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110808590|NCT00099983|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110685037|NCT00414765|Aldesleukin|aldesleukin|mesh-list
110808591|NCT00099983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110808592|NCT00099983|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110808593|NCT00099983|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110808594|NCT00099983|Dopamine Agents|dopamine agents|mesh-ancestor
110808595|NCT00099359|Lamivudine|lamivudine|mesh-list
110808596|NCT00099359|Zidovudine|zidovudine|mesh-list
110808597|NCT00099359|Nevirapine|nevirapine|mesh-list
110808598|NCT00099359|Nelfinavir|nelfinavir|mesh-list
110808599|NCT00099359|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110808600|NCT00099359|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110808601|NCT00099359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110808602|NCT00099359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110808603|NCT00099359|Antiviral Agents|antiviral agents|mesh-ancestor
110808604|NCT00099359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110808605|NCT00099359|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110808606|NCT00099359|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110808608|NCT00099359|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110808609|NCT00099359|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110808610|NCT00099359|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110808611|NCT00099359|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110808612|NCT00099359|Protease Inhibitors|protease inhibitors|mesh-ancestor
110808613|NCT00092417|Vaccines|vaccines|mesh-list
110808614|NCT00092417|Immunologic Factors|immunologic factors|mesh-ancestor
110808615|NCT00092417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110808616|NCT00091949|Pioglitazone|pioglitazone|mesh-list
110808617|NCT00091949|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110808618|NCT00091949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110808619|NCT02258542|Benralizumab|benralizumab|mesh-list
110808620|NCT02258542|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110808621|NCT02258542|Respiratory System Agents|respiratory system agents|mesh-ancestor
110808622|NCT00091793|Denosumab|denosumab|mesh-list
110808623|NCT00091793|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110685450|NCT01017354|Micronutrients|micronutrients|mesh-ancestor
110808624|NCT00091793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110808625|NCT00098813|Romidepsin|romidepsin|mesh-list
110808626|NCT00098813|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110808627|NCT00098813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110808628|NCT00098813|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110808629|NCT00098813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110808630|NCT00098813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110808631|NCT01081613|Bevacizumab|bevacizumab|mesh-list
110808632|NCT01081613|89Zr-bevacizumab|89zr-bevacizumab|mesh-list
110808633|NCT01081613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110808634|NCT01081613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110685592|NCT00303628|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110808635|NCT01081613|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110808636|NCT01081613|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110808637|NCT01081613|Growth Substances|growth substances|mesh-ancestor
110808638|NCT01081613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110808639|NCT01081613|Growth Inhibitors|growth inhibitors|mesh-ancestor
110808640|NCT01081613|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110808641|NCT01081613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110808642|NCT02227264|Parathyroid Hormone|parathyroid hormone|mesh-list
110808643|NCT02227264|Cinacalcet|cinacalcet|mesh-list
110685669|NCT00474786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110808644|NCT02227264|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110808645|NCT02227264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110808646|NCT02227264|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
110808647|NCT02227264|Hormone Antagonists|hormone antagonists|mesh-ancestor
110808648|NCT02227264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110685884|NCT01017822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110808649|NCT02227420|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
110808650|NCT02227420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110808651|NCT04772248|Adalimumab|adalimumab|mesh-list
110808652|NCT04772248|Infliximab|infliximab|mesh-list
110808653|NCT04772248|Golimumab|golimumab|mesh-list
110808654|NCT04772248|Certolizumab Pegol|certolizumab pegol|mesh-list
110808655|NCT04772248|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
110808656|NCT04772248|Etanercept|etanercept|mesh-list
110808657|NCT04772248|Tofacitinib|tofacitinib|mesh-list
110808658|NCT04772248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110686027|NCT00495612|Omalizumab|omalizumab|mesh-list
110808659|NCT04772248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110808660|NCT04772248|Dermatologic Agents|dermatologic agents|mesh-ancestor
110808661|NCT04772248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110808662|NCT04772248|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110808663|NCT04772248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110808664|NCT04772248|Analgesics|analgesics|mesh-ancestor
110808665|NCT04772248|Sensory System Agents|sensory system agents|mesh-ancestor
110808666|NCT04772248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110808667|NCT04772248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110808668|NCT04772248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110686098|NCT00494676|Methamphetamine|methamphetamine|mesh-list
110808669|NCT04772248|Immunologic Factors|immunologic factors|mesh-ancestor
110808670|NCT04772248|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
110808671|NCT04772248|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110808672|NCT04772248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110686240|NCT00402597|Anticoagulants|anticoagulants|mesh-ancestor
110808673|NCT04772248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110808674|NCT00090857|Letrozole|letrozole|mesh-list
110808675|NCT00090857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110808676|NCT00090857|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110808677|NCT00090857|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110808678|NCT00090857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110446015|NCT00580047|Calcium|calcium|mesh-list
110808679|NCT00090857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110808680|NCT00090857|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110808681|NCT00090857|Hormone Antagonists|hormone antagonists|mesh-ancestor
110808682|NCT00090857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110808683|NCT00090857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110808684|NCT01775644|Bevacizumab|bevacizumab|mesh-list
110808685|NCT01775644|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110808686|NCT01775644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110686467|NCT00331864|Ranibizumab|ranibizumab|mesh-list
110808687|NCT01775644|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110808688|NCT01775644|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110808689|NCT01775644|Growth Substances|growth substances|mesh-ancestor
110808690|NCT01775644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110808691|NCT01775644|Growth Inhibitors|growth inhibitors|mesh-ancestor
110686523|NCT00391053|Vaccines|vaccines|mesh-list
110808692|NCT04259086|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110808693|NCT04259086|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110808694|NCT04259086|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110686667|NCT00464490|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110808695|NCT04259086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110808696|NCT04259086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110808697|NCT04259086|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110808698|NCT04259086|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110808699|NCT04259086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110808700|NCT04259086|Cholinergic Agents|cholinergic agents|mesh-ancestor
110686738|NCT00412113|Amlodipine|amlodipine|mesh-list
110808701|NCT04259086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110808702|NCT00090779|Ritonavir|ritonavir|mesh-list
110808703|NCT00090779|Lopinavir|lopinavir|mesh-list
110808704|NCT00090779|Tenofovir|tenofovir|mesh-list
110808705|NCT00090779|Emtricitabine|emtricitabine|mesh-list
110686803|NCT01039545|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110808706|NCT00090779|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110808707|NCT00090779|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110808708|NCT00090779|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110808709|NCT00090779|Protease Inhibitors|protease inhibitors|mesh-ancestor
110808710|NCT00090779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110808711|NCT00090779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110808712|NCT00090779|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110808713|NCT00090779|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110808714|NCT00090779|Antiviral Agents|antiviral agents|mesh-ancestor
110808715|NCT00090779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110686873|NCT00556439|Immunologic Factors|immunologic factors|mesh-ancestor
110808716|NCT00090779|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110808717|NCT00090779|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110808718|NCT00090779|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110808719|NCT00090779|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110808720|NCT01081691|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110808721|NCT01081691|Immunologic Factors|immunologic factors|mesh-ancestor
110853174|NCT03801707|Antiviral Agents|antiviral agents|mesh-ancestor
110808722|NCT01081691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110808723|NCT01081847|Mannitol|mannitol|mesh-list
110808724|NCT01081847|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
110808725|NCT01081847|Freund's Adjuvant|freund's adjuvant|mesh-list
110808726|NCT01081847|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110808727|NCT01081847|Immunologic Factors|immunologic factors|mesh-ancestor
110808728|NCT01081847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110808729|NCT01081847|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110808730|NCT01081847|Diuretics|diuretics|mesh-ancestor
110808731|NCT01081847|Natriuretic Agents|natriuretic agents|mesh-ancestor
110808732|NCT02224456|Tenofovir|tenofovir|mesh-list
110808733|NCT02224456|Antiviral Agents|antiviral agents|mesh-ancestor
110526313|NCT04255121|Mydriatics|mydriatics|mesh-ancestor
110808734|NCT02224456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110808735|NCT02224456|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110808736|NCT02224456|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110808737|NCT02224456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110808738|NCT02224456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110808739|NCT02224456|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110808740|NCT02224456|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110808741|NCT02224534|Clopidogrel|clopidogrel|mesh-list
110687130|NCT00490490|Iodine|iodine|mesh-list
110808742|NCT02224534|Ticagrelor|ticagrelor|mesh-list
110808743|NCT02224534|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110808744|NCT02224534|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110808745|NCT02224534|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110808746|NCT02224534|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110808747|NCT02224534|Purinergic Agents|purinergic agents|mesh-ancestor
110808748|NCT02224534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110808749|NCT02224534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110808750|NCT02224534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110808752|NCT04174612|Daunorubicin|daunorubicin|mesh-list
110808753|NCT04174612|Midostaurin|midostaurin|mesh-list
110808754|NCT04174612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110808755|NCT04174612|Antimetabolites|antimetabolites|mesh-ancestor
110687278|NCT05280197|Sensory System Agents|sensory system agents|mesh-ancestor
110808756|NCT04174612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110808757|NCT04174612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110808758|NCT04174612|Antiviral Agents|antiviral agents|mesh-ancestor
110808759|NCT04174612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110808760|NCT04174612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110808761|NCT04174612|Immunologic Factors|immunologic factors|mesh-ancestor
110808762|NCT04174612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110808763|NCT04174612|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110808764|NCT04174612|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110808765|NCT04174612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110808766|NCT04174612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110808767|NCT04174612|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110808768|NCT01082003|Pentoxifylline|pentoxifylline|mesh-list
110808769|NCT01082003|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110808770|NCT01082003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110808771|NCT01082003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110808772|NCT01082003|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110687345|NCT01011530|Pevonedistat|pevonedistat|mesh-list
110808773|NCT01082003|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110808774|NCT01082003|Protective Agents|protective agents|mesh-ancestor
110808775|NCT01082003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110808776|NCT01082003|Vasodilator Agents|vasodilator agents|mesh-ancestor
110808777|NCT01082003|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110808778|NCT01082003|Antioxidants|antioxidants|mesh-ancestor
110808779|NCT01082237|Escitalopram|escitalopram|mesh-list
110808780|NCT01082237|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110808781|NCT01082237|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110808782|NCT01082237|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110687404|NCT00560417|Insulin|insulin|mesh-list
110808783|NCT01082237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110808784|NCT01082237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110808785|NCT01082237|Serotonin Agents|serotonin agents|mesh-ancestor
110808786|NCT01082237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110808787|NCT02228122|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
110808788|NCT02228122|Laxatives|laxatives|mesh-ancestor
110808789|NCT02228122|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110808790|NCT01082315|Cetuximab|cetuximab|mesh-list
110808791|NCT01082315|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110808792|NCT01082315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110808793|NCT01082471|Morphine|morphine|mesh-list
110808794|NCT01082471|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110808795|NCT01082471|Narcotics|narcotics|mesh-ancestor
110808796|NCT01082471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110808797|NCT01082471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110808798|NCT01082471|Analgesics|analgesics|mesh-ancestor
110808799|NCT01082471|Sensory System Agents|sensory system agents|mesh-ancestor
110808800|NCT01082471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110808801|NCT03553498|Acetaminophen|acetaminophen|mesh-list
110808802|NCT03553498|Hydromorphone|hydromorphone|mesh-list
110808803|NCT03553498|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110808804|NCT03553498|Analgesics|analgesics|mesh-ancestor
110808805|NCT03553498|Sensory System Agents|sensory system agents|mesh-ancestor
110808806|NCT03553498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110808807|NCT03553498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110808808|NCT03553498|Antipyretics|antipyretics|mesh-ancestor
110808809|NCT03553498|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110808810|NCT03553498|Narcotics|narcotics|mesh-ancestor
110808811|NCT03553498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110808812|NCT01589393|Enoxaparin|enoxaparin|mesh-list
110808813|NCT01589393|Anticoagulants|anticoagulants|mesh-ancestor
110808814|NCT01589393|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110808815|NCT01589393|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110808816|NCT01589393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110808817|NCT01589471|Botulinum Toxins|botulinum toxins|mesh-list
110808818|NCT01589471|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110808819|NCT01589471|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110808820|NCT01589471|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110808821|NCT01589471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110808822|NCT01589471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110808823|NCT01589471|Cholinergic Agents|cholinergic agents|mesh-ancestor
110808824|NCT01589471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110808825|NCT01589471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110808826|NCT01589471|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110808827|NCT01589471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110808828|NCT00096941|Pertuzumab|pertuzumab|mesh-list
110808829|NCT00096941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110808830|NCT00096941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110808831|NCT00096785|Entecavir|entecavir|mesh-list
110808832|NCT00096785|Adefovir|adefovir|mesh-list
110808833|NCT00096785|Antiviral Agents|antiviral agents|mesh-ancestor
110808834|NCT00096785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110808835|NCT00096785|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110808836|NCT00096785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110808837|NCT00096785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110808838|NCT00096785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110808839|NCT01326767|Paclitaxel|paclitaxel|mesh-list
110808840|NCT01326767|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110808841|NCT01326767|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110808842|NCT01326767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110405940|NCT01298570|Antidotes|antidotes|mesh-ancestor
110808843|NCT01326767|Tubulin Modulators|tubulin modulators|mesh-ancestor
110808844|NCT01326767|Antimitotic Agents|antimitotic agents|mesh-ancestor
110808845|NCT01326767|Mitosis Modulators|mitosis modulators|mesh-ancestor
110808846|NCT01326767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110808847|NCT03963479|Vitamin B 6|vitamin b 6|mesh-list
110808848|NCT03963479|Pyridoxal|pyridoxal|mesh-list
110808849|NCT03963479|Pyridoxine|pyridoxine|mesh-list
110808850|NCT03963479|Vitamins|vitamins|mesh-ancestor
110808851|NCT03963479|Micronutrients|micronutrients|mesh-ancestor
110808852|NCT03963479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110808853|NCT03963479|Vitamin B Complex|vitamin b complex|mesh-ancestor
110808854|NCT02228512|Prednisone|prednisone|mesh-list
110808855|NCT02228512|Cyclophosphamide|cyclophosphamide|mesh-list
110808856|NCT02228512|Rituximab|rituximab|mesh-list
110808857|NCT02228512|Doxorubicin|doxorubicin|mesh-list
110808858|NCT02228512|Etoposide|etoposide|mesh-list
110808859|NCT02228512|Vincristine|vincristine|mesh-list
110808860|NCT02228512|Pomalidomide|pomalidomide|mesh-list
110808861|NCT02228512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110808862|NCT02228512|Immunologic Factors|immunologic factors|mesh-ancestor
110808863|NCT02228512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110808864|NCT02228512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110808865|NCT02228512|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110808866|NCT02228512|Alkylating Agents|alkylating agents|mesh-ancestor
110808867|NCT02228512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110808868|NCT02228512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110808869|NCT02228512|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110808870|NCT02228512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110808871|NCT02228512|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110808872|NCT02228512|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110808873|NCT02228512|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110808874|NCT02228512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110808875|NCT02228512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110808876|NCT02228512|Glucocorticoids|glucocorticoids|mesh-ancestor
110808877|NCT02228512|Hormones|hormones|mesh-ancestor
110808878|NCT02228512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110808879|NCT02228512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110808880|NCT02228512|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110808881|NCT02228512|Tubulin Modulators|tubulin modulators|mesh-ancestor
110808882|NCT02228512|Antimitotic Agents|antimitotic agents|mesh-ancestor
110808883|NCT02228512|Mitosis Modulators|mitosis modulators|mesh-ancestor
110808884|NCT02228512|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110808885|NCT02228512|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110808886|NCT02228512|Growth Substances|growth substances|mesh-ancestor
110808887|NCT02228512|Growth Inhibitors|growth inhibitors|mesh-ancestor
110808888|NCT01082627|Somatostatin|somatostatin|mesh-list
110808889|NCT01082627|Hormones|hormones|mesh-ancestor
110808890|NCT01082627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110808891|NCT01082627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110808892|NCT03515044|Rifaximin|rifaximin|mesh-list
110808893|NCT03515044|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110808894|NCT03515044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110853219|NCT05014334|Antacids|antacids|mesh-ancestor
110808895|NCT03515044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110808896|NCT01082705|Lumefantrine|lumefantrine|mesh-list
110808897|NCT01082705|Artemether|artemether|mesh-list
110808898|NCT01082705|Piperaquine|piperaquine|mesh-list
110808899|NCT01082705|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
110808900|NCT01082705|Artenimol|artenimol|mesh-list
110808901|NCT01082705|Antimalarials|antimalarials|mesh-ancestor
110808902|NCT01082705|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110808903|NCT01082705|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110808904|NCT01082705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110808905|NCT01582997|Dabrafenib|dabrafenib|mesh-list
110808906|NCT01582997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110808907|NCT01582997|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110808908|NCT01582997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110808909|NCT01582997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110808910|NCT01090505|Oxaliplatin|oxaliplatin|mesh-list
110406406|NCT01296698|Autonomic Agents|autonomic agents|mesh-ancestor
110808911|NCT01090505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110808913|NCT01085981|Niacinamide|niacinamide|mesh-list
110808914|NCT01085981|Nicotinic Acids|nicotinic acids|mesh-list
110808915|NCT01085981|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110808916|NCT01085981|Antimetabolites|antimetabolites|mesh-ancestor
110808917|NCT01085981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110808918|NCT01085981|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110808919|NCT01085981|Vasodilator Agents|vasodilator agents|mesh-ancestor
110808920|NCT01085981|Vitamin B Complex|vitamin b complex|mesh-ancestor
110808921|NCT01085981|Vitamins|vitamins|mesh-ancestor
110808922|NCT01085981|Micronutrients|micronutrients|mesh-ancestor
110808923|NCT01085981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110808924|NCT03345082|Ranibizumab|ranibizumab|mesh-list
110808925|NCT03345082|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110808926|NCT03345082|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110808927|NCT03345082|Growth Substances|growth substances|mesh-ancestor
110808928|NCT03345082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110808929|NCT03345082|Growth Inhibitors|growth inhibitors|mesh-ancestor
110808930|NCT03345082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110808931|NCT02228902|Ferrous fumarate|ferrous fumarate|mesh-list
110808932|NCT02228902|Ferrous gluconate|ferrous gluconate|mesh-list
110808933|NCT02228902|Trace Elements|trace elements|mesh-ancestor
110808934|NCT02228902|Micronutrients|micronutrients|mesh-ancestor
110808935|NCT02228902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110808936|NCT02228902|Hematinics|hematinics|mesh-ancestor
110808937|NCT03288454|Apixaban|apixaban|mesh-list
110808938|NCT03288454|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110808939|NCT03288454|Antithrombins|antithrombins|mesh-ancestor
110808940|NCT03288454|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110808941|NCT03288454|Protease Inhibitors|protease inhibitors|mesh-ancestor
110808942|NCT03288454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110808943|NCT03288454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110808944|NCT03288454|Anticoagulants|anticoagulants|mesh-ancestor
110808945|NCT00090545|Sorafenib|sorafenib|mesh-list
110808946|NCT00090545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110808947|NCT00090545|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110808948|NCT00090545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110808949|NCT00090545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110808950|NCT02829814|Cyclobenzaprine|cyclobenzaprine|mesh-list
110808951|NCT02829814|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110808952|NCT02829814|Antidepressive Agents|antidepressive agents|mesh-ancestor
110808953|NCT02829814|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110808954|NCT02829814|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110808955|NCT02829814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110808956|NCT02829814|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110808957|NCT02829814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110808958|NCT02829814|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110808959|NCT02829814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110808960|NCT03916042|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110406502|NCT01006603|Glimepiride|glimepiride|mesh-list
110808961|NCT03916042|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110808962|NCT02229058|Paclitaxel|paclitaxel|mesh-list
110808963|NCT02229058|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110808964|NCT02229058|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110808965|NCT02229058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110808966|NCT02229058|Tubulin Modulators|tubulin modulators|mesh-ancestor
110808967|NCT02229058|Antimitotic Agents|antimitotic agents|mesh-ancestor
110808968|NCT02229058|Mitosis Modulators|mitosis modulators|mesh-ancestor
110808969|NCT02229058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110808970|NCT02229292|Tranexamic Acid|tranexamic acid|mesh-list
110808971|NCT02229292|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110808972|NCT02229292|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110808973|NCT02229292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110808974|NCT02229292|Hemostatics|hemostatics|mesh-ancestor
110808975|NCT02229292|Coagulants|coagulants|mesh-ancestor
110808976|NCT00070109|Trabectedin|trabectedin|mesh-list
110808977|NCT00070109|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110808978|NCT00070109|Alkylating Agents|alkylating agents|mesh-ancestor
110406550|NCT00997243|Antimetabolites|antimetabolites|mesh-ancestor
110808979|NCT00070109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110808980|NCT00070109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110808982|NCT00069953|Fluorouracil|fluorouracil|mesh-list
110808983|NCT00069953|Lenograstim|lenograstim|mesh-list
110808984|NCT00069953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110808985|NCT00069953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110808986|NCT00069953|Tubulin Modulators|tubulin modulators|mesh-ancestor
110808987|NCT00069953|Antimitotic Agents|antimitotic agents|mesh-ancestor
110808988|NCT00069953|Mitosis Modulators|mitosis modulators|mesh-ancestor
110808989|NCT00069953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110808990|NCT00069953|Antimetabolites|antimetabolites|mesh-ancestor
110808991|NCT00069953|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110808992|NCT00069953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110808993|NCT00069953|Immunologic Factors|immunologic factors|mesh-ancestor
110808994|NCT00069953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110808995|NCT00069953|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110808996|NCT02750800|Adalimumab|adalimumab|mesh-list
110808997|NCT02750800|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110808998|NCT02750800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110808999|NCT02750800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110809000|NCT02229760|Ritonavir|ritonavir|mesh-list
110809001|NCT02229760|Tipranavir|tipranavir|mesh-list
110809002|NCT02229760|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110809003|NCT02229760|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110809004|NCT02229760|Protease Inhibitors|protease inhibitors|mesh-ancestor
110809005|NCT02229760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110809006|NCT02229760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110809007|NCT02229760|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110809008|NCT02229760|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110809009|NCT02229760|Antiviral Agents|antiviral agents|mesh-ancestor
110809010|NCT02229760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110406814|NCT01010776|Paliperidone Palmitate|paliperidone palmitate|mesh-list
110809011|NCT02229760|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110809012|NCT02229760|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110809013|NCT03662542|Golimumab|golimumab|mesh-list
110809014|NCT03662542|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110809015|NCT03662542|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110809016|NCT03662542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110809017|NCT03662542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110809018|NCT03662542|Immunologic Factors|immunologic factors|mesh-ancestor
110809019|NCT03662542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110809020|NCT01329562|Naproxen|naproxen|mesh-list
110809021|NCT01329562|Sumatriptan|sumatriptan|mesh-list
110809022|NCT01329562|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110809023|NCT01329562|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110809024|NCT01329562|Analgesics|analgesics|mesh-ancestor
110809025|NCT01329562|Sensory System Agents|sensory system agents|mesh-ancestor
110809026|NCT01329562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110809027|NCT01329562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110809028|NCT01329562|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110809029|NCT01329562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110809030|NCT01329562|Gout Suppressants|gout suppressants|mesh-ancestor
110809031|NCT01329562|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110809032|NCT01329562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110809033|NCT01329562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110809034|NCT01329562|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110809035|NCT01329562|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110809036|NCT01329562|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110809037|NCT01329562|Serotonin Agents|serotonin agents|mesh-ancestor
110809038|NCT01329562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110809039|NCT02230228|Vitamin A|vitamin a|mesh-list
110809040|NCT02230228|Retinol acetate|retinol acetate|mesh-list
110809041|NCT02230228|Vitamins|vitamins|mesh-ancestor
110809042|NCT02230228|Micronutrients|micronutrients|mesh-ancestor
110809043|NCT02230228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110809044|NCT02230228|Protective Agents|protective agents|mesh-ancestor
110809045|NCT02230228|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110809046|NCT02230228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110809047|NCT02230228|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110809048|NCT02230228|Immunologic Factors|immunologic factors|mesh-ancestor
110809049|NCT01090661|Moxifloxacin|moxifloxacin|mesh-list
110809050|NCT01090661|Mipomersen|mipomersen|mesh-list
110809051|NCT01090661|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
110809052|NCT01090661|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110809053|NCT01090661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110809054|NCT01090661|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110809055|NCT01090661|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110809056|NCT01090661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110809057|NCT01090661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110809058|NCT01090661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110809059|NCT01090661|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110809060|NCT01090661|Contraceptive Agents|contraceptive agents|mesh-ancestor
110809061|NCT01090661|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110809062|NCT01090661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110809063|NCT01090661|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110809064|NCT01090661|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110809065|NCT01090661|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110809066|NCT01090661|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110809067|NCT01090661|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110809068|NCT01090661|Antimetabolites|antimetabolites|mesh-ancestor
110809069|NCT01090661|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110809071|NCT05563480|Gemcitabine|gemcitabine|mesh-list
110809072|NCT05563480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110809073|NCT05563480|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110809074|NCT05563480|Antimetabolites|antimetabolites|mesh-ancestor
110407049|NCT01009840|Alkylating Agents|alkylating agents|mesh-ancestor
110809075|NCT05563480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110809076|NCT05546398|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
110809077|NCT05546398|Ezetimibe|ezetimibe|mesh-list
110809078|NCT05546398|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110809079|NCT05546398|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110407125|NCT01008904|Antacids|antacids|mesh-ancestor
110809080|NCT05546398|Antimetabolites|antimetabolites|mesh-ancestor
110809081|NCT05546398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110809082|NCT05546398|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110809083|NCT05546398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110809084|NCT05546398|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110809085|NCT05546398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110809086|NCT05472766|Anticoagulants|anticoagulants|mesh-list
110809087|NCT05472766|Factor Xa Inhibitors|factor xa inhibitors|mesh-list
110809088|NCT05472766|Antithrombins|antithrombins|mesh-ancestor
110809089|NCT05472766|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110809090|NCT05472766|Protease Inhibitors|protease inhibitors|mesh-ancestor
110809091|NCT05472766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110809092|NCT05472766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110809093|NCT03653026|Upadacitinib|upadacitinib|mesh-list
110809094|NCT03653026|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
110407361|NCT01213173|Metoprolol|metoprolol|mesh-list
110809095|NCT03653026|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110809096|NCT03653026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110407400|NCT04288765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110809097|NCT03653026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110809098|NCT03653026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110809099|NCT02232724|Choline|choline|mesh-list
110809100|NCT02232724|Lipotropic Agents|lipotropic agents|mesh-ancestor
110809101|NCT02232724|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110809102|NCT02232724|Antimetabolites|antimetabolites|mesh-ancestor
110809103|NCT02232724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110809104|NCT02232724|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110809105|NCT02232724|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110809106|NCT02232724|Nootropic Agents|nootropic agents|mesh-ancestor
110809107|NCT02234440|Metformin|metformin|mesh-list
110809108|NCT02234440|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110809109|NCT02234440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110809110|NCT04981678|Buprenorphine|buprenorphine|mesh-list
110809111|NCT04981678|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110809113|NCT04981678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110809114|NCT04981678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110407551|NCT01208103|Antibodies|antibodies|mesh-list
110809115|NCT04981678|Analgesics|analgesics|mesh-ancestor
110809116|NCT04981678|Sensory System Agents|sensory system agents|mesh-ancestor
110809117|NCT04981678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110809118|NCT04981678|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110809119|NCT02230618|Insulin|insulin|mesh-list
110809120|NCT02230618|Insulin Aspart|insulin aspart|mesh-list
110809121|NCT02230618|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110809122|NCT02230618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110809123|NCT01337986|4-Aminopyridine|4-aminopyridine|mesh-list
110809124|NCT01337986|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
110809125|NCT01337986|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110809126|NCT01337986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110809127|NCT04669288|Azithromycin|azithromycin|mesh-list
110809128|NCT04669288|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110809129|NCT04669288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110809130|NCT02262520|Digoxin|digoxin|mesh-list
110809131|NCT02262520|Apixaban|apixaban|mesh-list
110809132|NCT02262520|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110809133|NCT02262520|Antithrombins|antithrombins|mesh-ancestor
110809134|NCT02262520|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110809135|NCT02262520|Protease Inhibitors|protease inhibitors|mesh-ancestor
110809136|NCT02262520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110809137|NCT02262520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110809138|NCT02262520|Anticoagulants|anticoagulants|mesh-ancestor
110809139|NCT02262520|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110809140|NCT02262520|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110809141|NCT02262520|Protective Agents|protective agents|mesh-ancestor
110809142|NCT02262520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110809143|NCT02233504|Deferasirox|deferasirox|mesh-list
110809144|NCT02233504|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110809145|NCT02233504|Chelating Agents|chelating agents|mesh-ancestor
110809146|NCT02233504|Sequestering Agents|sequestering agents|mesh-ancestor
110809147|NCT02233504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110809148|NCT02262598|Telmisartan|telmisartan|mesh-list
110809149|NCT02262598|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110809150|NCT02262598|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110809151|NCT02262598|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110809152|NCT02262598|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110809153|NCT02262598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110809154|NCT02262598|Diuretics|diuretics|mesh-ancestor
110809155|NCT02262598|Natriuretic Agents|natriuretic agents|mesh-ancestor
110809156|NCT02262598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110809157|NCT02262598|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110809158|NCT02262598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110809159|NCT03723538|Dexmedetomidine|dexmedetomidine|mesh-list
110809160|NCT03723538|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110809161|NCT03723538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110809162|NCT03723538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110809163|NCT03723538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110809164|NCT03723538|Analgesics|analgesics|mesh-ancestor
110407927|NCT02863471|Gemcitabine|gemcitabine|mesh-list
110809165|NCT03723538|Sensory System Agents|sensory system agents|mesh-ancestor
110809166|NCT03723538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110809167|NCT03723538|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110809168|NCT03723538|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110809169|NCT03723538|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110809170|NCT03723538|Adrenergic Agents|adrenergic agents|mesh-ancestor
110809171|NCT03723538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110809172|NCT03723538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110809173|NCT01337674|Metoprolol|metoprolol|mesh-list
110809174|NCT01337674|Amlodipine|amlodipine|mesh-list
110809175|NCT01337674|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110809176|NCT01337674|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110408004|NCT02890823|Cholecalciferol|cholecalciferol|mesh-list
110809177|NCT01337674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110809178|NCT01337674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110809179|NCT01337674|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110809180|NCT01337674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110809181|NCT01337674|Vasodilator Agents|vasodilator agents|mesh-ancestor
110809182|NCT01337674|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110809183|NCT01337674|Sympatholytics|sympatholytics|mesh-ancestor
110809184|NCT01337674|Autonomic Agents|autonomic agents|mesh-ancestor
110809185|NCT01337674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110809186|NCT01337674|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110809187|NCT01337674|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110809188|NCT01337674|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110809189|NCT01337674|Adrenergic Agents|adrenergic agents|mesh-ancestor
110809190|NCT01337674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110809191|NCT02262676|Rivaroxaban|rivaroxaban|mesh-list
110809192|NCT02262676|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110809193|NCT02262676|Antithrombins|antithrombins|mesh-ancestor
110809194|NCT02262676|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110809195|NCT02262676|Protease Inhibitors|protease inhibitors|mesh-ancestor
110809196|NCT02262676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110809197|NCT02262676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110809198|NCT02262676|Anticoagulants|anticoagulants|mesh-ancestor
110809199|NCT02233582|Ibuprofen|ibuprofen|mesh-list
110809200|NCT02233582|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110809201|NCT02233582|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110809202|NCT02233582|Analgesics|analgesics|mesh-ancestor
110809203|NCT02233582|Sensory System Agents|sensory system agents|mesh-ancestor
110809204|NCT02233582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110809205|NCT02233582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110809206|NCT02233582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110809207|NCT02233582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110809208|NCT02233582|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110809209|NCT02233582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110809210|NCT02233582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110809212|NCT02580370|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110809213|NCT02580370|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110809214|NCT02580370|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110809215|NCT02580370|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110809216|NCT02580370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110809217|NCT02580370|Cholinergic Agents|cholinergic agents|mesh-ancestor
110809218|NCT02580370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110809219|NCT02580370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110809220|NCT02580370|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110809221|NCT02580370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110809222|NCT02233816|Vaccines|vaccines|mesh-list
110809223|NCT02233816|Immunologic Factors|immunologic factors|mesh-ancestor
110809224|NCT02233816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110809225|NCT02750410|Dulaglutide|dulaglutide|mesh-list
110809226|NCT02750410|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110809227|NCT02750410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110809228|NCT02750332|Nitisinone|nitisinone|mesh-list
110809229|NCT02750332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110809230|NCT02750332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110809231|NCT02233894|Ipratropium|ipratropium|mesh-list
110809232|NCT02233894|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110809233|NCT02233894|Autonomic Agents|autonomic agents|mesh-ancestor
110809234|NCT02233894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110809235|NCT02233894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110809236|NCT02233894|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110809237|NCT02233894|Respiratory System Agents|respiratory system agents|mesh-ancestor
110809238|NCT02233894|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110809239|NCT02233894|Cholinergic Agents|cholinergic agents|mesh-ancestor
110809240|NCT02233894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110809241|NCT02233894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110809242|NCT02233972|Midazolam|midazolam|mesh-list
110809243|NCT02233972|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110809244|NCT02233972|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110853257|NCT03050450|Growth Substances|growth substances|mesh-ancestor
110809245|NCT02233972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110809246|NCT02233972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110809247|NCT02233972|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110809248|NCT02233972|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110809249|NCT02233972|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110809250|NCT02233972|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110809251|NCT02233972|Anesthetics, General|anesthetics, general|mesh-ancestor
110809252|NCT02233972|Anesthetics|anesthetics|mesh-ancestor
110809253|NCT02233972|GABA Modulators|gaba modulators|mesh-ancestor
110809254|NCT02233972|GABA Agents|gaba agents|mesh-ancestor
110809255|NCT02233972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110809256|NCT02233972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110809257|NCT02234050|Trabectedin|trabectedin|mesh-list
110809258|NCT02234050|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110809259|NCT02234050|Alkylating Agents|alkylating agents|mesh-ancestor
110809260|NCT02234050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110809261|NCT02234050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110809262|NCT02263066|Factor VIII|factor viii|mesh-list
110809263|NCT02263066|Coagulants|coagulants|mesh-ancestor
110809264|NCT02235532|Fluorides|fluorides|mesh-list
110809265|NCT02235532|Cariostatic Agents|cariostatic agents|mesh-ancestor
110809266|NCT02235532|Protective Agents|protective agents|mesh-ancestor
110809267|NCT02235532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110809268|NCT00069095|Leucovorin|leucovorin|mesh-list
110809269|NCT00069095|Bevacizumab|bevacizumab|mesh-list
110809270|NCT00069095|Fluorouracil|fluorouracil|mesh-list
110809271|NCT00069095|Capecitabine|capecitabine|mesh-list
110809272|NCT00069095|Oxaliplatin|oxaliplatin|mesh-list
110809273|NCT00069095|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110809274|NCT00069095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110809275|NCT00069095|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110809276|NCT00069095|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110809277|NCT00069095|Growth Substances|growth substances|mesh-ancestor
110809278|NCT00069095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110809279|NCT00069095|Growth Inhibitors|growth inhibitors|mesh-ancestor
110809280|NCT00069095|Antimetabolites|antimetabolites|mesh-ancestor
110809281|NCT00069095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110809282|NCT00069095|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110809283|NCT00069095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110809284|NCT00069095|Immunologic Factors|immunologic factors|mesh-ancestor
110809285|NCT00069095|Antidotes|antidotes|mesh-ancestor
110809286|NCT00069095|Protective Agents|protective agents|mesh-ancestor
110408470|NCT05597735|Tecovirimat|tecovirimat|mesh-list
110809287|NCT00069095|Vitamin B Complex|vitamin b complex|mesh-ancestor
110809288|NCT00069095|Vitamins|vitamins|mesh-ancestor
110809289|NCT00069095|Micronutrients|micronutrients|mesh-ancestor
110809290|NCT00086411|Bupropion|bupropion|mesh-list
110809291|NCT00086411|Nicotine|nicotine|mesh-list
110809292|NCT00086411|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110809293|NCT00086411|Autonomic Agents|autonomic agents|mesh-ancestor
110809294|NCT00086411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110809295|NCT00086411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110809296|NCT00086411|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110809297|NCT00086411|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110809298|NCT00086411|Cholinergic Agents|cholinergic agents|mesh-ancestor
110809299|NCT00086411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110809300|NCT00086411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110809301|NCT00086411|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110325453|NCT00473070|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110809302|NCT00086411|Antidepressive Agents|antidepressive agents|mesh-ancestor
110809303|NCT00086411|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110853264|NCT03505021|Simendan|simendan|mesh-list
110809304|NCT00086411|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110809305|NCT00086411|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110809306|NCT00086411|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110809307|NCT00086411|Dopamine Agents|dopamine agents|mesh-ancestor
110809308|NCT00086411|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110809309|NCT00086411|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110809310|NCT00086411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110809311|NCT01086527|Montelukast|montelukast|mesh-list
110809312|NCT01086527|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110809313|NCT01086527|Respiratory System Agents|respiratory system agents|mesh-ancestor
110809314|NCT01086527|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110809315|NCT01086527|Hormone Antagonists|hormone antagonists|mesh-ancestor
110809316|NCT01086527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110809317|NCT01086527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110809318|NCT01086527|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110809319|NCT01086527|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110408744|NCT04283656|Estrogens|estrogens|mesh-ancestor
110809320|NCT01086527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110809321|NCT01093937|Varenicline|varenicline|mesh-list
110809322|NCT01093937|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110809323|NCT01093937|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110809324|NCT01093937|Cholinergic Agents|cholinergic agents|mesh-ancestor
110809325|NCT01093937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110809326|NCT01093937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110809327|NCT01093937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110809328|NCT01094015|Lidocaine|lidocaine|mesh-list
110809329|NCT01094015|Prilocaine|prilocaine|mesh-list
110809330|NCT01094015|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
110809331|NCT01094015|Anesthetics, Local|anesthetics, local|mesh-ancestor
110809332|NCT01094015|Anesthetics|anesthetics|mesh-ancestor
110809333|NCT01094015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110809334|NCT01094015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110809335|NCT01094015|Sensory System Agents|sensory system agents|mesh-ancestor
110809336|NCT01094015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110809337|NCT01094015|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110809338|NCT01094015|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110809339|NCT01094015|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110809340|NCT01094015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110809341|NCT01094015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110809342|NCT01094015|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
110809344|NCT01090895|Vitamins|vitamins|mesh-ancestor
110809345|NCT01090895|Micronutrients|micronutrients|mesh-ancestor
110809346|NCT01090895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110809347|NCT01090895|Antioxidants|antioxidants|mesh-ancestor
110809348|NCT01090895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110809349|NCT01090895|Protective Agents|protective agents|mesh-ancestor
110809350|NCT03956303|Levobupivacaine|levobupivacaine|mesh-list
110809351|NCT03956303|Anesthetics, Local|anesthetics, local|mesh-ancestor
110809353|NCT03956303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110809354|NCT03956303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110809355|NCT03956303|Sensory System Agents|sensory system agents|mesh-ancestor
110809356|NCT03956303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110809357|NCT01094249|Valproic Acid|valproic acid|mesh-list
110809358|NCT01094249|Paliperidone Palmitate|paliperidone palmitate|mesh-list
110809359|NCT01094249|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110809360|NCT01094249|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110809361|NCT01094249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110809362|NCT01094249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110809363|NCT01094249|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110809364|NCT01094249|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110809365|NCT01094249|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110809366|NCT01094249|Serotonin Agents|serotonin agents|mesh-ancestor
110809367|NCT01094249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110809368|NCT01094249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110809369|NCT01094249|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110809370|NCT01094249|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110809371|NCT01094249|Dopamine Agents|dopamine agents|mesh-ancestor
110809372|NCT01094249|Anticonvulsants|anticonvulsants|mesh-ancestor
110809373|NCT01094249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110809374|NCT01094249|GABA Agents|gaba agents|mesh-ancestor
110809375|NCT01094249|Antimanic Agents|antimanic agents|mesh-ancestor
110809376|NCT00055601|Paclitaxel|paclitaxel|mesh-list
110809377|NCT00055601|Gemcitabine|gemcitabine|mesh-list
110809378|NCT00055601|Fluorouracil|fluorouracil|mesh-list
110809379|NCT00055601|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110809380|NCT00055601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110809381|NCT00055601|Tubulin Modulators|tubulin modulators|mesh-ancestor
110809382|NCT00055601|Antimitotic Agents|antimitotic agents|mesh-ancestor
110809383|NCT00055601|Mitosis Modulators|mitosis modulators|mesh-ancestor
110809384|NCT00055601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110809385|NCT00055601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110809386|NCT00055601|Antimetabolites|antimetabolites|mesh-ancestor
110809387|NCT00055601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110809388|NCT00055601|Immunologic Factors|immunologic factors|mesh-ancestor
110809389|NCT00055601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110809390|NCT01583621|Cholecalciferol|cholecalciferol|mesh-list
110809391|NCT01583621|Vitamin D|vitamin d|mesh-list
110809392|NCT01583621|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110809393|NCT01583621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110809394|NCT01583621|Vitamins|vitamins|mesh-ancestor
110809395|NCT01583621|Micronutrients|micronutrients|mesh-ancestor
110809396|NCT01583621|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110809397|NCT03806231|Dinoprostone|dinoprostone|mesh-list
110409275|NCT02185820|Hormones|hormones|mesh-ancestor
110809398|NCT03806231|Oxytocics|oxytocics|mesh-ancestor
110809399|NCT03806231|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110809400|NCT03806231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110809401|NCT01091051|Ustekinumab|ustekinumab|mesh-list
110809402|NCT01091051|Dermatologic Agents|dermatologic agents|mesh-ancestor
110809403|NCT01327079|Methadone|methadone|mesh-list
110809404|NCT01327079|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110809405|NCT01327079|Narcotics|narcotics|mesh-ancestor
110809406|NCT01327079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110809407|NCT01327079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110809408|NCT01327079|Analgesics|analgesics|mesh-ancestor
110809409|NCT01327079|Sensory System Agents|sensory system agents|mesh-ancestor
110809410|NCT01327079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110809411|NCT01327079|Antitussive Agents|antitussive agents|mesh-ancestor
110809412|NCT01327079|Respiratory System Agents|respiratory system agents|mesh-ancestor
110809413|NCT01091207|Sorafenib|sorafenib|mesh-list
110809414|NCT01091207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110809415|NCT01091207|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110809416|NCT01091207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110809417|NCT01091207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110809419|NCT00054275|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110809420|NCT00054275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110809421|NCT00054275|Tubulin Modulators|tubulin modulators|mesh-ancestor
110809422|NCT00054275|Antimitotic Agents|antimitotic agents|mesh-ancestor
110409466|NCT00600496|Sirolimus|sirolimus|mesh-list
110809423|NCT00054275|Mitosis Modulators|mitosis modulators|mesh-ancestor
110809424|NCT00054275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110809425|NCT00054275|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110809426|NCT00054275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110809427|NCT01095185|Simvastatin|simvastatin|mesh-list
110809428|NCT01095185|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110809429|NCT01095185|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110809430|NCT01095185|Antimetabolites|antimetabolites|mesh-ancestor
110853286|NCT03329248|Leucovorin|leucovorin|mesh-list
110809431|NCT01095185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110809433|NCT01095185|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110809434|NCT01095185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110809436|NCT01583777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110809437|NCT01583777|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110809438|NCT01583777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110809439|NCT01583777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110809440|NCT00053417|4-Aminopyridine|4-aminopyridine|mesh-list
110809441|NCT00053417|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
110809442|NCT00053417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110809443|NCT00053417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110809444|NCT00052715|Poly ICLC|poly iclc|mesh-list
110809445|NCT00052715|Interferon Inducers|interferon inducers|mesh-ancestor
110809446|NCT00052715|Immunologic Factors|immunologic factors|mesh-ancestor
110809447|NCT00052715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110809448|NCT03955601|Cyclophosphamide|cyclophosphamide|mesh-list
110809449|NCT03955601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110809450|NCT03955601|Immunologic Factors|immunologic factors|mesh-ancestor
110809451|NCT03955601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110809452|NCT03955601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110809453|NCT03955601|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110809454|NCT03955601|Alkylating Agents|alkylating agents|mesh-ancestor
110809455|NCT03955601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110809456|NCT03955601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110809457|NCT03955601|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110809458|NCT00051311|Cyclosporine|cyclosporine|mesh-list
110809459|NCT00051311|Prednisone|prednisone|mesh-list
110809460|NCT00051311|Cyclophosphamide|cyclophosphamide|mesh-list
110809461|NCT00051311|Doxorubicin|doxorubicin|mesh-list
110809462|NCT00051311|Methotrexate|methotrexate|mesh-list
110809463|NCT00051311|Fludarabine|fludarabine|mesh-list
110809464|NCT00051311|Etoposide|etoposide|mesh-list
110809465|NCT00051311|Vincristine|vincristine|mesh-list
110809466|NCT00051311|Cyclosporins|cyclosporins|mesh-list
110809467|NCT00051311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110809468|NCT00051311|Immunologic Factors|immunologic factors|mesh-ancestor
110809469|NCT00051311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110809470|NCT00051311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110809471|NCT00051311|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110809472|NCT00051311|Alkylating Agents|alkylating agents|mesh-ancestor
110809473|NCT00051311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110809474|NCT00051311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110809475|NCT00051311|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110809476|NCT00051311|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110809477|NCT00051311|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110809478|NCT00051311|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110809479|NCT00051311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110809480|NCT00051311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110809481|NCT00051311|Glucocorticoids|glucocorticoids|mesh-ancestor
110809482|NCT00051311|Hormones|hormones|mesh-ancestor
110809483|NCT00051311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110809484|NCT00051311|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110809485|NCT00051311|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110809486|NCT00051311|Abortifacient Agents|abortifacient agents|mesh-ancestor
110809487|NCT00051311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110809488|NCT00051311|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110809489|NCT00051311|Antimetabolites|antimetabolites|mesh-ancestor
110809490|NCT00051311|Dermatologic Agents|dermatologic agents|mesh-ancestor
110809492|NCT00051311|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110809493|NCT00051311|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110809494|NCT00051311|Tubulin Modulators|tubulin modulators|mesh-ancestor
110809495|NCT00051311|Antimitotic Agents|antimitotic agents|mesh-ancestor
110809496|NCT00051311|Mitosis Modulators|mitosis modulators|mesh-ancestor
110809497|NCT00051311|Antifungal Agents|antifungal agents|mesh-ancestor
110809498|NCT00051311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110809499|NCT00051311|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110809501|NCT01091753|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110809502|NCT01091753|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110809503|NCT01091753|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110809504|NCT01091753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110809505|NCT01091753|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110809506|NCT01091753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110809507|NCT01091753|Vasodilator Agents|vasodilator agents|mesh-ancestor
110809508|NCT00049673|Thalidomide|thalidomide|mesh-list
110809509|NCT00049673|Prednisone|prednisone|mesh-list
110809510|NCT00049673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110809511|NCT00049673|Glucocorticoids|glucocorticoids|mesh-ancestor
110809512|NCT00049673|Hormones|hormones|mesh-ancestor
110809513|NCT00049673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110809514|NCT00049673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110809515|NCT00049673|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110809516|NCT00049673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110809517|NCT00049673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110809518|NCT00049673|Immunologic Factors|immunologic factors|mesh-ancestor
110809519|NCT00049673|Leprostatic Agents|leprostatic agents|mesh-ancestor
110809520|NCT00049673|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110809521|NCT00049673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110809522|NCT00049673|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110809523|NCT00049673|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110809524|NCT00049673|Growth Substances|growth substances|mesh-ancestor
110809525|NCT00049673|Growth Inhibitors|growth inhibitors|mesh-ancestor
110809526|NCT00049127|Imatinib Mesylate|imatinib mesylate|mesh-list
110809527|NCT00049127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110809528|NCT00049127|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110809529|NCT00049127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110809530|NCT00049127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110809531|NCT00066365|Molgramostim|molgramostim|mesh-list
110809532|NCT00066365|Sargramostim|sargramostim|mesh-list
110809533|NCT00066365|Immunologic Factors|immunologic factors|mesh-ancestor
110809534|NCT00066365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110809535|NCT00066365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110809536|NCT00048581|Abatacept|abatacept|mesh-list
110809537|NCT00048581|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110809538|NCT00048581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110809539|NCT00048581|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110809540|NCT00048581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110809541|NCT00048581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110809542|NCT00048581|Immunologic Factors|immunologic factors|mesh-ancestor
110809543|NCT00048581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110809544|NCT00048581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110809545|NCT00048347|Interferon beta-1a|interferon beta-1a|mesh-list
110809546|NCT00048347|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110809547|NCT00048347|Immunologic Factors|immunologic factors|mesh-ancestor
110809548|NCT00048347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110809549|NCT00048347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110809551|NCT00048347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110809552|NCT03957629|Interferons|interferons|mesh-list
110809553|NCT03957629|Tenofovir|tenofovir|mesh-list
110809554|NCT03957629|Interferon-alpha|interferon-alpha|mesh-list
110809555|NCT03957629|Interferon alpha-2|interferon alpha-2|mesh-list
110809556|NCT03957629|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110809557|NCT03957629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110809558|NCT03957629|Antiviral Agents|antiviral agents|mesh-ancestor
110809559|NCT03957629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110809560|NCT03957629|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110527134|NCT02764736|Atorvastatin|atorvastatin|mesh-list
110809561|NCT03957629|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110809562|NCT03957629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110809563|NCT03957629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110809564|NCT03957629|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110809565|NCT03957629|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110809566|NCT03957629|Immunologic Factors|immunologic factors|mesh-ancestor
110809567|NCT03957629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110809568|NCT00065507|Entecavir|entecavir|mesh-list
110809569|NCT00065507|Adefovir|adefovir|mesh-list
110809570|NCT00065507|Antiviral Agents|antiviral agents|mesh-ancestor
110809571|NCT00065507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110809572|NCT00065507|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110809573|NCT00065507|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110809574|NCT00065507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110410322|NCT01294787|Respiratory System Agents|respiratory system agents|mesh-ancestor
110809575|NCT00065507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110809576|NCT01095575|Morphine|morphine|mesh-list
110809577|NCT01095575|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110809578|NCT01095575|Narcotics|narcotics|mesh-ancestor
110809579|NCT01095575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110809580|NCT01095575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110809582|NCT01095575|Sensory System Agents|sensory system agents|mesh-ancestor
110809583|NCT01095575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110809584|NCT00065429|Lorvotuzumab mertansine|lorvotuzumab mertansine|mesh-list
110809585|NCT00065429|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110809586|NCT00065429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110809587|NCT00065429|Immunotoxins|immunotoxins|mesh-ancestor
110809588|NCT00065429|Immunoconjugates|immunoconjugates|mesh-ancestor
110809589|NCT00065429|Immunologic Factors|immunologic factors|mesh-ancestor
110809590|NCT00065429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110410443|NCT01169103|Hormones|hormones|mesh-list
110809591|NCT00065429|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110809592|NCT01095731|Acetic Acid|acetic acid|mesh-list
110809593|NCT01095731|Retinol acetate|retinol acetate|mesh-list
110809594|NCT01095731|Glycine|glycine|mesh-list
110809595|NCT01095731|Glycine Agents|glycine agents|mesh-ancestor
110809596|NCT01095731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110410649|NCT01288469|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
110809597|NCT01095731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110809598|NCT01095731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110809599|NCT01095731|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110809600|NCT01095731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110809601|NCT01095731|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110809602|NCT01095731|Immunologic Factors|immunologic factors|mesh-ancestor
110809603|NCT01095731|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110410724|NCT02885961|Dabigatran|dabigatran|mesh-list
110809604|NCT01095731|Protective Agents|protective agents|mesh-ancestor
110809605|NCT01095731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110809606|NCT01095809|Triamcinolone|triamcinolone|mesh-list
110809607|NCT01095809|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110809608|NCT01095809|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110809610|NCT01095809|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110809611|NCT01095809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110809612|NCT01095809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110809613|NCT01095809|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110809614|NCT01095809|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110809615|NCT01095809|Growth Substances|growth substances|mesh-ancestor
110809616|NCT01095809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110809617|NCT01095809|Growth Inhibitors|growth inhibitors|mesh-ancestor
110809618|NCT01095809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110809619|NCT01095809|Glucocorticoids|glucocorticoids|mesh-ancestor
110809620|NCT01095809|Hormones|hormones|mesh-ancestor
110809621|NCT01095809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110809622|NCT01095809|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110809623|NCT01095809|Immunologic Factors|immunologic factors|mesh-ancestor
110809624|NCT01095809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110809625|NCT01095809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110809626|NCT00048035|Epoetin Alfa|epoetin alfa|mesh-list
110809627|NCT00048035|Hematinics|hematinics|mesh-ancestor
110809628|NCT01092221|Allopurinol|allopurinol|mesh-list
110809629|NCT01092221|Antimetabolites|antimetabolites|mesh-ancestor
110809630|NCT01092221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110809631|NCT01092221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110809632|NCT01092221|Gout Suppressants|gout suppressants|mesh-ancestor
110809633|NCT01092221|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110809634|NCT01092221|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110809635|NCT01092221|Antioxidants|antioxidants|mesh-ancestor
110809636|NCT01092221|Protective Agents|protective agents|mesh-ancestor
110809637|NCT01092221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110809638|NCT00047879|Interferons|interferons|mesh-list
110809639|NCT00047879|Interferon-alpha|interferon-alpha|mesh-list
110809640|NCT00047879|Interferon alpha-2|interferon alpha-2|mesh-list
110809641|NCT00047879|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110809642|NCT00047879|Thalidomide|thalidomide|mesh-list
110809643|NCT00047879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110809644|NCT00047879|Antiviral Agents|antiviral agents|mesh-ancestor
110809645|NCT00047879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110809646|NCT00047879|Immunologic Factors|immunologic factors|mesh-ancestor
110809647|NCT00047879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110809648|NCT00047879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110809649|NCT00047879|Leprostatic Agents|leprostatic agents|mesh-ancestor
110809650|NCT00047879|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110809651|NCT00047879|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110809652|NCT00047879|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110809653|NCT00047879|Growth Substances|growth substances|mesh-ancestor
110809654|NCT00047879|Growth Inhibitors|growth inhibitors|mesh-ancestor
110809656|NCT00064337|Dexamethasone|dexamethasone|mesh-list
110809657|NCT00064337|Cyclophosphamide|cyclophosphamide|mesh-list
110809658|NCT00064337|Melphalan|melphalan|mesh-list
110809659|NCT00064337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110809660|NCT00064337|Immunologic Factors|immunologic factors|mesh-ancestor
110809661|NCT00064337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110809662|NCT00064337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110809663|NCT00064337|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110809664|NCT00064337|Alkylating Agents|alkylating agents|mesh-ancestor
110809665|NCT00064337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110809666|NCT00064337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110809667|NCT00064337|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110809668|NCT00064337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110809669|NCT00064337|Antiemetics|antiemetics|mesh-ancestor
110809670|NCT00064337|Autonomic Agents|autonomic agents|mesh-ancestor
110809671|NCT00064337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110809672|NCT00064337|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110809673|NCT00064337|Glucocorticoids|glucocorticoids|mesh-ancestor
110809675|NCT00064337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110809676|NCT00064337|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110809677|NCT00064337|Leprostatic Agents|leprostatic agents|mesh-ancestor
110809678|NCT00064337|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110809679|NCT00064337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110809680|NCT00064337|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110411325|NCT01158261|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
110809681|NCT00064337|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110809682|NCT00064337|Growth Substances|growth substances|mesh-ancestor
110809683|NCT00064337|Growth Inhibitors|growth inhibitors|mesh-ancestor
110809684|NCT01096121|Enalapril|enalapril|mesh-list
110809685|NCT01096121|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110809686|NCT01096121|Protease Inhibitors|protease inhibitors|mesh-ancestor
110809687|NCT01096121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110809688|NCT01096121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110809689|NCT01096121|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110809690|NCT00064259|Fluorouracil|fluorouracil|mesh-list
110809691|NCT00064259|Oblimersen|oblimersen|mesh-list
110809692|NCT00064259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110809693|NCT00064259|Antimetabolites|antimetabolites|mesh-ancestor
110809694|NCT00064259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110809695|NCT00064259|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110809696|NCT00064259|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110809697|NCT00064259|Immunologic Factors|immunologic factors|mesh-ancestor
110809698|NCT00064259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110809699|NCT03954197|Hormones|hormones|mesh-list
110809700|NCT03954197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110809701|NCT03954197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110809702|NCT00044213|Vitamins|vitamins|mesh-list
110411545|NCT02884479|Docetaxel|docetaxel|mesh-list
110809703|NCT00044213|Edetic Acid|edetic acid|mesh-list
110809704|NCT00044213|Pentetic Acid|pentetic acid|mesh-list
110809705|NCT00044213|Micronutrients|micronutrients|mesh-ancestor
110411598|NCT01740427|Hormone Antagonists|hormone antagonists|mesh-ancestor
110809706|NCT00044213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110809707|NCT00044213|Anticoagulants|anticoagulants|mesh-ancestor
110809708|NCT00044213|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110809709|NCT00044213|Chelating Agents|chelating agents|mesh-ancestor
110809710|NCT00044213|Sequestering Agents|sequestering agents|mesh-ancestor
110527286|NCT02760992|Baclofen|baclofen|mesh-list
110809711|NCT00044213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110809712|NCT00044213|Antidotes|antidotes|mesh-ancestor
110809713|NCT00044213|Protective Agents|protective agents|mesh-ancestor
110809714|NCT00044213|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110809715|NCT00064025|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
110809716|NCT00064025|Medroxyprogesterone|medroxyprogesterone|mesh-list
110809717|NCT00064025|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110809718|NCT00064025|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110809719|NCT00064025|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110809720|NCT00064025|Contraceptive Agents|contraceptive agents|mesh-ancestor
110809721|NCT00064025|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110809722|NCT00064025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110809723|NCT00064025|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110809724|NCT00064025|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110809725|NCT00064025|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110809726|NCT00064025|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110134902|NCT01994642|Ciprofloxacin|ciprofloxacin|mesh-list
110809727|NCT00064025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110809729|NCT01096199|Everolimus|everolimus|mesh-list
110809730|NCT01096199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110411814|NCT01146873|Ritonavir|ritonavir|mesh-list
110809731|NCT01096199|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110809732|NCT01096199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110809733|NCT01096199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110809734|NCT01096199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110809735|NCT01096199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110809736|NCT01096199|Immunologic Factors|immunologic factors|mesh-ancestor
110809737|NCT01096199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110809738|NCT01096277|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110853372|NCT04887194|Anesthetics|anesthetics|mesh-ancestor
110809739|NCT01096277|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110809740|NCT01096277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110809741|NCT01096277|Incretins|incretins|mesh-ancestor
110809742|NCT01096277|Hormones|hormones|mesh-ancestor
110809743|NCT01096277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110809744|NCT01096277|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110809745|NCT01096277|Protease Inhibitors|protease inhibitors|mesh-ancestor
110411875|NCT01145625|Minoxidil|minoxidil|mesh-list
110809746|NCT01096277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110809747|NCT01096277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110863866|NCT04495283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110809748|NCT01096355|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
110809749|NCT01096355|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
110809750|NCT01096355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110809751|NCT01096355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110809752|NCT01096511|Moxifloxacin|moxifloxacin|mesh-list
110809753|NCT01096511|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
110809754|NCT01096511|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110809755|NCT01096511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110809756|NCT01096511|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110412061|NCT00604357|Sirolimus|sirolimus|mesh-list
110809757|NCT01096511|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110809758|NCT01096511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110809759|NCT01096511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110809760|NCT01096511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110809761|NCT01096511|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110809762|NCT01096511|Contraceptive Agents|contraceptive agents|mesh-ancestor
110809763|NCT01096511|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110809764|NCT01096511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110809765|NCT01096511|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110809766|NCT01096511|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110809767|NCT01096511|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110809768|NCT01092455|Heparin|heparin|mesh-list
110809769|NCT01092455|Calcium heparin|calcium heparin|mesh-list
110809770|NCT01092455|Anticoagulants|anticoagulants|mesh-ancestor
110809771|NCT01092455|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110809772|NCT01092455|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110809773|NCT01092455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110809774|NCT02264938|Antioxidants|antioxidants|mesh-list
110809775|NCT02264938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110809776|NCT02264938|Protective Agents|protective agents|mesh-ancestor
110809777|NCT02264938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110809778|NCT02511886|Arbaclofen placarbil|arbaclofen placarbil|mesh-list
110809779|NCT02511886|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110809780|NCT02511886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110809781|NCT02511886|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110809782|NCT02511886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110809783|NCT02511886|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
110809784|NCT02511886|GABA Agonists|gaba agonists|mesh-ancestor
110809785|NCT02511886|GABA Agents|gaba agents|mesh-ancestor
110809786|NCT02511886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110809787|NCT02511886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110809788|NCT00043979|Cyclosporine|cyclosporine|mesh-list
110809789|NCT00043979|Sirolimus|sirolimus|mesh-list
110809790|NCT00043979|Prednisone|prednisone|mesh-list
110809791|NCT00043979|Cyclophosphamide|cyclophosphamide|mesh-list
110809792|NCT00043979|Melphalan|melphalan|mesh-list
110809793|NCT00043979|Doxorubicin|doxorubicin|mesh-list
110809794|NCT00043979|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110809795|NCT00043979|Fludarabine|fludarabine|mesh-list
110809796|NCT00043979|Fludarabine phosphate|fludarabine phosphate|mesh-list
110809797|NCT00043979|Etoposide|etoposide|mesh-list
110809798|NCT00043979|Vincristine|vincristine|mesh-list
110809799|NCT00043979|Tacrolimus|tacrolimus|mesh-list
110809800|NCT00043979|Cyclosporins|cyclosporins|mesh-list
110809801|NCT00043979|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110809802|NCT00043979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110809803|NCT00043979|Immunologic Factors|immunologic factors|mesh-ancestor
110809804|NCT00043979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110809805|NCT00043979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110809806|NCT00043979|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110412544|NCT00607945|Rosiglitazone|rosiglitazone|mesh-list
110809807|NCT00043979|Alkylating Agents|alkylating agents|mesh-ancestor
110809808|NCT00043979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110809809|NCT00043979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110809810|NCT00043979|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110809811|NCT00043979|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110809812|NCT00043979|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110809813|NCT00043979|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110809814|NCT00043979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110809815|NCT00043979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110809816|NCT00043979|Glucocorticoids|glucocorticoids|mesh-ancestor
110809817|NCT00043979|Hormones|hormones|mesh-ancestor
110809818|NCT00043979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110809819|NCT00043979|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110809820|NCT00043979|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110809821|NCT00043979|Antimetabolites|antimetabolites|mesh-ancestor
110809822|NCT00043979|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110809823|NCT00043979|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110809824|NCT00043979|Tubulin Modulators|tubulin modulators|mesh-ancestor
110809825|NCT00043979|Antimitotic Agents|antimitotic agents|mesh-ancestor
110809826|NCT00043979|Mitosis Modulators|mitosis modulators|mesh-ancestor
110809827|NCT00043979|Antifungal Agents|antifungal agents|mesh-ancestor
110809828|NCT00043979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110809829|NCT00043979|Dermatologic Agents|dermatologic agents|mesh-ancestor
110809830|NCT00043979|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110809831|NCT00043979|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110809832|NCT01436032|Ketorolac|ketorolac|mesh-list
110809833|NCT01436032|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
110809834|NCT01436032|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110809835|NCT01436032|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110809836|NCT01436032|Analgesics|analgesics|mesh-ancestor
110809837|NCT01436032|Sensory System Agents|sensory system agents|mesh-ancestor
110809838|NCT01436032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110809839|NCT01436032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110809840|NCT01436032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110809841|NCT01436032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110809842|NCT01436032|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110809843|NCT01436032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110809844|NCT01436032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110809845|NCT01092533|Mycophenolic Acid|mycophenolic acid|mesh-list
110809846|NCT01092533|Prednisolone|prednisolone|mesh-list
110809847|NCT01092533|Prednisone|prednisone|mesh-list
110809848|NCT01092533|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110809849|NCT01092533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110809850|NCT01092533|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110809851|NCT01092533|Antitubercular Agents|antitubercular agents|mesh-ancestor
110809852|NCT01092533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110809853|NCT01092533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110809854|NCT01092533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110527429|NCT00648141|Analgesics|analgesics|mesh-ancestor
110809855|NCT01092533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110809856|NCT01092533|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110809857|NCT01092533|Glucocorticoids|glucocorticoids|mesh-ancestor
110809858|NCT01092533|Hormones|hormones|mesh-ancestor
110809859|NCT01092533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110809860|NCT01092533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110809861|NCT01092533|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110809862|NCT01431820|Luliconazole|luliconazole|mesh-list
110809863|NCT01431820|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110809864|NCT01431820|Antifungal Agents|antifungal agents|mesh-ancestor
110809865|NCT01431820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110809866|NCT01425970|Interferons|interferons|mesh-list
110809867|NCT01425970|Ribavirin|ribavirin|mesh-list
110809868|NCT01425970|Interferon-alpha|interferon-alpha|mesh-list
110809869|NCT01425970|Interferon alpha-2|interferon alpha-2|mesh-list
110809870|NCT01425970|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110809871|NCT01425970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110809872|NCT01425970|Antiviral Agents|antiviral agents|mesh-ancestor
110809873|NCT01425970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110809874|NCT01425970|Antimetabolites|antimetabolites|mesh-ancestor
110809875|NCT01425970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110809876|NCT01425970|Immunologic Factors|immunologic factors|mesh-ancestor
110809877|NCT01425970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110809878|NCT01619332|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110809879|NCT01619332|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110809880|NCT01619332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110809881|NCT01619332|Incretins|incretins|mesh-ancestor
110809882|NCT01619332|Hormones|hormones|mesh-ancestor
110809883|NCT01619332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110809884|NCT01619332|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110809885|NCT01619332|Protease Inhibitors|protease inhibitors|mesh-ancestor
110809886|NCT01619332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110809887|NCT01619332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110809888|NCT01616524|Interferons|interferons|mesh-list
110809889|NCT01616524|Ribavirin|ribavirin|mesh-list
110809890|NCT01616524|Interferon-alpha|interferon-alpha|mesh-list
110809891|NCT01616524|Interferon alpha-2|interferon alpha-2|mesh-list
110809892|NCT01616524|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110809893|NCT01616524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110809894|NCT01616524|Antiviral Agents|antiviral agents|mesh-ancestor
110809895|NCT01616524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110809896|NCT01616524|Antimetabolites|antimetabolites|mesh-ancestor
110809897|NCT01616524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110809898|NCT01616524|Immunologic Factors|immunologic factors|mesh-ancestor
110809899|NCT01616524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110809900|NCT02265328|Prednisolone|prednisolone|mesh-list
110809901|NCT02265328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110809902|NCT02265328|Glucocorticoids|glucocorticoids|mesh-ancestor
110809903|NCT02265328|Hormones|hormones|mesh-ancestor
110809904|NCT02265328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110809905|NCT02265328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110809906|NCT02265328|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110809907|NCT02265328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110809908|NCT02265406|Anti-Infective Agents|anti-infective agents|mesh-list
110809909|NCT01421056|1-(3',4'-dichloro-2-fluoro(1,1'-biphenyl)-4-yl)cyclopropanecarboxylic acid|1-(3',4'-dichloro-2-fluoro(1,1'-biphenyl)-4-yl)cyclopropanecarboxylic acid|mesh-list
110364428|NCT01215097|Hormones|hormones|mesh-ancestor
110809910|NCT01421056|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
110809911|NCT01421056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110809912|NCT01421056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110809913|NCT01416064|Molindone|molindone|mesh-list
110809914|NCT01416064|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110809915|NCT01416064|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110809916|NCT01416064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110809917|NCT01416064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110809918|NCT01416064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110809919|NCT01594216|Exemestane|exemestane|mesh-list
110809920|NCT01594216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110809921|NCT01594216|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110809922|NCT01594216|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110809923|NCT01594216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110809924|NCT01594216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110809925|NCT01594216|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110809926|NCT01594216|Hormone Antagonists|hormone antagonists|mesh-ancestor
110809927|NCT01594216|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110809928|NCT01594216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110809929|NCT02263690|Lidocaine|lidocaine|mesh-list
110809930|NCT02263690|Anesthetics, Local|anesthetics, local|mesh-ancestor
110809931|NCT02263690|Anesthetics|anesthetics|mesh-ancestor
110809932|NCT02263690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110809933|NCT02263690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110413084|NCT04482309|Trastuzumab|trastuzumab|mesh-list
110809934|NCT02263690|Sensory System Agents|sensory system agents|mesh-ancestor
110809935|NCT02263690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110809936|NCT02263690|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110809937|NCT02263690|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110809938|NCT02263690|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110809939|NCT02263690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110809940|NCT02263690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110809941|NCT02265562|Alprostadil|alprostadil|mesh-list
110809942|NCT02265562|Misoprostol|misoprostol|mesh-list
110809943|NCT02265562|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110809944|NCT02265562|Abortifacient Agents|abortifacient agents|mesh-ancestor
110413154|NCT04268498|Immunologic Factors|immunologic factors|mesh-ancestor
110809945|NCT02265562|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110809946|NCT02265562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110809947|NCT02265562|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110809948|NCT02265562|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110809949|NCT02265562|Oxytocics|oxytocics|mesh-ancestor
110809950|NCT02265562|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110809951|NCT02265562|Vasodilator Agents|vasodilator agents|mesh-ancestor
110809952|NCT02265562|Urological Agents|urological agents|mesh-ancestor
110809953|NCT01399684|Leucovorin|leucovorin|mesh-list
110809954|NCT01399684|Folic Acid|folic acid|mesh-list
110809955|NCT01399684|Bevacizumab|bevacizumab|mesh-list
110809956|NCT01399684|Fluorouracil|fluorouracil|mesh-list
110809957|NCT01399684|Oxaliplatin|oxaliplatin|mesh-list
110809958|NCT01399684|Levoleucovorin|levoleucovorin|mesh-list
110809959|NCT01399684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110809960|NCT01399684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110809961|NCT01399684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110809962|NCT01399684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110809963|NCT01399684|Growth Substances|growth substances|mesh-ancestor
110809964|NCT01399684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110809965|NCT01399684|Growth Inhibitors|growth inhibitors|mesh-ancestor
110809966|NCT01399684|Antimetabolites|antimetabolites|mesh-ancestor
110809967|NCT01399684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110809968|NCT01399684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110809969|NCT01399684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110809970|NCT01399684|Immunologic Factors|immunologic factors|mesh-ancestor
110809971|NCT01399684|Antidotes|antidotes|mesh-ancestor
110809972|NCT01399684|Protective Agents|protective agents|mesh-ancestor
110809973|NCT01399684|Vitamin B Complex|vitamin b complex|mesh-ancestor
110809974|NCT01399684|Vitamins|vitamins|mesh-ancestor
110809975|NCT01399684|Micronutrients|micronutrients|mesh-ancestor
110809976|NCT01399684|Hematinics|hematinics|mesh-ancestor
110809977|NCT01397968|Cenobamate|cenobamate|mesh-list
110809978|NCT01397968|Anticonvulsants|anticonvulsants|mesh-ancestor
110809979|NCT01397578|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110809980|NCT01397578|Immunologic Factors|immunologic factors|mesh-ancestor
110809981|NCT01397578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110809982|NCT02265718|Methylphenidate|methylphenidate|mesh-list
110809983|NCT02265718|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110809984|NCT02265718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110809985|NCT02265718|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110809986|NCT02265718|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110809987|NCT02265718|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110809988|NCT02265718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110809989|NCT02265718|Dopamine Agents|dopamine agents|mesh-ancestor
110809990|NCT02265718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110809991|NCT01381666|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110809992|NCT02266030|Aspirin|aspirin|mesh-list
110809993|NCT02266030|Cilostazol|cilostazol|mesh-list
110809994|NCT02266030|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110809995|NCT02266030|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110809996|NCT02266030|Analgesics|analgesics|mesh-ancestor
110809997|NCT02266030|Sensory System Agents|sensory system agents|mesh-ancestor
110809998|NCT02266030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110809999|NCT02266030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110810000|NCT02266030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110810001|NCT02266030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110810002|NCT02266030|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110810003|NCT02266030|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110810004|NCT02266030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110810005|NCT02266030|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110810006|NCT02266030|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110810007|NCT02266030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110810008|NCT02266030|Antipyretics|antipyretics|mesh-ancestor
110810009|NCT02266030|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110810010|NCT02266030|Autonomic Agents|autonomic agents|mesh-ancestor
110810011|NCT02266030|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110810012|NCT02266030|Respiratory System Agents|respiratory system agents|mesh-ancestor
110810013|NCT02266030|Vasodilator Agents|vasodilator agents|mesh-ancestor
110810014|NCT02266030|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110810015|NCT02266030|Protective Agents|protective agents|mesh-ancestor
110810016|NCT02266030|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110810017|NCT02266030|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110810018|NCT01527916|Donepezil|donepezil|mesh-list
110853390|NCT02496910|Amlodipine|amlodipine|mesh-list
110810020|NCT01527916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110810021|NCT01527916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110810022|NCT01527916|Cholinergic Agents|cholinergic agents|mesh-ancestor
110810023|NCT01527916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110810024|NCT01527916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110810025|NCT01527916|Nootropic Agents|nootropic agents|mesh-ancestor
110810027|NCT01373086|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110810028|NCT01373086|Hormone Antagonists|hormone antagonists|mesh-ancestor
110810029|NCT01373086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110810030|NCT01373086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110810031|NCT01373086|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110810032|NCT01373086|Diuretics|diuretics|mesh-ancestor
110810033|NCT01373086|Natriuretic Agents|natriuretic agents|mesh-ancestor
110810034|NCT01373086|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110810035|NCT01519804|Paclitaxel|paclitaxel|mesh-list
110810036|NCT01519804|Carboplatin|carboplatin|mesh-list
110810037|NCT01519804|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110810038|NCT01519804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110810039|NCT01519804|Tubulin Modulators|tubulin modulators|mesh-ancestor
110810040|NCT01519804|Antimitotic Agents|antimitotic agents|mesh-ancestor
110810041|NCT01519804|Mitosis Modulators|mitosis modulators|mesh-ancestor
110810042|NCT01519804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110810043|NCT02263924|Tocotrienols|tocotrienols|mesh-list
110810044|NCT02263924|Vitamin E|vitamin e|mesh-list
110810045|NCT02263924|Tocopherols|tocopherols|mesh-list
110810046|NCT02263924|Antioxidants|antioxidants|mesh-ancestor
110810047|NCT02263924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110810048|NCT02263924|Protective Agents|protective agents|mesh-ancestor
110413473|NCT02697344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110810049|NCT02263924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110810050|NCT02263924|Vitamins|vitamins|mesh-ancestor
110810051|NCT02263924|Micronutrients|micronutrients|mesh-ancestor
110810052|NCT02264002|Metoprolol|metoprolol|mesh-list
110810053|NCT02264002|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110810054|NCT02264002|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110810055|NCT02264002|Sympatholytics|sympatholytics|mesh-ancestor
110810056|NCT02264002|Autonomic Agents|autonomic agents|mesh-ancestor
110810057|NCT02264002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110810058|NCT02264002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110810059|NCT02264002|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110810060|NCT02264002|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110810061|NCT02264002|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110810062|NCT02264002|Adrenergic Agents|adrenergic agents|mesh-ancestor
110810063|NCT02264002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110810064|NCT02264002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110810065|NCT01517776|Temozolomide|temozolomide|mesh-list
110810066|NCT01517776|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110810067|NCT01517776|Alkylating Agents|alkylating agents|mesh-ancestor
110413575|NCT02412670|Abortifacient Agents|abortifacient agents|mesh-ancestor
110810068|NCT01517776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110810069|NCT01517776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110810070|NCT02266264|Hydrocortisone|hydrocortisone|mesh-list
110810071|NCT02266264|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
110810072|NCT02266264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110810073|NCT01516918|Ribavirin|ribavirin|mesh-list
110810074|NCT01516918|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110810075|NCT01516918|Antimetabolites|antimetabolites|mesh-ancestor
110810076|NCT01516918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110810077|NCT01516918|Antiviral Agents|antiviral agents|mesh-ancestor
110810078|NCT01516918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110810079|NCT01508026|Valsartan|valsartan|mesh-list
110810080|NCT01508026|Nebivolol|nebivolol|mesh-list
110810081|NCT01508026|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110810082|NCT01508026|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110810083|NCT01508026|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110810084|NCT01508026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110810085|NCT01508026|Vasodilator Agents|vasodilator agents|mesh-ancestor
110810086|NCT01508026|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
110810087|NCT01508026|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110810088|NCT01508026|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110810089|NCT01508026|Adrenergic Agents|adrenergic agents|mesh-ancestor
110810090|NCT01508026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110810091|NCT01508026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110810093|NCT01357642|Racepinephrine|racepinephrine|mesh-list
110810094|NCT01357642|Epinephryl borate|epinephryl borate|mesh-list
110135282|NCT01996501|Olanzapine|olanzapine|mesh-list
110810095|NCT01357642|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110810097|NCT01357642|Adrenergic Agents|adrenergic agents|mesh-ancestor
110810098|NCT01357642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110810099|NCT01357642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110810100|NCT01357642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110810101|NCT01357642|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110810102|NCT01357642|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110810103|NCT01357642|Autonomic Agents|autonomic agents|mesh-ancestor
110810104|NCT01357642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110810105|NCT01357642|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110810106|NCT01357642|Respiratory System Agents|respiratory system agents|mesh-ancestor
110810107|NCT01357642|Mydriatics|mydriatics|mesh-ancestor
110810108|NCT01357642|Sympathomimetics|sympathomimetics|mesh-ancestor
110810109|NCT01357642|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110810110|NCT03135340|Anesthetics|anesthetics|mesh-list
110810111|NCT03135340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110810112|NCT03135340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110810113|NCT01356160|Ribavirin|ribavirin|mesh-list
110810114|NCT01356160|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110810115|NCT01356160|Ledipasvir|ledipasvir|mesh-list
110810116|NCT01356160|Antimetabolites|antimetabolites|mesh-ancestor
110810117|NCT01356160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110810118|NCT01356160|Antiviral Agents|antiviral agents|mesh-ancestor
110810119|NCT01356160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110810120|NCT02264158|Telmisartan|telmisartan|mesh-list
110810121|NCT02264158|Lacidipine|lacidipine|mesh-list
110810122|NCT02264158|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110810123|NCT02264158|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110810124|NCT02264158|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110810125|NCT02264158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110810126|NCT02264158|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110810127|NCT02264158|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110810128|NCT02264158|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110810129|NCT02264158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110810130|NCT02264236|Vaccines|vaccines|mesh-list
110810131|NCT02264236|Immunologic Factors|immunologic factors|mesh-ancestor
110810132|NCT02264236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110810133|NCT01476904|Epinephrine|epinephrine|mesh-list
110810134|NCT01476904|Racepinephrine|racepinephrine|mesh-list
110810135|NCT01476904|Epinephryl borate|epinephryl borate|mesh-list
110810136|NCT01476904|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110810137|NCT01476904|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110810138|NCT01476904|Adrenergic Agents|adrenergic agents|mesh-ancestor
110810139|NCT01476904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110810140|NCT01476904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110810141|NCT01476904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110810142|NCT01476904|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110810143|NCT01476904|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110810144|NCT01476904|Autonomic Agents|autonomic agents|mesh-ancestor
110810145|NCT01476904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110810146|NCT01476904|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110810147|NCT01476904|Respiratory System Agents|respiratory system agents|mesh-ancestor
110810148|NCT01476904|Mydriatics|mydriatics|mesh-ancestor
110810149|NCT01476904|Sympathomimetics|sympathomimetics|mesh-ancestor
110810150|NCT01476904|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110810151|NCT01337752|Dexamethasone|dexamethasone|mesh-list
110810152|NCT01337752|Bortezomib|bortezomib|mesh-list
110810153|NCT01337752|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110810154|NCT01337752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110810155|NCT01337752|Antiemetics|antiemetics|mesh-ancestor
110810156|NCT01337752|Autonomic Agents|autonomic agents|mesh-ancestor
110810157|NCT01337752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110810158|NCT01337752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110810159|NCT01337752|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110810160|NCT01337752|Glucocorticoids|glucocorticoids|mesh-ancestor
110810161|NCT01337752|Hormones|hormones|mesh-ancestor
110810162|NCT01337752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110810163|NCT01337752|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110810164|NCT01337752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110810165|NCT01337752|Immunologic Factors|immunologic factors|mesh-ancestor
110810166|NCT01318642|Gemcitabine|gemcitabine|mesh-list
110810167|NCT01318642|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110810168|NCT01318642|Antimetabolites|antimetabolites|mesh-ancestor
110135347|NCT01997099|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110810169|NCT01318642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110810170|NCT01318642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110810172|NCT01318252|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110810173|NCT01318252|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110810174|NCT01313572|Adenosine|adenosine|mesh-list
110810175|NCT01313572|Analgesics|analgesics|mesh-ancestor
110810176|NCT01313572|Sensory System Agents|sensory system agents|mesh-ancestor
110810177|NCT01313572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110810178|NCT01313572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110810179|NCT01313572|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110810180|NCT01313572|Vasodilator Agents|vasodilator agents|mesh-ancestor
110810181|NCT01313572|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
110810182|NCT01313572|Purinergic Agonists|purinergic agonists|mesh-ancestor
110810183|NCT01313572|Purinergic Agents|purinergic agents|mesh-ancestor
110810184|NCT01313572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110810185|NCT01313572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110810186|NCT02265484|Rifaximin|rifaximin|mesh-list
110810187|NCT02265484|Bromocriptine|bromocriptine|mesh-list
110810188|NCT02265484|Lactulose|lactulose|mesh-list
110810189|NCT02265484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110810190|NCT02265484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110810191|NCT02265484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110810192|NCT02265484|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110810193|NCT02265484|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110810194|NCT02265484|Hormone Antagonists|hormone antagonists|mesh-ancestor
110810195|NCT02265484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110810196|NCT02265484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110810197|NCT02265484|Dopamine Agonists|dopamine agonists|mesh-ancestor
110810198|NCT02265484|Dopamine Agents|dopamine agents|mesh-ancestor
110810199|NCT02265484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110810200|NCT02265484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110810201|NCT02264626|Remifentanil|remifentanil|mesh-list
110810202|NCT02264626|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110810203|NCT02264626|Narcotics|narcotics|mesh-ancestor
110810204|NCT02264626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110810205|NCT02264626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110810206|NCT02264626|Analgesics|analgesics|mesh-ancestor
110810207|NCT02264626|Sensory System Agents|sensory system agents|mesh-ancestor
110810208|NCT02264626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110810209|NCT03993262|Bortezomib|bortezomib|mesh-list
110810210|NCT03993262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110810211|NCT02267044|Ropivacaine|ropivacaine|mesh-list
110810212|NCT02267044|Anesthetics, Local|anesthetics, local|mesh-ancestor
110414213|NCT05646719|Miotics|miotics|mesh-ancestor
110810213|NCT02267044|Anesthetics|anesthetics|mesh-ancestor
110810214|NCT02267044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110810215|NCT02267044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110810216|NCT02267044|Sensory System Agents|sensory system agents|mesh-ancestor
110810217|NCT02267044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110810218|NCT02267122|Mupirocin|mupirocin|mesh-list
110810219|NCT02267122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110810220|NCT02267122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110810221|NCT02267122|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110810222|NCT02267122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110810223|NCT02267122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110810224|NCT01261312|Guadecitabine|guadecitabine|mesh-list
110810225|NCT01261312|Azacitidine|azacitidine|mesh-list
110810226|NCT01261312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110810227|NCT01261312|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110810228|NCT01261312|Antimetabolites|antimetabolites|mesh-ancestor
110810229|NCT01261312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110810230|NCT01261312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110810231|NCT01254370|Travoprost|travoprost|mesh-list
110810232|NCT01254370|Latanoprost|latanoprost|mesh-list
110810233|NCT01254370|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110810234|NCT01254370|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110810235|NCT01254370|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110810236|NCT01254136|Trastuzumab|trastuzumab|mesh-list
110810237|NCT01254136|Vinorelbine|vinorelbine|mesh-list
110810238|NCT01254136|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110810239|NCT01254136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110810240|NCT01254136|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110810241|NCT01254136|Tubulin Modulators|tubulin modulators|mesh-ancestor
110810242|NCT01254136|Antimitotic Agents|antimitotic agents|mesh-ancestor
110810243|NCT01254136|Mitosis Modulators|mitosis modulators|mesh-ancestor
110135425|NCT01997658|Antiemetics|antiemetics|mesh-ancestor
110810244|NCT01254136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110810246|NCT02268370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110810247|NCT02268370|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110810248|NCT02268370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110810249|NCT02268370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110810250|NCT00039377|Leucovorin|leucovorin|mesh-list
110810251|NCT00039377|Cytarabine|cytarabine|mesh-list
110810252|NCT00039377|Cyclophosphamide|cyclophosphamide|mesh-list
110810253|NCT00039377|Methotrexate|methotrexate|mesh-list
110810254|NCT00039377|Etoposide|etoposide|mesh-list
110810255|NCT00039377|Vincristine|vincristine|mesh-list
110810256|NCT00039377|Etoposide phosphate|etoposide phosphate|mesh-list
110810257|NCT00039377|Imatinib Mesylate|imatinib mesylate|mesh-list
110810258|NCT00039377|Tacrolimus|tacrolimus|mesh-list
110810259|NCT00039377|Levoleucovorin|levoleucovorin|mesh-list
110810260|NCT00039377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110810261|NCT00039377|Immunologic Factors|immunologic factors|mesh-ancestor
110810262|NCT00039377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110810263|NCT00039377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110810264|NCT00039377|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110810265|NCT00039377|Alkylating Agents|alkylating agents|mesh-ancestor
110810266|NCT00039377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110810267|NCT00039377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110810268|NCT00039377|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110810269|NCT00039377|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110810270|NCT00039377|Abortifacient Agents|abortifacient agents|mesh-ancestor
110810271|NCT00039377|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110810272|NCT00039377|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110810273|NCT00039377|Antimetabolites|antimetabolites|mesh-ancestor
110810274|NCT00039377|Dermatologic Agents|dermatologic agents|mesh-ancestor
110810275|NCT00039377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110810276|NCT00039377|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110853414|NCT03342352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110810277|NCT00039377|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110810278|NCT00039377|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110810279|NCT00039377|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110810280|NCT00039377|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110810281|NCT00039377|Antiviral Agents|antiviral agents|mesh-ancestor
110810282|NCT00039377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110810283|NCT00039377|Antidotes|antidotes|mesh-ancestor
110810284|NCT00039377|Protective Agents|protective agents|mesh-ancestor
110810285|NCT00039377|Vitamin B Complex|vitamin b complex|mesh-ancestor
110810286|NCT00039377|Vitamins|vitamins|mesh-ancestor
110810287|NCT00039377|Micronutrients|micronutrients|mesh-ancestor
110810288|NCT00039377|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110810289|NCT00039377|Tubulin Modulators|tubulin modulators|mesh-ancestor
110810290|NCT00039377|Antimitotic Agents|antimitotic agents|mesh-ancestor
110810291|NCT00039377|Mitosis Modulators|mitosis modulators|mesh-ancestor
110810292|NCT00039377|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110810293|NCT01096745|Cisplatin|cisplatin|mesh-list
110810294|NCT01096745|Gemcitabine|gemcitabine|mesh-list
110810295|NCT01096745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110810296|NCT01096745|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110810297|NCT01096745|Antimetabolites|antimetabolites|mesh-ancestor
110414419|NCT05330130|Hormones|hormones|mesh-ancestor
110810298|NCT01096745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110810299|NCT03953729|Ibuprofen|ibuprofen|mesh-list
110810300|NCT03953729|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110810301|NCT03953729|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110810302|NCT03953729|Analgesics|analgesics|mesh-ancestor
110810303|NCT03953729|Sensory System Agents|sensory system agents|mesh-ancestor
110810304|NCT03953729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110810305|NCT03953729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110810306|NCT03953729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110810307|NCT03953729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110810308|NCT03953729|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110810309|NCT03953729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110810310|NCT03953729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110810311|NCT01097213|Ethanol|ethanol|mesh-list
110810312|NCT01097213|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110810313|NCT01097213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110810314|NCT01097213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110810315|NCT01097213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110810316|NCT00154102|Leucovorin|leucovorin|mesh-list
110810317|NCT00154102|Folic Acid|folic acid|mesh-list
110810318|NCT00154102|Fluorouracil|fluorouracil|mesh-list
110810319|NCT00154102|Irinotecan|irinotecan|mesh-list
110810320|NCT00154102|Cetuximab|cetuximab|mesh-list
110810321|NCT00154102|Levoleucovorin|levoleucovorin|mesh-list
110810322|NCT00154102|Antimetabolites|antimetabolites|mesh-ancestor
110810323|NCT00154102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110810324|NCT00154102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110810325|NCT00154102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110810326|NCT00154102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110810327|NCT00154102|Immunologic Factors|immunologic factors|mesh-ancestor
110810328|NCT00154102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110810329|NCT00154102|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110810330|NCT00154102|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110810331|NCT00154102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110810332|NCT00154102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110810333|NCT00154102|Antidotes|antidotes|mesh-ancestor
110810334|NCT00154102|Protective Agents|protective agents|mesh-ancestor
110810335|NCT00154102|Vitamin B Complex|vitamin b complex|mesh-ancestor
110810337|NCT00154102|Micronutrients|micronutrients|mesh-ancestor
110810338|NCT00154102|Hematinics|hematinics|mesh-ancestor
110810339|NCT01269658|Azithromycin|azithromycin|mesh-list
110810340|NCT01269658|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110810341|NCT01269658|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110810342|NCT01269658|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110810343|NCT01269658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110810344|NCT01229644|Crenolanib|crenolanib|mesh-list
110810345|NCT01229644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110810346|NCT02267980|Ketamine|ketamine|mesh-list
110810347|NCT02267980|Sevoflurane|sevoflurane|mesh-list
110810348|NCT02267980|Analgesics|analgesics|mesh-ancestor
110810349|NCT02267980|Sensory System Agents|sensory system agents|mesh-ancestor
110810350|NCT02267980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110810351|NCT02267980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110810352|NCT02267980|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110810353|NCT02267980|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110810354|NCT02267980|Anesthetics, General|anesthetics, general|mesh-ancestor
110810355|NCT02267980|Anesthetics|anesthetics|mesh-ancestor
110810356|NCT02267980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110810357|NCT02267980|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110810358|NCT02267980|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110810359|NCT02267980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110810360|NCT02267980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110810361|NCT02267980|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110810362|NCT02267980|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110810363|NCT01224262|Vaccines|vaccines|mesh-list
110810364|NCT01224262|Immunologic Factors|immunologic factors|mesh-ancestor
110810365|NCT01224262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110810366|NCT01222702|Vancomycin|vancomycin|mesh-list
110810367|NCT01222702|Oxazolidinones|oxazolidinones|mesh-list
110810368|NCT01222702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110810369|NCT01222702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110810370|NCT01222702|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110810371|NCT01222702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110810372|NCT01222702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110810373|NCT01204762|Entecavir|entecavir|mesh-list
110810374|NCT01204762|Antiviral Agents|antiviral agents|mesh-ancestor
110810375|NCT01204762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110810376|NCT02236078|Isoniazid|isoniazid|mesh-list
110810377|NCT02236078|Antitubercular Agents|antitubercular agents|mesh-ancestor
110810378|NCT02236078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110810379|NCT02236078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110810380|NCT02236078|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
110810381|NCT02236078|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110810382|NCT02236078|Antimetabolites|antimetabolites|mesh-ancestor
110810383|NCT02236078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110810384|NCT02236078|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110810385|NCT01198834|Etodolac|etodolac|mesh-list
110810386|NCT01198834|Lidocaine|lidocaine|mesh-list
110810387|NCT01198834|Anesthetics, Local|anesthetics, local|mesh-ancestor
110810388|NCT01198834|Anesthetics|anesthetics|mesh-ancestor
110810389|NCT01198834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110810390|NCT01198834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110810391|NCT01198834|Sensory System Agents|sensory system agents|mesh-ancestor
110810392|NCT01198834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110810393|NCT01198834|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110810394|NCT01198834|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110810395|NCT01198834|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110810397|NCT01198834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110810398|NCT01198834|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110810399|NCT01198834|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110810400|NCT01198834|Analgesics|analgesics|mesh-ancestor
110810401|NCT01198834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110810402|NCT01198834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110810403|NCT01198834|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110810404|NCT01198834|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110810405|NCT01198834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110810406|NCT01193140|Temozolomide|temozolomide|mesh-list
110810407|NCT01193140|Veliparib|veliparib|mesh-list
110810408|NCT01193140|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110810409|NCT01193140|Alkylating Agents|alkylating agents|mesh-ancestor
110810410|NCT01193140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110810411|NCT01193140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110810412|NCT01193140|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110810413|NCT01193140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110810414|NCT01189396|Albuterol|albuterol|mesh-list
110810415|NCT01189396|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110810416|NCT01189396|Autonomic Agents|autonomic agents|mesh-ancestor
110810417|NCT01189396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110414585|NCT05023980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110810418|NCT01189396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110810419|NCT01189396|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110810420|NCT01189396|Respiratory System Agents|respiratory system agents|mesh-ancestor
110810421|NCT01189396|Tocolytic Agents|tocolytic agents|mesh-ancestor
110810422|NCT01189396|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110810423|NCT01189396|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110810424|NCT01189396|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110810425|NCT01189396|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110810426|NCT01189396|Adrenergic Agents|adrenergic agents|mesh-ancestor
110810427|NCT01189396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110810428|NCT01189396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110810429|NCT05626972|Tenecteplase|tenecteplase|mesh-list
110810430|NCT05626972|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110810431|NCT05626972|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110810432|NCT05626972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110810434|NCT01174732|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110810435|NCT01174732|Autonomic Agents|autonomic agents|mesh-ancestor
110810436|NCT01174732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110810437|NCT01174732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110810438|NCT01174732|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110810439|NCT01174732|Respiratory System Agents|respiratory system agents|mesh-ancestor
110810440|NCT01174732|Tocolytic Agents|tocolytic agents|mesh-ancestor
110810441|NCT01174732|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110810442|NCT01174732|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110810443|NCT01174732|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110810444|NCT01174732|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110810445|NCT01174732|Adrenergic Agents|adrenergic agents|mesh-ancestor
110810446|NCT01174732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110810447|NCT01174732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110810448|NCT01076764|Heparin|heparin|mesh-list
110810449|NCT01076764|Calcium heparin|calcium heparin|mesh-list
110810450|NCT01076764|Otamixaban|otamixaban|mesh-list
110810451|NCT01076764|Eptifibatide|eptifibatide|mesh-list
110810452|NCT01076764|Anticoagulants|anticoagulants|mesh-ancestor
110810453|NCT01076764|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110810454|NCT01076764|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110810455|NCT01076764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110810456|NCT01076764|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110810457|NCT01076764|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110810458|NCT01076764|Antithrombins|antithrombins|mesh-ancestor
110810459|NCT01076764|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110810460|NCT01076764|Protease Inhibitors|protease inhibitors|mesh-ancestor
110810461|NCT01076764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110810462|NCT02269072|Anastrozole|anastrozole|mesh-list
110810463|NCT02269072|Leuprolide|leuprolide|mesh-list
110810464|NCT02269072|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
110810465|NCT02269072|Testosterone|testosterone|mesh-list
110810466|NCT02269072|Androgens|androgens|mesh-ancestor
110810467|NCT02269072|Hormones|hormones|mesh-ancestor
110810468|NCT02269072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110810469|NCT02269072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110810470|NCT02269072|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110810471|NCT02269072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110810472|NCT02269072|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110810473|NCT02269072|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110810474|NCT02269072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110810475|NCT02269072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110810476|NCT02269072|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110810477|NCT02269072|Hormone Antagonists|hormone antagonists|mesh-ancestor
110810478|NCT02269072|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110810479|NCT02269072|Fertility Agents|fertility agents|mesh-ancestor
110810480|NCT02269072|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110810481|NCT02269072|Natriuretic Agents|natriuretic agents|mesh-ancestor
110810483|NCT01071850|Ipragliflozin|ipragliflozin|mesh-list
110810484|NCT01071850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110810485|NCT01071850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110810486|NCT01071850|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110810487|NCT01071850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110810488|NCT02269228|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
110810489|NCT02269228|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110810490|NCT01037062|Entecavir|entecavir|mesh-list
110810491|NCT01037062|Antiviral Agents|antiviral agents|mesh-ancestor
110810492|NCT01037062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110810493|NCT01167166|ON 01910|on 01910|mesh-list
110810494|NCT01167166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110414709|NCT04505774|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110810495|NCT01167166|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110810496|NCT01167166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110810497|NCT01167166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110810498|NCT01035502|Idarubicin|idarubicin|mesh-list
110810499|NCT01035502|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110810500|NCT01035502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110810501|NCT01035502|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110810502|NCT01035502|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110810503|NCT01035502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110810504|NCT01035502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110810505|NCT01030432|Ribavirin|ribavirin|mesh-list
110810506|NCT01030432|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110810507|NCT01030432|Interferon-alpha|interferon-alpha|mesh-list
110810508|NCT01030432|Asunaprevir|asunaprevir|mesh-list
110810509|NCT01030432|Antimetabolites|antimetabolites|mesh-ancestor
110810510|NCT01030432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110810511|NCT01030432|Antiviral Agents|antiviral agents|mesh-ancestor
110810512|NCT01030432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110810513|NCT01030432|Immunologic Factors|immunologic factors|mesh-ancestor
110810514|NCT01030432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110810515|NCT01030432|Protease Inhibitors|protease inhibitors|mesh-ancestor
110810516|NCT01030432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110810517|NCT02269462|Efavirenz|efavirenz|mesh-list
110810518|NCT02269462|Nevirapine|nevirapine|mesh-list
110810519|NCT02269462|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110810520|NCT02269462|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110810521|NCT02269462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110810522|NCT02269462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110810523|NCT02269462|Antiviral Agents|antiviral agents|mesh-ancestor
110810524|NCT02269462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110810525|NCT02269462|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110810526|NCT02269462|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110810527|NCT02269462|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110810528|NCT02269462|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110810529|NCT02269462|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110810530|NCT02269462|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110810531|NCT02269462|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110810532|NCT02269462|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110810533|NCT02261506|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110810534|NCT02261506|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
110810535|NCT02261506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110810536|NCT02261506|Antitubercular Agents|antitubercular agents|mesh-ancestor
110810537|NCT02269540|Acetylcysteine|acetylcysteine|mesh-list
110810538|NCT02269540|Sertraline|sertraline|mesh-list
110810539|NCT02269540|Citalopram|citalopram|mesh-list
110810540|NCT02269540|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110810541|NCT02269540|Antiviral Agents|antiviral agents|mesh-ancestor
110810542|NCT02269540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110810543|NCT02269540|Expectorants|expectorants|mesh-ancestor
110810544|NCT02269540|Respiratory System Agents|respiratory system agents|mesh-ancestor
110810545|NCT02269540|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110810547|NCT02269540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110810548|NCT02269540|Protective Agents|protective agents|mesh-ancestor
110810549|NCT02269540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110810550|NCT02269540|Antidotes|antidotes|mesh-ancestor
110810551|NCT02269540|Antidepressive Agents|antidepressive agents|mesh-ancestor
110810552|NCT02269540|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110810553|NCT02269540|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110810554|NCT02269540|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110810555|NCT02269540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110810556|NCT02269540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110810557|NCT02269540|Serotonin Agents|serotonin agents|mesh-ancestor
110810558|NCT02269540|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110810559|NCT01023880|Delanzomib|delanzomib|mesh-list
110810560|NCT01023880|Proteasome Inhibitors|proteasome inhibitors|mesh-ancestor
110853454|NCT03324490|Dexmedetomidine|dexmedetomidine|mesh-list
110810561|NCT01023880|Protease Inhibitors|protease inhibitors|mesh-ancestor
110810562|NCT01023880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110810563|NCT01023880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110810564|NCT02650804|Coenzyme Q10|coenzyme q10|mesh-list
110810565|NCT02650804|Gemcitabine|gemcitabine|mesh-list
110810566|NCT02650804|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110810567|NCT02650804|Antimetabolites|antimetabolites|mesh-ancestor
110810568|NCT02650804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110810569|NCT02650804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110810570|NCT02650804|Vitamins|vitamins|mesh-ancestor
110810571|NCT02650804|Micronutrients|micronutrients|mesh-ancestor
110810572|NCT02650804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110810573|NCT02269696|Metoprolol|metoprolol|mesh-list
110810574|NCT02269696|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110810575|NCT02269696|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110810576|NCT02269696|Sympatholytics|sympatholytics|mesh-ancestor
110810577|NCT02269696|Autonomic Agents|autonomic agents|mesh-ancestor
110810578|NCT02269696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110810579|NCT02269696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110810580|NCT02269696|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110810581|NCT02269696|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110810582|NCT02269696|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110810583|NCT02269696|Adrenergic Agents|adrenergic agents|mesh-ancestor
110810584|NCT02269696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110810585|NCT02269696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110810586|NCT03135184|Coal Tar|coal tar|mesh-list
110810587|NCT03135184|Keratolytic Agents|keratolytic agents|mesh-ancestor
110810588|NCT03135184|Dermatologic Agents|dermatologic agents|mesh-ancestor
110810589|NCT05613400|Simvastatin|simvastatin|mesh-list
110810590|NCT05613400|Ezetimibe|ezetimibe|mesh-list
110810591|NCT05613400|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110810592|NCT05613400|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110810593|NCT05613400|Antimetabolites|antimetabolites|mesh-ancestor
110810594|NCT05613400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110810595|NCT05613400|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110810596|NCT05613400|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110810598|NCT02261662|Ribavirin|ribavirin|mesh-list
110810599|NCT02261662|Betamethasone|betamethasone|mesh-list
110810600|NCT02261662|Antimetabolites|antimetabolites|mesh-ancestor
110810601|NCT02261662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110810602|NCT02261662|Antiviral Agents|antiviral agents|mesh-ancestor
110810603|NCT02261662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110810604|NCT02261662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110810605|NCT02261662|Glucocorticoids|glucocorticoids|mesh-ancestor
110810606|NCT02261662|Hormones|hormones|mesh-ancestor
110810607|NCT02261662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110810608|NCT02261662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110810609|NCT02261662|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110810610|NCT02261662|Respiratory System Agents|respiratory system agents|mesh-ancestor
110810611|NCT02261896|Ciprofloxacin|ciprofloxacin|mesh-list
110810612|NCT02261896|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110810613|NCT02261896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110810614|NCT02261896|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110810615|NCT02261896|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110810616|NCT02261896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110810617|NCT02261896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110810618|NCT02261896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110810619|NCT02261896|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110810620|NCT02261896|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110810621|NCT00035555|Cyclosporine|cyclosporine|mesh-list
110810622|NCT00035555|Mycophenolic Acid|mycophenolic acid|mesh-list
110810623|NCT00035555|Abatacept|abatacept|mesh-list
110810624|NCT00035555|Cyclosporins|cyclosporins|mesh-list
110810625|NCT00035555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110810626|NCT00035555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110810627|NCT00035555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110810628|NCT00035555|Immunologic Factors|immunologic factors|mesh-ancestor
110810629|NCT00035555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110810630|NCT00035555|Antifungal Agents|antifungal agents|mesh-ancestor
110810631|NCT00035555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110810632|NCT00035555|Dermatologic Agents|dermatologic agents|mesh-ancestor
110810633|NCT00035555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110810634|NCT00035555|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110810635|NCT00035555|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110810636|NCT00035555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110810637|NCT00035555|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110810638|NCT00035555|Antitubercular Agents|antitubercular agents|mesh-ancestor
110810639|NCT00035555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110810640|NCT00035555|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110810641|NCT00035555|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110810642|NCT01093157|Hormones|hormones|mesh-list
110810643|NCT01093157|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
110810644|NCT01093157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110810645|NCT01093157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110810646|NCT01093235|Cyclophosphamide|cyclophosphamide|mesh-list
110810647|NCT01093235|Bevacizumab|bevacizumab|mesh-list
110810648|NCT01093235|Docetaxel|docetaxel|mesh-list
110810649|NCT01093235|Fluorouracil|fluorouracil|mesh-list
110810650|NCT01093235|Epirubicin|epirubicin|mesh-list
110810651|NCT01093235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110810652|NCT01093235|Immunologic Factors|immunologic factors|mesh-ancestor
110810653|NCT01093235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110810654|NCT01093235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110810655|NCT01093235|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110810656|NCT01093235|Alkylating Agents|alkylating agents|mesh-ancestor
110810657|NCT01093235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110810658|NCT01093235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110810659|NCT01093235|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110810660|NCT01093235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110810661|NCT01093235|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110810662|NCT01093235|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110810663|NCT01093235|Growth Substances|growth substances|mesh-ancestor
110810664|NCT01093235|Growth Inhibitors|growth inhibitors|mesh-ancestor
110810665|NCT01093235|Tubulin Modulators|tubulin modulators|mesh-ancestor
110810666|NCT01093235|Antimitotic Agents|antimitotic agents|mesh-ancestor
110810667|NCT01093235|Mitosis Modulators|mitosis modulators|mesh-ancestor
110810668|NCT01093235|Antimetabolites|antimetabolites|mesh-ancestor
110810669|NCT01093235|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110810670|NCT01093235|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110810671|NCT01093235|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110810672|NCT01093235|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110810673|NCT01093235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110810674|NCT01097681|Ipragliflozin|ipragliflozin|mesh-list
110810675|NCT01097681|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110810676|NCT01097681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110810677|NCT01097681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110810678|NCT01097681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110810679|NCT01088009|Lamivudine|lamivudine|mesh-list
110810680|NCT01088009|Adefovir|adefovir|mesh-list
110810681|NCT01088009|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110810682|NCT01088009|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110810683|NCT01088009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110810684|NCT01088009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110810685|NCT01088009|Antiviral Agents|antiviral agents|mesh-ancestor
110810686|NCT01088009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110810687|NCT01088009|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110810688|NCT01088009|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110810689|NCT03894046|Imipenem|imipenem|mesh-list
110810690|NCT03894046|Colistin|colistin|mesh-list
110810691|NCT03894046|Sulbactam|sulbactam|mesh-list
110810693|NCT03894046|Cilastatin|cilastatin|mesh-list
110810694|NCT03894046|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110810695|NCT03894046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110810696|NCT03894046|Protease Inhibitors|protease inhibitors|mesh-ancestor
110810697|NCT03894046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110810698|NCT03894046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110415412|NCT00929695|Glucocorticoids|glucocorticoids|mesh-ancestor
110810699|NCT03894046|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110810700|NCT04475614|Vitamin B Complex|vitamin b complex|mesh-list
110810701|NCT04475614|Vitamins|vitamins|mesh-ancestor
110810702|NCT04475614|Micronutrients|micronutrients|mesh-ancestor
110810703|NCT04475614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110810704|NCT01143064|Progesterone|progesterone|mesh-list
110810705|NCT01143064|Progestins|progestins|mesh-ancestor
110810706|NCT01143064|Hormones|hormones|mesh-ancestor
110863867|NCT04495283|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110810707|NCT01143064|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110810708|NCT01143064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110810709|NCT00033371|Eflornithine|eflornithine|mesh-list
110810710|NCT00033371|Celecoxib|celecoxib|mesh-list
110810711|NCT00033371|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110810712|NCT00033371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110810713|NCT00033371|Analgesics|analgesics|mesh-ancestor
110415536|NCT00610909|Paroxetine|paroxetine|mesh-list
110810714|NCT00033371|Sensory System Agents|sensory system agents|mesh-ancestor
110810715|NCT00033371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110810716|NCT00033371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110810717|NCT00033371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110810718|NCT00033371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110810719|NCT00033371|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110810720|NCT00033371|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110810721|NCT00033371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110810722|NCT00033371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110415627|NCT01136733|Everolimus|everolimus|mesh-list
110810723|NCT00033371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110810724|NCT00033371|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
110810725|NCT00033371|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110810726|NCT00033371|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110810727|NCT00033371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110810728|NCT00033371|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
110810729|NCT01001338|Allopurinol|allopurinol|mesh-list
110810730|NCT01001338|Lesinurad|lesinurad|mesh-list
110810731|NCT01001338|Antimetabolites|antimetabolites|mesh-ancestor
110810732|NCT01001338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110810733|NCT01001338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110810734|NCT01001338|Gout Suppressants|gout suppressants|mesh-ancestor
110810735|NCT01001338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110810736|NCT01001338|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110810737|NCT01001338|Antioxidants|antioxidants|mesh-ancestor
110810738|NCT01001338|Protective Agents|protective agents|mesh-ancestor
110810739|NCT01001338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110810740|NCT01001338|Uricosuric Agents|uricosuric agents|mesh-ancestor
110810741|NCT03952715|Ibuprofen|ibuprofen|mesh-list
110810742|NCT03952715|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110810743|NCT03952715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110810744|NCT03952715|Analgesics|analgesics|mesh-ancestor
110810745|NCT03952715|Sensory System Agents|sensory system agents|mesh-ancestor
110810746|NCT03952715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110810747|NCT03952715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110810748|NCT03952715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110810749|NCT03952715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110810750|NCT03952715|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110810751|NCT03952715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110810752|NCT03952715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110810753|NCT01137526|Donepezil|donepezil|mesh-list
110810754|NCT01137526|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110810755|NCT01137526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110415732|NCT01133847|Guanfacine|guanfacine|mesh-list
110810756|NCT01137526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110810757|NCT01137526|Cholinergic Agents|cholinergic agents|mesh-ancestor
110810758|NCT01137526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110810759|NCT01137526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110810760|NCT01137526|Nootropic Agents|nootropic agents|mesh-ancestor
110810761|NCT00993382|Amiodarone|amiodarone|mesh-list
110810762|NCT00993382|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110810763|NCT00993382|Vasodilator Agents|vasodilator agents|mesh-ancestor
110810764|NCT00993382|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
110810765|NCT00993382|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110810766|NCT00993382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110810767|NCT00993382|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110810768|NCT00993382|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110810769|NCT00993382|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110810770|NCT00993382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110810771|NCT00993382|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110810772|NCT00993382|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110810773|NCT00993382|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110810774|NCT00081731|Candesartan cilexetil|candesartan cilexetil|mesh-list
110810775|NCT00081731|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110810776|NCT00081731|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110810777|NCT00081731|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110810778|NCT00081731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110810780|NCT05628610|Carboplatin|carboplatin|mesh-list
110810781|NCT05628610|Tislelizumab|tislelizumab|mesh-list
110810782|NCT05628610|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110810783|NCT05628610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110810784|NCT05628610|Tubulin Modulators|tubulin modulators|mesh-ancestor
110810785|NCT05628610|Antimitotic Agents|antimitotic agents|mesh-ancestor
110810786|NCT05628610|Mitosis Modulators|mitosis modulators|mesh-ancestor
110810787|NCT05628610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110810788|NCT05628610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110810789|NCT00079937|Fluticasone|fluticasone|mesh-list
110810790|NCT00079937|Omalizumab|omalizumab|mesh-list
110810791|NCT00079937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110810792|NCT00079937|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110810793|NCT00079937|Autonomic Agents|autonomic agents|mesh-ancestor
110810794|NCT00079937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110810795|NCT00079937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110810796|NCT00079937|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110810797|NCT00079937|Respiratory System Agents|respiratory system agents|mesh-ancestor
110810798|NCT00079937|Dermatologic Agents|dermatologic agents|mesh-ancestor
110810799|NCT00079937|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110810800|NCT00909610|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
110810801|NCT00909610|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
110810802|NCT00909610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110810803|NCT03961607|Aminolevulinic Acid|aminolevulinic acid|mesh-list
110415911|NCT00625209|Fludrocortisone|fludrocortisone|mesh-list
110810804|NCT03961607|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110810805|NCT03961607|Dermatologic Agents|dermatologic agents|mesh-ancestor
110810806|NCT03126110|Nivolumab|nivolumab|mesh-list
110810807|NCT03126110|Ipilimumab|ipilimumab|mesh-list
110810808|NCT03126110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110810809|NCT03126110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110810810|NCT03126110|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110810811|NCT03126110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110810812|NCT00908128|Mycophenolic Acid|mycophenolic acid|mesh-list
110810813|NCT00908128|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110810814|NCT00908128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110810815|NCT00908128|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110810816|NCT00908128|Antitubercular Agents|antitubercular agents|mesh-ancestor
110810817|NCT00908128|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110810818|NCT00908128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110810819|NCT00908128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110810820|NCT00908128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110810821|NCT00906334|ON 01910|on 01910|mesh-list
110810822|NCT00906334|Glycine|glycine|mesh-list
110810823|NCT00906334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110810824|NCT00906334|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110810825|NCT00906334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110810826|NCT00906334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110810827|NCT00906334|Glycine Agents|glycine agents|mesh-ancestor
110810828|NCT00906334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110810829|NCT00906334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110810830|NCT00905164|Topiramate|topiramate|mesh-list
110810831|NCT00905164|Anticonvulsants|anticonvulsants|mesh-ancestor
110810832|NCT00905164|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110810833|NCT00905164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110810834|NCT00978016|Arbaclofen placarbil|arbaclofen placarbil|mesh-list
110810835|NCT00978016|Baclofen|baclofen|mesh-list
110810836|NCT00978016|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
110810837|NCT00978016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110810838|NCT00978016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110810839|NCT00978016|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110810840|NCT00978016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110810842|NCT00978016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110810843|NCT00978016|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
110810844|NCT00978016|GABA Agonists|gaba agonists|mesh-ancestor
110810846|NCT00978016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110810847|NCT01129648|Allopurinol|allopurinol|mesh-list
110810848|NCT01129648|Antimetabolites|antimetabolites|mesh-ancestor
110810849|NCT01129648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110810850|NCT01129648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110810851|NCT01129648|Gout Suppressants|gout suppressants|mesh-ancestor
110810852|NCT01129648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110810853|NCT01129648|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110810854|NCT01129648|Antioxidants|antioxidants|mesh-ancestor
110810855|NCT01129648|Protective Agents|protective agents|mesh-ancestor
110810856|NCT01129648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110810857|NCT04438720|Nifedipine|nifedipine|mesh-list
110810858|NCT04438720|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110810859|NCT04438720|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110810860|NCT04438720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110810861|NCT04438720|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110810862|NCT04438720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110810863|NCT04438720|Vasodilator Agents|vasodilator agents|mesh-ancestor
110810864|NCT04438720|Tocolytic Agents|tocolytic agents|mesh-ancestor
110810865|NCT04438720|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110810866|NCT05464810|Letrozole|letrozole|mesh-list
110810867|NCT05464810|Simvastatin|simvastatin|mesh-list
110810868|NCT05464810|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110810869|NCT05464810|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110810870|NCT05464810|Antimetabolites|antimetabolites|mesh-ancestor
110810871|NCT05464810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110810872|NCT05464810|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110810873|NCT05464810|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110810874|NCT05464810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110810875|NCT05464810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110810876|NCT05464810|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110810877|NCT05464810|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110810878|NCT05464810|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110810879|NCT05464810|Hormone Antagonists|hormone antagonists|mesh-ancestor
110810880|NCT05464810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110810881|NCT05464810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110810882|NCT03176966|Vitamin E|vitamin e|mesh-list
110810883|NCT03176966|Ropinirole|ropinirole|mesh-list
110810884|NCT03176966|Vitamins|vitamins|mesh-ancestor
110810885|NCT03176966|Micronutrients|micronutrients|mesh-ancestor
110810886|NCT03176966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110810887|NCT03176966|Antioxidants|antioxidants|mesh-ancestor
110810888|NCT03176966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110810889|NCT03176966|Protective Agents|protective agents|mesh-ancestor
110810890|NCT03176966|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110810891|NCT03176966|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110810892|NCT03176966|Dopamine Agonists|dopamine agonists|mesh-ancestor
110810893|NCT03176966|Dopamine Agents|dopamine agents|mesh-ancestor
110810894|NCT03176966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110810895|NCT03209570|Zinc Oxide|zinc oxide|mesh-list
110810896|NCT03209570|Dermatologic Agents|dermatologic agents|mesh-ancestor
110810897|NCT03209570|Sunscreening Agents|sunscreening agents|mesh-ancestor
110810898|NCT03209570|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110810899|NCT03209570|Protective Agents|protective agents|mesh-ancestor
110810900|NCT03209570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110810901|NCT04405102|Ozanimod|ozanimod|mesh-list
110810902|NCT04405102|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
110810903|NCT04405102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110810904|NCT04405102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110810905|NCT04405102|Immunologic Factors|immunologic factors|mesh-ancestor
110863868|NCT04495283|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110810906|NCT04405102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110810907|NCT03209492|Leuprolide|leuprolide|mesh-list
110810908|NCT03209492|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110810909|NCT03209492|Fertility Agents|fertility agents|mesh-ancestor
110810910|NCT03209492|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110810911|NCT03209492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110810912|NCT03209492|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110810913|NCT03209492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110810914|NCT00894868|Vildagliptin|vildagliptin|mesh-list
110810915|NCT00894868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110810916|NCT00894868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110810917|NCT00894868|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110810918|NCT00894868|Protease Inhibitors|protease inhibitors|mesh-ancestor
110810919|NCT00894868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110810920|NCT00894868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110810921|NCT01122784|Vaccines|vaccines|mesh-list
110810922|NCT01122784|Immunologic Factors|immunologic factors|mesh-ancestor
110810923|NCT01122784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110810924|NCT03208244|Antiviral Agents|antiviral agents|mesh-list
110810925|NCT03208244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110810926|NCT01088165|Adalimumab|adalimumab|mesh-list
110810927|NCT01088165|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110810928|NCT01088165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110810929|NCT01088165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110810930|NCT00892762|Travoprost|travoprost|mesh-list
110810931|NCT00892762|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110810932|NCT00892762|Latanoprost|latanoprost|mesh-list
110810933|NCT00892762|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110810934|NCT00892762|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110810935|NCT00890968|Triamcinolone|triamcinolone|mesh-list
110810936|NCT00890968|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110810937|NCT00890968|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110810938|NCT00890968|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110810939|NCT00890968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110810940|NCT00890968|Glucocorticoids|glucocorticoids|mesh-ancestor
110810941|NCT00890968|Hormones|hormones|mesh-ancestor
110810942|NCT00890968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110810943|NCT00890968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110810944|NCT00890968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110810945|NCT00890968|Immunologic Factors|immunologic factors|mesh-ancestor
110810946|NCT00890968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110810947|NCT00890968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110810948|NCT01098383|Acetylcholine|acetylcholine|mesh-list
110810949|NCT01098383|Donepezil|donepezil|mesh-list
110810950|NCT01098383|Choline|choline|mesh-list
110810951|NCT01098383|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110810952|NCT01098383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110810953|NCT01098383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110810954|NCT01098383|Cholinergic Agents|cholinergic agents|mesh-ancestor
110810955|NCT01098383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110810956|NCT01098383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110810957|NCT01098383|Nootropic Agents|nootropic agents|mesh-ancestor
110810958|NCT01098383|Lipotropic Agents|lipotropic agents|mesh-ancestor
110810959|NCT01098383|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110810960|NCT01098383|Antimetabolites|antimetabolites|mesh-ancestor
110810961|NCT01098383|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110810962|NCT01098383|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110810963|NCT01098383|Vasodilator Agents|vasodilator agents|mesh-ancestor
110810964|NCT01098383|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110810965|NCT00890890|BMS 708163|bms 708163|mesh-list
110810966|NCT00890890|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
110810967|NCT00890890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110810968|NCT00890890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110810969|NCT03175172|Pembrolizumab|pembrolizumab|mesh-list
110810970|NCT03175172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110810971|NCT03175172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110810972|NCT03175172|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110810973|NCT03175172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110810974|NCT00961090|Aminolevulinic Acid|aminolevulinic acid|mesh-list
110810975|NCT00961090|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110810976|NCT00961090|Dermatologic Agents|dermatologic agents|mesh-ancestor
110810977|NCT01088477|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110810978|NCT01088477|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110810979|NCT01088477|Estradiol|estradiol|mesh-list
110810980|NCT01088477|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110810981|NCT01088477|Estrogens|estrogens|mesh-ancestor
110810982|NCT01088477|Hormones|hormones|mesh-ancestor
110810983|NCT01088477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110416130|NCT01214616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110810984|NCT01088477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110810985|NCT01088477|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110810986|NCT01088477|Contraceptive Agents|contraceptive agents|mesh-ancestor
110810987|NCT01088477|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110810988|NCT01088477|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110810989|NCT01088555|Sodium thiosulfate|sodium thiosulfate|mesh-list
110810990|NCT01088555|Antidotes|antidotes|mesh-ancestor
110810991|NCT01088555|Protective Agents|protective agents|mesh-ancestor
110810992|NCT01088555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110810994|NCT01088555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110810995|NCT01088555|Antitubercular Agents|antitubercular agents|mesh-ancestor
110810996|NCT01088555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110810997|NCT01088555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110810998|NCT01088555|Chelating Agents|chelating agents|mesh-ancestor
110810999|NCT01088555|Sequestering Agents|sequestering agents|mesh-ancestor
110811000|NCT04474210|JNJ-56136379|jnj-56136379|mesh-list
110811001|NCT04474210|Antiviral Agents|antiviral agents|mesh-ancestor
110811002|NCT04474210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110811003|NCT00078767|Sertraline|sertraline|mesh-list
110811004|NCT00078767|Antidepressive Agents|antidepressive agents|mesh-ancestor
110811005|NCT00078767|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110811006|NCT00078767|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110811007|NCT00078767|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110811008|NCT00078767|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110811009|NCT00078767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110811010|NCT00078767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110811011|NCT00078767|Serotonin Agents|serotonin agents|mesh-ancestor
110811012|NCT00078767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110811013|NCT04474288|Antibodies|antibodies|mesh-list
110811014|NCT04474288|Immunologic Factors|immunologic factors|mesh-ancestor
110811015|NCT04474288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110811016|NCT00078377|Modafinil|modafinil|mesh-list
110811017|NCT00078377|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110811018|NCT00078377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110811019|NCT00078377|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
110811020|NCT00078377|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110811021|NCT00078377|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110811022|NCT00078377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110811023|NCT01107496|Viloxazine|viloxazine|mesh-list
110811024|NCT01107496|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110811025|NCT01107496|Antidepressive Agents|antidepressive agents|mesh-ancestor
110811026|NCT01107496|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110811027|NCT01107496|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110811028|NCT01107496|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110811029|NCT01107496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110811030|NCT01107496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110811031|NCT01107496|Adrenergic Agents|adrenergic agents|mesh-ancestor
110811032|NCT01107496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110811033|NCT01107496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110811034|NCT00886600|Losartan|losartan|mesh-list
110811035|NCT00886600|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110811036|NCT00886600|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110811037|NCT00886600|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110811038|NCT00886600|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110811039|NCT00886600|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110416191|NCT04746547|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110811040|NCT00886600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110811041|NCT00886600|Diuretics|diuretics|mesh-ancestor
110811042|NCT00886600|Natriuretic Agents|natriuretic agents|mesh-ancestor
110811043|NCT00886600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110811044|NCT00886600|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110811045|NCT00886600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110811046|NCT02591654|Pembrolizumab|pembrolizumab|mesh-list
110811047|NCT02591654|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110811048|NCT02591654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110853566|NCT01333800|Hormones|hormones|mesh-ancestor
110811049|NCT02591654|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110811050|NCT02591654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110811051|NCT03134872|Carboplatin|carboplatin|mesh-list
110811052|NCT03134872|Pemetrexed|pemetrexed|mesh-list
110811053|NCT03134872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110811054|NCT03134872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110811055|NCT03134872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110811056|NCT03134872|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110811057|NCT03134872|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110811058|NCT03952481|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110811059|NCT03952481|Lifitegrast|lifitegrast|mesh-list
110811060|NCT03952481|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110811061|NCT05135312|Etanercept|etanercept|mesh-list
110811062|NCT05135312|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110811063|NCT05135312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110811064|NCT05135312|Analgesics|analgesics|mesh-ancestor
110811065|NCT05135312|Sensory System Agents|sensory system agents|mesh-ancestor
110811066|NCT05135312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110811067|NCT05135312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110811068|NCT05135312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110811069|NCT05135312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110811070|NCT05135312|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110811071|NCT05135312|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110811072|NCT05135312|Immunologic Factors|immunologic factors|mesh-ancestor
110811073|NCT00881452|Citric Acid|citric acid|mesh-list
110811074|NCT00881452|Anticoagulants|anticoagulants|mesh-ancestor
110811075|NCT00881452|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110811076|NCT00881452|Chelating Agents|chelating agents|mesh-ancestor
110811077|NCT00881452|Sequestering Agents|sequestering agents|mesh-ancestor
110811078|NCT00881452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110811079|NCT03952325|Pembrolizumab|pembrolizumab|mesh-list
110811080|NCT03952325|Nivolumab|nivolumab|mesh-list
110811081|NCT03952325|Atezolizumab|atezolizumab|mesh-list
110811082|NCT03952325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110811083|NCT03952325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110811084|NCT03952325|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110811085|NCT03952325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110811086|NCT00948142|Linezolid|linezolid|mesh-list
110811087|NCT00948142|Fusidic Acid|fusidic acid|mesh-list
110811088|NCT00948142|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110811089|NCT00948142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110811090|NCT00948142|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110811091|NCT00948142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110811092|NCT00948142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110811093|NCT00947518|Chlorhexidine|chlorhexidine|mesh-list
110811094|NCT00947518|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110811095|NCT00947518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110811096|NCT00947518|Disinfectants|disinfectants|mesh-ancestor
110811097|NCT00945802|Ciprofloxacin|ciprofloxacin|mesh-list
110811098|NCT00945802|Dexamethasone|dexamethasone|mesh-list
110811099|NCT00945802|Dexamethasone acetate|dexamethasone acetate|mesh-list
110811100|NCT00945802|BB 1101|bb 1101|mesh-list
110811101|NCT00945802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110811102|NCT00945802|Antiemetics|antiemetics|mesh-ancestor
110811103|NCT00945802|Autonomic Agents|autonomic agents|mesh-ancestor
110811104|NCT00945802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110811105|NCT00945802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110811106|NCT00945802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110811107|NCT00945802|Glucocorticoids|glucocorticoids|mesh-ancestor
110811108|NCT00945802|Hormones|hormones|mesh-ancestor
110811109|NCT00945802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110811110|NCT00945802|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110811111|NCT00945802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110811112|NCT00945802|Protease Inhibitors|protease inhibitors|mesh-ancestor
110811113|NCT00945802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110811114|NCT00945802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110811115|NCT00945802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110811116|NCT00945802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110811117|NCT00945802|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110811118|NCT00945802|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110811119|NCT00945802|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110811120|NCT00945802|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110811121|NCT01105624|Azithromycin|azithromycin|mesh-list
110811122|NCT01105624|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110811123|NCT01105624|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110811124|NCT01105624|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110811125|NCT01105624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110811126|NCT01102660|Naproxen|naproxen|mesh-list
110811127|NCT01102660|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110811128|NCT01102660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110811129|NCT01102660|Analgesics|analgesics|mesh-ancestor
110811130|NCT01102660|Sensory System Agents|sensory system agents|mesh-ancestor
110811131|NCT01102660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110811132|NCT01102660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110811133|NCT01102660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110811134|NCT01102660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110811135|NCT01102660|Gout Suppressants|gout suppressants|mesh-ancestor
110811136|NCT01102660|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110811137|NCT01102660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110811138|NCT01102660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110811139|NCT03135106|Itraconazole|itraconazole|mesh-list
110811141|NCT03135106|Antifungal Agents|antifungal agents|mesh-ancestor
110811142|NCT03135106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110811143|NCT03135106|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110811144|NCT03135106|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110811145|NCT03135106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110811146|NCT03135106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110811147|NCT03135106|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110811148|NCT03135106|Hormone Antagonists|hormone antagonists|mesh-ancestor
110811149|NCT03135106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110811150|NCT03135106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110811151|NCT03135106|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110811152|NCT03135106|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110811153|NCT03135106|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110811154|NCT00872014|Sorafenib|sorafenib|mesh-list
110811155|NCT00872014|Trebananib|trebananib|mesh-list
110811156|NCT00872014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110811157|NCT00872014|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110811158|NCT00872014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110811159|NCT00872014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110811160|NCT00872014|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110811161|NCT00872014|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110416271|NCT04203043|Antioxidants|antioxidants|mesh-ancestor
110811162|NCT00872014|Growth Substances|growth substances|mesh-ancestor
110811163|NCT00872014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110811164|NCT00872014|Growth Inhibitors|growth inhibitors|mesh-ancestor
110811165|NCT00871936|Metformin|metformin|mesh-list
110811166|NCT00871936|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110811167|NCT00871936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110811168|NCT00870688|Valproic Acid|valproic acid|mesh-list
110811169|NCT00870688|Anticonvulsants|anticonvulsants|mesh-ancestor
110811170|NCT00870688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110811171|NCT00870688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110811172|NCT00870688|GABA Agents|gaba agents|mesh-ancestor
110811173|NCT00870688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110811174|NCT00870688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110811175|NCT00870688|Antimanic Agents|antimanic agents|mesh-ancestor
110811176|NCT00870688|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110811177|NCT00870688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110811178|NCT00870688|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110811179|NCT00870454|Pregabalin|pregabalin|mesh-list
110811180|NCT00870454|Analgesics|analgesics|mesh-ancestor
110811181|NCT00870454|Sensory System Agents|sensory system agents|mesh-ancestor
110811182|NCT00870454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110853572|NCT04494100|Lidocaine|lidocaine|mesh-list
110811183|NCT00870454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110811184|NCT00870454|Anticonvulsants|anticonvulsants|mesh-ancestor
110811185|NCT00870454|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110811186|NCT00870454|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110811187|NCT00870454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110811188|NCT00870454|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110811189|NCT00870454|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110811190|NCT00870454|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110811191|NCT00870454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110811192|NCT00870454|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110811193|NCT05096962|Antibodies|antibodies|mesh-list
110811194|NCT05096962|Immunologic Factors|immunologic factors|mesh-ancestor
110811195|NCT05096962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110811196|NCT00869128|Melatonin|melatonin|mesh-list
110811197|NCT00869128|Antioxidants|antioxidants|mesh-ancestor
110811198|NCT00869128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110811199|NCT00869128|Protective Agents|protective agents|mesh-ancestor
110811200|NCT00869128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110811201|NCT00869128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110811202|NCT00945646|Dexamethasone|dexamethasone|mesh-list
110811203|NCT00945646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110811204|NCT00945646|Antiemetics|antiemetics|mesh-ancestor
110811205|NCT00945646|Autonomic Agents|autonomic agents|mesh-ancestor
110811206|NCT00945646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110811207|NCT00945646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110811208|NCT00945646|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110811209|NCT00945646|Glucocorticoids|glucocorticoids|mesh-ancestor
110811210|NCT00945646|Hormones|hormones|mesh-ancestor
110811211|NCT00945646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110528776|NCT03851627|Methyltestosterone|methyltestosterone|mesh-list
110811212|NCT00945646|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110811213|NCT00945646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110811214|NCT00077675|Vancomycin|vancomycin|mesh-list
110811215|NCT00077675|Penicillins|penicillins|mesh-list
110811216|NCT00077675|Telavancin|telavancin|mesh-list
110811217|NCT00077675|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110811218|NCT00077675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110811219|NCT00934180|Ondansetron|ondansetron|mesh-list
110811220|NCT00934180|Antiemetics|antiemetics|mesh-ancestor
110811221|NCT00934180|Autonomic Agents|autonomic agents|mesh-ancestor
110811222|NCT00934180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110811223|NCT00934180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110811224|NCT00934180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110811225|NCT00934180|Antipruritics|antipruritics|mesh-ancestor
110811226|NCT00934180|Dermatologic Agents|dermatologic agents|mesh-ancestor
110811227|NCT00934180|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110811228|NCT00934180|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110811229|NCT00934180|Serotonin Agents|serotonin agents|mesh-ancestor
110811230|NCT00934180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110811231|NCT00934180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110811232|NCT02576444|Olaparib|olaparib|mesh-list
110811233|NCT02576444|Adavosertib|adavosertib|mesh-list
110811234|NCT02576444|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110811235|NCT02576444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110811236|NCT02576444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110811237|NCT02576444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110811238|NCT00929968|Fluticasone|fluticasone|mesh-list
110811239|NCT00929968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110811240|NCT00929968|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110811241|NCT00929968|Autonomic Agents|autonomic agents|mesh-ancestor
110811242|NCT00929968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110811243|NCT00929968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110811244|NCT00929968|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110811245|NCT00929968|Respiratory System Agents|respiratory system agents|mesh-ancestor
110811246|NCT00929968|Dermatologic Agents|dermatologic agents|mesh-ancestor
110811247|NCT00929968|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110811248|NCT03957083|Oxytocin|oxytocin|mesh-list
110811249|NCT03957083|Oxytocics|oxytocics|mesh-ancestor
110811250|NCT03957083|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110811251|NCT03957083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110811252|NCT04945616|Aspirin|aspirin|mesh-list
110811253|NCT04945616|Clopidogrel|clopidogrel|mesh-list
110811254|NCT04945616|Ticagrelor|ticagrelor|mesh-list
110811255|NCT04945616|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110811256|NCT04945616|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110811257|NCT04945616|Analgesics|analgesics|mesh-ancestor
110811258|NCT04945616|Sensory System Agents|sensory system agents|mesh-ancestor
110811259|NCT04945616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110811260|NCT04945616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110811261|NCT04945616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110811262|NCT04945616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110811263|NCT04945616|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110811264|NCT04945616|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110811265|NCT04945616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110811266|NCT04945616|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110811267|NCT04945616|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110811268|NCT04945616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110811269|NCT04945616|Antipyretics|antipyretics|mesh-ancestor
110811270|NCT04945616|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110811271|NCT04945616|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110811272|NCT04945616|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110811273|NCT04945616|Purinergic Agents|purinergic agents|mesh-ancestor
110811274|NCT04945616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110811275|NCT04473820|Lidocaine|lidocaine|mesh-list
110811276|NCT04473820|Prilocaine|prilocaine|mesh-list
110811277|NCT04473820|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
110416380|NCT00909181|Mandelic Acids|mandelic acids|mesh-list
110811278|NCT04473820|Anesthetics, Local|anesthetics, local|mesh-ancestor
110811279|NCT04473820|Anesthetics|anesthetics|mesh-ancestor
110811280|NCT04473820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110811281|NCT04473820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110811282|NCT04473820|Sensory System Agents|sensory system agents|mesh-ancestor
110811283|NCT04473820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110811284|NCT04473820|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110811285|NCT04473820|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110811286|NCT04473820|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110811287|NCT04473820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110811288|NCT04473820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110811290|NCT05064332|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110811291|NCT05064332|Contraceptive Agents|contraceptive agents|mesh-list
110811292|NCT05064332|Contraceptives, Oral|contraceptives, oral|mesh-list
110811293|NCT05064332|Estradiol|estradiol|mesh-list
110811294|NCT05064332|Estrogens|estrogens|mesh-ancestor
110811295|NCT05064332|Hormones|hormones|mesh-ancestor
110811296|NCT05064332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110811297|NCT05064332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110811298|NCT05064332|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110811299|NCT05064332|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110811300|NCT05064332|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110811301|NCT05064332|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110811302|NCT00855712|Cardioplegic Solutions|cardioplegic solutions|mesh-list
110811303|NCT00855712|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110811304|NCT00850174|Oxcarbazepine|oxcarbazepine|mesh-list
110811305|NCT00850174|Anticonvulsants|anticonvulsants|mesh-ancestor
110811306|NCT00850174|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110811307|NCT00850174|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110811308|NCT00850174|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110811309|NCT00850174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110811310|NCT00850174|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110811311|NCT00850174|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110811312|NCT00849862|Levetiracetam|levetiracetam|mesh-list
110811313|NCT00849862|Anticonvulsants|anticonvulsants|mesh-ancestor
110811314|NCT00849862|Nootropic Agents|nootropic agents|mesh-ancestor
110811316|NCT00077207|Vincristine|vincristine|mesh-list
110811317|NCT00077207|Temozolomide|temozolomide|mesh-list
110811318|NCT00077207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110811319|NCT00077207|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110811320|NCT00077207|Tubulin Modulators|tubulin modulators|mesh-ancestor
110811321|NCT00077207|Antimitotic Agents|antimitotic agents|mesh-ancestor
110811322|NCT00077207|Mitosis Modulators|mitosis modulators|mesh-ancestor
110811323|NCT00077207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110811324|NCT00077207|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110811325|NCT00077207|Alkylating Agents|alkylating agents|mesh-ancestor
110811326|NCT01099085|Simvastatin|simvastatin|mesh-list
110811327|NCT01099085|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110811328|NCT01099085|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110811329|NCT01099085|Antimetabolites|antimetabolites|mesh-ancestor
110811330|NCT01099085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110811331|NCT01099085|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110811332|NCT01099085|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110811333|NCT01099085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110811334|NCT03206918|Zanubrutinib|zanubrutinib|mesh-list
110811335|NCT03206918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110811336|NCT03206918|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110811337|NCT03206918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110811338|NCT03206918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110811339|NCT05095064|Irinotecan|irinotecan|mesh-list
110811340|NCT05095064|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110811341|NCT05095064|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110416405|NCT01286753|Vemurafenib|vemurafenib|mesh-list
110811342|NCT05095064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110811343|NCT05095064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110811344|NCT05095064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110811345|NCT03169244|Bupropion|bupropion|mesh-list
110811346|NCT03169244|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110811347|NCT03169244|Antidepressive Agents|antidepressive agents|mesh-ancestor
110811348|NCT03169244|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110811349|NCT03169244|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110811350|NCT03169244|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110811351|NCT03169244|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110811352|NCT03169244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110811353|NCT03169244|Dopamine Agents|dopamine agents|mesh-ancestor
110811354|NCT03169244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110811355|NCT03169244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110811356|NCT03169244|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110811357|NCT03169244|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110811358|NCT03169244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110528923|NCT03690089|Mydriatics|mydriatics|mesh-ancestor
110811359|NCT02486042|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
110811360|NCT02486042|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
110811361|NCT02486042|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
110811362|NCT02486042|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110811363|NCT00920764|Atrasentan|atrasentan|mesh-list
110811364|NCT00920764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110811365|NCT00920764|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
110811366|NCT00920764|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
110811367|NCT00920764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110811368|NCT05376046|Thrombin|thrombin|mesh-list
110811369|NCT05376046|Hemostatics|hemostatics|mesh-ancestor
110811370|NCT05376046|Coagulants|coagulants|mesh-ancestor
110811371|NCT03034304|Carboplatin|carboplatin|mesh-list
110811372|NCT03034304|Gemcitabine|gemcitabine|mesh-list
110811373|NCT03034304|Doxorubicin|doxorubicin|mesh-list
110811374|NCT03034304|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110811375|NCT03034304|Ifosfamide|ifosfamide|mesh-list
110811376|NCT03034304|Antibodies|antibodies|mesh-list
110811377|NCT03034304|Immunologic Factors|immunologic factors|mesh-ancestor
110811378|NCT03034304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110811379|NCT03034304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110811380|NCT03034304|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110811381|NCT03034304|Antimetabolites|antimetabolites|mesh-ancestor
110811382|NCT03034304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110853604|NCT01333878|Immunologic Factors|immunologic factors|mesh-ancestor
110811383|NCT03034304|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110811384|NCT03034304|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110811385|NCT03034304|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110811386|NCT03034304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110811387|NCT03034304|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110811388|NCT03034304|Alkylating Agents|alkylating agents|mesh-ancestor
110811390|NCT00914602|Carbidopa|carbidopa|mesh-list
110811391|NCT00914602|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
110811392|NCT00914602|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110811393|NCT00914602|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110811394|NCT00914602|Dopamine Agents|dopamine agents|mesh-ancestor
110811395|NCT00914602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110811396|NCT00914602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110811397|NCT00914602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110811398|NCT00914602|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
110811399|NCT00914602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110811400|NCT00914602|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110811401|NCT00914602|Immunologic Factors|immunologic factors|mesh-ancestor
110811402|NCT00914602|Dopamine Agonists|dopamine agonists|mesh-ancestor
110811403|NCT00914290|Baclofen|baclofen|mesh-list
110811404|NCT00914290|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110811405|NCT00914290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110811406|NCT00914290|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110811407|NCT00914290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110811408|NCT00914290|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
110811409|NCT00914290|GABA Agonists|gaba agonists|mesh-ancestor
110811410|NCT00914290|GABA Agents|gaba agents|mesh-ancestor
110811411|NCT00914290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110811412|NCT00914290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110811413|NCT00057941|Fulvestrant|fulvestrant|mesh-list
110811414|NCT00057941|Anastrozole|anastrozole|mesh-list
110811415|NCT00057941|Gefitinib|gefitinib|mesh-list
110811416|NCT00057941|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110811417|NCT00057941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110811418|NCT00057941|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110811419|NCT00057941|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110811420|NCT00057941|Hormone Antagonists|hormone antagonists|mesh-ancestor
110811421|NCT00057941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110811422|NCT00057941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110811423|NCT00057941|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110811424|NCT00057941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110811425|NCT00057941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110811426|NCT00057941|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110811427|NCT00057941|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110811428|NCT03005522|Dexamethasone|dexamethasone|mesh-list
110811429|NCT03005522|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110811430|NCT03005522|Antiemetics|antiemetics|mesh-ancestor
110811431|NCT03005522|Autonomic Agents|autonomic agents|mesh-ancestor
110811432|NCT03005522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110811433|NCT03005522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110811434|NCT03005522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110811436|NCT03005522|Hormones|hormones|mesh-ancestor
110811437|NCT03005522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110811438|NCT03005522|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110811439|NCT03005522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110811440|NCT02998736|Tadalafil|tadalafil|mesh-list
110811441|NCT02998736|Vasodilator Agents|vasodilator agents|mesh-ancestor
110811442|NCT02998736|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110811443|NCT02998736|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110811444|NCT02998736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110811445|NCT02998736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110811446|NCT02998736|Urological Agents|urological agents|mesh-ancestor
110811447|NCT00075881|Bortezomib|bortezomib|mesh-list
110811448|NCT00075881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110811449|NCT00838630|Cilostazol|cilostazol|mesh-list
110811450|NCT00838630|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110811451|NCT00838630|Autonomic Agents|autonomic agents|mesh-ancestor
110811452|NCT00838630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110811454|NCT00838630|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110811455|NCT00838630|Respiratory System Agents|respiratory system agents|mesh-ancestor
110811456|NCT00838630|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110811457|NCT00838630|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110811458|NCT00838630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110416476|NCT01280981|Tranexamic Acid|tranexamic acid|mesh-list
110811459|NCT00838630|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110811460|NCT00838630|Vasodilator Agents|vasodilator agents|mesh-ancestor
110811461|NCT00838630|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110811462|NCT00838630|Protective Agents|protective agents|mesh-ancestor
110811463|NCT00838630|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110811464|NCT00838630|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110811465|NCT00838630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110811466|NCT02996474|Pembrolizumab|pembrolizumab|mesh-list
110811467|NCT02996474|Decitabine|decitabine|mesh-list
110811468|NCT02996474|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110811469|NCT02996474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110811470|NCT02996474|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110811471|NCT02996474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110811472|NCT02996474|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110811473|NCT02996474|Antimetabolites|antimetabolites|mesh-ancestor
110811474|NCT02996474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110811475|NCT00821002|Latanoprost|latanoprost|mesh-list
110811476|NCT00821002|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110811477|NCT00821002|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110811478|NCT00820924|Lapatinib|lapatinib|mesh-list
110811479|NCT00820924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110811480|NCT00820924|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110811481|NCT00820924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110811482|NCT00820924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110811483|NCT00820300|Latanoprost|latanoprost|mesh-list
110811484|NCT00820300|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110811485|NCT00820300|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110811486|NCT00814372|Metformin|metformin|mesh-list
110811487|NCT00814372|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110811488|NCT00814372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110811489|NCT03134638|Carboplatin|carboplatin|mesh-list
110811490|NCT03134638|Fulvestrant|fulvestrant|mesh-list
110811491|NCT03134638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110811492|NCT03134638|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110811493|NCT03134638|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110811494|NCT03134638|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110811495|NCT03134638|Hormone Antagonists|hormone antagonists|mesh-ancestor
110811496|NCT03134638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110811497|NCT03134638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110811498|NCT03205046|Acalabrutinib|acalabrutinib|mesh-list
110811499|NCT03205046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110811500|NCT04855526|Dronabinol|dronabinol|mesh-list
110811501|NCT04855526|Hallucinogens|hallucinogens|mesh-ancestor
110811502|NCT04855526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110811503|NCT04855526|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110811504|NCT04855526|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110811505|NCT04855526|Analgesics|analgesics|mesh-ancestor
110811506|NCT04855526|Sensory System Agents|sensory system agents|mesh-ancestor
110811507|NCT04855526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110529076|NCT02744456|Diuretics|diuretics|mesh-ancestor
110416518|NCT05566223|Analgesics|analgesics|mesh-ancestor
110811508|NCT04855526|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
110811509|NCT04855526|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110811510|NCT04855526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110811511|NCT04855526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110811512|NCT04855526|Hormones|hormones|mesh-ancestor
110811513|NCT04855526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110811514|NCT02339090|Hormones|hormones|mesh-list
110811515|NCT02339090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110811516|NCT02339090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110811517|NCT05442008|Erenumab|erenumab|mesh-list
110811518|NCT05442008|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
110811519|NCT05442008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110811520|NCT05442008|Analgesics|analgesics|mesh-ancestor
110811521|NCT05442008|Sensory System Agents|sensory system agents|mesh-ancestor
110811522|NCT05442008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110811523|NCT05442008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110811524|NCT03524092|Mirikizumab|mirikizumab|mesh-list
110811525|NCT03524092|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110811526|NCT03524092|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110811527|NCT03524092|Analgesics|analgesics|mesh-ancestor
110811528|NCT03524092|Sensory System Agents|sensory system agents|mesh-ancestor
110811529|NCT03524092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110811530|NCT03524092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110811531|NCT03524092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110811532|NCT03524092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110811533|NCT03524092|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110811534|NCT03524092|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110811535|NCT03331562|Ergocalciferols|ergocalciferols|mesh-list
110811536|NCT03331562|Pembrolizumab|pembrolizumab|mesh-list
110811537|NCT03331562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110811538|NCT03331562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110811539|NCT03331562|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110811540|NCT03331562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110811541|NCT03331562|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110811542|NCT03331562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110811543|NCT03331562|Vitamins|vitamins|mesh-ancestor
110811544|NCT03331562|Micronutrients|micronutrients|mesh-ancestor
110811545|NCT03331562|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110811546|NCT00814294|Insulin|insulin|mesh-list
110811547|NCT00814294|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110811548|NCT00814294|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110811549|NCT00814294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110811550|NCT02038634|Betamethasone|betamethasone|mesh-list
110811551|NCT02038634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110811552|NCT02038634|Glucocorticoids|glucocorticoids|mesh-ancestor
110811553|NCT02038634|Hormones|hormones|mesh-ancestor
110811554|NCT02038634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110811555|NCT02038634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110811556|NCT02038634|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110811557|NCT02038634|Respiratory System Agents|respiratory system agents|mesh-ancestor
110811558|NCT00808288|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110811559|NCT00808288|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110811560|NCT00808288|Autonomic Agents|autonomic agents|mesh-ancestor
110811561|NCT00808288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110811562|NCT00808288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110811563|NCT00808288|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110811564|NCT00808288|Respiratory System Agents|respiratory system agents|mesh-ancestor
110811565|NCT00808288|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110811566|NCT00808288|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110811567|NCT00808288|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110811568|NCT00808288|Adrenergic Agents|adrenergic agents|mesh-ancestor
110811569|NCT00808288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110811570|NCT00808288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110811571|NCT03636308|Paclitaxel|paclitaxel|mesh-list
110811572|NCT03636308|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110811573|NCT03636308|Gemcitabine|gemcitabine|mesh-list
110811574|NCT03636308|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110811575|NCT03636308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110811576|NCT03636308|Tubulin Modulators|tubulin modulators|mesh-ancestor
110811577|NCT03636308|Antimitotic Agents|antimitotic agents|mesh-ancestor
110811578|NCT03636308|Mitosis Modulators|mitosis modulators|mesh-ancestor
110811579|NCT03636308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110811580|NCT03636308|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110811581|NCT03636308|Antimetabolites|antimetabolites|mesh-ancestor
110811582|NCT00836056|Clindamycin|clindamycin|mesh-list
110811583|NCT00836056|Clindamycin palmitate|clindamycin palmitate|mesh-list
110811584|NCT00836056|Clindamycin phosphate|clindamycin phosphate|mesh-list
110811585|NCT00836056|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110811586|NCT00836056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110811587|NCT00836056|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110811588|NCT00836056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110811589|NCT00836056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110811590|NCT00835666|Finasteride|finasteride|mesh-list
110811591|NCT00835666|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
110811592|NCT00835666|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110811593|NCT00835666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110811594|NCT00835666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110811595|NCT00835666|Hormone Antagonists|hormone antagonists|mesh-ancestor
110811596|NCT00835666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110811597|NCT00835666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110811598|NCT00835666|Urological Agents|urological agents|mesh-ancestor
110811599|NCT00835588|Pantoprazole|pantoprazole|mesh-list
110811600|NCT00835588|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110811601|NCT00835588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110811602|NCT00835588|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110811603|NCT00835588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110811604|NCT00835588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110811605|NCT00713518|Ranibizumab|ranibizumab|mesh-list
110811606|NCT00713518|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110811607|NCT00713518|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110811608|NCT00713518|Growth Substances|growth substances|mesh-ancestor
110811609|NCT00713518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110811610|NCT00713518|Growth Inhibitors|growth inhibitors|mesh-ancestor
110811611|NCT00713518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110811612|NCT04468958|Immunoglobulins|immunoglobulins|mesh-list
110811613|NCT04468958|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110811614|NCT04468958|Immunologic Factors|immunologic factors|mesh-ancestor
110811615|NCT04468958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110811616|NCT00708292|Dexamethasone|dexamethasone|mesh-list
110811617|NCT00708292|Bortezomib|bortezomib|mesh-list
110811618|NCT00708292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110811619|NCT00708292|Antiemetics|antiemetics|mesh-ancestor
110811620|NCT00708292|Autonomic Agents|autonomic agents|mesh-ancestor
110811621|NCT00708292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110811622|NCT00708292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110811623|NCT00708292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110811624|NCT00708292|Glucocorticoids|glucocorticoids|mesh-ancestor
110811625|NCT00708292|Hormones|hormones|mesh-ancestor
110811626|NCT00708292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110811627|NCT00708292|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110811628|NCT00708292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110811629|NCT00790660|Ipragliflozin|ipragliflozin|mesh-list
110811630|NCT00790660|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110811631|NCT00790660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110811632|NCT00790660|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110811633|NCT00790660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110811634|NCT01330082|Photosensitizing Agents|photosensitizing agents|mesh-list
110811635|NCT01330082|Dermatologic Agents|dermatologic agents|mesh-ancestor
110811636|NCT00835354|Cefprozil|cefprozil|mesh-list
110811637|NCT00835354|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110811638|NCT00835354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110811639|NCT00698230|Metformin|metformin|mesh-list
110811640|NCT00698230|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110811641|NCT00698230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110811642|NCT01330238|Zoledronic Acid|zoledronic acid|mesh-list
110811643|NCT01330238|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110811644|NCT01330238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110811645|NCT01330472|Alprazolam|alprazolam|mesh-list
110811646|NCT01330472|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110811647|NCT01330472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110811648|NCT01330472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110811649|NCT01330472|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110811650|NCT01330472|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110811651|NCT01330472|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110811652|NCT01330472|GABA Modulators|gaba modulators|mesh-ancestor
110811653|NCT01330472|GABA Agents|gaba agents|mesh-ancestor
110811654|NCT01330472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110811655|NCT01330472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110811656|NCT00835276|Fexofenadine|fexofenadine|mesh-list
110811657|NCT00835276|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110811658|NCT00835276|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110811659|NCT00835276|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110811660|NCT00835276|Histamine Antagonists|histamine antagonists|mesh-ancestor
110811661|NCT00835276|Histamine Agents|histamine agents|mesh-ancestor
110811662|NCT00835276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110811663|NCT00835276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110811664|NCT00835276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110811665|NCT03344536|Fulvestrant|fulvestrant|mesh-list
110811666|NCT03344536|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110811667|NCT03344536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110811668|NCT03344536|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110811669|NCT03344536|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110811670|NCT03344536|Hormone Antagonists|hormone antagonists|mesh-ancestor
110811671|NCT03344536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110811672|NCT03344536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110811673|NCT01759238|Bevacizumab|bevacizumab|mesh-list
110811674|NCT01759238|Capecitabine|capecitabine|mesh-list
110811675|NCT01759238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110811676|NCT01759238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110811677|NCT01759238|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110811678|NCT01759238|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110811679|NCT01759238|Growth Substances|growth substances|mesh-ancestor
110811680|NCT01759238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110811681|NCT01759238|Growth Inhibitors|growth inhibitors|mesh-ancestor
110811682|NCT01759238|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110811683|NCT01759238|Antimetabolites|antimetabolites|mesh-ancestor
110811684|NCT01759238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110811685|NCT00835042|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110811686|NCT00835042|Moexipril|moexipril|mesh-list
110811687|NCT00835042|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110811688|NCT00835042|Diuretics|diuretics|mesh-ancestor
110811689|NCT00835042|Natriuretic Agents|natriuretic agents|mesh-ancestor
110811690|NCT00835042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110811691|NCT00835042|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110811692|NCT00835042|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110811693|NCT00835042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110811694|NCT00835042|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110811695|NCT00835042|Protease Inhibitors|protease inhibitors|mesh-ancestor
110811696|NCT00835042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110811697|NCT00834964|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
110811698|NCT00834964|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110811699|NCT00834964|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110811700|NCT00834964|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110811701|NCT00834964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110811702|NCT00834964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110811703|NCT00834964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110811704|NCT00834964|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110811705|NCT00834964|Antidepressive Agents|antidepressive agents|mesh-ancestor
110811706|NCT00834964|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110811707|NCT03070522|Prednisone|prednisone|mesh-list
110811708|NCT03070522|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110811709|NCT03070522|Glucocorticoids|glucocorticoids|mesh-ancestor
110811710|NCT03070522|Hormones|hormones|mesh-ancestor
110863870|NCT04495283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110811711|NCT03070522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110811712|NCT03070522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110811713|NCT03070522|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110811714|NCT03070522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110811715|NCT00834574|Cefdinir|cefdinir|mesh-list
110811716|NCT00834574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110811717|NCT00834574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110811718|NCT04879966|Infliximab|infliximab|mesh-list
110811719|NCT04879966|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110811720|NCT04879966|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110811721|NCT04879966|Dermatologic Agents|dermatologic agents|mesh-ancestor
110811722|NCT04879966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110811723|NCT04879966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110811724|NCT00834418|Leflunomide|leflunomide|mesh-list
110811725|NCT00834418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110529296|NCT00910715|Doxycycline|doxycycline|mesh-list
110811726|NCT00834418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110811727|NCT00834418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110811728|NCT00834418|Immunologic Factors|immunologic factors|mesh-ancestor
110811729|NCT00834418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110811730|NCT04621318|Denosumab|denosumab|mesh-list
110811731|NCT04621318|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110811732|NCT04621318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110811733|NCT00834340|Glimepiride|glimepiride|mesh-list
110811734|NCT00834340|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110811735|NCT00834340|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110811736|NCT00834340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110811737|NCT00834340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110811738|NCT00834340|Immunologic Factors|immunologic factors|mesh-ancestor
110811739|NCT00683722|Remestemcel-l|remestemcel-l|mesh-list
110811740|NCT00683722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110811741|NCT00683722|Antiviral Agents|antiviral agents|mesh-ancestor
110811742|NCT00683722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110811743|NCT04473274|Pioglitazone|pioglitazone|mesh-list
110811744|NCT04473274|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110811745|NCT04473274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110811746|NCT00679588|Enoxaparin|enoxaparin|mesh-list
110811747|NCT00679588|Semuloparin|semuloparin|mesh-list
110811748|NCT00679588|Enoxaparin sodium|enoxaparin sodium|mesh-list
110811749|NCT00679588|Anticoagulants|anticoagulants|mesh-ancestor
110811750|NCT00679588|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110811751|NCT00679588|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110811752|NCT00679588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110811753|NCT00151996|Guanfacine|guanfacine|mesh-list
110811754|NCT00151996|Methylphenidate|methylphenidate|mesh-list
110811755|NCT00151996|Amphetamine|amphetamine|mesh-list
110811756|NCT00151996|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110811757|NCT00151996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110811758|NCT00151996|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110811759|NCT00151996|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110811760|NCT00151996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110863871|NCT04495283|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110811761|NCT00151996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110811762|NCT00151996|Dopamine Agents|dopamine agents|mesh-ancestor
110811763|NCT00151996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110811764|NCT00151996|Sympathomimetics|sympathomimetics|mesh-ancestor
110811765|NCT00151996|Autonomic Agents|autonomic agents|mesh-ancestor
110811766|NCT00151996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110811767|NCT00151996|Adrenergic Agents|adrenergic agents|mesh-ancestor
110811768|NCT00151996|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110811769|NCT00151996|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110811770|NCT00151996|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110811771|NCT00151996|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110811772|NCT00151996|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110811773|NCT00830206|Azithromycin|azithromycin|mesh-list
110811774|NCT00830206|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110811775|NCT00830206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110811776|NCT00829504|Ropinirole|ropinirole|mesh-list
110811777|NCT00829504|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110811778|NCT00829504|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110811779|NCT00829504|Dopamine Agonists|dopamine agonists|mesh-ancestor
110811780|NCT00829504|Dopamine Agents|dopamine agents|mesh-ancestor
110811781|NCT00829504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110811782|NCT00829504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110811783|NCT00829504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110811784|NCT00829426|Alprazolam|alprazolam|mesh-list
110811785|NCT00829426|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110811786|NCT00829426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110811787|NCT00829426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110811788|NCT00829426|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110811789|NCT00829426|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110811790|NCT00829426|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110811791|NCT00829426|GABA Modulators|gaba modulators|mesh-ancestor
110811792|NCT00829426|GABA Agents|gaba agents|mesh-ancestor
110811793|NCT00829426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110811794|NCT00829426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110811795|NCT00152464|Levocetirizine|levocetirizine|mesh-list
110811796|NCT00152464|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110811797|NCT00152464|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110811798|NCT00152464|Histamine Antagonists|histamine antagonists|mesh-ancestor
110416644|NCT01263509|Vitamins|vitamins|mesh-ancestor
110811799|NCT00152464|Histamine Agents|histamine agents|mesh-ancestor
110811800|NCT00152464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110529369|NCT03195374|Narcotics|narcotics|mesh-ancestor
110137025|NCT05967403|Propofol|propofol|mesh-list
110811801|NCT00152464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110811802|NCT00152464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110811803|NCT04472806|Endostar protein|endostar protein|mesh-list
110811804|NCT04472806|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110811805|NCT04472806|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110811806|NCT04472806|Growth Substances|growth substances|mesh-ancestor
110811807|NCT04472806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110811808|NCT04472806|Growth Inhibitors|growth inhibitors|mesh-ancestor
110811809|NCT04472806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110811810|NCT00674440|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
110811811|NCT00674440|Dopamine Agents|dopamine agents|mesh-ancestor
110811812|NCT00674440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110811813|NCT00674440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110811814|NCT00674440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110811815|NCT01858948|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110811816|NCT01858948|Antidepressive Agents|antidepressive agents|mesh-ancestor
110811817|NCT01858948|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110811818|NCT01858948|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110811819|NCT01858948|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110811820|NCT01858948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110811821|NCT01858948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110811822|NCT00770848|Prednisone|prednisone|mesh-list
110811823|NCT00770848|Mitoxantrone|mitoxantrone|mesh-list
110811824|NCT00770848|Rilotumumab|rilotumumab|mesh-list
110811825|NCT00770848|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110811826|NCT00770848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110811827|NCT00770848|Glucocorticoids|glucocorticoids|mesh-ancestor
110811828|NCT00770848|Hormones|hormones|mesh-ancestor
110811829|NCT00770848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110811830|NCT00770848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110811831|NCT00770848|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110811832|NCT00770848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110811833|NCT00770848|Analgesics|analgesics|mesh-ancestor
110811834|NCT00770848|Sensory System Agents|sensory system agents|mesh-ancestor
110811835|NCT00770848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110811836|NCT00770848|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110811837|NCT00770848|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110811838|NCT00770848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110811839|NCT00770848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110811840|NCT00770848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110811841|NCT00770848|Immunologic Factors|immunologic factors|mesh-ancestor
110811842|NCT00672412|Lamivudine|lamivudine|mesh-list
110811843|NCT00672412|Zidovudine|zidovudine|mesh-list
110811844|NCT00672412|Nevirapine|nevirapine|mesh-list
110811845|NCT00672412|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110416683|NCT04321655|Ibuprofen|ibuprofen|mesh-list
110811846|NCT00672412|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110811847|NCT00672412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110811848|NCT00672412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110811849|NCT00672412|Antiviral Agents|antiviral agents|mesh-ancestor
110811850|NCT00672412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110811851|NCT00672412|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110811852|NCT00672412|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110811853|NCT00672412|Antimetabolites|antimetabolites|mesh-ancestor
110811854|NCT00672412|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110811855|NCT00672412|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110811856|NCT01315262|Sildenafil Citrate|sildenafil citrate|mesh-list
110811857|NCT01315262|Vasodilator Agents|vasodilator agents|mesh-ancestor
110811858|NCT01315262|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110811859|NCT01315262|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110811861|NCT01315262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110811862|NCT01315262|Urological Agents|urological agents|mesh-ancestor
110811863|NCT03197324|Bexagliflozin|bexagliflozin|mesh-list
110811864|NCT03197324|Digoxin|digoxin|mesh-list
110811865|NCT03197324|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110811866|NCT03197324|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110811867|NCT03197324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110811868|NCT03197324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110811869|NCT03197324|Protective Agents|protective agents|mesh-ancestor
110811870|NCT03197324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110811871|NCT03197324|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110811872|NCT01330706|Polihexanide|polihexanide|mesh-list
110811873|NCT01330706|Disinfectants|disinfectants|mesh-ancestor
110811874|NCT01330706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110811876|NCT01156220|Diuretics|diuretics|mesh-ancestor
110811877|NCT01156220|Natriuretic Agents|natriuretic agents|mesh-ancestor
110811878|NCT01156220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110811879|NCT01156220|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110811880|NCT01156220|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110811881|NCT01156220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110811882|NCT03192488|Cetirizine|cetirizine|mesh-list
110811883|NCT03192488|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110811884|NCT03192488|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110811885|NCT03192488|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110811886|NCT03192488|Histamine Antagonists|histamine antagonists|mesh-ancestor
110811887|NCT03192488|Histamine Agents|histamine agents|mesh-ancestor
110811888|NCT03192488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110811889|NCT03192488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110811890|NCT03192488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110811891|NCT01642004|Docetaxel|docetaxel|mesh-list
110811892|NCT01642004|Nivolumab|nivolumab|mesh-list
110811893|NCT01642004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110811894|NCT01642004|Tubulin Modulators|tubulin modulators|mesh-ancestor
110811895|NCT01642004|Antimitotic Agents|antimitotic agents|mesh-ancestor
110811896|NCT01642004|Mitosis Modulators|mitosis modulators|mesh-ancestor
110811897|NCT01642004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110811898|NCT01642004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110416708|NCT01260311|Fesoterodine|fesoterodine|mesh-list
110811899|NCT01642004|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110811900|NCT03907826|Antibodies|antibodies|mesh-list
110811901|NCT03907826|Antibodies, Blocking|antibodies, blocking|mesh-list
110811902|NCT03907826|Immunologic Factors|immunologic factors|mesh-ancestor
110811903|NCT03907826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110811904|NCT00042289|Ritonavir|ritonavir|mesh-list
110811905|NCT00042289|Lopinavir|lopinavir|mesh-list
110811906|NCT00042289|Atazanavir Sulfate|atazanavir sulfate|mesh-list
110811907|NCT00042289|Darunavir|darunavir|mesh-list
110811908|NCT00042289|Nelfinavir|nelfinavir|mesh-list
110811909|NCT00042289|Indinavir|indinavir|mesh-list
110811910|NCT00042289|Fosamprenavir|fosamprenavir|mesh-list
110811911|NCT00042289|Amprenavir|amprenavir|mesh-list
110811912|NCT00042289|Tenofovir|tenofovir|mesh-list
110811913|NCT00042289|Emtricitabine|emtricitabine|mesh-list
110811914|NCT00042289|Raltegravir Potassium|raltegravir potassium|mesh-list
110811915|NCT00042289|Nevirapine|nevirapine|mesh-list
110811916|NCT00042289|Dolutegravir|dolutegravir|mesh-list
110811917|NCT00042289|Maraviroc|maraviroc|mesh-list
110811918|NCT00042289|Abacavir|abacavir|mesh-list
110811919|NCT00042289|Didanosine|didanosine|mesh-list
110811920|NCT00042289|Cobicistat|cobicistat|mesh-list
110811921|NCT00042289|Rilpivirine|rilpivirine|mesh-list
110811922|NCT00042289|Tipranavir|tipranavir|mesh-list
110811923|NCT00042289|Elvitegravir|elvitegravir|mesh-list
110811924|NCT00042289|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
110811925|NCT00042289|Moxifloxacin|moxifloxacin|mesh-list
110811926|NCT00042289|Efavirenz|efavirenz|mesh-list
110811927|NCT00042289|Rifampin|rifampin|mesh-list
110811928|NCT00042289|Isoniazid|isoniazid|mesh-list
110811929|NCT00042289|Linezolid|linezolid|mesh-list
110811930|NCT00042289|Cycloserine|cycloserine|mesh-list
110811931|NCT00042289|Amikacin|amikacin|mesh-list
110811932|NCT00042289|Pyrazinamide|pyrazinamide|mesh-list
110811933|NCT00042289|Ethambutol|ethambutol|mesh-list
110811934|NCT00042289|Bedaquiline|bedaquiline|mesh-list
110811935|NCT00042289|Etravirine|etravirine|mesh-list
110811936|NCT00042289|Clofazimine|clofazimine|mesh-list
110811937|NCT00042289|Ofloxacin|ofloxacin|mesh-list
110811938|NCT00042289|Aminosalicylic Acid|aminosalicylic acid|mesh-list
110811939|NCT00042289|Ethionamide|ethionamide|mesh-list
110811940|NCT00042289|Kanamycin|kanamycin|mesh-list
110811941|NCT00042289|Prothionamide|prothionamide|mesh-list
110811942|NCT00042289|Capreomycin|capreomycin|mesh-list
110811943|NCT00042289|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110811944|NCT00042289|Etonogestrel|etonogestrel|mesh-list
110811945|NCT00042289|Estradiol|estradiol|mesh-list
110811946|NCT00042289|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110811947|NCT00042289|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110811948|NCT00042289|Protease Inhibitors|protease inhibitors|mesh-ancestor
110811949|NCT00042289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110529521|NCT02733380|Hormones|hormones|mesh-ancestor
110863872|NCT03634020|Sirolimus|sirolimus|mesh-list
110811950|NCT00042289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110811951|NCT00042289|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110811952|NCT00042289|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110811953|NCT00042289|Antiviral Agents|antiviral agents|mesh-ancestor
110811954|NCT00042289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110811955|NCT00042289|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110811956|NCT00042289|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110811957|NCT00042289|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110811958|NCT00042289|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110811959|NCT00042289|Estrogens|estrogens|mesh-ancestor
110811960|NCT00042289|Hormones|hormones|mesh-ancestor
110811961|NCT00042289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110811962|NCT00042289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110811963|NCT00042289|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110811964|NCT00042289|Contraceptive Agents|contraceptive agents|mesh-ancestor
110811965|NCT00042289|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110811966|NCT00042289|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110811967|NCT00042289|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110811968|NCT00042289|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110811969|NCT00042289|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110811970|NCT00042289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110811971|NCT00042289|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110811972|NCT00042289|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110811973|NCT00042289|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110811974|NCT00042289|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110811975|NCT00042289|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110811976|NCT00042289|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110811977|NCT00042289|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110811978|NCT00042289|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110811979|NCT00042289|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110811980|NCT00042289|Antitubercular Agents|antitubercular agents|mesh-ancestor
110811981|NCT00042289|Leprostatic Agents|leprostatic agents|mesh-ancestor
110811982|NCT00042289|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110811983|NCT00042289|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110811984|NCT00042289|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110811985|NCT00042289|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110811986|NCT00042289|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
110811987|NCT00042289|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110811988|NCT00042289|Antimetabolites|antimetabolites|mesh-ancestor
110811989|NCT00042289|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110811990|NCT00042289|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110811991|NCT00042289|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110811992|NCT00042289|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
110811993|NCT00042289|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110811994|NCT00042289|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110811995|NCT00042289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110811996|NCT00042289|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110811997|NCT00039871|Ribavirin|ribavirin|mesh-list
110811998|NCT00039871|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110811999|NCT00039871|Interferon-alpha|interferon-alpha|mesh-list
110812000|NCT00039871|Antimetabolites|antimetabolites|mesh-ancestor
110812001|NCT00039871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110812002|NCT00039871|Antiviral Agents|antiviral agents|mesh-ancestor
110812003|NCT00039871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110812004|NCT00039871|Immunologic Factors|immunologic factors|mesh-ancestor
110812005|NCT00039871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110812006|NCT01096693|Substance P|substance p|mesh-list
110812007|NCT01096693|Neurokinin A|neurokinin a|mesh-list
110812008|NCT01096693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110812009|NCT01096693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110812010|NCT01096693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110812011|NCT00015457|Amlodipine|amlodipine|mesh-list
110812012|NCT00015457|Botulinum Toxins|botulinum toxins|mesh-list
110812013|NCT00015457|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110812014|NCT00015457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110812015|NCT00015457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110812016|NCT00015457|Cholinergic Agents|cholinergic agents|mesh-ancestor
110812017|NCT00015457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110812018|NCT00015457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110812019|NCT00015457|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110812020|NCT00015457|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110812021|NCT00015457|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110812022|NCT00015457|Vasodilator Agents|vasodilator agents|mesh-ancestor
110812023|NCT03564470|Dasatinib|dasatinib|mesh-list
110812024|NCT03564470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110812025|NCT03564470|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110812026|NCT03564470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110812027|NCT03564470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110812028|NCT03191396|Liraglutide|liraglutide|mesh-list
110812030|NCT03191396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110812031|NCT03191396|Incretins|incretins|mesh-ancestor
110812032|NCT03191396|Hormones|hormones|mesh-ancestor
110812033|NCT03191396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110812034|NCT03509636|Fluzoparib|fluzoparib|mesh-list
110812035|NCT03509636|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110812036|NCT03509636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110812037|NCT03509636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110812038|NCT03509636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110812039|NCT01333670|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110812040|NCT00007345|Romidepsin|romidepsin|mesh-list
110812041|NCT00007345|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110812042|NCT00007345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110812043|NCT00007345|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110812044|NCT00007345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110812045|NCT00007345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110812046|NCT01584271|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110812047|NCT01584271|Carbamide Peroxide|carbamide peroxide|mesh-list
110812048|NCT01584271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110812049|NCT01584271|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110812050|NCT00031447|Acyclovir|acyclovir|mesh-list
110812051|NCT00031447|Antiviral Agents|antiviral agents|mesh-ancestor
110812052|NCT00031447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110812053|NCT00006289|Neurotropin|neurotropin|mesh-list
110812054|NCT00006289|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110812055|NCT00006289|Immunologic Factors|immunologic factors|mesh-ancestor
110812056|NCT00006289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110812057|NCT00006289|Analgesics|analgesics|mesh-ancestor
110812058|NCT00006289|Sensory System Agents|sensory system agents|mesh-ancestor
110812059|NCT00006289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110812060|NCT00006289|Anticonvulsants|anticonvulsants|mesh-ancestor
110812061|NCT05625841|Propolis|propolis|mesh-list
110812062|NCT05625841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110812063|NCT01103401|Tobramycin|tobramycin|mesh-list
110812064|NCT01103401|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
110812065|NCT01103401|Dexamethasone|dexamethasone|mesh-list
110812066|NCT01103401|Dexamethasone acetate|dexamethasone acetate|mesh-list
110812067|NCT01103401|Ketorolac|ketorolac|mesh-list
110812068|NCT01103401|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
110812069|NCT01103401|BB 1101|bb 1101|mesh-list
110812070|NCT01103401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110812071|NCT01103401|Antiemetics|antiemetics|mesh-ancestor
110812072|NCT01103401|Autonomic Agents|autonomic agents|mesh-ancestor
110812073|NCT01103401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110812074|NCT01103401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110812075|NCT01103401|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110812076|NCT01103401|Glucocorticoids|glucocorticoids|mesh-ancestor
110812078|NCT01103401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110812079|NCT01103401|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110812080|NCT01103401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110812081|NCT01103401|Protease Inhibitors|protease inhibitors|mesh-ancestor
110812082|NCT01103401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110812083|NCT01103401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110812084|NCT01103401|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110812085|NCT01103401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110812086|NCT01103401|Analgesics|analgesics|mesh-ancestor
110812087|NCT01103401|Sensory System Agents|sensory system agents|mesh-ancestor
110812088|NCT01103401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110812089|NCT01103401|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110812090|NCT01103401|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110812091|NCT01103401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110812092|NCT01103401|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110812093|NCT01103401|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110812094|NCT00005047|Doxorubicin|doxorubicin|mesh-list
110812095|NCT00005047|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110812096|NCT00005047|Methotrexate|methotrexate|mesh-list
110812097|NCT00005047|Vinblastine|vinblastine|mesh-list
110812098|NCT00005047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110812099|NCT00005047|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110812100|NCT00005047|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110812101|NCT00005047|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110812102|NCT00005047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110812103|NCT00005047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110137296|NCT05834777|Icatibant|icatibant|mesh-list
110812104|NCT00005047|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110812105|NCT00005047|Abortifacient Agents|abortifacient agents|mesh-ancestor
110812106|NCT00005047|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110812107|NCT00005047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110812108|NCT00005047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110812109|NCT00005047|Antimetabolites|antimetabolites|mesh-ancestor
110812110|NCT00005047|Dermatologic Agents|dermatologic agents|mesh-ancestor
110812111|NCT00005047|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110812112|NCT00005047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110812113|NCT00005047|Immunologic Factors|immunologic factors|mesh-ancestor
110812114|NCT00005047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110812115|NCT00005047|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110812116|NCT00005047|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110812117|NCT00005047|Tubulin Modulators|tubulin modulators|mesh-ancestor
110812118|NCT00005047|Antimitotic Agents|antimitotic agents|mesh-ancestor
110812119|NCT00005047|Mitosis Modulators|mitosis modulators|mesh-ancestor
110812120|NCT01103635|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110812121|NCT01103635|Ipilimumab|ipilimumab|mesh-list
110812122|NCT01103635|Tremelimumab|tremelimumab|mesh-list
110812123|NCT01103635|Antibodies|antibodies|mesh-list
110812124|NCT01103635|Immunoglobulins|immunoglobulins|mesh-list
110812125|NCT01103635|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110812126|NCT01103635|Immunologic Factors|immunologic factors|mesh-ancestor
110416846|NCT01258595|Vaccines|vaccines|mesh-list
110812127|NCT01103635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110812128|NCT01103635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110812129|NCT01103635|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110812130|NCT01103635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110812131|NCT03949075|Enalapril|enalapril|mesh-list
110812132|NCT03949075|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110812133|NCT03949075|Protease Inhibitors|protease inhibitors|mesh-ancestor
110812134|NCT03949075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110812135|NCT03949075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110812136|NCT03949075|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110812137|NCT01101529|Aprepitant|aprepitant|mesh-list
110812138|NCT01101529|Antiemetics|antiemetics|mesh-ancestor
110812139|NCT01101529|Autonomic Agents|autonomic agents|mesh-ancestor
110812140|NCT01101529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110812141|NCT01101529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110812142|NCT01101529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110812143|NCT01101529|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110812144|NCT01101529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110812145|NCT01101529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110812146|NCT01100125|Insulin|insulin|mesh-list
110812147|NCT01100125|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110812148|NCT01100125|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110812149|NCT01100125|Insulin, Long-Acting|insulin, long-acting|mesh-list
110812150|NCT01100125|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110812151|NCT01100125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110812152|NCT01100125|Incretins|incretins|mesh-ancestor
110812153|NCT01100125|Hormones|hormones|mesh-ancestor
110812154|NCT01100125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110416876|NCT04311645|Charcoal|charcoal|mesh-list
110812155|NCT01100125|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110812156|NCT01100125|Protease Inhibitors|protease inhibitors|mesh-ancestor
110812157|NCT01100125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110812158|NCT01100125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110812159|NCT01100203|Eplerenone|eplerenone|mesh-list
110812160|NCT01100203|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110812161|NCT01100203|Hormone Antagonists|hormone antagonists|mesh-ancestor
110812162|NCT01100203|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110812163|NCT01100203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110812164|NCT01100203|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110812165|NCT01100203|Diuretics|diuretics|mesh-ancestor
110812166|NCT01100203|Natriuretic Agents|natriuretic agents|mesh-ancestor
110812167|NCT01100203|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110812168|NCT03948685|Carvedilol|carvedilol|mesh-list
110812169|NCT03948685|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110812170|NCT03948685|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110812171|NCT03948685|Adrenergic Agents|adrenergic agents|mesh-ancestor
110812172|NCT03948685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110812173|NCT03948685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110812174|NCT03948685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110812175|NCT03948685|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110812176|NCT03948685|Antioxidants|antioxidants|mesh-ancestor
110812177|NCT03948685|Protective Agents|protective agents|mesh-ancestor
110812178|NCT03948685|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110812179|NCT03948685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110529761|NCT02726126|Fentanyl|fentanyl|mesh-list
110812180|NCT03948685|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110812181|NCT03948685|Vasodilator Agents|vasodilator agents|mesh-ancestor
110812182|NCT03948685|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110812183|NCT03948685|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110812184|NCT01585051|Vitamin D|vitamin d|mesh-list
110812185|NCT01585051|Vitamins|vitamins|mesh-ancestor
110812186|NCT01585051|Micronutrients|micronutrients|mesh-ancestor
110812187|NCT01585051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110812188|NCT01585051|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110812189|NCT01103791|Docetaxel|docetaxel|mesh-list
110812190|NCT01103791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110812191|NCT01103791|Tubulin Modulators|tubulin modulators|mesh-ancestor
110812192|NCT01103791|Antimitotic Agents|antimitotic agents|mesh-ancestor
110812193|NCT01103791|Mitosis Modulators|mitosis modulators|mesh-ancestor
110812194|NCT01103791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110812195|NCT03800173|Galidesivir|galidesivir|mesh-list
110812196|NCT03800173|Antiviral Agents|antiviral agents|mesh-ancestor
110812197|NCT03800173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110812198|NCT00003631|Cytarabine|cytarabine|mesh-list
110812199|NCT00003631|Cyclophosphamide|cyclophosphamide|mesh-list
110812200|NCT00003631|Melphalan|melphalan|mesh-list
110812201|NCT00003631|Ifosfamide|ifosfamide|mesh-list
110812202|NCT00003631|Carmustine|carmustine|mesh-list
110812203|NCT00003631|Carboplatin|carboplatin|mesh-list
110812204|NCT00003631|Etoposide|etoposide|mesh-list
110812205|NCT00003631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110812206|NCT00003631|Immunologic Factors|immunologic factors|mesh-ancestor
110812207|NCT00003631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110812208|NCT00003631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110812209|NCT00003631|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110812210|NCT00003631|Alkylating Agents|alkylating agents|mesh-ancestor
110812211|NCT00003631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110812212|NCT00003631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110812213|NCT00003631|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110812214|NCT00003631|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110853669|NCT02488564|Metformin|metformin|mesh-list
110812215|NCT00003631|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110812216|NCT00003631|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110812217|NCT00003631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110812218|NCT00003631|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110812219|NCT00003631|Antimetabolites|antimetabolites|mesh-ancestor
110812220|NCT00003631|Antiviral Agents|antiviral agents|mesh-ancestor
110812221|NCT00003631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110812222|NCT01101685|Escitalopram|escitalopram|mesh-list
110812223|NCT01101685|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110812224|NCT01101685|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110812225|NCT01101685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110812226|NCT01101685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110812227|NCT01101685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110812228|NCT01101685|Serotonin Agents|serotonin agents|mesh-ancestor
110812229|NCT01101685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110812230|NCT00030901|Selenium|selenium|mesh-list
110812231|NCT00030901|Antioxidants|antioxidants|mesh-ancestor
110812232|NCT00030901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110812233|NCT00030901|Protective Agents|protective agents|mesh-ancestor
110812234|NCT00030901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110812235|NCT00030901|Trace Elements|trace elements|mesh-ancestor
110812236|NCT00030901|Micronutrients|micronutrients|mesh-ancestor
110812237|NCT01104259|Vinorelbine|vinorelbine|mesh-list
110812238|NCT01104259|Veliparib|veliparib|mesh-list
110812239|NCT01104259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110812240|NCT01104259|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110812241|NCT01104259|Tubulin Modulators|tubulin modulators|mesh-ancestor
110812242|NCT01104259|Antimitotic Agents|antimitotic agents|mesh-ancestor
110812243|NCT01104259|Mitosis Modulators|mitosis modulators|mesh-ancestor
110812244|NCT01104259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110812245|NCT01104259|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110812246|NCT01104259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110812247|NCT01104337|Acetaminophen|acetaminophen|mesh-list
110812248|NCT01104337|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110812249|NCT01104337|Analgesics|analgesics|mesh-ancestor
110812250|NCT01104337|Sensory System Agents|sensory system agents|mesh-ancestor
110812251|NCT01104337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110812252|NCT01104337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110529824|NCT02716142|Oxytocics|oxytocics|mesh-ancestor
110812254|NCT01100359|Carboplatin|carboplatin|mesh-list
110812255|NCT01100359|Doxorubicin|doxorubicin|mesh-list
110812257|NCT01100359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110812258|NCT01100359|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110812259|NCT01100359|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110812260|NCT01100359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110812261|NCT01100359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110812262|NCT01100359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110812263|NCT00003199|Tamoxifen|tamoxifen|mesh-list
110812264|NCT00003199|Aldesleukin|aldesleukin|mesh-list
110812265|NCT00003199|Melphalan|melphalan|mesh-list
110812266|NCT00003199|Busulfan|busulfan|mesh-list
110812267|NCT00003199|Thiotepa|thiotepa|mesh-list
110812268|NCT00003199|Interleukin-2|interleukin-2|mesh-list
110812269|NCT00003199|Sargramostim|sargramostim|mesh-list
110812270|NCT00003199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110416931|NCT02869672|Vaccines|vaccines|mesh-list
110812271|NCT00003199|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110812272|NCT00003199|Alkylating Agents|alkylating agents|mesh-ancestor
110812273|NCT00003199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110812274|NCT00003199|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110812275|NCT00003199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110812276|NCT00003199|Immunologic Factors|immunologic factors|mesh-ancestor
110812277|NCT00003199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110812278|NCT00003199|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110812279|NCT00003199|Analgesics|analgesics|mesh-ancestor
110812280|NCT00003199|Sensory System Agents|sensory system agents|mesh-ancestor
110812281|NCT00003199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110812282|NCT00003199|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110812283|NCT00003199|Hormone Antagonists|hormone antagonists|mesh-ancestor
110812284|NCT00003199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110812285|NCT00003199|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110812286|NCT00003199|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110812287|NCT00003199|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110853672|NCT02488564|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110812288|NCT00003199|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110812289|NCT00003199|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110812290|NCT00003199|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110812291|NCT00003199|Antiviral Agents|antiviral agents|mesh-ancestor
110812292|NCT00003199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110812293|NCT01327261|Levodopa|levodopa|mesh-list
110812294|NCT01327261|Benserazide|benserazide|mesh-list
110812295|NCT01327261|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110812296|NCT01327261|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110812297|NCT01327261|Dopamine Agents|dopamine agents|mesh-ancestor
110812298|NCT01327261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110812299|NCT01327261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110812300|NCT01327261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110812301|NCT01327261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110812302|NCT01101919|Tofacitinib|tofacitinib|mesh-list
110812303|NCT01101919|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
110812304|NCT01101919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110812305|NCT01101919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110812306|NCT01101919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110812307|NCT03951415|Durvalumab|durvalumab|mesh-list
110812308|NCT03951415|Olaparib|olaparib|mesh-list
110812309|NCT03951415|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
110812310|NCT03951415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110812311|NCT03951415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110812312|NCT03951415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110812313|NCT03951415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110812314|NCT00001849|Edetic Acid|edetic acid|mesh-list
110812315|NCT00001849|Pentetic Acid|pentetic acid|mesh-list
110812316|NCT00001849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110812317|NCT00001849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110812318|NCT00001849|Antidotes|antidotes|mesh-ancestor
110812319|NCT00001849|Protective Agents|protective agents|mesh-ancestor
110812320|NCT00001849|Chelating Agents|chelating agents|mesh-ancestor
110812321|NCT00001849|Sequestering Agents|sequestering agents|mesh-ancestor
110812322|NCT00001849|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110812323|NCT00001849|Anticoagulants|anticoagulants|mesh-ancestor
110812324|NCT00001849|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110812325|NCT01104571|Trastuzumab|trastuzumab|mesh-list
110812326|NCT01104571|Lapatinib|lapatinib|mesh-list
110812327|NCT01104571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110812328|NCT01104571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110812329|NCT01104571|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110812331|NCT01104571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110812332|NCT01104649|Riluzole|riluzole|mesh-list
110812333|NCT01104649|Anticonvulsants|anticonvulsants|mesh-ancestor
110812334|NCT01104649|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110812335|NCT01104649|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110812336|NCT01104649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110812337|NCT01104649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110812338|NCT01104649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110812339|NCT01104649|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110812340|NCT01104649|Protective Agents|protective agents|mesh-ancestor
110812341|NCT01327729|Interferons|interferons|mesh-list
110812342|NCT01327729|Interferon-alpha|interferon-alpha|mesh-list
110812343|NCT01327729|Interferon alpha-2|interferon alpha-2|mesh-list
110812344|NCT01327729|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110812345|NCT01327729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110812346|NCT01327729|Antiviral Agents|antiviral agents|mesh-ancestor
110812347|NCT01327729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110812348|NCT01327729|Immunologic Factors|immunologic factors|mesh-ancestor
110812349|NCT01327729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110812350|NCT01342952|Ambrisentan|ambrisentan|mesh-list
110812351|NCT01342952|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110812352|NCT01104883|Iodine|iodine|mesh-list
110812353|NCT01104883|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110812354|NCT01104883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110812355|NCT01104883|Trace Elements|trace elements|mesh-ancestor
110812356|NCT01104883|Micronutrients|micronutrients|mesh-ancestor
110812357|NCT01104883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110812358|NCT01104961|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110812359|NCT04371380|Rilpivirine|rilpivirine|mesh-list
110812360|NCT04371380|Cabotegravir|cabotegravir|mesh-list
110812361|NCT04371380|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110812362|NCT04371380|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110812363|NCT04371380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110812364|NCT04371380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110812365|NCT04371380|Antiviral Agents|antiviral agents|mesh-ancestor
110812366|NCT04371380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110812367|NCT04371380|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110812368|NCT04371380|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110812369|NCT04371380|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110812370|NCT04371380|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110812371|NCT01341080|Varenicline|varenicline|mesh-list
110812372|NCT01341080|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110812373|NCT01341080|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110812374|NCT01341080|Cholinergic Agents|cholinergic agents|mesh-ancestor
110812375|NCT01341080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110812376|NCT01341080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110812377|NCT01341080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110812378|NCT01333982|Amoxicillin|amoxicillin|mesh-list
110812379|NCT01333982|Gentamicins|gentamicins|mesh-list
110812380|NCT01333982|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110812381|NCT01333982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110812382|NCT01333982|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110812383|NCT01333982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110812384|NCT01333982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110812385|NCT01334060|Vaccines|vaccines|mesh-list
110812386|NCT01334060|Immunologic Factors|immunologic factors|mesh-ancestor
110812387|NCT01334060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110812388|NCT04130828|Ferrous fumarate|ferrous fumarate|mesh-list
110812389|NCT04130828|Trace Elements|trace elements|mesh-ancestor
110812390|NCT04130828|Micronutrients|micronutrients|mesh-ancestor
110812391|NCT04130828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110812392|NCT01332344|Fluticasone|fluticasone|mesh-list
110812393|NCT01332344|Xhance|xhance|mesh-list
110812394|NCT01332344|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110812395|NCT01332344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110812396|NCT01332344|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110812397|NCT01332344|Autonomic Agents|autonomic agents|mesh-ancestor
110812398|NCT01332344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110812399|NCT01332344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110812400|NCT01332344|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110812401|NCT01332344|Respiratory System Agents|respiratory system agents|mesh-ancestor
110812402|NCT01332344|Dermatologic Agents|dermatologic agents|mesh-ancestor
110812403|NCT01332344|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110812404|NCT01332344|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110812405|NCT01332344|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110812406|NCT01332344|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110812407|NCT01332344|Adrenergic Agents|adrenergic agents|mesh-ancestor
110812408|NCT01332344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110812409|NCT01332344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110812410|NCT01332422|Fluticasone|fluticasone|mesh-list
110812411|NCT01332422|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110812412|NCT01332422|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
110812413|NCT01332422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110812414|NCT01332422|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110812415|NCT01332422|Autonomic Agents|autonomic agents|mesh-ancestor
110812416|NCT01332422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110812417|NCT01332422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110812418|NCT01332422|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110812419|NCT01332422|Respiratory System Agents|respiratory system agents|mesh-ancestor
110812420|NCT01332422|Dermatologic Agents|dermatologic agents|mesh-ancestor
110812421|NCT01332422|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110812422|NCT01332422|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110812423|NCT01332422|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110812424|NCT01332422|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110812425|NCT01332422|Adrenergic Agents|adrenergic agents|mesh-ancestor
110812426|NCT01332422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110812427|NCT01332422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110812428|NCT01332422|Glucocorticoids|glucocorticoids|mesh-ancestor
110812429|NCT01332422|Hormones|hormones|mesh-ancestor
110812430|NCT01332422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110812431|NCT01332422|Sympathomimetics|sympathomimetics|mesh-ancestor
110812432|NCT03162224|Durvalumab|durvalumab|mesh-list
110812433|NCT03162224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110812434|NCT03162224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110812435|NCT00904046|Pioglitazone|pioglitazone|mesh-list
110812436|NCT00904046|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
110812437|NCT00904046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110812438|NCT00904046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110812439|NCT01332734|Magnesium Sulfate|magnesium sulfate|mesh-list
110812440|NCT01332734|Analgesics|analgesics|mesh-ancestor
110812441|NCT01332734|Sensory System Agents|sensory system agents|mesh-ancestor
110416994|NCT01256411|Vasodilator Agents|vasodilator agents|mesh-ancestor
110812442|NCT01332734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110812443|NCT01332734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110812444|NCT01332734|Anesthetics|anesthetics|mesh-ancestor
110812445|NCT01332734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110812446|NCT01332734|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110812447|NCT01332734|Anticonvulsants|anticonvulsants|mesh-ancestor
110812448|NCT01332734|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110812449|NCT01332734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110812450|NCT01332734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110812451|NCT01332734|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110812452|NCT01332734|Tocolytic Agents|tocolytic agents|mesh-ancestor
110812453|NCT01332734|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110812454|NCT03326492|Antivenins|antivenins|mesh-list
110812455|NCT03326492|Immunologic Factors|immunologic factors|mesh-ancestor
110812456|NCT03326492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110812457|NCT01524536|Prednisone|prednisone|mesh-list
110812458|NCT01524536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110812459|NCT01524536|Glucocorticoids|glucocorticoids|mesh-ancestor
110812460|NCT01524536|Hormones|hormones|mesh-ancestor
110812461|NCT01524536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110812462|NCT01524536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110812463|NCT01524536|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110812464|NCT01524536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110812465|NCT00533468|Lidocaine|lidocaine|mesh-list
110812466|NCT00533468|Anesthetics, Local|anesthetics, local|mesh-ancestor
110812467|NCT00533468|Anesthetics|anesthetics|mesh-ancestor
110812468|NCT00533468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110812469|NCT00533468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110812470|NCT00533468|Sensory System Agents|sensory system agents|mesh-ancestor
110812471|NCT00533468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110812472|NCT00533468|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110812473|NCT00533468|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110812474|NCT00533468|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110812475|NCT00533468|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110812476|NCT00533468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110812478|NCT01333124|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110812479|NCT01333124|Antimetabolites|antimetabolites|mesh-ancestor
110812480|NCT01333124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110812481|NCT01333124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110812482|NCT03035630|Sunitinib|sunitinib|mesh-list
110812483|NCT03035630|Avelumab|avelumab|mesh-list
110812484|NCT03035630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110812485|NCT03035630|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110812486|NCT03035630|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110812487|NCT03035630|Growth Substances|growth substances|mesh-ancestor
110812488|NCT03035630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110812489|NCT03035630|Growth Inhibitors|growth inhibitors|mesh-ancestor
110812490|NCT03035630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110812491|NCT03035630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110812492|NCT03035630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110812493|NCT03035630|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110812494|NCT00004124|Prednisone|prednisone|mesh-list
110812495|NCT00004124|Goserelin|goserelin|mesh-list
110812496|NCT00004124|Mitoxantrone|mitoxantrone|mesh-list
110812497|NCT00004124|Bicalutamide|bicalutamide|mesh-list
110812498|NCT00004124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110812499|NCT00004124|Glucocorticoids|glucocorticoids|mesh-ancestor
110812500|NCT00004124|Hormones|hormones|mesh-ancestor
110853686|NCT02966873|Acetylcysteine|acetylcysteine|mesh-list
110812501|NCT00004124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110812502|NCT00004124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110812503|NCT00004124|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110416999|NCT00996580|Levonorgestrel|levonorgestrel|mesh-list
110812504|NCT00004124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110812505|NCT00004124|Analgesics|analgesics|mesh-ancestor
110812506|NCT00004124|Sensory System Agents|sensory system agents|mesh-ancestor
110812507|NCT00004124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110812508|NCT00004124|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110812509|NCT00004124|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110812510|NCT00004124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110812511|NCT00004124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110812512|NCT00004124|Androgen Antagonists|androgen antagonists|mesh-ancestor
110812513|NCT00004124|Hormone Antagonists|hormone antagonists|mesh-ancestor
110812514|NCT01333358|Alemtuzumab|alemtuzumab|mesh-list
110812515|NCT01333358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110812516|NCT01333358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110812517|NCT01334684|Metformin|metformin|mesh-list
110812518|NCT01334684|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110812519|NCT01334684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110812520|NCT01334762|Letrozole|letrozole|mesh-list
110812521|NCT01334762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110812522|NCT01334762|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110812523|NCT01334762|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110812524|NCT01334762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110812525|NCT01334762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110812526|NCT01334762|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110812527|NCT01334762|Hormone Antagonists|hormone antagonists|mesh-ancestor
110812528|NCT01334762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110812529|NCT01334762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110812530|NCT00383552|Mometasone Furoate|mometasone furoate|mesh-list
110812531|NCT00383552|Formoterol Fumarate|formoterol fumarate|mesh-list
110812532|NCT00383552|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110812533|NCT00383552|Autonomic Agents|autonomic agents|mesh-ancestor
110812534|NCT00383552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110812535|NCT00383552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110812536|NCT00383552|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110812537|NCT00383552|Respiratory System Agents|respiratory system agents|mesh-ancestor
110812538|NCT00383552|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110812539|NCT00383552|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110812540|NCT00383552|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110812541|NCT00383552|Adrenergic Agents|adrenergic agents|mesh-ancestor
110812542|NCT00383552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110812543|NCT00383552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110812544|NCT00383552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110812545|NCT00383552|Dermatologic Agents|dermatologic agents|mesh-ancestor
110812546|NCT00383552|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110812547|NCT01335074|Sirolimus|sirolimus|mesh-list
110812548|NCT01335074|Sorafenib|sorafenib|mesh-list
110812549|NCT01335074|Temsirolimus|temsirolimus|mesh-list
110812550|NCT01335074|MTOR Inhibitors|mtor inhibitors|mesh-list
110812551|NCT01335074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110812552|NCT01335074|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110812553|NCT01335074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110812554|NCT01335074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110812555|NCT01335074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110812557|NCT01335074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110812558|NCT01335074|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110812559|NCT01335074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110812560|NCT01335074|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110812561|NCT01335074|Antifungal Agents|antifungal agents|mesh-ancestor
110812562|NCT01337492|Sorafenib|sorafenib|mesh-list
110812563|NCT01337492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110812564|NCT01337492|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110812565|NCT01337492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110812566|NCT01337492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110812567|NCT01337570|Dapivirine|dapivirine|mesh-list
110812568|NCT01337570|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110812569|NCT01337570|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110812570|NCT01337570|Antiviral Agents|antiviral agents|mesh-ancestor
110812571|NCT01337570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110812573|NCT01337804|Omeprazole, sodium bicarbonate drug combination|omeprazole, sodium bicarbonate drug combination|mesh-list
110812574|NCT01337804|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110812575|NCT01337804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110812576|NCT01337804|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110812577|NCT01337804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110812578|NCT01337804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110812579|NCT01776424|Aspirin|aspirin|mesh-list
110812580|NCT01776424|Pantoprazole|pantoprazole|mesh-list
110812581|NCT01776424|Rivaroxaban|rivaroxaban|mesh-list
110812582|NCT01776424|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110812583|NCT01776424|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110812584|NCT01776424|Analgesics|analgesics|mesh-ancestor
110812585|NCT01776424|Sensory System Agents|sensory system agents|mesh-ancestor
110812586|NCT01776424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110812587|NCT01776424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110812588|NCT01776424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110812589|NCT01776424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110812590|NCT01776424|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110812591|NCT01776424|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110812592|NCT01776424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110812593|NCT01776424|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110812594|NCT01776424|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110812595|NCT01776424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110812596|NCT01776424|Antipyretics|antipyretics|mesh-ancestor
110812597|NCT01776424|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110812598|NCT01776424|Antithrombins|antithrombins|mesh-ancestor
110812599|NCT01776424|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110812600|NCT01776424|Protease Inhibitors|protease inhibitors|mesh-ancestor
110812601|NCT01776424|Anticoagulants|anticoagulants|mesh-ancestor
110812602|NCT01776424|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110812603|NCT01776424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110812604|NCT01776424|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110812605|NCT00642148|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
110812606|NCT00642148|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110812607|NCT00642148|Autonomic Agents|autonomic agents|mesh-ancestor
110812608|NCT00642148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110812609|NCT00642148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110812610|NCT00642148|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110812611|NCT00642148|Respiratory System Agents|respiratory system agents|mesh-ancestor
110812612|NCT00642148|Glucocorticoids|glucocorticoids|mesh-ancestor
110812613|NCT00642148|Hormones|hormones|mesh-ancestor
110812614|NCT00642148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110812615|NCT00642148|Sympathomimetics|sympathomimetics|mesh-ancestor
110812616|NCT00629980|Azithromycin|azithromycin|mesh-list
110812617|NCT00629980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110812618|NCT00629980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110812619|NCT00629590|Azithromycin|azithromycin|mesh-list
110812620|NCT00629590|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110812621|NCT00629590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110812622|NCT00626704|Doxorubicin|doxorubicin|mesh-list
110812623|NCT00626704|Conatumumab|conatumumab|mesh-list
110812624|NCT00626704|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110812625|NCT00626704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110812626|NCT00626704|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110530194|NCT00650793|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110812627|NCT00626704|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110812628|NCT00626704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110812629|NCT00626704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110812630|NCT00626704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110812631|NCT00765700|Ketoprofen|ketoprofen|mesh-list
110812632|NCT00765700|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110812633|NCT00765700|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110812634|NCT00765700|Analgesics|analgesics|mesh-ancestor
110812635|NCT00765700|Sensory System Agents|sensory system agents|mesh-ancestor
110812636|NCT00765700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110812637|NCT00765700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110812638|NCT00765700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110812639|NCT00765700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110812640|NCT00765700|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110812641|NCT00765700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110812642|NCT00765700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110812643|NCT02280694|Celecoxib|celecoxib|mesh-list
110812644|NCT02280694|Cyclophosphamide|cyclophosphamide|mesh-list
110812645|NCT02280694|Capecitabine|capecitabine|mesh-list
110812646|NCT02280694|Methotrexate|methotrexate|mesh-list
110812647|NCT02280694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110812648|NCT02280694|Immunologic Factors|immunologic factors|mesh-ancestor
110812649|NCT02280694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110812650|NCT02280694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110812651|NCT02280694|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110812652|NCT02280694|Alkylating Agents|alkylating agents|mesh-ancestor
110812653|NCT02280694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110812654|NCT02280694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110812655|NCT02280694|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110812656|NCT02280694|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110812657|NCT02280694|Antimetabolites|antimetabolites|mesh-ancestor
110812658|NCT02280694|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110812659|NCT02280694|Abortifacient Agents|abortifacient agents|mesh-ancestor
110812660|NCT02280694|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110812661|NCT02280694|Dermatologic Agents|dermatologic agents|mesh-ancestor
110812662|NCT02280694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110812663|NCT02280694|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110812664|NCT02280694|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110812665|NCT02280694|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110812666|NCT02280694|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110812667|NCT02280694|Analgesics|analgesics|mesh-ancestor
110812668|NCT02280694|Sensory System Agents|sensory system agents|mesh-ancestor
110812669|NCT02280694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110812670|NCT02280694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110812671|NCT02280694|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110812672|NCT02280694|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110812673|NCT02280772|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
110812674|NCT02280772|Cathartics|cathartics|mesh-ancestor
110812675|NCT02280772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110812676|NCT02280850|Nitroglycerin|nitroglycerin|mesh-list
110812677|NCT02280850|Vasodilator Agents|vasodilator agents|mesh-ancestor
110812678|NCT02281006|Sodium thiosulfate|sodium thiosulfate|mesh-list
110812679|NCT02281006|Antidotes|antidotes|mesh-ancestor
110812680|NCT02281006|Protective Agents|protective agents|mesh-ancestor
110812681|NCT02281006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110812682|NCT02281006|Antioxidants|antioxidants|mesh-ancestor
110812683|NCT02281006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110812684|NCT02281006|Antitubercular Agents|antitubercular agents|mesh-ancestor
110812685|NCT02281006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110812686|NCT02281006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110812687|NCT02281006|Chelating Agents|chelating agents|mesh-ancestor
110812688|NCT02281006|Sequestering Agents|sequestering agents|mesh-ancestor
110812689|NCT00758290|Triclosan|triclosan|mesh-list
110812690|NCT00758290|Fluorides|fluorides|mesh-list
110812691|NCT00758290|Cariostatic Agents|cariostatic agents|mesh-ancestor
110812692|NCT00758290|Protective Agents|protective agents|mesh-ancestor
110812693|NCT00758290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110812694|NCT00758290|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110812695|NCT00758290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110812696|NCT00758290|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
110812697|NCT00758290|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110812698|NCT00758290|Antimetabolites|antimetabolites|mesh-ancestor
110812699|NCT00758290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110812700|NCT00758290|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110812701|NCT03799627|Epoetin Alfa|epoetin alfa|mesh-list
110812702|NCT03799627|Glycine|glycine|mesh-list
110812703|NCT03799627|Hematinics|hematinics|mesh-ancestor
110812704|NCT03799627|Glycine Agents|glycine agents|mesh-ancestor
110812705|NCT03799627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110812706|NCT03799627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110812707|NCT03799627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110812708|NCT02274142|Methamphetamine|methamphetamine|mesh-list
110812709|NCT02274142|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110812710|NCT02274142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110812711|NCT02274142|Sympathomimetics|sympathomimetics|mesh-ancestor
110812712|NCT02274142|Autonomic Agents|autonomic agents|mesh-ancestor
110812713|NCT02274142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110812714|NCT02274142|Dopamine Agents|dopamine agents|mesh-ancestor
110812715|NCT02274142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110812716|NCT02274142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110812717|NCT02274142|Adrenergic Agents|adrenergic agents|mesh-ancestor
110812718|NCT02274142|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110812719|NCT02274142|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110812720|NCT02274142|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110812721|NCT02274142|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110812722|NCT00752050|Botulinum Toxins|botulinum toxins|mesh-list
110812723|NCT00752050|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110812724|NCT00752050|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110812725|NCT00752050|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110812726|NCT00752050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110812727|NCT00752050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110812728|NCT00752050|Cholinergic Agents|cholinergic agents|mesh-ancestor
110812729|NCT00752050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110812730|NCT00752050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110812731|NCT00752050|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110812732|NCT00752050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110812733|NCT02276014|Beta Carotene|beta carotene|mesh-list
110812734|NCT02276014|Carotenoids|carotenoids|mesh-list
110812735|NCT02276014|Antioxidants|antioxidants|mesh-ancestor
110812736|NCT02276014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110812737|NCT02276014|Protective Agents|protective agents|mesh-ancestor
110812738|NCT02276014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110812739|NCT02276014|Provitamins|provitamins|mesh-ancestor
110812740|NCT02276014|Vitamins|vitamins|mesh-ancestor
110812741|NCT02276014|Micronutrients|micronutrients|mesh-ancestor
110812742|NCT01102387|Octenidine|octenidine|mesh-list
110812743|NCT01102387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110812744|NCT01102387|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110812745|NCT02277808|Amikacin|amikacin|mesh-list
110812746|NCT02277808|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110812747|NCT02277808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110812748|NCT02281240|Oprelvekin|oprelvekin|mesh-list
110812749|NCT02281240|Heparin|heparin|mesh-list
110812750|NCT02281240|Anticoagulants|anticoagulants|mesh-ancestor
110812751|NCT02281240|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110812752|NCT02281240|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110812753|NCT02281240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110812754|NCT02281240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110812755|NCT01102465|Losartan|losartan|mesh-list
110812756|NCT01102465|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110812757|NCT01102465|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110812758|NCT01102465|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110812759|NCT01102465|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110812760|NCT01102465|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110812761|NCT01102465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110812762|NCT01102465|Diuretics|diuretics|mesh-ancestor
110812763|NCT01102465|Natriuretic Agents|natriuretic agents|mesh-ancestor
110812764|NCT01102465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110812765|NCT01102465|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110812766|NCT01102465|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110812767|NCT01105819|Chlorhexidine|chlorhexidine|mesh-list
110812768|NCT01105819|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110812769|NCT01105819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110812770|NCT01105819|Disinfectants|disinfectants|mesh-ancestor
110812771|NCT00749632|Mandelic Acids|mandelic acids|mesh-list
110812773|NCT00749632|Parasympatholytics|parasympatholytics|mesh-ancestor
110812774|NCT00749632|Autonomic Agents|autonomic agents|mesh-ancestor
110812775|NCT00749632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110812776|NCT00749632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110812777|NCT00749632|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110812778|NCT00749632|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110812779|NCT00749632|Cholinergic Agents|cholinergic agents|mesh-ancestor
110812780|NCT00749632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110812781|NCT00749632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110812782|NCT00749632|Urological Agents|urological agents|mesh-ancestor
110812783|NCT00749632|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110812784|NCT00749632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110812785|NCT01105273|Cyclophosphamide|cyclophosphamide|mesh-list
110812786|NCT01105273|Fludarabine|fludarabine|mesh-list
110812787|NCT01105273|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110812788|NCT01105273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110812789|NCT01105273|Immunologic Factors|immunologic factors|mesh-ancestor
110812790|NCT01105273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110812791|NCT01105273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110812792|NCT01105273|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110812793|NCT01105273|Alkylating Agents|alkylating agents|mesh-ancestor
110812794|NCT01105273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110812795|NCT01105273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110812796|NCT01105273|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110812797|NCT05215327|Vaccines|vaccines|mesh-list
110812798|NCT05215327|Immunologic Factors|immunologic factors|mesh-ancestor
110812799|NCT05215327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110812800|NCT00743938|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110812801|NCT00743938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110812802|NCT00743938|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110812803|NCT00743938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110812804|NCT00743938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110812805|NCT01105351|Folic Acid|folic acid|mesh-list
110812806|NCT01105351|Vitamin B Complex|vitamin b complex|mesh-list
110812807|NCT01105351|Hematinics|hematinics|mesh-ancestor
110812808|NCT01105351|Vitamins|vitamins|mesh-ancestor
110812809|NCT01105351|Micronutrients|micronutrients|mesh-ancestor
110812810|NCT01105351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110812811|NCT00662506|Deoxyglucose|deoxyglucose|mesh-list
110812812|NCT00662506|Temozolomide|temozolomide|mesh-list
110812813|NCT00662506|Cediranib|cediranib|mesh-list
110812814|NCT00662506|Maleic acid|maleic acid|mesh-list
110812815|NCT00662506|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110812816|NCT00662506|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110812817|NCT00662506|Alkylating Agents|alkylating agents|mesh-ancestor
110812818|NCT00662506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110812819|NCT00662506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110812820|NCT00662506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110812821|NCT00662506|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110812822|NCT00662506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110812823|NCT00662506|Antimetabolites|antimetabolites|mesh-ancestor
110812824|NCT00662506|Antiviral Agents|antiviral agents|mesh-ancestor
110812825|NCT00662506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110812826|NCT03947125|Buprenorphine|buprenorphine|mesh-list
110812827|NCT03947125|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110812828|NCT03947125|Narcotics|narcotics|mesh-ancestor
110812829|NCT03947125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110812830|NCT03947125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110812831|NCT03947125|Analgesics|analgesics|mesh-ancestor
110812832|NCT03947125|Sensory System Agents|sensory system agents|mesh-ancestor
110812833|NCT03947125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110812834|NCT03947125|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110812835|NCT00658762|Paroxetine|paroxetine|mesh-list
110812836|NCT00658762|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110812837|NCT00658762|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110812838|NCT00658762|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110812839|NCT00658762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110812840|NCT00658762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110812841|NCT00658762|Serotonin Agents|serotonin agents|mesh-ancestor
110812842|NCT00658762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110812843|NCT00658762|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110812844|NCT00658762|Antidepressive Agents|antidepressive agents|mesh-ancestor
110812845|NCT00658762|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110812846|NCT00658762|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110812847|NCT00658762|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110812848|NCT00658762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110812849|NCT00658372|Paroxetine|paroxetine|mesh-list
110812850|NCT00658372|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110812851|NCT00658372|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110812852|NCT00658372|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110812853|NCT00658372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110812854|NCT00658372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110812855|NCT00658372|Serotonin Agents|serotonin agents|mesh-ancestor
110812856|NCT00658372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110812857|NCT00658372|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110812858|NCT00658372|Antidepressive Agents|antidepressive agents|mesh-ancestor
110812859|NCT00658372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110812860|NCT00658372|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110812861|NCT00658372|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110812862|NCT00658372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110812863|NCT03946657|Anesthetics|anesthetics|mesh-list
110812864|NCT03946657|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
110812865|NCT03946657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110812866|NCT03946657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110812867|NCT03946657|Anesthetics, General|anesthetics, general|mesh-ancestor
110812868|NCT00616798|Antipsychotic Agents|antipsychotic agents|mesh-list
110812869|NCT00616798|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110812870|NCT00616798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110812871|NCT00616798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110812872|NCT00616798|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110812873|NCT01106053|Pramipexole|pramipexole|mesh-list
110812874|NCT01106053|Antioxidants|antioxidants|mesh-ancestor
110812875|NCT01106053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110812876|NCT01106053|Protective Agents|protective agents|mesh-ancestor
110812877|NCT01106053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110812878|NCT01106053|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110812879|NCT01106053|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110812880|NCT01106053|Dopamine Agonists|dopamine agonists|mesh-ancestor
110812881|NCT01106053|Dopamine Agents|dopamine agents|mesh-ancestor
110812882|NCT01106053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110812883|NCT00616330|Clindamycin|clindamycin|mesh-list
110812884|NCT00616330|Clindamycin palmitate|clindamycin palmitate|mesh-list
110812885|NCT00616330|Clindamycin phosphate|clindamycin phosphate|mesh-list
110812886|NCT00616330|Butoconazole|butoconazole|mesh-list
110812887|NCT00616330|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110812888|NCT00616330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110812889|NCT00616330|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110812890|NCT00616330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110812891|NCT00616330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110812892|NCT00616330|Antifungal Agents|antifungal agents|mesh-ancestor
110812893|NCT00612820|Fluticasone|fluticasone|mesh-list
110812894|NCT00612820|Xhance|xhance|mesh-list
110812895|NCT00612820|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|mesh-list
110812896|NCT00612820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110812897|NCT00612820|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110812898|NCT00612820|Autonomic Agents|autonomic agents|mesh-ancestor
110812899|NCT00612820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110812900|NCT00612820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110812901|NCT00612820|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110812902|NCT00612820|Respiratory System Agents|respiratory system agents|mesh-ancestor
110812903|NCT00612820|Dermatologic Agents|dermatologic agents|mesh-ancestor
110812904|NCT00612820|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110812905|NCT00612820|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
110812906|NCT00612820|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110812907|NCT00612820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110812908|NCT00612820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110812909|NCT00612742|Testosterone|testosterone|mesh-list
110812910|NCT00612742|Androgens|androgens|mesh-ancestor
110812911|NCT00612742|Hormones|hormones|mesh-ancestor
110812912|NCT00612742|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110812913|NCT00612742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110812914|NCT05016895|Azithromycin|azithromycin|mesh-list
110812915|NCT05016895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110812916|NCT05016895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110812917|NCT01106131|Pioglitazone|pioglitazone|mesh-list
110812918|NCT01106131|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110812919|NCT01106131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110812920|NCT00612118|Azelastine|azelastine|mesh-list
110812921|NCT00612118|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|mesh-list
110812922|NCT00612118|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110812923|NCT00612118|Autonomic Agents|autonomic agents|mesh-ancestor
110812924|NCT00612118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110812925|NCT00612118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110812926|NCT00612118|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110812927|NCT00612118|Respiratory System Agents|respiratory system agents|mesh-ancestor
110812928|NCT00612118|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
110812929|NCT00612118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110812930|NCT00612118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110812931|NCT00612118|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110812932|NCT00612118|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110812933|NCT00612118|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110812934|NCT00612118|Histamine Antagonists|histamine antagonists|mesh-ancestor
110812935|NCT00612118|Histamine Agents|histamine agents|mesh-ancestor
110812936|NCT00612118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110812937|NCT00612118|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
110812938|NCT00612118|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110812940|NCT00743002|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110812941|NCT00743002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110812942|NCT03944863|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110812943|NCT03944863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110812944|NCT01102699|Lenograstim|lenograstim|mesh-list
110812945|NCT01102699|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110812946|NCT01102699|Immunologic Factors|immunologic factors|mesh-ancestor
110812947|NCT01102699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110812948|NCT00603616|Rifaximin|rifaximin|mesh-list
110812949|NCT00603616|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110812950|NCT00603616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110812951|NCT00603616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110812952|NCT02280070|Leucovorin|leucovorin|mesh-list
110812953|NCT02280070|Fluorouracil|fluorouracil|mesh-list
110812954|NCT02280070|Tegafur|tegafur|mesh-list
110812955|NCT02280070|Oxaliplatin|oxaliplatin|mesh-list
110812956|NCT02280070|Antibodies|antibodies|mesh-list
110812957|NCT02280070|Immunoglobulins|immunoglobulins|mesh-list
110812958|NCT02280070|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
110812959|NCT02280070|Immunologic Factors|immunologic factors|mesh-ancestor
110812960|NCT02280070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110812961|NCT02280070|Antimetabolites|antimetabolites|mesh-ancestor
110812962|NCT02280070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110812963|NCT02280070|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110812964|NCT02280070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110812965|NCT02280070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110812966|NCT02280070|Antidotes|antidotes|mesh-ancestor
110812967|NCT02280070|Protective Agents|protective agents|mesh-ancestor
110853743|NCT02488486|Anesthetics|anesthetics|mesh-ancestor
110812968|NCT02280070|Vitamin B Complex|vitamin b complex|mesh-ancestor
110812969|NCT02280070|Vitamins|vitamins|mesh-ancestor
110812970|NCT02280070|Micronutrients|micronutrients|mesh-ancestor
110812971|NCT01108783|Desloratadine|desloratadine|mesh-list
110812972|NCT01108783|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110812973|NCT01108783|Cholinergic Agents|cholinergic agents|mesh-ancestor
110812974|NCT01108783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110812975|NCT01108783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110417243|NCT01121757|Antimetabolites|antimetabolites|mesh-ancestor
110812976|NCT01108783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110812977|NCT01108783|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110812978|NCT01108783|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110812979|NCT01108783|Histamine Antagonists|histamine antagonists|mesh-ancestor
110812980|NCT01108783|Histamine Agents|histamine agents|mesh-ancestor
110812981|NCT02743780|MGV354|mgv354|mesh-list
110812982|NCT02743780|Enzyme Activators|enzyme activators|mesh-ancestor
110812983|NCT02743780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110812984|NCT02280148|Propofol|propofol|mesh-list
110812985|NCT02280148|Anesthetics|anesthetics|mesh-ancestor
110812986|NCT02280148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110812987|NCT02280148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110812988|NCT02280148|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110812989|NCT02280148|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110812990|NCT02280148|Anesthetics, General|anesthetics, general|mesh-ancestor
110812991|NCT00602602|Bevacizumab|bevacizumab|mesh-list
110812992|NCT00602602|Gemcitabine|gemcitabine|mesh-list
110812993|NCT00602602|Fluorouracil|fluorouracil|mesh-list
110812994|NCT00602602|Oxaliplatin|oxaliplatin|mesh-list
110812995|NCT00602602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110812996|NCT00602602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110812997|NCT00602602|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110812998|NCT00602602|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110812999|NCT00602602|Growth Substances|growth substances|mesh-ancestor
110813000|NCT00602602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110813001|NCT00602602|Growth Inhibitors|growth inhibitors|mesh-ancestor
110813002|NCT00602602|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110813003|NCT00602602|Antimetabolites|antimetabolites|mesh-ancestor
110813004|NCT00602602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110813005|NCT00602602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110813006|NCT00602602|Immunologic Factors|immunologic factors|mesh-ancestor
110813007|NCT04177654|Albendazole|albendazole|mesh-list
110813008|NCT04177654|Mebendazole|mebendazole|mesh-list
110813009|NCT04177654|Benzimidazole|benzimidazole|mesh-list
110813010|NCT04177654|Anthelmintics|anthelmintics|mesh-ancestor
110813011|NCT04177654|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110813012|NCT04177654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110813013|NCT04177654|Anticestodal Agents|anticestodal agents|mesh-ancestor
110813014|NCT04177654|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110813015|NCT04177654|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110813016|NCT04177654|Tubulin Modulators|tubulin modulators|mesh-ancestor
110813017|NCT04177654|Antimitotic Agents|antimitotic agents|mesh-ancestor
110813018|NCT04177654|Mitosis Modulators|mitosis modulators|mesh-ancestor
110813019|NCT04177654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110813020|NCT04177654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110813021|NCT04177654|Antinematodal Agents|antinematodal agents|mesh-ancestor
110813022|NCT02281396|Vaccines|vaccines|mesh-list
110813023|NCT02281396|Immunologic Factors|immunologic factors|mesh-ancestor
110813024|NCT02281396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110813025|NCT04471480|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
110813026|NCT04471480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110813027|NCT04471480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110813028|NCT04471480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110813029|NCT02880956|Tilavonemab|tilavonemab|mesh-list
110813030|NCT02880956|Nootropic Agents|nootropic agents|mesh-ancestor
110813031|NCT01111513|Analgesics|analgesics|mesh-list
110813032|NCT01111513|Ropivacaine|ropivacaine|mesh-list
110813033|NCT01111513|Anesthetics, Local|anesthetics, local|mesh-ancestor
110813034|NCT01111513|Anesthetics|anesthetics|mesh-ancestor
110813035|NCT01111513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110813036|NCT01111513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110813037|NCT01111513|Sensory System Agents|sensory system agents|mesh-ancestor
110813038|NCT01111513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110813039|NCT01111591|Celecoxib|celecoxib|mesh-list
110813040|NCT01111591|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
110853745|NCT02488486|Narcotics|narcotics|mesh-ancestor
110813041|NCT01111591|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110813043|NCT01111591|Analgesics|analgesics|mesh-ancestor
110813044|NCT01111591|Sensory System Agents|sensory system agents|mesh-ancestor
110813045|NCT01111591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110813046|NCT01111591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110813047|NCT01111591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110813048|NCT01111591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110813049|NCT01111591|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110813050|NCT01111591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110813051|NCT01111591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110813052|NCT01111669|Tranexamic Acid|tranexamic acid|mesh-list
110813053|NCT01111669|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110813054|NCT01111669|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110813055|NCT01111669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110813056|NCT01111669|Hemostatics|hemostatics|mesh-ancestor
110813057|NCT01111669|Coagulants|coagulants|mesh-ancestor
110813058|NCT01108939|Antimalarials|antimalarials|mesh-list
110813059|NCT01108939|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110813060|NCT01108939|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110813061|NCT01108939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110813062|NCT00654706|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110813063|NCT00654706|Sertindole|sertindole|mesh-list
110813064|NCT00654706|Antidepressive Agents|antidepressive agents|mesh-ancestor
110813065|NCT00654706|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110813066|NCT00654706|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110813067|NCT00654706|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110813068|NCT00654706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110813069|NCT00654706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110813070|NCT03944473|Neostigmine|neostigmine|mesh-list
110813071|NCT03944473|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110813072|NCT03944473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110813073|NCT03944473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110813074|NCT03944473|Cholinergic Agents|cholinergic agents|mesh-ancestor
110813075|NCT03944473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110813076|NCT03944473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110813077|NCT03944473|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110813078|NCT03944473|Autonomic Agents|autonomic agents|mesh-ancestor
110813079|NCT03944473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110813080|NCT03944317|Azithromycin|azithromycin|mesh-list
110813081|NCT03944317|Pyrimethamine|pyrimethamine|mesh-list
110813082|NCT03944317|Sulfadoxine|sulfadoxine|mesh-list
110813083|NCT03944317|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
110417317|NCT01252667|Antimetabolites|antimetabolites|mesh-ancestor
110813084|NCT03944317|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110813085|NCT03944317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110813086|NCT03944317|Antimalarials|antimalarials|mesh-ancestor
110813087|NCT03944317|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110813088|NCT03944317|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110813089|NCT03944317|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110813090|NCT03944317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110813091|NCT03944317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110813092|NCT03944317|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110813093|NCT02280538|Hyaluronic Acid|hyaluronic acid|mesh-list
110813094|NCT02280538|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110813095|NCT02280538|Immunologic Factors|immunologic factors|mesh-ancestor
110813096|NCT02280538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110813097|NCT02280538|Viscosupplements|viscosupplements|mesh-ancestor
110813098|NCT02280538|Protective Agents|protective agents|mesh-ancestor
110813099|NCT01111747|Mitogens|mitogens|mesh-list
110813100|NCT01111747|Mitosis Modulators|mitosis modulators|mesh-ancestor
110813101|NCT01111747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110813102|NCT02281708|Cisplatin|cisplatin|mesh-list
110813103|NCT02281708|Vinorelbine|vinorelbine|mesh-list
110813104|NCT02281708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110813105|NCT02281708|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110813106|NCT02281708|Tubulin Modulators|tubulin modulators|mesh-ancestor
110813107|NCT02281708|Antimitotic Agents|antimitotic agents|mesh-ancestor
110813108|NCT02281708|Mitosis Modulators|mitosis modulators|mesh-ancestor
110813109|NCT02281708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110813110|NCT01111903|Lenalidomide|lenalidomide|mesh-list
110813111|NCT01111903|Immunologic Factors|immunologic factors|mesh-ancestor
110813112|NCT01111903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110853749|NCT04144517|Pembrolizumab|pembrolizumab|mesh-list
110813113|NCT01111903|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110813114|NCT01111903|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110813115|NCT01111903|Growth Substances|growth substances|mesh-ancestor
110813116|NCT01111903|Growth Inhibitors|growth inhibitors|mesh-ancestor
110813117|NCT01111903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110813118|NCT02280616|Budesonide|budesonide|mesh-list
110813119|NCT02280616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110813120|NCT02280616|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110813121|NCT02280616|Autonomic Agents|autonomic agents|mesh-ancestor
110813122|NCT02280616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110813123|NCT02280616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110813124|NCT02280616|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110813125|NCT02280616|Respiratory System Agents|respiratory system agents|mesh-ancestor
110813126|NCT02280616|Glucocorticoids|glucocorticoids|mesh-ancestor
110813127|NCT02280616|Hormones|hormones|mesh-ancestor
110813128|NCT02280616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110813129|NCT01111981|Clobetasol|clobetasol|mesh-list
110813130|NCT01111981|Emollients|emollients|mesh-list
110813131|NCT01111981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110813132|NCT01111981|Glucocorticoids|glucocorticoids|mesh-ancestor
110813133|NCT01111981|Hormones|hormones|mesh-ancestor
110813134|NCT01111981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110813135|NCT01111981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110813136|NCT01111981|Dermatologic Agents|dermatologic agents|mesh-ancestor
110813137|NCT02283424|Carboplatin|carboplatin|mesh-list
110813138|NCT02283424|Docetaxel|docetaxel|mesh-list
110813139|NCT02283424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110813140|NCT02283424|Tubulin Modulators|tubulin modulators|mesh-ancestor
110813141|NCT02283424|Antimitotic Agents|antimitotic agents|mesh-ancestor
110813142|NCT02283424|Mitosis Modulators|mitosis modulators|mesh-ancestor
110813143|NCT02283424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110813144|NCT03942601|Sirolimus|sirolimus|mesh-list
110813145|NCT03942601|Dexamethasone|dexamethasone|mesh-list
110813146|NCT03942601|Dexamethasone acetate|dexamethasone acetate|mesh-list
110813147|NCT03942601|Temsirolimus|temsirolimus|mesh-list
110813148|NCT03942601|MTOR Inhibitors|mtor inhibitors|mesh-list
110813149|NCT03942601|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
110813150|NCT03942601|BB 1101|bb 1101|mesh-list
110813151|NCT03942601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110813152|NCT03942601|Antiemetics|antiemetics|mesh-ancestor
110813153|NCT03942601|Autonomic Agents|autonomic agents|mesh-ancestor
110813154|NCT03942601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110813155|NCT03942601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110813156|NCT03942601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110813157|NCT03942601|Glucocorticoids|glucocorticoids|mesh-ancestor
110813158|NCT03942601|Hormones|hormones|mesh-ancestor
110813159|NCT03942601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110813160|NCT03942601|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110813161|NCT03942601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110813162|NCT03942601|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110813163|NCT03942601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110813164|NCT03942601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110813165|NCT03942601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110813166|NCT03942601|Immunologic Factors|immunologic factors|mesh-ancestor
110813167|NCT03942601|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110813168|NCT03942601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110813169|NCT03942601|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110813170|NCT03942601|Antifungal Agents|antifungal agents|mesh-ancestor
110813171|NCT03942601|Protease Inhibitors|protease inhibitors|mesh-ancestor
110813172|NCT00598312|Leuprolide|leuprolide|mesh-list
110813173|NCT00598312|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110813174|NCT00598312|Fertility Agents|fertility agents|mesh-ancestor
110813175|NCT00598312|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110813176|NCT00598312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110813177|NCT00598312|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110813178|NCT00598312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110813179|NCT00595426|Warfarin|warfarin|mesh-list
110813180|NCT00595426|Anticoagulants|anticoagulants|mesh-ancestor
110813181|NCT01112137|Clopidogrel|clopidogrel|mesh-list
110813182|NCT01112137|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110813183|NCT01112137|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110813184|NCT01112137|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110813185|NCT01112137|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110813186|NCT01112137|Purinergic Agents|purinergic agents|mesh-ancestor
110813187|NCT01112137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110813188|NCT01112137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110813189|NCT01112137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110813191|NCT02282098|Gout Suppressants|gout suppressants|mesh-ancestor
110813192|NCT02282098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110813193|NCT02282098|Tubulin Modulators|tubulin modulators|mesh-ancestor
110813194|NCT02282098|Antimitotic Agents|antimitotic agents|mesh-ancestor
110813195|NCT02282098|Mitosis Modulators|mitosis modulators|mesh-ancestor
110813196|NCT02282098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110813197|NCT02282098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110813198|NCT01208935|Nicotine|nicotine|mesh-list
110813199|NCT01208935|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110813200|NCT01208935|Autonomic Agents|autonomic agents|mesh-ancestor
110813201|NCT01208935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110813202|NCT01208935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110813203|NCT01208935|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110813204|NCT01208935|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110813205|NCT01208935|Cholinergic Agents|cholinergic agents|mesh-ancestor
110813206|NCT01208935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110813207|NCT01208935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110813208|NCT00584974|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
110813209|NCT00584974|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110813210|NCT00584974|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110813211|NCT00584974|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110813212|NCT00584974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110813213|NCT00584974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110813214|NCT00584974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110813215|NCT00584974|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110813216|NCT00584974|Antidepressive Agents|antidepressive agents|mesh-ancestor
110813217|NCT00584974|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110813218|NCT01107067|Testosterone|testosterone|mesh-list
110813219|NCT01107067|Androgens|androgens|mesh-ancestor
110813220|NCT01107067|Hormones|hormones|mesh-ancestor
110138377|NCT04429022|Hydromorphone|hydromorphone|mesh-list
110813221|NCT01107067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110813222|NCT01107067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110813223|NCT02282176|Azithromycin|azithromycin|mesh-list
110417387|NCT00991276|Pramipexole|pramipexole|mesh-list
110813224|NCT02282176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110813225|NCT02282176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110813226|NCT00580216|Biotin|biotin|mesh-list
110813227|NCT00580216|Warfarin|warfarin|mesh-list
110813228|NCT00580216|Idraparinux|idraparinux|mesh-list
110813229|NCT00580216|Idrabiotaparinux|idrabiotaparinux|mesh-list
110813230|NCT00580216|Anticoagulants|anticoagulants|mesh-ancestor
110813231|NCT00580216|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110813232|NCT00580216|Antithrombins|antithrombins|mesh-ancestor
110813233|NCT00580216|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110813234|NCT00580216|Protease Inhibitors|protease inhibitors|mesh-ancestor
110813235|NCT00580216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110813236|NCT00580216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110813237|NCT00580216|Vitamin B Complex|vitamin b complex|mesh-ancestor
110813238|NCT00580216|Vitamins|vitamins|mesh-ancestor
110813239|NCT00580216|Micronutrients|micronutrients|mesh-ancestor
110813240|NCT00580216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110813241|NCT01107145|Artesunate|artesunate|mesh-list
110813242|NCT01107145|Chloroquine|chloroquine|mesh-list
110813243|NCT01107145|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
110813244|NCT01107145|Lumefantrine|lumefantrine|mesh-list
110813245|NCT01107145|Artemether|artemether|mesh-list
110813246|NCT01107145|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
110813247|NCT01107145|Mefloquine|mefloquine|mesh-list
110853760|NCT03327766|Calcifediol|calcifediol|mesh-list
110813248|NCT01107145|Antimalarials|antimalarials|mesh-ancestor
110813249|NCT01107145|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110813250|NCT01107145|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110813251|NCT01107145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110813252|NCT01107145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110813253|NCT01107145|Antiviral Agents|antiviral agents|mesh-ancestor
110813254|NCT01107145|Schistosomicides|schistosomicides|mesh-ancestor
110813255|NCT01107145|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110813256|NCT01107145|Anthelmintics|anthelmintics|mesh-ancestor
110813257|NCT01107145|Amebicides|amebicides|mesh-ancestor
110813258|NCT01107145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110813259|NCT01107145|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110813260|NCT01107145|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110813261|NCT01107145|Analgesics|analgesics|mesh-ancestor
110813262|NCT01107145|Sensory System Agents|sensory system agents|mesh-ancestor
110813263|NCT01107145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110417407|NCT00991276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110813264|NCT01107145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110813265|NCT01107145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110813266|NCT01107145|Filaricides|filaricides|mesh-ancestor
110813267|NCT01107145|Antinematodal Agents|antinematodal agents|mesh-ancestor
110813268|NCT03944005|Anesthetics|anesthetics|mesh-list
110813269|NCT03944005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110813270|NCT03944005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110813271|NCT01209403|Insulin|insulin|mesh-list
110813272|NCT01209403|Insulin Aspart|insulin aspart|mesh-list
110813273|NCT01209403|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110813274|NCT01209403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110813275|NCT01112215|Mycophenolic Acid|mycophenolic acid|mesh-list
110813276|NCT01112215|Azathioprine|azathioprine|mesh-list
110813277|NCT01112215|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110813278|NCT01112215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110813279|NCT01112215|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110813280|NCT01112215|Antitubercular Agents|antitubercular agents|mesh-ancestor
110813281|NCT01112215|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110813282|NCT01112215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110813283|NCT01112215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110813284|NCT01112215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110813285|NCT01112215|Antimetabolites|antimetabolites|mesh-ancestor
110813286|NCT01112215|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110813287|NCT01112215|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110813288|NCT01112215|Immunologic Factors|immunologic factors|mesh-ancestor
110813289|NCT01112215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110813290|NCT01112215|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110813291|NCT01107223|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110813292|NCT01107223|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
110813293|NCT01107223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110813294|NCT01107223|Antitubercular Agents|antitubercular agents|mesh-ancestor
110813295|NCT02286388|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110813296|NCT02286388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110813297|NCT02286544|Atorvastatin|atorvastatin|mesh-list
110138456|NCT04321408|Protective Agents|protective agents|mesh-ancestor
110813298|NCT02286544|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110813299|NCT02286544|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110813300|NCT02286544|Antimetabolites|antimetabolites|mesh-ancestor
110813301|NCT02286544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110813302|NCT02286544|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110813303|NCT02286544|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110813304|NCT02286544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110813305|NCT01338116|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110813306|NCT01338116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110813308|NCT00384904|Atazanavir Sulfate|atazanavir sulfate|mesh-list
110813309|NCT00384904|Tenofovir|tenofovir|mesh-list
110813310|NCT00384904|Famotidine|famotidine|mesh-list
110813311|NCT00384904|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110813312|NCT00384904|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110813313|NCT00384904|Protease Inhibitors|protease inhibitors|mesh-ancestor
110813314|NCT00384904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110813315|NCT00384904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110813316|NCT00384904|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110813317|NCT00384904|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110813318|NCT00384904|Antiviral Agents|antiviral agents|mesh-ancestor
110813319|NCT00384904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110813320|NCT00384904|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110813321|NCT00384904|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110813322|NCT00384904|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110813323|NCT00384904|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110813324|NCT00384904|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110813325|NCT00384904|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110813326|NCT00384904|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110813327|NCT00384904|Histamine Antagonists|histamine antagonists|mesh-ancestor
110813328|NCT00384904|Histamine Agents|histamine agents|mesh-ancestor
110813329|NCT00384904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110813330|NCT00384904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110813331|NCT01335386|Glycerol|glycerol|mesh-list
110813332|NCT01335386|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
110813333|NCT01335386|Protective Agents|protective agents|mesh-ancestor
110813334|NCT01335386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110813335|NCT00383578|Metformin|metformin|mesh-list
110813336|NCT00383578|Vildagliptin|vildagliptin|mesh-list
110813337|NCT00383578|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110813338|NCT00383578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110813339|NCT00383578|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110813340|NCT00383578|Protease Inhibitors|protease inhibitors|mesh-ancestor
110813341|NCT00383578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110813342|NCT00383578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110813343|NCT00383422|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
110813344|NCT00383422|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110813345|NCT00383422|Hormone Antagonists|hormone antagonists|mesh-ancestor
110813346|NCT00383422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110813347|NCT00383422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110813348|NCT00383422|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110813349|NCT00383422|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110813350|NCT00383422|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110813351|NCT02286622|Deflazacort|deflazacort|mesh-list
110813352|NCT02286622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110813353|NCT02286622|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110813354|NCT02286622|Immunologic Factors|immunologic factors|mesh-ancestor
110813355|NCT02286622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110813356|NCT00564226|Tolterodine Tartrate|tolterodine tartrate|mesh-list
110813357|NCT00564226|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110813358|NCT00564226|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110813359|NCT00564226|Cholinergic Agents|cholinergic agents|mesh-ancestor
110813360|NCT00564226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110813361|NCT00564226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110813362|NCT00564226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110813363|NCT00564226|Urological Agents|urological agents|mesh-ancestor
110813364|NCT03635684|Acetaminophen|acetaminophen|mesh-list
110813365|NCT03635684|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110813366|NCT03635684|Analgesics|analgesics|mesh-ancestor
110813367|NCT03635684|Sensory System Agents|sensory system agents|mesh-ancestor
110813368|NCT03635684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110813369|NCT03635684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110813370|NCT03635684|Antipyretics|antipyretics|mesh-ancestor
110813371|NCT00092690|Atorvastatin|atorvastatin|mesh-list
110813373|NCT00092690|Ezetimibe|ezetimibe|mesh-list
110813374|NCT00092690|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110813375|NCT00092690|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110813376|NCT00092690|Antimetabolites|antimetabolites|mesh-ancestor
110417458|NCT02867800|Acetaminophen|acetaminophen|mesh-list
110813377|NCT00092690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110813378|NCT00092690|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110813379|NCT00092690|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110813380|NCT00092690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110530948|NCT00884793|Antiviral Agents|antiviral agents|mesh-ancestor
110813381|NCT02286700|Desonide|desonide|mesh-list
110813382|NCT02286700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110813383|NCT01338896|Rotigotine|rotigotine|mesh-list
110813384|NCT01338896|Dopamine Agonists|dopamine agonists|mesh-ancestor
110813385|NCT01338896|Dopamine Agents|dopamine agents|mesh-ancestor
110813386|NCT01338896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110813387|NCT01338896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110813388|NCT01338896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110813389|NCT05185544|Pemetrexed|pemetrexed|mesh-list
110813390|NCT05185544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110813391|NCT05185544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110813392|NCT05185544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110813393|NCT05185544|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110813394|NCT05185544|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110813395|NCT00382096|Metformin|metformin|mesh-list
110813396|NCT00382096|Vildagliptin|vildagliptin|mesh-list
110813397|NCT00382096|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110813398|NCT00382096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110813399|NCT00382096|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110813400|NCT00382096|Protease Inhibitors|protease inhibitors|mesh-ancestor
110813401|NCT00382096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110813402|NCT00382096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110813403|NCT00482092|Remestemcel-l|remestemcel-l|mesh-list
110813404|NCT00482092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110813405|NCT00482092|Antiviral Agents|antiviral agents|mesh-ancestor
110813406|NCT00482092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110813407|NCT00379990|Prednisolone|prednisolone|mesh-list
110813408|NCT00379990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110813409|NCT00379990|Glucocorticoids|glucocorticoids|mesh-ancestor
110813410|NCT00379990|Hormones|hormones|mesh-ancestor
110813411|NCT00379990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110813412|NCT00379990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110813413|NCT00379990|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110813414|NCT00379990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110813415|NCT00377182|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110813416|NCT00377182|Antiviral Agents|antiviral agents|mesh-ancestor
110813417|NCT00377182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110813418|NCT01341938|Nicotine|nicotine|mesh-list
110813419|NCT01341938|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110813420|NCT01341938|Autonomic Agents|autonomic agents|mesh-ancestor
110813421|NCT01341938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110813422|NCT01341938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110813423|NCT01341938|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110813424|NCT01341938|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110813425|NCT01341938|Cholinergic Agents|cholinergic agents|mesh-ancestor
110813426|NCT01341938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110813427|NCT01341938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110813428|NCT02284048|Ticagrelor|ticagrelor|mesh-list
110813429|NCT02284048|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110813430|NCT02284048|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110813431|NCT02284048|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110813432|NCT02284048|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110813433|NCT02284048|Purinergic Agents|purinergic agents|mesh-ancestor
110813434|NCT02284048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110813435|NCT02284048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110813436|NCT02284048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110813437|NCT00374296|Mocetinostat|mocetinostat|mesh-list
110813438|NCT00374296|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110813439|NCT00374296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110813440|NCT00374296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110813441|NCT00547066|Veltuzumab|veltuzumab|mesh-list
110813442|NCT00547066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110813443|NCT01315496|Immunoglobulins|immunoglobulins|mesh-list
110813444|NCT01315496|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110813446|NCT01315496|Immunoglobulin G|immunoglobulin g|mesh-list
110813447|NCT01315496|Immunologic Factors|immunologic factors|mesh-ancestor
110813448|NCT01315496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110813450|NCT00544960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110813451|NCT00544960|Tubulin Modulators|tubulin modulators|mesh-ancestor
110813452|NCT00544960|Antimitotic Agents|antimitotic agents|mesh-ancestor
110813453|NCT00544960|Mitosis Modulators|mitosis modulators|mesh-ancestor
110813454|NCT00544960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110813455|NCT01339286|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
110813456|NCT01339286|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110813457|NCT01339286|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110813458|NCT01339286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110813459|NCT01339286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110813461|NCT01339286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110813462|NCT01339286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110813463|NCT00468442|Sirolimus|sirolimus|mesh-list
110813464|NCT00468442|Rituximab|rituximab|mesh-list
110813465|NCT00468442|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110813466|NCT00468442|Daclizumab|daclizumab|mesh-list
110813467|NCT00468442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110813468|NCT00468442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110813469|NCT00468442|Immunologic Factors|immunologic factors|mesh-ancestor
110813470|NCT00468442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110813471|NCT00468442|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110813472|NCT00468442|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110813473|NCT00468442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110813474|NCT00468442|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110813475|NCT00468442|Antifungal Agents|antifungal agents|mesh-ancestor
110813476|NCT00468442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110813477|NCT01339442|Fulvestrant|fulvestrant|mesh-list
110813478|NCT01339442|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110813479|NCT01339442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110813480|NCT01339442|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110813481|NCT01339442|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110813482|NCT01339442|Hormone Antagonists|hormone antagonists|mesh-ancestor
110813483|NCT01339442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110813484|NCT01339442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110813485|NCT02286934|Carvedilol|carvedilol|mesh-list
110813486|NCT02286934|Isoproterenol|isoproterenol|mesh-list
110813487|NCT02286934|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110813488|NCT02286934|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110813489|NCT02286934|Adrenergic Agents|adrenergic agents|mesh-ancestor
110813490|NCT02286934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110813491|NCT02286934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110813492|NCT02286934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110813493|NCT02286934|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110813494|NCT02286934|Antioxidants|antioxidants|mesh-ancestor
110813495|NCT02286934|Protective Agents|protective agents|mesh-ancestor
110813496|NCT02286934|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110813497|NCT02286934|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110813498|NCT02286934|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110813499|NCT02286934|Vasodilator Agents|vasodilator agents|mesh-ancestor
110813500|NCT02286934|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110813501|NCT02286934|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110813502|NCT02286934|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110813503|NCT02286934|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110813504|NCT02286934|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110813505|NCT02286934|Autonomic Agents|autonomic agents|mesh-ancestor
110813506|NCT02286934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110813507|NCT02286934|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110813508|NCT02286934|Respiratory System Agents|respiratory system agents|mesh-ancestor
110813509|NCT02286934|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110813510|NCT02286934|Sympathomimetics|sympathomimetics|mesh-ancestor
110813511|NCT02282410|Factor VIII|factor viii|mesh-list
110813512|NCT02282410|Coagulants|coagulants|mesh-ancestor
110813513|NCT00092612|Ezetimibe|ezetimibe|mesh-list
110813514|NCT00092612|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110813515|NCT00092612|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110813516|NCT00092612|Antimetabolites|antimetabolites|mesh-ancestor
110813517|NCT00092612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110813518|NCT00092612|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110813520|NCT00540358|Gemcitabine|gemcitabine|mesh-list
110813521|NCT00540358|Iniparib|iniparib|mesh-list
110813522|NCT00540358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110813523|NCT00540358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110813524|NCT00540358|Antimetabolites|antimetabolites|mesh-ancestor
110813525|NCT00540358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110813526|NCT00540358|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110813527|NCT00540358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110813528|NCT00462202|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
110813529|NCT00462202|Anticoagulants|anticoagulants|mesh-ancestor
110813530|NCT00462202|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110813531|NCT00462202|Antimetabolites|antimetabolites|mesh-ancestor
110813532|NCT00462202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110813533|NCT00462202|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110813534|NCT00462202|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110813535|NCT00462202|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110813536|NCT00462202|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110813537|NCT00462202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110813538|NCT02287246|Bupivacaine|bupivacaine|mesh-list
110813539|NCT02287246|Anesthetics, Local|anesthetics, local|mesh-ancestor
110813540|NCT02287246|Anesthetics|anesthetics|mesh-ancestor
110813541|NCT02287246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110813542|NCT02287246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110813543|NCT02287246|Sensory System Agents|sensory system agents|mesh-ancestor
110813544|NCT02287246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110813545|NCT04470544|Camostat|camostat|mesh-list
110813546|NCT04470544|Protease Inhibitors|protease inhibitors|mesh-ancestor
110813547|NCT04470544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110813548|NCT04470544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110813549|NCT04470544|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
110813550|NCT04470544|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110813551|NCT00535366|Fluticasone|fluticasone|mesh-list
110813552|NCT00535366|Ciclesonide|ciclesonide|mesh-list
110813553|NCT00535366|Tiotropium Bromide|tiotropium bromide|mesh-list
110813554|NCT00535366|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110813555|NCT00535366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110813556|NCT00535366|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110813557|NCT00535366|Autonomic Agents|autonomic agents|mesh-ancestor
110813558|NCT00535366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110813559|NCT00535366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110813560|NCT00535366|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110813561|NCT00535366|Respiratory System Agents|respiratory system agents|mesh-ancestor
110813562|NCT00535366|Dermatologic Agents|dermatologic agents|mesh-ancestor
110813563|NCT00535366|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110813564|NCT00535366|Parasympatholytics|parasympatholytics|mesh-ancestor
110813565|NCT00535366|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110813566|NCT00535366|Cholinergic Agents|cholinergic agents|mesh-ancestor
110813567|NCT00535366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110813568|NCT00535366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110813569|NCT00535366|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110813570|NCT00535366|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110813571|NCT00535366|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110813572|NCT00535366|Adrenergic Agents|adrenergic agents|mesh-ancestor
110813573|NCT00535366|Glucocorticoids|glucocorticoids|mesh-ancestor
110813574|NCT00535366|Hormones|hormones|mesh-ancestor
110813575|NCT00535366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110813576|NCT00369070|Paclitaxel|paclitaxel|mesh-list
110813577|NCT00369070|Bevacizumab|bevacizumab|mesh-list
110813578|NCT00369070|Carboplatin|carboplatin|mesh-list
110813579|NCT00369070|Motesanib diphosphate|motesanib diphosphate|mesh-list
110813580|NCT00369070|Imetelstat|imetelstat|mesh-list
110813581|NCT00369070|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110813582|NCT00369070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110813583|NCT00369070|Tubulin Modulators|tubulin modulators|mesh-ancestor
110813584|NCT00369070|Antimitotic Agents|antimitotic agents|mesh-ancestor
110813585|NCT00369070|Mitosis Modulators|mitosis modulators|mesh-ancestor
110813586|NCT00369070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110813587|NCT00369070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110813588|NCT00369070|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110813589|NCT00369070|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110813590|NCT00369070|Growth Substances|growth substances|mesh-ancestor
110813591|NCT00369070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110813592|NCT00369070|Growth Inhibitors|growth inhibitors|mesh-ancestor
110138761|NCT03975829|Trametinib|trametinib|mesh-list
110813593|NCT00369070|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110813594|NCT00369070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110813595|NCT02284204|Midazolam|midazolam|mesh-list
110813596|NCT02284204|Ketamine|ketamine|mesh-list
110853790|NCT01297764|Vorinostat|vorinostat|mesh-list
110813597|NCT02284204|Sevoflurane|sevoflurane|mesh-list
110813598|NCT02284204|Analgesics|analgesics|mesh-ancestor
110813599|NCT02284204|Sensory System Agents|sensory system agents|mesh-ancestor
110813600|NCT02284204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110813601|NCT02284204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110813602|NCT02284204|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110813603|NCT02284204|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110813604|NCT02284204|Anesthetics, General|anesthetics, general|mesh-ancestor
110813605|NCT02284204|Anesthetics|anesthetics|mesh-ancestor
110813606|NCT02284204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110813607|NCT02284204|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110813608|NCT02284204|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110813609|NCT02284204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110813610|NCT02284204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110813611|NCT02284204|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110813612|NCT02284204|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110813613|NCT02284204|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110813614|NCT02284204|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110813615|NCT02284204|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110813617|NCT02284204|GABA Agents|gaba agents|mesh-ancestor
110813618|NCT02284204|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110813619|NCT02284204|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110813620|NCT01352416|Ranolazine|ranolazine|mesh-list
110813621|NCT01352416|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110813622|NCT01352416|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110813623|NCT01352416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110813624|NCT00531622|Escitalopram|escitalopram|mesh-list
110813625|NCT00531622|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110813626|NCT00531622|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110813627|NCT00531622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110813628|NCT00531622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110813629|NCT00531622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110813630|NCT00531622|Serotonin Agents|serotonin agents|mesh-ancestor
110813631|NCT00531622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110813632|NCT00364546|Tapentadol|tapentadol|mesh-list
110813633|NCT00364546|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110813634|NCT00364546|Narcotics|narcotics|mesh-ancestor
110813635|NCT00364546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110813636|NCT00364546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110813637|NCT00364546|Analgesics|analgesics|mesh-ancestor
110813638|NCT00364546|Sensory System Agents|sensory system agents|mesh-ancestor
110813639|NCT00364546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110813640|NCT00364546|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110813641|NCT00364546|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110813642|NCT00364546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110813643|NCT00364546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110813644|NCT00364546|Adrenergic Agents|adrenergic agents|mesh-ancestor
110813645|NCT00364546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110813646|NCT00361582|Tapentadol|tapentadol|mesh-list
110813647|NCT00361582|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110813648|NCT00361582|Narcotics|narcotics|mesh-ancestor
110813649|NCT00361582|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110813650|NCT00361582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110813651|NCT00361582|Analgesics|analgesics|mesh-ancestor
110813652|NCT00361582|Sensory System Agents|sensory system agents|mesh-ancestor
110813653|NCT00361582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110813654|NCT00361582|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110813655|NCT00361582|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110813656|NCT00361582|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110813657|NCT00361582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110813658|NCT00361582|Adrenergic Agents|adrenergic agents|mesh-ancestor
110813659|NCT00361582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110813660|NCT00450970|Satraplatin|satraplatin|mesh-list
110813661|NCT00450970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110813662|NCT02282800|Vitamin D|vitamin d|mesh-list
110813663|NCT02282800|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
110813664|NCT02282800|Vitamins|vitamins|mesh-ancestor
110813665|NCT02282800|Micronutrients|micronutrients|mesh-ancestor
110813666|NCT02282800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110813667|NCT02282800|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110813669|NCT05208034|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110813670|NCT05208034|Abortifacient Agents|abortifacient agents|mesh-ancestor
110813671|NCT05208034|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110813672|NCT05208034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110813673|NCT05208034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110813674|NCT05208034|Antimetabolites|antimetabolites|mesh-ancestor
110813675|NCT05208034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110813676|NCT05208034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110813677|NCT05208034|Dermatologic Agents|dermatologic agents|mesh-ancestor
110813678|NCT05208034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110813679|NCT05208034|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110813680|NCT05208034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110531245|NCT00911313|Metformin|metformin|mesh-list
110813681|NCT05208034|Immunologic Factors|immunologic factors|mesh-ancestor
110813682|NCT05208034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110813683|NCT05208034|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110813684|NCT02284282|Lidocaine|lidocaine|mesh-list
110813685|NCT02284282|Morphine|morphine|mesh-list
110813686|NCT02284282|Bupivacaine|bupivacaine|mesh-list
110813687|NCT02284282|Anesthetics, Local|anesthetics, local|mesh-ancestor
110813688|NCT02284282|Anesthetics|anesthetics|mesh-ancestor
110813689|NCT02284282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110813690|NCT02284282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110813691|NCT02284282|Sensory System Agents|sensory system agents|mesh-ancestor
110813692|NCT02284282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110813693|NCT02284282|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110813694|NCT02284282|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110813695|NCT02284282|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110813696|NCT02284282|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110813697|NCT02284282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110813698|NCT02284282|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110813699|NCT02284282|Narcotics|narcotics|mesh-ancestor
110813700|NCT02284282|Analgesics|analgesics|mesh-ancestor
110813701|NCT00359086|Mocetinostat|mocetinostat|mesh-list
110813702|NCT00359086|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110813703|NCT00359086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110813704|NCT00359086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110813705|NCT03133780|Midazolam|midazolam|mesh-list
110813706|NCT03133780|Ketamine|ketamine|mesh-list
110813707|NCT03133780|Analgesics|analgesics|mesh-ancestor
110813708|NCT03133780|Sensory System Agents|sensory system agents|mesh-ancestor
110813709|NCT03133780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110813710|NCT03133780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110813711|NCT03133780|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110813712|NCT03133780|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110813713|NCT03133780|Anesthetics, General|anesthetics, general|mesh-ancestor
110813714|NCT03133780|Anesthetics|anesthetics|mesh-ancestor
110813715|NCT03133780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110813716|NCT03133780|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110813717|NCT03133780|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110813718|NCT03133780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110813719|NCT03133780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110813720|NCT03133780|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110813721|NCT03133780|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110813722|NCT03133780|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110813723|NCT03133780|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110813724|NCT03133780|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110813725|NCT03133780|GABA Modulators|gaba modulators|mesh-ancestor
110813726|NCT03133780|GABA Agents|gaba agents|mesh-ancestor
110813727|NCT02282956|Droperidol|droperidol|mesh-list
110813728|NCT02282956|Morphine|morphine|mesh-list
110813729|NCT02282956|Ropivacaine|ropivacaine|mesh-list
110813730|NCT02282956|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110813731|NCT02282956|Narcotics|narcotics|mesh-ancestor
110813732|NCT02282956|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110813733|NCT02282956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110813734|NCT02282956|Analgesics|analgesics|mesh-ancestor
110813735|NCT02282956|Sensory System Agents|sensory system agents|mesh-ancestor
110813736|NCT02282956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110813737|NCT02282956|Anesthetics, Local|anesthetics, local|mesh-ancestor
110813738|NCT02282956|Anesthetics|anesthetics|mesh-ancestor
110813739|NCT02282956|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110813740|NCT02282956|Antiemetics|antiemetics|mesh-ancestor
110813741|NCT02282956|Autonomic Agents|autonomic agents|mesh-ancestor
110813742|NCT02282956|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110813743|NCT02282956|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110813744|NCT02282956|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110813745|NCT02282956|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110813746|NCT02282956|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110813747|NCT02282956|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110813748|NCT02282956|Dopamine Agents|dopamine agents|mesh-ancestor
110813749|NCT02282956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110813750|NCT02282956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110813751|NCT02287558|Pomalidomide|pomalidomide|mesh-list
110813752|NCT02287558|Immunologic Factors|immunologic factors|mesh-ancestor
110813753|NCT02287558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110813754|NCT02287558|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110813755|NCT02287558|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110813756|NCT02287558|Growth Substances|growth substances|mesh-ancestor
110813757|NCT02287558|Growth Inhibitors|growth inhibitors|mesh-ancestor
110813758|NCT02287558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110813759|NCT04470076|Carboplatin|carboplatin|mesh-list
110813760|NCT04470076|Gemcitabine|gemcitabine|mesh-list
110813762|NCT04470076|Afatinib|afatinib|mesh-list
110813763|NCT04470076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110813764|NCT04470076|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110813765|NCT04470076|Antimetabolites|antimetabolites|mesh-ancestor
110863873|NCT03634020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110813766|NCT04470076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110813767|NCT04470076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110813768|NCT04470076|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110813769|NCT04470076|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110813770|NCT04470076|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110813771|NCT00445198|Navitoclax|navitoclax|mesh-list
110813772|NCT00445198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110813773|NCT00345748|Abatacept|abatacept|mesh-list
110813774|NCT00345748|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110813775|NCT00345748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110813776|NCT00345748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110813777|NCT00345748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110813778|NCT00345748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110813779|NCT00345748|Immunologic Factors|immunologic factors|mesh-ancestor
110813780|NCT00345748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110813781|NCT00345748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110813782|NCT00439738|Amlodipine|amlodipine|mesh-list
110813783|NCT00439738|Valsartan|valsartan|mesh-list
110813784|NCT00439738|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110813785|NCT00439738|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110813786|NCT00439738|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110813787|NCT00439738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110813788|NCT00439738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110813789|NCT00439738|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110813790|NCT00439738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110813791|NCT00439738|Vasodilator Agents|vasodilator agents|mesh-ancestor
110813792|NCT00439738|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110813793|NCT00439738|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110813794|NCT00439738|Diuretics|diuretics|mesh-ancestor
110813795|NCT00439738|Natriuretic Agents|natriuretic agents|mesh-ancestor
110813796|NCT00439738|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110813797|NCT00435916|Dacetuzumab|dacetuzumab|mesh-list
110813798|NCT00435916|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110813799|NCT00435916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110813801|NCT00523042|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110813802|NCT00523042|Insulin Aspart|insulin aspart|mesh-list
110813803|NCT00523042|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110813804|NCT00523042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110813805|NCT00338104|Insulin|insulin|mesh-list
110813806|NCT00338104|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110813807|NCT00338104|Insulin Glargine|insulin glargine|mesh-list
110813808|NCT00338104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110813809|NCT00338104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110813810|NCT00519142|Mitiglinide|mitiglinide|mesh-list
110813811|NCT00519142|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110813812|NCT00519142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110813813|NCT02284672|Dexmedetomidine|dexmedetomidine|mesh-list
110813814|NCT02284672|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110813815|NCT02284672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110813816|NCT02284672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110813817|NCT02284672|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110813818|NCT02284672|Analgesics|analgesics|mesh-ancestor
110813819|NCT02284672|Sensory System Agents|sensory system agents|mesh-ancestor
110813821|NCT02284672|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110813822|NCT02284672|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110813823|NCT02284672|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110813824|NCT02284672|Adrenergic Agents|adrenergic agents|mesh-ancestor
110813825|NCT02284672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110813826|NCT02284672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110813827|NCT02283190|Asparaginase|asparaginase|mesh-list
110813828|NCT02283190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110813829|NCT00333502|Camptothecin|camptothecin|mesh-list
110813830|NCT00333502|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110813831|NCT00333502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110813832|NCT00333502|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110813833|NCT00333502|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110813834|NCT00333502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110813835|NCT00333502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110813836|NCT05982704|Cilgavimab and tixagevimab drug combination|cilgavimab and tixagevimab drug combination|mesh-list
110813837|NCT05982704|Antiviral Agents|antiviral agents|mesh-ancestor
110813838|NCT05982704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110813839|NCT05982678|Trastuzumab|trastuzumab|mesh-list
110813840|NCT05982678|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
110813841|NCT05982678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110813842|NCT05982678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110813843|NCT05982678|Immunoconjugates|immunoconjugates|mesh-ancestor
110813844|NCT05982678|Immunologic Factors|immunologic factors|mesh-ancestor
110813845|NCT05982678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110813846|NCT05982587|Calcium Carbonate|calcium carbonate|mesh-list
110813847|NCT05982587|Antacids|antacids|mesh-ancestor
110813848|NCT05982587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110813849|NCT05982587|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110813850|NCT05982522|Paclitaxel|paclitaxel|mesh-list
110813851|NCT05982522|Tislelizumab|tislelizumab|mesh-list
110813852|NCT05982522|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110813853|NCT05982522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110813854|NCT05982522|Tubulin Modulators|tubulin modulators|mesh-ancestor
110813855|NCT05982522|Antimitotic Agents|antimitotic agents|mesh-ancestor
110813856|NCT05982522|Mitosis Modulators|mitosis modulators|mesh-ancestor
110813857|NCT05982522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110813858|NCT05982522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110813859|NCT05982483|Bupivacaine|bupivacaine|mesh-list
110813860|NCT05982483|Anesthetics, Local|anesthetics, local|mesh-ancestor
110813861|NCT05982483|Anesthetics|anesthetics|mesh-ancestor
110813862|NCT05982483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110813863|NCT05982483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110813864|NCT05982483|Sensory System Agents|sensory system agents|mesh-ancestor
110813865|NCT05982483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110813866|NCT05982470|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110813867|NCT05982470|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110813868|NCT05982470|Estradiol|estradiol|mesh-list
110813869|NCT05982470|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110813871|NCT05982470|Estrogens|estrogens|mesh-ancestor
110813872|NCT05982470|Hormones|hormones|mesh-ancestor
110813873|NCT05982470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110813874|NCT05982470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110813875|NCT05982470|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110813876|NCT05982470|Contraceptive Agents|contraceptive agents|mesh-ancestor
110813877|NCT05982470|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110813878|NCT05982470|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110813879|NCT05982470|Progestins|progestins|mesh-ancestor
110813880|NCT05982340|Lithium Carbonate|lithium carbonate|mesh-list
110813881|NCT05982340|Antidepressive Agents|antidepressive agents|mesh-ancestor
110813882|NCT05982340|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110813883|NCT05982340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110417707|NCT05625308|Antioxidants|antioxidants|mesh-ancestor
110813884|NCT05982340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110813885|NCT05982340|Antimanic Agents|antimanic agents|mesh-ancestor
110813886|NCT05982340|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110813887|NCT05982340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110813888|NCT05982340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110813889|NCT05982314|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110813890|NCT05982314|Immunologic Factors|immunologic factors|mesh-ancestor
110813891|NCT05982314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110813892|NCT05982301|Paclitaxel|paclitaxel|mesh-list
110813897|NCT05982301|Antimitotic Agents|antimitotic agents|mesh-ancestor
110813898|NCT05982301|Mitosis Modulators|mitosis modulators|mesh-ancestor
110813899|NCT05982301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110813900|NCT05982197|Curcumin|curcumin|mesh-list
110813901|NCT05982197|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110813902|NCT05982197|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110813903|NCT05982197|Analgesics|analgesics|mesh-ancestor
110813904|NCT05982197|Sensory System Agents|sensory system agents|mesh-ancestor
110813905|NCT05982197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110813906|NCT05982197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110813908|NCT05982197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110813909|NCT05982197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110813910|NCT05982197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110813911|NCT05982197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110813912|NCT05982093|Triptorelin Pamoate|triptorelin pamoate|mesh-list
110813913|NCT05982093|Luteolytic Agents|luteolytic agents|mesh-ancestor
110813914|NCT05982093|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110813915|NCT05982093|Contraceptive Agents|contraceptive agents|mesh-ancestor
110813916|NCT05982093|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110813917|NCT05982093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110813918|NCT05982093|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110813919|NCT05982093|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110813920|NCT05982093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110813921|NCT05981976|Abatacept|abatacept|mesh-list
110813922|NCT05981976|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110813923|NCT05981976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110813924|NCT05981976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110813925|NCT05981976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110813926|NCT05981976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110813927|NCT05981976|Immunologic Factors|immunologic factors|mesh-ancestor
110813928|NCT05981976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110813929|NCT05981976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110813930|NCT05981742|Metformin|metformin|mesh-list
110813931|NCT05981742|Cabergoline|cabergoline|mesh-list
110813932|NCT05981742|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110813933|NCT05981742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110813934|NCT05981742|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110813935|NCT05981742|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110813936|NCT05981742|Dopamine Agonists|dopamine agonists|mesh-ancestor
110813937|NCT05981742|Dopamine Agents|dopamine agents|mesh-ancestor
110813938|NCT05981742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110813939|NCT05981742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110813940|NCT05981534|Vitamin D|vitamin d|mesh-list
110813941|NCT05981534|Vitamins|vitamins|mesh-ancestor
110188085|NCT04580134|Risperidone|risperidone|mesh-list
110813942|NCT05981534|Micronutrients|micronutrients|mesh-ancestor
110813943|NCT05981534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110813944|NCT05981534|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110813945|NCT05981209|Dexamethasone|dexamethasone|mesh-list
110813946|NCT05981209|Dexamethasone acetate|dexamethasone acetate|mesh-list
110813947|NCT05981209|Elotuzumab|elotuzumab|mesh-list
110813948|NCT05981209|Ichthammol|ichthammol|mesh-list
110813949|NCT05981209|BB 1101|bb 1101|mesh-list
110813950|NCT05981209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110813951|NCT05981209|Antiemetics|antiemetics|mesh-ancestor
110813952|NCT05981209|Autonomic Agents|autonomic agents|mesh-ancestor
110813953|NCT05981209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110813954|NCT05981209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110813955|NCT05981209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110813956|NCT05981209|Glucocorticoids|glucocorticoids|mesh-ancestor
110813957|NCT05981209|Hormones|hormones|mesh-ancestor
110813958|NCT05981209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110813959|NCT05981209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110813960|NCT05981209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110813961|NCT05981209|Protease Inhibitors|protease inhibitors|mesh-ancestor
110813962|NCT05981209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110813963|NCT05981209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110813964|NCT05981209|Dermatologic Agents|dermatologic agents|mesh-ancestor
110813985|NCT05981053|Resveratrol|resveratrol|mesh-list
110813986|NCT05981053|Antioxidants|antioxidants|mesh-ancestor
110813987|NCT05981053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110813988|NCT05981053|Protective Agents|protective agents|mesh-ancestor
110813989|NCT05981053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110813990|NCT05981053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110813991|NCT05981053|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110813992|NCT05981014|Paclitaxel|paclitaxel|mesh-list
110813993|NCT05981014|Cyclophosphamide|cyclophosphamide|mesh-list
110813994|NCT05981014|Doxorubicin|doxorubicin|mesh-list
110813995|NCT05981014|Fludarabine|fludarabine|mesh-list
110813996|NCT05981014|Interleukin-2|interleukin-2|mesh-list
110813997|NCT05981014|Epirubicin|epirubicin|mesh-list
110813998|NCT05981014|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110813999|NCT05981014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110814000|NCT05981014|Tubulin Modulators|tubulin modulators|mesh-ancestor
110814001|NCT05981014|Antimitotic Agents|antimitotic agents|mesh-ancestor
110814002|NCT05981014|Mitosis Modulators|mitosis modulators|mesh-ancestor
110814003|NCT05981014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110814004|NCT05981014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110814005|NCT05981014|Immunologic Factors|immunologic factors|mesh-ancestor
110814006|NCT05981014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110814007|NCT05981014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110814008|NCT05981014|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110814009|NCT05981014|Alkylating Agents|alkylating agents|mesh-ancestor
110814010|NCT05981014|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110814011|NCT05981014|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110814012|NCT05981014|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110814013|NCT05981014|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110814014|NCT05981014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110814015|NCT05981014|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110814016|NCT05981014|Analgesics|analgesics|mesh-ancestor
110814017|NCT05981014|Sensory System Agents|sensory system agents|mesh-ancestor
110814018|NCT05981014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110814019|NCT05981001|Paclitaxel|paclitaxel|mesh-list
110814020|NCT05981001|Cyclophosphamide|cyclophosphamide|mesh-list
110814021|NCT05981001|Carboplatin|carboplatin|mesh-list
110814022|NCT05981001|Gemcitabine|gemcitabine|mesh-list
110814023|NCT05981001|Fludarabine|fludarabine|mesh-list
110814024|NCT05981001|Interleukin-2|interleukin-2|mesh-list
110814025|NCT05981001|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110814026|NCT05981001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110814027|NCT05981001|Tubulin Modulators|tubulin modulators|mesh-ancestor
110814028|NCT05981001|Antimitotic Agents|antimitotic agents|mesh-ancestor
110814029|NCT05981001|Mitosis Modulators|mitosis modulators|mesh-ancestor
110814030|NCT05981001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110814031|NCT05981001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110814032|NCT05981001|Immunologic Factors|immunologic factors|mesh-ancestor
110814033|NCT05981001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110814034|NCT05981001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110814035|NCT05981001|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110814036|NCT05981001|Alkylating Agents|alkylating agents|mesh-ancestor
110814037|NCT05981001|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110814038|NCT05981001|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110814039|NCT05981001|Antimetabolites|antimetabolites|mesh-ancestor
110814040|NCT05981001|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110814041|NCT05981001|Analgesics|analgesics|mesh-ancestor
110814042|NCT05981001|Sensory System Agents|sensory system agents|mesh-ancestor
110814043|NCT05981001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110139247|NCT02913196|Prednisone|prednisone|mesh-list
110814045|NCT05980871|Ceftriaxone|ceftriaxone|mesh-list
110814046|NCT05980871|Penicillins|penicillins|mesh-list
110814047|NCT05980871|Penicillin G|penicillin g|mesh-list
110814048|NCT05980871|Penicillin G Benzathine|penicillin g benzathine|mesh-list
110814049|NCT05980871|Penicillin G Procaine|penicillin g procaine|mesh-list
110814050|NCT05980871|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110814051|NCT05980871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110814052|NCT05980871|Antimalarials|antimalarials|mesh-ancestor
110814053|NCT05980871|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110814054|NCT05980871|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110814055|NCT05980715|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
110814056|NCT05980715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110814057|NCT05980715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110814058|NCT05980715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110814059|NCT05980689|Capecitabine|capecitabine|mesh-list
110814060|NCT05980689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110814061|NCT05980689|Antimetabolites|antimetabolites|mesh-ancestor
110814062|NCT05980689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110417780|NCT04319978|Glucocorticoids|glucocorticoids|mesh-ancestor
110814063|NCT05980689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110814064|NCT05980598|Pembrolizumab|pembrolizumab|mesh-list
110814065|NCT05980598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110814066|NCT05980598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110814067|NCT05980598|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110814068|NCT05980598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110814069|NCT05980559|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
110814070|NCT05980559|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110814071|NCT05980559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110814072|NCT05980559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110814073|NCT05980559|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110814074|NCT05980559|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110814075|NCT05980559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110814076|NCT05980559|Cholinergic Agents|cholinergic agents|mesh-ancestor
110814077|NCT05980559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110814078|NCT05980481|Capecitabine|capecitabine|mesh-list
110814079|NCT05980481|Oxaliplatin|oxaliplatin|mesh-list
110814080|NCT05980481|Trastuzumab|trastuzumab|mesh-list
110814081|NCT05980481|Disitamab vedotin|disitamab vedotin|mesh-list
110814082|NCT05980481|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110814083|NCT05980481|Antimetabolites|antimetabolites|mesh-ancestor
110814084|NCT05980481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110814085|NCT05980481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110814086|NCT05980481|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110814087|NCT05980481|Immunoconjugates|immunoconjugates|mesh-ancestor
110814088|NCT05980481|Immunologic Factors|immunologic factors|mesh-ancestor
110814089|NCT05980481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110814090|NCT05979597|Dexamethasone|dexamethasone|mesh-list
110814091|NCT05979597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110814092|NCT05979597|Antiemetics|antiemetics|mesh-ancestor
110814093|NCT05979597|Autonomic Agents|autonomic agents|mesh-ancestor
110814094|NCT05979597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110814095|NCT05979597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110814096|NCT05979597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110814097|NCT05979597|Glucocorticoids|glucocorticoids|mesh-ancestor
110814098|NCT05979597|Hormones|hormones|mesh-ancestor
110814099|NCT05979597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110814100|NCT05979597|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110814101|NCT05979597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110814103|NCT05979389|Androgen Antagonists|androgen antagonists|mesh-ancestor
110814104|NCT05979389|Hormone Antagonists|hormone antagonists|mesh-ancestor
110814105|NCT05979389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110814106|NCT05979389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110814107|NCT05979389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110814108|NCT05979038|Metformin|metformin|mesh-list
110814109|NCT05979038|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110814110|NCT05979038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110814111|NCT05978219|Mirtazapine|mirtazapine|mesh-list
110814112|NCT05978219|Antidepressive Agents|antidepressive agents|mesh-ancestor
110814113|NCT05978219|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110814114|NCT05978219|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110814115|NCT05978219|Histamine Antagonists|histamine antagonists|mesh-ancestor
110814116|NCT05978219|Histamine Agents|histamine agents|mesh-ancestor
110814117|NCT05978219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110814118|NCT05978219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110814119|NCT05978219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110814120|NCT05978219|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110814121|NCT05978219|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110814122|NCT05978219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110814123|NCT05978219|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
110814124|NCT05978219|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110814125|NCT05978219|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110814126|NCT05978219|Adrenergic Agents|adrenergic agents|mesh-ancestor
110814127|NCT05978219|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110814128|NCT05978219|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110814129|NCT05978219|Serotonin Agents|serotonin agents|mesh-ancestor
110814130|NCT05978219|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110814131|NCT05977673|Tislelizumab|tislelizumab|mesh-list
110814132|NCT05977673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110814133|NCT05977673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110814134|NCT05975489|Caffeine|caffeine|mesh-list
110814135|NCT05975489|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110814136|NCT05975489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110814137|NCT05975489|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110814138|NCT05975489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110814139|NCT05975489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110814140|NCT05975489|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110814141|NCT05975489|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110814142|NCT05975489|Purinergic Agents|purinergic agents|mesh-ancestor
110814143|NCT05975489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110814144|NCT05966688|Azithromycin|azithromycin|mesh-list
110814145|NCT05966688|Ethambutol|ethambutol|mesh-list
110814146|NCT05966688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110814147|NCT05966688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110814148|NCT05966688|Antitubercular Agents|antitubercular agents|mesh-ancestor
110814149|NCT05965583|Itraconazole|itraconazole|mesh-list
110814150|NCT05965583|Antifungal Agents|antifungal agents|mesh-ancestor
110814151|NCT05965583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110814152|NCT05965583|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110814153|NCT05965583|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110814154|NCT05965583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110814155|NCT05965583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110814156|NCT05965583|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110814157|NCT05965583|Hormone Antagonists|hormone antagonists|mesh-ancestor
110417825|NCT02702180|Sargramostim|sargramostim|mesh-list
110814158|NCT05965583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110814159|NCT05965583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110814160|NCT05965583|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110814161|NCT05965544|Fentanyl|fentanyl|mesh-list
110814162|NCT05965544|Bupivacaine|bupivacaine|mesh-list
110814163|NCT05965544|Anesthetics, Local|anesthetics, local|mesh-ancestor
110814164|NCT05965544|Anesthetics|anesthetics|mesh-ancestor
110814165|NCT05965544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110814166|NCT05965544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110814167|NCT05965544|Sensory System Agents|sensory system agents|mesh-ancestor
110814168|NCT05965544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110814169|NCT05965544|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110814170|NCT05965544|Narcotics|narcotics|mesh-ancestor
110814171|NCT05965544|Analgesics|analgesics|mesh-ancestor
110814172|NCT05965544|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110814173|NCT05965544|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110814174|NCT05965544|Anesthetics, General|anesthetics, general|mesh-ancestor
110814175|NCT05947201|Paclitaxel|paclitaxel|mesh-list
110814176|NCT05947201|Fluorouracil|fluorouracil|mesh-list
110814177|NCT05947201|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110814178|NCT05947201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110814179|NCT05947201|Tubulin Modulators|tubulin modulators|mesh-ancestor
110814180|NCT05947201|Antimitotic Agents|antimitotic agents|mesh-ancestor
110814181|NCT05947201|Mitosis Modulators|mitosis modulators|mesh-ancestor
110814182|NCT05947201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110814183|NCT05947201|Antimetabolites|antimetabolites|mesh-ancestor
110814184|NCT05947201|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110814185|NCT05947201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110814186|NCT05947201|Immunologic Factors|immunologic factors|mesh-ancestor
110814187|NCT05947201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110814188|NCT05945823|Calcium, Dietary|calcium, dietary|mesh-list
110814189|NCT05945823|Leucovorin|leucovorin|mesh-list
110814190|NCT05945823|Pembrolizumab|pembrolizumab|mesh-list
110814191|NCT05945823|Oxaliplatin|oxaliplatin|mesh-list
110814192|NCT05945823|Futibatinib|futibatinib|mesh-list
110814193|NCT05945823|Calcium|calcium|mesh-list
110814194|NCT05945823|Levoleucovorin|levoleucovorin|mesh-list
110814195|NCT05945823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110814196|NCT05945823|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110814197|NCT05945823|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110814198|NCT05945823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110814199|NCT05945823|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110814200|NCT05945823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110814201|NCT05945823|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110814202|NCT05945823|Antidotes|antidotes|mesh-ancestor
110814203|NCT05945823|Protective Agents|protective agents|mesh-ancestor
110814204|NCT05945823|Vitamin B Complex|vitamin b complex|mesh-ancestor
110814205|NCT05945823|Vitamins|vitamins|mesh-ancestor
110814206|NCT05945823|Micronutrients|micronutrients|mesh-ancestor
110814207|NCT05944016|Dapagliflozin|dapagliflozin|mesh-list
110814208|NCT05944016|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110814209|NCT05944016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110814210|NCT05944016|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110814211|NCT05944016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110814212|NCT05914389|Capecitabine|capecitabine|mesh-list
110814213|NCT05914389|Oxaliplatin|oxaliplatin|mesh-list
110814214|NCT05914389|Antibodies|antibodies|mesh-list
110814215|NCT05914389|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110814216|NCT05914389|Immunologic Factors|immunologic factors|mesh-ancestor
110814217|NCT05914389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110814218|NCT05914389|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110814219|NCT05914389|Antimetabolites|antimetabolites|mesh-ancestor
110814220|NCT05914389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110814221|NCT05914389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110814222|NCT05909553|Venetoclax|venetoclax|mesh-list
110814223|NCT05909553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110814224|NCT05909267|Carbidopa|carbidopa|mesh-list
110814225|NCT05909267|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110814226|NCT05909267|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110814227|NCT05909267|Dopamine Agents|dopamine agents|mesh-ancestor
110814228|NCT05909267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110814229|NCT05909267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110814230|NCT05909267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110814231|NCT05909267|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
110814232|NCT05909267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110814233|NCT05906589|Psyllium|psyllium|mesh-list
110814234|NCT05906589|Cathartics|cathartics|mesh-ancestor
110814235|NCT05906589|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110814236|NCT05886140|Paclitaxel|paclitaxel|mesh-list
110814237|NCT05886140|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110814238|NCT05886140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110814239|NCT05886140|Tubulin Modulators|tubulin modulators|mesh-ancestor
110814240|NCT05886140|Antimitotic Agents|antimitotic agents|mesh-ancestor
110814241|NCT05886140|Mitosis Modulators|mitosis modulators|mesh-ancestor
110814242|NCT05886140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110814243|NCT05885074|Empagliflozin|empagliflozin|mesh-list
110814244|NCT05885074|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110814245|NCT05885074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110814246|NCT05885074|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110814247|NCT05885074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110814248|NCT05872685|Oxaliplatin|oxaliplatin|mesh-list
110814249|NCT05872685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110814250|NCT05870319|Carboplatin|carboplatin|mesh-list
110814251|NCT05870319|Pemetrexed|pemetrexed|mesh-list
110814252|NCT05870319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110814253|NCT05870319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110814254|NCT05870319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110814255|NCT05870319|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110814256|NCT05870319|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110814257|NCT05863364|Rifaximin|rifaximin|mesh-list
110814258|NCT05863364|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110814259|NCT05863364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110814260|NCT05863364|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110814261|NCT05848375|Levobupivacaine|levobupivacaine|mesh-list
110814262|NCT05848375|Ropivacaine|ropivacaine|mesh-list
110814263|NCT05848375|Anesthetics, Local|anesthetics, local|mesh-ancestor
110814264|NCT05848375|Anesthetics|anesthetics|mesh-ancestor
110814265|NCT05848375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110814266|NCT05848375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110814267|NCT05848375|Sensory System Agents|sensory system agents|mesh-ancestor
110814268|NCT05848375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110814270|NCT05816252|Pembrolizumab|pembrolizumab|mesh-list
110814271|NCT05816252|Osimertinib|osimertinib|mesh-list
110814272|NCT05816252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110814273|NCT05816252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110814274|NCT05816252|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110814275|NCT05816252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110814276|NCT05816252|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110814277|NCT05816252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110814278|NCT05801172|Ketoprofen|ketoprofen|mesh-list
110814279|NCT05801172|Lidocaine|lidocaine|mesh-list
110814280|NCT05801172|Anesthetics|anesthetics|mesh-list
110814281|NCT05801172|Anesthetics, Local|anesthetics, local|mesh-ancestor
110814282|NCT05801172|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110531832|NCT03794336|Acarbose|acarbose|mesh-list
110814283|NCT05801172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110814284|NCT05801172|Sensory System Agents|sensory system agents|mesh-ancestor
110814285|NCT05801172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110814286|NCT05801172|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110814287|NCT05801172|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110814288|NCT05801172|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110814289|NCT05801172|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110814290|NCT05801172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110814291|NCT05801172|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110814292|NCT05801172|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110814293|NCT05801172|Analgesics|analgesics|mesh-ancestor
110814294|NCT05801172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110814295|NCT05801172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110814296|NCT05801172|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110814297|NCT05801172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110814298|NCT05772871|Levamisole|levamisole|mesh-list
110814299|NCT05772871|Prednisone|prednisone|mesh-list
110814300|NCT05772871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110814301|NCT05772871|Glucocorticoids|glucocorticoids|mesh-ancestor
110814302|NCT05772871|Hormones|hormones|mesh-ancestor
110814303|NCT05772871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110814304|NCT05772871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110814305|NCT05772871|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110814306|NCT05772871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110814307|NCT05772871|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110814308|NCT05772871|Immunologic Factors|immunologic factors|mesh-ancestor
110814309|NCT05772871|Antinematodal Agents|antinematodal agents|mesh-ancestor
110814310|NCT05772871|Anthelmintics|anthelmintics|mesh-ancestor
110814311|NCT05772871|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110814312|NCT05772871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110814313|NCT05772871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110814314|NCT05761223|Pembrolizumab|pembrolizumab|mesh-list
110814315|NCT05761223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110814316|NCT05761223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110814317|NCT05761223|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110814318|NCT05761223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110814319|NCT05758818|Moxifloxacin|moxifloxacin|mesh-list
110814320|NCT05758818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110814321|NCT05758818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110814322|NCT05758818|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110814323|NCT05758818|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110814324|NCT05758818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110417898|NCT02865616|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110814325|NCT05758818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110814326|NCT05758818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110814327|NCT05757648|Anesthetics|anesthetics|mesh-list
110814328|NCT05757648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110814329|NCT05757648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110814330|NCT05696093|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110814331|NCT05696093|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
110814332|NCT05696093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110814333|NCT05696093|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110814334|NCT05696093|Antimalarials|antimalarials|mesh-ancestor
110814335|NCT05696093|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110814336|NCT05696093|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110814337|NCT05679258|Daratumumab|daratumumab|mesh-list
110814338|NCT05679258|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110814339|NCT05679258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110814340|NCT05679258|Immunologic Factors|immunologic factors|mesh-ancestor
110814341|NCT05679258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110814342|NCT05674877|Dexmedetomidine|dexmedetomidine|mesh-list
110814343|NCT05674877|Ketamine|ketamine|mesh-list
110814344|NCT05674877|Analgesics, Opioid|analgesics, opioid|mesh-list
110814345|NCT05674877|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110814346|NCT05674877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110814347|NCT05674877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110814348|NCT05674877|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110814349|NCT05674877|Analgesics|analgesics|mesh-ancestor
110814350|NCT05674877|Sensory System Agents|sensory system agents|mesh-ancestor
110814351|NCT05674877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110814352|NCT05674877|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110814353|NCT05674877|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110814354|NCT05674877|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110814355|NCT05674877|Adrenergic Agents|adrenergic agents|mesh-ancestor
110814356|NCT05674877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110814357|NCT05674877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110814358|NCT05674877|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110814359|NCT05674877|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110814360|NCT05674877|Anesthetics, General|anesthetics, general|mesh-ancestor
110814361|NCT05674877|Anesthetics|anesthetics|mesh-ancestor
110814362|NCT05674877|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110814363|NCT05674877|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110814364|NCT05674877|Narcotics|narcotics|mesh-ancestor
110814366|NCT05659914|Olaparib|olaparib|mesh-list
110814367|NCT05659914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110814368|NCT05659914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110814369|NCT05659914|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110814370|NCT05659914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110814371|NCT05659914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110814372|NCT05570812|Neurosteroids|neurosteroids|mesh-list
110814373|NCT05570812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110814374|NCT05570812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110814375|NCT05570812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110814376|NCT05534672|Sirolimus|sirolimus|mesh-list
110814377|NCT05534672|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110814378|NCT05534672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110814379|NCT05534672|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110814380|NCT05534672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110814381|NCT05534672|Antifungal Agents|antifungal agents|mesh-ancestor
110814382|NCT05534672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110814383|NCT05534672|Immunologic Factors|immunologic factors|mesh-ancestor
110814384|NCT05534672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110814385|NCT05527548|Alendronate|alendronate|mesh-list
110814386|NCT05527548|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110814387|NCT05527548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110814388|NCT05498675|Valsartan|valsartan|mesh-list
110814389|NCT05498675|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
110814390|NCT05498675|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110814391|NCT05498675|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110814392|NCT05498675|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110814393|NCT05498675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110814394|NCT05469204|Acetaminophen|acetaminophen|mesh-list
110814395|NCT05469204|Digoxin|digoxin|mesh-list
110814396|NCT05469204|Midazolam|midazolam|mesh-list
110814397|NCT05469204|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110814398|NCT05469204|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110814399|NCT05469204|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110814400|NCT05469204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110814401|NCT05469204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110814402|NCT05469204|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110814403|NCT05469204|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110814404|NCT05469204|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110814405|NCT05469204|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110814406|NCT05469204|Anesthetics, General|anesthetics, general|mesh-ancestor
110814407|NCT05469204|Anesthetics|anesthetics|mesh-ancestor
110814408|NCT05469204|GABA Modulators|gaba modulators|mesh-ancestor
110814409|NCT05469204|GABA Agents|gaba agents|mesh-ancestor
110814410|NCT05469204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110814411|NCT05469204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110814412|NCT05469204|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110814413|NCT05469204|Analgesics|analgesics|mesh-ancestor
110814414|NCT05469204|Sensory System Agents|sensory system agents|mesh-ancestor
110814415|NCT05469204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110814416|NCT05469204|Antipyretics|antipyretics|mesh-ancestor
110814417|NCT05469204|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110814418|NCT05469204|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110814419|NCT05469204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110814420|NCT05469204|Protective Agents|protective agents|mesh-ancestor
110814421|NCT05456295|Carbon Fiber|carbon fiber|mesh-list
110814422|NCT05456295|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110814423|NCT05456295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110814424|NCT05419362|Avelumab|avelumab|mesh-list
110814425|NCT05419362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110814426|NCT05419362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110814427|NCT05390528|Antibodies, Bispecific|antibodies, bispecific|mesh-list
110814428|NCT05390528|Immunologic Factors|immunologic factors|mesh-ancestor
110814429|NCT05390528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110814430|NCT05384119|Fulvestrant|fulvestrant|mesh-list
110532000|NCT00615446|Sunitinib|sunitinib|mesh-list
110814432|NCT05384119|Aromatase Inhibitors|aromatase inhibitors|mesh-list
110814433|NCT05384119|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110814434|NCT05384119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110814435|NCT05384119|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110814436|NCT05384119|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110814437|NCT05384119|Hormone Antagonists|hormone antagonists|mesh-ancestor
110814438|NCT05384119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110814439|NCT05384119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110814440|NCT05384119|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110814441|NCT05384119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110814442|NCT05384119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110814443|NCT05384119|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110814444|NCT05374057|Ibuprofen|ibuprofen|mesh-list
110814445|NCT05374057|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110814446|NCT05374057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110814447|NCT05374057|Analgesics|analgesics|mesh-ancestor
110814448|NCT05374057|Sensory System Agents|sensory system agents|mesh-ancestor
110814449|NCT05374057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110814450|NCT05374057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110814451|NCT05374057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110814452|NCT05374057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110814453|NCT05374057|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110814454|NCT05374057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110814455|NCT05374057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110814456|NCT05371093|Prednisone|prednisone|mesh-list
110814457|NCT05371093|Cyclophosphamide|cyclophosphamide|mesh-list
110814458|NCT05371093|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110814459|NCT05371093|Rituximab|rituximab|mesh-list
110814460|NCT05371093|Doxorubicin|doxorubicin|mesh-list
110814461|NCT05371093|Fludarabine|fludarabine|mesh-list
110814462|NCT05371093|Vincristine|vincristine|mesh-list
110814463|NCT05371093|Lenalidomide|lenalidomide|mesh-list
110814464|NCT05371093|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
110814465|NCT05371093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110814466|NCT05371093|Immunologic Factors|immunologic factors|mesh-ancestor
110814467|NCT05371093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110814468|NCT05371093|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110814469|NCT05371093|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110814470|NCT05371093|Alkylating Agents|alkylating agents|mesh-ancestor
110814471|NCT05371093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110814472|NCT05371093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110814473|NCT05371093|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110814474|NCT05371093|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110814475|NCT05371093|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110814476|NCT05371093|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110814477|NCT05371093|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110814478|NCT05371093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110814479|NCT05371093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110814480|NCT05371093|Glucocorticoids|glucocorticoids|mesh-ancestor
110814481|NCT05371093|Hormones|hormones|mesh-ancestor
110814482|NCT05371093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110814483|NCT05371093|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110814484|NCT05371093|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110814485|NCT05371093|Tubulin Modulators|tubulin modulators|mesh-ancestor
110814486|NCT05371093|Antimitotic Agents|antimitotic agents|mesh-ancestor
110814487|NCT05371093|Mitosis Modulators|mitosis modulators|mesh-ancestor
110814488|NCT05371093|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110814489|NCT05371093|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110814490|NCT05371093|Growth Substances|growth substances|mesh-ancestor
110814492|NCT05352516|Denosumab|denosumab|mesh-list
110814493|NCT05352516|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110814494|NCT05352516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110814495|NCT05346484|Pembrolizumab|pembrolizumab|mesh-list
110814496|NCT05346484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110814497|NCT05346484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110814498|NCT05346484|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110814499|NCT05346484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110814500|NCT05345613|Epinephrine|epinephrine|mesh-list
110814501|NCT05345613|Tranexamic Acid|tranexamic acid|mesh-list
110814502|NCT05345613|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110814503|NCT05345613|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110814504|NCT05345613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110814505|NCT05345613|Hemostatics|hemostatics|mesh-ancestor
110814506|NCT05345613|Coagulants|coagulants|mesh-ancestor
110814507|NCT05345613|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110814508|NCT05345613|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110814509|NCT05345613|Adrenergic Agents|adrenergic agents|mesh-ancestor
110814510|NCT05345613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110814511|NCT05345613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110814512|NCT05345613|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110814513|NCT05345613|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110814514|NCT05345613|Autonomic Agents|autonomic agents|mesh-ancestor
110814515|NCT05345613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110853873|NCT05464940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110814516|NCT05345613|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110814517|NCT05345613|Respiratory System Agents|respiratory system agents|mesh-ancestor
110814518|NCT05345613|Mydriatics|mydriatics|mesh-ancestor
110814519|NCT05345613|Sympathomimetics|sympathomimetics|mesh-ancestor
110814520|NCT05345613|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110814521|NCT05246514|Trastuzumab|trastuzumab|mesh-list
110814522|NCT05246514|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
110814523|NCT05246514|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110814524|NCT05246514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110814525|NCT05246514|Immunoconjugates|immunoconjugates|mesh-ancestor
110814526|NCT05246514|Immunologic Factors|immunologic factors|mesh-ancestor
110814527|NCT05246514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110814528|NCT05238831|Paclitaxel|paclitaxel|mesh-list
110814529|NCT05238831|Vinorelbine|vinorelbine|mesh-list
110814530|NCT05238831|Maytansine|maytansine|mesh-list
110814531|NCT05238831|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
110814532|NCT05238831|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110814533|NCT05238831|Bevacizumab|bevacizumab|mesh-list
110814534|NCT05238831|Carboplatin|carboplatin|mesh-list
110814535|NCT05238831|Capecitabine|capecitabine|mesh-list
110814536|NCT05238831|Trastuzumab|trastuzumab|mesh-list
110814537|NCT05238831|Irinotecan|irinotecan|mesh-list
110814538|NCT05238831|Atezolizumab|atezolizumab|mesh-list
110814539|NCT05238831|Letrozole|letrozole|mesh-list
110814540|NCT05238831|Fulvestrant|fulvestrant|mesh-list
110814541|NCT05238831|Olaparib|olaparib|mesh-list
110814542|NCT05238831|Palbociclib|palbociclib|mesh-list
110814543|NCT05238831|Pertuzumab|pertuzumab|mesh-list
110814544|NCT05238831|Anastrozole|anastrozole|mesh-list
110814545|NCT05238831|Niraparib|niraparib|mesh-list
110814546|NCT05238831|Vemurafenib|vemurafenib|mesh-list
110814547|NCT05238831|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
110814548|NCT05238831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110814549|NCT05238831|Endothelial Growth Factors|endothelial growth factors|mesh-list
110814550|NCT05238831|Antibodies|antibodies|mesh-list
110814551|NCT05238831|Immunoglobulins|immunoglobulins|mesh-list
110814552|NCT05238831|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110814553|NCT05238831|Immunoglobulin G|immunoglobulin g|mesh-list
110814554|NCT05238831|Entrectinib|entrectinib|mesh-list
110814555|NCT05238831|Immunoconjugates|immunoconjugates|mesh-list
110814556|NCT05238831|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-list
110814557|NCT05238831|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110814558|NCT05238831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110814559|NCT05238831|Tubulin Modulators|tubulin modulators|mesh-ancestor
110814560|NCT05238831|Antimitotic Agents|antimitotic agents|mesh-ancestor
110814561|NCT05238831|Mitosis Modulators|mitosis modulators|mesh-ancestor
110814562|NCT05238831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110814563|NCT05238831|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110814564|NCT05238831|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110814565|NCT05238831|Growth Substances|growth substances|mesh-ancestor
110814566|NCT05238831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110814567|NCT05238831|Growth Inhibitors|growth inhibitors|mesh-ancestor
110814568|NCT05238831|Immunologic Factors|immunologic factors|mesh-ancestor
110814569|NCT05238831|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110814570|NCT05238831|Antimetabolites|antimetabolites|mesh-ancestor
110814571|NCT05238831|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110814572|NCT05238831|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110814573|NCT05238831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110814574|NCT05238831|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110814575|NCT05238831|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110814576|NCT05238831|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110814577|NCT05238831|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110814578|NCT05238831|Hormone Antagonists|hormone antagonists|mesh-ancestor
110814579|NCT05238831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110814580|NCT05238831|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110814581|NCT05238831|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110814582|NCT05238831|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110814584|NCT05238831|Immunotoxins|immunotoxins|mesh-ancestor
110814585|NCT05222516|Broncho-Vaxom|broncho-vaxom|mesh-list
110814586|NCT05222516|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110814587|NCT05222516|Immunologic Factors|immunologic factors|mesh-ancestor
110418017|NCT01111851|Aprepitant|aprepitant|mesh-list
110814588|NCT05222516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110814589|NCT05209360|Carbon Fiber|carbon fiber|mesh-list
110814590|NCT05209360|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110814591|NCT05209360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110814592|NCT05180474|Antibodies|antibodies|mesh-list
110814593|NCT05180474|Antibodies, Bispecific|antibodies, bispecific|mesh-list
110814594|NCT05180474|Immunologic Factors|immunologic factors|mesh-ancestor
110814595|NCT05180474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110814596|NCT05149131|Leuprolide|leuprolide|mesh-list
110814597|NCT05149131|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110814598|NCT05149131|Fertility Agents|fertility agents|mesh-ancestor
110814599|NCT05149131|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110814600|NCT05149131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110814601|NCT05149131|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110814602|NCT05149131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110814603|NCT05139043|Dexamethasone|dexamethasone|mesh-list
110814604|NCT05139043|Dexamethasone acetate|dexamethasone acetate|mesh-list
110814605|NCT05139043|Ichthammol|ichthammol|mesh-list
110814606|NCT05139043|BB 1101|bb 1101|mesh-list
110814607|NCT05139043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110814608|NCT05139043|Antiemetics|antiemetics|mesh-ancestor
110814609|NCT05139043|Autonomic Agents|autonomic agents|mesh-ancestor
110814610|NCT05139043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110814611|NCT05139043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110814612|NCT05139043|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110814613|NCT05139043|Glucocorticoids|glucocorticoids|mesh-ancestor
110814614|NCT05139043|Hormones|hormones|mesh-ancestor
110814615|NCT05139043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110814616|NCT05139043|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110814617|NCT05139043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110814618|NCT05139043|Protease Inhibitors|protease inhibitors|mesh-ancestor
110814619|NCT05139043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110814620|NCT05139043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110814621|NCT05139043|Dermatologic Agents|dermatologic agents|mesh-ancestor
110814622|NCT05136703|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
110814623|NCT05136703|Antiviral Agents|antiviral agents|mesh-ancestor
110814624|NCT05136703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110814625|NCT05116293|Acetaminophen|acetaminophen|mesh-list
110814626|NCT05116293|Digoxin|digoxin|mesh-list
110814627|NCT05116293|Midazolam|midazolam|mesh-list
110814628|NCT05116293|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110814629|NCT05116293|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110814630|NCT05116293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110814631|NCT05116293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110814632|NCT05116293|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110814633|NCT05116293|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110814634|NCT05116293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110814635|NCT05116293|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110814636|NCT05116293|Anesthetics, General|anesthetics, general|mesh-ancestor
110814637|NCT05116293|Anesthetics|anesthetics|mesh-ancestor
110814638|NCT05116293|GABA Modulators|gaba modulators|mesh-ancestor
110814639|NCT05116293|GABA Agents|gaba agents|mesh-ancestor
110814640|NCT05116293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110814641|NCT05116293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110814642|NCT05116293|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110814643|NCT05116293|Analgesics|analgesics|mesh-ancestor
110814644|NCT05116293|Sensory System Agents|sensory system agents|mesh-ancestor
110814645|NCT05116293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110814646|NCT05116293|Antipyretics|antipyretics|mesh-ancestor
110814647|NCT05116293|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110814649|NCT05116293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110814650|NCT05116293|Protective Agents|protective agents|mesh-ancestor
110814651|NCT05116189|Paclitaxel|paclitaxel|mesh-list
110814652|NCT05116189|Docetaxel|docetaxel|mesh-list
110814653|NCT05116189|Bevacizumab|bevacizumab|mesh-list
110814654|NCT05116189|Pembrolizumab|pembrolizumab|mesh-list
110814655|NCT05116189|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110814656|NCT05116189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110814657|NCT05116189|Tubulin Modulators|tubulin modulators|mesh-ancestor
110814658|NCT05116189|Antimitotic Agents|antimitotic agents|mesh-ancestor
110814659|NCT05116189|Mitosis Modulators|mitosis modulators|mesh-ancestor
110814660|NCT05116189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110814661|NCT05116189|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110814662|NCT05116189|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110814663|NCT05116189|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110814665|NCT05116189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110814666|NCT05116189|Growth Inhibitors|growth inhibitors|mesh-ancestor
110814667|NCT05116189|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110814668|NCT05104567|Pembrolizumab|pembrolizumab|mesh-list
110814669|NCT05104567|Cetuximab|cetuximab|mesh-list
110814670|NCT05104567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110814671|NCT05104567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110814672|NCT05104567|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110814673|NCT05104567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110814674|NCT05097651|Cannabidiol|cannabidiol|mesh-list
110814675|NCT05097651|Anticonvulsants|anticonvulsants|mesh-ancestor
110814676|NCT05086224|Lidocaine|lidocaine|mesh-list
110814677|NCT05086224|Anesthetics, Local|anesthetics, local|mesh-list
110814678|NCT05086224|Anesthetics|anesthetics|mesh-list
110814679|NCT05086224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110814680|NCT05086224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110814681|NCT05086224|Sensory System Agents|sensory system agents|mesh-ancestor
110814682|NCT05086224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110814683|NCT05086224|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110814684|NCT05086224|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110814685|NCT05086224|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110814686|NCT05086224|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110814687|NCT05086224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110814688|NCT05038904|Acalabrutinib|acalabrutinib|mesh-list
110814689|NCT05038904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110814690|NCT05005182|Hydroxyurea|hydroxyurea|mesh-list
110814691|NCT05005182|Luspatercept|luspatercept|mesh-list
110814692|NCT05005182|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
110814693|NCT05005182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110814694|NCT05005182|Antisickling Agents|antisickling agents|mesh-ancestor
110814695|NCT05005182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110814696|NCT05005182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110814697|NCT05005182|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110814698|NCT05005182|Hematinics|hematinics|mesh-ancestor
110814699|NCT05005182|Immunologic Factors|immunologic factors|mesh-ancestor
110814700|NCT05005182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110814701|NCT05000216|Mycophenolic Acid|mycophenolic acid|mesh-list
110814702|NCT05000216|Methotrexate|methotrexate|mesh-list
110814703|NCT05000216|Vaccines|vaccines|mesh-list
110814704|NCT05000216|Immunosuppressive Agents|immunosuppressive agents|mesh-list
110814705|NCT05000216|Immunologic Factors|immunologic factors|mesh-ancestor
110814706|NCT05000216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110814707|NCT05000216|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110814708|NCT05000216|Abortifacient Agents|abortifacient agents|mesh-ancestor
110814709|NCT05000216|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110814710|NCT05000216|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110814711|NCT05000216|Antimetabolites|antimetabolites|mesh-ancestor
110814712|NCT05000216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110814713|NCT05000216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110814714|NCT05000216|Dermatologic Agents|dermatologic agents|mesh-ancestor
110814715|NCT05000216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110814716|NCT05000216|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110814717|NCT05000216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110814718|NCT05000216|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110814719|NCT05000216|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110814720|NCT05000216|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110814721|NCT05000216|Antitubercular Agents|antitubercular agents|mesh-ancestor
110418083|NCT01254890|Sorafenib|sorafenib|mesh-list
110814722|NCT05000216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110814723|NCT05000216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110814724|NCT04996251|Bupivacaine|bupivacaine|mesh-list
110814725|NCT04996251|Anesthetics, Local|anesthetics, local|mesh-ancestor
110814726|NCT04996251|Anesthetics|anesthetics|mesh-ancestor
110814727|NCT04996251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110814728|NCT04996251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110814729|NCT04996251|Sensory System Agents|sensory system agents|mesh-ancestor
110814730|NCT04996251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110814731|NCT04976387|Acetaminophen|acetaminophen|mesh-list
110814732|NCT04976387|Ibuprofen|ibuprofen|mesh-list
110853890|NCT03799757|Bupivacaine|bupivacaine|mesh-list
110814733|NCT04976387|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
110532288|NCT04214990|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110814734|NCT04976387|Hydrocodone|hydrocodone|mesh-list
110814735|NCT04976387|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110814736|NCT04976387|Analgesics|analgesics|mesh-ancestor
110814737|NCT04976387|Sensory System Agents|sensory system agents|mesh-ancestor
110814738|NCT04976387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110814739|NCT04976387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110814740|NCT04976387|Antipyretics|antipyretics|mesh-ancestor
110814741|NCT04976387|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110814742|NCT04976387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110814743|NCT04976387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110814744|NCT04976387|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110814745|NCT04976387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110814746|NCT04976387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110814747|NCT04976387|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110814748|NCT04976387|Narcotics|narcotics|mesh-ancestor
110814749|NCT04976387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110814750|NCT04976387|Antitussive Agents|antitussive agents|mesh-ancestor
110814751|NCT04976387|Respiratory System Agents|respiratory system agents|mesh-ancestor
110814753|NCT04941872|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110814754|NCT04941872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110814755|NCT04939272|Venetoclax|venetoclax|mesh-list
110814756|NCT04939272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110814757|NCT04935359|Paclitaxel|paclitaxel|mesh-list
110814758|NCT04935359|Gemcitabine|gemcitabine|mesh-list
110814759|NCT04935359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110814760|NCT04935359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110814761|NCT04935359|Tubulin Modulators|tubulin modulators|mesh-ancestor
110814762|NCT04935359|Antimitotic Agents|antimitotic agents|mesh-ancestor
110814763|NCT04935359|Mitosis Modulators|mitosis modulators|mesh-ancestor
110814764|NCT04935359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110814765|NCT04935359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110814766|NCT04935359|Antimetabolites|antimetabolites|mesh-ancestor
110814767|NCT04915755|Niraparib|niraparib|mesh-list
110814768|NCT04915755|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110814769|NCT04915755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110814770|NCT04915755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110814771|NCT04915755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110814772|NCT04914897|Pembrolizumab|pembrolizumab|mesh-list
110814773|NCT04914897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110814774|NCT04914897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110814775|NCT04914897|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110814776|NCT04914897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110814777|NCT04897321|Cyclophosphamide|cyclophosphamide|mesh-list
110814778|NCT04897321|Fludarabine|fludarabine|mesh-list
110814779|NCT04897321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110814780|NCT04897321|Immunologic Factors|immunologic factors|mesh-ancestor
110814781|NCT04897321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110814782|NCT04897321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110814783|NCT04897321|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110814784|NCT04897321|Alkylating Agents|alkylating agents|mesh-ancestor
110814785|NCT04897321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110814786|NCT04897321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110814787|NCT04897321|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110814788|NCT04879823|Acetaminophen|acetaminophen|mesh-list
110814789|NCT04879823|Dexamethasone|dexamethasone|mesh-list
110814790|NCT04879823|Ibuprofen|ibuprofen|mesh-list
110814791|NCT04879823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110814792|NCT04879823|Antiemetics|antiemetics|mesh-ancestor
110814793|NCT04879823|Autonomic Agents|autonomic agents|mesh-ancestor
110814794|NCT04879823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110814795|NCT04879823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110814796|NCT04879823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110814797|NCT04879823|Glucocorticoids|glucocorticoids|mesh-ancestor
110814798|NCT04879823|Hormones|hormones|mesh-ancestor
110814799|NCT04879823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110853897|NCT03327454|Etanercept|etanercept|mesh-list
110814800|NCT04879823|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110814801|NCT04879823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110814802|NCT04879823|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110814803|NCT04879823|Analgesics|analgesics|mesh-ancestor
110814804|NCT04879823|Sensory System Agents|sensory system agents|mesh-ancestor
110814805|NCT04879823|Antipyretics|antipyretics|mesh-ancestor
110814806|NCT04879823|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110532372|NCT00616070|Hormones|hormones|mesh-ancestor
110814807|NCT04879823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110814808|NCT04879823|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110814810|NCT04879823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110814811|NCT04879524|Botulinum Toxins|botulinum toxins|mesh-list
110814812|NCT04879524|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110814813|NCT04879524|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110814814|NCT04879524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110814815|NCT04879524|Cholinergic Agents|cholinergic agents|mesh-ancestor
110814816|NCT04879524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110814817|NCT04879524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110814818|NCT04844918|Tirzepatide|tirzepatide|mesh-list
110814819|NCT04844918|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110814820|NCT04844918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110814821|NCT04844918|Incretins|incretins|mesh-ancestor
110814822|NCT04844918|Hormones|hormones|mesh-ancestor
110814823|NCT04844918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110814824|NCT04826354|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110814825|NCT04826354|Ezetimibe|ezetimibe|mesh-list
110814826|NCT04826354|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110814827|NCT04826354|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110814828|NCT04826354|Antimetabolites|antimetabolites|mesh-ancestor
110814829|NCT04826354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110814830|NCT04826354|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110814831|NCT04826354|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110814832|NCT04826354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110814833|NCT04781998|Liraglutide|liraglutide|mesh-list
110814834|NCT04781998|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110814835|NCT04781998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110814836|NCT04781998|Incretins|incretins|mesh-ancestor
110814837|NCT04781998|Hormones|hormones|mesh-ancestor
110814838|NCT04781998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110814839|NCT04770610|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110814840|NCT04770610|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110814841|NCT04708613|Corticosterone|corticosterone|mesh-list
110814842|NCT04708613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110814843|NCT04677387|Naloxone|naloxone|mesh-list
110814844|NCT04677387|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110814845|NCT04677387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110814846|NCT04677387|Sensory System Agents|sensory system agents|mesh-ancestor
110814847|NCT04677387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110814848|NCT04664738|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
110814849|NCT04664738|Hemostatics|hemostatics|mesh-ancestor
110814850|NCT04664738|Coagulants|coagulants|mesh-ancestor
110814851|NCT04663347|Cytarabine|cytarabine|mesh-list
110814852|NCT04663347|Dexamethasone|dexamethasone|mesh-list
110814853|NCT04663347|Prednisone|prednisone|mesh-list
110814854|NCT04663347|Cyclophosphamide|cyclophosphamide|mesh-list
110814855|NCT04663347|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110814856|NCT04663347|Ifosfamide|ifosfamide|mesh-list
110814857|NCT04663347|Rituximab|rituximab|mesh-list
110814858|NCT04663347|Carboplatin|carboplatin|mesh-list
110814859|NCT04663347|Gemcitabine|gemcitabine|mesh-list
110814860|NCT04663347|Doxorubicin|doxorubicin|mesh-list
110814861|NCT04663347|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110814862|NCT04663347|Oxaliplatin|oxaliplatin|mesh-list
110814863|NCT04663347|Etoposide|etoposide|mesh-list
110814864|NCT04663347|Vincristine|vincristine|mesh-list
110814865|NCT04663347|Lenalidomide|lenalidomide|mesh-list
110814866|NCT04663347|Etoposide phosphate|etoposide phosphate|mesh-list
110814867|NCT04663347|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110814868|NCT04663347|Immunologic Factors|immunologic factors|mesh-ancestor
110814869|NCT04663347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110814870|NCT04663347|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110814871|NCT04663347|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110814872|NCT04663347|Alkylating Agents|alkylating agents|mesh-ancestor
110814873|NCT04663347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110814874|NCT04663347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110814875|NCT04663347|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110814876|NCT04663347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110814877|NCT04663347|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110814879|NCT04663347|Autonomic Agents|autonomic agents|mesh-ancestor
110814880|NCT04663347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110814881|NCT04663347|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110814882|NCT04663347|Glucocorticoids|glucocorticoids|mesh-ancestor
110814883|NCT04663347|Hormones|hormones|mesh-ancestor
110814884|NCT04663347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110814885|NCT04663347|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110814886|NCT04663347|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110814887|NCT04663347|Antimetabolites|antimetabolites|mesh-ancestor
110814888|NCT04663347|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110814889|NCT04663347|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110814890|NCT04663347|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110814891|NCT04663347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110814892|NCT04663347|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110814893|NCT04663347|Antiviral Agents|antiviral agents|mesh-ancestor
110814894|NCT04663347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110814895|NCT04663347|Tubulin Modulators|tubulin modulators|mesh-ancestor
110814896|NCT04663347|Antimitotic Agents|antimitotic agents|mesh-ancestor
110814897|NCT04663347|Mitosis Modulators|mitosis modulators|mesh-ancestor
110814898|NCT04663347|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110814899|NCT04663347|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110814900|NCT04663347|Growth Substances|growth substances|mesh-ancestor
110814901|NCT04663347|Growth Inhibitors|growth inhibitors|mesh-ancestor
110814902|NCT04623541|Prednisone|prednisone|mesh-list
110814903|NCT04623541|Cyclophosphamide|cyclophosphamide|mesh-list
110814904|NCT04623541|Rituximab|rituximab|mesh-list
110814905|NCT04623541|Doxorubicin|doxorubicin|mesh-list
110814906|NCT04623541|Vincristine|vincristine|mesh-list
110814907|NCT04623541|Lenalidomide|lenalidomide|mesh-list
110814908|NCT04623541|Venetoclax|venetoclax|mesh-list
110814909|NCT04623541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110814910|NCT04623541|Immunologic Factors|immunologic factors|mesh-ancestor
110814911|NCT04623541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110814912|NCT04623541|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110814913|NCT04623541|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110814914|NCT04623541|Alkylating Agents|alkylating agents|mesh-ancestor
110418206|NCT01254656|Efavirenz|efavirenz|mesh-list
110814915|NCT04623541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110814916|NCT04623541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110814917|NCT04623541|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110814918|NCT04623541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110814919|NCT04623541|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110814920|NCT04623541|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110814921|NCT04623541|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110814922|NCT04623541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110814923|NCT04623541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110814924|NCT04623541|Glucocorticoids|glucocorticoids|mesh-ancestor
110814925|NCT04623541|Hormones|hormones|mesh-ancestor
110814926|NCT04623541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110814927|NCT04623541|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110814928|NCT04623541|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110814929|NCT04623541|Tubulin Modulators|tubulin modulators|mesh-ancestor
110814930|NCT04623541|Antimitotic Agents|antimitotic agents|mesh-ancestor
110814931|NCT04623541|Mitosis Modulators|mitosis modulators|mesh-ancestor
110814932|NCT04623541|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110814933|NCT04623541|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110814934|NCT04623541|Growth Substances|growth substances|mesh-ancestor
110814935|NCT04623541|Growth Inhibitors|growth inhibitors|mesh-ancestor
110814936|NCT04601402|Avelumab|avelumab|mesh-list
110814937|NCT04601402|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110853909|NCT03799913|Cyclophosphamide|cyclophosphamide|mesh-list
110814939|NCT04584255|Niraparib|niraparib|mesh-list
110814940|NCT04584255|Dostarlimab|dostarlimab|mesh-list
110814941|NCT04584255|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110814942|NCT04584255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110814943|NCT04584255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110814944|NCT04584255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110814945|NCT04569032|Prednisone|prednisone|mesh-list
110814946|NCT04569032|Cyclophosphamide|cyclophosphamide|mesh-list
110814947|NCT04569032|Doxorubicin|doxorubicin|mesh-list
110814948|NCT04569032|Brentuximab Vedotin|brentuximab vedotin|mesh-list
110814949|NCT04569032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110814950|NCT04569032|Immunologic Factors|immunologic factors|mesh-ancestor
110814951|NCT04569032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110814952|NCT04569032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110814953|NCT04569032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110814954|NCT04569032|Alkylating Agents|alkylating agents|mesh-ancestor
110814955|NCT04569032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110814956|NCT04569032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110814957|NCT04569032|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110814958|NCT04569032|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110814959|NCT04569032|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110814960|NCT04569032|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110814962|NCT04569032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110814963|NCT04569032|Glucocorticoids|glucocorticoids|mesh-ancestor
110814964|NCT04569032|Hormones|hormones|mesh-ancestor
110814965|NCT04569032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110814966|NCT04569032|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110814967|NCT04569032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110814968|NCT04569032|Immunotoxins|immunotoxins|mesh-ancestor
110814969|NCT04569032|Immunoconjugates|immunoconjugates|mesh-ancestor
110814970|NCT04562896|Carbon Fiber|carbon fiber|mesh-list
110814971|NCT04562896|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110814972|NCT04562896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110814973|NCT04562246|Antibodies|antibodies|mesh-list
110814974|NCT04562246|Immunologic Factors|immunologic factors|mesh-ancestor
110814975|NCT04562246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110814976|NCT04560595|Caffeine|caffeine|mesh-list
110814977|NCT04560595|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110814978|NCT04560595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110814979|NCT04560595|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110814980|NCT04560595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110814981|NCT04560595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110814982|NCT04560595|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110814983|NCT04560595|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110814984|NCT04560595|Purinergic Agents|purinergic agents|mesh-ancestor
110814985|NCT04560595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110814986|NCT04545710|Osimertinib|osimertinib|mesh-list
110814987|NCT04545710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110814988|NCT04545710|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110814989|NCT04545710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110814990|NCT04545710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110814991|NCT04539938|Trastuzumab|trastuzumab|mesh-list
110814992|NCT04539938|Tucatinib|tucatinib|mesh-list
110814993|NCT04539938|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
110814994|NCT04539938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110814995|NCT04539938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110814996|NCT04539938|Immunoconjugates|immunoconjugates|mesh-ancestor
110814997|NCT04539938|Immunologic Factors|immunologic factors|mesh-ancestor
110814998|NCT04539938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110814999|NCT04539938|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110815000|NCT04539938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110815001|NCT04539938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110815002|NCT04530981|Repaglinide|repaglinide|mesh-list
110815003|NCT04530981|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110815004|NCT04530981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110815005|NCT04526899|Cemiplimab|cemiplimab|mesh-list
110815006|NCT04526899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110815007|NCT04526899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110815008|NCT04520178|Carbidopa|carbidopa|mesh-list
110815009|NCT04520178|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
110815010|NCT04520178|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110815012|NCT04520178|Dopamine Agents|dopamine agents|mesh-ancestor
110815013|NCT04520178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110815014|NCT04520178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110815015|NCT04520178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110815016|NCT04520178|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
110815017|NCT04520178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110815018|NCT04520178|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110815019|NCT04520178|Antidepressive Agents|antidepressive agents|mesh-ancestor
110815020|NCT04520178|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110815021|NCT04418427|Aflibercept|aflibercept|mesh-list
110815022|NCT04418427|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110815023|NCT04418427|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110815024|NCT04418427|Growth Substances|growth substances|mesh-ancestor
110815025|NCT04418427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110815026|NCT04418427|Growth Inhibitors|growth inhibitors|mesh-ancestor
110815027|NCT04418427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110815028|NCT04416165|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110815029|NCT04416165|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110815030|NCT04416165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110815031|NCT04415944|Carboplatin|carboplatin|mesh-list
110815032|NCT04415944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110815033|NCT04398368|Gemcitabine|gemcitabine|mesh-list
110532587|NCT00618644|Ranibizumab|ranibizumab|mesh-list
110815034|NCT04398368|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110815035|NCT04398368|Antimetabolites|antimetabolites|mesh-ancestor
110815036|NCT04398368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110815037|NCT04398368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110815038|NCT04378959|Lidocaine|lidocaine|mesh-list
110815039|NCT04378959|Anesthetics, Local|anesthetics, local|mesh-ancestor
110815040|NCT04378959|Anesthetics|anesthetics|mesh-ancestor
110815041|NCT04378959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110815042|NCT04378959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110815043|NCT04378959|Sensory System Agents|sensory system agents|mesh-ancestor
110815044|NCT04378959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110815045|NCT04378959|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110815046|NCT04378959|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110815047|NCT04378959|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110815048|NCT04378959|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110815049|NCT04378959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110815050|NCT04310930|Azithromycin|azithromycin|mesh-list
110815051|NCT04310930|Moxifloxacin|moxifloxacin|mesh-list
110815052|NCT04310930|Clarithromycin|clarithromycin|mesh-list
110815053|NCT04310930|Doxycycline|doxycycline|mesh-list
110815054|NCT04310930|Linezolid|linezolid|mesh-list
110815055|NCT04310930|Imipenem|imipenem|mesh-list
110815056|NCT04310930|Amikacin|amikacin|mesh-list
110815057|NCT04310930|Ethambutol|ethambutol|mesh-list
110815058|NCT04310930|Rifabutin|rifabutin|mesh-list
110815059|NCT04310930|Tigecycline|tigecycline|mesh-list
110815060|NCT04310930|Bedaquiline|bedaquiline|mesh-list
110815061|NCT04310930|Clofazimine|clofazimine|mesh-list
110815062|NCT04310930|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
110815063|NCT04310930|Cefoxitin|cefoxitin|mesh-list
110815064|NCT04310930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110815065|NCT04310930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110815066|NCT04310930|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110815067|NCT04310930|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110815068|NCT04310930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110815069|NCT04310930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110815070|NCT04310930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110418279|NCT01109979|Diuretics|diuretics|mesh-ancestor
110815071|NCT04310930|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110815072|NCT04310930|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110815073|NCT04310930|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110815074|NCT04310930|Antimalarials|antimalarials|mesh-ancestor
110815075|NCT04310930|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110815076|NCT04310930|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110815077|NCT04310930|Antitubercular Agents|antitubercular agents|mesh-ancestor
110815078|NCT04310930|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110815079|NCT04310930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110815080|NCT04310930|Leprostatic Agents|leprostatic agents|mesh-ancestor
110815081|NCT04310930|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110815082|NCT04297995|Carboplatin|carboplatin|mesh-list
110815083|NCT04297995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110815084|NCT04224688|Rozanolixizumab|rozanolixizumab|mesh-list
110815085|NCT04224688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110815086|NCT04224688|Immunologic Factors|immunologic factors|mesh-ancestor
110815087|NCT04224688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110815088|NCT04204122|Moxifloxacin|moxifloxacin|mesh-list
110815089|NCT04204122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110815090|NCT04204122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110815091|NCT04204122|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110815092|NCT04204122|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110815093|NCT04204122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110815094|NCT04204122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110815095|NCT04204122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110815096|NCT04200456|Rozanolixizumab|rozanolixizumab|mesh-list
110815097|NCT04200456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110815098|NCT04200456|Immunologic Factors|immunologic factors|mesh-ancestor
110815099|NCT04200456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110815101|NCT04196413|Fludarabine|fludarabine|mesh-list
110815102|NCT04196413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110815103|NCT04196413|Immunologic Factors|immunologic factors|mesh-ancestor
110815104|NCT04196413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110815105|NCT04196413|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110815106|NCT04196413|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110815107|NCT04196413|Alkylating Agents|alkylating agents|mesh-ancestor
110815108|NCT04196413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110815109|NCT04196413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110815110|NCT04196413|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110815112|NCT04164732|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
110815113|NCT04164732|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110815114|NCT04164732|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110815115|NCT04164732|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110815116|NCT04164732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110815117|NCT04126135|Nicotine|nicotine|mesh-list
110815118|NCT04126135|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110815119|NCT04126135|Autonomic Agents|autonomic agents|mesh-ancestor
110815120|NCT04126135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110815121|NCT04126135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110815122|NCT04126135|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110815123|NCT04126135|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110815124|NCT04126135|Cholinergic Agents|cholinergic agents|mesh-ancestor
110815125|NCT04126135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110815126|NCT04126135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110815127|NCT04117932|Ustekinumab|ustekinumab|mesh-list
110815128|NCT04117932|Dermatologic Agents|dermatologic agents|mesh-ancestor
110815129|NCT04033354|Paclitaxel|paclitaxel|mesh-list
110815130|NCT04033354|Carboplatin|carboplatin|mesh-list
110815131|NCT04033354|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110815132|NCT04033354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110815133|NCT04033354|Tubulin Modulators|tubulin modulators|mesh-ancestor
110815134|NCT04033354|Antimitotic Agents|antimitotic agents|mesh-ancestor
110815135|NCT04033354|Mitosis Modulators|mitosis modulators|mesh-ancestor
110815136|NCT04033354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110815137|NCT03952403|Bevacizumab|bevacizumab|mesh-list
110815138|NCT03952403|Carboplatin|carboplatin|mesh-list
110815139|NCT03952403|Pemetrexed|pemetrexed|mesh-list
110815140|NCT03952403|Antibodies|antibodies|mesh-list
110815141|NCT03952403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110815142|NCT03952403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110815143|NCT03952403|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110815144|NCT03952403|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110815145|NCT03952403|Growth Substances|growth substances|mesh-ancestor
110815146|NCT03952403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110815147|NCT03952403|Growth Inhibitors|growth inhibitors|mesh-ancestor
110853923|NCT01304069|Analgesics|analgesics|mesh-ancestor
110815148|NCT03952403|Immunologic Factors|immunologic factors|mesh-ancestor
110815149|NCT03952403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110815150|NCT03952403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110815151|NCT03952403|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110815152|NCT03952403|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110815153|NCT03918278|Paclitaxel|paclitaxel|mesh-list
110815154|NCT03918278|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110815155|NCT03918278|Carboplatin|carboplatin|mesh-list
110815156|NCT03918278|Gemcitabine|gemcitabine|mesh-list
110815157|NCT03918278|Pembrolizumab|pembrolizumab|mesh-list
110815158|NCT03918278|Pemetrexed|pemetrexed|mesh-list
110815159|NCT03918278|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110815160|NCT03918278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110815161|NCT03918278|Tubulin Modulators|tubulin modulators|mesh-ancestor
110815162|NCT03918278|Antimitotic Agents|antimitotic agents|mesh-ancestor
110815163|NCT03918278|Mitosis Modulators|mitosis modulators|mesh-ancestor
110815164|NCT03918278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110815165|NCT03918278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110815166|NCT03918278|Antimetabolites|antimetabolites|mesh-ancestor
110815167|NCT03918278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110815168|NCT03918278|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110815169|NCT03918278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110815170|NCT03918278|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110815171|NCT03918278|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110815172|NCT03904251|Cytarabine|cytarabine|mesh-list
110815173|NCT03904251|Daunorubicin|daunorubicin|mesh-list
110815175|NCT03904251|Calicheamicins|calicheamicins|mesh-list
110815176|NCT03904251|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110815177|NCT03904251|Antimetabolites|antimetabolites|mesh-ancestor
110815178|NCT03904251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110815179|NCT03904251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110815180|NCT03904251|Antiviral Agents|antiviral agents|mesh-ancestor
110815181|NCT03904251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110815182|NCT03904251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110815183|NCT03904251|Immunologic Factors|immunologic factors|mesh-ancestor
110815184|NCT03904251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110418310|NCT05506982|Psilocybin|psilocybin|mesh-list
110815185|NCT03904251|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110815186|NCT03904251|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110815187|NCT03904251|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110815188|NCT03904251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110815189|NCT03904251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110815190|NCT03904251|Immunotoxins|immunotoxins|mesh-ancestor
110815191|NCT03904251|Immunoconjugates|immunoconjugates|mesh-ancestor
110815192|NCT03748784|Aflibercept|aflibercept|mesh-list
110815193|NCT03748784|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110815194|NCT03748784|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110815195|NCT03748784|Growth Substances|growth substances|mesh-ancestor
110815196|NCT03748784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110815197|NCT03748784|Growth Inhibitors|growth inhibitors|mesh-ancestor
110815198|NCT03748784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110815199|NCT03727776|Hormones|hormones|mesh-list
110815200|NCT03727776|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
110815201|NCT03727776|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
110815202|NCT03727776|beta-Endorphin|beta-endorphin|mesh-list
110815203|NCT03727776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110815204|NCT03727776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110815205|NCT03727776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110815206|NCT03727776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110815207|NCT03701711|Lenalidomide|lenalidomide|mesh-list
110815208|NCT03701711|Immunologic Factors|immunologic factors|mesh-ancestor
110815209|NCT03701711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110815210|NCT03701711|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110815211|NCT03701711|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110815212|NCT03701711|Growth Substances|growth substances|mesh-ancestor
110815213|NCT03701711|Growth Inhibitors|growth inhibitors|mesh-ancestor
110815214|NCT03701711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110815215|NCT03654274|Norethindrone|norethindrone|mesh-list
110815216|NCT03654274|Norethindrone Acetate|norethindrone acetate|mesh-list
110815217|NCT03654274|Estradiol|estradiol|mesh-list
110815218|NCT03654274|Relugolix|relugolix|mesh-list
110815219|NCT03654274|Estrogens|estrogens|mesh-ancestor
110815220|NCT03654274|Hormones|hormones|mesh-ancestor
110815221|NCT03654274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110815222|NCT03654274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110815223|NCT03654274|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110815224|NCT03654274|Contraceptive Agents|contraceptive agents|mesh-ancestor
110815225|NCT03654274|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110815226|NCT03654274|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110815227|NCT03654274|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110815228|NCT03654274|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110815229|NCT03654274|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110815230|NCT03654274|Androgen Antagonists|androgen antagonists|mesh-ancestor
110815231|NCT03654274|Hormone Antagonists|hormone antagonists|mesh-ancestor
110815232|NCT03635021|Bevacizumab|bevacizumab|mesh-list
110815233|NCT03635021|Panitumumab|panitumumab|mesh-list
110815234|NCT03635021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110815235|NCT03635021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110815236|NCT03635021|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110815237|NCT03635021|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110815238|NCT03635021|Growth Substances|growth substances|mesh-ancestor
110815239|NCT03635021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110815240|NCT03635021|Growth Inhibitors|growth inhibitors|mesh-ancestor
110815241|NCT03551964|Ticagrelor|ticagrelor|mesh-list
110815242|NCT03551964|Cangrelor|cangrelor|mesh-list
110815243|NCT03551964|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110815244|NCT03551964|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110815245|NCT03551964|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110815246|NCT03551964|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110815247|NCT03551964|Purinergic Agents|purinergic agents|mesh-ancestor
110140481|NCT04112641|Niacin|niacin|mesh-list
110815248|NCT03551964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110815249|NCT03551964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110815250|NCT03551964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110815251|NCT03449108|Aldesleukin|aldesleukin|mesh-list
110815252|NCT03449108|Cyclophosphamide|cyclophosphamide|mesh-list
110815253|NCT03449108|Nivolumab|nivolumab|mesh-list
110815254|NCT03449108|Fludarabine|fludarabine|mesh-list
110815255|NCT03449108|Ipilimumab|ipilimumab|mesh-list
110532803|NCT04212000|Ketoconazole|ketoconazole|mesh-list
110815256|NCT03449108|Interleukin-2|interleukin-2|mesh-list
110815257|NCT03449108|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110815258|NCT03449108|Immunologic Factors|immunologic factors|mesh-ancestor
110815259|NCT03449108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110815260|NCT03449108|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110815261|NCT03449108|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110815262|NCT03449108|Alkylating Agents|alkylating agents|mesh-ancestor
110815263|NCT03449108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110815264|NCT03449108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110815265|NCT03449108|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110815266|NCT03449108|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110815267|NCT03449108|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110815268|NCT03449108|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110815269|NCT03449108|Analgesics|analgesics|mesh-ancestor
110815270|NCT03449108|Sensory System Agents|sensory system agents|mesh-ancestor
110815271|NCT03449108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110815272|NCT03449108|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110815273|NCT03449108|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110815274|NCT03449108|Antiviral Agents|antiviral agents|mesh-ancestor
110815275|NCT03449108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110815276|NCT03417882|Pembrolizumab|pembrolizumab|mesh-list
110815277|NCT03417882|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110815278|NCT03417882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110815279|NCT03417882|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110815280|NCT03417882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110815281|NCT03330457|Betrixaban|betrixaban|mesh-list
110815282|NCT03330457|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110815283|NCT03330457|Antithrombins|antithrombins|mesh-ancestor
110815284|NCT03330457|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110815285|NCT03330457|Protease Inhibitors|protease inhibitors|mesh-ancestor
110815286|NCT03330457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110815287|NCT03330457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110815288|NCT03330457|Anticoagulants|anticoagulants|mesh-ancestor
110815289|NCT03286556|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110815290|NCT03286556|Autoantibodies|autoantibodies|mesh-list
110815291|NCT03286556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110815292|NCT03286556|Immunologic Factors|immunologic factors|mesh-ancestor
110815293|NCT03286556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110815294|NCT03154359|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
110815295|NCT03154359|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110815296|NCT03154359|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110815297|NCT03154359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110815298|NCT03154359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110815299|NCT03154359|Adrenergic Agents|adrenergic agents|mesh-ancestor
110815300|NCT03154359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110815301|NCT03154359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110815302|NCT03152318|Cyclophosphamide|cyclophosphamide|mesh-list
110815303|NCT03152318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110815304|NCT03152318|Immunologic Factors|immunologic factors|mesh-ancestor
110815305|NCT03152318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110815306|NCT03152318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110815307|NCT03152318|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110815308|NCT03152318|Alkylating Agents|alkylating agents|mesh-ancestor
110815309|NCT03152318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110815310|NCT03152318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110815311|NCT03152318|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110815312|NCT03115424|Liraglutide|liraglutide|mesh-list
110815313|NCT03115424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110815314|NCT03115424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110815315|NCT03115424|Incretins|incretins|mesh-ancestor
110815316|NCT03115424|Hormones|hormones|mesh-ancestor
110815317|NCT03115424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110815318|NCT03083704|Enoxaparin|enoxaparin|mesh-list
110815319|NCT03083704|Rivaroxaban|rivaroxaban|mesh-list
110815320|NCT03083704|Apixaban|apixaban|mesh-list
110815321|NCT03083704|Edoxaban|edoxaban|mesh-list
110815322|NCT03083704|Enoxaparin sodium|enoxaparin sodium|mesh-list
110815323|NCT03083704|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110815324|NCT03083704|Antithrombins|antithrombins|mesh-ancestor
110815325|NCT03083704|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110815326|NCT03083704|Protease Inhibitors|protease inhibitors|mesh-ancestor
110815327|NCT03083704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110815328|NCT03083704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110815329|NCT03083704|Anticoagulants|anticoagulants|mesh-ancestor
110815330|NCT03083704|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110815331|NCT03083704|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110815332|NCT03059940|Nicotine|nicotine|mesh-list
110815333|NCT03059940|Carbon Monoxide|carbon monoxide|mesh-list
110815334|NCT03059940|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110815335|NCT03059940|Autonomic Agents|autonomic agents|mesh-ancestor
110815336|NCT03059940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110815337|NCT03059940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110815338|NCT03059940|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110815339|NCT03059940|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110815340|NCT03059940|Cholinergic Agents|cholinergic agents|mesh-ancestor
110815341|NCT03059940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110815342|NCT03059940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110815343|NCT03059940|Antimetabolites|antimetabolites|mesh-ancestor
110815344|NCT03059940|Gasotransmitters|gasotransmitters|mesh-ancestor
110815345|NCT03033914|Doxorubicin|doxorubicin|mesh-list
110815346|NCT03033914|Bleomycin|bleomycin|mesh-list
110815347|NCT03033914|Nivolumab|nivolumab|mesh-list
110815348|NCT03033914|Dacarbazine|dacarbazine|mesh-list
110815349|NCT03033914|Vinblastine|vinblastine|mesh-list
110815350|NCT03033914|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110815351|NCT03033914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110815352|NCT03033914|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110815353|NCT03033914|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110815354|NCT03033914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110815355|NCT03033914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110815356|NCT03033914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110815357|NCT03033914|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110815358|NCT03033914|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110815359|NCT03033914|Alkylating Agents|alkylating agents|mesh-ancestor
110815360|NCT03033914|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110815361|NCT03033914|Tubulin Modulators|tubulin modulators|mesh-ancestor
110815362|NCT03033914|Antimitotic Agents|antimitotic agents|mesh-ancestor
110815363|NCT03033914|Mitosis Modulators|mitosis modulators|mesh-ancestor
110815364|NCT03010358|Obinutuzumab|obinutuzumab|mesh-list
110815365|NCT03010358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110815366|NCT03010358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110815367|NCT02721654|Plasma-lyte 148|plasma-lyte 148|mesh-list
110815368|NCT02721654|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110815369|NCT02721654|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110815370|NCT02596100|Betrixaban|betrixaban|mesh-list
110815371|NCT02596100|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110815372|NCT02596100|Antithrombins|antithrombins|mesh-ancestor
110815373|NCT02596100|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110815374|NCT02596100|Protease Inhibitors|protease inhibitors|mesh-ancestor
110815375|NCT02596100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110815376|NCT02596100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110815377|NCT02596100|Anticoagulants|anticoagulants|mesh-ancestor
110815378|NCT02319837|Leuprolide|leuprolide|mesh-list
110815379|NCT02319837|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110815380|NCT02319837|Fertility Agents|fertility agents|mesh-ancestor
110815381|NCT02319837|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110815382|NCT02319837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110815383|NCT02319837|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110815384|NCT02319837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110815385|NCT02141438|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
110815386|NCT02141438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110815387|NCT01802632|Osimertinib|osimertinib|mesh-list
110815388|NCT01802632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110815389|NCT01802632|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110815390|NCT01802632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110815391|NCT01802632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110815392|NCT01782352|Vitamin D|vitamin d|mesh-list
110815393|NCT01782352|Ergocalciferols|ergocalciferols|mesh-list
110815394|NCT01782352|Cholecalciferol|cholecalciferol|mesh-list
110815395|NCT01782352|Vitamins|vitamins|mesh-list
110815396|NCT01782352|Micronutrients|micronutrients|mesh-ancestor
110815397|NCT01782352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110815398|NCT01782352|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110815399|NCT01782352|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110815400|NCT01765868|Betrixaban|betrixaban|mesh-list
110815401|NCT01765868|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110815402|NCT01765868|Antithrombins|antithrombins|mesh-ancestor
110815403|NCT01765868|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110815404|NCT01765868|Protease Inhibitors|protease inhibitors|mesh-ancestor
110815405|NCT01765868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110815406|NCT01765868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110815407|NCT01765868|Anticoagulants|anticoagulants|mesh-ancestor
110815408|NCT01641718|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
110815409|NCT01641718|Hemostatics|hemostatics|mesh-ancestor
110815410|NCT01641718|Coagulants|coagulants|mesh-ancestor
110532952|NCT03897335|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110815411|NCT01481974|Treprostinil|treprostinil|mesh-list
110815412|NCT01481974|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110815413|NCT00968799|Cisplatin|cisplatin|mesh-list
110815414|NCT00968799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110815415|NCT00751231|Clopidogrel|clopidogrel|mesh-list
110815416|NCT00751231|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110815417|NCT00751231|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110815418|NCT00751231|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110815419|NCT00751231|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110815420|NCT00751231|Purinergic Agents|purinergic agents|mesh-ancestor
110815421|NCT00751231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110815422|NCT00751231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110815423|NCT00751231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110815424|NCT00332956|Vaccines|vaccines|mesh-list
110815425|NCT00332956|Immunologic Factors|immunologic factors|mesh-ancestor
110815426|NCT00332956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110815427|NCT00324220|Mocetinostat|mocetinostat|mesh-list
110815428|NCT00324220|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110815429|NCT00324220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110815430|NCT00324220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110815431|NCT02287792|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110815432|NCT02287792|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110815433|NCT02287792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110815434|NCT00417118|Escitalopram|escitalopram|mesh-list
110815435|NCT00417118|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110815436|NCT00417118|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110815437|NCT00417118|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110815438|NCT00417118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110815439|NCT00417118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110815440|NCT00417118|Serotonin Agents|serotonin agents|mesh-ancestor
110815441|NCT00417118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110815442|NCT02883452|Infliximab|infliximab|mesh-list
110815443|NCT02883452|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110815444|NCT02883452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110815445|NCT02883452|Dermatologic Agents|dermatologic agents|mesh-ancestor
110815446|NCT02883452|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110815447|NCT02883452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110815448|NCT00508066|Bupivacaine|bupivacaine|mesh-list
110815449|NCT00508066|Anesthetics, Local|anesthetics, local|mesh-ancestor
110815450|NCT00508066|Anesthetics|anesthetics|mesh-ancestor
110815451|NCT00508066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110815452|NCT00508066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110815453|NCT00508066|Sensory System Agents|sensory system agents|mesh-ancestor
110815454|NCT00508066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110815455|NCT01336010|Ribavirin|ribavirin|mesh-list
110815456|NCT01336010|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110815457|NCT01336010|Antimetabolites|antimetabolites|mesh-ancestor
110815458|NCT01336010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110815459|NCT01336010|Antiviral Agents|antiviral agents|mesh-ancestor
110815460|NCT01336010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110815461|NCT02207504|Crizotinib|crizotinib|mesh-list
110815462|NCT02207504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110815463|NCT02207504|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110815464|NCT02207504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110815465|NCT02207504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110815466|NCT01342016|Prednisone|prednisone|mesh-list
110815467|NCT01342016|Tacrolimus|tacrolimus|mesh-list
110815468|NCT01342016|Leflunomide|leflunomide|mesh-list
110815469|NCT01342016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110815470|NCT01342016|Glucocorticoids|glucocorticoids|mesh-ancestor
110815471|NCT01342016|Hormones|hormones|mesh-ancestor
110815472|NCT01342016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110815473|NCT01342016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110815474|NCT01342016|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110815475|NCT01342016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110815476|NCT01342016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110815478|NCT01342016|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110815479|NCT01342016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110815480|NCT01342016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110815481|NCT01336166|Vaccines|vaccines|mesh-list
110815482|NCT01336166|Immunologic Factors|immunologic factors|mesh-ancestor
110815483|NCT01336166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110533029|NCT01497509|Narcotics|narcotics|mesh-ancestor
110815484|NCT04470310|Pioglitazone|pioglitazone|mesh-list
110815485|NCT04470310|Glimepiride|glimepiride|mesh-list
110815486|NCT04470310|Alogliptin|alogliptin|mesh-list
110815487|NCT04470310|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110815488|NCT04470310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110815489|NCT04470310|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110815490|NCT04470310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110815491|NCT04470310|Immunologic Factors|immunologic factors|mesh-ancestor
110815492|NCT04470310|Incretins|incretins|mesh-ancestor
110815493|NCT04470310|Hormones|hormones|mesh-ancestor
110815494|NCT04470310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110815495|NCT04470310|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110815496|NCT04470310|Protease Inhibitors|protease inhibitors|mesh-ancestor
110815497|NCT04470310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110815498|NCT04470310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110815499|NCT02083250|Fludarabine|fludarabine|mesh-list
110815500|NCT02083250|Fludarabine phosphate|fludarabine phosphate|mesh-list
110815501|NCT02083250|Busulfan|busulfan|mesh-list
110815502|NCT02083250|Vorinostat|vorinostat|mesh-list
110815503|NCT02083250|Clofarabine|clofarabine|mesh-list
110815504|NCT02083250|Thymoglobulin|thymoglobulin|mesh-list
110815505|NCT02083250|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110815506|NCT02083250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110815507|NCT02083250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110815508|NCT02083250|Antimetabolites|antimetabolites|mesh-ancestor
110815509|NCT02083250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110815510|NCT02083250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110815511|NCT02083250|Immunologic Factors|immunologic factors|mesh-ancestor
110815512|NCT02083250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110815513|NCT02083250|Alkylating Agents|alkylating agents|mesh-ancestor
110815514|NCT02083250|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110815515|NCT02083250|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110815516|NCT02083250|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110815517|NCT02083250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110815518|NCT00412828|Glembatumumab vedotin|glembatumumab vedotin|mesh-list
110815519|NCT00412828|Immunoconjugates|immunoconjugates|mesh-ancestor
110815520|NCT00412828|Immunologic Factors|immunologic factors|mesh-ancestor
110815521|NCT00412828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110815522|NCT00412828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110815523|NCT00412828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110815524|NCT00315640|Hydrocortisone|hydrocortisone|mesh-list
110815525|NCT00315640|Anecortave|anecortave|mesh-list
110815526|NCT00315640|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110815527|NCT00315640|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110815528|NCT00315640|Growth Substances|growth substances|mesh-ancestor
110815529|NCT00315640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110815530|NCT00315640|Growth Inhibitors|growth inhibitors|mesh-ancestor
110815531|NCT00315640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110815532|NCT00315640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110815533|NCT00411892|Insulin|insulin|mesh-list
110815534|NCT00411892|Pioglitazone|pioglitazone|mesh-list
110815535|NCT00411892|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110815536|NCT00411892|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110815537|NCT00411892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110815538|NCT01336322|Metformin|metformin|mesh-list
110815539|NCT01336322|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110815540|NCT01336322|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110815541|NCT01336322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110815542|NCT01336322|Incretins|incretins|mesh-ancestor
110815543|NCT01336322|Hormones|hormones|mesh-ancestor
110815544|NCT01336322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110815545|NCT01336322|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110815546|NCT01336322|Protease Inhibitors|protease inhibitors|mesh-ancestor
110815548|NCT01336322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110815549|NCT01339676|Vitamin D|vitamin d|mesh-list
110815550|NCT01339676|Cholecalciferol|cholecalciferol|mesh-list
110815551|NCT01339676|Vitamins|vitamins|mesh-ancestor
110815552|NCT01339676|Micronutrients|micronutrients|mesh-ancestor
110815553|NCT01339676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110815554|NCT01339676|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110815555|NCT01339676|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110815556|NCT01339754|Trabectedin|trabectedin|mesh-list
110815557|NCT01339754|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110815558|NCT01339754|Alkylating Agents|alkylating agents|mesh-ancestor
110815559|NCT01339754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110815560|NCT01339754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110815561|NCT00313768|Paclitaxel|paclitaxel|mesh-list
110815562|NCT00313768|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110815563|NCT00313768|Bevacizumab|bevacizumab|mesh-list
110815564|NCT00313768|Carboplatin|carboplatin|mesh-list
110815565|NCT00313768|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110815566|NCT00313768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110815567|NCT00313768|Tubulin Modulators|tubulin modulators|mesh-ancestor
110815568|NCT00313768|Antimitotic Agents|antimitotic agents|mesh-ancestor
110815569|NCT00313768|Mitosis Modulators|mitosis modulators|mesh-ancestor
110815570|NCT00313768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110815571|NCT00313768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110815572|NCT00313768|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110815573|NCT00313768|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110815574|NCT00313768|Growth Substances|growth substances|mesh-ancestor
110815575|NCT00313768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110815576|NCT00313768|Growth Inhibitors|growth inhibitors|mesh-ancestor
110815577|NCT01339988|Cyclophosphamide|cyclophosphamide|mesh-list
110815578|NCT01339988|Busulfan|busulfan|mesh-list
110815579|NCT01339988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110815580|NCT01339988|Immunologic Factors|immunologic factors|mesh-ancestor
110815581|NCT01339988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110815582|NCT01339988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110815583|NCT01339988|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110815584|NCT01339988|Alkylating Agents|alkylating agents|mesh-ancestor
110815585|NCT01339988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110815586|NCT01339988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110815587|NCT01339988|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110815588|NCT00406588|Levodopa|levodopa|mesh-list
110815589|NCT00406588|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110815590|NCT00406588|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110815591|NCT00406588|Dopamine Agents|dopamine agents|mesh-ancestor
110815592|NCT00406588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110815593|NCT00406588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110815594|NCT00406588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110815595|NCT01342328|Dexmedetomidine|dexmedetomidine|mesh-list
110815596|NCT01342328|Propofol|propofol|mesh-list
110815597|NCT01342328|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110815598|NCT01342328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110815599|NCT01342328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110815600|NCT01342328|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110815601|NCT01342328|Analgesics|analgesics|mesh-ancestor
110815602|NCT01342328|Sensory System Agents|sensory system agents|mesh-ancestor
110815603|NCT01342328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110815604|NCT01342328|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110815605|NCT01342328|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110815606|NCT01342328|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110815607|NCT01342328|Adrenergic Agents|adrenergic agents|mesh-ancestor
110815608|NCT01342328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110815609|NCT01342328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110815610|NCT01342328|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110815611|NCT01342328|Anesthetics, General|anesthetics, general|mesh-ancestor
110815612|NCT01342328|Anesthetics|anesthetics|mesh-ancestor
110815613|NCT00313222|Bosentan|bosentan|mesh-list
110815614|NCT00313222|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110815615|NCT00313222|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
110815616|NCT00313222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110815617|NCT05184530|Evolocumab|evolocumab|mesh-list
110815618|NCT05184530|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
110815619|NCT05184530|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110815620|NCT05184530|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110815621|NCT05184530|Antimetabolites|antimetabolites|mesh-ancestor
110815622|NCT05184530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110815623|NCT05184530|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110815624|NCT05184530|Protease Inhibitors|protease inhibitors|mesh-ancestor
110815625|NCT05184530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110815626|NCT05184530|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110815627|NCT05184374|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
110815628|NCT05184374|Hormones|hormones|mesh-ancestor
110815629|NCT05184374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110815630|NCT05184374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110815631|NCT05187494|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
110815632|NCT05187494|Anesthetics, Local|anesthetics, local|mesh-ancestor
110815633|NCT05187494|Anesthetics|anesthetics|mesh-ancestor
110815634|NCT05187494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110815635|NCT05187494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110815636|NCT05187494|Sensory System Agents|sensory system agents|mesh-ancestor
110815637|NCT05187494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110815638|NCT05187494|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
110815640|NCT01342562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110815641|NCT01342562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110815642|NCT00116116|Lamivudine|lamivudine|mesh-list
110815643|NCT00116116|Efavirenz|efavirenz|mesh-list
110815644|NCT00116116|Stavudine|stavudine|mesh-list
110815645|NCT00116116|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110815646|NCT00116116|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110815647|NCT00116116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110815648|NCT00116116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110815649|NCT00116116|Antiviral Agents|antiviral agents|mesh-ancestor
110815650|NCT00116116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110815651|NCT00116116|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110815652|NCT00116116|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110815653|NCT00116116|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110815654|NCT00116116|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110815655|NCT00116116|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110815656|NCT00116116|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110815657|NCT00116116|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110815658|NCT00116116|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110815659|NCT00116116|Antimetabolites|antimetabolites|mesh-ancestor
110815660|NCT02287870|Lidocaine|lidocaine|mesh-list
110815661|NCT02287870|Chloroprocaine|chloroprocaine|mesh-list
110815662|NCT02287870|Procaine|procaine|mesh-list
110815663|NCT02287870|Anesthetics, Local|anesthetics, local|mesh-ancestor
110815664|NCT02287870|Anesthetics|anesthetics|mesh-ancestor
110815665|NCT02287870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110815666|NCT02287870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110815667|NCT02287870|Sensory System Agents|sensory system agents|mesh-ancestor
110815668|NCT02287870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110815669|NCT02287870|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110815670|NCT02287870|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110815671|NCT02287870|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110815672|NCT02287870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110815673|NCT02287870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110815674|NCT01340456|Rifampin|rifampin|mesh-list
110815675|NCT01340456|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110815676|NCT01340456|Antitubercular Agents|antitubercular agents|mesh-ancestor
110815677|NCT01340456|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110815678|NCT01340456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110815679|NCT01340456|Leprostatic Agents|leprostatic agents|mesh-ancestor
110815680|NCT01340456|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110815681|NCT01340456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110815682|NCT01340456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110815683|NCT01340456|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110815684|NCT01340456|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110815685|NCT01340456|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110815686|NCT01340456|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110815687|NCT01340456|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110815688|NCT01340456|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110815689|NCT00110422|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110815690|NCT00110422|Irbesartan|irbesartan|mesh-list
110815691|NCT00110422|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110815692|NCT00110422|Diuretics|diuretics|mesh-ancestor
110815693|NCT00110422|Natriuretic Agents|natriuretic agents|mesh-ancestor
110815694|NCT00110422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110815695|NCT00110422|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110815696|NCT00110422|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110815697|NCT00110422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110815698|NCT00110422|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110815699|NCT00110422|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110815700|NCT00305656|Cediranib|cediranib|mesh-list
110815701|NCT00305656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110815702|NCT00305656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110815703|NCT00305656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110815704|NCT00305656|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110815705|NCT02284984|Rituximab|rituximab|mesh-list
110815706|NCT02284984|Belimumab|belimumab|mesh-list
110815707|NCT02284984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110815708|NCT02284984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110815710|NCT02284984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110815711|NCT02284984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110815712|NCT02284984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110815713|NCT00305188|Leucovorin|leucovorin|mesh-list
110815714|NCT00305188|Fluorouracil|fluorouracil|mesh-list
110815715|NCT00305188|Oxaliplatin|oxaliplatin|mesh-list
110815716|NCT00305188|Xaliproden|xaliproden|mesh-list
110815717|NCT00305188|Antimetabolites|antimetabolites|mesh-ancestor
110815718|NCT00305188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110815719|NCT00305188|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110815720|NCT00305188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110815721|NCT00305188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110815722|NCT00305188|Immunologic Factors|immunologic factors|mesh-ancestor
110815723|NCT00305188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110815724|NCT00305188|Antidotes|antidotes|mesh-ancestor
110815725|NCT00305188|Protective Agents|protective agents|mesh-ancestor
110815726|NCT00305188|Vitamin B Complex|vitamin b complex|mesh-ancestor
110815727|NCT00305188|Vitamins|vitamins|mesh-ancestor
110815728|NCT00305188|Micronutrients|micronutrients|mesh-ancestor
110815729|NCT00305188|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110815730|NCT00305188|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110815731|NCT00305188|Serotonin Agents|serotonin agents|mesh-ancestor
110815732|NCT00305188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110815733|NCT00297310|Tacrolimus|tacrolimus|mesh-list
110815734|NCT00297310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110815735|NCT00297310|Immunologic Factors|immunologic factors|mesh-ancestor
110815736|NCT00297310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110815737|NCT00297310|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110815738|NCT00297310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110815739|NCT00297310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110815740|NCT00095290|Ramipril|ramipril|mesh-list
110815741|NCT00095290|Irbesartan|irbesartan|mesh-list
110815742|NCT00095290|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110815743|NCT00095290|Protease Inhibitors|protease inhibitors|mesh-ancestor
110815744|NCT00095290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110815745|NCT00095290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110815746|NCT00095290|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110815747|NCT00095290|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110815748|NCT00095290|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110815749|NCT01340846|Ketoconazole|ketoconazole|mesh-list
110815750|NCT01340846|Dabrafenib|dabrafenib|mesh-list
110815751|NCT01340846|Warfarin|warfarin|mesh-list
110815752|NCT01340846|Gemfibrozil|gemfibrozil|mesh-list
110815753|NCT01340846|Anticoagulants|anticoagulants|mesh-ancestor
110815754|NCT01340846|Antifungal Agents|antifungal agents|mesh-ancestor
110815755|NCT01340846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110815756|NCT01340846|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110815757|NCT01340846|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110815758|NCT01340846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110815759|NCT01340846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110815760|NCT01340846|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110815761|NCT01340846|Hormone Antagonists|hormone antagonists|mesh-ancestor
110815762|NCT01340846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110815763|NCT01340846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110815764|NCT01340846|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110815765|NCT01340846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110815766|NCT01340846|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110815767|NCT01340846|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110815768|NCT01340846|Antimetabolites|antimetabolites|mesh-ancestor
110815769|NCT01340846|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110815770|NCT01340846|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
110815771|NCT01342874|Inositol|inositol|mesh-list
110815772|NCT01342874|Vitamin B Complex|vitamin b complex|mesh-ancestor
110815773|NCT01342874|Vitamins|vitamins|mesh-ancestor
110815774|NCT01342874|Micronutrients|micronutrients|mesh-ancestor
110815775|NCT01342874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110815776|NCT01337258|Dutasteride|dutasteride|mesh-list
110815777|NCT01337258|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
110815778|NCT01337258|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110815779|NCT01337258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110815780|NCT01337258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110815781|NCT01337258|Hormone Antagonists|hormone antagonists|mesh-ancestor
110815782|NCT01337258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110815783|NCT01337258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110815784|NCT02603809|Lisinopril|lisinopril|mesh-list
110815785|NCT02603809|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110815786|NCT02603809|Protease Inhibitors|protease inhibitors|mesh-ancestor
110815787|NCT02603809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110815788|NCT02603809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110815789|NCT02603809|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110815790|NCT02603809|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110815791|NCT02603809|Protective Agents|protective agents|mesh-ancestor
110815792|NCT02603809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110815793|NCT01341158|Interferons|interferons|mesh-list
110815794|NCT01341158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110815795|NCT01341158|Antiviral Agents|antiviral agents|mesh-ancestor
110815796|NCT01341158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110815797|NCT00393952|Fluticasone|fluticasone|mesh-list
110815799|NCT00393952|Formoterol Fumarate|formoterol fumarate|mesh-list
110815800|NCT00393952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110815801|NCT00393952|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110815802|NCT00393952|Autonomic Agents|autonomic agents|mesh-ancestor
110815803|NCT00393952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110815804|NCT00393952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110815805|NCT00393952|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110815806|NCT00393952|Respiratory System Agents|respiratory system agents|mesh-ancestor
110815807|NCT00393952|Dermatologic Agents|dermatologic agents|mesh-ancestor
110815808|NCT00393952|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110815809|NCT00393952|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110815810|NCT00393952|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110815811|NCT00393952|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110815812|NCT00393952|Adrenergic Agents|adrenergic agents|mesh-ancestor
110815813|NCT00393952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110815814|NCT00393952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110815815|NCT02285374|Tenofovir|tenofovir|mesh-list
110815816|NCT02285374|Emtricitabine|emtricitabine|mesh-list
110815817|NCT02285374|Efavirenz|efavirenz|mesh-list
110815818|NCT02285374|Dolutegravir|dolutegravir|mesh-list
110815819|NCT02285374|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110815820|NCT02285374|Antiviral Agents|antiviral agents|mesh-ancestor
110815821|NCT02285374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110815822|NCT02285374|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110815823|NCT02285374|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110815824|NCT02285374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110815825|NCT02285374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110815826|NCT02285374|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110815827|NCT02285374|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110815828|NCT02285374|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110815829|NCT02285374|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110815830|NCT02285374|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110815831|NCT02285374|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110815832|NCT02285374|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110815833|NCT02285374|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110815834|NCT02285374|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110815835|NCT02285374|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110815836|NCT01112449|Selenium|selenium|mesh-list
110815837|NCT01112449|Antioxidants|antioxidants|mesh-ancestor
110815838|NCT01112449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110815839|NCT01112449|Protective Agents|protective agents|mesh-ancestor
110815840|NCT01112449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110815841|NCT01112449|Trace Elements|trace elements|mesh-ancestor
110815842|NCT01112449|Micronutrients|micronutrients|mesh-ancestor
110815843|NCT01341392|Amlodipine|amlodipine|mesh-list
110815844|NCT01341392|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110815845|NCT01341392|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110815846|NCT01341392|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110815847|NCT01341392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110815848|NCT01341392|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110815849|NCT01341392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110815850|NCT01341392|Vasodilator Agents|vasodilator agents|mesh-ancestor
110815851|NCT04390958|Paclitaxel|paclitaxel|mesh-list
110815852|NCT04390958|Capecitabine|capecitabine|mesh-list
110815853|NCT04390958|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110815854|NCT04390958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110815855|NCT04390958|Tubulin Modulators|tubulin modulators|mesh-ancestor
110815856|NCT04390958|Antimitotic Agents|antimitotic agents|mesh-ancestor
110815857|NCT04390958|Mitosis Modulators|mitosis modulators|mesh-ancestor
110815858|NCT04390958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110815859|NCT04390958|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110815860|NCT04390958|Antimetabolites|antimetabolites|mesh-ancestor
110815861|NCT03943459|Atorvastatin|atorvastatin|mesh-list
110815862|NCT03943459|Quercetin|quercetin|mesh-list
110815863|NCT03943459|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110815864|NCT03943459|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110815865|NCT03943459|Antimetabolites|antimetabolites|mesh-ancestor
110815866|NCT03943459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110815867|NCT03943459|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110815868|NCT03943459|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110815869|NCT03943459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110815870|NCT03943459|Antioxidants|antioxidants|mesh-ancestor
110815871|NCT03943459|Protective Agents|protective agents|mesh-ancestor
110815872|NCT03943459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110815873|NCT04832438|Carboplatin|carboplatin|mesh-list
110815874|NCT04832438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110815875|NCT05182970|Metformin|metformin|mesh-list
110815876|NCT05182970|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110815877|NCT05182970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110815878|NCT01315886|Fentanyl|fentanyl|mesh-list
110815879|NCT01315886|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110815880|NCT01315886|Narcotics|narcotics|mesh-ancestor
110815881|NCT01315886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110815882|NCT01315886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110815883|NCT01315886|Analgesics|analgesics|mesh-ancestor
110815884|NCT01315886|Sensory System Agents|sensory system agents|mesh-ancestor
110815885|NCT01315886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110815886|NCT01315886|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110815887|NCT01315886|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110815888|NCT01315886|Anesthetics, General|anesthetics, general|mesh-ancestor
110815889|NCT01315886|Anesthetics|anesthetics|mesh-ancestor
110815890|NCT00065728|Anecortave|anecortave|mesh-list
110815891|NCT00065728|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110815892|NCT00065728|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110815893|NCT00065728|Growth Substances|growth substances|mesh-ancestor
110815894|NCT00065728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110815895|NCT00065728|Growth Inhibitors|growth inhibitors|mesh-ancestor
110815896|NCT00065728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110815897|NCT00064714|Exenatide|exenatide|mesh-list
110815898|NCT00064714|Daclizumab|daclizumab|mesh-list
110815899|NCT00064714|Immunosuppressive Agents|immunosuppressive agents|mesh-list
110815900|NCT00064714|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110815901|NCT00064714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110815902|NCT00064714|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110815903|NCT00064714|Incretins|incretins|mesh-ancestor
110815904|NCT00064714|Hormones|hormones|mesh-ancestor
110815905|NCT00064714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110815906|NCT00064714|Immunologic Factors|immunologic factors|mesh-ancestor
110815907|NCT01109485|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
110815908|NCT01109485|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110815909|NCT01109485|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110815910|NCT01109485|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110815911|NCT01109485|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110815912|NCT01109485|Analgesics|analgesics|mesh-ancestor
110815913|NCT01109485|Sensory System Agents|sensory system agents|mesh-ancestor
110815914|NCT01109485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110815915|NCT01109485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110815916|NCT01109485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110815917|NCT01109485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110815918|NCT01109485|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110815919|NCT01109485|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110815921|NCT01109485|Histamine Antagonists|histamine antagonists|mesh-ancestor
110815922|NCT01109485|Histamine Agents|histamine agents|mesh-ancestor
110815923|NCT01109485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110815924|NCT01109485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110815926|NCT00292396|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110815927|NCT00292396|Immunologic Factors|immunologic factors|mesh-ancestor
110815928|NCT00292396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110815929|NCT03942289|Norepinephrine|norepinephrine|mesh-list
110815930|NCT03942289|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110815931|NCT03942289|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110815932|NCT03942289|Adrenergic Agents|adrenergic agents|mesh-ancestor
110815933|NCT03942289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110815934|NCT03942289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110815935|NCT03942289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110815936|NCT03942289|Sympathomimetics|sympathomimetics|mesh-ancestor
110815937|NCT03942289|Autonomic Agents|autonomic agents|mesh-ancestor
110815938|NCT03942289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110815939|NCT03942289|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110815940|NCT00284128|Losartan|losartan|mesh-list
110815941|NCT00284128|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110815942|NCT00284128|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110815943|NCT00284128|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110815944|NCT00284128|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110815945|NCT00284128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110815946|NCT00035542|Metformin|metformin|mesh-list
110815947|NCT00035542|Glyburide|glyburide|mesh-list
110815948|NCT00035542|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110815949|NCT00035542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110815950|NCT01209715|Fluticasone|fluticasone|mesh-list
110815951|NCT01209715|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110815952|NCT01209715|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
110815953|NCT01209715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110815954|NCT01209715|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110815955|NCT01209715|Autonomic Agents|autonomic agents|mesh-ancestor
110815956|NCT01209715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110815957|NCT01209715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110815958|NCT01209715|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110815959|NCT01209715|Respiratory System Agents|respiratory system agents|mesh-ancestor
110815960|NCT01209715|Dermatologic Agents|dermatologic agents|mesh-ancestor
110815961|NCT01209715|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110815962|NCT01209715|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110815963|NCT01209715|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110815964|NCT01209715|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110815965|NCT01209715|Adrenergic Agents|adrenergic agents|mesh-ancestor
110815966|NCT01209715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110815967|NCT01209715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110815968|NCT01209715|Glucocorticoids|glucocorticoids|mesh-ancestor
110815969|NCT01209715|Hormones|hormones|mesh-ancestor
110815970|NCT01209715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110815971|NCT01209715|Sympathomimetics|sympathomimetics|mesh-ancestor
110815972|NCT03740893|Durvalumab|durvalumab|mesh-list
110815973|NCT03740893|Olaparib|olaparib|mesh-list
110815974|NCT03740893|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110815975|NCT03740893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110815976|NCT03740893|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110815977|NCT03740893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110815978|NCT03740893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110815979|NCT00005788|Aldesleukin|aldesleukin|mesh-list
110815980|NCT00005788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110815981|NCT00005788|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110815982|NCT00005788|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110815983|NCT00005788|Antiviral Agents|antiviral agents|mesh-ancestor
110815984|NCT00005788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110815985|NCT03945955|Melatonin|melatonin|mesh-list
110815986|NCT03945955|Antioxidants|antioxidants|mesh-ancestor
110815987|NCT03945955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110815988|NCT03945955|Protective Agents|protective agents|mesh-ancestor
110815989|NCT03945955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110815990|NCT03945955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110815991|NCT00005608|Leucovorin|leucovorin|mesh-list
110815992|NCT00005608|Tegafur|tegafur|mesh-list
110815994|NCT00005608|Levoleucovorin|levoleucovorin|mesh-list
110815995|NCT00005608|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110815996|NCT00005608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110815997|NCT00005608|Antidotes|antidotes|mesh-ancestor
110815998|NCT00005608|Protective Agents|protective agents|mesh-ancestor
110815999|NCT00005608|Vitamin B Complex|vitamin b complex|mesh-ancestor
110816000|NCT00005608|Vitamins|vitamins|mesh-ancestor
110816001|NCT00005608|Micronutrients|micronutrients|mesh-ancestor
110816002|NCT00005608|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110816003|NCT00005608|Antimetabolites|antimetabolites|mesh-ancestor
110816004|NCT00005608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110816005|NCT00005608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110816006|NCT02288338|Atorvastatin|atorvastatin|mesh-list
110533546|NCT02153645|Amantadine|amantadine|mesh-list
110816007|NCT02288338|Ezetimibe|ezetimibe|mesh-list
110816008|NCT02288338|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110816009|NCT02288338|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110816010|NCT02288338|Antimetabolites|antimetabolites|mesh-ancestor
110816011|NCT02288338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110816012|NCT02288338|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110816013|NCT02288338|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110816014|NCT02288338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110816015|NCT00388960|Etoposide|etoposide|mesh-list
110816016|NCT00388960|Amrubicin|amrubicin|mesh-list
110190075|NCT00051090|Efavirenz|efavirenz|mesh-list
110816017|NCT00388960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110816018|NCT00388960|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110816019|NCT00388960|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110816020|NCT00388960|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110816021|NCT00388960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110816022|NCT00388960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110816023|NCT03941899|Levobupivacaine|levobupivacaine|mesh-list
110816024|NCT03941899|Anesthetics, Local|anesthetics, local|mesh-ancestor
110816025|NCT03941899|Anesthetics|anesthetics|mesh-ancestor
110816026|NCT03941899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110816027|NCT03941899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110816028|NCT03941899|Sensory System Agents|sensory system agents|mesh-ancestor
110816029|NCT03941899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110816030|NCT00004912|Megestrol|megestrol|mesh-list
110816031|NCT00004912|Megestrol Acetate|megestrol acetate|mesh-list
110816032|NCT00004912|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110816033|NCT00004912|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110816034|NCT00004912|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110816035|NCT00004912|Contraceptive Agents|contraceptive agents|mesh-ancestor
110816036|NCT00004912|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110816037|NCT00004912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110816038|NCT00004912|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110816039|NCT00004912|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110816040|NCT00004912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110816041|NCT00004912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110816042|NCT00004912|Appetite Stimulants|appetite stimulants|mesh-ancestor
110816043|NCT00004912|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110816044|NCT02529787|Dexlansoprazole|dexlansoprazole|mesh-list
110816045|NCT02529787|Lansoprazole|lansoprazole|mesh-list
110816046|NCT02529787|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110816047|NCT02529787|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110816048|NCT02529787|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110816049|NCT02529787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110853999|NCT03501277|Pioglitazone|pioglitazone|mesh-list
110816050|NCT02529787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110816051|NCT00267592|Temozolomide|temozolomide|mesh-list
110816052|NCT00267592|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110816053|NCT00267592|Alkylating Agents|alkylating agents|mesh-ancestor
110816054|NCT00267592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110816055|NCT00267592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110816056|NCT00267280|Atorvastatin|atorvastatin|mesh-list
110816057|NCT00267280|Simvastatin|simvastatin|mesh-list
110816058|NCT00267280|Torcetrapib|torcetrapib|mesh-list
110816059|NCT00267280|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110816060|NCT00267280|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110816061|NCT00267280|Antimetabolites|antimetabolites|mesh-ancestor
110816062|NCT00267280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110816063|NCT00267280|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110816064|NCT00267280|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110816065|NCT00267280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110816066|NCT03530488|Lidocaine|lidocaine|mesh-list
110816067|NCT03530488|Anesthetics, Local|anesthetics, local|mesh-ancestor
110816068|NCT03530488|Anesthetics|anesthetics|mesh-ancestor
110816069|NCT03530488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110816070|NCT03530488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110816071|NCT03530488|Sensory System Agents|sensory system agents|mesh-ancestor
110816072|NCT03530488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110816073|NCT03530488|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110816074|NCT03530488|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110816075|NCT03530488|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110816076|NCT03530488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110816077|NCT03530488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110816078|NCT00262990|Doxorubicin|doxorubicin|mesh-list
110816079|NCT00262990|Epothilone B|epothilone b|mesh-list
110816080|NCT00262990|Epothilones|epothilones|mesh-list
110816081|NCT00262990|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110816082|NCT00262990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110816083|NCT00262990|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110816084|NCT00262990|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110816085|NCT00262990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110816086|NCT00262990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110816087|NCT00262990|Tubulin Modulators|tubulin modulators|mesh-ancestor
110816088|NCT00262990|Antimitotic Agents|antimitotic agents|mesh-ancestor
110816089|NCT00262990|Mitosis Modulators|mitosis modulators|mesh-ancestor
110816090|NCT01110031|Ofatumumab|ofatumumab|mesh-list
110816091|NCT01110031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110816092|NCT02741596|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110816093|NCT02741596|Immunologic Factors|immunologic factors|mesh-ancestor
110816094|NCT02741596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110816095|NCT01210339|Esomeprazole|esomeprazole|mesh-list
110816096|NCT01210339|Clopidogrel|clopidogrel|mesh-list
110816097|NCT01210339|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110816098|NCT01210339|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110816099|NCT01210339|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110816100|NCT01210339|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110816101|NCT01210339|Purinergic Agents|purinergic agents|mesh-ancestor
110816102|NCT01210339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110816103|NCT01210339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110816104|NCT01210339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110816105|NCT01210339|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110816106|NCT01210339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110816107|NCT01210339|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110816108|NCT01210339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110816109|NCT03684694|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
110816110|NCT03684694|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110816111|NCT03684694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110816112|NCT03147248|Infliximab|infliximab|mesh-list
110816113|NCT03147248|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110816114|NCT03147248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110816115|NCT03147248|Dermatologic Agents|dermatologic agents|mesh-ancestor
110816116|NCT03147248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110816118|NCT00250822|Gemcitabine|gemcitabine|mesh-list
110816119|NCT00250822|Oxaliplatin|oxaliplatin|mesh-list
110816120|NCT00250822|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110816121|NCT00250822|Antimetabolites|antimetabolites|mesh-ancestor
110816122|NCT00250822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110816123|NCT00250822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110816124|NCT00004096|Carboplatin|carboplatin|mesh-list
110816125|NCT00004096|Vinorelbine|vinorelbine|mesh-list
110816126|NCT00004096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110816127|NCT00004096|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110816128|NCT00004096|Tubulin Modulators|tubulin modulators|mesh-ancestor
110816129|NCT00004096|Antimitotic Agents|antimitotic agents|mesh-ancestor
110816130|NCT00004096|Mitosis Modulators|mitosis modulators|mesh-ancestor
110816131|NCT00004096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110816132|NCT00002224|Nelfinavir|nelfinavir|mesh-list
110816133|NCT00002224|Stavudine|stavudine|mesh-list
110816134|NCT00002224|Didanosine|didanosine|mesh-list
110816135|NCT00002224|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110816136|NCT00002224|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110816137|NCT00002224|Protease Inhibitors|protease inhibitors|mesh-ancestor
110816138|NCT00002224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110816139|NCT00002224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110816140|NCT00002224|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110816141|NCT00002224|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110816142|NCT00002224|Antiviral Agents|antiviral agents|mesh-ancestor
110816143|NCT00002224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110816144|NCT00002224|Antimetabolites|antimetabolites|mesh-ancestor
110816145|NCT00002224|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110816146|NCT00002224|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110816147|NCT01207921|Lenalidomide|lenalidomide|mesh-list
110816148|NCT01207921|Immunologic Factors|immunologic factors|mesh-ancestor
110816149|NCT01207921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110816150|NCT01207921|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110816151|NCT01207921|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110816152|NCT01207921|Growth Substances|growth substances|mesh-ancestor
110816153|NCT01207921|Growth Inhibitors|growth inhibitors|mesh-ancestor
110816154|NCT01207921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110816155|NCT01108393|Agomelatine|agomelatine|mesh-list
110816156|NCT01108393|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110816157|NCT01108393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110816158|NCT01108393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110816159|NCT01113229|Misoprostol|misoprostol|mesh-list
110816160|NCT01113229|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110816161|NCT01113229|Abortifacient Agents|abortifacient agents|mesh-ancestor
110816162|NCT01113229|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110816163|NCT01113229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110816164|NCT01113229|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110816165|NCT01113229|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110816166|NCT01113229|Oxytocics|oxytocics|mesh-ancestor
110816167|NCT03530176|Listerine|listerine|mesh-list
110816168|NCT03530176|Fluorides|fluorides|mesh-list
110816169|NCT03530176|Sodium Fluoride|sodium fluoride|mesh-list
110816170|NCT03530176|Cariostatic Agents|cariostatic agents|mesh-ancestor
110816171|NCT03530176|Protective Agents|protective agents|mesh-ancestor
110816172|NCT03530176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110816173|NCT03530176|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110816174|NCT03530176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110816175|NCT03151304|Azacitidine|azacitidine|mesh-list
110816176|NCT03151304|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110816177|NCT03151304|Antimetabolites|antimetabolites|mesh-ancestor
110816178|NCT03151304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110816179|NCT03151304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110816180|NCT03151304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110816181|NCT03530020|Lithium Carbonate|lithium carbonate|mesh-list
110816182|NCT03530020|Antidepressive Agents|antidepressive agents|mesh-ancestor
110816183|NCT03530020|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110816184|NCT03530020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110816185|NCT03530020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110816186|NCT03530020|Antimanic Agents|antimanic agents|mesh-ancestor
110816187|NCT03530020|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110816188|NCT03530020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110816189|NCT03530020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110816190|NCT02288962|Cabergoline|cabergoline|mesh-list
110816191|NCT02288962|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110816192|NCT02288962|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110816193|NCT02288962|Dopamine Agonists|dopamine agonists|mesh-ancestor
110816194|NCT02288962|Dopamine Agents|dopamine agents|mesh-ancestor
110816195|NCT02288962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110816196|NCT02288962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110816197|NCT02288962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110816198|NCT03942991|Carticaine|carticaine|mesh-list
110816199|NCT03942991|Mepivacaine|mepivacaine|mesh-list
110816200|NCT03942991|Anesthetics, Local|anesthetics, local|mesh-ancestor
110816201|NCT03942991|Anesthetics|anesthetics|mesh-ancestor
110816202|NCT03942991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110816203|NCT03942991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110816204|NCT03942991|Sensory System Agents|sensory system agents|mesh-ancestor
110816205|NCT03942991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110816206|NCT00162292|Methotrexate|methotrexate|mesh-list
110816207|NCT00162292|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110816208|NCT00162292|Abortifacient Agents|abortifacient agents|mesh-ancestor
110816209|NCT00162292|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110816210|NCT00162292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110816211|NCT00162292|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110816212|NCT00162292|Antimetabolites|antimetabolites|mesh-ancestor
110816213|NCT00162292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110816214|NCT00162292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110816215|NCT00162292|Dermatologic Agents|dermatologic agents|mesh-ancestor
110816216|NCT00162292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110816217|NCT00162292|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110816218|NCT00162292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110816219|NCT00162292|Immunologic Factors|immunologic factors|mesh-ancestor
110816220|NCT00162292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110816221|NCT00162292|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110816222|NCT00135382|Efavirenz|efavirenz|mesh-list
110816223|NCT00135382|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110816224|NCT00135382|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110816225|NCT00135382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110816226|NCT00135382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110816227|NCT00135382|Antiviral Agents|antiviral agents|mesh-ancestor
110816228|NCT00135382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110816229|NCT00135382|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110816230|NCT00135382|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110816231|NCT00135382|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110816232|NCT00135382|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110816233|NCT00135382|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110816234|NCT00135382|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110816235|NCT03531970|Dexamethasone|dexamethasone|mesh-list
110816236|NCT03531970|Dexamethasone acetate|dexamethasone acetate|mesh-list
110816237|NCT03531970|Lidocaine|lidocaine|mesh-list
110816238|NCT03531970|Epinephrine|epinephrine|mesh-list
110816239|NCT03531970|BB 1101|bb 1101|mesh-list
110816240|NCT03531970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110816241|NCT03531970|Antiemetics|antiemetics|mesh-ancestor
110816242|NCT03531970|Autonomic Agents|autonomic agents|mesh-ancestor
110816243|NCT03531970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110816244|NCT03531970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110816245|NCT03531970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110816246|NCT03531970|Glucocorticoids|glucocorticoids|mesh-ancestor
110816247|NCT03531970|Hormones|hormones|mesh-ancestor
110816248|NCT03531970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110816249|NCT03531970|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110816250|NCT03531970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110816251|NCT03531970|Protease Inhibitors|protease inhibitors|mesh-ancestor
110816252|NCT03531970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110816253|NCT03531970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110816254|NCT03531970|Anesthetics, Local|anesthetics, local|mesh-ancestor
110816255|NCT03531970|Anesthetics|anesthetics|mesh-ancestor
110816256|NCT03531970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110816257|NCT03531970|Sensory System Agents|sensory system agents|mesh-ancestor
110816258|NCT03531970|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110816259|NCT03531970|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110816260|NCT03531970|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110816261|NCT03531970|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110816262|NCT03531970|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110816263|NCT03531970|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110816264|NCT03531970|Adrenergic Agents|adrenergic agents|mesh-ancestor
110816265|NCT03531970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110816266|NCT03531970|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110816267|NCT03531970|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110816268|NCT03531970|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110816269|NCT03531970|Respiratory System Agents|respiratory system agents|mesh-ancestor
110816270|NCT03531970|Mydriatics|mydriatics|mesh-ancestor
110816271|NCT03531970|Sympathomimetics|sympathomimetics|mesh-ancestor
110816272|NCT03531970|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110816273|NCT01211821|Metoprolol|metoprolol|mesh-list
110816274|NCT01211821|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110816275|NCT01211821|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110816276|NCT01211821|Sympatholytics|sympatholytics|mesh-ancestor
110816277|NCT01211821|Autonomic Agents|autonomic agents|mesh-ancestor
110816278|NCT01211821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110816279|NCT01211821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110816280|NCT01211821|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110816281|NCT01211821|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110816282|NCT01211821|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110816284|NCT01211821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110816285|NCT01211821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110816286|NCT03527836|Lidocaine|lidocaine|mesh-list
110816287|NCT03527836|Bupivacaine|bupivacaine|mesh-list
110816288|NCT03527836|Anesthetics, Local|anesthetics, local|mesh-ancestor
110816289|NCT03527836|Anesthetics|anesthetics|mesh-ancestor
110816290|NCT03527836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110816291|NCT03527836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110816292|NCT03527836|Sensory System Agents|sensory system agents|mesh-ancestor
110816293|NCT03527836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110816294|NCT03527836|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110816295|NCT03527836|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110816296|NCT03527836|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110816297|NCT03527836|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110816298|NCT03527836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110816299|NCT05724862|Anesthetics|anesthetics|mesh-list
110816300|NCT05724862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110816301|NCT05724862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110816302|NCT03940651|Anesthetics|anesthetics|mesh-list
110816303|NCT03940651|Anesthetics, General|anesthetics, general|mesh-list
110816304|NCT03940651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110816305|NCT03940651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110816306|NCT03152552|Empagliflozin|empagliflozin|mesh-list
110816307|NCT03152552|Licogliflozin|licogliflozin|mesh-list
110816308|NCT03152552|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110816309|NCT03152552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110816310|NCT03152552|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110816311|NCT03152552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110816312|NCT01211275|Cisplatin|cisplatin|mesh-list
110816313|NCT01211275|Pemetrexed|pemetrexed|mesh-list
110816314|NCT01211275|Axitinib|axitinib|mesh-list
110816315|NCT01211275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110816316|NCT01211275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110816317|NCT01211275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110816318|NCT01211275|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110816319|NCT01211275|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110816320|NCT01211275|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110816321|NCT03529084|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110816322|NCT03529084|Gefitinib|gefitinib|mesh-list
110816323|NCT03529084|Nazartinib|nazartinib|mesh-list
110816324|NCT03529084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110816325|NCT03529084|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110816326|NCT03529084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110816327|NCT03529084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110816328|NCT03942757|Bilirubin|bilirubin|mesh-list
110816329|NCT03942757|Antioxidants|antioxidants|mesh-ancestor
110816330|NCT03942757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110816331|NCT03942757|Protective Agents|protective agents|mesh-ancestor
110816332|NCT03942757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110816333|NCT05724628|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110816334|NCT05724628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110816335|NCT01208701|Atorvastatin|atorvastatin|mesh-list
110816336|NCT01208701|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110816337|NCT01208701|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110816338|NCT01208701|Antimetabolites|antimetabolites|mesh-ancestor
110816339|NCT01208701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110816340|NCT01208701|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110816341|NCT01208701|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110816342|NCT01208701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110816343|NCT03528772|Minoxidil|minoxidil|mesh-list
110816344|NCT03528772|Nitroglycerin|nitroglycerin|mesh-list
110816345|NCT03528772|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110816346|NCT03528772|Vasodilator Agents|vasodilator agents|mesh-ancestor
110816347|NCT01316744|Ketamine|ketamine|mesh-list
110816348|NCT01316744|Analgesics|analgesics|mesh-ancestor
110816349|NCT01316744|Sensory System Agents|sensory system agents|mesh-ancestor
110816350|NCT01316744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110816351|NCT01316744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110816352|NCT01316744|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110816353|NCT01316744|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110816354|NCT01316744|Anesthetics, General|anesthetics, general|mesh-ancestor
110816355|NCT01316744|Anesthetics|anesthetics|mesh-ancestor
110141571|NCT02013570|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110816356|NCT01316744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110816357|NCT01316744|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110816358|NCT01316744|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110816359|NCT01316744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110816360|NCT01316744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110816361|NCT01213381|Carboplatin|carboplatin|mesh-list
110816362|NCT01213381|Gemcitabine|gemcitabine|mesh-list
110816363|NCT01213381|Iniparib|iniparib|mesh-list
110816364|NCT01213381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110816365|NCT01213381|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110816366|NCT01213381|Antimetabolites|antimetabolites|mesh-ancestor
110816367|NCT01213381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110816368|NCT01213381|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110816369|NCT01213381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110816370|NCT01316978|Ibuprofen|ibuprofen|mesh-list
110816371|NCT01316978|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110816372|NCT01316978|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110816373|NCT01316978|Analgesics|analgesics|mesh-ancestor
110816374|NCT01316978|Sensory System Agents|sensory system agents|mesh-ancestor
110816375|NCT01316978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110816376|NCT01316978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110816377|NCT01316978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110816378|NCT01316978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110816379|NCT01316978|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110816380|NCT01316978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110816381|NCT01316978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110816382|NCT01317212|Carboplatin|carboplatin|mesh-list
110816383|NCT01317212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110816384|NCT05250752|Dapagliflozin|dapagliflozin|mesh-list
110816385|NCT05250752|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110816386|NCT05250752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110816387|NCT05250752|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110816388|NCT05250752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110816389|NCT01211509|Montelukast|montelukast|mesh-list
110816390|NCT01211509|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110816391|NCT01211509|Respiratory System Agents|respiratory system agents|mesh-ancestor
110816392|NCT01211509|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110854026|NCT02487706|Antiviral Agents|antiviral agents|mesh-ancestor
110816393|NCT01211509|Hormone Antagonists|hormone antagonists|mesh-ancestor
110816394|NCT01211509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110816395|NCT01211509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110816396|NCT01211509|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110816397|NCT01211509|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110816398|NCT01211509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110816399|NCT05072600|Pembrolizumab|pembrolizumab|mesh-list
110816400|NCT05072600|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
110816401|NCT05072600|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110816402|NCT05072600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110816403|NCT05072600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110816404|NCT04441528|Hyaluronic Acid|hyaluronic acid|mesh-list
110816405|NCT04441528|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110816406|NCT04441528|Immunologic Factors|immunologic factors|mesh-ancestor
110816407|NCT04441528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110816408|NCT04441528|Viscosupplements|viscosupplements|mesh-ancestor
110816409|NCT04441528|Protective Agents|protective agents|mesh-ancestor
110816410|NCT01344512|Ciprofloxacin|ciprofloxacin|mesh-list
110816411|NCT01344512|Ceftazidime|ceftazidime|mesh-list
110816412|NCT01344512|Voriconazole|voriconazole|mesh-list
110816413|NCT01344512|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110816414|NCT01344512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110816415|NCT01344512|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110816416|NCT01344512|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110816417|NCT01344512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110816418|NCT01344512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110816419|NCT01344512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110816420|NCT01344512|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110816421|NCT01344512|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110816422|NCT01344512|Antifungal Agents|antifungal agents|mesh-ancestor
110816423|NCT01344512|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110816424|NCT01344512|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110816425|NCT01344512|Hormone Antagonists|hormone antagonists|mesh-ancestor
110816426|NCT01344512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110816428|NCT01344512|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110816429|NCT05064488|Metformin|metformin|mesh-list
110816430|NCT05064488|Digoxin|digoxin|mesh-list
110816431|NCT05064488|Sumatriptan|sumatriptan|mesh-list
110816432|NCT05064488|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110816433|NCT05064488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110816434|NCT05064488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110816435|NCT05064488|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110816436|NCT05064488|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110816437|NCT05064488|Antimetabolites|antimetabolites|mesh-ancestor
110816438|NCT05064488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110816439|NCT05064488|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110816440|NCT05064488|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110816441|NCT05064488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110816442|NCT05064488|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110816443|NCT05064488|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110816444|NCT05064488|Protective Agents|protective agents|mesh-ancestor
110816445|NCT05064488|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110816446|NCT05064488|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110816447|NCT05064488|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110816448|NCT05064488|Serotonin Agents|serotonin agents|mesh-ancestor
110816449|NCT05064488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110816450|NCT01344590|Ethanol|ethanol|mesh-list
110816451|NCT01344590|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110816452|NCT01344590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110816453|NCT01344590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110816454|NCT01344590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110816455|NCT01114087|Imatinib Mesylate|imatinib mesylate|mesh-list
110816456|NCT01114087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110816457|NCT01114087|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110816458|NCT01114087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110816459|NCT01114087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110816460|NCT01212133|Liraglutide|liraglutide|mesh-list
110816461|NCT01212133|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110816462|NCT01212133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110816463|NCT01212133|Incretins|incretins|mesh-ancestor
110816464|NCT01212133|Hormones|hormones|mesh-ancestor
110816465|NCT01212133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110816466|NCT04269356|Magnesium Oxide|magnesium oxide|mesh-list
110816467|NCT04269356|Magnesium Hydroxide|magnesium hydroxide|mesh-list
110816468|NCT04269356|Antacids|antacids|mesh-ancestor
110816469|NCT04269356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110816470|NCT04269356|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110816471|NCT01118065|Everolimus|everolimus|mesh-list
110816472|NCT01118065|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110816473|NCT01118065|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110816474|NCT01118065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110816475|NCT01118065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110816476|NCT01118065|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110816477|NCT01118065|Immunologic Factors|immunologic factors|mesh-ancestor
110816478|NCT01118065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110816479|NCT01118065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110816480|NCT03528616|Propranolol|propranolol|mesh-list
110816481|NCT03528616|Digoxin|digoxin|mesh-list
110816482|NCT03528616|Adenosine|adenosine|mesh-list
110816483|NCT03528616|Amiodarone|amiodarone|mesh-list
110816484|NCT03528616|Flecainide|flecainide|mesh-list
110816485|NCT03528616|Procainamide|procainamide|mesh-list
110816486|NCT03528616|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110816487|NCT03528616|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110816488|NCT03528616|Adrenergic Agents|adrenergic agents|mesh-ancestor
110816489|NCT03528616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110816490|NCT03528616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110816491|NCT03528616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110816492|NCT03528616|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110816493|NCT03528616|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110816494|NCT03528616|Vasodilator Agents|vasodilator agents|mesh-ancestor
110816495|NCT03528616|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110816496|NCT03528616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110816497|NCT03528616|Protective Agents|protective agents|mesh-ancestor
110816498|NCT03528616|Analgesics|analgesics|mesh-ancestor
110816499|NCT03528616|Sensory System Agents|sensory system agents|mesh-ancestor
110816500|NCT03528616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110816501|NCT03528616|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
110816503|NCT03528616|Purinergic Agents|purinergic agents|mesh-ancestor
110816504|NCT03528616|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
110816505|NCT03528616|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110816506|NCT03528616|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110816507|NCT03528616|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110816508|NCT03528616|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110816509|NCT03528616|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110816510|NCT03528616|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110816511|NCT03528616|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110816512|NCT03528616|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110816513|NCT02529631|Orlistat|orlistat|mesh-list
110816514|NCT02529631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110816515|NCT02529631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110816516|NCT02529631|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110816517|NCT02529631|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110816518|NCT04469062|Mirikizumab|mirikizumab|mesh-list
110816519|NCT04469062|Vedolizumab|vedolizumab|mesh-list
110816520|NCT04469062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110816521|NCT04469062|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110816522|NCT04469062|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110816523|NCT04469062|Analgesics|analgesics|mesh-ancestor
110816524|NCT04469062|Sensory System Agents|sensory system agents|mesh-ancestor
110534083|NCT04182828|Lidocaine|lidocaine|mesh-list
110816525|NCT04469062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110816526|NCT04469062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110816527|NCT04469062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110816528|NCT04469062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110816529|NCT04469062|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110816530|NCT03528538|Fenugreek seed meal|fenugreek seed meal|mesh-list
110816531|NCT03528538|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110816532|NCT03528538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110816533|NCT03145766|Immunoglobulins|immunoglobulins|mesh-list
110816534|NCT03145766|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110816535|NCT03145766|Antibodies|antibodies|mesh-list
110816536|NCT03145766|Immunologic Factors|immunologic factors|mesh-ancestor
110816537|NCT03145766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110816538|NCT01115179|Propofol|propofol|mesh-list
110816539|NCT01115179|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
110816540|NCT01115179|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110816541|NCT01115179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110816542|NCT01115179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110816543|NCT01115179|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110816544|NCT01115179|Anesthetics, General|anesthetics, general|mesh-ancestor
110816545|NCT01115179|Anesthetics|anesthetics|mesh-ancestor
110816546|NCT01115179|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
110816547|NCT01115179|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
110816548|NCT01115179|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110816549|NCT04468438|Estrogens|estrogens|mesh-list
110816550|NCT04468438|Hormones|hormones|mesh-ancestor
110816551|NCT04468438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110816552|NCT04468438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110816553|NCT04468282|Vigabatrin|vigabatrin|mesh-list
110816554|NCT04468282|Anticonvulsants|anticonvulsants|mesh-ancestor
110816555|NCT04468282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110816556|NCT04468282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110816557|NCT04468282|GABA Agents|gaba agents|mesh-ancestor
110816558|NCT04468282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110816559|NCT04468282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110816560|NCT01121731|Interferons|interferons|mesh-list
110816561|NCT01121731|Interferon alpha-2|interferon alpha-2|mesh-list
110816562|NCT01121731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110816563|NCT01121731|Antiviral Agents|antiviral agents|mesh-ancestor
110816564|NCT01121731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110816565|NCT01215799|Bafetinib|bafetinib|mesh-list
110816566|NCT01215799|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110816567|NCT01215799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110816568|NCT01215799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110816569|NCT03145064|Zanubrutinib|zanubrutinib|mesh-list
110816570|NCT03145064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110816571|NCT03145064|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110816572|NCT03145064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110816573|NCT03145064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110816574|NCT03527134|Amantadine|amantadine|mesh-list
110816575|NCT03527134|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110816576|NCT03527134|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110816577|NCT03527134|Antiviral Agents|antiviral agents|mesh-ancestor
110816578|NCT03527134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110816579|NCT03527134|Dopamine Agents|dopamine agents|mesh-ancestor
110816580|NCT03527134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110816581|NCT03527134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110816582|NCT03527134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110816583|NCT03527134|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110816584|NCT03527134|Analgesics|analgesics|mesh-ancestor
110816585|NCT03527134|Sensory System Agents|sensory system agents|mesh-ancestor
110816586|NCT03527134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110816587|NCT01213693|Fluticasone|fluticasone|mesh-list
110854053|NCT01316900|Bromides|bromides|mesh-list
110816588|NCT01213693|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110816589|NCT01213693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110816590|NCT01213693|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110816591|NCT01213693|Autonomic Agents|autonomic agents|mesh-ancestor
110816592|NCT01213693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110816593|NCT01213693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110816594|NCT01213693|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110816595|NCT01213693|Respiratory System Agents|respiratory system agents|mesh-ancestor
110816596|NCT01213693|Dermatologic Agents|dermatologic agents|mesh-ancestor
110816597|NCT01213693|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110816598|NCT01213693|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110816599|NCT01213693|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110816600|NCT01213693|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110534149|NCT02679924|Hyaluronic Acid|hyaluronic acid|mesh-list
110816601|NCT01213693|Adrenergic Agents|adrenergic agents|mesh-ancestor
110816602|NCT01213693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110816603|NCT01213693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110816604|NCT01213849|Fluticasone|fluticasone|mesh-list
110816606|NCT01213849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110816607|NCT01213849|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110816608|NCT01213849|Autonomic Agents|autonomic agents|mesh-ancestor
110816609|NCT01213849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110816610|NCT01213849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110816611|NCT01213849|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110816612|NCT01213849|Respiratory System Agents|respiratory system agents|mesh-ancestor
110816613|NCT01213849|Dermatologic Agents|dermatologic agents|mesh-ancestor
110816614|NCT01213849|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110816615|NCT01121809|Raltegravir Potassium|raltegravir potassium|mesh-list
110816617|NCT01121809|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110816618|NCT01121809|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110816619|NCT01121809|Antiviral Agents|antiviral agents|mesh-ancestor
110816620|NCT01121809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110816621|NCT01121809|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110816622|NCT01121809|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110816623|NCT01121809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110816624|NCT01121809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110816625|NCT01121809|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110816626|NCT01121809|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110816627|NCT03937687|Caffeine|caffeine|mesh-list
110816628|NCT03937687|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110816629|NCT03937687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110816630|NCT03937687|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110816631|NCT03937687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110816632|NCT03937687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110816633|NCT03937687|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110816634|NCT03937687|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110816635|NCT03937687|Purinergic Agents|purinergic agents|mesh-ancestor
110816636|NCT03937687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110816637|NCT05110144|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110816638|NCT05110144|Amitriptyline|amitriptyline|mesh-list
110816639|NCT05110144|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110816640|NCT05110144|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110816641|NCT05110144|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110816642|NCT05110144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110816643|NCT05110144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110816644|NCT05110144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110816645|NCT05110144|Analgesics|analgesics|mesh-ancestor
110816646|NCT05110144|Sensory System Agents|sensory system agents|mesh-ancestor
110816647|NCT05110144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110816648|NCT05110144|Antidepressive Agents|antidepressive agents|mesh-ancestor
110816649|NCT05110144|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110816650|NCT05110144|Dopamine Agents|dopamine agents|mesh-ancestor
110816651|NCT05110144|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110816652|NCT05110144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110816653|NCT05110144|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110816654|NCT05110144|Adrenergic Agents|adrenergic agents|mesh-ancestor
110816655|NCT01212367|Interferons|interferons|mesh-list
110816656|NCT01212367|Interferon-alpha|interferon-alpha|mesh-list
110816657|NCT01212367|Interferon alpha-2|interferon alpha-2|mesh-list
110816658|NCT01212367|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
110816659|NCT01212367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110816660|NCT01212367|Antiviral Agents|antiviral agents|mesh-ancestor
110816661|NCT01212367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110816662|NCT01212367|Immunologic Factors|immunologic factors|mesh-ancestor
110816663|NCT01212367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110816664|NCT01216111|Paclitaxel|paclitaxel|mesh-list
110816665|NCT01216111|Docetaxel|docetaxel|mesh-list
110816666|NCT01216111|Cyclophosphamide|cyclophosphamide|mesh-list
110816667|NCT01216111|Fluorouracil|fluorouracil|mesh-list
110816668|NCT01216111|Epirubicin|epirubicin|mesh-list
110816669|NCT01216111|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110816670|NCT01216111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110816671|NCT01216111|Tubulin Modulators|tubulin modulators|mesh-ancestor
110816672|NCT01216111|Antimitotic Agents|antimitotic agents|mesh-ancestor
110816673|NCT01216111|Mitosis Modulators|mitosis modulators|mesh-ancestor
110816674|NCT01216111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110816675|NCT01216111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110816676|NCT01216111|Immunologic Factors|immunologic factors|mesh-ancestor
110816677|NCT01216111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110816678|NCT01216111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110816679|NCT01216111|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110816680|NCT01216111|Alkylating Agents|alkylating agents|mesh-ancestor
110816681|NCT01216111|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110816682|NCT01216111|Antimetabolites|antimetabolites|mesh-ancestor
110816683|NCT01216111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110816684|NCT01216111|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110816685|NCT01216111|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110816686|NCT01216111|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110816687|NCT01216111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110816689|NCT01216267|Dexlansoprazole|dexlansoprazole|mesh-list
110816690|NCT01216267|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110816691|NCT01216267|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110816692|NCT01216267|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110816693|NCT01216267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110816694|NCT01216267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110816695|NCT01216345|Gemcitabine|gemcitabine|mesh-list
110816696|NCT01216345|Oxaliplatin|oxaliplatin|mesh-list
110816697|NCT01216345|Cetuximab|cetuximab|mesh-list
110816698|NCT01216345|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110816699|NCT01216345|Antimetabolites|antimetabolites|mesh-ancestor
110816700|NCT01216345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110816701|NCT01216345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110816702|NCT01216345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110816703|NCT01118533|Pyrithione zinc|pyrithione zinc|mesh-list
110816704|NCT01118533|Keratolytic Agents|keratolytic agents|mesh-ancestor
110816705|NCT01118533|Dermatologic Agents|dermatologic agents|mesh-ancestor
110816706|NCT01118611|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110816707|NCT01118611|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110816708|NCT01118611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110816709|NCT01212523|Propofol|propofol|mesh-list
110816710|NCT01212523|Isoflurane|isoflurane|mesh-list
110816711|NCT01212523|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110816712|NCT01212523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110816713|NCT01212523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110816714|NCT01212523|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110816715|NCT01212523|Anesthetics, General|anesthetics, general|mesh-ancestor
110816716|NCT01212523|Anesthetics|anesthetics|mesh-ancestor
110816717|NCT01212523|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110816718|NCT01122121|Leuprolide|leuprolide|mesh-list
110816719|NCT01122121|Flutamide|flutamide|mesh-list
110816720|NCT01122121|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110816721|NCT01122121|Fertility Agents|fertility agents|mesh-ancestor
110816722|NCT01122121|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110816723|NCT01122121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110816724|NCT01122121|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110816725|NCT01122121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110816726|NCT01122121|Androgen Antagonists|androgen antagonists|mesh-ancestor
110816727|NCT01122121|Hormone Antagonists|hormone antagonists|mesh-ancestor
110816728|NCT01122121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110816729|NCT01115725|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
110816731|NCT01115725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110816732|NCT01115725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110816734|NCT01122199|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110816735|NCT01122199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110816736|NCT01122199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110816737|NCT01122199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110816738|NCT01122199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110816739|NCT01122199|Immunologic Factors|immunologic factors|mesh-ancestor
110816740|NCT01122199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110816741|NCT01122199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110816742|NCT01118923|Magnesium Hydroxide|magnesium hydroxide|mesh-list
110816743|NCT01118923|Antacids|antacids|mesh-ancestor
110816744|NCT01118923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110816745|NCT01118923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110816746|NCT01119079|Anesthetics|anesthetics|mesh-list
110816747|NCT01119079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110816748|NCT01119079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110534328|NCT02681562|Olaparib|olaparib|mesh-list
110816749|NCT01119157|Vaccines|vaccines|mesh-list
110816750|NCT01119157|Immunologic Factors|immunologic factors|mesh-ancestor
110816751|NCT01119157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110816753|NCT01120015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110816754|NCT01216579|Mannitol|mannitol|mesh-list
110816755|NCT01216579|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110816756|NCT01216579|Diuretics|diuretics|mesh-ancestor
110816757|NCT01216579|Natriuretic Agents|natriuretic agents|mesh-ancestor
110816758|NCT01216579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110816759|NCT03528070|Tranilast|tranilast|mesh-list
110816760|NCT03528070|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110816761|NCT03528070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110816762|NCT03528070|Analgesics|analgesics|mesh-ancestor
110816763|NCT03528070|Sensory System Agents|sensory system agents|mesh-ancestor
110816764|NCT03528070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110816765|NCT03528070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110816766|NCT03528070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110816767|NCT03528070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110816768|NCT03528070|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110816769|NCT03528070|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110816770|NCT03528070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110816771|NCT03528070|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110816772|NCT03528070|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110816773|NCT03528070|Histamine Antagonists|histamine antagonists|mesh-ancestor
110816774|NCT03528070|Histamine Agents|histamine agents|mesh-ancestor
110816775|NCT03528070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110816776|NCT03528070|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110816777|NCT03528070|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110816778|NCT03935815|Ropivacaine|ropivacaine|mesh-list
110816779|NCT03935815|Anesthetics, Local|anesthetics, local|mesh-ancestor
110816780|NCT03935815|Anesthetics|anesthetics|mesh-ancestor
110816781|NCT03935815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110816782|NCT03935815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110816783|NCT03935815|Sensory System Agents|sensory system agents|mesh-ancestor
110854070|NCT02490982|Analgesics|analgesics|mesh-ancestor
110816785|NCT01216657|Sunitinib|sunitinib|mesh-list
110816786|NCT01216657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110816787|NCT01216657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110816788|NCT01216657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110816789|NCT01216657|Growth Substances|growth substances|mesh-ancestor
110816790|NCT01216657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110816791|NCT01216657|Growth Inhibitors|growth inhibitors|mesh-ancestor
110816792|NCT01216657|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110816793|NCT01216657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110816794|NCT01216657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110816795|NCT04400188|Temozolomide|temozolomide|mesh-list
110816796|NCT04400188|Fluzoparib|fluzoparib|mesh-list
110816797|NCT04400188|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110816799|NCT04400188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110816800|NCT04400188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110816801|NCT04400188|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110816802|NCT04400188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110816803|NCT04163458|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110816804|NCT04163458|Menotropins|menotropins|mesh-list
110816805|NCT04163458|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110816806|NCT04163458|Fertility Agents|fertility agents|mesh-ancestor
110816807|NCT04163458|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110816808|NCT04163458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110816809|NCT01115959|Valproic Acid|valproic acid|mesh-list
110816810|NCT01115959|Anticonvulsants|anticonvulsants|mesh-ancestor
110816811|NCT01115959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110816812|NCT01115959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110816813|NCT01115959|GABA Agents|gaba agents|mesh-ancestor
110816814|NCT01115959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110816815|NCT01115959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110816816|NCT01115959|Antimanic Agents|antimanic agents|mesh-ancestor
110816817|NCT01115959|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110816818|NCT01115959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110816819|NCT01115959|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110816820|NCT03936907|Nabiximols|nabiximols|mesh-list
110816821|NCT03936907|Analgesics|analgesics|mesh-ancestor
110816822|NCT03936907|Sensory System Agents|sensory system agents|mesh-ancestor
110816823|NCT03936907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110534369|NCT00642252|Fluorides|fluorides|mesh-list
110816824|NCT03936907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110816825|NCT01116115|Palmitic Acid|palmitic acid|mesh-list
110816826|NCT01116115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110816827|NCT01116115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110816828|NCT01217203|Lenalidomide|lenalidomide|mesh-list
110816829|NCT01217203|Immunologic Factors|immunologic factors|mesh-ancestor
110816830|NCT01217203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110816831|NCT01217203|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110816832|NCT01217203|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110816833|NCT01217203|Growth Substances|growth substances|mesh-ancestor
110816834|NCT01217203|Growth Inhibitors|growth inhibitors|mesh-ancestor
110816835|NCT01217203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110816836|NCT01120171|Cyclophosphamide|cyclophosphamide|mesh-list
110816837|NCT01120171|Doxorubicin|doxorubicin|mesh-list
110816838|NCT01120171|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110816839|NCT01120171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110816840|NCT01120171|Immunologic Factors|immunologic factors|mesh-ancestor
110816841|NCT01120171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110816842|NCT01120171|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110816843|NCT01120171|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110816844|NCT01120171|Alkylating Agents|alkylating agents|mesh-ancestor
110816845|NCT01120171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110816846|NCT01120171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110816847|NCT01120171|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110816848|NCT01120171|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110816849|NCT01120171|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110816850|NCT01120171|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110816851|NCT01120171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110816852|NCT01116193|Dexamethasone|dexamethasone|mesh-list
110816853|NCT01116193|Lenalidomide|lenalidomide|mesh-list
110816854|NCT01116193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110816856|NCT01116193|Autonomic Agents|autonomic agents|mesh-ancestor
110816857|NCT01116193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110816858|NCT01116193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110816859|NCT01116193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110816860|NCT01116193|Glucocorticoids|glucocorticoids|mesh-ancestor
110816862|NCT01116193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110816863|NCT01116193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110816864|NCT01116193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110816865|NCT01116193|Immunologic Factors|immunologic factors|mesh-ancestor
110816866|NCT01116193|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110816867|NCT01116193|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110816868|NCT01116193|Growth Substances|growth substances|mesh-ancestor
110816869|NCT01116193|Growth Inhibitors|growth inhibitors|mesh-ancestor
110816870|NCT01120327|Amlodipine|amlodipine|mesh-list
110816871|NCT01120327|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110142092|NCT02016820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110816872|NCT01120327|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110816873|NCT01120327|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110816874|NCT01120327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110816875|NCT01120327|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110816876|NCT01120327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110816877|NCT01120327|Vasodilator Agents|vasodilator agents|mesh-ancestor
110816878|NCT01116271|Irinotecan|irinotecan|mesh-list
110816879|NCT01116271|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110816880|NCT01116271|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110816881|NCT01116271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110816882|NCT01116271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110816883|NCT01116271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110816884|NCT01217359|Interferons|interferons|mesh-list
110816885|NCT01217359|Interferon-alpha|interferon-alpha|mesh-list
110816886|NCT01217359|Interferon alpha-2|interferon alpha-2|mesh-list
110816887|NCT01217359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110816888|NCT01217359|Antiviral Agents|antiviral agents|mesh-ancestor
110816889|NCT01217359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110816890|NCT01217359|Immunologic Factors|immunologic factors|mesh-ancestor
110816891|NCT01217359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110816892|NCT01212679|Mitogens|mitogens|mesh-list
110816893|NCT01212679|Mitosis Modulators|mitosis modulators|mesh-ancestor
110816894|NCT01212679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110816895|NCT03193684|Empagliflozin|empagliflozin|mesh-list
110816896|NCT03193684|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110816897|NCT03193684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110816898|NCT03193684|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110816899|NCT03193684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110816900|NCT01217671|Protease Inhibitors|protease inhibitors|mesh-list
110816901|NCT01217671|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
110816902|NCT01217671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110816903|NCT01217671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110816904|NCT01217671|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
110816905|NCT01217671|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110816906|NCT01116583|Gabapentin|gabapentin|mesh-list
110816907|NCT01116583|Analgesics|analgesics|mesh-ancestor
110816908|NCT01116583|Sensory System Agents|sensory system agents|mesh-ancestor
110816909|NCT01116583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110816910|NCT01116583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110816911|NCT01116583|Anticonvulsants|anticonvulsants|mesh-ancestor
110816912|NCT01116583|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110816913|NCT01116583|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110816914|NCT01116583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110816915|NCT01116583|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110816916|NCT01116583|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110816917|NCT01116583|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110816918|NCT01116583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110816919|NCT01116583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110816920|NCT01116583|Antimanic Agents|antimanic agents|mesh-ancestor
110816921|NCT03935347|Vidarabine|vidarabine|mesh-list
110816923|NCT03935347|Cyclophosphamide|cyclophosphamide|mesh-list
110816924|NCT03935347|Pembrolizumab|pembrolizumab|mesh-list
110816925|NCT03935347|Fludarabine|fludarabine|mesh-list
110816926|NCT03935347|Fludarabine phosphate|fludarabine phosphate|mesh-list
110816927|NCT03935347|Interleukin-2|interleukin-2|mesh-list
110816928|NCT03935347|Immunoglobulins|immunoglobulins|mesh-list
110816929|NCT03935347|Immunoglobulin G|immunoglobulin g|mesh-list
110816930|NCT03935347|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110816931|NCT03935347|Immunologic Factors|immunologic factors|mesh-ancestor
110816932|NCT03935347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110816933|NCT03935347|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110816934|NCT03935347|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110816935|NCT03935347|Alkylating Agents|alkylating agents|mesh-ancestor
110816936|NCT03935347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110816937|NCT03935347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110816938|NCT03935347|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110816939|NCT03935347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110816940|NCT03935347|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110816941|NCT03935347|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110816942|NCT03935347|Antimetabolites|antimetabolites|mesh-ancestor
110816943|NCT03935347|Antiviral Agents|antiviral agents|mesh-ancestor
110816944|NCT03935347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110816945|NCT03935347|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110816946|NCT03935347|Analgesics|analgesics|mesh-ancestor
110816947|NCT03935347|Sensory System Agents|sensory system agents|mesh-ancestor
110816948|NCT03935347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110816949|NCT03935347|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110816950|NCT03935347|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110816952|NCT04467346|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110816953|NCT04467346|Alkylating Agents|alkylating agents|mesh-ancestor
110816954|NCT04467346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110816955|NCT04467346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110816956|NCT03939871|Vinorelbine|vinorelbine|mesh-list
110816957|NCT03939871|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110816958|NCT03939871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110816959|NCT03939871|Tubulin Modulators|tubulin modulators|mesh-ancestor
110816960|NCT03939871|Antimitotic Agents|antimitotic agents|mesh-ancestor
110816961|NCT03939871|Mitosis Modulators|mitosis modulators|mesh-ancestor
110816962|NCT03939871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110816963|NCT01122667|Anacetrapib|anacetrapib|mesh-list
110816964|NCT01122667|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110816965|NCT01122667|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110816966|NCT01122667|Antimetabolites|antimetabolites|mesh-ancestor
110816967|NCT01122667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110816968|NCT01122667|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110816969|NCT01120561|Trastuzumab|trastuzumab|mesh-list
110816970|NCT01120561|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
110534531|NCT02673606|Estradiol|estradiol|mesh-list
110816971|NCT01120561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110816972|NCT01120561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110816973|NCT01120561|Immunotoxins|immunotoxins|mesh-ancestor
110816974|NCT01120561|Immunoconjugates|immunoconjugates|mesh-ancestor
110816975|NCT01120561|Immunologic Factors|immunologic factors|mesh-ancestor
110816976|NCT01120561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110816977|NCT01120561|Tubulin Modulators|tubulin modulators|mesh-ancestor
110816978|NCT01120561|Antimitotic Agents|antimitotic agents|mesh-ancestor
110816979|NCT01120561|Mitosis Modulators|mitosis modulators|mesh-ancestor
110816980|NCT01120561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110816981|NCT01217125|Sirolimus|sirolimus|mesh-list
110816982|NCT01217125|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110191069|NCT00026351|Rituximab|rituximab|mesh-list
110816983|NCT01217125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110816984|NCT01217125|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110816985|NCT01217125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110816986|NCT01217125|Antifungal Agents|antifungal agents|mesh-ancestor
110816987|NCT01217125|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110816988|NCT01217125|Immunologic Factors|immunologic factors|mesh-ancestor
110816989|NCT01217125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110816990|NCT03635372|Sucralfate|sucralfate|mesh-list
110816991|NCT03635372|Hydrotalcite|hydrotalcite|mesh-list
110816992|NCT03635372|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110816993|NCT03635372|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110816994|NCT03635372|Antacids|antacids|mesh-ancestor
110816995|NCT03635372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110816996|NCT01116817|Ritonavir|ritonavir|mesh-list
110816997|NCT01116817|Lopinavir|lopinavir|mesh-list
110816998|NCT01116817|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110816999|NCT01116817|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110817000|NCT01116817|Protease Inhibitors|protease inhibitors|mesh-ancestor
110817001|NCT01116817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110817002|NCT01116817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110817003|NCT01116817|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110817004|NCT01116817|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110817005|NCT01116817|Antiviral Agents|antiviral agents|mesh-ancestor
110817006|NCT01116817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110817007|NCT01116817|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110817008|NCT01116817|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110817009|NCT01120795|Interferons|interferons|mesh-list
110817010|NCT01120795|Ribavirin|ribavirin|mesh-list
110817011|NCT01120795|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110817012|NCT01120795|Interferon-alpha|interferon-alpha|mesh-list
110817013|NCT01120795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110817014|NCT01120795|Antiviral Agents|antiviral agents|mesh-ancestor
110817015|NCT01120795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110817016|NCT01120795|Antimetabolites|antimetabolites|mesh-ancestor
110817017|NCT01120795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110817018|NCT01120795|Immunologic Factors|immunologic factors|mesh-ancestor
110817019|NCT01120795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110817020|NCT04467892|Methylprednisolone|methylprednisolone|mesh-list
110817021|NCT04467892|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110817022|NCT04467892|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110817023|NCT04467892|Prednisolone|prednisolone|mesh-list
110817024|NCT04467892|Prednisolone acetate|prednisolone acetate|mesh-list
110817025|NCT04467892|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110817026|NCT04467892|Prednisolone phosphate|prednisolone phosphate|mesh-list
110817027|NCT04467892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110817028|NCT04467892|Antiemetics|antiemetics|mesh-ancestor
110817029|NCT04467892|Autonomic Agents|autonomic agents|mesh-ancestor
110817030|NCT04467892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110817031|NCT04467892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110817032|NCT04467892|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110817033|NCT04467892|Glucocorticoids|glucocorticoids|mesh-ancestor
110817034|NCT04467892|Hormones|hormones|mesh-ancestor
110817035|NCT04467892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110817036|NCT04467892|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110817037|NCT04467892|Protective Agents|protective agents|mesh-ancestor
110817038|NCT04467892|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110817039|NCT04467892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110817040|NCT01122979|Insulin|insulin|mesh-list
110817041|NCT01122979|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110817042|NCT01122979|Insulin Glargine|insulin glargine|mesh-list
110817043|NCT01122979|Insulin glulisine|insulin glulisine|mesh-list
110817044|NCT01122979|Insulin, Isophane|insulin, isophane|mesh-list
110817045|NCT01122979|Isophane Insulin, Human|isophane insulin, human|mesh-list
110817046|NCT01122979|Isophane insulin, beef|isophane insulin, beef|mesh-list
110817047|NCT01122979|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110817048|NCT01122979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110817049|NCT04179110|Pembrolizumab|pembrolizumab|mesh-list
110817050|NCT04179110|Ramucirumab|ramucirumab|mesh-list
110817051|NCT04179110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110817052|NCT04179110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110418552|NCT01096017|Albuterol|albuterol|mesh-list
110817053|NCT04179110|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110817054|NCT04179110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110817055|NCT01123057|Riboflavin|riboflavin|mesh-list
110817056|NCT01123057|Vitamin B Complex|vitamin b complex|mesh-ancestor
110817057|NCT01123057|Vitamins|vitamins|mesh-ancestor
110817058|NCT01123057|Micronutrients|micronutrients|mesh-ancestor
110817059|NCT01123057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110817060|NCT01123057|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110817061|NCT01123057|Dermatologic Agents|dermatologic agents|mesh-ancestor
110817062|NCT03524950|Dexmedetomidine|dexmedetomidine|mesh-list
110817063|NCT03524950|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110817064|NCT03524950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110817065|NCT03524950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110817066|NCT03524950|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110817067|NCT03524950|Analgesics|analgesics|mesh-ancestor
110817068|NCT03524950|Sensory System Agents|sensory system agents|mesh-ancestor
110817069|NCT03524950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110817070|NCT03524950|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110817071|NCT03524950|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110817072|NCT03524950|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110817073|NCT03524950|Adrenergic Agents|adrenergic agents|mesh-ancestor
110817074|NCT03524950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110817075|NCT03524950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110817076|NCT04714190|Paclitaxel|paclitaxel|mesh-list
110817077|NCT04714190|Irinotecan|irinotecan|mesh-list
110817078|NCT04714190|Apatinib|apatinib|mesh-list
110817079|NCT04714190|Trastuzumab|trastuzumab|mesh-list
110817080|NCT04714190|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110817081|NCT04714190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110817082|NCT04714190|Tubulin Modulators|tubulin modulators|mesh-ancestor
110817083|NCT04714190|Antimitotic Agents|antimitotic agents|mesh-ancestor
110817084|NCT04714190|Mitosis Modulators|mitosis modulators|mesh-ancestor
110817085|NCT04714190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110817086|NCT04714190|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110817087|NCT04714190|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110817088|NCT04714190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110817089|NCT04714190|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110817090|NCT04714190|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110817091|NCT03524872|Analgesics|analgesics|mesh-list
110817092|NCT03524872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110817093|NCT03524872|Sensory System Agents|sensory system agents|mesh-ancestor
110817094|NCT03524872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110817095|NCT04143724|Luspatercept|luspatercept|mesh-list
110817096|NCT04143724|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
110817097|NCT04143724|Hematinics|hematinics|mesh-ancestor
110817098|NCT04143724|Immunologic Factors|immunologic factors|mesh-ancestor
110817099|NCT04143724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110817101|NCT01345370|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110817102|NCT01345370|Alkylating Agents|alkylating agents|mesh-ancestor
110817103|NCT01345370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110817104|NCT01345370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110817105|NCT04702802|Hyaluronic Acid|hyaluronic acid|mesh-list
110817106|NCT04702802|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110817107|NCT04702802|Immunologic Factors|immunologic factors|mesh-ancestor
110817108|NCT04702802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110817109|NCT04702802|Viscosupplements|viscosupplements|mesh-ancestor
110817110|NCT04702802|Protective Agents|protective agents|mesh-ancestor
110817111|NCT01214941|Itraconazole|itraconazole|mesh-list
110817112|NCT01214941|Ticlopidine|ticlopidine|mesh-list
110817113|NCT01214941|Antifungal Agents|antifungal agents|mesh-ancestor
110817114|NCT01214941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110817115|NCT01214941|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110817116|NCT01214941|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110817117|NCT01214941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110817118|NCT01214941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110817119|NCT01214941|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110817120|NCT01214941|Hormone Antagonists|hormone antagonists|mesh-ancestor
110817121|NCT01214941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110817122|NCT01214941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110817123|NCT01214941|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110817124|NCT01214941|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110817125|NCT01214941|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110817126|NCT01214941|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110817127|NCT01214941|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110817128|NCT01214941|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110817129|NCT01214941|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110817130|NCT01214941|Purinergic Agents|purinergic agents|mesh-ancestor
110817131|NCT01214941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110817132|NCT01214941|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110817133|NCT05301634|Bupivacaine|bupivacaine|mesh-list
110817134|NCT05301634|Anesthetics, Local|anesthetics, local|mesh-ancestor
110817135|NCT05301634|Anesthetics|anesthetics|mesh-ancestor
110817136|NCT05301634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110817137|NCT05301634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110817138|NCT05301634|Sensory System Agents|sensory system agents|mesh-ancestor
110817139|NCT05301634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110817140|NCT01328821|Pentoxifylline|pentoxifylline|mesh-list
110817141|NCT01328821|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110817142|NCT01328821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110817143|NCT01328821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110817144|NCT01328821|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110817145|NCT01328821|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110817146|NCT01328821|Protective Agents|protective agents|mesh-ancestor
110817147|NCT01328821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110817148|NCT01328821|Vasodilator Agents|vasodilator agents|mesh-ancestor
110817149|NCT01328821|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110817150|NCT01328821|Antioxidants|antioxidants|mesh-ancestor
110817151|NCT01345448|Brimonidine Tartrate|brimonidine tartrate|mesh-list
110817152|NCT01345448|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110817153|NCT01345448|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110817154|NCT01345448|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110817155|NCT01345448|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110817156|NCT01345448|Adrenergic Agents|adrenergic agents|mesh-ancestor
110817157|NCT01345448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110817158|NCT01345448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110817159|NCT01345448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110817160|NCT04001894|Clopidogrel|clopidogrel|mesh-list
110817162|NCT04001894|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110817163|NCT04001894|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110817164|NCT04001894|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110817165|NCT04001894|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110817166|NCT04001894|Purinergic Agents|purinergic agents|mesh-ancestor
110817167|NCT04001894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110817168|NCT04001894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110817169|NCT04001894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110817170|NCT01212913|Insulin|insulin|mesh-list
110817172|NCT01212913|Insulin Glargine|insulin glargine|mesh-list
110817173|NCT01212913|Insulin Aspart|insulin aspart|mesh-list
110817174|NCT01212913|Insulin glulisine|insulin glulisine|mesh-list
110817175|NCT01212913|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
110817176|NCT01212913|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110817177|NCT01212913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110817178|NCT01345604|Ropivacaine|ropivacaine|mesh-list
110817179|NCT01345604|Anesthetics, Local|anesthetics, local|mesh-ancestor
110817180|NCT01345604|Anesthetics|anesthetics|mesh-ancestor
110817181|NCT01345604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110817182|NCT01345604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110817183|NCT01345604|Sensory System Agents|sensory system agents|mesh-ancestor
110817184|NCT01345604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110817185|NCT01218217|Rifampin|rifampin|mesh-list
110817186|NCT01218217|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110817187|NCT01218217|Antitubercular Agents|antitubercular agents|mesh-ancestor
110817188|NCT01218217|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110817189|NCT01218217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110817190|NCT01218217|Leprostatic Agents|leprostatic agents|mesh-ancestor
110817191|NCT01218217|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110817192|NCT01218217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110817193|NCT01218217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110418560|NCT01096017|Tocolytic Agents|tocolytic agents|mesh-ancestor
110817194|NCT01218217|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110817195|NCT01218217|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110817196|NCT01218217|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110817197|NCT01218217|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110817198|NCT01218217|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110817199|NCT01218217|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110817200|NCT03522532|Zinc|zinc|mesh-list
110817201|NCT03522532|Trace Elements|trace elements|mesh-ancestor
110817202|NCT03522532|Micronutrients|micronutrients|mesh-ancestor
110817203|NCT03522532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110817204|NCT01215019|Mannitol|mannitol|mesh-list
110817205|NCT01215019|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110817206|NCT01215019|Diuretics|diuretics|mesh-ancestor
110817207|NCT01215019|Natriuretic Agents|natriuretic agents|mesh-ancestor
110817208|NCT01215019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110817209|NCT03795428|VIP-ELP fusion molecule PB1046|vip-elp fusion molecule pb1046|mesh-list
110817210|NCT03795428|Vasodilator Agents|vasodilator agents|mesh-ancestor
110817211|NCT01215331|Insulin|insulin|mesh-list
110817212|NCT01215331|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110817213|NCT01215331|Metformin|metformin|mesh-list
110817214|NCT01215331|Glyburide|glyburide|mesh-list
110817215|NCT01215331|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110817216|NCT01215331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110817217|NCT03526276|Fluorides|fluorides|mesh-list
110817218|NCT03526276|Cariostatic Agents|cariostatic agents|mesh-ancestor
110817219|NCT03526276|Protective Agents|protective agents|mesh-ancestor
110817220|NCT03526276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110817221|NCT04466254|Cetuximab|cetuximab|mesh-list
110817222|NCT04466254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110817223|NCT04466254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110817224|NCT04466176|Fluticasone|fluticasone|mesh-list
110817225|NCT04466176|Xhance|xhance|mesh-list
110817226|NCT04466176|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110817227|NCT04466176|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
110817228|NCT04466176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110817229|NCT04466176|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110817230|NCT04466176|Autonomic Agents|autonomic agents|mesh-ancestor
110817231|NCT04466176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110817232|NCT04466176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110817233|NCT04466176|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110817234|NCT04466176|Respiratory System Agents|respiratory system agents|mesh-ancestor
110817235|NCT04466176|Dermatologic Agents|dermatologic agents|mesh-ancestor
110817236|NCT04466176|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110817237|NCT04466176|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110817238|NCT04466176|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110817239|NCT04466176|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110817240|NCT04466176|Adrenergic Agents|adrenergic agents|mesh-ancestor
110817241|NCT04466176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110817242|NCT04466176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110817243|NCT04466176|Glucocorticoids|glucocorticoids|mesh-ancestor
110817244|NCT04466176|Hormones|hormones|mesh-ancestor
110817245|NCT04466176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110817247|NCT01215409|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
110817248|NCT01215409|Vasodilator Agents|vasodilator agents|mesh-ancestor
110817249|NCT01215409|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110817250|NCT01215409|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110817251|NCT01215409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110817252|NCT01215409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110817253|NCT01215409|Urological Agents|urological agents|mesh-ancestor
110817254|NCT03936205|Dexmedetomidine|dexmedetomidine|mesh-list
110817255|NCT03936205|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110817256|NCT03936205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110817257|NCT03936205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110817258|NCT03936205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110817259|NCT03936205|Analgesics|analgesics|mesh-ancestor
110817260|NCT03936205|Sensory System Agents|sensory system agents|mesh-ancestor
110817261|NCT03936205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110817262|NCT03936205|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110817263|NCT03936205|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110817264|NCT03936205|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110817265|NCT03936205|Adrenergic Agents|adrenergic agents|mesh-ancestor
110817266|NCT03936205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110817267|NCT03936205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110817268|NCT04674020|Erenumab|erenumab|mesh-list
110817269|NCT04674020|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
110817270|NCT04674020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110817272|NCT04674020|Sensory System Agents|sensory system agents|mesh-ancestor
110817273|NCT04674020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110817274|NCT04674020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110817275|NCT01123525|Adenosine|adenosine|mesh-list
110817276|NCT01123525|Analgesics|analgesics|mesh-ancestor
110817277|NCT01123525|Sensory System Agents|sensory system agents|mesh-ancestor
110817278|NCT01123525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110817279|NCT01123525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110817280|NCT01123525|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110817281|NCT01123525|Vasodilator Agents|vasodilator agents|mesh-ancestor
110817282|NCT01123525|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
110817283|NCT01123525|Purinergic Agonists|purinergic agonists|mesh-ancestor
110817284|NCT01123525|Purinergic Agents|purinergic agents|mesh-ancestor
110817285|NCT01123525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110817286|NCT01123525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110817287|NCT01215565|Sunitinib|sunitinib|mesh-list
110817288|NCT01215565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110817289|NCT01215565|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110817290|NCT01215565|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110817291|NCT01215565|Growth Substances|growth substances|mesh-ancestor
110817292|NCT01215565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110817293|NCT01215565|Growth Inhibitors|growth inhibitors|mesh-ancestor
110817294|NCT01215565|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110817295|NCT01215565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110817296|NCT01215565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110817297|NCT01121497|Physostigmine|physostigmine|mesh-list
110817298|NCT01121497|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110817299|NCT01121497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110817300|NCT01121497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110817301|NCT01121497|Cholinergic Agents|cholinergic agents|mesh-ancestor
110817302|NCT01121497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110817303|NCT01121497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110817304|NCT01121497|Miotics|miotics|mesh-ancestor
110817305|NCT01121497|Autonomic Agents|autonomic agents|mesh-ancestor
110817306|NCT01121497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110817307|NCT01213147|Clomiphene|clomiphene|mesh-list
110817308|NCT01213147|Enclomiphene|enclomiphene|mesh-list
110817309|NCT01213147|Zuclomiphene|zuclomiphene|mesh-list
110817310|NCT01213147|Buserelin|buserelin|mesh-list
110817311|NCT01213147|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110817312|NCT01213147|Hormone Antagonists|hormone antagonists|mesh-ancestor
110817313|NCT01213147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110817314|NCT01213147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110817315|NCT01213147|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110817316|NCT01213147|Fertility Agents|fertility agents|mesh-ancestor
110817317|NCT01213147|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110142549|NCT02020122|Pregabalin|pregabalin|mesh-list
110817318|NCT01213147|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110817319|NCT01213147|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110817321|NCT03143816|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110817322|NCT03143816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110817323|NCT01117129|Rituximab|rituximab|mesh-list
110817324|NCT01117129|Methotrexate|methotrexate|mesh-list
110817325|NCT01117129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110817326|NCT01117129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110817327|NCT01117129|Immunologic Factors|immunologic factors|mesh-ancestor
110817328|NCT01117129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110817329|NCT01117129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110817330|NCT01117129|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110817331|NCT01117129|Abortifacient Agents|abortifacient agents|mesh-ancestor
110817332|NCT01117129|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110817333|NCT01117129|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110817334|NCT01117129|Antimetabolites|antimetabolites|mesh-ancestor
110817335|NCT01117129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110817336|NCT01117129|Dermatologic Agents|dermatologic agents|mesh-ancestor
110817337|NCT01117129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110817338|NCT01117129|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110817339|NCT01117129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110817340|NCT01117129|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110817341|NCT03133988|Margetuximab|margetuximab|mesh-list
110817342|NCT03133988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110817343|NCT03934411|Tramadol|tramadol|mesh-list
110817344|NCT03934411|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110817345|NCT03934411|Narcotics|narcotics|mesh-ancestor
110817346|NCT03934411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110817347|NCT03934411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110817349|NCT03934411|Sensory System Agents|sensory system agents|mesh-ancestor
110817350|NCT03934411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110817351|NCT01218451|Vaccines|vaccines|mesh-list
110817352|NCT01218451|Immunologic Factors|immunologic factors|mesh-ancestor
110817353|NCT01218451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110817354|NCT01346930|Macitentan|macitentan|mesh-list
110817355|NCT01346930|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
110817356|NCT01346930|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
110817357|NCT01346930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110817358|NCT01346930|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
110817359|NCT01219153|Letrozole|letrozole|mesh-list
110817360|NCT01219153|LHRH, N-acetyl-(4-chlorophenylalanyl)(1)-(4-chlorophenylalanyl)(2)-tryptophyl(3)-arginyl(6)-alanine(10)-|lhrh, n-acetyl-(4-chlorophenylalanyl)(1)-(4-chlorophenylalanyl)(2)-tryptophyl(3)-arginyl(6)-alanine(10)-|mesh-list
110817361|NCT01219153|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
110817362|NCT01219153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110817363|NCT01219153|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110817364|NCT01219153|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110817365|NCT01219153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110817366|NCT01219153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110817367|NCT01219153|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110817368|NCT01219153|Hormone Antagonists|hormone antagonists|mesh-ancestor
110817369|NCT01219153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110817370|NCT01219153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110817371|NCT01219153|Hormones|hormones|mesh-ancestor
110817372|NCT03526042|Losartan|losartan|mesh-list
110817373|NCT03526042|Enalapril|enalapril|mesh-list
110817374|NCT03526042|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
110817375|NCT03526042|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
110817376|NCT03526042|Enzyme Inhibitors|enzyme inhibitors|mesh-list
110817377|NCT03526042|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110817378|NCT03526042|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110817379|NCT03526042|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110817380|NCT03526042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110817381|NCT03526042|Protease Inhibitors|protease inhibitors|mesh-ancestor
110817382|NCT01124539|Camptothecin|camptothecin|mesh-list
110817383|NCT01124539|10-hydroxycamptothecin|10-hydroxycamptothecin|mesh-list
110817384|NCT01124539|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110817385|NCT01124539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110817386|NCT01124539|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110817387|NCT01124539|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110817388|NCT01124539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110817389|NCT01124539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110817390|NCT03781375|Etanercept|etanercept|mesh-list
110817391|NCT03781375|Methotrexate|methotrexate|mesh-list
110817392|NCT03781375|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110817393|NCT03781375|Abortifacient Agents|abortifacient agents|mesh-ancestor
110817394|NCT03781375|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110817395|NCT03781375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110817396|NCT03781375|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110817397|NCT03781375|Antimetabolites|antimetabolites|mesh-ancestor
110817398|NCT03781375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110817399|NCT03781375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110817400|NCT03781375|Dermatologic Agents|dermatologic agents|mesh-ancestor
110817401|NCT03781375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110817402|NCT03781375|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110817403|NCT03781375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110817404|NCT03781375|Immunologic Factors|immunologic factors|mesh-ancestor
110817405|NCT03781375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110817406|NCT03781375|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110817407|NCT03781375|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110817408|NCT03781375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110817409|NCT03781375|Analgesics|analgesics|mesh-ancestor
110817410|NCT03781375|Sensory System Agents|sensory system agents|mesh-ancestor
110817411|NCT03781375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110817412|NCT03781375|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110817413|NCT03781375|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110817414|NCT01123915|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
110817415|NCT01123915|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
110817416|NCT01123915|Protective Agents|protective agents|mesh-ancestor
110817417|NCT01123915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110817418|NCT01123915|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110817420|NCT01123915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110817421|NCT01218529|Lapatinib|lapatinib|mesh-list
110817422|NCT01218529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110817423|NCT01218529|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110817424|NCT01218529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110817425|NCT01218529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110817426|NCT03938467|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
110817427|NCT03938467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110817428|NCT01218607|Bosentan|bosentan|mesh-list
110817429|NCT01218607|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110817430|NCT01218607|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
110817431|NCT01218607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110817432|NCT03933787|Saxagliptin|saxagliptin|mesh-list
110817433|NCT03933787|Incretins|incretins|mesh-ancestor
110817434|NCT03933787|Hormones|hormones|mesh-ancestor
110817435|NCT03933787|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110817436|NCT03933787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110817437|NCT03933787|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110817438|NCT03933787|Protease Inhibitors|protease inhibitors|mesh-ancestor
110817439|NCT03933787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110817440|NCT03933787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110817441|NCT03933787|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110817442|NCT03934333|Budesonide|budesonide|mesh-list
110817443|NCT03934333|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110817444|NCT03934333|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110817445|NCT03934333|Autonomic Agents|autonomic agents|mesh-ancestor
110817446|NCT03934333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110817447|NCT03934333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110817448|NCT03934333|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110817449|NCT03934333|Respiratory System Agents|respiratory system agents|mesh-ancestor
110817450|NCT03934333|Glucocorticoids|glucocorticoids|mesh-ancestor
110817451|NCT03934333|Hormones|hormones|mesh-ancestor
110817452|NCT03934333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110817453|NCT01124227|Icodextrin|icodextrin|mesh-list
110817454|NCT01124227|Dialysis Solutions|dialysis solutions|mesh-ancestor
110817455|NCT01124227|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110817456|NCT03931915|Leuprolide|leuprolide|mesh-list
110817457|NCT03931915|Relugolix|relugolix|mesh-list
110817458|NCT03931915|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110817459|NCT03931915|Fertility Agents|fertility agents|mesh-ancestor
110817460|NCT03931915|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110817461|NCT03931915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110817462|NCT03931915|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110817463|NCT03931915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110817464|NCT03931915|Androgen Antagonists|androgen antagonists|mesh-ancestor
110817465|NCT03931915|Hormone Antagonists|hormone antagonists|mesh-ancestor
110817466|NCT03931915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110817467|NCT03932071|Zoledronic Acid|zoledronic acid|mesh-list
110817468|NCT03932071|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110817469|NCT03932071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110817470|NCT01124383|Lidocaine|lidocaine|mesh-list
110817471|NCT01124383|Ephedrine|ephedrine|mesh-list
110817472|NCT01124383|Midazolam|midazolam|mesh-list
110817473|NCT01124383|Sufentanil|sufentanil|mesh-list
110817474|NCT01124383|Dsuvia|dsuvia|mesh-list
110817475|NCT01124383|Anesthetics|anesthetics|mesh-list
110817476|NCT01124383|Propofol|propofol|mesh-list
110817477|NCT01124383|Sevoflurane|sevoflurane|mesh-list
110817478|NCT01124383|Rocuronium|rocuronium|mesh-list
110817479|NCT01124383|Anesthetics, Local|anesthetics, local|mesh-ancestor
110817480|NCT01124383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110817481|NCT01124383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110817482|NCT01124383|Sensory System Agents|sensory system agents|mesh-ancestor
110817483|NCT01124383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110817484|NCT01124383|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110817485|NCT01124383|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110817486|NCT01124383|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110817487|NCT01124383|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110817488|NCT01124383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110817489|NCT01124383|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110817490|NCT01124383|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110817491|NCT01124383|Anesthetics, General|anesthetics, general|mesh-ancestor
110817492|NCT01124383|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110817493|NCT01124383|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110817494|NCT01124383|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110817495|NCT01124383|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110817496|NCT01124383|GABA Modulators|gaba modulators|mesh-ancestor
110817497|NCT01124383|GABA Agents|gaba agents|mesh-ancestor
110817498|NCT01124383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110817499|NCT01124383|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110817500|NCT01124383|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110817501|NCT01124383|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110817502|NCT01124383|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110817503|NCT01124383|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110817504|NCT01124383|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110817505|NCT01124383|Narcotics|narcotics|mesh-ancestor
110817506|NCT01124383|Analgesics|analgesics|mesh-ancestor
110817507|NCT01124383|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110817508|NCT01124383|Sympathomimetics|sympathomimetics|mesh-ancestor
110817509|NCT01124383|Autonomic Agents|autonomic agents|mesh-ancestor
110817510|NCT01124383|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110817511|NCT01124383|Adrenergic Agents|adrenergic agents|mesh-ancestor
110817512|NCT01226017|Oxytocin|oxytocin|mesh-list
110817513|NCT01226017|Oxytocics|oxytocics|mesh-ancestor
110817514|NCT01226017|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110817515|NCT01226017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110817516|NCT01222819|Lenograstim|lenograstim|mesh-list
110817517|NCT01222819|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110817518|NCT01222819|Immunologic Factors|immunologic factors|mesh-ancestor
110817519|NCT01222819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110817520|NCT01222897|Valacyclovir|valacyclovir|mesh-list
110817521|NCT01222897|Antiviral Agents|antiviral agents|mesh-ancestor
110817522|NCT01222897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110817523|NCT03150056|Prednisone|prednisone|mesh-list
110817524|NCT03150056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110817525|NCT03150056|Glucocorticoids|glucocorticoids|mesh-ancestor
110817526|NCT03150056|Hormones|hormones|mesh-ancestor
110817527|NCT03150056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110817528|NCT03150056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110817529|NCT03150056|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110817530|NCT03150056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110817531|NCT01329367|Antioxidants|antioxidants|mesh-list
110817532|NCT01329367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110817533|NCT01329367|Protective Agents|protective agents|mesh-ancestor
110817534|NCT01329367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110817535|NCT01222975|Risperidone|risperidone|mesh-list
110817536|NCT01222975|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110817537|NCT01222975|Serotonin Agents|serotonin agents|mesh-ancestor
110817538|NCT01222975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110817539|NCT01222975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110817540|NCT01222975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110817541|NCT01222975|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110817542|NCT01222975|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110817543|NCT01222975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110817544|NCT01222975|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110817545|NCT01222975|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110817546|NCT01222975|Dopamine Agents|dopamine agents|mesh-ancestor
110817547|NCT01129063|Clopidogrel|clopidogrel|mesh-list
110817548|NCT01129063|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110817549|NCT01129063|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110817550|NCT01129063|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110817551|NCT01129063|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110817552|NCT01129063|Purinergic Agents|purinergic agents|mesh-ancestor
110817553|NCT01129063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110817554|NCT01129063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110817555|NCT01129063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110817556|NCT01317368|Ropivacaine|ropivacaine|mesh-list
110191662|NCT00028925|Topotecan|topotecan|mesh-list
110817557|NCT01317368|Anesthetics, Local|anesthetics, local|mesh-ancestor
110817558|NCT01317368|Anesthetics|anesthetics|mesh-ancestor
110817559|NCT01317368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110817560|NCT01317368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110817561|NCT01317368|Sensory System Agents|sensory system agents|mesh-ancestor
110817562|NCT01317368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110817563|NCT01219699|Fulvestrant|fulvestrant|mesh-list
110817564|NCT01219699|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110817565|NCT01219699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110817566|NCT01219699|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110817567|NCT01219699|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110535119|NCT04172220|Midazolam|midazolam|mesh-list
110817568|NCT01219699|Hormone Antagonists|hormone antagonists|mesh-ancestor
110817569|NCT01219699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110817570|NCT01219699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110817571|NCT03933319|Doxorubicin|doxorubicin|mesh-list
110817572|NCT03933319|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110817573|NCT03933319|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110817574|NCT03933319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110817575|NCT03933319|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110817576|NCT03933319|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110817577|NCT03933319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110817578|NCT03933319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110817579|NCT01223053|Ketoprofen|ketoprofen|mesh-list
110817580|NCT01223053|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110817581|NCT01223053|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110817582|NCT01223053|Analgesics|analgesics|mesh-ancestor
110817583|NCT01223053|Sensory System Agents|sensory system agents|mesh-ancestor
110817584|NCT01223053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110817585|NCT01223053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110817586|NCT01223053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110817587|NCT01223053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110817588|NCT01223053|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110817589|NCT01223053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110817590|NCT01223053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110817591|NCT01223131|Insulin|insulin|mesh-list
110817592|NCT01223131|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110817593|NCT01223131|Insulin Glargine|insulin glargine|mesh-list
110817594|NCT01223131|Insulin, Isophane|insulin, isophane|mesh-list
110817595|NCT01223131|Isophane Insulin, Human|isophane insulin, human|mesh-list
110817596|NCT01223131|Isophane insulin, beef|isophane insulin, beef|mesh-list
110817597|NCT01223131|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110817598|NCT01223131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110817599|NCT01125553|Insulin|insulin|mesh-list
110817600|NCT01125553|Insulin Aspart|insulin aspart|mesh-list
110817601|NCT01125553|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110817602|NCT01125553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110817603|NCT02640664|Ranibizumab|ranibizumab|mesh-list
110817604|NCT02640664|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110817605|NCT02640664|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110817606|NCT02640664|Growth Substances|growth substances|mesh-ancestor
110817607|NCT02640664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110817608|NCT02640664|Growth Inhibitors|growth inhibitors|mesh-ancestor
110817609|NCT02640664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110817610|NCT01317446|Fluorides|fluorides|mesh-list
110817611|NCT01317446|Tin Fluorides|tin fluorides|mesh-list
110817612|NCT01317446|Cariostatic Agents|cariostatic agents|mesh-ancestor
110817613|NCT01317446|Protective Agents|protective agents|mesh-ancestor
110817614|NCT01317446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110817615|NCT02529241|Delpazolid|delpazolid|mesh-list
110817616|NCT02529241|Oxazolidinones|oxazolidinones|mesh-list
110817617|NCT02529241|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110817618|NCT02529241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110817619|NCT02529241|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110817620|NCT02529241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110817621|NCT02529241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110817622|NCT02456012|Esomeprazole|esomeprazole|mesh-list
110817623|NCT02456012|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110817624|NCT02456012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110817625|NCT02456012|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110817626|NCT02456012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110817627|NCT02456012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110817628|NCT00812006|Rizatriptan|rizatriptan|mesh-list
110817629|NCT00812006|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110817630|NCT00812006|Serotonin Agents|serotonin agents|mesh-ancestor
110817631|NCT00812006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110817632|NCT00812006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110817633|NCT00812006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110817634|NCT03133234|Osimertinib|osimertinib|mesh-list
110817635|NCT03133234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110817636|NCT03133234|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110817637|NCT03133234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110817638|NCT03133234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110817639|NCT01125787|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110817640|NCT01125787|Ofatumumab|ofatumumab|mesh-list
110817641|NCT01125787|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110817642|NCT01125787|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110817643|NCT01125787|Alkylating Agents|alkylating agents|mesh-ancestor
110817644|NCT01125787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110817645|NCT01125787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110817646|NCT01125787|Immunologic Factors|immunologic factors|mesh-ancestor
110817647|NCT01125787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110817648|NCT02457442|Remifentanil|remifentanil|mesh-list
110817649|NCT02457442|Propofol|propofol|mesh-list
110817650|NCT02457442|Sevoflurane|sevoflurane|mesh-list
110817651|NCT02457442|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110817652|NCT02457442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110817653|NCT02457442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110817654|NCT02457442|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110817655|NCT02457442|Anesthetics, General|anesthetics, general|mesh-ancestor
110817656|NCT02457442|Anesthetics|anesthetics|mesh-ancestor
110817657|NCT02457442|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110817658|NCT02457442|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110817659|NCT02457442|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110817660|NCT02457442|Narcotics|narcotics|mesh-ancestor
110817661|NCT02457442|Analgesics|analgesics|mesh-ancestor
110817662|NCT02457442|Sensory System Agents|sensory system agents|mesh-ancestor
110817663|NCT02457442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110817664|NCT03132038|Nivolumab|nivolumab|mesh-list
110817665|NCT03132038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110817666|NCT03132038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110817667|NCT03132038|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110817668|NCT03132038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110817669|NCT01129375|Omeprazole|omeprazole|mesh-list
110817670|NCT01129375|Clopidogrel|clopidogrel|mesh-list
110817671|NCT01129375|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110817672|NCT01129375|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110817673|NCT01129375|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110817674|NCT01129375|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110817675|NCT01129375|Purinergic Agents|purinergic agents|mesh-ancestor
110817676|NCT01129375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110817677|NCT01129375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110817678|NCT01129375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110817679|NCT01129375|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110817680|NCT01129375|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110817681|NCT01129375|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110817682|NCT01129375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110817683|NCT01352702|Dabigatran|dabigatran|mesh-list
110817684|NCT01352702|Phenprocoumon|phenprocoumon|mesh-list
110817685|NCT01352702|Antithrombins|antithrombins|mesh-ancestor
110817686|NCT01352702|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110817687|NCT01352702|Protease Inhibitors|protease inhibitors|mesh-ancestor
110817688|NCT01352702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110817689|NCT01352702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110817690|NCT01352702|Anticoagulants|anticoagulants|mesh-ancestor
110817691|NCT03525730|Pyrimethamine|pyrimethamine|mesh-list
110817692|NCT03525730|Valproic Acid|valproic acid|mesh-list
110817693|NCT03525730|Antimalarials|antimalarials|mesh-ancestor
110817694|NCT03525730|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110817695|NCT03525730|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110817696|NCT03525730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110817697|NCT03525730|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110817698|NCT03525730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110817699|NCT03525730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110817700|NCT03525730|Anticonvulsants|anticonvulsants|mesh-ancestor
110817701|NCT03525730|GABA Agents|gaba agents|mesh-ancestor
110817702|NCT03525730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110817703|NCT03525730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110817704|NCT03525730|Antimanic Agents|antimanic agents|mesh-ancestor
110817705|NCT03525730|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110817706|NCT03525730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110817707|NCT03525730|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110817708|NCT01223443|Paclitaxel|paclitaxel|mesh-list
110817709|NCT01223443|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110817710|NCT01223443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110817711|NCT01223443|Tubulin Modulators|tubulin modulators|mesh-ancestor
110817712|NCT01223443|Antimitotic Agents|antimitotic agents|mesh-ancestor
110817713|NCT01223443|Mitosis Modulators|mitosis modulators|mesh-ancestor
110817714|NCT01223443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110817715|NCT03525652|Vaccines|vaccines|mesh-list
110817716|NCT03525652|Immunologic Factors|immunologic factors|mesh-ancestor
110817717|NCT03525652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110817718|NCT02290054|Anesthetics|anesthetics|mesh-list
110817719|NCT02290054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110817720|NCT02290054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110817721|NCT01347944|Lenalidomide|lenalidomide|mesh-list
110817722|NCT01347944|Immunologic Factors|immunologic factors|mesh-ancestor
110817723|NCT01347944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110817724|NCT01347944|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110817725|NCT01347944|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110817726|NCT01347944|Growth Substances|growth substances|mesh-ancestor
110817727|NCT01347944|Growth Inhibitors|growth inhibitors|mesh-ancestor
110817728|NCT01347944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110817729|NCT02290132|Thymoglobulin|thymoglobulin|mesh-list
110817730|NCT02290132|Immunologic Factors|immunologic factors|mesh-ancestor
110817731|NCT02290132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110817732|NCT02290132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110817733|NCT01220245|Heparin|heparin|mesh-list
110817734|NCT01220245|Anticoagulants|anticoagulants|mesh-ancestor
110817735|NCT01220245|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110817736|NCT01220245|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110817737|NCT01220245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110817738|NCT03931135|Dexamethasone|dexamethasone|mesh-list
110817739|NCT03931135|Morphine|morphine|mesh-list
110817740|NCT03931135|Cyclizine|cyclizine|mesh-list
110817741|NCT03931135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110817742|NCT03931135|Antiemetics|antiemetics|mesh-ancestor
110817743|NCT03931135|Autonomic Agents|autonomic agents|mesh-ancestor
110817744|NCT03931135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110817745|NCT03931135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110817746|NCT03931135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110817747|NCT03931135|Glucocorticoids|glucocorticoids|mesh-ancestor
110817748|NCT03931135|Hormones|hormones|mesh-ancestor
110817749|NCT03931135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110817750|NCT03931135|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110571747|NCT02620163|Amlodipine|amlodipine|mesh-list
110817751|NCT03931135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110817752|NCT03931135|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110817754|NCT03931135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110817755|NCT03931135|Analgesics|analgesics|mesh-ancestor
110817756|NCT03931135|Sensory System Agents|sensory system agents|mesh-ancestor
110817757|NCT03931135|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110817758|NCT03931135|Histamine Antagonists|histamine antagonists|mesh-ancestor
110817759|NCT03931135|Histamine Agents|histamine agents|mesh-ancestor
110817760|NCT03931135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110817761|NCT03931135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110817762|NCT01353170|Dialysis Solutions|dialysis solutions|mesh-list
110817763|NCT01353170|Calcium|calcium|mesh-list
110817764|NCT01353170|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110817765|NCT01353170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110817766|NCT01353170|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110817767|NCT03620318|Crenolanib|crenolanib|mesh-list
110817768|NCT03620318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110817769|NCT01125943|Bevacizumab|bevacizumab|mesh-list
110817770|NCT01125943|Nitroprusside|nitroprusside|mesh-list
110817771|NCT01125943|Acetylcholine|acetylcholine|mesh-list
110817772|NCT01125943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110817773|NCT01125943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110817774|NCT01125943|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110817775|NCT01125943|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110817776|NCT01125943|Growth Substances|growth substances|mesh-ancestor
110817777|NCT01125943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110817778|NCT01125943|Growth Inhibitors|growth inhibitors|mesh-ancestor
110817779|NCT01125943|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110817780|NCT01125943|Vasodilator Agents|vasodilator agents|mesh-ancestor
110817781|NCT01125943|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
110817782|NCT01125943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110817783|NCT01125943|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110817784|NCT01125943|Cholinergic Agents|cholinergic agents|mesh-ancestor
110817785|NCT01125943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110817786|NCT01223755|Sirolimus|sirolimus|mesh-list
110817787|NCT01223755|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110817788|NCT01223755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110817789|NCT01223755|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110817790|NCT01223755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110817791|NCT01223755|Antifungal Agents|antifungal agents|mesh-ancestor
110817792|NCT01223755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110817793|NCT01223755|Immunologic Factors|immunologic factors|mesh-ancestor
110817794|NCT01223755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110817795|NCT01126177|Interferons|interferons|mesh-list
110817796|NCT01126177|Interferon-beta|interferon-beta|mesh-list
110817797|NCT01126177|Interferon beta-1a|interferon beta-1a|mesh-list
110817798|NCT01126177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110817799|NCT01126177|Antiviral Agents|antiviral agents|mesh-ancestor
110817800|NCT01126177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110817801|NCT01126177|Immunologic Factors|immunologic factors|mesh-ancestor
110817802|NCT01126177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110817803|NCT01126177|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110817804|NCT03680092|Cyclophosphamide|cyclophosphamide|mesh-list
110817805|NCT03680092|Methotrexate|methotrexate|mesh-list
110817806|NCT03680092|Abatacept|abatacept|mesh-list
110817807|NCT03680092|Tacrolimus|tacrolimus|mesh-list
110817808|NCT03680092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110817809|NCT03680092|Immunologic Factors|immunologic factors|mesh-ancestor
110817810|NCT03680092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110817811|NCT03680092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110817812|NCT03680092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110817813|NCT03680092|Alkylating Agents|alkylating agents|mesh-ancestor
110817814|NCT03680092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110817815|NCT03680092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110817816|NCT03680092|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110817817|NCT03680092|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110817818|NCT03680092|Abortifacient Agents|abortifacient agents|mesh-ancestor
110817819|NCT03680092|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110817820|NCT03680092|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110817821|NCT03680092|Antimetabolites|antimetabolites|mesh-ancestor
110817822|NCT03680092|Dermatologic Agents|dermatologic agents|mesh-ancestor
110817823|NCT03680092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110817824|NCT03680092|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110817825|NCT03680092|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110817826|NCT03680092|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110817827|NCT03680092|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110817828|NCT03680092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110817829|NCT03671044|Docetaxel|docetaxel|mesh-list
110817830|NCT03671044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110817831|NCT03671044|Tubulin Modulators|tubulin modulators|mesh-ancestor
110817832|NCT03671044|Antimitotic Agents|antimitotic agents|mesh-ancestor
110817833|NCT03671044|Mitosis Modulators|mitosis modulators|mesh-ancestor
110817834|NCT03671044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110817835|NCT05790070|Betaine|betaine|mesh-list
110817836|NCT05790070|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110817837|NCT05790070|Lipotropic Agents|lipotropic agents|mesh-ancestor
110817838|NCT05790070|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110817839|NCT05790070|Antimetabolites|antimetabolites|mesh-ancestor
110817844|NCT05789680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110817846|NCT05789667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110817847|NCT05789667|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110817848|NCT05789667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110817849|NCT05789667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110817855|NCT05789342|Itraconazole|itraconazole|mesh-list
110817856|NCT05789342|Oseltamivir|oseltamivir|mesh-list
110817857|NCT05789342|Digoxin|digoxin|mesh-list
110817858|NCT05789342|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110817859|NCT05789342|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110817860|NCT05789342|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110817861|NCT05789342|Antimetabolites|antimetabolites|mesh-ancestor
110817862|NCT05789342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110817863|NCT05789342|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110817864|NCT05789342|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110817865|NCT05789342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110817866|NCT05789342|Antifungal Agents|antifungal agents|mesh-ancestor
110817867|NCT05789342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110817868|NCT05789342|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110535423|NCT00633347|Fertility Agents|fertility agents|mesh-ancestor
110817869|NCT05789342|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110817870|NCT05789342|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110817871|NCT05789342|Hormone Antagonists|hormone antagonists|mesh-ancestor
110817872|NCT05789342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110817873|NCT05789342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110817874|NCT05789342|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110817875|NCT05789342|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110817876|NCT05789342|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110817877|NCT05789342|Protective Agents|protective agents|mesh-ancestor
110817878|NCT05789342|Antiviral Agents|antiviral agents|mesh-ancestor
110817879|NCT05789186|Fluoxetine|fluoxetine|mesh-list
110817880|NCT05789186|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110817881|NCT05789186|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110817882|NCT05789186|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110817883|NCT05789186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110817884|NCT05789186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110817885|NCT05789186|Serotonin Agents|serotonin agents|mesh-ancestor
110817886|NCT05789186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110817887|NCT05789186|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110817888|NCT05789186|Antidepressive Agents|antidepressive agents|mesh-ancestor
110817889|NCT05789186|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110817890|NCT05789186|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110817891|NCT05789186|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110817892|NCT05789186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110817893|NCT05789030|Prednisone|prednisone|mesh-list
110817894|NCT05789030|Betamethasone dipropionate, betamethasone sodium phosphate drug combination|betamethasone dipropionate, betamethasone sodium phosphate drug combination|mesh-list
110817895|NCT05789030|Betamethasone|betamethasone|mesh-list
110817896|NCT05789030|Leflunomide|leflunomide|mesh-list
110817897|NCT05789030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110817898|NCT05789030|Glucocorticoids|glucocorticoids|mesh-ancestor
110817899|NCT05789030|Hormones|hormones|mesh-ancestor
110817900|NCT05789030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110817901|NCT05789030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110817902|NCT05789030|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110817903|NCT05789030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110817904|NCT05789030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110817905|NCT05789030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110817906|NCT05789030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110817907|NCT05789030|Immunologic Factors|immunologic factors|mesh-ancestor
110817908|NCT05789030|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110817909|NCT05789030|Respiratory System Agents|respiratory system agents|mesh-ancestor
110817910|NCT05789017|Mycophenolic Acid|mycophenolic acid|mesh-list
110817911|NCT05789017|Prednisone|prednisone|mesh-list
110817912|NCT05789017|Leflunomide|leflunomide|mesh-list
110817913|NCT05789017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110817914|NCT05789017|Glucocorticoids|glucocorticoids|mesh-ancestor
110817915|NCT05789017|Hormones|hormones|mesh-ancestor
110817916|NCT05789017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110817917|NCT05789017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110817918|NCT05789017|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110817919|NCT05789017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110817920|NCT05789017|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110817921|NCT05789017|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110817922|NCT05789017|Antitubercular Agents|antitubercular agents|mesh-ancestor
110817923|NCT05789017|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110817924|NCT05789017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110817925|NCT05789017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110817926|NCT05789017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110817927|NCT05789017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110817928|NCT05789017|Immunologic Factors|immunologic factors|mesh-ancestor
110817929|NCT05788991|Metronidazole|metronidazole|mesh-list
110817930|NCT05788991|Dequalinium|dequalinium|mesh-list
110817931|NCT05788991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110817932|NCT05788991|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110817933|NCT05788991|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110817934|NCT05788991|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110817935|NCT05788991|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110817936|NCT05788913|Heparin|heparin|mesh-list
110817937|NCT05788913|Anticoagulants|anticoagulants|mesh-ancestor
110817938|NCT05788913|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110817939|NCT05788913|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110817940|NCT05788913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110817941|NCT05788900|Heparin|heparin|mesh-list
110817942|NCT05788900|Anticoagulants|anticoagulants|mesh-ancestor
110817944|NCT05788900|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110817945|NCT05788900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110817946|NCT05788835|Chlorotrianisene|chlorotrianisene|mesh-list
110817947|NCT05788835|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
110817948|NCT05788835|Estrogens|estrogens|mesh-ancestor
110817949|NCT05788835|Hormones|hormones|mesh-ancestor
110817950|NCT05788835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110817951|NCT05788835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110817952|NCT05788835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110817953|NCT05788835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110817954|NCT05788705|Glycyrrhizic Acid|glycyrrhizic acid|mesh-list
110817955|NCT05788705|Boswellic acid|boswellic acid|mesh-list
110817956|NCT05788705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110817957|NCT05788705|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110817958|NCT05788705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110817959|NCT05788705|Analgesics|analgesics|mesh-ancestor
110817960|NCT05788705|Sensory System Agents|sensory system agents|mesh-ancestor
110817961|NCT05788705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110817962|NCT05788705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110817963|NCT05788705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110817964|NCT05788679|Azacitidine|azacitidine|mesh-list
110817965|NCT05788679|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110817966|NCT05788679|Antimetabolites|antimetabolites|mesh-ancestor
110817967|NCT05788679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110817968|NCT05788679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110817969|NCT05788679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110817970|NCT05767086|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
110817971|NCT05767086|Medroxyprogesterone|medroxyprogesterone|mesh-list
110817972|NCT05767086|Cetrorelix|cetrorelix|mesh-list
110817973|NCT05767086|Hormones|hormones|mesh-list
110817974|NCT05767086|Dydrogesterone|dydrogesterone|mesh-list
110817975|NCT05767086|Hormone Antagonists|hormone antagonists|mesh-list
110817976|NCT05767086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110817977|NCT05767086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110817978|NCT05767086|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110817979|NCT05767086|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110817980|NCT05767086|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110817981|NCT05767086|Contraceptive Agents|contraceptive agents|mesh-ancestor
110817982|NCT05767086|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110817983|NCT05767086|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110817984|NCT05767086|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110446048|NCT00635284|Sirolimus|sirolimus|mesh-list
110818005|NCT05722886|Trastuzumab|trastuzumab|mesh-list
110818006|NCT05722886|Atezolizumab|atezolizumab|mesh-list
110818008|NCT05722886|Vemurafenib|vemurafenib|mesh-list
110818009|NCT05722886|Entrectinib|entrectinib|mesh-list
110818010|NCT05722886|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110818011|NCT05722886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110818012|NCT05722886|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110818013|NCT05722886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110818014|NCT05722886|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110818015|NCT05722886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110818016|NCT05702905|Metformin|metformin|mesh-list
110818017|NCT05702905|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110818018|NCT05702905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110818019|NCT05697471|Dienogest|dienogest|mesh-list
110818020|NCT05697471|Danazol|danazol|mesh-list
110818021|NCT05697471|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110818022|NCT05697471|Contraceptive Agents|contraceptive agents|mesh-ancestor
110818023|NCT05697471|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110818024|NCT05697471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110818025|NCT05697471|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110818026|NCT05697471|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110818027|NCT05697471|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110818028|NCT05697471|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110818029|NCT05697471|Hormone Antagonists|hormone antagonists|mesh-ancestor
110818030|NCT05697471|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110818031|NCT05697471|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110818032|NCT05697471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110818033|NCT05697471|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110818034|NCT05670561|Sufentanil|sufentanil|mesh-list
110818035|NCT05670561|Esketamine|esketamine|mesh-list
110818036|NCT05670561|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110818037|NCT05670561|Narcotics|narcotics|mesh-ancestor
110818038|NCT05670561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110818039|NCT05670561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110818040|NCT05670561|Analgesics|analgesics|mesh-ancestor
110818041|NCT05670561|Sensory System Agents|sensory system agents|mesh-ancestor
110818042|NCT05670561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110818043|NCT05670561|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110818044|NCT05670561|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110818045|NCT05670561|Anesthetics, General|anesthetics, general|mesh-ancestor
110818046|NCT05670561|Anesthetics|anesthetics|mesh-ancestor
110818047|NCT05670561|Antidepressive Agents|antidepressive agents|mesh-ancestor
110818048|NCT05670561|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110818049|NCT05635877|Esmolol|esmolol|mesh-list
110818050|NCT05635877|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110818051|NCT05635877|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110818052|NCT05635877|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110818053|NCT05635877|Adrenergic Agents|adrenergic agents|mesh-ancestor
110818054|NCT05635877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110818055|NCT05635877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110818056|NCT05635877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110818057|NCT05629546|Nivolumab|nivolumab|mesh-list
110818058|NCT05629546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110818059|NCT05629546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110143292|NCT02024568|Anticonvulsants|anticonvulsants|mesh-ancestor
110818060|NCT05629546|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110818061|NCT05629546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110818062|NCT05596006|Domperidone|domperidone|mesh-list
110818063|NCT05596006|Antiemetics|antiemetics|mesh-ancestor
110818064|NCT05596006|Autonomic Agents|autonomic agents|mesh-ancestor
110818065|NCT05596006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110818066|NCT05596006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110818067|NCT05596006|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110818068|NCT05596006|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110818069|NCT05596006|Dopamine Agents|dopamine agents|mesh-ancestor
110818070|NCT05596006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110818071|NCT05596006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110818072|NCT05587374|Gemcitabine|gemcitabine|mesh-list
110818073|NCT05587374|Antibodies, Bispecific|antibodies, bispecific|mesh-list
110818074|NCT05587374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110818075|NCT05587374|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110818076|NCT05587374|Antimetabolites|antimetabolites|mesh-ancestor
110818077|NCT05587374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110818078|NCT05587374|Immunologic Factors|immunologic factors|mesh-ancestor
110818079|NCT05587374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110818080|NCT05586529|Cholecalciferol|cholecalciferol|mesh-list
110818081|NCT05586529|Vitamin D|vitamin d|mesh-list
110818082|NCT05586529|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110818083|NCT05586529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110818084|NCT05586529|Vitamins|vitamins|mesh-ancestor
110818085|NCT05586529|Micronutrients|micronutrients|mesh-ancestor
110818086|NCT05586529|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110818087|NCT05558280|Dinutuximab|dinutuximab|mesh-list
110818088|NCT05558280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110818089|NCT05555303|Amikacin|amikacin|mesh-list
110818090|NCT05555303|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110818091|NCT05555303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110818092|NCT05549752|Amiodarone|amiodarone|mesh-list
110818093|NCT05549752|Flecainide|flecainide|mesh-list
110818094|NCT05549752|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110818095|NCT05549752|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110818096|NCT05549752|Vasodilator Agents|vasodilator agents|mesh-ancestor
110818097|NCT05549752|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
110818098|NCT05549752|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110818099|NCT05549752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110818100|NCT05549752|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110818101|NCT05549752|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110818102|NCT05549752|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110818103|NCT05549752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110818104|NCT05549752|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110818105|NCT05549752|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110818106|NCT05549752|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110818107|NCT05549752|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110818108|NCT05538091|Atezolizumab|atezolizumab|mesh-list
110818109|NCT05538091|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110818110|NCT05538091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110818111|NCT05538091|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110818112|NCT05538091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110818130|NCT05499832|Tenecteplase|tenecteplase|mesh-list
110818131|NCT05499832|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110818132|NCT05499832|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110818133|NCT05499832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110818135|NCT05461456|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110818136|NCT05461456|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110818137|NCT05461456|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110818138|NCT05461456|Histamine Antagonists|histamine antagonists|mesh-ancestor
110818139|NCT05461456|Histamine Agents|histamine agents|mesh-ancestor
110818140|NCT05461456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110818141|NCT05461456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110818142|NCT05461456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110818143|NCT05441930|Levofloxacin|levofloxacin|mesh-list
110818144|NCT05441930|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110818145|NCT05441930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110818146|NCT05441930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110818147|NCT05441930|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110818148|NCT05441930|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110818149|NCT05441930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110818150|NCT05441930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110818151|NCT05441930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110818152|NCT05441930|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110818153|NCT05441930|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110818154|NCT05394727|Insulin|insulin|mesh-list
110818155|NCT05394727|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110818156|NCT05394727|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110818157|NCT05394727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110818158|NCT05350501|Nivolumab|nivolumab|mesh-list
110818159|NCT05350501|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110818160|NCT05350501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110818161|NCT05350501|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110818162|NCT05350501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110818163|NCT05322512|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110818164|NCT05322512|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110818165|NCT05322512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110818166|NCT05268926|Dapagliflozin|dapagliflozin|mesh-list
110818167|NCT05268926|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110818168|NCT05268926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110818169|NCT05268926|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110818170|NCT05268926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110818171|NCT05267366|Bevacizumab|bevacizumab|mesh-list
110818172|NCT05267366|Carboplatin|carboplatin|mesh-list
110818173|NCT05267366|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
110818174|NCT05267366|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110818175|NCT05267366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110818176|NCT05267366|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110818177|NCT05267366|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110818178|NCT05267366|Growth Substances|growth substances|mesh-ancestor
110818179|NCT05267366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110818180|NCT05267366|Growth Inhibitors|growth inhibitors|mesh-ancestor
110818181|NCT05267366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110818182|NCT05267288|Afatinib|afatinib|mesh-list
110818183|NCT05267288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110818184|NCT05267288|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110818185|NCT05267288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110818186|NCT05267288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110818187|NCT05218629|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
110818188|NCT05218629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110818189|NCT05218629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110818190|NCT05218629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110818191|NCT05191667|Paclitaxel|paclitaxel|mesh-list
110818192|NCT05191667|Carboplatin|carboplatin|mesh-list
110818193|NCT05191667|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110818194|NCT05191667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110818195|NCT05191667|Tubulin Modulators|tubulin modulators|mesh-ancestor
110818196|NCT05191667|Antimitotic Agents|antimitotic agents|mesh-ancestor
110818197|NCT05191667|Mitosis Modulators|mitosis modulators|mesh-ancestor
110818198|NCT05191667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110818199|NCT05112263|Cyclosporine|cyclosporine|mesh-list
110818200|NCT05112263|Cyclosporins|cyclosporins|mesh-list
110818201|NCT05112263|Tofacitinib|tofacitinib|mesh-list
110818202|NCT05112263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110818203|NCT05112263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110818204|NCT05112263|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110818205|NCT05112263|Immunologic Factors|immunologic factors|mesh-ancestor
110818206|NCT05112263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110818207|NCT05112263|Antifungal Agents|antifungal agents|mesh-ancestor
110818208|NCT05112263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110818209|NCT05112263|Dermatologic Agents|dermatologic agents|mesh-ancestor
110818210|NCT05112263|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110818211|NCT05112263|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110818212|NCT05112263|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
110818213|NCT05112263|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110818214|NCT05104281|Osimertinib|osimertinib|mesh-list
110818215|NCT05104281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110818216|NCT05104281|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110818217|NCT05104281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110818218|NCT05104281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110818219|NCT05084378|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110818220|NCT05084378|Chlorhexidine|chlorhexidine|mesh-list
110818221|NCT05084378|Povidone-Iodine|povidone-iodine|mesh-list
110818222|NCT05084378|Povidone|povidone|mesh-list
110818223|NCT05084378|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110818224|NCT05084378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110818225|NCT05084378|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110818226|NCT05084378|Disinfectants|disinfectants|mesh-ancestor
110818227|NCT05084378|Plasma Substitutes|plasma substitutes|mesh-ancestor
110818228|NCT05084378|Blood Substitutes|blood substitutes|mesh-ancestor
110818229|NCT05072249|Naloxone|naloxone|mesh-list
110818230|NCT05072249|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110818231|NCT05072249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110818232|NCT05072249|Sensory System Agents|sensory system agents|mesh-ancestor
110818233|NCT05072249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110818234|NCT05048017|Pembrolizumab|pembrolizumab|mesh-list
110818235|NCT05048017|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
110818236|NCT05048017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110818237|NCT05048017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110818238|NCT05048017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110818240|NCT05040984|Mirabegron|mirabegron|mesh-list
110818241|NCT05040984|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110818242|NCT05040984|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110818243|NCT05040984|Cholinergic Agents|cholinergic agents|mesh-ancestor
110818244|NCT05040984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110418604|NCT02878161|Antimetabolites|antimetabolites|mesh-ancestor
110818245|NCT05040984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110818246|NCT05040984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110818247|NCT05040984|Urological Agents|urological agents|mesh-ancestor
110818248|NCT05040984|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
110818249|NCT05040984|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110818250|NCT05040984|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110818251|NCT05040984|Adrenergic Agents|adrenergic agents|mesh-ancestor
110818252|NCT05017272|Analgesics, Opioid|analgesics, opioid|mesh-list
110818253|NCT05017272|Narcotics|narcotics|mesh-ancestor
110818254|NCT05017272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110818255|NCT05017272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110818256|NCT05017272|Analgesics|analgesics|mesh-ancestor
110818257|NCT05017272|Sensory System Agents|sensory system agents|mesh-ancestor
110818258|NCT05017272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110818259|NCT04981912|Rituximab|rituximab|mesh-list
110818260|NCT04981912|Venetoclax|venetoclax|mesh-list
110818261|NCT04981912|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110818262|NCT04981912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110818263|NCT04981912|Immunologic Factors|immunologic factors|mesh-ancestor
110818264|NCT04981912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110818265|NCT04981912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110818266|NCT04974879|Osimertinib|osimertinib|mesh-list
110818267|NCT04974879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110818268|NCT04974879|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110818269|NCT04974879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110818270|NCT04974879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110818271|NCT04933058|Acetaminophen|acetaminophen|mesh-list
110818272|NCT04933058|Fentanyl|fentanyl|mesh-list
110818273|NCT04933058|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110818274|NCT04933058|Narcotics|narcotics|mesh-ancestor
110818275|NCT04933058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110818276|NCT04933058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110818277|NCT04933058|Analgesics|analgesics|mesh-ancestor
110818278|NCT04933058|Sensory System Agents|sensory system agents|mesh-ancestor
110818279|NCT04933058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110818280|NCT04933058|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110818281|NCT04933058|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110818282|NCT04933058|Anesthetics, General|anesthetics, general|mesh-ancestor
110818283|NCT04933058|Anesthetics|anesthetics|mesh-ancestor
110818284|NCT04933058|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110818287|NCT04918810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110818288|NCT04918810|Tubulin Modulators|tubulin modulators|mesh-ancestor
110818289|NCT04918810|Antimitotic Agents|antimitotic agents|mesh-ancestor
110818290|NCT04918810|Mitosis Modulators|mitosis modulators|mesh-ancestor
110818291|NCT04918810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110818292|NCT04894864|Analgesics, Opioid|analgesics, opioid|mesh-list
110818293|NCT04894864|Anesthetics|anesthetics|mesh-list
110818294|NCT04894864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110818295|NCT04894864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110818296|NCT04894864|Narcotics|narcotics|mesh-ancestor
110818297|NCT04894864|Analgesics|analgesics|mesh-ancestor
110818298|NCT04894864|Sensory System Agents|sensory system agents|mesh-ancestor
110818299|NCT04894864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110818300|NCT04880395|Lamivudine|lamivudine|mesh-list
110818301|NCT04880395|Emtricitabine|emtricitabine|mesh-list
110818302|NCT04880395|Dolutegravir|dolutegravir|mesh-list
110818303|NCT04880395|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110818304|NCT04880395|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110818305|NCT04880395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110818306|NCT04880395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110818307|NCT04880395|Antiviral Agents|antiviral agents|mesh-ancestor
110818308|NCT04880395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110818309|NCT04880395|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110818310|NCT04880395|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110818311|NCT04880395|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110818312|NCT04880395|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110818313|NCT04849013|Ketanserin|ketanserin|mesh-list
110818314|NCT04849013|Mescaline|mescaline|mesh-list
110818315|NCT04849013|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110818317|NCT04849013|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110818318|NCT04849013|Serotonin Agents|serotonin agents|mesh-ancestor
110818319|NCT04849013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110818320|NCT04849013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110818321|NCT04849013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110818322|NCT04849013|Hallucinogens|hallucinogens|mesh-ancestor
110818323|NCT04849013|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110818324|NCT04849013|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110818325|NCT04808245|Atezolizumab|atezolizumab|mesh-list
110818326|NCT04808245|Imiquimod|imiquimod|mesh-list
110818327|NCT04808245|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110818328|NCT04808245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110818329|NCT04808245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110818330|NCT04808245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110818331|NCT04808245|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110818332|NCT04808245|Immunologic Factors|immunologic factors|mesh-ancestor
110818333|NCT04808245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110818334|NCT04808245|Interferon Inducers|interferon inducers|mesh-ancestor
110818335|NCT04790513|Evolocumab|evolocumab|mesh-list
110818336|NCT04790513|Alirocumab|alirocumab|mesh-list
110818337|NCT04790513|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
110818338|NCT04790513|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110818339|NCT04790513|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110818340|NCT04790513|Antimetabolites|antimetabolites|mesh-ancestor
110818341|NCT04790513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110818342|NCT04790513|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110818343|NCT04790513|Protease Inhibitors|protease inhibitors|mesh-ancestor
110818344|NCT04790513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110818345|NCT04790513|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110818346|NCT04777071|Edetic Acid|edetic acid|mesh-list
110818347|NCT04777071|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
110818348|NCT04777071|Chelating Agents|chelating agents|mesh-ancestor
110818349|NCT04777071|Sequestering Agents|sequestering agents|mesh-ancestor
110818350|NCT04777071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110818351|NCT04777071|Anticoagulants|anticoagulants|mesh-ancestor
110818352|NCT04777071|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110818353|NCT04777071|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110818354|NCT04747847|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
110818355|NCT04747847|Atorvastatin|atorvastatin|mesh-list
110818356|NCT04747847|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110818358|NCT04747847|Antimetabolites|antimetabolites|mesh-ancestor
110818359|NCT04747847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110818360|NCT04747847|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110818361|NCT04747847|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110818362|NCT04747847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110818363|NCT04747847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110818364|NCT04646837|Paclitaxel|paclitaxel|mesh-list
110818365|NCT04646837|Carboplatin|carboplatin|mesh-list
110818366|NCT04646837|Durvalumab|durvalumab|mesh-list
110818367|NCT04646837|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110818368|NCT04646837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110818369|NCT04646837|Tubulin Modulators|tubulin modulators|mesh-ancestor
110818370|NCT04646837|Antimitotic Agents|antimitotic agents|mesh-ancestor
110818371|NCT04646837|Mitosis Modulators|mitosis modulators|mesh-ancestor
110818372|NCT04646837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110818373|NCT04646837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110818374|NCT04600167|Isoniazid|isoniazid|mesh-list
110818375|NCT04600167|Rifapentine|rifapentine|mesh-list
110818376|NCT04600167|Antitubercular Agents|antitubercular agents|mesh-ancestor
110818377|NCT04600167|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110818378|NCT04600167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110818379|NCT04600167|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
110818380|NCT04600167|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110818381|NCT04600167|Antimetabolites|antimetabolites|mesh-ancestor
110818382|NCT04600167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110818383|NCT04600167|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110818384|NCT04600167|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110818385|NCT04600167|Leprostatic Agents|leprostatic agents|mesh-ancestor
110818386|NCT04560725|Choline|choline|mesh-list
110818387|NCT04560725|Lipotropic Agents|lipotropic agents|mesh-ancestor
110818388|NCT04560725|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110818389|NCT04560725|Antimetabolites|antimetabolites|mesh-ancestor
110535944|NCT00650442|Contraceptive Agents|contraceptive agents|mesh-ancestor
110818390|NCT04560725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110818391|NCT04560725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110818392|NCT04560725|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110818393|NCT04560725|Nootropic Agents|nootropic agents|mesh-ancestor
110818394|NCT04522284|Capecitabine|capecitabine|mesh-list
110818395|NCT04522284|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110818396|NCT04522284|Antimetabolites|antimetabolites|mesh-ancestor
110818397|NCT04522284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110818398|NCT04522284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110818399|NCT04489888|Paclitaxel|paclitaxel|mesh-list
110818400|NCT04489888|Carboplatin|carboplatin|mesh-list
110818401|NCT04489888|Pembrolizumab|pembrolizumab|mesh-list
110818402|NCT04489888|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110818403|NCT04489888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110818404|NCT04489888|Tubulin Modulators|tubulin modulators|mesh-ancestor
110818405|NCT04489888|Antimitotic Agents|antimitotic agents|mesh-ancestor
110818406|NCT04489888|Mitosis Modulators|mitosis modulators|mesh-ancestor
110818407|NCT04489888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110818408|NCT04489888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110818409|NCT04489888|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110818410|NCT04443309|Lenvatinib|lenvatinib|mesh-list
110818411|NCT04443309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110818412|NCT04443309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110818413|NCT04443309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110818414|NCT04443309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110818415|NCT04401800|Lenvatinib|lenvatinib|mesh-list
110818416|NCT04401800|Tislelizumab|tislelizumab|mesh-list
110818417|NCT04401800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110818418|NCT04401800|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110818419|NCT04401800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110818420|NCT04401800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110818421|NCT04401800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110818422|NCT04400110|Amoxicillin|amoxicillin|mesh-list
110818423|NCT04400110|Clavulanic Acids|clavulanic acids|mesh-list
110818424|NCT04400110|Clavulanic Acid|clavulanic acid|mesh-list
110818425|NCT04400110|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110818426|NCT04400110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110818427|NCT04400110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110818428|NCT04400110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110818429|NCT04400110|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110818436|NCT04368078|Lenvatinib|lenvatinib|mesh-list
110818437|NCT04368078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110818438|NCT04368078|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110818439|NCT04368078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110818440|NCT04368078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110818441|NCT04350463|Nivolumab|nivolumab|mesh-list
110818442|NCT04350463|Pulrodemstat besilate|pulrodemstat besilate|mesh-list
110818443|NCT04350463|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110818444|NCT04350463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110818445|NCT04350463|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110818446|NCT04350463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110818447|NCT04350463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110818448|NCT04347616|Aldesleukin|aldesleukin|mesh-list
110818449|NCT04347616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110818450|NCT04347616|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110818451|NCT04347616|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110818452|NCT04347616|Antiviral Agents|antiviral agents|mesh-ancestor
110818453|NCT04347616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110818454|NCT04265950|Vaccines|vaccines|mesh-list
110818455|NCT04265950|Immunologic Factors|immunologic factors|mesh-ancestor
110818456|NCT04265950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110818457|NCT04249778|Dapagliflozin|dapagliflozin|mesh-list
110818458|NCT04249778|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110818459|NCT04249778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110818460|NCT04249778|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110818461|NCT04249778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110818462|NCT04247815|Methotrexate|methotrexate|mesh-list
110818463|NCT04247815|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110818465|NCT04247815|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110818466|NCT04247815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110818467|NCT04247815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110818468|NCT04247815|Antimetabolites|antimetabolites|mesh-ancestor
110818469|NCT04247815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110818470|NCT04247815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110818471|NCT04247815|Dermatologic Agents|dermatologic agents|mesh-ancestor
110818472|NCT04247815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110818473|NCT04247815|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110818474|NCT04247815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110818475|NCT04247815|Immunologic Factors|immunologic factors|mesh-ancestor
110818476|NCT04247815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110818477|NCT04247815|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110818478|NCT04227522|Rucaparib|rucaparib|mesh-list
110818479|NCT04227522|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110818480|NCT04227522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110818481|NCT04227522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110818482|NCT04227522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110818483|NCT04216953|Atezolizumab|atezolizumab|mesh-list
110818484|NCT04216953|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110818485|NCT04216953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110818486|NCT04216953|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110818487|NCT04216953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110818488|NCT04211168|Lenvatinib|lenvatinib|mesh-list
110818489|NCT04211168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110818490|NCT04211168|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110818491|NCT04211168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110818492|NCT04211168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110818493|NCT04196257|Paclitaxel|paclitaxel|mesh-list
110818494|NCT04196257|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110818495|NCT04196257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110818496|NCT04196257|Tubulin Modulators|tubulin modulators|mesh-ancestor
110818497|NCT04196257|Antimitotic Agents|antimitotic agents|mesh-ancestor
110818498|NCT04196257|Mitosis Modulators|mitosis modulators|mesh-ancestor
110818499|NCT04196257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110818500|NCT04193553|Lenvatinib|lenvatinib|mesh-list
110818501|NCT04193553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110818502|NCT04193553|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110818503|NCT04193553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110818504|NCT04193553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110818505|NCT04188548|Trastuzumab|trastuzumab|mesh-list
110818506|NCT04188548|Pertuzumab|pertuzumab|mesh-list
110818507|NCT04188548|Everolimus|everolimus|mesh-list
110818508|NCT04188548|Aromatase Inhibitors|aromatase inhibitors|mesh-list
110818509|NCT04188548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110818510|NCT04188548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110818511|NCT04188548|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110818512|NCT04188548|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110818513|NCT04188548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110818514|NCT04188548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110818515|NCT04188548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110818516|NCT04188548|Immunologic Factors|immunologic factors|mesh-ancestor
110818517|NCT04188548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110818518|NCT04188548|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110818519|NCT04188548|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110818520|NCT04188548|Hormone Antagonists|hormone antagonists|mesh-ancestor
110818521|NCT04188548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110818522|NCT04183101|Enalapril|enalapril|mesh-list
110818523|NCT04183101|Enalaprilat|enalaprilat|mesh-list
110818524|NCT04183101|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110818525|NCT04183101|Protease Inhibitors|protease inhibitors|mesh-ancestor
110818526|NCT04183101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110818527|NCT04183101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110818528|NCT04183101|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110818529|NCT04155632|Acetylcysteine|acetylcysteine|mesh-list
110818530|NCT04155632|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110818531|NCT04155632|Antiviral Agents|antiviral agents|mesh-ancestor
110818532|NCT04155632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110818533|NCT04155632|Expectorants|expectorants|mesh-ancestor
110818534|NCT04155632|Respiratory System Agents|respiratory system agents|mesh-ancestor
110818535|NCT04155632|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110818536|NCT04155632|Antioxidants|antioxidants|mesh-ancestor
110818537|NCT04155632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110818538|NCT04155632|Protective Agents|protective agents|mesh-ancestor
110818539|NCT04155632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110818540|NCT04155632|Antidotes|antidotes|mesh-ancestor
110818541|NCT04088630|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
110818542|NCT04088630|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
110818543|NCT04088630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110818544|NCT04088630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110818545|NCT04088630|Immunologic Factors|immunologic factors|mesh-ancestor
110818546|NCT04088630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110818547|NCT04073134|Evolocumab|evolocumab|mesh-list
110818548|NCT04073134|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
110818549|NCT04073134|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110818550|NCT04073134|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110818551|NCT04073134|Antimetabolites|antimetabolites|mesh-ancestor
110818552|NCT04073134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110818553|NCT04073134|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110818554|NCT04073134|Protease Inhibitors|protease inhibitors|mesh-ancestor
110818555|NCT04073134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110818556|NCT04073134|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110818557|NCT04034485|Evolocumab|evolocumab|mesh-list
110818558|NCT04034485|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
110818559|NCT04034485|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110818560|NCT04034485|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110818561|NCT04034485|Antimetabolites|antimetabolites|mesh-ancestor
110818562|NCT04034485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110818563|NCT04034485|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110818564|NCT04034485|Protease Inhibitors|protease inhibitors|mesh-ancestor
110818565|NCT04034485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110818566|NCT04034485|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110818567|NCT04010071|Axitinib|axitinib|mesh-list
110818568|NCT04010071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110818569|NCT04010071|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110818570|NCT04010071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110818571|NCT04010071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110818572|NCT03988920|Sevelamer|sevelamer|mesh-list
110818573|NCT03988920|Chelating Agents|chelating agents|mesh-ancestor
110818574|NCT03988920|Sequestering Agents|sequestering agents|mesh-ancestor
110818575|NCT03988920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110818576|NCT03925402|Ertapenem|ertapenem|mesh-list
110818577|NCT03925402|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110818578|NCT03925402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110818579|NCT03892577|Immunomodulating Agents|immunomodulating agents|mesh-list
110818580|NCT03892577|Immunologic Factors|immunologic factors|mesh-ancestor
110818581|NCT03892577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110818583|NCT03875079|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110818584|NCT03875079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110818585|NCT03875079|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110818586|NCT03875079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110818587|NCT03866252|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
110818588|NCT03866252|Hallucinogens|hallucinogens|mesh-ancestor
110818589|NCT03866252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110818590|NCT03866252|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110818591|NCT03866252|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110818592|NCT03866252|Serotonin Agents|serotonin agents|mesh-ancestor
110818593|NCT03866252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110818594|NCT03866252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110818595|NCT03866252|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110818596|NCT03769298|Tacrolimus|tacrolimus|mesh-list
110818597|NCT03769298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110818598|NCT03769298|Immunologic Factors|immunologic factors|mesh-ancestor
110818599|NCT03769298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110818600|NCT03769298|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110818601|NCT03769298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110818602|NCT03769298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110818603|NCT03688451|Rituximab|rituximab|mesh-list
110818604|NCT03688451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110818605|NCT03688451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110818606|NCT03688451|Immunologic Factors|immunologic factors|mesh-ancestor
110818607|NCT03688451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110818608|NCT03688451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110818609|NCT03626064|Nicotine|nicotine|mesh-list
110818610|NCT03626064|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110818611|NCT03626064|Autonomic Agents|autonomic agents|mesh-ancestor
110418618|NCT02878161|Protective Agents|protective agents|mesh-ancestor
110818612|NCT03626064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110818613|NCT03626064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110818614|NCT03626064|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110818615|NCT03626064|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110818616|NCT03626064|Cholinergic Agents|cholinergic agents|mesh-ancestor
110818617|NCT03626064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110818618|NCT03626064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110818619|NCT03613532|Fludarabine|fludarabine|mesh-list
110818620|NCT03613532|Azacitidine|azacitidine|mesh-list
110818621|NCT03613532|Busulfan|busulfan|mesh-list
110818622|NCT03613532|Decitabine|decitabine|mesh-list
110818623|NCT03613532|Venetoclax|venetoclax|mesh-list
110818624|NCT03613532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110818625|NCT03613532|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110818626|NCT03613532|Antimetabolites|antimetabolites|mesh-ancestor
110818627|NCT03613532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110818628|NCT03613532|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110818629|NCT03613532|Immunologic Factors|immunologic factors|mesh-ancestor
110818630|NCT03613532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110818631|NCT03613532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110818632|NCT03613532|Alkylating Agents|alkylating agents|mesh-ancestor
110818633|NCT03613532|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110818634|NCT03613532|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110818635|NCT03593018|Gemcitabine|gemcitabine|mesh-list
110818636|NCT03593018|Azacitidine|azacitidine|mesh-list
110818637|NCT03593018|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110818638|NCT03593018|Romidepsin|romidepsin|mesh-list
110818639|NCT03593018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110818640|NCT03593018|Antimetabolites|antimetabolites|mesh-ancestor
110818641|NCT03593018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110818642|NCT03593018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110818643|NCT03593018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110818644|NCT03593018|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110818645|NCT03593018|Alkylating Agents|alkylating agents|mesh-ancestor
110818646|NCT03593018|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110818647|NCT03593018|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110818648|NCT03570099|Naloxone|naloxone|mesh-list
110818649|NCT03570099|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110818650|NCT03570099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110818651|NCT03570099|Sensory System Agents|sensory system agents|mesh-ancestor
110143891|NCT02028260|Modafinil|modafinil|mesh-list
110818652|NCT03570099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110818653|NCT03529396|Chloroquine|chloroquine|mesh-list
110818654|NCT03529396|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
110818655|NCT03529396|Primaquine|primaquine|mesh-list
110818656|NCT03529396|Amebicides|amebicides|mesh-ancestor
110818657|NCT03529396|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110818658|NCT03529396|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110818659|NCT03529396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110818660|NCT03529396|Antimalarials|antimalarials|mesh-ancestor
110818661|NCT03529396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110818662|NCT03529396|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110818663|NCT03529396|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110818664|NCT03529396|Analgesics|analgesics|mesh-ancestor
110818665|NCT03529396|Sensory System Agents|sensory system agents|mesh-ancestor
110818666|NCT03529396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110818667|NCT03529396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110818668|NCT03529396|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110818669|NCT03529396|Filaricides|filaricides|mesh-ancestor
110818670|NCT03529396|Antinematodal Agents|antinematodal agents|mesh-ancestor
110818671|NCT03529396|Anthelmintics|anthelmintics|mesh-ancestor
110818672|NCT03436563|Atezolizumab|atezolizumab|mesh-list
110818673|NCT03436563|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110818674|NCT03436563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110818675|NCT03436563|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110818676|NCT03436563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110818677|NCT03426254|Talazoparib|talazoparib|mesh-list
110818678|NCT03426254|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110818679|NCT03426254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110818680|NCT03426254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110818681|NCT03426254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110818682|NCT03411031|Thalidomide|thalidomide|mesh-list
110818683|NCT03411031|Dexamethasone|dexamethasone|mesh-list
110818684|NCT03411031|Lenalidomide|lenalidomide|mesh-list
110536243|NCT00620204|Atorvastatin|atorvastatin|mesh-list
110818685|NCT03411031|Elotuzumab|elotuzumab|mesh-list
110818686|NCT03411031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110818687|NCT03411031|Antiemetics|antiemetics|mesh-ancestor
110818688|NCT03411031|Autonomic Agents|autonomic agents|mesh-ancestor
110818689|NCT03411031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110818690|NCT03411031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110818691|NCT03411031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110818692|NCT03411031|Glucocorticoids|glucocorticoids|mesh-ancestor
110818693|NCT03411031|Hormones|hormones|mesh-ancestor
110818694|NCT03411031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110818695|NCT03411031|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110818696|NCT03411031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110818697|NCT03411031|Immunologic Factors|immunologic factors|mesh-ancestor
110818698|NCT03411031|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110818699|NCT03411031|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110818700|NCT03411031|Growth Substances|growth substances|mesh-ancestor
110818701|NCT03411031|Growth Inhibitors|growth inhibitors|mesh-ancestor
110818702|NCT03411031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110818703|NCT03411031|Leprostatic Agents|leprostatic agents|mesh-ancestor
110818704|NCT03411031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110818705|NCT03411031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110818706|NCT03358017|Zoledronic Acid|zoledronic acid|mesh-list
110818707|NCT03358017|Atorvastatin|atorvastatin|mesh-list
110818708|NCT03358017|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110818709|NCT03358017|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110818710|NCT03358017|Antimetabolites|antimetabolites|mesh-ancestor
110818711|NCT03358017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110818712|NCT03358017|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110818713|NCT03358017|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110818714|NCT03358017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110818715|NCT03358017|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110818716|NCT03358017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110818718|NCT03289351|Piperacillin|piperacillin|mesh-list
110818719|NCT03289351|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
110818720|NCT03289351|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110818721|NCT03289351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110818722|NCT03289351|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110818723|NCT03289351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110818724|NCT03289351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110818725|NCT03280667|Denosumab|denosumab|mesh-list
110818726|NCT03280667|Pembrolizumab|pembrolizumab|mesh-list
110818727|NCT03280667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110818728|NCT03280667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110818729|NCT03280667|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110818730|NCT03280667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110818731|NCT03280667|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110818732|NCT03280667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110818733|NCT03272347|Tenofovir|tenofovir|mesh-list
110818734|NCT03272347|Lamivudine|lamivudine|mesh-list
110818735|NCT03272347|Islatravir|islatravir|mesh-list
110818736|NCT03272347|Antiviral Agents|antiviral agents|mesh-ancestor
110818737|NCT03272347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110818738|NCT03272347|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110818739|NCT03272347|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110818740|NCT03272347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110818741|NCT03272347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110818742|NCT03272347|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110818743|NCT03272347|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110818744|NCT03251300|Mirabegron|mirabegron|mesh-list
110818745|NCT03251300|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
110818746|NCT03251300|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110818747|NCT03251300|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110818748|NCT03251300|Adrenergic Agents|adrenergic agents|mesh-ancestor
110818749|NCT03251300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110818750|NCT03251300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110818751|NCT03251300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110818752|NCT03251300|Urological Agents|urological agents|mesh-ancestor
110818753|NCT03228693|Triamcinolone|triamcinolone|mesh-list
110818754|NCT03228693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110818755|NCT03228693|Glucocorticoids|glucocorticoids|mesh-ancestor
110818756|NCT03228693|Hormones|hormones|mesh-ancestor
110818757|NCT03228693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110818758|NCT03228693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110818759|NCT03108690|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110818760|NCT03108690|Meropenem|meropenem|mesh-list
110818761|NCT03108690|Tazobactam|tazobactam|mesh-list
110818762|NCT03108690|Piperacillin|piperacillin|mesh-list
110818764|NCT03108690|Cefuroxime|cefuroxime|mesh-list
110818765|NCT03108690|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
110818766|NCT03108690|Lactams|lactams|mesh-list
110818767|NCT03108690|beta-Lactams|beta-lactams|mesh-list
110818768|NCT03108690|Penicillin G|penicillin g|mesh-list
110818769|NCT03108690|Dicloxacillin|dicloxacillin|mesh-list
110818770|NCT03108690|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
110818771|NCT03108690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110818772|NCT03108690|Antitubercular Agents|antitubercular agents|mesh-ancestor
110818773|NCT03108690|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110818774|NCT03108690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110818775|NCT03108690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110818776|NCT03103152|Aspirin|aspirin|mesh-list
110818777|NCT03103152|Vitamin D|vitamin d|mesh-list
110818778|NCT03103152|Ergocalciferols|ergocalciferols|mesh-list
110818779|NCT03103152|Cholecalciferol|cholecalciferol|mesh-list
110818780|NCT03103152|Vitamins|vitamins|mesh-list
110818781|NCT03103152|Micronutrients|micronutrients|mesh-ancestor
110818782|NCT03103152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110818783|NCT03103152|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110818784|NCT03103152|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110818785|NCT03103152|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110818786|NCT03103152|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110818787|NCT03103152|Analgesics|analgesics|mesh-ancestor
110818788|NCT03103152|Sensory System Agents|sensory system agents|mesh-ancestor
110818789|NCT03103152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110818790|NCT03103152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110818791|NCT03103152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110818792|NCT03103152|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110818793|NCT03103152|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110818794|NCT03103152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110818795|NCT03103152|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110818796|NCT03103152|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110818797|NCT03103152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110818798|NCT03103152|Antipyretics|antipyretics|mesh-ancestor
110818799|NCT02937285|Interferons|interferons|mesh-list
110818800|NCT02937285|Interferon-beta|interferon-beta|mesh-list
110818801|NCT02937285|Interferon beta-1a|interferon beta-1a|mesh-list
110818802|NCT02937285|Mitoxantrone|mitoxantrone|mesh-list
110818803|NCT02937285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110818804|NCT02937285|Antiviral Agents|antiviral agents|mesh-ancestor
110818805|NCT02937285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110818806|NCT02937285|Analgesics|analgesics|mesh-ancestor
110818807|NCT02937285|Sensory System Agents|sensory system agents|mesh-ancestor
110818808|NCT02937285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110818809|NCT02937285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110818810|NCT02937285|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110818811|NCT02937285|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110818812|NCT02937285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110818813|NCT02937285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110818814|NCT02937285|Immunologic Factors|immunologic factors|mesh-ancestor
110818815|NCT02937285|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110818816|NCT02878785|Decitabine|decitabine|mesh-list
110818817|NCT02878785|Talazoparib|talazoparib|mesh-list
110818818|NCT02878785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110818819|NCT02878785|Antimetabolites|antimetabolites|mesh-ancestor
110818820|NCT02878785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110818821|NCT02878785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110818822|NCT02878785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110818823|NCT02878785|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110818824|NCT02825576|Glycopyrrolate|glycopyrrolate|mesh-list
110818825|NCT02825576|Neostigmine|neostigmine|mesh-list
110818826|NCT02825576|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110818827|NCT02825576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110818828|NCT02825576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110818829|NCT02825576|Cholinergic Agents|cholinergic agents|mesh-ancestor
110818830|NCT02825576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110854263|NCT03790787|Empagliflozin|empagliflozin|mesh-list
110818831|NCT02825576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110818832|NCT02825576|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110818833|NCT02825576|Autonomic Agents|autonomic agents|mesh-ancestor
110818834|NCT02825576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110818835|NCT02825576|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110818836|NCT02825576|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110818837|NCT02825576|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110818838|NCT02660645|Aminolevulinic Acid|aminolevulinic acid|mesh-list
110818839|NCT02660645|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110818840|NCT02660645|Dermatologic Agents|dermatologic agents|mesh-ancestor
110818841|NCT02315196|Paclitaxel|paclitaxel|mesh-list
110818842|NCT02315196|Carboplatin|carboplatin|mesh-list
110818843|NCT02315196|Doxorubicin|doxorubicin|mesh-list
110818844|NCT02315196|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110818845|NCT02315196|Epirubicin|epirubicin|mesh-list
110818846|NCT02315196|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110818847|NCT02315196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110818848|NCT02315196|Tubulin Modulators|tubulin modulators|mesh-ancestor
110818849|NCT02315196|Antimitotic Agents|antimitotic agents|mesh-ancestor
110818850|NCT02315196|Mitosis Modulators|mitosis modulators|mesh-ancestor
110818851|NCT02315196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110818852|NCT02315196|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110818853|NCT02315196|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110818854|NCT02315196|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110818855|NCT02315196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110818856|NCT02179853|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
110818857|NCT02179853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110818858|NCT01917877|Dexamethasone|dexamethasone|mesh-list
110818859|NCT01917877|Bevacizumab|bevacizumab|mesh-list
110818860|NCT01917877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110818861|NCT01917877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110818862|NCT01917877|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110818863|NCT01917877|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110818864|NCT01917877|Growth Substances|growth substances|mesh-ancestor
110818865|NCT01917877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110818866|NCT01917877|Growth Inhibitors|growth inhibitors|mesh-ancestor
110818867|NCT01917877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110818868|NCT01917877|Antiemetics|antiemetics|mesh-ancestor
110818869|NCT01917877|Autonomic Agents|autonomic agents|mesh-ancestor
110818870|NCT01917877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110818871|NCT01917877|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110818872|NCT01917877|Glucocorticoids|glucocorticoids|mesh-ancestor
110818873|NCT01917877|Hormones|hormones|mesh-ancestor
110818874|NCT01917877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110818875|NCT01917877|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110818876|NCT01570296|Gefitinib|gefitinib|mesh-list
110818877|NCT01570296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110818878|NCT01570296|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110818879|NCT01570296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110818880|NCT01570296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110818881|NCT00496873|Cyclophosphamide|cyclophosphamide|mesh-list
110818883|NCT00496873|Pentostatin|pentostatin|mesh-list
110818884|NCT00496873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110818885|NCT00496873|Immunologic Factors|immunologic factors|mesh-ancestor
110818886|NCT00496873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110818887|NCT00496873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110818888|NCT00496873|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110818889|NCT00496873|Alkylating Agents|alkylating agents|mesh-ancestor
110818890|NCT00496873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110818891|NCT00496873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110818892|NCT00496873|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110818893|NCT00496873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110818894|NCT00496873|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
110818895|NCT00496873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110818896|NCT00492778|Cisplatin|cisplatin|mesh-list
110818897|NCT00492778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110818898|NCT03931369|Tolvaptan|tolvaptan|mesh-list
110854268|NCT01334268|Paclitaxel|paclitaxel|mesh-list
110818899|NCT03931369|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
110818900|NCT03931369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110818901|NCT03931369|Natriuretic Agents|natriuretic agents|mesh-ancestor
110818902|NCT03931369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110818903|NCT00359216|Mometasone Furoate|mometasone furoate|mesh-list
110818904|NCT00359216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110818905|NCT00359216|Dermatologic Agents|dermatologic agents|mesh-ancestor
110818906|NCT00359216|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110818907|NCT01239550|Insulin Detemir|insulin detemir|mesh-list
110818908|NCT01239550|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110818909|NCT01239550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110818910|NCT03721328|Vancomycin|vancomycin|mesh-list
110818911|NCT03721328|Tobramycin|tobramycin|mesh-list
110536465|NCT02646774|Micafungin|micafungin|mesh-list
110818912|NCT03721328|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110818913|NCT03721328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110818914|NCT01220791|Progesterone|progesterone|mesh-list
110818915|NCT01220791|Progestins|progestins|mesh-ancestor
110818916|NCT01220791|Hormones|hormones|mesh-ancestor
110818917|NCT01220791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110818918|NCT01220791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110818919|NCT01353482|Pemetrexed|pemetrexed|mesh-list
110818920|NCT01353482|Vorinostat|vorinostat|mesh-list
110818921|NCT01353482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110818922|NCT01353482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110818923|NCT01353482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110818924|NCT01353482|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110818925|NCT01353482|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110818926|NCT01353482|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110818927|NCT02291380|Botulinum Toxins|botulinum toxins|mesh-list
110818928|NCT02291380|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110818929|NCT02291380|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110818930|NCT02291380|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110818931|NCT02291380|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110818932|NCT02291380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110818933|NCT02291380|Cholinergic Agents|cholinergic agents|mesh-ancestor
110818934|NCT02291380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110818935|NCT02291380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110818936|NCT02291380|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110818937|NCT02291380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110818938|NCT01353716|Dolutegravir|dolutegravir|mesh-list
110818939|NCT01353716|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110818940|NCT01353716|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110818941|NCT01353716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110818942|NCT01353716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110818943|NCT01353716|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110818944|NCT01353716|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110818945|NCT01353716|Antiviral Agents|antiviral agents|mesh-ancestor
110818946|NCT01353716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110818947|NCT04481672|Magnesium Sulfate|magnesium sulfate|mesh-list
110818948|NCT04481672|Analgesics|analgesics|mesh-ancestor
110818949|NCT04481672|Sensory System Agents|sensory system agents|mesh-ancestor
110818950|NCT04481672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110818951|NCT04481672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110818953|NCT04481672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110818954|NCT04481672|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110818955|NCT04481672|Anticonvulsants|anticonvulsants|mesh-ancestor
110818957|NCT04481672|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110818958|NCT04481672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110818959|NCT04481672|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110818960|NCT04481672|Tocolytic Agents|tocolytic agents|mesh-ancestor
110818961|NCT04481672|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110818962|NCT01224067|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110818963|NCT01224067|Antidepressive Agents|antidepressive agents|mesh-ancestor
110818964|NCT01224067|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110818965|NCT01224067|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110818966|NCT01224067|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110818967|NCT01224067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110818968|NCT01224067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110818969|NCT04465942|Paclitaxel|paclitaxel|mesh-list
110818970|NCT04465942|Pembrolizumab|pembrolizumab|mesh-list
110818971|NCT04465942|Nivolumab|nivolumab|mesh-list
110818972|NCT04465942|Pemetrexed|pemetrexed|mesh-list
110818973|NCT04465942|Atezolizumab|atezolizumab|mesh-list
110818974|NCT04465942|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110418635|NCT01092663|Incretins|incretins|mesh-ancestor
110818975|NCT04465942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110818976|NCT04465942|Tubulin Modulators|tubulin modulators|mesh-ancestor
110818977|NCT04465942|Antimitotic Agents|antimitotic agents|mesh-ancestor
110818978|NCT04465942|Mitosis Modulators|mitosis modulators|mesh-ancestor
110818979|NCT04465942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110818980|NCT04465942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110818981|NCT04465942|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110818982|NCT04465942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110818983|NCT04465942|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110818984|NCT04465942|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110818985|NCT01126645|Sorafenib|sorafenib|mesh-list
110818986|NCT01126645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110536550|NCT04167306|Bupropion|bupropion|mesh-list
110818987|NCT01126645|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110818988|NCT01126645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110818989|NCT01126645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110818990|NCT01343186|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110818991|NCT01343186|Interferon-alpha|interferon-alpha|mesh-list
110818992|NCT01343186|Antiviral Agents|antiviral agents|mesh-ancestor
110818993|NCT01343186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110818994|NCT01343186|Immunologic Factors|immunologic factors|mesh-ancestor
110818995|NCT01343186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110818997|NCT01329289|Dexamethasone acetate|dexamethasone acetate|mesh-list
110818998|NCT01329289|Bortezomib|bortezomib|mesh-list
110818999|NCT01329289|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
110819000|NCT01329289|Pasireotide|pasireotide|mesh-list
110819001|NCT01329289|BB 1101|bb 1101|mesh-list
110819002|NCT01329289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110819003|NCT01329289|Antiemetics|antiemetics|mesh-ancestor
110819004|NCT01329289|Autonomic Agents|autonomic agents|mesh-ancestor
110819005|NCT01329289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110819006|NCT01329289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110819007|NCT01329289|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110819008|NCT01329289|Glucocorticoids|glucocorticoids|mesh-ancestor
110819009|NCT01329289|Hormones|hormones|mesh-ancestor
110819010|NCT01329289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110819011|NCT01329289|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110819012|NCT01329289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110819013|NCT01329289|Protease Inhibitors|protease inhibitors|mesh-ancestor
110819014|NCT01329289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110819015|NCT01329289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110819016|NCT02291536|Dronabinol|dronabinol|mesh-list
110819017|NCT02291536|Cannabidiol|cannabidiol|mesh-list
110819018|NCT02291536|Anticonvulsants|anticonvulsants|mesh-ancestor
110819019|NCT02291536|Hallucinogens|hallucinogens|mesh-ancestor
110819020|NCT02291536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110819021|NCT02291536|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110819022|NCT02291536|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110819023|NCT02291536|Analgesics|analgesics|mesh-ancestor
110819024|NCT02291536|Sensory System Agents|sensory system agents|mesh-ancestor
110819025|NCT02291536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110144275|NCT02033356|Lidocaine|lidocaine|mesh-list
110819026|NCT02291536|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
110819027|NCT02291536|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110819029|NCT02291536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110819030|NCT02291536|Hormones|hormones|mesh-ancestor
110819031|NCT02291536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110819032|NCT01317992|Ibudilast|ibudilast|mesh-list
110819033|NCT01317992|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110819034|NCT01317992|Autonomic Agents|autonomic agents|mesh-ancestor
110819035|NCT01317992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110819036|NCT01317992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110819037|NCT01317992|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110819038|NCT01317992|Respiratory System Agents|respiratory system agents|mesh-ancestor
110819039|NCT01317992|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110819040|NCT01317992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110819041|NCT01317992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110819042|NCT01317992|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110819043|NCT01317992|Vasodilator Agents|vasodilator agents|mesh-ancestor
110819044|NCT01348412|Oxaliplatin|oxaliplatin|mesh-list
110819045|NCT01348412|Raltitrexed|raltitrexed|mesh-list
110819046|NCT01348412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110819047|NCT01348412|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110819048|NCT01348412|Antimetabolites|antimetabolites|mesh-ancestor
110819049|NCT01348412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110819050|NCT01348412|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110819051|NCT01348412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110819052|NCT01353794|Sorafenib|sorafenib|mesh-list
110819053|NCT01353794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110819054|NCT01353794|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110819055|NCT01353794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110819056|NCT01353794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110819057|NCT01224301|Vaccines|vaccines|mesh-list
110819058|NCT01224301|Immunologic Factors|immunologic factors|mesh-ancestor
110819059|NCT01224301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110819060|NCT01221025|Parecoxib|parecoxib|mesh-list
110819061|NCT01221025|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110819062|NCT01221025|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110819063|NCT01221025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110819064|NCT01221025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110819065|NCT01221025|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110819066|NCT01221025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110819067|NCT01221025|Analgesics|analgesics|mesh-ancestor
110819068|NCT01221025|Sensory System Agents|sensory system agents|mesh-ancestor
110819069|NCT01221025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110819070|NCT01221025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110819071|NCT01221025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110819072|NCT01221025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110819073|NCT03523390|Avelumab|avelumab|mesh-list
110819074|NCT03523390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110819075|NCT03523390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110819076|NCT01221103|Dexamethasone|dexamethasone|mesh-list
110819077|NCT01221103|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110819078|NCT01221103|Ofatumumab|ofatumumab|mesh-list
110819079|NCT01221103|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110819080|NCT01221103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110819081|NCT01221103|Antiemetics|antiemetics|mesh-ancestor
110819082|NCT01221103|Autonomic Agents|autonomic agents|mesh-ancestor
110819083|NCT01221103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110819084|NCT01221103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110819085|NCT01221103|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110819086|NCT01221103|Glucocorticoids|glucocorticoids|mesh-ancestor
110819087|NCT01221103|Hormones|hormones|mesh-ancestor
110819088|NCT01221103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110819089|NCT01221103|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110819090|NCT01221103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110819091|NCT01221103|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110854294|NCT03326050|Gemifloxacin|gemifloxacin|mesh-list
110819092|NCT01221103|Alkylating Agents|alkylating agents|mesh-ancestor
110819093|NCT01221103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110819094|NCT01221103|Immunologic Factors|immunologic factors|mesh-ancestor
110819095|NCT03706898|Sofosbuvir|sofosbuvir|mesh-list
110819096|NCT03706898|Dolutegravir|dolutegravir|mesh-list
110819097|NCT03706898|Elsulfavirine|elsulfavirine|mesh-list
110819098|NCT03706898|Antiviral Agents|antiviral agents|mesh-ancestor
110819099|NCT03706898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110819100|NCT03706898|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110819101|NCT03706898|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110819102|NCT03706898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110819103|NCT03706898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110819104|NCT03706898|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110819105|NCT03706898|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110819106|NCT03927313|Aspirin|aspirin|mesh-list
110819107|NCT03927313|Rifampin|rifampin|mesh-list
110819108|NCT03927313|Linezolid|linezolid|mesh-list
110819109|NCT03927313|Dexamethasone|dexamethasone|mesh-list
110819110|NCT03927313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110819111|NCT03927313|Antiemetics|antiemetics|mesh-ancestor
110819112|NCT03927313|Autonomic Agents|autonomic agents|mesh-ancestor
110819113|NCT03927313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110819114|NCT03927313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110819115|NCT03927313|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110819116|NCT03927313|Glucocorticoids|glucocorticoids|mesh-ancestor
110819117|NCT03927313|Hormones|hormones|mesh-ancestor
110819118|NCT03927313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110819119|NCT03927313|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110819120|NCT03927313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110819121|NCT03927313|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110819122|NCT03927313|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110819123|NCT03927313|Analgesics|analgesics|mesh-ancestor
110819124|NCT03927313|Sensory System Agents|sensory system agents|mesh-ancestor
110819125|NCT03927313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110819126|NCT03927313|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110819127|NCT03927313|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110819128|NCT03927313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110819129|NCT03927313|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110819130|NCT03927313|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110819131|NCT03927313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110819132|NCT03927313|Antipyretics|antipyretics|mesh-ancestor
110819133|NCT03927313|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110819134|NCT03927313|Antitubercular Agents|antitubercular agents|mesh-ancestor
110819135|NCT03927313|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110819136|NCT03927313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110819137|NCT03927313|Leprostatic Agents|leprostatic agents|mesh-ancestor
110819138|NCT03927313|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110819140|NCT03927313|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110819141|NCT03927313|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110819142|NCT03927313|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110819143|NCT03927313|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110819144|NCT03927313|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110819145|NCT03927313|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110819146|NCT01224457|Phenobarbital|phenobarbital|mesh-list
110819147|NCT01224457|Anticonvulsants|anticonvulsants|mesh-ancestor
110819148|NCT01224457|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110819149|NCT01224457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110819150|NCT01224457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110819151|NCT01224457|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110819152|NCT01224457|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110819153|NCT01224457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110819154|NCT01224457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110819155|NCT01224457|GABA Modulators|gaba modulators|mesh-ancestor
110819156|NCT01224457|GABA Agents|gaba agents|mesh-ancestor
110819157|NCT01224457|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110819158|NCT01224457|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110819159|NCT01224457|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110819160|NCT03133312|Chlorhexidine|chlorhexidine|mesh-list
110819161|NCT03133312|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110819162|NCT03133312|Povidone-Iodine|povidone-iodine|mesh-list
110819163|NCT03133312|Povidone|povidone|mesh-list
110819164|NCT03133312|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110819165|NCT03133312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110819166|NCT03133312|Disinfectants|disinfectants|mesh-ancestor
110819167|NCT03133312|Dermatologic Agents|dermatologic agents|mesh-ancestor
110819168|NCT03133312|Plasma Substitutes|plasma substitutes|mesh-ancestor
110819169|NCT03133312|Blood Substitutes|blood substitutes|mesh-ancestor
110819170|NCT01318148|Caspofungin|caspofungin|mesh-list
110819171|NCT01318148|Antifungal Agents|antifungal agents|mesh-ancestor
110819172|NCT01318148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110819173|NCT01318148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110446051|NCT00635284|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110819174|NCT01318148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110819176|NCT01354262|Ergocalciferols|ergocalciferols|mesh-list
110819177|NCT01354262|Cholecalciferol|cholecalciferol|mesh-list
110819178|NCT01354262|Vitamins|vitamins|mesh-list
110819179|NCT01354262|Micronutrients|micronutrients|mesh-ancestor
110819180|NCT01354262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110819181|NCT01354262|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110819182|NCT01354262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110819183|NCT01343498|Dactolisib|dactolisib|mesh-list
110819184|NCT01343498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110819185|NCT01221337|Heparin|heparin|mesh-list
110819186|NCT01221337|Anticoagulants|anticoagulants|mesh-ancestor
110819187|NCT01221337|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110819188|NCT01221337|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110819189|NCT01221337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110819190|NCT01354418|Phenylephrine|phenylephrine|mesh-list
110819191|NCT01354418|Oxymetazoline|oxymetazoline|mesh-list
110819192|NCT01354418|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110819193|NCT01354418|Mydriatics|mydriatics|mesh-ancestor
110819194|NCT01354418|Autonomic Agents|autonomic agents|mesh-ancestor
110819195|NCT01354418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110819196|NCT01354418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110819197|NCT01354418|Sympathomimetics|sympathomimetics|mesh-ancestor
110819198|NCT01354418|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110819199|NCT01354418|Nasal Decongestants|nasal decongestants|mesh-ancestor
110819200|NCT01354418|Respiratory System Agents|respiratory system agents|mesh-ancestor
110819201|NCT01354418|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110819202|NCT01354418|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110819203|NCT01354418|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110819204|NCT01354418|Adrenergic Agents|adrenergic agents|mesh-ancestor
110819205|NCT01354418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110819206|NCT01354418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110819207|NCT01354418|Protective Agents|protective agents|mesh-ancestor
110819208|NCT02818868|Apixaban|apixaban|mesh-list
110819209|NCT02818868|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110819210|NCT02818868|Antithrombins|antithrombins|mesh-ancestor
110819211|NCT02818868|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110819212|NCT02818868|Protease Inhibitors|protease inhibitors|mesh-ancestor
110819213|NCT02818868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110819214|NCT02818868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110819215|NCT02818868|Anticoagulants|anticoagulants|mesh-ancestor
110819216|NCT01224535|Micronutrients|micronutrients|mesh-list
110819217|NCT01224535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110819218|NCT02289274|Aceclofenac|aceclofenac|mesh-list
110819219|NCT02289274|Eperisone|eperisone|mesh-list
110819220|NCT02289274|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110819221|NCT02289274|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110819222|NCT02289274|Analgesics|analgesics|mesh-ancestor
110819223|NCT02289274|Sensory System Agents|sensory system agents|mesh-ancestor
110819224|NCT02289274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110819225|NCT02289274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110819226|NCT02289274|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110819227|NCT02289274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110819228|NCT02289274|Anticonvulsants|anticonvulsants|mesh-ancestor
110819229|NCT02289274|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110819230|NCT02289274|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110819231|NCT02289274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110819232|NCT02289274|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110819233|NCT02289274|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110819234|NCT02289274|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110819235|NCT02289274|Parasympatholytics|parasympatholytics|mesh-ancestor
110819236|NCT02289274|Autonomic Agents|autonomic agents|mesh-ancestor
110819237|NCT02289274|Vasodilator Agents|vasodilator agents|mesh-ancestor
110819238|NCT01224613|Vaccines|vaccines|mesh-list
110819239|NCT01224613|Immunologic Factors|immunologic factors|mesh-ancestor
110819240|NCT01224613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110819241|NCT03930433|Nebivolol|nebivolol|mesh-list
110819242|NCT03930433|Diltiazem|diltiazem|mesh-list
110819243|NCT03930433|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110819244|NCT03930433|Vasodilator Agents|vasodilator agents|mesh-ancestor
110819245|NCT03930433|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
110819246|NCT03930433|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110819247|NCT03930433|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110819248|NCT03930433|Adrenergic Agents|adrenergic agents|mesh-ancestor
110819249|NCT03930433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110819250|NCT03930433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110819251|NCT03930433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110819252|NCT03930433|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110819253|NCT03930433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110819254|NCT03930433|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110819255|NCT01224769|Rituximab|rituximab|mesh-list
110819256|NCT01224769|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110819257|NCT01224769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110819258|NCT01224769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110819259|NCT01224769|Immunologic Factors|immunologic factors|mesh-ancestor
110819260|NCT01224769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110819261|NCT01224769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110819262|NCT01224769|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110819263|NCT01224769|Alkylating Agents|alkylating agents|mesh-ancestor
110819264|NCT01224769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110819265|NCT02289430|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110819266|NCT02289430|Ezetimibe|ezetimibe|mesh-list
110819267|NCT02289430|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110819268|NCT02289430|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110819269|NCT02289430|Antimetabolites|antimetabolites|mesh-ancestor
110819270|NCT02289430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110819271|NCT02289430|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110819272|NCT02289430|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110819273|NCT02289430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110819274|NCT01224847|Lidocaine|lidocaine|mesh-list
110819275|NCT01224847|Cocaine|cocaine|mesh-list
110819276|NCT01224847|Tetracaine|tetracaine|mesh-list
110819277|NCT01224847|Anesthetics, Local|anesthetics, local|mesh-ancestor
110819278|NCT01224847|Anesthetics|anesthetics|mesh-ancestor
110819279|NCT01224847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110819280|NCT01224847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110819281|NCT01224847|Sensory System Agents|sensory system agents|mesh-ancestor
110819282|NCT01224847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110819283|NCT01224847|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110819284|NCT01224847|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110819285|NCT01224847|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110819286|NCT01224847|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110819287|NCT01224847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110819288|NCT01224847|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110819289|NCT01224847|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110819290|NCT01224847|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110819291|NCT01224847|Dopamine Agents|dopamine agents|mesh-ancestor
110819292|NCT01224847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110819293|NCT02289586|Fentanyl|fentanyl|mesh-list
110819294|NCT02289586|Midazolam|midazolam|mesh-list
110819295|NCT02289586|Remifentanil|remifentanil|mesh-list
110819296|NCT02289586|Dezocine|dezocine|mesh-list
110819297|NCT02289586|Propofol|propofol|mesh-list
110819298|NCT02289586|Rocuronium|rocuronium|mesh-list
110819299|NCT02289586|Anesthetics|anesthetics|mesh-ancestor
110819300|NCT02289586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110819301|NCT02289586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110819302|NCT02289586|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110854314|NCT01334424|Propofol|propofol|mesh-list
110819303|NCT02289586|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110819304|NCT02289586|Anesthetics, General|anesthetics, general|mesh-ancestor
110819305|NCT02289586|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110819306|NCT02289586|Narcotics|narcotics|mesh-ancestor
110819307|NCT02289586|Analgesics|analgesics|mesh-ancestor
110819308|NCT02289586|Sensory System Agents|sensory system agents|mesh-ancestor
110819309|NCT02289586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110819310|NCT02289586|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110819311|NCT02289586|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110819312|NCT02289586|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110819313|NCT02289586|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110819314|NCT02289586|GABA Modulators|gaba modulators|mesh-ancestor
110819315|NCT02289586|GABA Agents|gaba agents|mesh-ancestor
110819316|NCT02289586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110819317|NCT02289586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110819318|NCT02289586|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110819319|NCT02289586|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110819320|NCT02289586|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110819321|NCT03740581|Insulin|insulin|mesh-list
110819322|NCT03740581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110819323|NCT03740581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110819325|NCT03874897|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110819326|NCT03874897|Immunologic Factors|immunologic factors|mesh-ancestor
110819327|NCT03874897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110819328|NCT01127035|Immunomodulating Agents|immunomodulating agents|mesh-list
110819329|NCT01127035|Immunologic Factors|immunologic factors|mesh-ancestor
110819330|NCT01127035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110819331|NCT02294266|Ethanol|ethanol|mesh-list
110819332|NCT02294266|Methamphetamine|methamphetamine|mesh-list
110819333|NCT02294266|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110819334|NCT02294266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110819335|NCT02294266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110819336|NCT02294266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110819337|NCT02294266|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110819338|NCT02294266|Sympathomimetics|sympathomimetics|mesh-ancestor
110819339|NCT02294266|Autonomic Agents|autonomic agents|mesh-ancestor
110819340|NCT02294266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110819341|NCT02294266|Dopamine Agents|dopamine agents|mesh-ancestor
110819342|NCT02294266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110819343|NCT02294266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110819344|NCT02294266|Adrenergic Agents|adrenergic agents|mesh-ancestor
110819345|NCT02294266|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110819346|NCT02294266|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110819347|NCT02294266|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110819348|NCT02294266|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110819349|NCT02294344|Cyclophosphamide|cyclophosphamide|mesh-list
110819350|NCT02294344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110819351|NCT02294344|Immunologic Factors|immunologic factors|mesh-ancestor
110819352|NCT02294344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110819353|NCT02294344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110819354|NCT02294344|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110819355|NCT02294344|Alkylating Agents|alkylating agents|mesh-ancestor
110819356|NCT02294344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110819357|NCT02294344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110819358|NCT02294344|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110819359|NCT01130311|Vitamin D|vitamin d|mesh-list
110819360|NCT01130311|Cholecalciferol|cholecalciferol|mesh-list
110819361|NCT01130311|Vitamins|vitamins|mesh-ancestor
110819362|NCT01130311|Micronutrients|micronutrients|mesh-ancestor
110819363|NCT01130311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110819364|NCT01130311|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110819365|NCT01130311|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110819367|NCT03926377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110819368|NCT03926377|Glucocorticoids|glucocorticoids|mesh-ancestor
110819369|NCT03926377|Hormones|hormones|mesh-ancestor
110819370|NCT03926377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110819371|NCT03926377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110819372|NCT03132688|Propofol|propofol|mesh-list
110854320|NCT01334424|Anesthetics|anesthetics|mesh-ancestor
110819373|NCT03132688|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110819374|NCT03132688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110819375|NCT03132688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110819376|NCT03132688|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110819377|NCT03132688|Anesthetics, General|anesthetics, general|mesh-ancestor
110819378|NCT03132688|Anesthetics|anesthetics|mesh-ancestor
110819379|NCT01227811|Darifenacin|darifenacin|mesh-list
110819380|NCT01227811|Muscarinic Antagonists|muscarinic antagonists|mesh-list
110819381|NCT01227811|Cholinergic Agents|cholinergic agents|mesh-list
110819382|NCT01227811|Cholinergic Antagonists|cholinergic antagonists|mesh-list
110819383|NCT01227811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110819384|NCT01227811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110819385|NCT01227811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110819386|NCT01227811|Urological Agents|urological agents|mesh-ancestor
110819387|NCT01225081|Pioglitazone|pioglitazone|mesh-list
110819388|NCT01225081|Ipragliflozin|ipragliflozin|mesh-list
110819389|NCT01225081|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110819390|NCT01225081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110819391|NCT01225081|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110819392|NCT01225081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110819393|NCT02298166|Cytarabine|cytarabine|mesh-list
110819394|NCT02298166|Mitoxantrone|mitoxantrone|mesh-list
110819395|NCT02298166|Crenolanib|crenolanib|mesh-list
110819396|NCT02298166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110819397|NCT02298166|Antimetabolites|antimetabolites|mesh-ancestor
110819398|NCT02298166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110819399|NCT02298166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110819400|NCT02298166|Antiviral Agents|antiviral agents|mesh-ancestor
110819401|NCT02298166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110819402|NCT02298166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110819403|NCT02298166|Immunologic Factors|immunologic factors|mesh-ancestor
110819404|NCT02298166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110819406|NCT02298166|Sensory System Agents|sensory system agents|mesh-ancestor
110819407|NCT02298166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110819408|NCT02298166|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110819409|NCT02298166|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110819410|NCT02298166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110819411|NCT01127269|Insulin Glargine|insulin glargine|mesh-list
110819412|NCT01127269|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110819413|NCT01127269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110819414|NCT01221883|Diazepam|diazepam|mesh-list
110819415|NCT01221883|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110819416|NCT01221883|Anticonvulsants|anticonvulsants|mesh-ancestor
110819417|NCT01221883|Antiemetics|antiemetics|mesh-ancestor
110819418|NCT01221883|Autonomic Agents|autonomic agents|mesh-ancestor
110819419|NCT01221883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110819420|NCT01221883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110819421|NCT01221883|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110819422|NCT01221883|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110819423|NCT01221883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110819424|NCT01221883|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110819425|NCT01221883|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110819426|NCT01221883|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110819427|NCT01221883|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110819428|NCT01221883|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110819429|NCT01221883|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110819430|NCT01221883|Anesthetics, General|anesthetics, general|mesh-ancestor
110819431|NCT01221883|Anesthetics|anesthetics|mesh-ancestor
110819432|NCT01221883|GABA Modulators|gaba modulators|mesh-ancestor
110819433|NCT01221883|GABA Agents|gaba agents|mesh-ancestor
110819434|NCT01221883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110819435|NCT01221883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110819436|NCT02294656|Triamcinolone|triamcinolone|mesh-list
110819437|NCT02294656|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110819438|NCT02294656|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110819439|NCT02294656|Ranibizumab|ranibizumab|mesh-list
110819440|NCT02294656|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110819441|NCT02294656|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110819442|NCT02294656|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110819443|NCT02294656|Growth Substances|growth substances|mesh-ancestor
110819444|NCT02294656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110819445|NCT02294656|Growth Inhibitors|growth inhibitors|mesh-ancestor
110819446|NCT02294656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110819447|NCT02294656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110819449|NCT02294656|Hormones|hormones|mesh-ancestor
110819450|NCT02294656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110819451|NCT02294656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110819452|NCT02294656|Immunologic Factors|immunologic factors|mesh-ancestor
110819453|NCT02294656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110819454|NCT02294656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110819455|NCT01225237|Ramosetron|ramosetron|mesh-list
110819456|NCT01225237|Antiemetics|antiemetics|mesh-ancestor
110819457|NCT01225237|Autonomic Agents|autonomic agents|mesh-ancestor
110819458|NCT01225237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110819459|NCT01225237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110819460|NCT01225237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110819461|NCT01225237|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110819462|NCT01225237|Serotonin Agents|serotonin agents|mesh-ancestor
110819463|NCT01225237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110819464|NCT01225237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110819465|NCT03517930|Loratadine|loratadine|mesh-list
110819466|NCT03517930|Pseudoephedrine|pseudoephedrine|mesh-list
110819467|NCT03517930|Ephedrine|ephedrine|mesh-list
110819468|NCT03517930|Antipruritics|antipruritics|mesh-ancestor
110819469|NCT03517930|Dermatologic Agents|dermatologic agents|mesh-ancestor
110819470|NCT03517930|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110819471|NCT03517930|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110819472|NCT03517930|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110819473|NCT03517930|Histamine Antagonists|histamine antagonists|mesh-ancestor
110819474|NCT03517930|Histamine Agents|histamine agents|mesh-ancestor
110819475|NCT03517930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110819476|NCT03517930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110819477|NCT03517930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110819478|NCT03517930|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110819479|NCT03517930|Autonomic Agents|autonomic agents|mesh-ancestor
110819480|NCT03517930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110819481|NCT03517930|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110819482|NCT03517930|Respiratory System Agents|respiratory system agents|mesh-ancestor
110819483|NCT03517930|Nasal Decongestants|nasal decongestants|mesh-ancestor
110819484|NCT03517930|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110819485|NCT03517930|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110819486|NCT03517930|Sympathomimetics|sympathomimetics|mesh-ancestor
110819487|NCT03517930|Adrenergic Agents|adrenergic agents|mesh-ancestor
110819488|NCT01130467|Methylphenidate|methylphenidate|mesh-list
110819489|NCT01130467|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
110819490|NCT01130467|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110819491|NCT01130467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110819492|NCT01130467|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110819493|NCT01130467|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110819494|NCT01130467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110819495|NCT01130467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110819496|NCT01130467|Dopamine Agents|dopamine agents|mesh-ancestor
110819497|NCT01130467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110819498|NCT01130467|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110819499|NCT01130467|Adrenergic Agents|adrenergic agents|mesh-ancestor
110819501|NCT02295046|Atorvastatin|atorvastatin|mesh-list
110819502|NCT02295046|Calcium|calcium|mesh-list
110819503|NCT02295046|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110819504|NCT02295046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110819505|NCT02295046|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110819506|NCT02295046|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110819507|NCT02295046|Antimetabolites|antimetabolites|mesh-ancestor
110819508|NCT02295046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110819509|NCT02295046|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110819510|NCT02295046|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110819511|NCT02295046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110819512|NCT02295046|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110819513|NCT02295046|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110819514|NCT02295046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110819515|NCT02295046|Vasodilator Agents|vasodilator agents|mesh-ancestor
110819517|NCT03517618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110819518|NCT03517618|Antidotes|antidotes|mesh-ancestor
110819519|NCT03517618|Protective Agents|protective agents|mesh-ancestor
110819520|NCT03517618|Vitamin B Complex|vitamin b complex|mesh-ancestor
110819521|NCT03517618|Vitamins|vitamins|mesh-ancestor
110819522|NCT03517618|Micronutrients|micronutrients|mesh-ancestor
110819523|NCT02295124|Oxycodone|oxycodone|mesh-list
110819524|NCT02295124|Hydromorphone|hydromorphone|mesh-list
110819525|NCT02295124|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110819526|NCT02295124|Narcotics|narcotics|mesh-ancestor
110819527|NCT02295124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110819528|NCT02295124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110819529|NCT02295124|Analgesics|analgesics|mesh-ancestor
110819530|NCT02295124|Sensory System Agents|sensory system agents|mesh-ancestor
110819531|NCT02295124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110819532|NCT03925051|Denosumab|denosumab|mesh-list
110819533|NCT03925051|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110819534|NCT03925051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110819535|NCT03514576|Pasireotide|pasireotide|mesh-list
110819536|NCT03514576|Hormones|hormones|mesh-ancestor
110819537|NCT03514576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110819538|NCT03514576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110819539|NCT02299024|Analgesics, Opioid|analgesics, opioid|mesh-list
110819540|NCT02299024|Narcotics|narcotics|mesh-ancestor
110819541|NCT02299024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110819542|NCT02299024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110819543|NCT02299024|Analgesics|analgesics|mesh-ancestor
110819544|NCT02299024|Sensory System Agents|sensory system agents|mesh-ancestor
110819545|NCT02299024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110819546|NCT03929419|Insulin|insulin|mesh-list
110819547|NCT03929419|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110819548|NCT03929419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110819549|NCT01228279|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110819550|NCT01228279|Icodextrin|icodextrin|mesh-list
110819551|NCT01228279|Dialysis Solutions|dialysis solutions|mesh-ancestor
110819552|NCT03514342|Ropivacaine|ropivacaine|mesh-list
110819553|NCT03514342|Anesthetics, Local|anesthetics, local|mesh-ancestor
110819554|NCT03514342|Anesthetics|anesthetics|mesh-ancestor
110819555|NCT03514342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110819556|NCT03514342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110819557|NCT03514342|Sensory System Agents|sensory system agents|mesh-ancestor
110819558|NCT03514342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110819559|NCT01228045|Trastuzumab|trastuzumab|mesh-list
110819560|NCT01228045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110819561|NCT01228045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110819562|NCT03514030|Antibodies|antibodies|mesh-list
110819563|NCT03514030|Immunologic Factors|immunologic factors|mesh-ancestor
110819564|NCT03514030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110819565|NCT03517462|Ivermectin|ivermectin|mesh-list
110819566|NCT03517462|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110819567|NCT03517462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110819568|NCT03929575|Calcium|calcium|mesh-list
110819569|NCT03929575|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110819570|NCT03929575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110819571|NCT02292472|Botulinum Toxins|botulinum toxins|mesh-list
110819572|NCT02292472|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110819573|NCT02292472|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110819574|NCT02292472|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110819575|NCT02292472|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110819576|NCT02292472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110819577|NCT02292472|Cholinergic Agents|cholinergic agents|mesh-ancestor
110819578|NCT02292472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110854343|NCT03498313|Hormones|hormones|mesh-ancestor
110819579|NCT02292472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110819580|NCT02292472|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110819581|NCT02292472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110819582|NCT01131247|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110819583|NCT01131247|Ofatumumab|ofatumumab|mesh-list
110537130|NCT02825225|Anesthetics|anesthetics|mesh-list
110819584|NCT01131247|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110819585|NCT01131247|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110819586|NCT01131247|Alkylating Agents|alkylating agents|mesh-ancestor
110819587|NCT01131247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110819588|NCT01131247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110819589|NCT01131247|Immunologic Factors|immunologic factors|mesh-ancestor
110819590|NCT01131247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110819592|NCT03513874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110819593|NCT03513874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110819594|NCT01228357|Milnacipran|milnacipran|mesh-list
110819595|NCT01228357|Mirtazapine|mirtazapine|mesh-list
110819596|NCT01228357|Sertraline|sertraline|mesh-list
110819597|NCT01228357|Fluoxetine|fluoxetine|mesh-list
110819598|NCT01228357|Paroxetine|paroxetine|mesh-list
110819599|NCT01228357|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
110819600|NCT01228357|Nortriptyline|nortriptyline|mesh-list
110819601|NCT01228357|Antidepressive Agents|antidepressive agents|mesh-ancestor
110819602|NCT01228357|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110819603|NCT01228357|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110819604|NCT01228357|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110819605|NCT01228357|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110819606|NCT01228357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110819607|NCT01228357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110819608|NCT01228357|Serotonin Agents|serotonin agents|mesh-ancestor
110819609|NCT01228357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110819610|NCT01228357|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110819611|NCT01228357|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110819612|NCT01228357|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110819613|NCT01228357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110819614|NCT01228357|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110819615|NCT01228357|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110819616|NCT01228357|Histamine Antagonists|histamine antagonists|mesh-ancestor
110819617|NCT01228357|Histamine Agents|histamine agents|mesh-ancestor
110819618|NCT01228357|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110819619|NCT01228357|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110819620|NCT01228357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110819621|NCT01228357|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
110819623|NCT01228357|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110819624|NCT01228357|Adrenergic Agents|adrenergic agents|mesh-ancestor
110819625|NCT01228357|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110819626|NCT01228357|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110819627|NCT01228357|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110819628|NCT01228357|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110819629|NCT01228357|Analgesics|analgesics|mesh-ancestor
110819630|NCT01228357|Sensory System Agents|sensory system agents|mesh-ancestor
110819631|NCT01228357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110819632|NCT01228357|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110819633|NCT01228357|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110819634|NCT01130701|Capecitabine|capecitabine|mesh-list
110819635|NCT01130701|Panitumumab|panitumumab|mesh-list
110819636|NCT01130701|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110819637|NCT01130701|Antimetabolites|antimetabolites|mesh-ancestor
110819638|NCT01130701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110819639|NCT01130701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110819640|NCT01130701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110819641|NCT02292550|Ceritinib|ceritinib|mesh-list
110819642|NCT02292550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110819643|NCT02292550|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110819644|NCT02292550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110819645|NCT02292550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110819646|NCT03925285|Bevacizumab|bevacizumab|mesh-list
110819647|NCT03925285|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110819648|NCT03925285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110819649|NCT03925285|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110819650|NCT03925285|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110819651|NCT03925285|Growth Substances|growth substances|mesh-ancestor
110819652|NCT03925285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110819653|NCT03925285|Growth Inhibitors|growth inhibitors|mesh-ancestor
110819654|NCT04464694|Ranibizumab|ranibizumab|mesh-list
110819655|NCT04464694|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110819656|NCT04464694|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110819657|NCT04464694|Growth Substances|growth substances|mesh-ancestor
110819658|NCT04464694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110819659|NCT04464694|Growth Inhibitors|growth inhibitors|mesh-ancestor
110819660|NCT04464694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110819661|NCT01130779|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110819662|NCT01130779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110537203|NCT00633659|Plasma Substitutes|plasma substitutes|mesh-ancestor
110819664|NCT01130779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110819665|NCT01130779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110819666|NCT03513484|Azacitidine|azacitidine|mesh-list
110819667|NCT03513484|Nintedanib|nintedanib|mesh-list
110819668|NCT03513484|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
110819669|NCT03513484|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110819670|NCT03513484|Antimetabolites|antimetabolites|mesh-ancestor
110819671|NCT03513484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110819672|NCT03513484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110819673|NCT03513484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110819674|NCT03513484|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110819675|NCT03519724|Neostigmine|neostigmine|mesh-list
110819676|NCT03519724|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110819677|NCT03519724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110819678|NCT03519724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110819679|NCT03519724|Cholinergic Agents|cholinergic agents|mesh-ancestor
110819680|NCT03519724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110819681|NCT03519724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110819682|NCT03519724|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110819683|NCT03519724|Autonomic Agents|autonomic agents|mesh-ancestor
110819684|NCT03519724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110819685|NCT03920449|Botulinum Toxins|botulinum toxins|mesh-list
110819686|NCT03920449|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110819687|NCT03920449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110819688|NCT03920449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110819689|NCT03920449|Cholinergic Agents|cholinergic agents|mesh-ancestor
110819690|NCT03920449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110819691|NCT03920449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110819692|NCT03920059|Mycophenolic Acid|mycophenolic acid|mesh-list
110819693|NCT03920059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110819694|NCT03920059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110819695|NCT03920059|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110819696|NCT03920059|Antitubercular Agents|antitubercular agents|mesh-ancestor
110819697|NCT03920059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110819698|NCT03920059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110819699|NCT03920059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110819700|NCT03920059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110819701|NCT01132027|Tacrolimus|tacrolimus|mesh-list
110819702|NCT01132027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110819703|NCT01132027|Immunologic Factors|immunologic factors|mesh-ancestor
110819704|NCT01132027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110819705|NCT01132027|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110819706|NCT01132027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110819707|NCT01132027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110819708|NCT03136484|Canagliflozin|canagliflozin|mesh-list
110819709|NCT03136484|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110819710|NCT03136484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110819711|NCT03136484|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110819712|NCT03136484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110819714|NCT01132183|Anticonvulsants|anticonvulsants|mesh-ancestor
110819715|NCT01132183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110819716|NCT01132183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110819717|NCT01132183|GABA Agents|gaba agents|mesh-ancestor
110819718|NCT01132183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110819719|NCT01132183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110819720|NCT01132183|Antimanic Agents|antimanic agents|mesh-ancestor
110819721|NCT01132183|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110819722|NCT01132183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110819723|NCT01132183|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110819724|NCT03923881|Cetuximab|cetuximab|mesh-list
110819725|NCT03923881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110819726|NCT03923881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110819727|NCT02295748|Deflazacort|deflazacort|mesh-list
110819728|NCT02295748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110819729|NCT02295748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110819730|NCT02295748|Immunologic Factors|immunologic factors|mesh-ancestor
110819731|NCT02295748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110819732|NCT03923803|Calcitonin|calcitonin|mesh-list
110819733|NCT03923803|Salmon calcitonin|salmon calcitonin|mesh-list
110819734|NCT03923803|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
110819735|NCT03923803|Katacalcin|katacalcin|mesh-list
110819736|NCT03923803|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110819737|NCT03923803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110819738|NCT03923803|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110819739|NCT03923803|Vasodilator Agents|vasodilator agents|mesh-ancestor
110819740|NCT02295826|Aspirin|aspirin|mesh-list
110819741|NCT02295826|Dabigatran|dabigatran|mesh-list
110819742|NCT02295826|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110819743|NCT02295826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110819744|NCT02295826|Analgesics|analgesics|mesh-ancestor
110819745|NCT02295826|Sensory System Agents|sensory system agents|mesh-ancestor
110819746|NCT02295826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110819747|NCT02295826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110819748|NCT02295826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110819749|NCT02295826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110819750|NCT02295826|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110819751|NCT02295826|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110819752|NCT02295826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110819753|NCT02295826|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110819754|NCT02295826|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110819755|NCT02295826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110819756|NCT02295826|Antipyretics|antipyretics|mesh-ancestor
110819757|NCT02295826|Antithrombins|antithrombins|mesh-ancestor
110819758|NCT02295826|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110819759|NCT02295826|Protease Inhibitors|protease inhibitors|mesh-ancestor
110819760|NCT02295826|Anticoagulants|anticoagulants|mesh-ancestor
110819761|NCT01348724|Naloxegol|naloxegol|mesh-list
110819762|NCT01348724|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110819763|NCT01348724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110819764|NCT01348724|Sensory System Agents|sensory system agents|mesh-ancestor
110819765|NCT01348724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110819766|NCT03519022|Cocaine|cocaine|mesh-list
110819767|NCT03519022|Methylphenidate|methylphenidate|mesh-list
110819768|NCT03519022|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110819769|NCT03519022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110819770|NCT03519022|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110819771|NCT03519022|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110819772|NCT03519022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110819773|NCT03519022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110819774|NCT03519022|Dopamine Agents|dopamine agents|mesh-ancestor
110819775|NCT03519022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110819776|NCT03519022|Anesthetics, Local|anesthetics, local|mesh-ancestor
110819777|NCT03519022|Anesthetics|anesthetics|mesh-ancestor
110819778|NCT03519022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110819779|NCT03519022|Sensory System Agents|sensory system agents|mesh-ancestor
110819780|NCT03519022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110819781|NCT03519022|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110819782|NCT03923257|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
110819783|NCT03923257|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110819784|NCT03923257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110819785|NCT03516526|Natalizumab|natalizumab|mesh-list
110819786|NCT03516526|Immunologic Factors|immunologic factors|mesh-ancestor
110819787|NCT03516526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110819788|NCT02293330|Levobupivacaine|levobupivacaine|mesh-list
110819789|NCT02293330|Anesthetics, Local|anesthetics, local|mesh-ancestor
110819790|NCT02293330|Anesthetics|anesthetics|mesh-ancestor
110819791|NCT02293330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110819792|NCT02293330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110819793|NCT02293330|Sensory System Agents|sensory system agents|mesh-ancestor
110819794|NCT02293330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110819795|NCT01348880|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
110819796|NCT01348880|Vasodilator Agents|vasodilator agents|mesh-ancestor
110819797|NCT01348880|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110819798|NCT01348880|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110819799|NCT01348880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110819800|NCT01348880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110819801|NCT01348880|Urological Agents|urological agents|mesh-ancestor
110819802|NCT03923179|Etoposide|etoposide|mesh-list
110819803|NCT03923179|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110819804|NCT03923179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110819805|NCT03923179|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110819806|NCT03923179|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110819807|NCT03923179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110819808|NCT03923179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110819809|NCT01318460|Simendan|simendan|mesh-list
110819810|NCT01318460|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110819811|NCT01318460|Vasodilator Agents|vasodilator agents|mesh-ancestor
110819812|NCT01318460|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110819813|NCT01318460|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110819814|NCT01318460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110819815|NCT01318460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110819816|NCT01318460|Protective Agents|protective agents|mesh-ancestor
110819817|NCT01318460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110819818|NCT02299726|Spironolactone|spironolactone|mesh-list
110819819|NCT02299726|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110819820|NCT02299726|Hormone Antagonists|hormone antagonists|mesh-ancestor
110819821|NCT02299726|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110819822|NCT02299726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110819823|NCT02299726|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110819824|NCT02299726|Diuretics|diuretics|mesh-ancestor
110819825|NCT02299726|Natriuretic Agents|natriuretic agents|mesh-ancestor
110819826|NCT03647852|Methylprednisolone|methylprednisolone|mesh-list
110819827|NCT03647852|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110819828|NCT03647852|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110819829|NCT03647852|Prednisolone|prednisolone|mesh-list
110819830|NCT03647852|Prednisolone acetate|prednisolone acetate|mesh-list
110819831|NCT03647852|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110819832|NCT03647852|Prednisolone phosphate|prednisolone phosphate|mesh-list
110819833|NCT03647852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110819834|NCT03647852|Antiemetics|antiemetics|mesh-ancestor
110819835|NCT03647852|Autonomic Agents|autonomic agents|mesh-ancestor
110819836|NCT03647852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110819837|NCT03647852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110819838|NCT03647852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110819839|NCT03647852|Glucocorticoids|glucocorticoids|mesh-ancestor
110819840|NCT03647852|Hormones|hormones|mesh-ancestor
110819841|NCT03647852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110819843|NCT03647852|Protective Agents|protective agents|mesh-ancestor
110819844|NCT03647852|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110819845|NCT03647852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110819846|NCT01354886|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
110819847|NCT01354886|Hormones|hormones|mesh-ancestor
110819848|NCT01354886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110819849|NCT01354886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110819850|NCT02299882|Vancomycin|vancomycin|mesh-list
110819851|NCT02299882|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110819852|NCT02299882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110819853|NCT01355120|Ipilimumab|ipilimumab|mesh-list
110854367|NCT02601014|Nivolumab|nivolumab|mesh-list
110819854|NCT01355120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110819855|NCT01355120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110819856|NCT01355120|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110819857|NCT01355120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110819858|NCT02300038|Lidocaine|lidocaine|mesh-list
110819859|NCT02300038|Anesthetics, Local|anesthetics, local|mesh-ancestor
110819860|NCT02300038|Anesthetics|anesthetics|mesh-ancestor
110819861|NCT02300038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110819862|NCT02300038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110819863|NCT02300038|Sensory System Agents|sensory system agents|mesh-ancestor
110819864|NCT02300038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110819865|NCT02300038|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110819866|NCT02300038|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110819867|NCT02300038|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110819868|NCT02300038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110819869|NCT02300038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110819870|NCT01355198|Acetylcysteine|acetylcysteine|mesh-list
110819871|NCT01355198|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110819872|NCT01355198|Glycine|glycine|mesh-list
110819873|NCT01355198|Antiviral Agents|antiviral agents|mesh-ancestor
110819874|NCT01355198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110819875|NCT01355198|Expectorants|expectorants|mesh-ancestor
110819876|NCT01355198|Respiratory System Agents|respiratory system agents|mesh-ancestor
110819877|NCT01355198|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110819878|NCT01355198|Antioxidants|antioxidants|mesh-ancestor
110819879|NCT01355198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110819880|NCT01355198|Protective Agents|protective agents|mesh-ancestor
110819881|NCT01355198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110819882|NCT01355198|Antidotes|antidotes|mesh-ancestor
110819883|NCT01355198|Glycine Agents|glycine agents|mesh-ancestor
110819884|NCT01355198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110819885|NCT01355276|Domperidone|domperidone|mesh-list
110819886|NCT01355276|Cinitapride|cinitapride|mesh-list
110819887|NCT01355276|Antiemetics|antiemetics|mesh-ancestor
110819888|NCT01355276|Autonomic Agents|autonomic agents|mesh-ancestor
110819889|NCT01355276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110819890|NCT01355276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110819891|NCT01355276|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110819892|NCT01355276|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110819893|NCT01355276|Dopamine Agents|dopamine agents|mesh-ancestor
110819894|NCT01355276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110819895|NCT01355276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110819896|NCT01355276|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110819898|NCT02589860|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110819899|NCT02589860|Alkylating Agents|alkylating agents|mesh-ancestor
110819900|NCT02589860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110819901|NCT02589860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110819902|NCT02589860|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110819903|NCT02589860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110819904|NCT02589860|Immunologic Factors|immunologic factors|mesh-ancestor
110819905|NCT02589860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110819906|NCT01355354|Digoxin|digoxin|mesh-list
110819907|NCT01355354|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110819908|NCT01355354|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110819909|NCT01355354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110863874|NCT03634020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110819910|NCT01355354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110819911|NCT01355354|Protective Agents|protective agents|mesh-ancestor
110819912|NCT01355354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110819913|NCT03513172|Brimonidine Tartrate|brimonidine tartrate|mesh-list
110819914|NCT03513172|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110819915|NCT03513172|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110819916|NCT03513172|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110819917|NCT03513172|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110819918|NCT03513172|Adrenergic Agents|adrenergic agents|mesh-ancestor
110819919|NCT03513172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110819920|NCT03513172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110819921|NCT03513172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110819922|NCT01349270|Prednisone|prednisone|mesh-list
110819923|NCT01349270|Immunoglobulins|immunoglobulins|mesh-list
110819924|NCT01349270|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110819925|NCT01349270|Antibodies|antibodies|mesh-list
110819926|NCT01349270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110819927|NCT01349270|Glucocorticoids|glucocorticoids|mesh-ancestor
110819928|NCT01349270|Hormones|hormones|mesh-ancestor
110819929|NCT01349270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110819930|NCT01349270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110819931|NCT01349270|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110819932|NCT01349270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110819933|NCT01349270|Immunologic Factors|immunologic factors|mesh-ancestor
110819934|NCT01132417|Tigecycline|tigecycline|mesh-list
110819935|NCT01132417|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110819936|NCT01132417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110819937|NCT01132417|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110819938|NCT01132417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110819939|NCT01132417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110819940|NCT02300194|Morphine|morphine|mesh-list
110819941|NCT02300194|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110819942|NCT02300194|Narcotics|narcotics|mesh-ancestor
110819943|NCT02300194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110819944|NCT02300194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110819945|NCT02300194|Analgesics|analgesics|mesh-ancestor
110819946|NCT02300194|Sensory System Agents|sensory system agents|mesh-ancestor
110819947|NCT02300194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110819948|NCT01225705|Ritonavir|ritonavir|mesh-list
110819949|NCT01225705|Atazanavir Sulfate|atazanavir sulfate|mesh-list
110819950|NCT01225705|Raltegravir Potassium|raltegravir potassium|mesh-list
110819951|NCT01225705|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110819952|NCT01225705|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110819953|NCT01225705|Protease Inhibitors|protease inhibitors|mesh-ancestor
110819954|NCT01225705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110819955|NCT01225705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110819956|NCT01225705|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110819957|NCT01225705|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110819959|NCT01225705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110819960|NCT01225705|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110819961|NCT01225705|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110819962|NCT01225705|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110819963|NCT01225705|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110819964|NCT01128985|Canagliflozin|canagliflozin|mesh-list
110819965|NCT01128985|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110819966|NCT01128985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110819967|NCT01128985|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110819968|NCT01128985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110819969|NCT03922555|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
110819970|NCT03922555|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110819971|NCT03922555|Antimetabolites|antimetabolites|mesh-ancestor
110819972|NCT03922555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110819973|NCT03922555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110819974|NCT03512860|Valproic Acid|valproic acid|mesh-list
110819975|NCT03512860|Anticonvulsants|anticonvulsants|mesh-ancestor
110819976|NCT03512860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110819977|NCT03512860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110819978|NCT03512860|GABA Agents|gaba agents|mesh-ancestor
110819979|NCT03512860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110819980|NCT03512860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110819981|NCT03512860|Antimanic Agents|antimanic agents|mesh-ancestor
110819982|NCT03512860|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110819983|NCT03512860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110819984|NCT03512860|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110819985|NCT01357694|Psychotropic Drugs|psychotropic drugs|mesh-list
110819986|NCT02528695|Hypoglycemic Agents|hypoglycemic agents|mesh-list
110819987|NCT02528695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110819988|NCT02296762|Sirolimus|sirolimus|mesh-list
110819989|NCT02296762|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110819990|NCT02296762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110819991|NCT02296762|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110819992|NCT02296762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110819993|NCT02296762|Antifungal Agents|antifungal agents|mesh-ancestor
110819994|NCT02296762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110819995|NCT02296762|Immunologic Factors|immunologic factors|mesh-ancestor
110819996|NCT02296762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110819997|NCT01132573|Clofarabine|clofarabine|mesh-list
110819998|NCT01132573|Entinostat|entinostat|mesh-list
110819999|NCT01132573|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
110820000|NCT01132573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110820001|NCT01132573|Antimetabolites|antimetabolites|mesh-ancestor
110820002|NCT01132573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110820003|NCT01132573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110820004|NCT01132573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110820005|NCT01131559|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
110820006|NCT01131559|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110820007|NCT01131559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110820008|NCT01131559|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110820009|NCT01131559|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110820010|NCT01131559|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110820011|NCT01131559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110820012|NCT01131559|Dopamine Agents|dopamine agents|mesh-ancestor
110820013|NCT01131559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110820014|NCT03518320|Gemcitabine|gemcitabine|mesh-list
110820015|NCT03518320|Nivolumab|nivolumab|mesh-list
110820016|NCT03518320|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110820017|NCT03518320|Antimetabolites|antimetabolites|mesh-ancestor
110820018|NCT03518320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110820019|NCT03518320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110820020|NCT03518320|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110820021|NCT03518320|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110820022|NCT01134289|Bupivacaine|bupivacaine|mesh-list
110820023|NCT01134289|Levobupivacaine|levobupivacaine|mesh-list
110820024|NCT01134289|Anesthetics, Local|anesthetics, local|mesh-ancestor
110820025|NCT01134289|Anesthetics|anesthetics|mesh-ancestor
110820026|NCT01134289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110820027|NCT01134289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110820028|NCT01134289|Sensory System Agents|sensory system agents|mesh-ancestor
110820029|NCT01134289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110820030|NCT02300350|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
110820031|NCT02300350|Digoxin|digoxin|mesh-list
110820032|NCT02300350|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110820033|NCT02300350|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110820034|NCT02300350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110820035|NCT02300350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110820036|NCT02300350|Protective Agents|protective agents|mesh-ancestor
110820037|NCT02300350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110820038|NCT02300350|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110820039|NCT02300350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110820040|NCT01349348|Tolvaptan|tolvaptan|mesh-list
110820041|NCT01349348|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
110820042|NCT01349348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110820043|NCT01349348|Natriuretic Agents|natriuretic agents|mesh-ancestor
110820044|NCT01349348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110820045|NCT02300428|Ferrous fumarate|ferrous fumarate|mesh-list
110820046|NCT02300428|Ferrous gluconate|ferrous gluconate|mesh-list
110820047|NCT02300428|Trace Elements|trace elements|mesh-ancestor
110820048|NCT02300428|Micronutrients|micronutrients|mesh-ancestor
110820049|NCT02300428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110820050|NCT02300428|Hematinics|hematinics|mesh-ancestor
110820051|NCT02293876|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110820052|NCT02293876|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110820053|NCT02296996|Trametinib|trametinib|mesh-list
110820054|NCT02296996|Dabrafenib|dabrafenib|mesh-list
110820055|NCT02296996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110820056|NCT02296996|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110820057|NCT02296996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110820058|NCT02296996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110820059|NCT01132729|Valacyclovir|valacyclovir|mesh-list
110820060|NCT01132729|Antiviral Agents|antiviral agents|mesh-ancestor
110820061|NCT01132729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110820062|NCT02294110|Anesthetics|anesthetics|mesh-list
110820063|NCT02294110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110820064|NCT02294110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110820065|NCT03512548|Itraconazole|itraconazole|mesh-list
110820066|NCT03512548|Antifungal Agents|antifungal agents|mesh-ancestor
110820067|NCT03512548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110820068|NCT03512548|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110820069|NCT03512548|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110820070|NCT03512548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110820071|NCT03512548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110820072|NCT03512548|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110820073|NCT03512548|Hormone Antagonists|hormone antagonists|mesh-ancestor
110820074|NCT03512548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110820075|NCT03512548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110820076|NCT03512548|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110820077|NCT03515668|Methylphenidate|methylphenidate|mesh-list
110820078|NCT03515668|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110820079|NCT03515668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110820080|NCT03515668|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110820081|NCT03515668|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110820082|NCT03515668|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110820083|NCT03515668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110820084|NCT03515668|Dopamine Agents|dopamine agents|mesh-ancestor
110820085|NCT03515668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110820086|NCT01356212|Ketorolac|ketorolac|mesh-list
110820087|NCT01356212|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
110820088|NCT01356212|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110820089|NCT01356212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110820090|NCT01356212|Analgesics|analgesics|mesh-ancestor
110820091|NCT01356212|Sensory System Agents|sensory system agents|mesh-ancestor
110820092|NCT01356212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110820093|NCT01356212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110820094|NCT01356212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110820095|NCT01356212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110820096|NCT01356212|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110820097|NCT01356212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110820098|NCT01356212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110820099|NCT02302378|Bupivacaine|bupivacaine|mesh-list
110820100|NCT02302378|Anesthetics, Local|anesthetics, local|mesh-ancestor
110537654|NCT00654576|Olanzapine|olanzapine|mesh-list
110820101|NCT02302378|Anesthetics|anesthetics|mesh-ancestor
110820102|NCT02302378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110820103|NCT02302378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110820104|NCT02302378|Sensory System Agents|sensory system agents|mesh-ancestor
110820105|NCT02302378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110820106|NCT01356368|Docetaxel|docetaxel|mesh-list
110820107|NCT01356368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110820108|NCT01356368|Tubulin Modulators|tubulin modulators|mesh-ancestor
110820109|NCT01356368|Antimitotic Agents|antimitotic agents|mesh-ancestor
110820110|NCT01356368|Mitosis Modulators|mitosis modulators|mesh-ancestor
110820111|NCT01356368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110820112|NCT02302456|Tranexamic Acid|tranexamic acid|mesh-list
110820114|NCT02302456|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110820115|NCT02302456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110820116|NCT02302456|Hemostatics|hemostatics|mesh-ancestor
110820117|NCT02302456|Coagulants|coagulants|mesh-ancestor
110820118|NCT01356524|Progesterone|progesterone|mesh-list
110820119|NCT01356524|Progestins|progestins|mesh-ancestor
110820120|NCT01356524|Hormones|hormones|mesh-ancestor
110820121|NCT01356524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110820122|NCT01356524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110820123|NCT01232023|Indobufen|indobufen|mesh-list
110820124|NCT01232023|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110820125|NCT01232023|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110820126|NCT01232023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110820127|NCT01232023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110820128|NCT01232023|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110820129|NCT01232023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110820130|NCT01232023|Analgesics|analgesics|mesh-ancestor
110820131|NCT01232023|Sensory System Agents|sensory system agents|mesh-ancestor
110820132|NCT01232023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110820134|NCT01232023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110820135|NCT01232023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110820136|NCT02300740|Niacinamide|niacinamide|mesh-list
110820137|NCT02300740|Niacin|niacin|mesh-list
110820138|NCT02300740|Nicotinic Acids|nicotinic acids|mesh-list
110820139|NCT02300740|Vitamin B Complex|vitamin b complex|mesh-ancestor
110820140|NCT02300740|Vitamins|vitamins|mesh-ancestor
110820141|NCT02300740|Micronutrients|micronutrients|mesh-ancestor
110820142|NCT02300740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110820143|NCT02300740|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110820144|NCT02300740|Antimetabolites|antimetabolites|mesh-ancestor
110820145|NCT02300740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110820146|NCT02300740|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110820147|NCT02300740|Vasodilator Agents|vasodilator agents|mesh-ancestor
110820148|NCT02300818|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110820149|NCT02300818|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110820150|NCT02297386|Testosterone|testosterone|mesh-list
110820151|NCT02297386|Dihydrotestosterone|dihydrotestosterone|mesh-list
110820152|NCT02297386|Androgens|androgens|mesh-ancestor
110820153|NCT02297386|Hormones|hormones|mesh-ancestor
110820154|NCT02297386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110820155|NCT02297386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110820156|NCT04464616|Anesthetics|anesthetics|mesh-list
110820157|NCT04464616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110820158|NCT04464616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110820159|NCT01356680|Prednisone|prednisone|mesh-list
110820160|NCT01356680|Cyclophosphamide|cyclophosphamide|mesh-list
110820161|NCT01356680|Dacarbazine|dacarbazine|mesh-list
110820162|NCT01356680|Etoposide|etoposide|mesh-list
110820163|NCT01356680|Vincristine|vincristine|mesh-list
110820164|NCT01356680|Doxorubicin|doxorubicin|mesh-list
110820165|NCT01356680|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110820166|NCT01356680|Bleomycin|bleomycin|mesh-list
110820167|NCT01356680|Vinblastine|vinblastine|mesh-list
110820168|NCT01356680|Procarbazine|procarbazine|mesh-list
110820169|NCT01356680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110820170|NCT01356680|Immunologic Factors|immunologic factors|mesh-ancestor
110820171|NCT01356680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110820172|NCT01356680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110820173|NCT01356680|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110820174|NCT01356680|Alkylating Agents|alkylating agents|mesh-ancestor
110820175|NCT01356680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110820176|NCT01356680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110820177|NCT01356680|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110820178|NCT01356680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110820179|NCT01356680|Glucocorticoids|glucocorticoids|mesh-ancestor
110820180|NCT01356680|Hormones|hormones|mesh-ancestor
110820181|NCT01356680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110820182|NCT01356680|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110820183|NCT01356680|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110820184|NCT01356680|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110820185|NCT01356680|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110820186|NCT01356680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110820187|NCT01356680|Tubulin Modulators|tubulin modulators|mesh-ancestor
110820188|NCT01356680|Antimitotic Agents|antimitotic agents|mesh-ancestor
110820189|NCT01356680|Mitosis Modulators|mitosis modulators|mesh-ancestor
110820190|NCT01356680|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110820191|NCT04464850|Iron|iron|mesh-list
110820192|NCT04464850|Ferrous fumarate|ferrous fumarate|mesh-list
110820193|NCT04464850|Folic Acid|folic acid|mesh-list
110820194|NCT04464850|Trace Elements|trace elements|mesh-ancestor
110820195|NCT04464850|Micronutrients|micronutrients|mesh-ancestor
110820196|NCT04464850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110820197|NCT04464850|Hematinics|hematinics|mesh-ancestor
110820198|NCT04464850|Vitamin B Complex|vitamin b complex|mesh-ancestor
110820199|NCT04464850|Vitamins|vitamins|mesh-ancestor
110820200|NCT01356758|Adalimumab|adalimumab|mesh-list
110820201|NCT01356758|Infliximab|infliximab|mesh-list
110820202|NCT01356758|Etanercept|etanercept|mesh-list
110820203|NCT01356758|Ustekinumab|ustekinumab|mesh-list
110820204|NCT01356758|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110820205|NCT01356758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110820206|NCT01356758|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110820207|NCT01356758|Dermatologic Agents|dermatologic agents|mesh-ancestor
110820208|NCT01356758|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110820209|NCT01356758|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110820210|NCT01356758|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110820211|NCT01356758|Analgesics|analgesics|mesh-ancestor
110820212|NCT01356758|Sensory System Agents|sensory system agents|mesh-ancestor
110820213|NCT01356758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110820214|NCT01356758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110820215|NCT01356758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110820216|NCT01356758|Immunologic Factors|immunologic factors|mesh-ancestor
110820218|NCT01134523|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110820219|NCT01134523|Epirubicin|epirubicin|mesh-list
110820220|NCT01134523|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110820221|NCT01134523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110820222|NCT01134523|Tubulin Modulators|tubulin modulators|mesh-ancestor
110820223|NCT01134523|Antimitotic Agents|antimitotic agents|mesh-ancestor
110820224|NCT01134523|Mitosis Modulators|mitosis modulators|mesh-ancestor
110820225|NCT01134523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110820226|NCT01134523|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110820227|NCT01134523|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110820228|NCT01134523|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110820229|NCT01134523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110820230|NCT01349738|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110820231|NCT01349738|Ciprofloxacin|ciprofloxacin|mesh-list
110820232|NCT01349738|Levofloxacin|levofloxacin|mesh-list
110820233|NCT01349738|Ofloxacin|ofloxacin|mesh-list
110820234|NCT01349738|Gentamicins|gentamicins|mesh-list
110820235|NCT01349738|Cefazolin|cefazolin|mesh-list
110820236|NCT01349738|Tobramycin|tobramycin|mesh-list
110820237|NCT01349738|Ampicillin|ampicillin|mesh-list
110820238|NCT01349738|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
110820239|NCT01349738|Nitrofurantoin|nitrofurantoin|mesh-list
110820240|NCT01349738|Sulbactam|sulbactam|mesh-list
110820241|NCT01349738|Trimethoprim|trimethoprim|mesh-list
110820242|NCT01349738|Sulfamethoxazole|sulfamethoxazole|mesh-list
110820243|NCT01349738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110820244|NCT01349738|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110820245|NCT01349738|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110820246|NCT01349738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110820247|NCT01349738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110820248|NCT01349738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110820249|NCT01349738|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110820250|NCT01349738|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110820251|NCT01349738|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110820252|NCT01349738|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110820253|NCT01349738|Antimalarials|antimalarials|mesh-ancestor
110820254|NCT01349738|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110820255|NCT01349738|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110820256|NCT01349738|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110820257|NCT01349738|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110820258|NCT01349738|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
110820259|NCT01349738|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110820261|NCT02302768|Antioxidants|antioxidants|mesh-ancestor
110820262|NCT02302768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110820264|NCT02302768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110820265|NCT02302768|Trace Elements|trace elements|mesh-ancestor
110820266|NCT02302768|Micronutrients|micronutrients|mesh-ancestor
110820267|NCT03921775|Propofol|propofol|mesh-list
110820268|NCT03921775|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110820269|NCT03921775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110820270|NCT03921775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110820271|NCT03921775|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110820272|NCT03921775|Anesthetics, General|anesthetics, general|mesh-ancestor
110820273|NCT03921775|Anesthetics|anesthetics|mesh-ancestor
110820274|NCT01356992|Enoxaparin|enoxaparin|mesh-list
110820275|NCT01356992|Anticoagulants|anticoagulants|mesh-ancestor
110820276|NCT01356992|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110418685|NCT01090323|Deferasirox|deferasirox|mesh-list
110820277|NCT01356992|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110820278|NCT01356992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110820279|NCT01350050|Carticaine|carticaine|mesh-list
110820280|NCT01350050|Anesthetics, Local|anesthetics, local|mesh-ancestor
110820281|NCT01350050|Anesthetics|anesthetics|mesh-ancestor
110820282|NCT01350050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110820283|NCT01350050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110820284|NCT01350050|Sensory System Agents|sensory system agents|mesh-ancestor
110820285|NCT01350050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110820286|NCT03918889|Midazolam|midazolam|mesh-list
110820287|NCT03918889|Dexmedetomidine|dexmedetomidine|mesh-list
110820288|NCT03918889|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110145539|NCT00005853|Etanercept|etanercept|mesh-list
110820289|NCT03918889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110820290|NCT03918889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110820291|NCT03918889|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110820292|NCT03918889|Analgesics|analgesics|mesh-ancestor
110820293|NCT03918889|Sensory System Agents|sensory system agents|mesh-ancestor
110820294|NCT03918889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110820295|NCT03918889|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110820296|NCT03918889|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110820297|NCT03918889|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110820298|NCT03918889|Adrenergic Agents|adrenergic agents|mesh-ancestor
110820299|NCT03918889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110820300|NCT03918889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110820301|NCT03918889|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110820302|NCT03918889|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110820303|NCT03918889|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110820304|NCT03918889|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110820305|NCT03918889|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110820306|NCT03918889|Anesthetics, General|anesthetics, general|mesh-ancestor
110820307|NCT03918889|Anesthetics|anesthetics|mesh-ancestor
110820308|NCT03918889|GABA Modulators|gaba modulators|mesh-ancestor
110820309|NCT03918889|GABA Agents|gaba agents|mesh-ancestor
110820310|NCT02297620|Ipragliflozin|ipragliflozin|mesh-list
110820311|NCT02297620|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110820312|NCT02297620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110820313|NCT02297620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110820314|NCT02297620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110820315|NCT03739801|Irinotecan|irinotecan|mesh-list
110820316|NCT03739801|Ramucirumab|ramucirumab|mesh-list
110820317|NCT03739801|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110820318|NCT03739801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110820319|NCT03739801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110820320|NCT03739801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110820321|NCT03739801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110820322|NCT03512236|Insulin Lispro|insulin lispro|mesh-list
110820323|NCT03512236|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110820324|NCT03512236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110820325|NCT02303002|Botulinum Toxins|botulinum toxins|mesh-list
110820326|NCT02303002|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110820327|NCT02303002|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110820328|NCT02303002|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110820329|NCT02303002|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110820330|NCT02303002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110820331|NCT02303002|Cholinergic Agents|cholinergic agents|mesh-ancestor
110820332|NCT02303002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110820333|NCT02303002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110820334|NCT02303002|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110820335|NCT02303002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110820336|NCT02297854|Valganciclovir|valganciclovir|mesh-list
110820337|NCT02297854|Antiviral Agents|antiviral agents|mesh-ancestor
110820338|NCT02297854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110820339|NCT03511768|Octreotide|octreotide|mesh-list
110820340|NCT03511768|Al18F-NOTA-octreotide|al18f-nota-octreotide|mesh-list
110820341|NCT03511768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110820342|NCT03511768|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110820343|NCT03511768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110820344|NCT03511768|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110820345|NCT03511768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110820346|NCT01134991|Minocycline|minocycline|mesh-list
110820347|NCT01134991|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110820348|NCT01134991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110820349|NCT03515200|Cytarabine|cytarabine|mesh-list
110820350|NCT03515200|Dexamethasone|dexamethasone|mesh-list
110820351|NCT03515200|Hydrocortisone|hydrocortisone|mesh-list
110820352|NCT03515200|Doxorubicin|doxorubicin|mesh-list
110820353|NCT03515200|Methotrexate|methotrexate|mesh-list
110820354|NCT03515200|Bortezomib|bortezomib|mesh-list
110820355|NCT03515200|Dasatinib|dasatinib|mesh-list
110820356|NCT03515200|Palbociclib|palbociclib|mesh-list
110820357|NCT03515200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110820358|NCT03515200|Antiemetics|antiemetics|mesh-ancestor
110820359|NCT03515200|Autonomic Agents|autonomic agents|mesh-ancestor
110820360|NCT03515200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110820361|NCT03515200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110820362|NCT03515200|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110820363|NCT03515200|Glucocorticoids|glucocorticoids|mesh-ancestor
110820364|NCT03515200|Hormones|hormones|mesh-ancestor
110820365|NCT03515200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110820366|NCT03515200|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110820367|NCT03515200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110820368|NCT03515200|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110820369|NCT03515200|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110820370|NCT03515200|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110820371|NCT03515200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110820372|NCT03515200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110820373|NCT03515200|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110820374|NCT03515200|Abortifacient Agents|abortifacient agents|mesh-ancestor
110820375|NCT03515200|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110820376|NCT03515200|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110820378|NCT03515200|Dermatologic Agents|dermatologic agents|mesh-ancestor
110820379|NCT03515200|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110820380|NCT03515200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110820381|NCT03515200|Immunologic Factors|immunologic factors|mesh-ancestor
110820382|NCT03515200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110820383|NCT03515200|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110820384|NCT03515200|Antiviral Agents|antiviral agents|mesh-ancestor
110820385|NCT03515200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110820386|NCT03515200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110820387|NCT03918265|Tacrolimus|tacrolimus|mesh-list
110854420|NCT02490436|Cetuximab|cetuximab|mesh-list
110820388|NCT03918265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110820390|NCT03918265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110820391|NCT03918265|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110820392|NCT03918265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110820393|NCT03918265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110820394|NCT03920839|Paclitaxel|paclitaxel|mesh-list
110820395|NCT03920839|Carboplatin|carboplatin|mesh-list
110820396|NCT03920839|Gemcitabine|gemcitabine|mesh-list
110820397|NCT03920839|Pemetrexed|pemetrexed|mesh-list
110820398|NCT03920839|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110820399|NCT03920839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110820400|NCT03920839|Tubulin Modulators|tubulin modulators|mesh-ancestor
110820401|NCT03920839|Antimitotic Agents|antimitotic agents|mesh-ancestor
110820402|NCT03920839|Mitosis Modulators|mitosis modulators|mesh-ancestor
110820403|NCT03920839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110820404|NCT03920839|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110820405|NCT03920839|Antimetabolites|antimetabolites|mesh-ancestor
110820406|NCT03920839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110820407|NCT03920839|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110820408|NCT03920839|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110820409|NCT02301130|Durvalumab|durvalumab|mesh-list
110820410|NCT02301130|Tremelimumab|tremelimumab|mesh-list
110820411|NCT02301130|Mogamulizumab|mogamulizumab|mesh-list
110820412|NCT02301130|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110820413|NCT02301130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110820414|NCT02301130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110820415|NCT02301130|Immunologic Factors|immunologic factors|mesh-ancestor
110820416|NCT02301130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110820417|NCT03920605|Tenofovir|tenofovir|mesh-list
110820418|NCT03920605|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110820419|NCT03920605|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110820420|NCT03920605|Antiviral Agents|antiviral agents|mesh-ancestor
110820421|NCT03920605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110820422|NCT03920605|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110820423|NCT03920605|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110820424|NCT03920605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110820425|NCT03920605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110820426|NCT03920605|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110820427|NCT03920605|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110820428|NCT02301208|Nedaplatin|nedaplatin|mesh-list
110820429|NCT02301208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110820430|NCT02298010|Capecitabine|capecitabine|mesh-list
110820431|NCT02298010|Oxaliplatin|oxaliplatin|mesh-list
110820432|NCT02298010|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110820433|NCT02298010|Antimetabolites|antimetabolites|mesh-ancestor
110820434|NCT02298010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110820435|NCT02298010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110820436|NCT01229605|Cyclophosphamide|cyclophosphamide|mesh-list
110820437|NCT01229605|Docetaxel|docetaxel|mesh-list
110820438|NCT01229605|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110145680|NCT00386412|Antiviral Agents|antiviral agents|mesh-ancestor
110820439|NCT01229605|Immunologic Factors|immunologic factors|mesh-ancestor
110820440|NCT01229605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110820441|NCT01229605|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110820442|NCT01229605|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110820443|NCT01229605|Alkylating Agents|alkylating agents|mesh-ancestor
110820444|NCT01229605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110820445|NCT01229605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110820446|NCT01229605|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110820447|NCT01229605|Tubulin Modulators|tubulin modulators|mesh-ancestor
110820448|NCT01229605|Antimitotic Agents|antimitotic agents|mesh-ancestor
110820449|NCT01229605|Mitosis Modulators|mitosis modulators|mesh-ancestor
110820450|NCT01319006|Glycine|glycine|mesh-list
110820451|NCT01319006|Glycine Agents|glycine agents|mesh-ancestor
110820452|NCT01319006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110820453|NCT01319006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110820454|NCT01319006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110820455|NCT01358240|Econazole|econazole|mesh-list
110820456|NCT01358240|Antifungal Agents|antifungal agents|mesh-ancestor
110820457|NCT01358240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110820458|NCT01358240|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110820459|NCT01358240|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110820460|NCT01358240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110820461|NCT01358240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110820462|NCT01358240|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110820463|NCT01358240|Hormone Antagonists|hormone antagonists|mesh-ancestor
110820464|NCT01358240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110820465|NCT01358240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110820466|NCT01131949|Lamotrigine|lamotrigine|mesh-list
110820467|NCT01131949|Anticonvulsants|anticonvulsants|mesh-ancestor
110820468|NCT01131949|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110820469|NCT01131949|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110820470|NCT01131949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110820471|NCT01131949|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110820472|NCT01131949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110820474|NCT01131949|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110820475|NCT01131949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110820476|NCT01131949|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110820477|NCT01131949|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110820478|NCT03511222|Pembrolizumab|pembrolizumab|mesh-list
110820479|NCT03511222|Nivolumab|nivolumab|mesh-list
110820480|NCT03511222|Vorolanib|vorolanib|mesh-list
110820481|NCT03511222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110820482|NCT03511222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110538033|NCT02688374|Nicotine|nicotine|mesh-list
110820483|NCT03511222|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110820484|NCT03511222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110820485|NCT03511222|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110820486|NCT03511222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110820487|NCT01230463|Ketorolac|ketorolac|mesh-list
110820488|NCT01230463|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
110820489|NCT01230463|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110820490|NCT01230463|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110820491|NCT01230463|Analgesics|analgesics|mesh-ancestor
110820492|NCT01230463|Sensory System Agents|sensory system agents|mesh-ancestor
110820493|NCT01230463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110820494|NCT01230463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110820495|NCT01230463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110820496|NCT01230463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110820497|NCT01230463|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110820498|NCT01230463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110820499|NCT01230463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110820500|NCT01358396|Chrysarobin|chrysarobin|mesh-list
110820501|NCT01358396|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110820502|NCT01358396|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110820503|NCT01358396|Analgesics|analgesics|mesh-ancestor
110820504|NCT01358396|Sensory System Agents|sensory system agents|mesh-ancestor
110820505|NCT01358396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110820506|NCT01358396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110820507|NCT01358396|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110820508|NCT01358396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110820509|NCT01135615|Calcium|calcium|mesh-list
110820510|NCT01135615|Sevelamer|sevelamer|mesh-list
110820511|NCT01135615|Calcium acetate|calcium acetate|mesh-list
110820512|NCT01135615|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110820513|NCT01135615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110820514|NCT01135615|Chelating Agents|chelating agents|mesh-ancestor
110820515|NCT01135615|Sequestering Agents|sequestering agents|mesh-ancestor
110820516|NCT01135615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110820517|NCT01361516|Anesthetics|anesthetics|mesh-list
110820518|NCT01361516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110820519|NCT01361516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110820520|NCT03920137|Nicotine|nicotine|mesh-list
110820521|NCT03920137|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110820522|NCT03920137|Autonomic Agents|autonomic agents|mesh-ancestor
110820523|NCT03920137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110820524|NCT03920137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110820525|NCT03920137|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110854509|NCT03788681|Estradiol|estradiol|mesh-list
110820526|NCT03920137|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110820527|NCT03920137|Cholinergic Agents|cholinergic agents|mesh-ancestor
110820528|NCT03920137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110820529|NCT03920137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110820530|NCT03132610|Andrographolide|andrographolide|mesh-list
110820531|NCT03132610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110820532|NCT03132610|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110820533|NCT03132610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110820534|NCT03132610|Analgesics|analgesics|mesh-ancestor
110820535|NCT03132610|Sensory System Agents|sensory system agents|mesh-ancestor
110820536|NCT03132610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110820537|NCT03132610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110820538|NCT03132610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110820539|NCT03132610|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110820540|NCT03132610|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110820541|NCT03132610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110820542|NCT03132610|Antiviral Agents|antiviral agents|mesh-ancestor
110820543|NCT03132610|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110820544|NCT02298088|Clopidogrel|clopidogrel|mesh-list
110820545|NCT02298088|Ticagrelor|ticagrelor|mesh-list
110820546|NCT02298088|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110820547|NCT02298088|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110335437|NCT00498953|Immunologic Factors|immunologic factors|mesh-ancestor
110820548|NCT02298088|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110820549|NCT02298088|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110820550|NCT02298088|Purinergic Agents|purinergic agents|mesh-ancestor
110820551|NCT02298088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110820552|NCT02298088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110820553|NCT02298088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110820554|NCT01133119|Bupivacaine|bupivacaine|mesh-list
110820555|NCT01133119|Anesthetics, Local|anesthetics, local|mesh-ancestor
110820556|NCT01133119|Anesthetics|anesthetics|mesh-ancestor
110820557|NCT01133119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110820558|NCT01133119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110820560|NCT01133119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110820561|NCT01230541|Udenafil|udenafil|mesh-list
110820562|NCT01230541|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110820563|NCT01230541|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110820564|NCT01230541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110820565|NCT01230541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110820566|NCT01229761|Trimethoprim|trimethoprim|mesh-list
110820567|NCT01229761|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
110820568|NCT01229761|Sulfamethoxazole|sulfamethoxazole|mesh-list
110820569|NCT01229761|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110820570|NCT01229761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110820571|NCT01229761|Antimalarials|antimalarials|mesh-ancestor
110820572|NCT01229761|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110820573|NCT01229761|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110820574|NCT01229761|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110820575|NCT01229761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110820576|NCT01229761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110820577|NCT01229761|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110820578|NCT01229761|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
110820579|NCT01229761|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110820580|NCT01229761|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110820581|NCT01229839|Ethiodized Oil|ethiodized oil|mesh-list
110820582|NCT01229839|Antineoplastic Agents|antineoplastic agents|mesh-list
110820583|NCT03514810|Ketoprofen|ketoprofen|mesh-list
110820584|NCT03514810|Sertraline|sertraline|mesh-list
110820585|NCT03514810|Antidepressive Agents|antidepressive agents|mesh-ancestor
110820586|NCT03514810|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110820587|NCT03514810|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110820588|NCT03514810|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110820589|NCT03514810|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110820590|NCT03514810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110820591|NCT03514810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110820592|NCT03514810|Serotonin Agents|serotonin agents|mesh-ancestor
110820593|NCT03514810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110820594|NCT03514810|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110820595|NCT03514810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110820596|NCT03514810|Analgesics|analgesics|mesh-ancestor
110820597|NCT03514810|Sensory System Agents|sensory system agents|mesh-ancestor
110820598|NCT03514810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110820599|NCT03514810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110820600|NCT03514810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110820601|NCT03514810|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110820602|NCT03514810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110820603|NCT02301676|Dexmedetomidine|dexmedetomidine|mesh-list
110820604|NCT02301676|Propofol|propofol|mesh-list
110820605|NCT02301676|Sevoflurane|sevoflurane|mesh-list
110820606|NCT02301676|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110820607|NCT02301676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110820608|NCT02301676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110820609|NCT02301676|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110820610|NCT02301676|Analgesics|analgesics|mesh-ancestor
110820611|NCT02301676|Sensory System Agents|sensory system agents|mesh-ancestor
110820612|NCT02301676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110820613|NCT02301676|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110820614|NCT02301676|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110820615|NCT02301676|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110820616|NCT02301676|Adrenergic Agents|adrenergic agents|mesh-ancestor
110820617|NCT02301676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110194523|NCT00067509|Progesterone|progesterone|mesh-list
110820618|NCT02301676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110820619|NCT02301676|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110820620|NCT02301676|Anesthetics, General|anesthetics, general|mesh-ancestor
110820621|NCT02301676|Anesthetics|anesthetics|mesh-ancestor
110820622|NCT02301676|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110820623|NCT02301676|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110820624|NCT01135771|Insulin|insulin|mesh-list
110820625|NCT01135771|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110820626|NCT01135771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110820627|NCT01133353|Tetrabenazine|tetrabenazine|mesh-list
110820628|NCT01133353|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110538168|NCT02687984|Dopamine Agents|dopamine agents|mesh-ancestor
110820629|NCT01133353|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110820630|NCT01133353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110820631|NCT01133353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110820632|NCT01133353|Adrenergic Agents|adrenergic agents|mesh-ancestor
110820633|NCT01133353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110820634|NCT01133353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110820635|NCT01135927|Insulin|insulin|mesh-list
110820636|NCT01135927|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110820637|NCT01135927|Insulin Detemir|insulin detemir|mesh-list
110820638|NCT01135927|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110820639|NCT01135927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110820640|NCT02301910|Tenecteplase|tenecteplase|mesh-list
110820641|NCT02301910|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110820642|NCT02301910|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110820643|NCT02301910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110820644|NCT01585753|Maraviroc|maraviroc|mesh-list
110820645|NCT01585753|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110820646|NCT01585753|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110820647|NCT01585753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110820648|NCT01585753|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110820649|NCT01585753|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110820650|NCT01585753|Antiviral Agents|antiviral agents|mesh-ancestor
110820651|NCT01585753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110820652|NCT01585753|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
110820653|NCT01136005|Provitamins|provitamins|mesh-list
110820654|NCT01136005|Vitamins|vitamins|mesh-ancestor
110820655|NCT01136005|Micronutrients|micronutrients|mesh-ancestor
110820656|NCT01136005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110820657|NCT03509740|Acetaminophen|acetaminophen|mesh-list
110820658|NCT03509740|Tramadol|tramadol|mesh-list
110820659|NCT03509740|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110820660|NCT03509740|Analgesics|analgesics|mesh-ancestor
110820661|NCT03509740|Sensory System Agents|sensory system agents|mesh-ancestor
110820662|NCT03509740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110820663|NCT03509740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110820664|NCT03509740|Antipyretics|antipyretics|mesh-ancestor
110820665|NCT03509740|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110820666|NCT03509740|Narcotics|narcotics|mesh-ancestor
110820667|NCT03509740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110820668|NCT03918187|Midazolam|midazolam|mesh-list
110820669|NCT03918187|Nalbuphine|nalbuphine|mesh-list
110820670|NCT03918187|Bupivacaine|bupivacaine|mesh-list
110820671|NCT03918187|Anesthetics, Local|anesthetics, local|mesh-ancestor
110820672|NCT03918187|Anesthetics|anesthetics|mesh-ancestor
110820673|NCT03918187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110820674|NCT03918187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110820675|NCT03918187|Sensory System Agents|sensory system agents|mesh-ancestor
110820676|NCT03918187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110820677|NCT03918187|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110820678|NCT03918187|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110820679|NCT03918187|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110820680|NCT03918187|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110820681|NCT03918187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110820682|NCT03918187|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110820683|NCT03918187|Anesthetics, General|anesthetics, general|mesh-ancestor
110820684|NCT03918187|GABA Modulators|gaba modulators|mesh-ancestor
110820685|NCT03918187|GABA Agents|gaba agents|mesh-ancestor
110820686|NCT03918187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110820687|NCT03918187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110820688|NCT03918187|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110820689|NCT03918187|Narcotics|narcotics|mesh-ancestor
110820690|NCT03918187|Analgesics|analgesics|mesh-ancestor
110820691|NCT03507634|Lidocaine|lidocaine|mesh-list
110820692|NCT03507634|Fentanyl|fentanyl|mesh-list
110820693|NCT03507634|Dexmedetomidine|dexmedetomidine|mesh-list
110820694|NCT03507634|Remifentanil|remifentanil|mesh-list
110820695|NCT03507634|Analgesics, Opioid|analgesics, opioid|mesh-list
110820696|NCT03507634|Anesthetics|anesthetics|mesh-list
110820697|NCT03507634|Anesthetics, Local|anesthetics, local|mesh-ancestor
110820698|NCT03507634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110820699|NCT03507634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110820700|NCT03507634|Sensory System Agents|sensory system agents|mesh-ancestor
110820701|NCT03507634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110820702|NCT03507634|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110820703|NCT03507634|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110538253|NCT02684708|Prednisone|prednisone|mesh-list
110820704|NCT03507634|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110820705|NCT03507634|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110854543|NCT03790085|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110820706|NCT03507634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110820707|NCT03507634|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110820708|NCT03507634|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110820709|NCT03507634|Analgesics|analgesics|mesh-ancestor
110820710|NCT03507634|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110820711|NCT03507634|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110820712|NCT03507634|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110820713|NCT03507634|Adrenergic Agents|adrenergic agents|mesh-ancestor
110820714|NCT03507634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110820715|NCT03507634|Narcotics|narcotics|mesh-ancestor
110820716|NCT03507634|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110820717|NCT03507634|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110820718|NCT03507634|Anesthetics, General|anesthetics, general|mesh-ancestor
110820719|NCT03507556|Metronidazole|metronidazole|mesh-list
110820720|NCT03507556|Ciprofloxacin|ciprofloxacin|mesh-list
110820721|NCT03507556|Minocycline|minocycline|mesh-list
110820722|NCT03507556|Zinc Oxide|zinc oxide|mesh-list
110820723|NCT03507556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110820724|NCT03507556|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110820725|NCT03507556|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110820726|NCT03507556|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110820727|NCT03507556|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110820728|NCT03507556|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110820729|NCT03507556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110820730|NCT03507556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110820731|NCT03507556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110820732|NCT03507556|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110820733|NCT03507556|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110820734|NCT03507556|Dermatologic Agents|dermatologic agents|mesh-ancestor
110820735|NCT03507556|Sunscreening Agents|sunscreening agents|mesh-ancestor
110820736|NCT03507556|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110820737|NCT03507556|Protective Agents|protective agents|mesh-ancestor
110820738|NCT03507556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110820739|NCT01232257|Acetylcysteine|acetylcysteine|mesh-list
110820740|NCT01232257|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110820741|NCT01232257|Antiviral Agents|antiviral agents|mesh-ancestor
110820742|NCT01232257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110820743|NCT01232257|Expectorants|expectorants|mesh-ancestor
110820744|NCT01232257|Respiratory System Agents|respiratory system agents|mesh-ancestor
110820745|NCT01232257|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110820746|NCT01232257|Antioxidants|antioxidants|mesh-ancestor
110820747|NCT01232257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110820748|NCT01232257|Protective Agents|protective agents|mesh-ancestor
110820749|NCT01232257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110820750|NCT01232257|Antidotes|antidotes|mesh-ancestor
110820751|NCT03509662|Ascorbic Acid|ascorbic acid|mesh-list
110820753|NCT03509662|Vitamins|vitamins|mesh-ancestor
110820754|NCT03509662|Micronutrients|micronutrients|mesh-ancestor
110820755|NCT03509662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110820756|NCT03509662|Antioxidants|antioxidants|mesh-ancestor
110820757|NCT03509662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110820758|NCT03509662|Protective Agents|protective agents|mesh-ancestor
110820759|NCT03509662|Vitamin B Complex|vitamin b complex|mesh-ancestor
110820760|NCT03504982|Moxifloxacin|moxifloxacin|mesh-list
110820761|NCT03504982|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110820762|NCT03504982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110820763|NCT03504982|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110820764|NCT03504982|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110820765|NCT03504982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110820766|NCT03504982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110820767|NCT03504982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110820768|NCT01133431|Glimepiride|glimepiride|mesh-list
110820769|NCT01133431|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110820770|NCT01133431|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110820771|NCT01133431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110820772|NCT01133431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110820773|NCT01133431|Immunologic Factors|immunologic factors|mesh-ancestor
110820774|NCT05610007|Prilocaine|prilocaine|mesh-list
110820775|NCT05610007|Anesthetics, Local|anesthetics, local|mesh-ancestor
110820776|NCT05610007|Anesthetics|anesthetics|mesh-ancestor
110820777|NCT05610007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110820778|NCT05610007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110820779|NCT05610007|Sensory System Agents|sensory system agents|mesh-ancestor
110820780|NCT05610007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110538319|NCT02811341|Scopolamine|scopolamine|mesh-list
110820781|NCT01232413|Ipragliflozin|ipragliflozin|mesh-list
110820782|NCT01232413|Moxifloxacin|moxifloxacin|mesh-list
110820783|NCT01232413|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110820784|NCT01232413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110820785|NCT01232413|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110820786|NCT01232413|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110820787|NCT01232413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110820788|NCT01232413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110820789|NCT01232413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110820790|NCT01232413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110820791|NCT01232413|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110820792|NCT01232413|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110820793|NCT02303782|Azacitidine|azacitidine|mesh-list
110820794|NCT02303782|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110820795|NCT02303782|Antimetabolites|antimetabolites|mesh-ancestor
110820796|NCT02303782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110820797|NCT02303782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110820798|NCT02303782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110820799|NCT01233505|Capecitabine|capecitabine|mesh-list
110820800|NCT01233505|Oxaliplatin|oxaliplatin|mesh-list
110820802|NCT01233505|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110820803|NCT01233505|Antimetabolites|antimetabolites|mesh-ancestor
110820804|NCT01233505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110820805|NCT01233505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110820806|NCT01233505|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110820807|NCT01233505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110820808|NCT04925180|Cyproterone Acetate|cyproterone acetate|mesh-list
110820809|NCT04925180|Cyproterone|cyproterone|mesh-list
110820811|NCT04925180|Hormone Antagonists|hormone antagonists|mesh-ancestor
110820812|NCT04925180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110820813|NCT04925180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110820814|NCT04925180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110820815|NCT04925180|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110820816|NCT04925180|Contraceptive Agents|contraceptive agents|mesh-ancestor
110820817|NCT04925180|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110820818|NCT01133509|Vaccines|vaccines|mesh-list
110820819|NCT01133509|Immunologic Factors|immunologic factors|mesh-ancestor
110820820|NCT01133509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110820821|NCT02306902|Fenofibrate|fenofibrate|mesh-list
110820822|NCT02306902|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110820823|NCT02306902|Antimetabolites|antimetabolites|mesh-ancestor
110820824|NCT02306902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110820825|NCT02306902|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110820826|NCT01230697|Sorafenib|sorafenib|mesh-list
110820827|NCT01230697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110820828|NCT01230697|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110820829|NCT01230697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110820830|NCT01230697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110820831|NCT01361984|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110820832|NCT01361984|Formoterol Fumarate|formoterol fumarate|mesh-list
110820833|NCT01361984|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110820834|NCT01361984|Autonomic Agents|autonomic agents|mesh-ancestor
110820835|NCT01361984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110820836|NCT01361984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110820837|NCT01361984|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110820838|NCT01361984|Respiratory System Agents|respiratory system agents|mesh-ancestor
110820839|NCT01361984|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110820840|NCT01361984|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110820841|NCT01361984|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110820842|NCT01361984|Adrenergic Agents|adrenergic agents|mesh-ancestor
110820843|NCT01361984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110820844|NCT01361984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110820845|NCT01230775|Anagrelide|anagrelide|mesh-list
110820846|NCT01230775|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110820847|NCT01230775|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110820848|NCT01230775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110820849|NCT01230775|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110820850|NCT01136317|Omeprazole|omeprazole|mesh-list
110820851|NCT01136317|Rabeprazole|rabeprazole|mesh-list
110820852|NCT01136317|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110820853|NCT01136317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110820854|NCT01136317|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110820855|NCT01136317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110820856|NCT01136317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110820857|NCT03507244|Dexamethasone|dexamethasone|mesh-list
110820858|NCT03507244|Pemetrexed|pemetrexed|mesh-list
110820859|NCT03507244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110820860|NCT03507244|Antiemetics|antiemetics|mesh-ancestor
110820861|NCT03507244|Autonomic Agents|autonomic agents|mesh-ancestor
110820862|NCT03507244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110820863|NCT03507244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110820864|NCT03507244|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110820865|NCT03507244|Glucocorticoids|glucocorticoids|mesh-ancestor
110820866|NCT03507244|Hormones|hormones|mesh-ancestor
110820867|NCT03507244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110820868|NCT03507244|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110820869|NCT03507244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110820870|NCT03507244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110820871|NCT03507244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110820872|NCT03507244|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110820873|NCT03507244|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110820874|NCT01136395|Rituximab|rituximab|mesh-list
110820875|NCT01136395|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110820876|NCT01136395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110820877|NCT01136395|Immunologic Factors|immunologic factors|mesh-ancestor
110820878|NCT01136395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110820879|NCT01136395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110820880|NCT02304094|Methylprednisolone|methylprednisolone|mesh-list
110820881|NCT02304094|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110820882|NCT02304094|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110820884|NCT02304094|Prednisolone acetate|prednisolone acetate|mesh-list
110820885|NCT02304094|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110820886|NCT02304094|Prednisolone phosphate|prednisolone phosphate|mesh-list
110820887|NCT02304094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110820888|NCT02304094|Antiemetics|antiemetics|mesh-ancestor
110820889|NCT02304094|Autonomic Agents|autonomic agents|mesh-ancestor
110820890|NCT02304094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110820891|NCT02304094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110820892|NCT02304094|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110820894|NCT02304094|Hormones|hormones|mesh-ancestor
110820895|NCT02304094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110820896|NCT02304094|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110820897|NCT02304094|Protective Agents|protective agents|mesh-ancestor
110820898|NCT02304094|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110820899|NCT02304094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110820900|NCT03507166|Trastuzumab|trastuzumab|mesh-list
110820901|NCT03507166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110820902|NCT03507166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110820903|NCT01233583|Adalimumab|adalimumab|mesh-list
110820904|NCT01233583|Infliximab|infliximab|mesh-list
110820905|NCT01233583|Etanercept|etanercept|mesh-list
110820906|NCT01233583|Acitretin|acitretin|mesh-list
110820907|NCT01233583|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110820908|NCT01233583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110820909|NCT01233583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110820910|NCT01233583|Dermatologic Agents|dermatologic agents|mesh-ancestor
110820911|NCT01233583|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110820912|NCT01233583|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110820913|NCT01233583|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110820914|NCT01233583|Analgesics|analgesics|mesh-ancestor
110820915|NCT01233583|Sensory System Agents|sensory system agents|mesh-ancestor
110820916|NCT01233583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110820917|NCT01233583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110820918|NCT01233583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110820919|NCT01233583|Immunologic Factors|immunologic factors|mesh-ancestor
110820920|NCT01233583|Keratolytic Agents|keratolytic agents|mesh-ancestor
110820921|NCT02304250|Dexamethasone|dexamethasone|mesh-list
110820922|NCT02304250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110820923|NCT02304250|Antiemetics|antiemetics|mesh-ancestor
110820924|NCT02304250|Autonomic Agents|autonomic agents|mesh-ancestor
110820925|NCT02304250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110820926|NCT02304250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110820927|NCT02304250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110820928|NCT02304250|Glucocorticoids|glucocorticoids|mesh-ancestor
110820929|NCT02304250|Hormones|hormones|mesh-ancestor
110538466|NCT02812979|Albuterol|albuterol|mesh-list
110820930|NCT02304250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110820932|NCT02304250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110820933|NCT01136551|Huperzine A|huperzine a|mesh-list
110820934|NCT01136551|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110820935|NCT01136551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110820936|NCT01136551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110820937|NCT01136551|Cholinergic Agents|cholinergic agents|mesh-ancestor
110820938|NCT01136551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110820939|NCT01136551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110820940|NCT01136551|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110820941|NCT01136551|Protective Agents|protective agents|mesh-ancestor
110820942|NCT03132142|Cinnamaldehyde|cinnamaldehyde|mesh-list
110820943|NCT03132142|Capsaicin|capsaicin|mesh-list
110820944|NCT03132142|Menthol|menthol|mesh-list
110820945|NCT03132142|Antipruritics|antipruritics|mesh-ancestor
110820946|NCT03132142|Dermatologic Agents|dermatologic agents|mesh-ancestor
110820947|NCT03132142|Sensory System Agents|sensory system agents|mesh-ancestor
110820948|NCT03132142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110820949|NCT03132142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110820950|NCT03132142|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110820951|NCT03132142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110820952|NCT03132142|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
110820953|NCT03132142|Protective Agents|protective agents|mesh-ancestor
110820954|NCT01232647|Vitamins|vitamins|mesh-list
110820955|NCT01232647|Vitamin K|vitamin k|mesh-list
110820956|NCT01232647|Vitamin K 2|vitamin k 2|mesh-list
110820957|NCT01232647|Vitamin K 1|vitamin k 1|mesh-list
110820958|NCT01232647|Menatetrenone|menatetrenone|mesh-list
110820959|NCT01232647|Micronutrients|micronutrients|mesh-ancestor
110820960|NCT01232647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110820961|NCT01232647|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110820962|NCT01232647|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110820963|NCT01232647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110820964|NCT01232647|Hemostatics|hemostatics|mesh-ancestor
110820965|NCT01232647|Coagulants|coagulants|mesh-ancestor
110820966|NCT03917095|Mesalamine|mesalamine|mesh-list
110820967|NCT03917095|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110820968|NCT03917095|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110820969|NCT03917095|Analgesics|analgesics|mesh-ancestor
110820970|NCT03917095|Sensory System Agents|sensory system agents|mesh-ancestor
110820971|NCT03917095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110820972|NCT03917095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110820973|NCT03917095|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110820974|NCT03917095|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110820975|NCT01133743|Thalidomide|thalidomide|mesh-list
110820976|NCT01133743|Dexamethasone|dexamethasone|mesh-list
110820977|NCT01133743|Lenalidomide|lenalidomide|mesh-list
110820978|NCT01133743|Immunomodulating Agents|immunomodulating agents|mesh-list
110820979|NCT01133743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110820980|NCT01133743|Antiemetics|antiemetics|mesh-ancestor
110820981|NCT01133743|Autonomic Agents|autonomic agents|mesh-ancestor
110820982|NCT01133743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110820983|NCT01133743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110820984|NCT01133743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110820985|NCT01133743|Glucocorticoids|glucocorticoids|mesh-ancestor
110820986|NCT01133743|Hormones|hormones|mesh-ancestor
110820987|NCT01133743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110820988|NCT01133743|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110820989|NCT01133743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110820990|NCT01133743|Immunologic Factors|immunologic factors|mesh-ancestor
110820991|NCT01133743|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110820992|NCT01133743|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110820993|NCT01133743|Growth Substances|growth substances|mesh-ancestor
110820994|NCT01133743|Growth Inhibitors|growth inhibitors|mesh-ancestor
110820995|NCT01133743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110820996|NCT01133743|Leprostatic Agents|leprostatic agents|mesh-ancestor
110820997|NCT01133743|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110820998|NCT01133743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110820999|NCT01138423|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110821000|NCT01138423|Moxonidine|moxonidine|mesh-list
110821001|NCT01138423|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110821002|NCT01138423|Diuretics|diuretics|mesh-ancestor
110538545|NCT02812355|Heparin|heparin|mesh-list
110821003|NCT01138423|Natriuretic Agents|natriuretic agents|mesh-ancestor
110821004|NCT01138423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110821005|NCT01138423|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110821006|NCT01138423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110821007|NCT01138423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110821008|NCT01136863|Felodipine|felodipine|mesh-list
110821009|NCT01136863|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110821010|NCT01136863|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110821011|NCT01136863|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110821012|NCT01136863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110821013|NCT01136863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110821014|NCT01136863|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110854627|NCT02486848|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110821015|NCT01136863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110821017|NCT03961516|Pancrelipase|pancrelipase|mesh-list
110821018|NCT03961516|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110821019|NCT03508882|Botulinum Toxins|botulinum toxins|mesh-list
110821020|NCT03508882|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110821021|NCT03508882|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110821022|NCT03508882|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110821023|NCT03508882|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110821024|NCT03508882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110821025|NCT03508882|Cholinergic Agents|cholinergic agents|mesh-ancestor
110821026|NCT03508882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110821027|NCT03508882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110821028|NCT03508882|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110821029|NCT03508882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110821030|NCT05553145|Antibodies|antibodies|mesh-list
110821031|NCT05553145|Autoantibodies|autoantibodies|mesh-list
110821032|NCT05553145|Immunologic Factors|immunologic factors|mesh-ancestor
110821033|NCT05553145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110821034|NCT03504280|Cholecalciferol|cholecalciferol|mesh-list
110821035|NCT03504280|Vitamin D|vitamin d|mesh-list
110821036|NCT03504280|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110821037|NCT03504280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110821038|NCT03504280|Vitamins|vitamins|mesh-ancestor
110821039|NCT03504280|Micronutrients|micronutrients|mesh-ancestor
110821040|NCT03504280|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110821041|NCT03504202|Trimetazidine|trimetazidine|mesh-list
110821042|NCT03504202|Vasodilator Agents|vasodilator agents|mesh-ancestor
110821043|NCT01136941|Zileuton|zileuton|mesh-list
110821044|NCT01136941|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110821045|NCT01136941|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110821046|NCT01136941|Analgesics|analgesics|mesh-ancestor
110821047|NCT01136941|Sensory System Agents|sensory system agents|mesh-ancestor
110821048|NCT01136941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110821049|NCT01136941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110821050|NCT01136941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110821051|NCT01136941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110821052|NCT01136941|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
110821053|NCT01136941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110821054|NCT01136941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110821055|NCT01136941|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110821056|NCT01136941|Hormone Antagonists|hormone antagonists|mesh-ancestor
110821057|NCT01136941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110821058|NCT01232803|Tenofovir|tenofovir|mesh-list
110821059|NCT01232803|Antiviral Agents|antiviral agents|mesh-ancestor
110821060|NCT01232803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110821061|NCT01232803|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110821062|NCT01232803|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110821063|NCT01232803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110821064|NCT01232803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110821065|NCT01232803|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110821066|NCT01232803|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110821067|NCT03504046|Pancrelipase|pancrelipase|mesh-list
110821068|NCT03504046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110821069|NCT01139203|Lamivudine|lamivudine|mesh-list
110821070|NCT01139203|Adefovir|adefovir|mesh-list
110821071|NCT01139203|Entecavir|entecavir|mesh-list
110821072|NCT01139203|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110821073|NCT01139203|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110821074|NCT01139203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110821075|NCT01139203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110821076|NCT01139203|Antiviral Agents|antiviral agents|mesh-ancestor
110821077|NCT01139203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110821078|NCT01139203|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110821079|NCT01139203|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110821080|NCT05187715|Simvastatin|simvastatin|mesh-list
110821081|NCT05187715|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110821082|NCT05187715|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110821083|NCT05187715|Antimetabolites|antimetabolites|mesh-ancestor
110821084|NCT05187715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110821085|NCT05187715|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110821086|NCT05187715|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110821087|NCT05187715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110821088|NCT02312440|Tranexamic Acid|tranexamic acid|mesh-list
110821089|NCT02312440|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110821090|NCT02312440|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110821091|NCT02312440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110821093|NCT02312440|Coagulants|coagulants|mesh-ancestor
110821094|NCT01137019|Everolimus|everolimus|mesh-list
110821095|NCT01137019|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110821096|NCT01137019|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110821097|NCT01137019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110821098|NCT01137019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110821099|NCT01137019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110821100|NCT01137019|Immunologic Factors|immunologic factors|mesh-ancestor
110821101|NCT01137019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110821102|NCT01137019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110821103|NCT03508804|Lidocaine|lidocaine|mesh-list
110821104|NCT03508804|Prilocaine|prilocaine|mesh-list
110821105|NCT03508804|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
110821106|NCT03508804|Anesthetics, Local|anesthetics, local|mesh-ancestor
110821107|NCT03508804|Anesthetics|anesthetics|mesh-ancestor
110821108|NCT03508804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110821109|NCT03508804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110821110|NCT03508804|Sensory System Agents|sensory system agents|mesh-ancestor
110821111|NCT03508804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110821112|NCT03508804|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110821113|NCT03508804|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110821114|NCT03508804|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110821115|NCT03508804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110821116|NCT03508804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110821117|NCT03508804|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
110821119|NCT01231165|Amiloride|amiloride|mesh-list
110821120|NCT01231165|Clopidogrel|clopidogrel|mesh-list
110821121|NCT01231165|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
110821122|NCT01231165|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110821123|NCT01231165|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110821124|NCT01231165|Analgesics|analgesics|mesh-ancestor
110821125|NCT01231165|Sensory System Agents|sensory system agents|mesh-ancestor
110821126|NCT01231165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110821127|NCT01231165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110821128|NCT01231165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110821129|NCT01231165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110821130|NCT01231165|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110821131|NCT01231165|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110821132|NCT01231165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110821133|NCT01231165|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110821134|NCT01231165|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110821135|NCT01231165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110821137|NCT01231165|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110821138|NCT01231165|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110821139|NCT01231165|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110821140|NCT01231165|Purinergic Agents|purinergic agents|mesh-ancestor
110821141|NCT01231165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110821142|NCT01231165|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110821143|NCT01231165|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110821144|NCT01231165|Antimetabolites|antimetabolites|mesh-ancestor
110821145|NCT01231165|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110821146|NCT01231165|Diuretics|diuretics|mesh-ancestor
110821147|NCT01231165|Natriuretic Agents|natriuretic agents|mesh-ancestor
110821148|NCT01231165|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
110821149|NCT01231165|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110821150|NCT01231165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110821151|NCT01231165|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
110821152|NCT01231165|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110821153|NCT01231243|Hydrogen Peroxide|hydrogen peroxide|mesh-list
110821154|NCT01231243|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110821155|NCT01231243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110821156|NCT03503890|Rovalpituzumab tesirine|rovalpituzumab tesirine|mesh-list
110821157|NCT03503890|Immunoconjugates|immunoconjugates|mesh-ancestor
110821158|NCT03503890|Immunologic Factors|immunologic factors|mesh-ancestor
110821159|NCT03503890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110821160|NCT01233895|Bortezomib|bortezomib|mesh-list
110821161|NCT01233895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110821162|NCT05221645|Rituximab|rituximab|mesh-list
110821163|NCT05221645|Pembrolizumab|pembrolizumab|mesh-list
110821164|NCT05221645|Carboplatin|carboplatin|mesh-list
110821165|NCT05221645|Etoposide|etoposide|mesh-list
110821166|NCT05221645|Ifosfamide|ifosfamide|mesh-list
110821167|NCT05221645|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110821168|NCT05221645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110821169|NCT05221645|Immunologic Factors|immunologic factors|mesh-ancestor
110821170|NCT05221645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110821171|NCT05221645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110821172|NCT05221645|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110821173|NCT05221645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110821174|NCT05221645|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110821175|NCT05221645|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110821176|NCT05221645|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110821177|NCT05221645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110821178|NCT05221645|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110821180|NCT03506620|Ropivacaine|ropivacaine|mesh-list
110821181|NCT03506620|Anesthetics, Local|anesthetics, local|mesh-ancestor
110821182|NCT03506620|Anesthetics|anesthetics|mesh-ancestor
110418740|NCT01198548|Leucovorin|leucovorin|mesh-list
110821183|NCT03506620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110821184|NCT03506620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110821185|NCT03506620|Sensory System Agents|sensory system agents|mesh-ancestor
110821186|NCT03506620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110821187|NCT02305030|Opicapone|opicapone|mesh-list
110821188|NCT02305030|Warfarin|warfarin|mesh-list
110821189|NCT02305030|Anticoagulants|anticoagulants|mesh-ancestor
110821190|NCT02305030|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
110821191|NCT02305030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110821192|NCT02305030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110821193|NCT02305030|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110821194|NCT02305030|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110821195|NCT01139437|Vaccines|vaccines|mesh-list
110821196|NCT01139437|Immunologic Factors|immunologic factors|mesh-ancestor
110821197|NCT01139437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110821198|NCT01137253|Trimethaphan|trimethaphan|mesh-list
110821199|NCT01137253|Trimethaphan camsylate|trimethaphan camsylate|mesh-list
110821200|NCT01137253|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110821201|NCT01137253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110821202|NCT01137253|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
110821203|NCT01137253|Autonomic Agents|autonomic agents|mesh-ancestor
110821204|NCT01137253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110821205|NCT01137253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110821206|NCT01137253|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
110821207|NCT01137253|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110821208|NCT01137253|Cholinergic Agents|cholinergic agents|mesh-ancestor
110821209|NCT01137253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110821210|NCT01137253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110821211|NCT01137253|Vasodilator Agents|vasodilator agents|mesh-ancestor
110821212|NCT05493163|Fibrinolytic Agents|fibrinolytic agents|mesh-list
110821213|NCT05493163|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110821214|NCT05493163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110821215|NCT03506542|Mitomycins|mitomycins|mesh-list
110821216|NCT03506542|Mitomycin|mitomycin|mesh-list
110821217|NCT03506542|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110821218|NCT03506542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110821219|NCT03506542|Alkylating Agents|alkylating agents|mesh-ancestor
110821220|NCT03506542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110821221|NCT03506542|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110821222|NCT03506542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110821223|NCT02305186|Pembrolizumab|pembrolizumab|mesh-list
110821224|NCT02305186|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110821225|NCT02305186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110821226|NCT02305186|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110821227|NCT02305186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110821228|NCT02312908|Clonazepam|clonazepam|mesh-list
110821229|NCT02312908|Anticonvulsants|anticonvulsants|mesh-ancestor
110821230|NCT02312908|GABA Modulators|gaba modulators|mesh-ancestor
110821231|NCT02312908|GABA Agents|gaba agents|mesh-ancestor
110821232|NCT02312908|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110821233|NCT02312908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110854695|NCT03321292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110821234|NCT02312908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110821235|NCT02308930|Vitamin D|vitamin d|mesh-list
110821236|NCT02308930|Vitamins|vitamins|mesh-list
110821237|NCT02308930|Vitamin A|vitamin a|mesh-list
110821238|NCT02308930|Retinol palmitate|retinol palmitate|mesh-list
110821239|NCT02308930|Micronutrients|micronutrients|mesh-ancestor
110821240|NCT02308930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110821241|NCT02308930|Antioxidants|antioxidants|mesh-ancestor
110821242|NCT02308930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110821243|NCT02308930|Protective Agents|protective agents|mesh-ancestor
110821244|NCT02308930|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110821245|NCT02308930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110821246|NCT02308930|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110821247|NCT01139671|Remifentanil|remifentanil|mesh-list
110821248|NCT01139671|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110821249|NCT01139671|Narcotics|narcotics|mesh-ancestor
110821250|NCT01139671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110821251|NCT01139671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110821252|NCT01139671|Analgesics|analgesics|mesh-ancestor
110821253|NCT01139671|Sensory System Agents|sensory system agents|mesh-ancestor
110821254|NCT01139671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110821256|NCT02313064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110821257|NCT05088889|Nivolumab|nivolumab|mesh-list
110821258|NCT05088889|Ipilimumab|ipilimumab|mesh-list
110821259|NCT05088889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110821260|NCT05088889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110821261|NCT05088889|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110821262|NCT05088889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110821263|NCT01234051|Docetaxel|docetaxel|mesh-list
110821264|NCT01234051|Oxaliplatin|oxaliplatin|mesh-list
110821265|NCT01234051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110821266|NCT01234051|Tubulin Modulators|tubulin modulators|mesh-ancestor
110821267|NCT01234051|Antimitotic Agents|antimitotic agents|mesh-ancestor
110821268|NCT01234051|Mitosis Modulators|mitosis modulators|mesh-ancestor
110821269|NCT01234051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110821270|NCT03341962|Calcium|calcium|mesh-list
110821271|NCT03341962|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110821272|NCT03341962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110821273|NCT01234597|Insulin|insulin|mesh-list
110821274|NCT01234597|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110821275|NCT01234597|Insulin Glargine|insulin glargine|mesh-list
110821276|NCT01234597|Insulin glulisine|insulin glulisine|mesh-list
110821277|NCT01234597|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110821278|NCT01234597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110821279|NCT02313220|Dapagliflozin|dapagliflozin|mesh-list
110821280|NCT02313220|Exenatide|exenatide|mesh-list
110821281|NCT02313220|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110821282|NCT02313220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110821283|NCT02313220|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110821284|NCT02313220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110821285|NCT02313220|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110821286|NCT02313220|Incretins|incretins|mesh-ancestor
110821287|NCT02313220|Hormones|hormones|mesh-ancestor
110821288|NCT02313220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110821289|NCT02309320|Gontivimab|gontivimab|mesh-list
110821290|NCT02309320|Antiviral Agents|antiviral agents|mesh-ancestor
110821291|NCT02309320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110821292|NCT01139749|Salicylic Acid|salicylic acid|mesh-list
110821293|NCT01139749|Ciclopirox|ciclopirox|mesh-list
110821294|NCT01139749|Salicylates|salicylates|mesh-list
110821295|NCT01139749|Isotretinoin|isotretinoin|mesh-list
110821296|NCT01139749|Dermatologic Agents|dermatologic agents|mesh-ancestor
110821297|NCT01139749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110821298|NCT01139749|Antifungal Agents|antifungal agents|mesh-ancestor
110821299|NCT01139749|Keratolytic Agents|keratolytic agents|mesh-ancestor
110821300|NCT01139749|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110821301|NCT01139749|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110821302|NCT01139749|Analgesics|analgesics|mesh-ancestor
110821303|NCT01139749|Sensory System Agents|sensory system agents|mesh-ancestor
110821304|NCT01139749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110821305|NCT01139749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110821306|NCT01139749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110821307|NCT01139749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110821308|NCT01139749|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110821309|NCT01139749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110821310|NCT01139749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110821311|NCT02305810|Everolimus|everolimus|mesh-list
110821312|NCT02305810|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110821313|NCT02305810|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110821314|NCT02305810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110821315|NCT02305810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110821316|NCT02305810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110821317|NCT02305810|Immunologic Factors|immunologic factors|mesh-ancestor
110821318|NCT02305810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110821319|NCT02305810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110821320|NCT01142869|Cetuximab|cetuximab|mesh-list
110821321|NCT01142869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110821322|NCT01142869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110821323|NCT01139905|Ritonavir|ritonavir|mesh-list
110821324|NCT01139905|Lopinavir|lopinavir|mesh-list
110821325|NCT01139905|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110821326|NCT01139905|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110821327|NCT01139905|Protease Inhibitors|protease inhibitors|mesh-ancestor
110821328|NCT01139905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110821329|NCT01139905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110821330|NCT01139905|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110821331|NCT01139905|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110821332|NCT01139905|Antiviral Agents|antiviral agents|mesh-ancestor
110821333|NCT01139905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110821334|NCT01139905|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110146592|NCT00006045|Cytarabine|cytarabine|mesh-list
110821335|NCT01139905|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110821336|NCT05044429|Lidocaine|lidocaine|mesh-list
110821337|NCT05044429|Anesthetics, Local|anesthetics, local|mesh-ancestor
110821338|NCT05044429|Anesthetics|anesthetics|mesh-ancestor
110821339|NCT05044429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110821340|NCT05044429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110821341|NCT05044429|Sensory System Agents|sensory system agents|mesh-ancestor
110821342|NCT05044429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110821343|NCT05044429|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110821344|NCT05044429|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110821345|NCT05044429|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110821346|NCT05044429|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110821347|NCT05044429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110821348|NCT02309554|Nonoxynol|nonoxynol|mesh-list
110821349|NCT02309554|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
110821350|NCT02309554|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
110821351|NCT02309554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110821352|NCT02309554|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110821353|NCT02309554|Contraceptive Agents|contraceptive agents|mesh-ancestor
110821354|NCT02309554|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110821355|NCT02309554|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110821356|NCT01143025|Ropivacaine|ropivacaine|mesh-list
110821357|NCT01143025|Anesthetics, Local|anesthetics, local|mesh-ancestor
110821358|NCT01143025|Anesthetics|anesthetics|mesh-ancestor
110821359|NCT01143025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110821360|NCT01143025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110821361|NCT01143025|Sensory System Agents|sensory system agents|mesh-ancestor
110821362|NCT01143025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110821363|NCT03502642|Morphine|morphine|mesh-list
110821364|NCT03502642|Ropivacaine|ropivacaine|mesh-list
110821365|NCT03502642|Anesthetics|anesthetics|mesh-ancestor
110821366|NCT03502642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110821367|NCT03502642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110821368|NCT03502642|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110821369|NCT03502642|Narcotics|narcotics|mesh-ancestor
110821370|NCT03502642|Analgesics|analgesics|mesh-ancestor
110821371|NCT03502642|Sensory System Agents|sensory system agents|mesh-ancestor
110821372|NCT03502642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110821373|NCT03502642|Anesthetics, Local|anesthetics, local|mesh-ancestor
110821374|NCT02306278|Gabapentin|gabapentin|mesh-list
110821375|NCT02306278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110821376|NCT02306278|Analgesics|analgesics|mesh-ancestor
110821377|NCT02306278|Sensory System Agents|sensory system agents|mesh-ancestor
110821378|NCT02306278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110821379|NCT02306278|Anticonvulsants|anticonvulsants|mesh-ancestor
110821380|NCT02306278|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110821381|NCT02306278|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110538919|NCT04011241|Itraconazole|itraconazole|mesh-list
110821382|NCT02306278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110821383|NCT02306278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110821384|NCT02306278|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110821385|NCT02306278|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110821387|NCT02306278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110821388|NCT02306278|Antimanic Agents|antimanic agents|mesh-ancestor
110821389|NCT01234129|Zoledronic Acid|zoledronic acid|mesh-list
110821390|NCT01234129|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110821391|NCT01234129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110821392|NCT02313922|Etanercept|etanercept|mesh-list
110821393|NCT02313922|Methotrexate|methotrexate|mesh-list
110821394|NCT02313922|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110821395|NCT02313922|Abortifacient Agents|abortifacient agents|mesh-ancestor
110821396|NCT02313922|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110821397|NCT02313922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110821398|NCT02313922|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110821399|NCT02313922|Antimetabolites|antimetabolites|mesh-ancestor
110821400|NCT02313922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110821401|NCT02313922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110854754|NCT02486926|GABA Agents|gaba agents|mesh-ancestor
110821403|NCT02313922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110821404|NCT02313922|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110821405|NCT02313922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110821406|NCT02313922|Immunologic Factors|immunologic factors|mesh-ancestor
110821407|NCT02313922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110821408|NCT02313922|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110821409|NCT02313922|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110821410|NCT02313922|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110821411|NCT02313922|Analgesics|analgesics|mesh-ancestor
110821412|NCT02313922|Sensory System Agents|sensory system agents|mesh-ancestor
110821413|NCT02313922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110821414|NCT02313922|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110821415|NCT02313922|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110821416|NCT03627013|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110821417|NCT03508102|Remifentanil|remifentanil|mesh-list
110821418|NCT03508102|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110821419|NCT03508102|Narcotics|narcotics|mesh-ancestor
110821420|NCT03508102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110821421|NCT03508102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110821422|NCT03508102|Analgesics|analgesics|mesh-ancestor
110821423|NCT03508102|Sensory System Agents|sensory system agents|mesh-ancestor
110821424|NCT03508102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110821425|NCT03505528|Paclitaxel|paclitaxel|mesh-list
110821426|NCT03505528|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110821427|NCT03505528|Phenelzine|phenelzine|mesh-list
110821428|NCT03505528|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110821429|NCT03505528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110821430|NCT03505528|Tubulin Modulators|tubulin modulators|mesh-ancestor
110821431|NCT03505528|Antimitotic Agents|antimitotic agents|mesh-ancestor
110821432|NCT03505528|Mitosis Modulators|mitosis modulators|mesh-ancestor
110821433|NCT03505528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110821434|NCT03505528|Antidepressive Agents|antidepressive agents|mesh-ancestor
110821435|NCT03505528|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110821436|NCT03505528|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
110821437|NCT03505528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110821438|NCT01234285|Heparin|heparin|mesh-list
110821439|NCT01234285|Calcium heparin|calcium heparin|mesh-list
110821440|NCT01234285|Anticoagulants|anticoagulants|mesh-ancestor
110821441|NCT01234285|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110821442|NCT01234285|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110821443|NCT01234285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110821444|NCT02314312|Cyclosporine|cyclosporine|mesh-list
110821445|NCT02314312|Prednisolone|prednisolone|mesh-list
110821446|NCT02314312|Everolimus|everolimus|mesh-list
110821447|NCT02314312|Cyclosporins|cyclosporins|mesh-list
110821448|NCT02314312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110821449|NCT02314312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110821450|NCT02314312|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110821451|NCT02314312|Immunologic Factors|immunologic factors|mesh-ancestor
110821452|NCT02314312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110821453|NCT02314312|Antifungal Agents|antifungal agents|mesh-ancestor
110821454|NCT02314312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110821455|NCT02314312|Dermatologic Agents|dermatologic agents|mesh-ancestor
110821456|NCT02314312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110821457|NCT02314312|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110821458|NCT02314312|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110821459|NCT02314312|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110821460|NCT02314312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110821461|NCT02314312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110821462|NCT02314312|Glucocorticoids|glucocorticoids|mesh-ancestor
110821463|NCT02314312|Hormones|hormones|mesh-ancestor
110821464|NCT02314312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110821465|NCT02314312|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110821466|NCT02316340|Hydroxychloroquine|hydroxychloroquine|mesh-list
110821467|NCT02316340|Vorinostat|vorinostat|mesh-list
110821468|NCT02316340|Antimalarials|antimalarials|mesh-ancestor
110821469|NCT02316340|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110572336|NCT00798148|Etoposide|etoposide|mesh-list
110821470|NCT02316340|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110821471|NCT02316340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110821472|NCT02316340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110821473|NCT02316340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110821474|NCT02316340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110821475|NCT02316340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110821476|NCT02316340|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110821477|NCT01140997|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110821478|NCT01140997|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110821479|NCT01140997|Antiviral Agents|antiviral agents|mesh-ancestor
110821480|NCT01140997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110821481|NCT02310490|Mannitol|mannitol|mesh-list
110821482|NCT02310490|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110821483|NCT02310490|Diuretics|diuretics|mesh-ancestor
110821484|NCT02310490|Natriuretic Agents|natriuretic agents|mesh-ancestor
110821485|NCT02310490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110821486|NCT02316496|Irinotecan|irinotecan|mesh-list
110821487|NCT02316496|Cetuximab|cetuximab|mesh-list
110821488|NCT02316496|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110821489|NCT02316496|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110821490|NCT02316496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110821491|NCT02316496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110821492|NCT02316496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110821493|NCT02316496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110821494|NCT01140529|Dexmedetomidine|dexmedetomidine|mesh-list
110821495|NCT01140529|Haloperidol|haloperidol|mesh-list
110821496|NCT01140529|Haloperidol decanoate|haloperidol decanoate|mesh-list
110821497|NCT01140529|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110821498|NCT01140529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110821499|NCT01140529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110821500|NCT01140529|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110821501|NCT01140529|Analgesics|analgesics|mesh-ancestor
110821502|NCT01140529|Sensory System Agents|sensory system agents|mesh-ancestor
110821503|NCT01140529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110821504|NCT01140529|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110821505|NCT01140529|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110821506|NCT01140529|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110821507|NCT01140529|Adrenergic Agents|adrenergic agents|mesh-ancestor
110821508|NCT01140529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110821509|NCT01140529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110821510|NCT01140529|Antiemetics|antiemetics|mesh-ancestor
110821511|NCT01140529|Autonomic Agents|autonomic agents|mesh-ancestor
110821512|NCT01140529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110821513|NCT01140529|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110821514|NCT01140529|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110821515|NCT01140529|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110821516|NCT01140529|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110821517|NCT01140529|Dopamine Agents|dopamine agents|mesh-ancestor
110821518|NCT01140529|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110821519|NCT01141153|Aspirin|aspirin|mesh-list
110821520|NCT01141153|Acenocoumarol|acenocoumarol|mesh-list
110821521|NCT01141153|Clopidogrel|clopidogrel|mesh-list
110821522|NCT01141153|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110821523|NCT01141153|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110821524|NCT01141153|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110821525|NCT01141153|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110821526|NCT01141153|Purinergic Agents|purinergic agents|mesh-ancestor
110821527|NCT01141153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110821528|NCT01141153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110821529|NCT01141153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110821530|NCT01141153|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110821532|NCT01141153|Analgesics|analgesics|mesh-ancestor
110821533|NCT01141153|Sensory System Agents|sensory system agents|mesh-ancestor
110539063|NCT03549715|Durvalumab|durvalumab|mesh-list
110821534|NCT01141153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110821535|NCT01141153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110195386|NCT00399204|Metformin|metformin|mesh-list
110821536|NCT01141153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110821537|NCT01141153|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110821538|NCT01141153|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110821539|NCT01141153|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110821540|NCT01141153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110821542|NCT01141153|Anticoagulants|anticoagulants|mesh-ancestor
110821543|NCT01235143|Sevoflurane|sevoflurane|mesh-list
110821544|NCT01235143|Desflurane|desflurane|mesh-list
110821545|NCT01235143|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110821546|NCT01235143|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110821547|NCT01235143|Anesthetics, General|anesthetics, general|mesh-ancestor
110821548|NCT01235143|Anesthetics|anesthetics|mesh-ancestor
110821549|NCT01235143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110821550|NCT01235143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110821551|NCT01238029|Capecitabine|capecitabine|mesh-list
110821552|NCT01238029|Vinorelbine|vinorelbine|mesh-list
110821553|NCT01238029|Lapatinib|lapatinib|mesh-list
110821554|NCT01238029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110821555|NCT01238029|Antimetabolites|antimetabolites|mesh-ancestor
110821556|NCT01238029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110821557|NCT01238029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110821558|NCT01238029|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110821559|NCT01238029|Tubulin Modulators|tubulin modulators|mesh-ancestor
110821560|NCT01238029|Antimitotic Agents|antimitotic agents|mesh-ancestor
110821561|NCT01238029|Mitosis Modulators|mitosis modulators|mesh-ancestor
110821562|NCT01238029|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110821564|NCT01235221|4-Aminopyridine|4-aminopyridine|mesh-list
110821565|NCT01235221|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
110821566|NCT01235221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110821567|NCT01235221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110821568|NCT03139604|Prednisone|prednisone|mesh-list
110821569|NCT03139604|Methylprednisolone|methylprednisolone|mesh-list
110821570|NCT03139604|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110821571|NCT03139604|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110821572|NCT03139604|Prednisolone|prednisolone|mesh-list
110821573|NCT03139604|Prednisolone acetate|prednisolone acetate|mesh-list
110821574|NCT03139604|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110821575|NCT03139604|Prednisolone phosphate|prednisolone phosphate|mesh-list
110821576|NCT03139604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110821577|NCT03139604|Glucocorticoids|glucocorticoids|mesh-ancestor
110821578|NCT03139604|Hormones|hormones|mesh-ancestor
110821579|NCT03139604|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110821580|NCT03139604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110821581|NCT03139604|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110821582|NCT03139604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110821583|NCT03139604|Antiemetics|antiemetics|mesh-ancestor
110821584|NCT03139604|Autonomic Agents|autonomic agents|mesh-ancestor
110821585|NCT03139604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110821586|NCT03139604|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110821587|NCT03139604|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110821588|NCT03139604|Protective Agents|protective agents|mesh-ancestor
110821589|NCT01350596|Ibuprofen|ibuprofen|mesh-list
110821590|NCT01350596|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110821591|NCT01350596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110821592|NCT01350596|Analgesics|analgesics|mesh-ancestor
110821593|NCT01350596|Sensory System Agents|sensory system agents|mesh-ancestor
110854798|NCT05693246|Glycopyrrolate|glycopyrrolate|mesh-list
110821594|NCT01350596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110821595|NCT01350596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110821596|NCT01350596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110821597|NCT01350596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110821598|NCT01350596|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110821599|NCT01350596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110821600|NCT01350596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110821601|NCT04462588|Metronidazole|metronidazole|mesh-list
110821602|NCT04462588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110821603|NCT04462588|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110821604|NCT04462588|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110821605|NCT04462588|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110821606|NCT04462822|Fluticasone|fluticasone|mesh-list
110821607|NCT04462822|Xhance|xhance|mesh-list
110821608|NCT04462822|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110821609|NCT04462822|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
110821610|NCT04462822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110821611|NCT04462822|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110821612|NCT04462822|Autonomic Agents|autonomic agents|mesh-ancestor
110821613|NCT04462822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110821614|NCT04462822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110821615|NCT04462822|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110821616|NCT04462822|Respiratory System Agents|respiratory system agents|mesh-ancestor
110821617|NCT04462822|Dermatologic Agents|dermatologic agents|mesh-ancestor
110821618|NCT04462822|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110821619|NCT04462822|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110821620|NCT04462822|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110821621|NCT04462822|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110821622|NCT04462822|Adrenergic Agents|adrenergic agents|mesh-ancestor
110821623|NCT04462822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110821624|NCT04462822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110821625|NCT04462822|Glucocorticoids|glucocorticoids|mesh-ancestor
110821626|NCT04462822|Hormones|hormones|mesh-ancestor
110821627|NCT04462822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110821628|NCT04462822|Sympathomimetics|sympathomimetics|mesh-ancestor
110821629|NCT01362218|Aspirin|aspirin|mesh-list
110821630|NCT01362218|Ramipril|ramipril|mesh-list
110821631|NCT01362218|Simvastatin|simvastatin|mesh-list
110821632|NCT01362218|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110821633|NCT01362218|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110821634|NCT01362218|Antimetabolites|antimetabolites|mesh-ancestor
110821635|NCT01362218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110146883|NCT00006195|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110821636|NCT01362218|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110821637|NCT01362218|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110821638|NCT01362218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110821639|NCT01362218|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110821640|NCT01362218|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110821641|NCT01362218|Analgesics|analgesics|mesh-ancestor
110821642|NCT01362218|Sensory System Agents|sensory system agents|mesh-ancestor
110821643|NCT01362218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110821644|NCT01362218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110821645|NCT01362218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110821646|NCT01362218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110821647|NCT01362218|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110821648|NCT01362218|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110821649|NCT01362218|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110821650|NCT01362218|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110821651|NCT01362218|Antipyretics|antipyretics|mesh-ancestor
110821652|NCT01362218|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110821653|NCT01362218|Protease Inhibitors|protease inhibitors|mesh-ancestor
110821654|NCT01362218|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110821655|NCT02316964|Aldesleukin|aldesleukin|mesh-list
110821656|NCT02316964|Decitabine|decitabine|mesh-list
110821657|NCT02316964|Azacitidine|azacitidine|mesh-list
110821658|NCT02316964|Interleukin-2|interleukin-2|mesh-list
110854806|NCT03316066|Ropivacaine|ropivacaine|mesh-list
110821659|NCT02316964|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110821660|NCT02316964|Antimetabolites|antimetabolites|mesh-ancestor
110821661|NCT02316964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110821662|NCT02316964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110821663|NCT02316964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110821664|NCT02316964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110821665|NCT02316964|Analgesics|analgesics|mesh-ancestor
110821666|NCT02316964|Sensory System Agents|sensory system agents|mesh-ancestor
110821667|NCT02316964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110821668|NCT02316964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110821669|NCT02316964|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110821670|NCT02316964|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110821671|NCT02316964|Antiviral Agents|antiviral agents|mesh-ancestor
110821672|NCT02316964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110821673|NCT02875340|Risperidone|risperidone|mesh-list
110821674|NCT02875340|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110821675|NCT02875340|Serotonin Agents|serotonin agents|mesh-ancestor
110821676|NCT02875340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110821677|NCT02875340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110821678|NCT02875340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110821679|NCT02875340|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110821680|NCT02875340|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110821681|NCT02875340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110821682|NCT02875340|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110821683|NCT02875340|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110539213|NCT02802683|Levobupivacaine|levobupivacaine|mesh-list
110821684|NCT02875340|Dopamine Agents|dopamine agents|mesh-ancestor
110821686|NCT04462666|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110821687|NCT04462666|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110821688|NCT04462666|Analgesics|analgesics|mesh-ancestor
110821689|NCT04462666|Sensory System Agents|sensory system agents|mesh-ancestor
110821690|NCT04462666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110821691|NCT04462666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110821692|NCT04462666|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110821693|NCT04462666|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110821694|NCT04462666|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110821695|NCT04462666|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110821696|NCT04462666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110821697|NCT04462666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110821698|NCT01359020|Acetaminophen|acetaminophen|mesh-list
110821699|NCT01359020|Dipyrone|dipyrone|mesh-list
110821700|NCT01359020|Ibuprofen|ibuprofen|mesh-list
110821701|NCT01359020|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110821702|NCT01359020|Analgesics|analgesics|mesh-ancestor
110821703|NCT01359020|Sensory System Agents|sensory system agents|mesh-ancestor
110821704|NCT01359020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110821705|NCT01359020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110821706|NCT01359020|Antipyretics|antipyretics|mesh-ancestor
110821707|NCT01359020|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110821708|NCT01359020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110821709|NCT01359020|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110821710|NCT01359020|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110821711|NCT01359020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110821712|NCT01359020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110821713|NCT01359098|Ciprofloxacin|ciprofloxacin|mesh-list
110821714|NCT01359098|Dexamethasone|dexamethasone|mesh-list
110821715|NCT01359098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110821716|NCT01359098|Antiemetics|antiemetics|mesh-ancestor
110821717|NCT01359098|Autonomic Agents|autonomic agents|mesh-ancestor
110821718|NCT01359098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110821719|NCT01359098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110821720|NCT01359098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110821721|NCT01359098|Glucocorticoids|glucocorticoids|mesh-ancestor
110821722|NCT01359098|Hormones|hormones|mesh-ancestor
110821723|NCT01359098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110821724|NCT01359098|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110821725|NCT01359098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110821726|NCT01359098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110821727|NCT01359098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110821728|NCT01359098|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110821729|NCT01359098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110821730|NCT01359098|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110821731|NCT01359098|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110821732|NCT01359098|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110821733|NCT01359098|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110821734|NCT01319240|Insulin|insulin|mesh-list
110821735|NCT01319240|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110821736|NCT01319240|Liraglutide|liraglutide|mesh-list
110821737|NCT01319240|Insulin, Long-Acting|insulin, long-acting|mesh-list
110821738|NCT01319240|Xultophy|xultophy|mesh-list
110821739|NCT01319240|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110821740|NCT01319240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110821741|NCT01319240|Incretins|incretins|mesh-ancestor
110821742|NCT01319240|Hormones|hormones|mesh-ancestor
110821743|NCT01319240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110821744|NCT04463056|Eculizumab|eculizumab|mesh-list
110821745|NCT04463056|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
110821746|NCT04463056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110821747|NCT04463056|Immunologic Factors|immunologic factors|mesh-ancestor
110821748|NCT04463056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110821749|NCT02315950|Botulinum Toxins|botulinum toxins|mesh-list
110821750|NCT02315950|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110195597|NCT00072852|Irinotecan|irinotecan|mesh-list
110821751|NCT02315950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110821752|NCT02315950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110821753|NCT02315950|Cholinergic Agents|cholinergic agents|mesh-ancestor
110821754|NCT02315950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110821755|NCT02315950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110821756|NCT03319316|Durvalumab|durvalumab|mesh-list
110821757|NCT03319316|Tremelimumab|tremelimumab|mesh-list
110539294|NCT02799797|Anesthetics, General|anesthetics, general|mesh-ancestor
110821758|NCT03319316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110821759|NCT03319316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110821760|NCT02316028|Decitabine|decitabine|mesh-list
110821761|NCT02316028|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110821762|NCT02316028|Antimetabolites|antimetabolites|mesh-ancestor
110821763|NCT02316028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110821764|NCT02316028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110821765|NCT02316028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110821766|NCT01359488|Hormones|hormones|mesh-list
110821767|NCT01359488|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
110821768|NCT01359488|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110821769|NCT01359488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110821770|NCT01141465|Fluticasone|fluticasone|mesh-list
110821771|NCT01141465|Xhance|xhance|mesh-list
110821772|NCT01141465|Budesonide|budesonide|mesh-list
110821773|NCT01141465|Formoterol Fumarate|formoterol fumarate|mesh-list
110821774|NCT01141465|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110821775|NCT01141465|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
110821776|NCT01141465|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
110821777|NCT01141465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110821778|NCT01141465|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110821779|NCT01141465|Autonomic Agents|autonomic agents|mesh-ancestor
110821780|NCT01141465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110821781|NCT01141465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110821782|NCT01141465|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110821783|NCT01141465|Respiratory System Agents|respiratory system agents|mesh-ancestor
110821784|NCT01141465|Dermatologic Agents|dermatologic agents|mesh-ancestor
110821785|NCT01141465|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110821786|NCT01141465|Glucocorticoids|glucocorticoids|mesh-ancestor
110821788|NCT01141465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110821789|NCT01141465|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110821790|NCT01141465|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110821791|NCT01141465|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110821792|NCT01141465|Adrenergic Agents|adrenergic agents|mesh-ancestor
110821793|NCT01141465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110821794|NCT01141465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110821795|NCT01141465|Sympathomimetics|sympathomimetics|mesh-ancestor
110821796|NCT01141543|Plerixafor|plerixafor|mesh-list
110821797|NCT01141543|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110821798|NCT01141543|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110821799|NCT01141543|Antiviral Agents|antiviral agents|mesh-ancestor
110821800|NCT01141543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110821801|NCT03300518|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110821802|NCT03300518|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110821803|NCT03300518|Estradiol|estradiol|mesh-list
110821804|NCT03300518|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110821805|NCT03300518|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
110821806|NCT03300518|Ganirelix|ganirelix|mesh-list
110821807|NCT03300518|Estrogens|estrogens|mesh-ancestor
110821808|NCT03300518|Hormones|hormones|mesh-ancestor
110821809|NCT03300518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110821810|NCT03300518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110821811|NCT03300518|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110821812|NCT03300518|Contraceptive Agents|contraceptive agents|mesh-ancestor
110821813|NCT03300518|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110821814|NCT03300518|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110821815|NCT03300518|Hormone Antagonists|hormone antagonists|mesh-ancestor
110821816|NCT02317198|Clopidogrel|clopidogrel|mesh-list
110821817|NCT02317198|Ticagrelor|ticagrelor|mesh-list
110821818|NCT02317198|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
110821819|NCT02317198|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110821820|NCT02317198|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110418788|NCT00977938|Purinergic Agents|purinergic agents|mesh-ancestor
110821821|NCT02317198|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110821822|NCT02317198|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110821823|NCT02317198|Purinergic Agents|purinergic agents|mesh-ancestor
110821824|NCT02317198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110821825|NCT02317198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110821826|NCT02317198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110821827|NCT01359722|Acetylcysteine|acetylcysteine|mesh-list
110821828|NCT01359722|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110821829|NCT01359722|Antiviral Agents|antiviral agents|mesh-ancestor
110821830|NCT01359722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110821831|NCT01359722|Expectorants|expectorants|mesh-ancestor
110821832|NCT01359722|Respiratory System Agents|respiratory system agents|mesh-ancestor
110821833|NCT01359722|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110821834|NCT01359722|Antioxidants|antioxidants|mesh-ancestor
110821835|NCT01359722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110821836|NCT01359722|Protective Agents|protective agents|mesh-ancestor
110821837|NCT01359722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110821838|NCT01359722|Antidotes|antidotes|mesh-ancestor
110821839|NCT01238185|Aspirin|aspirin|mesh-list
110821840|NCT01238185|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110821841|NCT01238185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110821842|NCT01238185|Analgesics|analgesics|mesh-ancestor
110821843|NCT01238185|Sensory System Agents|sensory system agents|mesh-ancestor
110821844|NCT01238185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110821845|NCT01238185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110821846|NCT01238185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110821847|NCT01238185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110821848|NCT01238185|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110821849|NCT01238185|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110821850|NCT01238185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110821851|NCT01238185|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110821852|NCT01238185|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110821853|NCT01238185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110821854|NCT01238185|Antipyretics|antipyretics|mesh-ancestor
110821855|NCT01143805|Tofacitinib|tofacitinib|mesh-list
110821856|NCT01143805|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
110821857|NCT01143805|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110854897|NCT02486458|Listerine|listerine|mesh-list
110821858|NCT01143805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110821859|NCT01143805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110821860|NCT01362764|Abiraterone Acetate|abiraterone acetate|mesh-list
110821861|NCT01362764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110821862|NCT01362764|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110821863|NCT01362764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110821864|NCT01362764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110821865|NCT01362764|Hormone Antagonists|hormone antagonists|mesh-ancestor
110821866|NCT01362764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110821867|NCT01362764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110821868|NCT01362764|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110821870|NCT03498118|Anesthetics, Local|anesthetics, local|mesh-ancestor
110821871|NCT03498118|Anesthetics|anesthetics|mesh-ancestor
110821872|NCT03498118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110821873|NCT03498118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110821874|NCT03498118|Sensory System Agents|sensory system agents|mesh-ancestor
110821875|NCT03498118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110821876|NCT05188742|Mirabegron|mirabegron|mesh-list
110821877|NCT05188742|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
110821878|NCT05188742|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110821879|NCT05188742|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110821880|NCT05188742|Adrenergic Agents|adrenergic agents|mesh-ancestor
110821881|NCT05188742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110821882|NCT05188742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110821883|NCT05188742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110821884|NCT05188742|Urological Agents|urological agents|mesh-ancestor
110821885|NCT02324452|Fluorouracil|fluorouracil|mesh-list
110821886|NCT02324452|Capecitabine|capecitabine|mesh-list
110821887|NCT02324452|Antimetabolites|antimetabolites|mesh-ancestor
110821888|NCT02324452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110821889|NCT02324452|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110821890|NCT02324452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110821891|NCT02324452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110821892|NCT02324452|Immunologic Factors|immunologic factors|mesh-ancestor
110821893|NCT02324452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110821894|NCT02321176|Resveratrol|resveratrol|mesh-list
110821895|NCT02321176|Antioxidants|antioxidants|mesh-ancestor
110821896|NCT02321176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110821897|NCT02321176|Protective Agents|protective agents|mesh-ancestor
110821898|NCT02321176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110821899|NCT02321176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110821900|NCT02321176|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110821901|NCT01351298|Lidocaine|lidocaine|mesh-list
110821902|NCT01351298|Xylometazoline|xylometazoline|mesh-list
110821903|NCT01351298|Anesthetics, Local|anesthetics, local|mesh-ancestor
110821904|NCT01351298|Anesthetics|anesthetics|mesh-ancestor
110821905|NCT01351298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110539447|NCT00642122|Budesonide|budesonide|mesh-list
110821906|NCT01351298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110821907|NCT01351298|Sensory System Agents|sensory system agents|mesh-ancestor
110821908|NCT01351298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110821909|NCT01351298|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110821910|NCT01351298|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110821911|NCT01351298|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110821912|NCT01351298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110821913|NCT01351298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110821915|NCT01351298|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110821916|NCT01351298|Respiratory System Agents|respiratory system agents|mesh-ancestor
110821917|NCT02324686|Vitamin K|vitamin k|mesh-list
110821918|NCT02324686|Vitamin K 1|vitamin k 1|mesh-list
110821919|NCT02324686|Vitamins|vitamins|mesh-ancestor
110821920|NCT02324686|Micronutrients|micronutrients|mesh-ancestor
110821921|NCT02324686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110821922|NCT02324686|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110821923|NCT02324686|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110821924|NCT02324686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110821925|NCT02324686|Hemostatics|hemostatics|mesh-ancestor
110821926|NCT02324686|Coagulants|coagulants|mesh-ancestor
110821927|NCT01360034|Indomethacin|indomethacin|mesh-list
110821928|NCT01360034|Nifedipine|nifedipine|mesh-list
110821929|NCT01360034|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110821930|NCT01360034|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110821931|NCT01360034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110821932|NCT01360034|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110821933|NCT01360034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110821934|NCT01360034|Vasodilator Agents|vasodilator agents|mesh-ancestor
110821935|NCT01360034|Tocolytic Agents|tocolytic agents|mesh-ancestor
110821936|NCT01360034|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110821937|NCT01360034|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110821938|NCT01360034|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110821939|NCT01360034|Analgesics|analgesics|mesh-ancestor
110821940|NCT01360034|Sensory System Agents|sensory system agents|mesh-ancestor
110821941|NCT01360034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110821942|NCT01360034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110821943|NCT01360034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110821944|NCT01360034|Gout Suppressants|gout suppressants|mesh-ancestor
110821945|NCT01360034|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110821946|NCT01360034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110821947|NCT01363310|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110821948|NCT01363310|Escitalopram|escitalopram|mesh-list
110821949|NCT01363310|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110821950|NCT01363310|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110821951|NCT01363310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110821952|NCT01363310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110821953|NCT01363310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110821954|NCT01363310|Serotonin Agents|serotonin agents|mesh-ancestor
110821955|NCT01363310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110821956|NCT01363310|Antidepressive Agents|antidepressive agents|mesh-ancestor
110821957|NCT01363310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110821958|NCT01363310|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110821959|NCT01363310|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110821960|NCT01363310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110821961|NCT01363544|Methylphenidate|methylphenidate|mesh-list
110821962|NCT01363544|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110821963|NCT01363544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110821964|NCT01363544|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110821965|NCT01363544|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110821966|NCT01363544|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110821967|NCT01363544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110821968|NCT01363544|Dopamine Agents|dopamine agents|mesh-ancestor
110821969|NCT01363544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110821970|NCT03257618|Temozolomide|temozolomide|mesh-list
110821971|NCT03257618|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110821972|NCT03257618|Alkylating Agents|alkylating agents|mesh-ancestor
110821973|NCT03257618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110854932|NCT03526848|Immunologic Factors|immunologic factors|mesh-ancestor
110821974|NCT03257618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110821975|NCT01363778|Tivozanib|tivozanib|mesh-list
110821976|NCT01363778|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110821977|NCT01363778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110821978|NCT01363778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110821979|NCT04175834|Cetirizine|cetirizine|mesh-list
110821980|NCT04175834|Histamine Antagonists|histamine antagonists|mesh-list
110821981|NCT04175834|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
110821982|NCT04175834|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110821983|NCT04175834|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110821984|NCT04175834|Histamine Agents|histamine agents|mesh-ancestor
110821985|NCT04175834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110821986|NCT04175834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110821987|NCT04175834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110821988|NCT02324998|Olaparib|olaparib|mesh-list
110821989|NCT02324998|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110821990|NCT02324998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110821991|NCT02324998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110821992|NCT02324998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110821993|NCT03500848|Mycophenolic Acid|mycophenolic acid|mesh-list
110821994|NCT03500848|Sirolimus|sirolimus|mesh-list
110821995|NCT03500848|Tacrolimus|tacrolimus|mesh-list
110821996|NCT03500848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110821997|NCT03500848|Immunologic Factors|immunologic factors|mesh-ancestor
110821998|NCT03500848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110821999|NCT03500848|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110822000|NCT03500848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110822001|NCT03500848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110822002|NCT03500848|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110822003|NCT03500848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110822004|NCT03500848|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110822005|NCT03500848|Antitubercular Agents|antitubercular agents|mesh-ancestor
110822006|NCT03500848|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110822007|NCT03500848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110822008|NCT03500848|Antifungal Agents|antifungal agents|mesh-ancestor
110822010|NCT01360190|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110822011|NCT01360190|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110822012|NCT01360190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110822013|NCT01360190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110822014|NCT01360190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110822015|NCT01360190|Serotonin Agents|serotonin agents|mesh-ancestor
110822016|NCT01360190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110822017|NCT01360190|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110822018|NCT01360190|Antidepressive Agents|antidepressive agents|mesh-ancestor
110822019|NCT01360190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110822020|NCT01360190|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110822021|NCT01360190|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110822022|NCT01360190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110822023|NCT01363934|Darbepoetin alfa|darbepoetin alfa|mesh-list
110822024|NCT01363934|Hematinics|hematinics|mesh-ancestor
110822025|NCT03132376|Caseins|caseins|mesh-list
110822026|NCT03132376|Chelating Agents|chelating agents|mesh-ancestor
110822027|NCT03132376|Sequestering Agents|sequestering agents|mesh-ancestor
110822028|NCT03132376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110822029|NCT01364012|Paclitaxel|paclitaxel|mesh-list
110822030|NCT01364012|Bevacizumab|bevacizumab|mesh-list
110822031|NCT01364012|Carboplatin|carboplatin|mesh-list
110822032|NCT01364012|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110822033|NCT01364012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110822034|NCT01364012|Tubulin Modulators|tubulin modulators|mesh-ancestor
110822035|NCT01364012|Antimitotic Agents|antimitotic agents|mesh-ancestor
110822036|NCT01364012|Mitosis Modulators|mitosis modulators|mesh-ancestor
110822037|NCT01364012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110822038|NCT01364012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110822039|NCT01364012|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110822040|NCT01364012|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110822041|NCT01364012|Growth Substances|growth substances|mesh-ancestor
110822042|NCT01364012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110822043|NCT01364012|Growth Inhibitors|growth inhibitors|mesh-ancestor
110822044|NCT02318056|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110822045|NCT02318056|Bacitracin|bacitracin|mesh-list
110822046|NCT02318056|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
110822047|NCT02318056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110822048|NCT02318056|Laxatives|laxatives|mesh-ancestor
110822049|NCT02318056|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110822050|NCT02318056|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110822051|NCT01360424|Teriparatide|teriparatide|mesh-list
110822052|NCT01360424|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110822053|NCT01360424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110822054|NCT01360424|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110822055|NCT01364324|Antitubercular Agents|antitubercular agents|mesh-list
110822056|NCT01364324|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110822057|NCT01364324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110822058|NCT01364402|Epoetin Alfa|epoetin alfa|mesh-list
110822059|NCT01364402|Hematinics|hematinics|mesh-ancestor
110822060|NCT03552380|Nivolumab|nivolumab|mesh-list
110822061|NCT03552380|Ipilimumab|ipilimumab|mesh-list
110822062|NCT03552380|Entinostat|entinostat|mesh-list
110822063|NCT03552380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110822064|NCT03552380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110822065|NCT03552380|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110822066|NCT03552380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110822067|NCT03552380|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110822068|NCT03552380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110822069|NCT02318290|Analgesics|analgesics|mesh-list
110822070|NCT02318290|Narcotics|narcotics|mesh-list
110822071|NCT02318290|Sensory System Agents|sensory system agents|mesh-ancestor
110822072|NCT02318290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110822073|NCT02318290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110822074|NCT02318290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110822075|NCT03467360|Etoposide|etoposide|mesh-list
110822076|NCT03467360|Acetazolamide|acetazolamide|mesh-list
110822077|NCT03467360|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110822078|NCT03467360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110822079|NCT03467360|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110822080|NCT03467360|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110822081|NCT03467360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110822082|NCT03467360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110822083|NCT03467360|Anticonvulsants|anticonvulsants|mesh-ancestor
110822084|NCT03467360|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110822085|NCT03467360|Diuretics|diuretics|mesh-ancestor
110822086|NCT03467360|Natriuretic Agents|natriuretic agents|mesh-ancestor
110822087|NCT03467360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110822088|NCT03452072|Timolol|timolol|mesh-list
110822089|NCT03452072|Petrolatum|petrolatum|mesh-list
110822090|NCT03452072|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110822091|NCT03452072|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110822092|NCT03452072|Adrenergic Agents|adrenergic agents|mesh-ancestor
110822093|NCT03452072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110822094|NCT03452072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110822095|NCT03452072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110822096|NCT03452072|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110822097|NCT03452072|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110822098|NCT03452072|Emollients|emollients|mesh-ancestor
110822099|NCT03452072|Dermatologic Agents|dermatologic agents|mesh-ancestor
110822100|NCT03433040|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
110822101|NCT03433040|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
110822102|NCT03433040|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110418801|NCT04290208|Antipyretics|antipyretics|mesh-ancestor
110822103|NCT03433040|Hormone Antagonists|hormone antagonists|mesh-ancestor
110822104|NCT03433040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110822105|NCT03433040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110822106|NCT03433040|Progestins|progestins|mesh-ancestor
110822107|NCT03433040|Hormones|hormones|mesh-ancestor
110822108|NCT02318446|Folic Acid|folic acid|mesh-list
110822109|NCT02318446|Hematinics|hematinics|mesh-ancestor
110822110|NCT02318446|Vitamin B Complex|vitamin b complex|mesh-ancestor
110822111|NCT02318446|Vitamins|vitamins|mesh-ancestor
110822112|NCT02318446|Micronutrients|micronutrients|mesh-ancestor
110822113|NCT02318446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110822114|NCT02325934|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110822115|NCT02325934|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110822116|NCT02325934|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110822117|NCT02325934|Antiviral Agents|antiviral agents|mesh-ancestor
110822118|NCT02325934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110822119|NCT01360658|Immunoglobulins|immunoglobulins|mesh-list
110822120|NCT01360658|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110822121|NCT01360658|Antibodies|antibodies|mesh-list
110822122|NCT01360658|gamma-Globulins|gamma-globulins|mesh-list
110822123|NCT01360658|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110822124|NCT01360658|Immunologic Factors|immunologic factors|mesh-ancestor
110822125|NCT01360658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110539664|NCT02795039|Fulvestrant|fulvestrant|mesh-list
110822126|NCT02318758|Ethanol|ethanol|mesh-list
110822127|NCT02318758|Treprostinil|treprostinil|mesh-list
110822128|NCT02318758|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110822129|NCT02318758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110822130|NCT02318758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110822131|NCT02318758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110822132|NCT02318758|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110822134|NCT02441686|Lenalidomide|lenalidomide|mesh-list
110822135|NCT02441686|Bortezomib|bortezomib|mesh-list
110822136|NCT02441686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110822137|NCT02441686|Antiemetics|antiemetics|mesh-ancestor
110822138|NCT02441686|Autonomic Agents|autonomic agents|mesh-ancestor
110822139|NCT02441686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110822140|NCT02441686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110822141|NCT02441686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110822142|NCT02441686|Glucocorticoids|glucocorticoids|mesh-ancestor
110822143|NCT02441686|Hormones|hormones|mesh-ancestor
110822144|NCT02441686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110822145|NCT02441686|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110822146|NCT02441686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110822147|NCT02441686|Immunologic Factors|immunologic factors|mesh-ancestor
110822148|NCT02441686|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110822149|NCT02441686|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110854963|NCT03160716|Lidocaine|lidocaine|mesh-list
110822150|NCT02441686|Growth Substances|growth substances|mesh-ancestor
110822151|NCT02441686|Growth Inhibitors|growth inhibitors|mesh-ancestor
110822152|NCT03500146|Cholinergic Antagonists|cholinergic antagonists|mesh-list
110822153|NCT03500146|Cholinergic Agents|cholinergic agents|mesh-ancestor
110822154|NCT03500146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110822155|NCT03500146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110822156|NCT03500146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110822157|NCT01352234|Aspirin|aspirin|mesh-list
110822158|NCT01352234|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110822159|NCT01352234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110822160|NCT01352234|Analgesics|analgesics|mesh-ancestor
110822161|NCT01352234|Sensory System Agents|sensory system agents|mesh-ancestor
110822162|NCT01352234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110822163|NCT01352234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110822164|NCT01352234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110822165|NCT01352234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110822166|NCT01352234|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110822167|NCT01352234|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110822168|NCT01352234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110822169|NCT01352234|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110822170|NCT01352234|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110822171|NCT01352234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110822172|NCT01352234|Antipyretics|antipyretics|mesh-ancestor
110822173|NCT01364792|Valacyclovir|valacyclovir|mesh-list
110418804|NCT01090011|Cetuximab|cetuximab|mesh-list
110822174|NCT01364792|Antiviral Agents|antiviral agents|mesh-ancestor
110822175|NCT01364792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110822176|NCT02318836|Lofexidine|lofexidine|mesh-list
110822177|NCT02318836|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110822178|NCT02318836|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110822179|NCT02318836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110822180|NCT02318836|Sensory System Agents|sensory system agents|mesh-ancestor
110822181|NCT02318836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110822182|NCT02318836|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110822183|NCT02318836|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110822184|NCT02318836|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110822185|NCT02318836|Adrenergic Agents|adrenergic agents|mesh-ancestor
110822186|NCT02318836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110822187|NCT02318836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110822188|NCT01352312|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110822189|NCT01352312|Ofatumumab|ofatumumab|mesh-list
110822190|NCT01352312|Pentostatin|pentostatin|mesh-list
110822191|NCT01352312|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110822192|NCT01352312|Alkylating Agents|alkylating agents|mesh-ancestor
110822193|NCT01352312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110822194|NCT01352312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110822195|NCT01352312|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
110822196|NCT01352312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110822197|NCT02939209|Hydromorphone|hydromorphone|mesh-list
110822198|NCT02939209|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110822199|NCT02939209|Narcotics|narcotics|mesh-ancestor
110854993|NCT00092586|Ezetimibe|ezetimibe|mesh-list
110822200|NCT02939209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110539740|NCT04009525|Antitubercular Agents|antitubercular agents|mesh-ancestor
110822201|NCT02939209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110822202|NCT02939209|Analgesics|analgesics|mesh-ancestor
110822203|NCT02939209|Sensory System Agents|sensory system agents|mesh-ancestor
110822204|NCT02939209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110822205|NCT01141855|Varenicline|varenicline|mesh-list
110822206|NCT01141855|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110822207|NCT01141855|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110822208|NCT01141855|Cholinergic Agents|cholinergic agents|mesh-ancestor
110822209|NCT01141855|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110822210|NCT01141855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110822211|NCT01141855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110822213|NCT01236859|Analgesics|analgesics|mesh-ancestor
110822214|NCT01236859|Sensory System Agents|sensory system agents|mesh-ancestor
110822215|NCT01236859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110822216|NCT01236859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110822217|NCT01236859|Anticonvulsants|anticonvulsants|mesh-ancestor
110822218|NCT01236859|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110822219|NCT01236859|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110822220|NCT01236859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110822221|NCT01236859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110822222|NCT01236859|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110822223|NCT01236859|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110822224|NCT01236859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110822225|NCT01236859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110822226|NCT01236859|Antimanic Agents|antimanic agents|mesh-ancestor
110822227|NCT01145365|Anesthetics|anesthetics|mesh-list
110822228|NCT01145365|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110822229|NCT01145365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110822230|NCT04967092|Anti-Allergic Agents|anti-allergic agents|mesh-list
110822231|NCT01365104|Deferoxamine|deferoxamine|mesh-list
110822232|NCT01365104|Siderophores|siderophores|mesh-ancestor
110822233|NCT01365104|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110822234|NCT01365104|Chelating Agents|chelating agents|mesh-ancestor
110822235|NCT01365104|Sequestering Agents|sequestering agents|mesh-ancestor
110822236|NCT01365104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110822237|NCT03492970|Melatonin|melatonin|mesh-list
110822238|NCT03492970|Antioxidants|antioxidants|mesh-ancestor
110822239|NCT03492970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110822240|NCT03492970|Protective Agents|protective agents|mesh-ancestor
110822241|NCT03492970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110822242|NCT03492970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110822243|NCT01362374|Leucovorin|leucovorin|mesh-list
110822244|NCT01362374|Paclitaxel|paclitaxel|mesh-list
110822245|NCT01362374|Docetaxel|docetaxel|mesh-list
110822246|NCT01362374|Oxaliplatin|oxaliplatin|mesh-list
110822247|NCT01362374|Ipatasertib|ipatasertib|mesh-list
110822248|NCT01362374|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110822249|NCT01362374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110822250|NCT01362374|Tubulin Modulators|tubulin modulators|mesh-ancestor
110822251|NCT01362374|Antimitotic Agents|antimitotic agents|mesh-ancestor
110822252|NCT01362374|Mitosis Modulators|mitosis modulators|mesh-ancestor
110822253|NCT01362374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110822254|NCT01362374|Antidotes|antidotes|mesh-ancestor
110822255|NCT01362374|Protective Agents|protective agents|mesh-ancestor
110822256|NCT01362374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110822257|NCT01362374|Vitamin B Complex|vitamin b complex|mesh-ancestor
110822258|NCT01362374|Vitamins|vitamins|mesh-ancestor
110822259|NCT01362374|Micronutrients|micronutrients|mesh-ancestor
110822260|NCT01362374|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110822261|NCT01362374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110822262|NCT01142011|Belimumab|belimumab|mesh-list
110822263|NCT01142011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110822264|NCT01142011|Immunologic Factors|immunologic factors|mesh-ancestor
110822265|NCT01142011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110822266|NCT02319460|Thrombin|thrombin|mesh-list
110822267|NCT02319460|Hemostatics|hemostatics|mesh-ancestor
110822268|NCT02319460|Coagulants|coagulants|mesh-ancestor
110822269|NCT04722952|Cytarabine|cytarabine|mesh-list
110822270|NCT04722952|Azacitidine|azacitidine|mesh-list
110822271|NCT04722952|Homoharringtonine|homoharringtonine|mesh-list
110822272|NCT04722952|Visilizumab|visilizumab|mesh-list
110822273|NCT04722952|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110822275|NCT04722952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110822276|NCT04722952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110822277|NCT04722952|Antiviral Agents|antiviral agents|mesh-ancestor
110822278|NCT04722952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110822279|NCT04722952|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110822280|NCT04722952|Immunologic Factors|immunologic factors|mesh-ancestor
110822281|NCT04722952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110822282|NCT04722952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110822283|NCT04722952|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110822284|NCT04722952|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110822285|NCT01365260|Hyaluronic Acid|hyaluronic acid|mesh-list
110822286|NCT01365260|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110822287|NCT01365260|Immunologic Factors|immunologic factors|mesh-ancestor
110822288|NCT01365260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110822289|NCT01365260|Viscosupplements|viscosupplements|mesh-ancestor
110822290|NCT01365260|Protective Agents|protective agents|mesh-ancestor
110822291|NCT01235455|Interferons|interferons|mesh-list
110822292|NCT01235455|Interferon-beta|interferon-beta|mesh-list
110822293|NCT01235455|Interferon beta-1b|interferon beta-1b|mesh-list
110822294|NCT01235455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110822295|NCT01235455|Antiviral Agents|antiviral agents|mesh-ancestor
110822296|NCT01235455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110822297|NCT01235455|Immunologic Factors|immunologic factors|mesh-ancestor
110822298|NCT01235455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110822299|NCT01235455|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110822300|NCT01145677|Topiramate|topiramate|mesh-list
110822301|NCT01145677|Anticonvulsants|anticonvulsants|mesh-ancestor
110822302|NCT01145677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110822303|NCT01145677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110822304|NCT02319616|Clobetasol|clobetasol|mesh-list
110822305|NCT02319616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110822306|NCT02319616|Glucocorticoids|glucocorticoids|mesh-ancestor
110822307|NCT02319616|Hormones|hormones|mesh-ancestor
110822308|NCT02319616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110822309|NCT02319616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110822310|NCT01142245|Esomeprazole|esomeprazole|mesh-list
110822311|NCT01142245|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110822312|NCT01142245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110822313|NCT01142245|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110822314|NCT01142245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110822315|NCT01142245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110822316|NCT02319772|Galidesivir|galidesivir|mesh-list
110822317|NCT02319772|Antiviral Agents|antiviral agents|mesh-ancestor
110822318|NCT02319772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110822319|NCT03499132|Anesthetics|anesthetics|mesh-list
110822320|NCT03499132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110418811|NCT02877615|S44819|s44819|mesh-list
110822321|NCT03499132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110822322|NCT01142401|Bortezomib|bortezomib|mesh-list
110822323|NCT01142401|Fulvestrant|fulvestrant|mesh-list
110822324|NCT01142401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110822325|NCT01142401|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110822326|NCT01142401|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110822327|NCT01142401|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110822328|NCT01142401|Hormone Antagonists|hormone antagonists|mesh-ancestor
110822329|NCT01142401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110822330|NCT01142401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110822331|NCT03498898|Adrenergic Agents|adrenergic agents|mesh-list
110822332|NCT03498898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110822333|NCT03498898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110822334|NCT03498898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110822335|NCT03498820|Remifentanil|remifentanil|mesh-list
110822336|NCT03498820|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110822337|NCT03498820|Narcotics|narcotics|mesh-ancestor
110822338|NCT03498820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110822339|NCT03498820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110822340|NCT03498820|Analgesics|analgesics|mesh-ancestor
110822341|NCT03498820|Sensory System Agents|sensory system agents|mesh-ancestor
110822342|NCT03498820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110822343|NCT05158309|Capsaicin|capsaicin|mesh-list
110822344|NCT05158309|Antipruritics|antipruritics|mesh-ancestor
110822345|NCT05158309|Dermatologic Agents|dermatologic agents|mesh-ancestor
110822346|NCT05158309|Sensory System Agents|sensory system agents|mesh-ancestor
110822347|NCT05158309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110822348|NCT05158309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110822349|NCT02320084|Nitisinone|nitisinone|mesh-list
110822350|NCT02320084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110822351|NCT02320084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110822352|NCT02320240|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110822353|NCT02320240|Fluvoxamine|fluvoxamine|mesh-list
110822354|NCT02320240|Citalopram|citalopram|mesh-list
110822355|NCT02320240|Fluoxetine|fluoxetine|mesh-list
110822356|NCT02320240|Paroxetine|paroxetine|mesh-list
110822357|NCT02320240|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
110822358|NCT02320240|Sertraline|sertraline|mesh-list
110822359|NCT02320240|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
110822360|NCT02320240|Escitalopram|escitalopram|mesh-list
110822361|NCT02320240|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110822362|NCT02320240|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110822363|NCT02320240|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110822364|NCT02320240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110822365|NCT02320240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110822366|NCT02320240|Serotonin Agents|serotonin agents|mesh-ancestor
110822367|NCT02320240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110822368|NCT02320240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110822369|NCT02320240|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110822370|NCT02320240|Antidepressive Agents|antidepressive agents|mesh-ancestor
110822371|NCT02320240|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110822372|NCT02320240|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110822373|NCT02320240|Analgesics|analgesics|mesh-ancestor
110822374|NCT02320240|Sensory System Agents|sensory system agents|mesh-ancestor
110822375|NCT02320240|Dopamine Agents|dopamine agents|mesh-ancestor
110822376|NCT02320240|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110822377|NCT02320240|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110822378|NCT02320240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110822379|NCT02320240|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110822380|NCT02320240|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110822381|NCT02320240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110822382|NCT02320240|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110822383|NCT02320240|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110822384|NCT03492736|Melatonin|melatonin|mesh-list
110822385|NCT03492736|Antioxidants|antioxidants|mesh-ancestor
110822386|NCT03492736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110822387|NCT03492736|Protective Agents|protective agents|mesh-ancestor
110822388|NCT03492736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110822389|NCT03492736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110822390|NCT02320474|Aflibercept|aflibercept|mesh-list
110822391|NCT02320474|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110822392|NCT02320474|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110822393|NCT02320474|Growth Substances|growth substances|mesh-ancestor
110822394|NCT02320474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110822395|NCT02320474|Growth Inhibitors|growth inhibitors|mesh-ancestor
110822396|NCT02320474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110822397|NCT03492580|Dapagliflozin|dapagliflozin|mesh-list
110822398|NCT03492580|Empagliflozin|empagliflozin|mesh-list
110822399|NCT03492580|Canagliflozin|canagliflozin|mesh-list
110822400|NCT03492580|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
110822401|NCT03492580|Hypoglycemic Agents|hypoglycemic agents|mesh-list
110822402|NCT03492580|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
110822403|NCT03492580|Glucagon|glucagon|mesh-list
110822404|NCT03492580|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
110822405|NCT03492580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110822406|NCT03492580|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110822407|NCT03492580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110822408|NCT03492580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110822409|NCT03492580|Hormones|hormones|mesh-ancestor
110822410|NCT03492580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110822411|NCT03492580|Incretins|incretins|mesh-ancestor
110822412|NCT03492580|Protease Inhibitors|protease inhibitors|mesh-ancestor
110822413|NCT03492580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110822414|NCT01238965|Calcium, Dietary|calcium, dietary|mesh-list
110822415|NCT01238965|Leucovorin|leucovorin|mesh-list
110822416|NCT01238965|Fluorouracil|fluorouracil|mesh-list
110822417|NCT01238965|Panobinostat|panobinostat|mesh-list
110822418|NCT01238965|Calcium|calcium|mesh-list
110822419|NCT01238965|Levoleucovorin|levoleucovorin|mesh-list
110822420|NCT01238965|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
110822421|NCT01238965|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110822422|NCT01238965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110822423|NCT01238965|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110822424|NCT01238965|Antimetabolites|antimetabolites|mesh-ancestor
110822425|NCT01238965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110822426|NCT01238965|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110822427|NCT01238965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110822428|NCT01238965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110822429|NCT01238965|Immunologic Factors|immunologic factors|mesh-ancestor
110822431|NCT01238965|Protective Agents|protective agents|mesh-ancestor
110822432|NCT01238965|Vitamin B Complex|vitamin b complex|mesh-ancestor
110822433|NCT01238965|Vitamins|vitamins|mesh-ancestor
110822434|NCT01238965|Micronutrients|micronutrients|mesh-ancestor
110822435|NCT01238965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110822436|NCT01142557|Interferons|interferons|mesh-list
110822437|NCT01142557|Interferon-beta|interferon-beta|mesh-list
110822438|NCT01142557|Interferon beta-1a|interferon beta-1a|mesh-list
110822439|NCT01142557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110822440|NCT01142557|Antiviral Agents|antiviral agents|mesh-ancestor
110822441|NCT01142557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110822442|NCT01142557|Immunologic Factors|immunologic factors|mesh-ancestor
110822443|NCT01142557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110822444|NCT01142557|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110822445|NCT04496908|Misoprostol|misoprostol|mesh-list
110822446|NCT04496908|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110822447|NCT04496908|Abortifacient Agents|abortifacient agents|mesh-ancestor
110822448|NCT04496908|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110822449|NCT04496908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110822450|NCT04496908|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110822451|NCT04496908|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110822452|NCT04496908|Oxytocics|oxytocics|mesh-ancestor
110822453|NCT01144117|Epoetin Alfa|epoetin alfa|mesh-list
110822454|NCT01144117|Hematinics|hematinics|mesh-ancestor
110822455|NCT04371640|Sirolimus|sirolimus|mesh-list
110822456|NCT04371640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110822457|NCT04371640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110822458|NCT04371640|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110822459|NCT04371640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110822460|NCT04371640|Antifungal Agents|antifungal agents|mesh-ancestor
110822461|NCT04371640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110822462|NCT04371640|Immunologic Factors|immunologic factors|mesh-ancestor
110822463|NCT04371640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110822464|NCT04356196|Verapamil|verapamil|mesh-list
110822465|NCT04356196|Bisoprolol|bisoprolol|mesh-list
110822466|NCT04356196|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110822467|NCT04356196|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110822468|NCT04356196|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110822469|NCT04356196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110822470|NCT04356196|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110822471|NCT04356196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110822472|NCT04356196|Vasodilator Agents|vasodilator agents|mesh-ancestor
110822473|NCT04356196|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110822474|NCT04356196|Sympatholytics|sympatholytics|mesh-ancestor
110822475|NCT04356196|Autonomic Agents|autonomic agents|mesh-ancestor
110822476|NCT04356196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110822477|NCT04356196|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110822478|NCT04356196|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110822479|NCT04356196|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110822480|NCT04356196|Adrenergic Agents|adrenergic agents|mesh-ancestor
110822481|NCT04356196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110822482|NCT02115139|Ipilimumab|ipilimumab|mesh-list
110822483|NCT02115139|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110822484|NCT02115139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110822485|NCT02115139|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110822486|NCT02115139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110822487|NCT02047981|Azithromycin|azithromycin|mesh-list
110822488|NCT02047981|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110822489|NCT02047981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110822490|NCT04802356|Dexamethasone|dexamethasone|mesh-list
110822491|NCT04802356|Lenalidomide|lenalidomide|mesh-list
110822492|NCT04802356|Bortezomib|bortezomib|mesh-list
110822493|NCT04802356|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110822494|NCT04802356|Antiemetics|antiemetics|mesh-ancestor
110822495|NCT04802356|Autonomic Agents|autonomic agents|mesh-ancestor
110822496|NCT04802356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110822497|NCT04802356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110822498|NCT04802356|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110822499|NCT04802356|Glucocorticoids|glucocorticoids|mesh-ancestor
110822500|NCT04802356|Hormones|hormones|mesh-ancestor
110822501|NCT04802356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110822502|NCT04802356|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110822503|NCT04802356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110822504|NCT04802356|Immunologic Factors|immunologic factors|mesh-ancestor
110822505|NCT04802356|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110540039|NCT02789579|Levofloxacin|levofloxacin|mesh-list
110822506|NCT04802356|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110822507|NCT04802356|Growth Substances|growth substances|mesh-ancestor
110822508|NCT04802356|Growth Inhibitors|growth inhibitors|mesh-ancestor
110822509|NCT01142635|Bromides|bromides|mesh-list
110822510|NCT01142635|Rocuronium|rocuronium|mesh-list
110822511|NCT01142635|Anticonvulsants|anticonvulsants|mesh-ancestor
110822512|NCT01142635|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110822513|NCT01142635|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110822514|NCT01142635|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110822515|NCT01142635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110822516|NCT01142635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110822517|NCT01144195|Panitumumab|panitumumab|mesh-list
110822518|NCT01144195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110822519|NCT01144195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110822520|NCT05631769|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
110822521|NCT02528383|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110822522|NCT02528383|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110822523|NCT02528383|Estradiol|estradiol|mesh-list
110822524|NCT02528383|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110822525|NCT02528383|Estrogens|estrogens|mesh-ancestor
110822526|NCT02528383|Hormones|hormones|mesh-ancestor
110147795|NCT00006007|Gemcitabine|gemcitabine|mesh-list
110822527|NCT02528383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110822528|NCT02528383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110822529|NCT02528383|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110822530|NCT02528383|Contraceptive Agents|contraceptive agents|mesh-ancestor
110822531|NCT02528383|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110822532|NCT02528383|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110822533|NCT01146067|Rivastigmine|rivastigmine|mesh-list
110822534|NCT01146067|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110822535|NCT01146067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110822536|NCT01146067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110822537|NCT01146067|Cholinergic Agents|cholinergic agents|mesh-ancestor
110822538|NCT01146067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110822539|NCT01146067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110822540|NCT01146067|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110822541|NCT01146067|Protective Agents|protective agents|mesh-ancestor
110822542|NCT01237249|Dexamethasone|dexamethasone|mesh-list
110822544|NCT01237249|Melphalan|melphalan|mesh-list
110822545|NCT01237249|Lenalidomide|lenalidomide|mesh-list
110822546|NCT01237249|Bortezomib|bortezomib|mesh-list
110822547|NCT01237249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110822548|NCT01237249|Antiemetics|antiemetics|mesh-ancestor
110822549|NCT01237249|Autonomic Agents|autonomic agents|mesh-ancestor
110822550|NCT01237249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110822551|NCT01237249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110822552|NCT01237249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110822553|NCT01237249|Glucocorticoids|glucocorticoids|mesh-ancestor
110822554|NCT01237249|Hormones|hormones|mesh-ancestor
110822555|NCT01237249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110822556|NCT01237249|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110822557|NCT01237249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110822558|NCT01237249|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110822559|NCT01237249|Alkylating Agents|alkylating agents|mesh-ancestor
110822560|NCT01237249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110822561|NCT01237249|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110822562|NCT01237249|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110822563|NCT01237249|Immunologic Factors|immunologic factors|mesh-ancestor
110822564|NCT01237249|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110822565|NCT01237249|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110822566|NCT01237249|Growth Substances|growth substances|mesh-ancestor
110822567|NCT01237249|Growth Inhibitors|growth inhibitors|mesh-ancestor
110822568|NCT03646162|Zuclomiphene|zuclomiphene|mesh-list
110822569|NCT03646162|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110822570|NCT03646162|Hormone Antagonists|hormone antagonists|mesh-ancestor
110822571|NCT03646162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110822572|NCT03646162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110822573|NCT03646162|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110822574|NCT03646162|Fertility Agents|fertility agents|mesh-ancestor
110822575|NCT03646162|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110822576|NCT03646162|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110822577|NCT03646162|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110822578|NCT01244347|Folic Acid|folic acid|mesh-list
110822579|NCT01244347|Vitamin B Complex|vitamin b complex|mesh-list
110822580|NCT01244347|Hematinics|hematinics|mesh-ancestor
110822581|NCT01244347|Vitamins|vitamins|mesh-ancestor
110822582|NCT01244347|Micronutrients|micronutrients|mesh-ancestor
110822583|NCT01244347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110822584|NCT01763827|Ezetimibe|ezetimibe|mesh-list
110822585|NCT01763827|Evolocumab|evolocumab|mesh-list
110822586|NCT01763827|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110822587|NCT01763827|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110822588|NCT01763827|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110822589|NCT01763827|Antimetabolites|antimetabolites|mesh-ancestor
110822590|NCT01763827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110822591|NCT01763827|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110822592|NCT01763827|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
110822593|NCT01763827|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110822594|NCT01763827|Protease Inhibitors|protease inhibitors|mesh-ancestor
110822595|NCT01763827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110822596|NCT01763827|Immunologic Factors|immunologic factors|mesh-ancestor
110822597|NCT01763827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110822598|NCT01146145|Ketamine|ketamine|mesh-list
110822599|NCT01146145|Morphine|morphine|mesh-list
110822600|NCT01146145|Analgesics|analgesics|mesh-ancestor
110855071|NCT03786419|Atezolizumab|atezolizumab|mesh-list
110822601|NCT01146145|Sensory System Agents|sensory system agents|mesh-ancestor
110822603|NCT01146145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110822604|NCT01146145|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110822605|NCT01146145|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110822606|NCT01146145|Anesthetics, General|anesthetics, general|mesh-ancestor
110822607|NCT01146145|Anesthetics|anesthetics|mesh-ancestor
110822608|NCT01146145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110822609|NCT01146145|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110822610|NCT01146145|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110822611|NCT01146145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110822612|NCT01146145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110822613|NCT01146145|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110822614|NCT01146145|Narcotics|narcotics|mesh-ancestor
110822615|NCT01146535|Interferons|interferons|mesh-list
110822616|NCT01146535|Interferon-alpha|interferon-alpha|mesh-list
110822617|NCT01146535|Oseltamivir|oseltamivir|mesh-list
110822618|NCT01146535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110822619|NCT01146535|Antiviral Agents|antiviral agents|mesh-ancestor
110822620|NCT01146535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110822621|NCT01146535|Immunologic Factors|immunologic factors|mesh-ancestor
110822622|NCT01146535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110822623|NCT01146535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110822624|NCT01146535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110822625|NCT01732783|Panitumumab|panitumumab|mesh-list
110822626|NCT01732783|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110822627|NCT01732783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110822628|NCT04355728|Heparin|heparin|mesh-list
110822629|NCT04355728|Calcium heparin|calcium heparin|mesh-list
110822630|NCT04355728|Anticoagulants|anticoagulants|mesh-ancestor
110822631|NCT04355728|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110822632|NCT04355728|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110822633|NCT04355728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110822634|NCT01693783|Ipilimumab|ipilimumab|mesh-list
110822635|NCT01693783|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110822636|NCT01693783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110822637|NCT01693783|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110822638|NCT01693783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110822639|NCT02528461|Sofosbuvir|sofosbuvir|mesh-list
110822640|NCT02528461|Liver Extracts|liver extracts|mesh-list
110822641|NCT02528461|Hematinics|hematinics|mesh-ancestor
110822642|NCT02528461|Antiviral Agents|antiviral agents|mesh-ancestor
110822643|NCT02528461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110822644|NCT01237483|Cetuximab|cetuximab|mesh-list
110822645|NCT01237483|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110822646|NCT01237483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110822647|NCT01240213|Vitamin D|vitamin d|mesh-list
110822648|NCT01240213|Vitamins|vitamins|mesh-ancestor
110822649|NCT01240213|Micronutrients|micronutrients|mesh-ancestor
110822650|NCT01240213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110822651|NCT01240213|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110822652|NCT01375777|Ezetimibe|ezetimibe|mesh-list
110822653|NCT01375777|Evolocumab|evolocumab|mesh-list
110822654|NCT01375777|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110822655|NCT01375777|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110540188|NCT00881868|Clobetasol|clobetasol|mesh-list
110822656|NCT01375777|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110822657|NCT01375777|Antimetabolites|antimetabolites|mesh-ancestor
110822658|NCT01375777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110822660|NCT01375777|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
110822661|NCT01375777|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110822662|NCT01375777|Protease Inhibitors|protease inhibitors|mesh-ancestor
110822663|NCT01375777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110822664|NCT01375777|Immunologic Factors|immunologic factors|mesh-ancestor
110822665|NCT01375777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110822666|NCT02431702|Haloperidol|haloperidol|mesh-list
110822667|NCT02431702|Olanzapine|olanzapine|mesh-list
110822668|NCT02431702|Risperidone|risperidone|mesh-list
110822669|NCT02431702|Aripiprazole|aripiprazole|mesh-list
110822670|NCT02431702|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110822671|NCT02431702|Paliperidone Palmitate|paliperidone palmitate|mesh-list
110822672|NCT02431702|Haloperidol decanoate|haloperidol decanoate|mesh-list
110822673|NCT02431702|Perphenazine|perphenazine|mesh-list
110822674|NCT02431702|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110822675|NCT02431702|Serotonin Agents|serotonin agents|mesh-ancestor
110822676|NCT02431702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110822677|NCT02431702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110822678|NCT02431702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110822679|NCT02431702|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110822680|NCT02431702|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110822681|NCT02431702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110822682|NCT02431702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110822683|NCT02431702|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110822684|NCT02431702|Dopamine Agents|dopamine agents|mesh-ancestor
110822685|NCT02431702|Antiemetics|antiemetics|mesh-ancestor
110822686|NCT02431702|Autonomic Agents|autonomic agents|mesh-ancestor
110822687|NCT02431702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110822688|NCT02431702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110822689|NCT02431702|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110822690|NCT02431702|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110822691|NCT02431702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110822692|NCT02431702|Antidepressive Agents|antidepressive agents|mesh-ancestor
110822693|NCT02431702|Dopamine Agonists|dopamine agonists|mesh-ancestor
110822694|NCT02431702|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110822695|NCT02431702|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110822696|NCT02431702|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110822697|NCT02431702|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110822698|NCT02431702|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110822699|NCT01145209|Cyclophosphamide|cyclophosphamide|mesh-list
110822700|NCT01145209|Fludarabine|fludarabine|mesh-list
110822701|NCT01145209|Fludarabine phosphate|fludarabine phosphate|mesh-list
110822702|NCT01145209|Ofatumumab|ofatumumab|mesh-list
110822703|NCT01145209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110822704|NCT01145209|Immunologic Factors|immunologic factors|mesh-ancestor
110822705|NCT01145209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110822706|NCT01145209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110822707|NCT01145209|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110822708|NCT01145209|Alkylating Agents|alkylating agents|mesh-ancestor
110822709|NCT01145209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110822710|NCT01145209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110822711|NCT01145209|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110822712|NCT01145209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110822713|NCT01145209|Antimetabolites|antimetabolites|mesh-ancestor
110822714|NCT02086552|Lenalidomide|lenalidomide|mesh-list
110822715|NCT02086552|Immunologic Factors|immunologic factors|mesh-ancestor
110822716|NCT02086552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110822717|NCT02086552|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110822718|NCT02086552|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110822719|NCT02086552|Growth Substances|growth substances|mesh-ancestor
110822720|NCT02086552|Growth Inhibitors|growth inhibitors|mesh-ancestor
110822721|NCT02086552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110822722|NCT02321878|Liraglutide|liraglutide|mesh-list
110822723|NCT02321878|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110822724|NCT02321878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110822725|NCT02321878|Incretins|incretins|mesh-ancestor
110822726|NCT02321878|Hormones|hormones|mesh-ancestor
110822727|NCT02321878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110822728|NCT03625141|Atezolizumab|atezolizumab|mesh-list
110822729|NCT03625141|Vemurafenib|vemurafenib|mesh-list
110822730|NCT03625141|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110822731|NCT03625141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110822732|NCT03625141|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110822733|NCT03625141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110822734|NCT03625141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110822735|NCT03625141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110822737|NCT03491410|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110822738|NCT03491410|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110822739|NCT03491410|Analgesics|analgesics|mesh-ancestor
110822740|NCT03491410|Sensory System Agents|sensory system agents|mesh-ancestor
110822741|NCT03491410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110822742|NCT03491410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110822743|NCT03491410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110822744|NCT03491410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110822745|NCT03491410|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110822746|NCT03491410|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110822747|NCT03491410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110822748|NCT03491410|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110822749|NCT03491410|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110822750|NCT03491410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110822751|NCT03491410|Antipyretics|antipyretics|mesh-ancestor
110822752|NCT00876031|Etoposide|etoposide|mesh-list
110822754|NCT00876031|Trofosfamide|trofosfamide|mesh-list
110822755|NCT00876031|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110822756|NCT00876031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110822757|NCT00876031|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110822758|NCT00876031|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110822759|NCT00876031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110822760|NCT00876031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110822761|NCT00876031|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110822762|NCT00876031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110822763|NCT00876031|Immunologic Factors|immunologic factors|mesh-ancestor
110822764|NCT00876031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110418821|NCT02437279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110822765|NCT00876031|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110822766|NCT00876031|Alkylating Agents|alkylating agents|mesh-ancestor
110822767|NCT02322346|Levobupivacaine|levobupivacaine|mesh-list
110822768|NCT02322346|Anesthetics, Local|anesthetics, local|mesh-ancestor
110822769|NCT02322346|Anesthetics|anesthetics|mesh-ancestor
110822770|NCT02322346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110822771|NCT02322346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110822772|NCT02322346|Sensory System Agents|sensory system agents|mesh-ancestor
110822773|NCT02322346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110822774|NCT01146301|Clopidogrel|clopidogrel|mesh-list
110822775|NCT01146301|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110822776|NCT01146301|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110822777|NCT01146301|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110822778|NCT01146301|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110822779|NCT01146301|Purinergic Agents|purinergic agents|mesh-ancestor
110822780|NCT01146301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110822781|NCT01146301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110822782|NCT01146301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110822783|NCT00807859|Paclitaxel|paclitaxel|mesh-list
110822784|NCT00807859|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110822785|NCT00807859|Capecitabine|capecitabine|mesh-list
110822786|NCT00807859|Trastuzumab|trastuzumab|mesh-list
110822787|NCT00807859|Lapatinib|lapatinib|mesh-list
110822788|NCT00807859|Trebananib|trebananib|mesh-list
110822789|NCT00807859|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110822790|NCT00807859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110822791|NCT00807859|Tubulin Modulators|tubulin modulators|mesh-ancestor
110822792|NCT00807859|Antimitotic Agents|antimitotic agents|mesh-ancestor
110822793|NCT00807859|Mitosis Modulators|mitosis modulators|mesh-ancestor
110822794|NCT00807859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110822795|NCT00807859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110822796|NCT00807859|Antimetabolites|antimetabolites|mesh-ancestor
110822797|NCT00807859|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110822798|NCT00807859|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110822799|NCT00807859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110822800|NCT00807859|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110822801|NCT00807859|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110822802|NCT00807859|Growth Substances|growth substances|mesh-ancestor
110822803|NCT00807859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110822804|NCT00807859|Growth Inhibitors|growth inhibitors|mesh-ancestor
110822805|NCT01246453|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
110822806|NCT01246453|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110822807|NCT01246453|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110822808|NCT01246453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110822809|NCT03491098|Mometasone Furoate|mometasone furoate|mesh-list
110822810|NCT03491098|Prednisolone|prednisolone|mesh-list
110822811|NCT03491098|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110822812|NCT03491098|Methylprednisolone|methylprednisolone|mesh-list
110822813|NCT03491098|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110822814|NCT03491098|Prednisolone acetate|prednisolone acetate|mesh-list
110822815|NCT03491098|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110822816|NCT03491098|Prednisolone phosphate|prednisolone phosphate|mesh-list
110822817|NCT03491098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110822818|NCT03491098|Glucocorticoids|glucocorticoids|mesh-ancestor
110822819|NCT03491098|Hormones|hormones|mesh-ancestor
110822820|NCT03491098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110822821|NCT03491098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110822822|NCT03491098|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110822823|NCT03491098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110822824|NCT03491098|Antiemetics|antiemetics|mesh-ancestor
110822825|NCT03491098|Autonomic Agents|autonomic agents|mesh-ancestor
110148091|NCT03996148|Remifentanil|remifentanil|mesh-list
110822826|NCT03491098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110822827|NCT03491098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110822828|NCT03491098|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110822830|NCT03491098|Dermatologic Agents|dermatologic agents|mesh-ancestor
110822831|NCT03491098|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110822832|NCT02322502|Propofol|propofol|mesh-list
110822833|NCT02322502|Sevoflurane|sevoflurane|mesh-list
110822834|NCT02322502|Desflurane|desflurane|mesh-list
110822835|NCT02322502|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110822836|NCT02322502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110822837|NCT02322502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110822838|NCT02322502|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110822839|NCT02322502|Anesthetics, General|anesthetics, general|mesh-ancestor
110822840|NCT02322502|Anesthetics|anesthetics|mesh-ancestor
110822841|NCT02322502|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110822842|NCT02322502|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110822843|NCT02322580|Etanercept|etanercept|mesh-list
110822844|NCT02322580|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110822845|NCT02322580|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110822846|NCT02322580|Analgesics|analgesics|mesh-ancestor
110822847|NCT02322580|Sensory System Agents|sensory system agents|mesh-ancestor
110822848|NCT02322580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110822849|NCT02322580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110822850|NCT02322580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110822851|NCT02322580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110822852|NCT02322580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110822853|NCT02322580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110822854|NCT02322580|Immunologic Factors|immunologic factors|mesh-ancestor
110822855|NCT03190174|Sirolimus|sirolimus|mesh-list
110822856|NCT03190174|Nivolumab|nivolumab|mesh-list
110822857|NCT03190174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110822858|NCT03190174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110822859|NCT03190174|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110822860|NCT03190174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110822861|NCT03190174|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110822862|NCT03190174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110822863|NCT03190174|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110822864|NCT03190174|Antifungal Agents|antifungal agents|mesh-ancestor
110822865|NCT03190174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110822866|NCT03190174|Immunologic Factors|immunologic factors|mesh-ancestor
110822867|NCT03190174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110822868|NCT03490708|Tranilast|tranilast|mesh-list
110822869|NCT03490708|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110822870|NCT03490708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110822871|NCT03490708|Analgesics|analgesics|mesh-ancestor
110822872|NCT03490708|Sensory System Agents|sensory system agents|mesh-ancestor
110822873|NCT03490708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110822874|NCT03490708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110822875|NCT03490708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110822876|NCT03490708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110822877|NCT03490708|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110822878|NCT03490708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110822879|NCT03490708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110822880|NCT03490708|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110822881|NCT03490708|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110822882|NCT03490708|Histamine Antagonists|histamine antagonists|mesh-ancestor
110822883|NCT03490708|Histamine Agents|histamine agents|mesh-ancestor
110822884|NCT03490708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110822885|NCT03490708|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110822886|NCT03490708|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110822887|NCT00924326|Vidarabine|vidarabine|mesh-list
110822888|NCT00924326|Aldesleukin|aldesleukin|mesh-list
110822889|NCT00924326|Cyclophosphamide|cyclophosphamide|mesh-list
110822890|NCT00924326|Fludarabine|fludarabine|mesh-list
110822891|NCT00924326|Fludarabine phosphate|fludarabine phosphate|mesh-list
110822892|NCT00924326|Interleukin-2|interleukin-2|mesh-list
110822893|NCT00924326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110822894|NCT00924326|Immunologic Factors|immunologic factors|mesh-ancestor
110822895|NCT00924326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110822896|NCT00924326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110822897|NCT00924326|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110822898|NCT00924326|Alkylating Agents|alkylating agents|mesh-ancestor
110822899|NCT00924326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110822900|NCT00924326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110822902|NCT00924326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110822903|NCT00924326|Antimetabolites|antimetabolites|mesh-ancestor
110822904|NCT00924326|Antiviral Agents|antiviral agents|mesh-ancestor
110822905|NCT00924326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110822906|NCT00924326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110822907|NCT00924326|Analgesics|analgesics|mesh-ancestor
110822908|NCT00924326|Sensory System Agents|sensory system agents|mesh-ancestor
110822909|NCT00924326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110196771|NCT00214942|Fentanyl|fentanyl|mesh-list
110822910|NCT00924326|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110822911|NCT00924326|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110822913|NCT03496870|Carbidopa|carbidopa|mesh-list
110822914|NCT03496870|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
110822915|NCT03496870|Opicapone|opicapone|mesh-list
110822916|NCT03496870|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110822917|NCT03496870|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110822918|NCT03496870|Dopamine Agents|dopamine agents|mesh-ancestor
110822919|NCT03496870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110822920|NCT03496870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110822921|NCT03496870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110822922|NCT03496870|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
110822923|NCT03496870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110822924|NCT03496870|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110822925|NCT03496870|Immunologic Factors|immunologic factors|mesh-ancestor
110822926|NCT03496870|Dopamine Agonists|dopamine agonists|mesh-ancestor
110822927|NCT03496870|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
110822928|NCT01370096|Epoprostenol|epoprostenol|mesh-list
110822929|NCT01370096|Vasopressins|vasopressins|mesh-list
110822930|NCT01370096|Arginine Vasopressin|arginine vasopressin|mesh-list
110822931|NCT01370096|Tezosentan|tezosentan|mesh-list
110822932|NCT01370096|Hemostatics|hemostatics|mesh-ancestor
110822933|NCT01370096|Coagulants|coagulants|mesh-ancestor
110822934|NCT01370096|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110822935|NCT01370096|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
110822936|NCT01370096|Natriuretic Agents|natriuretic agents|mesh-ancestor
110822937|NCT01370096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110822938|NCT01370096|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110822939|NCT01370096|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110822940|NCT01370096|Vasodilator Agents|vasodilator agents|mesh-ancestor
110822941|NCT03131570|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110822942|NCT03131570|Immunologic Factors|immunologic factors|mesh-ancestor
110822943|NCT03131570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110822944|NCT01370876|Oxaliplatin|oxaliplatin|mesh-list
110822945|NCT01370876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110822946|NCT02875028|Vorapaxar|vorapaxar|mesh-list
110822947|NCT02875028|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110822948|NCT01371344|Tacrolimus|tacrolimus|mesh-list
110822949|NCT01371344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110822950|NCT01371344|Immunologic Factors|immunologic factors|mesh-ancestor
110822951|NCT01371344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110822952|NCT01371344|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110822953|NCT01371344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110822954|NCT01371344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110822955|NCT03631004|Olanzapine|olanzapine|mesh-list
110822956|NCT03631004|Antiemetics|antiemetics|mesh-ancestor
110822957|NCT03631004|Autonomic Agents|autonomic agents|mesh-ancestor
110822958|NCT03631004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110822959|NCT03631004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110822960|NCT03631004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110822961|NCT03631004|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110822962|NCT03631004|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110822963|NCT03631004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110822964|NCT03631004|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110822965|NCT03631004|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110822966|NCT03631004|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110822967|NCT03631004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110822968|NCT03631004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110822969|NCT03631004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110822970|NCT03631004|Serotonin Agents|serotonin agents|mesh-ancestor
110822971|NCT01366118|Oxaliplatin|oxaliplatin|mesh-list
110822972|NCT01366118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110822973|NCT00943618|Bupropion|bupropion|mesh-list
110822974|NCT00943618|Varenicline|varenicline|mesh-list
110822975|NCT00943618|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110822976|NCT00943618|Antidepressive Agents|antidepressive agents|mesh-ancestor
110822977|NCT00943618|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110446071|NCT04131283|Epinephrine|epinephrine|mesh-list
110822978|NCT00943618|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110446433|NCT01188668|Aripiprazole|aripiprazole|mesh-list
110446510|NCT01182194|Drospirenone|drospirenone|mesh-list
110446731|NCT01185782|Hormones|hormones|mesh-list
110446954|NCT02757196|Prednisolone phosphate|prednisolone phosphate|mesh-list
110822980|NCT00943618|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110447631|NCT01074216|Micronutrients|micronutrients|mesh-ancestor
110447709|NCT02041234|Hormones|hormones|mesh-ancestor
110447801|NCT02745886|Metformin|metformin|mesh-list
110448084|NCT04306510|Immunoglobulins|immunoglobulins|mesh-list
110448607|NCT02730364|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110448759|NCT04304196|TEMPO|tempo|mesh-list
110822981|NCT00943618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110448984|NCT02714998|Antimetabolites|antimetabolites|mesh-ancestor
110822982|NCT00943618|Dopamine Agents|dopamine agents|mesh-ancestor
110449066|NCT04000906|Paclitaxel|paclitaxel|mesh-list
110449353|NCT02708446|Oxytocics|oxytocics|mesh-ancestor
110449504|NCT01120691|Albuterol|albuterol|mesh-list
110449578|NCT00935493|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110449651|NCT00625547|Dopamine Agonists|dopamine agonists|mesh-ancestor
110822983|NCT00943618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110822984|NCT00943618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110822985|NCT00943618|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110822986|NCT00943618|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110822987|NCT00943618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110450382|NCT05244538|Remifentanil|remifentanil|mesh-list
110450530|NCT01055496|Rituximab|rituximab|mesh-list
110450531|NCT01055496|Gemcitabine|gemcitabine|mesh-list
110450532|NCT01055496|Vincristine|vincristine|mesh-list
110450533|NCT01055496|Cisplatin|cisplatin|mesh-list
110450534|NCT01055496|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
110450535|NCT01055496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110450536|NCT01055496|Immunologic Factors|immunologic factors|mesh-ancestor
110450537|NCT01055496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110450538|NCT01055496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110450539|NCT01055496|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110450540|NCT01055496|Alkylating Agents|alkylating agents|mesh-ancestor
110450542|NCT01055496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110822988|NCT00943618|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110450826|NCT01114529|Cyclosporine|cyclosporine|mesh-list
110450977|NCT01114139|Hematinics|hematinics|mesh-ancestor
110451128|NCT02698306|Glucocorticoids|glucocorticoids|mesh-ancestor
110451202|NCT02697838|Tubulin Modulators|tubulin modulators|mesh-ancestor
110451360|NCT02699710|Folic Acid|folic acid|mesh-list
110822990|NCT00943618|Cholinergic Agents|cholinergic agents|mesh-ancestor
110822991|NCT01372670|Hydroxyzine|hydroxyzine|mesh-list
110822992|NCT01372670|Antipruritics|antipruritics|mesh-ancestor
110451885|NCT01104701|Exenatide|exenatide|mesh-list
110822993|NCT01372670|Dermatologic Agents|dermatologic agents|mesh-ancestor
110452391|NCT02878265|Zinc|zinc|mesh-list
110452473|NCT04255251|Cariostatic Agents|cariostatic agents|mesh-ancestor
110452698|NCT05295394|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110822994|NCT01372670|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110822995|NCT01372670|Histamine Antagonists|histamine antagonists|mesh-ancestor
110453154|NCT00621868|Ipragliflozin|ipragliflozin|mesh-list
110453224|NCT00618280|Nicotine|nicotine|mesh-list
110453531|NCT01176032|Vasodilator Agents|vasodilator agents|mesh-ancestor
110822997|NCT01372670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110453607|NCT01193842|Hormones|hormones|mesh-ancestor
110453676|NCT03844750|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110454313|NCT02679820|Copper|copper|mesh-list
110822998|NCT01372670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110822999|NCT01372670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110454657|NCT01159574|Immunologic Factors|immunologic factors|mesh-ancestor
110823001|NCT02322658|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110454958|NCT02667730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110455183|NCT02665936|Glucocorticoids|glucocorticoids|mesh-ancestor
110455255|NCT02669368|Anesthetics|anesthetics|mesh-ancestor
110455326|NCT00646516|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110455495|NCT04171180|Budesonide|budesonide|mesh-list
110455851|NCT02661100|Pembrolizumab|pembrolizumab|mesh-list
110456000|NCT01156142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110823002|NCT02322658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110456298|NCT00649090|Exemestane|exemestane|mesh-list
110456460|NCT04201756|Afatinib|afatinib|mesh-list
110456749|NCT02644720|Hormones|hormones|mesh-ancestor
110823003|NCT02322658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110823004|NCT04218656|Rivaroxaban|rivaroxaban|mesh-list
110823005|NCT04218656|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110457511|NCT01121666|Hormones|hormones|mesh-ancestor
110457652|NCT04290858|Nitric Oxide|nitric oxide|mesh-list
110457799|NCT00709189|Folic Acid|folic acid|mesh-list
110458032|NCT02635282|Narcotics|narcotics|mesh-ancestor
110458099|NCT00656812|Rituximab|rituximab|mesh-list
110458183|NCT00657514|Ranolazine|ranolazine|mesh-list
110458325|NCT00597766|Lidocaine|lidocaine|mesh-list
110823006|NCT04218656|Antithrombins|antithrombins|mesh-ancestor
110458698|NCT00659074|Antiemetics|antiemetics|mesh-ancestor
110823007|NCT04218656|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110459149|NCT05779514|Urological Agents|urological agents|mesh-ancestor
110459223|NCT05734508|Antiviral Agents|antiviral agents|mesh-ancestor
110459297|NCT05565001|Autonomic Agents|autonomic agents|mesh-ancestor
110459371|NCT05311033|Hemostatics|hemostatics|mesh-ancestor
110823008|NCT04218656|Protease Inhibitors|protease inhibitors|mesh-ancestor
110459601|NCT04252768|Paclitaxel|paclitaxel|mesh-list
110459820|NCT03094637|Antimetabolites|antimetabolites|mesh-ancestor
110459821|NCT03094637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110459822|NCT03055507|Acetaminophen|acetaminophen|mesh-list
110459823|NCT03055507|Ibuprofen|ibuprofen|mesh-list
110459824|NCT03055507|Oxycodone|oxycodone|mesh-list
110459825|NCT03055507|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110459826|NCT03055507|Analgesics|analgesics|mesh-ancestor
110459827|NCT03055507|Sensory System Agents|sensory system agents|mesh-ancestor
110459828|NCT03055507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110459829|NCT03055507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110459830|NCT03055507|Antipyretics|antipyretics|mesh-ancestor
110459831|NCT03055507|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110459832|NCT03055507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110459838|NCT03055507|Narcotics|narcotics|mesh-ancestor
110823009|NCT04218656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110460266|NCT01142726|Abortifacient Agents|abortifacient agents|mesh-ancestor
110460486|NCT00961350|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110460801|NCT04282746|Ketamine|ketamine|mesh-list
110460863|NCT04284150|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110461548|NCT00676156|Vitamins|vitamins|mesh-ancestor
110823010|NCT04218656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110461982|NCT03993535|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110461983|NCT03993535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110461984|NCT02626936|Insulin|insulin|mesh-list
110461985|NCT02626936|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110461986|NCT02626936|Glucagon|glucagon|mesh-list
110461987|NCT02626936|Hormones|hormones|mesh-list
110461988|NCT02626936|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110461989|NCT02626936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110461990|NCT02626936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110461991|NCT02626936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110461992|NCT00912262|Capsaicin|capsaicin|mesh-list
110461993|NCT00912262|Antipruritics|antipruritics|mesh-ancestor
110461994|NCT00912262|Dermatologic Agents|dermatologic agents|mesh-ancestor
110461995|NCT00912262|Sensory System Agents|sensory system agents|mesh-ancestor
110462066|NCT00590317|Ondansetron|ondansetron|mesh-list
110462067|NCT00590317|Prochlorperazine|prochlorperazine|mesh-list
110462068|NCT00590317|Antiemetics|antiemetics|mesh-ancestor
110462069|NCT00590317|Autonomic Agents|autonomic agents|mesh-ancestor
110462070|NCT00590317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110462071|NCT00590317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110462072|NCT00590317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110462073|NCT00590317|Antipruritics|antipruritics|mesh-ancestor
110462074|NCT00590317|Dermatologic Agents|dermatologic agents|mesh-ancestor
110823011|NCT04218656|Anticoagulants|anticoagulants|mesh-ancestor
110462355|NCT02606539|Antidotes|antidotes|mesh-ancestor
110462509|NCT01124162|Losartan|losartan|mesh-list
110462662|NCT00906087|Timolol|timolol|mesh-list
110823012|NCT02710084|Oxytocin|oxytocin|mesh-list
110823013|NCT02710084|Oxytocics|oxytocics|mesh-ancestor
110463026|NCT01110200|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110463396|NCT00625898|Docetaxel|docetaxel|mesh-list
110463548|NCT02848443|Trifluridine|trifluridine|mesh-list
110823015|NCT02710084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110823016|NCT02849990|Prednisone|prednisone|mesh-list
110823017|NCT02849990|Cortisone|cortisone|mesh-list
110823018|NCT02849990|Indomethacin|indomethacin|mesh-list
110823019|NCT02849990|Abiraterone Acetate|abiraterone acetate|mesh-list
110464519|NCT04138888|Olmesartan|olmesartan|mesh-list
110823020|NCT02849990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110823021|NCT02849990|Glucocorticoids|glucocorticoids|mesh-ancestor
110465191|NCT02878772|Analgesics|analgesics|mesh-ancestor
110465418|NCT04135456|Mannitol|mannitol|mesh-list
110465490|NCT04130230|Autonomic Agents|autonomic agents|mesh-ancestor
110465563|NCT04933682|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110465716|NCT01078922|Ofatumumab|ofatumumab|mesh-list
110466236|NCT04258098|Metronidazole|metronidazole|mesh-list
110466311|NCT00626678|Hormones|hormones|mesh-ancestor
110466460|NCT02618668|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110466609|NCT00914797|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110466681|NCT04111003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110466829|NCT00092703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110466911|NCT02617810|Anesthetics|anesthetics|mesh-ancestor
110466985|NCT00895245|Hormones|hormones|mesh-ancestor
110467069|NCT00915577|Interferons|interferons|mesh-list
110467132|NCT00899847|Hormones|hormones|mesh-ancestor
110467278|NCT00610506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110467350|NCT00922272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110467427|NCT00700492|Progesterone|progesterone|mesh-list
110467651|NCT00892437|Antiviral Agents|antiviral agents|mesh-ancestor
110467873|NCT02602483|Ascorbic Acid|ascorbic acid|mesh-list
110468097|NCT00848926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110468177|NCT05176314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110468621|NCT00913458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110469132|NCT00888615|Tubulin Modulators|tubulin modulators|mesh-ancestor
110469279|NCT00832624|Incretins|incretins|mesh-ancestor
110469580|NCT02820987|Piperacillin|piperacillin|mesh-list
110823023|NCT02849990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110823024|NCT02849990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110469949|NCT02237508|Charcoal|charcoal|mesh-list
110823025|NCT02849990|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110823026|NCT02849990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110471151|NCT05313308|Anesthetics, General|anesthetics, general|mesh-ancestor
110471152|NCT05313308|Anesthetics|anesthetics|mesh-ancestor
110471153|NCT05313308|GABA Modulators|gaba modulators|mesh-ancestor
110471154|NCT05313308|GABA Agents|gaba agents|mesh-ancestor
110471155|NCT05313308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110471156|NCT05313308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110471300|NCT04860804|Anesthetics|anesthetics|mesh-ancestor
110471301|NCT04860804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110471302|NCT04860804|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110471303|NCT04860804|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110471304|NCT04860804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110471305|NCT04817345|Plerixafor|plerixafor|mesh-list
110471306|NCT04817345|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110471307|NCT04817345|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110471308|NCT04817345|Antiviral Agents|antiviral agents|mesh-ancestor
110471309|NCT04817345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110823027|NCT02849990|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110471448|NCT03867500|Vitamins|vitamins|mesh-ancestor
110823028|NCT02849990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110472283|NCT02786823|Hematinics|hematinics|mesh-ancestor
110823029|NCT02849990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110823030|NCT02849990|Hormone Antagonists|hormone antagonists|mesh-ancestor
110473194|NCT02845908|Vitamins|vitamins|mesh-ancestor
110473267|NCT02781909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110473341|NCT05241912|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110473421|NCT04778904|Nivolumab|nivolumab|mesh-list
110823031|NCT02849990|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110473871|NCT01028222|Dacarbazine|dacarbazine|mesh-list
110473940|NCT02841306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110474164|NCT02768649|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110474240|NCT02767713|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110474392|NCT04091971|Anesthetics|anesthetics|mesh-ancestor
110823032|NCT02849990|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110823033|NCT02849990|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110823034|NCT02849990|Analgesics|analgesics|mesh-ancestor
110474760|NCT02763969|Histamine Agents|histamine agents|mesh-ancestor
110474833|NCT02757495|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110474911|NCT02755311|Cisplatin|cisplatin|mesh-list
110474984|NCT05429775|Autonomic Agents|autonomic agents|mesh-ancestor
110475205|NCT04217733|Anticonvulsants|anticonvulsants|mesh-ancestor
110823035|NCT02849990|Sensory System Agents|sensory system agents|mesh-ancestor
110823036|NCT02849990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110475590|NCT02736123|Nivolumab|nivolumab|mesh-list
110823037|NCT02849990|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110823038|NCT02849990|Gout Suppressants|gout suppressants|mesh-ancestor
110476176|NCT02728869|Vaccines|vaccines|mesh-list
110476464|NCT02693769|Fluticasone|fluticasone|mesh-list
110477220|NCT02711007|Apatinib|apatinib|mesh-list
110477304|NCT02708511|Copper|copper|mesh-list
110823039|NCT02849990|Tocolytic Agents|tocolytic agents|mesh-ancestor
110477597|NCT02608060|Epoetin Alfa|epoetin alfa|mesh-list
110477898|NCT03292666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110478191|NCT03414723|Ramipril|ramipril|mesh-list
110478342|NCT02590627|Antimalarials|antimalarials|mesh-ancestor
110478428|NCT01743651|Baclofen|baclofen|mesh-list
110478569|NCT01018394|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110478570|NCT01018394|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110478571|NCT01018394|Cholinergic Agents|cholinergic agents|mesh-ancestor
110478572|NCT01018394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110478573|NCT01018394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110478574|NCT04301336|Zinc|zinc|mesh-list
110478575|NCT04301336|Folic Acid|folic acid|mesh-list
110478576|NCT04301336|Vitamin B Complex|vitamin b complex|mesh-list
110478577|NCT04301336|Hydroxyurea|hydroxyurea|mesh-list
110478578|NCT04301336|Morphine|morphine|mesh-list
110478579|NCT04301336|Zinc Sulfate|zinc sulfate|mesh-list
110478580|NCT04301336|Simvastatin|simvastatin|mesh-list
110478581|NCT04301336|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110478582|NCT04301336|Narcotics|narcotics|mesh-ancestor
110478583|NCT04301336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110478584|NCT04301336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110478585|NCT04301336|Analgesics|analgesics|mesh-ancestor
110478586|NCT04301336|Sensory System Agents|sensory system agents|mesh-ancestor
110478587|NCT04301336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110478588|NCT04301336|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110478589|NCT04301336|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110478590|NCT04301336|Antimetabolites|antimetabolites|mesh-ancestor
110478591|NCT04301336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110478592|NCT04301336|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110478730|NCT00799708|Estradiol|estradiol|mesh-list
110478951|NCT04298684|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110479027|NCT00794950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110479104|NCT02591017|Anesthetics, General|anesthetics, general|mesh-ancestor
110479259|NCT02603068|Treprostinil|treprostinil|mesh-list
110479776|NCT03272217|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110480075|NCT02698995|Narcotics|narcotics|mesh-ancestor
110480294|NCT00915460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110480295|NCT00915460|Immunologic Factors|immunologic factors|mesh-ancestor
110480296|NCT00915460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110480297|NCT00915460|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110480298|NCT00617643|Nevirapine|nevirapine|mesh-list
110480299|NCT00617643|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110480301|NCT00617643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110823041|NCT02849990|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110481295|NCT00618969|Busulfan|busulfan|mesh-list
110481495|NCT02578537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110823042|NCT01366352|Methylnaltrexone|methylnaltrexone|mesh-list
110481798|NCT04304144|Bortezomib|bortezomib|mesh-list
110482168|NCT00621387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110823046|NCT01366352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110823048|NCT03490396|Hyaluronic Acid|hyaluronic acid|mesh-list
110823049|NCT03490396|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110823051|NCT03490396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110823052|NCT03490396|Viscosupplements|viscosupplements|mesh-ancestor
110823053|NCT03490396|Protective Agents|protective agents|mesh-ancestor
110823054|NCT03490396|Plasma Substitutes|plasma substitutes|mesh-ancestor
110823055|NCT03490396|Blood Substitutes|blood substitutes|mesh-ancestor
110823056|NCT05136040|Bupivacaine|bupivacaine|mesh-list
110823057|NCT05136040|Anesthetics, Local|anesthetics, local|mesh-ancestor
110823058|NCT05136040|Anesthetics|anesthetics|mesh-ancestor
110823059|NCT05136040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110823060|NCT05136040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110823061|NCT05136040|Sensory System Agents|sensory system agents|mesh-ancestor
110823062|NCT05136040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110823063|NCT03496246|Vitamin D|vitamin d|mesh-list
110823064|NCT03496246|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
110482804|NCT01385059|Axitinib|axitinib|mesh-list
110823066|NCT03496246|Calcifediol|calcifediol|mesh-list
110823067|NCT03496246|Calcium|calcium|mesh-list
110823068|NCT03496246|Vitamins|vitamins|mesh-ancestor
110823069|NCT03496246|Micronutrients|micronutrients|mesh-ancestor
110823070|NCT03496246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110823071|NCT03496246|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110823072|NCT03496246|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110823073|NCT02017964|Cyclophosphamide|cyclophosphamide|mesh-list
110823075|NCT02017964|Methotrexate|methotrexate|mesh-list
110823076|NCT02017964|Etoposide|etoposide|mesh-list
110823077|NCT02017964|Vincristine|vincristine|mesh-list
110823078|NCT02017964|Etoposide phosphate|etoposide phosphate|mesh-list
110823079|NCT02017964|Podophyllotoxin|podophyllotoxin|mesh-list
110823080|NCT02017964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110823081|NCT02017964|Immunologic Factors|immunologic factors|mesh-ancestor
110823082|NCT02017964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110823083|NCT02017964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110823084|NCT02017964|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110823085|NCT02017964|Alkylating Agents|alkylating agents|mesh-ancestor
110823086|NCT02017964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110823087|NCT02017964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110823088|NCT02017964|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110823089|NCT02017964|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110823090|NCT02017964|Abortifacient Agents|abortifacient agents|mesh-ancestor
110823091|NCT02017964|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110823092|NCT02017964|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110823093|NCT02017964|Antimetabolites|antimetabolites|mesh-ancestor
110823094|NCT02017964|Dermatologic Agents|dermatologic agents|mesh-ancestor
110823095|NCT02017964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110823096|NCT02017964|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110823097|NCT02017964|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110823098|NCT02017964|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110823099|NCT02017964|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110823100|NCT02017964|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110823101|NCT02017964|Tubulin Modulators|tubulin modulators|mesh-ancestor
110823102|NCT02017964|Antimitotic Agents|antimitotic agents|mesh-ancestor
110823103|NCT02017964|Mitosis Modulators|mitosis modulators|mesh-ancestor
110823104|NCT02017964|Keratolytic Agents|keratolytic agents|mesh-ancestor
110823105|NCT05121298|Upadacitinib|upadacitinib|mesh-list
110823106|NCT05121298|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
110823107|NCT05121298|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110823108|NCT05121298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110823109|NCT05121298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110823110|NCT05121298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110823111|NCT01956110|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
110823112|NCT01956110|Hormones|hormones|mesh-ancestor
110823113|NCT01956110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110823114|NCT01956110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110823115|NCT03489928|Misoprostol|misoprostol|mesh-list
110823116|NCT03489928|Dinoprostone|dinoprostone|mesh-list
110823117|NCT03489928|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110823118|NCT03489928|Abortifacient Agents|abortifacient agents|mesh-ancestor
110823119|NCT03489928|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110823120|NCT03489928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110823121|NCT03489928|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110823122|NCT03489928|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110823123|NCT03489928|Oxytocics|oxytocics|mesh-ancestor
110823124|NCT02323282|Ropivacaine|ropivacaine|mesh-list
110823125|NCT02323282|Anesthetics, Local|anesthetics, local|mesh-ancestor
110823126|NCT02323282|Anesthetics|anesthetics|mesh-ancestor
110823127|NCT02323282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110823128|NCT02323282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110823129|NCT02323282|Sensory System Agents|sensory system agents|mesh-ancestor
110823130|NCT02323282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110823131|NCT01802086|Lidocaine|lidocaine|mesh-list
110823132|NCT01802086|Prilocaine|prilocaine|mesh-list
110823133|NCT01802086|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
110823134|NCT01802086|Anesthetics, Local|anesthetics, local|mesh-ancestor
110823135|NCT01802086|Anesthetics|anesthetics|mesh-ancestor
110823136|NCT01802086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110823137|NCT01802086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110823138|NCT01802086|Sensory System Agents|sensory system agents|mesh-ancestor
110823139|NCT01802086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110307579|NCT00267683|Glyburide|glyburide|mesh-list
110823140|NCT01802086|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110823141|NCT01802086|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110823142|NCT01802086|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110823143|NCT01802086|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110823144|NCT01802086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110823145|NCT01802086|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
110823146|NCT05347316|Colchicine|colchicine|mesh-list
110823147|NCT05347316|Gout Suppressants|gout suppressants|mesh-ancestor
110823148|NCT05347316|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110823149|NCT05347316|Tubulin Modulators|tubulin modulators|mesh-ancestor
110823150|NCT05347316|Antimitotic Agents|antimitotic agents|mesh-ancestor
110823151|NCT05347316|Mitosis Modulators|mitosis modulators|mesh-ancestor
110823152|NCT05347316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110823153|NCT05347316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110823154|NCT03495466|Anesthetics|anesthetics|mesh-list
110823155|NCT03495466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110823156|NCT03495466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110823157|NCT01372826|Naloxegol|naloxegol|mesh-list
110823158|NCT01372826|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110823159|NCT01372826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110823160|NCT01372826|Sensory System Agents|sensory system agents|mesh-ancestor
110823161|NCT01372826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110823162|NCT01371968|Alfentanil|alfentanil|mesh-list
110823163|NCT01371968|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110823164|NCT01371968|Narcotics|narcotics|mesh-ancestor
110823165|NCT01371968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110823166|NCT01371968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110823167|NCT01371968|Analgesics|analgesics|mesh-ancestor
110823168|NCT01371968|Sensory System Agents|sensory system agents|mesh-ancestor
110823169|NCT01371968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110823170|NCT01371968|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110823171|NCT01371968|Anesthetics, General|anesthetics, general|mesh-ancestor
110823172|NCT01371968|Anesthetics|anesthetics|mesh-ancestor
110823173|NCT04989322|Carboplatin|carboplatin|mesh-list
110823174|NCT04989322|Pembrolizumab|pembrolizumab|mesh-list
110823175|NCT04989322|Pemetrexed|pemetrexed|mesh-list
110823176|NCT04989322|Lenvatinib|lenvatinib|mesh-list
110823177|NCT04989322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110823178|NCT04989322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110823179|NCT04989322|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110823180|NCT04989322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110823181|NCT04989322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110823182|NCT04989322|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110823183|NCT04989322|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110823184|NCT04989322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110823185|NCT01367054|Metformin|metformin|mesh-list
110823186|NCT01367054|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110540724|NCT00961753|Ibuprofen|ibuprofen|mesh-list
110823187|NCT01367054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110823188|NCT03634514|Hormones|hormones|mesh-list
110823189|NCT03634514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110823190|NCT03634514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110823191|NCT02323438|Menthol|menthol|mesh-list
110823192|NCT02323438|Nicotine|nicotine|mesh-list
110823193|NCT02323438|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110823194|NCT02323438|Autonomic Agents|autonomic agents|mesh-ancestor
110823195|NCT02323438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110823196|NCT02323438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110823197|NCT02323438|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110823198|NCT02323438|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110823199|NCT02323438|Cholinergic Agents|cholinergic agents|mesh-ancestor
110823200|NCT02323438|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110855175|NCT03781895|Vitamin D|vitamin d|mesh-list
110855178|NCT03781895|Vitamins|vitamins|mesh-ancestor
110823201|NCT02323438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110823202|NCT02323438|Antipruritics|antipruritics|mesh-ancestor
110823203|NCT02323438|Dermatologic Agents|dermatologic agents|mesh-ancestor
110823204|NCT01372904|Dexamethasone|dexamethasone|mesh-list
110823205|NCT01372904|Dexamethasone acetate|dexamethasone acetate|mesh-list
110823206|NCT01372904|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
110823207|NCT01372904|BB 1101|bb 1101|mesh-list
110823208|NCT01372904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110823209|NCT01372904|Antiemetics|antiemetics|mesh-ancestor
110823210|NCT01372904|Autonomic Agents|autonomic agents|mesh-ancestor
110823211|NCT01372904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110823212|NCT01372904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110823213|NCT01372904|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110823214|NCT01372904|Glucocorticoids|glucocorticoids|mesh-ancestor
110823215|NCT01372904|Hormones|hormones|mesh-ancestor
110823216|NCT01372904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110823217|NCT01372904|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110823219|NCT01372904|Protease Inhibitors|protease inhibitors|mesh-ancestor
110823220|NCT01372904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110823221|NCT01372904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110823222|NCT01372982|Letrozole|letrozole|mesh-list
110823223|NCT01372982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110823224|NCT01372982|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110823225|NCT01372982|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110823226|NCT01372982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110823227|NCT01372982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110823228|NCT01372982|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110823229|NCT01372982|Hormone Antagonists|hormone antagonists|mesh-ancestor
110823230|NCT01372982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110823231|NCT01372982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110823232|NCT02323516|Aspirin|aspirin|mesh-list
110823233|NCT02323516|Loperamide|loperamide|mesh-list
110823234|NCT02323516|Antidiarrheals|antidiarrheals|mesh-list
110823235|NCT02323516|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110823236|NCT02323516|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110823237|NCT02323516|Analgesics|analgesics|mesh-ancestor
110823238|NCT02323516|Sensory System Agents|sensory system agents|mesh-ancestor
110823239|NCT02323516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110823240|NCT02323516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110823241|NCT02323516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110823242|NCT02323516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110823243|NCT02323516|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110823244|NCT02323516|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110823245|NCT02323516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110823246|NCT02323516|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110823247|NCT02323516|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110823248|NCT02323516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110823249|NCT02323516|Antipyretics|antipyretics|mesh-ancestor
110823250|NCT02323516|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110823251|NCT01367210|Maraviroc|maraviroc|mesh-list
110823252|NCT01367210|Darunavir|darunavir|mesh-list
110823253|NCT01367210|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
110823254|NCT01367210|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110823255|NCT01367210|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110823256|NCT01367210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110823257|NCT01367210|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110823258|NCT01367210|Antiviral Agents|antiviral agents|mesh-ancestor
110823259|NCT01367210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110823260|NCT01367210|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
110823261|NCT01367210|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110823262|NCT01367210|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110823263|NCT01367210|Protease Inhibitors|protease inhibitors|mesh-ancestor
110823264|NCT01367210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110823265|NCT02323594|Asunaprevir|asunaprevir|mesh-list
110823266|NCT02323594|Protease Inhibitors|protease inhibitors|mesh-ancestor
110823267|NCT02323594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110823268|NCT02323594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110823269|NCT01372280|Galantamine|galantamine|mesh-list
110855188|NCT03781505|Acetaminophen|acetaminophen|mesh-list
110823270|NCT01372280|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110823271|NCT01372280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110823272|NCT01372280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110823273|NCT01372280|Cholinergic Agents|cholinergic agents|mesh-ancestor
110823274|NCT01372280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110823275|NCT01372280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110823276|NCT01372280|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110823277|NCT01372280|Autonomic Agents|autonomic agents|mesh-ancestor
110823278|NCT01372280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110823279|NCT01372280|Nootropic Agents|nootropic agents|mesh-ancestor
110823280|NCT01373060|Ipragliflozin|ipragliflozin|mesh-list
110823281|NCT01373060|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110823282|NCT01373060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110823283|NCT01373060|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110823284|NCT01373060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110823285|NCT04742140|Magnesium Sulfate|magnesium sulfate|mesh-list
110823286|NCT04742140|Analgesics|analgesics|mesh-ancestor
110823287|NCT04742140|Sensory System Agents|sensory system agents|mesh-ancestor
110823288|NCT04742140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110823289|NCT04742140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110823291|NCT04742140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110823292|NCT04742140|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110823293|NCT04742140|Anticonvulsants|anticonvulsants|mesh-ancestor
110823294|NCT04742140|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110823295|NCT04742140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110823296|NCT04742140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110823297|NCT04742140|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110823298|NCT04742140|Tocolytic Agents|tocolytic agents|mesh-ancestor
110823299|NCT04742140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110823300|NCT04580992|Ajmaline|ajmaline|mesh-list
110197336|NCT00412321|Siltuximab|siltuximab|mesh-list
110823301|NCT04580992|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110823302|NCT04580992|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110823303|NCT04580992|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110823304|NCT04580992|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110823305|NCT04580992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110823306|NCT04590274|Azithromycin|azithromycin|mesh-list
110823307|NCT04590274|Hydroxychloroquine|hydroxychloroquine|mesh-list
110823308|NCT04590274|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110823309|NCT04590274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110823310|NCT04590274|Antimalarials|antimalarials|mesh-ancestor
110823311|NCT04590274|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110823312|NCT04590274|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110823313|NCT04590274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110823314|NCT04590274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110823315|NCT04590274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110823316|NCT01367288|Zoledronic Acid|zoledronic acid|mesh-list
110823317|NCT01367288|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110823318|NCT01367288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110823319|NCT04455178|Indapamide|indapamide|mesh-list
110823320|NCT04455178|Spironolactone|spironolactone|mesh-list
110823321|NCT04455178|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110823322|NCT04455178|Hormone Antagonists|hormone antagonists|mesh-ancestor
110823323|NCT04455178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110823324|NCT04455178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110823325|NCT04455178|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110823326|NCT04455178|Diuretics|diuretics|mesh-ancestor
110823327|NCT04455178|Natriuretic Agents|natriuretic agents|mesh-ancestor
110823328|NCT04455178|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110823329|NCT04455178|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110823330|NCT04455178|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110823331|NCT04455178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110823332|NCT01367522|Methylnaltrexone|methylnaltrexone|mesh-list
110823333|NCT01367522|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110540860|NCT04160598|Fentanyl|fentanyl|mesh-list
110823334|NCT01367522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110823335|NCT01367522|Sensory System Agents|sensory system agents|mesh-ancestor
110823336|NCT01367522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110823337|NCT02446834|Metformin|metformin|mesh-list
110823338|NCT02446834|Acarbose|acarbose|mesh-list
110823339|NCT02446834|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110823340|NCT02446834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110823341|NCT02446834|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
110823342|NCT02446834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110823343|NCT02446834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110823344|NCT03489616|Pemetrexed|pemetrexed|mesh-list
110823345|NCT03489616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110823346|NCT03489616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110823347|NCT03489616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110823348|NCT03489616|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110823349|NCT03489616|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110823350|NCT02323906|Sorafenib|sorafenib|mesh-list
110823351|NCT02323906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110823352|NCT02323906|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110823353|NCT02323906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110823354|NCT02323906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110823355|NCT03116828|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
110823356|NCT03116828|Anticonvulsants|anticonvulsants|mesh-ancestor
110823357|NCT03116828|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110823358|NCT03116828|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110482827|NCT04100434|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110823359|NCT03116828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110823360|NCT03116828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110823361|NCT01319942|Sorafenib|sorafenib|mesh-list
110823362|NCT01319942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110823363|NCT01319942|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110823364|NCT01319942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110823365|NCT01319942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110823366|NCT01373138|Pseudoephedrine|pseudoephedrine|mesh-list
110823367|NCT01373138|Ephedrine|ephedrine|mesh-list
110823368|NCT01373138|Desloratadine|desloratadine|mesh-list
110823369|NCT01373138|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110823370|NCT01373138|Cholinergic Agents|cholinergic agents|mesh-ancestor
110823371|NCT01373138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110823372|NCT01373138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110823373|NCT01373138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110823374|NCT01373138|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110823375|NCT01373138|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110823376|NCT01373138|Histamine Antagonists|histamine antagonists|mesh-ancestor
110823377|NCT01373138|Histamine Agents|histamine agents|mesh-ancestor
110823378|NCT01373138|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110823379|NCT01373138|Autonomic Agents|autonomic agents|mesh-ancestor
110823380|NCT01373138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110823381|NCT01373138|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110823382|NCT01373138|Respiratory System Agents|respiratory system agents|mesh-ancestor
110823383|NCT01373138|Nasal Decongestants|nasal decongestants|mesh-ancestor
110823384|NCT01373138|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110823385|NCT01373138|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110823386|NCT01373138|Sympathomimetics|sympathomimetics|mesh-ancestor
110823387|NCT01373138|Adrenergic Agents|adrenergic agents|mesh-ancestor
110823388|NCT01373216|Exenatide|exenatide|mesh-list
110823389|NCT01373216|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110823390|NCT01373216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110823391|NCT01373216|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110823392|NCT01373216|Incretins|incretins|mesh-ancestor
110823393|NCT01373216|Hormones|hormones|mesh-ancestor
110823394|NCT01373216|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110823395|NCT03487354|Misoprostol|misoprostol|mesh-list
110823396|NCT03487354|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110823397|NCT03487354|Abortifacient Agents|abortifacient agents|mesh-ancestor
110823398|NCT03487354|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110823399|NCT03487354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110823400|NCT03487354|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110823401|NCT03487354|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110823402|NCT03487354|Oxytocics|oxytocics|mesh-ancestor
110823403|NCT04461340|Sirolimus|sirolimus|mesh-list
110823404|NCT04461340|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110823405|NCT04461340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110823406|NCT04461340|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110823407|NCT04461340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110823408|NCT04461340|Antifungal Agents|antifungal agents|mesh-ancestor
110823409|NCT04461340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110823410|NCT04461340|Immunologic Factors|immunologic factors|mesh-ancestor
110823411|NCT04461340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110823413|NCT05154968|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110823414|NCT05154968|Diuretics|diuretics|mesh-ancestor
110823415|NCT05154968|Natriuretic Agents|natriuretic agents|mesh-ancestor
110823416|NCT05154968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110823417|NCT01373372|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
110823418|NCT01373372|Hormones|hormones|mesh-ancestor
110823419|NCT01373372|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110823420|NCT01373372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110823421|NCT04146142|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110823422|NCT04146142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110823423|NCT02324296|Cisplatin|cisplatin|mesh-list
110823424|NCT02324296|Etoposide|etoposide|mesh-list
110823425|NCT02324296|Ifosfamide|ifosfamide|mesh-list
110823426|NCT02324296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110823427|NCT02324296|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110823428|NCT02324296|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110823429|NCT02324296|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110823430|NCT02324296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110823431|NCT02324296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110823432|NCT02324296|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110823433|NCT02324296|Alkylating Agents|alkylating agents|mesh-ancestor
110823439|NCT03487198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110823440|NCT03487198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110823441|NCT03487198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110823442|NCT03487198|Dopamine Agonists|dopamine agonists|mesh-ancestor
110823443|NCT03487198|Dopamine Agents|dopamine agents|mesh-ancestor
110823448|NCT03881020|Fluorides|fluorides|mesh-list
110823449|NCT03881020|Cariostatic Agents|cariostatic agents|mesh-ancestor
110823450|NCT03881020|Protective Agents|protective agents|mesh-ancestor
110823451|NCT03881020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110823452|NCT01367600|Methylnaltrexone|methylnaltrexone|mesh-list
110823453|NCT01367600|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110823454|NCT01367600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110823455|NCT01367600|Sensory System Agents|sensory system agents|mesh-ancestor
110823456|NCT01367600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110823457|NCT01367678|Chlorhexidine|chlorhexidine|mesh-list
110823458|NCT01367678|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110823459|NCT01367678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110823460|NCT01367678|Disinfectants|disinfectants|mesh-ancestor
110823461|NCT03487042|Bimatoprost|bimatoprost|mesh-list
110823462|NCT03487042|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110823463|NCT03487042|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110823464|NCT03487042|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110823465|NCT03115294|Theophylline|theophylline|mesh-list
110823466|NCT03115294|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110823467|NCT03115294|Autonomic Agents|autonomic agents|mesh-ancestor
110823468|NCT03115294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110823469|NCT03115294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110823470|NCT03115294|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110823471|NCT03115294|Respiratory System Agents|respiratory system agents|mesh-ancestor
110823472|NCT03115294|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110823473|NCT03115294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110823474|NCT03115294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110823475|NCT03115294|Vasodilator Agents|vasodilator agents|mesh-ancestor
110823476|NCT03115294|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110823477|NCT03115294|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110823478|NCT03115294|Purinergic Agents|purinergic agents|mesh-ancestor
110823479|NCT03115294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110823480|NCT01367756|Citalopram|citalopram|mesh-list
110823481|NCT01367756|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110541018|NCT00967135|Pregabalin|pregabalin|mesh-list
110823482|NCT01367756|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110823484|NCT01367756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110823485|NCT01367756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110823486|NCT01367756|Serotonin Agents|serotonin agents|mesh-ancestor
110823487|NCT01367756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110823488|NCT01367756|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110823489|NCT01367756|Antidepressive Agents|antidepressive agents|mesh-ancestor
110823490|NCT01367756|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110823491|NCT04624958|Rituximab|rituximab|mesh-list
110823492|NCT04624958|Zanubrutinib|zanubrutinib|mesh-list
110823493|NCT04624958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110823494|NCT04624958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110823495|NCT04624958|Immunologic Factors|immunologic factors|mesh-ancestor
110823496|NCT04624958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110823497|NCT04624958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110823498|NCT04624958|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110823499|NCT04624958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110823500|NCT04624958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110823501|NCT03485482|Bisoprolol|bisoprolol|mesh-list
110823502|NCT03485482|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110823503|NCT03485482|Sympatholytics|sympatholytics|mesh-ancestor
110823504|NCT03485482|Autonomic Agents|autonomic agents|mesh-ancestor
110823505|NCT03485482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110823506|NCT03485482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110823507|NCT03485482|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110823508|NCT03485482|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110823509|NCT03485482|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110823510|NCT03485482|Adrenergic Agents|adrenergic agents|mesh-ancestor
110823511|NCT03485482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110823512|NCT03485482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110823513|NCT02946424|Simvastatin|simvastatin|mesh-list
110823514|NCT02946424|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110823515|NCT02946424|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110823516|NCT02946424|Antimetabolites|antimetabolites|mesh-ancestor
110823517|NCT02946424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110823518|NCT02946424|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110823519|NCT02946424|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110823520|NCT02946424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110823521|NCT00783536|Etanercept|etanercept|mesh-list
110823522|NCT00783536|Methotrexate|methotrexate|mesh-list
110823523|NCT00783536|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110823524|NCT00783536|Abortifacient Agents|abortifacient agents|mesh-ancestor
110823525|NCT00783536|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110823526|NCT00783536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110823527|NCT00783536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110823528|NCT00783536|Antimetabolites|antimetabolites|mesh-ancestor
110823529|NCT00783536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110823530|NCT00783536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110823531|NCT00783536|Dermatologic Agents|dermatologic agents|mesh-ancestor
110823532|NCT00783536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110823533|NCT00783536|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110823534|NCT00783536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110823535|NCT00783536|Immunologic Factors|immunologic factors|mesh-ancestor
110823536|NCT00783536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110823537|NCT00783536|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110823538|NCT00783536|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110823539|NCT00783536|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110823540|NCT00783536|Analgesics|analgesics|mesh-ancestor
110823541|NCT00783536|Sensory System Agents|sensory system agents|mesh-ancestor
110823542|NCT00783536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110823543|NCT00783536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110823544|NCT00783536|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110823545|NCT01367912|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110823546|NCT01367912|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110823547|NCT01367912|Estradiol|estradiol|mesh-list
110823548|NCT01367912|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110823549|NCT01367912|Estrogens|estrogens|mesh-ancestor
110823551|NCT01367912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110823552|NCT01367912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110823553|NCT01367912|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110823554|NCT01367912|Contraceptive Agents|contraceptive agents|mesh-ancestor
110823555|NCT01367912|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110823556|NCT01367912|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110823557|NCT03115112|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110823558|NCT03115112|Bexagliflozin|bexagliflozin|mesh-list
110823559|NCT03115112|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110823560|NCT03115112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110823561|NCT03115112|Incretins|incretins|mesh-ancestor
110823562|NCT03115112|Hormones|hormones|mesh-ancestor
110823563|NCT03115112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110823564|NCT03115112|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110823565|NCT03115112|Protease Inhibitors|protease inhibitors|mesh-ancestor
110823566|NCT03115112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110823567|NCT03115112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110823568|NCT01373528|Budesonide|budesonide|mesh-list
110823569|NCT01373528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110823570|NCT01373528|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110823571|NCT01373528|Autonomic Agents|autonomic agents|mesh-ancestor
110823572|NCT01373528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110823573|NCT01373528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110823574|NCT01373528|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110823575|NCT01373528|Respiratory System Agents|respiratory system agents|mesh-ancestor
110823576|NCT01373528|Glucocorticoids|glucocorticoids|mesh-ancestor
110823577|NCT01373528|Hormones|hormones|mesh-ancestor
110823578|NCT01373528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110823579|NCT03634202|Capecitabine|capecitabine|mesh-list
110823580|NCT03634202|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110823581|NCT03634202|Antimetabolites|antimetabolites|mesh-ancestor
110823582|NCT03634202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110823583|NCT03634202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110823584|NCT05019560|Sevoflurane|sevoflurane|mesh-list
110823585|NCT05019560|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110823586|NCT05019560|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110823587|NCT05019560|Anesthetics, General|anesthetics, general|mesh-ancestor
110823588|NCT05019560|Anesthetics|anesthetics|mesh-ancestor
110823589|NCT05019560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110823590|NCT05019560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110823591|NCT01373606|Terlipressin|terlipressin|mesh-list
110823592|NCT01373606|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110823593|NCT01373606|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110823594|NCT01367990|Norepinephrine|norepinephrine|mesh-list
110823595|NCT01367990|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110823596|NCT01367990|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110823597|NCT01367990|Adrenergic Agents|adrenergic agents|mesh-ancestor
110823598|NCT01367990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110823599|NCT01367990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110823600|NCT01367990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110823601|NCT01367990|Sympathomimetics|sympathomimetics|mesh-ancestor
110823602|NCT01367990|Autonomic Agents|autonomic agents|mesh-ancestor
110823603|NCT01367990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110823604|NCT01367990|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110823605|NCT03556358|Paclitaxel|paclitaxel|mesh-list
110823606|NCT03556358|Cyclophosphamide|cyclophosphamide|mesh-list
110823607|NCT03556358|Trastuzumab|trastuzumab|mesh-list
110823608|NCT03556358|Epirubicin|epirubicin|mesh-list
110823609|NCT03556358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110823610|NCT03556358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110823611|NCT03556358|Tubulin Modulators|tubulin modulators|mesh-ancestor
110823612|NCT03556358|Antimitotic Agents|antimitotic agents|mesh-ancestor
110823613|NCT03556358|Mitosis Modulators|mitosis modulators|mesh-ancestor
110823614|NCT03556358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110823615|NCT03556358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110823616|NCT03556358|Immunologic Factors|immunologic factors|mesh-ancestor
110823617|NCT03556358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110823618|NCT03556358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110823619|NCT03556358|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110823620|NCT03556358|Alkylating Agents|alkylating agents|mesh-ancestor
110823621|NCT03556358|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110823622|NCT03556358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110823623|NCT03556358|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110823624|NCT03556358|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110823625|NCT03556358|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110823626|NCT03556358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110823627|NCT01374308|Interferons|interferons|mesh-list
110541169|NCT00657306|Hydrocortisone|hydrocortisone|mesh-list
110823628|NCT01374308|Interferon-alpha|interferon-alpha|mesh-list
110823629|NCT01374308|Interferon alpha-2|interferon alpha-2|mesh-list
110823630|NCT01374308|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110823631|NCT01374308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110823632|NCT01374308|Antiviral Agents|antiviral agents|mesh-ancestor
110823633|NCT01374308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110823634|NCT01374308|Immunologic Factors|immunologic factors|mesh-ancestor
110823635|NCT01374308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110823636|NCT01368068|Tibolone|tibolone|mesh-list
110823637|NCT01368068|Escitalopram|escitalopram|mesh-list
110823638|NCT01368068|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110823639|NCT01368068|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110823640|NCT01368068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110823641|NCT01368068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110823642|NCT01368068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110823643|NCT01368068|Serotonin Agents|serotonin agents|mesh-ancestor
110823644|NCT01368068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110823645|NCT01368068|Androgen Antagonists|androgen antagonists|mesh-ancestor
110823646|NCT01368068|Hormone Antagonists|hormone antagonists|mesh-ancestor
110823647|NCT01368068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110823648|NCT01368068|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110823649|NCT01368068|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110823650|NCT01368068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110823651|NCT01368068|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110823652|NCT01368068|Anabolic Agents|anabolic agents|mesh-ancestor
110823653|NCT01368068|Hormones|hormones|mesh-ancestor
110823658|NCT01373684|Antiviral Agents|antiviral agents|mesh-ancestor
110823659|NCT01373684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110823660|NCT01373684|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110823661|NCT01373684|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110823662|NCT01373684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110823663|NCT01373684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110823664|NCT01373684|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110823665|NCT01373684|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110823669|NCT02891798|Dexamethasone|dexamethasone|mesh-list
110823670|NCT02891798|Dexamethasone acetate|dexamethasone acetate|mesh-list
110823671|NCT02891798|Clonidine|clonidine|mesh-list
110823672|NCT02891798|Buprenorphine|buprenorphine|mesh-list
110823673|NCT02891798|Bupivacaine|bupivacaine|mesh-list
110823674|NCT02891798|BB 1101|bb 1101|mesh-list
110823675|NCT02891798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110823676|NCT02891798|Antiemetics|antiemetics|mesh-ancestor
110823677|NCT02891798|Autonomic Agents|autonomic agents|mesh-ancestor
110823678|NCT02891798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110823679|NCT02891798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110823680|NCT02891798|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110823681|NCT02891798|Glucocorticoids|glucocorticoids|mesh-ancestor
110823682|NCT02891798|Hormones|hormones|mesh-ancestor
110823683|NCT02891798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110823684|NCT02891798|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110823685|NCT02891798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110823686|NCT02891798|Protease Inhibitors|protease inhibitors|mesh-ancestor
110823687|NCT02891798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110823688|NCT02891798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110823689|NCT02891798|Anesthetics, Local|anesthetics, local|mesh-ancestor
110823690|NCT02891798|Anesthetics|anesthetics|mesh-ancestor
110823691|NCT02891798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110823692|NCT02891798|Sensory System Agents|sensory system agents|mesh-ancestor
110823693|NCT02891798|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110823694|NCT02891798|Narcotics|narcotics|mesh-ancestor
110823695|NCT02891798|Analgesics|analgesics|mesh-ancestor
110823696|NCT02891798|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110823697|NCT02891798|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110823698|NCT02891798|Sympatholytics|sympatholytics|mesh-ancestor
110823699|NCT02891798|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110823700|NCT02891798|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110823701|NCT02891798|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110823702|NCT02891798|Adrenergic Agents|adrenergic agents|mesh-ancestor
110823703|NCT02891798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110823704|NCT01374464|Levobupivacaine|levobupivacaine|mesh-list
110823705|NCT01374464|Anesthetics, Local|anesthetics, local|mesh-ancestor
110823706|NCT01374464|Anesthetics|anesthetics|mesh-ancestor
110823707|NCT01374464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110823708|NCT01374464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110823709|NCT01374464|Sensory System Agents|sensory system agents|mesh-ancestor
110823710|NCT01374464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110823711|NCT01374620|Paclitaxel|paclitaxel|mesh-list
110823712|NCT01374620|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110823713|NCT01374620|Cyclophosphamide|cyclophosphamide|mesh-list
110823714|NCT01374620|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110823715|NCT01374620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110823716|NCT01374620|Tubulin Modulators|tubulin modulators|mesh-ancestor
110823717|NCT01374620|Antimitotic Agents|antimitotic agents|mesh-ancestor
110823718|NCT01374620|Mitosis Modulators|mitosis modulators|mesh-ancestor
110823719|NCT01374620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110823720|NCT01374620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110823721|NCT01374620|Immunologic Factors|immunologic factors|mesh-ancestor
110823722|NCT01374620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110823723|NCT01374620|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110823724|NCT01374620|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110823725|NCT01374620|Alkylating Agents|alkylating agents|mesh-ancestor
110823726|NCT01374620|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110823727|NCT01374698|Aspirin|aspirin|mesh-list
110823728|NCT01374698|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110823729|NCT01374698|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110823730|NCT01374698|Analgesics|analgesics|mesh-ancestor
110823731|NCT01374698|Sensory System Agents|sensory system agents|mesh-ancestor
110823732|NCT01374698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110823733|NCT01374698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110823734|NCT01374698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110823735|NCT01374698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110823736|NCT01374698|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110823737|NCT01374698|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110823738|NCT01374698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110823739|NCT01374698|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110823740|NCT01374698|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110823741|NCT01374698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110823742|NCT01374698|Antipyretics|antipyretics|mesh-ancestor
110823743|NCT01368458|Antipsychotic Agents|antipsychotic agents|mesh-list
110823744|NCT01368458|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110823745|NCT01368458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110418858|NCT01077375|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110823746|NCT01368458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110823747|NCT01368458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110823749|NCT05197088|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110823750|NCT05197088|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110823751|NCT05197088|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110823752|NCT05197088|Adrenergic Agents|adrenergic agents|mesh-ancestor
110823753|NCT05197088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110823754|NCT05197088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110823755|NCT05197088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110823756|NCT05197088|Urological Agents|urological agents|mesh-ancestor
110823757|NCT01375088|Propolis|propolis|mesh-list
110823758|NCT01375088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110823759|NCT01368848|Bevacizumab|bevacizumab|mesh-list
110823760|NCT01368848|Docetaxel|docetaxel|mesh-list
110823761|NCT01368848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110823762|NCT01368848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110823763|NCT01368848|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110823764|NCT01368848|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110823765|NCT01368848|Growth Substances|growth substances|mesh-ancestor
110823766|NCT01368848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110823767|NCT01368848|Growth Inhibitors|growth inhibitors|mesh-ancestor
110823768|NCT01368848|Tubulin Modulators|tubulin modulators|mesh-ancestor
110823769|NCT01368848|Antimitotic Agents|antimitotic agents|mesh-ancestor
110823770|NCT01368848|Mitosis Modulators|mitosis modulators|mesh-ancestor
110823771|NCT01368848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110823772|NCT03604874|Oxytocin|oxytocin|mesh-list
110823773|NCT03604874|Oxytocics|oxytocics|mesh-ancestor
110823774|NCT03604874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110823775|NCT03604874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110823776|NCT01369082|Cyclosporine|cyclosporine|mesh-list
110823777|NCT01369082|Sirolimus|sirolimus|mesh-list
110541312|NCT00660894|Antidotes|antidotes|mesh-ancestor
110823778|NCT01369082|Mycophenolic Acid|mycophenolic acid|mesh-list
110823779|NCT01369082|Tacrolimus|tacrolimus|mesh-list
110823780|NCT01369082|Cyclosporins|cyclosporins|mesh-list
110823781|NCT01369082|Immunosuppressive Agents|immunosuppressive agents|mesh-list
110823782|NCT01369082|Immunologic Factors|immunologic factors|mesh-ancestor
110823783|NCT01369082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110823784|NCT01369082|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110823785|NCT01369082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110823786|NCT01369082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110823787|NCT01369082|Antifungal Agents|antifungal agents|mesh-ancestor
110823788|NCT01369082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110823789|NCT01369082|Dermatologic Agents|dermatologic agents|mesh-ancestor
110823790|NCT01369082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110823791|NCT01369082|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110823792|NCT01369082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110823793|NCT01369082|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110823794|NCT01369082|Antitubercular Agents|antitubercular agents|mesh-ancestor
110823795|NCT01369082|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110823797|NCT03382730|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110823798|NCT03382730|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110823799|NCT03382730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110823800|NCT03382730|Disinfectants|disinfectants|mesh-ancestor
110823801|NCT03382730|Dermatologic Agents|dermatologic agents|mesh-ancestor
110823802|NCT03135262|Rituximab|rituximab|mesh-list
110823803|NCT03135262|Obinutuzumab|obinutuzumab|mesh-list
110823804|NCT03135262|Venetoclax|venetoclax|mesh-list
110823805|NCT03135262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110823806|NCT03135262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110823808|NCT03135262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110823809|NCT03135262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110823810|NCT01375244|Lisinopril|lisinopril|mesh-list
110823811|NCT01375244|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110823812|NCT01375244|Protease Inhibitors|protease inhibitors|mesh-ancestor
110823813|NCT01375244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110823814|NCT01375244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110823815|NCT01375244|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110823816|NCT01375244|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110823817|NCT01375244|Protective Agents|protective agents|mesh-ancestor
110823818|NCT01375244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110823819|NCT01375322|Amlodipine|amlodipine|mesh-list
110823820|NCT01375322|Valsartan|valsartan|mesh-list
110823821|NCT01375322|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110823822|NCT01375322|Benazepril|benazepril|mesh-list
110823823|NCT01375322|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110823824|NCT01375322|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110823825|NCT01375322|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110823826|NCT01375322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110823827|NCT01375322|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110823828|NCT01375322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110823829|NCT01375322|Vasodilator Agents|vasodilator agents|mesh-ancestor
110823830|NCT01375322|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110823831|NCT01375322|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110823832|NCT01375322|Diuretics|diuretics|mesh-ancestor
110823833|NCT01375322|Natriuretic Agents|natriuretic agents|mesh-ancestor
110823834|NCT01375322|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110855233|NCT01313429|Alkylating Agents|alkylating agents|mesh-ancestor
110823835|NCT01375322|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110823836|NCT01375322|Protease Inhibitors|protease inhibitors|mesh-ancestor
110823837|NCT01375322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110823838|NCT01369238|Pyranoprofen|pyranoprofen|mesh-list
110823839|NCT01369238|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110823840|NCT01369238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110823841|NCT01369238|Analgesics|analgesics|mesh-ancestor
110823842|NCT01369238|Sensory System Agents|sensory system agents|mesh-ancestor
110823843|NCT01369238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110823844|NCT01369238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110823845|NCT01369238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110823846|NCT01369238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110823847|NCT01369238|Gout Suppressants|gout suppressants|mesh-ancestor
110823848|NCT03485404|Vitamins|vitamins|mesh-list
110823849|NCT03485404|Folic Acid|folic acid|mesh-list
110823850|NCT03485404|Vitamin B 12|vitamin b 12|mesh-list
110823851|NCT03485404|Vitamin B Complex|vitamin b complex|mesh-list
110823852|NCT03485404|Micronutrients|micronutrients|mesh-ancestor
110823853|NCT03485404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110823854|NCT03485404|Hematinics|hematinics|mesh-ancestor
110823855|NCT05195294|Lenvatinib|lenvatinib|mesh-list
110823856|NCT05195294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110823857|NCT05195294|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110823858|NCT05195294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110823859|NCT05195294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110823860|NCT03072628|Nicotine|nicotine|mesh-list
110823861|NCT03072628|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110823862|NCT03072628|Autonomic Agents|autonomic agents|mesh-ancestor
110823863|NCT03072628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110823864|NCT03072628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110823865|NCT03072628|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110823866|NCT03072628|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110823867|NCT03072628|Cholinergic Agents|cholinergic agents|mesh-ancestor
110823868|NCT03072628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110823869|NCT03072628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110823870|NCT05195060|Sotrovimab|sotrovimab|mesh-list
110823871|NCT05195060|Molnupiravir|molnupiravir|mesh-list
110823872|NCT05195060|Casirivimab and imdevimab drug combination|casirivimab and imdevimab drug combination|mesh-list
110823873|NCT05195060|Antiviral Agents|antiviral agents|mesh-ancestor
110823874|NCT05195060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110823875|NCT03535194|Mirikizumab|mirikizumab|mesh-list
110823876|NCT03535194|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110823877|NCT03535194|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110823878|NCT03535194|Analgesics|analgesics|mesh-ancestor
110823879|NCT03535194|Sensory System Agents|sensory system agents|mesh-ancestor
110823880|NCT03535194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110308320|NCT00306735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110823881|NCT03535194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110823882|NCT03535194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110823883|NCT03535194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110823884|NCT03535194|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110823885|NCT03535194|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110823886|NCT03633812|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
110823887|NCT03633812|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110823888|NCT03633812|Adrenergic Agents|adrenergic agents|mesh-ancestor
110823889|NCT03633812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110823890|NCT03633812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110823891|NCT03633812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110823892|NCT05194904|Ketorolac|ketorolac|mesh-list
110823893|NCT05194904|Dexmedetomidine|dexmedetomidine|mesh-list
110823894|NCT05194904|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110823895|NCT05194904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110823896|NCT05194904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110823897|NCT05194904|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110823898|NCT05194904|Analgesics|analgesics|mesh-ancestor
110823899|NCT05194904|Sensory System Agents|sensory system agents|mesh-ancestor
110823900|NCT05194904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110823901|NCT05194904|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110823902|NCT05194904|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110823903|NCT05194904|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110823904|NCT05194904|Adrenergic Agents|adrenergic agents|mesh-ancestor
110823905|NCT05194904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110823906|NCT05194904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110823907|NCT05194904|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110823908|NCT05194904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110823909|NCT05194904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110823910|NCT05194904|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110823911|NCT05194904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110823912|NCT01375400|Aspirin|aspirin|mesh-list
110823913|NCT01375400|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110823914|NCT01375400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110823915|NCT01375400|Analgesics|analgesics|mesh-ancestor
110823916|NCT01375400|Sensory System Agents|sensory system agents|mesh-ancestor
110823917|NCT01375400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110823918|NCT01375400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110823919|NCT01375400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110823920|NCT01375400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110823921|NCT01375400|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110823922|NCT01375400|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110823923|NCT01375400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110823924|NCT01375400|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110823925|NCT01375400|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110823926|NCT01375400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110823927|NCT01375400|Antipyretics|antipyretics|mesh-ancestor
110823928|NCT01319864|Plerixafor|plerixafor|mesh-list
110823929|NCT01319864|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110823930|NCT01319864|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110823932|NCT01319864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110823933|NCT05194046|Amoxicillin|amoxicillin|mesh-list
110823934|NCT05194046|Clarithromycin|clarithromycin|mesh-list
110823935|NCT05194046|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110823936|NCT05194046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110823937|NCT05194046|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110823938|NCT05194046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110823939|NCT05194046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110823940|NCT05194046|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110823941|NCT05194046|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110823942|NCT01369472|Carvedilol|carvedilol|mesh-list
110823943|NCT01369472|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110823944|NCT01369472|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110823945|NCT01369472|Adrenergic Agents|adrenergic agents|mesh-ancestor
110823946|NCT01369472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110823947|NCT01369472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110823948|NCT01369472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110823949|NCT01369472|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110823950|NCT01369472|Antioxidants|antioxidants|mesh-ancestor
110823951|NCT01369472|Protective Agents|protective agents|mesh-ancestor
110823952|NCT01369472|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110823953|NCT01369472|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110823954|NCT01369472|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110823955|NCT01369472|Vasodilator Agents|vasodilator agents|mesh-ancestor
110823956|NCT01369472|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110823957|NCT01369472|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110823958|NCT03559530|Anti-Infective Agents|anti-infective agents|mesh-list
110823959|NCT03559530|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110823961|NCT05193734|Agglutinins|agglutinins|mesh-ancestor
110823962|NCT05193734|Immunologic Factors|immunologic factors|mesh-ancestor
110823963|NCT05193734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110823964|NCT05193734|Coagulants|coagulants|mesh-ancestor
110823965|NCT01375556|Ethanol|ethanol|mesh-list
110823966|NCT01375556|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110823967|NCT01375556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110823968|NCT01375556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110823969|NCT01375556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110823970|NCT03486496|Gefitinib|gefitinib|mesh-list
110823971|NCT03486496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110823972|NCT03486496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110823973|NCT03486496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110823974|NCT03486496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110823975|NCT02091934|Dipivefrin|dipivefrin|mesh-list
110823976|NCT02091934|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110823977|NCT02091934|Adrenergic Agents|adrenergic agents|mesh-ancestor
110823978|NCT02091934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110823979|NCT02091934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110823980|NCT02091934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110823981|NCT01375634|Midazolam|midazolam|mesh-list
110823982|NCT01375634|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110823983|NCT01375634|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110823984|NCT01375634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110823985|NCT01375634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110823986|NCT01375634|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110823987|NCT01375634|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110823988|NCT01375634|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110823989|NCT01375634|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110823990|NCT01375634|Anesthetics, General|anesthetics, general|mesh-ancestor
110823991|NCT01375634|Anesthetics|anesthetics|mesh-ancestor
110823992|NCT01375634|GABA Modulators|gaba modulators|mesh-ancestor
110823993|NCT01375634|GABA Agents|gaba agents|mesh-ancestor
110823994|NCT01375634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110823995|NCT01375634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110823996|NCT05388448|Amoxicillin|amoxicillin|mesh-list
110823997|NCT05388448|Rifampin|rifampin|mesh-list
110823998|NCT05388448|Clavulanic Acids|clavulanic acids|mesh-list
110823999|NCT05388448|Clavulanic Acid|clavulanic acid|mesh-list
110824000|NCT05388448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110824001|NCT05388448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110824002|NCT05388448|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110824003|NCT05388448|Antitubercular Agents|antitubercular agents|mesh-ancestor
110824004|NCT05388448|Leprostatic Agents|leprostatic agents|mesh-ancestor
110541532|NCT00873093|Cyclophosphamide|cyclophosphamide|mesh-list
110824005|NCT05388448|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110824006|NCT05388448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110824007|NCT05388448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110824008|NCT05388448|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110824009|NCT05388448|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110824010|NCT05388448|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110824011|NCT05388448|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110824012|NCT05388448|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110824013|NCT05388448|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110824014|NCT05388448|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110824015|NCT05108740|Everolimus|everolimus|mesh-list
110824016|NCT05108740|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110824017|NCT05108740|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110824018|NCT05108740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110824019|NCT05108740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110824020|NCT05108740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110824021|NCT05108740|Immunologic Factors|immunologic factors|mesh-ancestor
110824022|NCT05108740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110824023|NCT05108740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110824024|NCT05105750|Aspirin|aspirin|mesh-list
110824025|NCT05105750|Indobufen|indobufen|mesh-list
110824026|NCT05105750|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110824027|NCT05105750|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110824028|NCT05105750|Analgesics|analgesics|mesh-ancestor
110824029|NCT05105750|Sensory System Agents|sensory system agents|mesh-ancestor
110824030|NCT05105750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110824031|NCT05105750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110824032|NCT05105750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110824033|NCT05105750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110824034|NCT05105750|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110824035|NCT05105750|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110824036|NCT05105750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110824037|NCT05105750|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110824038|NCT05105750|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110824039|NCT05105750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110824040|NCT05105750|Antipyretics|antipyretics|mesh-ancestor
110824041|NCT03485170|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110824042|NCT03485170|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110824043|NCT03485170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110824044|NCT05152264|Analgesics|analgesics|mesh-list
110824045|NCT05152264|Sensory System Agents|sensory system agents|mesh-ancestor
110824046|NCT05152264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110824047|NCT05152264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110824048|NCT05152186|Disinfectants|disinfectants|mesh-list
110824049|NCT05152186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110824050|NCT03485092|Empagliflozin|empagliflozin|mesh-list
110824051|NCT03485092|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110824052|NCT03485092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110824053|NCT03485092|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110824054|NCT03485092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110824055|NCT03481582|Nitroglycerin|nitroglycerin|mesh-list
110824056|NCT03481582|Vasodilator Agents|vasodilator agents|mesh-ancestor
110824057|NCT01376102|Ibandronic Acid|ibandronic acid|mesh-list
110824058|NCT01376102|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110824059|NCT01376102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110824060|NCT05064800|Ritonavir|ritonavir|mesh-list
110824061|NCT05064800|Nirmatrelvir|nirmatrelvir|mesh-list
110824062|NCT05064800|Dabigatran|dabigatran|mesh-list
110824063|NCT05064800|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110824064|NCT05064800|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110824065|NCT05064800|Protease Inhibitors|protease inhibitors|mesh-ancestor
110824066|NCT05064800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110824067|NCT05064800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110824068|NCT05064800|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110824069|NCT05064800|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110824070|NCT05064800|Antiviral Agents|antiviral agents|mesh-ancestor
110824071|NCT05064800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110824072|NCT05064800|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110824073|NCT05064800|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110824074|NCT05064800|Antithrombins|antithrombins|mesh-ancestor
110824075|NCT05064800|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110824076|NCT05064800|Anticoagulants|anticoagulants|mesh-ancestor
110824077|NCT01376180|Lamotrigine|lamotrigine|mesh-list
110824078|NCT01376180|Anticonvulsants|anticonvulsants|mesh-ancestor
110824079|NCT01376180|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110824080|NCT01376180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110824081|NCT01376180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110824082|NCT01376180|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110824083|NCT01376180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110824084|NCT01376180|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110824085|NCT01376180|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110824086|NCT01376180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110824087|NCT01376180|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110824088|NCT01376180|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110824089|NCT03633734|Folfirinox|folfirinox|mesh-list
110824090|NCT03633734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110824091|NCT01376258|Finasteride|finasteride|mesh-list
110824092|NCT01376258|Dutasteride|dutasteride|mesh-list
110824093|NCT01376258|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
110824094|NCT01376258|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110824095|NCT01376258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110824096|NCT01376258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110824097|NCT01376258|Hormone Antagonists|hormone antagonists|mesh-ancestor
110824098|NCT01376258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110824099|NCT01376258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110824100|NCT01376258|Urological Agents|urological agents|mesh-ancestor
110824101|NCT05151874|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110824102|NCT05151874|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110824103|NCT05151874|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110824104|NCT05151874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110824105|NCT05151874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110824106|NCT05151874|Cholinergic Agents|cholinergic agents|mesh-ancestor
110824107|NCT05151874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110418868|NCT04306653|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110824108|NCT05151874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110824109|NCT05151874|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110824110|NCT05151874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110824111|NCT03531840|Olaparib|olaparib|mesh-list
110824112|NCT03531840|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110824113|NCT03531840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110824114|NCT03531840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110824115|NCT03531840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110824116|NCT05151796|Aspirin|aspirin|mesh-list
110824117|NCT05151796|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110824118|NCT05151796|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110824119|NCT05151796|Analgesics|analgesics|mesh-ancestor
110824120|NCT05151796|Sensory System Agents|sensory system agents|mesh-ancestor
110824121|NCT05151796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110824122|NCT05151796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110824123|NCT05151796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110824124|NCT05151796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110824125|NCT05151796|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110824126|NCT05151796|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110824127|NCT05151796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110824128|NCT05151796|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110824129|NCT05151796|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110824130|NCT05151796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110824131|NCT05151796|Antipyretics|antipyretics|mesh-ancestor
110824132|NCT04460092|Insulin|insulin|mesh-list
110824133|NCT04460092|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110824134|NCT04460092|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110824135|NCT04460092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110824136|NCT03110900|Lorazepam|lorazepam|mesh-list
110824137|NCT03110900|Haloperidol|haloperidol|mesh-list
110824138|NCT03110900|Haloperidol decanoate|haloperidol decanoate|mesh-list
110824139|NCT03110900|Loxapine|loxapine|mesh-list
110824140|NCT03110900|Antiemetics|antiemetics|mesh-ancestor
110824141|NCT03110900|Autonomic Agents|autonomic agents|mesh-ancestor
110824142|NCT03110900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110824143|NCT03110900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110824144|NCT03110900|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110824145|NCT03110900|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110824146|NCT03110900|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110824147|NCT03110900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110824148|NCT03110900|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110824149|NCT03110900|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110824150|NCT03110900|Dopamine Agents|dopamine agents|mesh-ancestor
110824151|NCT03110900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110541685|NCT02624973|Trastuzumab|trastuzumab|mesh-list
110824152|NCT03110900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110824153|NCT03110900|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110824154|NCT03110900|Anticonvulsants|anticonvulsants|mesh-ancestor
110824155|NCT03110900|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110824156|NCT03110900|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110824157|NCT03110900|GABA Modulators|gaba modulators|mesh-ancestor
110824158|NCT03110900|GABA Agents|gaba agents|mesh-ancestor
110824159|NCT03486184|Cystatins|cystatins|mesh-list
110824160|NCT03486184|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
110824161|NCT03486184|Protease Inhibitors|protease inhibitors|mesh-ancestor
110824162|NCT03486184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110824163|NCT03486184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110824164|NCT03109756|Gaboxadol|gaboxadol|mesh-list
110824165|NCT03109756|Analgesics|analgesics|mesh-ancestor
110824166|NCT03109756|Sensory System Agents|sensory system agents|mesh-ancestor
110824167|NCT03109756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110824168|NCT03109756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110824169|NCT03109756|Anticonvulsants|anticonvulsants|mesh-ancestor
110824170|NCT03109756|GABA Agonists|gaba agonists|mesh-ancestor
110824171|NCT03109756|GABA Agents|gaba agents|mesh-ancestor
110824172|NCT03109756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110824173|NCT03109756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110824174|NCT03867734|Aztreonam|aztreonam|mesh-list
110824175|NCT03867734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110308619|NCT00282126|Potassium Citrate|potassium citrate|mesh-list
110824176|NCT03867734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110824177|NCT05759546|Fulvestrant|fulvestrant|mesh-list
110824179|NCT05759546|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110824180|NCT05759546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110824181|NCT05759546|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110824182|NCT05759546|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110824183|NCT05759546|Hormone Antagonists|hormone antagonists|mesh-ancestor
110824184|NCT05759546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110824185|NCT05759546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110824186|NCT05759546|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110824187|NCT05759546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110824188|NCT05759546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110824189|NCT05151016|Triptorelin Pamoate|triptorelin pamoate|mesh-list
110824190|NCT05151016|Mifepristone|mifepristone|mesh-list
110824191|NCT05151016|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
110824192|NCT05151016|Abortifacient Agents|abortifacient agents|mesh-ancestor
110824193|NCT05151016|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110824194|NCT05151016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110824195|NCT05151016|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110824196|NCT05151016|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110824197|NCT05151016|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110824198|NCT05151016|Contraceptive Agents|contraceptive agents|mesh-ancestor
110824199|NCT05151016|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
110824200|NCT05151016|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
110824201|NCT05151016|Hormone Antagonists|hormone antagonists|mesh-ancestor
110824202|NCT05151016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110824203|NCT05151016|Luteolytic Agents|luteolytic agents|mesh-ancestor
110824204|NCT05151016|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110824205|NCT05151016|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
110824206|NCT05151016|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110824207|NCT05151016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110824208|NCT04459312|Antibodies|antibodies|mesh-list
110824209|NCT04459312|Immunologic Factors|immunologic factors|mesh-ancestor
110824210|NCT04459312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110824211|NCT04871360|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
110824212|NCT04871360|Laxatives|laxatives|mesh-ancestor
110824213|NCT04871360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110824214|NCT05153200|Adalimumab|adalimumab|mesh-list
110824215|NCT05153200|Upadacitinib|upadacitinib|mesh-list
110824216|NCT05153200|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110824217|NCT05153200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110824218|NCT05153200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110824219|NCT05153200|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
110824220|NCT05153200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110824221|NCT05153200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110824222|NCT05153200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110824223|NCT03481036|Antiviral Agents|antiviral agents|mesh-list
110824224|NCT03481036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110541764|NCT02782403|Axitinib|axitinib|mesh-list
110824225|NCT03477136|Vitamin D|vitamin d|mesh-list
110824226|NCT03477136|Vitamins|vitamins|mesh-ancestor
110824227|NCT03477136|Micronutrients|micronutrients|mesh-ancestor
110824228|NCT03477136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110824229|NCT03477136|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110824230|NCT03552068|Clonidine|clonidine|mesh-list
110824231|NCT03552068|Analgesics|analgesics|mesh-ancestor
110824232|NCT03552068|Sensory System Agents|sensory system agents|mesh-ancestor
110824233|NCT03552068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110824234|NCT03552068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110824235|NCT03552068|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110824236|NCT03552068|Sympatholytics|sympatholytics|mesh-ancestor
110824237|NCT03552068|Autonomic Agents|autonomic agents|mesh-ancestor
110824238|NCT03552068|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110824239|NCT03552068|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110824240|NCT03552068|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110824241|NCT03552068|Adrenergic Agents|adrenergic agents|mesh-ancestor
110824242|NCT03552068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110824243|NCT03552068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110824244|NCT00702988|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
110824245|NCT00702988|Hormones|hormones|mesh-ancestor
110824246|NCT00702988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110824247|NCT00702988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110824248|NCT05759312|Metformin|metformin|mesh-list
110824249|NCT05759312|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110824250|NCT05759312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110824252|NCT03446456|Arginine Vasopressin|arginine vasopressin|mesh-list
110824253|NCT03446456|Hemostatics|hemostatics|mesh-ancestor
110824254|NCT03446456|Coagulants|coagulants|mesh-ancestor
110824255|NCT03446456|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110824256|NCT03446456|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
110824257|NCT03446456|Natriuretic Agents|natriuretic agents|mesh-ancestor
110824258|NCT03446456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110824259|NCT03396692|Morphine|morphine|mesh-list
110824260|NCT03396692|Ropivacaine|ropivacaine|mesh-list
110824261|NCT03396692|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110824262|NCT03396692|Narcotics|narcotics|mesh-ancestor
110824263|NCT03396692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110824264|NCT03396692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110824265|NCT03396692|Analgesics|analgesics|mesh-ancestor
110824266|NCT03396692|Sensory System Agents|sensory system agents|mesh-ancestor
110824267|NCT03396692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110824268|NCT03396692|Anesthetics, Local|anesthetics, local|mesh-ancestor
110824269|NCT03396692|Anesthetics|anesthetics|mesh-ancestor
110824270|NCT03480958|Morphine|morphine|mesh-list
110824271|NCT03480958|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110824272|NCT03480958|Narcotics|narcotics|mesh-ancestor
110824273|NCT03480958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110824274|NCT03480958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110824275|NCT03480958|Analgesics|analgesics|mesh-ancestor
110824276|NCT03480958|Sensory System Agents|sensory system agents|mesh-ancestor
110824277|NCT03480958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110824278|NCT03495102|Dulaglutide|dulaglutide|mesh-list
110824279|NCT03495102|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110824280|NCT03495102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110824281|NCT04859608|Eculizumab|eculizumab|mesh-list
110824282|NCT04859608|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
110824283|NCT04859608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110824284|NCT04859608|Immunologic Factors|immunologic factors|mesh-ancestor
110824285|NCT04859608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110824286|NCT04754386|Antibodies|antibodies|mesh-list
110824287|NCT04754386|Immunologic Factors|immunologic factors|mesh-ancestor
110824288|NCT04754386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110824289|NCT05198180|Hydrogen Peroxide|hydrogen peroxide|mesh-list
110824290|NCT05198180|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110824291|NCT05198180|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110824292|NCT05198180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110824293|NCT03253172|Potassium Citrate|potassium citrate|mesh-list
110824294|NCT03253172|Diuretics|diuretics|mesh-ancestor
110824295|NCT03253172|Natriuretic Agents|natriuretic agents|mesh-ancestor
110824296|NCT03253172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110824297|NCT03253172|Expectorants|expectorants|mesh-ancestor
110824298|NCT03253172|Respiratory System Agents|respiratory system agents|mesh-ancestor
110824299|NCT03483376|Anti-Infective Agents|anti-infective agents|mesh-list
110824300|NCT03483376|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110824301|NCT03480646|Prednisone|prednisone|mesh-list
110824302|NCT03480646|(R)-N-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)-1H-indole-3-carboxamide|(r)-n-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)-1h-indole-3-carboxamide|mesh-list
110824303|NCT03480646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110824304|NCT03480646|Glucocorticoids|glucocorticoids|mesh-ancestor
110824306|NCT03480646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110824307|NCT03480646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110824308|NCT03480646|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110824309|NCT03480646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110824310|NCT03480646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110824311|NCT03480646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110824312|NCT03483142|Misoprostol|misoprostol|mesh-list
110824313|NCT03483142|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110824314|NCT03483142|Abortifacient Agents|abortifacient agents|mesh-ancestor
110824315|NCT03483142|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110824316|NCT03483142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110824317|NCT03483142|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110824318|NCT03483142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110824319|NCT03483142|Oxytocics|oxytocics|mesh-ancestor
110824320|NCT03726372|Bromides|bromides|mesh-list
110824321|NCT03726372|Rocuronium|rocuronium|mesh-list
110824322|NCT03726372|Anticonvulsants|anticonvulsants|mesh-ancestor
110824323|NCT03726372|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110824324|NCT03726372|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110824325|NCT03726372|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110824326|NCT03726372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110824327|NCT03726372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110824328|NCT03104816|Acetaminophen|acetaminophen|mesh-list
110824329|NCT03104816|Hydromorphone|hydromorphone|mesh-list
110824330|NCT03104816|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110824331|NCT03104816|Analgesics|analgesics|mesh-ancestor
110824332|NCT03104816|Sensory System Agents|sensory system agents|mesh-ancestor
110824333|NCT03104816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110824334|NCT03104816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110824335|NCT03104816|Antipyretics|antipyretics|mesh-ancestor
110824336|NCT03104816|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110824337|NCT03104816|Narcotics|narcotics|mesh-ancestor
110824338|NCT03104816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110824339|NCT04720976|Pembrolizumab|pembrolizumab|mesh-list
110824340|NCT04720976|Sotorasib|sotorasib|mesh-list
110824341|NCT04720976|Osimertinib|osimertinib|mesh-list
110824342|NCT04720976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110824343|NCT04720976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110824344|NCT04720976|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110824345|NCT04720976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110824346|NCT04720976|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110824347|NCT04720976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110824348|NCT03480568|Alirocumab|alirocumab|mesh-list
110824349|NCT03480568|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
110824350|NCT03480568|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110824351|NCT03480568|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110824352|NCT03480568|Antimetabolites|antimetabolites|mesh-ancestor
110824353|NCT03480568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110824354|NCT03480568|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110824355|NCT03480568|Protease Inhibitors|protease inhibitors|mesh-ancestor
110824356|NCT03480568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110824357|NCT03480568|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110824358|NCT04707326|Lamivudine|lamivudine|mesh-list
110824359|NCT04707326|Dolutegravir|dolutegravir|mesh-list
110824360|NCT04707326|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110824361|NCT04707326|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110824362|NCT04707326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110824363|NCT04707326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110824364|NCT04707326|Antiviral Agents|antiviral agents|mesh-ancestor
110824365|NCT04707326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110824366|NCT04707326|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110824367|NCT04707326|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110824368|NCT04707326|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110824369|NCT04707326|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110824370|NCT03559062|Ivacaftor|ivacaftor|mesh-list
110824371|NCT03559062|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
110824372|NCT03559062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110824373|NCT03559062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110824374|NCT05759000|Dapagliflozin|dapagliflozin|mesh-list
110824375|NCT05759000|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110824376|NCT05759000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110824377|NCT05759000|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110824378|NCT05759000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110824379|NCT03726216|Dalbavancin|dalbavancin|mesh-list
110824380|NCT03726216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110824381|NCT03726216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110824382|NCT00089791|Denosumab|denosumab|mesh-list
110824383|NCT00089791|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110824384|NCT00089791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110824385|NCT02876510|Aldesleukin|aldesleukin|mesh-list
110824386|NCT02876510|Cyclophosphamide|cyclophosphamide|mesh-list
110824387|NCT02876510|Fludarabine|fludarabine|mesh-list
110824388|NCT02876510|Fludarabine phosphate|fludarabine phosphate|mesh-list
110824389|NCT02876510|Atezolizumab|atezolizumab|mesh-list
110824390|NCT02876510|Interleukin-2|interleukin-2|mesh-list
110824391|NCT02876510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110824392|NCT02876510|Immunologic Factors|immunologic factors|mesh-ancestor
110824393|NCT02876510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110824394|NCT02876510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110824395|NCT02876510|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110824396|NCT02876510|Alkylating Agents|alkylating agents|mesh-ancestor
110824397|NCT02876510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110824398|NCT02876510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110824399|NCT02876510|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110824400|NCT02876510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110824401|NCT02876510|Antimetabolites|antimetabolites|mesh-ancestor
110824402|NCT02876510|Antiviral Agents|antiviral agents|mesh-ancestor
110824403|NCT02876510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110824404|NCT02876510|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110824405|NCT02876510|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110824406|NCT02876510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110824407|NCT02876510|Analgesics|analgesics|mesh-ancestor
110824408|NCT02876510|Sensory System Agents|sensory system agents|mesh-ancestor
110824409|NCT02876510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110824410|NCT02876510|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110824411|NCT02876510|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110824412|NCT03380455|Cimetidine|cimetidine|mesh-list
110824413|NCT03380455|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110824414|NCT03380455|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110824415|NCT03380455|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110824416|NCT03380455|Histamine Antagonists|histamine antagonists|mesh-ancestor
110824417|NCT03380455|Histamine Agents|histamine agents|mesh-ancestor
110824418|NCT03380455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110824419|NCT03380455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110824420|NCT03380455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110824421|NCT03380455|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110824422|NCT03380455|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110824423|NCT03380455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110824424|NCT02815280|Minocycline|minocycline|mesh-list
110824425|NCT02815280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110824426|NCT02815280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110824427|NCT03482752|Molgramostim|molgramostim|mesh-list
110824428|NCT03482752|Sargramostim|sargramostim|mesh-list
110824429|NCT03482752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110824430|NCT03482752|Immunologic Factors|immunologic factors|mesh-ancestor
110824431|NCT03482752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110824432|NCT04729543|Azacitidine|azacitidine|mesh-list
110824433|NCT04729543|Interleukin-2|interleukin-2|mesh-list
110824434|NCT04729543|Valproic Acid|valproic acid|mesh-list
110824435|NCT04729543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110824436|NCT04729543|Antimetabolites|antimetabolites|mesh-ancestor
110824437|NCT04729543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110824438|NCT04729543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110824439|NCT04729543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110824440|NCT04729543|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110824441|NCT04729543|Analgesics|analgesics|mesh-ancestor
110824442|NCT04729543|Sensory System Agents|sensory system agents|mesh-ancestor
110824443|NCT04729543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110824444|NCT04729543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110824445|NCT04729543|Anticonvulsants|anticonvulsants|mesh-ancestor
110824446|NCT04729543|GABA Agents|gaba agents|mesh-ancestor
110824447|NCT04729543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110824448|NCT04729543|Antimanic Agents|antimanic agents|mesh-ancestor
110824449|NCT04729543|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110824450|NCT04729543|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110824451|NCT04729543|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110824452|NCT01310712|Oxybutynin|oxybutynin|mesh-list
110824453|NCT01310712|Parasympatholytics|parasympatholytics|mesh-ancestor
110824454|NCT01310712|Autonomic Agents|autonomic agents|mesh-ancestor
110824455|NCT01310712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110824456|NCT01310712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110824457|NCT01310712|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110824458|NCT01310712|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110824459|NCT01310712|Cholinergic Agents|cholinergic agents|mesh-ancestor
110824460|NCT01310712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110824461|NCT01310712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110824462|NCT01310712|Urological Agents|urological agents|mesh-ancestor
110824463|NCT02737930|Fluoxetine|fluoxetine|mesh-list
110824464|NCT02737930|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110824465|NCT02737930|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110824466|NCT02737930|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110824467|NCT02737930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110824468|NCT02737930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110824469|NCT02737930|Serotonin Agents|serotonin agents|mesh-ancestor
110824470|NCT02737930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110824471|NCT02737930|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110824472|NCT02737930|Antidepressive Agents|antidepressive agents|mesh-ancestor
110824473|NCT02737930|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110824474|NCT02737930|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110824475|NCT02737930|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110824476|NCT02737930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110824477|NCT01242787|Entecavir|entecavir|mesh-list
110824478|NCT01242787|Antiviral Agents|antiviral agents|mesh-ancestor
110824479|NCT01242787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110824480|NCT03476356|Clomiphene|clomiphene|mesh-list
110824481|NCT03476356|Enclomiphene|enclomiphene|mesh-list
110824482|NCT03476356|Zuclomiphene|zuclomiphene|mesh-list
110824483|NCT03476356|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110824484|NCT03476356|Hormone Antagonists|hormone antagonists|mesh-ancestor
110824485|NCT03476356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110824486|NCT03476356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110824487|NCT03476356|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110824488|NCT03476356|Fertility Agents|fertility agents|mesh-ancestor
110824489|NCT03476356|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110824490|NCT03476356|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110824491|NCT03476356|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110824492|NCT03723096|Pomalidomide|pomalidomide|mesh-list
110824493|NCT03723096|Immunologic Factors|immunologic factors|mesh-ancestor
110824494|NCT03723096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110824495|NCT03723096|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110824496|NCT03723096|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110824497|NCT03723096|Growth Substances|growth substances|mesh-ancestor
110824498|NCT03723096|Growth Inhibitors|growth inhibitors|mesh-ancestor
110824499|NCT03723096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110824500|NCT02534012|Anesthetics|anesthetics|mesh-list
110824501|NCT02534012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110824502|NCT02534012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110824503|NCT05626387|Mycophenolic Acid|mycophenolic acid|mesh-list
110824504|NCT05626387|Prednisolone|prednisolone|mesh-list
110824505|NCT05626387|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110824506|NCT05626387|Methylprednisolone|methylprednisolone|mesh-list
110824507|NCT05626387|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110824508|NCT05626387|Prednisolone acetate|prednisolone acetate|mesh-list
110824509|NCT05626387|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110824510|NCT05626387|Prednisolone phosphate|prednisolone phosphate|mesh-list
110824511|NCT05626387|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110824512|NCT05626387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110824513|NCT05626387|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110824514|NCT05626387|Antitubercular Agents|antitubercular agents|mesh-ancestor
110824515|NCT05626387|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110824516|NCT05626387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110824517|NCT05626387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110824518|NCT05626387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110824519|NCT05626387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110824520|NCT05626387|Glucocorticoids|glucocorticoids|mesh-ancestor
110824521|NCT05626387|Hormones|hormones|mesh-ancestor
110863875|NCT03634020|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110824522|NCT05626387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110855289|NCT03780569|Temozolomide|temozolomide|mesh-list
110824523|NCT05626387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110542067|NCT00648440|Midodrine|midodrine|mesh-list
110824524|NCT05626387|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110824525|NCT05626387|Antiemetics|antiemetics|mesh-ancestor
110824526|NCT05626387|Autonomic Agents|autonomic agents|mesh-ancestor
110824527|NCT05626387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110824528|NCT05626387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110824529|NCT05626387|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110824530|NCT05626387|Protective Agents|protective agents|mesh-ancestor
110824531|NCT03722940|Magnesium Sulfate|magnesium sulfate|mesh-list
110824532|NCT03722940|Analgesics|analgesics|mesh-ancestor
110824533|NCT03722940|Sensory System Agents|sensory system agents|mesh-ancestor
110824534|NCT03722940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110824535|NCT03722940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110824536|NCT03722940|Anesthetics|anesthetics|mesh-ancestor
110824537|NCT03722940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110824538|NCT03722940|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110824539|NCT03722940|Anticonvulsants|anticonvulsants|mesh-ancestor
110824540|NCT03722940|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110824541|NCT03722940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110824542|NCT03722940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110824543|NCT03722940|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110824544|NCT03722940|Tocolytic Agents|tocolytic agents|mesh-ancestor
110824545|NCT03722940|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110824546|NCT01146925|Deferiprone|deferiprone|mesh-list
110824547|NCT01146925|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110824548|NCT01146925|Chelating Agents|chelating agents|mesh-ancestor
110824549|NCT01146925|Sequestering Agents|sequestering agents|mesh-ancestor
110824550|NCT01146925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110824551|NCT04635254|Histamine|histamine|mesh-list
110824552|NCT04635254|Histamine Agonists|histamine agonists|mesh-ancestor
110824553|NCT04635254|Histamine Agents|histamine agents|mesh-ancestor
110824554|NCT04635254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110824555|NCT04635254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110824556|NCT04635254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110824557|NCT03476044|Selenium|selenium|mesh-list
110824558|NCT03476044|Antioxidants|antioxidants|mesh-ancestor
110824559|NCT03476044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110824560|NCT03476044|Protective Agents|protective agents|mesh-ancestor
110824561|NCT03476044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110824562|NCT03476044|Trace Elements|trace elements|mesh-ancestor
110824563|NCT03476044|Micronutrients|micronutrients|mesh-ancestor
110824564|NCT01250821|Menotropins|menotropins|mesh-list
110824565|NCT01250821|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110824566|NCT01250821|Fertility Agents|fertility agents|mesh-ancestor
110824567|NCT01250821|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110824568|NCT01250821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110824569|NCT03493698|Midazolam|midazolam|mesh-list
110824570|NCT03493698|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110824571|NCT03493698|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110824572|NCT03493698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110824573|NCT03493698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110824574|NCT03493698|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110824575|NCT03493698|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110824576|NCT03493698|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110824577|NCT03493698|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110824578|NCT03493698|Anesthetics, General|anesthetics, general|mesh-ancestor
110824579|NCT03493698|Anesthetics|anesthetics|mesh-ancestor
110824580|NCT03493698|GABA Modulators|gaba modulators|mesh-ancestor
110824581|NCT03493698|GABA Agents|gaba agents|mesh-ancestor
110824582|NCT03493698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110824583|NCT03493698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110824584|NCT01148173|Ifosfamide|ifosfamide|mesh-list
110824585|NCT01148173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110824586|NCT01148173|Alkylating Agents|alkylating agents|mesh-ancestor
110824587|NCT01148173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110824588|NCT01148173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110824589|NCT01898312|Mifepristone|mifepristone|mesh-list
110824590|NCT01898312|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
110824591|NCT01898312|Abortifacient Agents|abortifacient agents|mesh-ancestor
110824592|NCT01898312|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110824593|NCT01898312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110824594|NCT01898312|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110824595|NCT01898312|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110824596|NCT01898312|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110824597|NCT01898312|Contraceptive Agents|contraceptive agents|mesh-ancestor
110824598|NCT01898312|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
110824599|NCT01898312|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
110824600|NCT01898312|Hormone Antagonists|hormone antagonists|mesh-ancestor
110824601|NCT01898312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110824602|NCT01898312|Luteolytic Agents|luteolytic agents|mesh-ancestor
110824603|NCT01898312|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110824604|NCT01898312|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
110824605|NCT03528174|Pancrelipase|pancrelipase|mesh-list
110824606|NCT03528174|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110824607|NCT05756660|Sodium thiosulfate|sodium thiosulfate|mesh-list
110824608|NCT05756660|Cisplatin|cisplatin|mesh-list
110824609|NCT05756660|Vorinostat|vorinostat|mesh-list
110824610|NCT05756660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110824611|NCT05756660|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110824612|NCT05756660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110824613|NCT05756660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110824614|NCT05756660|Antidotes|antidotes|mesh-ancestor
110824615|NCT05756660|Protective Agents|protective agents|mesh-ancestor
110824616|NCT05756660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110824617|NCT05756660|Antioxidants|antioxidants|mesh-ancestor
110824618|NCT05756660|Antitubercular Agents|antitubercular agents|mesh-ancestor
110824619|NCT05756660|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110824620|NCT05756660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110824621|NCT05756660|Chelating Agents|chelating agents|mesh-ancestor
110824622|NCT05756660|Sequestering Agents|sequestering agents|mesh-ancestor
110824623|NCT03482440|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
110824624|NCT03482440|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110824626|NCT03482440|Analgesics|analgesics|mesh-ancestor
110824627|NCT03482440|Sensory System Agents|sensory system agents|mesh-ancestor
110824628|NCT03482440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110824629|NCT03482440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110824630|NCT03482440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110824631|NCT03482440|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110824632|NCT04638634|Immunoglobulins|immunoglobulins|mesh-list
110824633|NCT04638634|Immunologic Factors|immunologic factors|mesh-ancestor
110824634|NCT04638634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110824635|NCT01253473|Budesonide|budesonide|mesh-list
110824636|NCT01253473|Albuterol|albuterol|mesh-list
110824637|NCT01253473|Formoterol Fumarate|formoterol fumarate|mesh-list
110824638|NCT01253473|Ipratropium|ipratropium|mesh-list
110824639|NCT01253473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110824640|NCT01253473|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110824641|NCT01253473|Autonomic Agents|autonomic agents|mesh-ancestor
110824642|NCT01253473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110824643|NCT01253473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110824644|NCT01253473|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110824645|NCT01253473|Respiratory System Agents|respiratory system agents|mesh-ancestor
110824646|NCT01253473|Glucocorticoids|glucocorticoids|mesh-ancestor
110824647|NCT01253473|Hormones|hormones|mesh-ancestor
110824648|NCT01253473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110824649|NCT01253473|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110824650|NCT01253473|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110824651|NCT01253473|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110824652|NCT01253473|Adrenergic Agents|adrenergic agents|mesh-ancestor
110824653|NCT01253473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110824654|NCT01253473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110824655|NCT01253473|Tocolytic Agents|tocolytic agents|mesh-ancestor
110824656|NCT01253473|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110824657|NCT01253473|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110824658|NCT01253473|Cholinergic Agents|cholinergic agents|mesh-ancestor
110824659|NCT01883804|Methyldopa|methyldopa|mesh-list
110824660|NCT01883804|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110824661|NCT01883804|Sympatholytics|sympatholytics|mesh-ancestor
110824662|NCT01883804|Autonomic Agents|autonomic agents|mesh-ancestor
110824663|NCT01883804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110824664|NCT01883804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110824665|NCT01883804|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110824666|NCT01883804|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110824667|NCT01883804|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110824668|NCT01883804|Adrenergic Agents|adrenergic agents|mesh-ancestor
110824669|NCT01883804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110824670|NCT01883804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110824671|NCT01247935|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
110824672|NCT01247935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110824673|NCT01247935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110824675|NCT03480100|Nasal Decongestants|nasal decongestants|mesh-ancestor
110824676|NCT03480100|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110824677|NCT03480100|Respiratory System Agents|respiratory system agents|mesh-ancestor
110824679|NCT02348203|Zileuton|zileuton|mesh-list
110824680|NCT02348203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110824681|NCT02348203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110824682|NCT02348203|Analgesics|analgesics|mesh-ancestor
110824683|NCT02348203|Sensory System Agents|sensory system agents|mesh-ancestor
110824684|NCT02348203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110824685|NCT02348203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110824686|NCT02348203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110824687|NCT02348203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110824688|NCT02348203|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110824689|NCT02348203|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110824690|NCT02348203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110824691|NCT02348203|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110824692|NCT02348203|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110824693|NCT02348203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110824694|NCT02348203|Antipyretics|antipyretics|mesh-ancestor
110824695|NCT02348203|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
110824696|NCT02348203|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110824697|NCT02348203|Hormone Antagonists|hormone antagonists|mesh-ancestor
110309145|NCT00308880|Hemostatics|hemostatics|mesh-ancestor
110824698|NCT02348203|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110824699|NCT03493542|Vaccines|vaccines|mesh-list
110824700|NCT03493542|Immunologic Factors|immunologic factors|mesh-ancestor
110824701|NCT03493542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110824702|NCT03482362|Vinorelbine|vinorelbine|mesh-list
110824703|NCT03482362|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110824704|NCT03482362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110824705|NCT03482362|Tubulin Modulators|tubulin modulators|mesh-ancestor
110824706|NCT03482362|Antimitotic Agents|antimitotic agents|mesh-ancestor
110824707|NCT03482362|Mitosis Modulators|mitosis modulators|mesh-ancestor
110824708|NCT03482362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110824709|NCT04500470|Ketoprofen|ketoprofen|mesh-list
110824710|NCT04500470|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110824711|NCT04500470|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110824712|NCT04500470|Analgesics|analgesics|mesh-ancestor
110824713|NCT04500470|Sensory System Agents|sensory system agents|mesh-ancestor
110824714|NCT04500470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110824715|NCT04500470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110824716|NCT04500470|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110824717|NCT04500470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110824718|NCT04500470|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110824719|NCT04500470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110824720|NCT04500470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110824721|NCT03493386|Glycine|glycine|mesh-list
110824722|NCT03493386|Glycine Agents|glycine agents|mesh-ancestor
110824723|NCT03493386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110824724|NCT03493386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110824725|NCT03493386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110824726|NCT04937816|Empagliflozin|empagliflozin|mesh-list
110824727|NCT04937816|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110824728|NCT04937816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110855306|NCT01313585|Tocolytic Agents|tocolytic agents|mesh-ancestor
110824729|NCT04937816|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110824730|NCT04937816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110824731|NCT01366898|Methotrexate|methotrexate|mesh-list
110824732|NCT01366898|Idarubicin|idarubicin|mesh-list
110824733|NCT01366898|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110824734|NCT01366898|Abortifacient Agents|abortifacient agents|mesh-ancestor
110824735|NCT01366898|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110824736|NCT01366898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110824737|NCT01366898|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110824738|NCT01366898|Antimetabolites|antimetabolites|mesh-ancestor
110824739|NCT01366898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110824740|NCT01366898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110824741|NCT01366898|Dermatologic Agents|dermatologic agents|mesh-ancestor
110824742|NCT01366898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110824743|NCT01366898|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110824744|NCT01366898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110824745|NCT01366898|Immunologic Factors|immunologic factors|mesh-ancestor
110824746|NCT01366898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110824747|NCT01366898|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110824748|NCT01366898|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110824749|NCT01366898|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110824750|NCT01366898|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110824751|NCT01248871|Sufentanil|sufentanil|mesh-list
110824752|NCT01248871|Remifentanil|remifentanil|mesh-list
110824753|NCT01248871|Dsuvia|dsuvia|mesh-list
110824754|NCT01248871|Propofol|propofol|mesh-list
110824755|NCT01248871|Sevoflurane|sevoflurane|mesh-list
110824756|NCT01248871|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110824757|NCT01248871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110824758|NCT01248871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110824759|NCT01248871|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110824760|NCT01248871|Anesthetics, General|anesthetics, general|mesh-ancestor
110824761|NCT01248871|Anesthetics|anesthetics|mesh-ancestor
110824762|NCT01248871|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110824763|NCT01248871|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110824764|NCT01248871|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110824765|NCT01248871|Narcotics|narcotics|mesh-ancestor
110824766|NCT01248871|Analgesics|analgesics|mesh-ancestor
110824767|NCT01248871|Sensory System Agents|sensory system agents|mesh-ancestor
110824768|NCT01248871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110824769|NCT01248871|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110824770|NCT01251133|Vaccines|vaccines|mesh-list
110824771|NCT01251133|Immunologic Factors|immunologic factors|mesh-ancestor
110824772|NCT01251133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110824773|NCT03720288|Acetazolamide|acetazolamide|mesh-list
110824774|NCT03720288|Anticonvulsants|anticonvulsants|mesh-ancestor
110824775|NCT03720288|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110824776|NCT03720288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110824777|NCT03720288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110824778|NCT03720288|Diuretics|diuretics|mesh-ancestor
110824779|NCT03720288|Natriuretic Agents|natriuretic agents|mesh-ancestor
110824780|NCT03720288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110824781|NCT03916393|Denatonium|denatonium|mesh-list
110824782|NCT03916393|Aversive Agents|aversive agents|mesh-ancestor
110824783|NCT03916393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110824784|NCT03916393|Abuse-Deterrent Formulations|abuse-deterrent formulations|mesh-ancestor
110824785|NCT03916393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110824786|NCT03916393|Sensory System Agents|sensory system agents|mesh-ancestor
110824787|NCT03916393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110824788|NCT03907813|Bupivacaine|bupivacaine|mesh-list
110824789|NCT03907813|Anesthetics, Local|anesthetics, local|mesh-ancestor
110824790|NCT03907813|Anesthetics|anesthetics|mesh-ancestor
110824791|NCT03907813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110824792|NCT03907813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110824793|NCT03907813|Sensory System Agents|sensory system agents|mesh-ancestor
110824794|NCT03907813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110824795|NCT00938912|Lacosamide|lacosamide|mesh-list
110824796|NCT00938912|Anticonvulsants|anticonvulsants|mesh-ancestor
110824797|NCT00938912|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110824798|NCT00938912|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110824799|NCT00938912|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110824800|NCT00938912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110824801|NCT01251211|Botulinum Toxins|botulinum toxins|mesh-list
110824802|NCT01251211|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110824803|NCT01251211|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110824804|NCT01251211|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110418915|NCT02888327|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110824805|NCT01251211|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110824806|NCT01251211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110824807|NCT01251211|Cholinergic Agents|cholinergic agents|mesh-ancestor
110824808|NCT01251211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110824809|NCT01251211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110824810|NCT01251211|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110824811|NCT01251211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110824812|NCT03473340|Pirfenidone|pirfenidone|mesh-list
110824813|NCT03473340|Analgesics|analgesics|mesh-ancestor
110824814|NCT03473340|Sensory System Agents|sensory system agents|mesh-ancestor
110824815|NCT03473340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110824816|NCT03473340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110824817|NCT03473340|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110824818|NCT03473340|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110824819|NCT03473340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110824820|NCT03473340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110542357|NCT04008979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110824821|NCT03473340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110824822|NCT01147705|Allopurinol|allopurinol|mesh-list
110824823|NCT01147705|Antimetabolites|antimetabolites|mesh-ancestor
110824824|NCT01147705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110824825|NCT01147705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110824826|NCT01147705|Gout Suppressants|gout suppressants|mesh-ancestor
110824827|NCT01147705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110824828|NCT01147705|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110824829|NCT01147705|Antioxidants|antioxidants|mesh-ancestor
110824830|NCT01147705|Protective Agents|protective agents|mesh-ancestor
110824831|NCT01147705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110824832|NCT03907111|Chitosan|chitosan|mesh-list
110824833|NCT03907111|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110824834|NCT03907111|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110824835|NCT03907111|Antimetabolites|antimetabolites|mesh-ancestor
110824836|NCT03907111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110824837|NCT03907111|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110824838|NCT03907111|Chelating Agents|chelating agents|mesh-ancestor
110824839|NCT03907111|Sequestering Agents|sequestering agents|mesh-ancestor
110824840|NCT03907111|Hemostatics|hemostatics|mesh-ancestor
110824841|NCT03907111|Coagulants|coagulants|mesh-ancestor
110824842|NCT03912727|Thioctic Acid|thioctic acid|mesh-list
110824843|NCT03912727|Antioxidants|antioxidants|mesh-ancestor
110824844|NCT03912727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110824845|NCT03912727|Protective Agents|protective agents|mesh-ancestor
110824846|NCT03912727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110824847|NCT03912727|Vitamin B Complex|vitamin b complex|mesh-ancestor
110824849|NCT03912727|Micronutrients|micronutrients|mesh-ancestor
110824850|NCT03661567|Methylprednisolone|methylprednisolone|mesh-list
110824851|NCT03661567|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110824852|NCT03661567|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110824853|NCT03661567|Prednisolone|prednisolone|mesh-list
110824854|NCT03661567|Prednisolone acetate|prednisolone acetate|mesh-list
110824855|NCT03661567|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110824856|NCT03661567|Prednisolone phosphate|prednisolone phosphate|mesh-list
110824857|NCT03661567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110824858|NCT03661567|Antiemetics|antiemetics|mesh-ancestor
110824859|NCT03661567|Autonomic Agents|autonomic agents|mesh-ancestor
110855324|NCT02485990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110824860|NCT03661567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110824861|NCT03661567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110824862|NCT03661567|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110824863|NCT03661567|Glucocorticoids|glucocorticoids|mesh-ancestor
110824864|NCT03661567|Hormones|hormones|mesh-ancestor
110824865|NCT03661567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110824866|NCT03661567|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110824867|NCT03661567|Protective Agents|protective agents|mesh-ancestor
110824868|NCT03661567|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110824869|NCT03661567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110824870|NCT03739138|Pembrolizumab|pembrolizumab|mesh-list
110824871|NCT03739138|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110824872|NCT03739138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110824873|NCT03739138|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110824874|NCT03739138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110824875|NCT03472326|GS-9131|gs-9131|mesh-list
110824876|NCT03472326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110824877|NCT03472326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110824878|NCT03472326|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110824879|NCT03472326|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110824880|NCT03472326|Antiviral Agents|antiviral agents|mesh-ancestor
110824881|NCT03472326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110824882|NCT03472326|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110824883|NCT03472326|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110824884|NCT03472014|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
110824885|NCT03472014|Antiviral Agents|antiviral agents|mesh-ancestor
110824886|NCT03472014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110824887|NCT04182100|Aspirin|aspirin|mesh-list
110824888|NCT04182100|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110824889|NCT04182100|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110824890|NCT04182100|Analgesics|analgesics|mesh-ancestor
110824891|NCT04182100|Sensory System Agents|sensory system agents|mesh-ancestor
110824892|NCT04182100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110824893|NCT04182100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110824894|NCT04182100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110542439|NCT00970957|Bevacizumab|bevacizumab|mesh-list
110824895|NCT04182100|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110824896|NCT04182100|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110824897|NCT04182100|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110824898|NCT04182100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110824899|NCT04182100|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110824900|NCT04182100|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110824901|NCT04182100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110824902|NCT04182100|Antipyretics|antipyretics|mesh-ancestor
110824903|NCT03479320|Lidocaine|lidocaine|mesh-list
110824904|NCT03479320|Anesthetics, Local|anesthetics, local|mesh-ancestor
110824905|NCT03479320|Anesthetics|anesthetics|mesh-ancestor
110418980|NCT02866396|Sensory System Agents|sensory system agents|mesh-ancestor
110824906|NCT03479320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110824907|NCT03479320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110824908|NCT03479320|Sensory System Agents|sensory system agents|mesh-ancestor
110824909|NCT03479320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110824910|NCT03479320|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110824911|NCT03479320|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110824912|NCT03479320|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110824913|NCT03479320|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110419044|NCT03432949|BB 1101|bb 1101|mesh-list
110824914|NCT03479320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110824915|NCT03912415|Paclitaxel|paclitaxel|mesh-list
110824916|NCT03912415|Bevacizumab|bevacizumab|mesh-list
110824917|NCT03912415|Carboplatin|carboplatin|mesh-list
110824918|NCT03912415|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110824919|NCT03912415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110824920|NCT03912415|Tubulin Modulators|tubulin modulators|mesh-ancestor
110824921|NCT03912415|Antimitotic Agents|antimitotic agents|mesh-ancestor
110824922|NCT03912415|Mitosis Modulators|mitosis modulators|mesh-ancestor
110824923|NCT03912415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110824924|NCT03912415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110824925|NCT03912415|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110824926|NCT03912415|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110824927|NCT03912415|Growth Substances|growth substances|mesh-ancestor
110824928|NCT03912415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110824929|NCT03912415|Growth Inhibitors|growth inhibitors|mesh-ancestor
110824931|NCT03525834|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110824932|NCT03525834|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110824933|NCT03525834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110824934|NCT03525834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110824935|NCT03525834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110824936|NCT03525834|Immunologic Factors|immunologic factors|mesh-ancestor
110824937|NCT03525834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110824938|NCT03525834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110824939|NCT00925652|Cyclophosphamide|cyclophosphamide|mesh-list
110824940|NCT00925652|Bevacizumab|bevacizumab|mesh-list
110824941|NCT00925652|Methotrexate|methotrexate|mesh-list
110824942|NCT00925652|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110824943|NCT00925652|Immunologic Factors|immunologic factors|mesh-ancestor
110824944|NCT00925652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110824945|NCT00925652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110824946|NCT00925652|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110824947|NCT00925652|Alkylating Agents|alkylating agents|mesh-ancestor
110824948|NCT00925652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110824949|NCT00925652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110824950|NCT00925652|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110824951|NCT00925652|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110824952|NCT00925652|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110419163|NCT02864602|Dexamethasone acetate|dexamethasone acetate|mesh-list
110824953|NCT00925652|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110824954|NCT00925652|Growth Substances|growth substances|mesh-ancestor
110824955|NCT00925652|Growth Inhibitors|growth inhibitors|mesh-ancestor
110824956|NCT00925652|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110824957|NCT00925652|Abortifacient Agents|abortifacient agents|mesh-ancestor
110824958|NCT00925652|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110824959|NCT00925652|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110824960|NCT00925652|Antimetabolites|antimetabolites|mesh-ancestor
110824961|NCT00925652|Dermatologic Agents|dermatologic agents|mesh-ancestor
110824962|NCT00925652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110824963|NCT00925652|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110824964|NCT00925652|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110824965|NCT04872686|Povidone-Iodine|povidone-iodine|mesh-list
110824966|NCT04872686|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110824967|NCT04872686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110824968|NCT03954106|Defibrotide|defibrotide|mesh-list
110824969|NCT03954106|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110824970|NCT03954106|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110824971|NCT03954106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110824972|NCT03954106|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110824973|NCT03525444|Ivacaftor|ivacaftor|mesh-list
110824974|NCT03525444|Elexacaftor|elexacaftor|mesh-list
110824975|NCT03525444|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
110824976|NCT03525444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110824977|NCT03525444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110824978|NCT01251835|Rifampin|rifampin|mesh-list
110824979|NCT01251835|Sitaxsentan|sitaxsentan|mesh-list
110824980|NCT01251835|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110824981|NCT01251835|Antitubercular Agents|antitubercular agents|mesh-ancestor
110824982|NCT01251835|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110824983|NCT01251835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110824984|NCT01251835|Leprostatic Agents|leprostatic agents|mesh-ancestor
110824985|NCT01251835|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110824986|NCT01251835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110824987|NCT01251835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110824988|NCT01251835|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110824989|NCT01251835|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110824990|NCT01251835|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110824991|NCT01251835|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110824992|NCT01251835|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110824993|NCT01251835|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110824994|NCT01251835|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
110824995|NCT03632876|Vitamin A|vitamin a|mesh-list
110824996|NCT03632876|Retinol palmitate|retinol palmitate|mesh-list
110824997|NCT03632876|Antioxidants|antioxidants|mesh-ancestor
110824998|NCT03632876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110824999|NCT03632876|Protective Agents|protective agents|mesh-ancestor
110825000|NCT03632876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110825001|NCT03632876|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110825002|NCT03632876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110825003|NCT03632876|Vitamins|vitamins|mesh-ancestor
110825004|NCT03632876|Micronutrients|micronutrients|mesh-ancestor
110825005|NCT03914755|Tucatinib|tucatinib|mesh-list
110825006|NCT03914755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110825007|NCT03914755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110825008|NCT03914755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110825009|NCT03914755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110825010|NCT03905317|Bevacizumab|bevacizumab|mesh-list
110825011|NCT03905317|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110825012|NCT03905317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110825013|NCT03905317|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110825014|NCT03905317|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110825015|NCT03905317|Growth Substances|growth substances|mesh-ancestor
110825016|NCT03905317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110825017|NCT03905317|Growth Inhibitors|growth inhibitors|mesh-ancestor
110825018|NCT03487848|Sofosbuvir|sofosbuvir|mesh-list
110825019|NCT03487848|Antiviral Agents|antiviral agents|mesh-ancestor
110825020|NCT03487848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110825021|NCT01251991|Psyllium|psyllium|mesh-list
110825022|NCT01251991|Calcium polycarbophil|calcium polycarbophil|mesh-list
110825023|NCT01251991|Cathartics|cathartics|mesh-ancestor
110825024|NCT01251991|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110825025|NCT01251991|Antidiarrheals|antidiarrheals|mesh-ancestor
110825026|NCT04458454|Methocarbamol|methocarbamol|mesh-list
110825027|NCT04458454|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110825028|NCT04458454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110825029|NCT04458454|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110825030|NCT04458454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110825031|NCT03914677|Mecamylamine|mecamylamine|mesh-list
110825032|NCT03914677|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110825033|NCT03914677|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
110825034|NCT03914677|Autonomic Agents|autonomic agents|mesh-ancestor
110825035|NCT03914677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110825036|NCT03914677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110825037|NCT03914677|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
110825038|NCT03914677|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110825039|NCT03914677|Cholinergic Agents|cholinergic agents|mesh-ancestor
110825040|NCT03914677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110825041|NCT03914677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110825042|NCT03479086|Topiramate|topiramate|mesh-list
110825043|NCT03479086|Naltrexone|naltrexone|mesh-list
110825044|NCT03479086|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110825045|NCT03479086|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110825046|NCT03479086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110825047|NCT03479086|Sensory System Agents|sensory system agents|mesh-ancestor
110825048|NCT03479086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110825049|NCT03479086|Anticonvulsants|anticonvulsants|mesh-ancestor
110825050|NCT03479086|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110825051|NCT01252069|Ulipristal acetate|ulipristal acetate|mesh-list
110825052|NCT01252069|Progestins|progestins|mesh-list
110825053|NCT01252069|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110825054|NCT01252069|Contraceptive Agents|contraceptive agents|mesh-ancestor
110419312|NCT02850445|Serotonin Agents|serotonin agents|mesh-ancestor
110825055|NCT01252069|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110825056|NCT01252069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110825057|NCT01252069|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110825058|NCT01252069|Hormones|hormones|mesh-ancestor
110825059|NCT01252069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110825060|NCT01252225|Lidocaine|lidocaine|mesh-list
110825061|NCT01252225|Anesthetics, Local|anesthetics, local|mesh-ancestor
110825062|NCT01252225|Anesthetics|anesthetics|mesh-ancestor
110855340|NCT03315442|Caffeine|caffeine|mesh-list
110825063|NCT01252225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110825064|NCT01252225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110825065|NCT01252225|Sensory System Agents|sensory system agents|mesh-ancestor
110825066|NCT01252225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110825067|NCT01252225|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110825068|NCT01252225|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110825069|NCT01252225|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110825070|NCT01252225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110825071|NCT01252225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110825072|NCT04459702|Ritonavir|ritonavir|mesh-list
110825073|NCT04459702|Lopinavir|lopinavir|mesh-list
110825074|NCT04459702|Azithromycin|azithromycin|mesh-list
110825075|NCT04459702|Hydroxychloroquine|hydroxychloroquine|mesh-list
110825076|NCT04459702|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110825077|NCT04459702|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110825078|NCT04459702|Protease Inhibitors|protease inhibitors|mesh-ancestor
110825079|NCT04459702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110825080|NCT04459702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110825081|NCT04459702|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110825082|NCT04459702|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110825083|NCT04459702|Antiviral Agents|antiviral agents|mesh-ancestor
110825084|NCT04459702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110825085|NCT04459702|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110825086|NCT04459702|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110825087|NCT04459702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110825088|NCT04459702|Antimalarials|antimalarials|mesh-ancestor
110825089|NCT04459702|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110825090|NCT04459702|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110825091|NCT04459702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110825092|NCT03574792|Oxycodone|oxycodone|mesh-list
110825093|NCT03574792|Methadone|methadone|mesh-list
110825094|NCT03574792|Gabapentin|gabapentin|mesh-list
110825095|NCT03574792|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
110825096|NCT03574792|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110825097|NCT03574792|Narcotics|narcotics|mesh-ancestor
110825098|NCT03574792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110825099|NCT03574792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110419402|NCT02888561|Dobutamine|dobutamine|mesh-list
110825100|NCT03574792|Analgesics|analgesics|mesh-ancestor
110825101|NCT03574792|Sensory System Agents|sensory system agents|mesh-ancestor
110825102|NCT03574792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110825103|NCT03574792|Anticonvulsants|anticonvulsants|mesh-ancestor
110825104|NCT03574792|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110825105|NCT03574792|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110825106|NCT03574792|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110825107|NCT03574792|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110825108|NCT03574792|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110825109|NCT03574792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110825110|NCT03574792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110825111|NCT03574792|Antimanic Agents|antimanic agents|mesh-ancestor
110825112|NCT03574792|Antitussive Agents|antitussive agents|mesh-ancestor
110825113|NCT03574792|Respiratory System Agents|respiratory system agents|mesh-ancestor
110419450|NCT01236365|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110825114|NCT03574792|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110825115|NCT03574792|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110825116|NCT03574792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110825117|NCT03574792|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110542662|NCT02779283|Leucovorin|leucovorin|mesh-list
110825118|NCT03574792|Antidepressive Agents|antidepressive agents|mesh-ancestor
110825119|NCT03904849|Cannabidiol|cannabidiol|mesh-list
110825120|NCT03904849|Anticonvulsants|anticonvulsants|mesh-ancestor
110825121|NCT01250743|Vitamins|vitamins|mesh-list
110825122|NCT01250743|Ascorbic Acid|ascorbic acid|mesh-list
110825123|NCT01250743|Micronutrients|micronutrients|mesh-ancestor
110825124|NCT01250743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110825125|NCT01250743|Antioxidants|antioxidants|mesh-ancestor
110825126|NCT01250743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110825127|NCT01250743|Protective Agents|protective agents|mesh-ancestor
110825128|NCT01254175|Vaccines|vaccines|mesh-list
110825129|NCT01254175|Immunologic Factors|immunologic factors|mesh-ancestor
110825130|NCT01254175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110825131|NCT04377620|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
110825132|NCT04377620|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110825133|NCT04377620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110825134|NCT04377620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110825135|NCT03478540|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
110825136|NCT03478540|Antiviral Agents|antiviral agents|mesh-ancestor
110825137|NCT03478540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110825138|NCT03903367|Fentanyl|fentanyl|mesh-list
110825139|NCT03903367|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110825141|NCT03903367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110825142|NCT03903367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110825143|NCT03903367|Analgesics|analgesics|mesh-ancestor
110825144|NCT03903367|Sensory System Agents|sensory system agents|mesh-ancestor
110825145|NCT03903367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110825146|NCT03903367|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110825147|NCT03903367|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110825148|NCT03903367|Anesthetics, General|anesthetics, general|mesh-ancestor
110825149|NCT03903367|Anesthetics|anesthetics|mesh-ancestor
110825150|NCT03486834|Vaccines|vaccines|mesh-list
110825151|NCT03486834|Immunologic Factors|immunologic factors|mesh-ancestor
110825152|NCT03486834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110825153|NCT02523664|Hydrocortisone|hydrocortisone|mesh-list
110825154|NCT02523664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110825155|NCT03177460|Daratumumab|daratumumab|mesh-list
110825156|NCT03177460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110825157|NCT03717168|Hormones|hormones|mesh-list
110825158|NCT03717168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110825159|NCT03717168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110825160|NCT00708448|Bevacizumab|bevacizumab|mesh-list
110825161|NCT00708448|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110825162|NCT00708448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110825163|NCT00708448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110825164|NCT00708448|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110825165|NCT00708448|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110825166|NCT00708448|Growth Substances|growth substances|mesh-ancestor
110825167|NCT00708448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110825168|NCT00708448|Growth Inhibitors|growth inhibitors|mesh-ancestor
110825169|NCT00708448|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110825170|NCT00708448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110825171|NCT00708448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110825172|NCT02892604|Insulin|insulin|mesh-list
110825173|NCT02892604|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110825174|NCT02892604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110825175|NCT03478306|Melatonin|melatonin|mesh-list
110825176|NCT03478306|Antioxidants|antioxidants|mesh-ancestor
110825177|NCT03478306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110825178|NCT03478306|Protective Agents|protective agents|mesh-ancestor
110825179|NCT03478306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110825180|NCT03478306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110825181|NCT03103100|Lidocaine|lidocaine|mesh-list
110825182|NCT03103100|Bupivacaine|bupivacaine|mesh-list
110825183|NCT03103100|Anesthetics, Local|anesthetics, local|mesh-ancestor
110825184|NCT03103100|Anesthetics|anesthetics|mesh-ancestor
110825185|NCT03103100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110825186|NCT03103100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110825187|NCT03103100|Sensory System Agents|sensory system agents|mesh-ancestor
110825188|NCT03103100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110825189|NCT03103100|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110825190|NCT03103100|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110825191|NCT03103100|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110825192|NCT03103100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110825193|NCT03103100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110825194|NCT03639168|Cisplatin|cisplatin|mesh-list
110825195|NCT03639168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110825196|NCT03131050|Scopolamine|scopolamine|mesh-list
110825197|NCT03131050|Escitalopram|escitalopram|mesh-list
110825198|NCT03131050|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
110825199|NCT03131050|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110825200|NCT03131050|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110825201|NCT03131050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110825202|NCT03131050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110825203|NCT03131050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110825204|NCT03131050|Serotonin Agents|serotonin agents|mesh-ancestor
110825205|NCT03131050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110825206|NCT03131050|Parasympatholytics|parasympatholytics|mesh-ancestor
110825207|NCT03131050|Autonomic Agents|autonomic agents|mesh-ancestor
110825208|NCT03131050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110825209|NCT03131050|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110825210|NCT03131050|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110825211|NCT03131050|Cholinergic Agents|cholinergic agents|mesh-ancestor
110309674|NCT00316563|Dronabinol|dronabinol|mesh-list
110825212|NCT03131050|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110825213|NCT03131050|Antiemetics|antiemetics|mesh-ancestor
110825214|NCT03131050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110825215|NCT03131050|Mydriatics|mydriatics|mesh-ancestor
110825216|NCT03719820|Clopidogrel|clopidogrel|mesh-list
110825217|NCT03719820|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110825218|NCT03719820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110825219|NCT03719820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110825220|NCT03719820|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110825221|NCT03719820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110825222|NCT03719820|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110825223|NCT03719820|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110825224|NCT03719820|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110825225|NCT03719820|Purinergic Agents|purinergic agents|mesh-ancestor
110825226|NCT03719820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110825227|NCT03719820|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110825228|NCT03719820|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110825229|NCT03719820|Antimetabolites|antimetabolites|mesh-ancestor
110825230|NCT03719820|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110825231|NCT03719820|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110825232|NCT04206020|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110825233|NCT04206020|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110825234|NCT03466086|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110825235|NCT03466086|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110825236|NCT01254799|Doxycycline|doxycycline|mesh-list
110825237|NCT01254799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110825238|NCT01254799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110825239|NCT01254799|Antimalarials|antimalarials|mesh-ancestor
110825240|NCT01254799|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110825241|NCT01254799|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110825242|NCT03718884|Mirikizumab|mirikizumab|mesh-list
110825243|NCT03718884|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110825244|NCT03718884|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110825245|NCT03718884|Analgesics|analgesics|mesh-ancestor
110825246|NCT03718884|Sensory System Agents|sensory system agents|mesh-ancestor
110825247|NCT03718884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110825248|NCT03718884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110825249|NCT03718884|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110825250|NCT03718884|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110825251|NCT03718884|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110825252|NCT03718884|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110825253|NCT03718806|Zoliflodacin|zoliflodacin|mesh-list
110855371|NCT03720067|Propranolol|propranolol|mesh-list
110825254|NCT03718806|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110825255|NCT03718806|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110825256|NCT03718806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110825257|NCT03718806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110825258|NCT03718806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110825259|NCT03716856|Cyclophosphamide|cyclophosphamide|mesh-list
110825260|NCT03716856|Fludarabine|fludarabine|mesh-list
110825261|NCT03716856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110825262|NCT03716856|Immunologic Factors|immunologic factors|mesh-ancestor
110825263|NCT03716856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110825264|NCT03716856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110825265|NCT03716856|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110825266|NCT03716856|Alkylating Agents|alkylating agents|mesh-ancestor
110419714|NCT01074255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110825267|NCT03716856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110825268|NCT03716856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110825269|NCT03716856|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110825270|NCT03910543|Tofacitinib|tofacitinib|mesh-list
110825271|NCT03910543|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
110825272|NCT03910543|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110825273|NCT03910543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110825274|NCT03910543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110825275|NCT03101462|Vaccines|vaccines|mesh-list
110825276|NCT03101462|Immunologic Factors|immunologic factors|mesh-ancestor
110825277|NCT03101462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110825278|NCT03904537|Antibodies|antibodies|mesh-list
110825279|NCT03904537|Immunologic Factors|immunologic factors|mesh-ancestor
110825280|NCT03904537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110825281|NCT03904225|Tegafur|tegafur|mesh-list
110825282|NCT03904225|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110825283|NCT03904225|Antimetabolites|antimetabolites|mesh-ancestor
110825284|NCT03904225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110825285|NCT03904225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110825286|NCT03910231|Tolvaptan|tolvaptan|mesh-list
110825287|NCT03910231|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
110825288|NCT03910231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110825289|NCT03910231|Natriuretic Agents|natriuretic agents|mesh-ancestor
110825290|NCT03910231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110825291|NCT01149109|Temozolomide|temozolomide|mesh-list
110825292|NCT01149109|Lomustine|lomustine|mesh-list
110825293|NCT01149109|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110825294|NCT01149109|Alkylating Agents|alkylating agents|mesh-ancestor
110825295|NCT01149109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110825296|NCT01149109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110825297|NCT05667415|Cisplatin|cisplatin|mesh-list
110825298|NCT05667415|Disulfiram|disulfiram|mesh-list
110825299|NCT05667415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110825300|NCT05667415|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110825301|NCT05667415|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
110825302|NCT05667415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110825303|NCT05667415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110825304|NCT01586143|Acetaminophen|acetaminophen|mesh-list
110825305|NCT01586143|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110825306|NCT01586143|Analgesics|analgesics|mesh-ancestor
110825307|NCT01586143|Sensory System Agents|sensory system agents|mesh-ancestor
110825308|NCT01586143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110825309|NCT01586143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110825310|NCT01586143|Antipyretics|antipyretics|mesh-ancestor
110825311|NCT01256359|Docetaxel|docetaxel|mesh-list
110825312|NCT01256359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110825313|NCT01256359|Tubulin Modulators|tubulin modulators|mesh-ancestor
110825314|NCT01256359|Antimitotic Agents|antimitotic agents|mesh-ancestor
110825315|NCT01256359|Mitosis Modulators|mitosis modulators|mesh-ancestor
110825316|NCT01256359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110825317|NCT02527993|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110825318|NCT02527993|Liraglutide|liraglutide|mesh-list
110825320|NCT02527993|Verapamil|verapamil|mesh-list
110825321|NCT02527993|Pasireotide|pasireotide|mesh-list
110825322|NCT02527993|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110825323|NCT02527993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110825324|NCT02527993|Incretins|incretins|mesh-ancestor
110825325|NCT02527993|Hormones|hormones|mesh-ancestor
110825326|NCT02527993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110825327|NCT02527993|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110825328|NCT02527993|Protease Inhibitors|protease inhibitors|mesh-ancestor
110825329|NCT02527993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110825330|NCT02527993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110825331|NCT02527993|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110825332|NCT02527993|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110825333|NCT02527993|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110825334|NCT02527993|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110825335|NCT02527993|Vasodilator Agents|vasodilator agents|mesh-ancestor
110825336|NCT02527993|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
110825337|NCT04927052|Lidocaine|lidocaine|mesh-list
110825338|NCT04927052|Anesthetics, Local|anesthetics, local|mesh-ancestor
110825339|NCT04927052|Anesthetics|anesthetics|mesh-ancestor
110825340|NCT04927052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110825341|NCT04927052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110825342|NCT04927052|Sensory System Agents|sensory system agents|mesh-ancestor
110825343|NCT04927052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110825344|NCT04927052|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110825345|NCT04927052|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110825346|NCT04927052|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110825347|NCT04927052|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110825348|NCT04927052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110825349|NCT01149499|Valacyclovir|valacyclovir|mesh-list
110825350|NCT01149499|Antiviral Agents|antiviral agents|mesh-ancestor
110825351|NCT01149499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110825352|NCT03900871|Aspirin|aspirin|mesh-list
110825353|NCT03900871|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110825354|NCT03900871|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110825355|NCT03900871|Analgesics|analgesics|mesh-ancestor
110825356|NCT03900871|Sensory System Agents|sensory system agents|mesh-ancestor
110825357|NCT03900871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110825358|NCT03900871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110825359|NCT03900871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110825360|NCT03900871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110825361|NCT03900871|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110825362|NCT03900871|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110825363|NCT03900871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110825364|NCT03900871|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110825365|NCT03900871|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110825366|NCT03900871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110825367|NCT03900871|Antipyretics|antipyretics|mesh-ancestor
110825369|NCT01149577|Antiemetics|antiemetics|mesh-ancestor
110825370|NCT01149577|Autonomic Agents|autonomic agents|mesh-ancestor
110825371|NCT01149577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110825372|NCT01149577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110825373|NCT01149577|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110825374|NCT01149577|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110825375|NCT01149577|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110825376|NCT01149577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110825377|NCT01149577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110825378|NCT01149577|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110825379|NCT01149577|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110825380|NCT01149577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110825381|NCT01149577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110825382|NCT01149577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110825383|NCT01149577|Serotonin Agents|serotonin agents|mesh-ancestor
110825384|NCT03894007|Maytansine|maytansine|mesh-list
110825385|NCT03894007|Docetaxel|docetaxel|mesh-list
110825386|NCT03894007|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
110825387|NCT03894007|Cyclophosphamide|cyclophosphamide|mesh-list
110825388|NCT03894007|Carboplatin|carboplatin|mesh-list
110825389|NCT03894007|Trastuzumab|trastuzumab|mesh-list
110825390|NCT03894007|Atezolizumab|atezolizumab|mesh-list
110825392|NCT03894007|Pertuzumab|pertuzumab|mesh-list
110825393|NCT03894007|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110825394|NCT03894007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110825395|NCT03894007|Tubulin Modulators|tubulin modulators|mesh-ancestor
110825396|NCT03894007|Antimitotic Agents|antimitotic agents|mesh-ancestor
110825397|NCT03894007|Mitosis Modulators|mitosis modulators|mesh-ancestor
110825398|NCT03894007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110825399|NCT03894007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110825400|NCT03894007|Immunologic Factors|immunologic factors|mesh-ancestor
110825401|NCT03894007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110825402|NCT03894007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110825403|NCT03894007|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110825404|NCT03894007|Alkylating Agents|alkylating agents|mesh-ancestor
110825405|NCT03894007|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110825406|NCT03894007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110825407|NCT03894007|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110825408|NCT03894007|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110825409|NCT03894007|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110825410|NCT03894007|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110825411|NCT03894007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110825412|NCT03894007|Immunotoxins|immunotoxins|mesh-ancestor
110825413|NCT03894007|Immunoconjugates|immunoconjugates|mesh-ancestor
110825414|NCT01150747|Azithromycin|azithromycin|mesh-list
110825415|NCT01150747|Ceftriaxone|ceftriaxone|mesh-list
110825416|NCT01150747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110825417|NCT01150747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110825418|NCT03893695|Nivolumab|nivolumab|mesh-list
110542968|NCT00545233|Ribavirin|ribavirin|mesh-list
110825419|NCT03893695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110825420|NCT03893695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110825421|NCT03893695|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110825422|NCT03893695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110825423|NCT01258309|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
110825424|NCT01258309|Ketorolac|ketorolac|mesh-list
110825425|NCT01258309|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
110825426|NCT01258309|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110825427|NCT01258309|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110825428|NCT01258309|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110825429|NCT01258309|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110825430|NCT01258309|Analgesics|analgesics|mesh-ancestor
110825431|NCT01258309|Sensory System Agents|sensory system agents|mesh-ancestor
110825432|NCT01258309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110420121|NCT04452565|Autonomic Agents|autonomic agents|mesh-ancestor
110825433|NCT01258309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110825434|NCT01258309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110309899|NCT00281255|Dobutamine|dobutamine|mesh-list
110825435|NCT01258309|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110825436|NCT01258309|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110825437|NCT01258309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110825438|NCT01258309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110825439|NCT01258309|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110825440|NCT01258309|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110825441|NCT01258309|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110825442|NCT01258309|Histamine Antagonists|histamine antagonists|mesh-ancestor
110825443|NCT01258309|Histamine Agents|histamine agents|mesh-ancestor
110825444|NCT01258309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110825446|NCT01256905|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110825447|NCT01256905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110825448|NCT01256905|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
110825449|NCT01256905|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110825450|NCT01256905|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110825451|NCT01256905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110825452|NCT01586299|Acetaminophen|acetaminophen|mesh-list
110825454|NCT01586299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110825455|NCT01586299|Analgesics|analgesics|mesh-ancestor
110825456|NCT01586299|Sensory System Agents|sensory system agents|mesh-ancestor
110825457|NCT01586299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110825458|NCT01586299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110825459|NCT01586299|Antipyretics|antipyretics|mesh-ancestor
110825460|NCT01586299|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110825461|NCT01586299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110825462|NCT01586299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110825463|NCT01586299|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110825464|NCT01586299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110420194|NCT04292704|Miconazole|miconazole|mesh-list
110825465|NCT01586299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110825466|NCT02874794|Valsartan|valsartan|mesh-list
110825467|NCT02874794|Enalapril|enalapril|mesh-list
110825468|NCT02874794|Enalaprilat|enalaprilat|mesh-list
110825469|NCT02874794|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
110825470|NCT02874794|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110825471|NCT02874794|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110825472|NCT02874794|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110825473|NCT02874794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110825474|NCT02874794|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110825475|NCT02874794|Protease Inhibitors|protease inhibitors|mesh-ancestor
110825476|NCT02874794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110825477|NCT03102710|Lidocaine|lidocaine|mesh-list
110825478|NCT03102710|Capsaicin|capsaicin|mesh-list
110825479|NCT03102710|Anesthetics, Local|anesthetics, local|mesh-ancestor
110825480|NCT03102710|Anesthetics|anesthetics|mesh-ancestor
110825481|NCT03102710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110825482|NCT03102710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110825483|NCT03102710|Sensory System Agents|sensory system agents|mesh-ancestor
110825484|NCT03102710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110420208|NCT05242783|Terlipressin|terlipressin|mesh-list
110825485|NCT03102710|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110825486|NCT03102710|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110825487|NCT03102710|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110825488|NCT03102710|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110825489|NCT03102710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110825490|NCT03102710|Antipruritics|antipruritics|mesh-ancestor
110825491|NCT03102710|Dermatologic Agents|dermatologic agents|mesh-ancestor
110825492|NCT01149967|Dexetimide|dexetimide|mesh-list
110825493|NCT01149967|Citalopram|citalopram|mesh-list
110825494|NCT01149967|Escitalopram|escitalopram|mesh-list
110825495|NCT01149967|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110825496|NCT01149967|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110825497|NCT01149967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110825498|NCT01149967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110825499|NCT01149967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110825500|NCT01149967|Serotonin Agents|serotonin agents|mesh-ancestor
110825501|NCT01149967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110825502|NCT01149967|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110825503|NCT01149967|Antidepressive Agents|antidepressive agents|mesh-ancestor
110825504|NCT01149967|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110825505|NCT01149967|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110825506|NCT01149967|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110825507|NCT01149967|Parasympatholytics|parasympatholytics|mesh-ancestor
110825508|NCT01149967|Autonomic Agents|autonomic agents|mesh-ancestor
110420255|NCT02846155|Simethicone|simethicone|mesh-list
110825509|NCT01149967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110825510|NCT01149967|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110825511|NCT01149967|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110825512|NCT01149967|Cholinergic Agents|cholinergic agents|mesh-ancestor
110825513|NCT05505409|Pirfenidone|pirfenidone|mesh-list
110825514|NCT05505409|Glucocorticoids|glucocorticoids|mesh-list
110825515|NCT05505409|Immunosuppressive Agents|immunosuppressive agents|mesh-list
110825516|NCT05505409|Hormones|hormones|mesh-ancestor
110825517|NCT05505409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110825518|NCT05505409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110825519|NCT05505409|Analgesics|analgesics|mesh-ancestor
110825520|NCT05505409|Sensory System Agents|sensory system agents|mesh-ancestor
110855399|NCT01444092|Autonomic Agents|autonomic agents|mesh-ancestor
110825522|NCT05505409|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110825523|NCT05505409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110825524|NCT05505409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110825525|NCT05505409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110825526|NCT05505409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110825527|NCT05505409|Immunologic Factors|immunologic factors|mesh-ancestor
110825528|NCT04770740|Vitamin K|vitamin k|mesh-list
110825529|NCT04770740|Vitamin K 2|vitamin k 2|mesh-list
110825530|NCT04770740|Menaquinone 7|menaquinone 7|mesh-list
110825531|NCT04770740|Vitamins|vitamins|mesh-ancestor
110825532|NCT04770740|Micronutrients|micronutrients|mesh-ancestor
110825533|NCT04770740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110825534|NCT04770740|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110825535|NCT04770740|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110825536|NCT04770740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110825537|NCT04770740|Hemostatics|hemostatics|mesh-ancestor
110825538|NCT04770740|Coagulants|coagulants|mesh-ancestor
110825539|NCT03896971|Cyclosporine|cyclosporine|mesh-list
110825540|NCT03896971|Cyclosporins|cyclosporins|mesh-list
110825541|NCT03896971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110825542|NCT03896971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110825543|NCT03896971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110825544|NCT03896971|Immunologic Factors|immunologic factors|mesh-ancestor
110825545|NCT03896971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110825546|NCT03896971|Antifungal Agents|antifungal agents|mesh-ancestor
110825547|NCT03896971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110825548|NCT03896971|Dermatologic Agents|dermatologic agents|mesh-ancestor
110825549|NCT03896971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110825550|NCT03896971|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110825551|NCT01258777|Golimumab|golimumab|mesh-list
110825552|NCT01258777|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110825553|NCT01258777|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110825554|NCT01258777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110825555|NCT01258777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110825556|NCT01258777|Immunologic Factors|immunologic factors|mesh-ancestor
110825557|NCT01258777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110825558|NCT03896893|Emollients|emollients|mesh-list
110825559|NCT03896893|Dermatologic Agents|dermatologic agents|mesh-ancestor
110825560|NCT01257373|Cobalt|cobalt|mesh-list
110825561|NCT01257373|Chromium|chromium|mesh-list
110825562|NCT01257373|Sirolimus|sirolimus|mesh-list
110825563|NCT01257373|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110825564|NCT01257373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110825565|NCT01257373|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110825566|NCT01257373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110825567|NCT01257373|Antifungal Agents|antifungal agents|mesh-ancestor
110420370|NCT00968968|Lapatinib|lapatinib|mesh-list
110825568|NCT01257373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110825569|NCT01257373|Immunologic Factors|immunologic factors|mesh-ancestor
110825570|NCT01257373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110825571|NCT01257373|Trace Elements|trace elements|mesh-ancestor
110825572|NCT01257373|Micronutrients|micronutrients|mesh-ancestor
110825573|NCT03899233|Tranexamic Acid|tranexamic acid|mesh-list
110825574|NCT03899233|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110825575|NCT03899233|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110825576|NCT03899233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110825577|NCT03899233|Hemostatics|hemostatics|mesh-ancestor
110825578|NCT03899233|Coagulants|coagulants|mesh-ancestor
110825579|NCT03101150|Vitamin D|vitamin d|mesh-list
110825580|NCT03101150|Ergocalciferols|ergocalciferols|mesh-list
110825581|NCT03101150|Cholecalciferol|cholecalciferol|mesh-list
110825582|NCT03101150|Vitamins|vitamins|mesh-list
110825583|NCT03101150|Micronutrients|micronutrients|mesh-ancestor
110825584|NCT03101150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110825585|NCT03101150|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110825586|NCT03101150|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110825588|NCT03899077|Triptorelin Pamoate|triptorelin pamoate|mesh-list
110825589|NCT03899077|Leuprolide|leuprolide|mesh-list
110825590|NCT03899077|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110825591|NCT03899077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110825592|NCT03899077|Luteolytic Agents|luteolytic agents|mesh-ancestor
110825593|NCT03899077|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110825594|NCT03899077|Contraceptive Agents|contraceptive agents|mesh-ancestor
110825595|NCT03899077|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110825596|NCT03899077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110825597|NCT03899077|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110825598|NCT03899077|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110825599|NCT03899077|Fertility Agents|fertility agents|mesh-ancestor
110825600|NCT01255579|Fluticasone|fluticasone|mesh-list
110825601|NCT01255579|Beclomethasone|beclomethasone|mesh-list
110825602|NCT01255579|Formoterol Fumarate|formoterol fumarate|mesh-list
110825603|NCT01255579|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110825604|NCT01255579|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
110825605|NCT01255579|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110825606|NCT01255579|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110825607|NCT01255579|Autonomic Agents|autonomic agents|mesh-ancestor
110825608|NCT01255579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110825609|NCT01255579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110825610|NCT01255579|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110825611|NCT01255579|Respiratory System Agents|respiratory system agents|mesh-ancestor
110825612|NCT01255579|Dermatologic Agents|dermatologic agents|mesh-ancestor
110825613|NCT01255579|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110825614|NCT01255579|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110825615|NCT01255579|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110825616|NCT01255579|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110825617|NCT01255579|Adrenergic Agents|adrenergic agents|mesh-ancestor
110825618|NCT01255579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110825619|NCT01255579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110825620|NCT01255579|Glucocorticoids|glucocorticoids|mesh-ancestor
110825621|NCT01255579|Hormones|hormones|mesh-ancestor
110825622|NCT01255579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110825623|NCT01255579|Sympathomimetics|sympathomimetics|mesh-ancestor
110825624|NCT03101930|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110825625|NCT03101930|Liraglutide|liraglutide|mesh-list
110825626|NCT03101930|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110825627|NCT03101930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110825628|NCT03101930|Incretins|incretins|mesh-ancestor
110825629|NCT03101930|Hormones|hormones|mesh-ancestor
110825630|NCT03101930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110825631|NCT03101930|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110825632|NCT03101930|Protease Inhibitors|protease inhibitors|mesh-ancestor
110825633|NCT03101930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110825634|NCT03101930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110825635|NCT04239950|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
110825636|NCT04239950|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110825637|NCT04239950|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110825638|NCT05415254|Calcitriol|calcitriol|mesh-list
110825639|NCT05415254|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110825640|NCT05415254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110825641|NCT05415254|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
110825642|NCT05415254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110825643|NCT05415254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110825644|NCT05415254|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110825645|NCT05415254|Vitamins|vitamins|mesh-ancestor
110825646|NCT05415254|Micronutrients|micronutrients|mesh-ancestor
110825647|NCT05415254|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110825648|NCT01150201|Losartan|losartan|mesh-list
110825649|NCT01150201|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110825650|NCT01150201|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110825651|NCT01150201|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110825652|NCT01150201|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110825653|NCT01150201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110825654|NCT01257451|Vildagliptin|vildagliptin|mesh-list
110825655|NCT01257451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110825656|NCT01257451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110825657|NCT01257451|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110825658|NCT01257451|Protease Inhibitors|protease inhibitors|mesh-ancestor
110825659|NCT01257451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110825660|NCT01257451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110825662|NCT01257529|Analgesics|analgesics|mesh-ancestor
110825663|NCT01257529|Sensory System Agents|sensory system agents|mesh-ancestor
110825664|NCT01257529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110825665|NCT01257529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110825666|NCT01257529|Anticonvulsants|anticonvulsants|mesh-ancestor
110825667|NCT01257529|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110825668|NCT01257529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110825669|NCT01257529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110825670|NCT01257529|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110825671|NCT01257529|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110825672|NCT01257529|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110825673|NCT01257529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110825674|NCT01257529|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110825675|NCT03896113|Celecoxib|celecoxib|mesh-list
110825676|NCT03896113|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110825677|NCT03896113|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110825678|NCT03896113|Analgesics|analgesics|mesh-ancestor
110825679|NCT03896113|Sensory System Agents|sensory system agents|mesh-ancestor
110825680|NCT03896113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110825681|NCT03896113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110825682|NCT03896113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110825683|NCT03896113|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110825684|NCT03896113|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110825685|NCT03896113|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110825686|NCT03896113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110825687|NCT03896113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110825688|NCT03100838|Nifedipine|nifedipine|mesh-list
110825689|NCT03100838|Omeprazole|omeprazole|mesh-list
110825690|NCT03100838|Omeprazole, sodium bicarbonate drug combination|omeprazole, sodium bicarbonate drug combination|mesh-list
110825691|NCT03100838|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110825692|NCT03100838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110825693|NCT03100838|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110825694|NCT03100838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110825695|NCT03100838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110825696|NCT03100838|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110825697|NCT03100838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110825698|NCT03100838|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110825699|NCT03100838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110825700|NCT03100838|Vasodilator Agents|vasodilator agents|mesh-ancestor
110825701|NCT03100838|Tocolytic Agents|tocolytic agents|mesh-ancestor
110825702|NCT03100838|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110825703|NCT01260025|Endostatins|endostatins|mesh-list
110825704|NCT01260025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110825705|NCT01260025|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110825706|NCT01260025|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110825707|NCT01260025|Growth Substances|growth substances|mesh-ancestor
110825708|NCT01260025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110825709|NCT01260025|Growth Inhibitors|growth inhibitors|mesh-ancestor
110825710|NCT03984578|Pembrolizumab|pembrolizumab|mesh-list
110825711|NCT03984578|Capecitabine|capecitabine|mesh-list
110825712|NCT03984578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110825713|NCT03984578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110825714|NCT03984578|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110825715|NCT03984578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110543259|NCT02660684|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110825716|NCT03984578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110825717|NCT03984578|Antimetabolites|antimetabolites|mesh-ancestor
110825718|NCT03892525|Atezolizumab|atezolizumab|mesh-list
110825719|NCT03892525|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110825720|NCT03892525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110825721|NCT03892525|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110825722|NCT03892525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110825723|NCT05418452|Metformin|metformin|mesh-list
110825724|NCT05418452|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110825725|NCT05418452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110825726|NCT01260103|Temozolomide|temozolomide|mesh-list
110825727|NCT01260103|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110825728|NCT01260103|Alkylating Agents|alkylating agents|mesh-ancestor
110825729|NCT01260103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110825730|NCT01260103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110825731|NCT03480750|Carboplatin|carboplatin|mesh-list
110825732|NCT03480750|Doxorubicin|doxorubicin|mesh-list
110825733|NCT03480750|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110825734|NCT03480750|Trientine|trientine|mesh-list
110825735|NCT03480750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110825736|NCT03480750|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110825737|NCT03480750|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110825738|NCT03480750|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110825739|NCT03480750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110825740|NCT03480750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110825741|NCT03480750|Chelating Agents|chelating agents|mesh-ancestor
110825742|NCT03480750|Sequestering Agents|sequestering agents|mesh-ancestor
110825743|NCT03892447|Ferulic acid|ferulic acid|mesh-list
110825744|NCT03892447|Dopamine|dopamine|mesh-list
110825745|NCT03892447|Alprostadil|alprostadil|mesh-list
110825746|NCT03892447|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110825747|NCT03892447|Sympathomimetics|sympathomimetics|mesh-ancestor
110825748|NCT03892447|Autonomic Agents|autonomic agents|mesh-ancestor
110825749|NCT03892447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110825750|NCT03892447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110825751|NCT03892447|Dopamine Agents|dopamine agents|mesh-ancestor
110825752|NCT03892447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110825753|NCT03892447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110825754|NCT03892447|Protective Agents|protective agents|mesh-ancestor
110825755|NCT03892447|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110825756|NCT03892447|Vasodilator Agents|vasodilator agents|mesh-ancestor
110825757|NCT03892447|Urological Agents|urological agents|mesh-ancestor
110825758|NCT03892447|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110825759|NCT03892447|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110825760|NCT03892447|Analgesics|analgesics|mesh-ancestor
110825761|NCT03892447|Sensory System Agents|sensory system agents|mesh-ancestor
110825762|NCT03892447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110825763|NCT03892447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110825764|NCT03892447|Anticoagulants|anticoagulants|mesh-ancestor
110825765|NCT03892447|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110825766|NCT03892447|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
110825767|NCT03892447|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110825768|NCT03892447|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110825769|NCT03892447|Antioxidants|antioxidants|mesh-ancestor
110825770|NCT03716700|Immunoglobulins|immunoglobulins|mesh-list
110825771|NCT03716700|gamma-Globulins|gamma-globulins|mesh-list
110825772|NCT03716700|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110825773|NCT03716700|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110825774|NCT03716700|Immunologic Factors|immunologic factors|mesh-ancestor
110825775|NCT03716700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110825776|NCT05250596|Colchicine|colchicine|mesh-list
110825777|NCT05250596|Atorvastatin|atorvastatin|mesh-list
110825778|NCT05250596|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110825779|NCT05250596|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110825780|NCT05250596|Antimetabolites|antimetabolites|mesh-ancestor
110825781|NCT05250596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110825782|NCT05250596|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110825783|NCT05250596|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110825784|NCT05250596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110825785|NCT05250596|Gout Suppressants|gout suppressants|mesh-ancestor
110825786|NCT05250596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110825787|NCT05250596|Tubulin Modulators|tubulin modulators|mesh-ancestor
110825788|NCT05250596|Antimitotic Agents|antimitotic agents|mesh-ancestor
110825789|NCT05250596|Mitosis Modulators|mitosis modulators|mesh-ancestor
110825790|NCT05250596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110825791|NCT04788914|Charcoal|charcoal|mesh-list
110825792|NCT04788914|Antidotes|antidotes|mesh-ancestor
110825793|NCT04788914|Protective Agents|protective agents|mesh-ancestor
110825794|NCT04788914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110825795|NCT03716622|Clarithromycin|clarithromycin|mesh-list
110825796|NCT03716622|Furazolidone|furazolidone|mesh-list
110825797|NCT03716622|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110825798|NCT03716622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110825799|NCT03716622|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110825800|NCT03716622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110825801|NCT03716622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110825802|NCT03716622|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110825803|NCT03716622|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110825804|NCT03716622|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110825805|NCT03716622|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110825806|NCT03716622|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
110825807|NCT03716622|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110825808|NCT03716622|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110420450|NCT05334043|Curcumin|curcumin|mesh-list
110825809|NCT03716622|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
110825810|NCT03892213|Benzonidazole|benzonidazole|mesh-list
110825811|NCT03892213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110825812|NCT03892213|Immunologic Factors|immunologic factors|mesh-ancestor
110825813|NCT03892213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110825814|NCT03892213|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
110825815|NCT03892213|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110825816|NCT03892213|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110825817|NCT03892213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110825818|NCT03412734|Chlorhexidine|chlorhexidine|mesh-list
110825819|NCT03412734|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110825820|NCT03412734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110825821|NCT03412734|Disinfectants|disinfectants|mesh-ancestor
110825822|NCT04881032|Temozolomide|temozolomide|mesh-list
110825823|NCT04881032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110825824|NCT04881032|Alkylating Agents|alkylating agents|mesh-ancestor
110825825|NCT04881032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110825826|NCT04881032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110825827|NCT03891979|Metronidazole|metronidazole|mesh-list
110825828|NCT03891979|Ciprofloxacin|ciprofloxacin|mesh-list
110825829|NCT03891979|Pembrolizumab|pembrolizumab|mesh-list
110825830|NCT03891979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110825831|NCT03891979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110825832|NCT03891979|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110825833|NCT03891979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110825834|NCT03891979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110825835|NCT03891979|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110825836|NCT03891979|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110825837|NCT03891979|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110825838|NCT03891979|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110825839|NCT03891979|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110825840|NCT03891979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110825841|NCT03891979|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110855450|NCT02483026|Vitamin D|vitamin d|mesh-list
110825842|NCT03891979|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110825844|NCT01260415|Panitumumab|panitumumab|mesh-list
110825845|NCT01260415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110825846|NCT01260415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110825847|NCT04608344|Atorvastatin|atorvastatin|mesh-list
110825848|NCT04608344|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110825849|NCT04608344|Pravastatin|pravastatin|mesh-list
110825850|NCT04608344|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110825851|NCT04608344|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110825852|NCT04608344|Antimetabolites|antimetabolites|mesh-ancestor
110825853|NCT04608344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110825854|NCT04608344|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110420462|NCT02838823|Antibodies|antibodies|mesh-list
110825855|NCT04608344|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110825856|NCT04608344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110825857|NCT03891433|Meropenem|meropenem|mesh-list
110825858|NCT03891433|Tazobactam|tazobactam|mesh-list
110825859|NCT03891433|Piperacillin|piperacillin|mesh-list
110825860|NCT03891433|Ertapenem|ertapenem|mesh-list
110825861|NCT03891433|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110825862|NCT03891433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110825863|NCT03891433|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110825864|NCT03891433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110825865|NCT03891433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110825866|NCT03895411|Sotalol|sotalol|mesh-list
110825867|NCT03895411|Propafenone|propafenone|mesh-list
110825868|NCT03895411|Metoprolol|metoprolol|mesh-list
110825869|NCT03895411|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110825870|NCT03895411|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110825871|NCT03895411|Adrenergic Agents|adrenergic agents|mesh-ancestor
110825872|NCT03895411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110825873|NCT03895411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110825874|NCT03895411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110825875|NCT03895411|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110825876|NCT03895411|Sympatholytics|sympatholytics|mesh-ancestor
110825877|NCT03895411|Autonomic Agents|autonomic agents|mesh-ancestor
110825878|NCT03895411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110825879|NCT03895411|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110825880|NCT03895411|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110825881|NCT03895411|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110825882|NCT03895411|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110825883|NCT03895411|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110825884|NCT01259323|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110825885|NCT01259323|Immunologic Factors|immunologic factors|mesh-ancestor
110825886|NCT01259323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110825887|NCT03891277|Ferrous succinate|ferrous succinate|mesh-list
110825889|NCT03888157|Liraglutide|liraglutide|mesh-list
110825890|NCT03888157|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110825891|NCT03888157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110825892|NCT03888157|Incretins|incretins|mesh-ancestor
110825893|NCT03888157|Hormones|hormones|mesh-ancestor
110825894|NCT03888157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110825895|NCT01154491|Epoetin Alfa|epoetin alfa|mesh-list
110825896|NCT01154491|Hematinics|hematinics|mesh-ancestor
110825897|NCT01260571|Benzoyl Peroxide|benzoyl peroxide|mesh-list
110825898|NCT01260571|Dermatologic Agents|dermatologic agents|mesh-ancestor
110825899|NCT02527603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
110825900|NCT02527603|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
110825901|NCT02527603|Analgesics|analgesics|mesh-ancestor
110825902|NCT02527603|Sensory System Agents|sensory system agents|mesh-ancestor
110825903|NCT02527603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110825904|NCT02527603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110825905|NCT02527603|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110825906|NCT02527603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110825907|NCT01259479|Satraplatin|satraplatin|mesh-list
110825908|NCT01259479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110825909|NCT01260727|Vaccines|vaccines|mesh-list
110825910|NCT01260727|Immunologic Factors|immunologic factors|mesh-ancestor
110825911|NCT01260727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110825912|NCT03890809|Deucravacitinib|deucravacitinib|mesh-list
110825913|NCT03890809|Dermatologic Agents|dermatologic agents|mesh-ancestor
110825914|NCT03890809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110825915|NCT03890809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110825916|NCT03890809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110825917|NCT03891121|Botulinum Toxins|botulinum toxins|mesh-list
110825918|NCT03891121|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110825919|NCT03891121|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110825920|NCT03891121|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110825921|NCT03891121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110825922|NCT03891121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110825923|NCT03891121|Cholinergic Agents|cholinergic agents|mesh-ancestor
110825924|NCT03891121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110825925|NCT03891121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110825926|NCT03891121|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110825927|NCT03891121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110825929|NCT01154569|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110825930|NCT01154569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110825931|NCT03891043|Selenium|selenium|mesh-list
110825932|NCT03891043|Antioxidants|antioxidants|mesh-ancestor
110825933|NCT03891043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110825934|NCT03891043|Protective Agents|protective agents|mesh-ancestor
110825935|NCT03891043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110825936|NCT03891043|Trace Elements|trace elements|mesh-ancestor
110825937|NCT03891043|Micronutrients|micronutrients|mesh-ancestor
110825938|NCT03890341|Drospirenone|drospirenone|mesh-list
110825939|NCT03890341|Midazolam|midazolam|mesh-list
110825940|NCT03890341|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110825941|NCT03890341|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
110825942|NCT03890341|Betadex|betadex|mesh-list
110825943|NCT03890341|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110825944|NCT03890341|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110825945|NCT03890341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110825946|NCT03890341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110825947|NCT03890341|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110825948|NCT03890341|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110825949|NCT03890341|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110825950|NCT03890341|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110825951|NCT03890341|Anesthetics, General|anesthetics, general|mesh-ancestor
110825952|NCT03890341|Anesthetics|anesthetics|mesh-ancestor
110825953|NCT03890341|GABA Modulators|gaba modulators|mesh-ancestor
110825954|NCT03890341|GABA Agents|gaba agents|mesh-ancestor
110825955|NCT03890341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110825956|NCT03890341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110825957|NCT03890341|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110825958|NCT03890341|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110825959|NCT03890341|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110825960|NCT03890341|Contraceptive Agents|contraceptive agents|mesh-ancestor
110825961|NCT03890341|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110825962|NCT03890341|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110825963|NCT03890341|Estrogens|estrogens|mesh-ancestor
110825964|NCT03890341|Hormones|hormones|mesh-ancestor
110825965|NCT03890341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110825966|NCT03890341|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110825967|NCT03890341|Hormone Antagonists|hormone antagonists|mesh-ancestor
110825968|NCT03890341|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110825969|NCT03890341|Diuretics|diuretics|mesh-ancestor
110825970|NCT03890341|Natriuretic Agents|natriuretic agents|mesh-ancestor
110825971|NCT03890341|Sequestering Agents|sequestering agents|mesh-ancestor
110825972|NCT01259557|Botulinum Toxins|botulinum toxins|mesh-list
110825973|NCT01259557|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110825974|NCT01259557|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110825975|NCT01259557|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110825976|NCT01259557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110825977|NCT01259557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110825978|NCT01259557|Cholinergic Agents|cholinergic agents|mesh-ancestor
110825979|NCT01259557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110825980|NCT01259557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110825981|NCT01259557|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110825982|NCT01259557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110825983|NCT03894085|Paroxetine|paroxetine|mesh-list
110825984|NCT03894085|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110825985|NCT03894085|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110825986|NCT03894085|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110825987|NCT03894085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110825988|NCT03894085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110825989|NCT03894085|Serotonin Agents|serotonin agents|mesh-ancestor
110825990|NCT03894085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110825991|NCT03894085|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110825992|NCT03894085|Antidepressive Agents|antidepressive agents|mesh-ancestor
110825993|NCT03894085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110825994|NCT03894085|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110825995|NCT03894085|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110825996|NCT03894085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110825998|NCT01152931|Vitamin E|vitamin e|mesh-list
110825999|NCT01152931|Tocopherols|tocopherols|mesh-list
110826000|NCT01152931|Tocotrienols|tocotrienols|mesh-list
110826001|NCT01152931|alpha-Tocopherol|alpha-tocopherol|mesh-list
110826002|NCT01152931|Vitamin A|vitamin a|mesh-list
110826003|NCT01152931|Zinc|zinc|mesh-list
110826004|NCT01152931|Selenium|selenium|mesh-list
110826005|NCT01152931|Artesunate|artesunate|mesh-list
110826006|NCT01152931|Lumefantrine|lumefantrine|mesh-list
110826007|NCT01152931|Artemether|artemether|mesh-list
110826008|NCT01152931|Amodiaquine|amodiaquine|mesh-list
110826009|NCT01152931|Retinol palmitate|retinol palmitate|mesh-list
110826010|NCT01152931|Micronutrients|micronutrients|mesh-ancestor
110826011|NCT01152931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110826012|NCT01152931|Trace Elements|trace elements|mesh-ancestor
110826013|NCT01152931|Antioxidants|antioxidants|mesh-ancestor
110826014|NCT01152931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110826015|NCT01152931|Protective Agents|protective agents|mesh-ancestor
110826016|NCT01152931|Antimalarials|antimalarials|mesh-ancestor
110826017|NCT01152931|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110826018|NCT01152931|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110826019|NCT01152931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110826020|NCT01152931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110826021|NCT01152931|Antiviral Agents|antiviral agents|mesh-ancestor
110826022|NCT01152931|Schistosomicides|schistosomicides|mesh-ancestor
110420812|NCT00892957|Thrombin|thrombin|mesh-list
110826023|NCT01152931|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110826024|NCT01152931|Anthelmintics|anthelmintics|mesh-ancestor
110826025|NCT01152931|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110826026|NCT01261117|Ibuprofen|ibuprofen|mesh-list
110826027|NCT01261117|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110826028|NCT01261117|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110826029|NCT01261117|Analgesics|analgesics|mesh-ancestor
110826030|NCT01261117|Sensory System Agents|sensory system agents|mesh-ancestor
110826031|NCT01261117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110826032|NCT01261117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110826033|NCT01261117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110826034|NCT01261117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110826035|NCT01261117|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110826036|NCT01261117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110826037|NCT01261117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110826038|NCT03889717|Vitamin D|vitamin d|mesh-list
110826039|NCT03889717|Vitamins|vitamins|mesh-ancestor
110826040|NCT03889717|Micronutrients|micronutrients|mesh-ancestor
110826041|NCT03889717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110826042|NCT03889717|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110826043|NCT03885895|Tranexamic Acid|tranexamic acid|mesh-list
110826044|NCT03885895|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110826045|NCT03885895|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110826046|NCT03885895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110826047|NCT03885895|Hemostatics|hemostatics|mesh-ancestor
110826048|NCT03885895|Coagulants|coagulants|mesh-ancestor
110826049|NCT01154647|Citalopram|citalopram|mesh-list
110826050|NCT01154647|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110826051|NCT01154647|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110826052|NCT01154647|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110826053|NCT01154647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110826054|NCT01154647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110826055|NCT01154647|Serotonin Agents|serotonin agents|mesh-ancestor
110826056|NCT01154647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110826057|NCT01154647|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110826058|NCT01154647|Antidepressive Agents|antidepressive agents|mesh-ancestor
110826059|NCT01154647|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110826060|NCT01153165|Citalopram|citalopram|mesh-list
110826061|NCT01153165|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110826062|NCT01153165|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110826063|NCT01153165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110826064|NCT01153165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110826065|NCT01153165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110826066|NCT01153165|Serotonin Agents|serotonin agents|mesh-ancestor
110826067|NCT01153165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110826068|NCT01153165|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110826069|NCT01153165|Antidepressive Agents|antidepressive agents|mesh-ancestor
110826070|NCT01153165|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110826071|NCT01155505|Lenalidomide|lenalidomide|mesh-list
110826072|NCT01155505|Immunologic Factors|immunologic factors|mesh-ancestor
110826073|NCT01155505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110826074|NCT01155505|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110826075|NCT01155505|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110826076|NCT01155505|Growth Substances|growth substances|mesh-ancestor
110826077|NCT01155505|Growth Inhibitors|growth inhibitors|mesh-ancestor
110826078|NCT01155505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110826079|NCT01153243|Vitamin D|vitamin d|mesh-list
110826080|NCT01153243|Ergocalciferols|ergocalciferols|mesh-list
110826081|NCT01153243|Vitamins|vitamins|mesh-ancestor
110826082|NCT01153243|Micronutrients|micronutrients|mesh-ancestor
110826083|NCT01153243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110826084|NCT01153243|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110826085|NCT01153243|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110826086|NCT03432858|Vancomycin|vancomycin|mesh-list
110826087|NCT03432858|Cefazolin|cefazolin|mesh-list
110826088|NCT03432858|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110826089|NCT03432858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110826090|NCT01154803|Micronutrients|micronutrients|mesh-list
110826091|NCT01154803|Trace Elements|trace elements|mesh-list
110826092|NCT01154803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110826093|NCT03885427|Ketamine|ketamine|mesh-list
110826094|NCT03885427|Analgesics|analgesics|mesh-ancestor
110826095|NCT03885427|Sensory System Agents|sensory system agents|mesh-ancestor
110826096|NCT03885427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110826097|NCT03885427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110826098|NCT03885427|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110826099|NCT03885427|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110826100|NCT03885427|Anesthetics, General|anesthetics, general|mesh-ancestor
110826101|NCT03885427|Anesthetics|anesthetics|mesh-ancestor
110826102|NCT03885427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110826103|NCT03885427|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110826104|NCT03885427|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110826105|NCT03885427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110826106|NCT03885427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110826107|NCT03456960|Aspirin|aspirin|mesh-list
110826108|NCT03456960|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110826109|NCT03456960|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110826111|NCT03456960|Sensory System Agents|sensory system agents|mesh-ancestor
110826112|NCT03456960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110826113|NCT03456960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110826114|NCT03456960|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110826115|NCT03456960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110826116|NCT03456960|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110826117|NCT03456960|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110826118|NCT03456960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110826119|NCT03456960|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110826120|NCT03456960|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110826121|NCT03456960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110826122|NCT03456960|Antipyretics|antipyretics|mesh-ancestor
110826123|NCT03716388|Mesalamine|mesalamine|mesh-list
110826124|NCT03716388|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110826125|NCT03716388|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110826126|NCT03716388|Analgesics|analgesics|mesh-ancestor
110826127|NCT03716388|Sensory System Agents|sensory system agents|mesh-ancestor
110826128|NCT03716388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110826129|NCT03716388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110826130|NCT03716388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110826131|NCT03716388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110826132|NCT01311336|Loratadine|loratadine|mesh-list
110826133|NCT01311336|Antipruritics|antipruritics|mesh-ancestor
110826134|NCT01311336|Dermatologic Agents|dermatologic agents|mesh-ancestor
110826135|NCT01311336|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110826136|NCT01311336|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110826137|NCT01311336|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110826138|NCT01311336|Histamine Antagonists|histamine antagonists|mesh-ancestor
110826139|NCT01311336|Histamine Agents|histamine agents|mesh-ancestor
110826140|NCT01311336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110826141|NCT01311336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110826142|NCT01311336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110826143|NCT03430986|Lidocaine|lidocaine|mesh-list
110826144|NCT03430986|Anesthetics, Local|anesthetics, local|mesh-ancestor
110826145|NCT03430986|Anesthetics|anesthetics|mesh-ancestor
110826146|NCT03430986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110826147|NCT03430986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110826148|NCT03430986|Sensory System Agents|sensory system agents|mesh-ancestor
110826149|NCT03430986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110826150|NCT03430986|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110826151|NCT03430986|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110826152|NCT03430986|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110826153|NCT03430986|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110826154|NCT03430986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110826155|NCT01261741|Memantine|memantine|mesh-list
110826156|NCT01261741|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110826157|NCT01261741|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110826158|NCT01261741|Dopamine Agents|dopamine agents|mesh-ancestor
110826159|NCT01261741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110826160|NCT01261741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110826161|NCT01261741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110826162|NCT01261741|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110826163|NCT01261741|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110826164|NCT01157455|Aspirin|aspirin|mesh-list
110826165|NCT01157455|Everolimus|everolimus|mesh-list
110826166|NCT01157455|Heparin|heparin|mesh-list
110826167|NCT01157455|Bivalirudin|bivalirudin|mesh-list
110826168|NCT01157455|Clopidogrel|clopidogrel|mesh-list
110826169|NCT01157455|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110826170|NCT01157455|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110826171|NCT01157455|Analgesics|analgesics|mesh-ancestor
110826172|NCT01157455|Sensory System Agents|sensory system agents|mesh-ancestor
110826173|NCT01157455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110826174|NCT01157455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110826175|NCT01157455|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110826176|NCT01157455|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110826177|NCT01157455|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110826178|NCT01157455|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110855495|NCT04867343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110826179|NCT01157455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110826180|NCT01157455|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110826181|NCT01157455|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110826182|NCT01157455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110826183|NCT01157455|Antipyretics|antipyretics|mesh-ancestor
110421091|NCT04285528|Analgesics|analgesics|mesh-ancestor
110826184|NCT01157455|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110826185|NCT01157455|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110826186|NCT01157455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110826187|NCT01157455|Immunologic Factors|immunologic factors|mesh-ancestor
110826188|NCT01157455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110826189|NCT01157455|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110826190|NCT01157455|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110826191|NCT01157455|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110826192|NCT01157455|Purinergic Agents|purinergic agents|mesh-ancestor
110826193|NCT01157455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110826194|NCT01157455|Anticoagulants|anticoagulants|mesh-ancestor
110826195|NCT01157455|Antithrombins|antithrombins|mesh-ancestor
110826196|NCT01157455|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110826197|NCT01157455|Protease Inhibitors|protease inhibitors|mesh-ancestor
110826198|NCT03713892|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
110826199|NCT03713892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110826200|NCT03713892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110826201|NCT03884881|Meropenem|meropenem|mesh-list
110826202|NCT03884881|Imipenem|imipenem|mesh-list
110826203|NCT03884881|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110826204|NCT03884881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110826205|NCT01154881|Insulin|insulin|mesh-list
110826206|NCT01154881|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110826207|NCT01154881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110826208|NCT03886441|Beclomethasone|beclomethasone|mesh-list
110826209|NCT03886441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110826210|NCT03886441|Glucocorticoids|glucocorticoids|mesh-ancestor
110826211|NCT03886441|Hormones|hormones|mesh-ancestor
110826212|NCT03886441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110826213|NCT03886441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110826214|NCT03886441|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110826215|NCT03886441|Respiratory System Agents|respiratory system agents|mesh-ancestor
110826216|NCT03713346|Caseins|caseins|mesh-list
110826217|NCT03713346|Chelating Agents|chelating agents|mesh-ancestor
110421211|NCT04284202|Dasatinib|dasatinib|mesh-list
110826218|NCT03713346|Sequestering Agents|sequestering agents|mesh-ancestor
110826219|NCT03713346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110826220|NCT01154959|Moxifloxacin|moxifloxacin|mesh-list
110826221|NCT01154959|Rifampin|rifampin|mesh-list
110826222|NCT01154959|Isoniazid|isoniazid|mesh-list
110826223|NCT01154959|Pyrazinamide|pyrazinamide|mesh-list
110826224|NCT01154959|Ethambutol|ethambutol|mesh-list
110826225|NCT01154959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110826226|NCT01154959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110826227|NCT01154959|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110826228|NCT01154959|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110826229|NCT01154959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110826230|NCT01154959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110826231|NCT01154959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110826232|NCT01154959|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110826233|NCT01154959|Antitubercular Agents|antitubercular agents|mesh-ancestor
110826234|NCT01154959|Leprostatic Agents|leprostatic agents|mesh-ancestor
110826235|NCT01154959|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110826236|NCT01154959|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110826237|NCT01154959|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110826238|NCT01154959|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110826239|NCT01154959|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110826240|NCT01154959|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110826241|NCT01154959|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110826242|NCT01154959|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
110826244|NCT01154959|Antimetabolites|antimetabolites|mesh-ancestor
110826245|NCT01154959|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110826247|NCT03881293|Anesthetics, Local|anesthetics, local|mesh-ancestor
110826248|NCT03881293|Anesthetics|anesthetics|mesh-ancestor
110826249|NCT03881293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110826250|NCT03881293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110826251|NCT03881293|Sensory System Agents|sensory system agents|mesh-ancestor
110826252|NCT03881293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110826253|NCT03881293|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110826254|NCT03881293|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110482834|NCT00991952|Irinotecan|irinotecan|mesh-list
110826255|NCT03881293|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110826256|NCT03881293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110826257|NCT03881293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110826258|NCT01155037|Vaccines|vaccines|mesh-list
110826259|NCT01155037|Immunologic Factors|immunologic factors|mesh-ancestor
110826260|NCT01155037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110826261|NCT01261897|Ropivacaine|ropivacaine|mesh-list
110826262|NCT01261897|Anesthetics, Local|anesthetics, local|mesh-ancestor
110826263|NCT01261897|Anesthetics|anesthetics|mesh-ancestor
110826264|NCT01261897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110826265|NCT01261897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110826266|NCT01261897|Sensory System Agents|sensory system agents|mesh-ancestor
110826267|NCT01261897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110826268|NCT03448536|Acetaminophen|acetaminophen|mesh-list
110826269|NCT03448536|Naproxen|naproxen|mesh-list
110826270|NCT03448536|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110826271|NCT03448536|Analgesics|analgesics|mesh-ancestor
110826272|NCT03448536|Sensory System Agents|sensory system agents|mesh-ancestor
110826273|NCT03448536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110826274|NCT03448536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110826275|NCT03448536|Antipyretics|antipyretics|mesh-ancestor
110826276|NCT03448536|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110826277|NCT03448536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110826278|NCT03448536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110826279|NCT03448536|Gout Suppressants|gout suppressants|mesh-ancestor
110826280|NCT03448536|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110826281|NCT03448536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110826282|NCT03448536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110826283|NCT01155115|Nitric Oxide|nitric oxide|mesh-list
110826284|NCT01155115|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110826285|NCT01155115|Autonomic Agents|autonomic agents|mesh-ancestor
110826286|NCT01155115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110826287|NCT01155115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110826288|NCT01155115|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110826289|NCT01155115|Respiratory System Agents|respiratory system agents|mesh-ancestor
110826290|NCT01155115|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110826291|NCT01155115|Antioxidants|antioxidants|mesh-ancestor
110826292|NCT01155115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110826293|NCT01155115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110826294|NCT01155115|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
110826295|NCT01155115|Vasodilator Agents|vasodilator agents|mesh-ancestor
110826296|NCT01155115|Gasotransmitters|gasotransmitters|mesh-ancestor
110826297|NCT01155115|Protective Agents|protective agents|mesh-ancestor
110826298|NCT03713190|Empagliflozin|empagliflozin|mesh-list
110826299|NCT03713190|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110826300|NCT03713190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110826301|NCT03713190|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110826302|NCT03713190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110826303|NCT03718182|Cholecalciferol|cholecalciferol|mesh-list
110826304|NCT03718182|Vitamin D|vitamin d|mesh-list
110826305|NCT03718182|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110826306|NCT03718182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110826307|NCT03718182|Vitamins|vitamins|mesh-ancestor
110826308|NCT03718182|Micronutrients|micronutrients|mesh-ancestor
110826309|NCT03718182|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110826310|NCT03881449|Aripiprazole|aripiprazole|mesh-list
110826311|NCT03881449|Antidepressive Agents|antidepressive agents|mesh-ancestor
110826312|NCT03881449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110826313|NCT03881449|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110826314|NCT03881449|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110826315|NCT03881449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110826316|NCT03881449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110826317|NCT03881449|Dopamine Agonists|dopamine agonists|mesh-ancestor
110826318|NCT03881449|Dopamine Agents|dopamine agents|mesh-ancestor
110826319|NCT03881449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110826320|NCT03881449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110826321|NCT03881449|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110826322|NCT03881449|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110826323|NCT03881449|Serotonin Agents|serotonin agents|mesh-ancestor
110826324|NCT03881449|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110826325|NCT03881449|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110826326|NCT03881449|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110826327|NCT03881449|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110826328|NCT03884491|Vortioxetine|vortioxetine|mesh-list
110826329|NCT03884491|Antidepressive Agents|antidepressive agents|mesh-ancestor
110826330|NCT03884491|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110826331|NCT03884491|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110826332|NCT03884491|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110826333|NCT03884491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110826334|NCT03884491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110826335|NCT03884491|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110826336|NCT03884491|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110826337|NCT03884491|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110826338|NCT03884491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110826339|NCT03884491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110826340|NCT03884491|Serotonin Agents|serotonin agents|mesh-ancestor
110826341|NCT03884491|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110826342|NCT03884491|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110826343|NCT03884491|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110826344|NCT03884491|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110826345|NCT03880981|Acetaminophen|acetaminophen|mesh-list
110826347|NCT03880981|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110826348|NCT03880981|Analgesics|analgesics|mesh-ancestor
110826349|NCT03880981|Sensory System Agents|sensory system agents|mesh-ancestor
110826350|NCT03880981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110826351|NCT03880981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110826352|NCT03880981|Antipyretics|antipyretics|mesh-ancestor
110826353|NCT03880981|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110826354|NCT03880981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110826355|NCT03880981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110826356|NCT03880981|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110826357|NCT03880981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110826358|NCT03880981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110826360|NCT03424044|Pancrelipase|pancrelipase|mesh-list
110826361|NCT03424044|Pancreatin|pancreatin|mesh-list
110826362|NCT03424044|Hormones|hormones|mesh-list
110863876|NCT03634020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110826363|NCT03424044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110826364|NCT03424044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110826365|NCT03424044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110826366|NCT03880903|Albuterol|albuterol|mesh-list
110826367|NCT03880903|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110826368|NCT03880903|Autonomic Agents|autonomic agents|mesh-ancestor
110826369|NCT03880903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110826370|NCT03880903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110826371|NCT03880903|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110826372|NCT03880903|Respiratory System Agents|respiratory system agents|mesh-ancestor
110826373|NCT03880903|Tocolytic Agents|tocolytic agents|mesh-ancestor
110826374|NCT03880903|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110826375|NCT03880903|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110826376|NCT03880903|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110826377|NCT03880903|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110826378|NCT03880903|Adrenergic Agents|adrenergic agents|mesh-ancestor
110826379|NCT03880903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110826380|NCT03880903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110826381|NCT01155895|Amlodipine|amlodipine|mesh-list
110826382|NCT01155895|Benazepril|benazepril|mesh-list
110826383|NCT01155895|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110826384|NCT01155895|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110826385|NCT01155895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110826386|NCT01155895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110826387|NCT01155895|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110826388|NCT01155895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110826389|NCT01155895|Vasodilator Agents|vasodilator agents|mesh-ancestor
110826390|NCT01155895|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110543936|NCT02655770|Liraglutide|liraglutide|mesh-list
110826391|NCT01155895|Protease Inhibitors|protease inhibitors|mesh-ancestor
110826392|NCT01155895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110826393|NCT01265641|Moxifloxacin|moxifloxacin|mesh-list
110826394|NCT01265641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110826395|NCT01265641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110826396|NCT01265641|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110826397|NCT01265641|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110826398|NCT01265641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110826399|NCT01265641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110826400|NCT01265641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110826401|NCT01589809|Niacinamide|niacinamide|mesh-list
110826402|NCT01589809|Niacin|niacin|mesh-list
110826403|NCT01589809|Nicotinic Acids|nicotinic acids|mesh-list
110826404|NCT01589809|Vitamins|vitamins|mesh-ancestor
110826405|NCT01589809|Micronutrients|micronutrients|mesh-ancestor
110826406|NCT01589809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110826407|NCT01589809|Vitamin B Complex|vitamin b complex|mesh-ancestor
110826408|NCT01589809|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110826409|NCT01589809|Antimetabolites|antimetabolites|mesh-ancestor
110826410|NCT01589809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110826411|NCT01589809|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110826412|NCT01589809|Vasodilator Agents|vasodilator agents|mesh-ancestor
110826413|NCT01264237|Etoricoxib|etoricoxib|mesh-list
110826414|NCT01264237|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110826415|NCT01264237|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110826416|NCT01264237|Analgesics|analgesics|mesh-ancestor
110826417|NCT01264237|Sensory System Agents|sensory system agents|mesh-ancestor
110826418|NCT01264237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110826419|NCT01264237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110826420|NCT01264237|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110826421|NCT01264237|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110826422|NCT01264237|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110826423|NCT01264237|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110826424|NCT01264237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110826425|NCT01264237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110826426|NCT03880825|Metformin|metformin|mesh-list
110826427|NCT03880825|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110826428|NCT03880825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110826429|NCT01159639|Clopidogrel|clopidogrel|mesh-list
110826430|NCT01159639|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110826431|NCT01159639|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110863877|NCT03634020|Antifungal Agents|antifungal agents|mesh-ancestor
110826432|NCT01159639|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110826433|NCT01159639|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110826434|NCT01159639|Purinergic Agents|purinergic agents|mesh-ancestor
110826435|NCT01159639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110826436|NCT01159639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110826437|NCT01159639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110826438|NCT03880357|Betamethasone|betamethasone|mesh-list
110826439|NCT03880357|Betamethasone Valerate|betamethasone valerate|mesh-list
110826440|NCT03880357|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
110826441|NCT03880357|Betamethasone benzoate|betamethasone benzoate|mesh-list
110826442|NCT03880357|Calcipotriene|calcipotriene|mesh-list
110826443|NCT03880357|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
110826444|NCT03880357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110826445|NCT03880357|Glucocorticoids|glucocorticoids|mesh-ancestor
110826446|NCT03880357|Hormones|hormones|mesh-ancestor
110826447|NCT03880357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110826448|NCT03880357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110826449|NCT03880357|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110826450|NCT03880357|Respiratory System Agents|respiratory system agents|mesh-ancestor
110826451|NCT03880357|Dermatologic Agents|dermatologic agents|mesh-ancestor
110826452|NCT01266031|Bevacizumab|bevacizumab|mesh-list
110826453|NCT01266031|Vorinostat|vorinostat|mesh-list
110826454|NCT01266031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110826455|NCT01266031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110826456|NCT01266031|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110826457|NCT01266031|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110826458|NCT01266031|Growth Substances|growth substances|mesh-ancestor
110826459|NCT01266031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110826460|NCT01266031|Growth Inhibitors|growth inhibitors|mesh-ancestor
110826461|NCT01266031|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110826462|NCT01266031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110826463|NCT01266031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110826464|NCT03880045|Vasopressins|vasopressins|mesh-list
110826465|NCT03880045|Arginine Vasopressin|arginine vasopressin|mesh-list
110826466|NCT03880045|Hemostatics|hemostatics|mesh-ancestor
110826467|NCT03880045|Coagulants|coagulants|mesh-ancestor
110826468|NCT03880045|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110826469|NCT03880045|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
110826470|NCT03880045|Natriuretic Agents|natriuretic agents|mesh-ancestor
110826471|NCT03880045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110826472|NCT03879889|Nicotine|nicotine|mesh-list
110826473|NCT03879889|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110826474|NCT03879889|Autonomic Agents|autonomic agents|mesh-ancestor
110826475|NCT03879889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110826476|NCT03879889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110826477|NCT03879889|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110826478|NCT03879889|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110826479|NCT03879889|Cholinergic Agents|cholinergic agents|mesh-ancestor
110826480|NCT03879889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110826481|NCT03879889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110826482|NCT01266187|Leucovorin|leucovorin|mesh-list
110826483|NCT01266187|Cetuximab|cetuximab|mesh-list
110826484|NCT01266187|Fluorouracil|fluorouracil|mesh-list
110826485|NCT01266187|Oxaliplatin|oxaliplatin|mesh-list
110826486|NCT01266187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110826487|NCT01266187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110826488|NCT01266187|Antimetabolites|antimetabolites|mesh-ancestor
110826489|NCT01266187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110826490|NCT01266187|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110826491|NCT01266187|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110826492|NCT01266187|Immunologic Factors|immunologic factors|mesh-ancestor
110826493|NCT01266187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110826494|NCT01266187|Antidotes|antidotes|mesh-ancestor
110826495|NCT01266187|Protective Agents|protective agents|mesh-ancestor
110826496|NCT01266187|Vitamin B Complex|vitamin b complex|mesh-ancestor
110826497|NCT01266187|Vitamins|vitamins|mesh-ancestor
110826498|NCT01266187|Micronutrients|micronutrients|mesh-ancestor
110826499|NCT01586533|Mesalamine|mesalamine|mesh-list
110826500|NCT01586533|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110826501|NCT01586533|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110826502|NCT01586533|Analgesics|analgesics|mesh-ancestor
110826503|NCT01586533|Sensory System Agents|sensory system agents|mesh-ancestor
110826504|NCT01586533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110826505|NCT01586533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110826506|NCT01586533|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110826507|NCT01586533|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110826508|NCT03880123|Ixazomib|ixazomib|mesh-list
110826509|NCT03880123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110826510|NCT03880123|Protease Inhibitors|protease inhibitors|mesh-ancestor
110826511|NCT03880123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110826512|NCT03880123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110826513|NCT01266499|Colistin|colistin|mesh-list
110826514|NCT01266499|Polymyxins|polymyxins|mesh-list
110826515|NCT01266499|Gentamicins|gentamicins|mesh-list
110826516|NCT01266499|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110826517|NCT01266499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110826518|NCT01266499|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110826519|NCT01266499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110826520|NCT01266499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110826521|NCT00075725|Calcium, Dietary|calcium, dietary|mesh-list
110826522|NCT00075725|Leucovorin|leucovorin|mesh-list
110826523|NCT00075725|Folic Acid|folic acid|mesh-list
110826524|NCT00075725|Cytarabine|cytarabine|mesh-list
110826525|NCT00075725|Dexamethasone|dexamethasone|mesh-list
110826526|NCT00075725|Dexamethasone acetate|dexamethasone acetate|mesh-list
110826527|NCT00075725|Prednisone|prednisone|mesh-list
110826528|NCT00075725|Cortisone|cortisone|mesh-list
110826529|NCT00075725|Cyclophosphamide|cyclophosphamide|mesh-list
110826530|NCT00075725|Doxorubicin|doxorubicin|mesh-list
110826531|NCT00075725|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110826532|NCT00075725|Methotrexate|methotrexate|mesh-list
110826533|NCT00075725|Vincristine|vincristine|mesh-list
110826534|NCT00075725|Daunorubicin|daunorubicin|mesh-list
110826535|NCT00075725|Asparaginase|asparaginase|mesh-list
110826536|NCT00075725|Mercaptopurine|mercaptopurine|mesh-list
110826537|NCT00075725|Pegaspargase|pegaspargase|mesh-list
110826538|NCT00075725|Thioguanine|thioguanine|mesh-list
110826539|NCT00075725|BB 1101|bb 1101|mesh-list
110826540|NCT00075725|Calcium|calcium|mesh-list
110826541|NCT00075725|2-Aminopurine|2-aminopurine|mesh-list
110826542|NCT00075725|Levoleucovorin|levoleucovorin|mesh-list
110826543|NCT00075725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110826544|NCT00075725|Immunologic Factors|immunologic factors|mesh-ancestor
110826545|NCT00075725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110826546|NCT00075725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110826547|NCT00075725|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110826548|NCT00075725|Alkylating Agents|alkylating agents|mesh-ancestor
110826549|NCT00075725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110826550|NCT00075725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110826551|NCT00075725|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110826552|NCT00075725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110826553|NCT00075725|Antiemetics|antiemetics|mesh-ancestor
110826554|NCT00075725|Autonomic Agents|autonomic agents|mesh-ancestor
110826555|NCT00075725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110826556|NCT00075725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110826557|NCT00075725|Glucocorticoids|glucocorticoids|mesh-ancestor
110826558|NCT00075725|Hormones|hormones|mesh-ancestor
110826559|NCT00075725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110826561|NCT00075725|Protease Inhibitors|protease inhibitors|mesh-ancestor
110826562|NCT00075725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110826563|NCT00075725|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110826564|NCT00075725|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110826565|NCT00075725|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110826566|NCT00075725|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110826567|NCT00075725|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110826568|NCT00075725|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110826569|NCT00075725|Abortifacient Agents|abortifacient agents|mesh-ancestor
110826570|NCT00075725|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110826571|NCT00075725|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110826572|NCT00075725|Antimetabolites|antimetabolites|mesh-ancestor
110826573|NCT00075725|Dermatologic Agents|dermatologic agents|mesh-ancestor
110826574|NCT00075725|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110826575|NCT00075725|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110826576|NCT00075725|Antiviral Agents|antiviral agents|mesh-ancestor
110826577|NCT00075725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110826578|NCT00075725|Antidotes|antidotes|mesh-ancestor
110826579|NCT00075725|Protective Agents|protective agents|mesh-ancestor
110826580|NCT00075725|Vitamin B Complex|vitamin b complex|mesh-ancestor
110826581|NCT00075725|Vitamins|vitamins|mesh-ancestor
110826582|NCT00075725|Micronutrients|micronutrients|mesh-ancestor
110826583|NCT00075725|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110826584|NCT00075725|Tubulin Modulators|tubulin modulators|mesh-ancestor
110826585|NCT00075725|Antimitotic Agents|antimitotic agents|mesh-ancestor
110826586|NCT00075725|Mitosis Modulators|mitosis modulators|mesh-ancestor
110826587|NCT00075725|Hematinics|hematinics|mesh-ancestor
110826588|NCT02953782|Cetuximab|cetuximab|mesh-list
110826589|NCT02953782|Magrolimab|magrolimab|mesh-list
110826590|NCT02953782|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110826591|NCT02953782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110826592|NCT01264783|RNS60|rns60|mesh-list
110826593|NCT01264783|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110826594|NCT01264783|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110826595|NCT01264783|Analgesics|analgesics|mesh-ancestor
110826596|NCT01264783|Sensory System Agents|sensory system agents|mesh-ancestor
110421753|NCT05210725|Anticoagulants|anticoagulants|mesh-ancestor
110826597|NCT01264783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110826598|NCT01264783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110826599|NCT01264783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110826600|NCT01264783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110826601|NCT01264783|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110826602|NCT01160029|Nateglinide|nateglinide|mesh-list
110826603|NCT01160029|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110826604|NCT01160029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110826605|NCT00057863|Paclitaxel|paclitaxel|mesh-list
110826606|NCT00057863|Oxaliplatin|oxaliplatin|mesh-list
110826607|NCT00057863|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110826608|NCT00057863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110826609|NCT00057863|Tubulin Modulators|tubulin modulators|mesh-ancestor
110826610|NCT00057863|Antimitotic Agents|antimitotic agents|mesh-ancestor
110826611|NCT00057863|Mitosis Modulators|mitosis modulators|mesh-ancestor
110826612|NCT00057863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110826613|NCT01266655|Baclofen|baclofen|mesh-list
110826614|NCT01266655|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110826615|NCT01266655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110421791|NCT02829151|Autonomic Agents|autonomic agents|mesh-ancestor
110826616|NCT01266655|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110826617|NCT01266655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110826618|NCT01266655|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
110826619|NCT01266655|GABA Agonists|gaba agonists|mesh-ancestor
110826620|NCT01266655|GABA Agents|gaba agents|mesh-ancestor
110826621|NCT01266655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110826622|NCT01266655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110826623|NCT00075023|Thalidomide|thalidomide|mesh-list
110826624|NCT00075023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110826625|NCT00075023|Immunologic Factors|immunologic factors|mesh-ancestor
110826626|NCT00075023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110826627|NCT00075023|Leprostatic Agents|leprostatic agents|mesh-ancestor
110826628|NCT00075023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110826629|NCT00075023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110826630|NCT00075023|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110826631|NCT00075023|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110826632|NCT00075023|Growth Substances|growth substances|mesh-ancestor
110826633|NCT00075023|Growth Inhibitors|growth inhibitors|mesh-ancestor
110826634|NCT00075023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110826636|NCT01100801|Oxaliplatin|oxaliplatin|mesh-list
110826637|NCT01100801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110826638|NCT01263145|Paclitaxel|paclitaxel|mesh-list
110826639|NCT01263145|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110826640|NCT01263145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110826641|NCT01263145|Tubulin Modulators|tubulin modulators|mesh-ancestor
110826642|NCT01263145|Antimitotic Agents|antimitotic agents|mesh-ancestor
110826643|NCT01263145|Mitosis Modulators|mitosis modulators|mesh-ancestor
110826644|NCT01263145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110826645|NCT03717558|Ivermectin|ivermectin|mesh-list
110826646|NCT03717558|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110826647|NCT03717558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110826648|NCT00074711|Calcium, Dietary|calcium, dietary|mesh-list
110826649|NCT00074711|Calcium Carbonate|calcium carbonate|mesh-list
110826650|NCT00074711|Calcium|calcium|mesh-list
110826651|NCT00074711|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110826652|NCT00074711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110826653|NCT00074711|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110826654|NCT00074711|Antacids|antacids|mesh-ancestor
110826655|NCT00074711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110826656|NCT00074711|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110826657|NCT03960905|Meropenem|meropenem|mesh-list
110826658|NCT03960905|Ceftazidime|ceftazidime|mesh-list
110826659|NCT03960905|Cefepime|cefepime|mesh-list
110826660|NCT03960905|Anti-Infective Agents|anti-infective agents|mesh-list
110826661|NCT03960905|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110826662|NCT05619120|Mexiletine|mexiletine|mesh-list
110826663|NCT05619120|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110826664|NCT05619120|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110826665|NCT05619120|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110826666|NCT05619120|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110826667|NCT05619120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110826668|NCT01265017|Hydrocortisone|hydrocortisone|mesh-list
110826669|NCT01265017|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
110826670|NCT01265017|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
110826671|NCT01265017|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
110826672|NCT01265017|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
110826673|NCT01265017|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110826674|NCT01265017|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110826675|NCT01265017|Medroxyprogesterone|medroxyprogesterone|mesh-list
110826676|NCT01265017|Estradiol|estradiol|mesh-list
110826677|NCT01265017|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110826678|NCT01265017|Hormones|hormones|mesh-ancestor
110826679|NCT01265017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110826680|NCT01265017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110826681|NCT01265017|Estrogens|estrogens|mesh-ancestor
110421943|NCT02820025|Doxapram|doxapram|mesh-list
110826682|NCT01265017|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110826683|NCT01265017|Contraceptive Agents|contraceptive agents|mesh-ancestor
110826684|NCT01265017|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110826685|NCT01265017|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110826686|NCT01265017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110826687|NCT01265017|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110826688|NCT01265017|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110826689|NCT01265017|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110826690|NCT01265017|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110826691|NCT01265017|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110826692|NCT01265017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110826693|NCT03420300|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
110826694|NCT03420300|Antiviral Agents|antiviral agents|mesh-ancestor
110826695|NCT03420300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110826696|NCT03879811|Nivolumab|nivolumab|mesh-list
110826697|NCT03879811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110826698|NCT03879811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110826699|NCT03879811|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110826700|NCT03879811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110826701|NCT01158859|Pregabalin|pregabalin|mesh-list
110826702|NCT01158859|Analgesics|analgesics|mesh-ancestor
110826703|NCT01158859|Sensory System Agents|sensory system agents|mesh-ancestor
110422003|NCT02818621|Analgesics|analgesics|mesh-ancestor
110826704|NCT01158859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110826705|NCT01158859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110826706|NCT01158859|Anticonvulsants|anticonvulsants|mesh-ancestor
110826707|NCT01158859|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110826708|NCT01158859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110826709|NCT01158859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110826710|NCT01158859|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110826711|NCT01158859|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110826712|NCT01158859|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110826713|NCT01158859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110826714|NCT01158859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110826716|NCT01100021|Tamsulosin|tamsulosin|mesh-list
110826717|NCT01100021|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110826718|NCT01100021|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110826719|NCT01100021|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110826720|NCT01100021|Adrenergic Agents|adrenergic agents|mesh-ancestor
110826721|NCT01100021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110826722|NCT01100021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110826723|NCT01100021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110826724|NCT01100021|Urological Agents|urological agents|mesh-ancestor
110826725|NCT01100021|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110826726|NCT03407430|Pregabalin|pregabalin|mesh-list
110826727|NCT03407430|Analgesics|analgesics|mesh-ancestor
110826728|NCT03407430|Sensory System Agents|sensory system agents|mesh-ancestor
110826729|NCT03407430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110826730|NCT03407430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110826731|NCT03407430|Anticonvulsants|anticonvulsants|mesh-ancestor
110826732|NCT03407430|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110826733|NCT03407430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110826734|NCT03407430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110826735|NCT03407430|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110826736|NCT03407430|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110826737|NCT03407430|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110826738|NCT03407430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110826739|NCT03407430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110826740|NCT01266811|Dexamethasone|dexamethasone|mesh-list
110826741|NCT01266811|Dexamethasone acetate|dexamethasone acetate|mesh-list
110826742|NCT01266811|Bortezomib|bortezomib|mesh-list
110826743|NCT01266811|Siltuximab|siltuximab|mesh-list
110826744|NCT01266811|BB 1101|bb 1101|mesh-list
110826745|NCT01266811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110826746|NCT01266811|Antiemetics|antiemetics|mesh-ancestor
110826747|NCT01266811|Autonomic Agents|autonomic agents|mesh-ancestor
110826748|NCT01266811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110826749|NCT01266811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110826750|NCT01266811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110826751|NCT01266811|Glucocorticoids|glucocorticoids|mesh-ancestor
110826752|NCT01266811|Hormones|hormones|mesh-ancestor
110826753|NCT01266811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110826754|NCT01266811|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110826755|NCT01266811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110826756|NCT01266811|Protease Inhibitors|protease inhibitors|mesh-ancestor
110826757|NCT01266811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110826758|NCT01266811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110826759|NCT01158937|Meropenem|meropenem|mesh-list
110826760|NCT01158937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110826761|NCT01158937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110826762|NCT03407118|Insulin Lispro|insulin lispro|mesh-list
110826763|NCT03407118|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110826764|NCT03407118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110826765|NCT01100177|Sunitinib|sunitinib|mesh-list
110826766|NCT01100177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110826767|NCT01100177|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110826768|NCT01100177|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110826769|NCT01100177|Growth Substances|growth substances|mesh-ancestor
110826770|NCT01100177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110826771|NCT01100177|Growth Inhibitors|growth inhibitors|mesh-ancestor
110826772|NCT01100177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110826773|NCT01100177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110826774|NCT01100177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110826775|NCT01100333|Hormones|hormones|mesh-list
110826776|NCT01100333|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
110826777|NCT01100333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110826778|NCT01100333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110826779|NCT01327235|Cisplatin|cisplatin|mesh-list
110826780|NCT01327235|Endostar protein|endostar protein|mesh-list
110826781|NCT01327235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110826782|NCT01327235|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110826784|NCT01327235|Growth Substances|growth substances|mesh-ancestor
110826785|NCT01327235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110826786|NCT01327235|Growth Inhibitors|growth inhibitors|mesh-ancestor
110826787|NCT03406260|Lasmiditan|lasmiditan|mesh-list
110826788|NCT03406260|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110826789|NCT03406260|Serotonin Agents|serotonin agents|mesh-ancestor
110826790|NCT03406260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110826791|NCT03406260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110826792|NCT03406260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110826793|NCT01089179|Metformin|metformin|mesh-list
110826794|NCT01089179|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110826795|NCT01089179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110826796|NCT01160185|Paclitaxel|paclitaxel|mesh-list
110826797|NCT01160185|Topotecan|topotecan|mesh-list
110826798|NCT01160185|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110826799|NCT01160185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110826800|NCT01160185|Tubulin Modulators|tubulin modulators|mesh-ancestor
110826801|NCT01160185|Antimitotic Agents|antimitotic agents|mesh-ancestor
110826802|NCT01160185|Mitosis Modulators|mitosis modulators|mesh-ancestor
110826803|NCT01160185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110826804|NCT01160185|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110826805|NCT01160185|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110826806|NCT01160185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110826807|NCT03419364|Niacinamide|niacinamide|mesh-list
110826808|NCT03419364|Niacin|niacin|mesh-list
110826809|NCT03419364|Nicotinic Acids|nicotinic acids|mesh-list
110826810|NCT03419364|Vitamin B Complex|vitamin b complex|mesh-ancestor
110826811|NCT03419364|Vitamins|vitamins|mesh-ancestor
110826812|NCT03419364|Micronutrients|micronutrients|mesh-ancestor
110826813|NCT03419364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110826814|NCT03419364|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110826815|NCT03419364|Antimetabolites|antimetabolites|mesh-ancestor
110826816|NCT03419364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110826817|NCT03419364|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110826818|NCT03419364|Vasodilator Agents|vasodilator agents|mesh-ancestor
110826819|NCT01265173|Ciprofloxacin|ciprofloxacin|mesh-list
110826820|NCT01265173|Ceftriaxone|ceftriaxone|mesh-list
110826821|NCT01265173|Cefotaxime|cefotaxime|mesh-list
110826822|NCT01265173|Cefoxitin|cefoxitin|mesh-list
110826823|NCT01265173|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110826824|NCT01265173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110826825|NCT01265173|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110826826|NCT01265173|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110826827|NCT01265173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110826828|NCT01265173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110826829|NCT01265173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110826830|NCT01265173|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110826831|NCT01265173|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110826832|NCT01159327|Sorafenib|sorafenib|mesh-list
110826833|NCT01159327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110826834|NCT01159327|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110826835|NCT01159327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110826836|NCT01159327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110826837|NCT01160341|Methyltestosterone|methyltestosterone|mesh-list
110826838|NCT01160341|Testosterone|testosterone|mesh-list
110826839|NCT01160341|Testosterone undecanoate|testosterone undecanoate|mesh-list
110826840|NCT01160341|Testosterone enanthate|testosterone enanthate|mesh-list
110826841|NCT01160341|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
110826842|NCT01160341|Androgens|androgens|mesh-ancestor
110826843|NCT01160341|Hormones|hormones|mesh-ancestor
110826844|NCT01160341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110826845|NCT01160341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110826846|NCT01160341|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110826847|NCT01160341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110826848|NCT01160341|Anabolic Agents|anabolic agents|mesh-ancestor
110826849|NCT03882775|Heparin|heparin|mesh-list
110826851|NCT03882775|Anticoagulants|anticoagulants|mesh-ancestor
110826852|NCT03882775|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110826853|NCT03882775|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110826854|NCT03882775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110826855|NCT03882775|Antithrombins|antithrombins|mesh-ancestor
110826856|NCT03882775|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110826857|NCT03882775|Protease Inhibitors|protease inhibitors|mesh-ancestor
110826858|NCT03882775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110826859|NCT03877705|Listerine|listerine|mesh-list
110826861|NCT03877705|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110826862|NCT03877705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110826863|NCT03877705|Cariostatic Agents|cariostatic agents|mesh-ancestor
110826864|NCT03877705|Protective Agents|protective agents|mesh-ancestor
110422229|NCT01238588|Sevelamer|sevelamer|mesh-list
110826865|NCT03877705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110826866|NCT01160419|Leucovorin|leucovorin|mesh-list
110826867|NCT01160419|Folic Acid|folic acid|mesh-list
110826868|NCT01160419|Docetaxel|docetaxel|mesh-list
110826869|NCT01160419|Oxaliplatin|oxaliplatin|mesh-list
110826870|NCT01160419|Levoleucovorin|levoleucovorin|mesh-list
110826871|NCT01160419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110826872|NCT01160419|Tubulin Modulators|tubulin modulators|mesh-ancestor
110826873|NCT01160419|Antimitotic Agents|antimitotic agents|mesh-ancestor
110826874|NCT01160419|Mitosis Modulators|mitosis modulators|mesh-ancestor
110826875|NCT01160419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110826876|NCT01160419|Antidotes|antidotes|mesh-ancestor
110826877|NCT01160419|Protective Agents|protective agents|mesh-ancestor
110826878|NCT01160419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110826879|NCT01160419|Vitamin B Complex|vitamin b complex|mesh-ancestor
110826880|NCT01160419|Vitamins|vitamins|mesh-ancestor
110826881|NCT01160419|Micronutrients|micronutrients|mesh-ancestor
110826882|NCT01160419|Hematinics|hematinics|mesh-ancestor
110826883|NCT02954172|Paclitaxel|paclitaxel|mesh-list
110826884|NCT02954172|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110826885|NCT02954172|Bevacizumab|bevacizumab|mesh-list
110826886|NCT02954172|Carboplatin|carboplatin|mesh-list
110826887|NCT02954172|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110826888|NCT02954172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110826889|NCT02954172|Tubulin Modulators|tubulin modulators|mesh-ancestor
110826890|NCT02954172|Antimitotic Agents|antimitotic agents|mesh-ancestor
110826891|NCT02954172|Mitosis Modulators|mitosis modulators|mesh-ancestor
110826892|NCT02954172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110826893|NCT02954172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110826894|NCT02954172|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110826895|NCT02954172|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110826896|NCT02954172|Growth Substances|growth substances|mesh-ancestor
110826897|NCT02954172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110826898|NCT02954172|Growth Inhibitors|growth inhibitors|mesh-ancestor
110826899|NCT01156519|Hydrocortisone|hydrocortisone|mesh-list
110826900|NCT01156519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110826901|NCT02953938|Ranibizumab|ranibizumab|mesh-list
110826902|NCT02953938|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110826903|NCT02953938|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110826904|NCT02953938|Growth Substances|growth substances|mesh-ancestor
110826905|NCT02953938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110826906|NCT02953938|Growth Inhibitors|growth inhibitors|mesh-ancestor
110826907|NCT02953938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110826908|NCT01161667|Naratriptan|naratriptan|mesh-list
110826909|NCT01161667|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110826910|NCT01161667|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110826911|NCT01161667|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110826912|NCT01161667|Serotonin Agents|serotonin agents|mesh-ancestor
110826913|NCT01161667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110826914|NCT01161667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110826915|NCT01161667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110826916|NCT02526979|Mirabegron|mirabegron|mesh-list
110826917|NCT02526979|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
110826918|NCT02526979|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110826919|NCT02526979|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110826920|NCT02526979|Adrenergic Agents|adrenergic agents|mesh-ancestor
110826921|NCT02526979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110826922|NCT02526979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110826923|NCT02526979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110826924|NCT02526979|Urological Agents|urological agents|mesh-ancestor
110826925|NCT03882541|Midazolam|midazolam|mesh-list
110826926|NCT03882541|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110826927|NCT03882541|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110826928|NCT03882541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110826929|NCT03882541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110826930|NCT03882541|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110826931|NCT03882541|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110826932|NCT03882541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110826933|NCT03882541|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110826934|NCT03882541|Anesthetics, General|anesthetics, general|mesh-ancestor
110826936|NCT03882541|GABA Modulators|gaba modulators|mesh-ancestor
110826937|NCT03882541|GABA Agents|gaba agents|mesh-ancestor
110826938|NCT03882541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110826939|NCT03882541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110826940|NCT01267903|Vaccines|vaccines|mesh-list
110826941|NCT01267903|Immunologic Factors|immunologic factors|mesh-ancestor
110826942|NCT01267903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110826943|NCT03576313|Ivermectin|ivermectin|mesh-list
110826944|NCT03576313|Piperaquine|piperaquine|mesh-list
110826945|NCT03576313|Artenimol|artenimol|mesh-list
110826946|NCT03576313|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110826947|NCT03576313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110826948|NCT03576313|Antimalarials|antimalarials|mesh-ancestor
110826949|NCT03576313|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110826950|NCT01161979|Zonisamide|zonisamide|mesh-list
110826951|NCT01161979|Anticonvulsants|anticonvulsants|mesh-ancestor
110826952|NCT01161979|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110826953|NCT01161979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110826954|NCT01161979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110826955|NCT01161979|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110826956|NCT01161979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110826957|NCT01160731|Etoposide|etoposide|mesh-list
110826958|NCT01160731|Panobinostat|panobinostat|mesh-list
110826959|NCT01160731|Etoposide phosphate|etoposide phosphate|mesh-list
110826960|NCT01160731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110826961|NCT01160731|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110826962|NCT01160731|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110826963|NCT01160731|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110826964|NCT01160731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110826965|NCT01160731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110826966|NCT01160731|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110826967|NCT01160965|Ropivacaine|ropivacaine|mesh-list
110826968|NCT01160965|Levobupivacaine|levobupivacaine|mesh-list
110826969|NCT01160965|Anesthetics, Local|anesthetics, local|mesh-ancestor
110826970|NCT01160965|Anesthetics|anesthetics|mesh-ancestor
110826971|NCT01160965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110826972|NCT01160965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110826973|NCT01160965|Sensory System Agents|sensory system agents|mesh-ancestor
110826974|NCT01160965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110826975|NCT01156909|Rituximab|rituximab|mesh-list
110826976|NCT01156909|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110826977|NCT01156909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110826978|NCT01156909|Immunologic Factors|immunologic factors|mesh-ancestor
110826979|NCT01156909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110826980|NCT01156909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110826981|NCT01162603|Latanoprost|latanoprost|mesh-list
110826982|NCT01162603|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110826983|NCT01162603|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110826984|NCT03881995|Insulin Glargine|insulin glargine|mesh-list
110826985|NCT03881995|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110826986|NCT03881995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110826987|NCT02527213|Sodium thiosulfate|sodium thiosulfate|mesh-list
110826988|NCT02527213|Antidotes|antidotes|mesh-ancestor
110826989|NCT02527213|Protective Agents|protective agents|mesh-ancestor
110826990|NCT02527213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110826991|NCT02527213|Antioxidants|antioxidants|mesh-ancestor
110826992|NCT02527213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110826993|NCT02527213|Antitubercular Agents|antitubercular agents|mesh-ancestor
110826994|NCT02527213|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110826995|NCT02527213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110826996|NCT02527213|Chelating Agents|chelating agents|mesh-ancestor
110826997|NCT02527213|Sequestering Agents|sequestering agents|mesh-ancestor
110826998|NCT01161277|Haloperidol|haloperidol|mesh-list
110826999|NCT01161277|Aripiprazole|aripiprazole|mesh-list
110544532|NCT02650388|Chrysarobin|chrysarobin|mesh-list
110827000|NCT01161277|Haloperidol decanoate|haloperidol decanoate|mesh-list
110827001|NCT01161277|Antidepressive Agents|antidepressive agents|mesh-ancestor
110827002|NCT01161277|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110827003|NCT01161277|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110827004|NCT01161277|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110827005|NCT01161277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110483148|NCT01014767|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110827006|NCT01161277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110827007|NCT01161277|Dopamine Agonists|dopamine agonists|mesh-ancestor
110827008|NCT01161277|Dopamine Agents|dopamine agents|mesh-ancestor
110827009|NCT01161277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110483447|NCT02537925|Nedaplatin|nedaplatin|mesh-list
110422674|NCT01040403|Olodaterol|olodaterol|mesh-list
110827010|NCT01161277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110483670|NCT02572375|Appetite Depressants|appetite depressants|mesh-ancestor
110827011|NCT01161277|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110827012|NCT01161277|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110483973|NCT00714181|Hydroxychloroquine|hydroxychloroquine|mesh-list
110827013|NCT01161277|Serotonin Agents|serotonin agents|mesh-ancestor
110827014|NCT01161277|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110827015|NCT01161277|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110827016|NCT01161277|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110484266|NCT00718471|Heparin|heparin|mesh-list
110827017|NCT01161277|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110827019|NCT01161277|Autonomic Agents|autonomic agents|mesh-ancestor
110484416|NCT02683863|Dimethyl Fumarate|dimethyl fumarate|mesh-list
110827020|NCT01161277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110827021|NCT01161277|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110484561|NCT00577993|Doxorubicin|doxorubicin|mesh-list
110827022|NCT01161277|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110827024|NCT01268215|Calfactant|calfactant|mesh-list
110827025|NCT01268215|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110827026|NCT01268215|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110827027|NCT01268215|Autonomic Agents|autonomic agents|mesh-ancestor
110484862|NCT00726505|Dapagliflozin|dapagliflozin|mesh-list
110827028|NCT01268215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110827029|NCT01268215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110827030|NCT01268215|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110827031|NCT01268215|Respiratory System Agents|respiratory system agents|mesh-ancestor
110827032|NCT01268215|Glucocorticoids|glucocorticoids|mesh-ancestor
110827033|NCT01268215|Hormones|hormones|mesh-ancestor
110827034|NCT01268215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110827035|NCT01268215|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
110827036|NCT01269307|Ketamine|ketamine|mesh-list
110827037|NCT01269307|Propofol|propofol|mesh-list
110827038|NCT01269307|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110827039|NCT01269307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110422779|NCT02537314|Benzocaine|benzocaine|mesh-list
110827040|NCT01269307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110827042|NCT01269307|Anesthetics, General|anesthetics, general|mesh-ancestor
110827043|NCT01269307|Anesthetics|anesthetics|mesh-ancestor
110827044|NCT01269307|Analgesics|analgesics|mesh-ancestor
110827045|NCT01269307|Sensory System Agents|sensory system agents|mesh-ancestor
110827046|NCT01269307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110827047|NCT01269307|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110827048|NCT01269307|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110485286|NCT00727987|Antimetabolites|antimetabolites|mesh-ancestor
110827049|NCT01269307|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110827050|NCT01269307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110485362|NCT00734695|Antioxidants|antioxidants|mesh-ancestor
110485514|NCT00641979|Glucocorticoids|glucocorticoids|mesh-ancestor
110827051|NCT01269307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110827052|NCT03874585|Nicotine|nicotine|mesh-list
110827053|NCT03874585|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110827054|NCT03874585|Autonomic Agents|autonomic agents|mesh-ancestor
110827055|NCT03874585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110827056|NCT03874585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110827057|NCT03874585|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110827058|NCT03874585|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110827059|NCT03874585|Cholinergic Agents|cholinergic agents|mesh-ancestor
110827060|NCT03874585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110827061|NCT03874585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110827063|NCT01268371|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110827064|NCT01268371|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110827065|NCT01268371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110827066|NCT01268371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110827067|NCT01268371|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110485883|NCT00738595|Nicotine|nicotine|mesh-list
110827068|NCT01268371|Immunologic Factors|immunologic factors|mesh-ancestor
110827069|NCT01268371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110827070|NCT01268371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110827071|NCT01267669|Somatostatin|somatostatin|mesh-list
110827073|NCT01267669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110827074|NCT01267669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110827075|NCT05666869|Esketamine|esketamine|mesh-list
110827076|NCT05666869|Antidepressive Agents|antidepressive agents|mesh-ancestor
110544608|NCT00649688|Metoprolol|metoprolol|mesh-list
110827077|NCT05666869|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110827078|NCT01164943|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
110827079|NCT01164943|Hormones|hormones|mesh-ancestor
110827080|NCT01164943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110827081|NCT01164943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110827082|NCT01269541|Rifampin|rifampin|mesh-list
110827083|NCT01269541|Mupirocin|mupirocin|mesh-list
110827084|NCT01269541|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110827085|NCT01269541|Antitubercular Agents|antitubercular agents|mesh-ancestor
110827086|NCT01269541|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110827087|NCT01269541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110827088|NCT01269541|Leprostatic Agents|leprostatic agents|mesh-ancestor
110422955|NCT04081831|Aspirin|aspirin|mesh-list
110827089|NCT01269541|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110827090|NCT01269541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110827091|NCT01269541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110827092|NCT01269541|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110827093|NCT01269541|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110827094|NCT01269541|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110827095|NCT01269541|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110827096|NCT01269541|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110827097|NCT01269541|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110827098|NCT01269541|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110827099|NCT03877003|Choline|choline|mesh-list
110827100|NCT03877003|Lipotropic Agents|lipotropic agents|mesh-ancestor
110827101|NCT03877003|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110827102|NCT03877003|Antimetabolites|antimetabolites|mesh-ancestor
110486278|NCT05560009|Cariostatic Agents|cariostatic agents|mesh-ancestor
110827103|NCT03877003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110827104|NCT03877003|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110827105|NCT03877003|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110827106|NCT03877003|Nootropic Agents|nootropic agents|mesh-ancestor
110827107|NCT01280149|Substance P|substance p|mesh-list
110827108|NCT01280149|Neurokinin A|neurokinin a|mesh-list
110827109|NCT01280149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110827110|NCT01280149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110486728|NCT00650247|Sumatriptan|sumatriptan|mesh-list
110827111|NCT01280149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110827112|NCT01165255|Bupropion|bupropion|mesh-list
110827113|NCT01165255|Antidepressive Agents|antidepressive agents|mesh-list
110827114|NCT01165255|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110827115|NCT01165255|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110827116|NCT01165255|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110487016|NCT00709111|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110827117|NCT01165255|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110827118|NCT01165255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110487238|NCT04288700|Propranolol|propranolol|mesh-list
110827119|NCT01165255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110827120|NCT01165255|Dopamine Agents|dopamine agents|mesh-ancestor
110827121|NCT01165255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110827122|NCT01165255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110487535|NCT02861378|Phentolamine|phentolamine|mesh-list
110827123|NCT01165255|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110827124|NCT01165255|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110827125|NCT01165255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110827126|NCT01167049|Capecitabine|capecitabine|mesh-list
110827127|NCT01167049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110487833|NCT05972512|Biotin|biotin|mesh-list
110827129|NCT01167049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110827130|NCT01167049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110827131|NCT01311414|Urapidil|urapidil|mesh-list
110827132|NCT01311414|Cafedrine|cafedrine|mesh-list
110827133|NCT01311414|Theodrenaline|theodrenaline|mesh-list
110827134|NCT01311414|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110827135|NCT01311414|Vasodilator Agents|vasodilator agents|mesh-ancestor
110827136|NCT01311414|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110827137|NCT01311414|Serotonin Agents|serotonin agents|mesh-ancestor
110488272|NCT05050136|Volixibat|volixibat|mesh-list
110488348|NCT04733534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110488423|NCT04494425|Paclitaxel|paclitaxel|mesh-list
110488498|NCT04145258|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110488574|NCT03767348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110488650|NCT03505762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110827138|NCT01311414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110423077|NCT02806375|Busulfan|busulfan|mesh-list
110488721|NCT03358472|Antimetabolites|antimetabolites|mesh-ancestor
110827139|NCT01311414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110488795|NCT03017820|Ipilimumab|ipilimumab|mesh-list
110827140|NCT01311414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110488869|NCT02723955|Paclitaxel|paclitaxel|mesh-list
110827141|NCT01311414|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110489022|NCT00878254|Alkylating Agents|alkylating agents|mesh-ancestor
110827142|NCT01311414|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110827143|NCT01311414|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110489170|NCT04281290|Bleomycin|bleomycin|mesh-list
110827144|NCT01311414|Adrenergic Agents|adrenergic agents|mesh-ancestor
110827145|NCT03715296|Lenalidomide|lenalidomide|mesh-list
110855631|NCT01308983|Amiloride|amiloride|mesh-list
110827146|NCT03715296|Immunologic Factors|immunologic factors|mesh-ancestor
110827147|NCT03715296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110544683|NCT02631252|Etoposide|etoposide|mesh-list
110827149|NCT03715296|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110827150|NCT03715296|Growth Substances|growth substances|mesh-ancestor
110489762|NCT04284098|Dexmedetomidine|dexmedetomidine|mesh-list
110827152|NCT03715296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110827153|NCT01347762|Nabilone|nabilone|mesh-list
110827154|NCT01347762|Antiemetics|antiemetics|mesh-ancestor
110827155|NCT01347762|Autonomic Agents|autonomic agents|mesh-ancestor
110827156|NCT01347762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110489999|NCT00630500|Memantine|memantine|mesh-list
110490053|NCT02858804|Growth Inhibitors|growth inhibitors|mesh-ancestor
110490127|NCT00743587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110827157|NCT01347762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110827158|NCT01347762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110490220|NCT02856854|GABA Agents|gaba agents|mesh-ancestor
110827159|NCT01347762|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110827160|NCT01347762|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110827161|NCT01347762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110490426|NCT00744679|Natalizumab|natalizumab|mesh-list
110827162|NCT01347762|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110827163|NCT03874273|Crizotinib|crizotinib|mesh-list
110827164|NCT03874273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110827165|NCT03874273|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110827166|NCT03874273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110490716|NCT00694369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110490790|NCT00954512|Vitamin B Complex|vitamin b complex|mesh-ancestor
110827167|NCT03874273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110827168|NCT05657652|Cytarabine|cytarabine|mesh-list
110827169|NCT05657652|Venetoclax|venetoclax|mesh-list
110827170|NCT05657652|Cladribine|cladribine|mesh-list
110491089|NCT00586066|Memantine|memantine|mesh-list
110827171|NCT05657652|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110491225|NCT02561923|Coagulants|coagulants|mesh-ancestor
110827172|NCT05657652|Antimetabolites|antimetabolites|mesh-ancestor
110827173|NCT05657652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110827174|NCT05657652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110491387|NCT00727246|Choline|choline|mesh-list
110827175|NCT05657652|Antiviral Agents|antiviral agents|mesh-ancestor
110827176|NCT05657652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110827178|NCT05657652|Immunologic Factors|immunologic factors|mesh-ancestor
110827179|NCT05657652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110827180|NCT01167127|Oxycodone|oxycodone|mesh-list
110827181|NCT01167127|Naloxone|naloxone|mesh-list
110827182|NCT01167127|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110827183|NCT01167127|Narcotics|narcotics|mesh-ancestor
110827184|NCT01167127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110827185|NCT01167127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110827186|NCT01167127|Analgesics|analgesics|mesh-ancestor
110827187|NCT01167127|Sensory System Agents|sensory system agents|mesh-ancestor
110491918|NCT00752479|Hormones|hormones|mesh-ancestor
110827188|NCT01167127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110492096|NCT00753103|Hormones|hormones|mesh-ancestor
110827189|NCT01167127|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110492244|NCT00725842|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110827190|NCT01280305|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
110492319|NCT00757393|Vitamins|vitamins|mesh-list
110827191|NCT01280305|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110827192|NCT01280305|Hormone Antagonists|hormone antagonists|mesh-ancestor
110492544|NCT00716092|Protease Inhibitors|protease inhibitors|mesh-ancestor
110827193|NCT01280305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110827194|NCT01280305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110492767|NCT00713830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110492842|NCT05190094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110492911|NCT05683912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110492912|NCT00679939|Metformin|metformin|mesh-list
110492913|NCT00679939|Rosiglitazone|rosiglitazone|mesh-list
110492914|NCT00679939|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110492915|NCT00679939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110492916|NCT04082260|Alemtuzumab|alemtuzumab|mesh-list
110492919|NCT02587390|Simvastatin|simvastatin|mesh-list
110827195|NCT01280305|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110827196|NCT01280305|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110827197|NCT01280305|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110827198|NCT03872011|Vitamins|vitamins|mesh-list
110827199|NCT03872011|Ascorbic Acid|ascorbic acid|mesh-list
110827201|NCT03872011|Hydrocortisone|hydrocortisone|mesh-list
110493065|NCT00759421|Olanzapine|olanzapine|mesh-list
110493136|NCT00678379|Analgesics|analgesics|mesh-ancestor
110827203|NCT03872011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110827204|NCT03872011|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110827205|NCT03872011|Antioxidants|antioxidants|mesh-ancestor
110827206|NCT03872011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110827207|NCT03872011|Protective Agents|protective agents|mesh-ancestor
110827208|NCT03872011|Vitamin B Complex|vitamin b complex|mesh-ancestor
110827209|NCT03438396|Tisotumab vedotin|tisotumab vedotin|mesh-list
110493499|NCT04079140|Oxytocics|oxytocics|mesh-ancestor
110827210|NCT03438396|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110493575|NCT05380778|Anesthetics|anesthetics|mesh-list
110493648|NCT05856383|Vinorelbine|vinorelbine|mesh-list
110827211|NCT03438396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110493800|NCT05614115|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110827213|NCT03876067|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110494016|NCT04881682|Immunoglobulins|immunoglobulins|mesh-list
110827214|NCT01163929|Paclitaxel|paclitaxel|mesh-list
110827215|NCT01163929|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110827216|NCT01163929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110827217|NCT01163929|Tubulin Modulators|tubulin modulators|mesh-ancestor
110827218|NCT01163929|Antimitotic Agents|antimitotic agents|mesh-ancestor
110494388|NCT03107988|Topotecan|topotecan|mesh-list
110827219|NCT01163929|Mitosis Modulators|mitosis modulators|mesh-ancestor
110494461|NCT02600117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110827220|NCT01163929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110827221|NCT03871777|Chlorhexidine|chlorhexidine|mesh-list
110827222|NCT03871777|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110827223|NCT03871777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110827224|NCT03871777|Disinfectants|disinfectants|mesh-ancestor
110827225|NCT00073307|Sorafenib|sorafenib|mesh-list
110827226|NCT00073307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110827227|NCT00073307|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110827228|NCT00073307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110494901|NCT00770497|Protease Inhibitors|protease inhibitors|mesh-ancestor
110827229|NCT00073307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110827231|NCT01270789|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110827232|NCT01270789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110827234|NCT01270789|Hormones|hormones|mesh-ancestor
110827235|NCT01270789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110827236|NCT01164085|Ketorolac|ketorolac|mesh-list
110495343|NCT00767689|Vitamin B Complex|vitamin b complex|mesh-ancestor
110827237|NCT01164085|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110827238|NCT01164085|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110827239|NCT01164085|Analgesics|analgesics|mesh-ancestor
110495662|NCT00671437|Cetuximab|cetuximab|mesh-list
110827240|NCT01164085|Sensory System Agents|sensory system agents|mesh-ancestor
110827241|NCT01164085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110827242|NCT01164085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110827243|NCT01164085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110827244|NCT01164085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110827245|NCT01164085|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110496166|NCT00665431|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110827247|NCT01164085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110496285|NCT00780637|Bradykinin|bradykinin|mesh-list
110827249|NCT01271179|Allopurinol|allopurinol|mesh-list
110827250|NCT01271179|Adenosine|adenosine|mesh-list
110827251|NCT01271179|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110827253|NCT01271179|Sensory System Agents|sensory system agents|mesh-ancestor
110827254|NCT01271179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110827255|NCT01271179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110827256|NCT01271179|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110827257|NCT01271179|Vasodilator Agents|vasodilator agents|mesh-ancestor
110827258|NCT01271179|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
110827259|NCT01271179|Purinergic Agonists|purinergic agonists|mesh-ancestor
110827260|NCT01271179|Purinergic Agents|purinergic agents|mesh-ancestor
110827261|NCT01271179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110827262|NCT01271179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110827263|NCT01271179|Antimetabolites|antimetabolites|mesh-ancestor
110827264|NCT01271179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110827265|NCT01271179|Gout Suppressants|gout suppressants|mesh-ancestor
110827266|NCT01271179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110827267|NCT01271179|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110827268|NCT01271179|Antioxidants|antioxidants|mesh-ancestor
110827269|NCT01271179|Protective Agents|protective agents|mesh-ancestor
110496822|NCT00791713|Dopamine Agents|dopamine agents|mesh-ancestor
110827270|NCT01271179|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110496967|NCT02870231|Liraglutide|liraglutide|mesh-list
110827272|NCT03388164|Citalopram|citalopram|mesh-list
110827273|NCT03388164|Escitalopram|escitalopram|mesh-list
110827274|NCT03388164|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110827275|NCT03388164|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110827276|NCT03388164|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110827277|NCT03388164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110497341|NCT00929708|AZD-3199|azd-3199|mesh-list
110827278|NCT03388164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110827279|NCT03388164|Serotonin Agents|serotonin agents|mesh-ancestor
110827280|NCT03388164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110827281|NCT03388164|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110827282|NCT03388164|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110827283|NCT03388164|Parasympatholytics|parasympatholytics|mesh-ancestor
110827285|NCT03388164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110827286|NCT03388164|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110827287|NCT03388164|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110827288|NCT03388164|Cholinergic Agents|cholinergic agents|mesh-ancestor
110827289|NCT03388164|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110827290|NCT03388164|Antidepressive Agents|antidepressive agents|mesh-ancestor
110827291|NCT03388164|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110827292|NCT01268761|Cetrorelix|cetrorelix|mesh-list
110827293|NCT01268761|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110498076|NCT04046029|Heparin|heparin|mesh-list
110827294|NCT01268761|Fertility Agents|fertility agents|mesh-ancestor
110498217|NCT00685191|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110827295|NCT01268761|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110827296|NCT01268761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110827297|NCT01268761|Hormone Antagonists|hormone antagonists|mesh-ancestor
110498365|NCT00794443|Diphosphonates|diphosphonates|mesh-list
110827298|NCT01268761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110827301|NCT01268839|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110827302|NCT01268839|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110827303|NCT01268839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110498744|NCT04136535|Carboplatin|carboplatin|mesh-list
110827304|NCT01268839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110827305|NCT01268839|Antiviral Agents|antiviral agents|mesh-ancestor
110827306|NCT01268839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110499040|NCT05745142|Sunitinib|sunitinib|mesh-list
110827307|NCT01268839|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110827308|NCT01268839|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110827309|NCT01268839|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110827310|NCT01268839|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110827311|NCT01268839|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110827312|NCT01268839|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110827313|NCT01268839|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110827314|NCT01268839|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110827315|NCT03403374|Evolocumab|evolocumab|mesh-list
110827316|NCT03403374|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
110827317|NCT03403374|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110827318|NCT03403374|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110827319|NCT03403374|Antimetabolites|antimetabolites|mesh-ancestor
110827320|NCT03403374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110827321|NCT03403374|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110827322|NCT03403374|Protease Inhibitors|protease inhibitors|mesh-ancestor
110499336|NCT04902885|Etoposide|etoposide|mesh-list
110827323|NCT03403374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110146795|NCT00006126|Busulfan|busulfan|mesh-list
110827324|NCT03403374|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110827326|NCT01165567|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110827327|NCT01165567|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110827328|NCT01165567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110827329|NCT01165567|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110827330|NCT01165567|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110827331|NCT01165567|Serotonin Agents|serotonin agents|mesh-ancestor
110827332|NCT01165567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110827333|NCT01165567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110827336|NCT03387462|Antiviral Agents|antiviral agents|mesh-ancestor
110499996|NCT02622243|Glycopyrrolate|glycopyrrolate|mesh-list
110827337|NCT03387462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110827338|NCT03387462|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110500064|NCT00975689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110500140|NCT00696969|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110500286|NCT02619201|Serotonin Agents|serotonin agents|mesh-ancestor
110500361|NCT04133961|Sympathomimetics|sympathomimetics|mesh-ancestor
110500505|NCT04251962|Fentanyl|fentanyl|mesh-list
110827339|NCT03387462|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110827341|NCT03387462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110827342|NCT03387462|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110827343|NCT03387462|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110827344|NCT03756883|Fluticasone|fluticasone|mesh-list
110827345|NCT03756883|Xhance|xhance|mesh-list
110827346|NCT03756883|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110827347|NCT03756883|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
110827348|NCT03756883|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110827349|NCT03756883|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110827350|NCT03756883|Autonomic Agents|autonomic agents|mesh-ancestor
110827351|NCT03756883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110827352|NCT03756883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110827353|NCT03756883|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110827354|NCT03756883|Respiratory System Agents|respiratory system agents|mesh-ancestor
110827355|NCT03756883|Dermatologic Agents|dermatologic agents|mesh-ancestor
110827356|NCT03756883|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110827357|NCT03756883|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110827358|NCT03756883|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110827359|NCT03756883|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110827360|NCT03756883|Adrenergic Agents|adrenergic agents|mesh-ancestor
110827361|NCT03756883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110827362|NCT03756883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110827363|NCT03756883|Glucocorticoids|glucocorticoids|mesh-ancestor
110827364|NCT03756883|Hormones|hormones|mesh-ancestor
110827365|NCT03756883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110827366|NCT03756883|Sympathomimetics|sympathomimetics|mesh-ancestor
110827367|NCT01586611|Leucovorin|leucovorin|mesh-list
110827368|NCT01586611|Gemcitabine|gemcitabine|mesh-list
110827369|NCT01586611|Oxaliplatin|oxaliplatin|mesh-list
110827370|NCT01586611|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110501006|NCT00858117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110501078|NCT00592683|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110501153|NCT00846495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110827372|NCT01586611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110827373|NCT01586611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110544911|NCT00580606|Glycerol|glycerol|mesh-list
110827374|NCT01586611|Antidotes|antidotes|mesh-ancestor
110827375|NCT01586611|Protective Agents|protective agents|mesh-ancestor
110827376|NCT01586611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110501456|NCT00913107|Antimanic Agents|antimanic agents|mesh-ancestor
110501529|NCT00815269|Desflurane|desflurane|mesh-list
110827377|NCT01586611|Vitamin B Complex|vitamin b complex|mesh-ancestor
110827378|NCT01586611|Vitamins|vitamins|mesh-ancestor
110827379|NCT01586611|Micronutrients|micronutrients|mesh-ancestor
110827380|NCT03386448|Scopolamine|scopolamine|mesh-list
110827381|NCT03386448|Naltrexone|naltrexone|mesh-list
110501819|NCT00811837|Midazolam|midazolam|mesh-list
110827382|NCT03386448|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
110501899|NCT04203368|Adenosine|adenosine|mesh-list
110827383|NCT03386448|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110827384|NCT03386448|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110827385|NCT03386448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110827386|NCT03386448|Sensory System Agents|sensory system agents|mesh-ancestor
110827387|NCT03386448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110827388|NCT03386448|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110827390|NCT03386448|Autonomic Agents|autonomic agents|mesh-ancestor
110827391|NCT03386448|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110827392|NCT03386448|Mydriatics|mydriatics|mesh-ancestor
110423804|NCT02781805|Alendronate|alendronate|mesh-list
110827393|NCT03386448|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110827395|NCT03386448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110827396|NCT03386448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110827397|NCT03386448|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110827398|NCT03386448|Parasympatholytics|parasympatholytics|mesh-ancestor
110827399|NCT01280929|Ranibizumab|ranibizumab|mesh-list
110502271|NCT00643201|Enoxaparin|enoxaparin|mesh-list
110827400|NCT01280929|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110827401|NCT01280929|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110827402|NCT01280929|Growth Substances|growth substances|mesh-ancestor
110827403|NCT01280929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110423863|NCT00638131|Bosentan|bosentan|mesh-list
110827404|NCT01280929|Growth Inhibitors|growth inhibitors|mesh-ancestor
110827405|NCT01280929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110827406|NCT01268917|Aspirin|aspirin|mesh-list
110827407|NCT01268917|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110827408|NCT01268917|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110827409|NCT01268917|Analgesics|analgesics|mesh-ancestor
110827410|NCT01268917|Sensory System Agents|sensory system agents|mesh-ancestor
110827411|NCT01268917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110502471|NCT00817375|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110827412|NCT01268917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110827413|NCT01268917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110502534|NCT00627445|Metformin|metformin|mesh-list
110827414|NCT01268917|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110827415|NCT01268917|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110827416|NCT01268917|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110827417|NCT01268917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110827418|NCT01268917|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110827419|NCT01268917|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110827420|NCT01268917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110827422|NCT01281163|Lapatinib|lapatinib|mesh-list
110827423|NCT01281163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110827424|NCT01281163|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110827425|NCT01281163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110827426|NCT01281163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110827427|NCT01268995|Cyclosporine|cyclosporine|mesh-list
110827428|NCT01268995|Tacrolimus|tacrolimus|mesh-list
110827429|NCT01268995|Cyclosporins|cyclosporins|mesh-list
110827430|NCT01268995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110502813|NCT00568399|Sequestering Agents|sequestering agents|mesh-ancestor
110827432|NCT01268995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110502891|NCT00967499|Antipruritics|antipruritics|mesh-ancestor
110827433|NCT01268995|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110503034|NCT02861261|Autonomic Agents|autonomic agents|mesh-ancestor
110503257|NCT02548975|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110827435|NCT01268995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110827436|NCT01268995|Antifungal Agents|antifungal agents|mesh-ancestor
110827437|NCT01268995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110827438|NCT01268995|Dermatologic Agents|dermatologic agents|mesh-ancestor
110827439|NCT01268995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110827440|NCT00009737|Leucovorin|leucovorin|mesh-list
110827441|NCT00009737|Fluorouracil|fluorouracil|mesh-list
110827442|NCT00009737|Capecitabine|capecitabine|mesh-list
110503406|NCT00825019|Paroxetine|paroxetine|mesh-list
110503483|NCT05337332|Triamcinolone|triamcinolone|mesh-list
110827443|NCT00009737|Antimetabolites|antimetabolites|mesh-ancestor
110827444|NCT00009737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110827445|NCT00009737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110827446|NCT00009737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110827447|NCT00009737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110503931|NCT02837640|Levodopa|levodopa|mesh-list
110827448|NCT00009737|Immunologic Factors|immunologic factors|mesh-ancestor
110504078|NCT05878262|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110504079|NCT05878262|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110504080|NCT05878262|Analgesics|analgesics|mesh-ancestor
110504081|NCT05878262|Sensory System Agents|sensory system agents|mesh-ancestor
110504082|NCT05878262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110504083|NCT05878262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110504084|NCT05878262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110504085|NCT05878262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110544980|NCT02762123|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110504156|NCT05877781|Hormones|hormones|mesh-ancestor
110827449|NCT00009737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110827451|NCT00009737|Protective Agents|protective agents|mesh-ancestor
110827452|NCT00009737|Vitamin B Complex|vitamin b complex|mesh-ancestor
110827453|NCT00009737|Vitamins|vitamins|mesh-ancestor
110827454|NCT00009737|Micronutrients|micronutrients|mesh-ancestor
110827455|NCT03711240|Leucovorin|leucovorin|mesh-list
110827456|NCT03711240|Bevacizumab|bevacizumab|mesh-list
110827457|NCT03711240|Oxaliplatin|oxaliplatin|mesh-list
110827458|NCT03711240|Irinotecan|irinotecan|mesh-list
110827459|NCT03711240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110827460|NCT03711240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110827461|NCT03711240|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110827462|NCT03711240|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110827463|NCT03711240|Growth Substances|growth substances|mesh-ancestor
110827464|NCT03711240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110827465|NCT03711240|Growth Inhibitors|growth inhibitors|mesh-ancestor
110504227|NCT05737121|Anticoagulants|anticoagulants|mesh-ancestor
110827466|NCT03711240|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110827467|NCT03711240|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110827468|NCT03711240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110504357|NCT05364008|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
110504501|NCT04669457|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110504502|NCT04669457|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110504583|NCT04324463|Antipyretics|antipyretics|mesh-ancestor
110827469|NCT03711240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110827470|NCT03711240|Antidotes|antidotes|mesh-ancestor
110827471|NCT03711240|Protective Agents|protective agents|mesh-ancestor
110504734|NCT03621748|Anesthetics|anesthetics|mesh-list
110827472|NCT03711240|Vitamin B Complex|vitamin b complex|mesh-ancestor
110827473|NCT03711240|Vitamins|vitamins|mesh-ancestor
110827474|NCT03711240|Micronutrients|micronutrients|mesh-ancestor
110827475|NCT01271881|Heparin|heparin|mesh-list
110827476|NCT01271881|Anticoagulants|anticoagulants|mesh-ancestor
110827477|NCT01271881|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110504945|NCT01264315|Lenalidomide|lenalidomide|mesh-list
110827478|NCT01271881|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110505094|NCT00633438|Celecoxib|celecoxib|mesh-list
110827479|NCT01271881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110827481|NCT05459844|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
110827482|NCT05459844|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110827483|NCT05459844|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110505388|NCT00832377|Timolol|timolol|mesh-list
110505458|NCT02841488|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110827484|NCT05459844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110827485|NCT05459844|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110827486|NCT05459844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110827488|NCT03874975|Vitamins|vitamins|mesh-ancestor
110827489|NCT03874975|Micronutrients|micronutrients|mesh-ancestor
110505751|NCT02840708|Immunologic Factors|immunologic factors|mesh-ancestor
110827490|NCT03874975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110505817|NCT03223220|Midazolam|midazolam|mesh-list
110827491|NCT03874975|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110827492|NCT01164709|Nelfinavir|nelfinavir|mesh-list
110827493|NCT01164709|Bortezomib|bortezomib|mesh-list
110506034|NCT05018520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110827494|NCT01164709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110506107|NCT04243434|Glucocorticoids|glucocorticoids|mesh-ancestor
110424209|NCT02773459|Capecitabine|capecitabine|mesh-list
110827495|NCT01164709|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110827496|NCT01164709|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110827497|NCT01164709|Protease Inhibitors|protease inhibitors|mesh-ancestor
110827498|NCT01164709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110506327|NCT00573859|Adrenergic Agents|adrenergic agents|mesh-ancestor
110506404|NCT05660694|Vasodilator Agents|vasodilator agents|mesh-ancestor
110827499|NCT01164709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110827500|NCT01164709|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110827501|NCT01164709|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110827502|NCT01164709|Antiviral Agents|antiviral agents|mesh-ancestor
110827503|NCT01164709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110827504|NCT03960671|Midazolam|midazolam|mesh-list
110827505|NCT03960671|Diazepam|diazepam|mesh-list
110507020|NCT00634140|Ezetimibe|ezetimibe|mesh-list
110827506|NCT03960671|Propofol|propofol|mesh-list
110507145|NCT03365609|Antacids|antacids|mesh-ancestor
110507218|NCT02545777|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110855716|NCT02482324|Ibuprofen|ibuprofen|mesh-list
110827507|NCT03960671|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110507296|NCT02544919|SMOFlipid|smoflipid|mesh-list
110507380|NCT00837187|Analgesics|analgesics|mesh-ancestor
110827508|NCT03960671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110507528|NCT02811978|Bortezomib|bortezomib|mesh-list
110827509|NCT03960671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110507587|NCT04041349|Mitogens|mitogens|mesh-list
110827510|NCT03960671|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110827511|NCT03960671|Anesthetics, General|anesthetics, general|mesh-ancestor
110827512|NCT03960671|Anesthetics|anesthetics|mesh-ancestor
110507727|NCT00961961|Antidepressive Agents|antidepressive agents|mesh-ancestor
110827513|NCT03960671|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110507806|NCT02545153|Coagulants|coagulants|mesh-ancestor
110827514|NCT03960671|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110507955|NCT02806752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110507956|NCT02806752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110507957|NCT02806752|Immunologic Factors|immunologic factors|mesh-ancestor
110507958|NCT02806752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110507959|NCT02806752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110507960|NCT00854425|Asparaginase|asparaginase|mesh-list
110507961|NCT00854425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110507962|NCT02544529|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
110507963|NCT02544529|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110507964|NCT02544529|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110507965|NCT02544529|Echothiophate Iodide|echothiophate iodide|mesh-list
110507966|NCT02544529|Laxatives|laxatives|mesh-ancestor
110507967|NCT02544529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110507974|NCT02544529|Miotics|miotics|mesh-ancestor
110827515|NCT03960671|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110827516|NCT03960671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110155387|NCT00016978|Leucovorin|leucovorin|mesh-list
110827517|NCT03960671|GABA Modulators|gaba modulators|mesh-ancestor
110827518|NCT03960671|GABA Agents|gaba agents|mesh-ancestor
110827519|NCT03960671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110827520|NCT03960671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110827522|NCT03960671|Antiemetics|antiemetics|mesh-ancestor
110827523|NCT03960671|Autonomic Agents|autonomic agents|mesh-ancestor
110827524|NCT03960671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110827525|NCT03960671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110827526|NCT03960671|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110827527|NCT03960671|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110508321|NCT05978206|Nandrolone|nandrolone|mesh-list
110508393|NCT05977868|Tigecycline|tigecycline|mesh-list
110827528|NCT01281553|Cisapride|cisapride|mesh-list
110508538|NCT05838521|Immunoconjugates|immunoconjugates|mesh-ancestor
110508539|NCT05838521|Immunologic Factors|immunologic factors|mesh-ancestor
110508540|NCT05838521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110508626|NCT05602636|GABA Modulators|gaba modulators|mesh-ancestor
110827529|NCT01281553|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110827530|NCT01281553|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110827531|NCT01281553|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110827532|NCT01281553|Serotonin Agents|serotonin agents|mesh-ancestor
110827533|NCT01281553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110827534|NCT01281553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110508783|NCT05168657|Pancrelipase|pancrelipase|mesh-list
110508851|NCT04954664|Antiemetics|antiemetics|mesh-ancestor
110508852|NCT04954664|Autonomic Agents|autonomic agents|mesh-ancestor
110508853|NCT04954664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110156210|NCT04526119|Z 338|z 338|mesh-list
110508854|NCT04954664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110508855|NCT04954664|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110508856|NCT04954664|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110508857|NCT04954664|Histamine Antagonists|histamine antagonists|mesh-ancestor
110508864|NCT04900792|Vitamins|vitamins|mesh-ancestor
110827537|NCT01164787|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110827538|NCT01164787|Protease Inhibitors|protease inhibitors|mesh-ancestor
110827539|NCT01164787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110827540|NCT01164787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110827541|NCT01164787|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110827542|NCT01269151|Ranibizumab|ranibizumab|mesh-list
110827543|NCT01269151|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110827544|NCT01269151|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110424426|NCT04224103|Antioxidants|antioxidants|mesh-ancestor
110827545|NCT01269151|Growth Substances|growth substances|mesh-ancestor
110827546|NCT01269151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110827547|NCT01269151|Growth Inhibitors|growth inhibitors|mesh-ancestor
110827548|NCT01269151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110827549|NCT00028769|Paclitaxel|paclitaxel|mesh-list
110827550|NCT00028769|Etoposide|etoposide|mesh-list
110827552|NCT00028769|Goserelin|goserelin|mesh-list
110827553|NCT00028769|Bicalutamide|bicalutamide|mesh-list
110827554|NCT00028769|Flutamide|flutamide|mesh-list
110827555|NCT00028769|Estramustine|estramustine|mesh-list
110509214|NCT03492437|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110509215|NCT03492437|Protease Inhibitors|protease inhibitors|mesh-ancestor
110509216|NCT03492437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110509218|NCT03492437|Anticoagulants|anticoagulants|mesh-ancestor
110827557|NCT00028769|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110509360|NCT02102113|Dronabinol|dronabinol|mesh-list
110509435|NCT01771107|Brentuximab Vedotin|brentuximab vedotin|mesh-list
110827558|NCT00028769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110827559|NCT00028769|Tubulin Modulators|tubulin modulators|mesh-ancestor
110827560|NCT00028769|Antimitotic Agents|antimitotic agents|mesh-ancestor
110509596|NCT05757063|Anesthetics|anesthetics|mesh-ancestor
110827561|NCT00028769|Mitosis Modulators|mitosis modulators|mesh-ancestor
110509659|NCT00812955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110827562|NCT00028769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110827563|NCT00028769|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110509879|NCT00955721|Antimetabolites|antimetabolites|mesh-ancestor
110827564|NCT00028769|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110827565|NCT00028769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110827566|NCT00028769|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110827567|NCT00028769|Fertility Agents|fertility agents|mesh-ancestor
110827568|NCT00028769|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110827569|NCT00028769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110827570|NCT00028769|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110510396|NCT00864799|Misoprostol|misoprostol|mesh-list
110827571|NCT00028769|Androgen Antagonists|androgen antagonists|mesh-ancestor
110827572|NCT00028769|Hormone Antagonists|hormone antagonists|mesh-ancestor
110510542|NCT00872209|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110827573|NCT00028769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110827574|NCT00028769|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110510618|NCT00870883|Expectorants|expectorants|mesh-ancestor
110827575|NCT00028769|Alkylating Agents|alkylating agents|mesh-ancestor
110827576|NCT01281787|Losartan|losartan|mesh-list
110827578|NCT01281787|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110827579|NCT01281787|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110827580|NCT01281787|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110510983|NCT00873925|Vitamin D|vitamin d|mesh-list
110511059|NCT00874003|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
110511060|NCT00874003|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110827581|NCT01281787|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110827582|NCT01281787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110511208|NCT04038853|Vitamin D|vitamin d|mesh-list
110827584|NCT01281787|Autonomic Agents|autonomic agents|mesh-ancestor
110827585|NCT01281787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110827586|NCT01281787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110511429|NCT02785068|Leucovorin|leucovorin|mesh-list
110511508|NCT05275686|Autonomic Agents|autonomic agents|mesh-ancestor
110827587|NCT01281787|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110827588|NCT01281787|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110827589|NCT01281787|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110511818|NCT05339802|Linezolid|linezolid|mesh-list
110827590|NCT01281787|Adrenergic Agents|adrenergic agents|mesh-ancestor
110511972|NCT00879385|Decitabine|decitabine|mesh-list
110827591|NCT01281787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110512101|NCT04227990|Docetaxel|docetaxel|mesh-list
110827592|NCT02953314|Ivacaftor|ivacaftor|mesh-list
110827593|NCT02953314|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
110827594|NCT02953314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110512323|NCT02778906|Abatacept|abatacept|mesh-list
110512471|NCT02836028|Talazoparib|talazoparib|mesh-list
110512507|NCT04225728|Iron|iron|mesh-list
110827595|NCT02953314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110827596|NCT00007475|Cyclophosphamide|cyclophosphamide|mesh-list
110827597|NCT00007475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110512623|NCT00635076|Alprazolam|alprazolam|mesh-list
110827598|NCT00007475|Immunologic Factors|immunologic factors|mesh-ancestor
110827599|NCT00007475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110512844|NCT00946985|Serotonin Agents|serotonin agents|mesh-ancestor
110827600|NCT00007475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110827601|NCT00007475|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110827602|NCT00007475|Alkylating Agents|alkylating agents|mesh-ancestor
110827603|NCT00007475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110827604|NCT00007475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110827605|NCT00007475|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110827607|NCT03714360|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110827608|NCT03714360|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110827609|NCT03714360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110827610|NCT03714360|Hemostatics|hemostatics|mesh-ancestor
110827611|NCT03714360|Coagulants|coagulants|mesh-ancestor
110827612|NCT01169857|Bortezomib|bortezomib|mesh-list
110827613|NCT01169857|Proteasome Inhibitors|proteasome inhibitors|mesh-list
110513447|NCT00893269|Zolpidem|zolpidem|mesh-list
110827614|NCT01169857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110513503|NCT02768688|Analgesics|analgesics|mesh-ancestor
110827615|NCT01169857|Protease Inhibitors|protease inhibitors|mesh-ancestor
110827616|NCT01169857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110513651|NCT02768376|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110513722|NCT00607087|Insulin Aspart|insulin aspart|mesh-list
110827617|NCT01169857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110827618|NCT01169935|Dextrans|dextrans|mesh-list
110514027|NCT00894439|BLI-489|bli-489|mesh-list
110827619|NCT01169935|Anticoagulants|anticoagulants|mesh-ancestor
110827620|NCT01169935|Plasma Substitutes|plasma substitutes|mesh-ancestor
110827621|NCT01169935|Blood Substitutes|blood substitutes|mesh-ancestor
110827622|NCT01168063|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110827625|NCT01168063|Clarithromycin|clarithromycin|mesh-list
110827626|NCT01168063|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
110514617|NCT04221672|Terlipressin|terlipressin|mesh-list
110827627|NCT01168063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110424632|NCT00951496|Paclitaxel|paclitaxel|mesh-list
110827628|NCT01168063|Antitubercular Agents|antitubercular agents|mesh-ancestor
110827629|NCT01168063|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110827630|NCT01168063|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110514845|NCT02540395|Hormones|hormones|mesh-ancestor
110827631|NCT01168063|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110514928|NCT00905905|Ezetimibe|ezetimibe|mesh-list
110827632|NCT01168063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110515058|NCT00906139|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110827633|NCT01168063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110827634|NCT01168063|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110827635|NCT01168063|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110827636|NCT01166035|Lenalidomide|lenalidomide|mesh-list
110827637|NCT01166035|Cetuximab|cetuximab|mesh-list
110827638|NCT01166035|Immunologic Factors|immunologic factors|mesh-ancestor
110515419|NCT05381207|Respiratory System Agents|respiratory system agents|mesh-ancestor
110515420|NCT05381207|Dermatologic Agents|dermatologic agents|mesh-ancestor
110827639|NCT01166035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110515568|NCT02824406|Acetazolamide|acetazolamide|mesh-list
110515634|NCT00899821|Aldesleukin|aldesleukin|mesh-list
110827640|NCT01166035|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110827641|NCT01166035|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110827642|NCT01166035|Growth Substances|growth substances|mesh-ancestor
110827643|NCT01166035|Growth Inhibitors|growth inhibitors|mesh-ancestor
110827644|NCT01166035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110515930|NCT02825186|Antiemetics|antiemetics|mesh-ancestor
110827645|NCT01166035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110827646|NCT01168375|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110516093|NCT02749656|Hormones|hormones|mesh-ancestor
110827649|NCT03869281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110827650|NCT01281943|Sirolimus|sirolimus|mesh-list
110827651|NCT01281943|Doxorubicin|doxorubicin|mesh-list
110516381|NCT04240496|GABA Agents|gaba agents|mesh-ancestor
110827652|NCT01281943|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110827653|NCT01281943|Temsirolimus|temsirolimus|mesh-list
110827654|NCT01281943|MTOR Inhibitors|mtor inhibitors|mesh-list
110827655|NCT01281943|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110827656|NCT01281943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110827657|NCT01281943|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110827658|NCT01281943|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110827660|NCT01281943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110827661|NCT01281943|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110827662|NCT01281943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110517052|NCT00931957|Glucocorticoids|glucocorticoids|mesh-ancestor
110517193|NCT04306692|Vitamins|vitamins|mesh-ancestor
110827664|NCT01281943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110827665|NCT01281943|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110827666|NCT01281943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110827667|NCT01281943|Antifungal Agents|antifungal agents|mesh-ancestor
110827668|NCT03869047|Dexmedetomidine|dexmedetomidine|mesh-list
110517635|NCT05654298|Sumatriptan|sumatriptan|mesh-list
110827670|NCT03869047|Anesthetics, Local|anesthetics, local|mesh-ancestor
110517781|NCT05247268|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
110827671|NCT03869047|Anesthetics|anesthetics|mesh-ancestor
110827672|NCT03869047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110827673|NCT03869047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110518157|NCT03988933|Rifampin|rifampin|mesh-list
110827674|NCT03869047|Sensory System Agents|sensory system agents|mesh-ancestor
110827675|NCT03869047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110827676|NCT03869047|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110827677|NCT03869047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110545205|NCT00129922|Cyclophosphamide|cyclophosphamide|mesh-list
110827678|NCT03869047|Analgesics|analgesics|mesh-ancestor
110827679|NCT03869047|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110827680|NCT03869047|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110827681|NCT03869047|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110827682|NCT03869047|Adrenergic Agents|adrenergic agents|mesh-ancestor
110827683|NCT03869047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110827684|NCT03869047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110827685|NCT01168531|Dexamethasone|dexamethasone|mesh-list
110827686|NCT01168531|Pregabalin|pregabalin|mesh-list
110827687|NCT01168531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110827688|NCT01168531|Antiemetics|antiemetics|mesh-ancestor
110827689|NCT01168531|Autonomic Agents|autonomic agents|mesh-ancestor
110518225|NCT03644667|Antiemetics|antiemetics|mesh-ancestor
110827690|NCT01168531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110518361|NCT02617589|Alkylating Agents|alkylating agents|mesh-ancestor
110827691|NCT01168531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110827692|NCT01168531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110827693|NCT01168531|Glucocorticoids|glucocorticoids|mesh-ancestor
110827694|NCT01168531|Hormones|hormones|mesh-ancestor
110827695|NCT01168531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110827696|NCT01168531|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110827697|NCT01168531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110827698|NCT01168531|Analgesics|analgesics|mesh-ancestor
110827699|NCT01168531|Sensory System Agents|sensory system agents|mesh-ancestor
110827700|NCT01168531|Anticonvulsants|anticonvulsants|mesh-ancestor
110827701|NCT01168531|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110827702|NCT01168531|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110827703|NCT01168531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110519087|NCT00936793|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110519169|NCT00937183|Vaccines|vaccines|mesh-list
110519232|NCT05905913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110827704|NCT01168531|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110827705|NCT01168531|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110827706|NCT01168531|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110519393|NCT05825924|Nicotine|nicotine|mesh-list
110827707|NCT01168531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110827708|NCT01168531|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110827709|NCT01170169|Omeprazole|omeprazole|mesh-list
110827710|NCT01170169|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110827711|NCT01170169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110827712|NCT01170169|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110827713|NCT01170169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110519761|NCT04462523|Glucocorticoids|glucocorticoids|mesh-ancestor
110519836|NCT04352205|Growth Substances|growth substances|mesh-ancestor
110519837|NCT04352205|Growth Inhibitors|growth inhibitors|mesh-ancestor
110827714|NCT01170169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110827716|NCT01587313|Isosorbide|isosorbide|mesh-list
110827717|NCT01587313|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
110827718|NCT01587313|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
110827719|NCT01587313|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110827720|NCT01587313|Diuretics|diuretics|mesh-ancestor
110827721|NCT01587313|Natriuretic Agents|natriuretic agents|mesh-ancestor
110827722|NCT01587313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110827723|NCT01587313|Vasodilator Agents|vasodilator agents|mesh-ancestor
110827724|NCT01587313|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
110827725|NCT01587313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110827726|NCT01587313|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110519980|NCT04007276|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110827727|NCT01282333|Gemcitabine|gemcitabine|mesh-list
110827729|NCT01282333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110827730|NCT01282333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110827731|NCT01282333|Antimetabolites|antimetabolites|mesh-ancestor
110827732|NCT01282333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110424868|NCT02757079|Melatonin|melatonin|mesh-list
110827733|NCT01282333|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110827734|NCT01282333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110827735|NCT01166425|Lithium Carbonate|lithium carbonate|mesh-list
110827736|NCT01166425|Antidepressive Agents|antidepressive agents|mesh-ancestor
110520055|NCT03728556|Antibodies|antibodies|mesh-list
110827737|NCT01166425|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110827738|NCT01166425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110827739|NCT01166425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110827740|NCT01166425|Antimanic Agents|antimanic agents|mesh-ancestor
110827741|NCT01166425|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110827742|NCT01166425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110827743|NCT01166425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110827744|NCT03868969|Fosfomycin|fosfomycin|mesh-list
110827745|NCT03868969|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110827746|NCT03868969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110827747|NCT01311570|Buprenorphine|buprenorphine|mesh-list
110827748|NCT01311570|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110827749|NCT01311570|Narcotics|narcotics|mesh-ancestor
110827750|NCT01311570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110424927|NCT04268602|Anesthetics|anesthetics|mesh-list
110827751|NCT01311570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110827752|NCT01311570|Analgesics|analgesics|mesh-ancestor
110827753|NCT01311570|Sensory System Agents|sensory system agents|mesh-ancestor
110520487|NCT01164228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110827754|NCT01311570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110520641|NCT00028990|Paclitaxel|paclitaxel|mesh-list
110827758|NCT01170325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110827759|NCT01170325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110827760|NCT01170325|GABA Agents|gaba agents|mesh-ancestor
110827761|NCT01170325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110827762|NCT01170325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110827763|NCT01170325|Antimanic Agents|antimanic agents|mesh-ancestor
110827764|NCT01170325|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110827765|NCT01170325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110827766|NCT01170325|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110827768|NCT05542446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110827769|NCT05542446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110521449|NCT03978091|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110521450|NCT03978091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110827771|NCT03355326|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
110827772|NCT03355326|Protective Agents|protective agents|mesh-ancestor
110521523|NCT00931385|Respiratory System Agents|respiratory system agents|mesh-ancestor
110827773|NCT03355326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110827774|NCT01170637|Ibuprofen|ibuprofen|mesh-list
110827775|NCT01170637|Pseudoephedrine|pseudoephedrine|mesh-list
110827776|NCT01170637|Ephedrine|ephedrine|mesh-list
110827777|NCT01170637|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110827778|NCT01170637|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110827779|NCT01170637|Analgesics|analgesics|mesh-ancestor
110827780|NCT01170637|Sensory System Agents|sensory system agents|mesh-ancestor
110827781|NCT01170637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110521814|NCT05415644|Metformin|metformin|mesh-list
110827782|NCT01170637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110827783|NCT01170637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110827784|NCT01170637|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110827785|NCT01170637|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110827786|NCT01170637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110827787|NCT01170637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110522342|NCT04256525|Aspirin|aspirin|mesh-list
110827789|NCT01170637|Autonomic Agents|autonomic agents|mesh-ancestor
110827790|NCT01170637|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110827791|NCT01170637|Respiratory System Agents|respiratory system agents|mesh-ancestor
110827792|NCT01170637|Nasal Decongestants|nasal decongestants|mesh-ancestor
110827793|NCT01170637|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110827794|NCT01170637|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110827796|NCT01170637|Adrenergic Agents|adrenergic agents|mesh-ancestor
110827797|NCT01170637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110827798|NCT03873025|Pembrolizumab|pembrolizumab|mesh-list
110522707|NCT06004687|Mannitol|mannitol|mesh-list
110827799|NCT03873025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110827800|NCT03873025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110827801|NCT03873025|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110522997|NCT05773950|Fosaprepitant|fosaprepitant|mesh-list
110523148|NCT05529290|Antipyretics|antipyretics|mesh-ancestor
110827802|NCT03873025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110827803|NCT02526745|Vaccines|vaccines|mesh-list
110827804|NCT02526745|Immunologic Factors|immunologic factors|mesh-ancestor
110827805|NCT02526745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110827806|NCT01169389|Bupivacaine|bupivacaine|mesh-list
110827807|NCT01169389|Anesthetics, Local|anesthetics, local|mesh-ancestor
110827808|NCT01169389|Anesthetics|anesthetics|mesh-ancestor
110827809|NCT01169389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110523293|NCT05193071|Purinergic Agents|purinergic agents|mesh-ancestor
110827810|NCT01169389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110523367|NCT05042505|Incretins|incretins|mesh-ancestor
110827811|NCT01169389|Sensory System Agents|sensory system agents|mesh-ancestor
110827812|NCT01169389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110827813|NCT01170871|Pemetrexed|pemetrexed|mesh-list
110827814|NCT01170871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110827815|NCT01170871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110827816|NCT01170871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110827817|NCT01170871|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110827818|NCT01170871|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110827819|NCT03868111|Sufentanil|sufentanil|mesh-list
110827820|NCT03868111|Remifentanil|remifentanil|mesh-list
110827821|NCT03868111|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110827822|NCT03868111|Narcotics|narcotics|mesh-ancestor
110827823|NCT03868111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110827824|NCT03868111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110827825|NCT03868111|Analgesics|analgesics|mesh-ancestor
110827826|NCT03868111|Sensory System Agents|sensory system agents|mesh-ancestor
110855853|NCT01320917|Levonorgestrel|levonorgestrel|mesh-list
110523582|NCT04158713|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110523583|NCT04158713|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110425312|NCT01189500|Tamoxifen|tamoxifen|mesh-list
110523584|NCT04158713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110523585|NCT04149210|Fluorometholone|fluorometholone|mesh-list
110523586|NCT04149210|Lubricant Eye Drops|lubricant eye drops|mesh-list
110523587|NCT04149210|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110523588|NCT04149210|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110523589|NCT04149210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110523590|NCT04149210|Glucocorticoids|glucocorticoids|mesh-ancestor
110523592|NCT04149210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110523593|NCT04149210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110523594|NCT04149210|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110171062|NCT00043537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110523622|NCT04076059|Androgens|androgens|mesh-list
110523623|NCT04076059|Hormones|hormones|mesh-ancestor
110523624|NCT04076059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110523625|NCT04076059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110523626|NCT04047836|Nicotine|nicotine|mesh-list
110523627|NCT04047836|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110523628|NCT04047836|Autonomic Agents|autonomic agents|mesh-ancestor
110523629|NCT04047836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110523630|NCT04047836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110523631|NCT04047836|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110523632|NCT04047836|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110523633|NCT04047836|Cholinergic Agents|cholinergic agents|mesh-ancestor
110523634|NCT04047836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110523649|NCT03962465|Cytarabine|cytarabine|mesh-list
110827827|NCT03868111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110545384|NCT02657096|Hybenx|hybenx|mesh-list
110827828|NCT03868111|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110827829|NCT03868111|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110827830|NCT03868111|Anesthetics, General|anesthetics, general|mesh-ancestor
110827832|NCT01282879|Itraconazole|itraconazole|mesh-list
110827833|NCT01282879|Antifungal Agents|antifungal agents|mesh-ancestor
110827834|NCT01282879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110827835|NCT01282879|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110827836|NCT01282879|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110827837|NCT01282879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110827838|NCT01282879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110827839|NCT01282879|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110827840|NCT01282879|Hormone Antagonists|hormone antagonists|mesh-ancestor
110855882|NCT05713396|Losartan|losartan|mesh-list
110827841|NCT01282879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110827842|NCT01282879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110827843|NCT01282879|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110827844|NCT03868033|Zoledronic Acid|zoledronic acid|mesh-list
110827845|NCT03868033|Denosumab|denosumab|mesh-list
110827846|NCT03868033|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110827847|NCT03868033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110827848|NCT01166815|Zinc Sulfate|zinc sulfate|mesh-list
110827849|NCT01166815|Astringents|astringents|mesh-ancestor
110827850|NCT01166815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110827851|NCT01166815|Dermatologic Agents|dermatologic agents|mesh-ancestor
110827852|NCT03751657|Insulin|insulin|mesh-list
110827853|NCT03751657|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110827854|NCT03751657|Metformin|metformin|mesh-list
110827855|NCT03751657|Insulin Glargine|insulin glargine|mesh-list
110827856|NCT03751657|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
110827857|NCT03751657|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110523961|NCT02827877|Trace Elements|trace elements|mesh-ancestor
110827858|NCT03751657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110171689|NCT00046267|Niacin|niacin|mesh-list
110827859|NCT03751657|Protease Inhibitors|protease inhibitors|mesh-ancestor
110827860|NCT03751657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110524336|NCT05370326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110524482|NCT02785250|Immunologic Factors|immunologic factors|mesh-ancestor
110524638|NCT02783378|Antacids|antacids|mesh-ancestor
110827861|NCT03751657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110827862|NCT03873415|Deucravacitinib|deucravacitinib|mesh-list
110524715|NCT02722746|Epinephrine|epinephrine|mesh-list
110827863|NCT03873415|Dermatologic Agents|dermatologic agents|mesh-ancestor
110827864|NCT03873415|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110827865|NCT03873415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110524849|NCT02600247|Acetaminophen|acetaminophen|mesh-list
110827866|NCT03873415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110827867|NCT00025259|Cytarabine|cytarabine|mesh-list
110827868|NCT00025259|Dexamethasone|dexamethasone|mesh-list
110827869|NCT00025259|Prednisone|prednisone|mesh-list
110827870|NCT00025259|Dexamethasone acetate|dexamethasone acetate|mesh-list
110827871|NCT00025259|Cortisone|cortisone|mesh-list
110827872|NCT00025259|Cyclophosphamide|cyclophosphamide|mesh-list
110827874|NCT00025259|Doxorubicin|doxorubicin|mesh-list
110827875|NCT00025259|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110827877|NCT00025259|Vincristine|vincristine|mesh-list
110827878|NCT00025259|Etoposide phosphate|etoposide phosphate|mesh-list
110827879|NCT00025259|Bleomycin|bleomycin|mesh-list
110827880|NCT00025259|Podophyllotoxin|podophyllotoxin|mesh-list
110827881|NCT00025259|Lenograstim|lenograstim|mesh-list
110827882|NCT00025259|BB 1101|bb 1101|mesh-list
110827883|NCT00025259|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110827885|NCT00025259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110827886|NCT00025259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110525733|NCT02710656|Paclitaxel|paclitaxel|mesh-list
110827887|NCT00025259|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110827888|NCT00025259|Alkylating Agents|alkylating agents|mesh-ancestor
110525878|NCT00921557|Calcium|calcium|mesh-list
110525879|NCT00921557|Vitamins|vitamins|mesh-ancestor
110827889|NCT00025259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110827890|NCT00025259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110827891|NCT00025259|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110526402|NCT00637871|Hormone Antagonists|hormone antagonists|mesh-ancestor
110827892|NCT00025259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110827893|NCT00025259|Antiemetics|antiemetics|mesh-ancestor
110827894|NCT00025259|Autonomic Agents|autonomic agents|mesh-ancestor
110827895|NCT00025259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110526699|NCT02770716|Terlipressin|terlipressin|mesh-list
110827896|NCT00025259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110827897|NCT00025259|Glucocorticoids|glucocorticoids|mesh-ancestor
110526990|NCT02769494|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110827899|NCT00025259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110827900|NCT00025259|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110827901|NCT00025259|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110827902|NCT00025259|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110527287|NCT02760992|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110827903|NCT00025259|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110827904|NCT00025259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110827905|NCT00025259|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110827906|NCT00025259|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110827907|NCT00025259|Antimetabolites|antimetabolites|mesh-ancestor
110827908|NCT00025259|Antiviral Agents|antiviral agents|mesh-ancestor
110827909|NCT00025259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110827910|NCT00025259|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110827911|NCT00025259|Tubulin Modulators|tubulin modulators|mesh-ancestor
110827912|NCT00025259|Antimitotic Agents|antimitotic agents|mesh-ancestor
110827913|NCT00025259|Mitosis Modulators|mitosis modulators|mesh-ancestor
110827914|NCT00025259|Protease Inhibitors|protease inhibitors|mesh-ancestor
110827915|NCT00025259|Keratolytic Agents|keratolytic agents|mesh-ancestor
110527373|NCT00647907|Voriconazole|voriconazole|mesh-list
110827916|NCT00025259|Dermatologic Agents|dermatologic agents|mesh-ancestor
110827917|NCT01171651|Sorafenib|sorafenib|mesh-list
110827918|NCT01171651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110827919|NCT01171651|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110827920|NCT01171651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110827921|NCT01171651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110827922|NCT03866629|Lifitegrast|lifitegrast|mesh-list
110827923|NCT03866629|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110827924|NCT03866629|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110827925|NCT01280071|Aminophylline|aminophylline|mesh-list
110527595|NCT00649233|Metoprolol|metoprolol|mesh-list
110827926|NCT01280071|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110827927|NCT01280071|Autonomic Agents|autonomic agents|mesh-ancestor
110827928|NCT01280071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110528072|NCT02751632|Serotonin Agents|serotonin agents|mesh-ancestor
110827929|NCT01280071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110528148|NCT02705274|Bevacizumab|bevacizumab|mesh-list
110827930|NCT01280071|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110827931|NCT01280071|Respiratory System Agents|respiratory system agents|mesh-ancestor
110827932|NCT01280071|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110827933|NCT01280071|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110827934|NCT01280071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110528293|NCT02701608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110827935|NCT01280071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110827936|NCT01280071|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110528439|NCT05428670|Immunologic Factors|immunologic factors|mesh-ancestor
110827937|NCT01280071|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110827938|NCT01280071|Purinergic Agents|purinergic agents|mesh-ancestor
110528584|NCT00617370|Paclitaxel|paclitaxel|mesh-list
110827939|NCT01280071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110528733|NCT00616746|Ethanol|ethanol|mesh-list
110827940|NCT01280071|Protective Agents|protective agents|mesh-ancestor
110827941|NCT02526199|Dexamethasone|dexamethasone|mesh-list
110827943|NCT02526199|Bupivacaine|bupivacaine|mesh-list
110827944|NCT02526199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110827945|NCT02526199|Antiemetics|antiemetics|mesh-ancestor
110827946|NCT02526199|Autonomic Agents|autonomic agents|mesh-ancestor
110827947|NCT02526199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110827948|NCT02526199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110827949|NCT02526199|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110827950|NCT02526199|Glucocorticoids|glucocorticoids|mesh-ancestor
110827951|NCT02526199|Hormones|hormones|mesh-ancestor
110529248|NCT00908375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110529323|NCT03695510|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110827952|NCT02526199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110529471|NCT02728700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110529546|NCT02737670|Anticoagulants|anticoagulants|mesh-ancestor
110827953|NCT02526199|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110827954|NCT02526199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110827955|NCT02526199|Anesthetics, Local|anesthetics, local|mesh-ancestor
110827956|NCT02526199|Anesthetics|anesthetics|mesh-ancestor
110827957|NCT02526199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110827958|NCT02526199|Sensory System Agents|sensory system agents|mesh-ancestor
110827959|NCT02526199|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110827960|NCT02526199|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110827961|NCT02526199|Adrenergic Agents|adrenergic agents|mesh-ancestor
110529841|NCT03015974|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110827962|NCT02526199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110827963|NCT02526199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110827964|NCT02526199|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110827965|NCT02526199|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110827966|NCT02526199|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110827967|NCT02526199|Respiratory System Agents|respiratory system agents|mesh-ancestor
110827968|NCT02526199|Mydriatics|mydriatics|mesh-ancestor
110827969|NCT02526199|Sympathomimetics|sympathomimetics|mesh-ancestor
110425789|NCT02760823|Vitamins|vitamins|mesh-ancestor
110529989|NCT02716766|Capecitabine|capecitabine|mesh-list
110827970|NCT02526199|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110827971|NCT01284049|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
110827972|NCT01284049|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
110827973|NCT01284049|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
110827974|NCT01284049|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110827976|NCT03863977|Dexamethasone acetate|dexamethasone acetate|mesh-list
110827977|NCT03863977|Bupivacaine|bupivacaine|mesh-list
110827978|NCT03863977|BB 1101|bb 1101|mesh-list
110827979|NCT03863977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110827980|NCT03863977|Antiemetics|antiemetics|mesh-ancestor
110827981|NCT03863977|Autonomic Agents|autonomic agents|mesh-ancestor
110827982|NCT03863977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110545504|NCT00649844|Ziprasidone|ziprasidone|mesh-list
110827983|NCT03863977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110827984|NCT03863977|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110827985|NCT03863977|Glucocorticoids|glucocorticoids|mesh-ancestor
110530867|NCT02706860|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110827987|NCT03863977|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110827988|NCT03863977|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110827989|NCT03863977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110827990|NCT03863977|Protease Inhibitors|protease inhibitors|mesh-ancestor
110827991|NCT03863977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110827992|NCT03863977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110827993|NCT03863977|Anesthetics, Local|anesthetics, local|mesh-ancestor
110827994|NCT03863977|Anesthetics|anesthetics|mesh-ancestor
110531373|NCT02632071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110827995|NCT03863977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110827996|NCT03863977|Sensory System Agents|sensory system agents|mesh-ancestor
110827997|NCT01171807|Dexamethasone|dexamethasone|mesh-list
110827998|NCT01171807|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
110531819|NCT03930446|Ethanol|ethanol|mesh-list
110827999|NCT01171807|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110828000|NCT01171807|Antiemetics|antiemetics|mesh-ancestor
110828001|NCT01171807|Autonomic Agents|autonomic agents|mesh-ancestor
110425906|NCT02753647|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110828002|NCT01171807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110828003|NCT01171807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110828004|NCT01171807|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110828005|NCT01171807|Glucocorticoids|glucocorticoids|mesh-ancestor
110828006|NCT01171807|Hormones|hormones|mesh-ancestor
110532038|NCT02703272|Tubulin Modulators|tubulin modulators|mesh-ancestor
110828007|NCT01171807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110828008|NCT01171807|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110828009|NCT01171807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110828010|NCT05445648|Tislelizumab|tislelizumab|mesh-list
110828011|NCT05445648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110532488|NCT02705378|Naloxegol|naloxegol|mesh-list
110532553|NCT03170882|Dexamethasone|dexamethasone|mesh-list
110828012|NCT05445648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110828013|NCT01171885|Ropivacaine|ropivacaine|mesh-list
110828015|NCT01171885|Anesthetics|anesthetics|mesh-ancestor
110828016|NCT01171885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110828017|NCT01171885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110828018|NCT01171885|Sensory System Agents|sensory system agents|mesh-ancestor
110532846|NCT00620646|Autonomic Agents|autonomic agents|mesh-ancestor
110532924|NCT04019015|Thrombin|thrombin|mesh-list
110533072|NCT00618228|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110828019|NCT01171885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110828020|NCT01286233|Metformin|metformin|mesh-list
110828021|NCT01286233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110828022|NCT01286233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110828023|NCT01175161|Copper|copper|mesh-list
110828024|NCT01175161|Trace Elements|trace elements|mesh-ancestor
110828025|NCT01175161|Micronutrients|micronutrients|mesh-ancestor
110828026|NCT01175161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110828028|NCT01172041|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110828029|NCT01172041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110828030|NCT01284205|BCG Vaccine|bcg vaccine|mesh-list
110828031|NCT01284205|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110828032|NCT01284205|Immunologic Factors|immunologic factors|mesh-ancestor
110828033|NCT01284205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110828034|NCT00024167|Ketoconazole|ketoconazole|mesh-list
110828035|NCT00024167|Dexamethasone|dexamethasone|mesh-list
110828036|NCT00024167|Prednisone|prednisone|mesh-list
110828037|NCT00024167|Estramustine|estramustine|mesh-list
110828038|NCT00024167|Docetaxel|docetaxel|mesh-list
110828039|NCT00024167|Doxorubicin|doxorubicin|mesh-list
110828040|NCT00024167|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110828041|NCT00024167|Vinblastine|vinblastine|mesh-list
110828042|NCT00024167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110828043|NCT00024167|Antiemetics|antiemetics|mesh-ancestor
110828044|NCT00024167|Autonomic Agents|autonomic agents|mesh-ancestor
110828045|NCT00024167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110533654|NCT00616382|Antioxidants|antioxidants|mesh-ancestor
110828046|NCT00024167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110828047|NCT00024167|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110828048|NCT00024167|Glucocorticoids|glucocorticoids|mesh-ancestor
110828050|NCT00024167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110533958|NCT02685306|Paclitaxel|paclitaxel|mesh-list
110828051|NCT00024167|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110828052|NCT00024167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110828053|NCT00024167|Tubulin Modulators|tubulin modulators|mesh-ancestor
110828054|NCT00024167|Antimitotic Agents|antimitotic agents|mesh-ancestor
110426026|NCT04288713|Eculizumab|eculizumab|mesh-list
110828055|NCT00024167|Mitosis Modulators|mitosis modulators|mesh-ancestor
110534316|NCT02679456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110534389|NCT02681796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110828056|NCT00024167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110828057|NCT00024167|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110828058|NCT00024167|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110828059|NCT00024167|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110828060|NCT00024167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110828061|NCT00024167|Antifungal Agents|antifungal agents|mesh-ancestor
110426058|NCT02750137|Tetracaine|tetracaine|mesh-list
110828062|NCT00024167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110828063|NCT00024167|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110828064|NCT00024167|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110828065|NCT00024167|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110828066|NCT00024167|Hormone Antagonists|hormone antagonists|mesh-ancestor
110828067|NCT00024167|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110828068|NCT00024167|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110828069|NCT00024167|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110828070|NCT00024167|Alkylating Agents|alkylating agents|mesh-ancestor
110828071|NCT03867097|Iloprost|iloprost|mesh-list
110828072|NCT03867097|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110828073|NCT03867097|Vasodilator Agents|vasodilator agents|mesh-ancestor
110828074|NCT00022763|Enfuvirtide|enfuvirtide|mesh-list
110426134|NCT02749747|Sulpiride|sulpiride|mesh-list
110828075|NCT00022763|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110828076|NCT00022763|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110828077|NCT00022763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110828079|NCT00022763|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110828080|NCT00022763|Antiviral Agents|antiviral agents|mesh-ancestor
110828081|NCT00022763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110828082|NCT01285141|polysaccharide-K|polysaccharide-k|mesh-list
110828083|NCT01285141|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110534670|NCT02672358|Trametinib|trametinib|mesh-list
110828085|NCT01285141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110828086|NCT01285141|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110828087|NCT01285141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110828088|NCT01285141|Antiviral Agents|antiviral agents|mesh-ancestor
110828089|NCT01285141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110828090|NCT01285141|Interferon Inducers|interferon inducers|mesh-ancestor
110828091|NCT01285141|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110828092|NCT01285141|Protective Agents|protective agents|mesh-ancestor
110828093|NCT01285219|Lenograstim|lenograstim|mesh-list
110828094|NCT01285219|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110828095|NCT01285219|Immunologic Factors|immunologic factors|mesh-ancestor
110828096|NCT01285219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110828097|NCT01284439|Hyaluronic Acid|hyaluronic acid|mesh-list
110828098|NCT01284439|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110828099|NCT01284439|Immunologic Factors|immunologic factors|mesh-ancestor
110828100|NCT01284439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110828101|NCT01284439|Viscosupplements|viscosupplements|mesh-ancestor
110828102|NCT01284439|Protective Agents|protective agents|mesh-ancestor
110535015|NCT00646932|Micronutrients|micronutrients|mesh-ancestor
110828103|NCT01172431|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110828104|NCT01172431|Indapamide|indapamide|mesh-list
110828105|NCT01172431|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110828106|NCT01172431|Diuretics|diuretics|mesh-ancestor
110828107|NCT01172431|Natriuretic Agents|natriuretic agents|mesh-ancestor
110828108|NCT01172431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110535612|NCT02840591|Nootropic Agents|nootropic agents|mesh-ancestor
110828109|NCT01172431|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110828110|NCT01172431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110426235|NCT01015833|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110828111|NCT01172431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110828113|NCT01172509|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110536056|NCT02648490|Sensory System Agents|sensory system agents|mesh-ancestor
110828114|NCT01172509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110828115|NCT01172509|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110536229|NCT00650598|Diclofenac|diclofenac|mesh-list
110536276|NCT04247633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110828116|NCT01172509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110828117|NCT01172509|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
110828118|NCT01172509|GABA Agonists|gaba agonists|mesh-ancestor
110828119|NCT01172509|GABA Agents|gaba agents|mesh-ancestor
110828120|NCT01172509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110536719|NCT00651066|Protease Inhibitors|protease inhibitors|mesh-ancestor
110828121|NCT01172509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110828122|NCT01089959|Esomeprazole|esomeprazole|mesh-list
110828123|NCT01089959|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110536935|NCT00910806|Nevirapine|nevirapine|mesh-list
110828124|NCT01089959|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110828125|NCT01089959|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110828126|NCT01089959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110828127|NCT01089959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110828128|NCT01090037|Epoprostenol|epoprostenol|mesh-list
110828129|NCT01090037|Beraprost|beraprost|mesh-list
110537226|NCT04243109|Antiemetics|antiemetics|mesh-ancestor
110537300|NCT02652312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110537374|NCT00650364|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110828130|NCT01090037|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110828131|NCT01090037|Vasodilator Agents|vasodilator agents|mesh-ancestor
110537668|NCT00654576|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110828132|NCT01090037|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110828133|NCT01285375|Curcumin|curcumin|mesh-list
110545657|NCT02576626|Glycopyrrolate|glycopyrrolate|mesh-list
110537962|NCT02819999|Etoposide|etoposide|mesh-list
110828134|NCT01285375|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110677030|NCT03110978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110677031|NCT03085810|Ocrelizumab|ocrelizumab|mesh-list
110538194|NCT02683070|Tramadol|tramadol|mesh-list
110677032|NCT03085810|Immunologic Factors|immunologic factors|mesh-ancestor
110677033|NCT03085810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110677034|NCT03077451|Nelfinavir|nelfinavir|mesh-list
110677035|NCT03077451|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110538626|NCT02807909|Hormone Antagonists|hormone antagonists|mesh-ancestor
110538696|NCT02807285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110677036|NCT03077451|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110677038|NCT03077451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110538847|NCT04184492|Insulin|insulin|mesh-list
110677039|NCT03077451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110677041|NCT03077451|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110677042|NCT03077451|Antiviral Agents|antiviral agents|mesh-ancestor
110677043|NCT03077451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110677044|NCT02998268|Paclitaxel|paclitaxel|mesh-list
110677045|NCT02998268|Carboplatin|carboplatin|mesh-list
110677046|NCT02998268|Pembrolizumab|pembrolizumab|mesh-list
110677047|NCT02998268|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110539295|NCT02799797|Anesthetics|anesthetics|mesh-ancestor
110677048|NCT02998268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110677049|NCT02998268|Tubulin Modulators|tubulin modulators|mesh-ancestor
110677050|NCT02998268|Antimitotic Agents|antimitotic agents|mesh-ancestor
110677051|NCT02998268|Mitosis Modulators|mitosis modulators|mesh-ancestor
110539662|NCT04164264|Anesthetics, General|anesthetics, general|mesh-ancestor
110539742|NCT04032366|Nitric Oxide|nitric oxide|mesh-list
110539813|NCT00690417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110539888|NCT04138485|Immunoglobulins|immunoglobulins|mesh-list
110677052|NCT02998268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110677053|NCT02998268|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110677054|NCT02998268|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110677055|NCT02947685|Trastuzumab|trastuzumab|mesh-list
110677056|NCT02947685|Pertuzumab|pertuzumab|mesh-list
110677057|NCT02947685|Letrozole|letrozole|mesh-list
110677058|NCT02947685|Fulvestrant|fulvestrant|mesh-list
110677060|NCT02947685|Anastrozole|anastrozole|mesh-list
110677061|NCT02947685|Exemestane|exemestane|mesh-list
110540182|NCT00959569|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110677062|NCT02947685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110677063|NCT02947685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110540480|NCT04095494|Anesthetics|anesthetics|mesh-ancestor
110677064|NCT02947685|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110540568|NCT05238649|Vaccines|vaccines|mesh-list
110540626|NCT02791919|Antiviral Agents|antiviral agents|mesh-ancestor
110540708|NCT00659568|Metformin|metformin|mesh-list
110677065|NCT02947685|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110677066|NCT02947685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110677067|NCT02947685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110677068|NCT02947685|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110677069|NCT02947685|Hormone Antagonists|hormone antagonists|mesh-ancestor
110540991|NCT02790671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110828135|NCT01285375|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110828136|NCT01285375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110677070|NCT02947685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110677071|NCT02947685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110541289|NCT02785601|Trazodone|trazodone|mesh-list
110828137|NCT01285375|Analgesics|analgesics|mesh-ancestor
110677072|NCT02947685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110677073|NCT02947685|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110541586|NCT00974389|Tegafur|tegafur|mesh-list
110677074|NCT02947685|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110541658|NCT00692055|Analgesics|analgesics|mesh-ancestor
110677075|NCT02871882|Bile Acids and Salts|bile acids and salts|mesh-list
110677076|NCT02871882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110677078|NCT02824276|Oxycodone|oxycodone|mesh-list
110677079|NCT02824276|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110677081|NCT02824276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110541957|NCT05221151|Dermatologic Agents|dermatologic agents|mesh-ancestor
110677082|NCT02824276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110677083|NCT02824276|Analgesics|analgesics|mesh-ancestor
110677084|NCT02824276|Sensory System Agents|sensory system agents|mesh-ancestor
110542176|NCT05195645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110542255|NCT02781467|Analgesics|analgesics|mesh-ancestor
110677085|NCT02824276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110677086|NCT02813135|Cytarabine|cytarabine|mesh-list
110677088|NCT02813135|Cyclophosphamide|cyclophosphamide|mesh-list
110677089|NCT02813135|Temozolomide|temozolomide|mesh-list
110677090|NCT02813135|Carboplatin|carboplatin|mesh-list
110677091|NCT02813135|Nivolumab|nivolumab|mesh-list
110542922|NCT00867087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110542923|NCT00867087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110542924|NCT00867087|Immunologic Factors|immunologic factors|mesh-ancestor
110542925|NCT00867087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110542926|NCT00867087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110542927|NCT00867087|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110542928|NCT00867087|Immunotoxins|immunotoxins|mesh-ancestor
110542929|NCT00867087|Immunoconjugates|immunoconjugates|mesh-ancestor
110542930|NCT02778425|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
110542931|NCT02778425|Somatostatin|somatostatin|mesh-list
110542932|NCT02778425|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110542933|NCT02778425|Adrenergic Agents|adrenergic agents|mesh-ancestor
110542934|NCT02778425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110542937|NCT02778425|Hormones|hormones|mesh-ancestor
110677093|NCT02813135|Everolimus|everolimus|mesh-list
110677094|NCT02813135|Topotecan|topotecan|mesh-list
110677095|NCT02813135|Olaparib|olaparib|mesh-list
110677096|NCT02813135|Futibatinib|futibatinib|mesh-list
110677097|NCT02813135|Adavosertib|adavosertib|mesh-list
110677098|NCT02813135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110677099|NCT02813135|Immunologic Factors|immunologic factors|mesh-ancestor
110677100|NCT02813135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110543444|NCT02775773|Hemostatics|hemostatics|mesh-ancestor
110677101|NCT02813135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110677102|NCT02813135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110677103|NCT02813135|Alkylating Agents|alkylating agents|mesh-ancestor
110677104|NCT02813135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110677105|NCT02813135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110677106|NCT02813135|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110677107|NCT02813135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110677108|NCT02813135|Antiemetics|antiemetics|mesh-ancestor
110677109|NCT02813135|Autonomic Agents|autonomic agents|mesh-ancestor
110677110|NCT02813135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110677111|NCT02813135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110677112|NCT02813135|Glucocorticoids|glucocorticoids|mesh-ancestor
110677113|NCT02813135|Hormones|hormones|mesh-ancestor
110855988|NCT01560689|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110677114|NCT02813135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110677115|NCT02813135|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110677116|NCT02813135|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110677117|NCT02813135|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110543649|NCT00988663|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110677118|NCT02813135|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110677119|NCT02813135|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110543943|NCT00986713|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
110677121|NCT02813135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110677122|NCT02813135|Antimetabolites|antimetabolites|mesh-ancestor
110677123|NCT02813135|Antiviral Agents|antiviral agents|mesh-ancestor
110677124|NCT02813135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110677125|NCT02813135|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110677126|NCT02813135|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110677127|NCT02813135|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110677129|NCT02732288|Antioxidants|antioxidants|mesh-ancestor
110544609|NCT00649688|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110677130|NCT02732288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110677131|NCT02732288|Protective Agents|protective agents|mesh-ancestor
110677132|NCT02732288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110677133|NCT02732288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110677135|NCT02687958|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110677136|NCT02687958|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110677137|NCT02687958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110544904|NCT00541099|Growth Substances|growth substances|mesh-ancestor
110544976|NCT02762123|Digoxin|digoxin|mesh-list
110677138|NCT02687958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110545127|NCT02696915|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110545201|NCT02630004|Protective Agents|protective agents|mesh-ancestor
110545274|NCT00599924|Micronutrients|micronutrients|mesh-ancestor
110545349|NCT02649530|LGK974|lgk974|mesh-list
110677139|NCT02687958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110677140|NCT02687958|Immunologic Factors|immunologic factors|mesh-ancestor
110677141|NCT02687958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110677142|NCT02687958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110677143|NCT02478710|Vancomycin|vancomycin|mesh-list
110677144|NCT02478710|Tobramycin|tobramycin|mesh-list
110677145|NCT02478710|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110677146|NCT02478710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110677147|NCT02476279|Indomethacin|indomethacin|mesh-list
110677148|NCT02476279|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110545646|NCT02760095|Astringents|astringents|mesh-ancestor
110545721|NCT02653742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110677149|NCT02476279|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110677150|NCT02476279|Analgesics|analgesics|mesh-ancestor
110677152|NCT02476279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110677153|NCT02476279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110546094|NCT02653196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110426721|NCT02730481|Paclitaxel|paclitaxel|mesh-list
110677154|NCT02476279|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110546243|NCT04330690|Artesunate|artesunate|mesh-list
110677155|NCT02476279|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110677156|NCT02476279|Gout Suppressants|gout suppressants|mesh-ancestor
110677157|NCT02476279|Tocolytic Agents|tocolytic agents|mesh-ancestor
110677158|NCT02476279|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110677159|NCT02476279|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110677160|NCT02476279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110677161|NCT02476279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110677162|NCT02425865|Golimumab|golimumab|mesh-list
110677163|NCT02425865|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110677164|NCT02425865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110677165|NCT02425865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110677166|NCT02425865|Immunologic Factors|immunologic factors|mesh-ancestor
110677167|NCT02425865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110677168|NCT02425852|Prednisolone|prednisolone|mesh-list
110677169|NCT02425852|Hydrocortisone|hydrocortisone|mesh-list
110677171|NCT02425852|Azathioprine|azathioprine|mesh-list
110677172|NCT02425852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110677173|NCT02425852|Glucocorticoids|glucocorticoids|mesh-ancestor
110677174|NCT02425852|Hormones|hormones|mesh-ancestor
110677175|NCT02425852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110677176|NCT02425852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110677177|NCT02425852|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110677178|NCT02425852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110677179|NCT02425852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110677180|NCT02425852|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110677181|NCT02425852|Dermatologic Agents|dermatologic agents|mesh-ancestor
110677183|NCT02425852|Antimetabolites|antimetabolites|mesh-ancestor
110677184|NCT02425852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110677185|NCT02425852|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110426784|NCT02729935|Analgesics|analgesics|mesh-ancestor
110677186|NCT02425852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110677187|NCT02425852|Immunologic Factors|immunologic factors|mesh-ancestor
110677189|NCT02382549|Immunologic Factors|immunologic factors|mesh-ancestor
110677190|NCT02382549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110677191|NCT02333188|Leucovorin|leucovorin|mesh-list
110677192|NCT02333188|Paclitaxel|paclitaxel|mesh-list
110677193|NCT02333188|Fluorouracil|fluorouracil|mesh-list
110677194|NCT02333188|Irinotecan|irinotecan|mesh-list
110547327|NCT00683202|Analgesics|analgesics|mesh-ancestor
110677195|NCT02333188|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110677196|NCT02333188|Calcium|calcium|mesh-list
110677197|NCT02333188|Levoleucovorin|levoleucovorin|mesh-list
110677198|NCT02333188|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110547556|NCT04139928|Antacids|antacids|mesh-ancestor
110677199|NCT02333188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110677200|NCT02333188|Tubulin Modulators|tubulin modulators|mesh-ancestor
110677201|NCT02333188|Antimitotic Agents|antimitotic agents|mesh-ancestor
110677202|NCT02333188|Mitosis Modulators|mitosis modulators|mesh-ancestor
110677203|NCT02333188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110677204|NCT02333188|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110677205|NCT02333188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110677206|NCT02333188|Antimetabolites|antimetabolites|mesh-ancestor
110677207|NCT02333188|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110677208|NCT02333188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110677209|NCT02333188|Immunologic Factors|immunologic factors|mesh-ancestor
110677210|NCT02333188|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110547771|NCT00991783|Digoxin|digoxin|mesh-list
110677211|NCT02333188|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110547846|NCT02735603|Moxifloxacin|moxifloxacin|mesh-list
110677212|NCT02333188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110677213|NCT02333188|Antidotes|antidotes|mesh-ancestor
110677214|NCT02333188|Protective Agents|protective agents|mesh-ancestor
110677215|NCT02333188|Vitamin B Complex|vitamin b complex|mesh-ancestor
110677216|NCT02333188|Vitamins|vitamins|mesh-ancestor
110677217|NCT02333188|Micronutrients|micronutrients|mesh-ancestor
110677218|NCT02282358|Mocetinostat|mocetinostat|mesh-list
110677219|NCT02282358|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110677220|NCT02282358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110677221|NCT02282358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110677222|NCT02177578|Temozolomide|temozolomide|mesh-list
110547916|NCT01564303|Antidotes|antidotes|mesh-ancestor
110677223|NCT02177578|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110677224|NCT02177578|Alkylating Agents|alkylating agents|mesh-ancestor
110677225|NCT02177578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110548058|NCT00691236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110677228|NCT02166463|Methylprednisolone|methylprednisolone|mesh-list
110677229|NCT02166463|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110677230|NCT02166463|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110548226|NCT00721552|Hormones|hormones|mesh-ancestor
110677231|NCT02166463|Prednisolone|prednisolone|mesh-list
110677233|NCT02166463|Cortisone|cortisone|mesh-list
110677234|NCT02166463|Cyclophosphamide|cyclophosphamide|mesh-list
110677235|NCT02166463|Doxorubicin|doxorubicin|mesh-list
110677236|NCT02166463|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110677237|NCT02166463|Etoposide|etoposide|mesh-list
110677238|NCT02166463|Vincristine|vincristine|mesh-list
110548571|NCT00723268|Prednisolone|prednisolone|mesh-list
110548640|NCT02641652|Serotonin Agents|serotonin agents|mesh-ancestor
110677239|NCT02166463|Etoposide phosphate|etoposide phosphate|mesh-list
110548747|NCT04166786|Ethanol|ethanol|mesh-list
110677240|NCT02166463|Brentuximab Vedotin|brentuximab vedotin|mesh-list
110677241|NCT02166463|Bleomycin|bleomycin|mesh-list
110677242|NCT02166463|Podophyllotoxin|podophyllotoxin|mesh-list
110677243|NCT02166463|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110677245|NCT02166463|Immunoglobulins|immunoglobulins|mesh-list
110677246|NCT02166463|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110677247|NCT02166463|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110677248|NCT02166463|Prednisolone phosphate|prednisolone phosphate|mesh-list
110677249|NCT02166463|Immunoconjugates|immunoconjugates|mesh-list
110677250|NCT02166463|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110549080|NCT02640794|Aspirin|aspirin|mesh-list
110677251|NCT02166463|Immunologic Factors|immunologic factors|mesh-ancestor
110549164|NCT00992797|Vitamin D|vitamin d|mesh-list
110677252|NCT02166463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110677253|NCT02166463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110677254|NCT02166463|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110677255|NCT02166463|Alkylating Agents|alkylating agents|mesh-ancestor
110549373|NCT00713440|Sensory System Agents|sensory system agents|mesh-ancestor
110828138|NCT01285375|Sensory System Agents|sensory system agents|mesh-ancestor
110828139|NCT01285375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110427006|NCT01224821|Antibodies|antibodies|mesh-list
110677256|NCT02166463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110677258|NCT02166463|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110677259|NCT02166463|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110549746|NCT00714064|Edetic Acid|edetic acid|mesh-list
110677260|NCT02166463|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110549902|NCT04139070|Bleomycin|bleomycin|mesh-list
110677261|NCT02166463|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110677262|NCT02166463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110549978|NCT00726700|Prednisone|prednisone|mesh-list
110677263|NCT02166463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110677264|NCT02166463|Glucocorticoids|glucocorticoids|mesh-ancestor
110677265|NCT02166463|Hormones|hormones|mesh-ancestor
110828140|NCT01285375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110550267|NCT02723435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110828141|NCT01285375|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110828142|NCT01285375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110677266|NCT02166463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110677267|NCT02166463|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110677268|NCT02166463|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110677269|NCT02166463|Tubulin Modulators|tubulin modulators|mesh-ancestor
110677270|NCT02166463|Antimitotic Agents|antimitotic agents|mesh-ancestor
110677271|NCT02166463|Mitosis Modulators|mitosis modulators|mesh-ancestor
110677272|NCT02166463|Antiemetics|antiemetics|mesh-ancestor
110677273|NCT02166463|Autonomic Agents|autonomic agents|mesh-ancestor
110677274|NCT02166463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110677275|NCT02166463|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110677276|NCT02166463|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110677277|NCT02166463|Protective Agents|protective agents|mesh-ancestor
110677278|NCT02166463|Immunotoxins|immunotoxins|mesh-ancestor
110677280|NCT02166463|Dermatologic Agents|dermatologic agents|mesh-ancestor
110677281|NCT02112526|Acalabrutinib|acalabrutinib|mesh-list
110677282|NCT02112526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110677283|NCT02094794|Cyclophosphamide|cyclophosphamide|mesh-list
110551462|NCT01001845|alpha-Tocopherol|alpha-tocopherol|mesh-list
110551536|NCT05429567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110677285|NCT02094794|Etoposide phosphate|etoposide phosphate|mesh-list
110677286|NCT02094794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110677287|NCT02094794|Immunologic Factors|immunologic factors|mesh-ancestor
110677288|NCT02094794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110677289|NCT02094794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110677290|NCT02094794|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110551759|NCT00654290|Propranolol|propranolol|mesh-list
110677291|NCT02094794|Alkylating Agents|alkylating agents|mesh-ancestor
110677292|NCT02094794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110677293|NCT02094794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110677294|NCT02094794|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110427116|NCT02714725|Analgesics|analgesics|mesh-ancestor
110677295|NCT02094794|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110677296|NCT02094794|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110677297|NCT02094794|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110677298|NCT02094794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110552438|NCT00727870|Glycerol|glycerol|mesh-list
110552520|NCT04930237|Bisacodyl|bisacodyl|mesh-list
110677299|NCT01892709|Hydromorphone|hydromorphone|mesh-list
110677300|NCT01892709|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110677301|NCT01892709|Narcotics|narcotics|mesh-ancestor
110677302|NCT01892709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110552745|NCT00654524|Vitamin D|vitamin d|mesh-list
110677303|NCT01892709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110677304|NCT01892709|Analgesics|analgesics|mesh-ancestor
110677305|NCT01892709|Sensory System Agents|sensory system agents|mesh-ancestor
110552871|NCT05325190|Serotonin Agents|serotonin agents|mesh-ancestor
110677306|NCT01892709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110677308|NCT01806571|Daunorubicin|daunorubicin|mesh-list
110553093|NCT00613457|Daunorubicin|daunorubicin|mesh-list
110677310|NCT01806571|Antimetabolites|antimetabolites|mesh-ancestor
110828143|NCT01285375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110677311|NCT01806571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110553437|NCT00636935|Primaquine|primaquine|mesh-list
110677312|NCT01806571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110677313|NCT01806571|Antiviral Agents|antiviral agents|mesh-ancestor
110677314|NCT01806571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110828144|NCT01285375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110677315|NCT01806571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110677316|NCT01806571|Immunologic Factors|immunologic factors|mesh-ancestor
110677317|NCT01806571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110677318|NCT01806571|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110677319|NCT01806571|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110677320|NCT01806571|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110677321|NCT01806571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110677322|NCT01633177|Vitamin D|vitamin d|mesh-list
110677323|NCT01633177|Ergocalciferols|ergocalciferols|mesh-list
110554125|NCT04158050|Omalizumab|omalizumab|mesh-list
110677324|NCT01633177|Cholecalciferol|cholecalciferol|mesh-list
110677325|NCT01633177|Vitamins|vitamins|mesh-list
110554197|NCT02633930|Amoxicillin|amoxicillin|mesh-list
110677326|NCT01633177|Micronutrients|micronutrients|mesh-ancestor
110324453|NCT01053962|Plecanatide|plecanatide|mesh-list
110554419|NCT00660140|Antimetabolites|antimetabolites|mesh-ancestor
110677327|NCT01633177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110677328|NCT01633177|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110677329|NCT01633177|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110554711|NCT00661076|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110554783|NCT00665678|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110554859|NCT00665834|Atorvastatin|atorvastatin|mesh-list
110828145|NCT01285375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110828146|NCT05625893|Bevacizumab|bevacizumab|mesh-list
110828147|NCT05625893|Atezolizumab|atezolizumab|mesh-list
110828148|NCT05625893|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110555154|NCT05343299|Anesthetics|anesthetics|mesh-list
110555228|NCT02614404|Antimalarials|antimalarials|mesh-ancestor
110828149|NCT05625893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110555451|NCT02701517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110828151|NCT05625893|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110828152|NCT05625893|Growth Substances|growth substances|mesh-ancestor
110828153|NCT05625893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110828154|NCT05625893|Growth Inhibitors|growth inhibitors|mesh-ancestor
110555903|NCT00615797|Autonomic Agents|autonomic agents|mesh-ancestor
110555977|NCT01009801|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110677332|NCT01517451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110556201|NCT05323565|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110677333|NCT01517451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110677334|NCT01409200|Ascorbic Acid|ascorbic acid|mesh-list
110677335|NCT01409200|Methyltestosterone|methyltestosterone|mesh-list
110677336|NCT01409200|Axitinib|axitinib|mesh-list
110677337|NCT01409200|Hormones|hormones|mesh-list
110677338|NCT01409200|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
110677339|NCT01409200|Androgens|androgens|mesh-list
110677340|NCT01409200|Androgen Antagonists|androgen antagonists|mesh-list
110556717|NCT00921388|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110828155|NCT05625893|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110556797|NCT00619541|Sorafenib|sorafenib|mesh-list
110556873|NCT00698932|Protease Inhibitors|protease inhibitors|mesh-ancestor
110677341|NCT01409200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110677342|NCT01409200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110677344|NCT01409200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110677345|NCT01409200|Protective Agents|protective agents|mesh-ancestor
110677346|NCT01409200|Vitamins|vitamins|mesh-ancestor
110677347|NCT01409200|Micronutrients|micronutrients|mesh-ancestor
110677348|NCT01409200|Estrogens|estrogens|mesh-ancestor
110677349|NCT01409200|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110677350|NCT01409200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110677351|NCT01409200|Anabolic Agents|anabolic agents|mesh-ancestor
110677352|NCT01409200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110677353|NCT01409200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110557166|NCT00695110|Androgens|androgens|mesh-ancestor
110677355|NCT01204216|Biotin|biotin|mesh-list
110557312|NCT04808531|Narcotics|narcotics|mesh-ancestor
110677356|NCT01204216|Vitamin B Complex|vitamin b complex|mesh-ancestor
110677357|NCT01204216|Vitamins|vitamins|mesh-ancestor
110677358|NCT01204216|Micronutrients|micronutrients|mesh-ancestor
110677359|NCT01204216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110677360|NCT01104350|Gemcitabine|gemcitabine|mesh-list
110677361|NCT01104350|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110677362|NCT01104350|Antimetabolites|antimetabolites|mesh-ancestor
110677363|NCT01104350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110677365|NCT01100892|Insulin Detemir|insulin detemir|mesh-list
110677366|NCT01100892|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110677367|NCT01100892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110677368|NCT01025089|Cyclophosphamide|cyclophosphamide|mesh-list
110558138|NCT00692510|Anesthetics|anesthetics|mesh-ancestor
110677370|NCT01025089|Cetuximab|cetuximab|mesh-list
110677371|NCT01025089|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110558214|NCT02167763|Copper|copper|mesh-list
110677372|NCT01025089|Immunologic Factors|immunologic factors|mesh-ancestor
110677373|NCT01025089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110558365|NCT00489853|Budesonide|budesonide|mesh-list
110856056|NCT02477956|Cholecalciferol|cholecalciferol|mesh-list
110677374|NCT01025089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110558443|NCT00499603|Paclitaxel|paclitaxel|mesh-list
110677375|NCT01025089|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110677376|NCT01025089|Alkylating Agents|alkylating agents|mesh-ancestor
110558570|NCT00693758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110677377|NCT01025089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110677378|NCT01025089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110677379|NCT01025089|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110677380|NCT01025089|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110677381|NCT01025089|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110677382|NCT01025089|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110677383|NCT01025089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110677384|NCT01025089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110677386|NCT00999037|Chelating Agents|chelating agents|mesh-ancestor
110677387|NCT00999037|Sequestering Agents|sequestering agents|mesh-ancestor
110677388|NCT00999037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110677389|NCT00921856|Acetylcholine|acetylcholine|mesh-list
110677390|NCT00921856|Vasodilator Agents|vasodilator agents|mesh-ancestor
110559096|NCT01017367|Antibodies|antibodies|mesh-list
110677391|NCT00921856|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110677392|NCT00921856|Cholinergic Agents|cholinergic agents|mesh-ancestor
110677393|NCT00921856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110677394|NCT00921856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110677395|NCT00921856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110677397|NCT00861705|Cyclophosphamide|cyclophosphamide|mesh-list
110677398|NCT00861705|Bevacizumab|bevacizumab|mesh-list
110677399|NCT00861705|Carboplatin|carboplatin|mesh-list
110677400|NCT00861705|Doxorubicin|doxorubicin|mesh-list
110559535|NCT00852540|Linezolid|linezolid|mesh-list
110677401|NCT00861705|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110677402|NCT00861705|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110559679|NCT00860262|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110677403|NCT00861705|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110324523|NCT00431171|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110677404|NCT00861705|Antibodies|antibodies|mesh-list
110677405|NCT00861705|Immunoglobulins|immunoglobulins|mesh-list
110677406|NCT00861705|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110677407|NCT00861705|Immunoglobulin G|immunoglobulin g|mesh-list
110677408|NCT00861705|Endothelial Growth Factors|endothelial growth factors|mesh-list
110559969|NCT02619032|Anesthetics|anesthetics|mesh-ancestor
110677409|NCT00861705|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110677411|NCT00861705|Tubulin Modulators|tubulin modulators|mesh-ancestor
110677413|NCT00861705|Mitosis Modulators|mitosis modulators|mesh-ancestor
110683092|NCT03986008|Incretins|incretins|mesh-ancestor
110677414|NCT00861705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110677415|NCT00861705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110683312|NCT03547427|Pramlintide|pramlintide|mesh-list
110677417|NCT00861705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110677418|NCT00861705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110677419|NCT00861705|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110677420|NCT00861705|Alkylating Agents|alkylating agents|mesh-ancestor
110677421|NCT00861705|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110677422|NCT00861705|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110683911|NCT00930839|Antipyretics|antipyretics|mesh-ancestor
110677423|NCT00861705|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110683993|NCT00936689|Hormones|hormones|mesh-ancestor
110677424|NCT00861705|Growth Substances|growth substances|mesh-ancestor
110677425|NCT00861705|Growth Inhibitors|growth inhibitors|mesh-ancestor
110677426|NCT00861705|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110684196|NCT00939497|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110677427|NCT00861705|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110677428|NCT00861705|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110677430|NCT00833664|Terbinafine|terbinafine|mesh-list
110677431|NCT00833664|Antifungal Agents|antifungal agents|mesh-ancestor
110677432|NCT00833664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110677433|NCT00833664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110684794|NCT00307294|Growth Inhibitors|growth inhibitors|mesh-ancestor
110684871|NCT00306670|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110684946|NCT01009970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110685027|NCT01589055|Nicotine|nicotine|mesh-list
110685097|NCT01014468|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110685176|NCT00565409|Analgesics|analgesics|mesh-ancestor
110677434|NCT00833664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110677436|NCT00696111|Progesterone|progesterone|mesh-list
110677437|NCT00696111|Estrogens|estrogens|mesh-list
110677438|NCT00696111|Progestins|progestins|mesh-ancestor
110677439|NCT00696111|Hormones|hormones|mesh-ancestor
110685394|NCT04250064|Growth Inhibitors|growth inhibitors|mesh-ancestor
110685467|NCT01040559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110685542|NCT01017666|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
110685617|NCT00414453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110677440|NCT00696111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110685840|NCT00501644|Antiviral Agents|antiviral agents|mesh-ancestor
110677441|NCT00696111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110677442|NCT00696111|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110677443|NCT00696111|Fertility Agents|fertility agents|mesh-ancestor
110677444|NCT00696111|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110677445|NCT00696111|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110686134|NCT00486330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110686208|NCT00499616|Cyclophosphamide|cyclophosphamide|mesh-list
110677446|NCT00696111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110677447|NCT00224393|Etanercept|etanercept|mesh-list
110686284|NCT00402285|Lycopene|lycopene|mesh-list
110686357|NCT00400569|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110677448|NCT00224393|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110677449|NCT00224393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110677450|NCT00224393|Analgesics|analgesics|mesh-ancestor
110677451|NCT00224393|Sensory System Agents|sensory system agents|mesh-ancestor
110686723|NCT01042041|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110686801|NCT01039545|Diclofenac|diclofenac|mesh-list
110686883|NCT00387465|Entinostat|entinostat|mesh-list
110686944|NCT00386607|Diuretics|diuretics|mesh-ancestor
110677452|NCT00224393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110334157|NCT00491426|Metronidazole|metronidazole|mesh-list
110677453|NCT00224393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110687322|NCT00494780|Glucocorticoids|glucocorticoids|mesh-ancestor
110687387|NCT00946829|Telmisartan|telmisartan|mesh-list
110677454|NCT00224393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110677455|NCT00224393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110687549|NCT03965351|Probenecid|probenecid|mesh-list
110677456|NCT00224393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110677457|NCT00224393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110677458|NCT00224393|Immunologic Factors|immunologic factors|mesh-ancestor
110677459|NCT00199862|Antibodies|antibodies|mesh-list
110677460|NCT00199862|Immunologic Factors|immunologic factors|mesh-ancestor
110677461|NCT00199862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110677462|NCT00128310|Gemcitabine|gemcitabine|mesh-list
110677463|NCT00128310|Vinorelbine|vinorelbine|mesh-list
110677464|NCT00128310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110677465|NCT00128310|Antimetabolites|antimetabolites|mesh-ancestor
110405888|NCT01261338|Antimetabolites|antimetabolites|mesh-ancestor
110677466|NCT00128310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110406034|NCT04387110|Ocrelizumab|ocrelizumab|mesh-list
110677468|NCT00128310|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110406110|NCT01235793|Temozolomide|temozolomide|mesh-list
110677469|NCT00128310|Tubulin Modulators|tubulin modulators|mesh-ancestor
110677470|NCT00128310|Antimitotic Agents|antimitotic agents|mesh-ancestor
110677471|NCT00128310|Mitosis Modulators|mitosis modulators|mesh-ancestor
110677472|NCT00885443|Propofol|propofol|mesh-list
110677473|NCT00885443|Sevoflurane|sevoflurane|mesh-list
110677474|NCT00885443|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110677475|NCT00885443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110677476|NCT00885443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110677477|NCT00885443|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110677478|NCT00885443|Anesthetics, General|anesthetics, general|mesh-ancestor
110677479|NCT00885443|Anesthetics|anesthetics|mesh-ancestor
110677480|NCT00885443|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110324598|NCT00431678|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110677481|NCT00885443|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110677482|NCT00882869|Sorafenib|sorafenib|mesh-list
110677483|NCT00882869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110406886|NCT01018186|Xhance|xhance|mesh-list
110677484|NCT00882869|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110677485|NCT00882869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110407146|NCT01004614|Amlodipine|amlodipine|mesh-list
110677486|NCT00882869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110677488|NCT00882947|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110677489|NCT00882947|Vasodilator Agents|vasodilator agents|mesh-ancestor
110677490|NCT00531050|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110677491|NCT00531050|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110677492|NCT00531050|Autonomic Agents|autonomic agents|mesh-ancestor
110677493|NCT00531050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110677494|NCT00531050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110677495|NCT00531050|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110677496|NCT00531050|Respiratory System Agents|respiratory system agents|mesh-ancestor
110677497|NCT00531050|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110677498|NCT00531050|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110677499|NCT00531050|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110677500|NCT00531050|Adrenergic Agents|adrenergic agents|mesh-ancestor
110677501|NCT00531050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110677502|NCT00531050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110677503|NCT00530348|Interferons|interferons|mesh-list
110677504|NCT00530348|Interferon-beta|interferon-beta|mesh-list
110677505|NCT00530348|Interferon beta-1a|interferon beta-1a|mesh-list
110677506|NCT00530348|Alemtuzumab|alemtuzumab|mesh-list
110407714|NCT01198587|Zinc Sulfate|zinc sulfate|mesh-list
110407786|NCT02864095|Autonomic Agents|autonomic agents|mesh-ancestor
110407860|NCT00972283|Insulin Glargine|insulin glargine|mesh-list
110677507|NCT00530348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110677508|NCT00530348|Antiviral Agents|antiviral agents|mesh-ancestor
110677509|NCT00530348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110677510|NCT00530348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110677511|NCT00530348|Immunologic Factors|immunologic factors|mesh-ancestor
110677512|NCT00530348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110677514|NCT01007864|Pramipexole|pramipexole|mesh-list
110677515|NCT01007864|Ropinirole|ropinirole|mesh-list
110677516|NCT01007864|Piribedil|piribedil|mesh-list
110677517|NCT01007864|Antioxidants|antioxidants|mesh-ancestor
110677518|NCT01007864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110677519|NCT01007864|Protective Agents|protective agents|mesh-ancestor
110677520|NCT01007864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110677521|NCT01007864|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110677522|NCT01007864|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110677523|NCT01007864|Dopamine Agonists|dopamine agonists|mesh-ancestor
110677524|NCT01007864|Dopamine Agents|dopamine agents|mesh-ancestor
110677525|NCT01007864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110427501|NCT02707393|Thiotepa|thiotepa|mesh-list
110677526|NCT01008020|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
110677527|NCT01008020|Antioxidants|antioxidants|mesh-ancestor
110677528|NCT01008020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110677529|NCT01008020|Protective Agents|protective agents|mesh-ancestor
110677530|NCT01008020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110677531|NCT01008020|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
110677532|NCT01008020|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110677533|NCT01008020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110677534|NCT01008020|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110677535|NCT01008098|Escitalopram|escitalopram|mesh-list
110677536|NCT01008098|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110677537|NCT01008098|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110677538|NCT01008098|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110677539|NCT01008098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110677540|NCT01008098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110677541|NCT01008098|Serotonin Agents|serotonin agents|mesh-ancestor
110677542|NCT01008098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110677544|NCT00530270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110677545|NCT00530270|Antiemetics|antiemetics|mesh-ancestor
110677546|NCT00530270|Autonomic Agents|autonomic agents|mesh-ancestor
110677547|NCT00530270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110677548|NCT00530270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110677549|NCT00530270|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110677550|NCT00530270|Glucocorticoids|glucocorticoids|mesh-ancestor
110677551|NCT00530270|Hormones|hormones|mesh-ancestor
110677552|NCT00530270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110677553|NCT00530270|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110677554|NCT00530270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110677555|NCT01008488|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110677556|NCT01008488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110677558|NCT01001624|Antioxidants|antioxidants|mesh-ancestor
110856073|NCT05708248|Protective Agents|protective agents|mesh-ancestor
110677559|NCT01001624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110677560|NCT01001624|Protective Agents|protective agents|mesh-ancestor
110677561|NCT01001624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110677562|NCT01001624|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110677563|NCT01001780|Cyclophosphamide|cyclophosphamide|mesh-list
110677564|NCT01001780|Rituximab|rituximab|mesh-list
110677565|NCT01001780|Pentostatin|pentostatin|mesh-list
110677566|NCT01001780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110677567|NCT01001780|Immunologic Factors|immunologic factors|mesh-ancestor
110677568|NCT01001780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110677569|NCT01001780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110677570|NCT01001780|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110677571|NCT01001780|Alkylating Agents|alkylating agents|mesh-ancestor
110677572|NCT01001780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110677573|NCT01001780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110677574|NCT01001780|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110677575|NCT01001780|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110677576|NCT01001780|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
110677577|NCT01001780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110677578|NCT01008566|Sorafenib|sorafenib|mesh-list
110677579|NCT01008566|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110677580|NCT01008566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110677581|NCT01008566|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110677582|NCT01008566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110677583|NCT01008566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110677584|NCT01008566|Immunologic Factors|immunologic factors|mesh-ancestor
110677585|NCT01008566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110677586|NCT03885596|Acetaminophen|acetaminophen|mesh-list
110677587|NCT03885596|Celecoxib|celecoxib|mesh-list
110677588|NCT03885596|Ketorolac|ketorolac|mesh-list
110677589|NCT03885596|Lidocaine|lidocaine|mesh-list
110677590|NCT03885596|Fentanyl|fentanyl|mesh-list
110677591|NCT03885596|Bupivacaine|bupivacaine|mesh-list
110677592|NCT03885596|Anesthetics, Local|anesthetics, local|mesh-ancestor
110677593|NCT03885596|Anesthetics|anesthetics|mesh-ancestor
110677594|NCT03885596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110677595|NCT03885596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110677596|NCT03885596|Sensory System Agents|sensory system agents|mesh-ancestor
110677597|NCT03885596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110677598|NCT03885596|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110677599|NCT03885596|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110677600|NCT03885596|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110677601|NCT03885596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110863878|NCT03634020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110677602|NCT03885596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110677603|NCT03885596|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110677604|NCT03885596|Narcotics|narcotics|mesh-ancestor
110677605|NCT03885596|Analgesics|analgesics|mesh-ancestor
110677606|NCT03885596|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110677607|NCT03885596|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110677608|NCT03885596|Anesthetics, General|anesthetics, general|mesh-ancestor
110677609|NCT03885596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110677610|NCT03885596|Antipyretics|antipyretics|mesh-ancestor
110677611|NCT03885596|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110677612|NCT03885596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110677613|NCT03885596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110677614|NCT03885596|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110677615|NCT03885596|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110677616|NCT03885596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110677617|NCT01002092|Endostar protein|endostar protein|mesh-list
110677618|NCT01002092|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110856077|NCT05708248|Antioxidants|antioxidants|mesh-ancestor
110677619|NCT01002092|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110677620|NCT01002092|Growth Substances|growth substances|mesh-ancestor
110677621|NCT01002092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110677622|NCT01002092|Growth Inhibitors|growth inhibitors|mesh-ancestor
110677623|NCT01002092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110677624|NCT03999866|Pyrithione zinc|pyrithione zinc|mesh-list
110677625|NCT03999866|Keratolytic Agents|keratolytic agents|mesh-ancestor
110677626|NCT03999866|Dermatologic Agents|dermatologic agents|mesh-ancestor
110677627|NCT00529100|Cisplatin|cisplatin|mesh-list
110677628|NCT00529100|Pemetrexed|pemetrexed|mesh-list
110677629|NCT00529100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110677630|NCT00529100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110677631|NCT00529100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110352021|NCT04959825|Melatonin|melatonin|mesh-list
110677632|NCT00529100|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110677633|NCT00529100|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110677634|NCT05732948|Cyclophosphamide|cyclophosphamide|mesh-list
110677635|NCT05732948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110677636|NCT05732948|Immunologic Factors|immunologic factors|mesh-ancestor
110677637|NCT05732948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110677638|NCT05732948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110677639|NCT05732948|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110677640|NCT05732948|Alkylating Agents|alkylating agents|mesh-ancestor
110677641|NCT05732948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110677642|NCT05732948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110677643|NCT05732948|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110677645|NCT00529802|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110677646|NCT00529802|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110677647|NCT00529802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110677648|NCT00529802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110677649|NCT00529802|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110677650|NCT00529802|Immunologic Factors|immunologic factors|mesh-ancestor
110677651|NCT00529802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110677652|NCT00529802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110677653|NCT00528866|Docetaxel|docetaxel|mesh-list
110677654|NCT00528866|Bicalutamide|bicalutamide|mesh-list
110677655|NCT00528866|Flutamide|flutamide|mesh-list
110677656|NCT00528866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110677657|NCT00528866|Tubulin Modulators|tubulin modulators|mesh-ancestor
110677658|NCT00528866|Antimitotic Agents|antimitotic agents|mesh-ancestor
110677659|NCT00528866|Mitosis Modulators|mitosis modulators|mesh-ancestor
110677660|NCT00528866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110677661|NCT00528866|Androgen Antagonists|androgen antagonists|mesh-ancestor
110677662|NCT00528866|Hormone Antagonists|hormone antagonists|mesh-ancestor
110677663|NCT00528866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110677664|NCT00528866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110677665|NCT00528866|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110677666|NCT05730920|Methadone|methadone|mesh-list
110677667|NCT05730920|Bupivacaine|bupivacaine|mesh-list
110677668|NCT05730920|Anesthetics, Local|anesthetics, local|mesh-ancestor
110677669|NCT05730920|Anesthetics|anesthetics|mesh-ancestor
110677670|NCT05730920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110677671|NCT05730920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110677672|NCT05730920|Sensory System Agents|sensory system agents|mesh-ancestor
110677673|NCT05730920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110677674|NCT05730920|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110677675|NCT05730920|Narcotics|narcotics|mesh-ancestor
110677676|NCT05730920|Analgesics|analgesics|mesh-ancestor
110677677|NCT05730920|Antitussive Agents|antitussive agents|mesh-ancestor
110677678|NCT05730920|Respiratory System Agents|respiratory system agents|mesh-ancestor
110677679|NCT03999008|Budesonide|budesonide|mesh-list
110677680|NCT03999008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110677681|NCT03999008|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110677682|NCT03999008|Autonomic Agents|autonomic agents|mesh-ancestor
110677683|NCT03999008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110677684|NCT03999008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110677685|NCT03999008|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110677686|NCT03999008|Respiratory System Agents|respiratory system agents|mesh-ancestor
110677687|NCT03999008|Glucocorticoids|glucocorticoids|mesh-ancestor
110677688|NCT03999008|Hormones|hormones|mesh-ancestor
110677689|NCT03999008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110677690|NCT05140148|Amantadine|amantadine|mesh-list
110677691|NCT05140148|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110677692|NCT05140148|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110677693|NCT05140148|Antiviral Agents|antiviral agents|mesh-ancestor
110677694|NCT05140148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110677695|NCT05140148|Dopamine Agents|dopamine agents|mesh-ancestor
110677696|NCT05140148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110677697|NCT05140148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110677698|NCT05140148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110677699|NCT05140148|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110677700|NCT05140148|Analgesics|analgesics|mesh-ancestor
110677701|NCT05140148|Sensory System Agents|sensory system agents|mesh-ancestor
110677702|NCT05140148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110677703|NCT04932746|Dexmedetomidine|dexmedetomidine|mesh-list
110677704|NCT04932746|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110677705|NCT04932746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110677706|NCT04932746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110324823|NCT00463203|Irinotecan|irinotecan|mesh-list
110427917|NCT02709265|Fosfomycin|fosfomycin|mesh-list
110677707|NCT04932746|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110677708|NCT04932746|Analgesics|analgesics|mesh-ancestor
110677709|NCT04932746|Sensory System Agents|sensory system agents|mesh-ancestor
110677710|NCT04932746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110677711|NCT04932746|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110677712|NCT04932746|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110677713|NCT04932746|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110677714|NCT04932746|Adrenergic Agents|adrenergic agents|mesh-ancestor
110677715|NCT04932746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110677716|NCT04932746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110677717|NCT00614393|Irinotecan|irinotecan|mesh-list
110677718|NCT00614393|Cetuximab|cetuximab|mesh-list
110677719|NCT00614393|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110677720|NCT00614393|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110677721|NCT00614393|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110677723|NCT00614393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110677724|NCT00614393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110677725|NCT00614393|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110677726|NCT00614393|Immunologic Factors|immunologic factors|mesh-ancestor
110677727|NCT00614393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110677728|NCT00880529|Morphine|morphine|mesh-list
110677729|NCT00880529|Bupivacaine|bupivacaine|mesh-list
110677730|NCT00880529|Anesthetics, Local|anesthetics, local|mesh-ancestor
110677731|NCT00880529|Anesthetics|anesthetics|mesh-ancestor
110677732|NCT00880529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110677733|NCT00880529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110677734|NCT00880529|Sensory System Agents|sensory system agents|mesh-ancestor
110677735|NCT00880529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110677736|NCT00880529|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110677737|NCT00880529|Narcotics|narcotics|mesh-ancestor
110677738|NCT00880529|Analgesics|analgesics|mesh-ancestor
110677739|NCT00880841|Buprenorphine|buprenorphine|mesh-list
110677740|NCT00880841|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
110677741|NCT00880841|Naloxone|naloxone|mesh-list
110677742|NCT00880841|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110677743|NCT00880841|Narcotics|narcotics|mesh-ancestor
110677744|NCT00880841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110677745|NCT00880841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110677746|NCT00880841|Analgesics|analgesics|mesh-ancestor
110677747|NCT00880841|Sensory System Agents|sensory system agents|mesh-ancestor
110677748|NCT00880841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110677749|NCT00880841|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110677750|NCT00883259|Metformin|metformin|mesh-list
110677751|NCT00883259|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110677752|NCT00883259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110677753|NCT00885599|Listerine|listerine|mesh-list
110371039|NCT00567216|Nadolol|nadolol|mesh-list
110677754|NCT00885599|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
110677755|NCT00885599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110677756|NCT04366115|Dexamethasone|dexamethasone|mesh-list
110677757|NCT04366115|Dexamethasone acetate|dexamethasone acetate|mesh-list
110677758|NCT04366115|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
110677759|NCT04366115|BB 1101|bb 1101|mesh-list
110677760|NCT04366115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110677761|NCT04366115|Antiemetics|antiemetics|mesh-ancestor
110677762|NCT04366115|Autonomic Agents|autonomic agents|mesh-ancestor
110677763|NCT04366115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110677764|NCT04366115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110408274|NCT05926895|Hormones|hormones|mesh-ancestor
110677765|NCT04366115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110677766|NCT04366115|Glucocorticoids|glucocorticoids|mesh-ancestor
110677767|NCT04366115|Hormones|hormones|mesh-ancestor
110677768|NCT04366115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110677769|NCT04366115|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110677770|NCT04366115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110677771|NCT04366115|Protease Inhibitors|protease inhibitors|mesh-ancestor
110677772|NCT04366115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110677773|NCT04366115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110677774|NCT04038125|Dexamethasone|dexamethasone|mesh-list
110677775|NCT04038125|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110677776|NCT04038125|Antiemetics|antiemetics|mesh-ancestor
110677777|NCT04038125|Autonomic Agents|autonomic agents|mesh-ancestor
110677778|NCT04038125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110677779|NCT04038125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110677780|NCT04038125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110677781|NCT04038125|Glucocorticoids|glucocorticoids|mesh-ancestor
110677782|NCT04038125|Hormones|hormones|mesh-ancestor
110863879|NCT03634020|Immunologic Factors|immunologic factors|mesh-ancestor
110677783|NCT04038125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110677784|NCT04038125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110677785|NCT04038125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110677786|NCT00881153|Cefprozil|cefprozil|mesh-list
110677787|NCT00881153|Cephalosporins|cephalosporins|mesh-list
110677788|NCT00881153|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110677789|NCT00881153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110677790|NCT00885833|Fludarabine|fludarabine|mesh-list
110677791|NCT00885833|Busulfan|busulfan|mesh-list
110677792|NCT00885833|Thymoglobulin|thymoglobulin|mesh-list
110677793|NCT00885833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110677794|NCT00885833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110677795|NCT00885833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110677796|NCT00885833|Immunologic Factors|immunologic factors|mesh-ancestor
110677797|NCT00885833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110677798|NCT00885833|Alkylating Agents|alkylating agents|mesh-ancestor
110677799|NCT00885833|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110677800|NCT00885833|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110677801|NCT00612677|Oxaliplatin|oxaliplatin|mesh-list
110677802|NCT00612677|Pemetrexed|pemetrexed|mesh-list
110677803|NCT00612677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110677804|NCT00612677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110677805|NCT00612677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110677806|NCT00612677|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110677807|NCT00612677|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110677808|NCT04038749|Cabergoline|cabergoline|mesh-list
110677809|NCT04038749|Bromocriptine|bromocriptine|mesh-list
110677810|NCT04038749|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110677811|NCT04038749|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110677812|NCT04038749|Dopamine Agonists|dopamine agonists|mesh-ancestor
110677813|NCT04038749|Dopamine Agents|dopamine agents|mesh-ancestor
110677814|NCT04038749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110677815|NCT04038749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110677816|NCT04038749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110677817|NCT04038749|Hormone Antagonists|hormone antagonists|mesh-ancestor
110677818|NCT04038749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110677819|NCT00881231|Cilostazol|cilostazol|mesh-list
110428197|NCT01009983|Panitumumab|panitumumab|mesh-list
110677820|NCT00881231|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110677821|NCT00881231|Autonomic Agents|autonomic agents|mesh-ancestor
110677822|NCT00881231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110677823|NCT00881231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110677824|NCT00881231|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110677825|NCT00881231|Respiratory System Agents|respiratory system agents|mesh-ancestor
110677826|NCT00881231|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110677827|NCT00881231|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110677828|NCT00881231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110677829|NCT00881231|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110677830|NCT00881231|Vasodilator Agents|vasodilator agents|mesh-ancestor
110677831|NCT00881231|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110677832|NCT00881231|Protective Agents|protective agents|mesh-ancestor
110677833|NCT00881231|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110677834|NCT00881231|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110677835|NCT00881231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110677836|NCT00883727|Plasma-lyte 148|plasma-lyte 148|mesh-list
110677837|NCT00883727|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110677838|NCT00883727|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110677839|NCT00881387|Rituximab|rituximab|mesh-list
110677840|NCT00881387|Gemcitabine|gemcitabine|mesh-list
110677841|NCT00881387|Vinorelbine|vinorelbine|mesh-list
110677842|NCT00881387|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110677843|NCT00881387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110677844|NCT00881387|Immunologic Factors|immunologic factors|mesh-ancestor
110677845|NCT00881387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110428240|NCT01215227|Rasagiline|rasagiline|mesh-list
110677846|NCT00881387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110677847|NCT00881387|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110677848|NCT00881387|Antimetabolites|antimetabolites|mesh-ancestor
110677849|NCT00881387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110677850|NCT00881387|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110677851|NCT00881387|Tubulin Modulators|tubulin modulators|mesh-ancestor
110677852|NCT00881387|Antimitotic Agents|antimitotic agents|mesh-ancestor
110677853|NCT00881387|Mitosis Modulators|mitosis modulators|mesh-ancestor
110677854|NCT00883883|Cefdinir|cefdinir|mesh-list
110677855|NCT00883883|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110677856|NCT00883883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110677857|NCT00881543|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110863881|NCT03253276|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
110677858|NCT00881543|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
110677859|NCT00881543|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110324970|NCT01051466|Analgesics|analgesics|mesh-ancestor
110677860|NCT00881543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110677861|NCT00881543|Incretins|incretins|mesh-ancestor
110677862|NCT00881543|Hormones|hormones|mesh-ancestor
110677863|NCT00881543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110677864|NCT00881543|Protease Inhibitors|protease inhibitors|mesh-ancestor
110677865|NCT00881543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110677866|NCT00881543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110677867|NCT00881855|Cefprozil|cefprozil|mesh-list
110677868|NCT00881855|Cephalosporins|cephalosporins|mesh-list
110677869|NCT00881855|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110428347|NCT03586687|Glucocorticoids|glucocorticoids|mesh-ancestor
110677870|NCT00881855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110677871|NCT04015115|Analgesics, Opioid|analgesics, opioid|mesh-list
110677872|NCT04015115|Narcotics|narcotics|mesh-ancestor
110677873|NCT04015115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110677874|NCT04015115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110677875|NCT04015115|Analgesics|analgesics|mesh-ancestor
110677876|NCT04015115|Sensory System Agents|sensory system agents|mesh-ancestor
110677877|NCT04015115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110677878|NCT02543645|Atezolizumab|atezolizumab|mesh-list
110677879|NCT02543645|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110677880|NCT02543645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110677881|NCT02543645|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110677882|NCT02543645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110677883|NCT02543411|Lidocaine|lidocaine|mesh-list
110677884|NCT02543411|Anesthetics, Local|anesthetics, local|mesh-ancestor
110677885|NCT02543411|Anesthetics|anesthetics|mesh-ancestor
110428417|NCT04074187|Rituximab|rituximab|mesh-list
110677886|NCT02543411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110677887|NCT02543411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110677888|NCT02543411|Sensory System Agents|sensory system agents|mesh-ancestor
110677889|NCT02543411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110677890|NCT02543411|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110677891|NCT02543411|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110677892|NCT02543411|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110677893|NCT02543411|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110677894|NCT02543411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110677895|NCT00882323|Cyclophosphamide|cyclophosphamide|mesh-list
110677896|NCT00882323|Fludarabine|fludarabine|mesh-list
110677897|NCT00882323|Thymoglobulin|thymoglobulin|mesh-list
110677898|NCT00882323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110677899|NCT00882323|Immunologic Factors|immunologic factors|mesh-ancestor
110677900|NCT00882323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110677901|NCT00882323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110677902|NCT00882323|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110677903|NCT00882323|Alkylating Agents|alkylating agents|mesh-ancestor
110677904|NCT00882323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110677905|NCT00882323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110677906|NCT00882323|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110677907|NCT00882401|Vitamin D|vitamin d|mesh-list
110677908|NCT00882401|Ergocalciferols|ergocalciferols|mesh-list
110677909|NCT00882401|Vitamins|vitamins|mesh-ancestor
110677910|NCT00882401|Micronutrients|micronutrients|mesh-ancestor
110677911|NCT00882401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110677912|NCT00882401|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110677913|NCT00882401|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110677914|NCT00886457|Interferons|interferons|mesh-list
110428494|NCT03596125|Acetylcysteine|acetylcysteine|mesh-list
110677915|NCT00886457|Interferon-alpha|interferon-alpha|mesh-list
110677916|NCT00886457|Interferon alpha-2|interferon alpha-2|mesh-list
110677917|NCT00886457|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110677918|NCT00886457|Decitabine|decitabine|mesh-list
110677919|NCT00886457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110677920|NCT00886457|Antiviral Agents|antiviral agents|mesh-ancestor
110677921|NCT00886457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110677922|NCT00886457|Immunologic Factors|immunologic factors|mesh-ancestor
110677923|NCT00886457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110677924|NCT00886457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110677925|NCT00886457|Antimetabolites|antimetabolites|mesh-ancestor
110677926|NCT00886457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110677927|NCT00886457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110677928|NCT04038671|Anti-Infective Agents|anti-infective agents|mesh-list
110677929|NCT04038671|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110677930|NCT04038671|Charcoal|charcoal|mesh-list
110677931|NCT04038671|Antidotes|antidotes|mesh-ancestor
110677932|NCT04038671|Protective Agents|protective agents|mesh-ancestor
110677933|NCT04038671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110677934|NCT02543099|Policosanol|policosanol|mesh-list
110677935|NCT02543099|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110677936|NCT02543099|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110677937|NCT02543099|Antimetabolites|antimetabolites|mesh-ancestor
110677938|NCT02543099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110677939|NCT02543099|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110677940|NCT02543099|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110677941|NCT00882635|Heparin|heparin|mesh-list
110677942|NCT00882635|Enoxaparin|enoxaparin|mesh-list
110677943|NCT00882635|Calcium heparin|calcium heparin|mesh-list
110677944|NCT00882635|Anticoagulants|anticoagulants|mesh-ancestor
110677945|NCT00882635|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110677946|NCT00882635|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110677947|NCT00882635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110677948|NCT00609869|Rituximab|rituximab|mesh-list
110677949|NCT00609869|Lenalidomide|lenalidomide|mesh-list
110677950|NCT00609869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110677951|NCT00609869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110677952|NCT00609869|Immunologic Factors|immunologic factors|mesh-ancestor
110677953|NCT00609869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110677954|NCT00609869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110677955|NCT00609869|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110677956|NCT00609869|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110677957|NCT00609869|Growth Substances|growth substances|mesh-ancestor
110428673|NCT01209143|Estradiol|estradiol|mesh-list
110677958|NCT00609869|Growth Inhibitors|growth inhibitors|mesh-ancestor
110677959|NCT00888797|Etodolac|etodolac|mesh-list
110677960|NCT00888797|Propranolol|propranolol|mesh-list
110677961|NCT00888797|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110677962|NCT00888797|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110677963|NCT00888797|Adrenergic Agents|adrenergic agents|mesh-ancestor
110677964|NCT00888797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110677965|NCT00888797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110677966|NCT00888797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110677967|NCT00888797|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110677968|NCT00888797|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110677969|NCT00888797|Vasodilator Agents|vasodilator agents|mesh-ancestor
110677970|NCT00888797|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110677971|NCT00888797|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110677973|NCT00888797|Sensory System Agents|sensory system agents|mesh-ancestor
110677974|NCT00888797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110677975|NCT00888797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110677976|NCT00888797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110677977|NCT00888797|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110677978|NCT00888797|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110677979|NCT00888797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110677980|NCT00884663|Propranolol|propranolol|mesh-list
110677981|NCT00884663|Candesartan|candesartan|mesh-list
110677982|NCT00884663|Candesartan cilexetil|candesartan cilexetil|mesh-list
110677983|NCT00884663|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110677984|NCT00884663|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110677985|NCT00884663|Adrenergic Agents|adrenergic agents|mesh-ancestor
110677986|NCT00884663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110677987|NCT00884663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110677988|NCT00884663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110677989|NCT00884663|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110677990|NCT00884663|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110677991|NCT00884663|Vasodilator Agents|vasodilator agents|mesh-ancestor
110677992|NCT00884663|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110677993|NCT00884663|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110677994|NCT00887003|Methylprednisolone|methylprednisolone|mesh-list
110677995|NCT00887003|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110677996|NCT00887003|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110677997|NCT00887003|Prednisolone|prednisolone|mesh-list
110677998|NCT00887003|Prednisolone acetate|prednisolone acetate|mesh-list
110677999|NCT00887003|Bupivacaine|bupivacaine|mesh-list
110678000|NCT00887003|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110678001|NCT00887003|Prednisolone phosphate|prednisolone phosphate|mesh-list
110678002|NCT00887003|Anesthetics, Local|anesthetics, local|mesh-ancestor
110428866|NCT02701933|Ketamine|ketamine|mesh-list
110678003|NCT00887003|Anesthetics|anesthetics|mesh-ancestor
110678004|NCT00887003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110678005|NCT00887003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110678006|NCT00887003|Sensory System Agents|sensory system agents|mesh-ancestor
110678007|NCT00887003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110678008|NCT00887003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110678010|NCT00887003|Autonomic Agents|autonomic agents|mesh-ancestor
110678011|NCT00887003|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110678012|NCT00887003|Glucocorticoids|glucocorticoids|mesh-ancestor
110678013|NCT00887003|Hormones|hormones|mesh-ancestor
110678014|NCT00887003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110678015|NCT00887003|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110678016|NCT00887003|Protective Agents|protective agents|mesh-ancestor
110678017|NCT00887003|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110678018|NCT00887003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110678019|NCT00887081|Ribavirin|ribavirin|mesh-list
110678020|NCT00887081|Interferon-alpha|interferon-alpha|mesh-list
110678021|NCT00887081|Interferon alpha-2|interferon alpha-2|mesh-list
110678022|NCT00887081|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
110678023|NCT00887081|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110678024|NCT00887081|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110678025|NCT00887081|Antimetabolites|antimetabolites|mesh-ancestor
110678026|NCT00887081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110678027|NCT00887081|Antiviral Agents|antiviral agents|mesh-ancestor
110678028|NCT00887081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110678029|NCT00887081|Immunologic Factors|immunologic factors|mesh-ancestor
110678030|NCT00887081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110678031|NCT00887081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110678032|NCT03998696|Cisplatin|cisplatin|mesh-list
110678033|NCT03998696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110678034|NCT00611975|Bupropion|bupropion|mesh-list
110678035|NCT00611975|Fluoxetine|fluoxetine|mesh-list
110678036|NCT00611975|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110678037|NCT00611975|Antidepressive Agents|antidepressive agents|mesh-ancestor
110678038|NCT00611975|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110678039|NCT00611975|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110678040|NCT00611975|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110678041|NCT00611975|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110678042|NCT00611975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110678043|NCT00611975|Dopamine Agents|dopamine agents|mesh-ancestor
110678044|NCT00611975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110678045|NCT00611975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110678046|NCT00611975|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110678047|NCT00611975|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110428931|NCT01011309|Schistosomicides|schistosomicides|mesh-ancestor
110678048|NCT00611975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110678049|NCT00611975|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110678050|NCT00611975|Serotonin Agents|serotonin agents|mesh-ancestor
110678051|NCT05695352|Meloxicam|meloxicam|mesh-list
110678052|NCT05695352|Levonorgestrel|levonorgestrel|mesh-list
110678053|NCT05695352|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110678054|NCT05695352|Contraceptive Agents|contraceptive agents|mesh-ancestor
110678055|NCT05695352|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110678056|NCT05695352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110678057|NCT05695352|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110678058|NCT05695352|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110678059|NCT05695352|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110678060|NCT05695352|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110678061|NCT05695352|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110678062|NCT05695352|Analgesics|analgesics|mesh-ancestor
110678063|NCT05695352|Sensory System Agents|sensory system agents|mesh-ancestor
110678064|NCT05695352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110678065|NCT05695352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110678066|NCT05695352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110678067|NCT05695352|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110678068|NCT05695352|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110678069|NCT05695352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110678070|NCT05695352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110678071|NCT04895306|Methyltestosterone|methyltestosterone|mesh-list
110678072|NCT04895306|Testosterone|testosterone|mesh-list
110678073|NCT04895306|Testosterone undecanoate|testosterone undecanoate|mesh-list
110678074|NCT04895306|Testosterone enanthate|testosterone enanthate|mesh-list
110678075|NCT04895306|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
110678076|NCT04895306|Androgens|androgens|mesh-ancestor
110678077|NCT04895306|Hormones|hormones|mesh-ancestor
110678078|NCT04895306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110678079|NCT04895306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110678080|NCT04895306|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110678081|NCT04895306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110678082|NCT04895306|Anabolic Agents|anabolic agents|mesh-ancestor
110678083|NCT02542241|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110678084|NCT00889343|Leucovorin|leucovorin|mesh-list
110678085|NCT00889343|Fluorouracil|fluorouracil|mesh-list
110678086|NCT00889343|Oxaliplatin|oxaliplatin|mesh-list
110678087|NCT00889343|Irinotecan|irinotecan|mesh-list
110678088|NCT00889343|Sorafenib|sorafenib|mesh-list
110678089|NCT00889343|Antimetabolites|antimetabolites|mesh-ancestor
110678090|NCT00889343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110678091|NCT00889343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110678092|NCT00889343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110678093|NCT00889343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110678094|NCT00889343|Immunologic Factors|immunologic factors|mesh-ancestor
110678095|NCT00889343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110678096|NCT00889343|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110678097|NCT00889343|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110678098|NCT00889343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110678099|NCT00889343|Antidotes|antidotes|mesh-ancestor
110678100|NCT00889343|Protective Agents|protective agents|mesh-ancestor
110678101|NCT00889343|Vitamin B Complex|vitamin b complex|mesh-ancestor
110678102|NCT00889343|Vitamins|vitamins|mesh-ancestor
110678103|NCT00889343|Micronutrients|micronutrients|mesh-ancestor
110678104|NCT00889343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110678105|NCT00884819|Fenofibrate|fenofibrate|mesh-list
110678106|NCT00884819|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110678107|NCT00884819|Antimetabolites|antimetabolites|mesh-ancestor
110678108|NCT00884819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110678109|NCT00884819|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110678110|NCT00573131|Paclitaxel|paclitaxel|mesh-list
110678111|NCT00573131|Cisplatin|cisplatin|mesh-list
110856194|NCT03766607|Tubulin Modulators|tubulin modulators|mesh-ancestor
110678112|NCT00573131|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110678113|NCT00573131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110678114|NCT00573131|Tubulin Modulators|tubulin modulators|mesh-ancestor
110678115|NCT00573131|Antimitotic Agents|antimitotic agents|mesh-ancestor
110678116|NCT00573131|Mitosis Modulators|mitosis modulators|mesh-ancestor
110678117|NCT00573131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110678118|NCT01565018|Rotigotine|rotigotine|mesh-list
110678119|NCT01565018|Dopamine Agonists|dopamine agonists|mesh-ancestor
110678120|NCT01565018|Dopamine Agents|dopamine agents|mesh-ancestor
110678121|NCT01565018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110678122|NCT01565018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110678123|NCT01565018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110678125|NCT01565096|Glimepiride|glimepiride|mesh-list
110678126|NCT01565096|Vildagliptin|vildagliptin|mesh-list
110678127|NCT01565096|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110678128|NCT01565096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110678129|NCT01565096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110678130|NCT01565096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110678131|NCT01565096|Immunologic Factors|immunologic factors|mesh-ancestor
110678132|NCT01565096|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110678133|NCT01565096|Protease Inhibitors|protease inhibitors|mesh-ancestor
110678134|NCT01565096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110678135|NCT01565096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110678136|NCT00889499|Tropisetron|tropisetron|mesh-list
110678137|NCT00889499|Antiemetics|antiemetics|mesh-ancestor
110678138|NCT00889499|Autonomic Agents|autonomic agents|mesh-ancestor
110678139|NCT00889499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110678140|NCT00889499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110678141|NCT00889499|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110678142|NCT00889499|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110678143|NCT00889499|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110678144|NCT00889499|Serotonin Agents|serotonin agents|mesh-ancestor
110678145|NCT00889499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110678146|NCT00889499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110678147|NCT00889655|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
110678148|NCT00889655|Laxatives|laxatives|mesh-ancestor
110678149|NCT00889655|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110678150|NCT05002946|Naltrexone|naltrexone|mesh-list
110678151|NCT05002946|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110678152|NCT05002946|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110678153|NCT05002946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110678154|NCT05002946|Sensory System Agents|sensory system agents|mesh-ancestor
110678155|NCT05002946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110678156|NCT04641338|Dipyrone|dipyrone|mesh-list
110678157|NCT04641338|Codeine|codeine|mesh-list
110678158|NCT04641338|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110678160|NCT04641338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110678161|NCT04641338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110678162|NCT04641338|Analgesics|analgesics|mesh-ancestor
110678163|NCT04641338|Sensory System Agents|sensory system agents|mesh-ancestor
110678164|NCT04641338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110678165|NCT04641338|Antitussive Agents|antitussive agents|mesh-ancestor
110678166|NCT04641338|Respiratory System Agents|respiratory system agents|mesh-ancestor
110678167|NCT04641338|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110678168|NCT04641338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110678169|NCT04641338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110678170|NCT04641338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110678172|NCT04635098|Dexmedetomidine|dexmedetomidine|mesh-list
110429460|NCT04213105|Denosumab|denosumab|mesh-list
110678173|NCT04635098|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110678174|NCT04635098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110678175|NCT04635098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110678176|NCT04635098|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110678177|NCT04635098|Analgesics|analgesics|mesh-ancestor
110678178|NCT04635098|Sensory System Agents|sensory system agents|mesh-ancestor
110678179|NCT04635098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110678180|NCT04635098|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110678181|NCT04635098|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110678182|NCT04635098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110678183|NCT04635098|Adrenergic Agents|adrenergic agents|mesh-ancestor
110678184|NCT04635098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110678185|NCT04635098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110678186|NCT00521144|Topotecan|topotecan|mesh-list
110678187|NCT00521144|Obatoclax|obatoclax|mesh-list
110678188|NCT00521144|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110678189|NCT00521144|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110678190|NCT00521144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110678191|NCT00521144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110678192|NCT00521144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110678193|NCT00520676|Carboplatin|carboplatin|mesh-list
110678194|NCT00520676|Docetaxel|docetaxel|mesh-list
110678195|NCT00520676|Pemetrexed|pemetrexed|mesh-list
110678196|NCT00520676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110429590|NCT01000311|Vaccines|vaccines|mesh-list
110678197|NCT00520676|Tubulin Modulators|tubulin modulators|mesh-ancestor
110678198|NCT00520676|Antimitotic Agents|antimitotic agents|mesh-ancestor
110678200|NCT00520676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110678201|NCT00520676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110678202|NCT00520676|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110678203|NCT00520676|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110678204|NCT00889733|Cisplatin|cisplatin|mesh-list
110678205|NCT00889733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110678206|NCT00887627|Conivaptan|conivaptan|mesh-list
110678207|NCT00887627|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
110678208|NCT00887627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110678209|NCT00887627|Natriuretic Agents|natriuretic agents|mesh-ancestor
110678210|NCT00887627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110678211|NCT00885287|Lumefantrine|lumefantrine|mesh-list
110678212|NCT00885287|Artemether|artemether|mesh-list
110678213|NCT00885287|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
110678214|NCT00885287|Antimalarials|antimalarials|mesh-ancestor
110678215|NCT00885287|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110678216|NCT00885287|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110678217|NCT00885287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110678218|NCT02542007|Sirolimus|sirolimus|mesh-list
110678219|NCT02542007|Temsirolimus|temsirolimus|mesh-list
110678220|NCT02542007|MTOR Inhibitors|mtor inhibitors|mesh-list
110678221|NCT02542007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110678222|NCT02542007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110678223|NCT02542007|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110678224|NCT02542007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110678225|NCT02542007|Antifungal Agents|antifungal agents|mesh-ancestor
110678226|NCT02542007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110678227|NCT02542007|Immunologic Factors|immunologic factors|mesh-ancestor
110678228|NCT02542007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110678229|NCT02542007|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110678230|NCT02542007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110678231|NCT02542007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110678232|NCT00892541|Paliperidone Palmitate|paliperidone palmitate|mesh-list
110678233|NCT00892541|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110678234|NCT00892541|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110678235|NCT00892541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110678236|NCT00892541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110678237|NCT00892541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110325336|NCT00464958|Tizanidine|tizanidine|mesh-list
110678238|NCT00892541|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110678239|NCT00892541|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110678240|NCT00892541|Serotonin Agents|serotonin agents|mesh-ancestor
110678241|NCT00892541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110678242|NCT00892541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110678243|NCT00892541|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110678244|NCT00892541|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110678245|NCT00892541|Dopamine Agents|dopamine agents|mesh-ancestor
110678246|NCT00890279|Imidapril|imidapril|mesh-list
110678247|NCT00890279|Cilnidipine|cilnidipine|mesh-list
110678248|NCT00890279|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110678249|NCT00890279|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110678250|NCT00890279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110678251|NCT00890279|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110678252|NCT00890279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110678253|NCT00890279|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110678254|NCT00890279|Protease Inhibitors|protease inhibitors|mesh-ancestor
110678255|NCT00890279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110678256|NCT00890279|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110678257|NCT00608543|Aripiprazole|aripiprazole|mesh-list
110678258|NCT00608543|Antidepressive Agents|antidepressive agents|mesh-ancestor
110678259|NCT00608543|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110678260|NCT00608543|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110678261|NCT00608543|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110678262|NCT00608543|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110678263|NCT00608543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110678264|NCT00608543|Dopamine Agonists|dopamine agonists|mesh-ancestor
110678265|NCT00608543|Dopamine Agents|dopamine agents|mesh-ancestor
110678266|NCT00608543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110678267|NCT00608543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110678268|NCT00608543|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110863882|NCT03253276|Cathartics|cathartics|mesh-ancestor
110678269|NCT00608543|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110678270|NCT00608543|Serotonin Agents|serotonin agents|mesh-ancestor
110678271|NCT00608543|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110678272|NCT00608543|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110678273|NCT00608543|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110678274|NCT00608543|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110678275|NCT02541383|Thalidomide|thalidomide|mesh-list
110678276|NCT02541383|Dexamethasone|dexamethasone|mesh-list
110678277|NCT02541383|Dexamethasone acetate|dexamethasone acetate|mesh-list
110678278|NCT02541383|Bortezomib|bortezomib|mesh-list
110678279|NCT02541383|Daratumumab|daratumumab|mesh-list
110678280|NCT02541383|BB 1101|bb 1101|mesh-list
110678281|NCT02541383|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110678282|NCT02541383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110678283|NCT02541383|Antiemetics|antiemetics|mesh-ancestor
110678284|NCT02541383|Autonomic Agents|autonomic agents|mesh-ancestor
110678285|NCT02541383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110678286|NCT02541383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110678287|NCT02541383|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110678288|NCT02541383|Glucocorticoids|glucocorticoids|mesh-ancestor
110678289|NCT02541383|Hormones|hormones|mesh-ancestor
110678290|NCT02541383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110678291|NCT02541383|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110678292|NCT02541383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110678293|NCT02541383|Protease Inhibitors|protease inhibitors|mesh-ancestor
110678294|NCT02541383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110678295|NCT02541383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110678296|NCT02541383|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110678297|NCT02541383|Immunologic Factors|immunologic factors|mesh-ancestor
110678298|NCT02541383|Leprostatic Agents|leprostatic agents|mesh-ancestor
110678299|NCT02541383|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110678300|NCT02541383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110678301|NCT02541383|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110678302|NCT02541383|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110678303|NCT02541383|Growth Substances|growth substances|mesh-ancestor
110678304|NCT02541383|Growth Inhibitors|growth inhibitors|mesh-ancestor
110678305|NCT04036487|Propofol|propofol|mesh-list
110678306|NCT04036487|Desflurane|desflurane|mesh-list
110678307|NCT04036487|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110678308|NCT04036487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110678309|NCT04036487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110325409|NCT02957630|Natriuretic Agents|natriuretic agents|mesh-ancestor
110678310|NCT04036487|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110678311|NCT04036487|Anesthetics, General|anesthetics, general|mesh-ancestor
110678312|NCT04036487|Anesthetics|anesthetics|mesh-ancestor
110678313|NCT04036487|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110678314|NCT05278793|Ferrous fumarate|ferrous fumarate|mesh-list
110678315|NCT05278793|Trace Elements|trace elements|mesh-ancestor
110678316|NCT05278793|Micronutrients|micronutrients|mesh-ancestor
110678317|NCT05278793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110678318|NCT04037657|Propofol|propofol|mesh-list
110678319|NCT04037657|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110678320|NCT04037657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110678321|NCT04037657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110678322|NCT04037657|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110678323|NCT04037657|Anesthetics, General|anesthetics, general|mesh-ancestor
110678324|NCT04037657|Anesthetics|anesthetics|mesh-ancestor
110678325|NCT00893009|Theophylline|theophylline|mesh-list
110678326|NCT00893009|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110678327|NCT00893009|Autonomic Agents|autonomic agents|mesh-ancestor
110678328|NCT00893009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110678329|NCT00893009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110678330|NCT00893009|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110678331|NCT00893009|Respiratory System Agents|respiratory system agents|mesh-ancestor
110678332|NCT00893009|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110678333|NCT00893009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110678334|NCT00893009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110678335|NCT00893009|Vasodilator Agents|vasodilator agents|mesh-ancestor
110678336|NCT00893009|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110678337|NCT00893009|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110678338|NCT00893009|Purinergic Agents|purinergic agents|mesh-ancestor
110678339|NCT00893009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110678340|NCT00890747|Sunitinib|sunitinib|mesh-list
110678341|NCT00890747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110678342|NCT00890747|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110678343|NCT00890747|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110678345|NCT00890747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110678346|NCT00890747|Growth Inhibitors|growth inhibitors|mesh-ancestor
110678347|NCT00890747|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110678348|NCT00890747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110678349|NCT00890747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110678350|NCT04017845|Tribenoside|tribenoside|mesh-list
110678351|NCT04017845|Lidocaine|lidocaine|mesh-list
110678352|NCT04017845|Diltiazem|diltiazem|mesh-list
110678353|NCT04017845|Calcium Channel Blockers|calcium channel blockers|mesh-list
110678354|NCT04017845|Nitroglycerin|nitroglycerin|mesh-list
110678355|NCT04017845|Bisacodyl|bisacodyl|mesh-list
110678356|NCT04017845|Anesthetics, Local|anesthetics, local|mesh-ancestor
110678357|NCT04017845|Anesthetics|anesthetics|mesh-ancestor
110678358|NCT04017845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110678359|NCT04017845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110678360|NCT04017845|Sensory System Agents|sensory system agents|mesh-ancestor
110678361|NCT04017845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110678362|NCT04017845|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110678363|NCT04017845|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110678364|NCT04017845|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110077013|NCT02855229|Modafinil|modafinil|mesh-list
110678365|NCT04017845|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110678366|NCT04017845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110678367|NCT04017845|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110678368|NCT04017845|Vasodilator Agents|vasodilator agents|mesh-ancestor
110678369|NCT04017845|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110678370|NCT04017845|Cathartics|cathartics|mesh-ancestor
110678371|NCT04017845|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110678372|NCT04017845|Laxatives|laxatives|mesh-ancestor
110678373|NCT04017845|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110678374|NCT04017845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110678375|NCT04017845|Analgesics|analgesics|mesh-ancestor
110678376|NCT04017845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110678377|NCT04017845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110678378|NCT00520130|Cytarabine|cytarabine|mesh-list
110678379|NCT00520130|Cyclosporine|cyclosporine|mesh-list
110678380|NCT00520130|Rituximab|rituximab|mesh-list
110678381|NCT00520130|Alemtuzumab|alemtuzumab|mesh-list
110678382|NCT00520130|Fludarabine|fludarabine|mesh-list
110678383|NCT00520130|Cyclosporins|cyclosporins|mesh-list
110678384|NCT00520130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110678385|NCT00520130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110678386|NCT00520130|Immunologic Factors|immunologic factors|mesh-ancestor
110678387|NCT00520130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110678388|NCT00520130|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110678389|NCT00520130|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110678390|NCT00520130|Antimetabolites|antimetabolites|mesh-ancestor
110678391|NCT00520130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110678392|NCT00520130|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110678393|NCT00520130|Antiviral Agents|antiviral agents|mesh-ancestor
110678394|NCT00520130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110678395|NCT00520130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110678396|NCT00520130|Antifungal Agents|antifungal agents|mesh-ancestor
110430082|NCT00622687|Iloprost|iloprost|mesh-list
110678397|NCT00520130|Dermatologic Agents|dermatologic agents|mesh-ancestor
110678398|NCT00520130|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110678400|NCT00519896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110678401|NCT00519896|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110678402|NCT00519896|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110678403|NCT00519896|Growth Substances|growth substances|mesh-ancestor
110678404|NCT00519896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110678405|NCT00519896|Growth Inhibitors|growth inhibitors|mesh-ancestor
110678406|NCT00519896|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110678407|NCT00519896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110678408|NCT00519896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110678409|NCT00527618|Valacyclovir|valacyclovir|mesh-list
110678410|NCT00527618|Acyclovir|acyclovir|mesh-list
110678411|NCT00527618|Antiviral Agents|antiviral agents|mesh-ancestor
110678412|NCT00527618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110678413|NCT00527072|Infliximab|infliximab|mesh-list
110678414|NCT00527072|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110678415|NCT00527072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110678416|NCT00527072|Dermatologic Agents|dermatologic agents|mesh-ancestor
110678417|NCT00527072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110678418|NCT00527072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110678419|NCT00519428|Dexetimide|dexetimide|mesh-list
110678421|NCT00519428|Bupropion|bupropion|mesh-list
110678422|NCT00519428|Escitalopram|escitalopram|mesh-list
110678423|NCT00519428|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110678424|NCT00519428|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110678425|NCT00519428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110863883|NCT03253276|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110678426|NCT00519428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110678427|NCT00519428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110678428|NCT00519428|Serotonin Agents|serotonin agents|mesh-ancestor
110678429|NCT00519428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110678430|NCT00519428|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110678431|NCT00519428|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110678432|NCT00519428|Parasympatholytics|parasympatholytics|mesh-ancestor
110678433|NCT00519428|Autonomic Agents|autonomic agents|mesh-ancestor
110678434|NCT00519428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110678435|NCT00519428|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110678436|NCT00519428|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110678437|NCT00519428|Cholinergic Agents|cholinergic agents|mesh-ancestor
110678438|NCT00519428|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110678439|NCT00519428|Antidepressive Agents|antidepressive agents|mesh-ancestor
110678440|NCT00519428|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110678441|NCT00519428|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110678442|NCT00519428|Dopamine Agents|dopamine agents|mesh-ancestor
110678443|NCT00519428|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110863884|NCT01372644|Pasireotide|pasireotide|mesh-list
110678444|NCT00519428|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110678445|NCT00519428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110678446|NCT00431847|Anesthetics|anesthetics|mesh-list
110678447|NCT00431847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110678448|NCT00431847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110678449|NCT00431067|Afatinib|afatinib|mesh-list
110678450|NCT00431067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110678451|NCT00431067|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110678452|NCT00431067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110863885|NCT01372644|Hormones|hormones|mesh-ancestor
110678453|NCT00431067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110678454|NCT00430989|Nitrous Oxide|nitrous oxide|mesh-list
110678455|NCT00430989|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110678456|NCT00430989|Anesthetics, General|anesthetics, general|mesh-ancestor
110678457|NCT00430989|Anesthetics|anesthetics|mesh-ancestor
110678458|NCT00430989|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110678459|NCT00430989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110678460|NCT00430989|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110678461|NCT00430989|Analgesics|analgesics|mesh-ancestor
110678462|NCT00430989|Sensory System Agents|sensory system agents|mesh-ancestor
110678463|NCT00430989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110678464|NCT00518882|Liraglutide|liraglutide|mesh-list
110678465|NCT00518882|Exenatide|exenatide|mesh-list
110678466|NCT00518882|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110678467|NCT00518882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110678468|NCT00518882|Incretins|incretins|mesh-ancestor
110678469|NCT00518882|Hormones|hormones|mesh-ancestor
110678470|NCT00518882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110678471|NCT00518882|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110678472|NCT00518180|Lactitol|lactitol|mesh-list
110678473|NCT00518180|Vaccines|vaccines|mesh-list
110678474|NCT00518180|Immunologic Factors|immunologic factors|mesh-ancestor
110678475|NCT00518180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110678476|NCT00518180|Cathartics|cathartics|mesh-ancestor
110678477|NCT00518180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110678478|NCT00525902|Adalimumab|adalimumab|mesh-list
110678479|NCT00525902|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110678480|NCT00525902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110678481|NCT00525902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110678482|NCT00525824|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110678483|NCT00525824|Simvastatin|simvastatin|mesh-list
110678484|NCT00525824|Ezetimibe|ezetimibe|mesh-list
110678485|NCT00525824|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110678486|NCT00525824|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110678487|NCT00525824|Antimetabolites|antimetabolites|mesh-ancestor
110371294|NCT01153009|Analgesics|analgesics|mesh-ancestor
110678488|NCT00525824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110678489|NCT00525824|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110678490|NCT00525824|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110678491|NCT00525824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110678492|NCT00525590|Carmustine|carmustine|mesh-list
110678493|NCT00525590|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110678494|NCT00525590|Alkylating Agents|alkylating agents|mesh-ancestor
110678495|NCT00525590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110678496|NCT00525590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110678497|NCT00430677|Mycophenolic Acid|mycophenolic acid|mesh-list
110678498|NCT00430677|Prednisone|prednisone|mesh-list
110678499|NCT00430677|Prednisolone|prednisolone|mesh-list
110678500|NCT00430677|Abatacept|abatacept|mesh-list
110678501|NCT00430677|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110430417|NCT00640081|Leucovorin|leucovorin|mesh-list
110678502|NCT00430677|Glucocorticoids|glucocorticoids|mesh-ancestor
110678503|NCT00430677|Hormones|hormones|mesh-ancestor
110678504|NCT00430677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110678505|NCT00430677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110678506|NCT00430677|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110678507|NCT00430677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110678508|NCT00430677|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110678509|NCT00430677|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110678510|NCT00430677|Antitubercular Agents|antitubercular agents|mesh-ancestor
110678511|NCT00430677|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110678512|NCT00430677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110678513|NCT00430677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110678514|NCT00430677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110678515|NCT00430677|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110678516|NCT00430677|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110678517|NCT00430677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110678518|NCT00430677|Immunologic Factors|immunologic factors|mesh-ancestor
110678519|NCT00430677|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110678521|NCT02631759|Anticonvulsants|anticonvulsants|mesh-ancestor
110678522|NCT02631759|Nootropic Agents|nootropic agents|mesh-ancestor
110678523|NCT01035801|Insulin Lispro|insulin lispro|mesh-list
110678524|NCT01035801|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110678525|NCT01035801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110678526|NCT00525512|Tiotropium Bromide|tiotropium bromide|mesh-list
110678527|NCT00525512|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110678528|NCT00525512|Autonomic Agents|autonomic agents|mesh-ancestor
110678529|NCT00525512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110678530|NCT00525512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110678531|NCT00525512|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110678532|NCT00525512|Respiratory System Agents|respiratory system agents|mesh-ancestor
110678533|NCT00525512|Parasympatholytics|parasympatholytics|mesh-ancestor
110678534|NCT00525512|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110678535|NCT00525512|Cholinergic Agents|cholinergic agents|mesh-ancestor
110352926|NCT05469750|Letrozole|letrozole|mesh-list
110678536|NCT00525512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110678537|NCT00525512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110678538|NCT04501406|Pioglitazone|pioglitazone|mesh-list
110678539|NCT04501406|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110678540|NCT04501406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110678541|NCT03656666|Thalidomide|thalidomide|mesh-list
110678543|NCT03656666|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110678544|NCT03656666|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110678545|NCT03656666|Analgesics|analgesics|mesh-ancestor
110678546|NCT03656666|Sensory System Agents|sensory system agents|mesh-ancestor
110678547|NCT03656666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110678548|NCT03656666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110678549|NCT03656666|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110678550|NCT03656666|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110678551|NCT03656666|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
110678552|NCT03656666|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110678553|NCT03656666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110678554|NCT03656666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110678555|NCT03656666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110678556|NCT03656666|Immunologic Factors|immunologic factors|mesh-ancestor
110678557|NCT03656666|Leprostatic Agents|leprostatic agents|mesh-ancestor
110678558|NCT03656666|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110678559|NCT03656666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110678560|NCT03656666|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110430654|NCT02683291|Hormones|hormones|mesh-ancestor
110678561|NCT03656666|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110678562|NCT03656666|Growth Substances|growth substances|mesh-ancestor
110678563|NCT03656666|Growth Inhibitors|growth inhibitors|mesh-ancestor
110678564|NCT03656666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110678565|NCT00430521|Vaccines|vaccines|mesh-list
110678566|NCT00430521|Immunologic Factors|immunologic factors|mesh-ancestor
110678567|NCT00430521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110678568|NCT01036035|Tolterodine Tartrate|tolterodine tartrate|mesh-list
110678569|NCT01036035|Pilocarpine|pilocarpine|mesh-list
110678570|NCT01036035|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110678571|NCT01036035|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110678572|NCT01036035|Cholinergic Agents|cholinergic agents|mesh-ancestor
110678573|NCT01036035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110678574|NCT01036035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110678575|NCT01036035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110678576|NCT01036035|Urological Agents|urological agents|mesh-ancestor
110678577|NCT01036035|Miotics|miotics|mesh-ancestor
110678578|NCT01036035|Autonomic Agents|autonomic agents|mesh-ancestor
110678579|NCT01036035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110678580|NCT01036035|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
110678581|NCT01036035|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110678582|NCT01036659|Ecallantide|ecallantide|mesh-list
110678583|NCT01036659|Bradykinin|bradykinin|mesh-list
110678584|NCT01036659|Kallikreins|kallikreins|mesh-list
110678585|NCT01036659|Kininogens|kininogens|mesh-list
110678586|NCT01036659|Vasodilator Agents|vasodilator agents|mesh-ancestor
110678587|NCT01036659|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
110678588|NCT01036659|Protease Inhibitors|protease inhibitors|mesh-ancestor
110678589|NCT01036659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110678590|NCT01036659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110678591|NCT01036659|Analgesics|analgesics|mesh-ancestor
110678592|NCT01036659|Sensory System Agents|sensory system agents|mesh-ancestor
110678593|NCT01036659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110678594|NCT01036659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110678595|NCT01036659|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110678596|NCT01036659|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110678597|NCT01036659|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110678598|NCT01036659|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110678599|NCT01036659|Coagulants|coagulants|mesh-ancestor
110678600|NCT01036659|Fertility Agents, Male|fertility agents, male|mesh-ancestor
110678601|NCT01036659|Fertility Agents|fertility agents|mesh-ancestor
110678602|NCT01036659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110678603|NCT01033149|Acetylcysteine|acetylcysteine|mesh-list
110678604|NCT01033149|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110678605|NCT01033149|Antiviral Agents|antiviral agents|mesh-ancestor
110678606|NCT01033149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110678607|NCT01033149|Expectorants|expectorants|mesh-ancestor
110678608|NCT01033149|Respiratory System Agents|respiratory system agents|mesh-ancestor
110678609|NCT01033149|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110678610|NCT01033149|Antioxidants|antioxidants|mesh-ancestor
110678611|NCT01033149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110678612|NCT01033149|Protective Agents|protective agents|mesh-ancestor
110678613|NCT01033149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110678615|NCT06051344|Zoledronic Acid|zoledronic acid|mesh-list
110325708|NCT00436943|Dopamine Agents|dopamine agents|mesh-ancestor
110678616|NCT06051344|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110678617|NCT06051344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110678618|NCT06051240|Lithium Carbonate|lithium carbonate|mesh-list
110678619|NCT06051240|Antidepressive Agents|antidepressive agents|mesh-ancestor
110678620|NCT06051240|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110678621|NCT06051240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110678622|NCT06051240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110678623|NCT06051240|Antimanic Agents|antimanic agents|mesh-ancestor
110678624|NCT06051240|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110678625|NCT06051240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110678626|NCT06051240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110678627|NCT06051227|Fentanyl|fentanyl|mesh-list
110678628|NCT06051227|Esketamine|esketamine|mesh-list
110678629|NCT06051227|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110678630|NCT06051227|Narcotics|narcotics|mesh-ancestor
110678631|NCT06051227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110678632|NCT06051227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110678633|NCT06051227|Analgesics|analgesics|mesh-ancestor
110678634|NCT06051227|Sensory System Agents|sensory system agents|mesh-ancestor
110678635|NCT06051227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110678636|NCT06051227|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110678637|NCT06051227|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110678638|NCT06051227|Anesthetics, General|anesthetics, general|mesh-ancestor
110678639|NCT06051227|Anesthetics|anesthetics|mesh-ancestor
110678640|NCT06051227|Antidepressive Agents|antidepressive agents|mesh-ancestor
110678641|NCT06051227|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110678642|NCT06050954|Pembrolizumab|pembrolizumab|mesh-list
110678643|NCT06050954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110408300|NCT05926869|Dapsone|dapsone|mesh-list
110678645|NCT06050954|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110678646|NCT06050954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110678647|NCT06050941|Cytarabine|cytarabine|mesh-list
110678648|NCT06050941|Idarubicin|idarubicin|mesh-list
110678649|NCT06050941|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110678650|NCT06050941|Antimetabolites|antimetabolites|mesh-ancestor
110678651|NCT06050941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110678652|NCT06050941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110678653|NCT06050941|Antiviral Agents|antiviral agents|mesh-ancestor
110678654|NCT06050941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110678655|NCT06050941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110678656|NCT06050941|Immunologic Factors|immunologic factors|mesh-ancestor
110678657|NCT06050941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110128616|NCT04006210|Levodopa|levodopa|mesh-list
110678658|NCT06050941|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110678659|NCT06050941|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110678660|NCT06050941|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110431101|NCT01194245|Insulin|insulin|mesh-list
110678662|NCT06050863|Chlorhexidine|chlorhexidine|mesh-list
110678663|NCT06050863|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110678664|NCT06050863|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110678665|NCT06050863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110678666|NCT06050863|Disinfectants|disinfectants|mesh-ancestor
110678667|NCT06050863|Dermatologic Agents|dermatologic agents|mesh-ancestor
110678668|NCT06050785|Vancomycin|vancomycin|mesh-list
110678669|NCT06050785|Gentamicins|gentamicins|mesh-list
110678670|NCT06050785|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110678671|NCT06050785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110678672|NCT06050785|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110678673|NCT06050785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110678674|NCT06050785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110678675|NCT06050512|Dexamethasone|dexamethasone|mesh-list
110678676|NCT06050512|Ixazomib|ixazomib|mesh-list
110678677|NCT06050512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110678678|NCT06050512|Antiemetics|antiemetics|mesh-ancestor
110678679|NCT06050512|Autonomic Agents|autonomic agents|mesh-ancestor
110678680|NCT06050512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110678681|NCT06050512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110678682|NCT06050512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110678683|NCT06050512|Glucocorticoids|glucocorticoids|mesh-ancestor
110678684|NCT06050512|Hormones|hormones|mesh-ancestor
110678685|NCT06050512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110678686|NCT06050512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110678688|NCT06050512|Protease Inhibitors|protease inhibitors|mesh-ancestor
110678689|NCT06050512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110678690|NCT06050512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110678691|NCT06050343|Insulin|insulin|mesh-list
110678692|NCT06050343|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110678693|NCT06050343|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110678694|NCT06050343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110678696|NCT06050252|Gemcitabine|gemcitabine|mesh-list
110678697|NCT06050252|Durvalumab|durvalumab|mesh-list
110678698|NCT06050252|Immunoglobulins|immunoglobulins|mesh-list
110678699|NCT06050252|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110678700|NCT06050252|Immunoglobulin G|immunoglobulin g|mesh-list
110678701|NCT06050252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110678702|NCT06050252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110678703|NCT06050252|Antimetabolites|antimetabolites|mesh-ancestor
110678704|NCT06050252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110678705|NCT06050252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110678706|NCT06050252|Immunologic Factors|immunologic factors|mesh-ancestor
110678707|NCT06050252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110678708|NCT06050200|Liver Extracts|liver extracts|mesh-list
110678709|NCT06050200|Hematinics|hematinics|mesh-ancestor
110678710|NCT06050122|Veratrum Alkaloids|veratrum alkaloids|mesh-list
110678711|NCT06050122|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110678712|NCT06050044|Bupivacaine|bupivacaine|mesh-list
110678713|NCT06050044|Anesthetics, Local|anesthetics, local|mesh-ancestor
110678714|NCT06050044|Anesthetics|anesthetics|mesh-ancestor
110678715|NCT06050044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110678716|NCT06050044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110678717|NCT06050044|Sensory System Agents|sensory system agents|mesh-ancestor
110678718|NCT06050044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110678719|NCT06050031|Antioxidants|antioxidants|mesh-list
110678720|NCT06050031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110678721|NCT06050031|Protective Agents|protective agents|mesh-ancestor
110678722|NCT06050031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110431398|NCT01181531|Vitamins|vitamins|mesh-ancestor
110678723|NCT06049966|Carboplatin|carboplatin|mesh-list
110678724|NCT06049966|Etoposide|etoposide|mesh-list
110678725|NCT06049966|Atezolizumab|atezolizumab|mesh-list
110678726|NCT06049966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110678727|NCT06049966|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110678728|NCT06049966|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110678729|NCT06049966|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110678730|NCT06049966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110678731|NCT06049966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110678732|NCT06049966|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110678733|NCT06049966|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110678734|NCT06049953|Antipsychotic Agents|antipsychotic agents|mesh-list
110678735|NCT06049953|Antidepressive Agents|antidepressive agents|mesh-list
110678736|NCT06049953|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110678737|NCT06049953|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110678738|NCT06049953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110678739|NCT06049953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110678741|NCT06049940|Immunologic Factors|immunologic factors|mesh-ancestor
110678742|NCT06049940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110678743|NCT06049927|Vaccines|vaccines|mesh-list
110678744|NCT06049927|Immunologic Factors|immunologic factors|mesh-ancestor
110678745|NCT06049927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110678746|NCT06049901|Nitazoxanide|nitazoxanide|mesh-list
110678747|NCT06049901|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110678748|NCT06049901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110678749|NCT06049797|Clonidine|clonidine|mesh-list
110678750|NCT06049797|Pregabalin|pregabalin|mesh-list
110678751|NCT06049797|Gabapentin|gabapentin|mesh-list
110678752|NCT06049797|Citalopram|citalopram|mesh-list
110678753|NCT06049797|Paroxetine|paroxetine|mesh-list
110678754|NCT06049797|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
110678755|NCT06049797|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
110678756|NCT06049797|Oxybutynin|oxybutynin|mesh-list
110678757|NCT06049797|Escitalopram|escitalopram|mesh-list
110678758|NCT06049797|Analgesics|analgesics|mesh-ancestor
110678759|NCT06049797|Sensory System Agents|sensory system agents|mesh-ancestor
110678760|NCT06049797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110678761|NCT06049797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110678762|NCT06049797|Anticonvulsants|anticonvulsants|mesh-ancestor
110678763|NCT06049797|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110678764|NCT06049797|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110678765|NCT06049797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110678766|NCT06049797|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110678767|NCT06049797|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110678768|NCT06049797|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110678769|NCT06049797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110678770|NCT06049797|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110678771|NCT06049797|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110678772|NCT06049797|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110678773|NCT06049797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110678774|NCT06049797|Antimanic Agents|antimanic agents|mesh-ancestor
110678775|NCT06049797|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110678776|NCT06049797|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110678777|NCT06049797|Serotonin Agents|serotonin agents|mesh-ancestor
110678778|NCT06049797|Parasympatholytics|parasympatholytics|mesh-ancestor
110678779|NCT06049797|Autonomic Agents|autonomic agents|mesh-ancestor
110678780|NCT06049797|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110678781|NCT06049797|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110678782|NCT06049797|Cholinergic Agents|cholinergic agents|mesh-ancestor
110678783|NCT06049797|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110678784|NCT06049797|Antidepressive Agents|antidepressive agents|mesh-ancestor
110678785|NCT06049797|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110678786|NCT06049797|Sympatholytics|sympatholytics|mesh-ancestor
110678787|NCT06049797|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110678788|NCT06049797|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110678789|NCT06049797|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110678790|NCT06049797|Adrenergic Agents|adrenergic agents|mesh-ancestor
110678791|NCT06049797|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110678792|NCT06049797|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110678793|NCT06049797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110678794|NCT06049797|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110678795|NCT06049797|Urological Agents|urological agents|mesh-ancestor
110678796|NCT06049758|Levofloxacin|levofloxacin|mesh-list
110678798|NCT06049758|Anticoagulants|anticoagulants|mesh-ancestor
110678799|NCT06049758|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110678800|NCT06049758|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110678801|NCT06049758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110678802|NCT06049758|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110678803|NCT06049758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110678804|NCT06049758|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110678805|NCT06049758|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110678806|NCT06049758|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110678807|NCT06049758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110678808|NCT06049758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110678809|NCT06049758|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110678810|NCT06049758|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110678811|NCT06049745|Misoprostol|misoprostol|mesh-list
110678812|NCT06049745|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110678813|NCT06049745|Abortifacient Agents|abortifacient agents|mesh-ancestor
110678814|NCT06049745|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110678815|NCT06049745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110678816|NCT06049745|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110678817|NCT06049745|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110678818|NCT06049745|Oxytocics|oxytocics|mesh-ancestor
110678819|NCT06049693|Ferrous gluconate|ferrous gluconate|mesh-list
110678820|NCT06049693|Hematinics|hematinics|mesh-ancestor
110678821|NCT06049680|SMOFlipid|smoflipid|mesh-list
110856262|NCT01561781|Digoxin|digoxin|mesh-list
110678822|NCT06049680|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
110678823|NCT06049680|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
110678824|NCT06049680|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110678825|NCT06049654|Fexofenadine|fexofenadine|mesh-list
110678826|NCT06049654|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110678827|NCT06049654|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110678828|NCT06049654|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110678829|NCT06049654|Histamine Antagonists|histamine antagonists|mesh-ancestor
110678830|NCT06049654|Histamine Agents|histamine agents|mesh-ancestor
110678831|NCT06049654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110678832|NCT06049654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110678833|NCT06049654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110678834|NCT06049589|Chlorhexidine|chlorhexidine|mesh-list
110678835|NCT06049589|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110678836|NCT06049589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110678837|NCT06049589|Disinfectants|disinfectants|mesh-ancestor
110678838|NCT06049576|Nivolumab|nivolumab|mesh-list
110678840|NCT06049576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110678841|NCT06049576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110678842|NCT06049576|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110325929|NCT00438113|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110431883|NCT00642421|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110678843|NCT06049576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110678844|NCT06049212|Carboplatin|carboplatin|mesh-list
110678845|NCT06049212|Pembrolizumab|pembrolizumab|mesh-list
110678846|NCT06049212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110678847|NCT06049212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110678848|NCT06049212|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110678849|NCT06049212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110678850|NCT06049186|Metformin|metformin|mesh-list
110678851|NCT06049186|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110678852|NCT06049186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110678853|NCT06048874|Ropivacaine|ropivacaine|mesh-list
110678854|NCT06048874|Anesthetics, Local|anesthetics, local|mesh-ancestor
110678855|NCT06048874|Anesthetics|anesthetics|mesh-ancestor
110678856|NCT06048874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110678857|NCT06048874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110678858|NCT06048874|Sensory System Agents|sensory system agents|mesh-ancestor
110678859|NCT06048874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110678860|NCT06048848|Ropivacaine|ropivacaine|mesh-list
110678861|NCT06048848|Anesthetics, Local|anesthetics, local|mesh-ancestor
110678862|NCT06048848|Anesthetics|anesthetics|mesh-ancestor
110678863|NCT06048848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110678864|NCT06048848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110678865|NCT06048848|Sensory System Agents|sensory system agents|mesh-ancestor
110678866|NCT06048848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110678868|NCT06048614|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
110678869|NCT06048614|Protective Agents|protective agents|mesh-ancestor
110678870|NCT06048614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110678871|NCT06048588|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110678872|NCT06048588|Calcium|calcium|mesh-list
110678873|NCT06048588|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110678874|NCT06048588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110678875|NCT06048588|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110678876|NCT06048588|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110678877|NCT06048588|Antimetabolites|antimetabolites|mesh-ancestor
110678878|NCT06048588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110678879|NCT06048588|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110678880|NCT06048588|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110678881|NCT06048588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110678882|NCT06048341|Ropivacaine|ropivacaine|mesh-list
110678883|NCT06048341|Anesthetics, Local|anesthetics, local|mesh-ancestor
110678884|NCT06048341|Anesthetics|anesthetics|mesh-ancestor
110678885|NCT06048341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110678886|NCT06048341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110678887|NCT06048341|Sensory System Agents|sensory system agents|mesh-ancestor
110678888|NCT06048341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110678889|NCT06045884|Ropivacaine|ropivacaine|mesh-list
110678890|NCT06045884|Anesthetics, Local|anesthetics, local|mesh-ancestor
110678891|NCT06045884|Anesthetics|anesthetics|mesh-ancestor
110678892|NCT06045884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110678893|NCT06045884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110678894|NCT06045884|Sensory System Agents|sensory system agents|mesh-ancestor
110678895|NCT06045884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110678896|NCT06044805|Chloroquine|chloroquine|mesh-list
110678897|NCT06044805|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
110678898|NCT06044805|Primaquine|primaquine|mesh-list
110678899|NCT06044805|Amebicides|amebicides|mesh-ancestor
110678900|NCT06044805|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110678901|NCT06044805|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110678902|NCT06044805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110678903|NCT06044805|Antimalarials|antimalarials|mesh-ancestor
110678904|NCT06044805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110678905|NCT06044805|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110678906|NCT06044805|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110678907|NCT06044805|Analgesics|analgesics|mesh-ancestor
110678908|NCT06044805|Sensory System Agents|sensory system agents|mesh-ancestor
110678909|NCT06044805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110678910|NCT06044805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110678911|NCT06044805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110678912|NCT06044805|Filaricides|filaricides|mesh-ancestor
110678913|NCT06044805|Antinematodal Agents|antinematodal agents|mesh-ancestor
110678914|NCT06044805|Anthelmintics|anthelmintics|mesh-ancestor
110678915|NCT06044779|Bupivacaine|bupivacaine|mesh-list
110678916|NCT06044779|Anesthetics, Local|anesthetics, local|mesh-ancestor
110678917|NCT06044779|Anesthetics|anesthetics|mesh-ancestor
110326007|NCT00438386|Serotonin Agents|serotonin agents|mesh-ancestor
110678918|NCT06044779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110678919|NCT06044779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110678920|NCT06044779|Sensory System Agents|sensory system agents|mesh-ancestor
110678921|NCT06044779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110678922|NCT06043362|Nicotine|nicotine|mesh-list
110678923|NCT06043362|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110678924|NCT06043362|Autonomic Agents|autonomic agents|mesh-ancestor
110678925|NCT06043362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110678926|NCT06043362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110678927|NCT06043362|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110678928|NCT06043362|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110678929|NCT06043362|Cholinergic Agents|cholinergic agents|mesh-ancestor
110678930|NCT06043362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110678931|NCT06043362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110678932|NCT06042569|Cyclophosphamide|cyclophosphamide|mesh-list
110678933|NCT06042569|Docetaxel|docetaxel|mesh-list
110678934|NCT06042569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110678935|NCT06042569|Immunologic Factors|immunologic factors|mesh-ancestor
110678936|NCT06042569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110678937|NCT06042569|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110678938|NCT06042569|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110678939|NCT06042569|Alkylating Agents|alkylating agents|mesh-ancestor
110314111|NCT00332904|Diuretics|diuretics|mesh-ancestor
110678940|NCT06042569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110678942|NCT06042569|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110678943|NCT06042569|Tubulin Modulators|tubulin modulators|mesh-ancestor
110678944|NCT06042569|Antimitotic Agents|antimitotic agents|mesh-ancestor
110678945|NCT06042569|Mitosis Modulators|mitosis modulators|mesh-ancestor
110678946|NCT06042478|Omalizumab|omalizumab|mesh-list
110678947|NCT06042478|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110678948|NCT06042478|Remibrutinib|remibrutinib|mesh-list
110678949|NCT06042478|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110678950|NCT06042478|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110678951|NCT06042478|Respiratory System Agents|respiratory system agents|mesh-ancestor
110678952|NCT06042478|Immunologic Factors|immunologic factors|mesh-ancestor
110432310|NCT00609154|Incretins|incretins|mesh-ancestor
110678953|NCT06042478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110678954|NCT06042478|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110678955|NCT06042478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110678956|NCT06042478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110678957|NCT06041646|Dexmedetomidine|dexmedetomidine|mesh-list
110678958|NCT06041646|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110678959|NCT06041646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110678960|NCT06041646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110678961|NCT06041646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110678962|NCT06041646|Analgesics|analgesics|mesh-ancestor
110678963|NCT06041646|Sensory System Agents|sensory system agents|mesh-ancestor
110678964|NCT06041646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110678965|NCT06041646|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110678966|NCT06041646|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110678967|NCT06041646|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110432436|NCT05908305|Autonomic Agents|autonomic agents|mesh-ancestor
110678968|NCT06041646|Adrenergic Agents|adrenergic agents|mesh-ancestor
110678969|NCT06041646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110678970|NCT06041646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110678971|NCT06040060|Ketamine|ketamine|mesh-list
110678972|NCT06040060|Analgesics|analgesics|mesh-ancestor
110678973|NCT06040060|Sensory System Agents|sensory system agents|mesh-ancestor
110678974|NCT06040060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110678975|NCT06040060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110678976|NCT06040060|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110678977|NCT06040060|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110678978|NCT06040060|Anesthetics, General|anesthetics, general|mesh-ancestor
110678979|NCT06040060|Anesthetics|anesthetics|mesh-ancestor
110678980|NCT06040060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110678981|NCT06040060|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110678982|NCT06040060|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110678983|NCT06040060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110678984|NCT06040060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110678985|NCT06040034|Lidocaine|lidocaine|mesh-list
110678986|NCT06040034|Anesthetics, Local|anesthetics, local|mesh-ancestor
110678987|NCT06040034|Anesthetics|anesthetics|mesh-ancestor
110678988|NCT06040034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110678989|NCT06040034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110678990|NCT06040034|Sensory System Agents|sensory system agents|mesh-ancestor
110678991|NCT06040034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110678993|NCT06040034|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110678994|NCT06040034|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110678995|NCT06040034|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110678996|NCT06040034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110678997|NCT06038981|Tranexamic Acid|tranexamic acid|mesh-list
110678998|NCT06038981|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110678999|NCT06038981|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110432637|NCT05736874|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110679000|NCT06038981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110679001|NCT06038981|Hemostatics|hemostatics|mesh-ancestor
110679002|NCT06038981|Coagulants|coagulants|mesh-ancestor
110679003|NCT06028464|Carbamazepine|carbamazepine|mesh-list
110679004|NCT06028464|Anticonvulsants|anticonvulsants|mesh-ancestor
110679005|NCT06028464|Antimanic Agents|antimanic agents|mesh-ancestor
110679006|NCT06028464|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110679007|NCT06028464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110679008|NCT06028464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110679009|NCT06028464|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110679010|NCT06028464|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110679011|NCT06028464|Analgesics|analgesics|mesh-ancestor
110679012|NCT06028464|Sensory System Agents|sensory system agents|mesh-ancestor
110560340|NCT00638729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110679013|NCT06028464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110679014|NCT06028464|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110679015|NCT06028464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110679016|NCT06028464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110679017|NCT06028464|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110679018|NCT06028464|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110679020|NCT05990400|Finasteride|finasteride|mesh-list
110679021|NCT05990400|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110679022|NCT05990400|Vasodilator Agents|vasodilator agents|mesh-ancestor
110679023|NCT05990400|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
110679024|NCT05990400|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110679025|NCT05990400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110679026|NCT05990400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110679027|NCT05990400|Hormone Antagonists|hormone antagonists|mesh-ancestor
110679028|NCT05990400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110679029|NCT05990400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110679030|NCT05990400|Urological Agents|urological agents|mesh-ancestor
110679031|NCT05983302|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
110679032|NCT05983302|Hemostatics|hemostatics|mesh-ancestor
110679033|NCT05983302|Coagulants|coagulants|mesh-ancestor
110679034|NCT05970731|Beclomethasone|beclomethasone|mesh-list
110679035|NCT05970731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110679036|NCT05970731|Glucocorticoids|glucocorticoids|mesh-ancestor
110679037|NCT05970731|Hormones|hormones|mesh-ancestor
110679038|NCT05970731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110679039|NCT05970731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110679040|NCT05970731|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110679041|NCT05970731|Respiratory System Agents|respiratory system agents|mesh-ancestor
110679042|NCT05965440|Dapagliflozin|dapagliflozin|mesh-list
110679043|NCT05965440|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110679044|NCT05965440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110679045|NCT05965440|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110679046|NCT05965440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110679047|NCT05949684|Epoetin Alfa|epoetin alfa|mesh-list
110679048|NCT05949684|Luspatercept|luspatercept|mesh-list
110679049|NCT05949684|Hematinics|hematinics|mesh-ancestor
110679050|NCT05941247|Hemay005|hemay005|mesh-list
110679051|NCT05941247|Dermatologic Agents|dermatologic agents|mesh-ancestor
110679052|NCT05941247|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
110679053|NCT05941247|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110679054|NCT05941247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110679055|NCT05941247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110679056|NCT05934942|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
110679057|NCT05934942|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110679058|NCT05934942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110679059|NCT05932303|Itraconazole|itraconazole|mesh-list
110679060|NCT05932303|Carbamazepine|carbamazepine|mesh-list
110679061|NCT05932303|Gemfibrozil|gemfibrozil|mesh-list
110679062|NCT05932303|Antifungal Agents|antifungal agents|mesh-ancestor
110679063|NCT05932303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110679064|NCT05932303|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110679065|NCT05932303|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110679066|NCT05932303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110679067|NCT05932303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110679068|NCT05932303|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110679069|NCT05932303|Hormone Antagonists|hormone antagonists|mesh-ancestor
110679070|NCT05932303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110679071|NCT05932303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110679072|NCT05932303|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110679073|NCT05932303|Anticonvulsants|anticonvulsants|mesh-ancestor
110679074|NCT05932303|Antimanic Agents|antimanic agents|mesh-ancestor
110679075|NCT05932303|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110679076|NCT05932303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110679077|NCT05932303|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110679078|NCT05932303|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110679080|NCT05932303|Sensory System Agents|sensory system agents|mesh-ancestor
110679081|NCT05932303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110679082|NCT05932303|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110679083|NCT05932303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110314252|NCT00305747|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
110679084|NCT05932303|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110679085|NCT05932303|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110679086|NCT05932303|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110679087|NCT05932303|Antimetabolites|antimetabolites|mesh-ancestor
110679088|NCT05932303|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110679089|NCT05932303|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
110679090|NCT05926505|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
110679091|NCT05926505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110679092|NCT05924594|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
110679093|NCT05924594|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110679094|NCT05924594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110679095|NCT05924594|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110679096|NCT05924594|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110679097|NCT05924594|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110679098|NCT05924594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110679099|NCT05924594|Dopamine Agents|dopamine agents|mesh-ancestor
110679100|NCT05924594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110679101|NCT05897658|Levetiracetam|levetiracetam|mesh-list
110679102|NCT05897658|Anticonvulsants|anticonvulsants|mesh-ancestor
110679103|NCT05897658|Nootropic Agents|nootropic agents|mesh-ancestor
110679104|NCT05891548|Aflibercept|aflibercept|mesh-list
110679105|NCT05891548|Axitinib|axitinib|mesh-list
110679106|NCT05891548|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110679107|NCT05891548|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110679108|NCT05891548|Growth Substances|growth substances|mesh-ancestor
110679109|NCT05891548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110679110|NCT05891548|Growth Inhibitors|growth inhibitors|mesh-ancestor
110679111|NCT05891548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110679112|NCT05891548|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110679113|NCT05891548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110679114|NCT05891548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110679115|NCT05874154|Botulinum Toxins|botulinum toxins|mesh-list
110679116|NCT05874154|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110679117|NCT05874154|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110679118|NCT05874154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110679119|NCT05874154|Cholinergic Agents|cholinergic agents|mesh-ancestor
110679120|NCT05874154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110679121|NCT05874154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110679122|NCT05874141|Hormones|hormones|mesh-list
110679123|NCT05874141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110679124|NCT05874141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110679125|NCT05855577|Terazosin|terazosin|mesh-list
110679126|NCT05855577|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110679127|NCT05855577|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110679128|NCT05855577|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110679129|NCT05855577|Adrenergic Agents|adrenergic agents|mesh-ancestor
110679130|NCT05855577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110679131|NCT05855577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110679132|NCT05855577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110679133|NCT05855577|Urological Agents|urological agents|mesh-ancestor
110679134|NCT05852262|Cephalexin|cephalexin|mesh-list
110679135|NCT05852262|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110679136|NCT05852262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110679137|NCT05850520|Aflibercept|aflibercept|mesh-list
110679138|NCT05850520|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110679139|NCT05850520|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110679140|NCT05850520|Growth Substances|growth substances|mesh-ancestor
110679141|NCT05850520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110679142|NCT05850520|Growth Inhibitors|growth inhibitors|mesh-ancestor
110679143|NCT05850520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110679144|NCT05846659|Pembrolizumab|pembrolizumab|mesh-list
110679145|NCT05846659|Nivolumab|nivolumab|mesh-list
110679146|NCT05846659|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
110679147|NCT05846659|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110679148|NCT05846659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110679149|NCT05846659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110679150|NCT05846646|Pembrolizumab|pembrolizumab|mesh-list
110679151|NCT05846646|Nivolumab|nivolumab|mesh-list
110679152|NCT05846646|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
110408306|NCT05926869|Antimalarials|antimalarials|mesh-ancestor
110679153|NCT05846646|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110679155|NCT05846646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110679156|NCT05809453|Lidocaine|lidocaine|mesh-list
110679157|NCT05809453|Cocaine|cocaine|mesh-list
110679158|NCT05809453|Anesthetics, Local|anesthetics, local|mesh-ancestor
110679159|NCT05809453|Anesthetics|anesthetics|mesh-ancestor
110679160|NCT05809453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110679161|NCT05809453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110679162|NCT05809453|Sensory System Agents|sensory system agents|mesh-ancestor
110679163|NCT05809453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110679164|NCT05809453|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110679165|NCT05809453|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110679166|NCT05809453|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110679167|NCT05809453|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110679168|NCT05809453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110679169|NCT05809453|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110679170|NCT05809453|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110679171|NCT05809453|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110679172|NCT05809453|Dopamine Agents|dopamine agents|mesh-ancestor
110679173|NCT05809453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110679174|NCT05737693|Midazolam|midazolam|mesh-list
110679175|NCT05737693|Ketamine|ketamine|mesh-list
110679176|NCT05737693|Analgesics|analgesics|mesh-ancestor
110679177|NCT05737693|Sensory System Agents|sensory system agents|mesh-ancestor
110679178|NCT05737693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110679179|NCT05737693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110433286|NCT02636322|Prednisone|prednisone|mesh-list
110679180|NCT05737693|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110679181|NCT05737693|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110679182|NCT05737693|Anesthetics, General|anesthetics, general|mesh-ancestor
110679183|NCT05737693|Anesthetics|anesthetics|mesh-ancestor
110679184|NCT05737693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110679185|NCT05737693|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110679186|NCT05737693|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110679187|NCT05737693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110679188|NCT05737693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110679189|NCT05737693|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110679190|NCT05737693|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110679191|NCT05737693|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110679192|NCT05737693|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110679193|NCT05737693|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110679194|NCT05737693|GABA Modulators|gaba modulators|mesh-ancestor
110679195|NCT05737693|GABA Agents|gaba agents|mesh-ancestor
110679196|NCT05718323|Niraparib|niraparib|mesh-list
110679197|NCT05718323|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110679198|NCT05718323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110679199|NCT05718323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110679200|NCT05718323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110679201|NCT05712356|Paclitaxel|paclitaxel|mesh-list
110679202|NCT05712356|Docetaxel|docetaxel|mesh-list
110679203|NCT05712356|Gemcitabine|gemcitabine|mesh-list
110679204|NCT05712356|Durvalumab|durvalumab|mesh-list
110679205|NCT05712356|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110679210|NCT05712356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110679211|NCT05712356|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110679212|NCT05712356|Antimetabolites|antimetabolites|mesh-ancestor
110679213|NCT05712356|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110679214|NCT05694819|Goserelin|goserelin|mesh-list
110679215|NCT05694819|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110679216|NCT05694819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110679217|NCT05693077|Vancomycin|vancomycin|mesh-list
110679218|NCT05693077|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110679219|NCT05693077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110679220|NCT05684055|Antihypertensive Agents|antihypertensive agents|mesh-list
110679221|NCT05681481|Prednisone|prednisone|mesh-list
110679222|NCT05681481|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110679223|NCT05681481|Glucocorticoids|glucocorticoids|mesh-ancestor
110679224|NCT05681481|Hormones|hormones|mesh-ancestor
110679225|NCT05681481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110679226|NCT05681481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110679227|NCT05681481|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110679228|NCT05681481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110679232|NCT05670106|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
110679233|NCT05670106|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110679240|NCT05669989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110679241|NCT05669989|Antiemetics|antiemetics|mesh-ancestor
110679242|NCT05669989|Autonomic Agents|autonomic agents|mesh-ancestor
110679243|NCT05669989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110679244|NCT05669989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110679245|NCT05669989|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110679246|NCT05669989|Glucocorticoids|glucocorticoids|mesh-ancestor
110679247|NCT05669989|Hormones|hormones|mesh-ancestor
110679248|NCT05669989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110679249|NCT05669989|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110679250|NCT05669989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110433527|NCT00003601|Tretinoin|tretinoin|mesh-list
110679251|NCT05669989|Immunologic Factors|immunologic factors|mesh-ancestor
110679252|NCT05669989|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110679253|NCT05669989|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110679254|NCT05669989|Growth Substances|growth substances|mesh-ancestor
110679255|NCT05669989|Growth Inhibitors|growth inhibitors|mesh-ancestor
110679256|NCT05669989|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110679257|NCT05668988|Carboplatin|carboplatin|mesh-list
110679258|NCT05668988|Pemetrexed|pemetrexed|mesh-list
110679259|NCT05668988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110433586|NCT00002514|Antiemetics|antiemetics|mesh-ancestor
110679260|NCT05668988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110679261|NCT05668988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110679262|NCT05668988|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110679263|NCT05668988|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110679264|NCT05644600|Nintedanib|nintedanib|mesh-list
110679265|NCT05644600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110679266|NCT05644600|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110679267|NCT05644600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110679268|NCT05644600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110679269|NCT05643794|Rozanolixizumab|rozanolixizumab|mesh-list
110679270|NCT05643794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110679271|NCT05643794|Immunologic Factors|immunologic factors|mesh-ancestor
110679272|NCT05643794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110679273|NCT05628883|Cyclophosphamide|cyclophosphamide|mesh-list
110679274|NCT05628883|Fludarabine|fludarabine|mesh-list
110679275|NCT05628883|Interleukin-2|interleukin-2|mesh-list
110679276|NCT05628883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110679277|NCT05628883|Immunologic Factors|immunologic factors|mesh-ancestor
110679278|NCT05628883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110679279|NCT05628883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110679280|NCT05628883|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110679281|NCT05628883|Alkylating Agents|alkylating agents|mesh-ancestor
110679282|NCT05628883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110679283|NCT05628883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110679284|NCT05628883|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110679285|NCT05628883|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110679286|NCT05628883|Analgesics|analgesics|mesh-ancestor
110679288|NCT05628883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110679289|NCT05609630|Upadacitinib|upadacitinib|mesh-list
110679290|NCT05609630|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
110679291|NCT05609630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110679292|NCT05609630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110679293|NCT05609630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110679294|NCT05609630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110679301|NCT05590793|Triptorelin Pamoate|triptorelin pamoate|mesh-list
110679302|NCT05590793|Luteolytic Agents|luteolytic agents|mesh-ancestor
110679303|NCT05590793|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110679304|NCT05590793|Contraceptive Agents|contraceptive agents|mesh-ancestor
110679305|NCT05590793|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110679306|NCT05590793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110679307|NCT05590793|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110679308|NCT05590793|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110679309|NCT05590793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110679313|NCT05590455|Adalimumab|adalimumab|mesh-list
110679314|NCT05590455|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110679315|NCT05590455|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110679316|NCT05590455|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110679317|NCT05586360|Simvastatin|simvastatin|mesh-list
110679318|NCT05586360|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110679319|NCT05586360|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110679320|NCT05586360|Antimetabolites|antimetabolites|mesh-ancestor
110679321|NCT05586360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110679322|NCT05586360|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110679323|NCT05586360|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110679324|NCT05586360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110679325|NCT05582876|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
110679326|NCT05582876|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
110679327|NCT05582876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110679328|NCT05581004|Atezolizumab|atezolizumab|mesh-list
110679329|NCT05581004|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110679330|NCT05581004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110679331|NCT05581004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110679332|NCT05581004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110679333|NCT05580003|Moxifloxacin|moxifloxacin|mesh-list
110679334|NCT05580003|Midazolam|midazolam|mesh-list
110679335|NCT05580003|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110679336|NCT05580003|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110679337|NCT05580003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110679338|NCT05580003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110679339|NCT05580003|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110679340|NCT05580003|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110679341|NCT05580003|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110679342|NCT05580003|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110679343|NCT05580003|Anesthetics, General|anesthetics, general|mesh-ancestor
110679344|NCT05580003|Anesthetics|anesthetics|mesh-ancestor
110679345|NCT05580003|GABA Modulators|gaba modulators|mesh-ancestor
110679346|NCT05580003|GABA Agents|gaba agents|mesh-ancestor
110679347|NCT05580003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110679348|NCT05580003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110679349|NCT05580003|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110679350|NCT05580003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110679351|NCT05580003|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110679352|NCT05580003|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110679353|NCT05580003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110679354|NCT05580003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110679355|NCT05578976|Prednisone|prednisone|mesh-list
110679356|NCT05578976|Cyclophosphamide|cyclophosphamide|mesh-list
110679364|NCT05578976|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110679365|NCT05578976|Alkylating Agents|alkylating agents|mesh-ancestor
110679366|NCT05578976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110679367|NCT05578976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110679368|NCT05578976|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110679369|NCT05578976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110679370|NCT05578976|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110679371|NCT05578976|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110679372|NCT05578976|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110679373|NCT05578976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110679374|NCT05578976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110679375|NCT05578976|Glucocorticoids|glucocorticoids|mesh-ancestor
110679376|NCT05578976|Hormones|hormones|mesh-ancestor
110679377|NCT05578976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110679378|NCT05578976|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110679379|NCT05578976|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110679380|NCT05578976|Tubulin Modulators|tubulin modulators|mesh-ancestor
110679381|NCT05578976|Antimitotic Agents|antimitotic agents|mesh-ancestor
110679382|NCT05578976|Mitosis Modulators|mitosis modulators|mesh-ancestor
110679383|NCT05572229|Lenalidomide|lenalidomide|mesh-list
110679384|NCT05572229|Daratumumab|daratumumab|mesh-list
110679385|NCT05572229|Immunologic Factors|immunologic factors|mesh-ancestor
110679386|NCT05572229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110679387|NCT05572229|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110679388|NCT05572229|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110679389|NCT05572229|Growth Substances|growth substances|mesh-ancestor
110679390|NCT05572229|Growth Inhibitors|growth inhibitors|mesh-ancestor
110679391|NCT05572229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110679392|NCT05570825|Pembrolizumab|pembrolizumab|mesh-list
110679393|NCT05570825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110679394|NCT05570825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110679395|NCT05570825|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110679396|NCT05570825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110679397|NCT05569408|Cilgavimab and tixagevimab drug combination|cilgavimab and tixagevimab drug combination|mesh-list
110679398|NCT05569408|Antiviral Agents|antiviral agents|mesh-ancestor
110679399|NCT05569408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110679400|NCT05558410|Acetaminophen|acetaminophen|mesh-list
110679401|NCT05558410|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110679402|NCT05558410|Analgesics|analgesics|mesh-ancestor
110679403|NCT05558410|Sensory System Agents|sensory system agents|mesh-ancestor
110679404|NCT05558410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110679405|NCT05558410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110679406|NCT05558410|Antipyretics|antipyretics|mesh-ancestor
110679407|NCT05550207|Meloxicam|meloxicam|mesh-list
110679408|NCT05550207|Rizatriptan|rizatriptan|mesh-list
110679409|NCT05550207|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110679410|NCT05550207|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110679411|NCT05550207|Analgesics|analgesics|mesh-ancestor
110679412|NCT05550207|Sensory System Agents|sensory system agents|mesh-ancestor
110679413|NCT05550207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110679414|NCT05550207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110679415|NCT05550207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110679416|NCT05550207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110679417|NCT05550207|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110679418|NCT05550207|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110679419|NCT05550207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110679420|NCT05550207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110679421|NCT05550207|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110679422|NCT05550207|Serotonin Agents|serotonin agents|mesh-ancestor
110679423|NCT05550207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110353826|NCT05329116|Antioxidants|antioxidants|mesh-ancestor
110679453|NCT05526157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110679455|NCT05526157|Incretins|incretins|mesh-ancestor
110679456|NCT05526157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110679457|NCT05526157|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110679465|NCT05512949|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
110679467|NCT05512949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110679468|NCT05508152|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110679469|NCT05508152|Amoxicillin|amoxicillin|mesh-list
110679470|NCT05508152|Clavulanic Acid|clavulanic acid|mesh-list
110679471|NCT05508152|Clavulanic Acids|clavulanic acids|mesh-list
110679472|NCT05508152|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
110679473|NCT05508152|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110679474|NCT05508152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110679475|NCT05508152|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110433897|NCT00910195|Antipyretics|antipyretics|mesh-ancestor
110679476|NCT05508152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110679477|NCT05508152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110679478|NCT05492565|Tenofovir|tenofovir|mesh-list
110679479|NCT05492565|Emtricitabine|emtricitabine|mesh-list
110679480|NCT05492565|Antiviral Agents|antiviral agents|mesh-ancestor
110679481|NCT05492565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110679482|NCT05492565|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110679483|NCT05492565|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110679484|NCT05492565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110679485|NCT05492565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110679486|NCT05492565|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110679487|NCT05492565|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110679488|NCT05486104|Hemay005|hemay005|mesh-list
110679489|NCT05486104|Dermatologic Agents|dermatologic agents|mesh-ancestor
110679490|NCT05486104|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
110679491|NCT05486104|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110679492|NCT05486104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110679493|NCT05486104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110679494|NCT05470985|Ozanimod|ozanimod|mesh-list
110679495|NCT05470985|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
110679496|NCT05470985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110679497|NCT05470985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110679498|NCT05470985|Immunologic Factors|immunologic factors|mesh-ancestor
110679499|NCT05470985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110679504|NCT05452174|Antidepressive Agents|antidepressive agents|mesh-ancestor
110679505|NCT05452174|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110679506|NCT05452174|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110679507|NCT05452174|Histamine Antagonists|histamine antagonists|mesh-ancestor
110679508|NCT05452174|Histamine Agents|histamine agents|mesh-ancestor
110679509|NCT05452174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110679510|NCT05452174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110679511|NCT05452174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110679512|NCT05452174|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110679513|NCT05452174|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110679514|NCT05452174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110856359|NCT03756623|Metformin|metformin|mesh-list
110679515|NCT05452174|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
110679516|NCT05452174|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110679517|NCT05452174|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110679518|NCT05452174|Adrenergic Agents|adrenergic agents|mesh-ancestor
110679519|NCT05452174|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110679520|NCT05452174|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110679521|NCT05452174|Serotonin Agents|serotonin agents|mesh-ancestor
110679522|NCT05452174|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110679523|NCT05448547|Hormones|hormones|mesh-list
110679524|NCT05448547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110679525|NCT05448547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110679526|NCT05446779|Hydrocortisone|hydrocortisone|mesh-list
110679527|NCT05446779|Epinephrine|epinephrine|mesh-list
110679528|NCT05446779|Racepinephrine|racepinephrine|mesh-list
110679529|NCT05446779|Epinephryl borate|epinephryl borate|mesh-list
110679530|NCT05446779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110679531|NCT05446779|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110679532|NCT05446779|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110679533|NCT05446779|Adrenergic Agents|adrenergic agents|mesh-ancestor
110679534|NCT05446779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110679535|NCT05446779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110679536|NCT05446779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110679537|NCT05446779|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110679538|NCT05446779|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110679539|NCT05446779|Autonomic Agents|autonomic agents|mesh-ancestor
110679540|NCT05446779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110679541|NCT05446779|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110679542|NCT05446779|Respiratory System Agents|respiratory system agents|mesh-ancestor
110679543|NCT05446779|Mydriatics|mydriatics|mesh-ancestor
110679544|NCT05446779|Sympathomimetics|sympathomimetics|mesh-ancestor
110679545|NCT05446779|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110679546|NCT05423197|Panitumumab|panitumumab|mesh-list
110679547|NCT05423197|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110679548|NCT05423197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110679549|NCT05411471|Vaccines|vaccines|mesh-list
110679550|NCT05411471|Immunologic Factors|immunologic factors|mesh-ancestor
110679551|NCT05411471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110679552|NCT05399602|Anesthetics|anesthetics|mesh-list
110679553|NCT05399602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110679554|NCT05399602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110679555|NCT05399498|Psilocybin|psilocybin|mesh-list
110433969|NCT03746301|Rivaroxaban|rivaroxaban|mesh-list
110679556|NCT05399498|Hallucinogens|hallucinogens|mesh-ancestor
110679557|NCT05399498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110679558|NCT05399498|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110679559|NCT05384262|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110679560|NCT05384262|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110679561|NCT05384262|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110679562|NCT05384262|Antimetabolites|antimetabolites|mesh-ancestor
110679563|NCT05384262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110679564|NCT05384262|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110679565|NCT05384262|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110679567|NCT05378464|Trastuzumab|trastuzumab|mesh-list
110679568|NCT05378464|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110679569|NCT05378464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110679570|NCT05325645|Brexpiprazole|brexpiprazole|mesh-list
110679571|NCT05325645|Serotonin Agents|serotonin agents|mesh-ancestor
110679572|NCT05325645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110679573|NCT05325645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110679574|NCT05325645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110679575|NCT05325645|Dopamine Agonists|dopamine agonists|mesh-ancestor
110679576|NCT05325645|Dopamine Agents|dopamine agents|mesh-ancestor
110679577|NCT05323812|Edaravone|edaravone|mesh-list
110679578|NCT05323812|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110679579|NCT05323812|Antioxidants|antioxidants|mesh-ancestor
110679580|NCT05323812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110679581|NCT05323812|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110679582|NCT05323812|Protective Agents|protective agents|mesh-ancestor
110679583|NCT05323812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110679584|NCT05317416|Lenalidomide|lenalidomide|mesh-list
110679585|NCT05317416|Immunologic Factors|immunologic factors|mesh-ancestor
110679586|NCT05317416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110679587|NCT05317416|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110679588|NCT05317416|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110679589|NCT05317416|Growth Substances|growth substances|mesh-ancestor
110371957|NCT00570999|Mitogens|mitogens|mesh-list
110679590|NCT05317416|Growth Inhibitors|growth inhibitors|mesh-ancestor
110679591|NCT05317416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110679592|NCT05304390|Carbon Monoxide|carbon monoxide|mesh-list
110679593|NCT05304390|Antimetabolites|antimetabolites|mesh-ancestor
110679594|NCT05304390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110679595|NCT05304390|Gasotransmitters|gasotransmitters|mesh-ancestor
110679596|NCT05304390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110679597|NCT05304390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110679598|NCT05301062|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
110679599|NCT05301062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110679600|NCT05286762|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
110679601|NCT05286762|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110679602|NCT05286762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110679603|NCT05286762|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110679604|NCT05286762|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110679605|NCT05286762|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110679606|NCT05286762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110679607|NCT05286762|Dopamine Agents|dopamine agents|mesh-ancestor
110679608|NCT05286762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110679609|NCT05271630|Proteasome Inhibitors|proteasome inhibitors|mesh-list
110679610|NCT05271630|Immunomodulating Agents|immunomodulating agents|mesh-list
110679611|NCT05271630|Protease Inhibitors|protease inhibitors|mesh-ancestor
110679612|NCT05271630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110679613|NCT05271630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110679614|NCT05271630|Immunologic Factors|immunologic factors|mesh-ancestor
110679615|NCT05271630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110679617|NCT05267600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110679618|NCT05267600|Glucocorticoids|glucocorticoids|mesh-ancestor
110679620|NCT05267600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110679621|NCT05267600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110679622|NCT05267600|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110679623|NCT05267600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110679624|NCT05254236|Vaccines|vaccines|mesh-list
110679625|NCT05254236|Immunologic Factors|immunologic factors|mesh-ancestor
110679626|NCT05254236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110679627|NCT05245071|Maytansine|maytansine|mesh-list
110679628|NCT05245071|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110679629|NCT05245071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110679630|NCT05245071|Tubulin Modulators|tubulin modulators|mesh-ancestor
110679631|NCT05245071|Antimitotic Agents|antimitotic agents|mesh-ancestor
110679632|NCT05245071|Mitosis Modulators|mitosis modulators|mesh-ancestor
110679633|NCT05245071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110679634|NCT05242965|Vaccines|vaccines|mesh-list
110679635|NCT05242965|Sargramostim|sargramostim|mesh-list
110679636|NCT05242965|Immunologic Factors|immunologic factors|mesh-ancestor
110434172|NCT04259008|Manganese|manganese|mesh-list
110679637|NCT05242965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110679638|NCT05233956|Chrysarobin|chrysarobin|mesh-list
110679639|NCT05233956|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110679641|NCT05233956|Analgesics|analgesics|mesh-ancestor
110679642|NCT05233956|Sensory System Agents|sensory system agents|mesh-ancestor
110679643|NCT05233956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110679644|NCT05233956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110679645|NCT05233956|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110679646|NCT05233956|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110679647|NCT05189457|Docetaxel|docetaxel|mesh-list
110679648|NCT05189457|Tislelizumab|tislelizumab|mesh-list
110679649|NCT05189457|Leuprolide|leuprolide|mesh-list
110679650|NCT05189457|Triptorelin Pamoate|triptorelin pamoate|mesh-list
110679651|NCT05189457|Hormones|hormones|mesh-list
110032327|NCT01397019|Irinotecan|irinotecan|mesh-list
110679652|NCT05189457|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
110679653|NCT05189457|Relugolix|relugolix|mesh-list
110679654|NCT05189457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110679655|NCT05189457|Tubulin Modulators|tubulin modulators|mesh-ancestor
110679656|NCT05189457|Antimitotic Agents|antimitotic agents|mesh-ancestor
110679657|NCT05189457|Mitosis Modulators|mitosis modulators|mesh-ancestor
110679658|NCT05189457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110679659|NCT05189457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110679660|NCT05189457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110679661|NCT05189457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110679662|NCT05189457|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110679663|NCT05189457|Fertility Agents|fertility agents|mesh-ancestor
110679664|NCT05189457|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110679665|NCT05189457|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110679666|NCT05189457|Luteolytic Agents|luteolytic agents|mesh-ancestor
110679667|NCT05189457|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110679668|NCT05189457|Contraceptive Agents|contraceptive agents|mesh-ancestor
110679669|NCT05189457|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110679670|NCT05189457|Androgen Antagonists|androgen antagonists|mesh-ancestor
110679671|NCT05189457|Hormone Antagonists|hormone antagonists|mesh-ancestor
110679672|NCT05180318|Ketamine|ketamine|mesh-list
110679673|NCT05180318|Esketamine|esketamine|mesh-list
110679674|NCT05180318|Analgesics|analgesics|mesh-ancestor
110679675|NCT05180318|Sensory System Agents|sensory system agents|mesh-ancestor
110679676|NCT05180318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110679677|NCT05180318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110679678|NCT05180318|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110679679|NCT05180318|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110679680|NCT05180318|Anesthetics, General|anesthetics, general|mesh-ancestor
110679681|NCT05180318|Anesthetics|anesthetics|mesh-ancestor
110679682|NCT05180318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110679683|NCT05180318|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110679684|NCT05180318|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110679685|NCT05180318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110679686|NCT05180318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110679687|NCT05180318|Antidepressive Agents|antidepressive agents|mesh-ancestor
110679688|NCT05180318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110679689|NCT05159245|Trastuzumab|trastuzumab|mesh-list
110679690|NCT05159245|Atezolizumab|atezolizumab|mesh-list
110679691|NCT05159245|Pertuzumab|pertuzumab|mesh-list
110679692|NCT05159245|Trametinib|trametinib|mesh-list
110679693|NCT05159245|Vemurafenib|vemurafenib|mesh-list
110679694|NCT05159245|Dabrafenib|dabrafenib|mesh-list
110679695|NCT05159245|Pralsetinib|pralsetinib|mesh-list
110679696|NCT05159245|Entrectinib|entrectinib|mesh-list
110679697|NCT05159245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110679698|NCT05159245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110679699|NCT05159245|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110679700|NCT05159245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110679701|NCT05159245|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110679702|NCT05159245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110679703|NCT05130268|Dronedarone|dronedarone|mesh-list
110679704|NCT05130268|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110679705|NCT05127044|Bilirubin|bilirubin|mesh-list
110679706|NCT05127044|Antioxidants|antioxidants|mesh-ancestor
110679707|NCT05127044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110679708|NCT05127044|Protective Agents|protective agents|mesh-ancestor
110679709|NCT05127044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110679710|NCT05116995|Rivaroxaban|rivaroxaban|mesh-list
110679711|NCT05116995|Ticagrelor|ticagrelor|mesh-list
110679712|NCT05116995|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110679713|NCT05116995|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110314862|NCT00335205|Ropinirole|ropinirole|mesh-list
110679714|NCT05116995|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110679715|NCT05116995|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110679716|NCT05116995|Purinergic Agents|purinergic agents|mesh-ancestor
110679717|NCT05116995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110679718|NCT05116995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110679719|NCT05116995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110679720|NCT05116995|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110679722|NCT05116995|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110679723|NCT05116995|Protease Inhibitors|protease inhibitors|mesh-ancestor
110679724|NCT05116995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110679725|NCT05116995|Anticoagulants|anticoagulants|mesh-ancestor
110679726|NCT05116917|Nivolumab|nivolumab|mesh-list
110679727|NCT05116917|Ipilimumab|ipilimumab|mesh-list
110679728|NCT05116917|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110679750|NCT05095857|Anesthetics, General|anesthetics, general|mesh-ancestor
110679751|NCT05095857|Anesthetics|anesthetics|mesh-ancestor
110679752|NCT05095857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110679753|NCT05095857|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110679754|NCT05095857|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110679755|NCT05095857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110679756|NCT05095857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110679757|NCT05095857|Antidepressive Agents|antidepressive agents|mesh-ancestor
110679758|NCT05095857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110679786|NCT05041842|Trastuzumab|trastuzumab|mesh-list
110679787|NCT05041842|Pertuzumab|pertuzumab|mesh-list
110679788|NCT05041842|Tucatinib|tucatinib|mesh-list
110679789|NCT05041842|Hormones|hormones|mesh-list
110679790|NCT05041842|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110679791|NCT05041842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110679792|NCT05041842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110679793|NCT05041842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110679794|NCT05041842|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110679795|NCT05041842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110679796|NCT05041842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110679806|NCT05014412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110679807|NCT05014412|Antiemetics|antiemetics|mesh-ancestor
110679808|NCT05014412|Autonomic Agents|autonomic agents|mesh-ancestor
110679809|NCT05014412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110679810|NCT05014412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110679811|NCT05014412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110679812|NCT05014412|Glucocorticoids|glucocorticoids|mesh-ancestor
110679814|NCT05014412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110679815|NCT05014412|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110679816|NCT05014412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110679817|NCT05004662|Nicotine|nicotine|mesh-list
110679818|NCT05004662|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110679819|NCT05004662|Autonomic Agents|autonomic agents|mesh-ancestor
110679820|NCT05004662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110679821|NCT05004662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110679822|NCT05004662|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110679823|NCT05004662|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110679824|NCT05004662|Cholinergic Agents|cholinergic agents|mesh-ancestor
110679825|NCT05004662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110679826|NCT05004662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110679827|NCT04997993|Leflunomide|leflunomide|mesh-list
110679828|NCT04997993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110434714|NCT00629889|Pregabalin|pregabalin|mesh-list
110679829|NCT04997993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110679830|NCT04997993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110679831|NCT04997993|Immunologic Factors|immunologic factors|mesh-ancestor
110679832|NCT04997993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110679833|NCT04996823|Ipilimumab|ipilimumab|mesh-list
110679834|NCT04996823|Axitinib|axitinib|mesh-list
110679835|NCT04996823|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110679836|NCT04996823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110679837|NCT04996823|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110679838|NCT04996823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110679839|NCT04996823|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110679840|NCT04996823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110679841|NCT04996004|Doxorubicin|doxorubicin|mesh-list
110679842|NCT04996004|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110679843|NCT04996004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110679844|NCT04996004|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110679850|NCT04977167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110679851|NCT04975152|Cemiplimab|cemiplimab|mesh-list
110679852|NCT04975152|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110679853|NCT04975152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110679854|NCT04959812|Sufentanil|sufentanil|mesh-list
110856403|NCT03755609|Fentanyl|fentanyl|mesh-list
110679855|NCT04959812|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110679856|NCT04959812|Narcotics|narcotics|mesh-ancestor
110679857|NCT04959812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110679858|NCT04959812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110679859|NCT04959812|Analgesics|analgesics|mesh-ancestor
110679860|NCT04959812|Sensory System Agents|sensory system agents|mesh-ancestor
110679861|NCT04959812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110679862|NCT04959812|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110679863|NCT04959812|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110679864|NCT04959812|Anesthetics, General|anesthetics, general|mesh-ancestor
110679865|NCT04959812|Anesthetics|anesthetics|mesh-ancestor
110679866|NCT04922034|Amoxicillin|amoxicillin|mesh-list
110679867|NCT04922034|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110434826|NCT04254640|Cladribine|cladribine|mesh-list
110679868|NCT04922034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110679869|NCT04905693|Treprostinil|treprostinil|mesh-list
110679870|NCT04905693|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110679871|NCT04897516|Benzonidazole|benzonidazole|mesh-list
110679872|NCT04897516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110679873|NCT04897516|Immunologic Factors|immunologic factors|mesh-ancestor
110679874|NCT04897516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110679875|NCT04897516|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
110679876|NCT04897516|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110679877|NCT04897516|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110679878|NCT04897516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110679879|NCT04892277|Cyclophosphamide|cyclophosphamide|mesh-list
110679880|NCT04892277|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110679881|NCT04892277|Fludarabine|fludarabine|mesh-list
110679882|NCT04892277|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110679883|NCT04892277|Immunologic Factors|immunologic factors|mesh-ancestor
110679884|NCT04892277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110679885|NCT04892277|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110679886|NCT04892277|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110679887|NCT04892277|Alkylating Agents|alkylating agents|mesh-ancestor
110679888|NCT04892277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110679889|NCT04892277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110679890|NCT04892277|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110679891|NCT04844775|Monophosphoryl lipid A|monophosphoryl lipid a|mesh-list
110679892|NCT04844775|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110679893|NCT04844775|Immunologic Factors|immunologic factors|mesh-ancestor
110679894|NCT04844775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110679895|NCT04843917|Immunoglobulins|immunoglobulins|mesh-list
110679896|NCT04843917|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110679897|NCT04843917|Antibodies|antibodies|mesh-list
110679898|NCT04843917|Immunoglobulin G|immunoglobulin g|mesh-list
110679899|NCT04843917|Immunologic Factors|immunologic factors|mesh-ancestor
110679900|NCT04843917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110679901|NCT04798339|Darbepoetin alfa|darbepoetin alfa|mesh-list
110679902|NCT04798339|Hematinics|hematinics|mesh-ancestor
110679903|NCT04791514|Treprostinil|treprostinil|mesh-list
110679904|NCT04791514|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110679905|NCT04789096|Pembrolizumab|pembrolizumab|mesh-list
110679906|NCT04789096|Trastuzumab|trastuzumab|mesh-list
110679907|NCT04789096|Capecitabine|capecitabine|mesh-list
110679908|NCT04789096|Tucatinib|tucatinib|mesh-list
110679909|NCT04789096|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110679910|NCT04789096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110679911|NCT04789096|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110679912|NCT04789096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110679913|NCT04789096|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110679914|NCT04789096|Antimetabolites|antimetabolites|mesh-ancestor
110679915|NCT04789096|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110679916|NCT04789096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110679927|NCT04762498|Abortifacient Agents|abortifacient agents|mesh-ancestor
110679928|NCT04762498|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110679929|NCT04762498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110679930|NCT04762498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110679931|NCT04762498|Antimetabolites|antimetabolites|mesh-ancestor
110679932|NCT04762498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110679933|NCT04762498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110679934|NCT04762498|Dermatologic Agents|dermatologic agents|mesh-ancestor
110679935|NCT04762498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110856406|NCT03755609|Narcotics|narcotics|mesh-ancestor
110679936|NCT04762498|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110679937|NCT04762498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110679939|NCT04762498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110679940|NCT04762498|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110679941|NCT04745559|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110679942|NCT04745559|Immunologic Factors|immunologic factors|mesh-ancestor
110679943|NCT04745559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110679945|NCT04741997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110679946|NCT04741997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110679947|NCT04741997|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110679948|NCT04741997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110679949|NCT04681105|Acetaminophen|acetaminophen|mesh-list
110679950|NCT04681105|Diphenhydramine|diphenhydramine|mesh-list
110679951|NCT04681105|Promethazine|promethazine|mesh-list
110679952|NCT04681105|Dexamethasone|dexamethasone|mesh-list
110679953|NCT04681105|Dexamethasone acetate|dexamethasone acetate|mesh-list
110679954|NCT04681105|Ibuprofen|ibuprofen|mesh-list
110679955|NCT04681105|Ranitidine|ranitidine|mesh-list
110679956|NCT04681105|Antibodies|antibodies|mesh-list
110679957|NCT04681105|Immunoglobulins|immunoglobulins|mesh-list
110327047|NCT00443963|Ranitidine|ranitidine|mesh-list
110679958|NCT04681105|Antibodies, Bispecific|antibodies, bispecific|mesh-list
110679959|NCT04681105|BB 1101|bb 1101|mesh-list
110679960|NCT04681105|Immunologic Factors|immunologic factors|mesh-ancestor
110679961|NCT04681105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110679962|NCT04681105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110679963|NCT04681105|Antiemetics|antiemetics|mesh-ancestor
110679964|NCT04681105|Autonomic Agents|autonomic agents|mesh-ancestor
110679965|NCT04681105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110679966|NCT04681105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110679967|NCT04681105|Glucocorticoids|glucocorticoids|mesh-ancestor
110679968|NCT04681105|Hormones|hormones|mesh-ancestor
110679969|NCT04681105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110679970|NCT04681105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110679971|NCT04681105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110679972|NCT04681105|Protease Inhibitors|protease inhibitors|mesh-ancestor
110435259|NCT00647959|Doxycycline|doxycycline|mesh-list
110679973|NCT04681105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110679974|NCT04681105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110679975|NCT04681105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110679976|NCT04681105|Analgesics|analgesics|mesh-ancestor
110679977|NCT04681105|Sensory System Agents|sensory system agents|mesh-ancestor
110679978|NCT04681105|Antipyretics|antipyretics|mesh-ancestor
110679979|NCT04681105|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110679980|NCT04681105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110679981|NCT04681105|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110679982|NCT04681105|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110679983|NCT04681105|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110679984|NCT04681105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110679985|NCT04681105|Anesthetics, Local|anesthetics, local|mesh-ancestor
110679986|NCT04681105|Anesthetics|anesthetics|mesh-ancestor
110679987|NCT04681105|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110679988|NCT04681105|Histamine Antagonists|histamine antagonists|mesh-ancestor
110679989|NCT04681105|Histamine Agents|histamine agents|mesh-ancestor
110679990|NCT04681105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110679991|NCT04681105|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110679992|NCT04681105|Antipruritics|antipruritics|mesh-ancestor
110679993|NCT04681105|Dermatologic Agents|dermatologic agents|mesh-ancestor
110679994|NCT04681105|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110679995|NCT04681105|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110679996|NCT04659603|Gemcitabine|gemcitabine|mesh-list
110679997|NCT04659603|Maytansine|maytansine|mesh-list
110408313|NCT05926804|Clarithromycin|clarithromycin|mesh-list
110679998|NCT04659603|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110679999|NCT04659603|Antimetabolites|antimetabolites|mesh-ancestor
110680000|NCT04659603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110680001|NCT04659603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110680002|NCT04659603|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110680003|NCT04659603|Tubulin Modulators|tubulin modulators|mesh-ancestor
110680004|NCT04659603|Antimitotic Agents|antimitotic agents|mesh-ancestor
110435374|NCT02663323|Sirolimus|sirolimus|mesh-list
110680005|NCT04659603|Mitosis Modulators|mitosis modulators|mesh-ancestor
110680006|NCT04644068|Paclitaxel|paclitaxel|mesh-list
110680007|NCT04644068|Carboplatin|carboplatin|mesh-list
110680008|NCT04644068|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110680009|NCT04644068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110680011|NCT04644068|Antimitotic Agents|antimitotic agents|mesh-ancestor
110680012|NCT04644068|Mitosis Modulators|mitosis modulators|mesh-ancestor
110680013|NCT04644068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110680014|NCT04643002|Dexamethasone|dexamethasone|mesh-list
110680015|NCT04643002|Pomalidomide|pomalidomide|mesh-list
110680016|NCT04643002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110680017|NCT04643002|Antiemetics|antiemetics|mesh-ancestor
110680018|NCT04643002|Autonomic Agents|autonomic agents|mesh-ancestor
110680019|NCT04643002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110680020|NCT04643002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110680021|NCT04643002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110680022|NCT04643002|Glucocorticoids|glucocorticoids|mesh-ancestor
110680023|NCT04643002|Hormones|hormones|mesh-ancestor
110680024|NCT04643002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110680025|NCT04643002|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110680026|NCT04643002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110680027|NCT04643002|Immunologic Factors|immunologic factors|mesh-ancestor
110680028|NCT04643002|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110680029|NCT04643002|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110680030|NCT04643002|Growth Substances|growth substances|mesh-ancestor
110680031|NCT04643002|Growth Inhibitors|growth inhibitors|mesh-ancestor
110680032|NCT04598451|Prednisone|prednisone|mesh-list
110680033|NCT04598451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110680034|NCT04598451|Glucocorticoids|glucocorticoids|mesh-ancestor
110680035|NCT04598451|Hormones|hormones|mesh-ancestor
110680036|NCT04598451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110680037|NCT04598451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110680038|NCT04598451|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110680039|NCT04598451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110680040|NCT04589845|Trastuzumab|trastuzumab|mesh-list
110680041|NCT04589845|Atezolizumab|atezolizumab|mesh-list
110680042|NCT04589845|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
110680043|NCT04589845|Maytansine|maytansine|mesh-list
110680044|NCT04589845|Ipatasertib|ipatasertib|mesh-list
110680045|NCT04589845|Pralsetinib|pralsetinib|mesh-list
110680046|NCT04589845|Entrectinib|entrectinib|mesh-list
110680047|NCT04589845|Inavolisib|inavolisib|mesh-list
110680048|NCT04589845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110680049|NCT04589845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110680050|NCT04589845|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110680051|NCT04589845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110680052|NCT04589845|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110680053|NCT04589845|Tubulin Modulators|tubulin modulators|mesh-ancestor
110680054|NCT04589845|Antimitotic Agents|antimitotic agents|mesh-ancestor
110680055|NCT04589845|Mitosis Modulators|mitosis modulators|mesh-ancestor
110680056|NCT04589845|Immunotoxins|immunotoxins|mesh-ancestor
110680057|NCT04589845|Immunoconjugates|immunoconjugates|mesh-ancestor
110680058|NCT04589845|Immunologic Factors|immunologic factors|mesh-ancestor
110680059|NCT04589845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110680060|NCT04589845|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110680061|NCT04589845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110680062|NCT04589845|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
110680063|NCT04589611|Amobarbital|amobarbital|mesh-list
110680064|NCT04589611|Hyaluronic Acid|hyaluronic acid|mesh-list
110680065|NCT04589611|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110680066|NCT04589611|Immunologic Factors|immunologic factors|mesh-ancestor
110680067|NCT04589611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110680068|NCT04589611|Viscosupplements|viscosupplements|mesh-ancestor
110680069|NCT04589611|Protective Agents|protective agents|mesh-ancestor
110680070|NCT04589611|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110680071|NCT04589611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110680072|NCT04589611|GABA Modulators|gaba modulators|mesh-ancestor
110680074|NCT04589611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110680075|NCT04589611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110680076|NCT04578756|Cariprazine|cariprazine|mesh-list
110680077|NCT04578756|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110680078|NCT04578756|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110680079|NCT04578756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110680080|NCT04578756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110680081|NCT04578756|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110680082|NCT04567303|Ranibizumab|ranibizumab|mesh-list
110680083|NCT04567303|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110680084|NCT04567303|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110680085|NCT04567303|Growth Substances|growth substances|mesh-ancestor
110680086|NCT04567303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110680087|NCT04567303|Growth Inhibitors|growth inhibitors|mesh-ancestor
110680088|NCT04567303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110680089|NCT04561466|Bezafibrate|bezafibrate|mesh-list
110680090|NCT04561466|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110680091|NCT04561466|Antimetabolites|antimetabolites|mesh-ancestor
110680092|NCT04561466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110680093|NCT04561466|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110680094|NCT04553263|Bupropion hydrochloride, naltrexone hydrochoride drug combination|bupropion hydrochloride, naltrexone hydrochoride drug combination|mesh-list
110680095|NCT04553263|Naltrexone|naltrexone|mesh-list
110680096|NCT04553263|Bupropion|bupropion|mesh-list
110680097|NCT04553263|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110680098|NCT04553263|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110680099|NCT04553263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110680100|NCT04553263|Sensory System Agents|sensory system agents|mesh-ancestor
110680101|NCT04553263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110680102|NCT04553263|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110680103|NCT04553263|Antidepressive Agents|antidepressive agents|mesh-ancestor
110680104|NCT04553263|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110680105|NCT04553263|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110680106|NCT04553263|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110680107|NCT04553263|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110435582|NCT02655757|Incretins|incretins|mesh-ancestor
110680108|NCT04553263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110680109|NCT04553263|Dopamine Agents|dopamine agents|mesh-ancestor
110680118|NCT04547777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110680119|NCT04525157|Afamelanotide|afamelanotide|mesh-list
110680120|NCT04525157|Dermatologic Agents|dermatologic agents|mesh-ancestor
110680121|NCT04519645|Lacosamide|lacosamide|mesh-list
110680122|NCT04519645|Anticonvulsants|anticonvulsants|mesh-ancestor
110680123|NCT04519645|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110680124|NCT04519645|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110680125|NCT04519645|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110680126|NCT04519645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110680136|NCT04511702|Methotrexate|methotrexate|mesh-list
110680137|NCT04511702|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110680138|NCT04511702|Abortifacient Agents|abortifacient agents|mesh-ancestor
110680139|NCT04511702|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110680140|NCT04511702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110680141|NCT04511702|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110680142|NCT04511702|Antimetabolites|antimetabolites|mesh-ancestor
110680143|NCT04511702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110680144|NCT04511702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110680145|NCT04511702|Dermatologic Agents|dermatologic agents|mesh-ancestor
110680146|NCT04511702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110680147|NCT04511702|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110680148|NCT04511702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110680149|NCT04511702|Immunologic Factors|immunologic factors|mesh-ancestor
110680150|NCT04511702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110680151|NCT04511702|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110680152|NCT04505410|Infliximab|infliximab|mesh-list
110680154|NCT04505410|Tofacitinib|tofacitinib|mesh-list
110680155|NCT04505410|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110680156|NCT04505410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110680157|NCT04505410|Dermatologic Agents|dermatologic agents|mesh-ancestor
110680158|NCT04505410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110680159|NCT04505410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110680160|NCT04505410|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
110680161|NCT04505410|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110680162|NCT04505410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110680163|NCT04505410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110680164|NCT04503694|Nivolumab|nivolumab|mesh-list
110680165|NCT04503694|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110680166|NCT04503694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110856418|NCT03760445|Daunorubicin|daunorubicin|mesh-list
110680167|NCT04503694|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110680168|NCT04503694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110680169|NCT04493151|Imipenem|imipenem|mesh-list
110680170|NCT04493151|Relebactam|relebactam|mesh-list
110680171|NCT04493151|Cilastatin|cilastatin|mesh-list
110680172|NCT04493151|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110680173|NCT04493151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110680174|NCT04493151|Protease Inhibitors|protease inhibitors|mesh-ancestor
110680175|NCT04493151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110680176|NCT04493151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110680177|NCT04493151|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110680178|NCT04468165|Dimethyl Fumarate|dimethyl fumarate|mesh-list
110680179|NCT04468165|Dermatologic Agents|dermatologic agents|mesh-ancestor
110435744|NCT04170439|Trace Elements|trace elements|mesh-ancestor
110680180|NCT04468165|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110680181|NCT04468165|Immunologic Factors|immunologic factors|mesh-ancestor
110680182|NCT04468165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110680185|NCT04454476|Trametinib|trametinib|mesh-list
110680186|NCT04454476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110680187|NCT04454476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110680188|NCT04454476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110680189|NCT04454476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110680190|NCT04452461|Leucovorin|leucovorin|mesh-list
110680191|NCT04452461|Paclitaxel|paclitaxel|mesh-list
110680192|NCT04452461|Gemcitabine|gemcitabine|mesh-list
110680193|NCT04452461|Oxaliplatin|oxaliplatin|mesh-list
110680194|NCT04452461|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110680195|NCT04452461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110680196|NCT04452461|Tubulin Modulators|tubulin modulators|mesh-ancestor
110680197|NCT04452461|Antimitotic Agents|antimitotic agents|mesh-ancestor
110680198|NCT04452461|Mitosis Modulators|mitosis modulators|mesh-ancestor
110680199|NCT04452461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110680200|NCT04452461|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110680201|NCT04452461|Antimetabolites|antimetabolites|mesh-ancestor
110680202|NCT04452461|Antidotes|antidotes|mesh-ancestor
110680203|NCT04452461|Protective Agents|protective agents|mesh-ancestor
110680204|NCT04452461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110680205|NCT04452461|Vitamin B Complex|vitamin b complex|mesh-ancestor
110680206|NCT04452461|Vitamins|vitamins|mesh-ancestor
110680207|NCT04452461|Micronutrients|micronutrients|mesh-ancestor
110680208|NCT04420884|Pembrolizumab|pembrolizumab|mesh-list
110680209|NCT04420884|Fluorouracil|fluorouracil|mesh-list
110680210|NCT04420884|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110680211|NCT04420884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110680212|NCT04420884|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110680213|NCT04420884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110680214|NCT04420884|Antimetabolites|antimetabolites|mesh-ancestor
110680215|NCT04420884|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110680216|NCT04420884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110680217|NCT04420884|Immunologic Factors|immunologic factors|mesh-ancestor
110680218|NCT04420884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110680219|NCT04388839|Dactinomycin|dactinomycin|mesh-list
110680220|NCT04388839|Cyclophosphamide|cyclophosphamide|mesh-list
110680221|NCT04388839|Vincristine|vincristine|mesh-list
110680222|NCT04388839|Vinorelbine|vinorelbine|mesh-list
110680223|NCT04388839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110680224|NCT04388839|Immunologic Factors|immunologic factors|mesh-ancestor
110680225|NCT04388839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110680226|NCT04388839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110680227|NCT04388839|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110680228|NCT04388839|Alkylating Agents|alkylating agents|mesh-ancestor
110680229|NCT04388839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110680230|NCT04388839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110680231|NCT04388839|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110680232|NCT04388839|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110680233|NCT04388839|Tubulin Modulators|tubulin modulators|mesh-ancestor
110680234|NCT04388839|Antimitotic Agents|antimitotic agents|mesh-ancestor
110680235|NCT04388839|Mitosis Modulators|mitosis modulators|mesh-ancestor
110680236|NCT04388839|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110680237|NCT04388839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110680238|NCT04388839|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110680239|NCT04388839|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110680241|NCT04388839|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110680242|NCT04301323|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110680243|NCT04301323|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110680244|NCT04278404|Metformin|metformin|mesh-list
110680245|NCT04278404|Interferons|interferons|mesh-list
110680246|NCT04278404|Ritonavir|ritonavir|mesh-list
110680247|NCT04278404|Ribavirin|ribavirin|mesh-list
110680248|NCT04278404|Lopinavir|lopinavir|mesh-list
110680249|NCT04278404|Oseltamivir|oseltamivir|mesh-list
110680250|NCT04278404|Remdesivir|remdesivir|mesh-list
110680251|NCT04278404|Azithromycin|azithromycin|mesh-list
110680252|NCT04278404|Clindamycin|clindamycin|mesh-list
110680253|NCT04278404|Meropenem|meropenem|mesh-list
110680254|NCT04278404|Voriconazole|voriconazole|mesh-list
110680255|NCT04278404|Ceftazidime|ceftazidime|mesh-list
110680256|NCT04278404|Cefepime|cefepime|mesh-list
110680257|NCT04278404|Fosfomycin|fosfomycin|mesh-list
110680258|NCT04278404|Cefdinir|cefdinir|mesh-list
110680259|NCT04278404|Dexamethasone|dexamethasone|mesh-list
110680260|NCT04278404|Budesonide|budesonide|mesh-list
110680261|NCT04278404|Hydrocortisone|hydrocortisone|mesh-list
110680262|NCT04278404|Colchicine|colchicine|mesh-list
110680263|NCT04278404|Amiodarone|amiodarone|mesh-list
110680264|NCT04278404|Bosentan|bosentan|mesh-list
110680265|NCT04278404|Guanfacine|guanfacine|mesh-list
110680266|NCT04278404|Labetalol|labetalol|mesh-list
110680267|NCT04278404|Nicardipine|nicardipine|mesh-list
110680268|NCT04278404|Nifedipine|nifedipine|mesh-list
110680269|NCT04278404|Milrinone|milrinone|mesh-list
110680270|NCT04278404|Furosemide|furosemide|mesh-list
110680272|NCT04278404|Dexmedetomidine|dexmedetomidine|mesh-list
110680273|NCT04278404|Oxycodone|oxycodone|mesh-list
110680274|NCT04278404|Gabapentin|gabapentin|mesh-list
110680275|NCT04278404|Nalbuphine|nalbuphine|mesh-list
110680276|NCT04278404|Clobazam|clobazam|mesh-list
110680277|NCT04278404|Zolpidem|zolpidem|mesh-list
110680278|NCT04278404|Risperidone|risperidone|mesh-list
110680279|NCT04278404|Amphetamine|amphetamine|mesh-list
110680280|NCT04278404|Dextroamphetamine|dextroamphetamine|mesh-list
110680281|NCT04278404|Sertraline|sertraline|mesh-list
110435969|NCT02658253|Antacids|antacids|mesh-ancestor
110680282|NCT04278404|Tranexamic Acid|tranexamic acid|mesh-list
110680283|NCT04278404|Aminocaproic Acid|aminocaproic acid|mesh-list
110680284|NCT04278404|Terbutaline|terbutaline|mesh-list
110680285|NCT04278404|Sevelamer|sevelamer|mesh-list
110680286|NCT04278404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110680287|NCT04278404|Antiemetics|antiemetics|mesh-ancestor
110680288|NCT04278404|Autonomic Agents|autonomic agents|mesh-ancestor
110680289|NCT04278404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110680290|NCT04278404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110680291|NCT04278404|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110680292|NCT04278404|Glucocorticoids|glucocorticoids|mesh-ancestor
110680293|NCT04278404|Hormones|hormones|mesh-ancestor
110680294|NCT04278404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110680295|NCT04278404|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110680296|NCT04278404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110680297|NCT04278404|Protease Inhibitors|protease inhibitors|mesh-ancestor
110680298|NCT04278404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110680299|NCT04278404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110680300|NCT04278404|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110680301|NCT04278404|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110680302|NCT04278404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110680303|NCT04278404|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110680304|NCT04278404|Analgesics|analgesics|mesh-ancestor
110680305|NCT04278404|Sensory System Agents|sensory system agents|mesh-ancestor
110680306|NCT04278404|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110680307|NCT04278404|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110680308|NCT04278404|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110680309|NCT04278404|Adrenergic Agents|adrenergic agents|mesh-ancestor
110680310|NCT04278404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110680311|NCT04278404|Antiviral Agents|antiviral agents|mesh-ancestor
110680312|NCT04278404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110680313|NCT04278404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110680314|NCT04278404|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110680315|NCT04278404|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110680316|NCT04278404|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110680317|NCT04278404|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110680318|NCT04278404|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110680319|NCT04278404|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110680320|NCT04278404|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110680321|NCT04278404|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110680323|NCT04278404|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110680324|NCT04278404|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110680325|NCT04278404|Respiratory System Agents|respiratory system agents|mesh-ancestor
110680326|NCT04278404|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110680327|NCT04278404|Hemostatics|hemostatics|mesh-ancestor
110680328|NCT04278404|Coagulants|coagulants|mesh-ancestor
110680329|NCT04278404|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110680330|NCT04278404|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110680331|NCT04278404|Narcotics|narcotics|mesh-ancestor
110680332|NCT04278404|Anticonvulsants|anticonvulsants|mesh-ancestor
110680333|NCT04278404|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110680334|NCT04278404|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110680335|NCT04278404|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110680336|NCT04278404|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110680337|NCT04278404|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110680338|NCT04278404|Antimanic Agents|antimanic agents|mesh-ancestor
110680339|NCT04278404|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110680340|NCT04278404|Serotonin Agents|serotonin agents|mesh-ancestor
110680341|NCT04278404|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110680342|NCT04278404|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110327400|NCT00442221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110327401|NCT00454259|Fentanyl|fentanyl|mesh-list
110327402|NCT00454259|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110327403|NCT00454259|Narcotics|narcotics|mesh-ancestor
110327404|NCT00454259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110680348|NCT04278404|Diuretics|diuretics|mesh-ancestor
110680349|NCT04278404|Natriuretic Agents|natriuretic agents|mesh-ancestor
110680350|NCT04278404|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110680351|NCT04278404|Gout Suppressants|gout suppressants|mesh-ancestor
110680352|NCT04278404|Tubulin Modulators|tubulin modulators|mesh-ancestor
110680353|NCT04278404|Antimitotic Agents|antimitotic agents|mesh-ancestor
110680354|NCT04278404|Mitosis Modulators|mitosis modulators|mesh-ancestor
110680355|NCT04278404|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110680356|NCT04278404|Hormone Antagonists|hormone antagonists|mesh-ancestor
110680357|NCT04278404|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110680358|NCT04278404|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110680359|NCT04278404|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110680360|NCT04278404|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110680361|NCT04278404|Vasodilator Agents|vasodilator agents|mesh-ancestor
110680362|NCT04278404|Tocolytic Agents|tocolytic agents|mesh-ancestor
110680363|NCT04278404|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110680364|NCT04278404|Antifungal Agents|antifungal agents|mesh-ancestor
110680365|NCT04278404|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110680366|NCT04278404|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110680367|NCT04278404|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110680368|NCT04278404|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
110680369|NCT04278404|GABA Agonists|gaba agonists|mesh-ancestor
110680370|NCT04278404|GABA Agents|gaba agents|mesh-ancestor
110680371|NCT04278404|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110680372|NCT04278404|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
110680373|NCT04278404|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110680374|NCT04278404|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110680375|NCT04278404|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110680376|NCT04278404|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110680377|NCT04278404|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110680378|NCT04278404|Sympathomimetics|sympathomimetics|mesh-ancestor
110680379|NCT04278404|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110680380|NCT04278404|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110680381|NCT04278404|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110680382|NCT04278404|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
110680383|NCT04278404|Chelating Agents|chelating agents|mesh-ancestor
110680384|NCT04278404|Sequestering Agents|sequestering agents|mesh-ancestor
110680385|NCT04278404|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110680386|NCT04278404|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110680387|NCT04278404|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110680388|NCT04278404|Protective Agents|protective agents|mesh-ancestor
110680389|NCT04278404|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110680390|NCT04278404|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110680391|NCT04278404|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110680392|NCT04278404|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110680393|NCT04278404|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110680394|NCT04278404|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110680395|NCT04275999|Ivermectin|ivermectin|mesh-list
110680396|NCT04275999|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110436347|NCT00650923|Growth Substances|growth substances|mesh-ancestor
110680397|NCT04275999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110680398|NCT04182204|Rituximab|rituximab|mesh-list
110680399|NCT04182204|Gemcitabine|gemcitabine|mesh-list
110680400|NCT04182204|Oxaliplatin|oxaliplatin|mesh-list
110680401|NCT04182204|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
110680402|NCT04182204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110680403|NCT04182204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110680404|NCT04182204|Immunologic Factors|immunologic factors|mesh-ancestor
110680405|NCT04182204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110680406|NCT04182204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110680407|NCT04182204|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110680408|NCT04182204|Antimetabolites|antimetabolites|mesh-ancestor
110680409|NCT04182204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110680410|NCT04182204|Immunoconjugates|immunoconjugates|mesh-ancestor
110680440|NCT04179864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110680441|NCT04179864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110680442|NCT04179864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110680443|NCT04179864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110680444|NCT04166071|Naltrexone|naltrexone|mesh-list
110680445|NCT04166071|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110680446|NCT04166071|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110680447|NCT04166071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110680448|NCT04166071|Sensory System Agents|sensory system agents|mesh-ancestor
110680449|NCT04166071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110680450|NCT04119674|Temozolomide|temozolomide|mesh-list
110680451|NCT04119674|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110680452|NCT04119674|Alkylating Agents|alkylating agents|mesh-ancestor
110680453|NCT04119674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110680454|NCT04119674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110680455|NCT04091386|Factor VIII|factor viii|mesh-list
110680456|NCT04091386|Coagulants|coagulants|mesh-ancestor
110680457|NCT04042155|Rivaroxaban|rivaroxaban|mesh-list
110680458|NCT04042155|Apixaban|apixaban|mesh-list
110680459|NCT04042155|Edoxaban|edoxaban|mesh-list
110680460|NCT04042155|Dabigatran|dabigatran|mesh-list
110680461|NCT04042155|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110680462|NCT04042155|Antithrombins|antithrombins|mesh-ancestor
110680463|NCT04042155|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110680464|NCT04042155|Protease Inhibitors|protease inhibitors|mesh-ancestor
110680465|NCT04042155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110680466|NCT04042155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110680467|NCT04042155|Anticoagulants|anticoagulants|mesh-ancestor
110680468|NCT04032847|Pembrolizumab|pembrolizumab|mesh-list
110680469|NCT04032847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110680470|NCT04032847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110436532|NCT01125930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110680471|NCT04032847|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110680472|NCT04032847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110680473|NCT04031430|Antihypertensive Agents|antihypertensive agents|mesh-list
110680474|NCT04013542|Nivolumab|nivolumab|mesh-list
110680475|NCT04013542|Ipilimumab|ipilimumab|mesh-list
110680476|NCT04013542|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110680477|NCT04013542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110680478|NCT04013542|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110680479|NCT04013542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110680480|NCT03990571|Avelumab|avelumab|mesh-list
110680481|NCT03990571|Axitinib|axitinib|mesh-list
110680482|NCT03990571|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110680483|NCT03990571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110680484|NCT03990571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110680485|NCT03990571|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110680486|NCT03990571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110856441|NCT03760445|GABA Agents|gaba agents|mesh-ancestor
110680487|NCT03990571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110680488|NCT03990571|Immunologic Factors|immunologic factors|mesh-ancestor
110680489|NCT03990571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110680490|NCT03970096|Cyclosporine|cyclosporine|mesh-list
110680491|NCT03970096|Sirolimus|sirolimus|mesh-list
110680492|NCT03970096|Cyclophosphamide|cyclophosphamide|mesh-list
110680494|NCT03970096|Thiotepa|thiotepa|mesh-list
110680495|NCT03970096|Methotrexate|methotrexate|mesh-list
110680496|NCT03970096|Fludarabine|fludarabine|mesh-list
110680497|NCT03970096|Tacrolimus|tacrolimus|mesh-list
110680498|NCT03970096|Cyclosporins|cyclosporins|mesh-list
110680499|NCT03970096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110680500|NCT03970096|Immunologic Factors|immunologic factors|mesh-ancestor
110680501|NCT03970096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110680502|NCT03970096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110680503|NCT03970096|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110680504|NCT03970096|Alkylating Agents|alkylating agents|mesh-ancestor
110680505|NCT03970096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110436722|NCT00912808|Donepezil|donepezil|mesh-list
110680506|NCT03970096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110680507|NCT03970096|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110680508|NCT03970096|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110680509|NCT03970096|Abortifacient Agents|abortifacient agents|mesh-ancestor
110680510|NCT03970096|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110680511|NCT03970096|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110680512|NCT03970096|Antimetabolites|antimetabolites|mesh-ancestor
110680513|NCT03970096|Dermatologic Agents|dermatologic agents|mesh-ancestor
110680514|NCT03970096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110680515|NCT03970096|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110680516|NCT03970096|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110680517|NCT03970096|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110680518|NCT03970096|Antifungal Agents|antifungal agents|mesh-ancestor
110680519|NCT03970096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110680520|NCT03970096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110680521|NCT03970096|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110680522|NCT03944434|Leuprolide|leuprolide|mesh-list
110680523|NCT03944434|Goserelin|goserelin|mesh-list
110680524|NCT03944434|Triptorelin Pamoate|triptorelin pamoate|mesh-list
110680525|NCT03944434|Aromatase Inhibitors|aromatase inhibitors|mesh-list
110680526|NCT03944434|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110680527|NCT03944434|Fertility Agents|fertility agents|mesh-ancestor
110680528|NCT03944434|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110680529|NCT03944434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110680530|NCT03944434|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110680531|NCT03944434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110680532|NCT03944434|Luteolytic Agents|luteolytic agents|mesh-ancestor
110680533|NCT03944434|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110680534|NCT03944434|Contraceptive Agents|contraceptive agents|mesh-ancestor
110680535|NCT03944434|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110680536|NCT03944434|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110680537|NCT03944434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110680538|NCT03944434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110680539|NCT03944434|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110680540|NCT03944434|Hormone Antagonists|hormone antagonists|mesh-ancestor
110680541|NCT03944434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110680542|NCT03905265|Moxidectin|moxidectin|mesh-list
110680543|NCT03905265|Anthelmintics|anthelmintics|mesh-ancestor
110680544|NCT03905265|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110680545|NCT03905265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110680546|NCT03905265|Antinematodal Agents|antinematodal agents|mesh-ancestor
110680547|NCT03901469|Talazoparib|talazoparib|mesh-list
110680548|NCT03901469|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110680549|NCT03901469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110680550|NCT03901469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110680551|NCT03901469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110680552|NCT03848845|Pembrolizumab|pembrolizumab|mesh-list
110680553|NCT03848845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110680554|NCT03848845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110436978|NCT00960063|Tubulin Modulators|tubulin modulators|mesh-ancestor
110680555|NCT03848845|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110680556|NCT03848845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110680558|NCT03807765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110680559|NCT03807765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110680560|NCT03807765|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110680561|NCT03807765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110680562|NCT03781440|Lidocaine|lidocaine|mesh-list
110680563|NCT03781440|Anesthetics, Local|anesthetics, local|mesh-ancestor
110680564|NCT03781440|Anesthetics|anesthetics|mesh-ancestor
110680565|NCT03781440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110354928|NCT02899364|Antidotes|antidotes|mesh-ancestor
110680603|NCT03771612|Gout Suppressants|gout suppressants|mesh-ancestor
110680604|NCT03771612|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110680605|NCT03771612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110680606|NCT03771612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110680607|NCT03760523|14-O-phosphonooxymethyltriptolide disodium salt|14-o-phosphonooxymethyltriptolide disodium salt|mesh-list
110680608|NCT03760523|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110680609|NCT03760523|Alkylating Agents|alkylating agents|mesh-ancestor
110680610|NCT03760523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110680611|NCT03760523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110680612|NCT03714815|Macitentan|macitentan|mesh-list
110680613|NCT03714815|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
110680614|NCT03714815|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
110680615|NCT03714815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110680616|NCT03714815|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
110680617|NCT03712943|Nivolumab|nivolumab|mesh-list
110680618|NCT03712943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110680619|NCT03712943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110680620|NCT03712943|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110680621|NCT03712943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110680622|NCT03686488|Ramucirumab|ramucirumab|mesh-list
110680623|NCT03686488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110680624|NCT03656536|Gemcitabine|gemcitabine|mesh-list
110680625|NCT03656536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110680626|NCT03656536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110680627|NCT03656536|Antimetabolites|antimetabolites|mesh-ancestor
110680628|NCT03656536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110680629|NCT03640312|Candesartan|candesartan|mesh-list
110680630|NCT03640312|Candesartan cilexetil|candesartan cilexetil|mesh-list
110680631|NCT03640312|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110680632|NCT03640312|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110680633|NCT03640312|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110680634|NCT03640312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110680635|NCT03635983|Nivolumab|nivolumab|mesh-list
110680636|NCT03635983|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110680643|NCT03628209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110680644|NCT03628209|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110680645|NCT03628209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110680646|NCT03628209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110680648|NCT03628209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110680649|NCT03625388|Dasatinib|dasatinib|mesh-list
110680650|NCT03625388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110680651|NCT03625388|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110680652|NCT03625388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110680653|NCT03625388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110680654|NCT03598309|Curcumin|curcumin|mesh-list
110680655|NCT03598309|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110680656|NCT03598309|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110680657|NCT03598309|Analgesics|analgesics|mesh-ancestor
110680658|NCT03598309|Sensory System Agents|sensory system agents|mesh-ancestor
110680659|NCT03598309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110680660|NCT03598309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110680661|NCT03598309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110680662|NCT03598309|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110680663|NCT03598309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110680664|NCT03598309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110856456|NCT03760445|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110680665|NCT03598309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110680674|NCT03576417|Nivolumab|nivolumab|mesh-list
110680675|NCT03576417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110437352|NCT02638831|Analgesics|analgesics|mesh-ancestor
110680676|NCT03576417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110680677|NCT03576417|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110680678|NCT03576417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110680679|NCT03570827|Ascorbic Acid|ascorbic acid|mesh-list
110680680|NCT03570827|Methyltestosterone|methyltestosterone|mesh-list
110680681|NCT03570827|Androgens|androgens|mesh-list
110680682|NCT03570827|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
110680683|NCT03570827|Hormones|hormones|mesh-ancestor
110680684|NCT03570827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110437429|NCT02645461|Hormones|hormones|mesh-ancestor
110680685|NCT03570827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110680686|NCT03570827|Antioxidants|antioxidants|mesh-ancestor
110680687|NCT03570827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110680688|NCT03570827|Protective Agents|protective agents|mesh-ancestor
110680689|NCT03570827|Vitamins|vitamins|mesh-ancestor
110680690|NCT03570827|Micronutrients|micronutrients|mesh-ancestor
110680691|NCT03570827|Estrogens|estrogens|mesh-ancestor
110680692|NCT03570827|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110680693|NCT03570827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110680694|NCT03570827|Anabolic Agents|anabolic agents|mesh-ancestor
110680695|NCT03543189|Nivolumab|nivolumab|mesh-list
110680696|NCT03543189|Androgens|androgens|mesh-list
110680697|NCT03543189|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110680698|NCT03543189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110680699|NCT03543189|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110680700|NCT03543189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110680701|NCT03543189|Hormones|hormones|mesh-ancestor
110680702|NCT03543189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110680703|NCT03543189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110680704|NCT03538938|Nicotine|nicotine|mesh-list
110680705|NCT03538938|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110680706|NCT03538938|Autonomic Agents|autonomic agents|mesh-ancestor
110680707|NCT03538938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110680708|NCT03538938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110680709|NCT03538938|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110680710|NCT03538938|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110680711|NCT03538938|Cholinergic Agents|cholinergic agents|mesh-ancestor
110680712|NCT03538938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110680713|NCT03538938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110680714|NCT03501368|Trametinib|trametinib|mesh-list
110680715|NCT03501368|Ceritinib|ceritinib|mesh-list
110680716|NCT03501368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110680717|NCT03501368|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110680718|NCT03501368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110680719|NCT03501368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110680720|NCT03404310|Zinc Sulfate|zinc sulfate|mesh-list
110680721|NCT03404310|Astringents|astringents|mesh-ancestor
110680722|NCT03404310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110680723|NCT03404310|Dermatologic Agents|dermatologic agents|mesh-ancestor
110680724|NCT03387553|Immunomodulating Agents|immunomodulating agents|mesh-list
110680725|NCT03387553|Immunologic Factors|immunologic factors|mesh-ancestor
110680726|NCT03387553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110680727|NCT03367533|Ketamine|ketamine|mesh-list
110680728|NCT03367533|Analgesics|analgesics|mesh-ancestor
110680729|NCT03367533|Sensory System Agents|sensory system agents|mesh-ancestor
110680730|NCT03367533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110680731|NCT03367533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110680732|NCT03367533|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110680733|NCT03367533|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110680734|NCT03367533|Anesthetics, General|anesthetics, general|mesh-ancestor
110680735|NCT03367533|Anesthetics|anesthetics|mesh-ancestor
110680736|NCT03367533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110680737|NCT03367533|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110680738|NCT03367533|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110680739|NCT03367533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110680740|NCT03367533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110680741|NCT03340896|Docetaxel|docetaxel|mesh-list
110680742|NCT03340896|Fluorouracil|fluorouracil|mesh-list
110680743|NCT03340896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110680744|NCT03340896|Tubulin Modulators|tubulin modulators|mesh-ancestor
110680745|NCT03340896|Antimitotic Agents|antimitotic agents|mesh-ancestor
110680746|NCT03340896|Mitosis Modulators|mitosis modulators|mesh-ancestor
110680747|NCT03340896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110680748|NCT03340896|Antimetabolites|antimetabolites|mesh-ancestor
110680749|NCT03340896|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110680750|NCT03340896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110680751|NCT03340896|Immunologic Factors|immunologic factors|mesh-ancestor
110680752|NCT03340896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110680754|NCT03299088|Trametinib|trametinib|mesh-list
110680755|NCT03299088|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110680756|NCT03299088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110680757|NCT03299088|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110680758|NCT03299088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110680759|NCT03299088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110680760|NCT03299088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110680761|NCT03290079|Pembrolizumab|pembrolizumab|mesh-list
110680762|NCT03290079|Lenvatinib|lenvatinib|mesh-list
110680763|NCT03290079|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110680764|NCT03290079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110680765|NCT03290079|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110680766|NCT03290079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110680767|NCT03290079|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110680768|NCT03290079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110680769|NCT03272464|Trametinib|trametinib|mesh-list
110680770|NCT03272464|Dabrafenib|dabrafenib|mesh-list
110680771|NCT03272464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110680772|NCT03272464|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110680773|NCT03272464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110680774|NCT03272464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110680775|NCT03263481|Secretin|secretin|mesh-list
110680776|NCT03263481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110680777|NCT03263481|Hormones|hormones|mesh-ancestor
110680778|NCT03263481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110680779|NCT03263481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110680780|NCT03221426|Leucovorin|leucovorin|mesh-list
110680781|NCT03221426|Docetaxel|docetaxel|mesh-list
110680782|NCT03221426|Pembrolizumab|pembrolizumab|mesh-list
110680783|NCT03221426|Fluorouracil|fluorouracil|mesh-list
110680784|NCT03221426|Capecitabine|capecitabine|mesh-list
110680785|NCT03221426|Oxaliplatin|oxaliplatin|mesh-list
110680786|NCT03221426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110680788|NCT03221426|Antimitotic Agents|antimitotic agents|mesh-ancestor
110680789|NCT03221426|Mitosis Modulators|mitosis modulators|mesh-ancestor
110680790|NCT03221426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110680791|NCT03221426|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110680792|NCT03221426|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110680793|NCT03221426|Antimetabolites|antimetabolites|mesh-ancestor
110680794|NCT03221426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110680795|NCT03221426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110680796|NCT03221426|Immunologic Factors|immunologic factors|mesh-ancestor
110680797|NCT03221426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110680798|NCT03221426|Antidotes|antidotes|mesh-ancestor
110680799|NCT03221426|Protective Agents|protective agents|mesh-ancestor
110680800|NCT03221426|Vitamin B Complex|vitamin b complex|mesh-ancestor
110680801|NCT03221426|Vitamins|vitamins|mesh-ancestor
110680802|NCT03221426|Micronutrients|micronutrients|mesh-ancestor
110680803|NCT03177291|Pirfenidone|pirfenidone|mesh-list
110680804|NCT03177291|Paclitaxel|paclitaxel|mesh-list
110680805|NCT03177291|Carboplatin|carboplatin|mesh-list
110680806|NCT03177291|Pemetrexed|pemetrexed|mesh-list
110680807|NCT03177291|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110680808|NCT03177291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110680809|NCT03177291|Tubulin Modulators|tubulin modulators|mesh-ancestor
110680810|NCT03177291|Antimitotic Agents|antimitotic agents|mesh-ancestor
110680811|NCT03177291|Mitosis Modulators|mitosis modulators|mesh-ancestor
110680812|NCT03177291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110680813|NCT03177291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110680814|NCT03177291|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110680815|NCT03177291|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110680817|NCT03177291|Sensory System Agents|sensory system agents|mesh-ancestor
110680818|NCT03177291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110680819|NCT03177291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110680820|NCT03177291|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110680821|NCT03177291|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110680822|NCT03177291|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110680823|NCT03177291|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110680824|NCT03148275|Trametinib|trametinib|mesh-list
110680825|NCT03148275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110680826|NCT03148275|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110680827|NCT03148275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110680828|NCT03148275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110680829|NCT03079011|Letrozole|letrozole|mesh-list
110680830|NCT03079011|Fulvestrant|fulvestrant|mesh-list
110680831|NCT03079011|Palbociclib|palbociclib|mesh-list
110680832|NCT03079011|Anastrozole|anastrozole|mesh-list
110680833|NCT03079011|Exemestane|exemestane|mesh-list
110680834|NCT03079011|Aromatase Inhibitors|aromatase inhibitors|mesh-list
110680835|NCT03079011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110680836|NCT03079011|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110680837|NCT03079011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110680838|NCT03079011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110680839|NCT03079011|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110680840|NCT03079011|Hormone Antagonists|hormone antagonists|mesh-ancestor
110680841|NCT03079011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110680842|NCT03079011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110680843|NCT03079011|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110680844|NCT03079011|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110680845|NCT03079011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110680846|NCT03071406|Nivolumab|nivolumab|mesh-list
110680847|NCT03071406|Ipilimumab|ipilimumab|mesh-list
110680848|NCT03071406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110680849|NCT03071406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110680850|NCT03071406|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110680851|NCT03071406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110680852|NCT02945800|Paclitaxel|paclitaxel|mesh-list
110680853|NCT02945800|Gemcitabine|gemcitabine|mesh-list
110680854|NCT02945800|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110680855|NCT02945800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110680856|NCT02945800|Tubulin Modulators|tubulin modulators|mesh-ancestor
110680857|NCT02945800|Antimitotic Agents|antimitotic agents|mesh-ancestor
110680858|NCT02945800|Mitosis Modulators|mitosis modulators|mesh-ancestor
110680859|NCT02945800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110355223|NCT02897765|Nivolumab|nivolumab|mesh-list
110680860|NCT02945800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110680861|NCT02945800|Antimetabolites|antimetabolites|mesh-ancestor
110680862|NCT02877303|Cytarabine|cytarabine|mesh-list
110680863|NCT02877303|Dexamethasone|dexamethasone|mesh-list
110680864|NCT02877303|Dexamethasone acetate|dexamethasone acetate|mesh-list
110680865|NCT02877303|Prednisone|prednisone|mesh-list
110680866|NCT02877303|Cortisone|cortisone|mesh-list
110680867|NCT02877303|Cyclophosphamide|cyclophosphamide|mesh-list
110680868|NCT02877303|Rituximab|rituximab|mesh-list
110680869|NCT02877303|Doxorubicin|doxorubicin|mesh-list
110680870|NCT02877303|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110680871|NCT02877303|Methotrexate|methotrexate|mesh-list
110680872|NCT02877303|Vincristine|vincristine|mesh-list
110680873|NCT02877303|Mercaptopurine|mercaptopurine|mesh-list
110680874|NCT02877303|Ofatumumab|ofatumumab|mesh-list
110680875|NCT02877303|Blinatumomab|blinatumomab|mesh-list
110680876|NCT02877303|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
110680877|NCT02877303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110680878|NCT02877303|Muromonab-CD3|muromonab-cd3|mesh-list
110680879|NCT02877303|Antibodies|antibodies|mesh-list
110680880|NCT02877303|Immunoglobulins|immunoglobulins|mesh-list
110680881|NCT02877303|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110680882|NCT02877303|Antibodies, Bispecific|antibodies, bispecific|mesh-list
110680883|NCT02877303|BB 1101|bb 1101|mesh-list
110680884|NCT02877303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110438066|NCT00948441|Ethanol|ethanol|mesh-list
110680885|NCT02877303|Immunologic Factors|immunologic factors|mesh-ancestor
110680886|NCT02877303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110680887|NCT02877303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110680888|NCT02877303|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110680889|NCT02877303|Alkylating Agents|alkylating agents|mesh-ancestor
110680890|NCT02877303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110680891|NCT02877303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110680892|NCT02877303|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110680893|NCT02877303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110680894|NCT02877303|Antiemetics|antiemetics|mesh-ancestor
110680895|NCT02877303|Autonomic Agents|autonomic agents|mesh-ancestor
110438124|NCT04202224|Antipyretics|antipyretics|mesh-ancestor
110680896|NCT02877303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110680897|NCT02877303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110680898|NCT02877303|Glucocorticoids|glucocorticoids|mesh-ancestor
110680899|NCT02877303|Hormones|hormones|mesh-ancestor
110680900|NCT02877303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110680901|NCT02877303|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110680902|NCT02877303|Protease Inhibitors|protease inhibitors|mesh-ancestor
110680903|NCT02877303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110680904|NCT02877303|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110680905|NCT02877303|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110359856|NCT00848328|Rituximab|rituximab|mesh-list
110680906|NCT02877303|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110680907|NCT02877303|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110680908|NCT02877303|Abortifacient Agents|abortifacient agents|mesh-ancestor
110680909|NCT02877303|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110680910|NCT02877303|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110680911|NCT02877303|Antimetabolites|antimetabolites|mesh-ancestor
110680912|NCT02877303|Dermatologic Agents|dermatologic agents|mesh-ancestor
110680913|NCT02877303|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110680914|NCT02877303|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110680915|NCT02877303|Antiviral Agents|antiviral agents|mesh-ancestor
110680916|NCT02877303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110680917|NCT02877303|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110680918|NCT02877303|Tubulin Modulators|tubulin modulators|mesh-ancestor
110680919|NCT02877303|Antimitotic Agents|antimitotic agents|mesh-ancestor
110680920|NCT02877303|Mitosis Modulators|mitosis modulators|mesh-ancestor
110680921|NCT02877303|Immunotoxins|immunotoxins|mesh-ancestor
110680922|NCT02877303|Immunoconjugates|immunoconjugates|mesh-ancestor
110680923|NCT02866383|Nivolumab|nivolumab|mesh-list
110680924|NCT02866383|Ipilimumab|ipilimumab|mesh-list
110680925|NCT02866383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110680926|NCT02866383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110680927|NCT02866383|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110680928|NCT02866383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110680929|NCT02841215|Ivermectin|ivermectin|mesh-list
110680930|NCT02841215|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110680931|NCT02841215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110680932|NCT02807571|Anesthetics|anesthetics|mesh-list
110680933|NCT02807571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110680934|NCT02807571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110680935|NCT02793466|Durvalumab|durvalumab|mesh-list
110680936|NCT02793466|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110680937|NCT02793466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110680938|NCT02793466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110680965|NCT02638090|Vorinostat|vorinostat|mesh-list
110680966|NCT02638090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110680967|NCT02638090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110680968|NCT02638090|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110680969|NCT02638090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110680970|NCT02638090|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110680971|NCT02638090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110680977|NCT02461368|Triamcinolone|triamcinolone|mesh-list
110680978|NCT02461368|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110680979|NCT02461368|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110680980|NCT02461368|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110680981|NCT02461368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110680982|NCT02461368|Glucocorticoids|glucocorticoids|mesh-ancestor
110680983|NCT02461368|Hormones|hormones|mesh-ancestor
110438433|NCT02845024|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110680984|NCT02461368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110680985|NCT02461368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110856475|NCT05692856|Sympathomimetics|sympathomimetics|mesh-ancestor
110680986|NCT02461368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110680987|NCT02461368|Immunologic Factors|immunologic factors|mesh-ancestor
110680988|NCT02461368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110680989|NCT02461368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110680990|NCT02428985|Riociguat|riociguat|mesh-list
110680991|NCT02428985|Enzyme Activators|enzyme activators|mesh-ancestor
110680992|NCT02428985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110680993|NCT02373072|Trimethobenzamide|trimethobenzamide|mesh-list
110680994|NCT02373072|Antiemetics|antiemetics|mesh-ancestor
110680995|NCT02373072|Autonomic Agents|autonomic agents|mesh-ancestor
110680996|NCT02373072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110680997|NCT02373072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110680998|NCT02373072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110680999|NCT02303678|D2C7-(scdsFv)-PE38KDEL|d2c7-(scdsfv)-pe38kdel|mesh-list
110681000|NCT02303678|Immunoconjugates|immunoconjugates|mesh-ancestor
110681001|NCT02303678|Immunologic Factors|immunologic factors|mesh-ancestor
110681002|NCT02303678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110681003|NCT02285140|Vancomycin|vancomycin|mesh-list
110681004|NCT02285140|Cefazolin|cefazolin|mesh-list
110681005|NCT02285140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110681006|NCT02285140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110681007|NCT02257736|Prednisone|prednisone|mesh-list
110681008|NCT02257736|Abiraterone Acetate|abiraterone acetate|mesh-list
110681009|NCT02257736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110681010|NCT02257736|Glucocorticoids|glucocorticoids|mesh-ancestor
110681011|NCT02257736|Hormones|hormones|mesh-ancestor
110681012|NCT02257736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110681013|NCT02257736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110681014|NCT02257736|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110681015|NCT02257736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110681016|NCT02257736|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110681017|NCT02257736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110681018|NCT02257736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110681019|NCT02257736|Hormone Antagonists|hormone antagonists|mesh-ancestor
110681020|NCT02257736|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110681022|NCT02254278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110681024|NCT02252172|Lenalidomide|lenalidomide|mesh-list
110681025|NCT02252172|Daratumumab|daratumumab|mesh-list
110681026|NCT02252172|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110681027|NCT02252172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110681028|NCT02252172|Antiemetics|antiemetics|mesh-ancestor
110681029|NCT02252172|Autonomic Agents|autonomic agents|mesh-ancestor
110681030|NCT02252172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110681031|NCT02252172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110681032|NCT02252172|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110681033|NCT02252172|Glucocorticoids|glucocorticoids|mesh-ancestor
110681034|NCT02252172|Hormones|hormones|mesh-ancestor
110681035|NCT02252172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110681036|NCT02252172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110681037|NCT02252172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110681038|NCT02252172|Immunologic Factors|immunologic factors|mesh-ancestor
110681039|NCT02252172|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110681040|NCT02252172|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110681041|NCT02252172|Growth Substances|growth substances|mesh-ancestor
110681042|NCT02252172|Growth Inhibitors|growth inhibitors|mesh-ancestor
110681043|NCT02174549|Tirapazamine|tirapazamine|mesh-list
110681044|NCT02174549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110681045|NCT02059499|Fluorouracil|fluorouracil|mesh-list
110681046|NCT02059499|Imiquimod|imiquimod|mesh-list
110681047|NCT02059499|Antimetabolites|antimetabolites|mesh-ancestor
110681048|NCT02059499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110681049|NCT02059499|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110681050|NCT02059499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110681051|NCT02059499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110681052|NCT02059499|Immunologic Factors|immunologic factors|mesh-ancestor
110681053|NCT02059499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110681054|NCT02059499|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110681055|NCT02059499|Interferon Inducers|interferon inducers|mesh-ancestor
110681056|NCT01701674|Aldesleukin|aldesleukin|mesh-list
110681057|NCT01701674|Cyclophosphamide|cyclophosphamide|mesh-list
110681058|NCT01701674|Fludarabine|fludarabine|mesh-list
110681059|NCT01701674|Ipilimumab|ipilimumab|mesh-list
110681060|NCT01701674|Interleukin-2|interleukin-2|mesh-list
110681061|NCT01701674|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110681062|NCT01701674|Immunologic Factors|immunologic factors|mesh-ancestor
110681063|NCT01701674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110681064|NCT01701674|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110681065|NCT01701674|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110681066|NCT01701674|Alkylating Agents|alkylating agents|mesh-ancestor
110681067|NCT01701674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110681068|NCT01701674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110681069|NCT01701674|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110681070|NCT01701674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110681071|NCT01701674|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110681072|NCT01701674|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110681073|NCT01701674|Analgesics|analgesics|mesh-ancestor
110681074|NCT01701674|Sensory System Agents|sensory system agents|mesh-ancestor
110681075|NCT01701674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110681076|NCT01701674|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110681077|NCT01701674|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110681078|NCT01701674|Antiviral Agents|antiviral agents|mesh-ancestor
110681079|NCT01701674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110681080|NCT01607879|Androgens|androgens|mesh-list
110681081|NCT01607879|Hormones|hormones|mesh-ancestor
110681082|NCT01607879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110681083|NCT01607879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110681084|NCT01336933|Prednisone|prednisone|mesh-list
110681085|NCT01336933|Cyclophosphamide|cyclophosphamide|mesh-list
110681087|NCT01336933|Vincristine|vincristine|mesh-list
110681088|NCT01336933|Etoposide phosphate|etoposide phosphate|mesh-list
110681089|NCT01336933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110355442|NCT00551889|Analgesics|analgesics|mesh-ancestor
110681090|NCT01336933|Immunologic Factors|immunologic factors|mesh-ancestor
110681091|NCT01336933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110328134|NCT00488709|Antimetabolites|antimetabolites|mesh-ancestor
110681092|NCT01336933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110681093|NCT01336933|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110681094|NCT01336933|Alkylating Agents|alkylating agents|mesh-ancestor
110681095|NCT01336933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110681096|NCT01336933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110681097|NCT01336933|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110681098|NCT01336933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110681099|NCT01336933|Glucocorticoids|glucocorticoids|mesh-ancestor
110681100|NCT01336933|Hormones|hormones|mesh-ancestor
110681101|NCT01336933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110681102|NCT01336933|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110681103|NCT01336933|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110681104|NCT01336933|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110681105|NCT01336933|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110681106|NCT01336933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110681107|NCT01336933|Tubulin Modulators|tubulin modulators|mesh-ancestor
110681108|NCT01336933|Antimitotic Agents|antimitotic agents|mesh-ancestor
110681109|NCT01336933|Mitosis Modulators|mitosis modulators|mesh-ancestor
110681110|NCT01107522|Temozolomide|temozolomide|mesh-list
110681111|NCT01107522|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110681113|NCT01107522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110681114|NCT01107522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110681115|NCT01087619|Parathyroid Hormone|parathyroid hormone|mesh-list
110681116|NCT01087619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110681117|NCT01087619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110681118|NCT01065454|Riociguat|riociguat|mesh-list
110681119|NCT01065454|Enzyme Activators|enzyme activators|mesh-ancestor
110681120|NCT01065454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110681121|NCT00352027|Prednisone|prednisone|mesh-list
110681122|NCT00352027|Hydrocortisone|hydrocortisone|mesh-list
110681123|NCT00352027|Cyclophosphamide|cyclophosphamide|mesh-list
110681124|NCT00352027|Mechlorethamine|mechlorethamine|mesh-list
110681125|NCT00352027|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
110681126|NCT00352027|Doxorubicin|doxorubicin|mesh-list
110681127|NCT00352027|Etoposide|etoposide|mesh-list
110681128|NCT00352027|Vincristine|vincristine|mesh-list
110681129|NCT00352027|Bleomycin|bleomycin|mesh-list
110681130|NCT00352027|Vinblastine|vinblastine|mesh-list
110681131|NCT00352027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110681132|NCT00352027|Immunologic Factors|immunologic factors|mesh-ancestor
110681133|NCT00352027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110681134|NCT00352027|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110681135|NCT00352027|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110681136|NCT00352027|Alkylating Agents|alkylating agents|mesh-ancestor
110681137|NCT00352027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110681138|NCT00352027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110681139|NCT00352027|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110681140|NCT00352027|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110681141|NCT00352027|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110681142|NCT00352027|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110681143|NCT00352027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110681144|NCT00352027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110681145|NCT00352027|Glucocorticoids|glucocorticoids|mesh-ancestor
110681146|NCT00352027|Hormones|hormones|mesh-ancestor
110681147|NCT00352027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110681148|NCT00352027|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110681149|NCT00352027|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110681150|NCT00352027|Tubulin Modulators|tubulin modulators|mesh-ancestor
110681151|NCT00352027|Antimitotic Agents|antimitotic agents|mesh-ancestor
110681152|NCT00352027|Mitosis Modulators|mitosis modulators|mesh-ancestor
110681153|NCT00262470|Indomethacin|indomethacin|mesh-list
110681154|NCT00262470|Octreotide|octreotide|mesh-list
110681155|NCT00262470|Propranolol|propranolol|mesh-list
110681156|NCT00262470|Clonidine|clonidine|mesh-list
110681157|NCT00262470|Mecamylamine|mecamylamine|mesh-list
110681158|NCT00262470|Acetazolamide|acetazolamide|mesh-list
110681159|NCT00262470|Isosorbide|isosorbide|mesh-list
110681160|NCT00262470|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
110681162|NCT00262470|Midodrine|midodrine|mesh-list
110681163|NCT00262470|Memantine|memantine|mesh-list
110681164|NCT00262470|Entacapone|entacapone|mesh-list
110681165|NCT00262470|Melatonin|melatonin|mesh-list
110681166|NCT00262470|Modafinil|modafinil|mesh-list
110681167|NCT00262470|Sertraline|sertraline|mesh-list
110681168|NCT00262470|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
110328209|NCT01242579|Maraviroc|maraviroc|mesh-list
110681169|NCT00262470|Antioxidants|antioxidants|mesh-ancestor
110681170|NCT00262470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110681171|NCT00262470|Protective Agents|protective agents|mesh-ancestor
110681172|NCT00262470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110681173|NCT00262470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110681174|NCT00262470|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110681175|NCT00262470|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110681177|NCT00262470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110681178|NCT00262470|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110681179|NCT00262470|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110681180|NCT00262470|Vasodilator Agents|vasodilator agents|mesh-ancestor
110681181|NCT00262470|Antidepressive Agents|antidepressive agents|mesh-ancestor
110681182|NCT00262470|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110681183|NCT00262470|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110681184|NCT00262470|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110681185|NCT00262470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110681186|NCT00262470|Serotonin Agents|serotonin agents|mesh-ancestor
110681187|NCT00262470|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110681188|NCT00262470|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110681189|NCT00262470|Dopamine Agents|dopamine agents|mesh-ancestor
110681190|NCT00262470|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110681191|NCT00262470|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110681192|NCT00262470|Analgesics|analgesics|mesh-ancestor
110681193|NCT00262470|Sensory System Agents|sensory system agents|mesh-ancestor
110681194|NCT00262470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110681195|NCT00262470|Sympatholytics|sympatholytics|mesh-ancestor
110681196|NCT00262470|Autonomic Agents|autonomic agents|mesh-ancestor
110681197|NCT00262470|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110681198|NCT00262470|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110681199|NCT00262470|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110681200|NCT00262470|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110681201|NCT00262470|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110681202|NCT00262470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110681203|NCT00262470|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110681204|NCT00262470|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110681205|NCT00262470|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
110681206|NCT00262470|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110681207|NCT00262470|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110681208|NCT00262470|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110681209|NCT00262470|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110681210|NCT00262470|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110439042|NCT01212770|Thalidomide|thalidomide|mesh-list
110681211|NCT00262470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110681212|NCT00262470|Gout Suppressants|gout suppressants|mesh-ancestor
110681213|NCT00262470|Tocolytic Agents|tocolytic agents|mesh-ancestor
110681214|NCT00262470|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110681215|NCT00262470|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110681216|NCT00262470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110681217|NCT00262470|Anticonvulsants|anticonvulsants|mesh-ancestor
110681218|NCT00262470|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110681219|NCT00262470|Diuretics|diuretics|mesh-ancestor
110681220|NCT00262470|Natriuretic Agents|natriuretic agents|mesh-ancestor
110681221|NCT00262470|Sympathomimetics|sympathomimetics|mesh-ancestor
110681222|NCT00262470|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110681223|NCT00262470|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110681224|NCT00262470|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110681225|NCT00262470|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
110681226|NCT00262470|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
110681227|NCT00262470|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
110681228|NCT00262470|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
110681229|NCT00262470|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110681230|NCT00262470|Cholinergic Agents|cholinergic agents|mesh-ancestor
110681231|NCT00047060|Cyclosporine|cyclosporine|mesh-list
110681232|NCT00047060|Fludarabine|fludarabine|mesh-list
110681233|NCT00047060|Alemtuzumab|alemtuzumab|mesh-list
110681234|NCT00047060|Cyclosporins|cyclosporins|mesh-list
110681235|NCT00047060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110681236|NCT00047060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110681237|NCT00047060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110681239|NCT00047060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110681240|NCT00047060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110681241|NCT00047060|Antifungal Agents|antifungal agents|mesh-ancestor
110681242|NCT00047060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110681243|NCT00047060|Dermatologic Agents|dermatologic agents|mesh-ancestor
110681244|NCT00047060|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110439160|NCT03314935|Paclitaxel|paclitaxel|mesh-list
110681245|NCT00047060|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110681246|NCT00047060|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110681248|NCT00440271|Raltegravir Potassium|raltegravir potassium|mesh-list
110681249|NCT00440271|Maraviroc|maraviroc|mesh-list
110681250|NCT00440271|Tipranavir|tipranavir|mesh-list
110681251|NCT00440271|Enfuvirtide|enfuvirtide|mesh-list
110681252|NCT00440271|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
110681253|NCT00440271|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110681254|NCT00440271|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110681255|NCT00440271|Protease Inhibitors|protease inhibitors|mesh-ancestor
110681256|NCT00440271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110681257|NCT00440271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110681258|NCT00440271|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110681259|NCT00440271|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110681260|NCT00440271|Antiviral Agents|antiviral agents|mesh-ancestor
110681261|NCT00440271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110681262|NCT00440271|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110681263|NCT00440271|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110681264|NCT00440271|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110681265|NCT00440271|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110681266|NCT00440271|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110681267|NCT00440271|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110681268|NCT00440271|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
110681269|NCT00440271|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110681271|NCT00346216|Celecoxib|celecoxib|mesh-list
110681272|NCT00346216|Naproxen|naproxen|mesh-list
110681273|NCT00346216|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110681274|NCT00346216|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110681275|NCT00346216|Analgesics|analgesics|mesh-ancestor
110681276|NCT00346216|Sensory System Agents|sensory system agents|mesh-ancestor
110681277|NCT00346216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110681278|NCT00346216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110681279|NCT00346216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110681280|NCT00346216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110681281|NCT00346216|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110681282|NCT00346216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110681283|NCT00346216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110681284|NCT00346216|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110681285|NCT00346216|Gout Suppressants|gout suppressants|mesh-ancestor
110681286|NCT01051648|Triamcinolone|triamcinolone|mesh-list
110681287|NCT01051648|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110681288|NCT01051648|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110681289|NCT01051648|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110681290|NCT01051648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110681291|NCT01051648|Glucocorticoids|glucocorticoids|mesh-ancestor
110681292|NCT01051648|Hormones|hormones|mesh-ancestor
110681293|NCT01051648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110681294|NCT01051648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110681295|NCT01051648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110681296|NCT01051648|Immunologic Factors|immunologic factors|mesh-ancestor
110681297|NCT01051648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110681298|NCT01051648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110681299|NCT00429273|Guanfacine|guanfacine|mesh-list
110681300|NCT00429273|Methylphenidate|methylphenidate|mesh-list
110681301|NCT00429273|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
110439460|NCT02837614|Sensory System Agents|sensory system agents|mesh-ancestor
110681302|NCT00429273|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110681303|NCT00429273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110681304|NCT00429273|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110681305|NCT00429273|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110681306|NCT00429273|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110681307|NCT00429273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110681308|NCT00429273|Dopamine Agents|dopamine agents|mesh-ancestor
110681309|NCT00429273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110681310|NCT00429273|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110681311|NCT00429273|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110681312|NCT00429273|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110681314|NCT00429273|Adrenergic Agents|adrenergic agents|mesh-ancestor
110681315|NCT00359632|Linezolid|linezolid|mesh-list
110681316|NCT00359632|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110681317|NCT00359632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110681318|NCT00359632|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110681319|NCT00359632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110681320|NCT00359632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110681321|NCT01324960|Aldesleukin|aldesleukin|mesh-list
110681322|NCT01324960|Azacitidine|azacitidine|mesh-list
110681323|NCT01324960|Histamine|histamine|mesh-list
110681324|NCT01324960|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110681325|NCT01324960|Antimetabolites|antimetabolites|mesh-ancestor
110681326|NCT01324960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110681327|NCT01324960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110681328|NCT01324960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110681329|NCT01324960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110681330|NCT01324960|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110681331|NCT01324960|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110681332|NCT01324960|Antiviral Agents|antiviral agents|mesh-ancestor
110681333|NCT01324960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110681334|NCT01324960|Histamine Agonists|histamine agonists|mesh-ancestor
110681335|NCT01324960|Histamine Agents|histamine agents|mesh-ancestor
110681336|NCT01324960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110681337|NCT00417885|Sunitinib|sunitinib|mesh-list
110681338|NCT00417885|Exemestane|exemestane|mesh-list
110681339|NCT00417885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110681340|NCT00417885|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110681341|NCT00417885|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110681342|NCT00417885|Growth Substances|growth substances|mesh-ancestor
110681343|NCT00417885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110681344|NCT00417885|Growth Inhibitors|growth inhibitors|mesh-ancestor
110681345|NCT00417885|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110681346|NCT00417885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110681347|NCT00417885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110681348|NCT00417885|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110681349|NCT00417885|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110681350|NCT00417885|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110681351|NCT00417885|Hormone Antagonists|hormone antagonists|mesh-ancestor
110681352|NCT00417885|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110681353|NCT01036893|Prucalopride|prucalopride|mesh-list
110681354|NCT01036893|Laxatives|laxatives|mesh-ancestor
110681355|NCT01036893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110681356|NCT01036893|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
110681357|NCT01036893|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110681358|NCT01036893|Serotonin Agents|serotonin agents|mesh-ancestor
110681359|NCT01036893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110681360|NCT01036893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110681361|NCT01036893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110681362|NCT00525044|Ambroxol|ambroxol|mesh-list
110681363|NCT00525044|Expectorants|expectorants|mesh-ancestor
110681364|NCT00525044|Respiratory System Agents|respiratory system agents|mesh-ancestor
110681365|NCT00355342|Fluticasone|fluticasone|mesh-list
110681366|NCT00355342|Xhance|xhance|mesh-list
110681367|NCT00355342|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110681368|NCT00355342|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110681369|NCT00355342|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110681370|NCT00355342|Autonomic Agents|autonomic agents|mesh-ancestor
110681371|NCT00355342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110681372|NCT00355342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110681373|NCT00355342|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110681374|NCT00355342|Respiratory System Agents|respiratory system agents|mesh-ancestor
110681375|NCT00355342|Dermatologic Agents|dermatologic agents|mesh-ancestor
110681376|NCT00355342|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110439842|NCT00662467|Analgesics|analgesics|mesh-ancestor
110681377|NCT00355342|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110681378|NCT00355342|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110681379|NCT00355342|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110681380|NCT00355342|Adrenergic Agents|adrenergic agents|mesh-ancestor
110681381|NCT00355342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110681382|NCT00355342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110681383|NCT01051804|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110681384|NCT01051804|Lubricant Eye Drops|lubricant eye drops|mesh-list
110681385|NCT01051804|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110681386|NCT01573754|Hydroxychloroquine|hydroxychloroquine|mesh-list
110681387|NCT01573754|Antimalarials|antimalarials|mesh-ancestor
110681388|NCT01573754|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110681389|NCT01573754|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110681390|NCT01573754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110681391|NCT01573754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110681392|NCT01573754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110681393|NCT01573754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110681394|NCT03989830|Endostatins|endostatins|mesh-list
110681395|NCT03989830|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110681396|NCT03989830|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110681397|NCT03989830|Growth Substances|growth substances|mesh-ancestor
110681398|NCT03989830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110681399|NCT03989830|Growth Inhibitors|growth inhibitors|mesh-ancestor
110681400|NCT03989830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110681401|NCT02533648|Allopurinol|allopurinol|mesh-list
110681402|NCT02533648|Antimetabolites|antimetabolites|mesh-ancestor
110681403|NCT02533648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110681404|NCT02533648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110681405|NCT02533648|Gout Suppressants|gout suppressants|mesh-ancestor
110681406|NCT02533648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110681407|NCT02533648|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110681408|NCT02533648|Antioxidants|antioxidants|mesh-ancestor
110681409|NCT02533648|Protective Agents|protective agents|mesh-ancestor
110681410|NCT02533648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110681411|NCT02533492|Triclosan|triclosan|mesh-list
110681412|NCT02533492|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110681413|NCT02533492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110681414|NCT02533492|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
110681415|NCT02533492|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110681416|NCT02533492|Antimetabolites|antimetabolites|mesh-ancestor
110681417|NCT02533492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110681418|NCT02533492|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110681419|NCT01056874|Maraviroc|maraviroc|mesh-list
110681420|NCT01056874|Digoxin|digoxin|mesh-list
110440093|NCT01162421|Adalimumab|adalimumab|mesh-list
110681421|NCT01056874|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110681422|NCT01056874|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110681423|NCT01056874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110681424|NCT01056874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110681425|NCT01056874|Protective Agents|protective agents|mesh-ancestor
110681426|NCT01056874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110681427|NCT01056874|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110681428|NCT01056874|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110681429|NCT01056874|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110681430|NCT01056874|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110681431|NCT01056874|Antiviral Agents|antiviral agents|mesh-ancestor
110681432|NCT01056874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110681433|NCT01056874|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
110681434|NCT00355030|Leuprolide|leuprolide|mesh-list
110681435|NCT00355030|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110681436|NCT00355030|Fertility Agents|fertility agents|mesh-ancestor
110681437|NCT00355030|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110681438|NCT00355030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110681439|NCT00355030|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110681440|NCT00355030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110681441|NCT01057030|BMS 708163|bms 708163|mesh-list
110681442|NCT01057030|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-list
110681444|NCT01057030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110681445|NCT01057186|Alfacalcidol|alfacalcidol|mesh-list
110440218|NCT02834260|Glucocorticoids|glucocorticoids|mesh-ancestor
110681446|NCT01057186|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
110681447|NCT01057186|Sevelamer|sevelamer|mesh-list
110681448|NCT01057186|Chelating Agents|chelating agents|mesh-ancestor
110681449|NCT01057186|Sequestering Agents|sequestering agents|mesh-ancestor
110681450|NCT01057186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110681451|NCT01057186|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110681452|NCT01057186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110681453|NCT01057186|Vitamins|vitamins|mesh-ancestor
110681454|NCT01057186|Micronutrients|micronutrients|mesh-ancestor
110681455|NCT01057264|Paclitaxel|paclitaxel|mesh-list
110681456|NCT01057264|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110681457|NCT01057264|Bevacizumab|bevacizumab|mesh-list
110681458|NCT01057264|Gemcitabine|gemcitabine|mesh-list
110681459|NCT01057264|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110681460|NCT01057264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110681461|NCT01057264|Tubulin Modulators|tubulin modulators|mesh-ancestor
110681462|NCT01057264|Antimitotic Agents|antimitotic agents|mesh-ancestor
110681463|NCT01057264|Mitosis Modulators|mitosis modulators|mesh-ancestor
110681464|NCT01057264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110681465|NCT01057264|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110681466|NCT01057264|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110681467|NCT01057264|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110681469|NCT01057264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110328511|NCT00462215|Vaccines|vaccines|mesh-list
110681470|NCT01057264|Growth Inhibitors|growth inhibitors|mesh-ancestor
110681471|NCT01057264|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110681472|NCT01057264|Antimetabolites|antimetabolites|mesh-ancestor
110681473|NCT03991312|Itraconazole|itraconazole|mesh-list
110681474|NCT03991312|Rifampin|rifampin|mesh-list
110681475|NCT03991312|Mitapivat|mitapivat|mesh-list
110681476|NCT03991312|Antifungal Agents|antifungal agents|mesh-ancestor
110681477|NCT03991312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110681478|NCT03991312|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110681479|NCT03991312|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110681480|NCT03991312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110681481|NCT03991312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110681482|NCT03991312|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110681483|NCT03991312|Hormone Antagonists|hormone antagonists|mesh-ancestor
110681484|NCT03991312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110681485|NCT03991312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110681486|NCT03991312|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110681487|NCT03991312|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110681488|NCT03991312|Antitubercular Agents|antitubercular agents|mesh-ancestor
110681489|NCT03991312|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110681490|NCT03991312|Leprostatic Agents|leprostatic agents|mesh-ancestor
110681491|NCT03991312|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110681492|NCT03991312|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110681493|NCT03991312|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110681494|NCT03991312|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110681495|NCT03991312|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110681496|NCT03991312|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110681497|NCT03991312|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110681498|NCT03991312|Enzyme Activators|enzyme activators|mesh-ancestor
110681499|NCT01057342|Paclitaxel|paclitaxel|mesh-list
110681500|NCT01057342|Carboplatin|carboplatin|mesh-list
110681501|NCT01057342|Vadimezan|vadimezan|mesh-list
110681502|NCT01057342|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110681503|NCT01057342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110681504|NCT01057342|Tubulin Modulators|tubulin modulators|mesh-ancestor
110681505|NCT01057342|Antimitotic Agents|antimitotic agents|mesh-ancestor
110681506|NCT01057342|Mitosis Modulators|mitosis modulators|mesh-ancestor
110681507|NCT01057342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110681509|NCT01057498|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110681510|NCT01057498|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110681511|NCT01057498|Analgesics|analgesics|mesh-ancestor
110681512|NCT01057498|Sensory System Agents|sensory system agents|mesh-ancestor
110408364|NCT05924152|Adagrasib|adagrasib|mesh-list
110681513|NCT01057498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110681514|NCT01057498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110681515|NCT01057498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110681516|NCT01057498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110681517|NCT01057498|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110681519|NCT03742258|Cortisone|cortisone|mesh-list
110681520|NCT03742258|Cyclophosphamide|cyclophosphamide|mesh-list
110681521|NCT03742258|Rituximab|rituximab|mesh-list
110681522|NCT03742258|Doxorubicin|doxorubicin|mesh-list
110681523|NCT03742258|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110440578|NCT00596947|Tacrolimus|tacrolimus|mesh-list
110681524|NCT03742258|Vincristine|vincristine|mesh-list
110681525|NCT03742258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110681526|NCT03742258|Antibodies|antibodies|mesh-list
110681527|NCT03742258|Immunoglobulins|immunoglobulins|mesh-list
110681528|NCT03742258|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110681529|NCT03742258|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
110681530|NCT03742258|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110681531|NCT03742258|Immunologic Factors|immunologic factors|mesh-ancestor
110681532|NCT03742258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110681533|NCT03742258|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110681534|NCT03742258|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110681535|NCT03742258|Alkylating Agents|alkylating agents|mesh-ancestor
110681536|NCT03742258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110681537|NCT03742258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110681538|NCT03742258|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110681539|NCT03742258|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110681540|NCT03742258|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110681541|NCT03742258|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110681542|NCT03742258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110681543|NCT03742258|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110681544|NCT03742258|Glucocorticoids|glucocorticoids|mesh-ancestor
110856599|NCT05691764|Cyclosporine|cyclosporine|mesh-list
110681546|NCT03742258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110681547|NCT03742258|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110681548|NCT03742258|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110681549|NCT03742258|Tubulin Modulators|tubulin modulators|mesh-ancestor
110681550|NCT03742258|Antimitotic Agents|antimitotic agents|mesh-ancestor
110681551|NCT03742258|Mitosis Modulators|mitosis modulators|mesh-ancestor
110681552|NCT03742258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110681554|NCT00354172|Mycophenolic Acid|mycophenolic acid|mesh-list
110681555|NCT00354172|Aldesleukin|aldesleukin|mesh-list
110681556|NCT00354172|Methylprednisolone|methylprednisolone|mesh-list
110681557|NCT00354172|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110681558|NCT00354172|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110681559|NCT00354172|Prednisolone|prednisolone|mesh-list
110681560|NCT00354172|Prednisolone acetate|prednisolone acetate|mesh-list
110681561|NCT00354172|Cyclophosphamide|cyclophosphamide|mesh-list
110681562|NCT00354172|Fludarabine|fludarabine|mesh-list
110681563|NCT00354172|Fludarabine phosphate|fludarabine phosphate|mesh-list
110681564|NCT00354172|Interleukin-2|interleukin-2|mesh-list
110681565|NCT00354172|Cyclosporins|cyclosporins|mesh-list
110681566|NCT00354172|Lenograstim|lenograstim|mesh-list
110681567|NCT00354172|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110681568|NCT00354172|Prednisolone phosphate|prednisolone phosphate|mesh-list
110681569|NCT00354172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110681570|NCT00354172|Immunologic Factors|immunologic factors|mesh-ancestor
110681571|NCT00354172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110681572|NCT00354172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110681573|NCT00354172|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110681574|NCT00354172|Alkylating Agents|alkylating agents|mesh-ancestor
110440765|NCT04153123|Mydriatics|mydriatics|mesh-ancestor
110681575|NCT00354172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110681576|NCT00354172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110681577|NCT00354172|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110681578|NCT00354172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110681579|NCT00354172|Antimetabolites|antimetabolites|mesh-ancestor
110681580|NCT00354172|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110681581|NCT00354172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110681582|NCT00354172|Antifungal Agents|antifungal agents|mesh-ancestor
110681583|NCT00354172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110681584|NCT00354172|Dermatologic Agents|dermatologic agents|mesh-ancestor
110681585|NCT00354172|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110681586|NCT00354172|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110681587|NCT00354172|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110681588|NCT00354172|Antitubercular Agents|antitubercular agents|mesh-ancestor
110681589|NCT00354172|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110681590|NCT00354172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110681591|NCT00354172|Antiemetics|antiemetics|mesh-ancestor
110681592|NCT00354172|Autonomic Agents|autonomic agents|mesh-ancestor
110681593|NCT00354172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110681594|NCT00354172|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110681595|NCT00354172|Glucocorticoids|glucocorticoids|mesh-ancestor
110681597|NCT00354172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110681598|NCT00354172|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110681599|NCT00354172|Protective Agents|protective agents|mesh-ancestor
110681600|NCT00354172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110681601|NCT00354172|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110681602|NCT00354172|Analgesics|analgesics|mesh-ancestor
110681603|NCT00354172|Sensory System Agents|sensory system agents|mesh-ancestor
110681604|NCT00354172|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110681605|NCT00354172|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110681606|NCT00354172|Antiviral Agents|antiviral agents|mesh-ancestor
110681607|NCT00353704|Pregabalin|pregabalin|mesh-list
110681608|NCT00353704|Morphine|morphine|mesh-list
110681609|NCT00353704|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110681610|NCT00353704|Narcotics|narcotics|mesh-ancestor
110681611|NCT00353704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110681612|NCT00353704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110681613|NCT00353704|Analgesics|analgesics|mesh-ancestor
110681614|NCT00353704|Sensory System Agents|sensory system agents|mesh-ancestor
110681615|NCT00353704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110681616|NCT00353704|Anticonvulsants|anticonvulsants|mesh-ancestor
110681617|NCT00353704|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110681618|NCT00353704|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110440936|NCT02825290|Luteolytic Agents|luteolytic agents|mesh-ancestor
110681619|NCT00353704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110681620|NCT00353704|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110681622|NCT00353704|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110681623|NCT00353704|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110681624|NCT03742180|Ketorolac|ketorolac|mesh-list
110681625|NCT03742180|Dexmedetomidine|dexmedetomidine|mesh-list
110681626|NCT03742180|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110681627|NCT03742180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110681628|NCT03742180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110681629|NCT03742180|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110681630|NCT03742180|Analgesics|analgesics|mesh-ancestor
110681631|NCT03742180|Sensory System Agents|sensory system agents|mesh-ancestor
110681632|NCT03742180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110681633|NCT03742180|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110681634|NCT03742180|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110681635|NCT03742180|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110681636|NCT03742180|Adrenergic Agents|adrenergic agents|mesh-ancestor
110681637|NCT03742180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110681638|NCT03742180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110681639|NCT03742180|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110681640|NCT03742180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110681641|NCT03742180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110681642|NCT03742180|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110681643|NCT03742180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110681644|NCT00512252|Cytarabine|cytarabine|mesh-list
110681645|NCT00512252|Plerixafor|plerixafor|mesh-list
110681646|NCT00512252|Etoposide|etoposide|mesh-list
110681647|NCT00512252|Mitoxantrone|mitoxantrone|mesh-list
110681648|NCT00512252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110681649|NCT00512252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110681650|NCT00512252|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110681651|NCT00512252|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110681652|NCT00512252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110681653|NCT00512252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110681654|NCT00512252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110681655|NCT00512252|Antimetabolites|antimetabolites|mesh-ancestor
110681656|NCT00512252|Antiviral Agents|antiviral agents|mesh-ancestor
110681657|NCT00512252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110681658|NCT00512252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110681659|NCT00512252|Immunologic Factors|immunologic factors|mesh-ancestor
110681660|NCT00512252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110681661|NCT00512252|Analgesics|analgesics|mesh-ancestor
110681662|NCT00512252|Sensory System Agents|sensory system agents|mesh-ancestor
110408369|NCT05920798|Pembrolizumab|pembrolizumab|mesh-list
110681663|NCT00512252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110681664|NCT00512252|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110681665|NCT00512252|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110681666|NCT00516386|Mecasermin|mecasermin|mesh-list
110681667|NCT00516386|Growth Substances|growth substances|mesh-ancestor
110681668|NCT00516386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110681669|NCT00512096|Paclitaxel|paclitaxel|mesh-list
110681670|NCT00512096|Cisplatin|cisplatin|mesh-list
110681671|NCT00512096|Ifosfamide|ifosfamide|mesh-list
110681672|NCT00512096|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110681673|NCT00512096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110681674|NCT00512096|Tubulin Modulators|tubulin modulators|mesh-ancestor
110681675|NCT00512096|Antimitotic Agents|antimitotic agents|mesh-ancestor
110681676|NCT00512096|Mitosis Modulators|mitosis modulators|mesh-ancestor
110681677|NCT00512096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110681678|NCT00512096|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110681679|NCT00512096|Alkylating Agents|alkylating agents|mesh-ancestor
110681680|NCT04462796|Magnesium citrate|magnesium citrate|mesh-list
110681681|NCT04462796|Cathartics|cathartics|mesh-ancestor
110681682|NCT04462796|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110681683|NCT00524030|Pregabalin|pregabalin|mesh-list
110681684|NCT00524030|Analgesics|analgesics|mesh-ancestor
110681685|NCT00524030|Sensory System Agents|sensory system agents|mesh-ancestor
110681686|NCT00524030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110681687|NCT00524030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110681688|NCT00524030|Anticonvulsants|anticonvulsants|mesh-ancestor
110681689|NCT00524030|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110681690|NCT00524030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110681691|NCT00524030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110356040|NCT05255367|Phenol|phenol|mesh-list
110681692|NCT00524030|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110681693|NCT00524030|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110681694|NCT00524030|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110681695|NCT00524030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110328751|NCT00497523|Hormones|hormones|mesh-ancestor
110681696|NCT00524030|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110681697|NCT00523718|Riluzole|riluzole|mesh-list
110681698|NCT00523718|Anticonvulsants|anticonvulsants|mesh-ancestor
110681699|NCT00523718|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110681700|NCT00523718|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110681701|NCT00523718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110681702|NCT00523718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110441366|NCT00674557|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
110681703|NCT00523718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110681704|NCT00523718|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110681705|NCT00523718|Protective Agents|protective agents|mesh-ancestor
110681706|NCT00523640|Bevacizumab|bevacizumab|mesh-list
110681707|NCT00523640|Gemcitabine|gemcitabine|mesh-list
110681708|NCT00523640|Capecitabine|capecitabine|mesh-list
110681709|NCT00523640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110681710|NCT00523640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110681711|NCT00523640|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110681712|NCT00523640|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110681713|NCT00523640|Growth Substances|growth substances|mesh-ancestor
110681714|NCT00523640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110681715|NCT00523640|Growth Inhibitors|growth inhibitors|mesh-ancestor
110681716|NCT00523640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110681717|NCT00523640|Antimetabolites|antimetabolites|mesh-ancestor
110681718|NCT00523640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110681719|NCT00345358|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110681720|NCT00345358|Immunologic Factors|immunologic factors|mesh-ancestor
110681721|NCT00345358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110681722|NCT00516074|Exenatide|exenatide|mesh-list
110681723|NCT00516074|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110681724|NCT00516074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110681725|NCT00516074|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110681726|NCT00516074|Incretins|incretins|mesh-ancestor
110681727|NCT00516074|Hormones|hormones|mesh-ancestor
110681728|NCT00516074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110681729|NCT01057654|Pravastatin|pravastatin|mesh-list
110681730|NCT01057654|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110681731|NCT01057654|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110681732|NCT01057654|Antimetabolites|antimetabolites|mesh-ancestor
110681733|NCT01057654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110681734|NCT01057654|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110681735|NCT01057654|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110681736|NCT01057654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110681737|NCT00515294|Caffeine|caffeine|mesh-list
110681738|NCT00515294|Methamphetamine|methamphetamine|mesh-list
110681739|NCT00515294|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110681740|NCT00515294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110681741|NCT00515294|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110681742|NCT00515294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110441541|NCT01200758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110681743|NCT00515294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110681744|NCT00515294|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110681745|NCT00515294|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110681746|NCT00515294|Purinergic Agents|purinergic agents|mesh-ancestor
110681747|NCT00515294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110681748|NCT00515294|Sympathomimetics|sympathomimetics|mesh-ancestor
110681749|NCT00515294|Autonomic Agents|autonomic agents|mesh-ancestor
110681750|NCT00515294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110681751|NCT00515294|Dopamine Agents|dopamine agents|mesh-ancestor
110441617|NCT00678145|Epinephrine|epinephrine|mesh-list
110681752|NCT00515294|Adrenergic Agents|adrenergic agents|mesh-ancestor
110681753|NCT00515294|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110681754|NCT00515294|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110681755|NCT00515294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110681756|NCT00515294|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110681758|NCT00345046|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110681759|NCT00345046|Methylprednisolone|methylprednisolone|mesh-list
110681760|NCT00345046|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110681761|NCT00345046|Prednisolone acetate|prednisolone acetate|mesh-list
110681762|NCT00345046|Prednisone|prednisone|mesh-list
110681763|NCT00345046|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110681764|NCT00345046|Prednisolone phosphate|prednisolone phosphate|mesh-list
110681766|NCT00345046|Glucocorticoids|glucocorticoids|mesh-ancestor
110681767|NCT00345046|Hormones|hormones|mesh-ancestor
110681768|NCT00345046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110681769|NCT00345046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110681770|NCT00345046|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110681771|NCT00345046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110681773|NCT00345046|Autonomic Agents|autonomic agents|mesh-ancestor
110681774|NCT00345046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110441740|NCT02821390|Nepafenac|nepafenac|mesh-list
110681775|NCT00345046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110681776|NCT00345046|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110681777|NCT00345046|Protective Agents|protective agents|mesh-ancestor
110681778|NCT00515216|Leucovorin|leucovorin|mesh-list
110681779|NCT00515216|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
110681780|NCT00515216|Tetrahydrofolates|tetrahydrofolates|mesh-list
110681781|NCT00515216|Fluorouracil|fluorouracil|mesh-list
110681782|NCT00515216|Oxaliplatin|oxaliplatin|mesh-list
110681783|NCT00515216|Levoleucovorin|levoleucovorin|mesh-list
110681784|NCT00515216|Antimetabolites|antimetabolites|mesh-ancestor
110681785|NCT00515216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110681786|NCT00515216|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110681787|NCT00515216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110681788|NCT00515216|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110681789|NCT00515216|Immunologic Factors|immunologic factors|mesh-ancestor
110681790|NCT00515216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110681791|NCT00515216|Antidotes|antidotes|mesh-ancestor
110681792|NCT00515216|Protective Agents|protective agents|mesh-ancestor
110681793|NCT00515216|Vitamin B Complex|vitamin b complex|mesh-ancestor
110681794|NCT00515216|Vitamins|vitamins|mesh-ancestor
110681795|NCT00515216|Micronutrients|micronutrients|mesh-ancestor
110681796|NCT01004978|Cisplatin|cisplatin|mesh-list
110681797|NCT01004978|Doxorubicin|doxorubicin|mesh-list
110681798|NCT01004978|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110681799|NCT01004978|Sorafenib|sorafenib|mesh-list
110681800|NCT01004978|Mitomycins|mitomycins|mesh-list
110681801|NCT01004978|Mitomycin|mitomycin|mesh-list
110681802|NCT01004978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110681803|NCT01004978|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110681804|NCT01004978|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110681805|NCT01004978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110681806|NCT01004978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110681807|NCT01004978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110681808|NCT01004978|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110681809|NCT01004978|Alkylating Agents|alkylating agents|mesh-ancestor
110681810|NCT01004978|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110681811|NCT00440193|Enoxaparin|enoxaparin|mesh-list
110681812|NCT00440193|Rivaroxaban|rivaroxaban|mesh-list
110681813|NCT00440193|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110681814|NCT00440193|Antithrombins|antithrombins|mesh-ancestor
110681815|NCT00440193|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110681816|NCT00440193|Protease Inhibitors|protease inhibitors|mesh-ancestor
110681817|NCT00440193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110681818|NCT00440193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110681819|NCT00440193|Anticoagulants|anticoagulants|mesh-ancestor
110681820|NCT00440193|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110681821|NCT00440193|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110681822|NCT00511472|Insulin Glargine|insulin glargine|mesh-list
110681823|NCT00511472|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110681824|NCT00511472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110681826|NCT01033305|Cyclosporins|cyclosporins|mesh-list
110681827|NCT01033305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110681828|NCT01033305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110681829|NCT01033305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110681830|NCT01033305|Immunologic Factors|immunologic factors|mesh-ancestor
110681831|NCT01033305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110681832|NCT01033305|Antifungal Agents|antifungal agents|mesh-ancestor
110681833|NCT01033305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110681834|NCT01033305|Dermatologic Agents|dermatologic agents|mesh-ancestor
110681835|NCT01033305|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110681836|NCT01033305|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110681837|NCT00514904|Vaccines|vaccines|mesh-list
110681838|NCT00514904|Immunologic Factors|immunologic factors|mesh-ancestor
110681839|NCT00514904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110681840|NCT00440115|Bupropion|bupropion|mesh-list
110681841|NCT00440115|Nicotine|nicotine|mesh-list
110681842|NCT00440115|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110681843|NCT00440115|Autonomic Agents|autonomic agents|mesh-ancestor
110681844|NCT00440115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110681845|NCT00440115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110681846|NCT00440115|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110681847|NCT00440115|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110681848|NCT00440115|Cholinergic Agents|cholinergic agents|mesh-ancestor
110681849|NCT00440115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110681850|NCT00440115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110681851|NCT00440115|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110681852|NCT00440115|Antidepressive Agents|antidepressive agents|mesh-ancestor
110681853|NCT00440115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110681854|NCT00440115|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110681855|NCT00440115|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110681856|NCT00440115|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110681857|NCT00440115|Dopamine Agents|dopamine agents|mesh-ancestor
110681858|NCT00440115|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110681859|NCT00440115|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110681860|NCT00440115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110681861|NCT01033461|Calcium|calcium|mesh-list
110681862|NCT01033461|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110681863|NCT01033461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110681864|NCT01030731|Ceftobiprole|ceftobiprole|mesh-list
110681865|NCT01030731|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
110681866|NCT01030731|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110681867|NCT01030731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110681868|NCT00416715|Calcium, Dietary|calcium, dietary|mesh-list
110681869|NCT00416715|Vitamin D|vitamin d|mesh-list
110681870|NCT00416715|Cholecalciferol|cholecalciferol|mesh-list
110681871|NCT00416715|Letrozole|letrozole|mesh-list
110681872|NCT00416715|Calcium Carbonate|calcium carbonate|mesh-list
110681873|NCT00416715|Citric Acid|citric acid|mesh-list
110681874|NCT00416715|Sodium Citrate|sodium citrate|mesh-list
110681875|NCT00416715|Calcium|calcium|mesh-list
110681876|NCT00416715|Vitamins|vitamins|mesh-ancestor
110681877|NCT00416715|Micronutrients|micronutrients|mesh-ancestor
110681878|NCT00416715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110681879|NCT00416715|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110681880|NCT00416715|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110681881|NCT00416715|Anticoagulants|anticoagulants|mesh-ancestor
110681882|NCT00416715|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110681883|NCT00416715|Chelating Agents|chelating agents|mesh-ancestor
110681884|NCT00416715|Sequestering Agents|sequestering agents|mesh-ancestor
110681885|NCT00416715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110681886|NCT00416715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110681887|NCT00416715|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110681888|NCT00416715|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110681889|NCT00416715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110681890|NCT00416715|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110681891|NCT00416715|Hormone Antagonists|hormone antagonists|mesh-ancestor
110856635|NCT05199818|Palonosetron|palonosetron|mesh-list
110681892|NCT00416715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110681893|NCT00416715|Antacids|antacids|mesh-ancestor
110681894|NCT00416715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110681895|NCT01037517|Plerixafor|plerixafor|mesh-list
110681896|NCT01037517|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110681897|NCT01037517|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110681898|NCT01037517|Antiviral Agents|antiviral agents|mesh-ancestor
110681899|NCT01037517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110681900|NCT00406029|Levodopa|levodopa|mesh-list
110681901|NCT00406029|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110681902|NCT00406029|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110681903|NCT00406029|Dopamine Agents|dopamine agents|mesh-ancestor
110681904|NCT00406029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110681905|NCT00406029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110681906|NCT00406029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110681907|NCT00514514|Cyclosporine|cyclosporine|mesh-list
110681908|NCT00514514|Mycophenolic Acid|mycophenolic acid|mesh-list
110681909|NCT00514514|Everolimus|everolimus|mesh-list
110681910|NCT00514514|Cyclosporins|cyclosporins|mesh-list
110681911|NCT00514514|Basiliximab|basiliximab|mesh-list
110681912|NCT00514514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110681913|NCT00514514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110681914|NCT00514514|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110681915|NCT00514514|Immunologic Factors|immunologic factors|mesh-ancestor
110681916|NCT00514514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110681917|NCT00514514|Antifungal Agents|antifungal agents|mesh-ancestor
110681918|NCT00514514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110681919|NCT00514514|Dermatologic Agents|dermatologic agents|mesh-ancestor
110681920|NCT00514514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110681921|NCT00514514|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110681922|NCT00514514|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110681923|NCT00514514|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110681924|NCT00514514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110681925|NCT00514514|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110681926|NCT00514514|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110681928|NCT00514514|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110681929|NCT00405639|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
110681930|NCT00405639|Natriuretic Agents|natriuretic agents|mesh-ancestor
110681931|NCT00405639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110681932|NCT00439725|Rivaroxaban|rivaroxaban|mesh-list
110681933|NCT00439725|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110681934|NCT00439725|Antithrombins|antithrombins|mesh-ancestor
110681935|NCT00439725|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110681936|NCT00439725|Protease Inhibitors|protease inhibitors|mesh-ancestor
110681937|NCT00439725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110681938|NCT00439725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110681939|NCT00439725|Anticoagulants|anticoagulants|mesh-ancestor
110681940|NCT00521586|Vaccines|vaccines|mesh-list
110681941|NCT00521586|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110681942|NCT00521586|Immunologic Factors|immunologic factors|mesh-ancestor
110681943|NCT00521586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110681944|NCT00515502|Tiotropium Bromide|tiotropium bromide|mesh-list
110681945|NCT00515502|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110681946|NCT00515502|Autonomic Agents|autonomic agents|mesh-ancestor
110681947|NCT00515502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110681948|NCT00515502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110681949|NCT00515502|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110681950|NCT00515502|Respiratory System Agents|respiratory system agents|mesh-ancestor
110681951|NCT00515502|Parasympatholytics|parasympatholytics|mesh-ancestor
110681952|NCT00515502|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110681953|NCT00515502|Cholinergic Agents|cholinergic agents|mesh-ancestor
110681954|NCT00515502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110681955|NCT00515502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110681956|NCT01010646|Ribavirin|ribavirin|mesh-list
110681957|NCT01010646|Interferon-alpha|interferon-alpha|mesh-list
110681958|NCT01010646|Interferon alpha-2|interferon alpha-2|mesh-list
110681959|NCT01010646|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
110681960|NCT01010646|Antimetabolites|antimetabolites|mesh-ancestor
110681961|NCT01010646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110681962|NCT01010646|Antiviral Agents|antiviral agents|mesh-ancestor
110681963|NCT01010646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110681964|NCT01010646|Immunologic Factors|immunologic factors|mesh-ancestor
110681965|NCT01010646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110681966|NCT01010646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110681967|NCT00439647|Zoledronic Acid|zoledronic acid|mesh-list
110681968|NCT00439647|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110681969|NCT00439647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110681970|NCT00515112|Testosterone|testosterone|mesh-list
110681971|NCT00515112|Androgens|androgens|mesh-ancestor
110681972|NCT00515112|Hormones|hormones|mesh-ancestor
110681973|NCT00515112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110681974|NCT00515112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110681975|NCT03742557|Ketamine|ketamine|mesh-list
110681976|NCT03742557|Analgesics|analgesics|mesh-ancestor
110681977|NCT03742557|Sensory System Agents|sensory system agents|mesh-ancestor
110681978|NCT03742557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110681979|NCT03742557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110681980|NCT03742557|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110681981|NCT03742557|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110681982|NCT03742557|Anesthetics, General|anesthetics, general|mesh-ancestor
110681983|NCT03742557|Anesthetics|anesthetics|mesh-ancestor
110681984|NCT03742557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110681985|NCT03742557|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110681986|NCT03742557|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110681987|NCT03742557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110681988|NCT03742557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110681989|NCT01324089|Resveratrol|resveratrol|mesh-list
110681990|NCT01324089|Piperine|piperine|mesh-list
110681991|NCT01324089|Antioxidants|antioxidants|mesh-ancestor
110681992|NCT01324089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110681993|NCT01324089|Protective Agents|protective agents|mesh-ancestor
110681994|NCT01324089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110681995|NCT01324089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110681996|NCT01324089|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110681997|NCT01324089|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110329036|NCT00464594|Acarbose|acarbose|mesh-list
110681999|NCT00404547|Glucocorticoids|glucocorticoids|mesh-ancestor
110682000|NCT00404547|Hormones|hormones|mesh-ancestor
110682001|NCT00404547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110682002|NCT00404547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110682003|NCT00404547|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110682004|NCT00515034|Imipenem|imipenem|mesh-list
110682005|NCT00515034|Doripenem|doripenem|mesh-list
110682006|NCT00515034|Cilastatin|cilastatin|mesh-list
110682007|NCT00515034|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110682008|NCT00515034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110682009|NCT00515034|Protease Inhibitors|protease inhibitors|mesh-ancestor
110682010|NCT00515034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110682011|NCT00515034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110682012|NCT00404235|Paclitaxel|paclitaxel|mesh-list
110682013|NCT00404235|Carboplatin|carboplatin|mesh-list
110682014|NCT00404235|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110682015|NCT00404235|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110682016|NCT00404235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110682017|NCT00404235|Tubulin Modulators|tubulin modulators|mesh-ancestor
110682018|NCT00404235|Antimitotic Agents|antimitotic agents|mesh-ancestor
110682019|NCT00404235|Mitosis Modulators|mitosis modulators|mesh-ancestor
110682020|NCT00404235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110682021|NCT00509262|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110682022|NCT00509262|Glipizide|glipizide|mesh-list
110682023|NCT00509262|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110682024|NCT00509262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110682025|NCT00509262|Incretins|incretins|mesh-ancestor
110682026|NCT00509262|Hormones|hormones|mesh-ancestor
110856653|NCT02474134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110682027|NCT00509262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110682028|NCT00509262|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110682029|NCT00509262|Protease Inhibitors|protease inhibitors|mesh-ancestor
110682030|NCT00509262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110682031|NCT00509262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110682032|NCT00509106|Ceftriaxone|ceftriaxone|mesh-list
110682033|NCT00509106|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
110682034|NCT00509106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110682035|NCT00509106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110682036|NCT00607919|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
110682037|NCT00607919|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110682038|NCT00607919|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110398191|NCT01064401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110682039|NCT00607919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110682040|NCT00607919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110682041|NCT00607919|Adrenergic Agents|adrenergic agents|mesh-ancestor
110682042|NCT00607919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110682043|NCT00607919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110682044|NCT00344968|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
110682045|NCT00344968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110682046|NCT00344968|Glucocorticoids|glucocorticoids|mesh-ancestor
110682047|NCT00344968|Hormones|hormones|mesh-ancestor
110651820|NCT00934232|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110682048|NCT00344968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110682049|NCT00344968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110682050|NCT00509028|Budesonide|budesonide|mesh-list
110682051|NCT00509028|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110682052|NCT00509028|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110682053|NCT00509028|Autonomic Agents|autonomic agents|mesh-ancestor
110682054|NCT00509028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110682055|NCT00509028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110682056|NCT00509028|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110682057|NCT00509028|Respiratory System Agents|respiratory system agents|mesh-ancestor
110651885|NCT01015209|Chitosan|chitosan|mesh-list
110682058|NCT00509028|Glucocorticoids|glucocorticoids|mesh-ancestor
110682059|NCT00509028|Hormones|hormones|mesh-ancestor
110682060|NCT00509028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110682061|NCT00352846|Vitamin D|vitamin d|mesh-list
110682062|NCT00352846|Zoledronic Acid|zoledronic acid|mesh-list
110682063|NCT00352846|Calcium Carbonate|calcium carbonate|mesh-list
110682064|NCT00352846|Calcium|calcium|mesh-list
110682065|NCT00352846|Vitamins|vitamins|mesh-ancestor
110682066|NCT00352846|Micronutrients|micronutrients|mesh-ancestor
110682067|NCT00352846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110682068|NCT00352846|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110651956|NCT00446134|Ribavirin|ribavirin|mesh-list
110682069|NCT00352846|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110682070|NCT00352846|Antacids|antacids|mesh-ancestor
110682071|NCT00352846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110682072|NCT00352846|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110329109|NCT00464789|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
110682073|NCT00508872|Leucovorin|leucovorin|mesh-list
110682074|NCT00508872|Bevacizumab|bevacizumab|mesh-list
110682075|NCT00508872|Fluorouracil|fluorouracil|mesh-list
110682076|NCT00508872|Oxaliplatin|oxaliplatin|mesh-list
110682077|NCT00508872|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110682078|NCT00508872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110682079|NCT00508872|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110682080|NCT00508872|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110682081|NCT00508872|Growth Substances|growth substances|mesh-ancestor
110682082|NCT00508872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110682083|NCT00508872|Growth Inhibitors|growth inhibitors|mesh-ancestor
110682084|NCT00508872|Antimetabolites|antimetabolites|mesh-ancestor
110682085|NCT00508872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110682086|NCT00508872|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110682087|NCT00508872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110682088|NCT00508872|Immunologic Factors|immunologic factors|mesh-ancestor
110682089|NCT00508872|Antidotes|antidotes|mesh-ancestor
110682090|NCT00508872|Protective Agents|protective agents|mesh-ancestor
110682091|NCT00508872|Vitamin B Complex|vitamin b complex|mesh-ancestor
110682092|NCT00508872|Vitamins|vitamins|mesh-ancestor
110682093|NCT00508872|Micronutrients|micronutrients|mesh-ancestor
110682094|NCT00508482|Lactulose|lactulose|mesh-list
110682095|NCT00508482|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110682096|NCT00344032|Vaccines|vaccines|mesh-list
110682097|NCT00344032|Immunologic Factors|immunologic factors|mesh-ancestor
110682098|NCT00344032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110682099|NCT00607373|Mipomersen|mipomersen|mesh-list
110682100|NCT00607373|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110682101|NCT00607373|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110682102|NCT00607373|Antimetabolites|antimetabolites|mesh-ancestor
110682103|NCT00607373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110682104|NCT00607373|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110682105|NCT00508404|Panitumumab|panitumumab|mesh-list
110682106|NCT00508404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110682107|NCT00508404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110682108|NCT00352690|Paclitaxel|paclitaxel|mesh-list
110682109|NCT00352690|Carboplatin|carboplatin|mesh-list
110682110|NCT00352690|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
110682111|NCT00352690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110682112|NCT00352690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110682113|NCT00352690|Tubulin Modulators|tubulin modulators|mesh-ancestor
110682114|NCT00352690|Antimitotic Agents|antimitotic agents|mesh-ancestor
110682115|NCT00352690|Mitosis Modulators|mitosis modulators|mesh-ancestor
110682116|NCT00352690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110682117|NCT00895505|Warfarin|warfarin|mesh-list
110682118|NCT00895505|Phenprocoumon|phenprocoumon|mesh-list
110682119|NCT00895505|Anticoagulants|anticoagulants|mesh-ancestor
110682120|NCT03502577|Cyclophosphamide|cyclophosphamide|mesh-list
110682121|NCT03502577|Fludarabine|fludarabine|mesh-list
110682122|NCT03502577|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-list
110682123|NCT03502577|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110682124|NCT03502577|Immunologic Factors|immunologic factors|mesh-ancestor
110682125|NCT03502577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110682126|NCT03502577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110682127|NCT03502577|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110682128|NCT03502577|Alkylating Agents|alkylating agents|mesh-ancestor
110682129|NCT03502577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110682130|NCT03502577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110682131|NCT03502577|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110682132|NCT03502577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110682133|NCT03249012|Calcium, Dietary|calcium, dietary|mesh-list
110682134|NCT03249012|Calcitriol|calcitriol|mesh-list
110682135|NCT03249012|Calcium Carbonate|calcium carbonate|mesh-list
110682136|NCT03249012|Calcium|calcium|mesh-list
110682137|NCT03249012|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110682138|NCT03249012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110682139|NCT03249012|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110682140|NCT03249012|Antacids|antacids|mesh-ancestor
110682141|NCT03249012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110682142|NCT03249012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110682143|NCT03249012|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
110682144|NCT03249012|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110682145|NCT03249012|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110682146|NCT03249012|Vitamins|vitamins|mesh-ancestor
110682147|NCT03249012|Micronutrients|micronutrients|mesh-ancestor
110682148|NCT03477539|Lenalidomide|lenalidomide|mesh-list
110682149|NCT03477539|Daratumumab|daratumumab|mesh-list
110682150|NCT03477539|Immunologic Factors|immunologic factors|mesh-ancestor
110682151|NCT03477539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110329188|NCT00592111|Prednisone|prednisone|mesh-list
110652323|NCT05472779|Estradiol|estradiol|mesh-list
110682152|NCT03477539|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110682153|NCT03477539|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110682154|NCT03477539|Growth Substances|growth substances|mesh-ancestor
110682155|NCT03477539|Growth Inhibitors|growth inhibitors|mesh-ancestor
110682156|NCT03477539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110682158|NCT00893477|Sargramostim|sargramostim|mesh-list
110682159|NCT00893477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110682160|NCT00893477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110682161|NCT00893477|Immunologic Factors|immunologic factors|mesh-ancestor
110682162|NCT00893477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110682163|NCT00893477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110682165|NCT00609245|Anticonvulsants|anticonvulsants|mesh-ancestor
110682166|NCT00609245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110682167|NCT00609245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110682168|NCT00609245|GABA Agents|gaba agents|mesh-ancestor
110682169|NCT00609245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110682170|NCT00609245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110682171|NCT00609245|Antimanic Agents|antimanic agents|mesh-ancestor
110682172|NCT00609245|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110652450|NCT00458302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110682173|NCT00609245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110682174|NCT00609245|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110682175|NCT01010802|Epoetin Alfa|epoetin alfa|mesh-list
110682177|NCT04036253|Epoetin Alfa|epoetin alfa|mesh-list
110682178|NCT04036253|Hematinics|hematinics|mesh-ancestor
110682179|NCT00893555|Voriconazole|voriconazole|mesh-list
110682180|NCT00893555|Antifungal Agents|antifungal agents|mesh-ancestor
110682181|NCT00893555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110682182|NCT00893555|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110682183|NCT00893555|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110682184|NCT00893555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110682185|NCT00893555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110682186|NCT00893555|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110682187|NCT00893555|Hormone Antagonists|hormone antagonists|mesh-ancestor
110682188|NCT00893555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110682189|NCT00893555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110682190|NCT00893555|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110682191|NCT02541071|Clonidine|clonidine|mesh-list
110682192|NCT02541071|Yohimbine|yohimbine|mesh-list
110682193|NCT02541071|Analgesics|analgesics|mesh-ancestor
110682194|NCT02541071|Sensory System Agents|sensory system agents|mesh-ancestor
110682195|NCT02541071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110682196|NCT02541071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110682197|NCT02541071|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110682198|NCT02541071|Sympatholytics|sympatholytics|mesh-ancestor
110682199|NCT02541071|Autonomic Agents|autonomic agents|mesh-ancestor
110682200|NCT02541071|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110682201|NCT02541071|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110682202|NCT02541071|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110682203|NCT02541071|Adrenergic Agents|adrenergic agents|mesh-ancestor
110682204|NCT02541071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110682205|NCT02541071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110682206|NCT02541071|Mydriatics|mydriatics|mesh-ancestor
110682207|NCT02541071|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
110652647|NCT00944918|Fulvestrant|fulvestrant|mesh-list
110682208|NCT02541071|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110682209|NCT02541071|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110682210|NCT02541071|Urological Agents|urological agents|mesh-ancestor
110682211|NCT01058824|Lincomycin|lincomycin|mesh-list
110682212|NCT01058824|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110682213|NCT01058824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110682214|NCT01058824|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110682215|NCT01058824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110682216|NCT01058824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110682217|NCT00895739|Cyclosporine|cyclosporine|mesh-list
110682218|NCT00895739|Alemtuzumab|alemtuzumab|mesh-list
110682219|NCT00895739|Cyclosporins|cyclosporins|mesh-list
110682220|NCT00895739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110682221|NCT00895739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110682222|NCT00895739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110682223|NCT00895739|Immunologic Factors|immunologic factors|mesh-ancestor
110682224|NCT00895739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110682225|NCT00895739|Antifungal Agents|antifungal agents|mesh-ancestor
110329260|NCT04328272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110682226|NCT00895739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110682227|NCT00895739|Dermatologic Agents|dermatologic agents|mesh-ancestor
110682228|NCT00895739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110682229|NCT00895739|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110682230|NCT00895739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110682231|NCT00895739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110682233|NCT01058902|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110682234|NCT01058902|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110682235|NCT01058902|Analgesics|analgesics|mesh-ancestor
110682236|NCT01058902|Sensory System Agents|sensory system agents|mesh-ancestor
110682237|NCT01058902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110682238|NCT01058902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110682239|NCT01058902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110682240|NCT01058902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110682241|NCT01058902|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110682242|NCT01058902|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110682243|NCT01058902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110682244|NCT01058902|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110682245|NCT01058902|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110682246|NCT01058902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110682247|NCT01058902|Antipyretics|antipyretics|mesh-ancestor
110682248|NCT00609167|Dexamethasone|dexamethasone|mesh-list
110682249|NCT00609167|Cyclophosphamide|cyclophosphamide|mesh-list
110682251|NCT00609167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110682252|NCT00609167|Immunologic Factors|immunologic factors|mesh-ancestor
110652820|NCT00941252|Immunologic Factors|immunologic factors|mesh-ancestor
110682253|NCT00609167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110682254|NCT00609167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110682255|NCT00609167|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110682256|NCT00609167|Alkylating Agents|alkylating agents|mesh-ancestor
110682257|NCT00609167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110682258|NCT00609167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110682259|NCT00609167|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110682260|NCT00609167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110682261|NCT00609167|Antiemetics|antiemetics|mesh-ancestor
110682262|NCT00609167|Autonomic Agents|autonomic agents|mesh-ancestor
110682263|NCT00609167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110682264|NCT00609167|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110682265|NCT00609167|Glucocorticoids|glucocorticoids|mesh-ancestor
110682266|NCT00609167|Hormones|hormones|mesh-ancestor
110682267|NCT00609167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110682268|NCT00609167|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110682269|NCT01055236|Hydroxyzine|hydroxyzine|mesh-list
110682270|NCT01055236|Antipruritics|antipruritics|mesh-ancestor
110682271|NCT01055236|Dermatologic Agents|dermatologic agents|mesh-ancestor
110682272|NCT01055236|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110682273|NCT01055236|Histamine Antagonists|histamine antagonists|mesh-ancestor
110682274|NCT01055236|Histamine Agents|histamine agents|mesh-ancestor
110682275|NCT01055236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110682276|NCT01055236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110682277|NCT01055236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110682278|NCT00606281|Aripiprazole|aripiprazole|mesh-list
110682279|NCT00606281|Antidepressive Agents|antidepressive agents|mesh-ancestor
110682280|NCT00606281|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110682281|NCT00606281|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110682282|NCT00606281|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110682283|NCT00606281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110682284|NCT00606281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110682285|NCT00606281|Dopamine Agonists|dopamine agonists|mesh-ancestor
110682286|NCT00606281|Dopamine Agents|dopamine agents|mesh-ancestor
110682287|NCT00606281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110682288|NCT00606281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110682289|NCT00606281|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110682290|NCT00606281|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110682291|NCT00606281|Serotonin Agents|serotonin agents|mesh-ancestor
110682292|NCT00606281|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110682294|NCT00606281|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110682295|NCT00606281|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110682296|NCT00506142|Vincristine|vincristine|mesh-list
110682297|NCT00506142|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110682298|NCT00506142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110682299|NCT00506142|Tubulin Modulators|tubulin modulators|mesh-ancestor
110682300|NCT00506142|Antimitotic Agents|antimitotic agents|mesh-ancestor
110682301|NCT00506142|Mitosis Modulators|mitosis modulators|mesh-ancestor
110682302|NCT00506142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110682303|NCT00891605|Paclitaxel|paclitaxel|mesh-list
110682304|NCT00891605|Navitoclax|navitoclax|mesh-list
110682305|NCT00891605|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110682306|NCT00891605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110682307|NCT00891605|Tubulin Modulators|tubulin modulators|mesh-ancestor
110682308|NCT00891605|Antimitotic Agents|antimitotic agents|mesh-ancestor
110682309|NCT00891605|Mitosis Modulators|mitosis modulators|mesh-ancestor
110682310|NCT00891605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110682311|NCT00893711|Vitamin D|vitamin d|mesh-list
110682312|NCT00893711|Vitamins|vitamins|mesh-ancestor
110682313|NCT00893711|Micronutrients|micronutrients|mesh-ancestor
110682314|NCT00893711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110682315|NCT00893711|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110682316|NCT00514020|Leucovorin|leucovorin|mesh-list
110682317|NCT00514020|Fluorouracil|fluorouracil|mesh-list
110682318|NCT00514020|Oxaliplatin|oxaliplatin|mesh-list
110682319|NCT00514020|Calcium|calcium|mesh-list
110682320|NCT00514020|Levoleucovorin|levoleucovorin|mesh-list
110682321|NCT00514020|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110682322|NCT00514020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110682323|NCT00514020|Antimetabolites|antimetabolites|mesh-ancestor
110408391|NCT05880862|Autonomic Agents|autonomic agents|mesh-ancestor
110682324|NCT00514020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110682325|NCT00514020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110682326|NCT00514020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110682327|NCT00514020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110682328|NCT00514020|Immunologic Factors|immunologic factors|mesh-ancestor
110682329|NCT00514020|Antidotes|antidotes|mesh-ancestor
110682330|NCT00514020|Protective Agents|protective agents|mesh-ancestor
110682331|NCT00514020|Vitamin B Complex|vitamin b complex|mesh-ancestor
110682332|NCT00514020|Vitamins|vitamins|mesh-ancestor
110682333|NCT00514020|Micronutrients|micronutrients|mesh-ancestor
110682334|NCT03560531|Palbociclib|palbociclib|mesh-list
110682335|NCT03560531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110682336|NCT03560531|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110682337|NCT03560531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110682338|NCT03560531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110682339|NCT00896285|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
110682340|NCT00896285|Analgesics|analgesics|mesh-list
110682341|NCT00896285|Opiate Alkaloids|opiate alkaloids|mesh-list
110682342|NCT00896285|Sensory System Agents|sensory system agents|mesh-ancestor
110682343|NCT00896285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110682344|NCT00896285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110682345|NCT00896285|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110682346|NCT00896285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110682347|NCT00896285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110682348|NCT00896285|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110682349|NCT00896285|Narcotics|narcotics|mesh-ancestor
110682350|NCT00896285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110682351|NCT00891761|Dexamethasone|dexamethasone|mesh-list
110682352|NCT00891761|Dexamethasone acetate|dexamethasone acetate|mesh-list
110682353|NCT00891761|Ondansetron|ondansetron|mesh-list
110682354|NCT00891761|Casopitant|casopitant|mesh-list
110682355|NCT00891761|BB 1101|bb 1101|mesh-list
110682356|NCT00891761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110682357|NCT00891761|Antiemetics|antiemetics|mesh-ancestor
110682358|NCT00891761|Autonomic Agents|autonomic agents|mesh-ancestor
110682359|NCT00891761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110682360|NCT00891761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110682361|NCT00891761|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110682362|NCT00891761|Glucocorticoids|glucocorticoids|mesh-ancestor
110682363|NCT00891761|Hormones|hormones|mesh-ancestor
110682364|NCT00891761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110682365|NCT00891761|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110682366|NCT00891761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110682367|NCT00891761|Protease Inhibitors|protease inhibitors|mesh-ancestor
110682368|NCT00891761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110682369|NCT00891761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110682370|NCT00891761|Antipruritics|antipruritics|mesh-ancestor
110682371|NCT00891761|Dermatologic Agents|dermatologic agents|mesh-ancestor
110682372|NCT00891761|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110682373|NCT00891761|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110682374|NCT00891761|Serotonin Agents|serotonin agents|mesh-ancestor
110682375|NCT00891761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110682376|NCT00891761|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110682378|NCT01012830|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110682379|NCT01012830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110682380|NCT01012830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110682381|NCT01012830|Cholinergic Agents|cholinergic agents|mesh-ancestor
110682382|NCT01012830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110682383|NCT01012830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110682384|NCT01012830|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110682385|NCT01012830|Protective Agents|protective agents|mesh-ancestor
110682386|NCT00513474|Cyclosporine|cyclosporine|mesh-list
110682387|NCT00513474|Sirolimus|sirolimus|mesh-list
110682388|NCT00513474|Cyclophosphamide|cyclophosphamide|mesh-list
110682389|NCT00513474|Busulfan|busulfan|mesh-list
110682390|NCT00513474|Methotrexate|methotrexate|mesh-list
110682391|NCT00513474|Fludarabine|fludarabine|mesh-list
110682392|NCT00513474|Etoposide|etoposide|mesh-list
110682393|NCT00513474|Allopurinol|allopurinol|mesh-list
110682394|NCT00513474|Rasburicase|rasburicase|mesh-list
110682395|NCT00513474|Tacrolimus|tacrolimus|mesh-list
110682396|NCT00513474|Cyclosporins|cyclosporins|mesh-list
110682397|NCT00513474|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110682398|NCT00513474|Immunologic Factors|immunologic factors|mesh-ancestor
110682399|NCT00513474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110682401|NCT00513474|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110682402|NCT00513474|Alkylating Agents|alkylating agents|mesh-ancestor
110682403|NCT00513474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110682404|NCT00513474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110682405|NCT00513474|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110682406|NCT00513474|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110682407|NCT00513474|Abortifacient Agents|abortifacient agents|mesh-ancestor
110682408|NCT00513474|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110682409|NCT00513474|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110682410|NCT00513474|Antimetabolites|antimetabolites|mesh-ancestor
110682411|NCT00513474|Dermatologic Agents|dermatologic agents|mesh-ancestor
110682412|NCT00513474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110682413|NCT00513474|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110682414|NCT00513474|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110682415|NCT00513474|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110682416|NCT00513474|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110682417|NCT00513474|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110682418|NCT00513474|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110682419|NCT00513474|Antifungal Agents|antifungal agents|mesh-ancestor
110682420|NCT00513474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110682421|NCT00513474|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110682422|NCT00513474|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110653447|NCT00549848|Antimetabolites|antimetabolites|mesh-ancestor
110682423|NCT00513474|Gout Suppressants|gout suppressants|mesh-ancestor
110682424|NCT00513474|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110682425|NCT00513474|Antioxidants|antioxidants|mesh-ancestor
110682426|NCT00513474|Protective Agents|protective agents|mesh-ancestor
110682427|NCT01010958|Valproic Acid|valproic acid|mesh-list
110682428|NCT01010958|Anticonvulsants|anticonvulsants|mesh-ancestor
110682429|NCT01010958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110682430|NCT01010958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110682431|NCT01010958|GABA Agents|gaba agents|mesh-ancestor
110682432|NCT01010958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110682433|NCT01010958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110682434|NCT01010958|Antimanic Agents|antimanic agents|mesh-ancestor
110682435|NCT01010958|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110682436|NCT01010958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110682437|NCT01010958|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110682438|NCT00896519|Prednisone|prednisone|mesh-list
110682439|NCT00896519|Cyclophosphamide|cyclophosphamide|mesh-list
110682440|NCT00896519|Rituximab|rituximab|mesh-list
110682441|NCT00896519|Doxorubicin|doxorubicin|mesh-list
110682442|NCT00896519|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110682443|NCT00896519|Vincristine|vincristine|mesh-list
110682444|NCT00896519|Sargramostim|sargramostim|mesh-list
110682445|NCT00896519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110682446|NCT00896519|Immunologic Factors|immunologic factors|mesh-ancestor
110682447|NCT00896519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110682448|NCT00896519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110682449|NCT00896519|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110682450|NCT00896519|Alkylating Agents|alkylating agents|mesh-ancestor
110682451|NCT00896519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110682452|NCT00896519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110682453|NCT00896519|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110682454|NCT00896519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110682455|NCT00896519|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110682456|NCT00896519|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110682457|NCT00896519|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110682458|NCT00896519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110682459|NCT00896519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110682460|NCT00896519|Glucocorticoids|glucocorticoids|mesh-ancestor
110682461|NCT00896519|Hormones|hormones|mesh-ancestor
110682462|NCT00896519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110682463|NCT00896519|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110682464|NCT00896519|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110682465|NCT00896519|Tubulin Modulators|tubulin modulators|mesh-ancestor
110682466|NCT00896519|Antimitotic Agents|antimitotic agents|mesh-ancestor
110682467|NCT00896519|Mitosis Modulators|mitosis modulators|mesh-ancestor
110682468|NCT00505752|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
110682469|NCT00505752|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
110682470|NCT00505752|Hormones|hormones|mesh-ancestor
110682471|NCT00505752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110682472|NCT00505752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110682473|NCT00505752|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110682475|NCT01011036|Clobazam|clobazam|mesh-list
110682476|NCT01011036|Tolterodine Tartrate|tolterodine tartrate|mesh-list
110682477|NCT01011036|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110682478|NCT01011036|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110682479|NCT01011036|Cholinergic Agents|cholinergic agents|mesh-ancestor
110682480|NCT01011036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110682481|NCT01011036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110682482|NCT01011036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110682483|NCT01011036|Urological Agents|urological agents|mesh-ancestor
110653662|NCT00110149|Rituximab|rituximab|mesh-list
110682484|NCT01011036|Anticonvulsants|anticonvulsants|mesh-ancestor
110682485|NCT01011036|GABA Modulators|gaba modulators|mesh-ancestor
110682486|NCT01011036|GABA Agents|gaba agents|mesh-ancestor
110682487|NCT01011036|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110682488|NCT01011036|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110682489|NCT01011036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110682490|NCT01011036|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110682491|NCT01011036|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
110682492|NCT01011036|GABA Agonists|gaba agonists|mesh-ancestor
110682493|NCT03601637|Ivacaftor|ivacaftor|mesh-list
110682494|NCT03601637|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
110682495|NCT03601637|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110682496|NCT03601637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110682497|NCT00894023|Abciximab|abciximab|mesh-list
110682498|NCT00894023|Anticoagulants|anticoagulants|mesh-ancestor
110682499|NCT00894023|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110682500|NCT00892073|Metformin|metformin|mesh-list
110682501|NCT00892073|Diazoxide|diazoxide|mesh-list
110682502|NCT00892073|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110682503|NCT00892073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110682504|NCT00892073|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110856708|NCT02477098|Ropivacaine|ropivacaine|mesh-list
110682505|NCT00892073|Vasodilator Agents|vasodilator agents|mesh-ancestor
110682506|NCT00896831|N-Methylaspartate|n-methylaspartate|mesh-list
110682507|NCT00896831|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
110682508|NCT00896831|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110682509|NCT00896831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110682510|NCT00896831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110682511|NCT00896831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110682512|NCT02541227|Cerebrolysin|cerebrolysin|mesh-list
110682513|NCT02541227|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110682514|NCT02541227|Protective Agents|protective agents|mesh-ancestor
110682515|NCT02541227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110682516|NCT02541227|Nootropic Agents|nootropic agents|mesh-ancestor
110682517|NCT00896987|Lamotrigine|lamotrigine|mesh-list
110682518|NCT00896987|Carbamazepine|carbamazepine|mesh-list
110682519|NCT00896987|Anticonvulsants|anticonvulsants|mesh-ancestor
110682520|NCT00896987|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110682521|NCT00896987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110682522|NCT00896987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110682523|NCT00896987|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110682524|NCT00896987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110682525|NCT00896987|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110682526|NCT00896987|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110653834|NCT00555620|Antimetabolites|antimetabolites|mesh-ancestor
110682527|NCT00896987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110682528|NCT00896987|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110329560|NCT00593164|Anesthetics|anesthetics|mesh-ancestor
110682529|NCT00896987|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110682530|NCT00896987|Antimanic Agents|antimanic agents|mesh-ancestor
110682531|NCT00896987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110682532|NCT00896987|Analgesics|analgesics|mesh-ancestor
110682533|NCT00896987|Sensory System Agents|sensory system agents|mesh-ancestor
110682534|NCT00896987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110682535|NCT00896987|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110682536|NCT00896987|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110682538|NCT00897065|Immunologic Factors|immunologic factors|mesh-ancestor
110682539|NCT00897065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110682540|NCT00343252|Teriparatide|teriparatide|mesh-list
110682541|NCT00343252|Risedronic Acid|risedronic acid|mesh-list
110682542|NCT00343252|Etidronic Acid|etidronic acid|mesh-list
110682543|NCT00343252|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110653901|NCT00956462|Dexamethasone|dexamethasone|mesh-list
110682544|NCT00343252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110682545|NCT00343252|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110682546|NCT00343252|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110682547|NCT00343252|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110682548|NCT00343252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110682549|NCT00892229|Misoprostol|misoprostol|mesh-list
110682550|NCT00892229|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110682551|NCT00892229|Abortifacient Agents|abortifacient agents|mesh-ancestor
110682552|NCT00892229|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110682553|NCT00892229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110682554|NCT00892229|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110682555|NCT00892229|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110682556|NCT00892229|Oxytocics|oxytocics|mesh-ancestor
110682557|NCT00897221|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110682558|NCT00897221|Deferiprone|deferiprone|mesh-list
110682559|NCT00897221|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110682560|NCT00897221|Chelating Agents|chelating agents|mesh-ancestor
110682561|NCT00897221|Sequestering Agents|sequestering agents|mesh-ancestor
110682562|NCT00897221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110682563|NCT00892307|Adenosine|adenosine|mesh-list
110682564|NCT00892307|Analgesics|analgesics|mesh-ancestor
110682565|NCT00892307|Sensory System Agents|sensory system agents|mesh-ancestor
110682566|NCT00892307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110682567|NCT00892307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110682568|NCT00892307|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110682569|NCT00892307|Vasodilator Agents|vasodilator agents|mesh-ancestor
110682570|NCT00892307|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
110682571|NCT00892307|Purinergic Agonists|purinergic agonists|mesh-ancestor
110682573|NCT00892307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110682574|NCT00892307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110682575|NCT00342628|Vaccines|vaccines|mesh-list
110654015|NCT00956150|Lactulose|lactulose|mesh-list
110682576|NCT00342628|Immunologic Factors|immunologic factors|mesh-ancestor
110682577|NCT00342628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110682578|NCT00897377|Temozolomide|temozolomide|mesh-list
110682579|NCT00897377|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110682580|NCT00897377|Alkylating Agents|alkylating agents|mesh-ancestor
110682581|NCT00897377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110682582|NCT00897377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110682583|NCT00894569|Paclitaxel|paclitaxel|mesh-list
110682584|NCT00894569|Carboplatin|carboplatin|mesh-list
110682585|NCT00894569|Cetuximab|cetuximab|mesh-list
110682586|NCT00894569|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110682587|NCT00894569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110682588|NCT00894569|Tubulin Modulators|tubulin modulators|mesh-ancestor
110682589|NCT00894569|Antimitotic Agents|antimitotic agents|mesh-ancestor
110682590|NCT00894569|Mitosis Modulators|mitosis modulators|mesh-ancestor
110682591|NCT00894569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110682592|NCT00894569|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110682593|NCT00337168|Cytarabine|cytarabine|mesh-list
110682594|NCT00337168|Clofarabine|clofarabine|mesh-list
110654073|NCT00957320|Pegaspargase|pegaspargase|mesh-list
110682595|NCT00337168|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110682596|NCT00337168|Antimetabolites|antimetabolites|mesh-ancestor
110682597|NCT00337168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110682598|NCT00337168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110682599|NCT00337168|Antiviral Agents|antiviral agents|mesh-ancestor
110356943|NCT04662788|Antibodies|antibodies|mesh-list
110682600|NCT00337168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110682601|NCT00337168|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110682602|NCT00337168|Immunologic Factors|immunologic factors|mesh-ancestor
110682603|NCT00337168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110682605|NCT00892385|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110682606|NCT00892385|Alkylating Agents|alkylating agents|mesh-ancestor
110654126|NCT03024684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110682607|NCT00892385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110682608|NCT00892385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110682609|NCT00892463|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110682610|NCT00892463|Antidepressive Agents|antidepressive agents|mesh-ancestor
110682611|NCT00892463|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110682612|NCT00892463|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110682613|NCT00892463|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110682614|NCT00892463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110682615|NCT00892463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110682617|NCT01011114|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110682618|NCT01011114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110682619|NCT01011114|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
110682620|NCT01011114|Hormone Antagonists|hormone antagonists|mesh-ancestor
110682621|NCT01011114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110682622|NCT00606905|Immunoglobulins|immunoglobulins|mesh-list
110682623|NCT00606905|gamma-Globulins|gamma-globulins|mesh-list
110682624|NCT00606905|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110682625|NCT00606905|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110682626|NCT00606905|Immunologic Factors|immunologic factors|mesh-ancestor
110682627|NCT00606905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110682628|NCT01055392|Lithium Carbonate|lithium carbonate|mesh-list
110682629|NCT01055392|Antidepressive Agents|antidepressive agents|mesh-ancestor
110682630|NCT01055392|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110682631|NCT01055392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110682632|NCT01055392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110682633|NCT01055392|Antimanic Agents|antimanic agents|mesh-ancestor
110682634|NCT01055392|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110682635|NCT01055392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110682636|NCT01055392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110682638|NCT03063762|Atezolizumab|atezolizumab|mesh-list
110682639|NCT03063762|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110682640|NCT03063762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110682641|NCT03063762|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110682642|NCT03063762|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110856721|NCT05571670|Sirolimus|sirolimus|mesh-list
110682643|NCT03063762|Growth Substances|growth substances|mesh-ancestor
110682644|NCT03063762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110682645|NCT03063762|Growth Inhibitors|growth inhibitors|mesh-ancestor
110682646|NCT03063762|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110682647|NCT03063762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110682649|NCT05278637|Ticagrelor|ticagrelor|mesh-list
110682650|NCT05278637|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110682651|NCT05278637|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110682652|NCT05278637|Analgesics|analgesics|mesh-ancestor
110682653|NCT05278637|Sensory System Agents|sensory system agents|mesh-ancestor
110301583|NCT00247052|Diclofenac|diclofenac|mesh-list
110682654|NCT05278637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110682655|NCT05278637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110682656|NCT05278637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110682657|NCT05278637|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110682658|NCT05278637|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110682659|NCT05278637|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110682660|NCT05278637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110682661|NCT05278637|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110682662|NCT05278637|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110682663|NCT05278637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110682664|NCT05278637|Antipyretics|antipyretics|mesh-ancestor
110682665|NCT05278637|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110682666|NCT05278637|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110682667|NCT05278637|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110682668|NCT05278637|Purinergic Agents|purinergic agents|mesh-ancestor
110682669|NCT05278637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110682670|NCT04017377|Paclitaxel|paclitaxel|mesh-list
110682671|NCT04017377|Cisplatin|cisplatin|mesh-list
110682672|NCT04017377|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110682673|NCT04017377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110682674|NCT04017377|Tubulin Modulators|tubulin modulators|mesh-ancestor
110682675|NCT04017377|Antimitotic Agents|antimitotic agents|mesh-ancestor
110682676|NCT04017377|Mitosis Modulators|mitosis modulators|mesh-ancestor
110682677|NCT04017377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110682678|NCT04035785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
110682679|NCT04035707|Rocuronium|rocuronium|mesh-list
110682680|NCT04035707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110682681|NCT04035707|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110682682|NCT04035707|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110682683|NCT04035707|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110682684|NCT04035707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110682685|NCT02539745|Vitamin D|vitamin d|mesh-list
110682686|NCT02539745|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
110682687|NCT02539745|Vitamins|vitamins|mesh-ancestor
110682688|NCT02539745|Micronutrients|micronutrients|mesh-ancestor
110682689|NCT02539745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110682690|NCT02539745|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110682691|NCT00894959|Heparin|heparin|mesh-list
110682692|NCT00894959|Calcium heparin|calcium heparin|mesh-list
110682693|NCT00894959|Anticoagulants|anticoagulants|mesh-ancestor
110682694|NCT00894959|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110682695|NCT00894959|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110682696|NCT00894959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110682698|NCT00895115|Vitamins|vitamins|mesh-ancestor
110682699|NCT00895115|Micronutrients|micronutrients|mesh-ancestor
110682700|NCT00895115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110682701|NCT00895115|Antioxidants|antioxidants|mesh-ancestor
110682702|NCT00895115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110682703|NCT00895115|Protective Agents|protective agents|mesh-ancestor
110682704|NCT00901745|Norepinephrine|norepinephrine|mesh-list
110682705|NCT00901745|Angiotensin II|angiotensin ii|mesh-list
110682706|NCT00901745|Giapreza|giapreza|mesh-list
110682707|NCT00901745|Angiotensinogen|angiotensinogen|mesh-list
110682708|NCT00901745|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110682709|NCT00901745|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110682710|NCT00901745|Adrenergic Agents|adrenergic agents|mesh-ancestor
110682711|NCT00901745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110682712|NCT00901745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110682713|NCT00901745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110682714|NCT00901745|Sympathomimetics|sympathomimetics|mesh-ancestor
110682715|NCT00901745|Autonomic Agents|autonomic agents|mesh-ancestor
110682716|NCT00901745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110682717|NCT00901745|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110682718|NCT00901745|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110682719|NCT00901745|Protease Inhibitors|protease inhibitors|mesh-ancestor
110682720|NCT00901745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110682721|NCT02540837|Bupivacaine|bupivacaine|mesh-list
110682722|NCT02540837|Anesthetics, Local|anesthetics, local|mesh-ancestor
110682723|NCT02540837|Anesthetics|anesthetics|mesh-ancestor
110682724|NCT02540837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110682725|NCT02540837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110682726|NCT02540837|Sensory System Agents|sensory system agents|mesh-ancestor
110682727|NCT02540837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110682728|NCT00901823|Diazoxide|diazoxide|mesh-list
110682729|NCT00901823|Choline|choline|mesh-list
110682730|NCT00901823|Lipotropic Agents|lipotropic agents|mesh-ancestor
110682731|NCT00901823|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110682732|NCT00901823|Antimetabolites|antimetabolites|mesh-ancestor
110682733|NCT00901823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110682734|NCT00901823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110682735|NCT00901823|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110682736|NCT00901823|Nootropic Agents|nootropic agents|mesh-ancestor
110682737|NCT00901823|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110682738|NCT00901823|Vasodilator Agents|vasodilator agents|mesh-ancestor
110682739|NCT00902057|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
110682740|NCT00902057|Hemostatics|hemostatics|mesh-ancestor
110682741|NCT00902057|Coagulants|coagulants|mesh-ancestor
110682742|NCT00902057|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
110682743|NCT00902057|Natriuretic Agents|natriuretic agents|mesh-ancestor
110682744|NCT00902057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110682745|NCT00902135|Interferons|interferons|mesh-list
110682746|NCT00902135|Interferon-beta|interferon-beta|mesh-list
110682747|NCT00902135|Interferon beta-1b|interferon beta-1b|mesh-list
110682748|NCT00902135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110682749|NCT00902135|Antiviral Agents|antiviral agents|mesh-ancestor
110682750|NCT00902135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110682751|NCT00902135|Immunologic Factors|immunologic factors|mesh-ancestor
110682753|NCT00902135|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110682754|NCT02540369|Aflibercept|aflibercept|mesh-list
110682755|NCT02540369|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110682756|NCT02540369|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110682757|NCT02540369|Growth Substances|growth substances|mesh-ancestor
110682758|NCT02540369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110682759|NCT02540369|Growth Inhibitors|growth inhibitors|mesh-ancestor
110682760|NCT02540369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110682761|NCT00605267|Tamoxifen|tamoxifen|mesh-list
110682762|NCT00605267|Goserelin|goserelin|mesh-list
110682763|NCT00605267|Anastrozole|anastrozole|mesh-list
110682764|NCT00605267|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110682765|NCT00605267|Hormone Antagonists|hormone antagonists|mesh-ancestor
110682766|NCT00605267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110682767|NCT00605267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110682768|NCT00605267|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110682769|NCT00605267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110682770|NCT00605267|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110682771|NCT00605267|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110682772|NCT00605267|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110682773|NCT00605267|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110682774|NCT00605267|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110682775|NCT00605267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110682776|NCT00605267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110682777|NCT00902525|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110682778|NCT00902525|Immunologic Factors|immunologic factors|mesh-ancestor
110682779|NCT00902525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110682780|NCT00902603|Iloprost|iloprost|mesh-list
110682781|NCT00902603|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110682782|NCT00902603|Vasodilator Agents|vasodilator agents|mesh-ancestor
110682783|NCT00902681|Fesoterodine|fesoterodine|mesh-list
110682784|NCT00902681|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110682785|NCT00902681|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110682786|NCT00902681|Cholinergic Agents|cholinergic agents|mesh-ancestor
110682787|NCT00902681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110682788|NCT00902681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110682789|NCT00902681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110682790|NCT00902681|Urological Agents|urological agents|mesh-ancestor
110682791|NCT00906113|Melphalan|melphalan|mesh-list
110682792|NCT00906113|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110682793|NCT00906113|Alkylating Agents|alkylating agents|mesh-ancestor
110682794|NCT00906113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110682795|NCT00906113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110682796|NCT00906113|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110682797|NCT00906113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110682798|NCT00906113|Immunologic Factors|immunologic factors|mesh-ancestor
110682799|NCT00906113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110682800|NCT00902837|Oxycodone|oxycodone|mesh-list
110682801|NCT00902837|Naloxone|naloxone|mesh-list
110682802|NCT00902837|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110682803|NCT00902837|Narcotics|narcotics|mesh-ancestor
110682804|NCT00902837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110682805|NCT00902837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110682806|NCT00902837|Analgesics|analgesics|mesh-ancestor
110682807|NCT00902837|Sensory System Agents|sensory system agents|mesh-ancestor
110682808|NCT00902837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110682809|NCT00902837|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110682810|NCT00605813|Sertraline|sertraline|mesh-list
110682811|NCT00605813|Antidepressive Agents|antidepressive agents|mesh-ancestor
110682812|NCT00605813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110682813|NCT00605813|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110682814|NCT00605813|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110654990|NCT00747539|Interferon-alpha|interferon-alpha|mesh-list
110682815|NCT00605813|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110682816|NCT00605813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110682817|NCT00605813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110682818|NCT00605813|Serotonin Agents|serotonin agents|mesh-ancestor
110682819|NCT00605813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110682820|NCT00906269|Sildenafil Citrate|sildenafil citrate|mesh-list
110682821|NCT00906269|Vasodilator Agents|vasodilator agents|mesh-ancestor
110682822|NCT00906269|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110682823|NCT00906269|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110682824|NCT00906269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110687710|NCT00316186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110687711|NCT01065220|Cyproterone Acetate|cyproterone acetate|mesh-list
110687712|NCT01065220|Testolactone|testolactone|mesh-list
110687713|NCT01065220|Lynestrenol|lynestrenol|mesh-list
110687714|NCT01065220|Estradiol|estradiol|mesh-list
110687715|NCT01065220|Cyproterone|cyproterone|mesh-list
110687716|NCT01065220|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-list
110687717|NCT01065220|Estrogens|estrogens|mesh-ancestor
110687718|NCT01065220|Hormones|hormones|mesh-ancestor
110317756|NCT00352092|Mycophenolic Acid|mycophenolic acid|mesh-list
110687719|NCT01065220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110687720|NCT01065220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110856752|NCT02473198|Bupivacaine|bupivacaine|mesh-list
110687721|NCT01065220|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110687722|NCT01065220|Contraceptive Agents|contraceptive agents|mesh-ancestor
110687723|NCT01065220|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110687724|NCT01065220|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110687725|NCT01065220|Androgen Antagonists|androgen antagonists|mesh-ancestor
110687726|NCT01065220|Hormone Antagonists|hormone antagonists|mesh-ancestor
110687727|NCT01065220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110687728|NCT01065220|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110687729|NCT01065220|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110655105|NCT03962803|Vaccines|vaccines|mesh-list
110687730|NCT01065220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110687731|NCT01065220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110687732|NCT01065220|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110687733|NCT01065220|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110687734|NCT01065220|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110687735|NCT01065220|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110687736|NCT00943943|Plerixafor|plerixafor|mesh-list
110687737|NCT00943943|Sorafenib|sorafenib|mesh-list
110687738|NCT00943943|Lenograstim|lenograstim|mesh-list
110687739|NCT00943943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110687740|NCT00943943|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110687741|NCT00943943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110687742|NCT00943943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110687743|NCT00943943|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110687744|NCT00943943|Immunologic Factors|immunologic factors|mesh-ancestor
110655157|NCT00750113|Tocolytic Agents|tocolytic agents|mesh-ancestor
110687745|NCT00943943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110687746|NCT00943943|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110687747|NCT00943943|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110687748|NCT00943943|Antiviral Agents|antiviral agents|mesh-ancestor
110687749|NCT00943943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110687750|NCT00948779|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110687751|NCT00948779|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
110687752|NCT00948779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110687753|NCT00948779|Antitubercular Agents|antitubercular agents|mesh-ancestor
110687754|NCT00453102|Rituximab|rituximab|mesh-list
110687755|NCT00453102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110687756|NCT00453102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110687757|NCT00453102|Immunologic Factors|immunologic factors|mesh-ancestor
110687758|NCT00453102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110687759|NCT00453102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110687760|NCT00299182|Cytarabine|cytarabine|mesh-list
110687761|NCT00299182|Dexamethasone|dexamethasone|mesh-list
110687762|NCT00299182|Cyclophosphamide|cyclophosphamide|mesh-list
110687763|NCT00299182|Rituximab|rituximab|mesh-list
110687764|NCT00299182|Doxorubicin|doxorubicin|mesh-list
110687765|NCT00299182|Methotrexate|methotrexate|mesh-list
110687766|NCT00299182|Vincristine|vincristine|mesh-list
110687767|NCT00299182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110655277|NCT01013805|Vitamins|vitamins|mesh-ancestor
110687768|NCT00299182|Immunologic Factors|immunologic factors|mesh-ancestor
110687769|NCT00299182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110687770|NCT00299182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110687771|NCT00299182|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110687772|NCT00299182|Alkylating Agents|alkylating agents|mesh-ancestor
110687773|NCT00299182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110687774|NCT00299182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110687775|NCT00299182|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110687776|NCT00299182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110687777|NCT00299182|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110687778|NCT00299182|Antiemetics|antiemetics|mesh-ancestor
110687780|NCT00299182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110687781|NCT00299182|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110687782|NCT00299182|Glucocorticoids|glucocorticoids|mesh-ancestor
110687783|NCT00299182|Hormones|hormones|mesh-ancestor
110687784|NCT00299182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110405653|NCT01030666|Chlorhexidine|chlorhexidine|mesh-list
110687785|NCT00299182|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110687786|NCT00299182|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110687787|NCT00299182|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110687788|NCT00299182|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110687789|NCT00299182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110687790|NCT00299182|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110687791|NCT00299182|Abortifacient Agents|abortifacient agents|mesh-ancestor
110687792|NCT00299182|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110687793|NCT00299182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110687794|NCT00299182|Antimetabolites|antimetabolites|mesh-ancestor
110687795|NCT00299182|Dermatologic Agents|dermatologic agents|mesh-ancestor
110687796|NCT00299182|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110687797|NCT00299182|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110687798|NCT00299182|Antiviral Agents|antiviral agents|mesh-ancestor
110687799|NCT00299182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110687800|NCT00299182|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110687801|NCT00299182|Tubulin Modulators|tubulin modulators|mesh-ancestor
110687802|NCT00299182|Antimitotic Agents|antimitotic agents|mesh-ancestor
110687803|NCT00299182|Mitosis Modulators|mitosis modulators|mesh-ancestor
110687805|NCT00467142|Bevacizumab|bevacizumab|mesh-list
110687806|NCT00467142|Fluorouracil|fluorouracil|mesh-list
110687808|NCT00467142|Calcium|calcium|mesh-list
110687809|NCT00467142|Levoleucovorin|levoleucovorin|mesh-list
110687810|NCT00467142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110687811|NCT00467142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110687812|NCT00467142|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110687813|NCT00467142|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110687814|NCT00467142|Growth Substances|growth substances|mesh-ancestor
110687815|NCT00467142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110687816|NCT00467142|Growth Inhibitors|growth inhibitors|mesh-ancestor
110687817|NCT00467142|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110687818|NCT00467142|Antimetabolites|antimetabolites|mesh-ancestor
110687819|NCT00467142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110687820|NCT00467142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110687821|NCT00467142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110687822|NCT00467142|Immunologic Factors|immunologic factors|mesh-ancestor
110687823|NCT00467142|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110687824|NCT00467142|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110687825|NCT00467142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110655466|NCT00093145|Paclitaxel|paclitaxel|mesh-list
110687826|NCT00467142|Antidotes|antidotes|mesh-ancestor
110687827|NCT00467142|Protective Agents|protective agents|mesh-ancestor
110687828|NCT00467142|Vitamin B Complex|vitamin b complex|mesh-ancestor
110687829|NCT00467142|Vitamins|vitamins|mesh-ancestor
110687830|NCT00467142|Micronutrients|micronutrients|mesh-ancestor
110687831|NCT01065376|Cabergoline|cabergoline|mesh-list
110687832|NCT01065376|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110687833|NCT01065376|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110687834|NCT01065376|Dopamine Agonists|dopamine agonists|mesh-ancestor
110687835|NCT01065376|Dopamine Agents|dopamine agents|mesh-ancestor
110687836|NCT01065376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110687837|NCT01065376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110687838|NCT01065376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110687839|NCT00944177|Metformin|metformin|mesh-list
110687840|NCT00944177|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110687841|NCT00944177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110687842|NCT00553475|Pregabalin|pregabalin|mesh-list
110687843|NCT00553475|Analgesics|analgesics|mesh-ancestor
110687844|NCT00553475|Sensory System Agents|sensory system agents|mesh-ancestor
110687845|NCT00553475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110687846|NCT00553475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110687847|NCT00553475|Anticonvulsants|anticonvulsants|mesh-ancestor
110687848|NCT00553475|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110687849|NCT00553475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110687850|NCT00553475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110687851|NCT00553475|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110687852|NCT00553475|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110687853|NCT00553475|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110687854|NCT00553475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110687855|NCT00553475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110687856|NCT00329602|Ropinirole|ropinirole|mesh-list
110687857|NCT00329602|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110687858|NCT00329602|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110687859|NCT00329602|Dopamine Agonists|dopamine agonists|mesh-ancestor
110687860|NCT00329602|Dopamine Agents|dopamine agents|mesh-ancestor
110687861|NCT00329602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110687862|NCT00329602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110687863|NCT00329602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110687865|NCT01060696|Scopolamine|scopolamine|mesh-list
110687866|NCT01060696|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
110687867|NCT01060696|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110687868|NCT01060696|Antiemetics|antiemetics|mesh-ancestor
110687869|NCT01060696|Autonomic Agents|autonomic agents|mesh-ancestor
110687870|NCT01060696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110687871|NCT01060696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110687872|NCT01060696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110687873|NCT01060696|Mydriatics|mydriatics|mesh-ancestor
110687874|NCT01060696|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110687875|NCT01060696|Cholinergic Agents|cholinergic agents|mesh-ancestor
110687876|NCT01060696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110687877|NCT01060696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110687878|NCT01060696|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110687879|NCT01060696|Parasympatholytics|parasympatholytics|mesh-ancestor
110687880|NCT01060696|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110687881|NCT01060696|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110687882|NCT01060696|Analgesics|analgesics|mesh-ancestor
110687883|NCT01060696|Sensory System Agents|sensory system agents|mesh-ancestor
110687884|NCT01060696|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110687885|NCT01060696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110687886|NCT01060696|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110687887|NCT01060696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110687888|NCT01065610|Oxytocin|oxytocin|mesh-list
110687889|NCT01065610|Oxytocics|oxytocics|mesh-ancestor
110687890|NCT01065610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110687891|NCT01065610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110687892|NCT00463866|Budesonide|budesonide|mesh-list
110687893|NCT00463866|Formoterol Fumarate|formoterol fumarate|mesh-list
110687894|NCT00463866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110687895|NCT00463866|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110687896|NCT00463866|Autonomic Agents|autonomic agents|mesh-ancestor
110687897|NCT00463866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110687898|NCT00463866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110687899|NCT00463866|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110687900|NCT00463866|Respiratory System Agents|respiratory system agents|mesh-ancestor
110687901|NCT00463866|Glucocorticoids|glucocorticoids|mesh-ancestor
110687902|NCT00463866|Hormones|hormones|mesh-ancestor
110687903|NCT00463866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110687904|NCT00463866|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110687905|NCT00463866|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110687906|NCT00463866|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110687907|NCT00463866|Adrenergic Agents|adrenergic agents|mesh-ancestor
110687908|NCT00463866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110687909|NCT00463866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110687910|NCT00313846|Buprenorphine|buprenorphine|mesh-list
110687911|NCT00313846|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110687912|NCT00313846|Narcotics|narcotics|mesh-ancestor
110687913|NCT00313846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110687914|NCT00313846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110687915|NCT00313846|Analgesics|analgesics|mesh-ancestor
110687916|NCT00313846|Sensory System Agents|sensory system agents|mesh-ancestor
110687917|NCT00313846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110687918|NCT00313846|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110687919|NCT00949247|Bevacizumab|bevacizumab|mesh-list
110687920|NCT00949247|Trastuzumab|trastuzumab|mesh-list
110687921|NCT00949247|Carboplatin|carboplatin|mesh-list
110687922|NCT00949247|Docetaxel|docetaxel|mesh-list
110687923|NCT00949247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110687924|NCT00949247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110687925|NCT00949247|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110687926|NCT00949247|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110687927|NCT00949247|Growth Substances|growth substances|mesh-ancestor
110687928|NCT00949247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110687929|NCT00949247|Growth Inhibitors|growth inhibitors|mesh-ancestor
110687930|NCT00949247|Tubulin Modulators|tubulin modulators|mesh-ancestor
110687931|NCT00949247|Antimitotic Agents|antimitotic agents|mesh-ancestor
110687932|NCT00949247|Mitosis Modulators|mitosis modulators|mesh-ancestor
110687933|NCT00949247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110687934|NCT00551135|Pregabalin|pregabalin|mesh-list
110687935|NCT00551135|Analgesics|analgesics|mesh-ancestor
110687936|NCT00551135|Sensory System Agents|sensory system agents|mesh-ancestor
110687937|NCT00551135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110687938|NCT00551135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110687939|NCT00551135|Anticonvulsants|anticonvulsants|mesh-ancestor
110687940|NCT00551135|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110687941|NCT00551135|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110687942|NCT00551135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110687943|NCT00551135|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110687944|NCT00551135|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110687945|NCT00551135|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110687946|NCT00551135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110687947|NCT00551135|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110687948|NCT00944333|Clopidogrel|clopidogrel|mesh-list
110687949|NCT00944333|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110687950|NCT00944333|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110687951|NCT00944333|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110687952|NCT00944333|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110687953|NCT00944333|Purinergic Agents|purinergic agents|mesh-ancestor
110687954|NCT00944333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110687955|NCT00944333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110655921|NCT00975078|Prednisone|prednisone|mesh-list
110687956|NCT00944333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110687957|NCT00299104|Methylprednisolone|methylprednisolone|mesh-list
110687958|NCT00299104|Rituximab|rituximab|mesh-list
110687959|NCT00299104|Methotrexate|methotrexate|mesh-list
110687960|NCT00299104|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110687961|NCT00299104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110687962|NCT00299104|Immunologic Factors|immunologic factors|mesh-ancestor
110687963|NCT00299104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110687964|NCT00299104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110687965|NCT00299104|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110687966|NCT00299104|Abortifacient Agents|abortifacient agents|mesh-ancestor
110687967|NCT00299104|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110687968|NCT00299104|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110687969|NCT00299104|Antimetabolites|antimetabolites|mesh-ancestor
110656041|NCT00981318|Antiviral Agents|antiviral agents|mesh-ancestor
110687970|NCT00299104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110687971|NCT00299104|Dermatologic Agents|dermatologic agents|mesh-ancestor
110687972|NCT00299104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110687973|NCT00299104|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110687974|NCT00299104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110687975|NCT00299104|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110687976|NCT00299104|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110687977|NCT00299104|Antiemetics|antiemetics|mesh-ancestor
110687978|NCT00299104|Autonomic Agents|autonomic agents|mesh-ancestor
110687979|NCT00299104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110687980|NCT00299104|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110687981|NCT00299104|Glucocorticoids|glucocorticoids|mesh-ancestor
110687982|NCT00299104|Hormones|hormones|mesh-ancestor
110687983|NCT00299104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110687984|NCT00299104|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110687985|NCT00299104|Protective Agents|protective agents|mesh-ancestor
110687986|NCT03979456|Rituximab|rituximab|mesh-list
110687987|NCT03979456|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110687988|NCT03979456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110687989|NCT03979456|Immunologic Factors|immunologic factors|mesh-ancestor
110687990|NCT03979456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110687991|NCT03979456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110687992|NCT00313612|Oxaliplatin|oxaliplatin|mesh-list
110687993|NCT00313612|Topotecan|topotecan|mesh-list
110687994|NCT00313612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110687995|NCT00313612|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110687996|NCT00313612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110687997|NCT00313612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110687998|NCT00313612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110688000|NCT00507416|Dexamethasone|dexamethasone|mesh-list
110688001|NCT00507416|Prednisone|prednisone|mesh-list
110688002|NCT00507416|Bortezomib|bortezomib|mesh-list
110688003|NCT00507416|Melphalan|melphalan|mesh-list
110688004|NCT00507416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110688005|NCT00507416|Antiemetics|antiemetics|mesh-ancestor
110688006|NCT00507416|Autonomic Agents|autonomic agents|mesh-ancestor
110688007|NCT00507416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110688008|NCT00507416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110688009|NCT00507416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110688010|NCT00507416|Glucocorticoids|glucocorticoids|mesh-ancestor
110405875|NCT04321278|Azithromycin|azithromycin|mesh-list
110688011|NCT00507416|Hormones|hormones|mesh-ancestor
110688012|NCT00507416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110688013|NCT00507416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110688014|NCT00507416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110656228|NCT00982332|Hormones|hormones|mesh-ancestor
110688015|NCT00507416|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110688016|NCT00507416|Alkylating Agents|alkylating agents|mesh-ancestor
110688017|NCT00507416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110688018|NCT00507416|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110688019|NCT00507416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110688020|NCT00507416|Immunologic Factors|immunologic factors|mesh-ancestor
110688021|NCT00507416|Leprostatic Agents|leprostatic agents|mesh-ancestor
110688022|NCT00507416|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110688023|NCT00507416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110688024|NCT00507416|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110688025|NCT00507416|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110688026|NCT00507416|Growth Substances|growth substances|mesh-ancestor
110688027|NCT00507416|Growth Inhibitors|growth inhibitors|mesh-ancestor
110688028|NCT00489476|Loxapine|loxapine|mesh-list
110688029|NCT00489476|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110688030|NCT00489476|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110688031|NCT00489476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110688032|NCT00489476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110688033|NCT00489476|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110688034|NCT00489476|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110688035|NCT00489476|Dopamine Agents|dopamine agents|mesh-ancestor
110688036|NCT00489476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110688037|NCT00489476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110688038|NCT04216043|Caseins|caseins|mesh-list
110656362|NCT00982722|Calcium|calcium|mesh-list
110688039|NCT04216043|Chelating Agents|chelating agents|mesh-ancestor
110688040|NCT04216043|Sequestering Agents|sequestering agents|mesh-ancestor
110688041|NCT04216043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110688042|NCT00957125|Bevacizumab|bevacizumab|mesh-list
110688043|NCT00957125|Docetaxel|docetaxel|mesh-list
110688044|NCT00957125|Epirubicin|epirubicin|mesh-list
110688045|NCT00957125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110688046|NCT00957125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110688047|NCT00957125|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110688048|NCT00957125|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110688049|NCT00957125|Growth Substances|growth substances|mesh-ancestor
110688050|NCT00957125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110688051|NCT00957125|Growth Inhibitors|growth inhibitors|mesh-ancestor
110688052|NCT00957125|Tubulin Modulators|tubulin modulators|mesh-ancestor
110688053|NCT00957125|Antimitotic Agents|antimitotic agents|mesh-ancestor
110688054|NCT00957125|Mitosis Modulators|mitosis modulators|mesh-ancestor
110688055|NCT00957125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110688056|NCT00957125|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110688057|NCT00957125|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110688058|NCT00957125|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110688059|NCT00957125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110688060|NCT00957203|Istradefylline|istradefylline|mesh-list
110688061|NCT00957203|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
110688062|NCT00957203|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110688063|NCT00957203|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110688064|NCT00957203|Purinergic Agents|purinergic agents|mesh-ancestor
110688065|NCT00957203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110856858|NCT01340118|Hormones|hormones|mesh-ancestor
110688066|NCT00957203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110688067|NCT00957203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110688068|NCT00952913|Lansoprazole|lansoprazole|mesh-list
110688069|NCT00952913|Dexlansoprazole|dexlansoprazole|mesh-list
110688070|NCT00952913|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110688071|NCT00952913|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110688072|NCT00952913|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110688073|NCT00952913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110688074|NCT00952913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110688075|NCT00952991|Vildagliptin|vildagliptin|mesh-list
110688076|NCT00952991|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110688077|NCT00952991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110688078|NCT00952991|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110688079|NCT00952991|Protease Inhibitors|protease inhibitors|mesh-ancestor
110688080|NCT00952991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110688081|NCT00952991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110688082|NCT00953303|Dexamethasone|dexamethasone|mesh-list
110688083|NCT00953303|Dexamethasone acetate|dexamethasone acetate|mesh-list
110405956|NCT01259856|Analgesics|analgesics|mesh-ancestor
110688084|NCT00953303|Prednisone|prednisone|mesh-list
110688085|NCT00953303|Torsemide|torsemide|mesh-list
110688086|NCT00953303|Dobutamine|dobutamine|mesh-list
110688087|NCT00953303|Dopamine|dopamine|mesh-list
110688088|NCT00953303|Furosemide|furosemide|mesh-list
110688089|NCT00953303|Nitroglycerin|nitroglycerin|mesh-list
110688090|NCT00953303|Glucocorticoids|glucocorticoids|mesh-list
110688091|NCT00953303|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
110688092|NCT00953303|BB 1101|bb 1101|mesh-list
110688093|NCT00953303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110688094|NCT00953303|Antiemetics|antiemetics|mesh-ancestor
110688095|NCT00953303|Autonomic Agents|autonomic agents|mesh-ancestor
110688096|NCT00953303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110656588|NCT00414310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110688097|NCT00953303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110688098|NCT00953303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110688099|NCT00953303|Hormones|hormones|mesh-ancestor
110688100|NCT00953303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110688101|NCT00953303|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110688102|NCT00953303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110688103|NCT00953303|Protease Inhibitors|protease inhibitors|mesh-ancestor
110688104|NCT00953303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110688105|NCT00953303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110688106|NCT00953303|Diuretics|diuretics|mesh-ancestor
110688107|NCT00953303|Natriuretic Agents|natriuretic agents|mesh-ancestor
110688108|NCT00953303|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110688109|NCT00953303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110688110|NCT00953303|Vasodilator Agents|vasodilator agents|mesh-ancestor
110688111|NCT00953303|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110688112|NCT00953303|Sympathomimetics|sympathomimetics|mesh-ancestor
110688113|NCT00953303|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
110688114|NCT00953303|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110688115|NCT00953303|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110688116|NCT00953303|Adrenergic Agents|adrenergic agents|mesh-ancestor
110688117|NCT00953303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110688118|NCT00953303|Protective Agents|protective agents|mesh-ancestor
110688119|NCT00953303|Dopamine Agents|dopamine agents|mesh-ancestor
110688120|NCT00953303|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110688121|NCT05300555|Warfarin|warfarin|mesh-list
110688122|NCT05300555|Rivaroxaban|rivaroxaban|mesh-list
110688123|NCT05300555|Anticoagulants|anticoagulants|mesh-ancestor
110688124|NCT05300555|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110688125|NCT05300555|Antithrombins|antithrombins|mesh-ancestor
110688126|NCT05300555|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110688127|NCT05300555|Protease Inhibitors|protease inhibitors|mesh-ancestor
110688128|NCT05300555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110688129|NCT05300555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110688130|NCT04010669|Somatostatin|somatostatin|mesh-list
110688131|NCT04010669|Hormones|hormones|mesh-ancestor
110856862|NCT03401398|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
110688132|NCT04010669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110688133|NCT04010669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110688134|NCT00452790|Vaccines|vaccines|mesh-list
110688135|NCT00452790|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110688136|NCT00452790|Immunologic Factors|immunologic factors|mesh-ancestor
110688137|NCT00452790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110688138|NCT00953381|Omeprazole|omeprazole|mesh-list
110688139|NCT00953381|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110688140|NCT00953381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110688141|NCT00953381|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110688142|NCT00953381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110688143|NCT00953381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110688144|NCT05300477|Acetazolamide|acetazolamide|mesh-list
110688145|NCT05300477|Epoetin Alfa|epoetin alfa|mesh-list
110688146|NCT05300477|Hematinics|hematinics|mesh-ancestor
110688147|NCT05300477|Anticonvulsants|anticonvulsants|mesh-ancestor
110688148|NCT05300477|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110688149|NCT05300477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110688150|NCT05300477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110688151|NCT05300477|Diuretics|diuretics|mesh-ancestor
110688152|NCT05300477|Natriuretic Agents|natriuretic agents|mesh-ancestor
110688153|NCT05300477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110688154|NCT00953459|Sunitinib|sunitinib|mesh-list
110688155|NCT00953459|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110688156|NCT00953459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110656916|NCT05919472|Iron|iron|mesh-list
110688157|NCT00953459|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110688158|NCT00953459|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110688159|NCT00953459|Growth Substances|growth substances|mesh-ancestor
110688160|NCT00953459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110688161|NCT00953459|Growth Inhibitors|growth inhibitors|mesh-ancestor
110688162|NCT00953459|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110688163|NCT00953459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110688164|NCT00953459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110688165|NCT00953459|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110688167|NCT00953537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110688168|NCT00953537|Antimetabolites|antimetabolites|mesh-ancestor
110688169|NCT00953537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110688170|NCT00953537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110688171|NCT00463788|Cisplatin|cisplatin|mesh-list
110688172|NCT00463788|Cetuximab|cetuximab|mesh-list
110688173|NCT00463788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110688174|NCT00463788|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110688176|NCT00548249|Trace Elements|trace elements|mesh-ancestor
110688177|NCT00548249|Micronutrients|micronutrients|mesh-ancestor
110688178|NCT00548249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110688179|NCT01025466|Memantine|memantine|mesh-list
110688180|NCT01025466|Rivastigmine|rivastigmine|mesh-list
110688181|NCT01025466|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110688182|NCT01025466|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110688183|NCT01025466|Dopamine Agents|dopamine agents|mesh-ancestor
110688184|NCT01025466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110688185|NCT01025466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110688186|NCT01025466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110688187|NCT01025466|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110688188|NCT01025466|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110688189|NCT01025466|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110688190|NCT01025466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110688191|NCT01025466|Cholinergic Agents|cholinergic agents|mesh-ancestor
110688192|NCT01025466|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110688193|NCT01025466|Protective Agents|protective agents|mesh-ancestor
110688194|NCT01025544|Vaccines|vaccines|mesh-list
110688195|NCT01025544|Immunologic Factors|immunologic factors|mesh-ancestor
110688196|NCT01025544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110688197|NCT03839940|Dexamethasone|dexamethasone|mesh-list
110688198|NCT03839940|Everolimus|everolimus|mesh-list
110688199|NCT03839940|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110688200|NCT03839940|Antiemetics|antiemetics|mesh-ancestor
110688201|NCT03839940|Autonomic Agents|autonomic agents|mesh-ancestor
110688202|NCT03839940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110856873|NCT04409964|Remifentanil|remifentanil|mesh-list
110688203|NCT03839940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110688204|NCT03839940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110688205|NCT03839940|Glucocorticoids|glucocorticoids|mesh-ancestor
110688206|NCT03839940|Hormones|hormones|mesh-ancestor
110688207|NCT03839940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110688208|NCT03839940|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110688209|NCT03839940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110688210|NCT03839940|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110688211|NCT03839940|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110688212|NCT03839940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110688213|NCT03839940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110688214|NCT03839940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110688215|NCT03839940|Immunologic Factors|immunologic factors|mesh-ancestor
110688216|NCT01027494|Ciprofloxacin|ciprofloxacin|mesh-list
110688217|NCT01027494|Dexamethasone|dexamethasone|mesh-list
110688218|NCT01027494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110688219|NCT01027494|Antiemetics|antiemetics|mesh-ancestor
110688220|NCT01027494|Autonomic Agents|autonomic agents|mesh-ancestor
110688221|NCT01027494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110688222|NCT01027494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110688223|NCT01027494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110688224|NCT01027494|Glucocorticoids|glucocorticoids|mesh-ancestor
110688225|NCT01027494|Hormones|hormones|mesh-ancestor
110688226|NCT01027494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110688227|NCT01027494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110688228|NCT01027494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110688229|NCT01027494|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110688230|NCT01027494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110688231|NCT01027494|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110688232|NCT01027494|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110688233|NCT01027494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110688234|NCT01027494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110688235|NCT01027494|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110688236|NCT01027494|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110688238|NCT01025700|Antiemetics|antiemetics|mesh-ancestor
110688239|NCT01025700|Autonomic Agents|autonomic agents|mesh-ancestor
110688240|NCT01025700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110688241|NCT01025700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110688242|NCT01025700|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110688243|NCT01025700|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110688244|NCT01025700|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110688245|NCT01025700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110688246|NCT01025700|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110688247|NCT00462462|Ethanol|ethanol|mesh-list
110688248|NCT00462462|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110688249|NCT00462462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110688250|NCT00462462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110688251|NCT00462462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110688252|NCT00462384|Epoetin Alfa|epoetin alfa|mesh-list
110688253|NCT00462384|Hematinics|hematinics|mesh-ancestor
110688254|NCT00452400|Olodaterol|olodaterol|mesh-list
110688255|NCT00452400|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110688256|NCT00452400|Autonomic Agents|autonomic agents|mesh-ancestor
110688257|NCT00452400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110688258|NCT00452400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110688259|NCT00452400|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110688260|NCT00452400|Respiratory System Agents|respiratory system agents|mesh-ancestor
110688261|NCT01566474|Melatonin|melatonin|mesh-list
110688262|NCT01566474|Omeprazole|omeprazole|mesh-list
110688263|NCT01566474|Antioxidants|antioxidants|mesh-ancestor
110688264|NCT01566474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110688265|NCT01566474|Protective Agents|protective agents|mesh-ancestor
110688266|NCT01566474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110688267|NCT01566474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110688268|NCT01566474|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110688269|NCT01566474|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110688270|NCT01566474|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110688271|NCT01566474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110688272|NCT01025778|Cyclophosphamide|cyclophosphamide|mesh-list
110688273|NCT01025778|Thiotepa|thiotepa|mesh-list
110688274|NCT01025778|Etoposide|etoposide|mesh-list
110688275|NCT01025778|Clofarabine|clofarabine|mesh-list
110688276|NCT01025778|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110688277|NCT01025778|Immunologic Factors|immunologic factors|mesh-ancestor
110688278|NCT01025778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110688279|NCT01025778|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110688280|NCT01025778|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110688281|NCT01025778|Alkylating Agents|alkylating agents|mesh-ancestor
110688282|NCT01025778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110688283|NCT01025778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110688284|NCT01025778|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110688285|NCT01025778|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110688286|NCT01025778|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110688287|NCT01025778|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110688288|NCT01025778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110688289|NCT01025778|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110688290|NCT01025778|Antimetabolites|antimetabolites|mesh-ancestor
110688291|NCT00443430|Prednisone|prednisone|mesh-list
110688292|NCT00443430|Prednisolone|prednisolone|mesh-list
110688293|NCT00443430|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110688294|NCT00443430|Methylprednisolone|methylprednisolone|mesh-list
110688295|NCT00443430|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110688296|NCT00443430|Prednisolone acetate|prednisolone acetate|mesh-list
110688297|NCT00443430|Etanercept|etanercept|mesh-list
110688298|NCT00443430|Methotrexate|methotrexate|mesh-list
110688299|NCT00443430|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110688300|NCT00443430|Prednisolone phosphate|prednisolone phosphate|mesh-list
110688301|NCT00443430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110688302|NCT00443430|Glucocorticoids|glucocorticoids|mesh-ancestor
110688303|NCT00443430|Hormones|hormones|mesh-ancestor
110688304|NCT00443430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110688305|NCT00443430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110688306|NCT00443430|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110688307|NCT00443430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110688308|NCT00443430|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110688309|NCT00443430|Abortifacient Agents|abortifacient agents|mesh-ancestor
110408421|NCT05736341|Anesthetics|anesthetics|mesh-ancestor
110688311|NCT00443430|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110688312|NCT00443430|Antimetabolites|antimetabolites|mesh-ancestor
110688313|NCT00443430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110688314|NCT00443430|Dermatologic Agents|dermatologic agents|mesh-ancestor
110688315|NCT00443430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110688316|NCT00443430|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110688317|NCT00443430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110688318|NCT00443430|Immunologic Factors|immunologic factors|mesh-ancestor
110688319|NCT00443430|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110688320|NCT00443430|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110688321|NCT00443430|Antiemetics|antiemetics|mesh-ancestor
110688322|NCT00443430|Autonomic Agents|autonomic agents|mesh-ancestor
110688323|NCT00443430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110688324|NCT00443430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110688325|NCT00443430|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110688326|NCT00443430|Protective Agents|protective agents|mesh-ancestor
110688327|NCT00443430|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110688328|NCT00443430|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110688329|NCT00443430|Analgesics|analgesics|mesh-ancestor
110688330|NCT00443430|Sensory System Agents|sensory system agents|mesh-ancestor
110688331|NCT03898986|Vaccines|vaccines|mesh-list
110688332|NCT03898986|Immunologic Factors|immunologic factors|mesh-ancestor
110688333|NCT03898986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110688334|NCT01022658|Insulin|insulin|mesh-list
110688335|NCT01022658|Insulin Detemir|insulin detemir|mesh-list
110688336|NCT01022658|Insulin Aspart|insulin aspart|mesh-list
110688337|NCT01022658|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110688338|NCT01022658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110688339|NCT01022736|Gabapentin|gabapentin|mesh-list
110688340|NCT01022736|Analgesics|analgesics|mesh-ancestor
110688341|NCT01022736|Sensory System Agents|sensory system agents|mesh-ancestor
110688342|NCT01022736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110688343|NCT01022736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110688345|NCT01022736|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110688346|NCT01022736|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110688347|NCT01022736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110688348|NCT01022736|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110688349|NCT01022736|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110688350|NCT01022736|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110688351|NCT01022736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110688352|NCT01022736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110688353|NCT01022736|Antimanic Agents|antimanic agents|mesh-ancestor
110688354|NCT01025934|Bevacizumab|bevacizumab|mesh-list
110688355|NCT01025934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110688356|NCT01025934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110688357|NCT01025934|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110688358|NCT01025934|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110688359|NCT01025934|Growth Substances|growth substances|mesh-ancestor
110688360|NCT01025934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110688361|NCT01025934|Growth Inhibitors|growth inhibitors|mesh-ancestor
110688362|NCT01026090|Dronedarone|dronedarone|mesh-list
110688363|NCT01026090|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110688364|NCT00460746|Ritonavir|ritonavir|mesh-list
110688365|NCT00460746|Darunavir|darunavir|mesh-list
110688366|NCT00460746|Etravirine|etravirine|mesh-list
110688367|NCT00460746|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110688368|NCT00460746|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110688369|NCT00460746|Protease Inhibitors|protease inhibitors|mesh-ancestor
110688370|NCT00460746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110688371|NCT00460746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110688372|NCT00460746|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110688373|NCT00460746|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110688374|NCT00460746|Antiviral Agents|antiviral agents|mesh-ancestor
110688375|NCT00460746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110688376|NCT00460746|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110688377|NCT00460746|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110688378|NCT00460746|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110688379|NCT00460746|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110688380|NCT01026558|Ceftobiprole|ceftobiprole|mesh-list
110688381|NCT01026558|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
110688382|NCT01026558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110688383|NCT01026558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110688384|NCT00373425|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110688385|NCT00373425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110688386|NCT00373425|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110406255|NCT01052272|Allopurinol|allopurinol|mesh-list
110688387|NCT00373425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110688388|NCT00373425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110688389|NCT00459342|Dasatinib|dasatinib|mesh-list
110688390|NCT00459342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110688391|NCT00459342|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110688392|NCT00459342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110688393|NCT00459342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110688394|NCT00442962|Tenofovir|tenofovir|mesh-list
110688395|NCT00442962|Emtricitabine|emtricitabine|mesh-list
110688396|NCT00442962|Efavirenz|efavirenz|mesh-list
110688397|NCT00442962|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110688398|NCT00442962|Antiviral Agents|antiviral agents|mesh-ancestor
110688399|NCT00442962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110688400|NCT00442962|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110688401|NCT00442962|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110688402|NCT00442962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110856895|NCT01342146|Hormones|hormones|mesh-list
110688403|NCT00442962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110688404|NCT00442962|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110688405|NCT00442962|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110688406|NCT00442962|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110688407|NCT00442962|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110688408|NCT00442962|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110688409|NCT00442962|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110688410|NCT00442962|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110688411|NCT00442962|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110688412|NCT01028508|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
110688413|NCT01028508|Antidepressive Agents|antidepressive agents|mesh-ancestor
110688414|NCT01028508|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110688415|NCT01028508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110688416|NCT01028508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110688417|NCT01028508|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110688418|NCT01028508|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110688419|NCT01028508|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110688420|NCT01028508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110688421|NCT01028508|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110688422|NCT01026636|Ceftobiprole|ceftobiprole|mesh-list
110688423|NCT01026636|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
110688424|NCT01026636|Cephalosporins|cephalosporins|mesh-list
110688425|NCT01026636|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110688426|NCT01026636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110688427|NCT00313300|Apixaban|apixaban|mesh-list
110688428|NCT00313300|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110688429|NCT00313300|Antithrombins|antithrombins|mesh-ancestor
110688430|NCT00313300|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110688431|NCT00313300|Protease Inhibitors|protease inhibitors|mesh-ancestor
110688432|NCT00313300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110688433|NCT00313300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110688434|NCT00313300|Anticoagulants|anticoagulants|mesh-ancestor
110688435|NCT00459186|Prednisone|prednisone|mesh-list
110688436|NCT00459186|Docetaxel|docetaxel|mesh-list
110688437|NCT00459186|Everolimus|everolimus|mesh-list
110688438|NCT00459186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110688439|NCT00459186|Tubulin Modulators|tubulin modulators|mesh-ancestor
110688440|NCT00459186|Antimitotic Agents|antimitotic agents|mesh-ancestor
110688441|NCT00459186|Mitosis Modulators|mitosis modulators|mesh-ancestor
110688442|NCT00459186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110688443|NCT00459186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110688444|NCT00459186|Glucocorticoids|glucocorticoids|mesh-ancestor
110688445|NCT00459186|Hormones|hormones|mesh-ancestor
110688446|NCT00459186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110688447|NCT00459186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110688448|NCT00459186|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110688449|NCT00459186|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110688450|NCT00459186|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110688451|NCT00459186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110688452|NCT00459186|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110688453|NCT00459186|Immunologic Factors|immunologic factors|mesh-ancestor
110688454|NCT01026714|Rifampin|rifampin|mesh-list
110688455|NCT01026714|Fluconazole|fluconazole|mesh-list
110688456|NCT01026714|Flurbiprofen|flurbiprofen|mesh-list
110688457|NCT01026714|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110688458|NCT01026714|Antitubercular Agents|antitubercular agents|mesh-ancestor
110688459|NCT01026714|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110688460|NCT01026714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110688461|NCT01026714|Leprostatic Agents|leprostatic agents|mesh-ancestor
110688462|NCT01026714|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110688463|NCT01026714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110688464|NCT01026714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110688465|NCT01026714|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110688466|NCT01026714|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110688467|NCT01026714|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110688468|NCT01026714|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110688469|NCT01026714|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110688470|NCT01026714|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110688471|NCT01026714|Antifungal Agents|antifungal agents|mesh-ancestor
110688472|NCT01026714|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110688473|NCT01026714|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110688474|NCT01026714|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110688475|NCT01026714|Hormone Antagonists|hormone antagonists|mesh-ancestor
110688476|NCT01026714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110688477|NCT01026714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110688478|NCT01026714|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110688479|NCT01026714|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110688481|NCT01026714|Sensory System Agents|sensory system agents|mesh-ancestor
110688482|NCT01026714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110688483|NCT01026714|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110688484|NCT01026714|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110688485|NCT01026714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110688486|NCT01026714|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110688487|NCT01026714|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110688488|NCT03996252|Calcitriol|calcitriol|mesh-list
110688489|NCT03996252|Fluorouracil|fluorouracil|mesh-list
110688490|NCT03996252|Calcipotriene|calcipotriene|mesh-list
110688491|NCT03996252|Antimetabolites|antimetabolites|mesh-ancestor
110688492|NCT03996252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110688493|NCT03996252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110688494|NCT03996252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110688495|NCT03996252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110688496|NCT03996252|Immunologic Factors|immunologic factors|mesh-ancestor
110688497|NCT03996252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110688498|NCT03996252|Dermatologic Agents|dermatologic agents|mesh-ancestor
110688499|NCT03996252|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110688500|NCT03996252|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
110688501|NCT03996252|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110688502|NCT03996252|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110688503|NCT03996252|Vitamins|vitamins|mesh-ancestor
110688504|NCT03996252|Micronutrients|micronutrients|mesh-ancestor
110688505|NCT03996252|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110688506|NCT00313144|Protease Inhibitors|protease inhibitors|mesh-list
110688507|NCT00313144|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
110688508|NCT00313144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110688509|NCT00313144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110688510|NCT00313144|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
110688511|NCT00313144|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110688512|NCT00459108|Dasatinib|dasatinib|mesh-list
110688513|NCT00459108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110688514|NCT00459108|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110688515|NCT00459108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110688516|NCT00459108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110688517|NCT00328198|Alemtuzumab|alemtuzumab|mesh-list
110688518|NCT00328198|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110688519|NCT00328198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110688520|NCT00450450|Lenograstim|lenograstim|mesh-list
110688521|NCT00450450|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110688522|NCT00450450|Immunologic Factors|immunologic factors|mesh-ancestor
110688523|NCT00450450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110688528|NCT03440892|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110688529|NCT03440892|Abortifacient Agents|abortifacient agents|mesh-ancestor
110688530|NCT03440892|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110688531|NCT03440892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110688532|NCT03440892|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110688533|NCT03440892|Antimetabolites|antimetabolites|mesh-ancestor
110688534|NCT03440892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110688535|NCT03440892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110133369|NCT01983449|Hormones|hormones|mesh-ancestor
110688536|NCT03440892|Dermatologic Agents|dermatologic agents|mesh-ancestor
110688537|NCT03440892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110688538|NCT03440892|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110688539|NCT03440892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110688540|NCT03440892|Immunologic Factors|immunologic factors|mesh-ancestor
110688541|NCT03440892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110688542|NCT03440892|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110688543|NCT03440892|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110688544|NCT03440892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110688545|NCT03440892|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
110688546|NCT03440892|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110688547|NCT03440892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110688548|NCT03440892|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110688549|NCT03440892|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110688550|NCT03440892|Analgesics|analgesics|mesh-ancestor
110688551|NCT03440892|Sensory System Agents|sensory system agents|mesh-ancestor
110688552|NCT03440892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110688553|NCT03440892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110688554|NCT03440892|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110688555|NCT00442572|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110688556|NCT00442572|Antiviral Agents|antiviral agents|mesh-ancestor
110688557|NCT00442572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110688558|NCT01023360|Esomeprazole|esomeprazole|mesh-list
110688559|NCT01023360|Rabeprazole|rabeprazole|mesh-list
110688560|NCT01023360|Pantoprazole|pantoprazole|mesh-list
110688561|NCT01023360|Clopidogrel|clopidogrel|mesh-list
110688562|NCT01023360|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
110688563|NCT01023360|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110688564|NCT01023360|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110688565|NCT01023360|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110688566|NCT01023360|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110688567|NCT01023360|Purinergic Agents|purinergic agents|mesh-ancestor
110688568|NCT01023360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110688569|NCT01023360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110688570|NCT01023360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110688571|NCT01023360|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110688572|NCT01023360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110688573|NCT01023360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110688574|NCT03685890|Nivolumab|nivolumab|mesh-list
110688575|NCT03685890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110688576|NCT03685890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110688577|NCT03685890|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110688578|NCT03685890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110688579|NCT00442416|Epoetin Alfa|epoetin alfa|mesh-list
110688580|NCT00442416|Hematinics|hematinics|mesh-ancestor
110688584|NCT00441792|Midazolam|midazolam|mesh-list
110688585|NCT00441792|Etomidate|etomidate|mesh-list
110688586|NCT00441792|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110688587|NCT00441792|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110688588|NCT00441792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110688589|NCT00441792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110688590|NCT00441792|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110688591|NCT00441792|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110688592|NCT00441792|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110688593|NCT00441792|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110688594|NCT00441792|Anesthetics, General|anesthetics, general|mesh-ancestor
110688595|NCT00441792|Anesthetics|anesthetics|mesh-ancestor
110688596|NCT00441792|GABA Modulators|gaba modulators|mesh-ancestor
110688597|NCT00441792|GABA Agents|gaba agents|mesh-ancestor
110688598|NCT00441792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110318636|NCT04708353|Analgesics|analgesics|mesh-ancestor
110688599|NCT00441792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110688600|NCT00312208|Cyclophosphamide|cyclophosphamide|mesh-list
110688602|NCT00312208|Doxorubicin|doxorubicin|mesh-list
110688603|NCT00312208|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110688604|NCT00312208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110688605|NCT00312208|Immunologic Factors|immunologic factors|mesh-ancestor
110688606|NCT00312208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110688607|NCT00312208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110688608|NCT00312208|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110856916|NCT04762836|Antimetabolites|antimetabolites|mesh-ancestor
110688609|NCT00312208|Alkylating Agents|alkylating agents|mesh-ancestor
110688610|NCT00312208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110688611|NCT00312208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110688612|NCT00312208|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110688613|NCT00312208|Tubulin Modulators|tubulin modulators|mesh-ancestor
110688614|NCT00312208|Antimitotic Agents|antimitotic agents|mesh-ancestor
110688615|NCT00312208|Mitosis Modulators|mitosis modulators|mesh-ancestor
110688616|NCT00312208|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110688617|NCT00312208|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110688618|NCT00312208|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110688619|NCT00312208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110688620|NCT00297778|Pramipexole|pramipexole|mesh-list
110688621|NCT00297778|Antioxidants|antioxidants|mesh-ancestor
110688622|NCT00297778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110688623|NCT00297778|Protective Agents|protective agents|mesh-ancestor
110688624|NCT00297778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110688625|NCT00297778|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110688626|NCT00297778|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110688627|NCT00297778|Dopamine Agonists|dopamine agonists|mesh-ancestor
110688628|NCT00297778|Dopamine Agents|dopamine agents|mesh-ancestor
110688629|NCT00297778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110688630|NCT03848832|Cannabidiol|cannabidiol|mesh-list
110688631|NCT03848832|Anticonvulsants|anticonvulsants|mesh-ancestor
110688632|NCT00327340|Docetaxel|docetaxel|mesh-list
110688633|NCT00327340|Mitoxantrone|mitoxantrone|mesh-list
110688634|NCT00327340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110688635|NCT00327340|Tubulin Modulators|tubulin modulators|mesh-ancestor
110688636|NCT00327340|Antimitotic Agents|antimitotic agents|mesh-ancestor
110688637|NCT00327340|Mitosis Modulators|mitosis modulators|mesh-ancestor
110688638|NCT00327340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110688639|NCT00327340|Analgesics|analgesics|mesh-ancestor
110688640|NCT00327340|Sensory System Agents|sensory system agents|mesh-ancestor
110688641|NCT00327340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110688642|NCT00327340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110688643|NCT00327340|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110688644|NCT00327340|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110688645|NCT00327340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110688646|NCT00958139|Permethrin|permethrin|mesh-list
110688647|NCT00958139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110688648|NCT00958139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110688649|NCT00450216|Ibuprofen|ibuprofen|mesh-list
110688650|NCT00450216|Famotidine|famotidine|mesh-list
110688651|NCT00450216|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110688652|NCT00450216|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110688653|NCT00450216|Analgesics|analgesics|mesh-ancestor
110688654|NCT00450216|Sensory System Agents|sensory system agents|mesh-ancestor
110688655|NCT00450216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110688656|NCT00450216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110688657|NCT00450216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110688658|NCT00450216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110688659|NCT00450216|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110688660|NCT00450216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110688661|NCT00450216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110688662|NCT00450216|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110688663|NCT00450216|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110688664|NCT00450216|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110688665|NCT00450216|Histamine Antagonists|histamine antagonists|mesh-ancestor
110688666|NCT00450216|Histamine Agents|histamine agents|mesh-ancestor
110688667|NCT00450216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110688668|NCT01566006|Mycophenolic Acid|mycophenolic acid|mesh-list
110688669|NCT01566006|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
110688670|NCT01566006|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110688671|NCT01566006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110688672|NCT01566006|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110688673|NCT01566006|Antitubercular Agents|antitubercular agents|mesh-ancestor
110688674|NCT01566006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110688675|NCT01566006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110688676|NCT01566006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110688677|NCT01566006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110688678|NCT01566006|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110688679|NCT00958451|Ergocalciferols|ergocalciferols|mesh-list
110688680|NCT00958451|Vitamin D|vitamin d|mesh-list
110688681|NCT00958451|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110688682|NCT00958451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110688683|NCT00958451|Vitamins|vitamins|mesh-ancestor
110683011|NCT00904631|Sensory System Agents|sensory system agents|mesh-ancestor
110688684|NCT00958451|Micronutrients|micronutrients|mesh-ancestor
110688685|NCT00958451|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110688686|NCT05352191|Beclomethasone|beclomethasone|mesh-list
110688687|NCT05352191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110688688|NCT05352191|Glucocorticoids|glucocorticoids|mesh-ancestor
110688689|NCT05352191|Hormones|hormones|mesh-ancestor
110688690|NCT05352191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110688691|NCT05352191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110688692|NCT05352191|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110688693|NCT05352191|Respiratory System Agents|respiratory system agents|mesh-ancestor
110688694|NCT00954005|Rituximab|rituximab|mesh-list
110688695|NCT00954005|Gemcitabine|gemcitabine|mesh-list
110688696|NCT00954005|Oxaliplatin|oxaliplatin|mesh-list
110688697|NCT00954005|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110688698|NCT00954005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110688699|NCT00954005|Immunologic Factors|immunologic factors|mesh-ancestor
110688700|NCT00954005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110688701|NCT00954005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110208775|NCT00195871|Cytarabine|cytarabine|mesh-list
110688702|NCT00954005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110688703|NCT00954005|Antimetabolites|antimetabolites|mesh-ancestor
110688704|NCT00954005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110688705|NCT01023750|Fenofibrate|fenofibrate|mesh-list
110688706|NCT01023750|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110688707|NCT01023750|Antimetabolites|antimetabolites|mesh-ancestor
110688708|NCT01023750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110688709|NCT01023750|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110688710|NCT05300009|Methotrexate|methotrexate|mesh-list
110688711|NCT05300009|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110688712|NCT05300009|Abortifacient Agents|abortifacient agents|mesh-ancestor
110688713|NCT05300009|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110688714|NCT05300009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110688715|NCT05300009|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110688716|NCT05300009|Antimetabolites|antimetabolites|mesh-ancestor
110688717|NCT05300009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110688718|NCT05300009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110688719|NCT05300009|Dermatologic Agents|dermatologic agents|mesh-ancestor
110688720|NCT05300009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110688721|NCT05300009|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110688722|NCT05300009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110688723|NCT05300009|Immunologic Factors|immunologic factors|mesh-ancestor
110688724|NCT05300009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110688725|NCT05300009|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110688726|NCT05352113|Antidepressive Agents|antidepressive agents|mesh-list
110688727|NCT05352113|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
110688728|NCT05352113|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110688729|NCT05352113|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110688730|NCT05352113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110688731|NCT05352113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110688732|NCT05352113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110688733|NCT05352113|Serotonin Agents|serotonin agents|mesh-ancestor
110688734|NCT05352113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110688735|NCT00547703|Nortriptyline|nortriptyline|mesh-list
110688736|NCT00547703|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110688737|NCT00547703|Antidepressive Agents|antidepressive agents|mesh-ancestor
110688738|NCT00547703|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110688739|NCT00547703|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110688740|NCT00547703|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110688741|NCT00547703|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110688742|NCT00547703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110688744|NCT00547703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110688745|NCT00547703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110688746|NCT00297232|Natalizumab|natalizumab|mesh-list
110688747|NCT00297232|Immunologic Factors|immunologic factors|mesh-ancestor
110688748|NCT00297232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110688749|NCT01062802|Atorvastatin|atorvastatin|mesh-list
110688750|NCT01062802|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110688751|NCT01062802|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110688752|NCT01062802|Antimetabolites|antimetabolites|mesh-ancestor
110688753|NCT01062802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110688754|NCT01062802|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110688755|NCT01062802|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110688756|NCT01062802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110688757|NCT03867383|Calcium, Dietary|calcium, dietary|mesh-list
110688758|NCT03867383|Calcium|calcium|mesh-list
110688759|NCT03867383|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110688760|NCT03867383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110688761|NCT03867383|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110688762|NCT00954395|Fibrin Fibrinogen Degradation Products|fibrin fibrinogen degradation products|mesh-list
110688763|NCT00954395|Fibrin fragment D|fibrin fragment d|mesh-list
110688764|NCT00954395|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110688765|NCT00954395|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110688766|NCT00954395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110688767|NCT00954395|Hemostatics|hemostatics|mesh-ancestor
110688768|NCT00954395|Coagulants|coagulants|mesh-ancestor
110688769|NCT00954395|Anticoagulants|anticoagulants|mesh-ancestor
110688770|NCT03741101|Trametinib|trametinib|mesh-list
110688771|NCT03741101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110688772|NCT03741101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110688773|NCT03741101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110688774|NCT03741101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110688775|NCT00449670|Vaccines|vaccines|mesh-list
110688776|NCT00449670|Immunologic Factors|immunologic factors|mesh-ancestor
110688777|NCT00449670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110688778|NCT04010903|Insulin|insulin|mesh-list
110688779|NCT04010903|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110688780|NCT04010903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110688781|NCT05299931|Ustekinumab|ustekinumab|mesh-list
110688782|NCT05299931|Dermatologic Agents|dermatologic agents|mesh-ancestor
110688783|NCT00296374|Atorvastatin|atorvastatin|mesh-list
110688784|NCT00296374|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110688785|NCT00296374|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110688786|NCT00296374|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110688787|NCT00296374|Antimetabolites|antimetabolites|mesh-ancestor
110688788|NCT00296374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110688789|NCT00296374|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110688790|NCT00296374|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110688791|NCT00296374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110688792|NCT03387761|Nivolumab|nivolumab|mesh-list
110688793|NCT03387761|Ipilimumab|ipilimumab|mesh-list
110688794|NCT03387761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110688795|NCT03387761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110688796|NCT03387761|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110688797|NCT03387761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110688798|NCT01060774|Lidocaine|lidocaine|mesh-list
110688799|NCT01060774|Bupivacaine|bupivacaine|mesh-list
110688800|NCT01060774|Anesthetics, Local|anesthetics, local|mesh-ancestor
110688801|NCT01060774|Anesthetics|anesthetics|mesh-ancestor
110688802|NCT01060774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110688803|NCT01060774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110688804|NCT01060774|Sensory System Agents|sensory system agents|mesh-ancestor
110688805|NCT01060774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110688806|NCT01060774|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110688807|NCT01060774|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110688808|NCT01060774|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110688809|NCT01060774|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110688810|NCT01060774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110688811|NCT00954785|Diclofenac|diclofenac|mesh-list
110688812|NCT00954785|Etoricoxib|etoricoxib|mesh-list
110688813|NCT00954785|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110688814|NCT00954785|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110688815|NCT00954785|Analgesics|analgesics|mesh-ancestor
110688816|NCT00954785|Sensory System Agents|sensory system agents|mesh-ancestor
110688817|NCT00954785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110688818|NCT00954785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110688819|NCT00954785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110688820|NCT00954785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110688821|NCT00954785|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110688822|NCT00954785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110688823|NCT00954785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110688824|NCT00954785|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110688825|NCT00548717|Mycophenolic Acid|mycophenolic acid|mesh-list
110688826|NCT00548717|Sirolimus|sirolimus|mesh-list
110688827|NCT00548717|Bortezomib|bortezomib|mesh-list
110688828|NCT00548717|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110688829|NCT00548717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110688830|NCT00548717|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110688831|NCT00548717|Antitubercular Agents|antitubercular agents|mesh-ancestor
110688832|NCT00548717|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110688833|NCT00548717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110688834|NCT00548717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110688835|NCT00548717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110688836|NCT00548717|Antifungal Agents|antifungal agents|mesh-ancestor
110688837|NCT00548717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110688838|NCT00548717|Immunologic Factors|immunologic factors|mesh-ancestor
110688839|NCT00548717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110688840|NCT00441168|Dexamethasone|dexamethasone|mesh-list
110688841|NCT00441168|Vincristine|vincristine|mesh-list
110688842|NCT00441168|Doxorubicin|doxorubicin|mesh-list
110688843|NCT00441168|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110688844|NCT00441168|Bortezomib|bortezomib|mesh-list
110688845|NCT00441168|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110688846|NCT00441168|Antiemetics|antiemetics|mesh-ancestor
110688847|NCT00441168|Autonomic Agents|autonomic agents|mesh-ancestor
110688848|NCT00441168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110856969|NCT05158608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110688849|NCT00441168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110688850|NCT00441168|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110688851|NCT00441168|Glucocorticoids|glucocorticoids|mesh-ancestor
110688852|NCT00441168|Hormones|hormones|mesh-ancestor
110688853|NCT00441168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110688854|NCT00441168|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110688855|NCT00441168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110688856|NCT00441168|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110688857|NCT00441168|Tubulin Modulators|tubulin modulators|mesh-ancestor
110688858|NCT00441168|Antimitotic Agents|antimitotic agents|mesh-ancestor
110688859|NCT00441168|Mitosis Modulators|mitosis modulators|mesh-ancestor
110688860|NCT00441168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110688861|NCT00441168|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110688862|NCT00441168|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110688863|NCT00441168|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110688864|NCT00441168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110688865|NCT01062958|Vitamins|vitamins|mesh-list
110688866|NCT01062958|Folic Acid|folic acid|mesh-list
110688867|NCT01062958|Vitamin B 12|vitamin b 12|mesh-list
110688868|NCT01062958|Hydroxocobalamin|hydroxocobalamin|mesh-list
110688869|NCT01062958|Micronutrients|micronutrients|mesh-ancestor
110688870|NCT01062958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110688871|NCT01062958|Hematinics|hematinics|mesh-ancestor
110688872|NCT01062958|Vitamin B Complex|vitamin b complex|mesh-ancestor
110688873|NCT01028976|Ascorbic Acid|ascorbic acid|mesh-list
110688874|NCT01028976|Vitamins|vitamins|mesh-ancestor
110688875|NCT01028976|Micronutrients|micronutrients|mesh-ancestor
110688876|NCT01028976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110688877|NCT01028976|Antioxidants|antioxidants|mesh-ancestor
110688878|NCT01028976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110688879|NCT01028976|Protective Agents|protective agents|mesh-ancestor
110688880|NCT01024140|Escitalopram|escitalopram|mesh-list
110688881|NCT01024140|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110688882|NCT01024140|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110688883|NCT01024140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110688884|NCT01024140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110688885|NCT01024140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110688886|NCT01024140|Serotonin Agents|serotonin agents|mesh-ancestor
110688887|NCT01024140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110688888|NCT00457626|Valsartan|valsartan|mesh-list
110688889|NCT00457626|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110688890|NCT00457626|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110688891|NCT00457626|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110688892|NCT00457626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110688894|NCT02748707|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110688895|NCT02748707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110688896|NCT02748707|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110688897|NCT02748707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110688898|NCT02748707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110688899|NCT02748707|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110688900|NCT02748707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110688901|NCT02748707|Analgesics|analgesics|mesh-ancestor
110688902|NCT02748707|Sensory System Agents|sensory system agents|mesh-ancestor
110688903|NCT02748707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110688904|NCT02748707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110688905|NCT02748707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110688906|NCT02748707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110688907|NCT02748707|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110688908|NCT02748707|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110688909|NCT05014061|Adenosine|adenosine|mesh-list
110688910|NCT05014061|Analgesics|analgesics|mesh-ancestor
110688911|NCT05014061|Sensory System Agents|sensory system agents|mesh-ancestor
110688912|NCT05014061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110688913|NCT05014061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110688914|NCT05014061|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110688915|NCT05014061|Vasodilator Agents|vasodilator agents|mesh-ancestor
110688916|NCT05014061|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
110688917|NCT05014061|Purinergic Agonists|purinergic agonists|mesh-ancestor
110688918|NCT05014061|Purinergic Agents|purinergic agents|mesh-ancestor
110688919|NCT05014061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110688920|NCT05014061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110688921|NCT00373113|Capecitabine|capecitabine|mesh-list
110688922|NCT00373113|Sunitinib|sunitinib|mesh-list
110688923|NCT00373113|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110688924|NCT00373113|Antimetabolites|antimetabolites|mesh-ancestor
110688925|NCT00373113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110688926|NCT00373113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110688927|NCT00373113|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110688928|NCT00373113|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110688929|NCT00373113|Growth Substances|growth substances|mesh-ancestor
110688930|NCT00373113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110688931|NCT00373113|Growth Inhibitors|growth inhibitors|mesh-ancestor
110688932|NCT00373113|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110688933|NCT00373113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110688934|NCT01045941|Gemcitabine|gemcitabine|mesh-list
110688935|NCT01045941|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110688936|NCT01045941|Antimetabolites|antimetabolites|mesh-ancestor
110688937|NCT01045941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110688938|NCT01045941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110688939|NCT00407511|Pregabalin|pregabalin|mesh-list
110688940|NCT00407511|Analgesics|analgesics|mesh-ancestor
110688941|NCT00407511|Sensory System Agents|sensory system agents|mesh-ancestor
110688942|NCT00407511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110688943|NCT00407511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110688944|NCT00407511|Anticonvulsants|anticonvulsants|mesh-ancestor
110688945|NCT00407511|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110688946|NCT00407511|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110688947|NCT00407511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110688948|NCT00407511|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110688949|NCT00407511|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110688950|NCT00407511|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110688951|NCT00407511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110688952|NCT00407511|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110688953|NCT00384189|Ciclesonide|ciclesonide|mesh-list
110688954|NCT00384189|Albuterol|albuterol|mesh-list
110688955|NCT00384189|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110688956|NCT00384189|Autonomic Agents|autonomic agents|mesh-ancestor
110688957|NCT00384189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110688958|NCT00384189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110688959|NCT00384189|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110688960|NCT00384189|Respiratory System Agents|respiratory system agents|mesh-ancestor
110688961|NCT00384189|Tocolytic Agents|tocolytic agents|mesh-ancestor
110688962|NCT00384189|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110688963|NCT00384189|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110688964|NCT00384189|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110688965|NCT00384189|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110688966|NCT00384189|Adrenergic Agents|adrenergic agents|mesh-ancestor
110688967|NCT00384189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110688968|NCT00384189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110688969|NCT00384189|Glucocorticoids|glucocorticoids|mesh-ancestor
110688970|NCT00384189|Hormones|hormones|mesh-ancestor
110688971|NCT00384189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110688972|NCT00384189|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110688973|NCT00326716|Ritonavir|ritonavir|mesh-list
110688974|NCT00326716|Atazanavir Sulfate|atazanavir sulfate|mesh-list
110856995|NCT01342692|Idarubicin|idarubicin|mesh-list
110688975|NCT00326716|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
110688976|NCT00326716|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110688977|NCT00326716|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110688978|NCT00326716|Protease Inhibitors|protease inhibitors|mesh-ancestor
110688979|NCT00326716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110688980|NCT00326716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110688981|NCT00326716|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110688982|NCT00326716|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110688983|NCT00326716|Antiviral Agents|antiviral agents|mesh-ancestor
110688984|NCT00326716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110688985|NCT00326716|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110688986|NCT00326716|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110688987|NCT00326716|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110688988|NCT00326716|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110688989|NCT01063192|Leucovorin|leucovorin|mesh-list
110688990|NCT01063192|Gemcitabine|gemcitabine|mesh-list
110688991|NCT01063192|Fluorouracil|fluorouracil|mesh-list
110688992|NCT01063192|Oxaliplatin|oxaliplatin|mesh-list
110688993|NCT01063192|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110688994|NCT01063192|Antimetabolites|antimetabolites|mesh-ancestor
110688995|NCT01063192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110688996|NCT01063192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110688997|NCT01063192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110688998|NCT01063192|Immunologic Factors|immunologic factors|mesh-ancestor
110688999|NCT01063192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110689000|NCT01063192|Antidotes|antidotes|mesh-ancestor
110689001|NCT01063192|Protective Agents|protective agents|mesh-ancestor
110689002|NCT01063192|Vitamin B Complex|vitamin b complex|mesh-ancestor
110689003|NCT01063192|Vitamins|vitamins|mesh-ancestor
110689004|NCT01063192|Micronutrients|micronutrients|mesh-ancestor
110689005|NCT01063426|Enoxaparin|enoxaparin|mesh-list
110689006|NCT01063426|Enoxaparin sodium|enoxaparin sodium|mesh-list
110689007|NCT01063426|Atorvastatin|atorvastatin|mesh-list
110689008|NCT01063426|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110689009|NCT01063426|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110689010|NCT01063426|Antimetabolites|antimetabolites|mesh-ancestor
110689011|NCT01063426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110689012|NCT01063426|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110689013|NCT01063426|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110689014|NCT01063426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110689015|NCT01063426|Anticoagulants|anticoagulants|mesh-ancestor
110689016|NCT01063426|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110689017|NCT01063426|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110689018|NCT00548405|Interferons|interferons|mesh-list
110689019|NCT00548405|Interferon-beta|interferon-beta|mesh-list
110689020|NCT00548405|Interferon beta-1a|interferon beta-1a|mesh-list
110689021|NCT00548405|Alemtuzumab|alemtuzumab|mesh-list
110689022|NCT00548405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110689023|NCT00548405|Antiviral Agents|antiviral agents|mesh-ancestor
110689024|NCT00548405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110689025|NCT00548405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110689026|NCT00548405|Immunologic Factors|immunologic factors|mesh-ancestor
110689027|NCT00548405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110689028|NCT00548405|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110689029|NCT04919369|Vitamins|vitamins|mesh-list
110689030|NCT04919369|Vitamin A|vitamin a|mesh-list
110689031|NCT04919369|Atezolizumab|atezolizumab|mesh-list
110689032|NCT04919369|Tretinoin|tretinoin|mesh-list
110689033|NCT04919369|Retinol palmitate|retinol palmitate|mesh-list
110689034|NCT04919369|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110689035|NCT04919369|Micronutrients|micronutrients|mesh-ancestor
110689036|NCT04919369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110689037|NCT04919369|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110689038|NCT04919369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110689039|NCT04919369|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110689040|NCT04919369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110689041|NCT04919369|Immunologic Factors|immunologic factors|mesh-ancestor
110689042|NCT04919369|Keratolytic Agents|keratolytic agents|mesh-ancestor
110689043|NCT04919369|Dermatologic Agents|dermatologic agents|mesh-ancestor
110689044|NCT04919369|Antioxidants|antioxidants|mesh-ancestor
110689045|NCT04919369|Protective Agents|protective agents|mesh-ancestor
110689046|NCT04919369|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110689048|NCT00959075|Vitamins|vitamins|mesh-ancestor
110689049|NCT00959075|Micronutrients|micronutrients|mesh-ancestor
110689050|NCT00959075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110689051|NCT00959075|Vitamin B Complex|vitamin b complex|mesh-ancestor
110689052|NCT00295750|Leuprolide|leuprolide|mesh-list
110689053|NCT00295750|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110689054|NCT00295750|Fertility Agents|fertility agents|mesh-ancestor
110689055|NCT00295750|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110689056|NCT00295750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110689057|NCT00295750|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110689058|NCT00295750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110689059|NCT00959231|Cyclosporine|cyclosporine|mesh-list
110689060|NCT00959231|Mycophenolic Acid|mycophenolic acid|mesh-list
110689061|NCT00959231|Cyclophosphamide|cyclophosphamide|mesh-list
110689062|NCT00959231|Fludarabine|fludarabine|mesh-list
110689063|NCT00959231|Fludarabine phosphate|fludarabine phosphate|mesh-list
110689064|NCT00959231|Cyclosporins|cyclosporins|mesh-list
110689065|NCT00959231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110689066|NCT00959231|Immunologic Factors|immunologic factors|mesh-ancestor
110689067|NCT00959231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110689068|NCT00959231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110689069|NCT00959231|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110689070|NCT00959231|Alkylating Agents|alkylating agents|mesh-ancestor
110689071|NCT00959231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110689072|NCT00959231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110689073|NCT00959231|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110689074|NCT00959231|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110689075|NCT00959231|Antimetabolites|antimetabolites|mesh-ancestor
110689076|NCT00959231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110689077|NCT00959231|Antifungal Agents|antifungal agents|mesh-ancestor
110689078|NCT00959231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110689079|NCT00959231|Dermatologic Agents|dermatologic agents|mesh-ancestor
110689080|NCT00959231|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110689081|NCT00959231|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110689082|NCT00959231|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110689083|NCT00959231|Antitubercular Agents|antitubercular agents|mesh-ancestor
110689084|NCT00959231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110689085|NCT03948581|Vedolizumab|vedolizumab|mesh-list
110689086|NCT03948581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110689087|NCT00548327|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
110689088|NCT00548327|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110689089|NCT00548327|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110689090|NCT00548327|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110689091|NCT00548327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110689092|NCT00548327|Adrenergic Agents|adrenergic agents|mesh-ancestor
110689093|NCT00548327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110689094|NCT00548327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110689095|NCT04720547|Zolpidem|zolpidem|mesh-list
110689096|NCT04720547|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110689097|NCT04720547|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110689098|NCT04720547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110689099|NCT04720547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110689100|NCT04720547|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
110689101|NCT04720547|GABA Agonists|gaba agonists|mesh-ancestor
110689102|NCT04720547|GABA Agents|gaba agents|mesh-ancestor
110689103|NCT04720547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110689104|NCT04720547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110689105|NCT00959387|Paclitaxel|paclitaxel|mesh-list
110689106|NCT00959387|Cisplatin|cisplatin|mesh-list
110689107|NCT00959387|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110689108|NCT00959387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110689109|NCT00959387|Tubulin Modulators|tubulin modulators|mesh-ancestor
110689110|NCT00959387|Antimitotic Agents|antimitotic agents|mesh-ancestor
110689111|NCT00959387|Mitosis Modulators|mitosis modulators|mesh-ancestor
110689112|NCT00959387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110689113|NCT04718285|Favipiravir|favipiravir|mesh-list
110689114|NCT04718285|Montelukast|montelukast|mesh-list
110689115|NCT04718285|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110689116|NCT04718285|Respiratory System Agents|respiratory system agents|mesh-ancestor
110689117|NCT04718285|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110689118|NCT04718285|Hormone Antagonists|hormone antagonists|mesh-ancestor
110689119|NCT04718285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110689120|NCT04718285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110689121|NCT04718285|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110689122|NCT04718285|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110689123|NCT04718285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110689124|NCT04718285|Antiviral Agents|antiviral agents|mesh-ancestor
110689125|NCT04718285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110689126|NCT00959621|Aspirin|aspirin|mesh-list
110689127|NCT00959621|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110689128|NCT00959621|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110689129|NCT00959621|Analgesics|analgesics|mesh-ancestor
110689130|NCT00959621|Sensory System Agents|sensory system agents|mesh-ancestor
110689131|NCT00959621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110689132|NCT00959621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110689133|NCT00959621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110689134|NCT00959621|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110689136|NCT00959621|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110689137|NCT00959621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110689138|NCT00959621|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110689139|NCT00959621|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110689140|NCT00959621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110689141|NCT00959621|Antipyretics|antipyretics|mesh-ancestor
110689142|NCT00959777|Lenograstim|lenograstim|mesh-list
110689143|NCT00959777|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110689144|NCT00959777|Immunologic Factors|immunologic factors|mesh-ancestor
110689145|NCT00959777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110689146|NCT00959933|Ribavirin|ribavirin|mesh-list
110689147|NCT00959933|Antimetabolites|antimetabolites|mesh-ancestor
110689148|NCT00959933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110689149|NCT00959933|Antiviral Agents|antiviral agents|mesh-ancestor
110689150|NCT00959933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110689151|NCT00960245|Nadolol|nadolol|mesh-list
110689152|NCT00960245|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110689153|NCT00960245|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110689154|NCT00960245|Adrenergic Agents|adrenergic agents|mesh-ancestor
110689155|NCT00960245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110689156|NCT00960245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110689157|NCT00960245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110857043|NCT03685188|Dsuvia|dsuvia|mesh-list
110689158|NCT00960245|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110689159|NCT00960245|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110689160|NCT00960245|Sympatholytics|sympatholytics|mesh-ancestor
110689161|NCT00960245|Autonomic Agents|autonomic agents|mesh-ancestor
110689162|NCT00960245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110689163|NCT00406653|Abatacept|abatacept|mesh-list
110689164|NCT00406653|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110689165|NCT00406653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110689166|NCT00406653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110689167|NCT00406653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110689168|NCT00406653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110689169|NCT00406653|Immunologic Factors|immunologic factors|mesh-ancestor
110689170|NCT00406653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110689171|NCT00406653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110689172|NCT00547157|Cisplatin|cisplatin|mesh-list
110689173|NCT00547157|Panitumumab|panitumumab|mesh-list
110689174|NCT00547157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110689175|NCT00547157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110689176|NCT00960479|Ribavirin|ribavirin|mesh-list
110689177|NCT00960479|Antimetabolites|antimetabolites|mesh-ancestor
110689178|NCT00960479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110689179|NCT00960479|Antiviral Agents|antiviral agents|mesh-ancestor
110689180|NCT00960479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110689181|NCT00960557|Combretastatin|combretastatin|mesh-list
110689182|NCT00960557|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110689183|NCT00960557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110689184|NCT00960557|Tubulin Modulators|tubulin modulators|mesh-ancestor
110689185|NCT00960557|Antimitotic Agents|antimitotic agents|mesh-ancestor
110689186|NCT00960557|Mitosis Modulators|mitosis modulators|mesh-ancestor
110689187|NCT00960557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110689188|NCT00960635|Vitamin D|vitamin d|mesh-list
110689189|NCT00960635|Cholecalciferol|cholecalciferol|mesh-list
110689190|NCT00960635|Calcitriol|calcitriol|mesh-list
110689191|NCT00960635|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
110689192|NCT00960635|Vitamins|vitamins|mesh-ancestor
110689193|NCT00960635|Micronutrients|micronutrients|mesh-ancestor
110689194|NCT00960635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110689195|NCT00960635|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110689196|NCT00960635|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110689197|NCT00960635|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
110689198|NCT00960635|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110689199|NCT00960635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110689200|NCT00960635|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110689201|NCT00960713|Rituximab|rituximab|mesh-list
110689202|NCT00960713|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110689203|NCT00960713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110689204|NCT00960713|Immunologic Factors|immunologic factors|mesh-ancestor
110689205|NCT00960713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110689206|NCT00960713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110689207|NCT04009889|Silicon|silicon|mesh-list
110689208|NCT04009889|Trace Elements|trace elements|mesh-ancestor
110689209|NCT04009889|Micronutrients|micronutrients|mesh-ancestor
110689211|NCT00962507|Everolimus|everolimus|mesh-list
110689212|NCT00962507|Panobinostat|panobinostat|mesh-list
110689213|NCT00962507|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110689214|NCT00962507|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110689215|NCT00962507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110689216|NCT00962507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110689217|NCT00962507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110689218|NCT00962507|Immunologic Factors|immunologic factors|mesh-ancestor
110857048|NCT03685188|Analgesics|analgesics|mesh-ancestor
110689219|NCT00962507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110689220|NCT00962507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110689221|NCT00962507|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110689222|NCT00384033|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110689223|NCT00384033|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
110689224|NCT00384033|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110689225|NCT00384033|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110689226|NCT00384033|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110689227|NCT00384033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110689228|NCT00384033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110689229|NCT00384033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110689230|NCT00384033|Analgesics|analgesics|mesh-ancestor
110689231|NCT00384033|Sensory System Agents|sensory system agents|mesh-ancestor
110689232|NCT00384033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110689233|NCT00384033|Antidepressive Agents|antidepressive agents|mesh-ancestor
110689234|NCT00384033|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110689235|NCT00384033|Dopamine Agents|dopamine agents|mesh-ancestor
110689236|NCT00962663|Ibuprofen|ibuprofen|mesh-list
110689237|NCT00962663|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110689238|NCT00962663|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110689239|NCT00962663|Analgesics|analgesics|mesh-ancestor
110689240|NCT00962663|Sensory System Agents|sensory system agents|mesh-ancestor
110689241|NCT00962663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110689242|NCT00962663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110689243|NCT00962663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110689244|NCT00962663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110689245|NCT00962663|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110689246|NCT00962663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110689247|NCT00962663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110689248|NCT00962975|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110689249|NCT00962975|Antiviral Agents|antiviral agents|mesh-ancestor
110689250|NCT00962975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110689251|NCT00075387|Sodium thiosulfate|sodium thiosulfate|mesh-list
110689252|NCT00075387|Cyclophosphamide|cyclophosphamide|mesh-list
110689253|NCT00075387|Carboplatin|carboplatin|mesh-list
110689254|NCT00075387|Etoposide|etoposide|mesh-list
110689255|NCT00075387|Etoposide phosphate|etoposide phosphate|mesh-list
110689256|NCT00075387|Antidotes|antidotes|mesh-list
110689257|NCT00075387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110689258|NCT00075387|Immunologic Factors|immunologic factors|mesh-ancestor
110689259|NCT00075387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110689260|NCT00075387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110689261|NCT00075387|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110689262|NCT00075387|Alkylating Agents|alkylating agents|mesh-ancestor
110689263|NCT00075387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110689264|NCT00075387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110689265|NCT00075387|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110689266|NCT00075387|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110689267|NCT00075387|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110689268|NCT00075387|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110689269|NCT00075387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110689270|NCT00075387|Protective Agents|protective agents|mesh-ancestor
110689271|NCT00075387|Antioxidants|antioxidants|mesh-ancestor
110689272|NCT00075387|Antitubercular Agents|antitubercular agents|mesh-ancestor
110689273|NCT00075387|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110689274|NCT00075387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110689275|NCT00075387|Chelating Agents|chelating agents|mesh-ancestor
110689276|NCT00075387|Sequestering Agents|sequestering agents|mesh-ancestor
110689277|NCT00963131|Antioxidants|antioxidants|mesh-list
110689278|NCT00963131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110689279|NCT00963131|Protective Agents|protective agents|mesh-ancestor
110857065|NCT05251584|Gentamicins|gentamicins|mesh-list
110689280|NCT00963131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110689281|NCT00963209|Tamoxifen|tamoxifen|mesh-list
110689282|NCT00963209|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110689283|NCT00963209|Hormone Antagonists|hormone antagonists|mesh-ancestor
110689284|NCT00963209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110689285|NCT00963209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110689286|NCT00963209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110689287|NCT00963209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110689288|NCT00963209|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110689289|NCT00963209|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110689290|NCT00963209|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110689292|NCT00963443|Pseudoephedrine|pseudoephedrine|mesh-list
110689293|NCT00963443|Ephedrine|ephedrine|mesh-list
110689294|NCT00963443|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110689295|NCT00963443|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110689296|NCT00963443|Analgesics|analgesics|mesh-ancestor
110689297|NCT00963443|Sensory System Agents|sensory system agents|mesh-ancestor
110689298|NCT00963443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110689299|NCT00963443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110657096|NCT05882812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110689300|NCT00963443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110689301|NCT00963443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110689302|NCT00963443|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110689303|NCT00963443|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110689304|NCT00963443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110689305|NCT00963443|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110689306|NCT00963443|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110689307|NCT00963443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110689308|NCT00963443|Antipyretics|antipyretics|mesh-ancestor
110689309|NCT00963443|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110689310|NCT00963443|Autonomic Agents|autonomic agents|mesh-ancestor
110689311|NCT00963443|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110689312|NCT00963443|Respiratory System Agents|respiratory system agents|mesh-ancestor
110689313|NCT00963443|Nasal Decongestants|nasal decongestants|mesh-ancestor
110689314|NCT00963443|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110689315|NCT00963443|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110689316|NCT00963443|Sympathomimetics|sympathomimetics|mesh-ancestor
110689317|NCT00963443|Adrenergic Agents|adrenergic agents|mesh-ancestor
110689318|NCT00963443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110689319|NCT00963833|Interferons|interferons|mesh-list
110689320|NCT00963833|Interferon-beta|interferon-beta|mesh-list
110689321|NCT00963833|Interferon beta-1b|interferon beta-1b|mesh-list
110689322|NCT00963833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110689323|NCT00963833|Antiviral Agents|antiviral agents|mesh-ancestor
110689324|NCT00963833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110689325|NCT00963833|Immunologic Factors|immunologic factors|mesh-ancestor
110689326|NCT00963833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110689327|NCT00963833|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110689328|NCT00967655|Capecitabine|capecitabine|mesh-list
110689329|NCT00967655|Irinotecan|irinotecan|mesh-list
110689330|NCT00967655|Panitumumab|panitumumab|mesh-list
110689331|NCT00967655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110689332|NCT00967655|Antimetabolites|antimetabolites|mesh-ancestor
110319362|NCT00328367|Dopamine Agonists|dopamine agonists|mesh-ancestor
110689333|NCT00967655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110689334|NCT00967655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110689335|NCT00967655|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110689336|NCT00967655|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110689337|NCT00967655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110689338|NCT00967655|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110689339|NCT00546377|Cyclophosphamide|cyclophosphamide|mesh-list
110689340|NCT00546377|Rituximab|rituximab|mesh-list
110689341|NCT00546377|Mitoxantrone|mitoxantrone|mesh-list
110689342|NCT00546377|Pentostatin|pentostatin|mesh-list
110689343|NCT00546377|Sargramostim|sargramostim|mesh-list
110689344|NCT00546377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110689345|NCT00546377|Immunologic Factors|immunologic factors|mesh-ancestor
110689346|NCT00546377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110689347|NCT00546377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110689348|NCT00546377|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110689349|NCT00546377|Alkylating Agents|alkylating agents|mesh-ancestor
110689350|NCT00546377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110689351|NCT00546377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110689352|NCT00546377|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110689353|NCT00546377|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110689354|NCT00546377|Analgesics|analgesics|mesh-ancestor
110689355|NCT00546377|Sensory System Agents|sensory system agents|mesh-ancestor
110689356|NCT00546377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110689357|NCT00546377|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110407229|NCT00978757|Ketamine|ketamine|mesh-list
110689358|NCT00546377|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110689359|NCT00546377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110689360|NCT00546377|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
110689361|NCT00967967|Mometasone Furoate|mometasone furoate|mesh-list
110689362|NCT00967967|Desloratadine|desloratadine|mesh-list
110689363|NCT00967967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110689364|NCT00967967|Dermatologic Agents|dermatologic agents|mesh-ancestor
110689365|NCT00967967|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110689366|NCT00967967|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110689367|NCT00967967|Cholinergic Agents|cholinergic agents|mesh-ancestor
110689368|NCT00967967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110689369|NCT00967967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110689370|NCT00967967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110689371|NCT00967967|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110689372|NCT00967967|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110689373|NCT00967967|Histamine Antagonists|histamine antagonists|mesh-ancestor
110689374|NCT00967967|Histamine Agents|histamine agents|mesh-ancestor
110689375|NCT00964457|Cetuximab|cetuximab|mesh-list
110689376|NCT00964457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110689377|NCT00964457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110689378|NCT00964535|Budesonide|budesonide|mesh-list
110689379|NCT00964535|Formoterol Fumarate|formoterol fumarate|mesh-list
110689380|NCT00964535|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
110689381|NCT00964535|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110689382|NCT00964535|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110689383|NCT00964535|Autonomic Agents|autonomic agents|mesh-ancestor
110689384|NCT00964535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110689385|NCT00964535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110689386|NCT00964535|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110689387|NCT00964535|Respiratory System Agents|respiratory system agents|mesh-ancestor
110689388|NCT00964535|Glucocorticoids|glucocorticoids|mesh-ancestor
110689389|NCT00964535|Hormones|hormones|mesh-ancestor
110689390|NCT00964535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110689391|NCT00964535|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110689392|NCT00964535|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110689393|NCT00964535|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110689394|NCT00964535|Adrenergic Agents|adrenergic agents|mesh-ancestor
110689395|NCT00964535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110689396|NCT00964535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110689397|NCT00964691|Chloroquine|chloroquine|mesh-list
110689398|NCT00964691|Pyrimethamine|pyrimethamine|mesh-list
110689399|NCT00964691|Sulfadoxine|sulfadoxine|mesh-list
110689400|NCT00964691|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
110689401|NCT00964691|Amebicides|amebicides|mesh-ancestor
110689402|NCT00964691|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110689403|NCT00964691|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110689404|NCT00964691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110689405|NCT00964691|Antimalarials|antimalarials|mesh-ancestor
110689406|NCT00964691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110689407|NCT00964691|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110689408|NCT00964691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110689409|NCT00964691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110689410|NCT00964691|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110689411|NCT00964769|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110689412|NCT00964769|Immunologic Factors|immunologic factors|mesh-ancestor
110689413|NCT00964769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110689414|NCT00968435|Bevacizumab|bevacizumab|mesh-list
110689415|NCT00968435|Cetuximab|cetuximab|mesh-list
110689416|NCT00968435|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110689417|NCT00968435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110689418|NCT00968435|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110689419|NCT00968435|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110689420|NCT00968435|Growth Substances|growth substances|mesh-ancestor
110689421|NCT00968435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110689422|NCT00968435|Growth Inhibitors|growth inhibitors|mesh-ancestor
110689423|NCT05253287|Hormones|hormones|mesh-list
110689424|NCT05253287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110689425|NCT05253287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110689426|NCT00968591|Everolimus|everolimus|mesh-list
110689427|NCT00968591|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110689428|NCT00968591|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110689429|NCT00968591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110689430|NCT00968591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110407298|NCT00628810|Bevacizumab|bevacizumab|mesh-list
110689431|NCT00968591|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110689432|NCT00968591|Immunologic Factors|immunologic factors|mesh-ancestor
110689433|NCT00968591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110689434|NCT00968591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110689435|NCT00968903|Methylprednisolone|methylprednisolone|mesh-list
110689436|NCT00968903|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110689437|NCT00968903|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110689438|NCT00968903|Prednisolone|prednisolone|mesh-list
110689439|NCT00968903|Prednisolone acetate|prednisolone acetate|mesh-list
110689440|NCT00968903|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110689441|NCT00968903|Prednisolone phosphate|prednisolone phosphate|mesh-list
110689442|NCT00968903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110689443|NCT00968903|Antiemetics|antiemetics|mesh-ancestor
110689444|NCT00968903|Autonomic Agents|autonomic agents|mesh-ancestor
110689445|NCT00968903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110689446|NCT00968903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110689447|NCT00968903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110689448|NCT00968903|Glucocorticoids|glucocorticoids|mesh-ancestor
110689449|NCT00968903|Hormones|hormones|mesh-ancestor
110689450|NCT00968903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110689451|NCT00968903|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110689452|NCT00968903|Protective Agents|protective agents|mesh-ancestor
110689453|NCT00968903|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110689454|NCT00968903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110689455|NCT00969137|Nicotine|nicotine|mesh-list
110689456|NCT00969137|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110689457|NCT00969137|Autonomic Agents|autonomic agents|mesh-ancestor
110689458|NCT00969137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110689459|NCT00969137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110689460|NCT00969137|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110689461|NCT00969137|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110689462|NCT00969137|Cholinergic Agents|cholinergic agents|mesh-ancestor
110689463|NCT00969137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110689464|NCT00969137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110689465|NCT00965315|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110689466|NCT00965315|Fenofibrate|fenofibrate|mesh-list
110689467|NCT00965315|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110689468|NCT00965315|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110689469|NCT00965315|Antimetabolites|antimetabolites|mesh-ancestor
110689470|NCT00965315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110689471|NCT00965315|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110689472|NCT00965315|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110689473|NCT00965315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110689474|NCT00969293|Ecallantide|ecallantide|mesh-list
110689475|NCT00969293|Analgesics|analgesics|mesh-ancestor
110689476|NCT00969293|Sensory System Agents|sensory system agents|mesh-ancestor
110689477|NCT00969293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110689478|NCT00969293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110689479|NCT00969293|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110689480|NCT00969293|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110689481|NCT00969293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110689482|NCT00969293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110689483|NCT00969449|Naproxen|naproxen|mesh-list
110689484|NCT00969449|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110689485|NCT00969449|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110689486|NCT00969449|Analgesics|analgesics|mesh-ancestor
110689487|NCT00969449|Sensory System Agents|sensory system agents|mesh-ancestor
110689488|NCT00969449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110689489|NCT00969449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110689490|NCT00969449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110689491|NCT00969449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110689492|NCT00969449|Gout Suppressants|gout suppressants|mesh-ancestor
110689493|NCT00969449|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110689494|NCT00969449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110689495|NCT00969449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110689496|NCT00965393|Bradykinin|bradykinin|mesh-list
110689497|NCT00965393|Kininogens|kininogens|mesh-list
110689498|NCT00965393|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-list
110689499|NCT00965393|Vasodilator Agents|vasodilator agents|mesh-ancestor
110689500|NCT00965393|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
110689501|NCT00965393|Protease Inhibitors|protease inhibitors|mesh-ancestor
110689502|NCT00965393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110689503|NCT00965393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110689504|NCT00965549|Insulin|insulin|mesh-list
110689505|NCT00965549|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110689506|NCT00965549|Insulin Glargine|insulin glargine|mesh-list
110689507|NCT00965549|Insulin Aspart|insulin aspart|mesh-list
110689508|NCT00965549|Insulin glulisine|insulin glulisine|mesh-list
110657109|NCT05874245|Analgesics|analgesics|mesh-ancestor
110689509|NCT00965549|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110689510|NCT00965549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110689511|NCT00966251|Pidilizumab|pidilizumab|mesh-list
110689512|NCT00966251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110689513|NCT00966251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110689514|NCT00966329|Maraviroc|maraviroc|mesh-list
110689515|NCT00966329|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110689516|NCT00966329|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110689517|NCT00966329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110689518|NCT00966329|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110689519|NCT00966329|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110689520|NCT00966329|Antiviral Agents|antiviral agents|mesh-ancestor
110689521|NCT00966329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110689522|NCT00966329|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
110689523|NCT00970697|Becaplermin|becaplermin|mesh-list
110689524|NCT00970697|Anticoagulants|anticoagulants|mesh-ancestor
110689525|NCT00970697|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
110689526|NCT00970697|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110689527|NCT00970697|Growth Substances|growth substances|mesh-ancestor
110689528|NCT00970697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110689529|NCT00967031|Capecitabine|capecitabine|mesh-list
110689530|NCT00967031|Lapatinib|lapatinib|mesh-list
110689531|NCT00967031|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110689532|NCT00967031|Antimetabolites|antimetabolites|mesh-ancestor
110689533|NCT00967031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110689534|NCT00967031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110689535|NCT00967031|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110689536|NCT00967031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110689537|NCT00967109|Chrysarobin|chrysarobin|mesh-list
110689538|NCT00967109|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110689539|NCT00967109|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110689540|NCT00967109|Analgesics|analgesics|mesh-ancestor
110689541|NCT00967109|Sensory System Agents|sensory system agents|mesh-ancestor
110689542|NCT00967109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110689543|NCT00967109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110689544|NCT00967109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110689545|NCT00967109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110689546|NCT00545753|Permethrin|permethrin|mesh-list
110689547|NCT00545753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110689548|NCT00545753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110689549|NCT00970931|Chlorthalidone|chlorthalidone|mesh-list
110689551|NCT00970931|Diuretics|diuretics|mesh-list
110689552|NCT00970931|Natriuretic Agents|natriuretic agents|mesh-ancestor
110689553|NCT00970931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110689554|NCT00970931|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110689555|NCT00970931|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110689556|NCT00970931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110689557|NCT00970931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110689558|NCT00970931|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
110689559|NCT00970931|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110689560|NCT00970931|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
110689561|NCT00970931|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110689562|NCT00406419|Methotrexate|methotrexate|mesh-list
110689563|NCT00406419|Ocrelizumab|ocrelizumab|mesh-list
110689564|NCT00406419|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110689565|NCT00406419|Abortifacient Agents|abortifacient agents|mesh-ancestor
110689566|NCT00406419|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110689567|NCT00406419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110689568|NCT00406419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110689569|NCT00406419|Antimetabolites|antimetabolites|mesh-ancestor
110689570|NCT00406419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110689571|NCT00406419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110689572|NCT00406419|Dermatologic Agents|dermatologic agents|mesh-ancestor
110689573|NCT00406419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110689574|NCT00406419|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110689575|NCT00406419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110689576|NCT00406419|Immunologic Factors|immunologic factors|mesh-ancestor
110689577|NCT00406419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110689578|NCT00406419|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110689579|NCT00967421|Ethanol|ethanol|mesh-list
110689580|NCT00967421|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110689581|NCT00967421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110689582|NCT00967421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110689583|NCT00967421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110689584|NCT00971165|Losartan|losartan|mesh-list
110689585|NCT00971165|Chlorthalidone|chlorthalidone|mesh-list
110689586|NCT00971165|Amiloride|amiloride|mesh-list
110689587|NCT00971165|Diuretics|diuretics|mesh-list
110689588|NCT00971165|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110689589|NCT00971165|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110689590|NCT00971165|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110689591|NCT00971165|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110689592|NCT00971165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110689593|NCT00971165|Natriuretic Agents|natriuretic agents|mesh-ancestor
110689594|NCT00971165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110689595|NCT00971165|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110689596|NCT00971165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110689597|NCT00971165|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
110689598|NCT00971165|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110689599|NCT00971165|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
110689600|NCT00971165|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110689601|NCT00971399|Ondansetron|ondansetron|mesh-list
110689602|NCT00971399|Ramosetron|ramosetron|mesh-list
110689603|NCT00971399|Antiemetics|antiemetics|mesh-ancestor
110689604|NCT00971399|Autonomic Agents|autonomic agents|mesh-ancestor
110689605|NCT00971399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110689606|NCT00971399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110689607|NCT00971399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110689608|NCT00971399|Antipruritics|antipruritics|mesh-ancestor
110689609|NCT00971399|Dermatologic Agents|dermatologic agents|mesh-ancestor
110689610|NCT00971399|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110689611|NCT00971399|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110689612|NCT00971399|Serotonin Agents|serotonin agents|mesh-ancestor
110689613|NCT00971399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110689614|NCT00971399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110689615|NCT00973505|Anastrozole|anastrozole|mesh-list
110689616|NCT00973505|Aromatase Inhibitors|aromatase inhibitors|mesh-list
110689617|NCT00973505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110689618|NCT00973505|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110689619|NCT00973505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110689620|NCT00973505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110689621|NCT00973505|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110689622|NCT00973505|Hormone Antagonists|hormone antagonists|mesh-ancestor
110689623|NCT00973505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110689624|NCT00973505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110689625|NCT00973505|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110689626|NCT00973583|Vitamin D|vitamin d|mesh-list
110689627|NCT00973583|Vitamins|vitamins|mesh-ancestor
110689628|NCT00973583|Micronutrients|micronutrients|mesh-ancestor
110689629|NCT00973583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110689630|NCT00973583|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110689631|NCT00972101|Mycophenolic Acid|mycophenolic acid|mesh-list
110689632|NCT00972101|Rituximab|rituximab|mesh-list
110689633|NCT00972101|Fludarabine|fludarabine|mesh-list
110689634|NCT00972101|Fludarabine phosphate|fludarabine phosphate|mesh-list
110689635|NCT00972101|Etoposide|etoposide|mesh-list
110689636|NCT00972101|Melphalan|melphalan|mesh-list
110689637|NCT00972101|Thiotepa|thiotepa|mesh-list
110689638|NCT00972101|Tacrolimus|tacrolimus|mesh-list
110689639|NCT00972101|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110689640|NCT00972101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110689641|NCT00972101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110689642|NCT00972101|Immunologic Factors|immunologic factors|mesh-ancestor
110689643|NCT00972101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110689644|NCT00972101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110689645|NCT00972101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110689647|NCT00972101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110689648|NCT00972101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110689649|NCT00972101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110689650|NCT00972101|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110689651|NCT00972101|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110689652|NCT00972101|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110689653|NCT00972101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110689654|NCT00972101|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110689655|NCT00972101|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110689656|NCT00972101|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110689657|NCT00972101|Antitubercular Agents|antitubercular agents|mesh-ancestor
110689658|NCT00972101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110689659|NCT00972101|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110689660|NCT00972101|Alkylating Agents|alkylating agents|mesh-ancestor
110689661|NCT00972101|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110689663|NCT00325468|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110689664|NCT00325468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110689665|NCT00972257|Timolol|timolol|mesh-list
110689666|NCT00972257|Brimonidine Tartrate|brimonidine tartrate|mesh-list
110689667|NCT00972257|Dorzolamide|dorzolamide|mesh-list
110689668|NCT00972257|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110689669|NCT00972257|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110689670|NCT00972257|Adrenergic Agents|adrenergic agents|mesh-ancestor
110689671|NCT00972257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110689672|NCT00972257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110689673|NCT00972257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110689674|NCT00972257|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110689675|NCT00972257|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110689676|NCT00972257|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110689677|NCT00972257|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110689678|NCT00972257|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110689679|NCT00972257|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110689680|NCT00972257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110689681|NCT00311584|Irinotecan|irinotecan|mesh-list
110689682|NCT00311584|Temozolomide|temozolomide|mesh-list
110689683|NCT00311584|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110857242|NCT03302650|Giapreza|giapreza|mesh-list
110689684|NCT00311584|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110689686|NCT00311584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110689687|NCT00311584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110689688|NCT00311584|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110689689|NCT00311584|Alkylating Agents|alkylating agents|mesh-ancestor
110689690|NCT00383331|Gemcitabine|gemcitabine|mesh-list
110689691|NCT00383331|Pemetrexed|pemetrexed|mesh-list
110689692|NCT00383331|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110689693|NCT00383331|Antimetabolites|antimetabolites|mesh-ancestor
110689694|NCT00383331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110689695|NCT00383331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110689696|NCT00383331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110689697|NCT00383331|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110689698|NCT00383331|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110689699|NCT03934541|Vaccines|vaccines|mesh-list
110689700|NCT03934541|Immunologic Factors|immunologic factors|mesh-ancestor
110689701|NCT03934541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110689702|NCT00325234|Carboplatin|carboplatin|mesh-list
110689703|NCT00325234|Gemcitabine|gemcitabine|mesh-list
110689704|NCT00325234|Pemetrexed|pemetrexed|mesh-list
110689705|NCT00325234|Vinorelbine|vinorelbine|mesh-list
110689706|NCT00325234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110689707|NCT00325234|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110689708|NCT00325234|Antimetabolites|antimetabolites|mesh-ancestor
110689709|NCT00325234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110689710|NCT00325234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110689711|NCT00325234|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110689712|NCT00325234|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110689713|NCT00325234|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110689714|NCT00325234|Tubulin Modulators|tubulin modulators|mesh-ancestor
110689715|NCT00325234|Antimitotic Agents|antimitotic agents|mesh-ancestor
110689716|NCT00325234|Mitosis Modulators|mitosis modulators|mesh-ancestor
110689717|NCT01063504|Teriparatide|teriparatide|mesh-list
110689718|NCT01063504|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110689719|NCT01063504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110689720|NCT01063504|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110689721|NCT00366249|Ertapenem|ertapenem|mesh-list
110689722|NCT00366249|Tigecycline|tigecycline|mesh-list
110689723|NCT00366249|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110689724|NCT00366249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110689725|NCT00366249|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110689726|NCT00366249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110689727|NCT00366249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110689728|NCT03927911|Bupivacaine|bupivacaine|mesh-list
110689729|NCT03927911|Anesthetics, Local|anesthetics, local|mesh-ancestor
110689730|NCT03927911|Anesthetics|anesthetics|mesh-ancestor
110689731|NCT03927911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110689732|NCT03927911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110689733|NCT03927911|Sensory System Agents|sensory system agents|mesh-ancestor
110689734|NCT03927911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110689735|NCT00383019|Latanoprost|latanoprost|mesh-list
110689736|NCT00383019|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110689737|NCT00383019|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110689739|NCT00310804|Immunologic Factors|immunologic factors|mesh-ancestor
110689740|NCT00310804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110689741|NCT00590187|Sapacitabine|sapacitabine|mesh-list
110689742|NCT00590187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110689743|NCT03978364|Azacitidine|azacitidine|mesh-list
110689744|NCT03978364|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110689745|NCT03978364|Antimetabolites|antimetabolites|mesh-ancestor
110689746|NCT03978364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110689747|NCT03978364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110857273|NCT03306940|Botulinum Toxins|botulinum toxins|mesh-list
110689748|NCT03978364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110689749|NCT01046487|Cyclophosphamide|cyclophosphamide|mesh-list
110689750|NCT01046487|Imatinib Mesylate|imatinib mesylate|mesh-list
110689751|NCT01046487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110689752|NCT01046487|Immunologic Factors|immunologic factors|mesh-ancestor
110689753|NCT01046487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110689754|NCT01046487|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110689755|NCT01046487|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110689756|NCT01046487|Alkylating Agents|alkylating agents|mesh-ancestor
110689757|NCT01046487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110689758|NCT01046487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110689759|NCT01046487|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110689760|NCT01046487|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110689761|NCT01046487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110689762|NCT03978286|Vortioxetine|vortioxetine|mesh-list
110689763|NCT03978286|Sertraline|sertraline|mesh-list
110689764|NCT03978286|Antidepressive Agents|antidepressive agents|mesh-ancestor
110689765|NCT03978286|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110689766|NCT03978286|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110689767|NCT03978286|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110689768|NCT03978286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110689769|NCT03978286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110689770|NCT03978286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110689771|NCT03978286|Serotonin Agents|serotonin agents|mesh-ancestor
110689772|NCT03978286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110689773|NCT03978286|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110689774|NCT03978286|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110689775|NCT03978286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110689776|NCT03978286|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110689777|NCT03978286|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110689778|NCT03978286|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110689779|NCT03978286|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110689780|NCT03933449|Paclitaxel|paclitaxel|mesh-list
110689781|NCT03933449|Docetaxel|docetaxel|mesh-list
110689782|NCT03933449|Pembrolizumab|pembrolizumab|mesh-list
110689783|NCT03933449|Irinotecan|irinotecan|mesh-list
110689784|NCT03933449|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110689785|NCT03933449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110689786|NCT03933449|Tubulin Modulators|tubulin modulators|mesh-ancestor
110689787|NCT03933449|Antimitotic Agents|antimitotic agents|mesh-ancestor
110689788|NCT03933449|Mitosis Modulators|mitosis modulators|mesh-ancestor
110689789|NCT03933449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110689790|NCT03933449|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110689791|NCT03933449|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110689792|NCT03933449|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110689793|NCT03933449|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110689794|NCT03933449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110689795|NCT00974441|Valproic Acid|valproic acid|mesh-list
110689796|NCT00974441|Anticonvulsants|anticonvulsants|mesh-ancestor
110689797|NCT00974441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110689798|NCT00974441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110689800|NCT00974441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110689801|NCT00974441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110689802|NCT00974441|Antimanic Agents|antimanic agents|mesh-ancestor
110689803|NCT00974441|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110689804|NCT00974441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110689806|NCT01049451|Methylprednisolone|methylprednisolone|mesh-list
110689807|NCT01049451|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110689808|NCT01049451|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110689809|NCT01049451|Prednisolone|prednisolone|mesh-list
110689810|NCT01049451|Prednisolone acetate|prednisolone acetate|mesh-list
110689811|NCT01049451|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110689812|NCT01049451|Prednisolone phosphate|prednisolone phosphate|mesh-list
110689813|NCT01049451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110689814|NCT01049451|Antiemetics|antiemetics|mesh-ancestor
110689815|NCT01049451|Autonomic Agents|autonomic agents|mesh-ancestor
110689816|NCT01049451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110689817|NCT01049451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110689818|NCT01049451|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110689819|NCT01049451|Glucocorticoids|glucocorticoids|mesh-ancestor
110689820|NCT01049451|Hormones|hormones|mesh-ancestor
110689821|NCT01049451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110689822|NCT01049451|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110689823|NCT01049451|Protective Agents|protective agents|mesh-ancestor
110689824|NCT01049451|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110689825|NCT01049451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110689826|NCT00972569|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
110689827|NCT00972569|Natriuretic Agents|natriuretic agents|mesh-ancestor
110689828|NCT00972569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110689829|NCT00974753|Ketorolac|ketorolac|mesh-list
110689830|NCT00974753|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
110689831|NCT00974753|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110689832|NCT00974753|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110689833|NCT00974753|Analgesics|analgesics|mesh-ancestor
110689834|NCT00974753|Sensory System Agents|sensory system agents|mesh-ancestor
110689835|NCT00974753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110689836|NCT00974753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110689837|NCT00974753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110689838|NCT00974753|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110689839|NCT00974753|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110689840|NCT00974753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110689841|NCT00974753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110689842|NCT00972803|Chlorhexidine|chlorhexidine|mesh-list
110689843|NCT00972803|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110408452|NCT05688332|Metformin|metformin|mesh-list
110689844|NCT00972803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110689845|NCT00972803|Disinfectants|disinfectants|mesh-ancestor
110689847|NCT02908269|Immunologic Factors|immunologic factors|mesh-ancestor
110689848|NCT02908269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110689849|NCT00974987|Temozolomide|temozolomide|mesh-list
110689850|NCT00974987|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110689851|NCT00974987|Alkylating Agents|alkylating agents|mesh-ancestor
110689852|NCT00974987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110689853|NCT00974987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110689854|NCT00975065|Metformin|metformin|mesh-list
110689855|NCT00975065|Vildagliptin|vildagliptin|mesh-list
110689856|NCT00975065|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110689857|NCT00975065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110689858|NCT00975065|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110689859|NCT00975065|Protease Inhibitors|protease inhibitors|mesh-ancestor
110689860|NCT00975065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110689861|NCT00975065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110689862|NCT00972881|Capecitabine|capecitabine|mesh-list
110689863|NCT00972881|Irinotecan|irinotecan|mesh-list
110689864|NCT00972881|Cetuximab|cetuximab|mesh-list
110689865|NCT00972881|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110689866|NCT00972881|Antimetabolites|antimetabolites|mesh-ancestor
110689867|NCT00972881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110689868|NCT00972881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110689869|NCT00972881|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110689870|NCT00972881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110689871|NCT00972881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110689872|NCT00972881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110689873|NCT00290758|Genistein|genistein|mesh-list
110689874|NCT00290758|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110689875|NCT00290758|Protective Agents|protective agents|mesh-ancestor
110689876|NCT00290758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110689877|NCT00290758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110689878|NCT00290758|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110689879|NCT00290758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110689880|NCT00290758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110689881|NCT00290758|Phytoestrogens|phytoestrogens|mesh-ancestor
110689882|NCT00290758|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
110689883|NCT00290758|Estrogens|estrogens|mesh-ancestor
110689884|NCT00290758|Hormones|hormones|mesh-ancestor
110689885|NCT00290758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110689886|NCT00975299|Bombesin|bombesin|mesh-list
110689887|NCT00975299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110689888|NCT00975299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110689889|NCT00975299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110689890|NCT01060930|Epinephrine|epinephrine|mesh-list
110689891|NCT01060930|Norepinephrine|norepinephrine|mesh-list
110689892|NCT01060930|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
110689893|NCT01060930|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110689894|NCT01060930|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110689895|NCT01060930|Adrenergic Agents|adrenergic agents|mesh-ancestor
110689896|NCT01060930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110689897|NCT01060930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110689898|NCT01060930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110689899|NCT01060930|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110689900|NCT01060930|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110689901|NCT01060930|Autonomic Agents|autonomic agents|mesh-ancestor
110689902|NCT01060930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110689903|NCT01060930|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110689904|NCT01060930|Respiratory System Agents|respiratory system agents|mesh-ancestor
110689905|NCT01060930|Mydriatics|mydriatics|mesh-ancestor
110689906|NCT01060930|Sympathomimetics|sympathomimetics|mesh-ancestor
110689907|NCT01060930|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110689908|NCT01060930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110689909|NCT00973037|Tamoxifen|tamoxifen|mesh-list
110689910|NCT00973037|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110689911|NCT00973037|Hormone Antagonists|hormone antagonists|mesh-ancestor
110689912|NCT00973037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110689913|NCT00973037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110689914|NCT00973037|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110689915|NCT00973037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110689916|NCT00973037|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110689917|NCT00973037|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110689918|NCT00973037|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110689919|NCT00973115|Simvastatin|simvastatin|mesh-list
110689920|NCT00973115|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110689921|NCT00973115|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110689922|NCT00973115|Antimetabolites|antimetabolites|mesh-ancestor
110689923|NCT00973115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110689924|NCT00973115|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110689925|NCT00973115|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110689926|NCT00973115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110689927|NCT00973193|Panitumumab|panitumumab|mesh-list
110689928|NCT00973193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110689929|NCT00973193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110689930|NCT00975533|Insulin|insulin|mesh-list
110689931|NCT00975533|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110689932|NCT00975533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110689933|NCT00372567|Sunitinib|sunitinib|mesh-list
110689934|NCT00372567|Imatinib Mesylate|imatinib mesylate|mesh-list
110689935|NCT00372567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110689936|NCT00372567|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110689937|NCT00372567|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110689938|NCT00372567|Growth Substances|growth substances|mesh-ancestor
110689939|NCT00372567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110689940|NCT00372567|Growth Inhibitors|growth inhibitors|mesh-ancestor
110689941|NCT00372567|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110689942|NCT00372567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110689943|NCT00372567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110689944|NCT00973271|Atorvastatin|atorvastatin|mesh-list
110689945|NCT00973271|Fenofibric acid|fenofibric acid|mesh-list
110689946|NCT00973271|Fenofibrate|fenofibrate|mesh-list
110689947|NCT00973271|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110689948|NCT00973271|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110689949|NCT00973271|Antimetabolites|antimetabolites|mesh-ancestor
110689950|NCT00973271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110689951|NCT00973271|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110689952|NCT00973271|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110689953|NCT00973271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110689954|NCT00975767|Docetaxel|docetaxel|mesh-list
110689955|NCT00975767|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110689956|NCT00975767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110689957|NCT00975767|Tubulin Modulators|tubulin modulators|mesh-ancestor
110689958|NCT00975767|Antimitotic Agents|antimitotic agents|mesh-ancestor
110689959|NCT00975767|Mitosis Modulators|mitosis modulators|mesh-ancestor
110689960|NCT00975767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110689961|NCT00975767|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110689962|NCT00975767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110689963|NCT00365547|Bevacizumab|bevacizumab|mesh-list
110689964|NCT00365547|Topotecan|topotecan|mesh-list
110689965|NCT00365547|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110689966|NCT00365547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110689968|NCT00365547|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110689969|NCT00365547|Growth Substances|growth substances|mesh-ancestor
110689970|NCT00365547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110689971|NCT00365547|Growth Inhibitors|growth inhibitors|mesh-ancestor
110689972|NCT00365547|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110689973|NCT00365547|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110689974|NCT00365547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110689975|NCT00365547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110689976|NCT00979589|Aspirin|aspirin|mesh-list
110689977|NCT00979589|Clopidogrel|clopidogrel|mesh-list
110689978|NCT00979589|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110689979|NCT00979589|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110689980|NCT00979589|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110689981|NCT00979589|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110689982|NCT00979589|Purinergic Agents|purinergic agents|mesh-ancestor
110689983|NCT00979589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110689984|NCT00979589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110689985|NCT00979589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110689986|NCT00979589|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110689987|NCT00979589|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110689989|NCT00979589|Sensory System Agents|sensory system agents|mesh-ancestor
110689990|NCT00979589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110689991|NCT00979589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110689992|NCT00979589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110689993|NCT00979589|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110689994|NCT00979589|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110689995|NCT00979589|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110689996|NCT00979589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110689997|NCT00979589|Antipyretics|antipyretics|mesh-ancestor
110689998|NCT00294658|Prednisone|prednisone|mesh-list
110689999|NCT00294658|Prednisolone|prednisolone|mesh-list
110690000|NCT00294658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110690001|NCT00294658|Glucocorticoids|glucocorticoids|mesh-ancestor
110690002|NCT00294658|Hormones|hormones|mesh-ancestor
110690003|NCT00294658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110690004|NCT00294658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110690005|NCT00294658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110690006|NCT00294658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110690007|NCT00979667|Oseltamivir|oseltamivir|mesh-list
110690008|NCT00979667|Zanamivir|zanamivir|mesh-list
110690009|NCT00979667|Antiviral Agents|antiviral agents|mesh-ancestor
110690010|NCT00979667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110690011|NCT00979667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110690012|NCT00979667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110690013|NCT03978052|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
110690014|NCT03978052|Antioxidants|antioxidants|mesh-ancestor
110690015|NCT03978052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110690016|NCT03978052|Protective Agents|protective agents|mesh-ancestor
110690017|NCT03978052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110690018|NCT03978052|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
110690019|NCT03978052|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110690020|NCT03978052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110690021|NCT03978052|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110690022|NCT03923933|Chlorthalidone|chlorthalidone|mesh-list
110690023|NCT03923933|Bumetanide|bumetanide|mesh-list
110690024|NCT03923933|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110690025|NCT03923933|Diuretics|diuretics|mesh-ancestor
110690026|NCT03923933|Natriuretic Agents|natriuretic agents|mesh-ancestor
110690027|NCT03923933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110690028|NCT03923933|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110690029|NCT03923933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110690030|NCT03923933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110690031|NCT03923933|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110690032|NCT01066468|Imatinib Mesylate|imatinib mesylate|mesh-list
110690033|NCT01066468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110690034|NCT01066468|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110690035|NCT01066468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110690036|NCT01066468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110690037|NCT00980135|Hydrocortisone|hydrocortisone|mesh-list
110690038|NCT00980135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110690039|NCT00980213|Sunitinib|sunitinib|mesh-list
110690040|NCT00980213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110690041|NCT00980213|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110690042|NCT00980213|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110690043|NCT00980213|Growth Substances|growth substances|mesh-ancestor
110690044|NCT00980213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110690045|NCT00980213|Growth Inhibitors|growth inhibitors|mesh-ancestor
110690046|NCT00980213|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110690047|NCT00980213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110690048|NCT00980213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110690049|NCT00976469|Vaccines|vaccines|mesh-list
110690050|NCT00976469|Immunologic Factors|immunologic factors|mesh-ancestor
110690051|NCT00976469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110690052|NCT00980603|Docetaxel|docetaxel|mesh-list
110690053|NCT00980603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110690054|NCT00980603|Tubulin Modulators|tubulin modulators|mesh-ancestor
110690055|NCT00980603|Antimitotic Agents|antimitotic agents|mesh-ancestor
110690056|NCT00980603|Mitosis Modulators|mitosis modulators|mesh-ancestor
110690057|NCT00980603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110690058|NCT00274456|Paclitaxel|paclitaxel|mesh-list
110690059|NCT00274456|Docetaxel|docetaxel|mesh-list
110690060|NCT00274456|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110690061|NCT00274456|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110690062|NCT00274456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110690063|NCT00274456|Tubulin Modulators|tubulin modulators|mesh-ancestor
110690064|NCT00274456|Antimitotic Agents|antimitotic agents|mesh-ancestor
110690065|NCT00274456|Mitosis Modulators|mitosis modulators|mesh-ancestor
110690066|NCT00274456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110690067|NCT00977093|Pentetic Acid|pentetic acid|mesh-list
110690068|NCT00977093|Antidotes|antidotes|mesh-ancestor
110690069|NCT00977093|Protective Agents|protective agents|mesh-ancestor
110690070|NCT00977093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110690071|NCT00977093|Chelating Agents|chelating agents|mesh-ancestor
110690072|NCT00977093|Sequestering Agents|sequestering agents|mesh-ancestor
110690073|NCT00977093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110690074|NCT00977093|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110690075|NCT00977249|Varenicline|varenicline|mesh-list
110690076|NCT00977249|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110690077|NCT00977249|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110690078|NCT00977249|Cholinergic Agents|cholinergic agents|mesh-ancestor
110690079|NCT00977249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110657142|NCT05824143|Antimanic Agents|antimanic agents|mesh-ancestor
110690080|NCT00977249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110690081|NCT00977249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110690082|NCT01069822|Midazolam|midazolam|mesh-list
110690083|NCT01069822|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110690084|NCT01069822|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110690085|NCT01069822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110690086|NCT01069822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110690087|NCT01069822|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110690088|NCT01069822|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110690089|NCT01069822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110690090|NCT01069822|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110690091|NCT01069822|Anesthetics, General|anesthetics, general|mesh-ancestor
110690092|NCT01069822|Anesthetics|anesthetics|mesh-ancestor
110690093|NCT01069822|GABA Modulators|gaba modulators|mesh-ancestor
110690094|NCT01069822|GABA Agents|gaba agents|mesh-ancestor
110690095|NCT01069822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110690096|NCT01069822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110690097|NCT00364923|10-deazaaminopterin|10-deazaaminopterin|mesh-list
110690098|NCT00364923|Aminopterin|aminopterin|mesh-list
110690099|NCT00364923|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110690100|NCT00364923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110690101|NCT00364923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110690102|NCT00364923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110690103|NCT00273052|Metoprolol|metoprolol|mesh-list
110690104|NCT00273052|Carvedilol|carvedilol|mesh-list
110690105|NCT00273052|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110690106|NCT00273052|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110690107|NCT00273052|Sympatholytics|sympatholytics|mesh-ancestor
110690108|NCT00273052|Autonomic Agents|autonomic agents|mesh-ancestor
110690109|NCT00273052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110690110|NCT00273052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110690111|NCT00273052|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110690112|NCT00273052|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110690113|NCT00273052|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110690114|NCT00273052|Adrenergic Agents|adrenergic agents|mesh-ancestor
110690115|NCT00273052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110690116|NCT00273052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110690117|NCT00273052|Antioxidants|antioxidants|mesh-ancestor
110690118|NCT00273052|Protective Agents|protective agents|mesh-ancestor
110690119|NCT00273052|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110690120|NCT00273052|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110690121|NCT00273052|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110690122|NCT00273052|Vasodilator Agents|vasodilator agents|mesh-ancestor
110690123|NCT00273052|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110690124|NCT00273052|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110690125|NCT01046721|Exenatide|exenatide|mesh-list
110690126|NCT01046721|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110690127|NCT01046721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110690128|NCT01046721|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110690129|NCT01046721|Incretins|incretins|mesh-ancestor
110690130|NCT01046721|Hormones|hormones|mesh-ancestor
110690131|NCT01046721|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110690132|NCT01046799|Entecavir|entecavir|mesh-list
110690133|NCT01046799|Antiviral Agents|antiviral agents|mesh-ancestor
110690134|NCT01046799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110690135|NCT00290290|Chlorhexidine|chlorhexidine|mesh-list
110690136|NCT00290290|Povidone-Iodine|povidone-iodine|mesh-list
110690138|NCT00290290|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110690139|NCT00290290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110690140|NCT00290290|Disinfectants|disinfectants|mesh-ancestor
110690141|NCT00290290|Plasma Substitutes|plasma substitutes|mesh-ancestor
110690142|NCT00290290|Blood Substitutes|blood substitutes|mesh-ancestor
110690143|NCT01049685|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
110690144|NCT01049685|Antiviral Agents|antiviral agents|mesh-ancestor
110690145|NCT01049685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110690146|NCT01580943|Chlorhexidine|chlorhexidine|mesh-list
110690147|NCT01580943|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110690148|NCT01580943|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110690149|NCT01580943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110690150|NCT01580943|Disinfectants|disinfectants|mesh-ancestor
110690151|NCT01580943|Dermatologic Agents|dermatologic agents|mesh-ancestor
110690152|NCT02534961|Cefazolin|cefazolin|mesh-list
110690153|NCT02534961|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110690154|NCT02534961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110690155|NCT01046955|Alemtuzumab|alemtuzumab|mesh-list
110690156|NCT01046955|Thymoglobulin|thymoglobulin|mesh-list
110690157|NCT01046955|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110690158|NCT01046955|Daclizumab|daclizumab|mesh-list
110690159|NCT01046955|Immunologic Factors|immunologic factors|mesh-ancestor
110690160|NCT01046955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110690161|NCT01046955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110690162|NCT01046955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110857385|NCT01344174|Glucocorticoids|glucocorticoids|mesh-ancestor
110690163|NCT01046955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110690164|NCT00272038|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110690165|NCT00272038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110690166|NCT00272038|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110690167|NCT00272038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110690168|NCT00272038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110690169|NCT00271024|Naltrexone|naltrexone|mesh-list
110690170|NCT00271024|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110690171|NCT00271024|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110690172|NCT00271024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110690173|NCT00271024|Sensory System Agents|sensory system agents|mesh-ancestor
110690174|NCT00271024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110690175|NCT00381693|Azacitidine|azacitidine|mesh-list
110690176|NCT00381693|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110690177|NCT00381693|Antimetabolites|antimetabolites|mesh-ancestor
110690178|NCT00381693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110690179|NCT00381693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110690180|NCT00381693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110690181|NCT00545363|Ibandronic Acid|ibandronic acid|mesh-list
110690182|NCT00545363|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110690183|NCT00545363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110690184|NCT00977405|Gentamicins|gentamicins|mesh-list
110690185|NCT00977405|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110690186|NCT00977405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110690187|NCT00977405|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110690188|NCT00977405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110690189|NCT00977405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110690190|NCT00977795|Aminolevulinic Acid|aminolevulinic acid|mesh-list
110690191|NCT00977795|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110690192|NCT00977795|Dermatologic Agents|dermatologic agents|mesh-ancestor
110690193|NCT00977873|Cholecalciferol|cholecalciferol|mesh-list
110690194|NCT00977873|Vitamin D|vitamin d|mesh-list
110690195|NCT00977873|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110690196|NCT00977873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110690197|NCT00977873|Vitamins|vitamins|mesh-ancestor
110690198|NCT00977873|Micronutrients|micronutrients|mesh-ancestor
110690199|NCT00977873|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110690200|NCT00457392|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110690201|NCT00457392|Sunitinib|sunitinib|mesh-list
110690202|NCT00457392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110690203|NCT00457392|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110690204|NCT00457392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110690205|NCT00457392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110690206|NCT00457392|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110690207|NCT00457392|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110690208|NCT00457392|Growth Substances|growth substances|mesh-ancestor
110690209|NCT00457392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110690210|NCT00457392|Growth Inhibitors|growth inhibitors|mesh-ancestor
110690211|NCT00545051|Ibandronic Acid|ibandronic acid|mesh-list
110690212|NCT00545051|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110690213|NCT00545051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110690214|NCT00381615|Vaccines|vaccines|mesh-list
110690215|NCT00381615|Immunologic Factors|immunologic factors|mesh-ancestor
110690216|NCT00381615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110690217|NCT00978107|Flucytosine|flucytosine|mesh-list
110690218|NCT00978107|Antifungal Agents|antifungal agents|mesh-ancestor
110690219|NCT00978107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110690220|NCT00978107|Antimetabolites|antimetabolites|mesh-ancestor
110690221|NCT00978107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110690222|NCT01029132|Galantamine|galantamine|mesh-list
110690223|NCT01029132|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110690224|NCT01029132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110690225|NCT01029132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110690226|NCT01029132|Cholinergic Agents|cholinergic agents|mesh-ancestor
110690227|NCT01029132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110690228|NCT01029132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110690229|NCT01029132|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110690230|NCT01029132|Autonomic Agents|autonomic agents|mesh-ancestor
110690231|NCT01029132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110690232|NCT01029132|Nootropic Agents|nootropic agents|mesh-ancestor
110690233|NCT04008017|Eosinophil Cationic Protein|eosinophil cationic protein|mesh-list
110690234|NCT04008017|Immunologic Factors|immunologic factors|mesh-ancestor
110690235|NCT04008017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110690236|NCT01049763|Oseltamivir|oseltamivir|mesh-list
110690237|NCT01049763|Antiviral Agents|antiviral agents|mesh-ancestor
110690238|NCT01049763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110690239|NCT01049763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110690240|NCT01049763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110690241|NCT00981773|Maraviroc|maraviroc|mesh-list
110690242|NCT00981773|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110690243|NCT00981773|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110690244|NCT00981773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110690245|NCT00981773|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110690246|NCT00981773|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110690247|NCT00981773|Antiviral Agents|antiviral agents|mesh-ancestor
110690248|NCT00981773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110690249|NCT00981773|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
110690250|NCT01049841|Sirolimus|sirolimus|mesh-list
110690251|NCT01049841|Temsirolimus|temsirolimus|mesh-list
110690252|NCT01049841|MTOR Inhibitors|mtor inhibitors|mesh-list
110690253|NCT01049841|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110690254|NCT01049841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110690255|NCT01049841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110690256|NCT01049841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110690257|NCT01049841|Immunologic Factors|immunologic factors|mesh-ancestor
110690258|NCT01049841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110690259|NCT01049841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110690260|NCT01049841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110690261|NCT01049841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110690262|NCT01049841|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110690263|NCT01049841|Antifungal Agents|antifungal agents|mesh-ancestor
110690264|NCT00978263|Metformin|metformin|mesh-list
110690265|NCT00978263|Hypoglycemic Agents|hypoglycemic agents|mesh-list
110690266|NCT00978263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110690267|NCT00981851|Albuterol|albuterol|mesh-list
110690268|NCT00981851|Tiotropium Bromide|tiotropium bromide|mesh-list
110690269|NCT00981851|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110690270|NCT00981851|Autonomic Agents|autonomic agents|mesh-ancestor
110690271|NCT00981851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110690272|NCT00981851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110690273|NCT00981851|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110690274|NCT00981851|Respiratory System Agents|respiratory system agents|mesh-ancestor
110690275|NCT00981851|Parasympatholytics|parasympatholytics|mesh-ancestor
110690276|NCT00981851|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110690277|NCT00981851|Cholinergic Agents|cholinergic agents|mesh-ancestor
110690278|NCT00981851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110690279|NCT00981851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110690280|NCT00981851|Tocolytic Agents|tocolytic agents|mesh-ancestor
110690281|NCT00981851|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110690282|NCT00981851|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110690283|NCT00981851|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110690284|NCT00981851|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110690285|NCT00981851|Adrenergic Agents|adrenergic agents|mesh-ancestor
110690286|NCT00981929|Losartan|losartan|mesh-list
110690287|NCT00981929|Tramadol|tramadol|mesh-list
110690288|NCT00981929|Caffeine|caffeine|mesh-list
110690289|NCT00981929|Omeprazole|omeprazole|mesh-list
110690290|NCT00981929|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110690291|NCT00981929|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110690292|NCT00981929|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110690293|NCT00981929|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110690294|NCT00981929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110690295|NCT00981929|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110690296|NCT00981929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110690297|NCT00981929|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110690298|NCT00981929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110690299|NCT00981929|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110690300|NCT00981929|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110690301|NCT00981929|Purinergic Agents|purinergic agents|mesh-ancestor
110690302|NCT00981929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110690303|NCT00981929|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110690304|NCT00981929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110690305|NCT00981929|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110690306|NCT00981929|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110690307|NCT00981929|Narcotics|narcotics|mesh-ancestor
110690308|NCT00981929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110690309|NCT00981929|Analgesics|analgesics|mesh-ancestor
110690310|NCT00981929|Sensory System Agents|sensory system agents|mesh-ancestor
110690311|NCT00981929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110690312|NCT00364845|Darbepoetin alfa|darbepoetin alfa|mesh-list
110690313|NCT00364845|Hematinics|hematinics|mesh-ancestor
110690314|NCT00978653|Allopurinol|allopurinol|mesh-list
110690315|NCT00978653|Antimetabolites|antimetabolites|mesh-ancestor
110690316|NCT00978653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110690317|NCT00978653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110690318|NCT00978653|Gout Suppressants|gout suppressants|mesh-ancestor
110690319|NCT00978653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110690320|NCT00978653|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110690321|NCT00978653|Antioxidants|antioxidants|mesh-ancestor
110690322|NCT00978653|Protective Agents|protective agents|mesh-ancestor
110690323|NCT00978653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110690324|NCT00293722|Etanercept|etanercept|mesh-list
110690325|NCT00293722|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110690326|NCT00293722|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110690327|NCT00293722|Analgesics|analgesics|mesh-ancestor
110690328|NCT00293722|Sensory System Agents|sensory system agents|mesh-ancestor
110690329|NCT00293722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110690330|NCT00293722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110690331|NCT00293722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110690332|NCT00293722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110690333|NCT00293722|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110690334|NCT00293722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110690335|NCT00293722|Immunologic Factors|immunologic factors|mesh-ancestor
110690337|NCT00381303|Darunavir|darunavir|mesh-list
110690338|NCT00381303|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110690339|NCT00381303|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110690340|NCT00381303|Protease Inhibitors|protease inhibitors|mesh-ancestor
110690341|NCT00381303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110690342|NCT00381303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110690343|NCT00381303|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110690344|NCT00381303|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110690345|NCT00381303|Antiviral Agents|antiviral agents|mesh-ancestor
110690346|NCT00381303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110690347|NCT00381303|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110690348|NCT00381303|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110690350|NCT00364689|Lactulose|lactulose|mesh-list
110690351|NCT00364689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110690352|NCT00364689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110690353|NCT00364689|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110690354|NCT00545129|Tanezumab|tanezumab|mesh-list
110690355|NCT00545129|Analgesics|analgesics|mesh-ancestor
110690356|NCT00545129|Sensory System Agents|sensory system agents|mesh-ancestor
110690357|NCT00545129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110690358|NCT00545129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110690359|NCT00956111|Vaccines|vaccines|mesh-list
110690360|NCT00956111|Immunologic Factors|immunologic factors|mesh-ancestor
110690361|NCT00956111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110690362|NCT00982631|Sirolimus|sirolimus|mesh-list
110690363|NCT00982631|Temsirolimus|temsirolimus|mesh-list
110690364|NCT00982631|MTOR Inhibitors|mtor inhibitors|mesh-list
110690365|NCT00982631|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110690366|NCT00982631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110690367|NCT00982631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110690368|NCT00982631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110690369|NCT00982631|Immunologic Factors|immunologic factors|mesh-ancestor
110690370|NCT00982631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110690371|NCT00982631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110690372|NCT00982631|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110690373|NCT00982631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110690374|NCT00982631|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110690375|NCT00982631|Antifungal Agents|antifungal agents|mesh-ancestor
110690376|NCT00364611|Bevacizumab|bevacizumab|mesh-list
110690377|NCT00364611|Trastuzumab|trastuzumab|mesh-list
110690378|NCT00364611|Docetaxel|docetaxel|mesh-list
110690379|NCT00364611|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110690380|NCT00364611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110690381|NCT00364611|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110690382|NCT00364611|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110690383|NCT00364611|Growth Substances|growth substances|mesh-ancestor
110690384|NCT00364611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110690385|NCT00364611|Growth Inhibitors|growth inhibitors|mesh-ancestor
110690386|NCT00364611|Tubulin Modulators|tubulin modulators|mesh-ancestor
110690387|NCT00364611|Antimitotic Agents|antimitotic agents|mesh-ancestor
110690388|NCT00364611|Mitosis Modulators|mitosis modulators|mesh-ancestor
110690389|NCT00364611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110690390|NCT00956189|Aripiprazole|aripiprazole|mesh-list
110690391|NCT00956189|Amisulpride|amisulpride|mesh-list
110690392|NCT00956189|Antidepressive Agents|antidepressive agents|mesh-ancestor
110690393|NCT00956189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110690394|NCT00956189|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110690395|NCT00956189|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110690396|NCT00956189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110690397|NCT00956189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110690398|NCT00956189|Dopamine Agonists|dopamine agonists|mesh-ancestor
110690399|NCT00956189|Dopamine Agents|dopamine agents|mesh-ancestor
110690400|NCT00956189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110690401|NCT00956189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110690402|NCT00956189|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110690403|NCT00956189|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110690404|NCT00956189|Serotonin Agents|serotonin agents|mesh-ancestor
110690405|NCT00956189|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110690406|NCT00956189|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110690407|NCT00956189|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110690408|NCT00956189|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110690409|NCT00956189|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110690410|NCT00956267|Letrozole|letrozole|mesh-list
110857488|NCT03220854|Antibodies|antibodies|mesh-list
110690411|NCT00956267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110690412|NCT00956267|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110690413|NCT00956267|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110690414|NCT00956267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110690415|NCT00956267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110690416|NCT00956267|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110690417|NCT00956267|Hormone Antagonists|hormone antagonists|mesh-ancestor
110690418|NCT00956267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110690419|NCT00956267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110690420|NCT04007003|Insulin|insulin|mesh-list
110690421|NCT04007003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110320446|NCT00432354|Antimetabolites|antimetabolites|mesh-ancestor
110690422|NCT04007003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110690424|NCT00364533|Tapentadol|tapentadol|mesh-list
110690425|NCT00364533|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110690426|NCT00364533|Narcotics|narcotics|mesh-ancestor
110690427|NCT00364533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110690428|NCT00364533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110690429|NCT00364533|Analgesics|analgesics|mesh-ancestor
110690430|NCT00364533|Sensory System Agents|sensory system agents|mesh-ancestor
110690431|NCT00364533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110690432|NCT00364533|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110690433|NCT00364533|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110690434|NCT00364533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110690435|NCT00364533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110690436|NCT00364533|Adrenergic Agents|adrenergic agents|mesh-ancestor
110690437|NCT00364533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110690438|NCT01047423|Simvastatin|simvastatin|mesh-list
110690439|NCT01047423|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110690440|NCT01047423|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110690441|NCT01047423|Antimetabolites|antimetabolites|mesh-ancestor
110690442|NCT01047423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110690443|NCT01047423|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110690444|NCT01047423|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110690445|NCT01047423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110690446|NCT00984737|Insulin|insulin|mesh-list
110690447|NCT00984737|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110690448|NCT00984737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110690449|NCT01047579|Rivastigmine|rivastigmine|mesh-list
110690450|NCT01047579|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110690451|NCT01047579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110690452|NCT01047579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110690453|NCT01047579|Cholinergic Agents|cholinergic agents|mesh-ancestor
110690454|NCT01047579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110690455|NCT01047579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110690456|NCT01047579|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110690457|NCT01047579|Protective Agents|protective agents|mesh-ancestor
110690458|NCT04006847|Dasatinib|dasatinib|mesh-list
110690459|NCT04006847|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
110690460|NCT04006847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110690461|NCT04006847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110690462|NCT04006847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110690463|NCT04006847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110690464|NCT00984893|Zoledronic Acid|zoledronic acid|mesh-list
110690465|NCT00984893|Diphosphonates|diphosphonates|mesh-list
110690466|NCT00984893|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110690467|NCT00984893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110690468|NCT00983021|Insulin|insulin|mesh-list
110690469|NCT00983021|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110690470|NCT00983021|Liraglutide|liraglutide|mesh-list
110690471|NCT00983021|Insulin, Long-Acting|insulin, long-acting|mesh-list
110690472|NCT00983021|Xultophy|xultophy|mesh-list
110690473|NCT00983021|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110690474|NCT00983021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110690475|NCT00983021|Incretins|incretins|mesh-ancestor
110690476|NCT00983021|Hormones|hormones|mesh-ancestor
110690477|NCT00983021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110690478|NCT00984971|Tenofovir|tenofovir|mesh-list
110690479|NCT00984971|Antiviral Agents|antiviral agents|mesh-ancestor
110690480|NCT00984971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110690481|NCT00984971|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110690482|NCT00984971|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110690483|NCT00984971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110690484|NCT00984971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110690485|NCT00984971|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110690486|NCT00984971|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110690487|NCT00544817|Temozolomide|temozolomide|mesh-list
110690488|NCT00544817|Sorafenib|sorafenib|mesh-list
110690489|NCT00544817|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110690490|NCT00544817|Alkylating Agents|alkylating agents|mesh-ancestor
110690491|NCT00544817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110690492|NCT00544817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110690493|NCT00544817|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110690494|NCT00544817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110690495|NCT00289978|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
110690496|NCT00289978|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
110690497|NCT00289978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110690498|NCT00289978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110690499|NCT00289978|Immunologic Factors|immunologic factors|mesh-ancestor
110690500|NCT00289978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110690502|NCT00983177|Gout Suppressants|gout suppressants|mesh-ancestor
110690503|NCT00983177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110690504|NCT00983177|Tubulin Modulators|tubulin modulators|mesh-ancestor
110690505|NCT00983177|Antimitotic Agents|antimitotic agents|mesh-ancestor
110690506|NCT00983177|Mitosis Modulators|mitosis modulators|mesh-ancestor
110690507|NCT00983177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110690508|NCT00983177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110857547|NCT03299296|Antithrombins|antithrombins|mesh-ancestor
110690509|NCT00983255|Tedizolid phosphate|tedizolid phosphate|mesh-list
110690510|NCT00983255|Tedizolid|tedizolid|mesh-list
110690511|NCT00983255|Oxazolidinones|oxazolidinones|mesh-list
110690512|NCT00983255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110690513|NCT00983255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110690514|NCT00983255|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110690515|NCT00983255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110690516|NCT00983255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110690517|NCT00988403|Levan|levan|mesh-list
110690518|NCT00988403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110690519|NCT00988481|Topiramate|topiramate|mesh-list
110690520|NCT00988481|Anticonvulsants|anticonvulsants|mesh-ancestor
110690521|NCT00988481|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110690522|NCT00988481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110690523|NCT00289900|Atorvastatin|atorvastatin|mesh-list
110690524|NCT00289900|Simvastatin|simvastatin|mesh-list
110690525|NCT00289900|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110690526|NCT00289900|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110690527|NCT00289900|Antimetabolites|antimetabolites|mesh-ancestor
110690528|NCT00289900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110690529|NCT00289900|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110690530|NCT00289900|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110690531|NCT00289900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110690532|NCT00543725|Efavirenz|efavirenz|mesh-list
110690533|NCT00543725|Rilpivirine|rilpivirine|mesh-list
110690534|NCT00543725|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110690535|NCT00543725|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110690536|NCT00543725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110690537|NCT00543725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110690538|NCT00543725|Antiviral Agents|antiviral agents|mesh-ancestor
110690539|NCT00543725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110690540|NCT00543725|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110690541|NCT00543725|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110690542|NCT00543725|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110690543|NCT00543725|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110690544|NCT00543725|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110690545|NCT00543725|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110690546|NCT00543725|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110690547|NCT00543725|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110690548|NCT00985361|Vitamin D|vitamin d|mesh-list
110690549|NCT00985361|Cholecalciferol|cholecalciferol|mesh-list
110690550|NCT00985361|Vitamins|vitamins|mesh-list
110690551|NCT00985361|Micronutrients|micronutrients|mesh-ancestor
110690552|NCT00985361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110690553|NCT00985361|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110690554|NCT00985361|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110690555|NCT00269152|Carboplatin|carboplatin|mesh-list
110690556|NCT00269152|Pemetrexed|pemetrexed|mesh-list
110690557|NCT00269152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110690558|NCT00269152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110690559|NCT00269152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110690560|NCT00269152|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110690561|NCT00269152|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110690562|NCT00988715|Cyclosporine|cyclosporine|mesh-list
110690563|NCT00988715|Mycophenolic Acid|mycophenolic acid|mesh-list
110690564|NCT00988715|Fludarabine|fludarabine|mesh-list
110690565|NCT00988715|Fludarabine phosphate|fludarabine phosphate|mesh-list
110690566|NCT00988715|Cyclosporins|cyclosporins|mesh-list
110690567|NCT00988715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110690568|NCT00988715|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110690569|NCT00988715|Antimetabolites|antimetabolites|mesh-ancestor
110690570|NCT00988715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110690571|NCT00988715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110690572|NCT00988715|Immunologic Factors|immunologic factors|mesh-ancestor
110690573|NCT00988715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110690574|NCT00988715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110690575|NCT00988715|Antifungal Agents|antifungal agents|mesh-ancestor
110690576|NCT00988715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110690577|NCT00988715|Dermatologic Agents|dermatologic agents|mesh-ancestor
110690578|NCT00988715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110690579|NCT00988715|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110690580|NCT00988715|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110690581|NCT00988715|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110690582|NCT00988715|Antitubercular Agents|antitubercular agents|mesh-ancestor
110690583|NCT00988715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110690584|NCT03975166|Fluticasone|fluticasone|mesh-list
110690586|NCT03975166|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110690587|NCT03975166|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
110690588|NCT03975166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110690589|NCT03975166|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110690590|NCT03975166|Autonomic Agents|autonomic agents|mesh-ancestor
110690591|NCT03975166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110690592|NCT03975166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110690593|NCT03975166|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110690594|NCT03975166|Respiratory System Agents|respiratory system agents|mesh-ancestor
110690595|NCT03975166|Dermatologic Agents|dermatologic agents|mesh-ancestor
110690596|NCT03975166|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110690597|NCT03975166|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110690598|NCT03975166|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110690599|NCT03975166|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110690600|NCT03975166|Adrenergic Agents|adrenergic agents|mesh-ancestor
110690601|NCT03975166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110690602|NCT03975166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110690603|NCT03975166|Glucocorticoids|glucocorticoids|mesh-ancestor
110690604|NCT03975166|Hormones|hormones|mesh-ancestor
110690605|NCT03975166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110690606|NCT03975166|Sympathomimetics|sympathomimetics|mesh-ancestor
110690607|NCT01325818|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110690608|NCT01325818|Pravastatin|pravastatin|mesh-list
110690609|NCT01325818|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110690610|NCT01325818|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110690611|NCT01325818|Antimetabolites|antimetabolites|mesh-ancestor
110690612|NCT01325818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110690613|NCT01325818|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110690614|NCT01325818|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110690615|NCT01325818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110690616|NCT00379899|Vitamin D|vitamin d|mesh-list
110690617|NCT00379899|Cinacalcet|cinacalcet|mesh-list
110690618|NCT00379899|Vitamins|vitamins|mesh-ancestor
110690619|NCT00379899|Micronutrients|micronutrients|mesh-ancestor
110690620|NCT00379899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110690621|NCT00379899|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110690622|NCT00379899|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110690623|NCT00379899|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
110690624|NCT00379899|Hormone Antagonists|hormone antagonists|mesh-ancestor
110690625|NCT00379899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110690626|NCT02535039|Methylprednisolone|methylprednisolone|mesh-list
110690627|NCT02535039|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110690628|NCT02535039|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110690629|NCT02535039|Prednisolone|prednisolone|mesh-list
110690630|NCT02535039|Prednisolone acetate|prednisolone acetate|mesh-list
110690631|NCT02535039|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110690632|NCT02535039|Prednisolone phosphate|prednisolone phosphate|mesh-list
110690634|NCT02535039|Antiemetics|antiemetics|mesh-ancestor
110690635|NCT02535039|Autonomic Agents|autonomic agents|mesh-ancestor
110690636|NCT02535039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110690637|NCT02535039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110690638|NCT02535039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110690639|NCT02535039|Glucocorticoids|glucocorticoids|mesh-ancestor
110690641|NCT02535039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110690642|NCT02535039|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110690643|NCT02535039|Protective Agents|protective agents|mesh-ancestor
110690644|NCT02535039|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110690645|NCT02535039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110690646|NCT00363129|Vitamin E|vitamin e|mesh-list
110690647|NCT00363129|Vitamins|vitamins|mesh-ancestor
110690648|NCT00363129|Micronutrients|micronutrients|mesh-ancestor
110690649|NCT00363129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110690650|NCT00363129|Antioxidants|antioxidants|mesh-ancestor
110690651|NCT00363129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110690652|NCT00363129|Protective Agents|protective agents|mesh-ancestor
110690653|NCT00268996|Darapladib|darapladib|mesh-list
110690654|NCT00268996|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
110690655|NCT00268996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110690656|NCT00268996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110690657|NCT00379587|Rituximab|rituximab|mesh-list
110690658|NCT00379587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110690659|NCT00379587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110690660|NCT00379587|Immunologic Factors|immunologic factors|mesh-ancestor
110690661|NCT00379587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110690662|NCT00379587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110690663|NCT00363051|Everolimus|everolimus|mesh-list
110690664|NCT00363051|Octreotide|octreotide|mesh-list
110690665|NCT00363051|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110690666|NCT00363051|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110690667|NCT00363051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110690668|NCT00363051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110690669|NCT00363051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110690670|NCT00363051|Immunologic Factors|immunologic factors|mesh-ancestor
110690671|NCT00363051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110690672|NCT00363051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110690673|NCT00363051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110690674|NCT00363051|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110690675|NCT00379353|Thalidomide|thalidomide|mesh-list
110690676|NCT00379353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110690677|NCT00379353|Immunologic Factors|immunologic factors|mesh-ancestor
110690678|NCT00379353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110690679|NCT00379353|Leprostatic Agents|leprostatic agents|mesh-ancestor
110690680|NCT00379353|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110690681|NCT00379353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110690682|NCT00379353|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110690683|NCT00379353|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110690684|NCT00379353|Growth Substances|growth substances|mesh-ancestor
110690685|NCT00379353|Growth Inhibitors|growth inhibitors|mesh-ancestor
110690686|NCT00379353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110690687|NCT01047657|Orlistat|orlistat|mesh-list
110690688|NCT01047657|Sibutramine|sibutramine|mesh-list
110690689|NCT01047657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110690690|NCT01047657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110690691|NCT01047657|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110690692|NCT01047657|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110690693|NCT01047657|Antidepressive Agents|antidepressive agents|mesh-ancestor
110690694|NCT01047657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110690695|NCT01047657|Appetite Depressants|appetite depressants|mesh-ancestor
110690696|NCT00378573|Bevacizumab|bevacizumab|mesh-list
110690697|NCT00378573|Gemcitabine|gemcitabine|mesh-list
110690698|NCT00378573|Docetaxel|docetaxel|mesh-list
110690699|NCT00378573|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110690700|NCT00378573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110690701|NCT00378573|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110690702|NCT00378573|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110690703|NCT00378573|Growth Substances|growth substances|mesh-ancestor
110857601|NCT01348308|Maraviroc|maraviroc|mesh-list
110690704|NCT00378573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110690705|NCT00378573|Growth Inhibitors|growth inhibitors|mesh-ancestor
110408569|NCT04983966|Desflurane|desflurane|mesh-list
110690706|NCT00378573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110690707|NCT00378573|Antimetabolites|antimetabolites|mesh-ancestor
110690708|NCT00378573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110690709|NCT00378573|Tubulin Modulators|tubulin modulators|mesh-ancestor
110690710|NCT00378573|Antimitotic Agents|antimitotic agents|mesh-ancestor
110690711|NCT00378573|Mitosis Modulators|mitosis modulators|mesh-ancestor
110690712|NCT01047891|Sorafenib|sorafenib|mesh-list
110690713|NCT01047891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110690714|NCT01047891|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110690715|NCT01047891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110690716|NCT01047891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110690717|NCT02534571|Epinephrine|epinephrine|mesh-list
110690718|NCT02534571|Hemostatics|hemostatics|mesh-list
110657168|NCT05664568|Cephalexin|cephalexin|mesh-list
110690719|NCT02534571|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110690720|NCT02534571|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110690721|NCT02534571|Adrenergic Agents|adrenergic agents|mesh-ancestor
110690722|NCT02534571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110690723|NCT02534571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110690724|NCT02534571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110690725|NCT02534571|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110690726|NCT02534571|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110690727|NCT02534571|Autonomic Agents|autonomic agents|mesh-ancestor
110690728|NCT02534571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110690729|NCT02534571|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110690730|NCT02534571|Respiratory System Agents|respiratory system agents|mesh-ancestor
110690731|NCT02534571|Mydriatics|mydriatics|mesh-ancestor
110690732|NCT02534571|Sympathomimetics|sympathomimetics|mesh-ancestor
110690733|NCT02534571|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110690734|NCT02534571|Coagulants|coagulants|mesh-ancestor
110690735|NCT00457002|Enoxaparin|enoxaparin|mesh-list
110690736|NCT00457002|Apixaban|apixaban|mesh-list
110690737|NCT00457002|Anticoagulants|anticoagulants|mesh-ancestor
110690738|NCT00457002|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110690739|NCT00457002|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110690740|NCT00457002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110690741|NCT00457002|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110690742|NCT00457002|Antithrombins|antithrombins|mesh-ancestor
110690743|NCT00457002|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110690744|NCT00457002|Protease Inhibitors|protease inhibitors|mesh-ancestor
110690745|NCT00457002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110690746|NCT00362115|Olmesartan|olmesartan|mesh-list
110690747|NCT00362115|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
110690748|NCT00362115|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110690749|NCT00362115|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110690750|NCT00362115|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110690751|NCT00362115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110690752|NCT00485264|Raltegravir Potassium|raltegravir potassium|mesh-list
110690753|NCT00485264|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110690754|NCT00485264|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110690755|NCT00485264|Antiviral Agents|antiviral agents|mesh-ancestor
110690756|NCT00485264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110690757|NCT00485264|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110690758|NCT00485264|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110690759|NCT00485264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110690760|NCT00485264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110690761|NCT00293254|Raltegravir Potassium|raltegravir potassium|mesh-list
110690762|NCT00293254|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110690763|NCT00293254|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110690764|NCT00293254|Antiviral Agents|antiviral agents|mesh-ancestor
110690765|NCT00293254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110690766|NCT00293254|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110690767|NCT00293254|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110690768|NCT00293254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110690769|NCT00293254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110690770|NCT03975010|Naltrexone|naltrexone|mesh-list
110690771|NCT03975010|Buprenorphine|buprenorphine|mesh-list
110690772|NCT03975010|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110690773|NCT03975010|Narcotics|narcotics|mesh-ancestor
110690774|NCT03975010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110690775|NCT03975010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110690776|NCT03975010|Analgesics|analgesics|mesh-ancestor
110690777|NCT03975010|Sensory System Agents|sensory system agents|mesh-ancestor
110690778|NCT03975010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110690779|NCT03975010|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110690780|NCT03975010|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110690781|NCT01016990|Valproic Acid|valproic acid|mesh-list
110408640|NCT04666038|Immunologic Factors|immunologic factors|mesh-ancestor
110690782|NCT01016990|Anticonvulsants|anticonvulsants|mesh-ancestor
110690783|NCT01016990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110690784|NCT01016990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110690785|NCT01016990|GABA Agents|gaba agents|mesh-ancestor
110690786|NCT01016990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110690787|NCT01016990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110690788|NCT01016990|Antimanic Agents|antimanic agents|mesh-ancestor
110690789|NCT01016990|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110690790|NCT01016990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110690791|NCT01016990|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110690792|NCT01048047|Amlodipine|amlodipine|mesh-list
110690793|NCT01048047|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110690794|NCT01048047|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110690795|NCT01048047|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110690796|NCT01048047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110690797|NCT01048047|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110690798|NCT01048047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110690799|NCT01048047|Vasodilator Agents|vasodilator agents|mesh-ancestor
110690800|NCT01324635|Panobinostat|panobinostat|mesh-list
110690801|NCT01324635|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
110690802|NCT01324635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110690803|NCT01324635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110690804|NCT01324635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110690805|NCT00456846|Paclitaxel|paclitaxel|mesh-list
110690806|NCT00456846|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110690807|NCT00456846|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110690808|NCT00456846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110690809|NCT00456846|Tubulin Modulators|tubulin modulators|mesh-ancestor
110690810|NCT00456846|Antimitotic Agents|antimitotic agents|mesh-ancestor
110690811|NCT00456846|Mitosis Modulators|mitosis modulators|mesh-ancestor
110690812|NCT00456846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110690813|NCT03324282|Avelumab|avelumab|mesh-list
110690814|NCT03324282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110690815|NCT03324282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110690816|NCT00484094|Sirolimus|sirolimus|mesh-list
110690817|NCT00484094|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110690818|NCT00484094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110690819|NCT00484094|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110690820|NCT00484094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110690821|NCT00484094|Antifungal Agents|antifungal agents|mesh-ancestor
110690822|NCT00484094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110690823|NCT00484094|Immunologic Factors|immunologic factors|mesh-ancestor
110690824|NCT00484094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110690825|NCT01029288|Hypoglycemic Agents|hypoglycemic agents|mesh-list
110690826|NCT01029288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110690827|NCT01029444|Insulin Aspart|insulin aspart|mesh-list
110690828|NCT01029444|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110690829|NCT01029444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110690830|NCT01029522|Atorvastatin|atorvastatin|mesh-list
110690831|NCT01029522|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110690832|NCT01029522|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110690833|NCT01029522|Antimetabolites|antimetabolites|mesh-ancestor
110690834|NCT01029522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110690835|NCT01029522|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110690836|NCT01029522|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110690837|NCT01029522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110690838|NCT00447876|Botulinum Toxins|botulinum toxins|mesh-list
110690839|NCT00447876|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110690840|NCT00447876|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110690841|NCT00447876|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110690842|NCT00447876|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110690843|NCT00447876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110690844|NCT00447876|Cholinergic Agents|cholinergic agents|mesh-ancestor
110690845|NCT00447876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110690846|NCT00447876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110690847|NCT00447876|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110857675|NCT04019262|Temozolomide|temozolomide|mesh-list
110690848|NCT00447876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110690849|NCT01565772|Etoposide|etoposide|mesh-list
110690850|NCT01565772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110690851|NCT01565772|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110690852|NCT01565772|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110690853|NCT01565772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110690854|NCT01565772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110690855|NCT01565772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110690856|NCT00456300|Exenatide|exenatide|mesh-list
110690857|NCT00456300|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110690858|NCT00456300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110690859|NCT00456300|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110690861|NCT00456300|Hormones|hormones|mesh-ancestor
110690862|NCT00456300|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110690863|NCT00267748|Sunitinib|sunitinib|mesh-list
110690864|NCT00267748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110690865|NCT00267748|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110690866|NCT00267748|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110690867|NCT00267748|Growth Substances|growth substances|mesh-ancestor
110690868|NCT00267748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110690869|NCT00267748|Growth Inhibitors|growth inhibitors|mesh-ancestor
110690870|NCT00267748|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110690871|NCT00267748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110690872|NCT00267748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110690874|NCT00267202|Immunomodulating Agents|immunomodulating agents|mesh-list
110690875|NCT00267202|Immunologic Factors|immunologic factors|mesh-list
110690876|NCT00267202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110690877|NCT00267202|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110690878|NCT00267202|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110690879|NCT00267202|Respiratory System Agents|respiratory system agents|mesh-ancestor
110690880|NCT01067638|Tranexamic Acid|tranexamic acid|mesh-list
110690881|NCT01067638|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110690882|NCT01067638|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110690883|NCT01067638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110690884|NCT01067638|Hemostatics|hemostatics|mesh-ancestor
110690885|NCT01067638|Coagulants|coagulants|mesh-ancestor
110690886|NCT00267046|Doxorubicin|doxorubicin|mesh-list
110690887|NCT00267046|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110690888|NCT00267046|Vincristine|vincristine|mesh-list
110690889|NCT00267046|Ifosfamide|ifosfamide|mesh-list
110690890|NCT00267046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110690891|NCT00267046|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110690892|NCT00267046|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110690893|NCT00267046|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110690894|NCT00267046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110690895|NCT00267046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110690896|NCT00267046|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110690897|NCT00267046|Tubulin Modulators|tubulin modulators|mesh-ancestor
110690898|NCT00267046|Antimitotic Agents|antimitotic agents|mesh-ancestor
110690899|NCT00267046|Mitosis Modulators|mitosis modulators|mesh-ancestor
110690900|NCT00267046|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110690901|NCT00267046|Alkylating Agents|alkylating agents|mesh-ancestor
110690902|NCT01029678|Vinorelbine|vinorelbine|mesh-list
110690903|NCT01029678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110690904|NCT01029678|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110690905|NCT01029678|Tubulin Modulators|tubulin modulators|mesh-ancestor
110690906|NCT01029678|Antimitotic Agents|antimitotic agents|mesh-ancestor
110135773|NCT02000206|Ketamine|ketamine|mesh-list
110690907|NCT01029678|Mitosis Modulators|mitosis modulators|mesh-ancestor
110690908|NCT01029678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110690909|NCT00286468|Alogliptin|alogliptin|mesh-list
110690910|NCT00286468|Glyburide|glyburide|mesh-list
110690911|NCT00286468|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110690912|NCT00286468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110690913|NCT00286468|Incretins|incretins|mesh-ancestor
110690914|NCT00286468|Hormones|hormones|mesh-ancestor
110690915|NCT00286468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110690916|NCT00286468|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110690917|NCT00286468|Protease Inhibitors|protease inhibitors|mesh-ancestor
110690918|NCT00286468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110690919|NCT00286468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110690920|NCT00507026|Diclofenac|diclofenac|mesh-list
110690921|NCT00507026|Ketorolac|ketorolac|mesh-list
110690922|NCT00507026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110690923|NCT00507026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110690924|NCT00507026|Analgesics|analgesics|mesh-ancestor
110690925|NCT00507026|Sensory System Agents|sensory system agents|mesh-ancestor
110690926|NCT00507026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110690927|NCT00507026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110690928|NCT00507026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110690929|NCT00507026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110690930|NCT00507026|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110690931|NCT00507026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110690932|NCT00507026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110690933|NCT01019174|Cyclophosphamide|cyclophosphamide|mesh-list
110690934|NCT01019174|Lenalidomide|lenalidomide|mesh-list
110690935|NCT01019174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110690936|NCT01019174|Immunologic Factors|immunologic factors|mesh-ancestor
110690937|NCT01019174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110690938|NCT01019174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110690939|NCT01019174|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110690940|NCT01019174|Alkylating Agents|alkylating agents|mesh-ancestor
110690941|NCT01019174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110690942|NCT01019174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110690943|NCT01019174|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110690944|NCT01019174|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110690945|NCT01019174|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110690946|NCT01019174|Growth Substances|growth substances|mesh-ancestor
110690947|NCT01019174|Growth Inhibitors|growth inhibitors|mesh-ancestor
110690948|NCT01017224|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
110690949|NCT01017224|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110690950|NCT01017224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110690951|NCT01011920|Cytarabine|cytarabine|mesh-list
110690952|NCT01011920|Rituximab|rituximab|mesh-list
110690953|NCT01011920|Methotrexate|methotrexate|mesh-list
110690954|NCT01011920|Thiotepa|thiotepa|mesh-list
110690955|NCT01011920|Carmustine|carmustine|mesh-list
110690956|NCT01011920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110690957|NCT01011920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110690958|NCT01011920|Immunologic Factors|immunologic factors|mesh-ancestor
110690959|NCT01011920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110690960|NCT01011920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110690961|NCT01011920|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110690962|NCT01011920|Abortifacient Agents|abortifacient agents|mesh-ancestor
110690963|NCT01011920|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110690964|NCT01011920|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110690966|NCT01011920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110690967|NCT01011920|Dermatologic Agents|dermatologic agents|mesh-ancestor
110690968|NCT01011920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110690969|NCT01011920|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110690970|NCT01011920|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110690971|NCT01011920|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110690972|NCT01011920|Antiviral Agents|antiviral agents|mesh-ancestor
110690973|NCT01011920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110690974|NCT01011920|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110690975|NCT01011920|Alkylating Agents|alkylating agents|mesh-ancestor
110690976|NCT01011920|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110690977|NCT03976102|Rituximab|rituximab|mesh-list
110690978|NCT03976102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110690979|NCT03976102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110690980|NCT03976102|Immunologic Factors|immunologic factors|mesh-ancestor
110690981|NCT03976102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110690982|NCT03976102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110690983|NCT00506948|Mycophenolic Acid|mycophenolic acid|mesh-list
110690984|NCT00506948|Sirolimus|sirolimus|mesh-list
110690985|NCT00506948|Thymoglobulin|thymoglobulin|mesh-list
110690986|NCT00506948|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110690987|NCT00506948|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110690988|NCT00506948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110690989|NCT00506948|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110690990|NCT00506948|Antitubercular Agents|antitubercular agents|mesh-ancestor
110690991|NCT00506948|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110690992|NCT00506948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110690993|NCT00506948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110690994|NCT00506948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110690995|NCT00506948|Antifungal Agents|antifungal agents|mesh-ancestor
110690996|NCT00506948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110690997|NCT00506948|Immunologic Factors|immunologic factors|mesh-ancestor
110690998|NCT00506948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110690999|NCT00286234|Niacin|niacin|mesh-list
110691000|NCT00286234|Nicotinic Acids|nicotinic acids|mesh-list
110691001|NCT00286234|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110691002|NCT00286234|Antimetabolites|antimetabolites|mesh-ancestor
110691003|NCT00286234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110691004|NCT00286234|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110691005|NCT00286234|Vasodilator Agents|vasodilator agents|mesh-ancestor
110691006|NCT00286234|Vitamin B Complex|vitamin b complex|mesh-ancestor
110691007|NCT00286234|Vitamins|vitamins|mesh-ancestor
110691008|NCT00286234|Micronutrients|micronutrients|mesh-ancestor
110691009|NCT00286234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110691010|NCT01019408|Chloroquine|chloroquine|mesh-list
110691011|NCT01019408|Amebicides|amebicides|mesh-ancestor
110691012|NCT01019408|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110691013|NCT01019408|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110691014|NCT01019408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110691015|NCT01019408|Antimalarials|antimalarials|mesh-ancestor
110691016|NCT01019408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110691017|NCT01067950|Pancrelipase|pancrelipase|mesh-list
110691018|NCT01067950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110691019|NCT00445848|Bevacizumab|bevacizumab|mesh-list
110691020|NCT00445848|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110691021|NCT00445848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110691022|NCT00445848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110691023|NCT00445848|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110691024|NCT00445848|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110691025|NCT00445848|Growth Substances|growth substances|mesh-ancestor
110857714|NCT04289142|Adrenergic Agents|adrenergic agents|mesh-ancestor
110691026|NCT00445848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110691027|NCT00445848|Growth Inhibitors|growth inhibitors|mesh-ancestor
110691028|NCT00445848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110691029|NCT00445848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110691030|NCT00445848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110691031|NCT00286156|Sirolimus|sirolimus|mesh-list
110691032|NCT00286156|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110691033|NCT00286156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110691034|NCT00286156|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110691035|NCT00286156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110691036|NCT00286156|Antifungal Agents|antifungal agents|mesh-ancestor
110691037|NCT00286156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110691038|NCT00286156|Immunologic Factors|immunologic factors|mesh-ancestor
110691039|NCT00286156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110691040|NCT00455520|Tapentadol|tapentadol|mesh-list
110691041|NCT00455520|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110691042|NCT00455520|Narcotics|narcotics|mesh-ancestor
110691043|NCT00455520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110691044|NCT00455520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110691045|NCT00455520|Analgesics|analgesics|mesh-ancestor
110691046|NCT00455520|Sensory System Agents|sensory system agents|mesh-ancestor
110691047|NCT00455520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110691048|NCT00455520|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110691049|NCT00455520|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110691050|NCT00455520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110691051|NCT00455520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110691052|NCT00455520|Adrenergic Agents|adrenergic agents|mesh-ancestor
110691053|NCT00455520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110691054|NCT00284050|Ranibizumab|ranibizumab|mesh-list
110691055|NCT00284050|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110691056|NCT00284050|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110691057|NCT00284050|Growth Substances|growth substances|mesh-ancestor
110691058|NCT00284050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110691059|NCT00284050|Growth Inhibitors|growth inhibitors|mesh-ancestor
110691060|NCT00284050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110691061|NCT00293020|Fentanyl|fentanyl|mesh-list
110691062|NCT00293020|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110691063|NCT00293020|Narcotics|narcotics|mesh-ancestor
110691064|NCT00293020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110691065|NCT00293020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110691066|NCT00293020|Analgesics|analgesics|mesh-ancestor
110691067|NCT00293020|Sensory System Agents|sensory system agents|mesh-ancestor
110691068|NCT00293020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110691069|NCT00293020|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110691070|NCT00293020|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110691071|NCT00293020|Anesthetics, General|anesthetics, general|mesh-ancestor
110691072|NCT00293020|Anesthetics|anesthetics|mesh-ancestor
110691073|NCT00377637|Mycophenolic Acid|mycophenolic acid|mesh-list
110691074|NCT00377637|Cyclophosphamide|cyclophosphamide|mesh-list
110691075|NCT00377637|Azathioprine|azathioprine|mesh-list
110691076|NCT00377637|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110691077|NCT00377637|Immunologic Factors|immunologic factors|mesh-ancestor
110691078|NCT00377637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110691079|NCT00377637|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110691080|NCT00377637|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110691081|NCT00377637|Alkylating Agents|alkylating agents|mesh-ancestor
110691082|NCT00377637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110683012|NCT00904631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110691083|NCT00377637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110691084|NCT00377637|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110691085|NCT00377637|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110691086|NCT00377637|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110691087|NCT00377637|Antitubercular Agents|antitubercular agents|mesh-ancestor
110691088|NCT00377637|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110691089|NCT00377637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110691090|NCT00377637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110857736|NCT05726734|Antacids|antacids|mesh-ancestor
110691092|NCT00377637|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110691093|NCT00377403|Acetaminophen|acetaminophen|mesh-list
110691094|NCT00377403|Amoxicillin|amoxicillin|mesh-list
110691095|NCT00377403|Phenylpropanolamine|phenylpropanolamine|mesh-list
110691096|NCT00377403|Pseudoephedrine|pseudoephedrine|mesh-list
110691097|NCT00377403|Ephedrine|ephedrine|mesh-list
110691098|NCT00377403|Dextromethorphan|dextromethorphan|mesh-list
110691099|NCT00377403|Guaifenesin|guaifenesin|mesh-list
110691100|NCT00377403|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
110691101|NCT00377403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110691102|NCT00377403|Analgesics|analgesics|mesh-ancestor
110691103|NCT00377403|Sensory System Agents|sensory system agents|mesh-ancestor
110691104|NCT00377403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110691105|NCT00377403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110691106|NCT00377403|Antipyretics|antipyretics|mesh-ancestor
110691107|NCT00377403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110691108|NCT00377403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110691109|NCT00377403|Antitussive Agents|antitussive agents|mesh-ancestor
110691110|NCT00377403|Respiratory System Agents|respiratory system agents|mesh-ancestor
110691111|NCT00377403|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110691112|NCT00377403|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110691113|NCT00377403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110691114|NCT00377403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110691115|NCT00377403|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110691116|NCT00377403|Autonomic Agents|autonomic agents|mesh-ancestor
110691117|NCT00377403|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110691118|NCT00377403|Nasal Decongestants|nasal decongestants|mesh-ancestor
110691119|NCT00377403|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110691120|NCT00377403|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110691121|NCT00377403|Sympathomimetics|sympathomimetics|mesh-ancestor
110691122|NCT00377403|Adrenergic Agents|adrenergic agents|mesh-ancestor
110691123|NCT00377403|Expectorants|expectorants|mesh-ancestor
110691124|NCT00377403|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110691125|NCT00377403|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110691126|NCT00377403|Appetite Depressants|appetite depressants|mesh-ancestor
110691127|NCT00377403|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110691128|NCT00370149|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110691129|NCT00370149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110691131|NCT00292942|Mannitol|mannitol|mesh-list
110691132|NCT00292942|Antimalarials|antimalarials|mesh-ancestor
110691133|NCT00292942|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110691134|NCT00292942|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110691135|NCT00292942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110691136|NCT00292942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110691137|NCT00292942|Antiviral Agents|antiviral agents|mesh-ancestor
110691138|NCT00292942|Schistosomicides|schistosomicides|mesh-ancestor
110691139|NCT00292942|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110691140|NCT00292942|Anthelmintics|anthelmintics|mesh-ancestor
110691141|NCT00292942|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110691142|NCT00292942|Diuretics|diuretics|mesh-ancestor
110691143|NCT00292942|Natriuretic Agents|natriuretic agents|mesh-ancestor
110691144|NCT00292942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110691145|NCT00483938|Interferons|interferons|mesh-list
110691146|NCT00483938|Ribavirin|ribavirin|mesh-list
110691147|NCT00483938|Interferon-alpha|interferon-alpha|mesh-list
110691148|NCT00483938|Interferon alpha-2|interferon alpha-2|mesh-list
110691149|NCT00483938|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110691150|NCT00483938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110691151|NCT00483938|Antiviral Agents|antiviral agents|mesh-ancestor
110691152|NCT00483938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110691153|NCT00483938|Antimetabolites|antimetabolites|mesh-ancestor
110691154|NCT00483938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110691155|NCT00483938|Immunologic Factors|immunologic factors|mesh-ancestor
110691156|NCT00483938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110691157|NCT00370071|Interferons|interferons|mesh-list
110409013|NCT03069352|Antiviral Agents|antiviral agents|mesh-ancestor
110691158|NCT00370071|Interferon-beta|interferon-beta|mesh-list
110691159|NCT00370071|Interferon beta-1b|interferon beta-1b|mesh-list
110691160|NCT00370071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110691161|NCT00370071|Antiviral Agents|antiviral agents|mesh-ancestor
110691162|NCT00370071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110691163|NCT00370071|Immunologic Factors|immunologic factors|mesh-ancestor
110691164|NCT00370071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110691165|NCT00370071|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110691166|NCT00369915|Scopolamine|scopolamine|mesh-list
110691167|NCT00369915|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
110691168|NCT00369915|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110691169|NCT00369915|Antiemetics|antiemetics|mesh-ancestor
110691170|NCT00369915|Autonomic Agents|autonomic agents|mesh-ancestor
110691171|NCT00369915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110691172|NCT00369915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110691173|NCT00369915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110691174|NCT00369915|Mydriatics|mydriatics|mesh-ancestor
110691175|NCT00369915|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110691176|NCT00369915|Cholinergic Agents|cholinergic agents|mesh-ancestor
110691177|NCT00369915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110691178|NCT00369915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110691179|NCT00369915|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110691180|NCT00369915|Parasympatholytics|parasympatholytics|mesh-ancestor
110691181|NCT03991845|Levocetirizine|levocetirizine|mesh-list
110691182|NCT03991845|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110691183|NCT03991845|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110691184|NCT03991845|Histamine Antagonists|histamine antagonists|mesh-ancestor
110691185|NCT03991845|Histamine Agents|histamine agents|mesh-ancestor
110691186|NCT03991845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110691187|NCT03991845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110691188|NCT03991845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110691189|NCT01017380|Celecoxib|celecoxib|mesh-list
110691190|NCT01017380|Etoricoxib|etoricoxib|mesh-list
110691191|NCT01017380|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110691192|NCT01017380|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110691193|NCT01017380|Analgesics|analgesics|mesh-ancestor
110691194|NCT01017380|Sensory System Agents|sensory system agents|mesh-ancestor
110691195|NCT01017380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110691196|NCT01017380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110691197|NCT01017380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110691198|NCT01017380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110691199|NCT01017380|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110691200|NCT01017380|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110691201|NCT01017380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110691202|NCT01017380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110691203|NCT00369681|Rituximab|rituximab|mesh-list
110691205|NCT00369681|Dacarbazine|dacarbazine|mesh-list
110691206|NCT00369681|Bleomycin|bleomycin|mesh-list
110691207|NCT00369681|Vinblastine|vinblastine|mesh-list
110691208|NCT00369681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110691209|NCT00369681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110691210|NCT00369681|Immunologic Factors|immunologic factors|mesh-ancestor
110691211|NCT00369681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110691212|NCT00369681|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110691213|NCT00369681|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110691214|NCT00369681|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110691215|NCT00369681|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110691216|NCT00369681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110691217|NCT00369681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110691218|NCT00369681|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110691219|NCT00369681|Alkylating Agents|alkylating agents|mesh-ancestor
110691220|NCT00369681|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110691221|NCT00369681|Tubulin Modulators|tubulin modulators|mesh-ancestor
110691222|NCT00369681|Antimitotic Agents|antimitotic agents|mesh-ancestor
110691223|NCT00369681|Mitosis Modulators|mitosis modulators|mesh-ancestor
110691224|NCT00266812|Temozolomide|temozolomide|mesh-list
110691225|NCT00266812|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110691226|NCT00266812|Alkylating Agents|alkylating agents|mesh-ancestor
110691227|NCT00266812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110691228|NCT00266812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110691229|NCT04249544|Pramipexole|pramipexole|mesh-list
110691230|NCT04249544|Antioxidants|antioxidants|mesh-ancestor
110691231|NCT04249544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110691232|NCT04249544|Protective Agents|protective agents|mesh-ancestor
110691233|NCT04249544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110691234|NCT04249544|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110691235|NCT04249544|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110691237|NCT04249544|Dopamine Agents|dopamine agents|mesh-ancestor
110691238|NCT04249544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110691239|NCT00488774|Golimumab|golimumab|mesh-list
110691240|NCT00488774|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110691241|NCT00488774|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110691242|NCT00488774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110691243|NCT00488774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110691244|NCT00488774|Immunologic Factors|immunologic factors|mesh-ancestor
110691245|NCT00488774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110691246|NCT00361569|Estrogens|estrogens|mesh-list
110691247|NCT00361569|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
110691248|NCT00361569|Estrogens, conjugated synthetic A|estrogens, conjugated synthetic a|mesh-list
110691249|NCT00361569|Hormones|hormones|mesh-ancestor
110691250|NCT00361569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110691251|NCT00361569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110691252|NCT01011998|Imatinib Mesylate|imatinib mesylate|mesh-list
110691253|NCT01011998|Valproic Acid|valproic acid|mesh-list
110691254|NCT01011998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110691255|NCT01011998|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110691256|NCT01011998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110691257|NCT01011998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110691258|NCT01011998|Anticonvulsants|anticonvulsants|mesh-ancestor
110691259|NCT01011998|GABA Agents|gaba agents|mesh-ancestor
110691260|NCT01011998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110691261|NCT01011998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110691262|NCT01011998|Antimanic Agents|antimanic agents|mesh-ancestor
110691263|NCT01011998|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110691264|NCT01011998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110691265|NCT01011998|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110691266|NCT01017458|Methyltestosterone|methyltestosterone|mesh-list
110691267|NCT01017458|Testosterone|testosterone|mesh-list
110691268|NCT01017458|Testosterone undecanoate|testosterone undecanoate|mesh-list
110691269|NCT01017458|Testosterone enanthate|testosterone enanthate|mesh-list
110691270|NCT01017458|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
110691271|NCT01017458|Androgens|androgens|mesh-ancestor
110691272|NCT01017458|Hormones|hormones|mesh-ancestor
110691273|NCT01017458|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110691274|NCT01017458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110691275|NCT01017458|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110691276|NCT01017458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110691277|NCT01017458|Anabolic Agents|anabolic agents|mesh-ancestor
110691278|NCT02534415|Hyaluronic Acid|hyaluronic acid|mesh-list
110691279|NCT02534415|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110691280|NCT02534415|Immunologic Factors|immunologic factors|mesh-ancestor
110691281|NCT02534415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110691282|NCT02534415|Viscosupplements|viscosupplements|mesh-ancestor
110691283|NCT02534415|Protective Agents|protective agents|mesh-ancestor
110691284|NCT00488618|Cariprazine|cariprazine|mesh-list
110691285|NCT00488618|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110691286|NCT00488618|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110691287|NCT00488618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110691288|NCT00488618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110691289|NCT00488618|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110691290|NCT01019642|Cholecalciferol|cholecalciferol|mesh-list
110691291|NCT01019642|Vitamin D|vitamin d|mesh-list
110691292|NCT01019642|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110691293|NCT01019642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110691294|NCT01019642|Vitamins|vitamins|mesh-ancestor
110691295|NCT01019642|Micronutrients|micronutrients|mesh-ancestor
110691296|NCT01019642|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110691297|NCT00266656|Hormones|hormones|mesh-list
110657199|NCT05525858|Immunotoxins|immunotoxins|mesh-ancestor
110691298|NCT00266656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110691299|NCT00266656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110691300|NCT00483548|Ziprasidone|ziprasidone|mesh-list
110691301|NCT00483548|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110691302|NCT00483548|Serotonin Agents|serotonin agents|mesh-ancestor
110691303|NCT00483548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110691304|NCT00483548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110691305|NCT00483548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110691306|NCT00483548|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110691307|NCT00483548|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110691308|NCT00483548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110691309|NCT00483548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110691310|NCT00483548|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110691311|NCT00483548|Dopamine Agents|dopamine agents|mesh-ancestor
110691312|NCT00445770|Etanercept|etanercept|mesh-list
110691313|NCT00445770|Methotrexate|methotrexate|mesh-list
110691314|NCT00445770|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110691315|NCT00445770|Abortifacient Agents|abortifacient agents|mesh-ancestor
110691316|NCT00445770|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110691317|NCT00445770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110691318|NCT00445770|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110691319|NCT00445770|Antimetabolites|antimetabolites|mesh-ancestor
110691320|NCT00445770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110691321|NCT00445770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110691322|NCT00445770|Dermatologic Agents|dermatologic agents|mesh-ancestor
110691323|NCT00445770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110691324|NCT00445770|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110691325|NCT00445770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110691326|NCT00445770|Immunologic Factors|immunologic factors|mesh-ancestor
110691327|NCT00445770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110691328|NCT00445770|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110691329|NCT00445770|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110691330|NCT00445770|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110691331|NCT00445770|Analgesics|analgesics|mesh-ancestor
110691332|NCT00445770|Sensory System Agents|sensory system agents|mesh-ancestor
110691333|NCT00445770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110691334|NCT00445770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110691335|NCT00445770|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110691336|NCT00266032|Drospirenone|drospirenone|mesh-list
110691337|NCT00266032|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110691338|NCT00266032|Hormone Antagonists|hormone antagonists|mesh-ancestor
110691339|NCT00266032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110691340|NCT00266032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110691341|NCT00266032|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110691342|NCT00266032|Diuretics|diuretics|mesh-ancestor
110691343|NCT00266032|Natriuretic Agents|natriuretic agents|mesh-ancestor
110691345|NCT01019798|Sunitinib|sunitinib|mesh-list
110691346|NCT01019798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110691347|NCT01019798|Tubulin Modulators|tubulin modulators|mesh-ancestor
110691348|NCT01019798|Antimitotic Agents|antimitotic agents|mesh-ancestor
110691349|NCT01019798|Mitosis Modulators|mitosis modulators|mesh-ancestor
110691350|NCT01019798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110691351|NCT01019798|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110691352|NCT01019798|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110691353|NCT01019798|Growth Substances|growth substances|mesh-ancestor
110691354|NCT01019798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110691355|NCT01019798|Growth Inhibitors|growth inhibitors|mesh-ancestor
110691356|NCT01019798|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110691357|NCT01019798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110691358|NCT00483002|Varenicline|varenicline|mesh-list
110691359|NCT00483002|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110691360|NCT00483002|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110691361|NCT00483002|Cholinergic Agents|cholinergic agents|mesh-ancestor
110691362|NCT00483002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110691363|NCT00483002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110691364|NCT00483002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110691365|NCT00482612|Mirtazapine|mirtazapine|mesh-list
110691366|NCT00482612|Antidepressive Agents|antidepressive agents|mesh-ancestor
110691367|NCT00482612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110691368|NCT00482612|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110691369|NCT00482612|Histamine Antagonists|histamine antagonists|mesh-ancestor
110691370|NCT00482612|Histamine Agents|histamine agents|mesh-ancestor
110691371|NCT00482612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110691372|NCT00482612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110691373|NCT00482612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110691374|NCT00482612|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110691375|NCT00482612|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110691376|NCT00482612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110691377|NCT00482612|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
110691378|NCT00482612|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110691379|NCT00482612|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110691380|NCT00482612|Adrenergic Agents|adrenergic agents|mesh-ancestor
110691381|NCT00482612|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110691382|NCT00482612|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110691383|NCT00482612|Serotonin Agents|serotonin agents|mesh-ancestor
110691384|NCT00482612|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110691386|NCT00282568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110691387|NCT00282568|Immunologic Factors|immunologic factors|mesh-ancestor
110691388|NCT00282568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110691389|NCT00282568|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110691390|NCT00282568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110691391|NCT00282568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110691392|NCT02532322|Acetaminophen|acetaminophen|mesh-list
110691393|NCT02532322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110691394|NCT02532322|Analgesics|analgesics|mesh-ancestor
110691395|NCT02532322|Sensory System Agents|sensory system agents|mesh-ancestor
110691396|NCT02532322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110691397|NCT02532322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110691398|NCT02532322|Antipyretics|antipyretics|mesh-ancestor
110691399|NCT00445692|Clarithromycin|clarithromycin|mesh-list
110691400|NCT00445692|Dexamethasone|dexamethasone|mesh-list
110691401|NCT00445692|Dexamethasone acetate|dexamethasone acetate|mesh-list
110691402|NCT00445692|Lenalidomide|lenalidomide|mesh-list
110691403|NCT00445692|Ichthammol|ichthammol|mesh-list
110691404|NCT00445692|BB 1101|bb 1101|mesh-list
110691405|NCT00445692|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110691406|NCT00445692|Antiemetics|antiemetics|mesh-ancestor
110691407|NCT00445692|Autonomic Agents|autonomic agents|mesh-ancestor
110691408|NCT00445692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110691409|NCT00445692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110691410|NCT00445692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110691411|NCT00445692|Glucocorticoids|glucocorticoids|mesh-ancestor
110691412|NCT00445692|Hormones|hormones|mesh-ancestor
110691413|NCT00445692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110691414|NCT00445692|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110691415|NCT00445692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110691416|NCT00445692|Immunologic Factors|immunologic factors|mesh-ancestor
110691417|NCT00445692|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110691418|NCT00445692|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110691419|NCT00445692|Growth Substances|growth substances|mesh-ancestor
110691420|NCT00445692|Growth Inhibitors|growth inhibitors|mesh-ancestor
110691421|NCT00445692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110691422|NCT00445692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110691423|NCT00445692|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110691424|NCT00445692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110691425|NCT00445692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110691426|NCT00445692|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110691427|NCT00445692|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110691428|NCT00445692|Protease Inhibitors|protease inhibitors|mesh-ancestor
110691429|NCT00445692|Dermatologic Agents|dermatologic agents|mesh-ancestor
110691430|NCT00282412|Cyclosporine|cyclosporine|mesh-list
110691431|NCT00282412|Mycophenolic Acid|mycophenolic acid|mesh-list
110691432|NCT00282412|Cyclophosphamide|cyclophosphamide|mesh-list
110691433|NCT00282412|Fludarabine|fludarabine|mesh-list
110691434|NCT00282412|Alemtuzumab|alemtuzumab|mesh-list
110691435|NCT00282412|Cyclosporins|cyclosporins|mesh-list
110691436|NCT00282412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110691437|NCT00282412|Immunologic Factors|immunologic factors|mesh-ancestor
110691438|NCT00282412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110691439|NCT00282412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110691440|NCT00282412|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110691441|NCT00282412|Alkylating Agents|alkylating agents|mesh-ancestor
110691442|NCT00282412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110691443|NCT00282412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110691444|NCT00282412|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110691445|NCT00282412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110691446|NCT00282412|Antifungal Agents|antifungal agents|mesh-ancestor
110691447|NCT00282412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110691448|NCT00282412|Dermatologic Agents|dermatologic agents|mesh-ancestor
110691449|NCT00282412|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110691450|NCT00282412|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110691451|NCT00282412|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110691452|NCT00282412|Antitubercular Agents|antitubercular agents|mesh-ancestor
110691453|NCT00282412|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110691454|NCT00282412|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110691455|NCT00282256|Tacrolimus|tacrolimus|mesh-list
110691456|NCT00282256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110691457|NCT00282256|Immunologic Factors|immunologic factors|mesh-ancestor
110691458|NCT00282256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110691459|NCT00282256|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110691460|NCT00282256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110691461|NCT00282256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110691463|NCT00265330|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110691464|NCT00265330|Serotonin Agents|serotonin agents|mesh-ancestor
110691465|NCT00265330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110691466|NCT00265330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110691467|NCT00265330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110691468|NCT00265330|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110691469|NCT00265330|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110691470|NCT00265330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110691471|NCT00265330|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110691472|NCT00265330|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110691473|NCT00265330|Dopamine Agents|dopamine agents|mesh-ancestor
110691474|NCT00543569|Mycophenolic Acid|mycophenolic acid|mesh-list
110691475|NCT00543569|Alefacept|alefacept|mesh-list
110691476|NCT00543569|Tacrolimus|tacrolimus|mesh-list
110691477|NCT00543569|Basiliximab|basiliximab|mesh-list
110691478|NCT00543569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110691479|NCT00543569|Immunologic Factors|immunologic factors|mesh-ancestor
110691480|NCT00543569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110691481|NCT00543569|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110691482|NCT00543569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110691483|NCT00543569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110691484|NCT00543569|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110691485|NCT00543569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110691486|NCT00543569|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110691487|NCT00543569|Antitubercular Agents|antitubercular agents|mesh-ancestor
110691488|NCT00543569|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110691489|NCT00543569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110691490|NCT00543569|Dermatologic Agents|dermatologic agents|mesh-ancestor
110691491|NCT00984347|Oxytocin|oxytocin|mesh-list
110691492|NCT00984347|Oxytocics|oxytocics|mesh-ancestor
110691493|NCT00984347|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110691494|NCT00984347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110691495|NCT00984425|Sorafenib|sorafenib|mesh-list
110691496|NCT00984425|Lapatinib|lapatinib|mesh-list
110691497|NCT00984425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110691498|NCT00984425|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110691499|NCT00984425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110691500|NCT00984425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110691501|NCT05596955|Naltrexone|naltrexone|mesh-list
110691502|NCT05596955|Buprenorphine|buprenorphine|mesh-list
110691503|NCT05596955|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110691504|NCT05596955|Narcotics|narcotics|mesh-ancestor
110691505|NCT05596955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110691506|NCT05596955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110691507|NCT05596955|Analgesics|analgesics|mesh-ancestor
110691508|NCT05596955|Sensory System Agents|sensory system agents|mesh-ancestor
110691509|NCT05596955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110691510|NCT05596955|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110691511|NCT05596955|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110691512|NCT00445458|Paclitaxel|paclitaxel|mesh-list
110691513|NCT00445458|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110691514|NCT00445458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110691515|NCT00445458|Tubulin Modulators|tubulin modulators|mesh-ancestor
110211520|NCT00097071|Insulin Lispro|insulin lispro|mesh-list
110691516|NCT00445458|Antimitotic Agents|antimitotic agents|mesh-ancestor
110691517|NCT00445458|Mitosis Modulators|mitosis modulators|mesh-ancestor
110691518|NCT00445458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110691519|NCT03914417|Imiquimod|imiquimod|mesh-list
110691520|NCT03914417|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110691521|NCT03914417|Immunologic Factors|immunologic factors|mesh-ancestor
110691522|NCT03914417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110691523|NCT03914417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110691524|NCT03914417|Interferon Inducers|interferon inducers|mesh-ancestor
110691525|NCT05586113|Bismuth|bismuth|mesh-list
110691526|NCT05586113|Antacids|antacids|mesh-ancestor
110691527|NCT05586113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110691528|NCT05586113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110691529|NCT00541385|Artesunate|artesunate|mesh-list
110691530|NCT00541385|Lumefantrine|lumefantrine|mesh-list
110691531|NCT00541385|Pyronaridine|pyronaridine|mesh-list
110691532|NCT00541385|Pyronaridine tetraphosphate, artesunate drug combination|pyronaridine tetraphosphate, artesunate drug combination|mesh-list
110691533|NCT00541385|Antimalarials|antimalarials|mesh-ancestor
110691534|NCT00541385|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110408491|NCT05435235|Dapagliflozin|dapagliflozin|mesh-list
110691535|NCT00541385|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110691536|NCT00541385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110691537|NCT00541385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110691540|NCT00541385|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110691541|NCT00541385|Anthelmintics|anthelmintics|mesh-ancestor
110691542|NCT00988949|Spiradoline|spiradoline|mesh-list
110691543|NCT00988949|Analgesics|analgesics|mesh-ancestor
110691544|NCT00988949|Sensory System Agents|sensory system agents|mesh-ancestor
110691545|NCT00988949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110691546|NCT00988949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110691547|NCT00988949|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110691548|NCT00988949|Diuretics|diuretics|mesh-ancestor
110691549|NCT00988949|Natriuretic Agents|natriuretic agents|mesh-ancestor
110691550|NCT00989027|Oxytocin|oxytocin|mesh-list
110691551|NCT00989027|Carboprost|carboprost|mesh-list
110691552|NCT00989027|Carboprost tromethamine|carboprost tromethamine|mesh-list
110691553|NCT00989027|Ergonovine|ergonovine|mesh-list
110691554|NCT00989027|Oxytocics|oxytocics|mesh-ancestor
110691555|NCT00989027|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110691556|NCT00989027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110691557|NCT00989027|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110691558|NCT00989027|Abortifacient Agents|abortifacient agents|mesh-ancestor
110691559|NCT00265096|Golimumab|golimumab|mesh-list
110691560|NCT00265096|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110691561|NCT00265096|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110691562|NCT00265096|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110691563|NCT00265096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110691564|NCT00265096|Immunologic Factors|immunologic factors|mesh-ancestor
110691565|NCT00265096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110691566|NCT00986609|Poly I-C|poly i-c|mesh-list
110691567|NCT00986609|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
110691568|NCT00986609|Vaccines|vaccines|mesh-list
110691569|NCT00986609|Poly ICLC|poly iclc|mesh-list
110691570|NCT00986609|Adjuvants, Vaccine|adjuvants, vaccine|mesh-list
110691571|NCT00986609|Immunologic Factors|immunologic factors|mesh-ancestor
110691572|NCT00986609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110691573|NCT00986609|Interferon Inducers|interferon inducers|mesh-ancestor
110691574|NCT00986609|Laxatives|laxatives|mesh-ancestor
110691575|NCT00986609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110691576|NCT00986609|Antiviral Agents|antiviral agents|mesh-ancestor
110691577|NCT00986609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110691578|NCT00986609|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110691579|NCT00281320|Asenapine|asenapine|mesh-list
110691580|NCT00281320|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110691581|NCT00281320|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110691582|NCT00281320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110691583|NCT00281320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110691584|NCT00281320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110691585|NCT00541307|Heparin|heparin|mesh-list
110691586|NCT00541307|Anticoagulants|anticoagulants|mesh-ancestor
110691587|NCT00541307|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110691588|NCT00541307|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110691589|NCT00541307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110691590|NCT05003258|Dexamethasone|dexamethasone|mesh-list
110691591|NCT05003258|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110691592|NCT05003258|Antiemetics|antiemetics|mesh-ancestor
110691593|NCT05003258|Autonomic Agents|autonomic agents|mesh-ancestor
110691594|NCT05003258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110691595|NCT05003258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110691596|NCT05003258|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110691597|NCT05003258|Glucocorticoids|glucocorticoids|mesh-ancestor
110691598|NCT05003258|Hormones|hormones|mesh-ancestor
110691599|NCT05003258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110691600|NCT05003258|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110691601|NCT05003258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110691602|NCT05499689|Bupivacaine|bupivacaine|mesh-list
110691603|NCT05499689|Anesthetics, Local|anesthetics, local|mesh-ancestor
110691604|NCT05499689|Anesthetics|anesthetics|mesh-ancestor
110691605|NCT05499689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110691606|NCT05499689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110691607|NCT05499689|Sensory System Agents|sensory system agents|mesh-ancestor
110691608|NCT05499689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110691609|NCT01012232|Ropivacaine|ropivacaine|mesh-list
110691610|NCT01012232|Anesthetics, Local|anesthetics, local|mesh-ancestor
110691611|NCT01012232|Anesthetics|anesthetics|mesh-ancestor
110691612|NCT01012232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110691613|NCT01012232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110691614|NCT01012232|Sensory System Agents|sensory system agents|mesh-ancestor
110691615|NCT01012232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110691616|NCT00541229|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110691617|NCT00541229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110691618|NCT00541229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110691619|NCT00541229|Incretins|incretins|mesh-ancestor
110691620|NCT00541229|Hormones|hormones|mesh-ancestor
110691621|NCT00541229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110691622|NCT00541229|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110691623|NCT00541229|Protease Inhibitors|protease inhibitors|mesh-ancestor
110691624|NCT00541229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110691625|NCT00541229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110691626|NCT04006691|Mitomycins|mitomycins|mesh-list
110691627|NCT04006691|Mitomycin|mitomycin|mesh-list
110691628|NCT04006691|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110691629|NCT04006691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110691630|NCT04006691|Alkylating Agents|alkylating agents|mesh-ancestor
110691631|NCT04006691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110691632|NCT04006691|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110691633|NCT04006691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110691634|NCT00986765|Aspirin|aspirin|mesh-list
110691635|NCT00986765|Enoxaparin|enoxaparin|mesh-list
110691636|NCT00986765|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110691637|NCT00986765|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110691638|NCT00986765|Analgesics|analgesics|mesh-ancestor
110691639|NCT00986765|Sensory System Agents|sensory system agents|mesh-ancestor
110691640|NCT00986765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110858009|NCT03136068|Digoxin|digoxin|mesh-list
110691641|NCT00986765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110691642|NCT00986765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110691643|NCT00986765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110691644|NCT00986765|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110691645|NCT00986765|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110691646|NCT00986765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110691647|NCT00986765|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110691648|NCT00986765|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110691649|NCT00986765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110691650|NCT00986765|Antipyretics|antipyretics|mesh-ancestor
110691651|NCT00986765|Anticoagulants|anticoagulants|mesh-ancestor
110691652|NCT00986843|Irinotecan|irinotecan|mesh-list
110691653|NCT00986843|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110691654|NCT00986843|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110691655|NCT00986843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110691656|NCT00986843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110691657|NCT00986843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110691658|NCT01019876|Cyclophosphamide|cyclophosphamide|mesh-list
110691659|NCT01019876|Fludarabine|fludarabine|mesh-list
110691660|NCT01019876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110691661|NCT01019876|Immunologic Factors|immunologic factors|mesh-ancestor
110691662|NCT01019876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110691663|NCT01019876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110657211|NCT05524584|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110691664|NCT01019876|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110691665|NCT01019876|Alkylating Agents|alkylating agents|mesh-ancestor
110691666|NCT01019876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110691667|NCT01019876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110691668|NCT01019876|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110691669|NCT05463419|Vaccines|vaccines|mesh-list
110691670|NCT05463419|Immunologic Factors|immunologic factors|mesh-ancestor
110691671|NCT05463419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110691672|NCT01017770|Artesunate|artesunate|mesh-list
110691673|NCT01017770|Lumefantrine|lumefantrine|mesh-list
110691674|NCT01017770|Artemether|artemether|mesh-list
110691675|NCT01017770|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
110691676|NCT01017770|Amodiaquine|amodiaquine|mesh-list
110691677|NCT01017770|Antimalarials|antimalarials|mesh-ancestor
110691678|NCT01017770|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110691679|NCT01017770|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110691680|NCT01017770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110691681|NCT01017770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110691682|NCT01017770|Antiviral Agents|antiviral agents|mesh-ancestor
110691683|NCT01017770|Schistosomicides|schistosomicides|mesh-ancestor
110691684|NCT01017770|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110691685|NCT01017770|Anthelmintics|anthelmintics|mesh-ancestor
110691686|NCT01017926|Triazolam|triazolam|mesh-list
110691687|NCT01017926|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110691688|NCT01017926|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110691689|NCT01017926|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110691690|NCT01017926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110691691|NCT01017926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110691692|NCT01017926|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110691693|NCT01017926|GABA Modulators|gaba modulators|mesh-ancestor
110691694|NCT01017926|GABA Agents|gaba agents|mesh-ancestor
110691695|NCT01017926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110691696|NCT01017926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110691697|NCT00481832|Cyclosporine|cyclosporine|mesh-list
110691698|NCT00481832|Mycophenolic Acid|mycophenolic acid|mesh-list
110691699|NCT00481832|Methylprednisolone|methylprednisolone|mesh-list
110691700|NCT00481832|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110691701|NCT00481832|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110691702|NCT00481832|Prednisolone|prednisolone|mesh-list
110691703|NCT00481832|Prednisolone acetate|prednisolone acetate|mesh-list
110691704|NCT00481832|Cyclophosphamide|cyclophosphamide|mesh-list
110691705|NCT00481832|Carmustine|carmustine|mesh-list
110691706|NCT00481832|Rituximab|rituximab|mesh-list
110691707|NCT00481832|Etoposide|etoposide|mesh-list
110691708|NCT00481832|Cyclosporins|cyclosporins|mesh-list
110691709|NCT00481832|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110691710|NCT00481832|Lenograstim|lenograstim|mesh-list
110691711|NCT00481832|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110691712|NCT00481832|Prednisolone phosphate|prednisolone phosphate|mesh-list
110691713|NCT00481832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110691714|NCT00481832|Immunologic Factors|immunologic factors|mesh-ancestor
110691715|NCT00481832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110691716|NCT00481832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110691717|NCT00481832|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110691718|NCT00481832|Alkylating Agents|alkylating agents|mesh-ancestor
110691719|NCT00481832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110691720|NCT00481832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110691721|NCT00481832|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110691722|NCT00481832|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110691723|NCT00481832|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110691724|NCT00481832|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110691725|NCT00481832|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110691726|NCT00481832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110691727|NCT00481832|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110691728|NCT00481832|Antifungal Agents|antifungal agents|mesh-ancestor
110691729|NCT00481832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110691730|NCT00481832|Dermatologic Agents|dermatologic agents|mesh-ancestor
110691731|NCT00481832|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110691732|NCT00481832|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110691733|NCT00481832|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110691734|NCT00481832|Antitubercular Agents|antitubercular agents|mesh-ancestor
110691735|NCT00481832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110691736|NCT00481832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110691737|NCT00481832|Antiemetics|antiemetics|mesh-ancestor
110691738|NCT00481832|Autonomic Agents|autonomic agents|mesh-ancestor
110691739|NCT00481832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110691740|NCT00481832|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110691741|NCT00481832|Glucocorticoids|glucocorticoids|mesh-ancestor
110691742|NCT00481832|Hormones|hormones|mesh-ancestor
110691743|NCT00481832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110691744|NCT00481832|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110691745|NCT00481832|Protective Agents|protective agents|mesh-ancestor
110691746|NCT00481832|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110691747|NCT00481676|Omalizumab|omalizumab|mesh-list
110691748|NCT00481676|Loratadine|loratadine|mesh-list
110691749|NCT00481676|Clemastine|clemastine|mesh-list
110691750|NCT00481676|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110691751|NCT00481676|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110691752|NCT00481676|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110691753|NCT00481676|Respiratory System Agents|respiratory system agents|mesh-ancestor
110691754|NCT00481676|Immunologic Factors|immunologic factors|mesh-ancestor
110691755|NCT00481676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110691756|NCT00481676|Antipruritics|antipruritics|mesh-ancestor
110691757|NCT00481676|Dermatologic Agents|dermatologic agents|mesh-ancestor
110691758|NCT00481676|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110691759|NCT00481676|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110691760|NCT00481676|Histamine Antagonists|histamine antagonists|mesh-ancestor
110691761|NCT00481676|Histamine Agents|histamine agents|mesh-ancestor
110691762|NCT00481676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110691763|NCT00481676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110691764|NCT00987233|Triamcinolone|triamcinolone|mesh-list
110691765|NCT00987233|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110691766|NCT00987233|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110691767|NCT00987233|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110691768|NCT00987233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110691769|NCT00987233|Glucocorticoids|glucocorticoids|mesh-ancestor
110691770|NCT00987233|Hormones|hormones|mesh-ancestor
110691771|NCT00987233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110691772|NCT00987233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110691773|NCT00987233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110691774|NCT00987233|Immunologic Factors|immunologic factors|mesh-ancestor
110691775|NCT00987233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110691776|NCT00987233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110691777|NCT04377503|Methylprednisolone|methylprednisolone|mesh-list
110691778|NCT04377503|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110691779|NCT04377503|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110691780|NCT04377503|Prednisolone|prednisolone|mesh-list
110691781|NCT04377503|Prednisolone acetate|prednisolone acetate|mesh-list
110691782|NCT04377503|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110691783|NCT04377503|Prednisolone phosphate|prednisolone phosphate|mesh-list
110691784|NCT04377503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110691786|NCT04377503|Autonomic Agents|autonomic agents|mesh-ancestor
110691787|NCT04377503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110691788|NCT04377503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110691789|NCT04377503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110691790|NCT04377503|Glucocorticoids|glucocorticoids|mesh-ancestor
110691791|NCT04377503|Hormones|hormones|mesh-ancestor
110691792|NCT04377503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110691793|NCT04377503|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110691794|NCT04377503|Protective Agents|protective agents|mesh-ancestor
110691795|NCT04377503|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110691796|NCT04377503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110691797|NCT00542789|Esomeprazole|esomeprazole|mesh-list
110691798|NCT00542789|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110691799|NCT00542789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110691800|NCT00542789|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110691801|NCT00542789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110691802|NCT00542789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110691803|NCT00464672|Vaccines|vaccines|mesh-list
110691804|NCT00464672|Immunologic Factors|immunologic factors|mesh-ancestor
110691805|NCT00464672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110691806|NCT03996434|Cetrorelix|cetrorelix|mesh-list
110691807|NCT03996434|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110691808|NCT03996434|Fertility Agents|fertility agents|mesh-ancestor
110691809|NCT03996434|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110691810|NCT03996434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110691811|NCT03996434|Hormone Antagonists|hormone antagonists|mesh-ancestor
110691812|NCT03996434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110691813|NCT00987779|Gabapentin|gabapentin|mesh-list
110691814|NCT00987779|Analgesics|analgesics|mesh-ancestor
110691815|NCT00987779|Sensory System Agents|sensory system agents|mesh-ancestor
110691816|NCT00987779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110691817|NCT00987779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110691818|NCT00987779|Anticonvulsants|anticonvulsants|mesh-ancestor
110691819|NCT00987779|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110691820|NCT00987779|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110691821|NCT00987779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110691822|NCT00987779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110691823|NCT00987779|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110691824|NCT00987779|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110691825|NCT00987779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110691826|NCT00987779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110691827|NCT00987779|Antimanic Agents|antimanic agents|mesh-ancestor
110691828|NCT01018160|Rabeprazole|rabeprazole|mesh-list
110691829|NCT01018160|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110691830|NCT01018160|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110691831|NCT01018160|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110691832|NCT01018160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110691833|NCT01018160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110691834|NCT00473876|Metformin|metformin|mesh-list
110691835|NCT00473876|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110691836|NCT00473876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110691837|NCT00463580|Infliximab|infliximab|mesh-list
110691838|NCT00463580|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110691839|NCT00463580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110691840|NCT00463580|Dermatologic Agents|dermatologic agents|mesh-ancestor
110691841|NCT00463580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110691842|NCT00463580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110691843|NCT01020734|Cyclosporine|cyclosporine|mesh-list
110691844|NCT01020734|Cyclophosphamide|cyclophosphamide|mesh-list
110691845|NCT01020734|Busulfan|busulfan|mesh-list
110691846|NCT01020734|Methotrexate|methotrexate|mesh-list
110691847|NCT01020734|Fludarabine|fludarabine|mesh-list
110691848|NCT01020734|Fludarabine phosphate|fludarabine phosphate|mesh-list
110691849|NCT01020734|Cyclosporins|cyclosporins|mesh-list
110691850|NCT01020734|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110691851|NCT01020734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110691852|NCT01020734|Immunologic Factors|immunologic factors|mesh-ancestor
110691853|NCT01020734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110691854|NCT01020734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110691855|NCT01020734|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110691856|NCT01020734|Alkylating Agents|alkylating agents|mesh-ancestor
110691857|NCT01020734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110691858|NCT01020734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110691859|NCT01020734|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110691860|NCT01020734|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110691861|NCT01020734|Abortifacient Agents|abortifacient agents|mesh-ancestor
110691862|NCT01020734|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110691863|NCT01020734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110691864|NCT01020734|Antimetabolites|antimetabolites|mesh-ancestor
110691865|NCT01020734|Dermatologic Agents|dermatologic agents|mesh-ancestor
110691866|NCT01020734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110691867|NCT01020734|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110691868|NCT01020734|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110691869|NCT01020734|Antifungal Agents|antifungal agents|mesh-ancestor
110691870|NCT01020734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110691871|NCT01020734|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110691872|NCT00540449|Efavirenz|efavirenz|mesh-list
110691873|NCT00540449|Rilpivirine|rilpivirine|mesh-list
110691874|NCT00540449|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110691875|NCT00540449|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110691876|NCT00540449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110691877|NCT00540449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110691878|NCT00540449|Antiviral Agents|antiviral agents|mesh-ancestor
110691879|NCT00540449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110691880|NCT00540449|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110691881|NCT00540449|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110691882|NCT00540449|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110691883|NCT00540449|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110691884|NCT00540449|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110691885|NCT00540449|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110691886|NCT00540449|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110691887|NCT00540449|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110691888|NCT03911843|Vitamin D|vitamin d|mesh-list
110691889|NCT03911843|Vitamins|vitamins|mesh-ancestor
110691890|NCT03911843|Micronutrients|micronutrients|mesh-ancestor
110691891|NCT03911843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110691892|NCT03911843|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110691893|NCT00361335|Golimumab|golimumab|mesh-list
110691894|NCT00361335|Methotrexate|methotrexate|mesh-list
110691895|NCT00361335|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110691896|NCT00361335|Abortifacient Agents|abortifacient agents|mesh-ancestor
110691897|NCT00361335|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110691898|NCT00361335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110691899|NCT00361335|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110691900|NCT00361335|Antimetabolites|antimetabolites|mesh-ancestor
110691901|NCT00361335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110691902|NCT00361335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110691903|NCT00361335|Dermatologic Agents|dermatologic agents|mesh-ancestor
110691904|NCT00361335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110691905|NCT00361335|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110691906|NCT00361335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110691907|NCT00361335|Immunologic Factors|immunologic factors|mesh-ancestor
110691908|NCT00361335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110858049|NCT01318590|Anesthetics|anesthetics|mesh-ancestor
110691909|NCT00361335|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110691910|NCT00361335|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110691911|NCT00361335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110691912|NCT00264550|Golimumab|golimumab|mesh-list
110691913|NCT00264550|Methotrexate|methotrexate|mesh-list
110691914|NCT00264550|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110691915|NCT00264550|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110691916|NCT00264550|Abortifacient Agents|abortifacient agents|mesh-ancestor
110691917|NCT00264550|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110691918|NCT00264550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110691919|NCT00264550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110691920|NCT00264550|Antimetabolites|antimetabolites|mesh-ancestor
110691921|NCT00264550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110691922|NCT00264550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110691923|NCT00264550|Dermatologic Agents|dermatologic agents|mesh-ancestor
110691924|NCT00264550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110691925|NCT00264550|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110691926|NCT00264550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110691927|NCT00264550|Immunologic Factors|immunologic factors|mesh-ancestor
110691928|NCT00264550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110691929|NCT00264550|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110691930|NCT00264550|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110691931|NCT00264550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110691932|NCT04004507|Phentolamine|phentolamine|mesh-list
110691933|NCT04004507|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110691934|NCT04004507|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110691935|NCT04004507|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110691936|NCT04004507|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110691937|NCT04004507|Adrenergic Agents|adrenergic agents|mesh-ancestor
110691938|NCT04004507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110691939|NCT04004507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110691940|NCT04004507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110691941|NCT04004507|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110691942|NCT01070290|Capecitabine|capecitabine|mesh-list
110691943|NCT01070290|Oxaliplatin|oxaliplatin|mesh-list
110691944|NCT01070290|Irinotecan|irinotecan|mesh-list
110691945|NCT01070290|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110691946|NCT01070290|Antimetabolites|antimetabolites|mesh-ancestor
110691947|NCT01070290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110691948|NCT01070290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110691949|NCT01070290|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110691950|NCT01070290|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110691951|NCT01070290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110691952|NCT01070446|Choline|choline|mesh-list
110691953|NCT01070446|Lipotropic Agents|lipotropic agents|mesh-ancestor
110691954|NCT01070446|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110691955|NCT01070446|Antimetabolites|antimetabolites|mesh-ancestor
110691956|NCT01070446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110691957|NCT01070446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110691958|NCT01070446|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110691959|NCT01070446|Nootropic Agents|nootropic agents|mesh-ancestor
110691960|NCT01050387|Vitamin D|vitamin d|mesh-list
110691961|NCT01050387|Vitamins|vitamins|mesh-ancestor
110691962|NCT01050387|Micronutrients|micronutrients|mesh-ancestor
110691963|NCT01050387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110691964|NCT01050387|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110691965|NCT01070524|Budesonide|budesonide|mesh-list
110691966|NCT01070524|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
110691967|NCT01070524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110691968|NCT01070524|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110691969|NCT01070524|Autonomic Agents|autonomic agents|mesh-ancestor
110691970|NCT01070524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110691971|NCT01070524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110691972|NCT01070524|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110691973|NCT01070524|Respiratory System Agents|respiratory system agents|mesh-ancestor
110691974|NCT01070524|Glucocorticoids|glucocorticoids|mesh-ancestor
110691975|NCT01070524|Hormones|hormones|mesh-ancestor
110691976|NCT01070524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110691977|NCT01070524|Sympathomimetics|sympathomimetics|mesh-ancestor
110691978|NCT01071304|Midazolam|midazolam|mesh-list
110691979|NCT01071304|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110691980|NCT01071304|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110691981|NCT01071304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110691982|NCT01071304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110691983|NCT01071304|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110691984|NCT01071304|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110691985|NCT01071304|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110691986|NCT01071304|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110691987|NCT01071304|Anesthetics, General|anesthetics, general|mesh-ancestor
110691988|NCT01071304|Anesthetics|anesthetics|mesh-ancestor
110691989|NCT01071304|GABA Modulators|gaba modulators|mesh-ancestor
110691990|NCT01071304|GABA Agents|gaba agents|mesh-ancestor
110691991|NCT01071304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110691992|NCT01071304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110691993|NCT01069042|Enalapril|enalapril|mesh-list
110691994|NCT01069042|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110691995|NCT01069042|Protease Inhibitors|protease inhibitors|mesh-ancestor
110691996|NCT01069042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110691997|NCT01069042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110691998|NCT01069042|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110691999|NCT00368979|Dutasteride|dutasteride|mesh-list
110692000|NCT00368979|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
110692001|NCT00368979|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110692002|NCT00368979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110692003|NCT00368979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110692004|NCT00368979|Hormone Antagonists|hormone antagonists|mesh-ancestor
110692005|NCT00368979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110692006|NCT00368979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110692008|NCT00264238|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110692009|NCT00264238|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110692010|NCT00264238|Dopamine Agents|dopamine agents|mesh-ancestor
110692011|NCT00264238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110692012|NCT00264238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110692013|NCT00264238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110692014|NCT00264238|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110692015|NCT00264238|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110692016|NCT00540293|Atorvastatin|atorvastatin|mesh-list
110692017|NCT00540293|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110692018|NCT00540293|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110692019|NCT00540293|Antimetabolites|antimetabolites|mesh-ancestor
110692020|NCT00540293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110692021|NCT00540293|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110692022|NCT00540293|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110692023|NCT00540293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110692024|NCT01050621|Ascorbic Acid|ascorbic acid|mesh-list
110692025|NCT01050621|Vitamins|vitamins|mesh-ancestor
110692026|NCT01050621|Micronutrients|micronutrients|mesh-ancestor
110692027|NCT01050621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110692028|NCT01050621|Antioxidants|antioxidants|mesh-ancestor
110692029|NCT01050621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110692030|NCT01050621|Protective Agents|protective agents|mesh-ancestor
110692031|NCT00359073|Montelukast|montelukast|mesh-list
110692032|NCT00359073|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110692033|NCT00359073|Respiratory System Agents|respiratory system agents|mesh-ancestor
110692034|NCT00359073|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110692035|NCT00359073|Hormone Antagonists|hormone antagonists|mesh-ancestor
110692036|NCT00359073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110692037|NCT00359073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110692038|NCT00359073|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110692039|NCT00359073|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110692040|NCT00359073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110692041|NCT00368745|Pregabalin|pregabalin|mesh-list
110692042|NCT00368745|Analgesics|analgesics|mesh-ancestor
110692043|NCT00368745|Sensory System Agents|sensory system agents|mesh-ancestor
110692044|NCT00368745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110692045|NCT00368745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110692046|NCT00368745|Anticonvulsants|anticonvulsants|mesh-ancestor
110692047|NCT00368745|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110692048|NCT00368745|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110692049|NCT00368745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110692050|NCT00368745|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110692051|NCT00368745|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110692052|NCT00368745|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110692053|NCT00368745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110692054|NCT00368745|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110692056|NCT04573673|Cathartics|cathartics|mesh-ancestor
110692057|NCT04573673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110692058|NCT04573673|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110692059|NCT04573673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110692060|NCT04573673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110692061|NCT01050699|Fentanyl|fentanyl|mesh-list
110692062|NCT01050699|Midazolam|midazolam|mesh-list
110692063|NCT01050699|Dexmedetomidine|dexmedetomidine|mesh-list
110692064|NCT01050699|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110692065|NCT01050699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110692066|NCT01050699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110692067|NCT01050699|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110692068|NCT01050699|Analgesics|analgesics|mesh-ancestor
110692069|NCT01050699|Sensory System Agents|sensory system agents|mesh-ancestor
110692070|NCT01050699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110692071|NCT01050699|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110692072|NCT01050699|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110692073|NCT01050699|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110692074|NCT01050699|Adrenergic Agents|adrenergic agents|mesh-ancestor
110692075|NCT01050699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110692076|NCT01050699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110692077|NCT01050699|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110692078|NCT01050699|Narcotics|narcotics|mesh-ancestor
110692079|NCT01050699|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110692080|NCT01050699|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110692081|NCT01050699|Anesthetics, General|anesthetics, general|mesh-ancestor
110692082|NCT01050699|Anesthetics|anesthetics|mesh-ancestor
110692083|NCT01050699|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110692084|NCT01050699|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110692085|NCT01050699|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110692086|NCT01050699|GABA Modulators|gaba modulators|mesh-ancestor
110692087|NCT01050699|GABA Agents|gaba agents|mesh-ancestor
110692088|NCT02408315|Misoprostol|misoprostol|mesh-list
110692089|NCT02408315|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110692090|NCT02408315|Abortifacient Agents|abortifacient agents|mesh-ancestor
110692091|NCT02408315|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110692092|NCT02408315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110692093|NCT02408315|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110692094|NCT02408315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110692095|NCT02408315|Oxytocics|oxytocics|mesh-ancestor
110692096|NCT05711693|Bepridil|bepridil|mesh-list
110692097|NCT05711693|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110692098|NCT05711693|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110692099|NCT05711693|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110692100|NCT05711693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110692101|NCT05711693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110692102|NCT05711693|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110692103|NCT05711693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110692104|NCT05711693|Vasodilator Agents|vasodilator agents|mesh-ancestor
110692105|NCT04005365|Propranolol|propranolol|mesh-list
110692106|NCT04005365|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110692107|NCT04005365|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110692108|NCT04005365|Adrenergic Agents|adrenergic agents|mesh-ancestor
110692109|NCT04005365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110692110|NCT04005365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110692111|NCT04005365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110692112|NCT04005365|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110692113|NCT04005365|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110692114|NCT04005365|Vasodilator Agents|vasodilator agents|mesh-ancestor
110692115|NCT01027182|Raltegravir Potassium|raltegravir potassium|mesh-list
110692116|NCT01027182|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110692117|NCT01027182|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110692118|NCT01027182|Antiviral Agents|antiviral agents|mesh-ancestor
110692119|NCT01027182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110692120|NCT01027182|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110692121|NCT01027182|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110692122|NCT01027182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110692123|NCT01027182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110692124|NCT00358917|Ritonavir|ritonavir|mesh-list
110692125|NCT00358917|Lopinavir|lopinavir|mesh-list
110692126|NCT00358917|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
110692127|NCT00358917|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110692128|NCT00358917|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110692130|NCT00358917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110692131|NCT00358917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110692132|NCT00358917|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110692133|NCT00358917|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110692134|NCT00358917|Antiviral Agents|antiviral agents|mesh-ancestor
110692135|NCT00358917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110692136|NCT00358917|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110692137|NCT00358917|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110692138|NCT00358917|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110692139|NCT01048515|Caffeine|caffeine|mesh-list
110692140|NCT01048515|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110692141|NCT01048515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110692142|NCT01048515|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110692143|NCT01048515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110692144|NCT01048515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110692145|NCT01048515|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110692146|NCT01048515|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110692147|NCT01048515|Purinergic Agents|purinergic agents|mesh-ancestor
110692148|NCT01048515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110692149|NCT01050777|Paromomycin|paromomycin|mesh-list
110692150|NCT01050777|Meglumine Antimoniate|meglumine antimoniate|mesh-list
110692151|NCT01050777|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110692152|NCT01050777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110692153|NCT01050777|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110692154|NCT01050777|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110692155|NCT00264004|Cediranib|cediranib|mesh-list
110692156|NCT00264004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110692157|NCT00264004|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110692158|NCT00264004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110692159|NCT00264004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110692160|NCT01069198|Vitamin A|vitamin a|mesh-list
110692161|NCT01069198|Albendazole|albendazole|mesh-list
110692162|NCT01069198|Vitamins|vitamins|mesh-ancestor
110692163|NCT01069198|Micronutrients|micronutrients|mesh-ancestor
110692164|NCT01069198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110692165|NCT01069198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110692166|NCT01069198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110692167|NCT01069198|Anthelmintics|anthelmintics|mesh-ancestor
110692168|NCT01069198|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110692169|NCT01069198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110692170|NCT01069198|Anticestodal Agents|anticestodal agents|mesh-ancestor
110692171|NCT01069198|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110692172|NCT01069198|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110692173|NCT01069198|Tubulin Modulators|tubulin modulators|mesh-ancestor
110692174|NCT01069198|Antimitotic Agents|antimitotic agents|mesh-ancestor
110692175|NCT01069198|Mitosis Modulators|mitosis modulators|mesh-ancestor
110692176|NCT00368355|Cytarabine|cytarabine|mesh-list
110692177|NCT00368355|Cyclophosphamide|cyclophosphamide|mesh-list
110692178|NCT00368355|Alemtuzumab|alemtuzumab|mesh-list
110692179|NCT00368355|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110692180|NCT00368355|Immunologic Factors|immunologic factors|mesh-ancestor
110692181|NCT00368355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110692182|NCT00368355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110692183|NCT00368355|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110692184|NCT00368355|Alkylating Agents|alkylating agents|mesh-ancestor
110692185|NCT00368355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110692186|NCT00368355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110692187|NCT00368355|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110692188|NCT00368355|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110692189|NCT00368355|Antimetabolites|antimetabolites|mesh-ancestor
110692190|NCT00368355|Antiviral Agents|antiviral agents|mesh-ancestor
110692191|NCT00368355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110692192|NCT00368355|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110692193|NCT01070680|Dexmedetomidine|dexmedetomidine|mesh-list
110692194|NCT01070680|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110692195|NCT01070680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110692196|NCT01070680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110692197|NCT01070680|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110692198|NCT01070680|Analgesics|analgesics|mesh-ancestor
110692199|NCT01070680|Sensory System Agents|sensory system agents|mesh-ancestor
110692200|NCT01070680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110692201|NCT01070680|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110692202|NCT01070680|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110692203|NCT01070680|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110692204|NCT01070680|Adrenergic Agents|adrenergic agents|mesh-ancestor
110692205|NCT01070680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110692206|NCT01070680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110692208|NCT00445146|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110692209|NCT00445146|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110692210|NCT00445146|Antiviral Agents|antiviral agents|mesh-ancestor
110692211|NCT00445146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110692212|NCT00445146|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110692213|NCT00445146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110692214|NCT00445146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110692215|NCT01581736|Insulin|insulin|mesh-list
110692216|NCT01581736|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110692217|NCT01581736|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110692218|NCT01581736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110692219|NCT01030302|Bortezomib|bortezomib|mesh-list
110692220|NCT01030302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110692221|NCT00368277|Amlodipine|amlodipine|mesh-list
110692222|NCT00368277|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110692223|NCT00368277|Ramipril|ramipril|mesh-list
110692224|NCT00368277|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110692225|NCT00368277|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110692226|NCT00368277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110692227|NCT00368277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110692228|NCT00368277|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110692229|NCT00368277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110692230|NCT00368277|Vasodilator Agents|vasodilator agents|mesh-ancestor
110692231|NCT00368277|Diuretics|diuretics|mesh-ancestor
110692232|NCT00368277|Natriuretic Agents|natriuretic agents|mesh-ancestor
110692233|NCT00368277|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110692234|NCT00368277|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110692235|NCT00368277|Protease Inhibitors|protease inhibitors|mesh-ancestor
110692236|NCT00368277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110692237|NCT00280150|Paclitaxel|paclitaxel|mesh-list
110692238|NCT00280150|Bevacizumab|bevacizumab|mesh-list
110692239|NCT00280150|Carboplatin|carboplatin|mesh-list
110692240|NCT00280150|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110692241|NCT00280150|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110692242|NCT00280150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110692243|NCT00280150|Tubulin Modulators|tubulin modulators|mesh-ancestor
110692244|NCT00280150|Antimitotic Agents|antimitotic agents|mesh-ancestor
110692245|NCT00280150|Mitosis Modulators|mitosis modulators|mesh-ancestor
110692246|NCT00280150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110692247|NCT00280150|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110692248|NCT00280150|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110692249|NCT00280150|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110692250|NCT00280150|Growth Substances|growth substances|mesh-ancestor
110692251|NCT00280150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110692252|NCT00280150|Growth Inhibitors|growth inhibitors|mesh-ancestor
110692253|NCT00280150|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110692254|NCT00280150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110692255|NCT00279916|Triamcinolone|triamcinolone|mesh-list
110692256|NCT00279916|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110692257|NCT00279916|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110692258|NCT00279916|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110692259|NCT00279916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110692260|NCT00279916|Glucocorticoids|glucocorticoids|mesh-ancestor
110692261|NCT00279916|Hormones|hormones|mesh-ancestor
110692262|NCT00279916|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110692263|NCT00279916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110692264|NCT00279916|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110692265|NCT00279916|Immunologic Factors|immunologic factors|mesh-ancestor
110692266|NCT00279916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110692267|NCT00279916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110692268|NCT02534337|Leucovorin|leucovorin|mesh-list
110692269|NCT02534337|Gemcitabine|gemcitabine|mesh-list
110692270|NCT02534337|Fluorouracil|fluorouracil|mesh-list
110692271|NCT02534337|Oxaliplatin|oxaliplatin|mesh-list
110692272|NCT02534337|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110692273|NCT02534337|Antimetabolites|antimetabolites|mesh-ancestor
110692274|NCT02534337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110692275|NCT02534337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110692276|NCT02534337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110692278|NCT02534337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110692279|NCT02534337|Antidotes|antidotes|mesh-ancestor
110692280|NCT02534337|Protective Agents|protective agents|mesh-ancestor
110692281|NCT02534337|Vitamin B Complex|vitamin b complex|mesh-ancestor
110692283|NCT02534337|Micronutrients|micronutrients|mesh-ancestor
110692284|NCT01325896|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110692285|NCT01325896|Antiviral Agents|antiviral agents|mesh-ancestor
110692286|NCT01325896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110692287|NCT01050933|Carbon Monoxide|carbon monoxide|mesh-list
110692288|NCT01050933|Antimetabolites|antimetabolites|mesh-ancestor
110692289|NCT01050933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110410148|NCT02886195|Pemetrexed|pemetrexed|mesh-list
110692290|NCT01050933|Gasotransmitters|gasotransmitters|mesh-ancestor
110692291|NCT01050933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110692292|NCT01050933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110692293|NCT00358527|Mometasone Furoate|mometasone furoate|mesh-list
110692294|NCT00358527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110692295|NCT00358527|Dermatologic Agents|dermatologic agents|mesh-ancestor
110692296|NCT00358527|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110692297|NCT00251758|Dexlansoprazole|dexlansoprazole|mesh-list
110692298|NCT00251758|Lansoprazole|lansoprazole|mesh-list
110692299|NCT00251758|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110692300|NCT00251758|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110692301|NCT00251758|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110692302|NCT00251758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110692303|NCT00251758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110692304|NCT00279214|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
110692305|NCT00279214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110692306|NCT00262834|Vorinostat|vorinostat|mesh-list
110692307|NCT00262834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110692308|NCT00262834|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110692309|NCT00262834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110692310|NCT00262834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110692311|NCT04417361|Erenumab|erenumab|mesh-list
110692312|NCT04417361|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
110692313|NCT04417361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110692314|NCT04417361|Analgesics|analgesics|mesh-ancestor
110692315|NCT04417361|Sensory System Agents|sensory system agents|mesh-ancestor
110692316|NCT04417361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110692317|NCT04417361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110692318|NCT00541775|Metformin|metformin|mesh-list
110692319|NCT00541775|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110692320|NCT00541775|Rosiglitazone|rosiglitazone|mesh-list
110692321|NCT00541775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110692322|NCT00541775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110692323|NCT00541775|Incretins|incretins|mesh-ancestor
110692324|NCT00541775|Hormones|hormones|mesh-ancestor
110692325|NCT00541775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110692326|NCT00541775|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110692327|NCT00541775|Protease Inhibitors|protease inhibitors|mesh-ancestor
110692328|NCT00541775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110692329|NCT00541775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110692330|NCT04004117|Fentanyl|fentanyl|mesh-list
110692331|NCT04004117|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110692332|NCT04004117|Narcotics|narcotics|mesh-ancestor
110692333|NCT04004117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110692334|NCT04004117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110692335|NCT04004117|Analgesics|analgesics|mesh-ancestor
110692336|NCT04004117|Sensory System Agents|sensory system agents|mesh-ancestor
110692337|NCT04004117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110692338|NCT04004117|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110692339|NCT04004117|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110692340|NCT04004117|Anesthetics, General|anesthetics, general|mesh-ancestor
110692341|NCT04004117|Anesthetics|anesthetics|mesh-ancestor
110692342|NCT00539513|Acetylcysteine|acetylcysteine|mesh-list
110692343|NCT00539513|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110692344|NCT00539513|Antiviral Agents|antiviral agents|mesh-ancestor
110692345|NCT00539513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110692346|NCT00539513|Expectorants|expectorants|mesh-ancestor
110692347|NCT00539513|Respiratory System Agents|respiratory system agents|mesh-ancestor
110692348|NCT00539513|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110692349|NCT00539513|Antioxidants|antioxidants|mesh-ancestor
110692350|NCT00539513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110692351|NCT00539513|Protective Agents|protective agents|mesh-ancestor
110692352|NCT00539513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110692353|NCT00539513|Antidotes|antidotes|mesh-ancestor
110692354|NCT02997761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110692355|NCT02997761|Blinatumomab|blinatumomab|mesh-list
110692356|NCT02997761|Antibodies|antibodies|mesh-list
110692357|NCT02997761|Immunoglobulins|immunoglobulins|mesh-list
110692358|NCT02997761|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110692359|NCT02997761|Muromonab-CD3|muromonab-cd3|mesh-list
110692360|NCT02997761|Antibodies, Bispecific|antibodies, bispecific|mesh-list
110692361|NCT02997761|Immunologic Factors|immunologic factors|mesh-ancestor
110692362|NCT02997761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110692363|NCT02997761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110692364|NCT02997761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110692365|NCT00454584|Etanercept|etanercept|mesh-list
110692366|NCT00454584|Ustekinumab|ustekinumab|mesh-list
110692367|NCT00454584|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110692368|NCT00454584|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110410216|NCT01173471|Niacinamide|niacinamide|mesh-list
110692369|NCT00454584|Analgesics|analgesics|mesh-ancestor
110692370|NCT00454584|Sensory System Agents|sensory system agents|mesh-ancestor
110692371|NCT00454584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110692372|NCT00454584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110692373|NCT00454584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110692374|NCT00454584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110692375|NCT00454584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110692376|NCT00454584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110692377|NCT00454584|Immunologic Factors|immunologic factors|mesh-ancestor
110692378|NCT00454584|Dermatologic Agents|dermatologic agents|mesh-ancestor
110692379|NCT04204343|Bupivacaine|bupivacaine|mesh-list
110692380|NCT04204343|Anesthetics, Local|anesthetics, local|mesh-ancestor
110692381|NCT04204343|Anesthetics|anesthetics|mesh-ancestor
110692382|NCT04204343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110692383|NCT04204343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110692384|NCT04204343|Sensory System Agents|sensory system agents|mesh-ancestor
110692385|NCT04204343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110692386|NCT02845271|Acetaminophen|acetaminophen|mesh-list
110692387|NCT02845271|Tramadol|tramadol|mesh-list
110692388|NCT02845271|Codeine|codeine|mesh-list
110692389|NCT02845271|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110692390|NCT02845271|Analgesics|analgesics|mesh-ancestor
110692391|NCT02845271|Sensory System Agents|sensory system agents|mesh-ancestor
110692392|NCT02845271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110692393|NCT02845271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110692394|NCT02845271|Antipyretics|antipyretics|mesh-ancestor
110692395|NCT02845271|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110692396|NCT02845271|Narcotics|narcotics|mesh-ancestor
110692397|NCT02845271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110692398|NCT02845271|Antitussive Agents|antitussive agents|mesh-ancestor
110692399|NCT02845271|Respiratory System Agents|respiratory system agents|mesh-ancestor
110692400|NCT00445068|Panobinostat|panobinostat|mesh-list
110692401|NCT00445068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110692402|NCT00445068|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110692403|NCT00445068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110692404|NCT00445068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110692405|NCT02404337|Betaine|betaine|mesh-list
110692406|NCT02404337|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110692407|NCT02404337|Lipotropic Agents|lipotropic agents|mesh-ancestor
110692408|NCT02404337|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110692409|NCT02404337|Antimetabolites|antimetabolites|mesh-ancestor
110692410|NCT02404337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110692411|NCT02404337|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110692412|NCT05360147|Metformin|metformin|mesh-list
110692413|NCT05360147|Liraglutide|liraglutide|mesh-list
110692414|NCT05360147|Hypoglycemic Agents|hypoglycemic agents|mesh-list
110692415|NCT05360147|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
110692416|NCT05360147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110692417|NCT05360147|Incretins|incretins|mesh-ancestor
110692418|NCT05360147|Hormones|hormones|mesh-ancestor
110692419|NCT05360147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110692420|NCT00444912|Plerixafor|plerixafor|mesh-list
110692421|NCT00444912|Rituximab|rituximab|mesh-list
110692422|NCT00444912|Lenograstim|lenograstim|mesh-list
110692423|NCT00444912|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110692424|NCT00444912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110692425|NCT00444912|Immunologic Factors|immunologic factors|mesh-ancestor
110692426|NCT00444912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110692427|NCT00444912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110692428|NCT00444912|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110692430|NCT00444912|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110692431|NCT00444912|Antiviral Agents|antiviral agents|mesh-ancestor
110692432|NCT00444912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110692433|NCT00538733|Clarithromycin|clarithromycin|mesh-list
110692434|NCT00538733|Thalidomide|thalidomide|mesh-list
110692435|NCT00538733|Dexamethasone|dexamethasone|mesh-list
110692436|NCT00538733|Lenalidomide|lenalidomide|mesh-list
110692437|NCT00538733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110692438|NCT00538733|Antiemetics|antiemetics|mesh-ancestor
110692439|NCT00538733|Autonomic Agents|autonomic agents|mesh-ancestor
110692440|NCT00538733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110692441|NCT00538733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110692442|NCT00538733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110692443|NCT00538733|Glucocorticoids|glucocorticoids|mesh-ancestor
110692444|NCT00538733|Hormones|hormones|mesh-ancestor
110692445|NCT00538733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110692446|NCT00538733|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110692447|NCT00538733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110692448|NCT00538733|Immunologic Factors|immunologic factors|mesh-ancestor
110692449|NCT00538733|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110692450|NCT00538733|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110692451|NCT00538733|Growth Substances|growth substances|mesh-ancestor
110692452|NCT00538733|Growth Inhibitors|growth inhibitors|mesh-ancestor
110692453|NCT00538733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110692454|NCT00538733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110692455|NCT00538733|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110692456|NCT00538733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110692457|NCT00538733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110692458|NCT00538733|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110692459|NCT00538733|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110692460|NCT00538733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110692461|NCT00538733|Leprostatic Agents|leprostatic agents|mesh-ancestor
110692462|NCT00444678|Capecitabine|capecitabine|mesh-list
110692463|NCT00444678|Oxaliplatin|oxaliplatin|mesh-list
110692464|NCT00444678|Cetuximab|cetuximab|mesh-list
110692465|NCT00444678|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110692466|NCT00444678|Antimetabolites|antimetabolites|mesh-ancestor
110692467|NCT00444678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110692468|NCT00444678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110692469|NCT00444678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110692470|NCT00539981|Hemagglutinins|hemagglutinins|mesh-list
110692471|NCT00539981|Immunologic Factors|immunologic factors|mesh-ancestor
110692472|NCT00539981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110692473|NCT00539981|Agglutinins|agglutinins|mesh-ancestor
110692474|NCT00539981|Coagulants|coagulants|mesh-ancestor
110692475|NCT00990197|Nicotine|nicotine|mesh-list
110692476|NCT00990197|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110692477|NCT00990197|Autonomic Agents|autonomic agents|mesh-ancestor
110692478|NCT00990197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110692479|NCT00990197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110692480|NCT00990197|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110692481|NCT00990197|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110692482|NCT00990197|Cholinergic Agents|cholinergic agents|mesh-ancestor
110692483|NCT00990197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110692484|NCT00990197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110692485|NCT01051011|Metformin|metformin|mesh-list
110692486|NCT01051011|Insulin Glargine|insulin glargine|mesh-list
110692487|NCT01051011|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
110692488|NCT01051011|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110692489|NCT01051011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110692490|NCT01051011|Incretins|incretins|mesh-ancestor
110692492|NCT01051011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110692493|NCT01048827|Busulfan|busulfan|mesh-list
110692494|NCT01048827|Alkylating Agents|alkylating agents|mesh-ancestor
110692495|NCT01048827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110692496|NCT01048827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110692497|NCT01048827|Immunologic Factors|immunologic factors|mesh-ancestor
110692498|NCT01048827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110692499|NCT01048827|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110692500|NCT01048827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110692501|NCT01048827|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110692502|NCT02023463|Leuprolide|leuprolide|mesh-list
110692503|NCT02023463|Goserelin|goserelin|mesh-list
110692504|NCT02023463|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110692505|NCT02023463|Fertility Agents|fertility agents|mesh-ancestor
110692506|NCT02023463|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110692507|NCT02023463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110692508|NCT02023463|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110692509|NCT02023463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110692510|NCT01302327|Exenatide|exenatide|mesh-list
110692511|NCT01302327|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110692512|NCT01302327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110692513|NCT01302327|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110692514|NCT01302327|Incretins|incretins|mesh-ancestor
110692515|NCT01302327|Hormones|hormones|mesh-ancestor
110692516|NCT01302327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110692517|NCT01048983|Minocycline|minocycline|mesh-list
110692518|NCT01048983|Curcumin|curcumin|mesh-list
110692519|NCT01048983|Modafinil|modafinil|mesh-list
110683013|NCT00904631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110692520|NCT01048983|Bupropion|bupropion|mesh-list
110692521|NCT01048983|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110692522|NCT01048983|Antidepressive Agents|antidepressive agents|mesh-ancestor
110692523|NCT01048983|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110692524|NCT01048983|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110692525|NCT01048983|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110692526|NCT01048983|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110692527|NCT01048983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110692529|NCT01048983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110692530|NCT01048983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110692531|NCT01048983|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110692532|NCT01048983|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110692533|NCT01048983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110692534|NCT01048983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110692535|NCT01048983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110692536|NCT01048983|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110692537|NCT01048983|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110692538|NCT01048983|Analgesics|analgesics|mesh-ancestor
110692539|NCT01048983|Sensory System Agents|sensory system agents|mesh-ancestor
110692540|NCT01048983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110692541|NCT01048983|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110692542|NCT01048983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110692543|NCT01048983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110692544|NCT01048983|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110692545|NCT01048983|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
110692546|NCT01048983|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110692547|NCT01048983|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110692548|NCT01340417|Melatonin|melatonin|mesh-list
110692549|NCT01340417|Antioxidants|antioxidants|mesh-ancestor
110692550|NCT01340417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110692551|NCT01340417|Protective Agents|protective agents|mesh-ancestor
110692552|NCT01340417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110692553|NCT01340417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110692554|NCT01049061|Farletuzumab|farletuzumab|mesh-list
110692555|NCT01049061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110692556|NCT00367341|Escitalopram|escitalopram|mesh-list
110692557|NCT00367341|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110692558|NCT00367341|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110692559|NCT00367341|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110692560|NCT00367341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110692561|NCT00367341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110692562|NCT00367341|Serotonin Agents|serotonin agents|mesh-ancestor
110692563|NCT00367341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110692564|NCT01052961|Oseltamivir|oseltamivir|mesh-list
110692565|NCT01052961|Antiviral Agents|antiviral agents|mesh-ancestor
110692566|NCT01052961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110692567|NCT01052961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110692568|NCT01052961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110692569|NCT00440466|Epoetin Alfa|epoetin alfa|mesh-list
110692570|NCT00440466|Hematinics|hematinics|mesh-ancestor
110692571|NCT01051167|Cetuximab|cetuximab|mesh-list
110692572|NCT01051167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110692573|NCT01051167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110692574|NCT01325441|Paclitaxel|paclitaxel|mesh-list
110692575|NCT01325441|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110692576|NCT01325441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110692577|NCT01325441|Tubulin Modulators|tubulin modulators|mesh-ancestor
110692578|NCT01325441|Antimitotic Agents|antimitotic agents|mesh-ancestor
110692579|NCT01325441|Mitosis Modulators|mitosis modulators|mesh-ancestor
110692580|NCT01325441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110692581|NCT00616967|Paclitaxel|paclitaxel|mesh-list
110692582|NCT00616967|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110692583|NCT00616967|Carboplatin|carboplatin|mesh-list
110692584|NCT00616967|Vorinostat|vorinostat|mesh-list
110692585|NCT00616967|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110692586|NCT00616967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110692587|NCT00616967|Tubulin Modulators|tubulin modulators|mesh-ancestor
110692588|NCT00616967|Antimitotic Agents|antimitotic agents|mesh-ancestor
110692589|NCT00616967|Mitosis Modulators|mitosis modulators|mesh-ancestor
110692590|NCT00616967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110692591|NCT00616967|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110692592|NCT00616967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110692593|NCT05360537|Insulin Glargine|insulin glargine|mesh-list
110692594|NCT05360537|Liraglutide|liraglutide|mesh-list
110692595|NCT05360537|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110692596|NCT05360537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110692597|NCT05360537|Incretins|incretins|mesh-ancestor
110692598|NCT05360537|Hormones|hormones|mesh-ancestor
110692599|NCT05360537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110692600|NCT05590637|Pimavanserin|pimavanserin|mesh-list
110692601|NCT05590637|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110692602|NCT05590637|Antidepressive Agents|antidepressive agents|mesh-ancestor
110692603|NCT05590637|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110692604|NCT05590637|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110692605|NCT05590637|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110692606|NCT05590637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110692607|NCT05590637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110692608|NCT05590637|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110692609|NCT05590637|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110692610|NCT05590637|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110692611|NCT05590637|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110692612|NCT05590637|Serotonin Agents|serotonin agents|mesh-ancestor
110692613|NCT05590637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110692614|NCT05590637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110692615|NCT00989651|Paclitaxel|paclitaxel|mesh-list
110692616|NCT00989651|Bevacizumab|bevacizumab|mesh-list
110692617|NCT00989651|Cisplatin|cisplatin|mesh-list
110692618|NCT00989651|Carboplatin|carboplatin|mesh-list
110692619|NCT00989651|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110692620|NCT00989651|Veliparib|veliparib|mesh-list
110692621|NCT00989651|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110692622|NCT00989651|Endothelial Growth Factors|endothelial growth factors|mesh-list
110692623|NCT00989651|Antibodies|antibodies|mesh-list
110692624|NCT00989651|Immunoglobulins|immunoglobulins|mesh-list
110692625|NCT00989651|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110692626|NCT00989651|Immunoglobulin G|immunoglobulin g|mesh-list
110692627|NCT00989651|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110692628|NCT00989651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110692629|NCT00989651|Tubulin Modulators|tubulin modulators|mesh-ancestor
110692630|NCT00989651|Antimitotic Agents|antimitotic agents|mesh-ancestor
110692631|NCT00989651|Mitosis Modulators|mitosis modulators|mesh-ancestor
110692632|NCT00989651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110692633|NCT00989651|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110692634|NCT00989651|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110692635|NCT00989651|Growth Substances|growth substances|mesh-ancestor
110692636|NCT00989651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110692637|NCT00989651|Growth Inhibitors|growth inhibitors|mesh-ancestor
110692638|NCT00989651|Immunologic Factors|immunologic factors|mesh-ancestor
110692639|NCT00989651|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110692640|NCT00989651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110692641|NCT05590559|Morphine|morphine|mesh-list
110692642|NCT05590559|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110692643|NCT05590559|Narcotics|narcotics|mesh-ancestor
110692644|NCT05590559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110692645|NCT05590559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110692647|NCT05590559|Sensory System Agents|sensory system agents|mesh-ancestor
110692648|NCT05590559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110692649|NCT00989729|Methylprednisolone|methylprednisolone|mesh-list
110692650|NCT00989729|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110692651|NCT00989729|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110692652|NCT00989729|Prednisolone|prednisolone|mesh-list
110692653|NCT00989729|Prednisolone acetate|prednisolone acetate|mesh-list
110692654|NCT00989729|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110692655|NCT00989729|Prednisolone phosphate|prednisolone phosphate|mesh-list
110692656|NCT00989729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110692657|NCT00989729|Antiemetics|antiemetics|mesh-ancestor
110692658|NCT00989729|Autonomic Agents|autonomic agents|mesh-ancestor
110692659|NCT00989729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110692660|NCT00989729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110692661|NCT00989729|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110692662|NCT00989729|Glucocorticoids|glucocorticoids|mesh-ancestor
110692663|NCT00989729|Hormones|hormones|mesh-ancestor
110692664|NCT00989729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110692665|NCT00989729|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110692666|NCT00989729|Protective Agents|protective agents|mesh-ancestor
110692667|NCT00989729|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110692668|NCT00989729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110692669|NCT00989807|Aztreonam|aztreonam|mesh-list
110692670|NCT00989807|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110692671|NCT00989807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110692672|NCT00990587|Ciclopirox|ciclopirox|mesh-list
110692673|NCT00990587|Antifungal Agents|antifungal agents|mesh-ancestor
110692674|NCT00990587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110692675|NCT00537329|Anidulafungin|anidulafungin|mesh-list
110692676|NCT00537329|Antifungal Agents|antifungal agents|mesh-ancestor
110692677|NCT00537329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110692678|NCT03905135|Avelumab|avelumab|mesh-list
110692679|NCT03905135|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110692680|NCT03905135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110692681|NCT00991055|Pioglitazone|pioglitazone|mesh-list
110692682|NCT00991055|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110692683|NCT00991055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110692685|NCT00991133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110692686|NCT00991133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110692687|NCT00991133|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110692688|NCT00991133|Antimetabolites|antimetabolites|mesh-ancestor
110692689|NCT00991211|Cyclophosphamide|cyclophosphamide|mesh-list
110692690|NCT00991211|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110692691|NCT00991211|Doxorubicin|doxorubicin|mesh-list
110692692|NCT00991211|Vincristine|vincristine|mesh-list
110692693|NCT00991211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110692694|NCT00991211|Immunologic Factors|immunologic factors|mesh-ancestor
110692695|NCT00991211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110692696|NCT00991211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110692697|NCT00991211|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110692698|NCT00991211|Alkylating Agents|alkylating agents|mesh-ancestor
110692699|NCT00991211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110692700|NCT00991211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110692701|NCT00991211|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110692702|NCT00991211|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110692703|NCT00991211|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110692704|NCT00991211|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110692705|NCT00991211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110692706|NCT00991211|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110692707|NCT00991211|Tubulin Modulators|tubulin modulators|mesh-ancestor
110692708|NCT00991211|Antimitotic Agents|antimitotic agents|mesh-ancestor
110692709|NCT00991211|Mitosis Modulators|mitosis modulators|mesh-ancestor
110692710|NCT00357903|Etanercept|etanercept|mesh-list
110692711|NCT00357903|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110692712|NCT00357903|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110692713|NCT00357903|Analgesics|analgesics|mesh-ancestor
110692714|NCT00357903|Sensory System Agents|sensory system agents|mesh-ancestor
110692715|NCT00357903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110692716|NCT00357903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110692717|NCT00357903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110692718|NCT00357903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110692719|NCT00357903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110692720|NCT00357903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110692721|NCT00357903|Immunologic Factors|immunologic factors|mesh-ancestor
110692722|NCT01053039|Morphine|morphine|mesh-list
110692723|NCT01053039|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110692724|NCT01053039|Narcotics|narcotics|mesh-ancestor
110692725|NCT01053039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110692726|NCT01053039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110692727|NCT01053039|Analgesics|analgesics|mesh-ancestor
110692728|NCT01053039|Sensory System Agents|sensory system agents|mesh-ancestor
110692729|NCT01053039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110692730|NCT01051401|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110692731|NCT01051401|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110692732|NCT01051401|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110692733|NCT01051401|Antimetabolites|antimetabolites|mesh-ancestor
110692734|NCT01051401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110692735|NCT01051401|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110692736|NCT01051401|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110692737|NCT01051401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110692738|NCT00348933|Vitamin B 12|vitamin b 12|mesh-list
110692739|NCT00348933|Hydroxocobalamin|hydroxocobalamin|mesh-list
110692740|NCT00348933|Betaine|betaine|mesh-list
110692741|NCT00348933|Vitamins|vitamins|mesh-ancestor
110692742|NCT00348933|Micronutrients|micronutrients|mesh-ancestor
110692743|NCT00348933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110692744|NCT00348933|Vitamin B Complex|vitamin b complex|mesh-ancestor
110692745|NCT00348933|Hematinics|hematinics|mesh-ancestor
110692746|NCT00348933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110692747|NCT00348933|Lipotropic Agents|lipotropic agents|mesh-ancestor
110692748|NCT00348933|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110692749|NCT00348933|Antimetabolites|antimetabolites|mesh-ancestor
110692750|NCT00348933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110692751|NCT00348933|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110692752|NCT01051479|Choline|choline|mesh-list
110692753|NCT01051479|Lipotropic Agents|lipotropic agents|mesh-ancestor
110692754|NCT01051479|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110692755|NCT01051479|Antimetabolites|antimetabolites|mesh-ancestor
110692756|NCT01051479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110692757|NCT01051479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110692758|NCT01051479|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110692759|NCT01051479|Nootropic Agents|nootropic agents|mesh-ancestor
110692760|NCT01055691|Metformin|metformin|mesh-list
110692761|NCT01055691|Dapagliflozin|dapagliflozin|mesh-list
110692762|NCT01055691|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110692763|NCT01055691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110692764|NCT01055691|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110692765|NCT01055691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110692766|NCT03896477|Vaccines|vaccines|mesh-list
110692767|NCT03896477|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110692768|NCT03896477|Immunologic Factors|immunologic factors|mesh-ancestor
110692769|NCT03896477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110692770|NCT00444600|Triamcinolone|triamcinolone|mesh-list
110692771|NCT00444600|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110692772|NCT00444600|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110692773|NCT00444600|Ranibizumab|ranibizumab|mesh-list
110692774|NCT00444600|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110692775|NCT00444600|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110692776|NCT00444600|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110692777|NCT00444600|Growth Substances|growth substances|mesh-ancestor
110692778|NCT00444600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110692779|NCT00444600|Growth Inhibitors|growth inhibitors|mesh-ancestor
110692780|NCT00444600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110692781|NCT00444600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110692782|NCT00444600|Glucocorticoids|glucocorticoids|mesh-ancestor
110692783|NCT00444600|Hormones|hormones|mesh-ancestor
110692784|NCT00444600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110692785|NCT00444600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110692786|NCT00444600|Immunologic Factors|immunologic factors|mesh-ancestor
110692787|NCT00444600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110692788|NCT00444600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110692789|NCT05357027|Cyclophosphamide|cyclophosphamide|mesh-list
110692790|NCT05357027|Fludarabine|fludarabine|mesh-list
110692791|NCT05357027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110692792|NCT05357027|Immunologic Factors|immunologic factors|mesh-ancestor
110692793|NCT05357027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110692795|NCT05357027|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110692796|NCT05357027|Alkylating Agents|alkylating agents|mesh-ancestor
110692797|NCT05357027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110692798|NCT05357027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110692799|NCT05357027|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110692800|NCT00443898|Terbinafine|terbinafine|mesh-list
110692801|NCT00443898|Antifungal Agents|antifungal agents|mesh-ancestor
110692802|NCT00443898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110692803|NCT00443898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110692804|NCT00443898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110692805|NCT00537017|Levodopa|levodopa|mesh-list
110692806|NCT00537017|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110692807|NCT00537017|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110692808|NCT00537017|Dopamine Agents|dopamine agents|mesh-ancestor
110692809|NCT00537017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110692810|NCT00537017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110692811|NCT00537017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110692812|NCT00348309|Rosiglitazone|rosiglitazone|mesh-list
110692813|NCT00348309|Donepezil|donepezil|mesh-list
110692814|NCT00348309|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110692815|NCT00348309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110692816|NCT00348309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110692817|NCT00348309|Cholinergic Agents|cholinergic agents|mesh-ancestor
110692818|NCT00348309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110692819|NCT00348309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110692820|NCT00348309|Nootropic Agents|nootropic agents|mesh-ancestor
110692821|NCT00348309|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110692822|NCT04451837|Dapagliflozin|dapagliflozin|mesh-list
110683014|NCT00904631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110692823|NCT04451837|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110692824|NCT04451837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110692825|NCT04451837|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110692826|NCT04451837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110692827|NCT05493683|Tislelizumab|tislelizumab|mesh-list
110692828|NCT05493683|Disitamab vedotin|disitamab vedotin|mesh-list
110692829|NCT05493683|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110692830|NCT05493683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110692831|NCT05493683|Immunoconjugates|immunoconjugates|mesh-ancestor
110692832|NCT05493683|Immunologic Factors|immunologic factors|mesh-ancestor
110692833|NCT05493683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110692834|NCT05440487|Chelating Agents|chelating agents|mesh-list
110692835|NCT05440487|Sequestering Agents|sequestering agents|mesh-ancestor
110692836|NCT05440487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110692837|NCT00440310|Talaporfin|talaporfin|mesh-list
110692838|NCT00440310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110692839|NCT00440310|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110692840|NCT00440310|Dermatologic Agents|dermatologic agents|mesh-ancestor
110692841|NCT01055847|Aztreonam|aztreonam|mesh-list
110692842|NCT01055847|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110692843|NCT01055847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110692844|NCT02533791|Vaccines|vaccines|mesh-list
110692845|NCT02533791|Immunologic Factors|immunologic factors|mesh-ancestor
110692846|NCT02533791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110692847|NCT05426681|Glyburide|glyburide|mesh-list
110692848|NCT05426681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110692849|NCT05426681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110692850|NCT01055925|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
110692851|NCT01055925|Laxatives|laxatives|mesh-ancestor
110692852|NCT01055925|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110692853|NCT00440232|Frovatriptan|frovatriptan|mesh-list
110692854|NCT00440232|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110692855|NCT00440232|Serotonin Agents|serotonin agents|mesh-ancestor
110692856|NCT00440232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110692857|NCT00440232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110692858|NCT00440232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110692859|NCT01564199|Fluticasone|fluticasone|mesh-list
110692860|NCT01564199|Xhance|xhance|mesh-list
110692861|NCT01564199|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110692862|NCT01564199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110692863|NCT01564199|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110692864|NCT01564199|Autonomic Agents|autonomic agents|mesh-ancestor
110858211|NCT02464462|Vitamin D|vitamin d|mesh-list
110692865|NCT01564199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110692866|NCT01564199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110692868|NCT01564199|Respiratory System Agents|respiratory system agents|mesh-ancestor
110692869|NCT01564199|Dermatologic Agents|dermatologic agents|mesh-ancestor
110692870|NCT01564199|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110692871|NCT01564199|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110692872|NCT01564199|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110692873|NCT01564199|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110692874|NCT01564199|Adrenergic Agents|adrenergic agents|mesh-ancestor
110692875|NCT01564199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110692876|NCT01564199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110692877|NCT02533323|Gemcitabine|gemcitabine|mesh-list
110692878|NCT02533323|Oxaliplatin|oxaliplatin|mesh-list
110692879|NCT02533323|Pegaspargase|pegaspargase|mesh-list
110692880|NCT02533323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110692881|NCT02533323|Antimetabolites|antimetabolites|mesh-ancestor
110692882|NCT02533323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110692883|NCT02533323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110692884|NCT05379959|Methamphetamine|methamphetamine|mesh-list
110692885|NCT05379959|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110692886|NCT05379959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110692887|NCT05379959|Sympathomimetics|sympathomimetics|mesh-ancestor
110692888|NCT05379959|Autonomic Agents|autonomic agents|mesh-ancestor
110692889|NCT05379959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110692890|NCT05379959|Dopamine Agents|dopamine agents|mesh-ancestor
110692891|NCT05379959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110692892|NCT05379959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110692893|NCT05379959|Adrenergic Agents|adrenergic agents|mesh-ancestor
110692894|NCT05379959|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110692895|NCT05379959|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110692896|NCT05379959|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110692897|NCT05379959|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110692899|NCT05357885|Immunologic Factors|immunologic factors|mesh-ancestor
110692900|NCT05357885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110692901|NCT04003181|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110692902|NCT04003181|Bile Acids and Salts|bile acids and salts|mesh-list
110692903|NCT04003181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110692904|NCT04003181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110692905|NCT00356889|Bevacizumab|bevacizumab|mesh-list
110692906|NCT00356889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110692907|NCT00356889|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110692908|NCT00356889|Antibodies|antibodies|mesh-list
110692909|NCT00356889|Immunoglobulins|immunoglobulins|mesh-list
110692910|NCT00356889|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110692911|NCT00356889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110692912|NCT00356889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110692913|NCT00356889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110692914|NCT00356889|Growth Substances|growth substances|mesh-ancestor
110692915|NCT00356889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110692916|NCT00356889|Growth Inhibitors|growth inhibitors|mesh-ancestor
110692917|NCT00356889|Immunologic Factors|immunologic factors|mesh-ancestor
110692918|NCT00356889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110692919|NCT00356889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110692920|NCT00356889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110692921|NCT05186363|Pyrimethamine|pyrimethamine|mesh-list
110692922|NCT05186363|Sulfadoxine|sulfadoxine|mesh-list
110692923|NCT05186363|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
110692924|NCT05186363|Amodiaquine|amodiaquine|mesh-list
110692925|NCT05186363|Antimalarials|antimalarials|mesh-ancestor
110692926|NCT05186363|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110692927|NCT05186363|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110692928|NCT05186363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110692929|NCT05186363|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110692930|NCT05186363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110692931|NCT05186363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110692932|NCT05186363|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110692933|NCT03742323|Idelalisib|idelalisib|mesh-list
110692934|NCT03742323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110692935|NCT03742323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110692936|NCT03742323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110692937|NCT04715022|Ascorbic Acid|ascorbic acid|mesh-list
110692938|NCT04715022|Antioxidants|antioxidants|mesh-ancestor
110692939|NCT04715022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110692940|NCT04715022|Protective Agents|protective agents|mesh-ancestor
110692941|NCT04715022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110692942|NCT04715022|Vitamins|vitamins|mesh-ancestor
110692943|NCT04715022|Micronutrients|micronutrients|mesh-ancestor
110692944|NCT00356811|Paclitaxel|paclitaxel|mesh-list
110692945|NCT00356811|Lapatinib|lapatinib|mesh-list
110692946|NCT00356811|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110692947|NCT00356811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110692948|NCT00356811|Tubulin Modulators|tubulin modulators|mesh-ancestor
110692949|NCT00356811|Antimitotic Agents|antimitotic agents|mesh-ancestor
110692950|NCT00356811|Mitosis Modulators|mitosis modulators|mesh-ancestor
110692951|NCT00356811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110692952|NCT00356811|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110692953|NCT00356811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110692954|NCT00439218|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
110692955|NCT00439218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110692956|NCT01030614|Dexamethasone|dexamethasone|mesh-list
110692957|NCT01030614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110692958|NCT01030614|Antiemetics|antiemetics|mesh-ancestor
110692959|NCT01030614|Autonomic Agents|autonomic agents|mesh-ancestor
110692960|NCT01030614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110692961|NCT01030614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110692962|NCT01030614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110692963|NCT01030614|Glucocorticoids|glucocorticoids|mesh-ancestor
110692964|NCT01030614|Hormones|hormones|mesh-ancestor
110692965|NCT01030614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110692966|NCT01030614|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110692967|NCT01030614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110692968|NCT01030692|Rivastigmine|rivastigmine|mesh-list
110692969|NCT01030692|Huperzine A|huperzine a|mesh-list
110692970|NCT01030692|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110692971|NCT01030692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110692972|NCT01030692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110410820|NCT00959647|Bevacizumab|bevacizumab|mesh-list
110692973|NCT01030692|Cholinergic Agents|cholinergic agents|mesh-ancestor
110692974|NCT01030692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110692975|NCT01030692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110692976|NCT01030692|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110692977|NCT01030692|Protective Agents|protective agents|mesh-ancestor
110692978|NCT03138252|Oxytocin|oxytocin|mesh-list
110692979|NCT03138252|Oxytocics|oxytocics|mesh-ancestor
110692980|NCT03138252|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110692981|NCT03138252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110692982|NCT04994561|Niacinamide|niacinamide|mesh-list
110692983|NCT04994561|Metformin|metformin|mesh-list
110692984|NCT04994561|Dasatinib|dasatinib|mesh-list
110692985|NCT04994561|Resveratrol|resveratrol|mesh-list
110692986|NCT04994561|Quercetin|quercetin|mesh-list
110692987|NCT04994561|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110692988|NCT04994561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110692989|NCT04994561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110692990|NCT04994561|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110692991|NCT04994561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110692992|NCT04994561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110692993|NCT04994561|Antioxidants|antioxidants|mesh-ancestor
110692994|NCT04994561|Protective Agents|protective agents|mesh-ancestor
110692995|NCT04994561|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110692996|NCT04994561|Vitamin B Complex|vitamin b complex|mesh-ancestor
110692997|NCT04994561|Vitamins|vitamins|mesh-ancestor
110692998|NCT04994561|Micronutrients|micronutrients|mesh-ancestor
110692999|NCT01030770|Ranibizumab|ranibizumab|mesh-list
110693000|NCT01030770|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110693001|NCT01030770|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110693002|NCT01030770|Growth Substances|growth substances|mesh-ancestor
110693003|NCT01030770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110858235|NCT01351272|Dopamine Agents|dopamine agents|mesh-ancestor
110693004|NCT01030770|Growth Inhibitors|growth inhibitors|mesh-ancestor
110693005|NCT01030770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110693007|NCT04941443|Methadone|methadone|mesh-list
110693008|NCT04941443|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110693009|NCT04941443|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110693010|NCT04941443|Analgesics|analgesics|mesh-ancestor
110693011|NCT04941443|Sensory System Agents|sensory system agents|mesh-ancestor
110693012|NCT04941443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110693013|NCT04941443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110693014|NCT04941443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110693015|NCT04941443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110693016|NCT04941443|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110693017|NCT04941443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110693018|NCT04941443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110693019|NCT04941443|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110693020|NCT04941443|Narcotics|narcotics|mesh-ancestor
110693021|NCT04941443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110693022|NCT04941443|Antitussive Agents|antitussive agents|mesh-ancestor
110693023|NCT04941443|Respiratory System Agents|respiratory system agents|mesh-ancestor
110693024|NCT03994692|Ether|ether|mesh-list
110693025|NCT03994692|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110693026|NCT03994692|Anesthetics, General|anesthetics, general|mesh-ancestor
110693027|NCT03994692|Anesthetics|anesthetics|mesh-ancestor
110693028|NCT03994692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110693029|NCT03994692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110693030|NCT01030926|Insulin|insulin|mesh-list
110693031|NCT01030926|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110693032|NCT01030926|Insulin Glargine|insulin glargine|mesh-list
110693033|NCT01030926|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110693034|NCT01030926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110693035|NCT00536939|Paclitaxel|paclitaxel|mesh-list
110693036|NCT00536939|Bevacizumab|bevacizumab|mesh-list
110693037|NCT00536939|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110693038|NCT00536939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110693039|NCT00536939|Tubulin Modulators|tubulin modulators|mesh-ancestor
110693040|NCT00536939|Antimitotic Agents|antimitotic agents|mesh-ancestor
110693041|NCT00536939|Mitosis Modulators|mitosis modulators|mesh-ancestor
110693042|NCT00536939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110693043|NCT00536939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110693044|NCT00536939|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110693045|NCT00536939|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110693046|NCT00536939|Growth Substances|growth substances|mesh-ancestor
110693047|NCT00536939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110693049|NCT04597697|Insulin|insulin|mesh-list
110693050|NCT04597697|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110693051|NCT04597697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110693052|NCT00347919|Lapatinib|lapatinib|mesh-list
110657276|NCT05405751|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110693053|NCT00347919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110693054|NCT00347919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110693055|NCT00347919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110693056|NCT00347919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110693057|NCT00439140|Botulinum Toxins|botulinum toxins|mesh-list
110693058|NCT00439140|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110693059|NCT00439140|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110693060|NCT00439140|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110693061|NCT00439140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110693062|NCT00439140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110693063|NCT00439140|Cholinergic Agents|cholinergic agents|mesh-ancestor
110693064|NCT00439140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110693065|NCT00439140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110693066|NCT00439140|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110693067|NCT00439140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110693068|NCT00356421|Insulin|insulin|mesh-list
110693069|NCT00356421|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110693070|NCT00356421|Insulin Lispro|insulin lispro|mesh-list
110693071|NCT00356421|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110693072|NCT00356421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110693073|NCT03990129|Dipyrone|dipyrone|mesh-list
110693074|NCT03990129|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110693075|NCT03990129|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110693076|NCT03990129|Analgesics|analgesics|mesh-ancestor
110693077|NCT03990129|Sensory System Agents|sensory system agents|mesh-ancestor
110693078|NCT03990129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110693079|NCT03990129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110693080|NCT03990129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110693081|NCT03990129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110693082|NCT03990129|Antipyretics|antipyretics|mesh-ancestor
110693083|NCT01051947|Metoprolol|metoprolol|mesh-list
110693084|NCT01051947|Nebivolol|nebivolol|mesh-list
110693085|NCT01051947|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110693086|NCT01051947|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110693087|NCT01051947|Sympatholytics|sympatholytics|mesh-ancestor
110693088|NCT01051947|Autonomic Agents|autonomic agents|mesh-ancestor
110693089|NCT01051947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110693090|NCT01051947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110693091|NCT01051947|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110693092|NCT01051947|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110693093|NCT01051947|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110693094|NCT01051947|Adrenergic Agents|adrenergic agents|mesh-ancestor
110693095|NCT01051947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110693096|NCT01051947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110693097|NCT01051947|Vasodilator Agents|vasodilator agents|mesh-ancestor
110693098|NCT01051947|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
110693099|NCT01051947|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110693100|NCT01051947|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110693102|NCT01052025|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110693103|NCT01052025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110693104|NCT01052025|Analgesics|analgesics|mesh-ancestor
110693105|NCT01052025|Sensory System Agents|sensory system agents|mesh-ancestor
110693106|NCT01052025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110693107|NCT01052025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110693108|NCT01052025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110693109|NCT01052025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110693110|NCT01052025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110693111|NCT01052025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110693112|NCT01052025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110693113|NCT00443820|Terbinafine|terbinafine|mesh-list
110693114|NCT00443820|Antifungal Agents|antifungal agents|mesh-ancestor
110693115|NCT00443820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110693116|NCT00443820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110693117|NCT00443820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110693118|NCT00438672|Dexamethasone|dexamethasone|mesh-list
110693119|NCT00438672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110693120|NCT00438672|Antiemetics|antiemetics|mesh-ancestor
110693121|NCT00438672|Autonomic Agents|autonomic agents|mesh-ancestor
110693122|NCT00438672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110693123|NCT00438672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110693124|NCT00438672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110693125|NCT00438672|Glucocorticoids|glucocorticoids|mesh-ancestor
110693127|NCT00438672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110693128|NCT00438672|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110693129|NCT00438672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110693130|NCT00438360|Cyclosporine|cyclosporine|mesh-list
110693131|NCT00438360|Cyclosporins|cyclosporins|mesh-list
110693132|NCT00438360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110693133|NCT00438360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110693134|NCT00438360|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110693135|NCT00438360|Immunologic Factors|immunologic factors|mesh-ancestor
110693136|NCT00438360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110693137|NCT00438360|Antifungal Agents|antifungal agents|mesh-ancestor
110693138|NCT00438360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110693139|NCT00438360|Dermatologic Agents|dermatologic agents|mesh-ancestor
110693140|NCT00438360|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110693141|NCT00438360|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110693142|NCT00536471|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110693143|NCT00536471|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110693144|NCT00536471|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110693145|NCT00536471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110693146|NCT00536471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110693147|NCT00536471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110693148|NCT00536471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110693149|NCT00536471|Analgesics|analgesics|mesh-ancestor
110693150|NCT00536471|Sensory System Agents|sensory system agents|mesh-ancestor
110693151|NCT00536471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110693152|NCT00536471|Antidepressive Agents|antidepressive agents|mesh-ancestor
110693153|NCT00536471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110693154|NCT00536471|Dopamine Agents|dopamine agents|mesh-ancestor
110693155|NCT00437658|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
110693156|NCT00437658|Medroxyprogesterone|medroxyprogesterone|mesh-list
110693157|NCT00437658|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110693158|NCT00437658|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110693159|NCT00437658|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110693160|NCT00437658|Contraceptive Agents|contraceptive agents|mesh-ancestor
110693161|NCT00437658|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110693162|NCT00437658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110693163|NCT00437658|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110693164|NCT00437658|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110693165|NCT00437658|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110693166|NCT00437658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110693167|NCT00437658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110693168|NCT04002635|Letrozole|letrozole|mesh-list
110693169|NCT04002635|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110693170|NCT04002635|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110693171|NCT04002635|Estradiol|estradiol|mesh-list
110693172|NCT04002635|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110693173|NCT04002635|Progesterone|progesterone|mesh-list
110693174|NCT04002635|Estrogens|estrogens|mesh-ancestor
110693175|NCT04002635|Hormones|hormones|mesh-ancestor
110693176|NCT04002635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110693177|NCT04002635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110693178|NCT04002635|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110693179|NCT04002635|Contraceptive Agents|contraceptive agents|mesh-ancestor
110693180|NCT04002635|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110693181|NCT04002635|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110693182|NCT04002635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110693183|NCT04002635|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110693184|NCT04002635|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110693185|NCT04002635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110693186|NCT04002635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110693187|NCT04002635|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110693188|NCT04002635|Hormone Antagonists|hormone antagonists|mesh-ancestor
110693189|NCT04002635|Progestins|progestins|mesh-ancestor
110138025|NCT04914195|Leuprolide|leuprolide|mesh-list
110693190|NCT01052181|Cholecalciferol|cholecalciferol|mesh-list
110693191|NCT01052181|Vitamin D|vitamin d|mesh-list
110693192|NCT01052181|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110693193|NCT01052181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110693194|NCT01052181|Vitamins|vitamins|mesh-ancestor
110693195|NCT01052181|Micronutrients|micronutrients|mesh-ancestor
110657283|NCT05387187|Pentoxifylline|pentoxifylline|mesh-list
110693196|NCT01052181|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110693197|NCT01056237|Mycophenolic Acid|mycophenolic acid|mesh-list
110693198|NCT01056237|Azathioprine|azathioprine|mesh-list
110693199|NCT01056237|Tacrolimus|tacrolimus|mesh-list
110693200|NCT01056237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110693201|NCT01056237|Immunologic Factors|immunologic factors|mesh-ancestor
110693202|NCT01056237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110693203|NCT01056237|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110693204|NCT01056237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110693205|NCT01056237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110693206|NCT01056237|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110693207|NCT01056237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110693208|NCT01056237|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110693209|NCT01056237|Antitubercular Agents|antitubercular agents|mesh-ancestor
110693210|NCT01056237|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110693211|NCT01056237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110693212|NCT01056237|Antimetabolites|antimetabolites|mesh-ancestor
110693213|NCT01056237|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110693214|NCT01056237|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110693215|NCT02533557|Lidocaine|lidocaine|mesh-list
110693216|NCT02533557|Epinephrine|epinephrine|mesh-list
110693217|NCT02533557|Racepinephrine|racepinephrine|mesh-list
110693218|NCT02533557|Epinephryl borate|epinephryl borate|mesh-list
110693219|NCT02533557|Anesthetics, Local|anesthetics, local|mesh-ancestor
110693220|NCT02533557|Anesthetics|anesthetics|mesh-ancestor
110693221|NCT02533557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110693222|NCT02533557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110693223|NCT02533557|Sensory System Agents|sensory system agents|mesh-ancestor
110693224|NCT02533557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110693225|NCT02533557|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110693226|NCT02533557|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110693227|NCT02533557|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110693228|NCT02533557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110693229|NCT02533557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110693230|NCT02533557|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110693231|NCT02533557|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110693232|NCT02533557|Adrenergic Agents|adrenergic agents|mesh-ancestor
110693233|NCT02533557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110693234|NCT02533557|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110693235|NCT02533557|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110693236|NCT02533557|Autonomic Agents|autonomic agents|mesh-ancestor
110693237|NCT02533557|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110693238|NCT02533557|Respiratory System Agents|respiratory system agents|mesh-ancestor
110693239|NCT02533557|Mydriatics|mydriatics|mesh-ancestor
110693240|NCT02533557|Sympathomimetics|sympathomimetics|mesh-ancestor
110693241|NCT02533557|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110693242|NCT00356265|Phenylephrine|phenylephrine|mesh-list
110693243|NCT00356265|Oxymetazoline|oxymetazoline|mesh-list
110693244|NCT00356265|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110693245|NCT00356265|Mydriatics|mydriatics|mesh-ancestor
110693246|NCT00356265|Autonomic Agents|autonomic agents|mesh-ancestor
110693247|NCT00356265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110693248|NCT00356265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110693249|NCT00356265|Sympathomimetics|sympathomimetics|mesh-ancestor
110693250|NCT00356265|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110693251|NCT00356265|Nasal Decongestants|nasal decongestants|mesh-ancestor
110693252|NCT00356265|Respiratory System Agents|respiratory system agents|mesh-ancestor
110693253|NCT00356265|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110693254|NCT00356265|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110693255|NCT00356265|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110693256|NCT00356265|Adrenergic Agents|adrenergic agents|mesh-ancestor
110693257|NCT00356265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110693258|NCT00356265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110693259|NCT00356265|Protective Agents|protective agents|mesh-ancestor
110693260|NCT01052259|Gusperimus|gusperimus|mesh-list
110693261|NCT01052259|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110693262|NCT01052259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110693263|NCT01052259|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110693264|NCT01052259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110693265|NCT01052259|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110693266|NCT01052259|Immunologic Factors|immunologic factors|mesh-ancestor
110693267|NCT01052259|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110693268|NCT01052259|Protective Agents|protective agents|mesh-ancestor
110693269|NCT01056549|Exenatide|exenatide|mesh-list
110693270|NCT01056549|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110693271|NCT01056549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110693272|NCT01056549|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110693273|NCT01056549|Incretins|incretins|mesh-ancestor
110693274|NCT01056549|Hormones|hormones|mesh-ancestor
110693275|NCT01056549|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110693276|NCT01052337|Anesthetics|anesthetics|mesh-list
110693277|NCT01052337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110693278|NCT01052337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110693279|NCT00535145|Paliperidone Palmitate|paliperidone palmitate|mesh-list
110693280|NCT00535145|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110693281|NCT00535145|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110693282|NCT00535145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110693283|NCT00535145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110693284|NCT00535145|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110693285|NCT00535145|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110693286|NCT00535145|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110693287|NCT00535145|Serotonin Agents|serotonin agents|mesh-ancestor
110693288|NCT00535145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110693289|NCT00535145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110693290|NCT00535145|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110693291|NCT00535145|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110693292|NCT00535145|Dopamine Agents|dopamine agents|mesh-ancestor
110693293|NCT01056627|Valproic Acid|valproic acid|mesh-list
110693294|NCT01056627|Anticonvulsants|anticonvulsants|mesh-ancestor
110693295|NCT01056627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110693296|NCT01056627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110693297|NCT01056627|GABA Agents|gaba agents|mesh-ancestor
110693298|NCT01056627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110693299|NCT01056627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110693300|NCT01056627|Antimanic Agents|antimanic agents|mesh-ancestor
110693301|NCT01056627|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110693302|NCT01056627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110693303|NCT01056627|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110693304|NCT01053585|Baclofen|baclofen|mesh-list
110693305|NCT01053585|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110693306|NCT01053585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110693307|NCT01053585|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110693308|NCT01053585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110693309|NCT01053585|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
110693310|NCT01053585|GABA Agonists|gaba agonists|mesh-ancestor
110693311|NCT01053585|GABA Agents|gaba agents|mesh-ancestor
110693312|NCT01053585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110693313|NCT01053585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110693314|NCT01564355|Triamcinolone|triamcinolone|mesh-list
110693315|NCT01564355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110693316|NCT01564355|Glucocorticoids|glucocorticoids|mesh-ancestor
110693317|NCT01564355|Hormones|hormones|mesh-ancestor
110693318|NCT01564355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110693319|NCT01564355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110693320|NCT01056705|Vaccines|vaccines|mesh-list
110693321|NCT01056705|Immunologic Factors|immunologic factors|mesh-ancestor
110693322|NCT01056705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110693323|NCT00437268|Irinotecan|irinotecan|mesh-list
110693324|NCT00437268|Cetuximab|cetuximab|mesh-list
110693325|NCT00437268|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110693326|NCT00437268|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110693327|NCT00437268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110693328|NCT00437268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110693329|NCT00437268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110693330|NCT00437268|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110693331|NCT04002089|Bupivacaine|bupivacaine|mesh-list
110693332|NCT04002089|Anesthetics, Local|anesthetics, local|mesh-ancestor
110693333|NCT04002089|Anesthetics|anesthetics|mesh-ancestor
110693334|NCT04002089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110693335|NCT04002089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110693336|NCT04002089|Sensory System Agents|sensory system agents|mesh-ancestor
110693337|NCT04002089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110693338|NCT04002245|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
110693339|NCT04002245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110693340|NCT01056861|Botulinum Toxins|botulinum toxins|mesh-list
110693341|NCT01056861|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110693342|NCT01056861|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110693343|NCT01056861|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110693344|NCT01056861|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110693345|NCT01056861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110693346|NCT01056861|Cholinergic Agents|cholinergic agents|mesh-ancestor
110693347|NCT01056861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110693348|NCT01056861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110693349|NCT01056861|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110693350|NCT01056861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110693351|NCT05355467|Tenofovir|tenofovir|mesh-list
110693352|NCT05355467|Antiviral Agents|antiviral agents|mesh-ancestor
110693353|NCT05355467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110693354|NCT05355467|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110693355|NCT05355467|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110693356|NCT05355467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110693357|NCT05355467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110693358|NCT05355467|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110693359|NCT05355467|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110693360|NCT04139525|Heparin|heparin|mesh-list
110693361|NCT04139525|Calcium heparin|calcium heparin|mesh-list
110693362|NCT04139525|Citric Acid|citric acid|mesh-list
110693363|NCT04139525|Sodium Citrate|sodium citrate|mesh-list
110693364|NCT04139525|Anticoagulants|anticoagulants|mesh-ancestor
110693365|NCT04139525|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110693366|NCT04139525|Chelating Agents|chelating agents|mesh-ancestor
110693367|NCT04139525|Sequestering Agents|sequestering agents|mesh-ancestor
110693368|NCT04139525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110693369|NCT04139525|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110693370|NCT04139525|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110693371|NCT00437034|Aflibercept|aflibercept|mesh-list
110693372|NCT00437034|Endothelial Growth Factors|endothelial growth factors|mesh-list
110693373|NCT00437034|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110693374|NCT00437034|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110693375|NCT00437034|Growth Substances|growth substances|mesh-ancestor
110693376|NCT00437034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110693377|NCT00437034|Growth Inhibitors|growth inhibitors|mesh-ancestor
110693378|NCT00437034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110693379|NCT00337467|Ritonavir|ritonavir|mesh-list
110693380|NCT00337467|Atazanavir Sulfate|atazanavir sulfate|mesh-list
110693381|NCT00337467|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110323398|NCT00353717|Paclitaxel|paclitaxel|mesh-list
110693382|NCT00337467|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110693383|NCT00337467|Protease Inhibitors|protease inhibitors|mesh-ancestor
110693384|NCT00337467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110693385|NCT00337467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110693386|NCT00337467|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110693387|NCT00337467|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110693388|NCT00337467|Antiviral Agents|antiviral agents|mesh-ancestor
110693389|NCT00337467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110858270|NCT04235686|Dopamine Agents|dopamine agents|mesh-ancestor
110693390|NCT00337467|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110693391|NCT00337467|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110693392|NCT00428220|Sunitinib|sunitinib|mesh-list
110693393|NCT00428220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110693394|NCT00428220|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110693395|NCT00428220|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110693396|NCT00428220|Growth Substances|growth substances|mesh-ancestor
110693397|NCT00428220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110693398|NCT00428220|Growth Inhibitors|growth inhibitors|mesh-ancestor
110693399|NCT00428220|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110693400|NCT00428220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110657293|NCT05387187|Antioxidants|antioxidants|mesh-ancestor
110693401|NCT00428220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110693402|NCT01057329|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110693403|NCT01057329|Olanzapine|olanzapine|mesh-list
110693404|NCT01057329|Aripiprazole|aripiprazole|mesh-list
110693405|NCT01057329|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
110693406|NCT01057329|Antiemetics|antiemetics|mesh-ancestor
110693407|NCT01057329|Autonomic Agents|autonomic agents|mesh-ancestor
110693408|NCT01057329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110693409|NCT01057329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110693410|NCT01057329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110693411|NCT01057329|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110693412|NCT01057329|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110693413|NCT01057329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110693414|NCT01057329|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110693415|NCT01057329|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110693416|NCT01057329|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110693417|NCT01057329|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110693418|NCT01057329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110693419|NCT01057329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110693420|NCT01057329|Serotonin Agents|serotonin agents|mesh-ancestor
110693421|NCT01057329|Antidepressive Agents|antidepressive agents|mesh-ancestor
110693422|NCT01057329|Dopamine Agonists|dopamine agonists|mesh-ancestor
110693423|NCT01057329|Dopamine Agents|dopamine agents|mesh-ancestor
110693424|NCT01057329|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110693425|NCT01057329|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110693426|NCT01057329|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110693427|NCT01057329|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110693428|NCT01057329|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110693429|NCT01057329|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110693430|NCT01057329|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110693431|NCT01057329|Analgesics|analgesics|mesh-ancestor
110693432|NCT01057329|Sensory System Agents|sensory system agents|mesh-ancestor
110693433|NCT01057329|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110693434|NCT01057329|Adrenergic Agents|adrenergic agents|mesh-ancestor
110693435|NCT01057407|Sevelamer|sevelamer|mesh-list
110693436|NCT01057407|Chelating Agents|chelating agents|mesh-ancestor
110693437|NCT01057407|Sequestering Agents|sequestering agents|mesh-ancestor
110693438|NCT01057407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110693439|NCT02873975|Prexasertib|prexasertib|mesh-list
110693440|NCT02873975|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110693441|NCT02873975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110693442|NCT02873975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110693443|NCT01057563|Paclitaxel|paclitaxel|mesh-list
110693444|NCT01057563|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110693445|NCT01057563|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110693446|NCT01057563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110693447|NCT01057563|Tubulin Modulators|tubulin modulators|mesh-ancestor
110693448|NCT01057563|Antimitotic Agents|antimitotic agents|mesh-ancestor
110693449|NCT01057563|Mitosis Modulators|mitosis modulators|mesh-ancestor
110693450|NCT01057563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110693452|NCT00345579|Anticoagulants|anticoagulants|mesh-ancestor
110693453|NCT00345579|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110858278|NCT02079948|Folic Acid|folic acid|mesh-list
110693454|NCT00345579|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110693455|NCT00345579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110693456|NCT04002323|Lamivudine|lamivudine|mesh-list
110693457|NCT04002323|Dolutegravir|dolutegravir|mesh-list
110693458|NCT04002323|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110693459|NCT04002323|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110693460|NCT04002323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110693461|NCT04002323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110693462|NCT04002323|Antiviral Agents|antiviral agents|mesh-ancestor
110693463|NCT04002323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110693464|NCT04002323|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110693465|NCT04002323|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110693466|NCT04002323|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110693467|NCT04002323|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110693468|NCT04001855|Acetic Acid|acetic acid|mesh-list
110693469|NCT04001855|Retinol acetate|retinol acetate|mesh-list
110693470|NCT04001855|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110693471|NCT04001855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110693472|NCT04001855|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110693473|NCT04001855|Immunologic Factors|immunologic factors|mesh-ancestor
110693474|NCT04001855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110693475|NCT04001855|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110693476|NCT04001855|Protective Agents|protective agents|mesh-ancestor
110693477|NCT04001855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110693478|NCT00335829|Bevacizumab|bevacizumab|mesh-list
110693479|NCT00335829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110693480|NCT00335829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110693481|NCT00335829|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110693482|NCT00335829|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110693483|NCT00335829|Growth Substances|growth substances|mesh-ancestor
110693484|NCT00335829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110693485|NCT00335829|Growth Inhibitors|growth inhibitors|mesh-ancestor
110693486|NCT02533011|Heparin|heparin|mesh-list
110693487|NCT02533011|Anticoagulants|anticoagulants|mesh-ancestor
110693488|NCT02533011|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110693489|NCT02533011|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110693490|NCT02533011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110693491|NCT05262257|Metformin|metformin|mesh-list
110693492|NCT05262257|Dapagliflozin|dapagliflozin|mesh-list
110693493|NCT05262257|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110693494|NCT05262257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110693495|NCT05262257|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110693496|NCT05262257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110693497|NCT03989817|Vasoactive Intestinal Peptide|vasoactive intestinal peptide|mesh-list
110693498|NCT03989817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110693499|NCT03989817|Vasodilator Agents|vasodilator agents|mesh-ancestor
110693500|NCT03989817|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110693501|NCT03989817|Protective Agents|protective agents|mesh-ancestor
110693502|NCT03989817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110693503|NCT01059123|Amoxicillin|amoxicillin|mesh-list
110693504|NCT01059123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110693505|NCT01059123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110693506|NCT03986385|Capecitabine|capecitabine|mesh-list
110693507|NCT03986385|Oxaliplatin|oxaliplatin|mesh-list
110693508|NCT03986385|Apatinib|apatinib|mesh-list
110693509|NCT03986385|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110693510|NCT03986385|Antimetabolites|antimetabolites|mesh-ancestor
110693511|NCT03986385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110693512|NCT03986385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110693513|NCT03986385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110693514|NCT03986385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110693515|NCT00344019|Atorvastatin|atorvastatin|mesh-list
110693516|NCT00344019|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110693517|NCT00344019|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110693518|NCT00344019|Antimetabolites|antimetabolites|mesh-ancestor
110693519|NCT00344019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110693520|NCT00344019|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110693521|NCT00344019|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110693522|NCT00344019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110693523|NCT00535847|Interferons|interferons|mesh-list
110693525|NCT00535847|Interferon-alpha|interferon-alpha|mesh-list
110693526|NCT00535847|Interferon alpha-2|interferon alpha-2|mesh-list
110693527|NCT00535847|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110693528|NCT00535847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110693529|NCT00535847|Antiviral Agents|antiviral agents|mesh-ancestor
110693530|NCT00535847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110693531|NCT00535847|Antimetabolites|antimetabolites|mesh-ancestor
110693532|NCT00535847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110693533|NCT00535847|Immunologic Factors|immunologic factors|mesh-ancestor
110693534|NCT00535847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110693535|NCT03606785|Tranexamic Acid|tranexamic acid|mesh-list
110693536|NCT03606785|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110693537|NCT03606785|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110693538|NCT03606785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110693539|NCT03606785|Hemostatics|hemostatics|mesh-ancestor
110693540|NCT03606785|Coagulants|coagulants|mesh-ancestor
110693541|NCT05356169|Venetoclax|venetoclax|mesh-list
110693542|NCT05356169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110693543|NCT01057875|Caffeine|caffeine|mesh-list
110693544|NCT01057875|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110693545|NCT01057875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110693546|NCT01057875|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110693547|NCT01057875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110693548|NCT01057875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110693549|NCT01057875|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110693550|NCT01057875|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110693551|NCT01057875|Purinergic Agents|purinergic agents|mesh-ancestor
110693552|NCT01057875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110693553|NCT04001387|Anesthetics|anesthetics|mesh-list
110693554|NCT04001387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110693555|NCT04001387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110693556|NCT00334737|Epoetin Alfa|epoetin alfa|mesh-list
110693557|NCT00334737|Darbepoetin alfa|darbepoetin alfa|mesh-list
110693558|NCT00334737|Hematinics|hematinics|mesh-ancestor
110693559|NCT03986073|Linagliptin|linagliptin|mesh-list
110693560|NCT03986073|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110693561|NCT03986073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110693562|NCT03986073|Incretins|incretins|mesh-ancestor
110693563|NCT03986073|Hormones|hormones|mesh-ancestor
110693564|NCT03986073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110693565|NCT03986073|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110693566|NCT03986073|Protease Inhibitors|protease inhibitors|mesh-ancestor
110693567|NCT03986073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110693568|NCT03986073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110693569|NCT05347199|Amisulpride|amisulpride|mesh-list
110693570|NCT05347199|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110693571|NCT05347199|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110693572|NCT05347199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110693573|NCT05347199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110693574|NCT05347199|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110693575|NCT05347199|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110693576|NCT05347199|Dopamine Agents|dopamine agents|mesh-ancestor
110693577|NCT05347199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110693578|NCT05347199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110693579|NCT05347199|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110693580|NCT05347199|Antidepressive Agents|antidepressive agents|mesh-ancestor
110693581|NCT01060137|Fentanyl|fentanyl|mesh-list
110693582|NCT01060137|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110693583|NCT01060137|Narcotics|narcotics|mesh-ancestor
110693584|NCT01060137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110693585|NCT01060137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110693586|NCT01060137|Analgesics|analgesics|mesh-ancestor
110693587|NCT01060137|Sensory System Agents|sensory system agents|mesh-ancestor
110693588|NCT01060137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110693589|NCT01060137|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110693590|NCT01060137|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110693591|NCT01060137|Anesthetics, General|anesthetics, general|mesh-ancestor
110693592|NCT01060137|Anesthetics|anesthetics|mesh-ancestor
110693593|NCT01058109|Calcium, Dietary|calcium, dietary|mesh-list
110693594|NCT01058109|Calcium|calcium|mesh-list
110693595|NCT01058109|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110693596|NCT01058109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110693597|NCT01058109|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110693598|NCT00992069|Efavirenz|efavirenz|mesh-list
110693599|NCT00992069|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110693600|NCT00992069|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110693601|NCT00992069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110693602|NCT00992069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110693603|NCT00992069|Antiviral Agents|antiviral agents|mesh-ancestor
110693604|NCT00992069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110693605|NCT00992069|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110693606|NCT00992069|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110693607|NCT00992069|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110693608|NCT00992069|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110693609|NCT00992069|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110693610|NCT00992069|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110693611|NCT01060293|Dopamine|dopamine|mesh-list
110693612|NCT01060293|Furosemide|furosemide|mesh-list
110693613|NCT01060293|Diuretics|diuretics|mesh-ancestor
110693614|NCT01060293|Natriuretic Agents|natriuretic agents|mesh-ancestor
110693615|NCT01060293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110657308|NCT05364073|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110693616|NCT01060293|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110693617|NCT01060293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110693618|NCT01060293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110693619|NCT01060293|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110693620|NCT01060293|Sympathomimetics|sympathomimetics|mesh-ancestor
110693621|NCT01060293|Autonomic Agents|autonomic agents|mesh-ancestor
110693622|NCT01060293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110693623|NCT01060293|Dopamine Agents|dopamine agents|mesh-ancestor
110693624|NCT01060293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110693625|NCT01060293|Protective Agents|protective agents|mesh-ancestor
110693626|NCT05343767|Metformin|metformin|mesh-list
110693627|NCT05343767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110693628|NCT05343767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110693629|NCT01054677|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110693630|NCT01054677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110693631|NCT03989037|Carboplatin|carboplatin|mesh-list
110693632|NCT03989037|Docetaxel|docetaxel|mesh-list
110693633|NCT03989037|Trastuzumab|trastuzumab|mesh-list
110693634|NCT03989037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110693635|NCT03989037|Tubulin Modulators|tubulin modulators|mesh-ancestor
110693636|NCT03989037|Antimitotic Agents|antimitotic agents|mesh-ancestor
110693637|NCT03989037|Mitosis Modulators|mitosis modulators|mesh-ancestor
110693638|NCT03989037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110693639|NCT03989037|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110693640|NCT00416598|Cytarabine|cytarabine|mesh-list
110693641|NCT00416598|Etoposide|etoposide|mesh-list
110693642|NCT00416598|Podophyllotoxin|podophyllotoxin|mesh-list
110693643|NCT00416598|Daunorubicin|daunorubicin|mesh-list
110693644|NCT00416598|Etoposide phosphate|etoposide phosphate|mesh-list
110693645|NCT00416598|Busulfan|busulfan|mesh-list
110693646|NCT00416598|Decitabine|decitabine|mesh-list
110693647|NCT00416598|Lenograstim|lenograstim|mesh-list
110693648|NCT00416598|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110693649|NCT00416598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110693650|NCT00416598|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110693651|NCT00416598|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110693652|NCT00416598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110693653|NCT00416598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110693654|NCT00416598|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110693655|NCT00416598|Antimetabolites|antimetabolites|mesh-ancestor
110693656|NCT00416598|Antiviral Agents|antiviral agents|mesh-ancestor
110693657|NCT00416598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110693658|NCT00416598|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110693659|NCT00416598|Immunologic Factors|immunologic factors|mesh-ancestor
110693660|NCT00416598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110693661|NCT00416598|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110693662|NCT00416598|Alkylating Agents|alkylating agents|mesh-ancestor
110693663|NCT00416598|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110693664|NCT00416598|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110693665|NCT00416598|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110693666|NCT00416598|Keratolytic Agents|keratolytic agents|mesh-ancestor
110693667|NCT00416598|Dermatologic Agents|dermatologic agents|mesh-ancestor
110693668|NCT00416598|Tubulin Modulators|tubulin modulators|mesh-ancestor
110693669|NCT00416598|Antimitotic Agents|antimitotic agents|mesh-ancestor
110693670|NCT00416598|Mitosis Modulators|mitosis modulators|mesh-ancestor
110693671|NCT00534599|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110693672|NCT00534599|Antidepressive Agents|antidepressive agents|mesh-ancestor
110693673|NCT00534599|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110693674|NCT00534599|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110693675|NCT00534599|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110693676|NCT00534599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110693677|NCT00534599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110693678|NCT04001465|Methacholine Chloride|methacholine chloride|mesh-list
110693679|NCT04001465|Miotics|miotics|mesh-ancestor
110693680|NCT04001465|Autonomic Agents|autonomic agents|mesh-ancestor
110693681|NCT04001465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110693682|NCT04001465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110693683|NCT04001465|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110693684|NCT04001465|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
110693685|NCT04001465|Respiratory System Agents|respiratory system agents|mesh-ancestor
110693686|NCT04001465|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
110693687|NCT04001465|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110693688|NCT04001465|Cholinergic Agents|cholinergic agents|mesh-ancestor
110693689|NCT04001465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110693690|NCT04001465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110693691|NCT00992381|Naproxen|naproxen|mesh-list
110693692|NCT00992381|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110693693|NCT00992381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110693694|NCT00992381|Analgesics|analgesics|mesh-ancestor
110693695|NCT00992381|Sensory System Agents|sensory system agents|mesh-ancestor
110693696|NCT00992381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110693697|NCT00992381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110693698|NCT00992381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110693699|NCT00992381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110693700|NCT00992381|Gout Suppressants|gout suppressants|mesh-ancestor
110693701|NCT00992381|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110693702|NCT00992381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110693703|NCT00992381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110693704|NCT00992537|Insulin|insulin|mesh-list
110693705|NCT00992537|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110693706|NCT00992537|Insulin Aspart|insulin aspart|mesh-list
110693707|NCT00992537|Insulin, Long-Acting|insulin, long-acting|mesh-list
110693708|NCT00992537|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
110693709|NCT00992537|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110693710|NCT00992537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110693711|NCT00992693|Ribavirin|ribavirin|mesh-list
110693712|NCT00992693|Antimetabolites|antimetabolites|mesh-ancestor
110693713|NCT00992693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110693714|NCT00992693|Antiviral Agents|antiviral agents|mesh-ancestor
110693715|NCT00992693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110693716|NCT00992771|Varenicline|varenicline|mesh-list
110693717|NCT00992771|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110693718|NCT00992771|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110693719|NCT00992771|Cholinergic Agents|cholinergic agents|mesh-ancestor
110693720|NCT00992771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110693721|NCT00992771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110693722|NCT00992771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110693723|NCT00992849|Bevacizumab|bevacizumab|mesh-list
110683015|NCT00904631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110693724|NCT00992849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110693725|NCT00992849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110693726|NCT00992849|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110693727|NCT00992849|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110693728|NCT00992849|Growth Substances|growth substances|mesh-ancestor
110693729|NCT00992849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110693732|NCT04001231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110693733|NCT04001231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110693734|NCT04001231|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110693735|NCT04001231|Incretins|incretins|mesh-ancestor
110693736|NCT04001231|Hormones|hormones|mesh-ancestor
110693737|NCT04001231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110693738|NCT03892889|Aripiprazole|aripiprazole|mesh-list
110693739|NCT03892889|Antidepressive Agents|antidepressive agents|mesh-ancestor
110693741|NCT03892889|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110693742|NCT03892889|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110693743|NCT03892889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110693744|NCT03892889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110693745|NCT03892889|Dopamine Agonists|dopamine agonists|mesh-ancestor
110693746|NCT03892889|Dopamine Agents|dopamine agents|mesh-ancestor
110693747|NCT03892889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110693748|NCT03892889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110693749|NCT03892889|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110693750|NCT03892889|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110693751|NCT03892889|Serotonin Agents|serotonin agents|mesh-ancestor
110693752|NCT03892889|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110693753|NCT03892889|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110693754|NCT03892889|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110693755|NCT03892889|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110693756|NCT00993707|Hyaluronic Acid|hyaluronic acid|mesh-list
110693757|NCT00993707|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110693758|NCT00993707|Immunologic Factors|immunologic factors|mesh-ancestor
110693759|NCT00993707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110693760|NCT00993707|Viscosupplements|viscosupplements|mesh-ancestor
110693761|NCT00993707|Protective Agents|protective agents|mesh-ancestor
110693762|NCT00473330|Ranibizumab|ranibizumab|mesh-list
110693763|NCT00473330|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110693764|NCT00473330|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110693765|NCT00473330|Growth Substances|growth substances|mesh-ancestor
110693766|NCT00473330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110693767|NCT00473330|Growth Inhibitors|growth inhibitors|mesh-ancestor
110693768|NCT00473330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110693769|NCT00416520|Sevelamer|sevelamer|mesh-list
110693770|NCT00416520|Chelating Agents|chelating agents|mesh-ancestor
110693771|NCT00416520|Sequestering Agents|sequestering agents|mesh-ancestor
110693772|NCT00416520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110693773|NCT00533429|Bevacizumab|bevacizumab|mesh-list
110693774|NCT00533429|Carboplatin|carboplatin|mesh-list
110693775|NCT00533429|Pemetrexed|pemetrexed|mesh-list
110693776|NCT00533429|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110693777|NCT00533429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110693778|NCT00533429|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110693779|NCT00533429|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110693780|NCT00533429|Growth Substances|growth substances|mesh-ancestor
110693781|NCT00533429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110693782|NCT00533429|Growth Inhibitors|growth inhibitors|mesh-ancestor
110693783|NCT00533429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110693784|NCT00533429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110693785|NCT00533429|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110693786|NCT00533429|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110693787|NCT01034124|Vitamin K|vitamin k|mesh-list
110693788|NCT01034124|Midazolam|midazolam|mesh-list
110693789|NCT01034124|Warfarin|warfarin|mesh-list
110693790|NCT01034124|Vitamins|vitamins|mesh-ancestor
110693791|NCT01034124|Micronutrients|micronutrients|mesh-ancestor
110693792|NCT01034124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110693793|NCT01034124|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110693794|NCT01034124|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110693795|NCT01034124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110693796|NCT01034124|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110693797|NCT01034124|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110693798|NCT01034124|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110693799|NCT01034124|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110693800|NCT01034124|Anesthetics, General|anesthetics, general|mesh-ancestor
110693801|NCT01034124|Anesthetics|anesthetics|mesh-ancestor
110693802|NCT01034124|GABA Modulators|gaba modulators|mesh-ancestor
110693804|NCT01034124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110693805|NCT01034124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110693806|NCT01034124|Anticoagulants|anticoagulants|mesh-ancestor
110693807|NCT01034124|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110693808|NCT01034124|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110693809|NCT01034124|Hemostatics|hemostatics|mesh-ancestor
110693810|NCT01034124|Coagulants|coagulants|mesh-ancestor
110693811|NCT00339183|Panitumumab|panitumumab|mesh-list
110693812|NCT00339183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110693813|NCT00339183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110693814|NCT01060605|Sirolimus|sirolimus|mesh-list
110693815|NCT01060605|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110693816|NCT01060605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110693817|NCT01060605|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110693818|NCT01060605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110693819|NCT01060605|Antifungal Agents|antifungal agents|mesh-ancestor
110693820|NCT01060605|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110693821|NCT01060605|Immunologic Factors|immunologic factors|mesh-ancestor
110693822|NCT01060605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110693823|NCT00532883|Hydroxyurea|hydroxyurea|mesh-list
110693824|NCT00532883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110693825|NCT00532883|Antisickling Agents|antisickling agents|mesh-ancestor
110693826|NCT00532883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110693827|NCT00532883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110693828|NCT00532883|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110693829|NCT00993863|Ibuprofen|ibuprofen|mesh-list
110693830|NCT00993863|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110693831|NCT00993863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110693832|NCT00993863|Analgesics|analgesics|mesh-ancestor
110693833|NCT00993863|Sensory System Agents|sensory system agents|mesh-ancestor
110693834|NCT00993863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110693835|NCT00993863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110693836|NCT00993863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110693837|NCT00993863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110693838|NCT00993863|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110693839|NCT00993863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110693840|NCT00993863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110693841|NCT00995423|Paclitaxel|paclitaxel|mesh-list
110693842|NCT00995423|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110693843|NCT00995423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110693844|NCT00995423|Tubulin Modulators|tubulin modulators|mesh-ancestor
110693845|NCT00995423|Antimitotic Agents|antimitotic agents|mesh-ancestor
110693846|NCT00995423|Mitosis Modulators|mitosis modulators|mesh-ancestor
110693847|NCT00995423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110693848|NCT00995657|Fluticasone|fluticasone|mesh-list
110693849|NCT00995657|Xhance|xhance|mesh-list
110693850|NCT00995657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110693851|NCT00995657|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110693852|NCT00995657|Autonomic Agents|autonomic agents|mesh-ancestor
110693853|NCT00995657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110693854|NCT00995657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110693855|NCT00995657|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110693856|NCT00995657|Respiratory System Agents|respiratory system agents|mesh-ancestor
110693857|NCT00995657|Dermatologic Agents|dermatologic agents|mesh-ancestor
110693858|NCT00995657|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110693859|NCT00994097|Gemcitabine|gemcitabine|mesh-list
110693860|NCT00994097|Pemetrexed|pemetrexed|mesh-list
110693861|NCT00994097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110693862|NCT00994097|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110693863|NCT00994097|Antimetabolites|antimetabolites|mesh-ancestor
110693864|NCT00994097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110693865|NCT00994097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110693866|NCT00994097|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110693867|NCT00994097|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110693868|NCT04000919|Carbidopa|carbidopa|mesh-list
110693869|NCT04000919|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110693870|NCT04000919|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110693871|NCT04000919|Dopamine Agents|dopamine agents|mesh-ancestor
110693872|NCT04000919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110693873|NCT04000919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110693874|NCT04000919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110858316|NCT01352130|Granisetron|granisetron|mesh-list
110693875|NCT04000919|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
110411712|NCT04268563|Metformin|metformin|mesh-list
110693877|NCT00994253|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110693878|NCT00994253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110693879|NCT00994253|Diuretics|diuretics|mesh-ancestor
110693880|NCT00994253|Natriuretic Agents|natriuretic agents|mesh-ancestor
110693881|NCT00994253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110693882|NCT00994253|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110693883|NCT00994253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110693884|NCT00994253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110693885|NCT00338949|Olanzapine|olanzapine|mesh-list
110693886|NCT00338949|Risperidone|risperidone|mesh-list
110693887|NCT00338949|Ziprasidone|ziprasidone|mesh-list
110693888|NCT00338949|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110693889|NCT00338949|Serotonin Agents|serotonin agents|mesh-ancestor
110693890|NCT00338949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110693891|NCT00338949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110693892|NCT00338949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110693893|NCT00338949|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110693894|NCT00338949|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110693895|NCT00338949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110693896|NCT00338949|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110693897|NCT00338949|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110693898|NCT00338949|Dopamine Agents|dopamine agents|mesh-ancestor
110693899|NCT00338949|Antiemetics|antiemetics|mesh-ancestor
110693900|NCT00338949|Autonomic Agents|autonomic agents|mesh-ancestor
110693901|NCT00338949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110693902|NCT00338949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110693903|NCT00338949|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110693904|NCT00338949|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110693905|NCT00338949|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110693906|NCT01325259|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110693907|NCT01325259|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110693908|NCT01325259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110693909|NCT00332709|Zoledronic Acid|zoledronic acid|mesh-list
110693910|NCT00332709|Letrozole|letrozole|mesh-list
110693911|NCT00332709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110693912|NCT00332709|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110693913|NCT00332709|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110693914|NCT00332709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110693915|NCT00332709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110693916|NCT00332709|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110693917|NCT00332709|Hormone Antagonists|hormone antagonists|mesh-ancestor
110693918|NCT00332709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110693919|NCT00332709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110693920|NCT00332709|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110693921|NCT03988725|Vitamin E|vitamin e|mesh-list
110693922|NCT03988725|Vitamins|vitamins|mesh-ancestor
110693923|NCT03988725|Micronutrients|micronutrients|mesh-ancestor
110693924|NCT03988725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110693925|NCT03988725|Antioxidants|antioxidants|mesh-ancestor
110693926|NCT03988725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110693927|NCT03988725|Protective Agents|protective agents|mesh-ancestor
110693928|NCT00332241|Aripiprazole|aripiprazole|mesh-list
110693929|NCT00332241|Antidepressive Agents|antidepressive agents|mesh-ancestor
110693930|NCT00332241|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110693931|NCT00332241|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110693932|NCT00332241|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110693933|NCT00332241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110693934|NCT00332241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110858332|NCT00005780|Prednisone|prednisone|mesh-list
110693935|NCT00332241|Dopamine Agonists|dopamine agonists|mesh-ancestor
110693936|NCT00332241|Dopamine Agents|dopamine agents|mesh-ancestor
110693937|NCT00332241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110693938|NCT00332241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110693939|NCT00332241|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110693940|NCT00332241|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110693941|NCT00332241|Serotonin Agents|serotonin agents|mesh-ancestor
110693942|NCT00332241|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110693943|NCT00332241|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110693944|NCT00332241|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110693945|NCT00332241|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110693946|NCT01058577|Somatostatin|somatostatin|mesh-list
110693947|NCT01058577|Hormones|hormones|mesh-ancestor
110693948|NCT01058577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110693949|NCT01058577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110693951|NCT03983889|Midazolam|midazolam|mesh-list
110693952|NCT03983889|Dexmedetomidine|dexmedetomidine|mesh-list
110693953|NCT03983889|Remifentanil|remifentanil|mesh-list
110693954|NCT03983889|Propofol|propofol|mesh-list
110693955|NCT03983889|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110693956|NCT03983889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110693957|NCT03983889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110693958|NCT03983889|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110693959|NCT03983889|Analgesics|analgesics|mesh-ancestor
110693960|NCT03983889|Sensory System Agents|sensory system agents|mesh-ancestor
110693961|NCT03983889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110693962|NCT03983889|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110693963|NCT03983889|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110693964|NCT03983889|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110693965|NCT03983889|Adrenergic Agents|adrenergic agents|mesh-ancestor
110693966|NCT03983889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110693967|NCT03983889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110693968|NCT03983889|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110693969|NCT03983889|Anesthetics, General|anesthetics, general|mesh-ancestor
110693970|NCT03983889|Anesthetics|anesthetics|mesh-ancestor
110693971|NCT03983889|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110693972|NCT03983889|Narcotics|narcotics|mesh-ancestor
110693973|NCT03983889|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110693974|NCT03983889|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110693975|NCT03983889|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110693976|NCT03983889|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110693977|NCT03983889|GABA Modulators|gaba modulators|mesh-ancestor
110693978|NCT03983889|GABA Agents|gaba agents|mesh-ancestor
110693979|NCT00337935|Epoetin Alfa|epoetin alfa|mesh-list
110693980|NCT00337935|Hematinics|hematinics|mesh-ancestor
110693981|NCT00337779|Glatiramer Acetate|glatiramer acetate|mesh-list
110693982|NCT00337779|(T,G)-A-L|(t,g)-a-l|mesh-list
110693983|NCT00337779|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110693984|NCT00337779|Immunologic Factors|immunologic factors|mesh-ancestor
110693985|NCT00337779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110693986|NCT00337779|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110693987|NCT00337779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110693988|NCT00352755|Leucovorin|leucovorin|mesh-list
110693989|NCT00352755|Fluorouracil|fluorouracil|mesh-list
110693990|NCT00352755|Oxaliplatin|oxaliplatin|mesh-list
110693991|NCT00352755|Antimetabolites|antimetabolites|mesh-ancestor
110858333|NCT00005780|Cyclophosphamide|cyclophosphamide|mesh-list
110693992|NCT00352755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110693993|NCT00352755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110693994|NCT00352755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110693995|NCT00352755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110693996|NCT00352755|Immunologic Factors|immunologic factors|mesh-ancestor
110693997|NCT00352755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110693998|NCT00352755|Antidotes|antidotes|mesh-ancestor
110693999|NCT00352755|Protective Agents|protective agents|mesh-ancestor
110694000|NCT00352755|Vitamin B Complex|vitamin b complex|mesh-ancestor
110694001|NCT00352755|Vitamins|vitamins|mesh-ancestor
110694002|NCT00352755|Micronutrients|micronutrients|mesh-ancestor
110694003|NCT00533897|Abatacept|abatacept|mesh-list
110694004|NCT00533897|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110694005|NCT00533897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110694006|NCT00533897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110694007|NCT00533897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110694008|NCT00533897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110694009|NCT00533897|Immunologic Factors|immunologic factors|mesh-ancestor
110694010|NCT00533897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110694011|NCT00533897|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110694012|NCT00426660|Maraviroc|maraviroc|mesh-list
110694013|NCT00426660|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110694014|NCT00426660|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110694015|NCT00426660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110694016|NCT00426660|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110694017|NCT00426660|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110694018|NCT00426660|Antiviral Agents|antiviral agents|mesh-ancestor
110694019|NCT00426660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110694020|NCT00426660|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
110694021|NCT00426270|Immunoglobulins|immunoglobulins|mesh-list
110694022|NCT00426270|Immunologic Factors|immunologic factors|mesh-ancestor
110694023|NCT00426270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110694024|NCT00330681|Edaravone|edaravone|mesh-list
110694025|NCT00330681|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110694026|NCT00330681|Antioxidants|antioxidants|mesh-ancestor
110694027|NCT00330681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110694029|NCT00330681|Protective Agents|protective agents|mesh-ancestor
110694030|NCT00330681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110694032|NCT00329901|Immunologic Factors|immunologic factors|mesh-ancestor
110694033|NCT00329901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110694034|NCT00436956|Prednisone|prednisone|mesh-list
110694035|NCT00436956|Cediranib|cediranib|mesh-list
110694036|NCT00436956|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110694037|NCT00436956|Glucocorticoids|glucocorticoids|mesh-ancestor
110694038|NCT00436956|Hormones|hormones|mesh-ancestor
110694039|NCT00436956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110694040|NCT00436956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110694041|NCT00436956|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110694042|NCT00436956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110694043|NCT00436956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110694044|NCT00436956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110694045|NCT00436956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110694046|NCT00436644|Topotecan|topotecan|mesh-list
110694047|NCT00436644|Lapatinib|lapatinib|mesh-list
110694048|NCT00436644|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110694049|NCT00436644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110694050|NCT00436644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110694051|NCT00436644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110694052|NCT00436644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110694053|NCT00436644|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110694054|NCT00324987|Bevacizumab|bevacizumab|mesh-list
110694055|NCT00324987|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110694056|NCT00324987|Imatinib Mesylate|imatinib mesylate|mesh-list
110694057|NCT00324987|Endothelial Growth Factors|endothelial growth factors|mesh-list
110694058|NCT00324987|Antibodies|antibodies|mesh-list
110694059|NCT00324987|Immunoglobulins|immunoglobulins|mesh-list
110694060|NCT00324987|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110694061|NCT00324987|Immunoglobulin G|immunoglobulin g|mesh-list
110694062|NCT00324987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110694063|NCT00324987|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110694064|NCT00324987|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110694065|NCT00324987|Growth Substances|growth substances|mesh-ancestor
110694066|NCT00324987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110694067|NCT00324987|Growth Inhibitors|growth inhibitors|mesh-ancestor
110694068|NCT00324987|Immunologic Factors|immunologic factors|mesh-ancestor
110694069|NCT00324987|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110694070|NCT00324987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110694071|NCT00324987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110694072|NCT00324675|Rosiglitazone|rosiglitazone|mesh-list
110694073|NCT00324675|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110694074|NCT00324675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110694075|NCT01055145|Moxifloxacin|moxifloxacin|mesh-list
110694076|NCT01055145|Levofloxacin|levofloxacin|mesh-list
110694077|NCT01055145|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110694078|NCT01055145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110694079|NCT01055145|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110694080|NCT01055145|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110694081|NCT01055145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110694082|NCT01055145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110694083|NCT01055145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110694084|NCT01055145|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110694085|NCT01055145|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110694086|NCT01055145|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110694087|NCT00436566|Paclitaxel|paclitaxel|mesh-list
110694088|NCT00436566|Cyclophosphamide|cyclophosphamide|mesh-list
110694089|NCT00436566|Doxorubicin|doxorubicin|mesh-list
110694090|NCT00436566|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110694091|NCT00436566|Trastuzumab|trastuzumab|mesh-list
110694092|NCT00436566|Lapatinib|lapatinib|mesh-list
110694093|NCT00436566|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110694094|NCT00436566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110694095|NCT00436566|Tubulin Modulators|tubulin modulators|mesh-ancestor
110694096|NCT00436566|Antimitotic Agents|antimitotic agents|mesh-ancestor
110694097|NCT00436566|Mitosis Modulators|mitosis modulators|mesh-ancestor
110694098|NCT00436566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110411936|NCT01143051|Epinephrine|epinephrine|mesh-list
110694099|NCT00436566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110694100|NCT00436566|Immunologic Factors|immunologic factors|mesh-ancestor
110694101|NCT00436566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110408555|NCT05053087|Anesthetics|anesthetics|mesh-ancestor
110694102|NCT00436566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110694103|NCT00436566|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110694104|NCT00436566|Alkylating Agents|alkylating agents|mesh-ancestor
110694105|NCT00436566|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110694106|NCT00436566|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110694107|NCT00436566|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110694108|NCT00436566|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110694109|NCT00436566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110694110|NCT00436566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110694111|NCT00436566|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110694112|NCT01060683|Chrysarobin|chrysarobin|mesh-list
110694113|NCT01060683|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110694114|NCT01060683|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110694115|NCT01060683|Analgesics|analgesics|mesh-ancestor
110694116|NCT01060683|Sensory System Agents|sensory system agents|mesh-ancestor
110694117|NCT01060683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110694118|NCT01060683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110694119|NCT01060683|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110694120|NCT01060683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110694122|NCT01055301|Dexamethasone|dexamethasone|mesh-list
110694123|NCT01055301|Cyclophosphamide|cyclophosphamide|mesh-list
110694124|NCT01055301|Melphalan|melphalan|mesh-list
110694125|NCT01055301|Doxorubicin|doxorubicin|mesh-list
110694126|NCT01055301|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110694127|NCT01055301|Etoposide|etoposide|mesh-list
110694128|NCT01055301|Lenalidomide|lenalidomide|mesh-list
110694129|NCT01055301|Bortezomib|bortezomib|mesh-list
110694130|NCT01055301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110694131|NCT01055301|Immunologic Factors|immunologic factors|mesh-ancestor
110694132|NCT01055301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110694133|NCT01055301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110694134|NCT01055301|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110694135|NCT01055301|Alkylating Agents|alkylating agents|mesh-ancestor
110694136|NCT01055301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110694137|NCT01055301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110694138|NCT01055301|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110694139|NCT01055301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110694140|NCT01055301|Antiemetics|antiemetics|mesh-ancestor
110694141|NCT01055301|Autonomic Agents|autonomic agents|mesh-ancestor
110694142|NCT01055301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110694143|NCT01055301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110694144|NCT01055301|Glucocorticoids|glucocorticoids|mesh-ancestor
110694145|NCT01055301|Hormones|hormones|mesh-ancestor
110694146|NCT01055301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110694147|NCT01055301|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110694148|NCT01055301|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110694149|NCT01055301|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110694150|NCT01055301|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110694151|NCT01055301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110694152|NCT01055301|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110694153|NCT01055301|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110694154|NCT01055301|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110694155|NCT01055301|Growth Substances|growth substances|mesh-ancestor
110694156|NCT01055301|Growth Inhibitors|growth inhibitors|mesh-ancestor
110694157|NCT01055301|Leprostatic Agents|leprostatic agents|mesh-ancestor
110694158|NCT01055301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110694159|NCT01055301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110694160|NCT01055379|Rasagiline|rasagiline|mesh-list
110694161|NCT01055379|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
110694162|NCT01055379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110694163|NCT01055379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110694164|NCT01055379|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110694165|NCT01055379|Protective Agents|protective agents|mesh-ancestor
110694166|NCT01055379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110694167|NCT03988101|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110694169|NCT03988101|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110694170|NCT03988101|Antimetabolites|antimetabolites|mesh-ancestor
110694171|NCT03988101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110694172|NCT03988101|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110694173|NCT03988101|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110694174|NCT03988101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110694176|NCT00352365|Immunologic Factors|immunologic factors|mesh-ancestor
110694177|NCT00352365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110694178|NCT00352365|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110694179|NCT00352365|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110694180|NCT00352365|Growth Substances|growth substances|mesh-ancestor
110694181|NCT00352365|Growth Inhibitors|growth inhibitors|mesh-ancestor
110694182|NCT00352365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110694183|NCT01055535|Plasminogen|plasminogen|mesh-list
110694184|NCT01055535|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110694185|NCT01055535|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110694186|NCT01055535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110694187|NCT03987867|Paclitaxel|paclitaxel|mesh-list
110694188|NCT03987867|Carboplatin|carboplatin|mesh-list
110694189|NCT03987867|Pemetrexed|pemetrexed|mesh-list
110694190|NCT03987867|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
110694191|NCT03987867|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110694192|NCT03987867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110694193|NCT03987867|Tubulin Modulators|tubulin modulators|mesh-ancestor
110694194|NCT03987867|Antimitotic Agents|antimitotic agents|mesh-ancestor
110694195|NCT03987867|Mitosis Modulators|mitosis modulators|mesh-ancestor
110694196|NCT03987867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110694197|NCT03987867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110694198|NCT03987867|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110694199|NCT03987867|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110694200|NCT03987867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110694201|NCT00532493|Prazosin|prazosin|mesh-list
110694202|NCT00532493|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110694203|NCT00532493|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110694204|NCT00532493|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110694205|NCT00532493|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110694206|NCT00532493|Adrenergic Agents|adrenergic agents|mesh-ancestor
110694207|NCT00532493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110694208|NCT00532493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110694209|NCT00532493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110694210|NCT00996515|Azacitidine|azacitidine|mesh-list
110694211|NCT00996515|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110694212|NCT00996515|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110694213|NCT00996515|Antimetabolites|antimetabolites|mesh-ancestor
110694214|NCT00996515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110694215|NCT00996515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110694216|NCT00996515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110694217|NCT00996515|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110694218|NCT00994799|Ranibizumab|ranibizumab|mesh-list
110694219|NCT00994799|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110694220|NCT00994799|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110694221|NCT00994799|Growth Substances|growth substances|mesh-ancestor
110694222|NCT00994799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110694223|NCT00994799|Growth Inhibitors|growth inhibitors|mesh-ancestor
110694224|NCT00994799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110694225|NCT00533507|Vaccines|vaccines|mesh-list
110858398|NCT02465008|Levobupivacaine|levobupivacaine|mesh-list
110694226|NCT00533507|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110694227|NCT00533507|Immunologic Factors|immunologic factors|mesh-ancestor
110694228|NCT00533507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110694229|NCT00352053|Tenofovir|tenofovir|mesh-list
110694230|NCT00352053|Antiviral Agents|antiviral agents|mesh-ancestor
110694231|NCT00352053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110694232|NCT00352053|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110694233|NCT00352053|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110694234|NCT00352053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110694235|NCT00352053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110694236|NCT00352053|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110694237|NCT00352053|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110694238|NCT00995033|Varenicline|varenicline|mesh-list
110694239|NCT00995033|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110694240|NCT00995033|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110694241|NCT00995033|Cholinergic Agents|cholinergic agents|mesh-ancestor
110694242|NCT00995033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110694243|NCT00995033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110694244|NCT00995033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110694245|NCT00997061|Topotecan|topotecan|mesh-list
110694246|NCT00997061|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110560282|NCT02615288|Cholecalciferol|cholecalciferol|mesh-list
110694247|NCT00997061|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110694248|NCT00997061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110694249|NCT00997061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110694250|NCT00997061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110694251|NCT00351819|Testosterone|testosterone|mesh-list
110694252|NCT00351819|Androgens|androgens|mesh-ancestor
110694253|NCT00351819|Hormones|hormones|mesh-ancestor
110694254|NCT00351819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110694255|NCT00351819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110694256|NCT00998933|Testosterone|testosterone|mesh-list
110694257|NCT00998933|Androgens|androgens|mesh-ancestor
110694258|NCT00998933|Hormones|hormones|mesh-ancestor
110694259|NCT00998933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110694260|NCT00998933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110694261|NCT00323115|Temozolomide|temozolomide|mesh-list
110694262|NCT00323115|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110694263|NCT00323115|Alkylating Agents|alkylating agents|mesh-ancestor
110694264|NCT00323115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110694265|NCT00323115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110694266|NCT00322881|Paclitaxel|paclitaxel|mesh-list
110694267|NCT00322881|Carboplatin|carboplatin|mesh-list
110694268|NCT00322881|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110694269|NCT00322881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110694270|NCT00322881|Tubulin Modulators|tubulin modulators|mesh-ancestor
110858413|NCT04105114|Buspirone|buspirone|mesh-list
110694271|NCT00322881|Antimitotic Agents|antimitotic agents|mesh-ancestor
110694272|NCT00322881|Mitosis Modulators|mitosis modulators|mesh-ancestor
110694273|NCT00322881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110694274|NCT00415194|Pemetrexed|pemetrexed|mesh-list
110694275|NCT00415194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110694276|NCT00415194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110694277|NCT00415194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110694278|NCT00415194|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110694279|NCT00415194|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110694280|NCT00436332|Bevacizumab|bevacizumab|mesh-list
110694281|NCT00436332|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110694282|NCT00436332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110694283|NCT00436332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110694284|NCT00436332|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110694285|NCT00436332|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110694286|NCT00436332|Growth Substances|growth substances|mesh-ancestor
110694287|NCT00436332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110694288|NCT00436332|Growth Inhibitors|growth inhibitors|mesh-ancestor
110694289|NCT00436332|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110694290|NCT00436332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110694291|NCT00436332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110694292|NCT00532259|Pidilizumab|pidilizumab|mesh-list
110694293|NCT00532259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110694294|NCT00532259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110694295|NCT00322491|Plerixafor|plerixafor|mesh-list
110694296|NCT00322491|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110694297|NCT00322491|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110694298|NCT00322491|Antiviral Agents|antiviral agents|mesh-ancestor
110694299|NCT00322491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110694300|NCT01034514|Technetium Tc 99m Aggregated Albumin|technetium tc 99m aggregated albumin|mesh-list
110694301|NCT01034514|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110694302|NCT01034514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110694303|NCT00997607|Vaccines|vaccines|mesh-list
110694304|NCT00997607|Immunologic Factors|immunologic factors|mesh-ancestor
110694305|NCT00997607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110694306|NCT00997685|Capecitabine|capecitabine|mesh-list
110694307|NCT00997685|Oxaliplatin|oxaliplatin|mesh-list
110694308|NCT00997685|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110694309|NCT00997685|Antimetabolites|antimetabolites|mesh-ancestor
110694310|NCT00997685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110694311|NCT00997685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110694312|NCT00997919|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110694313|NCT00997919|Immunologic Factors|immunologic factors|mesh-ancestor
110214335|NCT00248482|Cisplatin|cisplatin|mesh-list
110694314|NCT00997919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110694315|NCT00997997|Moxifloxacin|moxifloxacin|mesh-list
110694316|NCT00997997|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
110694317|NCT00997997|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110694318|NCT00997997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110694319|NCT00997997|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110694320|NCT00997997|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110694321|NCT00997997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110694322|NCT00997997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110412153|NCT05379283|Lidocaine|lidocaine|mesh-list
110694323|NCT00997997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110694324|NCT00997997|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110694325|NCT00997997|Contraceptive Agents|contraceptive agents|mesh-ancestor
110694326|NCT00997997|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110694327|NCT00997997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110694328|NCT00997997|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110694329|NCT00997997|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110694330|NCT00997997|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110694332|NCT00998075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110694333|NCT00998075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110694334|NCT00998075|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110694335|NCT00998075|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110694336|NCT00998075|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110694337|NCT00531947|Selegiline|selegiline|mesh-list
110694338|NCT00531947|Antidepressive Agents|antidepressive agents|mesh-ancestor
110694339|NCT00531947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110694340|NCT00531947|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110694341|NCT00531947|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110694342|NCT00531947|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
110694343|NCT00531947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110694344|NCT00531947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110694345|NCT00531947|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110694346|NCT00531947|Protective Agents|protective agents|mesh-ancestor
110694347|NCT00531947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110694348|NCT01003847|Fenofibrate|fenofibrate|mesh-list
110694349|NCT01003847|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110694350|NCT01003847|Antimetabolites|antimetabolites|mesh-ancestor
110694351|NCT01003847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110694352|NCT01003847|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110694353|NCT00530855|Lacosamide|lacosamide|mesh-list
110694354|NCT00530855|Anticonvulsants|anticonvulsants|mesh-ancestor
110694355|NCT00530855|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110694356|NCT00530855|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110694357|NCT00530855|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110694358|NCT00530855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110694359|NCT01004237|Valsartan|valsartan|mesh-list
110694360|NCT01004237|Pravastatin|pravastatin|mesh-list
110694361|NCT01004237|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110694362|NCT01004237|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110694363|NCT01004237|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110694364|NCT01004237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110694365|NCT01004237|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110694366|NCT01004237|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110694367|NCT01004237|Antimetabolites|antimetabolites|mesh-ancestor
110694368|NCT01004237|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110694369|NCT01004237|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110694370|NCT01004237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110694371|NCT01004315|Tolterodine Tartrate|tolterodine tartrate|mesh-list
110694372|NCT01004315|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110694373|NCT01004315|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110694374|NCT01004315|Cholinergic Agents|cholinergic agents|mesh-ancestor
110694375|NCT01004315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110694376|NCT01004315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110694377|NCT01004315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110694378|NCT01004315|Urological Agents|urological agents|mesh-ancestor
110694379|NCT05239637|Heparin|heparin|mesh-list
110694380|NCT05239637|Calcium heparin|calcium heparin|mesh-list
110694381|NCT05239637|Anticoagulants|anticoagulants|mesh-ancestor
110694382|NCT05239637|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110694383|NCT05239637|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110694384|NCT05239637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110694385|NCT01005095|Vitamin D|vitamin d|mesh-list
110694386|NCT01005095|Ergocalciferols|ergocalciferols|mesh-list
110694387|NCT01005095|Cholecalciferol|cholecalciferol|mesh-list
110694388|NCT01005095|Vitamins|vitamins|mesh-list
110694389|NCT01005095|Micronutrients|micronutrients|mesh-ancestor
110694390|NCT01005095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110694391|NCT01005095|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110694392|NCT01005095|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110694393|NCT01005641|Lapatinib|lapatinib|mesh-list
110694395|NCT01005641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110694396|NCT01005641|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110694397|NCT01005641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110694398|NCT01005641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110694399|NCT01005641|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110694400|NCT01005641|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110694401|NCT01005641|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110694402|NCT01005641|Hormone Antagonists|hormone antagonists|mesh-ancestor
110694403|NCT01005641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110694404|NCT01005641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110694405|NCT01005797|Sorafenib|sorafenib|mesh-list
110694406|NCT01005797|Panobinostat|panobinostat|mesh-list
110694407|NCT01005797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110694408|NCT01005797|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110694409|NCT01005797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110694410|NCT01005797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110694411|NCT01005797|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110694412|NCT01006031|Interferons|interferons|mesh-list
110694413|NCT01006031|Ribavirin|ribavirin|mesh-list
110694414|NCT01006031|Interferon-alpha|interferon-alpha|mesh-list
110694415|NCT01006031|Interferon alpha-2|interferon alpha-2|mesh-list
110694416|NCT01006031|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110694417|NCT01006031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110694418|NCT01006031|Antiviral Agents|antiviral agents|mesh-ancestor
110694419|NCT01006031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110694420|NCT01006031|Antimetabolites|antimetabolites|mesh-ancestor
110694421|NCT01006031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110694422|NCT01006031|Immunologic Factors|immunologic factors|mesh-ancestor
110694423|NCT01006031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110694424|NCT01006187|Lidocaine|lidocaine|mesh-list
110694425|NCT01006187|Anesthetics, Local|anesthetics, local|mesh-ancestor
110694426|NCT01006187|Anesthetics|anesthetics|mesh-ancestor
110694427|NCT01006187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110694428|NCT01006187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110694429|NCT01006187|Sensory System Agents|sensory system agents|mesh-ancestor
110694430|NCT01006187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110694431|NCT01006187|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110694432|NCT01006187|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110694433|NCT01006187|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110694434|NCT01006187|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110694435|NCT01006187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110694436|NCT00530777|Valacyclovir|valacyclovir|mesh-list
110694437|NCT00530777|Antiviral Agents|antiviral agents|mesh-ancestor
110694438|NCT00530777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110694439|NCT01006499|Pentoxifylline|pentoxifylline|mesh-list
110694440|NCT01006499|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110694441|NCT01006499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110694442|NCT01006499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110694443|NCT01006499|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110694444|NCT01006499|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110694445|NCT01006499|Protective Agents|protective agents|mesh-ancestor
110694446|NCT01006499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110694447|NCT01006499|Vasodilator Agents|vasodilator agents|mesh-ancestor
110694448|NCT01006499|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110694449|NCT01006499|Antioxidants|antioxidants|mesh-ancestor
110694450|NCT03882047|Fluticasone|fluticasone|mesh-list
110694451|NCT03882047|Xhance|xhance|mesh-list
110694452|NCT03882047|Mometasone Furoate|mometasone furoate|mesh-list
110694453|NCT03882047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110694454|NCT03882047|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110694455|NCT03882047|Autonomic Agents|autonomic agents|mesh-ancestor
110657368|NCT05132829|Cefazolin|cefazolin|mesh-list
110694456|NCT03882047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110694457|NCT03882047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110694458|NCT03882047|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110694459|NCT03882047|Respiratory System Agents|respiratory system agents|mesh-ancestor
110694460|NCT03882047|Dermatologic Agents|dermatologic agents|mesh-ancestor
110694461|NCT03882047|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110694462|NCT01007279|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110694463|NCT01007279|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110694464|NCT01007279|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110694465|NCT01007279|Antimetabolites|antimetabolites|mesh-ancestor
110694466|NCT01007279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110694467|NCT01007279|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110694468|NCT01007279|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110694469|NCT01007279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110694470|NCT00530621|Pemetrexed|pemetrexed|mesh-list
110694471|NCT00530621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110694472|NCT00530621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110694473|NCT00530621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110694474|NCT00530621|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110694475|NCT00530621|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110694476|NCT00531479|Voriconazole|voriconazole|mesh-list
110694477|NCT00531479|Anidulafungin|anidulafungin|mesh-list
110694478|NCT00531479|Antifungal Agents|antifungal agents|mesh-ancestor
110694479|NCT00531479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110694480|NCT00531479|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110694481|NCT00531479|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110694482|NCT00531479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110694483|NCT00531479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110694484|NCT00531479|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110694485|NCT00531479|Hormone Antagonists|hormone antagonists|mesh-ancestor
110694486|NCT00531479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110694487|NCT00531479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110694488|NCT00531479|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110694489|NCT00999479|Ferrous fumarate|ferrous fumarate|mesh-list
110694490|NCT00999479|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110694491|NCT00999479|Norethindrone|norethindrone|mesh-list
110694492|NCT00999479|Norethindrone Acetate|norethindrone acetate|mesh-list
110694493|NCT00999479|Estradiol|estradiol|mesh-list
110694494|NCT00999479|Estrogens|estrogens|mesh-ancestor
110694495|NCT00999479|Hormones|hormones|mesh-ancestor
110694496|NCT00999479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110694497|NCT00999479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110694498|NCT00999479|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110694499|NCT00999479|Contraceptive Agents|contraceptive agents|mesh-ancestor
110694500|NCT00999479|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110694501|NCT00999479|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110694502|NCT00999479|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110694503|NCT00999479|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110694504|NCT00999479|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110694505|NCT00999479|Trace Elements|trace elements|mesh-ancestor
110694506|NCT00999479|Micronutrients|micronutrients|mesh-ancestor
110694507|NCT00999557|Bimatoprost|bimatoprost|mesh-list
110694508|NCT00999557|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110694509|NCT00999557|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110694510|NCT00999557|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110694511|NCT01008137|Vaccines|vaccines|mesh-list
110694512|NCT01008137|Immunologic Factors|immunologic factors|mesh-ancestor
110694513|NCT01008137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110694514|NCT00999791|Diclofenac|diclofenac|mesh-list
110694515|NCT00999791|Bevacizumab|bevacizumab|mesh-list
110694516|NCT00999791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110694517|NCT00999791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110694518|NCT00999791|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110694519|NCT00999791|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110694520|NCT00999791|Growth Substances|growth substances|mesh-ancestor
110694521|NCT00999791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110694522|NCT00999791|Growth Inhibitors|growth inhibitors|mesh-ancestor
110694523|NCT00999791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110694524|NCT00999791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110694525|NCT00999791|Analgesics|analgesics|mesh-ancestor
110694526|NCT00999791|Sensory System Agents|sensory system agents|mesh-ancestor
110694527|NCT00999791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110694528|NCT00999791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110694529|NCT00999791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110694530|NCT00999791|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110694531|NCT00999791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110694532|NCT00999791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110694533|NCT00999869|Triamcinolone|triamcinolone|mesh-list
110694534|NCT00999869|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110694535|NCT00999869|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110694536|NCT00999869|Botulinum Toxins|botulinum toxins|mesh-list
110694537|NCT00999869|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110694538|NCT00999869|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110694539|NCT00999869|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110694540|NCT00999869|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110694541|NCT00999869|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110858498|NCT01330563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110694542|NCT00999869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110694543|NCT00999869|Cholinergic Agents|cholinergic agents|mesh-ancestor
110694544|NCT00999869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110412378|NCT00605683|Serotonin Agents|serotonin agents|mesh-ancestor
110694545|NCT00999869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110694546|NCT00999869|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110694547|NCT00999869|Glucocorticoids|glucocorticoids|mesh-ancestor
110694549|NCT00999869|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110694550|NCT00999869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110694551|NCT00999869|Immunologic Factors|immunologic factors|mesh-ancestor
110694552|NCT00999869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110694553|NCT00999869|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110694554|NCT00999869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110694555|NCT01008293|Lactulose|lactulose|mesh-list
110694556|NCT01008293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110694557|NCT01008527|Poly ICLC|poly iclc|mesh-list
110694558|NCT01008527|Interferon Inducers|interferon inducers|mesh-ancestor
110694559|NCT01008527|Immunologic Factors|immunologic factors|mesh-ancestor
110694560|NCT01008527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110694561|NCT01000415|Cisplatin|cisplatin|mesh-list
110694562|NCT01000415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110694563|NCT01008761|Azithromycin|azithromycin|mesh-list
110694564|NCT01008761|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110694565|NCT01008761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110694566|NCT01008917|Sirolimus|sirolimus|mesh-list
110694567|NCT01008917|Sorafenib|sorafenib|mesh-list
110694568|NCT01008917|Temsirolimus|temsirolimus|mesh-list
110694569|NCT01008917|MTOR Inhibitors|mtor inhibitors|mesh-list
110694570|NCT01008917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110694571|NCT01008917|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110694572|NCT01008917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110694573|NCT01008917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110694574|NCT01008917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110694575|NCT01008917|Immunologic Factors|immunologic factors|mesh-ancestor
110694576|NCT01008917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110694577|NCT01008917|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110694578|NCT01008917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110694579|NCT01008917|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110694580|NCT01008917|Antifungal Agents|antifungal agents|mesh-ancestor
110694581|NCT01009073|Irinotecan|irinotecan|mesh-list
110694582|NCT01009073|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110694583|NCT01009073|Navitoclax|navitoclax|mesh-list
110694584|NCT01009073|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110694585|NCT01009073|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110694586|NCT01009073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110694587|NCT01009073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110694588|NCT01009073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110694589|NCT01009073|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110694590|NCT00530075|Gusperimus|gusperimus|mesh-list
110657375|NCT05132829|Sensory System Agents|sensory system agents|mesh-ancestor
110694591|NCT00530075|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110694592|NCT00530075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110694593|NCT00530075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110694594|NCT00530075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110694595|NCT00530075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110694596|NCT00530075|Immunologic Factors|immunologic factors|mesh-ancestor
110694597|NCT00530075|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110694598|NCT00530075|Protective Agents|protective agents|mesh-ancestor
110694599|NCT01001585|Sevoflurane|sevoflurane|mesh-list
110694600|NCT01001585|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110694601|NCT01001585|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110694602|NCT01001585|Anesthetics, General|anesthetics, general|mesh-ancestor
110694603|NCT01001585|Anesthetics|anesthetics|mesh-ancestor
110694604|NCT01001585|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110694605|NCT01001585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110694606|NCT01001897|Misoprostol|misoprostol|mesh-list
110694607|NCT01001897|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110694608|NCT01001897|Abortifacient Agents|abortifacient agents|mesh-ancestor
110694609|NCT01001897|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110694610|NCT01001897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110694611|NCT01001897|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110694612|NCT01001897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110694613|NCT01001897|Oxytocics|oxytocics|mesh-ancestor
110694614|NCT05734001|Hemostatics|hemostatics|mesh-list
110694615|NCT05734001|Coagulants|coagulants|mesh-ancestor
110694616|NCT01002911|Cefazolin|cefazolin|mesh-list
110694617|NCT01002911|Cephalexin|cephalexin|mesh-list
110694618|NCT01002911|Bacitracin|bacitracin|mesh-list
110694619|NCT01002911|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110694620|NCT01002911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110694621|NCT01002911|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110694622|NCT05059535|Acetaminophen|acetaminophen|mesh-list
110694623|NCT05059535|Analgesics|analgesics|mesh-list
110694625|NCT05059535|Sensory System Agents|sensory system agents|mesh-ancestor
110694626|NCT05059535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110694627|NCT05059535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110694628|NCT05059535|Antipyretics|antipyretics|mesh-ancestor
110694629|NCT00531011|Paclitaxel|paclitaxel|mesh-list
110694630|NCT00531011|Everolimus|everolimus|mesh-list
110694631|NCT00531011|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110694632|NCT00531011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110694633|NCT00531011|Tubulin Modulators|tubulin modulators|mesh-ancestor
110694634|NCT00531011|Antimitotic Agents|antimitotic agents|mesh-ancestor
110694635|NCT00531011|Mitosis Modulators|mitosis modulators|mesh-ancestor
110694636|NCT00531011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110694637|NCT00531011|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110694638|NCT00531011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110694639|NCT00531011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110694640|NCT00531011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110694641|NCT00531011|Immunologic Factors|immunologic factors|mesh-ancestor
110694642|NCT00531011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110694643|NCT04000295|Paclitaxel|paclitaxel|mesh-list
110694644|NCT04000295|Etoposide|etoposide|mesh-list
110694645|NCT04000295|Apatinib|apatinib|mesh-list
110694646|NCT04000295|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110694647|NCT04000295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110694648|NCT04000295|Tubulin Modulators|tubulin modulators|mesh-ancestor
110694649|NCT04000295|Antimitotic Agents|antimitotic agents|mesh-ancestor
110694650|NCT04000295|Mitosis Modulators|mitosis modulators|mesh-ancestor
110694651|NCT04000295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110694652|NCT04000295|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110694653|NCT04000295|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110694654|NCT04000295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110694655|NCT04000295|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110694656|NCT01003613|Tranilast|tranilast|mesh-list
110694657|NCT01003613|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
110694658|NCT01003613|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110694659|NCT01003613|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110694660|NCT01003613|Analgesics|analgesics|mesh-ancestor
110694661|NCT01003613|Sensory System Agents|sensory system agents|mesh-ancestor
110694662|NCT01003613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110694663|NCT01003613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110694664|NCT01003613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110694665|NCT01003613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110694666|NCT01003613|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110694667|NCT01003613|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110694668|NCT01003613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110694669|NCT01003613|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110694670|NCT01003613|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110694671|NCT01003613|Histamine Antagonists|histamine antagonists|mesh-ancestor
110694672|NCT01003613|Histamine Agents|histamine agents|mesh-ancestor
110694673|NCT01003613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110694674|NCT01003613|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110694675|NCT01003613|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110694676|NCT01003613|Hemostatics|hemostatics|mesh-ancestor
110694677|NCT01003613|Coagulants|coagulants|mesh-ancestor
110694678|NCT00471146|Gemcitabine|gemcitabine|mesh-list
110694679|NCT00471146|Axitinib|axitinib|mesh-list
110694680|NCT00471146|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110694681|NCT00471146|Antimetabolites|antimetabolites|mesh-ancestor
110858550|NCT01319448|Amodiaquine|amodiaquine|mesh-list
110694682|NCT00471146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110694683|NCT00471146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110694684|NCT00471146|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110694685|NCT00471146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110694686|NCT01021358|Ketoconazole|ketoconazole|mesh-list
110408565|NCT05038982|Abrocitinib|abrocitinib|mesh-list
110694689|NCT01021358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110694690|NCT01021358|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110694691|NCT01021358|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110694692|NCT01021358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110694693|NCT01021358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110694694|NCT01021358|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110694695|NCT01021358|Hormone Antagonists|hormone antagonists|mesh-ancestor
110694696|NCT01021358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110694697|NCT01021358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110694698|NCT01021358|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110694699|NCT01021358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110694700|NCT00469898|Carboplatin|carboplatin|mesh-list
110694701|NCT00469898|Irinotecan|irinotecan|mesh-list
110694702|NCT00469898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110694703|NCT00469898|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110694704|NCT00469898|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110694705|NCT00469898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110694706|NCT00469898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110694707|NCT01021436|Amikacin|amikacin|mesh-list
110694708|NCT01021436|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110694709|NCT01021436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110694710|NCT00529763|Dasatinib|dasatinib|mesh-list
110694711|NCT00529763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110694712|NCT00529763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110694713|NCT00529763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110694714|NCT00529763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110694715|NCT00486902|Ketamine|ketamine|mesh-list
110694716|NCT00486902|N-Methylaspartate|n-methylaspartate|mesh-list
110694717|NCT00486902|Analgesics|analgesics|mesh-ancestor
110694718|NCT00486902|Sensory System Agents|sensory system agents|mesh-ancestor
110694719|NCT00486902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110694720|NCT00486902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110694721|NCT00486902|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110694722|NCT00486902|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110694723|NCT00486902|Anesthetics, General|anesthetics, general|mesh-ancestor
110694724|NCT00486902|Anesthetics|anesthetics|mesh-ancestor
110694725|NCT00486902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110694726|NCT00486902|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110694727|NCT00486902|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110694728|NCT00486902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110694729|NCT00486902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110694730|NCT00486902|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
110694731|NCT03687827|Insulin|insulin|mesh-list
110694732|NCT03687827|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110694733|NCT03687827|Insulin Glargine|insulin glargine|mesh-list
110694734|NCT03687827|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110694735|NCT03687827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110694736|NCT00529529|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110694737|NCT00529529|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110694738|NCT00529529|Autonomic Agents|autonomic agents|mesh-ancestor
110694739|NCT00529529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110694740|NCT00529529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110694741|NCT00529529|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110694742|NCT00529529|Respiratory System Agents|respiratory system agents|mesh-ancestor
110694743|NCT00529529|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110694744|NCT00529529|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110694745|NCT00529529|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110694746|NCT00529529|Adrenergic Agents|adrenergic agents|mesh-ancestor
110694747|NCT00529529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110694748|NCT00529529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110694749|NCT05685953|Vaccines|vaccines|mesh-list
110694750|NCT05685953|Immunologic Factors|immunologic factors|mesh-ancestor
110694751|NCT05685953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110694752|NCT00486434|Calcitonin|calcitonin|mesh-list
110694753|NCT00486434|Salmon calcitonin|salmon calcitonin|mesh-list
110694754|NCT00486434|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
110694755|NCT00486434|Katacalcin|katacalcin|mesh-list
110694756|NCT00486434|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110694757|NCT00486434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110694758|NCT00486434|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110694759|NCT00486434|Vasodilator Agents|vasodilator agents|mesh-ancestor
110694760|NCT00529451|Ramipril|ramipril|mesh-list
110694761|NCT00529451|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110694762|NCT00529451|Protease Inhibitors|protease inhibitors|mesh-ancestor
110694763|NCT00529451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110694764|NCT00529451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110694765|NCT00529451|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110694766|NCT05641259|Azacitidine|azacitidine|mesh-list
110694767|NCT05641259|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110694768|NCT05641259|Antimetabolites|antimetabolites|mesh-ancestor
110694769|NCT05641259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110694770|NCT05641259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110694771|NCT05641259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110694772|NCT05405387|Budesonide|budesonide|mesh-list
110694773|NCT05405387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110694774|NCT05405387|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110694775|NCT05405387|Autonomic Agents|autonomic agents|mesh-ancestor
110694776|NCT05405387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110694777|NCT05405387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110694778|NCT05405387|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110694779|NCT05405387|Respiratory System Agents|respiratory system agents|mesh-ancestor
110694780|NCT05405387|Glucocorticoids|glucocorticoids|mesh-ancestor
110694781|NCT05405387|Hormones|hormones|mesh-ancestor
110694782|NCT05405387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110694783|NCT03999437|Terbinafine|terbinafine|mesh-list
110694784|NCT03999437|Butenafine|butenafine|mesh-list
110694785|NCT03999437|Antifungal Agents|antifungal agents|mesh-ancestor
110694786|NCT03999437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110694787|NCT03999437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110694788|NCT03999437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110694789|NCT05638217|Listerine|listerine|mesh-list
110694790|NCT05638217|Fluorides|fluorides|mesh-list
110694791|NCT05638217|Sodium Fluoride|sodium fluoride|mesh-list
110694792|NCT05638217|Fluorides, Topical|fluorides, topical|mesh-list
110694793|NCT05638217|Cariostatic Agents|cariostatic agents|mesh-ancestor
110694794|NCT05638217|Protective Agents|protective agents|mesh-ancestor
110694795|NCT05638217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110694796|NCT05638217|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110694797|NCT05638217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110694798|NCT05637281|Indomethacin|indomethacin|mesh-list
110694799|NCT05637281|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110694800|NCT05637281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110694801|NCT05637281|Analgesics|analgesics|mesh-ancestor
110694802|NCT05637281|Sensory System Agents|sensory system agents|mesh-ancestor
110694803|NCT05637281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110694804|NCT05637281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110657394|NCT05050448|Diclofenac|diclofenac|mesh-list
110694805|NCT05637281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110694806|NCT05637281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110694807|NCT05637281|Gout Suppressants|gout suppressants|mesh-ancestor
110694808|NCT05637281|Tocolytic Agents|tocolytic agents|mesh-ancestor
110694809|NCT05637281|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110694810|NCT05637281|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110694811|NCT05637281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110694812|NCT05637281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110694813|NCT00321711|Azacitidine|azacitidine|mesh-list
110694814|NCT00321711|Decitabine|decitabine|mesh-list
110694815|NCT00321711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110694816|NCT00321711|Antimetabolites|antimetabolites|mesh-ancestor
110694817|NCT00321711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110694818|NCT00321711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110694819|NCT00321711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110694820|NCT00486044|Simvastatin|simvastatin|mesh-list
110694821|NCT00486044|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110694822|NCT00486044|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110694823|NCT00486044|Antimetabolites|antimetabolites|mesh-ancestor
110694824|NCT00486044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110694825|NCT00486044|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110694826|NCT00486044|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110694827|NCT00486044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110694828|NCT00351273|Azithromycin|azithromycin|mesh-list
110694829|NCT00351273|Doxycycline|doxycycline|mesh-list
110694830|NCT00351273|Rifampin|rifampin|mesh-list
110694831|NCT00351273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110694832|NCT00351273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110694833|NCT00351273|Antimalarials|antimalarials|mesh-ancestor
110694834|NCT00351273|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110694835|NCT00351273|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110694836|NCT00351273|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110694837|NCT00351273|Antitubercular Agents|antitubercular agents|mesh-ancestor
110694838|NCT00351273|Leprostatic Agents|leprostatic agents|mesh-ancestor
110694839|NCT00351273|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110694840|NCT00351273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110694841|NCT00351273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110694842|NCT00351273|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110694843|NCT00351273|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110694844|NCT00351273|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110694845|NCT00351273|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110412704|NCT05936489|Aceclidine|aceclidine|mesh-list
110694846|NCT00351273|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110694847|NCT00351273|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110694848|NCT00327717|Zonisamide|zonisamide|mesh-list
110694849|NCT00327717|Anticonvulsants|anticonvulsants|mesh-ancestor
110694850|NCT00327717|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110694851|NCT00327717|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110694852|NCT00327717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110694853|NCT00327717|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110694854|NCT00327717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110694855|NCT00463346|Acamprosate|acamprosate|mesh-list
110694856|NCT00463346|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110694857|NCT01022528|Dexamethasone|dexamethasone|mesh-list
110694858|NCT01022528|Dexamethasone acetate|dexamethasone acetate|mesh-list
110694859|NCT01022528|BB 1101|bb 1101|mesh-list
110694860|NCT01022528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110694861|NCT01022528|Antiemetics|antiemetics|mesh-ancestor
110694862|NCT01022528|Autonomic Agents|autonomic agents|mesh-ancestor
110694863|NCT01022528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110694864|NCT01022528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110694865|NCT01022528|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110694866|NCT01022528|Glucocorticoids|glucocorticoids|mesh-ancestor
110694867|NCT01022528|Hormones|hormones|mesh-ancestor
110694868|NCT01022528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110694869|NCT01022528|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110694870|NCT01022528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110694871|NCT01022528|Protease Inhibitors|protease inhibitors|mesh-ancestor
110694872|NCT01022528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110694873|NCT01022528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110694874|NCT01025102|Sufentanil|sufentanil|mesh-list
110694875|NCT01025102|Ropivacaine|ropivacaine|mesh-list
110694876|NCT01025102|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110694877|NCT01025102|Narcotics|narcotics|mesh-ancestor
110694878|NCT01025102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110694879|NCT01025102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110694881|NCT01025102|Sensory System Agents|sensory system agents|mesh-ancestor
110694882|NCT01025102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110694883|NCT01025102|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110694884|NCT01025102|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110694885|NCT01025102|Anesthetics, General|anesthetics, general|mesh-ancestor
110694886|NCT01025102|Anesthetics|anesthetics|mesh-ancestor
110694887|NCT01025102|Anesthetics, Local|anesthetics, local|mesh-ancestor
110694888|NCT00424476|Belimumab|belimumab|mesh-list
110694889|NCT00424476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110694890|NCT00424476|Immunologic Factors|immunologic factors|mesh-ancestor
110694891|NCT00424476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110694892|NCT01037634|Oseltamivir|oseltamivir|mesh-list
110694893|NCT01037634|Antiviral Agents|antiviral agents|mesh-ancestor
110694894|NCT01037634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110694895|NCT01037634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110694896|NCT01037634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110694897|NCT01037712|Valacyclovir|valacyclovir|mesh-list
110694898|NCT01037712|Antiviral Agents|antiviral agents|mesh-ancestor
110694899|NCT01037712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110694900|NCT00453362|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110694901|NCT00453362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110694902|NCT00453362|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110694903|NCT00453362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110694904|NCT00453362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110694905|NCT00424398|Bepotastine besilate|bepotastine besilate|mesh-list
110694906|NCT00424398|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110694908|NCT00461786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110694909|NCT00461786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110694910|NCT00461786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110694911|NCT00461786|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110694912|NCT00461786|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110694913|NCT01021592|Bortezomib|bortezomib|mesh-list
110694914|NCT01021592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110694915|NCT00435162|Valsartan|valsartan|mesh-list
110694916|NCT00435162|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110694917|NCT00435162|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110694918|NCT00435162|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110694919|NCT00435162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110694920|NCT03836664|Timolol|timolol|mesh-list
110694921|NCT03836664|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110412748|NCT05924997|Apatinib|apatinib|mesh-list
110694922|NCT03836664|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110694923|NCT03836664|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110694924|NCT03836664|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110694925|NCT03836664|Adrenergic Agents|adrenergic agents|mesh-ancestor
110694926|NCT03836664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110694927|NCT03836664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110694928|NCT03836664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110694929|NCT03836664|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110694930|NCT03836664|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110694931|NCT00350727|Lapatinib|lapatinib|mesh-list
110694932|NCT00350727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110694933|NCT00350727|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110694934|NCT00350727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110694935|NCT00350727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110694936|NCT01032486|Rasagiline|rasagiline|mesh-list
110694937|NCT01032486|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
110694938|NCT01032486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110694939|NCT01032486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110694940|NCT01032486|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110694941|NCT01032486|Protective Agents|protective agents|mesh-ancestor
110694942|NCT01032486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110694943|NCT01061697|Pregabalin|pregabalin|mesh-list
110694944|NCT01061697|Analgesics|analgesics|mesh-ancestor
110694945|NCT01061697|Sensory System Agents|sensory system agents|mesh-ancestor
110858584|NCT01928199|Protease Inhibitors|protease inhibitors|mesh-ancestor
110694946|NCT01061697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110694947|NCT01061697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110694948|NCT01061697|Anticonvulsants|anticonvulsants|mesh-ancestor
110694949|NCT01061697|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110694950|NCT01061697|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110694951|NCT01061697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110694952|NCT01061697|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110694953|NCT01061697|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110694954|NCT01061697|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110694955|NCT01061697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110694956|NCT01061697|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110694957|NCT00434304|Ropinirole|ropinirole|mesh-list
110694958|NCT00434304|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110694959|NCT00434304|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110694960|NCT00434304|Dopamine Agonists|dopamine agonists|mesh-ancestor
110694961|NCT00434304|Dopamine Agents|dopamine agents|mesh-ancestor
110694962|NCT00434304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110694963|NCT00434304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110694964|NCT00434304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110694965|NCT00424008|Fluticasone|fluticasone|mesh-list
110694966|NCT00424008|Xhance|xhance|mesh-list
110694967|NCT00424008|Mometasone Furoate|mometasone furoate|mesh-list
110694968|NCT00424008|Formoterol Fumarate|formoterol fumarate|mesh-list
110694969|NCT00424008|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110694970|NCT00424008|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
110694971|NCT00424008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110694972|NCT00424008|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110694973|NCT00424008|Autonomic Agents|autonomic agents|mesh-ancestor
110694974|NCT00424008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110694975|NCT00424008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110694976|NCT00424008|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110694977|NCT00424008|Respiratory System Agents|respiratory system agents|mesh-ancestor
110694978|NCT00424008|Dermatologic Agents|dermatologic agents|mesh-ancestor
110694979|NCT00424008|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110694980|NCT00424008|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110694981|NCT00424008|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110694982|NCT00424008|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110694983|NCT00424008|Adrenergic Agents|adrenergic agents|mesh-ancestor
110694984|NCT00424008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110694985|NCT00424008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110694986|NCT00424008|Glucocorticoids|glucocorticoids|mesh-ancestor
110694988|NCT00424008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110694989|NCT00424008|Sympathomimetics|sympathomimetics|mesh-ancestor
110694990|NCT00423930|Bevacizumab|bevacizumab|mesh-list
110694991|NCT00423930|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110694992|NCT00423930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110694993|NCT00423930|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110694994|NCT00423930|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110694995|NCT00423930|Growth Substances|growth substances|mesh-ancestor
110694996|NCT00423930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110694997|NCT00423930|Growth Inhibitors|growth inhibitors|mesh-ancestor
110694998|NCT00423852|Paclitaxel|paclitaxel|mesh-list
110694999|NCT00423852|Carboplatin|carboplatin|mesh-list
110695000|NCT00423852|Ifosfamide|ifosfamide|mesh-list
110695001|NCT00423852|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110695002|NCT00423852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110695003|NCT00423852|Tubulin Modulators|tubulin modulators|mesh-ancestor
110695004|NCT00423852|Antimitotic Agents|antimitotic agents|mesh-ancestor
110695005|NCT00423852|Mitosis Modulators|mitosis modulators|mesh-ancestor
110695006|NCT00423852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110695007|NCT00423852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110695008|NCT00423852|Alkylating Agents|alkylating agents|mesh-ancestor
110695009|NCT00461708|Gemcitabine|gemcitabine|mesh-list
110695010|NCT00461708|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110695011|NCT00461708|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110695012|NCT00461708|Antimetabolites|antimetabolites|mesh-ancestor
110695013|NCT00461708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110695014|NCT00461708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110695015|NCT00461708|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110695016|NCT00461708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110695017|NCT00327171|Aflibercept|aflibercept|mesh-list
110695018|NCT00327171|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110695019|NCT00327171|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110695020|NCT00327171|Growth Substances|growth substances|mesh-ancestor
110695021|NCT00327171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110695022|NCT00327171|Growth Inhibitors|growth inhibitors|mesh-ancestor
110695023|NCT00327171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110695024|NCT01038024|Antioxidants|antioxidants|mesh-list
110695025|NCT01038024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110695026|NCT01038024|Protective Agents|protective agents|mesh-ancestor
110695027|NCT01038024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110695029|NCT00461630|Simvastatin|simvastatin|mesh-list
110695030|NCT00461630|Ezetimibe|ezetimibe|mesh-list
110695031|NCT00461630|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
110695032|NCT00461630|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110695033|NCT00461630|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110695034|NCT00461630|Antimetabolites|antimetabolites|mesh-ancestor
110695035|NCT00461630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110695036|NCT00461630|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110695037|NCT00461630|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110695038|NCT00461630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110695039|NCT00461630|Vasodilator Agents|vasodilator agents|mesh-ancestor
110695040|NCT00461630|Vitamin B Complex|vitamin b complex|mesh-ancestor
110695041|NCT00461630|Vitamins|vitamins|mesh-ancestor
110695042|NCT00461630|Micronutrients|micronutrients|mesh-ancestor
110695043|NCT00461630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110695044|NCT01061853|Sirolimus|sirolimus|mesh-list
110695045|NCT01061853|Betamethasone|betamethasone|mesh-list
110695046|NCT01061853|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110695047|NCT01061853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110695048|NCT01061853|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110695049|NCT01061853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110695050|NCT01061853|Antifungal Agents|antifungal agents|mesh-ancestor
110695051|NCT01061853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110695052|NCT01061853|Immunologic Factors|immunologic factors|mesh-ancestor
110695053|NCT01061853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110695054|NCT01061853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110695055|NCT01061853|Glucocorticoids|glucocorticoids|mesh-ancestor
110695056|NCT01061853|Hormones|hormones|mesh-ancestor
110695057|NCT01061853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110695058|NCT01061853|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110695059|NCT01061853|Respiratory System Agents|respiratory system agents|mesh-ancestor
110695060|NCT01325415|Moxifloxacin|moxifloxacin|mesh-list
110695061|NCT01325415|Naloxegol|naloxegol|mesh-list
110695062|NCT01325415|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110695063|NCT01325415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110695064|NCT01325415|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110695065|NCT01325415|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110695066|NCT01325415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110695067|NCT01325415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110695068|NCT01325415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110412898|NCT05635110|Leprostatic Agents|leprostatic agents|mesh-ancestor
110695069|NCT01325415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110695070|NCT01325415|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110695071|NCT01325415|Sensory System Agents|sensory system agents|mesh-ancestor
110695072|NCT01325415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110695073|NCT01022840|Ketamine|ketamine|mesh-list
110695074|NCT01022840|Esketamine|esketamine|mesh-list
110695075|NCT01022840|Analgesics|analgesics|mesh-ancestor
110695076|NCT01022840|Sensory System Agents|sensory system agents|mesh-ancestor
110695077|NCT01022840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110695078|NCT01022840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110695079|NCT01022840|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110695080|NCT01022840|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110695081|NCT01022840|Anesthetics, General|anesthetics, general|mesh-ancestor
110695082|NCT01022840|Anesthetics|anesthetics|mesh-ancestor
110695083|NCT01022840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110695084|NCT01022840|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110695085|NCT01022840|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110695086|NCT01022840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110695087|NCT01022840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110695088|NCT01022840|Antidepressive Agents|antidepressive agents|mesh-ancestor
110695089|NCT01022840|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110695090|NCT01025570|Gemcitabine|gemcitabine|mesh-list
110695091|NCT01025570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110695092|NCT01025570|Antimetabolites|antimetabolites|mesh-ancestor
110695093|NCT01025570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110695094|NCT01025570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110695095|NCT03983876|Adalimumab|adalimumab|mesh-list
110695096|NCT03983876|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110695098|NCT03983876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110695099|NCT00327015|Metformin|metformin|mesh-list
110695100|NCT00327015|Pioglitazone|pioglitazone|mesh-list
110695101|NCT00327015|Saxagliptin|saxagliptin|mesh-list
110695102|NCT00327015|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110695103|NCT00327015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110695104|NCT00327015|Incretins|incretins|mesh-ancestor
110695105|NCT00327015|Hormones|hormones|mesh-ancestor
110695106|NCT00327015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110695107|NCT00327015|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110695108|NCT00327015|Protease Inhibitors|protease inhibitors|mesh-ancestor
110695109|NCT00327015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110695110|NCT00327015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110695111|NCT00434148|Pasireotide|pasireotide|mesh-list
110695112|NCT00434148|Hormones|hormones|mesh-ancestor
110695113|NCT00434148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110695114|NCT00434148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110695115|NCT01063569|Hydrocortisone|hydrocortisone|mesh-list
110695116|NCT01063569|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
110695117|NCT01063569|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
110695118|NCT01063569|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
110695119|NCT01063569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110695120|NCT01063647|Treosulfan|treosulfan|mesh-list
110695121|NCT01063647|Busulfan|busulfan|mesh-list
110695122|NCT01063647|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110695123|NCT01063647|Alkylating Agents|alkylating agents|mesh-ancestor
110695124|NCT01063647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110695125|NCT01063647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110695126|NCT01063647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110695127|NCT01063647|Immunologic Factors|immunologic factors|mesh-ancestor
110695128|NCT01063647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110695130|NCT00468728|Vancomycin|vancomycin|mesh-list
110695131|NCT00468728|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110695132|NCT00468728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110695133|NCT00433914|Vaccines|vaccines|mesh-list
110695134|NCT00433914|Immunologic Factors|immunologic factors|mesh-ancestor
110695135|NCT00433914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110695136|NCT00468650|Sildenafil Citrate|sildenafil citrate|mesh-list
110695137|NCT00468650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110695138|NCT00468650|Vasodilator Agents|vasodilator agents|mesh-ancestor
110695139|NCT00468650|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110695140|NCT00468650|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110695141|NCT00468650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110695142|NCT00468650|Urological Agents|urological agents|mesh-ancestor
110695143|NCT00423150|Temozolomide|temozolomide|mesh-list
110695144|NCT00423150|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110695145|NCT00423150|Alkylating Agents|alkylating agents|mesh-ancestor
110695146|NCT00423150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110695147|NCT00423150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110695148|NCT00433836|Valsartan|valsartan|mesh-list
110695149|NCT00433836|Enalapril|enalapril|mesh-list
110695150|NCT00433836|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110695151|NCT00433836|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110695152|NCT00433836|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110695153|NCT00433836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110695154|NCT00433836|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110695155|NCT00433836|Protease Inhibitors|protease inhibitors|mesh-ancestor
110695156|NCT00433836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110695157|NCT01022918|Bevacizumab|bevacizumab|mesh-list
110695158|NCT01022918|Temozolomide|temozolomide|mesh-list
110695159|NCT01022918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110695160|NCT01022918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110695161|NCT01022918|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110695162|NCT01022918|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110695163|NCT01022918|Growth Substances|growth substances|mesh-ancestor
110695164|NCT01022918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110695165|NCT01022918|Growth Inhibitors|growth inhibitors|mesh-ancestor
110695166|NCT01022918|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110695167|NCT01022918|Alkylating Agents|alkylating agents|mesh-ancestor
110695168|NCT01022918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110695169|NCT00433446|Siltuximab|siltuximab|mesh-list
110695170|NCT00433446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110695171|NCT00468104|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
110695172|NCT00468104|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110695173|NCT00468104|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110695174|NCT00468104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110695175|NCT00326625|Glatiramer Acetate|glatiramer acetate|mesh-list
110695176|NCT00326625|(T,G)-A-L|(t,g)-a-l|mesh-list
110695177|NCT00326625|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110695178|NCT00326625|Immunologic Factors|immunologic factors|mesh-ancestor
110695179|NCT00326625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110695180|NCT00326625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110695181|NCT00326625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110695182|NCT00433290|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110695183|NCT00433290|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110695184|NCT00433290|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110695185|NCT00433290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110695186|NCT00433290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110695187|NCT00433290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110695188|NCT00433290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110695190|NCT00433290|Sensory System Agents|sensory system agents|mesh-ancestor
110695191|NCT00433290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110695192|NCT00433290|Antidepressive Agents|antidepressive agents|mesh-ancestor
110695193|NCT00433290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110695194|NCT00433290|Dopamine Agents|dopamine agents|mesh-ancestor
110695195|NCT00467870|Methyltestosterone|methyltestosterone|mesh-list
110695196|NCT00467870|Testosterone|testosterone|mesh-list
110695197|NCT00467870|Testosterone undecanoate|testosterone undecanoate|mesh-list
110695198|NCT00467870|Testosterone enanthate|testosterone enanthate|mesh-list
110695199|NCT00467870|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
110695200|NCT00467870|Androgens|androgens|mesh-ancestor
110695201|NCT00467870|Hormones|hormones|mesh-ancestor
110695202|NCT00467870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110695203|NCT00467870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110695204|NCT00467870|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110695205|NCT00467870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110695206|NCT00467870|Anabolic Agents|anabolic agents|mesh-ancestor
110695207|NCT00467558|Naltrexone|naltrexone|mesh-list
110695208|NCT00467558|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110695209|NCT00467558|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110695210|NCT00467558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110695211|NCT00467558|Sensory System Agents|sensory system agents|mesh-ancestor
110695212|NCT00467558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110695213|NCT00422292|Vaccines|vaccines|mesh-list
110695214|NCT00422292|Immunologic Factors|immunologic factors|mesh-ancestor
110695215|NCT00422292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110695216|NCT00452348|Fluticasone|fluticasone|mesh-list
110695217|NCT00452348|Xhance|xhance|mesh-list
110695218|NCT00452348|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110695219|NCT00452348|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
110695220|NCT00452348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110695221|NCT00452348|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110695222|NCT00452348|Autonomic Agents|autonomic agents|mesh-ancestor
110695223|NCT00452348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110695224|NCT00452348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110695225|NCT00452348|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110695226|NCT00452348|Respiratory System Agents|respiratory system agents|mesh-ancestor
110695227|NCT00452348|Dermatologic Agents|dermatologic agents|mesh-ancestor
110695228|NCT00452348|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110695229|NCT00452348|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110695230|NCT00452348|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110695231|NCT00452348|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110695232|NCT00452348|Adrenergic Agents|adrenergic agents|mesh-ancestor
110695233|NCT00452348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110695234|NCT00452348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110695235|NCT00452348|Glucocorticoids|glucocorticoids|mesh-ancestor
110695236|NCT00452348|Hormones|hormones|mesh-ancestor
110695237|NCT00452348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110695238|NCT00452348|Sympathomimetics|sympathomimetics|mesh-ancestor
110695239|NCT01323062|Bavituximab|bavituximab|mesh-list
110695240|NCT01323062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110695241|NCT01323062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110695242|NCT00320541|Paclitaxel|paclitaxel|mesh-list
110695243|NCT00320541|Bevacizumab|bevacizumab|mesh-list
110695244|NCT00320541|Gemcitabine|gemcitabine|mesh-list
110695245|NCT00320541|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110695246|NCT00320541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110695247|NCT00320541|Tubulin Modulators|tubulin modulators|mesh-ancestor
110695248|NCT00320541|Antimitotic Agents|antimitotic agents|mesh-ancestor
110695249|NCT00320541|Mitosis Modulators|mitosis modulators|mesh-ancestor
110695250|NCT00320541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110695251|NCT00320541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110695252|NCT00320541|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110695253|NCT00320541|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110695254|NCT00320541|Growth Substances|growth substances|mesh-ancestor
110695255|NCT00320541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110695256|NCT00320541|Growth Inhibitors|growth inhibitors|mesh-ancestor
110695257|NCT00320541|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110695258|NCT00320541|Antimetabolites|antimetabolites|mesh-ancestor
110695259|NCT00320385|Trastuzumab|trastuzumab|mesh-list
110695260|NCT00320385|Lapatinib|lapatinib|mesh-list
110695261|NCT00320385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110695262|NCT00320385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110695263|NCT00320385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110695264|NCT00320385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110695265|NCT00320385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110695266|NCT00309777|Simvastatin|simvastatin|mesh-list
110695267|NCT00309777|Pitavastatin|pitavastatin|mesh-list
110695268|NCT00309777|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110695269|NCT00309777|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110695270|NCT00309777|Antimetabolites|antimetabolites|mesh-ancestor
110695271|NCT00309777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110695272|NCT00309777|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110695273|NCT00309777|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110695274|NCT00309777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110695275|NCT00325143|Edetic Acid|edetic acid|mesh-list
110695276|NCT00325143|Pentetic Acid|pentetic acid|mesh-list
110695277|NCT00325143|Antidotes|antidotes|mesh-ancestor
110695278|NCT00325143|Protective Agents|protective agents|mesh-ancestor
110695279|NCT00325143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110695280|NCT00325143|Chelating Agents|chelating agents|mesh-ancestor
110695281|NCT00325143|Sequestering Agents|sequestering agents|mesh-ancestor
110695282|NCT00325143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110695283|NCT00325143|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110695284|NCT00325143|Anticoagulants|anticoagulants|mesh-ancestor
110695285|NCT00325143|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110695286|NCT00319839|Paclitaxel|paclitaxel|mesh-list
110695287|NCT00319839|Cetuximab|cetuximab|mesh-list
110695288|NCT00319839|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110695289|NCT00319839|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110695290|NCT00319839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110695291|NCT00319839|Tubulin Modulators|tubulin modulators|mesh-ancestor
110695292|NCT00319839|Antimitotic Agents|antimitotic agents|mesh-ancestor
110695293|NCT00319839|Mitosis Modulators|mitosis modulators|mesh-ancestor
110695294|NCT00319839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110695295|NCT00319839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110695296|NCT01062087|Lidocaine|lidocaine|mesh-list
110695297|NCT01062087|Bupivacaine|bupivacaine|mesh-list
110695298|NCT01062087|Anesthetics, Local|anesthetics, local|mesh-ancestor
110695299|NCT01062087|Anesthetics|anesthetics|mesh-ancestor
110695300|NCT01062087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110695301|NCT01062087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110695302|NCT01062087|Sensory System Agents|sensory system agents|mesh-ancestor
110695303|NCT01062087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110695304|NCT01062087|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110695305|NCT01062087|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110695306|NCT01062087|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110695307|NCT01062087|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110695308|NCT01062087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110695309|NCT00319449|Atorvastatin|atorvastatin|mesh-list
110695310|NCT00319449|Ezetimibe|ezetimibe|mesh-list
110695311|NCT00319449|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110695312|NCT00319449|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110695313|NCT00319449|Antimetabolites|antimetabolites|mesh-ancestor
110695314|NCT00319449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110695315|NCT00319449|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110695316|NCT00319449|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110695317|NCT00319449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110695318|NCT00308685|Albuterol|albuterol|mesh-list
110858661|NCT03619538|Nefopam|nefopam|mesh-list
110695319|NCT00308685|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110695320|NCT00308685|Autonomic Agents|autonomic agents|mesh-ancestor
110695321|NCT00308685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110695322|NCT00308685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110695323|NCT00308685|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110695324|NCT00308685|Respiratory System Agents|respiratory system agents|mesh-ancestor
110695325|NCT00308685|Tocolytic Agents|tocolytic agents|mesh-ancestor
110695326|NCT00308685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110695327|NCT00308685|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110695328|NCT00308685|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110695329|NCT00308685|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110695330|NCT00308685|Adrenergic Agents|adrenergic agents|mesh-ancestor
110695331|NCT00308685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110695332|NCT00308685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110695333|NCT01060917|Hypoglycemic Agents|hypoglycemic agents|mesh-list
110695334|NCT01060917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110695335|NCT03981081|Prednisone|prednisone|mesh-list
110695336|NCT03981081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110695337|NCT03981081|Glucocorticoids|glucocorticoids|mesh-ancestor
110695338|NCT03981081|Hormones|hormones|mesh-ancestor
110695339|NCT03981081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110695340|NCT03981081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110695341|NCT03981081|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110695342|NCT03981081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110695343|NCT03979209|Mometasone Furoate|mometasone furoate|mesh-list
110695344|NCT03979209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110695345|NCT03979209|Dermatologic Agents|dermatologic agents|mesh-ancestor
110695346|NCT03979209|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110695347|NCT00316719|Lamivudine|lamivudine|mesh-list
110695348|NCT00316719|Adefovir|adefovir|mesh-list
110695349|NCT00316719|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
110695350|NCT00316719|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110695351|NCT00316719|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110695352|NCT00316719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110695353|NCT00316719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110695354|NCT00316719|Antiviral Agents|antiviral agents|mesh-ancestor
110695355|NCT00316719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110695356|NCT00316719|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110695357|NCT00316719|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110695358|NCT01065987|Tizanidine|tizanidine|mesh-list
110695359|NCT01065987|Analgesics|analgesics|mesh-ancestor
110695360|NCT01065987|Sensory System Agents|sensory system agents|mesh-ancestor
110695361|NCT01065987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110695362|NCT01065987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110695363|NCT01065987|Anticonvulsants|anticonvulsants|mesh-ancestor
110695364|NCT01065987|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110695365|NCT01065987|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110695366|NCT01065987|Parasympatholytics|parasympatholytics|mesh-ancestor
110695367|NCT01065987|Autonomic Agents|autonomic agents|mesh-ancestor
110695368|NCT01065987|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110695369|NCT01065987|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110695370|NCT01065987|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110695371|NCT01065987|Adrenergic Agents|adrenergic agents|mesh-ancestor
110695372|NCT01065987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110695373|NCT01065987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110695374|NCT01064115|Cetirizine|cetirizine|mesh-list
110695375|NCT01064115|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110695376|NCT01064115|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110695377|NCT01064115|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110695378|NCT01064115|Histamine Antagonists|histamine antagonists|mesh-ancestor
110695379|NCT01064115|Histamine Agents|histamine agents|mesh-ancestor
110695380|NCT01064115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110695381|NCT01064115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110695382|NCT01064115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110695383|NCT00422058|Liraglutide|liraglutide|mesh-list
110695384|NCT00422058|Orlistat|orlistat|mesh-list
110695385|NCT00422058|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110695386|NCT00422058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110695387|NCT00422058|Incretins|incretins|mesh-ancestor
110695388|NCT00422058|Hormones|hormones|mesh-ancestor
110695389|NCT00422058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110695390|NCT00422058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110695391|NCT00422058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110695392|NCT00422058|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110695393|NCT00422058|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110695394|NCT01032798|Mepivacaine|mepivacaine|mesh-list
110695395|NCT01032798|Anesthetics, Local|anesthetics, local|mesh-ancestor
110695396|NCT01032798|Anesthetics|anesthetics|mesh-ancestor
110695397|NCT01032798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110695398|NCT01032798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110695399|NCT01032798|Sensory System Agents|sensory system agents|mesh-ancestor
110695400|NCT01032798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110695401|NCT00413244|Testosterone|testosterone|mesh-list
110695402|NCT00413244|Androgens|androgens|mesh-ancestor
110695403|NCT00413244|Hormones|hormones|mesh-ancestor
110695404|NCT00413244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110695405|NCT00413244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110695406|NCT01033032|Amrubicin|amrubicin|mesh-list
110695407|NCT01033032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110695408|NCT01038570|Oxytocin|oxytocin|mesh-list
110695409|NCT01038570|Oxytocics|oxytocics|mesh-ancestor
110695410|NCT01038570|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110695411|NCT01038570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110695412|NCT00420342|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
110695413|NCT00420342|Drospirenone|drospirenone|mesh-list
110695414|NCT00420342|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110695415|NCT00420342|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110695416|NCT00420342|Medroxyprogesterone|medroxyprogesterone|mesh-list
110695417|NCT00420342|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110695418|NCT00420342|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
110695419|NCT00420342|Estradiol|estradiol|mesh-list
110695420|NCT00420342|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110695421|NCT00420342|Estrogens|estrogens|mesh-ancestor
110695422|NCT00420342|Hormones|hormones|mesh-ancestor
110695423|NCT00420342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110695424|NCT00420342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110695425|NCT00420342|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110695426|NCT00420342|Contraceptive Agents|contraceptive agents|mesh-ancestor
110695427|NCT00420342|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110695428|NCT00420342|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110695429|NCT00420342|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110695430|NCT00420342|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110695431|NCT00420342|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110695432|NCT00420342|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110695433|NCT00420342|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110695434|NCT00420342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110695435|NCT00420342|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110695436|NCT00420342|Hormone Antagonists|hormone antagonists|mesh-ancestor
110695437|NCT00420342|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110695438|NCT00420342|Diuretics|diuretics|mesh-ancestor
110695439|NCT00420342|Natriuretic Agents|natriuretic agents|mesh-ancestor
110695440|NCT01038648|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110695441|NCT01038648|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110695442|NCT01038648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110695443|NCT01038648|Incretins|incretins|mesh-ancestor
110695444|NCT01038648|Hormones|hormones|mesh-ancestor
110695445|NCT01038648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110695446|NCT01038648|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110695447|NCT01038648|Protease Inhibitors|protease inhibitors|mesh-ancestor
110695448|NCT01038648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110695449|NCT01038648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110695450|NCT00432666|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
110695451|NCT00432666|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110695452|NCT00432666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110695453|NCT00432666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110695454|NCT00432666|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110695455|NCT00432666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110695456|NCT00432666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110695457|NCT00432666|Cholinergic Agents|cholinergic agents|mesh-ancestor
110695458|NCT00432666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110695459|NCT00451958|Leuprolide|leuprolide|mesh-list
110695460|NCT00451958|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110695461|NCT00451958|Fertility Agents|fertility agents|mesh-ancestor
110695462|NCT00451958|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110695463|NCT00451958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110695464|NCT00451958|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110695465|NCT00451958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110695466|NCT01025882|Gemcitabine|gemcitabine|mesh-list
110695467|NCT01025882|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110695468|NCT01025882|Antimetabolites|antimetabolites|mesh-ancestor
110695469|NCT01025882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110695470|NCT01025882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110695471|NCT01026116|Paclitaxel|paclitaxel|mesh-list
110695472|NCT01026116|Cyclophosphamide|cyclophosphamide|mesh-list
110695473|NCT01026116|Epirubicin|epirubicin|mesh-list
110695474|NCT01026116|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110695475|NCT01026116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110695476|NCT01026116|Tubulin Modulators|tubulin modulators|mesh-ancestor
110695477|NCT01026116|Antimitotic Agents|antimitotic agents|mesh-ancestor
110695478|NCT01026116|Mitosis Modulators|mitosis modulators|mesh-ancestor
110695479|NCT01026116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110695480|NCT01026116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110695481|NCT01026116|Immunologic Factors|immunologic factors|mesh-ancestor
110695482|NCT01026116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110695483|NCT01026116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110695484|NCT01026116|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110695485|NCT01026116|Alkylating Agents|alkylating agents|mesh-ancestor
110695486|NCT01026116|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110695487|NCT01026116|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110695488|NCT01026116|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110695489|NCT01026116|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110695490|NCT01026116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110695491|NCT00432276|Metformin|metformin|mesh-list
110695492|NCT00432276|Pioglitazone|pioglitazone|mesh-list
110695493|NCT00432276|Alogliptin|alogliptin|mesh-list
110695494|NCT00432276|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110695495|NCT00432276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110695496|NCT00432276|Incretins|incretins|mesh-ancestor
110695497|NCT00432276|Hormones|hormones|mesh-ancestor
110695498|NCT00432276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110695499|NCT00432276|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110695500|NCT00432276|Protease Inhibitors|protease inhibitors|mesh-ancestor
110695501|NCT00432276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110695502|NCT00432276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110695503|NCT01027520|Monensin|monensin|mesh-list
110695504|NCT01027520|Antifungal Agents|antifungal agents|mesh-ancestor
110695505|NCT01027520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110695506|NCT01027520|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110695508|NCT01027520|Coccidiostats|coccidiostats|mesh-ancestor
110695509|NCT01027520|Proton Ionophores|proton ionophores|mesh-ancestor
110695510|NCT01027520|Uncoupling Agents|uncoupling agents|mesh-ancestor
110695511|NCT01027520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110695512|NCT01027520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110695513|NCT01027520|Ionophores|ionophores|mesh-ancestor
110695514|NCT01027520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110695515|NCT01027520|Sodium Ionophores|sodium ionophores|mesh-ancestor
110695516|NCT01023230|Entecavir|entecavir|mesh-list
110695517|NCT01023230|Antiviral Agents|antiviral agents|mesh-ancestor
110695518|NCT01023230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110695519|NCT01027832|Tazobactam|tazobactam|mesh-list
110695521|NCT01027832|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
110695522|NCT01027832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110695523|NCT01027832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110695524|NCT01027832|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110695525|NCT01027832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110695526|NCT01027832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110695527|NCT00413010|Pregabalin|pregabalin|mesh-list
110695528|NCT00413010|Analgesics|analgesics|mesh-ancestor
110695529|NCT00413010|Sensory System Agents|sensory system agents|mesh-ancestor
110695530|NCT00413010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110695531|NCT00413010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110695532|NCT00413010|Anticonvulsants|anticonvulsants|mesh-ancestor
110695533|NCT00413010|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110657452|NCT04781088|Lenvatinib|lenvatinib|mesh-list
110695534|NCT00413010|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110695535|NCT00413010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110695536|NCT00413010|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110695537|NCT00413010|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110695538|NCT00413010|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110695539|NCT00413010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110695540|NCT00413010|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110695541|NCT00459290|Mifepristone|mifepristone|mesh-list
110695542|NCT00459290|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
110695543|NCT00459290|Abortifacient Agents|abortifacient agents|mesh-ancestor
110695544|NCT00459290|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110695545|NCT00459290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110695546|NCT00459290|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110695547|NCT00459290|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110695548|NCT00459290|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110695549|NCT00459290|Contraceptive Agents|contraceptive agents|mesh-ancestor
110695550|NCT00459290|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
110695551|NCT00459290|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
110695552|NCT00459290|Hormone Antagonists|hormone antagonists|mesh-ancestor
110695553|NCT00459290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110657500|NCT04680910|Propofol|propofol|mesh-list
110695554|NCT00459290|Luteolytic Agents|luteolytic agents|mesh-ancestor
110695555|NCT00459290|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110695556|NCT00459290|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
110695557|NCT00443534|Sunitinib|sunitinib|mesh-list
110695558|NCT00443534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110695559|NCT00443534|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110695560|NCT00443534|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110695561|NCT00443534|Growth Substances|growth substances|mesh-ancestor
110695562|NCT00443534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110695563|NCT00443534|Growth Inhibitors|growth inhibitors|mesh-ancestor
110695564|NCT00443534|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110695565|NCT00443534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110695566|NCT00443534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110695567|NCT00419952|Budesonide|budesonide|mesh-list
110695568|NCT00419952|Formoterol Fumarate|formoterol fumarate|mesh-list
110695569|NCT00419952|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
110695570|NCT00419952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110695571|NCT00419952|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110695572|NCT00419952|Autonomic Agents|autonomic agents|mesh-ancestor
110858700|NCT01656434|Contraceptive Agents|contraceptive agents|mesh-ancestor
110695573|NCT00419952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110695574|NCT00419952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110695575|NCT00419952|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110695576|NCT00419952|Respiratory System Agents|respiratory system agents|mesh-ancestor
110695577|NCT00419952|Glucocorticoids|glucocorticoids|mesh-ancestor
110695578|NCT00419952|Hormones|hormones|mesh-ancestor
110695579|NCT00419952|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110695580|NCT00419952|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110695581|NCT00419952|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110695582|NCT00419952|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110695583|NCT00419952|Adrenergic Agents|adrenergic agents|mesh-ancestor
110695584|NCT00419952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110695585|NCT00419952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110695586|NCT00443456|Amlodipine|amlodipine|mesh-list
110695587|NCT00443456|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110695588|NCT00443456|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110695589|NCT00443456|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110695590|NCT00443456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110695591|NCT00443456|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110695592|NCT00443456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110695593|NCT00443456|Vasodilator Agents|vasodilator agents|mesh-ancestor
110695594|NCT00419562|Insulin|insulin|mesh-list
110695595|NCT00419562|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110695596|NCT00419562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110695597|NCT03557294|Varenicline|varenicline|mesh-list
110695598|NCT03557294|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110695599|NCT03557294|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110695600|NCT03557294|Cholinergic Agents|cholinergic agents|mesh-ancestor
110695601|NCT03557294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110695602|NCT03557294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110695603|NCT03557294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110695604|NCT01026350|Antibodies|antibodies|mesh-list
110695605|NCT01026350|Immunologic Factors|immunologic factors|mesh-ancestor
110695606|NCT01026350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110695607|NCT01026428|Levodopa|levodopa|mesh-list
110695608|NCT01026428|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110695609|NCT01026428|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110695610|NCT01026428|Dopamine Agents|dopamine agents|mesh-ancestor
110695611|NCT01026428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110695612|NCT01026428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110695613|NCT01026428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110695614|NCT00308139|Exenatide|exenatide|mesh-list
110695615|NCT00308139|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110695616|NCT00308139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110695617|NCT00308139|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110695618|NCT00308139|Incretins|incretins|mesh-ancestor
110695619|NCT00308139|Hormones|hormones|mesh-ancestor
110695620|NCT00308139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110695621|NCT00459056|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110695622|NCT00459056|Carvedilol|carvedilol|mesh-list
110695623|NCT00459056|Lisinopril|lisinopril|mesh-list
110695624|NCT00459056|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110695625|NCT00459056|Diuretics|diuretics|mesh-ancestor
110695626|NCT00459056|Natriuretic Agents|natriuretic agents|mesh-ancestor
110695627|NCT00459056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110695628|NCT00459056|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110695629|NCT00459056|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110695630|NCT00459056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110695631|NCT00459056|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110695632|NCT00459056|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110695633|NCT00459056|Adrenergic Agents|adrenergic agents|mesh-ancestor
110695634|NCT00459056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110695635|NCT00459056|Antioxidants|antioxidants|mesh-ancestor
110695636|NCT00459056|Protective Agents|protective agents|mesh-ancestor
110695637|NCT00459056|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110695638|NCT00459056|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110695639|NCT00459056|Vasodilator Agents|vasodilator agents|mesh-ancestor
110695640|NCT00459056|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110695641|NCT00459056|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110695642|NCT00459056|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110695643|NCT00459056|Protease Inhibitors|protease inhibitors|mesh-ancestor
110695644|NCT00459056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110695645|NCT00459056|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110695646|NCT01062477|Vaccines|vaccines|mesh-list
110695647|NCT01062477|Immunologic Factors|immunologic factors|mesh-ancestor
110695648|NCT01062477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110695649|NCT01323374|Carbidopa|carbidopa|mesh-list
110695650|NCT01323374|Droxidopa|droxidopa|mesh-list
110695651|NCT01323374|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110695652|NCT01323374|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110695653|NCT01323374|Dopamine Agents|dopamine agents|mesh-ancestor
110695654|NCT01323374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110695655|NCT01323374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110695656|NCT01323374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110695657|NCT01323374|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
110695658|NCT01323374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110695659|NCT00431964|Azithromycin|azithromycin|mesh-list
110657835|NCT03635164|Durvalumab|durvalumab|mesh-list
110695660|NCT00431964|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110695661|NCT00431964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110695662|NCT00431496|Cinacalcet|cinacalcet|mesh-list
110695663|NCT00431496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110695664|NCT00431496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110695665|NCT00431496|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
110695667|NCT00431496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110695668|NCT00316173|Carboplatin|carboplatin|mesh-list
110695669|NCT00316173|Topotecan|topotecan|mesh-list
110695670|NCT00316173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110695671|NCT00316173|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110695672|NCT00316173|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110695673|NCT00316173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110695674|NCT00316173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110695675|NCT00412542|Thalidomide|thalidomide|mesh-list
110695676|NCT00412542|Irinotecan|irinotecan|mesh-list
110695677|NCT00412542|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110695678|NCT00412542|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110695679|NCT00412542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110695680|NCT00412542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110695681|NCT00412542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110695682|NCT00412542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110695683|NCT00412542|Immunologic Factors|immunologic factors|mesh-ancestor
110695684|NCT00412542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110695685|NCT00412542|Leprostatic Agents|leprostatic agents|mesh-ancestor
110695686|NCT00412542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110695687|NCT00412542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110695688|NCT00412542|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110695689|NCT00412542|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110695690|NCT00412542|Growth Substances|growth substances|mesh-ancestor
110695691|NCT00412542|Growth Inhibitors|growth inhibitors|mesh-ancestor
110695692|NCT00316017|Dextrans|dextrans|mesh-list
110695693|NCT00316017|Anticoagulants|anticoagulants|mesh-ancestor
110695694|NCT00316017|Plasma Substitutes|plasma substitutes|mesh-ancestor
110695695|NCT00316017|Blood Substitutes|blood substitutes|mesh-ancestor
110695696|NCT00451178|Prednisone|prednisone|mesh-list
110695697|NCT00451178|Cyclophosphamide|cyclophosphamide|mesh-list
110695698|NCT00451178|Rituximab|rituximab|mesh-list
110695699|NCT00451178|Doxorubicin|doxorubicin|mesh-list
110695700|NCT00451178|Vincristine|vincristine|mesh-list
110695701|NCT00451178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110695702|NCT00451178|Immunologic Factors|immunologic factors|mesh-ancestor
110695703|NCT00451178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110658087|NCT01267448|Glipizide|glipizide|mesh-list
110695704|NCT00451178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110695705|NCT00451178|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110695706|NCT00451178|Alkylating Agents|alkylating agents|mesh-ancestor
110695707|NCT00451178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110695708|NCT00451178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110695709|NCT00451178|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110695710|NCT00451178|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110695711|NCT00451178|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110695712|NCT00451178|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110695713|NCT00451178|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110695714|NCT00451178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110695715|NCT00451178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110695716|NCT00451178|Glucocorticoids|glucocorticoids|mesh-ancestor
110695717|NCT00451178|Hormones|hormones|mesh-ancestor
110695718|NCT00451178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110695719|NCT00451178|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110695720|NCT00451178|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110695721|NCT00451178|Tubulin Modulators|tubulin modulators|mesh-ancestor
110695722|NCT00451178|Antimitotic Agents|antimitotic agents|mesh-ancestor
110695723|NCT00451178|Mitosis Modulators|mitosis modulators|mesh-ancestor
110695724|NCT00450866|Epothilones|epothilones|mesh-list
110695725|NCT00450866|Epothilone B|epothilone b|mesh-list
110695726|NCT00450866|Tubulin Modulators|tubulin modulators|mesh-ancestor
110695727|NCT00450866|Antimitotic Agents|antimitotic agents|mesh-ancestor
110695728|NCT00450866|Mitosis Modulators|mitosis modulators|mesh-ancestor
110695729|NCT00450866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110695730|NCT00450866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110695731|NCT01026584|Aripiprazole|aripiprazole|mesh-list
110695732|NCT01026584|Antidepressive Agents|antidepressive agents|mesh-ancestor
110695733|NCT01026584|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110695734|NCT01026584|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110695735|NCT01026584|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110695736|NCT01026584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110695737|NCT01026584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110695738|NCT01026584|Dopamine Agonists|dopamine agonists|mesh-ancestor
110695739|NCT01026584|Dopamine Agents|dopamine agents|mesh-ancestor
110695740|NCT01026584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110695741|NCT01026584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110695742|NCT01026584|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110695743|NCT01026584|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110695744|NCT01026584|Serotonin Agents|serotonin agents|mesh-ancestor
110695745|NCT01026584|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110695746|NCT01026584|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110695747|NCT01026584|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110695748|NCT01026584|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110695750|NCT01023464|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110695751|NCT01023464|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110695752|NCT01023464|Dermatologic Agents|dermatologic agents|mesh-ancestor
110695753|NCT01023542|Everolimus|everolimus|mesh-list
110695754|NCT01023542|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110695755|NCT01023542|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110695756|NCT01023542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110695757|NCT01023542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110695758|NCT01023542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110695759|NCT01023542|Immunologic Factors|immunologic factors|mesh-ancestor
110695760|NCT01023542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110695761|NCT01023542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110695762|NCT01026740|Ceftobiprole|ceftobiprole|mesh-list
110695763|NCT01026740|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
110695764|NCT01026740|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110695765|NCT01026740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110695766|NCT01028534|Olmesartan|olmesartan|mesh-list
110695767|NCT01028534|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
110695768|NCT01028534|Calcium Channel Blockers|calcium channel blockers|mesh-list
110695769|NCT01028534|Angiotensin II|angiotensin ii|mesh-list
110695770|NCT01028534|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
110695771|NCT01028534|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110695772|NCT01028534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110695773|NCT01028534|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110695774|NCT01028534|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110695775|NCT01028534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110695776|NCT01028534|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110695777|NCT01028534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110695778|NCT00441974|Adefovir|adefovir|mesh-list
110695779|NCT00441974|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
110695780|NCT00441974|Antiviral Agents|antiviral agents|mesh-ancestor
110695781|NCT00441974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110695782|NCT00441974|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110695783|NCT00441974|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110695784|NCT00441974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110695785|NCT00441974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110695786|NCT00441584|Ribavirin|ribavirin|mesh-list
110695787|NCT00441584|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110695788|NCT00441584|Interferon-alpha|interferon-alpha|mesh-list
110695789|NCT00441584|Antimetabolites|antimetabolites|mesh-ancestor
110658386|NCT00500331|Pioglitazone|pioglitazone|mesh-list
110695790|NCT00441584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110695791|NCT00441584|Antiviral Agents|antiviral agents|mesh-ancestor
110695792|NCT00441584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110695793|NCT00441584|Immunologic Factors|immunologic factors|mesh-ancestor
110695794|NCT00441584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110695796|NCT00430716|Citric Acid|citric acid|mesh-list
110695797|NCT00430716|Sodium Citrate|sodium citrate|mesh-list
110695798|NCT00430716|Anticoagulants|anticoagulants|mesh-ancestor
110695799|NCT00430716|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110695800|NCT00430716|Chelating Agents|chelating agents|mesh-ancestor
110695801|NCT00430716|Sequestering Agents|sequestering agents|mesh-ancestor
110695802|NCT00430716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110695803|NCT00430716|Vasodilator Agents|vasodilator agents|mesh-ancestor
110695804|NCT00430716|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110695805|NCT00430716|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110695806|NCT00430716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110695807|NCT00430716|Urological Agents|urological agents|mesh-ancestor
110695808|NCT01028768|Teduglutide|teduglutide|mesh-list
110695809|NCT01028768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110695810|NCT01028768|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110695811|NCT01028768|Protective Agents|protective agents|mesh-ancestor
110695812|NCT01028768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110695813|NCT00441272|Pioglitazone|pioglitazone|mesh-list
110695814|NCT00441272|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110695815|NCT00441272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110695816|NCT01566552|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
110695817|NCT01566552|Antifungal Agents|antifungal agents|mesh-ancestor
110695818|NCT01566552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110695819|NCT01566552|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110695820|NCT01566552|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110695821|NCT01028924|Teduglutide|teduglutide|mesh-list
110695822|NCT01028924|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110695823|NCT01028924|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110695824|NCT01028924|Protective Agents|protective agents|mesh-ancestor
110695825|NCT01028924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110408611|NCT04867785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110695826|NCT00430638|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110695827|NCT00430638|Olmesartan|olmesartan|mesh-list
110695828|NCT00430638|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
110695829|NCT00430638|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110695830|NCT00430638|Diuretics|diuretics|mesh-ancestor
110695831|NCT00430638|Natriuretic Agents|natriuretic agents|mesh-ancestor
110695832|NCT00430638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110695833|NCT00430638|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110695834|NCT00430638|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110695835|NCT00430638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110695836|NCT00430638|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110695837|NCT00430638|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110695838|NCT03671330|Letrozole|letrozole|mesh-list
110695839|NCT03671330|Goserelin|goserelin|mesh-list
110695840|NCT03671330|Anastrozole|anastrozole|mesh-list
110695841|NCT03671330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110695842|NCT03671330|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110695843|NCT03671330|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110695844|NCT03671330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110858788|NCT05154734|Immunologic Factors|immunologic factors|mesh-ancestor
110695845|NCT03671330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110695846|NCT03671330|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110695847|NCT03671330|Hormone Antagonists|hormone antagonists|mesh-ancestor
110695848|NCT03671330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110695849|NCT03671330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110695850|NCT03671330|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110695851|NCT01038882|Midazolam|midazolam|mesh-list
110695852|NCT01038882|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110695853|NCT01038882|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110695854|NCT01038882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110695855|NCT01038882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110695856|NCT01038882|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110695857|NCT01038882|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110658828|NCT00684203|Antipyretics|antipyretics|mesh-ancestor
110695858|NCT01038882|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110695859|NCT01038882|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110695860|NCT01038882|Anesthetics, General|anesthetics, general|mesh-ancestor
110695861|NCT01038882|Anesthetics|anesthetics|mesh-ancestor
110695862|NCT01038882|GABA Modulators|gaba modulators|mesh-ancestor
110695863|NCT01038882|GABA Agents|gaba agents|mesh-ancestor
110695864|NCT01038882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110695865|NCT01038882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110695866|NCT00449930|Metformin|metformin|mesh-list
110695867|NCT00449930|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110695868|NCT00449930|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110658899|NCT00755963|Estradiol|estradiol|mesh-list
110695869|NCT00449930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110695870|NCT00449930|Incretins|incretins|mesh-ancestor
110695871|NCT00449930|Hormones|hormones|mesh-ancestor
110695872|NCT00449930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110695873|NCT00449930|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110695874|NCT00449930|Protease Inhibitors|protease inhibitors|mesh-ancestor
110695875|NCT00449930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110695876|NCT00449930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110695877|NCT00441116|Dutasteride|dutasteride|mesh-list
110695878|NCT00441116|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
110695879|NCT00441116|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110695880|NCT00441116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110695881|NCT00441116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110695882|NCT00441116|Hormone Antagonists|hormone antagonists|mesh-ancestor
110695883|NCT00441116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110695884|NCT00441116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110695885|NCT01024322|Diclofenac|diclofenac|mesh-list
110695886|NCT01024322|Prednisolone acetate|prednisolone acetate|mesh-list
110695887|NCT01024322|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110695888|NCT01024322|Methylprednisolone|methylprednisolone|mesh-list
110695889|NCT01024322|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110695890|NCT01024322|Prednisolone|prednisolone|mesh-list
110695891|NCT01024322|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110695892|NCT01024322|Prednisolone phosphate|prednisolone phosphate|mesh-list
110695893|NCT01024322|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110695894|NCT01024322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110695895|NCT01024322|Analgesics|analgesics|mesh-ancestor
110695896|NCT01024322|Sensory System Agents|sensory system agents|mesh-ancestor
110695897|NCT01024322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110695898|NCT01024322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110695899|NCT01024322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110695900|NCT01024322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110695901|NCT01024322|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110695902|NCT01024322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110695903|NCT01024322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110695904|NCT01024322|Antiemetics|antiemetics|mesh-ancestor
110695906|NCT01024322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110695907|NCT01024322|Glucocorticoids|glucocorticoids|mesh-ancestor
110695908|NCT01024322|Hormones|hormones|mesh-ancestor
110695909|NCT01024322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110695910|NCT01024322|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110695911|NCT01024322|Protective Agents|protective agents|mesh-ancestor
110695912|NCT01024322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110695913|NCT01024322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110695914|NCT03320642|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
110695915|NCT03320642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110695916|NCT03320642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110695917|NCT01566266|Amoxicillin|amoxicillin|mesh-list
110695918|NCT01566266|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110695919|NCT01566266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110695920|NCT00430248|Allopurinol|allopurinol|mesh-list
110695921|NCT00430248|Febuxostat|febuxostat|mesh-list
110695922|NCT00430248|Antimetabolites|antimetabolites|mesh-ancestor
110695923|NCT00430248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110695924|NCT00430248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110695925|NCT00430248|Gout Suppressants|gout suppressants|mesh-ancestor
110695926|NCT00430248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110695927|NCT00430248|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110695928|NCT00430248|Antioxidants|antioxidants|mesh-ancestor
110695929|NCT00430248|Protective Agents|protective agents|mesh-ancestor
110695930|NCT00430248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110695931|NCT00411762|Capecitabine|capecitabine|mesh-list
110695932|NCT00411762|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110695933|NCT00411762|Antimetabolites|antimetabolites|mesh-ancestor
110695934|NCT00411762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110695935|NCT00411762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110695936|NCT00429858|Gemcitabine|gemcitabine|mesh-list
110695937|NCT00429858|Tegafur|tegafur|mesh-list
110695938|NCT00429858|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110695939|NCT00429858|Antimetabolites|antimetabolites|mesh-ancestor
110695940|NCT00429858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110695941|NCT00429858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110695942|NCT01035216|CPG-oligonucleotide|cpg-oligonucleotide|mesh-list
110695943|NCT01035216|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110695944|NCT01035216|Immunologic Factors|immunologic factors|mesh-ancestor
110695945|NCT01035216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110695946|NCT00449150|Cetrorelix|cetrorelix|mesh-list
110695947|NCT00449150|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110695948|NCT00449150|Fertility Agents|fertility agents|mesh-ancestor
110695949|NCT00449150|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110695950|NCT00449150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110695951|NCT00449150|Hormone Antagonists|hormone antagonists|mesh-ancestor
110695952|NCT00449150|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110695953|NCT00428844|Vancomycin|vancomycin|mesh-list
110695954|NCT00428844|Daptomycin|daptomycin|mesh-list
110695955|NCT00428844|Teicoplanin|teicoplanin|mesh-list
110695956|NCT00428844|Floxacillin|floxacillin|mesh-list
110695957|NCT00428844|Oxacillin|oxacillin|mesh-list
110695958|NCT00428844|Nafcillin|nafcillin|mesh-list
110695959|NCT00428844|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110695960|NCT00428844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110695961|NCT00457418|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110695962|NCT00457418|Antiviral Agents|antiviral agents|mesh-ancestor
110695963|NCT00457418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110695964|NCT01039194|Galantamine|galantamine|mesh-list
110695965|NCT01039194|BMS 708163|bms 708163|mesh-list
110695966|NCT01039194|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110695967|NCT01039194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110858831|NCT03295162|Melatonin|melatonin|mesh-list
110695968|NCT01039194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110695969|NCT01039194|Cholinergic Agents|cholinergic agents|mesh-ancestor
110695970|NCT01039194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110695971|NCT01039194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110695972|NCT01039194|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110659260|NCT00481767|Vaccines|vaccines|mesh-list
110695973|NCT01039194|Autonomic Agents|autonomic agents|mesh-ancestor
110695974|NCT01039194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110695975|NCT01039194|Nootropic Agents|nootropic agents|mesh-ancestor
110695976|NCT01039194|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
110695977|NCT00449072|Loratadine|loratadine|mesh-list
110695978|NCT00449072|Antipruritics|antipruritics|mesh-ancestor
110695979|NCT00449072|Dermatologic Agents|dermatologic agents|mesh-ancestor
110695980|NCT00449072|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110695981|NCT00449072|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110659288|NCT00489411|Analgesics|analgesics|mesh-ancestor
110695982|NCT00449072|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110695983|NCT00449072|Histamine Antagonists|histamine antagonists|mesh-ancestor
110695984|NCT00449072|Histamine Agents|histamine agents|mesh-ancestor
110695985|NCT00449072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110695986|NCT00449072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110695987|NCT00449072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110695988|NCT00419094|Levetiracetam|levetiracetam|mesh-list
110695989|NCT00419094|Anticonvulsants|anticonvulsants|mesh-ancestor
110695990|NCT00419094|Nootropic Agents|nootropic agents|mesh-ancestor
110695991|NCT00448916|Pregabalin|pregabalin|mesh-list
110695992|NCT00448916|Analgesics|analgesics|mesh-ancestor
110695993|NCT00448916|Sensory System Agents|sensory system agents|mesh-ancestor
110695994|NCT00448916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110695995|NCT00448916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110695996|NCT00448916|Anticonvulsants|anticonvulsants|mesh-ancestor
110695997|NCT00448916|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110695998|NCT00448916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110695999|NCT00448916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110696000|NCT00448916|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110696001|NCT00448916|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110696002|NCT00448916|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110696003|NCT00448916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110696004|NCT00448916|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110696005|NCT00418938|Leucovorin|leucovorin|mesh-list
110696006|NCT00418938|Bevacizumab|bevacizumab|mesh-list
110696007|NCT00418938|Panitumumab|panitumumab|mesh-list
110696008|NCT00418938|Fluorouracil|fluorouracil|mesh-list
110696009|NCT00418938|Irinotecan|irinotecan|mesh-list
110696010|NCT00418938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110696011|NCT00418938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110696012|NCT00418938|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110696013|NCT00418938|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110696014|NCT00418938|Growth Substances|growth substances|mesh-ancestor
110696015|NCT00418938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110408618|NCT04812912|Hormones|hormones|mesh-list
110408619|NCT04812912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110408620|NCT04812912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110696016|NCT00418938|Growth Inhibitors|growth inhibitors|mesh-ancestor
110696017|NCT00418938|Antimetabolites|antimetabolites|mesh-ancestor
110696018|NCT00418938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110696019|NCT00418938|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110696020|NCT00418938|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110696021|NCT00418938|Immunologic Factors|immunologic factors|mesh-ancestor
110696022|NCT00418938|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110696023|NCT00418938|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110696024|NCT00418938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110696026|NCT00418938|Protective Agents|protective agents|mesh-ancestor
110696027|NCT00418938|Vitamin B Complex|vitamin b complex|mesh-ancestor
110696028|NCT00418938|Vitamins|vitamins|mesh-ancestor
110696029|NCT00418938|Micronutrients|micronutrients|mesh-ancestor
110696030|NCT00448760|Leucovorin|leucovorin|mesh-list
110696031|NCT00448760|Docetaxel|docetaxel|mesh-list
110696032|NCT00448760|Oxaliplatin|oxaliplatin|mesh-list
110696033|NCT00448760|Floxuridine|floxuridine|mesh-list
110696034|NCT00448760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110696035|NCT00448760|Tubulin Modulators|tubulin modulators|mesh-ancestor
110696036|NCT00448760|Antimitotic Agents|antimitotic agents|mesh-ancestor
110696037|NCT00448760|Mitosis Modulators|mitosis modulators|mesh-ancestor
110696038|NCT00448760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110696039|NCT00448760|Antidotes|antidotes|mesh-ancestor
110696040|NCT00448760|Protective Agents|protective agents|mesh-ancestor
110413881|NCT05938959|Ropivacaine|ropivacaine|mesh-list
110696041|NCT00448760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110696042|NCT00448760|Vitamin B Complex|vitamin b complex|mesh-ancestor
110696043|NCT00448760|Vitamins|vitamins|mesh-ancestor
110696044|NCT00448760|Micronutrients|micronutrients|mesh-ancestor
110696045|NCT00448760|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110696046|NCT00448760|Antimetabolites|antimetabolites|mesh-ancestor
110696047|NCT01039350|Darbepoetin alfa|darbepoetin alfa|mesh-list
110696048|NCT01039350|Hematinics|hematinics|mesh-ancestor
110696049|NCT01039506|Irinotecan|irinotecan|mesh-list
110696050|NCT01039506|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110696051|NCT01039506|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110696052|NCT01039506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110696053|NCT01039506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110696054|NCT01039506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110696055|NCT01033500|Abatacept|abatacept|mesh-list
110696056|NCT01033500|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110696057|NCT01033500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110696058|NCT01033500|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110696059|NCT01033500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110696060|NCT01033500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110696061|NCT01033500|Immunologic Factors|immunologic factors|mesh-ancestor
110696062|NCT01033500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110696063|NCT01033500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110696064|NCT01035450|Sirolimus|sirolimus|mesh-list
110696065|NCT01035450|Everolimus|everolimus|mesh-list
110696066|NCT01035450|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110696067|NCT01035450|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110696068|NCT01035450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110696069|NCT01035450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110696070|NCT01035450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110696071|NCT01035450|Immunologic Factors|immunologic factors|mesh-ancestor
110696072|NCT01035450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110696073|NCT01035450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110696074|NCT01035450|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110696075|NCT01035450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110696076|NCT01035450|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110696077|NCT01035450|Antifungal Agents|antifungal agents|mesh-ancestor
110696078|NCT01035528|Metformin|metformin|mesh-list
110696079|NCT01035528|Insulin Glargine|insulin glargine|mesh-list
110696080|NCT01035528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110696081|NCT01035528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110696082|NCT01033656|Methotrexate|methotrexate|mesh-list
110696083|NCT01033656|Azathioprine|azathioprine|mesh-list
110408646|NCT04666038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110696084|NCT01033656|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
110696085|NCT01033656|Leflunomide|leflunomide|mesh-list
110696086|NCT01033656|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110696087|NCT01033656|Abortifacient Agents|abortifacient agents|mesh-ancestor
110696088|NCT01033656|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110696089|NCT01033656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110696090|NCT01033656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110696091|NCT01033656|Antimetabolites|antimetabolites|mesh-ancestor
110696092|NCT01033656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110696093|NCT01033656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110696094|NCT01033656|Dermatologic Agents|dermatologic agents|mesh-ancestor
110659702|NCT00964418|Insulin Glargine|insulin glargine|mesh-list
110696095|NCT01033656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110696096|NCT01033656|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110696097|NCT01033656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110696098|NCT01033656|Immunologic Factors|immunologic factors|mesh-ancestor
110696099|NCT01033656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110696100|NCT01033656|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110696102|NCT01039740|Antidepressive Agents|antidepressive agents|mesh-ancestor
110696103|NCT01039740|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110696104|NCT01039740|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110696105|NCT01039740|Histamine Antagonists|histamine antagonists|mesh-ancestor
110696106|NCT01039740|Histamine Agents|histamine agents|mesh-ancestor
110696107|NCT01039740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110659760|NCT00539838|Prednisone|prednisone|mesh-list
110696108|NCT01039740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110696109|NCT01039740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110696110|NCT01039740|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110696111|NCT01039740|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110696112|NCT01039740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110696113|NCT01039740|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
110696114|NCT01039740|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110696115|NCT01039740|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110696116|NCT01039740|Adrenergic Agents|adrenergic agents|mesh-ancestor
110696117|NCT01039740|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110696118|NCT01039740|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110696119|NCT01039740|Serotonin Agents|serotonin agents|mesh-ancestor
110696120|NCT01039740|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110696121|NCT00448136|Bevacizumab|bevacizumab|mesh-list
110696122|NCT00448136|Streptozocin|streptozocin|mesh-list
110696123|NCT00448136|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110696124|NCT00448136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110696125|NCT00448136|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110696126|NCT00448136|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110696127|NCT00448136|Growth Substances|growth substances|mesh-ancestor
110696128|NCT00448136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110696129|NCT00448136|Growth Inhibitors|growth inhibitors|mesh-ancestor
110696130|NCT00448136|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110696131|NCT00447902|Ritonavir|ritonavir|mesh-list
110696132|NCT00447902|Tipranavir|tipranavir|mesh-list
110659893|NCT00974792|Vitamins|vitamins|mesh-ancestor
110696133|NCT00447902|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110696134|NCT00447902|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110696135|NCT00447902|Protease Inhibitors|protease inhibitors|mesh-ancestor
110696136|NCT00447902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110696137|NCT00447902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110696138|NCT00447902|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110696139|NCT00447902|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110696140|NCT00447902|Antiviral Agents|antiviral agents|mesh-ancestor
110696141|NCT00447902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110696142|NCT00447902|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110696143|NCT00447902|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110696144|NCT00307437|Ustekinumab|ustekinumab|mesh-list
110696145|NCT00307437|Dermatologic Agents|dermatologic agents|mesh-ancestor
110696146|NCT00440726|Cytarabine|cytarabine|mesh-list
110696147|NCT00440726|Dexamethasone|dexamethasone|mesh-list
110696148|NCT00440726|Doxorubicin|doxorubicin|mesh-list
110696149|NCT00440726|Methotrexate|methotrexate|mesh-list
110696150|NCT00440726|Vincristine|vincristine|mesh-list
110696151|NCT00440726|Bortezomib|bortezomib|mesh-list
110696152|NCT00440726|Asparaginase|asparaginase|mesh-list
110696153|NCT00440726|Pegaspargase|pegaspargase|mesh-list
110696154|NCT00440726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110696155|NCT00440726|Antiemetics|antiemetics|mesh-ancestor
110696156|NCT00440726|Autonomic Agents|autonomic agents|mesh-ancestor
110696157|NCT00440726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110696158|NCT00440726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110696159|NCT00440726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110696160|NCT00440726|Glucocorticoids|glucocorticoids|mesh-ancestor
110696161|NCT00440726|Hormones|hormones|mesh-ancestor
110696162|NCT00440726|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110696163|NCT00440726|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110660007|NCT00972296|Carbon Fiber|carbon fiber|mesh-list
110696164|NCT00440726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110696165|NCT00440726|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110696166|NCT00440726|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110696167|NCT00440726|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110696168|NCT00440726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110696169|NCT00440726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110696170|NCT00440726|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110696171|NCT00440726|Abortifacient Agents|abortifacient agents|mesh-ancestor
110696172|NCT00440726|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110696173|NCT00440726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110696175|NCT00440726|Dermatologic Agents|dermatologic agents|mesh-ancestor
110696176|NCT00440726|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110696177|NCT00440726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110696178|NCT00440726|Immunologic Factors|immunologic factors|mesh-ancestor
110696179|NCT00440726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110696180|NCT00440726|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110696181|NCT00440726|Antiviral Agents|antiviral agents|mesh-ancestor
110696182|NCT00440726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110696183|NCT00440726|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110696184|NCT00440726|Tubulin Modulators|tubulin modulators|mesh-ancestor
110696185|NCT00440726|Antimitotic Agents|antimitotic agents|mesh-ancestor
110696186|NCT00440726|Mitosis Modulators|mitosis modulators|mesh-ancestor
110696187|NCT01030016|Atenolol|atenolol|mesh-list
110696188|NCT01030016|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110696189|NCT01030016|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110696190|NCT01030016|Adrenergic Agents|adrenergic agents|mesh-ancestor
110696191|NCT01030016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110696192|NCT01030016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110696193|NCT01030016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110696194|NCT01030016|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110696195|NCT01030016|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110696196|NCT01030016|Sympatholytics|sympatholytics|mesh-ancestor
110696197|NCT01030016|Autonomic Agents|autonomic agents|mesh-ancestor
110696198|NCT01030016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110696199|NCT01030016|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110696201|NCT03996278|Immunologic Factors|immunologic factors|mesh-ancestor
110696202|NCT03996278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110696203|NCT03996278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110696204|NCT00447278|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
110696205|NCT00447278|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110696206|NCT00447278|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110696207|NCT00447278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110696208|NCT00447278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110696209|NCT00447278|Adrenergic Agents|adrenergic agents|mesh-ancestor
110660268|NCT02897076|Hormones|hormones|mesh-ancestor
110696210|NCT00447278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110696211|NCT00447278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110696212|NCT01030094|Topiramate|topiramate|mesh-list
110696213|NCT01030094|Carbamazepine|carbamazepine|mesh-list
110696214|NCT01030094|Valproic Acid|valproic acid|mesh-list
110696215|NCT01030094|Anticonvulsants|anticonvulsants|mesh-ancestor
110696216|NCT01030094|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110696217|NCT01030094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110696218|NCT01030094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110098638|NCT01743326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110696219|NCT01030094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110696220|NCT01030094|GABA Agents|gaba agents|mesh-ancestor
110696221|NCT01030094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110696222|NCT01030094|Antimanic Agents|antimanic agents|mesh-ancestor
110696223|NCT01030094|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110696224|NCT01030094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110696225|NCT01030094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110696226|NCT01030094|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110696227|NCT01030094|Analgesics|analgesics|mesh-ancestor
110696228|NCT01030094|Sensory System Agents|sensory system agents|mesh-ancestor
110098704|NCT01743885|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110696229|NCT01030094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110696230|NCT01030094|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110696231|NCT01030094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110696232|NCT01030094|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110696233|NCT01030094|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110696235|NCT01565798|Trace Elements|trace elements|mesh-ancestor
110696236|NCT01565798|Micronutrients|micronutrients|mesh-ancestor
110696237|NCT01565798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110696238|NCT01030328|Fenofibrate|fenofibrate|mesh-list
110696239|NCT01030328|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110696240|NCT01030328|Antimetabolites|antimetabolites|mesh-ancestor
110858862|NCT01339689|GABA Modulators|gaba modulators|mesh-ancestor
110696241|NCT01030328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110696242|NCT01030328|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110696244|NCT00405756|Prednisone|prednisone|mesh-list
110696245|NCT00405756|Lenalidomide|lenalidomide|mesh-list
110696246|NCT00405756|Melphalan|melphalan|mesh-list
110696247|NCT00405756|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110696248|NCT00405756|Glucocorticoids|glucocorticoids|mesh-ancestor
110696249|NCT00405756|Hormones|hormones|mesh-ancestor
110696250|NCT00405756|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110696251|NCT00405756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110696252|NCT00405756|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110696253|NCT00405756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110696254|NCT00405756|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110696255|NCT00405756|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110696256|NCT00405756|Analgesics|analgesics|mesh-ancestor
110696257|NCT00405756|Sensory System Agents|sensory system agents|mesh-ancestor
110696258|NCT00405756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110696259|NCT00405756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110696260|NCT00405756|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110696261|NCT00405756|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110696262|NCT00405756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110696263|NCT00405756|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110696264|NCT00405756|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110696265|NCT00405756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110696266|NCT00405756|Antipyretics|antipyretics|mesh-ancestor
110414121|NCT05833776|Fentanyl|fentanyl|mesh-list
110696267|NCT00405756|Immunologic Factors|immunologic factors|mesh-ancestor
110696268|NCT00405756|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110696269|NCT00405756|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110696270|NCT00405756|Growth Substances|growth substances|mesh-ancestor
110696271|NCT00405756|Growth Inhibitors|growth inhibitors|mesh-ancestor
110696272|NCT00405756|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110696273|NCT00405756|Alkylating Agents|alkylating agents|mesh-ancestor
110696274|NCT00405756|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110696275|NCT00405756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110696276|NCT00456092|Apremilast|apremilast|mesh-list
110696277|NCT00456092|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110696278|NCT00456092|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110696279|NCT00456092|Analgesics|analgesics|mesh-ancestor
110696280|NCT00456092|Sensory System Agents|sensory system agents|mesh-ancestor
110696281|NCT00456092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110696282|NCT00456092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110696283|NCT00456092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110696284|NCT00456092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110696285|NCT00456092|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
110696286|NCT00456092|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110696287|NCT00456092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110696288|NCT00456092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110696289|NCT01030640|Tanezumab|tanezumab|mesh-list
110696290|NCT01030640|Analgesics|analgesics|mesh-ancestor
110696291|NCT01030640|Sensory System Agents|sensory system agents|mesh-ancestor
110696292|NCT01030640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110696293|NCT01030640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110696294|NCT00411450|Panitumumab|panitumumab|mesh-list
110696295|NCT00411450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110696296|NCT00411450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110696297|NCT00404820|Vitamin D|vitamin d|mesh-list
110696298|NCT00404820|Zoledronic Acid|zoledronic acid|mesh-list
110696299|NCT00404820|Alendronate|alendronate|mesh-list
110696300|NCT00404820|Calcium|calcium|mesh-list
110696301|NCT00404820|Vitamins|vitamins|mesh-ancestor
110696302|NCT00404820|Micronutrients|micronutrients|mesh-ancestor
110696303|NCT00404820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110696304|NCT00404820|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110696305|NCT00404820|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110696306|NCT00446030|Cyclophosphamide|cyclophosphamide|mesh-list
110696307|NCT00446030|Bevacizumab|bevacizumab|mesh-list
110696308|NCT00446030|Carboplatin|carboplatin|mesh-list
110696309|NCT00446030|Docetaxel|docetaxel|mesh-list
110696310|NCT00446030|Doxorubicin|doxorubicin|mesh-list
110696311|NCT00446030|Trastuzumab|trastuzumab|mesh-list
110696312|NCT00446030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110696314|NCT00446030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110696315|NCT00446030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110696316|NCT00446030|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110696317|NCT00446030|Alkylating Agents|alkylating agents|mesh-ancestor
110696318|NCT00446030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110696319|NCT00446030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110696320|NCT00446030|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110696321|NCT00446030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110696322|NCT00446030|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110696323|NCT00446030|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110696324|NCT00446030|Growth Substances|growth substances|mesh-ancestor
110696325|NCT00446030|Growth Inhibitors|growth inhibitors|mesh-ancestor
110696326|NCT00446030|Tubulin Modulators|tubulin modulators|mesh-ancestor
110696327|NCT00446030|Antimitotic Agents|antimitotic agents|mesh-ancestor
110696328|NCT00446030|Mitosis Modulators|mitosis modulators|mesh-ancestor
110696329|NCT00446030|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110696330|NCT00446030|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110696331|NCT00446030|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110696332|NCT00446030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110696333|NCT00410514|Mirabegron|mirabegron|mesh-list
110696334|NCT00410514|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
110696335|NCT00410514|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110696336|NCT00410514|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110696337|NCT00410514|Adrenergic Agents|adrenergic agents|mesh-ancestor
110696338|NCT00410514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110696339|NCT00410514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110696340|NCT00410514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110696341|NCT00410514|Urological Agents|urological agents|mesh-ancestor
110696342|NCT03847610|Penicillins|penicillins|mesh-list
110696343|NCT03847610|Penicillin V|penicillin v|mesh-list
110696344|NCT03847610|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110696345|NCT03847610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110696346|NCT01036854|Ondansetron|ondansetron|mesh-list
110696347|NCT01036854|Antiemetics|antiemetics|mesh-ancestor
110696348|NCT01036854|Autonomic Agents|autonomic agents|mesh-ancestor
110696349|NCT01036854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110696350|NCT01036854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110696351|NCT01036854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110696352|NCT01036854|Antipruritics|antipruritics|mesh-ancestor
110696353|NCT01036854|Dermatologic Agents|dermatologic agents|mesh-ancestor
110696354|NCT01036854|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110696355|NCT01036854|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110696356|NCT01036854|Serotonin Agents|serotonin agents|mesh-ancestor
110696357|NCT01036854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110696358|NCT01036854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110696359|NCT01030796|Caffeine|caffeine|mesh-list
110696360|NCT01030796|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110696361|NCT01030796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110696362|NCT01030796|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110696363|NCT01030796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110696364|NCT01030796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110696365|NCT01030796|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110696366|NCT01030796|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110696367|NCT01030796|Purinergic Agents|purinergic agents|mesh-ancestor
110696368|NCT01030796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110696369|NCT00455858|Insulin Detemir|insulin detemir|mesh-list
110696370|NCT00455858|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110696371|NCT00455858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110696372|NCT00439556|Cytarabine|cytarabine|mesh-list
110696373|NCT00439556|Rituximab|rituximab|mesh-list
110696374|NCT00439556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110696375|NCT00439556|Methotrexate|methotrexate|mesh-list
110696376|NCT00439556|Etoposide|etoposide|mesh-list
110696377|NCT00439556|Etoposide phosphate|etoposide phosphate|mesh-list
110696378|NCT00439556|Bortezomib|bortezomib|mesh-list
110696379|NCT00439556|Melphalan|melphalan|mesh-list
110696380|NCT00439556|Mechlorethamine|mechlorethamine|mesh-list
110696381|NCT00439556|Carmustine|carmustine|mesh-list
110696382|NCT00439556|Podophyllotoxin|podophyllotoxin|mesh-list
110696383|NCT00439556|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
110696384|NCT00439556|Antibodies|antibodies|mesh-list
110696385|NCT00439556|Immunoglobulins|immunoglobulins|mesh-list
110696386|NCT00439556|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110696387|NCT00439556|Lenograstim|lenograstim|mesh-list
110696388|NCT00439556|Tacrolimus|tacrolimus|mesh-list
110696389|NCT00439556|Thymoglobulin|thymoglobulin|mesh-list
110696390|NCT00439556|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110696391|NCT00439556|Immunologic Factors|immunologic factors|mesh-ancestor
110696392|NCT00439556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110696393|NCT00439556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110696394|NCT00439556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110696395|NCT00439556|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110696396|NCT00439556|Abortifacient Agents|abortifacient agents|mesh-ancestor
110696397|NCT00439556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110696398|NCT00439556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110696399|NCT00439556|Antimetabolites|antimetabolites|mesh-ancestor
110696400|NCT00439556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110696401|NCT00439556|Dermatologic Agents|dermatologic agents|mesh-ancestor
110696402|NCT00439556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110696403|NCT00439556|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110696404|NCT00439556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110696405|NCT00439556|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110696406|NCT00439556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110696407|NCT00439556|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110696408|NCT00439556|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110696409|NCT00439556|Antiviral Agents|antiviral agents|mesh-ancestor
110696410|NCT00439556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110696411|NCT00439556|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110696412|NCT00439556|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110696413|NCT00439556|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110696414|NCT00439556|Alkylating Agents|alkylating agents|mesh-ancestor
110099109|NCT01746641|Remifentanil|remifentanil|mesh-list
110696415|NCT00439556|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110696416|NCT00439556|Keratolytic Agents|keratolytic agents|mesh-ancestor
110696417|NCT00439556|Tubulin Modulators|tubulin modulators|mesh-ancestor
110696418|NCT00439556|Antimitotic Agents|antimitotic agents|mesh-ancestor
110696419|NCT00439556|Mitosis Modulators|mitosis modulators|mesh-ancestor
110696420|NCT00410202|Tenofovir|tenofovir|mesh-list
110696421|NCT00410202|Lamivudine|lamivudine|mesh-list
110696422|NCT00410202|Entecavir|entecavir|mesh-list
110696423|NCT00410202|Adefovir|adefovir|mesh-list
110696424|NCT00410202|Antiviral Agents|antiviral agents|mesh-ancestor
110696425|NCT00410202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110696426|NCT00410202|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110696427|NCT00410202|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110696428|NCT00410202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110696429|NCT00410202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110696430|NCT00410202|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110696431|NCT00410202|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110696432|NCT03802058|Paclitaxel|paclitaxel|mesh-list
110696433|NCT03802058|Carboplatin|carboplatin|mesh-list
110696434|NCT03802058|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110696435|NCT03802058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110696436|NCT03802058|Tubulin Modulators|tubulin modulators|mesh-ancestor
110696437|NCT03802058|Antimitotic Agents|antimitotic agents|mesh-ancestor
110696438|NCT03802058|Mitosis Modulators|mitosis modulators|mesh-ancestor
110696439|NCT03802058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110696440|NCT00445328|Heparin|heparin|mesh-list
110696441|NCT00445328|Calcium heparin|calcium heparin|mesh-list
110696442|NCT00445328|Dalteparin|dalteparin|mesh-list
110696443|NCT00445328|Tinzaparin|tinzaparin|mesh-list
110696444|NCT00445328|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
110696445|NCT00445328|Anticoagulants|anticoagulants|mesh-ancestor
110696446|NCT00445328|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110858874|NCT03635931|Mitogens|mitogens|mesh-list
110696447|NCT00445328|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110696448|NCT00445328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110696449|NCT00455312|Methylprednisolone|methylprednisolone|mesh-list
110696450|NCT00455312|Cyclophosphamide|cyclophosphamide|mesh-list
110696451|NCT00455312|Fludarabine|fludarabine|mesh-list
110696452|NCT00455312|Alemtuzumab|alemtuzumab|mesh-list
110696453|NCT00455312|Thymoglobulin|thymoglobulin|mesh-list
110696454|NCT00455312|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110696455|NCT00455312|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110696456|NCT00455312|Immunologic Factors|immunologic factors|mesh-ancestor
110696457|NCT00455312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110696458|NCT00455312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110696459|NCT00455312|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110696460|NCT00455312|Alkylating Agents|alkylating agents|mesh-ancestor
110696461|NCT00455312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110696462|NCT00455312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110696463|NCT00455312|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110696464|NCT00455312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110696465|NCT00455312|Antiemetics|antiemetics|mesh-ancestor
110696466|NCT00455312|Autonomic Agents|autonomic agents|mesh-ancestor
110696467|NCT00455312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110696468|NCT00455312|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110696469|NCT00455312|Glucocorticoids|glucocorticoids|mesh-ancestor
110696470|NCT00455312|Hormones|hormones|mesh-ancestor
110696471|NCT00455312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110696472|NCT00455312|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110696473|NCT00455312|Protective Agents|protective agents|mesh-ancestor
110696474|NCT00455312|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110696475|NCT01031030|Cyclophosphamide|cyclophosphamide|mesh-list
110696476|NCT01031030|Fluorouracil|fluorouracil|mesh-list
110696477|NCT01031030|Methotrexate|methotrexate|mesh-list
110696478|NCT01031030|Epirubicin|epirubicin|mesh-list
110696479|NCT01031030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110696480|NCT01031030|Immunologic Factors|immunologic factors|mesh-ancestor
110696481|NCT01031030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110696482|NCT01031030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110696483|NCT01031030|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110696484|NCT01031030|Alkylating Agents|alkylating agents|mesh-ancestor
110696485|NCT01031030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110696486|NCT01031030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110696487|NCT01031030|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110696488|NCT01031030|Antimetabolites|antimetabolites|mesh-ancestor
110696489|NCT01031030|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110696490|NCT01031030|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110696491|NCT01031030|Abortifacient Agents|abortifacient agents|mesh-ancestor
110696492|NCT01031030|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110696493|NCT01031030|Dermatologic Agents|dermatologic agents|mesh-ancestor
110696494|NCT01031030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110696495|NCT01031030|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110696496|NCT01031030|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110696497|NCT01031030|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110696498|NCT01031030|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110696499|NCT01031030|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110696500|NCT01024712|Paclitaxel|paclitaxel|mesh-list
110696501|NCT01024712|Carboplatin|carboplatin|mesh-list
110696502|NCT01024712|Gefitinib|gefitinib|mesh-list
110696503|NCT01024712|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110696504|NCT01024712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110696505|NCT01024712|Tubulin Modulators|tubulin modulators|mesh-ancestor
110696506|NCT01024712|Antimitotic Agents|antimitotic agents|mesh-ancestor
110696507|NCT01024712|Mitosis Modulators|mitosis modulators|mesh-ancestor
110696508|NCT01024712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110696509|NCT01024712|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110696510|NCT01024712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110696511|NCT01323452|Entecavir|entecavir|mesh-list
110696512|NCT01323452|Antiviral Agents|antiviral agents|mesh-ancestor
110696513|NCT01323452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110696514|NCT00444626|Lidocaine|lidocaine|mesh-list
110696515|NCT00444626|Prilocaine|prilocaine|mesh-list
110696516|NCT00444626|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
110696517|NCT00444626|Hyaluronic Acid|hyaluronic acid|mesh-list
110696518|NCT00444626|Anesthetics, Local|anesthetics, local|mesh-ancestor
110696519|NCT00444626|Anesthetics|anesthetics|mesh-ancestor
110696520|NCT00444626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110696521|NCT00444626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110696522|NCT00444626|Sensory System Agents|sensory system agents|mesh-ancestor
110696523|NCT00444626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110696524|NCT00444626|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110696525|NCT00444626|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110696526|NCT00444626|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110696527|NCT00444626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110696528|NCT00444626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110696529|NCT00444626|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110696530|NCT00444626|Immunologic Factors|immunologic factors|mesh-ancestor
110696531|NCT00444626|Viscosupplements|viscosupplements|mesh-ancestor
110696532|NCT00444626|Protective Agents|protective agents|mesh-ancestor
110696533|NCT00444626|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
110696534|NCT01024868|Ropivacaine|ropivacaine|mesh-list
110696535|NCT01024868|Anesthetics, Local|anesthetics, local|mesh-ancestor
110696536|NCT01024868|Anesthetics|anesthetics|mesh-ancestor
110696537|NCT01024868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110696538|NCT01024868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110696539|NCT01024868|Sensory System Agents|sensory system agents|mesh-ancestor
110099131|NCT01746680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110696540|NCT01024868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110696541|NCT03795194|Clavulanic Acid|clavulanic acid|mesh-list
110696542|NCT03795194|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
110696543|NCT03795194|Clavulanic Acids|clavulanic acids|mesh-list
110696545|NCT03795194|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110696546|NCT03795194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110696547|NCT03795194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110696548|NCT03795194|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110696549|NCT03795194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110696550|NCT00404352|Interferon beta-1a|interferon beta-1a|mesh-list
110696551|NCT00404352|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110696552|NCT00404352|Immunologic Factors|immunologic factors|mesh-ancestor
110696553|NCT00404352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110696554|NCT00404352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110696555|NCT00404352|Antiviral Agents|antiviral agents|mesh-ancestor
110696556|NCT00404352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110696557|NCT00439244|Zoledronic Acid|zoledronic acid|mesh-list
110696558|NCT00439244|Teriparatide|teriparatide|mesh-list
110696559|NCT00439244|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110696560|NCT00439244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110696561|NCT00439244|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110696562|NCT04844762|Menthol|menthol|mesh-list
110696563|NCT04844762|Antipruritics|antipruritics|mesh-ancestor
110696564|NCT04844762|Dermatologic Agents|dermatologic agents|mesh-ancestor
110696565|NCT01323218|Vitamin D|vitamin d|mesh-list
110696566|NCT01323218|Vitamins|vitamins|mesh-ancestor
110696567|NCT01323218|Micronutrients|micronutrients|mesh-ancestor
110696568|NCT01323218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110696569|NCT01323218|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110696570|NCT01323296|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
110696571|NCT01323296|Hematinics|hematinics|mesh-ancestor
110696572|NCT01323296|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
110696573|NCT01323296|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110696574|NCT00438464|Finasteride|finasteride|mesh-list
110696575|NCT00438464|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
110696576|NCT00438464|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110696577|NCT00438464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110696578|NCT00438464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110696579|NCT00438464|Hormone Antagonists|hormone antagonists|mesh-ancestor
110858901|NCT03108274|Anesthetics|anesthetics|mesh-ancestor
110696580|NCT00438464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110099184|NCT01746992|Prednisone|prednisone|mesh-list
110696581|NCT00438464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110696582|NCT00438464|Urological Agents|urological agents|mesh-ancestor
110696584|NCT00437294|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110696585|NCT00437294|Antimetabolites|antimetabolites|mesh-ancestor
110696586|NCT00437294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110696587|NCT00437294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110696589|NCT01033760|Darunavir|darunavir|mesh-list
110696590|NCT01033760|Tenofovir|tenofovir|mesh-list
110696591|NCT01033760|Emtricitabine|emtricitabine|mesh-list
110696592|NCT01033760|Raltegravir Potassium|raltegravir potassium|mesh-list
110696593|NCT01033760|Maraviroc|maraviroc|mesh-list
110696594|NCT01033760|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110696595|NCT01033760|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110696596|NCT01033760|Protease Inhibitors|protease inhibitors|mesh-ancestor
110696597|NCT01033760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110696598|NCT01033760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110696599|NCT01033760|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110696600|NCT01033760|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110696601|NCT01033760|Antiviral Agents|antiviral agents|mesh-ancestor
110696602|NCT01033760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110696603|NCT01033760|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110696604|NCT01033760|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110696605|NCT01033760|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110696606|NCT01033760|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110696607|NCT01033760|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110696608|NCT01033760|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110696609|NCT01033760|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110696610|NCT01033760|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110696611|NCT01033760|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
110696612|NCT01031732|Tacrine|tacrine|mesh-list
110696613|NCT01031732|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110696614|NCT01031732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110696615|NCT01031732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110696616|NCT01031732|Cholinergic Agents|cholinergic agents|mesh-ancestor
110696617|NCT01031732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110696618|NCT01031732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110696619|NCT01031732|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110696620|NCT01031732|Autonomic Agents|autonomic agents|mesh-ancestor
110696621|NCT01031732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110696622|NCT01031732|Nootropic Agents|nootropic agents|mesh-ancestor
110696623|NCT01033994|Mitogens|mitogens|mesh-list
110696624|NCT01033994|Mitosis Modulators|mitosis modulators|mesh-ancestor
110696625|NCT01033994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110099385|NCT01747798|Auranofin|auranofin|mesh-list
110696626|NCT01031888|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110696627|NCT01031888|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110696628|NCT00436826|Interferons|interferons|mesh-list
110696629|NCT00436826|Interferon-beta|interferon-beta|mesh-list
110696630|NCT00436826|Cladribine|cladribine|mesh-list
110696631|NCT00436826|Interferon beta-1b|interferon beta-1b|mesh-list
110696632|NCT00436826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110696633|NCT00436826|Antiviral Agents|antiviral agents|mesh-ancestor
110696634|NCT00436826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110696635|NCT00436826|Immunologic Factors|immunologic factors|mesh-ancestor
110696636|NCT00436826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110696637|NCT00436826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110696638|NCT00436826|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110696639|NCT00410124|Everolimus|everolimus|mesh-list
110696640|NCT00410124|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110696641|NCT00410124|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110696642|NCT00410124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110696643|NCT00410124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110858912|NCT03108274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110099436|NCT01748279|Autonomic Agents|autonomic agents|mesh-ancestor
110696644|NCT00410124|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110696645|NCT00410124|Immunologic Factors|immunologic factors|mesh-ancestor
110696646|NCT00410124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110696647|NCT00410124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110696648|NCT01036932|Lenograstim|lenograstim|mesh-list
110696649|NCT01036932|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110696650|NCT01036932|Immunologic Factors|immunologic factors|mesh-ancestor
110696651|NCT01036932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110696652|NCT00410046|Etanercept|etanercept|mesh-list
110696653|NCT00410046|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110696654|NCT00410046|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110696655|NCT00410046|Analgesics|analgesics|mesh-ancestor
110696656|NCT00410046|Sensory System Agents|sensory system agents|mesh-ancestor
110696657|NCT00410046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110696658|NCT00410046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110696659|NCT00410046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110696660|NCT00410046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110696661|NCT00410046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110696662|NCT00410046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110099490|NCT01748435|Capsaicin|capsaicin|mesh-list
110696663|NCT00410046|Immunologic Factors|immunologic factors|mesh-ancestor
110696664|NCT00416624|Epoetin Alfa|epoetin alfa|mesh-list
110696665|NCT00416624|Darbepoetin alfa|darbepoetin alfa|mesh-list
110696666|NCT00416624|Hematinics|hematinics|mesh-ancestor
110696667|NCT02501954|Paclitaxel|paclitaxel|mesh-list
110696668|NCT02501954|Carboplatin|carboplatin|mesh-list
110696669|NCT02501954|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110696670|NCT02501954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110696671|NCT02501954|Tubulin Modulators|tubulin modulators|mesh-ancestor
110696672|NCT02501954|Antimitotic Agents|antimitotic agents|mesh-ancestor
110696673|NCT02501954|Mitosis Modulators|mitosis modulators|mesh-ancestor
110696674|NCT02501954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110696675|NCT00262600|Warfarin|warfarin|mesh-list
110696676|NCT00262600|Dabigatran|dabigatran|mesh-list
110696677|NCT00262600|Anticoagulants|anticoagulants|mesh-ancestor
110696678|NCT00262600|Antithrombins|antithrombins|mesh-ancestor
110696679|NCT00262600|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110696680|NCT00262600|Protease Inhibitors|protease inhibitors|mesh-ancestor
110696681|NCT00262600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110696682|NCT00262600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110696683|NCT00409578|Valsartan|valsartan|mesh-list
110696684|NCT00409578|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110696685|NCT00409578|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110696686|NCT00409578|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110696687|NCT00409578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110696688|NCT01037322|Cannabidiol|cannabidiol|mesh-list
110696689|NCT01037322|Anticonvulsants|anticonvulsants|mesh-ancestor
110696690|NCT01070758|Lanreotide|lanreotide|mesh-list
110696691|NCT01070758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110696692|NCT00428090|Rosiglitazone|rosiglitazone|mesh-list
110696693|NCT00428090|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110696694|NCT00428090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110696695|NCT01031966|Thymalfasin|thymalfasin|mesh-list
110696696|NCT01031966|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110696697|NCT01031966|Immunologic Factors|immunologic factors|mesh-ancestor
110696698|NCT01031966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110696699|NCT00436436|Temozolomide|temozolomide|mesh-list
110696700|NCT00436436|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
110696701|NCT00436436|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110696702|NCT00436436|Alkylating Agents|alkylating agents|mesh-ancestor
110696703|NCT00436436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110696704|NCT00436436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110696705|NCT00436436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110696706|NCT00262522|Ritonavir|ritonavir|mesh-list
110696707|NCT00262522|Lopinavir|lopinavir|mesh-list
110696708|NCT00262522|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
110696709|NCT00262522|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110696710|NCT00262522|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110696711|NCT00262522|Protease Inhibitors|protease inhibitors|mesh-ancestor
110696712|NCT00262522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110696713|NCT00262522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110696714|NCT00262522|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110696715|NCT00262522|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110696716|NCT00262522|Antiviral Agents|antiviral agents|mesh-ancestor
110696717|NCT00262522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110696718|NCT00262522|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110696719|NCT00262522|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110696720|NCT00262522|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110696721|NCT00436280|Rituximab|rituximab|mesh-list
110696722|NCT00436280|Gemcitabine|gemcitabine|mesh-list
110696723|NCT00436280|Oxaliplatin|oxaliplatin|mesh-list
110696724|NCT00436280|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110696725|NCT00436280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110696726|NCT00436280|Immunologic Factors|immunologic factors|mesh-ancestor
110696727|NCT00436280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110696728|NCT00436280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110696729|NCT00436280|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110696730|NCT00436280|Antimetabolites|antimetabolites|mesh-ancestor
110696731|NCT00436280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110696732|NCT00394836|Ofatumumab|ofatumumab|mesh-list
110696733|NCT00394836|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110696734|NCT00394836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110696735|NCT00394836|Immunologic Factors|immunologic factors|mesh-ancestor
110696736|NCT00394836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110696737|NCT01040598|Omalizumab|omalizumab|mesh-list
110696738|NCT01040598|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110696739|NCT01040598|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110696740|NCT01040598|Respiratory System Agents|respiratory system agents|mesh-ancestor
110696741|NCT01039974|Ketoconazole|ketoconazole|mesh-list
110696742|NCT01039974|Antifungal Agents|antifungal agents|mesh-ancestor
110696743|NCT01039974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110696744|NCT01039974|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110696745|NCT01039974|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110696746|NCT01039974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110696747|NCT01039974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110696748|NCT01039974|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110099930|NCT01750762|Lenalidomide|lenalidomide|mesh-list
110696749|NCT01039974|Hormone Antagonists|hormone antagonists|mesh-ancestor
110696750|NCT01039974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110696751|NCT01039974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110696752|NCT01039974|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110696753|NCT01032122|Rituximab|rituximab|mesh-list
110696754|NCT01032122|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110696755|NCT01032122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110696756|NCT01032122|Immunologic Factors|immunologic factors|mesh-ancestor
110408663|NCT04511039|Talazoparib|talazoparib|mesh-list
110696757|NCT01032122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110696758|NCT01032122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110696759|NCT03819660|Amifampridine|amifampridine|mesh-list
110696760|NCT03819660|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110696761|NCT03819660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110696762|NCT03819660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110099999|NCT01751269|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-list
110696763|NCT03819660|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
110696764|NCT03819660|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110696765|NCT03819660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110696766|NCT00394524|Insulin|insulin|mesh-list
110696767|NCT00394524|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110696768|NCT00394524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110696769|NCT00409344|Dexmedetomidine|dexmedetomidine|mesh-list
110696770|NCT00409344|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110696771|NCT00409344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110100057|NCT01751828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110696772|NCT00409344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110696773|NCT00409344|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110696774|NCT00409344|Analgesics|analgesics|mesh-ancestor
110696775|NCT00409344|Sensory System Agents|sensory system agents|mesh-ancestor
110696776|NCT00409344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110696777|NCT00409344|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110696778|NCT00409344|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110696779|NCT00409344|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110696780|NCT00409344|Adrenergic Agents|adrenergic agents|mesh-ancestor
110696781|NCT00409344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110696782|NCT00409344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110696783|NCT00415610|Nicardipine|nicardipine|mesh-list
110696784|NCT00415610|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110696785|NCT00415610|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110696786|NCT00415610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110696787|NCT00415610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110696788|NCT00415610|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110696789|NCT00415610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110696790|NCT00415610|Vasodilator Agents|vasodilator agents|mesh-ancestor
110696791|NCT01722812|Cromolyn Sodium|cromolyn sodium|mesh-list
110696792|NCT01722812|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
110696793|NCT01722812|Immunologic Factors|immunologic factors|mesh-ancestor
110696794|NCT01722812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110696795|NCT01722812|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110696796|NCT01722812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110696797|NCT01722812|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110696798|NCT01722812|Respiratory System Agents|respiratory system agents|mesh-ancestor
110696799|NCT00250432|Caspofungin|caspofungin|mesh-list
110696800|NCT00250432|Antifungal Agents|antifungal agents|mesh-ancestor
110696801|NCT00250432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110100249|NCT01753752|Antiviral Agents|antiviral agents|mesh-ancestor
110696802|NCT00250432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110696803|NCT00250432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110696804|NCT00249808|Antibodies|antibodies|mesh-list
110696805|NCT00249808|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110696806|NCT00249808|Immunologic Factors|immunologic factors|mesh-ancestor
110696807|NCT00249808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110696808|NCT00278512|Cyclophosphamide|cyclophosphamide|mesh-list
110696809|NCT00278512|Fludarabine|fludarabine|mesh-list
110696810|NCT00278512|Alemtuzumab|alemtuzumab|mesh-list
110696811|NCT00278512|Tacrolimus|tacrolimus|mesh-list
110696812|NCT00278512|Thymoglobulin|thymoglobulin|mesh-list
110696813|NCT00278512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110696814|NCT00278512|Immunologic Factors|immunologic factors|mesh-ancestor
110696815|NCT00278512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110696816|NCT00278512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110696817|NCT00278512|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110696818|NCT00278512|Alkylating Agents|alkylating agents|mesh-ancestor
110696819|NCT00278512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110696820|NCT00278512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110696821|NCT00278512|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110696822|NCT00278512|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110696823|NCT00278512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110696824|NCT00278512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110696825|NCT01072240|Rituximab|rituximab|mesh-list
110696826|NCT01072240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110696827|NCT01072240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110696828|NCT01072240|Immunologic Factors|immunologic factors|mesh-ancestor
110696829|NCT01072240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110696830|NCT01072240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110696831|NCT00427934|Maraviroc|maraviroc|mesh-list
110696832|NCT00427934|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110696833|NCT00427934|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110100445|NCT01755338|Methylprednisolone|methylprednisolone|mesh-list
110696834|NCT00427934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110696835|NCT00427934|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110696836|NCT00427934|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110696837|NCT00427934|Antiviral Agents|antiviral agents|mesh-ancestor
110696838|NCT00427934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110696839|NCT00427934|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
110696840|NCT00427700|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
110696841|NCT00427700|Clomiphene|clomiphene|mesh-list
110696842|NCT00427700|Enclomiphene|enclomiphene|mesh-list
110696843|NCT00427700|Zuclomiphene|zuclomiphene|mesh-list
110696844|NCT00427700|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110696845|NCT00427700|Hormone Antagonists|hormone antagonists|mesh-ancestor
110696846|NCT00427700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110696847|NCT00427700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110696848|NCT00427700|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110696849|NCT00427700|Fertility Agents|fertility agents|mesh-ancestor
110696850|NCT00427700|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110696851|NCT00427700|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110696852|NCT00427700|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110696853|NCT00427700|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110696854|NCT01324076|Doxorubicin|doxorubicin|mesh-list
110696855|NCT01324076|Sorafenib|sorafenib|mesh-list
110696856|NCT01324076|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110696857|NCT01324076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110696858|NCT01324076|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110696859|NCT01324076|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110696860|NCT01324076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110696861|NCT01324076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110696862|NCT01324076|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110696863|NCT00409188|Cyclophosphamide|cyclophosphamide|mesh-list
110696864|NCT00409188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110696865|NCT00409188|Immunologic Factors|immunologic factors|mesh-ancestor
110696866|NCT00409188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110696867|NCT00409188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110696868|NCT00409188|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110696869|NCT00409188|Alkylating Agents|alkylating agents|mesh-ancestor
110696870|NCT00409188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110696871|NCT00409188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110696872|NCT00409188|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110696873|NCT00434954|Insulin Aspart|insulin aspart|mesh-list
110696874|NCT00434954|Exenatide|exenatide|mesh-list
110696875|NCT00434954|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110696876|NCT00434954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110696877|NCT00434954|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110696878|NCT00434954|Incretins|incretins|mesh-ancestor
110696879|NCT00434954|Hormones|hormones|mesh-ancestor
110696880|NCT00434954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110696881|NCT00276484|Atorvastatin|atorvastatin|mesh-list
110696882|NCT00276484|Ezetimibe|ezetimibe|mesh-list
110696883|NCT00276484|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110696884|NCT00276484|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110696885|NCT00276484|Antimetabolites|antimetabolites|mesh-ancestor
110696886|NCT00276484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110696887|NCT00276484|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110696888|NCT00276484|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110696889|NCT00276484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110696890|NCT00426842|Midodrine|midodrine|mesh-list
110696891|NCT00426842|Sympathomimetics|sympathomimetics|mesh-ancestor
110696892|NCT00426842|Autonomic Agents|autonomic agents|mesh-ancestor
110696893|NCT00426842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110696894|NCT00426842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110696895|NCT00426842|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110696896|NCT00426842|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110696897|NCT00426842|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110696898|NCT00426842|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110696899|NCT00426842|Adrenergic Agents|adrenergic agents|mesh-ancestor
110696900|NCT00426842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110100750|NCT01756651|Fentanyl|fentanyl|mesh-list
110696901|NCT00426842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110696902|NCT00434876|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110696903|NCT00434876|Antidepressive Agents|antidepressive agents|mesh-ancestor
110696904|NCT00434876|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110696905|NCT00434876|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110696906|NCT00434876|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110100822|NCT01757015|Glycopyrrolate|glycopyrrolate|mesh-list
110696907|NCT00434876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110696908|NCT00434876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110696909|NCT01072318|Letrozole|letrozole|mesh-list
110696910|NCT01072318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110696911|NCT01072318|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110696912|NCT01072318|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110696913|NCT01072318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110696914|NCT01072318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110696915|NCT01072318|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110696916|NCT01072318|Hormone Antagonists|hormone antagonists|mesh-ancestor
110696917|NCT01072318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110696918|NCT01072318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110696919|NCT00276094|Tamoxifen|tamoxifen|mesh-list
110696920|NCT00276094|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110696921|NCT00276094|Hormone Antagonists|hormone antagonists|mesh-ancestor
110858935|NCT00696800|Progestins|progestins|mesh-ancestor
110696922|NCT00276094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110696923|NCT00276094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110696924|NCT00276094|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110696925|NCT00276094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110696926|NCT00276094|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110696927|NCT00276094|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110696928|NCT00276094|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110696929|NCT03975088|Ranibizumab|ranibizumab|mesh-list
110696930|NCT03975088|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110696931|NCT03975088|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110696932|NCT03975088|Growth Substances|growth substances|mesh-ancestor
110696933|NCT03975088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110696934|NCT03975088|Growth Inhibitors|growth inhibitors|mesh-ancestor
110696935|NCT03975088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110696936|NCT00276016|Phenylephrine|phenylephrine|mesh-list
110696937|NCT00276016|Oxymetazoline|oxymetazoline|mesh-list
110696938|NCT00276016|Pseudoephedrine|pseudoephedrine|mesh-list
110696939|NCT00276016|Ephedrine|ephedrine|mesh-list
110696940|NCT00276016|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110696941|NCT00276016|Mydriatics|mydriatics|mesh-ancestor
110696942|NCT00276016|Autonomic Agents|autonomic agents|mesh-ancestor
110696943|NCT00276016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110696944|NCT00276016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110696945|NCT00276016|Sympathomimetics|sympathomimetics|mesh-ancestor
110696946|NCT00276016|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110696947|NCT00276016|Nasal Decongestants|nasal decongestants|mesh-ancestor
110696948|NCT00276016|Respiratory System Agents|respiratory system agents|mesh-ancestor
110696949|NCT00276016|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110696950|NCT00276016|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110696951|NCT00276016|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110696952|NCT00276016|Adrenergic Agents|adrenergic agents|mesh-ancestor
110696953|NCT00276016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110696954|NCT00276016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110696955|NCT00276016|Protective Agents|protective agents|mesh-ancestor
110696956|NCT00276016|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110101075|NCT01758263|Adrenergic Agents|adrenergic agents|mesh-ancestor
110696957|NCT00276016|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110696958|NCT00276016|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110696959|NCT00434642|Bevacizumab|bevacizumab|mesh-list
110696960|NCT00434642|Carboplatin|carboplatin|mesh-list
110696961|NCT00434642|Gemcitabine|gemcitabine|mesh-list
110696962|NCT00434642|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110696963|NCT00434642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110696964|NCT00434642|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110696965|NCT00434642|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110696966|NCT00434642|Growth Substances|growth substances|mesh-ancestor
110696967|NCT00434642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110696968|NCT00434642|Growth Inhibitors|growth inhibitors|mesh-ancestor
110696969|NCT00434642|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110696970|NCT00434642|Antimetabolites|antimetabolites|mesh-ancestor
110696971|NCT00434642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110696972|NCT01032434|Sertraline|sertraline|mesh-list
110696973|NCT01032434|Antidepressive Agents|antidepressive agents|mesh-ancestor
110696974|NCT01032434|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110696975|NCT01032434|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110696976|NCT01032434|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110696977|NCT01032434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110696978|NCT01032434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110696979|NCT01032434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110696980|NCT01032434|Serotonin Agents|serotonin agents|mesh-ancestor
110696981|NCT01032434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110696982|NCT00426764|Romidepsin|romidepsin|mesh-list
110696983|NCT00426764|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110696984|NCT00426764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110696985|NCT00426764|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110696986|NCT00426764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110696987|NCT00426764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110696988|NCT01032668|Clopidogrel|clopidogrel|mesh-list
110101263|NCT01759706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110696989|NCT01032668|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110696990|NCT01032668|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110696991|NCT01032668|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110696992|NCT01032668|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110696993|NCT01032668|Purinergic Agents|purinergic agents|mesh-ancestor
110696994|NCT01032668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110696995|NCT01032668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110696996|NCT01032668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110696997|NCT00434252|Paclitaxel|paclitaxel|mesh-list
110696998|NCT00434252|Bevacizumab|bevacizumab|mesh-list
110696999|NCT00434252|Carboplatin|carboplatin|mesh-list
110697000|NCT00434252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110697001|NCT00434252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110697002|NCT00434252|Tubulin Modulators|tubulin modulators|mesh-ancestor
110697003|NCT00434252|Antimitotic Agents|antimitotic agents|mesh-ancestor
110697004|NCT00434252|Mitosis Modulators|mitosis modulators|mesh-ancestor
110697005|NCT00434252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110697006|NCT00434252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110697007|NCT00434252|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110697008|NCT00434252|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110697009|NCT00434252|Growth Substances|growth substances|mesh-ancestor
110697010|NCT00434252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110697011|NCT00434252|Growth Inhibitors|growth inhibitors|mesh-ancestor
110697012|NCT00425750|Docetaxel|docetaxel|mesh-list
110697013|NCT00425750|Bortezomib|bortezomib|mesh-list
110697014|NCT00425750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110697015|NCT00425750|Tubulin Modulators|tubulin modulators|mesh-ancestor
110697016|NCT00425750|Antimitotic Agents|antimitotic agents|mesh-ancestor
110697017|NCT00425750|Mitosis Modulators|mitosis modulators|mesh-ancestor
110697018|NCT00425750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110697019|NCT00414908|Pancrelipase|pancrelipase|mesh-list
110697020|NCT00414908|Pancreatin|pancreatin|mesh-list
110697021|NCT00414908|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110697023|NCT00242710|Estrogens|estrogens|mesh-list
110697024|NCT00242710|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
110697025|NCT00242710|Hormones|hormones|mesh-ancestor
110697026|NCT00242710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110697027|NCT00242710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110697028|NCT00242710|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110697029|NCT00242710|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110697030|NCT00242710|Hormone Antagonists|hormone antagonists|mesh-ancestor
110697031|NCT00242710|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110697032|NCT00408876|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110697033|NCT00408876|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110697034|NCT00408876|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110697035|NCT00408876|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110697036|NCT00408876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110697037|NCT00408876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110697038|NCT00408876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110697039|NCT00408876|Analgesics|analgesics|mesh-ancestor
110697040|NCT00408876|Sensory System Agents|sensory system agents|mesh-ancestor
110697041|NCT00408876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110697042|NCT00408876|Antidepressive Agents|antidepressive agents|mesh-ancestor
110697043|NCT00408876|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110697044|NCT00408876|Dopamine Agents|dopamine agents|mesh-ancestor
110697045|NCT00240994|Mycophenolic Acid|mycophenolic acid|mesh-list
110697046|NCT00240994|Sirolimus|sirolimus|mesh-list
110697047|NCT00240994|Alemtuzumab|alemtuzumab|mesh-list
110697048|NCT00240994|Tacrolimus|tacrolimus|mesh-list
110697049|NCT00240994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110697050|NCT00240994|Immunologic Factors|immunologic factors|mesh-ancestor
110697051|NCT00240994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110697052|NCT00240994|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110697053|NCT00240994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110697054|NCT00240994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110697055|NCT00240994|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110697056|NCT00240994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110697057|NCT00240994|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110697058|NCT00240994|Antitubercular Agents|antitubercular agents|mesh-ancestor
110101661|NCT01761201|Ofloxacin|ofloxacin|mesh-list
110697059|NCT00240994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110858949|NCT00598208|Hormones|hormones|mesh-ancestor
110697060|NCT00240994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110697061|NCT00240994|Antifungal Agents|antifungal agents|mesh-ancestor
110697062|NCT00240994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110697064|NCT01070836|Immunologic Factors|immunologic factors|mesh-ancestor
110697065|NCT01070836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110697066|NCT00239590|Methyltestosterone|methyltestosterone|mesh-list
110697068|NCT00239590|Testosterone undecanoate|testosterone undecanoate|mesh-list
110697069|NCT00239590|Testosterone enanthate|testosterone enanthate|mesh-list
110697070|NCT00239590|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
110697071|NCT00239590|Androgens|androgens|mesh-ancestor
110697072|NCT00239590|Hormones|hormones|mesh-ancestor
110697073|NCT00239590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110697074|NCT00239590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110697075|NCT00239590|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110697076|NCT00239590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110697077|NCT00239590|Anabolic Agents|anabolic agents|mesh-ancestor
110697078|NCT00433160|Teriparatide|teriparatide|mesh-list
110697079|NCT00433160|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110697080|NCT00433160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110697081|NCT00433160|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110697082|NCT00239356|Aripiprazole|aripiprazole|mesh-list
110697083|NCT00239356|Antidepressive Agents|antidepressive agents|mesh-ancestor
110697084|NCT00239356|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110101796|NCT01762046|Metformin|metformin|mesh-list
110697085|NCT00239356|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110697086|NCT00239356|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110697087|NCT00239356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110697088|NCT00239356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110697089|NCT00239356|Dopamine Agonists|dopamine agonists|mesh-ancestor
110697090|NCT00239356|Dopamine Agents|dopamine agents|mesh-ancestor
110697091|NCT00239356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110697092|NCT00239356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110697093|NCT00239356|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110697094|NCT00239356|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110697096|NCT00239356|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110697097|NCT00239356|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110697098|NCT00239356|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110697099|NCT00239356|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110697100|NCT00425438|Mycophenolic Acid|mycophenolic acid|mesh-list
110697101|NCT00425438|Prednisolone|prednisolone|mesh-list
110697102|NCT00425438|Cyclophosphamide|cyclophosphamide|mesh-list
110697103|NCT00425438|Azathioprine|azathioprine|mesh-list
110697104|NCT00425438|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110697105|NCT00425438|Immunologic Factors|immunologic factors|mesh-ancestor
110697106|NCT00425438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110697107|NCT00425438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110697108|NCT00425438|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110697109|NCT00425438|Alkylating Agents|alkylating agents|mesh-ancestor
110697110|NCT00425438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110697111|NCT00425438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110697112|NCT00425438|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110697113|NCT00425438|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110697114|NCT00425438|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110697115|NCT00425438|Antitubercular Agents|antitubercular agents|mesh-ancestor
110697116|NCT00425438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110697117|NCT00425438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110697118|NCT00425438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110101851|NCT01762306|Vitamins|vitamins|mesh-ancestor
110697119|NCT00425438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110697120|NCT00425438|Glucocorticoids|glucocorticoids|mesh-ancestor
110697121|NCT00425438|Hormones|hormones|mesh-ancestor
110697122|NCT00425438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110697123|NCT00425438|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110697124|NCT00425438|Antimetabolites|antimetabolites|mesh-ancestor
110697125|NCT00425438|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110697126|NCT01041066|Labetalol|labetalol|mesh-list
110697127|NCT01041066|Nicardipine|nicardipine|mesh-list
110697128|NCT01041066|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110858952|NCT00480662|Alendronate|alendronate|mesh-list
110697129|NCT01041066|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110697130|NCT01041066|Adrenergic Agents|adrenergic agents|mesh-ancestor
110697131|NCT01041066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110697132|NCT01041066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110697133|NCT01041066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110697134|NCT01041066|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110697135|NCT01041066|Sympathomimetics|sympathomimetics|mesh-ancestor
110697136|NCT01041066|Autonomic Agents|autonomic agents|mesh-ancestor
110697137|NCT01041066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110697138|NCT01041066|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110697139|NCT01041066|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110697140|NCT01041066|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110697141|NCT01041066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110697142|NCT01041066|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110697143|NCT01041066|Vasodilator Agents|vasodilator agents|mesh-ancestor
110697144|NCT01323608|Vitamin D|vitamin d|mesh-list
110697145|NCT01323608|Cholecalciferol|cholecalciferol|mesh-list
110697146|NCT01323608|Vitamins|vitamins|mesh-ancestor
110697147|NCT01323608|Micronutrients|micronutrients|mesh-ancestor
110697148|NCT01323608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110697149|NCT01323608|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110697150|NCT01323608|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110697151|NCT00275002|Temozolomide|temozolomide|mesh-list
110697152|NCT00275002|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
110101884|NCT01762436|Sympatholytics|sympatholytics|mesh-ancestor
110697153|NCT00275002|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110697154|NCT00275002|Alkylating Agents|alkylating agents|mesh-ancestor
110697155|NCT00275002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110697156|NCT00275002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110697157|NCT00275002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110697158|NCT00433004|Levonorgestrel|levonorgestrel|mesh-list
110697159|NCT00433004|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110697160|NCT00433004|Contraceptive Agents|contraceptive agents|mesh-ancestor
110697161|NCT00433004|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110697162|NCT00433004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110697163|NCT00433004|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110697164|NCT00433004|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110697165|NCT00433004|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110697166|NCT00393042|Amphetamine|amphetamine|mesh-list
110697167|NCT00393042|Adderall|adderall|mesh-list
110697168|NCT00393042|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
110697169|NCT00393042|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110697170|NCT00393042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110697172|NCT00393042|Autonomic Agents|autonomic agents|mesh-ancestor
110697173|NCT00393042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110697174|NCT00393042|Dopamine Agents|dopamine agents|mesh-ancestor
110697175|NCT00393042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110697176|NCT00393042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110697177|NCT00393042|Adrenergic Agents|adrenergic agents|mesh-ancestor
110697178|NCT00393042|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110697179|NCT00393042|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110697180|NCT00393042|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110697181|NCT00393042|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110697182|NCT01040286|Chlorhexidine|chlorhexidine|mesh-list
110697183|NCT01040286|Flurbiprofen|flurbiprofen|mesh-list
110697184|NCT01040286|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110697185|NCT01040286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110697186|NCT01040286|Disinfectants|disinfectants|mesh-ancestor
110697187|NCT01040286|Analgesics|analgesics|mesh-ancestor
110697188|NCT01040286|Sensory System Agents|sensory system agents|mesh-ancestor
110697189|NCT01040286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110697190|NCT01040286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110697191|NCT01040286|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110697192|NCT01040286|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110697193|NCT01040286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110697195|NCT01040286|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110697196|NCT01040286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110697197|NCT01040286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110697198|NCT01041378|Dexamethasone|dexamethasone|mesh-list
110697199|NCT01041378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110697200|NCT01041378|Antiemetics|antiemetics|mesh-ancestor
110697201|NCT01041378|Autonomic Agents|autonomic agents|mesh-ancestor
110697202|NCT01041378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110697203|NCT01041378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110697204|NCT01041378|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110697205|NCT01041378|Glucocorticoids|glucocorticoids|mesh-ancestor
110697206|NCT01041378|Hormones|hormones|mesh-ancestor
110697207|NCT01041378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110697208|NCT01041378|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110697209|NCT01041378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110697210|NCT03546192|Vaccines|vaccines|mesh-list
110697211|NCT03546192|Immunologic Factors|immunologic factors|mesh-ancestor
110697212|NCT03546192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110697213|NCT01043952|Remifentanil|remifentanil|mesh-list
110697214|NCT01043952|Propofol|propofol|mesh-list
110697215|NCT01043952|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110697216|NCT01043952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110697217|NCT01043952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110697218|NCT01043952|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110697219|NCT01043952|Anesthetics, General|anesthetics, general|mesh-ancestor
110697220|NCT01043952|Anesthetics|anesthetics|mesh-ancestor
110697221|NCT01043952|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110697222|NCT01043952|Narcotics|narcotics|mesh-ancestor
110697223|NCT01043952|Analgesics|analgesics|mesh-ancestor
110697224|NCT01043952|Sensory System Agents|sensory system agents|mesh-ancestor
110697225|NCT01043952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110697226|NCT00274846|Aldesleukin|aldesleukin|mesh-list
110697227|NCT00274846|Cyclophosphamide|cyclophosphamide|mesh-list
110697228|NCT00274846|Fludarabine|fludarabine|mesh-list
110697229|NCT00274846|Fludarabine phosphate|fludarabine phosphate|mesh-list
110697230|NCT00274846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110697231|NCT00274846|Immunologic Factors|immunologic factors|mesh-ancestor
110697232|NCT00274846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110697233|NCT00274846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110697234|NCT00274846|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110697235|NCT00274846|Alkylating Agents|alkylating agents|mesh-ancestor
110697236|NCT00274846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110697237|NCT00274846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110697238|NCT00274846|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110697239|NCT00274846|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110697240|NCT00274846|Antimetabolites|antimetabolites|mesh-ancestor
110697241|NCT00274846|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110697242|NCT00274846|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110697243|NCT00274846|Antiviral Agents|antiviral agents|mesh-ancestor
110697244|NCT00274846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110697245|NCT01072786|Vaccines|vaccines|mesh-list
110697246|NCT01072786|Immunologic Factors|immunologic factors|mesh-ancestor
110697247|NCT01072786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110697248|NCT03970798|Midazolam|midazolam|mesh-list
110697249|NCT03970798|Caffeine|caffeine|mesh-list
110697250|NCT03970798|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110697251|NCT03970798|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110697252|NCT03970798|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110697253|NCT03970798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110697254|NCT03970798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110697255|NCT03970798|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110697256|NCT03970798|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110697257|NCT03970798|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110697258|NCT03970798|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110697259|NCT03970798|Anesthetics, General|anesthetics, general|mesh-ancestor
110697260|NCT03970798|Anesthetics|anesthetics|mesh-ancestor
110697261|NCT03970798|GABA Modulators|gaba modulators|mesh-ancestor
110697262|NCT03970798|GABA Agents|gaba agents|mesh-ancestor
110697263|NCT03970798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110697264|NCT03970798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110697265|NCT03970798|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110697266|NCT03970798|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110697267|NCT03970798|Antimetabolites|antimetabolites|mesh-ancestor
110697268|NCT03970798|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110697269|NCT03970798|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110697271|NCT03970798|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110697272|NCT03970798|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110697273|NCT03970798|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110697274|NCT03970798|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110697275|NCT03970798|Purinergic Agents|purinergic agents|mesh-ancestor
110697276|NCT00414440|Everolimus|everolimus|mesh-list
110697277|NCT00414440|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110697278|NCT00414440|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110697279|NCT00414440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110697280|NCT00414440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110697281|NCT00414440|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110697282|NCT00414440|Immunologic Factors|immunologic factors|mesh-ancestor
110697283|NCT00414440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110697284|NCT00414440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110697285|NCT00209560|Fospropofol|fospropofol|mesh-list
110697286|NCT00209560|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110697287|NCT00209560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110697288|NCT00209560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110697289|NCT01073800|Atorvastatin|atorvastatin|mesh-list
110697290|NCT01073800|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110697291|NCT01073800|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110697292|NCT01073800|Antimetabolites|antimetabolites|mesh-ancestor
110697293|NCT01073800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110697294|NCT01073800|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110697295|NCT01073800|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110697296|NCT01073800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110697297|NCT01037660|Metformin|metformin|mesh-list
110697298|NCT01037660|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110697299|NCT01037660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110697300|NCT00236080|Modafinil|modafinil|mesh-list
110697301|NCT00236080|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110697302|NCT00236080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110697303|NCT00236080|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
110697304|NCT00236080|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110697305|NCT00236080|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110697306|NCT00236080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110697307|NCT01033058|Atorvastatin|atorvastatin|mesh-list
110697308|NCT01033058|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110697309|NCT01033058|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110697310|NCT01033058|Antimetabolites|antimetabolites|mesh-ancestor
110697311|NCT01033058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110697312|NCT01033058|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110697313|NCT01033058|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110697314|NCT01033058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110697315|NCT03973138|Ranibizumab|ranibizumab|mesh-list
110697316|NCT03973138|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110415162|NCT01359592|Alkylating Agents|alkylating agents|mesh-ancestor
110697317|NCT03973138|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110697318|NCT03973138|Growth Substances|growth substances|mesh-ancestor
110697319|NCT03973138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110697320|NCT03973138|Growth Inhibitors|growth inhibitors|mesh-ancestor
110697321|NCT03973138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110697322|NCT01072942|Ciprofloxacin|ciprofloxacin|mesh-list
110697323|NCT01072942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110697324|NCT01072942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110697325|NCT01072942|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110697326|NCT01072942|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110697327|NCT01072942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110697328|NCT01072942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110697329|NCT01072942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110697330|NCT01072942|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110697331|NCT01072942|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110697332|NCT00234052|Bevacizumab|bevacizumab|mesh-list
110697333|NCT00234052|Carboplatin|carboplatin|mesh-list
110697334|NCT00234052|Pemetrexed|pemetrexed|mesh-list
110697335|NCT00234052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110697336|NCT00234052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110697337|NCT00234052|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110697338|NCT00234052|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110697339|NCT00234052|Growth Substances|growth substances|mesh-ancestor
110697340|NCT00234052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110697341|NCT00234052|Growth Inhibitors|growth inhibitors|mesh-ancestor
110697342|NCT00234052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110697343|NCT00234052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110697344|NCT00234052|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110697345|NCT00234052|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110697346|NCT00408408|Cyclophosphamide|cyclophosphamide|mesh-list
110697348|NCT00408408|Gemcitabine|gemcitabine|mesh-list
110697349|NCT00408408|Docetaxel|docetaxel|mesh-list
110697350|NCT00408408|Doxorubicin|doxorubicin|mesh-list
110697351|NCT00408408|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110697352|NCT00408408|Capecitabine|capecitabine|mesh-list
110697353|NCT00408408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110697354|NCT00408408|Immunologic Factors|immunologic factors|mesh-ancestor
110697355|NCT00408408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110697356|NCT00408408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110697357|NCT00408408|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110697358|NCT00408408|Alkylating Agents|alkylating agents|mesh-ancestor
110697359|NCT00408408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110697360|NCT00408408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110697361|NCT00408408|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110697362|NCT00408408|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110697363|NCT00408408|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110697364|NCT00408408|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110697365|NCT00408408|Growth Substances|growth substances|mesh-ancestor
110697366|NCT00408408|Growth Inhibitors|growth inhibitors|mesh-ancestor
110697367|NCT00408408|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110697368|NCT00408408|Antimetabolites|antimetabolites|mesh-ancestor
110697369|NCT00408408|Tubulin Modulators|tubulin modulators|mesh-ancestor
110697370|NCT00408408|Antimitotic Agents|antimitotic agents|mesh-ancestor
110697371|NCT00408408|Mitosis Modulators|mitosis modulators|mesh-ancestor
110697372|NCT00408408|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110697373|NCT00408408|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110697374|NCT00408408|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110697375|NCT00408408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110697376|NCT00414050|Vaccines|vaccines|mesh-list
110697377|NCT00414050|Immunologic Factors|immunologic factors|mesh-ancestor
110697378|NCT00414050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110697379|NCT03973840|Methyltestosterone|methyltestosterone|mesh-list
110697380|NCT03973840|Testosterone|testosterone|mesh-list
110697381|NCT03973840|Testosterone undecanoate|testosterone undecanoate|mesh-list
110697382|NCT03973840|Testosterone enanthate|testosterone enanthate|mesh-list
110697383|NCT03973840|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
110697384|NCT03973840|Androgens|androgens|mesh-ancestor
110697385|NCT03973840|Hormones|hormones|mesh-ancestor
110697386|NCT03973840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110697387|NCT03973840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110697388|NCT03973840|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110697389|NCT03973840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110697390|NCT03973840|Anabolic Agents|anabolic agents|mesh-ancestor
110697391|NCT00413972|Simvastatin|simvastatin|mesh-list
110697392|NCT00413972|Ezetimibe|ezetimibe|mesh-list
110697393|NCT00413972|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110697394|NCT00413972|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110697395|NCT00413972|Antimetabolites|antimetabolites|mesh-ancestor
110697396|NCT00413972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110697397|NCT00413972|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110697398|NCT00413972|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110697399|NCT00413972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110697400|NCT00259012|Pantoprazole|pantoprazole|mesh-list
110697401|NCT00259012|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110697402|NCT00259012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110697403|NCT00259012|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110697404|NCT00259012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110697405|NCT00259012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110697407|NCT01044186|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110697408|NCT01044186|Chelating Agents|chelating agents|mesh-ancestor
110697409|NCT01044186|Sequestering Agents|sequestering agents|mesh-ancestor
110697410|NCT01044186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110697411|NCT00209170|Escitalopram|escitalopram|mesh-list
110697412|NCT00209170|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110697413|NCT00209170|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110697414|NCT00209170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110697415|NCT00209170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110697416|NCT00209170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110697417|NCT00209170|Serotonin Agents|serotonin agents|mesh-ancestor
110697418|NCT00209170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110697419|NCT01071694|Interferons|interferons|mesh-list
110697420|NCT01071694|Interferon-beta|interferon-beta|mesh-list
110697421|NCT01071694|Interferon beta-1b|interferon beta-1b|mesh-list
110697422|NCT01071694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110697423|NCT01071694|Antiviral Agents|antiviral agents|mesh-ancestor
110697424|NCT01071694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110697425|NCT01071694|Immunologic Factors|immunologic factors|mesh-ancestor
110697426|NCT01071694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110697427|NCT01071694|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110697428|NCT00413894|Epoetin Alfa|epoetin alfa|mesh-list
110697429|NCT00413894|Hematinics|hematinics|mesh-ancestor
110697430|NCT03972748|Itraconazole|itraconazole|mesh-list
110697431|NCT03972748|Antifungal Agents|antifungal agents|mesh-ancestor
110697432|NCT03972748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110697433|NCT03972748|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110697434|NCT03972748|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110697435|NCT03972748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110697436|NCT03972748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110697437|NCT03972748|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110697438|NCT03972748|Hormone Antagonists|hormone antagonists|mesh-ancestor
110697439|NCT03972748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110697440|NCT03972748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110697441|NCT03972748|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110697442|NCT01581814|Metformin|metformin|mesh-list
110697443|NCT01581814|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
110697444|NCT01581814|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110697445|NCT01581814|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110697446|NCT01581814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110697447|NCT01581814|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110697448|NCT01581814|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110697449|NCT01581814|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110697450|NCT01581814|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110697451|NCT01581814|Contraceptive Agents|contraceptive agents|mesh-ancestor
110697452|NCT01581814|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110697453|NCT01581814|Estrogens|estrogens|mesh-ancestor
110697454|NCT01581814|Hormones|hormones|mesh-ancestor
110697455|NCT01581814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110697456|NCT00407550|Gemcitabine|gemcitabine|mesh-list
110697457|NCT00407550|Pemetrexed|pemetrexed|mesh-list
110697458|NCT00407550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110697459|NCT00407550|Antimetabolites|antimetabolites|mesh-ancestor
110697460|NCT00407550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110697461|NCT00407550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110697462|NCT00407550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110697463|NCT00407550|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110697464|NCT00407550|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110697465|NCT00209092|Docetaxel|docetaxel|mesh-list
110697467|NCT00209092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110697468|NCT00209092|Tubulin Modulators|tubulin modulators|mesh-ancestor
110697469|NCT00209092|Antimitotic Agents|antimitotic agents|mesh-ancestor
110697470|NCT00209092|Mitosis Modulators|mitosis modulators|mesh-ancestor
110697471|NCT00209092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110697472|NCT00209092|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110697473|NCT00209092|Antimetabolites|antimetabolites|mesh-ancestor
110697475|NCT03972982|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110697476|NCT03972982|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110697477|NCT03972982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110697478|NCT00403494|Verapamil|verapamil|mesh-list
110697479|NCT00403494|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110697480|NCT00403494|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110697481|NCT00403494|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110697482|NCT00403494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110697483|NCT00403494|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110697484|NCT00403494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110697485|NCT00403494|Vasodilator Agents|vasodilator agents|mesh-ancestor
110697486|NCT00403260|Artesunate|artesunate|mesh-list
110697487|NCT00403260|Mefloquine|mefloquine|mesh-list
110697488|NCT00403260|Pyronaridine|pyronaridine|mesh-list
110697489|NCT00403260|Antimalarials|antimalarials|mesh-ancestor
110697490|NCT00403260|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110697491|NCT00403260|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110697492|NCT00403260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110697493|NCT00403260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110697494|NCT00403260|Antiviral Agents|antiviral agents|mesh-ancestor
110697495|NCT00403260|Schistosomicides|schistosomicides|mesh-ancestor
110697496|NCT00403260|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110697497|NCT00403260|Anthelmintics|anthelmintics|mesh-ancestor
110697498|NCT00406848|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110697499|NCT00406848|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110697500|NCT00406848|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110697501|NCT00406848|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110697502|NCT00406848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110697503|NCT00406848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110697504|NCT00406848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110697505|NCT00406848|Analgesics|analgesics|mesh-ancestor
110697506|NCT00406848|Sensory System Agents|sensory system agents|mesh-ancestor
110697507|NCT00406848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110697508|NCT00406848|Antidepressive Agents|antidepressive agents|mesh-ancestor
110697509|NCT00406848|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110697510|NCT00406848|Dopamine Agents|dopamine agents|mesh-ancestor
110697511|NCT00406692|Zonisamide|zonisamide|mesh-list
110697512|NCT00406692|Anticonvulsants|anticonvulsants|mesh-ancestor
110697513|NCT00406692|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110697514|NCT00406692|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110697515|NCT00406692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110102844|NCT01768260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110697516|NCT00406692|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110697517|NCT00406692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110697518|NCT00004494|Vasoactive Intestinal Peptide|vasoactive intestinal peptide|mesh-list
110697519|NCT00004494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110697520|NCT00004494|Vasodilator Agents|vasodilator agents|mesh-ancestor
110697521|NCT00004494|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110697522|NCT00004494|Protective Agents|protective agents|mesh-ancestor
110697523|NCT00004494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110697524|NCT00315705|Cyclophosphamide|cyclophosphamide|mesh-list
110697525|NCT00315705|Etoposide|etoposide|mesh-list
110697526|NCT00315705|Clofarabine|clofarabine|mesh-list
110697527|NCT00315705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110697528|NCT00315705|Immunologic Factors|immunologic factors|mesh-ancestor
110102908|NCT01768351|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110697529|NCT00315705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110697530|NCT00315705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110697531|NCT00315705|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110697532|NCT00315705|Alkylating Agents|alkylating agents|mesh-ancestor
110697533|NCT00315705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110697534|NCT00315705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110697535|NCT00315705|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110697536|NCT00315705|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110697537|NCT00315705|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110697538|NCT00315705|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110697539|NCT00315705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110697540|NCT00315705|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110697541|NCT00315705|Antimetabolites|antimetabolites|mesh-ancestor
110697543|NCT03982173|Tremelimumab|tremelimumab|mesh-list
110697544|NCT03982173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110697545|NCT03982173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110697546|NCT01062633|Erythritol|erythritol|mesh-list
110697547|NCT01062633|Sorbitol|sorbitol|mesh-list
110697548|NCT01062633|Vasodilator Agents|vasodilator agents|mesh-ancestor
110697549|NCT01062633|Cathartics|cathartics|mesh-ancestor
110697550|NCT01062633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110697551|NCT00307125|Rituximab|rituximab|mesh-list
110697552|NCT00307125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110697553|NCT00307125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110697554|NCT00307125|Immunologic Factors|immunologic factors|mesh-ancestor
110697555|NCT00307125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110697556|NCT00307125|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110697557|NCT01066299|Oxytocin|oxytocin|mesh-list
110697558|NCT01066299|Oxytocics|oxytocics|mesh-ancestor
110697559|NCT01066299|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110697560|NCT01066299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110697561|NCT00307047|Paclitaxel|paclitaxel|mesh-list
110697562|NCT00307047|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110697563|NCT00307047|Everolimus|everolimus|mesh-list
110697564|NCT00307047|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110697565|NCT00307047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110697566|NCT00307047|Tubulin Modulators|tubulin modulators|mesh-ancestor
110697567|NCT00307047|Antimitotic Agents|antimitotic agents|mesh-ancestor
110697568|NCT00307047|Mitosis Modulators|mitosis modulators|mesh-ancestor
110697569|NCT00307047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110697570|NCT00307047|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110697571|NCT00307047|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110697572|NCT00307047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110697573|NCT00307047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110697574|NCT00307047|Immunologic Factors|immunologic factors|mesh-ancestor
110697575|NCT00307047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110697576|NCT01066377|Sulfalene|sulfalene|mesh-list
110697577|NCT01066377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110697578|NCT01066377|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110697579|NCT01066377|Antimalarials|antimalarials|mesh-ancestor
110697580|NCT01066377|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110697581|NCT01066377|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110697582|NCT00306891|Cediranib|cediranib|mesh-list
110697583|NCT00306891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110697584|NCT00306891|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110697585|NCT00306891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110697586|NCT00306891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110697587|NCT03980847|Alendronate|alendronate|mesh-list
110697588|NCT03980847|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110697589|NCT03980847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110697590|NCT00391872|Clopidogrel|clopidogrel|mesh-list
110697591|NCT00391872|Ticagrelor|ticagrelor|mesh-list
110103218|NCT01769820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110697592|NCT00391872|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110697593|NCT00391872|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110697594|NCT00391872|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110697595|NCT00391872|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110697596|NCT00391872|Purinergic Agents|purinergic agents|mesh-ancestor
110697597|NCT00391872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110697598|NCT00391872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110697599|NCT00391872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110697600|NCT00391170|Dexamethasone|dexamethasone|mesh-list
110697601|NCT00391170|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110697602|NCT00391170|Antiemetics|antiemetics|mesh-ancestor
110697603|NCT00391170|Autonomic Agents|autonomic agents|mesh-ancestor
110697604|NCT00391170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110697605|NCT00391170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110697606|NCT00391170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110697607|NCT00391170|Glucocorticoids|glucocorticoids|mesh-ancestor
110697608|NCT00391170|Hormones|hormones|mesh-ancestor
110697609|NCT00391170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110697610|NCT00391170|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110697611|NCT00391170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110697612|NCT00402324|Valproic Acid|valproic acid|mesh-list
110697613|NCT00402324|Olanzapine|olanzapine|mesh-list
110697614|NCT00402324|Antiemetics|antiemetics|mesh-ancestor
110697615|NCT00402324|Autonomic Agents|autonomic agents|mesh-ancestor
110697616|NCT00402324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110697618|NCT00402324|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110697619|NCT00402324|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110697620|NCT00402324|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110697621|NCT00402324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110697622|NCT00402324|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110697623|NCT00402324|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110697624|NCT00402324|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110697625|NCT00402324|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110697626|NCT00402324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110697627|NCT00402324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110697628|NCT00402324|Serotonin Agents|serotonin agents|mesh-ancestor
110697629|NCT00402324|Anticonvulsants|anticonvulsants|mesh-ancestor
110697630|NCT00402324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110697631|NCT00402324|GABA Agents|gaba agents|mesh-ancestor
110697632|NCT00402324|Antimanic Agents|antimanic agents|mesh-ancestor
110697633|NCT00294723|Liraglutide|liraglutide|mesh-list
110697634|NCT00294723|Glimepiride|glimepiride|mesh-list
110697635|NCT00294723|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110697636|NCT00294723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110697637|NCT00294723|Incretins|incretins|mesh-ancestor
110697638|NCT00294723|Hormones|hormones|mesh-ancestor
110697639|NCT00294723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110697640|NCT00294723|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110697641|NCT00294723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110697642|NCT00294723|Immunologic Factors|immunologic factors|mesh-ancestor
110697643|NCT00375492|Exenatide|exenatide|mesh-list
110697644|NCT00375492|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110697645|NCT00375492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110697646|NCT00375492|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110697647|NCT00375492|Incretins|incretins|mesh-ancestor
110697648|NCT00375492|Hormones|hormones|mesh-ancestor
110697649|NCT00375492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110697650|NCT00306189|Denosumab|denosumab|mesh-list
110697651|NCT00306189|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110697652|NCT00306189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110697653|NCT00305877|Bevacizumab|bevacizumab|mesh-list
110697654|NCT00305877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110697655|NCT00305877|Cetuximab|cetuximab|mesh-list
110697656|NCT00305877|Gemcitabine|gemcitabine|mesh-list
110697657|NCT00305877|Capecitabine|capecitabine|mesh-list
110697658|NCT00305877|Antibodies|antibodies|mesh-list
110697659|NCT00305877|Immunoglobulins|immunoglobulins|mesh-list
110697660|NCT00305877|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110697661|NCT00305877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110697662|NCT00305877|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110697663|NCT00305877|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110697664|NCT00305877|Growth Substances|growth substances|mesh-ancestor
110697665|NCT00305877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110697666|NCT00305877|Growth Inhibitors|growth inhibitors|mesh-ancestor
110697667|NCT00305877|Immunologic Factors|immunologic factors|mesh-ancestor
110697668|NCT00305877|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110697669|NCT00305877|Antimetabolites|antimetabolites|mesh-ancestor
110697670|NCT00305877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110697671|NCT00312195|Buprenorphine|buprenorphine|mesh-list
110697672|NCT00312195|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110697673|NCT00312195|Narcotics|narcotics|mesh-ancestor
110697674|NCT00312195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110697675|NCT00312195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110697676|NCT00312195|Analgesics|analgesics|mesh-ancestor
110697677|NCT00312195|Sensory System Agents|sensory system agents|mesh-ancestor
110697678|NCT00312195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110697679|NCT00312195|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110697680|NCT02532777|Mycophenolic Acid|mycophenolic acid|mesh-list
110697681|NCT02532777|Prednisone|prednisone|mesh-list
110697682|NCT02532777|Methylprednisolone|methylprednisolone|mesh-list
110697683|NCT02532777|Cyclophosphamide|cyclophosphamide|mesh-list
110697684|NCT02532777|Leflunomide|leflunomide|mesh-list
110697685|NCT02532777|Enzyme Inhibitors|enzyme inhibitors|mesh-list
110697686|NCT02532777|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
110697687|NCT02532777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110103720|NCT01773096|Bisacodyl|bisacodyl|mesh-list
110697688|NCT02532777|Immunologic Factors|immunologic factors|mesh-ancestor
110697689|NCT02532777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110697690|NCT02532777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110697691|NCT02532777|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110697692|NCT02532777|Alkylating Agents|alkylating agents|mesh-ancestor
110697693|NCT02532777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110697694|NCT02532777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110697695|NCT02532777|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110697696|NCT02532777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110697698|NCT02532777|Hormones|hormones|mesh-ancestor
110103786|NCT01773616|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110697699|NCT02532777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110697700|NCT02532777|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110697701|NCT02532777|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110697702|NCT02532777|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110697703|NCT02532777|Antitubercular Agents|antitubercular agents|mesh-ancestor
110697704|NCT02532777|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110697705|NCT02532777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110697706|NCT02532777|Antiemetics|antiemetics|mesh-ancestor
110697707|NCT02532777|Autonomic Agents|autonomic agents|mesh-ancestor
110697708|NCT02532777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110697709|NCT02532777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110697710|NCT02532777|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110697711|NCT02532777|Protective Agents|protective agents|mesh-ancestor
110697712|NCT02532777|Protease Inhibitors|protease inhibitors|mesh-ancestor
110697713|NCT01062945|Doxazosin|doxazosin|mesh-list
110697714|NCT01062945|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110697715|NCT01062945|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110697716|NCT01062945|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110697717|NCT01062945|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110697718|NCT01062945|Adrenergic Agents|adrenergic agents|mesh-ancestor
110697719|NCT01062945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110697720|NCT01062945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110697721|NCT01062945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110697722|NCT01063023|Moxifloxacin|moxifloxacin|mesh-list
110697723|NCT01063023|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
110697724|NCT01063023|Asunaprevir|asunaprevir|mesh-list
110697725|NCT01063023|Protease Inhibitors|protease inhibitors|mesh-ancestor
110697726|NCT01063023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110697727|NCT01063023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110697728|NCT01063023|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110697729|NCT01063023|Contraceptive Agents|contraceptive agents|mesh-ancestor
110697730|NCT01063023|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110697731|NCT01063023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110697732|NCT01063023|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110697733|NCT01063023|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110697734|NCT01063023|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110697735|NCT01063023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110103972|NCT01775579|Antimetabolites|antimetabolites|mesh-ancestor
110697736|NCT01063023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110697737|NCT01063023|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110697738|NCT01063023|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110697739|NCT01063023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110697740|NCT01063101|Fucoidan|fucoidan|mesh-list
110697741|NCT01063101|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110697742|NCT01063101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110697743|NCT01063101|Anticoagulants|anticoagulants|mesh-ancestor
110697744|NCT01063101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110697745|NCT01066689|Rituximab|rituximab|mesh-list
110697746|NCT01066689|Citric Acid|citric acid|mesh-list
110697747|NCT01066689|Sodium Citrate|sodium citrate|mesh-list
110697748|NCT01066689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110697749|NCT01066689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110697750|NCT01066689|Immunologic Factors|immunologic factors|mesh-ancestor
110697751|NCT01066689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110697752|NCT01066689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110697753|NCT01066689|Anticoagulants|anticoagulants|mesh-ancestor
110697754|NCT01066689|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110697755|NCT01066689|Chelating Agents|chelating agents|mesh-ancestor
110697756|NCT01066689|Sequestering Agents|sequestering agents|mesh-ancestor
110104100|NCT01776788|Insulin|insulin|mesh-list
110697757|NCT01066689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110697758|NCT00293709|Etanercept|etanercept|mesh-list
110697759|NCT00293709|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110697760|NCT00293709|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110697761|NCT00293709|Analgesics|analgesics|mesh-ancestor
110697762|NCT00293709|Sensory System Agents|sensory system agents|mesh-ancestor
110697763|NCT00293709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110697764|NCT00293709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110697765|NCT00293709|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110415609|NCT01217814|Vitamins|vitamins|mesh-ancestor
110697766|NCT00293709|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110697767|NCT00293709|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110697768|NCT00293709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110697769|NCT00293709|Immunologic Factors|immunologic factors|mesh-ancestor
110697770|NCT01063257|Clofarabine|clofarabine|mesh-list
110697771|NCT01063257|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110697772|NCT01063257|Antimetabolites|antimetabolites|mesh-ancestor
110697773|NCT01063257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110697774|NCT01063257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110697775|NCT03977649|Erenumab|erenumab|mesh-list
110697776|NCT03977649|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
110697777|NCT03977649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110697778|NCT03977649|Analgesics|analgesics|mesh-ancestor
110697779|NCT03977649|Sensory System Agents|sensory system agents|mesh-ancestor
110697780|NCT03977649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110697781|NCT03977649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110697782|NCT01066767|Fexofenadine|fexofenadine|mesh-list
110697783|NCT01066767|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110697784|NCT01066767|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110697785|NCT01066767|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110697786|NCT01066767|Histamine Antagonists|histamine antagonists|mesh-ancestor
110697787|NCT01066767|Histamine Agents|histamine agents|mesh-ancestor
110697788|NCT01066767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110697789|NCT01066767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110697790|NCT01066767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110697792|NCT03980379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110697793|NCT03980379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110697794|NCT03980379|Immunologic Factors|immunologic factors|mesh-ancestor
110697795|NCT03980379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110697796|NCT03980379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110697797|NCT01064271|Risperidone|risperidone|mesh-list
110697798|NCT01064271|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110697799|NCT01064271|Serotonin Agents|serotonin agents|mesh-ancestor
110697800|NCT01064271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110697801|NCT01064271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110697802|NCT01064271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110697803|NCT01064271|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110697804|NCT01064271|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110697805|NCT01064271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110697806|NCT01064271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110697807|NCT01064271|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110697808|NCT01064271|Dopamine Agents|dopamine agents|mesh-ancestor
110697809|NCT01066845|Tadalafil|tadalafil|mesh-list
110408732|NCT04283656|Tenofovir|tenofovir|mesh-list
110697810|NCT01066845|Vasodilator Agents|vasodilator agents|mesh-ancestor
110697811|NCT01066845|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110697812|NCT01066845|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110697813|NCT01066845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110697814|NCT01066845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110697815|NCT01066845|Urological Agents|urological agents|mesh-ancestor
110697816|NCT01064349|Trastuzumab|trastuzumab|mesh-list
110104496|NCT01779908|Vitamin D|vitamin d|mesh-list
110697817|NCT01064349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110697818|NCT01064349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110409097|NCT02861417|Tacrolimus|tacrolimus|mesh-list
110697819|NCT00293397|Doxorubicin|doxorubicin|mesh-list
110697820|NCT00293397|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110409169|NCT02538198|Lenalidomide|lenalidomide|mesh-list
110697821|NCT00293397|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110409246|NCT02204241|Dexamethasone|dexamethasone|mesh-list
110697822|NCT00293397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110697823|NCT00293397|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110697824|NCT00293397|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110697825|NCT00293397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110697826|NCT00293397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110697827|NCT03981627|Insulin Aspart|insulin aspart|mesh-list
110697828|NCT03981627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110697829|NCT03981627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110697831|NCT01069263|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
110697832|NCT01069263|Protective Agents|protective agents|mesh-ancestor
110697833|NCT01069263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110697834|NCT01069263|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110697835|NCT01069263|Antioxidants|antioxidants|mesh-ancestor
110697836|NCT01069263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110409610|NCT05641649|Anticonvulsants|anticonvulsants|mesh-ancestor
110697838|NCT01067235|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110697839|NCT01067235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110697840|NCT01067235|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
110697841|NCT01067235|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110697842|NCT01067235|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110697843|NCT01067235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110697844|NCT00290745|Tamoxifen|tamoxifen|mesh-list
110697845|NCT00290745|Letrozole|letrozole|mesh-list
110409824|NCT01178853|Warfarin|warfarin|mesh-list
110697846|NCT00290745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110697847|NCT00290745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110697848|NCT00290745|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110697849|NCT00290745|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110697850|NCT00290745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110697851|NCT00290745|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110697852|NCT00290745|Hormone Antagonists|hormone antagonists|mesh-ancestor
110828156|NCT05625893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110410114|NCT00965341|Testosterone|testosterone|mesh-list
110697853|NCT00290745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110697854|NCT00290745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110697855|NCT00290745|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110410331|NCT01294553|Metformin|metformin|mesh-list
110697856|NCT00290745|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110697857|NCT00290745|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110410449|NCT01286168|Eusol|eusol|mesh-list
110697858|NCT00290745|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110697860|NCT03980223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110697861|NCT03980223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110697863|NCT03980223|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110697864|NCT03980223|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110697865|NCT01067391|Tadalafil|tadalafil|mesh-list
110697866|NCT01067391|Vasodilator Agents|vasodilator agents|mesh-ancestor
110410572|NCT01290887|Reslizumab|reslizumab|mesh-list
110697867|NCT01067391|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110697868|NCT01067391|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110697869|NCT01067391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110697870|NCT01067391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110697871|NCT01067391|Urological Agents|urological agents|mesh-ancestor
110697873|NCT00402168|Abatacept|abatacept|mesh-list
110697874|NCT00402168|Tacrolimus|tacrolimus|mesh-list
110697875|NCT00402168|Cyclosporins|cyclosporins|mesh-list
110697876|NCT00402168|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110410640|NCT01288469|Alirocumab|alirocumab|mesh-list
110697877|NCT00402168|Immunologic Factors|immunologic factors|mesh-ancestor
110697878|NCT00402168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110697879|NCT00402168|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110697880|NCT00402168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110410825|NCT00959647|Growth Substances|growth substances|mesh-ancestor
110697881|NCT00402168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110697882|NCT00402168|Antifungal Agents|antifungal agents|mesh-ancestor
110697883|NCT00402168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110697884|NCT00402168|Dermatologic Agents|dermatologic agents|mesh-ancestor
110697885|NCT00402168|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110697886|NCT00402168|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110697887|NCT00402168|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110697888|NCT00402168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110697889|NCT00290589|Methylprednisolone|methylprednisolone|mesh-list
110697890|NCT00290589|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110697891|NCT00290589|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110697892|NCT00290589|Prednisolone|prednisolone|mesh-list
110697893|NCT00290589|Prednisolone acetate|prednisolone acetate|mesh-list
110697894|NCT00290589|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110697895|NCT00290589|Prednisolone phosphate|prednisolone phosphate|mesh-list
110697896|NCT00290589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110697897|NCT00290589|Antiemetics|antiemetics|mesh-ancestor
110697898|NCT00290589|Autonomic Agents|autonomic agents|mesh-ancestor
110697899|NCT00290589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110697900|NCT00290589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110697901|NCT00290589|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110697902|NCT00290589|Glucocorticoids|glucocorticoids|mesh-ancestor
110697903|NCT00290589|Hormones|hormones|mesh-ancestor
110697904|NCT00290589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110697905|NCT00290589|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110697906|NCT00290589|Protective Agents|protective agents|mesh-ancestor
110697907|NCT00290589|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110697908|NCT00290589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110697910|NCT01067547|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
110697911|NCT01067547|Trace Elements|trace elements|mesh-ancestor
110697912|NCT01067547|Micronutrients|micronutrients|mesh-ancestor
110697913|NCT01067547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110697914|NCT01067547|Hematinics|hematinics|mesh-ancestor
110697915|NCT00290511|Dexamethasone|dexamethasone|mesh-list
110697916|NCT00290511|Rituximab|rituximab|mesh-list
110697917|NCT00290511|Fludarabine|fludarabine|mesh-list
110697918|NCT00290511|Fludarabine phosphate|fludarabine phosphate|mesh-list
110697920|NCT00290511|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110697921|NCT00290511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110697922|NCT00290511|Immunologic Factors|immunologic factors|mesh-ancestor
110697923|NCT00290511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110697924|NCT00290511|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110697925|NCT00290511|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110697926|NCT00290511|Antiemetics|antiemetics|mesh-ancestor
110697927|NCT00290511|Autonomic Agents|autonomic agents|mesh-ancestor
110697928|NCT00290511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110411684|NCT02853253|SMOFlipid|smoflipid|mesh-list
110697929|NCT00290511|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110411838|NCT01146795|Paclitaxel|paclitaxel|mesh-list
110697930|NCT00290511|Glucocorticoids|glucocorticoids|mesh-ancestor
110697931|NCT00290511|Hormones|hormones|mesh-ancestor
110828158|NCT01178047|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
110697932|NCT00290511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110697933|NCT00290511|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110697934|NCT00290511|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110412040|NCT01281956|Naluzotan|naluzotan|mesh-list
110697935|NCT00290511|Antimetabolites|antimetabolites|mesh-ancestor
110697936|NCT00290511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110412115|NCT00938431|Lacosamide|lacosamide|mesh-list
110697937|NCT00290511|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110697938|NCT00290511|Analgesics|analgesics|mesh-ancestor
110828159|NCT01178047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110697939|NCT00290511|Sensory System Agents|sensory system agents|mesh-ancestor
110697940|NCT00290511|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110697941|NCT00290511|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110697943|NCT00290433|Cytarabine|cytarabine|mesh-list
110697944|NCT00290433|Dexamethasone|dexamethasone|mesh-list
110105125|NCT01784562|Riociguat|riociguat|mesh-list
110697945|NCT00290433|Cyclophosphamide|cyclophosphamide|mesh-list
110697946|NCT00290433|Doxorubicin|doxorubicin|mesh-list
110697947|NCT00290433|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110697948|NCT00290433|Methotrexate|methotrexate|mesh-list
110697949|NCT00290433|Vincristine|vincristine|mesh-list
110697950|NCT00290433|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110697951|NCT00290433|Immunologic Factors|immunologic factors|mesh-ancestor
110697952|NCT00290433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110697953|NCT00290433|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110697954|NCT00290433|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110697955|NCT00290433|Alkylating Agents|alkylating agents|mesh-ancestor
110697956|NCT00290433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110697957|NCT00290433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110697958|NCT00290433|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110697959|NCT00290433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110697960|NCT00290433|Antiemetics|antiemetics|mesh-ancestor
110697961|NCT00290433|Autonomic Agents|autonomic agents|mesh-ancestor
110697962|NCT00290433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110697963|NCT00290433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110697964|NCT00290433|Glucocorticoids|glucocorticoids|mesh-ancestor
110697965|NCT00290433|Hormones|hormones|mesh-ancestor
110697966|NCT00290433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110697967|NCT00290433|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110697968|NCT00290433|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110697969|NCT00290433|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110697970|NCT00290433|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110697971|NCT00290433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110697972|NCT00290433|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110697973|NCT00290433|Abortifacient Agents|abortifacient agents|mesh-ancestor
110697974|NCT00290433|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110697975|NCT00290433|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110697976|NCT00290433|Antimetabolites|antimetabolites|mesh-ancestor
110697977|NCT00290433|Dermatologic Agents|dermatologic agents|mesh-ancestor
110697978|NCT00290433|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110697979|NCT00290433|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110697980|NCT00290433|Antiviral Agents|antiviral agents|mesh-ancestor
110697981|NCT00290433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110697982|NCT00290433|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110697983|NCT00290433|Tubulin Modulators|tubulin modulators|mesh-ancestor
110697984|NCT00290433|Antimitotic Agents|antimitotic agents|mesh-ancestor
110697985|NCT00290433|Mitosis Modulators|mitosis modulators|mesh-ancestor
110697986|NCT00304083|Doxorubicin|doxorubicin|mesh-list
110697987|NCT00304083|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110697988|NCT00304083|Etoposide|etoposide|mesh-list
110697989|NCT00304083|Ifosfamide|ifosfamide|mesh-list
110697990|NCT00304083|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110697991|NCT00304083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110697992|NCT00304083|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110697993|NCT00304083|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110697994|NCT00304083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110697995|NCT00304083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110697996|NCT00304083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110697997|NCT00304083|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110697998|NCT00304083|Alkylating Agents|alkylating agents|mesh-ancestor
110697999|NCT01069965|BGP 15|bgp 15|mesh-list
110698000|NCT01069965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110698001|NCT01069965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110698002|NCT00391092|Bevacizumab|bevacizumab|mesh-list
110698004|NCT00391092|Docetaxel|docetaxel|mesh-list
110698005|NCT00391092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110698006|NCT00391092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110698007|NCT00391092|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110698008|NCT00391092|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110698009|NCT00391092|Growth Substances|growth substances|mesh-ancestor
110698010|NCT00391092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110698011|NCT00391092|Growth Inhibitors|growth inhibitors|mesh-ancestor
110698012|NCT00391092|Tubulin Modulators|tubulin modulators|mesh-ancestor
110698013|NCT00391092|Antimitotic Agents|antimitotic agents|mesh-ancestor
110698014|NCT00391092|Mitosis Modulators|mitosis modulators|mesh-ancestor
110698015|NCT00391092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110698017|NCT00374868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110698018|NCT00374868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110413323|NCT03695744|Bortezomib|bortezomib|mesh-list
110698019|NCT00374868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110698020|NCT00374868|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110413470|NCT02697344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110698021|NCT00374868|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110698023|NCT01044342|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110698024|NCT01044342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110698025|NCT01044342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110698026|NCT01044342|Cholinergic Agents|cholinergic agents|mesh-ancestor
110698027|NCT01044342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110105567|NCT01787669|Dexamethasone|dexamethasone|mesh-list
110698028|NCT01044342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110698029|NCT01044342|Nootropic Agents|nootropic agents|mesh-ancestor
110698030|NCT00374556|Eszopiclone|eszopiclone|mesh-list
110698031|NCT00374556|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110698032|NCT00374556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110698033|NCT00374556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110698034|NCT01064973|Baclofen|baclofen|mesh-list
110698035|NCT01064973|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110698036|NCT01064973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110698037|NCT01064973|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110698038|NCT01064973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110698039|NCT01064973|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
110698040|NCT01064973|GABA Agonists|gaba agonists|mesh-ancestor
110698041|NCT01064973|GABA Agents|gaba agents|mesh-ancestor
110698042|NCT01064973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110698043|NCT01064973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110698044|NCT00374322|Lapatinib|lapatinib|mesh-list
110413913|NCT05937282|Analgesics|analgesics|mesh-ancestor
110698045|NCT00374322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110698046|NCT00374322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110698047|NCT00374322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110105697|NCT01788501|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110698048|NCT00374322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110698049|NCT00303459|Bosentan|bosentan|mesh-list
110698050|NCT00303459|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110698051|NCT00303459|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
110698052|NCT00303459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110698053|NCT00289887|Losartan|losartan|mesh-list
110698054|NCT00289887|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110698055|NCT00289887|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110698056|NCT00289887|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110698057|NCT00289887|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110698058|NCT00289887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110698059|NCT01068093|Ezetimibe|ezetimibe|mesh-list
110698060|NCT01068093|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110698061|NCT01068093|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110698062|NCT01068093|Antimetabolites|antimetabolites|mesh-ancestor
110698063|NCT01068093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110415905|NCT04254523|Analgesics|analgesics|mesh-ancestor
110698064|NCT01068093|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110698065|NCT00401544|Dextrans|dextrans|mesh-list
110698066|NCT00401544|Darbepoetin alfa|darbepoetin alfa|mesh-list
110698067|NCT00401544|Iron-Dextran Complex|iron-dextran complex|mesh-list
110698068|NCT00401544|Hematinics|hematinics|mesh-ancestor
110698069|NCT00401544|Anticoagulants|anticoagulants|mesh-ancestor
110698070|NCT00401544|Plasma Substitutes|plasma substitutes|mesh-ancestor
110698071|NCT00401544|Blood Substitutes|blood substitutes|mesh-ancestor
110698072|NCT00292461|Lamotrigine|lamotrigine|mesh-list
110698073|NCT00292461|Zonisamide|zonisamide|mesh-list
110698074|NCT00292461|Anticonvulsants|anticonvulsants|mesh-ancestor
110698075|NCT00292461|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110698076|NCT00292461|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110698077|NCT00292461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110698078|NCT00292461|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110698079|NCT00292461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110698080|NCT00292461|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110698081|NCT00292461|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110698082|NCT00292461|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110698083|NCT00292461|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110698084|NCT00292461|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110698087|NCT00288639|Sensory System Agents|sensory system agents|mesh-ancestor
110698088|NCT00288639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110698089|NCT00288639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110698090|NCT00288639|Anticonvulsants|anticonvulsants|mesh-ancestor
110698091|NCT00288639|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110698092|NCT00288639|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110698093|NCT00288639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110698094|NCT00288639|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110698095|NCT00288639|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110698096|NCT00288639|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110698097|NCT00288639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110698098|NCT00288639|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110698099|NCT00390858|Deferasirox|deferasirox|mesh-list
110698100|NCT00390858|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110698101|NCT00390858|Chelating Agents|chelating agents|mesh-ancestor
110698102|NCT00390858|Sequestering Agents|sequestering agents|mesh-ancestor
110698103|NCT00390858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110698104|NCT00390780|Clotrimazole|clotrimazole|mesh-list
110698105|NCT00390780|Miconazole|miconazole|mesh-list
110698106|NCT00390780|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110698107|NCT00390780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110698108|NCT00390780|Antifungal Agents|antifungal agents|mesh-ancestor
110698109|NCT00390780|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110698110|NCT00390780|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110698111|NCT00390780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110698112|NCT00390780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110698113|NCT00390780|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110698114|NCT00390780|Hormone Antagonists|hormone antagonists|mesh-ancestor
110698115|NCT00390780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110698116|NCT00390780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110698117|NCT00390780|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110698118|NCT00390780|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110698119|NCT00390546|Propranolol|propranolol|mesh-list
110698120|NCT00390546|Digoxin|digoxin|mesh-list
110414825|NCT04117893|Viscosupplements|viscosupplements|mesh-ancestor
110698121|NCT00390546|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110698122|NCT00390546|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110698123|NCT00390546|Adrenergic Agents|adrenergic agents|mesh-ancestor
110698124|NCT00390546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110414898|NCT03735979|Argatroban|argatroban|mesh-list
110698125|NCT00390546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110698126|NCT00390546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110698127|NCT00390546|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110698128|NCT00390546|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110698129|NCT00390546|Vasodilator Agents|vasodilator agents|mesh-ancestor
110698130|NCT00390546|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110698131|NCT00390546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110698132|NCT00390546|Protective Agents|protective agents|mesh-ancestor
110698133|NCT00400764|Rituximab|rituximab|mesh-list
110698134|NCT00400764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110698135|NCT00400764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110698136|NCT00400764|Immunologic Factors|immunologic factors|mesh-ancestor
110698137|NCT00400764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110698138|NCT00400764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110698139|NCT00302211|Bosentan|bosentan|mesh-list
110698140|NCT00302211|Sildenafil Citrate|sildenafil citrate|mesh-list
110698141|NCT00302211|Iloprost|iloprost|mesh-list
110698142|NCT00302211|Vasodilator Agents|vasodilator agents|mesh-ancestor
110698143|NCT00302211|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110698144|NCT00302211|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110415150|NCT01359592|Prednisone|prednisone|mesh-list
110698145|NCT00302211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110698146|NCT00302211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110698147|NCT00302211|Urological Agents|urological agents|mesh-ancestor
110698148|NCT00302211|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110698149|NCT00302211|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
110698150|NCT00302211|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110698151|NCT01045902|Moxifloxacin|moxifloxacin|mesh-list
110698152|NCT01045902|Ampicillin|ampicillin|mesh-list
110698153|NCT01045902|Sulbactam|sulbactam|mesh-list
110698154|NCT01045902|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
110698155|NCT01045902|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110698156|NCT01045902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110698157|NCT01045902|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110698158|NCT01045902|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110698159|NCT01045902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110698160|NCT01045902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110698162|NCT01045902|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110698163|NCT01045902|Contraceptive Agents|contraceptive agents|mesh-ancestor
110698164|NCT01045902|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110698165|NCT01045902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110698166|NCT01045902|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110698167|NCT01045902|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110415601|NCT01217814|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110698168|NCT01045902|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110698169|NCT01045902|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110698171|NCT01041690|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110698172|NCT01041690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110698173|NCT01041690|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110698174|NCT01041690|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110698175|NCT01041690|Growth Substances|growth substances|mesh-ancestor
110698176|NCT01041690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110698177|NCT01041690|Growth Inhibitors|growth inhibitors|mesh-ancestor
110698178|NCT00288015|Bevacizumab|bevacizumab|mesh-list
110415895|NCT04254523|Morphine|morphine|mesh-list
110698179|NCT00288015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110698180|NCT00288015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110698181|NCT00288015|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110698182|NCT00288015|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110698183|NCT00288015|Growth Substances|growth substances|mesh-ancestor
110698184|NCT00288015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110698185|NCT00288015|Growth Inhibitors|growth inhibitors|mesh-ancestor
110698186|NCT00389064|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110698187|NCT00389064|Antidepressive Agents|antidepressive agents|mesh-ancestor
110698188|NCT00389064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110698189|NCT00389064|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110698190|NCT00389064|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110698191|NCT00389064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110698192|NCT00389064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110698194|NCT01068327|Nelfinavir|nelfinavir|mesh-list
110698195|NCT01068327|Gemcitabine|gemcitabine|mesh-list
110698196|NCT01068327|Fluorouracil|fluorouracil|mesh-list
110698197|NCT01068327|Calcium|calcium|mesh-list
110698198|NCT01068327|Levoleucovorin|levoleucovorin|mesh-list
110698199|NCT01068327|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110698200|NCT01068327|Antimetabolites|antimetabolites|mesh-ancestor
110698201|NCT01068327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110698202|NCT01068327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110106229|NCT01800357|Aspirin|aspirin|mesh-list
110698203|NCT01068327|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110698204|NCT01068327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110698205|NCT01068327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110416394|NCT05579665|Hyaluronic Acid|hyaluronic acid|mesh-list
110698206|NCT01068327|Immunologic Factors|immunologic factors|mesh-ancestor
110698207|NCT01068327|Antidotes|antidotes|mesh-ancestor
110698208|NCT01068327|Protective Agents|protective agents|mesh-ancestor
110698209|NCT01068327|Vitamin B Complex|vitamin b complex|mesh-ancestor
110698210|NCT01068327|Vitamins|vitamins|mesh-ancestor
110698211|NCT01068327|Micronutrients|micronutrients|mesh-ancestor
110416055|NCT05330065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110698212|NCT01068327|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110698213|NCT01068327|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110698214|NCT01068327|Protease Inhibitors|protease inhibitors|mesh-ancestor
110859123|NCT04479566|Antacids|antacids|mesh-ancestor
110698215|NCT01068327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110698216|NCT01068327|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110698217|NCT01068327|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110698218|NCT01068327|Antiviral Agents|antiviral agents|mesh-ancestor
110698219|NCT01068327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110698221|NCT01045980|Ergocalciferols|ergocalciferols|mesh-list
110698222|NCT01045980|Cholecalciferol|cholecalciferol|mesh-list
110698224|NCT01045980|Micronutrients|micronutrients|mesh-ancestor
110698225|NCT01045980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110698226|NCT01045980|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110698227|NCT01045980|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110698230|NCT00388674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110698232|NCT00388362|Prednisone|prednisone|mesh-list
110417037|NCT00999544|Oxycodone|oxycodone|mesh-list
110698233|NCT00388362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110698235|NCT00388362|Hormones|hormones|mesh-ancestor
110698236|NCT00388362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110698237|NCT00388362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110698238|NCT00388362|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110698239|NCT00388362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110698240|NCT00388362|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110698241|NCT00388362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110698242|NCT00388362|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110698243|NCT00388362|Antifungal Agents|antifungal agents|mesh-ancestor
110417337|NCT01119105|Vancomycin|vancomycin|mesh-list
110698244|NCT00388362|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110698245|NCT00388362|Immunologic Factors|immunologic factors|mesh-ancestor
110698246|NCT01046058|Simeprevir|simeprevir|mesh-list
110698247|NCT01046058|Antiviral Agents|antiviral agents|mesh-ancestor
110698248|NCT01046058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110698249|NCT01046058|Protease Inhibitors|protease inhibitors|mesh-ancestor
110698250|NCT01046058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110698251|NCT01046058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110698252|NCT01046214|Bupropion|bupropion|mesh-list
110698253|NCT01046214|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110698254|NCT01046214|Antidepressive Agents|antidepressive agents|mesh-ancestor
110698255|NCT01046214|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110417614|NCT00629278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110417683|NCT05101928|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110417755|NCT01116687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110698256|NCT01046214|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110698257|NCT01046214|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110698258|NCT01046214|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110698259|NCT01046214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110698260|NCT01046214|Dopamine Agents|dopamine agents|mesh-ancestor
110698261|NCT01046214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110698262|NCT01046214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110417903|NCT02865460|Vitamins|vitamins|mesh-ancestor
110698263|NCT01046214|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110698264|NCT01046214|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110698265|NCT01046214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110698266|NCT01324284|Lubiprostone|lubiprostone|mesh-list
110698267|NCT01324284|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
110418046|NCT01256294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110698268|NCT01324284|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110418160|NCT02879955|Acarbose|acarbose|mesh-list
110418189|NCT01111149|Varenicline|varenicline|mesh-list
110698269|NCT01324284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110698270|NCT00387894|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110698271|NCT00387894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110698272|NCT00387894|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110698273|NCT00387894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110698274|NCT00387894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110698275|NCT00387426|Sunitinib|sunitinib|mesh-list
110698276|NCT00387426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110418488|NCT01251614|Adalimumab|adalimumab|mesh-list
110698277|NCT00387426|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110418544|NCT02878707|Sensory System Agents|sensory system agents|mesh-ancestor
110698278|NCT00387426|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110698279|NCT00387426|Growth Substances|growth substances|mesh-ancestor
110698280|NCT00387426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110698281|NCT00387426|Growth Inhibitors|growth inhibitors|mesh-ancestor
110698282|NCT00387426|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110698283|NCT00387426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110106712|NCT01804218|Autonomic Agents|autonomic agents|mesh-ancestor
110698284|NCT00387426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110698286|NCT00387348|Citalopram|citalopram|mesh-list
110698287|NCT00387348|Escitalopram|escitalopram|mesh-list
110698288|NCT00387348|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110698289|NCT00387348|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110698290|NCT00387348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110698291|NCT00387348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110698292|NCT00387348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110418749|NCT01198548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110698294|NCT00387348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110698295|NCT00387348|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110698296|NCT00387348|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110698297|NCT00387348|Parasympatholytics|parasympatholytics|mesh-ancestor
110698298|NCT00387348|Autonomic Agents|autonomic agents|mesh-ancestor
110698299|NCT00387348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110698300|NCT00387348|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110106854|NCT01807741|Asenapine|asenapine|mesh-list
110698301|NCT00387348|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110698302|NCT00387348|Cholinergic Agents|cholinergic agents|mesh-ancestor
110698303|NCT00387348|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110698304|NCT00387348|Antidepressive Agents|antidepressive agents|mesh-ancestor
110698305|NCT00387348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110698306|NCT03992820|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
110698307|NCT03992820|Anesthetics, Local|anesthetics, local|mesh-ancestor
110698308|NCT03992820|Anesthetics|anesthetics|mesh-ancestor
110419186|NCT00993148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110698309|NCT03992820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110698310|NCT03992820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110419260|NCT02555839|Immunologic Factors|immunologic factors|mesh-ancestor
110698311|NCT03992820|Sensory System Agents|sensory system agents|mesh-ancestor
110698312|NCT03992820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110698313|NCT03992820|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
110698314|NCT00413660|Tofacitinib|tofacitinib|mesh-list
110698315|NCT00413660|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
110698316|NCT00413660|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110698317|NCT00413660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110698318|NCT00413660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110698319|NCT01234532|Anastrozole|anastrozole|mesh-list
110698320|NCT01234532|Entinostat|entinostat|mesh-list
110698321|NCT01234532|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110698322|NCT01234532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110698323|NCT01234532|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110698324|NCT01234532|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110698325|NCT01234532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110698326|NCT01234532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110419416|NCT04319549|Eusol|eusol|mesh-list
110698327|NCT01234532|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110698328|NCT01234532|Hormone Antagonists|hormone antagonists|mesh-ancestor
110828160|NCT01178047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110698329|NCT01234532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110419611|NCT04778787|Dapagliflozin|dapagliflozin|mesh-list
110698330|NCT01234532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110698331|NCT01234532|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110419683|NCT02848963|Propofol|propofol|mesh-list
110698333|NCT00431444|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
110698334|NCT00431444|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110698335|NCT00431444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110698336|NCT00431444|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110698337|NCT00431444|Hormone Antagonists|hormone antagonists|mesh-ancestor
110698338|NCT00431444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110698339|NCT00431444|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110859135|NCT06030219|Moxifloxacin|moxifloxacin|mesh-list
110698340|NCT00431444|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110419892|NCT00903175|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110107178|NCT01810458|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110698342|NCT00430352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110698343|NCT00430352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110698344|NCT00430352|Immunologic Factors|immunologic factors|mesh-ancestor
110698345|NCT00430352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110698346|NCT00430352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110698348|NCT01068405|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110698349|NCT01068405|Abortifacient Agents|abortifacient agents|mesh-ancestor
110698350|NCT01068405|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110698351|NCT01068405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110698352|NCT01068405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110698353|NCT01068405|Antimetabolites|antimetabolites|mesh-ancestor
110107246|NCT01810887|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110698354|NCT01068405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110698355|NCT01068405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110698356|NCT01068405|Dermatologic Agents|dermatologic agents|mesh-ancestor
110698357|NCT01068405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110416202|NCT00924469|Hormones|hormones|mesh-ancestor
110698358|NCT01068405|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110698359|NCT01068405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110698360|NCT01068405|Immunologic Factors|immunologic factors|mesh-ancestor
110698361|NCT01068405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110698362|NCT01068405|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110698363|NCT00429572|Fludarabine|fludarabine|mesh-list
110698364|NCT00429572|Melphalan|melphalan|mesh-list
110698365|NCT00429572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110828161|NCT01178047|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110698366|NCT00429572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110107312|NCT01811251|Hormones|hormones|mesh-ancestor
110698367|NCT00429572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110698368|NCT00429572|Immunologic Factors|immunologic factors|mesh-ancestor
110698369|NCT00429572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110698370|NCT00429572|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110698371|NCT00429572|Alkylating Agents|alkylating agents|mesh-ancestor
110698372|NCT00429572|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110698373|NCT00429494|Leuprolide|leuprolide|mesh-list
110698374|NCT00429494|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110698375|NCT00429494|Fertility Agents|fertility agents|mesh-ancestor
110698376|NCT00429494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110107377|NCT01811836|Zinc|zinc|mesh-list
110698377|NCT00429494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110698378|NCT00429494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110698379|NCT00429494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110698380|NCT00429416|Cytarabine|cytarabine|mesh-list
110420765|NCT00893113|Alfuzosin|alfuzosin|mesh-list
110698382|NCT00429416|Fludarabine|fludarabine|mesh-list
110698383|NCT00429416|Fludarabine phosphate|fludarabine phosphate|mesh-list
110698384|NCT00429416|Molgramostim|molgramostim|mesh-list
110698385|NCT00429416|Tacrolimus|tacrolimus|mesh-list
110420907|NCT02833987|Warfarin|warfarin|mesh-list
110698388|NCT00429416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110698389|NCT00429416|Immunologic Factors|immunologic factors|mesh-ancestor
110698390|NCT00429416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110698391|NCT00429416|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110828162|NCT01178047|Protective Agents|protective agents|mesh-ancestor
110698392|NCT00429416|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110698393|NCT00429416|Alkylating Agents|alkylating agents|mesh-ancestor
110698394|NCT00429416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110698395|NCT00429416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110698396|NCT00429416|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110698397|NCT00429416|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110698398|NCT00429416|Antimetabolites|antimetabolites|mesh-ancestor
110698399|NCT00429416|Antiviral Agents|antiviral agents|mesh-ancestor
110698400|NCT00429416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110698401|NCT00429416|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110698402|NCT00429416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110698403|NCT00429416|Protective Agents|protective agents|mesh-ancestor
110698404|NCT00429182|Cyclophosphamide|cyclophosphamide|mesh-list
110698405|NCT00429182|Thiotepa|thiotepa|mesh-list
110698406|NCT00429182|Carboplatin|carboplatin|mesh-list
110698407|NCT00429182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110698408|NCT00429182|Immunologic Factors|immunologic factors|mesh-ancestor
110421125|NCT00964678|Adrenergic Agents|adrenergic agents|mesh-ancestor
110698409|NCT00429182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110698410|NCT00429182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110698411|NCT00429182|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110698412|NCT00429182|Alkylating Agents|alkylating agents|mesh-ancestor
110107565|NCT01812954|Analgesics|analgesics|mesh-ancestor
110828163|NCT01178047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110698413|NCT00429182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110698415|NCT00429182|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110698416|NCT00429104|Trastuzumab|trastuzumab|mesh-list
110698417|NCT00429104|Sargramostim|sargramostim|mesh-list
110698418|NCT00429104|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110698419|NCT00429104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110698420|NCT00429104|Immunologic Factors|immunologic factors|mesh-ancestor
110698421|NCT00429104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110698422|NCT00429026|Cyclophosphamide|cyclophosphamide|mesh-list
110698424|NCT00429026|Fludarabine|fludarabine|mesh-list
110698425|NCT00429026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110698426|NCT00429026|Immunologic Factors|immunologic factors|mesh-ancestor
110698427|NCT00429026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110698428|NCT00429026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110421474|NCT00630370|ATI 7505|ati 7505|mesh-list
110698429|NCT00429026|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110698430|NCT00429026|Alkylating Agents|alkylating agents|mesh-ancestor
110698431|NCT00429026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110698432|NCT00429026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110698433|NCT00429026|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110698434|NCT00301821|Prednisone|prednisone|mesh-list
110698435|NCT00301821|Cyclophosphamide|cyclophosphamide|mesh-list
110698437|NCT00301821|Doxorubicin|doxorubicin|mesh-list
110421609|NCT04281628|Ketamine|ketamine|mesh-list
110698438|NCT00301821|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110698439|NCT00301821|Vincristine|vincristine|mesh-list
110698440|NCT00301821|Epratuzumab|epratuzumab|mesh-list
110698441|NCT00301821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110698442|NCT00301821|Immunologic Factors|immunologic factors|mesh-ancestor
110421696|NCT02826343|Xenon|xenon|mesh-list
110828164|NCT01101113|Cinacalcet|cinacalcet|mesh-list
110421823|NCT04241731|Antimetabolites|antimetabolites|mesh-ancestor
110698443|NCT00301821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110698444|NCT00301821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110421901|NCT04195009|Anesthetics|anesthetics|mesh-list
110698445|NCT00301821|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110698446|NCT00301821|Alkylating Agents|alkylating agents|mesh-ancestor
110421967|NCT04238923|Vancomycin|vancomycin|mesh-list
110698447|NCT00301821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110698448|NCT00301821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110698449|NCT00301821|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110698450|NCT00301821|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110422107|NCT01239992|Niacin|niacin|mesh-list
110698451|NCT00301821|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110698452|NCT00301821|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110698453|NCT00301821|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110698454|NCT00301821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110698455|NCT00301821|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110698456|NCT00301821|Glucocorticoids|glucocorticoids|mesh-ancestor
110698458|NCT00301821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110698459|NCT00301821|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110698460|NCT00301821|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110698461|NCT00301821|Tubulin Modulators|tubulin modulators|mesh-ancestor
110698462|NCT00301821|Antimitotic Agents|antimitotic agents|mesh-ancestor
110698463|NCT00301821|Mitosis Modulators|mitosis modulators|mesh-ancestor
110698464|NCT03976713|Bromides|bromides|mesh-list
110698465|NCT03976713|Tiotropium Bromide|tiotropium bromide|mesh-list
110422470|NCT00627081|Remifentanil|remifentanil|mesh-list
110698466|NCT03976713|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110698467|NCT03976713|Autonomic Agents|autonomic agents|mesh-ancestor
110698468|NCT03976713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110698469|NCT03976713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110698470|NCT03976713|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110698471|NCT03976713|Respiratory System Agents|respiratory system agents|mesh-ancestor
110422612|NCT02815111|Anticonvulsants|anticonvulsants|mesh-ancestor
110698472|NCT03976713|Parasympatholytics|parasympatholytics|mesh-ancestor
110698473|NCT03976713|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110698474|NCT03976713|Cholinergic Agents|cholinergic agents|mesh-ancestor
110698475|NCT03976713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110698476|NCT03976713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110698477|NCT03976713|Anticonvulsants|anticonvulsants|mesh-ancestor
110698478|NCT00372996|Fulvestrant|fulvestrant|mesh-list
110698480|NCT00372996|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110698481|NCT00372996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110698482|NCT00372996|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110698483|NCT00372996|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110698484|NCT00372996|Hormone Antagonists|hormone antagonists|mesh-ancestor
110698485|NCT00372996|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110698486|NCT00372996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110698487|NCT00372996|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110698488|NCT00372996|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110698489|NCT00372996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110698490|NCT00372996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110698491|NCT00399360|Metformin|metformin|mesh-list
110698492|NCT00399360|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110698493|NCT00399360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110698494|NCT00428948|Tolvaptan|tolvaptan|mesh-list
110698495|NCT00428948|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
110698496|NCT00428948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110698497|NCT00428948|Natriuretic Agents|natriuretic agents|mesh-ancestor
110698498|NCT00428948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110698499|NCT00428792|Methylphenidate|methylphenidate|mesh-list
110698500|NCT00428792|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110698501|NCT00428792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110698502|NCT00428792|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110698503|NCT00428792|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110698504|NCT00428792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110698505|NCT00428792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110698506|NCT00428792|Dopamine Agents|dopamine agents|mesh-ancestor
110416356|NCT03690037|Hemostatics|hemostatics|mesh-ancestor
110698509|NCT00300885|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110698510|NCT00300885|Carboplatin|carboplatin|mesh-list
110698511|NCT00300885|Sorafenib|sorafenib|mesh-list
110422786|NCT00631150|Levetiracetam|levetiracetam|mesh-list
110698512|NCT00300885|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110698513|NCT00300885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110698514|NCT00300885|Tubulin Modulators|tubulin modulators|mesh-ancestor
110698515|NCT00300885|Antimitotic Agents|antimitotic agents|mesh-ancestor
110698516|NCT00300885|Mitosis Modulators|mitosis modulators|mesh-ancestor
110422934|NCT05520619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110698517|NCT00300885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110698518|NCT00300885|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110423005|NCT04301895|Remifentanil|remifentanil|mesh-list
110698519|NCT00300885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110698520|NCT00386334|Eszopiclone|eszopiclone|mesh-list
110698521|NCT00386334|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110698522|NCT00386334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110698523|NCT00386334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110698524|NCT01143116|Silver Nitrate|silver nitrate|mesh-list
110698525|NCT01143116|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110698526|NCT01143116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110698528|NCT00292227|Rotigotine|rotigotine|mesh-list
110698529|NCT00292227|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110698530|NCT00292227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110698531|NCT00292227|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110698532|NCT00292227|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110859154|NCT06030037|Lenvatinib|lenvatinib|mesh-list
110698533|NCT00292227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110698534|NCT00292227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110698535|NCT00292227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110698536|NCT00292227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110698537|NCT00292227|Dopamine Agonists|dopamine agonists|mesh-ancestor
110698538|NCT00292227|Dopamine Agents|dopamine agents|mesh-ancestor
110698539|NCT00292227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110698541|NCT00386100|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110698542|NCT00386100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110698543|NCT00300495|Amiodarone|amiodarone|mesh-list
110698544|NCT00300495|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110698545|NCT00300495|Vasodilator Agents|vasodilator agents|mesh-ancestor
110698546|NCT00300495|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
110698547|NCT00300495|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110698548|NCT00300495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110423353|NCT02797717|Dacarbazine|dacarbazine|mesh-list
110698549|NCT00300495|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110108163|NCT01816529|Diltiazem|diltiazem|mesh-list
110698550|NCT00300495|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110698551|NCT00300495|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110698552|NCT00300495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110698553|NCT00300495|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110698554|NCT00300495|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110698555|NCT00300495|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110698556|NCT03979989|Tapentadol|tapentadol|mesh-list
110698557|NCT03979989|Omeprazole|omeprazole|mesh-list
110698558|NCT03979989|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110698559|NCT03979989|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110698560|NCT03979989|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110698561|NCT03979989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110698562|NCT03979989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110698563|NCT03979989|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110698564|NCT03979989|Narcotics|narcotics|mesh-ancestor
110423790|NCT05166577|Antiviral Agents|antiviral agents|mesh-ancestor
110698565|NCT03979989|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110698566|NCT03979989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110698567|NCT03979989|Analgesics|analgesics|mesh-ancestor
110698568|NCT03979989|Sensory System Agents|sensory system agents|mesh-ancestor
110698569|NCT03979989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110698570|NCT03979989|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110698571|NCT03979989|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110698572|NCT03979989|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110698573|NCT03979989|Adrenergic Agents|adrenergic agents|mesh-ancestor
110698574|NCT03979989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110698575|NCT01325571|Tacrolimus|tacrolimus|mesh-list
110698576|NCT01325571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110698577|NCT01325571|Immunologic Factors|immunologic factors|mesh-ancestor
110698578|NCT01325571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110698579|NCT01325571|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110698580|NCT01325571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110698581|NCT01325571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110698582|NCT00386022|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
110424289|NCT02772601|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110828165|NCT01101113|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110828166|NCT01101113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110698584|NCT00386022|LHRH, N-Ac-2-Nal(1)-4-Cl-Phe(2)-3-Pal(3)-Arg(5)-Glu(6)-AlaNH2(10)-|lhrh, n-ac-2-nal(1)-4-cl-phe(2)-3-pal(3)-arg(5)-glu(6)-alanh2(10)-|mesh-list
110698586|NCT00386022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110698587|NCT00386022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110698588|NCT00386022|Hormone Antagonists|hormone antagonists|mesh-ancestor
110698590|NCT01068795|Anticoagulants|anticoagulants|mesh-ancestor
110698591|NCT01068795|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110698592|NCT01068795|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110828167|NCT01101113|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
110698593|NCT01068795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110698595|NCT00286455|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110698596|NCT00286455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110698597|NCT00286455|Incretins|incretins|mesh-ancestor
110698598|NCT00286455|Hormones|hormones|mesh-ancestor
110698599|NCT00286455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110698600|NCT00286455|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110698601|NCT00286455|Protease Inhibitors|protease inhibitors|mesh-ancestor
110424801|NCT01191840|Vancomycin|vancomycin|mesh-list
110698602|NCT00286455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110698603|NCT00286455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110698604|NCT00385944|Clopidogrel|clopidogrel|mesh-list
110698605|NCT00385944|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
110828168|NCT01101113|Hormone Antagonists|hormone antagonists|mesh-ancestor
110698606|NCT00385944|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110698607|NCT00385944|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110698608|NCT00385944|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110698609|NCT00385944|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110698610|NCT00385944|Purinergic Agents|purinergic agents|mesh-ancestor
110698611|NCT00385944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110425088|NCT02855866|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110698612|NCT00385944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110698613|NCT00385944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110698614|NCT00286221|Fentanyl|fentanyl|mesh-list
110425244|NCT01190436|Bisoprolol|bisoprolol|mesh-list
110698615|NCT00286221|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110698616|NCT00286221|Narcotics|narcotics|mesh-ancestor
110698617|NCT00286221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110698618|NCT00286221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110698619|NCT00286221|Analgesics|analgesics|mesh-ancestor
110698620|NCT00286221|Sensory System Agents|sensory system agents|mesh-ancestor
110698621|NCT00286221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110698622|NCT00286221|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110698623|NCT00286221|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110698624|NCT00286221|Anesthetics, General|anesthetics, general|mesh-ancestor
110698626|NCT00398112|Sunitinib|sunitinib|mesh-list
110698627|NCT00398112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110698628|NCT00398112|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110698629|NCT00398112|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110698630|NCT00398112|Growth Substances|growth substances|mesh-ancestor
110698631|NCT00398112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110698632|NCT00398112|Growth Inhibitors|growth inhibitors|mesh-ancestor
110698633|NCT00398112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110698634|NCT00398112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110108536|NCT01819220|Diuretics|diuretics|mesh-ancestor
110698635|NCT00398112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110698637|NCT01065129|Azacitidine|azacitidine|mesh-list
110698638|NCT01065129|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110698639|NCT01065129|Antimetabolites|antimetabolites|mesh-ancestor
110698640|NCT01065129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110698641|NCT01065129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110698643|NCT01065129|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110698644|NCT01065129|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110698645|NCT01065129|Antiviral Agents|antiviral agents|mesh-ancestor
110698646|NCT01065129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110698647|NCT01042314|Donepezil|donepezil|mesh-list
110698648|NCT01042314|BMS 708163|bms 708163|mesh-list
110698649|NCT01042314|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110698650|NCT01042314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110425735|NCT01021215|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110698651|NCT01042314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110698652|NCT01042314|Cholinergic Agents|cholinergic agents|mesh-ancestor
110698653|NCT01042314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110698654|NCT01042314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110698655|NCT01042314|Nootropic Agents|nootropic agents|mesh-ancestor
110698656|NCT01042314|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
110698657|NCT00372528|Pregabalin|pregabalin|mesh-list
110698658|NCT00372528|Analgesics|analgesics|mesh-ancestor
110698659|NCT00372528|Sensory System Agents|sensory system agents|mesh-ancestor
110698660|NCT00372528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110698661|NCT00372528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110698662|NCT00372528|Anticonvulsants|anticonvulsants|mesh-ancestor
110698663|NCT00372528|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110859166|NCT06029907|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110698664|NCT00372528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110108646|NCT01820026|Amoxicillin|amoxicillin|mesh-list
110698665|NCT00372528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110698666|NCT00372528|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110698667|NCT00372528|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110698668|NCT00372528|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110698669|NCT00372528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110698670|NCT00372528|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110698671|NCT00283803|Sulindac sulfone|sulindac sulfone|mesh-list
110426227|NCT02748265|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110698673|NCT00283803|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
110698674|NCT00283803|Androgen Antagonists|androgen antagonists|mesh-list
110698675|NCT00283803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110698676|NCT00283803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110698677|NCT00283803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110698678|NCT00283803|Hormone Antagonists|hormone antagonists|mesh-ancestor
110698679|NCT00283803|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110698680|NCT00283803|Protective Agents|protective agents|mesh-ancestor
110698681|NCT00283803|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110698682|NCT00283803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110698683|NCT00283803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110426519|NCT02739061|Fluvoxamine|fluvoxamine|mesh-list
110698684|NCT00283803|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110698685|NCT00283803|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110698687|NCT00283803|Sensory System Agents|sensory system agents|mesh-ancestor
110698688|NCT00283803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110108752|NCT01820767|Vitamins|vitamins|mesh-ancestor
110698689|NCT00283803|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110698690|NCT00283803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110698691|NCT01044810|Efavirenz|efavirenz|mesh-list
110698692|NCT01044810|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110698693|NCT01044810|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110698694|NCT01044810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110698695|NCT01044810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110698696|NCT01044810|Antiviral Agents|antiviral agents|mesh-ancestor
110698697|NCT01044810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110698698|NCT01044810|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110698699|NCT01044810|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110162033|NCT00110695|Paclitaxel|paclitaxel|mesh-list
110698700|NCT01044810|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110698701|NCT01044810|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110698702|NCT01044810|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110698703|NCT01044810|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110698705|NCT01033370|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110698706|NCT01033370|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110698707|NCT01033370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110698708|NCT01033370|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110698709|NCT01033370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110698710|NCT01044888|Heparin|heparin|mesh-list
110698711|NCT01044888|Anticoagulants|anticoagulants|mesh-ancestor
110698712|NCT01044888|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110108880|NCT01821404|Atorvastatin|atorvastatin|mesh-list
110698713|NCT01044888|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110698714|NCT01044888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110698717|NCT03742466|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110698718|NCT03742466|Prednisolone|prednisolone|mesh-list
110698719|NCT03742466|Prednisolone acetate|prednisolone acetate|mesh-list
110698720|NCT03742466|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110698721|NCT03742466|Prednisolone phosphate|prednisolone phosphate|mesh-list
110698722|NCT03742466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110427238|NCT02722369|Etoposide|etoposide|mesh-list
110698723|NCT03742466|Antiemetics|antiemetics|mesh-ancestor
110698724|NCT03742466|Autonomic Agents|autonomic agents|mesh-ancestor
110698725|NCT03742466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110698726|NCT03742466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110698727|NCT03742466|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110698729|NCT03742466|Hormones|hormones|mesh-ancestor
110698730|NCT03742466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110698731|NCT03742466|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110698732|NCT03742466|Protective Agents|protective agents|mesh-ancestor
110698733|NCT03742466|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110698734|NCT03742466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110698735|NCT01065285|Vaccines|vaccines|mesh-list
110698736|NCT01065285|Immunologic Factors|immunologic factors|mesh-ancestor
110698737|NCT01065285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110698738|NCT01033526|Aspirin|aspirin|mesh-list
110698739|NCT01033526|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110698740|NCT01033526|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110698741|NCT01033526|Analgesics|analgesics|mesh-ancestor
110698742|NCT01033526|Sensory System Agents|sensory system agents|mesh-ancestor
110698743|NCT01033526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110427741|NCT00605410|Bromides|bromides|mesh-list
110698744|NCT01033526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110698745|NCT01033526|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110698746|NCT01033526|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110698747|NCT01033526|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110698748|NCT01033526|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110698749|NCT01033526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110698750|NCT01033526|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110698751|NCT01033526|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110698752|NCT01033526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110698753|NCT01033526|Antipyretics|antipyretics|mesh-ancestor
110698754|NCT00397488|Sunitinib|sunitinib|mesh-list
110698755|NCT00397488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110698756|NCT00397488|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110698757|NCT00397488|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110698758|NCT00397488|Growth Substances|growth substances|mesh-ancestor
110109048|NCT01822639|Amlodipine|amlodipine|mesh-list
110698759|NCT00397488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110698760|NCT00397488|Growth Inhibitors|growth inhibitors|mesh-ancestor
110698761|NCT00397488|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110698762|NCT00397488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110698763|NCT00397488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110698764|NCT01581411|Plasminogen|plasminogen|mesh-list
110698765|NCT01581411|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
110698766|NCT01581411|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110698767|NCT01581411|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110698768|NCT01581411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110698769|NCT02900664|Trametinib|trametinib|mesh-list
110698770|NCT02900664|Spartalizumab|spartalizumab|mesh-list
110698771|NCT02900664|Nazartinib|nazartinib|mesh-list
110698772|NCT02900664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110698773|NCT02900664|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110698774|NCT02900664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110698775|NCT02900664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110698776|NCT02900664|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110698777|NCT02900664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110698779|NCT01324596|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110698780|NCT01324596|Methylprednisolone|methylprednisolone|mesh-list
110698781|NCT01324596|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110698782|NCT01324596|Prednisolone acetate|prednisolone acetate|mesh-list
110698783|NCT01324596|Cyclophosphamide|cyclophosphamide|mesh-list
110698784|NCT01324596|Rituximab|rituximab|mesh-list
110698785|NCT01324596|Doxorubicin|doxorubicin|mesh-list
110698786|NCT01324596|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110698787|NCT01324596|Vincristine|vincristine|mesh-list
110698788|NCT01324596|Bortezomib|bortezomib|mesh-list
110698790|NCT01324596|Prednisolone phosphate|prednisolone phosphate|mesh-list
110698791|NCT01324596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110698792|NCT01324596|Immunologic Factors|immunologic factors|mesh-ancestor
110698793|NCT01324596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110698794|NCT01324596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110428670|NCT01209143|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110698795|NCT01324596|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110698797|NCT01324596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110698798|NCT01324596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110698799|NCT01324596|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110416659|NCT01263197|Autonomic Agents|autonomic agents|mesh-ancestor
110698800|NCT01324596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110698801|NCT01324596|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110428959|NCT02697955|Epinephrine|epinephrine|mesh-list
110698802|NCT01324596|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110698803|NCT01324596|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110698804|NCT01324596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110429022|NCT00997893|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110698805|NCT01324596|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110698806|NCT01324596|Tubulin Modulators|tubulin modulators|mesh-ancestor
110698807|NCT01324596|Antimitotic Agents|antimitotic agents|mesh-ancestor
110698808|NCT01324596|Mitosis Modulators|mitosis modulators|mesh-ancestor
110698809|NCT01324596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110698810|NCT01324596|Glucocorticoids|glucocorticoids|mesh-ancestor
110698812|NCT01324596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110698813|NCT01324596|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110698814|NCT01324596|Antiemetics|antiemetics|mesh-ancestor
110698815|NCT01324596|Autonomic Agents|autonomic agents|mesh-ancestor
110698816|NCT01324596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110698817|NCT01324596|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110698818|NCT01324596|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110698819|NCT01324596|Protective Agents|protective agents|mesh-ancestor
110698820|NCT00424190|Vancomycin|vancomycin|mesh-list
110698821|NCT00424190|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
110698822|NCT00424190|Aztreonam|aztreonam|mesh-list
110698823|NCT00424190|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110698824|NCT00424190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110698825|NCT02859012|Axitinib|axitinib|mesh-list
110698826|NCT02859012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110698827|NCT02859012|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110698828|NCT02859012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110698829|NCT02859012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110698830|NCT00274287|Sargramostim|sargramostim|mesh-list
110698831|NCT00274287|Immunologic Factors|immunologic factors|mesh-ancestor
110109431|NCT01825473|Erythromycin|erythromycin|mesh-list
110698832|NCT00274287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110698833|NCT01045278|Interferons|interferons|mesh-list
110698834|NCT01045278|Ribavirin|ribavirin|mesh-list
110698835|NCT01045278|Interferon-alpha|interferon-alpha|mesh-list
110698836|NCT01045278|Interferon alpha-2|interferon alpha-2|mesh-list
110698837|NCT01045278|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110698838|NCT01045278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110698839|NCT01045278|Antiviral Agents|antiviral agents|mesh-ancestor
110698840|NCT01045278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110698841|NCT01045278|Antimetabolites|antimetabolites|mesh-ancestor
110698842|NCT01045278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110698843|NCT01045278|Immunologic Factors|immunologic factors|mesh-ancestor
110698844|NCT01045278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110698845|NCT00423800|Interferons|interferons|mesh-list
110698846|NCT00423800|Ribavirin|ribavirin|mesh-list
110698847|NCT00423800|Interferon-alpha|interferon-alpha|mesh-list
110698848|NCT00423800|Interferon alpha-2|interferon alpha-2|mesh-list
110698849|NCT00423800|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110698850|NCT00423800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110698851|NCT00423800|Antiviral Agents|antiviral agents|mesh-ancestor
110698852|NCT00423800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110698853|NCT00423800|Antimetabolites|antimetabolites|mesh-ancestor
110698854|NCT00423800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110698855|NCT00423800|Immunologic Factors|immunologic factors|mesh-ancestor
110698856|NCT00423800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110698857|NCT00405548|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
110698858|NCT00405548|Natriuretic Agents|natriuretic agents|mesh-ancestor
110698859|NCT00405548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110698860|NCT00405392|Ibandronic Acid|ibandronic acid|mesh-list
110698861|NCT00405392|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110698862|NCT00405392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110698863|NCT00282243|Tacrolimus|tacrolimus|mesh-list
110698864|NCT00282243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110698865|NCT00282243|Immunologic Factors|immunologic factors|mesh-ancestor
110698866|NCT00282243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110698867|NCT00282243|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110698868|NCT00282243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110698869|NCT00282243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110698870|NCT00272961|N-(2-acetyl-4,6-dimethylphenyl)-3-(3,4-dimethylisoxazol-5-ylsulfamoyl)thiophene-2-carboxamide|n-(2-acetyl-4,6-dimethylphenyl)-3-(3,4-dimethylisoxazol-5-ylsulfamoyl)thiophene-2-carboxamide|mesh-list
110698871|NCT00272961|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
110698872|NCT00272961|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
110698873|NCT00272961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110698874|NCT00282087|Gemcitabine|gemcitabine|mesh-list
110698876|NCT00282087|Doxorubicin|doxorubicin|mesh-list
110698877|NCT00282087|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110698878|NCT00282087|Antimetabolites|antimetabolites|mesh-ancestor
110109598|NCT01827020|Sensory System Agents|sensory system agents|mesh-ancestor
110698879|NCT00282087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110698880|NCT00282087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110698881|NCT00282087|Tubulin Modulators|tubulin modulators|mesh-ancestor
110698882|NCT00282087|Antimitotic Agents|antimitotic agents|mesh-ancestor
110698883|NCT00282087|Mitosis Modulators|mitosis modulators|mesh-ancestor
110698884|NCT00282087|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110109661|NCT01827293|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110698885|NCT00282087|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110698886|NCT00282087|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110698887|NCT00282087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110698889|NCT00281697|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110698890|NCT00281697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110698891|NCT00281697|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110698892|NCT00281697|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110698893|NCT00281697|Growth Substances|growth substances|mesh-ancestor
110698894|NCT00281697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110698895|NCT00281697|Growth Inhibitors|growth inhibitors|mesh-ancestor
110698897|NCT00232180|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110698898|NCT00232180|Hormone Antagonists|hormone antagonists|mesh-ancestor
110698899|NCT00232180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110698900|NCT00232180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110698901|NCT00232180|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110698902|NCT00232180|Diuretics|diuretics|mesh-ancestor
110698903|NCT00232180|Natriuretic Agents|natriuretic agents|mesh-ancestor
110698904|NCT00232180|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110698905|NCT01070277|Albendazole|albendazole|mesh-list
110698906|NCT01070277|Tinidazole|tinidazole|mesh-list
110698907|NCT01070277|Anthelmintics|anthelmintics|mesh-ancestor
110698908|NCT01070277|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110698909|NCT01070277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110698910|NCT01070277|Anticestodal Agents|anticestodal agents|mesh-ancestor
110698911|NCT01070277|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110698912|NCT01070277|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110698913|NCT01070277|Tubulin Modulators|tubulin modulators|mesh-ancestor
110698914|NCT01070277|Antimitotic Agents|antimitotic agents|mesh-ancestor
110698915|NCT01070277|Mitosis Modulators|mitosis modulators|mesh-ancestor
110430256|NCT05378399|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110698916|NCT01070277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110698917|NCT01070277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110698919|NCT01070277|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110698920|NCT01070277|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
110698921|NCT00270231|Naltrexone|naltrexone|mesh-list
110698922|NCT00270231|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110698923|NCT00270231|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110698924|NCT00270231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110698925|NCT00270231|Sensory System Agents|sensory system agents|mesh-ancestor
110698926|NCT00270231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110698927|NCT02532309|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110698928|NCT02532309|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110698929|NCT02532309|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110698930|NCT02532309|Antimetabolites|antimetabolites|mesh-ancestor
110698931|NCT02532309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110698932|NCT02532309|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110698933|NCT02532309|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110698934|NCT02532309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110698935|NCT00258856|Vaccines|vaccines|mesh-list
110698936|NCT00258856|Immunologic Factors|immunologic factors|mesh-ancestor
110698937|NCT00258856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110698938|NCT00269919|Risperidone|risperidone|mesh-list
110698939|NCT00269919|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110698940|NCT00269919|Serotonin Agents|serotonin agents|mesh-ancestor
110698941|NCT00269919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110698942|NCT00269919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110698943|NCT00269919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110698944|NCT00269919|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110698945|NCT00269919|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110698946|NCT00269919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110698947|NCT00269919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110698948|NCT00269919|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110698950|NCT00257920|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
110698951|NCT00257920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110698953|NCT00257920|Micronutrients|micronutrients|mesh-ancestor
110698954|NCT00257920|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110698956|NCT00268983|Rituximab|rituximab|mesh-list
110698957|NCT00268983|Tositumomab I-131|tositumomab i-131|mesh-list
110698958|NCT00268983|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110698959|NCT00268983|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110698960|NCT00268983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110698961|NCT00268983|Immunologic Factors|immunologic factors|mesh-ancestor
110698962|NCT00268983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110698963|NCT00268983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110698964|NCT00268983|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110698965|NCT00268983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110698966|NCT00268983|Trace Elements|trace elements|mesh-ancestor
110430455|NCT00638833|Memantine|memantine|mesh-list
110698967|NCT00268983|Micronutrients|micronutrients|mesh-ancestor
110698968|NCT01070511|Tadalafil|tadalafil|mesh-list
110698969|NCT01070511|Vasodilator Agents|vasodilator agents|mesh-ancestor
110698970|NCT01070511|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110698971|NCT01070511|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110698972|NCT01070511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110698973|NCT01070511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110698974|NCT01070511|Urological Agents|urological agents|mesh-ancestor
110698975|NCT01070667|Dronedarone|dronedarone|mesh-list
110698976|NCT01070667|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110698977|NCT00257608|Bevacizumab|bevacizumab|mesh-list
110698978|NCT00257608|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110698979|NCT00257608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110698980|NCT00257608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110698981|NCT00257608|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110698982|NCT00257608|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110698983|NCT00257608|Growth Substances|growth substances|mesh-ancestor
110698984|NCT00257608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110698985|NCT00257608|Growth Inhibitors|growth inhibitors|mesh-ancestor
110698986|NCT00257608|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110698987|NCT00257608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110430723|NCT02680717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110698988|NCT00257608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110698989|NCT00231478|Granisetron|granisetron|mesh-list
110698991|NCT00231478|Autonomic Agents|autonomic agents|mesh-ancestor
110698992|NCT00231478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110698993|NCT00231478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110698994|NCT00231478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110698995|NCT00231478|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110698996|NCT00231478|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110698997|NCT00231478|Serotonin Agents|serotonin agents|mesh-ancestor
110698998|NCT00231478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110698999|NCT00231478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110699000|NCT00207142|Ritonavir|ritonavir|mesh-list
110699001|NCT00207142|Atazanavir Sulfate|atazanavir sulfate|mesh-list
110699002|NCT00207142|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110699003|NCT00207142|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110699004|NCT00207142|Protease Inhibitors|protease inhibitors|mesh-ancestor
110699005|NCT00207142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110699006|NCT00207142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110699007|NCT00207142|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110699008|NCT00207142|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110699009|NCT00207142|Antiviral Agents|antiviral agents|mesh-ancestor
110699010|NCT00207142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110699011|NCT00207142|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110430918|NCT02869035|Dopamine Agents|dopamine agents|mesh-ancestor
110699012|NCT00207142|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110699013|NCT00268905|Carboplatin|carboplatin|mesh-list
110699014|NCT00268905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110699015|NCT00206518|Docetaxel|docetaxel|mesh-list
110699016|NCT00206518|Doxorubicin|doxorubicin|mesh-list
110699017|NCT00206518|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110699018|NCT00206518|Cyclophosphamide|cyclophosphamide|mesh-list
110699019|NCT00206518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110699020|NCT00206518|Tubulin Modulators|tubulin modulators|mesh-ancestor
110402146|NCT05983354|Ibuprofen|ibuprofen|mesh-list
110699021|NCT00206518|Antimitotic Agents|antimitotic agents|mesh-ancestor
110699022|NCT00206518|Mitosis Modulators|mitosis modulators|mesh-ancestor
110416890|NCT00995566|Sitaxsentan|sitaxsentan|mesh-list
110699023|NCT00206518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110699024|NCT00206518|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110699025|NCT00206518|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110699026|NCT00206518|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110699027|NCT00206518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110699028|NCT00206518|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110430992|NCT01177800|Infliximab|infliximab|mesh-list
110699029|NCT00206518|Immunologic Factors|immunologic factors|mesh-ancestor
110431051|NCT04205916|Glucocorticoids|glucocorticoids|mesh-ancestor
110699030|NCT00206518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110699031|NCT00206518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110699032|NCT00206518|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110699033|NCT00206518|Alkylating Agents|alkylating agents|mesh-ancestor
110699034|NCT00206518|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110699035|NCT00206440|Esomeprazole|esomeprazole|mesh-list
110699036|NCT00206440|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110699037|NCT00206440|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110699038|NCT00206440|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110699039|NCT00206440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110699040|NCT00206440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110699041|NCT00268437|Carboplatin|carboplatin|mesh-list
110699042|NCT00268437|Pemetrexed|pemetrexed|mesh-list
110699043|NCT00268437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110699044|NCT00268437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110431351|NCT04261270|Ritonavir|ritonavir|mesh-list
110699045|NCT00268437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110699046|NCT00268437|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110431418|NCT00610246|Sorafenib|sorafenib|mesh-list
110699047|NCT00268437|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110699048|NCT00423488|Simvastatin|simvastatin|mesh-list
110699049|NCT00423488|Ezetimibe|ezetimibe|mesh-list
110699050|NCT00423488|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110699051|NCT00423488|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110699052|NCT00423488|Antimetabolites|antimetabolites|mesh-ancestor
110699053|NCT00423488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110699054|NCT00423488|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110699055|NCT00423488|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110699056|NCT00423488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110699058|NCT00404066|Cyclophosphamide|cyclophosphamide|mesh-list
110699059|NCT00404066|Docetaxel|docetaxel|mesh-list
110699060|NCT00404066|Doxorubicin|doxorubicin|mesh-list
110699061|NCT00404066|Trastuzumab|trastuzumab|mesh-list
110699062|NCT00404066|Lapatinib|lapatinib|mesh-list
110699063|NCT00404066|Lenograstim|lenograstim|mesh-list
110431694|NCT01179347|Tiotropium Bromide|tiotropium bromide|mesh-list
110699064|NCT00404066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110699065|NCT00404066|Immunologic Factors|immunologic factors|mesh-ancestor
110699066|NCT00404066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110699067|NCT00404066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110699068|NCT00404066|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110699069|NCT00404066|Alkylating Agents|alkylating agents|mesh-ancestor
110699070|NCT00404066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110699071|NCT00404066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110699072|NCT00404066|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110431904|NCT01132482|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110699073|NCT00404066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110699074|NCT00404066|Antiemetics|antiemetics|mesh-ancestor
110699075|NCT00404066|Autonomic Agents|autonomic agents|mesh-ancestor
110699076|NCT00404066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110699077|NCT00404066|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110699078|NCT00404066|Glucocorticoids|glucocorticoids|mesh-ancestor
110699079|NCT00404066|Hormones|hormones|mesh-ancestor
110432053|NCT01145352|Analgesics|analgesics|mesh-ancestor
110699080|NCT00404066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110699081|NCT00404066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110699082|NCT00404066|Tubulin Modulators|tubulin modulators|mesh-ancestor
110699083|NCT00404066|Antimitotic Agents|antimitotic agents|mesh-ancestor
110699084|NCT00404066|Mitosis Modulators|mitosis modulators|mesh-ancestor
110699085|NCT00404066|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110699086|NCT00404066|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110699087|NCT00404066|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110699088|NCT00404066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110699089|NCT00404066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110699090|NCT00404066|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110699091|NCT00404066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110699093|NCT00423332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110699094|NCT00423332|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110699095|NCT00423332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110699096|NCT00423332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110699097|NCT00413036|Lenalidomide|lenalidomide|mesh-list
110699098|NCT00413036|Immunologic Factors|immunologic factors|mesh-ancestor
110699099|NCT00413036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110699100|NCT00413036|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110699101|NCT00413036|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110699102|NCT00413036|Growth Substances|growth substances|mesh-ancestor
110699103|NCT00413036|Growth Inhibitors|growth inhibitors|mesh-ancestor
110699104|NCT00413036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110699105|NCT00412958|Plasminogen|plasminogen|mesh-list
110699106|NCT00412958|Fibrinolysin|fibrinolysin|mesh-list
110699107|NCT00412958|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110699108|NCT00412958|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110699109|NCT00412958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110699110|NCT00423176|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110699111|NCT00423176|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
110699112|NCT00423176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110699113|NCT00423176|Antitubercular Agents|antitubercular agents|mesh-ancestor
110699114|NCT01040702|Methylphenidate|methylphenidate|mesh-list
110699115|NCT01040702|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110110340|NCT01840813|Abortifacient Agents|abortifacient agents|mesh-ancestor
110699116|NCT01040702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110432631|NCT05736874|Autonomic Agents|autonomic agents|mesh-ancestor
110699117|NCT01040702|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110699118|NCT01040702|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110699119|NCT01040702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110699120|NCT01040702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110699121|NCT01040702|Dopamine Agents|dopamine agents|mesh-ancestor
110699122|NCT01040702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110699123|NCT00268203|Tositumomab I-131|tositumomab i-131|mesh-list
110699124|NCT00268203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110699126|NCT00384930|Vasodilator Agents|vasodilator agents|mesh-ancestor
110699127|NCT00384930|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110699128|NCT00384930|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110699129|NCT00384930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110699130|NCT00384930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110699131|NCT00384930|Urological Agents|urological agents|mesh-ancestor
110699132|NCT00423098|Mycophenolic Acid|mycophenolic acid|mesh-list
110699133|NCT00423098|Prednisone|prednisone|mesh-list
110699134|NCT00423098|Methylprednisolone|methylprednisolone|mesh-list
110699135|NCT00423098|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110699136|NCT00423098|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110699137|NCT00423098|Prednisolone|prednisolone|mesh-list
110699138|NCT00423098|Prednisolone acetate|prednisolone acetate|mesh-list
110699139|NCT00423098|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110699140|NCT00423098|Prednisolone phosphate|prednisolone phosphate|mesh-list
110699141|NCT00423098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110699142|NCT00423098|Glucocorticoids|glucocorticoids|mesh-ancestor
110699144|NCT00423098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110699145|NCT00423098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110699146|NCT00423098|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110432969|NCT04524910|Growth Inhibitors|growth inhibitors|mesh-ancestor
110699147|NCT00423098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110699148|NCT00423098|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110433040|NCT04084717|Crizotinib|crizotinib|mesh-list
110699149|NCT00423098|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110699150|NCT00423098|Antitubercular Agents|antitubercular agents|mesh-ancestor
110699151|NCT00423098|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110699152|NCT00423098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110699153|NCT00423098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110699154|NCT00423098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110699155|NCT00423098|Antiemetics|antiemetics|mesh-ancestor
110699156|NCT00423098|Autonomic Agents|autonomic agents|mesh-ancestor
110699157|NCT00423098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110699158|NCT00423098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110699159|NCT00423098|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110699160|NCT00423098|Protective Agents|protective agents|mesh-ancestor
110699162|NCT01042704|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110699163|NCT01042704|Dexamethasone|dexamethasone|mesh-list
110699164|NCT01042704|Lenalidomide|lenalidomide|mesh-list
110699165|NCT01042704|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110699166|NCT01042704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110699167|NCT01042704|Antiemetics|antiemetics|mesh-ancestor
110699168|NCT01042704|Autonomic Agents|autonomic agents|mesh-ancestor
110699169|NCT01042704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110699170|NCT01042704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110699171|NCT01042704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110699172|NCT01042704|Glucocorticoids|glucocorticoids|mesh-ancestor
110699173|NCT01042704|Hormones|hormones|mesh-ancestor
110699174|NCT01042704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110699175|NCT01042704|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110699176|NCT01042704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110699177|NCT01042704|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110699178|NCT01042704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110699179|NCT01042704|Analgesics|analgesics|mesh-ancestor
110699180|NCT01042704|Sensory System Agents|sensory system agents|mesh-ancestor
110699181|NCT01042704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110699182|NCT01042704|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110699183|NCT01042704|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110699184|NCT01042704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110699185|NCT01042704|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110699187|NCT01042704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110699188|NCT01042704|Antipyretics|antipyretics|mesh-ancestor
110699189|NCT01042704|Immunologic Factors|immunologic factors|mesh-ancestor
110699190|NCT01042704|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110699191|NCT01042704|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110699192|NCT01042704|Growth Substances|growth substances|mesh-ancestor
110699193|NCT01042704|Growth Inhibitors|growth inhibitors|mesh-ancestor
110699194|NCT01042704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110699195|NCT01042704|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110699196|NCT01042704|Alkylating Agents|alkylating agents|mesh-ancestor
110699197|NCT00750698|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110699198|NCT00750698|Entinostat|entinostat|mesh-list
110699199|NCT00750698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110699200|NCT00750698|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110699201|NCT00750698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110699202|NCT00750698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110699203|NCT00750698|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110699205|NCT01046838|Vasodilator Agents|vasodilator agents|mesh-ancestor
110699206|NCT01046838|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110699207|NCT01046838|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110699208|NCT01046838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110699209|NCT01046838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110699211|NCT01042782|Everolimus|everolimus|mesh-list
110699212|NCT01042782|Mitomycin|mitomycin|mesh-list
110699213|NCT01042782|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110433667|NCT04264858|Immunoglobulins|immunoglobulins|mesh-list
110699214|NCT01042782|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110699215|NCT01042782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110699216|NCT01042782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110699217|NCT01042782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110699218|NCT01042782|Immunologic Factors|immunologic factors|mesh-ancestor
110699219|NCT01042782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110699220|NCT01042782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110699221|NCT01042782|Alkylating Agents|alkylating agents|mesh-ancestor
110699222|NCT01042782|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110699223|NCT01042782|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110699224|NCT00411788|Sirolimus|sirolimus|mesh-list
110699225|NCT00411788|Trastuzumab|trastuzumab|mesh-list
110699226|NCT00411788|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110699227|NCT00411788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110699228|NCT00411788|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110699229|NCT00411788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110699230|NCT00411788|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110699231|NCT00411788|Antifungal Agents|antifungal agents|mesh-ancestor
110699232|NCT00411788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110433939|NCT00970281|Serotonin Agents|serotonin agents|mesh-ancestor
110402295|NCT05907525|Propofol|propofol|mesh-list
110699233|NCT00411788|Immunologic Factors|immunologic factors|mesh-ancestor
110434012|NCT01131078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110699234|NCT00411788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110699235|NCT01046994|Hypoglycemic Agents|hypoglycemic agents|mesh-list
110699236|NCT01046994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110699237|NCT01040936|Atorvastatin|atorvastatin|mesh-list
110699238|NCT01040936|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110699239|NCT01040936|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110699240|NCT01040936|Antimetabolites|antimetabolites|mesh-ancestor
110434085|NCT04033471|Narcotics|narcotics|mesh-ancestor
110699241|NCT01040936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110699242|NCT01040936|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110699243|NCT01040936|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110699244|NCT01040936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110699245|NCT01041092|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
110699246|NCT01041092|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110434299|NCT01172873|Antimetabolites|antimetabolites|mesh-ancestor
110699247|NCT01041092|Hormone Antagonists|hormone antagonists|mesh-ancestor
110417100|NCT01255163|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110434372|NCT00968253|Hormones|hormones|mesh-ancestor
110699248|NCT01041092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110699249|NCT01041092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110699250|NCT01041092|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110110711|NCT01843257|Ethanol|ethanol|mesh-list
110699251|NCT01041092|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110699252|NCT01041092|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110699254|NCT01041170|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110699255|NCT01041170|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
110699256|NCT01041170|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110434446|NCT04255498|Etanercept|etanercept|mesh-list
110699257|NCT01041170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110699258|NCT01041170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110699259|NCT01041170|Hormones|hormones|mesh-ancestor
110699260|NCT01041170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110699261|NCT01041170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110699262|NCT01041482|Sorafenib|sorafenib|mesh-list
110699263|NCT01041482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110699264|NCT01041482|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110699265|NCT01041482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110699266|NCT01041482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110699267|NCT00422942|Rituximab|rituximab|mesh-list
110699268|NCT00422942|Methotrexate|methotrexate|mesh-list
110699269|NCT00422942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110699270|NCT00422942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110434747|NCT02861859|Olanzapine|olanzapine|mesh-list
110699271|NCT00422942|Immunologic Factors|immunologic factors|mesh-ancestor
110859223|NCT06029530|Mydriatics|mydriatics|mesh-ancestor
110699272|NCT00422942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110434796|NCT00646321|Hormones|hormones|mesh-ancestor
110699274|NCT00422942|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110699275|NCT00422942|Abortifacient Agents|abortifacient agents|mesh-ancestor
110699276|NCT00422942|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110699277|NCT00422942|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110699278|NCT00422942|Antimetabolites|antimetabolites|mesh-ancestor
110699279|NCT00422942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110699280|NCT00422942|Dermatologic Agents|dermatologic agents|mesh-ancestor
110699281|NCT00422942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110699282|NCT00422942|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110699283|NCT00422942|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110699284|NCT00422942|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110699285|NCT01039142|Acitretin|acitretin|mesh-list
110699286|NCT01039142|Keratolytic Agents|keratolytic agents|mesh-ancestor
110699287|NCT01039142|Dermatologic Agents|dermatologic agents|mesh-ancestor
110699288|NCT00422162|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110699289|NCT00422162|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110699290|NCT00422162|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110699291|NCT00422162|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110699292|NCT00422162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110699293|NCT00422162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110699294|NCT00422162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110699295|NCT00422162|Analgesics|analgesics|mesh-ancestor
110699296|NCT00422162|Sensory System Agents|sensory system agents|mesh-ancestor
110699297|NCT00422162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110699298|NCT00422162|Antidepressive Agents|antidepressive agents|mesh-ancestor
110699299|NCT00422162|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110699300|NCT00422162|Dopamine Agents|dopamine agents|mesh-ancestor
110699301|NCT00411632|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110699302|NCT00411632|Bexarotene|bexarotene|mesh-list
110699303|NCT00411632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110699304|NCT00411632|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110699305|NCT00411632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110699306|NCT00411632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110699307|NCT00422084|Artesunate|artesunate|mesh-list
110699308|NCT00422084|Lumefantrine|lumefantrine|mesh-list
110699309|NCT00422084|Artemether|artemether|mesh-list
110699310|NCT00422084|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
110699311|NCT00422084|Pyronaridine|pyronaridine|mesh-list
110699312|NCT00422084|Pyronaridine tetraphosphate, artesunate drug combination|pyronaridine tetraphosphate, artesunate drug combination|mesh-list
110699313|NCT00422084|Antimalarials|antimalarials|mesh-ancestor
110699314|NCT00422084|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110699315|NCT00422084|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110699316|NCT00422084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110699317|NCT00422084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110699318|NCT00422084|Antiviral Agents|antiviral agents|mesh-ancestor
110699319|NCT00422084|Schistosomicides|schistosomicides|mesh-ancestor
110699320|NCT00422084|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110699321|NCT00422084|Anthelmintics|anthelmintics|mesh-ancestor
110699322|NCT00421928|Oxycodone|oxycodone|mesh-list
110699323|NCT00421928|Tapentadol|tapentadol|mesh-list
110699324|NCT00421928|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110699325|NCT00421928|Narcotics|narcotics|mesh-ancestor
110699326|NCT00421928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110699327|NCT00421928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110699328|NCT00421928|Analgesics|analgesics|mesh-ancestor
110699329|NCT00421928|Sensory System Agents|sensory system agents|mesh-ancestor
110435417|NCT00648193|Serotonin Agents|serotonin agents|mesh-ancestor
110699330|NCT00421928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110435482|NCT00648427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110699331|NCT00421928|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110699332|NCT00421928|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110699333|NCT00421928|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110435567|NCT02658799|Diclofenac|diclofenac|mesh-list
110699334|NCT00421928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110699335|NCT00421928|Adrenergic Agents|adrenergic agents|mesh-ancestor
110699336|NCT00421928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110699338|NCT01047072|Cyclophosphamide|cyclophosphamide|mesh-list
110699339|NCT01047072|Rituximab|rituximab|mesh-list
110699340|NCT01047072|Fludarabine|fludarabine|mesh-list
110110984|NCT01844804|Infliximab|infliximab|mesh-list
110699341|NCT01047072|Fludarabine phosphate|fludarabine phosphate|mesh-list
110699342|NCT01047072|Tacrolimus|tacrolimus|mesh-list
110699343|NCT01047072|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110699344|NCT01047072|Immunologic Factors|immunologic factors|mesh-ancestor
110699345|NCT01047072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110699346|NCT01047072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110699347|NCT01047072|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110699348|NCT01047072|Alkylating Agents|alkylating agents|mesh-ancestor
110699349|NCT01047072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110435913|NCT02652091|Interferons|interferons|mesh-list
110699351|NCT01047072|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110699352|NCT01047072|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110699353|NCT01047072|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110699354|NCT01047072|Antimetabolites|antimetabolites|mesh-ancestor
110699355|NCT01047072|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110699356|NCT01047072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110699357|NCT01047072|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110699358|NCT01047072|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110699359|NCT01047072|Antitubercular Agents|antitubercular agents|mesh-ancestor
110699360|NCT01047072|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110699361|NCT01047072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110699363|NCT00372060|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110699364|NCT00372060|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110699365|NCT00372060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110699366|NCT00372060|Incretins|incretins|mesh-ancestor
110436265|NCT01121406|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110699368|NCT00372060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110699369|NCT00372060|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110699370|NCT00372060|Protease Inhibitors|protease inhibitors|mesh-ancestor
110699371|NCT00372060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110699372|NCT00372060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110699373|NCT01043172|Gemcitabine|gemcitabine|mesh-list
110699374|NCT01043172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110699375|NCT01043172|Antimetabolites|antimetabolites|mesh-ancestor
110699376|NCT01043172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110699377|NCT01043172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110699378|NCT01045434|Omeprazole|omeprazole|mesh-list
110699379|NCT01045434|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110699380|NCT01045434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110699381|NCT01045434|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110699382|NCT01045434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110859232|NCT06029309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110699383|NCT01045434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110699384|NCT01043484|Bevacizumab|bevacizumab|mesh-list
110699385|NCT01043484|Capecitabine|capecitabine|mesh-list
110699386|NCT01043484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110699387|NCT01043484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110436395|NCT00625170|Haloperidol|haloperidol|mesh-list
110699388|NCT01043484|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110699389|NCT01043484|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110699390|NCT01043484|Growth Substances|growth substances|mesh-ancestor
110699391|NCT01043484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110699392|NCT01043484|Growth Inhibitors|growth inhibitors|mesh-ancestor
110417248|NCT04319471|Antimetabolites|antimetabolites|mesh-ancestor
110699393|NCT01043484|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110699394|NCT01043484|Antimetabolites|antimetabolites|mesh-ancestor
110436611|NCT04669132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110699395|NCT01043484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110699397|NCT00396318|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110699398|NCT00396318|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110699399|NCT00396318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110699400|NCT00381888|PENTA|penta|mesh-list
110699401|NCT00381888|Fondaparinux|fondaparinux|mesh-list
110699402|NCT00381888|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110699403|NCT00381888|Antithrombins|antithrombins|mesh-ancestor
110699404|NCT00381888|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110699405|NCT00381888|Protease Inhibitors|protease inhibitors|mesh-ancestor
110436824|NCT00957801|Hormones|hormones|mesh-ancestor
110699406|NCT00381888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110699407|NCT00381888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110699408|NCT00381888|Anticoagulants|anticoagulants|mesh-ancestor
110436905|NCT00652795|Doxycycline|doxycycline|mesh-list
110699410|NCT00381888|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110699411|NCT00267969|Ustekinumab|ustekinumab|mesh-list
110699412|NCT00267969|Dermatologic Agents|dermatologic agents|mesh-ancestor
110699413|NCT00280293|Lamotrigine|lamotrigine|mesh-list
110699414|NCT00280293|Anticonvulsants|anticonvulsants|mesh-ancestor
110699415|NCT00280293|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110699416|NCT00280293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110437110|NCT02885909|Insulin|insulin|mesh-list
110699417|NCT00280293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110699418|NCT00280293|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110699419|NCT00280293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110699420|NCT00280293|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110699421|NCT00280293|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110437259|NCT00910858|Lenalidomide|lenalidomide|mesh-list
110699422|NCT00280293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110699423|NCT00280293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110699424|NCT00280293|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110699425|NCT00421148|Bromides|bromides|mesh-list
110699426|NCT00421148|Rocuronium|rocuronium|mesh-list
110699427|NCT00421148|Anticonvulsants|anticonvulsants|mesh-ancestor
110699428|NCT00421148|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110437398|NCT01136382|Hormones|hormones|mesh-ancestor
110699429|NCT00421148|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110699430|NCT00421148|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110699431|NCT00421148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110437472|NCT00910624|Ribavirin|ribavirin|mesh-list
110699432|NCT00421148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110699433|NCT00403754|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110699434|NCT00403754|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110699435|NCT00403754|Autonomic Agents|autonomic agents|mesh-ancestor
110699436|NCT00403754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110699437|NCT00403754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110699438|NCT00403754|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110699439|NCT00403754|Respiratory System Agents|respiratory system agents|mesh-ancestor
110699440|NCT00403754|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110111173|NCT01845701|Artesunate|artesunate|mesh-list
110699441|NCT00403754|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110699442|NCT00403754|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110699443|NCT00403754|Adrenergic Agents|adrenergic agents|mesh-ancestor
110699444|NCT00403754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110699445|NCT00403754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110699446|NCT00280059|Pregabalin|pregabalin|mesh-list
110699448|NCT00280059|Analgesics|analgesics|mesh-ancestor
110699449|NCT00280059|Sensory System Agents|sensory system agents|mesh-ancestor
110699450|NCT00280059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110437831|NCT02857491|Growth Inhibitors|growth inhibitors|mesh-ancestor
110699451|NCT00280059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110699452|NCT00280059|Anticonvulsants|anticonvulsants|mesh-ancestor
110699453|NCT00280059|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110699454|NCT00280059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110699455|NCT00280059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110699456|NCT00280059|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110699458|NCT00280059|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110699459|NCT00280059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110699460|NCT00280059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110699461|NCT00280059|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110699462|NCT00280059|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110699463|NCT00403130|Paclitaxel|paclitaxel|mesh-list
110699464|NCT00403130|Bevacizumab|bevacizumab|mesh-list
110699465|NCT00403130|Gemcitabine|gemcitabine|mesh-list
110438190|NCT02847442|Levodopa|levodopa|mesh-list
110699466|NCT00403130|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110683016|NCT00904631|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110699467|NCT00403130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110699468|NCT00403130|Tubulin Modulators|tubulin modulators|mesh-ancestor
110699469|NCT00403130|Antimitotic Agents|antimitotic agents|mesh-ancestor
110699470|NCT00403130|Mitosis Modulators|mitosis modulators|mesh-ancestor
110699471|NCT00403130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110699472|NCT00403130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110699473|NCT00403130|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110699474|NCT00403130|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110699475|NCT00403130|Growth Substances|growth substances|mesh-ancestor
110699476|NCT00403130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110699477|NCT00403130|Growth Inhibitors|growth inhibitors|mesh-ancestor
110699478|NCT00403130|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110699479|NCT00403130|Antimetabolites|antimetabolites|mesh-ancestor
110699480|NCT01039610|Moxifloxacin|moxifloxacin|mesh-list
110699481|NCT01039610|Linezolid|linezolid|mesh-list
110699482|NCT01039610|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110699483|NCT01039610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110699484|NCT01039610|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110699485|NCT01039610|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110699486|NCT01039610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110438692|NCT04481308|Fentanyl|fentanyl|mesh-list
110699487|NCT01039610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110438768|NCT02634463|Olanzapine|olanzapine|mesh-list
110699489|NCT01039610|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110699490|NCT00420290|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
110699491|NCT00420290|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110699493|NCT00267189|Everolimus|everolimus|mesh-list
110699494|NCT00267189|Azathioprine|azathioprine|mesh-list
110699495|NCT00267189|Tacrolimus|tacrolimus|mesh-list
110699496|NCT00267189|Cyclosporins|cyclosporins|mesh-list
110699497|NCT00267189|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
110699498|NCT00267189|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110438908|NCT00805324|Histamine Agents|histamine agents|mesh-ancestor
110699499|NCT00267189|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110699500|NCT00267189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110438974|NCT02841982|Analgesics|analgesics|mesh-ancestor
110699501|NCT00267189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110699502|NCT00267189|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110699504|NCT00267189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110859271|NCT06029049|Rocuronium|rocuronium|mesh-list
110699505|NCT00267189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110699506|NCT00267189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110699507|NCT00267189|Antimetabolites|antimetabolites|mesh-ancestor
110699508|NCT00267189|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110699509|NCT00267189|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110699510|NCT00267189|Antifungal Agents|antifungal agents|mesh-ancestor
110699511|NCT00267189|Dermatologic Agents|dermatologic agents|mesh-ancestor
110699512|NCT00402116|Temozolomide|temozolomide|mesh-list
110699513|NCT00402116|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110699514|NCT00402116|Alkylating Agents|alkylating agents|mesh-ancestor
110699515|NCT00402116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110699516|NCT00402116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110699517|NCT00401960|Daptomycin|daptomycin|mesh-list
110699518|NCT00401960|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110699519|NCT00401960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110699520|NCT00401726|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
110699521|NCT00401726|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110699522|NCT00401726|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110699523|NCT00401726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110699524|NCT00401726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110111544|NCT01848743|Tenofovir|tenofovir|mesh-list
110699525|NCT00401726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110699526|NCT00401726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110699527|NCT00401726|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110699528|NCT00401726|Antidepressive Agents|antidepressive agents|mesh-ancestor
110699529|NCT00401726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110699530|NCT00371826|Cyclosporine|cyclosporine|mesh-list
110699531|NCT00371826|Mycophenolic Acid|mycophenolic acid|mesh-list
110699532|NCT00371826|Prednisone|prednisone|mesh-list
110699533|NCT00371826|Everolimus|everolimus|mesh-list
110699534|NCT00371826|Cyclosporins|cyclosporins|mesh-list
110699535|NCT00371826|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
110699536|NCT00371826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110699537|NCT00371826|Glucocorticoids|glucocorticoids|mesh-ancestor
110699538|NCT00371826|Hormones|hormones|mesh-ancestor
110699539|NCT00371826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110699540|NCT00371826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110699541|NCT00371826|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110439159|NCT03314935|Leucovorin|leucovorin|mesh-list
110699542|NCT00371826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110699543|NCT00371826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110699544|NCT00371826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110086263|NCT05596071|Dsuvia|dsuvia|mesh-list
110699545|NCT00371826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110699546|NCT00371826|Immunologic Factors|immunologic factors|mesh-ancestor
110699547|NCT00371826|Antifungal Agents|antifungal agents|mesh-ancestor
110699548|NCT00371826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110699549|NCT00371826|Dermatologic Agents|dermatologic agents|mesh-ancestor
110699550|NCT00371826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110699551|NCT00371826|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110699553|NCT00371826|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110439523|NCT00661765|Varenicline|varenicline|mesh-list
110699554|NCT00371826|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110699555|NCT00371826|Antitubercular Agents|antitubercular agents|mesh-ancestor
110699556|NCT00371826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110699557|NCT03993366|Pramlintide|pramlintide|mesh-list
110699558|NCT03993366|Insulin Aspart|insulin aspart|mesh-list
110699559|NCT03993366|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110699560|NCT03993366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110699561|NCT02457702|Glycerol|glycerol|mesh-list
110699562|NCT02457702|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
110699563|NCT02457702|Protective Agents|protective agents|mesh-ancestor
110699564|NCT02457702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110699565|NCT00396084|Moxifloxacin|moxifloxacin|mesh-list
110699566|NCT00396084|Levofloxacin|levofloxacin|mesh-list
110699567|NCT00396084|Isoniazid|isoniazid|mesh-list
110699568|NCT00396084|Linezolid|linezolid|mesh-list
110699569|NCT00396084|Gatifloxacin|gatifloxacin|mesh-list
110699570|NCT00396084|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110439728|NCT02838472|Protective Agents|protective agents|mesh-ancestor
110699571|NCT00396084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110699572|NCT00396084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110699573|NCT00396084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110699574|NCT00396084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110859279|NCT06029023|Propolis|propolis|mesh-list
110699575|NCT00396084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110699576|NCT00396084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110699577|NCT00396084|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110699578|NCT00396084|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110439944|NCT00669643|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110699579|NCT00396084|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110699580|NCT00396084|Antitubercular Agents|antitubercular agents|mesh-ancestor
110699581|NCT00396084|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
110699582|NCT00396084|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110699583|NCT00396084|Antimetabolites|antimetabolites|mesh-ancestor
110699584|NCT00396084|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110699585|NCT00396084|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110699586|NCT00396084|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110699587|NCT00396084|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110699588|NCT00395850|Disulfiram|disulfiram|mesh-list
110699589|NCT00395850|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110699590|NCT00395850|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
110699591|NCT00395850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110699592|NCT00395850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110699593|NCT00420212|Dimethyl Fumarate|dimethyl fumarate|mesh-list
110440157|NCT01188551|Narcotics|narcotics|mesh-ancestor
110699594|NCT00420212|Dermatologic Agents|dermatologic agents|mesh-ancestor
110699595|NCT00420212|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110699596|NCT00420212|Immunologic Factors|immunologic factors|mesh-ancestor
110699597|NCT00420212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110699598|NCT00401258|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110699599|NCT00401258|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110699600|NCT00401258|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110699601|NCT00401258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110699602|NCT00401258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110440293|NCT02831218|Antipyretics|antipyretics|mesh-ancestor
110699603|NCT00401258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110699604|NCT00401258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110699605|NCT00401258|Analgesics|analgesics|mesh-ancestor
110440361|NCT02832778|Efavirenz|efavirenz|mesh-list
110699606|NCT00401258|Sensory System Agents|sensory system agents|mesh-ancestor
110699607|NCT00401258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110699608|NCT00401258|Antidepressive Agents|antidepressive agents|mesh-ancestor
110699609|NCT00401258|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110699610|NCT00401258|Dopamine Agents|dopamine agents|mesh-ancestor
110699611|NCT00380874|Pregabalin|pregabalin|mesh-list
110699612|NCT00380874|Analgesics|analgesics|mesh-ancestor
110699613|NCT00380874|Sensory System Agents|sensory system agents|mesh-ancestor
110699614|NCT00380874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110699615|NCT00380874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110699616|NCT00380874|Anticonvulsants|anticonvulsants|mesh-ancestor
110699617|NCT00380874|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110699618|NCT00380874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110699619|NCT00380874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110699620|NCT00380874|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110699621|NCT00380874|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110699622|NCT00380874|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110699623|NCT00380874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110699625|NCT00420056|Palbociclib|palbociclib|mesh-list
110699626|NCT00420056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110440795|NCT01104792|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110699627|NCT00420056|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110699628|NCT00420056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110699629|NCT00420056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110699630|NCT00411554|Inositol|inositol|mesh-list
110699631|NCT00411554|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110699632|NCT00411554|Voglibose|voglibose|mesh-list
110699633|NCT00411554|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110699634|NCT00411554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110699635|NCT00411554|Incretins|incretins|mesh-ancestor
110699636|NCT00411554|Hormones|hormones|mesh-ancestor
110699637|NCT00411554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110859283|NCT06029023|Analgesics|analgesics|mesh-ancestor
110699638|NCT00411554|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110699639|NCT00411554|Protease Inhibitors|protease inhibitors|mesh-ancestor
110699640|NCT00411554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110699641|NCT00411554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110699642|NCT00411554|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
110699643|NCT00411554|Vitamin B Complex|vitamin b complex|mesh-ancestor
110699645|NCT00411554|Micronutrients|micronutrients|mesh-ancestor
110699646|NCT00380718|Pemetrexed|pemetrexed|mesh-list
110699647|NCT00380718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110699648|NCT00380718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110441149|NCT02627053|Rivaroxaban|rivaroxaban|mesh-list
110699649|NCT00380718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110699650|NCT00380718|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110699651|NCT00380718|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110699652|NCT00380250|Lubiprostone|lubiprostone|mesh-list
110112154|NCT01853306|Veliparib|veliparib|mesh-list
110699653|NCT00380250|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
110699654|NCT00380250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110699655|NCT00380250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110699656|NCT00400400|Mycophenolic Acid|mycophenolic acid|mesh-list
110699657|NCT00400400|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110699658|NCT00400400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110441365|NCT00674557|Exemestane|exemestane|mesh-list
110699659|NCT00400400|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110699660|NCT00400400|Antitubercular Agents|antitubercular agents|mesh-ancestor
110699661|NCT00400400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110699662|NCT00400400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110699663|NCT00400400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110699664|NCT00400400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110699665|NCT00395694|Lamotrigine|lamotrigine|mesh-list
110699666|NCT00395694|Anticonvulsants|anticonvulsants|mesh-ancestor
110699667|NCT00395694|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110699668|NCT00395694|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110699669|NCT00395694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110699670|NCT00395694|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110699671|NCT00395694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110699672|NCT00395694|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110699673|NCT00395694|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110699674|NCT00395694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110699675|NCT00395694|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110699676|NCT00395694|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110699677|NCT00419744|Budesonide|budesonide|mesh-list
110699678|NCT00419744|Formoterol Fumarate|formoterol fumarate|mesh-list
110699679|NCT00419744|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
110699680|NCT00419744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110699681|NCT00419744|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110699682|NCT00419744|Autonomic Agents|autonomic agents|mesh-ancestor
110699683|NCT00419744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110699684|NCT00419744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110699685|NCT00419744|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110699686|NCT00419744|Respiratory System Agents|respiratory system agents|mesh-ancestor
110699687|NCT00419744|Glucocorticoids|glucocorticoids|mesh-ancestor
110699688|NCT00419744|Hormones|hormones|mesh-ancestor
110699689|NCT00419744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110699690|NCT00419744|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110699691|NCT00419744|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110699692|NCT00419744|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110699693|NCT00419744|Adrenergic Agents|adrenergic agents|mesh-ancestor
110699694|NCT00419744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110699695|NCT00419744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110699696|NCT01047774|Caseins|caseins|mesh-list
110699697|NCT01047774|Chelating Agents|chelating agents|mesh-ancestor
110699698|NCT01047774|Sequestering Agents|sequestering agents|mesh-ancestor
110859289|NCT06029023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110699699|NCT01047774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110699700|NCT00395304|Fluticasone|fluticasone|mesh-list
110699701|NCT00395304|Xhance|xhance|mesh-list
110699702|NCT00395304|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110699703|NCT00395304|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
110699704|NCT00395304|Montelukast|montelukast|mesh-list
110699705|NCT00395304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110699706|NCT00395304|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110699707|NCT00395304|Autonomic Agents|autonomic agents|mesh-ancestor
110699708|NCT00395304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110699709|NCT00395304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110699710|NCT00395304|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110699711|NCT00395304|Respiratory System Agents|respiratory system agents|mesh-ancestor
110699712|NCT00395304|Dermatologic Agents|dermatologic agents|mesh-ancestor
110699713|NCT00395304|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110699714|NCT00395304|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110699715|NCT00395304|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110699716|NCT00395304|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110699717|NCT00395304|Adrenergic Agents|adrenergic agents|mesh-ancestor
110699718|NCT00395304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110699719|NCT00395304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110699720|NCT00395304|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110699721|NCT00395304|Hormone Antagonists|hormone antagonists|mesh-ancestor
110699722|NCT00395304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110699723|NCT00395304|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110699724|NCT00395304|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110699725|NCT00395304|Glucocorticoids|glucocorticoids|mesh-ancestor
110699726|NCT00395304|Hormones|hormones|mesh-ancestor
110699727|NCT00395304|Sympathomimetics|sympathomimetics|mesh-ancestor
110699728|NCT00395226|Zinc Sulfate|zinc sulfate|mesh-list
110699729|NCT00395226|Astringents|astringents|mesh-ancestor
110699730|NCT00395226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110699731|NCT00395226|Dermatologic Agents|dermatologic agents|mesh-ancestor
110699732|NCT00394914|Pleconaril|pleconaril|mesh-list
110699733|NCT00394914|Antiviral Agents|antiviral agents|mesh-ancestor
110699734|NCT00394914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110699735|NCT00366444|Diclofenac|diclofenac|mesh-list
110442272|NCT04237246|Tacrolimus|tacrolimus|mesh-list
110112362|NCT01854723|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110699736|NCT00366444|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110699737|NCT00366444|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110699738|NCT00366444|Analgesics|analgesics|mesh-ancestor
110699739|NCT00366444|Sensory System Agents|sensory system agents|mesh-ancestor
110442336|NCT00874939|Cholinergic Agents|cholinergic agents|mesh-ancestor
110699740|NCT00366444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110699741|NCT00366444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110699742|NCT00366444|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110699743|NCT00366444|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110699744|NCT00366444|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110699745|NCT00366444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110699746|NCT00366444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110699747|NCT00365976|Eszopiclone|eszopiclone|mesh-list
110699748|NCT00365976|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110442558|NCT01185353|Methotrexate|methotrexate|mesh-list
110699749|NCT00365976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110699750|NCT00365976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110699751|NCT00378534|Cyclosporine|cyclosporine|mesh-list
110699752|NCT00378534|Cyclophosphamide|cyclophosphamide|mesh-list
110699753|NCT00378534|Fludarabine|fludarabine|mesh-list
110442628|NCT00687817|Paclitaxel|paclitaxel|mesh-list
110699754|NCT00378534|Cyclosporins|cyclosporins|mesh-list
110699755|NCT00378534|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110699756|NCT00378534|Immunologic Factors|immunologic factors|mesh-ancestor
110699757|NCT00378534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110699759|NCT00378534|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110699760|NCT00378534|Alkylating Agents|alkylating agents|mesh-ancestor
110442761|NCT01155167|Lidocaine|lidocaine|mesh-list
110699761|NCT00378534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110699762|NCT00378534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110699763|NCT00378534|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110112416|NCT01855100|Rivaroxaban|rivaroxaban|mesh-list
110699764|NCT00378534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110699765|NCT00378534|Antifungal Agents|antifungal agents|mesh-ancestor
110699766|NCT00378534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110699767|NCT00378534|Dermatologic Agents|dermatologic agents|mesh-ancestor
110442899|NCT00691405|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110442976|NCT02804386|Sofosbuvir|sofosbuvir|mesh-list
110699768|NCT00378534|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110699769|NCT00377676|Bromocriptine|bromocriptine|mesh-list
110699770|NCT00377676|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110699771|NCT00377676|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110699773|NCT00377676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110699774|NCT00377676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110443193|NCT02800252|Antipyretics|antipyretics|mesh-ancestor
110699775|NCT00377676|Dopamine Agonists|dopamine agonists|mesh-ancestor
110112460|NCT01855490|Exenatide|exenatide|mesh-list
110699776|NCT00377676|Dopamine Agents|dopamine agents|mesh-ancestor
110699777|NCT00377676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110699778|NCT00377676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110699780|NCT00377520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110699781|NCT00377520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110443396|NCT04135885|Folic Acid|folic acid|mesh-list
110699782|NCT00377520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110699783|NCT00377520|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110699784|NCT00377520|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110699785|NCT00377364|Acetaminophen|acetaminophen|mesh-list
110699786|NCT00377364|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110699787|NCT00377364|Analgesics|analgesics|mesh-ancestor
110699788|NCT00377364|Sensory System Agents|sensory system agents|mesh-ancestor
110699789|NCT00377364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110699790|NCT00377364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110699791|NCT00377364|Antipyretics|antipyretics|mesh-ancestor
110699792|NCT00365508|Nicotine|nicotine|mesh-list
110699793|NCT00365508|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110699794|NCT00365508|Autonomic Agents|autonomic agents|mesh-ancestor
110699795|NCT00365508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110699796|NCT00365508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110699797|NCT00365508|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110699798|NCT00365508|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110699799|NCT00365508|Cholinergic Agents|cholinergic agents|mesh-ancestor
110699800|NCT00365508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110699801|NCT00365508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110699802|NCT00365352|Gabapentin|gabapentin|mesh-list
110699803|NCT00365352|Analgesics|analgesics|mesh-ancestor
110699804|NCT00365352|Sensory System Agents|sensory system agents|mesh-ancestor
110699805|NCT00365352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110699806|NCT00365352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110699807|NCT00365352|Anticonvulsants|anticonvulsants|mesh-ancestor
110699808|NCT00365352|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110699809|NCT00365352|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110699810|NCT00365352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110699811|NCT00365352|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110699812|NCT00365352|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110699813|NCT00365352|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110699814|NCT00365352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110699815|NCT00365352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110699816|NCT00365352|Antimanic Agents|antimanic agents|mesh-ancestor
110699818|NCT00410384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110699819|NCT00410384|Immunologic Factors|immunologic factors|mesh-ancestor
110699820|NCT00410384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110699821|NCT00370032|Alosetron|alosetron|mesh-list
110699822|NCT00370032|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110699823|NCT00370032|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110699824|NCT00370032|Serotonin Agents|serotonin agents|mesh-ancestor
110699825|NCT00370032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110699826|NCT00370032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110699827|NCT00370032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110699828|NCT00410072|Tenofovir|tenofovir|mesh-list
110699829|NCT00410072|Entecavir|entecavir|mesh-list
110699830|NCT00410072|Antiviral Agents|antiviral agents|mesh-ancestor
110699831|NCT00410072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110699832|NCT00410072|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110699833|NCT00410072|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110699834|NCT00410072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110699835|NCT00410072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110699836|NCT00410072|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110699837|NCT00410072|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110699838|NCT00409838|Methotrexate|methotrexate|mesh-list
110699839|NCT00409838|Abatacept|abatacept|mesh-list
110699840|NCT00409838|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110699841|NCT00409838|Abortifacient Agents|abortifacient agents|mesh-ancestor
110699842|NCT00409838|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110699843|NCT00409838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110699844|NCT00409838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110699845|NCT00409838|Antimetabolites|antimetabolites|mesh-ancestor
110699846|NCT00409838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110112634|NCT01856205|Antibodies|antibodies|mesh-list
110699847|NCT00409838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110699848|NCT00409838|Dermatologic Agents|dermatologic agents|mesh-ancestor
110699849|NCT00409838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110699850|NCT00409838|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110699851|NCT00409838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110699852|NCT00409838|Immunologic Factors|immunologic factors|mesh-ancestor
110699853|NCT00409838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110699854|NCT00409838|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110699855|NCT00409838|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110699856|NCT00409838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110699858|NCT01041872|Propofol|propofol|mesh-list
110699859|NCT01041872|Anesthetics, Local|anesthetics, local|mesh-ancestor
110699860|NCT01041872|Anesthetics|anesthetics|mesh-ancestor
110699861|NCT01041872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110699862|NCT01041872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110699863|NCT01041872|Sensory System Agents|sensory system agents|mesh-ancestor
110699864|NCT01041872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110699865|NCT01041872|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110699866|NCT01041872|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110699867|NCT01041872|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110699868|NCT01041872|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110699869|NCT01041872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110699870|NCT01041872|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110699871|NCT01041872|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110699872|NCT01041872|Anesthetics, General|anesthetics, general|mesh-ancestor
110699873|NCT00399542|Lubiprostone|lubiprostone|mesh-list
110699874|NCT00399542|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
110699875|NCT00399542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110699876|NCT00399542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110699877|NCT01039766|Oxytocin|oxytocin|mesh-list
110699878|NCT01039766|Oxytocics|oxytocics|mesh-ancestor
110699879|NCT01039766|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110699880|NCT01039766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110699881|NCT00409682|Adalimumab|adalimumab|mesh-list
110699882|NCT00409682|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110699883|NCT00409682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110699884|NCT00409682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110699885|NCT01039844|Paclitaxel|paclitaxel|mesh-list
110699886|NCT01039844|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110112747|NCT01856985|Misoprostol|misoprostol|mesh-list
110699887|NCT01039844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110699888|NCT01039844|Tubulin Modulators|tubulin modulators|mesh-ancestor
110699889|NCT01039844|Antimitotic Agents|antimitotic agents|mesh-ancestor
110699890|NCT01039844|Mitosis Modulators|mitosis modulators|mesh-ancestor
110699891|NCT01039844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110699892|NCT01042028|Capecitabine|capecitabine|mesh-list
110699893|NCT01042028|Irinotecan|irinotecan|mesh-list
110699894|NCT01042028|Cetuximab|cetuximab|mesh-list
110699895|NCT01042028|Everolimus|everolimus|mesh-list
110699896|NCT01042028|Oxaliplatin|oxaliplatin|mesh-list
110699897|NCT01042028|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110699898|NCT01042028|Antimetabolites|antimetabolites|mesh-ancestor
110699899|NCT01042028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110699900|NCT01042028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110112787|NCT01857141|Dexmedetomidine|dexmedetomidine|mesh-list
110699901|NCT01042028|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110699902|NCT01042028|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110699903|NCT01042028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110699904|NCT01042028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110699905|NCT01042028|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110699906|NCT01042028|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110699907|NCT01042028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110699908|NCT01042028|Immunologic Factors|immunologic factors|mesh-ancestor
110699909|NCT01042028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110699910|NCT03993626|Nivolumab|nivolumab|mesh-list
110699911|NCT03993626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110699912|NCT03993626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110699913|NCT03993626|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110699914|NCT03993626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110699915|NCT00398216|Edoxaban|edoxaban|mesh-list
110699916|NCT00398216|Factor Xa Inhibitors|factor xa inhibitors|mesh-list
110699917|NCT00398216|Antithrombins|antithrombins|mesh-ancestor
110699918|NCT00398216|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110699919|NCT00398216|Protease Inhibitors|protease inhibitors|mesh-ancestor
110699920|NCT00398216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110699921|NCT00398216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110699922|NCT00398216|Anticoagulants|anticoagulants|mesh-ancestor
110699923|NCT00398138|Sargramostim|sargramostim|mesh-list
110699924|NCT00398138|Freund's Adjuvant|freund's adjuvant|mesh-list
110699925|NCT00398138|Immunologic Factors|immunologic factors|mesh-ancestor
110699926|NCT00398138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110699927|NCT00398138|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110699928|NCT00397982|Sirolimus|sirolimus|mesh-list
110699929|NCT00397982|Bevacizumab|bevacizumab|mesh-list
110699930|NCT00397982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110699931|NCT00397982|Temsirolimus|temsirolimus|mesh-list
110699932|NCT00397982|MTOR Inhibitors|mtor inhibitors|mesh-list
110699933|NCT00397982|Endothelial Growth Factors|endothelial growth factors|mesh-list
110699934|NCT00397982|Antibodies|antibodies|mesh-list
110699935|NCT00397982|Immunoglobulins|immunoglobulins|mesh-list
110699936|NCT00397982|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110699937|NCT00397982|Immunoglobulin G|immunoglobulin g|mesh-list
110699938|NCT00397982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110699939|NCT00397982|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110699940|NCT00397982|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110699941|NCT00397982|Growth Substances|growth substances|mesh-ancestor
110699942|NCT00397982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110699943|NCT00397982|Growth Inhibitors|growth inhibitors|mesh-ancestor
110699944|NCT00397982|Immunologic Factors|immunologic factors|mesh-ancestor
110699945|NCT00397982|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110699946|NCT00397982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110699947|NCT00397982|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110112901|NCT01857609|Metformin|metformin|mesh-list
110699948|NCT00397982|Antifungal Agents|antifungal agents|mesh-ancestor
110699949|NCT00397982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110699950|NCT00397982|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110699951|NCT00397982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110699952|NCT00397982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110699953|NCT03715166|Bumetanide|bumetanide|mesh-list
110699954|NCT03715166|Diuretics|diuretics|mesh-ancestor
110699955|NCT03715166|Natriuretic Agents|natriuretic agents|mesh-ancestor
110699956|NCT03715166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110699957|NCT03715166|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110699958|NCT03715166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110699959|NCT03715166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110699960|NCT01042574|Clevidipine|clevidipine|mesh-list
110699961|NCT01042574|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110699962|NCT01042574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110699963|NCT01042574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110699964|NCT01042574|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110699965|NCT01042574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110699966|NCT01042652|Raltegravir Potassium|raltegravir potassium|mesh-list
110699967|NCT01042652|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110699968|NCT01042652|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110699969|NCT01042652|Antiviral Agents|antiviral agents|mesh-ancestor
110699970|NCT01042652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110699971|NCT01042652|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110699972|NCT01042652|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110699973|NCT01042652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110699974|NCT01042652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110699975|NCT01040078|Vaccines|vaccines|mesh-list
110699976|NCT01040078|Immunologic Factors|immunologic factors|mesh-ancestor
110699977|NCT01040078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110699978|NCT01035320|Simvastatin|simvastatin|mesh-list
110699979|NCT01035320|Ezetimibe|ezetimibe|mesh-list
110699980|NCT01035320|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110699981|NCT01035320|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110699982|NCT01035320|Antimetabolites|antimetabolites|mesh-ancestor
110699983|NCT01035320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110699984|NCT01035320|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110699985|NCT01035320|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110699986|NCT01035320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110699987|NCT01042730|Pitavastatin|pitavastatin|mesh-list
110699988|NCT01042730|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110699996|NCT00396812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110699997|NCT00396812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110699998|NCT00396812|Immunologic Factors|immunologic factors|mesh-ancestor
110699999|NCT00396812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110700000|NCT00396812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110700001|NCT01566578|Mitogens|mitogens|mesh-list
110700002|NCT01566578|Mitosis Modulators|mitosis modulators|mesh-ancestor
110700003|NCT01566578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110700004|NCT01040234|Bupivacaine|bupivacaine|mesh-list
110700005|NCT01040234|Anesthetics, Local|anesthetics, local|mesh-ancestor
110700006|NCT01040234|Anesthetics|anesthetics|mesh-ancestor
110700007|NCT01040234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110700008|NCT01040234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110700009|NCT01040234|Sensory System Agents|sensory system agents|mesh-ancestor
110700010|NCT01040234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110700011|NCT00396656|Atenolol|atenolol|mesh-list
110700012|NCT00396656|Valsartan|valsartan|mesh-list
110700013|NCT00396656|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110700014|NCT00396656|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110700015|NCT00396656|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110700016|NCT00396656|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110700017|NCT00396656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110700018|NCT00396656|Diuretics|diuretics|mesh-ancestor
110700019|NCT00396656|Natriuretic Agents|natriuretic agents|mesh-ancestor
110700020|NCT00396656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110700021|NCT00396656|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110700022|NCT00396656|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110700023|NCT00396656|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110700024|NCT00396656|Sympatholytics|sympatholytics|mesh-ancestor
110700025|NCT00396656|Autonomic Agents|autonomic agents|mesh-ancestor
110700026|NCT00396656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110700027|NCT00396656|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110700028|NCT00396656|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110700029|NCT00396656|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110700030|NCT00396656|Adrenergic Agents|adrenergic agents|mesh-ancestor
110700031|NCT00396656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110700032|NCT00408434|Efatutazone|efatutazone|mesh-list
110700033|NCT00408434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110700040|NCT01040312|Cisplatin|cisplatin|mesh-list
110700041|NCT01040312|Carboplatin|carboplatin|mesh-list
110700042|NCT01040312|Nedaplatin|nedaplatin|mesh-list
110700043|NCT01040312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110700044|NCT00407030|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
110700045|NCT00407030|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110700046|NCT00407030|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110700047|NCT00407030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110700048|NCT00407030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110700049|NCT00407030|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110700050|NCT00407030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110700051|NCT00407030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110700052|NCT00407030|Cholinergic Agents|cholinergic agents|mesh-ancestor
110700053|NCT00407030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110700054|NCT00406640|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
110700055|NCT00406640|Escitalopram|escitalopram|mesh-list
110700056|NCT00406640|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110700057|NCT00406640|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110700058|NCT00406640|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110700059|NCT00406640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110700060|NCT00406640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110700061|NCT00406640|Serotonin Agents|serotonin agents|mesh-ancestor
110700062|NCT00406640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110700063|NCT00406640|Antidepressive Agents|antidepressive agents|mesh-ancestor
110700064|NCT00406640|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110700065|NCT00406640|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110700066|NCT01043510|Insulin|insulin|mesh-list
110700067|NCT01043510|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110700068|NCT01043510|Insulin Detemir|insulin detemir|mesh-list
110700069|NCT01043510|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110700070|NCT01043510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110700071|NCT01043666|Mirabegron|mirabegron|mesh-list
110700072|NCT01043666|Tolterodine Tartrate|tolterodine tartrate|mesh-list
110700073|NCT01043666|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
110700074|NCT01043666|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110700075|NCT01043666|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110700076|NCT01043666|Adrenergic Agents|adrenergic agents|mesh-ancestor
110700077|NCT01043666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110700078|NCT01043666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110700079|NCT01043666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110700080|NCT01043666|Urological Agents|urological agents|mesh-ancestor
110700081|NCT01043666|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110700082|NCT01043666|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110700083|NCT01043666|Cholinergic Agents|cholinergic agents|mesh-ancestor
110700084|NCT00394472|Lesogaberan|lesogaberan|mesh-list
110700085|NCT00394472|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110700086|NCT00394472|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
110700087|NCT00394472|GABA Agonists|gaba agonists|mesh-ancestor
110700088|NCT00394472|GABA Agents|gaba agents|mesh-ancestor
110700089|NCT00394472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110700090|NCT00394472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110113350|NCT01859858|Curcumin|curcumin|mesh-list
110700091|NCT00394472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110700092|NCT00395486|Atorvastatin|atorvastatin|mesh-list
110700093|NCT00395486|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110700094|NCT00395486|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110700095|NCT00395486|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110700096|NCT00395486|Antimetabolites|antimetabolites|mesh-ancestor
110700097|NCT00395486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110700098|NCT00395486|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110700099|NCT00395486|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110700100|NCT00395486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110700101|NCT01043744|Lumefantrine|lumefantrine|mesh-list
110700102|NCT01043744|Artemether|artemether|mesh-list
110700103|NCT01043744|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
110700104|NCT01043744|Antimalarials|antimalarials|mesh-ancestor
110700105|NCT01043744|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110700106|NCT01043744|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110700107|NCT01043744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110700108|NCT00395018|Entecavir|entecavir|mesh-list
110700109|NCT00395018|Antiviral Agents|antiviral agents|mesh-ancestor
110700110|NCT00395018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110700111|NCT01036412|Chlorhexidine|chlorhexidine|mesh-list
110700112|NCT01036412|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110700113|NCT01036412|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110700114|NCT01036412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110700115|NCT01036412|Disinfectants|disinfectants|mesh-ancestor
110700116|NCT01036412|Dermatologic Agents|dermatologic agents|mesh-ancestor
110700117|NCT00375518|Atorvastatin|atorvastatin|mesh-list
110700118|NCT00375518|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110700119|NCT00375518|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110700120|NCT00375518|Antimetabolites|antimetabolites|mesh-ancestor
110700121|NCT00375518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110700122|NCT00375518|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110700123|NCT00375518|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110700124|NCT00375518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110700125|NCT01045772|Rilonacept|rilonacept|mesh-list
110700126|NCT01045772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110700127|NCT01045928|Rituximab|rituximab|mesh-list
110700128|NCT01045928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110700129|NCT01045928|Lenalidomide|lenalidomide|mesh-list
110700130|NCT01045928|Antibodies|antibodies|mesh-list
110700131|NCT01045928|Immunoglobulins|immunoglobulins|mesh-list
110700132|NCT01045928|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110700133|NCT01045928|Immunologic Factors|immunologic factors|mesh-ancestor
110700134|NCT01045928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110700135|NCT01045928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110700136|NCT01045928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110683017|NCT00904631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110700137|NCT01045928|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110113520|NCT01860742|Interferons|interferons|mesh-list
110700138|NCT01045928|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110700139|NCT01045928|Growth Substances|growth substances|mesh-ancestor
110700140|NCT01045928|Growth Inhibitors|growth inhibitors|mesh-ancestor
110700141|NCT00256750|Cyclosporine|cyclosporine|mesh-list
110700142|NCT00256750|Abatacept|abatacept|mesh-list
110700143|NCT00256750|Cyclosporins|cyclosporins|mesh-list
110700144|NCT00256750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110700145|NCT00256750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110700146|NCT00256750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110700147|NCT00256750|Immunologic Factors|immunologic factors|mesh-ancestor
110700148|NCT00256750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110700149|NCT00256750|Antifungal Agents|antifungal agents|mesh-ancestor
110700150|NCT00256750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110700151|NCT00256750|Dermatologic Agents|dermatologic agents|mesh-ancestor
110700152|NCT00256750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110700153|NCT00256750|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110700154|NCT00256750|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110700155|NCT00256750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110700156|NCT00256750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110700157|NCT00279201|Insulin Glargine|insulin glargine|mesh-list
110700158|NCT00279201|Insulin Lispro|insulin lispro|mesh-list
110700159|NCT00279201|Insulin, Isophane|insulin, isophane|mesh-list
110700160|NCT00279201|Biphasic Insulins|biphasic insulins|mesh-list
110700161|NCT00279201|Isophane insulin, insulin lispro drug combination 50:50|isophane insulin, insulin lispro drug combination 50:50|mesh-list
110700162|NCT00279201|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110700163|NCT00279201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110700164|NCT00203476|Niacin|niacin|mesh-list
110700165|NCT00203476|Ezetimibe|ezetimibe|mesh-list
110700166|NCT00203476|Colestipol|colestipol|mesh-list
110700167|NCT00203476|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110700168|NCT00203476|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110700169|NCT00203476|Antimetabolites|antimetabolites|mesh-ancestor
110700170|NCT00203476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110700171|NCT00203476|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110700172|NCT00203476|Vasodilator Agents|vasodilator agents|mesh-ancestor
110700173|NCT00203476|Vitamin B Complex|vitamin b complex|mesh-ancestor
110700174|NCT00203476|Vitamins|vitamins|mesh-ancestor
110700175|NCT00203476|Micronutrients|micronutrients|mesh-ancestor
110700176|NCT00203476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110700177|NCT00203476|Sequestering Agents|sequestering agents|mesh-ancestor
110700178|NCT00203242|Valproic Acid|valproic acid|mesh-list
110700179|NCT00203242|Anticonvulsants|anticonvulsants|mesh-ancestor
110700180|NCT00203242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110700181|NCT00203242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110700182|NCT00203242|GABA Agents|gaba agents|mesh-ancestor
110700183|NCT00203242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110700184|NCT00203242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110700185|NCT00203242|Antimanic Agents|antimanic agents|mesh-ancestor
110700186|NCT00203242|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110700187|NCT00203242|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110700188|NCT00203242|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110700190|NCT00200356|Edaravone|edaravone|mesh-list
110700191|NCT00200356|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110700192|NCT00200356|Antioxidants|antioxidants|mesh-ancestor
110700193|NCT00200356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110700194|NCT00200356|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110700195|NCT00200356|Protective Agents|protective agents|mesh-ancestor
110700196|NCT00200356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110700197|NCT00200356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110700198|NCT00200356|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110700199|NCT00200356|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110700200|NCT00200356|Histamine Antagonists|histamine antagonists|mesh-ancestor
110700201|NCT00200356|Histamine Agents|histamine agents|mesh-ancestor
110700202|NCT00200356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110700203|NCT00227344|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
110700204|NCT00227266|Valproic Acid|valproic acid|mesh-list
110700205|NCT00227266|Anticonvulsants|anticonvulsants|mesh-ancestor
110700206|NCT00227266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110700207|NCT00227266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110700208|NCT00227266|GABA Agents|gaba agents|mesh-ancestor
110700209|NCT00227266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110418082|NCT01254890|Azacitidine|azacitidine|mesh-list
110700210|NCT00227266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110700211|NCT00227266|Antimanic Agents|antimanic agents|mesh-ancestor
110700212|NCT00227266|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110700213|NCT00227266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110700214|NCT00227266|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110700215|NCT00256282|Docetaxel|docetaxel|mesh-list
110700216|NCT00256282|Vinorelbine|vinorelbine|mesh-list
110700217|NCT00256282|Sargramostim|sargramostim|mesh-list
110700218|NCT00256282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110700219|NCT00256282|Tubulin Modulators|tubulin modulators|mesh-ancestor
110700220|NCT00256282|Antimitotic Agents|antimitotic agents|mesh-ancestor
110700221|NCT00256282|Mitosis Modulators|mitosis modulators|mesh-ancestor
110700222|NCT00256282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110700223|NCT00256282|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110700224|NCT00256282|Immunologic Factors|immunologic factors|mesh-ancestor
110700225|NCT00256282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110700226|NCT00256204|Rasagiline|rasagiline|mesh-list
110700227|NCT00256204|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
110700228|NCT00256204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110700229|NCT00256204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110700230|NCT00256204|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110700231|NCT00256204|Protective Agents|protective agents|mesh-ancestor
110700232|NCT00256204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110700233|NCT03972358|Misoprostol|misoprostol|mesh-list
110700234|NCT03972358|Mifepristone|mifepristone|mesh-list
110700235|NCT03972358|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110700236|NCT03972358|Abortifacient Agents|abortifacient agents|mesh-ancestor
110700237|NCT03972358|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110700238|NCT03972358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110700239|NCT03972358|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110700240|NCT03972358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110700241|NCT03972358|Oxytocics|oxytocics|mesh-ancestor
110700242|NCT03972358|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
110700243|NCT03972358|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110700244|NCT03972358|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110700245|NCT03972358|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110700246|NCT03972358|Contraceptive Agents|contraceptive agents|mesh-ancestor
110700247|NCT03972358|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
110700248|NCT03972358|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
110700249|NCT03972358|Hormone Antagonists|hormone antagonists|mesh-ancestor
110700250|NCT03972358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110700251|NCT03972358|Luteolytic Agents|luteolytic agents|mesh-ancestor
110700252|NCT03972358|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110700253|NCT03972358|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
110700254|NCT01073332|Antioxidants|antioxidants|mesh-list
110700255|NCT01073332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110700256|NCT01073332|Protective Agents|protective agents|mesh-ancestor
110700257|NCT01073332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110700259|NCT03972046|Dabrafenib|dabrafenib|mesh-list
110700260|NCT03972046|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
110700261|NCT03972046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110700262|NCT03972046|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110700263|NCT03972046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110700264|NCT03972046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110700265|NCT03972046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110700266|NCT01071772|Insulin|insulin|mesh-list
110700267|NCT01071772|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110700268|NCT01071772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110700269|NCT01074346|Interferons|interferons|mesh-list
110700270|NCT01074346|Interferon-beta|interferon-beta|mesh-list
110700271|NCT01074346|Interferon beta-1a|interferon beta-1a|mesh-list
110700272|NCT01074346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110700273|NCT01074346|Antiviral Agents|antiviral agents|mesh-ancestor
110700274|NCT01074346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110700275|NCT01074346|Immunologic Factors|immunologic factors|mesh-ancestor
110700276|NCT01074346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110700277|NCT01074346|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110700278|NCT00278889|Leucovorin|leucovorin|mesh-list
110700279|NCT00278889|Bevacizumab|bevacizumab|mesh-list
110700280|NCT00278889|Fluorouracil|fluorouracil|mesh-list
110700281|NCT00278889|Oxaliplatin|oxaliplatin|mesh-list
110700282|NCT00278889|Cediranib|cediranib|mesh-list
110700283|NCT00278889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110113975|NCT01863823|Amoxicillin|amoxicillin|mesh-list
110700284|NCT00278889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110700285|NCT00278889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110700286|NCT00278889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110418155|NCT02880345|Pembrolizumab|pembrolizumab|mesh-list
110700287|NCT00278889|Growth Substances|growth substances|mesh-ancestor
110700288|NCT00278889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110700289|NCT00278889|Growth Inhibitors|growth inhibitors|mesh-ancestor
110700290|NCT00278889|Antimetabolites|antimetabolites|mesh-ancestor
110700291|NCT00278889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110700292|NCT00278889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110700293|NCT00278889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110700294|NCT00278889|Immunologic Factors|immunologic factors|mesh-ancestor
110700296|NCT00278889|Protective Agents|protective agents|mesh-ancestor
110700297|NCT00278889|Vitamin B Complex|vitamin b complex|mesh-ancestor
110700298|NCT00278889|Vitamins|vitamins|mesh-ancestor
110700299|NCT00278889|Micronutrients|micronutrients|mesh-ancestor
110700300|NCT00278889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110700301|NCT00278889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110700302|NCT01070745|Ibuprofen|ibuprofen|mesh-list
110700303|NCT01070745|Indomethacin|indomethacin|mesh-list
110700304|NCT01070745|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110700305|NCT01070745|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110700306|NCT01070745|Analgesics|analgesics|mesh-ancestor
110700307|NCT01070745|Sensory System Agents|sensory system agents|mesh-ancestor
110114144|NCT01865201|Edaravone|edaravone|mesh-list
110700308|NCT01070745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110700309|NCT01070745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110700310|NCT01070745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110700311|NCT01070745|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110700312|NCT01070745|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110700313|NCT01070745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110700314|NCT01070745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110700315|NCT01070745|Gout Suppressants|gout suppressants|mesh-ancestor
110700316|NCT01070745|Tocolytic Agents|tocolytic agents|mesh-ancestor
110700317|NCT01070745|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110700318|NCT01071057|Morphine|morphine|mesh-list
110700319|NCT01071057|Naloxone|naloxone|mesh-list
110700320|NCT01071057|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110700321|NCT01071057|Narcotics|narcotics|mesh-ancestor
110700322|NCT01071057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110700323|NCT01071057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110700324|NCT01071057|Analgesics|analgesics|mesh-ancestor
110700325|NCT01071057|Sensory System Agents|sensory system agents|mesh-ancestor
110700326|NCT01071057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110700327|NCT01071057|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110700328|NCT00278109|Cyclophosphamide|cyclophosphamide|mesh-list
110700329|NCT00278109|Doxorubicin|doxorubicin|mesh-list
110700330|NCT00278109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110700331|NCT00278109|Immunologic Factors|immunologic factors|mesh-ancestor
110700332|NCT00278109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110700333|NCT00278109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110700334|NCT00278109|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110700335|NCT00278109|Alkylating Agents|alkylating agents|mesh-ancestor
110700336|NCT00278109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110700337|NCT00278109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110700338|NCT00278109|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110700339|NCT00278109|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110700340|NCT00278109|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110700341|NCT00278109|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110700342|NCT00278109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110700343|NCT00296517|Bupropion|bupropion|mesh-list
110700344|NCT00296517|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110700345|NCT00296517|Antidepressive Agents|antidepressive agents|mesh-ancestor
110700346|NCT00296517|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110700347|NCT00296517|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110700348|NCT00296517|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110700349|NCT00296517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110700350|NCT00296517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110700351|NCT00296517|Dopamine Agents|dopamine agents|mesh-ancestor
110700352|NCT00296517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110700353|NCT00296517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110700354|NCT00296517|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110700355|NCT00296517|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110700356|NCT00296517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110700357|NCT00224770|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
110700358|NCT00224770|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110700359|NCT00224770|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110700360|NCT00224770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110700361|NCT00266409|Alprazolam|alprazolam|mesh-list
110700362|NCT00266409|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110700363|NCT00266409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110700364|NCT00266409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110700365|NCT00266409|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110700366|NCT00266409|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110700367|NCT00266409|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110700368|NCT00266409|GABA Modulators|gaba modulators|mesh-ancestor
110700369|NCT00266409|GABA Agents|gaba agents|mesh-ancestor
110700370|NCT00266409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110443494|NCT00693199|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110700371|NCT00266409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110700373|NCT00265785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110700374|NCT00265785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110114470|NCT01867892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110700375|NCT00265785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110700376|NCT00265785|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110700377|NCT00265785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110700378|NCT02532153|Ketamine|ketamine|mesh-list
110700379|NCT02532153|Analgesics|analgesics|mesh-ancestor
110700380|NCT02532153|Sensory System Agents|sensory system agents|mesh-ancestor
110700381|NCT02532153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110700382|NCT02532153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110700383|NCT02532153|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110700384|NCT02532153|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110700385|NCT02532153|Anesthetics, General|anesthetics, general|mesh-ancestor
110700386|NCT02532153|Anesthetics|anesthetics|mesh-ancestor
110700387|NCT02532153|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110700388|NCT02532153|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110700389|NCT02532153|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110700390|NCT02532153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110700391|NCT02532153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110700392|NCT00265395|Interferons|interferons|mesh-list
110700393|NCT00265395|Ribavirin|ribavirin|mesh-list
110700394|NCT00265395|Interferon-alpha|interferon-alpha|mesh-list
110700395|NCT00265395|Interferon alpha-2|interferon alpha-2|mesh-list
110700396|NCT00265395|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110700397|NCT00265395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110700398|NCT00265395|Antiviral Agents|antiviral agents|mesh-ancestor
110700399|NCT00265395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110700400|NCT00265395|Antimetabolites|antimetabolites|mesh-ancestor
110700401|NCT00265395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110700402|NCT00265395|Immunologic Factors|immunologic factors|mesh-ancestor
110700403|NCT00265395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110700404|NCT01582113|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
110700405|NCT01582113|Nootropic Agents|nootropic agents|mesh-ancestor
110700406|NCT00195442|Factor VIII|factor viii|mesh-list
110700407|NCT00195442|Coagulants|coagulants|mesh-ancestor
110700408|NCT01070823|Natalizumab|natalizumab|mesh-list
110700409|NCT01070823|Immunologic Factors|immunologic factors|mesh-ancestor
110700410|NCT01070823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110700411|NCT01071135|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110700412|NCT01071135|Antidepressive Agents|antidepressive agents|mesh-ancestor
110700413|NCT01071135|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110700414|NCT01071135|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110700415|NCT01071135|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110700416|NCT01071135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110700417|NCT01071135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110700418|NCT00275301|Olanzapine|olanzapine|mesh-list
110700419|NCT00275301|Antiemetics|antiemetics|mesh-ancestor
110700420|NCT00275301|Autonomic Agents|autonomic agents|mesh-ancestor
110700421|NCT00275301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110700422|NCT00275301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110700423|NCT00275301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110700424|NCT00275301|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110700425|NCT00275301|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110700426|NCT00275301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110700427|NCT00275301|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110700428|NCT00275301|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110700429|NCT00275301|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110700430|NCT00275301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110114644|NCT01869257|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110700431|NCT00275301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110700432|NCT00275301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110700433|NCT00275301|Serotonin Agents|serotonin agents|mesh-ancestor
110700434|NCT02531997|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
110700435|NCT02531997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110700436|NCT02531997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110700437|NCT00251745|Dexlansoprazole|dexlansoprazole|mesh-list
110700438|NCT00251745|Lansoprazole|lansoprazole|mesh-list
110700439|NCT00251745|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110700440|NCT00251745|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110700441|NCT00251745|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110700442|NCT00251745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110700443|NCT00251745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110700444|NCT00255190|Dexlansoprazole|dexlansoprazole|mesh-list
110700445|NCT00255190|Lansoprazole|lansoprazole|mesh-list
110700446|NCT00255190|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110700447|NCT00255190|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110700448|NCT00255190|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110700449|NCT00255190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110700450|NCT00255190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110700451|NCT00359424|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
110700452|NCT00359424|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110700453|NCT00359424|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110700454|NCT00359424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110700455|NCT01049646|Angiotensin II|angiotensin ii|mesh-list
110700456|NCT01049646|Giapreza|giapreza|mesh-list
110700457|NCT01049646|Angiotensinogen|angiotensinogen|mesh-list
110700458|NCT01049646|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110700459|NCT01049646|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110700460|NCT01049646|Protease Inhibitors|protease inhibitors|mesh-ancestor
110700461|NCT01049646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110700462|NCT01049646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110700463|NCT02286414|Vitamins|vitamins|mesh-list
110700464|NCT02286414|Vitamin K|vitamin k|mesh-list
110700465|NCT02286414|Warfarin|warfarin|mesh-list
110700466|NCT02286414|Rivaroxaban|rivaroxaban|mesh-list
110700467|NCT02286414|Dabigatran|dabigatran|mesh-list
110700468|NCT02286414|Apixaban|apixaban|mesh-list
110700469|NCT02286414|Acenocoumarol|acenocoumarol|mesh-list
110700470|NCT02286414|Fluindione|fluindione|mesh-list
110700471|NCT02286414|Micronutrients|micronutrients|mesh-ancestor
110700472|NCT02286414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110700473|NCT02286414|Anticoagulants|anticoagulants|mesh-ancestor
110700474|NCT02286414|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110700475|NCT02286414|Antithrombins|antithrombins|mesh-ancestor
110700476|NCT02286414|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110700477|NCT02286414|Protease Inhibitors|protease inhibitors|mesh-ancestor
110700478|NCT02286414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110700479|NCT02286414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110700480|NCT02286414|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110700481|NCT02286414|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110700482|NCT02286414|Hemostatics|hemostatics|mesh-ancestor
110700483|NCT02286414|Coagulants|coagulants|mesh-ancestor
110700484|NCT00255034|Ribavirin|ribavirin|mesh-list
110700485|NCT00255034|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110700486|NCT00255034|Interferon-alpha|interferon-alpha|mesh-list
110700487|NCT00255034|Antimetabolites|antimetabolites|mesh-ancestor
110700488|NCT00255034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110700489|NCT00255034|Antiviral Agents|antiviral agents|mesh-ancestor
110700490|NCT00255034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110700491|NCT00255034|Immunologic Factors|immunologic factors|mesh-ancestor
110700492|NCT00255034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110700493|NCT00254566|Moxifloxacin|moxifloxacin|mesh-list
110700494|NCT00254566|Azithromycin|azithromycin|mesh-list
110700495|NCT00254566|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
110700496|NCT00254566|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110700497|NCT00254566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110700498|NCT00254566|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110700499|NCT00254566|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110700500|NCT00254566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110700501|NCT00254566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110700502|NCT00254566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110700503|NCT00254566|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110700504|NCT00254566|Contraceptive Agents|contraceptive agents|mesh-ancestor
110700505|NCT00254566|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110700506|NCT00254566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110700507|NCT00254566|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110700508|NCT00254566|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110700509|NCT00254566|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110700510|NCT02531854|Pemetrexed|pemetrexed|mesh-list
110700511|NCT02531854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110700512|NCT02531854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110114843|NCT01870219|Anesthetics, General|anesthetics, general|mesh-ancestor
110700513|NCT02531854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110700514|NCT02531854|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110700515|NCT02531854|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110700516|NCT01048086|Tretinoin|tretinoin|mesh-list
110700517|NCT01048086|Isotretinoin|isotretinoin|mesh-list
110700518|NCT01048086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110700519|NCT01048086|Keratolytic Agents|keratolytic agents|mesh-ancestor
110700520|NCT01048086|Dermatologic Agents|dermatologic agents|mesh-ancestor
110700521|NCT03830892|Nicotine|nicotine|mesh-list
110700522|NCT03830892|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110700523|NCT03830892|Autonomic Agents|autonomic agents|mesh-ancestor
110700524|NCT03830892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110700525|NCT03830892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110700526|NCT03830892|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110700527|NCT03830892|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110700528|NCT03830892|Cholinergic Agents|cholinergic agents|mesh-ancestor
110700529|NCT03830892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110114888|NCT01870440|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110700530|NCT03830892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110700531|NCT01049880|Ascorbic Acid|ascorbic acid|mesh-list
110700532|NCT01049880|Gemcitabine|gemcitabine|mesh-list
110700533|NCT01049880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110700534|NCT01049880|Antimetabolites|antimetabolites|mesh-ancestor
110700535|NCT01049880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110700536|NCT01049880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110700537|NCT01049880|Antioxidants|antioxidants|mesh-ancestor
110700538|NCT01049880|Protective Agents|protective agents|mesh-ancestor
110700539|NCT01049880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110700540|NCT01049880|Vitamins|vitamins|mesh-ancestor
110700541|NCT01049880|Micronutrients|micronutrients|mesh-ancestor
110700542|NCT00253630|Vorinostat|vorinostat|mesh-list
110700543|NCT00253630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110700544|NCT00253630|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110700545|NCT00253630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110700546|NCT00253630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110700547|NCT00358644|Decitabine|decitabine|mesh-list
110700548|NCT00358644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110700549|NCT00358644|Antimetabolites|antimetabolites|mesh-ancestor
110700550|NCT00358644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110700551|NCT00358644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110700552|NCT00358644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110700553|NCT01048320|Gemcitabine|gemcitabine|mesh-list
110700554|NCT01048320|Oxaliplatin|oxaliplatin|mesh-list
110700555|NCT01048320|Imatinib Mesylate|imatinib mesylate|mesh-list
110700556|NCT01048320|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110700557|NCT01048320|Antimetabolites|antimetabolites|mesh-ancestor
110058498|NCT01512511|Analgesics|analgesics|mesh-ancestor
110700558|NCT01048320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110700559|NCT01048320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110700560|NCT01048320|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110700561|NCT01048320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110700562|NCT03990480|Amlodipine|amlodipine|mesh-list
110700563|NCT03990480|Valsartan|valsartan|mesh-list
110700564|NCT03990480|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110700565|NCT03990480|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110700566|NCT03990480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110700567|NCT03990480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110700568|NCT03990480|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110700569|NCT03990480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110700570|NCT03990480|Vasodilator Agents|vasodilator agents|mesh-ancestor
110700571|NCT03990480|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110700572|NCT03990480|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110700573|NCT00369486|Triamcinolone|triamcinolone|mesh-list
110700574|NCT00369486|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110700575|NCT00369486|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110700576|NCT00369486|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110700577|NCT00369486|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110700578|NCT00369486|Glucocorticoids|glucocorticoids|mesh-ancestor
110700579|NCT00369486|Hormones|hormones|mesh-ancestor
110700580|NCT00369486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110700581|NCT00369486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110700582|NCT00369486|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110700583|NCT00369486|Immunologic Factors|immunologic factors|mesh-ancestor
110700584|NCT00369486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110700585|NCT00369486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110700586|NCT00363480|Fluticasone|fluticasone|mesh-list
110700587|NCT00363480|Albuterol|albuterol|mesh-list
110700588|NCT00363480|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110700589|NCT00363480|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110700590|NCT00363480|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110700591|NCT00363480|Autonomic Agents|autonomic agents|mesh-ancestor
110700592|NCT00363480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110115082|NCT01871701|Dexetimide|dexetimide|mesh-list
110700593|NCT00363480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110700594|NCT00363480|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110700595|NCT00363480|Respiratory System Agents|respiratory system agents|mesh-ancestor
110700596|NCT00363480|Dermatologic Agents|dermatologic agents|mesh-ancestor
110700597|NCT00363480|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110700598|NCT00363480|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110700600|NCT00363480|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110700601|NCT00363480|Adrenergic Agents|adrenergic agents|mesh-ancestor
110700602|NCT00363480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110700603|NCT00363480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110700604|NCT00363480|Tocolytic Agents|tocolytic agents|mesh-ancestor
110700605|NCT00363480|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110700606|NCT03990636|Aminolevulinic Acid|aminolevulinic acid|mesh-list
110700607|NCT03990636|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110700608|NCT03990636|Dermatologic Agents|dermatologic agents|mesh-ancestor
110700609|NCT01048398|Acetaminophen|acetaminophen|mesh-list
110700610|NCT01048398|Remifentanil|remifentanil|mesh-list
110700611|NCT01048398|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110700612|NCT01048398|Analgesics|analgesics|mesh-ancestor
110700613|NCT01048398|Sensory System Agents|sensory system agents|mesh-ancestor
110700614|NCT01048398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110700615|NCT01048398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110700616|NCT01048398|Antipyretics|antipyretics|mesh-ancestor
110700617|NCT01048398|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110700618|NCT01048398|Narcotics|narcotics|mesh-ancestor
110700619|NCT01048398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110700620|NCT01073644|Sunitinib|sunitinib|mesh-list
110700621|NCT01073644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110700622|NCT01073644|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110700623|NCT01073644|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110700624|NCT01073644|Growth Substances|growth substances|mesh-ancestor
110700625|NCT01073644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110700626|NCT01073644|Growth Inhibitors|growth inhibitors|mesh-ancestor
110700627|NCT01073644|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110700628|NCT01073644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110700629|NCT01073644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110700630|NCT03992586|Methamphetamine|methamphetamine|mesh-list
110700631|NCT03992586|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110700632|NCT03992586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110700633|NCT03992586|Sympathomimetics|sympathomimetics|mesh-ancestor
110700634|NCT03992586|Autonomic Agents|autonomic agents|mesh-ancestor
110700635|NCT03992586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110700636|NCT03992586|Dopamine Agents|dopamine agents|mesh-ancestor
110700637|NCT03992586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110700638|NCT03992586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110700639|NCT03992586|Adrenergic Agents|adrenergic agents|mesh-ancestor
110700640|NCT03992586|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110700641|NCT03992586|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110700642|NCT03992586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110700643|NCT03992586|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110700644|NCT00221104|Pravastatin|pravastatin|mesh-list
110700645|NCT00221104|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110700646|NCT00221104|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110115185|NCT01871935|Sufentanil|sufentanil|mesh-list
110700647|NCT00221104|Antimetabolites|antimetabolites|mesh-ancestor
110700648|NCT00221104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110700649|NCT00221104|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110700650|NCT00221104|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110700651|NCT00221104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110700652|NCT00189202|Sirolimus|sirolimus|mesh-list
110700653|NCT00189202|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110700654|NCT00189202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110700655|NCT00189202|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110700656|NCT00189202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110700657|NCT00189202|Antifungal Agents|antifungal agents|mesh-ancestor
110700658|NCT00189202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110700659|NCT00189202|Immunologic Factors|immunologic factors|mesh-ancestor
110700660|NCT00189202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110700661|NCT01071928|Docetaxel|docetaxel|mesh-list
110700662|NCT01071928|Vadimezan|vadimezan|mesh-list
110700663|NCT01071928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110700664|NCT01071928|Tubulin Modulators|tubulin modulators|mesh-ancestor
110700665|NCT01071928|Antimitotic Agents|antimitotic agents|mesh-ancestor
110700666|NCT01071928|Mitosis Modulators|mitosis modulators|mesh-ancestor
110700667|NCT01071928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110700668|NCT00187486|Temozolomide|temozolomide|mesh-list
110700669|NCT00187486|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110700670|NCT00187486|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110700671|NCT00187486|Alkylating Agents|alkylating agents|mesh-ancestor
110700672|NCT00187486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110700673|NCT00187486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110700674|NCT00187486|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110700675|NCT00187486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110700676|NCT00220636|Aripiprazole|aripiprazole|mesh-list
110700677|NCT00220636|Antidepressive Agents|antidepressive agents|mesh-ancestor
110700678|NCT00220636|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110700679|NCT00220636|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110700680|NCT00220636|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110700681|NCT00220636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110700682|NCT00220636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110700683|NCT00220636|Dopamine Agonists|dopamine agonists|mesh-ancestor
110700684|NCT00220636|Dopamine Agents|dopamine agents|mesh-ancestor
110700685|NCT00220636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110700686|NCT00220636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110700687|NCT00220636|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110700688|NCT00220636|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110700689|NCT00220636|Serotonin Agents|serotonin agents|mesh-ancestor
110700690|NCT00220636|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110700691|NCT00220636|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110700692|NCT00220636|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110700693|NCT00220636|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110700694|NCT00362232|Enoxaparin|enoxaparin|mesh-list
110700695|NCT00362232|Rivaroxaban|rivaroxaban|mesh-list
110700696|NCT00362232|Enoxaparin sodium|enoxaparin sodium|mesh-list
110115233|NCT01872026|ASP7991|asp7991|mesh-list
110700697|NCT00362232|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110700698|NCT00362232|Antithrombins|antithrombins|mesh-ancestor
110700699|NCT00362232|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110700700|NCT00362232|Protease Inhibitors|protease inhibitors|mesh-ancestor
110700701|NCT00362232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110700702|NCT00362232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110700703|NCT00362232|Anticoagulants|anticoagulants|mesh-ancestor
110700704|NCT00362232|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110700705|NCT00362232|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110700706|NCT01048554|Bevacizumab|bevacizumab|mesh-list
110700707|NCT01048554|Temozolomide|temozolomide|mesh-list
110700708|NCT01048554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110700709|NCT01048554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110700710|NCT01048554|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110700711|NCT01048554|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110700712|NCT01048554|Growth Substances|growth substances|mesh-ancestor
110700713|NCT01048554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110700714|NCT01048554|Growth Inhibitors|growth inhibitors|mesh-ancestor
110700715|NCT01048554|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110700716|NCT01048554|Alkylating Agents|alkylating agents|mesh-ancestor
110700717|NCT01048554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110700718|NCT00219544|Pregabalin|pregabalin|mesh-list
110700719|NCT00219544|Analgesics|analgesics|mesh-ancestor
110700720|NCT00219544|Sensory System Agents|sensory system agents|mesh-ancestor
110700721|NCT00219544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110700722|NCT00219544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110700723|NCT00219544|Anticonvulsants|anticonvulsants|mesh-ancestor
110700724|NCT00219544|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110700725|NCT00219544|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110700726|NCT00219544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110700727|NCT00219544|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110700728|NCT00219544|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110700729|NCT00219544|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110700730|NCT00219544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110700731|NCT00219544|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110700732|NCT00357552|Ritonavir|ritonavir|mesh-list
110700733|NCT00357552|Lopinavir|lopinavir|mesh-list
110700734|NCT00357552|Tenofovir|tenofovir|mesh-list
110700735|NCT00357552|Emtricitabine|emtricitabine|mesh-list
110700736|NCT00357552|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110700737|NCT00357552|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110700738|NCT00357552|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110700739|NCT00357552|Protease Inhibitors|protease inhibitors|mesh-ancestor
110700740|NCT00357552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110700741|NCT00357552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110700742|NCT00357552|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110700743|NCT00357552|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110700744|NCT00357552|Antiviral Agents|antiviral agents|mesh-ancestor
110700745|NCT00357552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110700746|NCT00357552|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110700747|NCT00357552|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110700748|NCT00357552|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110700749|NCT00357552|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110700750|NCT00187096|Cyclophosphamide|cyclophosphamide|mesh-list
110700751|NCT00187096|Fludarabine|fludarabine|mesh-list
110700753|NCT00187096|Interleukin-2|interleukin-2|mesh-list
110700754|NCT00187096|Clofarabine|clofarabine|mesh-list
110700755|NCT00187096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110700756|NCT00187096|Immunologic Factors|immunologic factors|mesh-ancestor
110700757|NCT00187096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110700758|NCT00187096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110700759|NCT00187096|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110700760|NCT00187096|Alkylating Agents|alkylating agents|mesh-ancestor
110700761|NCT00187096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110700762|NCT00187096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110700763|NCT00187096|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110700764|NCT00187096|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110700765|NCT00187096|Antimetabolites|antimetabolites|mesh-ancestor
110700766|NCT00187096|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110700767|NCT00187096|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110700768|NCT00187096|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110700769|NCT00187096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110700770|NCT00187096|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110700771|NCT00187096|Analgesics|analgesics|mesh-ancestor
110700772|NCT00187096|Sensory System Agents|sensory system agents|mesh-ancestor
110700773|NCT00187096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110700774|NCT00357396|Melphalan|melphalan|mesh-list
110700775|NCT00357396|Busulfan|busulfan|mesh-list
110700776|NCT00357396|Thiotepa|thiotepa|mesh-list
110700777|NCT00357396|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110700778|NCT00357396|Alkylating Agents|alkylating agents|mesh-ancestor
110700779|NCT00357396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110700780|NCT00357396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110700781|NCT00357396|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110700782|NCT00357396|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110700783|NCT00357396|Immunologic Factors|immunologic factors|mesh-ancestor
110700784|NCT00357396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110700785|NCT00186628|Acetaminophen|acetaminophen|mesh-list
110700786|NCT00186628|Diphenhydramine|diphenhydramine|mesh-list
110700787|NCT00186628|Promethazine|promethazine|mesh-list
110700788|NCT00186628|Cyclosporine|cyclosporine|mesh-list
110700789|NCT00186628|Hydrocortisone|hydrocortisone|mesh-list
110700790|NCT00186628|Methylprednisolone|methylprednisolone|mesh-list
110700791|NCT00186628|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110700792|NCT00186628|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110700793|NCT00186628|Prednisolone|prednisolone|mesh-list
110700794|NCT00186628|Prednisolone acetate|prednisolone acetate|mesh-list
110700795|NCT00186628|Rituximab|rituximab|mesh-list
110700796|NCT00186628|Granisetron|granisetron|mesh-list
110700797|NCT00186628|Lenograstim|lenograstim|mesh-list
110700798|NCT00186628|Cyclosporins|cyclosporins|mesh-list
110700799|NCT00186628|Thymoglobulin|thymoglobulin|mesh-list
110700800|NCT00186628|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110700801|NCT00186628|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110700802|NCT00186628|Prednisolone phosphate|prednisolone phosphate|mesh-list
110700803|NCT00186628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110700804|NCT00186628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110700805|NCT00186628|Immunologic Factors|immunologic factors|mesh-ancestor
110700806|NCT00186628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110700807|NCT00186628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110700808|NCT00186628|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110700809|NCT00186628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110700810|NCT00186628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110700811|NCT00186628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110700812|NCT00186628|Antifungal Agents|antifungal agents|mesh-ancestor
110700813|NCT00186628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110700814|NCT00186628|Dermatologic Agents|dermatologic agents|mesh-ancestor
110700815|NCT00186628|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110700816|NCT00186628|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110700817|NCT00186628|Analgesics|analgesics|mesh-ancestor
110700818|NCT00186628|Sensory System Agents|sensory system agents|mesh-ancestor
110700819|NCT00186628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110700820|NCT00186628|Antipyretics|antipyretics|mesh-ancestor
110700821|NCT00186628|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110700822|NCT00186628|Antiemetics|antiemetics|mesh-ancestor
110700823|NCT00186628|Autonomic Agents|autonomic agents|mesh-ancestor
110700824|NCT00186628|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110700825|NCT00186628|Glucocorticoids|glucocorticoids|mesh-ancestor
110700826|NCT00186628|Hormones|hormones|mesh-ancestor
110700827|NCT00186628|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110700828|NCT00186628|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110700829|NCT00186628|Protective Agents|protective agents|mesh-ancestor
110700830|NCT00186628|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110700831|NCT00186628|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110700832|NCT00186628|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110700833|NCT00186628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110700834|NCT00186628|Anesthetics, Local|anesthetics, local|mesh-ancestor
110700835|NCT00186628|Anesthetics|anesthetics|mesh-ancestor
110700836|NCT00186628|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110700837|NCT00186628|Histamine Antagonists|histamine antagonists|mesh-ancestor
110700838|NCT00186628|Histamine Agents|histamine agents|mesh-ancestor
110700839|NCT00186628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110700840|NCT00186628|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110700841|NCT00186628|Antipruritics|antipruritics|mesh-ancestor
110700842|NCT00186628|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110700843|NCT00186628|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110700844|NCT00186628|Serotonin Agents|serotonin agents|mesh-ancestor
110700845|NCT00368550|Sertraline|sertraline|mesh-list
110700846|NCT00368550|Antidepressive Agents|antidepressive agents|mesh-ancestor
110700847|NCT00368550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110700848|NCT00368550|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110700849|NCT00368550|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110700850|NCT00368550|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110700851|NCT00368550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110115564|NCT05854537|Lidocaine|lidocaine|mesh-list
110700852|NCT00368550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110700853|NCT00368550|Serotonin Agents|serotonin agents|mesh-ancestor
110700854|NCT00368550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110700855|NCT01050036|Busulfan|busulfan|mesh-list
110700856|NCT01050036|Alkylating Agents|alkylating agents|mesh-ancestor
110700857|NCT01050036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110700858|NCT01050036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110700859|NCT01050036|Immunologic Factors|immunologic factors|mesh-ancestor
110700860|NCT01050036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110700861|NCT01050036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110700862|NCT01050036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110700863|NCT01050036|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110700864|NCT00357006|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110115604|NCT05853965|Venetoclax|venetoclax|mesh-list
110700865|NCT00357006|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110700866|NCT00357006|Estradiol|estradiol|mesh-list
110700867|NCT00357006|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110700868|NCT00357006|Estrogens|estrogens|mesh-ancestor
110700869|NCT00357006|Hormones|hormones|mesh-ancestor
110700870|NCT00357006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110700871|NCT00357006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110443520|NCT02795572|Vitamin D|vitamin d|mesh-list
110700872|NCT00357006|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110700874|NCT00357006|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110700875|NCT00357006|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110700876|NCT01050114|Oxybutynin|oxybutynin|mesh-list
110700877|NCT01050114|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110700878|NCT01050114|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110700879|NCT01050114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110700880|NCT01050114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110700881|NCT01050114|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110700882|NCT01050114|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110700883|NCT01050114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110700884|NCT01050114|Cholinergic Agents|cholinergic agents|mesh-ancestor
110700885|NCT01050114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110700886|NCT01050114|Parasympatholytics|parasympatholytics|mesh-ancestor
110700887|NCT01050114|Autonomic Agents|autonomic agents|mesh-ancestor
110700888|NCT01050114|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110700889|NCT01050114|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110700890|NCT01050114|Urological Agents|urological agents|mesh-ancestor
110418738|NCT01198548|Vitamin D|vitamin d|mesh-list
110700892|NCT01048632|Androgens|androgens|mesh-ancestor
110700893|NCT01048632|Hormones|hormones|mesh-ancestor
110115690|NCT05815602|Mebeverine|mebeverine|mesh-list
110700894|NCT01048632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110700895|NCT01048632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110700896|NCT01048632|Anabolic Agents|anabolic agents|mesh-ancestor
110700897|NCT00165646|Rabeprazole|rabeprazole|mesh-list
110700898|NCT00165646|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110700899|NCT00165646|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110700900|NCT00165646|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110700901|NCT00165646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110700902|NCT00165646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110700903|NCT01050270|Acetylcysteine|acetylcysteine|mesh-list
110700904|NCT01050270|Ondansetron|ondansetron|mesh-list
110700905|NCT01050270|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110700906|NCT01050270|Antiemetics|antiemetics|mesh-ancestor
110700907|NCT01050270|Autonomic Agents|autonomic agents|mesh-ancestor
110700908|NCT01050270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110700909|NCT01050270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110700910|NCT01050270|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110700911|NCT01050270|Antipruritics|antipruritics|mesh-ancestor
110700912|NCT01050270|Dermatologic Agents|dermatologic agents|mesh-ancestor
110700913|NCT01050270|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110700914|NCT01050270|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110700915|NCT01050270|Serotonin Agents|serotonin agents|mesh-ancestor
110700916|NCT01050270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110700917|NCT01050270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110700918|NCT01050270|Antiviral Agents|antiviral agents|mesh-ancestor
110700919|NCT01050270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110700920|NCT01050270|Expectorants|expectorants|mesh-ancestor
110700921|NCT01050270|Respiratory System Agents|respiratory system agents|mesh-ancestor
110700922|NCT01050270|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110700923|NCT01050270|Antioxidants|antioxidants|mesh-ancestor
110700924|NCT01050270|Protective Agents|protective agents|mesh-ancestor
110700925|NCT01050270|Antidotes|antidotes|mesh-ancestor
110700926|NCT00367770|Bosentan|bosentan|mesh-list
110700927|NCT00367770|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110700928|NCT00367770|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
110700929|NCT00367770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110700930|NCT00185614|Cyclosporine|cyclosporine|mesh-list
110700931|NCT00185614|Mycophenolic Acid|mycophenolic acid|mesh-list
110700932|NCT00185614|Cyclophosphamide|cyclophosphamide|mesh-list
110700933|NCT00185614|Melphalan|melphalan|mesh-list
110700934|NCT00185614|Cyclosporins|cyclosporins|mesh-list
110700935|NCT00185614|Lenograstim|lenograstim|mesh-list
110700936|NCT00185614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110700937|NCT00185614|Immunologic Factors|immunologic factors|mesh-ancestor
110700938|NCT00185614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110700939|NCT00185614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110700940|NCT00185614|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110700941|NCT00185614|Alkylating Agents|alkylating agents|mesh-ancestor
110700942|NCT00185614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110700943|NCT00185614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110700944|NCT00185614|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110700945|NCT00185614|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110700946|NCT00185614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110700947|NCT00185614|Antifungal Agents|antifungal agents|mesh-ancestor
110700948|NCT00185614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110700949|NCT00185614|Dermatologic Agents|dermatologic agents|mesh-ancestor
110700950|NCT00185614|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110700951|NCT00185614|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110700952|NCT00185614|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110700953|NCT00185614|Antitubercular Agents|antitubercular agents|mesh-ancestor
110700954|NCT00185614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110700955|NCT01075438|Vaccines|vaccines|mesh-list
110700956|NCT01075438|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110700957|NCT01075438|Immunologic Factors|immunologic factors|mesh-ancestor
110700958|NCT01075438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110700959|NCT00361842|Irinotecan|irinotecan|mesh-list
110700960|NCT00361842|Floxuridine|floxuridine|mesh-list
110700961|NCT00361842|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110700962|NCT00361842|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110700963|NCT00361842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110700964|NCT00361842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110700965|NCT00361842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110700966|NCT00361842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110700967|NCT00361842|Antimetabolites|antimetabolites|mesh-ancestor
110700968|NCT01324752|Losartan|losartan|mesh-list
110700970|NCT01324752|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110700971|NCT01324752|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110700972|NCT01324752|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110700973|NCT01324752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110700974|NCT01050348|Atorvastatin|atorvastatin|mesh-list
110700975|NCT01050348|Calcium|calcium|mesh-list
110700976|NCT01050348|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110116000|NCT05252585|Everolimus|everolimus|mesh-list
110700977|NCT01050348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110700978|NCT01050348|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110700979|NCT01050348|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110700980|NCT01050348|Antimetabolites|antimetabolites|mesh-ancestor
110700981|NCT01050348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110700982|NCT01050348|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110700983|NCT01050348|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110700984|NCT01050348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110700985|NCT01053390|Leucovorin|leucovorin|mesh-list
110700986|NCT01053390|Fluorouracil|fluorouracil|mesh-list
110700987|NCT01053390|Epirubicin|epirubicin|mesh-list
110700988|NCT01053390|Somatostatin|somatostatin|mesh-list
110700989|NCT01053390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110700990|NCT01053390|Antimetabolites|antimetabolites|mesh-ancestor
110700991|NCT01053390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110700992|NCT01053390|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110700993|NCT01053390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110700994|NCT01053390|Immunologic Factors|immunologic factors|mesh-ancestor
110700995|NCT01053390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110700996|NCT01053390|Antidotes|antidotes|mesh-ancestor
110700997|NCT01053390|Protective Agents|protective agents|mesh-ancestor
110700998|NCT01053390|Vitamin B Complex|vitamin b complex|mesh-ancestor
110700999|NCT01053390|Vitamins|vitamins|mesh-ancestor
110701000|NCT01053390|Micronutrients|micronutrients|mesh-ancestor
110701001|NCT01053390|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110701002|NCT01053390|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110701003|NCT01053390|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110701004|NCT01053390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110701005|NCT01053390|Hormones|hormones|mesh-ancestor
110701006|NCT01053390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110701007|NCT00356148|Ampicillin|ampicillin|mesh-list
110701008|NCT00356148|Sulbactam|sulbactam|mesh-list
110701009|NCT00356148|Sultamicillin|sultamicillin|mesh-list
110701010|NCT00356148|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110701011|NCT00356148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110701012|NCT00356148|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110701013|NCT00356148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110701014|NCT00356148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110701015|NCT00361218|Citalopram|citalopram|mesh-list
110701016|NCT00361218|Escitalopram|escitalopram|mesh-list
110701017|NCT00361218|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
110701018|NCT00361218|Serotonin|serotonin|mesh-list
110701019|NCT00361218|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110443525|NCT02795572|Pyridoxine|pyridoxine|mesh-list
110701020|NCT00361218|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110701021|NCT00361218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110701022|NCT00361218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110701023|NCT00361218|Serotonin Agents|serotonin agents|mesh-ancestor
110701024|NCT00361218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110701025|NCT00361218|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110701026|NCT00361218|Antidepressive Agents|antidepressive agents|mesh-ancestor
110701027|NCT00361218|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110701028|NCT00361218|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110701029|NCT01049022|Moxifloxacin|moxifloxacin|mesh-list
110701030|NCT01049022|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
110701031|NCT01049022|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110701032|NCT01049022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110701033|NCT01049022|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110701034|NCT01049022|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110701035|NCT01049022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110701036|NCT01049022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110701037|NCT01049022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110701038|NCT01049022|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110701039|NCT01049022|Contraceptive Agents|contraceptive agents|mesh-ancestor
110701040|NCT01049022|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110701041|NCT01049022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110701042|NCT01049022|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110701043|NCT01049022|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110701044|NCT01049022|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110701045|NCT02534610|Etoricoxib|etoricoxib|mesh-list
110701046|NCT02534610|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110701047|NCT02534610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110701048|NCT02534610|Analgesics|analgesics|mesh-ancestor
110701049|NCT02534610|Sensory System Agents|sensory system agents|mesh-ancestor
110701050|NCT02534610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110701051|NCT02534610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110701052|NCT02534610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110701053|NCT02534610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110701054|NCT02534610|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110701055|NCT02534610|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110701056|NCT02534610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110701057|NCT02534610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110701058|NCT01050426|Leucovorin|leucovorin|mesh-list
110701059|NCT01050426|Cetuximab|cetuximab|mesh-list
110116288|NCT04700826|Apixaban|apixaban|mesh-list
110701060|NCT01050426|Levoleucovorin|levoleucovorin|mesh-list
110701061|NCT01050426|Antidotes|antidotes|mesh-ancestor
110701062|NCT01050426|Protective Agents|protective agents|mesh-ancestor
110701063|NCT01050426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110701064|NCT01050426|Vitamin B Complex|vitamin b complex|mesh-ancestor
110701065|NCT01050426|Vitamins|vitamins|mesh-ancestor
110701066|NCT01050426|Micronutrients|micronutrients|mesh-ancestor
110701067|NCT01050426|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110701068|NCT01050426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110701069|NCT00367458|Atorvastatin|atorvastatin|mesh-list
110701070|NCT00367458|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110701071|NCT00367458|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110701072|NCT00367458|Antimetabolites|antimetabolites|mesh-ancestor
110701073|NCT00367458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110701074|NCT00367458|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110701075|NCT00367458|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110701076|NCT00367458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110701077|NCT00252694|Candesartan|candesartan|mesh-list
110701078|NCT00252694|Candesartan cilexetil|candesartan cilexetil|mesh-list
110701079|NCT00252694|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110701080|NCT00252694|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110701081|NCT00252694|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110701082|NCT00252694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110701083|NCT00185380|Levonorgestrel|levonorgestrel|mesh-list
110701084|NCT00185380|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110701085|NCT00185380|Contraceptive Agents|contraceptive agents|mesh-ancestor
110701086|NCT00185380|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110701087|NCT00185380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110701088|NCT00185380|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110701089|NCT00185380|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110701090|NCT00185380|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110701091|NCT01077466|Natalizumab|natalizumab|mesh-list
110701092|NCT01077466|Immunologic Factors|immunologic factors|mesh-ancestor
110701093|NCT01077466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110701094|NCT00160654|Levetiracetam|levetiracetam|mesh-list
110701095|NCT00160654|Anticonvulsants|anticonvulsants|mesh-ancestor
110701096|NCT00160654|Nootropic Agents|nootropic agents|mesh-ancestor
110701098|NCT01582672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110701099|NCT01582672|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110701100|NCT01582672|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110701101|NCT01582672|Growth Substances|growth substances|mesh-ancestor
110701102|NCT01582672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110701103|NCT01582672|Growth Inhibitors|growth inhibitors|mesh-ancestor
110701104|NCT01582672|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110701105|NCT01582672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110701106|NCT01582672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110701107|NCT00366678|Vaccines|vaccines|mesh-list
110701108|NCT00366678|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110701109|NCT00366678|Immunologic Factors|immunologic factors|mesh-ancestor
110701110|NCT00366678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110701111|NCT01049178|Silymarin|silymarin|mesh-list
110701112|NCT01049178|Antioxidants|antioxidants|mesh-ancestor
110701113|NCT01049178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110701114|NCT01049178|Protective Agents|protective agents|mesh-ancestor
110701115|NCT01049178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110418970|NCT04075474|Listerine|listerine|mesh-list
110701116|NCT02534454|Nicotine|nicotine|mesh-list
110701117|NCT02534454|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110701118|NCT02534454|Autonomic Agents|autonomic agents|mesh-ancestor
110701119|NCT02534454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110701120|NCT02534454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110701121|NCT02534454|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110701122|NCT02534454|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110701123|NCT02534454|Cholinergic Agents|cholinergic agents|mesh-ancestor
110701124|NCT02534454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110701125|NCT02534454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110701126|NCT00355368|Rocuronium|rocuronium|mesh-list
110701127|NCT00355368|Succinylcholine|succinylcholine|mesh-list
110701128|NCT00355368|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110701129|NCT00355368|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110701130|NCT00355368|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110701131|NCT00355368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110701132|NCT00355368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110701133|NCT00355368|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
110701134|NCT01054092|Ipragliflozin|ipragliflozin|mesh-list
110701135|NCT01054092|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110701136|NCT01054092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110701137|NCT01054092|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110701138|NCT01054092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110701139|NCT00360282|Rizatriptan|rizatriptan|mesh-list
110701140|NCT00360282|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110701141|NCT00360282|Serotonin Agents|serotonin agents|mesh-ancestor
110701142|NCT00360282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110701143|NCT00360282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110701144|NCT00360282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110701145|NCT00373958|Vaccines|vaccines|mesh-list
110701146|NCT00373958|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110116498|NCT03792490|Fasudil|fasudil|mesh-list
110701147|NCT00373958|Immunologic Factors|immunologic factors|mesh-ancestor
110701148|NCT00373958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110701149|NCT00373880|Cocaine|cocaine|mesh-list
110701150|NCT00373880|Aripiprazole|aripiprazole|mesh-list
110701151|NCT00373880|Antidepressive Agents|antidepressive agents|mesh-ancestor
110701152|NCT00373880|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110701153|NCT00373880|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110701154|NCT00373880|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110701155|NCT00373880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110701156|NCT00373880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110701157|NCT00373880|Dopamine Agonists|dopamine agonists|mesh-ancestor
110701158|NCT00373880|Dopamine Agents|dopamine agents|mesh-ancestor
110701159|NCT00373880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110701160|NCT00373880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110701161|NCT00373880|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110701162|NCT00373880|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110701163|NCT00373880|Serotonin Agents|serotonin agents|mesh-ancestor
110701164|NCT00373880|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110701165|NCT00373880|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110701166|NCT00373880|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110701167|NCT00373880|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110701168|NCT00373880|Anesthetics, Local|anesthetics, local|mesh-ancestor
110701169|NCT00373880|Anesthetics|anesthetics|mesh-ancestor
110701170|NCT00373880|Sensory System Agents|sensory system agents|mesh-ancestor
110701171|NCT00373880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110701172|NCT00373880|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110701173|NCT00373880|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110701174|NCT00373880|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110701175|NCT00373880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110701176|NCT00184600|Insulin|insulin|mesh-list
110701177|NCT00184600|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110701178|NCT00184600|Insulin Aspart|insulin aspart|mesh-list
110701179|NCT00184600|Insulin, Long-Acting|insulin, long-acting|mesh-list
110701180|NCT00184600|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
110701181|NCT00184600|Insulin Detemir|insulin detemir|mesh-list
110701182|NCT00184600|Biphasic Insulins|biphasic insulins|mesh-list
110701183|NCT00184600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110701184|NCT00184600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110701185|NCT00265317|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110701186|NCT00265317|Sunitinib|sunitinib|mesh-list
110701187|NCT00265317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110701188|NCT00265317|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110701189|NCT00265317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110701190|NCT00265317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110701191|NCT00265317|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110701192|NCT00265317|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110701193|NCT00265317|Growth Substances|growth substances|mesh-ancestor
110701194|NCT00265317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110701195|NCT00265317|Growth Inhibitors|growth inhibitors|mesh-ancestor
110701197|NCT00373490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110701198|NCT00373490|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110701199|NCT00373490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110701200|NCT00373490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110701201|NCT00251589|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110701202|NCT00251589|Vorinostat|vorinostat|mesh-list
110701203|NCT00251589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110701204|NCT00251589|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110701205|NCT00251589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110701206|NCT00251589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110701207|NCT00251589|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110701208|NCT00265239|Edaravone|edaravone|mesh-list
110701209|NCT00265239|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110701210|NCT00265239|Antioxidants|antioxidants|mesh-ancestor
110701211|NCT00265239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110701212|NCT00265239|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110701213|NCT00265239|Protective Agents|protective agents|mesh-ancestor
110701214|NCT00265239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110701215|NCT00159874|Sildenafil Citrate|sildenafil citrate|mesh-list
110701216|NCT00159874|Citric Acid|citric acid|mesh-list
110701217|NCT00159874|Sodium Citrate|sodium citrate|mesh-list
110701218|NCT00159874|Anticoagulants|anticoagulants|mesh-ancestor
110701219|NCT00159874|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110701220|NCT00159874|Chelating Agents|chelating agents|mesh-ancestor
110701221|NCT00159874|Sequestering Agents|sequestering agents|mesh-ancestor
110701222|NCT00159874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110701223|NCT00159874|Vasodilator Agents|vasodilator agents|mesh-ancestor
110701224|NCT00159874|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110701225|NCT00159874|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110701226|NCT00159874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110701227|NCT00159874|Urological Agents|urological agents|mesh-ancestor
110701228|NCT00184054|Ascorbic Acid|ascorbic acid|mesh-list
110701229|NCT00184054|Arsenic Trioxide|arsenic trioxide|mesh-list
110701230|NCT00184054|Vitamins|vitamins|mesh-ancestor
110701231|NCT00184054|Micronutrients|micronutrients|mesh-ancestor
110701232|NCT00184054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110701233|NCT00184054|Antioxidants|antioxidants|mesh-ancestor
110701234|NCT00184054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110701235|NCT00184054|Protective Agents|protective agents|mesh-ancestor
110701236|NCT00184054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110701237|NCT02533908|Fentanyl|fentanyl|mesh-list
110701238|NCT02533908|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110701239|NCT02533908|Narcotics|narcotics|mesh-ancestor
110701240|NCT02533908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110701241|NCT02533908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110701242|NCT02533908|Analgesics|analgesics|mesh-ancestor
110701243|NCT02533908|Sensory System Agents|sensory system agents|mesh-ancestor
110701244|NCT02533908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110701245|NCT02533908|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110701246|NCT02533908|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110701247|NCT02533908|Anesthetics, General|anesthetics, general|mesh-ancestor
110701248|NCT02533908|Anesthetics|anesthetics|mesh-ancestor
110701249|NCT00183430|Prazosin|prazosin|mesh-list
110859480|NCT05929768|Daunorubicin|daunorubicin|mesh-list
110701250|NCT00183430|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110701251|NCT00183430|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110701252|NCT00183430|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110701253|NCT00183430|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110701255|NCT00183430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110701256|NCT00183430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110701257|NCT00183430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110701258|NCT00183274|Norepinephrine|norepinephrine|mesh-list
110701259|NCT00183274|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
110701260|NCT00183274|Serotonin|serotonin|mesh-list
110701261|NCT00183274|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-list
110701262|NCT00183274|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110701263|NCT00183274|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110701264|NCT00183274|Adrenergic Agents|adrenergic agents|mesh-ancestor
110701265|NCT00183274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110701266|NCT00183274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110701267|NCT00183274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110701269|NCT00183274|Autonomic Agents|autonomic agents|mesh-ancestor
110701270|NCT00183274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110701271|NCT00183274|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110701272|NCT00183274|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110701273|NCT00183274|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110701274|NCT00183274|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110701275|NCT00183274|Antidepressive Agents|antidepressive agents|mesh-ancestor
110701276|NCT00183274|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110701277|NCT00183274|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110701278|NCT00183274|Serotonin Agents|serotonin agents|mesh-ancestor
110701279|NCT00183196|Naltrexone|naltrexone|mesh-list
110701280|NCT00183196|Gabapentin|gabapentin|mesh-list
110701281|NCT00183196|Analgesics|analgesics|mesh-ancestor
110701282|NCT00183196|Sensory System Agents|sensory system agents|mesh-ancestor
110701283|NCT00183196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110701284|NCT00183196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110701285|NCT00183196|Anticonvulsants|anticonvulsants|mesh-ancestor
110701286|NCT00183196|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110701287|NCT00183196|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110701288|NCT00183196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110701289|NCT00183196|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110116987|NCT01873768|Coagulants|coagulants|mesh-ancestor
110701290|NCT00183196|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110701291|NCT00183196|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110701292|NCT00183196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110701293|NCT00183196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110701294|NCT00183196|Antimanic Agents|antimanic agents|mesh-ancestor
110701295|NCT00183196|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110701296|NCT00183196|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110701297|NCT00349752|Certolizumab Pegol|certolizumab pegol|mesh-list
110701298|NCT00349752|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110701299|NCT00349752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110701300|NCT00349752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110701301|NCT00349752|Immunologic Factors|immunologic factors|mesh-ancestor
110701302|NCT00349752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110701303|NCT00349752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110701304|NCT01055652|Dapagliflozin|dapagliflozin|mesh-list
110701305|NCT01055652|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110701306|NCT01055652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110701307|NCT01055652|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110701308|NCT01055652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110701309|NCT00348816|Prednisone|prednisone|mesh-list
110701310|NCT00348816|Docetaxel|docetaxel|mesh-list
110701311|NCT00348816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110701312|NCT00348816|Tubulin Modulators|tubulin modulators|mesh-ancestor
110701313|NCT00348816|Antimitotic Agents|antimitotic agents|mesh-ancestor
110701314|NCT00348816|Mitosis Modulators|mitosis modulators|mesh-ancestor
110701315|NCT00348816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110701316|NCT00348816|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110701317|NCT00348816|Glucocorticoids|glucocorticoids|mesh-ancestor
110701318|NCT00348816|Hormones|hormones|mesh-ancestor
110859483|NCT05929768|Tubulin Modulators|tubulin modulators|mesh-ancestor
110701319|NCT00348816|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110701320|NCT00348816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110701321|NCT00348816|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110701322|NCT03989310|Manganese|manganese|mesh-list
110701323|NCT03989310|Paclitaxel|paclitaxel|mesh-list
110701324|NCT03989310|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110701325|NCT03989310|Gemcitabine|gemcitabine|mesh-list
110701326|NCT03989310|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
110701327|NCT03989310|Antibodies|antibodies|mesh-list
110701328|NCT03989310|Immunoglobulins|immunoglobulins|mesh-list
110701329|NCT03989310|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110701330|NCT03989310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110701331|NCT03989310|Tubulin Modulators|tubulin modulators|mesh-ancestor
110701332|NCT03989310|Antimitotic Agents|antimitotic agents|mesh-ancestor
110701333|NCT03989310|Mitosis Modulators|mitosis modulators|mesh-ancestor
110701334|NCT03989310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110701335|NCT03989310|Immunologic Factors|immunologic factors|mesh-ancestor
110701336|NCT03989310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110701337|NCT03989310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110701338|NCT03989310|Antimetabolites|antimetabolites|mesh-ancestor
110701339|NCT03989310|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110701340|NCT03989310|Trace Elements|trace elements|mesh-ancestor
110701341|NCT03989310|Micronutrients|micronutrients|mesh-ancestor
110701342|NCT03966898|Letrozole|letrozole|mesh-list
110701343|NCT03966898|Anastrozole|anastrozole|mesh-list
110701344|NCT03966898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110701345|NCT03966898|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110701346|NCT03966898|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110701347|NCT03966898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110701348|NCT03966898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110701349|NCT03966898|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110701350|NCT03966898|Hormone Antagonists|hormone antagonists|mesh-ancestor
110701351|NCT03966898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110701352|NCT03966898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110117218|NCT01875653|Molgramostim|molgramostim|mesh-list
110701353|NCT03966898|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110701354|NCT03989700|Thiamine|thiamine|mesh-list
110701355|NCT03989700|Vitamins|vitamins|mesh-ancestor
110701356|NCT03989700|Micronutrients|micronutrients|mesh-ancestor
110701357|NCT03989700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110701358|NCT03989700|Vitamin B Complex|vitamin b complex|mesh-ancestor
110701359|NCT01051284|Gemcitabine|gemcitabine|mesh-list
110701360|NCT01051284|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110701361|NCT01051284|Antimetabolites|antimetabolites|mesh-ancestor
110701362|NCT01051284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110701363|NCT01051284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110701364|NCT01051362|Carboplatin|carboplatin|mesh-list
110701365|NCT01051362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110701366|NCT01055808|Insulin|insulin|mesh-list
110701367|NCT01055808|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110701368|NCT01055808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110701369|NCT00265083|Golimumab|golimumab|mesh-list
110701370|NCT00265083|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110701371|NCT00265083|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110859488|NCT05929768|Immunologic Factors|immunologic factors|mesh-ancestor
110701372|NCT00265083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110701373|NCT00265083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110701374|NCT00265083|Immunologic Factors|immunologic factors|mesh-ancestor
110701375|NCT00265083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110701376|NCT00264849|Omalizumab|omalizumab|mesh-list
110117292|NCT01876108|Omeprazole|omeprazole|mesh-list
110701377|NCT00264849|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110701378|NCT00264849|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110701379|NCT00264849|Respiratory System Agents|respiratory system agents|mesh-ancestor
110701380|NCT01073709|Acetaminophen|acetaminophen|mesh-list
110701381|NCT01073709|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110701382|NCT01073709|Analgesics|analgesics|mesh-ancestor
110701383|NCT01073709|Sensory System Agents|sensory system agents|mesh-ancestor
110701384|NCT01073709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110701385|NCT01073709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110701386|NCT01073709|Antipyretics|antipyretics|mesh-ancestor
110701387|NCT00211809|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
110701388|NCT00211809|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110701389|NCT00211809|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110701390|NCT00211809|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110701391|NCT00211809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110701392|NCT00211809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110701393|NCT00211809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110701394|NCT00211809|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110701395|NCT00211809|Antidepressive Agents|antidepressive agents|mesh-ancestor
110701396|NCT00211809|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110701397|NCT01071291|Niacin|niacin|mesh-list
110701398|NCT01071291|Nicotinic Acids|nicotinic acids|mesh-list
110701399|NCT01071291|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110701400|NCT01071291|Antimetabolites|antimetabolites|mesh-ancestor
110701401|NCT01071291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110701402|NCT01071291|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110701403|NCT01071291|Vasodilator Agents|vasodilator agents|mesh-ancestor
110701404|NCT01071291|Vitamin B Complex|vitamin b complex|mesh-ancestor
110701405|NCT01071291|Vitamins|vitamins|mesh-ancestor
110701406|NCT01071291|Micronutrients|micronutrients|mesh-ancestor
110701407|NCT01071291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110701408|NCT00129766|Palivizumab|palivizumab|mesh-list
110701409|NCT00129766|Antiviral Agents|antiviral agents|mesh-ancestor
110701410|NCT00129766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110701411|NCT00150592|Guanfacine|guanfacine|mesh-list
110701412|NCT00150592|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110701413|NCT00150592|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110701414|NCT00150592|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110701415|NCT00150592|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110701416|NCT00150592|Adrenergic Agents|adrenergic agents|mesh-ancestor
110701417|NCT00150592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110701418|NCT00150592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110701419|NCT00150592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110701420|NCT00149890|Cyclosporine|cyclosporine|mesh-list
110701421|NCT00149890|Cyclosporins|cyclosporins|mesh-list
110701422|NCT00149890|Basiliximab|basiliximab|mesh-list
110701423|NCT00149890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110701424|NCT00149890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110701425|NCT00149890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110701426|NCT00149890|Immunologic Factors|immunologic factors|mesh-ancestor
110117440|NCT01877122|Sensory System Agents|sensory system agents|mesh-ancestor
110701427|NCT00149890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110701428|NCT00149890|Antifungal Agents|antifungal agents|mesh-ancestor
110701429|NCT00149890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110701430|NCT00149890|Dermatologic Agents|dermatologic agents|mesh-ancestor
110701431|NCT00149890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110701432|NCT00149890|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110701433|NCT00174382|Donepezil|donepezil|mesh-list
110701434|NCT00174382|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110701435|NCT00174382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110701436|NCT00174382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110859512|NCT05926180|Anesthetics|anesthetics|mesh-ancestor
110701437|NCT00174382|Cholinergic Agents|cholinergic agents|mesh-ancestor
110701438|NCT00174382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110701439|NCT00174382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110701440|NCT00174382|Nootropic Agents|nootropic agents|mesh-ancestor
110701441|NCT00355134|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
110701442|NCT00355134|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
110701443|NCT00355134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110701444|NCT00355134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110701445|NCT00355134|Immunologic Factors|immunologic factors|mesh-ancestor
110701446|NCT00355134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110701447|NCT00171730|Pasireotide|pasireotide|mesh-list
110701448|NCT00171730|Hormones|hormones|mesh-ancestor
110701449|NCT00171730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110701450|NCT00171730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110701451|NCT00348348|Moxifloxacin|moxifloxacin|mesh-list
110701452|NCT00348348|Besifloxacin|besifloxacin|mesh-list
110701453|NCT00348348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110701454|NCT00348348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110701455|NCT00348348|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110701456|NCT00348348|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110701457|NCT00348348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110701458|NCT00348348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110701459|NCT00348348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110701460|NCT00354744|Dactinomycin|dactinomycin|mesh-list
110701461|NCT00354744|Cyclophosphamide|cyclophosphamide|mesh-list
110701462|NCT00354744|Ifosfamide|ifosfamide|mesh-list
110701463|NCT00354744|Isophosphamide mustard|isophosphamide mustard|mesh-list
110701464|NCT00354744|Doxorubicin|doxorubicin|mesh-list
110701465|NCT00354744|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110701466|NCT00354744|Irinotecan|irinotecan|mesh-list
110701467|NCT00354744|Etoposide|etoposide|mesh-list
110701468|NCT00354744|Vincristine|vincristine|mesh-list
110701469|NCT00354744|Camptothecin|camptothecin|mesh-list
110701470|NCT00354744|Lenograstim|lenograstim|mesh-list
110701471|NCT00354744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110701472|NCT00354744|Immunologic Factors|immunologic factors|mesh-ancestor
110701473|NCT00354744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110701474|NCT00354744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110701475|NCT00354744|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110701476|NCT00354744|Alkylating Agents|alkylating agents|mesh-ancestor
110701477|NCT00354744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110701478|NCT00354744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110701479|NCT00354744|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110701480|NCT00354744|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110701481|NCT00354744|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110701482|NCT00354744|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110701483|NCT00354744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110701484|NCT00354744|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110701485|NCT00354744|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110701486|NCT00354744|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110701487|NCT00354744|Tubulin Modulators|tubulin modulators|mesh-ancestor
110701488|NCT00354744|Antimitotic Agents|antimitotic agents|mesh-ancestor
110701489|NCT00354744|Mitosis Modulators|mitosis modulators|mesh-ancestor
110701490|NCT00354744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110701491|NCT00354744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110701492|NCT00354744|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110701493|NCT00354744|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110701494|NCT01055964|Tacrolimus|tacrolimus|mesh-list
110701495|NCT01055964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110701496|NCT01055964|Immunologic Factors|immunologic factors|mesh-ancestor
110117600|NCT01878539|Anticoagulants|anticoagulants|mesh-list
110701497|NCT01055964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110701498|NCT01055964|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110701499|NCT01055964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110701500|NCT01055964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110701501|NCT01056042|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
110701502|NCT01056042|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110701503|NCT01056042|Medroxyprogesterone|medroxyprogesterone|mesh-list
110701504|NCT01056042|Gestodene|gestodene|mesh-list
110701505|NCT01056042|Estradiol|estradiol|mesh-list
110701506|NCT01056042|Estrogens|estrogens|mesh-ancestor
110701507|NCT01056042|Hormones|hormones|mesh-ancestor
110701508|NCT01056042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110701509|NCT01056042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110701510|NCT01056042|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110701511|NCT01056042|Contraceptive Agents|contraceptive agents|mesh-ancestor
110701512|NCT01056042|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110701513|NCT01056042|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110701514|NCT01056042|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110701515|NCT01056042|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110701516|NCT01056042|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110701517|NCT01056042|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110701518|NCT01056042|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110701519|NCT01056042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110701520|NCT01056042|Progestins|progestins|mesh-ancestor
110701521|NCT00373256|Paclitaxel|paclitaxel|mesh-list
110701522|NCT00373256|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110701523|NCT00373256|Bevacizumab|bevacizumab|mesh-list
110701524|NCT00373256|Sunitinib|sunitinib|mesh-list
110701525|NCT00373256|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110701526|NCT00373256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110701527|NCT00373256|Tubulin Modulators|tubulin modulators|mesh-ancestor
110701528|NCT00373256|Antimitotic Agents|antimitotic agents|mesh-ancestor
110701529|NCT00373256|Mitosis Modulators|mitosis modulators|mesh-ancestor
110701530|NCT00373256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110701531|NCT00373256|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110701532|NCT00373256|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110701533|NCT00373256|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110117728|NCT01879514|Prednisone|prednisone|mesh-list
110701534|NCT00373256|Growth Substances|growth substances|mesh-ancestor
110701535|NCT00373256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110701536|NCT00373256|Growth Inhibitors|growth inhibitors|mesh-ancestor
110701537|NCT00373256|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110701538|NCT00373256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110701539|NCT01324544|Buprenorphine|buprenorphine|mesh-list
110701540|NCT01324544|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110701541|NCT01324544|Narcotics|narcotics|mesh-ancestor
110701542|NCT01324544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110701543|NCT01324544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110701544|NCT01324544|Analgesics|analgesics|mesh-ancestor
110701545|NCT01324544|Sensory System Agents|sensory system agents|mesh-ancestor
110701546|NCT01324544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110701547|NCT01324544|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110701548|NCT00394082|Paclitaxel|paclitaxel|mesh-list
110701549|NCT00394082|Bevacizumab|bevacizumab|mesh-list
110117771|NCT01879930|Antimalarials|antimalarials|mesh-ancestor
110701550|NCT00394082|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110701551|NCT00394082|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110701552|NCT00394082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110701553|NCT00394082|Tubulin Modulators|tubulin modulators|mesh-ancestor
110701554|NCT00394082|Antimitotic Agents|antimitotic agents|mesh-ancestor
110701555|NCT00394082|Mitosis Modulators|mitosis modulators|mesh-ancestor
110701556|NCT00394082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110701557|NCT00394082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110701558|NCT00394082|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110701559|NCT00394082|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110701560|NCT00394082|Growth Substances|growth substances|mesh-ancestor
110701561|NCT00394082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110701562|NCT00394082|Growth Inhibitors|growth inhibitors|mesh-ancestor
110701563|NCT00393848|Ketoconazole|ketoconazole|mesh-list
110701564|NCT00393848|Antifungal Agents|antifungal agents|mesh-ancestor
110701565|NCT00393848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110701566|NCT00393848|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110701567|NCT00393848|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110701568|NCT00393848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110701569|NCT00393848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110701570|NCT00393848|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110701571|NCT00393848|Hormone Antagonists|hormone antagonists|mesh-ancestor
110701572|NCT00393848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110701573|NCT00393848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110701574|NCT00393848|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110701575|NCT00393458|Formoterol Fumarate|formoterol fumarate|mesh-list
110701576|NCT00393458|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110701577|NCT00393458|Autonomic Agents|autonomic agents|mesh-ancestor
110701578|NCT00393458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110117894|NCT01880749|Immunologic Factors|immunologic factors|mesh-ancestor
110701579|NCT00393458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110701580|NCT00393458|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110701581|NCT00393458|Respiratory System Agents|respiratory system agents|mesh-ancestor
110701582|NCT00393458|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110701583|NCT00393458|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110701584|NCT00393458|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110701585|NCT00393458|Adrenergic Agents|adrenergic agents|mesh-ancestor
110701586|NCT00393458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110701587|NCT00393458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110701588|NCT01046006|Dexamethasone|dexamethasone|mesh-list
110701589|NCT01046006|Rituximab|rituximab|mesh-list
110701590|NCT01046006|Bortezomib|bortezomib|mesh-list
110701591|NCT01046006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110701592|NCT01046006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110701593|NCT01046006|Immunologic Factors|immunologic factors|mesh-ancestor
110701594|NCT01046006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110701595|NCT01046006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110701596|NCT01046006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110701597|NCT01046006|Antiemetics|antiemetics|mesh-ancestor
110701598|NCT01046006|Autonomic Agents|autonomic agents|mesh-ancestor
110117957|NCT01881503|HBOC 201|hboc 201|mesh-list
110701599|NCT01046006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110701600|NCT01046006|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110701601|NCT01046006|Glucocorticoids|glucocorticoids|mesh-ancestor
110701602|NCT01046006|Hormones|hormones|mesh-ancestor
110701603|NCT01046006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110701604|NCT01046006|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110701605|NCT01046162|Alprazolam|alprazolam|mesh-list
110701606|NCT01046162|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110701607|NCT01046162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110701608|NCT01046162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110701609|NCT01046162|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110701610|NCT01046162|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110701611|NCT01046162|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110701612|NCT01046162|GABA Modulators|gaba modulators|mesh-ancestor
110701613|NCT01046162|GABA Agents|gaba agents|mesh-ancestor
110701614|NCT01046162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110701615|NCT01046162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110701617|NCT00417482|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110701618|NCT00417482|Serotonin Agents|serotonin agents|mesh-ancestor
110701619|NCT00417482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110701620|NCT00417482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110701621|NCT00417482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110701622|NCT00417482|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110701623|NCT00417482|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110701624|NCT00417482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110701625|NCT00417482|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110701626|NCT00417482|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110701627|NCT00417482|Dopamine Agents|dopamine agents|mesh-ancestor
110701628|NCT00417248|Etoposide|etoposide|mesh-list
110701629|NCT00417248|Sorafenib|sorafenib|mesh-list
110701630|NCT00417248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110701631|NCT00417248|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110701632|NCT00417248|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110701633|NCT00417248|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110701634|NCT00417248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110701635|NCT00417248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110701636|NCT00417248|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110701637|NCT01046240|Palonosetron|palonosetron|mesh-list
110701638|NCT01046240|Antiemetics|antiemetics|mesh-ancestor
110701639|NCT01046240|Autonomic Agents|autonomic agents|mesh-ancestor
110701640|NCT01046240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110701641|NCT01046240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110701642|NCT01046240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110701643|NCT01046240|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110701644|NCT01046240|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110701645|NCT01046240|Serotonin Agents|serotonin agents|mesh-ancestor
110701646|NCT01046240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110701647|NCT01046240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110701648|NCT00392288|Ciclesonide|ciclesonide|mesh-list
110701649|NCT00392288|Glucocorticoids|glucocorticoids|mesh-ancestor
110701650|NCT00392288|Hormones|hormones|mesh-ancestor
110118199|NCT01884116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110701651|NCT00392288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110701652|NCT00392288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110701653|NCT00392288|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110701654|NCT00417170|Amlodipine|amlodipine|mesh-list
110701655|NCT00417170|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110701656|NCT00417170|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110701657|NCT00417170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110701658|NCT00417170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110701659|NCT00417170|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110701660|NCT00417170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110701661|NCT00417170|Vasodilator Agents|vasodilator agents|mesh-ancestor
110701662|NCT00392990|Cytarabine|cytarabine|mesh-list
110701663|NCT00392990|Cyclophosphamide|cyclophosphamide|mesh-list
110701664|NCT00392990|Ifosfamide|ifosfamide|mesh-list
110701665|NCT00392990|Rituximab|rituximab|mesh-list
110701666|NCT00392990|Doxorubicin|doxorubicin|mesh-list
110701667|NCT00392990|Methotrexate|methotrexate|mesh-list
110701668|NCT00392990|Etoposide|etoposide|mesh-list
110701669|NCT00392990|Vincristine|vincristine|mesh-list
110701670|NCT00392990|Etoposide phosphate|etoposide phosphate|mesh-list
110701671|NCT00392990|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110701672|NCT00392990|Podophyllotoxin|podophyllotoxin|mesh-list
110701673|NCT00392990|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110701674|NCT00392990|Immunologic Factors|immunologic factors|mesh-ancestor
110859621|NCT05803811|Dermatologic Agents|dermatologic agents|mesh-ancestor
110701675|NCT00392990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110701676|NCT00392990|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110701677|NCT00392990|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110701678|NCT00392990|Alkylating Agents|alkylating agents|mesh-ancestor
110701679|NCT00392990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110701680|NCT00392990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110701681|NCT00392990|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110701682|NCT00392990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110701683|NCT00392990|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110701684|NCT00392990|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110701685|NCT00392990|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110701686|NCT00392990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110701687|NCT00392990|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110701688|NCT00392990|Abortifacient Agents|abortifacient agents|mesh-ancestor
110701689|NCT00392990|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110701690|NCT00392990|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110701691|NCT00392990|Antimetabolites|antimetabolites|mesh-ancestor
110701692|NCT00392990|Dermatologic Agents|dermatologic agents|mesh-ancestor
110701693|NCT00392990|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110701694|NCT00392990|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110701695|NCT00392990|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110701696|NCT00392990|Antiviral Agents|antiviral agents|mesh-ancestor
110701697|NCT00392990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110701698|NCT00392990|Tubulin Modulators|tubulin modulators|mesh-ancestor
110701699|NCT00392990|Antimitotic Agents|antimitotic agents|mesh-ancestor
110701700|NCT00392990|Mitosis Modulators|mitosis modulators|mesh-ancestor
110701701|NCT00392990|Keratolytic Agents|keratolytic agents|mesh-ancestor
110701702|NCT00249873|Clopidogrel|clopidogrel|mesh-list
110701703|NCT00249873|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110701704|NCT00249873|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110701705|NCT00249873|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110701706|NCT00249873|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110701707|NCT00249873|Purinergic Agents|purinergic agents|mesh-ancestor
110701708|NCT00249873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110701709|NCT00249873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110701710|NCT00249873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110701711|NCT01037348|Ranibizumab|ranibizumab|mesh-list
110701712|NCT01037348|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110701713|NCT01037348|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110701715|NCT01037348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110701716|NCT01037348|Growth Inhibitors|growth inhibitors|mesh-ancestor
110701717|NCT01037348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110701718|NCT03490292|Paclitaxel|paclitaxel|mesh-list
110701719|NCT03490292|Carboplatin|carboplatin|mesh-list
110701720|NCT03490292|Avelumab|avelumab|mesh-list
110701721|NCT03490292|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110701722|NCT03490292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110701723|NCT03490292|Tubulin Modulators|tubulin modulators|mesh-ancestor
110701724|NCT03490292|Antimitotic Agents|antimitotic agents|mesh-ancestor
110701725|NCT03490292|Mitosis Modulators|mitosis modulators|mesh-ancestor
110701726|NCT03490292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110701727|NCT03490292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110701728|NCT01046630|Ketamine|ketamine|mesh-list
110701729|NCT01046630|Analgesics|analgesics|mesh-ancestor
110701730|NCT01046630|Sensory System Agents|sensory system agents|mesh-ancestor
110701731|NCT01046630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110701732|NCT01046630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110701733|NCT01046630|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110701734|NCT01046630|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110701735|NCT01046630|Anesthetics, General|anesthetics, general|mesh-ancestor
110701736|NCT01046630|Anesthetics|anesthetics|mesh-ancestor
110701737|NCT01046630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110701738|NCT01046630|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110701739|NCT01046630|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110701740|NCT01046630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110701741|NCT01046630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110701742|NCT01046708|Progesterone|progesterone|mesh-list
110701743|NCT01046708|Progestins|progestins|mesh-ancestor
110701744|NCT01046708|Hormones|hormones|mesh-ancestor
110701745|NCT01046708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110701746|NCT01046708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110701747|NCT01046786|Methylprednisolone|methylprednisolone|mesh-list
110701748|NCT01046786|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110701749|NCT01046786|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110701750|NCT01046786|Prednisolone|prednisolone|mesh-list
110701751|NCT01046786|Prednisolone acetate|prednisolone acetate|mesh-list
110701752|NCT01046786|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110701753|NCT01046786|Prednisolone phosphate|prednisolone phosphate|mesh-list
110701754|NCT01046786|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110701755|NCT01046786|Antiemetics|antiemetics|mesh-ancestor
110701756|NCT01046786|Autonomic Agents|autonomic agents|mesh-ancestor
110701757|NCT01046786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110701758|NCT01046786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110701759|NCT01046786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110701760|NCT01046786|Glucocorticoids|glucocorticoids|mesh-ancestor
110701761|NCT01046786|Hormones|hormones|mesh-ancestor
110701762|NCT01046786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110701763|NCT01046786|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110701764|NCT01046786|Protective Agents|protective agents|mesh-ancestor
110701765|NCT01046786|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110701766|NCT01046786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110701767|NCT00391976|Tobramycin|tobramycin|mesh-list
110701768|NCT00391976|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110701769|NCT00391976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110701770|NCT00762554|Fentanyl|fentanyl|mesh-list
110701771|NCT00762554|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110701772|NCT00762554|Narcotics|narcotics|mesh-ancestor
110701773|NCT00762554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110701774|NCT00762554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110701775|NCT00762554|Analgesics|analgesics|mesh-ancestor
110701776|NCT00762554|Sensory System Agents|sensory system agents|mesh-ancestor
110701777|NCT00762554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110701778|NCT00762554|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110701779|NCT00762554|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110701780|NCT00762554|Anesthetics, General|anesthetics, general|mesh-ancestor
110701781|NCT00762554|Anesthetics|anesthetics|mesh-ancestor
110701782|NCT00391898|Levodopa|levodopa|mesh-list
110701783|NCT00391898|Carbidopa|carbidopa|mesh-list
110701784|NCT00391898|Entacapone|entacapone|mesh-list
110701785|NCT00391898|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110701786|NCT00391898|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110701787|NCT00391898|Dopamine Agents|dopamine agents|mesh-ancestor
110701788|NCT00391898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110701789|NCT00391898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110701790|NCT00391898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110701791|NCT00391898|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
110701793|NCT00391898|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
110701794|NCT01046864|Leucovorin|leucovorin|mesh-list
110701795|NCT01046864|Fluorouracil|fluorouracil|mesh-list
110701796|NCT01046864|Irinotecan|irinotecan|mesh-list
110701797|NCT01046864|Antimetabolites|antimetabolites|mesh-ancestor
110701798|NCT01046864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110701799|NCT01046864|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110701800|NCT01046864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110701801|NCT01046864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110701802|NCT01046864|Immunologic Factors|immunologic factors|mesh-ancestor
110701803|NCT01046864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110701804|NCT01046864|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110701805|NCT01046864|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110701806|NCT01046864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110701807|NCT01046864|Antidotes|antidotes|mesh-ancestor
110701808|NCT01046864|Protective Agents|protective agents|mesh-ancestor
110701809|NCT01046864|Vitamin B Complex|vitamin b complex|mesh-ancestor
110701810|NCT01046864|Vitamins|vitamins|mesh-ancestor
110701811|NCT01046864|Micronutrients|micronutrients|mesh-ancestor
110701812|NCT01046942|Aspirin|aspirin|mesh-list
110701813|NCT01046942|Clopidogrel|clopidogrel|mesh-list
110701814|NCT01046942|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110701815|NCT01046942|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110701816|NCT01046942|Analgesics|analgesics|mesh-ancestor
110701817|NCT01046942|Sensory System Agents|sensory system agents|mesh-ancestor
110701818|NCT01046942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110701819|NCT01046942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110701820|NCT01046942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110701821|NCT01046942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110701822|NCT01046942|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110701823|NCT01046942|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110701824|NCT01046942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110701825|NCT01046942|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110701826|NCT01046942|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110701827|NCT01046942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110701828|NCT01046942|Antipyretics|antipyretics|mesh-ancestor
110701829|NCT01046942|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110701830|NCT01046942|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110701831|NCT01046942|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110701832|NCT01046942|Purinergic Agents|purinergic agents|mesh-ancestor
110701833|NCT01046942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110701834|NCT01049438|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110701835|NCT01049438|Doxycycline|doxycycline|mesh-list
110701836|NCT01049438|Minocycline|minocycline|mesh-list
110701837|NCT01049438|Mupirocin|mupirocin|mesh-list
110701838|NCT01049438|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
110701839|NCT01049438|Trimethoprim|trimethoprim|mesh-list
110701840|NCT01049438|Sulfamethoxazole|sulfamethoxazole|mesh-list
110701841|NCT01049438|Hexachlorophene|hexachlorophene|mesh-list
110701842|NCT01049438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110701843|NCT01049438|Antimalarials|antimalarials|mesh-ancestor
110701844|NCT01049438|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110701845|NCT01049438|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110701846|NCT01049438|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110701847|NCT01049438|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110701848|NCT01049438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110701849|NCT01049438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110701850|NCT01049438|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110701851|NCT01049438|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
110701852|NCT01049438|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110701853|NCT01049438|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110701854|NCT01049438|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110701855|NCT01047098|Iron|iron|mesh-list
110701856|NCT01047098|Trace Elements|trace elements|mesh-ancestor
110701857|NCT01047098|Micronutrients|micronutrients|mesh-ancestor
110701858|NCT01047098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110701859|NCT00391586|Paclitaxel|paclitaxel|mesh-list
110701860|NCT00391586|Etoposide|etoposide|mesh-list
110701861|NCT00391586|Vinorelbine|vinorelbine|mesh-list
110701862|NCT00391586|Docetaxel|docetaxel|mesh-list
110701863|NCT00391586|Gemcitabine|gemcitabine|mesh-list
110701864|NCT00391586|Irinotecan|irinotecan|mesh-list
110701865|NCT00391586|Pemetrexed|pemetrexed|mesh-list
110701866|NCT00391586|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110118524|NCT01886079|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110701867|NCT00391586|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110701868|NCT00391586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110701869|NCT00391586|Tubulin Modulators|tubulin modulators|mesh-ancestor
110701870|NCT00391586|Antimitotic Agents|antimitotic agents|mesh-ancestor
110701871|NCT00391586|Mitosis Modulators|mitosis modulators|mesh-ancestor
110701872|NCT00391586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110701873|NCT00391586|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110701874|NCT00391586|Antimetabolites|antimetabolites|mesh-ancestor
110701875|NCT00391586|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110701876|NCT00391586|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110701877|NCT00391586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110701878|NCT00391586|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110701879|NCT00391586|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110701880|NCT00391586|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110701881|NCT00391586|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110701882|NCT00391430|Sertraline|sertraline|mesh-list
110701883|NCT00391430|Antidepressive Agents|antidepressive agents|mesh-ancestor
110701884|NCT00391430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110701885|NCT00391430|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110701886|NCT00391430|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110701887|NCT00391430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110701888|NCT00391430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110701889|NCT00391430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110701890|NCT00391430|Serotonin Agents|serotonin agents|mesh-ancestor
110701891|NCT00391430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110701892|NCT00391274|Docetaxel|docetaxel|mesh-list
110701893|NCT00391274|Pemetrexed|pemetrexed|mesh-list
110701894|NCT00391274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110701895|NCT00391274|Tubulin Modulators|tubulin modulators|mesh-ancestor
110701896|NCT00391274|Antimitotic Agents|antimitotic agents|mesh-ancestor
110701897|NCT00391274|Mitosis Modulators|mitosis modulators|mesh-ancestor
110701898|NCT00391274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110701899|NCT00391274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110701900|NCT00391274|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110701901|NCT00391274|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110701902|NCT00391118|Paclitaxel|paclitaxel|mesh-list
110701903|NCT00391118|Carboplatin|carboplatin|mesh-list
110701904|NCT00391118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110701905|NCT00391118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110701906|NCT00391118|Tubulin Modulators|tubulin modulators|mesh-ancestor
110701907|NCT00391118|Antimitotic Agents|antimitotic agents|mesh-ancestor
110701908|NCT00391118|Mitosis Modulators|mitosis modulators|mesh-ancestor
110701909|NCT00391118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110701910|NCT00390884|Vaccines|vaccines|mesh-list
110701911|NCT00390884|Immunologic Factors|immunologic factors|mesh-ancestor
110701912|NCT00390884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110701913|NCT01047488|Pregabalin|pregabalin|mesh-list
110701914|NCT01047488|Imipramine|imipramine|mesh-list
110701915|NCT01047488|Analgesics|analgesics|mesh-ancestor
110701916|NCT01047488|Sensory System Agents|sensory system agents|mesh-ancestor
110701917|NCT01047488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110701918|NCT01047488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110701919|NCT01047488|Anticonvulsants|anticonvulsants|mesh-ancestor
110701920|NCT01047488|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110701921|NCT01047488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110701922|NCT01047488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110701923|NCT01047488|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110701924|NCT01047488|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110701925|NCT01047488|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110701926|NCT01047488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110701927|NCT01047488|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110701928|NCT01047488|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110701929|NCT01047488|Antidepressive Agents|antidepressive agents|mesh-ancestor
110701930|NCT01047488|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110701931|NCT01047488|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110701932|NCT01047488|Adrenergic Agents|adrenergic agents|mesh-ancestor
110701933|NCT01047488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110701934|NCT01047566|Digoxin|digoxin|mesh-list
110701935|NCT01047566|Dronedarone|dronedarone|mesh-list
110701936|NCT01047566|Calcium Channel Blockers|calcium channel blockers|mesh-list
110701937|NCT01047566|Calcium|calcium|mesh-list
110701938|NCT01047566|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
110701939|NCT01047566|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110701940|NCT01047566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110701941|NCT01047566|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110701942|NCT01047566|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110701943|NCT01047566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110701944|NCT01047566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110701945|NCT01047566|Protective Agents|protective agents|mesh-ancestor
110701946|NCT01047566|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110701947|NCT01047566|Adrenergic Agents|adrenergic agents|mesh-ancestor
110701948|NCT01047566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110701949|NCT01047566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110701950|NCT00365846|Alemtuzumab|alemtuzumab|mesh-list
110701951|NCT00365846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110701952|NCT00365846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110701953|NCT00264537|Golimumab|golimumab|mesh-list
110701954|NCT00264537|Methotrexate|methotrexate|mesh-list
110701955|NCT00264537|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110701956|NCT00264537|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110701957|NCT00264537|Abortifacient Agents|abortifacient agents|mesh-ancestor
110701958|NCT00264537|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110701959|NCT00264537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110701960|NCT00264537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110701961|NCT00264537|Antimetabolites|antimetabolites|mesh-ancestor
110701962|NCT00264537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110701963|NCT00264537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110701964|NCT00264537|Dermatologic Agents|dermatologic agents|mesh-ancestor
110701965|NCT00264537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110701966|NCT00264537|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110701967|NCT00264537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110701968|NCT00264537|Immunologic Factors|immunologic factors|mesh-ancestor
110701969|NCT00264537|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110701970|NCT00264537|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110701971|NCT00264537|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110701972|NCT00264537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110701973|NCT00371150|Entecavir|entecavir|mesh-list
110701974|NCT00371150|Antiviral Agents|antiviral agents|mesh-ancestor
110701975|NCT00371150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110701976|NCT00264303|Levocetirizine|levocetirizine|mesh-list
110701977|NCT00264303|Desloratadine|desloratadine|mesh-list
110701978|NCT00264303|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110701979|NCT00264303|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110701980|NCT00264303|Histamine Antagonists|histamine antagonists|mesh-ancestor
110701981|NCT00264303|Histamine Agents|histamine agents|mesh-ancestor
110701982|NCT00264303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110701983|NCT00264303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110701984|NCT00264303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110701985|NCT00264303|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110701986|NCT00264303|Cholinergic Agents|cholinergic agents|mesh-ancestor
110701987|NCT01071369|Betamethasone|betamethasone|mesh-list
110701988|NCT01071369|Betamethasone Valerate|betamethasone valerate|mesh-list
110701989|NCT01071369|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
110701990|NCT01071369|Betamethasone benzoate|betamethasone benzoate|mesh-list
110701991|NCT01071369|Lidocaine|lidocaine|mesh-list
110701992|NCT01071369|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
110118665|NCT01886664|Desflurane|desflurane|mesh-list
110701993|NCT01071369|Anesthetics, Local|anesthetics, local|mesh-ancestor
110701994|NCT01071369|Anesthetics|anesthetics|mesh-ancestor
110701995|NCT01071369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110701996|NCT01071369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110701997|NCT01071369|Sensory System Agents|sensory system agents|mesh-ancestor
110701998|NCT01071369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110701999|NCT01071369|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110702000|NCT01071369|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110702001|NCT01071369|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110702002|NCT01071369|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110702003|NCT01071369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110702004|NCT01071369|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110702005|NCT01071369|Glucocorticoids|glucocorticoids|mesh-ancestor
110702006|NCT01071369|Hormones|hormones|mesh-ancestor
110702007|NCT01071369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110702008|NCT01071369|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110702009|NCT01071369|Respiratory System Agents|respiratory system agents|mesh-ancestor
110702010|NCT00370682|Vaccines|vaccines|mesh-list
110702011|NCT00370682|Immunologic Factors|immunologic factors|mesh-ancestor
110702012|NCT00370682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110702013|NCT00264147|Diclofenac|diclofenac|mesh-list
110702014|NCT00264147|Etoricoxib|etoricoxib|mesh-list
110419852|NCT01231373|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110702015|NCT00264147|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110702016|NCT00264147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110702017|NCT00264147|Analgesics|analgesics|mesh-ancestor
110702018|NCT00264147|Sensory System Agents|sensory system agents|mesh-ancestor
110702019|NCT00264147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110702020|NCT00264147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110702021|NCT00264147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110702022|NCT00264147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110702023|NCT00264147|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110702024|NCT00264147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110702025|NCT00264147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110702026|NCT00264147|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110702027|NCT01044446|Dialysis Solutions|dialysis solutions|mesh-list
110702028|NCT01044446|Icodextrin|icodextrin|mesh-list
110702029|NCT01044446|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110702030|NCT03971019|Calcium, Dietary|calcium, dietary|mesh-list
110702031|NCT03971019|Atorvastatin|atorvastatin|mesh-list
110702032|NCT03971019|Simvastatin|simvastatin|mesh-list
110702033|NCT03971019|Calcium|calcium|mesh-list
110702034|NCT03971019|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110702035|NCT03971019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110702036|NCT03971019|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110702037|NCT03971019|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110702038|NCT03971019|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110702039|NCT03971019|Antimetabolites|antimetabolites|mesh-ancestor
110702040|NCT03971019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110702041|NCT03971019|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110702042|NCT03971019|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110859735|NCT05590325|Antiviral Agents|antiviral agents|mesh-ancestor
110859736|NCT05590325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110859740|NCT05568160|Vasopressins|vasopressins|mesh-list
110702044|NCT03974685|Niacinamide|niacinamide|mesh-list
110702045|NCT03974685|Niacin|niacin|mesh-list
110702046|NCT03974685|Nicotinic Acids|nicotinic acids|mesh-list
110702047|NCT03974685|Arginyl-glycyl-aspartic acid|arginyl-glycyl-aspartic acid|mesh-list
110702048|NCT03974685|Vitamin B Complex|vitamin b complex|mesh-ancestor
110702049|NCT03974685|Vitamins|vitamins|mesh-ancestor
110702050|NCT03974685|Micronutrients|micronutrients|mesh-ancestor
110702051|NCT03974685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110702052|NCT03974685|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110702053|NCT03974685|Antimetabolites|antimetabolites|mesh-ancestor
110702054|NCT03974685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110702055|NCT03974685|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110702056|NCT03974685|Vasodilator Agents|vasodilator agents|mesh-ancestor
110702057|NCT03974685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110702058|NCT00263211|Aspirin|aspirin|mesh-list
110702059|NCT00263211|Clopidogrel|clopidogrel|mesh-list
110702060|NCT00263211|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110702061|NCT00263211|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110702062|NCT00263211|Analgesics|analgesics|mesh-ancestor
110702063|NCT00263211|Sensory System Agents|sensory system agents|mesh-ancestor
110702064|NCT00263211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110702065|NCT00263211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110702066|NCT00263211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110702067|NCT00263211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110702068|NCT00263211|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110702069|NCT00263211|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110702070|NCT00263211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110702071|NCT00263211|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110702072|NCT00263211|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110702073|NCT00263211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110702074|NCT00263211|Antipyretics|antipyretics|mesh-ancestor
110702075|NCT00263211|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110702076|NCT00263211|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110702077|NCT00263211|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110702078|NCT00263211|Purinergic Agents|purinergic agents|mesh-ancestor
110702079|NCT00263211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110702080|NCT00248625|Acetylcysteine|acetylcysteine|mesh-list
110702081|NCT00248625|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110702082|NCT00248625|Antiviral Agents|antiviral agents|mesh-ancestor
110702083|NCT00248625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110702084|NCT00248625|Expectorants|expectorants|mesh-ancestor
110702085|NCT00248625|Respiratory System Agents|respiratory system agents|mesh-ancestor
110702086|NCT00248625|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110702087|NCT00248625|Antioxidants|antioxidants|mesh-ancestor
110118770|NCT01887405|Sympathomimetics|sympathomimetics|mesh-ancestor
110702088|NCT00248625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110419930|NCT00974974|Levodopa|levodopa|mesh-list
110702089|NCT00248625|Protective Agents|protective agents|mesh-ancestor
110702090|NCT00248625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110702091|NCT00248625|Antidotes|antidotes|mesh-ancestor
110702092|NCT00262821|Tirapazamine|tirapazamine|mesh-list
110702093|NCT00262821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110702094|NCT01326117|Tadalafil|tadalafil|mesh-list
110702095|NCT01326117|Vasodilator Agents|vasodilator agents|mesh-ancestor
110702096|NCT01326117|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110702097|NCT01326117|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110702098|NCT01326117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110702099|NCT01326117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110702100|NCT01326117|Urological Agents|urological agents|mesh-ancestor
110702101|NCT03970239|Ketanserin|ketanserin|mesh-list
110702103|NCT03970239|Altanserin|altanserin|mesh-list
110702104|NCT03970239|Cariostatic Agents|cariostatic agents|mesh-ancestor
110702105|NCT03970239|Protective Agents|protective agents|mesh-ancestor
110702106|NCT03970239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110702107|NCT03970239|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110702108|NCT03970239|Serotonin Agents|serotonin agents|mesh-ancestor
110702109|NCT03970239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110702110|NCT03970239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110702111|NCT03970239|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110702112|NCT03970239|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110702113|NCT00170950|Amlodipine|amlodipine|mesh-list
110702114|NCT00170950|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110702115|NCT00170950|Benazepril|benazepril|mesh-list
110702116|NCT00170950|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110702117|NCT00170950|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110702118|NCT00170950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110702119|NCT00170950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110702120|NCT00170950|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110702121|NCT00170950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110702122|NCT00170950|Vasodilator Agents|vasodilator agents|mesh-ancestor
110702123|NCT00170950|Diuretics|diuretics|mesh-ancestor
110702124|NCT00170950|Natriuretic Agents|natriuretic agents|mesh-ancestor
110702125|NCT00170950|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110702126|NCT00170950|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110702127|NCT00170950|Protease Inhibitors|protease inhibitors|mesh-ancestor
110702128|NCT00170950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110702129|NCT00262041|Vaccines|vaccines|mesh-list
110702130|NCT00262041|Immunologic Factors|immunologic factors|mesh-ancestor
110702131|NCT00262041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110702132|NCT00208767|Valsartan|valsartan|mesh-list
110702133|NCT00208767|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110702134|NCT00208767|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110702135|NCT00208767|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110702136|NCT00208767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110702137|NCT02531529|Fentanyl|fentanyl|mesh-list
110702138|NCT02531529|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110702139|NCT02531529|Narcotics|narcotics|mesh-ancestor
110702140|NCT02531529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110702141|NCT02531529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110702142|NCT02531529|Analgesics|analgesics|mesh-ancestor
110702143|NCT02531529|Sensory System Agents|sensory system agents|mesh-ancestor
110702144|NCT02531529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110702145|NCT02531529|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110702146|NCT02531529|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110702147|NCT02531529|Anesthetics, General|anesthetics, general|mesh-ancestor
110702148|NCT02531529|Anesthetics|anesthetics|mesh-ancestor
110702149|NCT01071525|Niacin|niacin|mesh-list
110702150|NCT01071525|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110702151|NCT01071525|Antimetabolites|antimetabolites|mesh-ancestor
110702152|NCT01071525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110702153|NCT01071525|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110702154|NCT01071525|Vasodilator Agents|vasodilator agents|mesh-ancestor
110702155|NCT01071525|Vitamin B Complex|vitamin b complex|mesh-ancestor
110702156|NCT01071525|Vitamins|vitamins|mesh-ancestor
110702157|NCT01071525|Micronutrients|micronutrients|mesh-ancestor
110702158|NCT01071525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110702159|NCT01072695|Ribavirin|ribavirin|mesh-list
110702160|NCT01072695|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110702161|NCT01072695|Antimetabolites|antimetabolites|mesh-ancestor
110702162|NCT01072695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110420004|NCT02846935|Decitabine|decitabine|mesh-list
110702163|NCT01072695|Antiviral Agents|antiviral agents|mesh-ancestor
110702164|NCT01072695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110702165|NCT00390806|Topotecan|topotecan|mesh-list
110702167|NCT00390806|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110702168|NCT00390806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110702169|NCT00390806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110702170|NCT00390806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110702171|NCT00135200|Tositumomab I-131|tositumomab i-131|mesh-list
110702172|NCT00135200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110702173|NCT01047722|Aspirin|aspirin|mesh-list
110702174|NCT01047722|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110702175|NCT01047722|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110702176|NCT01047722|Analgesics|analgesics|mesh-ancestor
110702177|NCT01047722|Sensory System Agents|sensory system agents|mesh-ancestor
110702178|NCT01047722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110702179|NCT01047722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110702180|NCT01047722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110702181|NCT01047722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110702182|NCT01047722|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110702183|NCT01047722|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110702184|NCT01047722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110702185|NCT01047722|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110702186|NCT01047722|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110702187|NCT01047722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110702188|NCT01047722|Antipyretics|antipyretics|mesh-ancestor
110702189|NCT00390416|Leucovorin|leucovorin|mesh-list
110702190|NCT00390416|Bevacizumab|bevacizumab|mesh-list
110702191|NCT00390416|Docetaxel|docetaxel|mesh-list
110702192|NCT00390416|Fluorouracil|fluorouracil|mesh-list
110702193|NCT00390416|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110702194|NCT00390416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110702195|NCT00390416|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110702196|NCT00390416|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110702197|NCT00390416|Growth Substances|growth substances|mesh-ancestor
110702198|NCT00390416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110702199|NCT00390416|Growth Inhibitors|growth inhibitors|mesh-ancestor
110702200|NCT00390416|Tubulin Modulators|tubulin modulators|mesh-ancestor
110702201|NCT00390416|Antimitotic Agents|antimitotic agents|mesh-ancestor
110702202|NCT00390416|Mitosis Modulators|mitosis modulators|mesh-ancestor
110702203|NCT00390416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110702204|NCT00390416|Antimetabolites|antimetabolites|mesh-ancestor
110702205|NCT00390416|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110702206|NCT00390416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110702207|NCT00390416|Immunologic Factors|immunologic factors|mesh-ancestor
110702208|NCT00390416|Antidotes|antidotes|mesh-ancestor
110702209|NCT00390416|Protective Agents|protective agents|mesh-ancestor
110702210|NCT00390416|Vitamin B Complex|vitamin b complex|mesh-ancestor
110702211|NCT00390416|Vitamins|vitamins|mesh-ancestor
110702212|NCT00390416|Micronutrients|micronutrients|mesh-ancestor
110702213|NCT00261495|Oxycodone|oxycodone|mesh-list
110702214|NCT00261495|Hydromorphone|hydromorphone|mesh-list
110702215|NCT00261495|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110702216|NCT00261495|Narcotics|narcotics|mesh-ancestor
110702217|NCT00261495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110702218|NCT00261495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110702219|NCT00261495|Analgesics|analgesics|mesh-ancestor
110702220|NCT00261495|Sensory System Agents|sensory system agents|mesh-ancestor
110702221|NCT00261495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110702222|NCT00168844|Tiotropium Bromide|tiotropium bromide|mesh-list
110702223|NCT00168844|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110702224|NCT00168844|Autonomic Agents|autonomic agents|mesh-ancestor
110702225|NCT00168844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110702226|NCT00168844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110702227|NCT00168844|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110702228|NCT00168844|Respiratory System Agents|respiratory system agents|mesh-ancestor
110702229|NCT00168844|Parasympatholytics|parasympatholytics|mesh-ancestor
110702230|NCT00168844|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110702231|NCT00168844|Cholinergic Agents|cholinergic agents|mesh-ancestor
110702232|NCT00168844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110702233|NCT00168844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110702234|NCT00365456|Risedronic Acid|risedronic acid|mesh-list
110702235|NCT00365456|Hormones|hormones|mesh-list
110702236|NCT00365456|Parathyroid Hormone|parathyroid hormone|mesh-list
110702237|NCT00365456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110702238|NCT00365456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110702239|NCT00365456|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110702240|NCT00365456|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110702241|NCT00365456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110702242|NCT00365456|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110118919|NCT01888107|Dopamine Agents|dopamine agents|mesh-ancestor
110702243|NCT00365456|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110702244|NCT01047956|Methadone|methadone|mesh-list
110702245|NCT01047956|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110702246|NCT01047956|Narcotics|narcotics|mesh-ancestor
110702247|NCT01047956|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110702248|NCT01047956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110702249|NCT01047956|Analgesics|analgesics|mesh-ancestor
110702250|NCT01047956|Sensory System Agents|sensory system agents|mesh-ancestor
110702251|NCT01047956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110702253|NCT01047956|Respiratory System Agents|respiratory system agents|mesh-ancestor
110702254|NCT03480698|Cerebrolysin|cerebrolysin|mesh-list
110702255|NCT03480698|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110702256|NCT03480698|Protective Agents|protective agents|mesh-ancestor
110702257|NCT03480698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110702258|NCT03480698|Nootropic Agents|nootropic agents|mesh-ancestor
110702259|NCT00206427|Lapatinib|lapatinib|mesh-list
110702260|NCT00206427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110702261|NCT00206427|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110702262|NCT00206427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110702263|NCT00206427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110702264|NCT00389324|Immunoglobulins|immunoglobulins|mesh-list
110702265|NCT00389324|Antibodies|antibodies|mesh-list
110702266|NCT00389324|gamma-Globulins|gamma-globulins|mesh-list
110702267|NCT00389324|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110702268|NCT00389324|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110702269|NCT00389324|Immunoglobulin G|immunoglobulin g|mesh-list
110702270|NCT00389324|Immunologic Factors|immunologic factors|mesh-ancestor
110702271|NCT00389324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110702272|NCT00365300|Pantoprazole|pantoprazole|mesh-list
110702273|NCT00365300|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110702274|NCT00365300|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110702275|NCT00365300|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110702276|NCT00365300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110702277|NCT00365300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110702278|NCT01048034|Azacitidine|azacitidine|mesh-list
110702279|NCT01048034|Epoetin Alfa|epoetin alfa|mesh-list
110702280|NCT01048034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110702281|NCT01048034|Antimetabolites|antimetabolites|mesh-ancestor
110702282|NCT01048034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110702283|NCT01048034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110702284|NCT01048034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110702285|NCT01048034|Hematinics|hematinics|mesh-ancestor
110702286|NCT00370292|Pemetrexed|pemetrexed|mesh-list
110702287|NCT00370292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110118960|NCT01888302|Sirolimus|sirolimus|mesh-list
110702288|NCT00370292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110702289|NCT00370292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110702290|NCT00370292|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110702291|NCT00370292|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110702292|NCT01049672|Alfentanil|alfentanil|mesh-list
110702293|NCT01049672|Heroin|heroin|mesh-list
110702294|NCT01049672|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110702295|NCT01049672|Narcotics|narcotics|mesh-ancestor
110702296|NCT01049672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110702297|NCT01049672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110702298|NCT01049672|Analgesics|analgesics|mesh-ancestor
110702299|NCT01049672|Sensory System Agents|sensory system agents|mesh-ancestor
110702300|NCT01049672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110702301|NCT01049672|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110702302|NCT01049672|Anesthetics, General|anesthetics, general|mesh-ancestor
110702303|NCT01049672|Anesthetics|anesthetics|mesh-ancestor
110702304|NCT01048190|Vaccines|vaccines|mesh-list
110702305|NCT01048190|Immunologic Factors|immunologic factors|mesh-ancestor
110702306|NCT01048190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110702307|NCT01048268|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
110702308|NCT01048268|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110702309|NCT01048268|Incretins|incretins|mesh-ancestor
110702310|NCT01048268|Hormones|hormones|mesh-ancestor
110702311|NCT01048268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110702312|NCT01048268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110702313|NCT03993236|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110702314|NCT03993236|Ezetimibe|ezetimibe|mesh-list
110702315|NCT03993236|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110702316|NCT03993236|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110702317|NCT03993236|Antimetabolites|antimetabolites|mesh-ancestor
110702318|NCT03993236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110702319|NCT03993236|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110702320|NCT03993236|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110702321|NCT03993236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110702322|NCT00388154|Cisplatin|cisplatin|mesh-list
110702323|NCT00388154|Gemcitabine|gemcitabine|mesh-list
110702324|NCT00388154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110702325|NCT00388154|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110702326|NCT00388154|Antimetabolites|antimetabolites|mesh-ancestor
110702327|NCT00388154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110702328|NCT02535104|Ranpirnase|ranpirnase|mesh-list
110118988|NCT01888458|Micafungin|micafungin|mesh-list
110702329|NCT02535104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110702330|NCT02535104|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110702331|NCT02535104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110702332|NCT02535104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110702333|NCT00386360|Risedronic Acid|risedronic acid|mesh-list
110702334|NCT00386360|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110702335|NCT00386360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110702336|NCT00386360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110702337|NCT00386360|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110702338|NCT00386360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110702339|NCT00386360|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110702340|NCT00369278|Mycophenolic Acid|mycophenolic acid|mesh-list
110702341|NCT00369278|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110702342|NCT00369278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110702343|NCT00369278|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110702344|NCT00369278|Antitubercular Agents|antitubercular agents|mesh-ancestor
110702345|NCT00369278|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110702346|NCT00369278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110702347|NCT00369278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110702348|NCT00369278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110702349|NCT00529373|Calcium, Dietary|calcium, dietary|mesh-list
110702350|NCT00529373|Vitamin D|vitamin d|mesh-list
110702351|NCT00529373|Cholecalciferol|cholecalciferol|mesh-list
110702352|NCT00529373|Calcium Carbonate|calcium carbonate|mesh-list
110702353|NCT00529373|Calcium|calcium|mesh-list
110702354|NCT00529373|Vitamins|vitamins|mesh-ancestor
110702355|NCT00529373|Micronutrients|micronutrients|mesh-ancestor
110702356|NCT00529373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110702357|NCT00529373|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110702358|NCT00529373|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110702359|NCT00529373|Antacids|antacids|mesh-ancestor
110702360|NCT00529373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110702361|NCT00529373|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110702362|NCT00369122|Bevacizumab|bevacizumab|mesh-list
110702363|NCT00369122|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110702364|NCT00369122|Cisplatin|cisplatin|mesh-list
110702365|NCT00369122|Endothelial Growth Factors|endothelial growth factors|mesh-list
110702366|NCT00369122|Antibodies|antibodies|mesh-list
110859907|NCT05436964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110859908|NCT05436964|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110859909|NCT05436964|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110859910|NCT05436964|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110859911|NCT05436964|Adrenergic Agents|adrenergic agents|mesh-ancestor
110859912|NCT05436964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110859914|NCT05429762|Maytansine|maytansine|mesh-list
110702367|NCT00369122|Immunoglobulins|immunoglobulins|mesh-list
110702368|NCT00369122|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110702369|NCT00369122|Immunoglobulin G|immunoglobulin g|mesh-list
110702370|NCT00369122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110702371|NCT00369122|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110702372|NCT00369122|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110702373|NCT00369122|Growth Substances|growth substances|mesh-ancestor
110702374|NCT00369122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110702375|NCT00369122|Growth Inhibitors|growth inhibitors|mesh-ancestor
110702376|NCT00369122|Immunologic Factors|immunologic factors|mesh-ancestor
110702377|NCT03999203|Nitric Oxide|nitric oxide|mesh-list
110702378|NCT03999203|Citric Acid|citric acid|mesh-list
110702379|NCT03999203|Sodium Citrate|sodium citrate|mesh-list
110702380|NCT03999203|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110702381|NCT03999203|Autonomic Agents|autonomic agents|mesh-ancestor
110702382|NCT03999203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110702383|NCT03999203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110702384|NCT03999203|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110859950|NCT05350202|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110702385|NCT03999203|Respiratory System Agents|respiratory system agents|mesh-ancestor
110702386|NCT03999203|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110702388|NCT03999203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110702389|NCT03999203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110702390|NCT03999203|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
110702391|NCT03999203|Vasodilator Agents|vasodilator agents|mesh-ancestor
110702392|NCT03999203|Gasotransmitters|gasotransmitters|mesh-ancestor
110702393|NCT03999203|Protective Agents|protective agents|mesh-ancestor
110702394|NCT03999203|Anticoagulants|anticoagulants|mesh-ancestor
110702395|NCT03999203|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110702396|NCT03999203|Chelating Agents|chelating agents|mesh-ancestor
110702397|NCT03999203|Sequestering Agents|sequestering agents|mesh-ancestor
110702398|NCT04854395|Bupivacaine|bupivacaine|mesh-list
110702399|NCT04854395|Anesthetics, Local|anesthetics, local|mesh-ancestor
110702400|NCT04854395|Anesthetics|anesthetics|mesh-ancestor
110702401|NCT04854395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110702402|NCT04854395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110702403|NCT04854395|Sensory System Agents|sensory system agents|mesh-ancestor
110702404|NCT04854395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110702405|NCT05173493|Amoxicillin|amoxicillin|mesh-list
110702406|NCT05173493|Levofloxacin|levofloxacin|mesh-list
110702407|NCT05173493|Tetracycline|tetracycline|mesh-list
110702408|NCT05173493|Furazolidone|furazolidone|mesh-list
110702409|NCT05173493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110702410|NCT05173493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110119041|NCT01888731|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110702411|NCT05173493|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110702412|NCT05173493|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110702413|NCT05173493|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110702414|NCT05173493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110702415|NCT05173493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110702416|NCT05173493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110702417|NCT05173493|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110702418|NCT05173493|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110702419|NCT05173493|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110702420|NCT05173493|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110702421|NCT05173493|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
110702422|NCT05173493|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110702423|NCT05173493|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110702424|NCT05173493|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
110702426|NCT03872843|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110702427|NCT03872843|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110702428|NCT03872843|Analgesics|analgesics|mesh-ancestor
110702429|NCT03872843|Sensory System Agents|sensory system agents|mesh-ancestor
110702430|NCT03872843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110702431|NCT03872843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110702432|NCT03872843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110702433|NCT03872843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110702434|NCT03872843|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110702435|NCT03872843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110702436|NCT03872843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110702438|NCT03966040|Immunologic Factors|immunologic factors|mesh-ancestor
110702439|NCT03966040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110702440|NCT03999125|Dexamethasone|dexamethasone|mesh-list
110702441|NCT03999125|Dexamethasone acetate|dexamethasone acetate|mesh-list
110702442|NCT03999125|Ranibizumab|ranibizumab|mesh-list
110702443|NCT03999125|Aflibercept|aflibercept|mesh-list
110702444|NCT03999125|BB 1101|bb 1101|mesh-list
110702445|NCT03999125|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110702446|NCT03999125|Antiemetics|antiemetics|mesh-ancestor
110702447|NCT03999125|Autonomic Agents|autonomic agents|mesh-ancestor
110702448|NCT03999125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110702449|NCT03999125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110702450|NCT03999125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110702451|NCT03999125|Glucocorticoids|glucocorticoids|mesh-ancestor
110702452|NCT03999125|Hormones|hormones|mesh-ancestor
110702453|NCT03999125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110702454|NCT03999125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110702455|NCT03999125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110702456|NCT03999125|Protease Inhibitors|protease inhibitors|mesh-ancestor
110702457|NCT03999125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110702458|NCT03999125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110702459|NCT03999125|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110702460|NCT03999125|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110702461|NCT03999125|Growth Substances|growth substances|mesh-ancestor
110702462|NCT03999125|Growth Inhibitors|growth inhibitors|mesh-ancestor
110702463|NCT00168064|Mechlorethamine|mechlorethamine|mesh-list
110702464|NCT00168064|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
110702465|NCT00168064|Alkylating Agents|alkylating agents|mesh-ancestor
110702466|NCT00168064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110702467|NCT00168064|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110702468|NCT00168064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110702470|NCT00166114|Escitalopram|escitalopram|mesh-list
110702471|NCT00166114|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110702472|NCT00166114|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110702473|NCT00166114|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110702474|NCT00166114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110702475|NCT00166114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110702476|NCT00166114|Serotonin Agents|serotonin agents|mesh-ancestor
110702477|NCT00166114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110702478|NCT00166114|Antidepressive Agents|antidepressive agents|mesh-ancestor
110702479|NCT00166114|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110702480|NCT00166114|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110702481|NCT00166114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110702482|NCT00166114|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110702483|NCT00166114|Adrenergic Agents|adrenergic agents|mesh-ancestor
110702484|NCT05032781|Minocycline|minocycline|mesh-list
110702485|NCT05032781|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110702486|NCT05032781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110702487|NCT00129376|Cyclophosphamide|cyclophosphamide|mesh-list
110702488|NCT00129376|Docetaxel|docetaxel|mesh-list
110702489|NCT00129376|Doxorubicin|doxorubicin|mesh-list
110702490|NCT00129376|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110702491|NCT00129376|Immunologic Factors|immunologic factors|mesh-ancestor
110702492|NCT00129376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110702493|NCT00129376|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110702494|NCT00129376|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110702495|NCT00129376|Alkylating Agents|alkylating agents|mesh-ancestor
110702496|NCT00129376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110702497|NCT00129376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110702498|NCT00129376|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110702499|NCT00129376|Tubulin Modulators|tubulin modulators|mesh-ancestor
110702500|NCT00129376|Antimitotic Agents|antimitotic agents|mesh-ancestor
110702501|NCT00129376|Mitosis Modulators|mitosis modulators|mesh-ancestor
110702502|NCT00129376|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110702503|NCT00129376|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110119102|NCT01888835|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110702504|NCT00129376|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110702505|NCT00129376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110702506|NCT04878107|Docetaxel|docetaxel|mesh-list
110702507|NCT04878107|Apatinib|apatinib|mesh-list
110702508|NCT04878107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110702509|NCT04878107|Tubulin Modulators|tubulin modulators|mesh-ancestor
110702510|NCT04878107|Antimitotic Agents|antimitotic agents|mesh-ancestor
110702511|NCT04878107|Mitosis Modulators|mitosis modulators|mesh-ancestor
110702512|NCT04878107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110702513|NCT04878107|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110702514|NCT04878107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110702515|NCT03998969|Pantoprazole|pantoprazole|mesh-list
110702516|NCT03998969|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110702517|NCT03998969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110702518|NCT03998969|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110702519|NCT03998969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110702520|NCT03998969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110702521|NCT00129220|Haloperidol|haloperidol|mesh-list
110702522|NCT00129220|Olanzapine|olanzapine|mesh-list
110702523|NCT00129220|Haloperidol decanoate|haloperidol decanoate|mesh-list
110702524|NCT00129220|Antiemetics|antiemetics|mesh-ancestor
110702525|NCT00129220|Autonomic Agents|autonomic agents|mesh-ancestor
110702526|NCT00129220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110702527|NCT00129220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110702528|NCT00129220|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110702529|NCT00129220|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110702530|NCT00129220|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110702531|NCT00129220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110702533|NCT00129220|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110702534|NCT00129220|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110702535|NCT00129220|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110702536|NCT00129220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110702537|NCT00129220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110702538|NCT00129220|Serotonin Agents|serotonin agents|mesh-ancestor
110702539|NCT00129220|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110702540|NCT00129220|Dopamine Agents|dopamine agents|mesh-ancestor
110702541|NCT00129220|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110702542|NCT03686813|Sildenafil Citrate|sildenafil citrate|mesh-list
110702543|NCT03686813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110702544|NCT03686813|Vasodilator Agents|vasodilator agents|mesh-ancestor
110702545|NCT03686813|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110702546|NCT03686813|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110702547|NCT03686813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110702548|NCT03686813|Urological Agents|urological agents|mesh-ancestor
110163167|NCT02752815|Glucocorticoids|glucocorticoids|mesh-ancestor
110702549|NCT00128830|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
110702550|NCT00128830|Etravirine|etravirine|mesh-list
110702551|NCT00128830|Enfuvirtide|enfuvirtide|mesh-list
110702552|NCT00128830|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
110702553|NCT00128830|Protease Inhibitors|protease inhibitors|mesh-list
110702554|NCT00128830|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110702555|NCT00128830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110702556|NCT00128830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110702557|NCT00128830|Antiviral Agents|antiviral agents|mesh-ancestor
110702558|NCT00128830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110702559|NCT00128830|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110702560|NCT00128830|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110702561|NCT00128830|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110702562|NCT00128830|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110702563|NCT00128830|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110702564|NCT01074892|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
110702565|NCT01074892|Levonorgestrel|levonorgestrel|mesh-list
110702566|NCT01074892|Medroxyprogesterone|medroxyprogesterone|mesh-list
110702567|NCT01074892|Progestins|progestins|mesh-list
110702568|NCT01074892|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110702569|NCT01074892|Contraceptive Agents|contraceptive agents|mesh-ancestor
110702570|NCT01074892|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110702571|NCT01074892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110702572|NCT01074892|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110702573|NCT01074892|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110702574|NCT01074892|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110702575|NCT01074892|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110702576|NCT01074892|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110702577|NCT01074892|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110702578|NCT01074892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110702579|NCT01074892|Hormones|hormones|mesh-ancestor
110702580|NCT01074892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110702581|NCT00128206|Rifampin|rifampin|mesh-list
110702582|NCT00128206|Isoniazid|isoniazid|mesh-list
110702583|NCT00128206|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110702584|NCT00128206|Antitubercular Agents|antitubercular agents|mesh-ancestor
110702585|NCT00128206|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110702586|NCT00128206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110702587|NCT00128206|Leprostatic Agents|leprostatic agents|mesh-ancestor
110702588|NCT00128206|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110702589|NCT00128206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110702590|NCT00128206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110702591|NCT00128206|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110702592|NCT00128206|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110702593|NCT00128206|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110702594|NCT00128206|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110702595|NCT00128206|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110702596|NCT00128206|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110702597|NCT00128206|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
110702598|NCT00128206|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110702599|NCT00128206|Antimetabolites|antimetabolites|mesh-ancestor
110702600|NCT00128206|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110702601|NCT01075828|Cetuximab|cetuximab|mesh-list
110702602|NCT01075828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110702603|NCT01075828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110702604|NCT01074970|Cisplatin|cisplatin|mesh-list
110702605|NCT01074970|Rucaparib|rucaparib|mesh-list
110702606|NCT01074970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110702607|NCT01074970|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110702608|NCT01074970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110702609|NCT01074970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110702610|NCT03968146|Acetaminophen|acetaminophen|mesh-list
110702611|NCT03968146|Ketorolac|ketorolac|mesh-list
110702612|NCT03968146|Fentanyl|fentanyl|mesh-list
110702613|NCT03968146|Meperidine|meperidine|mesh-list
110702614|NCT03968146|Morphine|morphine|mesh-list
110702615|NCT03968146|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110702616|NCT03968146|Narcotics|narcotics|mesh-ancestor
110702617|NCT03968146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110702618|NCT03968146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110702619|NCT03968146|Analgesics|analgesics|mesh-ancestor
110702620|NCT03968146|Sensory System Agents|sensory system agents|mesh-ancestor
110702621|NCT03968146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110702622|NCT03968146|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110702623|NCT03968146|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110702624|NCT03968146|Anesthetics, General|anesthetics, general|mesh-ancestor
110702625|NCT03968146|Anesthetics|anesthetics|mesh-ancestor
110702626|NCT03968146|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110702627|NCT03968146|Antipyretics|antipyretics|mesh-ancestor
110119332|NCT01892319|Insulin Detemir|insulin detemir|mesh-list
110702628|NCT03968146|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110702629|NCT03968146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110702630|NCT03968146|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110702631|NCT03968146|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110702632|NCT03968146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110702633|NCT03968146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110702634|NCT03966118|Paclitaxel|paclitaxel|mesh-list
110702635|NCT03966118|Avelumab|avelumab|mesh-list
110702636|NCT03966118|Ramucirumab|ramucirumab|mesh-list
110702637|NCT03966118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110702638|NCT03966118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110702639|NCT03966118|Tubulin Modulators|tubulin modulators|mesh-ancestor
110702640|NCT03966118|Antimitotic Agents|antimitotic agents|mesh-ancestor
110702641|NCT03966118|Mitosis Modulators|mitosis modulators|mesh-ancestor
110702642|NCT03966118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110702643|NCT03966118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110702644|NCT03968224|Metformin|metformin|mesh-list
110702645|NCT03968224|Dapagliflozin|dapagliflozin|mesh-list
110702646|NCT03968224|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110702647|NCT03968224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110702648|NCT03968224|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110119451|NCT01897051|Adrenergic Agents|adrenergic agents|mesh-ancestor
110702649|NCT03968224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110702650|NCT01075126|Valproic Acid|valproic acid|mesh-list
110702651|NCT01075126|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110702652|NCT01075126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110702653|NCT01075126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110702654|NCT01075126|Antimanic Agents|antimanic agents|mesh-ancestor
110702655|NCT01075126|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110702656|NCT01075126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110702657|NCT01075126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110702658|NCT01075126|Anticonvulsants|anticonvulsants|mesh-ancestor
110702659|NCT01075126|GABA Agents|gaba agents|mesh-ancestor
110702660|NCT01075126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110702661|NCT03823378|Upadacitinib|upadacitinib|mesh-list
110702662|NCT03823378|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
110702663|NCT03823378|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110702664|NCT03823378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110702665|NCT03823378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110702666|NCT03823378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110702667|NCT00141778|Ramipril|ramipril|mesh-list
110702668|NCT00141778|Spironolactone|spironolactone|mesh-list
110702669|NCT00141778|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
110702670|NCT00141778|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
110702671|NCT00141778|Enzyme Inhibitors|enzyme inhibitors|mesh-list
110702672|NCT00141778|Mineralocorticoids|mineralocorticoids|mesh-list
110702673|NCT00141778|Hormone Antagonists|hormone antagonists|mesh-ancestor
110702674|NCT00141778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110702675|NCT00141778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110702676|NCT00141778|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110702677|NCT00141778|Diuretics|diuretics|mesh-ancestor
110702678|NCT00141778|Natriuretic Agents|natriuretic agents|mesh-ancestor
110702679|NCT00141778|Protease Inhibitors|protease inhibitors|mesh-ancestor
110702680|NCT00141778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110702681|NCT00141778|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110702682|NCT00141778|Hormones|hormones|mesh-ancestor
110702683|NCT01079884|Esomeprazole|esomeprazole|mesh-list
110702684|NCT01079884|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110702685|NCT01079884|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110702686|NCT01079884|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110702687|NCT01079884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110702688|NCT01079884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110702689|NCT01075906|Colchicine|colchicine|mesh-list
110702690|NCT01075906|Gout Suppressants|gout suppressants|mesh-ancestor
110702691|NCT01075906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110420531|NCT00899431|Rituximab|rituximab|mesh-list
110702692|NCT01075906|Tubulin Modulators|tubulin modulators|mesh-ancestor
110702693|NCT01075906|Antimitotic Agents|antimitotic agents|mesh-ancestor
110702694|NCT01075906|Mitosis Modulators|mitosis modulators|mesh-ancestor
110702695|NCT01075906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110702696|NCT01075906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110702697|NCT01076062|Misoprostol|misoprostol|mesh-list
110702698|NCT01076062|Oxytocin|oxytocin|mesh-list
110702699|NCT01076062|Oxytocics|oxytocics|mesh-ancestor
110702700|NCT01076062|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110702701|NCT01076062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110702702|NCT01076062|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110702703|NCT01076062|Abortifacient Agents|abortifacient agents|mesh-ancestor
110702704|NCT01076062|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110702705|NCT01076062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110702706|NCT00115336|Ibuprofen|ibuprofen|mesh-list
110702707|NCT00115336|Ketorolac|ketorolac|mesh-list
110702708|NCT00115336|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110702709|NCT00115336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110702710|NCT00115336|Analgesics|analgesics|mesh-ancestor
110702711|NCT00115336|Sensory System Agents|sensory system agents|mesh-ancestor
110702712|NCT00115336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110860121|NCT05082662|Diclofenac|diclofenac|mesh-list
110702713|NCT00115336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110702714|NCT00115336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110702715|NCT00115336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110702716|NCT00115336|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110702717|NCT00115336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110702718|NCT00115336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110702720|NCT01076140|Nebivolol|nebivolol|mesh-list
110702721|NCT01076140|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110119772|NCT01901276|Omeprazole|omeprazole|mesh-list
110702722|NCT01076140|Protease Inhibitors|protease inhibitors|mesh-ancestor
110702723|NCT01076140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110702724|NCT01076140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110702725|NCT01076140|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110702726|NCT01076140|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110702727|NCT01076140|Protective Agents|protective agents|mesh-ancestor
110702728|NCT01076140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110702729|NCT01076140|Vasodilator Agents|vasodilator agents|mesh-ancestor
110702730|NCT01076140|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
110702731|NCT01076140|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110702732|NCT01076140|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110702733|NCT01076140|Adrenergic Agents|adrenergic agents|mesh-ancestor
110702734|NCT01076140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110702735|NCT00205803|Vaccines|vaccines|mesh-list
110702736|NCT00205803|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110702737|NCT00205803|Immunologic Factors|immunologic factors|mesh-ancestor
110702738|NCT00205803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110702739|NCT00127192|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110702740|NCT00127192|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110702741|NCT00127192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110702742|NCT00127192|Incretins|incretins|mesh-ancestor
110702743|NCT00127192|Hormones|hormones|mesh-ancestor
110702744|NCT00127192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110702745|NCT00127192|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110702747|NCT00127192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110702748|NCT00127192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110702749|NCT00127036|Bevacizumab|bevacizumab|mesh-list
110702750|NCT00127036|Capecitabine|capecitabine|mesh-list
110702751|NCT00127036|Oxaliplatin|oxaliplatin|mesh-list
110702752|NCT00127036|Irinotecan|irinotecan|mesh-list
110702753|NCT00127036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110702754|NCT00127036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110702755|NCT00127036|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110702756|NCT00127036|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110702757|NCT00127036|Growth Substances|growth substances|mesh-ancestor
110702758|NCT00127036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110702759|NCT00127036|Growth Inhibitors|growth inhibitors|mesh-ancestor
110702760|NCT00127036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110702761|NCT00127036|Antimetabolites|antimetabolites|mesh-ancestor
110702762|NCT00127036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110702763|NCT00127036|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110702764|NCT00127036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110702765|NCT00127036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110420608|NCT01228175|Vitamins|vitamins|mesh-ancestor
110702767|NCT00259857|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110702768|NCT00259857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110702769|NCT01071681|Telmisartan|telmisartan|mesh-list
110702770|NCT01071681|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110702771|NCT01071681|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110702772|NCT01071681|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110702773|NCT01071681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110702774|NCT00203307|Olanzapine|olanzapine|mesh-list
110702775|NCT00203307|Antiemetics|antiemetics|mesh-ancestor
110702776|NCT00203307|Autonomic Agents|autonomic agents|mesh-ancestor
110702777|NCT00203307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110702778|NCT00203307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110702779|NCT00203307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110702780|NCT00203307|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110702781|NCT00203307|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110702782|NCT00203307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110702783|NCT00203307|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110702784|NCT00203307|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110702785|NCT00203307|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110702786|NCT00203307|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110702787|NCT00203307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110702789|NCT00203307|Serotonin Agents|serotonin agents|mesh-ancestor
110702790|NCT00126568|Sorafenib|sorafenib|mesh-list
110702791|NCT00126568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110702792|NCT00126568|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110702793|NCT00126568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110702794|NCT00126568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110702795|NCT00202839|Ribavirin|ribavirin|mesh-list
110702796|NCT00202839|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110702797|NCT00202839|Interferon-alpha|interferon-alpha|mesh-list
110702798|NCT00202839|Antimetabolites|antimetabolites|mesh-ancestor
110702799|NCT00202839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110702800|NCT00202839|Antiviral Agents|antiviral agents|mesh-ancestor
110702801|NCT00202839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110702802|NCT00202839|Immunologic Factors|immunologic factors|mesh-ancestor
110702803|NCT00202839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110702804|NCT00126490|Aldesleukin|aldesleukin|mesh-list
110702805|NCT00126490|Bevacizumab|bevacizumab|mesh-list
110702806|NCT00126490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110702807|NCT00126490|Interleukin-2|interleukin-2|mesh-list
110702808|NCT00126490|Endothelial Growth Factors|endothelial growth factors|mesh-list
110702809|NCT00126490|Antibodies|antibodies|mesh-list
110702810|NCT00126490|Immunoglobulins|immunoglobulins|mesh-list
110702811|NCT00126490|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110702812|NCT00126490|Immunoglobulin G|immunoglobulin g|mesh-list
110702813|NCT00126490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110702814|NCT00126490|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110702815|NCT00126490|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110702816|NCT00126490|Growth Substances|growth substances|mesh-ancestor
110702817|NCT00126490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110702818|NCT00126490|Growth Inhibitors|growth inhibitors|mesh-ancestor
110702819|NCT00126490|Immunologic Factors|immunologic factors|mesh-ancestor
110702820|NCT00126490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110702821|NCT00126490|Analgesics|analgesics|mesh-ancestor
110702822|NCT00126490|Sensory System Agents|sensory system agents|mesh-ancestor
110702823|NCT00126490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110702824|NCT00126490|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110702825|NCT00126490|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110702826|NCT00126490|Antiviral Agents|antiviral agents|mesh-ancestor
110702827|NCT00126490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110702828|NCT00200967|Beclomethasone|beclomethasone|mesh-list
110702829|NCT00200967|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110702830|NCT00200967|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110702831|NCT00200967|Autonomic Agents|autonomic agents|mesh-ancestor
110702832|NCT00200967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110702833|NCT00200967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110702834|NCT00200967|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110702835|NCT00200967|Respiratory System Agents|respiratory system agents|mesh-ancestor
110702836|NCT00200967|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110702837|NCT00200967|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110702838|NCT00200967|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110702839|NCT00200967|Adrenergic Agents|adrenergic agents|mesh-ancestor
110702840|NCT00200967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110702841|NCT00200967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110702842|NCT00200967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110702843|NCT00200967|Glucocorticoids|glucocorticoids|mesh-ancestor
110702844|NCT00200967|Hormones|hormones|mesh-ancestor
110702845|NCT00200967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110702846|NCT02533440|Anesthetics|anesthetics|mesh-list
110702847|NCT02533440|Anesthetics, Local|anesthetics, local|mesh-list
110702848|NCT02533440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110702849|NCT02533440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110702850|NCT02533440|Sensory System Agents|sensory system agents|mesh-ancestor
110702851|NCT02533440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110702852|NCT00354432|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
110702853|NCT00354432|Caseins|caseins|mesh-list
110702854|NCT00354432|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110702855|NCT00354432|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110702856|NCT00354432|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110702857|NCT00354432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110702858|NCT00354432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110702859|NCT00354432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110702860|NCT00354432|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110702861|NCT00354432|Antidepressive Agents|antidepressive agents|mesh-ancestor
110702862|NCT00354432|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110702863|NCT00354432|Chelating Agents|chelating agents|mesh-ancestor
110702864|NCT00354432|Sequestering Agents|sequestering agents|mesh-ancestor
110702865|NCT00140140|Paclitaxel|paclitaxel|mesh-list
110702866|NCT00140140|Vinorelbine|vinorelbine|mesh-list
110702867|NCT00140140|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110702868|NCT00140140|Trastuzumab|trastuzumab|mesh-list
110702869|NCT00140140|Lenograstim|lenograstim|mesh-list
110702870|NCT00140140|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110702871|NCT00140140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110702872|NCT00140140|Tubulin Modulators|tubulin modulators|mesh-ancestor
110702873|NCT00140140|Antimitotic Agents|antimitotic agents|mesh-ancestor
110702874|NCT00140140|Mitosis Modulators|mitosis modulators|mesh-ancestor
110702875|NCT00140140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110702876|NCT00140140|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110702877|NCT00140140|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110702878|NCT00140140|Immunologic Factors|immunologic factors|mesh-ancestor
110702879|NCT00140140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110702880|NCT00346398|Immunomodulating Agents|immunomodulating agents|mesh-list
110702881|NCT00346398|Immunologic Factors|immunologic factors|mesh-ancestor
110702882|NCT00346398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110702883|NCT00346164|Doxorubicin|doxorubicin|mesh-list
110702884|NCT00346164|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110702885|NCT00346164|Ifosfamide|ifosfamide|mesh-list
110702886|NCT00346164|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110702887|NCT00346164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110702888|NCT00346164|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110332718|NCT01308580|Prednisone|prednisone|mesh-list
110702889|NCT00346164|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110702890|NCT00346164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110702891|NCT00346164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110702892|NCT00346164|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110702893|NCT00346164|Alkylating Agents|alkylating agents|mesh-ancestor
110702894|NCT01052298|Ciprofloxacin|ciprofloxacin|mesh-list
110702895|NCT01052298|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110702896|NCT01052298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110702897|NCT01052298|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110702898|NCT01052298|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110702899|NCT01052298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110702900|NCT01052298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110702901|NCT01052298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110702902|NCT01052298|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110702903|NCT01052298|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110702904|NCT00114244|Gemcitabine|gemcitabine|mesh-list
110702905|NCT00114244|Sorafenib|sorafenib|mesh-list
110702906|NCT00114244|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110702907|NCT00114244|Antimetabolites|antimetabolites|mesh-ancestor
110702908|NCT00114244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110702909|NCT00114244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110702910|NCT00114244|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110702911|NCT00114244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110702912|NCT01054872|Vaccines|vaccines|mesh-list
110702913|NCT01054872|Immunologic Factors|immunologic factors|mesh-ancestor
110702914|NCT01054872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110702915|NCT00337662|Olanzapine|olanzapine|mesh-list
110702916|NCT00337662|Risperidone|risperidone|mesh-list
110702917|NCT00337662|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110702918|NCT00337662|Serotonin Agents|serotonin agents|mesh-ancestor
110702919|NCT00337662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110702920|NCT00337662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110860138|NCT05065216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110032407|NCT05268627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110032408|NCT05268627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110032409|NCT05268627|Incretins|incretins|mesh-ancestor
110702921|NCT00337662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110702923|NCT00337662|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110120381|NCT01905150|Antimetabolites|antimetabolites|mesh-ancestor
110702924|NCT00337662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110702925|NCT00337662|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110702926|NCT00337662|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110702927|NCT00337662|Dopamine Agents|dopamine agents|mesh-ancestor
110702928|NCT00337662|Antiemetics|antiemetics|mesh-ancestor
110702929|NCT00337662|Autonomic Agents|autonomic agents|mesh-ancestor
110702930|NCT00337662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110702931|NCT00337662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110702932|NCT00337662|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110702933|NCT00337662|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110702934|NCT00337662|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110702935|NCT00138424|Cidofovir|cidofovir|mesh-list
110702936|NCT00138424|Antiviral Agents|antiviral agents|mesh-ancestor
110702937|NCT00138424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110702938|NCT00138424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110120449|NCT01905696|Protective Agents|protective agents|mesh-ancestor
110702939|NCT00138424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110702940|NCT00368966|Vaccines|vaccines|mesh-list
110702941|NCT00368966|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110702942|NCT00368966|Immunologic Factors|immunologic factors|mesh-ancestor
110702943|NCT00368966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110702944|NCT00114166|Topotecan|topotecan|mesh-list
110702945|NCT00114166|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110702946|NCT00114166|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110702947|NCT00114166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110702948|NCT00114166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110702949|NCT00114166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110702950|NCT00337428|Vaccines|vaccines|mesh-list
110702951|NCT00337428|Immunologic Factors|immunologic factors|mesh-ancestor
110702952|NCT00337428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110702953|NCT00235989|Interferons|interferons|mesh-list
110702954|NCT00235989|Interferon-beta|interferon-beta|mesh-list
110702955|NCT00235989|Interferon beta-1b|interferon beta-1b|mesh-list
110702956|NCT00235989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110702957|NCT00235989|Antiviral Agents|antiviral agents|mesh-ancestor
110702958|NCT00235989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110702959|NCT00235989|Immunologic Factors|immunologic factors|mesh-ancestor
110702960|NCT00235989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110702961|NCT00235989|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110702962|NCT00113386|Docetaxel|docetaxel|mesh-list
110702963|NCT00113386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110702964|NCT00113386|Tubulin Modulators|tubulin modulators|mesh-ancestor
110702965|NCT00113386|Antimitotic Agents|antimitotic agents|mesh-ancestor
110702966|NCT00113386|Mitosis Modulators|mitosis modulators|mesh-ancestor
110702967|NCT00113386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110702968|NCT00353262|Capecitabine|capecitabine|mesh-list
110702969|NCT00353262|Oxaliplatin|oxaliplatin|mesh-list
110702970|NCT00353262|Bevacizumab|bevacizumab|mesh-list
110702971|NCT00353262|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110702972|NCT00353262|Antimetabolites|antimetabolites|mesh-ancestor
110702973|NCT00353262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110702974|NCT00353262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110702975|NCT00353262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110702976|NCT00353262|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110702977|NCT00353262|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110702978|NCT00353262|Growth Substances|growth substances|mesh-ancestor
110702979|NCT00353262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110702980|NCT00353262|Growth Inhibitors|growth inhibitors|mesh-ancestor
110702981|NCT00125164|Mecasermin|mecasermin|mesh-list
110702982|NCT00125164|Growth Substances|growth substances|mesh-ancestor
110702983|NCT00125164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110702984|NCT03985410|Moxifloxacin|moxifloxacin|mesh-list
110702985|NCT03985410|Durlobactam|durlobactam|mesh-list
110702986|NCT03985410|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110420831|NCT05322733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110702987|NCT03985410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110702988|NCT03985410|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110702989|NCT03985410|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110148025|NCT00006381|Analgesics|analgesics|mesh-ancestor
110702990|NCT03985410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110702991|NCT03985410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110702992|NCT03985410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110702993|NCT03985410|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110702994|NCT00136318|Ribavirin|ribavirin|mesh-list
110702995|NCT00136318|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110702996|NCT00136318|Escitalopram|escitalopram|mesh-list
110702997|NCT00136318|Antimetabolites|antimetabolites|mesh-ancestor
110702998|NCT00136318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110702999|NCT00136318|Antiviral Agents|antiviral agents|mesh-ancestor
110703000|NCT00136318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110703001|NCT00136318|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110703002|NCT00136318|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110703003|NCT00136318|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110120632|NCT01907204|Hormones|hormones|mesh-ancestor
110703004|NCT00136318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110703005|NCT00136318|Serotonin Agents|serotonin agents|mesh-ancestor
110703006|NCT00136318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110703007|NCT01058850|Rindopepimut|rindopepimut|mesh-list
110703008|NCT01058850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110703009|NCT01058850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110703010|NCT00136084|Cytarabine|cytarabine|mesh-list
110703011|NCT00136084|Dexamethasone|dexamethasone|mesh-list
110703012|NCT00136084|Prednisone|prednisone|mesh-list
110703013|NCT00136084|Cyclophosphamide|cyclophosphamide|mesh-list
110703014|NCT00136084|Methotrexate|methotrexate|mesh-list
110703015|NCT00136084|Etoposide|etoposide|mesh-list
110703016|NCT00136084|Vincristine|vincristine|mesh-list
110703017|NCT00136084|Daunorubicin|daunorubicin|mesh-list
110703018|NCT00136084|Asparaginase|asparaginase|mesh-list
110703019|NCT00136084|Mitoxantrone|mitoxantrone|mesh-list
110703020|NCT00136084|Mercaptopurine|mercaptopurine|mesh-list
110703021|NCT00136084|Cladribine|cladribine|mesh-list
110703022|NCT00136084|Gemtuzumab|gemtuzumab|mesh-list
110703023|NCT00136084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110703024|NCT00136084|Immunologic Factors|immunologic factors|mesh-ancestor
110703025|NCT00136084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110703026|NCT00136084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110703027|NCT00136084|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110703028|NCT00136084|Alkylating Agents|alkylating agents|mesh-ancestor
110703029|NCT00136084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110703030|NCT00136084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110703031|NCT00136084|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110703032|NCT00136084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110703033|NCT00136084|Antiemetics|antiemetics|mesh-ancestor
110703034|NCT00136084|Autonomic Agents|autonomic agents|mesh-ancestor
110703035|NCT00136084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110703036|NCT00136084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110703037|NCT00136084|Glucocorticoids|glucocorticoids|mesh-ancestor
110703039|NCT00136084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110703040|NCT00136084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110703041|NCT00136084|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110703042|NCT00136084|Abortifacient Agents|abortifacient agents|mesh-ancestor
110703043|NCT00136084|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110703044|NCT00136084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110703045|NCT00136084|Antimetabolites|antimetabolites|mesh-ancestor
110703046|NCT00136084|Dermatologic Agents|dermatologic agents|mesh-ancestor
110120723|NCT01907724|Simeprevir|simeprevir|mesh-list
110703047|NCT00136084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110703048|NCT00136084|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110703049|NCT00136084|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110703050|NCT00136084|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110703051|NCT00136084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110703052|NCT00136084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110703053|NCT00136084|Antiviral Agents|antiviral agents|mesh-ancestor
110703054|NCT00136084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110703055|NCT00136084|Tubulin Modulators|tubulin modulators|mesh-ancestor
110703056|NCT00136084|Antimitotic Agents|antimitotic agents|mesh-ancestor
110703057|NCT00136084|Mitosis Modulators|mitosis modulators|mesh-ancestor
110703058|NCT00136084|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110703059|NCT00136084|Analgesics|analgesics|mesh-ancestor
110860150|NCT05008484|Vitamin D|vitamin d|mesh-list
110860151|NCT05008484|Vitamins|vitamins|mesh-ancestor
110860152|NCT05008484|Micronutrients|micronutrients|mesh-ancestor
110703060|NCT00136084|Sensory System Agents|sensory system agents|mesh-ancestor
110703061|NCT00136084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110703062|NCT00136084|Immunotoxins|immunotoxins|mesh-ancestor
110703063|NCT00136084|Immunoconjugates|immunoconjugates|mesh-ancestor
110420906|NCT02833831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110703064|NCT00364832|Epoetin Alfa|epoetin alfa|mesh-list
110703065|NCT00364832|Hematinics|hematinics|mesh-ancestor
110703066|NCT00235755|Ezogabine|ezogabine|mesh-list
110703067|NCT00235755|Anticonvulsants|anticonvulsants|mesh-ancestor
110703068|NCT00235755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110703069|NCT00235755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110703070|NCT01581879|Ziprasidone|ziprasidone|mesh-list
110703071|NCT01581879|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110703072|NCT01581879|Serotonin Agents|serotonin agents|mesh-ancestor
110703073|NCT01581879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110703074|NCT01581879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110703075|NCT01581879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110703076|NCT01581879|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110703077|NCT01581879|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110703078|NCT01581879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110703079|NCT01581879|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110703080|NCT01581879|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110703081|NCT01581879|Dopamine Agents|dopamine agents|mesh-ancestor
110703082|NCT00337194|Gemcitabine|gemcitabine|mesh-list
110703083|NCT00337194|Doxorubicin|doxorubicin|mesh-list
110703084|NCT00337194|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110703085|NCT00337194|Vinorelbine|vinorelbine|mesh-list
110703086|NCT00337194|Brentuximab Vedotin|brentuximab vedotin|mesh-list
110703087|NCT00337194|Antibodies|antibodies|mesh-list
110703088|NCT00337194|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110703089|NCT00337194|Immunologic Factors|immunologic factors|mesh-ancestor
110703090|NCT00337194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110703091|NCT00337194|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110703092|NCT00337194|Antimetabolites|antimetabolites|mesh-ancestor
110703093|NCT00337194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110703094|NCT00337194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110703095|NCT00337194|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110703096|NCT00337194|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110703097|NCT00337194|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110703098|NCT00337194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110703099|NCT00337194|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110703100|NCT00337194|Tubulin Modulators|tubulin modulators|mesh-ancestor
110703101|NCT00337194|Antimitotic Agents|antimitotic agents|mesh-ancestor
110703102|NCT00337194|Mitosis Modulators|mitosis modulators|mesh-ancestor
110703103|NCT00337194|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110703104|NCT00337194|Immunotoxins|immunotoxins|mesh-ancestor
110703105|NCT00337194|Immunoconjugates|immunoconjugates|mesh-ancestor
110703106|NCT01074021|Nimotuzumab|nimotuzumab|mesh-list
110703107|NCT01074021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110703108|NCT01074021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110703109|NCT01074333|Cetuximab|cetuximab|mesh-list
110703110|NCT01074333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110703111|NCT01074333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110703112|NCT00385736|Adalimumab|adalimumab|mesh-list
110703113|NCT00385736|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110703114|NCT00385736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110703115|NCT00385736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110703116|NCT01057212|Bevacizumab|bevacizumab|mesh-list
110703117|NCT01057212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110703118|NCT01057212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110703119|NCT01057212|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110703120|NCT01057212|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110703121|NCT01057212|Growth Substances|growth substances|mesh-ancestor
110703122|NCT01057212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110703123|NCT01057212|Growth Inhibitors|growth inhibitors|mesh-ancestor
110703124|NCT03988452|Ritonavir|ritonavir|mesh-list
110703125|NCT03988452|Darunavir|darunavir|mesh-list
110703126|NCT03988452|Tenofovir|tenofovir|mesh-list
110703127|NCT03988452|Lamivudine|lamivudine|mesh-list
110703128|NCT03988452|Zidovudine|zidovudine|mesh-list
110703129|NCT03988452|Dolutegravir|dolutegravir|mesh-list
110703130|NCT03988452|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110703131|NCT03988452|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110703132|NCT03988452|Protease Inhibitors|protease inhibitors|mesh-ancestor
110703133|NCT03988452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110703134|NCT03988452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110703135|NCT03988452|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110703136|NCT03988452|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110703137|NCT03988452|Antiviral Agents|antiviral agents|mesh-ancestor
110703138|NCT03988452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110703139|NCT03988452|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110420983|NCT00971932|Carboplatin|carboplatin|mesh-list
110703140|NCT03988452|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110703141|NCT03988452|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110703142|NCT03988452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110703143|NCT03988452|Antimetabolites|antimetabolites|mesh-ancestor
110703144|NCT03988452|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110703145|NCT03988452|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110703146|NCT01048580|Capecitabine|capecitabine|mesh-list
110703147|NCT01048580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110703148|NCT01048580|Antimetabolites|antimetabolites|mesh-ancestor
110703149|NCT01048580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110703150|NCT01048580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110703151|NCT00195819|Adalimumab|adalimumab|mesh-list
110703152|NCT00195819|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110121225|NCT01910987|Dexamethasone|dexamethasone|mesh-list
110703153|NCT00195819|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110703154|NCT00195819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110703155|NCT00527735|Paclitaxel|paclitaxel|mesh-list
110703156|NCT00527735|Carboplatin|carboplatin|mesh-list
110703157|NCT00527735|Ipilimumab|ipilimumab|mesh-list
110703158|NCT00527735|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110703159|NCT00527735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110703160|NCT00527735|Tubulin Modulators|tubulin modulators|mesh-ancestor
110703161|NCT00527735|Antimitotic Agents|antimitotic agents|mesh-ancestor
110703162|NCT00527735|Mitosis Modulators|mitosis modulators|mesh-ancestor
110703163|NCT00527735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110703164|NCT00527735|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110703165|NCT00527735|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110703166|NCT00336492|Infliximab|infliximab|mesh-list
110703167|NCT00336492|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110703168|NCT00336492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110703169|NCT00336492|Dermatologic Agents|dermatologic agents|mesh-ancestor
110703170|NCT00336492|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110703171|NCT00336492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110703172|NCT00194025|Valproic Acid|valproic acid|mesh-list
110703173|NCT00194025|Anticonvulsants|anticonvulsants|mesh-ancestor
110703174|NCT00194025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110703175|NCT00194025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110703176|NCT00194025|GABA Agents|gaba agents|mesh-ancestor
110703177|NCT00194025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110703178|NCT00194025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110703179|NCT00194025|Antimanic Agents|antimanic agents|mesh-ancestor
110703180|NCT00194025|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110703181|NCT00194025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110703182|NCT00194025|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110703183|NCT00521339|Apremilast|apremilast|mesh-list
110703184|NCT00521339|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110703185|NCT00521339|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110703186|NCT00521339|Analgesics|analgesics|mesh-ancestor
110703187|NCT00521339|Sensory System Agents|sensory system agents|mesh-ancestor
110703188|NCT00521339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110703189|NCT00521339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110703190|NCT00521339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110703191|NCT00521339|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110703192|NCT00521339|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
110703193|NCT00521339|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110703194|NCT00521339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110703195|NCT00521339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110703196|NCT00363896|Bromides|bromides|mesh-list
110703197|NCT00363896|Anticonvulsants|anticonvulsants|mesh-ancestor
110703198|NCT00527423|Aflibercept|aflibercept|mesh-list
110577716|NCT00838240|Cytarabine|cytarabine|mesh-list
110703199|NCT00527423|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110703200|NCT00527423|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110703201|NCT00527423|Growth Substances|growth substances|mesh-ancestor
110703202|NCT00527423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110703203|NCT00527423|Growth Inhibitors|growth inhibitors|mesh-ancestor
110703204|NCT00527423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110703205|NCT00527111|Fluorouracil|fluorouracil|mesh-list
110703207|NCT00527111|Antimetabolites|antimetabolites|mesh-ancestor
110703208|NCT00527111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110703209|NCT00527111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110703210|NCT00527111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110703211|NCT00527111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110703212|NCT00527111|Immunologic Factors|immunologic factors|mesh-ancestor
110703213|NCT00527111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110703214|NCT00527111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110703215|NCT00384956|Azacitidine|azacitidine|mesh-list
110703216|NCT00384956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110421110|NCT00961636|Niacin|niacin|mesh-list
110703217|NCT00384956|Antimetabolites|antimetabolites|mesh-ancestor
110703218|NCT00384956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110121463|NCT01912443|Bevacizumab|bevacizumab|mesh-list
110703219|NCT00384956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110703220|NCT00384956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110703221|NCT04090697|Oxandrolone|oxandrolone|mesh-list
110703222|NCT04090697|Androgens|androgens|mesh-ancestor
110703223|NCT04090697|Hormones|hormones|mesh-ancestor
110703224|NCT04090697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110703225|NCT04090697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110703226|NCT04090697|Anabolic Agents|anabolic agents|mesh-ancestor
110703227|NCT00367640|Immunomodulating Agents|immunomodulating agents|mesh-list
110703228|NCT00367640|Immunologic Factors|immunologic factors|mesh-list
110121523|NCT01912755|Epinephryl borate|epinephryl borate|mesh-list
110703229|NCT00367640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110703230|NCT01325220|Baclofen|baclofen|mesh-list
110703231|NCT01325220|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110703232|NCT01325220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110703233|NCT01325220|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110703234|NCT01325220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110703235|NCT01325220|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
110703236|NCT01325220|GABA Agonists|gaba agonists|mesh-ancestor
110703237|NCT01325220|GABA Agents|gaba agents|mesh-ancestor
110703238|NCT01325220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110703239|NCT01325220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110121602|NCT01913119|Romidepsin|romidepsin|mesh-list
110703240|NCT00367484|Interferons|interferons|mesh-list
110703241|NCT00367484|Interferon-beta|interferon-beta|mesh-list
110703242|NCT00367484|Interferon beta-1a|interferon beta-1a|mesh-list
110703243|NCT00367484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110703244|NCT00367484|Antiviral Agents|antiviral agents|mesh-ancestor
110703245|NCT00367484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110703246|NCT00367484|Immunologic Factors|immunologic factors|mesh-ancestor
110703247|NCT00367484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110703248|NCT00367484|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110703249|NCT00526799|Sorafenib|sorafenib|mesh-list
110703250|NCT00526799|Topotecan|topotecan|mesh-list
110703251|NCT00526799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110703252|NCT00526799|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110703253|NCT00526799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110121652|NCT01913847|Sildenafil Citrate|sildenafil citrate|mesh-list
110703254|NCT00526799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110703255|NCT00526799|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110703256|NCT00526799|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110703258|NCT01059084|Antiviral Agents|antiviral agents|mesh-ancestor
110703259|NCT01059084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110703260|NCT03992144|Amoxicillin|amoxicillin|mesh-list
110703261|NCT03992144|Metronidazole|metronidazole|mesh-list
110703262|NCT03992144|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110703263|NCT03992144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110121715|NCT01914133|Acarbose|acarbose|mesh-list
110703264|NCT03992144|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110703265|NCT03992144|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110703266|NCT02534870|Ritonavir|ritonavir|mesh-list
110703267|NCT02534870|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110703268|NCT02534870|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110703269|NCT02534870|Protease Inhibitors|protease inhibitors|mesh-ancestor
110703270|NCT02534870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110703271|NCT02534870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110703272|NCT02534870|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110703273|NCT02534870|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110703274|NCT02534870|Antiviral Agents|antiviral agents|mesh-ancestor
110703275|NCT02534870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110703276|NCT02534870|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110703277|NCT02534870|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110703279|NCT03992066|Darbepoetin alfa|darbepoetin alfa|mesh-list
110703280|NCT03992066|Hematinics|hematinics|mesh-ancestor
110703281|NCT03986268|Vitamin D|vitamin d|mesh-list
110703282|NCT03986268|Cholecalciferol|cholecalciferol|mesh-list
110703283|NCT03986268|Vitamins|vitamins|mesh-ancestor
110703284|NCT03986268|Micronutrients|micronutrients|mesh-ancestor
110703285|NCT03986268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110703286|NCT03986268|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110703287|NCT03986268|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110703288|NCT01048892|Cyclophosphamide|cyclophosphamide|mesh-list
110703289|NCT01048892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110703290|NCT01048892|Immunologic Factors|immunologic factors|mesh-ancestor
110703291|NCT01048892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110703292|NCT01048892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110703293|NCT01048892|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110703295|NCT01048892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110703296|NCT01048892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110703297|NCT01048892|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110703298|NCT01259648|Remifentanil|remifentanil|mesh-list
110703299|NCT01259648|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110703300|NCT01259648|Narcotics|narcotics|mesh-ancestor
110703301|NCT01259648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110703302|NCT01259648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110703303|NCT01259648|Analgesics|analgesics|mesh-ancestor
110703304|NCT01259648|Sensory System Agents|sensory system agents|mesh-ancestor
110703305|NCT01259648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110703306|NCT01049048|Vitamin D|vitamin d|mesh-list
110703307|NCT01049048|Cholecalciferol|cholecalciferol|mesh-list
110703308|NCT01049048|Vitamins|vitamins|mesh-ancestor
110703309|NCT01049048|Micronutrients|micronutrients|mesh-ancestor
110703310|NCT01049048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110703311|NCT01049048|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110703312|NCT01049048|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110703313|NCT00520481|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110703314|NCT00520481|Immunologic Factors|immunologic factors|mesh-ancestor
110703315|NCT00520481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110703316|NCT01044992|Levodopa|levodopa|mesh-list
110703317|NCT01044992|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110703318|NCT01044992|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110703319|NCT01044992|Dopamine Agents|dopamine agents|mesh-ancestor
110703320|NCT01044992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110703321|NCT01044992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110703322|NCT01044992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110703323|NCT00520403|Interferons|interferons|mesh-list
110703324|NCT00520403|Interferon-alpha|interferon-alpha|mesh-list
110703325|NCT00520403|Interferon alpha-2|interferon alpha-2|mesh-list
110703326|NCT00520403|Bevacizumab|bevacizumab|mesh-list
110703327|NCT00520403|Vinblastine|vinblastine|mesh-list
110703328|NCT00520403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110703329|NCT00520403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110703330|NCT00520403|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110703331|NCT00520403|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110703332|NCT00520403|Growth Substances|growth substances|mesh-ancestor
110703333|NCT00520403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110703334|NCT00520403|Growth Inhibitors|growth inhibitors|mesh-ancestor
110703336|NCT00520403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110703337|NCT00520403|Immunologic Factors|immunologic factors|mesh-ancestor
110121884|NCT01915264|Metformin|metformin|mesh-list
110703338|NCT00520403|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110703339|NCT00520403|Tubulin Modulators|tubulin modulators|mesh-ancestor
110703340|NCT00520403|Antimitotic Agents|antimitotic agents|mesh-ancestor
110703341|NCT00520403|Mitosis Modulators|mitosis modulators|mesh-ancestor
110703342|NCT00520403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110703343|NCT00520013|Paclitaxel|paclitaxel|mesh-list
110703344|NCT00520013|Bevacizumab|bevacizumab|mesh-list
110703345|NCT00520013|Carboplatin|carboplatin|mesh-list
110703346|NCT00520013|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110703347|NCT00520013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110703348|NCT00520013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110703349|NCT00520013|Tubulin Modulators|tubulin modulators|mesh-ancestor
110703350|NCT00520013|Antimitotic Agents|antimitotic agents|mesh-ancestor
110121933|NCT01915550|Insulin|insulin|mesh-list
110703351|NCT00520013|Mitosis Modulators|mitosis modulators|mesh-ancestor
110703352|NCT00520013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110703353|NCT00520013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110703354|NCT00520013|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110703355|NCT00520013|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110703356|NCT00520013|Growth Substances|growth substances|mesh-ancestor
110703357|NCT00520013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110703358|NCT00520013|Growth Inhibitors|growth inhibitors|mesh-ancestor
110703359|NCT00520013|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110703360|NCT00520013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110703361|NCT00526097|Bisacodyl|bisacodyl|mesh-list
110703362|NCT00526097|Cathartics|cathartics|mesh-ancestor
110703363|NCT00526097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110703364|NCT00526097|Laxatives|laxatives|mesh-ancestor
110703365|NCT00525785|Leucovorin|leucovorin|mesh-list
110703366|NCT00525785|Folic Acid|folic acid|mesh-list
110703367|NCT00525785|Fluorouracil|fluorouracil|mesh-list
110703368|NCT00525785|Oxaliplatin|oxaliplatin|mesh-list
110703369|NCT00525785|Levoleucovorin|levoleucovorin|mesh-list
110703370|NCT00525785|Antimetabolites|antimetabolites|mesh-ancestor
110703371|NCT00525785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110703372|NCT00525785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110703373|NCT00525785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110703374|NCT00525785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110703375|NCT00525785|Immunologic Factors|immunologic factors|mesh-ancestor
110703376|NCT00525785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110703377|NCT00525785|Antidotes|antidotes|mesh-ancestor
110703378|NCT00525785|Protective Agents|protective agents|mesh-ancestor
110703379|NCT00525785|Vitamin B Complex|vitamin b complex|mesh-ancestor
110703380|NCT00525785|Vitamins|vitamins|mesh-ancestor
110703381|NCT00525785|Micronutrients|micronutrients|mesh-ancestor
110703382|NCT00525785|Hematinics|hematinics|mesh-ancestor
110703383|NCT00525161|Sorafenib|sorafenib|mesh-list
110703384|NCT00525161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110703385|NCT00525161|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110703386|NCT00525161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110703387|NCT00525161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110703388|NCT00135694|Prednisone|prednisone|mesh-list
110703389|NCT00135694|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
110703390|NCT00135694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110122128|NCT01916863|Canagliflozin|canagliflozin|mesh-list
110703391|NCT00135694|Glucocorticoids|glucocorticoids|mesh-ancestor
110703392|NCT00135694|Hormones|hormones|mesh-ancestor
110703393|NCT00135694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110703394|NCT00135694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110703395|NCT00135694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110703396|NCT00135694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110703397|NCT00135694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110703398|NCT00135694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110703399|NCT00524459|Docetaxel|docetaxel|mesh-list
110703400|NCT00524459|Doxorubicin|doxorubicin|mesh-list
110703401|NCT00524459|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110703402|NCT00524459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110703403|NCT00524459|Tubulin Modulators|tubulin modulators|mesh-ancestor
110703404|NCT00524459|Antimitotic Agents|antimitotic agents|mesh-ancestor
110703405|NCT00524459|Mitosis Modulators|mitosis modulators|mesh-ancestor
110703406|NCT00524459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110703407|NCT00524459|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110703408|NCT00524459|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110703409|NCT00524459|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110703411|NCT00519623|Insulin|insulin|mesh-list
110703412|NCT00519623|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110122270|NCT01917331|Hormones|hormones|mesh-ancestor
110703413|NCT00519623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110703414|NCT01076530|Temozolomide|temozolomide|mesh-list
110703415|NCT01076530|Vorinostat|vorinostat|mesh-list
110703416|NCT01076530|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110703417|NCT01076530|Alkylating Agents|alkylating agents|mesh-ancestor
110703418|NCT01076530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110703419|NCT01076530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110703420|NCT01076530|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110703421|NCT01076530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110703422|NCT00519077|Gefitinib|gefitinib|mesh-list
110703423|NCT00519077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110703424|NCT00519077|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110703425|NCT00519077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110703426|NCT00519077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110703427|NCT00124618|Cetuximab|cetuximab|mesh-list
110703428|NCT00124618|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110703429|NCT00124618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110703430|NCT00124072|Folic Acid|folic acid|mesh-list
110703431|NCT00124072|Vitamin B 12|vitamin b 12|mesh-list
110703432|NCT00124072|Hydroxocobalamin|hydroxocobalamin|mesh-list
110703433|NCT00124072|Simvastatin|simvastatin|mesh-list
110703434|NCT00124072|Vitamins|vitamins|mesh-ancestor
110703435|NCT00124072|Micronutrients|micronutrients|mesh-ancestor
110703436|NCT00124072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110703437|NCT00124072|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110703438|NCT00124072|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110703439|NCT00124072|Antimetabolites|antimetabolites|mesh-ancestor
110703440|NCT00124072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110703441|NCT00124072|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110703442|NCT00124072|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110122315|NCT01917617|Antimetabolites|antimetabolites|mesh-ancestor
110703443|NCT00124072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110703444|NCT00124072|Hematinics|hematinics|mesh-ancestor
110703445|NCT00124072|Vitamin B Complex|vitamin b complex|mesh-ancestor
110703446|NCT01080352|Ascorbic Acid|ascorbic acid|mesh-list
110703447|NCT01080352|Vitamins|vitamins|mesh-ancestor
110703448|NCT01080352|Micronutrients|micronutrients|mesh-ancestor
110703449|NCT01080352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110703450|NCT01080352|Antioxidants|antioxidants|mesh-ancestor
110703451|NCT01080352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110703452|NCT01080352|Protective Agents|protective agents|mesh-ancestor
110703453|NCT00524303|Paclitaxel|paclitaxel|mesh-list
110122364|NCT01918098|Naloxone|naloxone|mesh-list
110703454|NCT00524303|Trastuzumab|trastuzumab|mesh-list
110703455|NCT00524303|Lapatinib|lapatinib|mesh-list
110703456|NCT00524303|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110703457|NCT00524303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110703458|NCT00524303|Tubulin Modulators|tubulin modulators|mesh-ancestor
110703459|NCT00524303|Antimitotic Agents|antimitotic agents|mesh-ancestor
110703460|NCT00524303|Mitosis Modulators|mitosis modulators|mesh-ancestor
110703461|NCT00524303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110703462|NCT00524303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110703463|NCT00524303|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110703464|NCT00524303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110703465|NCT04461041|Empagliflozin|empagliflozin|mesh-list
110703466|NCT04461041|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110703467|NCT04461041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110703468|NCT04461041|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110703469|NCT04461041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110703470|NCT00335556|Dactinomycin|dactinomycin|mesh-list
110703471|NCT00335556|Cyclophosphamide|cyclophosphamide|mesh-list
110703472|NCT00335556|Carboplatin|carboplatin|mesh-list
110703473|NCT00335556|Doxorubicin|doxorubicin|mesh-list
110860190|NCT04939597|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110703474|NCT00335556|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110703475|NCT00335556|Irinotecan|irinotecan|mesh-list
110703476|NCT00335556|Etoposide|etoposide|mesh-list
110703477|NCT00335556|Vincristine|vincristine|mesh-list
110703478|NCT00335556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110703479|NCT00335556|Immunologic Factors|immunologic factors|mesh-ancestor
110703480|NCT00335556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110703481|NCT00335556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110703482|NCT00335556|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110703483|NCT00335556|Alkylating Agents|alkylating agents|mesh-ancestor
110703484|NCT00335556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110703485|NCT00335556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110703486|NCT00335556|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110703487|NCT00335556|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110703488|NCT00335556|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110703489|NCT00335556|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110703490|NCT00335556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110703491|NCT00335556|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110703492|NCT00335556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110703493|NCT00335556|Tubulin Modulators|tubulin modulators|mesh-ancestor
110703494|NCT00335556|Antimitotic Agents|antimitotic agents|mesh-ancestor
110703495|NCT00335556|Mitosis Modulators|mitosis modulators|mesh-ancestor
110703496|NCT00335556|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110703497|NCT00335556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110703498|NCT00335556|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110703499|NCT00335556|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110703501|NCT00518687|Immunologic Factors|immunologic factors|mesh-ancestor
110703502|NCT00518687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110703503|NCT00134056|Prednisone|prednisone|mesh-list
110703504|NCT00134056|Docetaxel|docetaxel|mesh-list
110703505|NCT00134056|Atrasentan|atrasentan|mesh-list
110703506|NCT00134056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110703507|NCT00134056|Tubulin Modulators|tubulin modulators|mesh-ancestor
110703508|NCT00134056|Antimitotic Agents|antimitotic agents|mesh-ancestor
110703509|NCT00134056|Mitosis Modulators|mitosis modulators|mesh-ancestor
110703510|NCT00134056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110703511|NCT00134056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110703512|NCT00134056|Glucocorticoids|glucocorticoids|mesh-ancestor
110703513|NCT00134056|Hormones|hormones|mesh-ancestor
110703514|NCT00134056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110703515|NCT00134056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110703516|NCT00134056|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110703517|NCT00134056|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
110703518|NCT00134056|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
110703519|NCT00518531|Denosumab|denosumab|mesh-list
110703520|NCT00518531|Alendronate|alendronate|mesh-list
110703521|NCT00518531|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110703522|NCT00518531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110703523|NCT01326442|Vitamin D|vitamin d|mesh-list
110703525|NCT01326442|Micronutrients|micronutrients|mesh-ancestor
110703526|NCT01326442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110703527|NCT01326442|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110703528|NCT00523991|Tiotropium Bromide|tiotropium bromide|mesh-list
110703529|NCT00523991|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110703530|NCT00523991|Autonomic Agents|autonomic agents|mesh-ancestor
110703531|NCT00523991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110703532|NCT00523991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110703533|NCT00523991|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110703534|NCT00523991|Respiratory System Agents|respiratory system agents|mesh-ancestor
110703535|NCT00523991|Parasympatholytics|parasympatholytics|mesh-ancestor
110703536|NCT00523991|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110703537|NCT00523991|Cholinergic Agents|cholinergic agents|mesh-ancestor
110703538|NCT00523991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110703539|NCT00523991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110703540|NCT00350844|Hydroxyurea|hydroxyurea|mesh-list
110703541|NCT00350844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110703542|NCT00350844|Antisickling Agents|antisickling agents|mesh-ancestor
110703543|NCT00350844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110703544|NCT00350844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110122726|NCT01921374|Testosterone|testosterone|mesh-list
110703545|NCT00350844|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110703546|NCT00345540|Carboplatin|carboplatin|mesh-list
110703547|NCT00345540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110703548|NCT00335322|Ritonavir|ritonavir|mesh-list
110703549|NCT00335322|Atazanavir Sulfate|atazanavir sulfate|mesh-list
110703550|NCT00335322|Tenofovir|tenofovir|mesh-list
110703551|NCT00335322|Emtricitabine|emtricitabine|mesh-list
110703552|NCT00335322|Zidovudine|zidovudine|mesh-list
110703553|NCT00335322|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110703554|NCT00335322|Abacavir|abacavir|mesh-list
110703555|NCT00335322|Efavirenz|efavirenz|mesh-list
110443626|NCT01148693|Gentamicins|gentamicins|mesh-list
110703556|NCT00335322|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110703557|NCT00335322|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110703558|NCT00335322|Protease Inhibitors|protease inhibitors|mesh-ancestor
110703559|NCT00335322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110703560|NCT00335322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110703561|NCT00335322|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110703562|NCT00335322|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110703563|NCT00335322|Antiviral Agents|antiviral agents|mesh-ancestor
110703564|NCT00335322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110703565|NCT00335322|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110703566|NCT00335322|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110703567|NCT00335322|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110703568|NCT00335322|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110703569|NCT00335322|Antimetabolites|antimetabolites|mesh-ancestor
110703570|NCT00335322|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110703571|NCT00335322|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110703572|NCT00335322|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110703573|NCT00335322|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110703574|NCT00335322|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110703575|NCT01059396|Propranolol|propranolol|mesh-list
110703576|NCT01059396|Carvedilol|carvedilol|mesh-list
110703577|NCT01059396|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110703578|NCT01059396|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110703579|NCT01059396|Adrenergic Agents|adrenergic agents|mesh-ancestor
110703580|NCT01059396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110703581|NCT01059396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110703582|NCT01059396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110703583|NCT01059396|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110703584|NCT01059396|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110703585|NCT01059396|Vasodilator Agents|vasodilator agents|mesh-ancestor
110703586|NCT01059396|Antioxidants|antioxidants|mesh-ancestor
110122913|NCT01930331|Piperaquine|piperaquine|mesh-list
110703587|NCT01059396|Protective Agents|protective agents|mesh-ancestor
110703588|NCT01059396|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110703589|NCT01059396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110703590|NCT01059396|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110703591|NCT01059396|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110703592|NCT01059396|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110703593|NCT01059552|Vorinostat|vorinostat|mesh-list
110703594|NCT01059552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110703595|NCT01059552|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110703596|NCT01059552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110421432|NCT02832973|Bisoprolol|bisoprolol|mesh-list
110703597|NCT01059552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110703598|NCT03741894|Chlorhexidine|chlorhexidine|mesh-list
110703599|NCT03741894|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110703600|NCT03741894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110122990|NCT01930734|Dobutamine|dobutamine|mesh-list
110703601|NCT03741894|Disinfectants|disinfectants|mesh-ancestor
110703602|NCT03755765|Amoxicillin|amoxicillin|mesh-list
110703603|NCT03755765|Clavulanic Acid|clavulanic acid|mesh-list
110703604|NCT03755765|Clavulanic Acids|clavulanic acids|mesh-list
110703605|NCT03755765|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
110703606|NCT03755765|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110703607|NCT03755765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110703608|NCT03755765|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110703609|NCT03755765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110703610|NCT03755765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110703611|NCT01061112|Tolbutamide|tolbutamide|mesh-list
110703612|NCT01061112|Fluconazole|fluconazole|mesh-list
110703613|NCT01061112|Ketoprofen|ketoprofen|mesh-list
110703614|NCT01061112|Flurbiprofen|flurbiprofen|mesh-list
110703615|NCT01061112|Antifungal Agents|antifungal agents|mesh-ancestor
110703616|NCT01061112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110703617|NCT01061112|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110703618|NCT01061112|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110703619|NCT01061112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110703620|NCT01061112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110703621|NCT01061112|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110703622|NCT01061112|Hormone Antagonists|hormone antagonists|mesh-ancestor
110703623|NCT01061112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110703624|NCT01061112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110703625|NCT01061112|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110703626|NCT01061112|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110703627|NCT01061112|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110703628|NCT01061112|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110703629|NCT01061112|Analgesics|analgesics|mesh-ancestor
110703630|NCT01061112|Sensory System Agents|sensory system agents|mesh-ancestor
110703631|NCT01061112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110703632|NCT01061112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110703633|NCT01061112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110703634|NCT01061112|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110703635|NCT01061112|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110703636|NCT01061190|Propranolol|propranolol|mesh-list
110703637|NCT01061190|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110703638|NCT01061190|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110703639|NCT01061190|Adrenergic Agents|adrenergic agents|mesh-ancestor
110703640|NCT01061190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110703641|NCT01061190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110703642|NCT01061190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110703643|NCT01061190|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110703644|NCT01061190|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110703645|NCT01061190|Vasodilator Agents|vasodilator agents|mesh-ancestor
110703646|NCT00324168|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110123226|NCT01932203|Analgesics|analgesics|mesh-ancestor
110703647|NCT00324168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110703648|NCT00517829|Docetaxel|docetaxel|mesh-list
110703649|NCT00517829|Oxaliplatin|oxaliplatin|mesh-list
110703650|NCT00517829|Cetuximab|cetuximab|mesh-list
110703651|NCT00517829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110703652|NCT00517829|Tubulin Modulators|tubulin modulators|mesh-ancestor
110703653|NCT00517829|Antimitotic Agents|antimitotic agents|mesh-ancestor
110703654|NCT00517829|Mitosis Modulators|mitosis modulators|mesh-ancestor
110703655|NCT00517829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110703656|NCT00517829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110703657|NCT00343512|Docetaxel|docetaxel|mesh-list
110703658|NCT00343512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110703659|NCT00343512|Tubulin Modulators|tubulin modulators|mesh-ancestor
110860216|NCT04904302|Nivolumab|nivolumab|mesh-list
110860217|NCT04904302|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110860218|NCT04904302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110860219|NCT04904302|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110860220|NCT04904302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110860221|NCT04881240|Cyclophosphamide|cyclophosphamide|mesh-list
110860222|NCT04881240|Fludarabine|fludarabine|mesh-list
110703660|NCT00343512|Antimitotic Agents|antimitotic agents|mesh-ancestor
110703661|NCT00343512|Mitosis Modulators|mitosis modulators|mesh-ancestor
110703662|NCT00343512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110703663|NCT00334542|Simvastatin|simvastatin|mesh-list
110703664|NCT00334542|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110703665|NCT00334542|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110703666|NCT00334542|Antimetabolites|antimetabolites|mesh-ancestor
110703667|NCT00334542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110703668|NCT00334542|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110703669|NCT00334542|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110703670|NCT00334542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110703671|NCT00112294|Paclitaxel|paclitaxel|mesh-list
110703672|NCT00112294|Docetaxel|docetaxel|mesh-list
110703673|NCT00112294|Carboplatin|carboplatin|mesh-list
110703674|NCT00112294|Cetuximab|cetuximab|mesh-list
110703675|NCT00112294|Taxane|taxane|mesh-list
110703676|NCT00112294|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110703677|NCT00112294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110703678|NCT00112294|Tubulin Modulators|tubulin modulators|mesh-ancestor
110703679|NCT00112294|Antimitotic Agents|antimitotic agents|mesh-ancestor
110703680|NCT00112294|Mitosis Modulators|mitosis modulators|mesh-ancestor
110703681|NCT00112294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110703682|NCT00112294|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110703683|NCT00235443|Lacosamide|lacosamide|mesh-list
110703684|NCT00235443|Anticonvulsants|anticonvulsants|mesh-ancestor
110703685|NCT00235443|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110703686|NCT00235443|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110703687|NCT00235443|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110703688|NCT00235443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110703689|NCT00234039|Gemcitabine|gemcitabine|mesh-list
110703690|NCT00234039|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110703691|NCT00234039|Antimetabolites|antimetabolites|mesh-ancestor
110703692|NCT00234039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110703693|NCT00234039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110703694|NCT02531451|Aspirin|aspirin|mesh-list
110123471|NCT01933711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110703696|NCT02531451|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110703697|NCT02531451|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110703698|NCT02531451|Analgesics|analgesics|mesh-ancestor
110703699|NCT02531451|Sensory System Agents|sensory system agents|mesh-ancestor
110703700|NCT02531451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110703701|NCT02531451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110703702|NCT02531451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110703703|NCT02531451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110703704|NCT02531451|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110703705|NCT02531451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110123540|NCT01934205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110703706|NCT02531451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110703707|NCT02531451|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110703708|NCT02531451|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110703709|NCT02531451|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110703710|NCT02531451|Antipyretics|antipyretics|mesh-ancestor
110703711|NCT01073007|Simvastatin|simvastatin|mesh-list
110703712|NCT01073007|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110703713|NCT01073007|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110703714|NCT01073007|Antimetabolites|antimetabolites|mesh-ancestor
110703715|NCT01073007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110703716|NCT01073007|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110703717|NCT01073007|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110703718|NCT01073007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110703719|NCT03741621|Psyllium|psyllium|mesh-list
110860237|NCT04847453|Ixazomib|ixazomib|mesh-list
110123608|NCT01934777|Antioxidants|antioxidants|mesh-ancestor
110703721|NCT03741621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110703722|NCT00323622|Pyrimethamine|pyrimethamine|mesh-list
110703723|NCT00323622|Sulfadoxine|sulfadoxine|mesh-list
110703724|NCT00323622|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
110703725|NCT00323622|Amodiaquine|amodiaquine|mesh-list
110703726|NCT00323622|Vaccines|vaccines|mesh-list
110703727|NCT00323622|Immunologic Factors|immunologic factors|mesh-ancestor
110703728|NCT00323622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110703729|NCT00323622|Antimalarials|antimalarials|mesh-ancestor
110703730|NCT00323622|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110703731|NCT00323622|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110703732|NCT00323622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110703733|NCT00323622|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110703734|NCT00323622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110703735|NCT00323622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110703736|NCT00323622|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110703737|NCT01326039|Bupivacaine|bupivacaine|mesh-list
110703738|NCT01326039|Anesthetics, Local|anesthetics, local|mesh-ancestor
110703739|NCT01326039|Anesthetics|anesthetics|mesh-ancestor
110703740|NCT01326039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110703741|NCT01326039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110703742|NCT01326039|Sensory System Agents|sensory system agents|mesh-ancestor
110703743|NCT01326039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110703744|NCT01057758|Simvastatin|simvastatin|mesh-list
110703745|NCT01057758|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110703746|NCT01057758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110703747|NCT01057758|Antimetabolites|antimetabolites|mesh-ancestor
110703748|NCT01057758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110703749|NCT01057758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110123723|NCT01935492|Growth Inhibitors|growth inhibitors|mesh-ancestor
110703750|NCT01057758|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110703751|NCT01057758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110703752|NCT00186537|Rosiglitazone|rosiglitazone|mesh-list
110703753|NCT00186537|Fenofibrate|fenofibrate|mesh-list
110703754|NCT00186537|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110703755|NCT00186537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110703756|NCT00186537|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110703757|NCT00186537|Antimetabolites|antimetabolites|mesh-ancestor
110703758|NCT00186537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110703759|NCT00186537|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110703760|NCT03968835|Bacitracin|bacitracin|mesh-list
110703761|NCT03968835|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110703762|NCT03968835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110703763|NCT03968835|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110703764|NCT00322842|Plerixafor|plerixafor|mesh-list
110703765|NCT00322842|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110703766|NCT00322842|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110703767|NCT00322842|Antiviral Agents|antiviral agents|mesh-ancestor
110703768|NCT00322842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110703769|NCT04726085|Ibuprofen|ibuprofen|mesh-list
110703770|NCT04726085|Indomethacin|indomethacin|mesh-list
110703771|NCT04726085|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110703772|NCT04726085|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110703773|NCT04726085|Analgesics|analgesics|mesh-ancestor
110703774|NCT04726085|Sensory System Agents|sensory system agents|mesh-ancestor
110703775|NCT04726085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110123848|NCT01935830|Ritonavir|ritonavir|mesh-list
110703776|NCT04726085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110703777|NCT04726085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110703778|NCT04726085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110703779|NCT04726085|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110703780|NCT04726085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110703781|NCT04726085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110703782|NCT04726085|Gout Suppressants|gout suppressants|mesh-ancestor
110703783|NCT04726085|Tocolytic Agents|tocolytic agents|mesh-ancestor
110703784|NCT04726085|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110703785|NCT00255723|Carboplatin|carboplatin|mesh-list
110703787|NCT00255723|Ifosfamide|ifosfamide|mesh-list
110703788|NCT00255723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110123912|NCT01936064|Cyclophosphamide|cyclophosphamide|mesh-list
110703789|NCT00255723|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110703790|NCT00255723|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110703791|NCT00255723|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110703792|NCT00255723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110703793|NCT00255723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110703794|NCT00255723|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110703795|NCT00255723|Alkylating Agents|alkylating agents|mesh-ancestor
110703796|NCT01060176|Tranexamic Acid|tranexamic acid|mesh-list
110703797|NCT01060176|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110703798|NCT01060176|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110703799|NCT01060176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110703800|NCT01060176|Hemostatics|hemostatics|mesh-ancestor
110703801|NCT01060176|Coagulants|coagulants|mesh-ancestor
110703802|NCT00132808|Zoledronic Acid|zoledronic acid|mesh-list
110703803|NCT00132808|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110703804|NCT00132808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110703805|NCT03982992|Blinatumomab|blinatumomab|mesh-list
110703806|NCT03982992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110123980|NCT01936285|Colchicine|colchicine|mesh-list
110703807|NCT01061268|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110703808|NCT01061268|Lubricant Eye Drops|lubricant eye drops|mesh-list
110703809|NCT01061268|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110703810|NCT00517361|Bevacizumab|bevacizumab|mesh-list
110703811|NCT00517361|Carboplatin|carboplatin|mesh-list
110703812|NCT00517361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110703813|NCT00517361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110703814|NCT00517361|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110703815|NCT00517361|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110703816|NCT00517361|Growth Substances|growth substances|mesh-ancestor
110703817|NCT00517361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110703818|NCT00517361|Growth Inhibitors|growth inhibitors|mesh-ancestor
110703819|NCT00516893|Natalizumab|natalizumab|mesh-list
110703820|NCT00516893|Immunologic Factors|immunologic factors|mesh-ancestor
110421657|NCT00890929|Growth Inhibitors|growth inhibitors|mesh-ancestor
110703821|NCT00516893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110703822|NCT03657641|Pembrolizumab|pembrolizumab|mesh-list
110703823|NCT03657641|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110703824|NCT03657641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110703825|NCT03657641|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110703826|NCT03657641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110703827|NCT03649841|Ascorbic Acid|ascorbic acid|mesh-list
110703828|NCT03649841|Prednisone|prednisone|mesh-list
110703829|NCT03649841|Cortisone|cortisone|mesh-list
110703830|NCT03649841|Methyltestosterone|methyltestosterone|mesh-list
110703831|NCT03649841|Abiraterone Acetate|abiraterone acetate|mesh-list
110703832|NCT03649841|Hormones|hormones|mesh-list
110703833|NCT03649841|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
110703834|NCT03649841|Androgens|androgens|mesh-list
110703835|NCT03649841|Androgen Antagonists|androgen antagonists|mesh-list
110703836|NCT03649841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110703837|NCT03649841|Glucocorticoids|glucocorticoids|mesh-ancestor
110124090|NCT01937338|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110703838|NCT03649841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110703839|NCT03649841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110703840|NCT03649841|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110703841|NCT03649841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110703842|NCT03649841|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110703843|NCT03649841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110703844|NCT03649841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110124173|NCT01937767|Fentanyl|fentanyl|mesh-list
110703845|NCT03649841|Hormone Antagonists|hormone antagonists|mesh-ancestor
110703846|NCT03649841|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110703847|NCT03649841|Antioxidants|antioxidants|mesh-ancestor
110703848|NCT03649841|Protective Agents|protective agents|mesh-ancestor
110703849|NCT03649841|Vitamins|vitamins|mesh-ancestor
110703850|NCT03649841|Micronutrients|micronutrients|mesh-ancestor
110703851|NCT03649841|Estrogens|estrogens|mesh-ancestor
110703852|NCT03649841|Anabolic Agents|anabolic agents|mesh-ancestor
110703853|NCT00522431|Testosterone|testosterone|mesh-list
110703854|NCT00522431|Androgens|androgens|mesh-ancestor
110703855|NCT00522431|Hormones|hormones|mesh-ancestor
110703856|NCT00522431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110860260|NCT04818216|Nicotinic Acids|nicotinic acids|mesh-list
110703857|NCT00522431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110703859|NCT00185211|Interferon-beta|interferon-beta|mesh-list
110703860|NCT00185211|Interferon beta-1b|interferon beta-1b|mesh-list
110703861|NCT00185211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110703862|NCT00185211|Antiviral Agents|antiviral agents|mesh-ancestor
110703863|NCT00185211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110703864|NCT00185211|Immunologic Factors|immunologic factors|mesh-ancestor
110703865|NCT00185211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110703866|NCT00185211|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110703867|NCT00516737|Rizatriptan|rizatriptan|mesh-list
110703868|NCT00516737|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110703869|NCT00516737|Serotonin Agents|serotonin agents|mesh-ancestor
110124282|NCT01938456|Trametinib|trametinib|mesh-list
110703870|NCT00516737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110703871|NCT00516737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110703872|NCT00516737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110703873|NCT03540485|Melatonin|melatonin|mesh-list
110703874|NCT03540485|Antioxidants|antioxidants|mesh-ancestor
110703875|NCT03540485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110703876|NCT03540485|Protective Agents|protective agents|mesh-ancestor
110703877|NCT03540485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110703878|NCT03540485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110703879|NCT00132730|MK 0873|mk 0873|mesh-list
110703880|NCT00132730|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
110703881|NCT00132730|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110703882|NCT00132730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110703883|NCT00132730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110703884|NCT02531841|Dexamethasone acetate|dexamethasone acetate|mesh-list
110703885|NCT02531841|Dexamethasone|dexamethasone|mesh-list
110703886|NCT02531841|Etoposide phosphate|etoposide phosphate|mesh-list
110703887|NCT02531841|Etoposide|etoposide|mesh-list
110703888|NCT02531841|Ifosfamide|ifosfamide|mesh-list
110703889|NCT02531841|Isophosphamide mustard|isophosphamide mustard|mesh-list
110703890|NCT02531841|Thiotepa|thiotepa|mesh-list
110703891|NCT02531841|Carmustine|carmustine|mesh-list
110703892|NCT02531841|Busulfan|busulfan|mesh-list
110703893|NCT02531841|BB 1101|bb 1101|mesh-list
110703894|NCT02531841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110703895|NCT02531841|Antiemetics|antiemetics|mesh-ancestor
110703896|NCT02531841|Autonomic Agents|autonomic agents|mesh-ancestor
110703897|NCT02531841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110703898|NCT02531841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110703899|NCT02531841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110703900|NCT02531841|Glucocorticoids|glucocorticoids|mesh-ancestor
110703901|NCT02531841|Hormones|hormones|mesh-ancestor
110703902|NCT02531841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110703903|NCT02531841|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110703904|NCT02531841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110703905|NCT02531841|Protease Inhibitors|protease inhibitors|mesh-ancestor
110703906|NCT02531841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110703907|NCT02531841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110703908|NCT02531841|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110703909|NCT02531841|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110703910|NCT02531841|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110703911|NCT02531841|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110703912|NCT02531841|Alkylating Agents|alkylating agents|mesh-ancestor
110703913|NCT02531841|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110703914|NCT02531841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110703915|NCT02531841|Immunologic Factors|immunologic factors|mesh-ancestor
110703916|NCT01074411|Carboplatin|carboplatin|mesh-list
110703917|NCT01074411|Bortezomib|bortezomib|mesh-list
110703918|NCT01074411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110703919|NCT03973047|Ondansetron|ondansetron|mesh-list
110703920|NCT03973047|Antiemetics|antiemetics|mesh-ancestor
110703921|NCT03973047|Autonomic Agents|autonomic agents|mesh-ancestor
110703922|NCT03973047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110703923|NCT03973047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110703924|NCT03973047|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110703925|NCT03973047|Antipruritics|antipruritics|mesh-ancestor
110703926|NCT03973047|Dermatologic Agents|dermatologic agents|mesh-ancestor
110703927|NCT03973047|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110703928|NCT03973047|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110703929|NCT03973047|Serotonin Agents|serotonin agents|mesh-ancestor
110860270|NCT04785820|Nivolumab|nivolumab|mesh-list
110703930|NCT03973047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110703931|NCT03973047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110703933|NCT00522275|Anticonvulsants|anticonvulsants|mesh-ancestor
110703934|NCT00522275|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110703935|NCT00522275|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110703936|NCT00522275|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110703937|NCT00522275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110703938|NCT01074567|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
110703939|NCT01074567|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
110703940|NCT01074567|Protective Agents|protective agents|mesh-ancestor
110703941|NCT01074567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110703942|NCT01074567|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110703943|NCT01074567|Antioxidants|antioxidants|mesh-ancestor
110703944|NCT01074567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110703945|NCT00522041|Nitroglycerin|nitroglycerin|mesh-list
110703946|NCT00522041|Vasodilator Agents|vasodilator agents|mesh-ancestor
110703947|NCT00122980|Hydroxyurea|hydroxyurea|mesh-list
110703948|NCT00122980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110703949|NCT00122980|Antisickling Agents|antisickling agents|mesh-ancestor
110703950|NCT00122980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110703951|NCT00122980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110703952|NCT00122980|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110703953|NCT00340704|Tamsulosin|tamsulosin|mesh-list
110703954|NCT00340704|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110703955|NCT00340704|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110703956|NCT00340704|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110703957|NCT00340704|Adrenergic Agents|adrenergic agents|mesh-ancestor
110703958|NCT00340704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110703959|NCT00340704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110703960|NCT00340704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110703961|NCT00340704|Urological Agents|urological agents|mesh-ancestor
110703962|NCT00132496|Rabeprazole|rabeprazole|mesh-list
110703963|NCT00132496|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110703964|NCT00132496|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110703965|NCT00132496|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110703966|NCT00132496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110703967|NCT00132496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110703968|NCT01080586|Cyclosporine|cyclosporine|mesh-list
110703969|NCT01080586|Cyclosporins|cyclosporins|mesh-list
110703970|NCT01080586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110703971|NCT01080586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110703972|NCT01080586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110703973|NCT01080586|Immunologic Factors|immunologic factors|mesh-ancestor
110703974|NCT01080586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110703975|NCT01080586|Antifungal Agents|antifungal agents|mesh-ancestor
110703976|NCT01080586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110703977|NCT01080586|Dermatologic Agents|dermatologic agents|mesh-ancestor
110703978|NCT01080586|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110703979|NCT01080586|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110703981|NCT00231777|Aprepitant|aprepitant|mesh-list
110703982|NCT00231777|Antiemetics|antiemetics|mesh-ancestor
110703983|NCT00231777|Autonomic Agents|autonomic agents|mesh-ancestor
110703984|NCT00231777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110703985|NCT00231777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110703986|NCT00231777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110703987|NCT00231777|Antipruritics|antipruritics|mesh-ancestor
110703988|NCT00231777|Dermatologic Agents|dermatologic agents|mesh-ancestor
110703989|NCT00231777|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110703991|NCT00231777|Serotonin Agents|serotonin agents|mesh-ancestor
110703992|NCT00231777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110703993|NCT00231777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110703994|NCT00231777|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110703995|NCT01076842|Insulin|insulin|mesh-list
110703996|NCT01076842|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110703997|NCT01076842|Exenatide|exenatide|mesh-list
110703999|NCT01076842|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110704000|NCT01076842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110704001|NCT01076842|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110704002|NCT01076842|Incretins|incretins|mesh-ancestor
110704003|NCT01076842|Hormones|hormones|mesh-ancestor
110704004|NCT01076842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110704005|NCT01060410|Cyclophosphamide|cyclophosphamide|mesh-list
110704006|NCT01060410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110704007|NCT01060410|Immunologic Factors|immunologic factors|mesh-ancestor
110704008|NCT01060410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110704009|NCT01060410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110704010|NCT01060410|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110704011|NCT01060410|Alkylating Agents|alkylating agents|mesh-ancestor
110704012|NCT01060410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110704013|NCT01060410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110704014|NCT01060410|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110704015|NCT00231465|Docetaxel|docetaxel|mesh-list
110704016|NCT00231465|Gefitinib|gefitinib|mesh-list
110704017|NCT00231465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110704018|NCT00231465|Tubulin Modulators|tubulin modulators|mesh-ancestor
110704019|NCT00231465|Antimitotic Agents|antimitotic agents|mesh-ancestor
110704020|NCT00231465|Mitosis Modulators|mitosis modulators|mesh-ancestor
110704021|NCT00231465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110704022|NCT00231465|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110704023|NCT00231465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110704024|NCT00254397|Leuprolide|leuprolide|mesh-list
110704025|NCT00254397|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110704026|NCT00254397|Fertility Agents|fertility agents|mesh-ancestor
110704027|NCT00254397|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110704028|NCT00254397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110704029|NCT00254397|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110704030|NCT00254397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110704031|NCT00254163|Cyclophosphamide|cyclophosphamide|mesh-list
110704032|NCT00254163|Rituximab|rituximab|mesh-list
110704033|NCT00254163|Fludarabine|fludarabine|mesh-list
110704034|NCT00254163|Pentostatin|pentostatin|mesh-list
110704035|NCT00254163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110704036|NCT00254163|Immunologic Factors|immunologic factors|mesh-ancestor
110704037|NCT00254163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110704038|NCT00254163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110704039|NCT00254163|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110704040|NCT00254163|Alkylating Agents|alkylating agents|mesh-ancestor
110124818|NCT01941407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110704041|NCT00254163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110704042|NCT00254163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110704043|NCT00254163|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110704044|NCT00254163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110704045|NCT00254163|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
110704046|NCT00254163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110704047|NCT00110890|Cinacalcet|cinacalcet|mesh-list
110704048|NCT00110890|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110421884|NCT02823691|Metformin|metformin|mesh-list
110704049|NCT00110890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110704051|NCT00110890|Hormone Antagonists|hormone antagonists|mesh-ancestor
110704052|NCT00110890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110704053|NCT00182637|Bortezomib|bortezomib|mesh-list
110704054|NCT00182637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110704055|NCT01076998|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110704056|NCT01076998|Lubricant Eye Drops|lubricant eye drops|mesh-list
110704057|NCT01076998|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110704058|NCT00122278|Dexamethasone|dexamethasone|mesh-list
110704059|NCT00122278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110704060|NCT00122278|Antiemetics|antiemetics|mesh-ancestor
110704061|NCT00122278|Autonomic Agents|autonomic agents|mesh-ancestor
110704062|NCT00122278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110704063|NCT00122278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110704064|NCT00122278|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110704065|NCT00122278|Glucocorticoids|glucocorticoids|mesh-ancestor
110704066|NCT00122278|Hormones|hormones|mesh-ancestor
110704067|NCT00122278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110860281|NCT04767061|Metoprolol|metoprolol|mesh-list
110704069|NCT00122278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110704070|NCT00182091|Hormones|hormones|mesh-list
110704071|NCT00182091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110704072|NCT00182091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110704073|NCT03398135|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110704074|NCT03398135|Immunologic Factors|immunologic factors|mesh-ancestor
110704075|NCT03398135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110704076|NCT01072071|Furosemide|furosemide|mesh-list
110704077|NCT01072071|Diuretics|diuretics|mesh-ancestor
110704078|NCT01072071|Natriuretic Agents|natriuretic agents|mesh-ancestor
110704079|NCT01072071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110704080|NCT01072071|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110704081|NCT01072071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110704082|NCT01072071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110704083|NCT00181155|Allopurinol|allopurinol|mesh-list
110704084|NCT00181155|Antimetabolites|antimetabolites|mesh-ancestor
110704085|NCT00181155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110704086|NCT00181155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110704087|NCT00181155|Gout Suppressants|gout suppressants|mesh-ancestor
110704088|NCT00181155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110704089|NCT00181155|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110704090|NCT00181155|Antioxidants|antioxidants|mesh-ancestor
110704091|NCT00181155|Protective Agents|protective agents|mesh-ancestor
110704092|NCT00181155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110704093|NCT00322452|Paclitaxel|paclitaxel|mesh-list
110704094|NCT00322452|Carboplatin|carboplatin|mesh-list
110704095|NCT00322452|Gefitinib|gefitinib|mesh-list
110704096|NCT00322452|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110704097|NCT00322452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110704098|NCT00322452|Tubulin Modulators|tubulin modulators|mesh-ancestor
110704099|NCT00322452|Antimitotic Agents|antimitotic agents|mesh-ancestor
110704100|NCT00322452|Mitosis Modulators|mitosis modulators|mesh-ancestor
110704101|NCT00322452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110704102|NCT00322452|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110704103|NCT00322452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110704104|NCT00110812|Aldesleukin|aldesleukin|mesh-list
110704105|NCT00110812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110704106|NCT00110812|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110704107|NCT00110812|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110704108|NCT00110812|Antiviral Agents|antiviral agents|mesh-ancestor
110704109|NCT00110812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110704110|NCT00516269|Methylphenidate|methylphenidate|mesh-list
110704111|NCT00516269|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110704112|NCT00516269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110704113|NCT00516269|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110704114|NCT00516269|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110704115|NCT00516269|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110704116|NCT00516269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110704117|NCT00516269|Dopamine Agents|dopamine agents|mesh-ancestor
110704118|NCT00516269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110704119|NCT04639037|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
110704120|NCT00228813|Lenograstim|lenograstim|mesh-list
110704121|NCT00228813|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110704122|NCT00228813|Immunologic Factors|immunologic factors|mesh-ancestor
110704123|NCT00228813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110704124|NCT00322374|Epirubicin|epirubicin|mesh-list
110704125|NCT00322374|Epothilones|epothilones|mesh-list
110704126|NCT00322374|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110704127|NCT00322374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110704128|NCT00322374|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110704129|NCT00322374|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110704131|NCT00322374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110704132|NCT00322374|Tubulin Modulators|tubulin modulators|mesh-ancestor
110704133|NCT00322374|Antimitotic Agents|antimitotic agents|mesh-ancestor
110704134|NCT00322374|Mitosis Modulators|mitosis modulators|mesh-ancestor
110704135|NCT00174447|Ziprasidone|ziprasidone|mesh-list
110704136|NCT00174447|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110704137|NCT00174447|Serotonin Agents|serotonin agents|mesh-ancestor
110704138|NCT00174447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110704139|NCT00174447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110704140|NCT00174447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110704141|NCT00174447|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110704142|NCT00174447|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110704143|NCT00174447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110704144|NCT00174447|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110704145|NCT00174447|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110704146|NCT00174447|Dopamine Agents|dopamine agents|mesh-ancestor
110704147|NCT00321984|Dexlansoprazole|dexlansoprazole|mesh-list
110704148|NCT00321984|Lansoprazole|lansoprazole|mesh-list
110704149|NCT00321984|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110704150|NCT00321984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110704151|NCT00321984|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110704152|NCT00321984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110125075|NCT01943019|Protease Inhibitors|protease inhibitors|mesh-ancestor
110704153|NCT00321984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110704154|NCT01060488|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
110704155|NCT01060488|Hormones|hormones|mesh-ancestor
110704156|NCT01060488|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110704157|NCT01060488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110704158|NCT01060566|Ivacaftor|ivacaftor|mesh-list
110704159|NCT01060566|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
110704160|NCT01060566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110704161|NCT01060566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110704162|NCT02533284|Magnesium Sulfate|magnesium sulfate|mesh-list
110704163|NCT02533284|Analgesics|analgesics|mesh-ancestor
110704164|NCT02533284|Sensory System Agents|sensory system agents|mesh-ancestor
110125135|NCT01943487|Verapamil|verapamil|mesh-list
110704165|NCT02533284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110704166|NCT02533284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110704167|NCT02533284|Anesthetics|anesthetics|mesh-ancestor
110704168|NCT02533284|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110704169|NCT02533284|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110704170|NCT02533284|Anticonvulsants|anticonvulsants|mesh-ancestor
110704171|NCT02533284|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110704172|NCT02533284|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110704173|NCT02533284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110704174|NCT02533284|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110704175|NCT02533284|Tocolytic Agents|tocolytic agents|mesh-ancestor
110704176|NCT02533284|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110704177|NCT00515099|Thymoglobulin|thymoglobulin|mesh-list
110704178|NCT00515099|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110704179|NCT00515099|Immunologic Factors|immunologic factors|mesh-ancestor
110704180|NCT00515099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110704181|NCT00515099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110704182|NCT00110266|Deferasirox|deferasirox|mesh-list
110704183|NCT00110266|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110704184|NCT00110266|Chelating Agents|chelating agents|mesh-ancestor
110704185|NCT00110266|Sequestering Agents|sequestering agents|mesh-ancestor
110704186|NCT00110266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110704187|NCT00366548|Vaccines|vaccines|mesh-list
110704188|NCT00366548|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110704189|NCT00366548|Immunologic Factors|immunologic factors|mesh-ancestor
110704190|NCT00366548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110704191|NCT01074645|Tenofovir|tenofovir|mesh-list
110704192|NCT01074645|Antiviral Agents|antiviral agents|mesh-ancestor
110704193|NCT01074645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110704194|NCT01074645|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110704195|NCT01074645|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110704196|NCT01074645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110704197|NCT01074645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110704198|NCT01074645|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110704199|NCT01074645|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110704201|NCT00132028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110443656|NCT00693433|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110704202|NCT00132028|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110704203|NCT00132028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110704204|NCT00132028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110704205|NCT01045304|Carboplatin|carboplatin|mesh-list
110704206|NCT01045304|Gemcitabine|gemcitabine|mesh-list
110704207|NCT01045304|Iniparib|iniparib|mesh-list
110704208|NCT01045304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110704209|NCT01045304|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110704210|NCT01045304|Antimetabolites|antimetabolites|mesh-ancestor
110704211|NCT01045304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110125316|NCT01944735|Mannitol|mannitol|mesh-list
110704212|NCT01045304|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110704213|NCT01045304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110704214|NCT01080742|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110704215|NCT01080742|Bisoprolol|bisoprolol|mesh-list
110704216|NCT01080742|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110704217|NCT01080742|Diuretics|diuretics|mesh-ancestor
110704218|NCT01080742|Natriuretic Agents|natriuretic agents|mesh-ancestor
110704219|NCT01080742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110704220|NCT01080742|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110704221|NCT01080742|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110704222|NCT01080742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110704223|NCT01080742|Sympatholytics|sympatholytics|mesh-ancestor
110704224|NCT01080742|Autonomic Agents|autonomic agents|mesh-ancestor
110704225|NCT01080742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110704226|NCT01080742|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110125377|NCT01945450|Ampicillin|ampicillin|mesh-list
110704227|NCT01080742|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110704228|NCT01080742|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110704229|NCT01080742|Adrenergic Agents|adrenergic agents|mesh-ancestor
110704230|NCT01080742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110704231|NCT00131248|Metoclopramide|metoclopramide|mesh-list
110704232|NCT00131248|Ranitidine|ranitidine|mesh-list
110704233|NCT00131248|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
110704234|NCT00131248|Antiemetics|antiemetics|mesh-ancestor
110704235|NCT00131248|Autonomic Agents|autonomic agents|mesh-ancestor
110704236|NCT00131248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110704237|NCT00131248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110704238|NCT00131248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110704239|NCT00131248|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110704240|NCT00131248|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110704241|NCT00131248|Dopamine Agents|dopamine agents|mesh-ancestor
110704242|NCT00131248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110704243|NCT00131248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110704244|NCT00131248|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110704245|NCT00131248|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110704246|NCT00131248|Histamine Antagonists|histamine antagonists|mesh-ancestor
110704247|NCT00131248|Histamine Agents|histamine agents|mesh-ancestor
110704248|NCT00362414|Mitogens|mitogens|mesh-list
110704249|NCT00362414|Mitosis Modulators|mitosis modulators|mesh-ancestor
110704250|NCT00362414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110704251|NCT01080820|Hexadecyloxypropyl 9-(2-(phosphonomethoxy)propyl)adenine|hexadecyloxypropyl 9-(2-(phosphonomethoxy)propyl)adenine|mesh-list
110704252|NCT01080820|Antiviral Agents|antiviral agents|mesh-ancestor
110704253|NCT01080820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110704254|NCT01080820|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110704255|NCT01080820|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110704256|NCT01049204|Maraviroc|maraviroc|mesh-list
110704257|NCT01049204|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110704258|NCT01049204|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110704259|NCT01049204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110704260|NCT01049204|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110704261|NCT01049204|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110704262|NCT01049204|Antiviral Agents|antiviral agents|mesh-ancestor
110704263|NCT01049204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110704264|NCT01049204|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
110704265|NCT00096382|Aldesleukin|aldesleukin|mesh-list
110704266|NCT00096382|Cyclophosphamide|cyclophosphamide|mesh-list
110704267|NCT00096382|Fludarabine|fludarabine|mesh-list
110704268|NCT00096382|Fludarabine phosphate|fludarabine phosphate|mesh-list
110704269|NCT00096382|Interleukin-2|interleukin-2|mesh-list
110704270|NCT00096382|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110704271|NCT00096382|Immunologic Factors|immunologic factors|mesh-ancestor
110704272|NCT00096382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110704273|NCT00096382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110704274|NCT00096382|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110704275|NCT00096382|Alkylating Agents|alkylating agents|mesh-ancestor
110704276|NCT00096382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110704277|NCT00096382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110704278|NCT00096382|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110704279|NCT00096382|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110704280|NCT00096382|Antimetabolites|antimetabolites|mesh-ancestor
110704281|NCT00096382|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110704282|NCT00096382|Analgesics|analgesics|mesh-ancestor
110704283|NCT00096382|Sensory System Agents|sensory system agents|mesh-ancestor
110704284|NCT00096382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110704285|NCT00096382|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110704286|NCT00096382|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110125547|NCT04887389|Listerine|listerine|mesh-list
110704287|NCT00096382|Antiviral Agents|antiviral agents|mesh-ancestor
110704288|NCT00096382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110704290|NCT00384332|Antiemetics|antiemetics|mesh-ancestor
110704291|NCT00384332|Autonomic Agents|autonomic agents|mesh-ancestor
110704292|NCT00384332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110704293|NCT00384332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110704294|NCT00384332|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110704295|NCT00384332|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110704296|NCT00384332|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110704297|NCT00384332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110704298|NCT00384332|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110704299|NCT00384332|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110125593|NCT04722835|Albuterol|albuterol|mesh-list
110704300|NCT00384332|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110704301|NCT00384332|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110704302|NCT00384332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110704303|NCT00384332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110704304|NCT00384332|Serotonin Agents|serotonin agents|mesh-ancestor
110704305|NCT00096226|Paclitaxel|paclitaxel|mesh-list
110704306|NCT00096226|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110704307|NCT00096226|Carboplatin|carboplatin|mesh-list
110704308|NCT00096226|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110704309|NCT00096226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110704310|NCT00096226|Tubulin Modulators|tubulin modulators|mesh-ancestor
110704311|NCT00096226|Antimitotic Agents|antimitotic agents|mesh-ancestor
110704312|NCT00096226|Mitosis Modulators|mitosis modulators|mesh-ancestor
110704313|NCT00096226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110704314|NCT01078714|Bumetanide|bumetanide|mesh-list
110704315|NCT01078714|Diuretics|diuretics|mesh-ancestor
110704316|NCT01078714|Natriuretic Agents|natriuretic agents|mesh-ancestor
110704317|NCT01078714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110704318|NCT01078714|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110704319|NCT01078714|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110704320|NCT01078714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110704321|NCT03964324|Nitric Oxide|nitric oxide|mesh-list
110704322|NCT03964324|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110704323|NCT03964324|Autonomic Agents|autonomic agents|mesh-ancestor
110704324|NCT03964324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110704325|NCT03964324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110704326|NCT03964324|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110704327|NCT03964324|Respiratory System Agents|respiratory system agents|mesh-ancestor
110704328|NCT03964324|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110704329|NCT03964324|Antioxidants|antioxidants|mesh-ancestor
110704330|NCT03964324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110704331|NCT03964324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110704332|NCT03964324|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
110704333|NCT03964324|Vasodilator Agents|vasodilator agents|mesh-ancestor
110704334|NCT03964324|Gasotransmitters|gasotransmitters|mesh-ancestor
110704335|NCT03964324|Protective Agents|protective agents|mesh-ancestor
110704336|NCT01082848|Aripiprazole|aripiprazole|mesh-list
110704337|NCT01082848|Antidepressive Agents|antidepressive agents|mesh-ancestor
110704338|NCT01082848|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110704339|NCT01082848|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110704340|NCT01082848|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110704341|NCT01082848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110704342|NCT01082848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110704343|NCT01082848|Dopamine Agonists|dopamine agonists|mesh-ancestor
110704344|NCT01082848|Dopamine Agents|dopamine agents|mesh-ancestor
110422184|NCT02818309|Lesogaberan|lesogaberan|mesh-list
110704345|NCT01082848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110704346|NCT01082848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110704347|NCT01082848|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110704348|NCT01082848|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110704349|NCT01082848|Serotonin Agents|serotonin agents|mesh-ancestor
110704350|NCT01082848|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110704351|NCT01082848|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110704352|NCT01082848|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110704353|NCT01082848|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110704354|NCT01082926|Aldesleukin|aldesleukin|mesh-list
110704355|NCT01082926|Interleukin-2|interleukin-2|mesh-list
110704356|NCT01082926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110704357|NCT01082926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110704358|NCT01082926|Analgesics|analgesics|mesh-ancestor
110704359|NCT01082926|Sensory System Agents|sensory system agents|mesh-ancestor
110704360|NCT01082926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110704361|NCT01082926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110704362|NCT01082926|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110704363|NCT01082926|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110704364|NCT01082926|Antiviral Agents|antiviral agents|mesh-ancestor
110704365|NCT01082926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110704366|NCT03962920|Tigecycline|tigecycline|mesh-list
110704367|NCT03962920|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110704368|NCT03962920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110704369|NCT03962920|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110704370|NCT03962920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110704371|NCT03962920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110704372|NCT01078870|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110704373|NCT01078870|Escitalopram|escitalopram|mesh-list
110704374|NCT01078870|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110704375|NCT01078870|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110704376|NCT01078870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110704377|NCT01078870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110704378|NCT01078870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110704379|NCT01078870|Serotonin Agents|serotonin agents|mesh-ancestor
110704380|NCT01078870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110704381|NCT01078870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110125891|NCT05411276|Maleic acid|maleic acid|mesh-list
110704382|NCT01078870|Antidepressive Agents|antidepressive agents|mesh-ancestor
110704383|NCT01078870|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110704384|NCT01078870|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110704385|NCT01078870|Analgesics|analgesics|mesh-ancestor
110704386|NCT01078870|Sensory System Agents|sensory system agents|mesh-ancestor
110704387|NCT01078870|Dopamine Agents|dopamine agents|mesh-ancestor
110704388|NCT00105196|Aripiprazole|aripiprazole|mesh-list
110704389|NCT00105196|Antidepressive Agents|antidepressive agents|mesh-ancestor
110704390|NCT00105196|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110704391|NCT00105196|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110704392|NCT00105196|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110704393|NCT00105196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110704394|NCT00105196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110704395|NCT00105196|Dopamine Agonists|dopamine agonists|mesh-ancestor
110704396|NCT00105196|Dopamine Agents|dopamine agents|mesh-ancestor
110704397|NCT00105196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110704398|NCT00105196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110704399|NCT00105196|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110704400|NCT00105196|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110704401|NCT00105196|Serotonin Agents|serotonin agents|mesh-ancestor
110704402|NCT00105196|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110704403|NCT00105196|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110860315|NCT04767061|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110704404|NCT00105196|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110704405|NCT00105196|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110704406|NCT00104572|Vitamin D|vitamin d|mesh-list
110704407|NCT00104572|Anastrozole|anastrozole|mesh-list
110704408|NCT00104572|Calcium|calcium|mesh-list
110704409|NCT00104572|Testosterone|testosterone|mesh-list
110704410|NCT00104572|Aromatase Inhibitors|aromatase inhibitors|mesh-list
110704411|NCT00104572|Vitamins|vitamins|mesh-ancestor
110704412|NCT00104572|Micronutrients|micronutrients|mesh-ancestor
110704413|NCT00104572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110704414|NCT00104572|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110704415|NCT00104572|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110704416|NCT00104572|Androgens|androgens|mesh-ancestor
110704417|NCT00104572|Hormones|hormones|mesh-ancestor
110443661|NCT00693433|Antifungal Agents|antifungal agents|mesh-ancestor
110704418|NCT00104572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110704419|NCT00104572|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110704420|NCT00104572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110704421|NCT00104572|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110704422|NCT00104572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110704423|NCT00104572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110704424|NCT00104572|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110704425|NCT00104572|Hormone Antagonists|hormone antagonists|mesh-ancestor
110704426|NCT00514943|Cetuximab|cetuximab|mesh-list
110704427|NCT00514943|Afatinib|afatinib|mesh-list
110704428|NCT00514943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110704429|NCT00514943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110704430|NCT00514943|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110126066|NCT03539055|Dabigatran|dabigatran|mesh-list
110704431|NCT00514943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110704432|NCT00514943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110704433|NCT00103402|Alfuzosin|alfuzosin|mesh-list
110704434|NCT00103402|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110704435|NCT00103402|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110704436|NCT00103402|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110704437|NCT00103402|Adrenergic Agents|adrenergic agents|mesh-ancestor
110704438|NCT00103402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110704439|NCT00103402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110704440|NCT00103402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110704441|NCT00103402|Urological Agents|urological agents|mesh-ancestor
110704442|NCT00095836|Gefitinib|gefitinib|mesh-list
110704443|NCT00095836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110704444|NCT00095836|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110704445|NCT00095836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110704446|NCT00095836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110704447|NCT00168831|Tiotropium Bromide|tiotropium bromide|mesh-list
110704448|NCT00168831|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110704449|NCT00168831|Autonomic Agents|autonomic agents|mesh-ancestor
110704450|NCT00168831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110704451|NCT00168831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110704452|NCT00168831|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110704453|NCT00168831|Respiratory System Agents|respiratory system agents|mesh-ancestor
110704454|NCT00168831|Parasympatholytics|parasympatholytics|mesh-ancestor
110704455|NCT00168831|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110704456|NCT00168831|Cholinergic Agents|cholinergic agents|mesh-ancestor
110704457|NCT00168831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110704458|NCT00168831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110704459|NCT03330821|Cytarabine|cytarabine|mesh-list
110704460|NCT03330821|Idarubicin|idarubicin|mesh-list
110704461|NCT03330821|Enzyme Inhibitors|enzyme inhibitors|mesh-list
110704462|NCT03330821|Pevonedistat|pevonedistat|mesh-list
110704463|NCT03330821|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110704464|NCT03330821|Antimetabolites|antimetabolites|mesh-ancestor
110704465|NCT03330821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110704466|NCT03330821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110704468|NCT03330821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110704469|NCT03330821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110704470|NCT03330821|Immunologic Factors|immunologic factors|mesh-ancestor
110704471|NCT03330821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110704472|NCT03330821|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110704473|NCT03330821|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110704474|NCT03330821|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110704475|NCT00512135|Botulinum Toxins|botulinum toxins|mesh-list
110704476|NCT00512135|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110704477|NCT00512135|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110704478|NCT00512135|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
110704479|NCT00512135|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110704480|NCT00512135|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110704481|NCT00512135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110704482|NCT00512135|Cholinergic Agents|cholinergic agents|mesh-ancestor
110443663|NCT05414422|Analgesics|analgesics|mesh-ancestor
110704483|NCT00512135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110704484|NCT00512135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110704485|NCT00512135|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110704486|NCT00512135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110704487|NCT03235505|Nicotine|nicotine|mesh-list
110704488|NCT03235505|Varenicline|varenicline|mesh-list
110704489|NCT03235505|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110704490|NCT03235505|Autonomic Agents|autonomic agents|mesh-ancestor
110704491|NCT03235505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110704492|NCT03235505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110704494|NCT03235505|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110704495|NCT03235505|Cholinergic Agents|cholinergic agents|mesh-ancestor
110704496|NCT03235505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110704497|NCT03235505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110704498|NCT00251979|Esomeprazole|esomeprazole|mesh-list
110704499|NCT00251979|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110704500|NCT00251979|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110704501|NCT00251979|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110704502|NCT00251979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110704503|NCT00251979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110704504|NCT00511901|Epoetin Alfa|epoetin alfa|mesh-list
110704505|NCT00511901|Hematinics|hematinics|mesh-ancestor
110704506|NCT04580147|Aflibercept|aflibercept|mesh-list
110704507|NCT04580147|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110704508|NCT04580147|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110704509|NCT04580147|Growth Substances|growth substances|mesh-ancestor
110704510|NCT04580147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110704511|NCT04580147|Growth Inhibitors|growth inhibitors|mesh-ancestor
110704512|NCT04580147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110704513|NCT03147287|Fulvestrant|fulvestrant|mesh-list
110704514|NCT03147287|Palbociclib|palbociclib|mesh-list
110704515|NCT03147287|Avelumab|avelumab|mesh-list
110704516|NCT03147287|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110704517|NCT03147287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110704518|NCT03147287|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110704519|NCT03147287|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110704520|NCT03147287|Hormone Antagonists|hormone antagonists|mesh-ancestor
110704521|NCT03147287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110704522|NCT03147287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110704523|NCT03147287|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110704524|NCT03147287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110704525|NCT03147287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110704526|NCT03147287|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110704527|NCT00228423|Clopidogrel|clopidogrel|mesh-list
110704528|NCT00228423|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110704529|NCT00228423|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110704530|NCT00228423|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110704531|NCT00228423|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110704532|NCT00228423|Purinergic Agents|purinergic agents|mesh-ancestor
110704533|NCT00228423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110704534|NCT00228423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110860335|NCT04753294|Anesthetics, General|anesthetics, general|mesh-ancestor
110704535|NCT00228423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110704536|NCT00513695|Paclitaxel|paclitaxel|mesh-list
110704537|NCT00513695|Cyclophosphamide|cyclophosphamide|mesh-list
110704538|NCT00513695|Doxorubicin|doxorubicin|mesh-list
110704539|NCT00513695|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110704540|NCT00513695|Sunitinib|sunitinib|mesh-list
110704541|NCT00513695|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110704542|NCT00513695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110704543|NCT00513695|Tubulin Modulators|tubulin modulators|mesh-ancestor
110704544|NCT00513695|Antimitotic Agents|antimitotic agents|mesh-ancestor
110704545|NCT00513695|Mitosis Modulators|mitosis modulators|mesh-ancestor
110704546|NCT00513695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110704547|NCT00513695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110704548|NCT00513695|Immunologic Factors|immunologic factors|mesh-ancestor
110704549|NCT00513695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110704550|NCT00513695|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110704551|NCT00513695|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110704552|NCT00513695|Alkylating Agents|alkylating agents|mesh-ancestor
110704553|NCT00513695|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110704554|NCT00513695|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110704555|NCT00513695|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110704556|NCT00513695|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110704557|NCT00513695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110704558|NCT00513695|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110704559|NCT00513695|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110704560|NCT00513695|Growth Substances|growth substances|mesh-ancestor
110704561|NCT00513695|Growth Inhibitors|growth inhibitors|mesh-ancestor
110126615|NCT02900560|Pembrolizumab|pembrolizumab|mesh-list
110704562|NCT00513695|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110704563|NCT00162981|Clobazam|clobazam|mesh-list
110704564|NCT00162981|Anticonvulsants|anticonvulsants|mesh-ancestor
110704565|NCT00162981|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110704566|NCT00162981|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110704567|NCT00162981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110704568|NCT00162981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110704569|NCT00162981|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110704570|NCT00162981|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
110704571|NCT00162981|GABA Agonists|gaba agonists|mesh-ancestor
110704572|NCT00162981|GABA Agents|gaba agents|mesh-ancestor
110704573|NCT00162981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110704574|NCT00162981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110704576|NCT00099268|Carbidopa|carbidopa|mesh-list
110704577|NCT00099268|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
110704578|NCT00099268|Entacapone|entacapone|mesh-list
110704579|NCT00099268|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110704580|NCT00099268|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110704581|NCT00099268|Dopamine Agents|dopamine agents|mesh-ancestor
110704582|NCT00099268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110704583|NCT00099268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110704584|NCT00099268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110704585|NCT00099268|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
110704586|NCT00099268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110704587|NCT00099268|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110126735|NCT01946009|Cidofovir|cidofovir|mesh-list
110704588|NCT00099268|Immunologic Factors|immunologic factors|mesh-ancestor
110704589|NCT00099268|Dopamine Agonists|dopamine agonists|mesh-ancestor
110704590|NCT00099268|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
110704591|NCT00511355|Levonorgestrel|levonorgestrel|mesh-list
110704592|NCT00511355|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110704593|NCT00511355|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
110704594|NCT00511355|Estradiol|estradiol|mesh-list
110704595|NCT00511355|Estrogens|estrogens|mesh-ancestor
110704596|NCT00511355|Hormones|hormones|mesh-ancestor
110704597|NCT00511355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110704598|NCT00511355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110704599|NCT00511355|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110704600|NCT00511355|Contraceptive Agents|contraceptive agents|mesh-ancestor
110704601|NCT00511355|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110704602|NCT00511355|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110704603|NCT00511355|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110704604|NCT00511355|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110704605|NCT00511355|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110704606|NCT00511355|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110704607|NCT01083784|Valproic Acid|valproic acid|mesh-list
110704609|NCT01083784|Anticonvulsants|anticonvulsants|mesh-list
110704610|NCT01083784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110704611|NCT01083784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110704612|NCT01083784|GABA Agents|gaba agents|mesh-ancestor
110704613|NCT01083784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110704614|NCT01083784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110704615|NCT01083784|Antimanic Agents|antimanic agents|mesh-ancestor
110704616|NCT01083784|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110704617|NCT01083784|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110704618|NCT01083784|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110704619|NCT01083784|GABA Modulators|gaba modulators|mesh-ancestor
110704620|NCT00095212|Testosterone|testosterone|mesh-list
110704621|NCT00095212|Androgens|androgens|mesh-ancestor
110704622|NCT00095212|Hormones|hormones|mesh-ancestor
110704623|NCT00095212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110704624|NCT00095212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110704625|NCT02834975|Paclitaxel|paclitaxel|mesh-list
110704626|NCT02834975|Carboplatin|carboplatin|mesh-list
110704627|NCT02834975|Pembrolizumab|pembrolizumab|mesh-list
110704628|NCT02834975|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110704629|NCT02834975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110704630|NCT02834975|Tubulin Modulators|tubulin modulators|mesh-ancestor
110704631|NCT02834975|Antimitotic Agents|antimitotic agents|mesh-ancestor
110704632|NCT02834975|Mitosis Modulators|mitosis modulators|mesh-ancestor
110704633|NCT02834975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110704634|NCT02834975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110704635|NCT02834975|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110704636|NCT00120874|Memantine|memantine|mesh-list
110704637|NCT00120874|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110704638|NCT00120874|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110704639|NCT00120874|Dopamine Agents|dopamine agents|mesh-ancestor
110704640|NCT00120874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110422475|NCT00627081|Analgesics|analgesics|mesh-ancestor
110704641|NCT00120874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110704642|NCT00120874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110704643|NCT00120874|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110704644|NCT00120874|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110704645|NCT00120250|Eszopiclone|eszopiclone|mesh-list
110704646|NCT00120250|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110704647|NCT00120250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110704648|NCT00120250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110704649|NCT01081600|Trastuzumab|trastuzumab|mesh-list
110704650|NCT01081600|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110704651|NCT01081600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110704652|NCT01079338|Caffeine|caffeine|mesh-list
110704653|NCT01079338|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110704654|NCT01079338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110704655|NCT01079338|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110704656|NCT01079338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110704657|NCT01079338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110704658|NCT01079338|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110704659|NCT01079338|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110704660|NCT01079338|Purinergic Agents|purinergic agents|mesh-ancestor
110704661|NCT01079338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110704662|NCT00384176|Leucovorin|leucovorin|mesh-list
110704663|NCT00384176|Bevacizumab|bevacizumab|mesh-list
110704664|NCT00384176|Fluorouracil|fluorouracil|mesh-list
110704665|NCT00384176|Oxaliplatin|oxaliplatin|mesh-list
110704666|NCT00384176|Cediranib|cediranib|mesh-list
110704667|NCT00384176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110704668|NCT00384176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110704669|NCT00384176|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110704670|NCT00384176|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110704671|NCT00384176|Growth Substances|growth substances|mesh-ancestor
110704672|NCT00384176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110704673|NCT00384176|Growth Inhibitors|growth inhibitors|mesh-ancestor
110704674|NCT00384176|Antimetabolites|antimetabolites|mesh-ancestor
110704675|NCT00384176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110704676|NCT00384176|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110704677|NCT00384176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110704678|NCT00384176|Immunologic Factors|immunologic factors|mesh-ancestor
110704680|NCT00384176|Protective Agents|protective agents|mesh-ancestor
110704681|NCT00384176|Vitamin B Complex|vitamin b complex|mesh-ancestor
110704682|NCT00384176|Vitamins|vitamins|mesh-ancestor
110704683|NCT00384176|Micronutrients|micronutrients|mesh-ancestor
110704684|NCT00384176|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110704685|NCT00384176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110704686|NCT00513305|Cytarabine|cytarabine|mesh-list
110704687|NCT00513305|Arsenic Trioxide|arsenic trioxide|mesh-list
110704688|NCT00513305|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110704689|NCT00513305|Antimetabolites|antimetabolites|mesh-ancestor
110704690|NCT00513305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110704691|NCT00513305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110704692|NCT00513305|Antiviral Agents|antiviral agents|mesh-ancestor
110704693|NCT00513305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110704694|NCT00513305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110704695|NCT00513305|Immunologic Factors|immunologic factors|mesh-ancestor
110704696|NCT00513305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110704697|NCT00513071|Saracatinib|saracatinib|mesh-list
110704698|NCT00513071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110704699|NCT00513071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110704700|NCT00513071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110704701|NCT00510887|Dexamethasone|dexamethasone|mesh-list
110704702|NCT00510887|Rituximab|rituximab|mesh-list
110704703|NCT00510887|Fludarabine|fludarabine|mesh-list
110704704|NCT00510887|Bortezomib|bortezomib|mesh-list
110704705|NCT00510887|Mitoxantrone|mitoxantrone|mesh-list
110704706|NCT00510887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110704707|NCT00510887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110704708|NCT00510887|Immunologic Factors|immunologic factors|mesh-ancestor
110704709|NCT00510887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110704710|NCT00510887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110704711|NCT00510887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110704712|NCT00510887|Antiemetics|antiemetics|mesh-ancestor
110704713|NCT00510887|Autonomic Agents|autonomic agents|mesh-ancestor
110704714|NCT00510887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110704715|NCT00510887|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110704716|NCT00510887|Glucocorticoids|glucocorticoids|mesh-ancestor
110704717|NCT00510887|Hormones|hormones|mesh-ancestor
110704718|NCT00510887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110704719|NCT00510887|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110704720|NCT00510887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110704721|NCT00510887|Analgesics|analgesics|mesh-ancestor
110704722|NCT00510887|Sensory System Agents|sensory system agents|mesh-ancestor
110704723|NCT00510887|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110704724|NCT00510887|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110704725|NCT00510887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110704726|NCT01012349|Aspirin|aspirin|mesh-list
110704727|NCT01012349|Citric Acid|citric acid|mesh-list
110704728|NCT01012349|Sodium Citrate|sodium citrate|mesh-list
110704729|NCT01012349|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110704730|NCT01012349|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110704731|NCT01012349|Analgesics|analgesics|mesh-ancestor
110704732|NCT01012349|Sensory System Agents|sensory system agents|mesh-ancestor
110704733|NCT01012349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110704734|NCT01012349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110704735|NCT01012349|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110704736|NCT01012349|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110704737|NCT01012349|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110704738|NCT01012349|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110127284|NCT01949675|Vaccines|vaccines|mesh-list
110704739|NCT01012349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110704740|NCT01012349|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110704741|NCT01012349|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110704742|NCT01012349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110704743|NCT01012349|Antipyretics|antipyretics|mesh-ancestor
110704744|NCT01012349|Anticoagulants|anticoagulants|mesh-ancestor
110704745|NCT01012349|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110704746|NCT01012349|Chelating Agents|chelating agents|mesh-ancestor
110704747|NCT01012349|Sequestering Agents|sequestering agents|mesh-ancestor
110704748|NCT00358826|Atreleuton|atreleuton|mesh-list
110704749|NCT00358826|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
110704750|NCT00358826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110704751|NCT00358826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110704752|NCT01009541|Pregabalin|pregabalin|mesh-list
110704753|NCT01009541|Analgesics|analgesics|mesh-ancestor
110704754|NCT01009541|Sensory System Agents|sensory system agents|mesh-ancestor
110704755|NCT01009541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110704756|NCT01009541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110704757|NCT01009541|Anticonvulsants|anticonvulsants|mesh-ancestor
110704758|NCT01009541|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110704759|NCT01009541|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110704760|NCT01009541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110704761|NCT01009541|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110704762|NCT01009541|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110704763|NCT01009541|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110704764|NCT01009541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110704765|NCT01009541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110704766|NCT00510653|Imatinib Mesylate|imatinib mesylate|mesh-list
110704767|NCT00510653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110704768|NCT00510653|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110704769|NCT00510653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110704770|NCT00510653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110704772|NCT01009697|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110704773|NCT01009697|Narcotics|narcotics|mesh-ancestor
110704774|NCT01009697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110704775|NCT01009697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110704776|NCT01009697|Analgesics|analgesics|mesh-ancestor
110704777|NCT01009697|Sensory System Agents|sensory system agents|mesh-ancestor
110704778|NCT01009697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110704779|NCT01009697|Antitussive Agents|antitussive agents|mesh-ancestor
110704780|NCT01009697|Respiratory System Agents|respiratory system agents|mesh-ancestor
110704781|NCT01009853|Codeine|codeine|mesh-list
110704782|NCT01009853|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110704783|NCT01009853|Narcotics|narcotics|mesh-ancestor
110704784|NCT01009853|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110704785|NCT01009853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110704786|NCT01009853|Analgesics|analgesics|mesh-ancestor
110704787|NCT01009853|Sensory System Agents|sensory system agents|mesh-ancestor
110704788|NCT01009853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110704789|NCT01009853|Antitussive Agents|antitussive agents|mesh-ancestor
110704790|NCT01009853|Respiratory System Agents|respiratory system agents|mesh-ancestor
110704791|NCT00506285|Methylphenidate|methylphenidate|mesh-list
110704792|NCT00506285|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110704793|NCT00506285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110704794|NCT00506285|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110704795|NCT00506285|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110704796|NCT00506285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110704797|NCT00506285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110704798|NCT00506285|Dopamine Agents|dopamine agents|mesh-ancestor
110704799|NCT00506285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110704800|NCT00506129|Fludarabine|fludarabine|mesh-list
110704801|NCT00506129|Fludarabine phosphate|fludarabine phosphate|mesh-list
110704802|NCT00506129|Melphalan|melphalan|mesh-list
110704803|NCT00506129|Thymoglobulin|thymoglobulin|mesh-list
110704804|NCT00506129|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110704805|NCT00506129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110704806|NCT00506129|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110704807|NCT00506129|Antimetabolites|antimetabolites|mesh-ancestor
110704808|NCT00506129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110704809|NCT00506129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110704810|NCT00506129|Immunologic Factors|immunologic factors|mesh-ancestor
110704811|NCT00506129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110704812|NCT00506129|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110704813|NCT00506129|Alkylating Agents|alkylating agents|mesh-ancestor
110704814|NCT00506129|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110704815|NCT00358670|Infliximab|infliximab|mesh-list
110704816|NCT00358670|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110704817|NCT00358670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110704818|NCT00358670|Dermatologic Agents|dermatologic agents|mesh-ancestor
110704819|NCT00358670|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110704820|NCT00358670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110704821|NCT01010087|Oseltamivir|oseltamivir|mesh-list
110704822|NCT01010087|Antiviral Agents|antiviral agents|mesh-ancestor
110704823|NCT01010087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110704824|NCT01010087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110704825|NCT01010087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110704826|NCT00505661|Letrozole|letrozole|mesh-list
110704827|NCT00505661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110704828|NCT00505661|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110704829|NCT00505661|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110704830|NCT00505661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110704831|NCT00505661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110704832|NCT00505661|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110704833|NCT00505661|Hormone Antagonists|hormone antagonists|mesh-ancestor
110704834|NCT00505661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110704835|NCT00505661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110704836|NCT00383786|Vofopitant|vofopitant|mesh-list
110704837|NCT00383786|Antiemetics|antiemetics|mesh-ancestor
110704838|NCT00383786|Autonomic Agents|autonomic agents|mesh-ancestor
110704839|NCT00383786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110704840|NCT00383786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110704841|NCT00383786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110704842|NCT00383786|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110704843|NCT00383786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110704844|NCT00383786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110704845|NCT05358977|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
110704846|NCT05358977|Hemostatics|hemostatics|mesh-ancestor
110164693|NCT00020917|Leucovorin|leucovorin|mesh-list
110704847|NCT05358977|Coagulants|coagulants|mesh-ancestor
110704848|NCT01010243|Pioglitazone|pioglitazone|mesh-list
110704849|NCT01010243|Dexamethasone|dexamethasone|mesh-list
110704850|NCT01010243|Lenalidomide|lenalidomide|mesh-list
110704851|NCT01010243|Treosulfan|treosulfan|mesh-list
110704852|NCT01010243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110704853|NCT01010243|Antiemetics|antiemetics|mesh-ancestor
110704854|NCT01010243|Autonomic Agents|autonomic agents|mesh-ancestor
110704855|NCT01010243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110704856|NCT01010243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110704857|NCT01010243|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110704858|NCT01010243|Glucocorticoids|glucocorticoids|mesh-ancestor
110704859|NCT01010243|Hormones|hormones|mesh-ancestor
110704860|NCT01010243|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110704861|NCT01010243|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110704862|NCT01010243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110704863|NCT01010243|Immunologic Factors|immunologic factors|mesh-ancestor
110704864|NCT01010243|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110704865|NCT01010243|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110704866|NCT01010243|Growth Substances|growth substances|mesh-ancestor
110704867|NCT01010243|Growth Inhibitors|growth inhibitors|mesh-ancestor
110704868|NCT01010243|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110704869|NCT01010243|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110704870|NCT01010243|Alkylating Agents|alkylating agents|mesh-ancestor
110704871|NCT01010243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110704872|NCT00383708|Lanreotide|lanreotide|mesh-list
110704873|NCT00383708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110704874|NCT00504881|Brivaracetam|brivaracetam|mesh-list
110704875|NCT00504881|Anticonvulsants|anticonvulsants|mesh-ancestor
110704876|NCT00504725|Ketamine|ketamine|mesh-list
110704877|NCT00504725|Analgesics|analgesics|mesh-ancestor
110704878|NCT00504725|Sensory System Agents|sensory system agents|mesh-ancestor
110704879|NCT00504725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110704880|NCT00504725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110704881|NCT00504725|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110704882|NCT00504725|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110704883|NCT00504725|Anesthetics, General|anesthetics, general|mesh-ancestor
110704884|NCT00504725|Anesthetics|anesthetics|mesh-ancestor
110704885|NCT00504725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110127675|NCT01951911|Anesthetics|anesthetics|mesh-ancestor
110704886|NCT00504725|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110704887|NCT00504725|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110704888|NCT00504725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110704889|NCT00504725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110704891|NCT00383240|Formoterol Fumarate|formoterol fumarate|mesh-list
110704892|NCT00383240|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110704893|NCT00383240|Autonomic Agents|autonomic agents|mesh-ancestor
110704894|NCT00383240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110704895|NCT00383240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110704896|NCT00383240|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110704897|NCT00383240|Respiratory System Agents|respiratory system agents|mesh-ancestor
110704898|NCT00383240|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110704899|NCT00383240|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110704900|NCT00383240|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110704901|NCT00383240|Adrenergic Agents|adrenergic agents|mesh-ancestor
110704902|NCT00383240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110704903|NCT00383240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110704904|NCT00383240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110704905|NCT00383240|Dermatologic Agents|dermatologic agents|mesh-ancestor
110704906|NCT00383240|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110704907|NCT05130788|Nicotine|nicotine|mesh-list
110704908|NCT05130788|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110704909|NCT05130788|Autonomic Agents|autonomic agents|mesh-ancestor
110704910|NCT05130788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110704911|NCT05130788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110704912|NCT05130788|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110704913|NCT05130788|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110704914|NCT05130788|Cholinergic Agents|cholinergic agents|mesh-ancestor
110704915|NCT05130788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110704916|NCT05130788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110704917|NCT00362180|Mipomersen|mipomersen|mesh-list
110704918|NCT00362180|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110704919|NCT00362180|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110704920|NCT00362180|Antimetabolites|antimetabolites|mesh-ancestor
110127770|NCT05876585|Serotonin Agents|serotonin agents|mesh-ancestor
110704921|NCT00362180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110704922|NCT00362180|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110704923|NCT00383162|Naproxen|naproxen|mesh-list
110704924|NCT00383162|Sumatriptan|sumatriptan|mesh-list
110704925|NCT00383162|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110704926|NCT00383162|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110704927|NCT00383162|Analgesics|analgesics|mesh-ancestor
110704928|NCT00383162|Sensory System Agents|sensory system agents|mesh-ancestor
110704929|NCT00383162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110704930|NCT00383162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110704931|NCT00383162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110704932|NCT00383162|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110704933|NCT00383162|Gout Suppressants|gout suppressants|mesh-ancestor
110704934|NCT00383162|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110704935|NCT00383162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110704936|NCT00383162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110704937|NCT00383162|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110704938|NCT00383162|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110704939|NCT00383162|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110704940|NCT00383162|Serotonin Agents|serotonin agents|mesh-ancestor
110704941|NCT00383162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110704942|NCT01052792|Naproxen|naproxen|mesh-list
110704943|NCT01052792|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110704944|NCT01052792|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110704945|NCT01052792|Analgesics|analgesics|mesh-ancestor
110704946|NCT01052792|Sensory System Agents|sensory system agents|mesh-ancestor
110127891|NCT05875285|Antimetabolites|antimetabolites|mesh-ancestor
110704947|NCT01052792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110704948|NCT01052792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110704949|NCT01052792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110704950|NCT01052792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110704951|NCT01052792|Gout Suppressants|gout suppressants|mesh-ancestor
110704952|NCT01052792|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110704953|NCT01052792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110704954|NCT01052792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110704955|NCT01052870|Finasteride|finasteride|mesh-list
110704956|NCT01052870|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
110704957|NCT01052870|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110704958|NCT01052870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110704959|NCT01052870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110704960|NCT01052870|Hormone Antagonists|hormone antagonists|mesh-ancestor
110704961|NCT01052870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110704962|NCT01052870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110704963|NCT01052870|Urological Agents|urological agents|mesh-ancestor
110704964|NCT00358436|Bromides|bromides|mesh-list
110704965|NCT00358436|Anticonvulsants|anticonvulsants|mesh-ancestor
110704966|NCT01053026|Olmesartan|olmesartan|mesh-list
110704967|NCT01053026|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110704968|NCT01053026|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110704969|NCT01053026|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110704970|NCT01053026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110704971|NCT01045538|Capecitabine|capecitabine|mesh-list
110704972|NCT01045538|Vorinostat|vorinostat|mesh-list
110704973|NCT01045538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110704974|NCT01045538|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110704975|NCT01045538|Antimetabolites|antimetabolites|mesh-ancestor
110704976|NCT01045538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110704977|NCT01045538|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110704978|NCT01045538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110704979|NCT00361634|Etanercept|etanercept|mesh-list
110704980|NCT00361634|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110704981|NCT00361634|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110704982|NCT00361634|Analgesics|analgesics|mesh-ancestor
110704983|NCT00361634|Sensory System Agents|sensory system agents|mesh-ancestor
110704984|NCT00361634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110704985|NCT00361634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110704986|NCT00361634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110704987|NCT00361634|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110704988|NCT00361634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110704989|NCT00361634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110704990|NCT00361634|Immunologic Factors|immunologic factors|mesh-ancestor
110704991|NCT00357968|Clopidogrel|clopidogrel|mesh-list
110704992|NCT00357968|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
110704993|NCT00357968|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110704994|NCT00357968|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110704995|NCT00357968|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110704996|NCT00357968|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110704997|NCT00357968|Purinergic Agents|purinergic agents|mesh-ancestor
110704998|NCT00357968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110704999|NCT00357968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110705000|NCT00357968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110705002|NCT00357656|Coagulants|coagulants|mesh-ancestor
110705003|NCT00357500|Thalidomide|thalidomide|mesh-list
110705004|NCT00357500|Celecoxib|celecoxib|mesh-list
110705005|NCT00357500|Cyclophosphamide|cyclophosphamide|mesh-list
110705006|NCT00357500|Etoposide|etoposide|mesh-list
110705007|NCT00357500|Fenofibrate|fenofibrate|mesh-list
110705008|NCT00357500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110705009|NCT00357500|Immunologic Factors|immunologic factors|mesh-ancestor
110705010|NCT00357500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110705011|NCT00357500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110705012|NCT00357500|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110705013|NCT00357500|Alkylating Agents|alkylating agents|mesh-ancestor
110705014|NCT00357500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110705025|NCT00357500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110705026|NCT00357500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110705027|NCT00357500|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110705028|NCT00357500|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110705029|NCT00357500|Leprostatic Agents|leprostatic agents|mesh-ancestor
110705030|NCT00357500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110705031|NCT00357500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110705032|NCT00357500|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110705033|NCT00357500|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110705034|NCT00357500|Growth Substances|growth substances|mesh-ancestor
110705035|NCT00357500|Growth Inhibitors|growth inhibitors|mesh-ancestor
110705036|NCT00357500|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110705037|NCT00357500|Antimetabolites|antimetabolites|mesh-ancestor
110705038|NCT00357500|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110705039|NCT00357110|Fulvestrant|fulvestrant|mesh-list
110705040|NCT00357110|Anastrozole|anastrozole|mesh-list
110128119|NCT05790161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110705041|NCT00357110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110705042|NCT00357110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110705043|NCT00357110|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110705044|NCT00357110|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110705045|NCT00357110|Hormone Antagonists|hormone antagonists|mesh-ancestor
110705046|NCT00357110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110705047|NCT00357110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110705048|NCT00357110|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110705049|NCT00357110|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110705050|NCT00357110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110705051|NCT00357110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110705062|NCT00098722|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110705063|NCT00098722|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110705064|NCT00098722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110705065|NCT00098722|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110705066|NCT00098722|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110705067|NCT00098722|Antiviral Agents|antiviral agents|mesh-ancestor
110705068|NCT00098722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110705069|NCT00098722|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
110705070|NCT02531152|Latanoprost|latanoprost|mesh-list
110705071|NCT02531152|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110705072|NCT02531152|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110705073|NCT01084408|Paclitaxel|paclitaxel|mesh-list
110705074|NCT01084408|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110128200|NCT05641467|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110705075|NCT01084408|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110705076|NCT01084408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110705077|NCT01084408|Tubulin Modulators|tubulin modulators|mesh-ancestor
110705078|NCT01084408|Antimitotic Agents|antimitotic agents|mesh-ancestor
110705079|NCT01084408|Mitosis Modulators|mitosis modulators|mesh-ancestor
110705080|NCT01084408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110705081|NCT00098254|Sorafenib|sorafenib|mesh-list
110705082|NCT00098254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110705083|NCT00098254|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110705084|NCT00098254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110705085|NCT00098254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110705086|NCT00095056|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110705087|NCT00095056|Glipizide|glipizide|mesh-list
110705089|NCT00095056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110705090|NCT00095056|Incretins|incretins|mesh-ancestor
110705091|NCT00095056|Hormones|hormones|mesh-ancestor
110443677|NCT00872599|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110128257|NCT05463861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110705092|NCT00095056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110705093|NCT00095056|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110705095|NCT00095056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110705096|NCT00095056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110705097|NCT00098020|Isotretinoin|isotretinoin|mesh-list
110705098|NCT00098020|Dermatologic Agents|dermatologic agents|mesh-ancestor
110705099|NCT00381680|Leucovorin|leucovorin|mesh-list
110705100|NCT00381680|Cytarabine|cytarabine|mesh-list
110705101|NCT00381680|Dexamethasone|dexamethasone|mesh-list
110705102|NCT00381680|Prednisone|prednisone|mesh-list
110705103|NCT00381680|Cyclophosphamide|cyclophosphamide|mesh-list
110705104|NCT00381680|Doxorubicin|doxorubicin|mesh-list
110705105|NCT00381680|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110705106|NCT00381680|Methotrexate|methotrexate|mesh-list
110705107|NCT00381680|Etoposide|etoposide|mesh-list
110705108|NCT00381680|Vincristine|vincristine|mesh-list
110705109|NCT00381680|Etoposide phosphate|etoposide phosphate|mesh-list
110705110|NCT00381680|Asparaginase|asparaginase|mesh-list
110705111|NCT00381680|Mercaptopurine|mercaptopurine|mesh-list
110705112|NCT00381680|Pegaspargase|pegaspargase|mesh-list
110705113|NCT00381680|Levoleucovorin|levoleucovorin|mesh-list
110705114|NCT00381680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110705115|NCT00381680|Immunologic Factors|immunologic factors|mesh-ancestor
110705116|NCT00381680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110705117|NCT00381680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110705118|NCT00381680|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110705119|NCT00381680|Alkylating Agents|alkylating agents|mesh-ancestor
110705120|NCT00381680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110705121|NCT00381680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110705122|NCT00381680|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110705123|NCT00381680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110705124|NCT00381680|Antiemetics|antiemetics|mesh-ancestor
110705125|NCT00381680|Autonomic Agents|autonomic agents|mesh-ancestor
110705126|NCT00381680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110705127|NCT00381680|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110705128|NCT00381680|Glucocorticoids|glucocorticoids|mesh-ancestor
110705129|NCT00381680|Hormones|hormones|mesh-ancestor
110128387|NCT04994431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110705130|NCT00381680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110705131|NCT00381680|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110705132|NCT00381680|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110705133|NCT00381680|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110705134|NCT00381680|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110705135|NCT00381680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110705136|NCT00381680|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110705137|NCT00381680|Abortifacient Agents|abortifacient agents|mesh-ancestor
110705138|NCT00381680|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110705139|NCT00381680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110705140|NCT00381680|Antimetabolites|antimetabolites|mesh-ancestor
110705141|NCT00381680|Dermatologic Agents|dermatologic agents|mesh-ancestor
110705142|NCT00381680|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110705143|NCT00381680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110705144|NCT00381680|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110705145|NCT00381680|Antiviral Agents|antiviral agents|mesh-ancestor
110705146|NCT00381680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110705147|NCT00381680|Antidotes|antidotes|mesh-ancestor
110128443|NCT04756401|Ichthammol|ichthammol|mesh-list
110705148|NCT00381680|Protective Agents|protective agents|mesh-ancestor
110705149|NCT00381680|Vitamin B Complex|vitamin b complex|mesh-ancestor
110705150|NCT00381680|Vitamins|vitamins|mesh-ancestor
110705151|NCT00381680|Micronutrients|micronutrients|mesh-ancestor
110705152|NCT00381680|Tubulin Modulators|tubulin modulators|mesh-ancestor
110705153|NCT00381680|Antimitotic Agents|antimitotic agents|mesh-ancestor
110705154|NCT00381680|Mitosis Modulators|mitosis modulators|mesh-ancestor
110705155|NCT03292250|Durvalumab|durvalumab|mesh-list
110705156|NCT03292250|Tremelimumab|tremelimumab|mesh-list
110705157|NCT03292250|Nintedanib|nintedanib|mesh-list
110705158|NCT03292250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110705159|NCT03292250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110705160|NCT03292250|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110705161|NCT03292250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110128499|NCT04507217|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110705162|NCT03292250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110705163|NCT01053338|Diphenhydramine|diphenhydramine|mesh-list
110705164|NCT01053338|Promethazine|promethazine|mesh-list
110705165|NCT01053338|Ibuprofen|ibuprofen|mesh-list
110705166|NCT01053338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110705167|NCT01053338|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110705168|NCT01053338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110705169|NCT01053338|Analgesics|analgesics|mesh-ancestor
110705170|NCT01053338|Sensory System Agents|sensory system agents|mesh-ancestor
110705171|NCT01053338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110705172|NCT01053338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110705173|NCT01053338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110705174|NCT01053338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110705175|NCT01053338|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110705176|NCT01053338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110705177|NCT01053338|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110705178|NCT01053338|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110705179|NCT01053338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110705180|NCT01053338|Anesthetics, Local|anesthetics, local|mesh-ancestor
110705181|NCT01053338|Anesthetics|anesthetics|mesh-ancestor
110705182|NCT01053338|Antiemetics|antiemetics|mesh-ancestor
110705183|NCT01053338|Autonomic Agents|autonomic agents|mesh-ancestor
110705184|NCT01053338|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110705185|NCT01053338|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110705186|NCT01053338|Histamine Antagonists|histamine antagonists|mesh-ancestor
110705187|NCT01053338|Histamine Agents|histamine agents|mesh-ancestor
110705188|NCT01053338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110705189|NCT01053338|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110705190|NCT01053338|Antipruritics|antipruritics|mesh-ancestor
110705191|NCT01053338|Dermatologic Agents|dermatologic agents|mesh-ancestor
110705192|NCT01050374|Albendazole|albendazole|mesh-list
110705193|NCT01050374|Praziquantel|praziquantel|mesh-list
110705194|NCT01050374|Mebendazole|mebendazole|mesh-list
110705195|NCT01050374|Piperazine|piperazine|mesh-list
110705196|NCT01050374|Piperazine citrate|piperazine citrate|mesh-list
110705197|NCT01050374|DMP 777|dmp 777|mesh-list
110705199|NCT01050374|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110705200|NCT01050374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110705201|NCT01050374|Anticestodal Agents|anticestodal agents|mesh-ancestor
110705202|NCT01050374|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110705203|NCT01050374|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110705204|NCT01050374|Tubulin Modulators|tubulin modulators|mesh-ancestor
110705205|NCT01050374|Antimitotic Agents|antimitotic agents|mesh-ancestor
110705206|NCT01050374|Mitosis Modulators|mitosis modulators|mesh-ancestor
110705207|NCT01050374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110705208|NCT01050374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110705209|NCT01050374|Antinematodal Agents|antinematodal agents|mesh-ancestor
110705210|NCT01050374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110705211|NCT00360698|Insulin|insulin|mesh-list
110705212|NCT00360698|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110705213|NCT00360698|Metformin|metformin|mesh-list
110705214|NCT00360698|Insulin Glargine|insulin glargine|mesh-list
110705215|NCT00360698|Glimepiride|glimepiride|mesh-list
110705216|NCT00360698|Insulin glulisine|insulin glulisine|mesh-list
110705217|NCT00360698|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110705218|NCT00360698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110705219|NCT00360698|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110705220|NCT00360698|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110705221|NCT00360698|Immunologic Factors|immunologic factors|mesh-ancestor
110705222|NCT03990194|Leuprolide|leuprolide|mesh-list
110705223|NCT03990194|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110705224|NCT03990194|Fertility Agents|fertility agents|mesh-ancestor
110705225|NCT03990194|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110705226|NCT03990194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110705227|NCT03990194|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110705228|NCT03990194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110705229|NCT00380978|Narcotics|narcotics|mesh-list
110705230|NCT00380978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110705231|NCT00380978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110705232|NCT00380978|Analgesics|analgesics|mesh-ancestor
110705233|NCT00380978|Sensory System Agents|sensory system agents|mesh-ancestor
110705234|NCT00380978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110705235|NCT00162123|Ipilimumab|ipilimumab|mesh-list
110705236|NCT00162123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110705237|NCT00162123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110705238|NCT00162123|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110705239|NCT00162123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110705240|NCT00227721|Gemcitabine|gemcitabine|mesh-list
110705241|NCT00227721|Docetaxel|docetaxel|mesh-list
110705242|NCT00227721|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110705243|NCT00227721|Antimetabolites|antimetabolites|mesh-ancestor
110705244|NCT00227721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110705246|NCT00227721|Tubulin Modulators|tubulin modulators|mesh-ancestor
110705247|NCT00227721|Antimitotic Agents|antimitotic agents|mesh-ancestor
110705248|NCT00227721|Mitosis Modulators|mitosis modulators|mesh-ancestor
110705249|NCT01074723|Carotenoids|carotenoids|mesh-list
110705250|NCT01074723|Antioxidants|antioxidants|mesh-ancestor
110705251|NCT01074723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110705252|NCT01074723|Protective Agents|protective agents|mesh-ancestor
110705253|NCT01074723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110705254|NCT01074801|Insulin|insulin|mesh-list
110705255|NCT01074801|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110705256|NCT01074801|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110705257|NCT01074801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110705258|NCT01074879|Caseins|caseins|mesh-list
110705259|NCT01074879|Chelating Agents|chelating agents|mesh-ancestor
110705260|NCT01074879|Sequestering Agents|sequestering agents|mesh-ancestor
110705261|NCT01074879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110705262|NCT00226941|Diphenhydramine|diphenhydramine|mesh-list
110705263|NCT00226941|Promethazine|promethazine|mesh-list
110705264|NCT00226941|Capecitabine|capecitabine|mesh-list
110705265|NCT00226941|Oxaliplatin|oxaliplatin|mesh-list
110705266|NCT00226941|Cetuximab|cetuximab|mesh-list
110705267|NCT00226941|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110705268|NCT00226941|Antimetabolites|antimetabolites|mesh-ancestor
110705269|NCT00226941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110705270|NCT00226941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110705271|NCT00226941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110705272|NCT00226941|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110705273|NCT00226941|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110705274|NCT00226941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110705275|NCT00226941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110705276|NCT00226941|Anesthetics, Local|anesthetics, local|mesh-ancestor
110705277|NCT00226941|Anesthetics|anesthetics|mesh-ancestor
110705278|NCT00226941|Sensory System Agents|sensory system agents|mesh-ancestor
110129026|NCT02106572|Mitomycins|mitomycins|mesh-list
110705279|NCT00226941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110705280|NCT00226941|Antiemetics|antiemetics|mesh-ancestor
110705281|NCT00226941|Autonomic Agents|autonomic agents|mesh-ancestor
110705282|NCT00226941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110705283|NCT00226941|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110705284|NCT00226941|Histamine Antagonists|histamine antagonists|mesh-ancestor
110705285|NCT00226941|Histamine Agents|histamine agents|mesh-ancestor
110705286|NCT00226941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110705287|NCT00226941|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110705288|NCT00226941|Antipruritics|antipruritics|mesh-ancestor
110705289|NCT00226941|Dermatologic Agents|dermatologic agents|mesh-ancestor
110705290|NCT01075503|Ropivacaine|ropivacaine|mesh-list
110705291|NCT01075503|Anesthetics, Local|anesthetics, local|mesh-ancestor
110705292|NCT01075503|Anesthetics|anesthetics|mesh-ancestor
110705293|NCT01075503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110705294|NCT01075503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110705295|NCT01075503|Sensory System Agents|sensory system agents|mesh-ancestor
110129151|NCT01952951|Oxaliplatin|oxaliplatin|mesh-list
110705296|NCT01075503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110705297|NCT01075581|Epinephrine|epinephrine|mesh-list
110705298|NCT01075581|Racepinephrine|racepinephrine|mesh-list
110705299|NCT01075581|Epinephryl borate|epinephryl borate|mesh-list
110705300|NCT01075581|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110705301|NCT01075581|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110705302|NCT01075581|Adrenergic Agents|adrenergic agents|mesh-ancestor
110705303|NCT01075581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110705304|NCT01075581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110705305|NCT01075581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110705306|NCT01075581|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110705307|NCT01075581|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110705308|NCT01075581|Autonomic Agents|autonomic agents|mesh-ancestor
110705309|NCT01075581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110705310|NCT01075581|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110705311|NCT01075581|Respiratory System Agents|respiratory system agents|mesh-ancestor
110705312|NCT01075581|Mydriatics|mydriatics|mesh-ancestor
110705313|NCT01075581|Sympathomimetics|sympathomimetics|mesh-ancestor
110705314|NCT01075581|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110705315|NCT00356408|Certolizumab Pegol|certolizumab pegol|mesh-list
110705316|NCT00356408|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110705317|NCT00356408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110705318|NCT00356408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110705319|NCT00356408|Immunologic Factors|immunologic factors|mesh-ancestor
110705320|NCT00356408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110705321|NCT00356408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110705322|NCT00509795|Ranibizumab|ranibizumab|mesh-list
110705323|NCT00509795|Aflibercept|aflibercept|mesh-list
110705324|NCT00509795|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110705325|NCT00509795|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110705326|NCT00509795|Growth Substances|growth substances|mesh-ancestor
110705327|NCT00509795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110705328|NCT00509795|Growth Inhibitors|growth inhibitors|mesh-ancestor
110705329|NCT00509795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110705330|NCT00504257|Bevacizumab|bevacizumab|mesh-list
110705331|NCT00504257|Docetaxel|docetaxel|mesh-list
110705332|NCT00504257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110705333|NCT00504257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110705334|NCT00504257|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110705335|NCT00504257|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110705336|NCT00504257|Growth Substances|growth substances|mesh-ancestor
110705337|NCT00504257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110705338|NCT00504257|Growth Inhibitors|growth inhibitors|mesh-ancestor
110705339|NCT00504257|Tubulin Modulators|tubulin modulators|mesh-ancestor
110705340|NCT00504257|Antimitotic Agents|antimitotic agents|mesh-ancestor
110705341|NCT00504257|Mitosis Modulators|mitosis modulators|mesh-ancestor
110705342|NCT00504257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110705343|NCT00509093|Imatinib Mesylate|imatinib mesylate|mesh-list
110705344|NCT00509093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110705345|NCT00509093|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110705346|NCT00509093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110705347|NCT00509093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110705348|NCT05358509|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
110705349|NCT05358509|Ferric Compounds|ferric compounds|mesh-list
110129338|NCT01953952|Cisplatin|cisplatin|mesh-list
110705350|NCT05358509|Hematinics|hematinics|mesh-ancestor
110705351|NCT00160641|Certolizumab Pegol|certolizumab pegol|mesh-list
110705352|NCT00160641|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110705353|NCT00160641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110705354|NCT00160641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110705355|NCT00160641|Immunologic Factors|immunologic factors|mesh-ancestor
110705356|NCT00160641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110705357|NCT00160641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110705358|NCT00493025|Paclitaxel|paclitaxel|mesh-list
110705359|NCT00493025|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110705360|NCT00493025|Cisplatin|cisplatin|mesh-list
110705361|NCT00493025|Gefitinib|gefitinib|mesh-list
110705362|NCT00493025|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110705363|NCT00493025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110705364|NCT00493025|Tubulin Modulators|tubulin modulators|mesh-ancestor
110705365|NCT00493025|Antimitotic Agents|antimitotic agents|mesh-ancestor
110705366|NCT00493025|Mitosis Modulators|mitosis modulators|mesh-ancestor
110705367|NCT00493025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110705368|NCT00493025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110705369|NCT00493025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110705370|NCT01075113|Sorafenib|sorafenib|mesh-list
110705371|NCT01075113|Vorinostat|vorinostat|mesh-list
110705372|NCT01075113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110705373|NCT01075113|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110705374|NCT01075113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110705375|NCT01075113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110705376|NCT01075113|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110705377|NCT01073319|Rivastigmine|rivastigmine|mesh-list
110705378|NCT01073319|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110705379|NCT01073319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110705380|NCT01073319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110705381|NCT01073319|Cholinergic Agents|cholinergic agents|mesh-ancestor
110705382|NCT01073319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110705383|NCT01073319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110705384|NCT01073319|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110705385|NCT01073319|Protective Agents|protective agents|mesh-ancestor
110705386|NCT00160563|Levocetirizine|levocetirizine|mesh-list
110705387|NCT00160563|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110705388|NCT00160563|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110705389|NCT00160563|Histamine Antagonists|histamine antagonists|mesh-ancestor
110705390|NCT00160563|Histamine Agents|histamine agents|mesh-ancestor
110705391|NCT00160563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110705392|NCT00160563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110705393|NCT00160563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110705394|NCT01050452|Ivermectin|ivermectin|mesh-list
110705395|NCT01050452|Albendazole|albendazole|mesh-list
110705396|NCT01050452|Mebendazole|mebendazole|mesh-list
110705398|NCT01050452|Piperazine citrate|piperazine citrate|mesh-list
110705399|NCT01050452|DMP 777|dmp 777|mesh-list
110705400|NCT01050452|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110705401|NCT01050452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110705402|NCT01050452|Anthelmintics|anthelmintics|mesh-ancestor
110705403|NCT01050452|Anticestodal Agents|anticestodal agents|mesh-ancestor
110705404|NCT01050452|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110705405|NCT01050452|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110705406|NCT01050452|Tubulin Modulators|tubulin modulators|mesh-ancestor
110705407|NCT01050452|Antimitotic Agents|antimitotic agents|mesh-ancestor
110860397|NCT04726332|Prednisone|prednisone|mesh-list
110705408|NCT01050452|Mitosis Modulators|mitosis modulators|mesh-ancestor
110705409|NCT01050452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110705410|NCT01050452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110705411|NCT01050452|Antinematodal Agents|antinematodal agents|mesh-ancestor
110705412|NCT01050452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110705413|NCT00380588|Gemcitabine|gemcitabine|mesh-list
110705414|NCT00380588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110705415|NCT00380588|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110705416|NCT00380588|Antimetabolites|antimetabolites|mesh-ancestor
110705417|NCT00380588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110705418|NCT00379808|Montelukast|montelukast|mesh-list
110705419|NCT00379808|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110705420|NCT00379808|Respiratory System Agents|respiratory system agents|mesh-ancestor
110705421|NCT00379808|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110705422|NCT00379808|Hormone Antagonists|hormone antagonists|mesh-ancestor
110705423|NCT00379808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110705424|NCT00379808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110705425|NCT00379808|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110705426|NCT00379808|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110705427|NCT00379808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110705428|NCT03990038|Ropivacaine|ropivacaine|mesh-list
110705429|NCT03990038|Anesthetics, Local|anesthetics, local|mesh-ancestor
110705430|NCT03990038|Anesthetics|anesthetics|mesh-ancestor
110705431|NCT03990038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110705432|NCT03990038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110705433|NCT03990038|Sensory System Agents|sensory system agents|mesh-ancestor
110705434|NCT03990038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110705435|NCT00355784|Hormones|hormones|mesh-list
110705436|NCT00355784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110705437|NCT00355784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110705438|NCT02534636|Interferons|interferons|mesh-list
110705439|NCT02534636|Interferon-alpha|interferon-alpha|mesh-list
110705440|NCT02534636|Interferon alpha-2|interferon alpha-2|mesh-list
110705441|NCT02534636|Deucravacitinib|deucravacitinib|mesh-list
110705442|NCT02534636|Famotidine|famotidine|mesh-list
110705443|NCT02534636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110705444|NCT02534636|Antiviral Agents|antiviral agents|mesh-ancestor
110705445|NCT02534636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110705446|NCT02534636|Immunologic Factors|immunologic factors|mesh-ancestor
110705447|NCT02534636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110705448|NCT02534636|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110705449|NCT02534636|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110705450|NCT02534636|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110705451|NCT02534636|Histamine Antagonists|histamine antagonists|mesh-ancestor
110705452|NCT02534636|Histamine Agents|histamine agents|mesh-ancestor
110705453|NCT02534636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110705454|NCT02534636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110705455|NCT02534636|Dermatologic Agents|dermatologic agents|mesh-ancestor
110705456|NCT02534636|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110705457|NCT02534636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110705458|NCT01053650|Acetaminophen|acetaminophen|mesh-list
110705459|NCT01053650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110705460|NCT01053650|Analgesics|analgesics|mesh-ancestor
110129823|NCT01956981|Analgesics|analgesics|mesh-ancestor
110705461|NCT01053650|Sensory System Agents|sensory system agents|mesh-ancestor
110705462|NCT01053650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110705463|NCT01053650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110705464|NCT01053650|Antipyretics|antipyretics|mesh-ancestor
110705465|NCT01053728|Insulin Glargine|insulin glargine|mesh-list
110705466|NCT01053728|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110705467|NCT01053728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110705468|NCT01050608|Ethanol|ethanol|mesh-list
110705469|NCT01050608|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110423300|NCT02795065|Enoxaparin|enoxaparin|mesh-list
110705471|NCT01050608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110705472|NCT01050608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110860401|NCT04726332|Hormones|hormones|mesh-ancestor
110705473|NCT01053806|Lenalidomide|lenalidomide|mesh-list
110705474|NCT01053806|Azacitidine|azacitidine|mesh-list
110705475|NCT01053806|Immunologic Factors|immunologic factors|mesh-ancestor
110705476|NCT01053806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110705477|NCT01053806|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110705478|NCT01053806|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110705479|NCT01053806|Growth Substances|growth substances|mesh-ancestor
110705480|NCT01053806|Growth Inhibitors|growth inhibitors|mesh-ancestor
110705481|NCT01053806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110705482|NCT01053806|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110705483|NCT01053806|Antimetabolites|antimetabolites|mesh-ancestor
110705484|NCT01053806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110705485|NCT01053806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110705486|NCT00355472|Mogamulizumab|mogamulizumab|mesh-list
110705487|NCT00355472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110705488|NCT01053884|Anidulafungin|anidulafungin|mesh-list
110705489|NCT01053884|Antifungal Agents|antifungal agents|mesh-ancestor
110705490|NCT01053884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110705491|NCT00492557|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110705492|NCT00492557|Immunologic Factors|immunologic factors|mesh-ancestor
110705493|NCT00492557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110705494|NCT01010789|Modafinil|modafinil|mesh-list
110705495|NCT01010789|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110705496|NCT01010789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110705497|NCT01010789|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
110705498|NCT01010789|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110705499|NCT01010789|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110705500|NCT01010789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110705501|NCT01015235|Ketorolac|ketorolac|mesh-list
110705502|NCT01015235|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
110705503|NCT01015235|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110705504|NCT01015235|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110705505|NCT01015235|Analgesics|analgesics|mesh-ancestor
110705506|NCT01015235|Sensory System Agents|sensory system agents|mesh-ancestor
110705507|NCT01015235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110705508|NCT01015235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110705509|NCT01015235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110705510|NCT01015235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110705511|NCT01015235|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110705512|NCT01015235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110705513|NCT01015235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110705514|NCT00508157|Olanzapine|olanzapine|mesh-list
110705515|NCT00508157|Risperidone|risperidone|mesh-list
110705516|NCT00508157|Aripiprazole|aripiprazole|mesh-list
110705517|NCT00508157|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110705518|NCT00508157|Antipsychotic Agents|antipsychotic agents|mesh-list
110705519|NCT00508157|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110705520|NCT00508157|Serotonin Agents|serotonin agents|mesh-ancestor
110705521|NCT00508157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110705522|NCT00508157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110705523|NCT00508157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110705524|NCT00508157|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110705525|NCT00508157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110705526|NCT00508157|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110705527|NCT00508157|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110705528|NCT00508157|Dopamine Agents|dopamine agents|mesh-ancestor
110705529|NCT00508157|Antiemetics|antiemetics|mesh-ancestor
110705530|NCT00508157|Autonomic Agents|autonomic agents|mesh-ancestor
110705531|NCT00508157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110705532|NCT00508157|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110705533|NCT00508157|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110705534|NCT00508157|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110705535|NCT00508157|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110705536|NCT00508157|Antidepressive Agents|antidepressive agents|mesh-ancestor
110705537|NCT00508157|Dopamine Agonists|dopamine agonists|mesh-ancestor
110705538|NCT00508157|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110705539|NCT00508157|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110705540|NCT00508157|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110335305|NCT00495092|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110705541|NCT00508157|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110705542|NCT04331717|Leuprolide|leuprolide|mesh-list
110705543|NCT04331717|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110423372|NCT02797717|Hormones|hormones|mesh-ancestor
110705544|NCT04331717|Fertility Agents|fertility agents|mesh-ancestor
110705545|NCT04331717|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110705546|NCT04331717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110705547|NCT04331717|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110705548|NCT04331717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110705549|NCT01015391|Azathioprine|azathioprine|mesh-list
110705550|NCT01015391|Antimetabolites|antimetabolites|mesh-ancestor
110705551|NCT01015391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110705552|NCT01015391|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110705553|NCT01015391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110705554|NCT01015391|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110705555|NCT01015391|Immunologic Factors|immunologic factors|mesh-ancestor
110705556|NCT01015391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110705557|NCT01015391|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110705558|NCT01010945|Paclitaxel|paclitaxel|mesh-list
110705559|NCT01010945|Gemcitabine|gemcitabine|mesh-list
110705560|NCT01010945|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110705561|NCT01010945|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110705562|NCT01010945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110130265|NCT01960426|Adalimumab|adalimumab|mesh-list
110705563|NCT01010945|Tubulin Modulators|tubulin modulators|mesh-ancestor
110705564|NCT01010945|Antimitotic Agents|antimitotic agents|mesh-ancestor
110705565|NCT01010945|Mitosis Modulators|mitosis modulators|mesh-ancestor
110705566|NCT01010945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110705567|NCT01010945|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110705568|NCT01010945|Antimetabolites|antimetabolites|mesh-ancestor
110705569|NCT01010945|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110705570|NCT01010945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110705571|NCT00507689|Immunoglobulins|immunoglobulins|mesh-list
110705572|NCT00507689|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110705573|NCT00507689|Antibodies|antibodies|mesh-list
110705574|NCT00507689|Immunologic Factors|immunologic factors|mesh-ancestor
110705575|NCT00507689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110705576|NCT00491387|Metoprolol|metoprolol|mesh-list
110705577|NCT00491387|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110705578|NCT00491387|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110705579|NCT00491387|Sympatholytics|sympatholytics|mesh-ancestor
110705580|NCT00491387|Autonomic Agents|autonomic agents|mesh-ancestor
110705581|NCT00491387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110705582|NCT00491387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110705583|NCT00491387|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110705584|NCT00491387|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110705585|NCT00491387|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110705586|NCT00491387|Adrenergic Agents|adrenergic agents|mesh-ancestor
110705587|NCT00491387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110705588|NCT00491387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110705589|NCT01011257|Clopidogrel|clopidogrel|mesh-list
110705590|NCT01011257|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110705591|NCT01011257|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110130362|NCT01961388|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110705592|NCT01011257|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110705593|NCT01011257|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110705594|NCT01011257|Purinergic Agents|purinergic agents|mesh-ancestor
110705595|NCT01011257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110705596|NCT01011257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110705597|NCT01011257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110705598|NCT01015547|Sulfasalazine|sulfasalazine|mesh-list
110705599|NCT01015547|Infliximab|infliximab|mesh-list
110705600|NCT01015547|Methotrexate|methotrexate|mesh-list
110705601|NCT01015547|Naltrexone|naltrexone|mesh-list
110705602|NCT01015547|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110705603|NCT01015547|Abortifacient Agents|abortifacient agents|mesh-ancestor
110705604|NCT01015547|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110705605|NCT01015547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110860414|NCT04720963|Analgesics|analgesics|mesh-ancestor
110705606|NCT01015547|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110705607|NCT01015547|Antimetabolites|antimetabolites|mesh-ancestor
110705608|NCT01015547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110705609|NCT01015547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110705610|NCT01015547|Dermatologic Agents|dermatologic agents|mesh-ancestor
110705611|NCT01015547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110705612|NCT01015547|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110705613|NCT01015547|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110705614|NCT01015547|Immunologic Factors|immunologic factors|mesh-ancestor
110423448|NCT02792335|Antithrombins|antithrombins|mesh-ancestor
110705615|NCT01015547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110705616|NCT01015547|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110705617|NCT01015547|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110705618|NCT01015547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110705619|NCT01015547|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110705620|NCT01015547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110705621|NCT01015547|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110705622|NCT01015547|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110705623|NCT01015547|Analgesics|analgesics|mesh-ancestor
110705624|NCT01015547|Sensory System Agents|sensory system agents|mesh-ancestor
110705625|NCT01015547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110705626|NCT01015547|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110705627|NCT01015547|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110705628|NCT00491075|Gemcitabine|gemcitabine|mesh-list
110705630|NCT00491075|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110705631|NCT00491075|Antimetabolites|antimetabolites|mesh-ancestor
110705632|NCT00491075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110705633|NCT00491075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110705634|NCT00491075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110705635|NCT00491075|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110705636|NCT00491075|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110705637|NCT00507455|Tamsulosin|tamsulosin|mesh-list
110705638|NCT00507455|Solifenacin Succinate|solifenacin succinate|mesh-list
110705639|NCT00507455|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110705640|NCT00507455|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110705641|NCT00507455|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110705642|NCT00507455|Adrenergic Agents|adrenergic agents|mesh-ancestor
110705643|NCT00507455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110705644|NCT00507455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110705645|NCT00507455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110705646|NCT00507455|Urological Agents|urological agents|mesh-ancestor
110705647|NCT00507455|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110705648|NCT00507455|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110705649|NCT00507455|Cholinergic Agents|cholinergic agents|mesh-ancestor
110705650|NCT04275713|Metformin|metformin|mesh-list
110705651|NCT04275713|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110705652|NCT04275713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110705653|NCT00506831|Imatinib Mesylate|imatinib mesylate|mesh-list
110705654|NCT00506831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110705655|NCT00506831|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110705656|NCT00506831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110705657|NCT00506831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110705658|NCT00490919|Buprenorphine|buprenorphine|mesh-list
110705659|NCT00490919|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110705660|NCT00490919|Narcotics|narcotics|mesh-ancestor
110705661|NCT00490919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110705662|NCT00490919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110705663|NCT00490919|Analgesics|analgesics|mesh-ancestor
110705664|NCT00490919|Sensory System Agents|sensory system agents|mesh-ancestor
110705665|NCT00490919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110705666|NCT00490919|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110705667|NCT01015937|Losartan|losartan|mesh-list
110705668|NCT01015937|Enalapril|enalapril|mesh-list
110705669|NCT01015937|Angiotensin II|angiotensin ii|mesh-list
110705670|NCT01015937|Giapreza|giapreza|mesh-list
110705671|NCT01015937|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
110705672|NCT01015937|Angiotensinogen|angiotensinogen|mesh-list
110705673|NCT01015937|Turmeric extract|turmeric extract|mesh-list
110705674|NCT01015937|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110705675|NCT01015937|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110705676|NCT01015937|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110705677|NCT01015937|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110705678|NCT01015937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110705679|NCT01015937|Protease Inhibitors|protease inhibitors|mesh-ancestor
110705680|NCT01015937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110705681|NCT01015937|Antioxidants|antioxidants|mesh-ancestor
110705682|NCT01015937|Protective Agents|protective agents|mesh-ancestor
110705683|NCT01015937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110705684|NCT01015937|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110705685|NCT01015937|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110705686|NCT01012193|Cilostazol|cilostazol|mesh-list
110705687|NCT01012193|Clopidogrel|clopidogrel|mesh-list
110705688|NCT01012193|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110705689|NCT01012193|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110705690|NCT01012193|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110423525|NCT01196052|Immunotoxins|immunotoxins|mesh-ancestor
110705691|NCT01012193|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110705693|NCT01012193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110705694|NCT01012193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110705695|NCT01012193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110705696|NCT01012193|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110705697|NCT01012193|Autonomic Agents|autonomic agents|mesh-ancestor
110705698|NCT01012193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110705699|NCT01012193|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110705700|NCT01012193|Respiratory System Agents|respiratory system agents|mesh-ancestor
110705701|NCT01012193|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110705702|NCT01012193|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110705703|NCT01012193|Vasodilator Agents|vasodilator agents|mesh-ancestor
110705704|NCT01012193|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110705705|NCT01012193|Protective Agents|protective agents|mesh-ancestor
110705706|NCT01012193|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110705707|NCT01012193|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110705708|NCT01012193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110705709|NCT00503399|Teriparatide|teriparatide|mesh-list
110705710|NCT00503399|Risedronic Acid|risedronic acid|mesh-list
110705711|NCT00503399|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110705712|NCT00503399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110705713|NCT00503399|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110705714|NCT00503399|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110705715|NCT00503399|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110705716|NCT00503399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110705717|NCT00506519|Antithrombins|antithrombins|mesh-list
110705718|NCT00506519|Antithrombin III|antithrombin iii|mesh-list
110705719|NCT00506519|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110443689|NCT00693589|Folic Acid|folic acid|mesh-list
110130933|NCT01965080|Exemestane|exemestane|mesh-list
110705720|NCT00506519|Protease Inhibitors|protease inhibitors|mesh-ancestor
110705721|NCT00506519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110705722|NCT00506519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110705723|NCT00506519|Anticoagulants|anticoagulants|mesh-ancestor
110705724|NCT00503009|Fluticasone|fluticasone|mesh-list
110705725|NCT00503009|Xhance|xhance|mesh-list
110705726|NCT00503009|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110705727|NCT00503009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110705728|NCT00503009|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110705729|NCT00503009|Autonomic Agents|autonomic agents|mesh-ancestor
110705730|NCT00503009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110705731|NCT00503009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110705732|NCT00503009|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110705733|NCT00503009|Respiratory System Agents|respiratory system agents|mesh-ancestor
110860429|NCT04685135|Docetaxel|docetaxel|mesh-list
110705734|NCT00503009|Dermatologic Agents|dermatologic agents|mesh-ancestor
110705735|NCT00503009|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110705736|NCT00503009|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110705737|NCT00503009|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110705738|NCT00503009|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110705739|NCT00503009|Adrenergic Agents|adrenergic agents|mesh-ancestor
110705740|NCT00503009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110705741|NCT00503009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110705743|NCT01016093|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110705744|NCT01016093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110705745|NCT00160251|Ribavirin|ribavirin|mesh-list
110705746|NCT00160251|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110705747|NCT00160251|Antimetabolites|antimetabolites|mesh-ancestor
110705748|NCT00160251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110705749|NCT00160251|Antiviral Agents|antiviral agents|mesh-ancestor
110705750|NCT00160251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110705751|NCT01075425|Bortezomib|bortezomib|mesh-list
110705752|NCT01075425|Belinostat|belinostat|mesh-list
110705753|NCT01075425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110131035|NCT01965730|Hemostatics|hemostatics|mesh-ancestor
110705754|NCT01075425|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110705755|NCT01075425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110705756|NCT01075425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110705757|NCT00378014|Everolimus|everolimus|mesh-list
110705758|NCT00378014|Basiliximab|basiliximab|mesh-list
110705759|NCT00378014|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110705760|NCT00378014|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110705761|NCT00378014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110705762|NCT00378014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110705763|NCT00378014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110705764|NCT00378014|Immunologic Factors|immunologic factors|mesh-ancestor
110705765|NCT00378014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110131109|NCT01966289|Guadecitabine|guadecitabine|mesh-list
110705766|NCT00378014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110705767|NCT00485303|Prednisone|prednisone|mesh-list
110705768|NCT00485303|Abiraterone Acetate|abiraterone acetate|mesh-list
110705769|NCT00485303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110705770|NCT00485303|Glucocorticoids|glucocorticoids|mesh-ancestor
110705771|NCT00485303|Hormones|hormones|mesh-ancestor
110705772|NCT00485303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110705773|NCT00485303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110705774|NCT00485303|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110705775|NCT00485303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110705776|NCT00485303|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110705777|NCT00485303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110705778|NCT00485303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110705779|NCT00485303|Hormone Antagonists|hormone antagonists|mesh-ancestor
110705780|NCT00485303|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110705781|NCT01018823|Ertugliflozin|ertugliflozin|mesh-list
110705782|NCT01018823|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110705783|NCT01018823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110705784|NCT01018823|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110705785|NCT01018823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110705786|NCT01016249|Epinephrine|epinephrine|mesh-list
110705787|NCT01016249|Racepinephrine|racepinephrine|mesh-list
110705788|NCT01016249|Epinephryl borate|epinephryl borate|mesh-list
110705789|NCT01016249|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110705790|NCT01016249|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110705791|NCT01016249|Adrenergic Agents|adrenergic agents|mesh-ancestor
110705792|NCT01016249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110335564|NCT05144295|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
110705793|NCT01016249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110705794|NCT01016249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110705795|NCT01016249|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110705796|NCT01016249|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110705797|NCT01016249|Autonomic Agents|autonomic agents|mesh-ancestor
110705798|NCT01016249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110705799|NCT01016249|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110705800|NCT01016249|Respiratory System Agents|respiratory system agents|mesh-ancestor
110705801|NCT01016249|Mydriatics|mydriatics|mesh-ancestor
110705802|NCT01016249|Sympathomimetics|sympathomimetics|mesh-ancestor
110705803|NCT01016249|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110705804|NCT00377858|Insulin|insulin|mesh-list
110705805|NCT00377858|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110705806|NCT00377858|Insulin Glargine|insulin glargine|mesh-list
110705807|NCT00377858|Insulin Lispro|insulin lispro|mesh-list
110705808|NCT00377858|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110705809|NCT00377858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110705810|NCT00502775|Fluticasone|fluticasone|mesh-list
110705812|NCT00502775|Fexofenadine|fexofenadine|mesh-list
110705813|NCT00502775|Terfenadine|terfenadine|mesh-list
110705814|NCT00502775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110705815|NCT00502775|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110705816|NCT00502775|Autonomic Agents|autonomic agents|mesh-ancestor
110705817|NCT00502775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110705818|NCT00502775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110705819|NCT00502775|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110705820|NCT00502775|Respiratory System Agents|respiratory system agents|mesh-ancestor
110705821|NCT00502775|Dermatologic Agents|dermatologic agents|mesh-ancestor
110705822|NCT00502775|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110131336|NCT01967823|Fludarabine|fludarabine|mesh-list
110705823|NCT00502775|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110705824|NCT00502775|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110705825|NCT00502775|Histamine Antagonists|histamine antagonists|mesh-ancestor
110705826|NCT00502775|Histamine Agents|histamine agents|mesh-ancestor
110705827|NCT00502775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110705828|NCT00502775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110705829|NCT01013675|Vaccines|vaccines|mesh-list
110705830|NCT01013675|Immunologic Factors|immunologic factors|mesh-ancestor
110705831|NCT01013675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110705832|NCT01054118|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110705833|NCT01054118|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110705834|NCT01054118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110705835|NCT01054118|Incretins|incretins|mesh-ancestor
110705836|NCT01054118|Hormones|hormones|mesh-ancestor
110705837|NCT01054118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110705838|NCT01054118|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110705839|NCT01054118|Protease Inhibitors|protease inhibitors|mesh-ancestor
110705840|NCT01054118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110705841|NCT01054118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110705842|NCT01050842|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
110705843|NCT01050842|Bicalutamide|bicalutamide|mesh-list
110705844|NCT01050842|Androgen Antagonists|androgen antagonists|mesh-ancestor
110705845|NCT01050842|Hormone Antagonists|hormone antagonists|mesh-ancestor
110705846|NCT01050842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110705847|NCT01050842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110705848|NCT01050842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110705849|NCT01050842|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110705850|NCT01050842|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110705851|NCT01050842|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110705852|NCT01050842|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110705853|NCT00485069|Levodopa|levodopa|mesh-list
110705854|NCT00485069|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110705855|NCT00485069|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110705856|NCT00485069|Dopamine Agents|dopamine agents|mesh-ancestor
110705857|NCT00485069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110705858|NCT00485069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110705859|NCT00485069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110705860|NCT03989336|Manganese|manganese|mesh-list
110705861|NCT03989336|Paclitaxel|paclitaxel|mesh-list
110705862|NCT03989336|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110705863|NCT03989336|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
110705864|NCT03989336|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110705865|NCT03989336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110705867|NCT03989336|Antimitotic Agents|antimitotic agents|mesh-ancestor
110705868|NCT03989336|Mitosis Modulators|mitosis modulators|mesh-ancestor
110705869|NCT03989336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110705870|NCT03989336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110705871|NCT03989336|Trace Elements|trace elements|mesh-ancestor
110705872|NCT03989336|Micronutrients|micronutrients|mesh-ancestor
110705873|NCT03989336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110705874|NCT00355082|Lamotrigine|lamotrigine|mesh-list
110705875|NCT00355082|Anticonvulsants|anticonvulsants|mesh-list
110705876|NCT00355082|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110705877|NCT00355082|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110705878|NCT00355082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110705879|NCT00355082|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110705880|NCT00355082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110705881|NCT00355082|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110705882|NCT00355082|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110705883|NCT00355082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110705884|NCT00355082|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110705885|NCT00355082|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110705886|NCT00502307|Tivozanib|tivozanib|mesh-list
110705887|NCT00502307|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110705888|NCT00502307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110705889|NCT00502307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110705890|NCT00484679|Triamcinolone|triamcinolone|mesh-list
110705891|NCT00484679|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110705892|NCT00484679|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110705893|NCT00484679|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110705894|NCT00484679|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110705895|NCT00484679|Glucocorticoids|glucocorticoids|mesh-ancestor
110705896|NCT00484679|Hormones|hormones|mesh-ancestor
110705897|NCT00484679|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110705898|NCT00484679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110705899|NCT00484679|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110705900|NCT00484679|Immunologic Factors|immunologic factors|mesh-ancestor
110705901|NCT00484679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110131636|NCT01969669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110705902|NCT00484679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110705903|NCT00377312|Hormones|hormones|mesh-list
110705904|NCT00377312|Parathyroid Hormone|parathyroid hormone|mesh-list
110705905|NCT00377312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110705906|NCT00377312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110705907|NCT00377312|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110705908|NCT00377234|Risedronic Acid|risedronic acid|mesh-list
110705909|NCT00377234|Ibandronic Acid|ibandronic acid|mesh-list
110705910|NCT00377234|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110705911|NCT00377234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110705912|NCT00377234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110705913|NCT00377234|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110705914|NCT00377234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110705915|NCT00377234|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110705916|NCT00376688|Sirolimus|sirolimus|mesh-list
110705917|NCT00376688|Temsirolimus|temsirolimus|mesh-list
110705918|NCT00376688|MTOR Inhibitors|mtor inhibitors|mesh-list
110705919|NCT00376688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110705920|NCT00376688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110705921|NCT00376688|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110705922|NCT00376688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110705923|NCT00376688|Antifungal Agents|antifungal agents|mesh-ancestor
110705924|NCT00376688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110705925|NCT00376688|Immunologic Factors|immunologic factors|mesh-ancestor
110705926|NCT00376688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110705927|NCT00376688|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110705928|NCT00376688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110705929|NCT00376688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110705930|NCT00376220|Riluzole|riluzole|mesh-list
110705931|NCT00376220|Anticonvulsants|anticonvulsants|mesh-ancestor
110705932|NCT00376220|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110705933|NCT00376220|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110131755|NCT01970202|Anticoagulants|anticoagulants|mesh-ancestor
110705934|NCT00376220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110705935|NCT00376220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110705936|NCT00376220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110705937|NCT00376220|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110705938|NCT00376220|Protective Agents|protective agents|mesh-ancestor
110705939|NCT00375752|Letrozole|letrozole|mesh-list
110705940|NCT00375752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110705941|NCT00375752|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110705942|NCT00375752|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110705943|NCT00375752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110705944|NCT00375752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110705945|NCT00375752|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110131814|NCT01971034|Paclitaxel|paclitaxel|mesh-list
110705946|NCT00375752|Hormone Antagonists|hormone antagonists|mesh-ancestor
110705947|NCT00375752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110705948|NCT00375752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110705949|NCT00484289|Abatacept|abatacept|mesh-list
110705950|NCT00484289|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110705951|NCT00484289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110705952|NCT00484289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110705953|NCT00484289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110705954|NCT00484289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110705955|NCT00484289|Immunologic Factors|immunologic factors|mesh-ancestor
110705956|NCT00484289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110705957|NCT00484289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110705958|NCT01013831|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110705959|NCT01013831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110705960|NCT01013831|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110705961|NCT01013831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110705962|NCT01013831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110705963|NCT01013909|Terbinafine|terbinafine|mesh-list
110705964|NCT01013909|Bifonazole|bifonazole|mesh-list
110705965|NCT01013909|Antifungal Agents|antifungal agents|mesh-ancestor
110705966|NCT01013909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110705967|NCT01013909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110705968|NCT01013909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110705969|NCT01013987|Ritonavir|ritonavir|mesh-list
110705970|NCT01013987|Darunavir|darunavir|mesh-list
110705971|NCT01013987|Raltegravir Potassium|raltegravir potassium|mesh-list
110705972|NCT01013987|Maraviroc|maraviroc|mesh-list
110705973|NCT01013987|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110705974|NCT01013987|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110705975|NCT01013987|Protease Inhibitors|protease inhibitors|mesh-ancestor
110705976|NCT01013987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110705977|NCT01013987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110705978|NCT01013987|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110705979|NCT01013987|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110705980|NCT01013987|Antiviral Agents|antiviral agents|mesh-ancestor
110705981|NCT01013987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110705982|NCT01013987|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110705983|NCT01013987|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110423819|NCT02782819|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110705984|NCT01013987|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110705985|NCT01013987|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110705986|NCT01013987|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110705987|NCT01013987|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110705988|NCT01013987|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
110705989|NCT01019291|Formaldehyde|formaldehyde|mesh-list
110705990|NCT01019291|Disinfectants|disinfectants|mesh-ancestor
110705991|NCT01019291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110705992|NCT01019447|Anti-Infective Agents|anti-infective agents|mesh-list
110705993|NCT01019447|Triclosan|triclosan|mesh-list
110705994|NCT01019447|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110705995|NCT01019447|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110705996|NCT01019447|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
110705997|NCT01019447|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110705998|NCT01019447|Antimetabolites|antimetabolites|mesh-ancestor
110705999|NCT01019447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110706000|NCT01019447|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110706001|NCT00490529|Cyclophosphamide|cyclophosphamide|mesh-list
110706002|NCT00490529|Rituximab|rituximab|mesh-list
110706003|NCT00490529|Vaccines|vaccines|mesh-list
110706004|NCT00490529|Immunologic Factors|immunologic factors|mesh-ancestor
110443732|NCT02793544|Busulfan|busulfan|mesh-list
110706005|NCT00490529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110706006|NCT00490529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110706007|NCT00490529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110132058|NCT01972763|Ranibizumab|ranibizumab|mesh-list
110706008|NCT00490529|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110706009|NCT00490529|Alkylating Agents|alkylating agents|mesh-ancestor
110706010|NCT00490529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110706011|NCT00490529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110706012|NCT00490529|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110706013|NCT00490529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110706014|NCT00333840|Interferons|interferons|mesh-list
110706015|NCT00333840|Cytarabine|cytarabine|mesh-list
110706016|NCT00333840|Interferon-alpha|interferon-alpha|mesh-list
110706017|NCT00333840|Interferon alpha-2|interferon alpha-2|mesh-list
110706018|NCT00333840|Imatinib Mesylate|imatinib mesylate|mesh-list
110706019|NCT00333840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110706020|NCT00333840|Antiviral Agents|antiviral agents|mesh-ancestor
110706021|NCT00333840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110706022|NCT00333840|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110706023|NCT00333840|Antimetabolites|antimetabolites|mesh-ancestor
110132122|NCT01973309|Paclitaxel|paclitaxel|mesh-list
110706024|NCT00333840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110706025|NCT00333840|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110706026|NCT00333840|Immunologic Factors|immunologic factors|mesh-ancestor
110706027|NCT00333840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110706028|NCT00333840|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110706029|NCT00333840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110706030|NCT01019603|Nicotinic Acids|nicotinic acids|mesh-list
110706031|NCT01019603|Tazarotene|tazarotene|mesh-list
110706032|NCT01019603|Dermatologic Agents|dermatologic agents|mesh-ancestor
110706033|NCT01019603|Keratolytic Agents|keratolytic agents|mesh-ancestor
110132181|NCT01973751|Budesonide|budesonide|mesh-list
110706034|NCT01019603|Vitamin B Complex|vitamin b complex|mesh-ancestor
110706035|NCT01019603|Vitamins|vitamins|mesh-ancestor
110706036|NCT01019603|Micronutrients|micronutrients|mesh-ancestor
110706037|NCT01019603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110706038|NCT00321906|Sirolimus|sirolimus|mesh-list
110706039|NCT00321906|Azathioprine|azathioprine|mesh-list
110706040|NCT00321906|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110706041|NCT00321906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110706042|NCT00321906|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110706043|NCT00321906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110706044|NCT00321906|Antifungal Agents|antifungal agents|mesh-ancestor
110706045|NCT00321906|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110706046|NCT00321906|Immunologic Factors|immunologic factors|mesh-ancestor
110706047|NCT00321906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110706048|NCT00321906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110706049|NCT00321906|Antimetabolites|antimetabolites|mesh-ancestor
110706050|NCT00321906|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110706051|NCT00321906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110706052|NCT00339144|Dasatinib|dasatinib|mesh-list
110706053|NCT00339144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110706054|NCT00339144|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110706055|NCT00339144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110706056|NCT00339144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110706057|NCT00321828|Leucovorin|leucovorin|mesh-list
110706058|NCT00321828|Bevacizumab|bevacizumab|mesh-list
110706059|NCT00321828|Fluorouracil|fluorouracil|mesh-list
110706060|NCT00321828|Oxaliplatin|oxaliplatin|mesh-list
110706061|NCT00321828|Levoleucovorin|levoleucovorin|mesh-list
110132321|NCT01974518|Rituximab|rituximab|mesh-list
110706062|NCT00321828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110706063|NCT00321828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110706064|NCT00321828|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110706065|NCT00321828|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110706066|NCT00321828|Growth Substances|growth substances|mesh-ancestor
110706067|NCT00321828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110706068|NCT00321828|Growth Inhibitors|growth inhibitors|mesh-ancestor
110706069|NCT00321828|Antimetabolites|antimetabolites|mesh-ancestor
110706070|NCT00321828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110706071|NCT00321828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110706072|NCT00321828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110706073|NCT00321828|Immunologic Factors|immunologic factors|mesh-ancestor
110706074|NCT00321828|Antidotes|antidotes|mesh-ancestor
110706075|NCT00321828|Protective Agents|protective agents|mesh-ancestor
110706076|NCT00321828|Vitamin B Complex|vitamin b complex|mesh-ancestor
110706077|NCT00321828|Vitamins|vitamins|mesh-ancestor
110706078|NCT00321828|Micronutrients|micronutrients|mesh-ancestor
110706079|NCT00333138|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
110706080|NCT00333138|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
110706081|NCT00333138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110706082|NCT00333138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110706083|NCT00333138|Immunologic Factors|immunologic factors|mesh-ancestor
110706084|NCT00333138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110706085|NCT01061658|Vaccines|vaccines|mesh-list
110706086|NCT01061658|Immunologic Factors|immunologic factors|mesh-ancestor
110706087|NCT01061658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110706088|NCT01058382|Progesterone|progesterone|mesh-list
110706089|NCT01058382|Progestins|progestins|mesh-ancestor
110706090|NCT01058382|Hormones|hormones|mesh-ancestor
110706091|NCT01058382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110706092|NCT01058382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110706093|NCT01061814|Mipomersen|mipomersen|mesh-list
110706094|NCT01061814|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110706095|NCT01061814|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110706096|NCT01061814|Antimetabolites|antimetabolites|mesh-ancestor
110706097|NCT01061814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110706098|NCT01061814|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110706099|NCT00331422|Paclitaxel|paclitaxel|mesh-list
110706100|NCT00331422|Carboplatin|carboplatin|mesh-list
110706101|NCT00331422|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110706102|NCT00331422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110706103|NCT00331422|Tubulin Modulators|tubulin modulators|mesh-ancestor
110706104|NCT00331422|Antimitotic Agents|antimitotic agents|mesh-ancestor
110706105|NCT00331422|Mitosis Modulators|mitosis modulators|mesh-ancestor
110706106|NCT00331422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110706107|NCT00331344|Prednisone|prednisone|mesh-list
110706108|NCT00331344|Mitoxantrone|mitoxantrone|mesh-list
110706109|NCT00331344|Epothilone B|epothilone b|mesh-list
110706110|NCT00331344|Epothilones|epothilones|mesh-list
110706111|NCT00331344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110706112|NCT00331344|Glucocorticoids|glucocorticoids|mesh-ancestor
110706113|NCT00331344|Hormones|hormones|mesh-ancestor
110706114|NCT00331344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110706115|NCT00331344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110706116|NCT00331344|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110706117|NCT00331344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110706118|NCT00331344|Analgesics|analgesics|mesh-ancestor
110706119|NCT00331344|Sensory System Agents|sensory system agents|mesh-ancestor
110132629|NCT01976936|Lovastatin|lovastatin|mesh-list
110706120|NCT00331344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110706121|NCT00331344|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110706122|NCT00331344|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110706123|NCT00331344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110706124|NCT00331344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110706125|NCT00331344|Tubulin Modulators|tubulin modulators|mesh-ancestor
110706126|NCT00331344|Antimitotic Agents|antimitotic agents|mesh-ancestor
110706127|NCT00331344|Mitosis Modulators|mitosis modulators|mesh-ancestor
110706128|NCT00321672|Capsaicin|capsaicin|mesh-list
110706129|NCT00321672|Antipruritics|antipruritics|mesh-ancestor
110706130|NCT00321672|Dermatologic Agents|dermatologic agents|mesh-ancestor
110706131|NCT00321672|Sensory System Agents|sensory system agents|mesh-ancestor
110706132|NCT00321672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110706133|NCT00321672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110706134|NCT00330174|Acamprosate|acamprosate|mesh-list
110706135|NCT00330174|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110706137|NCT00320424|Fondaparinux|fondaparinux|mesh-list
110706138|NCT00320424|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110706139|NCT00320424|Antithrombins|antithrombins|mesh-ancestor
110706140|NCT00320424|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110706141|NCT00320424|Protease Inhibitors|protease inhibitors|mesh-ancestor
110706142|NCT00320424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110706143|NCT00320424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110706144|NCT00320424|Anticoagulants|anticoagulants|mesh-ancestor
110706145|NCT00320424|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110706146|NCT00320424|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110706147|NCT00338286|Epoetin Alfa|epoetin alfa|mesh-list
110706148|NCT00338286|Hematinics|hematinics|mesh-ancestor
110706149|NCT00329550|Certolizumab Pegol|certolizumab pegol|mesh-list
110706150|NCT00329550|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110706151|NCT00329550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110706152|NCT00329550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110706153|NCT00329550|Immunologic Factors|immunologic factors|mesh-ancestor
110706154|NCT00329550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110706155|NCT00329550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110706157|NCT00375674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110706158|NCT00375674|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110706159|NCT00375674|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110706160|NCT00375674|Growth Substances|growth substances|mesh-ancestor
110706161|NCT00375674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110706162|NCT00375674|Growth Inhibitors|growth inhibitors|mesh-ancestor
110706163|NCT00375674|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110706164|NCT00375674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110706165|NCT00375674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110706166|NCT03991910|Ramipril|ramipril|mesh-list
110706167|NCT03991910|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110706168|NCT03991910|Protease Inhibitors|protease inhibitors|mesh-ancestor
110706169|NCT03991910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110706170|NCT03991910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110706171|NCT03991910|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110706172|NCT00320190|Imatinib Mesylate|imatinib mesylate|mesh-list
110706173|NCT00320190|Dasatinib|dasatinib|mesh-list
110706174|NCT00320190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110706175|NCT00320190|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110706176|NCT00320190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110706177|NCT00320190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110706178|NCT02534402|Prednisone|prednisone|mesh-list
110706179|NCT02534402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110706180|NCT02534402|Glucocorticoids|glucocorticoids|mesh-ancestor
110706181|NCT02534402|Hormones|hormones|mesh-ancestor
110706182|NCT02534402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110706183|NCT02534402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110706184|NCT02534402|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110706185|NCT02534402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110706186|NCT00319956|Azithromycin|azithromycin|mesh-list
110706187|NCT00319956|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110706188|NCT00319956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110706189|NCT01062048|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110706190|NCT01062048|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110706191|NCT01062048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110706192|NCT01062048|Incretins|incretins|mesh-ancestor
110706193|NCT01062048|Hormones|hormones|mesh-ancestor
110706194|NCT01062048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110706195|NCT01062048|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110706196|NCT01062048|Protease Inhibitors|protease inhibitors|mesh-ancestor
110706197|NCT01062048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110706198|NCT01062048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110706199|NCT00349622|Ceftriaxone|ceftriaxone|mesh-list
110706200|NCT00349622|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110706201|NCT00349622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110706202|NCT03987698|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
110706203|NCT03987698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110706204|NCT03987698|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110706205|NCT03987698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110706206|NCT01054508|Nicotinic Acids|nicotinic acids|mesh-list
110706208|NCT01054508|Niacinamide|niacinamide|mesh-list
110706209|NCT01054508|Vitamin B Complex|vitamin b complex|mesh-ancestor
110706210|NCT01054508|Vitamins|vitamins|mesh-ancestor
110706211|NCT01054508|Micronutrients|micronutrients|mesh-ancestor
110706212|NCT01054508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110706213|NCT01054508|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110706214|NCT01054508|Antimetabolites|antimetabolites|mesh-ancestor
110706215|NCT01054508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110706216|NCT01054508|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110706217|NCT01054508|Vasodilator Agents|vasodilator agents|mesh-ancestor
110706218|NCT00348686|Felodipine|felodipine|mesh-list
110706219|NCT00348686|Candesartan|candesartan|mesh-list
110706220|NCT00348686|Candesartan cilexetil|candesartan cilexetil|mesh-list
110706221|NCT00348686|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110706222|NCT00348686|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110706223|NCT00348686|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110706224|NCT00348686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110706225|NCT00348686|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110706226|NCT00348686|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110706227|NCT00348686|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110706228|NCT00348686|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110706229|NCT00348686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110706230|NCT00348686|Vasodilator Agents|vasodilator agents|mesh-ancestor
110706231|NCT00360230|Vaccines|vaccines|mesh-list
110706232|NCT00360230|Immunologic Factors|immunologic factors|mesh-ancestor
110706233|NCT00360230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110706234|NCT03989024|Clomiphene|clomiphene|mesh-list
110706235|NCT03989024|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
110706236|NCT03989024|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110706237|NCT03989024|Hormone Antagonists|hormone antagonists|mesh-ancestor
110706238|NCT03989024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110706239|NCT03989024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110706240|NCT03989024|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110706241|NCT03989024|Fertility Agents|fertility agents|mesh-ancestor
110706242|NCT03989024|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110706243|NCT03989024|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110706244|NCT03989024|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110706245|NCT03989024|Hormones|hormones|mesh-ancestor
110706246|NCT03987308|Insulin Aspart|insulin aspart|mesh-list
110706247|NCT03987308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110706248|NCT03987308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110706249|NCT00348374|Insulin Lispro|insulin lispro|mesh-list
110706250|NCT00348374|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110706251|NCT00348374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110706252|NCT03742232|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
110706253|NCT03742232|Laxatives|laxatives|mesh-ancestor
110706254|NCT03742232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110706255|NCT03988478|Psychotropic Drugs|psychotropic drugs|mesh-list
110706256|NCT00352664|Donepezil|donepezil|mesh-list
110706257|NCT00352664|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110706258|NCT00352664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110706259|NCT00352664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110706260|NCT00352664|Cholinergic Agents|cholinergic agents|mesh-ancestor
110706261|NCT00352664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110706262|NCT00352664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110706263|NCT00352664|Nootropic Agents|nootropic agents|mesh-ancestor
110706264|NCT03991442|Amlodipine|amlodipine|mesh-list
110706265|NCT03991442|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110706266|NCT03991442|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110706267|NCT03991442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110706268|NCT03991442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110706269|NCT03991442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110706270|NCT03991442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110706272|NCT03742310|Vitamin D|vitamin d|mesh-list
110706273|NCT03742310|Calcitriol|calcitriol|mesh-list
110706274|NCT03742310|Vitamins|vitamins|mesh-ancestor
110706275|NCT03742310|Micronutrients|micronutrients|mesh-ancestor
110706276|NCT03742310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110706277|NCT03742310|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110706278|NCT03742310|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110706279|NCT03742310|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
110706280|NCT03742310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110706281|NCT03742310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110706282|NCT03742310|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110706283|NCT00490139|Trastuzumab|trastuzumab|mesh-list
110706284|NCT00490139|Lapatinib|lapatinib|mesh-list
110706285|NCT00490139|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110706286|NCT00490139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110706288|NCT00490139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110706289|NCT00490139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110706290|NCT00348140|Rosiglitazone|rosiglitazone|mesh-list
110706291|NCT00348140|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110706292|NCT00348140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110706293|NCT01051388|Rabeprazole|rabeprazole|mesh-list
110706294|NCT01051388|Gefarnate|gefarnate|mesh-list
110706295|NCT01051388|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110706296|NCT01051388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110706297|NCT01051388|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110706298|NCT01051388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110133207|NCT01981941|Gabapentin|gabapentin|mesh-list
110706299|NCT01051388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110706300|NCT00490061|Lapatinib|lapatinib|mesh-list
110706301|NCT00490061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110706302|NCT00490061|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110706303|NCT00490061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110706304|NCT00490061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110706305|NCT00483119|Cyclophosphamide|cyclophosphamide|mesh-list
110706306|NCT00483119|Immunoglobulins|immunoglobulins|mesh-list
110706307|NCT00483119|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110706308|NCT00483119|Antibodies|antibodies|mesh-list
110706309|NCT00483119|gamma-Globulins|gamma-globulins|mesh-list
110706310|NCT00483119|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110706311|NCT00483119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110706312|NCT00483119|Immunologic Factors|immunologic factors|mesh-ancestor
110706313|NCT00483119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110706314|NCT00483119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110706315|NCT00483119|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110706316|NCT00483119|Alkylating Agents|alkylating agents|mesh-ancestor
110706317|NCT00483119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110706318|NCT00483119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110706319|NCT00483119|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110706320|NCT01016639|Capecitabine|capecitabine|mesh-list
110706321|NCT01016639|Oxaliplatin|oxaliplatin|mesh-list
110133262|NCT01982578|Phytoestrogens|phytoestrogens|mesh-ancestor
110706322|NCT01016639|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110706323|NCT01016639|Antimetabolites|antimetabolites|mesh-ancestor
110706324|NCT01016639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110706325|NCT01016639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110706326|NCT00501293|Methylphenidate|methylphenidate|mesh-list
110706327|NCT00501293|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110706328|NCT00501293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110706329|NCT00501293|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110706330|NCT00501293|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110706331|NCT00501293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110706332|NCT00501293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110706333|NCT00501293|Dopamine Agents|dopamine agents|mesh-ancestor
110706334|NCT00501293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110706335|NCT01014221|Prednisolone|prednisolone|mesh-list
110706336|NCT01014221|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110706337|NCT01014221|Glucocorticoids|glucocorticoids|mesh-ancestor
110706338|NCT01014221|Hormones|hormones|mesh-ancestor
110860500|NCT04638660|Phentolamine|phentolamine|mesh-list
110706339|NCT01014221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110706340|NCT01014221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110706341|NCT01014221|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110706342|NCT01014221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110706343|NCT00482729|Metformin|metformin|mesh-list
110706344|NCT00482729|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110706345|NCT00482729|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110706346|NCT00482729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110706347|NCT00482729|Incretins|incretins|mesh-ancestor
110706349|NCT00482729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110706350|NCT00482729|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110706351|NCT00482729|Protease Inhibitors|protease inhibitors|mesh-ancestor
110706352|NCT00482729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110706353|NCT00482729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110706354|NCT00359762|Exenatide|exenatide|mesh-list
110706355|NCT00359762|Glimepiride|glimepiride|mesh-list
110133379|NCT01983501|Tucatinib|tucatinib|mesh-list
110706356|NCT00359762|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110706357|NCT00359762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110706358|NCT00359762|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110706359|NCT00359762|Incretins|incretins|mesh-ancestor
110706360|NCT00359762|Hormones|hormones|mesh-ancestor
110706361|NCT00359762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110706362|NCT00359762|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110706363|NCT00359762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110706364|NCT00359762|Immunologic Factors|immunologic factors|mesh-ancestor
110706366|NCT03988010|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110706367|NCT03988010|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110706368|NCT03988010|Antiviral Agents|antiviral agents|mesh-ancestor
110706369|NCT03988010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110706370|NCT03988010|Dopamine Agents|dopamine agents|mesh-ancestor
110706371|NCT03988010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110706372|NCT03988010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110706373|NCT03988010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110706374|NCT03988010|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110706375|NCT03988010|Analgesics|analgesics|mesh-ancestor
110706376|NCT03988010|Sensory System Agents|sensory system agents|mesh-ancestor
110706377|NCT03988010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110706378|NCT01055522|Interleukin-2|interleukin-2|mesh-list
110706380|NCT01055522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110706381|NCT01055522|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110706382|NCT01055522|Analgesics|analgesics|mesh-ancestor
110706383|NCT01055522|Sensory System Agents|sensory system agents|mesh-ancestor
110706384|NCT01055522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110706385|NCT01055522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110706386|NCT01055522|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110706387|NCT01055522|Alkylating Agents|alkylating agents|mesh-ancestor
110706388|NCT01055522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110706389|NCT03987152|Sirolimus|sirolimus|mesh-list
110706390|NCT03987152|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110706391|NCT03987152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110706392|NCT03987152|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110706393|NCT03987152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110706394|NCT03987152|Antifungal Agents|antifungal agents|mesh-ancestor
110706395|NCT03987152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110706396|NCT03987152|Immunologic Factors|immunologic factors|mesh-ancestor
110706397|NCT03987152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110706398|NCT00347438|Capecitabine|capecitabine|mesh-list
110706399|NCT00347438|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110706400|NCT00347438|Antimetabolites|antimetabolites|mesh-ancestor
110706401|NCT00347438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110706402|NCT00347438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110706403|NCT00329238|Warfarin|warfarin|mesh-list
110706404|NCT00329238|Dabigatran|dabigatran|mesh-list
110133438|NCT01983761|Melphalan|melphalan|mesh-list
110706405|NCT00329238|Anticoagulants|anticoagulants|mesh-ancestor
110706406|NCT00329238|Antithrombins|antithrombins|mesh-ancestor
110860585|NCT04375384|Cetuximab|cetuximab|mesh-list
110706407|NCT00329238|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110706408|NCT00329238|Protease Inhibitors|protease inhibitors|mesh-ancestor
110706409|NCT00329238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110706410|NCT00329238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110706411|NCT00329160|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110706412|NCT00329160|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110706413|NCT00329160|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110706414|NCT00329160|Antimetabolites|antimetabolites|mesh-ancestor
110706415|NCT00329160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110706416|NCT00329160|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110706417|NCT00329160|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110706418|NCT00329160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110706419|NCT00328926|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
110706420|NCT00328926|Hormones|hormones|mesh-list
110706421|NCT00328926|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
110706422|NCT00328926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110706423|NCT00328926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110706424|NCT00328926|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110706425|NCT00347360|Carvedilol|carvedilol|mesh-list
110706426|NCT00347360|Lisinopril|lisinopril|mesh-list
110706427|NCT00347360|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110706428|NCT00347360|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110706429|NCT00347360|Adrenergic Agents|adrenergic agents|mesh-ancestor
110706430|NCT00347360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110706431|NCT00347360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110706432|NCT00347360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110706433|NCT00347360|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110706434|NCT00347360|Antioxidants|antioxidants|mesh-ancestor
110706435|NCT00347360|Protective Agents|protective agents|mesh-ancestor
110706436|NCT00347360|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110706437|NCT00347360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110706438|NCT00347360|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110706439|NCT00347360|Vasodilator Agents|vasodilator agents|mesh-ancestor
110706440|NCT00347360|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110706441|NCT00347360|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110706442|NCT00347360|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110706443|NCT00347360|Protease Inhibitors|protease inhibitors|mesh-ancestor
110706444|NCT00347360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110706445|NCT00347360|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110706446|NCT00319020|Bosentan|bosentan|mesh-list
110706447|NCT00319020|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110706448|NCT00319020|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
110706449|NCT00319020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110706450|NCT01056224|Remifentanil|remifentanil|mesh-list
110706451|NCT01056224|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110706452|NCT01056224|Narcotics|narcotics|mesh-ancestor
110706453|NCT01056224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110706454|NCT01056224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110706455|NCT01056224|Analgesics|analgesics|mesh-ancestor
110706456|NCT01056224|Sensory System Agents|sensory system agents|mesh-ancestor
110706457|NCT01056224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110706458|NCT03982680|Gemcitabine|gemcitabine|mesh-list
110706459|NCT03982680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110706460|NCT03982680|Antimetabolites|antimetabolites|mesh-ancestor
110706461|NCT03982680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110706462|NCT03982680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110706463|NCT00352118|Docetaxel|docetaxel|mesh-list
110706464|NCT00352118|Fluorouracil|fluorouracil|mesh-list
110706465|NCT00352118|Lenograstim|lenograstim|mesh-list
110706466|NCT00352118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110706467|NCT00352118|Tubulin Modulators|tubulin modulators|mesh-ancestor
110706468|NCT00352118|Antimitotic Agents|antimitotic agents|mesh-ancestor
110706469|NCT00352118|Mitosis Modulators|mitosis modulators|mesh-ancestor
110706470|NCT00352118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110706471|NCT00352118|Antimetabolites|antimetabolites|mesh-ancestor
110706472|NCT00352118|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110706473|NCT00352118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110706474|NCT00352118|Immunologic Factors|immunologic factors|mesh-ancestor
110706475|NCT00352118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110706476|NCT00352118|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110706477|NCT00318474|Mycophenolic Acid|mycophenolic acid|mesh-list
110706478|NCT00318474|Enzyme Inhibitors|enzyme inhibitors|mesh-list
110706479|NCT00318474|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
110706480|NCT00318474|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110706481|NCT00318474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110706482|NCT00318474|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110706483|NCT00318474|Antitubercular Agents|antitubercular agents|mesh-ancestor
110706484|NCT00318474|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110706485|NCT00318474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110706486|NCT00318474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110706487|NCT00318474|Protease Inhibitors|protease inhibitors|mesh-ancestor
110706488|NCT00350870|Disulfiram|disulfiram|mesh-list
110706489|NCT00350870|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110706490|NCT00350870|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
110706491|NCT00350870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110706492|NCT00350870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110706493|NCT00350792|Carboplatin|carboplatin|mesh-list
110706494|NCT00350792|Pemetrexed|pemetrexed|mesh-list
110706495|NCT00350792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110706496|NCT00350792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110706497|NCT00350792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110706498|NCT00350792|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110706499|NCT00350792|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110706500|NCT00317772|Topotecan|topotecan|mesh-list
110706501|NCT00317772|Gefitinib|gefitinib|mesh-list
110706502|NCT00317772|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110706503|NCT00317772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110706504|NCT00317772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110706505|NCT00317772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110706506|NCT00317772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110706507|NCT00317772|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110706508|NCT01325298|Riboflavin|riboflavin|mesh-list
110706509|NCT01325298|Vitamin B Complex|vitamin b complex|mesh-ancestor
110706510|NCT01325298|Vitamins|vitamins|mesh-ancestor
110706511|NCT01325298|Micronutrients|micronutrients|mesh-ancestor
110706512|NCT01325298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110706513|NCT01325298|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110706514|NCT01325298|Dermatologic Agents|dermatologic agents|mesh-ancestor
110706515|NCT00350636|Mandelic Acids|mandelic acids|mesh-list
110706516|NCT00350636|Oxybutynin|oxybutynin|mesh-list
110706517|NCT00350636|Parasympatholytics|parasympatholytics|mesh-ancestor
110706518|NCT00350636|Autonomic Agents|autonomic agents|mesh-ancestor
110706519|NCT00350636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110706520|NCT00350636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110706521|NCT00350636|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110706522|NCT00350636|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110706523|NCT00350636|Cholinergic Agents|cholinergic agents|mesh-ancestor
110706524|NCT00350636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110706525|NCT00350636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110706526|NCT00350636|Urological Agents|urological agents|mesh-ancestor
110706527|NCT00350636|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110706528|NCT00350636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110706529|NCT01051544|Factor VIII|factor viii|mesh-list
110706530|NCT01051544|Coagulants|coagulants|mesh-ancestor
110706531|NCT01058720|Vitamin D|vitamin d|mesh-list
110706532|NCT01058720|Cholecalciferol|cholecalciferol|mesh-list
110706533|NCT01058720|Vitamins|vitamins|mesh-ancestor
110706534|NCT01058720|Micronutrients|micronutrients|mesh-ancestor
110706535|NCT01058720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110706536|NCT01058720|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110706537|NCT01058720|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110706538|NCT00346268|Parecoxib|parecoxib|mesh-list
110706539|NCT00346268|Morphine|morphine|mesh-list
110706540|NCT00346268|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110706541|NCT00346268|Narcotics|narcotics|mesh-ancestor
110706542|NCT00346268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110706543|NCT00346268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110706544|NCT00346268|Analgesics|analgesics|mesh-ancestor
110706545|NCT00346268|Sensory System Agents|sensory system agents|mesh-ancestor
110706546|NCT00346268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110706547|NCT00346268|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110706548|NCT00346268|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110706549|NCT00346268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110706550|NCT00346268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110706551|NCT00346268|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110706552|NCT00346268|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110706553|NCT00346268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110706554|NCT00346268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110706555|NCT00327444|Aflibercept|aflibercept|mesh-list
110706556|NCT00327444|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110706557|NCT00327444|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110706558|NCT00327444|Growth Substances|growth substances|mesh-ancestor
110706559|NCT00327444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110706560|NCT00327444|Growth Inhibitors|growth inhibitors|mesh-ancestor
110706561|NCT00327444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110706562|NCT01051622|Technetium Tc 99m Exametazime|technetium tc 99m exametazime|mesh-list
110706563|NCT01051622|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110706564|NCT01051622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110706565|NCT03982134|Panobinostat|panobinostat|mesh-list
110706566|NCT03982134|Spartalizumab|spartalizumab|mesh-list
110706567|NCT03982134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110133504|NCT01984073|Vasodilator Agents|vasodilator agents|mesh-ancestor
110706568|NCT03982134|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110706569|NCT03982134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110706570|NCT03982134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110706571|NCT03982134|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110706572|NCT03982134|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110706573|NCT00337610|Metformin|metformin|mesh-list
110706574|NCT00337610|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110706575|NCT00337610|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110706576|NCT00337610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110706577|NCT00337610|Incretins|incretins|mesh-ancestor
110706578|NCT00337610|Hormones|hormones|mesh-ancestor
110706579|NCT00337610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110706580|NCT00337610|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110706581|NCT00337610|Protease Inhibitors|protease inhibitors|mesh-ancestor
110706582|NCT00337610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110706583|NCT00337610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110706584|NCT01062204|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
110706585|NCT01062204|Laxatives|laxatives|mesh-ancestor
110706586|NCT01062204|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110706587|NCT01062282|Iloprost|iloprost|mesh-list
110706588|NCT01062282|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110706589|NCT01062282|Vasodilator Agents|vasodilator agents|mesh-ancestor
110706590|NCT03985280|Anesthetics|anesthetics|mesh-list
110706591|NCT03985280|Anesthetics, Local|anesthetics, local|mesh-list
110706592|NCT03985280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110706593|NCT03985280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110706594|NCT03985280|Sensory System Agents|sensory system agents|mesh-ancestor
110706595|NCT03985280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110706596|NCT01058876|Nicotine|nicotine|mesh-list
110706597|NCT01058876|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110706598|NCT01058876|Autonomic Agents|autonomic agents|mesh-ancestor
110706599|NCT01058876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110706600|NCT01058876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110706601|NCT01058876|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110706602|NCT01058876|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110706603|NCT01058876|Cholinergic Agents|cholinergic agents|mesh-ancestor
110706604|NCT01058876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110706605|NCT01058876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110706606|NCT03986762|Clavulanic Acids|clavulanic acids|mesh-list
110706607|NCT03986762|Clavulanic Acid|clavulanic acid|mesh-list
110706608|NCT03986762|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110706609|NCT03986762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110706610|NCT03986762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110706611|NCT03986762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110706612|NCT03986762|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110706614|NCT01051934|Bevacizumab|bevacizumab|mesh-list
110706615|NCT01051934|Carboplatin|carboplatin|mesh-list
110706616|NCT01051934|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110706617|NCT01051934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110706618|NCT01051934|Tubulin Modulators|tubulin modulators|mesh-ancestor
110706619|NCT01051934|Antimitotic Agents|antimitotic agents|mesh-ancestor
110706620|NCT01051934|Mitosis Modulators|mitosis modulators|mesh-ancestor
110706621|NCT01051934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110706622|NCT01051934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110706623|NCT01051934|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110706624|NCT01051934|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110706625|NCT01051934|Growth Substances|growth substances|mesh-ancestor
110706626|NCT01051934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110706627|NCT01051934|Growth Inhibitors|growth inhibitors|mesh-ancestor
110706628|NCT01325168|Oxytocin|oxytocin|mesh-list
110706629|NCT01325168|Oxytocics|oxytocics|mesh-ancestor
110706630|NCT01325168|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110706631|NCT01325168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110706632|NCT00316914|Magnesium Sulfate|magnesium sulfate|mesh-list
110706633|NCT00316914|Calcium|calcium|mesh-list
110706634|NCT00316914|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110706635|NCT00316914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110706636|NCT00316914|Analgesics|analgesics|mesh-ancestor
110706637|NCT00316914|Sensory System Agents|sensory system agents|mesh-ancestor
110706638|NCT00316914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110706639|NCT00316914|Anesthetics|anesthetics|mesh-ancestor
110706640|NCT00316914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110706641|NCT00316914|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110706642|NCT00316914|Anticonvulsants|anticonvulsants|mesh-ancestor
110706643|NCT00316914|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110706644|NCT00316914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110706645|NCT00316914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110706646|NCT00316914|Tocolytic Agents|tocolytic agents|mesh-ancestor
110706647|NCT00316914|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110706648|NCT00316602|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
110706649|NCT00316602|Antiviral Agents|antiviral agents|mesh-ancestor
110706650|NCT00316602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110706651|NCT00335972|Dexmedetomidine|dexmedetomidine|mesh-list
110706652|NCT00335972|Remifentanil|remifentanil|mesh-list
110706653|NCT00335972|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110706654|NCT00335972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110706655|NCT00335972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110706656|NCT00335972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110706657|NCT00335972|Analgesics|analgesics|mesh-ancestor
110706658|NCT00335972|Sensory System Agents|sensory system agents|mesh-ancestor
110706659|NCT00335972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110706660|NCT00335972|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110706661|NCT00335972|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110706662|NCT00335972|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110706663|NCT00335972|Adrenergic Agents|adrenergic agents|mesh-ancestor
110706664|NCT00335972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110706665|NCT00335972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110706666|NCT00335972|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110706667|NCT00335972|Narcotics|narcotics|mesh-ancestor
110706668|NCT03983460|Betamethasone|betamethasone|mesh-list
110706669|NCT03983460|Betamethasone Valerate|betamethasone valerate|mesh-list
110706670|NCT03983460|Clobetasol|clobetasol|mesh-list
110706671|NCT03983460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110706673|NCT03983460|Hormones|hormones|mesh-ancestor
110706674|NCT03983460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110706675|NCT03983460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110706676|NCT03983460|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110706677|NCT03983460|Respiratory System Agents|respiratory system agents|mesh-ancestor
110706679|NCT01056614|Fludarabine phosphate|fludarabine phosphate|mesh-list
110706680|NCT01056614|Fludarabine|fludarabine|mesh-list
110706681|NCT01056614|Busulfan|busulfan|mesh-list
110706682|NCT01056614|Tacrolimus|tacrolimus|mesh-list
110706683|NCT01056614|Thymoglobulin|thymoglobulin|mesh-list
110706684|NCT01056614|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110706685|NCT01056614|Immunoglobulins|immunoglobulins|mesh-list
110706686|NCT01056614|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110706687|NCT01056614|Abortifacient Agents|abortifacient agents|mesh-ancestor
110706688|NCT01056614|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110706689|NCT01056614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110706690|NCT01056614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110706691|NCT01056614|Antimetabolites|antimetabolites|mesh-ancestor
110706692|NCT01056614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110706693|NCT01056614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110706694|NCT01056614|Dermatologic Agents|dermatologic agents|mesh-ancestor
110706695|NCT01056614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110706696|NCT01056614|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110706697|NCT01056614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110706698|NCT01056614|Immunologic Factors|immunologic factors|mesh-ancestor
110706699|NCT01056614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110706700|NCT01056614|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110706701|NCT01056614|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110706702|NCT01056614|Alkylating Agents|alkylating agents|mesh-ancestor
110706703|NCT01056614|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110706704|NCT01056614|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110706705|NCT00346034|Pregabalin|pregabalin|mesh-list
110706706|NCT00346034|Analgesics|analgesics|mesh-ancestor
110706707|NCT00346034|Sensory System Agents|sensory system agents|mesh-ancestor
110706708|NCT00346034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110706709|NCT00346034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110706710|NCT00346034|Anticonvulsants|anticonvulsants|mesh-ancestor
110706711|NCT00346034|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110706712|NCT00346034|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110706713|NCT00346034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110706714|NCT00346034|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110706715|NCT00346034|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110706716|NCT00346034|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110706717|NCT00346034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110706718|NCT00346034|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110706719|NCT00345878|Vaccines|vaccines|mesh-list
110706720|NCT00345878|Immunologic Factors|immunologic factors|mesh-ancestor
110706721|NCT00345878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110706722|NCT01059110|Salicylates|salicylates|mesh-list
110706723|NCT01059110|Imiquimod|imiquimod|mesh-list
110706724|NCT01059110|Fluorouracil|fluorouracil|mesh-list
110706725|NCT01059110|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110706726|NCT01059110|Immunologic Factors|immunologic factors|mesh-ancestor
110706727|NCT01059110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110706728|NCT01059110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110706729|NCT01059110|Interferon Inducers|interferon inducers|mesh-ancestor
110706730|NCT01059110|Antimetabolites|antimetabolites|mesh-ancestor
110706731|NCT01059110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110706732|NCT01059110|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110706733|NCT01059110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110424572|NCT02769325|Cholinergic Agents|cholinergic agents|mesh-ancestor
110706734|NCT01059110|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110706735|NCT01059110|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110706737|NCT01059110|Sensory System Agents|sensory system agents|mesh-ancestor
110706738|NCT01059110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110706739|NCT01059110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110706740|NCT01059110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110706741|NCT01059110|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110706742|NCT01059110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110706743|NCT03991364|Methamphetamine|methamphetamine|mesh-list
110860626|NCT04111458|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110706744|NCT03991364|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110706745|NCT03991364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110706746|NCT03991364|Sympathomimetics|sympathomimetics|mesh-ancestor
110706747|NCT03991364|Autonomic Agents|autonomic agents|mesh-ancestor
110706748|NCT03991364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110706749|NCT03991364|Dopamine Agents|dopamine agents|mesh-ancestor
110706750|NCT03991364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110706751|NCT03991364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110706752|NCT03991364|Adrenergic Agents|adrenergic agents|mesh-ancestor
110706753|NCT03991364|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110706754|NCT03991364|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110706755|NCT03991364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110706756|NCT03991364|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110706757|NCT00335738|Carboplatin|carboplatin|mesh-list
110706759|NCT00335738|Vincristine|vincristine|mesh-list
110706760|NCT00335738|Etoposide phosphate|etoposide phosphate|mesh-list
110706761|NCT00335738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110706762|NCT00335738|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110706763|NCT00335738|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110706764|NCT00335738|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110706765|NCT00335738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110706766|NCT00335738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110706767|NCT00335738|Tubulin Modulators|tubulin modulators|mesh-ancestor
110706768|NCT00335738|Antimitotic Agents|antimitotic agents|mesh-ancestor
110706769|NCT00335738|Mitosis Modulators|mitosis modulators|mesh-ancestor
110706770|NCT02533076|Capsaicin|capsaicin|mesh-list
110706771|NCT02533076|Antipruritics|antipruritics|mesh-ancestor
110706772|NCT02533076|Dermatologic Agents|dermatologic agents|mesh-ancestor
110706773|NCT02533076|Sensory System Agents|sensory system agents|mesh-ancestor
110706774|NCT02533076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110706775|NCT02533076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110706776|NCT03991520|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
110706777|NCT03991520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110706778|NCT01056926|Nicotine|nicotine|mesh-list
110706779|NCT01056926|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110706780|NCT01056926|Autonomic Agents|autonomic agents|mesh-ancestor
110706781|NCT01056926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110706782|NCT01056926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110706783|NCT01056926|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110706784|NCT01056926|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110706785|NCT01056926|Cholinergic Agents|cholinergic agents|mesh-ancestor
110706786|NCT01056926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110706787|NCT01056926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110706788|NCT01059422|Lamivudine|lamivudine|mesh-list
110706789|NCT01059422|Abacavir|abacavir|mesh-list
110706790|NCT01059422|Raltegravir Potassium|raltegravir potassium|mesh-list
110706791|NCT01059422|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110706792|NCT01059422|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110706793|NCT01059422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110706794|NCT01059422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110706795|NCT01059422|Antiviral Agents|antiviral agents|mesh-ancestor
110706796|NCT01059422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110706797|NCT01059422|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110706798|NCT01059422|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110706799|NCT01059422|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110706800|NCT01059422|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110706801|NCT01052246|Clindamycin|clindamycin|mesh-list
110706802|NCT01052246|Clindamycin palmitate|clindamycin palmitate|mesh-list
110706803|NCT01052246|Clindamycin phosphate|clindamycin phosphate|mesh-list
110706804|NCT01052246|Benzoyl Peroxide|benzoyl peroxide|mesh-list
110706805|NCT01052246|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110706806|NCT01052246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110706807|NCT01052246|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110706808|NCT01052246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110706809|NCT01052246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110706810|NCT01052246|Dermatologic Agents|dermatologic agents|mesh-ancestor
110706811|NCT00334958|Rufinamide|rufinamide|mesh-list
110706812|NCT00334958|Anticonvulsants|anticonvulsants|mesh-ancestor
110860630|NCT04100018|Docetaxel|docetaxel|mesh-list
110706813|NCT00334958|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110706814|NCT00334958|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110706815|NCT00334958|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110706816|NCT00334958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110706817|NCT00326898|Sorafenib|sorafenib|mesh-list
110706818|NCT00326898|Sunitinib|sunitinib|mesh-list
110706819|NCT00326898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110706820|NCT00326898|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110706821|NCT00326898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110706822|NCT00326898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110706823|NCT00326898|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110706824|NCT00326898|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110706825|NCT00326898|Growth Substances|growth substances|mesh-ancestor
110706826|NCT00326898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110706827|NCT00326898|Growth Inhibitors|growth inhibitors|mesh-ancestor
110706828|NCT01062360|Aspirin|aspirin|mesh-list
110706829|NCT01062360|Pseudoephedrine|pseudoephedrine|mesh-list
110706830|NCT01062360|Ephedrine|ephedrine|mesh-list
110706831|NCT01062360|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110706832|NCT01062360|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110706833|NCT01062360|Analgesics|analgesics|mesh-ancestor
110706834|NCT01062360|Sensory System Agents|sensory system agents|mesh-ancestor
110706835|NCT01062360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110706836|NCT01062360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110706837|NCT01062360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110706838|NCT01062360|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110706839|NCT01062360|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110706840|NCT01062360|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110706841|NCT01062360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110706842|NCT01062360|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110706843|NCT01062360|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110706844|NCT01062360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110706845|NCT01062360|Antipyretics|antipyretics|mesh-ancestor
110706846|NCT01062360|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110706847|NCT01062360|Autonomic Agents|autonomic agents|mesh-ancestor
110706848|NCT01062360|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110706849|NCT01062360|Respiratory System Agents|respiratory system agents|mesh-ancestor
110706850|NCT01062360|Nasal Decongestants|nasal decongestants|mesh-ancestor
110706851|NCT01062360|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110706852|NCT01062360|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110706853|NCT01062360|Sympathomimetics|sympathomimetics|mesh-ancestor
110706854|NCT01062360|Adrenergic Agents|adrenergic agents|mesh-ancestor
110706855|NCT01062360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110706856|NCT01063842|Acetaminophen|acetaminophen|mesh-list
110706857|NCT01063842|Tramadol|tramadol|mesh-list
110706858|NCT01063842|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110706859|NCT01063842|Analgesics|analgesics|mesh-ancestor
110706860|NCT01063842|Sensory System Agents|sensory system agents|mesh-ancestor
110706861|NCT01063842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110706862|NCT01063842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110706863|NCT01063842|Antipyretics|antipyretics|mesh-ancestor
110706864|NCT01063842|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110706865|NCT01063842|Narcotics|narcotics|mesh-ancestor
110706866|NCT01063842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110706867|NCT01063920|Naproxen|naproxen|mesh-list
110706868|NCT01063920|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110706869|NCT01063920|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110706870|NCT01063920|Analgesics|analgesics|mesh-ancestor
110706871|NCT01063920|Sensory System Agents|sensory system agents|mesh-ancestor
110706872|NCT01063920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110706873|NCT01063920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110706874|NCT01063920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110706875|NCT01063920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110706876|NCT01063920|Gout Suppressants|gout suppressants|mesh-ancestor
110706877|NCT01063920|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110706878|NCT01063920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110706879|NCT01063920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110706880|NCT01062516|Esomeprazole|esomeprazole|mesh-list
110706881|NCT01062516|Famotidine|famotidine|mesh-list
110706882|NCT01062516|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110706883|NCT01062516|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110424724|NCT02758249|Anesthetics|anesthetics|mesh-ancestor
110860638|NCT04100018|Glucocorticoids|glucocorticoids|mesh-ancestor
110706884|NCT01062516|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110706885|NCT01062516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110706886|NCT01062516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110706887|NCT01062516|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110706888|NCT01062516|Histamine Antagonists|histamine antagonists|mesh-ancestor
110706889|NCT01062516|Histamine Agents|histamine agents|mesh-ancestor
110706890|NCT01062516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110706891|NCT01062516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110706892|NCT00334802|Paclitaxel|paclitaxel|mesh-list
110706894|NCT00334802|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110706895|NCT00334802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110706896|NCT00334802|Tubulin Modulators|tubulin modulators|mesh-ancestor
110706897|NCT00334802|Antimitotic Agents|antimitotic agents|mesh-ancestor
110706898|NCT00334802|Mitosis Modulators|mitosis modulators|mesh-ancestor
110706899|NCT00334802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110706900|NCT00334802|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110706901|NCT00334802|Antimetabolites|antimetabolites|mesh-ancestor
110706902|NCT03985358|Analgesics, Opioid|analgesics, opioid|mesh-list
110706903|NCT03985358|Narcotics|narcotics|mesh-ancestor
110706904|NCT03985358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110706905|NCT03985358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110706906|NCT03985358|Analgesics|analgesics|mesh-ancestor
110706907|NCT03985358|Sensory System Agents|sensory system agents|mesh-ancestor
110706908|NCT03985358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110706909|NCT01052324|Remifentanil|remifentanil|mesh-list
110133610|NCT01984931|Simethicone|simethicone|mesh-list
110706910|NCT01052324|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110706911|NCT01052324|Narcotics|narcotics|mesh-ancestor
110706912|NCT01052324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110706913|NCT01052324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110706914|NCT01052324|Analgesics|analgesics|mesh-ancestor
110706915|NCT01052324|Sensory System Agents|sensory system agents|mesh-ancestor
110706916|NCT01052324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110706917|NCT01059890|Metronidazole|metronidazole|mesh-list
110706918|NCT01059890|Ciprofloxacin|ciprofloxacin|mesh-list
110706919|NCT01059890|Cefotaxime|cefotaxime|mesh-list
110706920|NCT01059890|Cefoxitin|cefoxitin|mesh-list
110706921|NCT01059890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110706922|NCT01059890|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110706923|NCT01059890|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110706924|NCT01059890|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110706925|NCT01059890|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110706926|NCT01059890|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110706927|NCT01059890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110706928|NCT01059890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110706929|NCT01059890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110706930|NCT01059890|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110706931|NCT01059890|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110706932|NCT01057160|Rizatriptan|rizatriptan|mesh-list
110706933|NCT01057160|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110706934|NCT01057160|Serotonin Agents|serotonin agents|mesh-ancestor
110706935|NCT01057160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110706936|NCT01057160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110706937|NCT01057160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110706938|NCT03990974|Anti-Infective Agents|anti-infective agents|mesh-list
110706939|NCT03990974|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110706940|NCT00307086|Bortezomib|bortezomib|mesh-list
110706941|NCT00307086|Melphalan|melphalan|mesh-list
110706942|NCT00307086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110706943|NCT00307086|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110706944|NCT00307086|Alkylating Agents|alkylating agents|mesh-ancestor
110706945|NCT00307086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110860639|NCT04100018|Hormones|hormones|mesh-ancestor
110706946|NCT00307086|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110706947|NCT00307086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110706948|NCT00307086|Immunologic Factors|immunologic factors|mesh-ancestor
110706949|NCT00307086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110706950|NCT02533544|Tenofovir|tenofovir|mesh-list
110706951|NCT02533544|Antiviral Agents|antiviral agents|mesh-ancestor
110706952|NCT02533544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110706953|NCT02533544|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110706954|NCT02533544|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110706955|NCT02533544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110706956|NCT02533544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110706957|NCT02533544|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110706958|NCT02533544|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110706959|NCT03991208|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
110706961|NCT03991208|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110706962|NCT03991208|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110706963|NCT03991208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110706964|NCT00325416|Melphalan|melphalan|mesh-list
110706965|NCT00325416|Topotecan|topotecan|mesh-list
110706966|NCT00325416|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110706967|NCT00325416|Alkylating Agents|alkylating agents|mesh-ancestor
110443747|NCT02793544|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110706968|NCT00325416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110706969|NCT00325416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110706970|NCT00325416|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110706971|NCT00325416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110706972|NCT00325416|Immunologic Factors|immunologic factors|mesh-ancestor
110706973|NCT00325416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110706974|NCT00325416|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110706975|NCT00325416|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110706976|NCT00325416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110706977|NCT00314808|Dronabinol|dronabinol|mesh-list
110706978|NCT00314808|Hallucinogens|hallucinogens|mesh-ancestor
110706979|NCT00314808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110706980|NCT00314808|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110706981|NCT00314808|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110706982|NCT00314808|Analgesics|analgesics|mesh-ancestor
110706983|NCT00314808|Sensory System Agents|sensory system agents|mesh-ancestor
110706984|NCT00314808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110706985|NCT00314808|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
110706986|NCT00314808|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110706987|NCT00314808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110706988|NCT00314808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110706989|NCT00314808|Hormones|hormones|mesh-ancestor
110706990|NCT00314808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110706991|NCT01060514|Vinorelbine|vinorelbine|mesh-list
110706992|NCT01060514|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110706993|NCT01060514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110706994|NCT01060514|Tubulin Modulators|tubulin modulators|mesh-ancestor
110706995|NCT01060514|Antimitotic Agents|antimitotic agents|mesh-ancestor
110706996|NCT01060514|Mitosis Modulators|mitosis modulators|mesh-ancestor
110706997|NCT01060514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110706998|NCT01061216|Insulin|insulin|mesh-list
110706999|NCT01061216|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110707000|NCT01061216|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110707001|NCT01061216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110707002|NCT00314574|Omalizumab|omalizumab|mesh-list
110707003|NCT00314574|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110707004|NCT00314574|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110707005|NCT00314574|Respiratory System Agents|respiratory system agents|mesh-ancestor
110707006|NCT01064154|Carvedilol|carvedilol|mesh-list
110707007|NCT01064154|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110707008|NCT01064154|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110707009|NCT01064154|Adrenergic Agents|adrenergic agents|mesh-ancestor
110707010|NCT01064154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110707011|NCT01064154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110707012|NCT01064154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110707013|NCT01064154|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110707014|NCT01064154|Antioxidants|antioxidants|mesh-ancestor
110707015|NCT01064154|Protective Agents|protective agents|mesh-ancestor
110707016|NCT01064154|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110707017|NCT01064154|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110707018|NCT01064154|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110707019|NCT01064154|Vasodilator Agents|vasodilator agents|mesh-ancestor
110707020|NCT01064154|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110707021|NCT01064154|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110707022|NCT00314340|Acetaminophen|acetaminophen|mesh-list
110707023|NCT00314340|Morphine|morphine|mesh-list
110707024|NCT00314340|Hydrocodone|hydrocodone|mesh-list
110707025|NCT00314340|Phenobarbital|phenobarbital|mesh-list
110707026|NCT00314340|Amphetamine|amphetamine|mesh-list
110707027|NCT00314340|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110707028|NCT00314340|Narcotics|narcotics|mesh-ancestor
110707029|NCT00314340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110707030|NCT00314340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110707031|NCT00314340|Analgesics|analgesics|mesh-ancestor
110707032|NCT00314340|Sensory System Agents|sensory system agents|mesh-ancestor
110707033|NCT00314340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110707034|NCT00314340|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110707035|NCT00314340|Antipyretics|antipyretics|mesh-ancestor
110707036|NCT00314340|Antitussive Agents|antitussive agents|mesh-ancestor
110707037|NCT00314340|Respiratory System Agents|respiratory system agents|mesh-ancestor
110707038|NCT00314340|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110707039|NCT00314340|Sympathomimetics|sympathomimetics|mesh-ancestor
110707040|NCT00314340|Autonomic Agents|autonomic agents|mesh-ancestor
110707041|NCT00314340|Dopamine Agents|dopamine agents|mesh-ancestor
110707042|NCT00314340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110707043|NCT00314340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110707044|NCT00314340|Adrenergic Agents|adrenergic agents|mesh-ancestor
110707045|NCT00314340|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110707046|NCT00314340|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110707047|NCT00314340|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110707048|NCT00314340|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110707049|NCT00314340|Anticonvulsants|anticonvulsants|mesh-ancestor
110707050|NCT00314340|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110707051|NCT00314340|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110707052|NCT00314340|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110707053|NCT00314340|GABA Modulators|gaba modulators|mesh-ancestor
110707054|NCT00314340|GABA Agents|gaba agents|mesh-ancestor
110707055|NCT00314340|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110707056|NCT00314340|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110707057|NCT00314340|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110707058|NCT00306852|Mitomycins|mitomycins|mesh-list
110707059|NCT00306852|Mitomycin|mitomycin|mesh-list
110707060|NCT00306852|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110707061|NCT00306852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110707062|NCT00306852|Alkylating Agents|alkylating agents|mesh-ancestor
110707063|NCT00306852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110707064|NCT00306852|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110707065|NCT00306852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110707066|NCT00314262|Celecoxib|celecoxib|mesh-list
110707067|NCT00314262|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110707068|NCT00314262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110707069|NCT00314262|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110707070|NCT00314262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110707071|NCT00314262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110707072|NCT00314262|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110707073|NCT00314262|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110707074|NCT00314262|Analgesics|analgesics|mesh-ancestor
110707075|NCT00314262|Sensory System Agents|sensory system agents|mesh-ancestor
110707076|NCT00314262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110707077|NCT00314262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110707078|NCT00314262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110707079|NCT00314262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110707080|NCT00314262|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110707081|NCT00314262|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110707082|NCT00333866|Pregabalin|pregabalin|mesh-list
110707083|NCT00333866|Analgesics|analgesics|mesh-ancestor
110707084|NCT00333866|Sensory System Agents|sensory system agents|mesh-ancestor
110707085|NCT00333866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110860661|NCT04049539|Cytarabine|cytarabine|mesh-list
110707086|NCT00333866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110707087|NCT00333866|Anticonvulsants|anticonvulsants|mesh-ancestor
110707088|NCT00333866|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110707089|NCT00333866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110707090|NCT00333866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110707091|NCT00333866|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110707092|NCT00333866|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110707093|NCT00333866|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110707094|NCT00333866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110707095|NCT00333866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110707096|NCT00324740|Vorinostat|vorinostat|mesh-list
110707097|NCT00324740|Isotretinoin|isotretinoin|mesh-list
110707098|NCT00324740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110707099|NCT00324740|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110707100|NCT00324740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110707101|NCT00324740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110707102|NCT00324740|Dermatologic Agents|dermatologic agents|mesh-ancestor
110707103|NCT00333788|Certolizumab Pegol|certolizumab pegol|mesh-list
110707104|NCT00333788|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110707105|NCT00333788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110707106|NCT00333788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110424955|NCT05378100|Anesthetics|anesthetics|mesh-ancestor
110707107|NCT00333788|Immunologic Factors|immunologic factors|mesh-ancestor
110707108|NCT00333788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110707109|NCT00333788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110707110|NCT00332696|Methylprednisolone|methylprednisolone|mesh-list
110707111|NCT00332696|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110707112|NCT00332696|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110707114|NCT00332696|Prednisolone acetate|prednisolone acetate|mesh-list
110707115|NCT00332696|Octreotide|octreotide|mesh-list
110707116|NCT00332696|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110707117|NCT00332696|Prednisolone phosphate|prednisolone phosphate|mesh-list
110707118|NCT00332696|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110707119|NCT00332696|Antiemetics|antiemetics|mesh-ancestor
110707120|NCT00332696|Autonomic Agents|autonomic agents|mesh-ancestor
110707121|NCT00332696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110707122|NCT00332696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110707123|NCT00332696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110707124|NCT00332696|Glucocorticoids|glucocorticoids|mesh-ancestor
110707125|NCT00332696|Hormones|hormones|mesh-ancestor
110707126|NCT00332696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110707127|NCT00332696|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110707128|NCT00332696|Protective Agents|protective agents|mesh-ancestor
110707129|NCT00332696|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110707130|NCT00332696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110707131|NCT00313716|Epoetin Alfa|epoetin alfa|mesh-list
110707132|NCT00313716|Hematinics|hematinics|mesh-ancestor
110707133|NCT00313170|Fulvestrant|fulvestrant|mesh-list
110707134|NCT00313170|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110707135|NCT00313170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110707136|NCT00313170|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110707137|NCT00313170|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110707138|NCT00313170|Hormone Antagonists|hormone antagonists|mesh-ancestor
110707139|NCT00313170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110707140|NCT00313170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110707141|NCT00332462|Cyclosporine|cyclosporine|mesh-list
110707142|NCT00332462|Cyclosporins|cyclosporins|mesh-list
110707143|NCT00332462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110707144|NCT00332462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110707145|NCT00332462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110707146|NCT00332462|Immunologic Factors|immunologic factors|mesh-ancestor
110707147|NCT00332462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110707148|NCT00332462|Antifungal Agents|antifungal agents|mesh-ancestor
110707149|NCT00332462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110707150|NCT00332462|Dermatologic Agents|dermatologic agents|mesh-ancestor
110707151|NCT00332462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110707152|NCT00332462|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110707153|NCT00324038|Acetaminophen|acetaminophen|mesh-list
110707154|NCT00324038|Buprenorphine|buprenorphine|mesh-list
110707156|NCT00324038|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110707157|NCT00324038|Analgesics|analgesics|mesh-ancestor
110707158|NCT00324038|Sensory System Agents|sensory system agents|mesh-ancestor
110707159|NCT00324038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110707160|NCT00324038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110707161|NCT00324038|Antipyretics|antipyretics|mesh-ancestor
110707162|NCT00324038|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110707163|NCT00324038|Narcotics|narcotics|mesh-ancestor
110707164|NCT00324038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110707165|NCT00324038|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110707166|NCT00324038|Antitussive Agents|antitussive agents|mesh-ancestor
110707167|NCT00324038|Respiratory System Agents|respiratory system agents|mesh-ancestor
110707168|NCT03984110|Dexamethasone|dexamethasone|mesh-list
110707169|NCT03984110|Aflibercept|aflibercept|mesh-list
110707170|NCT03984110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110707171|NCT03984110|Antiemetics|antiemetics|mesh-ancestor
110707172|NCT03984110|Autonomic Agents|autonomic agents|mesh-ancestor
110707173|NCT03984110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110707174|NCT03984110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110707175|NCT03984110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110707176|NCT03984110|Glucocorticoids|glucocorticoids|mesh-ancestor
110707177|NCT03984110|Hormones|hormones|mesh-ancestor
110707178|NCT03984110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110707179|NCT03984110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110707180|NCT03984110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110707181|NCT03984110|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110707182|NCT03984110|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110707183|NCT03984110|Growth Substances|growth substances|mesh-ancestor
110707184|NCT03984110|Growth Inhibitors|growth inhibitors|mesh-ancestor
110707185|NCT00159861|Sildenafil Citrate|sildenafil citrate|mesh-list
110707186|NCT00159861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110707187|NCT00159861|Vasodilator Agents|vasodilator agents|mesh-ancestor
110707188|NCT00159861|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110707189|NCT00159861|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110707190|NCT00159861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110707191|NCT00159861|Urological Agents|urological agents|mesh-ancestor
110707193|NCT01057628|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110707194|NCT01057628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110707195|NCT01057628|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110707196|NCT01057628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110707197|NCT00331760|Cisplatin|cisplatin|mesh-list
110707198|NCT00331760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110707199|NCT00225147|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
110707200|NCT00225147|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
110707201|NCT00225147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110707202|NCT00225147|Immunologic Factors|immunologic factors|mesh-ancestor
110707203|NCT00225147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110707204|NCT00313014|Oxycodone|oxycodone|mesh-list
110707205|NCT00313014|Buprenorphine|buprenorphine|mesh-list
110707206|NCT00313014|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110707207|NCT00313014|Narcotics|narcotics|mesh-ancestor
110707208|NCT00313014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110707209|NCT00313014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110707210|NCT00313014|Analgesics|analgesics|mesh-ancestor
110707211|NCT00313014|Sensory System Agents|sensory system agents|mesh-ancestor
110707212|NCT00313014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110707213|NCT00313014|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110707214|NCT01075659|Nicotine|nicotine|mesh-list
110707215|NCT01075659|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110707216|NCT01075659|Autonomic Agents|autonomic agents|mesh-ancestor
110133686|NCT01985477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110707217|NCT01075659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110707218|NCT01075659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110707219|NCT01075659|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110707220|NCT01075659|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110707221|NCT01075659|Cholinergic Agents|cholinergic agents|mesh-ancestor
110707222|NCT01075659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110707223|NCT01075659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110707224|NCT01077453|Letrozole|letrozole|mesh-list
110707225|NCT01077453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110707226|NCT01077453|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110707227|NCT01077453|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110707228|NCT01077453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110707229|NCT01077453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110707230|NCT01077453|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110707231|NCT01077453|Hormone Antagonists|hormone antagonists|mesh-ancestor
110707232|NCT01077453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110707233|NCT01077453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110707234|NCT00157209|Cyclophosphamide|cyclophosphamide|mesh-list
110707235|NCT00157209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110707236|NCT00157209|Immunologic Factors|immunologic factors|mesh-ancestor
110707237|NCT00157209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110707238|NCT00157209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110707239|NCT00157209|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110707240|NCT00157209|Alkylating Agents|alkylating agents|mesh-ancestor
110707241|NCT00157209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110707242|NCT00157209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110707243|NCT00157209|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110707245|NCT00312858|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110707246|NCT00312858|Immunologic Factors|immunologic factors|mesh-ancestor
110707247|NCT00312858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110707248|NCT00156819|Fluticasone|fluticasone|mesh-list
110707249|NCT00156819|Xhance|xhance|mesh-list
110707250|NCT00156819|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110707251|NCT00156819|Montelukast|montelukast|mesh-list
110707252|NCT00156819|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110707253|NCT00156819|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110707254|NCT00156819|Autonomic Agents|autonomic agents|mesh-ancestor
110707255|NCT00156819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110707256|NCT00156819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110707257|NCT00156819|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110707258|NCT00156819|Respiratory System Agents|respiratory system agents|mesh-ancestor
110707259|NCT00156819|Dermatologic Agents|dermatologic agents|mesh-ancestor
110707260|NCT00156819|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110707261|NCT00156819|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110707263|NCT00156819|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110707264|NCT00156819|Adrenergic Agents|adrenergic agents|mesh-ancestor
110707265|NCT00156819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110707266|NCT00156819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110707267|NCT00156819|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110707268|NCT00156819|Hormone Antagonists|hormone antagonists|mesh-ancestor
110707269|NCT00156819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110707270|NCT00156819|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110707271|NCT00156819|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110707272|NCT00224133|Silodosin|silodosin|mesh-list
110707273|NCT00224133|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110707274|NCT00224133|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110707275|NCT00224133|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110707276|NCT00224133|Adrenergic Agents|adrenergic agents|mesh-ancestor
110707277|NCT00224133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110707278|NCT00224133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110707279|NCT00224133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110707280|NCT00224133|Urological Agents|urological agents|mesh-ancestor
110707281|NCT00224055|Ferric gluconate|ferric gluconate|mesh-list
110707282|NCT00224055|Hematinics|hematinics|mesh-ancestor
110707283|NCT00150969|Vitamin K|vitamin k|mesh-list
110707284|NCT00150969|Vitamin K 1|vitamin k 1|mesh-list
110707285|NCT00150969|Vitamins|vitamins|mesh-ancestor
110707286|NCT00150969|Micronutrients|micronutrients|mesh-ancestor
110707287|NCT00150969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110707288|NCT00150969|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110707289|NCT00150969|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110707290|NCT00150969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110707291|NCT00150969|Hemostatics|hemostatics|mesh-ancestor
110707292|NCT00150969|Coagulants|coagulants|mesh-ancestor
110707293|NCT00150345|Voriconazole|voriconazole|mesh-list
110707294|NCT00150345|Antifungal Agents|antifungal agents|mesh-ancestor
110707295|NCT00150345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110707296|NCT00150345|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110707297|NCT00150345|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110707298|NCT00150345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110860672|NCT04049539|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110707299|NCT00150345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110707300|NCT00150345|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110707301|NCT00150345|Hormone Antagonists|hormone antagonists|mesh-ancestor
110707302|NCT00150345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110707303|NCT00150345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110707304|NCT00150345|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110707305|NCT01077609|Fluticasone|fluticasone|mesh-list
110707307|NCT01077609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110707308|NCT01077609|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110707309|NCT01077609|Autonomic Agents|autonomic agents|mesh-ancestor
110707310|NCT01077609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110707311|NCT01077609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110707312|NCT01077609|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110707313|NCT01077609|Respiratory System Agents|respiratory system agents|mesh-ancestor
110707314|NCT01077609|Dermatologic Agents|dermatologic agents|mesh-ancestor
110707315|NCT01077609|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110707316|NCT00223977|Ferric gluconate|ferric gluconate|mesh-list
110707317|NCT00223977|Ferric Compounds|ferric compounds|mesh-list
110707318|NCT00223977|Hematinics|hematinics|mesh-ancestor
110707319|NCT00148941|Vaccines|vaccines|mesh-list
110707320|NCT00148941|Immunologic Factors|immunologic factors|mesh-ancestor
110707321|NCT00148941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110707322|NCT01073553|Cephalexin|cephalexin|mesh-list
110707323|NCT01073553|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110707324|NCT01073553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110707325|NCT00148317|Dexamethasone|dexamethasone|mesh-list
110707326|NCT00148317|Doxorubicin|doxorubicin|mesh-list
110707327|NCT00148317|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110707328|NCT00148317|Bortezomib|bortezomib|mesh-list
110707329|NCT00148317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110707330|NCT00148317|Antiemetics|antiemetics|mesh-ancestor
110707331|NCT00148317|Autonomic Agents|autonomic agents|mesh-ancestor
110707332|NCT00148317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110707333|NCT00148317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110707334|NCT00148317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110707335|NCT00148317|Glucocorticoids|glucocorticoids|mesh-ancestor
110707336|NCT00148317|Hormones|hormones|mesh-ancestor
110707337|NCT00148317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110707338|NCT00148317|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110707339|NCT00148317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110707340|NCT00148317|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110707341|NCT00148317|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110707342|NCT00148317|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110707343|NCT00148317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110133706|NCT01985594|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110707344|NCT00148317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110707345|NCT00323882|Ipilimumab|ipilimumab|mesh-list
110707346|NCT00323882|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110707347|NCT00323882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110707348|NCT00323882|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110707349|NCT00323882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110707350|NCT00331682|Docetaxel|docetaxel|mesh-list
110707351|NCT00331682|Alvocidib|alvocidib|mesh-list
110707352|NCT00331682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110707353|NCT00331682|Tubulin Modulators|tubulin modulators|mesh-ancestor
110707354|NCT00331682|Antimitotic Agents|antimitotic agents|mesh-ancestor
110707355|NCT00331682|Mitosis Modulators|mitosis modulators|mesh-ancestor
110707356|NCT00331682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110707357|NCT00331682|Growth Inhibitors|growth inhibitors|mesh-ancestor
110707358|NCT00331682|Growth Substances|growth substances|mesh-ancestor
110707359|NCT00331682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110707360|NCT00331682|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110707361|NCT00331682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110707362|NCT00323492|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110707363|NCT00323492|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110707364|NCT00323492|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110707365|NCT00323492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110860675|NCT04049539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110707366|NCT00323492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110707368|NCT00323492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110707369|NCT00323492|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110707370|NCT00323492|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110707371|NCT00331136|Artesunate|artesunate|mesh-list
110707372|NCT00331136|Pyronaridine|pyronaridine|mesh-list
110707373|NCT00331136|Pyronaridine tetraphosphate, artesunate drug combination|pyronaridine tetraphosphate, artesunate drug combination|mesh-list
110707374|NCT00331136|Antimalarials|antimalarials|mesh-ancestor
110707375|NCT00331136|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110707376|NCT00331136|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110707377|NCT00331136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110707378|NCT00331136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110707379|NCT00331136|Antiviral Agents|antiviral agents|mesh-ancestor
110707380|NCT00331136|Schistosomicides|schistosomicides|mesh-ancestor
110707381|NCT00331136|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110707382|NCT00331136|Anthelmintics|anthelmintics|mesh-ancestor
110707383|NCT00330668|Mecasermin|mecasermin|mesh-list
110707384|NCT00330668|Growth Substances|growth substances|mesh-ancestor
110707385|NCT00330668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110707386|NCT00306384|Alogliptin|alogliptin|mesh-list
110707387|NCT00306384|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110707388|NCT00306384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110707389|NCT00306384|Incretins|incretins|mesh-ancestor
110707390|NCT00306384|Hormones|hormones|mesh-ancestor
110707391|NCT00306384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110707392|NCT00306384|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110707393|NCT00306384|Protease Inhibitors|protease inhibitors|mesh-ancestor
110707394|NCT00306384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110707395|NCT00306384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110707396|NCT01062906|Lidocaine|lidocaine|mesh-list
110707397|NCT01062906|Fentanyl|fentanyl|mesh-list
110707398|NCT01062906|Anesthetics, Local|anesthetics, local|mesh-ancestor
110707399|NCT01062906|Anesthetics|anesthetics|mesh-ancestor
110707400|NCT01062906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110707401|NCT01062906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110707402|NCT01062906|Sensory System Agents|sensory system agents|mesh-ancestor
110707403|NCT01062906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110707404|NCT01062906|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110707405|NCT01062906|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110707406|NCT01062906|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110707407|NCT01062906|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110707408|NCT01062906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110707409|NCT01062906|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110707410|NCT01062906|Narcotics|narcotics|mesh-ancestor
110707411|NCT01062906|Analgesics|analgesics|mesh-ancestor
110707412|NCT01062906|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110707413|NCT01062906|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110707414|NCT01062906|Anesthetics, General|anesthetics, general|mesh-ancestor
110707415|NCT00305604|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110707416|NCT00305604|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110707417|NCT00305604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110707418|NCT00305604|Incretins|incretins|mesh-ancestor
110707419|NCT00305604|Hormones|hormones|mesh-ancestor
110707420|NCT00305604|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110707421|NCT00305604|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110707422|NCT00305604|Protease Inhibitors|protease inhibitors|mesh-ancestor
110707423|NCT00305604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110707424|NCT00305604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110707425|NCT01064232|Risperidone|risperidone|mesh-list
110707426|NCT01064232|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110707427|NCT01064232|Serotonin Agents|serotonin agents|mesh-ancestor
110707428|NCT01064232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110707429|NCT01064232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110707430|NCT01064232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110707431|NCT01064232|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110707432|NCT01064232|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110707433|NCT01064232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110707434|NCT01064232|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110707435|NCT01064232|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110707436|NCT01064232|Dopamine Agents|dopamine agents|mesh-ancestor
110707437|NCT00501059|Aspirin|aspirin|mesh-list
110707438|NCT00501059|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110707439|NCT00501059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110707440|NCT00501059|Analgesics|analgesics|mesh-ancestor
110707441|NCT00501059|Sensory System Agents|sensory system agents|mesh-ancestor
110707442|NCT00501059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110707443|NCT00501059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110707444|NCT00501059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110707445|NCT00501059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110707446|NCT00501059|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110707447|NCT00501059|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110707448|NCT00501059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110707449|NCT00501059|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110707450|NCT00501059|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110707451|NCT00501059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110707452|NCT00501059|Antipyretics|antipyretics|mesh-ancestor
110707453|NCT00344318|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110707454|NCT00344318|Immunologic Factors|immunologic factors|mesh-ancestor
110707455|NCT00344318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110707456|NCT00322868|Pioglitazone|pioglitazone|mesh-list
110707457|NCT00322868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110707458|NCT00322868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110707459|NCT01016717|Omeprazole|omeprazole|mesh-list
110707460|NCT01016717|Pantoprazole|pantoprazole|mesh-list
110707461|NCT01016717|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110707462|NCT01016717|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110707463|NCT01016717|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110707464|NCT01016717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110707465|NCT01016717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110707466|NCT01016795|Lenograstim|lenograstim|mesh-list
110707467|NCT01016795|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110707468|NCT01016795|Immunologic Factors|immunologic factors|mesh-ancestor
110707469|NCT01016795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110707470|NCT00343382|Pilocarpine|pilocarpine|mesh-list
110707471|NCT00343382|Miotics|miotics|mesh-ancestor
110707472|NCT00343382|Autonomic Agents|autonomic agents|mesh-ancestor
110707473|NCT00343382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110707474|NCT00343382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110707475|NCT00343382|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
110707476|NCT00343382|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110707477|NCT00343382|Cholinergic Agents|cholinergic agents|mesh-ancestor
110707478|NCT00343382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110707479|NCT00343382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110707480|NCT00481871|Vitamins|vitamins|mesh-list
110707481|NCT00481871|Folic Acid|folic acid|mesh-list
110707482|NCT00481871|Vitamin B 12|vitamin b 12|mesh-list
110425330|NCT00938860|Cyclosporine|cyclosporine|mesh-list
110707483|NCT00481871|Vitamin B Complex|vitamin b complex|mesh-list
110707484|NCT00481871|Gemcitabine|gemcitabine|mesh-list
110707485|NCT00481871|10-deazaaminopterin|10-deazaaminopterin|mesh-list
110707486|NCT00481871|Aminopterin|aminopterin|mesh-list
110707487|NCT00481871|Micronutrients|micronutrients|mesh-ancestor
110707488|NCT00481871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110707489|NCT00481871|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110707490|NCT00481871|Antimetabolites|antimetabolites|mesh-ancestor
110707491|NCT00481871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110707492|NCT00481871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110707493|NCT00481871|Hematinics|hematinics|mesh-ancestor
110707494|NCT00481871|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110707495|NCT00481871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110707496|NCT00329420|Certolizumab Pegol|certolizumab pegol|mesh-list
110707497|NCT00329420|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110707498|NCT00329420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110707499|NCT00329420|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110707500|NCT00329420|Immunologic Factors|immunologic factors|mesh-ancestor
110707501|NCT00329420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110707502|NCT00329420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110707504|NCT00329108|Ziprasidone|ziprasidone|mesh-list
110707505|NCT00329108|Antiemetics|antiemetics|mesh-ancestor
110707506|NCT00329108|Autonomic Agents|autonomic agents|mesh-ancestor
110707507|NCT00329108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110707508|NCT00329108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110707509|NCT00329108|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110707510|NCT00329108|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110707511|NCT00329108|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110707512|NCT00329108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110707513|NCT00329108|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110707514|NCT00329108|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110707515|NCT00329108|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110707516|NCT00329108|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110707517|NCT00329108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110707518|NCT00329108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110707519|NCT00329108|Serotonin Agents|serotonin agents|mesh-ancestor
110707520|NCT00329108|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110707521|NCT00329108|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110707522|NCT00329108|Dopamine Agents|dopamine agents|mesh-ancestor
110707523|NCT00329030|Rituximab|rituximab|mesh-list
110707524|NCT00329030|Tositumomab I-131|tositumomab i-131|mesh-list
110707525|NCT00329030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110707526|NCT00329030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110707527|NCT00329030|Immunologic Factors|immunologic factors|mesh-ancestor
110707528|NCT00329030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110707529|NCT00329030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110707530|NCT00328562|Gefitinib|gefitinib|mesh-list
110707531|NCT00328562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110707532|NCT00328562|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110707533|NCT00328562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110707534|NCT00328562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110707535|NCT00328172|Metformin|metformin|mesh-list
110707536|NCT00328172|Linagliptin|linagliptin|mesh-list
110707537|NCT00328172|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110707538|NCT00328172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110707539|NCT00328172|Incretins|incretins|mesh-ancestor
110707540|NCT00328172|Hormones|hormones|mesh-ancestor
110707541|NCT00328172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110707542|NCT00328172|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110707543|NCT00328172|Protease Inhibitors|protease inhibitors|mesh-ancestor
110707544|NCT00328172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110707545|NCT00328172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110707546|NCT01061372|Pregabalin|pregabalin|mesh-list
110707547|NCT01061372|Analgesics|analgesics|mesh-ancestor
110707548|NCT01061372|Sensory System Agents|sensory system agents|mesh-ancestor
110707549|NCT01061372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110707550|NCT01061372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110707551|NCT01061372|Anticonvulsants|anticonvulsants|mesh-ancestor
110707552|NCT01061372|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110707553|NCT01061372|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110707554|NCT01061372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110707555|NCT01061372|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110707556|NCT01061372|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110707557|NCT01061372|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110707558|NCT01061372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110707559|NCT01061372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110707560|NCT00328094|Insulin|insulin|mesh-list
110707561|NCT00328094|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110707562|NCT00328094|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110707563|NCT00328094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110707564|NCT00295932|Prednisone|prednisone|mesh-list
110707565|NCT00295932|Cyclophosphamide|cyclophosphamide|mesh-list
110707566|NCT00295932|Rituximab|rituximab|mesh-list
110707567|NCT00295932|Bortezomib|bortezomib|mesh-list
110707568|NCT00295932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110707569|NCT00295932|Immunologic Factors|immunologic factors|mesh-ancestor
110707570|NCT00295932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110707571|NCT00295932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110707572|NCT00295932|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110707573|NCT00295932|Alkylating Agents|alkylating agents|mesh-ancestor
110707574|NCT00295932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110707575|NCT00295932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110707576|NCT00295932|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110707577|NCT00295932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110707578|NCT00295932|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110707579|NCT00295932|Glucocorticoids|glucocorticoids|mesh-ancestor
110707580|NCT00295932|Hormones|hormones|mesh-ancestor
110707581|NCT00295932|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110707582|NCT00295932|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110707583|NCT01063140|Vaccines|vaccines|mesh-list
110707584|NCT01063140|Immunologic Factors|immunologic factors|mesh-ancestor
110707585|NCT01063140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110707586|NCT00305448|Fulvestrant|fulvestrant|mesh-list
110707587|NCT00305448|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110707588|NCT00305448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110707589|NCT00305448|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110707590|NCT00305448|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110707591|NCT00305448|Hormone Antagonists|hormone antagonists|mesh-ancestor
110707592|NCT00305448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110707593|NCT00305448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110707594|NCT01063218|Emollients|emollients|mesh-list
110707595|NCT01063218|Dermatologic Agents|dermatologic agents|mesh-ancestor
110707596|NCT00305058|Morphine|morphine|mesh-list
110707597|NCT00305058|Hydromorphone|hydromorphone|mesh-list
110707598|NCT00305058|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110707599|NCT00305058|Narcotics|narcotics|mesh-ancestor
110707600|NCT00305058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110707601|NCT00305058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110707602|NCT00305058|Analgesics|analgesics|mesh-ancestor
110707603|NCT00305058|Sensory System Agents|sensory system agents|mesh-ancestor
110707604|NCT00305058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110707605|NCT01061450|Simvastatin|simvastatin|mesh-list
110707606|NCT01061450|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110707607|NCT01061450|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110707608|NCT01061450|Antimetabolites|antimetabolites|mesh-ancestor
110707609|NCT01061450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110707610|NCT01061450|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110707611|NCT01061450|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110707612|NCT01061450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110707613|NCT03986294|Leucovorin|leucovorin|mesh-list
110707614|NCT03986294|Antidotes|antidotes|mesh-ancestor
110707615|NCT03986294|Protective Agents|protective agents|mesh-ancestor
110707616|NCT03986294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110707617|NCT03986294|Vitamin B Complex|vitamin b complex|mesh-ancestor
110707618|NCT03986294|Vitamins|vitamins|mesh-ancestor
110707619|NCT03986294|Micronutrients|micronutrients|mesh-ancestor
110707620|NCT00322556|Immunoglobulins|immunoglobulins|mesh-list
110707621|NCT00322556|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110707622|NCT00322556|Antibodies|antibodies|mesh-list
110707623|NCT00322556|Immunologic Factors|immunologic factors|mesh-ancestor
110707624|NCT00322556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110707625|NCT00321932|Calcium, Dietary|calcium, dietary|mesh-list
110707626|NCT00321932|Cholecalciferol|cholecalciferol|mesh-list
110707627|NCT00321932|Zoledronic Acid|zoledronic acid|mesh-list
110707628|NCT00321932|Calcium Carbonate|calcium carbonate|mesh-list
110707629|NCT00321932|Calcium|calcium|mesh-list
110860713|NCT03905694|Lumasiran|lumasiran|mesh-list
110707630|NCT00321932|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110707631|NCT00321932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110707632|NCT00321932|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110707633|NCT00321932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110707634|NCT00321932|Vitamins|vitamins|mesh-ancestor
110707635|NCT00321932|Micronutrients|micronutrients|mesh-ancestor
110707636|NCT00321932|Antacids|antacids|mesh-ancestor
110707637|NCT00321932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110707638|NCT00326612|Midazolam|midazolam|mesh-list
110707639|NCT00326612|Diazepam|diazepam|mesh-list
110707640|NCT00326612|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110707641|NCT00326612|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110707642|NCT00326612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110707643|NCT00326612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110707644|NCT00326612|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110707645|NCT00326612|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110707646|NCT00326612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110707647|NCT00326612|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110707648|NCT00326612|Anesthetics, General|anesthetics, general|mesh-ancestor
110707649|NCT00326612|Anesthetics|anesthetics|mesh-ancestor
110707650|NCT00326612|GABA Modulators|gaba modulators|mesh-ancestor
110707651|NCT00326612|GABA Agents|gaba agents|mesh-ancestor
110707652|NCT00326612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110707653|NCT00326612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110707654|NCT00326612|Anticonvulsants|anticonvulsants|mesh-ancestor
110707655|NCT00326612|Antiemetics|antiemetics|mesh-ancestor
110707656|NCT00326612|Autonomic Agents|autonomic agents|mesh-ancestor
110707657|NCT00326612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110707658|NCT00326612|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110707659|NCT00326612|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110707660|NCT00326612|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110707661|NCT01060826|Somatostatin|somatostatin|mesh-list
110707662|NCT01060826|Hormones|hormones|mesh-ancestor
110707663|NCT01060826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110707664|NCT01060826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110707665|NCT00321854|Pramipexole|pramipexole|mesh-list
110707666|NCT00321854|Antioxidants|antioxidants|mesh-ancestor
110707667|NCT00321854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110707668|NCT00321854|Protective Agents|protective agents|mesh-ancestor
110707669|NCT00321854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110707670|NCT00321854|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110707671|NCT00321854|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110707672|NCT00321854|Dopamine Agonists|dopamine agonists|mesh-ancestor
110707673|NCT00321854|Dopamine Agents|dopamine agents|mesh-ancestor
110707674|NCT00321854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110707675|NCT03982862|Triamcinolone|triamcinolone|mesh-list
110707676|NCT03982862|Lidocaine|lidocaine|mesh-list
110707677|NCT03982862|Botulinum Toxins|botulinum toxins|mesh-list
110707678|NCT03982862|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110707679|NCT03982862|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110707680|NCT03982862|Anesthetics, Local|anesthetics, local|mesh-ancestor
110707681|NCT03982862|Anesthetics|anesthetics|mesh-ancestor
110707682|NCT03982862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110707683|NCT03982862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110707684|NCT03982862|Sensory System Agents|sensory system agents|mesh-ancestor
110707685|NCT03982862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110707686|NCT03982862|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110707687|NCT03982862|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110707688|NCT03982862|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110707689|NCT03982862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110707690|NCT03982862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110860724|NCT03772028|Cisplatin|cisplatin|mesh-list
110707691|NCT03982862|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110707692|NCT03982862|Cholinergic Agents|cholinergic agents|mesh-ancestor
110707693|NCT03982862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110707694|NCT03982862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110707695|NCT03982862|Glucocorticoids|glucocorticoids|mesh-ancestor
110707697|NCT03982862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110707698|NCT03982862|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110707699|NCT01060904|Doxorubicin|doxorubicin|mesh-list
110707700|NCT01060904|Bleomycin|bleomycin|mesh-list
110707701|NCT01060904|Brentuximab Vedotin|brentuximab vedotin|mesh-list
110707702|NCT01060904|Dacarbazine|dacarbazine|mesh-list
110707703|NCT01060904|Vinblastine|vinblastine|mesh-list
110707704|NCT01060904|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110707705|NCT01060904|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110707706|NCT01060904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110707707|NCT01060904|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110707708|NCT01060904|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110707709|NCT01060904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110707710|NCT01060904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110707711|NCT01060904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110707712|NCT01060904|Immunotoxins|immunotoxins|mesh-ancestor
110707713|NCT01060904|Immunoconjugates|immunoconjugates|mesh-ancestor
110707714|NCT01060904|Immunologic Factors|immunologic factors|mesh-ancestor
110707715|NCT01060904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110707716|NCT01060904|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110707717|NCT01060904|Alkylating Agents|alkylating agents|mesh-ancestor
110707718|NCT01060904|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110707719|NCT01060904|Tubulin Modulators|tubulin modulators|mesh-ancestor
110707720|NCT01060904|Antimitotic Agents|antimitotic agents|mesh-ancestor
110707721|NCT01060904|Mitosis Modulators|mitosis modulators|mesh-ancestor
110707722|NCT01058174|Fluconazole|fluconazole|mesh-list
110707723|NCT01058174|Amphotericin B|amphotericin b|mesh-list
110707724|NCT01058174|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
110707725|NCT01058174|Caspofungin|caspofungin|mesh-list
110707726|NCT01058174|Micafungin|micafungin|mesh-list
110707727|NCT01058174|Antifungal Agents|antifungal agents|mesh-ancestor
110707728|NCT01058174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110707729|NCT01058174|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110707730|NCT01058174|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110707731|NCT01058174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110707732|NCT01058174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110707733|NCT01058174|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110707734|NCT01058174|Hormone Antagonists|hormone antagonists|mesh-ancestor
110707735|NCT01058174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110707736|NCT01058174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110707737|NCT01058174|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110707738|NCT01058174|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110707739|NCT01058174|Amebicides|amebicides|mesh-ancestor
110707740|NCT01058174|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110707741|NCT01058174|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110707742|NCT01058174|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110707743|NCT01058252|Indomethacin|indomethacin|mesh-list
110707744|NCT01058252|Letrozole|letrozole|mesh-list
110707745|NCT01058252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110707746|NCT01058252|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110707747|NCT01058252|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110707748|NCT01058252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110707749|NCT01058252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110707750|NCT01058252|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110707751|NCT01058252|Hormone Antagonists|hormone antagonists|mesh-ancestor
110707752|NCT01058252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110707753|NCT01058252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110707754|NCT01058252|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110707755|NCT01058252|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110707756|NCT01058252|Analgesics|analgesics|mesh-ancestor
110707757|NCT01058252|Sensory System Agents|sensory system agents|mesh-ancestor
110707758|NCT01058252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110707759|NCT01058252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110707760|NCT01058252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110707761|NCT01058252|Gout Suppressants|gout suppressants|mesh-ancestor
110707762|NCT01058252|Tocolytic Agents|tocolytic agents|mesh-ancestor
110707763|NCT01058252|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110707764|NCT01058252|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110707765|NCT01058408|Cisplatin|cisplatin|mesh-list
110707766|NCT01058408|Everolimus|everolimus|mesh-list
110707767|NCT01058408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110707768|NCT01058408|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110707769|NCT01058408|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110707770|NCT01058408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110707771|NCT01058408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110707772|NCT01058408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110707773|NCT01058408|Immunologic Factors|immunologic factors|mesh-ancestor
110707774|NCT01058408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110707775|NCT01061060|Epoprostenol|epoprostenol|mesh-list
110707776|NCT01061060|Beraprost|beraprost|mesh-list
110707777|NCT01061060|Tezosentan|tezosentan|mesh-list
110707778|NCT01061060|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110707779|NCT01061060|Vasodilator Agents|vasodilator agents|mesh-ancestor
110707780|NCT01061060|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110707781|NCT00310388|Ezogabine|ezogabine|mesh-list
110707782|NCT00310388|Anticonvulsants|anticonvulsants|mesh-ancestor
110707783|NCT00310388|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110707784|NCT00310388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110707785|NCT03981770|Anesthetics|anesthetics|mesh-list
110707786|NCT03981770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110707787|NCT03981770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110707788|NCT00500357|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110707789|NCT00500357|Immunologic Factors|immunologic factors|mesh-ancestor
110707790|NCT00500357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110707791|NCT01063556|Donepezil|donepezil|mesh-list
110707792|NCT01063556|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110707793|NCT01063556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110707794|NCT01063556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110707795|NCT01063556|Cholinergic Agents|cholinergic agents|mesh-ancestor
110707796|NCT01063556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110707797|NCT01063556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110707798|NCT01063556|Nootropic Agents|nootropic agents|mesh-ancestor
110707799|NCT03981458|Hyaluronic Acid|hyaluronic acid|mesh-list
110707800|NCT03981458|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110707801|NCT03981458|Immunologic Factors|immunologic factors|mesh-ancestor
110707802|NCT03981458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110707803|NCT03981458|Viscosupplements|viscosupplements|mesh-ancestor
110707804|NCT03981458|Protective Agents|protective agents|mesh-ancestor
110707805|NCT00309842|Cyclosporine|cyclosporine|mesh-list
110707806|NCT00309842|Mycophenolic Acid|mycophenolic acid|mesh-list
110707807|NCT00309842|Cyclophosphamide|cyclophosphamide|mesh-list
110707808|NCT00309842|Fludarabine|fludarabine|mesh-list
110707809|NCT00309842|Fludarabine phosphate|fludarabine phosphate|mesh-list
110707810|NCT00309842|Cyclosporins|cyclosporins|mesh-list
110707811|NCT00309842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110707812|NCT00309842|Immunologic Factors|immunologic factors|mesh-ancestor
110707813|NCT00309842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110707814|NCT00309842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110707815|NCT00309842|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110707816|NCT00309842|Alkylating Agents|alkylating agents|mesh-ancestor
110707817|NCT00309842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110707818|NCT00309842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110707819|NCT00309842|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110707820|NCT00309842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110707821|NCT00309842|Antimetabolites|antimetabolites|mesh-ancestor
110707822|NCT00309842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110707823|NCT00309842|Antifungal Agents|antifungal agents|mesh-ancestor
110707824|NCT00309842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110707825|NCT00309842|Dermatologic Agents|dermatologic agents|mesh-ancestor
110707826|NCT00309842|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110707827|NCT00309842|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110707828|NCT00309842|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110707829|NCT00309842|Antitubercular Agents|antitubercular agents|mesh-ancestor
110707830|NCT00309842|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110707832|NCT03985982|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110707833|NCT03985982|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110707834|NCT03985982|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110707835|NCT03985982|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110707836|NCT03985982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110707837|NCT03985982|Cholinergic Agents|cholinergic agents|mesh-ancestor
110707838|NCT03985982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110707839|NCT03985982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110707840|NCT03985982|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110707841|NCT03985982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110707842|NCT00499889|Vidarabine|vidarabine|mesh-list
110707843|NCT00499889|Methotrexate|methotrexate|mesh-list
110707844|NCT00499889|Fludarabine phosphate|fludarabine phosphate|mesh-list
110707845|NCT00499889|Fludarabine|fludarabine|mesh-list
110707846|NCT00499889|Busulfan|busulfan|mesh-list
110707847|NCT00499889|Imatinib Mesylate|imatinib mesylate|mesh-list
110707848|NCT00499889|Tacrolimus|tacrolimus|mesh-list
110707849|NCT00499889|Thymoglobulin|thymoglobulin|mesh-list
110707850|NCT00499889|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110707851|NCT00499889|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110707852|NCT00499889|Abortifacient Agents|abortifacient agents|mesh-ancestor
110707853|NCT00499889|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110707854|NCT00499889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110707855|NCT00499889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110707856|NCT00499889|Antimetabolites|antimetabolites|mesh-ancestor
110707857|NCT00499889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110425727|NCT01021215|Celecoxib|celecoxib|mesh-list
110707858|NCT00499889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110707859|NCT00499889|Dermatologic Agents|dermatologic agents|mesh-ancestor
110707860|NCT00499889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110707861|NCT00499889|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110707862|NCT00499889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110707863|NCT00499889|Immunologic Factors|immunologic factors|mesh-ancestor
110707864|NCT00499889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110707865|NCT00499889|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110707866|NCT00499889|Antiviral Agents|antiviral agents|mesh-ancestor
110707867|NCT00499889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110707868|NCT00499889|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110707869|NCT00499889|Alkylating Agents|alkylating agents|mesh-ancestor
110707870|NCT00499889|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110707871|NCT00499889|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110707872|NCT00499889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110707873|NCT00309608|Glimepiride|glimepiride|mesh-list
110707874|NCT00309608|Linagliptin|linagliptin|mesh-list
110707875|NCT00309608|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110707876|NCT00309608|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110707877|NCT00309608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110707878|NCT00309608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110707879|NCT00309608|Immunologic Factors|immunologic factors|mesh-ancestor
110707880|NCT00309608|Incretins|incretins|mesh-ancestor
110707881|NCT00309608|Hormones|hormones|mesh-ancestor
110707882|NCT00309608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110707883|NCT00309608|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110707884|NCT00309608|Protease Inhibitors|protease inhibitors|mesh-ancestor
110707885|NCT00309608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110707886|NCT00309608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110707887|NCT00308750|Carboplatin|carboplatin|mesh-list
110707888|NCT00308750|Docetaxel|docetaxel|mesh-list
110707889|NCT00308750|Pemetrexed|pemetrexed|mesh-list
110707890|NCT00308750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110707891|NCT00308750|Tubulin Modulators|tubulin modulators|mesh-ancestor
110707892|NCT00308750|Antimitotic Agents|antimitotic agents|mesh-ancestor
110707893|NCT00308750|Mitosis Modulators|mitosis modulators|mesh-ancestor
110707894|NCT00308750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110707895|NCT00308750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110707896|NCT00308750|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110860751|NCT03737240|Insulin, Long-Acting|insulin, long-acting|mesh-list
110707897|NCT00308750|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110707899|NCT00489359|Pemetrexed|pemetrexed|mesh-list
110707900|NCT00489359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110707901|NCT00489359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110707902|NCT00489359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110707903|NCT00489359|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110707904|NCT00489359|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110707905|NCT00481247|Imatinib Mesylate|imatinib mesylate|mesh-list
110707906|NCT00481247|Dasatinib|dasatinib|mesh-list
110707907|NCT00481247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110707908|NCT00481247|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110707909|NCT00481247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110707910|NCT00481247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110707911|NCT04101461|Iron|iron|mesh-list
110707912|NCT04101461|Hepcidins|hepcidins|mesh-list
110707913|NCT04101461|Trace Elements|trace elements|mesh-ancestor
110707914|NCT04101461|Micronutrients|micronutrients|mesh-ancestor
110707915|NCT04101461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110707916|NCT04101461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110707917|NCT01017107|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
110707918|NCT01017107|Protein C|protein c|mesh-list
110707919|NCT01017107|Anticoagulants|anticoagulants|mesh-ancestor
110707920|NCT01017107|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110707921|NCT01017107|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110707922|NCT01017107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110707923|NCT01017107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110707924|NCT03997019|Analgesics, Opioid|analgesics, opioid|mesh-list
110707925|NCT03997019|Narcotics|narcotics|mesh-ancestor
110707926|NCT03997019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110707927|NCT03997019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110707928|NCT03997019|Analgesics|analgesics|mesh-ancestor
110707929|NCT03997019|Sensory System Agents|sensory system agents|mesh-ancestor
110707930|NCT03997019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110707931|NCT00480857|Docetaxel|docetaxel|mesh-list
110707932|NCT00480857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110707933|NCT00480857|Tubulin Modulators|tubulin modulators|mesh-ancestor
110707934|NCT00480857|Antimitotic Agents|antimitotic agents|mesh-ancestor
110707935|NCT00480857|Mitosis Modulators|mitosis modulators|mesh-ancestor
110707936|NCT00480857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110707937|NCT00499031|Cetuximab|cetuximab|mesh-list
110707938|NCT00499031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110707939|NCT00499031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110707940|NCT00498797|Prednisolone|prednisolone|mesh-list
110707941|NCT00498797|Docetaxel|docetaxel|mesh-list
110707942|NCT00498797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110707943|NCT00498797|Tubulin Modulators|tubulin modulators|mesh-ancestor
110707944|NCT00498797|Antimitotic Agents|antimitotic agents|mesh-ancestor
110707945|NCT00498797|Mitosis Modulators|mitosis modulators|mesh-ancestor
110707946|NCT00498797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110707947|NCT00498797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110707948|NCT00498797|Glucocorticoids|glucocorticoids|mesh-ancestor
110707949|NCT00498797|Hormones|hormones|mesh-ancestor
110707950|NCT00498797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110707951|NCT00498797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110707952|NCT00498797|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110707953|NCT00498485|Sodium Oxybate|sodium oxybate|mesh-list
110707954|NCT00498485|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110707955|NCT00498485|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110707956|NCT00498485|Anesthetics, General|anesthetics, general|mesh-ancestor
110707957|NCT00498485|Anesthetics|anesthetics|mesh-ancestor
110707958|NCT00498485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110707959|NCT00498485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110707960|NCT00498173|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
110707961|NCT00498173|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110707962|NCT00498173|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110707963|NCT00498173|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110707964|NCT00498173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110707965|NCT00498173|Adrenergic Agents|adrenergic agents|mesh-ancestor
110707966|NCT00498173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110707967|NCT00498173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110707968|NCT00295620|Anastrozole|anastrozole|mesh-list
110707969|NCT00295620|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110707970|NCT00295620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110707971|NCT00295620|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110707972|NCT00295620|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110707973|NCT00295620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110707974|NCT00295620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110707975|NCT00295620|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110707976|NCT00295620|Hormone Antagonists|hormone antagonists|mesh-ancestor
110707977|NCT00295620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110707978|NCT00295620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110707979|NCT03980496|Omeprazole|omeprazole|mesh-list
110707980|NCT03980496|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110707981|NCT03980496|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110707982|NCT03980496|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110707983|NCT03980496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110707984|NCT03980496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110707985|NCT01063530|Fluorides|fluorides|mesh-list
110707986|NCT01063530|Cariostatic Agents|cariostatic agents|mesh-ancestor
110707987|NCT01063530|Protective Agents|protective agents|mesh-ancestor
110707988|NCT01063530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110707989|NCT00304356|Nitazoxanide|nitazoxanide|mesh-list
110707990|NCT00304356|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110707991|NCT00304356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110707992|NCT01069302|Clopidogrel|clopidogrel|mesh-list
110707993|NCT01069302|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110707994|NCT01069302|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110707995|NCT01069302|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110707996|NCT01069302|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110707997|NCT01069302|Purinergic Agents|purinergic agents|mesh-ancestor
110707998|NCT01069302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110707999|NCT01069302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110708000|NCT01069302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110708001|NCT00321620|Zoledronic Acid|zoledronic acid|mesh-list
110708002|NCT00321620|Denosumab|denosumab|mesh-list
110708003|NCT00321620|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110708004|NCT00321620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110708005|NCT00304278|Cisplatin|cisplatin|mesh-list
110708006|NCT00304278|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110708007|NCT00304278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110708008|NCT00304278|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110708009|NCT00304278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110708010|NCT00304278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110708012|NCT03981068|Cisplatin|cisplatin|mesh-list
110708013|NCT03981068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110708014|NCT03981068|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
110708015|NCT03981068|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110708016|NCT03981068|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110708017|NCT03981068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110708018|NCT01064102|Cetirizine|cetirizine|mesh-list
110708019|NCT01064102|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110708020|NCT01064102|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110708021|NCT01064102|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110708022|NCT01064102|Histamine Antagonists|histamine antagonists|mesh-ancestor
110708023|NCT01064102|Histamine Agents|histamine agents|mesh-ancestor
110708024|NCT01064102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110708025|NCT01064102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110708026|NCT01064102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110708027|NCT02532114|Niclosamide|niclosamide|mesh-list
110708028|NCT02532114|Anticestodal Agents|anticestodal agents|mesh-ancestor
110708029|NCT02532114|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110708030|NCT02532114|Anthelmintics|anthelmintics|mesh-ancestor
110708031|NCT02532114|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110708032|NCT02532114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110708033|NCT02532114|Antinematodal Agents|antinematodal agents|mesh-ancestor
110708034|NCT00307736|Bevacizumab|bevacizumab|mesh-list
110708035|NCT00307736|Fluorouracil|fluorouracil|mesh-list
110133883|NCT01986322|Vaccines|vaccines|mesh-list
110708036|NCT00307736|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110708037|NCT00307736|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110708038|NCT00307736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110708039|NCT00307736|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110708040|NCT00307736|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110708041|NCT00307736|Growth Substances|growth substances|mesh-ancestor
110708042|NCT00307736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110708043|NCT00307736|Growth Inhibitors|growth inhibitors|mesh-ancestor
110708044|NCT00307736|Antimetabolites|antimetabolites|mesh-ancestor
110708045|NCT00307736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110708046|NCT00307736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110708047|NCT00307736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110708048|NCT00307736|Immunologic Factors|immunologic factors|mesh-ancestor
110708049|NCT00307736|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110708050|NCT00307736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110708051|NCT00320528|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
110708052|NCT00320528|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110708053|NCT00320528|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110708054|NCT00320528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110708055|NCT00320528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110708056|NCT00320528|Adrenergic Agents|adrenergic agents|mesh-ancestor
110708057|NCT00320528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110708058|NCT00320528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110708059|NCT03979586|Hyaluronic Acid|hyaluronic acid|mesh-list
110708060|NCT03979586|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110708061|NCT03979586|Immunologic Factors|immunologic factors|mesh-ancestor
110708062|NCT03979586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110708063|NCT03979586|Viscosupplements|viscosupplements|mesh-ancestor
110708064|NCT03979586|Protective Agents|protective agents|mesh-ancestor
110708065|NCT00294762|Paclitaxel|paclitaxel|mesh-list
110708066|NCT00294762|Carboplatin|carboplatin|mesh-list
110708067|NCT00294762|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110708068|NCT00294762|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110708069|NCT00294762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110708070|NCT00294762|Tubulin Modulators|tubulin modulators|mesh-ancestor
110708071|NCT00294762|Antimitotic Agents|antimitotic agents|mesh-ancestor
110708072|NCT00294762|Mitosis Modulators|mitosis modulators|mesh-ancestor
110708073|NCT00294762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110708074|NCT00294762|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110708075|NCT00294762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110708076|NCT00294684|Methylprednisolone|methylprednisolone|mesh-list
110708077|NCT00294684|Prednisolone|prednisolone|mesh-list
110708078|NCT00294684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110708079|NCT00294684|Antiemetics|antiemetics|mesh-ancestor
110708080|NCT00294684|Autonomic Agents|autonomic agents|mesh-ancestor
110708081|NCT00294684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110708082|NCT00294684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110708083|NCT00294684|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110708084|NCT00294684|Glucocorticoids|glucocorticoids|mesh-ancestor
110708086|NCT00294684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110708087|NCT00294684|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110708088|NCT00294684|Protective Agents|protective agents|mesh-ancestor
110708089|NCT00294684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110708090|NCT00294684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110708091|NCT00307034|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110708092|NCT00307034|Immunologic Factors|immunologic factors|mesh-ancestor
110708093|NCT00307034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110708094|NCT01061996|Basiliximab|basiliximab|mesh-list
110708095|NCT01061996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110708096|NCT01061996|Immunologic Factors|immunologic factors|mesh-ancestor
110708097|NCT01061996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110708098|NCT01064180|Carvedilol|carvedilol|mesh-list
110708099|NCT01064180|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110708100|NCT01064180|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110133924|NCT01986582|Sympathomimetics|sympathomimetics|mesh-ancestor
110708101|NCT01064180|Adrenergic Agents|adrenergic agents|mesh-ancestor
110708102|NCT01064180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110708103|NCT01064180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110708104|NCT01064180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110708105|NCT01064180|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110708107|NCT01064180|Protective Agents|protective agents|mesh-ancestor
110708108|NCT01064180|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110708109|NCT01064180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110708110|NCT01064180|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110708111|NCT01064180|Vasodilator Agents|vasodilator agents|mesh-ancestor
110708112|NCT01064180|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110708113|NCT01064180|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110708114|NCT01069536|Metoclopramide|metoclopramide|mesh-list
110708115|NCT01069536|Antiemetics|antiemetics|mesh-ancestor
110708116|NCT01069536|Autonomic Agents|autonomic agents|mesh-ancestor
110708117|NCT01069536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110708118|NCT01069536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110708119|NCT01069536|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110708120|NCT01069536|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110708121|NCT01069536|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110708122|NCT01069536|Dopamine Agents|dopamine agents|mesh-ancestor
110708123|NCT01069536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110708124|NCT01069536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110708125|NCT00320216|Ustekinumab|ustekinumab|mesh-list
110708126|NCT00320216|Dermatologic Agents|dermatologic agents|mesh-ancestor
110708127|NCT00290706|Gemcitabine|gemcitabine|mesh-list
110708128|NCT00290706|Bortezomib|bortezomib|mesh-list
110708129|NCT00290706|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110708130|NCT00290706|Antimetabolites|antimetabolites|mesh-ancestor
110708131|NCT00290706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110708132|NCT00290706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110708133|NCT03978156|Dronabinol|dronabinol|mesh-list
110708134|NCT03978156|Hallucinogens|hallucinogens|mesh-ancestor
110708135|NCT03978156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110708136|NCT03978156|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110708137|NCT03978156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110708138|NCT03978156|Analgesics|analgesics|mesh-ancestor
110708139|NCT03978156|Sensory System Agents|sensory system agents|mesh-ancestor
110708140|NCT03978156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110708141|NCT03978156|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
110708142|NCT03978156|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110708143|NCT03978156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110708144|NCT03978156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110708145|NCT03978156|Hormones|hormones|mesh-ancestor
110708146|NCT03978156|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110708147|NCT03978234|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110708148|NCT03978234|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110708149|NCT03978234|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110708150|NCT03978234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110708151|NCT03978234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110708152|NCT03978234|Cholinergic Agents|cholinergic agents|mesh-ancestor
110708153|NCT03978234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110708154|NCT03978234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110708155|NCT03978234|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110426008|NCT04299633|Calcium|calcium|mesh-list
110133930|NCT01986582|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110708156|NCT03978234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110708157|NCT01066494|Cytarabine|cytarabine|mesh-list
110708158|NCT01066494|Amonafide|amonafide|mesh-list
110708159|NCT01066494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110708160|NCT01066494|Antimetabolites|antimetabolites|mesh-ancestor
110708161|NCT01066494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110708162|NCT01066494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110708163|NCT01066494|Antiviral Agents|antiviral agents|mesh-ancestor
110708164|NCT01066494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110708165|NCT01066494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110708166|NCT01066494|Immunologic Factors|immunologic factors|mesh-ancestor
110708167|NCT01066494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110708168|NCT01066494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110708170|NCT01069770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110708171|NCT01069770|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110708172|NCT01069770|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110708173|NCT01069770|Growth Substances|growth substances|mesh-ancestor
110708174|NCT01069770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110708175|NCT01069770|Growth Inhibitors|growth inhibitors|mesh-ancestor
110708176|NCT01069770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110708177|NCT01069770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110708178|NCT01069770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110708179|NCT00303108|Carboplatin|carboplatin|mesh-list
110708180|NCT00303108|Doxorubicin|doxorubicin|mesh-list
110708181|NCT00303108|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110708182|NCT00303108|Trastuzumab|trastuzumab|mesh-list
110708183|NCT00303108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110708184|NCT00303108|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110708185|NCT00303108|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110708186|NCT00303108|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110708187|NCT00303108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110708188|NCT00303108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110708189|NCT00303108|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110708190|NCT00302952|Lovastatin|lovastatin|mesh-list
110708191|NCT00302952|L 647318|l 647318|mesh-list
110708192|NCT00302952|Dihydromevinolin|dihydromevinolin|mesh-list
110708193|NCT00302952|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110708194|NCT00302952|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110708195|NCT00302952|Antimetabolites|antimetabolites|mesh-ancestor
110708196|NCT00302952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110708197|NCT00302952|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110708198|NCT00302952|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110708199|NCT00302952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110708200|NCT01066572|Lisinopril|lisinopril|mesh-list
110708201|NCT01066572|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
110708202|NCT01066572|Protease Inhibitors|protease inhibitors|mesh-ancestor
110708203|NCT01066572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110708204|NCT01066572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110708205|NCT01066572|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110708206|NCT01066572|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110708207|NCT01066572|Protective Agents|protective agents|mesh-ancestor
110708208|NCT01066572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110708209|NCT01066650|Everolimus|everolimus|mesh-list
110708210|NCT01066650|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110708211|NCT01066650|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110708212|NCT01066650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110708213|NCT01066650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110708214|NCT01066650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110708215|NCT01066650|Immunologic Factors|immunologic factors|mesh-ancestor
110708216|NCT01066650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110708217|NCT01066650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110708218|NCT01066728|Theophylline|theophylline|mesh-list
110708219|NCT01066728|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110708220|NCT01066728|Autonomic Agents|autonomic agents|mesh-ancestor
110708221|NCT01066728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110860783|NCT03564340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110708222|NCT01066728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110708223|NCT01066728|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110708224|NCT01066728|Respiratory System Agents|respiratory system agents|mesh-ancestor
110708225|NCT01066728|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110708226|NCT01066728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110708227|NCT01066728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110708228|NCT01066728|Vasodilator Agents|vasodilator agents|mesh-ancestor
110708229|NCT01066728|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110708230|NCT01066728|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110708231|NCT01066728|Purinergic Agents|purinergic agents|mesh-ancestor
110708232|NCT01066728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110708233|NCT01325610|Cholecalciferol|cholecalciferol|mesh-list
110708234|NCT01325610|Vitamin D|vitamin d|mesh-list
110708235|NCT01325610|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110708236|NCT01325610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110708237|NCT01325610|Vitamins|vitamins|mesh-ancestor
110708238|NCT01325610|Micronutrients|micronutrients|mesh-ancestor
110708239|NCT01325610|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110708240|NCT00301080|Cycloserine|cycloserine|mesh-list
110708241|NCT00301080|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110708242|NCT00301080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110708243|NCT00301080|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110708244|NCT00301080|Antitubercular Agents|antitubercular agents|mesh-ancestor
110708245|NCT00301080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110708246|NCT00301080|Antimetabolites|antimetabolites|mesh-ancestor
110708247|NCT00301080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110708248|NCT01066806|Calcium|calcium|mesh-list
110708249|NCT01066806|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110708250|NCT01066806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110708251|NCT03977610|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
110708252|NCT03977610|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110708253|NCT03977610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110708254|NCT01066884|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110708255|NCT01066884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110708256|NCT01066884|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110708257|NCT01066884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110708258|NCT01066884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110708259|NCT02532270|Phenylephrine|phenylephrine|mesh-list
110708260|NCT02532270|Oxymetazoline|oxymetazoline|mesh-list
110708261|NCT02532270|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110708262|NCT02532270|Mydriatics|mydriatics|mesh-ancestor
110708263|NCT02532270|Autonomic Agents|autonomic agents|mesh-ancestor
110708264|NCT02532270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110708265|NCT02532270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110708266|NCT02532270|Sympathomimetics|sympathomimetics|mesh-ancestor
110708267|NCT02532270|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110708268|NCT02532270|Nasal Decongestants|nasal decongestants|mesh-ancestor
110708269|NCT02532270|Respiratory System Agents|respiratory system agents|mesh-ancestor
110708270|NCT02532270|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110708271|NCT02532270|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110708272|NCT02532270|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110708273|NCT02532270|Adrenergic Agents|adrenergic agents|mesh-ancestor
110708274|NCT02532270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110133958|NCT01986673|Urological Agents|urological agents|mesh-ancestor
110708275|NCT02532270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110708276|NCT02532270|Protective Agents|protective agents|mesh-ancestor
110708277|NCT01581450|Nitrous Oxide|nitrous oxide|mesh-list
110708278|NCT01581450|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110708279|NCT01581450|Anesthetics, General|anesthetics, general|mesh-ancestor
110708280|NCT01581450|Anesthetics|anesthetics|mesh-ancestor
110708281|NCT01581450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110708282|NCT01581450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110708283|NCT01581450|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110708284|NCT01581450|Analgesics|analgesics|mesh-ancestor
110708285|NCT01581450|Sensory System Agents|sensory system agents|mesh-ancestor
110708286|NCT01581450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110708287|NCT00289848|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110708288|NCT00289848|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110708289|NCT00289848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110708290|NCT00289848|Incretins|incretins|mesh-ancestor
110708291|NCT00289848|Hormones|hormones|mesh-ancestor
110708292|NCT00289848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110708293|NCT00289848|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110708294|NCT00289848|Protease Inhibitors|protease inhibitors|mesh-ancestor
110708295|NCT00289848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110708296|NCT00289848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110708297|NCT00289536|Factor VIII|factor viii|mesh-list
110708298|NCT00289536|Coagulants|coagulants|mesh-ancestor
110708299|NCT01066962|Ritonavir|ritonavir|mesh-list
110708300|NCT01066962|Darunavir|darunavir|mesh-list
110708301|NCT01066962|Tenofovir|tenofovir|mesh-list
110708302|NCT01066962|Emtricitabine|emtricitabine|mesh-list
110708303|NCT01066962|Raltegravir Potassium|raltegravir potassium|mesh-list
110708304|NCT01066962|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110708305|NCT01066962|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110708306|NCT01066962|Protease Inhibitors|protease inhibitors|mesh-ancestor
110708307|NCT01066962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110708308|NCT01066962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110708309|NCT01066962|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110708310|NCT01066962|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110708311|NCT01066962|Antiviral Agents|antiviral agents|mesh-ancestor
110708312|NCT01066962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110708313|NCT01066962|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110708314|NCT01066962|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110708315|NCT01066962|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110708316|NCT01066962|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110708317|NCT01066962|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110708318|NCT01066962|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110708319|NCT01067118|Insulin|insulin|mesh-list
110708320|NCT01067118|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110708321|NCT01067118|Insulin Lispro|insulin lispro|mesh-list
110708322|NCT01067118|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110708323|NCT01067118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110708324|NCT01067274|Cytarabine|cytarabine|mesh-list
110708325|NCT01067274|Azacitidine|azacitidine|mesh-list
110708326|NCT01067274|Tretinoin|tretinoin|mesh-list
110708327|NCT01067274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110708328|NCT01067274|Antimetabolites|antimetabolites|mesh-ancestor
110708329|NCT01067274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110708330|NCT01067274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110708331|NCT01067274|Antiviral Agents|antiviral agents|mesh-ancestor
110708332|NCT01067274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110708333|NCT01067274|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110708334|NCT01067274|Immunologic Factors|immunologic factors|mesh-ancestor
110708335|NCT01067274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110708336|NCT01067274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110708337|NCT01067274|Keratolytic Agents|keratolytic agents|mesh-ancestor
110708338|NCT01067274|Dermatologic Agents|dermatologic agents|mesh-ancestor
110708339|NCT01065246|Catumaxomab|catumaxomab|mesh-list
110708340|NCT01065246|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110708341|NCT01325844|Anesthetics|anesthetics|mesh-list
110708342|NCT01325844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110708343|NCT01325844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110708344|NCT01067430|Diclofenac|diclofenac|mesh-list
110708345|NCT01067430|Etoricoxib|etoricoxib|mesh-list
110708346|NCT01067430|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110708347|NCT01067430|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110708348|NCT01067430|Analgesics|analgesics|mesh-ancestor
110443786|NCT03913234|Trastuzumab|trastuzumab|mesh-list
110708349|NCT01067430|Sensory System Agents|sensory system agents|mesh-ancestor
110708350|NCT01067430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110708351|NCT01067430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110708352|NCT01067430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110708353|NCT01067430|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110708354|NCT01067430|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110708355|NCT01067430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110708356|NCT01067430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110708357|NCT01067430|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110708358|NCT00305864|Temozolomide|temozolomide|mesh-list
110708359|NCT00305864|Motexafin gadolinium|motexafin gadolinium|mesh-list
110708360|NCT00305864|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110708361|NCT00305864|Alkylating Agents|alkylating agents|mesh-ancestor
110708362|NCT00305864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110708363|NCT00305864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110708364|NCT00305864|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110708365|NCT00305864|Dermatologic Agents|dermatologic agents|mesh-ancestor
110708366|NCT03982784|Morphine|morphine|mesh-list
110708367|NCT03982784|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110708368|NCT03982784|Narcotics|narcotics|mesh-ancestor
110708369|NCT03982784|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110708370|NCT03982784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110708371|NCT03982784|Analgesics|analgesics|mesh-ancestor
110708372|NCT03982784|Sensory System Agents|sensory system agents|mesh-ancestor
110708373|NCT03982784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110708374|NCT03978884|Losartan|losartan|mesh-list
110708375|NCT03978884|Amlodipine|amlodipine|mesh-list
110708376|NCT03978884|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110708377|NCT03978884|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110708378|NCT03978884|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110708379|NCT03978884|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110708380|NCT03978884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110708381|NCT03978884|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110708382|NCT03978884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110708383|NCT03978884|Vasodilator Agents|vasodilator agents|mesh-ancestor
110708384|NCT03978884|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110708385|NCT03978884|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110708386|NCT03978884|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110708387|NCT03978884|Diuretics|diuretics|mesh-ancestor
110708388|NCT03978884|Natriuretic Agents|natriuretic agents|mesh-ancestor
110708389|NCT03978884|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110708390|NCT00319982|Diltiazem|diltiazem|mesh-list
110708391|NCT00319982|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110708392|NCT00319982|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110708393|NCT00319982|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110708394|NCT00319982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110708395|NCT00319982|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110708396|NCT00319982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110708397|NCT00319982|Vasodilator Agents|vasodilator agents|mesh-ancestor
110708398|NCT00319592|Vaccines|vaccines|mesh-list
110708399|NCT00319592|Immunologic Factors|immunologic factors|mesh-ancestor
110708400|NCT00319592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110708401|NCT03980990|Metformin|metformin|mesh-list
110708402|NCT03980990|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110708403|NCT03980990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110708404|NCT03980756|Esomeprazole|esomeprazole|mesh-list
110708405|NCT03980756|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110708406|NCT03980756|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110708407|NCT03980756|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110708408|NCT03980756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110708409|NCT03980756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110708410|NCT03978494|Tacrolimus|tacrolimus|mesh-list
110708411|NCT03978494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110708412|NCT03978494|Immunologic Factors|immunologic factors|mesh-ancestor
110708413|NCT03978494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110708414|NCT03978494|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110708415|NCT03978494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110708416|NCT03978494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110708417|NCT01064570|Tretinoin|tretinoin|mesh-list
110708418|NCT01064570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110708419|NCT01064570|Keratolytic Agents|keratolytic agents|mesh-ancestor
110708420|NCT01064570|Dermatologic Agents|dermatologic agents|mesh-ancestor
110708421|NCT01581164|Vaccines|vaccines|mesh-list
110708422|NCT01581164|Immunologic Factors|immunologic factors|mesh-ancestor
110708423|NCT01581164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110708424|NCT00319046|Miglustat|miglustat|mesh-list
110708425|NCT00319046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110708426|NCT00319046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110708428|NCT00319046|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110708429|NCT00319046|Antiviral Agents|antiviral agents|mesh-ancestor
110708430|NCT00319046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110708431|NCT00319046|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
110708432|NCT00319046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110708433|NCT00319046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110708434|NCT00303602|Olanzapine|olanzapine|mesh-list
110708435|NCT00303602|Antiemetics|antiemetics|mesh-ancestor
110708436|NCT00303602|Autonomic Agents|autonomic agents|mesh-ancestor
110708437|NCT00303602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110708438|NCT00303602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110708439|NCT00303602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110708440|NCT00303602|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110708441|NCT00303602|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110708442|NCT00303602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110708443|NCT00303602|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110708444|NCT00303602|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110708445|NCT00303602|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110708446|NCT00303602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110708447|NCT00303602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110708448|NCT00303602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110708449|NCT00303602|Serotonin Agents|serotonin agents|mesh-ancestor
110708450|NCT03979976|Ramipril|ramipril|mesh-list
110708451|NCT03979976|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
110708452|NCT03979976|Enzyme Inhibitors|enzyme inhibitors|mesh-list
110708453|NCT03979976|Protease Inhibitors|protease inhibitors|mesh-ancestor
110708454|NCT03979976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110708455|NCT03979976|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110708456|NCT00299130|Methylprednisolone|methylprednisolone|mesh-list
110708457|NCT00299130|Rituximab|rituximab|mesh-list
110708458|NCT00299130|Methotrexate|methotrexate|mesh-list
110708459|NCT00299130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110708460|NCT00299130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110708461|NCT00299130|Immunologic Factors|immunologic factors|mesh-ancestor
110708462|NCT00299130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110708463|NCT00299130|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110708464|NCT00299130|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110708465|NCT00299130|Abortifacient Agents|abortifacient agents|mesh-ancestor
110708466|NCT00299130|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110708467|NCT00299130|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110708468|NCT00299130|Antimetabolites|antimetabolites|mesh-ancestor
110708469|NCT00299130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110708470|NCT00299130|Dermatologic Agents|dermatologic agents|mesh-ancestor
110708471|NCT00299130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110708472|NCT00299130|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110708473|NCT00299130|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110708474|NCT00299130|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110708475|NCT00299130|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110708476|NCT00299130|Antiemetics|antiemetics|mesh-ancestor
110708477|NCT00299130|Autonomic Agents|autonomic agents|mesh-ancestor
110708478|NCT00299130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110708479|NCT00299130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110708480|NCT00299130|Glucocorticoids|glucocorticoids|mesh-ancestor
110708481|NCT00299130|Hormones|hormones|mesh-ancestor
110708482|NCT00299130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110708483|NCT00299130|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110708484|NCT00299130|Protective Agents|protective agents|mesh-ancestor
110708485|NCT00288054|Docetaxel|docetaxel|mesh-list
110708486|NCT00288054|Cetuximab|cetuximab|mesh-list
110708487|NCT00288054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110708488|NCT00288054|Tubulin Modulators|tubulin modulators|mesh-ancestor
110708489|NCT00288054|Antimitotic Agents|antimitotic agents|mesh-ancestor
110708490|NCT00288054|Mitosis Modulators|mitosis modulators|mesh-ancestor
110708491|NCT00288054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110708492|NCT00288054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110708493|NCT00287586|Testosterone|testosterone|mesh-list
110708494|NCT00287586|Androgens|androgens|mesh-ancestor
110708495|NCT00287586|Hormones|hormones|mesh-ancestor
110708496|NCT00287586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110708497|NCT00287586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110708498|NCT01070160|Metformin|metformin|mesh-list
110708499|NCT01070160|Progesterone|progesterone|mesh-list
110708500|NCT01070160|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110708501|NCT01070160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110708502|NCT01070160|Progestins|progestins|mesh-ancestor
110708503|NCT01070160|Hormones|hormones|mesh-ancestor
110708504|NCT01070160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110708505|NCT03977298|Chlorhexidine|chlorhexidine|mesh-list
110708506|NCT03977298|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110708507|NCT03977298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110708508|NCT03977298|Disinfectants|disinfectants|mesh-ancestor
110708509|NCT03977220|Paclitaxel|paclitaxel|mesh-list
110708510|NCT03977220|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110708511|NCT03977220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110708512|NCT03977220|Tubulin Modulators|tubulin modulators|mesh-ancestor
110708513|NCT03977220|Antimitotic Agents|antimitotic agents|mesh-ancestor
110708514|NCT03977220|Mitosis Modulators|mitosis modulators|mesh-ancestor
110708515|NCT03977220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110708516|NCT00293202|Etanercept|etanercept|mesh-list
110708517|NCT00293202|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110708518|NCT00293202|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110708519|NCT00293202|Analgesics|analgesics|mesh-ancestor
110708520|NCT00293202|Sensory System Agents|sensory system agents|mesh-ancestor
110708521|NCT00293202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110708522|NCT00293202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110708523|NCT00293202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110708524|NCT00293202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110708525|NCT00293202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110708526|NCT00293202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110708527|NCT00293202|Immunologic Factors|immunologic factors|mesh-ancestor
110426378|NCT04216459|Vitamins|vitamins|mesh-ancestor
110708528|NCT00286494|Pioglitazone|pioglitazone|mesh-list
110708529|NCT00286494|Alogliptin|alogliptin|mesh-list
110708530|NCT00286494|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110708531|NCT00286494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110708532|NCT00286494|Incretins|incretins|mesh-ancestor
110708533|NCT00286494|Hormones|hormones|mesh-ancestor
110708534|NCT00286494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110708535|NCT00286494|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110708536|NCT00286494|Protease Inhibitors|protease inhibitors|mesh-ancestor
110708537|NCT00286494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110708538|NCT00286494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110708539|NCT00298740|Insulin|insulin|mesh-list
110708540|NCT00298740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110708541|NCT00298740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110708542|NCT01067898|Vitamin D|vitamin d|mesh-list
110708543|NCT01067898|Ergocalciferols|ergocalciferols|mesh-list
110708544|NCT01067898|Cholecalciferol|cholecalciferol|mesh-list
110708545|NCT01067898|Vitamins|vitamins|mesh-list
110708546|NCT01067898|Calcium Carbonate|calcium carbonate|mesh-list
110708547|NCT01067898|Micronutrients|micronutrients|mesh-ancestor
110708548|NCT01067898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110708549|NCT01067898|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110708550|NCT01067898|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110708551|NCT01067898|Antacids|antacids|mesh-ancestor
110708552|NCT01067898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110708553|NCT01067898|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110708554|NCT03979248|Deucravacitinib|deucravacitinib|mesh-list
110708555|NCT03979248|Rabeprazole|rabeprazole|mesh-list
110708556|NCT03979248|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110708557|NCT03979248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110708558|NCT03979248|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110708559|NCT03979248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110708560|NCT03979248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110708561|NCT03979248|Dermatologic Agents|dermatologic agents|mesh-ancestor
110708562|NCT03979248|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110708563|NCT00285012|Varenicline|varenicline|mesh-list
110708564|NCT00285012|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110708565|NCT00285012|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110708566|NCT00285012|Cholinergic Agents|cholinergic agents|mesh-ancestor
110708567|NCT00285012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110708568|NCT00285012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110708569|NCT00285012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110708570|NCT00284934|Mycophenolic Acid|mycophenolic acid|mesh-list
110708571|NCT00284934|Prednisone|prednisone|mesh-list
110708572|NCT00284934|Tacrolimus|tacrolimus|mesh-list
110708573|NCT00284934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110708574|NCT00284934|Glucocorticoids|glucocorticoids|mesh-ancestor
110708575|NCT00284934|Hormones|hormones|mesh-ancestor
110708576|NCT00284934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110708577|NCT00284934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110708578|NCT00284934|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110708579|NCT00284934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110708580|NCT00284934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110708581|NCT00284934|Immunologic Factors|immunologic factors|mesh-ancestor
110708582|NCT00284934|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110708583|NCT00284934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110708584|NCT00284934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110708585|NCT00284934|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110708586|NCT00284934|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110708587|NCT00284934|Antitubercular Agents|antitubercular agents|mesh-ancestor
110708588|NCT00284934|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110708589|NCT00284934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110708590|NCT00284856|Fluticasone|fluticasone|mesh-list
110708591|NCT00284856|Montelukast|montelukast|mesh-list
110708592|NCT00284856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110708593|NCT00284856|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110708594|NCT00284856|Autonomic Agents|autonomic agents|mesh-ancestor
110708595|NCT00284856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110708596|NCT00284856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110708597|NCT00284856|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110708598|NCT00284856|Respiratory System Agents|respiratory system agents|mesh-ancestor
110708599|NCT00284856|Dermatologic Agents|dermatologic agents|mesh-ancestor
110708600|NCT00284856|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110708601|NCT00284856|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110708602|NCT00284856|Hormone Antagonists|hormone antagonists|mesh-ancestor
110708603|NCT00284856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110708604|NCT00284856|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110708605|NCT00284856|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110708606|NCT00284856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110708607|NCT00298272|Methylprednisolone|methylprednisolone|mesh-list
110708609|NCT00298272|Etanercept|etanercept|mesh-list
110708610|NCT00298272|Rituximab|rituximab|mesh-list
110708611|NCT00298272|Methotrexate|methotrexate|mesh-list
110708612|NCT00298272|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110708613|NCT00298272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110708614|NCT00298272|Immunologic Factors|immunologic factors|mesh-ancestor
110708615|NCT00298272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110708616|NCT00298272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110708617|NCT00298272|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110708618|NCT00298272|Abortifacient Agents|abortifacient agents|mesh-ancestor
110708619|NCT00298272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110708620|NCT00298272|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110708621|NCT00298272|Antimetabolites|antimetabolites|mesh-ancestor
110708622|NCT00298272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110708623|NCT00298272|Dermatologic Agents|dermatologic agents|mesh-ancestor
110708624|NCT00298272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110708625|NCT00298272|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110708626|NCT00298272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110708627|NCT00298272|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110708628|NCT00298272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110708629|NCT00298272|Antiemetics|antiemetics|mesh-ancestor
110708630|NCT00298272|Autonomic Agents|autonomic agents|mesh-ancestor
110708631|NCT00298272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110708632|NCT00298272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110708633|NCT00298272|Glucocorticoids|glucocorticoids|mesh-ancestor
110708634|NCT00298272|Hormones|hormones|mesh-ancestor
110708635|NCT00298272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110708636|NCT00298272|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110708637|NCT00298272|Protective Agents|protective agents|mesh-ancestor
110708638|NCT00298272|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110708639|NCT00298272|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110708640|NCT00298272|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110708641|NCT00298272|Analgesics|analgesics|mesh-ancestor
110708642|NCT00298272|Sensory System Agents|sensory system agents|mesh-ancestor
110708643|NCT01068054|Cyclosporine|cyclosporine|mesh-list
110708644|NCT01068054|Tacrolimus|tacrolimus|mesh-list
110708645|NCT01068054|Cyclosporins|cyclosporins|mesh-list
110708646|NCT01068054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110708647|NCT01068054|Immunologic Factors|immunologic factors|mesh-ancestor
110708648|NCT01068054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110708649|NCT01068054|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110708650|NCT01068054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110708651|NCT01068054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110708652|NCT01068054|Antifungal Agents|antifungal agents|mesh-ancestor
110708653|NCT01068054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110708654|NCT01068054|Dermatologic Agents|dermatologic agents|mesh-ancestor
110708655|NCT01068054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110708656|NCT00298038|Rifaximin|rifaximin|mesh-list
110708657|NCT00298038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110708658|NCT00298038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110708659|NCT00298038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110708660|NCT00283686|Telmisartan|telmisartan|mesh-list
110708661|NCT00283686|Lisinopril|lisinopril|mesh-list
110708662|NCT00283686|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
110708663|NCT00283686|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110708664|NCT00283686|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110708665|NCT00283686|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110708666|NCT00283686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110708667|NCT00283686|Protease Inhibitors|protease inhibitors|mesh-ancestor
110708668|NCT00283686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110708669|NCT00283686|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110708670|NCT00283686|Protective Agents|protective agents|mesh-ancestor
110708671|NCT00283686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110708672|NCT00297882|Artesunate|artesunate|mesh-list
110708673|NCT00297882|Lumefantrine|lumefantrine|mesh-list
110708674|NCT00297882|Artemether|artemether|mesh-list
110708675|NCT00297882|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
110708676|NCT00297882|Amodiaquine|amodiaquine|mesh-list
110708677|NCT00297882|Antimalarials|antimalarials|mesh-ancestor
110708678|NCT00297882|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110708679|NCT00297882|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110426528|NCT02739061|Serotonin Agents|serotonin agents|mesh-ancestor
110708680|NCT00297882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110708681|NCT00297882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110708682|NCT00297882|Antiviral Agents|antiviral agents|mesh-ancestor
110708683|NCT00297882|Schistosomicides|schistosomicides|mesh-ancestor
110708684|NCT00297882|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110708685|NCT00297882|Anthelmintics|anthelmintics|mesh-ancestor
110708686|NCT01065870|Gemcitabine|gemcitabine|mesh-list
110708687|NCT01065870|Capecitabine|capecitabine|mesh-list
110708688|NCT01065870|Docetaxel|docetaxel|mesh-list
110708689|NCT01065870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110708690|NCT01065870|Antimetabolites|antimetabolites|mesh-ancestor
110708691|NCT01065870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110708692|NCT01065870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110708693|NCT01065870|Tubulin Modulators|tubulin modulators|mesh-ancestor
110708694|NCT01065870|Antimitotic Agents|antimitotic agents|mesh-ancestor
110708695|NCT01065870|Mitosis Modulators|mitosis modulators|mesh-ancestor
110347270|NCT04068103|Vitamins|vitamins|mesh-ancestor
110708696|NCT00297648|Certolizumab Pegol|certolizumab pegol|mesh-list
110708697|NCT00297648|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110708698|NCT00297648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110708699|NCT00297648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110708700|NCT00297648|Immunologic Factors|immunologic factors|mesh-ancestor
110708701|NCT00297648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110708702|NCT00297648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110708703|NCT01068132|Cetuximab|cetuximab|mesh-list
110708704|NCT01068132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110708705|NCT01068132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110708706|NCT00297492|Nicotine|nicotine|mesh-list
110708707|NCT00297492|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110708708|NCT00297492|Autonomic Agents|autonomic agents|mesh-ancestor
110708709|NCT00297492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110708710|NCT00297492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110708711|NCT00297492|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110708712|NCT00297492|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110708713|NCT00297492|Cholinergic Agents|cholinergic agents|mesh-ancestor
110708714|NCT00297492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110708715|NCT00297492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110708716|NCT00496769|Aspirin|aspirin|mesh-list
110708717|NCT00496769|Apixaban|apixaban|mesh-list
110708718|NCT00496769|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110708719|NCT00496769|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110708720|NCT00496769|Analgesics|analgesics|mesh-ancestor
110708721|NCT00496769|Sensory System Agents|sensory system agents|mesh-ancestor
110708722|NCT00496769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110708723|NCT00496769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110708724|NCT00496769|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110708725|NCT00496769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110708726|NCT00496769|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110708727|NCT00496769|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110708728|NCT00496769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110860862|NCT03395184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110708729|NCT00496769|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110708730|NCT00496769|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110708731|NCT00496769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110708732|NCT00496769|Antipyretics|antipyretics|mesh-ancestor
110708733|NCT00496769|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110708734|NCT00496769|Antithrombins|antithrombins|mesh-ancestor
110708735|NCT00496769|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110708736|NCT00496769|Protease Inhibitors|protease inhibitors|mesh-ancestor
110708737|NCT00496769|Anticoagulants|anticoagulants|mesh-ancestor
110708738|NCT01014845|Vaccines|vaccines|mesh-list
110708739|NCT01014845|Immunologic Factors|immunologic factors|mesh-ancestor
110708740|NCT01014845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110708741|NCT00488345|Tigecycline|tigecycline|mesh-list
110708742|NCT00488345|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110708743|NCT00488345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110708744|NCT00488345|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110708745|NCT00488345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110708746|NCT00488345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110708747|NCT00283062|Docetaxel|docetaxel|mesh-list
110708748|NCT00283062|Leuprolide|leuprolide|mesh-list
110708749|NCT00283062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110708750|NCT00283062|Tubulin Modulators|tubulin modulators|mesh-ancestor
110708751|NCT00283062|Antimitotic Agents|antimitotic agents|mesh-ancestor
110708752|NCT00283062|Mitosis Modulators|mitosis modulators|mesh-ancestor
110708753|NCT00283062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110134077|NCT01987570|Allopurinol|allopurinol|mesh-list
110708754|NCT00283062|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110708755|NCT00283062|Fertility Agents|fertility agents|mesh-ancestor
110708756|NCT00283062|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110708757|NCT00283062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110708758|NCT00283062|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110708759|NCT00282984|Varenicline|varenicline|mesh-list
110708760|NCT00282984|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110708761|NCT00282984|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110708762|NCT00282984|Cholinergic Agents|cholinergic agents|mesh-ancestor
110708763|NCT00282984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110708764|NCT00282984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110708765|NCT00282984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110708766|NCT00296400|Atorvastatin|atorvastatin|mesh-list
110708767|NCT00296400|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110708768|NCT00296400|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110708769|NCT00296400|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110708770|NCT00296400|Antimetabolites|antimetabolites|mesh-ancestor
110708771|NCT00296400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110708772|NCT00296400|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110708773|NCT00296400|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110708774|NCT00296400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110708775|NCT00296244|Mycophenolic Acid|mycophenolic acid|mesh-list
110708776|NCT00296244|Prednisone|prednisone|mesh-list
110708777|NCT00296244|Methylprednisolone|methylprednisolone|mesh-list
110708778|NCT00296244|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110708779|NCT00296244|Tacrolimus|tacrolimus|mesh-list
110708780|NCT00296244|Basiliximab|basiliximab|mesh-list
110708781|NCT00296244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110708782|NCT00296244|Glucocorticoids|glucocorticoids|mesh-ancestor
110708783|NCT00296244|Hormones|hormones|mesh-ancestor
110708784|NCT00296244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110708785|NCT00296244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110708786|NCT00296244|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110708787|NCT00296244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110708788|NCT00296244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110708789|NCT00296244|Immunologic Factors|immunologic factors|mesh-ancestor
110708790|NCT00296244|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110708791|NCT00296244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110708792|NCT00296244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110708793|NCT00296244|Antiemetics|antiemetics|mesh-ancestor
110708794|NCT00296244|Autonomic Agents|autonomic agents|mesh-ancestor
110708795|NCT00296244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110708796|NCT00296244|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110708797|NCT00296244|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110708798|NCT00296244|Protective Agents|protective agents|mesh-ancestor
110708799|NCT00296244|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110708800|NCT00296244|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110708801|NCT00296244|Antitubercular Agents|antitubercular agents|mesh-ancestor
110708802|NCT00296244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110708803|NCT00296244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110708804|NCT01068444|Pioglitazone|pioglitazone|mesh-list
110708805|NCT01068444|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110708806|NCT01068444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110708807|NCT00282048|Axitinib|axitinib|mesh-list
110708808|NCT00282048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110708809|NCT00282048|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110708810|NCT00282048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110708811|NCT00282048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110708812|NCT00474539|Vaccines|vaccines|mesh-list
110708813|NCT00474539|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110708814|NCT00474539|Immunologic Factors|immunologic factors|mesh-ancestor
110708815|NCT00474539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110708816|NCT01017809|Aprepitant|aprepitant|mesh-list
110708817|NCT01017809|Antiemetics|antiemetics|mesh-ancestor
110708818|NCT01017809|Autonomic Agents|autonomic agents|mesh-ancestor
110708819|NCT01017809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110708820|NCT01017809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110708821|NCT01017809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110708822|NCT01017809|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110708823|NCT01017809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110708824|NCT01017809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110708825|NCT01020539|Fludarabine|fludarabine|mesh-list
110708826|NCT01020539|Busulfan|busulfan|mesh-list
110708828|NCT01020539|Isotretinoin|isotretinoin|mesh-list
110708829|NCT01020539|Thymoglobulin|thymoglobulin|mesh-list
110708830|NCT01020539|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110708831|NCT01020539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110708832|NCT01020539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110708833|NCT01020539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110708834|NCT01020539|Immunologic Factors|immunologic factors|mesh-ancestor
110708835|NCT01020539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110708836|NCT01020539|Alkylating Agents|alkylating agents|mesh-ancestor
110708837|NCT01020539|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110708838|NCT01020539|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110708839|NCT01020539|Dermatologic Agents|dermatologic agents|mesh-ancestor
110708840|NCT01020539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110708841|NCT01020539|Immunotoxins|immunotoxins|mesh-ancestor
110708842|NCT01020539|Immunoconjugates|immunoconjugates|mesh-ancestor
110708843|NCT00281580|Amlodipine|amlodipine|mesh-list
110708844|NCT00281580|Telmisartan|telmisartan|mesh-list
110708845|NCT00281580|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110708846|NCT00281580|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110708847|NCT00281580|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110708848|NCT00281580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110708849|NCT00281580|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110708850|NCT00281580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110708851|NCT00281580|Vasodilator Agents|vasodilator agents|mesh-ancestor
110708852|NCT00281580|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110708853|NCT00281580|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110708854|NCT00495755|Alemtuzumab|alemtuzumab|mesh-list
110708855|NCT00495755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110708856|NCT00495755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110708857|NCT01070862|Thalidomide|thalidomide|mesh-list
110708858|NCT01070862|Dexamethasone|dexamethasone|mesh-list
110708859|NCT01070862|Dexamethasone acetate|dexamethasone acetate|mesh-list
110708860|NCT01070862|Doxorubicin|doxorubicin|mesh-list
110708861|NCT01070862|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110708862|NCT01070862|Melphalan|melphalan|mesh-list
110708863|NCT01070862|Cyclophosphamide|cyclophosphamide|mesh-list
110708864|NCT01070862|Vincristine|vincristine|mesh-list
110708865|NCT01070862|BB 1101|bb 1101|mesh-list
110708866|NCT01070862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110708867|NCT01070862|Antiemetics|antiemetics|mesh-ancestor
110708868|NCT01070862|Autonomic Agents|autonomic agents|mesh-ancestor
110708869|NCT01070862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110708870|NCT01070862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110708871|NCT01070862|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110708872|NCT01070862|Glucocorticoids|glucocorticoids|mesh-ancestor
110708873|NCT01070862|Hormones|hormones|mesh-ancestor
110708874|NCT01070862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110708875|NCT01070862|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110708876|NCT01070862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110708877|NCT01070862|Protease Inhibitors|protease inhibitors|mesh-ancestor
110708878|NCT01070862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110708879|NCT01070862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110708880|NCT01070862|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110708881|NCT01070862|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110708882|NCT01070862|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110708883|NCT01070862|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110708884|NCT01070862|Alkylating Agents|alkylating agents|mesh-ancestor
110708885|NCT01070862|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110708886|NCT01070862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110708887|NCT01070862|Immunologic Factors|immunologic factors|mesh-ancestor
110708888|NCT01070862|Leprostatic Agents|leprostatic agents|mesh-ancestor
110708889|NCT01070862|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110708890|NCT01070862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110708891|NCT01070862|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110708892|NCT01070862|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110708893|NCT01070862|Growth Substances|growth substances|mesh-ancestor
110708894|NCT01070862|Growth Inhibitors|growth inhibitors|mesh-ancestor
110708895|NCT01070862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110708896|NCT01070862|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110708897|NCT01070862|Tubulin Modulators|tubulin modulators|mesh-ancestor
110708898|NCT01070862|Antimitotic Agents|antimitotic agents|mesh-ancestor
110708899|NCT01070862|Mitosis Modulators|mitosis modulators|mesh-ancestor
110708900|NCT00495677|PF 232798|pf 232798|mesh-list
110708901|NCT00495677|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
110708902|NCT00495677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110708903|NCT00495677|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110708904|NCT00495677|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110708905|NCT00495677|Antiviral Agents|antiviral agents|mesh-ancestor
110708906|NCT00495677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110708907|NCT00495521|Aminosalicylic Acid|aminosalicylic acid|mesh-list
110708908|NCT00495521|Antitubercular Agents|antitubercular agents|mesh-ancestor
110708909|NCT00495521|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110708910|NCT00495521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110708912|NCT00494507|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110708913|NCT00494507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110708914|NCT00494507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110708915|NCT00292188|Pregabalin|pregabalin|mesh-list
110708916|NCT00292188|Analgesics|analgesics|mesh-ancestor
110708917|NCT00292188|Sensory System Agents|sensory system agents|mesh-ancestor
110708918|NCT00292188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110708919|NCT00292188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110708920|NCT00292188|Anticonvulsants|anticonvulsants|mesh-ancestor
110708921|NCT00292188|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110708922|NCT00292188|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110708923|NCT00292188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110708924|NCT00292188|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110708925|NCT00292188|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110708926|NCT00292188|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110708927|NCT00292188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110708928|NCT00292188|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110708929|NCT00271596|Citalopram|citalopram|mesh-list
110708930|NCT00271596|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110708931|NCT00271596|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110708932|NCT00271596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110708933|NCT00271596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110708934|NCT00271596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110708935|NCT00271596|Serotonin Agents|serotonin agents|mesh-ancestor
110708936|NCT00271596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110708937|NCT00271596|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110708938|NCT00271596|Antidepressive Agents|antidepressive agents|mesh-ancestor
110708939|NCT00271596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110708940|NCT01068756|Dapagliflozin|dapagliflozin|mesh-list
110708941|NCT01068756|Rifampin|rifampin|mesh-list
110708942|NCT01068756|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110708943|NCT01068756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110708944|NCT01068756|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110708945|NCT01068756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110708946|NCT01068756|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110708947|NCT01068756|Antitubercular Agents|antitubercular agents|mesh-ancestor
110708948|NCT01068756|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110708949|NCT01068756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110708950|NCT01068756|Leprostatic Agents|leprostatic agents|mesh-ancestor
110708951|NCT01068756|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110708952|NCT01068756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110708953|NCT01068756|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110708954|NCT01068756|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110708955|NCT01068756|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110708956|NCT01068756|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110708957|NCT01068756|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110708958|NCT01068756|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110708959|NCT00291642|Cetirizine|cetirizine|mesh-list
110708960|NCT00291642|Levocetirizine|levocetirizine|mesh-list
110860951|NCT03132454|Dexamethasone|dexamethasone|mesh-list
110708961|NCT00291642|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110708962|NCT00291642|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110708963|NCT00291642|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110708964|NCT00291642|Histamine Antagonists|histamine antagonists|mesh-ancestor
110708965|NCT00291642|Histamine Agents|histamine agents|mesh-ancestor
110708966|NCT00291642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110708967|NCT00291642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110708968|NCT00291642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110708969|NCT01070472|Misoprostol|misoprostol|mesh-list
110708970|NCT01070472|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110708971|NCT01070472|Abortifacient Agents|abortifacient agents|mesh-ancestor
110708972|NCT01070472|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110708973|NCT01070472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110708974|NCT01070472|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110708975|NCT01070472|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110708976|NCT01070472|Oxytocics|oxytocics|mesh-ancestor
110708977|NCT00280566|Ziprasidone|ziprasidone|mesh-list
110426869|NCT02720341|Armin|armin|mesh-list
110708979|NCT00280566|Serotonin Agents|serotonin agents|mesh-ancestor
110708980|NCT00280566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110708981|NCT00280566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110708982|NCT00280566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110708983|NCT00280566|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110708984|NCT00280566|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110708985|NCT00280566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110708986|NCT00280566|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110708987|NCT00280566|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110708988|NCT00280566|Dopamine Agents|dopamine agents|mesh-ancestor
110708989|NCT00270894|Cyclophosphamide|cyclophosphamide|mesh-list
110708990|NCT00270894|Docetaxel|docetaxel|mesh-list
110708991|NCT00270894|Trastuzumab|trastuzumab|mesh-list
110708992|NCT00270894|Epirubicin|epirubicin|mesh-list
110708993|NCT00270894|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110708994|NCT00270894|Immunologic Factors|immunologic factors|mesh-ancestor
110708995|NCT00270894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110708996|NCT00270894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110708997|NCT00270894|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110708998|NCT00270894|Alkylating Agents|alkylating agents|mesh-ancestor
110708999|NCT00270894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110709000|NCT00270894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110709001|NCT00270894|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110709002|NCT00270894|Tubulin Modulators|tubulin modulators|mesh-ancestor
110709003|NCT00270894|Antimitotic Agents|antimitotic agents|mesh-ancestor
110709004|NCT00270894|Mitosis Modulators|mitosis modulators|mesh-ancestor
110709005|NCT00270894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110709006|NCT00270894|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110709007|NCT00270894|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110709008|NCT00270894|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110709009|NCT00270894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110709010|NCT01070628|Levodopa|levodopa|mesh-list
110709011|NCT01070628|Carbidopa|carbidopa|mesh-list
110709012|NCT01070628|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
110709014|NCT01070628|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110709015|NCT01070628|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110709016|NCT01070628|Dopamine Agents|dopamine agents|mesh-ancestor
110709017|NCT01070628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110709018|NCT01070628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110709019|NCT01070628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110709020|NCT01070628|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
110709021|NCT01070628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110709022|NCT01070628|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110709023|NCT01070628|Immunologic Factors|immunologic factors|mesh-ancestor
110709024|NCT01070628|Dopamine Agonists|dopamine agonists|mesh-ancestor
110709025|NCT01070628|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
110709026|NCT01070940|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
110709027|NCT01070940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110709028|NCT01070940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110709029|NCT00317642|Cytarabine|cytarabine|mesh-list
110709030|NCT00317642|Clofarabine|clofarabine|mesh-list
110709031|NCT00317642|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110709032|NCT00317642|Antimetabolites|antimetabolites|mesh-ancestor
110709033|NCT00317642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110709034|NCT00317642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110709035|NCT00317642|Antiviral Agents|antiviral agents|mesh-ancestor
110709036|NCT00317642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110709037|NCT00317642|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110709038|NCT00317642|Immunologic Factors|immunologic factors|mesh-ancestor
110709039|NCT00317642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110709040|NCT01064726|Fluticasone|fluticasone|mesh-list
110709041|NCT01064726|Xhance|xhance|mesh-list
110709042|NCT01064726|Ibuprofen|ibuprofen|mesh-list
110709043|NCT01064726|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110709044|NCT01064726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110709045|NCT01064726|Analgesics|analgesics|mesh-ancestor
110709046|NCT01064726|Sensory System Agents|sensory system agents|mesh-ancestor
110709047|NCT01064726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110709048|NCT01064726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110709049|NCT01064726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110709050|NCT01064726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110709051|NCT01064726|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110709052|NCT01064726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110709053|NCT01064726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110709054|NCT01064726|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110709055|NCT01064726|Autonomic Agents|autonomic agents|mesh-ancestor
110709056|NCT01064726|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110709057|NCT01064726|Respiratory System Agents|respiratory system agents|mesh-ancestor
110709058|NCT01064726|Dermatologic Agents|dermatologic agents|mesh-ancestor
110709059|NCT01064726|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110709060|NCT00295022|Montelukast|montelukast|mesh-list
110709061|NCT00295022|Levocetirizine|levocetirizine|mesh-list
110709062|NCT00295022|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110709063|NCT00295022|Respiratory System Agents|respiratory system agents|mesh-ancestor
110709064|NCT00295022|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110709065|NCT00295022|Hormone Antagonists|hormone antagonists|mesh-ancestor
110709066|NCT00295022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110709067|NCT00295022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110709068|NCT00295022|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110709069|NCT00295022|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110709070|NCT00295022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110709071|NCT00295022|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110709072|NCT00295022|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110709073|NCT00295022|Histamine Antagonists|histamine antagonists|mesh-ancestor
110709074|NCT00295022|Histamine Agents|histamine agents|mesh-ancestor
110709075|NCT00295022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110709076|NCT01062152|Lenalidomide|lenalidomide|mesh-list
110709077|NCT01062152|Immunologic Factors|immunologic factors|mesh-ancestor
110709078|NCT01062152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110709079|NCT01062152|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110709080|NCT01062152|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110709081|NCT01062152|Growth Substances|growth substances|mesh-ancestor
110709082|NCT01062152|Growth Inhibitors|growth inhibitors|mesh-ancestor
110709083|NCT01062152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110709084|NCT00303446|Dutasteride|dutasteride|mesh-list
110709085|NCT00303446|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
110709086|NCT00303446|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110709087|NCT00303446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110861027|NCT02735902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110709088|NCT00303446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110709089|NCT00303446|Hormone Antagonists|hormone antagonists|mesh-ancestor
110709090|NCT00303446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110709091|NCT00303446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110709093|NCT01065038|Anagrelide|anagrelide|mesh-list
110709094|NCT01065038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110709095|NCT01065038|Antisickling Agents|antisickling agents|mesh-ancestor
110709096|NCT01065038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110709097|NCT01065038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110709098|NCT01065038|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110709099|NCT01065038|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110709100|NCT01065038|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110709101|NCT01065038|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110709102|NCT00291486|Capecitabine|capecitabine|mesh-list
110709103|NCT00291486|Antibodies|antibodies|mesh-list
110709104|NCT00291486|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110709105|NCT00291486|Immunologic Factors|immunologic factors|mesh-ancestor
110709106|NCT00291486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110709107|NCT00291486|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110709108|NCT00291486|Antimetabolites|antimetabolites|mesh-ancestor
110709109|NCT00291486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110709110|NCT00291486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110709111|NCT00301964|Bevacizumab|bevacizumab|mesh-list
110709112|NCT00301964|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110709113|NCT00301964|Antibodies|antibodies|mesh-list
110709114|NCT00301964|Immunoglobulins|immunoglobulins|mesh-list
110709115|NCT00301964|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110709116|NCT00301964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110709117|NCT00301964|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110709118|NCT00301964|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110709119|NCT00301964|Growth Substances|growth substances|mesh-ancestor
110709120|NCT00301964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110709121|NCT00301964|Growth Inhibitors|growth inhibitors|mesh-ancestor
110709122|NCT00301964|Immunologic Factors|immunologic factors|mesh-ancestor
110709123|NCT01070706|Paclitaxel|paclitaxel|mesh-list
110709124|NCT01070706|Gemcitabine|gemcitabine|mesh-list
110709125|NCT01070706|Sunitinib|sunitinib|mesh-list
110709126|NCT01070706|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110709128|NCT01070706|Tubulin Modulators|tubulin modulators|mesh-ancestor
110709129|NCT01070706|Antimitotic Agents|antimitotic agents|mesh-ancestor
110709130|NCT01070706|Mitosis Modulators|mitosis modulators|mesh-ancestor
110709131|NCT01070706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110709132|NCT01070706|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110709133|NCT01070706|Antimetabolites|antimetabolites|mesh-ancestor
110709134|NCT01070706|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110709135|NCT01070706|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110709136|NCT01070706|Growth Substances|growth substances|mesh-ancestor
110709137|NCT01070706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110709138|NCT01070706|Growth Inhibitors|growth inhibitors|mesh-ancestor
110709139|NCT01070706|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110709140|NCT01070706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110709141|NCT00268242|Gemcitabine|gemcitabine|mesh-list
110709142|NCT00268242|Mitoxantrone|mitoxantrone|mesh-list
110709143|NCT00268242|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110709144|NCT00268242|Antimetabolites|antimetabolites|mesh-ancestor
110709145|NCT00268242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110709146|NCT00268242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110709147|NCT00268242|Analgesics|analgesics|mesh-ancestor
110709148|NCT00268242|Sensory System Agents|sensory system agents|mesh-ancestor
110709149|NCT00268242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110709150|NCT00268242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110709151|NCT00268242|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110709152|NCT00268242|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110709153|NCT00268242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110134189|NCT01988961|Golimumab|golimumab|mesh-list
110709155|NCT00294554|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110709156|NCT00294554|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110709157|NCT00294554|Dopamine Agents|dopamine agents|mesh-ancestor
110709158|NCT00294554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110709159|NCT00294554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110709160|NCT00294554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110709161|NCT00294554|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110709162|NCT00294554|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110709163|NCT00294398|Fluticasone|fluticasone|mesh-list
110709164|NCT00294398|Xhance|xhance|mesh-list
110709165|NCT00294398|Budesonide|budesonide|mesh-list
110709166|NCT00294398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110709167|NCT00294398|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110709168|NCT00294398|Autonomic Agents|autonomic agents|mesh-ancestor
110709169|NCT00294398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110709170|NCT00294398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110709171|NCT00294398|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110709172|NCT00294398|Respiratory System Agents|respiratory system agents|mesh-ancestor
110709173|NCT00294398|Dermatologic Agents|dermatologic agents|mesh-ancestor
110709174|NCT00294398|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110709175|NCT00294398|Glucocorticoids|glucocorticoids|mesh-ancestor
110709176|NCT00294398|Hormones|hormones|mesh-ancestor
110709177|NCT00294398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110709178|NCT00279708|Atorvastatin|atorvastatin|mesh-list
110709179|NCT00279708|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110709180|NCT00279708|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110709181|NCT00279708|Antimetabolites|antimetabolites|mesh-ancestor
110709182|NCT00279708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110709183|NCT00279708|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110709184|NCT00279708|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110709185|NCT00279708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110709186|NCT00299702|Aripiprazole|aripiprazole|mesh-list
110709187|NCT00299702|Risperidone|risperidone|mesh-list
110709188|NCT00299702|Antidepressive Agents|antidepressive agents|mesh-ancestor
110709189|NCT00299702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110709190|NCT00299702|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110709191|NCT00299702|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110709192|NCT00299702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110709193|NCT00299702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110709194|NCT00299702|Dopamine Agonists|dopamine agonists|mesh-ancestor
110709195|NCT00299702|Dopamine Agents|dopamine agents|mesh-ancestor
110709196|NCT00299702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110709197|NCT00299702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110709198|NCT00299702|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110709199|NCT00299702|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110709200|NCT00299702|Serotonin Agents|serotonin agents|mesh-ancestor
110709201|NCT00299702|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110709202|NCT00299702|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110709203|NCT00299702|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110709204|NCT00299702|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110709205|NCT00291330|Warfarin|warfarin|mesh-list
110709206|NCT00291330|Dabigatran|dabigatran|mesh-list
110709207|NCT00291330|Anticoagulants|anticoagulants|mesh-ancestor
110709208|NCT00291330|Antithrombins|antithrombins|mesh-ancestor
110709209|NCT00291330|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110709210|NCT00291330|Protease Inhibitors|protease inhibitors|mesh-ancestor
110709211|NCT00291330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110709212|NCT00291330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110709213|NCT03975036|Antibodies|antibodies|mesh-list
110709214|NCT03975036|Immunologic Factors|immunologic factors|mesh-ancestor
110709215|NCT03975036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110709216|NCT00267150|Mycophenolic Acid|mycophenolic acid|mesh-list
110709217|NCT00267150|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110709218|NCT00267150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110709219|NCT00267150|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110709220|NCT00267150|Antitubercular Agents|antitubercular agents|mesh-ancestor
110709221|NCT00267150|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110709222|NCT00267150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110709223|NCT00267150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110709224|NCT00267150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110709226|NCT01582230|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110709227|NCT01582230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110709228|NCT01582230|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110709229|NCT01582230|Protease Inhibitors|protease inhibitors|mesh-ancestor
110709230|NCT01582230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110709231|NCT01582230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110709232|NCT00278148|Paclitaxel|paclitaxel|mesh-list
110709233|NCT00278148|Carboplatin|carboplatin|mesh-list
110709234|NCT00278148|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110709235|NCT00278148|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110709236|NCT00278148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110709237|NCT00278148|Tubulin Modulators|tubulin modulators|mesh-ancestor
110709238|NCT00278148|Antimitotic Agents|antimitotic agents|mesh-ancestor
110709239|NCT00278148|Mitosis Modulators|mitosis modulators|mesh-ancestor
110709240|NCT00278148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110709241|NCT00278148|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110709242|NCT00278148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110709243|NCT00299546|Golimumab|golimumab|mesh-list
110709244|NCT00299546|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110709245|NCT00299546|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110709246|NCT00299546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110709247|NCT00299546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110709248|NCT00299546|Immunologic Factors|immunologic factors|mesh-ancestor
110709249|NCT00299546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110709250|NCT03975270|Paclitaxel|paclitaxel|mesh-list
110709251|NCT03975270|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110709252|NCT03975270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110709253|NCT03975270|Tubulin Modulators|tubulin modulators|mesh-ancestor
110709254|NCT03975270|Antimitotic Agents|antimitotic agents|mesh-ancestor
110709255|NCT03975270|Mitosis Modulators|mitosis modulators|mesh-ancestor
110709256|NCT03975270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110709257|NCT01065116|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
110709258|NCT01065116|Antimalarials|antimalarials|mesh-ancestor
110709259|NCT01065116|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110709260|NCT01065116|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110709261|NCT01065116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110709262|NCT03977792|Docosanol|docosanol|mesh-list
110709263|NCT03977792|Antiviral Agents|antiviral agents|mesh-ancestor
110709264|NCT03977792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110709265|NCT01066598|Rituximab|rituximab|mesh-list
110709266|NCT01066598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110709267|NCT01066598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110709268|NCT01066598|Immunologic Factors|immunologic factors|mesh-ancestor
110709269|NCT01066598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110709270|NCT01066598|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110709271|NCT01066676|Ibuprofen|ibuprofen|mesh-list
110709272|NCT01066676|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110709273|NCT01066676|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110709274|NCT01066676|Analgesics|analgesics|mesh-ancestor
110709275|NCT01066676|Sensory System Agents|sensory system agents|mesh-ancestor
110709276|NCT01066676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110709277|NCT01066676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110709278|NCT01066676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110709279|NCT01066676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110709280|NCT01066676|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110709281|NCT01066676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110709282|NCT01066676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110709283|NCT01065194|Simendan|simendan|mesh-list
110709284|NCT01065194|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110709285|NCT01065194|Vasodilator Agents|vasodilator agents|mesh-ancestor
110709286|NCT01065194|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110709287|NCT01065194|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110709288|NCT01065194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110709289|NCT01065194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110709290|NCT01065194|Protective Agents|protective agents|mesh-ancestor
110709291|NCT01065194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110709292|NCT01065272|Dexamethasone|dexamethasone|mesh-list
110709293|NCT01065272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110709294|NCT01065272|Antiemetics|antiemetics|mesh-ancestor
110709295|NCT01065272|Autonomic Agents|autonomic agents|mesh-ancestor
110709296|NCT01065272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110709297|NCT01065272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110709298|NCT01065272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110709299|NCT01065272|Glucocorticoids|glucocorticoids|mesh-ancestor
110709300|NCT01065272|Hormones|hormones|mesh-ancestor
110709301|NCT01065272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110709302|NCT01065272|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110709303|NCT01065272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110709304|NCT00299156|Clofarabine|clofarabine|mesh-list
110709305|NCT00299156|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110709306|NCT00299156|Antimetabolites|antimetabolites|mesh-ancestor
110709307|NCT00299156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110709308|NCT00299156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110709309|NCT00277212|Lamotrigine|lamotrigine|mesh-list
110709310|NCT00277212|Anticonvulsants|anticonvulsants|mesh-list
110709311|NCT00277212|Aripiprazole|aripiprazole|mesh-list
110709312|NCT00277212|Antidepressive Agents|antidepressive agents|mesh-ancestor
110709313|NCT00277212|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110709314|NCT00277212|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110709315|NCT00277212|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110709316|NCT00277212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110709317|NCT00277212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110709318|NCT00277212|Dopamine Agonists|dopamine agonists|mesh-ancestor
110709319|NCT00277212|Dopamine Agents|dopamine agents|mesh-ancestor
110709320|NCT00277212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110709321|NCT00277212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110709322|NCT00277212|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110709323|NCT00277212|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110709324|NCT00277212|Serotonin Agents|serotonin agents|mesh-ancestor
110709325|NCT00277212|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110709326|NCT00277212|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110709327|NCT00277212|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110709328|NCT00277212|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110709329|NCT00277212|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110709330|NCT00277212|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110709331|NCT00277212|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110709332|NCT00277212|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110709333|NCT01066754|Fexofenadine|fexofenadine|mesh-list
110709334|NCT01066754|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110709335|NCT01066754|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110313185|NCT00299390|Sagopilone|sagopilone|mesh-list
110709336|NCT01066754|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110709337|NCT01066754|Histamine Antagonists|histamine antagonists|mesh-ancestor
110709338|NCT01066754|Histamine Agents|histamine agents|mesh-ancestor
110709339|NCT01066754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110709340|NCT01066754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110709341|NCT01066754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110709342|NCT00276744|Sirolimus|sirolimus|mesh-list
110709343|NCT00276744|Gemcitabine|gemcitabine|mesh-list
110709344|NCT00276744|Capecitabine|capecitabine|mesh-list
110709345|NCT00276744|Docetaxel|docetaxel|mesh-list
110709346|NCT00276744|Irinotecan|irinotecan|mesh-list
110709347|NCT00276744|Cetuximab|cetuximab|mesh-list
110709348|NCT00276744|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110709349|NCT00276744|Mitomycins|mitomycins|mesh-list
110709350|NCT00276744|Mitomycin|mitomycin|mesh-list
110709351|NCT00276744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110709352|NCT00276744|Antimetabolites|antimetabolites|mesh-ancestor
110709353|NCT00276744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110709354|NCT00276744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110709355|NCT00276744|Tubulin Modulators|tubulin modulators|mesh-ancestor
110709356|NCT00276744|Antimitotic Agents|antimitotic agents|mesh-ancestor
110709357|NCT00276744|Mitosis Modulators|mitosis modulators|mesh-ancestor
110709358|NCT00276744|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110709359|NCT00276744|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110709360|NCT00276744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110709361|NCT00276744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110709362|NCT00276744|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110709363|NCT00276744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110709364|NCT00276744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110709365|NCT00276744|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110709366|NCT00276744|Antifungal Agents|antifungal agents|mesh-ancestor
110709367|NCT00276744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110709368|NCT00276744|Immunologic Factors|immunologic factors|mesh-ancestor
110709369|NCT00276744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110709370|NCT00276744|Alkylating Agents|alkylating agents|mesh-ancestor
110709371|NCT00276744|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110709372|NCT00251316|Lithium Carbonate|lithium carbonate|mesh-list
110709373|NCT00251316|Antidepressive Agents|antidepressive agents|mesh-ancestor
110709374|NCT00251316|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110709375|NCT00251316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110709376|NCT00251316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110709377|NCT00251316|Antimanic Agents|antimanic agents|mesh-ancestor
110709378|NCT00251316|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110709379|NCT00251316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110709380|NCT00251316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110709381|NCT02532192|Cytarabine|cytarabine|mesh-list
110709382|NCT02532192|Ciprofloxacin|ciprofloxacin|mesh-list
110709383|NCT02532192|Fluconazole|fluconazole|mesh-list
110709384|NCT02532192|Dexamethasone|dexamethasone|mesh-list
110709385|NCT02532192|Rituximab|rituximab|mesh-list
110709386|NCT02532192|Cisplatin|cisplatin|mesh-list
110709387|NCT02532192|Belinostat|belinostat|mesh-list
110709388|NCT02532192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110709389|NCT02532192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110709390|NCT02532192|Immunologic Factors|immunologic factors|mesh-ancestor
110709391|NCT02532192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110709392|NCT02532192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110134263|NCT01989416|Disinfectants|disinfectants|mesh-ancestor
110709393|NCT02532192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110709394|NCT02532192|Antiemetics|antiemetics|mesh-ancestor
110709395|NCT02532192|Autonomic Agents|autonomic agents|mesh-ancestor
110709396|NCT02532192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110709397|NCT02532192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110709398|NCT02532192|Glucocorticoids|glucocorticoids|mesh-ancestor
110709399|NCT02532192|Hormones|hormones|mesh-ancestor
110709400|NCT02532192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110709401|NCT02532192|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110709402|NCT02532192|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110709403|NCT02532192|Antimetabolites|antimetabolites|mesh-ancestor
110709404|NCT02532192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110709405|NCT02532192|Antiviral Agents|antiviral agents|mesh-ancestor
110709406|NCT02532192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110709407|NCT02532192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110709408|NCT02532192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110709409|NCT02532192|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110709410|NCT02532192|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110709411|NCT02532192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110709412|NCT02532192|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110709413|NCT02532192|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110709414|NCT02532192|Antifungal Agents|antifungal agents|mesh-ancestor
110709415|NCT02532192|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110709416|NCT02532192|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110709417|NCT02532192|Hormone Antagonists|hormone antagonists|mesh-ancestor
110709418|NCT02532192|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110709419|NCT02532192|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110709420|NCT02532192|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110709421|NCT00293462|Sargramostim|sargramostim|mesh-list
110709422|NCT00293462|Immunologic Factors|immunologic factors|mesh-ancestor
110709423|NCT00293462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110709424|NCT00316082|Metformin|metformin|mesh-list
110709425|NCT00316082|Saxagliptin|saxagliptin|mesh-list
110709426|NCT00316082|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110709427|NCT00316082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110709428|NCT00316082|Incretins|incretins|mesh-ancestor
110709429|NCT00316082|Hormones|hormones|mesh-ancestor
110709430|NCT00316082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110709431|NCT00316082|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110709432|NCT00316082|Protease Inhibitors|protease inhibitors|mesh-ancestor
110709433|NCT00316082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110709434|NCT00316082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110709435|NCT00316004|Dextrans|dextrans|mesh-list
110709436|NCT00316004|Anticoagulants|anticoagulants|mesh-ancestor
110709437|NCT00316004|Plasma Substitutes|plasma substitutes|mesh-ancestor
110709438|NCT00316004|Blood Substitutes|blood substitutes|mesh-ancestor
110709439|NCT01066832|Paclitaxel|paclitaxel|mesh-list
110709440|NCT01066832|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110709441|NCT01066832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110709442|NCT01066832|Tubulin Modulators|tubulin modulators|mesh-ancestor
110709443|NCT01066832|Antimitotic Agents|antimitotic agents|mesh-ancestor
110709444|NCT01066832|Mitosis Modulators|mitosis modulators|mesh-ancestor
110709445|NCT01066832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110709446|NCT00298766|Bortezomib|bortezomib|mesh-list
110709447|NCT00298766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110709448|NCT03979664|Dexamethasone|dexamethasone|mesh-list
110709449|NCT03979664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110709450|NCT03979664|Antiemetics|antiemetics|mesh-ancestor
110709451|NCT03979664|Autonomic Agents|autonomic agents|mesh-ancestor
110709452|NCT03979664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110709453|NCT03979664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110709454|NCT03979664|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110709455|NCT03979664|Glucocorticoids|glucocorticoids|mesh-ancestor
110709456|NCT03979664|Hormones|hormones|mesh-ancestor
110709457|NCT03979664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110709458|NCT03979664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110709459|NCT03979664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110709460|NCT01325558|Gemcitabine|gemcitabine|mesh-list
110709461|NCT01325558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110709462|NCT01325558|Antimetabolites|antimetabolites|mesh-ancestor
110709463|NCT01325558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110709464|NCT01325558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110709465|NCT00315458|Buprenorphine|buprenorphine|mesh-list
110709466|NCT00315458|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110709467|NCT00315458|Narcotics|narcotics|mesh-ancestor
110709468|NCT00315458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110709469|NCT00315458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110709470|NCT00315458|Analgesics|analgesics|mesh-ancestor
110709471|NCT00315458|Sensory System Agents|sensory system agents|mesh-ancestor
110709472|NCT00315458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110709473|NCT00315458|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110709474|NCT01065662|Sirolimus|sirolimus|mesh-list
110709475|NCT01065662|Temsirolimus|temsirolimus|mesh-list
110709476|NCT01065662|MTOR Inhibitors|mtor inhibitors|mesh-list
110709477|NCT01065662|Cediranib|cediranib|mesh-list
110709478|NCT01065662|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110709479|NCT01065662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110709480|NCT01065662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110709481|NCT01065662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110709482|NCT01065662|Immunologic Factors|immunologic factors|mesh-ancestor
110709483|NCT01065662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110709484|NCT01065662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110709485|NCT01065662|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110709486|NCT01065662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110709487|NCT01065662|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110709488|NCT01065662|Antifungal Agents|antifungal agents|mesh-ancestor
110709489|NCT01581242|Adefovir|adefovir|mesh-list
110709490|NCT01581242|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
110709491|NCT01581242|Clevudine|clevudine|mesh-list
110709492|NCT01581242|Antiviral Agents|antiviral agents|mesh-ancestor
110709493|NCT01581242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110709494|NCT01581242|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110709495|NCT01581242|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110709496|NCT01581242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110709497|NCT01581242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110709498|NCT03982238|Metformin|metformin|mesh-list
110709499|NCT03982238|Dapagliflozin|dapagliflozin|mesh-list
110709500|NCT03982238|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110709501|NCT03982238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110709502|NCT03982238|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110709503|NCT03982238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110709504|NCT00293384|Dexamethasone|dexamethasone|mesh-list
110709505|NCT00293384|Dexamethasone acetate|dexamethasone acetate|mesh-list
110709506|NCT00293384|Cyclophosphamide|cyclophosphamide|mesh-list
110709507|NCT00293384|Aprepitant|aprepitant|mesh-list
110709508|NCT00293384|Granisetron|granisetron|mesh-list
110709509|NCT00293384|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
110709510|NCT00293384|BB 1101|bb 1101|mesh-list
110709511|NCT00293384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110709512|NCT00293384|Immunologic Factors|immunologic factors|mesh-ancestor
110709513|NCT00293384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110709514|NCT00293384|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110709515|NCT00293384|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110709516|NCT00293384|Alkylating Agents|alkylating agents|mesh-ancestor
110709517|NCT00293384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110709518|NCT00293384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110709519|NCT00293384|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110709520|NCT00293384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110709521|NCT00293384|Antiemetics|antiemetics|mesh-ancestor
110709522|NCT00293384|Autonomic Agents|autonomic agents|mesh-ancestor
110709523|NCT00293384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110709524|NCT00293384|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110709526|NCT00293384|Hormones|hormones|mesh-ancestor
110709527|NCT00293384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110709528|NCT00293384|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110709529|NCT00293384|Protease Inhibitors|protease inhibitors|mesh-ancestor
110709531|NCT00293384|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110709532|NCT00293384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110709533|NCT00293384|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110709534|NCT00293384|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110709535|NCT00293384|Serotonin Agents|serotonin agents|mesh-ancestor
110709536|NCT00297830|Zoledronic Acid|zoledronic acid|mesh-list
110709537|NCT00297830|Alendronate|alendronate|mesh-list
110709538|NCT00297830|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110709539|NCT00297830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110709540|NCT00296816|Bevacizumab|bevacizumab|mesh-list
110709541|NCT00296816|Docetaxel|docetaxel|mesh-list
110709542|NCT00296816|Oxaliplatin|oxaliplatin|mesh-list
110709543|NCT00296816|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110709544|NCT00296816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110709545|NCT00296816|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110709546|NCT00296816|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110709547|NCT00296816|Growth Substances|growth substances|mesh-ancestor
110709548|NCT00296816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110709549|NCT00296816|Growth Inhibitors|growth inhibitors|mesh-ancestor
110709550|NCT00296816|Tubulin Modulators|tubulin modulators|mesh-ancestor
110709551|NCT00296816|Antimitotic Agents|antimitotic agents|mesh-ancestor
110709552|NCT00296816|Mitosis Modulators|mitosis modulators|mesh-ancestor
110709553|NCT00296816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110709554|NCT01066988|Emollients|emollients|mesh-list
110709555|NCT01066988|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110709556|NCT01066988|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110709557|NCT01066988|Dermatologic Agents|dermatologic agents|mesh-ancestor
110709558|NCT00097786|Nateglinide|nateglinide|mesh-list
110709559|NCT00097786|Valsartan|valsartan|mesh-list
110709560|NCT00097786|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110709561|NCT00097786|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110709562|NCT00097786|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110709563|NCT00097786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110709564|NCT00097786|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110709565|NCT00097786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110709566|NCT01081756|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
110709567|NCT01081756|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110709568|NCT01081756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110134307|NCT01989845|Rivaroxaban|rivaroxaban|mesh-list
110709569|NCT01081990|Cyclobenzaprine|cyclobenzaprine|mesh-list
110709570|NCT01081990|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110709571|NCT01081990|Antidepressive Agents|antidepressive agents|mesh-ancestor
110709572|NCT01081990|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110709573|NCT01081990|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110709574|NCT01081990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110709575|NCT01081990|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110709576|NCT01081990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110709577|NCT01081990|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110709578|NCT01081990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110709579|NCT01084486|Metformin|metformin|mesh-list
110709580|NCT01084486|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110709581|NCT01084486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110709582|NCT01082146|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
110709583|NCT01082146|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110709584|NCT01082146|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110709585|NCT01082146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110709586|NCT01082146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110709587|NCT01082146|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110709588|NCT01082146|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
110709589|NCT01082146|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110709590|NCT01082146|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110709591|NCT01082146|Adrenergic Agents|adrenergic agents|mesh-ancestor
110709592|NCT01082146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110709593|NCT01082146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110709594|NCT01082146|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110709595|NCT01082146|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110709596|NCT01082146|Serotonin Agents|serotonin agents|mesh-ancestor
110709597|NCT01082146|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110709598|NCT01082146|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110709599|NCT01082146|Dopamine Agents|dopamine agents|mesh-ancestor
110709601|NCT01084720|Emollients|emollients|mesh-ancestor
110709602|NCT01084720|Dermatologic Agents|dermatologic agents|mesh-ancestor
110709603|NCT03963466|Tranexamic Acid|tranexamic acid|mesh-list
110709604|NCT03963466|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110709605|NCT03963466|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110709606|NCT03963466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110709607|NCT03963466|Hemostatics|hemostatics|mesh-ancestor
110709608|NCT03963466|Coagulants|coagulants|mesh-ancestor
110709609|NCT01084876|Paclitaxel|paclitaxel|mesh-list
110709610|NCT01084876|Trastuzumab|trastuzumab|mesh-list
110709611|NCT01084876|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110709612|NCT01084876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110709613|NCT01084876|Tubulin Modulators|tubulin modulators|mesh-ancestor
110709614|NCT01084876|Antimitotic Agents|antimitotic agents|mesh-ancestor
110709615|NCT01084876|Mitosis Modulators|mitosis modulators|mesh-ancestor
110709616|NCT01084876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110709617|NCT01084876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110709618|NCT00117676|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110709619|NCT00117676|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
110709620|NCT00117676|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110709621|NCT00117676|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110709622|NCT00117676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110709623|NCT00117676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110709624|NCT00117676|Antiviral Agents|antiviral agents|mesh-ancestor
110709625|NCT00117676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110709626|NCT00117676|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110709627|NCT00117676|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110709628|NCT00251004|Cyclosporine|cyclosporine|mesh-list
110709629|NCT00251004|Mycophenolic Acid|mycophenolic acid|mesh-list
110709630|NCT00251004|Everolimus|everolimus|mesh-list
110709631|NCT00251004|Cyclosporins|cyclosporins|mesh-list
110709632|NCT00251004|Basiliximab|basiliximab|mesh-list
110709633|NCT00251004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110709634|NCT00251004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110709635|NCT00251004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110709636|NCT00251004|Immunologic Factors|immunologic factors|mesh-ancestor
110709637|NCT00251004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110709638|NCT00251004|Antifungal Agents|antifungal agents|mesh-ancestor
110709639|NCT00251004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110709640|NCT00251004|Dermatologic Agents|dermatologic agents|mesh-ancestor
110709641|NCT00251004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110709642|NCT00251004|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110709643|NCT00251004|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110709644|NCT00251004|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110709645|NCT00251004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110709646|NCT00251004|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110709647|NCT00251004|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110709648|NCT00251004|Antitubercular Agents|antitubercular agents|mesh-ancestor
110709649|NCT00251004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110709650|NCT00275262|Leuprolide|leuprolide|mesh-list
110709651|NCT00275262|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110709652|NCT00275262|Fertility Agents|fertility agents|mesh-ancestor
110709654|NCT00275262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110709655|NCT00275262|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110709656|NCT00275262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110709657|NCT00275028|Cediranib|cediranib|mesh-list
110709658|NCT00275028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110709659|NCT00275028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110709660|NCT00275028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110709661|NCT00275028|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110709662|NCT00471497|Imatinib Mesylate|imatinib mesylate|mesh-list
110709663|NCT00471497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110709664|NCT00471497|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110709665|NCT00471497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110578747|NCT00770562|Antiemetics|antiemetics|mesh-ancestor
110709666|NCT00471497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110709667|NCT04357457|Almitrine|almitrine|mesh-list
110709668|NCT04357457|Respiratory System Agents|respiratory system agents|mesh-ancestor
110709669|NCT00493649|Cyclophosphamide|cyclophosphamide|mesh-list
110709670|NCT00493649|Docetaxel|docetaxel|mesh-list
110709671|NCT00493649|Trastuzumab|trastuzumab|mesh-list
110709672|NCT00493649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110709673|NCT00493649|Immunologic Factors|immunologic factors|mesh-ancestor
110709674|NCT00493649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110709675|NCT00493649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110709676|NCT00493649|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110709677|NCT00493649|Alkylating Agents|alkylating agents|mesh-ancestor
110709678|NCT00493649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110709679|NCT00493649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110709680|NCT00493649|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110709681|NCT00493649|Tubulin Modulators|tubulin modulators|mesh-ancestor
110709682|NCT00493649|Antimitotic Agents|antimitotic agents|mesh-ancestor
110709683|NCT00493649|Mitosis Modulators|mitosis modulators|mesh-ancestor
110709684|NCT00493649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110709685|NCT01021163|Acetylcysteine|acetylcysteine|mesh-list
110709686|NCT01021163|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110709687|NCT01021163|Antiviral Agents|antiviral agents|mesh-ancestor
110709688|NCT01021163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110709689|NCT01021163|Expectorants|expectorants|mesh-ancestor
110709690|NCT01021163|Respiratory System Agents|respiratory system agents|mesh-ancestor
110709691|NCT01021163|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110709692|NCT01021163|Antioxidants|antioxidants|mesh-ancestor
110709693|NCT01021163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110709694|NCT01021163|Protective Agents|protective agents|mesh-ancestor
110709695|NCT01021163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110709696|NCT01021163|Antidotes|antidotes|mesh-ancestor
110709697|NCT01022333|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
110709698|NCT01022333|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110709699|NCT01022333|Protective Agents|protective agents|mesh-ancestor
110709700|NCT01022333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110709701|NCT01022333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110709702|NCT00117598|Sirolimus|sirolimus|mesh-list
110709703|NCT00117598|Temsirolimus|temsirolimus|mesh-list
110709704|NCT00117598|MTOR Inhibitors|mtor inhibitors|mesh-list
110709705|NCT00117598|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110709706|NCT00117598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110709707|NCT00117598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110709708|NCT00117598|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110709709|NCT00117598|Immunologic Factors|immunologic factors|mesh-ancestor
110709710|NCT00117598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110709711|NCT00117598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110709712|NCT00117598|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110709713|NCT00117598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110709714|NCT00117598|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110709715|NCT00117598|Antifungal Agents|antifungal agents|mesh-ancestor
110709716|NCT01082458|Lidocaine|lidocaine|mesh-list
110709717|NCT01082458|Remifentanil|remifentanil|mesh-list
110709718|NCT01082458|Anesthetics, Local|anesthetics, local|mesh-ancestor
110709719|NCT01082458|Anesthetics|anesthetics|mesh-ancestor
110709720|NCT01082458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110709721|NCT01082458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110709722|NCT01082458|Sensory System Agents|sensory system agents|mesh-ancestor
110709723|NCT01082458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110709724|NCT01082458|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110709725|NCT01082458|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110427598|NCT00605098|Ritonavir|ritonavir|mesh-list
110709726|NCT01082458|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110709727|NCT01082458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110709728|NCT01082458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110709729|NCT01082458|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110709730|NCT01082458|Narcotics|narcotics|mesh-ancestor
110709731|NCT01082458|Analgesics|analgesics|mesh-ancestor
110709732|NCT00469859|Cytarabine|cytarabine|mesh-list
110709733|NCT00469859|Idarubicin|idarubicin|mesh-list
110861235|NCT01346787|Antiemetics|antiemetics|mesh-ancestor
110709734|NCT00469859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110709736|NCT00469859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110709737|NCT00469859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110709738|NCT00469859|Antiviral Agents|antiviral agents|mesh-ancestor
110709739|NCT00469859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110709740|NCT00469859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110709741|NCT00469859|Immunologic Factors|immunologic factors|mesh-ancestor
110709742|NCT00469859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110709743|NCT00469859|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110709744|NCT00469859|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110709745|NCT00469859|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110709746|NCT00469859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110709747|NCT01021475|Domperidone|domperidone|mesh-list
110709748|NCT01021475|Antiemetics|antiemetics|mesh-ancestor
110709749|NCT01021475|Autonomic Agents|autonomic agents|mesh-ancestor
110709750|NCT01021475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110709751|NCT01021475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110709752|NCT01021475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110709754|NCT01021475|Dopamine Agents|dopamine agents|mesh-ancestor
110709755|NCT01021475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110709756|NCT01021475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110709757|NCT01085032|Nicotine|nicotine|mesh-list
110709758|NCT01085032|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110709759|NCT01085032|Autonomic Agents|autonomic agents|mesh-ancestor
110709760|NCT01085032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110709761|NCT01085032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110709762|NCT01085032|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110709763|NCT01085032|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110709764|NCT01085032|Cholinergic Agents|cholinergic agents|mesh-ancestor
110709765|NCT01085032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110709766|NCT01085032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110709767|NCT01021787|Titanium dioxide|titanium dioxide|mesh-list
110709768|NCT01021787|Sunscreening Agents|sunscreening agents|mesh-ancestor
110709769|NCT01021787|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110709770|NCT01021787|Protective Agents|protective agents|mesh-ancestor
110709771|NCT01021787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110709772|NCT01021787|Dermatologic Agents|dermatologic agents|mesh-ancestor
110709773|NCT01021787|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110709774|NCT00093808|Capecitabine|capecitabine|mesh-list
110709775|NCT00093808|Trastuzumab|trastuzumab|mesh-list
110709776|NCT00093808|Vinorelbine|vinorelbine|mesh-list
110709777|NCT00093808|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110709778|NCT00093808|Antimetabolites|antimetabolites|mesh-ancestor
110709779|NCT00093808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110709780|NCT00093808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110709781|NCT00093808|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110709782|NCT00093808|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110709783|NCT00093808|Tubulin Modulators|tubulin modulators|mesh-ancestor
110709784|NCT00093808|Antimitotic Agents|antimitotic agents|mesh-ancestor
110709785|NCT00093808|Mitosis Modulators|mitosis modulators|mesh-ancestor
110709786|NCT00469079|Nicotine|nicotine|mesh-list
110709787|NCT00469079|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110709788|NCT00469079|Autonomic Agents|autonomic agents|mesh-ancestor
110709789|NCT00469079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110709790|NCT00469079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110709791|NCT00469079|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110709792|NCT00469079|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110709793|NCT00469079|Cholinergic Agents|cholinergic agents|mesh-ancestor
110709794|NCT00469079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110709795|NCT00469079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110709796|NCT01326754|Artesunate|artesunate|mesh-list
110709797|NCT01326754|Lumefantrine|lumefantrine|mesh-list
110709798|NCT01326754|Artemether|artemether|mesh-list
110427663|NCT03961165|Anticonvulsants|anticonvulsants|mesh-ancestor
110709799|NCT01326754|Piperaquine|piperaquine|mesh-list
110861243|NCT01064466|Etoposide|etoposide|mesh-list
110709800|NCT01326754|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
110709801|NCT01326754|Amodiaquine|amodiaquine|mesh-list
110709802|NCT01326754|Artenimol|artenimol|mesh-list
110709803|NCT01326754|Amodiaquine, artesunate drug combination|amodiaquine, artesunate drug combination|mesh-list
110709804|NCT01326754|Antimalarials|antimalarials|mesh-ancestor
110709805|NCT01326754|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110709806|NCT01326754|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110709807|NCT01326754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110709808|NCT01326754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110709809|NCT01326754|Antiviral Agents|antiviral agents|mesh-ancestor
110709810|NCT01326754|Schistosomicides|schistosomicides|mesh-ancestor
110709811|NCT01326754|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110709812|NCT01326754|Anthelmintics|anthelmintics|mesh-ancestor
110709813|NCT00093496|Gemcitabine|gemcitabine|mesh-list
110709814|NCT00093496|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110709815|NCT00093496|Antimetabolites|antimetabolites|mesh-ancestor
110709816|NCT00093496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110709817|NCT00093496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110709818|NCT00265122|Ustekinumab|ustekinumab|mesh-list
110709819|NCT00265122|Dermatologic Agents|dermatologic agents|mesh-ancestor
110709820|NCT00096538|Valganciclovir|valganciclovir|mesh-list
110709821|NCT00096538|Antiviral Agents|antiviral agents|mesh-ancestor
110709822|NCT00096538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110709823|NCT00116428|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
110709824|NCT03971214|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
110709825|NCT03971214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110709826|NCT03971214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110709827|NCT03971214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110709828|NCT01073748|Acetaminophen|acetaminophen|mesh-list
110709829|NCT01073748|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110709830|NCT01073748|Analgesics|analgesics|mesh-ancestor
110709831|NCT01073748|Sensory System Agents|sensory system agents|mesh-ancestor
110709832|NCT01073748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110709833|NCT01073748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110709834|NCT01073748|Antipyretics|antipyretics|mesh-ancestor
110709835|NCT00468845|Pregabalin|pregabalin|mesh-list
110709836|NCT00468845|Analgesics|analgesics|mesh-ancestor
110709837|NCT00468845|Sensory System Agents|sensory system agents|mesh-ancestor
110709838|NCT00468845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110709839|NCT00468845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110709840|NCT00468845|Anticonvulsants|anticonvulsants|mesh-ancestor
110709841|NCT00468845|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110709842|NCT00468845|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110709843|NCT00468845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110709844|NCT00468845|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110709845|NCT00468845|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110709846|NCT00468845|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110709847|NCT00468845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110709848|NCT00468845|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110709849|NCT00468299|Misoprostol|misoprostol|mesh-list
110709850|NCT00468299|Mifepristone|mifepristone|mesh-list
110709851|NCT00468299|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110709852|NCT00468299|Abortifacient Agents|abortifacient agents|mesh-ancestor
110709853|NCT00468299|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110709854|NCT00468299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110709855|NCT00468299|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110709856|NCT00468299|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110709857|NCT00468299|Oxytocics|oxytocics|mesh-ancestor
110709858|NCT00468299|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
110709859|NCT00468299|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110709860|NCT00468299|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110709861|NCT00468299|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110709862|NCT00468299|Contraceptive Agents|contraceptive agents|mesh-ancestor
110709863|NCT00468299|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
110709864|NCT00468299|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
110709865|NCT00468299|Hormone Antagonists|hormone antagonists|mesh-ancestor
110709866|NCT00468299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110709867|NCT00468299|Luteolytic Agents|luteolytic agents|mesh-ancestor
110709868|NCT00468299|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110709869|NCT00468299|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
110709870|NCT01021865|Glucagon|glucagon|mesh-list
110709871|NCT01021865|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
110709872|NCT01021865|Regadenoson|regadenoson|mesh-list
110709873|NCT01021865|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110709874|NCT01021865|Hormones|hormones|mesh-ancestor
110134373|NCT01990118|Antifungal Agents|antifungal agents|mesh-ancestor
110709875|NCT01021865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110709876|NCT01021865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110709877|NCT01021865|Incretins|incretins|mesh-ancestor
110709878|NCT01021865|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
110709879|NCT01021865|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
110709880|NCT01021865|Purinergic Agonists|purinergic agonists|mesh-ancestor
110709881|NCT01021865|Purinergic Agents|purinergic agents|mesh-ancestor
110709882|NCT01021865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110709883|NCT01021865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110709884|NCT00468143|Adderall|adderall|mesh-list
110709885|NCT00468143|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110709886|NCT00468143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110709887|NCT00467831|Acetylcysteine|acetylcysteine|mesh-list
110709888|NCT00467831|Erythromycin|erythromycin|mesh-list
110709889|NCT00467831|Erythromycin Estolate|erythromycin estolate|mesh-list
110709890|NCT00467831|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
110709891|NCT00467831|Erythromycin stearate|erythromycin stearate|mesh-list
110709892|NCT00467831|Zileuton|zileuton|mesh-list
110709893|NCT00467831|Losartan|losartan|mesh-list
110709894|NCT00467831|Pravastatin|pravastatin|mesh-list
110709895|NCT00467831|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110709896|NCT00467831|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110709897|NCT00467831|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110709898|NCT00467831|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110709899|NCT00467831|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110709900|NCT00467831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110709901|NCT00467831|Antiviral Agents|antiviral agents|mesh-ancestor
110709902|NCT00467831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110709903|NCT00467831|Expectorants|expectorants|mesh-ancestor
110709904|NCT00467831|Respiratory System Agents|respiratory system agents|mesh-ancestor
110709905|NCT00467831|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110709906|NCT00467831|Antioxidants|antioxidants|mesh-ancestor
110709907|NCT00467831|Protective Agents|protective agents|mesh-ancestor
110709908|NCT00467831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110709909|NCT00467831|Antidotes|antidotes|mesh-ancestor
110709910|NCT00467831|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110709911|NCT00467831|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110709912|NCT00467831|Antimetabolites|antimetabolites|mesh-ancestor
110709913|NCT00467831|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110709914|NCT00467831|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110709915|NCT00467831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110709916|NCT00467831|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110709917|NCT00467831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110709918|NCT00467831|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110709919|NCT00467831|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110709920|NCT00467831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110709921|NCT00467831|Analgesics|analgesics|mesh-ancestor
110709922|NCT00467831|Sensory System Agents|sensory system agents|mesh-ancestor
110709923|NCT00467831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110709924|NCT00467831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110709925|NCT00467831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110709926|NCT00467831|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
110709927|NCT00467831|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110709928|NCT00467831|Hormone Antagonists|hormone antagonists|mesh-ancestor
110709929|NCT00467831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110709930|NCT00467753|Oxcarbazepine|oxcarbazepine|mesh-list
110709931|NCT00467753|Anticonvulsants|anticonvulsants|mesh-ancestor
110709932|NCT00467753|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110709933|NCT00467753|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110134392|NCT01990378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110709934|NCT00467753|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110709935|NCT00467753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110709936|NCT00467753|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110709937|NCT00467753|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110709938|NCT01021943|Spironolactone|spironolactone|mesh-list
110709939|NCT01021943|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110709940|NCT01021943|Hormone Antagonists|hormone antagonists|mesh-ancestor
110709941|NCT01021943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110709942|NCT01021943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110709943|NCT01021943|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110709944|NCT01021943|Diuretics|diuretics|mesh-ancestor
110709945|NCT01021943|Natriuretic Agents|natriuretic agents|mesh-ancestor
110709946|NCT00116272|Etanercept|etanercept|mesh-list
110709947|NCT00116272|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110709948|NCT00116272|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110709949|NCT00116272|Analgesics|analgesics|mesh-ancestor
110709950|NCT00116272|Sensory System Agents|sensory system agents|mesh-ancestor
110709951|NCT00116272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110709952|NCT00116272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110709953|NCT00116272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110709954|NCT00116272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110709955|NCT00116272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110709956|NCT00116272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110709957|NCT00116272|Immunologic Factors|immunologic factors|mesh-ancestor
110709958|NCT01022021|Rituximab|rituximab|mesh-list
110709959|NCT01022021|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110709960|NCT01022021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110709961|NCT01022021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110709962|NCT01022021|Immunologic Factors|immunologic factors|mesh-ancestor
110709963|NCT01022021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110709964|NCT01022021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110709965|NCT01022021|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110709966|NCT01022021|Alkylating Agents|alkylating agents|mesh-ancestor
110709967|NCT01022021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110709968|NCT00467597|Levodopa|levodopa|mesh-list
110709969|NCT00467597|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110709970|NCT00467597|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110709971|NCT00467597|Dopamine Agents|dopamine agents|mesh-ancestor
110709972|NCT00467597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110709973|NCT00467597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110709974|NCT00467597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110709975|NCT00115804|Fluoxetine|fluoxetine|mesh-list
110709976|NCT00115804|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110709977|NCT00115804|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110709978|NCT00115804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110709979|NCT00115804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110709980|NCT00115804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110709981|NCT00115804|Serotonin Agents|serotonin agents|mesh-ancestor
110709982|NCT00115804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110709983|NCT00115804|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110709984|NCT00115804|Antidepressive Agents|antidepressive agents|mesh-ancestor
110709985|NCT00115804|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110709986|NCT00115804|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110709987|NCT00115804|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110709988|NCT00115804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110709989|NCT00467363|Aspirin|aspirin|mesh-list
110709990|NCT00467363|Folic Acid|folic acid|mesh-list
110709991|NCT00467363|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110709992|NCT00467363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110709993|NCT00467363|Analgesics|analgesics|mesh-ancestor
110709994|NCT00467363|Sensory System Agents|sensory system agents|mesh-ancestor
110709995|NCT00467363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110709996|NCT00467363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110709997|NCT00467363|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110709998|NCT00467363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110709999|NCT00467363|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110710000|NCT00467363|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110710001|NCT00467363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110710002|NCT00467363|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110710003|NCT00467363|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110710004|NCT00467363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110710005|NCT00467363|Antipyretics|antipyretics|mesh-ancestor
110710006|NCT00467363|Hematinics|hematinics|mesh-ancestor
110710007|NCT00467363|Vitamin B Complex|vitamin b complex|mesh-ancestor
110710008|NCT00467363|Vitamins|vitamins|mesh-ancestor
110710009|NCT00467363|Micronutrients|micronutrients|mesh-ancestor
110710010|NCT01071174|Dapivirine|dapivirine|mesh-list
110710011|NCT01071174|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110710012|NCT01071174|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110710013|NCT01071174|Antiviral Agents|antiviral agents|mesh-ancestor
110710014|NCT01071174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110710015|NCT00466505|Celecoxib|celecoxib|mesh-list
110710016|NCT00466505|Cetuximab|cetuximab|mesh-list
110710017|NCT00466505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110710018|NCT00466505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110710019|NCT00466505|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110710020|NCT00466505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110710021|NCT00466505|Analgesics|analgesics|mesh-ancestor
110710022|NCT00466505|Sensory System Agents|sensory system agents|mesh-ancestor
110710023|NCT00466505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110710024|NCT00466505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110710025|NCT00466505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110710026|NCT00466505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110710027|NCT00466505|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110710028|NCT00466505|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110710029|NCT00466505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110710030|NCT00466505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110710031|NCT02531568|Warfarin|warfarin|mesh-list
110710032|NCT02531568|Anticoagulants|anticoagulants|mesh-ancestor
110710033|NCT00467051|Paclitaxel|paclitaxel|mesh-list
110710034|NCT00467051|Carboplatin|carboplatin|mesh-list
110710035|NCT00467051|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110710036|NCT00467051|Ifosfamide|ifosfamide|mesh-list
110710037|NCT00467051|Isophosphamide mustard|isophosphamide mustard|mesh-list
110710038|NCT00467051|Lenograstim|lenograstim|mesh-list
110710039|NCT00467051|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110710040|NCT00467051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110710041|NCT00467051|Tubulin Modulators|tubulin modulators|mesh-ancestor
110710042|NCT00467051|Antimitotic Agents|antimitotic agents|mesh-ancestor
110710043|NCT00467051|Mitosis Modulators|mitosis modulators|mesh-ancestor
110710044|NCT00467051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110710045|NCT00467051|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110710046|NCT00467051|Immunologic Factors|immunologic factors|mesh-ancestor
110710047|NCT00467051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110710048|NCT00467051|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110710049|NCT00467051|Alkylating Agents|alkylating agents|mesh-ancestor
110710050|NCT00264498|Carboplatin|carboplatin|mesh-list
110710051|NCT00264498|Gemcitabine|gemcitabine|mesh-list
110710053|NCT00264498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110710054|NCT00264498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110710055|NCT00264498|Antimetabolites|antimetabolites|mesh-ancestor
110710056|NCT00264498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110710057|NCT00264498|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110710058|NCT00264498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110710059|NCT00466193|Zolpidem|zolpidem|mesh-list
110710060|NCT00466193|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110710061|NCT00466193|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110710062|NCT00466193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110710063|NCT00466193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110710064|NCT00466193|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
110710065|NCT00466193|GABA Agonists|gaba agonists|mesh-ancestor
110710066|NCT00466193|GABA Agents|gaba agents|mesh-ancestor
110710067|NCT00466193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110710068|NCT00466193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110710069|NCT01072578|Dapagliflozin|dapagliflozin|mesh-list
110710070|NCT01072578|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110710071|NCT01072578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110710072|NCT01072578|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110710073|NCT01072578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110710074|NCT01072734|Vaccines|vaccines|mesh-list
110710075|NCT01072734|Immunologic Factors|immunologic factors|mesh-ancestor
110710076|NCT01072734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110710077|NCT03970668|Insulin|insulin|mesh-list
110710078|NCT03970668|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110710079|NCT03970668|Linagliptin|linagliptin|mesh-list
110710080|NCT03970668|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110710081|NCT03970668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110710082|NCT03970668|Incretins|incretins|mesh-ancestor
110710083|NCT03970668|Hormones|hormones|mesh-ancestor
110710084|NCT03970668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110710085|NCT03970668|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110710086|NCT03970668|Protease Inhibitors|protease inhibitors|mesh-ancestor
110710087|NCT03970668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110710088|NCT03970668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110710089|NCT00454181|Interferons|interferons|mesh-list
110710090|NCT00454181|Interferon-alpha|interferon-alpha|mesh-list
110710091|NCT00454181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110710092|NCT00454181|Antiviral Agents|antiviral agents|mesh-ancestor
110710093|NCT00454181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110710094|NCT00454181|Immunologic Factors|immunologic factors|mesh-ancestor
110710095|NCT00454181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110710096|NCT01073826|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110710097|NCT01073826|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110710098|NCT01073826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110710099|NCT01073826|Incretins|incretins|mesh-ancestor
110427962|NCT00612469|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110710100|NCT01073826|Hormones|hormones|mesh-ancestor
110710101|NCT01073826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110710102|NCT01073826|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110710103|NCT01073826|Protease Inhibitors|protease inhibitors|mesh-ancestor
110710104|NCT01073826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110710105|NCT01073826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110710107|NCT01072812|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110710108|NCT01072812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110710109|NCT01072812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110710110|NCT01072812|Cholinergic Agents|cholinergic agents|mesh-ancestor
110710111|NCT01072812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110710112|NCT01072812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110710113|NCT00237042|Levonorgestrel|levonorgestrel|mesh-list
110710114|NCT00237042|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110710115|NCT00237042|Estradiol|estradiol|mesh-list
110710116|NCT00237042|Estrogens|estrogens|mesh-ancestor
110710117|NCT00237042|Hormones|hormones|mesh-ancestor
110710118|NCT00237042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110710119|NCT00237042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110710120|NCT00237042|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110710121|NCT00237042|Contraceptive Agents|contraceptive agents|mesh-ancestor
110710122|NCT00237042|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110710123|NCT00237042|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110710124|NCT00237042|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110710125|NCT00237042|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110710126|NCT00237042|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110710127|NCT00465647|Hydromorphone|hydromorphone|mesh-list
110710128|NCT00465647|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110710129|NCT00465647|Narcotics|narcotics|mesh-ancestor
110710130|NCT00465647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110710131|NCT00465647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110710132|NCT00465647|Analgesics|analgesics|mesh-ancestor
110710133|NCT00465647|Sensory System Agents|sensory system agents|mesh-ancestor
110710134|NCT00465647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110710135|NCT00090766|Valganciclovir|valganciclovir|mesh-list
110710136|NCT00090766|Antiviral Agents|antiviral agents|mesh-ancestor
110710137|NCT00090766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110710138|NCT03961828|Sofosbuvir|sofosbuvir|mesh-list
110710139|NCT03961828|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
110710140|NCT03961828|Ledipasvir|ledipasvir|mesh-list
110710141|NCT03961828|Antiviral Agents|antiviral agents|mesh-ancestor
110710142|NCT03961828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110710143|NCT00465179|Sunitinib|sunitinib|mesh-list
110710144|NCT00465179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110710145|NCT00465179|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110710146|NCT00465179|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110710147|NCT00465179|Growth Substances|growth substances|mesh-ancestor
110710148|NCT00465179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110710149|NCT00465179|Growth Inhibitors|growth inhibitors|mesh-ancestor
110710150|NCT00465179|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110710151|NCT00465179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110710152|NCT00465179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110710153|NCT00084136|Tenofovir|tenofovir|mesh-list
110710154|NCT00084136|Lamivudine|lamivudine|mesh-list
110710155|NCT00084136|Emtricitabine|emtricitabine|mesh-list
110710156|NCT00084136|Zidovudine|zidovudine|mesh-list
110710157|NCT00084136|Efavirenz|efavirenz|mesh-list
110710158|NCT00084136|Atazanavir Sulfate|atazanavir sulfate|mesh-list
110710159|NCT00084136|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110710160|NCT00084136|Didanosine|didanosine|mesh-list
110710161|NCT00084136|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
110710162|NCT00084136|Antiviral Agents|antiviral agents|mesh-ancestor
110710163|NCT00084136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110710164|NCT00084136|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110710165|NCT00084136|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110710166|NCT00084136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110710167|NCT00084136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110710168|NCT00084136|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110710169|NCT00084136|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110710170|NCT00084136|Antimetabolites|antimetabolites|mesh-ancestor
110710171|NCT00084136|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110710172|NCT00084136|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110710173|NCT00084136|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110710174|NCT00084136|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110710175|NCT00084136|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110710176|NCT00084136|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110710177|NCT00084136|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110710178|NCT00084136|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110710179|NCT00084136|Protease Inhibitors|protease inhibitors|mesh-ancestor
110710180|NCT03812380|Magnesium citrate|magnesium citrate|mesh-list
110710181|NCT03812380|Cathartics|cathartics|mesh-ancestor
110710182|NCT03812380|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110710183|NCT01085422|Temozolomide|temozolomide|mesh-list
110710184|NCT01085422|Veliparib|veliparib|mesh-list
110710185|NCT01085422|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110710186|NCT01085422|Alkylating Agents|alkylating agents|mesh-ancestor
110710187|NCT01085422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110710188|NCT01085422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110710189|NCT01085422|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110710190|NCT01085422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110710191|NCT01085656|Combretastatin|combretastatin|mesh-list
110710192|NCT01085656|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110710193|NCT01085656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110710195|NCT01085656|Antimitotic Agents|antimitotic agents|mesh-ancestor
110710196|NCT01085656|Mitosis Modulators|mitosis modulators|mesh-ancestor
110710197|NCT01085656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110710198|NCT01087138|Calcium|calcium|mesh-list
110710199|NCT01087138|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110710200|NCT01087138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110710201|NCT00464945|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110710202|NCT00464945|Immunologic Factors|immunologic factors|mesh-ancestor
110710203|NCT00464945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110710204|NCT00464087|Heparin|heparin|mesh-list
110710205|NCT00464087|Calcium heparin|calcium heparin|mesh-list
110710207|NCT00464087|Bivalirudin|bivalirudin|mesh-list
110710208|NCT00464087|Fondaparinux|fondaparinux|mesh-list
110710209|NCT00464087|Anticoagulants|anticoagulants|mesh-ancestor
110710210|NCT00464087|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110710211|NCT00464087|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110710212|NCT00464087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110710213|NCT00464087|Antithrombins|antithrombins|mesh-ancestor
110710214|NCT00464087|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110710215|NCT00464087|Protease Inhibitors|protease inhibitors|mesh-ancestor
110710216|NCT00464087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110710217|NCT00464087|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110710218|NCT00452699|Fluticasone|fluticasone|mesh-list
110710219|NCT00452699|Xhance|xhance|mesh-list
110710220|NCT00452699|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110710221|NCT00452699|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110710222|NCT00452699|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110710223|NCT00452699|Autonomic Agents|autonomic agents|mesh-ancestor
110710224|NCT00452699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110710225|NCT00452699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110710226|NCT00452699|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110710227|NCT00452699|Respiratory System Agents|respiratory system agents|mesh-ancestor
110710228|NCT00452699|Dermatologic Agents|dermatologic agents|mesh-ancestor
110710229|NCT00452699|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110710230|NCT00452699|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110710231|NCT00452699|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110710232|NCT00452699|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110710233|NCT00452699|Adrenergic Agents|adrenergic agents|mesh-ancestor
110710234|NCT00452699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110710235|NCT00452699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110710236|NCT00069784|Insulin|insulin|mesh-list
110710237|NCT00069784|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110710238|NCT00069784|Insulin Glargine|insulin glargine|mesh-list
110134468|NCT01990872|Vitamin D|vitamin d|mesh-list
110710239|NCT00069784|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110710240|NCT00069784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110710241|NCT00090610|Carboplatin|carboplatin|mesh-list
110710242|NCT00090610|Docetaxel|docetaxel|mesh-list
110710243|NCT00090610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110710244|NCT00090610|Tubulin Modulators|tubulin modulators|mesh-ancestor
110710245|NCT00090610|Antimitotic Agents|antimitotic agents|mesh-ancestor
110710246|NCT00090610|Mitosis Modulators|mitosis modulators|mesh-ancestor
110710247|NCT00090610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110710248|NCT01326988|Anesthetics|anesthetics|mesh-list
110710249|NCT01326988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110710250|NCT01326988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110710251|NCT03962296|Calcium Dobesilate|calcium dobesilate|mesh-list
110710252|NCT03962296|Calcium|calcium|mesh-list
110710253|NCT03962296|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110710254|NCT03962296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110710255|NCT03962296|Hemostatics|hemostatics|mesh-ancestor
110710256|NCT03962296|Coagulants|coagulants|mesh-ancestor
110710258|NCT01086046|Enoxaparin|enoxaparin|mesh-list
110710259|NCT01086046|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
110710260|NCT01086046|Tinzaparin|tinzaparin|mesh-list
110710261|NCT01086046|Dalteparin|dalteparin|mesh-list
110710262|NCT01086046|Anticoagulants|anticoagulants|mesh-ancestor
110710263|NCT01086046|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110710264|NCT01086046|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110710265|NCT01086046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110710266|NCT01090648|Etravirine|etravirine|mesh-list
110710267|NCT01090648|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110710268|NCT01090648|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110710269|NCT01090648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110710270|NCT01090648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110710271|NCT01090648|Antiviral Agents|antiviral agents|mesh-ancestor
110710272|NCT01090648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110710273|NCT03741244|Temozolomide|temozolomide|mesh-list
110710275|NCT03741244|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110710276|NCT03741244|Alkylating Agents|alkylating agents|mesh-ancestor
110710277|NCT03741244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110710278|NCT03741244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110710279|NCT03741244|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110710280|NCT03741244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110710281|NCT00463385|Thalidomide|thalidomide|mesh-list
110710282|NCT00463385|Prednisone|prednisone|mesh-list
110710283|NCT00463385|Pomalidomide|pomalidomide|mesh-list
110710284|NCT00463385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110710285|NCT00463385|Glucocorticoids|glucocorticoids|mesh-ancestor
110710286|NCT00463385|Hormones|hormones|mesh-ancestor
110710287|NCT00463385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110710288|NCT00463385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110710289|NCT00463385|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110710290|NCT00463385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110710291|NCT00463385|Immunologic Factors|immunologic factors|mesh-ancestor
110710292|NCT00463385|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110710293|NCT00463385|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110710294|NCT00463385|Growth Substances|growth substances|mesh-ancestor
110710295|NCT00463385|Growth Inhibitors|growth inhibitors|mesh-ancestor
110710296|NCT00463385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110710297|NCT00463385|Leprostatic Agents|leprostatic agents|mesh-ancestor
110710298|NCT00463385|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110710299|NCT00463385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110710300|NCT03839693|Botulinum Toxins|botulinum toxins|mesh-list
110710301|NCT03839693|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110710302|NCT03839693|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110710303|NCT03839693|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110710304|NCT03839693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110710305|NCT03839693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110710306|NCT03839693|Cholinergic Agents|cholinergic agents|mesh-ancestor
110710307|NCT03839693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110710308|NCT03839693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110710309|NCT03839693|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110710310|NCT03839693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110710311|NCT00068692|Leucovorin|leucovorin|mesh-list
110710312|NCT00068692|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
110710313|NCT00068692|Tetrahydrofolates|tetrahydrofolates|mesh-list
110710314|NCT00068692|Fluorouracil|fluorouracil|mesh-list
110710315|NCT00068692|Oxaliplatin|oxaliplatin|mesh-list
110710316|NCT00068692|Irinotecan|irinotecan|mesh-list
110710317|NCT00068692|Camptothecin|camptothecin|mesh-list
110710318|NCT00068692|Levoleucovorin|levoleucovorin|mesh-list
110710319|NCT00068692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110710320|NCT00068692|Antimetabolites|antimetabolites|mesh-ancestor
110710321|NCT00068692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110710322|NCT00068692|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110710323|NCT00068692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110710324|NCT00068692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110710325|NCT00068692|Immunologic Factors|immunologic factors|mesh-ancestor
110710326|NCT00068692|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110710327|NCT00068692|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110710328|NCT00068692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110710329|NCT00068692|Antidotes|antidotes|mesh-ancestor
110710330|NCT00068692|Protective Agents|protective agents|mesh-ancestor
110710331|NCT00068692|Vitamin B Complex|vitamin b complex|mesh-ancestor
110710332|NCT00068692|Vitamins|vitamins|mesh-ancestor
110710333|NCT00068692|Micronutrients|micronutrients|mesh-ancestor
110710334|NCT00068692|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110710335|NCT00463151|Rebamipide|rebamipide|mesh-list
110710336|NCT00463151|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110710337|NCT00463151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110710338|NCT00463151|Antioxidants|antioxidants|mesh-ancestor
110710339|NCT00463151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110710340|NCT00463151|Protective Agents|protective agents|mesh-ancestor
110710341|NCT00463151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110710342|NCT00463151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110710343|NCT00068380|Imatinib Mesylate|imatinib mesylate|mesh-list
110710344|NCT00068380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110710345|NCT00068380|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110710346|NCT00068380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110340145|NCT02943759|Chlorhexidine|chlorhexidine|mesh-list
110710347|NCT00068380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110710349|NCT00067990|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110710350|NCT00067990|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110710351|NCT00067990|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110710352|NCT00067990|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110710353|NCT00067990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110710354|NCT00263328|Tacrolimus|tacrolimus|mesh-list
110710355|NCT00263328|Tofacitinib|tofacitinib|mesh-list
110710356|NCT00263328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110710357|NCT00263328|Immunologic Factors|immunologic factors|mesh-ancestor
110710358|NCT00263328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110710359|NCT00263328|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110710360|NCT00263328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110710361|NCT00263328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110710362|NCT00263328|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
110710363|NCT00263328|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110710364|NCT03741660|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
110710365|NCT03741660|Cathartics|cathartics|mesh-ancestor
110710366|NCT03741660|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110710367|NCT00262860|Gemcitabine|gemcitabine|mesh-list
110710368|NCT00262860|Bortezomib|bortezomib|mesh-list
110710369|NCT00262860|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110710370|NCT00262860|Antimetabolites|antimetabolites|mesh-ancestor
110710371|NCT00262860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110710372|NCT00262860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110710373|NCT00236184|Rabeprazole|rabeprazole|mesh-list
110710374|NCT00236184|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110710375|NCT00236184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110710376|NCT00236184|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110710377|NCT00236184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110710378|NCT00236184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110710379|NCT00296504|Ritonavir|ritonavir|mesh-list
110710380|NCT00296504|Fosamprenavir|fosamprenavir|mesh-list
110710381|NCT00296504|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110710382|NCT00296504|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110710383|NCT00296504|Protease Inhibitors|protease inhibitors|mesh-ancestor
110710384|NCT00296504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110710385|NCT00296504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110710386|NCT00296504|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110710387|NCT00296504|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110710388|NCT00296504|Antiviral Agents|antiviral agents|mesh-ancestor
110710389|NCT00296504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110710390|NCT00296504|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110710391|NCT00296504|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110710392|NCT00313820|Pregabalin|pregabalin|mesh-list
110710393|NCT00313820|Analgesics|analgesics|mesh-ancestor
110710394|NCT00313820|Sensory System Agents|sensory system agents|mesh-ancestor
110710395|NCT00313820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110710396|NCT00313820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110710397|NCT00313820|Anticonvulsants|anticonvulsants|mesh-ancestor
110710398|NCT00313820|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110710399|NCT00313820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110710400|NCT00313820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110710401|NCT00313820|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110710402|NCT00313820|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110710403|NCT00313820|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110710404|NCT00313820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110710405|NCT00313820|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110710406|NCT00235872|Adalimumab|adalimumab|mesh-list
110710407|NCT00235872|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110710408|NCT00235872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110710409|NCT00235872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110710410|NCT00461981|Vaccines|vaccines|mesh-list
110710411|NCT00461981|Immunologic Factors|immunologic factors|mesh-ancestor
110710412|NCT00461981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110710413|NCT00296036|Pyridoxine|pyridoxine|mesh-list
110710414|NCT00296036|Vitamin B 6|vitamin b 6|mesh-list
110710415|NCT00296036|Vitamin B Complex|vitamin b complex|mesh-ancestor
110710416|NCT00296036|Vitamins|vitamins|mesh-ancestor
110710417|NCT00296036|Micronutrients|micronutrients|mesh-ancestor
110710418|NCT00296036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110710419|NCT01072890|Sirolimus|sirolimus|mesh-list
110710420|NCT01072890|Temsirolimus|temsirolimus|mesh-list
110710421|NCT01072890|MTOR Inhibitors|mtor inhibitors|mesh-list
110710422|NCT01072890|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110710423|NCT01072890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110710424|NCT01072890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110710425|NCT01072890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110710426|NCT01072890|Immunologic Factors|immunologic factors|mesh-ancestor
110710427|NCT01072890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110710428|NCT01072890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110710429|NCT01072890|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110710430|NCT01072890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110710431|NCT01072890|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110710432|NCT01072890|Antifungal Agents|antifungal agents|mesh-ancestor
110710433|NCT00089674|Denosumab|denosumab|mesh-list
110710434|NCT00089674|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110710435|NCT00089674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110710436|NCT01090882|Bupivacaine|bupivacaine|mesh-list
110710437|NCT01090882|Anesthetics, Local|anesthetics, local|mesh-ancestor
110710438|NCT01090882|Anesthetics|anesthetics|mesh-ancestor
110710439|NCT01090882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110710440|NCT01090882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110710441|NCT01090882|Sensory System Agents|sensory system agents|mesh-ancestor
110710442|NCT01090882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110710443|NCT01090960|Ipatasertib|ipatasertib|mesh-list
110710444|NCT01090960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110710445|NCT01090960|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110710446|NCT01090960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110710447|NCT01090960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110710448|NCT01067066|Temozolomide|temozolomide|mesh-list
110710449|NCT01067066|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110710450|NCT01067066|Alkylating Agents|alkylating agents|mesh-ancestor
110710451|NCT01067066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110710452|NCT01067066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110710453|NCT00313586|Azacitidine|azacitidine|mesh-list
110710454|NCT00313586|Entinostat|entinostat|mesh-list
110710455|NCT00313586|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
110710456|NCT00313586|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110710457|NCT00313586|Antimetabolites|antimetabolites|mesh-ancestor
110710458|NCT00313586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110710459|NCT00313586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110710460|NCT00313586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110710461|NCT01069328|Paclitaxel|paclitaxel|mesh-list
110710462|NCT01069328|Bevacizumab|bevacizumab|mesh-list
110710463|NCT01069328|Carboplatin|carboplatin|mesh-list
110710464|NCT01069328|Sorafenib|sorafenib|mesh-list
110710465|NCT01069328|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110710466|NCT01069328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110710467|NCT01069328|Tubulin Modulators|tubulin modulators|mesh-ancestor
110710468|NCT01069328|Antimitotic Agents|antimitotic agents|mesh-ancestor
110710469|NCT01069328|Mitosis Modulators|mitosis modulators|mesh-ancestor
110710470|NCT01069328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110710471|NCT01069328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110710472|NCT01069328|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110710473|NCT01069328|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110710474|NCT01069328|Growth Substances|growth substances|mesh-ancestor
110710475|NCT01069328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110134517|NCT01991158|Glucocorticoids|glucocorticoids|mesh-ancestor
110710476|NCT01069328|Growth Inhibitors|growth inhibitors|mesh-ancestor
110710477|NCT01069328|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110710478|NCT01069328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110710479|NCT01067222|Modafinil|modafinil|mesh-list
110710480|NCT01067222|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110710481|NCT01067222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110710482|NCT01067222|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
110710483|NCT01067222|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110710484|NCT01067222|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110710485|NCT01067222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110710487|NCT00312572|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110710488|NCT00312572|Narcotics|narcotics|mesh-ancestor
110710489|NCT00312572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110710490|NCT00312572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110710491|NCT00312572|Analgesics|analgesics|mesh-ancestor
110710492|NCT00312572|Sensory System Agents|sensory system agents|mesh-ancestor
110710493|NCT00312572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110710494|NCT00312572|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110710495|NCT00290732|Doxorubicin|doxorubicin|mesh-list
110710497|NCT00290732|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110710498|NCT00290732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110710499|NCT00290732|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110710500|NCT00290732|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110710501|NCT00290732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110710502|NCT00290732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110710503|NCT00312494|Ziprasidone|ziprasidone|mesh-list
110710504|NCT00312494|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110710505|NCT00312494|Serotonin Agents|serotonin agents|mesh-ancestor
110710506|NCT00312494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110710507|NCT00312494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110710508|NCT00312494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110710509|NCT00312494|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110710510|NCT00312494|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110710511|NCT00312494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110710512|NCT00312494|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110710513|NCT00312494|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110710514|NCT00312494|Dopamine Agents|dopamine agents|mesh-ancestor
110710515|NCT00312338|Moxifloxacin|moxifloxacin|mesh-list
110710516|NCT00312338|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
110710517|NCT00312338|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110710518|NCT00312338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110710519|NCT00312338|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110710520|NCT00312338|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110710521|NCT00312338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110710522|NCT00312338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110710523|NCT00312338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110710524|NCT00312338|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110710525|NCT00312338|Contraceptive Agents|contraceptive agents|mesh-ancestor
110710526|NCT00312338|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110710527|NCT00312338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110710528|NCT00312338|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110710529|NCT00312338|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110710530|NCT00312338|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110710531|NCT00290498|Cytarabine|cytarabine|mesh-list
110710532|NCT00290498|Dexamethasone|dexamethasone|mesh-list
110710533|NCT00290498|Prednisone|prednisone|mesh-list
110710534|NCT00290498|Cyclophosphamide|cyclophosphamide|mesh-list
110710535|NCT00290498|Rituximab|rituximab|mesh-list
110710536|NCT00290498|Doxorubicin|doxorubicin|mesh-list
110710537|NCT00290498|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110710538|NCT00290498|Methotrexate|methotrexate|mesh-list
110710539|NCT00290498|Vincristine|vincristine|mesh-list
110710540|NCT00290498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110710541|NCT00290498|Immunologic Factors|immunologic factors|mesh-ancestor
110710542|NCT00290498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110710543|NCT00290498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110710544|NCT00290498|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110710545|NCT00290498|Alkylating Agents|alkylating agents|mesh-ancestor
110710546|NCT00290498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110710547|NCT00290498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110710548|NCT00290498|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110710549|NCT00290498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110710550|NCT00290498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110710551|NCT00290498|Antiemetics|antiemetics|mesh-ancestor
110710552|NCT00290498|Autonomic Agents|autonomic agents|mesh-ancestor
110710553|NCT00290498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110710554|NCT00290498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110710555|NCT00290498|Glucocorticoids|glucocorticoids|mesh-ancestor
110710556|NCT00290498|Hormones|hormones|mesh-ancestor
110710557|NCT00290498|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110710558|NCT00290498|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110710559|NCT00290498|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110710560|NCT00290498|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110710561|NCT00290498|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110710562|NCT00290498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110710563|NCT00290498|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110710564|NCT00290498|Abortifacient Agents|abortifacient agents|mesh-ancestor
110710565|NCT00290498|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110710566|NCT00290498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110710567|NCT00290498|Antimetabolites|antimetabolites|mesh-ancestor
110710568|NCT00290498|Dermatologic Agents|dermatologic agents|mesh-ancestor
110710569|NCT00290498|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110710570|NCT00290498|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110710571|NCT00290498|Antiviral Agents|antiviral agents|mesh-ancestor
110710572|NCT00290498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110710573|NCT00290498|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110710574|NCT00290498|Tubulin Modulators|tubulin modulators|mesh-ancestor
110710575|NCT00290498|Antimitotic Agents|antimitotic agents|mesh-ancestor
110710576|NCT00290498|Mitosis Modulators|mitosis modulators|mesh-ancestor
110710577|NCT01069796|Paclitaxel|paclitaxel|mesh-list
110710578|NCT01069796|Bevacizumab|bevacizumab|mesh-list
110710579|NCT01069796|Capecitabine|capecitabine|mesh-list
110710580|NCT01069796|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110710581|NCT01069796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110710582|NCT01069796|Tubulin Modulators|tubulin modulators|mesh-ancestor
110710583|NCT01069796|Antimitotic Agents|antimitotic agents|mesh-ancestor
110710584|NCT01069796|Mitosis Modulators|mitosis modulators|mesh-ancestor
110710585|NCT01069796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110710586|NCT01069796|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110710587|NCT01069796|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110710588|NCT01069796|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110710589|NCT01069796|Growth Substances|growth substances|mesh-ancestor
110710590|NCT01069796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110710591|NCT01069796|Growth Inhibitors|growth inhibitors|mesh-ancestor
110710592|NCT01069796|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110710593|NCT01069796|Antimetabolites|antimetabolites|mesh-ancestor
110710594|NCT01067534|Albuterol|albuterol|mesh-list
110710595|NCT01067534|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110710596|NCT01067534|Autonomic Agents|autonomic agents|mesh-ancestor
110710597|NCT01067534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110710598|NCT01067534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110710599|NCT01067534|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110710600|NCT01067534|Respiratory System Agents|respiratory system agents|mesh-ancestor
110710601|NCT01067534|Tocolytic Agents|tocolytic agents|mesh-ancestor
110710602|NCT01067534|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110710603|NCT01067534|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110710604|NCT01067534|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110710605|NCT01067534|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110710606|NCT01067534|Adrenergic Agents|adrenergic agents|mesh-ancestor
110710607|NCT01067534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110710608|NCT01067534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110710609|NCT00451451|Glatiramer Acetate|glatiramer acetate|mesh-list
110710610|NCT00451451|Dimethyl Fumarate|dimethyl fumarate|mesh-list
110710611|NCT00451451|(T,G)-A-L|(t,g)-a-l|mesh-list
110710612|NCT00451451|Dermatologic Agents|dermatologic agents|mesh-ancestor
110710613|NCT00451451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110710614|NCT00451451|Immunologic Factors|immunologic factors|mesh-ancestor
110710615|NCT00451451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110710616|NCT00451451|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110710617|NCT00451451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110710618|NCT01062698|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
110710619|NCT01062698|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110710620|NCT01062698|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110710621|NCT01062698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110710622|NCT03977324|Chlorhexidine|chlorhexidine|mesh-list
110710623|NCT03977324|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110710624|NCT03977324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110710625|NCT03977324|Disinfectants|disinfectants|mesh-ancestor
110710626|NCT01069874|Vitamin D|vitamin d|mesh-list
110710627|NCT01069874|Cholecalciferol|cholecalciferol|mesh-list
110710628|NCT01069874|Vitamins|vitamins|mesh-ancestor
110710629|NCT01069874|Micronutrients|micronutrients|mesh-ancestor
110710630|NCT01069874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110710631|NCT01069874|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110710632|NCT01069874|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110710633|NCT01022645|Copper|copper|mesh-list
110710634|NCT01022645|Levonorgestrel|levonorgestrel|mesh-list
110710635|NCT01022645|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110710636|NCT01022645|Contraceptive Agents|contraceptive agents|mesh-ancestor
110710637|NCT01022645|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110710638|NCT01022645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110710639|NCT01022645|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110710640|NCT01022645|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110710641|NCT01022645|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110710642|NCT01022645|Trace Elements|trace elements|mesh-ancestor
110710643|NCT01022645|Micronutrients|micronutrients|mesh-ancestor
110710644|NCT01025765|Metformin|metformin|mesh-list
110710645|NCT01025765|Pioglitazone|pioglitazone|mesh-list
110710646|NCT01025765|Acarbose|acarbose|mesh-list
110710647|NCT01025765|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110710648|NCT01025765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110710649|NCT01025765|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
110710650|NCT01025765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110710651|NCT01025765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110710652|NCT03824912|Ketoconazole|ketoconazole|mesh-list
110710653|NCT03824912|Antifungal Agents|antifungal agents|mesh-ancestor
110710654|NCT03824912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110710655|NCT03824912|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110710656|NCT03824912|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110710657|NCT03824912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110710658|NCT03824912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110710659|NCT03824912|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110710660|NCT03824912|Hormone Antagonists|hormone antagonists|mesh-ancestor
110710661|NCT03824912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110710662|NCT03824912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110710663|NCT03824912|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110710664|NCT01062776|Furosemide|furosemide|mesh-list
110710665|NCT01062776|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110710666|NCT01062776|Diuretics|diuretics|mesh-ancestor
110710667|NCT01062776|Natriuretic Agents|natriuretic agents|mesh-ancestor
110710668|NCT01062776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110710669|NCT01062776|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110710670|NCT01062776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110710671|NCT01062776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110710672|NCT01025921|Colistin|colistin|mesh-list
110710673|NCT01025921|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110710674|NCT01025921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110710675|NCT01070030|Amlodipine|amlodipine|mesh-list
110710676|NCT01070030|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110710677|NCT01070030|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110710678|NCT01070030|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110710679|NCT01070030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110710680|NCT01070030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110710681|NCT01070030|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110710682|NCT01070030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110710683|NCT01070030|Vasodilator Agents|vasodilator agents|mesh-ancestor
110710685|NCT01070030|Natriuretic Agents|natriuretic agents|mesh-ancestor
110710686|NCT01070030|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110710687|NCT00461123|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
110710688|NCT00461123|Vasodilator Agents|vasodilator agents|mesh-ancestor
110710689|NCT00461123|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110710690|NCT00461123|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110710691|NCT00461123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110710692|NCT00461123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110710693|NCT00461123|Urological Agents|urological agents|mesh-ancestor
110710694|NCT00290342|Edetic Acid|edetic acid|mesh-list
110710695|NCT00290342|Pentetic Acid|pentetic acid|mesh-list
110710696|NCT00290342|Antidotes|antidotes|mesh-ancestor
110710697|NCT00290342|Protective Agents|protective agents|mesh-ancestor
110710698|NCT00290342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110710699|NCT00290342|Chelating Agents|chelating agents|mesh-ancestor
110710700|NCT00290342|Sequestering Agents|sequestering agents|mesh-ancestor
110710701|NCT00290342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110710702|NCT00290342|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110710703|NCT00290342|Anticoagulants|anticoagulants|mesh-ancestor
110710704|NCT00290342|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110710705|NCT00460811|Linaclotide|linaclotide|mesh-list
110710706|NCT00460811|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
110710707|NCT00460811|Enzyme Activators|enzyme activators|mesh-ancestor
110710708|NCT00460811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110710709|NCT00460811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110710710|NCT01070108|Ketamine|ketamine|mesh-list
110710711|NCT01070108|Analgesics|analgesics|mesh-ancestor
110710712|NCT01070108|Sensory System Agents|sensory system agents|mesh-ancestor
110710713|NCT01070108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110710714|NCT01070108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110710715|NCT01070108|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110710716|NCT01070108|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110710717|NCT01070108|Anesthetics, General|anesthetics, general|mesh-ancestor
110710718|NCT01070108|Anesthetics|anesthetics|mesh-ancestor
110710719|NCT01070108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110710720|NCT01070108|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110710721|NCT01070108|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110710722|NCT01070108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110710723|NCT01070108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110710724|NCT01067690|Indinavir|indinavir|mesh-list
110710725|NCT01067690|Bleomycin|bleomycin|mesh-list
110710726|NCT01067690|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110710727|NCT01067690|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110710728|NCT01067690|Protease Inhibitors|protease inhibitors|mesh-ancestor
110710729|NCT01067690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110710730|NCT01067690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110710731|NCT01067690|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110710732|NCT01067690|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110710733|NCT01067690|Antiviral Agents|antiviral agents|mesh-ancestor
110710734|NCT01067690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110710735|NCT01067690|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110710736|NCT01067690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110710737|NCT03982004|Pembrolizumab|pembrolizumab|mesh-list
110710738|NCT03982004|Imiquimod|imiquimod|mesh-list
110710739|NCT03982004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110710740|NCT03982004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110710741|NCT03982004|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110710742|NCT03982004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110710743|NCT03982004|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110710744|NCT03982004|Immunologic Factors|immunologic factors|mesh-ancestor
110861352|NCT02460640|Morphine|morphine|mesh-list
110710745|NCT03982004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110710746|NCT03982004|Interferon Inducers|interferon inducers|mesh-ancestor
110710747|NCT01026233|Brentuximab Vedotin|brentuximab vedotin|mesh-list
110710748|NCT01026233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110710749|NCT01026233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110710750|NCT01026233|Immunotoxins|immunotoxins|mesh-ancestor
110710751|NCT01026233|Immunoconjugates|immunoconjugates|mesh-ancestor
110710752|NCT01026233|Immunologic Factors|immunologic factors|mesh-ancestor
110710753|NCT01026233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110710754|NCT01062932|Cycloserine|cycloserine|mesh-list
110710755|NCT01062932|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110710756|NCT01062932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110710757|NCT01062932|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110710758|NCT01062932|Antitubercular Agents|antitubercular agents|mesh-ancestor
110710759|NCT01062932|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110710760|NCT01062932|Antimetabolites|antimetabolites|mesh-ancestor
110710761|NCT01062932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110710762|NCT01026311|Ubiquinone|ubiquinone|mesh-list
110710763|NCT01026311|Coenzyme Q10|coenzyme q10|mesh-list
110710764|NCT01026311|Micronutrients|micronutrients|mesh-ancestor
110710765|NCT01026311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110710766|NCT01026311|Vitamins|vitamins|mesh-ancestor
110710767|NCT01063010|Bevacizumab|bevacizumab|mesh-list
110710768|NCT01063010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110710769|NCT01063010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110710770|NCT01063010|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110710771|NCT01063010|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110710772|NCT01063010|Growth Substances|growth substances|mesh-ancestor
110710773|NCT01063010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110710774|NCT01063010|Growth Inhibitors|growth inhibitors|mesh-ancestor
110710775|NCT00460577|Bromides|bromides|mesh-list
110710776|NCT00460577|Fenoterol|fenoterol|mesh-list
110710777|NCT00460577|Formoterol Fumarate|formoterol fumarate|mesh-list
110710778|NCT00460577|Ipratropium|ipratropium|mesh-list
110710779|NCT00460577|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110710780|NCT00460577|Autonomic Agents|autonomic agents|mesh-ancestor
110710781|NCT00460577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110710782|NCT00460577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110710783|NCT00460577|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110710784|NCT00460577|Respiratory System Agents|respiratory system agents|mesh-ancestor
110710785|NCT00460577|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110710786|NCT00460577|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110710787|NCT00460577|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110710788|NCT00460577|Adrenergic Agents|adrenergic agents|mesh-ancestor
110710789|NCT00460577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110710790|NCT00460577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110710791|NCT00460577|Anticonvulsants|anticonvulsants|mesh-ancestor
110710792|NCT00460577|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110710793|NCT00460577|Cholinergic Agents|cholinergic agents|mesh-ancestor
110710794|NCT00460577|Sympathomimetics|sympathomimetics|mesh-ancestor
110710795|NCT00460577|Tocolytic Agents|tocolytic agents|mesh-ancestor
110710796|NCT00460577|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110710797|NCT01581320|Vitamin D|vitamin d|mesh-list
110710798|NCT01581320|Cholecalciferol|cholecalciferol|mesh-list
110710799|NCT01581320|Ibandronic Acid|ibandronic acid|mesh-list
110710800|NCT01581320|Vitamins|vitamins|mesh-ancestor
110710801|NCT01581320|Micronutrients|micronutrients|mesh-ancestor
110710802|NCT01581320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110710803|NCT01581320|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110710804|NCT01581320|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110710805|NCT00289016|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
110710806|NCT00289016|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110134638|NCT01992198|Hormones|hormones|mesh-ancestor
110710807|NCT00289016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110710808|NCT00288704|Rilonacept|rilonacept|mesh-list
110710809|NCT00288704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110710810|NCT00288626|Cytarabine|cytarabine|mesh-list
110710811|NCT00288626|Prednisone|prednisone|mesh-list
110710812|NCT00288626|Etoposide|etoposide|mesh-list
110710813|NCT00288626|Melphalan|melphalan|mesh-list
110710814|NCT00288626|Carmustine|carmustine|mesh-list
110710815|NCT00288626|Lenograstim|lenograstim|mesh-list
110710816|NCT00288626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110710817|NCT00288626|Glucocorticoids|glucocorticoids|mesh-ancestor
110710818|NCT00288626|Hormones|hormones|mesh-ancestor
110710819|NCT00288626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110710820|NCT00288626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110710821|NCT00288626|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110710822|NCT00288626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110710823|NCT00288626|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110710824|NCT00288626|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110710825|NCT00288626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110710826|NCT00288626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110710827|NCT00288626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110710828|NCT00288626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110710829|NCT00288626|Antimetabolites|antimetabolites|mesh-ancestor
110710830|NCT00288626|Antiviral Agents|antiviral agents|mesh-ancestor
110710831|NCT00288626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110710832|NCT00288626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110710833|NCT00288626|Immunologic Factors|immunologic factors|mesh-ancestor
110710834|NCT00288626|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110710835|NCT00288626|Alkylating Agents|alkylating agents|mesh-ancestor
110710836|NCT00288626|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110710837|NCT00288626|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110710838|NCT00087490|Vancomycin|vancomycin|mesh-list
110710839|NCT00087490|Linezolid|linezolid|mesh-list
110710840|NCT00087490|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110710841|NCT00087490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110710842|NCT00087490|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110710843|NCT00087490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110710844|NCT00087490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110710845|NCT00087178|Cyclophosphamide|cyclophosphamide|mesh-list
110710846|NCT00087178|Doxorubicin|doxorubicin|mesh-list
110710847|NCT00087178|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110710848|NCT00087178|Fluorouracil|fluorouracil|mesh-list
110710849|NCT00087178|Epirubicin|epirubicin|mesh-list
110710850|NCT00087178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110710851|NCT00087178|Immunologic Factors|immunologic factors|mesh-ancestor
110710852|NCT00087178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110710853|NCT00087178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110710854|NCT00087178|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110710855|NCT00087178|Alkylating Agents|alkylating agents|mesh-ancestor
110710856|NCT00087178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110710857|NCT00087178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110710858|NCT00087178|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110710859|NCT00087178|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110710860|NCT00087178|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110710861|NCT00087178|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110710862|NCT00087178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110710863|NCT00087178|Antimetabolites|antimetabolites|mesh-ancestor
110710864|NCT00087178|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110710865|NCT00288080|Dexamethasone|dexamethasone|mesh-list
110710866|NCT00288080|Prednisone|prednisone|mesh-list
110710867|NCT00288080|Docetaxel|docetaxel|mesh-list
110710868|NCT00288080|Androgen Antagonists|androgen antagonists|mesh-list
110710869|NCT00288080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110710870|NCT00288080|Antiemetics|antiemetics|mesh-ancestor
110710871|NCT00288080|Autonomic Agents|autonomic agents|mesh-ancestor
110710872|NCT00288080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110710873|NCT00288080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110710874|NCT00288080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110710875|NCT00288080|Glucocorticoids|glucocorticoids|mesh-ancestor
110710876|NCT00288080|Hormones|hormones|mesh-ancestor
110710877|NCT00288080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110710878|NCT00288080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110710879|NCT00288080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110710880|NCT00288080|Tubulin Modulators|tubulin modulators|mesh-ancestor
110710881|NCT00288080|Antimitotic Agents|antimitotic agents|mesh-ancestor
110710882|NCT00288080|Mitosis Modulators|mitosis modulators|mesh-ancestor
110710883|NCT00288080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110710884|NCT00288080|Hormone Antagonists|hormone antagonists|mesh-ancestor
110710885|NCT01068392|Prednisolone|prednisolone|mesh-list
110710886|NCT01068392|Oxaliplatin|oxaliplatin|mesh-list
110710887|NCT01068392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110710888|NCT01068392|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110710889|NCT01068392|Glucocorticoids|glucocorticoids|mesh-ancestor
110710890|NCT01068392|Hormones|hormones|mesh-ancestor
110710891|NCT01068392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110710892|NCT01068392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110710893|NCT01068392|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110710894|NCT01086826|Cisplatin|cisplatin|mesh-list
110710895|NCT01086826|Docetaxel|docetaxel|mesh-list
110710896|NCT01086826|Fluorouracil|fluorouracil|mesh-list
110710897|NCT01086826|Cetuximab|cetuximab|mesh-list
110710898|NCT01086826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110710899|NCT01086826|Tubulin Modulators|tubulin modulators|mesh-ancestor
110710900|NCT01086826|Antimitotic Agents|antimitotic agents|mesh-ancestor
110710901|NCT01086826|Mitosis Modulators|mitosis modulators|mesh-ancestor
110710902|NCT01086826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110710904|NCT01086826|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110710905|NCT01086826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110710906|NCT01086826|Immunologic Factors|immunologic factors|mesh-ancestor
110710907|NCT01086826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110710908|NCT01086826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110710909|NCT00287690|Genistein|genistein|mesh-list
110710910|NCT00287690|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110710911|NCT00287690|Protective Agents|protective agents|mesh-ancestor
110710912|NCT00287690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110710913|NCT00287690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110710914|NCT00287690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110710915|NCT00287690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110710916|NCT00287690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110710917|NCT00287690|Phytoestrogens|phytoestrogens|mesh-ancestor
110710918|NCT00287690|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
110710919|NCT00287690|Estrogens|estrogens|mesh-ancestor
110710920|NCT00287690|Hormones|hormones|mesh-ancestor
110710921|NCT00287690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110710922|NCT01070186|Sunitinib|sunitinib|mesh-list
110710923|NCT01070186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110710924|NCT01070186|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110710925|NCT01070186|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110710926|NCT01070186|Growth Substances|growth substances|mesh-ancestor
110710927|NCT01070186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110710928|NCT01070186|Growth Inhibitors|growth inhibitors|mesh-ancestor
110710929|NCT01070186|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110710930|NCT01070186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110710931|NCT01070186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110710932|NCT00066742|Etoposide|etoposide|mesh-list
110710933|NCT00066742|Etoposide phosphate|etoposide phosphate|mesh-list
110710934|NCT00066742|Tirapazamine|tirapazamine|mesh-list
110710935|NCT00066742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110710936|NCT00066742|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110710937|NCT00066742|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110710938|NCT00066742|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110710939|NCT00066742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110710940|NCT00066742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110710941|NCT01026467|Carboplatin|carboplatin|mesh-list
110710942|NCT01026467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110710943|NCT01094158|Cholic Acids|cholic acids|mesh-list
110710944|NCT01094158|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110710945|NCT00460109|Rituximab|rituximab|mesh-list
110710946|NCT00460109|Denileukin diftitox|denileukin diftitox|mesh-list
110710947|NCT00460109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110710948|NCT00460109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110710949|NCT00460109|Immunologic Factors|immunologic factors|mesh-ancestor
110710950|NCT00460109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110710951|NCT00460109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110710952|NCT03956212|Doxycycline|doxycycline|mesh-list
110710953|NCT03956212|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110710954|NCT03956212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110710955|NCT03956212|Antimalarials|antimalarials|mesh-ancestor
110710956|NCT03956212|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110710958|NCT01091818|Midazolam|midazolam|mesh-list
110710959|NCT01091818|Dexmedetomidine|dexmedetomidine|mesh-list
110710960|NCT01091818|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110710961|NCT01091818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110710962|NCT01091818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110710963|NCT01091818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110710964|NCT01091818|Analgesics|analgesics|mesh-ancestor
110710965|NCT01091818|Sensory System Agents|sensory system agents|mesh-ancestor
110710966|NCT01091818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110710967|NCT01091818|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110710968|NCT01091818|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110710969|NCT01091818|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110710970|NCT01091818|Adrenergic Agents|adrenergic agents|mesh-ancestor
110710971|NCT01091818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110710972|NCT01091818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110710973|NCT01091818|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110710974|NCT01091818|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110710975|NCT01091818|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110710976|NCT01091818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110710977|NCT01091818|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110710978|NCT01091818|Anesthetics, General|anesthetics, general|mesh-ancestor
110710980|NCT01091818|GABA Modulators|gaba modulators|mesh-ancestor
110710981|NCT01091818|GABA Agents|gaba agents|mesh-ancestor
110710982|NCT01091896|Bevacizumab|bevacizumab|mesh-list
110710983|NCT01091896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110710984|NCT01091896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110710985|NCT01091896|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110710986|NCT01091896|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110710987|NCT01091896|Growth Substances|growth substances|mesh-ancestor
110710988|NCT01091896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110710989|NCT01091896|Growth Inhibitors|growth inhibitors|mesh-ancestor
110710990|NCT00065260|Cyclosporine|cyclosporine|mesh-list
110710991|NCT00065260|Alemtuzumab|alemtuzumab|mesh-list
110710992|NCT00065260|Cyclosporins|cyclosporins|mesh-list
110710993|NCT00065260|Thymoglobulin|thymoglobulin|mesh-list
110710994|NCT00065260|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110710995|NCT00065260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110710996|NCT00065260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110710997|NCT00065260|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110710998|NCT00065260|Immunologic Factors|immunologic factors|mesh-ancestor
110710999|NCT00065260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110711000|NCT00065260|Antifungal Agents|antifungal agents|mesh-ancestor
110711001|NCT00065260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110711002|NCT00065260|Dermatologic Agents|dermatologic agents|mesh-ancestor
110711003|NCT00065260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110711004|NCT00065260|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110711005|NCT00065260|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110711006|NCT00065260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110711007|NCT01327066|Moxifloxacin|moxifloxacin|mesh-list
110711008|NCT01327066|Droxidopa|droxidopa|mesh-list
110711009|NCT01327066|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110711010|NCT01327066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110711011|NCT01327066|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110711012|NCT01327066|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110711013|NCT01327066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110711014|NCT01327066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110711015|NCT01327066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110711016|NCT01327066|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110711017|NCT01327066|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110711018|NCT01094626|Secretin|secretin|mesh-list
110711019|NCT01094626|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110711020|NCT01094626|Hormones|hormones|mesh-ancestor
110711021|NCT01094626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110711022|NCT01094626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110711023|NCT03956134|Tapentadol|tapentadol|mesh-list
110711024|NCT03956134|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110711025|NCT03956134|Narcotics|narcotics|mesh-ancestor
110711026|NCT03956134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110711027|NCT03956134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110711028|NCT03956134|Analgesics|analgesics|mesh-ancestor
110711029|NCT03956134|Sensory System Agents|sensory system agents|mesh-ancestor
110711030|NCT03956134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110711031|NCT03956134|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110711032|NCT03956134|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110711033|NCT03956134|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110711034|NCT03956134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110711035|NCT03956134|Adrenergic Agents|adrenergic agents|mesh-ancestor
110711036|NCT03956134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110711037|NCT00460031|Ketoconazole|ketoconazole|mesh-list
110711038|NCT00460031|Hydrocortisone|hydrocortisone|mesh-list
110711039|NCT00460031|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
110711040|NCT00460031|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
110711041|NCT00460031|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
110711042|NCT00460031|Lenalidomide|lenalidomide|mesh-list
110711043|NCT00460031|Immunologic Factors|immunologic factors|mesh-ancestor
110711044|NCT00460031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110711045|NCT00460031|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110711046|NCT00460031|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110711047|NCT00460031|Growth Substances|growth substances|mesh-ancestor
110711048|NCT00460031|Growth Inhibitors|growth inhibitors|mesh-ancestor
110711049|NCT00460031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110711050|NCT00460031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110711051|NCT00460031|Antifungal Agents|antifungal agents|mesh-ancestor
110711052|NCT00460031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110711053|NCT00460031|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110711054|NCT00460031|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110711055|NCT00460031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110711056|NCT00460031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110711057|NCT00460031|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110711058|NCT00460031|Hormone Antagonists|hormone antagonists|mesh-ancestor
110711059|NCT00460031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110711060|NCT00460031|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110711061|NCT00451217|Glycopyrrolate|glycopyrrolate|mesh-list
110711062|NCT00451217|Neostigmine|neostigmine|mesh-list
110711063|NCT00451217|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110711064|NCT00451217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110711065|NCT00451217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110711066|NCT00451217|Cholinergic Agents|cholinergic agents|mesh-ancestor
110711067|NCT00451217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110711068|NCT00451217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110711069|NCT00451217|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110711070|NCT00451217|Autonomic Agents|autonomic agents|mesh-ancestor
110711071|NCT00451217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110711072|NCT00451217|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110711073|NCT00451217|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110711074|NCT00451217|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110711075|NCT00459953|Nicotine|nicotine|mesh-list
110711076|NCT00459953|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110711077|NCT00459953|Autonomic Agents|autonomic agents|mesh-ancestor
110711078|NCT00459953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110711079|NCT00459953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110711080|NCT00459953|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110711081|NCT00459953|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110711082|NCT00459953|Cholinergic Agents|cholinergic agents|mesh-ancestor
110711083|NCT00459953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110711084|NCT00459953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110711085|NCT00459875|Sunitinib|sunitinib|mesh-list
110711086|NCT00459875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110711087|NCT00459875|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110711088|NCT00459875|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110711089|NCT00459875|Growth Substances|growth substances|mesh-ancestor
110711090|NCT00459875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110711091|NCT00459875|Growth Inhibitors|growth inhibitors|mesh-ancestor
110711092|NCT00459875|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110711093|NCT00459875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110711094|NCT00459875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110711095|NCT00311402|Aspirin|aspirin|mesh-list
110711096|NCT00311402|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
110711097|NCT00311402|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110711098|NCT00311402|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110711099|NCT00311402|Analgesics|analgesics|mesh-ancestor
110711100|NCT00311402|Sensory System Agents|sensory system agents|mesh-ancestor
110711101|NCT00311402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110711102|NCT00311402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110711103|NCT00311402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110711104|NCT00311402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110711105|NCT00311402|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110711106|NCT00311402|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110711107|NCT00311402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110711108|NCT00311402|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110711109|NCT00311402|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110711110|NCT00311402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110711111|NCT00311402|Antipyretics|antipyretics|mesh-ancestor
110711112|NCT03724175|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
110711113|NCT03724175|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
110711114|NCT03724175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110711115|NCT00450749|Lycopene|lycopene|mesh-list
110711116|NCT00450749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110711117|NCT00450749|Antioxidants|antioxidants|mesh-ancestor
110711118|NCT00450749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110711119|NCT00450749|Protective Agents|protective agents|mesh-ancestor
110711120|NCT00450749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110711121|NCT00450749|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110711122|NCT00450749|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110711123|NCT00450749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110711124|NCT00292370|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110711125|NCT00292370|Paroxetine|paroxetine|mesh-list
110711126|NCT00292370|Antidepressive Agents|antidepressive agents|mesh-ancestor
110711127|NCT00292370|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110711128|NCT00292370|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110711129|NCT00292370|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110711130|NCT00292370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110711131|NCT00292370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110711132|NCT00292370|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110711133|NCT00292370|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110711134|NCT00292370|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110711135|NCT00292370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110711136|NCT00292370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110711137|NCT00292370|Serotonin Agents|serotonin agents|mesh-ancestor
110711138|NCT00292370|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110711139|NCT00292370|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110711140|NCT00292370|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110711141|NCT00292370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110711142|NCT00065182|Docetaxel|docetaxel|mesh-list
110711143|NCT00065182|Topotecan|topotecan|mesh-list
110711144|NCT00065182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110711145|NCT00065182|Tubulin Modulators|tubulin modulators|mesh-ancestor
110711146|NCT00065182|Antimitotic Agents|antimitotic agents|mesh-ancestor
110711147|NCT00065182|Mitosis Modulators|mitosis modulators|mesh-ancestor
110711148|NCT00065182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110134812|NCT01993472|Analgesics|analgesics|mesh-ancestor
110711149|NCT00065182|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110711150|NCT00065182|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110711151|NCT00065182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110711152|NCT01026701|Bortezomib|bortezomib|mesh-list
110711153|NCT01026701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110711154|NCT01092130|Vitamin D|vitamin d|mesh-list
110429008|NCT00997893|Estradiol|estradiol|mesh-list
110711156|NCT01092130|Micronutrients|micronutrients|mesh-ancestor
110711157|NCT01092130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110711158|NCT01092130|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110711160|NCT00064792|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110711161|NCT00064792|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110711162|NCT00064792|Antimetabolites|antimetabolites|mesh-ancestor
110711163|NCT00064792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110711164|NCT00064792|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110711165|NCT00064792|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110711166|NCT00064792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110711167|NCT01095016|Fenoterol|fenoterol|mesh-list
110711168|NCT01095016|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110711169|NCT01095016|Autonomic Agents|autonomic agents|mesh-ancestor
110711170|NCT01095016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110711171|NCT01095016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110711172|NCT01095016|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110711173|NCT01095016|Respiratory System Agents|respiratory system agents|mesh-ancestor
110711174|NCT01095016|Sympathomimetics|sympathomimetics|mesh-ancestor
110711175|NCT01095016|Tocolytic Agents|tocolytic agents|mesh-ancestor
110711176|NCT01095016|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110711177|NCT01095016|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110711178|NCT01095016|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110711179|NCT01095016|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110711180|NCT01095016|Adrenergic Agents|adrenergic agents|mesh-ancestor
110711181|NCT01095016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110711182|NCT01095016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110711183|NCT01095172|Prednisolone|prednisolone|mesh-list
110711184|NCT01095172|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110711185|NCT01095172|Methylprednisolone|methylprednisolone|mesh-list
110711186|NCT01095172|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110711187|NCT01095172|Prednisolone acetate|prednisolone acetate|mesh-list
110711188|NCT01095172|Hydrocortisone|hydrocortisone|mesh-list
110711189|NCT01095172|Rituximab|rituximab|mesh-list
110711190|NCT01095172|Tacrolimus|tacrolimus|mesh-list
110711191|NCT01095172|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110711192|NCT01095172|Prednisolone phosphate|prednisolone phosphate|mesh-list
110711193|NCT01095172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110711194|NCT01095172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110711195|NCT01095172|Immunologic Factors|immunologic factors|mesh-ancestor
110711196|NCT01095172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110711197|NCT01095172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110134848|NCT01993784|Nimotuzumab|nimotuzumab|mesh-list
110711198|NCT01095172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110711199|NCT01095172|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110711200|NCT01095172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110711201|NCT01095172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110711202|NCT01095172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110711203|NCT01095172|Glucocorticoids|glucocorticoids|mesh-ancestor
110711205|NCT01095172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110711206|NCT01095172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110711207|NCT01095172|Antiemetics|antiemetics|mesh-ancestor
110711208|NCT01095172|Autonomic Agents|autonomic agents|mesh-ancestor
110711209|NCT01095172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110711210|NCT01095172|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110711211|NCT01095172|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110711212|NCT01095172|Protective Agents|protective agents|mesh-ancestor
110711213|NCT00286442|Metformin|metformin|mesh-list
110711214|NCT00286442|Alogliptin|alogliptin|mesh-list
110711215|NCT00286442|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110711216|NCT00286442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110711217|NCT00286442|Incretins|incretins|mesh-ancestor
110711218|NCT00286442|Hormones|hormones|mesh-ancestor
110711219|NCT00286442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110711220|NCT00286442|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110711221|NCT00286442|Protease Inhibitors|protease inhibitors|mesh-ancestor
110711222|NCT00286442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110711223|NCT00286442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110711225|NCT00063934|Doxorubicin|doxorubicin|mesh-list
110711226|NCT00063934|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110711227|NCT00063934|Oblimersen|oblimersen|mesh-list
110711228|NCT00063934|Lenograstim|lenograstim|mesh-list
110711229|NCT00063934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110711230|NCT00063934|Tubulin Modulators|tubulin modulators|mesh-ancestor
110711232|NCT00063934|Mitosis Modulators|mitosis modulators|mesh-ancestor
110711233|NCT00063934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110711234|NCT00063934|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110711235|NCT00063934|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110711236|NCT00063934|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110711237|NCT00063934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110711238|NCT00063934|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110711239|NCT00063934|Immunologic Factors|immunologic factors|mesh-ancestor
110134877|NCT01994265|Warfarin|warfarin|mesh-list
110711240|NCT00063934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110711241|NCT00063154|Pertuzumab|pertuzumab|mesh-list
110711242|NCT00063154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110711243|NCT00063154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110711244|NCT01092520|Gabapentin|gabapentin|mesh-list
110711245|NCT01092520|Analgesics|analgesics|mesh-ancestor
110711246|NCT01092520|Sensory System Agents|sensory system agents|mesh-ancestor
110711247|NCT01092520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110711248|NCT01092520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110711249|NCT01092520|Anticonvulsants|anticonvulsants|mesh-ancestor
110711250|NCT01092520|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110711251|NCT01092520|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110711252|NCT01092520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110711253|NCT01092520|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110711254|NCT01092520|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110711255|NCT01092520|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110711256|NCT01092520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110711257|NCT01092520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110711258|NCT01092520|Antimanic Agents|antimanic agents|mesh-ancestor
110711259|NCT00458705|Thalidomide|thalidomide|mesh-list
110711260|NCT00458705|Dexamethasone|dexamethasone|mesh-list
110711261|NCT00458705|Doxorubicin|doxorubicin|mesh-list
110711262|NCT00458705|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110711263|NCT00458705|Bortezomib|bortezomib|mesh-list
110711264|NCT00458705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110711265|NCT00458705|Antiemetics|antiemetics|mesh-ancestor
110711266|NCT00458705|Autonomic Agents|autonomic agents|mesh-ancestor
110711267|NCT00458705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110711268|NCT00458705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110711270|NCT00458705|Glucocorticoids|glucocorticoids|mesh-ancestor
110711271|NCT00458705|Hormones|hormones|mesh-ancestor
110711272|NCT00458705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110711273|NCT00458705|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110711274|NCT00458705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110711275|NCT00458705|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110711276|NCT00458705|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110711277|NCT00458705|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110711278|NCT00458705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110711279|NCT00458705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110711280|NCT00458705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110711281|NCT00458705|Immunologic Factors|immunologic factors|mesh-ancestor
110711282|NCT00458705|Leprostatic Agents|leprostatic agents|mesh-ancestor
110711283|NCT00458705|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110711284|NCT00458705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110711285|NCT00458705|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110711286|NCT00458705|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110711287|NCT00458705|Growth Substances|growth substances|mesh-ancestor
110134912|NCT01994642|Glucocorticoids|glucocorticoids|mesh-ancestor
110711288|NCT00458705|Growth Inhibitors|growth inhibitors|mesh-ancestor
110711289|NCT00062374|Deoxyglucose|deoxyglucose|mesh-list
110711290|NCT00062374|Alovudine|alovudine|mesh-list
110711291|NCT00062374|Cisplatin|cisplatin|mesh-list
110711292|NCT00062374|Irinotecan|irinotecan|mesh-list
110711293|NCT00062374|Camptothecin|camptothecin|mesh-list
110711294|NCT00062374|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110711295|NCT00062374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110711296|NCT00062374|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110711297|NCT00062374|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110711298|NCT00062374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110711299|NCT00062374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110711300|NCT00062374|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110711301|NCT00062374|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110711302|NCT00062374|Antimetabolites|antimetabolites|mesh-ancestor
110711303|NCT00062374|Antiviral Agents|antiviral agents|mesh-ancestor
110429150|NCT02700217|Narcotics|narcotics|mesh-ancestor
110711304|NCT00062374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110711305|NCT00285818|Mifepristone|mifepristone|mesh-list
110711306|NCT00285818|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
110711308|NCT00285818|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110711309|NCT00285818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110711310|NCT00285818|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110711311|NCT00285818|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110711312|NCT00285818|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110711313|NCT00285818|Contraceptive Agents|contraceptive agents|mesh-ancestor
110711314|NCT00285818|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
110711315|NCT00285818|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
110711316|NCT00285818|Hormone Antagonists|hormone antagonists|mesh-ancestor
110711317|NCT00285818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110711318|NCT00285818|Luteolytic Agents|luteolytic agents|mesh-ancestor
110711319|NCT00285818|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110711320|NCT00285818|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
110711321|NCT01023347|Paclitaxel|paclitaxel|mesh-list
110711322|NCT01023347|genexol-PM|genexol-pm|mesh-list
110711323|NCT01023347|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110711324|NCT01023347|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110711325|NCT01023347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110711326|NCT01023347|Tubulin Modulators|tubulin modulators|mesh-ancestor
110711327|NCT01023347|Antimitotic Agents|antimitotic agents|mesh-ancestor
110711328|NCT01023347|Mitosis Modulators|mitosis modulators|mesh-ancestor
110711329|NCT01023347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110711330|NCT01023425|Donepezil|donepezil|mesh-list
110711331|NCT01023425|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110711332|NCT01023425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110711333|NCT01023425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110711334|NCT01023425|Cholinergic Agents|cholinergic agents|mesh-ancestor
110134937|NCT01994668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110711335|NCT01023425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110711336|NCT01023425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110711337|NCT01023425|Nootropic Agents|nootropic agents|mesh-ancestor
110711338|NCT00285584|Bupropion|bupropion|mesh-list
110711339|NCT00285584|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110711340|NCT00285584|Antidepressive Agents|antidepressive agents|mesh-ancestor
110711341|NCT00285584|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110711342|NCT00285584|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110711343|NCT00285584|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110711344|NCT00285584|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110711345|NCT00285584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110711346|NCT00285584|Dopamine Agents|dopamine agents|mesh-ancestor
110711347|NCT00285584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110711348|NCT00285584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110711349|NCT00285584|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110711350|NCT00285584|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110711351|NCT00285584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110711352|NCT01583842|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
110711353|NCT01583842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110711354|NCT01583842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110711355|NCT01583842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110711356|NCT01583842|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110711357|NCT00291668|Certolizumab Pegol|certolizumab pegol|mesh-list
110711358|NCT00291668|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110711359|NCT00291668|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110711360|NCT00291668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110711361|NCT00291668|Immunologic Factors|immunologic factors|mesh-ancestor
110711362|NCT00291668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110711363|NCT00291668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110711364|NCT00458393|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110711365|NCT00458393|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110711366|NCT00458393|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110711367|NCT00458393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110711368|NCT00458393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110711369|NCT00458393|Antiviral Agents|antiviral agents|mesh-ancestor
110711370|NCT00458393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110711371|NCT00458393|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110711372|NCT00458393|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110711373|NCT03955354|Apatinib|apatinib|mesh-list
110711374|NCT03955354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110711375|NCT03955354|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110711376|NCT03955354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110711377|NCT03955354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110711378|NCT01095484|Rotigotine|rotigotine|mesh-list
110711379|NCT01095484|Dopamine Agonists|dopamine agonists|mesh-ancestor
110711380|NCT01095484|Dopamine Agents|dopamine agents|mesh-ancestor
110711381|NCT01095484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110711382|NCT01095484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110711383|NCT01095484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110711384|NCT01063478|Everolimus|everolimus|mesh-list
110711385|NCT01063478|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110711386|NCT01063478|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110711387|NCT01063478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110711388|NCT01063478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110711389|NCT01063478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110711390|NCT01063478|Immunologic Factors|immunologic factors|mesh-ancestor
110711391|NCT01063478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110711392|NCT01063478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110711393|NCT01327144|Acyclovir|acyclovir|mesh-list
110711394|NCT01327144|Famciclovir|famciclovir|mesh-list
110711395|NCT01327144|Antiviral Agents|antiviral agents|mesh-ancestor
110711396|NCT01327144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110711397|NCT01327144|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110711398|NCT01327144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110711399|NCT01327144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110711400|NCT01323101|Doxycycline|doxycycline|mesh-list
110711401|NCT01323101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110711402|NCT01323101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110711403|NCT01323101|Antimalarials|antimalarials|mesh-ancestor
110711404|NCT01323101|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110711405|NCT01323101|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110711406|NCT00310856|Vaccines|vaccines|mesh-list
110711407|NCT00310856|Immunologic Factors|immunologic factors|mesh-ancestor
110711408|NCT00310856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110711409|NCT03670355|Tenofovir|tenofovir|mesh-list
110711410|NCT03670355|Antiviral Agents|antiviral agents|mesh-ancestor
110711411|NCT03670355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110711412|NCT03670355|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110711413|NCT03670355|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110711414|NCT03670355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110711415|NCT03670355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110711416|NCT03670355|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110711417|NCT03670355|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110711418|NCT02532062|Vitamin D|vitamin d|mesh-list
110711419|NCT02532062|Cholecalciferol|cholecalciferol|mesh-list
110711420|NCT02532062|Vitamins|vitamins|mesh-ancestor
110711421|NCT02532062|Micronutrients|micronutrients|mesh-ancestor
110711422|NCT02532062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110711423|NCT02532062|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110711424|NCT02532062|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110711425|NCT00283712|Infliximab|infliximab|mesh-list
110711426|NCT00283712|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110711427|NCT00283712|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110711428|NCT00283712|Dermatologic Agents|dermatologic agents|mesh-ancestor
110711429|NCT00283712|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110711430|NCT00283712|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110711431|NCT00048724|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110711432|NCT00048724|Antiviral Agents|antiviral agents|mesh-ancestor
110711433|NCT00048724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110711434|NCT00449033|Gemcitabine|gemcitabine|mesh-list
110711435|NCT00449033|Sorafenib|sorafenib|mesh-list
110711436|NCT00449033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110711437|NCT00449033|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110711438|NCT00449033|Antimetabolites|antimetabolites|mesh-ancestor
110711439|NCT00449033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110711440|NCT00449033|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110711441|NCT00449033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110711442|NCT01024205|Sunitinib|sunitinib|mesh-list
110711443|NCT01024205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110711444|NCT01024205|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110135042|NCT01995188|Bevacizumab|bevacizumab|mesh-list
110711445|NCT01024205|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110711446|NCT01024205|Growth Substances|growth substances|mesh-ancestor
110711447|NCT01024205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110711448|NCT01024205|Growth Inhibitors|growth inhibitors|mesh-ancestor
110711449|NCT01024205|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110711450|NCT01024205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110711451|NCT01024205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110711452|NCT00448019|Cyclophosphamide|cyclophosphamide|mesh-list
110711453|NCT00448019|Bevacizumab|bevacizumab|mesh-list
110711454|NCT00448019|Rituximab|rituximab|mesh-list
110711455|NCT00448019|Fludarabine|fludarabine|mesh-list
110711456|NCT00448019|Fludarabine phosphate|fludarabine phosphate|mesh-list
110711457|NCT00448019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110711458|NCT00448019|Immunologic Factors|immunologic factors|mesh-ancestor
110711459|NCT00448019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110711460|NCT00448019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110711461|NCT00448019|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110711462|NCT00448019|Alkylating Agents|alkylating agents|mesh-ancestor
110711463|NCT00448019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110711464|NCT00448019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110711465|NCT00448019|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110711466|NCT00448019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110711467|NCT00448019|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110711468|NCT00448019|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110711469|NCT00448019|Growth Substances|growth substances|mesh-ancestor
110711470|NCT00448019|Growth Inhibitors|growth inhibitors|mesh-ancestor
110711471|NCT00448019|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110711472|NCT00448019|Antimetabolites|antimetabolites|mesh-ancestor
110711473|NCT00457691|Leucovorin|leucovorin|mesh-list
110711474|NCT00457691|Fluorouracil|fluorouracil|mesh-list
110711475|NCT00457691|Irinotecan|irinotecan|mesh-list
110711476|NCT00457691|Sunitinib|sunitinib|mesh-list
110711477|NCT00457691|Levoleucovorin|levoleucovorin|mesh-list
110711478|NCT00457691|Antimetabolites|antimetabolites|mesh-ancestor
110711479|NCT00457691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110711480|NCT00457691|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110711481|NCT00457691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110711482|NCT00457691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110711483|NCT00457691|Immunologic Factors|immunologic factors|mesh-ancestor
110711484|NCT00457691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110711485|NCT00457691|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110711486|NCT00457691|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110711487|NCT00457691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110711488|NCT00457691|Antidotes|antidotes|mesh-ancestor
110711489|NCT00457691|Protective Agents|protective agents|mesh-ancestor
110711490|NCT00457691|Vitamin B Complex|vitamin b complex|mesh-ancestor
110711491|NCT00457691|Vitamins|vitamins|mesh-ancestor
110711492|NCT00457691|Micronutrients|micronutrients|mesh-ancestor
110711493|NCT00457691|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110711494|NCT00457691|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110711495|NCT00457691|Growth Substances|growth substances|mesh-ancestor
110711496|NCT00457691|Growth Inhibitors|growth inhibitors|mesh-ancestor
110711497|NCT00457691|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110711498|NCT00447005|Axitinib|axitinib|mesh-list
110711499|NCT00447005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110861432|NCT03292822|Paclitaxel|paclitaxel|mesh-list
110711500|NCT00447005|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110711501|NCT00447005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110711502|NCT00447005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110711503|NCT01565759|Lithium Carbonate|lithium carbonate|mesh-list
110711504|NCT01565759|Antidepressive Agents|antidepressive agents|mesh-ancestor
110711505|NCT01565759|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110711506|NCT01565759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110711507|NCT01565759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110711508|NCT01565759|Antimanic Agents|antimanic agents|mesh-ancestor
110711509|NCT01565759|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110711510|NCT01565759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110711511|NCT01565759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110711512|NCT00446849|Mesalamine|mesalamine|mesh-list
110711513|NCT00446849|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110711514|NCT00446849|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110711515|NCT00446849|Analgesics|analgesics|mesh-ancestor
110711516|NCT00446849|Sensory System Agents|sensory system agents|mesh-ancestor
110711517|NCT00446849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110711518|NCT00446849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110711519|NCT00446849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110711520|NCT00446849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110711521|NCT01565837|Ipilimumab|ipilimumab|mesh-list
110711522|NCT01565837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110711523|NCT01565837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110711524|NCT01565837|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110711525|NCT01565837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110429372|NCT01203917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110711526|NCT00446459|Mycophenolic Acid|mycophenolic acid|mesh-list
110711527|NCT00446459|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110711528|NCT00446459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110711529|NCT00446459|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110711530|NCT00446459|Antitubercular Agents|antitubercular agents|mesh-ancestor
110711531|NCT00446459|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110711532|NCT00446459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110711533|NCT00446459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110711534|NCT00446459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110711535|NCT00456599|Gemcitabine|gemcitabine|mesh-list
110711536|NCT00456599|Oxaliplatin|oxaliplatin|mesh-list
110711537|NCT00456599|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110711538|NCT00456599|Antimetabolites|antimetabolites|mesh-ancestor
110711539|NCT00456599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110711540|NCT00456599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110711541|NCT00456521|Naltrexone|naltrexone|mesh-list
110711542|NCT00456521|Bupropion|bupropion|mesh-list
110711543|NCT00456521|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110711544|NCT00456521|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110711545|NCT00456521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110711546|NCT00456521|Sensory System Agents|sensory system agents|mesh-ancestor
110711547|NCT00456521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110711548|NCT00456521|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110711549|NCT00456521|Antidepressive Agents|antidepressive agents|mesh-ancestor
110711550|NCT00456521|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110711551|NCT00456521|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110711552|NCT00456521|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110711553|NCT00456521|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110711554|NCT00456521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110711555|NCT00456521|Dopamine Agents|dopamine agents|mesh-ancestor
110711556|NCT00456521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110711557|NCT00456521|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110711558|NCT00456521|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110711559|NCT00456521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110711560|NCT00456365|Pravastatin|pravastatin|mesh-list
110711561|NCT00456365|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110711562|NCT00456365|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110711563|NCT00456365|Antimetabolites|antimetabolites|mesh-ancestor
110861433|NCT03292822|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110711564|NCT00456365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110135166|NCT01996150|Eusol|eusol|mesh-list
110711565|NCT00456365|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110711566|NCT00456365|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110711567|NCT00456365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110711568|NCT03843047|Nicotine|nicotine|mesh-list
110711569|NCT03843047|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110711570|NCT03843047|Autonomic Agents|autonomic agents|mesh-ancestor
110711571|NCT03843047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110711572|NCT03843047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110711573|NCT03843047|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110711574|NCT03843047|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110711575|NCT03843047|Cholinergic Agents|cholinergic agents|mesh-ancestor
110711576|NCT03843047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110711577|NCT03843047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110711578|NCT00455741|Estradiol|estradiol|mesh-list
110711579|NCT00455741|Progesterone|progesterone|mesh-list
110711580|NCT00455741|Estrogens|estrogens|mesh-ancestor
110711581|NCT00455741|Hormones|hormones|mesh-ancestor
110711582|NCT00455741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110711583|NCT00455741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110711584|NCT00455741|Progestins|progestins|mesh-ancestor
110711585|NCT00445679|Paroxetine|paroxetine|mesh-list
110711586|NCT00445679|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110711587|NCT00445679|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110711588|NCT00445679|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110711589|NCT00445679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110711590|NCT00445679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110711591|NCT00445679|Serotonin Agents|serotonin agents|mesh-ancestor
110711592|NCT00445679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110711593|NCT00445679|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110711594|NCT00445679|Antidepressive Agents|antidepressive agents|mesh-ancestor
110711595|NCT00445679|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110711596|NCT00445679|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110711597|NCT00445679|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110711598|NCT00445679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110711599|NCT00445601|Gemcitabine|gemcitabine|mesh-list
110711600|NCT00445601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110711601|NCT00445601|Antimetabolites|antimetabolites|mesh-ancestor
110135192|NCT01996306|Antidotes|antidotes|mesh-ancestor
110711602|NCT00445601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110711603|NCT00445601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110711604|NCT00444587|Trastuzumab|trastuzumab|mesh-list
110711605|NCT00444587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110711606|NCT00444587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110711607|NCT00235716|Vitamins|vitamins|mesh-list
110711608|NCT00235716|Vitamin E|vitamin e|mesh-list
110711609|NCT00235716|Tocopherols|tocopherols|mesh-list
110711610|NCT00235716|Tocotrienols|tocotrienols|mesh-list
110711611|NCT00235716|alpha-Tocopherol|alpha-tocopherol|mesh-list
110711612|NCT00235716|Memantine|memantine|mesh-list
110711613|NCT00235716|Micronutrients|micronutrients|mesh-ancestor
110711614|NCT00235716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110711615|NCT00235716|Antioxidants|antioxidants|mesh-ancestor
110711616|NCT00235716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110711617|NCT00235716|Protective Agents|protective agents|mesh-ancestor
110711618|NCT00235716|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110711619|NCT00235716|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110711620|NCT00235716|Dopamine Agents|dopamine agents|mesh-ancestor
110711621|NCT00235716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110711622|NCT00235716|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110711623|NCT00235716|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110711624|NCT00274742|Blinatumomab|blinatumomab|mesh-list
110711625|NCT00274742|Antibodies, Bispecific|antibodies, bispecific|mesh-list
110711626|NCT00274742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110711627|NCT00274742|Immunologic Factors|immunologic factors|mesh-ancestor
110711628|NCT00274742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110711629|NCT03970044|Dapagliflozin|dapagliflozin|mesh-list
110711630|NCT03970044|Exenatide|exenatide|mesh-list
110711631|NCT03970044|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110711632|NCT03970044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110711633|NCT03970044|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110861440|NCT03297502|Tacrolimus|tacrolimus|mesh-list
110711634|NCT03970044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110711635|NCT03970044|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110711636|NCT03970044|Incretins|incretins|mesh-ancestor
110711637|NCT03970044|Hormones|hormones|mesh-ancestor
110711638|NCT03970044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110711639|NCT00444275|Esomeprazole|esomeprazole|mesh-list
110711640|NCT00444275|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110711641|NCT00444275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110711642|NCT00444275|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110711643|NCT00444275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110711644|NCT00444275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110711645|NCT00454805|Fulvestrant|fulvestrant|mesh-list
110711646|NCT00454805|Cediranib|cediranib|mesh-list
110711647|NCT00454805|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110711648|NCT00454805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110711649|NCT00454805|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110711650|NCT00454805|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110711651|NCT00454805|Hormone Antagonists|hormone antagonists|mesh-ancestor
110135231|NCT01996462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110711652|NCT00454805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110711653|NCT00454805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110711654|NCT00454805|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110711655|NCT00454805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110711656|NCT00454805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110711657|NCT00283244|Gemcitabine|gemcitabine|mesh-list
110711658|NCT00283244|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110711659|NCT00283244|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110711660|NCT00283244|Antimetabolites|antimetabolites|mesh-ancestor
110711661|NCT00283244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110711662|NCT00283244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110711663|NCT00283244|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110711664|NCT00283244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110711665|NCT00282464|Ziprasidone|ziprasidone|mesh-list
110711666|NCT00282464|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110711667|NCT00282464|Serotonin Agents|serotonin agents|mesh-ancestor
110711668|NCT00282464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110711669|NCT00282464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110711670|NCT00282464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110711671|NCT00282464|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110711672|NCT00282464|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110711673|NCT00282464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110711674|NCT00282464|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110711675|NCT00282464|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110711676|NCT00282464|Dopamine Agents|dopamine agents|mesh-ancestor
110711677|NCT03841331|Serlopitant|serlopitant|mesh-list
110711678|NCT03841331|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110711679|NCT03841331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110711680|NCT03841331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110711681|NCT03841331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110711682|NCT00262080|Ecallantide|ecallantide|mesh-list
110711683|NCT00262080|Analgesics|analgesics|mesh-ancestor
110711684|NCT00262080|Sensory System Agents|sensory system agents|mesh-ancestor
110711685|NCT00262080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110711686|NCT00262080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110711687|NCT00262080|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110711688|NCT00262080|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110711689|NCT00262080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110711690|NCT00262080|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110711691|NCT01073904|Levonorgestrel|levonorgestrel|mesh-list
110711692|NCT01073904|Norgestrel|norgestrel|mesh-list
110711693|NCT01073904|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110711694|NCT01073904|Contraceptive Agents|contraceptive agents|mesh-ancestor
110711695|NCT01073904|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110711696|NCT01073904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110711697|NCT01073904|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110711698|NCT01073904|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110711699|NCT01073904|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110711700|NCT01073904|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110711701|NCT00282308|Rituximab|rituximab|mesh-list
110711702|NCT00282308|Methotrexate|methotrexate|mesh-list
110711703|NCT00282308|Vaccines|vaccines|mesh-list
110135252|NCT01996475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110711704|NCT00282308|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110711705|NCT00282308|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
110711706|NCT00282308|Immunologic Factors|immunologic factors|mesh-ancestor
110711707|NCT00282308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110711708|NCT00282308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110711709|NCT00282308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110711710|NCT00282308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110711711|NCT00282308|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110711712|NCT00282308|Abortifacient Agents|abortifacient agents|mesh-ancestor
110711713|NCT00282308|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110711714|NCT00282308|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110711715|NCT00282308|Antimetabolites|antimetabolites|mesh-ancestor
110711716|NCT00282308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110711717|NCT00282308|Dermatologic Agents|dermatologic agents|mesh-ancestor
110711718|NCT00282308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110711719|NCT00282308|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110711720|NCT00282308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110711721|NCT00282308|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110711722|NCT00282308|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110711723|NCT00281840|Bevacizumab|bevacizumab|mesh-list
110711724|NCT00281840|Docetaxel|docetaxel|mesh-list
110711725|NCT00281840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110711726|NCT00281840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110711727|NCT00281840|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110711728|NCT00281840|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110711729|NCT00281840|Growth Substances|growth substances|mesh-ancestor
110711730|NCT00281840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110711731|NCT00281840|Growth Inhibitors|growth inhibitors|mesh-ancestor
110711732|NCT00281840|Tubulin Modulators|tubulin modulators|mesh-ancestor
110711733|NCT00281840|Antimitotic Agents|antimitotic agents|mesh-ancestor
110711734|NCT00281840|Mitosis Modulators|mitosis modulators|mesh-ancestor
110711735|NCT00281840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110711736|NCT00272792|Verapamil|verapamil|mesh-list
110711737|NCT00272792|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110711738|NCT00272792|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110711739|NCT00272792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110711740|NCT00272792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110711741|NCT00272792|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110711742|NCT00272792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110711743|NCT00272792|Vasodilator Agents|vasodilator agents|mesh-ancestor
110711744|NCT01069094|Leuprolide|leuprolide|mesh-list
110711745|NCT01069094|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110429596|NCT04209439|Anesthetics, Local|anesthetics, local|mesh-ancestor
110711746|NCT01069094|Fertility Agents|fertility agents|mesh-ancestor
110711747|NCT01069094|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110711748|NCT01069094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110711749|NCT01069094|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110711750|NCT01069094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110711751|NCT00048568|Methotrexate|methotrexate|mesh-list
110711753|NCT00048568|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110711754|NCT00048568|Abortifacient Agents|abortifacient agents|mesh-ancestor
110711755|NCT00048568|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110711756|NCT00048568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110711757|NCT00048568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110711758|NCT00048568|Antimetabolites|antimetabolites|mesh-ancestor
110711759|NCT00048568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110711760|NCT00048568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110711761|NCT00048568|Dermatologic Agents|dermatologic agents|mesh-ancestor
110711762|NCT00048568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110711763|NCT00048568|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110711764|NCT00048568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110711765|NCT00048568|Immunologic Factors|immunologic factors|mesh-ancestor
110711766|NCT00048568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110711767|NCT00048568|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110711768|NCT00048568|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110711769|NCT00048568|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110711770|NCT00262002|Vaccines|vaccines|mesh-list
110711771|NCT00262002|Immunologic Factors|immunologic factors|mesh-ancestor
110711772|NCT00262002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110711773|NCT01584076|Donepezil|donepezil|mesh-list
110711774|NCT01584076|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110711775|NCT01584076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110711776|NCT01584076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110711777|NCT01584076|Cholinergic Agents|cholinergic agents|mesh-ancestor
110711778|NCT01584076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110711779|NCT01584076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110711780|NCT01584076|Nootropic Agents|nootropic agents|mesh-ancestor
110711781|NCT03954964|Analgesics, Opioid|analgesics, opioid|mesh-list
110711782|NCT03954964|Narcotics|narcotics|mesh-ancestor
110711783|NCT03954964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110711784|NCT03954964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110711785|NCT03954964|Analgesics|analgesics|mesh-ancestor
110711786|NCT03954964|Sensory System Agents|sensory system agents|mesh-ancestor
110711787|NCT03954964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110711788|NCT00281528|Paclitaxel|paclitaxel|mesh-list
110711789|NCT00281528|Bevacizumab|bevacizumab|mesh-list
110711790|NCT00281528|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110711791|NCT00281528|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110711792|NCT00281528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110711793|NCT00281528|Tubulin Modulators|tubulin modulators|mesh-ancestor
110711794|NCT00281528|Antimitotic Agents|antimitotic agents|mesh-ancestor
110711795|NCT00281528|Mitosis Modulators|mitosis modulators|mesh-ancestor
110711796|NCT00281528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110711797|NCT00281528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110711798|NCT00281528|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110711799|NCT00281528|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110711800|NCT00281528|Growth Substances|growth substances|mesh-ancestor
110711801|NCT00281528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110711802|NCT00281528|Growth Inhibitors|growth inhibitors|mesh-ancestor
110711803|NCT01095640|Adapalene|adapalene|mesh-list
110711804|NCT01095640|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110711805|NCT01095640|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110711806|NCT01095640|Analgesics|analgesics|mesh-ancestor
110711807|NCT01095640|Sensory System Agents|sensory system agents|mesh-ancestor
110711808|NCT01095640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110135354|NCT01997112|Acetaminophen|acetaminophen|mesh-list
110711809|NCT01095640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110711810|NCT01095640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110711811|NCT01095640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110711812|NCT01095640|Dermatologic Agents|dermatologic agents|mesh-ancestor
110711813|NCT00280748|Pemetrexed|pemetrexed|mesh-list
110711814|NCT00280748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110711815|NCT00280748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110711816|NCT00280748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110711817|NCT00280748|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110711818|NCT00280748|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110711819|NCT03975374|Tobramycin|tobramycin|mesh-list
110711820|NCT03975374|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
110711821|NCT03975374|Dexamethasone|dexamethasone|mesh-list
110429667|NCT02869347|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110711822|NCT03975374|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110711823|NCT03975374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110711824|NCT03975374|Antiemetics|antiemetics|mesh-ancestor
110711825|NCT03975374|Autonomic Agents|autonomic agents|mesh-ancestor
110711826|NCT03975374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110711827|NCT03975374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110711828|NCT03975374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110711829|NCT03975374|Glucocorticoids|glucocorticoids|mesh-ancestor
110711830|NCT03975374|Hormones|hormones|mesh-ancestor
110711831|NCT03975374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110711832|NCT03975374|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110711833|NCT03975374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110711834|NCT03975374|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110711835|NCT03975374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110711836|NCT03975374|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110711837|NCT00061048|Alemtuzumab|alemtuzumab|mesh-list
110711838|NCT00061048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110711839|NCT00061048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110711840|NCT01581398|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110711841|NCT01581398|Interferon-alpha|interferon-alpha|mesh-list
110711842|NCT01581398|Antiviral Agents|antiviral agents|mesh-ancestor
110711843|NCT01581398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110711844|NCT01581398|Immunologic Factors|immunologic factors|mesh-ancestor
110711845|NCT01581398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110711846|NCT03741686|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
110711847|NCT03741686|Cathartics|cathartics|mesh-ancestor
110711848|NCT03741686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110711849|NCT00279812|Selenium|selenium|mesh-list
110711851|NCT00279812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110711852|NCT00279812|Protective Agents|protective agents|mesh-ancestor
110711853|NCT00279812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110711854|NCT00279812|Trace Elements|trace elements|mesh-ancestor
110711855|NCT00279812|Micronutrients|micronutrients|mesh-ancestor
110711856|NCT01070732|Acetaminophen|acetaminophen|mesh-list
110711857|NCT01070732|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110711858|NCT01070732|Analgesics|analgesics|mesh-ancestor
110711859|NCT01070732|Sensory System Agents|sensory system agents|mesh-ancestor
110711860|NCT01070732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110711861|NCT01070732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110711862|NCT01070732|Antipyretics|antipyretics|mesh-ancestor
110711863|NCT00207714|Infliximab|infliximab|mesh-list
110711864|NCT00207714|Golimumab|golimumab|mesh-list
110711865|NCT00207714|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110711866|NCT00207714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110711867|NCT00207714|Dermatologic Agents|dermatologic agents|mesh-ancestor
110711868|NCT00207714|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110711869|NCT00207714|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110711870|NCT00207714|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110711871|NCT00207714|Immunologic Factors|immunologic factors|mesh-ancestor
110711872|NCT00207714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110711873|NCT00207090|Rifampin|rifampin|mesh-list
110711874|NCT00207090|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110711875|NCT00207090|Antitubercular Agents|antitubercular agents|mesh-ancestor
110711876|NCT00207090|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110711877|NCT00207090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110711878|NCT00207090|Leprostatic Agents|leprostatic agents|mesh-ancestor
110711879|NCT00207090|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110711880|NCT00207090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110711881|NCT00207090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110711882|NCT00207090|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110711883|NCT00207090|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110711884|NCT00207090|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110711885|NCT00207090|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110711886|NCT00207090|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110711887|NCT00207090|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110711888|NCT00059332|Magnesium Sulfate|magnesium sulfate|mesh-list
110711889|NCT00059332|Analgesics|analgesics|mesh-ancestor
110711890|NCT00059332|Sensory System Agents|sensory system agents|mesh-ancestor
110711891|NCT00059332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110711892|NCT00059332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110135568|NCT01998503|Bortezomib|bortezomib|mesh-list
110711893|NCT00059332|Anesthetics|anesthetics|mesh-ancestor
110711894|NCT00059332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110711895|NCT00059332|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110711896|NCT00059332|Anticonvulsants|anticonvulsants|mesh-ancestor
110711897|NCT00059332|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110711898|NCT00059332|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110711899|NCT00059332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110711900|NCT00059332|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110711901|NCT00059332|Tocolytic Agents|tocolytic agents|mesh-ancestor
110711902|NCT00059332|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110711903|NCT00233454|Midostaurin|midostaurin|mesh-list
110711904|NCT00233454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110711905|NCT00233454|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110711906|NCT00233454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110711907|NCT00233454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110711908|NCT00047320|Carboplatin|carboplatin|mesh-list
110711909|NCT00047320|Etoposide|etoposide|mesh-list
110711910|NCT00047320|Ifosfamide|ifosfamide|mesh-list
110711911|NCT00047320|Isophosphamide mustard|isophosphamide mustard|mesh-list
110711912|NCT00047320|Thiotepa|thiotepa|mesh-list
110711913|NCT00047320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110711914|NCT00047320|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110711915|NCT00047320|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110711916|NCT00047320|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110711917|NCT00047320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110711918|NCT00047320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110711919|NCT00047320|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110711920|NCT00047320|Alkylating Agents|alkylating agents|mesh-ancestor
110711921|NCT00047320|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110711922|NCT00047320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110711923|NCT00047320|Immunologic Factors|immunologic factors|mesh-ancestor
110135613|NCT01998698|Lidocaine|lidocaine|mesh-list
110711924|NCT00047320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110711925|NCT00233064|Palivizumab|palivizumab|mesh-list
110711926|NCT00233064|Antiviral Agents|antiviral agents|mesh-ancestor
110711927|NCT00233064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110711928|NCT03973086|Cardiac Glycosides|cardiac glycosides|mesh-list
110711929|NCT03973086|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110711930|NCT03973086|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110711931|NCT03973086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110711932|NCT03973086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110711933|NCT03973086|Protective Agents|protective agents|mesh-ancestor
110711934|NCT03973086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110711935|NCT00206076|Mycophenolic Acid|mycophenolic acid|mesh-list
110711936|NCT00206076|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110711937|NCT00206076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110711938|NCT00206076|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110711939|NCT00206076|Antitubercular Agents|antitubercular agents|mesh-ancestor
110711940|NCT00206076|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110711941|NCT00206076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110711942|NCT00206076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110711943|NCT00206076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110711944|NCT00278954|Immunoglobulins|immunoglobulins|mesh-list
110711945|NCT00278954|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110711946|NCT00278954|Antibodies|antibodies|mesh-list
110711947|NCT00278954|gamma-Globulins|gamma-globulins|mesh-list
110711948|NCT00278954|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110711949|NCT00278954|Immunologic Factors|immunologic factors|mesh-ancestor
110711950|NCT00278954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110711951|NCT00278564|Methylprednisolone|methylprednisolone|mesh-list
110711952|NCT00278564|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110711953|NCT00278564|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110711954|NCT00278564|Prednisolone|prednisolone|mesh-list
110711955|NCT00278564|Prednisolone acetate|prednisolone acetate|mesh-list
110711956|NCT00278564|Cyclophosphamide|cyclophosphamide|mesh-list
110711957|NCT00278564|Rituximab|rituximab|mesh-list
110711958|NCT00278564|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110711959|NCT00278564|Prednisolone phosphate|prednisolone phosphate|mesh-list
110711960|NCT00278564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110711961|NCT00278564|Immunologic Factors|immunologic factors|mesh-ancestor
110711962|NCT00278564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110711963|NCT00278564|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110711964|NCT00278564|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110711965|NCT00278564|Alkylating Agents|alkylating agents|mesh-ancestor
110711966|NCT00278564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110711967|NCT00278564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110711968|NCT00278564|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110711969|NCT00278564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110711970|NCT00278564|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110711971|NCT00278564|Antiemetics|antiemetics|mesh-ancestor
110429815|NCT00621361|Etoposide|etoposide|mesh-list
110711972|NCT00278564|Autonomic Agents|autonomic agents|mesh-ancestor
110711973|NCT00278564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110711974|NCT00278564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110711975|NCT00278564|Glucocorticoids|glucocorticoids|mesh-ancestor
110711976|NCT00278564|Hormones|hormones|mesh-ancestor
110711977|NCT00278564|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110711978|NCT00278564|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110711979|NCT00278564|Protective Agents|protective agents|mesh-ancestor
110711980|NCT00278564|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110135765|NCT02000193|Fulvestrant|fulvestrant|mesh-list
110135774|NCT02000206|Alfentanil|alfentanil|mesh-list
110711981|NCT01071564|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
110711982|NCT01071564|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-list
110711983|NCT01071564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110711984|NCT01071564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110711985|NCT00268346|Gefitinib|gefitinib|mesh-list
110711986|NCT00268346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110711987|NCT00268346|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110711988|NCT00268346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110711989|NCT00268346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110711990|NCT00250718|Levofloxacin|levofloxacin|mesh-list
110711991|NCT00250718|Ofloxacin|ofloxacin|mesh-list
110711992|NCT00250718|Dexamethasone|dexamethasone|mesh-list
110711993|NCT00250718|Rituximab|rituximab|mesh-list
110711994|NCT00250718|Etoposide|etoposide|mesh-list
110711995|NCT00250718|Vincristine|vincristine|mesh-list
110711996|NCT00250718|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110711997|NCT00250718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110711998|NCT00250718|Immunologic Factors|immunologic factors|mesh-ancestor
110711999|NCT00250718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110712000|NCT00250718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110712001|NCT00250718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110712002|NCT00250718|Antiemetics|antiemetics|mesh-ancestor
110712003|NCT00250718|Autonomic Agents|autonomic agents|mesh-ancestor
110712004|NCT00250718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110712005|NCT00250718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110712006|NCT00250718|Glucocorticoids|glucocorticoids|mesh-ancestor
110712007|NCT00250718|Hormones|hormones|mesh-ancestor
110712008|NCT00250718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110712009|NCT00250718|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110712010|NCT00250718|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110712011|NCT00250718|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110712012|NCT00250718|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110712013|NCT00250718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110712014|NCT00250718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110712015|NCT00250718|Tubulin Modulators|tubulin modulators|mesh-ancestor
110712016|NCT00250718|Antimitotic Agents|antimitotic agents|mesh-ancestor
110712017|NCT00250718|Mitosis Modulators|mitosis modulators|mesh-ancestor
110712018|NCT00250718|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110712019|NCT00250718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110712020|NCT00250718|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110712021|NCT00250718|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110712022|NCT00250718|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110712023|NCT00276614|Bortezomib|bortezomib|mesh-list
110712024|NCT00276614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110712025|NCT00276458|Atorvastatin|atorvastatin|mesh-list
110712026|NCT00276458|Ezetimibe|ezetimibe|mesh-list
110712027|NCT00276458|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110712028|NCT00276458|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110712029|NCT00276458|Antimetabolites|antimetabolites|mesh-ancestor
110712030|NCT00276458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110712031|NCT00276458|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110712032|NCT00276458|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110712033|NCT00276458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110712034|NCT00276380|Aspirin|aspirin|mesh-list
110712035|NCT00276380|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110712036|NCT00276380|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110712037|NCT00276380|Analgesics|analgesics|mesh-ancestor
110712038|NCT00276380|Sensory System Agents|sensory system agents|mesh-ancestor
110712039|NCT00276380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110712040|NCT00276380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110712041|NCT00276380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110712042|NCT00276380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110712043|NCT00276380|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110712044|NCT00276380|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110712045|NCT00276380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110712046|NCT00276380|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110712047|NCT00276380|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110712048|NCT00276380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110712049|NCT00276380|Antipyretics|antipyretics|mesh-ancestor
110712050|NCT02531984|Azithromycin|azithromycin|mesh-list
110712051|NCT02531984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110712052|NCT02531984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110712053|NCT00267956|Ustekinumab|ustekinumab|mesh-list
110712054|NCT00267956|Dermatologic Agents|dermatologic agents|mesh-ancestor
110712055|NCT00267488|Topotecan|topotecan|mesh-list
110712056|NCT00267488|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110712057|NCT00267488|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110712058|NCT00267488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110712059|NCT00267488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110712060|NCT00267488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110712061|NCT01073696|Granisetron|granisetron|mesh-list
110712062|NCT01073696|Antiemetics|antiemetics|mesh-ancestor
110712063|NCT01073696|Autonomic Agents|autonomic agents|mesh-ancestor
110712064|NCT01073696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110712065|NCT01073696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110712066|NCT01073696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110712067|NCT01073696|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110712068|NCT01073696|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110712069|NCT01073696|Serotonin Agents|serotonin agents|mesh-ancestor
110712070|NCT01073696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110712071|NCT01073696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110712073|NCT00058552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110712074|NCT00058552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110712075|NCT01093768|Vasopressins|vasopressins|mesh-list
110712076|NCT01093768|Arginine Vasopressin|arginine vasopressin|mesh-list
110712077|NCT01093768|Oxytocin|oxytocin|mesh-list
110712078|NCT01093768|Oxytocics|oxytocics|mesh-ancestor
110712079|NCT01093768|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110712080|NCT01093768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110712081|NCT01093768|Hemostatics|hemostatics|mesh-ancestor
110712082|NCT01093768|Coagulants|coagulants|mesh-ancestor
110712083|NCT01093768|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110712084|NCT01093768|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
110712085|NCT01093768|Natriuretic Agents|natriuretic agents|mesh-ancestor
110712086|NCT00044512|Sorafenib|sorafenib|mesh-list
110712087|NCT00044512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110712088|NCT00044512|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110712089|NCT00044512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110712090|NCT00044512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110712091|NCT03805438|Chloroprocaine|chloroprocaine|mesh-list
110712092|NCT03805438|Anesthetics, Local|anesthetics, local|mesh-ancestor
110712093|NCT03805438|Anesthetics|anesthetics|mesh-ancestor
110712094|NCT03805438|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110712095|NCT03805438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110712096|NCT03805438|Sensory System Agents|sensory system agents|mesh-ancestor
110712097|NCT03805438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110712098|NCT01096420|Topiramate|topiramate|mesh-list
110712099|NCT01096420|Anticonvulsants|anticonvulsants|mesh-ancestor
110712100|NCT01096420|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110712101|NCT01096420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110712102|NCT03953716|Desogestrel|desogestrel|mesh-list
110712103|NCT03953716|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110712104|NCT03953716|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110712105|NCT03953716|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110712106|NCT03953716|Contraceptive Agents|contraceptive agents|mesh-ancestor
110712107|NCT03953716|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110712108|NCT03953716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110712109|NCT03953716|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110712110|NCT03953716|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110712112|NCT03953716|Hormones|hormones|mesh-ancestor
110712113|NCT03953716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110712114|NCT01096498|Levonorgestrel|levonorgestrel|mesh-list
110712115|NCT01096498|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110712116|NCT01096498|Contraceptive Agents|contraceptive agents|mesh-ancestor
110712117|NCT01096498|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110712118|NCT01096498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110712119|NCT01096498|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110712120|NCT01096498|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110712121|NCT01096498|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110712123|NCT00147537|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110712124|NCT00147537|Carboplatin|carboplatin|mesh-list
110712125|NCT00147537|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110712126|NCT00147537|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110712127|NCT00147537|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110712128|NCT00147537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110712129|NCT00147537|Tubulin Modulators|tubulin modulators|mesh-ancestor
110712130|NCT00147537|Antimitotic Agents|antimitotic agents|mesh-ancestor
110712131|NCT00147537|Mitosis Modulators|mitosis modulators|mesh-ancestor
110712132|NCT00147537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110712133|NCT00147537|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110712134|NCT00147537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110712135|NCT00147537|Immunologic Factors|immunologic factors|mesh-ancestor
110712136|NCT00147537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110712137|NCT00222729|Bevacizumab|bevacizumab|mesh-list
110712138|NCT00222729|Pemetrexed|pemetrexed|mesh-list
110712139|NCT00222729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110712140|NCT00222729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110712141|NCT00222729|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110712142|NCT00222729|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110712143|NCT00222729|Growth Substances|growth substances|mesh-ancestor
110712144|NCT00222729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110712145|NCT00222729|Growth Inhibitors|growth inhibitors|mesh-ancestor
110712146|NCT00222729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110712147|NCT00222729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110712148|NCT00222729|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110712149|NCT00222729|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110712150|NCT00147225|Carboplatin|carboplatin|mesh-list
110712151|NCT00147225|Doxorubicin|doxorubicin|mesh-list
110712152|NCT00147225|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110712153|NCT00147225|Ifosfamide|ifosfamide|mesh-list
110712154|NCT00147225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110712155|NCT00147225|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110712156|NCT00147225|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110712157|NCT00147225|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110712158|NCT00147225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110712159|NCT00147225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110712160|NCT00147225|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110712161|NCT00147225|Alkylating Agents|alkylating agents|mesh-ancestor
110712162|NCT00222105|Thalidomide|thalidomide|mesh-list
110712163|NCT00222105|Dexamethasone|dexamethasone|mesh-list
110712164|NCT00222105|Doxorubicin|doxorubicin|mesh-list
110712165|NCT00222105|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110712166|NCT00222105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110712167|NCT00222105|Antiemetics|antiemetics|mesh-ancestor
110712168|NCT00222105|Autonomic Agents|autonomic agents|mesh-ancestor
110712169|NCT00222105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110712170|NCT00222105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110712171|NCT00222105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110712172|NCT00222105|Glucocorticoids|glucocorticoids|mesh-ancestor
110712173|NCT00222105|Hormones|hormones|mesh-ancestor
110712174|NCT00222105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110712175|NCT00222105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110712176|NCT00222105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110712177|NCT00222105|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110712178|NCT00222105|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110712179|NCT00222105|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110712180|NCT00222105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110861486|NCT02820519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110712181|NCT00222105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110712182|NCT00222105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110350804|NCT02834559|Dalteparin|dalteparin|mesh-list
110712183|NCT00222105|Immunologic Factors|immunologic factors|mesh-ancestor
110712184|NCT00222105|Leprostatic Agents|leprostatic agents|mesh-ancestor
110712185|NCT00222105|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110712186|NCT00222105|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110712187|NCT00222105|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110712188|NCT00222105|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110712189|NCT00222105|Growth Substances|growth substances|mesh-ancestor
110712190|NCT00222105|Growth Inhibitors|growth inhibitors|mesh-ancestor
110712191|NCT00247676|Sunitinib|sunitinib|mesh-list
110712192|NCT00247676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110712193|NCT00247676|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110712194|NCT00247676|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110712195|NCT00247676|Growth Substances|growth substances|mesh-ancestor
110712196|NCT00247676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110712197|NCT00247676|Growth Inhibitors|growth inhibitors|mesh-ancestor
110712198|NCT00247676|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110712199|NCT00247676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110712200|NCT00247676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110712201|NCT00267020|Gemcitabine|gemcitabine|mesh-list
110712202|NCT00267020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110712203|NCT00267020|Antimetabolites|antimetabolites|mesh-ancestor
110712204|NCT00267020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110712205|NCT00267020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110712207|NCT03975062|Antithrombins|antithrombins|mesh-ancestor
110712208|NCT03975062|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110712209|NCT03975062|Protease Inhibitors|protease inhibitors|mesh-ancestor
110712210|NCT03975062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110712211|NCT03975062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110712212|NCT03975062|Anticoagulants|anticoagulants|mesh-ancestor
110712213|NCT03970772|Glucagon|glucagon|mesh-list
110712214|NCT03970772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110712215|NCT03970772|Hormones|hormones|mesh-ancestor
110712216|NCT03970772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110712217|NCT03970772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110712218|NCT00242216|Ritonavir|ritonavir|mesh-list
110712219|NCT00242216|Atazanavir Sulfate|atazanavir sulfate|mesh-list
110712220|NCT00242216|Fosamprenavir|fosamprenavir|mesh-list
110712221|NCT00242216|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110712222|NCT00242216|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110712223|NCT00242216|Protease Inhibitors|protease inhibitors|mesh-ancestor
110712224|NCT00242216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110712225|NCT00242216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110712226|NCT00242216|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110712227|NCT00242216|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110712228|NCT00242216|Antiviral Agents|antiviral agents|mesh-ancestor
110712229|NCT00242216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110136075|NCT02001935|Purinergic Agents|purinergic agents|mesh-ancestor
110712230|NCT00242216|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110712231|NCT00242216|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110712232|NCT00240110|Valproic Acid|valproic acid|mesh-list
110712233|NCT00240110|Lithium Carbonate|lithium carbonate|mesh-list
110712234|NCT00240110|Antidepressive Agents|antidepressive agents|mesh-ancestor
110712235|NCT00240110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110712236|NCT00240110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110712237|NCT00240110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110712238|NCT00240110|Antimanic Agents|antimanic agents|mesh-ancestor
110712239|NCT00240110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110712240|NCT00240110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110712241|NCT00240110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110712242|NCT00240110|Anticonvulsants|anticonvulsants|mesh-ancestor
110712243|NCT00240110|GABA Agents|gaba agents|mesh-ancestor
110712244|NCT00240110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110712245|NCT00239720|Muromonab-CD3|muromonab-cd3|mesh-list
110712246|NCT00239720|Immunologic Factors|immunologic factors|mesh-ancestor
110712247|NCT00239720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110712248|NCT00239720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110712249|NCT02532140|Cefepime|cefepime|mesh-list
110712250|NCT02532140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110712251|NCT02532140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110712252|NCT00266864|Methyltestosterone|methyltestosterone|mesh-list
110712253|NCT00266864|Testosterone|testosterone|mesh-list
110712254|NCT00266864|Testosterone undecanoate|testosterone undecanoate|mesh-list
110712255|NCT00266864|Testosterone enanthate|testosterone enanthate|mesh-list
110712256|NCT00266864|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
110712257|NCT00266864|Androgens|androgens|mesh-ancestor
110712258|NCT00266864|Hormones|hormones|mesh-ancestor
110712259|NCT00266864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110712260|NCT00266864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110712261|NCT00266864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110712262|NCT00266864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110712263|NCT00266864|Anabolic Agents|anabolic agents|mesh-ancestor
110712264|NCT00266708|Risedronic Acid|risedronic acid|mesh-list
110712265|NCT00266708|Etidronic Acid|etidronic acid|mesh-list
110712266|NCT00266708|Diphosphonates|diphosphonates|mesh-list
110712267|NCT00266708|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110712268|NCT00266708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110712269|NCT00266708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110712270|NCT00266708|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110712271|NCT00266708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110712272|NCT00266708|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110712273|NCT00266630|Carbamazepine|carbamazepine|mesh-list
110712274|NCT00266630|Valproic Acid|valproic acid|mesh-list
110712275|NCT00266630|Olanzapine|olanzapine|mesh-list
110712276|NCT00266630|Antiemetics|antiemetics|mesh-ancestor
110712277|NCT00266630|Autonomic Agents|autonomic agents|mesh-ancestor
110712278|NCT00266630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110712279|NCT00266630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110712280|NCT00266630|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110712281|NCT00266630|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110712282|NCT00266630|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110712283|NCT00266630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110712284|NCT00266630|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110712285|NCT00266630|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110712286|NCT00266630|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110712287|NCT00266630|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110712288|NCT00266630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110712289|NCT00266630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110712290|NCT00266630|Serotonin Agents|serotonin agents|mesh-ancestor
110712291|NCT00266630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110712292|NCT00266630|Antimanic Agents|antimanic agents|mesh-ancestor
110712293|NCT00266630|Anticonvulsants|anticonvulsants|mesh-ancestor
110712294|NCT00266630|GABA Agents|gaba agents|mesh-ancestor
110712295|NCT00266630|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110712296|NCT00266630|Analgesics|analgesics|mesh-ancestor
110712297|NCT00266630|Sensory System Agents|sensory system agents|mesh-ancestor
110712298|NCT00266630|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110712299|NCT00266630|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110712300|NCT00266630|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110712301|NCT02531672|Choline|choline|mesh-list
110712302|NCT02531672|Lipotropic Agents|lipotropic agents|mesh-ancestor
110712303|NCT02531672|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110712304|NCT02531672|Antimetabolites|antimetabolites|mesh-ancestor
110712305|NCT02531672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110712306|NCT02531672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110712307|NCT02531672|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110712308|NCT02531672|Nootropic Agents|nootropic agents|mesh-ancestor
110712309|NCT00129129|Vaccines|vaccines|mesh-list
110712310|NCT00129129|Immunologic Factors|immunologic factors|mesh-ancestor
110712311|NCT00129129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110712312|NCT00221403|Valproic Acid|valproic acid|mesh-list
110712313|NCT00221403|Risperidone|risperidone|mesh-list
110712314|NCT00221403|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110712315|NCT00221403|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110712316|NCT00221403|Serotonin Agents|serotonin agents|mesh-ancestor
110712317|NCT00221403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110712318|NCT00221403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110861497|NCT02616146|Etonogestrel|etonogestrel|mesh-list
110712319|NCT00221403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110712320|NCT00221403|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110712321|NCT00221403|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110712322|NCT00221403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110712323|NCT00221403|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110712324|NCT00221403|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110712325|NCT00221403|Dopamine Agents|dopamine agents|mesh-ancestor
110712326|NCT00221403|Anticonvulsants|anticonvulsants|mesh-ancestor
110712327|NCT00221403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110712329|NCT00221403|Antimanic Agents|antimanic agents|mesh-ancestor
110712330|NCT00145977|Vitamin D|vitamin d|mesh-list
110712331|NCT00145977|Alendronate|alendronate|mesh-list
110712332|NCT00145977|Calcium|calcium|mesh-list
110712333|NCT00145977|Vitamins|vitamins|mesh-ancestor
110712334|NCT00145977|Micronutrients|micronutrients|mesh-ancestor
110712335|NCT00145977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110712336|NCT00145977|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110712337|NCT00145977|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110712338|NCT00238238|Rituximab|rituximab|mesh-list
110712339|NCT00238238|Lenalidomide|lenalidomide|mesh-list
110712340|NCT00238238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110712341|NCT00238238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110136135|NCT02002195|Capecitabine|capecitabine|mesh-list
110712342|NCT00238238|Immunologic Factors|immunologic factors|mesh-ancestor
110712343|NCT00238238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110712344|NCT00238238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110712345|NCT00238238|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110712346|NCT00238238|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110430186|NCT02687425|Pioglitazone|pioglitazone|mesh-list
110712347|NCT00238238|Growth Substances|growth substances|mesh-ancestor
110712348|NCT00238238|Growth Inhibitors|growth inhibitors|mesh-ancestor
110712349|NCT01073852|Hydroxychloroquine|hydroxychloroquine|mesh-list
110712350|NCT01073852|Antimalarials|antimalarials|mesh-ancestor
110712351|NCT01073852|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110712352|NCT01073852|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110712353|NCT01073852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110712354|NCT01073852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110712355|NCT01073852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110712356|NCT01073852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110712358|NCT01071122|Nifedipine|nifedipine|mesh-list
110712359|NCT01071122|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110712360|NCT01071122|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110712361|NCT01071122|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110712362|NCT01071122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110712363|NCT01071122|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110712364|NCT01071122|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110712365|NCT01071122|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110712366|NCT01071122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110712367|NCT01071122|Vasodilator Agents|vasodilator agents|mesh-ancestor
110712368|NCT01071122|Tocolytic Agents|tocolytic agents|mesh-ancestor
110712369|NCT01071122|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110712370|NCT01072604|Aspirin|aspirin|mesh-list
110712371|NCT01072604|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110712372|NCT01072604|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110712373|NCT01072604|Analgesics|analgesics|mesh-ancestor
110712374|NCT01072604|Sensory System Agents|sensory system agents|mesh-ancestor
110712375|NCT01072604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110712376|NCT01072604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110712377|NCT01072604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110712378|NCT01072604|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110712379|NCT01072604|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110712380|NCT01072604|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110712381|NCT01072604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110712382|NCT01072604|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110712383|NCT01072604|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110712384|NCT01072604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110712385|NCT01072604|Antipyretics|antipyretics|mesh-ancestor
110712386|NCT00128661|Vaccines|vaccines|mesh-list
110712387|NCT00128661|Immunologic Factors|immunologic factors|mesh-ancestor
110712388|NCT00128661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110712389|NCT00145509|Asenapine|asenapine|mesh-list
110712390|NCT00145509|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110712391|NCT00145509|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110712392|NCT00145509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110712393|NCT00145509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110712394|NCT00145509|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110712396|NCT03965871|Antidepressive Agents|antidepressive agents|mesh-ancestor
110712397|NCT03965871|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110712398|NCT03965949|Hormones|hormones|mesh-list
110712399|NCT03965949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110712400|NCT03965949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110712401|NCT00220779|Immunoglobulins|immunoglobulins|mesh-list
110712402|NCT00220779|Antibodies|antibodies|mesh-list
110712403|NCT00220779|gamma-Globulins|gamma-globulins|mesh-list
110712404|NCT00220779|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110712405|NCT00220779|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110712406|NCT00220779|Immunoglobulin G|immunoglobulin g|mesh-list
110712407|NCT00220779|Immunologic Factors|immunologic factors|mesh-ancestor
110712408|NCT00220779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110712409|NCT00207740|Golimumab|golimumab|mesh-list
110712410|NCT00207740|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110712411|NCT00207740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110712412|NCT00207740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110712413|NCT00207740|Immunologic Factors|immunologic factors|mesh-ancestor
110712414|NCT00207740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110712415|NCT00265382|Ziprasidone|ziprasidone|mesh-list
110712416|NCT00265382|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110712417|NCT00265382|Serotonin Agents|serotonin agents|mesh-ancestor
110712418|NCT00265382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110712419|NCT00265382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110712420|NCT00265382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110712421|NCT00265382|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110712422|NCT00265382|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110712423|NCT00265382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110712424|NCT00265382|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110712425|NCT00265382|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110712426|NCT00265382|Dopamine Agents|dopamine agents|mesh-ancestor
110712427|NCT03974984|Anesthetics|anesthetics|mesh-list
110712428|NCT03974984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110712429|NCT03974984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110712430|NCT00206726|Fludarabine|fludarabine|mesh-list
110712431|NCT00206726|Alemtuzumab|alemtuzumab|mesh-list
110712432|NCT00206726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110712433|NCT00206726|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110712434|NCT00237458|Lacosamide|lacosamide|mesh-list
110712435|NCT00237458|Anticonvulsants|anticonvulsants|mesh-ancestor
110712436|NCT00237458|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110712437|NCT00237458|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110712438|NCT00237458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110712439|NCT00237458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110712440|NCT01581788|Valproic Acid|valproic acid|mesh-list
110712441|NCT01581788|Anticonvulsants|anticonvulsants|mesh-ancestor
110712442|NCT01581788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110712443|NCT01581788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110712444|NCT01581788|GABA Agents|gaba agents|mesh-ancestor
110712445|NCT01581788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110712446|NCT01581788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110712447|NCT01581788|Antimanic Agents|antimanic agents|mesh-ancestor
110712448|NCT01581788|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110712449|NCT01581788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110712450|NCT01581788|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110712451|NCT00265148|Rosiglitazone|rosiglitazone|mesh-list
110712452|NCT00265148|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110712453|NCT00265148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110712454|NCT00043186|Denosumab|denosumab|mesh-list
110712455|NCT00043186|Alendronate|alendronate|mesh-list
110712456|NCT00043186|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110712457|NCT00043186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110712458|NCT00041470|Paclitaxel|paclitaxel|mesh-list
110712459|NCT00041470|Vinorelbine|vinorelbine|mesh-list
110712460|NCT00041470|Trastuzumab|trastuzumab|mesh-list
110712461|NCT00041470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110712462|NCT00041470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110712463|NCT00041470|Tubulin Modulators|tubulin modulators|mesh-ancestor
110712464|NCT00041470|Antimitotic Agents|antimitotic agents|mesh-ancestor
110712465|NCT00041470|Mitosis Modulators|mitosis modulators|mesh-ancestor
110712466|NCT00041470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110712467|NCT00041470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110712468|NCT03953950|Losartan|losartan|mesh-list
110712469|NCT03953950|Spironolactone|spironolactone|mesh-list
110712470|NCT03953950|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110712471|NCT03953950|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110712472|NCT03953950|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110712473|NCT03953950|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110712474|NCT03953950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110712475|NCT03953950|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110712476|NCT03953950|Hormone Antagonists|hormone antagonists|mesh-ancestor
110712477|NCT03953950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110712478|NCT03953950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110712479|NCT03953950|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110712480|NCT03953950|Diuretics|diuretics|mesh-ancestor
110712481|NCT03953950|Natriuretic Agents|natriuretic agents|mesh-ancestor
110712482|NCT00206102|Risperidone|risperidone|mesh-list
110712483|NCT00206102|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110712484|NCT00206102|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110712485|NCT00206102|Serotonin Agents|serotonin agents|mesh-ancestor
110712486|NCT00206102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110712487|NCT00206102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110712488|NCT00206102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110712489|NCT00206102|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110712490|NCT00206102|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110712491|NCT00206102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110712492|NCT00206102|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110712493|NCT00206102|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110712494|NCT00206102|Dopamine Agents|dopamine agents|mesh-ancestor
110712495|NCT00206102|Antidepressive Agents|antidepressive agents|mesh-ancestor
110430340|NCT04318067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110712497|NCT03954262|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110712498|NCT03954262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110712499|NCT03954262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110712500|NCT03954262|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110712501|NCT03954262|Anesthetics, General|anesthetics, general|mesh-ancestor
110712502|NCT03954262|Anesthetics|anesthetics|mesh-ancestor
110712503|NCT00041080|Tamoxifen|tamoxifen|mesh-list
110712504|NCT00041080|Thalidomide|thalidomide|mesh-list
110712505|NCT00041080|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110712506|NCT00041080|Hormone Antagonists|hormone antagonists|mesh-ancestor
110712507|NCT00041080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110712508|NCT00041080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110712509|NCT00041080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110712510|NCT00041080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110712511|NCT00041080|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110712512|NCT00041080|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110712513|NCT00041080|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110712514|NCT00041080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110712515|NCT00041080|Immunologic Factors|immunologic factors|mesh-ancestor
110712516|NCT00041080|Leprostatic Agents|leprostatic agents|mesh-ancestor
110712517|NCT00041080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110712518|NCT00041080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110712519|NCT00041080|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110712520|NCT00041080|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110712521|NCT00041080|Growth Substances|growth substances|mesh-ancestor
110712522|NCT00041080|Growth Inhibitors|growth inhibitors|mesh-ancestor
110712523|NCT00205712|Dexmedetomidine|dexmedetomidine|mesh-list
110712524|NCT00205712|Ketamine|ketamine|mesh-list
110712525|NCT00205712|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110712526|NCT00205712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110712527|NCT00205712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110712528|NCT00205712|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110712529|NCT00205712|Analgesics|analgesics|mesh-ancestor
110316362|NCT00313742|Insulin|insulin|mesh-list
110712530|NCT00205712|Sensory System Agents|sensory system agents|mesh-ancestor
110712531|NCT00205712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110712532|NCT00205712|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110712533|NCT00205712|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110712535|NCT00205712|Adrenergic Agents|adrenergic agents|mesh-ancestor
110712536|NCT00205712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110712537|NCT00205712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110712538|NCT00205712|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110712539|NCT00205712|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110712540|NCT00205712|Anesthetics, General|anesthetics, general|mesh-ancestor
110712541|NCT00205712|Anesthetics|anesthetics|mesh-ancestor
110712542|NCT00205712|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110712543|NCT00205712|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110712544|NCT03969758|Metronidazole|metronidazole|mesh-list
110712545|NCT03969758|Ciprofloxacin|ciprofloxacin|mesh-list
110712546|NCT03969758|Cefixime|cefixime|mesh-list
110712547|NCT03969758|Liver Extracts|liver extracts|mesh-list
110712548|NCT03969758|Hematinics|hematinics|mesh-ancestor
110712549|NCT03969758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110712550|NCT03969758|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110712551|NCT03969758|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110712552|NCT03969758|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110712553|NCT03969758|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110712554|NCT03969758|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110712555|NCT03969758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110712556|NCT03969758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110712557|NCT03969758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110712558|NCT03969758|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110136277|NCT02002715|Hormones|hormones|mesh-ancestor
110712559|NCT03969758|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110712560|NCT00203294|Triamcinolone|triamcinolone|mesh-list
110712561|NCT00203294|Lidocaine|lidocaine|mesh-list
110712562|NCT00203294|Bupivacaine|bupivacaine|mesh-list
110712563|NCT00203294|Anesthetics, Local|anesthetics, local|mesh-ancestor
110712564|NCT00203294|Anesthetics|anesthetics|mesh-ancestor
110712565|NCT00203294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110712566|NCT00203294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110712567|NCT00203294|Sensory System Agents|sensory system agents|mesh-ancestor
110712568|NCT00203294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110712569|NCT00203294|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110430414|NCT01199861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110712570|NCT00203294|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110712571|NCT00203294|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110712572|NCT00203294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110136308|NCT02002923|Botulinum Toxins|botulinum toxins|mesh-list
110712573|NCT00203294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110712574|NCT00203294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110712575|NCT00203294|Glucocorticoids|glucocorticoids|mesh-ancestor
110712576|NCT00203294|Hormones|hormones|mesh-ancestor
110712577|NCT00203294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110712578|NCT01074086|Everolimus|everolimus|mesh-list
110712579|NCT01074086|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110712580|NCT01074086|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110712581|NCT01074086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110443889|NCT02790580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110712582|NCT01074086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110712583|NCT01074086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110712584|NCT01074086|Immunologic Factors|immunologic factors|mesh-ancestor
110136365|NCT02003677|Insulin|insulin|mesh-list
110712585|NCT01074086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110712586|NCT01074086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110712588|NCT00264290|Antiviral Agents|antiviral agents|mesh-ancestor
110712589|NCT00264290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110712590|NCT00234494|Bevacizumab|bevacizumab|mesh-list
110712591|NCT00234494|Gemcitabine|gemcitabine|mesh-list
110712592|NCT00234494|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110712593|NCT00234494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110712594|NCT00234494|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110712595|NCT00234494|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110712596|NCT00234494|Growth Substances|growth substances|mesh-ancestor
110712597|NCT00234494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110316445|NCT00344253|Interferons|interferons|mesh-list
110712599|NCT00234494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110712600|NCT00234494|Antimetabolites|antimetabolites|mesh-ancestor
110712601|NCT00234494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110712602|NCT00234104|Tolvaptan|tolvaptan|mesh-list
110712603|NCT00234104|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
110712604|NCT00234104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110712605|NCT00234104|Natriuretic Agents|natriuretic agents|mesh-ancestor
110712606|NCT00234104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110712607|NCT01582568|Certolizumab Pegol|certolizumab pegol|mesh-list
110712608|NCT01582568|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110712609|NCT01582568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110712610|NCT01582568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110712611|NCT01582568|Immunologic Factors|immunologic factors|mesh-ancestor
110712612|NCT01582568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110712613|NCT01582568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110712614|NCT00195338|Etanercept|etanercept|mesh-list
110712615|NCT00195338|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110712616|NCT00195338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110712617|NCT00195338|Analgesics|analgesics|mesh-ancestor
110712618|NCT00195338|Sensory System Agents|sensory system agents|mesh-ancestor
110712619|NCT00195338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110712620|NCT00195338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110712621|NCT00195338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110712622|NCT00195338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110712623|NCT00195338|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110712624|NCT00195338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110712625|NCT00195338|Immunologic Factors|immunologic factors|mesh-ancestor
110712626|NCT01096654|Epinephrine|epinephrine|mesh-list
110712627|NCT01096654|Racepinephrine|racepinephrine|mesh-list
110712628|NCT01096654|Epinephryl borate|epinephryl borate|mesh-list
110712629|NCT01096654|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110712630|NCT01096654|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110712631|NCT01096654|Adrenergic Agents|adrenergic agents|mesh-ancestor
110712632|NCT01096654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110712633|NCT01096654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110712634|NCT01096654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110712635|NCT01096654|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110712636|NCT01096654|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110712637|NCT01096654|Autonomic Agents|autonomic agents|mesh-ancestor
110712638|NCT01096654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110712639|NCT01096654|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110712640|NCT01096654|Respiratory System Agents|respiratory system agents|mesh-ancestor
110712641|NCT01096654|Mydriatics|mydriatics|mesh-ancestor
110712642|NCT01096654|Sympathomimetics|sympathomimetics|mesh-ancestor
110430487|NCT00603265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110712643|NCT01096654|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110712645|NCT00035932|Lopinavir|lopinavir|mesh-list
110712646|NCT00035932|Atazanavir Sulfate|atazanavir sulfate|mesh-list
110712647|NCT00035932|Saquinavir|saquinavir|mesh-list
110712648|NCT00035932|Tenofovir|tenofovir|mesh-list
110712649|NCT00035932|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110712650|NCT00035932|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110712651|NCT00035932|Protease Inhibitors|protease inhibitors|mesh-ancestor
110712652|NCT00035932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110712653|NCT00035932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110712654|NCT00035932|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110712655|NCT00035932|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110712656|NCT00035932|Antiviral Agents|antiviral agents|mesh-ancestor
110712657|NCT00035932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110712658|NCT00035932|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110712659|NCT00035932|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110712660|NCT00035932|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110712661|NCT00035932|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110712663|NCT03953326|Acetylcholine|acetylcholine|mesh-list
110712664|NCT03953326|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110712665|NCT03953326|Vasodilator Agents|vasodilator agents|mesh-ancestor
110712666|NCT03953326|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
110712667|NCT03953326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110712668|NCT03953326|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110712669|NCT03953326|Cholinergic Agents|cholinergic agents|mesh-ancestor
110712670|NCT03953326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110712671|NCT03953326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110712672|NCT01097278|Cholecalciferol|cholecalciferol|mesh-list
110712674|NCT01097278|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110712675|NCT01097278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110712676|NCT01097278|Vitamins|vitamins|mesh-ancestor
110712677|NCT01097278|Micronutrients|micronutrients|mesh-ancestor
110712678|NCT01097278|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110712679|NCT00022516|Cyclophosphamide|cyclophosphamide|mesh-list
110712680|NCT00022516|Methotrexate|methotrexate|mesh-list
110712681|NCT00022516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110712682|NCT00022516|Immunologic Factors|immunologic factors|mesh-ancestor
110712683|NCT00022516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110712684|NCT00022516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110712685|NCT00022516|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110712686|NCT00022516|Alkylating Agents|alkylating agents|mesh-ancestor
110712687|NCT00022516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110712688|NCT00022516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110712689|NCT00022516|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110712690|NCT00022516|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110712691|NCT00022516|Abortifacient Agents|abortifacient agents|mesh-ancestor
110712692|NCT00022516|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110712693|NCT00022516|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110712694|NCT00022516|Antimetabolites|antimetabolites|mesh-ancestor
110712695|NCT00022516|Dermatologic Agents|dermatologic agents|mesh-ancestor
110712696|NCT00022516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110712697|NCT00022516|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110712698|NCT00022516|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110712699|NCT01097512|Gemcitabine|gemcitabine|mesh-list
110712700|NCT01097512|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110712701|NCT01097512|Antimetabolites|antimetabolites|mesh-ancestor
110712702|NCT01097512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110712703|NCT01097512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110712704|NCT00033514|Trastuzumab|trastuzumab|mesh-list
110712705|NCT00033514|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110712706|NCT00033514|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110712707|NCT00033514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110712708|NCT00033514|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110712709|NCT00033514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110712710|NCT00033514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110712711|NCT00006916|Bleomycin|bleomycin|mesh-list
110712712|NCT00006916|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110712713|NCT00006916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110712714|NCT02529982|Curcumin|curcumin|mesh-list
110712715|NCT02529982|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110712716|NCT02529982|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110712717|NCT02529982|Analgesics|analgesics|mesh-ancestor
110712718|NCT02529982|Sensory System Agents|sensory system agents|mesh-ancestor
110712719|NCT02529982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110712720|NCT02529982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110712721|NCT02529982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110712722|NCT02529982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110712723|NCT02529982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110712724|NCT02529982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110712725|NCT02529982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110712726|NCT00454649|Paclitaxel|paclitaxel|mesh-list
110712727|NCT00454649|Docetaxel|docetaxel|mesh-list
110712728|NCT00454649|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110712729|NCT00454649|Cisplatin|cisplatin|mesh-list
110712730|NCT00454649|Carboplatin|carboplatin|mesh-list
110712731|NCT00454649|Gemcitabine|gemcitabine|mesh-list
110712732|NCT00454649|Capecitabine|capecitabine|mesh-list
110712733|NCT00454649|Pemetrexed|pemetrexed|mesh-list
110712734|NCT00454649|Axitinib|axitinib|mesh-list
110712735|NCT00454649|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110712736|NCT00454649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110712737|NCT00454649|Tubulin Modulators|tubulin modulators|mesh-ancestor
110712738|NCT00454649|Antimitotic Agents|antimitotic agents|mesh-ancestor
110712739|NCT00454649|Mitosis Modulators|mitosis modulators|mesh-ancestor
110712740|NCT00454649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110712741|NCT00454649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110712742|NCT00454649|Antimetabolites|antimetabolites|mesh-ancestor
110712743|NCT00454649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110712744|NCT00454649|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110712745|NCT00454649|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110712746|NCT00454649|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110712747|NCT00454571|Leuprolide|leuprolide|mesh-list
110712748|NCT00454571|Goserelin|goserelin|mesh-list
110712749|NCT00454571|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110712750|NCT00454571|Fertility Agents|fertility agents|mesh-ancestor
110712751|NCT00454571|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110712752|NCT00454571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110712753|NCT00454571|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110712754|NCT00454571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110712755|NCT01323257|Ritonavir|ritonavir|mesh-list
110712756|NCT01323257|Darunavir|darunavir|mesh-list
110712757|NCT01323257|Erythromycin|erythromycin|mesh-list
110712758|NCT01323257|Erythromycin Estolate|erythromycin estolate|mesh-list
110712759|NCT01323257|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
110712760|NCT01323257|Erythromycin stearate|erythromycin stearate|mesh-list
110712761|NCT01323257|Simeprevir|simeprevir|mesh-list
110712762|NCT01323257|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110712763|NCT01323257|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110712764|NCT01323257|Protease Inhibitors|protease inhibitors|mesh-ancestor
110712765|NCT01323257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110712766|NCT01323257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110712767|NCT01323257|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110712768|NCT01323257|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110712769|NCT01323257|Antiviral Agents|antiviral agents|mesh-ancestor
110712770|NCT01323257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110712771|NCT01323257|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110712772|NCT01323257|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110712773|NCT01323257|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110712774|NCT01323257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110712775|NCT01323257|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110712776|NCT03837743|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110712777|NCT01323335|Rasburicase|rasburicase|mesh-list
110712778|NCT01323335|Uric Acid|uric acid|mesh-list
110712779|NCT01323335|Gout Suppressants|gout suppressants|mesh-ancestor
110712780|NCT01323335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110712781|NCT01323335|Antioxidants|antioxidants|mesh-ancestor
110712782|NCT01323335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110712783|NCT01323335|Protective Agents|protective agents|mesh-ancestor
110712784|NCT01323335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110712785|NCT03836729|Tenofovir|tenofovir|mesh-list
110712786|NCT03836729|Emtricitabine|emtricitabine|mesh-list
110712787|NCT03836729|Antiviral Agents|antiviral agents|mesh-ancestor
110712788|NCT03836729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110712789|NCT03836729|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110712790|NCT03836729|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110712791|NCT03836729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110712792|NCT03836729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110712793|NCT03836729|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110712794|NCT03836729|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110712795|NCT01027481|Ranibizumab|ranibizumab|mesh-list
110712796|NCT01027481|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110712797|NCT01027481|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110712798|NCT01027481|Growth Substances|growth substances|mesh-ancestor
110712799|NCT01027481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110712800|NCT01027481|Growth Inhibitors|growth inhibitors|mesh-ancestor
110712801|NCT01027481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110712802|NCT00443729|Ritonavir|ritonavir|mesh-list
110712803|NCT00443729|Lopinavir|lopinavir|mesh-list
110712804|NCT00443729|Raltegravir Potassium|raltegravir potassium|mesh-list
110712805|NCT00443729|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110712806|NCT00443729|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110712808|NCT00443729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110712809|NCT00443729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110712810|NCT00443729|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110712811|NCT00443729|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110712812|NCT00443729|Antiviral Agents|antiviral agents|mesh-ancestor
110712813|NCT00443729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110712814|NCT00443729|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110712815|NCT00443729|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110712816|NCT00443729|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110712817|NCT00443729|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110712818|NCT00443651|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
110712819|NCT00443651|Rituximab|rituximab|mesh-list
110712820|NCT00443651|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110712821|NCT00443651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110712822|NCT00443651|Immunologic Factors|immunologic factors|mesh-ancestor
110712823|NCT00443651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110712824|NCT00443651|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110712825|NCT01027715|Anticonvulsants|anticonvulsants|mesh-list
110712826|NCT03567473|Dexamethasone|dexamethasone|mesh-list
110712827|NCT03567473|Dexamethasone acetate|dexamethasone acetate|mesh-list
110712828|NCT03567473|Epinephrine|epinephrine|mesh-list
110712829|NCT03567473|Racepinephrine|racepinephrine|mesh-list
110712830|NCT03567473|Epinephryl borate|epinephryl borate|mesh-list
110712831|NCT03567473|BB 1101|bb 1101|mesh-list
110712832|NCT03567473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110712833|NCT03567473|Antiemetics|antiemetics|mesh-ancestor
110712834|NCT03567473|Autonomic Agents|autonomic agents|mesh-ancestor
110712835|NCT03567473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110712836|NCT03567473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110712837|NCT03567473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110712838|NCT03567473|Glucocorticoids|glucocorticoids|mesh-ancestor
110712839|NCT03567473|Hormones|hormones|mesh-ancestor
110136618|NCT02005653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110712840|NCT03567473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110712841|NCT03567473|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110712842|NCT03567473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110712843|NCT03567473|Protease Inhibitors|protease inhibitors|mesh-ancestor
110712844|NCT03567473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110712845|NCT03567473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110712846|NCT03567473|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110712847|NCT03567473|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110712848|NCT03567473|Adrenergic Agents|adrenergic agents|mesh-ancestor
110712849|NCT03567473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110712850|NCT03567473|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110712851|NCT03567473|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110712852|NCT03567473|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110712853|NCT03567473|Respiratory System Agents|respiratory system agents|mesh-ancestor
110712854|NCT03567473|Mydriatics|mydriatics|mesh-ancestor
110712855|NCT03567473|Sympathomimetics|sympathomimetics|mesh-ancestor
110712856|NCT03567473|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110712857|NCT00443261|Azacitidine|azacitidine|mesh-list
110712858|NCT00443261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110712859|NCT00443261|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110712860|NCT00443261|Antimetabolites|antimetabolites|mesh-ancestor
110712861|NCT00443261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110712862|NCT00443261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110712863|NCT00439517|Cetuximab|cetuximab|mesh-list
110712864|NCT00439517|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110712865|NCT00439517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110712866|NCT01028261|CKD732|ckd732|mesh-list
110712867|NCT01028261|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110712868|NCT01028261|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110712869|NCT01028261|Growth Substances|growth substances|mesh-ancestor
110430712|NCT02680951|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110712870|NCT01028261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110712871|NCT01028261|Growth Inhibitors|growth inhibitors|mesh-ancestor
110712872|NCT01028261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110712874|NCT01028339|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110712875|NCT01028339|Diuretics|diuretics|mesh-ancestor
110712876|NCT01028339|Natriuretic Agents|natriuretic agents|mesh-ancestor
110712877|NCT01028339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110712878|NCT01031459|Interferons|interferons|mesh-list
110712879|NCT01031459|Interferon-beta|interferon-beta|mesh-list
110712880|NCT01031459|Interferon beta-1b|interferon beta-1b|mesh-list
110712881|NCT01031459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110712883|NCT01031459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110712884|NCT01031459|Immunologic Factors|immunologic factors|mesh-ancestor
110712885|NCT01031459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110712886|NCT01031459|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110712887|NCT00438815|Complement C1s|complement c1s|mesh-list
110712888|NCT00438815|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
110712889|NCT00438815|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
110712890|NCT00438815|Immunologic Factors|immunologic factors|mesh-ancestor
110712891|NCT00438815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110712892|NCT00438815|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
110712893|NCT00438815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110712894|NCT00438659|Mometasone Furoate|mometasone furoate|mesh-list
110712895|NCT00438659|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110712896|NCT00438659|Dermatologic Agents|dermatologic agents|mesh-ancestor
110712897|NCT00438659|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110712898|NCT01028495|Gemcitabine|gemcitabine|mesh-list
110712899|NCT01028495|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110712900|NCT01028495|Antimetabolites|antimetabolites|mesh-ancestor
110136633|NCT02005757|Analgesics|analgesics|mesh-ancestor
110712901|NCT01028495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110712902|NCT01028495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110712903|NCT00437645|Amlodipine|amlodipine|mesh-list
110712904|NCT00437645|Valsartan|valsartan|mesh-list
110712905|NCT00437645|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110712906|NCT00437645|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110712907|NCT00437645|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110712908|NCT00437645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110712909|NCT00437645|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110712910|NCT00437645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110712911|NCT00437645|Vasodilator Agents|vasodilator agents|mesh-ancestor
110712912|NCT00437645|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110712913|NCT00437645|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110712914|NCT03995147|Prednisone|prednisone|mesh-list
110712915|NCT03995147|Cyclophosphamide|cyclophosphamide|mesh-list
110712916|NCT03995147|Doxorubicin|doxorubicin|mesh-list
110712917|NCT03995147|Pembrolizumab|pembrolizumab|mesh-list
110712918|NCT03995147|Vincristine|vincristine|mesh-list
110712919|NCT03995147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110712920|NCT03995147|Immunologic Factors|immunologic factors|mesh-ancestor
110712921|NCT03995147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110712922|NCT03995147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110712923|NCT03995147|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110712924|NCT03995147|Alkylating Agents|alkylating agents|mesh-ancestor
110712925|NCT03995147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110712926|NCT03995147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110712927|NCT03995147|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110712928|NCT03995147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110712929|NCT03995147|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110712930|NCT03995147|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110712931|NCT03995147|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110712932|NCT03995147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110712933|NCT03995147|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110712934|NCT03995147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110712935|NCT03995147|Glucocorticoids|glucocorticoids|mesh-ancestor
110712936|NCT03995147|Hormones|hormones|mesh-ancestor
110712937|NCT03995147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110712938|NCT03995147|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110712939|NCT03995147|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110712940|NCT03995147|Tubulin Modulators|tubulin modulators|mesh-ancestor
110712941|NCT03995147|Antimitotic Agents|antimitotic agents|mesh-ancestor
110712942|NCT03995147|Mitosis Modulators|mitosis modulators|mesh-ancestor
110712943|NCT00437489|Insulin|insulin|mesh-list
110712944|NCT00437489|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110861547|NCT03284164|Tenofovir|tenofovir|mesh-list
110712945|NCT00437489|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110712946|NCT00437489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110712947|NCT01028573|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
110712949|NCT01028573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110712950|NCT04683575|Selenium|selenium|mesh-list
110712951|NCT04683575|Antioxidants|antioxidants|mesh-ancestor
110712952|NCT04683575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110712953|NCT04683575|Protective Agents|protective agents|mesh-ancestor
110712954|NCT04683575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110712955|NCT04683575|Trace Elements|trace elements|mesh-ancestor
110712956|NCT04683575|Micronutrients|micronutrients|mesh-ancestor
110712957|NCT00442559|Montelukast|montelukast|mesh-list
110712958|NCT00442559|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110712959|NCT00442559|Respiratory System Agents|respiratory system agents|mesh-ancestor
110712960|NCT00442559|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110712961|NCT00442559|Hormone Antagonists|hormone antagonists|mesh-ancestor
110712962|NCT00442559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110712963|NCT00442559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110712964|NCT00442559|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110712965|NCT00442559|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110712966|NCT00442559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110712968|NCT01323491|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110712969|NCT01323491|Autonomic Agents|autonomic agents|mesh-ancestor
110712970|NCT01323491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110712971|NCT01323491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110712972|NCT01323491|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110712973|NCT01323491|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110712974|NCT01323491|Cholinergic Agents|cholinergic agents|mesh-ancestor
110712975|NCT01323491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110712976|NCT01323491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110712977|NCT00441545|Sevelamer|sevelamer|mesh-list
110712978|NCT00441545|Chelating Agents|chelating agents|mesh-ancestor
110712979|NCT00441545|Sequestering Agents|sequestering agents|mesh-ancestor
110712980|NCT00441545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110712981|NCT00436553|Ranibizumab|ranibizumab|mesh-list
110712982|NCT00436553|Verteporfin|verteporfin|mesh-list
110712983|NCT00436553|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110712984|NCT00436553|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110712985|NCT00436553|Growth Substances|growth substances|mesh-ancestor
110712986|NCT00436553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110712987|NCT00436553|Growth Inhibitors|growth inhibitors|mesh-ancestor
110712988|NCT00436553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110712989|NCT00436553|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110712990|NCT00436553|Dermatologic Agents|dermatologic agents|mesh-ancestor
110712991|NCT01028729|Gemcitabine|gemcitabine|mesh-list
110712992|NCT01028729|Endostar protein|endostar protein|mesh-list
110712993|NCT01028729|Endostatins|endostatins|mesh-list
110712994|NCT01028729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110712995|NCT01028729|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110712996|NCT01028729|Antimetabolites|antimetabolites|mesh-ancestor
110712997|NCT01028729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110712998|NCT01028729|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110712999|NCT01028729|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110713000|NCT01028729|Growth Substances|growth substances|mesh-ancestor
110713001|NCT01028729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110713002|NCT01028729|Growth Inhibitors|growth inhibitors|mesh-ancestor
110713003|NCT03357419|Clindamycin|clindamycin|mesh-list
110713004|NCT03357419|Clindamycin palmitate|clindamycin palmitate|mesh-list
110713005|NCT03357419|Clindamycin phosphate|clindamycin phosphate|mesh-list
110713006|NCT03357419|Cephalexin|cephalexin|mesh-list
110713007|NCT03357419|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110713008|NCT03357419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110713009|NCT03357419|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110713010|NCT03357419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110713011|NCT03357419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110713012|NCT01031927|Glycine|glycine|mesh-list
110713013|NCT01031927|Glycine Agents|glycine agents|mesh-ancestor
110713014|NCT01031927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110713015|NCT01031927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110713016|NCT01031927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110713017|NCT01032083|Citalopram|citalopram|mesh-list
110713018|NCT01032083|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110713019|NCT01032083|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110713020|NCT01032083|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110713021|NCT01032083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110713022|NCT01032083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110713023|NCT01032083|Serotonin Agents|serotonin agents|mesh-ancestor
110713024|NCT01032083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110136663|NCT02005783|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110713025|NCT01032083|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110713026|NCT01032083|Antidepressive Agents|antidepressive agents|mesh-ancestor
110713027|NCT01032083|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110713028|NCT00436163|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110713029|NCT00436163|Antiviral Agents|antiviral agents|mesh-ancestor
110713030|NCT00436163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110713031|NCT00006604|Ritonavir|ritonavir|mesh-list
110713032|NCT00006604|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110713033|NCT00006604|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110713034|NCT00006604|Protease Inhibitors|protease inhibitors|mesh-ancestor
110713035|NCT00006604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110713036|NCT00006604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110713037|NCT00006604|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110713038|NCT00006604|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110713039|NCT00006604|Antiviral Agents|antiviral agents|mesh-ancestor
110713040|NCT00006604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110713041|NCT00006604|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110713042|NCT00006604|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110713043|NCT01097902|Ibuprofen|ibuprofen|mesh-list
110713044|NCT01097902|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110713045|NCT01097902|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110713046|NCT01097902|Analgesics|analgesics|mesh-ancestor
110713047|NCT01097902|Sensory System Agents|sensory system agents|mesh-ancestor
110713048|NCT01097902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110713049|NCT01097902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110713050|NCT01097902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110713051|NCT01097902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110713052|NCT01097902|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110713053|NCT01097902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110713054|NCT01097902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110713055|NCT00436007|Vaccines|vaccines|mesh-list
110713056|NCT00436007|Immunologic Factors|immunologic factors|mesh-ancestor
110713057|NCT00436007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110713058|NCT00435461|Fluticasone|fluticasone|mesh-list
110713059|NCT00435461|Xhance|xhance|mesh-list
110713060|NCT00435461|Fexofenadine|fexofenadine|mesh-list
110713061|NCT00435461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110713062|NCT00435461|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110713063|NCT00435461|Autonomic Agents|autonomic agents|mesh-ancestor
110713064|NCT00435461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110713065|NCT00435461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110713066|NCT00435461|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110713067|NCT00435461|Respiratory System Agents|respiratory system agents|mesh-ancestor
110713068|NCT00435461|Dermatologic Agents|dermatologic agents|mesh-ancestor
110713069|NCT00435461|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110713070|NCT00435461|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110713071|NCT00435461|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110713072|NCT00435461|Histamine Antagonists|histamine antagonists|mesh-ancestor
110713073|NCT00435461|Histamine Agents|histamine agents|mesh-ancestor
110713074|NCT00435461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110713075|NCT00435461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110713076|NCT01097980|Trazodone|trazodone|mesh-list
110713077|NCT01097980|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110713078|NCT01097980|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110713079|NCT01097980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110713081|NCT01097980|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110713082|NCT01097980|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110713083|NCT01097980|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110713084|NCT01097980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110713085|NCT01097980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110713086|NCT01097980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110713087|NCT01097980|Serotonin Agents|serotonin agents|mesh-ancestor
110713088|NCT01097980|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110713089|NCT01097980|Antidepressive Agents|antidepressive agents|mesh-ancestor
110713090|NCT01029275|Octreotide|octreotide|mesh-list
110713091|NCT01029275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110713092|NCT01029275|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110713093|NCT01029275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110713094|NCT04829903|Liraglutide|liraglutide|mesh-list
110713095|NCT04829903|Dulaglutide|dulaglutide|mesh-list
110713096|NCT04829903|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110713097|NCT04829903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110713098|NCT04829903|Incretins|incretins|mesh-ancestor
110713099|NCT04829903|Hormones|hormones|mesh-ancestor
110443896|NCT02790580|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110713100|NCT04829903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110713101|NCT00440999|Artesunate|artesunate|mesh-list
110713102|NCT00440999|Chloroquine|chloroquine|mesh-list
110713103|NCT00440999|Pyronaridine|pyronaridine|mesh-list
110713104|NCT00440999|Pyronaridine tetraphosphate, artesunate drug combination|pyronaridine tetraphosphate, artesunate drug combination|mesh-list
110713105|NCT00440999|Antimalarials|antimalarials|mesh-ancestor
110713106|NCT00440999|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110713107|NCT00440999|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110713108|NCT00440999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110713109|NCT00440999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110713110|NCT00440999|Antiviral Agents|antiviral agents|mesh-ancestor
110713111|NCT00440999|Schistosomicides|schistosomicides|mesh-ancestor
110713112|NCT00440999|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110713113|NCT00440999|Anthelmintics|anthelmintics|mesh-ancestor
110713114|NCT00440999|Amebicides|amebicides|mesh-ancestor
110713115|NCT00440999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110713116|NCT00434213|Methylphenidate|methylphenidate|mesh-list
110713117|NCT00434213|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110713118|NCT00434213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110713119|NCT00434213|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110713120|NCT00434213|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110713121|NCT00434213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110713122|NCT00434213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110713123|NCT00434213|Dopamine Agents|dopamine agents|mesh-ancestor
110713124|NCT00434213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110713125|NCT01029743|Aspirin|aspirin|mesh-list
110713127|NCT01029743|Rivaroxaban|rivaroxaban|mesh-list
110713128|NCT01029743|Fondaparinux|fondaparinux|mesh-list
110713129|NCT01029743|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110713130|NCT01029743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110713131|NCT01029743|Analgesics|analgesics|mesh-ancestor
110713132|NCT01029743|Sensory System Agents|sensory system agents|mesh-ancestor
110713133|NCT01029743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110713134|NCT01029743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110713135|NCT01029743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110713136|NCT01029743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110713137|NCT01029743|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110713138|NCT01029743|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110713139|NCT01029743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110713140|NCT01029743|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110713141|NCT01029743|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110713142|NCT01029743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110713143|NCT01029743|Antipyretics|antipyretics|mesh-ancestor
110713144|NCT01029743|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110713145|NCT01029743|Antithrombins|antithrombins|mesh-ancestor
110713146|NCT01029743|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110713148|NCT01029743|Anticoagulants|anticoagulants|mesh-ancestor
110713149|NCT01029821|Heparin|heparin|mesh-list
110713150|NCT01029821|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
110713151|NCT01029821|Tinzaparin|tinzaparin|mesh-list
110713152|NCT01029821|Dalteparin|dalteparin|mesh-list
110713153|NCT01029821|Anticoagulants|anticoagulants|mesh-ancestor
110713154|NCT01029821|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110713155|NCT01029821|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110713156|NCT01029821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110713157|NCT00006184|Cyclosporine|cyclosporine|mesh-list
110713158|NCT00006184|Prednisone|prednisone|mesh-list
110713159|NCT00006184|Cyclophosphamide|cyclophosphamide|mesh-list
110713160|NCT00006184|Doxorubicin|doxorubicin|mesh-list
110713161|NCT00006184|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110713162|NCT00006184|Methotrexate|methotrexate|mesh-list
110713163|NCT00006184|Fludarabine|fludarabine|mesh-list
110713164|NCT00006184|Fludarabine phosphate|fludarabine phosphate|mesh-list
110713165|NCT00006184|Etoposide|etoposide|mesh-list
110713166|NCT00006184|Vincristine|vincristine|mesh-list
110713167|NCT00006184|Bortezomib|bortezomib|mesh-list
110713168|NCT00006184|Molgramostim|molgramostim|mesh-list
110431015|NCT04124562|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110713169|NCT00006184|Cyclosporins|cyclosporins|mesh-list
110713170|NCT00006184|Immunoglobulins|immunoglobulins|mesh-list
110713171|NCT00006184|Lenograstim|lenograstim|mesh-list
110713172|NCT00006184|Sargramostim|sargramostim|mesh-list
110713173|NCT00006184|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
110713174|NCT00006184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110713175|NCT00006184|Immunologic Factors|immunologic factors|mesh-ancestor
110713176|NCT00006184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110713177|NCT00006184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110713178|NCT00006184|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110713179|NCT00006184|Alkylating Agents|alkylating agents|mesh-ancestor
110713180|NCT00006184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110713181|NCT00006184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110713182|NCT00006184|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110713183|NCT00006184|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110713184|NCT00006184|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110713185|NCT00006184|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110713186|NCT00006184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110713187|NCT00006184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110713188|NCT00006184|Glucocorticoids|glucocorticoids|mesh-ancestor
110713189|NCT00006184|Hormones|hormones|mesh-ancestor
110713190|NCT00006184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110713191|NCT00006184|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110713192|NCT00006184|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110713193|NCT00006184|Abortifacient Agents|abortifacient agents|mesh-ancestor
110713194|NCT00006184|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110713195|NCT00006184|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110713196|NCT00006184|Antimetabolites|antimetabolites|mesh-ancestor
110713197|NCT00006184|Dermatologic Agents|dermatologic agents|mesh-ancestor
110713198|NCT00006184|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110713199|NCT00006184|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110713200|NCT00006184|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110713201|NCT00006184|Tubulin Modulators|tubulin modulators|mesh-ancestor
110713202|NCT00006184|Antimitotic Agents|antimitotic agents|mesh-ancestor
110713203|NCT00006184|Mitosis Modulators|mitosis modulators|mesh-ancestor
110713204|NCT00006184|Antifungal Agents|antifungal agents|mesh-ancestor
110713205|NCT00006184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110713206|NCT00006184|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110713207|NCT00006184|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110713208|NCT00433199|Testosterone|testosterone|mesh-list
110713209|NCT00433199|Androgens|androgens|mesh-ancestor
110713210|NCT00433199|Hormones|hormones|mesh-ancestor
110136706|NCT02006225|Plerixafor|plerixafor|mesh-list
110713211|NCT00433199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110713212|NCT00433199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110713213|NCT00006046|Antibodies|antibodies|mesh-list
110713214|NCT00006046|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110713215|NCT00006046|Immunologic Factors|immunologic factors|mesh-ancestor
110713216|NCT00006046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110713217|NCT01098448|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110713218|NCT01098448|Amoxicillin|amoxicillin|mesh-list
110713219|NCT01098448|Metronidazole|metronidazole|mesh-list
110713220|NCT01098448|Tetracycline|tetracycline|mesh-list
110713221|NCT01098448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110713222|NCT01098448|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110713223|NCT01098448|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110713224|NCT01098448|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110713225|NCT01098448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110713226|NCT01098448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110713227|NCT01098526|Efavirenz|efavirenz|mesh-list
110713228|NCT01098526|Dolutegravir|dolutegravir|mesh-list
110713229|NCT01098526|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110713230|NCT01098526|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110713231|NCT01098526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110713232|NCT01098526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110713233|NCT01098526|Antiviral Agents|antiviral agents|mesh-ancestor
110713234|NCT01098526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110713235|NCT01098526|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110713236|NCT01098526|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110713237|NCT01098526|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110713238|NCT01098526|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110713239|NCT01098526|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110713240|NCT01098526|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110713241|NCT01098526|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110713242|NCT01098526|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110713243|NCT01098526|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110713244|NCT01098526|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110713245|NCT00005908|Tamoxifen|tamoxifen|mesh-list
110713246|NCT00005908|Cyclophosphamide|cyclophosphamide|mesh-list
110713247|NCT00005908|Docetaxel|docetaxel|mesh-list
110713248|NCT00005908|Doxorubicin|doxorubicin|mesh-list
110713249|NCT00005908|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110713250|NCT00005908|Capecitabine|capecitabine|mesh-list
110713251|NCT00005908|Anastrozole|anastrozole|mesh-list
110713252|NCT00005908|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110713253|NCT00005908|Immunologic Factors|immunologic factors|mesh-ancestor
110713254|NCT00005908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110713255|NCT00005908|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110713256|NCT00005908|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110713257|NCT00005908|Alkylating Agents|alkylating agents|mesh-ancestor
110713258|NCT00005908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110713259|NCT00005908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110713260|NCT00005908|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110713261|NCT00005908|Tubulin Modulators|tubulin modulators|mesh-ancestor
110713262|NCT00005908|Antimitotic Agents|antimitotic agents|mesh-ancestor
110713263|NCT00005908|Mitosis Modulators|mitosis modulators|mesh-ancestor
110713264|NCT00005908|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110713265|NCT00005908|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110136717|NCT02006355|Ropivacaine|ropivacaine|mesh-list
110713266|NCT00005908|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110713267|NCT00005908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110713268|NCT00005908|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110713269|NCT00005908|Antimetabolites|antimetabolites|mesh-ancestor
110713270|NCT00005908|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110713271|NCT00005908|Hormone Antagonists|hormone antagonists|mesh-ancestor
110713272|NCT00005908|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110713273|NCT00005908|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110713274|NCT00005908|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110713275|NCT00005908|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110713276|NCT00005908|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110713277|NCT00005908|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110713278|NCT00005908|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110713279|NCT00431951|Tecovirimat|tecovirimat|mesh-list
110713280|NCT00431951|Antiviral Agents|antiviral agents|mesh-ancestor
110713281|NCT00431951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110713282|NCT00004978|Aldesleukin|aldesleukin|mesh-list
110713283|NCT00004978|Interleukin-2|interleukin-2|mesh-list
110713284|NCT00004978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110713285|NCT00004978|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110713286|NCT00004978|Analgesics|analgesics|mesh-ancestor
110713287|NCT00004978|Sensory System Agents|sensory system agents|mesh-ancestor
110861582|NCT01335321|Hylan|hylan|mesh-list
110713288|NCT00004978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110713289|NCT00004978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110713290|NCT00004978|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110713291|NCT00004978|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110713292|NCT00004978|Antiviral Agents|antiviral agents|mesh-ancestor
110713293|NCT00004978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110713294|NCT01030601|Dexamethasone|dexamethasone|mesh-list
110713295|NCT01030601|Dexamethasone acetate|dexamethasone acetate|mesh-list
110713296|NCT01030601|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
110713298|NCT01030601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110713299|NCT01030601|Antiemetics|antiemetics|mesh-ancestor
110713300|NCT01030601|Autonomic Agents|autonomic agents|mesh-ancestor
110713301|NCT01030601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110713302|NCT01030601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110713303|NCT01030601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110713304|NCT01030601|Glucocorticoids|glucocorticoids|mesh-ancestor
110713305|NCT01030601|Hormones|hormones|mesh-ancestor
110713306|NCT01030601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110713307|NCT01030601|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110713308|NCT01030601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110713309|NCT01030601|Protease Inhibitors|protease inhibitors|mesh-ancestor
110713310|NCT01030601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110713311|NCT01030601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110713312|NCT00430937|Vancomycin|vancomycin|mesh-list
110713313|NCT00430937|Daptomycin|daptomycin|mesh-list
110713314|NCT00430937|Teicoplanin|teicoplanin|mesh-list
110713315|NCT00430937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110713316|NCT00430937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110713317|NCT01101412|Calcium, Dietary|calcium, dietary|mesh-list
110713318|NCT01101412|Ethanol|ethanol|mesh-list
110713319|NCT01101412|Trimethoprim|trimethoprim|mesh-list
110713320|NCT01101412|Sulfamethoxazole|sulfamethoxazole|mesh-list
110713321|NCT01101412|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
110713322|NCT01101412|Edetic Acid|edetic acid|mesh-list
110713323|NCT01101412|Calcium|calcium|mesh-list
110713324|NCT01101412|Pentetic Acid|pentetic acid|mesh-list
110713325|NCT01101412|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110713326|NCT01101412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110713327|NCT01101412|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110713328|NCT01101412|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110713329|NCT01101412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110713330|NCT01101412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110713331|NCT01101412|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110713332|NCT01101412|Antimalarials|antimalarials|mesh-ancestor
110713333|NCT01101412|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110713334|NCT01101412|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110713335|NCT01101412|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110713336|NCT01101412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110713337|NCT01101412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110713338|NCT01101412|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110713339|NCT01101412|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
110713340|NCT01101412|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110713341|NCT01101412|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110713342|NCT01101412|Anticoagulants|anticoagulants|mesh-ancestor
110713343|NCT01101412|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110713344|NCT01101412|Chelating Agents|chelating agents|mesh-ancestor
110713345|NCT01101412|Sequestering Agents|sequestering agents|mesh-ancestor
110713347|NCT01101412|Protective Agents|protective agents|mesh-ancestor
110713348|NCT01101412|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110713349|NCT00004888|Docetaxel|docetaxel|mesh-list
110713350|NCT00004888|Doxorubicin|doxorubicin|mesh-list
110713351|NCT00004888|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110713352|NCT00004888|Trastuzumab|trastuzumab|mesh-list
110713353|NCT00004888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110713354|NCT00004888|Tubulin Modulators|tubulin modulators|mesh-ancestor
110713355|NCT00004888|Antimitotic Agents|antimitotic agents|mesh-ancestor
110713356|NCT00004888|Mitosis Modulators|mitosis modulators|mesh-ancestor
110713357|NCT00004888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110713358|NCT00004888|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110713359|NCT00004888|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110713360|NCT00004888|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110713361|NCT00004888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110713362|NCT00004888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110713363|NCT01098760|Sorafenib|sorafenib|mesh-list
110713364|NCT01098760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110713365|NCT01098760|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110713366|NCT01098760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110713367|NCT01098760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110713368|NCT03950830|Disulfiram|disulfiram|mesh-list
110713369|NCT03950830|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110713370|NCT03950830|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
110713371|NCT03950830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110713372|NCT03950830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110713373|NCT00430781|Lapatinib|lapatinib|mesh-list
110713374|NCT00430781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110713375|NCT00430781|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110713376|NCT00430781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110713377|NCT00430781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110713378|NCT01033097|Betamethasone|betamethasone|mesh-list
110713379|NCT01033097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110713380|NCT01033097|Glucocorticoids|glucocorticoids|mesh-ancestor
110713381|NCT01033097|Hormones|hormones|mesh-ancestor
110713382|NCT01033097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110713383|NCT01033097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110713384|NCT01033097|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110713385|NCT01033097|Respiratory System Agents|respiratory system agents|mesh-ancestor
110713386|NCT00429299|Paclitaxel|paclitaxel|mesh-list
110713387|NCT00429299|Cyclophosphamide|cyclophosphamide|mesh-list
110713388|NCT00429299|Fluorouracil|fluorouracil|mesh-list
110713389|NCT00429299|Trastuzumab|trastuzumab|mesh-list
110713390|NCT00429299|Lapatinib|lapatinib|mesh-list
110713391|NCT00429299|Epirubicin|epirubicin|mesh-list
110713392|NCT00429299|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110713393|NCT00429299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110713394|NCT00429299|Tubulin Modulators|tubulin modulators|mesh-ancestor
110713395|NCT00429299|Antimitotic Agents|antimitotic agents|mesh-ancestor
110713396|NCT00429299|Mitosis Modulators|mitosis modulators|mesh-ancestor
110713397|NCT00429299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110713398|NCT00429299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110713399|NCT00429299|Immunologic Factors|immunologic factors|mesh-ancestor
110713400|NCT00429299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110713401|NCT00429299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110713402|NCT00429299|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110713403|NCT00429299|Alkylating Agents|alkylating agents|mesh-ancestor
110713404|NCT00429299|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110713405|NCT00429299|Antimetabolites|antimetabolites|mesh-ancestor
110713406|NCT00429299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110713407|NCT00429299|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110713408|NCT00429299|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110713409|NCT00429299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110713410|NCT00429299|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110713411|NCT00429299|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110713412|NCT00429299|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110713414|NCT01033877|Immunologic Factors|immunologic factors|mesh-ancestor
110713415|NCT01033877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110713416|NCT00428597|Sunitinib|sunitinib|mesh-list
110713417|NCT00428597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110713418|NCT00428597|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110713419|NCT00428597|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110713420|NCT00428597|Growth Substances|growth substances|mesh-ancestor
110713421|NCT00428597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110713422|NCT00428597|Growth Inhibitors|growth inhibitors|mesh-ancestor
110713423|NCT00428597|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110713424|NCT00428597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110713425|NCT00428597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110713426|NCT01033955|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110713427|NCT01033955|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110713428|NCT01033955|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110713429|NCT01033955|Antimetabolites|antimetabolites|mesh-ancestor
110713430|NCT01033955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110861593|NCT01333137|Gemcitabine|gemcitabine|mesh-list
110713431|NCT01033955|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110713432|NCT01033955|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110713433|NCT01033955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110713435|NCT00428441|Anticoagulants|anticoagulants|mesh-ancestor
110713436|NCT00144339|Tiotropium Bromide|tiotropium bromide|mesh-list
110713437|NCT00144339|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110713438|NCT00144339|Autonomic Agents|autonomic agents|mesh-ancestor
110713439|NCT00144339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110713440|NCT00144339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110713441|NCT00144339|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110713442|NCT00144339|Respiratory System Agents|respiratory system agents|mesh-ancestor
110713443|NCT00144339|Parasympatholytics|parasympatholytics|mesh-ancestor
110713444|NCT00144339|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110713445|NCT00144339|Cholinergic Agents|cholinergic agents|mesh-ancestor
110713446|NCT00144339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110713447|NCT00144339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110713448|NCT03967665|Acetylcysteine|acetylcysteine|mesh-list
110713449|NCT03967665|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110713450|NCT03967665|Antiviral Agents|antiviral agents|mesh-ancestor
110713451|NCT03967665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110713452|NCT03967665|Expectorants|expectorants|mesh-ancestor
110713453|NCT03967665|Respiratory System Agents|respiratory system agents|mesh-ancestor
110713454|NCT03967665|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110713455|NCT03967665|Antioxidants|antioxidants|mesh-ancestor
110713456|NCT03967665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110713457|NCT03967665|Protective Agents|protective agents|mesh-ancestor
110713458|NCT03967665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110713459|NCT03967665|Antidotes|antidotes|mesh-ancestor
110713460|NCT00144027|Antipsychotic Agents|antipsychotic agents|mesh-list
110713461|NCT00144027|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110713462|NCT00144027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110713463|NCT00144027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110713464|NCT00144027|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110713465|NCT00127803|Vaccines|vaccines|mesh-list
110713466|NCT00127803|Immunologic Factors|immunologic factors|mesh-ancestor
110713467|NCT00127803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110713468|NCT01077999|Paclitaxel|paclitaxel|mesh-list
110713469|NCT01077999|Carboplatin|carboplatin|mesh-list
110713470|NCT01077999|Panitumumab|panitumumab|mesh-list
110713471|NCT01077999|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110713472|NCT01077999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110431319|NCT00625014|Antiemetics|antiemetics|mesh-ancestor
110713473|NCT01077999|Tubulin Modulators|tubulin modulators|mesh-ancestor
110713474|NCT01077999|Antimitotic Agents|antimitotic agents|mesh-ancestor
110713475|NCT01077999|Mitosis Modulators|mitosis modulators|mesh-ancestor
110713476|NCT01077999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110713478|NCT01033409|Vaccines|vaccines|mesh-list
110713479|NCT01033409|Immunologic Factors|immunologic factors|mesh-ancestor
110713480|NCT01033409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110713481|NCT01037465|Acetylcysteine|acetylcysteine|mesh-list
110713482|NCT01037465|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110713483|NCT01037465|Antiviral Agents|antiviral agents|mesh-ancestor
110713484|NCT01037465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110713485|NCT01037465|Expectorants|expectorants|mesh-ancestor
110713486|NCT01037465|Respiratory System Agents|respiratory system agents|mesh-ancestor
110713487|NCT01037465|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110713488|NCT01037465|Antioxidants|antioxidants|mesh-ancestor
110713489|NCT01037465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110713490|NCT01037465|Protective Agents|protective agents|mesh-ancestor
110713491|NCT01037465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110713492|NCT01037465|Antidotes|antidotes|mesh-ancestor
110713493|NCT01582425|Isavuconazole|isavuconazole|mesh-list
110713494|NCT01582425|Methadone|methadone|mesh-list
110713495|NCT01582425|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110713496|NCT01582425|Narcotics|narcotics|mesh-ancestor
110713497|NCT01582425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110713498|NCT01582425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110713499|NCT01582425|Analgesics|analgesics|mesh-ancestor
110713500|NCT01582425|Sensory System Agents|sensory system agents|mesh-ancestor
110713501|NCT01582425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110713502|NCT01582425|Antitussive Agents|antitussive agents|mesh-ancestor
110713503|NCT01582425|Respiratory System Agents|respiratory system agents|mesh-ancestor
110713504|NCT01582425|Antifungal Agents|antifungal agents|mesh-ancestor
110713505|NCT01582425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110713506|NCT00143403|Leucovorin|leucovorin|mesh-list
110713507|NCT00143403|Folic Acid|folic acid|mesh-list
110713508|NCT00143403|Irinotecan|irinotecan|mesh-list
110713509|NCT00143403|Fluorouracil|fluorouracil|mesh-list
110713510|NCT00143403|Levoleucovorin|levoleucovorin|mesh-list
110713511|NCT00143403|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110713512|NCT00143403|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110713513|NCT00143403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110713514|NCT00143403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110713515|NCT00143403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110713516|NCT00143403|Antimetabolites|antimetabolites|mesh-ancestor
110713517|NCT00143403|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110713518|NCT00143403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110713519|NCT00143403|Immunologic Factors|immunologic factors|mesh-ancestor
110713520|NCT00143403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110713521|NCT00143403|Antidotes|antidotes|mesh-ancestor
110713522|NCT00143403|Protective Agents|protective agents|mesh-ancestor
110713523|NCT00143403|Vitamin B Complex|vitamin b complex|mesh-ancestor
110713524|NCT00143403|Vitamins|vitamins|mesh-ancestor
110713525|NCT00143403|Micronutrients|micronutrients|mesh-ancestor
110713526|NCT00143403|Hematinics|hematinics|mesh-ancestor
110713527|NCT00220701|Dexetimide|dexetimide|mesh-list
110713528|NCT00220701|Citalopram|citalopram|mesh-list
110713529|NCT00220701|Escitalopram|escitalopram|mesh-list
110713530|NCT00220701|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110713531|NCT00220701|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110713532|NCT00220701|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110713533|NCT00220701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110713534|NCT00220701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110713535|NCT00220701|Serotonin Agents|serotonin agents|mesh-ancestor
110713536|NCT00220701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110713537|NCT00220701|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110713538|NCT00220701|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110713539|NCT00220701|Parasympatholytics|parasympatholytics|mesh-ancestor
110713540|NCT00220701|Autonomic Agents|autonomic agents|mesh-ancestor
110713541|NCT00220701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110713542|NCT00220701|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110713543|NCT00220701|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110713544|NCT00220701|Cholinergic Agents|cholinergic agents|mesh-ancestor
110713545|NCT00220701|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110713546|NCT00220701|Antidepressive Agents|antidepressive agents|mesh-ancestor
110713547|NCT00220701|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110713548|NCT00127101|Vorinostat|vorinostat|mesh-list
110713549|NCT00127101|Bexarotene|bexarotene|mesh-list
110713550|NCT00127101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110713551|NCT00127101|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110713552|NCT00127101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110713553|NCT00127101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110713554|NCT00126555|Gefitinib|gefitinib|mesh-list
110713555|NCT00126555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110713556|NCT00126555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110713557|NCT00126555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110713558|NCT00126555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110713559|NCT00004228|Leucovorin|leucovorin|mesh-list
110713560|NCT00004228|Cytarabine|cytarabine|mesh-list
110713561|NCT00004228|Dexamethasone|dexamethasone|mesh-list
110713562|NCT00004228|Prednisone|prednisone|mesh-list
110713563|NCT00004228|Cyclophosphamide|cyclophosphamide|mesh-list
110713564|NCT00004228|Doxorubicin|doxorubicin|mesh-list
110713565|NCT00004228|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110713566|NCT00004228|Methotrexate|methotrexate|mesh-list
110713567|NCT00004228|Vincristine|vincristine|mesh-list
110713568|NCT00004228|Daunorubicin|daunorubicin|mesh-list
110713569|NCT00004228|Asparaginase|asparaginase|mesh-list
110713570|NCT00004228|Mercaptopurine|mercaptopurine|mesh-list
110713571|NCT00004228|Thioguanine|thioguanine|mesh-list
110713572|NCT00004228|Levoleucovorin|levoleucovorin|mesh-list
110713573|NCT00004228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110713574|NCT00004228|Immunologic Factors|immunologic factors|mesh-ancestor
110713575|NCT00004228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110713576|NCT00004228|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110713577|NCT00004228|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110713578|NCT00004228|Alkylating Agents|alkylating agents|mesh-ancestor
110713579|NCT00004228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110713580|NCT00004228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110713581|NCT00004228|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110713582|NCT00004228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110713583|NCT00004228|Antiemetics|antiemetics|mesh-ancestor
110713584|NCT00004228|Autonomic Agents|autonomic agents|mesh-ancestor
110713585|NCT00004228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110713586|NCT00004228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110713587|NCT00004228|Glucocorticoids|glucocorticoids|mesh-ancestor
110713588|NCT00004228|Hormones|hormones|mesh-ancestor
110713589|NCT00004228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110713590|NCT00004228|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110713591|NCT00004228|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110713592|NCT00004228|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110713593|NCT00004228|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110713594|NCT00004228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110713595|NCT00004228|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110713596|NCT00004228|Abortifacient Agents|abortifacient agents|mesh-ancestor
110713597|NCT00004228|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110713598|NCT00004228|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110713599|NCT00004228|Antimetabolites|antimetabolites|mesh-ancestor
110713600|NCT00004228|Dermatologic Agents|dermatologic agents|mesh-ancestor
110713601|NCT00004228|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110713602|NCT00004228|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110713603|NCT00004228|Antiviral Agents|antiviral agents|mesh-ancestor
110713604|NCT00004228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110713605|NCT00004228|Antidotes|antidotes|mesh-ancestor
110713606|NCT00004228|Protective Agents|protective agents|mesh-ancestor
110713607|NCT00004228|Vitamin B Complex|vitamin b complex|mesh-ancestor
110713608|NCT00004228|Vitamins|vitamins|mesh-ancestor
110713609|NCT00004228|Micronutrients|micronutrients|mesh-ancestor
110713610|NCT00004228|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110713611|NCT00004228|Tubulin Modulators|tubulin modulators|mesh-ancestor
110713612|NCT00004228|Antimitotic Agents|antimitotic agents|mesh-ancestor
110713613|NCT00004228|Mitosis Modulators|mitosis modulators|mesh-ancestor
110713614|NCT01101568|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110713615|NCT01101568|Simvastatin|simvastatin|mesh-list
110713616|NCT01101568|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110713617|NCT01101568|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110713618|NCT01101568|Antimetabolites|antimetabolites|mesh-ancestor
110713619|NCT01101568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110713620|NCT01101568|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110713621|NCT01101568|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110713622|NCT01101568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110713623|NCT01087840|Tenofovir|tenofovir|mesh-list
110713624|NCT01087840|Emtricitabine|emtricitabine|mesh-list
110713625|NCT01087840|Raltegravir Potassium|raltegravir potassium|mesh-list
110713627|NCT01087840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110713628|NCT01087840|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110713629|NCT01087840|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110431476|NCT04263844|Anesthetics|anesthetics|mesh-ancestor
110713630|NCT01087840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110713631|NCT01087840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110713632|NCT01087840|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110713633|NCT01087840|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110713634|NCT01087840|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110713635|NCT01087840|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110713636|NCT01098994|Vitamin E|vitamin e|mesh-list
110713637|NCT01098994|Tocopherols|tocopherols|mesh-list
110713638|NCT01098994|alpha-Tocopherol|alpha-tocopherol|mesh-list
110713639|NCT01098994|Vitamins|vitamins|mesh-ancestor
110713640|NCT01098994|Micronutrients|micronutrients|mesh-ancestor
110713641|NCT01098994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110713642|NCT01098994|Antioxidants|antioxidants|mesh-ancestor
110861611|NCT04431466|Ivermectin|ivermectin|mesh-list
110713643|NCT01098994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110713644|NCT01098994|Protective Agents|protective agents|mesh-ancestor
110713645|NCT01099072|Methylphenidate|methylphenidate|mesh-list
110713646|NCT01099072|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110713647|NCT01099072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110713648|NCT01099072|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110713649|NCT01099072|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110713650|NCT01099072|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110713651|NCT01099072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110713652|NCT01099072|Dopamine Agents|dopamine agents|mesh-ancestor
110713653|NCT01099072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110713655|NCT00031486|Antiviral Agents|antiviral agents|mesh-ancestor
110713656|NCT00031486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110713657|NCT01099150|Proanthocyanidin|proanthocyanidin|mesh-list
110713658|NCT01099150|Procyanidin|procyanidin|mesh-list
110713659|NCT01099150|Antioxidants|antioxidants|mesh-ancestor
110713660|NCT01099150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110713661|NCT01099150|Protective Agents|protective agents|mesh-ancestor
110713662|NCT01099150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110713663|NCT01099150|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110713664|NCT01099150|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110713665|NCT01099150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110713666|NCT02530060|Tenofovir|tenofovir|mesh-list
110713667|NCT02530060|Emtricitabine|emtricitabine|mesh-list
110713668|NCT02530060|Rilpivirine|rilpivirine|mesh-list
110713669|NCT02530060|Antiviral Agents|antiviral agents|mesh-ancestor
110713670|NCT02530060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110713671|NCT02530060|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110713672|NCT02530060|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110713673|NCT02530060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110713674|NCT02530060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110713675|NCT02530060|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110713676|NCT02530060|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110713677|NCT01101646|Rabeprazole|rabeprazole|mesh-list
110713678|NCT01101646|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110713679|NCT01101646|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110713680|NCT01101646|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110713681|NCT01101646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110713682|NCT01101646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110713683|NCT01101802|Mycophenolic Acid|mycophenolic acid|mesh-list
110713684|NCT01101802|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110713685|NCT01101802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110713686|NCT01101802|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110713687|NCT01101802|Antitubercular Agents|antitubercular agents|mesh-ancestor
110713688|NCT01101802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110713689|NCT01101802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110713690|NCT01101802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110713691|NCT01101802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110713692|NCT01099228|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
110713693|NCT01099228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110713694|NCT01099228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110713695|NCT01099228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110713696|NCT01099228|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110713697|NCT01088230|Botulinum Toxins|botulinum toxins|mesh-list
110443911|NCT02788786|Cetylpyridinium|cetylpyridinium|mesh-list
110713698|NCT01088230|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110713699|NCT01088230|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110713700|NCT01088230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110713701|NCT01088230|Cholinergic Agents|cholinergic agents|mesh-ancestor
110713702|NCT01088230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110713703|NCT01088230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110713704|NCT01099462|Ibuprofen|ibuprofen|mesh-list
110713705|NCT01099462|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110713706|NCT01099462|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110713707|NCT01099462|Analgesics|analgesics|mesh-ancestor
110713708|NCT01099462|Sensory System Agents|sensory system agents|mesh-ancestor
110713709|NCT01099462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110713710|NCT01099462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110713711|NCT01099462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110713712|NCT01099462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110713713|NCT01099462|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110713714|NCT01099462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110136809|NCT05970263|Cholinergic Agents|cholinergic agents|mesh-ancestor
110713715|NCT01099462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110713716|NCT00003298|Leucovorin|leucovorin|mesh-list
110713717|NCT00003298|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
110713718|NCT00003298|Tetrahydrofolates|tetrahydrofolates|mesh-list
110713719|NCT00003298|Paclitaxel|paclitaxel|mesh-list
110713720|NCT00003298|Cisplatin|cisplatin|mesh-list
110713721|NCT00003298|Fluorouracil|fluorouracil|mesh-list
110713722|NCT00003298|Calcium|calcium|mesh-list
110713723|NCT00003298|Levoleucovorin|levoleucovorin|mesh-list
110713724|NCT00003298|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110713725|NCT00003298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110713726|NCT00003298|Tubulin Modulators|tubulin modulators|mesh-ancestor
110713727|NCT00003298|Antimitotic Agents|antimitotic agents|mesh-ancestor
110713728|NCT00003298|Mitosis Modulators|mitosis modulators|mesh-ancestor
110713729|NCT00003298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110713730|NCT00003298|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110713731|NCT00003298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110713732|NCT00003298|Antimetabolites|antimetabolites|mesh-ancestor
110713733|NCT00003298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110713734|NCT00003298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110713735|NCT00003298|Immunologic Factors|immunologic factors|mesh-ancestor
110713736|NCT00003298|Antidotes|antidotes|mesh-ancestor
110713737|NCT00003298|Protective Agents|protective agents|mesh-ancestor
110713738|NCT00003298|Vitamin B Complex|vitamin b complex|mesh-ancestor
110713739|NCT00003298|Vitamins|vitamins|mesh-ancestor
110713740|NCT00003298|Micronutrients|micronutrients|mesh-ancestor
110713741|NCT03960970|Azithromycin|azithromycin|mesh-list
110713742|NCT03960970|Cefoxitin|cefoxitin|mesh-list
110713743|NCT03960970|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110713744|NCT03960970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110713745|NCT00002842|Leucovorin|leucovorin|mesh-list
110713746|NCT00002842|Fluorouracil|fluorouracil|mesh-list
110713747|NCT00002842|Floxuridine|floxuridine|mesh-list
110713748|NCT00002842|Calcium|calcium|mesh-list
110713749|NCT00002842|Levoleucovorin|levoleucovorin|mesh-list
110713750|NCT00002842|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110713751|NCT00002842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110713752|NCT00002842|Antimetabolites|antimetabolites|mesh-ancestor
110713753|NCT00002842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110713754|NCT00002842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110713755|NCT00002842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110713756|NCT00002842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110713757|NCT00002842|Immunologic Factors|immunologic factors|mesh-ancestor
110713758|NCT00002842|Antidotes|antidotes|mesh-ancestor
110713759|NCT00002842|Protective Agents|protective agents|mesh-ancestor
110713760|NCT00002842|Vitamin B Complex|vitamin b complex|mesh-ancestor
110713761|NCT00002842|Vitamins|vitamins|mesh-ancestor
110713762|NCT00002842|Micronutrients|micronutrients|mesh-ancestor
110713763|NCT00143247|Insulin|insulin|mesh-list
110713764|NCT00143247|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110713765|NCT00143247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110713766|NCT00125853|Atenolol|atenolol|mesh-list
110713767|NCT00125853|Nebivolol|nebivolol|mesh-list
110713768|NCT00125853|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110713769|NCT00125853|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110713770|NCT00125853|Sympatholytics|sympatholytics|mesh-ancestor
110713771|NCT00125853|Autonomic Agents|autonomic agents|mesh-ancestor
110713772|NCT00125853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110713773|NCT00125853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110713774|NCT00125853|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110713775|NCT00125853|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110713776|NCT00125853|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110713777|NCT00125853|Adrenergic Agents|adrenergic agents|mesh-ancestor
110713778|NCT00125853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110713779|NCT00125853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110713780|NCT00125853|Vasodilator Agents|vasodilator agents|mesh-ancestor
110713781|NCT00125853|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
110713782|NCT00125853|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110136821|NCT05969899|Bevacizumab|bevacizumab|mesh-list
110713783|NCT00125853|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110713785|NCT00219141|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110713786|NCT00219141|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110713787|NCT00219141|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110713788|NCT00219141|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110713789|NCT00219141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110713790|NCT03971487|Ocrelizumab|ocrelizumab|mesh-list
110713791|NCT03971487|Immunologic Factors|immunologic factors|mesh-ancestor
110713792|NCT03971487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110713793|NCT00233948|Nelfinavir|nelfinavir|mesh-list
110713794|NCT00233948|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110713795|NCT00233948|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110713796|NCT00233948|Protease Inhibitors|protease inhibitors|mesh-ancestor
110713797|NCT00233948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110713798|NCT00233948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110713799|NCT00233948|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110713800|NCT00233948|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110713801|NCT00233948|Antiviral Agents|antiviral agents|mesh-ancestor
110713802|NCT00233948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110713803|NCT00233480|Atorvastatin|atorvastatin|mesh-list
110713804|NCT00233480|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110713805|NCT00233480|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110713806|NCT00233480|Antimetabolites|antimetabolites|mesh-ancestor
110713807|NCT00233480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110713808|NCT00233480|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110713809|NCT00233480|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110713810|NCT00233480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110713811|NCT03801928|Infliximab|infliximab|mesh-list
110713812|NCT03801928|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110713813|NCT03801928|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110713814|NCT03801928|Dermatologic Agents|dermatologic agents|mesh-ancestor
110713815|NCT03801928|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110713816|NCT03801928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110713817|NCT02530918|Ranibizumab|ranibizumab|mesh-list
110713818|NCT02530918|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110713819|NCT02530918|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110713820|NCT02530918|Growth Substances|growth substances|mesh-ancestor
110713821|NCT02530918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110713822|NCT02530918|Growth Inhibitors|growth inhibitors|mesh-ancestor
110713823|NCT02530918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110713824|NCT03950518|Levamisole|levamisole|mesh-list
110713825|NCT03950518|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110713826|NCT03950518|Immunologic Factors|immunologic factors|mesh-ancestor
110713827|NCT03950518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110713828|NCT03950518|Antinematodal Agents|antinematodal agents|mesh-ancestor
110713829|NCT03950518|Anthelmintics|anthelmintics|mesh-ancestor
110713830|NCT03950518|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110713831|NCT03950518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110713832|NCT03950518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110713833|NCT01100164|Eszopiclone|eszopiclone|mesh-list
110713834|NCT01100164|Zopiclone|zopiclone|mesh-list
110713835|NCT01100164|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110713836|NCT01100164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110713837|NCT01100164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110713838|NCT01102114|Vaccines|vaccines|mesh-list
110713839|NCT01102114|Immunologic Factors|immunologic factors|mesh-ancestor
110713840|NCT01102114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110713841|NCT01327222|Bevacizumab|bevacizumab|mesh-list
110713842|NCT01327222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110713843|NCT01327222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110713844|NCT01327222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110713845|NCT01327222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110713846|NCT01327222|Growth Substances|growth substances|mesh-ancestor
110713847|NCT01327222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110713848|NCT01327222|Growth Inhibitors|growth inhibitors|mesh-ancestor
110713850|NCT03950362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110713851|NCT03950362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110713852|NCT00263588|Lapatinib|lapatinib|mesh-list
110713853|NCT00263588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110713854|NCT00263588|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110713855|NCT00263588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110713856|NCT00263588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110713857|NCT00213135|Cladribine|cladribine|mesh-list
110713858|NCT00213135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110713859|NCT00213135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110713860|NCT00213135|Immunologic Factors|immunologic factors|mesh-ancestor
110713861|NCT00213135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110713862|NCT00077974|Sunitinib|sunitinib|mesh-list
110713863|NCT00077974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110713864|NCT00077974|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110713865|NCT00077974|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110713866|NCT00077974|Growth Substances|growth substances|mesh-ancestor
110713867|NCT00077974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110713868|NCT00077974|Growth Inhibitors|growth inhibitors|mesh-ancestor
110713869|NCT00077974|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110713870|NCT00077974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110713871|NCT00077974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110713872|NCT00141921|Etanercept|etanercept|mesh-list
110713873|NCT00141921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110713874|NCT00141921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110713875|NCT00141921|Analgesics|analgesics|mesh-ancestor
110713876|NCT00141921|Sensory System Agents|sensory system agents|mesh-ancestor
110713877|NCT00141921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110713878|NCT00141921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110713879|NCT00141921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110713880|NCT00141921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110713881|NCT00141921|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110713882|NCT00141921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110713883|NCT00141921|Immunologic Factors|immunologic factors|mesh-ancestor
110713884|NCT01088620|Pemetrexed|pemetrexed|mesh-list
110713885|NCT01088620|Panitumumab|panitumumab|mesh-list
110713886|NCT01088620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110713887|NCT01088620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110713888|NCT01088620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110713889|NCT01088620|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110713890|NCT01088620|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110713891|NCT01088620|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110713892|NCT00026494|Temozolomide|temozolomide|mesh-list
110713893|NCT00026494|Vinorelbine|vinorelbine|mesh-list
110713894|NCT00026494|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110713895|NCT00026494|Alkylating Agents|alkylating agents|mesh-ancestor
110713896|NCT00026494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110713897|NCT00026494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110713898|NCT00026494|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110713899|NCT00026494|Tubulin Modulators|tubulin modulators|mesh-ancestor
110713900|NCT00026494|Antimitotic Agents|antimitotic agents|mesh-ancestor
110713901|NCT00026494|Mitosis Modulators|mitosis modulators|mesh-ancestor
110713902|NCT03950050|Ambroxol|ambroxol|mesh-list
110713903|NCT03950050|Expectorants|expectorants|mesh-ancestor
110713904|NCT03950050|Respiratory System Agents|respiratory system agents|mesh-ancestor
110713905|NCT00023764|Bortezomib|bortezomib|mesh-list
110713906|NCT00023764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110713907|NCT03961126|Clobetasol|clobetasol|mesh-list
110713908|NCT03961126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110713909|NCT03961126|Glucocorticoids|glucocorticoids|mesh-ancestor
110713910|NCT03961126|Hormones|hormones|mesh-ancestor
110713911|NCT03961126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110713912|NCT03961126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110713913|NCT01584778|Eosinophil Cationic Protein|eosinophil cationic protein|mesh-list
110713914|NCT01584778|Immunologic Factors|immunologic factors|mesh-ancestor
110713915|NCT01584778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110713916|NCT00189488|Methotrexate|methotrexate|mesh-list
110713917|NCT00189488|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110713918|NCT00189488|Abortifacient Agents|abortifacient agents|mesh-ancestor
110713919|NCT00189488|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110713920|NCT00189488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110713921|NCT00189488|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110343744|NCT06022939|Melphalan|melphalan|mesh-list
110713923|NCT00189488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110713924|NCT00189488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110713925|NCT00189488|Dermatologic Agents|dermatologic agents|mesh-ancestor
110713926|NCT00189488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110713927|NCT00189488|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110713928|NCT00189488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110713929|NCT00189488|Immunologic Factors|immunologic factors|mesh-ancestor
110713930|NCT00189488|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110713931|NCT00189488|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110713932|NCT00233324|Pulmonary Surfactants|pulmonary surfactants|mesh-list
110431771|NCT04183387|Simvastatin|simvastatin|mesh-list
110713933|NCT00233324|Respiratory System Agents|respiratory system agents|mesh-ancestor
110713935|NCT00023452|Rifapentine|rifapentine|mesh-list
110713936|NCT00023452|Antitubercular Agents|antitubercular agents|mesh-ancestor
110713937|NCT00023452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110713938|NCT00023452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110713939|NCT00023452|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
110713940|NCT00023452|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110713941|NCT00023452|Antimetabolites|antimetabolites|mesh-ancestor
110713942|NCT00023452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110713943|NCT00023452|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110713944|NCT00023452|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110713945|NCT00023452|Leprostatic Agents|leprostatic agents|mesh-ancestor
110713946|NCT01088932|SRX246|srx246|mesh-list
110713947|NCT01088932|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
110713948|NCT01088932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110713949|NCT01088932|Natriuretic Agents|natriuretic agents|mesh-ancestor
110713950|NCT01088932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110713951|NCT03961048|Ropivacaine|ropivacaine|mesh-list
110713952|NCT03961048|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110713953|NCT03961048|Anesthetics, Local|anesthetics, local|mesh-ancestor
110713954|NCT03961048|Anesthetics|anesthetics|mesh-ancestor
110713955|NCT03961048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110713956|NCT03961048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110713957|NCT03961048|Sensory System Agents|sensory system agents|mesh-ancestor
110713958|NCT03961048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110713959|NCT00022672|Trastuzumab|trastuzumab|mesh-list
110713960|NCT00022672|Anastrozole|anastrozole|mesh-list
110713961|NCT00022672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110713962|NCT00022672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110713963|NCT00022672|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110713964|NCT00022672|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110713965|NCT00022672|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110713966|NCT00022672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110713967|NCT00022672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110713968|NCT00022672|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110713969|NCT00022672|Hormone Antagonists|hormone antagonists|mesh-ancestor
110713970|NCT00022672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110713971|NCT00022672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110713972|NCT00141453|Olmesartan|olmesartan|mesh-list
110713973|NCT00141453|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
110713974|NCT00141453|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110136849|NCT05969743|Letermovir|letermovir|mesh-list
110713975|NCT00141453|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110713976|NCT00141453|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110713977|NCT00141453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110713978|NCT00076570|Sirolimus|sirolimus|mesh-list
110713979|NCT00076570|Tacrolimus|tacrolimus|mesh-list
110713980|NCT00076570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110713981|NCT00076570|Immunologic Factors|immunologic factors|mesh-ancestor
110713982|NCT00076570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110713983|NCT00076570|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110713984|NCT00076570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110713985|NCT00076570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110713986|NCT00076570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110713987|NCT00076570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110713988|NCT00076570|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110713989|NCT00076570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110713990|NCT00076570|Antifungal Agents|antifungal agents|mesh-ancestor
110713991|NCT00124449|Abatacept|abatacept|mesh-list
110713992|NCT00124449|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110443915|NCT02788786|Dermatologic Agents|dermatologic agents|mesh-ancestor
110713993|NCT00124449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110713994|NCT00124449|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110713995|NCT00124449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110713996|NCT00124449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110713997|NCT00124449|Immunologic Factors|immunologic factors|mesh-ancestor
110713998|NCT00124449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110713999|NCT00124449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110714001|NCT00076336|Telbivudine|telbivudine|mesh-list
110714002|NCT00076336|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110714003|NCT00076336|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110714004|NCT00076336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110431856|NCT00641329|Clonidine|clonidine|mesh-list
110714005|NCT00076336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110714006|NCT00076336|Antiviral Agents|antiviral agents|mesh-ancestor
110714007|NCT00076336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110714008|NCT00076336|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110714009|NCT00076336|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110714010|NCT00185588|Gemcitabine|gemcitabine|mesh-list
110714011|NCT00185588|Vatalanib|vatalanib|mesh-list
110714012|NCT00185588|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110714013|NCT00185588|Antimetabolites|antimetabolites|mesh-ancestor
110714014|NCT00185588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110714015|NCT00185588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110714016|NCT00185588|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110714017|NCT00185588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110714018|NCT00231842|Ifosfamide|ifosfamide|mesh-list
110714019|NCT00231842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110714020|NCT00231842|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110714021|NCT00231842|Alkylating Agents|alkylating agents|mesh-ancestor
110714022|NCT00231842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110714023|NCT01073150|Tea Tree Oil|tea tree oil|mesh-list
110714024|NCT01073150|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110714025|NCT01073150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110714026|NCT00076102|Pirfenidone|pirfenidone|mesh-list
110714027|NCT00076102|Analgesics|analgesics|mesh-ancestor
110714028|NCT00076102|Sensory System Agents|sensory system agents|mesh-ancestor
110714029|NCT00076102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110714030|NCT00076102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110714031|NCT00076102|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110714032|NCT00076102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110714033|NCT00076102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110714034|NCT00076102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110714035|NCT00076102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110714036|NCT03968588|Mycophenolic Acid|mycophenolic acid|mesh-list
110714037|NCT03968588|Tacrolimus|tacrolimus|mesh-list
110714038|NCT03968588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110714039|NCT03968588|Immunologic Factors|immunologic factors|mesh-ancestor
110714040|NCT03968588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110714041|NCT03968588|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110714042|NCT03968588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110714043|NCT03968588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110714044|NCT03968588|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110714045|NCT03968588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110714046|NCT03968588|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110861654|NCT00092625|Ezetimibe|ezetimibe|mesh-list
110714047|NCT03968588|Antitubercular Agents|antitubercular agents|mesh-ancestor
110714048|NCT03968588|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110714049|NCT03968588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110714050|NCT01582646|Terbutaline|terbutaline|mesh-list
110714051|NCT01582646|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110714052|NCT01582646|Autonomic Agents|autonomic agents|mesh-ancestor
110714053|NCT01582646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110714054|NCT01582646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110714055|NCT01582646|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110714056|NCT01582646|Respiratory System Agents|respiratory system agents|mesh-ancestor
110714057|NCT01582646|Sympathomimetics|sympathomimetics|mesh-ancestor
110714058|NCT01582646|Tocolytic Agents|tocolytic agents|mesh-ancestor
110714059|NCT01582646|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110714060|NCT01582646|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110714061|NCT01582646|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110714062|NCT01582646|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110714063|NCT01582646|Adrenergic Agents|adrenergic agents|mesh-ancestor
110714064|NCT01582646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110714065|NCT01582646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110714066|NCT03974360|Erenumab|erenumab|mesh-list
110714067|NCT03974360|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
110714068|NCT03974360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110714069|NCT03974360|Analgesics|analgesics|mesh-ancestor
110714070|NCT03974360|Sensory System Agents|sensory system agents|mesh-ancestor
110714071|NCT03974360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110714072|NCT03974360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110714073|NCT00184028|Oxaliplatin|oxaliplatin|mesh-list
110714074|NCT00184028|Docetaxel|docetaxel|mesh-list
110714075|NCT00184028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110714076|NCT00184028|Tubulin Modulators|tubulin modulators|mesh-ancestor
110714077|NCT00184028|Antimitotic Agents|antimitotic agents|mesh-ancestor
110714078|NCT00184028|Mitosis Modulators|mitosis modulators|mesh-ancestor
110431917|NCT00641407|Insulin|insulin|mesh-list
110714079|NCT00184028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110714081|NCT00183872|Irinotecan|irinotecan|mesh-list
110714082|NCT00183872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110714083|NCT00183872|Tubulin Modulators|tubulin modulators|mesh-ancestor
110714084|NCT00183872|Antimitotic Agents|antimitotic agents|mesh-ancestor
110714085|NCT00183872|Mitosis Modulators|mitosis modulators|mesh-ancestor
110714086|NCT00183872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110714087|NCT00183872|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110714088|NCT00183872|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110714089|NCT00183872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110714090|NCT03815175|Aspirin|aspirin|mesh-list
110714091|NCT03815175|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110714092|NCT03815175|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110714093|NCT03815175|Analgesics|analgesics|mesh-ancestor
110714094|NCT03815175|Sensory System Agents|sensory system agents|mesh-ancestor
110714095|NCT03815175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110714096|NCT03815175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110714097|NCT03815175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110714098|NCT03815175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110714099|NCT03815175|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110714100|NCT03815175|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110714101|NCT03815175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110714102|NCT03815175|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110714103|NCT03815175|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110714104|NCT03815175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110714105|NCT03815175|Antipyretics|antipyretics|mesh-ancestor
110714106|NCT01080027|Interferons|interferons|mesh-list
110714107|NCT01080027|Interferon-beta|interferon-beta|mesh-list
110714108|NCT01080027|Interferon beta-1a|interferon beta-1a|mesh-list
110714109|NCT01080027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110714110|NCT01080027|Antiviral Agents|antiviral agents|mesh-ancestor
110714111|NCT01080027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110714112|NCT01080027|Immunologic Factors|immunologic factors|mesh-ancestor
110714113|NCT01080027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110714114|NCT01080027|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110714115|NCT00262028|Vaccines|vaccines|mesh-list
110714116|NCT00262028|Immunologic Factors|immunologic factors|mesh-ancestor
110714117|NCT00262028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110714118|NCT00183248|Mycophenolic Acid|mycophenolic acid|mesh-list
110714119|NCT00183248|Sirolimus|sirolimus|mesh-list
110714120|NCT00183248|Alemtuzumab|alemtuzumab|mesh-list
110714121|NCT00183248|Tacrolimus|tacrolimus|mesh-list
110714122|NCT00183248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110714123|NCT00183248|Immunologic Factors|immunologic factors|mesh-ancestor
110714124|NCT00183248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110714125|NCT00183248|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110714126|NCT00183248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110714127|NCT00183248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110714128|NCT00183248|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110714129|NCT00183248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110714130|NCT00183248|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110714131|NCT00183248|Antitubercular Agents|antitubercular agents|mesh-ancestor
110714132|NCT00183248|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110714133|NCT00183248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110714134|NCT00183248|Antifungal Agents|antifungal agents|mesh-ancestor
110714135|NCT00183248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110714136|NCT00230282|Cyclophosphamide|cyclophosphamide|mesh-list
110714137|NCT00230282|Fludarabine|fludarabine|mesh-list
110714138|NCT00230282|Alemtuzumab|alemtuzumab|mesh-list
110714139|NCT00230282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110714140|NCT00230282|Immunologic Factors|immunologic factors|mesh-ancestor
110714141|NCT00230282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110714142|NCT00230282|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110714143|NCT00230282|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110714144|NCT00230282|Alkylating Agents|alkylating agents|mesh-ancestor
110714145|NCT00230282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110136909|NCT05969171|Gemcitabine|gemcitabine|mesh-list
110714146|NCT00230282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110714147|NCT00230282|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110714148|NCT00230282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110714149|NCT00261950|Cinacalcet|cinacalcet|mesh-list
110714150|NCT00261950|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110714151|NCT00261950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110714152|NCT00261950|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
110714153|NCT00261950|Hormone Antagonists|hormone antagonists|mesh-ancestor
110714154|NCT00261950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110714155|NCT00229658|Pramlintide|pramlintide|mesh-list
110714156|NCT00229658|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110714157|NCT00229658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110714158|NCT00182078|Sertraline|sertraline|mesh-list
110714159|NCT00182078|Antidepressive Agents|antidepressive agents|mesh-ancestor
110714160|NCT00182078|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110714161|NCT00182078|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110714162|NCT00182078|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110714163|NCT00182078|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110714164|NCT00182078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110714165|NCT00182078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110714166|NCT00182078|Serotonin Agents|serotonin agents|mesh-ancestor
110714167|NCT00182078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110714168|NCT00181844|Lamotrigine|lamotrigine|mesh-list
110714169|NCT00181844|Anticonvulsants|anticonvulsants|mesh-ancestor
110714170|NCT00181844|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110714171|NCT00181844|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110714172|NCT00181844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110714173|NCT00181844|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110714174|NCT00181844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110714176|NCT00181844|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110714177|NCT00181844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110714178|NCT00181844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110714179|NCT00181844|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110714180|NCT00181766|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
110714181|NCT00181766|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110714182|NCT00181766|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110714183|NCT00181766|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110714184|NCT00181766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110714185|NCT00181766|Adrenergic Agents|adrenergic agents|mesh-ancestor
110714186|NCT00181766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110714187|NCT00181766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110714188|NCT00180674|Warfarin|warfarin|mesh-list
110714189|NCT00180674|Anticoagulants|anticoagulants|mesh-ancestor
110714190|NCT01074632|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
110714191|NCT01074632|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110714192|NCT01074632|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110714193|NCT01074632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110714194|NCT01074632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110714195|NCT01074632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110714196|NCT01074632|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
110714197|NCT01074632|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110714198|NCT01074632|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110714199|NCT01074632|Adrenergic Agents|adrenergic agents|mesh-ancestor
110714200|NCT01074632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110714201|NCT01074632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110714202|NCT01074632|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110714203|NCT01074632|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110714204|NCT01074632|Serotonin Agents|serotonin agents|mesh-ancestor
110714205|NCT01074632|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110714206|NCT01074632|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110714207|NCT01074632|Dopamine Agents|dopamine agents|mesh-ancestor
110714209|NCT00076024|Axitinib|axitinib|mesh-list
110714210|NCT00076024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110714211|NCT00076024|Tubulin Modulators|tubulin modulators|mesh-ancestor
110714212|NCT00076024|Antimitotic Agents|antimitotic agents|mesh-ancestor
110714213|NCT00076024|Mitosis Modulators|mitosis modulators|mesh-ancestor
110714214|NCT00076024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110714215|NCT00076024|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110714216|NCT00076024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110714217|NCT01103050|Cetirizine|cetirizine|mesh-list
110714218|NCT01103050|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110714219|NCT01103050|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110714220|NCT01103050|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110714221|NCT01103050|Histamine Antagonists|histamine antagonists|mesh-ancestor
110714222|NCT01103050|Histamine Agents|histamine agents|mesh-ancestor
110714223|NCT01103050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110714224|NCT01103050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110714225|NCT01103050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110714226|NCT00075478|Cyclosporine|cyclosporine|mesh-list
110714227|NCT00075478|Mycophenolic Acid|mycophenolic acid|mesh-list
110714228|NCT00075478|Fludarabine|fludarabine|mesh-list
110714229|NCT00075478|Fludarabine phosphate|fludarabine phosphate|mesh-list
110714230|NCT00075478|Cyclosporins|cyclosporins|mesh-list
110714231|NCT00075478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110714232|NCT00075478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110714233|NCT00075478|Antimetabolites|antimetabolites|mesh-ancestor
110714234|NCT00075478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110714235|NCT00075478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110714236|NCT00075478|Immunologic Factors|immunologic factors|mesh-ancestor
110714237|NCT00075478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110714238|NCT00075478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110714239|NCT00075478|Antifungal Agents|antifungal agents|mesh-ancestor
110714240|NCT00075478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110714241|NCT00075478|Dermatologic Agents|dermatologic agents|mesh-ancestor
110714242|NCT00075478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110714243|NCT00075478|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110714244|NCT00075478|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110714245|NCT00075478|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110714246|NCT00075478|Antitubercular Agents|antitubercular agents|mesh-ancestor
110714247|NCT00075478|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110714248|NCT00175916|Brivaracetam|brivaracetam|mesh-list
110714249|NCT00175916|Anticonvulsants|anticonvulsants|mesh-ancestor
110714250|NCT01089088|Gemcitabine|gemcitabine|mesh-list
110714251|NCT01089088|Sunitinib|sunitinib|mesh-list
110714252|NCT01089088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110714253|NCT01089088|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110714254|NCT01089088|Antimetabolites|antimetabolites|mesh-ancestor
110714255|NCT01089088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110714256|NCT01089088|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110714257|NCT01089088|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110714258|NCT01089088|Growth Substances|growth substances|mesh-ancestor
110714259|NCT01089088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110714260|NCT01089088|Growth Inhibitors|growth inhibitors|mesh-ancestor
110714261|NCT01089088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110714262|NCT01089088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110714263|NCT00075400|Imatinib Mesylate|imatinib mesylate|mesh-list
110714264|NCT00075400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110714265|NCT00075400|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110714266|NCT00075400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110714267|NCT00075400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110714268|NCT01103206|Cinacalcet|cinacalcet|mesh-list
110714269|NCT01103206|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110714270|NCT01103206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110714271|NCT01103206|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
110714272|NCT01103206|Hormone Antagonists|hormone antagonists|mesh-ancestor
110714273|NCT01103206|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110714274|NCT00228566|Modafinil|modafinil|mesh-list
110714275|NCT00228566|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110714276|NCT00228566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110714277|NCT00228566|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
110714278|NCT00228566|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110714279|NCT00228566|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110714280|NCT00228566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110714281|NCT05625724|Aspirin|aspirin|mesh-list
110714282|NCT05625724|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110714283|NCT05625724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110714284|NCT05625724|Analgesics|analgesics|mesh-ancestor
110714285|NCT05625724|Sensory System Agents|sensory system agents|mesh-ancestor
110714286|NCT05625724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110714287|NCT05625724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110714288|NCT05625724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110714289|NCT05625724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110714290|NCT05625724|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110714291|NCT05625724|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110714292|NCT05625724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110714293|NCT05625724|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110714294|NCT05625724|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110714295|NCT05625724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110714296|NCT05625724|Antipyretics|antipyretics|mesh-ancestor
110714297|NCT01089166|Metformin|metformin|mesh-list
110714298|NCT01089166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110714299|NCT01089166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110714300|NCT00203502|Cyclophosphamide|cyclophosphamide|mesh-list
110714301|NCT00203502|Bevacizumab|bevacizumab|mesh-list
110714302|NCT00203502|Docetaxel|docetaxel|mesh-list
110714303|NCT00203502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110714304|NCT00203502|Immunologic Factors|immunologic factors|mesh-ancestor
110714305|NCT00203502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110714306|NCT00203502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110714307|NCT00203502|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110714308|NCT00203502|Alkylating Agents|alkylating agents|mesh-ancestor
110714309|NCT00203502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110714310|NCT00203502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110714311|NCT00203502|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110714312|NCT00203502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110714313|NCT00203502|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110714314|NCT00203502|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110714315|NCT00203502|Growth Substances|growth substances|mesh-ancestor
110714316|NCT00203502|Growth Inhibitors|growth inhibitors|mesh-ancestor
110714317|NCT00203502|Tubulin Modulators|tubulin modulators|mesh-ancestor
110714318|NCT00203502|Antimitotic Agents|antimitotic agents|mesh-ancestor
110714319|NCT00203502|Mitosis Modulators|mitosis modulators|mesh-ancestor
110714320|NCT01103518|Cyproterone Acetate|cyproterone acetate|mesh-list
110714322|NCT01103518|Estradiol|estradiol|mesh-list
110714323|NCT01103518|Cyproterone|cyproterone|mesh-list
110714324|NCT01103518|Estrogens|estrogens|mesh-ancestor
110714325|NCT01103518|Hormones|hormones|mesh-ancestor
110714326|NCT01103518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110714327|NCT01103518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110714328|NCT01103518|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110714329|NCT01103518|Contraceptive Agents|contraceptive agents|mesh-ancestor
110714330|NCT01103518|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110714331|NCT01103518|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110714332|NCT01103518|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110714333|NCT01103518|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110714334|NCT01103518|Androgen Antagonists|androgen antagonists|mesh-ancestor
110714335|NCT01103518|Hormone Antagonists|hormone antagonists|mesh-ancestor
110714336|NCT01103518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110714337|NCT01103518|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110714338|NCT01327534|Clopidogrel|clopidogrel|mesh-list
110714339|NCT01327534|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
110714340|NCT01327534|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110714341|NCT01327534|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110714342|NCT01327534|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110714343|NCT01327534|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110714344|NCT01327534|Purinergic Agents|purinergic agents|mesh-ancestor
110714345|NCT01327534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110714346|NCT01327534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110714347|NCT01327534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110714348|NCT00232596|Ezogabine|ezogabine|mesh-list
110714349|NCT00232596|Anticonvulsants|anticonvulsants|mesh-ancestor
110714350|NCT00232596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110714351|NCT00232596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110714353|NCT00073918|Cadexomer iodine|cadexomer iodine|mesh-list
110714354|NCT00073918|Cyclophosphamide|cyclophosphamide|mesh-list
110714355|NCT00073918|Etoposide|etoposide|mesh-list
110714356|NCT00073918|Etoposide phosphate|etoposide phosphate|mesh-list
110714357|NCT00073918|Tositumomab I-131|tositumomab i-131|mesh-list
110714358|NCT00073918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110714359|NCT00073918|Antibodies|antibodies|mesh-list
110714360|NCT00073918|Immunoglobulins|immunoglobulins|mesh-list
110714361|NCT00073918|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110714362|NCT00073918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110714363|NCT00073918|Immunologic Factors|immunologic factors|mesh-ancestor
110714364|NCT00073918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110714365|NCT00073918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110714366|NCT00073918|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110714367|NCT00073918|Alkylating Agents|alkylating agents|mesh-ancestor
110714368|NCT00073918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110714369|NCT00073918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110714370|NCT00073918|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110714371|NCT00073918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110714372|NCT00073918|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110714373|NCT00073918|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110714374|NCT00073918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110714375|NCT00073918|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110714376|NCT00073918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110714377|NCT00073918|Trace Elements|trace elements|mesh-ancestor
110714378|NCT00073918|Micronutrients|micronutrients|mesh-ancestor
110714379|NCT00231894|Pioglitazone|pioglitazone|mesh-list
110714380|NCT00231894|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110714381|NCT00231894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110714382|NCT00203424|Bevacizumab|bevacizumab|mesh-list
110714383|NCT00203424|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110714384|NCT00203424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110714385|NCT00203424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110714386|NCT00203424|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110714387|NCT00203424|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110714388|NCT00203424|Growth Substances|growth substances|mesh-ancestor
110714389|NCT00203424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110714390|NCT00203424|Growth Inhibitors|growth inhibitors|mesh-ancestor
110714391|NCT00203424|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110714392|NCT00203424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110714393|NCT00203424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110714394|NCT00203268|Dihydroergotamine|dihydroergotamine|mesh-list
110714395|NCT00203268|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110714396|NCT00203268|Dopamine Agonists|dopamine agonists|mesh-ancestor
110714397|NCT00203268|Dopamine Agents|dopamine agents|mesh-ancestor
110714398|NCT00203268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110714399|NCT00203268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110714400|NCT00203268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110714401|NCT00203268|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110714402|NCT00203268|Analgesics|analgesics|mesh-ancestor
110714403|NCT00203268|Sensory System Agents|sensory system agents|mesh-ancestor
110714404|NCT00203268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110714405|NCT00168818|Enoxaparin|enoxaparin|mesh-list
110714406|NCT00168818|Dabigatran|dabigatran|mesh-list
110714407|NCT00168818|Anticoagulants|anticoagulants|mesh-ancestor
110714408|NCT00168818|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110714409|NCT00168818|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110714410|NCT00168818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110714411|NCT00168818|Antithrombins|antithrombins|mesh-ancestor
110714412|NCT00168818|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110714413|NCT00168818|Protease Inhibitors|protease inhibitors|mesh-ancestor
110714414|NCT00168818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110714415|NCT00260832|Cytarabine|cytarabine|mesh-list
110714416|NCT00260832|Decitabine|decitabine|mesh-list
110714417|NCT00260832|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110714418|NCT00260832|Antimetabolites|antimetabolites|mesh-ancestor
110714419|NCT00260832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110714420|NCT00260832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110714421|NCT00260832|Antiviral Agents|antiviral agents|mesh-ancestor
110714422|NCT00260832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110714423|NCT00260832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110714424|NCT00260832|Immunologic Factors|immunologic factors|mesh-ancestor
110714425|NCT00260832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110714426|NCT00260832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110714427|NCT00168038|Immunoglobulins|immunoglobulins|mesh-list
110714428|NCT00168038|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110714429|NCT00168038|Antibodies|antibodies|mesh-list
110714430|NCT00168038|Immunologic Factors|immunologic factors|mesh-ancestor
110714431|NCT00168038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110714432|NCT00166712|Mycophenolic Acid|mycophenolic acid|mesh-list
110714433|NCT00166712|Sirolimus|sirolimus|mesh-list
110714434|NCT00166712|Alemtuzumab|alemtuzumab|mesh-list
110714435|NCT00166712|Tacrolimus|tacrolimus|mesh-list
110714436|NCT00166712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110714437|NCT00166712|Immunologic Factors|immunologic factors|mesh-ancestor
110714438|NCT00166712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110714439|NCT00166712|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110714440|NCT00166712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110714441|NCT00166712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110714442|NCT00166712|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110714443|NCT00166712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110714444|NCT00166712|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110714445|NCT00166712|Antitubercular Agents|antitubercular agents|mesh-ancestor
110714446|NCT00166712|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110714447|NCT00166712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110714448|NCT00166712|Antifungal Agents|antifungal agents|mesh-ancestor
110714449|NCT00166712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110714450|NCT00073528|Letrozole|letrozole|mesh-list
110714451|NCT00073528|Lapatinib|lapatinib|mesh-list
110714452|NCT00073528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110714453|NCT00073528|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110714454|NCT00073528|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110714455|NCT00073528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110714456|NCT00073528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110714457|NCT00073528|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110714458|NCT00073528|Hormone Antagonists|hormone antagonists|mesh-ancestor
110714459|NCT00073528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110714460|NCT00073528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110714461|NCT00073528|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110714462|NCT03801148|Dexlansoprazole|dexlansoprazole|mesh-list
110714463|NCT03801148|Lansoprazole|lansoprazole|mesh-list
110714464|NCT03801148|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110714465|NCT03801148|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110714466|NCT03801148|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110714467|NCT03801148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110714468|NCT03801148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110714469|NCT03960814|Insulin Detemir|insulin detemir|mesh-list
110714470|NCT03960814|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110714471|NCT03960814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110714472|NCT01103830|Moxifloxacin|moxifloxacin|mesh-list
110714473|NCT01103830|Lumefantrine|lumefantrine|mesh-list
110714474|NCT01103830|Artemether|artemether|mesh-list
110714475|NCT01103830|Piperaquine|piperaquine|mesh-list
110714476|NCT01103830|Artenimol|artenimol|mesh-list
110714477|NCT01103830|Artemisinins|artemisinins|mesh-list
110714478|NCT01103830|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
110714479|NCT01103830|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
110714480|NCT01103830|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110714481|NCT01103830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110714482|NCT01103830|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110714483|NCT01103830|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110714484|NCT01103830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110714485|NCT01103830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110714486|NCT01103830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110714487|NCT01103830|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110714488|NCT01103830|Contraceptive Agents|contraceptive agents|mesh-ancestor
110714489|NCT01103830|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110714490|NCT01103830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110714491|NCT01103830|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110714492|NCT01103830|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110714493|NCT01103830|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110714494|NCT01103830|Antimalarials|antimalarials|mesh-ancestor
110714495|NCT01103830|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110714496|NCT01103830|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110714497|NCT00072280|Dactinomycin|dactinomycin|mesh-list
110714498|NCT00072280|Cyclophosphamide|cyclophosphamide|mesh-list
110714499|NCT00072280|Ifosfamide|ifosfamide|mesh-list
110714500|NCT00072280|Isophosphamide mustard|isophosphamide mustard|mesh-list
110714501|NCT00072280|Etoposide|etoposide|mesh-list
110714502|NCT00072280|Vincristine|vincristine|mesh-list
110714503|NCT00072280|Lenograstim|lenograstim|mesh-list
110714505|NCT00072280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110714506|NCT00072280|Immunologic Factors|immunologic factors|mesh-ancestor
110714507|NCT00072280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110714508|NCT00072280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110714509|NCT00072280|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110714510|NCT00072280|Alkylating Agents|alkylating agents|mesh-ancestor
110714511|NCT00072280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110714512|NCT00072280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110714513|NCT00072280|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110714514|NCT00072280|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110714515|NCT00072280|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110714516|NCT00072280|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110714517|NCT00072280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110714518|NCT00072280|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110714519|NCT00072280|Tubulin Modulators|tubulin modulators|mesh-ancestor
110714520|NCT00072280|Antimitotic Agents|antimitotic agents|mesh-ancestor
110714521|NCT00072280|Mitosis Modulators|mitosis modulators|mesh-ancestor
110714522|NCT00072280|Protective Agents|protective agents|mesh-ancestor
110714523|NCT00072280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110714524|NCT00072280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110714525|NCT00072280|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110714526|NCT00072280|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110432372|NCT02864199|Antiviral Agents|antiviral agents|mesh-ancestor
110714527|NCT00072280|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110714528|NCT01106716|Lidocaine|lidocaine|mesh-list
110714529|NCT01106716|Anesthetics, Local|anesthetics, local|mesh-ancestor
110714530|NCT01106716|Anesthetics|anesthetics|mesh-ancestor
110714531|NCT01106716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110714532|NCT01106716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110714533|NCT01106716|Sensory System Agents|sensory system agents|mesh-ancestor
110714534|NCT01106716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110714535|NCT01106716|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110714536|NCT01106716|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110714537|NCT01106716|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110714538|NCT01106716|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110714539|NCT01106716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110714540|NCT00071812|Belimumab|belimumab|mesh-list
110714541|NCT00071812|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110714542|NCT00071812|Immunologic Factors|immunologic factors|mesh-ancestor
110714543|NCT00071812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110714544|NCT01104298|Doxorubicin|doxorubicin|mesh-list
110714545|NCT01104298|Trabectedin|trabectedin|mesh-list
110714546|NCT01104298|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110714547|NCT01104298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110714548|NCT01104298|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110714549|NCT01104298|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110714550|NCT01104298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110714551|NCT01104298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110714552|NCT01104298|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110714553|NCT01104298|Alkylating Agents|alkylating agents|mesh-ancestor
110714554|NCT01106872|Bevacizumab|bevacizumab|mesh-list
110714555|NCT01106872|Gemcitabine|gemcitabine|mesh-list
110714556|NCT01106872|Docetaxel|docetaxel|mesh-list
110714557|NCT01106872|Valproic Acid|valproic acid|mesh-list
110714558|NCT01106872|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110714559|NCT01106872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110714560|NCT01106872|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110714561|NCT01106872|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110714562|NCT01106872|Growth Substances|growth substances|mesh-ancestor
110714563|NCT01106872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110714564|NCT01106872|Growth Inhibitors|growth inhibitors|mesh-ancestor
110714565|NCT01106872|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110714566|NCT01106872|Antimetabolites|antimetabolites|mesh-ancestor
110714567|NCT01106872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110714568|NCT01106872|Tubulin Modulators|tubulin modulators|mesh-ancestor
110714569|NCT01106872|Antimitotic Agents|antimitotic agents|mesh-ancestor
110714570|NCT01106872|Mitosis Modulators|mitosis modulators|mesh-ancestor
110714571|NCT01106872|Anticonvulsants|anticonvulsants|mesh-ancestor
110714572|NCT01106872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110714573|NCT01106872|GABA Agents|gaba agents|mesh-ancestor
110714574|NCT01106872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110714575|NCT01106872|Antimanic Agents|antimanic agents|mesh-ancestor
110714576|NCT01106872|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110714577|NCT01106872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110714579|NCT03960268|Brodalumab|brodalumab|mesh-list
110714580|NCT03960268|Dermatologic Agents|dermatologic agents|mesh-ancestor
110714581|NCT05485480|Analgesics, Opioid|analgesics, opioid|mesh-list
110714582|NCT05485480|Narcotics|narcotics|mesh-ancestor
110714583|NCT05485480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110714584|NCT05485480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110714585|NCT05485480|Analgesics|analgesics|mesh-ancestor
110714586|NCT05485480|Sensory System Agents|sensory system agents|mesh-ancestor
110714587|NCT05485480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110714588|NCT05470270|Hydroxyurea|hydroxyurea|mesh-list
110714589|NCT05470270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110714590|NCT05470270|Antisickling Agents|antisickling agents|mesh-ancestor
110714591|NCT05470270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110714592|NCT05470270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110714593|NCT05470270|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110136992|NCT05967884|Cemiplimab|cemiplimab|mesh-list
110714594|NCT01107106|Ulipristal acetate|ulipristal acetate|mesh-list
110714595|NCT01107106|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110714596|NCT01107106|Contraceptive Agents|contraceptive agents|mesh-ancestor
110714597|NCT01107106|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110714598|NCT01107106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110714599|NCT01107106|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110714600|NCT00259610|Hydroxychloroquine|hydroxychloroquine|mesh-list
110714601|NCT00259610|Sulfasalazine|sulfasalazine|mesh-list
110714602|NCT00259610|Etanercept|etanercept|mesh-list
110714603|NCT00259610|Methotrexate|methotrexate|mesh-list
110714604|NCT00259610|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110714605|NCT00259610|Abortifacient Agents|abortifacient agents|mesh-ancestor
110714606|NCT00259610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110714607|NCT00259610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110714608|NCT00259610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110714609|NCT00259610|Antimetabolites|antimetabolites|mesh-ancestor
110714610|NCT00259610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110714611|NCT00259610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110714612|NCT00259610|Dermatologic Agents|dermatologic agents|mesh-ancestor
110714613|NCT00259610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110714614|NCT00259610|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110714615|NCT00259610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110714616|NCT00259610|Immunologic Factors|immunologic factors|mesh-ancestor
110714617|NCT00259610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110714618|NCT00259610|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110714619|NCT00259610|Antimalarials|antimalarials|mesh-ancestor
110714620|NCT00259610|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110714621|NCT00259610|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110714622|NCT00259610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110714623|NCT00259610|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110714624|NCT00259610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110714625|NCT00259610|Analgesics|analgesics|mesh-ancestor
110714626|NCT00259610|Sensory System Agents|sensory system agents|mesh-ancestor
110714627|NCT00259610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110714628|NCT00259610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110714629|NCT00259610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110714630|NCT00165776|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
110714631|NCT00165776|Botulinum Toxins|botulinum toxins|mesh-list
110714632|NCT00165776|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110714633|NCT00165776|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110714634|NCT00165776|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110714635|NCT00165776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110714636|NCT00165776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110714637|NCT00165776|Cholinergic Agents|cholinergic agents|mesh-ancestor
110714638|NCT00165776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110714639|NCT00165776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110714640|NCT00165776|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110714641|NCT00165776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110714642|NCT00165776|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110714643|NCT04459468|Ethiodized Oil|ethiodized oil|mesh-list
110714644|NCT04459468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110714645|NCT00165698|Alfacalcidol|alfacalcidol|mesh-list
110714646|NCT00165698|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
110714647|NCT00165698|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110714648|NCT00165698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110714649|NCT00165698|Vitamins|vitamins|mesh-ancestor
110714650|NCT00165698|Micronutrients|micronutrients|mesh-ancestor
110714651|NCT01075022|Vitamin D|vitamin d|mesh-list
110714652|NCT01075022|Cholecalciferol|cholecalciferol|mesh-list
110714653|NCT01075022|Vitamins|vitamins|mesh-ancestor
110714654|NCT01075022|Micronutrients|micronutrients|mesh-ancestor
110714655|NCT01075022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110714656|NCT01075022|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110714657|NCT01075022|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110714658|NCT00225758|Lapatinib|lapatinib|mesh-list
110714659|NCT00225758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110136998|NCT05967442|Magnesium Sulfate|magnesium sulfate|mesh-list
110714660|NCT00225758|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110714661|NCT00225758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110714662|NCT00225758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110714663|NCT01104532|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110714664|NCT01104532|Ipragliflozin|ipragliflozin|mesh-list
110714665|NCT01104532|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110714666|NCT01104532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110714667|NCT01104532|Incretins|incretins|mesh-ancestor
110714668|NCT01104532|Hormones|hormones|mesh-ancestor
110714669|NCT01104532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110714670|NCT01104532|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110714671|NCT01104532|Protease Inhibitors|protease inhibitors|mesh-ancestor
110714672|NCT01104532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110714673|NCT01104532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110714674|NCT01104532|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110714675|NCT01107574|Gabapentin|gabapentin|mesh-list
110714676|NCT01107574|Analgesics|analgesics|mesh-ancestor
110714677|NCT01107574|Sensory System Agents|sensory system agents|mesh-ancestor
110714678|NCT01107574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110714679|NCT01107574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110714680|NCT01107574|Anticonvulsants|anticonvulsants|mesh-ancestor
110714681|NCT01107574|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110714682|NCT01107574|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110714683|NCT01107574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110714684|NCT01107574|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110714685|NCT01107574|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110714686|NCT01107574|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110714687|NCT01107574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110714688|NCT01107574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110714689|NCT01107574|Antimanic Agents|antimanic agents|mesh-ancestor
110714690|NCT03971500|Ticagrelor|ticagrelor|mesh-list
110714691|NCT03971500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110714692|NCT03971500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110714693|NCT03971500|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110714694|NCT03971500|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110714695|NCT03971500|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110714696|NCT03971500|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110714697|NCT03971500|Purinergic Agents|purinergic agents|mesh-ancestor
110714698|NCT03971500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110714699|NCT00259298|Teriparatide|teriparatide|mesh-list
110714700|NCT00259298|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110714701|NCT00259298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110714702|NCT00259298|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110714703|NCT01108744|Mannitol|mannitol|mesh-list
110714704|NCT01108744|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110714705|NCT01108744|Diuretics|diuretics|mesh-ancestor
110714706|NCT01108744|Natriuretic Agents|natriuretic agents|mesh-ancestor
110714707|NCT01108744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110714708|NCT01581866|Ziprasidone|ziprasidone|mesh-list
110714709|NCT01581866|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110714710|NCT01581866|Serotonin Agents|serotonin agents|mesh-ancestor
110714711|NCT01581866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110714712|NCT01581866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110714713|NCT01581866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110714714|NCT01581866|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110714715|NCT01581866|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110714716|NCT01581866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110714717|NCT01581866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110714718|NCT01581866|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110137015|NCT05967442|Antiemetics|antiemetics|mesh-ancestor
110714719|NCT01581866|Dopamine Agents|dopamine agents|mesh-ancestor
110714720|NCT03892642|Avelumab|avelumab|mesh-list
110714721|NCT03892642|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110714722|NCT03892642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110714723|NCT01107808|Calcium, Dietary|calcium, dietary|mesh-list
110714724|NCT01107808|Vitamin D|vitamin d|mesh-list
110714725|NCT01107808|Ergocalciferols|ergocalciferols|mesh-list
110714727|NCT01107808|Calcium|calcium|mesh-list
110714728|NCT01107808|Vitamins|vitamins|mesh-ancestor
110714729|NCT01107808|Micronutrients|micronutrients|mesh-ancestor
110714730|NCT01107808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110714731|NCT01107808|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110714732|NCT01107808|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110714733|NCT01107808|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110714734|NCT01104844|Acetaminophen|acetaminophen|mesh-list
110714735|NCT01104844|Ibuprofen|ibuprofen|mesh-list
110714736|NCT01104844|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110714737|NCT01104844|Analgesics|analgesics|mesh-ancestor
110714738|NCT01104844|Sensory System Agents|sensory system agents|mesh-ancestor
110714739|NCT01104844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110714740|NCT01104844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110714741|NCT01104844|Antipyretics|antipyretics|mesh-ancestor
110714742|NCT01104844|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110714743|NCT01104844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110714744|NCT01104844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110714745|NCT01104844|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110714746|NCT01104844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110714747|NCT01104844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110714748|NCT03750136|Furosemide|furosemide|mesh-list
110714749|NCT03750136|Diuretics|diuretics|mesh-ancestor
110714750|NCT03750136|Natriuretic Agents|natriuretic agents|mesh-ancestor
110714751|NCT03750136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110714752|NCT03750136|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110714753|NCT03750136|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110714754|NCT03750136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110714756|NCT01108042|Fluorouracil|fluorouracil|mesh-list
110714757|NCT01108042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110714758|NCT01108042|Tubulin Modulators|tubulin modulators|mesh-ancestor
110714759|NCT01108042|Antimitotic Agents|antimitotic agents|mesh-ancestor
110714760|NCT01108042|Mitosis Modulators|mitosis modulators|mesh-ancestor
110714761|NCT01108042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110714762|NCT01108042|Antimetabolites|antimetabolites|mesh-ancestor
110714763|NCT01108042|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110714764|NCT01108042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110714765|NCT01108042|Immunologic Factors|immunologic factors|mesh-ancestor
110714766|NCT01108042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110714767|NCT01105234|Vitamin D|vitamin d|mesh-list
110714768|NCT01105234|Calcipotriene|calcipotriene|mesh-list
110714769|NCT01105234|Vitamins|vitamins|mesh-ancestor
110714770|NCT01105234|Micronutrients|micronutrients|mesh-ancestor
110714771|NCT01105234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110714772|NCT01105234|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110714773|NCT01105234|Dermatologic Agents|dermatologic agents|mesh-ancestor
110714774|NCT01108198|Mometasone Furoate|mometasone furoate|mesh-list
110714775|NCT01108198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110714776|NCT01108198|Dermatologic Agents|dermatologic agents|mesh-ancestor
110714777|NCT01108198|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110714778|NCT01108900|Sildenafil Citrate|sildenafil citrate|mesh-list
110714779|NCT01108900|Vasodilator Agents|vasodilator agents|mesh-ancestor
110714780|NCT01108900|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110714781|NCT01108900|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110714782|NCT01108900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110714783|NCT01108900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110714784|NCT01108900|Urological Agents|urological agents|mesh-ancestor
110714785|NCT01105390|Pemetrexed|pemetrexed|mesh-list
110714786|NCT01105390|Rilotumumab|rilotumumab|mesh-list
110714787|NCT01105390|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110714788|NCT01105390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110714789|NCT01105390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110714790|NCT01105390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110714791|NCT01105390|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110714792|NCT01105390|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110714793|NCT01105390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110714794|NCT01105390|Immunologic Factors|immunologic factors|mesh-ancestor
110714795|NCT01105390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110714796|NCT03947242|Trastuzumab|trastuzumab|mesh-list
110714797|NCT03947242|Vinorelbine|vinorelbine|mesh-list
110714798|NCT03947242|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110714799|NCT03947242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110344624|NCT05731895|BI 425809|bi 425809|mesh-list
110714800|NCT03947242|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110714801|NCT03947242|Tubulin Modulators|tubulin modulators|mesh-ancestor
110714802|NCT03947242|Antimitotic Agents|antimitotic agents|mesh-ancestor
110714803|NCT03947242|Mitosis Modulators|mitosis modulators|mesh-ancestor
110714804|NCT03947242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110714805|NCT03944980|Docetaxel|docetaxel|mesh-list
110714806|NCT03944980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110714807|NCT03944980|Tubulin Modulators|tubulin modulators|mesh-ancestor
110714808|NCT03944980|Antimitotic Agents|antimitotic agents|mesh-ancestor
110714809|NCT03944980|Mitosis Modulators|mitosis modulators|mesh-ancestor
110714810|NCT03944980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110714811|NCT03576664|Carvedilol|carvedilol|mesh-list
110714812|NCT03576664|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110714813|NCT03576664|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110714814|NCT03576664|Adrenergic Agents|adrenergic agents|mesh-ancestor
110714815|NCT03576664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110714816|NCT03576664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110714817|NCT03576664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110714818|NCT03576664|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110714819|NCT03576664|Antioxidants|antioxidants|mesh-ancestor
110714820|NCT03576664|Protective Agents|protective agents|mesh-ancestor
110714821|NCT03576664|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110714822|NCT03576664|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110714823|NCT03576664|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110714824|NCT03576664|Vasodilator Agents|vasodilator agents|mesh-ancestor
110714825|NCT03576664|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110714826|NCT03576664|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110714827|NCT01109134|Tirofiban|tirofiban|mesh-list
110714828|NCT01109134|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110714829|NCT01109134|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110714830|NCT01109134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110714831|NCT01109134|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110714833|NCT01108588|Clopidogrel|clopidogrel|mesh-list
110714834|NCT01108588|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110714835|NCT01108588|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110714836|NCT01108588|Analgesics|analgesics|mesh-ancestor
110714837|NCT01108588|Sensory System Agents|sensory system agents|mesh-ancestor
110714838|NCT01108588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110714839|NCT01108588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110714840|NCT01108588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110714841|NCT01108588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110714842|NCT01108588|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110714843|NCT01108588|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110714844|NCT01108588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110714845|NCT01108588|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110714846|NCT01108588|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110714847|NCT01108588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110714848|NCT01108588|Antipyretics|antipyretics|mesh-ancestor
110714849|NCT01108588|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110714850|NCT01108588|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110714851|NCT01108588|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110714852|NCT01108588|Purinergic Agents|purinergic agents|mesh-ancestor
110714853|NCT01108588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110714854|NCT01208740|Metformin|metformin|mesh-list
110714855|NCT01208740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110714856|NCT01208740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110714857|NCT01208818|Dexamethasone|dexamethasone|mesh-list
110714858|NCT01208818|Dexamethasone acetate|dexamethasone acetate|mesh-list
110714859|NCT01208818|Cyclophosphamide|cyclophosphamide|mesh-list
110714860|NCT01208818|Bortezomib|bortezomib|mesh-list
110714861|NCT01208818|BB 1101|bb 1101|mesh-list
110714862|NCT01208818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110714863|NCT01208818|Immunologic Factors|immunologic factors|mesh-ancestor
110714864|NCT01208818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110714865|NCT01208818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110714866|NCT01208818|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110714867|NCT01208818|Alkylating Agents|alkylating agents|mesh-ancestor
110714868|NCT01208818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110714869|NCT01208818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110137052|NCT05967377|Abortifacient Agents|abortifacient agents|mesh-ancestor
110714870|NCT01208818|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110714871|NCT01208818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110714872|NCT01208818|Antiemetics|antiemetics|mesh-ancestor
110714873|NCT01208818|Autonomic Agents|autonomic agents|mesh-ancestor
110714874|NCT01208818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110714875|NCT01208818|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110714876|NCT01208818|Glucocorticoids|glucocorticoids|mesh-ancestor
110714877|NCT01208818|Hormones|hormones|mesh-ancestor
110714878|NCT01208818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110714879|NCT01208818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110714880|NCT01208818|Protease Inhibitors|protease inhibitors|mesh-ancestor
110714881|NCT01208818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110714882|NCT01111630|Epoetin Alfa|epoetin alfa|mesh-list
110714883|NCT01111630|Hematinics|hematinics|mesh-ancestor
110714884|NCT03942796|Pregabalin|pregabalin|mesh-list
110714885|NCT03942796|Analgesics|analgesics|mesh-ancestor
110861789|NCT03156621|Alirocumab|alirocumab|mesh-list
110714886|NCT03942796|Sensory System Agents|sensory system agents|mesh-ancestor
110714887|NCT03942796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110714888|NCT03942796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110714889|NCT03942796|Anticonvulsants|anticonvulsants|mesh-ancestor
110714890|NCT03942796|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110714891|NCT03942796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110714892|NCT03942796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110714893|NCT03942796|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110714894|NCT03942796|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110714895|NCT03942796|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110714896|NCT03942796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110714897|NCT03942796|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110714898|NCT01114282|Bortezomib|bortezomib|mesh-list
110714899|NCT01114282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110714900|NCT01109212|Bindarit|bindarit|mesh-list
110714901|NCT01109212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110714902|NCT01109212|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110714903|NCT01109212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110714904|NCT01109212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110714905|NCT01111864|Micronutrients|micronutrients|mesh-list
110714906|NCT01111864|Trace Elements|trace elements|mesh-list
110714907|NCT01111864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110714908|NCT01111942|Cisplatin|cisplatin|mesh-list
110714909|NCT01111942|Carboplatin|carboplatin|mesh-list
110714910|NCT01111942|Docetaxel|docetaxel|mesh-list
110714911|NCT01111942|Fluorouracil|fluorouracil|mesh-list
110714912|NCT01111942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110714913|NCT01111942|Tubulin Modulators|tubulin modulators|mesh-ancestor
110714914|NCT01111942|Antimitotic Agents|antimitotic agents|mesh-ancestor
110714915|NCT01111942|Mitosis Modulators|mitosis modulators|mesh-ancestor
110714916|NCT01111942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110714917|NCT01111942|Antimetabolites|antimetabolites|mesh-ancestor
110714918|NCT01111942|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110714919|NCT01111942|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110714920|NCT01111942|Immunologic Factors|immunologic factors|mesh-ancestor
110714921|NCT01111942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110714922|NCT01211860|Diazoxide|diazoxide|mesh-list
110714923|NCT01211860|Choline|choline|mesh-list
110714924|NCT01211860|Lipotropic Agents|lipotropic agents|mesh-ancestor
110714925|NCT01211860|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110714926|NCT01211860|Antimetabolites|antimetabolites|mesh-ancestor
110714927|NCT01211860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110714928|NCT01211860|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110714929|NCT01211860|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110714930|NCT01211860|Nootropic Agents|nootropic agents|mesh-ancestor
110714931|NCT01211860|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110714932|NCT01211860|Vasodilator Agents|vasodilator agents|mesh-ancestor
110714933|NCT01211938|Cetuximab|cetuximab|mesh-list
110714934|NCT01211938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110714935|NCT01211938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110714936|NCT02947438|Epoetin Alfa|epoetin alfa|mesh-list
110714937|NCT02947438|Hematinics|hematinics|mesh-ancestor
110714938|NCT01209130|Rituximab|rituximab|mesh-list
110714939|NCT01209130|Pinatuzumab vedotin|pinatuzumab vedotin|mesh-list
110714940|NCT01209130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110714941|NCT01209130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110714942|NCT01209130|Immunologic Factors|immunologic factors|mesh-ancestor
110714943|NCT01209130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110714944|NCT01209130|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110714945|NCT01209130|Immunoconjugates|immunoconjugates|mesh-ancestor
110714946|NCT01209208|Budesonide|budesonide|mesh-list
110714947|NCT01209208|Mesalamine|mesalamine|mesh-list
110714948|NCT01209208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110714949|NCT01209208|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110714950|NCT01209208|Autonomic Agents|autonomic agents|mesh-ancestor
110714951|NCT01209208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110714952|NCT01209208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110714953|NCT01209208|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110714954|NCT01209208|Respiratory System Agents|respiratory system agents|mesh-ancestor
110714955|NCT01209208|Glucocorticoids|glucocorticoids|mesh-ancestor
110714956|NCT01209208|Hormones|hormones|mesh-ancestor
110861793|NCT03156621|Antimetabolites|antimetabolites|mesh-ancestor
110714957|NCT01209208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110714958|NCT01209208|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110714959|NCT01209208|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110714960|NCT01209208|Analgesics|analgesics|mesh-ancestor
110714961|NCT01209208|Sensory System Agents|sensory system agents|mesh-ancestor
110714962|NCT01209208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110714963|NCT01114750|Dextrans|dextrans|mesh-list
110714964|NCT01114750|Anticoagulants|anticoagulants|mesh-ancestor
110714965|NCT01114750|Plasma Substitutes|plasma substitutes|mesh-ancestor
110714966|NCT01114750|Blood Substitutes|blood substitutes|mesh-ancestor
110714967|NCT01328470|Cilostazol|cilostazol|mesh-list
110714968|NCT01328470|Clopidogrel|clopidogrel|mesh-list
110714969|NCT01328470|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110714970|NCT01328470|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110714971|NCT01328470|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110714972|NCT01328470|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110714973|NCT01328470|Purinergic Agents|purinergic agents|mesh-ancestor
110714974|NCT01328470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110714975|NCT01328470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110714976|NCT01328470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110714977|NCT01328470|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110714978|NCT01328470|Autonomic Agents|autonomic agents|mesh-ancestor
110714979|NCT01328470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110714980|NCT01328470|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110714981|NCT01328470|Respiratory System Agents|respiratory system agents|mesh-ancestor
110714982|NCT01328470|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110714983|NCT01328470|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110714984|NCT01328470|Vasodilator Agents|vasodilator agents|mesh-ancestor
110714985|NCT01328470|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110714986|NCT01328470|Protective Agents|protective agents|mesh-ancestor
110714987|NCT01328470|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110714988|NCT01328470|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110714989|NCT01328470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110714990|NCT01109446|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110714991|NCT03940378|Levamisole|levamisole|mesh-list
110714992|NCT03940378|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110714993|NCT03940378|Immunologic Factors|immunologic factors|mesh-ancestor
110714994|NCT03940378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110714995|NCT03940378|Antinematodal Agents|antinematodal agents|mesh-ancestor
110714996|NCT03940378|Anthelmintics|anthelmintics|mesh-ancestor
110714997|NCT03940378|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110714998|NCT03940378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110714999|NCT03940378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110715000|NCT01115062|Lidocaine|lidocaine|mesh-list
110715001|NCT01115062|Anesthetics, Local|anesthetics, local|mesh-ancestor
110715002|NCT01115062|Anesthetics|anesthetics|mesh-ancestor
110715003|NCT01115062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110715004|NCT01115062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110715005|NCT01115062|Sensory System Agents|sensory system agents|mesh-ancestor
110715006|NCT01115062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110715007|NCT01115062|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110715008|NCT01115062|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110715009|NCT01115062|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110715010|NCT01115062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110137454|NCT05686408|Tianeptine|tianeptine|mesh-list
110715011|NCT01115062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110715012|NCT01115140|Folic Acid|folic acid|mesh-list
110715013|NCT01115140|Vitamin B Complex|vitamin b complex|mesh-list
110715014|NCT01115140|Metformin|metformin|mesh-list
110715015|NCT01115140|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110715016|NCT01115140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110715017|NCT01115140|Hematinics|hematinics|mesh-ancestor
110715018|NCT01115140|Vitamins|vitamins|mesh-ancestor
110715019|NCT01115140|Micronutrients|micronutrients|mesh-ancestor
110715020|NCT01112644|Oxycodone|oxycodone|mesh-list
110715021|NCT01112644|Naloxone|naloxone|mesh-list
110715022|NCT01112644|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110715023|NCT01112644|Narcotics|narcotics|mesh-ancestor
110715024|NCT01112644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110715025|NCT01112644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110715026|NCT01112644|Analgesics|analgesics|mesh-ancestor
110715027|NCT01112644|Sensory System Agents|sensory system agents|mesh-ancestor
110715028|NCT01112644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110715030|NCT01112722|Histamine|histamine|mesh-list
110715031|NCT01112722|Histamine Agonists|histamine agonists|mesh-ancestor
110715032|NCT01112722|Histamine Agents|histamine agents|mesh-ancestor
110715033|NCT01112722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110715034|NCT01112722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110715035|NCT01112722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110715036|NCT01015222|Paclitaxel|paclitaxel|mesh-list
110715037|NCT01015222|Bevacizumab|bevacizumab|mesh-list
110715038|NCT01015222|Dasatinib|dasatinib|mesh-list
110715039|NCT01015222|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110715040|NCT01015222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110715041|NCT01015222|Tubulin Modulators|tubulin modulators|mesh-ancestor
110715042|NCT01015222|Antimitotic Agents|antimitotic agents|mesh-ancestor
110715043|NCT01015222|Mitosis Modulators|mitosis modulators|mesh-ancestor
110715044|NCT01015222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110715045|NCT01015222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110715046|NCT01015222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110715047|NCT01015222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110715048|NCT01015222|Growth Substances|growth substances|mesh-ancestor
110715049|NCT01015222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110715050|NCT01015222|Growth Inhibitors|growth inhibitors|mesh-ancestor
110715051|NCT01015222|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110715052|NCT01015222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110715053|NCT01212250|Carvedilol|carvedilol|mesh-list
110715054|NCT01212250|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110715055|NCT01212250|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110715056|NCT01212250|Adrenergic Agents|adrenergic agents|mesh-ancestor
110715057|NCT01212250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110715058|NCT01212250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110715059|NCT01212250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110715060|NCT01212250|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110715062|NCT01212250|Protective Agents|protective agents|mesh-ancestor
110715063|NCT01212250|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110715064|NCT01212250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110715065|NCT01212250|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110715066|NCT01212250|Vasodilator Agents|vasodilator agents|mesh-ancestor
110715067|NCT01212250|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110715068|NCT01212250|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110715069|NCT01209988|Tamsulosin|tamsulosin|mesh-list
110715070|NCT01209988|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110715071|NCT01209988|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110715072|NCT01209988|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110715073|NCT01209988|Adrenergic Agents|adrenergic agents|mesh-ancestor
110715074|NCT01209988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110715075|NCT01209988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110715076|NCT01209988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110715077|NCT01209988|Urological Agents|urological agents|mesh-ancestor
110715078|NCT03943186|Hyaluronic Acid|hyaluronic acid|mesh-list
110715079|NCT03943186|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110715080|NCT03943186|Immunologic Factors|immunologic factors|mesh-ancestor
110715081|NCT03943186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110715082|NCT03943186|Viscosupplements|viscosupplements|mesh-ancestor
110715083|NCT03943186|Protective Agents|protective agents|mesh-ancestor
110715084|NCT01210066|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
110715085|NCT01210066|Fentanyl|fentanyl|mesh-list
110715086|NCT01210066|Analgesics, Opioid|analgesics, opioid|mesh-list
110715087|NCT01210066|Narcotics|narcotics|mesh-ancestor
110715088|NCT01210066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110715089|NCT01210066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110715090|NCT01210066|Analgesics|analgesics|mesh-ancestor
110715091|NCT01210066|Sensory System Agents|sensory system agents|mesh-ancestor
110715092|NCT01210066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110715093|NCT01210066|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110715094|NCT01210066|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110715095|NCT01210066|Anesthetics, General|anesthetics, general|mesh-ancestor
110715096|NCT01210066|Anesthetics|anesthetics|mesh-ancestor
110715099|NCT01112878|Analgesics|analgesics|mesh-ancestor
110715100|NCT01112878|Sensory System Agents|sensory system agents|mesh-ancestor
110715101|NCT01112878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110715102|NCT01112878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110715103|NCT01112878|Anticonvulsants|anticonvulsants|mesh-ancestor
110715104|NCT01112878|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110715105|NCT01112878|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110715106|NCT01112878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110715107|NCT01112878|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110715108|NCT01112878|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110715109|NCT01112878|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110715110|NCT01112878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110715111|NCT01112878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110715112|NCT01112878|Antimanic Agents|antimanic agents|mesh-ancestor
110715113|NCT01112878|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110715114|NCT01112878|Sympatholytics|sympatholytics|mesh-ancestor
110715115|NCT01112878|Autonomic Agents|autonomic agents|mesh-ancestor
110137705|NCT05413343|Avibactam|avibactam|mesh-list
110715116|NCT01112878|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110715117|NCT01112878|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110715118|NCT01112878|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110715119|NCT01112878|Adrenergic Agents|adrenergic agents|mesh-ancestor
110715120|NCT01212406|Vitamin D|vitamin d|mesh-list
110715121|NCT01212406|Vitamins|vitamins|mesh-ancestor
110715122|NCT01212406|Micronutrients|micronutrients|mesh-ancestor
110715123|NCT01212406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110715124|NCT01212406|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110715125|NCT01109758|Fenofibrate|fenofibrate|mesh-list
110715126|NCT01109758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110715127|NCT01109758|Antimetabolites|antimetabolites|mesh-ancestor
110715128|NCT01109758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110715129|NCT01109758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110715130|NCT01328236|Dexamethasone|dexamethasone|mesh-list
110432981|NCT04341779|Tenofovir|tenofovir|mesh-list
110715131|NCT01328236|Doxorubicin|doxorubicin|mesh-list
110715132|NCT01328236|Bortezomib|bortezomib|mesh-list
110715133|NCT01328236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110715134|NCT01328236|Antiemetics|antiemetics|mesh-ancestor
110715135|NCT01328236|Autonomic Agents|autonomic agents|mesh-ancestor
110715136|NCT01328236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110715137|NCT01328236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110715138|NCT01328236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110715139|NCT01328236|Glucocorticoids|glucocorticoids|mesh-ancestor
110715140|NCT01328236|Hormones|hormones|mesh-ancestor
110715141|NCT01328236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110715142|NCT01328236|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110137753|NCT05302271|Prednisone|prednisone|mesh-list
110715143|NCT01328236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110715144|NCT01328236|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110715145|NCT01328236|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110715146|NCT01328236|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110715147|NCT01328236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110715148|NCT01328236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110715149|NCT01328392|Dexlansoprazole|dexlansoprazole|mesh-list
110715150|NCT01328392|Lansoprazole|lansoprazole|mesh-list
110715151|NCT01328392|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110715152|NCT01328392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110715153|NCT01328392|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110715154|NCT01328392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110715155|NCT01328392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110715156|NCT01115842|Vitamin D|vitamin d|mesh-list
110715157|NCT01115842|Vitamins|vitamins|mesh-ancestor
110715158|NCT01115842|Micronutrients|micronutrients|mesh-ancestor
110715159|NCT01115842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110715160|NCT01115842|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110715161|NCT01210378|Nitroglycerin|nitroglycerin|mesh-list
110715162|NCT01210378|Vasodilator Agents|vasodilator agents|mesh-ancestor
110715163|NCT01116154|Lenalidomide|lenalidomide|mesh-list
110715164|NCT01116154|Vorinostat|vorinostat|mesh-list
110715165|NCT01116154|Immunologic Factors|immunologic factors|mesh-ancestor
110715166|NCT01116154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110715167|NCT01116154|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110715168|NCT01116154|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110715169|NCT01116154|Growth Substances|growth substances|mesh-ancestor
110715170|NCT01116154|Growth Inhibitors|growth inhibitors|mesh-ancestor
110715171|NCT01116154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110715172|NCT01116154|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110715173|NCT01116154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110715174|NCT01116154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110715175|NCT01210456|Acetylcysteine|acetylcysteine|mesh-list
110715176|NCT01210456|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110715177|NCT01210456|Antiviral Agents|antiviral agents|mesh-ancestor
110715178|NCT01210456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110715179|NCT01210456|Expectorants|expectorants|mesh-ancestor
110715180|NCT01210456|Respiratory System Agents|respiratory system agents|mesh-ancestor
110715181|NCT01210456|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110715182|NCT01210456|Antioxidants|antioxidants|mesh-ancestor
110715183|NCT01210456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110715184|NCT01210456|Protective Agents|protective agents|mesh-ancestor
110715185|NCT01210456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110715186|NCT01210456|Antidotes|antidotes|mesh-ancestor
110715187|NCT01116310|Glycine|glycine|mesh-list
110715188|NCT01116310|Glycine Agents|glycine agents|mesh-ancestor
110715189|NCT01116310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110715190|NCT01116310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110715191|NCT01116310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110715192|NCT01210846|Tivozanib|tivozanib|mesh-list
110715193|NCT01210846|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110715194|NCT01210846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110715195|NCT01210846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110715196|NCT01116388|Caseins|caseins|mesh-list
110715197|NCT01116388|Chelating Agents|chelating agents|mesh-ancestor
110715198|NCT01116388|Sequestering Agents|sequestering agents|mesh-ancestor
110715199|NCT01116388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110715200|NCT01116622|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110715201|NCT01116622|Bexarotene|bexarotene|mesh-list
110715202|NCT01116622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110715203|NCT01116622|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110715204|NCT01116622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110715205|NCT01116622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110715206|NCT03941626|Immunomodulating Agents|immunomodulating agents|mesh-list
110433060|NCT04016389|Paclitaxel|paclitaxel|mesh-list
110715207|NCT03941626|Immunologic Factors|immunologic factors|mesh-ancestor
110137831|NCT05194592|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110715208|NCT03941626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110715209|NCT01211002|Endostatins|endostatins|mesh-list
110715210|NCT01211002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110715211|NCT01211002|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110715212|NCT01211002|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110715213|NCT01211002|Growth Substances|growth substances|mesh-ancestor
110715214|NCT01211002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110715215|NCT01211002|Growth Inhibitors|growth inhibitors|mesh-ancestor
110715216|NCT01211080|Propranolol|propranolol|mesh-list
110715217|NCT01211080|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110715218|NCT01211080|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110715219|NCT01211080|Adrenergic Agents|adrenergic agents|mesh-ancestor
110715220|NCT01211080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110715221|NCT01211080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110715222|NCT01211080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110715223|NCT01211080|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110715224|NCT01211080|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110715225|NCT01211080|Vasodilator Agents|vasodilator agents|mesh-ancestor
110715226|NCT01116700|Dexmedetomidine|dexmedetomidine|mesh-list
110715227|NCT01116700|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110715228|NCT01116700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110715229|NCT01116700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110715230|NCT01116700|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110715231|NCT01116700|Analgesics|analgesics|mesh-ancestor
110715232|NCT01116700|Sensory System Agents|sensory system agents|mesh-ancestor
110715233|NCT01116700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110715234|NCT01116700|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110715235|NCT01116700|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110715236|NCT01116700|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110715237|NCT01116700|Adrenergic Agents|adrenergic agents|mesh-ancestor
110715238|NCT01116700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110715239|NCT01116700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110715240|NCT01113424|Nicotine|nicotine|mesh-list
110715241|NCT01113424|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110715242|NCT01113424|Autonomic Agents|autonomic agents|mesh-ancestor
110715243|NCT01113424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110715244|NCT01113424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110715245|NCT01113424|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110715246|NCT01113424|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110715247|NCT01113424|Cholinergic Agents|cholinergic agents|mesh-ancestor
110715248|NCT01113424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110715249|NCT01113424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110715250|NCT01211158|Ketamine|ketamine|mesh-list
110715251|NCT01211158|Propofol|propofol|mesh-list
110715252|NCT01211158|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110715253|NCT01211158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110715254|NCT01211158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110715255|NCT01211158|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110715256|NCT01211158|Anesthetics, General|anesthetics, general|mesh-ancestor
110715257|NCT01211158|Anesthetics|anesthetics|mesh-ancestor
110715258|NCT01211158|Analgesics|analgesics|mesh-ancestor
110715259|NCT01211158|Sensory System Agents|sensory system agents|mesh-ancestor
110715260|NCT01211158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110715261|NCT01211158|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110715262|NCT01211158|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110715263|NCT01211158|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110715264|NCT01211158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110137988|NCT04985929|Vasodilator Agents|vasodilator agents|mesh-ancestor
110715265|NCT01211158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110715266|NCT01110226|Cisplatin|cisplatin|mesh-list
110715267|NCT01110226|Sodium arsenite|sodium arsenite|mesh-list
110715268|NCT01110226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110715269|NCT01110226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110715270|NCT01110226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110715271|NCT03789292|Adalimumab|adalimumab|mesh-list
110715272|NCT03789292|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110715273|NCT03789292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110715274|NCT03789292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110715275|NCT01211314|Enalapril|enalapril|mesh-list
110715276|NCT01211314|Lercanidipine|lercanidipine|mesh-list
110715277|NCT01211314|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110715278|NCT01211314|Protease Inhibitors|protease inhibitors|mesh-ancestor
110715279|NCT01211314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110715280|NCT01211314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110715281|NCT01211314|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110715282|NCT01211314|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110715283|NCT01211314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110715284|NCT01211314|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110715285|NCT01211314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110715286|NCT01110304|Analgesics|analgesics|mesh-list
110715287|NCT01110304|Sensory System Agents|sensory system agents|mesh-ancestor
110715288|NCT01110304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110715289|NCT01110304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110715290|NCT02529514|Baclofen|baclofen|mesh-list
110715291|NCT02529514|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110715292|NCT02529514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110715293|NCT02529514|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110715294|NCT02529514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110715295|NCT02529514|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
110715296|NCT02529514|GABA Agonists|gaba agonists|mesh-ancestor
110715297|NCT02529514|GABA Agents|gaba agents|mesh-ancestor
110715298|NCT02529514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110715299|NCT02529514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110715300|NCT01211470|Daptomycin|daptomycin|mesh-list
110715301|NCT01211470|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110715302|NCT01211470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110715303|NCT01114048|Thalidomide|thalidomide|mesh-list
110715304|NCT01114048|Dexamethasone|dexamethasone|mesh-list
110715305|NCT01114048|Cyclophosphamide|cyclophosphamide|mesh-list
110715306|NCT01114048|Bortezomib|bortezomib|mesh-list
110715307|NCT01114048|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110715308|NCT01114048|Immunologic Factors|immunologic factors|mesh-ancestor
110715309|NCT01114048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110715310|NCT01114048|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110715311|NCT01114048|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110715312|NCT01114048|Alkylating Agents|alkylating agents|mesh-ancestor
110715313|NCT01114048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110138085|NCT04886986|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
110715314|NCT01114048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110715315|NCT01114048|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110715316|NCT01114048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110715317|NCT01114048|Antiemetics|antiemetics|mesh-ancestor
110715318|NCT01114048|Autonomic Agents|autonomic agents|mesh-ancestor
110715319|NCT01114048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110715320|NCT01114048|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110715321|NCT01114048|Glucocorticoids|glucocorticoids|mesh-ancestor
110715322|NCT01114048|Hormones|hormones|mesh-ancestor
110715323|NCT01114048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110715324|NCT01114048|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110715325|NCT01114048|Leprostatic Agents|leprostatic agents|mesh-ancestor
110715326|NCT01114048|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110715327|NCT01114048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110715328|NCT01114048|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110715329|NCT01114048|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110715330|NCT01114048|Growth Substances|growth substances|mesh-ancestor
110715331|NCT01114048|Growth Inhibitors|growth inhibitors|mesh-ancestor
110715332|NCT01208194|Immunologic Factors|immunologic factors|mesh-list
110715333|NCT01208194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110715334|NCT01211704|Paliperidone Palmitate|paliperidone palmitate|mesh-list
110715335|NCT01211704|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110715336|NCT01211704|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110715337|NCT01211704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110715338|NCT01211704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110715339|NCT01211704|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110715340|NCT01211704|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110715341|NCT01211704|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110715342|NCT01211704|Serotonin Agents|serotonin agents|mesh-ancestor
110715343|NCT01211704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110715344|NCT01211704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110715345|NCT01211704|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110715346|NCT01211704|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110715347|NCT01211704|Dopamine Agents|dopamine agents|mesh-ancestor
110715348|NCT02529670|Lidocaine|lidocaine|mesh-list
110715349|NCT02529670|Anesthetics, Local|anesthetics, local|mesh-ancestor
110715350|NCT02529670|Anesthetics|anesthetics|mesh-ancestor
110715351|NCT02529670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110715352|NCT02529670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110715353|NCT02529670|Sensory System Agents|sensory system agents|mesh-ancestor
110715354|NCT02529670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110433202|NCT03492671|Antimetabolites|antimetabolites|mesh-ancestor
110715355|NCT02529670|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110715356|NCT02529670|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110861846|NCT01339143|Pioglitazone|pioglitazone|mesh-list
110715357|NCT02529670|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110715358|NCT02529670|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110715359|NCT02529670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110715361|NCT01117636|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110715362|NCT01117636|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110715363|NCT01117636|Analgesics|analgesics|mesh-ancestor
110715364|NCT01117636|Sensory System Agents|sensory system agents|mesh-ancestor
110715365|NCT01117636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110715366|NCT01117636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110715367|NCT01117636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110715368|NCT01117636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110715369|NCT01117636|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110715370|NCT01117636|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110715371|NCT01117636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110715372|NCT01117636|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110715373|NCT01117636|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110715374|NCT01117636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110715375|NCT01117636|Antipyretics|antipyretics|mesh-ancestor
110715376|NCT03938740|Insulin|insulin|mesh-list
110715377|NCT03938740|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110715378|NCT03938740|Insulin Lispro|insulin lispro|mesh-list
110715379|NCT03938740|Insulin, Long-Acting|insulin, long-acting|mesh-list
110715380|NCT03938740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110715381|NCT03938740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110715382|NCT01110616|Lorazepam|lorazepam|mesh-list
110715383|NCT01110616|Anticonvulsants|anticonvulsants|mesh-ancestor
110715384|NCT01110616|Antiemetics|antiemetics|mesh-ancestor
110715385|NCT01110616|Autonomic Agents|autonomic agents|mesh-ancestor
110715386|NCT01110616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110715387|NCT01110616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110715388|NCT01110616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110715389|NCT01110616|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110715390|NCT01110616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110715391|NCT01110616|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110715392|NCT01110616|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110715393|NCT01110616|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110715394|NCT01110616|GABA Modulators|gaba modulators|mesh-ancestor
110715395|NCT01110616|GABA Agents|gaba agents|mesh-ancestor
110715396|NCT01110616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110715397|NCT01110616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110715398|NCT03938662|Choline|choline|mesh-list
110715399|NCT03938662|Lipotropic Agents|lipotropic agents|mesh-ancestor
110715400|NCT03938662|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110715401|NCT03938662|Antimetabolites|antimetabolites|mesh-ancestor
110715402|NCT03938662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110715403|NCT03938662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110715404|NCT03938662|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110715405|NCT03938662|Nootropic Agents|nootropic agents|mesh-ancestor
110715406|NCT01213498|Atorvastatin|atorvastatin|mesh-list
110715407|NCT01213498|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110715408|NCT01213498|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110715409|NCT01213498|Antimetabolites|antimetabolites|mesh-ancestor
110715410|NCT01213498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110715411|NCT01213498|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110715412|NCT01213498|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110715413|NCT01213498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110715414|NCT01111084|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
110715415|NCT01111084|Hormones|hormones|mesh-ancestor
110715416|NCT01111084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110715417|NCT01111084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110715418|NCT01118260|Anesthetics|anesthetics|mesh-list
110715419|NCT01118260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110715420|NCT01118260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110715421|NCT01121770|PENTA|penta|mesh-list
110715422|NCT01121770|Fondaparinux|fondaparinux|mesh-list
110715423|NCT01121770|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110715424|NCT01121770|Antithrombins|antithrombins|mesh-ancestor
110715425|NCT01121770|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110715426|NCT01121770|Protease Inhibitors|protease inhibitors|mesh-ancestor
110715427|NCT01121770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110715428|NCT01121770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110715429|NCT01121770|Anticoagulants|anticoagulants|mesh-ancestor
110715430|NCT01121770|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110715431|NCT01121770|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110715433|NCT01121848|Fluorouracil|fluorouracil|mesh-list
110715434|NCT01121848|Oxaliplatin|oxaliplatin|mesh-list
110715435|NCT01121848|Antimetabolites|antimetabolites|mesh-ancestor
110715436|NCT01121848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110715437|NCT01121848|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110715438|NCT01121848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110715439|NCT01121848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110715440|NCT01121848|Immunologic Factors|immunologic factors|mesh-ancestor
110715441|NCT01121848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110715442|NCT01121848|Antidotes|antidotes|mesh-ancestor
110715443|NCT01121848|Protective Agents|protective agents|mesh-ancestor
110715444|NCT01121848|Vitamin B Complex|vitamin b complex|mesh-ancestor
110715445|NCT01121848|Vitamins|vitamins|mesh-ancestor
110715446|NCT01121848|Micronutrients|micronutrients|mesh-ancestor
110715447|NCT01122004|Pregabalin|pregabalin|mesh-list
110715448|NCT01122004|Analgesics|analgesics|mesh-ancestor
110715449|NCT01122004|Sensory System Agents|sensory system agents|mesh-ancestor
110715450|NCT01122004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110715451|NCT01122004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110715452|NCT01122004|Anticonvulsants|anticonvulsants|mesh-ancestor
110715453|NCT01122004|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110715454|NCT01122004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110715455|NCT01122004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110715456|NCT01122004|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110138324|NCT04520711|Pembrolizumab|pembrolizumab|mesh-list
110715457|NCT01122004|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110715458|NCT01122004|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110715459|NCT01122004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110715460|NCT01122004|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110715461|NCT03933982|Vinorelbine|vinorelbine|mesh-list
110715462|NCT03933982|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110715463|NCT03933982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110715464|NCT03933982|Tubulin Modulators|tubulin modulators|mesh-ancestor
110715465|NCT03933982|Antimitotic Agents|antimitotic agents|mesh-ancestor
110715466|NCT03933982|Mitosis Modulators|mitosis modulators|mesh-ancestor
110715467|NCT03933982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110715468|NCT01118572|Celecoxib|celecoxib|mesh-list
110715469|NCT01118572|Etodolac|etodolac|mesh-list
110715470|NCT01118572|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110715471|NCT01118572|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110715472|NCT01118572|Analgesics|analgesics|mesh-ancestor
110715473|NCT01118572|Sensory System Agents|sensory system agents|mesh-ancestor
110715474|NCT01118572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110715475|NCT01118572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110715476|NCT01118572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110715477|NCT01118572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110715478|NCT01118572|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110715479|NCT01118572|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110715480|NCT01118572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110715481|NCT01118572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110715482|NCT03937648|Lasmiditan|lasmiditan|mesh-list
110138386|NCT04429022|Analgesics|analgesics|mesh-ancestor
110715483|NCT03937648|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110715484|NCT03937648|Serotonin Agents|serotonin agents|mesh-ancestor
110715485|NCT03937648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110715486|NCT03937648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110715487|NCT03937648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110715488|NCT01219036|Budesonide|budesonide|mesh-list
110715489|NCT01219036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110861851|NCT01339143|Protease Inhibitors|protease inhibitors|mesh-ancestor
110715490|NCT01219036|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110715491|NCT01219036|Autonomic Agents|autonomic agents|mesh-ancestor
110715492|NCT01219036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110715493|NCT01219036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110715494|NCT01219036|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110715495|NCT01219036|Respiratory System Agents|respiratory system agents|mesh-ancestor
110715496|NCT01219036|Glucocorticoids|glucocorticoids|mesh-ancestor
110715497|NCT01219036|Hormones|hormones|mesh-ancestor
110715498|NCT01219036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110715499|NCT01124500|Methylphenidate|methylphenidate|mesh-list
110715500|NCT01124500|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110715501|NCT01124500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110715502|NCT01124500|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110715503|NCT01124500|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110715504|NCT01124500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110715505|NCT01124500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110715506|NCT01124500|Dopamine Agents|dopamine agents|mesh-ancestor
110715507|NCT01124500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110715508|NCT01118884|Promethazine|promethazine|mesh-list
110715509|NCT01118884|Diphenhydramine|diphenhydramine|mesh-list
110715510|NCT01118884|Antipruritics|antipruritics|mesh-ancestor
110715511|NCT01118884|Dermatologic Agents|dermatologic agents|mesh-ancestor
110715512|NCT01118884|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110715513|NCT01118884|Histamine Antagonists|histamine antagonists|mesh-ancestor
110715514|NCT01118884|Histamine Agents|histamine agents|mesh-ancestor
110715515|NCT01118884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110715516|NCT01118884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110715517|NCT01118884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110715518|NCT01118884|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110715519|NCT01118884|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110715520|NCT01118884|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110715521|NCT01118884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110715522|NCT01118884|Anesthetics, Local|anesthetics, local|mesh-ancestor
110715523|NCT01118884|Anesthetics|anesthetics|mesh-ancestor
110715524|NCT01118884|Sensory System Agents|sensory system agents|mesh-ancestor
110715525|NCT01118884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110715526|NCT01118884|Antiemetics|antiemetics|mesh-ancestor
110715527|NCT01118884|Autonomic Agents|autonomic agents|mesh-ancestor
110715528|NCT01118884|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110715529|NCT01119196|Dialysis Solutions|dialysis solutions|mesh-list
110715530|NCT01119196|Icodextrin|icodextrin|mesh-list
110715531|NCT01119196|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110715532|NCT01213888|Trientine|trientine|mesh-list
110715533|NCT01213888|Chelating Agents|chelating agents|mesh-ancestor
110715534|NCT01213888|Sequestering Agents|sequestering agents|mesh-ancestor
110715535|NCT01213888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110715536|NCT01119430|Fluoxetine|fluoxetine|mesh-list
110715537|NCT01119430|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110715538|NCT01119430|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110715539|NCT01119430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110715540|NCT01119430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110715541|NCT01119430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110715542|NCT01119430|Serotonin Agents|serotonin agents|mesh-ancestor
110715543|NCT01119430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110715544|NCT01119430|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110715545|NCT01119430|Antidepressive Agents|antidepressive agents|mesh-ancestor
110715546|NCT01119430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110715547|NCT01119430|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110715548|NCT01119430|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110715549|NCT01119430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110715550|NCT02529124|Caseins|caseins|mesh-list
110715551|NCT02529124|Chelating Agents|chelating agents|mesh-ancestor
110861870|NCT05250843|Lenvatinib|lenvatinib|mesh-list
110715552|NCT02529124|Sequestering Agents|sequestering agents|mesh-ancestor
110715553|NCT02529124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110715554|NCT03780244|Mannitol|mannitol|mesh-list
110715555|NCT03780244|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110715556|NCT03780244|Diuretics|diuretics|mesh-ancestor
110715557|NCT03780244|Natriuretic Agents|natriuretic agents|mesh-ancestor
110715558|NCT03780244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110715559|NCT01119742|Butenafine|butenafine|mesh-list
110715560|NCT01119742|Antifungal Agents|antifungal agents|mesh-ancestor
110715561|NCT01119742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110715562|NCT01216696|Ipilimumab|ipilimumab|mesh-list
110715563|NCT01216696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110715564|NCT01216696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110715565|NCT01216696|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110715566|NCT01216696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110715567|NCT03937258|Probenecid|probenecid|mesh-list
110715568|NCT03937258|Abrocitinib|abrocitinib|mesh-list
110715569|NCT03937258|Uricosuric Agents|uricosuric agents|mesh-ancestor
110715570|NCT03937258|Gout Suppressants|gout suppressants|mesh-ancestor
110715571|NCT03937258|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110715572|NCT03937258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110715573|NCT03937258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110715574|NCT03937258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110715575|NCT01124656|Pioglitazone|pioglitazone|mesh-list
110715576|NCT01124656|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
110715577|NCT01124656|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110715578|NCT01124656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110138536|NCT04231760|Antioxidants|antioxidants|mesh-ancestor
110715579|NCT01124656|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110715580|NCT01124656|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110715581|NCT01124656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110715582|NCT01122472|Lenalidomide|lenalidomide|mesh-list
110715583|NCT01122472|Immunologic Factors|immunologic factors|mesh-ancestor
110715584|NCT01122472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110715585|NCT01122472|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110715586|NCT01122472|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110715587|NCT01122472|Growth Substances|growth substances|mesh-ancestor
110715588|NCT01122472|Growth Inhibitors|growth inhibitors|mesh-ancestor
110715589|NCT01122472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110715590|NCT01214122|Warfarin|warfarin|mesh-list
110715591|NCT01214122|Anticoagulants|anticoagulants|mesh-ancestor
110715592|NCT03935152|Dydrogesterone|dydrogesterone|mesh-list
110715593|NCT03935152|Progestins|progestins|mesh-ancestor
110715594|NCT03935152|Hormones|hormones|mesh-ancestor
110715595|NCT03935152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110715596|NCT03935152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110715597|NCT01216852|Losartan|losartan|mesh-list
110715598|NCT01216852|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110715599|NCT01216852|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110715600|NCT01216852|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110715601|NCT01216852|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110715602|NCT01216852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110715603|NCT03933748|Teicoplanin|teicoplanin|mesh-list
110715604|NCT03933748|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110715605|NCT03933748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110715606|NCT01120366|Methotrexate|methotrexate|mesh-list
110715607|NCT01120366|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110715608|NCT01120366|Abortifacient Agents|abortifacient agents|mesh-ancestor
110715609|NCT01120366|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110715610|NCT01120366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110715611|NCT01120366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110715612|NCT01120366|Antimetabolites|antimetabolites|mesh-ancestor
110715613|NCT01120366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110715614|NCT01120366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110715615|NCT01120366|Dermatologic Agents|dermatologic agents|mesh-ancestor
110715616|NCT01120366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110715617|NCT01120366|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110715618|NCT01120366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110715619|NCT01120366|Immunologic Factors|immunologic factors|mesh-ancestor
110715620|NCT01120366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110715621|NCT01120366|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110715623|NCT01217086|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110715624|NCT01217086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110715625|NCT01217086|Dermatologic Agents|dermatologic agents|mesh-ancestor
110715626|NCT01217086|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110715627|NCT01217086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110715628|NCT01120444|Insulin|insulin|mesh-list
110715629|NCT01120444|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110715630|NCT01120444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110715631|NCT01217398|Bevacizumab|bevacizumab|mesh-list
110715632|NCT01217398|Temozolomide|temozolomide|mesh-list
110715633|NCT01217398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110715634|NCT01217398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110715635|NCT01217398|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110715636|NCT01217398|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110715637|NCT01217398|Growth Substances|growth substances|mesh-ancestor
110715638|NCT01217398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110715639|NCT01217398|Growth Inhibitors|growth inhibitors|mesh-ancestor
110715640|NCT01217398|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110715641|NCT01217398|Alkylating Agents|alkylating agents|mesh-ancestor
110715642|NCT01217398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110715643|NCT01125124|Silver Nitrate|silver nitrate|mesh-list
110715644|NCT01125124|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110715645|NCT01125124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110715646|NCT01214746|Atorvastatin|atorvastatin|mesh-list
110715647|NCT01214746|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110715648|NCT01214746|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110715649|NCT01214746|Antimetabolites|antimetabolites|mesh-ancestor
110715650|NCT01214746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110715651|NCT01214746|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110715652|NCT01214746|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110715653|NCT01214746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110715654|NCT03935074|Melphalan|melphalan|mesh-list
110715655|NCT03935074|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110715656|NCT03935074|Alkylating Agents|alkylating agents|mesh-ancestor
110715657|NCT03935074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110715658|NCT03935074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110715659|NCT03935074|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110715660|NCT03935074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110715661|NCT03935074|Immunologic Factors|immunologic factors|mesh-ancestor
110715662|NCT03935074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110715663|NCT01217632|Entecavir|entecavir|mesh-list
110715664|NCT01217632|Antiviral Agents|antiviral agents|mesh-ancestor
110715665|NCT01217632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110715666|NCT03933280|Dexmedetomidine|dexmedetomidine|mesh-list
110715667|NCT03933280|Nalbuphine|nalbuphine|mesh-list
110715668|NCT03933280|Propofol|propofol|mesh-list
110715669|NCT03933280|Benoxinate|benoxinate|mesh-list
110715670|NCT03933280|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110715671|NCT03933280|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110715672|NCT03933280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110715673|NCT03933280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110715674|NCT03933280|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110715676|NCT03933280|Sensory System Agents|sensory system agents|mesh-ancestor
110715677|NCT03933280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110715678|NCT03933280|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110715679|NCT03933280|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110715680|NCT03933280|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110715681|NCT03933280|Adrenergic Agents|adrenergic agents|mesh-ancestor
110715682|NCT03933280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110715683|NCT03933280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110715684|NCT03933280|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110715685|NCT03933280|Anesthetics, General|anesthetics, general|mesh-ancestor
110715686|NCT03933280|Anesthetics|anesthetics|mesh-ancestor
110715687|NCT03933280|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110715688|NCT03933280|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110715689|NCT03933280|Narcotics|narcotics|mesh-ancestor
110715690|NCT03933280|Anesthetics, Local|anesthetics, local|mesh-ancestor
110715691|NCT01120912|Insulin|insulin|mesh-list
110715692|NCT01120912|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110715693|NCT01120912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110715694|NCT01219582|Metformin|metformin|mesh-list
110715695|NCT01219582|Acarbose|acarbose|mesh-list
110715696|NCT01219582|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110715697|NCT01219582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110715698|NCT01219582|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
110715699|NCT01219582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110715700|NCT01219582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110715701|NCT03933358|Hormones|hormones|mesh-list
110715702|NCT03933358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110715703|NCT03933358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110715704|NCT01122940|Phenytoin|phenytoin|mesh-list
110715705|NCT01122940|Anticonvulsants|anticonvulsants|mesh-ancestor
110715706|NCT01122940|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110715707|NCT01122940|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110715708|NCT01122940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110715709|NCT01122940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110715710|NCT01122940|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110715711|NCT01122940|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110715712|NCT01219816|Epratuzumab|epratuzumab|mesh-list
110715713|NCT01219816|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110715714|NCT01219816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110715715|NCT01215136|Paclitaxel|paclitaxel|mesh-list
110715716|NCT01215136|Everolimus|everolimus|mesh-list
110715717|NCT01215136|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110715718|NCT01215136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110715719|NCT01215136|Tubulin Modulators|tubulin modulators|mesh-ancestor
110715720|NCT01215136|Antimitotic Agents|antimitotic agents|mesh-ancestor
110715721|NCT01215136|Mitosis Modulators|mitosis modulators|mesh-ancestor
110715722|NCT01215136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110715723|NCT01215136|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110715724|NCT01215136|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110715725|NCT01215136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110715726|NCT01215136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110715727|NCT01215136|Immunologic Factors|immunologic factors|mesh-ancestor
110715728|NCT01215136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110715729|NCT01218022|Losartan|losartan|mesh-list
110715730|NCT01218022|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110715731|NCT01218022|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110715732|NCT01218022|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110715733|NCT01218022|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110715734|NCT01218022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110715735|NCT01121458|Clevidipine|clevidipine|mesh-list
110715736|NCT01121458|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110715737|NCT01121458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110715738|NCT01121458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110715739|NCT01121458|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110715740|NCT01121458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110715741|NCT01215214|Midazolam|midazolam|mesh-list
110715742|NCT01215214|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110715743|NCT01215214|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110715744|NCT01215214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110715745|NCT01215214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110715746|NCT01215214|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110715747|NCT01215214|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110715748|NCT01215214|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110715749|NCT01215214|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110715750|NCT01215214|Anesthetics, General|anesthetics, general|mesh-ancestor
110715751|NCT01215214|Anesthetics|anesthetics|mesh-ancestor
110715752|NCT01215214|GABA Modulators|gaba modulators|mesh-ancestor
110715753|NCT01215214|GABA Agents|gaba agents|mesh-ancestor
110715754|NCT01215214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110715755|NCT01215214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110715756|NCT03936166|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110715757|NCT01125670|Darexaban|darexaban|mesh-list
110715758|NCT01125670|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110715759|NCT01125670|Antithrombins|antithrombins|mesh-ancestor
110715760|NCT01125670|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110715761|NCT01125670|Protease Inhibitors|protease inhibitors|mesh-ancestor
110715762|NCT01125670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110715763|NCT01125670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110715764|NCT01125670|Anticoagulants|anticoagulants|mesh-ancestor
110715765|NCT03934450|Primaquine|primaquine|mesh-list
110715766|NCT03934450|Antimalarials|antimalarials|mesh-ancestor
110715767|NCT03934450|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110715768|NCT03934450|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110715769|NCT03934450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110715770|NCT01215682|Vitamin D|vitamin d|mesh-list
110715771|NCT01215682|Vitamins|vitamins|mesh-ancestor
110715772|NCT01215682|Micronutrients|micronutrients|mesh-ancestor
110715773|NCT01215682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110715774|NCT01215682|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110715775|NCT03932344|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
110715776|NCT03932344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110715777|NCT01123408|Haloperidol|haloperidol|mesh-list
110715778|NCT01123408|Olanzapine|olanzapine|mesh-list
110715779|NCT01123408|Haloperidol decanoate|haloperidol decanoate|mesh-list
110715780|NCT01123408|Clozapine|clozapine|mesh-list
110715781|NCT01123408|Antiemetics|antiemetics|mesh-ancestor
110715782|NCT01123408|Autonomic Agents|autonomic agents|mesh-ancestor
110715783|NCT01123408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110715784|NCT01123408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110715785|NCT01123408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110715786|NCT01123408|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110715787|NCT01123408|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110715788|NCT01123408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110715789|NCT01123408|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110715790|NCT01123408|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110715791|NCT01123408|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110715792|NCT01123408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110715793|NCT01123408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110715794|NCT01123408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110715795|NCT01123408|Serotonin Agents|serotonin agents|mesh-ancestor
110715796|NCT01123408|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110715797|NCT01123408|Dopamine Agents|dopamine agents|mesh-ancestor
110715798|NCT01123408|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110715799|NCT01123408|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110715800|NCT01123408|GABA Antagonists|gaba antagonists|mesh-ancestor
110715801|NCT01123408|GABA Agents|gaba agents|mesh-ancestor
110715802|NCT00141297|Palbociclib|palbociclib|mesh-list
110715803|NCT00141297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110715804|NCT00141297|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110433655|NCT04178863|Timolol|timolol|mesh-list
110715805|NCT00141297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110715806|NCT00141297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110715807|NCT01123486|Hydromorphone|hydromorphone|mesh-list
110715808|NCT01123486|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110715810|NCT01123486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110715811|NCT01123486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110715812|NCT01123486|Analgesics|analgesics|mesh-ancestor
110715813|NCT01123486|Sensory System Agents|sensory system agents|mesh-ancestor
110715814|NCT01123486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110715815|NCT01123564|Ranibizumab|ranibizumab|mesh-list
110715816|NCT01123564|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110138715|NCT04034238|Tofacitinib|tofacitinib|mesh-list
110715817|NCT01123564|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110715818|NCT01123564|Growth Substances|growth substances|mesh-ancestor
110715819|NCT01123564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110715820|NCT01123564|Growth Inhibitors|growth inhibitors|mesh-ancestor
110715821|NCT01123564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110715822|NCT01222312|Docetaxel|docetaxel|mesh-list
110715823|NCT01222312|Oxaliplatin|oxaliplatin|mesh-list
110715824|NCT01222312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110715825|NCT01222312|Tubulin Modulators|tubulin modulators|mesh-ancestor
110715826|NCT01222312|Antimitotic Agents|antimitotic agents|mesh-ancestor
110715827|NCT01222312|Mitosis Modulators|mitosis modulators|mesh-ancestor
110715828|NCT01222312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110715829|NCT03932266|Docetaxel|docetaxel|mesh-list
110715830|NCT03932266|Endostar protein|endostar protein|mesh-list
110715831|NCT03932266|Endostatins|endostatins|mesh-list
110715832|NCT03932266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110715833|NCT03932266|Tubulin Modulators|tubulin modulators|mesh-ancestor
110715834|NCT03932266|Antimitotic Agents|antimitotic agents|mesh-ancestor
110715835|NCT03932266|Mitosis Modulators|mitosis modulators|mesh-ancestor
110715836|NCT03932266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110715837|NCT03932266|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110715838|NCT03932266|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110715839|NCT03932266|Growth Substances|growth substances|mesh-ancestor
110715840|NCT03932266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110715841|NCT03932266|Growth Inhibitors|growth inhibitors|mesh-ancestor
110715842|NCT00141219|Pregabalin|pregabalin|mesh-list
110715843|NCT00141219|Analgesics|analgesics|mesh-ancestor
110715844|NCT00141219|Sensory System Agents|sensory system agents|mesh-ancestor
110715845|NCT00141219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110715846|NCT00141219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110715847|NCT00141219|Anticonvulsants|anticonvulsants|mesh-ancestor
110715848|NCT00141219|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110715849|NCT00141219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110715850|NCT00141219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110715851|NCT00141219|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110715852|NCT00141219|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110715853|NCT00141219|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110715854|NCT00141219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110715855|NCT00141219|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110715856|NCT01222468|Nabilone|nabilone|mesh-list
110715857|NCT01222468|Antiemetics|antiemetics|mesh-ancestor
110715858|NCT01222468|Autonomic Agents|autonomic agents|mesh-ancestor
110715859|NCT01222468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110715860|NCT01222468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110715861|NCT01222468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110715862|NCT01222468|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110715863|NCT01222468|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110715864|NCT01222468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110715865|NCT01222468|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110715866|NCT01220284|Vinorelbine|vinorelbine|mesh-list
110715867|NCT01220284|Satraplatin|satraplatin|mesh-list
110715868|NCT01220284|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110715869|NCT01220284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110715870|NCT01220284|Tubulin Modulators|tubulin modulators|mesh-ancestor
110715871|NCT01220284|Antimitotic Agents|antimitotic agents|mesh-ancestor
110715872|NCT01220284|Mitosis Modulators|mitosis modulators|mesh-ancestor
110715873|NCT01220284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110715874|NCT01127464|Poly ICLC|poly iclc|mesh-list
110715875|NCT01127464|Interferon Inducers|interferon inducers|mesh-ancestor
110715876|NCT01127464|Immunologic Factors|immunologic factors|mesh-ancestor
110715877|NCT01127464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110715878|NCT01222780|Vincristine|vincristine|mesh-list
110433760|NCT04287777|Mupirocin|mupirocin|mesh-list
110715879|NCT01222780|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110715880|NCT01222780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110715881|NCT01222780|Tubulin Modulators|tubulin modulators|mesh-ancestor
110715882|NCT01222780|Antimitotic Agents|antimitotic agents|mesh-ancestor
110715883|NCT01222780|Mitosis Modulators|mitosis modulators|mesh-ancestor
110715884|NCT01222780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110715885|NCT01222936|Panobinostat|panobinostat|mesh-list
110715886|NCT01222936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110715887|NCT01222936|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110715888|NCT01222936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110715889|NCT01222936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110715890|NCT01125904|Crizotinib|crizotinib|mesh-list
110715891|NCT01125904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110715892|NCT01125904|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110715893|NCT01125904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110715894|NCT01125904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110715895|NCT01125982|Propofol|propofol|mesh-list
110715896|NCT01125982|Desflurane|desflurane|mesh-list
110715897|NCT01125982|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110715898|NCT01125982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110715899|NCT01125982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110715900|NCT01125982|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110715901|NCT01125982|Anesthetics, General|anesthetics, general|mesh-ancestor
110715902|NCT01125982|Anesthetics|anesthetics|mesh-ancestor
110715903|NCT01125982|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110715904|NCT01220362|Fentanyl|fentanyl|mesh-list
110715905|NCT01220362|Bupivacaine|bupivacaine|mesh-list
110715906|NCT01220362|Anesthetics, Local|anesthetics, local|mesh-ancestor
110715907|NCT01220362|Anesthetics|anesthetics|mesh-ancestor
110715908|NCT01220362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110715909|NCT01220362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110715910|NCT01220362|Sensory System Agents|sensory system agents|mesh-ancestor
110715911|NCT01220362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110715912|NCT01220362|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110715913|NCT01220362|Narcotics|narcotics|mesh-ancestor
110715914|NCT01220362|Analgesics|analgesics|mesh-ancestor
110715915|NCT01220362|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110715916|NCT01220362|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110715917|NCT01220362|Anesthetics, General|anesthetics, general|mesh-ancestor
110715918|NCT01220440|Methylphenidate|methylphenidate|mesh-list
110715919|NCT01220440|Dextroamphetamine|dextroamphetamine|mesh-list
110715920|NCT01220440|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110715921|NCT01220440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110715922|NCT01220440|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110715923|NCT01220440|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110715924|NCT01220440|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110715925|NCT01220440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110715926|NCT01220440|Dopamine Agents|dopamine agents|mesh-ancestor
110715927|NCT01220440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110715928|NCT01123876|Veliparib|veliparib|mesh-list
110715929|NCT01123876|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110715930|NCT01123876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110715931|NCT01123876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110715932|NCT01123876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110715933|NCT01124032|Methylphenidate|methylphenidate|mesh-list
110715934|NCT01124032|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110715935|NCT01124032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110715936|NCT01124032|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110715937|NCT01124032|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110715938|NCT01124032|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110715939|NCT01124032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110715940|NCT01124032|Dopamine Agents|dopamine agents|mesh-ancestor
110715941|NCT01124032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110715942|NCT03934294|Metoclopramide|metoclopramide|mesh-list
110715943|NCT03934294|Antiemetics|antiemetics|mesh-ancestor
110715944|NCT03934294|Autonomic Agents|autonomic agents|mesh-ancestor
110715945|NCT03934294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110715946|NCT03934294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110715947|NCT03934294|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110715948|NCT03934294|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110715949|NCT03934294|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110715950|NCT03934294|Dopamine Agents|dopamine agents|mesh-ancestor
110715951|NCT03934294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110715952|NCT03934294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110715953|NCT01218568|Rifaximin|rifaximin|mesh-list
110715955|NCT01218568|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110715956|NCT01218568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110715957|NCT01218568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110715958|NCT01127542|Lenalidomide|lenalidomide|mesh-list
110715959|NCT01127542|Immunologic Factors|immunologic factors|mesh-ancestor
110715960|NCT01127542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110715961|NCT01127542|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110715962|NCT01127542|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110715963|NCT01127542|Growth Substances|growth substances|mesh-ancestor
110715964|NCT01127542|Growth Inhibitors|growth inhibitors|mesh-ancestor
110715965|NCT01127542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110715966|NCT01127620|Cetirizine|cetirizine|mesh-list
110715967|NCT01127620|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110715968|NCT01127620|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110715969|NCT01127620|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110715970|NCT01127620|Histamine Antagonists|histamine antagonists|mesh-ancestor
110715971|NCT01127620|Histamine Agents|histamine agents|mesh-ancestor
110715972|NCT01127620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110715973|NCT01127620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110715974|NCT01127620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110715975|NCT01220518|Infliximab|infliximab|mesh-list
110715976|NCT01220518|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110715977|NCT01220518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110715978|NCT01220518|Dermatologic Agents|dermatologic agents|mesh-ancestor
110715979|NCT01220518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110715980|NCT01220518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110715981|NCT01220596|Interferons|interferons|mesh-list
110715982|NCT01220596|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110715983|NCT01220596|Interferon-alpha|interferon-alpha|mesh-list
110715984|NCT01220596|Entecavir|entecavir|mesh-list
110715985|NCT01220596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110715986|NCT01220596|Antiviral Agents|antiviral agents|mesh-ancestor
110715987|NCT01220596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110715988|NCT01220596|Immunologic Factors|immunologic factors|mesh-ancestor
110715989|NCT01220596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110715990|NCT01218724|Losartan|losartan|mesh-list
110715991|NCT01218724|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110715992|NCT01218724|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110715993|NCT01218724|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110715994|NCT01218724|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110715995|NCT01218724|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110715996|NCT01218724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110715997|NCT01218724|Diuretics|diuretics|mesh-ancestor
110715998|NCT01218724|Natriuretic Agents|natriuretic agents|mesh-ancestor
110715999|NCT01218724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110716000|NCT01218724|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110716001|NCT01218724|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110716002|NCT01126216|Paclitaxel|paclitaxel|mesh-list
110716003|NCT01126216|Cisplatin|cisplatin|mesh-list
110716004|NCT01126216|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110716005|NCT01126216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110716006|NCT01126216|Tubulin Modulators|tubulin modulators|mesh-ancestor
110716007|NCT01126216|Antimitotic Agents|antimitotic agents|mesh-ancestor
110716008|NCT01126216|Mitosis Modulators|mitosis modulators|mesh-ancestor
110716009|NCT01126216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110716010|NCT01329016|Metformin|metformin|mesh-list
110716011|NCT01329016|Glyburide|glyburide|mesh-list
110716012|NCT01329016|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110716013|NCT01329016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110716014|NCT01223326|Acetylcysteine|acetylcysteine|mesh-list
110716015|NCT01223326|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110716016|NCT01223326|Antiviral Agents|antiviral agents|mesh-ancestor
110716017|NCT01223326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110716018|NCT01223326|Expectorants|expectorants|mesh-ancestor
110716019|NCT01223326|Respiratory System Agents|respiratory system agents|mesh-ancestor
110716020|NCT01223326|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110716021|NCT01223326|Antioxidants|antioxidants|mesh-ancestor
110716022|NCT01223326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110716023|NCT01223326|Protective Agents|protective agents|mesh-ancestor
110716024|NCT01223326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110716025|NCT01223326|Antidotes|antidotes|mesh-ancestor
110716026|NCT01223560|Insulin Aspart|insulin aspart|mesh-list
110716027|NCT01223560|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110716028|NCT01223560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110716029|NCT01126294|Melatonin|melatonin|mesh-list
110716030|NCT01126294|Antioxidants|antioxidants|mesh-ancestor
110443974|NCT00870727|Aripiprazole|aripiprazole|mesh-list
110716031|NCT01126294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110716032|NCT01126294|Protective Agents|protective agents|mesh-ancestor
110716033|NCT01126294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110716034|NCT01126294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110716035|NCT00162266|Abatacept|abatacept|mesh-list
110716036|NCT00162266|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110716037|NCT00162266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110716038|NCT00162266|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110716039|NCT00162266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110716040|NCT00162266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110716041|NCT00162266|Immunologic Factors|immunologic factors|mesh-ancestor
110716042|NCT00162266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110716043|NCT00162266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110716044|NCT01126450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110716045|NCT01126450|Cetuximab|cetuximab|mesh-list
110716046|NCT01126450|Lenalidomide|lenalidomide|mesh-list
110716047|NCT01126450|Antibodies|antibodies|mesh-list
110716048|NCT01126450|Immunoglobulins|immunoglobulins|mesh-list
110716049|NCT01126450|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110716050|NCT01126450|Immunologic Factors|immunologic factors|mesh-ancestor
110716051|NCT01126450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110716052|NCT01126450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110716053|NCT01126450|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110716054|NCT01126450|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110716055|NCT01126450|Growth Substances|growth substances|mesh-ancestor
110716056|NCT01126450|Growth Inhibitors|growth inhibitors|mesh-ancestor
110716057|NCT01073384|Beclomethasone|beclomethasone|mesh-list
110716058|NCT01073384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110716059|NCT01073384|Glucocorticoids|glucocorticoids|mesh-ancestor
110716060|NCT01073384|Hormones|hormones|mesh-ancestor
110716061|NCT01073384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110716062|NCT01073384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110716063|NCT01073384|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110716064|NCT01073384|Respiratory System Agents|respiratory system agents|mesh-ancestor
110716065|NCT01126528|Vitamin D|vitamin d|mesh-list
110716066|NCT01126528|Cholecalciferol|cholecalciferol|mesh-list
110716067|NCT01126528|Vitamins|vitamins|mesh-ancestor
110716068|NCT01126528|Micronutrients|micronutrients|mesh-ancestor
110716069|NCT01126528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110716070|NCT01126528|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110716071|NCT01126528|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110716072|NCT00225212|Rituximab|rituximab|mesh-list
110716073|NCT00225212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110716074|NCT00225212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110716075|NCT00225212|Immunologic Factors|immunologic factors|mesh-ancestor
110716076|NCT00225212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110716077|NCT00225212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110716078|NCT03853330|Bupivacaine|bupivacaine|mesh-list
110716079|NCT03853330|Anesthetics, Local|anesthetics, local|mesh-ancestor
110716080|NCT03853330|Anesthetics|anesthetics|mesh-ancestor
110716081|NCT03853330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110716082|NCT03853330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110716083|NCT03853330|Sensory System Agents|sensory system agents|mesh-ancestor
110716084|NCT03853330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110716085|NCT01581944|Goserelin|goserelin|mesh-list
110716086|NCT01581944|Hormones|hormones|mesh-list
110716087|NCT01581944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110716088|NCT01581944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110716089|NCT01581944|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110716090|NCT01581944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110716091|NCT01226056|Everolimus|everolimus|mesh-list
110716092|NCT01226056|Sorafenib|sorafenib|mesh-list
110716093|NCT01226056|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110716094|NCT01226056|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110716095|NCT01226056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110716096|NCT01226056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110716097|NCT01226056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110716098|NCT01226056|Immunologic Factors|immunologic factors|mesh-ancestor
110716099|NCT01226056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110716100|NCT01226056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110716101|NCT00162032|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
110716102|NCT00162032|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110716103|NCT00162032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110716104|NCT01126606|Glycerol|glycerol|mesh-list
110716105|NCT01126606|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
110716106|NCT01126606|Protective Agents|protective agents|mesh-ancestor
110716107|NCT01126606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110716108|NCT01329406|Milnacipran|milnacipran|mesh-list
110716109|NCT01329406|Levomilnacipran|levomilnacipran|mesh-list
110716110|NCT01329406|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110716111|NCT01329406|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110716112|NCT01329406|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110716113|NCT01329406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110716114|NCT01329406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110716115|NCT01329406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110716116|NCT01329406|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110716117|NCT01329406|Analgesics|analgesics|mesh-ancestor
110716118|NCT01329406|Sensory System Agents|sensory system agents|mesh-ancestor
110716119|NCT01329406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110716120|NCT01329406|Antidepressive Agents|antidepressive agents|mesh-ancestor
110716121|NCT01329406|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110716122|NCT01126684|Atorvastatin|atorvastatin|mesh-list
110716123|NCT01126684|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110716124|NCT01126684|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110716125|NCT01126684|Antimetabolites|antimetabolites|mesh-ancestor
110716126|NCT01126684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110716127|NCT01126684|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110716128|NCT01126684|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110716129|NCT01126684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110716130|NCT01224028|Tacrolimus|tacrolimus|mesh-list
110716131|NCT01224028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110716132|NCT01224028|Immunologic Factors|immunologic factors|mesh-ancestor
110716133|NCT01224028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110716134|NCT01224028|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110716135|NCT01224028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110716136|NCT01224028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110716137|NCT01226212|Sulfalene|sulfalene|mesh-list
110716138|NCT01226212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110716139|NCT01226212|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110716140|NCT01226212|Antimalarials|antimalarials|mesh-ancestor
110716141|NCT01226212|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110716142|NCT01226212|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110716143|NCT01075490|Clonidine|clonidine|mesh-list
110716144|NCT01075490|Analgesics|analgesics|mesh-ancestor
110716145|NCT01075490|Sensory System Agents|sensory system agents|mesh-ancestor
110716146|NCT01075490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110716147|NCT01075490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110716148|NCT01075490|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110716149|NCT01075490|Sympatholytics|sympatholytics|mesh-ancestor
110716150|NCT01075490|Autonomic Agents|autonomic agents|mesh-ancestor
110716151|NCT01075490|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110716152|NCT01075490|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110716153|NCT01075490|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110716154|NCT01075490|Adrenergic Agents|adrenergic agents|mesh-ancestor
110716155|NCT01075490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110716156|NCT01075490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110716157|NCT01126138|Docetaxel|docetaxel|mesh-list
110716158|NCT01126138|Capecitabine|capecitabine|mesh-list
110716159|NCT01126138|Vinorelbine|vinorelbine|mesh-list
110716160|NCT01126138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110716161|NCT01126138|Tubulin Modulators|tubulin modulators|mesh-ancestor
110716162|NCT01126138|Antimitotic Agents|antimitotic agents|mesh-ancestor
110716163|NCT01126138|Mitosis Modulators|mitosis modulators|mesh-ancestor
110716164|NCT01126138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110716165|NCT01126138|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110716166|NCT01126138|Antimetabolites|antimetabolites|mesh-ancestor
110716167|NCT01126138|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110716168|NCT03930706|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110716169|NCT03930706|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110716170|NCT03930706|Estradiol|estradiol|mesh-list
110716171|NCT03930706|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110716172|NCT03930706|Estrogens|estrogens|mesh-ancestor
110716173|NCT03930706|Hormones|hormones|mesh-ancestor
110716174|NCT03930706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110716175|NCT03930706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110443978|NCT00870727|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110716176|NCT03930706|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110716177|NCT03930706|Contraceptive Agents|contraceptive agents|mesh-ancestor
110716178|NCT03930706|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110716179|NCT03930706|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110716180|NCT03932578|Atropine|atropine|mesh-list
110716181|NCT03932578|Metoclopramide|metoclopramide|mesh-list
110716182|NCT03932578|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110716183|NCT03932578|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110716184|NCT03932578|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110716185|NCT03932578|Autonomic Agents|autonomic agents|mesh-ancestor
110716186|NCT03932578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110716187|NCT03932578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110716188|NCT03932578|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110716189|NCT03932578|Respiratory System Agents|respiratory system agents|mesh-ancestor
110716190|NCT03932578|Mydriatics|mydriatics|mesh-ancestor
110716191|NCT03932578|Parasympatholytics|parasympatholytics|mesh-ancestor
110716192|NCT03932578|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110716193|NCT03932578|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110716194|NCT03932578|Cholinergic Agents|cholinergic agents|mesh-ancestor
110716195|NCT03932578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110716196|NCT03932578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110716197|NCT03932578|Antiemetics|antiemetics|mesh-ancestor
110716198|NCT03932578|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110716199|NCT03932578|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110716200|NCT03932578|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110716201|NCT03932578|Dopamine Agents|dopamine agents|mesh-ancestor
110716202|NCT00258440|Epoetin Alfa|epoetin alfa|mesh-list
110716203|NCT00258440|Hematinics|hematinics|mesh-ancestor
110716204|NCT01329250|Moxifloxacin|moxifloxacin|mesh-list
110716205|NCT01329250|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110716206|NCT01329250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110716207|NCT01329250|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110716208|NCT01329250|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110716209|NCT01329250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110716210|NCT01329250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110716211|NCT01329250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110716212|NCT00224120|Silodosin|silodosin|mesh-list
110716213|NCT00224120|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110716214|NCT00224120|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110716216|NCT00224120|Adrenergic Agents|adrenergic agents|mesh-ancestor
110716217|NCT00224120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110716218|NCT00224120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110716219|NCT00224120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110716220|NCT00224120|Urological Agents|urological agents|mesh-ancestor
110716221|NCT01226446|Vitamin D|vitamin d|mesh-list
110716222|NCT01226446|Vitamins|vitamins|mesh-ancestor
110716223|NCT01226446|Micronutrients|micronutrients|mesh-ancestor
110716224|NCT01226446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110716225|NCT01226446|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110716226|NCT01224418|Tacrolimus|tacrolimus|mesh-list
110716227|NCT01224418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110716228|NCT01224418|Immunologic Factors|immunologic factors|mesh-ancestor
110716229|NCT01224418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110716230|NCT01224418|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110716231|NCT01224418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110716232|NCT01224418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110716233|NCT00257660|Botulinum Toxins|botulinum toxins|mesh-list
110716234|NCT00257660|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110716235|NCT00257660|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110716236|NCT00257660|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110716237|NCT00257660|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110716238|NCT00257660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110716239|NCT00257660|Cholinergic Agents|cholinergic agents|mesh-ancestor
110716240|NCT00257660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110716241|NCT00257660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110716242|NCT00257660|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110716243|NCT00257660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110716244|NCT01129180|Azacitidine|azacitidine|mesh-list
110716245|NCT01129180|Bortezomib|bortezomib|mesh-list
110716246|NCT01129180|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110716247|NCT01129180|Antimetabolites|antimetabolites|mesh-ancestor
110716248|NCT01129180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110716249|NCT01129180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110716250|NCT01129180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110716251|NCT00224042|Ferric gluconate|ferric gluconate|mesh-list
110716252|NCT00224042|Hematinics|hematinics|mesh-ancestor
110716253|NCT01129258|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1h-imidazol-1-yl)propanamido)nicotinic acid|mesh-list
110716254|NCT01129258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110716255|NCT01129258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110716256|NCT01221376|Imatinib Mesylate|imatinib mesylate|mesh-list
110716257|NCT01221376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110716258|NCT01221376|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110716259|NCT01221376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110716260|NCT01221376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110716262|NCT01224652|Irinotecan|irinotecan|mesh-list
110716263|NCT01224652|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110716264|NCT01224652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110716265|NCT01224652|Tubulin Modulators|tubulin modulators|mesh-ancestor
110716266|NCT01224652|Antimitotic Agents|antimitotic agents|mesh-ancestor
110716267|NCT01224652|Mitosis Modulators|mitosis modulators|mesh-ancestor
110716268|NCT01224652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110716269|NCT01224652|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110716270|NCT01224652|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110716271|NCT01224652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110716272|NCT00160706|Certolizumab Pegol|certolizumab pegol|mesh-list
110716273|NCT00160706|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110716274|NCT00160706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110716275|NCT00160706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110716276|NCT00160706|Immunologic Factors|immunologic factors|mesh-ancestor
110716277|NCT00160706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110716278|NCT00160706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110716279|NCT01226602|Ticagrelor|ticagrelor|mesh-list
110716280|NCT01226602|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110716281|NCT01226602|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110716282|NCT01226602|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110716283|NCT01226602|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110716284|NCT01226602|Purinergic Agents|purinergic agents|mesh-ancestor
110716285|NCT01226602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110716286|NCT01226602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110716287|NCT01226602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110716288|NCT01226680|Tofacitinib|tofacitinib|mesh-list
110716289|NCT01226680|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
110716290|NCT01226680|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110716291|NCT01226680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110716292|NCT01226680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110716293|NCT00257192|Ziprasidone|ziprasidone|mesh-list
110716294|NCT00257192|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110716295|NCT00257192|Serotonin Agents|serotonin agents|mesh-ancestor
110716296|NCT00257192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110716297|NCT00257192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110716298|NCT00257192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110716299|NCT00257192|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110716300|NCT00257192|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110716301|NCT00257192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110716302|NCT00257192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110716303|NCT00257192|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110138943|NCT03707951|Acetylcysteine|acetylcysteine|mesh-list
110716304|NCT00257192|Dopamine Agents|dopamine agents|mesh-ancestor
110716305|NCT01224964|Montelukast|montelukast|mesh-list
110716306|NCT01224964|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110716307|NCT01224964|Respiratory System Agents|respiratory system agents|mesh-ancestor
110716308|NCT01224964|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110716309|NCT01224964|Hormone Antagonists|hormone antagonists|mesh-ancestor
110716310|NCT01224964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110716311|NCT01224964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110716312|NCT01224964|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110716313|NCT01224964|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110716314|NCT01224964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110716315|NCT03967964|Methyltestosterone|methyltestosterone|mesh-list
110716316|NCT03967964|Testosterone|testosterone|mesh-list
110716317|NCT03967964|Testosterone undecanoate|testosterone undecanoate|mesh-list
110716318|NCT03967964|Testosterone enanthate|testosterone enanthate|mesh-list
110716319|NCT03967964|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
110443981|NCT00870727|Dopamine Agonists|dopamine agonists|mesh-ancestor
110716320|NCT03967964|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
110716321|NCT03967964|Androgens|androgens|mesh-ancestor
110716323|NCT03967964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110716324|NCT03967964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110716325|NCT03967964|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110716326|NCT03967964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110716327|NCT03967964|Anabolic Agents|anabolic agents|mesh-ancestor
110716328|NCT03967964|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110716329|NCT03967964|Immunologic Factors|immunologic factors|mesh-ancestor
110716330|NCT01129414|Omeprazole|omeprazole|mesh-list
110716331|NCT01129414|Clopidogrel|clopidogrel|mesh-list
110716332|NCT01129414|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110716333|NCT01129414|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110716334|NCT01129414|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110716335|NCT01129414|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110716336|NCT01129414|Purinergic Agents|purinergic agents|mesh-ancestor
110716337|NCT01129414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110716338|NCT01129414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110716339|NCT01129414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110716340|NCT01129414|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110716341|NCT01129414|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110716342|NCT01129414|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110716343|NCT01129414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110716344|NCT03967886|Esomeprazole|esomeprazole|mesh-list
110716345|NCT03967886|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110716346|NCT03967886|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110716347|NCT03967886|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110716348|NCT03967886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110716349|NCT03967886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110716350|NCT03968042|Thiamine|thiamine|mesh-list
110716351|NCT03968042|Edaravone|edaravone|mesh-list
110716352|NCT03968042|Mitogens|mitogens|mesh-list
110716353|NCT03968042|Vitamins|vitamins|mesh-ancestor
110716354|NCT03968042|Micronutrients|micronutrients|mesh-ancestor
110716355|NCT03968042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110716356|NCT03968042|Mitosis Modulators|mitosis modulators|mesh-ancestor
110716357|NCT03968042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110716358|NCT03968042|Vitamin B Complex|vitamin b complex|mesh-ancestor
110716359|NCT03968042|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110716360|NCT03968042|Antioxidants|antioxidants|mesh-ancestor
110716361|NCT03968042|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110716362|NCT03968042|Protective Agents|protective agents|mesh-ancestor
110716363|NCT01128322|Niacin|niacin|mesh-list
110716364|NCT01128322|Amlodipine|amlodipine|mesh-list
110716365|NCT01128322|Telmisartan|telmisartan|mesh-list
110716366|NCT01128322|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110716367|NCT01128322|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110716368|NCT01128322|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110716369|NCT01128322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110716370|NCT01128322|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110716371|NCT01128322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110716372|NCT01128322|Vasodilator Agents|vasodilator agents|mesh-ancestor
110716373|NCT01128322|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110716374|NCT01128322|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110716375|NCT01128322|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110716376|NCT01128322|Antimetabolites|antimetabolites|mesh-ancestor
110716377|NCT01128322|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110716378|NCT01128322|Vitamin B Complex|vitamin b complex|mesh-ancestor
110716379|NCT01128322|Vitamins|vitamins|mesh-ancestor
110716380|NCT01128322|Micronutrients|micronutrients|mesh-ancestor
110716381|NCT01129570|Silybin|silybin|mesh-list
110716382|NCT01129570|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110716383|NCT01129570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110716384|NCT01129570|Protective Agents|protective agents|mesh-ancestor
110716385|NCT01129570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110716386|NCT01073540|Cephalexin|cephalexin|mesh-list
110716387|NCT01073540|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110716388|NCT01073540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110716389|NCT03740386|Phentolamine|phentolamine|mesh-list
110716390|NCT03740386|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110716391|NCT03740386|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110716392|NCT03740386|Adrenergic Agents|adrenergic agents|mesh-ancestor
110716393|NCT03740386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110716394|NCT03740386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110716395|NCT03740386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110716396|NCT03740386|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110716398|NCT03927352|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110716399|NCT03927352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110716400|NCT03927352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110716401|NCT01225198|Vitamins|vitamins|mesh-list
110716402|NCT01225198|Micronutrients|micronutrients|mesh-ancestor
110716403|NCT01225198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110716404|NCT01226992|Vancomycin|vancomycin|mesh-list
110716405|NCT01226992|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110716406|NCT01226992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110716407|NCT01128556|Bepotastine besilate|bepotastine besilate|mesh-list
110716408|NCT01128556|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110716409|NCT03740464|Lenograstim|lenograstim|mesh-list
110716410|NCT03740464|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110716411|NCT03740464|Immunologic Factors|immunologic factors|mesh-ancestor
110716412|NCT03740464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110716413|NCT03927118|Dexamethasone|dexamethasone|mesh-list
110716414|NCT03927118|Dexamethasone acetate|dexamethasone acetate|mesh-list
110716415|NCT03927118|BB 1101|bb 1101|mesh-list
110716416|NCT03927118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110716417|NCT03927118|Antiemetics|antiemetics|mesh-ancestor
110716418|NCT03927118|Autonomic Agents|autonomic agents|mesh-ancestor
110716419|NCT03927118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110716420|NCT03927118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110716421|NCT03927118|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110716422|NCT03927118|Glucocorticoids|glucocorticoids|mesh-ancestor
110716423|NCT03927118|Hormones|hormones|mesh-ancestor
110716424|NCT03927118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110716425|NCT03927118|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110716426|NCT03927118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110716427|NCT03927118|Protease Inhibitors|protease inhibitors|mesh-ancestor
110716428|NCT03927118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110716429|NCT03927118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110716430|NCT01227148|Insulin|insulin|mesh-list
110716431|NCT01227148|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110716432|NCT01227148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110716433|NCT01227226|Lubricant Eye Drops|lubricant eye drops|mesh-list
110716434|NCT01227226|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110716435|NCT01227226|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110716436|NCT01127308|Ertugliflozin|ertugliflozin|mesh-list
110716437|NCT01127308|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110716438|NCT01127308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110716439|NCT01127308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110716440|NCT01127308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110716441|NCT01128712|Pregabalin|pregabalin|mesh-list
110716442|NCT01128712|Analgesics|analgesics|mesh-ancestor
110716443|NCT01128712|Sensory System Agents|sensory system agents|mesh-ancestor
110716444|NCT01128712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110716445|NCT01128712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110716446|NCT01128712|Anticonvulsants|anticonvulsants|mesh-ancestor
110716447|NCT01128712|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110716448|NCT01128712|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110716449|NCT01128712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110716450|NCT01128712|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110716451|NCT01128712|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110716452|NCT01128712|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110716453|NCT01128712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110716454|NCT01128712|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110716455|NCT01127386|Lenalidomide|lenalidomide|mesh-list
110716456|NCT01127386|Immunologic Factors|immunologic factors|mesh-ancestor
110716457|NCT01127386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110716458|NCT01127386|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110716459|NCT01127386|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110716460|NCT01127386|Growth Substances|growth substances|mesh-ancestor
110716461|NCT01127386|Growth Inhibitors|growth inhibitors|mesh-ancestor
110716462|NCT01127386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110716463|NCT01130194|Procarbazine|procarbazine|mesh-list
110716464|NCT01130194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110716465|NCT01225744|Oxaliplatin|oxaliplatin|mesh-list
110716466|NCT01225744|Irinotecan|irinotecan|mesh-list
110716467|NCT01225744|Cetuximab|cetuximab|mesh-list
110716468|NCT01225744|Tegafur|tegafur|mesh-list
110716469|NCT01225744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110716470|NCT01225744|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110716471|NCT01225744|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110716472|NCT01225744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110716473|NCT01225744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110716474|NCT01225744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110716475|NCT01225744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110716476|NCT01225744|Antimetabolites|antimetabolites|mesh-ancestor
110716477|NCT03926806|Vitamins|vitamins|mesh-list
110716478|NCT03926806|Vitamin B Complex|vitamin b complex|mesh-list
110716479|NCT03926806|Micronutrients|micronutrients|mesh-ancestor
110434327|NCT02668861|Vitamin D|vitamin d|mesh-list
110716480|NCT03926806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110716481|NCT03926962|Nafithromycin|nafithromycin|mesh-list
110716482|NCT03926962|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110716483|NCT03926962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110716484|NCT03926962|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110716485|NCT03926962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110716486|NCT03926962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110716487|NCT03919786|Anesthetics|anesthetics|mesh-list
110716488|NCT03919786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110716489|NCT03919786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110716490|NCT03924544|Mitomycins|mitomycins|mesh-list
110716491|NCT03924544|Mitomycin|mitomycin|mesh-list
110716492|NCT03924544|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110716493|NCT03924544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110716494|NCT03924544|Alkylating Agents|alkylating agents|mesh-ancestor
110716495|NCT03924544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110716496|NCT03924544|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110716497|NCT03924544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110716498|NCT01131364|Doxorubicin|doxorubicin|mesh-list
110716499|NCT01131364|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110716500|NCT01131364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110716501|NCT01131364|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110716502|NCT01131364|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110716503|NCT01131364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110716504|NCT01131364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110716505|NCT02529202|Dexmedetomidine|dexmedetomidine|mesh-list
110716506|NCT02529202|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110716507|NCT02529202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110716508|NCT02529202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110716509|NCT02529202|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110716510|NCT02529202|Analgesics|analgesics|mesh-ancestor
110716511|NCT02529202|Sensory System Agents|sensory system agents|mesh-ancestor
110716512|NCT02529202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110716513|NCT02529202|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110716514|NCT02529202|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110716515|NCT02529202|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110716516|NCT02529202|Adrenergic Agents|adrenergic agents|mesh-ancestor
110716517|NCT02529202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110716518|NCT02529202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110716519|NCT00154310|Cyclosporine|cyclosporine|mesh-list
110716520|NCT00154310|Mycophenolic Acid|mycophenolic acid|mesh-list
110716521|NCT00154310|Everolimus|everolimus|mesh-list
110716522|NCT00154310|Cyclosporins|cyclosporins|mesh-list
110716523|NCT00154310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110716524|NCT00154310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110716525|NCT00154310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110716526|NCT00154310|Immunologic Factors|immunologic factors|mesh-ancestor
110716527|NCT00154310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110716528|NCT00154310|Antifungal Agents|antifungal agents|mesh-ancestor
110716529|NCT00154310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110716530|NCT00154310|Dermatologic Agents|dermatologic agents|mesh-ancestor
110716531|NCT00154310|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110716532|NCT00154310|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110716533|NCT00154310|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110716534|NCT00154310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110716535|NCT00154310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110716536|NCT00154310|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110716537|NCT00154310|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110716538|NCT00154310|Antitubercular Agents|antitubercular agents|mesh-ancestor
110716539|NCT00154310|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110716540|NCT03770728|Metformin|metformin|mesh-list
110716541|NCT03770728|Efpeglenatide|efpeglenatide|mesh-list
110716542|NCT03770728|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110716543|NCT03770728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110716544|NCT01132222|Ibuprofen|ibuprofen|mesh-list
110716545|NCT01132222|Pseudoephedrine|pseudoephedrine|mesh-list
110716546|NCT01132222|Ephedrine|ephedrine|mesh-list
110716547|NCT01132222|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110716548|NCT01132222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110716549|NCT01132222|Analgesics|analgesics|mesh-ancestor
110716550|NCT01132222|Sensory System Agents|sensory system agents|mesh-ancestor
110716551|NCT01132222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110716552|NCT01132222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110716553|NCT01132222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110716554|NCT01132222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110716555|NCT01132222|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110716556|NCT01132222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110716557|NCT01132222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110716558|NCT01132222|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110716559|NCT01132222|Autonomic Agents|autonomic agents|mesh-ancestor
110716560|NCT01132222|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110716561|NCT01132222|Respiratory System Agents|respiratory system agents|mesh-ancestor
110716562|NCT01132222|Nasal Decongestants|nasal decongestants|mesh-ancestor
110716563|NCT01132222|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110716564|NCT01132222|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110716565|NCT01132222|Sympathomimetics|sympathomimetics|mesh-ancestor
110716566|NCT01132222|Adrenergic Agents|adrenergic agents|mesh-ancestor
110716567|NCT01132222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110716568|NCT03926182|Aflutinib|aflutinib|mesh-list
110716569|NCT03926182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110716570|NCT03926182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110716571|NCT03926182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110716572|NCT01130506|Cytarabine|cytarabine|mesh-list
110716573|NCT01130506|Decitabine|decitabine|mesh-list
110716574|NCT01130506|Vorinostat|vorinostat|mesh-list
110716575|NCT01130506|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110716576|NCT01130506|Antimetabolites|antimetabolites|mesh-ancestor
110716577|NCT01130506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110716578|NCT01130506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110716579|NCT01130506|Antiviral Agents|antiviral agents|mesh-ancestor
110716580|NCT01130506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110716581|NCT01130506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110716582|NCT01130506|Immunologic Factors|immunologic factors|mesh-ancestor
110716583|NCT01130506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110716584|NCT01130506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110716585|NCT01130506|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110716586|NCT01130662|Decitabine|decitabine|mesh-list
110716587|NCT01130662|Midostaurin|midostaurin|mesh-list
110716588|NCT01130662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110716589|NCT01130662|Antimetabolites|antimetabolites|mesh-ancestor
110716590|NCT01130662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110716591|NCT01130662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110716592|NCT01130662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110716593|NCT01130662|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110716594|NCT03925714|Metformin|metformin|mesh-list
110716595|NCT03925714|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110716596|NCT03925714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110716597|NCT01228552|Ketoprofen|ketoprofen|mesh-list
110716598|NCT01228552|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110716599|NCT01228552|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110716600|NCT01228552|Analgesics|analgesics|mesh-ancestor
110716601|NCT01228552|Sensory System Agents|sensory system agents|mesh-ancestor
110716602|NCT01228552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110716603|NCT01228552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110716604|NCT01228552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110716605|NCT01228552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110716606|NCT01228552|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110716607|NCT01228552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110716608|NCT01228552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110716609|NCT03919084|Nicotine|nicotine|mesh-list
110716610|NCT03919084|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110716611|NCT03919084|Autonomic Agents|autonomic agents|mesh-ancestor
110716612|NCT03919084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110716613|NCT03919084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110716614|NCT03919084|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110716615|NCT03919084|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110716616|NCT03919084|Cholinergic Agents|cholinergic agents|mesh-ancestor
110716617|NCT03919084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110716618|NCT03919084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110716620|NCT03923842|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110716621|NCT03923842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110716622|NCT01132768|Atenolol|atenolol|mesh-list
110716623|NCT01132768|Olmesartan|olmesartan|mesh-list
110716624|NCT01132768|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
110716625|NCT01132768|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110716626|NCT01132768|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110716627|NCT01132768|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110716628|NCT01132768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110434477|NCT02666209|Antiemetics|antiemetics|mesh-ancestor
110716629|NCT01132768|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110716630|NCT01132768|Sympatholytics|sympatholytics|mesh-ancestor
110716632|NCT01132768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110716633|NCT01132768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110716634|NCT01132768|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110716635|NCT01132768|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110716636|NCT01132768|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110716637|NCT01132768|Adrenergic Agents|adrenergic agents|mesh-ancestor
110716638|NCT01132768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110716639|NCT01230034|Ramipril|ramipril|mesh-list
110716640|NCT01230034|Imidapril|imidapril|mesh-list
110716641|NCT01230034|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110716642|NCT01230034|Protease Inhibitors|protease inhibitors|mesh-ancestor
110716643|NCT01230034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110716644|NCT01230034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110716645|NCT01230034|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110716646|NCT03918616|Dopamine|dopamine|mesh-list
110716647|NCT03918616|Memantine|memantine|mesh-list
110716648|NCT03918616|Dopamine Agonists|dopamine agonists|mesh-list
110716649|NCT03918616|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110716650|NCT03918616|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110716651|NCT03918616|Dopamine Agents|dopamine agents|mesh-ancestor
110716652|NCT03918616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110716653|NCT03918616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110716654|NCT03918616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110716655|NCT03918616|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110716656|NCT03918616|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110716657|NCT03918616|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110716658|NCT03918616|Sympathomimetics|sympathomimetics|mesh-ancestor
110716659|NCT03918616|Autonomic Agents|autonomic agents|mesh-ancestor
110716660|NCT03918616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110716661|NCT03918616|Protective Agents|protective agents|mesh-ancestor
110716662|NCT01228630|Loratadine|loratadine|mesh-list
110716663|NCT01228630|Fexofenadine|fexofenadine|mesh-list
110716664|NCT01228630|Pseudoephedrine|pseudoephedrine|mesh-list
110716665|NCT01228630|Ephedrine|ephedrine|mesh-list
110716666|NCT01228630|Antipruritics|antipruritics|mesh-ancestor
110716667|NCT01228630|Dermatologic Agents|dermatologic agents|mesh-ancestor
110139039|NCT03534323|Venetoclax|venetoclax|mesh-list
110716668|NCT01228630|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110716669|NCT01228630|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110716670|NCT01228630|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110716671|NCT01228630|Histamine Antagonists|histamine antagonists|mesh-ancestor
110716672|NCT01228630|Histamine Agents|histamine agents|mesh-ancestor
110716673|NCT01228630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110716674|NCT01228630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110716675|NCT01228630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110716676|NCT01228630|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110716677|NCT01228630|Autonomic Agents|autonomic agents|mesh-ancestor
110716678|NCT01228630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110716679|NCT01228630|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110716680|NCT01228630|Respiratory System Agents|respiratory system agents|mesh-ancestor
110716681|NCT01228630|Nasal Decongestants|nasal decongestants|mesh-ancestor
110716682|NCT01228630|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110716683|NCT01228630|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110716684|NCT01228630|Sympathomimetics|sympathomimetics|mesh-ancestor
110716685|NCT01228630|Adrenergic Agents|adrenergic agents|mesh-ancestor
110716686|NCT01134406|Hylan|hylan|mesh-list
110716687|NCT01134406|Viscosupplements|viscosupplements|mesh-ancestor
110346523|NCT04524689|Pemetrexed|pemetrexed|mesh-list
110716688|NCT01134406|Protective Agents|protective agents|mesh-ancestor
110716689|NCT01134406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110716690|NCT01231828|Lactulose|lactulose|mesh-list
110716691|NCT01231828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110716692|NCT03923218|Vitamin D|vitamin d|mesh-list
110716693|NCT03923218|Cholecalciferol|cholecalciferol|mesh-list
110716694|NCT03923218|Vitamins|vitamins|mesh-ancestor
110716695|NCT03923218|Micronutrients|micronutrients|mesh-ancestor
110716696|NCT03923218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110716697|NCT03923218|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110716698|NCT03923218|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110716699|NCT03923140|Tranilast|tranilast|mesh-list
110716700|NCT03923140|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110716701|NCT03923140|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110716702|NCT03923140|Analgesics|analgesics|mesh-ancestor
110716703|NCT03923140|Sensory System Agents|sensory system agents|mesh-ancestor
110716704|NCT03923140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110716705|NCT03923140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110716706|NCT03923140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110716707|NCT03923140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110716708|NCT03923140|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110716709|NCT03923140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110716710|NCT03923140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110716711|NCT03923140|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110716712|NCT03923140|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110716713|NCT03923140|Histamine Antagonists|histamine antagonists|mesh-ancestor
110716714|NCT03923140|Histamine Agents|histamine agents|mesh-ancestor
110716715|NCT03923140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110716716|NCT03923140|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110716717|NCT03923140|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110716718|NCT01133080|Minocycline|minocycline|mesh-list
110139067|NCT03414658|Avelumab|avelumab|mesh-list
110716719|NCT01133080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110716720|NCT01133080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110716721|NCT01230580|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
110716722|NCT01230580|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
110716723|NCT01230580|Protease Inhibitors|protease inhibitors|mesh-list
110716724|NCT01230580|Antiviral Agents|antiviral agents|mesh-ancestor
110716725|NCT01230580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110716726|NCT01230580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110716727|NCT01230580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110716728|NCT01230580|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110716729|NCT01230580|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110716730|NCT01585792|Glimepiride|glimepiride|mesh-list
110716731|NCT01585792|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110716732|NCT01585792|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110716733|NCT01585792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110716734|NCT01585792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110716735|NCT01585792|Immunologic Factors|immunologic factors|mesh-ancestor
110716736|NCT01134484|Thalidomide|thalidomide|mesh-list
110716737|NCT01134484|Dexamethasone|dexamethasone|mesh-list
110716738|NCT01134484|Bortezomib|bortezomib|mesh-list
110716739|NCT01134484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110716740|NCT01134484|Antiemetics|antiemetics|mesh-ancestor
110716741|NCT01134484|Autonomic Agents|autonomic agents|mesh-ancestor
110716742|NCT01134484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110716743|NCT01134484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110716744|NCT01134484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110716745|NCT01134484|Glucocorticoids|glucocorticoids|mesh-ancestor
110716746|NCT01134484|Hormones|hormones|mesh-ancestor
110716747|NCT01134484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110716748|NCT01134484|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110716749|NCT01134484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110716750|NCT01134484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110716751|NCT01134484|Immunologic Factors|immunologic factors|mesh-ancestor
110716752|NCT01134484|Leprostatic Agents|leprostatic agents|mesh-ancestor
110716753|NCT01134484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110716754|NCT01134484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110716755|NCT01134484|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110716756|NCT01134484|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110716757|NCT01134484|Growth Substances|growth substances|mesh-ancestor
110716758|NCT01134484|Growth Inhibitors|growth inhibitors|mesh-ancestor
110716759|NCT01133470|Fexofenadine|fexofenadine|mesh-list
110716760|NCT01133470|Pseudoephedrine|pseudoephedrine|mesh-list
110716761|NCT01133470|Ephedrine|ephedrine|mesh-list
110716762|NCT01133470|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110716763|NCT01133470|Autonomic Agents|autonomic agents|mesh-ancestor
110716764|NCT01133470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110716765|NCT01133470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110716766|NCT01133470|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110716767|NCT01133470|Respiratory System Agents|respiratory system agents|mesh-ancestor
110716768|NCT01133470|Nasal Decongestants|nasal decongestants|mesh-ancestor
110716769|NCT01133470|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110716770|NCT01133470|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110716771|NCT01133470|Sympathomimetics|sympathomimetics|mesh-ancestor
110716772|NCT01133470|Adrenergic Agents|adrenergic agents|mesh-ancestor
110716773|NCT01133470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110716774|NCT01133470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110716775|NCT01133470|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110716776|NCT01133470|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110716777|NCT01133470|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110716778|NCT01133470|Histamine Antagonists|histamine antagonists|mesh-ancestor
110716779|NCT01133470|Histamine Agents|histamine agents|mesh-ancestor
110716781|NCT01134718|Antiviral Agents|antiviral agents|mesh-ancestor
110716782|NCT01134718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110716783|NCT01134718|Protease Inhibitors|protease inhibitors|mesh-ancestor
110716784|NCT01134718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110716785|NCT01134718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110716786|NCT03917758|Dapagliflozin|dapagliflozin|mesh-list
110716787|NCT03917758|Empagliflozin|empagliflozin|mesh-list
110716788|NCT03917758|Canagliflozin|canagliflozin|mesh-list
110716789|NCT03917758|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
110716790|NCT03917758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110716791|NCT03917758|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110716792|NCT03917758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110716793|NCT01230736|Timolol|timolol|mesh-list
110716794|NCT01230736|Travoprost|travoprost|mesh-list
110716795|NCT01230736|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110716796|NCT01230736|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110716797|NCT01230736|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110716798|NCT01230736|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110716799|NCT01230736|Adrenergic Agents|adrenergic agents|mesh-ancestor
110716800|NCT01230736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110716801|NCT01230736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110716802|NCT01230736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110716803|NCT01230736|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110716804|NCT01230736|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110716805|NCT01133548|Methyltestosterone|methyltestosterone|mesh-list
110716806|NCT01133548|Testosterone|testosterone|mesh-list
110716807|NCT01133548|Testosterone undecanoate|testosterone undecanoate|mesh-list
110716808|NCT01133548|Testosterone enanthate|testosterone enanthate|mesh-list
110716809|NCT01133548|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
110716810|NCT01133548|Androgens|androgens|mesh-ancestor
110716811|NCT01133548|Hormones|hormones|mesh-ancestor
110716812|NCT01133548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110716813|NCT01133548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110716814|NCT01133548|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110716815|NCT01133548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110716816|NCT01133548|Anabolic Agents|anabolic agents|mesh-ancestor
110716817|NCT03917134|Metronidazole|metronidazole|mesh-list
110716818|NCT03917134|Cephalosporins|cephalosporins|mesh-list
110716819|NCT03917134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110716820|NCT03917134|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110716821|NCT03917134|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110716822|NCT03917134|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110716823|NCT01232140|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110716824|NCT01232140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110716825|NCT01231126|Misoprostol|misoprostol|mesh-list
110716826|NCT01231126|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110716827|NCT01231126|Abortifacient Agents|abortifacient agents|mesh-ancestor
110716828|NCT01231126|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110716829|NCT01231126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110716830|NCT01231126|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110716831|NCT01231126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110716832|NCT01231126|Oxytocics|oxytocics|mesh-ancestor
110716833|NCT03769090|Budesonide|budesonide|mesh-list
110716834|NCT03769090|Albuterol|albuterol|mesh-list
110716835|NCT03769090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110443994|NCT02787928|Narcotics|narcotics|mesh-ancestor
110716836|NCT03769090|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110716838|NCT03769090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110716839|NCT03769090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110716840|NCT03769090|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110716841|NCT03769090|Respiratory System Agents|respiratory system agents|mesh-ancestor
110716843|NCT03769090|Hormones|hormones|mesh-ancestor
110716844|NCT03769090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110716845|NCT03769090|Tocolytic Agents|tocolytic agents|mesh-ancestor
110716846|NCT03769090|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110716847|NCT03769090|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110716848|NCT03769090|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110716849|NCT03769090|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110716850|NCT03769090|Adrenergic Agents|adrenergic agents|mesh-ancestor
110716851|NCT03769090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110716852|NCT03769090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110716853|NCT03921736|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110716854|NCT03921736|Perindopril|perindopril|mesh-list
110434703|NCT01143402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110716855|NCT03921736|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110716856|NCT03921736|Diuretics|diuretics|mesh-ancestor
110716857|NCT03921736|Natriuretic Agents|natriuretic agents|mesh-ancestor
110716858|NCT03921736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110716859|NCT03921736|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110716860|NCT03921736|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110716861|NCT03921736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110716862|NCT03921736|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110716863|NCT03921736|Protease Inhibitors|protease inhibitors|mesh-ancestor
110716864|NCT03921736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110716865|NCT05401006|Acitretin|acitretin|mesh-list
110716866|NCT05401006|Keratolytic Agents|keratolytic agents|mesh-ancestor
110716867|NCT05401006|Dermatologic Agents|dermatologic agents|mesh-ancestor
110716868|NCT01232374|Nimotuzumab|nimotuzumab|mesh-list
110716869|NCT01232374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110716870|NCT01232374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110716871|NCT01231438|Alfacalcidol|alfacalcidol|mesh-list
110716872|NCT01231438|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110716873|NCT01231438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110716874|NCT01131754|Heparin|heparin|mesh-list
110716875|NCT01131754|Anticoagulants|anticoagulants|mesh-ancestor
110716876|NCT01131754|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110716877|NCT01131754|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110716878|NCT01131754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110716879|NCT01231594|Trametinib|trametinib|mesh-list
110716880|NCT01231594|Dabrafenib|dabrafenib|mesh-list
110716881|NCT01231594|Antineoplastic Agents|antineoplastic agents|mesh-list
110716882|NCT01231594|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110716883|NCT01231594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110716884|NCT01231594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110716885|NCT01136278|Clonidine|clonidine|mesh-list
110716886|NCT01136278|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
110716887|NCT01136278|Analgesics|analgesics|mesh-ancestor
110716888|NCT01136278|Sensory System Agents|sensory system agents|mesh-ancestor
110716889|NCT01136278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110716890|NCT01136278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110716891|NCT01136278|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110716892|NCT01136278|Sympatholytics|sympatholytics|mesh-ancestor
110716893|NCT01136278|Autonomic Agents|autonomic agents|mesh-ancestor
110716894|NCT01136278|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110716895|NCT01136278|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110716896|NCT01136278|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110716897|NCT01136278|Adrenergic Agents|adrenergic agents|mesh-ancestor
110716898|NCT01136278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110716899|NCT01136278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110716900|NCT01136278|Hallucinogens|hallucinogens|mesh-ancestor
110716901|NCT01136278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110716902|NCT01136278|Serotonin Agents|serotonin agents|mesh-ancestor
110716903|NCT01136278|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110716904|NCT01136278|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110716905|NCT01136278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110716906|NCT05402722|Antibodies|antibodies|mesh-list
110716907|NCT05402722|Immunologic Factors|immunologic factors|mesh-ancestor
110716908|NCT05402722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110716910|NCT05480488|Warfarin|warfarin|mesh-list
110716911|NCT05480488|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110716912|NCT05480488|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110716913|NCT05480488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110716914|NCT05480488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110716915|NCT05480488|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110716916|NCT05480488|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110716917|NCT05480488|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110716918|NCT05480488|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110716919|NCT05480488|Anesthetics, General|anesthetics, general|mesh-ancestor
110716920|NCT05480488|Anesthetics|anesthetics|mesh-ancestor
110716921|NCT05480488|GABA Modulators|gaba modulators|mesh-ancestor
110716922|NCT05480488|GABA Agents|gaba agents|mesh-ancestor
110716923|NCT05480488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110716924|NCT05480488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110716925|NCT05480488|Anticoagulants|anticoagulants|mesh-ancestor
110716926|NCT01229332|Carbidopa|carbidopa|mesh-list
110716927|NCT01229332|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110716928|NCT01229332|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110716929|NCT01229332|Dopamine Agents|dopamine agents|mesh-ancestor
110434783|NCT01167192|Carboplatin|carboplatin|mesh-list
110716930|NCT01229332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110716931|NCT01229332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110716932|NCT01229332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110716933|NCT01229332|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
110716935|NCT03921034|Ropivacaine|ropivacaine|mesh-list
110716936|NCT03921034|Anesthetics, Local|anesthetics, local|mesh-ancestor
110716937|NCT03921034|Anesthetics|anesthetics|mesh-ancestor
110716938|NCT03921034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110716939|NCT03921034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110716940|NCT03921034|Sensory System Agents|sensory system agents|mesh-ancestor
110716941|NCT03921034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110716942|NCT01136590|Tranexamic Acid|tranexamic acid|mesh-list
110716943|NCT01136590|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110716944|NCT01136590|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110716945|NCT01136590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110716946|NCT01136590|Hemostatics|hemostatics|mesh-ancestor
110716947|NCT01136590|Coagulants|coagulants|mesh-ancestor
110716948|NCT03920878|Aflibercept|aflibercept|mesh-list
110716949|NCT03920878|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110716950|NCT03920878|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110716951|NCT03920878|Growth Substances|growth substances|mesh-ancestor
110716952|NCT03920878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110716953|NCT03920878|Growth Inhibitors|growth inhibitors|mesh-ancestor
110716954|NCT03920878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110716955|NCT03920644|Scopolamine|scopolamine|mesh-list
110716956|NCT03920644|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
110716957|NCT03920644|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110716958|NCT03920644|Antiemetics|antiemetics|mesh-ancestor
110716959|NCT03920644|Autonomic Agents|autonomic agents|mesh-ancestor
110716960|NCT03920644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110716961|NCT03920644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110716962|NCT03920644|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110716963|NCT03920644|Mydriatics|mydriatics|mesh-ancestor
110716964|NCT03920644|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110716965|NCT03920644|Cholinergic Agents|cholinergic agents|mesh-ancestor
110716966|NCT03920644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110716967|NCT03920644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110716968|NCT03920644|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110716969|NCT03920644|Parasympatholytics|parasympatholytics|mesh-ancestor
110716970|NCT01137916|Imatinib Mesylate|imatinib mesylate|mesh-list
110716971|NCT01137916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110716972|NCT01137916|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110716973|NCT01137916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110716974|NCT01137916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110716975|NCT01137994|Paclitaxel|paclitaxel|mesh-list
110716976|NCT01137994|Vinorelbine|vinorelbine|mesh-list
110716977|NCT01137994|Docetaxel|docetaxel|mesh-list
110716978|NCT01137994|Trastuzumab|trastuzumab|mesh-list
110716979|NCT01137994|Lapatinib|lapatinib|mesh-list
110716980|NCT01137994|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110716981|NCT01137994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110716982|NCT01137994|Tubulin Modulators|tubulin modulators|mesh-ancestor
110716984|NCT01137994|Mitosis Modulators|mitosis modulators|mesh-ancestor
110716985|NCT01137994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110716986|NCT01137994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110716987|NCT01137994|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110716988|NCT01137994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110716989|NCT01138072|Atorvastatin|atorvastatin|mesh-list
110716990|NCT01138072|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110716991|NCT01138072|Simvastatin|simvastatin|mesh-list
110716992|NCT01138072|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110716993|NCT01138072|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110716994|NCT01138072|Antimetabolites|antimetabolites|mesh-ancestor
110716995|NCT01138072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110716996|NCT01138072|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110716997|NCT01138072|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110716998|NCT01138072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110716999|NCT01131910|Vaccines|vaccines|mesh-list
110717000|NCT01131910|Immunologic Factors|immunologic factors|mesh-ancestor
110717001|NCT01131910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110717002|NCT03739606|Antibodies|antibodies|mesh-list
110717003|NCT03739606|Immunoglobulins|immunoglobulins|mesh-list
110717004|NCT03739606|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110717005|NCT03739606|Antibodies, Bispecific|antibodies, bispecific|mesh-list
110717006|NCT03739606|Immunologic Factors|immunologic factors|mesh-ancestor
110434852|NCT01129284|Hormones|hormones|mesh-ancestor
110717007|NCT03739606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110717008|NCT05533372|Methotrexate|methotrexate|mesh-list
110717009|NCT05533372|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110717010|NCT05533372|Abortifacient Agents|abortifacient agents|mesh-ancestor
110717011|NCT05533372|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110717012|NCT05533372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110717013|NCT05533372|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110717014|NCT05533372|Antimetabolites|antimetabolites|mesh-ancestor
110717015|NCT05533372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110717016|NCT05533372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110717017|NCT05533372|Dermatologic Agents|dermatologic agents|mesh-ancestor
110717018|NCT05533372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110717019|NCT05533372|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110717020|NCT05533372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110717021|NCT05533372|Immunologic Factors|immunologic factors|mesh-ancestor
110717022|NCT05533372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110717023|NCT05533372|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110717024|NCT01233622|Vildagliptin|vildagliptin|mesh-list
110717025|NCT01233622|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110717026|NCT01233622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110717027|NCT01233622|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110717028|NCT01233622|Protease Inhibitors|protease inhibitors|mesh-ancestor
110717029|NCT01233622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110717030|NCT01233622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110717031|NCT01138774|Thioctic Acid|thioctic acid|mesh-list
110717032|NCT01138774|Antioxidants|antioxidants|mesh-ancestor
110717033|NCT01138774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110717034|NCT01138774|Protective Agents|protective agents|mesh-ancestor
110717035|NCT01138774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110717036|NCT01138774|Vitamin B Complex|vitamin b complex|mesh-ancestor
110717037|NCT01138774|Vitamins|vitamins|mesh-ancestor
110717038|NCT01138774|Micronutrients|micronutrients|mesh-ancestor
110717039|NCT01131988|Tacrolimus|tacrolimus|mesh-list
110717040|NCT01131988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110717041|NCT01131988|Immunologic Factors|immunologic factors|mesh-ancestor
110717042|NCT01131988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110717043|NCT01131988|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110717044|NCT01131988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110717045|NCT01131988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110717046|NCT01138852|Ampicillin|ampicillin|mesh-list
110717047|NCT01138852|Cefuroxime|cefuroxime|mesh-list
110717048|NCT01138852|Cefuroxime axetil|cefuroxime axetil|mesh-list
110717049|NCT01138852|Sulbactam|sulbactam|mesh-list
110717050|NCT01138852|Sultamicillin|sultamicillin|mesh-list
110717051|NCT01138852|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110717052|NCT01138852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110717053|NCT01138852|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110717054|NCT01138852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110717055|NCT01138852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110717056|NCT05487196|Clonidine|clonidine|mesh-list
110717057|NCT05487196|Fentanyl|fentanyl|mesh-list
110717058|NCT05487196|Dexmedetomidine|dexmedetomidine|mesh-list
110717059|NCT05487196|Ropivacaine|ropivacaine|mesh-list
110717060|NCT05487196|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110717061|NCT05487196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110717062|NCT05487196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110717063|NCT05487196|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110717064|NCT05487196|Analgesics|analgesics|mesh-ancestor
110717065|NCT05487196|Sensory System Agents|sensory system agents|mesh-ancestor
110717066|NCT05487196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110717067|NCT05487196|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110717068|NCT05487196|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110717069|NCT05487196|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110717070|NCT05487196|Adrenergic Agents|adrenergic agents|mesh-ancestor
110717071|NCT05487196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110717072|NCT05487196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110717073|NCT05487196|Anesthetics, Local|anesthetics, local|mesh-ancestor
110717074|NCT05487196|Anesthetics|anesthetics|mesh-ancestor
110717075|NCT05487196|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110717076|NCT05487196|Narcotics|narcotics|mesh-ancestor
110717077|NCT05487196|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110717078|NCT05487196|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110717079|NCT05487196|Anesthetics, General|anesthetics, general|mesh-ancestor
110434942|NCT01221350|Vitamins|vitamins|mesh-ancestor
110717080|NCT05487196|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110717081|NCT05487196|Sympatholytics|sympatholytics|mesh-ancestor
110717082|NCT05487196|Autonomic Agents|autonomic agents|mesh-ancestor
110717083|NCT01585870|Sorafenib|sorafenib|mesh-list
110717084|NCT01585870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110717085|NCT01585870|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110717086|NCT01585870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110717087|NCT01585870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110717088|NCT05210140|Escitalopram|escitalopram|mesh-list
110717089|NCT05210140|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110717090|NCT05210140|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110717091|NCT05210140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110717092|NCT05210140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110717093|NCT05210140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110717094|NCT05210140|Serotonin Agents|serotonin agents|mesh-ancestor
110717095|NCT05210140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110717096|NCT01233934|Chlorpheniramine|chlorpheniramine|mesh-list
110717097|NCT01233934|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
110717098|NCT01233934|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110717099|NCT01233934|Histamine Antagonists|histamine antagonists|mesh-ancestor
110717100|NCT01233934|Histamine Agents|histamine agents|mesh-ancestor
110717101|NCT01233934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110717102|NCT01233934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110717103|NCT01233934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110717104|NCT01233934|Antipruritics|antipruritics|mesh-ancestor
110717105|NCT01233934|Dermatologic Agents|dermatologic agents|mesh-ancestor
110717106|NCT01233934|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110717107|NCT01236508|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110717108|NCT01236508|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110717109|NCT01236508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110717110|NCT05195944|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110717111|NCT05195944|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110717112|NCT05195944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110717113|NCT05195944|Incretins|incretins|mesh-ancestor
110717114|NCT05195944|Hormones|hormones|mesh-ancestor
110717115|NCT05195944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110717116|NCT05195944|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110717117|NCT05195944|Protease Inhibitors|protease inhibitors|mesh-ancestor
110717118|NCT05195944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110717119|NCT05195944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110717120|NCT01236586|Dexamethasone|dexamethasone|mesh-list
110862023|NCT05183841|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110717121|NCT01236586|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
110717122|NCT01236586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110717123|NCT01236586|Antiemetics|antiemetics|mesh-ancestor
110717124|NCT01236586|Autonomic Agents|autonomic agents|mesh-ancestor
110717125|NCT01236586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110717126|NCT01236586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110717127|NCT01236586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110717128|NCT01236586|Glucocorticoids|glucocorticoids|mesh-ancestor
110717129|NCT01236586|Hormones|hormones|mesh-ancestor
110717130|NCT01236586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110717131|NCT01236586|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110717132|NCT01236586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110717133|NCT01236586|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
110717134|NCT01236586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110717135|NCT01236586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110717136|NCT01234792|Nicotine|nicotine|mesh-list
110717137|NCT01234792|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110717138|NCT01234792|Autonomic Agents|autonomic agents|mesh-ancestor
110717139|NCT01234792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110717140|NCT01234792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110717141|NCT01234792|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110717142|NCT01234792|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110717143|NCT01234792|Cholinergic Agents|cholinergic agents|mesh-ancestor
110717144|NCT01234792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110717145|NCT01234792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110717146|NCT03467932|Insulin|insulin|mesh-list
110717147|NCT03467932|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110717148|NCT03467932|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110717149|NCT03467932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110717150|NCT01140100|Thiopental|thiopental|mesh-list
110717151|NCT01140100|Propofol|propofol|mesh-list
110717152|NCT01140100|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110717153|NCT01140100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110717154|NCT01140100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110717155|NCT01140100|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110717156|NCT01140100|Anesthetics, General|anesthetics, general|mesh-ancestor
110717158|NCT01140100|Anticonvulsants|anticonvulsants|mesh-ancestor
110717159|NCT01140100|GABA Modulators|gaba modulators|mesh-ancestor
110717160|NCT01140100|GABA Agents|gaba agents|mesh-ancestor
110717161|NCT01140100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110717162|NCT01140100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110717163|NCT01141036|Midazolam|midazolam|mesh-list
110717164|NCT01141036|Propofol|propofol|mesh-list
110717165|NCT01141036|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110717166|NCT01141036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110717167|NCT01141036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110717168|NCT01141036|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110717169|NCT01141036|Anesthetics, General|anesthetics, general|mesh-ancestor
110717170|NCT01141036|Anesthetics|anesthetics|mesh-ancestor
110717171|NCT01141036|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110717172|NCT01141036|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110717173|NCT01141036|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110717174|NCT01141036|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110717175|NCT01141036|GABA Modulators|gaba modulators|mesh-ancestor
110717176|NCT01141036|GABA Agents|gaba agents|mesh-ancestor
110717177|NCT01141036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110717178|NCT01141036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110717179|NCT04906720|Colchicine|colchicine|mesh-list
110717180|NCT04906720|Gout Suppressants|gout suppressants|mesh-ancestor
110717181|NCT04906720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110717182|NCT04906720|Tubulin Modulators|tubulin modulators|mesh-ancestor
110717183|NCT04906720|Antimitotic Agents|antimitotic agents|mesh-ancestor
110717184|NCT04906720|Mitosis Modulators|mitosis modulators|mesh-ancestor
110717185|NCT04906720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110717186|NCT04906720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110717187|NCT01141192|Vitamin D|vitamin d|mesh-list
110717188|NCT01141192|Cholecalciferol|cholecalciferol|mesh-list
110717189|NCT01141192|Vitamins|vitamins|mesh-ancestor
110717190|NCT01141192|Micronutrients|micronutrients|mesh-ancestor
110717191|NCT01141192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110717192|NCT01141192|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110717193|NCT01141192|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110717194|NCT01144000|Daptomycin|daptomycin|mesh-list
110717195|NCT01144000|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110717196|NCT01144000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110717197|NCT01140412|Ritonavir|ritonavir|mesh-list
110717198|NCT01140412|Fosamprenavir|fosamprenavir|mesh-list
110717199|NCT01140412|Maraviroc|maraviroc|mesh-list
110717200|NCT01140412|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110717201|NCT01140412|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110717202|NCT01140412|Protease Inhibitors|protease inhibitors|mesh-ancestor
110717203|NCT01140412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110717204|NCT01140412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110717205|NCT01140412|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110717206|NCT01140412|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110717207|NCT01140412|Antiviral Agents|antiviral agents|mesh-ancestor
110717208|NCT01140412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110717209|NCT01140412|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110717210|NCT01140412|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110717211|NCT01140412|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110717212|NCT01140412|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110717213|NCT01140412|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
110717214|NCT01234324|Cisplatin|cisplatin|mesh-list
110717215|NCT01234324|Capecitabine|capecitabine|mesh-list
110717216|NCT01234324|Epirubicin|epirubicin|mesh-list
110717217|NCT01234324|Panitumumab|panitumumab|mesh-list
110717218|NCT01234324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110717219|NCT01234324|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110717220|NCT01234324|Antimetabolites|antimetabolites|mesh-ancestor
110717221|NCT01234324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110717222|NCT01234324|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110717223|NCT01234324|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110717224|NCT01234324|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110717225|NCT01234324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110717226|NCT01234324|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110717227|NCT02334124|Ceftriaxone|ceftriaxone|mesh-list
110717228|NCT02334124|Floxacillin|floxacillin|mesh-list
110717229|NCT02334124|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110717230|NCT02334124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110435081|NCT01217060|Dexamethasone|dexamethasone|mesh-list
110717231|NCT01144156|Adalimumab|adalimumab|mesh-list
110717232|NCT01144156|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110717233|NCT01144156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110717234|NCT01144156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110717235|NCT01235260|Becaplermin|becaplermin|mesh-list
110717236|NCT01235260|Anticoagulants|anticoagulants|mesh-ancestor
110717237|NCT01235260|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
110717238|NCT01235260|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110717239|NCT01235260|Growth Substances|growth substances|mesh-ancestor
110862033|NCT05183841|Adrenergic Agents|adrenergic agents|mesh-ancestor
110717240|NCT01235260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110717241|NCT01144312|Fentanyl|fentanyl|mesh-list
110717242|NCT01144312|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110717243|NCT01144312|Narcotics|narcotics|mesh-ancestor
110717244|NCT01144312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110717245|NCT01144312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110717246|NCT01144312|Analgesics|analgesics|mesh-ancestor
110717247|NCT01144312|Sensory System Agents|sensory system agents|mesh-ancestor
110717248|NCT01144312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110717249|NCT01144312|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110717250|NCT01144312|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110717251|NCT01144312|Anesthetics, General|anesthetics, general|mesh-ancestor
110717252|NCT01144312|Anesthetics|anesthetics|mesh-ancestor
110717253|NCT01144390|Methadone|methadone|mesh-list
110717254|NCT01144390|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110717255|NCT01144390|Narcotics|narcotics|mesh-ancestor
110717256|NCT01144390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110717257|NCT01144390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110717258|NCT01144390|Analgesics|analgesics|mesh-ancestor
110717259|NCT01144390|Sensory System Agents|sensory system agents|mesh-ancestor
110717260|NCT01144390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110717261|NCT01144390|Antitussive Agents|antitussive agents|mesh-ancestor
110139197|NCT02965963|Protective Agents|protective agents|mesh-ancestor
110717262|NCT01144390|Respiratory System Agents|respiratory system agents|mesh-ancestor
110717263|NCT01329640|Paclitaxel|paclitaxel|mesh-list
110717264|NCT01329640|Cyclophosphamide|cyclophosphamide|mesh-list
110717265|NCT01329640|Trastuzumab|trastuzumab|mesh-list
110717266|NCT01329640|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110717267|NCT01329640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110717268|NCT01329640|Tubulin Modulators|tubulin modulators|mesh-ancestor
110717269|NCT01329640|Antimitotic Agents|antimitotic agents|mesh-ancestor
110717270|NCT01329640|Mitosis Modulators|mitosis modulators|mesh-ancestor
110717271|NCT01329640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110717272|NCT01329640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110717273|NCT01329640|Immunologic Factors|immunologic factors|mesh-ancestor
110717274|NCT01329640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110717275|NCT01329640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110347111|NCT04166435|Olaparib|olaparib|mesh-list
110717276|NCT01329640|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110717277|NCT01329640|Alkylating Agents|alkylating agents|mesh-ancestor
110717278|NCT01329640|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110717279|NCT01329640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110717280|NCT05335018|Lenalidomide|lenalidomide|mesh-list
110717281|NCT05335018|Immunologic Factors|immunologic factors|mesh-ancestor
110717282|NCT05335018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110717283|NCT05335018|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110717284|NCT05335018|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110717285|NCT05335018|Growth Substances|growth substances|mesh-ancestor
110717286|NCT05335018|Growth Inhibitors|growth inhibitors|mesh-ancestor
110717287|NCT05335018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110717288|NCT00114777|Cyclosporine|cyclosporine|mesh-list
110717289|NCT00114777|Abatacept|abatacept|mesh-list
110717290|NCT00114777|Cyclosporins|cyclosporins|mesh-list
110717291|NCT00114777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110717292|NCT00114777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110717293|NCT00114777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110717294|NCT00114777|Immunologic Factors|immunologic factors|mesh-ancestor
110717295|NCT00114777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110717296|NCT00114777|Antifungal Agents|antifungal agents|mesh-ancestor
110717297|NCT00114777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110717298|NCT00114777|Dermatologic Agents|dermatologic agents|mesh-ancestor
110717299|NCT00114777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110717300|NCT00114777|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110717301|NCT00114777|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110717302|NCT00114777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110717303|NCT00114777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110717304|NCT00139737|Ziprasidone|ziprasidone|mesh-list
110717305|NCT00139737|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110862065|NCT03276598|Diuretics|diuretics|mesh-ancestor
110717306|NCT00139737|Serotonin Agents|serotonin agents|mesh-ancestor
110717307|NCT00139737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110435148|NCT02663713|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110717308|NCT00139737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110717309|NCT00139737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110717310|NCT00139737|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110717311|NCT00139737|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110717312|NCT00139737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110717313|NCT00139737|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110717314|NCT00139737|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110717315|NCT00139737|Dopamine Agents|dopamine agents|mesh-ancestor
110717316|NCT00139659|Insulin|insulin|mesh-list
110717317|NCT00139659|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110717318|NCT00139659|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110717319|NCT00139659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110717320|NCT01076439|Fluticasone|fluticasone|mesh-list
110717322|NCT01076439|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
110717323|NCT01076439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110717324|NCT01076439|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110717325|NCT01076439|Autonomic Agents|autonomic agents|mesh-ancestor
110717326|NCT01076439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110717327|NCT01076439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110717328|NCT01076439|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110717329|NCT01076439|Respiratory System Agents|respiratory system agents|mesh-ancestor
110717330|NCT01076439|Dermatologic Agents|dermatologic agents|mesh-ancestor
110717331|NCT01076439|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110717332|NCT01076439|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110717333|NCT01076439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110717334|NCT01076439|Analgesics|analgesics|mesh-ancestor
110717335|NCT01076439|Sensory System Agents|sensory system agents|mesh-ancestor
110717336|NCT01076439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110717337|NCT01076439|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110717338|NCT01076439|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110717339|NCT01076439|Histamine Antagonists|histamine antagonists|mesh-ancestor
110717340|NCT01076439|Histamine Agents|histamine agents|mesh-ancestor
110717341|NCT01076439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110717342|NCT01076439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110717343|NCT03965637|Ascorbic Acid|ascorbic acid|mesh-list
110717344|NCT03965637|Vitamins|vitamins|mesh-ancestor
110717345|NCT03965637|Micronutrients|micronutrients|mesh-ancestor
110717346|NCT03965637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110717347|NCT03965637|Antioxidants|antioxidants|mesh-ancestor
110717348|NCT03965637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110717349|NCT03965637|Protective Agents|protective agents|mesh-ancestor
110717350|NCT01078779|Chloroquine|chloroquine|mesh-list
110717351|NCT01078779|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
110717352|NCT01078779|Amebicides|amebicides|mesh-ancestor
110717353|NCT01078779|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110717354|NCT01078779|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110717355|NCT01078779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110717356|NCT01078779|Antimalarials|antimalarials|mesh-ancestor
110717357|NCT01078779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110717358|NCT01078779|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110717359|NCT01078779|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110717360|NCT01078779|Analgesics|analgesics|mesh-ancestor
110717361|NCT01078779|Sensory System Agents|sensory system agents|mesh-ancestor
110717362|NCT01078779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110717363|NCT01078779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110717364|NCT01078779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110717365|NCT01078779|Filaricides|filaricides|mesh-ancestor
110717366|NCT01078779|Antinematodal Agents|antinematodal agents|mesh-ancestor
110717367|NCT01078779|Anthelmintics|anthelmintics|mesh-ancestor
110717368|NCT00114231|Capecitabine|capecitabine|mesh-list
110717369|NCT00114231|Oxaliplatin|oxaliplatin|mesh-list
110717370|NCT00114231|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110717371|NCT00114231|Antimetabolites|antimetabolites|mesh-ancestor
110717372|NCT00114231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110717373|NCT00114231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110717374|NCT00113919|Busulfan|busulfan|mesh-list
110717375|NCT00113919|Alkylating Agents|alkylating agents|mesh-ancestor
110717376|NCT00113919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110717377|NCT00113919|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110717378|NCT00113919|Immunologic Factors|immunologic factors|mesh-ancestor
110717379|NCT00113919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110717380|NCT00113919|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110717381|NCT00113919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110717382|NCT00113919|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110717383|NCT00113841|Curcumin|curcumin|mesh-list
110717384|NCT00113841|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110717385|NCT00113841|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110717386|NCT00113841|Analgesics|analgesics|mesh-ancestor
110717387|NCT00113841|Sensory System Agents|sensory system agents|mesh-ancestor
110717388|NCT00113841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110717389|NCT00113841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110717390|NCT00113841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110717391|NCT00113841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110717392|NCT00113841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110717393|NCT00113841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110717394|NCT00113841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110717395|NCT00113607|Dexamethasone|dexamethasone|mesh-list
110717396|NCT00113607|Trabectedin|trabectedin|mesh-list
110717397|NCT00113607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110717398|NCT00113607|Antiemetics|antiemetics|mesh-ancestor
110717399|NCT00113607|Autonomic Agents|autonomic agents|mesh-ancestor
110717400|NCT00113607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110717401|NCT00113607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110717402|NCT00113607|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110717403|NCT00113607|Glucocorticoids|glucocorticoids|mesh-ancestor
110717404|NCT00113607|Hormones|hormones|mesh-ancestor
110139282|NCT02844816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110717405|NCT00113607|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110717406|NCT00113607|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110717407|NCT00113607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110717408|NCT00113607|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110717409|NCT00113607|Alkylating Agents|alkylating agents|mesh-ancestor
110717410|NCT00113607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110717411|NCT00113529|Sunitinib|sunitinib|mesh-list
110717412|NCT00113529|Gefitinib|gefitinib|mesh-list
110717413|NCT00113529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110717414|NCT00113529|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110717415|NCT00113529|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110717416|NCT00113529|Growth Substances|growth substances|mesh-ancestor
110717417|NCT00113529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110717418|NCT00113529|Growth Inhibitors|growth inhibitors|mesh-ancestor
110717419|NCT00113529|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110717420|NCT00113529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110717421|NCT00113529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110717422|NCT01079013|Treosulfan|treosulfan|mesh-list
110717423|NCT01079013|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110717424|NCT01079013|Alkylating Agents|alkylating agents|mesh-ancestor
110717425|NCT01079013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110717426|NCT01079013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110717427|NCT00134901|Memantine|memantine|mesh-list
110717428|NCT00134901|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110717429|NCT00134901|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110717430|NCT00134901|Dopamine Agents|dopamine agents|mesh-ancestor
110717431|NCT00134901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110717432|NCT00134901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110717433|NCT00134901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110717434|NCT00134901|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110717435|NCT00134901|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110717436|NCT01076595|Interferons|interferons|mesh-list
110717437|NCT01076595|Interferon-beta|interferon-beta|mesh-list
110717438|NCT01076595|Interferon beta-1b|interferon beta-1b|mesh-list
110717439|NCT01076595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110717440|NCT01076595|Antiviral Agents|antiviral agents|mesh-ancestor
110717441|NCT01076595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110717442|NCT01076595|Immunologic Factors|immunologic factors|mesh-ancestor
110717443|NCT01076595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110717444|NCT01076595|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110717446|NCT00113373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110717447|NCT00113373|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110717448|NCT00113373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110717449|NCT00113373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110717450|NCT00113295|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110717451|NCT00113295|Paroxetine|paroxetine|mesh-list
110717452|NCT00113295|Antidepressive Agents|antidepressive agents|mesh-ancestor
110717453|NCT00113295|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110717454|NCT00113295|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110717455|NCT00113295|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110717456|NCT00113295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110717457|NCT00113295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110717458|NCT00113295|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110717459|NCT00113295|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110717460|NCT00113295|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110717461|NCT00113295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110717462|NCT00113295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110717463|NCT00113295|Serotonin Agents|serotonin agents|mesh-ancestor
110717464|NCT00113295|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110717465|NCT00113295|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110717466|NCT00113295|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110717467|NCT00113295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110717468|NCT00112905|Sorafenib|sorafenib|mesh-list
110717469|NCT00112905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110717470|NCT00112905|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110717471|NCT00112905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110717472|NCT00112905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110717473|NCT00427895|Vaccines|vaccines|mesh-list
110717474|NCT00427895|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110717475|NCT00427895|Immunologic Factors|immunologic factors|mesh-ancestor
110717476|NCT00427895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110717477|NCT01034189|Paclitaxel|paclitaxel|mesh-list
110717478|NCT01034189|Cetuximab|cetuximab|mesh-list
110717479|NCT01034189|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110717480|NCT01034189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110717481|NCT01034189|Tubulin Modulators|tubulin modulators|mesh-ancestor
110717482|NCT01034189|Antimitotic Agents|antimitotic agents|mesh-ancestor
110717483|NCT01034189|Mitosis Modulators|mitosis modulators|mesh-ancestor
110717484|NCT01034189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110717485|NCT01034189|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110717486|NCT00425945|Pycnogenols|pycnogenols|mesh-list
110717487|NCT00425945|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110717488|NCT00425945|Immunologic Factors|immunologic factors|mesh-ancestor
110717489|NCT00425945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110717490|NCT00425945|Antioxidants|antioxidants|mesh-ancestor
110717491|NCT00425945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110717492|NCT00425945|Protective Agents|protective agents|mesh-ancestor
110717493|NCT00425945|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110717495|NCT00121641|Saxagliptin|saxagliptin|mesh-list
110717496|NCT00121641|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110717497|NCT00121641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110717498|NCT00121641|Incretins|incretins|mesh-ancestor
110717499|NCT00121641|Hormones|hormones|mesh-ancestor
110717500|NCT00121641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110717501|NCT00121641|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110717502|NCT00121641|Protease Inhibitors|protease inhibitors|mesh-ancestor
110717503|NCT00121641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110717504|NCT00121641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110717505|NCT00425555|Panobinostat|panobinostat|mesh-list
110717506|NCT00425555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110717507|NCT00425555|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110717508|NCT00425555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110717509|NCT00425555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110717510|NCT00424775|Vorinostat|vorinostat|mesh-list
110717511|NCT00424775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110717512|NCT00424775|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110717513|NCT00424775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110717514|NCT00424775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110717515|NCT01034345|Sirolimus|sirolimus|mesh-list
110717516|NCT01034345|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
110717517|NCT01034345|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110717518|NCT01034345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110717519|NCT01034345|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110717520|NCT01034345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110717521|NCT01034345|Antifungal Agents|antifungal agents|mesh-ancestor
110139323|NCT02797470|Antimetabolites|antimetabolites|mesh-ancestor
110717522|NCT01034345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110717523|NCT01034345|Immunologic Factors|immunologic factors|mesh-ancestor
110717524|NCT01034345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110717525|NCT01034345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110717526|NCT01034345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110717527|NCT01763866|Atorvastatin|atorvastatin|mesh-list
110717528|NCT01763866|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110717529|NCT01763866|Simvastatin|simvastatin|mesh-list
110435372|NCT00648817|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110717531|NCT01763866|Evolocumab|evolocumab|mesh-list
110717532|NCT01763866|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110717533|NCT01763866|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110717534|NCT01763866|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110717535|NCT01763866|Antimetabolites|antimetabolites|mesh-ancestor
110717536|NCT01763866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110717537|NCT01763866|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110717538|NCT01763866|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110717539|NCT01763866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110717540|NCT01763866|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
110717541|NCT01763866|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110717542|NCT01763866|Protease Inhibitors|protease inhibitors|mesh-ancestor
110717543|NCT01763866|Immunologic Factors|immunologic factors|mesh-ancestor
110717544|NCT01763866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110717545|NCT00132873|Sodium Oxybate|sodium oxybate|mesh-list
110717546|NCT00132873|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110717547|NCT00132873|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110717548|NCT00132873|Anesthetics, General|anesthetics, general|mesh-ancestor
110717549|NCT00132873|Anesthetics|anesthetics|mesh-ancestor
110717550|NCT00132873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110717551|NCT00132873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110717552|NCT01588925|Dexamethasone|dexamethasone|mesh-list
110717553|NCT01588925|Dexamethasone acetate|dexamethasone acetate|mesh-list
110717554|NCT01588925|BB 1101|bb 1101|mesh-list
110717555|NCT01588925|Hyaluronic Acid|hyaluronic acid|mesh-list
110717556|NCT01588925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110717557|NCT01588925|Antiemetics|antiemetics|mesh-ancestor
110717558|NCT01588925|Autonomic Agents|autonomic agents|mesh-ancestor
110717559|NCT01588925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110717560|NCT01588925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110717561|NCT01588925|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110717562|NCT01588925|Glucocorticoids|glucocorticoids|mesh-ancestor
110717563|NCT01588925|Hormones|hormones|mesh-ancestor
110717564|NCT01588925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110717565|NCT01588925|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110717566|NCT01588925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110717567|NCT01588925|Protease Inhibitors|protease inhibitors|mesh-ancestor
110717568|NCT01588925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110717569|NCT01588925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110717570|NCT01588925|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110717572|NCT01588925|Viscosupplements|viscosupplements|mesh-ancestor
110717573|NCT01588925|Protective Agents|protective agents|mesh-ancestor
110717574|NCT01238146|Rituximab|rituximab|mesh-list
110717575|NCT01238146|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110717576|NCT01238146|Obatoclax|obatoclax|mesh-list
110717577|NCT01238146|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110717578|NCT01238146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110717579|NCT01238146|Immunologic Factors|immunologic factors|mesh-ancestor
110717580|NCT01238146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110717581|NCT01238146|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110717582|NCT01238146|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110717583|NCT01238146|Alkylating Agents|alkylating agents|mesh-ancestor
110717584|NCT01238146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110717585|NCT01238146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110717587|NCT01141894|Dobutamine|dobutamine|mesh-list
110717588|NCT01141894|Oxymetazoline|oxymetazoline|mesh-list
110717589|NCT01141894|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
110717590|NCT01141894|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110717591|NCT01141894|Mydriatics|mydriatics|mesh-ancestor
110717592|NCT01141894|Autonomic Agents|autonomic agents|mesh-ancestor
110717593|NCT01141894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110717594|NCT01141894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110717595|NCT01141894|Sympathomimetics|sympathomimetics|mesh-ancestor
110717596|NCT01141894|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110717597|NCT01141894|Nasal Decongestants|nasal decongestants|mesh-ancestor
110717598|NCT01141894|Respiratory System Agents|respiratory system agents|mesh-ancestor
110717599|NCT01141894|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110717600|NCT01141894|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110717601|NCT01141894|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110717602|NCT01141894|Adrenergic Agents|adrenergic agents|mesh-ancestor
110717603|NCT01141894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110435445|NCT00648271|Metoprolol|metoprolol|mesh-list
110717604|NCT01141894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110717605|NCT01141894|Protective Agents|protective agents|mesh-ancestor
110717606|NCT01141894|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
110717607|NCT01141894|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110717608|NCT01141894|Plasma Substitutes|plasma substitutes|mesh-ancestor
110717609|NCT01141894|Blood Substitutes|blood substitutes|mesh-ancestor
110717610|NCT01238224|Tadalafil|tadalafil|mesh-list
110717611|NCT01238224|Vasodilator Agents|vasodilator agents|mesh-ancestor
110717612|NCT01238224|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110717613|NCT01238224|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110717614|NCT01238224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110717615|NCT01238224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110717616|NCT01238224|Urological Agents|urological agents|mesh-ancestor
110717617|NCT01237444|Ritonavir|ritonavir|mesh-list
110717618|NCT01237444|Lopinavir|lopinavir|mesh-list
110717619|NCT01237444|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110717620|NCT01237444|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110717621|NCT01237444|Protease Inhibitors|protease inhibitors|mesh-ancestor
110717622|NCT01237444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110717623|NCT01237444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110717624|NCT01237444|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110717625|NCT01237444|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110717626|NCT01237444|Antiviral Agents|antiviral agents|mesh-ancestor
110717627|NCT01237444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110717628|NCT01237444|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110717629|NCT01237444|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110717630|NCT01145170|Nimotuzumab|nimotuzumab|mesh-list
110717631|NCT01145170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110717632|NCT01145170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110717633|NCT01141972|Vitamin D|vitamin d|mesh-list
110717634|NCT01141972|Vitamins|vitamins|mesh-ancestor
110717635|NCT01141972|Micronutrients|micronutrients|mesh-ancestor
110717636|NCT01141972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110717637|NCT01141972|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110717638|NCT04316806|Rifaximin|rifaximin|mesh-list
110717639|NCT04316806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110717640|NCT04316806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110717641|NCT04316806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110717642|NCT01145326|Lidocaine|lidocaine|mesh-list
110717643|NCT01145326|Anesthetics, Local|anesthetics, local|mesh-ancestor
110717644|NCT01145326|Anesthetics|anesthetics|mesh-ancestor
110717645|NCT01145326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110717646|NCT01145326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110717647|NCT01145326|Sensory System Agents|sensory system agents|mesh-ancestor
110717648|NCT01145326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110139348|NCT02721459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110717649|NCT01145326|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110717650|NCT01145326|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110717651|NCT01145326|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110717652|NCT01145326|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110717653|NCT01145326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110717654|NCT01144702|Artesunate|artesunate|mesh-list
110717655|NCT01144702|Mefloquine|mefloquine|mesh-list
110717656|NCT01144702|Antimalarials|antimalarials|mesh-ancestor
110717657|NCT01144702|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110717658|NCT01144702|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110717659|NCT01144702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110717660|NCT01144702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110717661|NCT01144702|Antiviral Agents|antiviral agents|mesh-ancestor
110717662|NCT01144702|Schistosomicides|schistosomicides|mesh-ancestor
110717663|NCT01144702|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110717664|NCT01144702|Anthelmintics|anthelmintics|mesh-ancestor
110717665|NCT01145404|Capecitabine|capecitabine|mesh-list
110717666|NCT01145404|Lapatinib|lapatinib|mesh-list
110717667|NCT01145404|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110717668|NCT01145404|Antimetabolites|antimetabolites|mesh-ancestor
110717669|NCT01145404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110717670|NCT01145404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110717671|NCT01145404|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110717672|NCT01145404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110717673|NCT01237522|Metformin|metformin|mesh-list
110717674|NCT01237522|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110717675|NCT01237522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110717676|NCT01235416|Motesanib diphosphate|motesanib diphosphate|mesh-list
110435518|NCT00648973|Promethazine|promethazine|mesh-list
110717677|NCT01235416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110717678|NCT01235416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110717679|NCT01235416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110717680|NCT04246996|Gentamicins|gentamicins|mesh-list
110717681|NCT04246996|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110717682|NCT04246996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110717683|NCT04246996|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110717684|NCT04246996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110717685|NCT04246996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110717686|NCT00424463|Edaravone|edaravone|mesh-list
110717687|NCT00424463|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110717688|NCT00424463|Antioxidants|antioxidants|mesh-ancestor
110717689|NCT00424463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110717690|NCT00424463|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110717691|NCT00424463|Protective Agents|protective agents|mesh-ancestor
110717692|NCT00424463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110717693|NCT01324115|Nitroarginine|nitroarginine|mesh-list
110717694|NCT01324115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110717695|NCT01324115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110717696|NCT01037621|Valacyclovir|valacyclovir|mesh-list
110717697|NCT01037621|Antiviral Agents|antiviral agents|mesh-ancestor
110717698|NCT01037621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110717699|NCT00424385|Sorafenib|sorafenib|mesh-list
110717700|NCT00424385|Imatinib Mesylate|imatinib mesylate|mesh-list
110717701|NCT00424385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110717702|NCT00424385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110717703|NCT00424385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110717704|NCT00424385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110717705|NCT01037699|Hormones|hormones|mesh-list
110717706|NCT01037699|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
110717707|NCT01037699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110717708|NCT01037699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110717709|NCT00423917|Bevacizumab|bevacizumab|mesh-list
110717710|NCT00423917|Fulvestrant|fulvestrant|mesh-list
110717711|NCT00423917|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110717712|NCT00423917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110717713|NCT00423917|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110717714|NCT00423917|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110717715|NCT00423917|Growth Substances|growth substances|mesh-ancestor
110717716|NCT00423917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110717717|NCT00423917|Growth Inhibitors|growth inhibitors|mesh-ancestor
110717718|NCT00423917|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110717719|NCT00423917|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110717720|NCT00423917|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110717721|NCT00423917|Hormone Antagonists|hormone antagonists|mesh-ancestor
110717722|NCT00423917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110717724|NCT00845026|Risperidone|risperidone|mesh-list
110717725|NCT00845026|Aripiprazole|aripiprazole|mesh-list
110717726|NCT00845026|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110717727|NCT00845026|Serotonin Agents|serotonin agents|mesh-ancestor
110717728|NCT00845026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110717729|NCT00845026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110717730|NCT00845026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110717731|NCT00845026|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110717732|NCT00845026|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110717733|NCT00845026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110717734|NCT00845026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110717735|NCT00845026|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110717736|NCT00845026|Dopamine Agents|dopamine agents|mesh-ancestor
110717737|NCT00845026|Antiemetics|antiemetics|mesh-ancestor
110717738|NCT00845026|Autonomic Agents|autonomic agents|mesh-ancestor
110717739|NCT00845026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110717740|NCT00845026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110717741|NCT00845026|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110717742|NCT00845026|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110717743|NCT00845026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110717744|NCT00845026|Antidepressive Agents|antidepressive agents|mesh-ancestor
110717745|NCT00845026|Dopamine Agonists|dopamine agonists|mesh-ancestor
110717746|NCT00845026|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110717747|NCT00845026|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110717748|NCT00845026|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110717749|NCT00845026|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110717750|NCT02445131|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110717751|NCT02445131|Obinutuzumab|obinutuzumab|mesh-list
110717752|NCT02445131|Idelalisib|idelalisib|mesh-list
110717753|NCT02445131|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110717754|NCT02445131|Alkylating Agents|alkylating agents|mesh-ancestor
110717755|NCT02445131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110717756|NCT02445131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110717757|NCT02445131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110717758|NCT02445131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110717759|NCT01238770|Cyclophosphamide|cyclophosphamide|mesh-list
110717760|NCT01238770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110139382|NCT02582775|Antimetabolites|antimetabolites|mesh-ancestor
110717761|NCT01238770|Immunologic Factors|immunologic factors|mesh-ancestor
110717762|NCT01238770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110717763|NCT01238770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110717764|NCT01238770|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110717765|NCT01238770|Alkylating Agents|alkylating agents|mesh-ancestor
110717766|NCT01238770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110717767|NCT01238770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110717768|NCT01238770|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110717769|NCT01145950|Etanercept|etanercept|mesh-list
110717770|NCT01145950|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110717771|NCT01145950|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110717772|NCT01145950|Analgesics|analgesics|mesh-ancestor
110717773|NCT01145950|Sensory System Agents|sensory system agents|mesh-ancestor
110717774|NCT01145950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110717775|NCT01145950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110717776|NCT01145950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110717777|NCT01145950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110717778|NCT01145950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110717779|NCT01145950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110717780|NCT01145950|Immunologic Factors|immunologic factors|mesh-ancestor
110717781|NCT01238926|Vitamins|vitamins|mesh-list
110717782|NCT01238926|Folic Acid|folic acid|mesh-list
110717783|NCT01238926|Hydroxocobalamin|hydroxocobalamin|mesh-list
110717784|NCT01238926|Vitamin B 12|vitamin b 12|mesh-list
110717785|NCT01238926|Vitamin B 6|vitamin b 6|mesh-list
110717786|NCT01238926|Pyridoxal|pyridoxal|mesh-list
110717787|NCT01238926|Pyridoxine|pyridoxine|mesh-list
110717788|NCT01238926|Vitamin B Complex|vitamin b complex|mesh-list
110717789|NCT01238926|Micronutrients|micronutrients|mesh-ancestor
110717790|NCT01238926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110717791|NCT01238926|Hematinics|hematinics|mesh-ancestor
110717792|NCT01239004|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
110717793|NCT01239004|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110717794|NCT01239004|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110717796|NCT01239004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110717797|NCT01239004|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110717798|NCT01142518|Interferons|interferons|mesh-list
110717799|NCT01142518|Interferon-beta|interferon-beta|mesh-list
110717800|NCT01142518|Interferon beta-1a|interferon beta-1a|mesh-list
110717801|NCT01142518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110717802|NCT01142518|Antiviral Agents|antiviral agents|mesh-ancestor
110717803|NCT01142518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110717804|NCT01142518|Immunologic Factors|immunologic factors|mesh-ancestor
110717805|NCT01142518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110717806|NCT01142518|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110717807|NCT00423449|Gemcitabine|gemcitabine|mesh-list
110717808|NCT00423449|Vorinostat|vorinostat|mesh-list
110717809|NCT00423449|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110717810|NCT00423449|Antimetabolites|antimetabolites|mesh-ancestor
110717811|NCT00423449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110717812|NCT00423449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110717813|NCT00423449|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110717814|NCT00423449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110717815|NCT00423293|Fluorouracil|fluorouracil|mesh-list
110717816|NCT00423293|Mitomycins|mitomycins|mesh-list
110717817|NCT00423293|Mitomycin|mitomycin|mesh-list
110717818|NCT00423293|Antimetabolites|antimetabolites|mesh-ancestor
110717819|NCT00423293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110717820|NCT00423293|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110717821|NCT00423293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110717822|NCT00423293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110717823|NCT00423293|Immunologic Factors|immunologic factors|mesh-ancestor
110717824|NCT00423293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110717825|NCT00423293|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110717826|NCT00423293|Alkylating Agents|alkylating agents|mesh-ancestor
110717827|NCT00423293|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110717828|NCT00423293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110717829|NCT00422903|Letrozole|letrozole|mesh-list
110717830|NCT00422903|Lapatinib|lapatinib|mesh-list
110717831|NCT00422903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110717832|NCT00422903|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110717833|NCT00422903|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110717834|NCT00422903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110717835|NCT00422903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110717836|NCT00422903|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110717837|NCT00422903|Hormone Antagonists|hormone antagonists|mesh-ancestor
110717838|NCT00422903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110717839|NCT00422903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110717840|NCT00422903|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110717841|NCT00422591|Cytarabine|cytarabine|mesh-list
110717842|NCT00422591|Idarubicin|idarubicin|mesh-list
110717843|NCT00422591|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110717844|NCT00422591|Antimetabolites|antimetabolites|mesh-ancestor
110717845|NCT00422591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110717846|NCT00422591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110717847|NCT00422591|Antiviral Agents|antiviral agents|mesh-ancestor
110717848|NCT00422591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110717849|NCT00422591|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110717850|NCT00422591|Immunologic Factors|immunologic factors|mesh-ancestor
110717851|NCT00422591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110717852|NCT00422591|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110717853|NCT00422591|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110717854|NCT00422591|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110717855|NCT00422591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110717856|NCT00422513|Epoetin Alfa|epoetin alfa|mesh-list
110717857|NCT00422513|Hematinics|hematinics|mesh-ancestor
110717858|NCT00202878|Simvastatin|simvastatin|mesh-list
110717859|NCT00202878|Ezetimibe|ezetimibe|mesh-list
110717860|NCT00202878|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
110717861|NCT00202878|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110717862|NCT00202878|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110717863|NCT00202878|Antimetabolites|antimetabolites|mesh-ancestor
110717864|NCT00202878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110717865|NCT00202878|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110717866|NCT00202878|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110717867|NCT00202878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110717868|NCT00414011|Moxifloxacin|moxifloxacin|mesh-list
110717869|NCT00414011|Gatifloxacin|gatifloxacin|mesh-list
110717870|NCT00414011|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110717871|NCT00414011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110717872|NCT00414011|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110717873|NCT00414011|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110717874|NCT00414011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110717875|NCT00414011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110717876|NCT00414011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110717877|NCT00414011|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110717878|NCT00414011|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110717879|NCT00260208|Cyclosporine|cyclosporine|mesh-list
110717880|NCT00260208|Tacrolimus|tacrolimus|mesh-list
110717881|NCT00260208|Cyclosporins|cyclosporins|mesh-list
110717882|NCT00260208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110717883|NCT00260208|Immunologic Factors|immunologic factors|mesh-ancestor
110717884|NCT00260208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110717885|NCT00260208|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110717886|NCT00260208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110717887|NCT00260208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110717888|NCT00260208|Antifungal Agents|antifungal agents|mesh-ancestor
110717889|NCT00260208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110717890|NCT00260208|Dermatologic Agents|dermatologic agents|mesh-ancestor
110717891|NCT00260208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110717892|NCT00202644|Hydroxyurea|hydroxyurea|mesh-list
110717893|NCT00202644|Anagrelide|anagrelide|mesh-list
110717894|NCT00202644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110717895|NCT00202644|Antisickling Agents|antisickling agents|mesh-ancestor
110717896|NCT00202644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110717897|NCT00202644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110717898|NCT00202644|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110717899|NCT00202644|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110717900|NCT00202644|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110717901|NCT00202644|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110717902|NCT00259740|Denosumab|denosumab|mesh-list
110717903|NCT00259740|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110717904|NCT00259740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110717905|NCT01073202|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
110717906|NCT01073202|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
110717907|NCT01073202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110717909|NCT01236040|Immunologic Factors|immunologic factors|mesh-ancestor
110717910|NCT01236040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110717911|NCT03812224|Erenumab|erenumab|mesh-list
110717912|NCT03812224|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
110717913|NCT03812224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110717914|NCT03812224|Analgesics|analgesics|mesh-ancestor
110717915|NCT03812224|Sensory System Agents|sensory system agents|mesh-ancestor
110717916|NCT03812224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110717917|NCT03812224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110717918|NCT01146028|Tizanidine|tizanidine|mesh-list
110717919|NCT01146028|Analgesics|analgesics|mesh-ancestor
110717920|NCT01146028|Sensory System Agents|sensory system agents|mesh-ancestor
110717921|NCT01146028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110717922|NCT01146028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110717923|NCT01146028|Anticonvulsants|anticonvulsants|mesh-ancestor
110717924|NCT01146028|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110717925|NCT01146028|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110717926|NCT01146028|Parasympatholytics|parasympatholytics|mesh-ancestor
110717927|NCT01146028|Autonomic Agents|autonomic agents|mesh-ancestor
110717928|NCT01146028|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110717929|NCT01146028|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110717930|NCT01146028|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110717931|NCT01146028|Adrenergic Agents|adrenergic agents|mesh-ancestor
110717932|NCT01146028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110717933|NCT01146028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110717934|NCT03530800|Dronabinol|dronabinol|mesh-list
110717935|NCT03530800|Hallucinogens|hallucinogens|mesh-ancestor
110717936|NCT03530800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110717937|NCT03530800|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110717938|NCT03530800|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110717939|NCT03530800|Analgesics|analgesics|mesh-ancestor
110717940|NCT03530800|Sensory System Agents|sensory system agents|mesh-ancestor
110717941|NCT03530800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110717942|NCT03530800|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
110717943|NCT03530800|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110717944|NCT03530800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110717945|NCT03530800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110717947|NCT03530800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110717948|NCT04982146|Acetylcysteine|acetylcysteine|mesh-list
110717949|NCT04982146|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110717950|NCT04982146|Antiviral Agents|antiviral agents|mesh-ancestor
110717951|NCT04982146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110717952|NCT04982146|Expectorants|expectorants|mesh-ancestor
110717953|NCT04982146|Respiratory System Agents|respiratory system agents|mesh-ancestor
110717954|NCT04982146|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110717955|NCT04982146|Antioxidants|antioxidants|mesh-ancestor
110717956|NCT04982146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110717957|NCT04982146|Protective Agents|protective agents|mesh-ancestor
110717958|NCT04982146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110717959|NCT04982146|Antidotes|antidotes|mesh-ancestor
110717960|NCT04958746|Propofol|propofol|mesh-list
110717961|NCT04958746|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110717962|NCT04958746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110717963|NCT04958746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110717964|NCT04958746|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110717965|NCT04958746|Anesthetics, General|anesthetics, general|mesh-ancestor
110717966|NCT04958746|Anesthetics|anesthetics|mesh-ancestor
110717967|NCT01146106|Pravastatin|pravastatin|mesh-list
110717968|NCT01146106|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110717969|NCT01146106|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110717970|NCT01146106|Antimetabolites|antimetabolites|mesh-ancestor
110717971|NCT01146106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110717972|NCT01146106|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110717973|NCT01146106|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110717974|NCT01146106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110717975|NCT03431584|Hyaluronic Acid|hyaluronic acid|mesh-list
110717976|NCT03431584|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110717977|NCT03431584|Immunologic Factors|immunologic factors|mesh-ancestor
110717978|NCT03431584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110717979|NCT03431584|Viscosupplements|viscosupplements|mesh-ancestor
110717980|NCT03431584|Protective Agents|protective agents|mesh-ancestor
110717981|NCT00259272|Olanzapine|olanzapine|mesh-list
110717982|NCT00259272|Antiemetics|antiemetics|mesh-ancestor
110717983|NCT00259272|Autonomic Agents|autonomic agents|mesh-ancestor
110717984|NCT00259272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110717985|NCT00259272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110717986|NCT00259272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110717987|NCT00259272|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110717988|NCT00259272|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110717989|NCT00259272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110717990|NCT00259272|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110717991|NCT00259272|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110717992|NCT00259272|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110717993|NCT00259272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110717994|NCT00259272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110717995|NCT00259272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110717996|NCT00259272|Serotonin Agents|serotonin agents|mesh-ancestor
110717997|NCT03106324|Lenalidomide|lenalidomide|mesh-list
110717998|NCT03106324|Immunologic Factors|immunologic factors|mesh-ancestor
110862123|NCT03267628|Analgesics|analgesics|mesh-ancestor
110717999|NCT03106324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110718000|NCT03106324|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110718001|NCT03106324|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110718002|NCT03106324|Growth Substances|growth substances|mesh-ancestor
110718003|NCT03106324|Growth Inhibitors|growth inhibitors|mesh-ancestor
110718004|NCT03106324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110718005|NCT01147276|Vildagliptin|vildagliptin|mesh-list
110718006|NCT01147276|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110718007|NCT01147276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110718008|NCT01147276|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110718009|NCT01147276|Protease Inhibitors|protease inhibitors|mesh-ancestor
110139495|NCT01886872|Antibodies|antibodies|mesh-list
110718010|NCT01147276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110718011|NCT01147276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110718012|NCT01239940|Paclitaxel|paclitaxel|mesh-list
110718013|NCT01239940|Everolimus|everolimus|mesh-list
110718014|NCT01239940|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110718015|NCT01239940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110718016|NCT01239940|Tubulin Modulators|tubulin modulators|mesh-ancestor
110718017|NCT01239940|Antimitotic Agents|antimitotic agents|mesh-ancestor
110718018|NCT01239940|Mitosis Modulators|mitosis modulators|mesh-ancestor
110718019|NCT01239940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110718021|NCT01239940|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110718022|NCT01239940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110718023|NCT01239940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110718024|NCT01239940|Immunologic Factors|immunologic factors|mesh-ancestor
110718025|NCT01239940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110718026|NCT02526004|Tobramycin|tobramycin|mesh-list
110718027|NCT02526004|Ceftazidime|ceftazidime|mesh-list
110718028|NCT02526004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110718029|NCT02526004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110718030|NCT00421889|Paclitaxel|paclitaxel|mesh-list
110718031|NCT00421889|Carboplatin|carboplatin|mesh-list
110718032|NCT00421889|Belinostat|belinostat|mesh-list
110718033|NCT00421889|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110718034|NCT00421889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110718035|NCT00421889|Tubulin Modulators|tubulin modulators|mesh-ancestor
110718036|NCT00421889|Antimitotic Agents|antimitotic agents|mesh-ancestor
110718037|NCT00421889|Mitosis Modulators|mitosis modulators|mesh-ancestor
110718038|NCT00421889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110718039|NCT00421889|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110718040|NCT00421889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110718041|NCT03913468|Ascorbic Acid|ascorbic acid|mesh-list
110718042|NCT03913468|Antioxidants|antioxidants|mesh-ancestor
110718043|NCT03913468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110718044|NCT03913468|Protective Agents|protective agents|mesh-ancestor
110718045|NCT03913468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110718046|NCT03913468|Vitamins|vitamins|mesh-ancestor
110718047|NCT03913468|Micronutrients|micronutrients|mesh-ancestor
110718048|NCT01147354|Selenium|selenium|mesh-list
110718049|NCT01147354|Antioxidants|antioxidants|mesh-ancestor
110718050|NCT01147354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110718051|NCT01147354|Protective Agents|protective agents|mesh-ancestor
110718052|NCT01147354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110718053|NCT01147354|Trace Elements|trace elements|mesh-ancestor
110718054|NCT01147354|Micronutrients|micronutrients|mesh-ancestor
110718055|NCT04744480|Anesthetics|anesthetics|mesh-list
110718056|NCT04744480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110718057|NCT04744480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110718058|NCT01147432|Capsaicin|capsaicin|mesh-list
110718060|NCT01147432|Dermatologic Agents|dermatologic agents|mesh-ancestor
110718061|NCT01147432|Sensory System Agents|sensory system agents|mesh-ancestor
110718062|NCT01147432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110718063|NCT01147432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110718064|NCT01147510|Montelukast|montelukast|mesh-list
110718065|NCT01147510|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110718066|NCT01147510|Respiratory System Agents|respiratory system agents|mesh-ancestor
110718067|NCT01147510|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110718068|NCT01147510|Hormone Antagonists|hormone antagonists|mesh-ancestor
110718069|NCT01147510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110718070|NCT01147510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110718071|NCT01147510|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110718072|NCT01147510|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110718073|NCT01147510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110718075|NCT03916432|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110718076|NCT03916432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110718077|NCT03916432|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110718078|NCT03916432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110718079|NCT03916432|Antifungal Agents|antifungal agents|mesh-ancestor
110718080|NCT03916432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110718081|NCT03916432|Immunologic Factors|immunologic factors|mesh-ancestor
110718082|NCT03916432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110718083|NCT00421733|Ergocalciferols|ergocalciferols|mesh-list
110718084|NCT00421733|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110718085|NCT00421733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110718086|NCT00421733|Vitamins|vitamins|mesh-ancestor
110718087|NCT00421733|Micronutrients|micronutrients|mesh-ancestor
110718088|NCT00421733|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110718090|NCT00421343|Vitamin D|vitamin d|mesh-list
110718091|NCT00421343|Alendronate|alendronate|mesh-list
110718092|NCT00421343|Calcium Carbonate|calcium carbonate|mesh-list
110718093|NCT00421343|Calcium|calcium|mesh-list
110718094|NCT00421343|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110718095|NCT00421343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110718096|NCT00421343|Vitamins|vitamins|mesh-ancestor
110718097|NCT00421343|Micronutrients|micronutrients|mesh-ancestor
110718098|NCT00421343|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110718099|NCT00421343|Antacids|antacids|mesh-ancestor
110718100|NCT00421343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110718101|NCT00421343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110718102|NCT01147588|Esomeprazole|esomeprazole|mesh-list
110718103|NCT01147588|Omeprazole|omeprazole|mesh-list
110718104|NCT01147588|Lansoprazole|lansoprazole|mesh-list
110718105|NCT01147588|Dexlansoprazole|dexlansoprazole|mesh-list
110718106|NCT01147588|Clopidogrel|clopidogrel|mesh-list
110718107|NCT01147588|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110718108|NCT01147588|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110718109|NCT01147588|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110718110|NCT01147588|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110718111|NCT01147588|Purinergic Agents|purinergic agents|mesh-ancestor
110718112|NCT01147588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110718113|NCT01147588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110718114|NCT01147588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110718115|NCT01147588|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110718116|NCT01147588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110718117|NCT01147588|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110718118|NCT01147588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110718119|NCT03908242|Salvianolic acid A|salvianolic acid a|mesh-list
110718120|NCT03908242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110718121|NCT03908242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110718122|NCT03908242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110718123|NCT03908242|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110718124|NCT00230178|Allopurinol|allopurinol|mesh-list
110718125|NCT00230178|Rasburicase|rasburicase|mesh-list
110718126|NCT00230178|Antimetabolites|antimetabolites|mesh-ancestor
110139534|NCT01856192|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110718127|NCT00230178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110718128|NCT00230178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110718129|NCT00230178|Gout Suppressants|gout suppressants|mesh-ancestor
110718130|NCT00230178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110718131|NCT00230178|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110718132|NCT00230178|Antioxidants|antioxidants|mesh-ancestor
110718133|NCT00230178|Protective Agents|protective agents|mesh-ancestor
110718134|NCT00230178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110718136|NCT03908008|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110718137|NCT03908008|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110718138|NCT03908008|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110718139|NCT03908008|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110718140|NCT03908008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110718141|NCT03908008|Cholinergic Agents|cholinergic agents|mesh-ancestor
110718142|NCT03908008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110718143|NCT03908008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110718144|NCT03908008|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110718145|NCT03908008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110718146|NCT01251172|Melphalan|melphalan|mesh-list
110718147|NCT01251172|Mechlorethamine|mechlorethamine|mesh-list
110718148|NCT01251172|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
110718149|NCT01251172|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
110718150|NCT01251172|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-list
110718151|NCT01251172|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110718152|NCT01251172|Alkylating Agents|alkylating agents|mesh-ancestor
110718153|NCT01251172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110718154|NCT01251172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110718155|NCT01251172|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110718156|NCT01251172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110718157|NCT01251172|Immunologic Factors|immunologic factors|mesh-ancestor
110718158|NCT01251172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110718159|NCT01251172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110718160|NCT00413777|Tolvaptan|tolvaptan|mesh-list
110718161|NCT00413777|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
110560296|NCT02963831|Durvalumab|durvalumab|mesh-list
110718162|NCT00413777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110718163|NCT00413777|Natriuretic Agents|natriuretic agents|mesh-ancestor
110718164|NCT00413777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110718165|NCT01250236|Brimonidine Tartrate|brimonidine tartrate|mesh-list
110718166|NCT01250236|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110718167|NCT01250236|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110718168|NCT01250236|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110718169|NCT01250236|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110718170|NCT01250236|Adrenergic Agents|adrenergic agents|mesh-ancestor
110718171|NCT01250236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110718172|NCT01250236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110718173|NCT01250236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110718174|NCT01074060|Plerixafor|plerixafor|mesh-list
110718175|NCT01074060|Cyclophosphamide|cyclophosphamide|mesh-list
110718176|NCT01074060|Lenograstim|lenograstim|mesh-list
110718177|NCT01074060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110718178|NCT01074060|Immunologic Factors|immunologic factors|mesh-ancestor
110718179|NCT01074060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110718180|NCT01074060|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110718181|NCT01074060|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110718182|NCT01074060|Alkylating Agents|alkylating agents|mesh-ancestor
110718183|NCT01074060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110718184|NCT01074060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110718185|NCT01074060|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110718186|NCT01074060|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110718187|NCT01074060|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110718188|NCT01074060|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110718189|NCT01074060|Antiviral Agents|antiviral agents|mesh-ancestor
110718190|NCT01074060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110718191|NCT03915340|Propafenone|propafenone|mesh-list
110718192|NCT03915340|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110718193|NCT03915340|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110718194|NCT03915340|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110718195|NCT03915340|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110718196|NCT03915340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110718197|NCT01581918|Carbamazepine|carbamazepine|mesh-list
110718198|NCT01581918|Anticonvulsants|anticonvulsants|mesh-ancestor
110718199|NCT01581918|Antimanic Agents|antimanic agents|mesh-ancestor
110718200|NCT01581918|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110718201|NCT01581918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110718202|NCT01581918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110718203|NCT01581918|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110436052|NCT02651311|Ibuprofen|ibuprofen|mesh-list
110718204|NCT01581918|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110718205|NCT01581918|Analgesics|analgesics|mesh-ancestor
110718206|NCT01581918|Sensory System Agents|sensory system agents|mesh-ancestor
110718207|NCT01581918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110718208|NCT01581918|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110718209|NCT01581918|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110718210|NCT01581918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110718211|NCT01581918|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110718212|NCT01581918|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110718213|NCT01582542|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
110718214|NCT01582542|Hemostatics|hemostatics|mesh-ancestor
110718215|NCT01582542|Coagulants|coagulants|mesh-ancestor
110718216|NCT01582542|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
110718217|NCT01582542|Natriuretic Agents|natriuretic agents|mesh-ancestor
110718218|NCT01582542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110718219|NCT03912766|Arginine Vasopressin|arginine vasopressin|mesh-list
110718220|NCT03912766|Hemostatics|hemostatics|mesh-ancestor
110718221|NCT03912766|Coagulants|coagulants|mesh-ancestor
110718222|NCT03912766|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110718223|NCT03912766|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
110718224|NCT03912766|Natriuretic Agents|natriuretic agents|mesh-ancestor
110718225|NCT03912766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110718226|NCT01251328|Anesthetics|anesthetics|mesh-list
110718227|NCT01251328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110718228|NCT01251328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110718229|NCT00420641|Paroxetine|paroxetine|mesh-list
110718230|NCT00420641|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110718231|NCT00420641|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110718232|NCT00420641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110718233|NCT00420641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110718234|NCT00420641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110718236|NCT00420641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110718237|NCT00420641|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110718238|NCT00420641|Antidepressive Agents|antidepressive agents|mesh-ancestor
110718239|NCT00420641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110718240|NCT00420641|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110718241|NCT00420641|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110718242|NCT00420641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110718243|NCT00257556|Menotropins|menotropins|mesh-list
110718244|NCT00257556|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
110718245|NCT00257556|Hormones|hormones|mesh-ancestor
110718246|NCT00257556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110718247|NCT00257556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110718248|NCT00257556|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110718249|NCT00257556|Fertility Agents|fertility agents|mesh-ancestor
110718250|NCT00257556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110718251|NCT03906916|Micafungin|micafungin|mesh-list
110718252|NCT03906916|Antifungal Agents|antifungal agents|mesh-ancestor
110718253|NCT03906916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110718254|NCT01250470|Sargramostim|sargramostim|mesh-list
110718255|NCT01250470|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
110718256|NCT01250470|Immunologic Factors|immunologic factors|mesh-ancestor
110718257|NCT01250470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110718258|NCT01250470|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110718259|NCT01250548|Apremilast|apremilast|mesh-list
110718260|NCT01250548|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110718261|NCT01250548|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110718262|NCT01250548|Analgesics|analgesics|mesh-ancestor
110718263|NCT01250548|Sensory System Agents|sensory system agents|mesh-ancestor
110718264|NCT01250548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110718265|NCT01250548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110718266|NCT01250548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110718267|NCT01250548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110718268|NCT01250548|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
110718269|NCT01250548|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110862148|NCT01367028|Bevacizumab|bevacizumab|mesh-list
110718270|NCT01250548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110718271|NCT01250548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110718272|NCT03906838|Ropivacaine|ropivacaine|mesh-list
110718273|NCT03906838|Anesthetics, Local|anesthetics, local|mesh-ancestor
110718274|NCT03906838|Anesthetics|anesthetics|mesh-ancestor
110718275|NCT03906838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110718276|NCT03906838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110718277|NCT03906838|Sensory System Agents|sensory system agents|mesh-ancestor
110718278|NCT03906838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110718279|NCT01251484|Nintedanib|nintedanib|mesh-list
110718280|NCT01251484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110718281|NCT01251484|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110718282|NCT01251484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110718283|NCT01251484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110718284|NCT03914638|Albuterol|albuterol|mesh-list
110718285|NCT03914638|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110718286|NCT03914638|Autonomic Agents|autonomic agents|mesh-ancestor
110718287|NCT03914638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110718288|NCT03914638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110718289|NCT03914638|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110718290|NCT03914638|Respiratory System Agents|respiratory system agents|mesh-ancestor
110718291|NCT03914638|Tocolytic Agents|tocolytic agents|mesh-ancestor
110718292|NCT03914638|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110718293|NCT03914638|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110718294|NCT03914638|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110718295|NCT03914638|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110718296|NCT03914638|Adrenergic Agents|adrenergic agents|mesh-ancestor
110718297|NCT03914638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110718298|NCT03914638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110718299|NCT01148446|Prednisone|prednisone|mesh-list
110718300|NCT01148446|Cyclophosphamide|cyclophosphamide|mesh-list
110718301|NCT01148446|Rituximab|rituximab|mesh-list
110718302|NCT01148446|Doxorubicin|doxorubicin|mesh-list
110718303|NCT01148446|Vincristine|vincristine|mesh-list
110718304|NCT01148446|Epirubicin|epirubicin|mesh-list
110718305|NCT01148446|Vinblastine|vinblastine|mesh-list
110718306|NCT01148446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110718307|NCT01148446|Immunologic Factors|immunologic factors|mesh-ancestor
110718308|NCT01148446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110718309|NCT01148446|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110718310|NCT01148446|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110718311|NCT01148446|Alkylating Agents|alkylating agents|mesh-ancestor
110718312|NCT01148446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110718313|NCT01148446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110718314|NCT01148446|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110718315|NCT01148446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110718316|NCT01148446|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110718317|NCT01148446|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110718318|NCT01148446|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110718319|NCT01148446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110718320|NCT01148446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110718321|NCT01148446|Glucocorticoids|glucocorticoids|mesh-ancestor
110718322|NCT01148446|Hormones|hormones|mesh-ancestor
110718323|NCT01148446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110718324|NCT01148446|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110718325|NCT01148446|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110718326|NCT01148446|Tubulin Modulators|tubulin modulators|mesh-ancestor
110718327|NCT01148446|Antimitotic Agents|antimitotic agents|mesh-ancestor
110718328|NCT01148446|Mitosis Modulators|mitosis modulators|mesh-ancestor
110718329|NCT03914404|Thioctic Acid|thioctic acid|mesh-list
110718330|NCT03914404|Antioxidants|antioxidants|mesh-ancestor
110718331|NCT03914404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110718332|NCT03914404|Protective Agents|protective agents|mesh-ancestor
110718333|NCT03914404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110718334|NCT03914404|Vitamin B Complex|vitamin b complex|mesh-ancestor
110718335|NCT03914404|Vitamins|vitamins|mesh-ancestor
110718336|NCT03914404|Micronutrients|micronutrients|mesh-ancestor
110718337|NCT01251640|Gemcitabine|gemcitabine|mesh-list
110718338|NCT01251640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110718339|NCT01251640|Antimetabolites|antimetabolites|mesh-ancestor
110718340|NCT01251640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110718341|NCT01251640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110718342|NCT00257166|Ziprasidone|ziprasidone|mesh-list
110718343|NCT00257166|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110718344|NCT00257166|Serotonin Agents|serotonin agents|mesh-ancestor
110718345|NCT00257166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110718346|NCT00257166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110718347|NCT00257166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110718348|NCT00257166|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110718349|NCT00257166|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110718350|NCT00257166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110718351|NCT00257166|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110436187|NCT00650299|GABA Agents|gaba agents|mesh-ancestor
110718352|NCT00257166|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110718353|NCT00257166|Dopamine Agents|dopamine agents|mesh-ancestor
110718354|NCT03914092|Triamcinolone|triamcinolone|mesh-list
110718355|NCT03914092|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110718356|NCT03914092|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110718357|NCT03914092|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110718358|NCT03914092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110718359|NCT03914092|Glucocorticoids|glucocorticoids|mesh-ancestor
110718360|NCT03914092|Hormones|hormones|mesh-ancestor
110718361|NCT03914092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110718362|NCT03914092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110718363|NCT03914092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110718364|NCT03914092|Immunologic Factors|immunologic factors|mesh-ancestor
110718365|NCT03914092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110718366|NCT03914092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110718367|NCT03913858|Anesthetics|anesthetics|mesh-list
110718368|NCT03913858|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110718369|NCT03913858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110718370|NCT00227370|Valganciclovir|valganciclovir|mesh-list
110718371|NCT00227370|Antiviral Agents|antiviral agents|mesh-ancestor
110718372|NCT00227370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110718373|NCT01251796|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110718374|NCT01251796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110718375|NCT01251796|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110718376|NCT01251796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110718377|NCT01251796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110718378|NCT01251874|Alovudine|alovudine|mesh-list
110718379|NCT01251874|Carboplatin|carboplatin|mesh-list
110718380|NCT01251874|Veliparib|veliparib|mesh-list
110718381|NCT01251874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110718382|NCT01251874|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110718383|NCT01251874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110718384|NCT01251874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110718385|NCT01251874|Antiviral Agents|antiviral agents|mesh-ancestor
110718386|NCT01251874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110718387|NCT03911440|Azithromycin|azithromycin|mesh-list
110718388|NCT03911440|Doxycycline|doxycycline|mesh-list
110718389|NCT03911440|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110718390|NCT03911440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110718391|NCT03911440|Antimalarials|antimalarials|mesh-ancestor
110718392|NCT03911440|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110718393|NCT03911440|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110718394|NCT00191100|Gemcitabine|gemcitabine|mesh-list
110718395|NCT00191100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110718396|NCT00191100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110718397|NCT00191100|Antimetabolites|antimetabolites|mesh-ancestor
110718398|NCT00191100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110718399|NCT01149226|Chloral Hydrate|chloral hydrate|mesh-list
110718400|NCT01149226|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110718401|NCT01149226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110718402|NCT01149226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110718403|NCT01252342|Oxytocin|oxytocin|mesh-list
110718404|NCT01252342|Oxytocics|oxytocics|mesh-ancestor
110718405|NCT01252342|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110718406|NCT01252342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110718407|NCT01254994|Entecavir|entecavir|mesh-list
110718408|NCT01254994|Antiviral Agents|antiviral agents|mesh-ancestor
110718409|NCT01254994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110718410|NCT03904732|Aspirin|aspirin|mesh-list
110718411|NCT03904732|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110718412|NCT03904732|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110718413|NCT03904732|Analgesics|analgesics|mesh-ancestor
110718414|NCT03904732|Sensory System Agents|sensory system agents|mesh-ancestor
110718415|NCT03904732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110718416|NCT03904732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110718417|NCT03904732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110718418|NCT03904732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110718419|NCT03904732|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110718420|NCT03904732|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110718421|NCT03904732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110718422|NCT03904732|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110718423|NCT03904732|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110718424|NCT03904732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110718425|NCT03904732|Antipyretics|antipyretics|mesh-ancestor
110436270|NCT02652325|Iodine|iodine|mesh-list
110718426|NCT01252420|Enoxaparin|enoxaparin|mesh-list
110718427|NCT01252420|Anticoagulants|anticoagulants|mesh-ancestor
110718428|NCT01252420|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110718429|NCT01252420|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110718430|NCT01252420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110718431|NCT01149304|Enoxaparin|enoxaparin|mesh-list
110718432|NCT01149304|Pentoxifylline|pentoxifylline|mesh-list
110718433|NCT01149304|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
110718434|NCT01149304|Anticoagulants|anticoagulants|mesh-ancestor
110718435|NCT01149304|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110718436|NCT01149304|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110718437|NCT01149304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110718438|NCT01149304|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110718439|NCT01149304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110718440|NCT01149304|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110718441|NCT01149304|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110718442|NCT01149304|Protective Agents|protective agents|mesh-ancestor
110718443|NCT01149304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110718444|NCT01149304|Vasodilator Agents|vasodilator agents|mesh-ancestor
110718445|NCT01149304|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110718446|NCT01149304|Antioxidants|antioxidants|mesh-ancestor
110718447|NCT01149304|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
110718448|NCT01149304|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110718449|NCT01254526|Paclitaxel|paclitaxel|mesh-list
110718450|NCT01254526|Bevacizumab|bevacizumab|mesh-list
110718451|NCT01254526|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110718452|NCT01254526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110718453|NCT01254526|Tubulin Modulators|tubulin modulators|mesh-ancestor
110718454|NCT01254526|Antimitotic Agents|antimitotic agents|mesh-ancestor
110718455|NCT01254526|Mitosis Modulators|mitosis modulators|mesh-ancestor
110718456|NCT01254526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110718457|NCT01254526|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110718458|NCT01254526|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110718459|NCT01254526|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110718460|NCT01254526|Growth Substances|growth substances|mesh-ancestor
110718461|NCT01254526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110718462|NCT01254526|Growth Inhibitors|growth inhibitors|mesh-ancestor
110718463|NCT01148992|Lofexidine|lofexidine|mesh-list
110718464|NCT01148992|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110718465|NCT01148992|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110718466|NCT01148992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110718467|NCT01148992|Sensory System Agents|sensory system agents|mesh-ancestor
110718468|NCT01148992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110718469|NCT01148992|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110718470|NCT01148992|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110718471|NCT01148992|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110718472|NCT01148992|Adrenergic Agents|adrenergic agents|mesh-ancestor
110718473|NCT01148992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110718474|NCT01148992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110718475|NCT03903952|Vitamin B 12|vitamin b 12|mesh-list
110718476|NCT03903952|Hydroxocobalamin|hydroxocobalamin|mesh-list
110718477|NCT03903952|Vitamins|vitamins|mesh-ancestor
110718478|NCT03903952|Micronutrients|micronutrients|mesh-ancestor
110718479|NCT03903952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110718480|NCT03903952|Vitamin B Complex|vitamin b complex|mesh-ancestor
110718481|NCT03903952|Hematinics|hematinics|mesh-ancestor
110718482|NCT00257010|Almotriptan|almotriptan|mesh-list
110718483|NCT00257010|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110718484|NCT00257010|Serotonin Agents|serotonin agents|mesh-ancestor
110718485|NCT00257010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110718486|NCT00257010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110718487|NCT00257010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110718488|NCT03901768|Dexamethasone|dexamethasone|mesh-list
110718489|NCT03901768|Triamcinolone|triamcinolone|mesh-list
110718490|NCT03901768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110718491|NCT03901768|Antiemetics|antiemetics|mesh-ancestor
110718492|NCT03901768|Autonomic Agents|autonomic agents|mesh-ancestor
110718493|NCT03901768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110718494|NCT03901768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110718495|NCT03901768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110718496|NCT03901768|Glucocorticoids|glucocorticoids|mesh-ancestor
110718497|NCT03901768|Hormones|hormones|mesh-ancestor
110718498|NCT03901768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110718499|NCT03901768|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110718500|NCT03901768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110718501|NCT03903718|Oseltamivir|oseltamivir|mesh-list
110718502|NCT03903718|MEDI8852|medi8852|mesh-list
110436338|NCT00650923|Temozolomide|temozolomide|mesh-list
110718503|NCT03903718|Antiviral Agents|antiviral agents|mesh-ancestor
110718504|NCT03903718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110718505|NCT03903718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110718506|NCT03903718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110718507|NCT03910504|Rocuronium|rocuronium|mesh-list
110718508|NCT03910504|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110718509|NCT03910504|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110718510|NCT03910504|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110718511|NCT03910504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110718512|NCT03910504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110718513|NCT03901690|Imiquimod|imiquimod|mesh-list
110718514|NCT03901690|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110718515|NCT03901690|Immunologic Factors|immunologic factors|mesh-ancestor
110718516|NCT03901690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110718517|NCT03901690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110718518|NCT03901690|Interferon Inducers|interferon inducers|mesh-ancestor
110718519|NCT03901378|Pembrolizumab|pembrolizumab|mesh-list
110718520|NCT03901378|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110718521|NCT03901378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110718522|NCT03901378|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110718523|NCT03901378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110718524|NCT00256854|Ropinirole|ropinirole|mesh-list
110718525|NCT00256854|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110718526|NCT00256854|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110718527|NCT00256854|Dopamine Agonists|dopamine agonists|mesh-ancestor
110718528|NCT00256854|Dopamine Agents|dopamine agents|mesh-ancestor
110718529|NCT00256854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110718530|NCT00256854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110718531|NCT00256854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110718532|NCT00189462|Montelukast|montelukast|mesh-list
110718533|NCT00189462|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110718534|NCT00189462|Respiratory System Agents|respiratory system agents|mesh-ancestor
110718535|NCT00189462|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110718536|NCT00189462|Hormone Antagonists|hormone antagonists|mesh-ancestor
110139638|NCT00433511|Alkylating Agents|alkylating agents|mesh-ancestor
110718537|NCT00189462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110718538|NCT00189462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110718539|NCT00189462|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110718540|NCT00189462|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110718541|NCT00189462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110718542|NCT01150318|Iodine|iodine|mesh-list
110718543|NCT01150318|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110718544|NCT01150318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110718545|NCT01150318|Trace Elements|trace elements|mesh-ancestor
110718546|NCT01150318|Micronutrients|micronutrients|mesh-ancestor
110718547|NCT01150318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110718548|NCT05667298|Immunomodulating Agents|immunomodulating agents|mesh-list
110718549|NCT05667298|Immunologic Factors|immunologic factors|mesh-ancestor
110718550|NCT05667298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110718551|NCT01256632|Ranibizumab|ranibizumab|mesh-list
110718552|NCT01256632|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110718553|NCT01256632|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110718554|NCT01256632|Growth Substances|growth substances|mesh-ancestor
110718555|NCT01256632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110718556|NCT01256632|Growth Inhibitors|growth inhibitors|mesh-ancestor
110718557|NCT01256632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110718558|NCT00256698|Fulvestrant|fulvestrant|mesh-list
110718559|NCT00256698|Anastrozole|anastrozole|mesh-list
110718560|NCT00256698|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110718561|NCT00256698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110718562|NCT00256698|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110718563|NCT00256698|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110718564|NCT00256698|Hormone Antagonists|hormone antagonists|mesh-ancestor
110718565|NCT00256698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110718566|NCT00256698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110718567|NCT00256698|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110718568|NCT00256698|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110718569|NCT00256698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110718570|NCT00256698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110718571|NCT01150630|Gemcitabine|gemcitabine|mesh-list
110718572|NCT01150630|Capecitabine|capecitabine|mesh-list
110718573|NCT01150630|Epirubicin|epirubicin|mesh-list
110718574|NCT01150630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110718575|NCT01150630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110718576|NCT01150630|Antimetabolites|antimetabolites|mesh-ancestor
110718577|NCT01150630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110718578|NCT01150630|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110718579|NCT01150630|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110718580|NCT01150630|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110718581|NCT01150630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110718582|NCT00189306|Imiquimod|imiquimod|mesh-list
110718583|NCT00189306|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110718584|NCT00189306|Immunologic Factors|immunologic factors|mesh-ancestor
110718585|NCT00189306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110718586|NCT00189306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110718587|NCT00189306|Interferon Inducers|interferon inducers|mesh-ancestor
110718588|NCT03898336|Micronutrients|micronutrients|mesh-list
110718589|NCT03898336|Trace Elements|trace elements|mesh-list
110718590|NCT03898336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110718592|NCT03972462|Temsirolimus|temsirolimus|mesh-list
110718593|NCT03972462|MTOR Inhibitors|mtor inhibitors|mesh-list
110718594|NCT03972462|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110718595|NCT03972462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110718596|NCT03972462|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110718597|NCT03972462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110718598|NCT03972462|Antifungal Agents|antifungal agents|mesh-ancestor
110718599|NCT03972462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110718600|NCT03972462|Immunologic Factors|immunologic factors|mesh-ancestor
110718601|NCT03972462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110718602|NCT03972462|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110718603|NCT03972462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110718604|NCT03972462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110718605|NCT01150786|Selenium|selenium|mesh-list
110718606|NCT01150786|Antioxidants|antioxidants|mesh-ancestor
110718607|NCT01150786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110718608|NCT01150786|Protective Agents|protective agents|mesh-ancestor
110718609|NCT01150786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110718610|NCT01150786|Trace Elements|trace elements|mesh-ancestor
110718611|NCT01150786|Micronutrients|micronutrients|mesh-ancestor
110718612|NCT03909724|Sunitinib|sunitinib|mesh-list
110718613|NCT03909724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110718614|NCT03909724|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110718615|NCT03909724|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110718616|NCT03909724|Growth Substances|growth substances|mesh-ancestor
110718617|NCT03909724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110718618|NCT03909724|Growth Inhibitors|growth inhibitors|mesh-ancestor
110718619|NCT03909724|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110718620|NCT03909724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110718621|NCT03909724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110718622|NCT03909646|Fluorouracil|fluorouracil|mesh-list
110718623|NCT03909646|Aminolevulinic Acid|aminolevulinic acid|mesh-list
110718624|NCT03909646|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
110718625|NCT03909646|Antimetabolites|antimetabolites|mesh-ancestor
110718626|NCT03909646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110718627|NCT03909646|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110718628|NCT03909646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110718629|NCT03909646|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110718630|NCT03909646|Immunologic Factors|immunologic factors|mesh-ancestor
110718631|NCT03909646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110718632|NCT03909646|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110718633|NCT03909646|Dermatologic Agents|dermatologic agents|mesh-ancestor
110718634|NCT01256866|Midazolam|midazolam|mesh-list
110718635|NCT01256866|Dexmedetomidine|dexmedetomidine|mesh-list
110718636|NCT01256866|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110718637|NCT01256866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110718638|NCT01256866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110718639|NCT01256866|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110718640|NCT01256866|Analgesics|analgesics|mesh-ancestor
110718641|NCT01256866|Sensory System Agents|sensory system agents|mesh-ancestor
110718642|NCT01256866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110718643|NCT01256866|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110718644|NCT01256866|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110718645|NCT01256866|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110718646|NCT01256866|Adrenergic Agents|adrenergic agents|mesh-ancestor
110718647|NCT01256866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110718648|NCT01256866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110718649|NCT01256866|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110718650|NCT01256866|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110718651|NCT01256866|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110139678|NCT02006498|Silymarin|silymarin|mesh-list
110718652|NCT01256866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110718653|NCT01256866|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110718654|NCT01256866|Anesthetics, General|anesthetics, general|mesh-ancestor
110718655|NCT01256866|Anesthetics|anesthetics|mesh-ancestor
110718656|NCT01256866|GABA Modulators|gaba modulators|mesh-ancestor
110718657|NCT01256866|GABA Agents|gaba agents|mesh-ancestor
110718658|NCT03902782|Dexamethasone|dexamethasone|mesh-list
110718659|NCT03902782|Dexamethasone acetate|dexamethasone acetate|mesh-list
110718660|NCT03902782|Epinephrine|epinephrine|mesh-list
110718661|NCT03902782|Bupivacaine|bupivacaine|mesh-list
110718662|NCT03902782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110718663|NCT03902782|Antiemetics|antiemetics|mesh-ancestor
110718664|NCT03902782|Autonomic Agents|autonomic agents|mesh-ancestor
110718665|NCT03902782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110718666|NCT03902782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110718667|NCT03902782|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110718668|NCT03902782|Glucocorticoids|glucocorticoids|mesh-ancestor
110718669|NCT03902782|Hormones|hormones|mesh-ancestor
110718670|NCT03902782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110718671|NCT03902782|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110718672|NCT03902782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110718673|NCT03902782|Anesthetics, Local|anesthetics, local|mesh-ancestor
110718674|NCT03902782|Anesthetics|anesthetics|mesh-ancestor
110718675|NCT03902782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110718676|NCT03902782|Sensory System Agents|sensory system agents|mesh-ancestor
110718677|NCT03902782|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110718678|NCT03902782|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110718679|NCT03902782|Adrenergic Agents|adrenergic agents|mesh-ancestor
110718680|NCT03902782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110718681|NCT03902782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110718682|NCT03902782|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110718683|NCT03902782|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110718684|NCT03902782|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110718685|NCT03902782|Respiratory System Agents|respiratory system agents|mesh-ancestor
110718686|NCT03902782|Mydriatics|mydriatics|mesh-ancestor
110718687|NCT03902782|Sympathomimetics|sympathomimetics|mesh-ancestor
110718688|NCT03902782|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110718689|NCT03908944|Methadone|methadone|mesh-list
110718690|NCT03908944|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110718691|NCT03908944|Narcotics|narcotics|mesh-ancestor
110718692|NCT03908944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110718693|NCT03908944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110718694|NCT03908944|Analgesics|analgesics|mesh-ancestor
110718695|NCT03908944|Sensory System Agents|sensory system agents|mesh-ancestor
110718696|NCT03908944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110718697|NCT03908944|Antitussive Agents|antitussive agents|mesh-ancestor
110718698|NCT03908944|Respiratory System Agents|respiratory system agents|mesh-ancestor
110718699|NCT03899506|Midazolam|midazolam|mesh-list
110718700|NCT03899506|Olanzapine|olanzapine|mesh-list
110718701|NCT03899506|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110718702|NCT03899506|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110718703|NCT03899506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110718704|NCT03899506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110718705|NCT03899506|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110718706|NCT03899506|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110718707|NCT03899506|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110718708|NCT03899506|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110718709|NCT03899506|Anesthetics, General|anesthetics, general|mesh-ancestor
110718710|NCT03899506|Anesthetics|anesthetics|mesh-ancestor
110718711|NCT03899506|GABA Modulators|gaba modulators|mesh-ancestor
110718712|NCT03899506|GABA Agents|gaba agents|mesh-ancestor
110718713|NCT03899506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110718714|NCT03899506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110718715|NCT03899506|Antiemetics|antiemetics|mesh-ancestor
110718716|NCT03899506|Autonomic Agents|autonomic agents|mesh-ancestor
110718717|NCT03899506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110718718|NCT03899506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110718719|NCT03899506|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110139701|NCT02006849|Hormones|hormones|mesh-ancestor
110718720|NCT03899506|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110718721|NCT03899506|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110718722|NCT03899506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110718723|NCT03899506|Serotonin Agents|serotonin agents|mesh-ancestor
110718724|NCT03896932|Immunoglobulins|immunoglobulins|mesh-list
110718725|NCT03896932|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110718726|NCT03896932|Antibodies|antibodies|mesh-list
110718727|NCT03896932|gamma-Globulins|gamma-globulins|mesh-list
110718728|NCT03896932|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110718729|NCT03896932|Immunologic Factors|immunologic factors|mesh-ancestor
110718730|NCT03896932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110718731|NCT01257334|Empagliflozin|empagliflozin|mesh-list
110718732|NCT01257334|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110718733|NCT01257334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110718734|NCT01257334|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110718735|NCT01257334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110718736|NCT01151176|Insulin|insulin|mesh-list
110718737|NCT01151176|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110718738|NCT01151176|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110718739|NCT01151176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110718741|NCT01257412|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110718742|NCT01257412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110718743|NCT01257412|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110718744|NCT01257412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110718745|NCT01257490|Bupropion|bupropion|mesh-list
110718746|NCT01257490|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110718747|NCT01257490|Antidepressive Agents|antidepressive agents|mesh-ancestor
110718748|NCT01257490|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110718749|NCT01257490|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110718750|NCT01257490|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110718751|NCT01257490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110718752|NCT01257490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110718753|NCT01257490|Dopamine Agents|dopamine agents|mesh-ancestor
110718754|NCT01257490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110718755|NCT01257490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110718756|NCT01257490|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110718757|NCT01257490|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110718758|NCT01257490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110718759|NCT03894280|Fluticasone|fluticasone|mesh-list
110718760|NCT03894280|Xhance|xhance|mesh-list
110718761|NCT03894280|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110718762|NCT03894280|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
110718763|NCT03894280|Charcoal|charcoal|mesh-list
110718764|NCT03894280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110718765|NCT03894280|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110718766|NCT03894280|Autonomic Agents|autonomic agents|mesh-ancestor
110862182|NCT04235634|Alprostadil|alprostadil|mesh-list
110718767|NCT03894280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110718768|NCT03894280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110718769|NCT03894280|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110718770|NCT03894280|Respiratory System Agents|respiratory system agents|mesh-ancestor
110718771|NCT03894280|Dermatologic Agents|dermatologic agents|mesh-ancestor
110718772|NCT03894280|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110718773|NCT03894280|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110718774|NCT03894280|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110718775|NCT03894280|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110718776|NCT03894280|Adrenergic Agents|adrenergic agents|mesh-ancestor
110718777|NCT03894280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110718778|NCT03894280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110718779|NCT03894280|Glucocorticoids|glucocorticoids|mesh-ancestor
110718781|NCT03894280|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110718782|NCT03894280|Sympathomimetics|sympathomimetics|mesh-ancestor
110718783|NCT03894280|Antidotes|antidotes|mesh-ancestor
110718784|NCT03894280|Protective Agents|protective agents|mesh-ancestor
110718785|NCT03899584|4-Aminopyridine|4-aminopyridine|mesh-list
110718786|NCT03899584|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
110718787|NCT03899584|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110718788|NCT03899584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110718789|NCT01150162|Omeprazole|omeprazole|mesh-list
110718790|NCT01150162|Rebamipide|rebamipide|mesh-list
110718791|NCT01150162|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110718792|NCT01150162|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110718793|NCT01150162|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110718794|NCT01150162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110718795|NCT01150162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110718796|NCT01150162|Antioxidants|antioxidants|mesh-ancestor
110718797|NCT01150162|Protective Agents|protective agents|mesh-ancestor
110718798|NCT01150162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110718799|NCT03893734|Methadone|methadone|mesh-list
110718800|NCT03893734|Hydromorphone|hydromorphone|mesh-list
110718801|NCT03893734|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110718802|NCT03893734|Narcotics|narcotics|mesh-ancestor
110718803|NCT03893734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110718804|NCT03893734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110718805|NCT03893734|Analgesics|analgesics|mesh-ancestor
110718806|NCT03893734|Sensory System Agents|sensory system agents|mesh-ancestor
110718807|NCT03893734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110718808|NCT03893734|Antitussive Agents|antitussive agents|mesh-ancestor
110718809|NCT03893734|Respiratory System Agents|respiratory system agents|mesh-ancestor
110718810|NCT03899194|Escitalopram|escitalopram|mesh-list
110718811|NCT03899194|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110718812|NCT03899194|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110718813|NCT03899194|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110718814|NCT03899194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110718815|NCT03899194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110718816|NCT03899194|Serotonin Agents|serotonin agents|mesh-ancestor
110718817|NCT03899194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110718818|NCT01151800|Benzocaine|benzocaine|mesh-list
110718819|NCT01151800|Anesthetics, Local|anesthetics, local|mesh-ancestor
110718820|NCT01151800|Anesthetics|anesthetics|mesh-ancestor
110718821|NCT01151800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110718822|NCT01151800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110718823|NCT01151800|Sensory System Agents|sensory system agents|mesh-ancestor
110718824|NCT01151800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110718825|NCT03896074|Bevacizumab|bevacizumab|mesh-list
110718826|NCT03896074|Atezolizumab|atezolizumab|mesh-list
110718827|NCT03896074|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110718828|NCT03896074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110718829|NCT03896074|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110718830|NCT03896074|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110718831|NCT03896074|Growth Substances|growth substances|mesh-ancestor
110718832|NCT03896074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110718833|NCT03896074|Growth Inhibitors|growth inhibitors|mesh-ancestor
110718834|NCT03896074|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110718835|NCT03896074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110718837|NCT03899038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110718838|NCT03899038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110718839|NCT01151878|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
110718840|NCT01151878|Cathartics|cathartics|mesh-ancestor
110718841|NCT01151878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110718842|NCT03898882|Oxytocin|oxytocin|mesh-list
110718843|NCT03898882|Oxytocics|oxytocics|mesh-ancestor
110718844|NCT03898882|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110718845|NCT03898882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110718846|NCT01151254|Propofol|propofol|mesh-list
110718847|NCT01151254|Sevoflurane|sevoflurane|mesh-list
110718848|NCT01151254|Isoflurane|isoflurane|mesh-list
110718849|NCT01151254|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110718850|NCT01151254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110718851|NCT01151254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110718852|NCT01151254|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110718853|NCT01151254|Anesthetics, General|anesthetics, general|mesh-ancestor
110718854|NCT01151254|Anesthetics|anesthetics|mesh-ancestor
110718855|NCT01151254|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110718856|NCT01151254|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110718857|NCT01255774|Ranibizumab|ranibizumab|mesh-list
110718858|NCT01255774|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110718859|NCT01255774|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110718860|NCT01255774|Growth Substances|growth substances|mesh-ancestor
110718861|NCT01255774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110718862|NCT01255774|Growth Inhibitors|growth inhibitors|mesh-ancestor
110718863|NCT01255774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110718864|NCT01255852|Atorvastatin|atorvastatin|mesh-list
110718865|NCT01255852|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110718866|NCT01255852|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110718867|NCT01255852|Antimetabolites|antimetabolites|mesh-ancestor
110718868|NCT01255852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110718869|NCT01255852|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110718870|NCT01255852|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110718871|NCT01255852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110718872|NCT03895528|Lonafarnib|lonafarnib|mesh-list
110718873|NCT03895528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110718874|NCT03895528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110718875|NCT01257958|Vitamin D|vitamin d|mesh-list
110718876|NCT01257958|Vitamins|vitamins|mesh-ancestor
110718877|NCT01257958|Micronutrients|micronutrients|mesh-ancestor
110718878|NCT01257958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110718879|NCT01257958|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110718881|NCT03893032|Amphetamine|amphetamine|mesh-list
110139756|NCT02007174|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110718882|NCT03893032|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110718883|NCT03893032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110718884|NCT03893032|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
110718885|NCT03893032|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110718886|NCT03893032|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110718887|NCT03893032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110718888|NCT03893032|Sympathomimetics|sympathomimetics|mesh-ancestor
110718889|NCT03893032|Autonomic Agents|autonomic agents|mesh-ancestor
110718890|NCT03893032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110718891|NCT03893032|Dopamine Agents|dopamine agents|mesh-ancestor
110718892|NCT03893032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110718893|NCT03893032|Adrenergic Agents|adrenergic agents|mesh-ancestor
110718894|NCT03893032|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110718895|NCT03893032|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110718896|NCT03893032|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110718897|NCT03893032|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110718899|NCT01258036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110718900|NCT01258036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110718901|NCT03889366|Aprepitant|aprepitant|mesh-list
110718902|NCT03889366|Antiemetics|antiemetics|mesh-ancestor
110718903|NCT03889366|Autonomic Agents|autonomic agents|mesh-ancestor
110718904|NCT03889366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110718905|NCT03889366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110718906|NCT03889366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110718907|NCT03889366|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110718908|NCT03889366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110718909|NCT03889366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110718910|NCT03894826|Vorinostat|vorinostat|mesh-list
110718911|NCT03894826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110718912|NCT03894826|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110718913|NCT03894826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110718914|NCT03894826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110718915|NCT03894748|Botulinum Toxins|botulinum toxins|mesh-list
110718916|NCT03894748|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110718917|NCT03894748|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110718918|NCT03894748|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110718919|NCT03894748|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110718920|NCT03894748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110718921|NCT03894748|Cholinergic Agents|cholinergic agents|mesh-ancestor
110718922|NCT03894748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110718923|NCT03894748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110718924|NCT03894748|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110718925|NCT03894748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110718926|NCT01153750|Imatinib Mesylate|imatinib mesylate|mesh-list
110718927|NCT01153750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110718928|NCT01153750|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110718929|NCT01153750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110718930|NCT01153750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110718931|NCT03888664|Interferons|interferons|mesh-list
110718932|NCT03888664|Interferon-gamma|interferon-gamma|mesh-list
110718933|NCT03888664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110718934|NCT03888664|Antiviral Agents|antiviral agents|mesh-ancestor
110718935|NCT03888664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110718936|NCT00256308|Oxaliplatin|oxaliplatin|mesh-list
110718937|NCT00256308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110718938|NCT01153828|Mupirocin|mupirocin|mesh-list
110718939|NCT01153828|Retapamulin|retapamulin|mesh-list
110718940|NCT01153828|Fusidic Acid|fusidic acid|mesh-list
110718941|NCT01153828|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110718942|NCT01153828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110718943|NCT01153828|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110718944|NCT01153828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110718945|NCT01153828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110718946|NCT01151722|Bevacizumab|bevacizumab|mesh-list
110718947|NCT01151722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110718948|NCT01151722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110718949|NCT01151722|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110718950|NCT01151722|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110718951|NCT01151722|Growth Substances|growth substances|mesh-ancestor
110718952|NCT01151722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110718953|NCT01151722|Growth Inhibitors|growth inhibitors|mesh-ancestor
110718955|NCT01258192|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110718956|NCT01258192|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110718957|NCT01258192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110718958|NCT01258192|Tubulin Modulators|tubulin modulators|mesh-ancestor
110718959|NCT01258192|Antimitotic Agents|antimitotic agents|mesh-ancestor
110718960|NCT01258192|Mitosis Modulators|mitosis modulators|mesh-ancestor
110718961|NCT01258192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110718962|NCT01326078|Propofol|propofol|mesh-list
110718963|NCT01326078|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110718964|NCT01326078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110718965|NCT01326078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110718966|NCT01326078|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110718967|NCT01326078|Anesthetics, General|anesthetics, general|mesh-ancestor
110718968|NCT01326078|Anesthetics|anesthetics|mesh-ancestor
110718969|NCT01260376|Acipimox|acipimox|mesh-list
110718970|NCT01260376|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110718971|NCT01260376|Antimetabolites|antimetabolites|mesh-ancestor
110718972|NCT01260376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110718973|NCT01260376|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110718974|NCT01259050|Copper|copper|mesh-list
110718975|NCT01259050|Trace Elements|trace elements|mesh-ancestor
110718976|NCT01259050|Micronutrients|micronutrients|mesh-ancestor
110718977|NCT01259050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110718978|NCT00255840|Ritonavir|ritonavir|mesh-list
110718979|NCT00255840|Lopinavir|lopinavir|mesh-list
110718980|NCT00255840|Lamivudine|lamivudine|mesh-list
110718981|NCT00255840|Nevirapine|nevirapine|mesh-list
110718982|NCT00255840|Stavudine|stavudine|mesh-list
110718983|NCT00255840|Efavirenz|efavirenz|mesh-list
110718984|NCT00255840|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110718985|NCT00255840|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110718986|NCT00255840|Protease Inhibitors|protease inhibitors|mesh-ancestor
110718987|NCT00255840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110718988|NCT00255840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110718989|NCT00255840|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110718990|NCT00255840|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110718991|NCT00255840|Antiviral Agents|antiviral agents|mesh-ancestor
110718992|NCT00255840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110718993|NCT00255840|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110718994|NCT00255840|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110718995|NCT00255840|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110718996|NCT00255840|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110718997|NCT00255840|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110718998|NCT00255840|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110718999|NCT00255840|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110719000|NCT00255840|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110719001|NCT00255840|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110719002|NCT00255840|Antimetabolites|antimetabolites|mesh-ancestor
110719003|NCT03972228|Antineoplastic Agents|antineoplastic agents|mesh-list
110719004|NCT00224874|Mycophenolic Acid|mycophenolic acid|mesh-list
110719005|NCT00224874|Etanercept|etanercept|mesh-list
110719006|NCT00224874|Pentostatin|pentostatin|mesh-list
110719007|NCT00224874|Denileukin diftitox|denileukin diftitox|mesh-list
110719008|NCT00224874|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110719009|NCT00224874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110719010|NCT00224874|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110719011|NCT00224874|Antitubercular Agents|antitubercular agents|mesh-ancestor
110719012|NCT00224874|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110719013|NCT00224874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110719014|NCT00224874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110719015|NCT00224874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110719016|NCT00224874|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110719017|NCT00224874|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110719018|NCT00224874|Analgesics|analgesics|mesh-ancestor
110719019|NCT00224874|Sensory System Agents|sensory system agents|mesh-ancestor
110719020|NCT00224874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110719021|NCT00224874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110719022|NCT00224874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110719023|NCT00224874|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110719024|NCT00224874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110719025|NCT00224874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110444041|NCT02623153|Tegafur|tegafur|mesh-list
110719026|NCT00224874|Immunologic Factors|immunologic factors|mesh-ancestor
110719027|NCT00224874|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
110719030|NCT03892330|Doxorubicin|doxorubicin|mesh-list
110719031|NCT03892330|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110719032|NCT03892330|Vincristine|vincristine|mesh-list
110719033|NCT03892330|Pirarubicin|pirarubicin|mesh-list
110719034|NCT03892330|Epirubicin|epirubicin|mesh-list
110719035|NCT03892330|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110719036|NCT03892330|Immunologic Factors|immunologic factors|mesh-ancestor
110719037|NCT03892330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110719038|NCT03892330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110719039|NCT03892330|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110719040|NCT03892330|Alkylating Agents|alkylating agents|mesh-ancestor
110719041|NCT03892330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110719042|NCT03892330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110862201|NCT03151551|Ixekizumab|ixekizumab|mesh-list
110719043|NCT03892330|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110719044|NCT03892330|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110719045|NCT03892330|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110719046|NCT03892330|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110719047|NCT03892330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110719048|NCT03892330|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110719049|NCT03892330|Tubulin Modulators|tubulin modulators|mesh-ancestor
110719050|NCT03892330|Antimitotic Agents|antimitotic agents|mesh-ancestor
110719051|NCT03892330|Mitosis Modulators|mitosis modulators|mesh-ancestor
110719052|NCT03892330|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110719053|NCT03892330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110719055|NCT00186186|Anticonvulsants|anticonvulsants|mesh-ancestor
110719056|NCT00186186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110719057|NCT00186186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110719058|NCT00186186|GABA Agents|gaba agents|mesh-ancestor
110719059|NCT00186186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110719060|NCT00186186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110719061|NCT00186186|Antimanic Agents|antimanic agents|mesh-ancestor
110719062|NCT00186186|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110719063|NCT00186186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110719064|NCT00186186|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110719065|NCT00185640|Cyclosporine|cyclosporine|mesh-list
110719066|NCT00185640|Mycophenolic Acid|mycophenolic acid|mesh-list
110719067|NCT00185640|Lenograstim|lenograstim|mesh-list
110719068|NCT00185640|Cyclosporins|cyclosporins|mesh-list
110719069|NCT00185640|Thymoglobulin|thymoglobulin|mesh-list
110719070|NCT00185640|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110719071|NCT00185640|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110719072|NCT00185640|Immunologic Factors|immunologic factors|mesh-ancestor
110719073|NCT00185640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110719074|NCT00185640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110719075|NCT00185640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110719076|NCT00185640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110719077|NCT00185640|Antifungal Agents|antifungal agents|mesh-ancestor
110719078|NCT00185640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110719079|NCT00185640|Dermatologic Agents|dermatologic agents|mesh-ancestor
110719080|NCT00185640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110719081|NCT00185640|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110719082|NCT00185640|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110719083|NCT00185640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110719084|NCT00185640|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110719085|NCT00185640|Antitubercular Agents|antitubercular agents|mesh-ancestor
110719086|NCT00185640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110719087|NCT03885388|Dactinomycin|dactinomycin|mesh-list
110719088|NCT03885388|Methotrexate|methotrexate|mesh-list
110719089|NCT03885388|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110719090|NCT03885388|Abortifacient Agents|abortifacient agents|mesh-ancestor
110719091|NCT03885388|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110719092|NCT03885388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110719093|NCT03885388|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110719094|NCT03885388|Antimetabolites|antimetabolites|mesh-ancestor
110719095|NCT03885388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110719096|NCT03885388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110719097|NCT03885388|Dermatologic Agents|dermatologic agents|mesh-ancestor
110719098|NCT03885388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110719099|NCT03885388|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110719100|NCT03885388|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110719101|NCT03885388|Immunologic Factors|immunologic factors|mesh-ancestor
110719102|NCT03885388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110719103|NCT03885388|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110719104|NCT03885388|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110719105|NCT03885388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110719106|NCT03885388|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110719107|NCT03885388|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110719108|NCT01152346|Azacitidine|azacitidine|mesh-list
110719109|NCT01152346|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110719110|NCT01152346|Antimetabolites|antimetabolites|mesh-ancestor
110719111|NCT01152346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110719112|NCT01152346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110719113|NCT01152346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110719114|NCT01260610|Tenofovir|tenofovir|mesh-list
110719115|NCT01260610|Telbivudine|telbivudine|mesh-list
110719117|NCT01260610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110719118|NCT01260610|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110719119|NCT01260610|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110719120|NCT01260610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110719121|NCT01260610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110719122|NCT01260610|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110719123|NCT01260610|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110719124|NCT01155700|Omalizumab|omalizumab|mesh-list
110719125|NCT01155700|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110719126|NCT01155700|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110719127|NCT01155700|Respiratory System Agents|respiratory system agents|mesh-ancestor
110719128|NCT03887884|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
110719129|NCT03887884|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110719130|NCT03887884|Immunologic Factors|immunologic factors|mesh-ancestor
110719131|NCT03887884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110719132|NCT03887884|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110719133|NCT03887884|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110719134|NCT03887884|Dopamine Agonists|dopamine agonists|mesh-ancestor
110719135|NCT03887884|Dopamine Agents|dopamine agents|mesh-ancestor
110719136|NCT03887884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110719137|NCT03887884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110719138|NCT01154530|Chlorhexidine|chlorhexidine|mesh-list
110719139|NCT01154530|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110719140|NCT01154530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110719141|NCT01154530|Disinfectants|disinfectants|mesh-ancestor
110719142|NCT03887416|Dapagliflozin|dapagliflozin|mesh-list
110719143|NCT03887416|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110719144|NCT03887416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110719145|NCT03887416|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110719146|NCT03887416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110719147|NCT01260844|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110719148|NCT01260844|Immunologic Factors|immunologic factors|mesh-ancestor
110719149|NCT01260844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110719150|NCT03891472|Fluorouracil|fluorouracil|mesh-list
110719151|NCT03891472|Oxaliplatin|oxaliplatin|mesh-list
110719152|NCT03891472|Irinotecan|irinotecan|mesh-list
110719153|NCT03891472|Antimetabolites|antimetabolites|mesh-ancestor
110719154|NCT03891472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110719155|NCT03891472|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110719156|NCT03891472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110719157|NCT03891472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110719158|NCT03891472|Immunologic Factors|immunologic factors|mesh-ancestor
110719159|NCT03891472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110719160|NCT03891472|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110719161|NCT03891472|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110719162|NCT03891472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110719163|NCT01262482|Oxaliplatin|oxaliplatin|mesh-list
110719164|NCT01262482|Sorafenib|sorafenib|mesh-list
110719165|NCT01262482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110719166|NCT01262482|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110719167|NCT01262482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110719168|NCT01262482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110719169|NCT01261078|Epinephrine|epinephrine|mesh-list
110719170|NCT01261078|Racepinephrine|racepinephrine|mesh-list
110719171|NCT01261078|Epinephryl borate|epinephryl borate|mesh-list
110719172|NCT01261078|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110719173|NCT01261078|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110719174|NCT01261078|Adrenergic Agents|adrenergic agents|mesh-ancestor
110719175|NCT01261078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110719176|NCT01261078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110719177|NCT01261078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110719178|NCT01261078|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110719179|NCT01261078|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110719181|NCT01261078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110719182|NCT01261078|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110719183|NCT01261078|Respiratory System Agents|respiratory system agents|mesh-ancestor
110719184|NCT01261078|Mydriatics|mydriatics|mesh-ancestor
110719185|NCT01261078|Sympathomimetics|sympathomimetics|mesh-ancestor
110719186|NCT01261078|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110719187|NCT01155934|Risperidone|risperidone|mesh-list
110719188|NCT01155934|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110719189|NCT01155934|Serotonin Agents|serotonin agents|mesh-ancestor
110719190|NCT01155934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110719191|NCT01155934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110719192|NCT01155934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110719193|NCT01155934|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110719194|NCT01155934|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110719195|NCT01155934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110719196|NCT01155934|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110719197|NCT01155934|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110719198|NCT01155934|Dopamine Agents|dopamine agents|mesh-ancestor
110719199|NCT03891550|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
110719200|NCT03891550|Antiviral Agents|antiviral agents|mesh-ancestor
110719201|NCT03891550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110719202|NCT01261156|Diltiazem|diltiazem|mesh-list
110719203|NCT01261156|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110719204|NCT01261156|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110719205|NCT01261156|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110719206|NCT01261156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110719207|NCT01261156|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110719208|NCT01261156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110719209|NCT01261156|Vasodilator Agents|vasodilator agents|mesh-ancestor
110719210|NCT03884530|Aspirin|aspirin|mesh-list
110719211|NCT03884530|Ticagrelor|ticagrelor|mesh-list
110719212|NCT03884530|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110719213|NCT03884530|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110719214|NCT03884530|Analgesics|analgesics|mesh-ancestor
110719215|NCT03884530|Sensory System Agents|sensory system agents|mesh-ancestor
110719216|NCT03884530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110719217|NCT03884530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110719218|NCT03884530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110719219|NCT03884530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110719220|NCT03884530|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110719221|NCT03884530|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110719222|NCT03884530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110719223|NCT03884530|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110719224|NCT03884530|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110719225|NCT03884530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110719226|NCT03884530|Antipyretics|antipyretics|mesh-ancestor
110719227|NCT03884530|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110719228|NCT03884530|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110719229|NCT03884530|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110719230|NCT03884530|Purinergic Agents|purinergic agents|mesh-ancestor
110719231|NCT03884530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110719232|NCT03891316|Sevoflurane|sevoflurane|mesh-list
110719233|NCT03891316|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110719234|NCT03891316|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110719235|NCT03891316|Anesthetics, General|anesthetics, general|mesh-ancestor
110719236|NCT03891316|Anesthetics|anesthetics|mesh-ancestor
110719237|NCT03891316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110719238|NCT03891316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110719239|NCT03887260|Fentanyl|fentanyl|mesh-list
110719240|NCT03887260|Morphine|morphine|mesh-list
110719241|NCT03887260|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110719242|NCT03887260|Narcotics|narcotics|mesh-ancestor
110719243|NCT03887260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110719244|NCT03887260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110719245|NCT03887260|Analgesics|analgesics|mesh-ancestor
110719246|NCT03887260|Sensory System Agents|sensory system agents|mesh-ancestor
110719247|NCT03887260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110719248|NCT03887260|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110719249|NCT03887260|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110719250|NCT03887260|Anesthetics, General|anesthetics, general|mesh-ancestor
110719251|NCT03887260|Anesthetics|anesthetics|mesh-ancestor
110719252|NCT03883984|Cysteamine|cysteamine|mesh-list
110719253|NCT03883984|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
110719254|NCT03883984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110719256|NCT01586494|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110719258|NCT01586494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110719259|NCT01586494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110719260|NCT01586494|Analgesics|analgesics|mesh-ancestor
110719261|NCT01586494|Sensory System Agents|sensory system agents|mesh-ancestor
110719262|NCT01586494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110719263|NCT03886948|Mirikizumab|mirikizumab|mesh-list
110719264|NCT03886948|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110719265|NCT03886948|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110719266|NCT03886948|Analgesics|analgesics|mesh-ancestor
110719267|NCT03886948|Sensory System Agents|sensory system agents|mesh-ancestor
110719268|NCT03886948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110719269|NCT03886948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110719270|NCT03886948|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110719271|NCT03886948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110719272|NCT03886948|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110719273|NCT03886948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110719274|NCT01259362|Cocaine|cocaine|mesh-list
110719275|NCT01259362|Anesthetics, Local|anesthetics, local|mesh-ancestor
110719276|NCT01259362|Anesthetics|anesthetics|mesh-ancestor
110719277|NCT01259362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110719278|NCT01259362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110719279|NCT01259362|Sensory System Agents|sensory system agents|mesh-ancestor
110719280|NCT01259362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110719281|NCT01259362|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110719282|NCT01259362|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110719283|NCT01259362|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110719284|NCT01259362|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110719285|NCT01259362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110719286|NCT01259362|Dopamine Agents|dopamine agents|mesh-ancestor
110719287|NCT01259362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110719288|NCT03891238|Avelumab|avelumab|mesh-list
110719289|NCT03891238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110719290|NCT03891238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110719291|NCT01261234|Cilostazol|cilostazol|mesh-list
110719292|NCT01261234|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110719293|NCT01261234|Autonomic Agents|autonomic agents|mesh-ancestor
110719294|NCT01261234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110719295|NCT01261234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110719296|NCT01261234|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110719297|NCT01261234|Respiratory System Agents|respiratory system agents|mesh-ancestor
110719298|NCT01261234|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110719299|NCT01261234|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110719300|NCT01261234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110719301|NCT01261234|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110719302|NCT01261234|Vasodilator Agents|vasodilator agents|mesh-ancestor
110719303|NCT01261234|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110719304|NCT01261234|Protective Agents|protective agents|mesh-ancestor
110719305|NCT01261234|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110719306|NCT01261234|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110719307|NCT01261234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110719308|NCT01152736|Nicotine|nicotine|mesh-list
110719309|NCT01152736|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110719310|NCT01152736|Autonomic Agents|autonomic agents|mesh-ancestor
110719311|NCT01152736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110719312|NCT01152736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110719313|NCT01152736|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110719314|NCT01152736|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110719315|NCT01152736|Cholinergic Agents|cholinergic agents|mesh-ancestor
110719316|NCT01152736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110719317|NCT01152736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110719318|NCT01154764|Ketoconazole|ketoconazole|mesh-list
110719319|NCT01154764|Antifungal Agents|antifungal agents|mesh-ancestor
110719320|NCT01154764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110719321|NCT01154764|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110719322|NCT01154764|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110719323|NCT01154764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110719324|NCT01154764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110719325|NCT01154764|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110719326|NCT01154764|Hormone Antagonists|hormone antagonists|mesh-ancestor
110719327|NCT01154764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110719328|NCT01154764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110719329|NCT01154764|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110719331|NCT01261546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110719332|NCT01261546|Antiemetics|antiemetics|mesh-ancestor
110719333|NCT01261546|Autonomic Agents|autonomic agents|mesh-ancestor
110719334|NCT01261546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110719335|NCT01261546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110719336|NCT01261546|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110719337|NCT01261546|Glucocorticoids|glucocorticoids|mesh-ancestor
110719338|NCT01261546|Hormones|hormones|mesh-ancestor
110719339|NCT01261546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110719340|NCT01261546|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110719341|NCT01261546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110719342|NCT03883360|Cannabidiol|cannabidiol|mesh-list
110719343|NCT03883360|Anticonvulsants|anticonvulsants|mesh-ancestor
110719344|NCT01261702|Magnesium Sulfate|magnesium sulfate|mesh-list
110719345|NCT01261702|Analgesics|analgesics|mesh-ancestor
110719346|NCT01261702|Sensory System Agents|sensory system agents|mesh-ancestor
110719347|NCT01261702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110719348|NCT01261702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110719349|NCT01261702|Anesthetics|anesthetics|mesh-ancestor
110719350|NCT01261702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110719351|NCT01261702|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110719352|NCT01261702|Anticonvulsants|anticonvulsants|mesh-ancestor
110719353|NCT01261702|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110719354|NCT01261702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110719355|NCT01261702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110719356|NCT01261702|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110719357|NCT01261702|Tocolytic Agents|tocolytic agents|mesh-ancestor
110719358|NCT01261702|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110719359|NCT01156246|Metformin|metformin|mesh-list
110719360|NCT01156246|Dapagliflozin|dapagliflozin|mesh-list
110719361|NCT01156246|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110719362|NCT01156246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110719363|NCT01156246|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110719364|NCT01156246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110719365|NCT03890770|Deucravacitinib|deucravacitinib|mesh-list
110719366|NCT03890770|Dermatologic Agents|dermatologic agents|mesh-ancestor
110719367|NCT03890770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110719368|NCT03890770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110719369|NCT03890770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110719370|NCT03883204|Risperidone|risperidone|mesh-list
110719371|NCT03883204|Aripiprazole|aripiprazole|mesh-list
110719372|NCT03883204|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110719373|NCT03883204|Serotonin Agents|serotonin agents|mesh-ancestor
110719374|NCT03883204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110719375|NCT03883204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110719376|NCT03883204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110719377|NCT03883204|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110719378|NCT03883204|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110719379|NCT03883204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110139871|NCT02008006|Cytarabine|cytarabine|mesh-list
110719380|NCT03883204|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110719381|NCT03883204|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110719382|NCT03883204|Dopamine Agents|dopamine agents|mesh-ancestor
110719383|NCT03883204|Antidepressive Agents|antidepressive agents|mesh-ancestor
110719384|NCT03883204|Dopamine Agonists|dopamine agonists|mesh-ancestor
110719385|NCT03883204|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110719386|NCT03883204|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110719387|NCT03883204|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110719388|NCT03883204|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110719389|NCT01263418|Ofatumumab|ofatumumab|mesh-list
110719390|NCT01263418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110719391|NCT03882814|Meperidine|meperidine|mesh-list
110719392|NCT03882814|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110719393|NCT03882814|Narcotics|narcotics|mesh-ancestor
110560298|NCT02963831|Immunologic Factors|immunologic factors|mesh-ancestor
110719394|NCT03882814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110719395|NCT03882814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110719396|NCT03882814|Analgesics|analgesics|mesh-ancestor
110719397|NCT03882814|Sensory System Agents|sensory system agents|mesh-ancestor
110719398|NCT03882814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110719399|NCT03882814|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110437232|NCT01124838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110719401|NCT03647566|Fluorides|fluorides|mesh-list
110719402|NCT03647566|Sodium Fluoride|sodium fluoride|mesh-list
110719403|NCT03647566|Cariostatic Agents|cariostatic agents|mesh-ancestor
110719404|NCT03647566|Protective Agents|protective agents|mesh-ancestor
110719405|NCT03647566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110719406|NCT03647566|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110719407|NCT03647566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110719408|NCT01156636|Sildenafil Citrate|sildenafil citrate|mesh-list
110719409|NCT01156636|Vasodilator Agents|vasodilator agents|mesh-ancestor
110719410|NCT01156636|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110719411|NCT01156636|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110719412|NCT01156636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110719413|NCT01156636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110719414|NCT01156636|Urological Agents|urological agents|mesh-ancestor
110719415|NCT03889288|Analgesics|analgesics|mesh-list
110719416|NCT03889288|Sensory System Agents|sensory system agents|mesh-ancestor
110719417|NCT03889288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110719418|NCT03889288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110719419|NCT01153204|Sildenafil Citrate|sildenafil citrate|mesh-list
110719420|NCT01153204|Citric Acid|citric acid|mesh-list
110719421|NCT01153204|Sodium Citrate|sodium citrate|mesh-list
110719422|NCT01153204|Anticoagulants|anticoagulants|mesh-ancestor
110719423|NCT01153204|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110719424|NCT01153204|Chelating Agents|chelating agents|mesh-ancestor
110719425|NCT01153204|Sequestering Agents|sequestering agents|mesh-ancestor
110719426|NCT01153204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110719427|NCT01153204|Vasodilator Agents|vasodilator agents|mesh-ancestor
110719428|NCT01153204|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110719429|NCT01153204|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110719430|NCT01153204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110719431|NCT01153204|Urological Agents|urological agents|mesh-ancestor
110719432|NCT03760666|Ribavirin|ribavirin|mesh-list
110719433|NCT03760666|Brequinar|brequinar|mesh-list
110719434|NCT03760666|Antimetabolites|antimetabolites|mesh-ancestor
110719435|NCT03760666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110719436|NCT03760666|Antiviral Agents|antiviral agents|mesh-ancestor
110719437|NCT03760666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110719438|NCT03760666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110719439|NCT03760666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110719440|NCT03760666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110719441|NCT03760666|Immunologic Factors|immunologic factors|mesh-ancestor
110719442|NCT03760666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110719443|NCT01263574|Ethanol|ethanol|mesh-list
110719444|NCT01263574|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110719445|NCT01263574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110719446|NCT01263574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110719447|NCT01263574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110719448|NCT03464734|Paclitaxel|paclitaxel|mesh-list
110719449|NCT03464734|Pembrolizumab|pembrolizumab|mesh-list
110719450|NCT03464734|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110719451|NCT03464734|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110719452|NCT03464734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110719453|NCT03464734|Tubulin Modulators|tubulin modulators|mesh-ancestor
110719454|NCT03464734|Antimitotic Agents|antimitotic agents|mesh-ancestor
110719455|NCT03464734|Mitosis Modulators|mitosis modulators|mesh-ancestor
110719456|NCT03464734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110719457|NCT03464734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110719458|NCT03464734|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110719459|NCT01156948|Misoprostol|misoprostol|mesh-list
110719460|NCT01156948|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110719461|NCT01156948|Abortifacient Agents|abortifacient agents|mesh-ancestor
110719462|NCT01156948|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110719463|NCT01156948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110719464|NCT01156948|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110719465|NCT01156948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110719466|NCT01156948|Oxytocics|oxytocics|mesh-ancestor
110719468|NCT01157026|Tocotrienols|tocotrienols|mesh-list
110719469|NCT01157026|Vitamin E|vitamin e|mesh-list
110719470|NCT01157026|Tocopherols|tocopherols|mesh-list
110719471|NCT01157026|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110719472|NCT01157026|Hormone Antagonists|hormone antagonists|mesh-ancestor
110437326|NCT02638909|Ceritinib|ceritinib|mesh-list
110719473|NCT01157026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110719474|NCT01157026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110719475|NCT01157026|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110719476|NCT01157026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110719477|NCT01157026|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110719478|NCT01157026|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110719479|NCT01157026|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110719480|NCT01157026|Antioxidants|antioxidants|mesh-ancestor
110719481|NCT01157026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110719482|NCT01157026|Protective Agents|protective agents|mesh-ancestor
110719483|NCT01157026|Vitamins|vitamins|mesh-ancestor
110719484|NCT01157026|Micronutrients|micronutrients|mesh-ancestor
110719485|NCT01263652|Dipyrone|dipyrone|mesh-list
110719486|NCT01263652|Diclofenac|diclofenac|mesh-list
110719487|NCT01263652|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
110719488|NCT01263652|Tramadol|tramadol|mesh-list
110719489|NCT01263652|Orphenadrine|orphenadrine|mesh-list
110719490|NCT01263652|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110719491|NCT01263652|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110719492|NCT01263652|Analgesics|analgesics|mesh-ancestor
110719493|NCT01263652|Sensory System Agents|sensory system agents|mesh-ancestor
110719494|NCT01263652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110719495|NCT01263652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110719496|NCT01263652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110719497|NCT01263652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110719498|NCT01263652|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110719499|NCT01263652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110719500|NCT01263652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110719501|NCT01263652|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110719502|NCT01263652|Narcotics|narcotics|mesh-ancestor
110139882|NCT02008006|Antimetabolites|antimetabolites|mesh-ancestor
110719503|NCT01263652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110719504|NCT01263652|Antipyretics|antipyretics|mesh-ancestor
110719505|NCT01263652|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110719506|NCT01263652|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110719507|NCT01263652|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110719508|NCT01263652|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110719509|NCT01263652|Parasympatholytics|parasympatholytics|mesh-ancestor
110719510|NCT01263652|Autonomic Agents|autonomic agents|mesh-ancestor
110719511|NCT01263652|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110719512|NCT01263652|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110719513|NCT01263652|Cholinergic Agents|cholinergic agents|mesh-ancestor
110719514|NCT01263652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110719515|NCT01263652|Cytochrome P-450 CYP2B6 Inhibitors|cytochrome p-450 cyp2b6 inhibitors|mesh-ancestor
110719516|NCT01263652|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110719517|NCT03881644|Sumatriptan|sumatriptan|mesh-list
110719518|NCT03881644|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
110719519|NCT03881644|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110719520|NCT03881644|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110719521|NCT03881644|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110719522|NCT03881644|Serotonin Agents|serotonin agents|mesh-ancestor
110719523|NCT03881644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110719524|NCT03881644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110719525|NCT03881644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110719526|NCT03881644|Growth Substances|growth substances|mesh-ancestor
110719527|NCT03881644|Vasodilator Agents|vasodilator agents|mesh-ancestor
110719528|NCT01259830|Etoricoxib|etoricoxib|mesh-list
110719529|NCT01259830|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110719530|NCT01259830|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110719531|NCT01259830|Analgesics|analgesics|mesh-ancestor
110719532|NCT01259830|Sensory System Agents|sensory system agents|mesh-ancestor
110719533|NCT01259830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110719534|NCT01259830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110719535|NCT01259830|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110719536|NCT01259830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110719537|NCT01259830|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110719538|NCT01259830|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110719539|NCT01259830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110719540|NCT01259830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110719542|NCT00224484|Immunologic Factors|immunologic factors|mesh-ancestor
110719543|NCT00224484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110719544|NCT01265680|Epoetin Alfa|epoetin alfa|mesh-list
110719545|NCT01265680|Hematinics|hematinics|mesh-ancestor
110719546|NCT01263808|Moxifloxacin|moxifloxacin|mesh-list
110719547|NCT01263808|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110719548|NCT01263808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110719549|NCT01263808|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110719550|NCT01263808|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110719551|NCT01263808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110719552|NCT01263808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110719553|NCT01263808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110719554|NCT01157572|Metoprolol|metoprolol|mesh-list
110719555|NCT01157572|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110719556|NCT01157572|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110719557|NCT01157572|Sympatholytics|sympatholytics|mesh-ancestor
110719558|NCT01157572|Autonomic Agents|autonomic agents|mesh-ancestor
110719559|NCT01157572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110719560|NCT01157572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110719561|NCT01157572|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110719562|NCT01157572|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110719563|NCT01157572|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110719564|NCT01157572|Adrenergic Agents|adrenergic agents|mesh-ancestor
110719565|NCT01157572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110719566|NCT01157572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110719567|NCT01074372|Alirocumab|alirocumab|mesh-list
110719568|NCT01074372|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
110719569|NCT01074372|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110719570|NCT01074372|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110719571|NCT01074372|Antimetabolites|antimetabolites|mesh-ancestor
110719572|NCT01074372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110719573|NCT01074372|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110719574|NCT01074372|Protease Inhibitors|protease inhibitors|mesh-ancestor
110719575|NCT01074372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110719576|NCT01074372|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110719577|NCT01267942|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
110719578|NCT01267942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110719579|NCT01267942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110719580|NCT01267942|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110719581|NCT01267942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110719582|NCT01267942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110719583|NCT00254982|Infliximab|infliximab|mesh-list
110719584|NCT00254982|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110719585|NCT00254982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110719586|NCT00254982|Dermatologic Agents|dermatologic agents|mesh-ancestor
110719587|NCT00254982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110719588|NCT00254982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110719589|NCT01586572|Vaccines|vaccines|mesh-list
110719590|NCT01586572|Immunologic Factors|immunologic factors|mesh-ancestor
110719591|NCT01586572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110719592|NCT00224016|Mandelic Acids|mandelic acids|mesh-list
110719593|NCT00224016|Oxybutynin|oxybutynin|mesh-list
110719594|NCT00224016|Parasympatholytics|parasympatholytics|mesh-ancestor
110719595|NCT00224016|Autonomic Agents|autonomic agents|mesh-ancestor
110719596|NCT00224016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110719597|NCT00224016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110139914|NCT02008162|Bromides|bromides|mesh-list
110719598|NCT00224016|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110719599|NCT00224016|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110719600|NCT00224016|Cholinergic Agents|cholinergic agents|mesh-ancestor
110719601|NCT00224016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110719602|NCT00224016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110719603|NCT00224016|Urological Agents|urological agents|mesh-ancestor
110719604|NCT00224016|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110719605|NCT00224016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110719606|NCT02527174|Cytarabine|cytarabine|mesh-list
110719607|NCT02527174|Idarubicin|idarubicin|mesh-list
110719608|NCT02527174|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110719609|NCT02527174|Antimetabolites|antimetabolites|mesh-ancestor
110719610|NCT02527174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110719611|NCT02527174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110719612|NCT02527174|Antiviral Agents|antiviral agents|mesh-ancestor
110719613|NCT02527174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110719614|NCT02527174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110719615|NCT02527174|Immunologic Factors|immunologic factors|mesh-ancestor
110719616|NCT02527174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110719617|NCT02527174|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110719618|NCT02527174|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110719619|NCT02527174|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110719620|NCT02527174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110719621|NCT01161940|Nizatidine|nizatidine|mesh-list
110719622|NCT01161940|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110719623|NCT01161940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110719624|NCT01161940|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110719625|NCT01161940|Histamine Antagonists|histamine antagonists|mesh-ancestor
110719626|NCT01161940|Histamine Agents|histamine agents|mesh-ancestor
110719627|NCT01161940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110719628|NCT01161940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110719629|NCT01161940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110719630|NCT01160068|Metformin|metformin|mesh-list
110719631|NCT01160068|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110719632|NCT01160068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110719633|NCT01266694|Colchicine|colchicine|mesh-list
110719634|NCT01266694|Gout Suppressants|gout suppressants|mesh-ancestor
110719635|NCT01266694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110719636|NCT01266694|Tubulin Modulators|tubulin modulators|mesh-ancestor
110719637|NCT01266694|Antimitotic Agents|antimitotic agents|mesh-ancestor
110719638|NCT01266694|Mitosis Modulators|mitosis modulators|mesh-ancestor
110719639|NCT01266694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110719640|NCT01266694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110719641|NCT03876886|Paclitaxel|paclitaxel|mesh-list
110719642|NCT03876886|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110719643|NCT03876886|Cyclophosphamide|cyclophosphamide|mesh-list
110719644|NCT03876886|Carboplatin|carboplatin|mesh-list
110719645|NCT03876886|Epirubicin|epirubicin|mesh-list
110719646|NCT03876886|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110719647|NCT03876886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110719648|NCT03876886|Tubulin Modulators|tubulin modulators|mesh-ancestor
110719649|NCT03876886|Antimitotic Agents|antimitotic agents|mesh-ancestor
110719650|NCT03876886|Mitosis Modulators|mitosis modulators|mesh-ancestor
110719651|NCT03876886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110719652|NCT03876886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110719653|NCT03876886|Immunologic Factors|immunologic factors|mesh-ancestor
110719654|NCT03876886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110719655|NCT03876886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110719656|NCT03876886|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110719657|NCT03876886|Alkylating Agents|alkylating agents|mesh-ancestor
110719658|NCT03876886|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110719659|NCT03876886|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110719660|NCT03876886|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110139954|NCT02008422|Oxaliplatin|oxaliplatin|mesh-list
110719661|NCT03876886|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110719662|NCT03876886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110719663|NCT01266772|Budesonide|budesonide|mesh-list
110719664|NCT01266772|Montelukast|montelukast|mesh-list
110719665|NCT01266772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110719666|NCT01266772|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110719667|NCT01266772|Autonomic Agents|autonomic agents|mesh-ancestor
110719668|NCT01266772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110719669|NCT01266772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110719670|NCT01266772|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110719671|NCT01266772|Respiratory System Agents|respiratory system agents|mesh-ancestor
110719672|NCT01266772|Glucocorticoids|glucocorticoids|mesh-ancestor
110719673|NCT01266772|Hormones|hormones|mesh-ancestor
110719674|NCT01266772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110719675|NCT01266772|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110719676|NCT01266772|Hormone Antagonists|hormone antagonists|mesh-ancestor
110719677|NCT01266772|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110719678|NCT01266772|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110719679|NCT01266772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110719680|NCT01264354|Adefovir|adefovir|mesh-list
110719681|NCT01264354|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
110719682|NCT01264354|Clevudine|clevudine|mesh-list
110719683|NCT01264354|Antiviral Agents|antiviral agents|mesh-ancestor
110719684|NCT01264354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110719685|NCT01264354|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110719686|NCT01264354|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110719687|NCT01264354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110719688|NCT01264354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110719690|NCT01264432|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110719691|NCT01264432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110719692|NCT01264432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110719693|NCT01264432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110719694|NCT02527096|Lamivudine|lamivudine|mesh-list
110719695|NCT02527096|Dolutegravir|dolutegravir|mesh-list
110719696|NCT02527096|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110719697|NCT02527096|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110719698|NCT02527096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110719699|NCT02527096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110437534|NCT01198522|Antibodies|antibodies|mesh-list
110719700|NCT02527096|Antiviral Agents|antiviral agents|mesh-ancestor
110719701|NCT02527096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110719702|NCT02527096|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110719703|NCT02527096|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110719704|NCT02527096|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110719705|NCT02527096|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110719706|NCT01160302|Curcumin|curcumin|mesh-list
110719707|NCT01160302|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110719708|NCT01160302|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110719709|NCT01160302|Analgesics|analgesics|mesh-ancestor
110719710|NCT01160302|Sensory System Agents|sensory system agents|mesh-ancestor
110719711|NCT01160302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110719712|NCT01160302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110719713|NCT01160302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110719714|NCT01160302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110719715|NCT01160302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110719716|NCT01160302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110719717|NCT01160302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110719718|NCT01162720|Oxymetazoline|oxymetazoline|mesh-list
110719719|NCT01162720|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110719720|NCT01162720|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110719721|NCT01162720|Adrenergic Agents|adrenergic agents|mesh-ancestor
110719722|NCT01162720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110719723|NCT01162720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110719724|NCT01162720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110719725|NCT01162720|Sympathomimetics|sympathomimetics|mesh-ancestor
110719726|NCT01162720|Autonomic Agents|autonomic agents|mesh-ancestor
110719727|NCT01162720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110719728|NCT01162720|Nasal Decongestants|nasal decongestants|mesh-ancestor
110719729|NCT01162720|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110719730|NCT01162720|Respiratory System Agents|respiratory system agents|mesh-ancestor
110719731|NCT01268176|Vitamin D|vitamin d|mesh-list
110719732|NCT01268176|Cholecalciferol|cholecalciferol|mesh-list
110719733|NCT01268176|Vitamins|vitamins|mesh-ancestor
110719734|NCT01268176|Micronutrients|micronutrients|mesh-ancestor
110719735|NCT01268176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110719736|NCT01268176|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110719737|NCT01268176|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110719738|NCT01264588|Calcium|calcium|mesh-list
110862255|NCT01316757|Mitosis Modulators|mitosis modulators|mesh-ancestor
110719739|NCT01264588|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110719740|NCT01264588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110719741|NCT05075200|Tranexamic Acid|tranexamic acid|mesh-list
110719742|NCT05075200|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110719743|NCT05075200|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110719744|NCT05075200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110719745|NCT05075200|Hemostatics|hemostatics|mesh-ancestor
110719746|NCT05075200|Coagulants|coagulants|mesh-ancestor
110719747|NCT01158274|Capecitabine|capecitabine|mesh-list
110719748|NCT01158274|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
110719749|NCT01158274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110719750|NCT01158274|Antimetabolites|antimetabolites|mesh-ancestor
110719751|NCT01158274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110719752|NCT01158274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110719753|NCT01158274|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
110719754|NCT01158274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110719755|NCT01267084|Ketoconazole|ketoconazole|mesh-list
110719756|NCT01267084|Dexamethasone|dexamethasone|mesh-list
110719757|NCT01267084|Trabectedin|trabectedin|mesh-list
110719758|NCT01267084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110719759|NCT01267084|Antiemetics|antiemetics|mesh-ancestor
110719760|NCT01267084|Autonomic Agents|autonomic agents|mesh-ancestor
110719761|NCT01267084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110719762|NCT01267084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110719763|NCT01267084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110719764|NCT01267084|Glucocorticoids|glucocorticoids|mesh-ancestor
110719765|NCT01267084|Hormones|hormones|mesh-ancestor
110719766|NCT01267084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110719767|NCT01267084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110719768|NCT01267084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110719769|NCT01267084|Antifungal Agents|antifungal agents|mesh-ancestor
110719770|NCT01267084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110719771|NCT01267084|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110719772|NCT01267084|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110719773|NCT01267084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110719774|NCT01267084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110719775|NCT01267084|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110719776|NCT01267084|Hormone Antagonists|hormone antagonists|mesh-ancestor
110719777|NCT01267084|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110719778|NCT01267084|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110719779|NCT01267084|Alkylating Agents|alkylating agents|mesh-ancestor
110719780|NCT01264822|Rabeprazole|rabeprazole|mesh-list
110719781|NCT01264822|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110719782|NCT01264822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110719783|NCT01264822|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110719784|NCT01264822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110719785|NCT01264822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110719786|NCT03876574|Dexamethasone|dexamethasone|mesh-list
110719787|NCT03876574|Gemcitabine|gemcitabine|mesh-list
110719788|NCT03876574|Floxuridine|floxuridine|mesh-list
110719789|NCT03876574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110719790|NCT03876574|Antiemetics|antiemetics|mesh-ancestor
110719791|NCT03876574|Autonomic Agents|autonomic agents|mesh-ancestor
110719792|NCT03876574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110719793|NCT03876574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110719794|NCT03876574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110719795|NCT03876574|Glucocorticoids|glucocorticoids|mesh-ancestor
110719796|NCT03876574|Hormones|hormones|mesh-ancestor
110719797|NCT03876574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110719798|NCT03876574|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110719799|NCT03876574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110719800|NCT03876574|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110719801|NCT03876574|Antimetabolites|antimetabolites|mesh-ancestor
110719802|NCT03876574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110719803|NCT01161082|Alirocumab|alirocumab|mesh-list
110719804|NCT01161082|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
110719805|NCT01161082|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110719806|NCT01161082|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110719807|NCT01161082|Antimetabolites|antimetabolites|mesh-ancestor
110719808|NCT01161082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110719809|NCT01161082|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110719810|NCT01161082|Protease Inhibitors|protease inhibitors|mesh-ancestor
110719811|NCT01161082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110719812|NCT01161082|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110719813|NCT01158586|Levobupivacaine|levobupivacaine|mesh-list
110719814|NCT01158586|Anesthetics, Local|anesthetics, local|mesh-ancestor
110719815|NCT01158586|Anesthetics|anesthetics|mesh-ancestor
110719816|NCT01158586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110719817|NCT01158586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110719818|NCT01158586|Sensory System Agents|sensory system agents|mesh-ancestor
110719819|NCT01158586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110719820|NCT01267396|Sertraline|sertraline|mesh-list
110719821|NCT01267396|Antidepressive Agents|antidepressive agents|mesh-ancestor
110719822|NCT01267396|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110719823|NCT01267396|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110719824|NCT01267396|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110719825|NCT01267396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110719826|NCT01267396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110719827|NCT01267396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110719828|NCT01267396|Serotonin Agents|serotonin agents|mesh-ancestor
110719829|NCT01267396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110719830|NCT01159132|Raltegravir Potassium|raltegravir potassium|mesh-list
110719831|NCT01159132|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110719832|NCT01159132|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110719833|NCT01159132|Antiviral Agents|antiviral agents|mesh-ancestor
110719834|NCT01159132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110719835|NCT01159132|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110719836|NCT01159132|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110719837|NCT01159132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110719838|NCT01159132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110719839|NCT01161316|Cetuximab|cetuximab|mesh-list
110719840|NCT01161316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110719841|NCT01161316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110719842|NCT01161550|Cytarabine|cytarabine|mesh-list
110719843|NCT01161550|Tretinoin|tretinoin|mesh-list
110719844|NCT01161550|Cladribine|cladribine|mesh-list
110719845|NCT01161550|Midostaurin|midostaurin|mesh-list
110719846|NCT01161550|Lenograstim|lenograstim|mesh-list
110719847|NCT01161550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110437683|NCT02224144|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
110719848|NCT01161550|Antimetabolites|antimetabolites|mesh-ancestor
110719849|NCT01161550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110719850|NCT01161550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110719851|NCT01161550|Antiviral Agents|antiviral agents|mesh-ancestor
110719852|NCT01161550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110719853|NCT01161550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110719854|NCT01161550|Immunologic Factors|immunologic factors|mesh-ancestor
110719855|NCT01161550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110719856|NCT01161550|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110719857|NCT01161550|Keratolytic Agents|keratolytic agents|mesh-ancestor
110719858|NCT01161550|Dermatologic Agents|dermatologic agents|mesh-ancestor
110719859|NCT01161550|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110719860|NCT01161550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110719861|NCT01159210|Thrombin|thrombin|mesh-list
110719862|NCT01159210|Hemostatics|hemostatics|mesh-ancestor
110719863|NCT01159210|Coagulants|coagulants|mesh-ancestor
110719864|NCT03879460|Naltrexone|naltrexone|mesh-list
110719865|NCT03879460|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110719866|NCT03879460|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110719867|NCT03879460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110719868|NCT03879460|Sensory System Agents|sensory system agents|mesh-ancestor
110719869|NCT03879460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110719870|NCT03877120|Diazepam|diazepam|mesh-list
110719871|NCT03877120|Dexmedetomidine|dexmedetomidine|mesh-list
110719872|NCT03877120|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110719873|NCT03877120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110719874|NCT03877120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110719875|NCT03877120|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110719876|NCT03877120|Analgesics|analgesics|mesh-ancestor
110719877|NCT03877120|Sensory System Agents|sensory system agents|mesh-ancestor
110719878|NCT03877120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110719879|NCT03877120|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110719880|NCT03877120|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110719881|NCT03877120|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110719882|NCT03877120|Adrenergic Agents|adrenergic agents|mesh-ancestor
110719883|NCT03877120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110719884|NCT03877120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110719885|NCT03877120|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110719886|NCT03877120|Anticonvulsants|anticonvulsants|mesh-ancestor
110719887|NCT03877120|Antiemetics|antiemetics|mesh-ancestor
110719888|NCT03877120|Autonomic Agents|autonomic agents|mesh-ancestor
110719889|NCT03877120|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110719890|NCT03877120|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110719891|NCT03877120|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110719892|NCT03877120|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110719893|NCT03877120|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110719894|NCT03877120|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110719895|NCT03877120|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110719896|NCT03877120|Anesthetics, General|anesthetics, general|mesh-ancestor
110719897|NCT03877120|Anesthetics|anesthetics|mesh-ancestor
110719898|NCT03877120|GABA Modulators|gaba modulators|mesh-ancestor
110719899|NCT03877120|GABA Agents|gaba agents|mesh-ancestor
110719900|NCT03879382|Cyclophosphamide|cyclophosphamide|mesh-list
110719901|NCT03879382|Fludarabine|fludarabine|mesh-list
110719902|NCT03879382|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110719903|NCT03879382|Immunologic Factors|immunologic factors|mesh-ancestor
110719904|NCT03879382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110719905|NCT03879382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110719906|NCT03879382|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110719907|NCT03879382|Alkylating Agents|alkylating agents|mesh-ancestor
110719908|NCT03879382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110719909|NCT03879382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110719910|NCT03879382|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110719911|NCT01166932|Amoxicillin|amoxicillin|mesh-list
110719912|NCT01166932|Ceftriaxone|ceftriaxone|mesh-list
110719913|NCT01166932|Clavulanic Acids|clavulanic acids|mesh-list
110719914|NCT01166932|Clavulanic Acid|clavulanic acid|mesh-list
110719915|NCT01166932|Oxacillin|oxacillin|mesh-list
110719916|NCT01166932|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110719917|NCT01166932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110719918|NCT01166932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110719919|NCT01166932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110719920|NCT01166932|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110719921|NCT01167010|Budesonide|budesonide|mesh-list
110719922|NCT01167010|Formoterol Fumarate|formoterol fumarate|mesh-list
110719923|NCT01167010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110719924|NCT01167010|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110719925|NCT01167010|Autonomic Agents|autonomic agents|mesh-ancestor
110719926|NCT01167010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110719927|NCT01167010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110719928|NCT01167010|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110719929|NCT01167010|Respiratory System Agents|respiratory system agents|mesh-ancestor
110719930|NCT01167010|Glucocorticoids|glucocorticoids|mesh-ancestor
110719931|NCT01167010|Hormones|hormones|mesh-ancestor
110719932|NCT01167010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110719933|NCT01167010|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110719934|NCT01167010|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110719935|NCT01167010|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110719936|NCT01167010|Adrenergic Agents|adrenergic agents|mesh-ancestor
110719937|NCT01167010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110719938|NCT01167010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110719939|NCT01280188|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
110719940|NCT01280188|Hemostatics|hemostatics|mesh-ancestor
110719941|NCT01280188|Coagulants|coagulants|mesh-ancestor
110719942|NCT01280188|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
110719943|NCT01280188|Natriuretic Agents|natriuretic agents|mesh-ancestor
110719944|NCT01280188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110719946|NCT03871972|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110719947|NCT03871972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110719948|NCT03871972|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110719949|NCT03871972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110719950|NCT03871972|Antifungal Agents|antifungal agents|mesh-ancestor
110719951|NCT03871972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110719952|NCT03871972|Immunologic Factors|immunologic factors|mesh-ancestor
110719953|NCT03871972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110719954|NCT01165060|Bezafibrate|bezafibrate|mesh-list
110719955|NCT01165060|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110719956|NCT01165060|Antimetabolites|antimetabolites|mesh-ancestor
110719957|NCT01165060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110719958|NCT01165060|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110719959|NCT01165294|Ketamine|ketamine|mesh-list
110719960|NCT01165294|Analgesics|analgesics|mesh-ancestor
110719961|NCT01165294|Sensory System Agents|sensory system agents|mesh-ancestor
110719962|NCT01165294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110719963|NCT01165294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110719964|NCT01165294|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110719965|NCT01165294|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110719966|NCT01165294|Anesthetics, General|anesthetics, general|mesh-ancestor
110719967|NCT01165294|Anesthetics|anesthetics|mesh-ancestor
110719968|NCT01165294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110719969|NCT01165294|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110719970|NCT01165294|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110719971|NCT01165294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110719972|NCT01165294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110719973|NCT01165372|Artesunate|artesunate|mesh-list
110719974|NCT01165372|Piperaquine|piperaquine|mesh-list
110719975|NCT01165372|Artenimol|artenimol|mesh-list
110719976|NCT01165372|Antimalarials|antimalarials|mesh-ancestor
110719977|NCT01165372|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110719978|NCT01165372|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110719979|NCT01165372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110444057|NCT02884037|Rifaximin|rifaximin|mesh-list
110719980|NCT01165372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110719981|NCT01165372|Antiviral Agents|antiviral agents|mesh-ancestor
110719982|NCT01165372|Schistosomicides|schistosomicides|mesh-ancestor
110719983|NCT01165372|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110719984|NCT01165372|Anthelmintics|anthelmintics|mesh-ancestor
110719985|NCT01280734|Melatonin|melatonin|mesh-list
110719986|NCT01280734|Antioxidants|antioxidants|mesh-ancestor
110719987|NCT01280734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110719988|NCT01280734|Protective Agents|protective agents|mesh-ancestor
110862291|NCT01367418|Ropivacaine|ropivacaine|mesh-list
110719989|NCT01280734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110719990|NCT01280734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110719991|NCT01269970|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110719992|NCT01269970|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110719993|NCT01269970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110719994|NCT01587430|Cytarabine|cytarabine|mesh-list
110719995|NCT01587430|Daunorubicin|daunorubicin|mesh-list
110719996|NCT01587430|Mitoxantrone|mitoxantrone|mesh-list
110719997|NCT01587430|Idarubicin|idarubicin|mesh-list
110719998|NCT01587430|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110719999|NCT01587430|Antimetabolites|antimetabolites|mesh-ancestor
110720000|NCT01587430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110720001|NCT01587430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110720002|NCT01587430|Antiviral Agents|antiviral agents|mesh-ancestor
110720003|NCT01587430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110720004|NCT01587430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110720005|NCT01587430|Immunologic Factors|immunologic factors|mesh-ancestor
110720006|NCT01587430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110720007|NCT01587430|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110720008|NCT01587430|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110720009|NCT01587430|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110720010|NCT01587430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110720011|NCT01587430|Analgesics|analgesics|mesh-ancestor
110720012|NCT01587430|Sensory System Agents|sensory system agents|mesh-ancestor
110720013|NCT01587430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110720014|NCT03874000|Metformin|metformin|mesh-list
110720015|NCT03874000|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110720016|NCT03874000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110720017|NCT03757234|Levofloxacin|levofloxacin|mesh-list
110720018|NCT03757234|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110720019|NCT03757234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110720020|NCT03757234|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110720021|NCT03757234|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110720022|NCT03757234|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110720023|NCT03757234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110720024|NCT03757234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110720025|NCT03757234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110720026|NCT03757234|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110720027|NCT03757234|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110720028|NCT03874156|Atorvastatin|atorvastatin|mesh-list
110720029|NCT03874156|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110720030|NCT03874156|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110720031|NCT03874156|Antimetabolites|antimetabolites|mesh-ancestor
110720032|NCT03874156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110720033|NCT03874156|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110720034|NCT03874156|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110720035|NCT03874156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110720036|NCT01167478|Caffeine|caffeine|mesh-list
110720037|NCT01167478|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110720038|NCT01167478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110720039|NCT01167478|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110720040|NCT01167478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110720041|NCT01167478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110720042|NCT01167478|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110720043|NCT01167478|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110720044|NCT01167478|Purinergic Agents|purinergic agents|mesh-ancestor
110720045|NCT01167478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110720046|NCT01587196|Naltrexone|naltrexone|mesh-list
110720047|NCT01587196|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110720048|NCT01587196|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110720049|NCT01587196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110720050|NCT01587196|Sensory System Agents|sensory system agents|mesh-ancestor
110444059|NCT02884037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110720051|NCT01587196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110720053|NCT01281514|Doxorubicin|doxorubicin|mesh-list
110720054|NCT01281514|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110720055|NCT01281514|Everolimus|everolimus|mesh-list
110720056|NCT01281514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110720057|NCT01281514|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110720058|NCT01281514|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110720059|NCT01281514|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110720060|NCT01281514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110720061|NCT01281514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110720062|NCT01281514|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110720063|NCT01281514|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110720064|NCT01281514|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110720065|NCT01281514|Immunologic Factors|immunologic factors|mesh-ancestor
110720066|NCT01281514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110720067|NCT00223080|Aluminum Hydroxide|aluminum hydroxide|mesh-list
110720068|NCT00223080|Immunologic Factors|immunologic factors|mesh-ancestor
110720069|NCT00223080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110720070|NCT00223080|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110720071|NCT00223080|Antacids|antacids|mesh-ancestor
110720072|NCT00223080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110720073|NCT00223080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110720074|NCT03971604|Vitamins|vitamins|mesh-list
110720075|NCT03971604|Vitamin E|vitamin e|mesh-list
110720076|NCT03971604|Vitamin A|vitamin a|mesh-list
110720077|NCT03971604|Micronutrients|micronutrients|mesh-ancestor
110720078|NCT03971604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110720079|NCT03971604|Antioxidants|antioxidants|mesh-ancestor
110720080|NCT03971604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110720081|NCT03971604|Protective Agents|protective agents|mesh-ancestor
110720082|NCT02531490|Labetalol|labetalol|mesh-list
110720083|NCT02531490|Methyldopa|methyldopa|mesh-list
110720084|NCT02531490|Nifedipine|nifedipine|mesh-list
110720085|NCT02531490|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110720086|NCT02531490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110720087|NCT02531490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110720088|NCT02531490|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110720089|NCT02531490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110720090|NCT02531490|Vasodilator Agents|vasodilator agents|mesh-ancestor
110720091|NCT02531490|Tocolytic Agents|tocolytic agents|mesh-ancestor
110720092|NCT02531490|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110720093|NCT02531490|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110720094|NCT02531490|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110720095|NCT02531490|Adrenergic Agents|adrenergic agents|mesh-ancestor
110720096|NCT02531490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110720097|NCT02531490|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110720098|NCT02531490|Sympathomimetics|sympathomimetics|mesh-ancestor
110720099|NCT02531490|Autonomic Agents|autonomic agents|mesh-ancestor
110720100|NCT02531490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110720101|NCT02531490|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110720102|NCT02531490|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110720103|NCT02531490|Sympatholytics|sympatholytics|mesh-ancestor
110720104|NCT02531490|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110720105|NCT02531490|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110720106|NCT02531490|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110720107|NCT03871114|Triamcinolone|triamcinolone|mesh-list
110720108|NCT03871114|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110720109|NCT03871114|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110720110|NCT03871114|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110720111|NCT03871114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110720112|NCT03871114|Glucocorticoids|glucocorticoids|mesh-ancestor
110720113|NCT03871114|Hormones|hormones|mesh-ancestor
110720114|NCT03871114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110720115|NCT03871114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110720116|NCT03871114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110720117|NCT03871114|Immunologic Factors|immunologic factors|mesh-ancestor
110720118|NCT03871114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110720119|NCT03871114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110720120|NCT01281748|Methylprednisolone|methylprednisolone|mesh-list
110720121|NCT01281748|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110720122|NCT01281748|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110720123|NCT01281748|Prednisolone|prednisolone|mesh-list
110720124|NCT01281748|Prednisolone acetate|prednisolone acetate|mesh-list
110720125|NCT01281748|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110720126|NCT01281748|Prednisolone phosphate|prednisolone phosphate|mesh-list
110720127|NCT01281748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110720128|NCT01281748|Antiemetics|antiemetics|mesh-ancestor
110720129|NCT01281748|Autonomic Agents|autonomic agents|mesh-ancestor
110720130|NCT01281748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110720131|NCT01281748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110720132|NCT01281748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110720133|NCT01281748|Glucocorticoids|glucocorticoids|mesh-ancestor
110720135|NCT01281748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110720136|NCT01281748|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110720137|NCT01281748|Protective Agents|protective agents|mesh-ancestor
110720138|NCT01281748|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110720139|NCT01281748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110720140|NCT00220740|Immunoglobulins|immunoglobulins|mesh-list
110720141|NCT00220740|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110720142|NCT00220740|Antibodies|antibodies|mesh-list
110720143|NCT00220740|gamma-Globulins|gamma-globulins|mesh-list
110720144|NCT00220740|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110720145|NCT00220740|Immunoglobulin G|immunoglobulin g|mesh-list
110720146|NCT00220740|Immunologic Factors|immunologic factors|mesh-ancestor
110720147|NCT00220740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110720148|NCT01273402|Antibodies|antibodies|mesh-list
110720149|NCT01273402|Immunoglobulins|immunoglobulins|mesh-list
110720150|NCT01273402|Antibodies, Bispecific|antibodies, bispecific|mesh-list
110720151|NCT01273402|Immunologic Factors|immunologic factors|mesh-ancestor
110720152|NCT01273402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110720153|NCT03873298|Nitric Oxide|nitric oxide|mesh-list
110720154|NCT03873298|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110720155|NCT03873298|Autonomic Agents|autonomic agents|mesh-ancestor
110720156|NCT03873298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110720157|NCT03873298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110720158|NCT03873298|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110720159|NCT03873298|Respiratory System Agents|respiratory system agents|mesh-ancestor
110720160|NCT03873298|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110720161|NCT03873298|Antioxidants|antioxidants|mesh-ancestor
110720162|NCT03873298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110720163|NCT03873298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110720164|NCT03873298|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
110720165|NCT03873298|Vasodilator Agents|vasodilator agents|mesh-ancestor
110720166|NCT03873298|Gasotransmitters|gasotransmitters|mesh-ancestor
110720167|NCT03873298|Protective Agents|protective agents|mesh-ancestor
110720168|NCT00184002|Prednisone|prednisone|mesh-list
110720169|NCT00184002|Cyclophosphamide|cyclophosphamide|mesh-list
110720170|NCT00184002|Doxorubicin|doxorubicin|mesh-list
110720171|NCT00184002|Vincristine|vincristine|mesh-list
110720172|NCT00184002|Rituximab|rituximab|mesh-list
110140105|NCT05778227|Eusol|eusol|mesh-list
110720173|NCT00184002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110720174|NCT00184002|Immunologic Factors|immunologic factors|mesh-ancestor
110720175|NCT00184002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110720176|NCT00184002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110720177|NCT00184002|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110720178|NCT00184002|Alkylating Agents|alkylating agents|mesh-ancestor
110720179|NCT00184002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110720180|NCT00184002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110720181|NCT00184002|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110720182|NCT00184002|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110720183|NCT00184002|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110720184|NCT00184002|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110720185|NCT00184002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110720186|NCT00184002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110720187|NCT00184002|Glucocorticoids|glucocorticoids|mesh-ancestor
110720188|NCT00184002|Hormones|hormones|mesh-ancestor
110720189|NCT00184002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110720190|NCT00184002|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110720191|NCT00184002|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110720192|NCT00184002|Tubulin Modulators|tubulin modulators|mesh-ancestor
110720193|NCT00184002|Antimitotic Agents|antimitotic agents|mesh-ancestor
110720194|NCT00184002|Mitosis Modulators|mitosis modulators|mesh-ancestor
110720195|NCT00184002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110720196|NCT01167946|Methylprednisolone|methylprednisolone|mesh-list
110720197|NCT01167946|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110720198|NCT01167946|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110720199|NCT01167946|Prednisolone|prednisolone|mesh-list
110720200|NCT01167946|Prednisolone acetate|prednisolone acetate|mesh-list
110720201|NCT01167946|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110720202|NCT01167946|Prednisolone phosphate|prednisolone phosphate|mesh-list
110720203|NCT01167946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110720204|NCT01167946|Antiemetics|antiemetics|mesh-ancestor
110720205|NCT01167946|Autonomic Agents|autonomic agents|mesh-ancestor
110720206|NCT01167946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110720207|NCT01167946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110720208|NCT01167946|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110720209|NCT01167946|Glucocorticoids|glucocorticoids|mesh-ancestor
110720210|NCT01167946|Hormones|hormones|mesh-ancestor
110720211|NCT01167946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110720212|NCT01167946|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110720213|NCT01167946|Protective Agents|protective agents|mesh-ancestor
110720214|NCT01167946|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110720215|NCT01167946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110720216|NCT01275508|Adalimumab|adalimumab|mesh-list
110720217|NCT01275508|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110720218|NCT01275508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110720219|NCT01275508|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110720220|NCT01073670|Acetaminophen|acetaminophen|mesh-list
110720221|NCT01073670|Indomethacin|indomethacin|mesh-list
110720222|NCT01073670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110720223|NCT01073670|Analgesics|analgesics|mesh-ancestor
110720224|NCT01073670|Sensory System Agents|sensory system agents|mesh-ancestor
110720225|NCT01073670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110720226|NCT01073670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110720227|NCT01073670|Antipyretics|antipyretics|mesh-ancestor
110720228|NCT01073670|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110720229|NCT01073670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110720230|NCT01073670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110720231|NCT01073670|Gout Suppressants|gout suppressants|mesh-ancestor
110720232|NCT01073670|Tocolytic Agents|tocolytic agents|mesh-ancestor
110720233|NCT01073670|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110720234|NCT01073670|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110720235|NCT01073670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110720236|NCT01073670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110720237|NCT03971370|Vaccines|vaccines|mesh-list
110720238|NCT03971370|Immunologic Factors|immunologic factors|mesh-ancestor
110720239|NCT03971370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110720240|NCT01168336|Betahistine|betahistine|mesh-list
110720241|NCT01168336|Vasodilator Agents|vasodilator agents|mesh-ancestor
110720242|NCT01168336|Histamine Agonists|histamine agonists|mesh-ancestor
110720243|NCT01168336|Histamine Agents|histamine agents|mesh-ancestor
110720244|NCT01168336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110720245|NCT01168336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110720246|NCT01168336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110720247|NCT00165672|Rabeprazole|rabeprazole|mesh-list
110720248|NCT00165672|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110720249|NCT00165672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110720250|NCT00165672|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110720251|NCT00165672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110720252|NCT00165672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110720253|NCT03870646|Hyaluronic Acid|hyaluronic acid|mesh-list
110720254|NCT03870646|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110720255|NCT03870646|Immunologic Factors|immunologic factors|mesh-ancestor
110720256|NCT03870646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110720257|NCT03870646|Viscosupplements|viscosupplements|mesh-ancestor
110720258|NCT03870646|Protective Agents|protective agents|mesh-ancestor
110720259|NCT01168492|Ketamine|ketamine|mesh-list
110720260|NCT01168492|Analgesics|analgesics|mesh-ancestor
110720261|NCT01168492|Sensory System Agents|sensory system agents|mesh-ancestor
110720262|NCT01168492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110720263|NCT01168492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110720264|NCT01168492|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110720265|NCT01168492|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110720266|NCT01168492|Anesthetics, General|anesthetics, general|mesh-ancestor
110720267|NCT01168492|Anesthetics|anesthetics|mesh-ancestor
110720268|NCT01168492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110720269|NCT01168492|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110720270|NCT01168492|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110720271|NCT01168492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110720272|NCT01168492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110720273|NCT03870490|Cefepime|cefepime|mesh-list
110720274|NCT03870490|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110720276|NCT01278082|Budesonide|budesonide|mesh-list
110720277|NCT01278082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110720278|NCT01278082|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110720279|NCT01278082|Autonomic Agents|autonomic agents|mesh-ancestor
110720280|NCT01278082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110720281|NCT01278082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110720282|NCT01278082|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110720283|NCT01278082|Respiratory System Agents|respiratory system agents|mesh-ancestor
110720284|NCT01278082|Glucocorticoids|glucocorticoids|mesh-ancestor
110720285|NCT01278082|Hormones|hormones|mesh-ancestor
110720286|NCT01278082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110720287|NCT03870256|Misoprostol|misoprostol|mesh-list
110720288|NCT03870256|Carbetocin|carbetocin|mesh-list
110720289|NCT03870256|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110720290|NCT03870256|Abortifacient Agents|abortifacient agents|mesh-ancestor
110720291|NCT03870256|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110720292|NCT03870256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110720293|NCT03870256|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110720294|NCT03870256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110720295|NCT03870256|Oxytocics|oxytocics|mesh-ancestor
110720296|NCT01166542|Paclitaxel|paclitaxel|mesh-list
110720297|NCT01166542|Carboplatin|carboplatin|mesh-list
110720298|NCT01166542|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110720299|NCT01166542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110720300|NCT01166542|Tubulin Modulators|tubulin modulators|mesh-ancestor
110720301|NCT01166542|Antimitotic Agents|antimitotic agents|mesh-ancestor
110720302|NCT01166542|Mitosis Modulators|mitosis modulators|mesh-ancestor
110720303|NCT01166542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110720304|NCT00169104|Trastuzumab|trastuzumab|mesh-list
110720305|NCT00169104|Vinorelbine|vinorelbine|mesh-list
110720306|NCT00169104|Lenograstim|lenograstim|mesh-list
110720307|NCT00169104|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110720308|NCT00169104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110720309|NCT00169104|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110720310|NCT00169104|Immunologic Factors|immunologic factors|mesh-ancestor
110720311|NCT00169104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110720312|NCT00169104|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110720313|NCT00169104|Tubulin Modulators|tubulin modulators|mesh-ancestor
110720314|NCT00169104|Antimitotic Agents|antimitotic agents|mesh-ancestor
110720315|NCT00169104|Mitosis Modulators|mitosis modulators|mesh-ancestor
110720316|NCT00169104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110720317|NCT03872830|Biphenylylacetic acid|biphenylylacetic acid|mesh-list
110720318|NCT03872830|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110720319|NCT03872830|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110720320|NCT03872830|Analgesics|analgesics|mesh-ancestor
110720321|NCT03872830|Sensory System Agents|sensory system agents|mesh-ancestor
110720322|NCT03872830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110720323|NCT03872830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110720324|NCT03872830|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110720325|NCT03872830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110720326|NCT02526316|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
110720327|NCT02526316|Freund's Adjuvant|freund's adjuvant|mesh-list
110720328|NCT02526316|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110720329|NCT02526316|Immunologic Factors|immunologic factors|mesh-ancestor
110720330|NCT02526316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110720331|NCT03872596|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110720332|NCT03872596|Antidepressive Agents|antidepressive agents|mesh-ancestor
110720333|NCT03872596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110720334|NCT03872596|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110720335|NCT03872596|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110720336|NCT03872596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110720337|NCT03872596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110720338|NCT00163020|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
110720339|NCT00163020|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
110720340|NCT00163020|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110720341|NCT00163020|Hormone Antagonists|hormone antagonists|mesh-ancestor
110720342|NCT00163020|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110720343|NCT00163020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110720344|NCT00163020|Progestins|progestins|mesh-ancestor
110720346|NCT01168804|Dexamethasone|dexamethasone|mesh-list
110720348|NCT01168804|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110720349|NCT01168804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110720350|NCT01168804|Antiemetics|antiemetics|mesh-ancestor
110720351|NCT01168804|Autonomic Agents|autonomic agents|mesh-ancestor
110720352|NCT01168804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110720353|NCT01168804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110720354|NCT01168804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110720355|NCT01168804|Glucocorticoids|glucocorticoids|mesh-ancestor
110720356|NCT01168804|Hormones|hormones|mesh-ancestor
110720357|NCT01168804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110720358|NCT01168804|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110720359|NCT01168804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110720360|NCT01168804|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110720361|NCT01168804|Alkylating Agents|alkylating agents|mesh-ancestor
110862372|NCT01367652|Letrozole|letrozole|mesh-list
110720362|NCT01168804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110720363|NCT03873532|Capecitabine|capecitabine|mesh-list
110720364|NCT03873532|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110720365|NCT03873532|Antimetabolites|antimetabolites|mesh-ancestor
110720366|NCT03873532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110720367|NCT03873532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110720368|NCT01282528|Infliximab|infliximab|mesh-list
110720369|NCT01282528|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110720370|NCT01282528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110720371|NCT01282528|Dermatologic Agents|dermatologic agents|mesh-ancestor
110720372|NCT01282528|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110720373|NCT01282528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110720374|NCT01169506|Silicon|silicon|mesh-list
110720375|NCT01169506|Trace Elements|trace elements|mesh-ancestor
110720376|NCT01169506|Micronutrients|micronutrients|mesh-ancestor
110720377|NCT01169506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110720378|NCT01169740|Bilirubin|bilirubin|mesh-list
110720379|NCT01169740|Antioxidants|antioxidants|mesh-ancestor
110720380|NCT01169740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110720381|NCT01169740|Protective Agents|protective agents|mesh-ancestor
110720382|NCT01169740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110720383|NCT01169584|Molgramostim|molgramostim|mesh-list
110720384|NCT01169584|Sargramostim|sargramostim|mesh-list
110720385|NCT01169584|Immunologic Factors|immunologic factors|mesh-ancestor
110720386|NCT01169584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110720387|NCT01169584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110720388|NCT01169818|Insulin Glargine|insulin glargine|mesh-list
110720389|NCT01169818|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110720390|NCT01169818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110720391|NCT01282762|Vaccines|vaccines|mesh-list
110720392|NCT01282762|Immunologic Factors|immunologic factors|mesh-ancestor
110720393|NCT01282762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110720394|NCT01282840|Tolterodine Tartrate|tolterodine tartrate|mesh-list
110720395|NCT01282840|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110720396|NCT01282840|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110720397|NCT01282840|Cholinergic Agents|cholinergic agents|mesh-ancestor
110720398|NCT01282840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110720399|NCT01282840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110720400|NCT01282840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110720401|NCT01282840|Urological Agents|urological agents|mesh-ancestor
110720402|NCT01172548|Imatinib Mesylate|imatinib mesylate|mesh-list
110720403|NCT01172548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110720404|NCT01172548|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110720405|NCT01172548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110720406|NCT01172548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110720407|NCT01172626|Valproic Acid|valproic acid|mesh-list
110720408|NCT01172626|Anticonvulsants|anticonvulsants|mesh-ancestor
110720409|NCT01172626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110720410|NCT01172626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110720411|NCT01172626|GABA Agents|gaba agents|mesh-ancestor
110720412|NCT01172626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110720413|NCT01172626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110720414|NCT01172626|Antimanic Agents|antimanic agents|mesh-ancestor
110720415|NCT01172626|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110720416|NCT01172626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110720417|NCT01172626|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110720418|NCT01172782|Hydromorphone|hydromorphone|mesh-list
110720419|NCT01172782|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110720420|NCT01172782|Narcotics|narcotics|mesh-ancestor
110720421|NCT01172782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110444064|NCT04233502|Protective Agents|protective agents|mesh-ancestor
110720422|NCT01172782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110720423|NCT01172782|Analgesics|analgesics|mesh-ancestor
110720424|NCT01172782|Sensory System Agents|sensory system agents|mesh-ancestor
110720425|NCT01172782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110720426|NCT03866746|Aflibercept|aflibercept|mesh-list
110720427|NCT03866746|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110720428|NCT03866746|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110720429|NCT03866746|Growth Substances|growth substances|mesh-ancestor
110720430|NCT03866746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110720431|NCT03866746|Growth Inhibitors|growth inhibitors|mesh-ancestor
110720432|NCT03866746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110720433|NCT03869398|Calcitriol|calcitriol|mesh-list
110720434|NCT03869398|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110720435|NCT03869398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110720436|NCT03869398|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
110720437|NCT03869398|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110720438|NCT03869398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110720439|NCT03869398|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110720440|NCT03869398|Vitamins|vitamins|mesh-ancestor
110720441|NCT03869398|Micronutrients|micronutrients|mesh-ancestor
110720442|NCT03869398|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110720443|NCT01170052|Sirolimus|sirolimus|mesh-list
110720444|NCT01170052|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110720445|NCT01170052|Temsirolimus|temsirolimus|mesh-list
110720446|NCT01170052|MTOR Inhibitors|mtor inhibitors|mesh-list
110720447|NCT01170052|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110720448|NCT01170052|Alkylating Agents|alkylating agents|mesh-ancestor
110720449|NCT01170052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110720450|NCT01170052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110720451|NCT01170052|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110720452|NCT01170052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110720453|NCT01170052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110720454|NCT01170052|Immunologic Factors|immunologic factors|mesh-ancestor
110720455|NCT01170052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110720456|NCT01170052|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110720457|NCT01170052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110720458|NCT01170052|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110720459|NCT01170052|Antifungal Agents|antifungal agents|mesh-ancestor
110720461|NCT01284478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110720462|NCT01284478|Antiemetics|antiemetics|mesh-ancestor
110720463|NCT01284478|Autonomic Agents|autonomic agents|mesh-ancestor
110720464|NCT01284478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110720465|NCT01284478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110720466|NCT01284478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110720467|NCT01284478|Glucocorticoids|glucocorticoids|mesh-ancestor
110720468|NCT01284478|Hormones|hormones|mesh-ancestor
110720469|NCT01284478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110720470|NCT01284478|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110720471|NCT01284478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110720472|NCT00252720|Candesartan|candesartan|mesh-list
110720473|NCT00252720|Candesartan cilexetil|candesartan cilexetil|mesh-list
110720474|NCT00252720|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110720475|NCT00252720|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110720476|NCT00252720|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110720477|NCT00252720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110720478|NCT01284556|Phenobarbital|phenobarbital|mesh-list
110720479|NCT01284556|Anticonvulsants|anticonvulsants|mesh-ancestor
110720480|NCT01284556|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110720481|NCT01284556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110720482|NCT01284556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110720483|NCT01284556|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110720484|NCT01284556|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110720485|NCT01284556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110720486|NCT01284556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110720487|NCT01284556|GABA Modulators|gaba modulators|mesh-ancestor
110720488|NCT01284556|GABA Agents|gaba agents|mesh-ancestor
110720489|NCT01284556|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110720490|NCT01284556|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110720491|NCT01284556|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110720493|NCT01170130|Anesthetics, Local|anesthetics, local|mesh-ancestor
110720494|NCT01170130|Anesthetics|anesthetics|mesh-ancestor
110720495|NCT01170130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110720496|NCT01170130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110720497|NCT01170130|Sensory System Agents|sensory system agents|mesh-ancestor
110720498|NCT01170130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110720499|NCT01170130|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110720500|NCT01170130|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110720501|NCT01170130|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110720502|NCT01170130|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110720503|NCT01170130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110720504|NCT03868852|Apatinib|apatinib|mesh-list
110720505|NCT03868852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110720506|NCT03868852|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110720507|NCT03868852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110720508|NCT03868852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110720509|NCT01283776|Cyclophosphamide|cyclophosphamide|mesh-list
110720510|NCT01283776|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110720511|NCT01283776|Immunologic Factors|immunologic factors|mesh-ancestor
110720512|NCT01283776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110720513|NCT01283776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110720514|NCT01283776|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110720515|NCT01283776|Alkylating Agents|alkylating agents|mesh-ancestor
110720516|NCT01283776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110720517|NCT01283776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110720518|NCT01283776|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110720519|NCT01163500|Ubiquinone|ubiquinone|mesh-list
110720520|NCT01163500|Coenzyme Q10|coenzyme q10|mesh-list
110720521|NCT01163500|Micronutrients|micronutrients|mesh-ancestor
110720522|NCT01163500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110720523|NCT01163500|Vitamins|vitamins|mesh-ancestor
110720524|NCT01163734|Ranolazine|ranolazine|mesh-list
110720525|NCT01163734|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110720526|NCT01163734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110438376|NCT00952419|Vaccines|vaccines|mesh-list
110720527|NCT01163734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110720528|NCT01284868|Propranolol|propranolol|mesh-list
110720529|NCT01284868|Bisoprolol|bisoprolol|mesh-list
110720530|NCT01284868|Mirabegron|mirabegron|mesh-list
110720531|NCT01284868|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110720532|NCT01284868|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110720533|NCT01284868|Adrenergic Agents|adrenergic agents|mesh-ancestor
110720534|NCT01284868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110720535|NCT01284868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110720536|NCT01284868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110720537|NCT01284868|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110720538|NCT01284868|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110720539|NCT01284868|Vasodilator Agents|vasodilator agents|mesh-ancestor
110720540|NCT01284868|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
110720541|NCT01284868|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110720542|NCT01284868|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110720543|NCT01284868|Urological Agents|urological agents|mesh-ancestor
110720544|NCT01284868|Sympatholytics|sympatholytics|mesh-ancestor
110720545|NCT01284868|Autonomic Agents|autonomic agents|mesh-ancestor
110720546|NCT01284868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110720547|NCT01284868|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110720548|NCT01170442|Vitamin D|vitamin d|mesh-list
110720549|NCT01170442|Ergocalciferols|ergocalciferols|mesh-list
110720550|NCT01170442|Cholecalciferol|cholecalciferol|mesh-list
110720551|NCT01170442|Vitamins|vitamins|mesh-list
110720552|NCT01170442|Micronutrients|micronutrients|mesh-ancestor
110720553|NCT01170442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110720554|NCT01170442|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110720555|NCT01170442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110720556|NCT00252564|Leucovorin|leucovorin|mesh-list
110720557|NCT00252564|Bevacizumab|bevacizumab|mesh-list
110720558|NCT00252564|Cetuximab|cetuximab|mesh-list
110720559|NCT00252564|Fluorouracil|fluorouracil|mesh-list
110720560|NCT00252564|Oxaliplatin|oxaliplatin|mesh-list
110720561|NCT00252564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110720562|NCT00252564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110720563|NCT00252564|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110720564|NCT00252564|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110720565|NCT00252564|Growth Substances|growth substances|mesh-ancestor
110720566|NCT00252564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110720568|NCT00252564|Antimetabolites|antimetabolites|mesh-ancestor
110720569|NCT00252564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110720570|NCT00252564|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110720571|NCT00252564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110720572|NCT00252564|Immunologic Factors|immunologic factors|mesh-ancestor
110720573|NCT00252564|Antidotes|antidotes|mesh-ancestor
110720574|NCT00252564|Protective Agents|protective agents|mesh-ancestor
110720575|NCT00252564|Vitamin B Complex|vitamin b complex|mesh-ancestor
110720576|NCT00252564|Vitamins|vitamins|mesh-ancestor
110720577|NCT00252564|Micronutrients|micronutrients|mesh-ancestor
110720578|NCT01284946|Deferasirox|deferasirox|mesh-list
110720579|NCT01284946|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110720580|NCT01284946|Chelating Agents|chelating agents|mesh-ancestor
110720581|NCT01284946|Sequestering Agents|sequestering agents|mesh-ancestor
110720582|NCT01284946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110720583|NCT01173562|Mebendazole|mebendazole|mesh-list
110720584|NCT01173562|Piperazine|piperazine|mesh-list
110720585|NCT01173562|Piperazine citrate|piperazine citrate|mesh-list
110720586|NCT01173562|DMP 777|dmp 777|mesh-list
110720587|NCT01173562|Antinematodal Agents|antinematodal agents|mesh-ancestor
110720588|NCT01173562|Anthelmintics|anthelmintics|mesh-ancestor
110720589|NCT01173562|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110720590|NCT01173562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110720591|NCT01173562|Tubulin Modulators|tubulin modulators|mesh-ancestor
110720592|NCT01173562|Antimitotic Agents|antimitotic agents|mesh-ancestor
110720593|NCT01173562|Mitosis Modulators|mitosis modulators|mesh-ancestor
110720594|NCT01173562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110720595|NCT01173562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110720596|NCT01173562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110720597|NCT00166296|Escitalopram|escitalopram|mesh-list
110720598|NCT00166296|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110720599|NCT00166296|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110720600|NCT00166296|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110720601|NCT00166296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110720602|NCT00166296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110720603|NCT00166296|Serotonin Agents|serotonin agents|mesh-ancestor
110720604|NCT00166296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110720605|NCT01173640|Midazolam|midazolam|mesh-list
110720606|NCT01173640|Resveratrol|resveratrol|mesh-list
110720607|NCT01173640|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110720608|NCT01173640|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110720609|NCT01173640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110720610|NCT01173640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110720611|NCT01173640|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110720612|NCT01173640|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110720613|NCT01173640|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110720614|NCT01173640|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110720615|NCT01173640|Anesthetics, General|anesthetics, general|mesh-ancestor
110720616|NCT01173640|Anesthetics|anesthetics|mesh-ancestor
110720617|NCT01173640|GABA Modulators|gaba modulators|mesh-ancestor
110720618|NCT01173640|GABA Agents|gaba agents|mesh-ancestor
110720619|NCT01173640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110720620|NCT01173640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110720621|NCT01173640|Antioxidants|antioxidants|mesh-ancestor
110720622|NCT01173640|Protective Agents|protective agents|mesh-ancestor
110720623|NCT01173640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110720624|NCT01173640|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110720625|NCT00252174|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
110720626|NCT00252174|Hallucinogens|hallucinogens|mesh-ancestor
110720627|NCT00252174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110720628|NCT00252174|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110720629|NCT00252174|Serotonin Agents|serotonin agents|mesh-ancestor
110720630|NCT00252174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110720631|NCT00252174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110720632|NCT00252174|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110720633|NCT00252174|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110720634|NCT00252174|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110720635|NCT00252174|Adrenergic Agents|adrenergic agents|mesh-ancestor
110720637|NCT03868306|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110720638|NCT03868306|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110720639|NCT03868306|Analgesics|analgesics|mesh-ancestor
110720640|NCT03868306|Sensory System Agents|sensory system agents|mesh-ancestor
110350485|NCT02932397|Propofol|propofol|mesh-list
110720641|NCT03868306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110720642|NCT03868306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110720643|NCT03868306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110720644|NCT03868306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110720645|NCT01164046|Vitamin K|vitamin k|mesh-list
110720646|NCT01164046|Heparin|heparin|mesh-list
110720647|NCT01164046|Enoxaparin|enoxaparin|mesh-list
110720648|NCT01164046|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
110720649|NCT01164046|Tinzaparin|tinzaparin|mesh-list
110720650|NCT01164046|Dalteparin|dalteparin|mesh-list
110720651|NCT01164046|Nadroparin|nadroparin|mesh-list
110720652|NCT01164046|Reviparin|reviparin|mesh-list
110720653|NCT01164046|Warfarin|warfarin|mesh-list
110720654|NCT01164046|Acenocoumarol|acenocoumarol|mesh-list
110720655|NCT01164046|Phenprocoumon|phenprocoumon|mesh-list
110720656|NCT01164046|Bemiparin|bemiparin|mesh-list
110720657|NCT01164046|Certoparin|certoparin|mesh-list
110720658|NCT01164046|Vitamins|vitamins|mesh-ancestor
110720659|NCT01164046|Micronutrients|micronutrients|mesh-ancestor
110720660|NCT01164046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110720661|NCT01164046|Anticoagulants|anticoagulants|mesh-ancestor
110720662|NCT01164046|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110140227|NCT05534620|Fludarabine|fludarabine|mesh-list
110720663|NCT01164046|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110720664|NCT01164046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110720665|NCT01164046|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110720666|NCT01164046|Hemostatics|hemostatics|mesh-ancestor
110720667|NCT01164046|Coagulants|coagulants|mesh-ancestor
110720668|NCT01075464|Paclitaxel|paclitaxel|mesh-list
110720669|NCT01075464|Bevacizumab|bevacizumab|mesh-list
110720670|NCT01075464|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110720671|NCT01075464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110720672|NCT01075464|Tubulin Modulators|tubulin modulators|mesh-ancestor
110720673|NCT01075464|Antimitotic Agents|antimitotic agents|mesh-ancestor
110720674|NCT01075464|Mitosis Modulators|mitosis modulators|mesh-ancestor
110720675|NCT01075464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110720676|NCT01075464|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110720677|NCT01075464|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110720678|NCT01075464|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110720679|NCT01075464|Growth Substances|growth substances|mesh-ancestor
110720680|NCT01075464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110720681|NCT01075464|Growth Inhibitors|growth inhibitors|mesh-ancestor
110720682|NCT01074996|Leucovorin|leucovorin|mesh-list
110720683|NCT01074996|Antidotes|antidotes|mesh-ancestor
110720684|NCT01074996|Protective Agents|protective agents|mesh-ancestor
110720685|NCT01074996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110720686|NCT01074996|Vitamin B Complex|vitamin b complex|mesh-ancestor
110720687|NCT01074996|Vitamins|vitamins|mesh-ancestor
110720688|NCT01074996|Micronutrients|micronutrients|mesh-ancestor
110720689|NCT00160524|Certolizumab Pegol|certolizumab pegol|mesh-list
110720690|NCT00160524|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110720691|NCT00160524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110720692|NCT00160524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110720693|NCT00160524|Immunologic Factors|immunologic factors|mesh-ancestor
110720694|NCT00160524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110720695|NCT00160524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110720696|NCT01077570|Repaglinide|repaglinide|mesh-list
110720697|NCT01077570|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110720698|NCT01077570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110720699|NCT01075698|Telmisartan|telmisartan|mesh-list
110720700|NCT01075698|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110720701|NCT01075698|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110720702|NCT01075698|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110720703|NCT01075698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110720704|NCT00159822|Voriconazole|voriconazole|mesh-list
110720705|NCT00159822|Antifungal Agents|antifungal agents|mesh-ancestor
110720706|NCT00159822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110720707|NCT00159822|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110720708|NCT00159822|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110720709|NCT00159822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110720710|NCT00159822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110720711|NCT00159822|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110720712|NCT00159822|Hormone Antagonists|hormone antagonists|mesh-ancestor
110720713|NCT00159822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110720714|NCT00159822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110720715|NCT00159822|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110720716|NCT00158262|Propranolol|propranolol|mesh-list
110720718|NCT00158262|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110720719|NCT00158262|Adrenergic Agents|adrenergic agents|mesh-ancestor
110720720|NCT00158262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110720721|NCT00158262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110720722|NCT00158262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110720723|NCT00158262|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110720724|NCT00158262|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110720725|NCT00158262|Vasodilator Agents|vasodilator agents|mesh-ancestor
110720726|NCT03868072|Tofacitinib|tofacitinib|mesh-list
110720727|NCT03868072|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
110720728|NCT03868072|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110720729|NCT03868072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110720730|NCT03868072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110720731|NCT02526394|Vaccines|vaccines|mesh-list
110720732|NCT02526394|Immunologic Factors|immunologic factors|mesh-ancestor
110720733|NCT02526394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110720734|NCT01283932|Pantoprazole|pantoprazole|mesh-list
110720735|NCT01283932|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110720736|NCT01283932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110720737|NCT01283932|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110720738|NCT01283932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110720739|NCT01283932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110720740|NCT01171300|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110720741|NCT01171300|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110720742|NCT01171300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110720743|NCT01171378|Ofatumumab|ofatumumab|mesh-list
110720744|NCT01171378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110720745|NCT01171456|Metformin|metformin|mesh-list
110720746|NCT01171456|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110720747|NCT01171456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110720748|NCT03865888|Cyclosporine|cyclosporine|mesh-list
110720749|NCT03865888|Tacrolimus|tacrolimus|mesh-list
110720750|NCT03865888|Cyclosporins|cyclosporins|mesh-list
110720751|NCT03865888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110720752|NCT03865888|Immunologic Factors|immunologic factors|mesh-ancestor
110720753|NCT03865888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110720754|NCT03865888|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110720755|NCT03865888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110720756|NCT03865888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110720758|NCT03865888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110720759|NCT03865888|Dermatologic Agents|dermatologic agents|mesh-ancestor
110720760|NCT03865888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110720761|NCT01284166|Timolol|timolol|mesh-list
110720762|NCT01284166|Brimonidine Tartrate|brimonidine tartrate|mesh-list
110720763|NCT01284166|Dorzolamide|dorzolamide|mesh-list
110720764|NCT01284166|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110720765|NCT01284166|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110720766|NCT01284166|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110720767|NCT01284166|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110720768|NCT01284166|Adrenergic Agents|adrenergic agents|mesh-ancestor
110720769|NCT01284166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110720770|NCT01284166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110720771|NCT01284166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110720772|NCT01284166|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110720773|NCT01284166|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110140249|NCT05410158|Ketamine|ketamine|mesh-list
110720774|NCT01284166|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110720775|NCT01284166|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110720776|NCT01284166|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110720777|NCT01284166|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110720778|NCT01284166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110720779|NCT01285414|Temozolomide|temozolomide|mesh-list
110720780|NCT01285414|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110720781|NCT01285414|Alkylating Agents|alkylating agents|mesh-ancestor
110720782|NCT01285414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110720783|NCT01285414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110720784|NCT01172002|Azathioprine|azathioprine|mesh-list
110720785|NCT01172002|Leflunomide|leflunomide|mesh-list
110720786|NCT01172002|Antimetabolites|antimetabolites|mesh-ancestor
110720787|NCT01172002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110720788|NCT01172002|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110720789|NCT01172002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110720790|NCT01172002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110720791|NCT01172002|Immunologic Factors|immunologic factors|mesh-ancestor
110720792|NCT01172002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110720793|NCT01172002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110720794|NCT01172002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110720795|NCT03867994|Carvedilol|carvedilol|mesh-list
110720796|NCT03867994|Atorvastatin|atorvastatin|mesh-list
110720797|NCT03867994|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110720798|NCT03867994|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110720799|NCT03867994|Antimetabolites|antimetabolites|mesh-ancestor
110720800|NCT03867994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110720801|NCT03867994|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110720802|NCT03867994|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110720803|NCT03867994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110720804|NCT03867994|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110720805|NCT03867994|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110720806|NCT03867994|Adrenergic Agents|adrenergic agents|mesh-ancestor
110720807|NCT03867994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110720808|NCT03867994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110720809|NCT03867994|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110720810|NCT03867994|Antioxidants|antioxidants|mesh-ancestor
110720811|NCT03867994|Protective Agents|protective agents|mesh-ancestor
110720812|NCT03867994|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110720813|NCT03867994|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110720814|NCT03867994|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110720815|NCT03867994|Vasodilator Agents|vasodilator agents|mesh-ancestor
110720816|NCT03867994|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110720817|NCT03867994|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110720818|NCT01172236|Lactoferrin|lactoferrin|mesh-list
110720819|NCT01172236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110720820|NCT02525848|Dexamethasone|dexamethasone|mesh-list
110720821|NCT02525848|Gabapentin|gabapentin|mesh-list
110720822|NCT02525848|Aprepitant|aprepitant|mesh-list
110720823|NCT02525848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110720824|NCT02525848|Antiemetics|antiemetics|mesh-ancestor
110720825|NCT02525848|Autonomic Agents|autonomic agents|mesh-ancestor
110720826|NCT02525848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110720827|NCT02525848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110720828|NCT02525848|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110720829|NCT02525848|Glucocorticoids|glucocorticoids|mesh-ancestor
110720830|NCT02525848|Hormones|hormones|mesh-ancestor
110438660|NCT02637193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110720831|NCT02525848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110720832|NCT02525848|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110720833|NCT02525848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110720835|NCT02525848|Sensory System Agents|sensory system agents|mesh-ancestor
110720836|NCT02525848|Anticonvulsants|anticonvulsants|mesh-ancestor
110720837|NCT02525848|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110720838|NCT02525848|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110720839|NCT02525848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110720840|NCT02525848|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110720841|NCT02525848|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110720842|NCT02525848|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110720843|NCT02525848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110720844|NCT02525848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110720845|NCT02525848|Antimanic Agents|antimanic agents|mesh-ancestor
110720846|NCT02525848|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110720847|NCT01269112|Citric Acid|citric acid|mesh-list
110720848|NCT01269112|Sodium Citrate|sodium citrate|mesh-list
110720849|NCT01269112|Anticoagulants|anticoagulants|mesh-ancestor
110720850|NCT01269112|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110720851|NCT01269112|Chelating Agents|chelating agents|mesh-ancestor
110720852|NCT01269112|Sequestering Agents|sequestering agents|mesh-ancestor
110720853|NCT01269112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110720854|NCT01174420|Mitomycins|mitomycins|mesh-list
110720855|NCT01174420|Mitomycin|mitomycin|mesh-list
110720856|NCT01174420|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110720857|NCT01174420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110720858|NCT01174420|Alkylating Agents|alkylating agents|mesh-ancestor
110720859|NCT01174420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110720860|NCT01174420|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110720861|NCT01174420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110720862|NCT01164826|Nabumetone|nabumetone|mesh-list
110720863|NCT01164826|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110720864|NCT01164826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110720865|NCT01164826|Analgesics|analgesics|mesh-ancestor
110720866|NCT01164826|Sensory System Agents|sensory system agents|mesh-ancestor
110720867|NCT01164826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110720868|NCT01164826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110720869|NCT01164826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110720870|NCT01164826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110720871|NCT01164826|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110720872|NCT01164826|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110720873|NCT01164826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110720874|NCT01164826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110720875|NCT03867370|Lenvatinib|lenvatinib|mesh-list
110720876|NCT03867370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110720877|NCT03867370|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110720878|NCT03867370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110720879|NCT03867370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110720880|NCT01172392|Interferons|interferons|mesh-list
110720881|NCT01172392|Interferon-alpha|interferon-alpha|mesh-list
110720882|NCT01172392|Interferon alpha-2|interferon alpha-2|mesh-list
110720883|NCT01172392|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110720884|NCT01172392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110720885|NCT01172392|Antiviral Agents|antiviral agents|mesh-ancestor
110720886|NCT01172392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110720887|NCT01172392|Immunologic Factors|immunologic factors|mesh-ancestor
110720888|NCT01172392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110720889|NCT01172470|Carboplatin|carboplatin|mesh-list
110720890|NCT01172470|Gemcitabine|gemcitabine|mesh-list
110720891|NCT01172470|Pemetrexed|pemetrexed|mesh-list
110720892|NCT01172470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110720893|NCT01172470|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110720894|NCT01172470|Antimetabolites|antimetabolites|mesh-ancestor
110140276|NCT05279690|Tubulin Modulators|tubulin modulators|mesh-ancestor
110720895|NCT01172470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110720896|NCT01172470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110720897|NCT01172470|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110720898|NCT01172470|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110720899|NCT01175044|Povidone-Iodine|povidone-iodine|mesh-list
110720900|NCT01175044|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110720901|NCT01175044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110720902|NCT03864016|Sufentanil|sufentanil|mesh-list
110720903|NCT03864016|Dsuvia|dsuvia|mesh-list
110720904|NCT03864016|Anesthetics|anesthetics|mesh-ancestor
110438732|NCT00599521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110720905|NCT03864016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110720906|NCT03864016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110720907|NCT03864016|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110720908|NCT03864016|Narcotics|narcotics|mesh-ancestor
110720909|NCT03864016|Analgesics|analgesics|mesh-ancestor
110720910|NCT03864016|Sensory System Agents|sensory system agents|mesh-ancestor
110720911|NCT03864016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110720912|NCT03864016|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110720913|NCT03864016|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110720914|NCT03864016|Anesthetics, General|anesthetics, general|mesh-ancestor
110720915|NCT03860662|Baclofen|baclofen|mesh-list
110720916|NCT03860662|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110720917|NCT03860662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110720918|NCT03860662|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110720919|NCT03860662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110720920|NCT03860662|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
110720921|NCT03860662|GABA Agonists|gaba agonists|mesh-ancestor
110720922|NCT03860662|GABA Agents|gaba agents|mesh-ancestor
110720923|NCT03860662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110720924|NCT03860662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110720925|NCT01177696|Psychotropic Drugs|psychotropic drugs|mesh-list
110720926|NCT01177852|Diphenhydramine|diphenhydramine|mesh-list
110720927|NCT01177852|Promethazine|promethazine|mesh-list
110720928|NCT01177852|Brompheniramine|brompheniramine|mesh-list
110720929|NCT01177852|Pseudoephedrine|pseudoephedrine|mesh-list
110720930|NCT01177852|Brompheniramine, pseudoephedrine drug combination|brompheniramine, pseudoephedrine drug combination|mesh-list
110720931|NCT01177852|Ephedrine|ephedrine|mesh-list
110720932|NCT01177852|Dipropizine|dipropizine|mesh-list
110720933|NCT01177852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110720934|NCT01177852|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110720935|NCT01177852|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110720936|NCT01177852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110720937|NCT01177852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110720938|NCT01177852|Anesthetics, Local|anesthetics, local|mesh-ancestor
110720940|NCT01177852|Sensory System Agents|sensory system agents|mesh-ancestor
110720941|NCT01177852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110720942|NCT01177852|Antiemetics|antiemetics|mesh-ancestor
110720943|NCT01177852|Autonomic Agents|autonomic agents|mesh-ancestor
110720944|NCT01177852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110720945|NCT01177852|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110720946|NCT01177852|Histamine Antagonists|histamine antagonists|mesh-ancestor
110720947|NCT01177852|Histamine Agents|histamine agents|mesh-ancestor
110720948|NCT01177852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110720949|NCT01177852|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110720950|NCT01177852|Antipruritics|antipruritics|mesh-ancestor
110720951|NCT01177852|Dermatologic Agents|dermatologic agents|mesh-ancestor
110720952|NCT01177852|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110720953|NCT01177852|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110720954|NCT01177852|Respiratory System Agents|respiratory system agents|mesh-ancestor
110720955|NCT01177852|Nasal Decongestants|nasal decongestants|mesh-ancestor
110720956|NCT01177852|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110720957|NCT01177852|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110720959|NCT01177852|Adrenergic Agents|adrenergic agents|mesh-ancestor
110720960|NCT01177852|Antitussive Agents|antitussive agents|mesh-ancestor
110720961|NCT03863392|Misoprostol|misoprostol|mesh-list
110720962|NCT03863392|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110720963|NCT03863392|Abortifacient Agents|abortifacient agents|mesh-ancestor
110720964|NCT03863392|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110720965|NCT03863392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110720966|NCT03863392|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110720967|NCT03863392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110720968|NCT03863392|Oxytocics|oxytocics|mesh-ancestor
110720969|NCT01175200|Lansoprazole|lansoprazole|mesh-list
110720970|NCT01175200|Dexlansoprazole|dexlansoprazole|mesh-list
110720971|NCT01175200|Clopidogrel|clopidogrel|mesh-list
110720972|NCT01175200|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
110720973|NCT01175200|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110720974|NCT01175200|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110720975|NCT01175200|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110720976|NCT01175200|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110720977|NCT01175200|Purinergic Agents|purinergic agents|mesh-ancestor
110720978|NCT01175200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110720979|NCT01175200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110720980|NCT01175200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110720982|NCT01175200|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110720983|NCT01175200|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110720984|NCT01175200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110720985|NCT03863626|Furosemide|furosemide|mesh-list
110720986|NCT03863626|Diuretics|diuretics|mesh-ancestor
110720987|NCT03863626|Natriuretic Agents|natriuretic agents|mesh-ancestor
110720988|NCT03863626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110720989|NCT03863626|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110720990|NCT03863626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110720991|NCT03863626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110720992|NCT01288378|Caspofungin|caspofungin|mesh-list
110720993|NCT01288378|Antifungal Agents|antifungal agents|mesh-ancestor
110720994|NCT01288378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110720995|NCT01288378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110720996|NCT01288378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110720997|NCT01178320|Niacin|niacin|mesh-list
110720998|NCT01178320|Niacinamide|niacinamide|mesh-list
110720999|NCT01178320|Nicotinic Acids|nicotinic acids|mesh-list
110721000|NCT01178320|Simvastatin|simvastatin|mesh-list
110721001|NCT01178320|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110721002|NCT01178320|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110721003|NCT01178320|Antimetabolites|antimetabolites|mesh-ancestor
110721004|NCT01178320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110721005|NCT01178320|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110721006|NCT01178320|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110721007|NCT01178320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110721008|NCT01178320|Vasodilator Agents|vasodilator agents|mesh-ancestor
110721009|NCT01178320|Vitamin B Complex|vitamin b complex|mesh-ancestor
110721010|NCT01178320|Vitamins|vitamins|mesh-ancestor
110721011|NCT01178320|Micronutrients|micronutrients|mesh-ancestor
110721012|NCT01178320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110721013|NCT01175512|Naltrexone|naltrexone|mesh-list
110721014|NCT01175512|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110721015|NCT01175512|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110721016|NCT01175512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110721017|NCT01175512|Sensory System Agents|sensory system agents|mesh-ancestor
110721018|NCT01175512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110721019|NCT03859570|Pentoxifylline|pentoxifylline|mesh-list
110721020|NCT03859570|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110721021|NCT03859570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110721022|NCT03859570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110721023|NCT03859570|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110721024|NCT03859570|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110721025|NCT03859570|Protective Agents|protective agents|mesh-ancestor
110721026|NCT03859570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110721027|NCT03859570|Vasodilator Agents|vasodilator agents|mesh-ancestor
110721028|NCT03859570|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110721029|NCT03859570|Antioxidants|antioxidants|mesh-ancestor
110721030|NCT03745222|Tislelizumab|tislelizumab|mesh-list
110721031|NCT03745222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110721032|NCT03745222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110721033|NCT01286584|Varenicline|varenicline|mesh-list
110721034|NCT01286584|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110721035|NCT01286584|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110721036|NCT01286584|Cholinergic Agents|cholinergic agents|mesh-ancestor
110721037|NCT01286584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110721038|NCT01286584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110721039|NCT01286584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110721040|NCT03743038|Minocycline|minocycline|mesh-list
110721041|NCT03743038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110721042|NCT03743038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110721043|NCT03864250|Prednisone|prednisone|mesh-list
110721044|NCT03864250|Tacrolimus|tacrolimus|mesh-list
110721045|NCT03864250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110721046|NCT03864250|Glucocorticoids|glucocorticoids|mesh-ancestor
110721047|NCT03864250|Hormones|hormones|mesh-ancestor
110721048|NCT03864250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110721049|NCT03864250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110721050|NCT03864250|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110721051|NCT03864250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110721052|NCT03864250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110721053|NCT03864250|Immunologic Factors|immunologic factors|mesh-ancestor
110721054|NCT03864250|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110721055|NCT03864250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110721056|NCT03864250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110721057|NCT01175746|Nicardipine|nicardipine|mesh-list
110721058|NCT01175746|Remifentanil|remifentanil|mesh-list
110721059|NCT01175746|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110721060|NCT01175746|Narcotics|narcotics|mesh-ancestor
110721061|NCT01175746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110721062|NCT01175746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110721063|NCT01175746|Analgesics|analgesics|mesh-ancestor
110721064|NCT01175746|Sensory System Agents|sensory system agents|mesh-ancestor
110721065|NCT01175746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110721066|NCT01175746|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110721067|NCT01175746|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110721068|NCT01175746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110721069|NCT01175746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110721070|NCT01175746|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110721071|NCT01175746|Vasodilator Agents|vasodilator agents|mesh-ancestor
110721072|NCT01174810|Exenatide|exenatide|mesh-list
110721073|NCT01174810|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110721074|NCT01174810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110721075|NCT01174810|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110721076|NCT01174810|Incretins|incretins|mesh-ancestor
110721077|NCT01174810|Hormones|hormones|mesh-ancestor
110721078|NCT01174810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110721079|NCT01178710|Simvastatin|simvastatin|mesh-list
110721080|NCT01178710|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110721081|NCT01178710|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110721082|NCT01178710|Antimetabolites|antimetabolites|mesh-ancestor
110721083|NCT01178710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110721084|NCT01178710|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110721085|NCT01178710|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110721086|NCT01178710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110721087|NCT01174888|Cytarabine|cytarabine|mesh-list
110721088|NCT01174888|Etoposide|etoposide|mesh-list
110721089|NCT01174888|Podophyllotoxin|podophyllotoxin|mesh-list
110721090|NCT01174888|Mitoxantrone|mitoxantrone|mesh-list
110721091|NCT01174888|Etoposide phosphate|etoposide phosphate|mesh-list
110721092|NCT01174888|Bortezomib|bortezomib|mesh-list
110721093|NCT01174888|Midostaurin|midostaurin|mesh-list
110721094|NCT01174888|Staurosporine|staurosporine|mesh-list
110862480|NCT01344291|Analgesics|analgesics|mesh-ancestor
110721095|NCT01174888|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110721096|NCT01174888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110721097|NCT01174888|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110721098|NCT01174888|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110721099|NCT01174888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110721100|NCT01174888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110721101|NCT01174888|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110721102|NCT01174888|Antimetabolites|antimetabolites|mesh-ancestor
110721103|NCT01174888|Antiviral Agents|antiviral agents|mesh-ancestor
110721104|NCT01174888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110721105|NCT01174888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110721106|NCT01174888|Immunologic Factors|immunologic factors|mesh-ancestor
110721107|NCT01174888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110721108|NCT01174888|Analgesics|analgesics|mesh-ancestor
110721109|NCT01174888|Sensory System Agents|sensory system agents|mesh-ancestor
110721110|NCT01174888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110721111|NCT01174888|Keratolytic Agents|keratolytic agents|mesh-ancestor
110721112|NCT01174888|Dermatologic Agents|dermatologic agents|mesh-ancestor
110721113|NCT01174888|Tubulin Modulators|tubulin modulators|mesh-ancestor
110721114|NCT01174888|Antimitotic Agents|antimitotic agents|mesh-ancestor
110721115|NCT01174888|Mitosis Modulators|mitosis modulators|mesh-ancestor
110721116|NCT01174888|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110721117|NCT01178788|Progesterone|progesterone|mesh-list
110721118|NCT01178788|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
110721119|NCT01178788|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
110721120|NCT01178788|Progestins|progestins|mesh-ancestor
110721121|NCT01178788|Hormones|hormones|mesh-ancestor
110721122|NCT01178788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110721123|NCT01178788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110721124|NCT01178788|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110721125|NCT01178788|Hormone Antagonists|hormone antagonists|mesh-ancestor
110721126|NCT00153816|Vitamin D|vitamin d|mesh-list
110721127|NCT00153816|Cholecalciferol|cholecalciferol|mesh-list
110721128|NCT00153816|Calcium Carbonate|calcium carbonate|mesh-list
110721129|NCT00153816|Calcium|calcium|mesh-list
110721130|NCT00153816|Vitamins|vitamins|mesh-ancestor
110721131|NCT00153816|Micronutrients|micronutrients|mesh-ancestor
110721132|NCT00153816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110721133|NCT00153816|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110721134|NCT00153816|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110721135|NCT00153816|Antacids|antacids|mesh-ancestor
110721136|NCT00153816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110721137|NCT00153816|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110721138|NCT02525146|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
110721139|NCT02525146|Antiviral Agents|antiviral agents|mesh-ancestor
110721140|NCT02525146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110721141|NCT01077648|Trastuzumab|trastuzumab|mesh-list
110721142|NCT01077648|Lapatinib|lapatinib|mesh-list
110721143|NCT01077648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110721144|NCT01077648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110721145|NCT01077648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110721146|NCT01077648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110721147|NCT01077648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110721148|NCT00151476|Celecoxib|celecoxib|mesh-list
110721149|NCT00151476|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110721150|NCT00151476|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110721151|NCT00151476|Analgesics|analgesics|mesh-ancestor
110721152|NCT00151476|Sensory System Agents|sensory system agents|mesh-ancestor
110721153|NCT00151476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110721154|NCT00151476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110721155|NCT00151476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110721156|NCT00151476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110721157|NCT00151476|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110721158|NCT00151476|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110721159|NCT00151476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110721160|NCT00151476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110721161|NCT01077726|Capecitabine|capecitabine|mesh-list
110444078|NCT03628066|Letrozole|letrozole|mesh-list
110721162|NCT01077726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110721163|NCT01077726|Antimetabolites|antimetabolites|mesh-ancestor
110721164|NCT01077726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110721165|NCT01077726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110721166|NCT01179100|Lidocaine|lidocaine|mesh-list
110721167|NCT01179100|Anesthetics, Local|anesthetics, local|mesh-ancestor
110721168|NCT01179100|Anesthetics|anesthetics|mesh-ancestor
110721169|NCT01179100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110721170|NCT01179100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110721171|NCT01179100|Sensory System Agents|sensory system agents|mesh-ancestor
110721172|NCT01179100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110721173|NCT01179100|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110721174|NCT01179100|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110721175|NCT01179100|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110721176|NCT01179100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110721177|NCT01179100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110721178|NCT03864172|Calcium, Dietary|calcium, dietary|mesh-list
110721179|NCT03864172|Calcium|calcium|mesh-list
110721180|NCT03864172|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110721181|NCT03864172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110721182|NCT03864172|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110721183|NCT02525302|Halofuginone|halofuginone|mesh-list
110721184|NCT02525302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110721185|NCT02525302|Coccidiostats|coccidiostats|mesh-ancestor
110721186|NCT02525302|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110721187|NCT02525302|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110721188|NCT02525302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110721189|NCT02525302|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110721190|NCT02525302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110721191|NCT02525302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110721192|NCT02525302|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110721193|NCT02525302|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110721194|NCT02525302|Growth Substances|growth substances|mesh-ancestor
110721195|NCT02525302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110721196|NCT02525302|Growth Inhibitors|growth inhibitors|mesh-ancestor
110721197|NCT01286194|Rabeprazole|rabeprazole|mesh-list
110721198|NCT01286194|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110721199|NCT01286194|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110721200|NCT01286194|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110721201|NCT01286194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110721202|NCT01286194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110721203|NCT01179256|Curcumin|curcumin|mesh-list
110140343|NCT04961580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110721204|NCT01179256|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110721205|NCT01179256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110721206|NCT01179256|Analgesics|analgesics|mesh-ancestor
110721207|NCT01179256|Sensory System Agents|sensory system agents|mesh-ancestor
110721208|NCT01179256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110721209|NCT01179256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110721210|NCT01179256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110721211|NCT01179256|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110721212|NCT01179256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110721213|NCT01179256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110721214|NCT01179256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110721215|NCT01179412|Iodine|iodine|mesh-list
110721216|NCT01179412|Cadexomer iodine|cadexomer iodine|mesh-list
110721217|NCT01179412|Povidone-Iodine|povidone-iodine|mesh-list
110721218|NCT01179412|Povidone|povidone|mesh-list
110721219|NCT01179412|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110721220|NCT01179412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110721221|NCT01179412|Trace Elements|trace elements|mesh-ancestor
110721222|NCT01179412|Micronutrients|micronutrients|mesh-ancestor
110721223|NCT01179412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110721224|NCT01179412|Plasma Substitutes|plasma substitutes|mesh-ancestor
110721225|NCT01179412|Blood Substitutes|blood substitutes|mesh-ancestor
110721226|NCT03862690|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
110721227|NCT03862690|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110721228|NCT03862690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110721229|NCT03862768|Sunitinib|sunitinib|mesh-list
110721230|NCT03862768|Imatinib Mesylate|imatinib mesylate|mesh-list
110721231|NCT03862768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110721232|NCT03862768|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110721233|NCT03862768|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110721234|NCT03862768|Growth Substances|growth substances|mesh-ancestor
110721235|NCT03862768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110721236|NCT03862768|Growth Inhibitors|growth inhibitors|mesh-ancestor
110721237|NCT03862768|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110721238|NCT03862768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110721239|NCT03862768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110721240|NCT03862456|Azithromycin|azithromycin|mesh-list
110721241|NCT03862456|Metronidazole|metronidazole|mesh-list
110721242|NCT03862456|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110721243|NCT03862456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110721244|NCT03862456|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110721245|NCT03862456|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110721246|NCT03859102|Acetaminophen|acetaminophen|mesh-list
110721247|NCT03859102|Dexamethasone|dexamethasone|mesh-list
110721248|NCT03859102|Gabapentin|gabapentin|mesh-list
110721249|NCT03859102|Ondansetron|ondansetron|mesh-list
110721250|NCT03859102|Anesthetics|anesthetics|mesh-list
110721251|NCT03859102|Anesthetics, Local|anesthetics, local|mesh-list
110721252|NCT03859102|Lansoprazole|lansoprazole|mesh-list
110721253|NCT03859102|Dexlansoprazole|dexlansoprazole|mesh-list
110140361|NCT04782830|Midodrine|midodrine|mesh-list
110721254|NCT03859102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110721255|NCT03859102|Antiemetics|antiemetics|mesh-ancestor
110721256|NCT03859102|Autonomic Agents|autonomic agents|mesh-ancestor
110721257|NCT03859102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110721258|NCT03859102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110721259|NCT03859102|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110721260|NCT03859102|Glucocorticoids|glucocorticoids|mesh-ancestor
110721261|NCT03859102|Hormones|hormones|mesh-ancestor
110721262|NCT03859102|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110721263|NCT03859102|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110721264|NCT03859102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110721265|NCT03859102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110721266|NCT03859102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110721267|NCT03859102|Analgesics|analgesics|mesh-ancestor
110721268|NCT03859102|Sensory System Agents|sensory system agents|mesh-ancestor
110721269|NCT03859102|Antipyretics|antipyretics|mesh-ancestor
110721270|NCT03859102|Anticonvulsants|anticonvulsants|mesh-ancestor
110721271|NCT03859102|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110721272|NCT03859102|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110721273|NCT03859102|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110721274|NCT03859102|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110721275|NCT03859102|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110721276|NCT03859102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110721277|NCT03859102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110721278|NCT03859102|Antimanic Agents|antimanic agents|mesh-ancestor
110721279|NCT03859102|Antipruritics|antipruritics|mesh-ancestor
110721280|NCT03859102|Dermatologic Agents|dermatologic agents|mesh-ancestor
110721281|NCT03859102|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110721282|NCT03859102|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110721284|NCT03859102|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110721285|NCT03859102|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110721286|NCT03859102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110721287|NCT00149994|Cyclosporine|cyclosporine|mesh-list
110721288|NCT00149994|Prednisone|prednisone|mesh-list
110721289|NCT00149994|Methylprednisolone|methylprednisolone|mesh-list
110721290|NCT00149994|Tacrolimus|tacrolimus|mesh-list
110721291|NCT00149994|Cyclosporins|cyclosporins|mesh-list
110721292|NCT00149994|Basiliximab|basiliximab|mesh-list
110721293|NCT00149994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110721294|NCT00149994|Glucocorticoids|glucocorticoids|mesh-ancestor
110721295|NCT00149994|Hormones|hormones|mesh-ancestor
110721296|NCT00149994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110721297|NCT00149994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110721298|NCT00149994|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110721299|NCT00149994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110721300|NCT00149994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110721301|NCT00149994|Immunologic Factors|immunologic factors|mesh-ancestor
110721302|NCT00149994|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110721303|NCT00149994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110721304|NCT00149994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110721305|NCT00149994|Antifungal Agents|antifungal agents|mesh-ancestor
110721306|NCT00149994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110721307|NCT00149994|Dermatologic Agents|dermatologic agents|mesh-ancestor
110721308|NCT00149994|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110721309|NCT00149994|Antiemetics|antiemetics|mesh-ancestor
110721310|NCT00149994|Autonomic Agents|autonomic agents|mesh-ancestor
110721311|NCT00149994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110721312|NCT00149994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110721313|NCT00149994|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110721315|NCT01179646|Pantoprazole|pantoprazole|mesh-list
110721316|NCT01179646|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110721317|NCT01179646|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110721318|NCT01179646|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110721319|NCT01179646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110721320|NCT01179646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110721321|NCT01075776|Natriuretic Peptide, C-Type|natriuretic peptide, c-type|mesh-list
110721322|NCT01075776|Acetylcholine|acetylcholine|mesh-list
110721323|NCT01075776|Vasodilator Agents|vasodilator agents|mesh-ancestor
110721324|NCT01075776|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110721325|NCT01075776|Cholinergic Agents|cholinergic agents|mesh-ancestor
110721326|NCT01075776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110721327|NCT01075776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110721328|NCT01075776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110721329|NCT01075776|Natriuretic Agents|natriuretic agents|mesh-ancestor
110721330|NCT01079910|Fluorides|fluorides|mesh-list
110721331|NCT01079910|Cariostatic Agents|cariostatic agents|mesh-ancestor
110721332|NCT01079910|Protective Agents|protective agents|mesh-ancestor
110721333|NCT01079910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110721334|NCT01286896|Sunitinib|sunitinib|mesh-list
110721335|NCT01286896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110721336|NCT01286896|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110721337|NCT01286896|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110721338|NCT01286896|Growth Substances|growth substances|mesh-ancestor
110721339|NCT01286896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110721340|NCT01286896|Growth Inhibitors|growth inhibitors|mesh-ancestor
110721341|NCT01286896|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110721342|NCT01286896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110721343|NCT01286896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110721344|NCT03857854|Pirfenidone|pirfenidone|mesh-list
110721345|NCT03857854|Analgesics|analgesics|mesh-ancestor
110721346|NCT03857854|Sensory System Agents|sensory system agents|mesh-ancestor
110721347|NCT03857854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110721348|NCT03857854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110721349|NCT03857854|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110721350|NCT03857854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110721351|NCT03857854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110721352|NCT03857854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110721353|NCT03857854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110721354|NCT01287052|Nitrous Oxide|nitrous oxide|mesh-list
110721355|NCT01287052|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110721356|NCT01287052|Anesthetics, General|anesthetics, general|mesh-ancestor
110721357|NCT01287052|Anesthetics|anesthetics|mesh-ancestor
110721358|NCT01287052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110721359|NCT01287052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110721360|NCT01287052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110721362|NCT01287052|Sensory System Agents|sensory system agents|mesh-ancestor
110721363|NCT01287052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110721364|NCT01288924|Parecoxib|parecoxib|mesh-list
110721365|NCT01288924|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110721366|NCT01288924|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110721367|NCT01288924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110721368|NCT01288924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110721369|NCT01288924|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110721370|NCT01288924|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110721371|NCT01288924|Analgesics|analgesics|mesh-ancestor
110721372|NCT01288924|Sensory System Agents|sensory system agents|mesh-ancestor
110721373|NCT01288924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110721374|NCT01288924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110721375|NCT01288924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110721376|NCT01288924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110721377|NCT01179724|Pantoprazole|pantoprazole|mesh-list
110721378|NCT01179724|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
110721379|NCT01179724|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110721380|NCT01179724|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110721381|NCT01179724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110721382|NCT01179724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110721383|NCT03862612|Anesthetics|anesthetics|mesh-list
110721384|NCT03862612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110721385|NCT03862612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110721386|NCT01287130|Cetuximab|cetuximab|mesh-list
110721387|NCT01287130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110721388|NCT01287130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110721390|NCT00149214|Docetaxel|docetaxel|mesh-list
110721391|NCT00149214|Doxorubicin|doxorubicin|mesh-list
110721392|NCT00149214|Pemetrexed|pemetrexed|mesh-list
110721393|NCT00149214|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110721394|NCT00149214|Immunologic Factors|immunologic factors|mesh-ancestor
110721395|NCT00149214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110721396|NCT00149214|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110721397|NCT00149214|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110721398|NCT00149214|Alkylating Agents|alkylating agents|mesh-ancestor
110721399|NCT00149214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110721400|NCT00149214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110721401|NCT00149214|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110721402|NCT00149214|Tubulin Modulators|tubulin modulators|mesh-ancestor
110721403|NCT00149214|Antimitotic Agents|antimitotic agents|mesh-ancestor
110721404|NCT00149214|Mitosis Modulators|mitosis modulators|mesh-ancestor
110721405|NCT00149214|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110721406|NCT00149214|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110721407|NCT00149214|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110721408|NCT00149214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110721409|NCT00149214|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110721410|NCT00149214|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110721411|NCT03034018|Suvorexant|suvorexant|mesh-list
110721412|NCT03034018|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110721413|NCT03034018|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110721414|NCT03034018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110721415|NCT03034018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110721416|NCT03034018|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
110721417|NCT03034018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110721418|NCT03034018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110721419|NCT02525458|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
110721420|NCT02525458|Vasodilator Agents|vasodilator agents|mesh-ancestor
110721421|NCT02525458|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
110721422|NCT02525458|Protective Agents|protective agents|mesh-ancestor
110721423|NCT02525458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110721424|NCT02555254|Methamphetamine|methamphetamine|mesh-list
110721425|NCT02555254|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110721426|NCT02555254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110721427|NCT02555254|Sympathomimetics|sympathomimetics|mesh-ancestor
110721428|NCT02555254|Autonomic Agents|autonomic agents|mesh-ancestor
110721429|NCT02555254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110439256|NCT04161001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110721430|NCT02555254|Dopamine Agents|dopamine agents|mesh-ancestor
110721431|NCT02555254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110721432|NCT02555254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110721433|NCT02555254|Adrenergic Agents|adrenergic agents|mesh-ancestor
110721434|NCT02555254|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110721435|NCT02555254|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110721436|NCT02555254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110721437|NCT02555254|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110721438|NCT00114972|Paclitaxel|paclitaxel|mesh-list
110721439|NCT00114972|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110721440|NCT00114972|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110721441|NCT00114972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110721442|NCT00114972|Tubulin Modulators|tubulin modulators|mesh-ancestor
110721443|NCT00114972|Antimitotic Agents|antimitotic agents|mesh-ancestor
110721444|NCT00114972|Mitosis Modulators|mitosis modulators|mesh-ancestor
110721445|NCT00114972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110721446|NCT02444728|Hydroxychloroquine|hydroxychloroquine|mesh-list
110721447|NCT02444728|Methylprednisolone|methylprednisolone|mesh-list
110721448|NCT02444728|Cyclophosphamide|cyclophosphamide|mesh-list
110721449|NCT02444728|Azathioprine|azathioprine|mesh-list
110721450|NCT02444728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110721451|NCT02444728|Immunologic Factors|immunologic factors|mesh-ancestor
110721452|NCT02444728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110721453|NCT02444728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110721454|NCT02444728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110721455|NCT02444728|Alkylating Agents|alkylating agents|mesh-ancestor
110721456|NCT02444728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110721457|NCT02444728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110721458|NCT02444728|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110721459|NCT02444728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110721460|NCT02444728|Antiemetics|antiemetics|mesh-ancestor
110721461|NCT02444728|Autonomic Agents|autonomic agents|mesh-ancestor
110721462|NCT02444728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110721463|NCT02444728|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110721464|NCT02444728|Glucocorticoids|glucocorticoids|mesh-ancestor
110721465|NCT02444728|Hormones|hormones|mesh-ancestor
110721466|NCT02444728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110721467|NCT02444728|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110721468|NCT02444728|Protective Agents|protective agents|mesh-ancestor
110721469|NCT02444728|Antimalarials|antimalarials|mesh-ancestor
110721470|NCT02444728|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110721471|NCT02444728|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110721472|NCT02444728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110721473|NCT02444728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110721474|NCT02444728|Antimetabolites|antimetabolites|mesh-ancestor
110721475|NCT02444728|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110721476|NCT00129402|Simvastatin|simvastatin|mesh-list
110721477|NCT00129402|Ezetimibe|ezetimibe|mesh-list
110721478|NCT00129402|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110721479|NCT00129402|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110721480|NCT00129402|Antimetabolites|antimetabolites|mesh-ancestor
110721481|NCT00129402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110721482|NCT00129402|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110721483|NCT00129402|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110721484|NCT00129402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110721485|NCT03739528|Levofloxacin|levofloxacin|mesh-list
110721486|NCT03739528|Ofloxacin|ofloxacin|mesh-list
110721487|NCT03739528|Tobramycin|tobramycin|mesh-list
110721488|NCT03739528|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
110721489|NCT03739528|Dexamethasone|dexamethasone|mesh-list
110721490|NCT03739528|Dexamethasone acetate|dexamethasone acetate|mesh-list
110721491|NCT03739528|BB 1101|bb 1101|mesh-list
110721492|NCT03739528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110721493|NCT03739528|Antiemetics|antiemetics|mesh-ancestor
110721494|NCT03739528|Autonomic Agents|autonomic agents|mesh-ancestor
110721495|NCT03739528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110721496|NCT03739528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110721497|NCT03739528|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110721498|NCT03739528|Glucocorticoids|glucocorticoids|mesh-ancestor
110721499|NCT03739528|Hormones|hormones|mesh-ancestor
110721500|NCT03739528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110721501|NCT03739528|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110721502|NCT03739528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110721503|NCT03739528|Protease Inhibitors|protease inhibitors|mesh-ancestor
110721504|NCT03739528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110721505|NCT03739528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110721506|NCT03739528|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110721507|NCT03739528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110721508|NCT03739528|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110721509|NCT03739528|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110721510|NCT03739528|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110721511|NCT03739528|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110721512|NCT03739528|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110721513|NCT03739528|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110721514|NCT03739528|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110721515|NCT03857386|Anesthetics|anesthetics|mesh-list
110721516|NCT03857386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110721517|NCT03857386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110721518|NCT01587586|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110721519|NCT01587586|Antiviral Agents|antiviral agents|mesh-ancestor
110721520|NCT01587586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110721521|NCT01289236|Milnacipran|milnacipran|mesh-list
110721522|NCT01289236|Levomilnacipran|levomilnacipran|mesh-list
110721523|NCT01289236|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110721524|NCT01289236|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110721525|NCT01289236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110721526|NCT01289236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110721527|NCT01289236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110721528|NCT01289236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110721529|NCT01289236|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110721530|NCT01289236|Analgesics|analgesics|mesh-ancestor
110721531|NCT01289236|Sensory System Agents|sensory system agents|mesh-ancestor
110721532|NCT01289236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110721533|NCT01289236|Antidepressive Agents|antidepressive agents|mesh-ancestor
110721534|NCT01289236|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110721535|NCT01289938|Diphenhydramine|diphenhydramine|mesh-list
110721536|NCT01289938|Promethazine|promethazine|mesh-list
110721537|NCT01289938|Metoclopramide|metoclopramide|mesh-list
110721538|NCT01289938|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110140471|NCT04200911|Sirolimus|sirolimus|mesh-list
110721539|NCT01289938|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110721540|NCT01289938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110721541|NCT01289938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110721542|NCT01289938|Anesthetics, Local|anesthetics, local|mesh-ancestor
110721543|NCT01289938|Anesthetics|anesthetics|mesh-ancestor
110721544|NCT01289938|Sensory System Agents|sensory system agents|mesh-ancestor
110721545|NCT01289938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110721546|NCT01289938|Antiemetics|antiemetics|mesh-ancestor
110721547|NCT01289938|Autonomic Agents|autonomic agents|mesh-ancestor
110721548|NCT01289938|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110721549|NCT01289938|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110721550|NCT01289938|Histamine Antagonists|histamine antagonists|mesh-ancestor
110721551|NCT01289938|Histamine Agents|histamine agents|mesh-ancestor
110721552|NCT01289938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110721553|NCT01289938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110721554|NCT01289938|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110721555|NCT01289938|Antipruritics|antipruritics|mesh-ancestor
110721556|NCT01289938|Dermatologic Agents|dermatologic agents|mesh-ancestor
110721557|NCT01289938|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110721558|NCT01289938|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110721559|NCT01289938|Dopamine Agents|dopamine agents|mesh-ancestor
110721560|NCT00114738|Rituximab|rituximab|mesh-list
110721561|NCT00114738|Bortezomib|bortezomib|mesh-list
110721562|NCT00114738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110721563|NCT00114738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110721564|NCT00114738|Immunologic Factors|immunologic factors|mesh-ancestor
110721565|NCT00114738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110721566|NCT00114738|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110721567|NCT01180348|Botulinum Toxins|botulinum toxins|mesh-list
110721568|NCT01180348|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110721569|NCT01180348|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110721570|NCT01180348|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110721571|NCT01180348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110721572|NCT01180348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110721573|NCT01180348|Cholinergic Agents|cholinergic agents|mesh-ancestor
110721574|NCT01180348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110721575|NCT01180348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110721576|NCT01180348|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110721577|NCT01180348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110721578|NCT01180426|Tosedostat|tosedostat|mesh-list
110721579|NCT01180426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110721580|NCT01180426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110721581|NCT00148122|Docetaxel|docetaxel|mesh-list
110721582|NCT00148122|Capecitabine|capecitabine|mesh-list
110721583|NCT00148122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110721584|NCT00148122|Tubulin Modulators|tubulin modulators|mesh-ancestor
110721585|NCT00148122|Antimitotic Agents|antimitotic agents|mesh-ancestor
110721586|NCT00148122|Mitosis Modulators|mitosis modulators|mesh-ancestor
110721587|NCT00148122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110721588|NCT00148122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110721589|NCT00148122|Antimetabolites|antimetabolites|mesh-ancestor
110721590|NCT01182142|Capecitabine|capecitabine|mesh-list
110721591|NCT01182142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110721592|NCT01182142|Antimetabolites|antimetabolites|mesh-ancestor
110721593|NCT01182142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110721594|NCT01182142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110721595|NCT01180816|Temozolomide|temozolomide|mesh-list
110721596|NCT01180816|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110721597|NCT01180816|Alkylating Agents|alkylating agents|mesh-ancestor
110721598|NCT01180816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110721599|NCT01180816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110721600|NCT01287598|Rosiglitazone|rosiglitazone|mesh-list
110721601|NCT01287598|Midazolam|midazolam|mesh-list
110721602|NCT01287598|Omeprazole|omeprazole|mesh-list
110721603|NCT01287598|Warfarin|warfarin|mesh-list
110721604|NCT01287598|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110721605|NCT01287598|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110721606|NCT01287598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110721607|NCT01287598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110721608|NCT01287598|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110721609|NCT01287598|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110721610|NCT01287598|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110721611|NCT01287598|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110721612|NCT01287598|Anesthetics, General|anesthetics, general|mesh-ancestor
110721613|NCT01287598|Anesthetics|anesthetics|mesh-ancestor
110721614|NCT01287598|GABA Modulators|gaba modulators|mesh-ancestor
110721615|NCT01287598|GABA Agents|gaba agents|mesh-ancestor
110721616|NCT01287598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110721617|NCT01287598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110721618|NCT01287598|Anticoagulants|anticoagulants|mesh-ancestor
110721619|NCT01287598|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110721620|NCT01287598|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110721621|NCT01287598|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110721622|NCT01287598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110721623|NCT01287598|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110721624|NCT03862144|Palonosetron|palonosetron|mesh-list
110721625|NCT03862144|Antiemetics|antiemetics|mesh-ancestor
110721626|NCT03862144|Autonomic Agents|autonomic agents|mesh-ancestor
110721627|NCT03862144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110721628|NCT03862144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110721629|NCT03862144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110721630|NCT03862144|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110721631|NCT03862144|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110721632|NCT03862144|Serotonin Agents|serotonin agents|mesh-ancestor
110721633|NCT03862144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110721634|NCT03862144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110721635|NCT01290172|Somatostatin|somatostatin|mesh-list
110721637|NCT01290172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110721638|NCT01290172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110721639|NCT03861598|Carvedilol|carvedilol|mesh-list
110721640|NCT03861598|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110721641|NCT03861598|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110721642|NCT03861598|Adrenergic Agents|adrenergic agents|mesh-ancestor
110721643|NCT03861598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110721644|NCT03861598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110721646|NCT03861598|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110721647|NCT03861598|Antioxidants|antioxidants|mesh-ancestor
110721648|NCT03861598|Protective Agents|protective agents|mesh-ancestor
110721649|NCT03861598|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110721650|NCT03861598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110721651|NCT03861598|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110721652|NCT03861598|Vasodilator Agents|vasodilator agents|mesh-ancestor
110721653|NCT03861598|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110721654|NCT03861598|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110439480|NCT02837770|Analgesics|analgesics|mesh-ancestor
110721655|NCT01184482|Cetuximab|cetuximab|mesh-list
110721656|NCT01184482|Lapatinib|lapatinib|mesh-list
110721657|NCT01184482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110721658|NCT01184482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110721659|NCT01184482|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110721660|NCT01184482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110721661|NCT01184482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110721662|NCT01184560|Orlistat|orlistat|mesh-list
110721663|NCT01184560|Sibutramine|sibutramine|mesh-list
110721664|NCT01184560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110721665|NCT01184560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110721666|NCT01184560|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110721667|NCT01184560|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110721668|NCT01184560|Antidepressive Agents|antidepressive agents|mesh-ancestor
110721669|NCT01184560|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110721670|NCT01184560|Appetite Depressants|appetite depressants|mesh-ancestor
110721671|NCT01184638|Propofol|propofol|mesh-list
110721672|NCT01184638|Sevoflurane|sevoflurane|mesh-list
110721673|NCT01184638|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110721674|NCT01184638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110721675|NCT01184638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110721676|NCT01184638|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110721677|NCT01184638|Anesthetics, General|anesthetics, general|mesh-ancestor
110721678|NCT01184638|Anesthetics|anesthetics|mesh-ancestor
110721679|NCT01184638|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110721680|NCT01184638|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110721681|NCT01290328|Epoetin Alfa|epoetin alfa|mesh-list
110721682|NCT01290328|Hematinics|hematinics|mesh-ancestor
110721683|NCT01184716|Vitamin D|vitamin d|mesh-list
110721684|NCT01184716|Vitamins|vitamins|mesh-ancestor
110721685|NCT01184716|Micronutrients|micronutrients|mesh-ancestor
110721686|NCT01184716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110721687|NCT01184716|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110721688|NCT01184794|Levobupivacaine|levobupivacaine|mesh-list
110721689|NCT01184794|Anesthetics, Local|anesthetics, local|mesh-ancestor
110721690|NCT01184794|Anesthetics|anesthetics|mesh-ancestor
110721691|NCT01184794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110721692|NCT01184794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110721693|NCT01184794|Sensory System Agents|sensory system agents|mesh-ancestor
110721694|NCT01184794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110721695|NCT01587508|Meloxicam|meloxicam|mesh-list
110721696|NCT01587508|Amitriptyline|amitriptyline|mesh-list
110721697|NCT01587508|Cyclobenzaprine|cyclobenzaprine|mesh-list
110862536|NCT04735965|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110721698|NCT01587508|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110721699|NCT01587508|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110721700|NCT01587508|Analgesics|analgesics|mesh-ancestor
110721701|NCT01587508|Sensory System Agents|sensory system agents|mesh-ancestor
110721702|NCT01587508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110721703|NCT01587508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110721704|NCT01587508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110721705|NCT01587508|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110721706|NCT01587508|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110721707|NCT01587508|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110721708|NCT01587508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110721709|NCT01587508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110721710|NCT01587508|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110721711|NCT01587508|Antidepressive Agents|antidepressive agents|mesh-ancestor
110721712|NCT01587508|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110721713|NCT01587508|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110721714|NCT01587508|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110721715|NCT01587508|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110721716|NCT01587508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110721717|NCT01587508|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110721718|NCT01587508|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110721719|NCT01587508|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110721720|NCT01587508|Adrenergic Agents|adrenergic agents|mesh-ancestor
110721721|NCT01587508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110721722|NCT00147498|Tofacitinib|tofacitinib|mesh-list
110721723|NCT00147498|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
110721724|NCT00147498|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110721725|NCT00147498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110721726|NCT00147498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110721727|NCT01176760|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
110721728|NCT01176760|Protease Inhibitors|protease inhibitors|mesh-ancestor
110721729|NCT01176760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110721730|NCT01176760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110721731|NCT01176760|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110721732|NCT01176760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110721733|NCT01080066|Cetuximab|cetuximab|mesh-list
110721734|NCT01080066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110721735|NCT01080066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110721736|NCT01185184|Tofacitinib|tofacitinib|mesh-list
110721737|NCT01185184|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
110721738|NCT01185184|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110721739|NCT01185184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110721740|NCT01185184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110721741|NCT00113568|Tranexamic Acid|tranexamic acid|mesh-list
110721742|NCT00113568|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110721743|NCT00113568|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110721744|NCT00113568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110721745|NCT00113568|Hemostatics|hemostatics|mesh-ancestor
110721746|NCT00113568|Coagulants|coagulants|mesh-ancestor
110721747|NCT01185262|Rituximab|rituximab|mesh-list
110721748|NCT01185262|Lenalidomide|lenalidomide|mesh-list
110721749|NCT01185262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110721750|NCT01185262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110721751|NCT01185262|Immunologic Factors|immunologic factors|mesh-ancestor
110721752|NCT01185262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110721753|NCT01185262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110721754|NCT01185262|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110721755|NCT01185262|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110721756|NCT01185262|Growth Substances|growth substances|mesh-ancestor
110721757|NCT01185262|Growth Inhibitors|growth inhibitors|mesh-ancestor
110721758|NCT00113490|Palivizumab|palivizumab|mesh-list
110721759|NCT00113490|Antiviral Agents|antiviral agents|mesh-ancestor
110862561|NCT02456428|Voglibose|voglibose|mesh-list
110721760|NCT00113490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110721762|NCT00146640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110721763|NCT00146640|Glucocorticoids|glucocorticoids|mesh-ancestor
110721764|NCT00146640|Hormones|hormones|mesh-ancestor
110721765|NCT00146640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110721766|NCT00146640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110721767|NCT00146640|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110721768|NCT00146640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110721769|NCT01185418|Haloperidol|haloperidol|mesh-list
110721770|NCT01185418|Risperidone|risperidone|mesh-list
110721771|NCT01185418|Aripiprazole|aripiprazole|mesh-list
110721772|NCT01185418|Haloperidol decanoate|haloperidol decanoate|mesh-list
110721773|NCT01185418|Amisulpride|amisulpride|mesh-list
110721774|NCT01185418|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110721775|NCT01185418|Serotonin Agents|serotonin agents|mesh-ancestor
110721776|NCT01185418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110721777|NCT01185418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110721778|NCT01185418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110721779|NCT01185418|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110721780|NCT01185418|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110721781|NCT01185418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110721782|NCT01185418|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110721783|NCT01185418|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110721784|NCT01185418|Dopamine Agents|dopamine agents|mesh-ancestor
110721785|NCT01185418|Antidepressive Agents|antidepressive agents|mesh-ancestor
110721786|NCT01185418|Dopamine Agonists|dopamine agonists|mesh-ancestor
110721787|NCT01185418|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110721788|NCT01185418|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110721789|NCT01185418|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110721790|NCT01185418|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110721791|NCT01185418|Antiemetics|antiemetics|mesh-ancestor
110721792|NCT01185418|Autonomic Agents|autonomic agents|mesh-ancestor
110721793|NCT01185418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110721794|NCT01185418|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110721795|NCT01185418|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110721796|NCT01185418|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110721797|NCT01185574|Vitamin D|vitamin d|mesh-list
110721798|NCT01185574|Vitamins|vitamins|mesh-ancestor
110721799|NCT01185574|Micronutrients|micronutrients|mesh-ancestor
110721800|NCT01185574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110721801|NCT01185574|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110721802|NCT03861364|Propofol|propofol|mesh-list
110721803|NCT03861364|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110721804|NCT03861364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110721805|NCT03861364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110721806|NCT03861364|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110721807|NCT03861364|Anesthetics, General|anesthetics, general|mesh-ancestor
110721808|NCT03861364|Anesthetics|anesthetics|mesh-ancestor
110721809|NCT01185808|Vitamin D|vitamin d|mesh-list
110721810|NCT01185808|Ergocalciferols|ergocalciferols|mesh-list
110721811|NCT01185808|Cholecalciferol|cholecalciferol|mesh-list
110721812|NCT01185808|Vitamins|vitamins|mesh-list
110721813|NCT01185808|Micronutrients|micronutrients|mesh-ancestor
110721814|NCT01185808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110721815|NCT01185808|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110721816|NCT01185808|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110721817|NCT01183624|Analgesics|analgesics|mesh-list
110721818|NCT01183624|Sensory System Agents|sensory system agents|mesh-ancestor
110721819|NCT01183624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110444092|NCT00625079|Sildenafil Citrate|sildenafil citrate|mesh-list
110721820|NCT01183624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110721822|NCT01291186|Racepinephrine|racepinephrine|mesh-list
110721823|NCT01291186|Bupivacaine|bupivacaine|mesh-list
110721824|NCT01291186|Epinephryl borate|epinephryl borate|mesh-list
110721825|NCT01291186|Anesthetics, Local|anesthetics, local|mesh-ancestor
110721826|NCT01291186|Anesthetics|anesthetics|mesh-ancestor
110721827|NCT01291186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110721828|NCT01291186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110721829|NCT01291186|Sensory System Agents|sensory system agents|mesh-ancestor
110721830|NCT01291186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110721831|NCT01291186|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110721832|NCT01291186|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110862577|NCT02456428|Incretins|incretins|mesh-list
110721833|NCT01291186|Adrenergic Agents|adrenergic agents|mesh-ancestor
110721834|NCT01291186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110721835|NCT01291186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110721836|NCT01291186|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110721837|NCT01291186|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110721838|NCT01291186|Autonomic Agents|autonomic agents|mesh-ancestor
110721839|NCT01291186|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110721840|NCT01291186|Respiratory System Agents|respiratory system agents|mesh-ancestor
110721841|NCT01291186|Mydriatics|mydriatics|mesh-ancestor
110721842|NCT01291186|Sympathomimetics|sympathomimetics|mesh-ancestor
110721843|NCT01291186|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110721844|NCT04979338|Bupivacaine|bupivacaine|mesh-list
110721845|NCT04979338|Anesthetics, Local|anesthetics, local|mesh-list
110721846|NCT04979338|Anesthetics|anesthetics|mesh-list
110721847|NCT04979338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110721848|NCT04979338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110721849|NCT04979338|Sensory System Agents|sensory system agents|mesh-ancestor
110721850|NCT04979338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110721851|NCT01177306|Guanfacine|guanfacine|mesh-list
110721852|NCT01177306|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110721853|NCT01177306|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110721854|NCT01177306|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110721855|NCT01177306|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110721856|NCT01177306|Adrenergic Agents|adrenergic agents|mesh-ancestor
110721857|NCT01177306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110721858|NCT01177306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110721859|NCT01177306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110721860|NCT01290406|Dactolisib|dactolisib|mesh-list
110721861|NCT01290406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110721862|NCT03854812|Magnesium Sulfate|magnesium sulfate|mesh-list
110721863|NCT03854812|Fentanyl|fentanyl|mesh-list
110721864|NCT03854812|Propofol|propofol|mesh-list
110721865|NCT03854812|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110721866|NCT03854812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110721867|NCT03854812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110721868|NCT03854812|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110721869|NCT03854812|Anesthetics, General|anesthetics, general|mesh-ancestor
110721870|NCT03854812|Anesthetics|anesthetics|mesh-ancestor
110721871|NCT03854812|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110721872|NCT03854812|Narcotics|narcotics|mesh-ancestor
110721873|NCT03854812|Analgesics|analgesics|mesh-ancestor
110721874|NCT03854812|Sensory System Agents|sensory system agents|mesh-ancestor
110721875|NCT03854812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110721876|NCT03854812|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110721877|NCT03854812|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110721878|NCT03854812|Anticonvulsants|anticonvulsants|mesh-ancestor
110721879|NCT03854812|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110721880|NCT03854812|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110721881|NCT03854812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110721882|NCT03854812|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110721883|NCT03854812|Tocolytic Agents|tocolytic agents|mesh-ancestor
110439708|NCT01207388|Blinatumomab|blinatumomab|mesh-list
110721884|NCT03854812|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110721885|NCT01186120|Umirolimus|umirolimus|mesh-list
110721886|NCT01186120|Everolimus|everolimus|mesh-list
110721887|NCT01186120|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110721888|NCT01186120|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110721889|NCT01186120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110721890|NCT01186120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110721891|NCT01186120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110721892|NCT01186120|Immunologic Factors|immunologic factors|mesh-ancestor
110721893|NCT01186120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110721894|NCT01186120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110721895|NCT01186120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110721897|NCT03855826|Nifekalant|nifekalant|mesh-list
110721898|NCT03855826|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110721899|NCT03855826|Vasodilator Agents|vasodilator agents|mesh-ancestor
110721900|NCT03855826|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
110721901|NCT03855826|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110721902|NCT03855826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110721903|NCT03855826|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110862579|NCT02456428|Hormones|hormones|mesh-ancestor
110721904|NCT03855826|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110721905|NCT03855826|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110721906|NCT03855826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110721907|NCT03855826|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110721908|NCT03855826|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110721909|NCT03855826|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110721910|NCT01184404|Bosentan|bosentan|mesh-list
110721911|NCT01184404|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110721912|NCT01184404|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
110721913|NCT01184404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110721914|NCT01186588|Canagliflozin|canagliflozin|mesh-list
110721915|NCT01186588|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110721916|NCT01186588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110721917|NCT01186588|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110721918|NCT01186588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110721919|NCT03854266|Heparin|heparin|mesh-list
110721920|NCT03854266|Calcium heparin|calcium heparin|mesh-list
110721921|NCT03854266|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
110721922|NCT03854266|Anticoagulants|anticoagulants|mesh-ancestor
110721923|NCT03854266|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110721924|NCT03854266|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110721925|NCT03854266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110721926|NCT01187992|Atorvastatin|atorvastatin|mesh-list
110721927|NCT01187992|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110721928|NCT01187992|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110721929|NCT01187992|Antimetabolites|antimetabolites|mesh-ancestor
110721930|NCT01187992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110721931|NCT01187992|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110721932|NCT01187992|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110721933|NCT01187992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110721934|NCT01191034|Imiquimod|imiquimod|mesh-list
110721935|NCT01191034|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110721936|NCT01191034|Immunologic Factors|immunologic factors|mesh-ancestor
110721937|NCT01191034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110721938|NCT01191034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110721939|NCT01191034|Interferon Inducers|interferon inducers|mesh-ancestor
110721940|NCT01188148|Memantine|memantine|mesh-list
110721941|NCT01188148|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110721942|NCT01188148|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110721943|NCT01188148|Dopamine Agents|dopamine agents|mesh-ancestor
110721944|NCT01188148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110721945|NCT01188148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110721946|NCT01188148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110721947|NCT01188148|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110721948|NCT01188148|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110721949|NCT01187212|Cisplatin|cisplatin|mesh-list
110721950|NCT01187212|Capecitabine|capecitabine|mesh-list
110721951|NCT01187212|Sorafenib|sorafenib|mesh-list
110721952|NCT01187212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110721953|NCT01187212|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110721954|NCT01187212|Antimetabolites|antimetabolites|mesh-ancestor
110721955|NCT01187212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110721956|NCT01187212|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110439794|NCT00668239|Triamcinolone|triamcinolone|mesh-list
110721957|NCT01187212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110721958|NCT03849508|Phenylephrine|phenylephrine|mesh-list
110721959|NCT03849508|Oxymetazoline|oxymetazoline|mesh-list
110721960|NCT03849508|Norepinephrine|norepinephrine|mesh-list
110721961|NCT03849508|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110721962|NCT03849508|Mydriatics|mydriatics|mesh-ancestor
110721963|NCT03849508|Autonomic Agents|autonomic agents|mesh-ancestor
110721964|NCT03849508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110721965|NCT03849508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110721966|NCT03849508|Sympathomimetics|sympathomimetics|mesh-ancestor
110721967|NCT03849508|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110721969|NCT03849508|Respiratory System Agents|respiratory system agents|mesh-ancestor
110721970|NCT03849508|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110721971|NCT03849508|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110721972|NCT03849508|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110721973|NCT03849508|Adrenergic Agents|adrenergic agents|mesh-ancestor
110721974|NCT03849508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110721975|NCT03849508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110721976|NCT03849508|Protective Agents|protective agents|mesh-ancestor
110721977|NCT03849664|Niacinamide|niacinamide|mesh-list
110721978|NCT03849664|Niacin|niacin|mesh-list
110721979|NCT03849664|Nicotinic Acids|nicotinic acids|mesh-list
110721980|NCT03849664|Riboflavin|riboflavin|mesh-list
110721981|NCT03849664|Flavin Mononucleotide|flavin mononucleotide|mesh-list
110721982|NCT03849664|Povidone|povidone|mesh-list
110721983|NCT03849664|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110721984|NCT03849664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110721985|NCT03849664|Plasma Substitutes|plasma substitutes|mesh-ancestor
110721986|NCT03849664|Blood Substitutes|blood substitutes|mesh-ancestor
110721987|NCT03849664|Vitamin B Complex|vitamin b complex|mesh-ancestor
110721988|NCT03849664|Vitamins|vitamins|mesh-ancestor
110721989|NCT03849664|Micronutrients|micronutrients|mesh-ancestor
110721990|NCT03849664|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110721991|NCT03849664|Antimetabolites|antimetabolites|mesh-ancestor
110721992|NCT03849664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110721993|NCT03849664|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110721994|NCT03849664|Vasodilator Agents|vasodilator agents|mesh-ancestor
110721995|NCT03849664|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110721996|NCT03849664|Dermatologic Agents|dermatologic agents|mesh-ancestor
110721997|NCT01293838|Escitalopram|escitalopram|mesh-list
110721998|NCT01293838|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110721999|NCT01293838|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110722000|NCT01293838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110722001|NCT01293838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110722002|NCT01293838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110722003|NCT01293838|Serotonin Agents|serotonin agents|mesh-ancestor
110722004|NCT01293838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110722005|NCT01188304|Aspirin|aspirin|mesh-list
110722006|NCT01188304|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110722007|NCT01188304|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110722008|NCT01188304|Analgesics|analgesics|mesh-ancestor
110722009|NCT01188304|Sensory System Agents|sensory system agents|mesh-ancestor
110722010|NCT01188304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110722011|NCT01188304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110722012|NCT01188304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110722013|NCT01188304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110722014|NCT01188304|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110722015|NCT01188304|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110722016|NCT01188304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110862618|NCT01344681|Itraconazole|itraconazole|mesh-list
110722017|NCT01188304|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110722018|NCT01188304|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110722019|NCT01188304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110722020|NCT01188304|Antipyretics|antipyretics|mesh-ancestor
110722021|NCT02524444|Pyrimethamine|pyrimethamine|mesh-list
110722022|NCT02524444|Sulfadoxine|sulfadoxine|mesh-list
110722023|NCT02524444|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
110722024|NCT02524444|Mefloquine|mefloquine|mesh-list
110722025|NCT02524444|Antimalarials|antimalarials|mesh-ancestor
110722026|NCT02524444|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110722027|NCT02524444|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110722028|NCT02524444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110722029|NCT02524444|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110722030|NCT02524444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110722031|NCT02524444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110722032|NCT02524444|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110722033|NCT03853642|Nitric Oxide|nitric oxide|mesh-list
110722034|NCT03853642|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110722035|NCT03853642|Autonomic Agents|autonomic agents|mesh-ancestor
110140576|NCT03984357|Antibodies|antibodies|mesh-list
110722036|NCT03853642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110722037|NCT03853642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110722038|NCT03853642|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110722039|NCT03853642|Respiratory System Agents|respiratory system agents|mesh-ancestor
110444099|NCT02786992|Misoprostol|misoprostol|mesh-list
110722040|NCT03853642|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110722042|NCT03853642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110722043|NCT03853642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110722044|NCT03853642|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
110722045|NCT03853642|Vasodilator Agents|vasodilator agents|mesh-ancestor
110722046|NCT03853642|Gasotransmitters|gasotransmitters|mesh-ancestor
110722047|NCT03853642|Protective Agents|protective agents|mesh-ancestor
110722048|NCT02296918|Rituximab|rituximab|mesh-list
110722049|NCT02296918|Obinutuzumab|obinutuzumab|mesh-list
110722050|NCT02296918|Venetoclax|venetoclax|mesh-list
110722051|NCT02296918|Acalabrutinib|acalabrutinib|mesh-list
110722052|NCT02296918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110722053|NCT02296918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110722054|NCT02296918|Immunologic Factors|immunologic factors|mesh-ancestor
110722055|NCT02296918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110722056|NCT02296918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110722057|NCT01294072|Curcumin|curcumin|mesh-list
110722058|NCT01294072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110722059|NCT01294072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110722060|NCT01294072|Analgesics|analgesics|mesh-ancestor
110722061|NCT01294072|Sensory System Agents|sensory system agents|mesh-ancestor
110722062|NCT01294072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110722063|NCT01294072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110722064|NCT01294072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110722065|NCT01294072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110722066|NCT01294072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110722067|NCT01294072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110722068|NCT01294072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110722069|NCT01191424|Formoterol Fumarate|formoterol fumarate|mesh-list
110722070|NCT01191424|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110722071|NCT01191424|Autonomic Agents|autonomic agents|mesh-ancestor
110722072|NCT01191424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110722073|NCT01191424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110722074|NCT01191424|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110722075|NCT01191424|Respiratory System Agents|respiratory system agents|mesh-ancestor
110722076|NCT01191424|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110722077|NCT01191424|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110722078|NCT01191424|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110722079|NCT01191424|Adrenergic Agents|adrenergic agents|mesh-ancestor
110722080|NCT01191424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110722081|NCT01191424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110722082|NCT01291654|Acetaminophen|acetaminophen|mesh-list
110722083|NCT01291654|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110722084|NCT01291654|Analgesics|analgesics|mesh-ancestor
110722085|NCT01291654|Sensory System Agents|sensory system agents|mesh-ancestor
110722086|NCT01291654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110722087|NCT01291654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110722088|NCT01291654|Antipyretics|antipyretics|mesh-ancestor
110722089|NCT03853096|Cefazolin|cefazolin|mesh-list
110722090|NCT03853096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110722091|NCT03853096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110722092|NCT05671276|Aspirin|aspirin|mesh-list
110722093|NCT05671276|Rivaroxaban|rivaroxaban|mesh-list
110722094|NCT05671276|Clopidogrel|clopidogrel|mesh-list
110722095|NCT05671276|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110140594|NCT03737968|Durvalumab|durvalumab|mesh-list
110722096|NCT05671276|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110722097|NCT05671276|Analgesics|analgesics|mesh-ancestor
110722098|NCT05671276|Sensory System Agents|sensory system agents|mesh-ancestor
110722099|NCT05671276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110722100|NCT05671276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110722101|NCT05671276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110722102|NCT05671276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110722103|NCT05671276|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110722104|NCT05671276|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110722105|NCT05671276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110722106|NCT05671276|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110722107|NCT05671276|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110722108|NCT05671276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110722109|NCT05671276|Antipyretics|antipyretics|mesh-ancestor
110722110|NCT05671276|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110722111|NCT05671276|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110722112|NCT05671276|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110722113|NCT05671276|Purinergic Agents|purinergic agents|mesh-ancestor
110444102|NCT02786992|Oxytocics|oxytocics|mesh-ancestor
110722114|NCT05671276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110722115|NCT05671276|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110722116|NCT05671276|Antithrombins|antithrombins|mesh-ancestor
110722117|NCT05671276|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110722118|NCT05671276|Protease Inhibitors|protease inhibitors|mesh-ancestor
110722119|NCT05671276|Anticoagulants|anticoagulants|mesh-ancestor
110722120|NCT03852160|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110722121|NCT03852160|Mirtazapine|mirtazapine|mesh-list
110722122|NCT03852160|Trazodone|trazodone|mesh-list
110722123|NCT03852160|Agomelatine|agomelatine|mesh-list
110722124|NCT03852160|Bupropion|bupropion|mesh-list
110722125|NCT03852160|Sertraline|sertraline|mesh-list
110722126|NCT03852160|Esketamine|esketamine|mesh-list
110722127|NCT03852160|Escitalopram|escitalopram|mesh-list
110722128|NCT03852160|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110722129|NCT03852160|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110722130|NCT03852160|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110722131|NCT03852160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110722132|NCT03852160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110722133|NCT03852160|Serotonin Agents|serotonin agents|mesh-ancestor
110722134|NCT03852160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110722135|NCT03852160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110722136|NCT03852160|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110722137|NCT03852160|Antidepressive Agents|antidepressive agents|mesh-ancestor
110722138|NCT03852160|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110722139|NCT03852160|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110722140|NCT03852160|Dopamine Agents|dopamine agents|mesh-ancestor
110722141|NCT03852160|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110722142|NCT03852160|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110722143|NCT03852160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110722144|NCT03852160|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110722145|NCT03852160|Analgesics|analgesics|mesh-ancestor
110722146|NCT03852160|Sensory System Agents|sensory system agents|mesh-ancestor
110722147|NCT03852160|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110722148|NCT03852160|Histamine Antagonists|histamine antagonists|mesh-ancestor
110722149|NCT03852160|Histamine Agents|histamine agents|mesh-ancestor
110722150|NCT03852160|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110722151|NCT03852160|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110722152|NCT03852160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110722153|NCT03852160|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
110722154|NCT03852160|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110722155|NCT03852160|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110722156|NCT03852160|Adrenergic Agents|adrenergic agents|mesh-ancestor
110722157|NCT03852160|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110722158|NCT03852160|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110722159|NCT03852160|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110722160|NCT03852160|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110722161|NCT02524210|Omeprazole|omeprazole|mesh-list
110722162|NCT02524210|Rabeprazole|rabeprazole|mesh-list
110722163|NCT02524210|Dabigatran|dabigatran|mesh-list
110722164|NCT02524210|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110722165|NCT02524210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110722166|NCT02524210|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110722167|NCT02524210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110722168|NCT02524210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110722169|NCT02524210|Antithrombins|antithrombins|mesh-ancestor
110722170|NCT02524210|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110722171|NCT02524210|Protease Inhibitors|protease inhibitors|mesh-ancestor
110722172|NCT02524210|Anticoagulants|anticoagulants|mesh-ancestor
110722173|NCT03847792|Dexamethasone|dexamethasone|mesh-list
110722174|NCT03847792|Fentanyl|fentanyl|mesh-list
110722175|NCT03847792|Bupivacaine|bupivacaine|mesh-list
110722176|NCT03847792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110722177|NCT03847792|Antiemetics|antiemetics|mesh-ancestor
110722178|NCT03847792|Autonomic Agents|autonomic agents|mesh-ancestor
110722179|NCT03847792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110722180|NCT03847792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110722181|NCT03847792|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110722182|NCT03847792|Glucocorticoids|glucocorticoids|mesh-ancestor
110722183|NCT03847792|Hormones|hormones|mesh-ancestor
110722184|NCT03847792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110722185|NCT03847792|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110722186|NCT03847792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110722187|NCT03847792|Anesthetics, Local|anesthetics, local|mesh-ancestor
110722189|NCT03847792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110722190|NCT03847792|Sensory System Agents|sensory system agents|mesh-ancestor
110722192|NCT03847792|Narcotics|narcotics|mesh-ancestor
110722193|NCT03847792|Analgesics|analgesics|mesh-ancestor
110722194|NCT03847792|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110722195|NCT03847792|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110722196|NCT03847792|Anesthetics, General|anesthetics, general|mesh-ancestor
110722197|NCT01294618|Interferons|interferons|mesh-list
110722198|NCT01294618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110722199|NCT01294618|Antiviral Agents|antiviral agents|mesh-ancestor
110722200|NCT01294618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110722201|NCT01194232|Sildenafil Citrate|sildenafil citrate|mesh-list
110722202|NCT01194232|Vasodilator Agents|vasodilator agents|mesh-ancestor
110722203|NCT01194232|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110722204|NCT01194232|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110722205|NCT01194232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110722206|NCT01194232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110722207|NCT01194232|Urological Agents|urological agents|mesh-ancestor
110722208|NCT01296334|Morphine|morphine|mesh-list
110722209|NCT01296334|Buprenorphine|buprenorphine|mesh-list
110722210|NCT01296334|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110722211|NCT01296334|Narcotics|narcotics|mesh-ancestor
110722212|NCT01296334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110722213|NCT01296334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110722214|NCT01296334|Analgesics|analgesics|mesh-ancestor
110722215|NCT01296334|Sensory System Agents|sensory system agents|mesh-ancestor
110722216|NCT01296334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110722217|NCT01296334|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110722218|NCT03847558|Hormones|hormones|mesh-list
110722219|NCT03847558|Testosterone|testosterone|mesh-list
110722220|NCT03847558|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
110722221|NCT03847558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110722222|NCT03847558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110722223|NCT03847558|Androgens|androgens|mesh-ancestor
110722224|NCT01189006|Dextromethorphan|dextromethorphan|mesh-list
110722225|NCT01189006|Antitussive Agents|antitussive agents|mesh-ancestor
110722226|NCT01189006|Respiratory System Agents|respiratory system agents|mesh-ancestor
110722227|NCT01189006|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110722228|NCT01189006|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110722229|NCT01189006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110722230|NCT01189006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110722231|NCT01189006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110722232|NCT01292356|Cetuximab|cetuximab|mesh-list
110722233|NCT01292356|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110722234|NCT01292356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110722235|NCT01294852|Pulmonary Surfactants|pulmonary surfactants|mesh-list
110722236|NCT01294852|Respiratory System Agents|respiratory system agents|mesh-ancestor
110722237|NCT03847246|Entecavir|entecavir|mesh-list
110722238|NCT03847246|Antiviral Agents|antiviral agents|mesh-ancestor
110722239|NCT03847246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110722240|NCT03849196|Bisacodyl|bisacodyl|mesh-list
110722241|NCT03849196|Cathartics|cathartics|mesh-ancestor
110722242|NCT03849196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110722243|NCT03849196|Laxatives|laxatives|mesh-ancestor
110722244|NCT01292668|Aminolevulinic Acid|aminolevulinic acid|mesh-list
110722245|NCT01292668|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
110722246|NCT01292668|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110722247|NCT01292668|Dermatologic Agents|dermatologic agents|mesh-ancestor
110722248|NCT01296802|Fenfluramine|fenfluramine|mesh-list
110722249|NCT01296802|Dexfenfluramine|dexfenfluramine|mesh-list
110722250|NCT01296802|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110722251|NCT01296802|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110722252|NCT01296802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110722253|NCT01296802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110722254|NCT01296802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110722255|NCT01296802|Serotonin Agents|serotonin agents|mesh-ancestor
110722256|NCT01296802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110722257|NCT01296802|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110722258|NCT01296958|Niclosamide|niclosamide|mesh-list
110722259|NCT01296958|Anticestodal Agents|anticestodal agents|mesh-ancestor
110722260|NCT01296958|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110722261|NCT01296958|Anthelmintics|anthelmintics|mesh-ancestor
110722262|NCT01296958|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110722263|NCT01296958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110722265|NCT01295086|Docetaxel|docetaxel|mesh-list
110722266|NCT01295086|Capecitabine|capecitabine|mesh-list
110722267|NCT01295086|Oxaliplatin|oxaliplatin|mesh-list
110722268|NCT01295086|Trastuzumab|trastuzumab|mesh-list
110722269|NCT01295086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110722270|NCT01295086|Tubulin Modulators|tubulin modulators|mesh-ancestor
110722271|NCT01295086|Antimitotic Agents|antimitotic agents|mesh-ancestor
110722272|NCT01295086|Mitosis Modulators|mitosis modulators|mesh-ancestor
110722273|NCT01295086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110722274|NCT01295086|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110722276|NCT01295086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110722277|NCT01194700|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
110722278|NCT01194700|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110722279|NCT01194700|Autonomic Agents|autonomic agents|mesh-ancestor
110722280|NCT01194700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110722281|NCT01194700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110722282|NCT01194700|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110722283|NCT01194700|Respiratory System Agents|respiratory system agents|mesh-ancestor
110722284|NCT01194700|Glucocorticoids|glucocorticoids|mesh-ancestor
110722285|NCT01194700|Hormones|hormones|mesh-ancestor
110722286|NCT01194700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110722287|NCT01194700|Sympathomimetics|sympathomimetics|mesh-ancestor
110722288|NCT01189318|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110722289|NCT01189318|Antidepressive Agents|antidepressive agents|mesh-ancestor
110722290|NCT01189318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110722291|NCT01189318|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110722292|NCT01189318|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110722293|NCT01189318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110722294|NCT01189318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110722295|NCT01194778|Vitamins|vitamins|mesh-list
110722296|NCT01194778|Vitamin K|vitamin k|mesh-list
110722297|NCT01194778|Vitamin K 2|vitamin k 2|mesh-list
110722298|NCT01194778|Vitamin K 1|vitamin k 1|mesh-list
110722299|NCT01194778|Micronutrients|micronutrients|mesh-ancestor
110722300|NCT01194778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110722301|NCT01194778|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110722302|NCT01194778|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110722303|NCT01194778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110722304|NCT01194778|Hemostatics|hemostatics|mesh-ancestor
110722305|NCT01194778|Coagulants|coagulants|mesh-ancestor
110722306|NCT01194934|Lenograstim|lenograstim|mesh-list
110722307|NCT01194934|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110722308|NCT01194934|Immunologic Factors|immunologic factors|mesh-ancestor
110722309|NCT01194934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110722310|NCT01297036|Donepezil|donepezil|mesh-list
110722311|NCT01297036|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110722312|NCT01297036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110722313|NCT01297036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110722314|NCT01297036|Cholinergic Agents|cholinergic agents|mesh-ancestor
110722315|NCT01297036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110722316|NCT01297036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110722317|NCT01297036|Nootropic Agents|nootropic agents|mesh-ancestor
110722318|NCT03848806|Calcitriol|calcitriol|mesh-list
110722319|NCT03848806|Calcipotriene|calcipotriene|mesh-list
110722320|NCT03848806|Dermatologic Agents|dermatologic agents|mesh-ancestor
110722321|NCT03848806|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110722322|NCT03848806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110722323|NCT03848806|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
110722324|NCT03848806|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110722325|NCT03848806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110722326|NCT03848806|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110722327|NCT03848806|Vitamins|vitamins|mesh-ancestor
110722328|NCT03848806|Micronutrients|micronutrients|mesh-ancestor
110722329|NCT03848806|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110722330|NCT01189864|Diclofenac|diclofenac|mesh-list
110722331|NCT01189864|Prednisolone acetate|prednisolone acetate|mesh-list
110722332|NCT01189864|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110722333|NCT01189864|Methylprednisolone|methylprednisolone|mesh-list
110722334|NCT01189864|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110722335|NCT01189864|Prednisolone|prednisolone|mesh-list
110722336|NCT01189864|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110722337|NCT01189864|Prednisolone phosphate|prednisolone phosphate|mesh-list
110722338|NCT01189864|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110722339|NCT01189864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110722341|NCT01189864|Sensory System Agents|sensory system agents|mesh-ancestor
110722342|NCT01189864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110722343|NCT01189864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110722344|NCT01189864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110722345|NCT01189864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110722346|NCT01189864|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110722347|NCT01189864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110722348|NCT01189864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110722349|NCT01189864|Antiemetics|antiemetics|mesh-ancestor
110722350|NCT01189864|Autonomic Agents|autonomic agents|mesh-ancestor
110722351|NCT01189864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110722352|NCT01189864|Glucocorticoids|glucocorticoids|mesh-ancestor
110722353|NCT01189864|Hormones|hormones|mesh-ancestor
110722354|NCT01189864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110722355|NCT01189864|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110722356|NCT01189864|Protective Agents|protective agents|mesh-ancestor
110722357|NCT01189864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110722358|NCT01189864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110722359|NCT01195246|Vaccines|vaccines|mesh-list
110722360|NCT01195246|Immunologic Factors|immunologic factors|mesh-ancestor
110722361|NCT01195246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110722362|NCT01191892|Carboplatin|carboplatin|mesh-list
110722363|NCT01191892|Gemcitabine|gemcitabine|mesh-list
110722364|NCT01191892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110722365|NCT01191892|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110722366|NCT01191892|Antimetabolites|antimetabolites|mesh-ancestor
110722367|NCT01191892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110722368|NCT01293058|Naloxone|naloxone|mesh-list
110722369|NCT01293058|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110722370|NCT01293058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110722371|NCT01293058|Sensory System Agents|sensory system agents|mesh-ancestor
110722372|NCT01293058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110722373|NCT01195324|Canagliflozin|canagliflozin|mesh-list
110722374|NCT01195324|Warfarin|warfarin|mesh-list
110722375|NCT01195324|Anticoagulants|anticoagulants|mesh-ancestor
110722376|NCT01195324|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110722377|NCT01195324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110722378|NCT01195324|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110722379|NCT01195324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110722380|NCT01293136|Analgesics, Opioid|analgesics, opioid|mesh-list
110722381|NCT01293136|Narcotics|narcotics|mesh-ancestor
110722382|NCT01293136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110722383|NCT01293136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110722384|NCT01293136|Analgesics|analgesics|mesh-ancestor
110722385|NCT01293136|Sensory System Agents|sensory system agents|mesh-ancestor
110722386|NCT01293136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110722387|NCT01293292|Teriparatide|teriparatide|mesh-list
110722388|NCT01293292|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110722389|NCT01293292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110722390|NCT01293292|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110722391|NCT01195714|Ofatumumab|ofatumumab|mesh-list
110722392|NCT01195714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110722393|NCT01190722|Diclofenac|diclofenac|mesh-list
110722394|NCT01190722|Etoricoxib|etoricoxib|mesh-list
110722395|NCT01190722|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110722396|NCT01190722|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110722397|NCT01190722|Analgesics|analgesics|mesh-ancestor
110722398|NCT01190722|Sensory System Agents|sensory system agents|mesh-ancestor
110722399|NCT01190722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110722400|NCT01190722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110722401|NCT01190722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110722402|NCT01190722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110722403|NCT01190722|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110722404|NCT01190722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110722405|NCT01190722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110722406|NCT01190722|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110722407|NCT01196260|Capecitabine|capecitabine|mesh-list
110722408|NCT01196260|Oxaliplatin|oxaliplatin|mesh-list
110722409|NCT01196260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110722410|NCT01196260|Antimetabolites|antimetabolites|mesh-ancestor
110722411|NCT01196260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110722412|NCT01196260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110722414|NCT01192984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110722415|NCT05412082|Leucovorin|leucovorin|mesh-list
110722416|NCT05412082|Fluorouracil|fluorouracil|mesh-list
110722417|NCT05412082|Capecitabine|capecitabine|mesh-list
110722418|NCT05412082|Oxaliplatin|oxaliplatin|mesh-list
110722419|NCT05412082|Antimetabolites|antimetabolites|mesh-ancestor
110722420|NCT05412082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110722421|NCT05412082|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110722422|NCT05412082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110722423|NCT05412082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110722424|NCT05412082|Immunologic Factors|immunologic factors|mesh-ancestor
110722425|NCT05412082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110722426|NCT05412082|Antidotes|antidotes|mesh-ancestor
110722427|NCT05412082|Protective Agents|protective agents|mesh-ancestor
110722428|NCT05412082|Vitamin B Complex|vitamin b complex|mesh-ancestor
110722429|NCT05412082|Vitamins|vitamins|mesh-ancestor
110722430|NCT05412082|Micronutrients|micronutrients|mesh-ancestor
110722431|NCT01193296|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110722432|NCT01193296|Vildagliptin|vildagliptin|mesh-list
110722433|NCT01193296|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110722434|NCT01193296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110722435|NCT01193296|Incretins|incretins|mesh-ancestor
110722436|NCT01193296|Hormones|hormones|mesh-ancestor
110722437|NCT01193296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110722438|NCT01193296|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110722439|NCT01193296|Protease Inhibitors|protease inhibitors|mesh-ancestor
110722440|NCT01193296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110722441|NCT01193296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110722442|NCT01197040|Mycophenolic Acid|mycophenolic acid|mesh-list
110722443|NCT01197040|Prednisone|prednisone|mesh-list
110722444|NCT01197040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110722445|NCT01197040|Glucocorticoids|glucocorticoids|mesh-ancestor
110722446|NCT01197040|Hormones|hormones|mesh-ancestor
110722447|NCT01197040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110722448|NCT01197040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110722449|NCT01197040|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110722450|NCT01197040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110722451|NCT01197040|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110722452|NCT01197040|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110722453|NCT01197040|Antitubercular Agents|antitubercular agents|mesh-ancestor
110722454|NCT01197040|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110722455|NCT01197040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110722456|NCT01197040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110722457|NCT01197040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110722458|NCT01193452|Leucovorin|leucovorin|mesh-list
110722459|NCT01193452|Fluorouracil|fluorouracil|mesh-list
110722460|NCT01193452|Levoleucovorin|levoleucovorin|mesh-list
110722461|NCT01193452|Antimetabolites|antimetabolites|mesh-ancestor
110722462|NCT01193452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110722463|NCT01193452|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110722464|NCT01193452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110722465|NCT01193452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110722466|NCT01193452|Immunologic Factors|immunologic factors|mesh-ancestor
110722467|NCT01193452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110722468|NCT01193452|Antidotes|antidotes|mesh-ancestor
110722469|NCT01193452|Protective Agents|protective agents|mesh-ancestor
110722470|NCT01193452|Vitamin B Complex|vitamin b complex|mesh-ancestor
110722471|NCT01193452|Vitamins|vitamins|mesh-ancestor
110722472|NCT01193452|Micronutrients|micronutrients|mesh-ancestor
110722473|NCT05670886|Carbetocin|carbetocin|mesh-list
110722474|NCT05670886|Oxytocics|oxytocics|mesh-ancestor
110722475|NCT05670886|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110722476|NCT05670886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110722477|NCT01295632|3-(4-((4-chlorophenyl)sulfonyl)-4-(2,5-difluorophenyl)cyclohexyl)propanoic acid|3-(4-((4-chlorophenyl)sulfonyl)-4-(2,5-difluorophenyl)cyclohexyl)propanoic acid|mesh-list
110722478|NCT01295632|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
110722479|NCT01295632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110722480|NCT01295632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110722481|NCT03844594|Eptifibatide|eptifibatide|mesh-list
110722482|NCT03844594|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110722483|NCT03848182|Gemcitabine|gemcitabine|mesh-list
110722484|NCT03848182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110722485|NCT03848182|Antimetabolites|antimetabolites|mesh-ancestor
110722486|NCT03848182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110722487|NCT03848182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110722488|NCT00146328|Tipranavir|tipranavir|mesh-list
110722489|NCT00146328|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110722490|NCT00146328|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110722491|NCT00146328|Antiviral Agents|antiviral agents|mesh-ancestor
110722492|NCT00146328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110722493|NCT04916938|Psychotropic Drugs|psychotropic drugs|mesh-list
110722494|NCT01295866|Nitric Oxide|nitric oxide|mesh-list
110722495|NCT01295866|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110722496|NCT01295866|Autonomic Agents|autonomic agents|mesh-ancestor
110722497|NCT01295866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110722498|NCT01295866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110722499|NCT01295866|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110722500|NCT01295866|Respiratory System Agents|respiratory system agents|mesh-ancestor
110722501|NCT01295866|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110722502|NCT01295866|Antioxidants|antioxidants|mesh-ancestor
110722503|NCT01295866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110722504|NCT01295866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110722505|NCT01295866|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
110722506|NCT01295866|Vasodilator Agents|vasodilator agents|mesh-ancestor
110722507|NCT01295866|Gasotransmitters|gasotransmitters|mesh-ancestor
110722508|NCT01295866|Protective Agents|protective agents|mesh-ancestor
110722509|NCT03848104|Cefoxitin|cefoxitin|mesh-list
110722510|NCT03848104|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110722511|NCT03848104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110722512|NCT05670808|Epinephrine|epinephrine|mesh-list
110722513|NCT05670808|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110722514|NCT05670808|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110722515|NCT05670808|Adrenergic Agents|adrenergic agents|mesh-ancestor
110722516|NCT05670808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110722517|NCT05670808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110722518|NCT05670808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110722519|NCT05670808|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110722520|NCT05670808|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110722521|NCT05670808|Autonomic Agents|autonomic agents|mesh-ancestor
110722522|NCT05670808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110722523|NCT05670808|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110722524|NCT05670808|Respiratory System Agents|respiratory system agents|mesh-ancestor
110722525|NCT05670808|Mydriatics|mydriatics|mesh-ancestor
110722526|NCT05670808|Sympathomimetics|sympathomimetics|mesh-ancestor
110722527|NCT05670808|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110722528|NCT01197664|Fluorouracil|fluorouracil|mesh-list
110722529|NCT01197664|Antimetabolites|antimetabolites|mesh-ancestor
110722530|NCT01197664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110722531|NCT01197664|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110722532|NCT01197664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110722533|NCT01197664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110722534|NCT01197664|Immunologic Factors|immunologic factors|mesh-ancestor
110722535|NCT01197664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110722536|NCT01199458|Alfentanil|alfentanil|mesh-list
110722537|NCT01199458|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110722538|NCT01199458|Narcotics|narcotics|mesh-ancestor
110722539|NCT01199458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110722540|NCT01199458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110722541|NCT01199458|Analgesics|analgesics|mesh-ancestor
110722542|NCT01199458|Sensory System Agents|sensory system agents|mesh-ancestor
110722543|NCT01199458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110722544|NCT01199458|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110722545|NCT01199458|Anesthetics, General|anesthetics, general|mesh-ancestor
110722546|NCT01199458|Anesthetics|anesthetics|mesh-ancestor
110722547|NCT01199614|Parathyroid Hormone|parathyroid hormone|mesh-list
110722548|NCT01199614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110722549|NCT01199614|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110722551|NCT01588522|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110722552|NCT01588522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110722553|NCT01588522|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
110444113|NCT04232644|Sympathomimetics|sympathomimetics|mesh-ancestor
110722554|NCT01588522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110722555|NCT01588522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110722556|NCT01588522|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110722557|NCT01588522|Vitamins|vitamins|mesh-ancestor
110722558|NCT01588522|Micronutrients|micronutrients|mesh-ancestor
110722559|NCT01588522|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110440379|NCT02832778|Antitubercular Agents|antitubercular agents|mesh-ancestor
110722560|NCT01296178|Idarubicin|idarubicin|mesh-list
110722561|NCT01296178|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110722562|NCT01296178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110722563|NCT01296178|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110722564|NCT01296178|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110722565|NCT01296178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110722566|NCT01296178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110722567|NCT01296256|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110722568|NCT01296256|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110722569|NCT01296256|Alkylating Agents|alkylating agents|mesh-ancestor
110722570|NCT01296256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110722571|NCT01296256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110722572|NCT03731182|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110722573|NCT03731182|Immunologic Factors|immunologic factors|mesh-ancestor
110722574|NCT03731182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110722575|NCT03730012|Atezolizumab|atezolizumab|mesh-list
110722576|NCT03730012|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110722577|NCT03730012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110722578|NCT03730012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110722579|NCT03730012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110722580|NCT03844360|Anti-Infective Agents|anti-infective agents|mesh-list
110722581|NCT03844360|Bortezomib|bortezomib|mesh-list
110722582|NCT03844360|Imatinib Mesylate|imatinib mesylate|mesh-list
110722583|NCT03844360|Dasatinib|dasatinib|mesh-list
110722584|NCT03844360|Pegaspargase|pegaspargase|mesh-list
110722585|NCT03844360|Lenograstim|lenograstim|mesh-list
110722586|NCT03844360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110722587|NCT03844360|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110722588|NCT03844360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110722589|NCT03844360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110722590|NCT03844360|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110722591|NCT03844360|Immunologic Factors|immunologic factors|mesh-ancestor
110722592|NCT03844360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110722593|NCT01198054|Lenalidomide|lenalidomide|mesh-list
110722594|NCT01198054|Immunologic Factors|immunologic factors|mesh-ancestor
110722595|NCT01198054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110722596|NCT01198054|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110722597|NCT01198054|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110722598|NCT01198054|Growth Substances|growth substances|mesh-ancestor
110722599|NCT01198054|Growth Inhibitors|growth inhibitors|mesh-ancestor
110722600|NCT01198054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110722601|NCT01202032|Bevacizumab|bevacizumab|mesh-list
110722602|NCT01202032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110722603|NCT01202032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110722604|NCT01202032|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110722605|NCT01202032|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110722606|NCT01202032|Growth Substances|growth substances|mesh-ancestor
110722607|NCT01202032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110722608|NCT01202032|Growth Inhibitors|growth inhibitors|mesh-ancestor
110722609|NCT03844984|Lidocaine|lidocaine|mesh-list
110722610|NCT03844984|Midazolam|midazolam|mesh-list
110722611|NCT03844984|Ketamine|ketamine|mesh-list
110722612|NCT03844984|Anesthetics, Local|anesthetics, local|mesh-ancestor
110722613|NCT03844984|Anesthetics|anesthetics|mesh-ancestor
110722614|NCT03844984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110722615|NCT03844984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110722616|NCT03844984|Sensory System Agents|sensory system agents|mesh-ancestor
110722617|NCT03844984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110722618|NCT03844984|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110722619|NCT03844984|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110722620|NCT03844984|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110722621|NCT03844984|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110722622|NCT03844984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110722623|NCT03844984|Analgesics|analgesics|mesh-ancestor
110722624|NCT03844984|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110722625|NCT03844984|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110722626|NCT03844984|Anesthetics, General|anesthetics, general|mesh-ancestor
110140728|NCT02726711|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110722627|NCT03844984|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110722628|NCT03844984|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110722629|NCT03844984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110722630|NCT03844984|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110722631|NCT03844984|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110722632|NCT03844984|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110722633|NCT03844984|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110722634|NCT03844984|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110722635|NCT03844984|GABA Modulators|gaba modulators|mesh-ancestor
110722636|NCT03844984|GABA Agents|gaba agents|mesh-ancestor
110722637|NCT03842020|Amiodarone|amiodarone|mesh-list
110722638|NCT03842020|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110722639|NCT03842020|Vasodilator Agents|vasodilator agents|mesh-ancestor
110722640|NCT03842020|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
110722641|NCT03842020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110722642|NCT03842020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110722643|NCT03842020|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110722644|NCT03842020|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110722645|NCT03842020|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110722646|NCT03842020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110722647|NCT03842020|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110722648|NCT03842020|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110722649|NCT03842020|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110722650|NCT01200004|Lenalidomide|lenalidomide|mesh-list
110722651|NCT01200004|Azacitidine|azacitidine|mesh-list
110722652|NCT01200004|Immunologic Factors|immunologic factors|mesh-ancestor
110722653|NCT01200004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110722654|NCT01200004|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110722655|NCT01200004|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110722656|NCT01200004|Growth Substances|growth substances|mesh-ancestor
110722657|NCT01200004|Growth Inhibitors|growth inhibitors|mesh-ancestor
110722658|NCT01200004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110722659|NCT01200004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110722660|NCT01200004|Antimetabolites|antimetabolites|mesh-ancestor
110722661|NCT01200004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110722662|NCT01200004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110722663|NCT01198210|Dexamethasone|dexamethasone|mesh-list
110722664|NCT01198210|Dexamethasone acetate|dexamethasone acetate|mesh-list
110722665|NCT01198210|Ketamine|ketamine|mesh-list
110722666|NCT01198210|BB 1101|bb 1101|mesh-list
110722667|NCT01198210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110722668|NCT01198210|Antiemetics|antiemetics|mesh-ancestor
110722669|NCT01198210|Autonomic Agents|autonomic agents|mesh-ancestor
110722670|NCT01198210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110722671|NCT01198210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110722672|NCT01198210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110722673|NCT01198210|Glucocorticoids|glucocorticoids|mesh-ancestor
110722674|NCT01198210|Hormones|hormones|mesh-ancestor
110722675|NCT01198210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110722676|NCT01198210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110722677|NCT01198210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110722678|NCT01198210|Protease Inhibitors|protease inhibitors|mesh-ancestor
110722679|NCT01198210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110722680|NCT01198210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110722681|NCT01198210|Analgesics|analgesics|mesh-ancestor
110722682|NCT01198210|Sensory System Agents|sensory system agents|mesh-ancestor
110140757|NCT02649998|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110722683|NCT01198210|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110722684|NCT01198210|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110722685|NCT01198210|Anesthetics, General|anesthetics, general|mesh-ancestor
110722686|NCT01198210|Anesthetics|anesthetics|mesh-ancestor
110722687|NCT01198210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110722688|NCT01198210|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110722689|NCT01198210|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110722690|NCT01198210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110722691|NCT03843736|Drospirenone|drospirenone|mesh-list
110722692|NCT03843736|Contraceptive Agents|contraceptive agents|mesh-list
110722693|NCT03843736|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110722694|NCT03843736|Contraceptives, Oral|contraceptives, oral|mesh-list
110722695|NCT03843736|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
110722696|NCT03843736|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110722697|NCT03843736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110444119|NCT04232644|Adrenergic Agents|adrenergic agents|mesh-ancestor
110722698|NCT03843736|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110722699|NCT03843736|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110722700|NCT03843736|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110722701|NCT03843736|Estrogens|estrogens|mesh-ancestor
110722702|NCT03843736|Hormones|hormones|mesh-ancestor
110722703|NCT03843736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110722704|NCT03843736|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110722705|NCT03843736|Hormone Antagonists|hormone antagonists|mesh-ancestor
110722706|NCT03843736|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110722707|NCT03843736|Diuretics|diuretics|mesh-ancestor
110722708|NCT03843736|Natriuretic Agents|natriuretic agents|mesh-ancestor
110440525|NCT00889252|Ketotifen|ketotifen|mesh-list
110722709|NCT01200472|Apremilast|apremilast|mesh-list
110722710|NCT01200472|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110722711|NCT01200472|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110722712|NCT01200472|Analgesics|analgesics|mesh-ancestor
110722713|NCT01200472|Sensory System Agents|sensory system agents|mesh-ancestor
110722714|NCT01200472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110722715|NCT01200472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110722716|NCT01200472|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110722717|NCT01200472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110722718|NCT01200472|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
110722719|NCT01200472|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110722720|NCT01200472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110722721|NCT01200472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110722722|NCT04638790|Dexamethasone|dexamethasone|mesh-list
110722723|NCT04638790|Cyclophosphamide|cyclophosphamide|mesh-list
110722724|NCT04638790|Dacarbazine|dacarbazine|mesh-list
110722725|NCT04638790|Doxorubicin|doxorubicin|mesh-list
110722726|NCT04638790|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110722727|NCT04638790|Etoposide|etoposide|mesh-list
110722728|NCT04638790|Vincristine|vincristine|mesh-list
110722729|NCT04638790|Bleomycin|bleomycin|mesh-list
110722730|NCT04638790|Vinblastine|vinblastine|mesh-list
110722731|NCT04638790|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110722732|NCT04638790|Immunologic Factors|immunologic factors|mesh-ancestor
110722733|NCT04638790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110722734|NCT04638790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110722735|NCT04638790|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110722736|NCT04638790|Alkylating Agents|alkylating agents|mesh-ancestor
110722737|NCT04638790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110722738|NCT04638790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110722739|NCT04638790|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110722740|NCT04638790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110722741|NCT04638790|Antiemetics|antiemetics|mesh-ancestor
110722742|NCT04638790|Autonomic Agents|autonomic agents|mesh-ancestor
110722743|NCT04638790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110722744|NCT04638790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110722745|NCT04638790|Glucocorticoids|glucocorticoids|mesh-ancestor
110722746|NCT04638790|Hormones|hormones|mesh-ancestor
110722747|NCT04638790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110722748|NCT04638790|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110722749|NCT04638790|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110722750|NCT04638790|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110722751|NCT04638790|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110722752|NCT04638790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110722753|NCT04638790|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110722754|NCT04638790|Tubulin Modulators|tubulin modulators|mesh-ancestor
110722755|NCT04638790|Antimitotic Agents|antimitotic agents|mesh-ancestor
110722756|NCT04638790|Mitosis Modulators|mitosis modulators|mesh-ancestor
110722757|NCT01200706|Amoxicillin|amoxicillin|mesh-list
110722758|NCT01200706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110722759|NCT01200706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110722760|NCT01200784|Niacinamide|niacinamide|mesh-list
110722762|NCT01200784|Nicotinic Acids|nicotinic acids|mesh-list
110722763|NCT01200784|Vitamin B Complex|vitamin b complex|mesh-ancestor
110722764|NCT01200784|Vitamins|vitamins|mesh-ancestor
110722765|NCT01200784|Micronutrients|micronutrients|mesh-ancestor
110722766|NCT01200784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110722767|NCT01200784|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110722768|NCT01200784|Antimetabolites|antimetabolites|mesh-ancestor
110722769|NCT01200784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110722770|NCT01200784|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110722771|NCT01200784|Vasodilator Agents|vasodilator agents|mesh-ancestor
110722772|NCT03841474|Sertraline|sertraline|mesh-list
110722774|NCT03841474|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110722775|NCT03841474|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110722776|NCT03841474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110722777|NCT03841474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110722778|NCT03841474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110722779|NCT03841474|Serotonin Agents|serotonin agents|mesh-ancestor
110722780|NCT03841474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110722781|NCT03841474|Antidepressive Agents|antidepressive agents|mesh-ancestor
110722782|NCT03841474|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110722783|NCT01198444|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
110722784|NCT01198444|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110722785|NCT01198444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110722786|NCT05670184|Ethanol|ethanol|mesh-list
110722787|NCT05670184|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
110722788|NCT05670184|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110722789|NCT05670184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110722790|NCT05670184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110722791|NCT05670184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110722792|NCT05670184|Hallucinogens|hallucinogens|mesh-ancestor
110722793|NCT05670184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110722794|NCT05670184|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110722795|NCT05670184|Serotonin Agents|serotonin agents|mesh-ancestor
110722796|NCT05670184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110722797|NCT05670184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110722798|NCT05670184|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110722800|NCT05084248|Ergocalciferols|ergocalciferols|mesh-list
110722801|NCT05084248|Vitamins|vitamins|mesh-ancestor
110722802|NCT05084248|Micronutrients|micronutrients|mesh-ancestor
110722803|NCT05084248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110722804|NCT05084248|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110722805|NCT05084248|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110722806|NCT03842800|Ketamine|ketamine|mesh-list
110722807|NCT03842800|Analgesics|analgesics|mesh-ancestor
110722808|NCT03842800|Sensory System Agents|sensory system agents|mesh-ancestor
110722809|NCT03842800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110722810|NCT03842800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110722811|NCT03842800|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110722812|NCT03842800|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110722813|NCT03842800|Anesthetics, General|anesthetics, general|mesh-ancestor
110722814|NCT03842800|Anesthetics|anesthetics|mesh-ancestor
110722815|NCT03842800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110722816|NCT03842800|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110722817|NCT03842800|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110722818|NCT03842800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110722819|NCT03842800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110722820|NCT01202422|Pregabalin|pregabalin|mesh-list
110722821|NCT01202422|Analgesics|analgesics|mesh-ancestor
110722822|NCT01202422|Sensory System Agents|sensory system agents|mesh-ancestor
110722823|NCT01202422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110722824|NCT01202422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110722825|NCT01202422|Anticonvulsants|anticonvulsants|mesh-ancestor
110722826|NCT01202422|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110722827|NCT01202422|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110722828|NCT01202422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110722829|NCT01202422|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110722830|NCT01202422|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110722831|NCT01202422|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110722832|NCT01202422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110722833|NCT01202422|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110722834|NCT03892018|Paclitaxel|paclitaxel|mesh-list
110722835|NCT03892018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110722836|NCT03892018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110722837|NCT03892018|Tubulin Modulators|tubulin modulators|mesh-ancestor
110722838|NCT03892018|Antimitotic Agents|antimitotic agents|mesh-ancestor
110722839|NCT03892018|Mitosis Modulators|mitosis modulators|mesh-ancestor
110722840|NCT03892018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110722841|NCT01198912|Doxycycline|doxycycline|mesh-list
110722842|NCT01198912|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110722843|NCT01198912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110722844|NCT01198912|Antimalarials|antimalarials|mesh-ancestor
110722845|NCT01198912|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110722846|NCT01198912|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110722847|NCT03842488|Raltegravir Potassium|raltegravir potassium|mesh-list
110722849|NCT03842488|Cobicistat|cobicistat|mesh-list
110722850|NCT03842488|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
110722851|NCT03842488|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110722852|NCT03842488|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110722853|NCT03842488|Antiviral Agents|antiviral agents|mesh-ancestor
110722854|NCT03842488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110722855|NCT03842488|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110722856|NCT03842488|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110722857|NCT03842488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110722858|NCT03842488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110722859|NCT03842488|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110722860|NCT03842488|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110722861|NCT03842488|Protease Inhibitors|protease inhibitors|mesh-ancestor
110722862|NCT03842488|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110722863|NCT03842488|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110722864|NCT03842254|Epoetin Alfa|epoetin alfa|mesh-list
110722865|NCT03842254|Hematinics|hematinics|mesh-ancestor
110722866|NCT01201642|Prednisolone|prednisolone|mesh-list
110722867|NCT01201642|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110722868|NCT01201642|Glucocorticoids|glucocorticoids|mesh-ancestor
110722869|NCT01201642|Hormones|hormones|mesh-ancestor
110722870|NCT01201642|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110722871|NCT01201642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110722872|NCT01201642|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110722873|NCT01201642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110722874|NCT05004064|Rituximab|rituximab|mesh-list
110722875|NCT05004064|Acalabrutinib|acalabrutinib|mesh-list
110722876|NCT05004064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110722877|NCT05004064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110722878|NCT05004064|Immunologic Factors|immunologic factors|mesh-ancestor
110722879|NCT05004064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110722880|NCT05004064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110722881|NCT04982692|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
110722882|NCT04982692|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110722883|NCT04982692|Immunologic Factors|immunologic factors|mesh-ancestor
110722884|NCT04982692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110722885|NCT01202734|Methylphenidate|methylphenidate|mesh-list
110722886|NCT01202734|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110722887|NCT01202734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110722888|NCT01202734|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110722889|NCT01202734|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110722890|NCT01202734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110722891|NCT01202734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110722892|NCT01202734|Dopamine Agents|dopamine agents|mesh-ancestor
110722893|NCT01202734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110722894|NCT03173092|Dexamethasone|dexamethasone|mesh-list
110722895|NCT03173092|Lenalidomide|lenalidomide|mesh-list
110722896|NCT03173092|Ixazomib|ixazomib|mesh-list
110722897|NCT03173092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110722898|NCT03173092|Antiemetics|antiemetics|mesh-ancestor
110722899|NCT03173092|Autonomic Agents|autonomic agents|mesh-ancestor
110722900|NCT03173092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110722901|NCT03173092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110722902|NCT03173092|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110722903|NCT03173092|Glucocorticoids|glucocorticoids|mesh-ancestor
110722904|NCT03173092|Hormones|hormones|mesh-ancestor
110722905|NCT03173092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110722906|NCT03173092|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110722907|NCT03173092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110722908|NCT03173092|Immunologic Factors|immunologic factors|mesh-ancestor
110722909|NCT03173092|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110722910|NCT03173092|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110722911|NCT03173092|Growth Substances|growth substances|mesh-ancestor
110722912|NCT03173092|Growth Inhibitors|growth inhibitors|mesh-ancestor
110722913|NCT03173092|Protease Inhibitors|protease inhibitors|mesh-ancestor
110722914|NCT03173092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110722915|NCT03173092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110722916|NCT02966314|Omalizumab|omalizumab|mesh-list
110722917|NCT02966314|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110722918|NCT02966314|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110722919|NCT02966314|Respiratory System Agents|respiratory system agents|mesh-ancestor
110722920|NCT01203982|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110722921|NCT01203982|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110722922|NCT01203982|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110722923|NCT01203982|Antimetabolites|antimetabolites|mesh-ancestor
110722924|NCT01203982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110722925|NCT01203982|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110722926|NCT01203982|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110722927|NCT01203982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110722928|NCT01202890|Bevacizumab|bevacizumab|mesh-list
110722929|NCT01202890|Lenalidomide|lenalidomide|mesh-list
110722930|NCT01202890|Doxorubicin|doxorubicin|mesh-list
110722931|NCT01202890|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110722932|NCT01202890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110722933|NCT01202890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110440748|NCT05660278|Caseins|caseins|mesh-list
110722934|NCT01202890|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110722935|NCT01202890|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110722936|NCT01202890|Growth Substances|growth substances|mesh-ancestor
110722937|NCT01202890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110722938|NCT01202890|Growth Inhibitors|growth inhibitors|mesh-ancestor
110722939|NCT01202890|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110722940|NCT01202890|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110722941|NCT01202890|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110722942|NCT01202890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110722943|NCT01202890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110722944|NCT01202890|Immunologic Factors|immunologic factors|mesh-ancestor
110722945|NCT01199224|Veliparib|veliparib|mesh-list
110722946|NCT01199224|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110722947|NCT01199224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110722948|NCT01199224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110722949|NCT01199224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110722950|NCT01204138|Apremilast|apremilast|mesh-list
110722951|NCT01204138|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110722952|NCT01204138|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110722953|NCT01204138|Analgesics|analgesics|mesh-ancestor
110722954|NCT01204138|Sensory System Agents|sensory system agents|mesh-ancestor
110722955|NCT01204138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110722956|NCT01204138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110722957|NCT01204138|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110722958|NCT01204138|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110722959|NCT01204138|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
110722960|NCT01204138|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110722961|NCT01204138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110722962|NCT01204138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110722963|NCT02927392|Leuprolide|leuprolide|mesh-list
110722964|NCT02927392|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110722965|NCT02927392|Fertility Agents|fertility agents|mesh-ancestor
110722966|NCT02927392|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110722967|NCT02927392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110722968|NCT02927392|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110722969|NCT02927392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110722970|NCT01204372|Gemcitabine|gemcitabine|mesh-list
110722971|NCT01204372|Trastuzumab|trastuzumab|mesh-list
110722972|NCT01204372|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110722973|NCT01204372|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110722974|NCT01204372|Antimetabolites|antimetabolites|mesh-ancestor
110722975|NCT01204372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110722976|NCT01204372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110722977|NCT01204372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110722978|NCT01204372|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110722979|NCT01204372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110722980|NCT01204450|Sirolimus|sirolimus|mesh-list
110722981|NCT01204450|Temsirolimus|temsirolimus|mesh-list
110722982|NCT01204450|MTOR Inhibitors|mtor inhibitors|mesh-list
110722983|NCT01204450|Valproic Acid|valproic acid|mesh-list
110722984|NCT01204450|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110722985|NCT01204450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110722986|NCT01204450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110722987|NCT01204450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110722988|NCT01204450|Immunologic Factors|immunologic factors|mesh-ancestor
110722989|NCT01204450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110722990|NCT01204450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110722991|NCT01204450|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110722992|NCT01204450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110722993|NCT01204450|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110722994|NCT01204450|Antifungal Agents|antifungal agents|mesh-ancestor
110722995|NCT01204450|Anticonvulsants|anticonvulsants|mesh-ancestor
110722996|NCT01204450|GABA Agents|gaba agents|mesh-ancestor
110722997|NCT01204450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110722998|NCT01204450|Antimanic Agents|antimanic agents|mesh-ancestor
110722999|NCT01204450|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110723000|NCT01204450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110723001|NCT01204450|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110723002|NCT03834454|Bupivacaine|bupivacaine|mesh-list
110723003|NCT03834454|Anesthetics, Local|anesthetics, local|mesh-ancestor
110723004|NCT03834454|Anesthetics|anesthetics|mesh-ancestor
110723005|NCT03834454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110723006|NCT03834454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110723007|NCT03834454|Sensory System Agents|sensory system agents|mesh-ancestor
110440832|NCT00660751|Analgesics|analgesics|mesh-ancestor
110723008|NCT03834454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110723010|NCT02428270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110723011|NCT02428270|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110723012|NCT02428270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110723013|NCT02428270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110723014|NCT03829930|Entinostat|entinostat|mesh-list
110723015|NCT03829930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110723016|NCT03829930|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110723017|NCT03829930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110723018|NCT03829930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110723019|NCT01203202|Clomipramine|clomipramine|mesh-list
110723020|NCT01203202|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110723021|NCT01203202|Antidepressive Agents|antidepressive agents|mesh-ancestor
110723022|NCT01203202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110723023|NCT01203202|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110723024|NCT01203202|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110723025|NCT01203202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110723026|NCT01203202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110723027|NCT01203202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110723028|NCT01203202|Serotonin Agents|serotonin agents|mesh-ancestor
110723029|NCT01203202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110723030|NCT02047474|Leucovorin|leucovorin|mesh-list
110723031|NCT02047474|Fluorouracil|fluorouracil|mesh-list
110723032|NCT02047474|Oxaliplatin|oxaliplatin|mesh-list
110723033|NCT02047474|Irinotecan|irinotecan|mesh-list
110723034|NCT02047474|Calcium|calcium|mesh-list
110723035|NCT02047474|Levoleucovorin|levoleucovorin|mesh-list
110723036|NCT02047474|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110723037|NCT02047474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110723038|NCT02047474|Antimetabolites|antimetabolites|mesh-ancestor
110723039|NCT02047474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110723040|NCT02047474|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110723041|NCT02047474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110723042|NCT02047474|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110723043|NCT02047474|Immunologic Factors|immunologic factors|mesh-ancestor
110723044|NCT02047474|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110723045|NCT02047474|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110723046|NCT02047474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110723047|NCT02047474|Antidotes|antidotes|mesh-ancestor
110723048|NCT02047474|Protective Agents|protective agents|mesh-ancestor
110723049|NCT02047474|Vitamin B Complex|vitamin b complex|mesh-ancestor
110723050|NCT02047474|Vitamins|vitamins|mesh-ancestor
110723051|NCT02047474|Micronutrients|micronutrients|mesh-ancestor
110723052|NCT01298284|Propranolol|propranolol|mesh-list
110723053|NCT01298284|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110723054|NCT01298284|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110723055|NCT01298284|Adrenergic Agents|adrenergic agents|mesh-ancestor
110723056|NCT01298284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110723057|NCT01298284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110723058|NCT01298284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110723059|NCT01298284|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110723060|NCT01298284|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110723061|NCT01298284|Vasodilator Agents|vasodilator agents|mesh-ancestor
110723062|NCT01204840|Hormones|hormones|mesh-list
110723063|NCT01204840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110723064|NCT01204840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110723066|NCT01203358|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
110723067|NCT01203358|Respiratory System Agents|respiratory system agents|mesh-ancestor
110723068|NCT05669560|Hydrogen Peroxide|hydrogen peroxide|mesh-list
110723069|NCT05669560|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110723070|NCT05669560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110723071|NCT03832426|Ritonavir|ritonavir|mesh-list
110723072|NCT03832426|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110723073|NCT03832426|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110723074|NCT03832426|Protease Inhibitors|protease inhibitors|mesh-ancestor
110723075|NCT03832426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110723076|NCT03832426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110723077|NCT03832426|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110723078|NCT03832426|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110723079|NCT03832426|Antiviral Agents|antiviral agents|mesh-ancestor
110723080|NCT03832426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110723081|NCT03832426|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110723082|NCT03832426|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110723083|NCT03840070|Hyaluronic Acid|hyaluronic acid|mesh-list
110723084|NCT03840070|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110723085|NCT03840070|Immunologic Factors|immunologic factors|mesh-ancestor
110723086|NCT03840070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110723087|NCT03840070|Viscosupplements|viscosupplements|mesh-ancestor
110723088|NCT03840070|Protective Agents|protective agents|mesh-ancestor
110723089|NCT03272698|Ketamine|ketamine|mesh-list
110723090|NCT03272698|Analgesics|analgesics|mesh-ancestor
110723091|NCT03272698|Sensory System Agents|sensory system agents|mesh-ancestor
110723092|NCT03272698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110723093|NCT03272698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110723094|NCT03272698|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110723095|NCT03272698|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110723096|NCT03272698|Anesthetics, General|anesthetics, general|mesh-ancestor
110723097|NCT03272698|Anesthetics|anesthetics|mesh-ancestor
110723098|NCT03272698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110723099|NCT03272698|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110723100|NCT03272698|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110723101|NCT03272698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110723102|NCT03272698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110723103|NCT01203514|Epoetin Alfa|epoetin alfa|mesh-list
110723104|NCT01203514|Hematinics|hematinics|mesh-ancestor
110723105|NCT01204996|Paclitaxel|paclitaxel|mesh-list
110723106|NCT01204996|Docetaxel|docetaxel|mesh-list
110723107|NCT01204996|Carboplatin|carboplatin|mesh-list
110723108|NCT01204996|Gemcitabine|gemcitabine|mesh-list
110723109|NCT01204996|Doxorubicin|doxorubicin|mesh-list
110723110|NCT01204996|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110723111|NCT01204996|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110723112|NCT01204996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110723113|NCT01204996|Tubulin Modulators|tubulin modulators|mesh-ancestor
110723114|NCT01204996|Antimitotic Agents|antimitotic agents|mesh-ancestor
110723115|NCT01204996|Mitosis Modulators|mitosis modulators|mesh-ancestor
110723116|NCT01204996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110723117|NCT01204996|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110723118|NCT01204996|Antimetabolites|antimetabolites|mesh-ancestor
110723119|NCT01204996|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110723120|NCT01204996|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110723121|NCT01204996|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110723122|NCT01204996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110723123|NCT01297192|Solifenacin Succinate|solifenacin succinate|mesh-list
110723124|NCT01297192|Mirabegron|mirabegron|mesh-list
110723125|NCT01297192|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110723126|NCT01297192|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110723127|NCT01297192|Cholinergic Agents|cholinergic agents|mesh-ancestor
110723128|NCT01297192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110723129|NCT01297192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110723130|NCT01297192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110723131|NCT01297192|Urological Agents|urological agents|mesh-ancestor
110723132|NCT01297192|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
110723133|NCT01297192|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110723134|NCT01297192|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110723135|NCT01297192|Adrenergic Agents|adrenergic agents|mesh-ancestor
110723136|NCT01205074|Ethanol|ethanol|mesh-list
110723137|NCT01205074|Propranolol|propranolol|mesh-list
110723138|NCT01205074|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
110723139|NCT01205074|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110723140|NCT01205074|Adrenergic Agents|adrenergic agents|mesh-ancestor
110723141|NCT01205074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110723142|NCT01205074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110723143|NCT01205074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110723144|NCT01205074|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110723145|NCT01205074|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110723146|NCT01205074|Vasodilator Agents|vasodilator agents|mesh-ancestor
110723147|NCT01205074|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110723148|NCT01205074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110723149|NCT01205074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110723150|NCT05667376|Curcumin|curcumin|mesh-list
110723151|NCT05667376|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110723152|NCT05667376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110723153|NCT05667376|Analgesics|analgesics|mesh-ancestor
110723154|NCT05667376|Sensory System Agents|sensory system agents|mesh-ancestor
110723155|NCT05667376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110723156|NCT05667376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110440978|NCT00676039|Citalopram|citalopram|mesh-list
110723157|NCT05667376|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110723158|NCT05667376|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110723159|NCT05667376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110723160|NCT05667376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110723161|NCT05667376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110723162|NCT03722524|Amlodipine|amlodipine|mesh-list
110723163|NCT03722524|Perindopril|perindopril|mesh-list
110723164|NCT03722524|Indapamide|indapamide|mesh-list
110723165|NCT03722524|Indapamide, perindopril drug combination|indapamide, perindopril drug combination|mesh-list
110723166|NCT03722524|Diuretics|diuretics|mesh-list
110723167|NCT03722524|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
110723168|NCT03722524|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110723169|NCT03722524|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110723170|NCT03722524|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110723171|NCT03722524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110723172|NCT03722524|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110723173|NCT03722524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110444158|NCT02616367|Ropivacaine|ropivacaine|mesh-list
110723174|NCT03722524|Vasodilator Agents|vasodilator agents|mesh-ancestor
110723175|NCT03722524|Natriuretic Agents|natriuretic agents|mesh-ancestor
110723176|NCT03722524|Protease Inhibitors|protease inhibitors|mesh-ancestor
110723177|NCT03722524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110723178|NCT03722524|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110723179|NCT05667220|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110723180|NCT05667220|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110723181|NCT05667220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110723183|NCT05667220|Hormones|hormones|mesh-ancestor
110723184|NCT05667220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110723185|NCT05667220|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110723187|NCT05667220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110723188|NCT05667220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110723189|NCT01203592|Albuterol|albuterol|mesh-list
110723190|NCT01203592|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110723191|NCT01203592|Autonomic Agents|autonomic agents|mesh-ancestor
110723192|NCT01203592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110723193|NCT01203592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110723194|NCT01203592|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110723195|NCT01203592|Respiratory System Agents|respiratory system agents|mesh-ancestor
110723196|NCT01203592|Tocolytic Agents|tocolytic agents|mesh-ancestor
110723197|NCT01203592|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110723198|NCT01203592|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110723199|NCT01203592|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110723200|NCT01203592|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110723201|NCT01203592|Adrenergic Agents|adrenergic agents|mesh-ancestor
110723202|NCT01203592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110723203|NCT01203592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110723204|NCT05281276|Celecoxib|celecoxib|mesh-list
110723205|NCT05281276|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110723206|NCT05281276|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110723207|NCT05281276|Analgesics|analgesics|mesh-ancestor
110723208|NCT05281276|Sensory System Agents|sensory system agents|mesh-ancestor
110723209|NCT05281276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110723210|NCT05281276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110723211|NCT05281276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110723212|NCT05281276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110723213|NCT05281276|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110723214|NCT05281276|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110723215|NCT05281276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110723216|NCT05281276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110723217|NCT03829150|Amoxicillin|amoxicillin|mesh-list
110723218|NCT03829150|Metronidazole|metronidazole|mesh-list
110723219|NCT03829150|Clarithromycin|clarithromycin|mesh-list
110723220|NCT03829150|Dexlansoprazole|dexlansoprazole|mesh-list
110723221|NCT03829150|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110723222|NCT03829150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110723223|NCT03829150|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110723224|NCT03829150|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110723225|NCT03829150|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110723226|NCT03829150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110723227|NCT03829150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110723228|NCT03829150|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110723229|NCT03829150|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110723230|NCT03829150|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110723231|NCT03829150|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110723232|NCT03829150|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110723233|NCT01205464|Doxycycline|doxycycline|mesh-list
110723234|NCT01205464|Tetracycline|tetracycline|mesh-list
110723235|NCT01205464|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110723236|NCT01205464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110723237|NCT01205464|Antimalarials|antimalarials|mesh-ancestor
110723238|NCT01205464|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110723239|NCT01205464|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110723240|NCT01205464|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110723241|NCT01205464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110723242|NCT01205464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110723243|NCT03828838|177Lu-PSMA-617|177lu-psma-617|mesh-list
110723244|NCT03828838|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110723245|NCT03828838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110723246|NCT03819010|Letrozole|letrozole|mesh-list
110723247|NCT03819010|Palbociclib|palbociclib|mesh-list
110723248|NCT03819010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110723249|NCT03819010|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110723250|NCT03819010|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110723251|NCT03819010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110723252|NCT03819010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110723253|NCT03819010|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110723254|NCT03819010|Hormone Antagonists|hormone antagonists|mesh-ancestor
110862797|NCT01369290|Analgesics|analgesics|mesh-ancestor
110723255|NCT03819010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110723256|NCT03819010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110723257|NCT03819010|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110723258|NCT03818932|Acetaminophen|acetaminophen|mesh-list
110723259|NCT03818932|Celecoxib|celecoxib|mesh-list
110723260|NCT03818932|Ketorolac|ketorolac|mesh-list
110723261|NCT03818932|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
110723262|NCT03818932|Diazepam|diazepam|mesh-list
110723263|NCT03818932|Gabapentin|gabapentin|mesh-list
110723264|NCT03818932|Hydrocodone|hydrocodone|mesh-list
110723265|NCT03818932|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110723266|NCT03818932|Analgesics|analgesics|mesh-ancestor
110723267|NCT03818932|Sensory System Agents|sensory system agents|mesh-ancestor
110723268|NCT03818932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110723269|NCT03818932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110723270|NCT03818932|Antipyretics|antipyretics|mesh-ancestor
110723271|NCT03818932|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110723272|NCT03818932|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110723273|NCT03818932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110723274|NCT03818932|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110723275|NCT03818932|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110723276|NCT03818932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110723277|NCT03818932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110723278|NCT03818932|Anticonvulsants|anticonvulsants|mesh-ancestor
110723279|NCT03818932|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110723280|NCT03818932|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110723281|NCT03818932|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110723282|NCT03818932|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110723283|NCT03818932|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110723284|NCT03818932|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110723285|NCT03818932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110723286|NCT03818932|Antimanic Agents|antimanic agents|mesh-ancestor
110723287|NCT03818932|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110723288|NCT03818932|Narcotics|narcotics|mesh-ancestor
110723289|NCT03818932|Antitussive Agents|antitussive agents|mesh-ancestor
110723290|NCT03818932|Respiratory System Agents|respiratory system agents|mesh-ancestor
110723291|NCT03818932|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110723292|NCT03818932|Antiemetics|antiemetics|mesh-ancestor
110723293|NCT03818932|Autonomic Agents|autonomic agents|mesh-ancestor
110723294|NCT03818932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110723295|NCT03818932|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110723296|NCT03818932|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110723297|NCT03818932|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110723298|NCT03818932|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110723299|NCT03818932|Anesthetics, General|anesthetics, general|mesh-ancestor
110723300|NCT03818932|Anesthetics|anesthetics|mesh-ancestor
110723301|NCT03818932|GABA Modulators|gaba modulators|mesh-ancestor
110723302|NCT03818932|GABA Agents|gaba agents|mesh-ancestor
110723303|NCT01205932|Enoxaparin|enoxaparin|mesh-list
110723304|NCT01205932|Rivaroxaban|rivaroxaban|mesh-list
110723305|NCT01205932|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110723306|NCT01205932|Antithrombins|antithrombins|mesh-ancestor
110723307|NCT01205932|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110723308|NCT01205932|Protease Inhibitors|protease inhibitors|mesh-ancestor
110723309|NCT01205932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110723310|NCT01205932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110723311|NCT01205932|Anticoagulants|anticoagulants|mesh-ancestor
110723312|NCT01205932|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110723313|NCT01205932|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110723314|NCT01300780|Etoricoxib|etoricoxib|mesh-list
110723315|NCT01300780|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110723316|NCT01300780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110723317|NCT01300780|Analgesics|analgesics|mesh-ancestor
110723318|NCT01300780|Sensory System Agents|sensory system agents|mesh-ancestor
110723319|NCT01300780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110723320|NCT01300780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110723321|NCT01300780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110723322|NCT01300780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110723323|NCT01300780|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110723324|NCT01300780|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110723325|NCT01300780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110723326|NCT01300780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110723327|NCT01297816|Minocycline|minocycline|mesh-list
110723328|NCT01297816|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110723329|NCT01297816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110723330|NCT01297894|Colistin|colistin|mesh-list
110723331|NCT01297894|Fosfomycin|fosfomycin|mesh-list
110723332|NCT01297894|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110723333|NCT01297894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110723334|NCT05666362|Benoxinate|benoxinate|mesh-list
110723335|NCT05666362|Anesthetics, Local|anesthetics, local|mesh-ancestor
110723336|NCT05666362|Anesthetics|anesthetics|mesh-ancestor
110723337|NCT05666362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110723338|NCT05666362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110723339|NCT05666362|Sensory System Agents|sensory system agents|mesh-ancestor
110723340|NCT05666362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110723341|NCT01206010|Varenicline|varenicline|mesh-list
110723342|NCT01206010|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110723343|NCT01206010|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110723344|NCT01206010|Cholinergic Agents|cholinergic agents|mesh-ancestor
110723345|NCT01206010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110723346|NCT01206010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110723347|NCT01206010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110723348|NCT05665114|Cytarabine|cytarabine|mesh-list
110723349|NCT05665114|Cyclophosphamide|cyclophosphamide|mesh-list
110723350|NCT05665114|Fludarabine|fludarabine|mesh-list
110723351|NCT05665114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110723352|NCT05665114|Immunologic Factors|immunologic factors|mesh-ancestor
110723353|NCT05665114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110723354|NCT05665114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110723355|NCT05665114|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110723356|NCT05665114|Alkylating Agents|alkylating agents|mesh-ancestor
110723357|NCT05665114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110723358|NCT05665114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110723359|NCT05665114|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110723360|NCT05665114|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110723361|NCT05665114|Antimetabolites|antimetabolites|mesh-ancestor
110723362|NCT05665114|Antiviral Agents|antiviral agents|mesh-ancestor
110723363|NCT05665114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110723364|NCT05345002|Tretinoin|tretinoin|mesh-list
110723365|NCT05345002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110723366|NCT05345002|Keratolytic Agents|keratolytic agents|mesh-ancestor
110723367|NCT05345002|Dermatologic Agents|dermatologic agents|mesh-ancestor
110723368|NCT03814642|Esomeprazole|esomeprazole|mesh-list
110723369|NCT03814642|Clopidogrel|clopidogrel|mesh-list
110723370|NCT03814642|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110723371|NCT03814642|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110723372|NCT03814642|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110723373|NCT03814642|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110723374|NCT03814642|Purinergic Agents|purinergic agents|mesh-ancestor
110723375|NCT03814642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110723376|NCT03814642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110723377|NCT03814642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110723378|NCT03814642|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110723379|NCT03814642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110723380|NCT03814642|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110723381|NCT03814642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110723382|NCT01299220|Acitretin|acitretin|mesh-list
110723383|NCT01299220|Keratolytic Agents|keratolytic agents|mesh-ancestor
110723384|NCT01299220|Dermatologic Agents|dermatologic agents|mesh-ancestor
110723386|NCT03813784|Oxaliplatin|oxaliplatin|mesh-list
110723387|NCT03813784|Apatinib|apatinib|mesh-list
110444174|NCT04232722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110723388|NCT03813784|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110723389|NCT03813784|Antimetabolites|antimetabolites|mesh-ancestor
110723390|NCT03813784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110723391|NCT03813784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110723392|NCT03813784|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110723393|NCT03813784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110723394|NCT03818308|Sofosbuvir|sofosbuvir|mesh-list
110723395|NCT03818308|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
110723396|NCT03818308|Velpatasvir|velpatasvir|mesh-list
110723397|NCT03818308|Antiviral Agents|antiviral agents|mesh-ancestor
110723398|NCT03818308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110723399|NCT03827044|Avelumab|avelumab|mesh-list
110723400|NCT03827044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110723401|NCT03827044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110723402|NCT00145626|Cyclophosphamide|cyclophosphamide|mesh-list
110723403|NCT00145626|Melphalan|melphalan|mesh-list
110723404|NCT00145626|Thiotepa|thiotepa|mesh-list
110723405|NCT00145626|Fludarabine|fludarabine|mesh-list
110723406|NCT00145626|Antibodies|antibodies|mesh-list
110723407|NCT00145626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110723408|NCT00145626|Immunologic Factors|immunologic factors|mesh-ancestor
110723409|NCT00145626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110723410|NCT00145626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110723411|NCT00145626|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110723412|NCT00145626|Alkylating Agents|alkylating agents|mesh-ancestor
110723413|NCT00145626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110723414|NCT00145626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110723415|NCT00145626|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110723416|NCT01206946|Betamethasone|betamethasone|mesh-list
110723417|NCT01206946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110723418|NCT01206946|Glucocorticoids|glucocorticoids|mesh-ancestor
110723419|NCT01206946|Hormones|hormones|mesh-ancestor
110723420|NCT01206946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110723421|NCT01206946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110723422|NCT01206946|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110723423|NCT01206946|Respiratory System Agents|respiratory system agents|mesh-ancestor
110723424|NCT03813940|Vaccines|vaccines|mesh-list
110723425|NCT03813940|Immunologic Factors|immunologic factors|mesh-ancestor
110723426|NCT03813940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110723427|NCT03967938|Olaparib|olaparib|mesh-list
110723428|NCT03967938|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110723429|NCT03967938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110723430|NCT03967938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110723431|NCT03967938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110723432|NCT01299298|Mipomersen|mipomersen|mesh-list
110723433|NCT01299298|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110723434|NCT01299298|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110723435|NCT01299298|Antimetabolites|antimetabolites|mesh-ancestor
110723436|NCT01299298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110723437|NCT01299298|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110723438|NCT00153062|Telmisartan|telmisartan|mesh-list
110723439|NCT00153062|Clopidogrel|clopidogrel|mesh-list
110723440|NCT00153062|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
110723441|NCT00153062|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110723442|NCT00153062|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110723443|NCT00153062|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110723444|NCT00153062|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110723445|NCT00153062|Purinergic Agents|purinergic agents|mesh-ancestor
110723446|NCT00153062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110141145|NCT02010970|Vasodilator Agents|vasodilator agents|mesh-ancestor
110723447|NCT00153062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110723448|NCT00153062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110723449|NCT00153062|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110723450|NCT00153062|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110723451|NCT00153062|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110723452|NCT00145470|Asenapine|asenapine|mesh-list
110723453|NCT00145470|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110723454|NCT00145470|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110723455|NCT00145470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110723456|NCT00145470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110723457|NCT00145470|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110723458|NCT03813394|Bevacizumab|bevacizumab|mesh-list
110723459|NCT03813394|Pembrolizumab|pembrolizumab|mesh-list
110723460|NCT03813394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110723461|NCT03813394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110723462|NCT03813394|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110723463|NCT03813394|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110723464|NCT03813394|Growth Substances|growth substances|mesh-ancestor
110723465|NCT03813394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110723466|NCT03813394|Growth Inhibitors|growth inhibitors|mesh-ancestor
110723467|NCT03813394|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110723468|NCT03813394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110723469|NCT03813316|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110723470|NCT03813316|Ertugliflozin|ertugliflozin|mesh-list
110723471|NCT03813316|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
110723472|NCT03813316|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
110723473|NCT03813316|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110723474|NCT03813316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110723475|NCT03813316|Incretins|incretins|mesh-ancestor
110723476|NCT03813316|Hormones|hormones|mesh-ancestor
110723477|NCT03813316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110723478|NCT03813316|Protease Inhibitors|protease inhibitors|mesh-ancestor
110723479|NCT03813316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110723480|NCT03813316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110723481|NCT01301248|Cisplatin|cisplatin|mesh-list
110723482|NCT01301248|Cetuximab|cetuximab|mesh-list
110723483|NCT01301248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110723484|NCT01301248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110723485|NCT03817684|BPN14770|bpn14770|mesh-list
110723486|NCT03817684|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
110723487|NCT03817684|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110723488|NCT03817684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110723489|NCT03817684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110723490|NCT01302028|Ipragliflozin|ipragliflozin|mesh-list
110723491|NCT01302028|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110723492|NCT01302028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110723493|NCT01302028|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110723494|NCT01302028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110723495|NCT01302106|Clofarabine|clofarabine|mesh-list
110723496|NCT01302106|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110723497|NCT01302106|Antimetabolites|antimetabolites|mesh-ancestor
110723498|NCT01302106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110723499|NCT01302106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110723500|NCT00152516|Levetiracetam|levetiracetam|mesh-list
110723501|NCT00152516|Anticonvulsants|anticonvulsants|mesh-ancestor
110723502|NCT00152516|Nootropic Agents|nootropic agents|mesh-ancestor
110723503|NCT00145158|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
110723504|NCT00145158|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110723505|NCT00145158|Immunologic Factors|immunologic factors|mesh-ancestor
110723506|NCT00145158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110723507|NCT05624008|Methamphetamine|methamphetamine|mesh-list
110723508|NCT05624008|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110723509|NCT05624008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110723510|NCT05624008|Sympathomimetics|sympathomimetics|mesh-ancestor
110141146|NCT02011126|Imetelstat|imetelstat|mesh-list
110723511|NCT05624008|Autonomic Agents|autonomic agents|mesh-ancestor
110723512|NCT05624008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110723513|NCT05624008|Dopamine Agents|dopamine agents|mesh-ancestor
110723514|NCT05624008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110723515|NCT05624008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110723516|NCT05624008|Adrenergic Agents|adrenergic agents|mesh-ancestor
110723517|NCT05624008|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110723518|NCT05624008|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110723519|NCT05624008|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110723520|NCT05624008|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110723521|NCT05623852|Fucoidan|fucoidan|mesh-list
110723522|NCT05623852|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110723523|NCT05623852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110723524|NCT05623852|Anticoagulants|anticoagulants|mesh-ancestor
110723525|NCT05623852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110723526|NCT01302340|Dronabinol|dronabinol|mesh-list
110723527|NCT01302340|Hallucinogens|hallucinogens|mesh-ancestor
110723528|NCT01302340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110723529|NCT01302340|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110723530|NCT01302340|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110723531|NCT01302340|Analgesics|analgesics|mesh-ancestor
110444176|NCT02622685|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
110723532|NCT01302340|Sensory System Agents|sensory system agents|mesh-ancestor
110723533|NCT01302340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110723534|NCT01302340|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
110862818|NCT04359147|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110723535|NCT01302340|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110723536|NCT01302340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110723537|NCT01302340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110723539|NCT01302340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110723540|NCT00150800|Brivaracetam|brivaracetam|mesh-list
110723541|NCT00150800|Anticonvulsants|anticonvulsants|mesh-ancestor
110723542|NCT03812770|Leucovorin|leucovorin|mesh-list
110723543|NCT03812770|Fluorouracil|fluorouracil|mesh-list
110723544|NCT03812770|Oxaliplatin|oxaliplatin|mesh-list
110723545|NCT03812770|Sorafenib|sorafenib|mesh-list
110723546|NCT03812770|Antimetabolites|antimetabolites|mesh-ancestor
110723547|NCT03812770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110723548|NCT03812770|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110723549|NCT03812770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110723550|NCT03812770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110723551|NCT03812770|Immunologic Factors|immunologic factors|mesh-ancestor
110723552|NCT03812770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110723553|NCT03812770|Antidotes|antidotes|mesh-ancestor
110723554|NCT03812770|Protective Agents|protective agents|mesh-ancestor
110723555|NCT03812770|Vitamin B Complex|vitamin b complex|mesh-ancestor
110723556|NCT03812770|Vitamins|vitamins|mesh-ancestor
110723557|NCT03812770|Micronutrients|micronutrients|mesh-ancestor
110723558|NCT03812770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110723559|NCT03812770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110723560|NCT00144300|Pramipexole|pramipexole|mesh-list
110723561|NCT00144300|Antioxidants|antioxidants|mesh-ancestor
110723562|NCT00144300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110723563|NCT00144300|Protective Agents|protective agents|mesh-ancestor
110723564|NCT00144300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110723565|NCT00144300|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110723566|NCT00144300|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110723567|NCT00144300|Dopamine Agonists|dopamine agonists|mesh-ancestor
110723568|NCT00144300|Dopamine Agents|dopamine agents|mesh-ancestor
110723569|NCT00144300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110723570|NCT00149630|Disulfiram|disulfiram|mesh-list
110723571|NCT00149630|Methadone|methadone|mesh-list
110723572|NCT00149630|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110723573|NCT00149630|Narcotics|narcotics|mesh-ancestor
110723574|NCT00149630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110723575|NCT00149630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110723576|NCT00149630|Analgesics|analgesics|mesh-ancestor
110723577|NCT00149630|Sensory System Agents|sensory system agents|mesh-ancestor
110723578|NCT00149630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110723579|NCT00149630|Antitussive Agents|antitussive agents|mesh-ancestor
110723580|NCT00149630|Respiratory System Agents|respiratory system agents|mesh-ancestor
110723581|NCT00149630|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110723582|NCT00149630|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
110723583|NCT00149630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110723584|NCT00149630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110723585|NCT01302496|Ipilimumab|ipilimumab|mesh-list
110723586|NCT01302496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110723587|NCT01302496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110723588|NCT01302496|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110723589|NCT01302496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110723590|NCT00127842|Etanercept|etanercept|mesh-list
110723591|NCT00127842|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110723592|NCT00127842|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110723593|NCT00127842|Analgesics|analgesics|mesh-ancestor
110723594|NCT00127842|Sensory System Agents|sensory system agents|mesh-ancestor
110723595|NCT00127842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110723596|NCT00127842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110723597|NCT00127842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110723598|NCT00127842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110723599|NCT00127842|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110723600|NCT00127842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110723601|NCT00127842|Immunologic Factors|immunologic factors|mesh-ancestor
110723603|NCT01075802|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110723604|NCT01075802|Hormone Antagonists|hormone antagonists|mesh-ancestor
110723605|NCT01075802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110723606|NCT01075802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110723607|NCT01075802|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110723608|NCT01075802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110723609|NCT01075802|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110723610|NCT01075802|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110723611|NCT01075802|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110723612|NCT03816592|Analgesics, Opioid|analgesics, opioid|mesh-list
110723614|NCT03816592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110723615|NCT03816592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110723616|NCT03816592|Narcotics|narcotics|mesh-ancestor
110723617|NCT03816592|Analgesics|analgesics|mesh-ancestor
110723618|NCT03816592|Sensory System Agents|sensory system agents|mesh-ancestor
110723619|NCT03816592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110723620|NCT01078038|Sirolimus|sirolimus|mesh-list
110723621|NCT01078038|Everolimus|everolimus|mesh-list
110723622|NCT01078038|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110723623|NCT01078038|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110723624|NCT01078038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110723625|NCT01078038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110723626|NCT01078038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110723627|NCT01078038|Immunologic Factors|immunologic factors|mesh-ancestor
110723628|NCT01078038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110723629|NCT01078038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110723630|NCT01078038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110723631|NCT01078038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110723632|NCT01078038|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110723633|NCT01078038|Antifungal Agents|antifungal agents|mesh-ancestor
110723634|NCT00223496|Aripiprazole|aripiprazole|mesh-list
110723635|NCT00223496|Antidepressive Agents|antidepressive agents|mesh-ancestor
110723636|NCT00223496|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110723637|NCT00223496|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110723638|NCT00223496|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110723639|NCT00223496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110141173|NCT02011620|Isosorbide|isosorbide|mesh-list
110723640|NCT00223496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110723641|NCT00223496|Dopamine Agonists|dopamine agonists|mesh-ancestor
110723642|NCT00223496|Dopamine Agents|dopamine agents|mesh-ancestor
110723643|NCT00223496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110723644|NCT00223496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110723645|NCT00223496|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110723646|NCT00223496|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110723647|NCT00223496|Serotonin Agents|serotonin agents|mesh-ancestor
110723648|NCT00223496|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110723649|NCT00223496|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110723650|NCT00223496|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110723651|NCT00223496|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110723652|NCT02531412|Spironolactone|spironolactone|mesh-list
110723653|NCT02531412|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110723654|NCT02531412|Hormone Antagonists|hormone antagonists|mesh-ancestor
110723655|NCT02531412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110723656|NCT02531412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110723657|NCT02531412|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110723658|NCT02531412|Diuretics|diuretics|mesh-ancestor
110723659|NCT02531412|Natriuretic Agents|natriuretic agents|mesh-ancestor
110723660|NCT00126672|Sirolimus|sirolimus|mesh-list
110723661|NCT00126672|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110723662|NCT00126672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110862831|NCT01369368|GABA Agents|gaba agents|mesh-ancestor
110723663|NCT00126672|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110723664|NCT00126672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110723665|NCT00126672|Antifungal Agents|antifungal agents|mesh-ancestor
110723666|NCT00126672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110723667|NCT00126672|Immunologic Factors|immunologic factors|mesh-ancestor
110723668|NCT00126672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110723669|NCT00145574|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
110723670|NCT00145574|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110723671|NCT00145574|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110723672|NCT00145574|Antimetabolites|antimetabolites|mesh-ancestor
110723673|NCT00145574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110723674|NCT00145574|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110723675|NCT05034562|Edetic Acid|edetic acid|mesh-list
110723676|NCT05034562|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
110723677|NCT05034562|Chelating Agents|chelating agents|mesh-ancestor
110723678|NCT05034562|Sequestering Agents|sequestering agents|mesh-ancestor
110723679|NCT05034562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110723680|NCT05034562|Anticoagulants|anticoagulants|mesh-ancestor
110723681|NCT05034562|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110723682|NCT05034562|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110723684|NCT00145496|Asenapine|asenapine|mesh-list
110723685|NCT00145496|Antiemetics|antiemetics|mesh-ancestor
110723686|NCT00145496|Autonomic Agents|autonomic agents|mesh-ancestor
110723687|NCT00145496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110723688|NCT00145496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110723689|NCT00145496|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110723690|NCT00145496|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110723691|NCT00145496|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110723692|NCT00145496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110723693|NCT00145496|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110723694|NCT00145496|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110723695|NCT00145496|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110723696|NCT00145496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110723697|NCT00145496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110723698|NCT00145496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110723699|NCT00145496|Serotonin Agents|serotonin agents|mesh-ancestor
110723700|NCT01299922|Cyclosporine|cyclosporine|mesh-list
110723701|NCT01299922|Mycophenolic Acid|mycophenolic acid|mesh-list
110723702|NCT01299922|Cyclosporins|cyclosporins|mesh-list
110723703|NCT01299922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110723704|NCT01299922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110723705|NCT01299922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110723706|NCT01299922|Immunologic Factors|immunologic factors|mesh-ancestor
110723707|NCT01299922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110723708|NCT01299922|Antifungal Agents|antifungal agents|mesh-ancestor
110723709|NCT01299922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110723710|NCT01299922|Dermatologic Agents|dermatologic agents|mesh-ancestor
110723711|NCT01299922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110723712|NCT01299922|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110723713|NCT01299922|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110723714|NCT01299922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110723715|NCT01299922|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110723716|NCT01299922|Antitubercular Agents|antitubercular agents|mesh-ancestor
110723717|NCT01299922|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110723718|NCT05030818|Aspirin|aspirin|mesh-list
110723719|NCT05030818|Ramipril|ramipril|mesh-list
110723720|NCT05030818|Atorvastatin|atorvastatin|mesh-list
110862843|NCT01369602|Nicotinic Acids|nicotinic acids|mesh-list
110723721|NCT05030818|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110723722|NCT05030818|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110723723|NCT05030818|Antimetabolites|antimetabolites|mesh-ancestor
110723724|NCT05030818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110723725|NCT05030818|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110723726|NCT05030818|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110723727|NCT05030818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110723728|NCT05030818|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110723729|NCT05030818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110723730|NCT05030818|Analgesics|analgesics|mesh-ancestor
110723731|NCT05030818|Sensory System Agents|sensory system agents|mesh-ancestor
110723732|NCT05030818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110723733|NCT05030818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110723734|NCT05030818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110723735|NCT05030818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110723736|NCT05030818|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110723737|NCT05030818|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110723738|NCT05030818|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110723739|NCT05030818|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110723740|NCT05030818|Antipyretics|antipyretics|mesh-ancestor
110723741|NCT05030818|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110723742|NCT05030818|Protease Inhibitors|protease inhibitors|mesh-ancestor
110723743|NCT05030818|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110723744|NCT01582022|Bupivacaine|bupivacaine|mesh-list
110723745|NCT01582022|Anesthetics, Local|anesthetics, local|mesh-ancestor
110723746|NCT01582022|Anesthetics|anesthetics|mesh-ancestor
110723747|NCT01582022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110723748|NCT01582022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110723749|NCT01582022|Sensory System Agents|sensory system agents|mesh-ancestor
110723750|NCT01582022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110723751|NCT01582412|Isavuconazole|isavuconazole|mesh-list
110723752|NCT01582412|Digoxin|digoxin|mesh-list
110723753|NCT01582412|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110723754|NCT01582412|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110723755|NCT01582412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110723756|NCT01582412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110723757|NCT01582412|Protective Agents|protective agents|mesh-ancestor
110441573|NCT02821858|Odalasvir|odalasvir|mesh-list
110723758|NCT01582412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110723759|NCT01582412|Antifungal Agents|antifungal agents|mesh-ancestor
110723760|NCT01582412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110723761|NCT00255164|Dexlansoprazole|dexlansoprazole|mesh-list
110723762|NCT00255164|Lansoprazole|lansoprazole|mesh-list
110723763|NCT00255164|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110723764|NCT00255164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110723765|NCT00255164|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110723766|NCT00255164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110723767|NCT00255164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110723768|NCT01300156|Oxaliplatin|oxaliplatin|mesh-list
110580378|NCT00732069|Ramipril|ramipril|mesh-list
110723769|NCT01300156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110723770|NCT00126594|Interferons|interferons|mesh-list
110723771|NCT00126594|Interferon-alpha|interferon-alpha|mesh-list
110723772|NCT00126594|Interferon alpha-2|interferon alpha-2|mesh-list
110723773|NCT00126594|Sorafenib|sorafenib|mesh-list
110723774|NCT00126594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110723775|NCT00126594|Antiviral Agents|antiviral agents|mesh-ancestor
110723776|NCT00126594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110723777|NCT00126594|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110723778|NCT00126594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110723779|NCT00126594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110723780|NCT00126594|Immunologic Factors|immunologic factors|mesh-ancestor
110723781|NCT00126594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110723782|NCT01080456|Tacrolimus|tacrolimus|mesh-list
110723783|NCT01080456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110723784|NCT01080456|Immunologic Factors|immunologic factors|mesh-ancestor
110723785|NCT01080456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110723786|NCT01080456|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110723787|NCT01080456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110723788|NCT01080456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110723789|NCT03811054|Apatinib|apatinib|mesh-list
110723790|NCT03811054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110723791|NCT03811054|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110723792|NCT03811054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110723793|NCT03811054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110723794|NCT00126438|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
110723795|NCT00126438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110723796|NCT00126438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110723797|NCT00126438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110723798|NCT00126438|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110723799|NCT01075854|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
110723800|NCT01075854|Hormones|hormones|mesh-ancestor
110723801|NCT01075854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110723802|NCT01075854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110723803|NCT03967392|Lidocaine|lidocaine|mesh-list
110723804|NCT03967392|Anesthetics, Local|anesthetics, local|mesh-ancestor
110723805|NCT03967392|Anesthetics|anesthetics|mesh-ancestor
110723806|NCT03967392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110723807|NCT03967392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110723808|NCT03967392|Sensory System Agents|sensory system agents|mesh-ancestor
110723809|NCT03967392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110723810|NCT03967392|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110723811|NCT03967392|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110723812|NCT03967392|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110723813|NCT03967392|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110723814|NCT03967392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110723815|NCT04898764|Mometasone Furoate|mometasone furoate|mesh-list
110723816|NCT04898764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110723817|NCT04898764|Dermatologic Agents|dermatologic agents|mesh-ancestor
110723818|NCT04898764|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110723819|NCT00142584|Metoprolol|metoprolol|mesh-list
110723820|NCT00142584|Nebivolol|nebivolol|mesh-list
110723821|NCT00142584|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110723822|NCT00142584|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110723823|NCT00142584|Sympatholytics|sympatholytics|mesh-ancestor
110723824|NCT00142584|Autonomic Agents|autonomic agents|mesh-ancestor
110723825|NCT00142584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110723826|NCT00142584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110723827|NCT00142584|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110723828|NCT00142584|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110723829|NCT00142584|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110723831|NCT00142584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110441648|NCT02690506|Pregabalin|pregabalin|mesh-list
110862882|NCT03252418|Micronutrients|micronutrients|mesh-ancestor
110723832|NCT00142584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110723834|NCT00142584|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
110723835|NCT00142584|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110723836|NCT00142584|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110723837|NCT04848064|Cyclophosphamide|cyclophosphamide|mesh-list
110723838|NCT04848064|Fludarabine|fludarabine|mesh-list
110723839|NCT04848064|Mogamulizumab|mogamulizumab|mesh-list
110723840|NCT04848064|Immunoglobulins|immunoglobulins|mesh-list
110723841|NCT04848064|Immunoglobulin G|immunoglobulin g|mesh-list
110723842|NCT04848064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110723843|NCT04848064|Immunologic Factors|immunologic factors|mesh-ancestor
110723844|NCT04848064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110723845|NCT04848064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110723846|NCT04848064|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110723847|NCT04848064|Alkylating Agents|alkylating agents|mesh-ancestor
110723848|NCT04848064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110723849|NCT04848064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110723850|NCT04848064|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110723851|NCT03816046|Botulinum Toxins|botulinum toxins|mesh-list
110723852|NCT03816046|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110723853|NCT03816046|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110723854|NCT03816046|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110141228|NCT02011828|Vitamin D|vitamin d|mesh-list
110723855|NCT03816046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110723856|NCT03816046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110723857|NCT03816046|Cholinergic Agents|cholinergic agents|mesh-ancestor
110723858|NCT03816046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110723859|NCT03816046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110723860|NCT03816046|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110723861|NCT03816046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110723862|NCT01080534|Tacrolimus|tacrolimus|mesh-list
110723863|NCT01080534|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110723864|NCT01080534|Immunologic Factors|immunologic factors|mesh-ancestor
110723865|NCT01080534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110723866|NCT01080534|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110723867|NCT01080534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110723868|NCT01080534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110723869|NCT00125190|Mecasermin|mecasermin|mesh-list
110723870|NCT00125190|Growth Substances|growth substances|mesh-ancestor
110723871|NCT00125190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110723872|NCT00141726|Etanercept|etanercept|mesh-list
110723873|NCT00141726|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110723874|NCT00141726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110723875|NCT00141726|Analgesics|analgesics|mesh-ancestor
110723876|NCT00141726|Sensory System Agents|sensory system agents|mesh-ancestor
110723877|NCT00141726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110723878|NCT00141726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110723879|NCT00141726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110723880|NCT00141726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110723881|NCT00141726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110723882|NCT00141726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110723883|NCT00141726|Immunologic Factors|immunologic factors|mesh-ancestor
110723884|NCT03967548|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110723885|NCT03967548|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110723886|NCT01301716|Paclitaxel|paclitaxel|mesh-list
110723887|NCT01301716|Bevacizumab|bevacizumab|mesh-list
110723888|NCT01301716|Carboplatin|carboplatin|mesh-list
110723889|NCT01301716|Pemetrexed|pemetrexed|mesh-list
110723890|NCT01301716|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110723891|NCT01301716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110723892|NCT01301716|Tubulin Modulators|tubulin modulators|mesh-ancestor
110723893|NCT01301716|Antimitotic Agents|antimitotic agents|mesh-ancestor
110723894|NCT01301716|Mitosis Modulators|mitosis modulators|mesh-ancestor
110723895|NCT01301716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110723896|NCT01301716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110723897|NCT01301716|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110723898|NCT01301716|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110723899|NCT01301716|Growth Substances|growth substances|mesh-ancestor
110723900|NCT01301716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110723901|NCT01301716|Growth Inhibitors|growth inhibitors|mesh-ancestor
110723902|NCT01301716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110723903|NCT01301716|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110723904|NCT01301716|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110723906|NCT01303042|Isophane insulin, insulin lispro drug combination 50:50|isophane insulin, insulin lispro drug combination 50:50|mesh-list
110723907|NCT01303042|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110723908|NCT01303042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110723910|NCT01300312|Eperisone|eperisone|mesh-list
110723911|NCT01300312|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110723912|NCT01300312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110723913|NCT01300312|Analgesics|analgesics|mesh-ancestor
110723914|NCT01300312|Sensory System Agents|sensory system agents|mesh-ancestor
110862943|NCT03982485|Paclitaxel|paclitaxel|mesh-list
110723915|NCT01300312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110723916|NCT01300312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110723917|NCT01300312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110723918|NCT01300312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110723919|NCT01300312|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110723920|NCT01300312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110723921|NCT01300312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110723923|NCT01300312|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110723924|NCT01300312|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110723925|NCT01300312|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110723926|NCT01300312|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110723927|NCT01300312|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110723928|NCT01300312|Parasympatholytics|parasympatholytics|mesh-ancestor
110723929|NCT01300312|Autonomic Agents|autonomic agents|mesh-ancestor
110723930|NCT01300312|Vasodilator Agents|vasodilator agents|mesh-ancestor
110723931|NCT01567384|Pemetrexed|pemetrexed|mesh-list
110723932|NCT01567384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110723933|NCT01567384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110723934|NCT01567384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110723935|NCT01567384|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110723936|NCT01567384|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110723937|NCT01080612|Pregabalin|pregabalin|mesh-list
110723938|NCT01080612|Analgesics|analgesics|mesh-ancestor
110723939|NCT01080612|Sensory System Agents|sensory system agents|mesh-ancestor
110723940|NCT01080612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110723941|NCT01080612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110723942|NCT01080612|Anticonvulsants|anticonvulsants|mesh-ancestor
110723943|NCT01080612|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110723944|NCT01080612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110723945|NCT01080612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110723946|NCT01080612|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110723947|NCT01080612|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110723948|NCT01080612|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110723949|NCT01080612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110723950|NCT01080612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110723951|NCT03815344|Misoprostol|misoprostol|mesh-list
110723952|NCT03815344|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110723953|NCT03815344|Abortifacient Agents|abortifacient agents|mesh-ancestor
110723954|NCT03815344|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110723955|NCT03815344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110723956|NCT03815344|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110723957|NCT03815344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110723958|NCT03815344|Oxytocics|oxytocics|mesh-ancestor
110723959|NCT03819790|Insulin|insulin|mesh-list
110723960|NCT03819790|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110723961|NCT03819790|Metformin|metformin|mesh-list
110723962|NCT03819790|Insulin Glargine|insulin glargine|mesh-list
110723963|NCT03819790|Lixisenatide|lixisenatide|mesh-list
110723964|NCT03819790|Gliclazide|gliclazide|mesh-list
110723965|NCT03819790|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110723966|NCT03819790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110723967|NCT01560442|Buprenorphine|buprenorphine|mesh-list
110723968|NCT01560442|Methadone|methadone|mesh-list
110723969|NCT01560442|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110723970|NCT01560442|Narcotics|narcotics|mesh-ancestor
110723971|NCT01560442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110723972|NCT01560442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110723973|NCT01560442|Analgesics|analgesics|mesh-ancestor
110723974|NCT01560442|Sensory System Agents|sensory system agents|mesh-ancestor
110723975|NCT01560442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110723976|NCT01560442|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110723977|NCT01560442|Antitussive Agents|antitussive agents|mesh-ancestor
110723978|NCT01560442|Respiratory System Agents|respiratory system agents|mesh-ancestor
110723979|NCT00110994|Sorafenib|sorafenib|mesh-list
110441800|NCT02818816|Laxatives|laxatives|mesh-ancestor
110723980|NCT00110994|Dacarbazine|dacarbazine|mesh-list
110723981|NCT00110994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110723982|NCT00110994|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110723983|NCT00110994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110723984|NCT00110994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110723985|NCT00110994|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110723986|NCT00110994|Alkylating Agents|alkylating agents|mesh-ancestor
110723987|NCT01560052|Methylprednisolone|methylprednisolone|mesh-list
110723988|NCT01560052|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110723989|NCT01560052|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110723990|NCT01560052|Prednisolone|prednisolone|mesh-list
110723991|NCT01560052|Prednisolone acetate|prednisolone acetate|mesh-list
110723992|NCT01560052|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110723993|NCT01560052|Prednisolone phosphate|prednisolone phosphate|mesh-list
110723994|NCT01560052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110723995|NCT01560052|Antiemetics|antiemetics|mesh-ancestor
110723996|NCT01560052|Autonomic Agents|autonomic agents|mesh-ancestor
110723997|NCT01560052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110723998|NCT01560052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110723999|NCT01560052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110724000|NCT01560052|Glucocorticoids|glucocorticoids|mesh-ancestor
110724001|NCT01560052|Hormones|hormones|mesh-ancestor
110724002|NCT01560052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110724003|NCT01560052|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110724004|NCT01560052|Protective Agents|protective agents|mesh-ancestor
110724005|NCT01560052|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110724006|NCT01560052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110724007|NCT05098132|Pembrolizumab|pembrolizumab|mesh-list
110724008|NCT05098132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110724009|NCT05098132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110724010|NCT05098132|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110724011|NCT05098132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110724012|NCT05622994|Rimonabant|rimonabant|mesh-list
110724013|NCT05622994|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110724014|NCT05622994|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
110724015|NCT05622994|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110724016|NCT05622994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110724017|NCT05622994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110724018|NCT05622994|Hormones|hormones|mesh-ancestor
110724019|NCT05622994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110724020|NCT05622994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110724021|NCT05622916|Ethanol|ethanol|mesh-list
110724022|NCT05622916|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110724023|NCT05622916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110724024|NCT05622916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110724025|NCT05622916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110724026|NCT03819556|Caseins|caseins|mesh-list
110724027|NCT03819556|Chelating Agents|chelating agents|mesh-ancestor
110724028|NCT03819556|Sequestering Agents|sequestering agents|mesh-ancestor
110724029|NCT03819556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110724030|NCT03804034|Molybdenum|molybdenum|mesh-list
110724031|NCT03804034|Trace Elements|trace elements|mesh-ancestor
110724032|NCT03804034|Micronutrients|micronutrients|mesh-ancestor
110724033|NCT03804034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110724034|NCT04246762|Vitamin K|vitamin k|mesh-list
110724035|NCT04246762|Midazolam|midazolam|mesh-list
110724037|NCT04246762|Omeprazole|omeprazole|mesh-list
110724038|NCT04246762|Warfarin|warfarin|mesh-list
110724039|NCT04246762|Vitamins|vitamins|mesh-ancestor
110724040|NCT04246762|Micronutrients|micronutrients|mesh-ancestor
110724041|NCT04246762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110724042|NCT04246762|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110724043|NCT04246762|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110724044|NCT04246762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110724045|NCT04246762|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110724046|NCT04246762|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110724047|NCT04246762|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110724048|NCT04246762|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110724049|NCT04246762|Anesthetics, General|anesthetics, general|mesh-ancestor
110724050|NCT04246762|Anesthetics|anesthetics|mesh-ancestor
110724051|NCT04246762|GABA Modulators|gaba modulators|mesh-ancestor
110724052|NCT04246762|GABA Agents|gaba agents|mesh-ancestor
110724053|NCT04246762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110724054|NCT04246762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110724055|NCT04246762|Anticoagulants|anticoagulants|mesh-ancestor
110441876|NCT04238884|Voriconazole|voriconazole|mesh-list
110724056|NCT04246762|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110724057|NCT04246762|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110724058|NCT04246762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110724059|NCT04246762|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110724060|NCT04246762|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110724061|NCT04246762|Purinergic Agents|purinergic agents|mesh-ancestor
110724062|NCT04246762|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110724063|NCT04246762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110724064|NCT04246762|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110724065|NCT04246762|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110724066|NCT04246762|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110724067|NCT04246762|Hemostatics|hemostatics|mesh-ancestor
110724068|NCT04246762|Coagulants|coagulants|mesh-ancestor
110724069|NCT03799120|Tamsulosin|tamsulosin|mesh-list
110724070|NCT03799120|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110724071|NCT03799120|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110724072|NCT03799120|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110724073|NCT03799120|Adrenergic Agents|adrenergic agents|mesh-ancestor
110724074|NCT03799120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110724075|NCT03799120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110724076|NCT03799120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110724077|NCT03799120|Urological Agents|urological agents|mesh-ancestor
110724078|NCT03792724|Nivolumab|nivolumab|mesh-list
110724079|NCT03792724|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110724080|NCT03792724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110724081|NCT03792724|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110724082|NCT03792724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110724083|NCT00144170|Ritonavir|ritonavir|mesh-list
110724084|NCT00144170|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
110724085|NCT00144170|Tipranavir|tipranavir|mesh-list
110724086|NCT00144170|Protease Inhibitors|protease inhibitors|mesh-list
110724087|NCT00144170|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110724088|NCT00144170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110724089|NCT00144170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110724090|NCT00144170|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110724091|NCT00144170|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110724092|NCT00144170|Antiviral Agents|antiviral agents|mesh-ancestor
110724093|NCT00144170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110724094|NCT00144170|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110724095|NCT00144170|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110724096|NCT00255086|Memantine|memantine|mesh-list
110724097|NCT00255086|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110724098|NCT00255086|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110724099|NCT00255086|Dopamine Agents|dopamine agents|mesh-ancestor
110724100|NCT00255086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110724101|NCT00255086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110724102|NCT00255086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110724103|NCT00255086|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110724104|NCT00255086|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110724105|NCT00110214|Prednisone|prednisone|mesh-list
110724106|NCT00110214|Bevacizumab|bevacizumab|mesh-list
110724107|NCT00110214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110724108|NCT00110214|Docetaxel|docetaxel|mesh-list
110724109|NCT00110214|Antibodies|antibodies|mesh-list
110724110|NCT00110214|Immunoglobulins|immunoglobulins|mesh-list
110724111|NCT00110214|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110724112|NCT00110214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110724113|NCT00110214|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110724114|NCT00110214|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110724115|NCT00110214|Growth Substances|growth substances|mesh-ancestor
110724116|NCT00110214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110724117|NCT00110214|Growth Inhibitors|growth inhibitors|mesh-ancestor
110724118|NCT00110214|Immunologic Factors|immunologic factors|mesh-ancestor
110724119|NCT00110214|Tubulin Modulators|tubulin modulators|mesh-ancestor
110724120|NCT00110214|Antimitotic Agents|antimitotic agents|mesh-ancestor
110724121|NCT00110214|Mitosis Modulators|mitosis modulators|mesh-ancestor
110724122|NCT00110214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110724123|NCT00110214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110724124|NCT00110214|Glucocorticoids|glucocorticoids|mesh-ancestor
110724125|NCT00110214|Hormones|hormones|mesh-ancestor
110724126|NCT00110214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110724127|NCT00110214|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110724128|NCT04176172|Nicotine|nicotine|mesh-list
110724129|NCT04176172|Varenicline|varenicline|mesh-list
110724130|NCT04176172|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110724131|NCT04176172|Autonomic Agents|autonomic agents|mesh-ancestor
110724132|NCT04176172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110724133|NCT04176172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110724134|NCT04176172|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110724135|NCT04176172|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110724136|NCT04176172|Cholinergic Agents|cholinergic agents|mesh-ancestor
110724137|NCT04176172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110724138|NCT04176172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110724139|NCT03795844|Liver Extracts|liver extracts|mesh-list
110724140|NCT03795844|Hematinics|hematinics|mesh-ancestor
110724141|NCT05669170|Methylphenidate|methylphenidate|mesh-list
110724142|NCT05669170|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110724143|NCT05669170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110724144|NCT05669170|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110724145|NCT05669170|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110724146|NCT05669170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110724147|NCT05669170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110724148|NCT05669170|Dopamine Agents|dopamine agents|mesh-ancestor
110724149|NCT05669170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110724150|NCT03799822|Vitamin K|vitamin k|mesh-list
110724151|NCT03799822|Rivaroxaban|rivaroxaban|mesh-list
110724152|NCT03799822|Vitamins|vitamins|mesh-ancestor
110724153|NCT03799822|Micronutrients|micronutrients|mesh-ancestor
110724154|NCT03799822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110724155|NCT03799822|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110724156|NCT03799822|Antithrombins|antithrombins|mesh-ancestor
110724157|NCT03799822|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110724158|NCT03799822|Protease Inhibitors|protease inhibitors|mesh-ancestor
110724159|NCT03799822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110724160|NCT03799822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110724161|NCT03799822|Anticoagulants|anticoagulants|mesh-ancestor
110724162|NCT03799822|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110724163|NCT03799822|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110724164|NCT03799822|Hemostatics|hemostatics|mesh-ancestor
110724165|NCT03799822|Coagulants|coagulants|mesh-ancestor
110724166|NCT03799900|Ketamine|ketamine|mesh-list
110724167|NCT03799900|Analgesics|analgesics|mesh-ancestor
110724168|NCT03799900|Sensory System Agents|sensory system agents|mesh-ancestor
110724169|NCT03799900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110141316|NCT02012088|Alkylating Agents|alkylating agents|mesh-ancestor
110724170|NCT03799900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110862994|NCT03251170|Anesthetics|anesthetics|mesh-ancestor
110724171|NCT03799900|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110724172|NCT03799900|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110724173|NCT03799900|Anesthetics, General|anesthetics, general|mesh-ancestor
110724175|NCT03799900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110724176|NCT03799900|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110724177|NCT03799900|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110724178|NCT03799900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110724179|NCT03799900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110724180|NCT05624866|Triamcinolone|triamcinolone|mesh-list
110724181|NCT05624866|Dexmedetomidine|dexmedetomidine|mesh-list
110724182|NCT05624866|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110724183|NCT05624866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110724184|NCT05624866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110724185|NCT05624866|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110724186|NCT05624866|Analgesics|analgesics|mesh-ancestor
110724187|NCT05624866|Sensory System Agents|sensory system agents|mesh-ancestor
110724188|NCT05624866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110724189|NCT05624866|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110724190|NCT05624866|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110724191|NCT05624866|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110724192|NCT05624866|Adrenergic Agents|adrenergic agents|mesh-ancestor
110724193|NCT05624866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110444187|NCT02787226|Sensory System Agents|sensory system agents|mesh-ancestor
110724194|NCT05624866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110724195|NCT05624866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110724196|NCT05624866|Glucocorticoids|glucocorticoids|mesh-ancestor
110724197|NCT05624866|Hormones|hormones|mesh-ancestor
110724198|NCT05624866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110724199|NCT01304602|Irinotecan|irinotecan|mesh-list
110724200|NCT01304602|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110724201|NCT01304602|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110724202|NCT01304602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110724203|NCT01304602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110724204|NCT01304602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110724205|NCT01304134|Morphine|morphine|mesh-list
110724206|NCT01304134|Oxycodone|oxycodone|mesh-list
110724207|NCT01304134|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110724208|NCT01304134|Narcotics|narcotics|mesh-ancestor
110724209|NCT01304134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110724210|NCT01304134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110724211|NCT01304134|Analgesics|analgesics|mesh-ancestor
110724212|NCT01304134|Sensory System Agents|sensory system agents|mesh-ancestor
110724213|NCT01304134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110724214|NCT00124020|Vancomycin|vancomycin|mesh-list
110724215|NCT00124020|Telavancin|telavancin|mesh-list
110724216|NCT00124020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110724217|NCT00124020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110724218|NCT05630794|TIC10 compound|tic10 compound|mesh-list
110724219|NCT05630794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110724220|NCT01080846|Misoprostol|misoprostol|mesh-list
110724221|NCT01080846|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110724222|NCT01080846|Abortifacient Agents|abortifacient agents|mesh-ancestor
110724223|NCT01080846|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110724224|NCT01080846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110724225|NCT01080846|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110724226|NCT01080846|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110724227|NCT01080846|Oxytocics|oxytocics|mesh-ancestor
110724228|NCT01076322|Albuterol|albuterol|mesh-list
110724229|NCT01076322|Procaterol|procaterol|mesh-list
110724230|NCT01076322|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110724231|NCT01076322|Autonomic Agents|autonomic agents|mesh-ancestor
110724232|NCT01076322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110724233|NCT01076322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110724234|NCT01076322|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110863004|NCT03251170|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110724235|NCT01076322|Respiratory System Agents|respiratory system agents|mesh-ancestor
110724236|NCT01076322|Tocolytic Agents|tocolytic agents|mesh-ancestor
110724237|NCT01076322|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110724238|NCT01076322|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110724239|NCT01076322|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110724240|NCT01076322|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110724241|NCT01076322|Adrenergic Agents|adrenergic agents|mesh-ancestor
110724242|NCT01076322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110724243|NCT01076322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110724244|NCT01076322|Sympathomimetics|sympathomimetics|mesh-ancestor
110724245|NCT03966066|Erythromycin|erythromycin|mesh-list
110724246|NCT03966066|Erythromycin Estolate|erythromycin estolate|mesh-list
110724247|NCT03966066|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
110724248|NCT03966066|Erythromycin stearate|erythromycin stearate|mesh-list
110724249|NCT03966066|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110724250|NCT03966066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110724251|NCT03966066|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110724252|NCT03966066|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110724253|NCT03966066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110724254|NCT03966066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110724255|NCT00215540|Pulmonary Surfactants|pulmonary surfactants|mesh-list
110724256|NCT00215540|Respiratory System Agents|respiratory system agents|mesh-ancestor
110724257|NCT01304212|Ketorolac|ketorolac|mesh-list
110724258|NCT01304212|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
110724259|NCT01304212|Epinephrine|epinephrine|mesh-list
110724260|NCT01304212|Racepinephrine|racepinephrine|mesh-list
110724261|NCT01304212|Morphine|morphine|mesh-list
110724262|NCT01304212|Ropivacaine|ropivacaine|mesh-list
110724263|NCT01304212|Epinephryl borate|epinephryl borate|mesh-list
110724264|NCT01304212|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110724265|NCT01304212|Narcotics|narcotics|mesh-ancestor
110724266|NCT01304212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110724267|NCT01304212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110724268|NCT01304212|Analgesics|analgesics|mesh-ancestor
110724269|NCT01304212|Sensory System Agents|sensory system agents|mesh-ancestor
110724270|NCT01304212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110724271|NCT01304212|Anesthetics, Local|anesthetics, local|mesh-ancestor
110724272|NCT01304212|Anesthetics|anesthetics|mesh-ancestor
110724273|NCT01304212|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110724274|NCT01304212|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110724275|NCT01304212|Adrenergic Agents|adrenergic agents|mesh-ancestor
110724276|NCT01304212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110724277|NCT01304212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110724278|NCT01304212|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110724279|NCT01304212|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110724280|NCT01304212|Autonomic Agents|autonomic agents|mesh-ancestor
110724281|NCT01304212|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110724282|NCT01304212|Respiratory System Agents|respiratory system agents|mesh-ancestor
110724283|NCT01304212|Mydriatics|mydriatics|mesh-ancestor
110724284|NCT01304212|Sympathomimetics|sympathomimetics|mesh-ancestor
110141345|NCT02012166|Octreotide|octreotide|mesh-list
110724285|NCT01304212|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110724286|NCT01304212|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110724287|NCT01304212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110724288|NCT01304212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110724289|NCT01304212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110724290|NCT01304212|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110724291|NCT01304212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110724292|NCT00143390|Anastrozole|anastrozole|mesh-list
110724293|NCT00143390|Exemestane|exemestane|mesh-list
110724294|NCT00143390|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110724295|NCT00143390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110724296|NCT00143390|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110724297|NCT00143390|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110724298|NCT00143390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110724299|NCT00143390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110724300|NCT00143390|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110724301|NCT00143390|Hormone Antagonists|hormone antagonists|mesh-ancestor
110724302|NCT00143390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110724303|NCT00143390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110724304|NCT03238534|Omeprazole|omeprazole|mesh-list
110724305|NCT03238534|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110724306|NCT03238534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110724307|NCT03238534|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110724308|NCT03238534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110724309|NCT03238534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110724310|NCT00141102|Celecoxib|celecoxib|mesh-list
110724311|NCT00141102|Diclofenac|diclofenac|mesh-list
110724312|NCT00141102|Omeprazole|omeprazole|mesh-list
110724313|NCT00141102|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110724314|NCT00141102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110724315|NCT00141102|Analgesics|analgesics|mesh-ancestor
110724316|NCT00141102|Sensory System Agents|sensory system agents|mesh-ancestor
110724317|NCT00141102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110724318|NCT00141102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110724319|NCT00141102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110724320|NCT00141102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110724321|NCT00141102|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110724322|NCT00141102|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110724323|NCT00141102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110724324|NCT00141102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110724325|NCT00141102|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110724326|NCT00141102|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110724327|NCT00141102|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110724328|NCT03663712|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
110724329|NCT03663712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110724330|NCT03663712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110724331|NCT01078428|Petrolatum|petrolatum|mesh-list
110724332|NCT01078428|Emollients|emollients|mesh-ancestor
110724333|NCT01078428|Dermatologic Agents|dermatologic agents|mesh-ancestor
110724334|NCT01081002|Lidocaine|lidocaine|mesh-list
110724335|NCT01081002|Anesthetics, Local|anesthetics, local|mesh-ancestor
110724336|NCT01081002|Anesthetics|anesthetics|mesh-ancestor
110724337|NCT01081002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110724338|NCT01081002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110724339|NCT01081002|Sensory System Agents|sensory system agents|mesh-ancestor
110724340|NCT01081002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110724341|NCT01081002|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110724342|NCT01081002|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110724344|NCT01081002|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110724345|NCT01081002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110724346|NCT03789058|Ibuprofen|ibuprofen|mesh-list
110724347|NCT03789058|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110724348|NCT03789058|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110724349|NCT03789058|Analgesics|analgesics|mesh-ancestor
110724350|NCT03789058|Sensory System Agents|sensory system agents|mesh-ancestor
110724351|NCT03789058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110724352|NCT03789058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110724353|NCT03789058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110724354|NCT03789058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110724355|NCT03789058|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110442165|NCT05658874|Hormones|hormones|mesh-ancestor
110724356|NCT03789058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110724357|NCT03789058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110724359|NCT03788902|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110724360|NCT03788902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110724361|NCT03788902|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110724362|NCT03788902|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110724363|NCT03788902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110724364|NCT03788902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110724365|NCT03788902|Dopamine Agents|dopamine agents|mesh-ancestor
110724366|NCT03788902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110724368|NCT05669092|Oxaliplatin|oxaliplatin|mesh-list
110724369|NCT05669092|Irinotecan|irinotecan|mesh-list
110724370|NCT05669092|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
110724371|NCT05669092|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110724372|NCT05669092|Antimetabolites|antimetabolites|mesh-ancestor
110724373|NCT05669092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110724374|NCT05669092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110724375|NCT05669092|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110724376|NCT05669092|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110724377|NCT05669092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110724378|NCT05669092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110724379|NCT00255008|Ribavirin|ribavirin|mesh-list
110724380|NCT00255008|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110724381|NCT00255008|Interferon-alpha|interferon-alpha|mesh-list
110724382|NCT00255008|Antimetabolites|antimetabolites|mesh-ancestor
110724383|NCT00255008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110724384|NCT00255008|Antiviral Agents|antiviral agents|mesh-ancestor
110724385|NCT00255008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110724386|NCT00255008|Immunologic Factors|immunologic factors|mesh-ancestor
110724387|NCT00255008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110724388|NCT01306240|Pulmonary Surfactants|pulmonary surfactants|mesh-list
110724389|NCT01306240|Respiratory System Agents|respiratory system agents|mesh-ancestor
110724390|NCT03714022|Abatacept|abatacept|mesh-list
110724391|NCT03714022|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110724392|NCT03714022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110724393|NCT03714022|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110724394|NCT03714022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110724395|NCT03714022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110724396|NCT03714022|Immunologic Factors|immunologic factors|mesh-ancestor
110724397|NCT03714022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110724398|NCT03714022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110724399|NCT00143312|Voriconazole|voriconazole|mesh-list
110724400|NCT00143312|Antifungal Agents|antifungal agents|mesh-ancestor
110724401|NCT00143312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110724402|NCT00143312|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110724403|NCT00143312|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110724404|NCT00143312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110724405|NCT00143312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110724406|NCT00143312|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110724407|NCT00143312|Hormone Antagonists|hormone antagonists|mesh-ancestor
110724408|NCT00143312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110724409|NCT00143312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110141370|NCT02012322|Ubiquinone|ubiquinone|mesh-list
110724410|NCT00143312|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110724411|NCT04833946|Andrographolide|andrographolide|mesh-list
110724412|NCT04833946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110724413|NCT04833946|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110724414|NCT04833946|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110724415|NCT04833946|Analgesics|analgesics|mesh-ancestor
110724416|NCT04833946|Sensory System Agents|sensory system agents|mesh-ancestor
110724417|NCT04833946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110724418|NCT04833946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110724419|NCT04833946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110724420|NCT04833946|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110724421|NCT04833946|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110724422|NCT04833946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110724423|NCT04833946|Antiviral Agents|antiviral agents|mesh-ancestor
110724424|NCT04833946|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110724425|NCT01077206|Simvastatin|simvastatin|mesh-list
110724426|NCT01077206|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110724427|NCT01077206|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110724428|NCT01077206|Antimetabolites|antimetabolites|mesh-ancestor
110724429|NCT01077206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110724430|NCT01077206|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110724431|NCT01077206|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110724432|NCT01077206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110724433|NCT05623540|Diphosphonates|diphosphonates|mesh-list
110724434|NCT05623540|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110724435|NCT05623540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110724436|NCT05622838|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
110724437|NCT05622838|Protein C Inhibitor|protein c inhibitor|mesh-list
110724438|NCT05622838|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
110724439|NCT05622838|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110724440|NCT05622838|Protease Inhibitors|protease inhibitors|mesh-ancestor
110724441|NCT05622838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110724442|NCT05622838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110724445|NCT01306318|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110724446|NCT01306318|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110724447|NCT01306318|Analgesics|analgesics|mesh-ancestor
110724448|NCT01306318|Sensory System Agents|sensory system agents|mesh-ancestor
110724449|NCT01306318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110724450|NCT01306318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110724451|NCT01306318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110724452|NCT01306318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110724453|NCT01306318|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110724454|NCT01306318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110724455|NCT01306318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110724456|NCT01306318|Anticonvulsants|anticonvulsants|mesh-ancestor
110724457|NCT01306318|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110724458|NCT01306318|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110724459|NCT01306318|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110724460|NCT01306318|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110724461|NCT01306318|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110724462|NCT01306318|Parasympatholytics|parasympatholytics|mesh-ancestor
110724463|NCT01306318|Autonomic Agents|autonomic agents|mesh-ancestor
110724464|NCT01306318|Vasodilator Agents|vasodilator agents|mesh-ancestor
110724465|NCT00254540|Sunitinib|sunitinib|mesh-list
110724466|NCT00254540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110724467|NCT00254540|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110724468|NCT00254540|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110724469|NCT00254540|Growth Substances|growth substances|mesh-ancestor
110724470|NCT00254540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110724471|NCT00254540|Growth Inhibitors|growth inhibitors|mesh-ancestor
110724472|NCT00254540|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110724473|NCT00254540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110724474|NCT00254540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110724475|NCT01326494|Prednisone|prednisone|mesh-list
110863071|NCT03004131|Xhance|xhance|mesh-list
110724476|NCT01326494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110724477|NCT01326494|Glucocorticoids|glucocorticoids|mesh-ancestor
110724478|NCT01326494|Hormones|hormones|mesh-ancestor
110724479|NCT01326494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110724480|NCT01326494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110724481|NCT01326494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110724482|NCT01326494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110724483|NCT05316220|Mesalamine|mesalamine|mesh-list
110724484|NCT05316220|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110724485|NCT05316220|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110724487|NCT05316220|Sensory System Agents|sensory system agents|mesh-ancestor
110724488|NCT05316220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110724489|NCT05316220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110724490|NCT05316220|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110724491|NCT05316220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110724492|NCT01305850|Losartan|losartan|mesh-list
110724493|NCT01305850|Enalapril|enalapril|mesh-list
110724494|NCT01305850|Enalaprilat|enalaprilat|mesh-list
110724495|NCT01305850|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110724496|NCT01305850|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110724497|NCT01305850|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110724498|NCT01305850|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110724499|NCT01305850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110724500|NCT01305850|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110724501|NCT01305850|Protease Inhibitors|protease inhibitors|mesh-ancestor
110724502|NCT01305850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110724503|NCT01306630|Capecitabine|capecitabine|mesh-list
110724504|NCT01306630|Tivozanib|tivozanib|mesh-list
110724505|NCT01306630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110724506|NCT01306630|Antimetabolites|antimetabolites|mesh-ancestor
110724507|NCT01306630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110724508|NCT01306630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110724509|NCT01306630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110724510|NCT01306630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110724511|NCT01306708|Amitriptyline|amitriptyline|mesh-list
110724512|NCT01306708|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110724513|NCT01306708|Antidepressive Agents|antidepressive agents|mesh-ancestor
110724514|NCT01306708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110724515|NCT01306708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110724516|NCT01306708|Analgesics|analgesics|mesh-ancestor
110724517|NCT01306708|Sensory System Agents|sensory system agents|mesh-ancestor
110724518|NCT01306708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110724519|NCT01306708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110724520|NCT01306708|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110724521|NCT01306708|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110724522|NCT01306708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110724523|NCT01306708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110724524|NCT01306708|Adrenergic Agents|adrenergic agents|mesh-ancestor
110724525|NCT01306708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110724526|NCT03794518|Pioglitazone|pioglitazone|mesh-list
110724527|NCT03794518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110724528|NCT03794518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110724529|NCT05566288|Moxifloxacin|moxifloxacin|mesh-list
110724530|NCT05566288|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110724531|NCT05566288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110724532|NCT05566288|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110724533|NCT05566288|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110724534|NCT05566288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110724535|NCT05566288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110724536|NCT05566288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110724537|NCT03790540|Benzocaine|benzocaine|mesh-list
110724538|NCT03790540|Anesthetics, Local|anesthetics, local|mesh-ancestor
110724539|NCT03790540|Anesthetics|anesthetics|mesh-ancestor
110724540|NCT03790540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110724541|NCT03790540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110724543|NCT03790540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110724544|NCT03794596|Aspirin|aspirin|mesh-list
110724545|NCT03794596|Avelumab|avelumab|mesh-list
110724546|NCT03794596|Lansoprazole|lansoprazole|mesh-list
110724547|NCT03794596|Dexlansoprazole|dexlansoprazole|mesh-list
110724548|NCT03794596|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
110724549|NCT03794596|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110724550|NCT03794596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110724551|NCT03794596|Analgesics|analgesics|mesh-ancestor
110724552|NCT03794596|Sensory System Agents|sensory system agents|mesh-ancestor
110724553|NCT03794596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110724554|NCT03794596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110724555|NCT03794596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110724556|NCT03794596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110724557|NCT03794596|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110724558|NCT03794596|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110724559|NCT03794596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110724560|NCT03794596|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110724561|NCT03794596|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110724562|NCT03794596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110724563|NCT03794596|Antipyretics|antipyretics|mesh-ancestor
110724564|NCT03794596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110724565|NCT03794596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110724566|NCT03794596|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110724567|NCT03794596|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110724568|NCT05571748|Thioctic Acid|thioctic acid|mesh-list
110724569|NCT05571748|Antioxidants|antioxidants|mesh-ancestor
110724570|NCT05571748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110724571|NCT05571748|Protective Agents|protective agents|mesh-ancestor
110724572|NCT05571748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110724573|NCT05571748|Vitamin B Complex|vitamin b complex|mesh-ancestor
110724575|NCT05571748|Micronutrients|micronutrients|mesh-ancestor
110682825|NCT00906269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110724576|NCT03790618|Methamphetamine|methamphetamine|mesh-list
110724577|NCT03790618|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
110724578|NCT03790618|Hallucinogens|hallucinogens|mesh-ancestor
110724579|NCT03790618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110724580|NCT03790618|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110724581|NCT03790618|Serotonin Agents|serotonin agents|mesh-ancestor
110724582|NCT03790618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110724583|NCT03790618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110724584|NCT03790618|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110724585|NCT03790618|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110724586|NCT03790618|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110724587|NCT03790618|Adrenergic Agents|adrenergic agents|mesh-ancestor
110724588|NCT03790618|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110724589|NCT03790618|Sympathomimetics|sympathomimetics|mesh-ancestor
110724590|NCT03790618|Autonomic Agents|autonomic agents|mesh-ancestor
110724591|NCT03790618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110724592|NCT03790618|Dopamine Agents|dopamine agents|mesh-ancestor
110724593|NCT03790618|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110724594|NCT03790228|Carboplatin|carboplatin|mesh-list
110724595|NCT03790228|Pemetrexed|pemetrexed|mesh-list
110724596|NCT03790228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110724597|NCT03790228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110724598|NCT03790228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110724599|NCT03790228|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110724600|NCT03790228|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110724601|NCT01304836|Mycophenolic Acid|mycophenolic acid|mesh-list
110724602|NCT01304836|Methylprednisolone|methylprednisolone|mesh-list
110724603|NCT01304836|Prednisolone|prednisolone|mesh-list
110724604|NCT01304836|Tacrolimus|tacrolimus|mesh-list
110724605|NCT01304836|Basiliximab|basiliximab|mesh-list
110724606|NCT01304836|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110724607|NCT01304836|Immunologic Factors|immunologic factors|mesh-ancestor
110724608|NCT01304836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110863083|NCT03004131|Antipruritics|antipruritics|mesh-ancestor
110724609|NCT01304836|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110724610|NCT01304836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110724611|NCT01304836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110724612|NCT01304836|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110724613|NCT01304836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110724614|NCT01304836|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110724615|NCT01304836|Antitubercular Agents|antitubercular agents|mesh-ancestor
110724616|NCT01304836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110724617|NCT01304836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110724618|NCT01304836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110724619|NCT01304836|Antiemetics|antiemetics|mesh-ancestor
110724620|NCT01304836|Autonomic Agents|autonomic agents|mesh-ancestor
110724621|NCT01304836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110724622|NCT01304836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110724623|NCT01304836|Glucocorticoids|glucocorticoids|mesh-ancestor
110724625|NCT01304836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110724626|NCT01304836|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110724627|NCT01304836|Protective Agents|protective agents|mesh-ancestor
110724628|NCT01304836|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110724629|NCT01306864|Hemostatics|hemostatics|mesh-list
110724630|NCT01306864|Coagulants|coagulants|mesh-ancestor
110724631|NCT01307332|Alemtuzumab|alemtuzumab|mesh-list
110724632|NCT01307332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110724633|NCT01307332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110724634|NCT03790384|Mitomycins|mitomycins|mesh-list
110724635|NCT03790384|Mitomycin|mitomycin|mesh-list
110724636|NCT03790384|BCG Vaccine|bcg vaccine|mesh-list
110724637|NCT03790384|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110724638|NCT03790384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110724639|NCT03790384|Alkylating Agents|alkylating agents|mesh-ancestor
110724640|NCT03790384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110724641|NCT03790384|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110724642|NCT03790384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110724643|NCT03790384|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110724644|NCT03790384|Immunologic Factors|immunologic factors|mesh-ancestor
110724645|NCT03790384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110724646|NCT01307488|Ritonavir|ritonavir|mesh-list
110724647|NCT01307488|Atazanavir Sulfate|atazanavir sulfate|mesh-list
110724648|NCT01307488|Lamivudine|lamivudine|mesh-list
110724649|NCT01307488|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110682826|NCT00906269|Urological Agents|urological agents|mesh-ancestor
110724650|NCT01307488|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110724651|NCT01307488|Protease Inhibitors|protease inhibitors|mesh-ancestor
110724652|NCT01307488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110724653|NCT01307488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110724654|NCT01307488|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110724655|NCT01307488|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110724656|NCT01307488|Antiviral Agents|antiviral agents|mesh-ancestor
110724657|NCT01307488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110724658|NCT01307488|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110724659|NCT01307488|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110724660|NCT01307488|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110724661|NCT01307488|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110724662|NCT03790072|Cyclophosphamide|cyclophosphamide|mesh-list
110724663|NCT03790072|Fludarabine|fludarabine|mesh-list
110724664|NCT03790072|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110724665|NCT03790072|Immunologic Factors|immunologic factors|mesh-ancestor
110724666|NCT03790072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110724667|NCT03790072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110724668|NCT03790072|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110724669|NCT03790072|Alkylating Agents|alkylating agents|mesh-ancestor
110724670|NCT03790072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110724671|NCT03790072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110724672|NCT03790072|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110724673|NCT01306006|Vaccines|vaccines|mesh-list
110724674|NCT01306006|Immunologic Factors|immunologic factors|mesh-ancestor
110724675|NCT01306006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110724676|NCT03794440|Sorafenib|sorafenib|mesh-list
110724677|NCT03794440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110724678|NCT03794440|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110724679|NCT03794440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110724680|NCT03794440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110724682|NCT00139776|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110724683|NCT00139776|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110724684|NCT00139776|Analgesics|analgesics|mesh-ancestor
110724685|NCT00139776|Sensory System Agents|sensory system agents|mesh-ancestor
110724686|NCT00139776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110724687|NCT00139776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110724688|NCT00139776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110724689|NCT00139776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110724690|NCT00139776|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110724691|NCT00139776|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110724692|NCT00139776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110724693|NCT00139776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110724694|NCT00413699|Tofacitinib|tofacitinib|mesh-list
110724695|NCT00413699|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
110724696|NCT00413699|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110724697|NCT00413699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110724698|NCT00413699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110724699|NCT03713320|Vorinostat|vorinostat|mesh-list
110724700|NCT03713320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110724701|NCT03713320|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110724702|NCT03713320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110141452|NCT02012946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110724703|NCT03713320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110724704|NCT03712930|Pamiparib|pamiparib|mesh-list
110724705|NCT03712930|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110724706|NCT03712930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110724707|NCT03712930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110724708|NCT03712930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110724709|NCT00420407|Vasopressins|vasopressins|mesh-list
110724710|NCT00420407|Arginine Vasopressin|arginine vasopressin|mesh-list
110724711|NCT00420407|Hemostatics|hemostatics|mesh-ancestor
110724712|NCT00420407|Coagulants|coagulants|mesh-ancestor
110724713|NCT00420407|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110724714|NCT00420407|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
110724715|NCT00420407|Natriuretic Agents|natriuretic agents|mesh-ancestor
110724716|NCT00420407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110724717|NCT03789370|Propofol|propofol|mesh-list
110724718|NCT03789370|Sevoflurane|sevoflurane|mesh-list
110724719|NCT03789370|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110724720|NCT03789370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110724721|NCT03789370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110724722|NCT03789370|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110724723|NCT03789370|Anesthetics, General|anesthetics, general|mesh-ancestor
110442540|NCT02809378|Antiemetics|antiemetics|mesh-ancestor
110724724|NCT03789370|Anesthetics|anesthetics|mesh-ancestor
110724725|NCT03789370|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110724726|NCT03789370|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110724727|NCT00420095|Insulin|insulin|mesh-list
110724728|NCT00420095|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110724729|NCT00420095|Insulin Lispro|insulin lispro|mesh-list
110724730|NCT00420095|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110724731|NCT00420095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110724732|NCT04904692|Dimercaprol|dimercaprol|mesh-list
110724733|NCT04904692|Chelating Agents|chelating agents|mesh-ancestor
110724734|NCT04904692|Sequestering Agents|sequestering agents|mesh-ancestor
110724735|NCT04904692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110724736|NCT01038089|Resveratrol|resveratrol|mesh-list
110724737|NCT01038089|Antioxidants|antioxidants|mesh-ancestor
110724738|NCT01038089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110724739|NCT01038089|Protective Agents|protective agents|mesh-ancestor
110724740|NCT01038089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110724741|NCT01038089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110724742|NCT01038089|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110724743|NCT05495464|Cyclophosphamide|cyclophosphamide|mesh-list
110724744|NCT05495464|Rituximab|rituximab|mesh-list
110724745|NCT05495464|Fludarabine|fludarabine|mesh-list
110724746|NCT05495464|Fludarabine phosphate|fludarabine phosphate|mesh-list
110724747|NCT05495464|Acalabrutinib|acalabrutinib|mesh-list
110724748|NCT05495464|Brexucabtagene autoleucel|brexucabtagene autoleucel|mesh-list
110724749|NCT05495464|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110724750|NCT05495464|Immunologic Factors|immunologic factors|mesh-ancestor
110724751|NCT05495464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110724752|NCT05495464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110724753|NCT05495464|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110724754|NCT05495464|Alkylating Agents|alkylating agents|mesh-ancestor
110724755|NCT05495464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110724756|NCT05495464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110724757|NCT05495464|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110724758|NCT05495464|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110724759|NCT05495464|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110724760|NCT05495464|Antimetabolites|antimetabolites|mesh-ancestor
110724761|NCT00419393|Levetiracetam|levetiracetam|mesh-list
110724762|NCT00419393|Anticonvulsants|anticonvulsants|mesh-ancestor
110724763|NCT00419393|Nootropic Agents|nootropic agents|mesh-ancestor
110724764|NCT01038167|Cyclosporine|cyclosporine|mesh-list
110724765|NCT01038167|Tacrolimus|tacrolimus|mesh-list
110724766|NCT01038167|Cyclosporins|cyclosporins|mesh-list
110724767|NCT01038167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110724768|NCT01038167|Immunologic Factors|immunologic factors|mesh-ancestor
110724769|NCT01038167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110724770|NCT01038167|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110724771|NCT01038167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110724772|NCT01038167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110724773|NCT01038167|Antifungal Agents|antifungal agents|mesh-ancestor
110724774|NCT01038167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110724775|NCT01038167|Dermatologic Agents|dermatologic agents|mesh-ancestor
110724776|NCT01038167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110724777|NCT03787030|Vitamin E|vitamin e|mesh-list
110724778|NCT03787030|Tocopherols|tocopherols|mesh-list
110724779|NCT03787030|alpha-Tocopherol|alpha-tocopherol|mesh-list
110724780|NCT03787030|Nitroglycerin|nitroglycerin|mesh-list
110724781|NCT03787030|Vitamins|vitamins|mesh-ancestor
110724782|NCT03787030|Micronutrients|micronutrients|mesh-ancestor
110724783|NCT03787030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110724784|NCT03787030|Antioxidants|antioxidants|mesh-ancestor
110724785|NCT03787030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110724786|NCT03787030|Protective Agents|protective agents|mesh-ancestor
110724787|NCT03787030|Vasodilator Agents|vasodilator agents|mesh-ancestor
110724788|NCT03786562|Morphine|morphine|mesh-list
110724789|NCT03786562|Nalbuphine|nalbuphine|mesh-list
110724790|NCT03786562|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110724791|NCT03786562|Narcotics|narcotics|mesh-ancestor
110724792|NCT03786562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110724793|NCT03786562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110724794|NCT03786562|Analgesics|analgesics|mesh-ancestor
110724795|NCT03786562|Sensory System Agents|sensory system agents|mesh-ancestor
110724796|NCT03786562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110724797|NCT01305148|Warfarin|warfarin|mesh-list
110724798|NCT01305148|Anticoagulants|anticoagulants|mesh-ancestor
110724799|NCT01305226|Streptokinase|streptokinase|mesh-list
110724800|NCT01305226|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110724801|NCT01305226|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110724802|NCT01305226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110724803|NCT01308268|Ivermectin|ivermectin|mesh-list
110724804|NCT01308268|Albendazole|albendazole|mesh-list
110724805|NCT01308268|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110724806|NCT01308268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110724807|NCT01308268|Anthelmintics|anthelmintics|mesh-ancestor
110724808|NCT01308268|Anticestodal Agents|anticestodal agents|mesh-ancestor
110724809|NCT01308268|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110724810|NCT01308268|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110724811|NCT01308268|Tubulin Modulators|tubulin modulators|mesh-ancestor
110724812|NCT01308268|Antimitotic Agents|antimitotic agents|mesh-ancestor
110724813|NCT01308268|Mitosis Modulators|mitosis modulators|mesh-ancestor
110863103|NCT03421041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110724814|NCT01308268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110724815|NCT01308268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110724817|NCT01308346|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110724818|NCT01308346|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110724819|NCT01308346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110724820|NCT01308346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110724821|NCT01308346|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110724822|NCT01308346|Immunologic Factors|immunologic factors|mesh-ancestor
110724823|NCT01308346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110724824|NCT01308346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110724825|NCT05694130|Prednisolone|prednisolone|mesh-list
110724826|NCT05694130|Tacrolimus|tacrolimus|mesh-list
110724827|NCT05694130|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110724828|NCT05694130|Immunologic Factors|immunologic factors|mesh-ancestor
110724829|NCT05694130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110724830|NCT05694130|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110724831|NCT05694130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110724832|NCT05694130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110724833|NCT05694130|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110724834|NCT05694130|Glucocorticoids|glucocorticoids|mesh-ancestor
110724835|NCT05694130|Hormones|hormones|mesh-ancestor
110724836|NCT05694130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110724837|NCT05694130|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110724838|NCT05694130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110724839|NCT00419159|Everolimus|everolimus|mesh-list
110724840|NCT00419159|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110724841|NCT00419159|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110724842|NCT00419159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110724843|NCT00419159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110724844|NCT00419159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110724845|NCT00419159|Immunologic Factors|immunologic factors|mesh-ancestor
110724846|NCT00419159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110724847|NCT00419159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110724848|NCT03717064|Pitavastatin|pitavastatin|mesh-list
110724849|NCT03717064|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110724850|NCT03717064|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110724851|NCT03717064|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110724852|NCT03717064|Antimetabolites|antimetabolites|mesh-ancestor
110724853|NCT03717064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110724854|NCT03717064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110724855|NCT03717064|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110724856|NCT03716050|Nitroglycerin|nitroglycerin|mesh-list
110724858|NCT02113163|Metformin|metformin|mesh-list
110724859|NCT02113163|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
110724860|NCT02113163|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110724861|NCT02113163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110724862|NCT02113163|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110724863|NCT02113163|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110724864|NCT00413153|Ritonavir|ritonavir|mesh-list
110724865|NCT00413153|Lopinavir|lopinavir|mesh-list
110724866|NCT00413153|Atazanavir Sulfate|atazanavir sulfate|mesh-list
110724867|NCT00413153|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110724868|NCT00413153|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110724869|NCT00413153|Protease Inhibitors|protease inhibitors|mesh-ancestor
110724870|NCT00413153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110724871|NCT00413153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110724872|NCT00413153|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110724873|NCT00413153|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110724874|NCT00413153|Antiviral Agents|antiviral agents|mesh-ancestor
110724875|NCT00413153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110724876|NCT00413153|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110724877|NCT00413153|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110442678|NCT02809066|Calcium|calcium|mesh-list
110724878|NCT02107937|Paclitaxel|paclitaxel|mesh-list
110724879|NCT02107937|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110724880|NCT02107937|Carboplatin|carboplatin|mesh-list
110863111|NCT03244774|Oxaliplatin|oxaliplatin|mesh-list
110724881|NCT02107937|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110724882|NCT02107937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110724883|NCT02107937|Tubulin Modulators|tubulin modulators|mesh-ancestor
110724884|NCT02107937|Antimitotic Agents|antimitotic agents|mesh-ancestor
110724885|NCT02107937|Mitosis Modulators|mitosis modulators|mesh-ancestor
110724886|NCT02107937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110724888|NCT01312402|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110724889|NCT01312402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110724890|NCT01312402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110724891|NCT05693428|Propofol|propofol|mesh-list
110724892|NCT05693428|Sevoflurane|sevoflurane|mesh-list
110724893|NCT05693428|Isoflurane|isoflurane|mesh-list
110724894|NCT05693428|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110724895|NCT05693428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110724896|NCT05693428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110724897|NCT05693428|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110724898|NCT05693428|Anesthetics, General|anesthetics, general|mesh-ancestor
110724899|NCT05693428|Anesthetics|anesthetics|mesh-ancestor
110724900|NCT05693428|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110724901|NCT05693428|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110724902|NCT01035281|Nabilone|nabilone|mesh-list
110724903|NCT01035281|Antiemetics|antiemetics|mesh-ancestor
110724904|NCT01035281|Autonomic Agents|autonomic agents|mesh-ancestor
110724905|NCT01035281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110724906|NCT01035281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110724907|NCT01035281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110724908|NCT01035281|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110724909|NCT01035281|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110724910|NCT01035281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110724911|NCT01035281|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110724912|NCT01561066|Octreotide|octreotide|mesh-list
110724913|NCT01561066|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
110724914|NCT01561066|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110724915|NCT01561066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110724916|NCT01561066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110724917|NCT01561066|Hemostatics|hemostatics|mesh-ancestor
110724918|NCT01561066|Coagulants|coagulants|mesh-ancestor
110724919|NCT00419003|Lamotrigine|lamotrigine|mesh-list
110724920|NCT00419003|Ketamine|ketamine|mesh-list
110724921|NCT00419003|Riluzole|riluzole|mesh-list
110724922|NCT00419003|Analgesics|analgesics|mesh-ancestor
110724923|NCT00419003|Sensory System Agents|sensory system agents|mesh-ancestor
110724924|NCT00419003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110724925|NCT00419003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110724926|NCT00419003|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110724927|NCT00419003|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110724928|NCT00419003|Anesthetics, General|anesthetics, general|mesh-ancestor
110724929|NCT00419003|Anesthetics|anesthetics|mesh-ancestor
110724930|NCT00419003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110724931|NCT00419003|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110724932|NCT00419003|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110724933|NCT00419003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110724934|NCT00419003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110724935|NCT00419003|Anticonvulsants|anticonvulsants|mesh-ancestor
110724936|NCT00419003|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110724937|NCT00419003|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110724938|NCT00419003|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110724939|NCT00419003|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110141510|NCT02013232|Dopamine Agents|dopamine agents|mesh-ancestor
110724940|NCT00419003|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110724941|NCT00419003|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110724942|NCT00419003|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110724943|NCT00419003|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110724944|NCT00419003|Protective Agents|protective agents|mesh-ancestor
110724945|NCT00418691|Methylphenidate|methylphenidate|mesh-list
110724946|NCT00418691|Modafinil|modafinil|mesh-list
110724947|NCT00418691|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110724948|NCT00418691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110863119|NCT03244774|Antimetabolites|antimetabolites|mesh-ancestor
110724949|NCT00418691|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110724950|NCT00418691|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110724951|NCT00418691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110724952|NCT00418691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110724953|NCT00418691|Dopamine Agents|dopamine agents|mesh-ancestor
110724954|NCT00418691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110724955|NCT00418691|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
110724956|NCT00418691|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110724957|NCT00418691|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110724959|NCT03781258|Anticoagulants|anticoagulants|mesh-ancestor
110724960|NCT00412373|Paliperidone Palmitate|paliperidone palmitate|mesh-list
110724961|NCT00412373|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110724962|NCT00412373|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110724963|NCT00412373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110724964|NCT00412373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110724965|NCT00412373|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110724966|NCT00412373|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110724967|NCT00412373|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110724968|NCT00412373|Serotonin Agents|serotonin agents|mesh-ancestor
110724969|NCT00412373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110724970|NCT00412373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110724971|NCT00412373|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110724972|NCT00412373|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110724973|NCT00412373|Dopamine Agents|dopamine agents|mesh-ancestor
110724974|NCT01308658|Ritonavir|ritonavir|mesh-list
110724975|NCT01308658|Darunavir|darunavir|mesh-list
110724976|NCT01308658|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110724977|NCT01308658|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110724978|NCT01308658|Protease Inhibitors|protease inhibitors|mesh-ancestor
110724979|NCT01308658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110724980|NCT01308658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110724981|NCT01308658|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110724982|NCT01308658|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110724983|NCT01308658|Antiviral Agents|antiviral agents|mesh-ancestor
110724984|NCT01308658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110724985|NCT01308658|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110724986|NCT01308658|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110724987|NCT03777514|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
110724988|NCT03777514|Hematinics|hematinics|mesh-ancestor
110724989|NCT03777514|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
110724990|NCT03777514|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110724991|NCT03777124|Carboplatin|carboplatin|mesh-list
110724992|NCT03777124|Pemetrexed|pemetrexed|mesh-list
110724993|NCT03777124|Apatinib|apatinib|mesh-list
110724994|NCT03777124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110724995|NCT03777124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110724996|NCT03777124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110724997|NCT03777124|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110724998|NCT03777124|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110724999|NCT03777124|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110725000|NCT00418379|Immunomodulating Agents|immunomodulating agents|mesh-list
110725001|NCT00418379|Immunologic Factors|immunologic factors|mesh-list
110725002|NCT00418379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110725003|NCT03780556|Lornoxicam|lornoxicam|mesh-list
110725004|NCT03780556|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110725005|NCT03780556|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110725006|NCT03780556|Analgesics|analgesics|mesh-ancestor
110725007|NCT03780556|Sensory System Agents|sensory system agents|mesh-ancestor
110725008|NCT03780556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110725009|NCT03780556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110725010|NCT03780556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110725011|NCT03780556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110725012|NCT00418145|Methylprednisolone|methylprednisolone|mesh-list
110725013|NCT00418145|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110725014|NCT00418145|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110725015|NCT00418145|Prednisolone|prednisolone|mesh-list
110725016|NCT00418145|Prednisolone acetate|prednisolone acetate|mesh-list
110725017|NCT00418145|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110725018|NCT00418145|Prednisolone phosphate|prednisolone phosphate|mesh-list
110725019|NCT00418145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110725020|NCT00418145|Antiemetics|antiemetics|mesh-ancestor
110725021|NCT00418145|Autonomic Agents|autonomic agents|mesh-ancestor
110725022|NCT00418145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110725023|NCT00418145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110725024|NCT00418145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110725025|NCT00418145|Glucocorticoids|glucocorticoids|mesh-ancestor
110725026|NCT00418145|Hormones|hormones|mesh-ancestor
110725027|NCT00418145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110725028|NCT00418145|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110725029|NCT00418145|Protective Agents|protective agents|mesh-ancestor
110725030|NCT00418145|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110725031|NCT00418145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110725033|NCT03780634|Antibodies|antibodies|mesh-list
110725034|NCT03780634|Immunoglobulins|immunoglobulins|mesh-list
110725035|NCT03780634|Immunologic Factors|immunologic factors|mesh-ancestor
110725036|NCT03780634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110725037|NCT03780634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110725038|NCT03780634|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110725039|NCT03780634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110725040|NCT03780634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110725041|NCT03777280|Cobalt|cobalt|mesh-list
110725042|NCT03777280|Chromium|chromium|mesh-list
110725043|NCT03777280|Trace Elements|trace elements|mesh-ancestor
110725044|NCT03777280|Micronutrients|micronutrients|mesh-ancestor
110725045|NCT03777280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110725046|NCT02043587|Leucovorin|leucovorin|mesh-list
110725047|NCT02043587|Cytarabine|cytarabine|mesh-list
110725048|NCT02043587|Prednisone|prednisone|mesh-list
110725049|NCT02043587|Hydrocortisone|hydrocortisone|mesh-list
110725050|NCT02043587|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
110725051|NCT02043587|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
110725052|NCT02043587|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
110725053|NCT02043587|Cyclophosphamide|cyclophosphamide|mesh-list
110725054|NCT02043587|Rituximab|rituximab|mesh-list
110725055|NCT02043587|Methotrexate|methotrexate|mesh-list
110725056|NCT02043587|Etoposide|etoposide|mesh-list
110725057|NCT02043587|Vincristine|vincristine|mesh-list
110725058|NCT02043587|Daunorubicin|daunorubicin|mesh-list
110725059|NCT02043587|Asparaginase|asparaginase|mesh-list
110725060|NCT02043587|Dasatinib|dasatinib|mesh-list
110725061|NCT02043587|Pegaspargase|pegaspargase|mesh-list
110725062|NCT02043587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110725063|NCT02043587|Immunologic Factors|immunologic factors|mesh-ancestor
110725064|NCT02043587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110725065|NCT02043587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110725066|NCT02043587|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110725067|NCT02043587|Alkylating Agents|alkylating agents|mesh-ancestor
110725068|NCT02043587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110725069|NCT02043587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110725070|NCT02043587|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110725071|NCT02043587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110725072|NCT02043587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110725073|NCT02043587|Glucocorticoids|glucocorticoids|mesh-ancestor
110725074|NCT02043587|Hormones|hormones|mesh-ancestor
110725075|NCT02043587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110725076|NCT02043587|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110725077|NCT02043587|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110725078|NCT02043587|Abortifacient Agents|abortifacient agents|mesh-ancestor
110725079|NCT02043587|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110725080|NCT02043587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110725081|NCT02043587|Antimetabolites|antimetabolites|mesh-ancestor
110725082|NCT02043587|Dermatologic Agents|dermatologic agents|mesh-ancestor
110725083|NCT02043587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110725084|NCT02043587|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110725085|NCT02043587|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110725086|NCT02043587|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110725087|NCT02043587|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110725088|NCT02043587|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110725089|NCT02043587|Antiviral Agents|antiviral agents|mesh-ancestor
110725090|NCT02043587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110725091|NCT02043587|Antidotes|antidotes|mesh-ancestor
110725092|NCT02043587|Protective Agents|protective agents|mesh-ancestor
110725093|NCT02043587|Vitamin B Complex|vitamin b complex|mesh-ancestor
110725094|NCT02043587|Vitamins|vitamins|mesh-ancestor
110725095|NCT02043587|Micronutrients|micronutrients|mesh-ancestor
110725096|NCT02043587|Tubulin Modulators|tubulin modulators|mesh-ancestor
110725097|NCT02043587|Antimitotic Agents|antimitotic agents|mesh-ancestor
110725098|NCT02043587|Mitosis Modulators|mitosis modulators|mesh-ancestor
110725099|NCT02043587|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110725100|NCT02043587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110725101|NCT01561222|Calcitriol|calcitriol|mesh-list
110442915|NCT02804776|Gefitinib|gefitinib|mesh-list
110725102|NCT01561222|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110725103|NCT01561222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110725104|NCT01561222|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
110725105|NCT01561222|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110725106|NCT01561222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110725107|NCT01561222|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110725108|NCT01561222|Vitamins|vitamins|mesh-ancestor
110725109|NCT01561222|Micronutrients|micronutrients|mesh-ancestor
110725110|NCT01561222|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110725111|NCT01035515|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3H-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3h-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|mesh-list
110725112|NCT01035515|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
110725113|NCT01035515|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110725114|NCT01035515|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110725115|NCT01035515|Purinergic Agents|purinergic agents|mesh-ancestor
110725116|NCT01035515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110725117|NCT01035515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110725118|NCT01035515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110725119|NCT01039025|Cyclophosphamide|cyclophosphamide|mesh-list
110725120|NCT01039025|Melphalan|melphalan|mesh-list
110725121|NCT01039025|Topotecan|topotecan|mesh-list
110725122|NCT01039025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110725123|NCT01039025|Immunologic Factors|immunologic factors|mesh-ancestor
110725124|NCT01039025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110725125|NCT01039025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110725126|NCT01039025|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110725127|NCT01039025|Alkylating Agents|alkylating agents|mesh-ancestor
110725128|NCT01039025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110725129|NCT01039025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110725130|NCT01039025|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110725131|NCT01039025|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110725132|NCT01039025|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110725133|NCT01039025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110725134|NCT03779776|Vitamins|vitamins|mesh-list
110725135|NCT03779776|Micronutrients|micronutrients|mesh-ancestor
110725136|NCT03779776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110725137|NCT00412217|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110725138|NCT00412217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110725139|NCT00412217|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110725140|NCT00412217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110725141|NCT00412217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110725142|NCT01035593|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
110725143|NCT01035593|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
110725144|NCT01035593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110725145|NCT01035593|Immunologic Factors|immunologic factors|mesh-ancestor
110725146|NCT01035593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110725147|NCT01317784|Antibodies|antibodies|mesh-list
110725148|NCT01317784|Immunoglobulins|immunoglobulins|mesh-list
110725149|NCT01317784|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
110725150|NCT01317784|Immunologic Factors|immunologic factors|mesh-ancestor
110725151|NCT01317784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110725152|NCT03779464|Gemcitabine|gemcitabine|mesh-list
110725153|NCT03779464|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110725154|NCT03779464|Antimetabolites|antimetabolites|mesh-ancestor
110725155|NCT03779464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110725156|NCT03779464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110725157|NCT01309126|Cetuximab|cetuximab|mesh-list
110725158|NCT01309126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110725159|NCT01309126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110725160|NCT03784378|Agerafenib|agerafenib|mesh-list
110725161|NCT03784378|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110725162|NCT03784378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110725163|NCT03784378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110725164|NCT01314898|Spironolactone|spironolactone|mesh-list
110725165|NCT01314898|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110725166|NCT01314898|Hormone Antagonists|hormone antagonists|mesh-ancestor
110725167|NCT01314898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110725168|NCT01314898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110725169|NCT01314898|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110725170|NCT01314898|Diuretics|diuretics|mesh-ancestor
110725171|NCT01314898|Natriuretic Agents|natriuretic agents|mesh-ancestor
110725172|NCT01315912|Letrozole|letrozole|mesh-list
110725173|NCT01315912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110725174|NCT01315912|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110725175|NCT01315912|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110725176|NCT01315912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110725177|NCT01315912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110725178|NCT01315912|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110725179|NCT01315912|Hormone Antagonists|hormone antagonists|mesh-ancestor
110725180|NCT01315912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110725181|NCT01315912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110725182|NCT03778450|Analgesics, Opioid|analgesics, opioid|mesh-list
110725183|NCT03778450|Analgesics|analgesics|mesh-list
110725184|NCT03778450|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
110725185|NCT03778450|Narcotics|narcotics|mesh-ancestor
110725186|NCT03778450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110725187|NCT03778450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110725188|NCT03778450|Sensory System Agents|sensory system agents|mesh-ancestor
110725189|NCT03778450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110725190|NCT03776500|Macozinone|macozinone|mesh-list
110725191|NCT03776500|Antitubercular Agents|antitubercular agents|mesh-ancestor
110725192|NCT03776500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110725193|NCT03776500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110725194|NCT03778138|Pemetrexed|pemetrexed|mesh-list
110725195|NCT03778138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110725196|NCT03778138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110725197|NCT03778138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110725198|NCT03778138|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110725199|NCT03778138|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110725200|NCT03783754|Amlodipine|amlodipine|mesh-list
110725201|NCT03783754|Telmisartan|telmisartan|mesh-list
110725202|NCT03783754|Indapamide|indapamide|mesh-list
110725203|NCT03783754|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110725204|NCT03783754|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110725205|NCT03783754|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110725206|NCT03783754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110725207|NCT03783754|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110725208|NCT03783754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110725209|NCT03783754|Vasodilator Agents|vasodilator agents|mesh-ancestor
110725210|NCT03783754|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110725211|NCT03783754|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110725212|NCT03783754|Diuretics|diuretics|mesh-ancestor
110725213|NCT03783754|Natriuretic Agents|natriuretic agents|mesh-ancestor
110725214|NCT03783754|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110725215|NCT01309438|Erythromycin|erythromycin|mesh-list
110725216|NCT01309438|Erythromycin Estolate|erythromycin estolate|mesh-list
110725217|NCT01309438|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
110725218|NCT01309438|Erythromycin stearate|erythromycin stearate|mesh-list
110725219|NCT01309438|Rivaroxaban|rivaroxaban|mesh-list
110725220|NCT01309438|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110725221|NCT01309438|Antithrombins|antithrombins|mesh-ancestor
110725222|NCT01309438|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110725223|NCT01309438|Protease Inhibitors|protease inhibitors|mesh-ancestor
110725224|NCT01309438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110725225|NCT01309438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110725226|NCT01309438|Anticoagulants|anticoagulants|mesh-ancestor
110725227|NCT01309438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110725228|NCT01309438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110725229|NCT01309438|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110725230|NCT01309438|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110725231|NCT03776032|Darbepoetin alfa|darbepoetin alfa|mesh-list
110725233|NCT03775798|Antiviral Agents|antiviral agents|mesh-list
110725234|NCT03775798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110725235|NCT03775876|Dexmedetomidine|dexmedetomidine|mesh-list
110725237|NCT03775876|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110725238|NCT03775876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110725239|NCT03775876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110725240|NCT03775876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110725241|NCT03775876|Analgesics|analgesics|mesh-ancestor
110725242|NCT03775876|Sensory System Agents|sensory system agents|mesh-ancestor
110725243|NCT03775876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110725244|NCT03775876|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110725245|NCT03775876|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110725246|NCT03775876|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110725247|NCT03775876|Adrenergic Agents|adrenergic agents|mesh-ancestor
110725248|NCT03775876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110725249|NCT03775876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110725250|NCT03775876|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110725251|NCT03775876|Anesthetics, General|anesthetics, general|mesh-ancestor
110725252|NCT03775876|Anesthetics|anesthetics|mesh-ancestor
110725253|NCT01320514|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
110725254|NCT01320514|Hemostatics|hemostatics|mesh-ancestor
110725255|NCT01320514|Coagulants|coagulants|mesh-ancestor
110725256|NCT03773536|Artesunate|artesunate|mesh-list
110725257|NCT03773536|Primaquine|primaquine|mesh-list
110725258|NCT03773536|Amodiaquine|amodiaquine|mesh-list
110725259|NCT03773536|Antimalarials|antimalarials|mesh-ancestor
110725260|NCT03773536|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110725261|NCT03773536|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110725262|NCT03773536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110725263|NCT03773536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110725264|NCT03773536|Antiviral Agents|antiviral agents|mesh-ancestor
110725265|NCT03773536|Schistosomicides|schistosomicides|mesh-ancestor
110725266|NCT03773536|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110725267|NCT03773536|Anthelmintics|anthelmintics|mesh-ancestor
110725268|NCT01320592|Paclitaxel|paclitaxel|mesh-list
110725269|NCT01320592|Palbociclib|palbociclib|mesh-list
110725270|NCT01320592|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110725271|NCT01320592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110725272|NCT01320592|Tubulin Modulators|tubulin modulators|mesh-ancestor
110725273|NCT01320592|Antimitotic Agents|antimitotic agents|mesh-ancestor
110725274|NCT01320592|Mitosis Modulators|mitosis modulators|mesh-ancestor
110725275|NCT01320592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110725276|NCT01320592|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110725277|NCT01320592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110725278|NCT03783676|Remifentanil|remifentanil|mesh-list
110725279|NCT03783676|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110725280|NCT03783676|Narcotics|narcotics|mesh-ancestor
110725281|NCT03783676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110725282|NCT03783676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110725283|NCT03783676|Analgesics|analgesics|mesh-ancestor
110725284|NCT03783676|Sensory System Agents|sensory system agents|mesh-ancestor
110725285|NCT03783676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110725286|NCT03783520|Sodium Hypochlorite|sodium hypochlorite|mesh-list
110725287|NCT03783520|Eusol|eusol|mesh-list
110725288|NCT03783520|Disinfectants|disinfectants|mesh-ancestor
110725289|NCT03783520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110725290|NCT01320982|Aspirin|aspirin|mesh-list
110725291|NCT01320982|Minocycline|minocycline|mesh-list
110725292|NCT01320982|Pramipexole|pramipexole|mesh-list
110725293|NCT01320982|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110725294|NCT01320982|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110725295|NCT01320982|Analgesics|analgesics|mesh-ancestor
110725296|NCT01320982|Sensory System Agents|sensory system agents|mesh-ancestor
110725297|NCT01320982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110725298|NCT01320982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110725299|NCT01320982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110725300|NCT01320982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110725301|NCT01320982|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110725302|NCT01320982|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110444209|NCT00870103|Antiemetics|antiemetics|mesh-ancestor
110863144|NCT02855697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110725303|NCT01320982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110725304|NCT01320982|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110725305|NCT01320982|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110725306|NCT01320982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110725307|NCT01320982|Antipyretics|antipyretics|mesh-ancestor
110725308|NCT01320982|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110725309|NCT01320982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110725310|NCT01320982|Antioxidants|antioxidants|mesh-ancestor
110725311|NCT01320982|Protective Agents|protective agents|mesh-ancestor
110725312|NCT01320982|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110725313|NCT01320982|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110725314|NCT01320982|Dopamine Agonists|dopamine agonists|mesh-ancestor
110725315|NCT01320982|Dopamine Agents|dopamine agents|mesh-ancestor
110725316|NCT01320982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110725317|NCT04893382|Plasma-lyte 148|plasma-lyte 148|mesh-list
110725318|NCT04893382|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110725319|NCT04893382|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110725321|NCT01321138|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110725322|NCT01321138|Narcotics|narcotics|mesh-ancestor
110725323|NCT01321138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110725324|NCT01321138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110725325|NCT01321138|Analgesics|analgesics|mesh-ancestor
110725326|NCT01321138|Sensory System Agents|sensory system agents|mesh-ancestor
110725327|NCT01321138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110725328|NCT04628572|Ceftazidime|ceftazidime|mesh-list
110725329|NCT04628572|Avibactam|avibactam|mesh-list
110725330|NCT04628572|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
110725331|NCT04628572|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110725332|NCT04628572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110725333|NCT04628572|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110725334|NCT04628572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110725335|NCT04628572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110725336|NCT03772990|Calcium|calcium|mesh-list
110725337|NCT03772990|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110725338|NCT03772990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110725339|NCT03782662|Itraconazole|itraconazole|mesh-list
110725340|NCT03782662|Rifampin|rifampin|mesh-list
110725341|NCT03782662|Verapamil|verapamil|mesh-list
110725342|NCT03782662|Midazolam|midazolam|mesh-list
110725343|NCT03782662|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110725344|NCT03782662|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110725345|NCT03782662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110725346|NCT03782662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110725347|NCT03782662|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110725348|NCT03782662|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110725349|NCT03782662|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110725350|NCT03782662|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110725351|NCT03782662|Anesthetics, General|anesthetics, general|mesh-ancestor
110725352|NCT03782662|Anesthetics|anesthetics|mesh-ancestor
110725353|NCT03782662|GABA Modulators|gaba modulators|mesh-ancestor
110725354|NCT03782662|GABA Agents|gaba agents|mesh-ancestor
110725355|NCT03782662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110725356|NCT03782662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110725357|NCT03782662|Antifungal Agents|antifungal agents|mesh-ancestor
110725358|NCT03782662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110725359|NCT03782662|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110725360|NCT03782662|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110725361|NCT03782662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110725362|NCT03782662|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110725363|NCT03782662|Hormone Antagonists|hormone antagonists|mesh-ancestor
110725364|NCT03782662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110725365|NCT03782662|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110725366|NCT03782662|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110725367|NCT03782662|Antitubercular Agents|antitubercular agents|mesh-ancestor
110725368|NCT03782662|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110725369|NCT03782662|Leprostatic Agents|leprostatic agents|mesh-ancestor
110725370|NCT03782662|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110725371|NCT03782662|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110725372|NCT03782662|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110725373|NCT03782662|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110725374|NCT03782662|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110725375|NCT03782662|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110725376|NCT03782662|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110725377|NCT03782662|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110725378|NCT03782662|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110725379|NCT03782662|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110725380|NCT03782662|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110725381|NCT03782662|Vasodilator Agents|vasodilator agents|mesh-ancestor
110725383|NCT01309984|Fospropofol|fospropofol|mesh-list
110725384|NCT01309984|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110725385|NCT01309984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110725386|NCT01309984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110725387|NCT01309984|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110725388|NCT01309984|Anesthetics, General|anesthetics, general|mesh-ancestor
110725389|NCT01309984|Anesthetics|anesthetics|mesh-ancestor
110725390|NCT03772054|Propofol|propofol|mesh-list
110725391|NCT03772054|Sevoflurane|sevoflurane|mesh-list
110725392|NCT03772054|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110725393|NCT03772054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110725394|NCT03772054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110725395|NCT03772054|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110725396|NCT03772054|Anesthetics, General|anesthetics, general|mesh-ancestor
110725397|NCT03772054|Anesthetics|anesthetics|mesh-ancestor
110725398|NCT03772054|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110725399|NCT03772054|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110725400|NCT03771820|Pembrolizumab|pembrolizumab|mesh-list
110725401|NCT03771820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110725402|NCT03771820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110725403|NCT03771820|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110725404|NCT03771820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110725405|NCT05531890|Betamethasone|betamethasone|mesh-list
110725406|NCT05531890|Betamethasone Valerate|betamethasone valerate|mesh-list
110725408|NCT05531890|Betamethasone benzoate|betamethasone benzoate|mesh-list
110725409|NCT05531890|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110725410|NCT05531890|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
110725411|NCT05531890|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110725412|NCT05531890|Glucocorticoids|glucocorticoids|mesh-ancestor
110725413|NCT05531890|Hormones|hormones|mesh-ancestor
110725414|NCT05531890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110725415|NCT05531890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110725416|NCT05531890|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110725417|NCT05531890|Respiratory System Agents|respiratory system agents|mesh-ancestor
110725418|NCT00123474|Dasatinib|dasatinib|mesh-list
110725419|NCT00123474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110725420|NCT00123474|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110725421|NCT00123474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110725422|NCT00123474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110725423|NCT00142298|Telbivudine|telbivudine|mesh-list
110725424|NCT00142298|Antiviral Agents|antiviral agents|mesh-ancestor
110725425|NCT00142298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110725426|NCT00142298|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110725427|NCT00142298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110725428|NCT00142298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110725429|NCT03774706|Misoprostol|misoprostol|mesh-list
110725430|NCT03774706|Tranexamic Acid|tranexamic acid|mesh-list
110725431|NCT03774706|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110725432|NCT03774706|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110725433|NCT03774706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110725434|NCT03774706|Hemostatics|hemostatics|mesh-ancestor
110725435|NCT03774706|Coagulants|coagulants|mesh-ancestor
110725436|NCT03774706|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110725437|NCT03774706|Abortifacient Agents|abortifacient agents|mesh-ancestor
110725438|NCT03774706|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110725439|NCT03774706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110725440|NCT03774706|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110725441|NCT03774706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110725443|NCT03967496|Metformin|metformin|mesh-list
110725444|NCT03967496|Amlodipine|amlodipine|mesh-list
110725445|NCT03967496|Lisinopril|lisinopril|mesh-list
110725446|NCT03967496|Bisoprolol|bisoprolol|mesh-list
110725447|NCT03967496|Hydralazine|hydralazine|mesh-list
110725448|NCT03967496|Anesthetics|anesthetics|mesh-list
110725449|NCT03967496|Atorvastatin|atorvastatin|mesh-list
110725450|NCT03967496|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110725451|NCT03967496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110725452|NCT03967496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110725453|NCT03967496|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110725454|NCT03967496|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110725455|NCT03967496|Antimetabolites|antimetabolites|mesh-ancestor
110725456|NCT03967496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110725457|NCT03967496|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110725458|NCT03967496|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110725459|NCT03967496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110725460|NCT03967496|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110725461|NCT03967496|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110725462|NCT03967496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110725463|NCT03967496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110725464|NCT03967496|Vasodilator Agents|vasodilator agents|mesh-ancestor
110141593|NCT02013960|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110725465|NCT03967496|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110725466|NCT03967496|Protease Inhibitors|protease inhibitors|mesh-ancestor
110725467|NCT03967496|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110725468|NCT03967496|Protective Agents|protective agents|mesh-ancestor
110725469|NCT03967496|Sympatholytics|sympatholytics|mesh-ancestor
110725470|NCT03967496|Autonomic Agents|autonomic agents|mesh-ancestor
110725471|NCT03967496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110725472|NCT03967496|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110725473|NCT03967496|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110725474|NCT03967496|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110725475|NCT03967496|Adrenergic Agents|adrenergic agents|mesh-ancestor
110725476|NCT03967496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110725477|NCT00412061|Everolimus|everolimus|mesh-list
110725478|NCT00412061|Octreotide|octreotide|mesh-list
110725479|NCT00412061|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110725480|NCT00412061|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110725481|NCT00412061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110725482|NCT00412061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110725483|NCT00412061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110725484|NCT00412061|Immunologic Factors|immunologic factors|mesh-ancestor
110725485|NCT00412061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110725486|NCT00412061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110725487|NCT00412061|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110725488|NCT00412061|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110725489|NCT03964350|Ethanol|ethanol|mesh-list
110725490|NCT03964350|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110725491|NCT03964350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110725492|NCT03964350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110725493|NCT03964350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110725494|NCT01310452|Insulin|insulin|mesh-list
110725495|NCT01310452|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110725496|NCT01310452|Insulin Detemir|insulin detemir|mesh-list
110725497|NCT01310452|Protamines|protamines|mesh-list
110725498|NCT01310452|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110725499|NCT01310452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110725500|NCT01310452|Heparin Antagonists|heparin antagonists|mesh-ancestor
110725501|NCT01310452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110725502|NCT01310452|Coagulants|coagulants|mesh-ancestor
110725503|NCT01035671|Vitamin E|vitamin e|mesh-list
110725504|NCT01035671|Tocopherylquinone|tocopherylquinone|mesh-list
110725505|NCT01035671|Anticoagulants|anticoagulants|mesh-ancestor
110725506|NCT01035671|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110725507|NCT01035671|Antioxidants|antioxidants|mesh-ancestor
110725508|NCT01035671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110725509|NCT01035671|Protective Agents|protective agents|mesh-ancestor
110725510|NCT01035671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110725511|NCT01035671|Vitamins|vitamins|mesh-ancestor
110725512|NCT01035671|Micronutrients|micronutrients|mesh-ancestor
110725513|NCT04560868|Nicotine|nicotine|mesh-list
110725514|NCT04560868|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110725515|NCT04560868|Autonomic Agents|autonomic agents|mesh-ancestor
110863163|NCT01346865|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110725516|NCT04560868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110725517|NCT04560868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110725518|NCT04560868|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110725519|NCT04560868|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110725520|NCT04560868|Cholinergic Agents|cholinergic agents|mesh-ancestor
110725521|NCT04560868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110725522|NCT04560868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110725523|NCT03769714|Bupivacaine|bupivacaine|mesh-list
110725524|NCT03769714|Anesthetics, Local|anesthetics, local|mesh-ancestor
110725525|NCT03769714|Anesthetics|anesthetics|mesh-ancestor
110725526|NCT03769714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110725527|NCT03769714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110725529|NCT03769714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110725530|NCT03769402|Citric Acid|citric acid|mesh-list
110725531|NCT03769402|Sodium Citrate|sodium citrate|mesh-list
110725532|NCT03769402|Anticoagulants|anticoagulants|mesh-ancestor
110725533|NCT03769402|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110725534|NCT03769402|Chelating Agents|chelating agents|mesh-ancestor
110725535|NCT03769402|Sequestering Agents|sequestering agents|mesh-ancestor
110725536|NCT03769402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110725538|NCT00411671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110364187|NCT04658355|Povidone|povidone|mesh-list
110725539|NCT00411671|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110725540|NCT00411671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110725541|NCT00411671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110725542|NCT01035983|Frovatriptan|frovatriptan|mesh-list
110725543|NCT01035983|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110725544|NCT01035983|Serotonin Agents|serotonin agents|mesh-ancestor
110725545|NCT01035983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110725546|NCT01035983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110725547|NCT01035983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110725548|NCT03770806|Acetaminophen|acetaminophen|mesh-list
110725549|NCT03770806|Celecoxib|celecoxib|mesh-list
110725550|NCT03770806|Oxycodone|oxycodone|mesh-list
110725551|NCT03770806|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110725552|NCT03770806|Analgesics|analgesics|mesh-ancestor
110725553|NCT03770806|Sensory System Agents|sensory system agents|mesh-ancestor
110725554|NCT03770806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110725555|NCT03770806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110725556|NCT03770806|Antipyretics|antipyretics|mesh-ancestor
110725557|NCT03770806|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110725558|NCT03770806|Narcotics|narcotics|mesh-ancestor
110725559|NCT03770806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110725560|NCT03770806|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110725561|NCT03770806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110725562|NCT03770806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110725563|NCT03770806|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110725564|NCT03770806|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110725565|NCT03770806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110725566|NCT03770806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110725567|NCT01039103|Methylprednisolone|methylprednisolone|mesh-list
110725568|NCT01039103|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110725569|NCT01039103|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110725570|NCT01039103|Prednisolone|prednisolone|mesh-list
110725571|NCT01039103|Prednisolone acetate|prednisolone acetate|mesh-list
110725572|NCT01039103|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110725573|NCT01039103|Prednisolone phosphate|prednisolone phosphate|mesh-list
110725574|NCT01039103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110725575|NCT01039103|Antiemetics|antiemetics|mesh-ancestor
110725576|NCT01039103|Autonomic Agents|autonomic agents|mesh-ancestor
110725577|NCT01039103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110725578|NCT01039103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110725579|NCT01039103|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110725580|NCT01039103|Glucocorticoids|glucocorticoids|mesh-ancestor
110725581|NCT01039103|Hormones|hormones|mesh-ancestor
110725582|NCT01039103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110725583|NCT01039103|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110725584|NCT01039103|Protective Agents|protective agents|mesh-ancestor
110725585|NCT01039103|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110725586|NCT01039103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110725587|NCT01039181|Vitamin D|vitamin d|mesh-list
110725588|NCT01039181|Calcitriol|calcitriol|mesh-list
110725589|NCT01039181|Vitamins|vitamins|mesh-ancestor
110725590|NCT01039181|Micronutrients|micronutrients|mesh-ancestor
110725591|NCT01039181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110725592|NCT01039181|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110725593|NCT01039181|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110725594|NCT01039181|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
110725595|NCT01039181|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110725596|NCT01039181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110725597|NCT01039181|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110725598|NCT03770026|Clomiphene|clomiphene|mesh-list
110725599|NCT03770026|Enclomiphene|enclomiphene|mesh-list
110725600|NCT03770026|Zuclomiphene|zuclomiphene|mesh-list
110725601|NCT03770026|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110725602|NCT03770026|Hormone Antagonists|hormone antagonists|mesh-ancestor
110725603|NCT03770026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110141620|NCT02013089|Everolimus|everolimus|mesh-list
110725604|NCT03770026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110725605|NCT03770026|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110725606|NCT03770026|Fertility Agents|fertility agents|mesh-ancestor
110725607|NCT03770026|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110725608|NCT03770026|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110725609|NCT03770026|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110725610|NCT03769870|Atorvastatin|atorvastatin|mesh-list
110725611|NCT03769870|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110725612|NCT03769870|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110725613|NCT03769870|Antimetabolites|antimetabolites|mesh-ancestor
110725614|NCT03769870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110725615|NCT03769870|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110725616|NCT03769870|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110725617|NCT03769870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110725618|NCT01589081|Nicotine|nicotine|mesh-list
110725619|NCT01589081|Progesterone|progesterone|mesh-list
110725620|NCT01589081|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110725621|NCT01589081|Autonomic Agents|autonomic agents|mesh-ancestor
110725622|NCT01589081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110725623|NCT01589081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110725624|NCT01589081|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110725625|NCT01589081|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110725626|NCT01589081|Cholinergic Agents|cholinergic agents|mesh-ancestor
110725627|NCT01589081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110725628|NCT01589081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110725629|NCT01589081|Progestins|progestins|mesh-ancestor
110725630|NCT01589081|Hormones|hormones|mesh-ancestor
110725631|NCT01589081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110725632|NCT01567540|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110725634|NCT01567540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110725635|NCT01567540|Incretins|incretins|mesh-ancestor
110725636|NCT01567540|Hormones|hormones|mesh-ancestor
110725637|NCT01567540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110725638|NCT01567540|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110725639|NCT01567540|Protease Inhibitors|protease inhibitors|mesh-ancestor
110725640|NCT01567540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110725641|NCT01567540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110725642|NCT01036841|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
110725643|NCT01036841|Hemostatics|hemostatics|mesh-ancestor
110725644|NCT01036841|Coagulants|coagulants|mesh-ancestor
110725645|NCT01036841|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
110725646|NCT01036841|Natriuretic Agents|natriuretic agents|mesh-ancestor
110725647|NCT01036841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110725648|NCT03709576|Azacitidine|azacitidine|mesh-list
110725649|NCT03709576|Pevonedistat|pevonedistat|mesh-list
110725650|NCT03709576|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110725651|NCT03709576|Antimetabolites|antimetabolites|mesh-ancestor
110725652|NCT03709576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110725653|NCT03709576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110725654|NCT03709576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110725655|NCT00122460|Cisplatin|cisplatin|mesh-list
110725656|NCT00122460|Carboplatin|carboplatin|mesh-list
110725657|NCT00122460|Fluorouracil|fluorouracil|mesh-list
110725658|NCT00122460|Cetuximab|cetuximab|mesh-list
110725659|NCT00122460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110725660|NCT00122460|Antimetabolites|antimetabolites|mesh-ancestor
110725661|NCT00122460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110725662|NCT00122460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110725663|NCT00122460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110725664|NCT00122460|Immunologic Factors|immunologic factors|mesh-ancestor
110725665|NCT00122460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110725666|NCT00122460|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110725667|NCT03763396|Ketoconazole|ketoconazole|mesh-list
110725668|NCT03763396|Posaconazole|posaconazole|mesh-list
110725669|NCT03763396|Antifungal Agents|antifungal agents|mesh-ancestor
110725670|NCT03763396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110725671|NCT03763396|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110725672|NCT03763396|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110725673|NCT03763396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110725674|NCT03763396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110725675|NCT03763396|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110725677|NCT03763396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110725678|NCT03763396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110725679|NCT03763396|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110725680|NCT03763396|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
110725681|NCT03763396|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110725682|NCT03763396|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110725683|NCT01320436|Aminosalicylic Acid|aminosalicylic acid|mesh-list
110725684|NCT01320436|Curcumin|curcumin|mesh-list
110725685|NCT01320436|Mesalamine|mesalamine|mesh-list
110725686|NCT01320436|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110725687|NCT01320436|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110725688|NCT01320436|Analgesics|analgesics|mesh-ancestor
110725689|NCT01320436|Sensory System Agents|sensory system agents|mesh-ancestor
110725690|NCT01320436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110725691|NCT01320436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110725692|NCT01320436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110725693|NCT01320436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110725694|NCT01320436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110725695|NCT01320436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110725696|NCT01320436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110725697|NCT01320436|Antitubercular Agents|antitubercular agents|mesh-ancestor
110725698|NCT01320436|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110725699|NCT01320436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110725700|NCT04794088|Imatinib Mesylate|imatinib mesylate|mesh-list
110725701|NCT04794088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110725702|NCT04794088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110725703|NCT04794088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110725704|NCT04794088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110725705|NCT03763084|Acetaminophen|acetaminophen|mesh-list
110725706|NCT03763084|Sufentanil|sufentanil|mesh-list
110725707|NCT03763084|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110725708|NCT03763084|Analgesics|analgesics|mesh-ancestor
110725709|NCT03763084|Sensory System Agents|sensory system agents|mesh-ancestor
110725710|NCT03763084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110725711|NCT03763084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110725712|NCT03763084|Antipyretics|antipyretics|mesh-ancestor
110725713|NCT03763084|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110725714|NCT03763084|Narcotics|narcotics|mesh-ancestor
110725715|NCT03763084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110725716|NCT03763084|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110725717|NCT03763084|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110725718|NCT03763084|Anesthetics, General|anesthetics, general|mesh-ancestor
110725719|NCT03763084|Anesthetics|anesthetics|mesh-ancestor
110725720|NCT01567618|Docetaxel|docetaxel|mesh-list
110725721|NCT01567618|Fluorouracil|fluorouracil|mesh-list
110725722|NCT01567618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110725723|NCT01567618|Tubulin Modulators|tubulin modulators|mesh-ancestor
110725724|NCT01567618|Antimitotic Agents|antimitotic agents|mesh-ancestor
110725725|NCT01567618|Mitosis Modulators|mitosis modulators|mesh-ancestor
110725726|NCT01567618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110725727|NCT01567618|Antimetabolites|antimetabolites|mesh-ancestor
110725728|NCT01567618|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110725729|NCT01567618|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110725730|NCT01567618|Immunologic Factors|immunologic factors|mesh-ancestor
110725731|NCT01567618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110167521|NCT00000575|Nedocromil|nedocromil|mesh-list
110725732|NCT04771078|Idecabtagene vicleucel|idecabtagene vicleucel|mesh-list
110725733|NCT04771078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110725734|NCT04771078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110725735|NCT03762928|Efavirenz|efavirenz|mesh-list
110725736|NCT03762928|Midazolam|midazolam|mesh-list
110725737|NCT03762928|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110725738|NCT03762928|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110725739|NCT03762928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110725740|NCT03762928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110725741|NCT03762928|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110725742|NCT03762928|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110725743|NCT03762928|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110725744|NCT03762928|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110725745|NCT03762928|Anesthetics, General|anesthetics, general|mesh-ancestor
110725746|NCT03762928|Anesthetics|anesthetics|mesh-ancestor
110725747|NCT03762928|GABA Modulators|gaba modulators|mesh-ancestor
110725748|NCT03762928|GABA Agents|gaba agents|mesh-ancestor
110725749|NCT03762928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110444215|NCT00870103|Hormones|hormones|mesh-ancestor
110725750|NCT03762928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110725751|NCT03762928|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110725752|NCT03762928|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110725754|NCT03762928|Antiviral Agents|antiviral agents|mesh-ancestor
110725755|NCT03762928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110725756|NCT03762928|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110725757|NCT03762928|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110725758|NCT03762928|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110725759|NCT03762928|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110725760|NCT03762928|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110725761|NCT03762928|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110725762|NCT01561456|Docetaxel|docetaxel|mesh-list
110725763|NCT01561456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110725764|NCT01561456|Tubulin Modulators|tubulin modulators|mesh-ancestor
110725765|NCT01561456|Antimitotic Agents|antimitotic agents|mesh-ancestor
110725766|NCT01561456|Mitosis Modulators|mitosis modulators|mesh-ancestor
110725767|NCT01561456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110725768|NCT00137436|Prednisone|prednisone|mesh-list
110725769|NCT00137436|Docetaxel|docetaxel|mesh-list
110725770|NCT00137436|Sunitinib|sunitinib|mesh-list
110725771|NCT00137436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110725772|NCT00137436|Tubulin Modulators|tubulin modulators|mesh-ancestor
110725773|NCT00137436|Antimitotic Agents|antimitotic agents|mesh-ancestor
110725774|NCT00137436|Mitosis Modulators|mitosis modulators|mesh-ancestor
110725775|NCT00137436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110725776|NCT00137436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110725777|NCT00137436|Glucocorticoids|glucocorticoids|mesh-ancestor
110725778|NCT00137436|Hormones|hormones|mesh-ancestor
110725779|NCT00137436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110725780|NCT00137436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110725781|NCT00137436|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110443581|NCT01150097|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110725782|NCT00137436|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110725783|NCT00137436|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110725784|NCT00137436|Growth Substances|growth substances|mesh-ancestor
110725785|NCT00137436|Growth Inhibitors|growth inhibitors|mesh-ancestor
110725786|NCT00137436|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110725787|NCT00137436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110725788|NCT03762538|Propofol|propofol|mesh-list
110725789|NCT03762538|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110725790|NCT03762538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110725791|NCT03762538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110725792|NCT03762538|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110725793|NCT03762538|Anesthetics, General|anesthetics, general|mesh-ancestor
110725794|NCT03762538|Anesthetics|anesthetics|mesh-ancestor
110725795|NCT03762382|Tenofovir|tenofovir|mesh-list
110725796|NCT03762382|Levonorgestrel|levonorgestrel|mesh-list
110725797|NCT03762382|Antiviral Agents|antiviral agents|mesh-ancestor
110725798|NCT03762382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110725799|NCT03762382|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110725800|NCT03762382|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110725801|NCT03762382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110725802|NCT03762382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110725803|NCT03762382|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110725804|NCT03762382|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110725805|NCT03762382|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110725806|NCT03762382|Contraceptive Agents|contraceptive agents|mesh-ancestor
110725807|NCT03762382|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110725808|NCT03762382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110725809|NCT03762382|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110725810|NCT03762382|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110725811|NCT03762382|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110725812|NCT03767920|Dexamethasone|dexamethasone|mesh-list
110725813|NCT03767920|Dexamethasone acetate|dexamethasone acetate|mesh-list
110725814|NCT03767920|Bupivacaine|bupivacaine|mesh-list
110725815|NCT03767920|BB 1101|bb 1101|mesh-list
110725816|NCT03767920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110725817|NCT03767920|Antiemetics|antiemetics|mesh-ancestor
110725818|NCT03767920|Autonomic Agents|autonomic agents|mesh-ancestor
110725819|NCT03767920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110725820|NCT03767920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110725821|NCT03767920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110725822|NCT03767920|Glucocorticoids|glucocorticoids|mesh-ancestor
110725823|NCT03767920|Hormones|hormones|mesh-ancestor
110725824|NCT03767920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110725825|NCT03767920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110725826|NCT03767920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110725827|NCT03767920|Protease Inhibitors|protease inhibitors|mesh-ancestor
110725828|NCT03767920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110725829|NCT03767920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110725830|NCT03767920|Anesthetics, Local|anesthetics, local|mesh-ancestor
110725831|NCT03767920|Anesthetics|anesthetics|mesh-ancestor
110725832|NCT03767920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110725833|NCT03767920|Sensory System Agents|sensory system agents|mesh-ancestor
110725834|NCT03834623|Nivolumab|nivolumab|mesh-list
110725835|NCT03834623|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110725836|NCT03834623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110725837|NCT03834623|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110725838|NCT03834623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110725839|NCT03762148|Vitamins|vitamins|mesh-list
110725840|NCT03762148|Ascorbic Acid|ascorbic acid|mesh-list
110725841|NCT03762148|Ferrous fumarate|ferrous fumarate|mesh-list
110725842|NCT03762148|Iron|iron|mesh-list
110725843|NCT03762148|Micronutrients|micronutrients|mesh-ancestor
110725844|NCT03762148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110725845|NCT03762148|Antioxidants|antioxidants|mesh-ancestor
110725846|NCT03762148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110725847|NCT03762148|Protective Agents|protective agents|mesh-ancestor
110725848|NCT03762148|Trace Elements|trace elements|mesh-ancestor
110725850|NCT01589159|Etoposide|etoposide|mesh-list
110725851|NCT01589159|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110725852|NCT01589159|Antimetabolites|antimetabolites|mesh-ancestor
110725853|NCT01589159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110725854|NCT01589159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110725855|NCT01589159|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110725856|NCT01589159|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110725857|NCT01589159|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110141661|NCT02014428|Hyaluronic Acid|hyaluronic acid|mesh-list
110725858|NCT01589159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110725859|NCT03711292|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110725860|NCT03711292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110725861|NCT03937895|Pembrolizumab|pembrolizumab|mesh-list
110725862|NCT03937895|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110725863|NCT03937895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110725864|NCT03937895|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110725865|NCT03937895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110725866|NCT03767296|Phenylephrine|phenylephrine|mesh-list
110725867|NCT03767296|Oxymetazoline|oxymetazoline|mesh-list
110725868|NCT03767296|Ephedrine|ephedrine|mesh-list
110725869|NCT03767296|Pseudoephedrine|pseudoephedrine|mesh-list
110725870|NCT03767296|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110725871|NCT03767296|Mydriatics|mydriatics|mesh-ancestor
110725872|NCT03767296|Autonomic Agents|autonomic agents|mesh-ancestor
110725873|NCT03767296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110725874|NCT03767296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110725875|NCT03767296|Sympathomimetics|sympathomimetics|mesh-ancestor
110725876|NCT03767296|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110725877|NCT03767296|Nasal Decongestants|nasal decongestants|mesh-ancestor
110725878|NCT03767296|Respiratory System Agents|respiratory system agents|mesh-ancestor
110725879|NCT03767296|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110725880|NCT03767296|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110725881|NCT03767296|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110725882|NCT03767296|Adrenergic Agents|adrenergic agents|mesh-ancestor
110725883|NCT03767296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110725884|NCT03767296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110725885|NCT03767296|Protective Agents|protective agents|mesh-ancestor
110725886|NCT03767296|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110725887|NCT03767296|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110725888|NCT03767296|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110725889|NCT00410813|Dasatinib|dasatinib|mesh-list
110725890|NCT00410813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110725891|NCT00410813|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110725892|NCT00410813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110725893|NCT00410813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110725894|NCT03760978|Dexmedetomidine|dexmedetomidine|mesh-list
110725895|NCT03760978|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110725896|NCT03760978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110725897|NCT03760978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110725898|NCT03760978|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110725899|NCT03760978|Analgesics|analgesics|mesh-ancestor
110725900|NCT03760978|Sensory System Agents|sensory system agents|mesh-ancestor
110725901|NCT03760978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110725902|NCT03760978|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110725903|NCT03760978|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110725904|NCT03760978|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110725905|NCT03760978|Adrenergic Agents|adrenergic agents|mesh-ancestor
110725906|NCT03760978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110725907|NCT03760978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110725908|NCT03766984|Diclofenac|diclofenac|mesh-list
110725909|NCT03766984|Tramadol|tramadol|mesh-list
110725910|NCT03766984|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110725911|NCT03766984|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110725912|NCT03766984|Analgesics|analgesics|mesh-ancestor
110725913|NCT03766984|Sensory System Agents|sensory system agents|mesh-ancestor
110725914|NCT03766984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110725915|NCT03766984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110725916|NCT03766984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110725917|NCT03766984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110725918|NCT03766984|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110725919|NCT03766984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110725920|NCT03766984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110725921|NCT03766984|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110725922|NCT03766984|Narcotics|narcotics|mesh-ancestor
110725923|NCT03766984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110725924|NCT00405821|Acyclovir|acyclovir|mesh-list
110725925|NCT00405821|Antiviral Agents|antiviral agents|mesh-ancestor
110725926|NCT00405821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110725927|NCT03928600|Misoprostol|misoprostol|mesh-list
110725928|NCT03928600|Dinoprostone|dinoprostone|mesh-list
110725929|NCT03928600|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110725930|NCT03928600|Abortifacient Agents|abortifacient agents|mesh-ancestor
110725931|NCT03928600|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110725932|NCT03928600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110725933|NCT03928600|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110725934|NCT03928600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110725935|NCT03928600|Oxytocics|oxytocics|mesh-ancestor
110725936|NCT01322152|Capecitabine|capecitabine|mesh-list
110725937|NCT01322152|Irinotecan|irinotecan|mesh-list
110725938|NCT01322152|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110725939|NCT01322152|Antimetabolites|antimetabolites|mesh-ancestor
110725940|NCT01322152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110725941|NCT01322152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110725942|NCT01322152|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110725943|NCT01322152|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110725944|NCT01322152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110725945|NCT01446016|Paclitaxel|paclitaxel|mesh-list
110725946|NCT01446016|Docetaxel|docetaxel|mesh-list
110725947|NCT01446016|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110725948|NCT01446016|Taxane|taxane|mesh-list
110725949|NCT01446016|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110725950|NCT01446016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110725951|NCT01446016|Tubulin Modulators|tubulin modulators|mesh-ancestor
110725952|NCT01446016|Antimitotic Agents|antimitotic agents|mesh-ancestor
110725953|NCT01446016|Mitosis Modulators|mitosis modulators|mesh-ancestor
110725954|NCT01446016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110725955|NCT00137046|Insulin|insulin|mesh-list
110725956|NCT00137046|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110725957|NCT00137046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110725958|NCT00137046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110725959|NCT03760354|Methylprednisolone|methylprednisolone|mesh-list
110725960|NCT03760354|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110725961|NCT03760354|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110725962|NCT03760354|Prednisolone|prednisolone|mesh-list
110725963|NCT03760354|Prednisolone acetate|prednisolone acetate|mesh-list
110725964|NCT03760354|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110725965|NCT03760354|Prednisolone phosphate|prednisolone phosphate|mesh-list
110725966|NCT03760354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110725967|NCT03760354|Antiemetics|antiemetics|mesh-ancestor
110725968|NCT03760354|Autonomic Agents|autonomic agents|mesh-ancestor
110725969|NCT03760354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110863214|NCT02454868|Remifentanil|remifentanil|mesh-list
110725970|NCT03760354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110725971|NCT03760354|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110725972|NCT03760354|Glucocorticoids|glucocorticoids|mesh-ancestor
110725973|NCT03760354|Hormones|hormones|mesh-ancestor
110725974|NCT03760354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110725975|NCT03760354|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110725976|NCT03760354|Protective Agents|protective agents|mesh-ancestor
110725977|NCT03760354|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110725978|NCT03760354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110725979|NCT03760276|Voriconazole|voriconazole|mesh-list
110725980|NCT03760276|Antifungal Agents|antifungal agents|mesh-ancestor
110725981|NCT03760276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110725982|NCT03760276|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110725983|NCT03760276|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110725984|NCT03760276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110725985|NCT03760276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110725986|NCT03760276|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110725987|NCT03760276|Hormone Antagonists|hormone antagonists|mesh-ancestor
110725988|NCT03760276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110725989|NCT03760276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110725990|NCT03760276|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110725991|NCT03766594|Folic Acid|folic acid|mesh-list
110725992|NCT03766594|Sildenafil Citrate|sildenafil citrate|mesh-list
110725993|NCT03766594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110725994|NCT03766594|Vasodilator Agents|vasodilator agents|mesh-ancestor
110725995|NCT03766594|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110725996|NCT03766594|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110725997|NCT03766594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110725998|NCT03766594|Urological Agents|urological agents|mesh-ancestor
110725999|NCT03766594|Hematinics|hematinics|mesh-ancestor
110726000|NCT03766594|Vitamin B Complex|vitamin b complex|mesh-ancestor
110726001|NCT03766594|Vitamins|vitamins|mesh-ancestor
110726002|NCT03766594|Micronutrients|micronutrients|mesh-ancestor
110726003|NCT03766594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110726004|NCT00122382|Methotrexate|methotrexate|mesh-list
110726005|NCT00122382|Abatacept|abatacept|mesh-list
110726006|NCT00122382|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110726007|NCT00122382|Abortifacient Agents|abortifacient agents|mesh-ancestor
110726008|NCT00122382|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110726009|NCT00122382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110726010|NCT00122382|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110726011|NCT00122382|Antimetabolites|antimetabolites|mesh-ancestor
110726012|NCT00122382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110726013|NCT00122382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110726014|NCT00122382|Dermatologic Agents|dermatologic agents|mesh-ancestor
110726015|NCT00122382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110726016|NCT00122382|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110726017|NCT00122382|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110726018|NCT00122382|Immunologic Factors|immunologic factors|mesh-ancestor
110726019|NCT00122382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110726020|NCT00122382|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110726021|NCT00122382|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110726022|NCT00122382|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110726023|NCT01028716|Mycophenolic Acid|mycophenolic acid|mesh-list
110726024|NCT01028716|Cyclophosphamide|cyclophosphamide|mesh-list
110726025|NCT01028716|Fludarabine|fludarabine|mesh-list
110726026|NCT01028716|Fludarabine phosphate|fludarabine phosphate|mesh-list
110726027|NCT01028716|Tacrolimus|tacrolimus|mesh-list
110726028|NCT01028716|Lenograstim|lenograstim|mesh-list
110726029|NCT01028716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110726031|NCT01028716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110726032|NCT01028716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110726033|NCT01028716|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110726034|NCT01028716|Alkylating Agents|alkylating agents|mesh-ancestor
110726035|NCT01028716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110726036|NCT01028716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110726037|NCT01028716|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110726038|NCT01028716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110726039|NCT01028716|Antimetabolites|antimetabolites|mesh-ancestor
110726040|NCT01028716|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110726041|NCT01028716|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110726042|NCT01028716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110726043|NCT01028716|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110726044|NCT01028716|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110726045|NCT01028716|Antitubercular Agents|antitubercular agents|mesh-ancestor
110726046|NCT01028716|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110726047|NCT01028716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110726048|NCT02531724|Simendan|simendan|mesh-list
110726049|NCT02531724|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110726050|NCT02531724|Vasodilator Agents|vasodilator agents|mesh-ancestor
110726051|NCT02531724|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110726052|NCT02531724|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110726053|NCT02531724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110726054|NCT02531724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110726055|NCT02531724|Protective Agents|protective agents|mesh-ancestor
110726056|NCT02531724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110726057|NCT03760198|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110726058|NCT03760198|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110726059|NCT03760198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110726060|NCT03760198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110726061|NCT03760198|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110726062|NCT03760198|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110726063|NCT03760198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110726064|NCT03760198|Cholinergic Agents|cholinergic agents|mesh-ancestor
110726065|NCT03760198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110726066|NCT00106704|Pioglitazone|pioglitazone|mesh-list
110726067|NCT00106704|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110726068|NCT00106704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110726069|NCT00106704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110726070|NCT00106704|Incretins|incretins|mesh-ancestor
110726071|NCT00106704|Hormones|hormones|mesh-ancestor
110726072|NCT00106704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110726073|NCT00106704|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110726074|NCT00106704|Protease Inhibitors|protease inhibitors|mesh-ancestor
110726075|NCT00106704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110726076|NCT00106704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110726077|NCT03759886|Metronidazole|metronidazole|mesh-list
110726078|NCT03759886|Paromomycin|paromomycin|mesh-list
110726079|NCT03759886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110726080|NCT03759886|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110726081|NCT03759886|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110726082|NCT03759886|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110726083|NCT01081158|Ritonavir|ritonavir|mesh-list
110726084|NCT01081158|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110726085|NCT01081158|Interferon-alpha|interferon-alpha|mesh-list
110726086|NCT01081158|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110726087|NCT01081158|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110726088|NCT01081158|Protease Inhibitors|protease inhibitors|mesh-ancestor
110726089|NCT01081158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110726090|NCT01081158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110726091|NCT01081158|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110726092|NCT01081158|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110726093|NCT01081158|Antiviral Agents|antiviral agents|mesh-ancestor
110726094|NCT01081158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110726095|NCT01081158|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110726096|NCT01081158|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110726097|NCT01081158|Immunologic Factors|immunologic factors|mesh-ancestor
110726098|NCT01081158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110726099|NCT00105066|Metformin|metformin|mesh-list
110726100|NCT00105066|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110726101|NCT00105066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110726103|NCT01322308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110726104|NCT01322308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110726105|NCT05208268|Rabeprazole|rabeprazole|mesh-list
110726106|NCT05208268|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110726107|NCT05208268|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110726108|NCT05208268|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110726109|NCT05208268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110726110|NCT05208268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110726111|NCT03759262|Vitamin D|vitamin d|mesh-list
110726112|NCT03759262|Cholecalciferol|cholecalciferol|mesh-list
110726113|NCT03759262|Vitamins|vitamins|mesh-ancestor
110726114|NCT03759262|Micronutrients|micronutrients|mesh-ancestor
110726116|NCT03759262|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110726117|NCT03759262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110726118|NCT00135330|Exenatide|exenatide|mesh-list
110726119|NCT00135330|Rosiglitazone|rosiglitazone|mesh-list
110726120|NCT00135330|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110726121|NCT00135330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110726122|NCT00135330|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110726123|NCT00135330|Incretins|incretins|mesh-ancestor
110726124|NCT00135330|Hormones|hormones|mesh-ancestor
110726125|NCT00135330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110726126|NCT01076478|Cilostazol|cilostazol|mesh-list
110726127|NCT01076478|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110726128|NCT01076478|Autonomic Agents|autonomic agents|mesh-ancestor
110726129|NCT01076478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110726130|NCT01076478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110726131|NCT01076478|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110726132|NCT01076478|Respiratory System Agents|respiratory system agents|mesh-ancestor
110726133|NCT01076478|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110726134|NCT01076478|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110726135|NCT01076478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110726136|NCT01076478|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110726137|NCT01076478|Vasodilator Agents|vasodilator agents|mesh-ancestor
110726138|NCT01076478|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110726139|NCT01076478|Protective Agents|protective agents|mesh-ancestor
110726140|NCT01076478|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110726141|NCT01076478|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110726142|NCT01076478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110726143|NCT01076556|Cyclophosphamide|cyclophosphamide|mesh-list
110726144|NCT01076556|Rituximab|rituximab|mesh-list
110726145|NCT01076556|Alvocidib|alvocidib|mesh-list
110726146|NCT01076556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110726147|NCT01076556|Antibodies|antibodies|mesh-list
110726148|NCT01076556|Immunoglobulins|immunoglobulins|mesh-list
110726149|NCT01076556|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110726150|NCT01076556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110726151|NCT01076556|Immunologic Factors|immunologic factors|mesh-ancestor
110726152|NCT01076556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110726153|NCT01076556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110726154|NCT01076556|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110726155|NCT01076556|Alkylating Agents|alkylating agents|mesh-ancestor
110726156|NCT01076556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110726157|NCT01076556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110726158|NCT01076556|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110726160|NCT01076556|Growth Substances|growth substances|mesh-ancestor
110726161|NCT01076556|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110726162|NCT01076556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110726163|NCT03965442|Esmolol|esmolol|mesh-list
110726164|NCT03965442|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110726165|NCT03965442|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110726166|NCT03965442|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110726167|NCT03965442|Adrenergic Agents|adrenergic agents|mesh-ancestor
110726168|NCT03965442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110726169|NCT03965442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110726170|NCT03965442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110726171|NCT00134082|Cyclophosphamide|cyclophosphamide|mesh-list
110726172|NCT00134082|Rituximab|rituximab|mesh-list
110726174|NCT00134082|Immunologic Factors|immunologic factors|mesh-ancestor
110726175|NCT00134082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110726176|NCT00134082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110726177|NCT00134082|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110726178|NCT00134082|Alkylating Agents|alkylating agents|mesh-ancestor
110726179|NCT00134082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110726180|NCT00134082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110726181|NCT00134082|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110726182|NCT00134082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110726183|NCT03765346|Oxycodone|oxycodone|mesh-list
110726184|NCT03765346|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110726185|NCT03765346|Narcotics|narcotics|mesh-ancestor
110141708|NCT02014558|Cephalexin|cephalexin|mesh-list
110726186|NCT03765346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110726187|NCT03765346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110726188|NCT03765346|Analgesics|analgesics|mesh-ancestor
110726189|NCT03765346|Sensory System Agents|sensory system agents|mesh-ancestor
110726190|NCT03765346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110726191|NCT01078818|Ferrous fumarate|ferrous fumarate|mesh-list
110726192|NCT01078818|Trace Elements|trace elements|mesh-ancestor
110726193|NCT01078818|Micronutrients|micronutrients|mesh-ancestor
110726194|NCT01078818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110726195|NCT01079052|Famotidine|famotidine|mesh-list
110726196|NCT01079052|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110726197|NCT01079052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110726198|NCT01079052|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110726199|NCT01079052|Histamine Antagonists|histamine antagonists|mesh-ancestor
110726200|NCT01079052|Histamine Agents|histamine agents|mesh-ancestor
110726201|NCT01079052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110726202|NCT01079052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110726203|NCT01079052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110726204|NCT01326468|Sirolimus|sirolimus|mesh-list
110726205|NCT01326468|Cisplatin|cisplatin|mesh-list
110726206|NCT01326468|Cetuximab|cetuximab|mesh-list
110726207|NCT01326468|Temsirolimus|temsirolimus|mesh-list
110726208|NCT01326468|MTOR Inhibitors|mtor inhibitors|mesh-list
110726209|NCT01326468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110726210|NCT01326468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110726211|NCT01326468|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110726212|NCT01326468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110726213|NCT01326468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110726214|NCT01326468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110726215|NCT01326468|Immunologic Factors|immunologic factors|mesh-ancestor
110726216|NCT01326468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110726217|NCT01326468|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110726218|NCT01326468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110726219|NCT01326468|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110726220|NCT01326468|Antifungal Agents|antifungal agents|mesh-ancestor
110726221|NCT01076634|Insulin|insulin|mesh-list
110726222|NCT01076634|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110726223|NCT01076634|Insulin, Long-Acting|insulin, long-acting|mesh-list
110726224|NCT01076634|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110726225|NCT01076634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110726226|NCT00132678|Risperidone|risperidone|mesh-list
110726227|NCT00132678|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110726228|NCT00132678|Serotonin Agents|serotonin agents|mesh-ancestor
110726229|NCT00132678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110726230|NCT00132678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110726231|NCT00132678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110726232|NCT00132678|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110726233|NCT00132678|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110726234|NCT00132678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110726235|NCT00132678|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110726236|NCT00132678|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110726237|NCT00132678|Dopamine Agents|dopamine agents|mesh-ancestor
110726238|NCT01081548|Atorvastatin|atorvastatin|mesh-list
110726239|NCT01081548|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110726240|NCT01081548|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110863262|NCT00423579|Ezetimibe|ezetimibe|mesh-list
110726241|NCT01081548|Antimetabolites|antimetabolites|mesh-ancestor
110726242|NCT01081548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110726243|NCT01081548|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110726244|NCT01081548|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110726245|NCT01081548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110726247|NCT00101400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110726248|NCT00101400|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110726249|NCT00101400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110726250|NCT00101400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110726251|NCT01076790|Dexmedetomidine|dexmedetomidine|mesh-list
110726252|NCT01076790|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110726253|NCT01076790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110726254|NCT01076790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110726255|NCT01076790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110726256|NCT01076790|Analgesics|analgesics|mesh-ancestor
110726257|NCT01076790|Sensory System Agents|sensory system agents|mesh-ancestor
110726258|NCT01076790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110726259|NCT01076790|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110726260|NCT01076790|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110726261|NCT01076790|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110726262|NCT01076790|Adrenergic Agents|adrenergic agents|mesh-ancestor
110726263|NCT01076790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110726264|NCT01076790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110726265|NCT01582932|Calcipotriene|calcipotriene|mesh-list
110726266|NCT01582932|Dermatologic Agents|dermatologic agents|mesh-ancestor
110726267|NCT03965286|Sofosbuvir|sofosbuvir|mesh-list
110726268|NCT03965286|Ledipasvir|ledipasvir|mesh-list
110726269|NCT03965286|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
110726270|NCT03965286|Antiviral Agents|antiviral agents|mesh-ancestor
110726271|NCT03965286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110726272|NCT01079286|Sirolimus|sirolimus|mesh-list
110726273|NCT01079286|Nelfinavir|nelfinavir|mesh-list
110726274|NCT01079286|Temsirolimus|temsirolimus|mesh-list
110726275|NCT01079286|MTOR Inhibitors|mtor inhibitors|mesh-list
110726276|NCT01079286|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110726277|NCT01079286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110726278|NCT01079286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110726279|NCT01079286|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110726280|NCT01079286|Immunologic Factors|immunologic factors|mesh-ancestor
110726281|NCT01079286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110726282|NCT01079286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110726283|NCT01079286|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110726284|NCT01079286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110726285|NCT01079286|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110726286|NCT01079286|Antifungal Agents|antifungal agents|mesh-ancestor
110726287|NCT01079286|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110726288|NCT01079286|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110726289|NCT01079286|Protease Inhibitors|protease inhibitors|mesh-ancestor
110726290|NCT01079286|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110726291|NCT01079286|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110726292|NCT01079286|Antiviral Agents|antiviral agents|mesh-ancestor
110726293|NCT01081704|Ustekinumab|ustekinumab|mesh-list
110726294|NCT01081704|Dermatologic Agents|dermatologic agents|mesh-ancestor
110726295|NCT00141518|Levodopa|levodopa|mesh-list
110726296|NCT00141518|Carbidopa|carbidopa|mesh-list
110726297|NCT00141518|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
110726298|NCT00141518|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110726299|NCT00141518|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110726300|NCT00141518|Dopamine Agents|dopamine agents|mesh-ancestor
110726301|NCT00141518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110726302|NCT00141518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110726303|NCT00141518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110726304|NCT00141518|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
110726305|NCT00141518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110726306|NCT00141518|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110726307|NCT00141518|Immunologic Factors|immunologic factors|mesh-ancestor
110726308|NCT00141518|Dopamine Agonists|dopamine agonists|mesh-ancestor
110726309|NCT01075880|Interferons|interferons|mesh-list
110726310|NCT01075880|Interferon-beta|interferon-beta|mesh-list
110726311|NCT01075880|Interferon beta-1a|interferon beta-1a|mesh-list
110726312|NCT01075880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110726313|NCT01075880|Antiviral Agents|antiviral agents|mesh-ancestor
110726314|NCT01075880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110726315|NCT01075880|Immunologic Factors|immunologic factors|mesh-ancestor
110726316|NCT01075880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110726317|NCT01075880|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110726318|NCT00098748|Maraviroc|maraviroc|mesh-list
110726319|NCT00098748|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110726320|NCT00098748|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110726321|NCT00098748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110726322|NCT00098748|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110726323|NCT00098748|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110726324|NCT00098748|Antiviral Agents|antiviral agents|mesh-ancestor
110726325|NCT00098748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110726326|NCT00098748|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
110726327|NCT00130520|Bevacizumab|bevacizumab|mesh-list
110726328|NCT00130520|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110726329|NCT00130520|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110726330|NCT00130520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110726331|NCT00130520|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110726332|NCT00130520|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110726333|NCT00130520|Growth Substances|growth substances|mesh-ancestor
110726334|NCT00130520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110726335|NCT00130520|Growth Inhibitors|growth inhibitors|mesh-ancestor
110726336|NCT00130520|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110726337|NCT00130520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110444226|NCT03365752|Anesthetics|anesthetics|mesh-list
110726338|NCT00130520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110726339|NCT00130442|Dacarbazine|dacarbazine|mesh-list
110726340|NCT00130442|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110726341|NCT00130442|Alkylating Agents|alkylating agents|mesh-ancestor
110726342|NCT00130442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110726343|NCT00130442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110726344|NCT00130208|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
110726345|NCT00130208|Anticoagulants|anticoagulants|mesh-ancestor
110726346|NCT00130208|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110726347|NCT00130208|Antimetabolites|antimetabolites|mesh-ancestor
110726348|NCT00130208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110726349|NCT00130208|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110726350|NCT00130208|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110726351|NCT00130208|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110726352|NCT00130208|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110726353|NCT00130208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110726354|NCT00253370|Cisplatin|cisplatin|mesh-list
110726355|NCT00253370|Docetaxel|docetaxel|mesh-list
110726356|NCT00253370|Sorafenib|sorafenib|mesh-list
110726357|NCT00253370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110726358|NCT00253370|Tubulin Modulators|tubulin modulators|mesh-ancestor
110726359|NCT00253370|Antimitotic Agents|antimitotic agents|mesh-ancestor
110726360|NCT00253370|Mitosis Modulators|mitosis modulators|mesh-ancestor
110726361|NCT00253370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110726362|NCT00253370|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110726363|NCT00253370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110726364|NCT03966170|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
110726365|NCT03966170|Nootropic Agents|nootropic agents|mesh-ancestor
110726366|NCT00140426|Risperidone|risperidone|mesh-list
110726367|NCT00140426|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110726368|NCT00140426|Serotonin Agents|serotonin agents|mesh-ancestor
110726369|NCT00140426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110726370|NCT00140426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110726371|NCT00140426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110726372|NCT00140426|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110726373|NCT00140426|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110726374|NCT00140426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110726375|NCT00140426|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110726376|NCT00140426|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110726377|NCT00140426|Dopamine Agents|dopamine agents|mesh-ancestor
110726378|NCT03966560|Timolol|timolol|mesh-list
110726379|NCT03966560|Brimonidine Tartrate|brimonidine tartrate|mesh-list
110726380|NCT03966560|Bimatoprost|bimatoprost|mesh-list
110726381|NCT03966560|Travoprost|travoprost|mesh-list
110726382|NCT03966560|Dorzolamide|dorzolamide|mesh-list
110726383|NCT03966560|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110726384|NCT03966560|Latanoprost|latanoprost|mesh-list
110726385|NCT03966560|Brinzolamide|brinzolamide|mesh-list
110726386|NCT03966560|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110726387|NCT03966560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110726388|NCT03966560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110726389|NCT03966560|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110726390|NCT03966560|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110726391|NCT03966560|Adrenergic Agents|adrenergic agents|mesh-ancestor
110726392|NCT03966560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110726393|NCT03966560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110726394|NCT03966560|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110726395|NCT03966560|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110726396|NCT03966560|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110726397|NCT03966560|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110726398|NCT03966560|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110726399|NCT03966560|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110726400|NCT01072058|Adalimumab|adalimumab|mesh-list
110726401|NCT01072058|Infliximab|infliximab|mesh-list
110726402|NCT01072058|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
110726403|NCT01072058|Etanercept|etanercept|mesh-list
110726404|NCT01072058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110726405|NCT01072058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110726406|NCT01072058|Dermatologic Agents|dermatologic agents|mesh-ancestor
110726407|NCT01072058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110726408|NCT01072058|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110726409|NCT01072058|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110726410|NCT01072058|Analgesics|analgesics|mesh-ancestor
110726411|NCT01072058|Sensory System Agents|sensory system agents|mesh-ancestor
110726412|NCT01072058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110726413|NCT01072058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110726415|NCT01072058|Immunologic Factors|immunologic factors|mesh-ancestor
110726416|NCT00121134|Cyclophosphamide|cyclophosphamide|mesh-list
110726417|NCT00121134|Bevacizumab|bevacizumab|mesh-list
110726418|NCT00121134|Capecitabine|capecitabine|mesh-list
110726419|NCT00121134|Methotrexate|methotrexate|mesh-list
110726420|NCT00121134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110726421|NCT00121134|Immunologic Factors|immunologic factors|mesh-ancestor
110726422|NCT00121134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110726423|NCT00121134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110726424|NCT00121134|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110726425|NCT00121134|Alkylating Agents|alkylating agents|mesh-ancestor
110726426|NCT00121134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110726427|NCT00121134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110726428|NCT00121134|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110726429|NCT00121134|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110726430|NCT00121134|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110141733|NCT02014558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110726431|NCT00121134|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110726432|NCT00121134|Growth Substances|growth substances|mesh-ancestor
110726433|NCT00121134|Growth Inhibitors|growth inhibitors|mesh-ancestor
110726434|NCT00121134|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110726435|NCT00121134|Antimetabolites|antimetabolites|mesh-ancestor
110726436|NCT00121134|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110726437|NCT00121134|Abortifacient Agents|abortifacient agents|mesh-ancestor
110726438|NCT00121134|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110726439|NCT00121134|Dermatologic Agents|dermatologic agents|mesh-ancestor
110726440|NCT00121134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110726441|NCT00121134|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110726442|NCT00121134|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110726443|NCT03966378|Grape Seed Extract|grape seed extract|mesh-list
110726444|NCT03966378|Calcium|calcium|mesh-list
110726445|NCT03966378|Caseins|caseins|mesh-list
110726446|NCT03966378|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110726447|NCT03966378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110726448|NCT03966378|Chelating Agents|chelating agents|mesh-ancestor
110726449|NCT03966378|Sequestering Agents|sequestering agents|mesh-ancestor
110726450|NCT03966378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110726451|NCT03966378|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110726452|NCT03966378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110726453|NCT03966378|Antioxidants|antioxidants|mesh-ancestor
110726454|NCT03966378|Protective Agents|protective agents|mesh-ancestor
110726455|NCT02657434|Carboplatin|carboplatin|mesh-list
110726456|NCT02657434|Pemetrexed|pemetrexed|mesh-list
110726457|NCT02657434|Atezolizumab|atezolizumab|mesh-list
110726458|NCT02657434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110726459|NCT02657434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110726460|NCT02657434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110726461|NCT02657434|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110726462|NCT02657434|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110726463|NCT02657434|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110726464|NCT02657434|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110726465|NCT00119262|Tamoxifen|tamoxifen|mesh-list
110726466|NCT00119262|Cyclophosphamide|cyclophosphamide|mesh-list
110726467|NCT00119262|Bevacizumab|bevacizumab|mesh-list
110726468|NCT00119262|Doxorubicin|doxorubicin|mesh-list
110726469|NCT00119262|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110726470|NCT00119262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110726471|NCT00119262|Antibodies|antibodies|mesh-list
110726472|NCT00119262|Immunoglobulins|immunoglobulins|mesh-list
110726473|NCT00119262|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110726474|NCT00119262|Lenograstim|lenograstim|mesh-list
110726475|NCT00119262|Aromatase Inhibitors|aromatase inhibitors|mesh-list
110726476|NCT00119262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110726477|NCT00119262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110726478|NCT00119262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110726479|NCT00119262|Immunologic Factors|immunologic factors|mesh-ancestor
110726480|NCT00119262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110726481|NCT00119262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110726482|NCT00119262|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110726483|NCT00119262|Alkylating Agents|alkylating agents|mesh-ancestor
110726484|NCT00119262|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110726485|NCT00119262|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110726486|NCT00119262|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110726487|NCT00119262|Growth Substances|growth substances|mesh-ancestor
110726488|NCT00119262|Growth Inhibitors|growth inhibitors|mesh-ancestor
110726489|NCT00119262|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110726490|NCT00119262|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110726491|NCT00119262|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110726492|NCT00119262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110726493|NCT00119262|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110726494|NCT00119262|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110726495|NCT00119262|Hormone Antagonists|hormone antagonists|mesh-ancestor
110726496|NCT00119262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110726497|NCT00119262|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110141775|NCT02014753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110726498|NCT00119262|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110726499|NCT00119262|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110726500|NCT00119262|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110726501|NCT00119262|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110726502|NCT00131664|Metformin|metformin|mesh-list
110726503|NCT00131664|Glimepiride|glimepiride|mesh-list
110726504|NCT00131664|Rosiglitazone|rosiglitazone|mesh-list
110726505|NCT00131664|Maleic acid|maleic acid|mesh-list
110726506|NCT00131664|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110726507|NCT00131664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110726508|NCT00131664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110726509|NCT00131664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110726510|NCT00131664|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110726511|NCT00131664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110726512|NCT00131664|Immunologic Factors|immunologic factors|mesh-ancestor
110726513|NCT05050318|Vaccines|vaccines|mesh-list
110726514|NCT05050318|Immunologic Factors|immunologic factors|mesh-ancestor
110726515|NCT05050318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110726516|NCT03778996|Sirolimus|sirolimus|mesh-list
110726517|NCT03778996|Phenytoin|phenytoin|mesh-list
110726518|NCT03778996|Methoxsalen|methoxsalen|mesh-list
110726519|NCT03778996|alpha-Methyltyrosine|alpha-methyltyrosine|mesh-list
110726520|NCT03778996|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110726521|NCT03778996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110726522|NCT03778996|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110726523|NCT03778996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110726524|NCT03778996|Antifungal Agents|antifungal agents|mesh-ancestor
110726525|NCT03778996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110726526|NCT03778996|Immunologic Factors|immunologic factors|mesh-ancestor
110726527|NCT03778996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110726528|NCT03778996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110726529|NCT03778996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110726530|NCT03778996|Anticonvulsants|anticonvulsants|mesh-ancestor
110726531|NCT03778996|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110726532|NCT03778996|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110726533|NCT03778996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110726534|NCT03778996|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110726535|NCT03778996|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110726536|NCT03778996|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110726537|NCT03778996|Dermatologic Agents|dermatologic agents|mesh-ancestor
110726538|NCT03764722|Simendan|simendan|mesh-list
110726539|NCT03764722|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110726540|NCT03764722|Vasodilator Agents|vasodilator agents|mesh-ancestor
110726541|NCT03764722|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110726542|NCT03764722|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110726543|NCT03764722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110726544|NCT03764722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110726545|NCT03764722|Protective Agents|protective agents|mesh-ancestor
110726546|NCT03764722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110726547|NCT05024734|Gemcitabine|gemcitabine|mesh-list
110726548|NCT05024734|Docetaxel|docetaxel|mesh-list
110726549|NCT05024734|Epirubicin|epirubicin|mesh-list
110726550|NCT05024734|Mitomycins|mitomycins|mesh-list
110726551|NCT05024734|Mitomycin|mitomycin|mesh-list
110726552|NCT05024734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110726553|NCT05024734|Antimetabolites|antimetabolites|mesh-ancestor
110726554|NCT05024734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110726555|NCT05024734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110726556|NCT05024734|Tubulin Modulators|tubulin modulators|mesh-ancestor
110726557|NCT05024734|Antimitotic Agents|antimitotic agents|mesh-ancestor
110726558|NCT05024734|Mitosis Modulators|mitosis modulators|mesh-ancestor
110726559|NCT05024734|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110726560|NCT05024734|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110726561|NCT05024734|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110726562|NCT05024734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110726563|NCT05024734|Alkylating Agents|alkylating agents|mesh-ancestor
110726564|NCT05024734|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110726565|NCT03699124|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
110726566|NCT03699124|Antiviral Agents|antiviral agents|mesh-ancestor
110726567|NCT03699124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110726568|NCT03756298|Capecitabine|capecitabine|mesh-list
110726569|NCT03756298|Atezolizumab|atezolizumab|mesh-list
110726570|NCT03756298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110726571|NCT03756298|Antimetabolites|antimetabolites|mesh-ancestor
110726572|NCT03756298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110726573|NCT03756298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110726574|NCT03756298|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110726575|NCT03756298|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110726576|NCT03756220|Ascorbic Acid|ascorbic acid|mesh-list
110726577|NCT03756220|Thiamine|thiamine|mesh-list
110726578|NCT03756220|Vitamins|vitamins|mesh-ancestor
110726579|NCT03756220|Micronutrients|micronutrients|mesh-ancestor
110726580|NCT03756220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110726581|NCT03756220|Antioxidants|antioxidants|mesh-ancestor
110726582|NCT03756220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110726583|NCT03756220|Protective Agents|protective agents|mesh-ancestor
110726584|NCT03756220|Vitamin B Complex|vitamin b complex|mesh-ancestor
110726585|NCT04980040|Alogliptin|alogliptin|mesh-list
110726586|NCT04980040|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110726587|NCT04980040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110726589|NCT04980040|Hormones|hormones|mesh-ancestor
110726590|NCT04980040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110726591|NCT04980040|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110726592|NCT04980040|Protease Inhibitors|protease inhibitors|mesh-ancestor
110726593|NCT04980040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110726594|NCT04980040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110726595|NCT00131352|Hylan|hylan|mesh-list
110726596|NCT00131352|Viscosupplements|viscosupplements|mesh-ancestor
110726597|NCT00131352|Protective Agents|protective agents|mesh-ancestor
110726598|NCT00131352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110726599|NCT00136916|Insulin|insulin|mesh-list
110726600|NCT00136916|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110726601|NCT00136916|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110726602|NCT00136916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110726603|NCT04633564|Bevacizumab|bevacizumab|mesh-list
110726604|NCT04633564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110726605|NCT04633564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110726606|NCT04633564|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110726607|NCT04633564|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110726608|NCT04633564|Growth Substances|growth substances|mesh-ancestor
110726609|NCT04633564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110726610|NCT04633564|Growth Inhibitors|growth inhibitors|mesh-ancestor
110726611|NCT03756064|Carboplatin|carboplatin|mesh-list
110726612|NCT03756064|Docetaxel|docetaxel|mesh-list
110444410|NCT02786446|Analgesics|analgesics|mesh-ancestor
110726613|NCT03756064|Trastuzumab|trastuzumab|mesh-list
110726614|NCT03756064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110726615|NCT03756064|Tubulin Modulators|tubulin modulators|mesh-ancestor
110726616|NCT03756064|Antimitotic Agents|antimitotic agents|mesh-ancestor
110726617|NCT03756064|Mitosis Modulators|mitosis modulators|mesh-ancestor
110726618|NCT03756064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110726619|NCT03756064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110726620|NCT04607980|Ustekinumab|ustekinumab|mesh-list
110726621|NCT04607980|Dermatologic Agents|dermatologic agents|mesh-ancestor
110726622|NCT03764020|Melatonin|melatonin|mesh-list
110726623|NCT03764020|Antioxidants|antioxidants|mesh-ancestor
110726624|NCT03764020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110726625|NCT03764020|Protective Agents|protective agents|mesh-ancestor
110726626|NCT03764020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110726627|NCT03764020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110726628|NCT00135512|Bupropion|bupropion|mesh-list
110726629|NCT00135512|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110726630|NCT00135512|Antidepressive Agents|antidepressive agents|mesh-ancestor
110726631|NCT00135512|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110726632|NCT00135512|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110726633|NCT00135512|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110726634|NCT00135512|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110726635|NCT00135512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110726636|NCT00135512|Dopamine Agents|dopamine agents|mesh-ancestor
110726637|NCT00135512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110726638|NCT00135512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110726639|NCT00135512|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110726640|NCT00135512|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110726641|NCT00135512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110726642|NCT00130728|Bevacizumab|bevacizumab|mesh-list
110726643|NCT00130728|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110726644|NCT00130728|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110726645|NCT00130728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110726646|NCT00130728|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110726647|NCT00130728|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110726648|NCT00130728|Growth Substances|growth substances|mesh-ancestor
110726649|NCT00130728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110726650|NCT00130728|Growth Inhibitors|growth inhibitors|mesh-ancestor
110726651|NCT00130728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110726652|NCT00130728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110726653|NCT00130728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110726654|NCT00129974|Gemcitabine|gemcitabine|mesh-list
110726655|NCT00129974|Pemetrexed|pemetrexed|mesh-list
110726656|NCT00129974|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110726657|NCT00129974|Antimetabolites|antimetabolites|mesh-ancestor
110726658|NCT00129974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110726659|NCT00129974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110726660|NCT00129974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110726661|NCT00129974|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110726662|NCT00129974|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110726663|NCT03966326|Fentanyl|fentanyl|mesh-list
110726664|NCT03966326|Anesthetics|anesthetics|mesh-list
110726665|NCT03966326|Sevoflurane|sevoflurane|mesh-list
110726666|NCT03966326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110726667|NCT03966326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110726668|NCT03966326|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110726669|NCT03966326|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110726670|NCT03966326|Anesthetics, General|anesthetics, general|mesh-ancestor
110726671|NCT03966326|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110726672|NCT03966326|Narcotics|narcotics|mesh-ancestor
110726673|NCT03966326|Analgesics|analgesics|mesh-ancestor
110726674|NCT03966326|Sensory System Agents|sensory system agents|mesh-ancestor
110726675|NCT03966326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110726676|NCT03966326|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110726677|NCT03966326|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110726678|NCT00119106|Tenofovir|tenofovir|mesh-list
110726679|NCT00119106|Antiviral Agents|antiviral agents|mesh-ancestor
110726680|NCT00119106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110726681|NCT00119106|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110726682|NCT00119106|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110726683|NCT00119106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110726684|NCT00119106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110726685|NCT00119106|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110726686|NCT00119106|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110726687|NCT03758014|Lomustine|lomustine|mesh-list
110726688|NCT03758014|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110726689|NCT03758014|Alkylating Agents|alkylating agents|mesh-ancestor
110726690|NCT03758014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110726691|NCT03758014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110726692|NCT00135356|Ritonavir|ritonavir|mesh-list
110726693|NCT00135356|Atazanavir Sulfate|atazanavir sulfate|mesh-list
110726694|NCT00135356|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
110726695|NCT00135356|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
110726696|NCT00135356|Protease Inhibitors|protease inhibitors|mesh-list
110726697|NCT00135356|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110726698|NCT00135356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110726699|NCT00135356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110726700|NCT00135356|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110726701|NCT00135356|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110726702|NCT00135356|Antiviral Agents|antiviral agents|mesh-ancestor
110726703|NCT00135356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110726704|NCT00135356|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110726705|NCT00135356|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110726706|NCT00135356|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110726707|NCT00118716|Fluticasone|fluticasone|mesh-list
110726708|NCT00118716|Xhance|xhance|mesh-list
110726709|NCT00118716|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110726710|NCT00118716|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110726711|NCT00118716|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110726712|NCT00118716|Autonomic Agents|autonomic agents|mesh-ancestor
110726713|NCT00118716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110726714|NCT00118716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110726715|NCT00118716|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110726716|NCT00118716|Respiratory System Agents|respiratory system agents|mesh-ancestor
110726717|NCT00118716|Dermatologic Agents|dermatologic agents|mesh-ancestor
110726718|NCT00118716|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110726719|NCT00118716|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110726720|NCT00118716|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110726721|NCT00118716|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110726722|NCT00118716|Adrenergic Agents|adrenergic agents|mesh-ancestor
110726723|NCT00118716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110726724|NCT00118716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110726725|NCT00118482|Fludrocortisone|fludrocortisone|mesh-list
110726726|NCT00118482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110726727|NCT03966950|Melatonin|melatonin|mesh-list
110726728|NCT03966950|Antioxidants|antioxidants|mesh-ancestor
110726729|NCT03966950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110726730|NCT03966950|Protective Agents|protective agents|mesh-ancestor
110726731|NCT03966950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110726732|NCT03966950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110726733|NCT03755752|Diminazene aceturate|diminazene aceturate|mesh-list
110726734|NCT03755752|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110726735|NCT03755752|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110726736|NCT03755752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110726737|NCT03755752|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
110726738|NCT01076582|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110726739|NCT01076582|Desogestrel|desogestrel|mesh-list
110726740|NCT01076582|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110726741|NCT01076582|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110726742|NCT01076582|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110726743|NCT01076582|Contraceptive Agents|contraceptive agents|mesh-ancestor
110726744|NCT01076582|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110726745|NCT01076582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110726746|NCT01076582|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110726747|NCT01076582|Estrogens|estrogens|mesh-ancestor
110726748|NCT01076582|Hormones|hormones|mesh-ancestor
110726749|NCT01076582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110726750|NCT01076582|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110726751|NCT01076582|Progestins|progestins|mesh-ancestor
110726752|NCT01081938|Insulin|insulin|mesh-list
110726753|NCT01081938|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110726754|NCT01081938|Insulin Glargine|insulin glargine|mesh-list
110726755|NCT01081938|Insulin glulisine|insulin glulisine|mesh-list
110726756|NCT01081938|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110726757|NCT01081938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110726758|NCT01082796|Glipizide|glipizide|mesh-list
110726759|NCT01082796|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110726760|NCT01082796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110726761|NCT03763786|Cetrorelix|cetrorelix|mesh-list
110726762|NCT03763786|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110726763|NCT03763786|Fertility Agents|fertility agents|mesh-ancestor
110726764|NCT03763786|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110726765|NCT03763786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110726766|NCT03763786|Hormone Antagonists|hormone antagonists|mesh-ancestor
110726767|NCT03763786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110726768|NCT01079364|Insulin|insulin|mesh-list
110726769|NCT01079364|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110726770|NCT01079364|Insulin Glargine|insulin glargine|mesh-list
110726771|NCT01079364|Insulin Aspart|insulin aspart|mesh-list
110726772|NCT01079364|Insulin glulisine|insulin glulisine|mesh-list
110726773|NCT01079364|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
110726774|NCT01079364|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110726775|NCT01079364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110726776|NCT01077752|Acetaminophen|acetaminophen|mesh-list
110726777|NCT01077752|Lidocaine|lidocaine|mesh-list
110726778|NCT01077752|Morphine|morphine|mesh-list
110726779|NCT01077752|Ropivacaine|ropivacaine|mesh-list
110726780|NCT01077752|Anesthetics, Local|anesthetics, local|mesh-ancestor
110726781|NCT01077752|Anesthetics|anesthetics|mesh-ancestor
110726782|NCT01077752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110726783|NCT01077752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110726784|NCT01077752|Sensory System Agents|sensory system agents|mesh-ancestor
110726785|NCT01077752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110726786|NCT01077752|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110726787|NCT01077752|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110726788|NCT01077752|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110726789|NCT01077752|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110726790|NCT01077752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110726791|NCT01077752|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110726792|NCT01077752|Narcotics|narcotics|mesh-ancestor
110726793|NCT01077752|Analgesics|analgesics|mesh-ancestor
110726794|NCT01077752|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110726795|NCT01077752|Antipyretics|antipyretics|mesh-ancestor
110726796|NCT00129272|Bupropion|bupropion|mesh-list
110726797|NCT00129272|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110726798|NCT00129272|Antidepressive Agents|antidepressive agents|mesh-ancestor
110726799|NCT00129272|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110726800|NCT00129272|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110726801|NCT00129272|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110726802|NCT00129272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110726803|NCT00129272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110726804|NCT00129272|Dopamine Agents|dopamine agents|mesh-ancestor
110726805|NCT00129272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110726806|NCT00129272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110726807|NCT00129272|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110726808|NCT00129272|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110726809|NCT00129272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110726810|NCT01326338|Nitazoxanide|nitazoxanide|mesh-list
110726811|NCT01326338|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110726812|NCT01326338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110726813|NCT03963648|Nitric Oxide|nitric oxide|mesh-list
110726814|NCT03963648|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110726815|NCT03963648|Autonomic Agents|autonomic agents|mesh-ancestor
110726816|NCT03963648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110726817|NCT03963648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110726818|NCT03963648|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110726819|NCT03963648|Respiratory System Agents|respiratory system agents|mesh-ancestor
110726820|NCT03963648|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110726821|NCT03963648|Antioxidants|antioxidants|mesh-ancestor
110726822|NCT03963648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110726823|NCT03963648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110726824|NCT03963648|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
110726825|NCT03963648|Vasodilator Agents|vasodilator agents|mesh-ancestor
110726826|NCT03963648|Gasotransmitters|gasotransmitters|mesh-ancestor
110726827|NCT03963648|Protective Agents|protective agents|mesh-ancestor
110726828|NCT04899232|Antithrombins|antithrombins|mesh-list
110726829|NCT04899232|Antithrombin III|antithrombin iii|mesh-list
110726830|NCT04899232|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110726831|NCT04899232|Protease Inhibitors|protease inhibitors|mesh-ancestor
110726832|NCT04899232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110726833|NCT04899232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110726834|NCT04899232|Anticoagulants|anticoagulants|mesh-ancestor
110726835|NCT03757858|Antibodies|antibodies|mesh-list
110726836|NCT03757858|Immunologic Factors|immunologic factors|mesh-ancestor
110726837|NCT03757858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110726838|NCT01079676|Lenograstim|lenograstim|mesh-list
110726839|NCT01079676|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110726840|NCT01079676|Immunologic Factors|immunologic factors|mesh-ancestor
110726841|NCT01079676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110726842|NCT01082250|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
110726843|NCT01082250|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110726844|NCT01082250|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110141806|NCT02015182|Anesthetics, Local|anesthetics, local|mesh-ancestor
110726845|NCT01082250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110726846|NCT01082250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110726847|NCT01082250|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110726848|NCT01082250|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
110726849|NCT01082250|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110726850|NCT01082250|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110726851|NCT01082250|Adrenergic Agents|adrenergic agents|mesh-ancestor
110726852|NCT01082250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110726853|NCT01082250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110726854|NCT01082250|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110726855|NCT01082250|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110726856|NCT01082250|Serotonin Agents|serotonin agents|mesh-ancestor
110726857|NCT01082250|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110726858|NCT01082250|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110726859|NCT01082250|Dopamine Agents|dopamine agents|mesh-ancestor
110726860|NCT00133952|Ruboxistaurin|ruboxistaurin|mesh-list
110726861|NCT00133952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110726862|NCT00133952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110726863|NCT04555096|Avasopasem manganese|avasopasem manganese|mesh-list
110726864|NCT04555096|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110726865|NCT04555096|Antioxidants|antioxidants|mesh-ancestor
110726866|NCT04555096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110726867|NCT04555096|Protective Agents|protective agents|mesh-ancestor
110726868|NCT04555096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110726869|NCT00097500|Metformin|metformin|mesh-list
110726870|NCT00097500|Insulin Glargine|insulin glargine|mesh-list
110726871|NCT00097500|Exenatide|exenatide|mesh-list
110726872|NCT00097500|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110726873|NCT00097500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110726874|NCT00097500|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110726875|NCT00097500|Incretins|incretins|mesh-ancestor
110726876|NCT00097500|Hormones|hormones|mesh-ancestor
110726877|NCT00097500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110726878|NCT01082484|Treprostinil|treprostinil|mesh-list
110726879|NCT01082484|Iloprost|iloprost|mesh-list
110726880|NCT01082484|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110726881|NCT01082484|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110726882|NCT01082484|Vasodilator Agents|vasodilator agents|mesh-ancestor
110726883|NCT05459974|Colchicine|colchicine|mesh-list
110726884|NCT05459974|Gout Suppressants|gout suppressants|mesh-ancestor
110726885|NCT05459974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110726886|NCT05459974|Tubulin Modulators|tubulin modulators|mesh-ancestor
110726887|NCT05459974|Antimitotic Agents|antimitotic agents|mesh-ancestor
110726888|NCT05459974|Mitosis Modulators|mitosis modulators|mesh-ancestor
110726889|NCT05459974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110726890|NCT05459974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110726891|NCT03754816|Anesthetics|anesthetics|mesh-list
110726892|NCT03754816|Levobupivacaine|levobupivacaine|mesh-list
110726893|NCT03754816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110726894|NCT03754816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110726895|NCT03754816|Anesthetics, Local|anesthetics, local|mesh-ancestor
110726896|NCT03754816|Sensory System Agents|sensory system agents|mesh-ancestor
110726897|NCT03754816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110726898|NCT04542694|Favipiravir|favipiravir|mesh-list
110726899|NCT04542694|Antiviral Agents|antiviral agents|mesh-ancestor
110726900|NCT04542694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110726901|NCT03965208|Heparin|heparin|mesh-list
110726902|NCT03965208|Calcium heparin|calcium heparin|mesh-list
110726903|NCT03965208|Bivalirudin|bivalirudin|mesh-list
110726904|NCT03965208|Anticoagulants|anticoagulants|mesh-ancestor
110726905|NCT03965208|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110726906|NCT03965208|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110726907|NCT03965208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110726909|NCT03965208|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110726910|NCT03965208|Protease Inhibitors|protease inhibitors|mesh-ancestor
110726911|NCT03965208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110726912|NCT01083264|Gestodene|gestodene|mesh-list
110726913|NCT01083264|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110726914|NCT01083264|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110726915|NCT01083264|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110726916|NCT01083264|Contraceptive Agents|contraceptive agents|mesh-ancestor
110726917|NCT01083264|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110726918|NCT01083264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110726919|NCT01083264|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110726920|NCT01083264|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110726921|NCT01083264|Progestins|progestins|mesh-ancestor
110726922|NCT01083264|Hormones|hormones|mesh-ancestor
110726923|NCT01083264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110726924|NCT00129116|Vaccines|vaccines|mesh-list
110726925|NCT00129116|Immunologic Factors|immunologic factors|mesh-ancestor
110726926|NCT00129116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110726928|NCT00117156|Fludarabine|fludarabine|mesh-list
110726929|NCT00117156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110726930|NCT00117156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110726931|NCT00117156|Immunologic Factors|immunologic factors|mesh-ancestor
110726932|NCT00117156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110726933|NCT00117156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110726934|NCT01083420|Minocycline|minocycline|mesh-list
110726935|NCT01083420|Dexamethasone|dexamethasone|mesh-list
110726936|NCT01083420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110726937|NCT01083420|Antiemetics|antiemetics|mesh-ancestor
110726938|NCT01083420|Autonomic Agents|autonomic agents|mesh-ancestor
110726939|NCT01083420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110726940|NCT01083420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110726941|NCT01083420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110726942|NCT01083420|Glucocorticoids|glucocorticoids|mesh-ancestor
110726943|NCT01083420|Hormones|hormones|mesh-ancestor
110726944|NCT01083420|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110726945|NCT01083420|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110726946|NCT01083420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110726947|NCT01083420|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110726948|NCT01083420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110726949|NCT00096954|Omalizumab|omalizumab|mesh-list
110726950|NCT00096954|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110726951|NCT00096954|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110726952|NCT00096954|Respiratory System Agents|respiratory system agents|mesh-ancestor
110726953|NCT00096486|Everolimus|everolimus|mesh-list
110726954|NCT00096486|Gefitinib|gefitinib|mesh-list
110726955|NCT00096486|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110726956|NCT00096486|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110726957|NCT00096486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110726958|NCT00096486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110726959|NCT00096486|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110726960|NCT00096486|Immunologic Factors|immunologic factors|mesh-ancestor
110726961|NCT00096486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110726962|NCT00096486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110726963|NCT00116844|Valacyclovir|valacyclovir|mesh-list
110726964|NCT00116844|Antiviral Agents|antiviral agents|mesh-ancestor
110726965|NCT00116844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110726966|NCT03963336|Acetazolamide|acetazolamide|mesh-list
110726967|NCT03963336|Anticonvulsants|anticonvulsants|mesh-ancestor
110726968|NCT03963336|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110726969|NCT03963336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110726970|NCT03963336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110726971|NCT03963336|Diuretics|diuretics|mesh-ancestor
110726972|NCT03963336|Natriuretic Agents|natriuretic agents|mesh-ancestor
110726973|NCT03963336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110726974|NCT00132314|Risperidone|risperidone|mesh-list
110726975|NCT00132314|Antipsychotic Agents|antipsychotic agents|mesh-list
110726976|NCT00132314|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110726977|NCT00132314|Serotonin Agents|serotonin agents|mesh-ancestor
110726978|NCT00132314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110726979|NCT00132314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110863345|NCT03778372|Methadone|methadone|mesh-list
110726980|NCT00132314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110726981|NCT00132314|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110726982|NCT00132314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110726983|NCT00132314|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110726984|NCT00132314|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110726985|NCT00132314|Dopamine Agents|dopamine agents|mesh-ancestor
110726986|NCT04539262|Remdesivir|remdesivir|mesh-list
110726987|NCT04539262|Antimetabolites|antimetabolites|mesh-ancestor
110726988|NCT04539262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110726989|NCT04539262|Antiviral Agents|antiviral agents|mesh-ancestor
110726990|NCT04539262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110726991|NCT04537234|Vaccines|vaccines|mesh-list
110726992|NCT04537234|Immunologic Factors|immunologic factors|mesh-ancestor
110726993|NCT04537234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110726994|NCT04537078|Triptorelin Pamoate|triptorelin pamoate|mesh-list
110726995|NCT04537078|Contraceptive Agents|contraceptive agents|mesh-list
110726996|NCT04537078|Contraceptives, Oral|contraceptives, oral|mesh-list
110726997|NCT04537078|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
110726998|NCT04537078|Cetrorelix|cetrorelix|mesh-list
110726999|NCT04537078|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
110727000|NCT04537078|Progesterone|progesterone|mesh-list
110727001|NCT04537078|Dydrogesterone|dydrogesterone|mesh-list
110727002|NCT04537078|Estradiol|estradiol|mesh-list
110727003|NCT04537078|Progestins|progestins|mesh-ancestor
110727004|NCT04537078|Hormones|hormones|mesh-ancestor
110727005|NCT04537078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110727006|NCT04537078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110727007|NCT04537078|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110727008|NCT04537078|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110727009|NCT04537078|Luteolytic Agents|luteolytic agents|mesh-ancestor
110727010|NCT04537078|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110727011|NCT04537078|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110727012|NCT04537078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110727013|NCT04537078|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110727014|NCT04537078|Fertility Agents|fertility agents|mesh-ancestor
110727015|NCT04537078|Hormone Antagonists|hormone antagonists|mesh-ancestor
110727016|NCT04537078|Estrogens|estrogens|mesh-ancestor
110727017|NCT04532164|Antifungal Agents|antifungal agents|mesh-list
110727018|NCT04532164|Clotrimazole|clotrimazole|mesh-list
110727019|NCT04532164|Miconazole|miconazole|mesh-list
110727020|NCT04532164|Butenafine|butenafine|mesh-list
110727021|NCT04532164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110727022|NCT04532164|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110727023|NCT04532164|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110727024|NCT04532164|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110727025|NCT04532164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110727026|NCT04532164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110727027|NCT04532164|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110727028|NCT04532164|Hormone Antagonists|hormone antagonists|mesh-ancestor
110727029|NCT04532164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110727030|NCT04532164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110727031|NCT04532164|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110727032|NCT04532164|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110727033|NCT04531540|Butenafine|butenafine|mesh-list
110727034|NCT04531540|Antifungal Agents|antifungal agents|mesh-ancestor
110727035|NCT04531540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110727036|NCT04799782|Mirtazapine|mirtazapine|mesh-list
110727037|NCT04799782|Antidepressive Agents|antidepressive agents|mesh-ancestor
110727038|NCT04799782|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110727039|NCT04799782|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110727040|NCT04799782|Histamine Antagonists|histamine antagonists|mesh-ancestor
110727041|NCT04799782|Histamine Agents|histamine agents|mesh-ancestor
110727042|NCT04799782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110727043|NCT04799782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110727044|NCT04799782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110727045|NCT04799782|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110727046|NCT04799782|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110727047|NCT04799782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110727048|NCT04799782|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
110727049|NCT04799782|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110727050|NCT04799782|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110727051|NCT04799782|Adrenergic Agents|adrenergic agents|mesh-ancestor
110727052|NCT04799782|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110727053|NCT04799782|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110727054|NCT04799782|Serotonin Agents|serotonin agents|mesh-ancestor
110727055|NCT04799782|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110727056|NCT04790812|Acetaminophen|acetaminophen|mesh-list
110727058|NCT04790812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110727059|NCT04790812|Analgesics|analgesics|mesh-ancestor
110727060|NCT04790812|Sensory System Agents|sensory system agents|mesh-ancestor
110727061|NCT04790812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110727062|NCT04790812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110727063|NCT04790812|Antipyretics|antipyretics|mesh-ancestor
110727064|NCT04790812|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110727065|NCT04790812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110727066|NCT04790812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110727067|NCT04790812|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110727068|NCT04790812|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110727070|NCT04790812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110727071|NCT03697252|Xanomeline|xanomeline|mesh-list
110727072|NCT03697252|Trospium chloride|trospium chloride|mesh-list
110727073|NCT03697252|Parasympatholytics|parasympatholytics|mesh-ancestor
110727074|NCT03697252|Autonomic Agents|autonomic agents|mesh-ancestor
110727076|NCT03697252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110727077|NCT03697252|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110727078|NCT03697252|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110727079|NCT03697252|Cholinergic Agents|cholinergic agents|mesh-ancestor
110727080|NCT03697252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110727081|NCT03697252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110727082|NCT03697252|Urological Agents|urological agents|mesh-ancestor
110727083|NCT03697252|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110727084|NCT03697252|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110727085|NCT03697252|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
110727086|NCT03697252|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110727087|NCT03701074|Acetaminophen|acetaminophen|mesh-list
110727088|NCT03701074|Ibuprofen|ibuprofen|mesh-list
110727089|NCT03701074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110727090|NCT03701074|Analgesics|analgesics|mesh-ancestor
110727091|NCT03701074|Sensory System Agents|sensory system agents|mesh-ancestor
110727092|NCT03701074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110727093|NCT03701074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110727094|NCT03701074|Antipyretics|antipyretics|mesh-ancestor
110727095|NCT03701074|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110727096|NCT03701074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110727097|NCT03701074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110727098|NCT03701074|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110727099|NCT03701074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110727100|NCT03701074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110727101|NCT03757390|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
110727102|NCT03757390|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110727103|NCT03757390|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110727104|NCT03757390|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110727105|NCT03757390|Antimetabolites|antimetabolites|mesh-ancestor
110727106|NCT03757390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110727107|NCT03757390|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110727108|NCT03757390|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110727109|NCT03757390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110727110|NCT03757390|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110727111|NCT03757156|Aspirin|aspirin|mesh-list
110727112|NCT03757156|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110727113|NCT03757156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110727114|NCT03757156|Analgesics|analgesics|mesh-ancestor
110727115|NCT03757156|Sensory System Agents|sensory system agents|mesh-ancestor
110727116|NCT03757156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110727117|NCT03757156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110727118|NCT03757156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110727119|NCT03757156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110727120|NCT03757156|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110727121|NCT03757156|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110727122|NCT03757156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110727123|NCT03757156|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110727124|NCT03757156|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110727125|NCT03757156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110727126|NCT03757156|Antipyretics|antipyretics|mesh-ancestor
110727127|NCT03750916|Docetaxel|docetaxel|mesh-list
110727128|NCT03750916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110727129|NCT03750916|Tubulin Modulators|tubulin modulators|mesh-ancestor
110727130|NCT03750916|Antimitotic Agents|antimitotic agents|mesh-ancestor
110727131|NCT03750916|Mitosis Modulators|mitosis modulators|mesh-ancestor
110727132|NCT03750916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110727133|NCT05322148|Loteprednol Etabonate|loteprednol etabonate|mesh-list
110727134|NCT05322148|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110727135|NCT03750760|Atorvastatin|atorvastatin|mesh-list
110727136|NCT03750760|Ezetimibe|ezetimibe|mesh-list
110727137|NCT03750760|Alirocumab|alirocumab|mesh-list
110727138|NCT03750760|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110727139|NCT03750760|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110444931|NCT01200368|Vaccines|vaccines|mesh-list
110727140|NCT03750760|Antimetabolites|antimetabolites|mesh-ancestor
110727141|NCT03750760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110727142|NCT03750760|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110727143|NCT03750760|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110727144|NCT03750760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110727145|NCT03750760|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
110727146|NCT03750760|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110727147|NCT03750760|Protease Inhibitors|protease inhibitors|mesh-ancestor
110727148|NCT01076894|Anesthetics|anesthetics|mesh-list
110727149|NCT01076894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110727150|NCT01076894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110727151|NCT00130832|Vaccines|vaccines|mesh-list
110727152|NCT00130832|Immunologic Factors|immunologic factors|mesh-ancestor
110727153|NCT00130832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110727154|NCT00096018|Thalidomide|thalidomide|mesh-list
110727155|NCT00096018|Fludarabine|fludarabine|mesh-list
110727156|NCT00096018|Fludarabine phosphate|fludarabine phosphate|mesh-list
110727157|NCT00096018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110727158|NCT00096018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110727159|NCT00096018|Antimetabolites|antimetabolites|mesh-ancestor
110727160|NCT00096018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110727161|NCT00096018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110727162|NCT00096018|Immunologic Factors|immunologic factors|mesh-ancestor
110727163|NCT00096018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110727164|NCT00096018|Leprostatic Agents|leprostatic agents|mesh-ancestor
110727165|NCT00096018|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110727166|NCT00096018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110727167|NCT00096018|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110727168|NCT00096018|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110727169|NCT00096018|Growth Substances|growth substances|mesh-ancestor
110727170|NCT00096018|Growth Inhibitors|growth inhibitors|mesh-ancestor
110727171|NCT01079754|Morphine|morphine|mesh-list
110727172|NCT01079754|Analgesics, Opioid|analgesics, opioid|mesh-list
110727173|NCT01079754|Narcotics|narcotics|mesh-ancestor
110727174|NCT01079754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110727175|NCT01079754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110727176|NCT01079754|Analgesics|analgesics|mesh-ancestor
110727177|NCT01079754|Sensory System Agents|sensory system agents|mesh-ancestor
110727178|NCT01079754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110727179|NCT04701658|Bamlanivimab|bamlanivimab|mesh-list
110727180|NCT04701658|Antiviral Agents|antiviral agents|mesh-ancestor
110727181|NCT04701658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110727182|NCT01322776|Cyclophosphamide|cyclophosphamide|mesh-list
110727183|NCT01322776|Fludarabine|fludarabine|mesh-list
110727184|NCT01322776|Bortezomib|bortezomib|mesh-list
110727185|NCT01322776|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110727186|NCT01322776|Immunologic Factors|immunologic factors|mesh-ancestor
110727187|NCT01322776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110727188|NCT01322776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110727189|NCT01322776|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110727190|NCT01322776|Alkylating Agents|alkylating agents|mesh-ancestor
110727191|NCT01322776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110727193|NCT01322776|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110727194|NCT00128102|Vorinostat|vorinostat|mesh-list
110727195|NCT00128102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110727196|NCT00128102|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110727197|NCT00128102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110727198|NCT00128102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110727199|NCT03965858|Esketamine|esketamine|mesh-list
110727200|NCT03965858|Antidepressive Agents|antidepressive agents|mesh-ancestor
110727201|NCT03965858|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110727202|NCT04668274|Resveratrol|resveratrol|mesh-list
110727203|NCT04668274|Antioxidants|antioxidants|mesh-ancestor
110727204|NCT04668274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110727205|NCT04668274|Protective Agents|protective agents|mesh-ancestor
110727206|NCT04668274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110727207|NCT04668274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110727208|NCT04668274|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110727209|NCT01077908|Antiviral Agents|antiviral agents|mesh-list
110727210|NCT01077908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110727211|NCT04406194|Favipiravir|favipiravir|mesh-list
110727212|NCT04406194|Antiviral Agents|antiviral agents|mesh-ancestor
110727213|NCT04406194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110727214|NCT03822884|Epoetin Alfa|epoetin alfa|mesh-list
110727215|NCT03822884|Hematinics|hematinics|mesh-ancestor
110727216|NCT03822416|Nicotine|nicotine|mesh-list
110682827|NCT00902915|Dexamethasone|dexamethasone|mesh-list
110727217|NCT03822416|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110727218|NCT03822416|Autonomic Agents|autonomic agents|mesh-ancestor
110727219|NCT03822416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110727220|NCT03822416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110727221|NCT03822416|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110727222|NCT03822416|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110727223|NCT03822416|Cholinergic Agents|cholinergic agents|mesh-ancestor
110727224|NCT03822416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110727225|NCT03822416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110727226|NCT04405570|Molnupiravir|molnupiravir|mesh-list
110727227|NCT04405570|Antiviral Agents|antiviral agents|mesh-ancestor
110727228|NCT04405570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110727229|NCT00127712|Amiodarone|amiodarone|mesh-list
110727230|NCT00127712|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110727231|NCT00127712|Vasodilator Agents|vasodilator agents|mesh-ancestor
110727232|NCT00127712|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
110727233|NCT00127712|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110727234|NCT00127712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110727235|NCT00127712|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110727236|NCT00127712|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110727237|NCT00127712|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110727238|NCT00127712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110727239|NCT00127712|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110727240|NCT00127712|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110727241|NCT00127712|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110727242|NCT01082744|Sufentanil|sufentanil|mesh-list
110727243|NCT01082744|Ropivacaine|ropivacaine|mesh-list
110727244|NCT01082744|Anesthetics, Local|anesthetics, local|mesh-ancestor
110727245|NCT01082744|Anesthetics|anesthetics|mesh-ancestor
110727246|NCT01082744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110727247|NCT01082744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110727248|NCT01082744|Sensory System Agents|sensory system agents|mesh-ancestor
110727249|NCT01082744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110727250|NCT01082744|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110727251|NCT01082744|Narcotics|narcotics|mesh-ancestor
110727252|NCT01082744|Analgesics|analgesics|mesh-ancestor
110727253|NCT01082744|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110727254|NCT01082744|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110727255|NCT01082744|Anesthetics, General|anesthetics, general|mesh-ancestor
110727256|NCT00096356|Vitamins|vitamins|mesh-list
110727257|NCT00096356|Vitamin E|vitamin e|mesh-list
110727258|NCT00096356|Tocopherols|tocopherols|mesh-list
110727259|NCT00096356|Tocotrienols|tocotrienols|mesh-list
110727260|NCT00096356|alpha-Tocopherol|alpha-tocopherol|mesh-list
110727261|NCT00096356|Micronutrients|micronutrients|mesh-ancestor
110863366|NCT03246880|Adrenergic Agents|adrenergic agents|mesh-ancestor
110727262|NCT00096356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110727263|NCT00096356|Antioxidants|antioxidants|mesh-ancestor
110727264|NCT00096356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110727265|NCT00096356|Protective Agents|protective agents|mesh-ancestor
110727266|NCT03749590|Magnesium Sulfate|magnesium sulfate|mesh-list
110727267|NCT03749590|Analgesics|analgesics|mesh-ancestor
110727268|NCT03749590|Sensory System Agents|sensory system agents|mesh-ancestor
110727269|NCT03749590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110727270|NCT03749590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110727271|NCT03749590|Anesthetics|anesthetics|mesh-ancestor
110727272|NCT03749590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110727273|NCT03749590|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110727274|NCT03749590|Anticonvulsants|anticonvulsants|mesh-ancestor
110727275|NCT03749590|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110727276|NCT03749590|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110727277|NCT03749590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110727278|NCT03749590|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110727279|NCT03749590|Tocolytic Agents|tocolytic agents|mesh-ancestor
110727280|NCT03749590|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110727281|NCT01076816|Dexmedetomidine|dexmedetomidine|mesh-list
110727282|NCT01076816|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110727283|NCT01076816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110727284|NCT01076816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110727285|NCT01076816|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110727286|NCT01076816|Analgesics|analgesics|mesh-ancestor
110727287|NCT01076816|Sensory System Agents|sensory system agents|mesh-ancestor
110727288|NCT01076816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110727289|NCT01076816|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110445085|NCT01092780|Modafinil|modafinil|mesh-list
110727290|NCT01076816|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110727291|NCT01076816|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110727292|NCT01076816|Adrenergic Agents|adrenergic agents|mesh-ancestor
110727293|NCT01076816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110727294|NCT01076816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110727296|NCT03749356|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110727297|NCT03749356|Immunologic Factors|immunologic factors|mesh-ancestor
110727298|NCT03749356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110727299|NCT03749356|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110727300|NCT03749356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110727301|NCT03749356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110727302|NCT04358068|Azithromycin|azithromycin|mesh-list
110727303|NCT04358068|Hydroxychloroquine|hydroxychloroquine|mesh-list
110727304|NCT04358068|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110727305|NCT04358068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110727306|NCT04358068|Antimalarials|antimalarials|mesh-ancestor
110727307|NCT04358068|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110727308|NCT04358068|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110727309|NCT04358068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110727310|NCT04358068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110727311|NCT04358068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110727312|NCT00096278|Calcium, Dietary|calcium, dietary|mesh-list
110727313|NCT00096278|Leucovorin|leucovorin|mesh-list
110727314|NCT00096278|Folic Acid|folic acid|mesh-list
110727315|NCT00096278|Bevacizumab|bevacizumab|mesh-list
110727316|NCT00096278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110727317|NCT00096278|Fluorouracil|fluorouracil|mesh-list
110727318|NCT00096278|Oxaliplatin|oxaliplatin|mesh-list
110727319|NCT00096278|Endothelial Growth Factors|endothelial growth factors|mesh-list
110727320|NCT00096278|Antibodies|antibodies|mesh-list
110727321|NCT00096278|Immunoglobulins|immunoglobulins|mesh-list
110727322|NCT00096278|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110727323|NCT00096278|Immunoglobulin G|immunoglobulin g|mesh-list
110727324|NCT00096278|Calcium|calcium|mesh-list
110727325|NCT00096278|Levoleucovorin|levoleucovorin|mesh-list
110727326|NCT00096278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110727327|NCT00096278|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110727328|NCT00096278|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110727329|NCT00096278|Growth Substances|growth substances|mesh-ancestor
110727330|NCT00096278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110727331|NCT00096278|Growth Inhibitors|growth inhibitors|mesh-ancestor
110727332|NCT00096278|Immunologic Factors|immunologic factors|mesh-ancestor
110727333|NCT00096278|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110727334|NCT00096278|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110727335|NCT00096278|Antimetabolites|antimetabolites|mesh-ancestor
110727336|NCT00096278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110727337|NCT00096278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110727338|NCT00096278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110727339|NCT00096278|Antidotes|antidotes|mesh-ancestor
110727340|NCT00096278|Protective Agents|protective agents|mesh-ancestor
110727341|NCT00096278|Vitamin B Complex|vitamin b complex|mesh-ancestor
110727342|NCT00096278|Vitamins|vitamins|mesh-ancestor
110727343|NCT00096278|Micronutrients|micronutrients|mesh-ancestor
110727344|NCT00096278|Hematinics|hematinics|mesh-ancestor
110727345|NCT00095940|Lapatinib|lapatinib|mesh-list
110727346|NCT00095940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110727347|NCT00095940|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110727348|NCT00095940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110727349|NCT00095940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110727350|NCT00114218|Gemcitabine|gemcitabine|mesh-list
110727351|NCT00114218|Docetaxel|docetaxel|mesh-list
110727352|NCT00114218|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110727353|NCT00114218|Antimetabolites|antimetabolites|mesh-ancestor
110727354|NCT00114218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110727355|NCT00114218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110727356|NCT00114218|Tubulin Modulators|tubulin modulators|mesh-ancestor
110727357|NCT00114218|Antimitotic Agents|antimitotic agents|mesh-ancestor
110727358|NCT00114218|Mitosis Modulators|mitosis modulators|mesh-ancestor
110727359|NCT01077986|Capecitabine|capecitabine|mesh-list
110727360|NCT01077986|Cetuximab|cetuximab|mesh-list
110727361|NCT01077986|Everolimus|everolimus|mesh-list
110727362|NCT01077986|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110727363|NCT01077986|Antimetabolites|antimetabolites|mesh-ancestor
110727364|NCT01077986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110727365|NCT01077986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110727366|NCT01077986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110727367|NCT01077986|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110727368|NCT01077986|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110727369|NCT01077986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110727370|NCT01077986|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110727371|NCT01077986|Immunologic Factors|immunologic factors|mesh-ancestor
110727372|NCT01077986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110727374|NCT03963024|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110727375|NCT03963024|Alkylating Agents|alkylating agents|mesh-ancestor
110727376|NCT03963024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110727377|NCT03963024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110727378|NCT01082718|Artesunate|artesunate|mesh-list
110727379|NCT01082718|Mefloquine|mefloquine|mesh-list
110727380|NCT01082718|Antimalarials|antimalarials|mesh-ancestor
110727381|NCT01082718|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110727382|NCT01082718|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110727383|NCT01082718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110727384|NCT01082718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110727385|NCT01082718|Antiviral Agents|antiviral agents|mesh-ancestor
110727386|NCT01082718|Schistosomicides|schistosomicides|mesh-ancestor
110727387|NCT01082718|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110727388|NCT01082718|Anthelmintics|anthelmintics|mesh-ancestor
110727389|NCT04380142|Levodopa|levodopa|mesh-list
110727390|NCT04380142|Carbidopa|carbidopa|mesh-list
110727391|NCT04380142|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110727392|NCT04380142|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110727393|NCT04380142|Dopamine Agents|dopamine agents|mesh-ancestor
110727394|NCT04380142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110727395|NCT04380142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110727396|NCT04380142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110727397|NCT04380142|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
110727398|NCT04380142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110727399|NCT04336228|Dexetimide|dexetimide|mesh-list
110727400|NCT04336228|Citalopram|citalopram|mesh-list
110727401|NCT04336228|Escitalopram|escitalopram|mesh-list
110727402|NCT04336228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110727403|NCT04336228|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110727404|NCT04336228|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110727405|NCT04336228|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110727406|NCT04336228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110727407|NCT04336228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110727408|NCT04336228|Serotonin Agents|serotonin agents|mesh-ancestor
110727409|NCT04336228|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110727410|NCT04336228|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110727411|NCT04336228|Parasympatholytics|parasympatholytics|mesh-ancestor
110727412|NCT04336228|Autonomic Agents|autonomic agents|mesh-ancestor
110727413|NCT04336228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110727414|NCT04336228|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110727415|NCT04336228|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110727416|NCT04336228|Cholinergic Agents|cholinergic agents|mesh-ancestor
110727417|NCT04336228|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110727418|NCT04336228|Antidepressive Agents|antidepressive agents|mesh-ancestor
110727419|NCT04336228|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110727420|NCT03917446|Propofol|propofol|mesh-list
110727421|NCT03917446|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110727422|NCT03917446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110727423|NCT03917446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110727424|NCT03917446|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110727425|NCT03917446|Anesthetics, General|anesthetics, general|mesh-ancestor
110727426|NCT03917446|Anesthetics|anesthetics|mesh-ancestor
110727427|NCT04332874|Dactinomycin|dactinomycin|mesh-list
110727428|NCT04332874|Pembrolizumab|pembrolizumab|mesh-list
110727429|NCT04332874|Melphalan|melphalan|mesh-list
110727430|NCT04332874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110727431|NCT04332874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110727432|NCT04332874|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110727433|NCT04332874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110727434|NCT04332874|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110727435|NCT04332874|Alkylating Agents|alkylating agents|mesh-ancestor
110727436|NCT04332874|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110727437|NCT04332874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110727439|NCT04332874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110727440|NCT04332874|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110727441|NCT04332874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110727442|NCT04332874|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110727443|NCT04332874|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110445226|NCT02883023|Bleomycin|bleomycin|mesh-list
110727444|NCT04332874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110727445|NCT04332874|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110727446|NCT03748108|Lidocaine|lidocaine|mesh-list
110727447|NCT03748108|Anesthetics, Local|anesthetics, local|mesh-ancestor
110727448|NCT03748108|Anesthetics|anesthetics|mesh-ancestor
110727449|NCT03748108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110727450|NCT03748108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110727451|NCT03748108|Sensory System Agents|sensory system agents|mesh-ancestor
110727452|NCT03748108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110727453|NCT03748108|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110863393|NCT03239314|Hormones|hormones|mesh-ancestor
110727454|NCT03748108|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110727455|NCT03748108|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110727456|NCT03748108|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110727457|NCT03748108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110727458|NCT04171414|Adalimumab|adalimumab|mesh-list
110727459|NCT04171414|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110727460|NCT04171414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110727461|NCT04171414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110727462|NCT04167670|Amoxicillin|amoxicillin|mesh-list
110727463|NCT04167670|Clarithromycin|clarithromycin|mesh-list
110727464|NCT04167670|Lansoprazole|lansoprazole|mesh-list
110727465|NCT04167670|Dexlansoprazole|dexlansoprazole|mesh-list
110727466|NCT04167670|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110727467|NCT04167670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110727468|NCT04167670|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110727469|NCT04167670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110727470|NCT04167670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110727471|NCT04167670|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110727472|NCT04167670|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110727473|NCT04167670|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110727474|NCT04167670|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110727475|NCT04167670|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110727476|NCT00113516|Paclitaxel|paclitaxel|mesh-list
110727477|NCT00113516|Carboplatin|carboplatin|mesh-list
110727478|NCT00113516|Sunitinib|sunitinib|mesh-list
110727479|NCT00113516|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110727480|NCT00113516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110727481|NCT00113516|Tubulin Modulators|tubulin modulators|mesh-ancestor
110727482|NCT00113516|Antimitotic Agents|antimitotic agents|mesh-ancestor
110727483|NCT00113516|Mitosis Modulators|mitosis modulators|mesh-ancestor
110727484|NCT00113516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110727485|NCT00113516|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110727486|NCT00113516|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110727487|NCT00113516|Growth Substances|growth substances|mesh-ancestor
110727488|NCT00113516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110727489|NCT00113516|Growth Inhibitors|growth inhibitors|mesh-ancestor
110727490|NCT00113516|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110727491|NCT00113516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110727492|NCT04142242|Vaccines|vaccines|mesh-list
110727493|NCT04142242|Immunologic Factors|immunologic factors|mesh-ancestor
110727494|NCT04142242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110727495|NCT03251326|Propranolol|propranolol|mesh-list
110727496|NCT03251326|Nabilone|nabilone|mesh-list
110727497|NCT03251326|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110727498|NCT03251326|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110727499|NCT03251326|Adrenergic Agents|adrenergic agents|mesh-ancestor
110727500|NCT03251326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110727501|NCT03251326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110727502|NCT03251326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110727503|NCT03251326|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110727504|NCT03251326|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110727505|NCT03251326|Vasodilator Agents|vasodilator agents|mesh-ancestor
110727506|NCT03251326|Antiemetics|antiemetics|mesh-ancestor
110727507|NCT03251326|Autonomic Agents|autonomic agents|mesh-ancestor
110727508|NCT03251326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110727509|NCT03251326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110727510|NCT03251326|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110727511|NCT03251326|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110727512|NCT03251326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110727513|NCT03251326|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110727514|NCT04140292|Vitamin D|vitamin d|mesh-list
110727515|NCT04140292|Cholecalciferol|cholecalciferol|mesh-list
110727516|NCT04140292|Vitamins|vitamins|mesh-ancestor
110727517|NCT04140292|Micronutrients|micronutrients|mesh-ancestor
110727518|NCT04140292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110727519|NCT04140292|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110727520|NCT04140292|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110727521|NCT00127166|Fluticasone|fluticasone|mesh-list
110727522|NCT00127166|Xhance|xhance|mesh-list
110727523|NCT00127166|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110727524|NCT00127166|Montelukast|montelukast|mesh-list
110727525|NCT00127166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110727526|NCT00127166|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110727527|NCT00127166|Autonomic Agents|autonomic agents|mesh-ancestor
110727528|NCT00127166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110727529|NCT00127166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110727530|NCT00127166|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110727531|NCT00127166|Respiratory System Agents|respiratory system agents|mesh-ancestor
110727532|NCT00127166|Dermatologic Agents|dermatologic agents|mesh-ancestor
110141882|NCT02015650|Cetuximab|cetuximab|mesh-list
110727533|NCT00127166|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110727534|NCT00127166|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110727535|NCT00127166|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110727536|NCT00127166|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110727537|NCT00127166|Adrenergic Agents|adrenergic agents|mesh-ancestor
110727538|NCT00127166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110727539|NCT00127166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110727540|NCT00127166|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110727541|NCT00127166|Hormone Antagonists|hormone antagonists|mesh-ancestor
110727542|NCT00127166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110727543|NCT00127166|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110727544|NCT00127166|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110727546|NCT00125138|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110727547|NCT00125138|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110727548|NCT00125138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110727549|NCT00125138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110727550|NCT00125138|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110727551|NCT04132336|Naproxen|naproxen|mesh-list
110727552|NCT04132336|Caffeine|caffeine|mesh-list
110727553|NCT04132336|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110727554|NCT04132336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110727555|NCT04132336|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110727556|NCT04132336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110727557|NCT04132336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110727558|NCT04132336|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110727559|NCT04132336|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110727560|NCT04132336|Purinergic Agents|purinergic agents|mesh-ancestor
110727561|NCT04132336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110727562|NCT04132336|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110727563|NCT04132336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110727564|NCT04132336|Analgesics|analgesics|mesh-ancestor
110727565|NCT04132336|Sensory System Agents|sensory system agents|mesh-ancestor
110727566|NCT04132336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110727567|NCT04132336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110727568|NCT04132336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110727569|NCT04132336|Gout Suppressants|gout suppressants|mesh-ancestor
110727570|NCT04132336|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110727571|NCT04131556|Maribavir|maribavir|mesh-list
110727572|NCT04131556|Antiviral Agents|antiviral agents|mesh-ancestor
110727573|NCT04131556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110727574|NCT04315636|Pulmonary Surfactants|pulmonary surfactants|mesh-list
110727575|NCT04315636|Respiratory System Agents|respiratory system agents|mesh-ancestor
110727576|NCT03691948|Analgesics, Opioid|analgesics, opioid|mesh-list
110727577|NCT03691948|Narcotics|narcotics|mesh-ancestor
110727578|NCT03691948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110727579|NCT03691948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110727580|NCT03691948|Analgesics|analgesics|mesh-ancestor
110727581|NCT03691948|Sensory System Agents|sensory system agents|mesh-ancestor
110727582|NCT03691948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110727584|NCT04124926|Dexlansoprazole|dexlansoprazole|mesh-list
110727585|NCT04124926|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110727586|NCT04124926|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110727587|NCT04124926|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110727588|NCT04124926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110727589|NCT04124926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110727590|NCT03746158|Curcumin|curcumin|mesh-list
110727591|NCT03746158|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110727592|NCT03746158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110727593|NCT03746158|Analgesics|analgesics|mesh-ancestor
110445382|NCT00951015|Efavirenz|efavirenz|mesh-list
110727594|NCT03746158|Sensory System Agents|sensory system agents|mesh-ancestor
110727595|NCT03746158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110727596|NCT03746158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110727597|NCT03746158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110727599|NCT03746158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110727600|NCT03746158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110727601|NCT03746158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110727602|NCT03747094|Fentanyl|fentanyl|mesh-list
110727603|NCT03747094|Ketamine|ketamine|mesh-list
110727604|NCT03747094|Analgesics|analgesics|mesh-ancestor
110727605|NCT03747094|Sensory System Agents|sensory system agents|mesh-ancestor
110727606|NCT03747094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110727607|NCT03747094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110727608|NCT03747094|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110727609|NCT03747094|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110727610|NCT03747094|Anesthetics, General|anesthetics, general|mesh-ancestor
110727611|NCT03747094|Anesthetics|anesthetics|mesh-ancestor
110727612|NCT03747094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110727613|NCT03747094|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110727614|NCT03747094|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110727615|NCT03747094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110727616|NCT03747094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110727617|NCT03747094|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110727618|NCT03747094|Narcotics|narcotics|mesh-ancestor
110727619|NCT03747094|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110727620|NCT04105972|Ivacaftor|ivacaftor|mesh-list
110727621|NCT04105972|Elexacaftor|elexacaftor|mesh-list
110727622|NCT04105972|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
110727623|NCT04105972|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110727624|NCT04105972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110727625|NCT00124982|Abatacept|abatacept|mesh-list
110727626|NCT00124982|Antirheumatic Agents|antirheumatic agents|mesh-list
110727627|NCT00124982|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110727628|NCT00124982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110727629|NCT00124982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110727630|NCT00124982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110727631|NCT00124982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110727632|NCT00124982|Immunologic Factors|immunologic factors|mesh-ancestor
110727633|NCT00124982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110727634|NCT04090528|Pembrolizumab|pembrolizumab|mesh-list
110727635|NCT04090528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110727636|NCT04090528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110727637|NCT04090528|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110727638|NCT04090528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110727639|NCT04249336|Listerine|listerine|mesh-list
110727640|NCT04249336|Calcium|calcium|mesh-list
110727641|NCT04249336|Fluorides|fluorides|mesh-list
110727642|NCT04249336|Sodium Fluoride|sodium fluoride|mesh-list
110727643|NCT04249336|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110727644|NCT04249336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110727645|NCT04249336|Cariostatic Agents|cariostatic agents|mesh-ancestor
110727646|NCT04249336|Protective Agents|protective agents|mesh-ancestor
110727647|NCT04249336|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110727648|NCT04249336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110727649|NCT03752476|Lactams|lactams|mesh-list
110727650|NCT03752476|beta-Lactams|beta-lactams|mesh-list
110727651|NCT03752476|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110727652|NCT03752476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110727653|NCT04078126|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
110727654|NCT04078126|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110727655|NCT04078126|Respiratory System Agents|respiratory system agents|mesh-ancestor
110727656|NCT04380688|Acalabrutinib|acalabrutinib|mesh-list
110727657|NCT04380688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110727658|NCT00124748|Imatinib Mesylate|imatinib mesylate|mesh-list
110727659|NCT00124748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110727660|NCT00124748|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110727661|NCT00124748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110727662|NCT00124748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110727663|NCT01078142|Sirolimus|sirolimus|mesh-list
110727664|NCT01078142|Rituximab|rituximab|mesh-list
110727665|NCT01078142|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110727666|NCT01078142|Temsirolimus|temsirolimus|mesh-list
110727667|NCT01078142|MTOR Inhibitors|mtor inhibitors|mesh-list
110445514|NCT01192178|Xhance|xhance|mesh-list
110727668|NCT01078142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110727669|NCT01078142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110727670|NCT01078142|Immunologic Factors|immunologic factors|mesh-ancestor
110727671|NCT01078142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110727672|NCT01078142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110727673|NCT01078142|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110727674|NCT01078142|Alkylating Agents|alkylating agents|mesh-ancestor
110727675|NCT01078142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110727676|NCT01078142|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110727677|NCT01078142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110727678|NCT01078142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110727679|NCT01078142|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110727680|NCT01078142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110727681|NCT01078142|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110727682|NCT01078142|Antifungal Agents|antifungal agents|mesh-ancestor
110727683|NCT04060654|Buprenorphine|buprenorphine|mesh-list
110727684|NCT04060654|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110727685|NCT04060654|Narcotics|narcotics|mesh-ancestor
110727686|NCT04060654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110727687|NCT04060654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110727688|NCT04060654|Analgesics|analgesics|mesh-ancestor
110727689|NCT04060654|Sensory System Agents|sensory system agents|mesh-ancestor
110727690|NCT04060654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110727691|NCT04060654|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110727692|NCT00096200|Paclitaxel|paclitaxel|mesh-list
110727693|NCT00096200|Carboplatin|carboplatin|mesh-list
110727694|NCT00096200|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110727695|NCT00096200|Sorafenib|sorafenib|mesh-list
110727696|NCT00096200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110727697|NCT00096200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110727698|NCT00096200|Tubulin Modulators|tubulin modulators|mesh-ancestor
110727699|NCT00096200|Antimitotic Agents|antimitotic agents|mesh-ancestor
110727700|NCT00096200|Mitosis Modulators|mitosis modulators|mesh-ancestor
110727701|NCT00096200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110727702|NCT00096200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110727703|NCT00096200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110727704|NCT00096044|Rituximab|rituximab|mesh-list
110727705|NCT00096044|Lenalidomide|lenalidomide|mesh-list
110727706|NCT00096044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110727707|NCT00096044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110727708|NCT00096044|Immunologic Factors|immunologic factors|mesh-ancestor
110727709|NCT00096044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110727710|NCT00096044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110727711|NCT00096044|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110727712|NCT00096044|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110727713|NCT00096044|Growth Substances|growth substances|mesh-ancestor
110727714|NCT00096044|Growth Inhibitors|growth inhibitors|mesh-ancestor
110727715|NCT03963128|Vitamin D|vitamin d|mesh-list
110727716|NCT03963128|Cholecalciferol|cholecalciferol|mesh-list
110727717|NCT03963128|Vitamins|vitamins|mesh-ancestor
110727718|NCT03963128|Micronutrients|micronutrients|mesh-ancestor
110727719|NCT03963128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110727720|NCT03963128|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110727721|NCT03963128|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110727722|NCT01083212|Gemfibrozil|gemfibrozil|mesh-list
110727723|NCT01083212|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110727724|NCT01083212|Antimetabolites|antimetabolites|mesh-ancestor
110727725|NCT01083212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110727726|NCT01083212|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110727727|NCT01083212|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
110727728|NCT01083212|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110727729|NCT01083212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110727731|NCT01083290|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110727732|NCT01083290|Hormone Antagonists|hormone antagonists|mesh-ancestor
110727733|NCT01083290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110727734|NCT01083290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110727735|NCT01083290|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110727736|NCT01083290|Diuretics|diuretics|mesh-ancestor
110727737|NCT01083290|Natriuretic Agents|natriuretic agents|mesh-ancestor
110727739|NCT01326650|Ergocalciferols|ergocalciferols|mesh-list
110727740|NCT01326650|Cholecalciferol|cholecalciferol|mesh-list
110727741|NCT01326650|Vitamins|vitamins|mesh-list
110727742|NCT01326650|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110727743|NCT01326650|Micronutrients|micronutrients|mesh-ancestor
110727744|NCT01326650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110727745|NCT01326650|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110727746|NCT01326650|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110727747|NCT03689374|Insulin|insulin|mesh-list
110727748|NCT03689374|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110727749|NCT03689374|Insulin Glargine|insulin glargine|mesh-list
110727750|NCT03689374|Insulin Aspart|insulin aspart|mesh-list
110727751|NCT03689374|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110727752|NCT03689374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110727753|NCT00113360|Everolimus|everolimus|mesh-list
110727754|NCT00113360|Octreotide|octreotide|mesh-list
110727755|NCT00113360|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110727756|NCT00113360|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110727757|NCT00113360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110727758|NCT00113360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110727759|NCT00113360|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110727760|NCT00113360|Immunologic Factors|immunologic factors|mesh-ancestor
110727761|NCT00113360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110727762|NCT00113360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110727763|NCT00113360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110727764|NCT00113360|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110727765|NCT03745300|Atorvastatin|atorvastatin|mesh-list
110727766|NCT03745300|Simvastatin|simvastatin|mesh-list
110727767|NCT03745300|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110727768|NCT03745300|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110727769|NCT03745300|Antimetabolites|antimetabolites|mesh-ancestor
110727770|NCT03745300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110727771|NCT03745300|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110727772|NCT03745300|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110727773|NCT03745300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110727774|NCT00112736|Sirolimus|sirolimus|mesh-list
110727775|NCT00112736|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110727776|NCT00112736|Temsirolimus|temsirolimus|mesh-list
110727777|NCT00112736|MTOR Inhibitors|mtor inhibitors|mesh-list
110727778|NCT00112736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110727779|NCT00112736|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110727780|NCT00112736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110727781|NCT00112736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110727782|NCT00112736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110727783|NCT00112736|Immunologic Factors|immunologic factors|mesh-ancestor
110727784|NCT00112736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110727785|NCT00112736|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110727786|NCT00112736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110727787|NCT00112736|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110727788|NCT00112736|Antifungal Agents|antifungal agents|mesh-ancestor
110727789|NCT04052620|Diclofenac|diclofenac|mesh-list
110727790|NCT04052620|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110727791|NCT04052620|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110727792|NCT04052620|Analgesics|analgesics|mesh-ancestor
110727793|NCT04052620|Sensory System Agents|sensory system agents|mesh-ancestor
110727794|NCT04052620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110727795|NCT04052620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110727796|NCT04052620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110727797|NCT04052620|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110727798|NCT04052620|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110727799|NCT04052620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110727800|NCT04052620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110727801|NCT00112580|Ipilimumab|ipilimumab|mesh-list
110727802|NCT00112580|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110727803|NCT00112580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110727804|NCT00112580|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110727805|NCT00112580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110727806|NCT04238650|Bevacizumab|bevacizumab|mesh-list
110727807|NCT04238650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110727808|NCT04238650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110727809|NCT04238650|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110727810|NCT04238650|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110727811|NCT04238650|Growth Substances|growth substances|mesh-ancestor
110727812|NCT04238650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110727813|NCT04238650|Growth Inhibitors|growth inhibitors|mesh-ancestor
110727814|NCT04049578|Balovaptan|balovaptan|mesh-list
110727815|NCT04049578|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
110727816|NCT04049578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110727817|NCT04049578|Natriuretic Agents|natriuretic agents|mesh-ancestor
110727818|NCT04049578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110727820|NCT00095498|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110727821|NCT00095498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110727822|NCT04237792|Dexmedetomidine|dexmedetomidine|mesh-list
110727823|NCT04237792|Propofol|propofol|mesh-list
110727824|NCT04237792|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110727825|NCT04237792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110727826|NCT04237792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110727827|NCT04237792|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110727828|NCT04237792|Analgesics|analgesics|mesh-ancestor
110727829|NCT04237792|Sensory System Agents|sensory system agents|mesh-ancestor
110727830|NCT04237792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110727831|NCT04237792|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110141928|NCT02015949|Dopamine Agents|dopamine agents|mesh-ancestor
110727832|NCT04237792|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110727833|NCT04237792|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110727834|NCT04237792|Adrenergic Agents|adrenergic agents|mesh-ancestor
110727835|NCT04237792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110727836|NCT04237792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110727837|NCT04237792|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110727838|NCT04237792|Anesthetics, General|anesthetics, general|mesh-ancestor
110727839|NCT04237792|Anesthetics|anesthetics|mesh-ancestor
110727840|NCT03744988|Androgens|androgens|mesh-list
110727841|NCT03744988|Hormones|hormones|mesh-ancestor
110727842|NCT03744988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110727843|NCT03744988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110727844|NCT03746782|Thrombin|thrombin|mesh-list
110727845|NCT03746782|Hemostatics|hemostatics|mesh-ancestor
110727846|NCT03746782|Coagulants|coagulants|mesh-ancestor
110727847|NCT04026568|4-Aminopyridine|4-aminopyridine|mesh-list
110727848|NCT04026568|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
110727849|NCT04026568|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110727850|NCT04026568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110727851|NCT04024228|Hemagglutinins|hemagglutinins|mesh-list
110727852|NCT04024228|Vaccines|vaccines|mesh-list
110727853|NCT04024228|Immunologic Factors|immunologic factors|mesh-ancestor
110727854|NCT04024228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110727855|NCT04024228|Agglutinins|agglutinins|mesh-ancestor
110727856|NCT04024228|Coagulants|coagulants|mesh-ancestor
110727857|NCT04023682|Hand Sanitizers|hand sanitizers|mesh-list
110727858|NCT04023682|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110727859|NCT04023682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110727860|NCT04023682|Disinfectants|disinfectants|mesh-ancestor
110727862|NCT04018612|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110727863|NCT04018612|Analgesics|analgesics|mesh-ancestor
110727864|NCT04018612|Sensory System Agents|sensory system agents|mesh-ancestor
110727865|NCT04018612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110727866|NCT04018612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110727867|NCT04018612|Antipyretics|antipyretics|mesh-ancestor
110727868|NCT04207840|Epinephrine|epinephrine|mesh-list
110727869|NCT04207840|Racepinephrine|racepinephrine|mesh-list
110727870|NCT04207840|Albuterol|albuterol|mesh-list
110727871|NCT04207840|Epinephryl borate|epinephryl borate|mesh-list
110727872|NCT04207840|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110727873|NCT04207840|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110727874|NCT04207840|Adrenergic Agents|adrenergic agents|mesh-ancestor
110727875|NCT04207840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110727876|NCT04207840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110727877|NCT04207840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110727878|NCT04207840|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110727879|NCT04207840|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110727880|NCT04207840|Autonomic Agents|autonomic agents|mesh-ancestor
110727881|NCT04207840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110727882|NCT04207840|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110727883|NCT04207840|Respiratory System Agents|respiratory system agents|mesh-ancestor
110727884|NCT04207840|Mydriatics|mydriatics|mesh-ancestor
110727885|NCT04207840|Sympathomimetics|sympathomimetics|mesh-ancestor
110727886|NCT04207840|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110727887|NCT04207840|Tocolytic Agents|tocolytic agents|mesh-ancestor
110727888|NCT04207840|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110727889|NCT04207840|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110727890|NCT03744364|Misoprostol|misoprostol|mesh-list
110727891|NCT03744364|Dinoprostone|dinoprostone|mesh-list
110682828|NCT00902915|Lenalidomide|lenalidomide|mesh-list
110727892|NCT03744364|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110727893|NCT03744364|Abortifacient Agents|abortifacient agents|mesh-ancestor
110727894|NCT03744364|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110727895|NCT03744364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110727897|NCT03744364|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110727898|NCT03744364|Oxytocics|oxytocics|mesh-ancestor
110727899|NCT03744208|Antibodies|antibodies|mesh-list
110727900|NCT03744208|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110727901|NCT03744208|Immunologic Factors|immunologic factors|mesh-ancestor
110727902|NCT03744208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110727903|NCT05069896|Mirikizumab|mirikizumab|mesh-list
110727904|NCT05069896|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110727905|NCT05069896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110727906|NCT05069896|Analgesics|analgesics|mesh-ancestor
110727907|NCT05069896|Sensory System Agents|sensory system agents|mesh-ancestor
110727908|NCT05069896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110727909|NCT05069896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110727910|NCT05069896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110727911|NCT05069896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110727912|NCT05069896|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110727913|NCT05069896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110727914|NCT01562626|Flucytosine|flucytosine|mesh-list
110727915|NCT01562626|Antifungal Agents|antifungal agents|mesh-ancestor
110727916|NCT01562626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110727917|NCT01562626|Antimetabolites|antimetabolites|mesh-ancestor
110727918|NCT01562626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110727919|NCT04470622|Aprepitant|aprepitant|mesh-list
110727920|NCT04470622|Antiemetics|antiemetics|mesh-ancestor
110727921|NCT04470622|Autonomic Agents|autonomic agents|mesh-ancestor
110727922|NCT04470622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110727923|NCT04470622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110727924|NCT04470622|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110727925|NCT04470622|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110727926|NCT04470622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110727927|NCT04470622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110727928|NCT04465396|Teduglutide|teduglutide|mesh-list
110727929|NCT04465396|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110727930|NCT04465396|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110727931|NCT04465396|Protective Agents|protective agents|mesh-ancestor
110727932|NCT04465396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110727933|NCT03996694|Oxycodone|oxycodone|mesh-list
110727934|NCT03996694|Buprenorphine|buprenorphine|mesh-list
110727935|NCT03996694|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110727936|NCT03996694|Narcotics|narcotics|mesh-ancestor
110727937|NCT03996694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110727938|NCT03996694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110727939|NCT03996694|Analgesics|analgesics|mesh-ancestor
110727940|NCT03996694|Sensory System Agents|sensory system agents|mesh-ancestor
110727941|NCT03996694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110727942|NCT03996694|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110727943|NCT03743896|Capsaicin|capsaicin|mesh-list
110727944|NCT03743896|Antipruritics|antipruritics|mesh-ancestor
110727945|NCT03743896|Dermatologic Agents|dermatologic agents|mesh-ancestor
110727946|NCT03743896|Sensory System Agents|sensory system agents|mesh-ancestor
110727947|NCT03743896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110727948|NCT03743896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110727949|NCT03737344|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
110727950|NCT03737344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110727951|NCT03751228|Deucravacitinib|deucravacitinib|mesh-list
110727952|NCT03751228|Dermatologic Agents|dermatologic agents|mesh-ancestor
110727953|NCT03751228|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110727954|NCT03751228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110727955|NCT03751228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110141979|NCT02016261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110727956|NCT03656692|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
110727957|NCT03656692|Hormones|hormones|mesh-ancestor
110727958|NCT03656692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110727959|NCT03656692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110727960|NCT04439266|Crizotinib|crizotinib|mesh-list
110727961|NCT04439266|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
110727962|NCT04439266|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110727963|NCT04439266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110727964|NCT04439266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110727965|NCT04439266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110727966|NCT01329796|Lidocaine|lidocaine|mesh-list
110727967|NCT01329796|Anesthetics, Local|anesthetics, local|mesh-ancestor
110727968|NCT01329796|Anesthetics|anesthetics|mesh-ancestor
110727969|NCT01329796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110727970|NCT01329796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110727971|NCT01329796|Sensory System Agents|sensory system agents|mesh-ancestor
110727972|NCT01329796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110727973|NCT01329796|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110727974|NCT01329796|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110727975|NCT01329796|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110727976|NCT01329796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110727977|NCT01329796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110727979|NCT04428502|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110727980|NCT04428502|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110727981|NCT04428502|Analgesics|analgesics|mesh-ancestor
110727982|NCT04428502|Sensory System Agents|sensory system agents|mesh-ancestor
110727983|NCT04428502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110727984|NCT04428502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110727985|NCT04428502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110727986|NCT04428502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110727987|NCT04428502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110727988|NCT04428502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110727989|NCT04428502|Immunologic Factors|immunologic factors|mesh-ancestor
110727990|NCT03736330|Pembrolizumab|pembrolizumab|mesh-list
110727991|NCT03736330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110727992|NCT03736330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110727993|NCT03736330|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110727994|NCT03736330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110727995|NCT04428424|Etanercept|etanercept|mesh-list
110727996|NCT04428424|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110727997|NCT04428424|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110727998|NCT04428424|Analgesics|analgesics|mesh-ancestor
110727999|NCT04428424|Sensory System Agents|sensory system agents|mesh-ancestor
110728000|NCT04428424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110728001|NCT04428424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110728002|NCT04428424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110728003|NCT04428424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110728004|NCT04428424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110728005|NCT04428424|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110728006|NCT04428424|Immunologic Factors|immunologic factors|mesh-ancestor
110728007|NCT00095238|Irbesartan|irbesartan|mesh-list
110728008|NCT00095238|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110728009|NCT00095238|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110728010|NCT00095238|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110728011|NCT00095238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110728012|NCT01087008|Zoledronic Acid|zoledronic acid|mesh-list
110728013|NCT01087008|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110728014|NCT01087008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110728015|NCT01084044|Urinastatin|urinastatin|mesh-list
110728016|NCT01084044|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
110728017|NCT01084044|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110728018|NCT01084044|Protease Inhibitors|protease inhibitors|mesh-ancestor
110728019|NCT01084044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110728020|NCT01084044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110728021|NCT01090518|Hydrocortisone|hydrocortisone|mesh-list
110728022|NCT01090518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110728023|NCT01090596|Naproxen|naproxen|mesh-list
110728024|NCT01090596|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110728025|NCT01090596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110728026|NCT01090596|Analgesics|analgesics|mesh-ancestor
110728027|NCT01090596|Sensory System Agents|sensory system agents|mesh-ancestor
110728028|NCT01090596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110728029|NCT01090596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110728030|NCT01090596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110728031|NCT01090596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110728032|NCT01090596|Gout Suppressants|gout suppressants|mesh-ancestor
110728033|NCT01090596|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110728034|NCT01090596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110728035|NCT01090596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110728036|NCT01084122|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
110728037|NCT01084122|Hematinics|hematinics|mesh-ancestor
110728038|NCT01084200|Propofol|propofol|mesh-list
110728039|NCT01084200|Sevoflurane|sevoflurane|mesh-list
110728040|NCT01084200|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110445824|NCT02771314|Osimertinib|osimertinib|mesh-list
110728041|NCT01084200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110728042|NCT01084200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110728043|NCT01084200|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110728044|NCT01084200|Anesthetics, General|anesthetics, general|mesh-ancestor
110728045|NCT01084200|Anesthetics|anesthetics|mesh-ancestor
110728046|NCT01084200|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110728047|NCT01084200|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110728048|NCT00094770|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110728049|NCT00094770|Glipizide|glipizide|mesh-list
110728050|NCT00094770|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110728051|NCT00094770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110728052|NCT00094770|Incretins|incretins|mesh-ancestor
110728053|NCT00094770|Hormones|hormones|mesh-ancestor
110728054|NCT00094770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110728055|NCT00094770|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110728056|NCT00094770|Protease Inhibitors|protease inhibitors|mesh-ancestor
110728057|NCT00094770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110728058|NCT00094770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110728059|NCT01087398|Cyclosporine|cyclosporine|mesh-list
110728060|NCT01087398|Cyclophosphamide|cyclophosphamide|mesh-list
110728061|NCT01087398|Busulfan|busulfan|mesh-list
110728062|NCT01087398|Methotrexate|methotrexate|mesh-list
110728063|NCT01087398|Fludarabine|fludarabine|mesh-list
110728064|NCT01087398|Cyclosporins|cyclosporins|mesh-list
110728065|NCT01087398|Thymoglobulin|thymoglobulin|mesh-list
110728066|NCT01087398|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110728067|NCT01087398|Immunologic Factors|immunologic factors|mesh-ancestor
110728068|NCT01087398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110728069|NCT01087398|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110728070|NCT01087398|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110728071|NCT01087398|Alkylating Agents|alkylating agents|mesh-ancestor
110728072|NCT01087398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110728073|NCT01087398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110728074|NCT01087398|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110728075|NCT01087398|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110728076|NCT01087398|Abortifacient Agents|abortifacient agents|mesh-ancestor
110728077|NCT01087398|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110728078|NCT01087398|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110728079|NCT01087398|Antimetabolites|antimetabolites|mesh-ancestor
110728080|NCT01087398|Dermatologic Agents|dermatologic agents|mesh-ancestor
110728081|NCT01087398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110728082|NCT01087398|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110728083|NCT01087398|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110728084|NCT01087398|Antifungal Agents|antifungal agents|mesh-ancestor
110728085|NCT01087398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110728086|NCT01087398|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110728087|NCT01087476|Doxycycline|doxycycline|mesh-list
110728088|NCT01087476|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110728089|NCT01087476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110728090|NCT01087476|Antimalarials|antimalarials|mesh-ancestor
110728091|NCT01087476|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110728092|NCT01087476|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110728093|NCT00069108|Leucovorin|leucovorin|mesh-list
110728094|NCT00069108|Capecitabine|capecitabine|mesh-list
110728095|NCT00069108|Oxaliplatin|oxaliplatin|mesh-list
110728096|NCT00069108|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110728097|NCT00069108|Antimetabolites|antimetabolites|mesh-ancestor
110728098|NCT00069108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110728099|NCT00069108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110728100|NCT00069108|Antidotes|antidotes|mesh-ancestor
110728101|NCT00069108|Protective Agents|protective agents|mesh-ancestor
110728102|NCT00069108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110728103|NCT00069108|Vitamin B Complex|vitamin b complex|mesh-ancestor
110728104|NCT00069108|Vitamins|vitamins|mesh-ancestor
110728105|NCT00069108|Micronutrients|micronutrients|mesh-ancestor
110728106|NCT00405587|Vemurafenib|vemurafenib|mesh-list
110728107|NCT00405587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110728108|NCT00405587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110728109|NCT00405587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110728110|NCT00405587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110728111|NCT01040429|Clonidine|clonidine|mesh-list
110728112|NCT01040429|Analgesics|analgesics|mesh-ancestor
110728113|NCT01040429|Sensory System Agents|sensory system agents|mesh-ancestor
110728114|NCT01040429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110728115|NCT01040429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110728116|NCT01040429|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110728117|NCT01040429|Sympatholytics|sympatholytics|mesh-ancestor
110728118|NCT01040429|Autonomic Agents|autonomic agents|mesh-ancestor
110728119|NCT01040429|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110728120|NCT01040429|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110728121|NCT01040429|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110728122|NCT01040429|Adrenergic Agents|adrenergic agents|mesh-ancestor
110728123|NCT01040429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110728124|NCT01040429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110728125|NCT01039883|Albaconazole|albaconazole|mesh-list
110728126|NCT01039883|Antifungal Agents|antifungal agents|mesh-ancestor
110728127|NCT01039883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110728128|NCT00405275|Hydroxychloroquine|hydroxychloroquine|mesh-list
110728129|NCT00405275|Sulfasalazine|sulfasalazine|mesh-list
110728131|NCT00405275|Methotrexate|methotrexate|mesh-list
110728132|NCT00405275|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110728133|NCT00405275|Abortifacient Agents|abortifacient agents|mesh-ancestor
110728134|NCT00405275|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110728135|NCT00405275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110728136|NCT00405275|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110728137|NCT00405275|Antimetabolites|antimetabolites|mesh-ancestor
110728138|NCT00405275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110728139|NCT00405275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110728140|NCT00405275|Dermatologic Agents|dermatologic agents|mesh-ancestor
110728141|NCT00405275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110728142|NCT00405275|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110728143|NCT00405275|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110728144|NCT00405275|Immunologic Factors|immunologic factors|mesh-ancestor
110728145|NCT00405275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110728146|NCT00405275|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110728147|NCT00405275|Antimalarials|antimalarials|mesh-ancestor
110728148|NCT00405275|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110728149|NCT00405275|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110728150|NCT00405275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110728151|NCT00405275|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110728152|NCT00405275|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110728153|NCT00405275|Analgesics|analgesics|mesh-ancestor
110728154|NCT00405275|Sensory System Agents|sensory system agents|mesh-ancestor
110728155|NCT00405275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110728156|NCT00405275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110728157|NCT00405275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110728158|NCT00404651|Vaccines|vaccines|mesh-list
110728159|NCT00404651|Immunologic Factors|immunologic factors|mesh-ancestor
110728160|NCT00404651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110728161|NCT00404495|Irinotecan|irinotecan|mesh-list
110728162|NCT00404495|Temozolomide|temozolomide|mesh-list
110728163|NCT00404495|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110728164|NCT00404495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110728165|NCT00404495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110728166|NCT00404495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110728167|NCT00404495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110728168|NCT00404495|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110728169|NCT00404495|Alkylating Agents|alkylating agents|mesh-ancestor
110728170|NCT00409409|Immunomodulating Agents|immunomodulating agents|mesh-list
110728171|NCT00409409|Immunologic Factors|immunologic factors|mesh-ancestor
110728172|NCT00409409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110728173|NCT00409331|Amifostine|amifostine|mesh-list
110728174|NCT00409331|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110728175|NCT00409331|Protective Agents|protective agents|mesh-ancestor
110728176|NCT00409331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110728177|NCT00362219|Morphine|morphine|mesh-list
110728178|NCT00362219|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110728179|NCT00362219|Narcotics|narcotics|mesh-ancestor
110728180|NCT00362219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110728181|NCT00362219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110728182|NCT00362219|Analgesics|analgesics|mesh-ancestor
110728183|NCT00362219|Sensory System Agents|sensory system agents|mesh-ancestor
110728184|NCT00362219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110728185|NCT01040585|Linezolid|linezolid|mesh-list
110728186|NCT01040585|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110728187|NCT01040585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110728188|NCT01040585|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110728189|NCT01040585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110728190|NCT01040585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110728191|NCT01040195|Hydroxychloroquine|hydroxychloroquine|mesh-list
110728192|NCT01040195|Methotrexate|methotrexate|mesh-list
110728193|NCT01040195|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110728194|NCT01040195|Abortifacient Agents|abortifacient agents|mesh-ancestor
110728195|NCT01040195|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110728196|NCT01040195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110728197|NCT01040195|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110728199|NCT01040195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110728200|NCT01040195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110728201|NCT01040195|Dermatologic Agents|dermatologic agents|mesh-ancestor
110728202|NCT01040195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110728203|NCT01040195|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110728204|NCT01040195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110728205|NCT01040195|Immunologic Factors|immunologic factors|mesh-ancestor
110728206|NCT01040195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110728207|NCT01040195|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110728208|NCT01040195|Antimalarials|antimalarials|mesh-ancestor
110728209|NCT01040195|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110728210|NCT01040195|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110728211|NCT01040195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110728212|NCT01040273|Bupivacaine|bupivacaine|mesh-list
110728213|NCT01040273|Anesthetics, Local|anesthetics, local|mesh-ancestor
110728214|NCT01040273|Anesthetics|anesthetics|mesh-ancestor
110728215|NCT01040273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110728216|NCT01040273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110728217|NCT01040273|Sensory System Agents|sensory system agents|mesh-ancestor
110728218|NCT01040273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110728219|NCT00408629|Adalimumab|adalimumab|mesh-list
110728220|NCT00408629|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110728221|NCT00408629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110728222|NCT00408629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110728223|NCT00408317|Pancrelipase|pancrelipase|mesh-list
110728224|NCT00408317|Pancreatin|pancreatin|mesh-list
110728225|NCT00408317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110728226|NCT00112502|Thalidomide|thalidomide|mesh-list
110728227|NCT00112502|Celecoxib|celecoxib|mesh-list
110728228|NCT00112502|Temozolomide|temozolomide|mesh-list
110728229|NCT00112502|Isotretinoin|isotretinoin|mesh-list
110728230|NCT00112502|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110728231|NCT00112502|Alkylating Agents|alkylating agents|mesh-ancestor
110728232|NCT00112502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110728233|NCT00112502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110728234|NCT00112502|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110728235|NCT00112502|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110728237|NCT00112502|Sensory System Agents|sensory system agents|mesh-ancestor
110728238|NCT00112502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110728239|NCT00112502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110728240|NCT00112502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110728241|NCT00112502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110728242|NCT00112502|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110728243|NCT00112502|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110728244|NCT00112502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110728245|NCT00112502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110728246|NCT00112502|Immunologic Factors|immunologic factors|mesh-ancestor
110728247|NCT00112502|Leprostatic Agents|leprostatic agents|mesh-ancestor
110728248|NCT00112502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110728249|NCT00112502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110728250|NCT00112502|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110728251|NCT00112502|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110728252|NCT00112502|Growth Substances|growth substances|mesh-ancestor
110728253|NCT00112502|Growth Inhibitors|growth inhibitors|mesh-ancestor
110728254|NCT00112502|Dermatologic Agents|dermatologic agents|mesh-ancestor
110728255|NCT03965546|Sorafenib|sorafenib|mesh-list
110728256|NCT03965546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110728257|NCT03965546|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110728258|NCT03965546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110728259|NCT03965546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110728261|NCT01083992|Vildagliptin|vildagliptin|mesh-list
110728262|NCT01083992|Vitamins|vitamins|mesh-ancestor
110728263|NCT01083992|Micronutrients|micronutrients|mesh-ancestor
110728264|NCT01083992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110728265|NCT01083992|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110728266|NCT01083992|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110728267|NCT01083992|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110728268|NCT01083992|Protease Inhibitors|protease inhibitors|mesh-ancestor
110728269|NCT01083992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110728270|NCT01083992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110728271|NCT03822182|Dexamethasone|dexamethasone|mesh-list
110728272|NCT03822182|Bupivacaine|bupivacaine|mesh-list
110728273|NCT03822182|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110728274|NCT03822182|Antiemetics|antiemetics|mesh-ancestor
110728275|NCT03822182|Autonomic Agents|autonomic agents|mesh-ancestor
110728276|NCT03822182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110728277|NCT03822182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110728278|NCT03822182|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110728279|NCT03822182|Glucocorticoids|glucocorticoids|mesh-ancestor
110728280|NCT03822182|Hormones|hormones|mesh-ancestor
110728281|NCT03822182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110728282|NCT03822182|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110728283|NCT03822182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110728284|NCT03822182|Anesthetics, Local|anesthetics, local|mesh-ancestor
110728285|NCT03822182|Anesthetics|anesthetics|mesh-ancestor
110728286|NCT03822182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110728287|NCT03822182|Sensory System Agents|sensory system agents|mesh-ancestor
110728288|NCT01078610|Adalimumab|adalimumab|mesh-list
110728289|NCT01078610|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110728290|NCT01078610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110728291|NCT01078610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110728292|NCT01080482|Tacrolimus|tacrolimus|mesh-list
110728293|NCT01080482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110728294|NCT01080482|Immunologic Factors|immunologic factors|mesh-ancestor
110728295|NCT01080482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110728296|NCT01080482|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110728297|NCT01080482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110728298|NCT01080482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110728299|NCT03965624|Ixazomib|ixazomib|mesh-list
110728300|NCT03965624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110728301|NCT03965624|Protease Inhibitors|protease inhibitors|mesh-ancestor
110728302|NCT03965624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110728303|NCT03965624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110728304|NCT01080560|Cyclosporine|cyclosporine|mesh-list
110728305|NCT01080560|Cyclosporins|cyclosporins|mesh-list
110728306|NCT01080560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110728307|NCT01080560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110728308|NCT01080560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110728310|NCT01080560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110728311|NCT01080560|Antifungal Agents|antifungal agents|mesh-ancestor
110728312|NCT01080560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110728313|NCT01080560|Dermatologic Agents|dermatologic agents|mesh-ancestor
110728314|NCT01080560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110728315|NCT01080560|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110728316|NCT00094328|Anastrozole|anastrozole|mesh-list
110728317|NCT00094328|Bicalutamide|bicalutamide|mesh-list
110728318|NCT00094328|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110728319|NCT00094328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110728320|NCT00094328|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110728321|NCT00094328|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110728322|NCT00094328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110728323|NCT00094328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110728325|NCT00094328|Hormone Antagonists|hormone antagonists|mesh-ancestor
110142066|NCT02016664|Sensory System Agents|sensory system agents|mesh-ancestor
110728326|NCT00094328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110728327|NCT00094328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110728328|NCT00094328|Androgen Antagonists|androgen antagonists|mesh-ancestor
110728329|NCT00094172|Atorvastatin|atorvastatin|mesh-list
110728330|NCT00094172|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110728331|NCT00094172|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110728332|NCT00094172|Antimetabolites|antimetabolites|mesh-ancestor
110728333|NCT00094172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110728334|NCT00094172|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110728335|NCT00094172|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110728336|NCT00094172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110728337|NCT00094094|Axitinib|axitinib|mesh-list
110728338|NCT00094094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110728339|NCT00094094|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110728340|NCT00094094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110728341|NCT00094094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110728342|NCT03962816|Vaccines|vaccines|mesh-list
110728343|NCT03962816|Immunologic Factors|immunologic factors|mesh-ancestor
110446125|NCT02854995|Hormones|hormones|mesh-ancestor
110728344|NCT03962816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110728345|NCT01080638|polysaccharide-K|polysaccharide-k|mesh-list
110728347|NCT01080638|Anticoagulants|anticoagulants|mesh-ancestor
110728348|NCT01080638|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110728349|NCT01080638|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110728350|NCT01080638|Immunologic Factors|immunologic factors|mesh-ancestor
110728351|NCT01080638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110728352|NCT01080638|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110728353|NCT01080638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110728354|NCT01080638|Antiviral Agents|antiviral agents|mesh-ancestor
110728355|NCT01080638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110728356|NCT01080638|Interferon Inducers|interferon inducers|mesh-ancestor
110728357|NCT01080638|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110728358|NCT01080638|Protective Agents|protective agents|mesh-ancestor
110728359|NCT00110396|Interferons|interferons|mesh-list
110728360|NCT00110396|Interferon-beta|interferon-beta|mesh-list
110728361|NCT00110396|Interferon beta-1a|interferon beta-1a|mesh-list
110728362|NCT00110396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110728364|NCT00110396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110728365|NCT00110396|Immunologic Factors|immunologic factors|mesh-ancestor
110728366|NCT00110396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110728367|NCT00110396|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110728368|NCT00093470|Tipifarnib|tipifarnib|mesh-list
110728369|NCT00093470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110728370|NCT00407537|Amlodipine|amlodipine|mesh-list
110728371|NCT00407537|Atorvastatin|atorvastatin|mesh-list
110728372|NCT00407537|Calcium|calcium|mesh-list
110728373|NCT00407537|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110728374|NCT00407537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110728375|NCT00407537|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110728376|NCT00407537|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110728377|NCT00407537|Antimetabolites|antimetabolites|mesh-ancestor
110728378|NCT00407537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110728379|NCT00407537|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110728380|NCT00407537|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110728381|NCT00407537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110728382|NCT00407537|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110728383|NCT00407537|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110728384|NCT00407537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110728385|NCT00407537|Vasodilator Agents|vasodilator agents|mesh-ancestor
110728386|NCT00094458|Infliximab|infliximab|mesh-list
110728387|NCT00094458|Azathioprine|azathioprine|mesh-list
110728388|NCT00094458|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110728389|NCT00094458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110728390|NCT00094458|Dermatologic Agents|dermatologic agents|mesh-ancestor
110728391|NCT00094458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110728392|NCT00094458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110728394|NCT00094458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110728395|NCT00094458|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110728396|NCT00094458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110728397|NCT00094458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110728398|NCT00094458|Immunologic Factors|immunologic factors|mesh-ancestor
110728399|NCT00094458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110728400|NCT00406367|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
110728401|NCT00406367|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110728402|NCT00406367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110728403|NCT00406367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110728404|NCT00406367|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110728405|NCT00406367|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110728406|NCT00406367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110728407|NCT00406367|Cholinergic Agents|cholinergic agents|mesh-ancestor
110728408|NCT00406367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110728409|NCT01041443|Tetrahydrouridine|tetrahydrouridine|mesh-list
110728410|NCT01041443|Antimetabolites|antimetabolites|mesh-ancestor
110728411|NCT01041443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110728412|NCT03961464|Cycloserine|cycloserine|mesh-list
110728413|NCT03961464|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110728414|NCT03961464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110728415|NCT03961464|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110728416|NCT03961464|Antitubercular Agents|antitubercular agents|mesh-ancestor
110728417|NCT03961464|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110728418|NCT03961464|Antimetabolites|antimetabolites|mesh-ancestor
110728419|NCT03961464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110728420|NCT01087554|Sirolimus|sirolimus|mesh-list
110728421|NCT01087554|Everolimus|everolimus|mesh-list
110728422|NCT01087554|MTOR Inhibitors|mtor inhibitors|mesh-list
110728423|NCT01087554|Temsirolimus|temsirolimus|mesh-list
110728424|NCT01087554|Vorinostat|vorinostat|mesh-list
110728425|NCT01087554|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110728426|NCT01087554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110728427|NCT01087554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110728428|NCT01087554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110728429|NCT01087554|Immunologic Factors|immunologic factors|mesh-ancestor
110728430|NCT01087554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110728431|NCT01087554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110728432|NCT01087554|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110728433|NCT01087554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110728434|NCT01087554|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110728435|NCT01087554|Antifungal Agents|antifungal agents|mesh-ancestor
110728437|NCT01087632|Folic Acid|folic acid|mesh-list
110728438|NCT01087632|Coenzyme Q10|coenzyme q10|mesh-list
110728439|NCT01087632|Policosanol|policosanol|mesh-list
110728440|NCT01087632|Red yeast rice|red yeast rice|mesh-list
110728441|NCT01087632|Hematinics|hematinics|mesh-ancestor
110728442|NCT01087632|Vitamin B Complex|vitamin b complex|mesh-ancestor
110728443|NCT01087632|Vitamins|vitamins|mesh-ancestor
110728444|NCT01087632|Micronutrients|micronutrients|mesh-ancestor
110728445|NCT01087632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110728446|NCT01087632|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110728447|NCT01087632|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110728448|NCT01087632|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110728449|NCT01087632|Antimetabolites|antimetabolites|mesh-ancestor
110728450|NCT01087632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110728451|NCT01087632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110728452|NCT01087632|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110728453|NCT01087632|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110728454|NCT00394589|Infliximab|infliximab|mesh-list
110142089|NCT02016820|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110728455|NCT00394589|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110728456|NCT00394589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110728457|NCT00394589|Dermatologic Agents|dermatologic agents|mesh-ancestor
110728458|NCT00394589|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110728459|NCT00394589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110728460|NCT00068406|Cisplatin|cisplatin|mesh-list
110728461|NCT00068406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110728463|NCT00403559|Pimecrolimus|pimecrolimus|mesh-list
110728464|NCT00403559|Antifungal Agents|antifungal agents|mesh-ancestor
110728465|NCT00403559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110728466|NCT00403559|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110728467|NCT00403559|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110728468|NCT00403559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110728469|NCT00403559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110728470|NCT00403559|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110728471|NCT00403559|Hormone Antagonists|hormone antagonists|mesh-ancestor
110728472|NCT00403559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110728473|NCT00403559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110728474|NCT00403559|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110728475|NCT00403559|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110728476|NCT00403559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110728477|NCT00403559|Analgesics|analgesics|mesh-ancestor
110728478|NCT00403559|Sensory System Agents|sensory system agents|mesh-ancestor
110728479|NCT00403559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110728480|NCT00403559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110728481|NCT00403559|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110728482|NCT00403559|Dermatologic Agents|dermatologic agents|mesh-ancestor
110728483|NCT00403559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110728484|NCT00403559|Immunologic Factors|immunologic factors|mesh-ancestor
110728485|NCT00403559|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110728486|NCT01087710|Vitamins|vitamins|mesh-list
110728487|NCT01087710|Antioxidants|antioxidants|mesh-list
110728488|NCT01087710|Micronutrients|micronutrients|mesh-ancestor
110728489|NCT01087710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110728490|NCT01087710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110728491|NCT01087710|Protective Agents|protective agents|mesh-ancestor
110728492|NCT00403481|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110728493|NCT00403481|Olmesartan|olmesartan|mesh-list
110728494|NCT00403481|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
110728496|NCT00403481|Diuretics|diuretics|mesh-ancestor
110728497|NCT00403481|Natriuretic Agents|natriuretic agents|mesh-ancestor
110728498|NCT00403481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110728499|NCT00403481|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110728500|NCT00403481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110728501|NCT00403481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110728502|NCT00403481|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110728503|NCT00403481|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110728504|NCT00402779|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110728505|NCT00402779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110728506|NCT00402779|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110728507|NCT00402779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110728508|NCT00402779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110728509|NCT00394433|Bevacizumab|bevacizumab|mesh-list
110728510|NCT00394433|Cisplatin|cisplatin|mesh-list
110728511|NCT00394433|Docetaxel|docetaxel|mesh-list
110728512|NCT00394433|Irinotecan|irinotecan|mesh-list
110728513|NCT00394433|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110728514|NCT00394433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110728515|NCT00394433|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110728516|NCT00394433|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110728517|NCT00394433|Growth Substances|growth substances|mesh-ancestor
110728518|NCT00394433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110728519|NCT00394433|Growth Inhibitors|growth inhibitors|mesh-ancestor
110728520|NCT00394433|Tubulin Modulators|tubulin modulators|mesh-ancestor
110728521|NCT00394433|Antimitotic Agents|antimitotic agents|mesh-ancestor
110728522|NCT00394433|Mitosis Modulators|mitosis modulators|mesh-ancestor
110728523|NCT00394433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110728524|NCT00394433|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110728525|NCT00394433|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110728526|NCT00394433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110728527|NCT00092534|Vaccines|vaccines|mesh-list
110728528|NCT00092534|Immunologic Factors|immunologic factors|mesh-ancestor
110728529|NCT00092534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110728530|NCT00068250|Rituximab|rituximab|mesh-list
110728531|NCT00068250|Methotrexate|methotrexate|mesh-list
110728532|NCT00068250|Temozolomide|temozolomide|mesh-list
110728533|NCT00068250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110728534|NCT00068250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110728535|NCT00068250|Immunologic Factors|immunologic factors|mesh-ancestor
110728536|NCT00068250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110728537|NCT00068250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110728538|NCT00068250|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110728539|NCT00068250|Abortifacient Agents|abortifacient agents|mesh-ancestor
110728540|NCT00068250|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110728541|NCT00068250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110728542|NCT00068250|Antimetabolites|antimetabolites|mesh-ancestor
110728543|NCT00068250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110728544|NCT00068250|Dermatologic Agents|dermatologic agents|mesh-ancestor
110728545|NCT00068250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110728546|NCT00068250|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110728547|NCT00068250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110728548|NCT00068250|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110728549|NCT00068250|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110728550|NCT00068250|Alkylating Agents|alkylating agents|mesh-ancestor
110728551|NCT03957720|Penicillamine|penicillamine|mesh-list
110728552|NCT03957720|Succimer|succimer|mesh-list
110728553|NCT03957720|Antidotes|antidotes|mesh-ancestor
110728554|NCT03957720|Protective Agents|protective agents|mesh-ancestor
110728555|NCT03957720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110728556|NCT03957720|Chelating Agents|chelating agents|mesh-ancestor
110728557|NCT03957720|Sequestering Agents|sequestering agents|mesh-ancestor
110728558|NCT03957720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110728559|NCT03957720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110728560|NCT00393029|Aldesleukin|aldesleukin|mesh-list
110728561|NCT00393029|Cyclophosphamide|cyclophosphamide|mesh-list
110728562|NCT00393029|Fludarabine|fludarabine|mesh-list
110728563|NCT00393029|Fludarabine phosphate|fludarabine phosphate|mesh-list
110728564|NCT00393029|Interleukin-2|interleukin-2|mesh-list
110728565|NCT00393029|Lenograstim|lenograstim|mesh-list
110728566|NCT00393029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110728567|NCT00393029|Immunologic Factors|immunologic factors|mesh-ancestor
110728568|NCT00393029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110728569|NCT00393029|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110728570|NCT00393029|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110728571|NCT00393029|Alkylating Agents|alkylating agents|mesh-ancestor
110728572|NCT00393029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110728573|NCT00393029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110728574|NCT00393029|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110728575|NCT00393029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110728576|NCT00393029|Antimetabolites|antimetabolites|mesh-ancestor
110728577|NCT00393029|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110728578|NCT00393029|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110728579|NCT00393029|Analgesics|analgesics|mesh-ancestor
110728580|NCT00393029|Sensory System Agents|sensory system agents|mesh-ancestor
110728581|NCT00393029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110728583|NCT00393029|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110728584|NCT00393029|Antiviral Agents|antiviral agents|mesh-ancestor
110728585|NCT00393029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110728586|NCT00402233|Pramipexole|pramipexole|mesh-list
110728587|NCT00402233|Antioxidants|antioxidants|mesh-ancestor
110728588|NCT00402233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110728589|NCT00402233|Protective Agents|protective agents|mesh-ancestor
110728590|NCT00402233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110728591|NCT00402233|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110728592|NCT00402233|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110728593|NCT00402233|Dopamine Agonists|dopamine agonists|mesh-ancestor
110728594|NCT00402233|Dopamine Agents|dopamine agents|mesh-ancestor
110728595|NCT00402233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110728596|NCT03993431|Methamphetamine|methamphetamine|mesh-list
110728597|NCT03993431|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110728598|NCT03993431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110728599|NCT03993431|Sympathomimetics|sympathomimetics|mesh-ancestor
110728600|NCT03993431|Autonomic Agents|autonomic agents|mesh-ancestor
110728601|NCT03993431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110728602|NCT03993431|Dopamine Agents|dopamine agents|mesh-ancestor
110728603|NCT03993431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110728604|NCT03993431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110728605|NCT03993431|Adrenergic Agents|adrenergic agents|mesh-ancestor
110728606|NCT03993431|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110728607|NCT03993431|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110728608|NCT03993431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110728609|NCT03993431|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110728610|NCT00401843|Dexamethasone|dexamethasone|mesh-list
110728612|NCT00401843|Siltuximab|siltuximab|mesh-list
110728613|NCT00401843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110728614|NCT00401843|Antiemetics|antiemetics|mesh-ancestor
110728615|NCT00401843|Autonomic Agents|autonomic agents|mesh-ancestor
110728616|NCT00401843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110728617|NCT00401843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110728618|NCT00401843|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110728619|NCT00401843|Glucocorticoids|glucocorticoids|mesh-ancestor
110728620|NCT00401843|Hormones|hormones|mesh-ancestor
110728621|NCT00401843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110728622|NCT00401843|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110728623|NCT00401843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110728625|NCT00401531|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110728626|NCT00401531|Immunologic Factors|immunologic factors|mesh-ancestor
110728627|NCT00401531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110728628|NCT00401375|Methylnaltrexone|methylnaltrexone|mesh-list
110728629|NCT00401375|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110728630|NCT00401375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110728631|NCT00401375|Sensory System Agents|sensory system agents|mesh-ancestor
110728632|NCT00401375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110728633|NCT00400517|Thalidomide|thalidomide|mesh-list
110728634|NCT00400517|Sargramostim|sargramostim|mesh-list
110728635|NCT00400517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110728636|NCT00400517|Immunologic Factors|immunologic factors|mesh-ancestor
110728637|NCT00400517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110728638|NCT00400517|Leprostatic Agents|leprostatic agents|mesh-ancestor
110728639|NCT00400517|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110728640|NCT00400517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110728641|NCT00400517|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110728642|NCT00400517|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110728643|NCT00400517|Growth Substances|growth substances|mesh-ancestor
110728644|NCT00400517|Growth Inhibitors|growth inhibitors|mesh-ancestor
110728646|NCT01044095|Vaccines|vaccines|mesh-list
110728647|NCT01044095|Immunologic Factors|immunologic factors|mesh-ancestor
110728648|NCT01044095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110728649|NCT00392171|Temozolomide|temozolomide|mesh-list
110728650|NCT00392171|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110728651|NCT00392171|Alkylating Agents|alkylating agents|mesh-ancestor
110728652|NCT00392171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110728653|NCT00392171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110728654|NCT00091832|Denosumab|denosumab|mesh-list
110728655|NCT00091832|Diphosphonates|diphosphonates|mesh-list
110728656|NCT00091832|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110728657|NCT00091832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110728658|NCT00391391|Vaccines|vaccines|mesh-list
110728659|NCT00391391|Immunologic Factors|immunologic factors|mesh-ancestor
110728660|NCT00391391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110728661|NCT01044251|Frovatriptan|frovatriptan|mesh-list
110728662|NCT01044251|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110728663|NCT01044251|Serotonin Agents|serotonin agents|mesh-ancestor
110728664|NCT01044251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110728665|NCT01044251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110728666|NCT01044251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110728667|NCT01044329|Triamcinolone|triamcinolone|mesh-list
110728668|NCT01044329|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110728669|NCT01044329|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110728670|NCT01044329|Bevacizumab|bevacizumab|mesh-list
110728671|NCT01044329|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110728672|NCT01044329|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110728673|NCT01044329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110728674|NCT01044329|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110728675|NCT01044329|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110728676|NCT01044329|Growth Substances|growth substances|mesh-ancestor
110728677|NCT01044329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110728678|NCT01044329|Growth Inhibitors|growth inhibitors|mesh-ancestor
110728679|NCT01044329|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110728680|NCT01044329|Glucocorticoids|glucocorticoids|mesh-ancestor
110728681|NCT01044329|Hormones|hormones|mesh-ancestor
110728682|NCT01044329|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110728683|NCT01044329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110728684|NCT01044329|Immunologic Factors|immunologic factors|mesh-ancestor
110728685|NCT01044329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110728686|NCT01044329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110728687|NCT00091442|Docetaxel|docetaxel|mesh-list
110728688|NCT00091442|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110728689|NCT00091442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110728690|NCT00091442|Tubulin Modulators|tubulin modulators|mesh-ancestor
110728691|NCT00091442|Antimitotic Agents|antimitotic agents|mesh-ancestor
110728692|NCT00091442|Mitosis Modulators|mitosis modulators|mesh-ancestor
110728693|NCT00091442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110728694|NCT00091442|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110728695|NCT00390689|Pramipexole|pramipexole|mesh-list
110728696|NCT00390689|Antioxidants|antioxidants|mesh-ancestor
110728697|NCT00390689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110728698|NCT00390689|Protective Agents|protective agents|mesh-ancestor
110728699|NCT00390689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110728700|NCT00390689|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110728701|NCT00390689|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110728702|NCT00390689|Dopamine Agonists|dopamine agonists|mesh-ancestor
110728703|NCT00390689|Dopamine Agents|dopamine agents|mesh-ancestor
110728704|NCT00390689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110728705|NCT01079078|Acetaminophen|acetaminophen|mesh-list
110728706|NCT01079078|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110728707|NCT01079078|Analgesics|analgesics|mesh-ancestor
110728708|NCT01079078|Sensory System Agents|sensory system agents|mesh-ancestor
110728709|NCT01079078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110728710|NCT01079078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110728711|NCT01079078|Antipyretics|antipyretics|mesh-ancestor
110728712|NCT00390455|Fulvestrant|fulvestrant|mesh-list
110728713|NCT00390455|Lapatinib|lapatinib|mesh-list
110728714|NCT00390455|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110728715|NCT00390455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110728716|NCT00390455|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110728717|NCT00390455|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110446505|NCT00698269|Insulin Detemir|insulin detemir|mesh-list
110728718|NCT00390455|Hormone Antagonists|hormone antagonists|mesh-ancestor
110728719|NCT00390455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110728720|NCT00390455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110728721|NCT00390455|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110728722|NCT00390455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110728723|NCT00390455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110728724|NCT03812510|Hydrogen Peroxide|hydrogen peroxide|mesh-list
110728725|NCT03812510|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110728726|NCT03812510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110728727|NCT01583114|Perindopril|perindopril|mesh-list
110728728|NCT01583114|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110728729|NCT01583114|Protease Inhibitors|protease inhibitors|mesh-ancestor
110728730|NCT01583114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110728731|NCT01583114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110728732|NCT01583114|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110728734|NCT01079312|Remifentanil|remifentanil|mesh-list
110728735|NCT01079312|Propofol|propofol|mesh-list
110728736|NCT01079312|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
110728737|NCT01079312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110728738|NCT01079312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110728739|NCT01079312|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110728740|NCT01079312|Anesthetics, General|anesthetics, general|mesh-ancestor
110728741|NCT01079312|Anesthetics|anesthetics|mesh-ancestor
110728742|NCT01079312|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110728743|NCT01079312|Narcotics|narcotics|mesh-ancestor
110728744|NCT01079312|Analgesics|analgesics|mesh-ancestor
110728745|NCT01079312|Sensory System Agents|sensory system agents|mesh-ancestor
110728746|NCT01079312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110728747|NCT01079312|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110728749|NCT01044485|Lapatinib|lapatinib|mesh-list
110728750|NCT01044485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110728751|NCT01044485|Tubulin Modulators|tubulin modulators|mesh-ancestor
110728752|NCT01044485|Antimitotic Agents|antimitotic agents|mesh-ancestor
110728753|NCT01044485|Mitosis Modulators|mitosis modulators|mesh-ancestor
110728754|NCT01044485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110728755|NCT01044485|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110728756|NCT01044485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110728757|NCT00119678|Prednisone|prednisone|mesh-list
110728758|NCT00119678|Abatacept|abatacept|mesh-list
110728759|NCT00119678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110728760|NCT00119678|Glucocorticoids|glucocorticoids|mesh-ancestor
110728761|NCT00119678|Hormones|hormones|mesh-ancestor
110728762|NCT00119678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110142164|NCT02017561|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110728763|NCT00119678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110728764|NCT00119678|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110728765|NCT00119678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110728766|NCT00119678|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110728767|NCT00119678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110728768|NCT00119678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110728769|NCT00119678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110728770|NCT00119678|Immunologic Factors|immunologic factors|mesh-ancestor
110728771|NCT00119678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110728772|NCT00110084|Paclitaxel|paclitaxel|mesh-list
110728773|NCT00110084|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110728774|NCT00110084|Gemcitabine|gemcitabine|mesh-list
110728775|NCT00110084|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110728776|NCT00110084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110728777|NCT00110084|Tubulin Modulators|tubulin modulators|mesh-ancestor
110728778|NCT00110084|Antimitotic Agents|antimitotic agents|mesh-ancestor
110728779|NCT00110084|Mitosis Modulators|mitosis modulators|mesh-ancestor
110728780|NCT00110084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110728781|NCT00110084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110728782|NCT00110084|Antimetabolites|antimetabolites|mesh-ancestor
110728783|NCT00390221|Daclizumab|daclizumab|mesh-list
110728784|NCT00390221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110728785|NCT00390221|Immunologic Factors|immunologic factors|mesh-ancestor
110728786|NCT00390221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110728787|NCT00389831|Rotigotine|rotigotine|mesh-list
110728788|NCT00389831|Dopamine Agonists|dopamine agonists|mesh-ancestor
110728789|NCT00389831|Dopamine Agents|dopamine agents|mesh-ancestor
110728790|NCT00389831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110728791|NCT00389831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110728792|NCT00389831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110728793|NCT00389519|Ramipril|ramipril|mesh-list
110728794|NCT00389519|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110728795|NCT00389519|Protease Inhibitors|protease inhibitors|mesh-ancestor
110728796|NCT00389519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110728797|NCT00389519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110728798|NCT00389519|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110728799|NCT00389441|Axitinib|axitinib|mesh-list
110728800|NCT00389441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110728801|NCT00389441|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110728802|NCT00389441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110728803|NCT00389441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110728804|NCT00118898|Ritonavir|ritonavir|mesh-list
110728805|NCT00118898|Atazanavir Sulfate|atazanavir sulfate|mesh-list
110728806|NCT00118898|Tenofovir|tenofovir|mesh-list
110728807|NCT00118898|Lamivudine|lamivudine|mesh-list
110728808|NCT00118898|Emtricitabine|emtricitabine|mesh-list
110728809|NCT00118898|Abacavir|abacavir|mesh-list
110728810|NCT00118898|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110728811|NCT00118898|Efavirenz|efavirenz|mesh-list
110728812|NCT00118898|Dideoxynucleosides|dideoxynucleosides|mesh-list
110728813|NCT00118898|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110728814|NCT00118898|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110728815|NCT00118898|Protease Inhibitors|protease inhibitors|mesh-ancestor
110728816|NCT00118898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110728817|NCT00118898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110728818|NCT00118898|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110728819|NCT00118898|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110728820|NCT00118898|Antiviral Agents|antiviral agents|mesh-ancestor
110728821|NCT00118898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110728822|NCT00118898|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110728823|NCT00118898|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110142178|NCT02017639|Simvastatin|simvastatin|mesh-list
110728824|NCT00118898|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110728825|NCT00118898|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110728826|NCT00118898|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110728827|NCT00118898|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110728828|NCT00118898|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110728829|NCT00118898|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110728830|NCT00118898|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110728831|NCT00118898|Antimetabolites|antimetabolites|mesh-ancestor
110728832|NCT00118430|Antidepressive Agents|antidepressive agents|mesh-list
110728833|NCT00118430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110728835|NCT01085552|Hematinics|hematinics|mesh-ancestor
110728836|NCT01085708|Rabeprazole|rabeprazole|mesh-list
110728837|NCT01085708|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110728838|NCT01085708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110728839|NCT01085708|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110728841|NCT01085708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110728842|NCT00090584|Tolterodine Tartrate|tolterodine tartrate|mesh-list
110728843|NCT00090584|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110728844|NCT00090584|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110728845|NCT00090584|Cholinergic Agents|cholinergic agents|mesh-ancestor
110728846|NCT00090584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110728847|NCT00090584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110728848|NCT00090584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110728849|NCT00090584|Urological Agents|urological agents|mesh-ancestor
110728850|NCT01079624|Glucagon|glucagon|mesh-list
110728851|NCT01079624|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
110728852|NCT01079624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110728853|NCT01079624|Hormones|hormones|mesh-ancestor
110728854|NCT01079624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110728855|NCT01079624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110728856|NCT01079624|Incretins|incretins|mesh-ancestor
110728857|NCT01086020|Atorvastatin|atorvastatin|mesh-list
110728858|NCT01086020|Ezetimibe|ezetimibe|mesh-list
110728859|NCT01086020|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110728860|NCT01086020|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110728861|NCT01086020|Antimetabolites|antimetabolites|mesh-ancestor
110728862|NCT01086020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110728863|NCT01086020|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110728864|NCT01086020|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110728865|NCT01086020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110728866|NCT03670810|Lasmiditan|lasmiditan|mesh-list
110728867|NCT03670810|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110446649|NCT01129583|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110728868|NCT03670810|Serotonin Agents|serotonin agents|mesh-ancestor
110728869|NCT03670810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110728870|NCT03670810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110728871|NCT03670810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110728872|NCT01086254|Gemcitabine|gemcitabine|mesh-list
110728873|NCT01086254|Iniparib|iniparib|mesh-list
110728874|NCT01086254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110728875|NCT01086254|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110728876|NCT01086254|Antimetabolites|antimetabolites|mesh-ancestor
110728877|NCT01086254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110728878|NCT01086254|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110863562|NCT01317927|Belinostat|belinostat|mesh-list
110728879|NCT01086254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110728880|NCT01086332|Nelfinavir|nelfinavir|mesh-list
110728881|NCT01086332|Gemcitabine|gemcitabine|mesh-list
110728882|NCT01086332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110728883|NCT01086332|Antimetabolites|antimetabolites|mesh-ancestor
110728884|NCT01086332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110728885|NCT01086332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110728886|NCT01086332|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110728887|NCT01086332|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110728888|NCT01086332|Protease Inhibitors|protease inhibitors|mesh-ancestor
110728889|NCT01086332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110728890|NCT01086332|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110728891|NCT01086332|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110728892|NCT01086332|Antiviral Agents|antiviral agents|mesh-ancestor
110728893|NCT01086332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110728894|NCT01811368|Cyclosporine|cyclosporine|mesh-list
110728895|NCT01811368|Mycophenolic Acid|mycophenolic acid|mesh-list
110728896|NCT01811368|Rituximab|rituximab|mesh-list
110728897|NCT01811368|Cyclosporins|cyclosporins|mesh-list
110728898|NCT01811368|Thymoglobulin|thymoglobulin|mesh-list
110728899|NCT01811368|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110728900|NCT01811368|Immunoglobulins|immunoglobulins|mesh-list
110728901|NCT01811368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110728902|NCT01811368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110728903|NCT01811368|Immunologic Factors|immunologic factors|mesh-ancestor
110728904|NCT01811368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110728905|NCT01811368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110728906|NCT01811368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110728907|NCT01811368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110728908|NCT01811368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110728909|NCT01811368|Antifungal Agents|antifungal agents|mesh-ancestor
110728910|NCT01811368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110728911|NCT01811368|Dermatologic Agents|dermatologic agents|mesh-ancestor
110728912|NCT01811368|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110728913|NCT01811368|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110728914|NCT01811368|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110728915|NCT01811368|Antitubercular Agents|antitubercular agents|mesh-ancestor
110728916|NCT01811368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110728917|NCT00089648|Sunitinib|sunitinib|mesh-list
110728918|NCT00089648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110728919|NCT00089648|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110728920|NCT00089648|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110728921|NCT00089648|Growth Substances|growth substances|mesh-ancestor
110728922|NCT00089648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110728923|NCT00089648|Growth Inhibitors|growth inhibitors|mesh-ancestor
110728924|NCT00089648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110728925|NCT00089648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110728926|NCT00089648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110728927|NCT01079702|Capecitabine|capecitabine|mesh-list
110728928|NCT01079702|Everolimus|everolimus|mesh-list
110728929|NCT01079702|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110728930|NCT01079702|Antimetabolites|antimetabolites|mesh-ancestor
110728931|NCT01079702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110728932|NCT01079702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110728933|NCT01079702|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110728934|NCT01079702|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110728935|NCT01079702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110728936|NCT01079702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110728937|NCT01079702|Immunologic Factors|immunologic factors|mesh-ancestor
110728938|NCT01079702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110728939|NCT00118040|Genistein|genistein|mesh-list
110142212|NCT02018081|Levofloxacin|levofloxacin|mesh-list
110728940|NCT00118040|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110728941|NCT00118040|Protective Agents|protective agents|mesh-ancestor
110728942|NCT00118040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110728943|NCT00118040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110728944|NCT00118040|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110728945|NCT00118040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110728946|NCT00118040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110728947|NCT00118040|Phytoestrogens|phytoestrogens|mesh-ancestor
110728948|NCT00118040|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
110728949|NCT00118040|Estrogens|estrogens|mesh-ancestor
110728950|NCT00118040|Hormones|hormones|mesh-ancestor
110863569|NCT02901483|Cisplatin|cisplatin|mesh-list
110728951|NCT00118040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110728952|NCT03961958|Propofol|propofol|mesh-list
110728953|NCT03961958|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110728954|NCT03961958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110728955|NCT03961958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110728956|NCT03961958|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110728957|NCT03961958|Anesthetics, General|anesthetics, general|mesh-ancestor
110728958|NCT03961958|Anesthetics|anesthetics|mesh-ancestor
110728959|NCT00389207|Atazanavir Sulfate|atazanavir sulfate|mesh-list
110728960|NCT00389207|Nevirapine|nevirapine|mesh-list
110728961|NCT00389207|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110728962|NCT00389207|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110728963|NCT00389207|Protease Inhibitors|protease inhibitors|mesh-ancestor
110728964|NCT00389207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110728965|NCT00389207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110728966|NCT00389207|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110728967|NCT00389207|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110728968|NCT00389207|Antiviral Agents|antiviral agents|mesh-ancestor
110728969|NCT00389207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110728970|NCT00389207|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110728971|NCT00389207|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110728972|NCT00389207|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110728973|NCT00389207|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110728974|NCT00388973|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110728975|NCT00388973|Antidepressive Agents|antidepressive agents|mesh-ancestor
110728976|NCT00388973|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110728977|NCT00388973|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110728978|NCT00388973|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110728979|NCT00388973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110728980|NCT00388973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110728982|NCT00388583|Immunologic Factors|immunologic factors|mesh-ancestor
110728983|NCT00388583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110728984|NCT00117572|Docetaxel|docetaxel|mesh-list
110728985|NCT00117572|Fluorouracil|fluorouracil|mesh-list
110728986|NCT00117572|Hydroxyurea|hydroxyurea|mesh-list
110728987|NCT00117572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110728988|NCT00117572|Tubulin Modulators|tubulin modulators|mesh-ancestor
110728989|NCT00117572|Antimitotic Agents|antimitotic agents|mesh-ancestor
110728990|NCT00117572|Mitosis Modulators|mitosis modulators|mesh-ancestor
110728991|NCT00117572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110728992|NCT00117572|Antimetabolites|antimetabolites|mesh-ancestor
110728993|NCT00117572|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110728994|NCT00117572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110728995|NCT00117572|Immunologic Factors|immunologic factors|mesh-ancestor
110728996|NCT00117572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110728997|NCT00117572|Antisickling Agents|antisickling agents|mesh-ancestor
110728998|NCT00117572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110728999|NCT00117572|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110729000|NCT00388505|Tobramycin|tobramycin|mesh-list
110729001|NCT00388505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110729002|NCT00388505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110729003|NCT00388349|Cyclophosphamide|cyclophosphamide|mesh-list
110729004|NCT00388349|Carmustine|carmustine|mesh-list
110729005|NCT00388349|Gemcitabine|gemcitabine|mesh-list
110729006|NCT00388349|Etoposide|etoposide|mesh-list
110729007|NCT00388349|Vinorelbine|vinorelbine|mesh-list
110729008|NCT00388349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110729009|NCT00388349|Immunologic Factors|immunologic factors|mesh-ancestor
110729010|NCT00388349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110729011|NCT00388349|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110729012|NCT00388349|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110729013|NCT00388349|Alkylating Agents|alkylating agents|mesh-ancestor
110729014|NCT00388349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110729015|NCT00388349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110729016|NCT00388349|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110729017|NCT00388349|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110729018|NCT00388349|Antimetabolites|antimetabolites|mesh-ancestor
110729019|NCT00388349|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110729020|NCT00388349|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110729021|NCT00388349|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110729022|NCT00388349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110729023|NCT00388349|Tubulin Modulators|tubulin modulators|mesh-ancestor
110729024|NCT00388349|Antimitotic Agents|antimitotic agents|mesh-ancestor
110729025|NCT00388349|Mitosis Modulators|mitosis modulators|mesh-ancestor
110729026|NCT00117338|Montelukast|montelukast|mesh-list
110729027|NCT00117338|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110729028|NCT00117338|Respiratory System Agents|respiratory system agents|mesh-ancestor
110729029|NCT00117338|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110729030|NCT00117338|Hormone Antagonists|hormone antagonists|mesh-ancestor
110729031|NCT00117338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110729032|NCT00117338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110729033|NCT00117338|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110444378|NCT01143077|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110729034|NCT00117338|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110444379|NCT01143077|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110729035|NCT00117338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110729037|NCT00388037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110729038|NCT00388037|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110729039|NCT00388037|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110729040|NCT00388037|Growth Substances|growth substances|mesh-ancestor
110729041|NCT00388037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110729042|NCT00388037|Growth Inhibitors|growth inhibitors|mesh-ancestor
110729043|NCT00388037|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110729044|NCT00388037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110729045|NCT00388037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110729046|NCT00387881|Naproxen|naproxen|mesh-list
110142246|NCT02018133|Vitamin D|vitamin d|mesh-list
110729047|NCT00387881|Sumatriptan|sumatriptan|mesh-list
110729048|NCT00387881|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110729049|NCT00387881|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110729050|NCT00387881|Analgesics|analgesics|mesh-ancestor
110729051|NCT00387881|Sensory System Agents|sensory system agents|mesh-ancestor
110729052|NCT00387881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110729053|NCT00387881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110729054|NCT00387881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110729055|NCT00387881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110729056|NCT00387881|Gout Suppressants|gout suppressants|mesh-ancestor
110729057|NCT00387881|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110729058|NCT00387881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110729059|NCT00387881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110729060|NCT00387881|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110729061|NCT00387881|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110729062|NCT00387881|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110729063|NCT00387881|Serotonin Agents|serotonin agents|mesh-ancestor
110729064|NCT00387881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110729065|NCT00084656|Ipilimumab|ipilimumab|mesh-list
110729066|NCT00084656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110729067|NCT00084656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110729068|NCT00084656|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110729069|NCT00084656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110729070|NCT00387647|Azacitidine|azacitidine|mesh-list
110729071|NCT00387647|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110729072|NCT00387647|Antimetabolites|antimetabolites|mesh-ancestor
110729073|NCT00387647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110729074|NCT00387647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110729075|NCT00387647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110729076|NCT00386009|Tadalafil|tadalafil|mesh-list
110729077|NCT00386009|Vasodilator Agents|vasodilator agents|mesh-ancestor
110729078|NCT00386009|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110729079|NCT00386009|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110729080|NCT00386009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110729081|NCT00386009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110729082|NCT00386009|Urological Agents|urological agents|mesh-ancestor
110729083|NCT01045889|Prednisone|prednisone|mesh-list
110729084|NCT01045889|Cyclophosphamide|cyclophosphamide|mesh-list
110729085|NCT01045889|Melphalan|melphalan|mesh-list
110729086|NCT01045889|Rituximab|rituximab|mesh-list
110729087|NCT01045889|Etoposide|etoposide|mesh-list
110729088|NCT01045889|Vincristine|vincristine|mesh-list
110729089|NCT01045889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110729090|NCT01045889|Immunologic Factors|immunologic factors|mesh-ancestor
110729091|NCT01045889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110729092|NCT01045889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110729093|NCT01045889|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110729094|NCT01045889|Alkylating Agents|alkylating agents|mesh-ancestor
110729095|NCT01045889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110729096|NCT01045889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110729097|NCT01045889|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110729098|NCT01045889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110729099|NCT01045889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110729100|NCT01045889|Glucocorticoids|glucocorticoids|mesh-ancestor
110729101|NCT01045889|Hormones|hormones|mesh-ancestor
110142269|NCT02018276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110729102|NCT01045889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110729103|NCT01045889|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110729104|NCT01045889|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110729105|NCT01045889|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110729106|NCT01045889|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110729107|NCT01045889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110729108|NCT01045889|Tubulin Modulators|tubulin modulators|mesh-ancestor
110729109|NCT01045889|Antimitotic Agents|antimitotic agents|mesh-ancestor
110729110|NCT01045889|Mitosis Modulators|mitosis modulators|mesh-ancestor
110729111|NCT00373685|Celecoxib|celecoxib|mesh-list
110729112|NCT00373685|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110729113|NCT00373685|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110729114|NCT00373685|Analgesics|analgesics|mesh-ancestor
110729115|NCT00373685|Sensory System Agents|sensory system agents|mesh-ancestor
110729116|NCT00373685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110729117|NCT00373685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110729118|NCT00373685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110729119|NCT00373685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110729120|NCT00373685|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110729121|NCT00373685|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110729122|NCT00373685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110729123|NCT00373685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110729124|NCT00373529|Clofarabine|clofarabine|mesh-list
110729125|NCT00373529|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110729126|NCT00373529|Antimetabolites|antimetabolites|mesh-ancestor
110729127|NCT00373529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110729128|NCT00373529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110729129|NCT00373295|Baclofen|baclofen|mesh-list
110729130|NCT00373295|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110729131|NCT00373295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110729132|NCT00373295|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110729133|NCT00373295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110729134|NCT00373295|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
110729135|NCT00373295|GABA Agonists|gaba agonists|mesh-ancestor
110729136|NCT00373295|GABA Agents|gaba agents|mesh-ancestor
110729137|NCT00373295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110729138|NCT00373295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110729139|NCT00385541|Morphine|morphine|mesh-list
110729140|NCT00385541|Hydromorphone|hydromorphone|mesh-list
110729141|NCT00385541|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110729142|NCT00385541|Narcotics|narcotics|mesh-ancestor
110729143|NCT00385541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110729144|NCT00385541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110729145|NCT00385541|Analgesics|analgesics|mesh-ancestor
110729146|NCT00385541|Sensory System Agents|sensory system agents|mesh-ancestor
110729147|NCT00385541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110729148|NCT01046045|Everolimus|everolimus|mesh-list
110729149|NCT01046045|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110729150|NCT01046045|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110729151|NCT01046045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110729152|NCT01046045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110729153|NCT01046045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110729154|NCT01046045|Immunologic Factors|immunologic factors|mesh-ancestor
110729155|NCT01046045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110729156|NCT01046045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110729157|NCT01044719|Meropenem|meropenem|mesh-list
110729158|NCT01044719|Tobramycin|tobramycin|mesh-list
110729159|NCT01044719|Ceftazidime|ceftazidime|mesh-list
110729160|NCT01044719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110729161|NCT01044719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110729162|NCT01045109|Vitamin D|vitamin d|mesh-list
110729163|NCT01045109|Ergocalciferols|ergocalciferols|mesh-list
110729164|NCT01045109|Cholecalciferol|cholecalciferol|mesh-list
110729165|NCT01045109|Vitamins|vitamins|mesh-list
110729166|NCT01045109|Micronutrients|micronutrients|mesh-ancestor
110729167|NCT01045109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110446947|NCT02757196|Methylprednisolone|methylprednisolone|mesh-list
110729168|NCT01045109|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110729169|NCT01045109|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110729170|NCT00094302|Spironolactone|spironolactone|mesh-list
110729171|NCT00094302|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
110729172|NCT00094302|Hormone Antagonists|hormone antagonists|mesh-ancestor
110729173|NCT00094302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110729174|NCT00094302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110729175|NCT00094302|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110729176|NCT00094302|Diuretics|diuretics|mesh-ancestor
110729177|NCT00094302|Natriuretic Agents|natriuretic agents|mesh-ancestor
110729178|NCT00372905|Rituximab|rituximab|mesh-list
110729179|NCT00372905|Bortezomib|bortezomib|mesh-list
110729180|NCT00372905|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110444391|NCT01143077|Serotonin Agents|serotonin agents|mesh-ancestor
110729181|NCT00372905|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110729182|NCT00372905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110729183|NCT00372905|Immunologic Factors|immunologic factors|mesh-ancestor
110729184|NCT00372905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110729185|NCT00372905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110729186|NCT00384839|Azacitidine|azacitidine|mesh-list
110729187|NCT00384839|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110729188|NCT00384839|Antimetabolites|antimetabolites|mesh-ancestor
110729189|NCT00384839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110729190|NCT00384839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110729191|NCT00384839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110729192|NCT01046279|Bevacizumab|bevacizumab|mesh-list
110729193|NCT01046279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110729194|NCT01046279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110729195|NCT01046279|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110729196|NCT01046279|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110729197|NCT01046279|Growth Substances|growth substances|mesh-ancestor
110729198|NCT01046279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110729199|NCT01046279|Growth Inhibitors|growth inhibitors|mesh-ancestor
110729200|NCT00384293|Niacin|niacin|mesh-list
110729201|NCT00384293|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110729202|NCT00384293|Antimetabolites|antimetabolites|mesh-ancestor
110729203|NCT00384293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110729204|NCT00384293|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110729205|NCT00384293|Vasodilator Agents|vasodilator agents|mesh-ancestor
110729206|NCT00384293|Vitamin B Complex|vitamin b complex|mesh-ancestor
110729207|NCT00384293|Vitamins|vitamins|mesh-ancestor
110729208|NCT00384293|Micronutrients|micronutrients|mesh-ancestor
110729209|NCT00384293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110729210|NCT01087866|Metformin|metformin|mesh-list
110729211|NCT01087866|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110729212|NCT01087866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110729213|NCT01090830|Paclitaxel|paclitaxel|mesh-list
110729214|NCT01090830|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110729215|NCT01090830|Bevacizumab|bevacizumab|mesh-list
110729216|NCT01090830|Carboplatin|carboplatin|mesh-list
110729217|NCT01090830|Belinostat|belinostat|mesh-list
110729218|NCT01090830|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110729219|NCT01090830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110729220|NCT01090830|Tubulin Modulators|tubulin modulators|mesh-ancestor
110729221|NCT01090830|Antimitotic Agents|antimitotic agents|mesh-ancestor
110729222|NCT01090830|Mitosis Modulators|mitosis modulators|mesh-ancestor
110729223|NCT01090830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110729224|NCT01090830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110729225|NCT01090830|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110729226|NCT01090830|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110729227|NCT01090830|Growth Substances|growth substances|mesh-ancestor
110729228|NCT01090830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110729229|NCT01090830|Growth Inhibitors|growth inhibitors|mesh-ancestor
110729230|NCT01090830|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110729231|NCT01090830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110729232|NCT01084824|Cantharidin|cantharidin|mesh-list
110729233|NCT01084824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110729234|NCT01084824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110729235|NCT01088022|Dexamethasone|dexamethasone|mesh-list
110729236|NCT01088022|Dexamethasone acetate|dexamethasone acetate|mesh-list
110729237|NCT01088022|Aprepitant|aprepitant|mesh-list
110729238|NCT01088022|Palonosetron|palonosetron|mesh-list
110729239|NCT01088022|BB 1101|bb 1101|mesh-list
110729240|NCT01088022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110729241|NCT01088022|Antiemetics|antiemetics|mesh-ancestor
110729242|NCT01088022|Autonomic Agents|autonomic agents|mesh-ancestor
110729243|NCT01088022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110729244|NCT01088022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110729245|NCT01088022|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110729246|NCT01088022|Glucocorticoids|glucocorticoids|mesh-ancestor
110729247|NCT01088022|Hormones|hormones|mesh-ancestor
110729248|NCT01088022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110729249|NCT01088022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110729250|NCT01088022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110729251|NCT01088022|Protease Inhibitors|protease inhibitors|mesh-ancestor
110729252|NCT01088022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110729253|NCT01088022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110729254|NCT01088022|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110729255|NCT01088022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110729256|NCT01088022|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110729257|NCT01088022|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110729258|NCT01088022|Serotonin Agents|serotonin agents|mesh-ancestor
110729259|NCT00067002|Cyclophosphamide|cyclophosphamide|mesh-list
110729260|NCT00067002|Melphalan|melphalan|mesh-list
110729261|NCT00067002|Thiotepa|thiotepa|mesh-list
110729262|NCT00067002|Rituximab|rituximab|mesh-list
110729263|NCT00067002|Fludarabine|fludarabine|mesh-list
110729264|NCT00067002|Fludarabine phosphate|fludarabine phosphate|mesh-list
110729265|NCT00067002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110729266|NCT00067002|Immunologic Factors|immunologic factors|mesh-ancestor
110729267|NCT00067002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110729268|NCT00067002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110729269|NCT00067002|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110729270|NCT00067002|Alkylating Agents|alkylating agents|mesh-ancestor
110729271|NCT00067002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110729272|NCT00067002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110729273|NCT00067002|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110729274|NCT00067002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110729275|NCT00067002|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110729276|NCT00067002|Antimetabolites|antimetabolites|mesh-ancestor
110729277|NCT01090908|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110729278|NCT01090908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110729279|NCT01084902|Latanoprost|latanoprost|mesh-list
110729280|NCT01084902|Brinzolamide|brinzolamide|mesh-list
110729281|NCT01084902|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110729282|NCT01084902|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110729283|NCT01084902|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110729284|NCT01084902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110729285|NCT01084902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110729286|NCT01084980|Tacrolimus|tacrolimus|mesh-list
110729287|NCT01084980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110729288|NCT01084980|Immunologic Factors|immunologic factors|mesh-ancestor
110729289|NCT01084980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110729290|NCT01084980|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110729291|NCT01084980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110729292|NCT01084980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110729293|NCT01085058|Lenograstim|lenograstim|mesh-list
110729294|NCT01085058|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110729295|NCT01085058|Immunologic Factors|immunologic factors|mesh-ancestor
110729296|NCT01085058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110729297|NCT01088178|Levonorgestrel|levonorgestrel|mesh-list
110729298|NCT01088178|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110729299|NCT01088178|Contraceptive Agents|contraceptive agents|mesh-ancestor
110729300|NCT01088178|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110729301|NCT01088178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110729302|NCT01088178|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110729303|NCT01088178|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110729304|NCT01088178|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110729305|NCT01088256|Etoricoxib|etoricoxib|mesh-list
110729306|NCT01088256|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110729307|NCT01088256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110729308|NCT01088256|Analgesics|analgesics|mesh-ancestor
110729309|NCT01088256|Sensory System Agents|sensory system agents|mesh-ancestor
110729310|NCT01088256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110729311|NCT01088256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110729312|NCT01088256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110729313|NCT01088256|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110729314|NCT01088256|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110729315|NCT01088256|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110729316|NCT01088256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110729317|NCT01088256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110729318|NCT01326858|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
110729319|NCT01326858|Ketotifen|ketotifen|mesh-list
110447106|NCT02758990|Antioxidants|antioxidants|mesh-ancestor
110729320|NCT01326858|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110729321|NCT01326858|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110729322|NCT01326858|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110729323|NCT01326858|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110729324|NCT01326858|Analgesics|analgesics|mesh-ancestor
110729325|NCT01326858|Sensory System Agents|sensory system agents|mesh-ancestor
110729326|NCT01326858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110444395|NCT02786446|Naproxen|naproxen|mesh-list
110729327|NCT01326858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110729328|NCT01326858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110729329|NCT01326858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110729330|NCT01326858|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110729331|NCT01326858|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110729332|NCT01326858|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110729333|NCT01326858|Histamine Antagonists|histamine antagonists|mesh-ancestor
110729334|NCT01326858|Histamine Agents|histamine agents|mesh-ancestor
110729335|NCT01326858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110729336|NCT01326858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110729337|NCT01326858|Antipruritics|antipruritics|mesh-ancestor
110729338|NCT01326858|Dermatologic Agents|dermatologic agents|mesh-ancestor
110729339|NCT00091572|Temozolomide|temozolomide|mesh-list
110729340|NCT00091572|Dacarbazine|dacarbazine|mesh-list
110729341|NCT00091572|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110729342|NCT00091572|Alkylating Agents|alkylating agents|mesh-ancestor
110729343|NCT00091572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110729344|NCT00091572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110729345|NCT01091220|Certolizumab Pegol|certolizumab pegol|mesh-list
110729346|NCT01091220|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110729347|NCT01091220|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110729348|NCT01091220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110729349|NCT01091220|Immunologic Factors|immunologic factors|mesh-ancestor
110729350|NCT01091220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110729351|NCT01091220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110729352|NCT00084266|Vancomycin|vancomycin|mesh-list
110729353|NCT00084266|Linezolid|linezolid|mesh-list
110729354|NCT00084266|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110729355|NCT00084266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110729356|NCT00084266|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110729357|NCT00084266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110729358|NCT00084266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110729359|NCT01086878|Trimethoprim|trimethoprim|mesh-list
110729360|NCT01086878|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
110729361|NCT01086878|Sulfamethoxazole|sulfamethoxazole|mesh-list
110729362|NCT01086878|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110729363|NCT01086878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110729364|NCT01086878|Antimalarials|antimalarials|mesh-ancestor
110729365|NCT01086878|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110729366|NCT01086878|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110729367|NCT01086878|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110729368|NCT01086878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110729369|NCT01086878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110729370|NCT01086878|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110729371|NCT01086878|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
110729372|NCT01086878|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110729373|NCT01086878|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110729374|NCT01086956|Sufentanil|sufentanil|mesh-list
110729375|NCT01086956|Ropivacaine|ropivacaine|mesh-list
110729376|NCT01086956|Anesthetics, Local|anesthetics, local|mesh-ancestor
110729377|NCT01086956|Anesthetics|anesthetics|mesh-ancestor
110729378|NCT01086956|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110142425|NCT02019290|Anesthetics|anesthetics|mesh-ancestor
110729379|NCT01086956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110729380|NCT01086956|Sensory System Agents|sensory system agents|mesh-ancestor
110729381|NCT01086956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110729382|NCT01086956|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110729383|NCT01086956|Narcotics|narcotics|mesh-ancestor
110729384|NCT01086956|Analgesics|analgesics|mesh-ancestor
110729385|NCT01086956|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110729386|NCT01086956|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110729387|NCT01086956|Anesthetics, General|anesthetics, general|mesh-ancestor
110729388|NCT00091026|Bevacizumab|bevacizumab|mesh-list
110729389|NCT00091026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110729390|NCT00091026|Cetuximab|cetuximab|mesh-list
110729391|NCT00091026|Gemcitabine|gemcitabine|mesh-list
110729392|NCT00091026|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110729393|NCT00091026|Antibodies|antibodies|mesh-list
110729394|NCT00091026|Immunoglobulins|immunoglobulins|mesh-list
110729395|NCT00091026|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110729396|NCT00091026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110729397|NCT00091026|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110729398|NCT00091026|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110729399|NCT00091026|Growth Substances|growth substances|mesh-ancestor
110729400|NCT00091026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110729401|NCT00091026|Growth Inhibitors|growth inhibitors|mesh-ancestor
110729402|NCT00091026|Immunologic Factors|immunologic factors|mesh-ancestor
110729403|NCT00091026|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110729404|NCT00091026|Antimetabolites|antimetabolites|mesh-ancestor
110729405|NCT00091026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110729406|NCT00091026|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110729407|NCT00091026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110729408|NCT01091376|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110729409|NCT01091376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110729410|NCT01091376|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110729411|NCT01091376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110729412|NCT01091376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110729413|NCT00115778|Immunoglobulins|immunoglobulins|mesh-list
110729414|NCT00115778|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110729415|NCT00115778|gamma-Globulins|gamma-globulins|mesh-list
110729416|NCT00115778|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110729417|NCT00115778|Immunologic Factors|immunologic factors|mesh-ancestor
110729418|NCT00115778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110729419|NCT00100178|Mycophenolic Acid|mycophenolic acid|mesh-list
110729420|NCT00100178|Daclizumab|daclizumab|mesh-list
110729421|NCT00100178|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110729422|NCT00100178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110729423|NCT00100178|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110729424|NCT00100178|Antitubercular Agents|antitubercular agents|mesh-ancestor
110729425|NCT00100178|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110729426|NCT00100178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110729427|NCT00100178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110729428|NCT00100178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110729429|NCT00100178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110729430|NCT00100178|Immunologic Factors|immunologic factors|mesh-ancestor
110729431|NCT00100178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110729432|NCT00099632|Ritonavir|ritonavir|mesh-list
110729433|NCT00099632|Lopinavir|lopinavir|mesh-list
110729434|NCT00099632|Tenofovir|tenofovir|mesh-list
110729435|NCT00099632|Lamivudine|lamivudine|mesh-list
110729436|NCT00099632|Emtricitabine|emtricitabine|mesh-list
110729437|NCT00099632|Zidovudine|zidovudine|mesh-list
110729438|NCT00099632|Nevirapine|nevirapine|mesh-list
110729439|NCT00099632|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110729440|NCT00099632|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
110729441|NCT00099632|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110729442|NCT00099632|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110729443|NCT00099632|Protease Inhibitors|protease inhibitors|mesh-ancestor
110729444|NCT00099632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110729445|NCT00099632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110729446|NCT00099632|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110729447|NCT00099632|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110729448|NCT00099632|Antiviral Agents|antiviral agents|mesh-ancestor
110729449|NCT00099632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110729450|NCT00099632|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110729451|NCT00099632|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110729452|NCT00099632|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110729453|NCT00099632|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110729454|NCT00099632|Antimetabolites|antimetabolites|mesh-ancestor
110729455|NCT00099632|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110729456|NCT00099632|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110729457|NCT01087190|Isoniazid|isoniazid|mesh-list
110729458|NCT01087190|Antitubercular Agents|antitubercular agents|mesh-ancestor
110729459|NCT01087190|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110729460|NCT01087190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110729461|NCT01087190|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
110729462|NCT01087190|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110729463|NCT01087190|Antimetabolites|antimetabolites|mesh-ancestor
110729464|NCT01087190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110729465|NCT01087190|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110729466|NCT01090466|Sirolimus|sirolimus|mesh-list
110729467|NCT01090466|Gemcitabine|gemcitabine|mesh-list
110729468|NCT01090466|Temsirolimus|temsirolimus|mesh-list
110729469|NCT01090466|MTOR Inhibitors|mtor inhibitors|mesh-list
110729470|NCT01090466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110729471|NCT01090466|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110729472|NCT01090466|Antimetabolites|antimetabolites|mesh-ancestor
110729473|NCT01090466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110729474|NCT01090466|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110729475|NCT01090466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110729476|NCT01090466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110729477|NCT01090466|Immunologic Factors|immunologic factors|mesh-ancestor
110729478|NCT01090466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110729479|NCT01090466|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110729480|NCT01090466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110729481|NCT01090466|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110729482|NCT01090466|Antifungal Agents|antifungal agents|mesh-ancestor
110729483|NCT04116398|Dexamethasone|dexamethasone|mesh-list
110729484|NCT04116398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110729485|NCT04116398|Antiemetics|antiemetics|mesh-ancestor
110729486|NCT04116398|Autonomic Agents|autonomic agents|mesh-ancestor
110729487|NCT04116398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110729488|NCT04116398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110729489|NCT04116398|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110729490|NCT04116398|Glucocorticoids|glucocorticoids|mesh-ancestor
110729491|NCT04116398|Hormones|hormones|mesh-ancestor
110729492|NCT04116398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110729493|NCT04116398|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110729494|NCT04116398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110729495|NCT00098774|Leucovorin|leucovorin|mesh-list
110729496|NCT00098774|Cytarabine|cytarabine|mesh-list
110729497|NCT00098774|Rituximab|rituximab|mesh-list
110729498|NCT00098774|Methotrexate|methotrexate|mesh-list
110729499|NCT00098774|Etoposide|etoposide|mesh-list
110729500|NCT00098774|Temozolomide|temozolomide|mesh-list
110729501|NCT00098774|Calcium|calcium|mesh-list
110729502|NCT00098774|Levoleucovorin|levoleucovorin|mesh-list
110729503|NCT00098774|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110729504|NCT00098774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110729505|NCT00098774|Immunologic Factors|immunologic factors|mesh-ancestor
110729506|NCT00098774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110729507|NCT00098774|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110729508|NCT00098774|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110729509|NCT00098774|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110729510|NCT00098774|Abortifacient Agents|abortifacient agents|mesh-ancestor
110729511|NCT00098774|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110729512|NCT00098774|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110729514|NCT00098774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110729515|NCT00098774|Dermatologic Agents|dermatologic agents|mesh-ancestor
110729516|NCT00098774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110729517|NCT00098774|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110729518|NCT00098774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110729519|NCT00098774|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110729520|NCT00098774|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110729521|NCT00098774|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110729522|NCT00098774|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110729523|NCT00098774|Antiviral Agents|antiviral agents|mesh-ancestor
110729524|NCT00098774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110729525|NCT00098774|Antidotes|antidotes|mesh-ancestor
110729526|NCT00098774|Protective Agents|protective agents|mesh-ancestor
110729527|NCT00098774|Vitamin B Complex|vitamin b complex|mesh-ancestor
110729528|NCT00098774|Vitamins|vitamins|mesh-ancestor
110729529|NCT00098774|Micronutrients|micronutrients|mesh-ancestor
110729530|NCT00098774|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110729532|NCT01081652|Progesterone|progesterone|mesh-list
110729533|NCT01081652|Progestins|progestins|mesh-ancestor
110729534|NCT01081652|Hormones|hormones|mesh-ancestor
110729535|NCT01081652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110729536|NCT01081652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110729537|NCT01087580|Prednisone|prednisone|mesh-list
110729538|NCT01087580|Docetaxel|docetaxel|mesh-list
110729539|NCT01087580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110729540|NCT01087580|Tubulin Modulators|tubulin modulators|mesh-ancestor
110729541|NCT01087580|Antimitotic Agents|antimitotic agents|mesh-ancestor
110729542|NCT01087580|Mitosis Modulators|mitosis modulators|mesh-ancestor
110729543|NCT01087580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110729544|NCT01087580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110447321|NCT01191086|Topiramate|topiramate|mesh-list
110729545|NCT01087580|Glucocorticoids|glucocorticoids|mesh-ancestor
110729546|NCT01087580|Hormones|hormones|mesh-ancestor
110729547|NCT01087580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110729548|NCT01087580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110729549|NCT01087580|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110729550|NCT01087658|Calcium|calcium|mesh-list
110729551|NCT01087658|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110729552|NCT01087658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110729553|NCT03958058|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110729554|NCT03958058|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
110729555|NCT03958058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110729556|NCT03958058|Antitubercular Agents|antitubercular agents|mesh-ancestor
110729557|NCT01081730|Ustekinumab|ustekinumab|mesh-list
110729558|NCT01081730|Dermatologic Agents|dermatologic agents|mesh-ancestor
110729559|NCT01090700|Simeprevir|simeprevir|mesh-list
110729560|NCT01090700|Dexetimide|dexetimide|mesh-list
110729561|NCT01090700|Citalopram|citalopram|mesh-list
110729562|NCT01090700|Escitalopram|escitalopram|mesh-list
110729563|NCT01090700|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110729564|NCT01090700|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110729565|NCT01090700|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110729566|NCT01090700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110729567|NCT01090700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110729568|NCT01090700|Serotonin Agents|serotonin agents|mesh-ancestor
110729569|NCT01090700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110729570|NCT01090700|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110729571|NCT01090700|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110729572|NCT01090700|Parasympatholytics|parasympatholytics|mesh-ancestor
110729573|NCT01090700|Autonomic Agents|autonomic agents|mesh-ancestor
110729574|NCT01090700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110729575|NCT01090700|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110729576|NCT01090700|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110729577|NCT01090700|Cholinergic Agents|cholinergic agents|mesh-ancestor
110729578|NCT01090700|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110729579|NCT01090700|Antidepressive Agents|antidepressive agents|mesh-ancestor
110729580|NCT01090700|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110729581|NCT01090700|Antiviral Agents|antiviral agents|mesh-ancestor
110729582|NCT01090700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110729583|NCT01090700|Protease Inhibitors|protease inhibitors|mesh-ancestor
110729584|NCT01090700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110729585|NCT03957902|Aspirin|aspirin|mesh-list
110729586|NCT03957902|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110729587|NCT03957902|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110729588|NCT03957902|Analgesics|analgesics|mesh-ancestor
110729589|NCT03957902|Sensory System Agents|sensory system agents|mesh-ancestor
110729590|NCT03957902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110729591|NCT03957902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110729592|NCT03957902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110729593|NCT03957902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110729594|NCT03957902|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110729595|NCT03957902|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110729596|NCT03957902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110729597|NCT03957902|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110729598|NCT03957902|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110729599|NCT03957902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110729600|NCT03957902|Antipyretics|antipyretics|mesh-ancestor
110729601|NCT00384059|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110729602|NCT00384059|Immunologic Factors|immunologic factors|mesh-ancestor
110359413|NCT03674671|Ketamine|ketamine|mesh-list
110729603|NCT00384059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110729604|NCT01046435|Amoxicillin|amoxicillin|mesh-list
110729605|NCT01046435|Metronidazole|metronidazole|mesh-list
110729606|NCT01046435|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110729607|NCT01046435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110729608|NCT01046435|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110729609|NCT01046435|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110729610|NCT00858364|Darbepoetin alfa|darbepoetin alfa|mesh-list
110729611|NCT00858364|Hematinics|hematinics|mesh-ancestor
110729612|NCT00382733|Topotecan|topotecan|mesh-list
110729613|NCT00382733|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110729614|NCT00382733|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110729615|NCT00382733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110729616|NCT00382733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110729617|NCT00382733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110729618|NCT03992885|Pemetrexed|pemetrexed|mesh-list
110729619|NCT03992885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110729620|NCT03992885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110729621|NCT03992885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110729622|NCT03992885|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110142511|NCT02019784|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110729623|NCT03992885|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110729624|NCT03739294|Fluticasone|fluticasone|mesh-list
110729625|NCT03739294|Xhance|xhance|mesh-list
110729626|NCT03739294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110729627|NCT03739294|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110729628|NCT03739294|Autonomic Agents|autonomic agents|mesh-ancestor
110729629|NCT03739294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110729630|NCT03739294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110729631|NCT03739294|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110729632|NCT03739294|Respiratory System Agents|respiratory system agents|mesh-ancestor
110729633|NCT03739294|Dermatologic Agents|dermatologic agents|mesh-ancestor
110729634|NCT03739294|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110729635|NCT03732508|Fluorouracil|fluorouracil|mesh-list
110729636|NCT03732508|Irinotecan|irinotecan|mesh-list
110729637|NCT03732508|Antimetabolites|antimetabolites|mesh-ancestor
110729638|NCT03732508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110729639|NCT03732508|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110729640|NCT03732508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110729641|NCT03732508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110729642|NCT03732508|Immunologic Factors|immunologic factors|mesh-ancestor
110729643|NCT03732508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110729644|NCT03732508|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110729645|NCT03732508|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110729646|NCT03732508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110729647|NCT03628924|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110729648|NCT03628924|Immunologic Factors|immunologic factors|mesh-ancestor
110729649|NCT03628924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110729650|NCT00112437|Vitamin D|vitamin d|mesh-list
110729651|NCT00112437|Cholecalciferol|cholecalciferol|mesh-list
110729652|NCT00112437|Calcium Carbonate|calcium carbonate|mesh-list
110729653|NCT00112437|Calcium|calcium|mesh-list
110729654|NCT00112437|Vitamins|vitamins|mesh-ancestor
110729655|NCT00112437|Micronutrients|micronutrients|mesh-ancestor
110729656|NCT00112437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110729657|NCT00112437|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110729658|NCT00112437|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110729659|NCT00112437|Antacids|antacids|mesh-ancestor
110729660|NCT00112437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110729661|NCT00112437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110729662|NCT03653416|Bupivacaine|bupivacaine|mesh-list
110729663|NCT03653416|Anesthetics, Local|anesthetics, local|mesh-ancestor
110729664|NCT03653416|Anesthetics|anesthetics|mesh-ancestor
110729665|NCT03653416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110729666|NCT03653416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110142526|NCT02019810|Sympathomimetics|sympathomimetics|mesh-ancestor
110729667|NCT03653416|Sensory System Agents|sensory system agents|mesh-ancestor
110729668|NCT03653416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110729669|NCT01076673|Hyaluronic Acid|hyaluronic acid|mesh-list
110729670|NCT01076673|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110729671|NCT01076673|Immunologic Factors|immunologic factors|mesh-ancestor
110729672|NCT01076673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110729673|NCT01076673|Viscosupplements|viscosupplements|mesh-ancestor
110729674|NCT01076673|Protective Agents|protective agents|mesh-ancestor
110729675|NCT00119379|Tenofovir|tenofovir|mesh-list
110729676|NCT00119379|Antiviral Agents|antiviral agents|mesh-ancestor
110729677|NCT00119379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110729678|NCT00119379|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110729679|NCT00119379|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110729680|NCT00119379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110729681|NCT00119379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110729682|NCT00119379|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110729683|NCT00119379|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110729684|NCT01080417|Mycophenolic Acid|mycophenolic acid|mesh-list
110729685|NCT01080417|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110729686|NCT01080417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110729687|NCT01080417|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110729688|NCT01080417|Antitubercular Agents|antitubercular agents|mesh-ancestor
110729689|NCT01080417|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110729690|NCT01080417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110729691|NCT01080417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110729692|NCT01080417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110729693|NCT01079481|Everolimus|everolimus|mesh-list
110729694|NCT01079481|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110729695|NCT01079481|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110729696|NCT01079481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110729697|NCT01079481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110729699|NCT01079481|Immunologic Factors|immunologic factors|mesh-ancestor
110729700|NCT01079481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110729701|NCT01079481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110729702|NCT03964779|Antibodies|antibodies|mesh-list
110729703|NCT03964779|Immunoglobulins|immunoglobulins|mesh-list
110729704|NCT03964779|Immunologic Factors|immunologic factors|mesh-ancestor
110729705|NCT03964779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110729706|NCT00131937|Sorafenib|sorafenib|mesh-list
110729707|NCT00131937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110729708|NCT00131937|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110729709|NCT00131937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110729710|NCT00131937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110729711|NCT01079559|Tobramycin|tobramycin|mesh-list
110729712|NCT01079559|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110729713|NCT01079559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110729714|NCT00131469|Teriparatide|teriparatide|mesh-list
110729715|NCT00131469|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110729716|NCT00131469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110729717|NCT00131469|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110729719|NCT00372593|Etoposide|etoposide|mesh-list
110729720|NCT00372593|Daunorubicin|daunorubicin|mesh-list
110729721|NCT00372593|Mitoxantrone|mitoxantrone|mesh-list
110729722|NCT00372593|Asparaginase|asparaginase|mesh-list
110729723|NCT00372593|Gemtuzumab|gemtuzumab|mesh-list
110729724|NCT00372593|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110729725|NCT00372593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110729726|NCT00372593|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110729727|NCT00372593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110729728|NCT00372593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110729729|NCT00372593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110729730|NCT00372593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110729731|NCT00372593|Antimetabolites|antimetabolites|mesh-ancestor
110729732|NCT00372593|Antiviral Agents|antiviral agents|mesh-ancestor
110729733|NCT00372593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110729734|NCT00372593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110729735|NCT00372593|Immunologic Factors|immunologic factors|mesh-ancestor
110729736|NCT00372593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110729737|NCT00372593|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110729738|NCT00372593|Analgesics|analgesics|mesh-ancestor
110729739|NCT00372593|Sensory System Agents|sensory system agents|mesh-ancestor
110729740|NCT00372593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110729741|NCT00372593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110729742|NCT00372593|Immunotoxins|immunotoxins|mesh-ancestor
110729743|NCT00372593|Immunoconjugates|immunoconjugates|mesh-ancestor
110729744|NCT01324583|Prednisolone|prednisolone|mesh-list
110729745|NCT01324583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110729746|NCT01324583|Glucocorticoids|glucocorticoids|mesh-ancestor
110729748|NCT01324583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110729749|NCT01324583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110729750|NCT01324583|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110142612|NCT02020330|Lumefantrine|lumefantrine|mesh-list
110729751|NCT01324583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110729752|NCT00382109|Sirolimus|sirolimus|mesh-list
110729753|NCT00382109|Cyclophosphamide|cyclophosphamide|mesh-list
110729754|NCT00382109|Thiotepa|thiotepa|mesh-list
110729755|NCT00382109|Methotrexate|methotrexate|mesh-list
110729756|NCT00382109|Tacrolimus|tacrolimus|mesh-list
110729757|NCT00382109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110729758|NCT00382109|Immunologic Factors|immunologic factors|mesh-ancestor
110729759|NCT00382109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110729760|NCT00382109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110729761|NCT00382109|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110729762|NCT00382109|Alkylating Agents|alkylating agents|mesh-ancestor
110729763|NCT00382109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110729764|NCT00382109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110729765|NCT00382109|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110729766|NCT00382109|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110729767|NCT00382109|Abortifacient Agents|abortifacient agents|mesh-ancestor
110729768|NCT00382109|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110729769|NCT00382109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110729770|NCT00382109|Antimetabolites|antimetabolites|mesh-ancestor
110729771|NCT00382109|Dermatologic Agents|dermatologic agents|mesh-ancestor
110729772|NCT00382109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110729773|NCT00382109|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110729774|NCT00382109|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110729775|NCT00382109|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110729776|NCT00382109|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110729777|NCT00382109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110729778|NCT00382109|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110729779|NCT00382109|Antifungal Agents|antifungal agents|mesh-ancestor
110729781|NCT00381797|Bevacizumab|bevacizumab|mesh-list
110729782|NCT00381797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110729783|NCT00381797|Irinotecan|irinotecan|mesh-list
110729784|NCT00381797|Camptothecin|camptothecin|mesh-list
110729785|NCT00381797|Endothelial Growth Factors|endothelial growth factors|mesh-list
110729786|NCT00381797|Antibodies|antibodies|mesh-list
110729787|NCT00381797|Immunoglobulins|immunoglobulins|mesh-list
110729788|NCT00381797|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110729789|NCT00381797|Immunoglobulin G|immunoglobulin g|mesh-list
110729790|NCT00381797|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110729791|NCT00381797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110729792|NCT00381797|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110729793|NCT00381797|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110729794|NCT00381797|Growth Substances|growth substances|mesh-ancestor
110729795|NCT00381797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110729796|NCT00381797|Growth Inhibitors|growth inhibitors|mesh-ancestor
110729797|NCT00381797|Immunologic Factors|immunologic factors|mesh-ancestor
110729798|NCT00381797|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110729799|NCT00381797|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110729800|NCT00381797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110729801|NCT00381797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110729802|NCT00381797|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110729803|NCT00381797|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110729804|NCT00381797|Antimetabolites|antimetabolites|mesh-ancestor
110729805|NCT00381797|Antiviral Agents|antiviral agents|mesh-ancestor
110729806|NCT00381797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110729807|NCT03665038|Brexanolone|brexanolone|mesh-list
110729808|NCT03665038|Neurosteroids|neurosteroids|mesh-ancestor
110729809|NCT03665038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110729810|NCT03665038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110729811|NCT03665038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110729812|NCT03665038|GABA Modulators|gaba modulators|mesh-ancestor
110729813|NCT03665038|GABA Agents|gaba agents|mesh-ancestor
110729814|NCT03664024|Carboplatin|carboplatin|mesh-list
110729815|NCT03664024|Pembrolizumab|pembrolizumab|mesh-list
110729816|NCT03664024|Pemetrexed|pemetrexed|mesh-list
110729817|NCT03664024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110729818|NCT03664024|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110729819|NCT03664024|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110729820|NCT03664024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110729821|NCT03664024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110729822|NCT03664024|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110729823|NCT03664024|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110729824|NCT03624946|Immunoglobulins|immunoglobulins|mesh-list
110729825|NCT03624946|Antibodies|antibodies|mesh-list
110729826|NCT03624946|gamma-Globulins|gamma-globulins|mesh-list
110729827|NCT03624946|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110729828|NCT03624946|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110729829|NCT03624946|Immunoglobulin G|immunoglobulin g|mesh-list
110729830|NCT03624946|Immunologic Factors|immunologic factors|mesh-ancestor
110729831|NCT03624946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110729832|NCT03735082|Paclitaxel|paclitaxel|mesh-list
110729833|NCT03735082|Carboplatin|carboplatin|mesh-list
110729834|NCT03735082|Apatinib|apatinib|mesh-list
110729835|NCT03735082|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110729836|NCT03735082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110729837|NCT03735082|Tubulin Modulators|tubulin modulators|mesh-ancestor
110729838|NCT03735082|Antimitotic Agents|antimitotic agents|mesh-ancestor
110729839|NCT03735082|Mitosis Modulators|mitosis modulators|mesh-ancestor
110729840|NCT03735082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110729841|NCT03735082|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110142656|NCT02020681|Fluorides|fluorides|mesh-list
110729842|NCT03735082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110729843|NCT00381095|Pregabalin|pregabalin|mesh-list
110729844|NCT00381095|Analgesics|analgesics|mesh-ancestor
110729845|NCT00381095|Sensory System Agents|sensory system agents|mesh-ancestor
110729846|NCT00381095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110729847|NCT00381095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110729848|NCT00381095|Anticonvulsants|anticonvulsants|mesh-ancestor
110729849|NCT00381095|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110729850|NCT00381095|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110729851|NCT00381095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110729852|NCT00381095|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110729853|NCT00381095|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110729854|NCT00381095|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110729855|NCT00381095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110729856|NCT00381095|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110729857|NCT03737656|Progesterone|progesterone|mesh-list
110729858|NCT03737656|Progestins|progestins|mesh-ancestor
110729860|NCT03737656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110729861|NCT03737656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110729862|NCT00112047|Tenofovir|tenofovir|mesh-list
110729863|NCT00112047|Lamivudine|lamivudine|mesh-list
110729864|NCT00112047|Emtricitabine|emtricitabine|mesh-list
110729865|NCT00112047|Zidovudine|zidovudine|mesh-list
110729866|NCT00112047|Efavirenz|efavirenz|mesh-list
110729867|NCT00112047|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
110729868|NCT00112047|Antiviral Agents|antiviral agents|mesh-ancestor
110729869|NCT00112047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110729870|NCT00112047|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110729871|NCT00112047|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110729872|NCT00112047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110729873|NCT00112047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110729874|NCT00112047|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110729875|NCT00112047|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110729876|NCT00112047|Antimetabolites|antimetabolites|mesh-ancestor
110729877|NCT00112047|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110729878|NCT00112047|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110729879|NCT00112047|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110729880|NCT00112047|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110729881|NCT00112047|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110729882|NCT00112047|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110729883|NCT03658876|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
110729884|NCT03658876|Hematinics|hematinics|mesh-ancestor
110729885|NCT03618628|Carbon Fiber|carbon fiber|mesh-list
110729886|NCT03618628|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110729887|NCT03618628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110729888|NCT03639922|Imatinib Mesylate|imatinib mesylate|mesh-list
110729889|NCT03639922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110729890|NCT03639922|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110729891|NCT03639922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110729892|NCT03639922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110729893|NCT03734614|Aspirin|aspirin|mesh-list
110729894|NCT03734614|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110729895|NCT03734614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110729896|NCT03734614|Analgesics|analgesics|mesh-ancestor
110729897|NCT03734614|Sensory System Agents|sensory system agents|mesh-ancestor
110729898|NCT03734614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110729899|NCT03734614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110729900|NCT03734614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110729901|NCT03734614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110729902|NCT03734614|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110729903|NCT03734614|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110729904|NCT03734614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110729905|NCT03734614|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110729906|NCT03734614|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110729907|NCT03734614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110729908|NCT03734614|Antipyretics|antipyretics|mesh-ancestor
110729909|NCT00380393|Vaccines|vaccines|mesh-list
110729910|NCT00380393|Immunologic Factors|immunologic factors|mesh-ancestor
110729911|NCT00380393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110729912|NCT00380081|Zolpidem|zolpidem|mesh-list
110729913|NCT00380081|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110729914|NCT00380081|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110142744|NCT02021240|Anesthetics|anesthetics|mesh-ancestor
110729915|NCT00380081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110729916|NCT00380081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110729917|NCT00380081|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
110729918|NCT00380081|GABA Agonists|gaba agonists|mesh-ancestor
110729919|NCT00380081|GABA Agents|gaba agents|mesh-ancestor
110729920|NCT00380081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110729921|NCT00380081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110729922|NCT03579940|Lasmiditan|lasmiditan|mesh-list
110729923|NCT03579940|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110729924|NCT03579940|Serotonin Agents|serotonin agents|mesh-ancestor
110729925|NCT03579940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110729926|NCT03579940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110729927|NCT03579940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110729928|NCT03732040|Fluorides|fluorides|mesh-list
110729929|NCT03732040|Cariostatic Agents|cariostatic agents|mesh-ancestor
110729930|NCT03732040|Protective Agents|protective agents|mesh-ancestor
110729931|NCT03732040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110729932|NCT00098306|Maraviroc|maraviroc|mesh-list
110729933|NCT00098306|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110729934|NCT00098306|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110729935|NCT00098306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110729936|NCT00098306|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110729937|NCT00098306|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110729938|NCT00098306|Antiviral Agents|antiviral agents|mesh-ancestor
110729939|NCT00098306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110729940|NCT00098306|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
110729941|NCT03615040|Astegolimab|astegolimab|mesh-list
110729942|NCT03615040|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110729943|NCT03615040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110729944|NCT03615040|Antiviral Agents|antiviral agents|mesh-ancestor
110729945|NCT03615040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110729946|NCT01090778|Hormones|hormones|mesh-list
110729947|NCT01090778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110729948|NCT01090778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110729949|NCT00068588|Capecitabine|capecitabine|mesh-list
110729950|NCT00068588|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110729951|NCT00068588|Antimetabolites|antimetabolites|mesh-ancestor
110729952|NCT00068588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110729953|NCT00068588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110729954|NCT01088282|Dipivefrin|dipivefrin|mesh-list
110729955|NCT01088282|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110729956|NCT01088282|Adrenergic Agents|adrenergic agents|mesh-ancestor
110729957|NCT01088282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110729958|NCT01088282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110729959|NCT01088282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110729960|NCT03963752|Megestrol|megestrol|mesh-list
110729961|NCT03963752|Megestrol Acetate|megestrol acetate|mesh-list
110729962|NCT03963752|Leuprolide|leuprolide|mesh-list
110729964|NCT03963752|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110729965|NCT03963752|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110729966|NCT03963752|Contraceptive Agents|contraceptive agents|mesh-ancestor
110729967|NCT03963752|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110729968|NCT03963752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110729969|NCT03963752|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110729970|NCT03963752|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110729971|NCT03963752|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110729972|NCT03963752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110729973|NCT03963752|Appetite Stimulants|appetite stimulants|mesh-ancestor
110729974|NCT03963752|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110729975|NCT03963752|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110729976|NCT03963752|Fertility Agents|fertility agents|mesh-ancestor
110729977|NCT03734302|Brexpiprazole|brexpiprazole|mesh-list
110729978|NCT03734302|Serotonin Agents|serotonin agents|mesh-ancestor
110729979|NCT03734302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110729980|NCT03734302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110729981|NCT03734302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110729982|NCT03734302|Dopamine Agonists|dopamine agonists|mesh-ancestor
110729983|NCT03734302|Dopamine Agents|dopamine agents|mesh-ancestor
110729984|NCT01310296|Lofexidine|lofexidine|mesh-list
110729985|NCT01310296|Clonidine|clonidine|mesh-list
110729986|NCT01310296|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110729987|NCT01310296|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110729988|NCT01310296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110729989|NCT01310296|Sensory System Agents|sensory system agents|mesh-ancestor
110729990|NCT01310296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110729991|NCT01310296|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110729992|NCT01310296|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110729993|NCT01310296|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110729994|NCT01310296|Adrenergic Agents|adrenergic agents|mesh-ancestor
110729995|NCT01310296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110729996|NCT01310296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110729997|NCT01310296|Analgesics|analgesics|mesh-ancestor
110447773|NCT02746744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110729998|NCT01310296|Sympatholytics|sympatholytics|mesh-ancestor
110729999|NCT01310296|Autonomic Agents|autonomic agents|mesh-ancestor
110730000|NCT03734068|Doxorubicin|doxorubicin|mesh-list
110730001|NCT03734068|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110730002|NCT03734068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110730003|NCT03734068|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110730004|NCT03734068|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110730005|NCT03734068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110730006|NCT03734068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110730007|NCT03575806|Chlorotrianisene|chlorotrianisene|mesh-list
110730008|NCT03575806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110730009|NCT03575806|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
110730010|NCT03575806|Estrogens|estrogens|mesh-ancestor
110730012|NCT03575806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110730013|NCT03575806|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110730014|NCT03575806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110730015|NCT03606460|Ocrelizumab|ocrelizumab|mesh-list
110730016|NCT03606460|Immunologic Factors|immunologic factors|mesh-ancestor
110730017|NCT03606460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110730018|NCT03729310|Triamcinolone|triamcinolone|mesh-list
110730019|NCT03729310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110730020|NCT03729310|Glucocorticoids|glucocorticoids|mesh-ancestor
110730021|NCT03729310|Hormones|hormones|mesh-ancestor
110730022|NCT03729310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110730023|NCT03729310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110730024|NCT03731494|Nickel|nickel|mesh-list
110730025|NCT03731494|Trace Elements|trace elements|mesh-ancestor
110730026|NCT03731494|Micronutrients|micronutrients|mesh-ancestor
110730027|NCT03731494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110730028|NCT00111813|Bortezomib|bortezomib|mesh-list
110730029|NCT00111813|Vorinostat|vorinostat|mesh-list
110730030|NCT00111813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110730031|NCT00111813|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110730032|NCT00111813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110730033|NCT00111813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110730034|NCT00118287|Etanercept|etanercept|mesh-list
110730035|NCT00118287|Azacitidine|azacitidine|mesh-list
110730036|NCT00118287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110730038|NCT00118287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110142780|NCT02021539|Tocolytic Agents|tocolytic agents|mesh-list
110730039|NCT00118287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110730040|NCT00118287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110730041|NCT00118287|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110730042|NCT00118287|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110730043|NCT00118287|Analgesics|analgesics|mesh-ancestor
110730044|NCT00118287|Sensory System Agents|sensory system agents|mesh-ancestor
110730045|NCT00118287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110730046|NCT00118287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110730047|NCT00118287|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110730048|NCT00118287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110730049|NCT00118287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110730050|NCT00118287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110730051|NCT00118287|Immunologic Factors|immunologic factors|mesh-ancestor
110730052|NCT03965247|Lithium Carbonate|lithium carbonate|mesh-list
110730053|NCT03965247|Antidepressive Agents|antidepressive agents|mesh-ancestor
110730054|NCT03965247|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110730055|NCT03965247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110730056|NCT03965247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110730057|NCT03965247|Antimanic Agents|antimanic agents|mesh-ancestor
110730058|NCT03965247|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110730059|NCT03965247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110730060|NCT03965247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110730061|NCT01079715|Propranolol|propranolol|mesh-list
110730062|NCT01079715|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110730063|NCT01079715|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110730064|NCT01079715|Adrenergic Agents|adrenergic agents|mesh-ancestor
110730065|NCT01079715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110730066|NCT01079715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110730067|NCT01079715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110730068|NCT01079715|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110730069|NCT01079715|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110730070|NCT01079715|Vasodilator Agents|vasodilator agents|mesh-ancestor
110730071|NCT00130689|Cetuximab|cetuximab|mesh-list
110447850|NCT02740894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110730072|NCT00130689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110730073|NCT00130689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110730074|NCT01326585|Dexamethasone|dexamethasone|mesh-list
110730075|NCT01326585|Dexamethasone acetate|dexamethasone acetate|mesh-list
110730076|NCT01326585|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
110730077|NCT01326585|BB 1101|bb 1101|mesh-list
110730078|NCT01326585|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110730079|NCT01326585|Antiemetics|antiemetics|mesh-ancestor
110730080|NCT01326585|Autonomic Agents|autonomic agents|mesh-ancestor
110730081|NCT01326585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110730082|NCT01326585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110730083|NCT01326585|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110730084|NCT01326585|Glucocorticoids|glucocorticoids|mesh-ancestor
110730085|NCT01326585|Hormones|hormones|mesh-ancestor
110730086|NCT01326585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110730087|NCT01326585|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110730088|NCT01326585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110730089|NCT01326585|Protease Inhibitors|protease inhibitors|mesh-ancestor
110142793|NCT02021851|Dexamethasone|dexamethasone|mesh-list
110730090|NCT01326585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110730091|NCT01326585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110730092|NCT03964935|Minocycline|minocycline|mesh-list
110730093|NCT03964935|Lycopene|lycopene|mesh-list
110730094|NCT03964935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110730095|NCT03964935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110730096|NCT03964935|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110730097|NCT03964935|Antioxidants|antioxidants|mesh-ancestor
110444451|NCT00864721|Sunitinib|sunitinib|mesh-list
110730098|NCT03964935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110730099|NCT03964935|Protective Agents|protective agents|mesh-ancestor
110730100|NCT03964935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110730101|NCT03964935|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110730102|NCT03964935|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110730103|NCT03964935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110730105|NCT03605212|Gout Suppressants|gout suppressants|mesh-ancestor
110730106|NCT03605212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110730107|NCT00117507|Deferasirox|deferasirox|mesh-list
110730108|NCT00117507|Chelating Agents|chelating agents|mesh-list
110730109|NCT00117507|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110730110|NCT00117507|Sequestering Agents|sequestering agents|mesh-ancestor
110730111|NCT00117507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110730112|NCT03621046|Zolpidem|zolpidem|mesh-list
110730113|NCT03621046|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110730114|NCT03621046|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110730115|NCT03621046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110730116|NCT03621046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110730117|NCT03621046|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
110730118|NCT03621046|GABA Agonists|gaba agonists|mesh-ancestor
110730119|NCT03621046|GABA Agents|gaba agents|mesh-ancestor
110730120|NCT03621046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110730121|NCT03621046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110730122|NCT03965013|Insulin Glargine|insulin glargine|mesh-list
110730123|NCT03965013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110730124|NCT03965013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110730125|NCT03603496|Nicotine|nicotine|mesh-list
110730126|NCT03603496|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110730127|NCT03603496|Autonomic Agents|autonomic agents|mesh-ancestor
110730128|NCT03603496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110730129|NCT03603496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110730130|NCT03603496|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110730131|NCT03603496|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110730132|NCT03603496|Cholinergic Agents|cholinergic agents|mesh-ancestor
110730133|NCT03603496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110730134|NCT03603496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110730135|NCT00096135|Leucovorin|leucovorin|mesh-list
110730136|NCT00096135|Cytarabine|cytarabine|mesh-list
110730137|NCT00096135|Dexamethasone|dexamethasone|mesh-list
110730138|NCT00096135|Hydrocortisone|hydrocortisone|mesh-list
110730139|NCT00096135|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
110730140|NCT00096135|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
110730141|NCT00096135|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
110730142|NCT00096135|Cyclophosphamide|cyclophosphamide|mesh-list
110730143|NCT00096135|Methotrexate|methotrexate|mesh-list
110730144|NCT00096135|Etoposide|etoposide|mesh-list
110730145|NCT00096135|Vincristine|vincristine|mesh-list
110730146|NCT00096135|Daunorubicin|daunorubicin|mesh-list
110730147|NCT00096135|Asparaginase|asparaginase|mesh-list
110447922|NCT02740426|Pirarubicin|pirarubicin|mesh-list
110730148|NCT00096135|Mercaptopurine|mercaptopurine|mesh-list
110730149|NCT00096135|Pegaspargase|pegaspargase|mesh-list
110730150|NCT00096135|Lenograstim|lenograstim|mesh-list
110730151|NCT00096135|Levoleucovorin|levoleucovorin|mesh-list
110730152|NCT00096135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110730153|NCT00096135|Immunologic Factors|immunologic factors|mesh-ancestor
110730154|NCT00096135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110730155|NCT00096135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110730156|NCT00096135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110730157|NCT00096135|Alkylating Agents|alkylating agents|mesh-ancestor
110730158|NCT00096135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110730159|NCT00096135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110730160|NCT00096135|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110730161|NCT00096135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110730162|NCT00096135|Antiemetics|antiemetics|mesh-ancestor
110730163|NCT00096135|Autonomic Agents|autonomic agents|mesh-ancestor
110730164|NCT00096135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110730165|NCT00096135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110730166|NCT00096135|Glucocorticoids|glucocorticoids|mesh-ancestor
110730167|NCT00096135|Hormones|hormones|mesh-ancestor
110730168|NCT00096135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110730169|NCT00096135|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110730170|NCT00096135|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110730171|NCT00096135|Abortifacient Agents|abortifacient agents|mesh-ancestor
110730172|NCT00096135|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110730173|NCT00096135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110730174|NCT00096135|Antimetabolites|antimetabolites|mesh-ancestor
110730175|NCT00096135|Dermatologic Agents|dermatologic agents|mesh-ancestor
110730176|NCT00096135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110730177|NCT00096135|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110730178|NCT00096135|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110730179|NCT00096135|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110730180|NCT00096135|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110730181|NCT00096135|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110730182|NCT00096135|Antiviral Agents|antiviral agents|mesh-ancestor
110730183|NCT00096135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110730184|NCT00096135|Antidotes|antidotes|mesh-ancestor
110730185|NCT00096135|Protective Agents|protective agents|mesh-ancestor
110730186|NCT00096135|Vitamin B Complex|vitamin b complex|mesh-ancestor
110730187|NCT00096135|Vitamins|vitamins|mesh-ancestor
110730188|NCT00096135|Micronutrients|micronutrients|mesh-ancestor
110730189|NCT00096135|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110730190|NCT00096135|Tubulin Modulators|tubulin modulators|mesh-ancestor
110730191|NCT00096135|Antimitotic Agents|antimitotic agents|mesh-ancestor
110730192|NCT00096135|Mitosis Modulators|mitosis modulators|mesh-ancestor
110730193|NCT00096135|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110730194|NCT00116805|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110730195|NCT00116805|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
110730196|NCT00116805|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110730197|NCT00116805|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110730198|NCT00116805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110863673|NCT03236818|Bosentan|bosentan|mesh-list
110730199|NCT00116805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110730200|NCT00116805|Antiviral Agents|antiviral agents|mesh-ancestor
110730201|NCT00116805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110730202|NCT00116805|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110730203|NCT00116805|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110730204|NCT00116649|Imiquimod|imiquimod|mesh-list
110730205|NCT00116649|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110730206|NCT00116649|Immunologic Factors|immunologic factors|mesh-ancestor
110730207|NCT00116649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110730208|NCT00116649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110730209|NCT00116649|Interferon Inducers|interferon inducers|mesh-ancestor
110730210|NCT01080651|Voriconazole|voriconazole|mesh-list
110730211|NCT01080651|Antifungal Agents|antifungal agents|mesh-ancestor
110730212|NCT01080651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110730213|NCT01080651|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110730214|NCT01080651|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110730215|NCT01080651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110730216|NCT01080651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110730217|NCT01080651|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110730218|NCT01080651|Hormone Antagonists|hormone antagonists|mesh-ancestor
110730219|NCT01080651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110730220|NCT01080651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110730221|NCT01080651|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110730222|NCT01080729|Hormones|hormones|mesh-list
110730223|NCT01080729|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
110730224|NCT01080729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110730225|NCT01080729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110730226|NCT03962907|Chlorhexidine|chlorhexidine|mesh-list
110730227|NCT03962907|Mupirocin|mupirocin|mesh-list
110730228|NCT03962907|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110730229|NCT03962907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110730230|NCT03962907|Disinfectants|disinfectants|mesh-ancestor
110730231|NCT03962907|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110730232|NCT03962907|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110730233|NCT03962907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110730234|NCT03962907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110730235|NCT00083889|Interferons|interferons|mesh-list
110730236|NCT00083889|Interferon-alpha|interferon-alpha|mesh-list
110730237|NCT00083889|Sunitinib|sunitinib|mesh-list
110730238|NCT00083889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110730239|NCT00083889|Antiviral Agents|antiviral agents|mesh-ancestor
110730240|NCT00083889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110730241|NCT00083889|Immunologic Factors|immunologic factors|mesh-ancestor
110730242|NCT00083889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110730243|NCT00083889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110444457|NCT00864721|Growth Inhibitors|growth inhibitors|mesh-ancestor
110730244|NCT00083889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110730245|NCT00083889|Growth Substances|growth substances|mesh-ancestor
110730246|NCT00083889|Growth Inhibitors|growth inhibitors|mesh-ancestor
110730247|NCT00083889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110730248|NCT00083889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110730249|NCT00083889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110730250|NCT03639532|Tacrine|tacrine|mesh-list
110730251|NCT03639532|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110730252|NCT03639532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110730253|NCT03639532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110730254|NCT03639532|Cholinergic Agents|cholinergic agents|mesh-ancestor
110730255|NCT03639532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110142854|NCT02022254|Warfarin|warfarin|mesh-list
110730256|NCT03639532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110730257|NCT03639532|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110730258|NCT03639532|Autonomic Agents|autonomic agents|mesh-ancestor
110730259|NCT03639532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110730260|NCT03639532|Nootropic Agents|nootropic agents|mesh-ancestor
110730261|NCT03571516|Teduglutide|teduglutide|mesh-list
110730262|NCT03571516|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110730263|NCT03571516|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110730265|NCT03571516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110730266|NCT03600376|Dantrolene|dantrolene|mesh-list
110730267|NCT03600376|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110730268|NCT03600376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110730269|NCT03600376|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110730270|NCT03600376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110730271|NCT03961659|Metformin|metformin|mesh-list
110730272|NCT03961659|Dapagliflozin|dapagliflozin|mesh-list
110730273|NCT03961659|Acarbose|acarbose|mesh-list
110730274|NCT03961659|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110730275|NCT03961659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110730276|NCT03961659|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110730277|NCT03961659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110730278|NCT03961659|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
110730279|NCT03961659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110730280|NCT03599362|Nivolumab|nivolumab|mesh-list
110730281|NCT03599362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110730282|NCT03599362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110730283|NCT03599362|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110730284|NCT03599362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110730285|NCT03741309|Calcium|calcium|mesh-list
110730286|NCT03741309|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110730287|NCT03741309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110730288|NCT00082407|Insulin Aspart|insulin aspart|mesh-list
110730289|NCT00082407|Exenatide|exenatide|mesh-list
110730290|NCT00082407|Biphasic Insulins|biphasic insulins|mesh-list
110730291|NCT00082407|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110730292|NCT00082407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110730293|NCT00082407|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110730294|NCT00082407|Incretins|incretins|mesh-ancestor
110730295|NCT00082407|Hormones|hormones|mesh-ancestor
110448080|NCT02613013|Anesthetics|anesthetics|mesh-ancestor
110730296|NCT00082407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110730297|NCT01080963|Daptomycin|daptomycin|mesh-list
110730298|NCT01080963|Cefuroxime|cefuroxime|mesh-list
110730299|NCT01080963|Cefuroxime axetil|cefuroxime axetil|mesh-list
110730300|NCT01080963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110730301|NCT01080963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110730302|NCT01083381|Risperidone|risperidone|mesh-list
110730303|NCT01083381|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110730304|NCT01083381|Serotonin Agents|serotonin agents|mesh-ancestor
110730305|NCT01083381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110730306|NCT01083381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110730307|NCT01083381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110730308|NCT01083381|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110730309|NCT01083381|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110730310|NCT01083381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110730311|NCT01083381|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110730312|NCT01083381|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110730313|NCT01083381|Dopamine Agents|dopamine agents|mesh-ancestor
110730315|NCT01087359|Antioxidants|antioxidants|mesh-ancestor
110730316|NCT01087359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110730317|NCT01087359|Protective Agents|protective agents|mesh-ancestor
110730318|NCT01087359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110730319|NCT01087359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110730320|NCT01087437|Calcium|calcium|mesh-list
110730321|NCT01087437|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110730322|NCT01087437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110730323|NCT01083537|Paclitaxel|paclitaxel|mesh-list
110730324|NCT01083537|Cisplatin|cisplatin|mesh-list
110730325|NCT01083537|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110730326|NCT01083537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110730327|NCT01083537|Tubulin Modulators|tubulin modulators|mesh-ancestor
110730328|NCT01083537|Antimitotic Agents|antimitotic agents|mesh-ancestor
110730329|NCT01083537|Mitosis Modulators|mitosis modulators|mesh-ancestor
110730330|NCT01083537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110730331|NCT03597022|Lipoprotein-associated coagulation inhibitor|lipoprotein-associated coagulation inhibitor|mesh-list
110730332|NCT03597022|Immunoglobulins|immunoglobulins|mesh-list
110730333|NCT03597022|Immunoglobulin G|immunoglobulin g|mesh-list
110730334|NCT03597022|Immunologic Factors|immunologic factors|mesh-ancestor
110730335|NCT03597022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110730336|NCT03597022|Anticoagulants|anticoagulants|mesh-ancestor
110730337|NCT03597022|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110730338|NCT03597022|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110730339|NCT03597022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110730340|NCT03597022|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110730341|NCT03597022|Protease Inhibitors|protease inhibitors|mesh-ancestor
110730342|NCT03597022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110730343|NCT03597022|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110730344|NCT03597022|Antithrombins|antithrombins|mesh-ancestor
110730345|NCT03569098|Hemagglutinins|hemagglutinins|mesh-list
110730346|NCT03569098|Botulinum Toxins|botulinum toxins|mesh-list
110730347|NCT03569098|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110730348|NCT03569098|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110730349|NCT03569098|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110730350|NCT03569098|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110730351|NCT03569098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110730352|NCT03569098|Cholinergic Agents|cholinergic agents|mesh-ancestor
110730353|NCT03569098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110730354|NCT03569098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110730355|NCT03569098|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110730356|NCT03569098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110730357|NCT03569098|Agglutinins|agglutinins|mesh-ancestor
110730358|NCT03569098|Immunologic Factors|immunologic factors|mesh-ancestor
110730359|NCT03569098|Coagulants|coagulants|mesh-ancestor
110730360|NCT03727282|Dobutamine|dobutamine|mesh-list
110730361|NCT03727282|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110730362|NCT03727282|Sympathomimetics|sympathomimetics|mesh-ancestor
110730363|NCT03727282|Autonomic Agents|autonomic agents|mesh-ancestor
110730364|NCT03727282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110730365|NCT03727282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110730366|NCT03727282|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
110730367|NCT03727282|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110730368|NCT03727282|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110730369|NCT03727282|Adrenergic Agents|adrenergic agents|mesh-ancestor
110730370|NCT03727282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110730371|NCT03727282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110730372|NCT03727282|Protective Agents|protective agents|mesh-ancestor
110730373|NCT03568942|Gepotidacin|gepotidacin|mesh-list
110730374|NCT03568942|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110730375|NCT03568942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110730376|NCT03568942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110730377|NCT03568942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110730378|NCT00110019|Paclitaxel|paclitaxel|mesh-list
110730379|NCT00110019|Carboplatin|carboplatin|mesh-list
110730380|NCT00110019|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110730381|NCT00110019|Sorafenib|sorafenib|mesh-list
110730382|NCT00110019|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110730383|NCT00110019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110730384|NCT00110019|Tubulin Modulators|tubulin modulators|mesh-ancestor
110730385|NCT00110019|Antimitotic Agents|antimitotic agents|mesh-ancestor
110730386|NCT00110019|Mitosis Modulators|mitosis modulators|mesh-ancestor
110730387|NCT00110019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110730388|NCT00110019|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110730389|NCT00110019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110730390|NCT03642262|Guaifenesin|guaifenesin|mesh-list
110730391|NCT03642262|Expectorants|expectorants|mesh-ancestor
110730392|NCT03642262|Respiratory System Agents|respiratory system agents|mesh-ancestor
110730393|NCT03727048|Ketorolac|ketorolac|mesh-list
110730394|NCT03727048|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
110730395|NCT03727048|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110730396|NCT03727048|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110730397|NCT03727048|Analgesics|analgesics|mesh-ancestor
110730398|NCT03727048|Sensory System Agents|sensory system agents|mesh-ancestor
110730399|NCT03727048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110730400|NCT03727048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110730401|NCT03727048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110730402|NCT03727048|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110730403|NCT03727048|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110730404|NCT03727048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110730405|NCT03727048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110730406|NCT00095979|Epothilones|epothilones|mesh-list
110730407|NCT00095979|Epothilone B|epothilone b|mesh-list
110730408|NCT00095979|Tubulin Modulators|tubulin modulators|mesh-ancestor
110730409|NCT00095979|Antimitotic Agents|antimitotic agents|mesh-ancestor
110730410|NCT00095979|Mitosis Modulators|mitosis modulators|mesh-ancestor
110730411|NCT00095979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110730412|NCT00095979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110730413|NCT01087593|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110730414|NCT01087593|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110730415|NCT01087593|Estradiol|estradiol|mesh-list
110730416|NCT01087593|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110730417|NCT01087593|Estrogens|estrogens|mesh-ancestor
110730418|NCT01087593|Hormones|hormones|mesh-ancestor
110730419|NCT01087593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110730420|NCT01087593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110730421|NCT01087593|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110730422|NCT01087593|Contraceptive Agents|contraceptive agents|mesh-ancestor
110730423|NCT01087593|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110730424|NCT01087593|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110730425|NCT00082173|Moxifloxacin|moxifloxacin|mesh-list
110730426|NCT00082173|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110730427|NCT00082173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110730428|NCT00082173|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110730429|NCT00082173|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110730430|NCT00082173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110730431|NCT00082173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110730432|NCT00082173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110730433|NCT01087749|Losartan|losartan|mesh-list
110730434|NCT01087749|Propranolol|propranolol|mesh-list
110730435|NCT01087749|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110730436|NCT01087749|Eprosartan|eprosartan|mesh-list
110730437|NCT01087749|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110730438|NCT01087749|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110730439|NCT01087749|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110730440|NCT01087749|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110730441|NCT01087749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110730442|NCT01087749|Diuretics|diuretics|mesh-ancestor
110730443|NCT01087749|Natriuretic Agents|natriuretic agents|mesh-ancestor
110730444|NCT01087749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110730445|NCT01087749|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110730446|NCT01087749|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110730447|NCT01087749|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110730448|NCT01087749|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110730449|NCT01087749|Adrenergic Agents|adrenergic agents|mesh-ancestor
110730450|NCT01087749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110730451|NCT01087749|Vasodilator Agents|vasodilator agents|mesh-ancestor
110730452|NCT01087749|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
110730453|NCT00108069|Tamoxifen|tamoxifen|mesh-list
110730454|NCT00108069|Bortezomib|bortezomib|mesh-list
110863714|NCT02874924|Sirolimus|sirolimus|mesh-list
110730455|NCT00108069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110730456|NCT00108069|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110730457|NCT00108069|Hormone Antagonists|hormone antagonists|mesh-ancestor
110730458|NCT00108069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110730459|NCT00108069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110730460|NCT00108069|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110730461|NCT00108069|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110730462|NCT00108069|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110730463|NCT00108069|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110730465|NCT00079274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110730466|NCT00079274|Cetuximab|cetuximab|mesh-list
110730467|NCT00079274|Fluorouracil|fluorouracil|mesh-list
110730468|NCT00079274|Oxaliplatin|oxaliplatin|mesh-list
110730469|NCT00079274|Irinotecan|irinotecan|mesh-list
110730470|NCT00079274|Antibodies|antibodies|mesh-list
110730471|NCT00079274|Immunoglobulins|immunoglobulins|mesh-list
110730472|NCT00079274|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110730473|NCT00079274|Levoleucovorin|levoleucovorin|mesh-list
110730474|NCT00079274|Immunologic Factors|immunologic factors|mesh-ancestor
110730475|NCT00079274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110730476|NCT00079274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110730477|NCT00079274|Antimetabolites|antimetabolites|mesh-ancestor
110730478|NCT00079274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110730479|NCT00079274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110730480|NCT00079274|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110730481|NCT00079274|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110730482|NCT00079274|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110730483|NCT00079274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110730484|NCT00079274|Antidotes|antidotes|mesh-ancestor
110730485|NCT00079274|Protective Agents|protective agents|mesh-ancestor
110730486|NCT00079274|Vitamin B Complex|vitamin b complex|mesh-ancestor
110730487|NCT00079274|Vitamins|vitamins|mesh-ancestor
110730488|NCT00079274|Micronutrients|micronutrients|mesh-ancestor
110730489|NCT01081964|Levofloxacin|levofloxacin|mesh-list
110730490|NCT01081964|Fluoroquinolones|fluoroquinolones|mesh-list
110730491|NCT01081964|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110730492|NCT01081964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110730493|NCT01081964|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110730494|NCT01081964|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110730495|NCT01081964|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110730496|NCT01081964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110730497|NCT01081964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110730498|NCT01081964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110730499|NCT01081964|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110730500|NCT01081964|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110730501|NCT01081964|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110730502|NCT00079040|Bevacizumab|bevacizumab|mesh-list
110730503|NCT00079040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110730504|NCT00079040|Etoposide|etoposide|mesh-list
110730505|NCT00079040|Etoposide phosphate|etoposide phosphate|mesh-list
110730506|NCT00079040|Antibodies|antibodies|mesh-list
110730507|NCT00079040|Immunoglobulins|immunoglobulins|mesh-list
110730508|NCT00079040|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110730509|NCT00079040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110730510|NCT00079040|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110730511|NCT00079040|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110730512|NCT00079040|Growth Substances|growth substances|mesh-ancestor
110730513|NCT00079040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110730514|NCT00079040|Growth Inhibitors|growth inhibitors|mesh-ancestor
110730515|NCT00079040|Immunologic Factors|immunologic factors|mesh-ancestor
110730516|NCT00079040|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110730517|NCT00079040|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110730518|NCT00079040|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110448299|NCT00625469|Bosentan|bosentan|mesh-list
110730519|NCT00079040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110863720|NCT02874924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110730520|NCT00079040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110730521|NCT01088516|Ritonavir|ritonavir|mesh-list
110730522|NCT01088516|Lopinavir|lopinavir|mesh-list
110730523|NCT01088516|Zidovudine|zidovudine|mesh-list
110730524|NCT01088516|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110730525|NCT01088516|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110730526|NCT01088516|Protease Inhibitors|protease inhibitors|mesh-ancestor
110730527|NCT01088516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110142962|NCT02022722|Anesthetics|anesthetics|mesh-ancestor
110730528|NCT01088516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110730529|NCT01088516|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110730530|NCT01088516|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110730531|NCT01088516|Antiviral Agents|antiviral agents|mesh-ancestor
110730532|NCT01088516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110730533|NCT01088516|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110730534|NCT01088516|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110730535|NCT01088516|Antimetabolites|antimetabolites|mesh-ancestor
110730536|NCT01088516|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110730537|NCT01088516|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110730538|NCT00078806|Etanercept|etanercept|mesh-list
110730539|NCT00078806|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110730540|NCT00078806|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110730541|NCT00078806|Analgesics|analgesics|mesh-ancestor
110730542|NCT00078806|Sensory System Agents|sensory system agents|mesh-ancestor
110730543|NCT00078806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110730544|NCT00078806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110730545|NCT00078806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110730546|NCT00078806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110730547|NCT00078806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110730548|NCT00078806|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110730549|NCT00078806|Immunologic Factors|immunologic factors|mesh-ancestor
110730550|NCT00078338|Interferons|interferons|mesh-list
110730551|NCT00078338|Interferon-beta|interferon-beta|mesh-list
110730552|NCT00078338|Interferon beta-1a|interferon beta-1a|mesh-list
110730553|NCT00078338|Glatiramer Acetate|glatiramer acetate|mesh-list
110730554|NCT00078338|(T,G)-A-L|(t,g)-a-l|mesh-list
110730555|NCT00078338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110730556|NCT00078338|Antiviral Agents|antiviral agents|mesh-ancestor
110730557|NCT00078338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110730558|NCT00078338|Immunologic Factors|immunologic factors|mesh-ancestor
110730559|NCT00078338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110730560|NCT00078338|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110730561|NCT00078338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110730562|NCT00078338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110730563|NCT01088594|Pioglitazone|pioglitazone|mesh-list
110730564|NCT01088594|Rosiglitazone|rosiglitazone|mesh-list
110730565|NCT01088594|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110730566|NCT01088594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110730567|NCT01082120|Pioglitazone|pioglitazone|mesh-list
110730568|NCT01082120|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110730569|NCT01082120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110730570|NCT03808688|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110730571|NCT03808688|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110730572|NCT03808298|Moxifloxacin|moxifloxacin|mesh-list
110730573|NCT03808298|Balovaptan|balovaptan|mesh-list
110730574|NCT03808298|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
110730575|NCT03808298|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110730576|NCT03808298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110730577|NCT03808298|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110730578|NCT03808298|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110730579|NCT03808298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110730580|NCT03808298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110730581|NCT03808298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110730582|NCT03808298|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110730583|NCT03808298|Contraceptive Agents|contraceptive agents|mesh-ancestor
110730584|NCT03808298|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110142980|NCT02022852|Antimetabolites|antimetabolites|mesh-ancestor
110730585|NCT03808298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110730586|NCT03808298|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110730587|NCT03808298|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110730588|NCT03808298|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110730589|NCT03808298|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
110863730|NCT04425863|Dexamethasone|dexamethasone|mesh-list
110730590|NCT03808298|Natriuretic Agents|natriuretic agents|mesh-ancestor
110730591|NCT00077636|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110730592|NCT00077636|Interferon-alpha|interferon-alpha|mesh-list
110730593|NCT00077636|Ribavirin|ribavirin|mesh-list
110730594|NCT00077636|Antiviral Agents|antiviral agents|mesh-ancestor
110730595|NCT00077636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110730596|NCT00077636|Immunologic Factors|immunologic factors|mesh-ancestor
110730597|NCT00077636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110730598|NCT00077636|Antimetabolites|antimetabolites|mesh-ancestor
110448370|NCT02731846|Xhance|xhance|mesh-list
110730599|NCT00077636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110730600|NCT01082198|Vaccines|vaccines|mesh-list
110730601|NCT01082198|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
110730602|NCT01082198|Immunologic Factors|immunologic factors|mesh-ancestor
110730603|NCT01082198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110730604|NCT01082198|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110730605|NCT01088750|Prednisolone|prednisolone|mesh-list
110730606|NCT01088750|Cyclophosphamide|cyclophosphamide|mesh-list
110730607|NCT01088750|Vinblastine|vinblastine|mesh-list
110730608|NCT01088750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110730609|NCT01088750|Immunologic Factors|immunologic factors|mesh-ancestor
110730610|NCT01088750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110730611|NCT01088750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110730612|NCT01088750|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110730613|NCT01088750|Alkylating Agents|alkylating agents|mesh-ancestor
110730614|NCT01088750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110730615|NCT01088750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110730616|NCT01088750|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110730617|NCT01088750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110730618|NCT01088750|Glucocorticoids|glucocorticoids|mesh-ancestor
110730619|NCT01088750|Hormones|hormones|mesh-ancestor
110730620|NCT01088750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110730621|NCT01088750|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110730622|NCT01088750|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110730623|NCT01088750|Tubulin Modulators|tubulin modulators|mesh-ancestor
110730624|NCT01088750|Antimitotic Agents|antimitotic agents|mesh-ancestor
110730625|NCT01088750|Mitosis Modulators|mitosis modulators|mesh-ancestor
110730626|NCT01091012|Sildenafil Citrate|sildenafil citrate|mesh-list
110730627|NCT01091012|Vasodilator Agents|vasodilator agents|mesh-ancestor
110730628|NCT01091012|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110730629|NCT01091012|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110730630|NCT01091012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110730631|NCT01091012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110730632|NCT01091012|Urological Agents|urological agents|mesh-ancestor
110730633|NCT01082276|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
110730634|NCT01082276|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110730635|NCT01082276|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110730636|NCT01082276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110730637|NCT01082276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110730638|NCT01082276|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110730639|NCT01082276|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
110730640|NCT01082276|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110730641|NCT01082276|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110730642|NCT01082276|Adrenergic Agents|adrenergic agents|mesh-ancestor
110730643|NCT01082276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110730644|NCT01082276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110730645|NCT01082276|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110730646|NCT01082276|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110730647|NCT01082276|Serotonin Agents|serotonin agents|mesh-ancestor
110730648|NCT01082276|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110730649|NCT01082276|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110730650|NCT01082276|Dopamine Agents|dopamine agents|mesh-ancestor
110730651|NCT01088906|Pemetrexed|pemetrexed|mesh-list
110730652|NCT01088906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110730653|NCT01088906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110730654|NCT01088906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110730655|NCT01088906|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110730656|NCT01088906|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110730657|NCT00095199|Docetaxel|docetaxel|mesh-list
110730658|NCT00095199|Pemetrexed|pemetrexed|mesh-list
110730659|NCT00095199|Cetuximab|cetuximab|mesh-list
110730660|NCT00095199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110863736|NCT04425863|Antiemetics|antiemetics|mesh-ancestor
110730661|NCT00095199|Tubulin Modulators|tubulin modulators|mesh-ancestor
110730662|NCT00095199|Antimitotic Agents|antimitotic agents|mesh-ancestor
110730663|NCT00095199|Mitosis Modulators|mitosis modulators|mesh-ancestor
110730664|NCT00095199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110730665|NCT00095199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110730666|NCT00095199|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110730667|NCT00095199|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110730668|NCT00095199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110730669|NCT00075764|Fulvestrant|fulvestrant|mesh-list
110730670|NCT00075764|Anastrozole|anastrozole|mesh-list
110730671|NCT00075764|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110730672|NCT00075764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110730673|NCT00075764|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110730675|NCT00075764|Hormone Antagonists|hormone antagonists|mesh-ancestor
110730676|NCT00075764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110730677|NCT00075764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110730678|NCT00075764|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110730679|NCT00075764|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110730680|NCT00075764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110730681|NCT00075764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110730682|NCT03567616|Dexamethasone|dexamethasone|mesh-list
110730683|NCT03567616|Venetoclax|venetoclax|mesh-list
110730684|NCT03567616|Pomalidomide|pomalidomide|mesh-list
110730685|NCT03567616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110730686|NCT03567616|Antiemetics|antiemetics|mesh-ancestor
110730687|NCT03567616|Autonomic Agents|autonomic agents|mesh-ancestor
110730688|NCT03567616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110730689|NCT03567616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110730690|NCT03567616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110730691|NCT03567616|Glucocorticoids|glucocorticoids|mesh-ancestor
110730692|NCT03567616|Hormones|hormones|mesh-ancestor
110730693|NCT03567616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110730694|NCT03567616|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110730695|NCT03567616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110730696|NCT03567616|Immunologic Factors|immunologic factors|mesh-ancestor
110730697|NCT03567616|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110730698|NCT03567616|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110730699|NCT03567616|Growth Substances|growth substances|mesh-ancestor
110730700|NCT03567616|Growth Inhibitors|growth inhibitors|mesh-ancestor
110730701|NCT03567382|Tenofovir|tenofovir|mesh-list
110730702|NCT03567382|Antiviral Agents|antiviral agents|mesh-ancestor
110730703|NCT03567382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110730704|NCT03567382|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110730705|NCT03567382|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110730706|NCT03567382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110730707|NCT03567382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110730708|NCT03567382|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110730709|NCT03567382|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110730710|NCT03591874|Brimonidine Tartrate|brimonidine tartrate|mesh-list
110730711|NCT03591874|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110730712|NCT03591874|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110730713|NCT03591874|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110730714|NCT03591874|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110730715|NCT03591874|Adrenergic Agents|adrenergic agents|mesh-ancestor
110730716|NCT03591874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110730717|NCT03591874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110730718|NCT03591874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110730719|NCT03730714|Epinephrine|epinephrine|mesh-list
110730720|NCT03730714|Racepinephrine|racepinephrine|mesh-list
110730721|NCT03730714|Morphine|morphine|mesh-list
110730722|NCT03730714|Anesthetics|anesthetics|mesh-list
110730723|NCT03730714|Anesthetics, Local|anesthetics, local|mesh-list
110730724|NCT03730714|Epinephryl borate|epinephryl borate|mesh-list
110730725|NCT03730714|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110730726|NCT03730714|Narcotics|narcotics|mesh-ancestor
110730727|NCT03730714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110730728|NCT03730714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110730729|NCT03730714|Analgesics|analgesics|mesh-ancestor
110730730|NCT03730714|Sensory System Agents|sensory system agents|mesh-ancestor
110730731|NCT03730714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110730732|NCT03730714|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110730733|NCT03730714|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110730734|NCT03730714|Adrenergic Agents|adrenergic agents|mesh-ancestor
110730735|NCT03730714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110730736|NCT03730714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110730737|NCT03730714|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110730738|NCT03730714|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110730739|NCT03730714|Autonomic Agents|autonomic agents|mesh-ancestor
110730740|NCT03730714|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110730741|NCT03730714|Respiratory System Agents|respiratory system agents|mesh-ancestor
110730742|NCT03730714|Mydriatics|mydriatics|mesh-ancestor
110730743|NCT03730714|Sympathomimetics|sympathomimetics|mesh-ancestor
110730744|NCT03730714|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110730745|NCT00106353|Temsirolimus|temsirolimus|mesh-list
110730746|NCT00106353|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110448514|NCT02733640|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110730747|NCT00106353|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110730748|NCT00106353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110730749|NCT00106353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110730750|NCT00106353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110730751|NCT00106353|Immunologic Factors|immunologic factors|mesh-ancestor
110730752|NCT00106353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110730753|NCT00106353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110730755|NCT01087983|Sirolimus|sirolimus|mesh-list
110730756|NCT01087983|Lapatinib|lapatinib|mesh-list
110730757|NCT01087983|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110730758|NCT01087983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110730759|NCT01087983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110730760|NCT01087983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110730761|NCT01087983|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110730762|NCT01087983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110730763|NCT01087983|Antifungal Agents|antifungal agents|mesh-ancestor
110730764|NCT01087983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110730765|NCT01087983|Immunologic Factors|immunologic factors|mesh-ancestor
110730766|NCT01087983|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110730767|NCT01087983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110730768|NCT01087983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110730769|NCT00080301|Capecitabine|capecitabine|mesh-list
110730770|NCT00080301|Epothilones|epothilones|mesh-list
110730771|NCT00080301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110730772|NCT00080301|Antimetabolites|antimetabolites|mesh-ancestor
110730773|NCT00080301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110730774|NCT00080301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110730775|NCT00080301|Tubulin Modulators|tubulin modulators|mesh-ancestor
110730776|NCT00080301|Antimitotic Agents|antimitotic agents|mesh-ancestor
110730777|NCT00080301|Mitosis Modulators|mitosis modulators|mesh-ancestor
110730778|NCT03961503|Vancomycin|vancomycin|mesh-list
110730779|NCT03961503|Daptomycin|daptomycin|mesh-list
110730780|NCT03961503|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110730781|NCT03961503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110730782|NCT00079677|Modafinil|modafinil|mesh-list
110730783|NCT00079677|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110730784|NCT00079677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110730785|NCT00079677|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
110730786|NCT00079677|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110730787|NCT00079677|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110730788|NCT00079677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110730789|NCT01081353|Aspirin|aspirin|mesh-list
110730790|NCT01081353|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110730791|NCT01081353|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110730792|NCT01081353|Analgesics|analgesics|mesh-ancestor
110730793|NCT01081353|Sensory System Agents|sensory system agents|mesh-ancestor
110730794|NCT01081353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110730795|NCT01081353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110730796|NCT01081353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110730797|NCT01081353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110730798|NCT01081353|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110730799|NCT01081353|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110730800|NCT01081353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110730801|NCT01081353|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110863741|NCT04425863|Glucocorticoids|glucocorticoids|mesh-ancestor
110730802|NCT01081353|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110730804|NCT01081353|Antipyretics|antipyretics|mesh-ancestor
110730805|NCT00095121|Lamivudine|lamivudine|mesh-list
110730806|NCT00095121|Adefovir|adefovir|mesh-list
110730807|NCT00095121|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
110730808|NCT00095121|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110730809|NCT00095121|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110730810|NCT00095121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110730811|NCT00095121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110730813|NCT00095121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110730814|NCT00095121|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110730815|NCT00095121|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110730816|NCT01081431|Lenalidomide|lenalidomide|mesh-list
110730817|NCT01081431|Immunologic Factors|immunologic factors|mesh-ancestor
110730818|NCT01081431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110730819|NCT01081431|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110730820|NCT01081431|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110448592|NCT02730364|Analgesics|analgesics|mesh-ancestor
110730822|NCT01081431|Growth Inhibitors|growth inhibitors|mesh-ancestor
110730823|NCT01081431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110730824|NCT03962829|1-(3-chlorophenyl)piperazine|1-(3-chlorophenyl)piperazine|mesh-list
110730825|NCT03962829|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110730826|NCT03962829|Serotonin Agents|serotonin agents|mesh-ancestor
110730827|NCT03962829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110730828|NCT03962829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110730829|NCT03962829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110730830|NCT01084473|Dexmedetomidine|dexmedetomidine|mesh-list
110730831|NCT01084473|Morphine|morphine|mesh-list
110730832|NCT01084473|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110730833|NCT01084473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110730834|NCT01084473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110730835|NCT01084473|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110730836|NCT01084473|Analgesics|analgesics|mesh-ancestor
110730837|NCT01084473|Sensory System Agents|sensory system agents|mesh-ancestor
110730838|NCT01084473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110730839|NCT01084473|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110730840|NCT01084473|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110730841|NCT01084473|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110730842|NCT01084473|Adrenergic Agents|adrenergic agents|mesh-ancestor
110730843|NCT01084473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110730844|NCT01084473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110730845|NCT01084473|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110730846|NCT01084473|Narcotics|narcotics|mesh-ancestor
110730847|NCT01088373|Lenalidomide|lenalidomide|mesh-list
110730848|NCT01088373|Azacitidine|azacitidine|mesh-list
110730849|NCT01088373|Immunologic Factors|immunologic factors|mesh-ancestor
110730850|NCT01088373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110730851|NCT01088373|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110730852|NCT01088373|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110730853|NCT01088373|Growth Substances|growth substances|mesh-ancestor
110730854|NCT01088373|Growth Inhibitors|growth inhibitors|mesh-ancestor
110730855|NCT01088373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110730856|NCT01088373|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110730857|NCT01088373|Antimetabolites|antimetabolites|mesh-ancestor
110730858|NCT01088373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110730859|NCT01088373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110730860|NCT01088451|Insulin|insulin|mesh-list
110730861|NCT01088451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110730862|NCT01088451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110730863|NCT00075218|Sunitinib|sunitinib|mesh-list
110730864|NCT00075218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110730865|NCT00075218|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110730866|NCT00075218|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110730867|NCT00075218|Growth Substances|growth substances|mesh-ancestor
110730868|NCT00075218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110730869|NCT00075218|Growth Inhibitors|growth inhibitors|mesh-ancestor
110730870|NCT00075218|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110730871|NCT00075218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110730872|NCT00075218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110730873|NCT01089140|Tranexamic Acid|tranexamic acid|mesh-list
110730874|NCT01089140|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110730875|NCT01089140|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110730876|NCT01089140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110730877|NCT01089140|Hemostatics|hemostatics|mesh-ancestor
110730878|NCT01089140|Coagulants|coagulants|mesh-ancestor
110730879|NCT00094653|Ipilimumab|ipilimumab|mesh-list
110730880|NCT00094653|Vaccines|vaccines|mesh-list
110730881|NCT00094653|Antibodies|antibodies|mesh-list
110730882|NCT00094653|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110730883|NCT00094653|Immunologic Factors|immunologic factors|mesh-ancestor
110730884|NCT00094653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110444490|NCT02897050|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110730885|NCT00094653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110730886|NCT00094653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110730887|NCT00094653|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110730888|NCT00094653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110730889|NCT00104247|Verapamil|verapamil|mesh-list
110730890|NCT00104247|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110730891|NCT00104247|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110730892|NCT00104247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110730893|NCT00104247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110448673|NCT03188068|Hormones|hormones|mesh-ancestor
110730894|NCT00104247|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110730895|NCT00104247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110730896|NCT00104247|Vasodilator Agents|vasodilator agents|mesh-ancestor
110730897|NCT05665348|Bevacizumab|bevacizumab|mesh-list
110730898|NCT05665348|Ipilimumab|ipilimumab|mesh-list
110730899|NCT05665348|Atezolizumab|atezolizumab|mesh-list
110730900|NCT05665348|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110730901|NCT05665348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110730902|NCT05665348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110730903|NCT05665348|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110730904|NCT05665348|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110730905|NCT05665348|Growth Substances|growth substances|mesh-ancestor
110730906|NCT05665348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110730907|NCT05665348|Growth Inhibitors|growth inhibitors|mesh-ancestor
110730908|NCT05665348|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110730909|NCT05665348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110730910|NCT05665348|Immunologic Factors|immunologic factors|mesh-ancestor
110730911|NCT03726736|Docetaxel|docetaxel|mesh-list
110730912|NCT03726736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110730913|NCT03726736|Tubulin Modulators|tubulin modulators|mesh-ancestor
110730914|NCT03726736|Antimitotic Agents|antimitotic agents|mesh-ancestor
110730915|NCT03726736|Mitosis Modulators|mitosis modulators|mesh-ancestor
110730916|NCT03726736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110730917|NCT03591406|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
110730918|NCT03591406|Hematinics|hematinics|mesh-ancestor
110730919|NCT03726580|Propofol|propofol|mesh-list
110730920|NCT03726580|Sevoflurane|sevoflurane|mesh-list
110730921|NCT03726580|Isoflurane|isoflurane|mesh-list
110730922|NCT03726580|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110730923|NCT03726580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110730924|NCT03726580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110730925|NCT03726580|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110730926|NCT03726580|Anesthetics, General|anesthetics, general|mesh-ancestor
110730927|NCT03726580|Anesthetics|anesthetics|mesh-ancestor
110730928|NCT03726580|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110730929|NCT03726580|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110730930|NCT03730558|Aflibercept|aflibercept|mesh-list
110730931|NCT03730558|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110730932|NCT03730558|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110730933|NCT03730558|Growth Substances|growth substances|mesh-ancestor
110730934|NCT03730558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110730935|NCT03730558|Growth Inhibitors|growth inhibitors|mesh-ancestor
110730936|NCT03730558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110730937|NCT03588910|Acetaminophen|acetaminophen|mesh-list
110730938|NCT03588910|Ibuprofen|ibuprofen|mesh-list
110730939|NCT03588910|Oxycodone|oxycodone|mesh-list
110730940|NCT03588910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110730941|NCT03588910|Analgesics|analgesics|mesh-ancestor
110863751|NCT04425863|Analgesics|analgesics|mesh-ancestor
110730942|NCT03588910|Sensory System Agents|sensory system agents|mesh-ancestor
110730943|NCT03588910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110730944|NCT03588910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110730945|NCT03588910|Antipyretics|antipyretics|mesh-ancestor
110730946|NCT03588910|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110730947|NCT03588910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110730948|NCT03588910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110730949|NCT03588910|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110730950|NCT03588910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110730951|NCT03588910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110730952|NCT03588910|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110730953|NCT03588910|Narcotics|narcotics|mesh-ancestor
110730954|NCT03588910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110730955|NCT03730402|Bupivacaine|bupivacaine|mesh-list
110730956|NCT03730402|Anesthetics, Local|anesthetics, local|mesh-ancestor
110730957|NCT03730402|Anesthetics|anesthetics|mesh-ancestor
110444492|NCT01095666|Metformin|metformin|mesh-list
110730958|NCT03730402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110730959|NCT03730402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110730960|NCT03730402|Sensory System Agents|sensory system agents|mesh-ancestor
110730961|NCT03730402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110730962|NCT00103857|Metformin|metformin|mesh-list
110730963|NCT00103857|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110730964|NCT00103857|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110730965|NCT00103857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110730966|NCT00103857|Incretins|incretins|mesh-ancestor
110730967|NCT00103857|Hormones|hormones|mesh-ancestor
110730968|NCT00103857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110730969|NCT00103857|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110730970|NCT00103857|Protease Inhibitors|protease inhibitors|mesh-ancestor
110730971|NCT00103857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110143093|NCT02023554|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110730972|NCT00103857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110730973|NCT03587584|Bupivacaine|bupivacaine|mesh-list
110730974|NCT03587584|Anesthetics, Local|anesthetics, local|mesh-ancestor
110730975|NCT03587584|Anesthetics|anesthetics|mesh-ancestor
110730976|NCT03587584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110730977|NCT03587584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110730978|NCT03587584|Sensory System Agents|sensory system agents|mesh-ancestor
110730979|NCT03587584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110730981|NCT03586726|Balovaptan|balovaptan|mesh-list
110730982|NCT03586726|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110730983|NCT03586726|Antitubercular Agents|antitubercular agents|mesh-ancestor
110730984|NCT03586726|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110730985|NCT03586726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110730986|NCT03586726|Leprostatic Agents|leprostatic agents|mesh-ancestor
110730987|NCT03586726|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110730988|NCT03586726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110730989|NCT03586726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110730990|NCT03586726|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110730991|NCT03586726|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110730992|NCT03586726|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110730993|NCT03586726|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110730994|NCT03586726|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110730995|NCT03586726|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110730996|NCT03586726|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
110730997|NCT03586726|Natriuretic Agents|natriuretic agents|mesh-ancestor
110730998|NCT03586726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110730999|NCT03721900|Ketamine|ketamine|mesh-list
110731000|NCT03721900|Analgesics|analgesics|mesh-ancestor
110731001|NCT03721900|Sensory System Agents|sensory system agents|mesh-ancestor
110731002|NCT03721900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110731003|NCT03721900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110731004|NCT03721900|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110731005|NCT03721900|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110731006|NCT03721900|Anesthetics, General|anesthetics, general|mesh-ancestor
110731007|NCT03721900|Anesthetics|anesthetics|mesh-ancestor
110731008|NCT03721900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110731009|NCT03721900|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110731010|NCT03721900|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110731012|NCT03721900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110731013|NCT03585712|Norgestrel|norgestrel|mesh-list
110731014|NCT03585712|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110731015|NCT03585712|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110731016|NCT03585712|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110731017|NCT03585712|Contraceptive Agents|contraceptive agents|mesh-ancestor
110143129|NCT02023710|Paclitaxel|paclitaxel|mesh-list
110731018|NCT03585712|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110731019|NCT03585712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110731020|NCT03585712|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110731021|NCT03585712|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110731022|NCT01082510|Tegafur|tegafur|mesh-list
110731023|NCT01082510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110731024|NCT01082510|Antimetabolites|antimetabolites|mesh-ancestor
110731025|NCT01082510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110731026|NCT01082510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110731027|NCT03583372|Tolterodine Tartrate|tolterodine tartrate|mesh-list
110731028|NCT03583372|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110731029|NCT03583372|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110731030|NCT03583372|Cholinergic Agents|cholinergic agents|mesh-ancestor
110731031|NCT03583372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110731032|NCT03583372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110731033|NCT03583372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110731034|NCT03583372|Urological Agents|urological agents|mesh-ancestor
110731036|NCT01091324|Silymarin|silymarin|mesh-list
110731037|NCT01091324|Antitussive Agents|antitussive agents|mesh-ancestor
110731038|NCT01091324|Respiratory System Agents|respiratory system agents|mesh-ancestor
110731039|NCT01091324|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110731040|NCT01091324|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110731041|NCT01091324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110731042|NCT01091324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110731043|NCT01091324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110731044|NCT01091324|Antioxidants|antioxidants|mesh-ancestor
110731045|NCT01091324|Protective Agents|protective agents|mesh-ancestor
110731046|NCT05782608|Ibuprofen|ibuprofen|mesh-list
110731047|NCT05782608|Ketorolac|ketorolac|mesh-list
110731048|NCT05782608|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110731049|NCT05782608|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110731050|NCT05782608|Analgesics|analgesics|mesh-ancestor
110731051|NCT05782608|Sensory System Agents|sensory system agents|mesh-ancestor
110731052|NCT05782608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110731053|NCT05782608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110731054|NCT05782608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110731055|NCT05782608|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110731056|NCT05782608|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110731057|NCT05782608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110731058|NCT05782608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110731059|NCT05782426|Paclitaxel|paclitaxel|mesh-list
110731060|NCT05782426|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110731061|NCT05782426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110731062|NCT05782426|Tubulin Modulators|tubulin modulators|mesh-ancestor
110731063|NCT05782426|Antimitotic Agents|antimitotic agents|mesh-ancestor
110731064|NCT05782426|Mitosis Modulators|mitosis modulators|mesh-ancestor
110731065|NCT05782426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110731066|NCT05782348|Listerine|listerine|mesh-list
110731067|NCT05782348|Sodium Fluoride|sodium fluoride|mesh-list
110731068|NCT05782348|Cariostatic Agents|cariostatic agents|mesh-ancestor
110731069|NCT05782348|Protective Agents|protective agents|mesh-ancestor
110731070|NCT05782348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110731071|NCT05782348|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110731072|NCT05782348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110731073|NCT05782192|Alogliptin|alogliptin|mesh-list
110731074|NCT05782192|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110731075|NCT05782192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110731076|NCT05782192|Incretins|incretins|mesh-ancestor
110731077|NCT05782192|Hormones|hormones|mesh-ancestor
110731078|NCT05782192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110731079|NCT05782192|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110731080|NCT05782192|Protease Inhibitors|protease inhibitors|mesh-ancestor
110731081|NCT05782192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110731082|NCT05782192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110731083|NCT05781997|Mydriatics|mydriatics|mesh-list
110731084|NCT05781997|Autonomic Agents|autonomic agents|mesh-ancestor
110731085|NCT05781997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110731086|NCT05781997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110731087|NCT05781854|Dexmedetomidine|dexmedetomidine|mesh-list
110731088|NCT05781854|Bupivacaine|bupivacaine|mesh-list
110731089|NCT05781854|Anesthetics, Local|anesthetics, local|mesh-ancestor
110731090|NCT05781854|Anesthetics|anesthetics|mesh-ancestor
110731091|NCT05781854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110444494|NCT01095666|Dapagliflozin|dapagliflozin|mesh-list
110731092|NCT05781854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110731094|NCT05781854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110731095|NCT05781854|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110731096|NCT05781854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110731097|NCT05781854|Analgesics|analgesics|mesh-ancestor
110731098|NCT05781854|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110731099|NCT05781854|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110731100|NCT05781854|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110731101|NCT05781854|Adrenergic Agents|adrenergic agents|mesh-ancestor
110731102|NCT05781854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110731103|NCT05781854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110731104|NCT05781685|Testosterone|testosterone|mesh-list
110731105|NCT05781685|Androgens|androgens|mesh-ancestor
110731106|NCT05781685|Hormones|hormones|mesh-ancestor
110731107|NCT05781685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110731108|NCT05781685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110731109|NCT05781633|Bevacizumab|bevacizumab|mesh-list
110731110|NCT05781633|Etoposide|etoposide|mesh-list
110731111|NCT05781633|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110731112|NCT05781633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110731113|NCT05781633|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110731114|NCT05781633|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110731115|NCT05781633|Growth Substances|growth substances|mesh-ancestor
110731116|NCT05781633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110731117|NCT05781633|Growth Inhibitors|growth inhibitors|mesh-ancestor
110731118|NCT05781633|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110731119|NCT05781633|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110731120|NCT05781633|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110731121|NCT05781633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110731122|NCT05781633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110731124|NCT05781620|Vitamins|vitamins|mesh-ancestor
110731125|NCT05781620|Micronutrients|micronutrients|mesh-ancestor
110731126|NCT05781620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110731127|NCT05781620|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110731128|NCT05781529|Hyaluronic Acid|hyaluronic acid|mesh-list
110731129|NCT05781529|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110731130|NCT05781529|Immunologic Factors|immunologic factors|mesh-ancestor
110731131|NCT05781529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110731132|NCT05781529|Viscosupplements|viscosupplements|mesh-ancestor
110731133|NCT05781529|Protective Agents|protective agents|mesh-ancestor
110731134|NCT05780554|Cyclophosphamide|cyclophosphamide|mesh-list
110731135|NCT05780554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110731136|NCT05780554|Immunologic Factors|immunologic factors|mesh-ancestor
110731137|NCT05780554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110731138|NCT05780554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110731139|NCT05780554|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110731140|NCT05780554|Alkylating Agents|alkylating agents|mesh-ancestor
110731141|NCT05780554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110731142|NCT05780554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110731143|NCT05780554|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110731144|NCT05869578|Anesthetics|anesthetics|mesh-list
110731145|NCT05869578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110731146|NCT05869578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110731147|NCT05869227|Capecitabine|capecitabine|mesh-list
110731148|NCT05869227|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110731149|NCT05869227|Antimetabolites|antimetabolites|mesh-ancestor
110731150|NCT05869227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110731151|NCT05869227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110731152|NCT05869201|Vaccines|vaccines|mesh-list
110731153|NCT05869201|Immunologic Factors|immunologic factors|mesh-ancestor
110731154|NCT05869201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110731155|NCT05869097|Trifluridine|trifluridine|mesh-list
110731156|NCT05869097|Bevacizumab|bevacizumab|mesh-list
110143215|NCT02024256|Anesthetics|anesthetics|mesh-ancestor
110731157|NCT05869097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110731158|NCT05869097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110731159|NCT05869097|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110731160|NCT05869097|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110731161|NCT05869097|Growth Substances|growth substances|mesh-ancestor
110731162|NCT05869097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110731163|NCT05869097|Growth Inhibitors|growth inhibitors|mesh-ancestor
110731164|NCT05869097|Antimetabolites|antimetabolites|mesh-ancestor
110731165|NCT05869097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110731166|NCT05869097|Antiviral Agents|antiviral agents|mesh-ancestor
110731167|NCT05869097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110731168|NCT05868993|Ropivacaine|ropivacaine|mesh-list
110731169|NCT05868993|Anesthetics, Local|anesthetics, local|mesh-ancestor
110731170|NCT05868993|Anesthetics|anesthetics|mesh-ancestor
110731171|NCT05868993|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110731172|NCT05868993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110731173|NCT05868993|Sensory System Agents|sensory system agents|mesh-ancestor
110731174|NCT05868993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110731175|NCT05868967|Fexuprazan|fexuprazan|mesh-list
110731176|NCT05868967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110731177|NCT05868720|Risperidone|risperidone|mesh-list
110731178|NCT05868720|Aripiprazole|aripiprazole|mesh-list
110731179|NCT05868720|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110731180|NCT05868720|Serotonin Agents|serotonin agents|mesh-ancestor
110731181|NCT05868720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110731182|NCT05868720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110731183|NCT05868720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110731184|NCT05868720|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110731185|NCT05868720|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110731186|NCT05868720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110731187|NCT05868720|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110731188|NCT05868720|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110731189|NCT05868720|Dopamine Agents|dopamine agents|mesh-ancestor
110731190|NCT05868720|Antidepressive Agents|antidepressive agents|mesh-ancestor
110448964|NCT02716090|Analgesics|analgesics|mesh-ancestor
110731191|NCT05868720|Dopamine Agonists|dopamine agonists|mesh-ancestor
110731192|NCT05868720|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110731193|NCT05868720|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110731194|NCT05868720|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110731195|NCT05868720|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110731196|NCT05868395|Rituximab|rituximab|mesh-list
110731197|NCT05868395|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110731198|NCT05868395|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110731199|NCT05868395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110731200|NCT05868395|Immunologic Factors|immunologic factors|mesh-ancestor
110731201|NCT05868395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110731202|NCT05868395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110731203|NCT05868395|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110731204|NCT05868395|Alkylating Agents|alkylating agents|mesh-ancestor
110731205|NCT05868395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110731206|NCT05868317|Fluorouracil|fluorouracil|mesh-list
110731207|NCT05868317|Irinotecan|irinotecan|mesh-list
110731208|NCT05868317|Folfirinox|folfirinox|mesh-list
110731209|NCT05868317|Oxaliplatin|oxaliplatin|mesh-list
110731210|NCT05868317|Antimetabolites|antimetabolites|mesh-ancestor
110731211|NCT05868317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110731212|NCT05868317|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110731213|NCT05868317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110731214|NCT05868317|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110731215|NCT05868317|Immunologic Factors|immunologic factors|mesh-ancestor
110731216|NCT05868317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110731217|NCT05868317|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110731218|NCT05868317|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110731219|NCT05868317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110731220|NCT05868200|Listerine|listerine|mesh-list
110731221|NCT05868200|Sodium Fluoride|sodium fluoride|mesh-list
110731222|NCT05868200|Cariostatic Agents|cariostatic agents|mesh-ancestor
110731223|NCT05868200|Protective Agents|protective agents|mesh-ancestor
110731224|NCT05868200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110731225|NCT05868200|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110731226|NCT05868200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110731227|NCT05868109|Nitric Oxide|nitric oxide|mesh-list
110731228|NCT05868109|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110731229|NCT05868109|Autonomic Agents|autonomic agents|mesh-ancestor
110731230|NCT05868109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110731231|NCT05868109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110731232|NCT05868109|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110731233|NCT05868109|Respiratory System Agents|respiratory system agents|mesh-ancestor
110731234|NCT05868109|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110731235|NCT05868109|Antioxidants|antioxidants|mesh-ancestor
110731236|NCT05868109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110731237|NCT05868109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110731238|NCT05868109|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
110731239|NCT05868109|Vasodilator Agents|vasodilator agents|mesh-ancestor
110731240|NCT05868109|Gasotransmitters|gasotransmitters|mesh-ancestor
110731241|NCT05868109|Protective Agents|protective agents|mesh-ancestor
110731242|NCT05867472|Sevoflurane|sevoflurane|mesh-list
110731243|NCT05867472|Isoflurane|isoflurane|mesh-list
110731244|NCT05867472|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110731245|NCT05867472|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110731246|NCT05867472|Anesthetics, General|anesthetics, general|mesh-ancestor
110731247|NCT05867472|Anesthetics|anesthetics|mesh-ancestor
110731248|NCT05867472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110731249|NCT05867472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110731250|NCT05865080|Ketamine|ketamine|mesh-list
110731251|NCT05865080|Analgesics|analgesics|mesh-ancestor
110731252|NCT05865080|Sensory System Agents|sensory system agents|mesh-ancestor
110731253|NCT05865080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110731254|NCT05865080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110731255|NCT05865080|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110731256|NCT05865080|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110731257|NCT05865080|Anesthetics, General|anesthetics, general|mesh-ancestor
110731258|NCT05865080|Anesthetics|anesthetics|mesh-ancestor
110731259|NCT05865080|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110731260|NCT05865080|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110731261|NCT05865080|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110731262|NCT05865080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110731263|NCT05865080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110731264|NCT05863286|Botulinum Toxins|botulinum toxins|mesh-list
110863798|NCT03236740|Metformin|metformin|mesh-list
110731265|NCT05863286|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110731266|NCT05863286|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110731267|NCT05863286|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110731268|NCT05863286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110731269|NCT05863286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110731270|NCT05863286|Cholinergic Agents|cholinergic agents|mesh-ancestor
110731271|NCT05863286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110731272|NCT05863286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110731273|NCT05863286|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110731274|NCT05863286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110731275|NCT05851768|Dexmedetomidine|dexmedetomidine|mesh-list
110731277|NCT05851768|Anesthetics, Local|anesthetics, local|mesh-ancestor
110731278|NCT05851768|Anesthetics|anesthetics|mesh-ancestor
110731279|NCT05851768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110731280|NCT05851768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110731281|NCT05851768|Sensory System Agents|sensory system agents|mesh-ancestor
110731282|NCT05851768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110731283|NCT05851768|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110731284|NCT05851768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110731285|NCT05851768|Analgesics|analgesics|mesh-ancestor
110731286|NCT05851768|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110731287|NCT05851768|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110731288|NCT05851768|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110731289|NCT05851768|Adrenergic Agents|adrenergic agents|mesh-ancestor
110731290|NCT05851768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110731291|NCT05851768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110731292|NCT05768373|Fluorides|fluorides|mesh-list
110731293|NCT05768373|Cariostatic Agents|cariostatic agents|mesh-ancestor
110731294|NCT05768373|Protective Agents|protective agents|mesh-ancestor
110731295|NCT05768373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110731296|NCT05734690|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
110731297|NCT05734690|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110731298|NCT05734690|Adrenergic Agents|adrenergic agents|mesh-ancestor
110731299|NCT05734690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110731300|NCT05734690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110731301|NCT05734690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110731302|NCT05733624|Cyclosporine|cyclosporine|mesh-list
110731303|NCT05733624|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110731305|NCT05733624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110731306|NCT05733624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110731307|NCT05733624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110731308|NCT05733624|Immunologic Factors|immunologic factors|mesh-ancestor
110731309|NCT05733624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110731310|NCT05733624|Antifungal Agents|antifungal agents|mesh-ancestor
110731311|NCT05733624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110731312|NCT05733624|Dermatologic Agents|dermatologic agents|mesh-ancestor
110731313|NCT05733624|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110731314|NCT05733624|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110731315|NCT05733624|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110731316|NCT05645900|Vaccines|vaccines|mesh-list
110731317|NCT05645900|Immunologic Factors|immunologic factors|mesh-ancestor
110731318|NCT05645900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110731319|NCT05642572|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110731320|NCT05642572|Osimertinib|osimertinib|mesh-list
110731321|NCT05642572|Ramucirumab|ramucirumab|mesh-list
110731322|NCT05642572|Antibodies|antibodies|mesh-list
110731323|NCT05642572|Immunoglobulins|immunoglobulins|mesh-list
110731324|NCT05642572|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110731325|NCT05642572|Lexatumumab|lexatumumab|mesh-list
110731326|NCT05642572|Immunologic Factors|immunologic factors|mesh-ancestor
110731327|NCT05642572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110731328|NCT05642572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110731329|NCT05642572|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110731330|NCT05642572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110731331|NCT05642572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110731332|NCT05518799|Midazolam|midazolam|mesh-list
110731333|NCT05518799|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110731334|NCT05518799|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110731335|NCT05518799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110731336|NCT05518799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110731337|NCT05518799|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110449119|NCT00611416|Caffeine|caffeine|mesh-list
110731338|NCT05518799|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110731339|NCT05518799|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110731340|NCT05518799|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110731341|NCT05518799|Anesthetics, General|anesthetics, general|mesh-ancestor
110731342|NCT05518799|Anesthetics|anesthetics|mesh-ancestor
110731343|NCT05518799|GABA Modulators|gaba modulators|mesh-ancestor
110731344|NCT05518799|GABA Agents|gaba agents|mesh-ancestor
110731345|NCT05518799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110731346|NCT05518799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110731347|NCT05447702|Paclitaxel|paclitaxel|mesh-list
110731348|NCT05447702|Cyclophosphamide|cyclophosphamide|mesh-list
110731349|NCT05447702|Apatinib|apatinib|mesh-list
110731350|NCT05447702|Epirubicin|epirubicin|mesh-list
110731351|NCT05447702|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110731352|NCT05447702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110731353|NCT05447702|Tubulin Modulators|tubulin modulators|mesh-ancestor
110731354|NCT05447702|Antimitotic Agents|antimitotic agents|mesh-ancestor
110731355|NCT05447702|Mitosis Modulators|mitosis modulators|mesh-ancestor
110731356|NCT05447702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110731357|NCT05447702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110731358|NCT05447702|Immunologic Factors|immunologic factors|mesh-ancestor
110731359|NCT05447702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110731360|NCT05447702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110731361|NCT05447702|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110731362|NCT05447702|Alkylating Agents|alkylating agents|mesh-ancestor
110731363|NCT05447702|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110731364|NCT05447702|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110731365|NCT05447702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110731366|NCT05447702|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110731367|NCT05447702|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110731368|NCT05447702|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110731369|NCT05418010|Natalizumab|natalizumab|mesh-list
110731370|NCT05418010|Immunologic Factors|immunologic factors|mesh-ancestor
110731371|NCT05418010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110731372|NCT05413369|Metformin|metformin|mesh-list
110731373|NCT05413369|Insulin Glargine|insulin glargine|mesh-list
110731374|NCT05413369|Lixisenatide|lixisenatide|mesh-list
110731375|NCT05413369|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
110731376|NCT05413369|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110731377|NCT05413369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110444518|NCT02785978|Dopamine Agents|dopamine agents|mesh-ancestor
110731378|NCT05413369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110731379|NCT05391971|Bupivacaine|bupivacaine|mesh-list
110731380|NCT05391971|Anesthetics, Local|anesthetics, local|mesh-ancestor
110731381|NCT05391971|Anesthetics|anesthetics|mesh-ancestor
110731382|NCT05391971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110731383|NCT05391971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110731384|NCT05391971|Sensory System Agents|sensory system agents|mesh-ancestor
110731385|NCT05391971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110731386|NCT05323396|Metronidazole|metronidazole|mesh-list
110731387|NCT05323396|Albendazole|albendazole|mesh-list
110731388|NCT05323396|Praziquantel|praziquantel|mesh-list
110731389|NCT05323396|Antiparasitic Agents|antiparasitic agents|mesh-list
110731390|NCT05323396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110731391|NCT05323396|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110731392|NCT05323396|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110731393|NCT05323396|Anthelmintics|anthelmintics|mesh-ancestor
110731394|NCT05323396|Anticestodal Agents|anticestodal agents|mesh-ancestor
110731395|NCT05323396|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110731396|NCT05323396|Tubulin Modulators|tubulin modulators|mesh-ancestor
110731397|NCT05323396|Antimitotic Agents|antimitotic agents|mesh-ancestor
110731398|NCT05323396|Mitosis Modulators|mitosis modulators|mesh-ancestor
110731399|NCT05323396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110731400|NCT05323396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110731401|NCT05266469|Ofatumumab|ofatumumab|mesh-list
110731402|NCT05266469|Ocrelizumab|ocrelizumab|mesh-list
110731403|NCT05266469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110731404|NCT05266469|Immunologic Factors|immunologic factors|mesh-ancestor
110731405|NCT05266469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110731407|NCT05178550|Anticoagulants|anticoagulants|mesh-ancestor
110731408|NCT05178550|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110731409|NCT05178550|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110731410|NCT05178550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110731411|NCT05168566|Maleic acid|maleic acid|mesh-list
110731412|NCT05168566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110731413|NCT05168566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110731414|NCT05085782|Propranolol|propranolol|mesh-list
110731415|NCT05085782|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110731416|NCT05085782|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110731417|NCT05085782|Adrenergic Agents|adrenergic agents|mesh-ancestor
110731418|NCT05085782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110731419|NCT05085782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110731420|NCT05085782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110731421|NCT05085782|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110731422|NCT05085782|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110731423|NCT05085782|Vasodilator Agents|vasodilator agents|mesh-ancestor
110731424|NCT05011123|Vaccines|vaccines|mesh-list
110731425|NCT05011123|Immunologic Factors|immunologic factors|mesh-ancestor
110731426|NCT05011123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110731427|NCT04829383|Bevacizumab|bevacizumab|mesh-list
110731428|NCT04829383|Atezolizumab|atezolizumab|mesh-list
110731429|NCT04829383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110731430|NCT04829383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110731431|NCT04829383|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110731432|NCT04829383|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110731433|NCT04829383|Growth Substances|growth substances|mesh-ancestor
110731434|NCT04829383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110731435|NCT04829383|Growth Inhibitors|growth inhibitors|mesh-ancestor
110731436|NCT04829383|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110731437|NCT04829383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110731438|NCT04821375|Bazedoxifene|bazedoxifene|mesh-list
110731439|NCT04821375|Estrogens|estrogens|mesh-list
110731440|NCT04821375|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
110731441|NCT04821375|Hormones|hormones|mesh-ancestor
110731442|NCT04821375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110731443|NCT04821375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110731444|NCT04821375|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110731445|NCT04821375|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110731446|NCT04821375|Hormone Antagonists|hormone antagonists|mesh-ancestor
110731447|NCT04821375|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110731448|NCT04732195|Pilocarpine|pilocarpine|mesh-list
110731449|NCT04732195|Miotics|miotics|mesh-ancestor
110731450|NCT04732195|Autonomic Agents|autonomic agents|mesh-ancestor
110731451|NCT04732195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110731452|NCT04732195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110731453|NCT04732195|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
110731454|NCT04732195|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110731455|NCT04732195|Cholinergic Agents|cholinergic agents|mesh-ancestor
110731456|NCT04732195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110731457|NCT04732195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110731458|NCT04704921|Ranibizumab|ranibizumab|mesh-list
110731459|NCT04704921|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110731460|NCT04704921|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110731462|NCT04704921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110731463|NCT04704921|Growth Inhibitors|growth inhibitors|mesh-ancestor
110731464|NCT04704921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110731465|NCT04703426|Pembrolizumab|pembrolizumab|mesh-list
110731466|NCT04703426|Sargramostim|sargramostim|mesh-list
110731467|NCT04703426|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110731468|NCT04703426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110731469|NCT04703426|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110731470|NCT04703426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110731471|NCT04703426|Immunologic Factors|immunologic factors|mesh-ancestor
110731472|NCT04703426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110731473|NCT04681482|Apixaban|apixaban|mesh-list
110731474|NCT04681482|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110731475|NCT04681482|Antithrombins|antithrombins|mesh-ancestor
110731476|NCT04681482|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110731477|NCT04681482|Protease Inhibitors|protease inhibitors|mesh-ancestor
110731478|NCT04681482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110731479|NCT04681482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110731480|NCT04681482|Anticoagulants|anticoagulants|mesh-ancestor
110731481|NCT04635644|Morphine|morphine|mesh-list
110731482|NCT04635644|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110731483|NCT04635644|Narcotics|narcotics|mesh-ancestor
110731484|NCT04635644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110731485|NCT04635644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110731486|NCT04635644|Analgesics|analgesics|mesh-ancestor
110731487|NCT04635644|Sensory System Agents|sensory system agents|mesh-ancestor
110731488|NCT04635644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110731489|NCT04631601|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
110731490|NCT04631601|Androgens|androgens|mesh-list
110731491|NCT04631601|Androgen Receptor Antagonists|androgen receptor antagonists|mesh-list
110731492|NCT04631601|Hormones|hormones|mesh-ancestor
110731493|NCT04631601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110731494|NCT04631601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110731495|NCT04631601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110731496|NCT04631601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110731497|NCT04631601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110731498|NCT04631601|Androgen Antagonists|androgen antagonists|mesh-ancestor
110731499|NCT04631601|Hormone Antagonists|hormone antagonists|mesh-ancestor
110731500|NCT04580277|Tofacitinib|tofacitinib|mesh-list
110731501|NCT04580277|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
110731502|NCT04580277|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110731503|NCT04580277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110731504|NCT04580277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110731505|NCT04571229|Mifamurtide|mifamurtide|mesh-list
110731506|NCT04571229|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110731507|NCT04571229|Immunologic Factors|immunologic factors|mesh-ancestor
110731508|NCT04571229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110731509|NCT04535713|Gemcitabine|gemcitabine|mesh-list
110731510|NCT04535713|Docetaxel|docetaxel|mesh-list
110731511|NCT04535713|Doxorubicin|doxorubicin|mesh-list
110731512|NCT04535713|Nivolumab|nivolumab|mesh-list
110731513|NCT04535713|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110731514|NCT04535713|Antimetabolites|antimetabolites|mesh-ancestor
110731515|NCT04535713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110731516|NCT04535713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110731517|NCT04535713|Tubulin Modulators|tubulin modulators|mesh-ancestor
110731518|NCT04535713|Antimitotic Agents|antimitotic agents|mesh-ancestor
110731519|NCT04535713|Mitosis Modulators|mitosis modulators|mesh-ancestor
110731520|NCT04535713|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110731521|NCT04535713|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110731522|NCT04535713|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110731523|NCT04535713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110731524|NCT04535713|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110731525|NCT04535713|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110731526|NCT04526132|Biphenylylacetic acid|biphenylylacetic acid|mesh-list
110731527|NCT04526132|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110335168|NCT00507195|Midazolam|midazolam|mesh-list
110731528|NCT04526132|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110731529|NCT04526132|Analgesics|analgesics|mesh-ancestor
110731530|NCT04526132|Sensory System Agents|sensory system agents|mesh-ancestor
110731531|NCT04526132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110731532|NCT04526132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110731533|NCT04526132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110731534|NCT04526132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110731535|NCT04514653|Ranibizumab|ranibizumab|mesh-list
110731536|NCT04514653|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110731537|NCT04514653|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110731538|NCT04514653|Growth Substances|growth substances|mesh-ancestor
110731539|NCT04514653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110731540|NCT04514653|Growth Inhibitors|growth inhibitors|mesh-ancestor
110731541|NCT04514653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110731542|NCT04507438|Donepezil|donepezil|mesh-list
110731543|NCT04507438|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110731544|NCT04507438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110731545|NCT04507438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110731546|NCT04507438|Cholinergic Agents|cholinergic agents|mesh-ancestor
110731547|NCT04507438|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110731548|NCT04507438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110731549|NCT04507438|Nootropic Agents|nootropic agents|mesh-ancestor
110731550|NCT04505670|Donepezil|donepezil|mesh-list
110731551|NCT04505670|Zinc Oxide|zinc oxide|mesh-list
110731552|NCT04505670|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110731553|NCT04505670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110731554|NCT04505670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110731555|NCT04505670|Cholinergic Agents|cholinergic agents|mesh-ancestor
110731556|NCT04505670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110731557|NCT04505670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110731558|NCT04505670|Nootropic Agents|nootropic agents|mesh-ancestor
110731559|NCT04505670|Dermatologic Agents|dermatologic agents|mesh-ancestor
110731560|NCT04505670|Sunscreening Agents|sunscreening agents|mesh-ancestor
110731561|NCT04505670|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110731562|NCT04505670|Protective Agents|protective agents|mesh-ancestor
110731563|NCT04493320|Levodopa|levodopa|mesh-list
110731564|NCT04493320|Carbidopa|carbidopa|mesh-list
110143347|NCT02024945|Autonomic Agents|autonomic agents|mesh-ancestor
110731565|NCT04493320|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
110731566|NCT04493320|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110731602|NCT04189744|Sulfadoxine|sulfadoxine|mesh-list
110731603|NCT04189744|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
110731604|NCT04189744|Artenimol|artenimol|mesh-list
110731605|NCT04189744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110731606|NCT04189744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110731607|NCT04189744|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110731608|NCT04189744|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110731609|NCT04189744|Antimalarials|antimalarials|mesh-ancestor
110731610|NCT04189744|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110731611|NCT04189744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110731612|NCT04189744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110731613|NCT04189744|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110731614|NCT04175470|Tocotrienols|tocotrienols|mesh-list
110731615|NCT04175470|Vitamin E|vitamin e|mesh-list
110731616|NCT04175470|Tocopherols|tocopherols|mesh-list
110731617|NCT04175470|Bevacizumab|bevacizumab|mesh-list
110731618|NCT04175470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110731619|NCT04175470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110731620|NCT04175470|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110731621|NCT04175470|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110731622|NCT04175470|Growth Substances|growth substances|mesh-ancestor
110731623|NCT04175470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110731624|NCT04175470|Growth Inhibitors|growth inhibitors|mesh-ancestor
110731625|NCT04175470|Antioxidants|antioxidants|mesh-ancestor
110731626|NCT04175470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110863846|NCT04614168|Glycerol|glycerol|mesh-list
110731627|NCT04175470|Protective Agents|protective agents|mesh-ancestor
110731628|NCT04175470|Vitamins|vitamins|mesh-ancestor
110731629|NCT04175470|Micronutrients|micronutrients|mesh-ancestor
110731630|NCT04165330|Nivolumab|nivolumab|mesh-list
110731631|NCT04165330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110731632|NCT04165330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110731633|NCT04165330|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110731634|NCT04165330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110731636|NCT04115878|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
110731637|NCT04115878|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110731638|NCT04115878|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110731639|NCT04115878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110731640|NCT04115878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110731641|NCT04115878|Adrenergic Agents|adrenergic agents|mesh-ancestor
110731642|NCT04115878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110731643|NCT04115878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110731644|NCT04115878|Parasympatholytics|parasympatholytics|mesh-ancestor
110731645|NCT04115878|Autonomic Agents|autonomic agents|mesh-ancestor
110731646|NCT04115878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110731647|NCT04115878|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110731648|NCT04115878|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110731649|NCT04115878|Cholinergic Agents|cholinergic agents|mesh-ancestor
110731650|NCT04115878|Urological Agents|urological agents|mesh-ancestor
110731651|NCT03965130|Glucagon|glucagon|mesh-list
110731652|NCT03965130|Hormones|hormones|mesh-ancestor
110731653|NCT03965130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110731654|NCT03965130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110731655|NCT03965130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110731656|NCT03900884|Letrozole|letrozole|mesh-list
110731657|NCT03900884|Venetoclax|venetoclax|mesh-list
110731658|NCT03900884|Palbociclib|palbociclib|mesh-list
110731659|NCT03900884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110731660|NCT03900884|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110731661|NCT03900884|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110731662|NCT03900884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110143368|NCT02025023|Triamcinolone|triamcinolone|mesh-list
110731663|NCT03900884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110731664|NCT03900884|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110731665|NCT03900884|Hormone Antagonists|hormone antagonists|mesh-ancestor
110731666|NCT03900884|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110731667|NCT03900884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110731668|NCT03900884|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110731669|NCT03878524|Vitamins|vitamins|mesh-list
110731670|NCT03878524|Leucovorin|leucovorin|mesh-list
110731671|NCT03878524|Vitamin A|vitamin a|mesh-list
110731672|NCT03878524|Sirolimus|sirolimus|mesh-list
110731673|NCT03878524|Celecoxib|celecoxib|mesh-list
110731674|NCT03878524|Paclitaxel|paclitaxel|mesh-list
110731675|NCT03878524|Maytansine|maytansine|mesh-list
110731676|NCT03878524|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
110731677|NCT03878524|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110731678|NCT03878524|Bevacizumab|bevacizumab|mesh-list
110731679|NCT03878524|Carboplatin|carboplatin|mesh-list
110731680|NCT03878524|Doxorubicin|doxorubicin|mesh-list
110731681|NCT03878524|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110731682|NCT03878524|Pembrolizumab|pembrolizumab|mesh-list
110731683|NCT03878524|Fluorouracil|fluorouracil|mesh-list
110731684|NCT03878524|Capecitabine|capecitabine|mesh-list
110731685|NCT03878524|Oxaliplatin|oxaliplatin|mesh-list
110731686|NCT03878524|Nivolumab|nivolumab|mesh-list
110731687|NCT03878524|Trastuzumab|trastuzumab|mesh-list
110731688|NCT03878524|Everolimus|everolimus|mesh-list
110731689|NCT03878524|Bortezomib|bortezomib|mesh-list
110731690|NCT03878524|Ipilimumab|ipilimumab|mesh-list
110731691|NCT03878524|Sorafenib|sorafenib|mesh-list
110731692|NCT03878524|Temsirolimus|temsirolimus|mesh-list
110731693|NCT03878524|Durvalumab|durvalumab|mesh-list
110731694|NCT03878524|Sunitinib|sunitinib|mesh-list
110731695|NCT03878524|Daunorubicin|daunorubicin|mesh-list
110731696|NCT03878524|Venetoclax|venetoclax|mesh-list
110731697|NCT03878524|Lenvatinib|lenvatinib|mesh-list
110731698|NCT03878524|Dasatinib|dasatinib|mesh-list
110731699|NCT03878524|Olaparib|olaparib|mesh-list
110731700|NCT03878524|Palbociclib|palbociclib|mesh-list
110731701|NCT03878524|Pertuzumab|pertuzumab|mesh-list
110731702|NCT03878524|Vorinostat|vorinostat|mesh-list
110731703|NCT03878524|Trametinib|trametinib|mesh-list
110731704|NCT03878524|Tretinoin|tretinoin|mesh-list
110731705|NCT03878524|Retinol palmitate|retinol palmitate|mesh-list
110731706|NCT03878524|Bicalutamide|bicalutamide|mesh-list
110731707|NCT03878524|Afatinib|afatinib|mesh-list
110731708|NCT03878524|Vemurafenib|vemurafenib|mesh-list
110731709|NCT03878524|Dabrafenib|dabrafenib|mesh-list
110731710|NCT03878524|Panobinostat|panobinostat|mesh-list
110731711|NCT03878524|Ponatinib|ponatinib|mesh-list
110731712|NCT03878524|Idelalisib|idelalisib|mesh-list
110731713|NCT03878524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110731714|NCT03878524|MTOR Inhibitors|mtor inhibitors|mesh-list
110449486|NCT05265442|Methadone|methadone|mesh-list
110731715|NCT03878524|Losartan|losartan|mesh-list
110731716|NCT03878524|Endothelial Growth Factors|endothelial growth factors|mesh-list
110731717|NCT03878524|Antibodies|antibodies|mesh-list
110731718|NCT03878524|Immunoglobulins|immunoglobulins|mesh-list
110731719|NCT03878524|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110731721|NCT03878524|Immunoglobulin G|immunoglobulin g|mesh-list
110731722|NCT03878524|Entrectinib|entrectinib|mesh-list
110731723|NCT03878524|Immunoconjugates|immunoconjugates|mesh-list
110731724|NCT03878524|Benzenesulfonamide|benzenesulfonamide|mesh-list
110731725|NCT03878524|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110731726|NCT03878524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110731727|NCT03878524|Tubulin Modulators|tubulin modulators|mesh-ancestor
110731728|NCT03878524|Antimitotic Agents|antimitotic agents|mesh-ancestor
110731729|NCT03878524|Mitosis Modulators|mitosis modulators|mesh-ancestor
110731730|NCT03878524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110731731|NCT03878524|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110731732|NCT03878524|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110731733|NCT03878524|Growth Substances|growth substances|mesh-ancestor
110731734|NCT03878524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110731735|NCT03878524|Growth Inhibitors|growth inhibitors|mesh-ancestor
110731736|NCT03878524|Micronutrients|micronutrients|mesh-ancestor
110731737|NCT03878524|Immunologic Factors|immunologic factors|mesh-ancestor
110731738|NCT03878524|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110731739|NCT03878524|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110731740|NCT03878524|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110731741|NCT03878524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110731742|NCT03878524|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110731743|NCT03878524|Antimetabolites|antimetabolites|mesh-ancestor
110731744|NCT03878524|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110731745|NCT03878524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110731746|NCT03878524|Antidotes|antidotes|mesh-ancestor
110731747|NCT03878524|Protective Agents|protective agents|mesh-ancestor
110731748|NCT03878524|Vitamin B Complex|vitamin b complex|mesh-ancestor
110731749|NCT03878524|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110731750|NCT03878524|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110731751|NCT03878524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110731752|NCT03878524|Antifungal Agents|antifungal agents|mesh-ancestor
110731753|NCT03878524|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110731754|NCT03878524|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110731755|NCT03878524|Analgesics|analgesics|mesh-ancestor
110731756|NCT03878524|Sensory System Agents|sensory system agents|mesh-ancestor
110731757|NCT03878524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110731758|NCT03878524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110731759|NCT03878524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110731760|NCT03878524|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110731761|NCT03878524|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110731762|NCT03878524|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110731763|NCT03878524|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110731764|NCT03878524|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110731765|NCT03878524|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110731766|NCT03878524|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110731767|NCT03878524|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110731768|NCT03878524|Keratolytic Agents|keratolytic agents|mesh-ancestor
110731769|NCT03878524|Dermatologic Agents|dermatologic agents|mesh-ancestor
110731770|NCT03878524|Antioxidants|antioxidants|mesh-ancestor
110731771|NCT03878524|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110731772|NCT03878524|Androgen Antagonists|androgen antagonists|mesh-ancestor
110731773|NCT03878524|Hormone Antagonists|hormone antagonists|mesh-ancestor
110731774|NCT03878524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110731775|NCT03878524|Immunotoxins|immunotoxins|mesh-ancestor
110731776|NCT03878524|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110731777|NCT03761030|Levodopa|levodopa|mesh-list
110731778|NCT03761030|Carbidopa|carbidopa|mesh-list
110731779|NCT03761030|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
110731780|NCT03761030|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110731781|NCT03761030|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110731782|NCT03761030|Dopamine Agents|dopamine agents|mesh-ancestor
110731783|NCT03761030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110731784|NCT03761030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110731785|NCT03761030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110731786|NCT03761030|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
110731787|NCT03761030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110731788|NCT03761030|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110731789|NCT03761030|Immunologic Factors|immunologic factors|mesh-ancestor
110731790|NCT03761030|Dopamine Agonists|dopamine agonists|mesh-ancestor
110731791|NCT03742505|Cholecalciferol|cholecalciferol|mesh-list
110731792|NCT03742505|Vitamin D|vitamin d|mesh-list
110731793|NCT03742505|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110731794|NCT03742505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110731796|NCT03742505|Micronutrients|micronutrients|mesh-ancestor
110731797|NCT03742505|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110731798|NCT03663205|Cisplatin|cisplatin|mesh-list
110731799|NCT03663205|Carboplatin|carboplatin|mesh-list
110731800|NCT03663205|Pemetrexed|pemetrexed|mesh-list
110731802|NCT03663205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110731803|NCT03663205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110731804|NCT03663205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110731805|NCT03663205|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110731806|NCT03663205|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110731807|NCT03663205|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110731808|NCT03638999|Ketorolac|ketorolac|mesh-list
110731809|NCT03638999|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
110731810|NCT03638999|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110731811|NCT03638999|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110731812|NCT03638999|Analgesics|analgesics|mesh-ancestor
110731813|NCT03638999|Sensory System Agents|sensory system agents|mesh-ancestor
110731814|NCT03638999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110731815|NCT03638999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110731816|NCT03638999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110731817|NCT03638999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110731818|NCT03638999|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110731819|NCT03638999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110731820|NCT03638999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110731821|NCT03600883|Sotorasib|sotorasib|mesh-list
110731822|NCT03600883|Midazolam|midazolam|mesh-list
110731823|NCT03600883|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110731824|NCT03600883|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110731825|NCT03600883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110731826|NCT03600883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110731827|NCT03600883|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110731828|NCT03600883|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110731829|NCT03600883|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110731830|NCT03600883|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110731831|NCT03600883|Anesthetics, General|anesthetics, general|mesh-ancestor
110731832|NCT03600883|Anesthetics|anesthetics|mesh-ancestor
110731833|NCT03600883|GABA Modulators|gaba modulators|mesh-ancestor
110731834|NCT03600883|GABA Agents|gaba agents|mesh-ancestor
110731835|NCT03600883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110731836|NCT03600883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110731837|NCT03600883|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110731838|NCT03600883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110731839|NCT03600883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110731840|NCT03575793|Nivolumab|nivolumab|mesh-list
110731841|NCT03575793|Ipilimumab|ipilimumab|mesh-list
110731842|NCT03575793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110731843|NCT03575793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110731844|NCT03575793|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110863869|NCT04495283|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110731845|NCT03575793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110731846|NCT03572088|Terlipressin|terlipressin|mesh-list
110731847|NCT03572088|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110731848|NCT03572088|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110731849|NCT03560934|Dronabinol|dronabinol|mesh-list
110731850|NCT03560934|Hallucinogens|hallucinogens|mesh-ancestor
110731851|NCT03560934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110731852|NCT03560934|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110731853|NCT03560934|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110731854|NCT03560934|Analgesics|analgesics|mesh-ancestor
110731855|NCT03560934|Sensory System Agents|sensory system agents|mesh-ancestor
110731856|NCT03560934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110731857|NCT03560934|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
110731858|NCT03560934|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110731859|NCT03560934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110731860|NCT03560934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110731861|NCT03560934|Hormones|hormones|mesh-ancestor
110731862|NCT03560934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110731863|NCT03527472|Memantine|memantine|mesh-list
110731864|NCT03527472|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110731865|NCT03527472|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110731866|NCT03527472|Dopamine Agents|dopamine agents|mesh-ancestor
110731867|NCT03527472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110731868|NCT03527472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110731869|NCT03527472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110731870|NCT03527472|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110731871|NCT03527472|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110731872|NCT03483012|Atezolizumab|atezolizumab|mesh-list
110731873|NCT03483012|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110731874|NCT03483012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110731875|NCT03483012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110731876|NCT03483012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110731877|NCT03477396|Estrogens|estrogens|mesh-list
110731878|NCT03477396|Aromatase Inhibitors|aromatase inhibitors|mesh-list
110731879|NCT03477396|Hormones|hormones|mesh-ancestor
110731880|NCT03477396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110731881|NCT03477396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110731882|NCT03477396|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110731883|NCT03477396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110731884|NCT03477396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110731885|NCT03477396|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110731886|NCT03477396|Hormone Antagonists|hormone antagonists|mesh-ancestor
110731887|NCT03388788|CGP 12177|cgp 12177|mesh-list
110731888|NCT03388788|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110731889|NCT03388788|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110731890|NCT03388788|Adrenergic Agents|adrenergic agents|mesh-ancestor
110731891|NCT03388788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110731892|NCT03388788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110731893|NCT03388788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110731894|NCT03388788|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110731895|NCT03388788|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110731896|NCT03283761|Leucovorin|leucovorin|mesh-list
110731897|NCT03283761|Paclitaxel|paclitaxel|mesh-list
110731898|NCT03283761|Fluorouracil|fluorouracil|mesh-list
110731899|NCT03283761|Oxaliplatin|oxaliplatin|mesh-list
110731900|NCT03283761|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110731901|NCT03283761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110731902|NCT03283761|Tubulin Modulators|tubulin modulators|mesh-ancestor
110731903|NCT03283761|Antimitotic Agents|antimitotic agents|mesh-ancestor
110731904|NCT03283761|Mitosis Modulators|mitosis modulators|mesh-ancestor
110731905|NCT03283761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110731906|NCT03283761|Antimetabolites|antimetabolites|mesh-ancestor
110731907|NCT03283761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110731908|NCT03283761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110731909|NCT03283761|Immunologic Factors|immunologic factors|mesh-ancestor
110731910|NCT03283761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110731911|NCT03283761|Antidotes|antidotes|mesh-ancestor
110731912|NCT03283761|Protective Agents|protective agents|mesh-ancestor
110731913|NCT03283761|Vitamin B Complex|vitamin b complex|mesh-ancestor
110731914|NCT03283761|Vitamins|vitamins|mesh-ancestor
110731915|NCT03283761|Micronutrients|micronutrients|mesh-ancestor
110731916|NCT03240081|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110731917|NCT03240081|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110731918|NCT03240081|Estradiol|estradiol|mesh-list
110731919|NCT03240081|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110731920|NCT03240081|Estrogens|estrogens|mesh-ancestor
110731921|NCT03240081|Hormones|hormones|mesh-ancestor
110731922|NCT03240081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110731923|NCT03240081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110731924|NCT03240081|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110731925|NCT03240081|Contraceptive Agents|contraceptive agents|mesh-ancestor
110731926|NCT03240081|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110731927|NCT03240081|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110731928|NCT03236857|Venetoclax|venetoclax|mesh-list
110731929|NCT03236857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110731930|NCT03097120|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
110731931|NCT03097120|Medroxyprogesterone|medroxyprogesterone|mesh-list
110731932|NCT03097120|Estrogens|estrogens|mesh-list
110731933|NCT03097120|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
110731934|NCT03097120|Hormones|hormones|mesh-ancestor
110731935|NCT03097120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110731936|NCT03097120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110731937|NCT03097120|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110731938|NCT03097120|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110731939|NCT03097120|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110731940|NCT03097120|Contraceptive Agents|contraceptive agents|mesh-ancestor
110731941|NCT03097120|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110731942|NCT03097120|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110731943|NCT03097120|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110731944|NCT03097120|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110731945|NCT03097120|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110731946|NCT03097120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110731947|NCT03056755|Letrozole|letrozole|mesh-list
110731948|NCT03056755|Fulvestrant|fulvestrant|mesh-list
110731950|NCT03056755|Goserelin|goserelin|mesh-list
110731951|NCT03056755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110731952|NCT03056755|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110731953|NCT03056755|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110731954|NCT03056755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110731955|NCT03056755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110731956|NCT03056755|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110731957|NCT03056755|Hormone Antagonists|hormone antagonists|mesh-ancestor
110731958|NCT03056755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110731959|NCT03056755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110731960|NCT03056755|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110731961|NCT03056755|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110731962|NCT03056755|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110731963|NCT03056755|Fertility Agents|fertility agents|mesh-ancestor
110731964|NCT03056755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110731965|NCT03003520|Prednisone|prednisone|mesh-list
110731966|NCT03003520|Prednisolone|prednisolone|mesh-list
110731967|NCT03003520|Cyclophosphamide|cyclophosphamide|mesh-list
110731968|NCT03003520|Rituximab|rituximab|mesh-list
110731969|NCT03003520|Doxorubicin|doxorubicin|mesh-list
110731970|NCT03003520|Vincristine|vincristine|mesh-list
110731971|NCT03003520|Lenalidomide|lenalidomide|mesh-list
110731972|NCT03003520|Durvalumab|durvalumab|mesh-list
110731973|NCT03003520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110731974|NCT03003520|Immunologic Factors|immunologic factors|mesh-ancestor
110731975|NCT03003520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110731976|NCT03003520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110731977|NCT03003520|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110731978|NCT03003520|Alkylating Agents|alkylating agents|mesh-ancestor
110731979|NCT03003520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110731980|NCT03003520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110731981|NCT03003520|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110863880|NCT03634020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110731982|NCT03003520|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110731983|NCT03003520|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110731984|NCT03003520|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110731985|NCT03003520|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110731986|NCT03003520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110731987|NCT03003520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110731988|NCT03003520|Glucocorticoids|glucocorticoids|mesh-ancestor
110731989|NCT03003520|Hormones|hormones|mesh-ancestor
110731990|NCT03003520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110731991|NCT03003520|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110731992|NCT03003520|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110731993|NCT03003520|Tubulin Modulators|tubulin modulators|mesh-ancestor
110731994|NCT03003520|Antimitotic Agents|antimitotic agents|mesh-ancestor
110731995|NCT03003520|Mitosis Modulators|mitosis modulators|mesh-ancestor
110731996|NCT03003520|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110731997|NCT03003520|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110731998|NCT03003520|Growth Substances|growth substances|mesh-ancestor
110731999|NCT03003520|Growth Inhibitors|growth inhibitors|mesh-ancestor
110732000|NCT02989597|Dexamethasone|dexamethasone|mesh-list
110732001|NCT02989597|Sufentanil|sufentanil|mesh-list
110732002|NCT02989597|Ketamine|ketamine|mesh-list
110732003|NCT02989597|Remifentanil|remifentanil|mesh-list
110732004|NCT02989597|Methadone|methadone|mesh-list
110732005|NCT02989597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110732006|NCT02989597|Antiemetics|antiemetics|mesh-ancestor
110732007|NCT02989597|Autonomic Agents|autonomic agents|mesh-ancestor
110732008|NCT02989597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110732009|NCT02989597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110732010|NCT02989597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110732011|NCT02989597|Glucocorticoids|glucocorticoids|mesh-ancestor
110732012|NCT02989597|Hormones|hormones|mesh-ancestor
110732013|NCT02989597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110732014|NCT02989597|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110732015|NCT02989597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110732016|NCT02989597|Analgesics|analgesics|mesh-ancestor
110732017|NCT02989597|Sensory System Agents|sensory system agents|mesh-ancestor
110732018|NCT02989597|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110732019|NCT02989597|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110732020|NCT02989597|Anesthetics, General|anesthetics, general|mesh-ancestor
110732021|NCT02989597|Anesthetics|anesthetics|mesh-ancestor
110732022|NCT02989597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110732023|NCT02989597|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110732024|NCT02989597|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110732026|NCT02989597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110732027|NCT02989597|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110732028|NCT02989597|Narcotics|narcotics|mesh-ancestor
110732029|NCT02989597|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110732030|NCT02989597|Antitussive Agents|antitussive agents|mesh-ancestor
110732031|NCT02989597|Respiratory System Agents|respiratory system agents|mesh-ancestor
110732032|NCT02958527|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
110732033|NCT02958527|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110732034|NCT02958527|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110732035|NCT02958527|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110732036|NCT02958527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110732037|NCT02958527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110732038|NCT02958527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110732039|NCT02958527|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110732040|NCT02958527|Antidepressive Agents|antidepressive agents|mesh-ancestor
110732041|NCT02958527|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110732042|NCT02768701|Cyclophosphamide|cyclophosphamide|mesh-list
110732043|NCT02768701|Pembrolizumab|pembrolizumab|mesh-list
110732044|NCT02768701|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110732045|NCT02768701|Immunologic Factors|immunologic factors|mesh-ancestor
110732046|NCT02768701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110732047|NCT02768701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110732048|NCT02768701|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110732049|NCT02768701|Alkylating Agents|alkylating agents|mesh-ancestor
110732050|NCT02768701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110732051|NCT02768701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110732052|NCT02768701|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110732053|NCT02768701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110732054|NCT02768701|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110732055|NCT02621944|Melatonin|melatonin|mesh-list
110732056|NCT02621944|Antioxidants|antioxidants|mesh-ancestor
110732057|NCT02621944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110732058|NCT02621944|Protective Agents|protective agents|mesh-ancestor
110732059|NCT02621944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110732060|NCT02621944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110732061|NCT02620046|Vedolizumab|vedolizumab|mesh-list
110732062|NCT02620046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110732063|NCT02586025|Docetaxel|docetaxel|mesh-list
110732064|NCT02586025|Trastuzumab|trastuzumab|mesh-list
110732065|NCT02586025|Pertuzumab|pertuzumab|mesh-list
110732066|NCT02586025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110732067|NCT02586025|Tubulin Modulators|tubulin modulators|mesh-ancestor
110732068|NCT02586025|Antimitotic Agents|antimitotic agents|mesh-ancestor
110732069|NCT02586025|Mitosis Modulators|mitosis modulators|mesh-ancestor
110732070|NCT02586025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110732071|NCT02586025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110732072|NCT02465164|Oxytocin|oxytocin|mesh-list
110732073|NCT02465164|Oxytocics|oxytocics|mesh-ancestor
110732074|NCT02465164|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110732075|NCT02465164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110732076|NCT02446600|Paclitaxel|paclitaxel|mesh-list
110732077|NCT02446600|Carboplatin|carboplatin|mesh-list
110732078|NCT02446600|Gemcitabine|gemcitabine|mesh-list
110732079|NCT02446600|Doxorubicin|doxorubicin|mesh-list
110732080|NCT02446600|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110732081|NCT02446600|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110732082|NCT02446600|Olaparib|olaparib|mesh-list
110732083|NCT02446600|Cediranib|cediranib|mesh-list
110732084|NCT02446600|Maleic acid|maleic acid|mesh-list
110732085|NCT02446600|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110732086|NCT02446600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110732087|NCT02446600|Tubulin Modulators|tubulin modulators|mesh-ancestor
110732088|NCT02446600|Antimitotic Agents|antimitotic agents|mesh-ancestor
110732089|NCT02446600|Mitosis Modulators|mitosis modulators|mesh-ancestor
110732090|NCT02446600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110732091|NCT02446600|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110732092|NCT02446600|Antimetabolites|antimetabolites|mesh-ancestor
110732093|NCT02446600|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110732094|NCT02446600|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110732095|NCT02446600|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110732096|NCT02446600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110732097|NCT02446600|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110682829|NCT00902915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110732100|NCT01955512|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110732101|NCT01955512|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110732102|NCT01955512|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110732103|NCT01955512|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110732104|NCT01955512|Purinergic Agents|purinergic agents|mesh-ancestor
110732105|NCT01955512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110732106|NCT01955512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110732107|NCT01955512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110732108|NCT01194570|Ocrelizumab|ocrelizumab|mesh-list
110732109|NCT01194570|Immunologic Factors|immunologic factors|mesh-ancestor
110732110|NCT01194570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110732111|NCT00227617|Leucovorin|leucovorin|mesh-list
110732112|NCT00227617|Bevacizumab|bevacizumab|mesh-list
110732113|NCT00227617|Fluorouracil|fluorouracil|mesh-list
110732114|NCT00227617|Oxaliplatin|oxaliplatin|mesh-list
110732115|NCT00227617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110732116|NCT00227617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110732117|NCT00227617|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110732118|NCT00227617|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110732119|NCT00227617|Growth Substances|growth substances|mesh-ancestor
110732120|NCT00227617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110732121|NCT00227617|Growth Inhibitors|growth inhibitors|mesh-ancestor
110732122|NCT00227617|Antimetabolites|antimetabolites|mesh-ancestor
110732123|NCT00227617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110732124|NCT00227617|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110732125|NCT00227617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110732127|NCT00227617|Antidotes|antidotes|mesh-ancestor
110732128|NCT00227617|Protective Agents|protective agents|mesh-ancestor
110732129|NCT00227617|Vitamin B Complex|vitamin b complex|mesh-ancestor
110732130|NCT00227617|Vitamins|vitamins|mesh-ancestor
110732131|NCT00227617|Micronutrients|micronutrients|mesh-ancestor
110732132|NCT05710081|Broncho-Vaxom|broncho-vaxom|mesh-list
110732133|NCT05710081|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110732134|NCT05710081|Immunologic Factors|immunologic factors|mesh-ancestor
110732135|NCT05710081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110732136|NCT05703191|Nitric Oxide|nitric oxide|mesh-list
110732137|NCT05703191|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110732138|NCT05703191|Autonomic Agents|autonomic agents|mesh-ancestor
110732139|NCT05703191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110732140|NCT05703191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110732141|NCT05703191|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110732142|NCT05703191|Respiratory System Agents|respiratory system agents|mesh-ancestor
110732143|NCT05703191|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110732144|NCT05703191|Antioxidants|antioxidants|mesh-ancestor
110732145|NCT05703191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110732146|NCT05703191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110732147|NCT05703191|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
110732148|NCT05703191|Vasodilator Agents|vasodilator agents|mesh-ancestor
110732149|NCT05703191|Gasotransmitters|gasotransmitters|mesh-ancestor
110732150|NCT05703191|Protective Agents|protective agents|mesh-ancestor
110732151|NCT05687071|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
110732152|NCT05687071|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110732153|NCT05687071|Antimetabolites|antimetabolites|mesh-ancestor
110732154|NCT05687071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110732155|NCT05687071|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110732156|NCT05687071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110732157|NCT05687071|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110732158|NCT05687071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110732159|NCT05657470|Tenecteplase|tenecteplase|mesh-list
110732161|NCT05657470|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110732162|NCT05657470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110732165|NCT05639686|Remifentanil|remifentanil|mesh-list
110732166|NCT05639686|Anesthetics|anesthetics|mesh-list
110732167|NCT05639686|Propofol|propofol|mesh-list
110732168|NCT05639686|Isoflurane|isoflurane|mesh-list
110732169|NCT05639686|Tranexamic Acid|tranexamic acid|mesh-list
110732170|NCT05639686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110732171|NCT05639686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110732172|NCT05639686|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110732173|NCT05639686|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110732174|NCT05639686|Anesthetics, General|anesthetics, general|mesh-ancestor
110732175|NCT05639686|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110732176|NCT05639686|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110732177|NCT05639686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110732179|NCT05639686|Coagulants|coagulants|mesh-ancestor
110732180|NCT05639686|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110732181|NCT05639686|Narcotics|narcotics|mesh-ancestor
110732182|NCT05639686|Analgesics|analgesics|mesh-ancestor
110732183|NCT05639686|Sensory System Agents|sensory system agents|mesh-ancestor
110732184|NCT05639686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110732185|NCT05639686|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110732186|NCT05633576|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110732187|NCT05633576|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110732188|NCT05586074|Cytarabine|cytarabine|mesh-list
110732189|NCT05586074|Fludarabine|fludarabine|mesh-list
110732190|NCT05586074|Azacitidine|azacitidine|mesh-list
110732191|NCT05586074|Decitabine|decitabine|mesh-list
110732192|NCT05586074|Idarubicin|idarubicin|mesh-list
110732193|NCT05586074|Lenograstim|lenograstim|mesh-list
110732194|NCT05586074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110732195|NCT05586074|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110732196|NCT05586074|Antimetabolites|antimetabolites|mesh-ancestor
110732197|NCT05586074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110732198|NCT05586074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110732199|NCT05586074|Immunologic Factors|immunologic factors|mesh-ancestor
110732200|NCT05586074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110732201|NCT05586074|Antiviral Agents|antiviral agents|mesh-ancestor
110732202|NCT05586074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110732203|NCT05586074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110732204|NCT05586074|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110732205|NCT05586074|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110732206|NCT05586074|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110732207|NCT05586074|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110732209|NCT05568615|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110732210|NCT05568615|Antioxidants|antioxidants|mesh-ancestor
110732211|NCT05568615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110732212|NCT05568615|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110732213|NCT05568615|Protective Agents|protective agents|mesh-ancestor
110732214|NCT05568615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110732215|NCT05541146|Paclitaxel|paclitaxel|mesh-list
110732216|NCT05541146|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110732217|NCT05541146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110732218|NCT05541146|Tubulin Modulators|tubulin modulators|mesh-ancestor
110732219|NCT05541146|Antimitotic Agents|antimitotic agents|mesh-ancestor
110732220|NCT05541146|Mitosis Modulators|mitosis modulators|mesh-ancestor
110732221|NCT05541146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110732222|NCT05532358|Midazolam|midazolam|mesh-list
110732223|NCT05532358|Fluvoxamine|fluvoxamine|mesh-list
110732224|NCT05532358|Caffeine|caffeine|mesh-list
110732225|NCT05532358|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110732226|NCT05532358|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110732227|NCT05532358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110732228|NCT05532358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110732229|NCT05532358|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110732230|NCT05532358|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110732231|NCT05532358|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110732232|NCT05532358|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110732233|NCT05532358|Anesthetics, General|anesthetics, general|mesh-ancestor
110732234|NCT05532358|Anesthetics|anesthetics|mesh-ancestor
110732235|NCT05532358|GABA Modulators|gaba modulators|mesh-ancestor
110732236|NCT05532358|GABA Agents|gaba agents|mesh-ancestor
110732237|NCT05532358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110732238|NCT05532358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110732239|NCT05532358|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110732241|NCT05532358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110732242|NCT05532358|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110732243|NCT05532358|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110732244|NCT05532358|Purinergic Agents|purinergic agents|mesh-ancestor
110732245|NCT05532358|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110732246|NCT05532358|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110732247|NCT05532358|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110732249|NCT05532358|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110732250|NCT05532358|Antidepressive Agents|antidepressive agents|mesh-ancestor
110732251|NCT05532358|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110732252|NCT05532358|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110732253|NCT05532358|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110732255|NCT05525416|Nitroprusside|nitroprusside|mesh-list
110732256|NCT05525416|Phentolamine|phentolamine|mesh-list
110732257|NCT05525416|Phenylephrine|phenylephrine|mesh-list
110732258|NCT05525416|Oxymetazoline|oxymetazoline|mesh-list
110732259|NCT05525416|Norepinephrine|norepinephrine|mesh-list
110732260|NCT05525416|Synephrine|synephrine|mesh-list
110732261|NCT05525416|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110732262|NCT05525416|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110732263|NCT05525416|Adrenergic Agents|adrenergic agents|mesh-ancestor
110732264|NCT05525416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110732265|NCT05525416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110732266|NCT05525416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110732267|NCT05525416|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110732268|NCT05525416|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110732269|NCT05525416|Vasodilator Agents|vasodilator agents|mesh-ancestor
110732270|NCT05525416|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110732271|NCT05525416|Mydriatics|mydriatics|mesh-ancestor
110732272|NCT05525416|Autonomic Agents|autonomic agents|mesh-ancestor
110732273|NCT05525416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110732274|NCT05525416|Sympathomimetics|sympathomimetics|mesh-ancestor
110732275|NCT05525416|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110732276|NCT05525416|Nasal Decongestants|nasal decongestants|mesh-ancestor
110732277|NCT05525416|Respiratory System Agents|respiratory system agents|mesh-ancestor
110732278|NCT05525416|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110732279|NCT05525416|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110732280|NCT05525416|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110732281|NCT05525416|Protective Agents|protective agents|mesh-ancestor
110732282|NCT05525416|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
110732283|NCT05525416|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110732284|NCT05491512|Carboplatin|carboplatin|mesh-list
110732285|NCT05491512|Fluorouracil|fluorouracil|mesh-list
110732286|NCT05491512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110732287|NCT05491512|Antimetabolites|antimetabolites|mesh-ancestor
110732288|NCT05491512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110732289|NCT05491512|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110732290|NCT05491512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110732291|NCT05491512|Immunologic Factors|immunologic factors|mesh-ancestor
110732292|NCT05491512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110732293|NCT05449405|Chlorpheniramine|chlorpheniramine|mesh-list
110863930|NCT03233152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110732294|NCT05449405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110732295|NCT05449405|Antipruritics|antipruritics|mesh-ancestor
110732296|NCT05449405|Dermatologic Agents|dermatologic agents|mesh-ancestor
110732297|NCT05449405|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110732298|NCT05449405|Histamine Antagonists|histamine antagonists|mesh-ancestor
110732299|NCT05449405|Histamine Agents|histamine agents|mesh-ancestor
110732300|NCT05449405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110732301|NCT05449405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110732302|NCT05449405|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110732303|NCT05394740|Leucovorin|leucovorin|mesh-list
110732304|NCT05394740|Fluorouracil|fluorouracil|mesh-list
110732305|NCT05394740|Capecitabine|capecitabine|mesh-list
110732306|NCT05394740|Oxaliplatin|oxaliplatin|mesh-list
110732307|NCT05394740|Nivolumab|nivolumab|mesh-list
110732308|NCT05394740|Antimetabolites|antimetabolites|mesh-ancestor
110732309|NCT05394740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110732310|NCT05394740|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110732311|NCT05394740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110732312|NCT05394740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110732313|NCT05394740|Immunologic Factors|immunologic factors|mesh-ancestor
110732314|NCT05394740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110362063|NCT01187953|Tacrolimus|tacrolimus|mesh-list
110732315|NCT05394740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110732316|NCT05394740|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110143555|NCT02026050|Dexamethasone|dexamethasone|mesh-list
110732318|NCT05394740|Protective Agents|protective agents|mesh-ancestor
110732319|NCT05394740|Vitamin B Complex|vitamin b complex|mesh-ancestor
110732320|NCT05394740|Vitamins|vitamins|mesh-ancestor
110732321|NCT05394740|Micronutrients|micronutrients|mesh-ancestor
110732322|NCT05390021|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110732323|NCT05390021|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110732324|NCT05390021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110732325|NCT05273996|Bupropion|bupropion|mesh-list
110732326|NCT05273996|Sertraline|sertraline|mesh-list
110732327|NCT05273996|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
110732328|NCT05273996|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110732329|NCT05273996|Antidepressive Agents|antidepressive agents|mesh-ancestor
110732330|NCT05273996|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110732331|NCT05273996|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110732332|NCT05273996|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110732333|NCT05273996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110732334|NCT05273996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110732336|NCT05273996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110732337|NCT05273996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110732338|NCT05273996|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110732339|NCT05273996|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110732340|NCT05273996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110732341|NCT05273996|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110732342|NCT05273996|Serotonin Agents|serotonin agents|mesh-ancestor
110732343|NCT05273996|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110732344|NCT05264025|Fexofenadine|fexofenadine|mesh-list
110732345|NCT05264025|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110732346|NCT05264025|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110732347|NCT05264025|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110732348|NCT05264025|Histamine Antagonists|histamine antagonists|mesh-ancestor
110732349|NCT05264025|Histamine Agents|histamine agents|mesh-ancestor
110732350|NCT05264025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110732351|NCT05264025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110732352|NCT05264025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110732353|NCT05262244|Bevacizumab|bevacizumab|mesh-list
110732354|NCT05262244|Vedolizumab|vedolizumab|mesh-list
110732355|NCT05262244|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110732356|NCT05262244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110732357|NCT05262244|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110732358|NCT05262244|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110732359|NCT05262244|Growth Substances|growth substances|mesh-ancestor
110732360|NCT05262244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110732361|NCT05262244|Growth Inhibitors|growth inhibitors|mesh-ancestor
110732362|NCT05262244|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110732363|NCT05244213|Paclitaxel|paclitaxel|mesh-list
110732364|NCT05244213|Carboplatin|carboplatin|mesh-list
110732365|NCT05244213|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110732366|NCT05244213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110732367|NCT05244213|Tubulin Modulators|tubulin modulators|mesh-ancestor
110732368|NCT05244213|Antimitotic Agents|antimitotic agents|mesh-ancestor
110732369|NCT05244213|Mitosis Modulators|mitosis modulators|mesh-ancestor
110732370|NCT05244213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110732371|NCT05231148|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110732372|NCT05231148|Calcium|calcium|mesh-list
110732373|NCT05231148|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110732374|NCT05231148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110732375|NCT05231148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110732376|NCT05169112|Leuprolide|leuprolide|mesh-list
110732377|NCT05169112|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110732378|NCT05169112|Fertility Agents|fertility agents|mesh-ancestor
110732379|NCT05169112|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110732380|NCT05169112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110732381|NCT05169112|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110732382|NCT05169112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110732383|NCT05137184|Fentanyl|fentanyl|mesh-list
110732384|NCT05137184|Morphine|morphine|mesh-list
110732385|NCT05137184|Methoxyflurane|methoxyflurane|mesh-list
110732386|NCT05137184|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110732387|NCT05137184|Narcotics|narcotics|mesh-ancestor
110444536|NCT05273710|Folic Acid|folic acid|mesh-list
110732388|NCT05137184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110732389|NCT05137184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110732391|NCT05137184|Sensory System Agents|sensory system agents|mesh-ancestor
110732392|NCT05137184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110732393|NCT05137184|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110732394|NCT05137184|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110732395|NCT05137184|Anesthetics, General|anesthetics, general|mesh-ancestor
110732396|NCT05137184|Anesthetics|anesthetics|mesh-ancestor
110732397|NCT05137184|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110732398|NCT05097209|Cisplatin|cisplatin|mesh-list
110732399|NCT05097209|Gemcitabine|gemcitabine|mesh-list
110863983|NCT03232450|Aspirin|aspirin|mesh-list
110732401|NCT05097209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110732402|NCT05097209|Antimetabolites|antimetabolites|mesh-ancestor
110732403|NCT05097209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110732404|NCT05067998|Vitamins|vitamins|mesh-list
110732405|NCT05067998|Micronutrients|micronutrients|mesh-ancestor
110732406|NCT05067998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110732407|NCT05025293|Zoledronic Acid|zoledronic acid|mesh-list
110732408|NCT05025293|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110732409|NCT05025293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110732410|NCT05021991|Pramoxine|pramoxine|mesh-list
110732411|NCT05021991|Anesthetics, Local|anesthetics, local|mesh-ancestor
110732412|NCT05021991|Anesthetics|anesthetics|mesh-ancestor
110732413|NCT05021991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110732414|NCT05021991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110732415|NCT05021991|Sensory System Agents|sensory system agents|mesh-ancestor
110732416|NCT05021991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110732417|NCT05001776|PENTA|penta|mesh-list
110732418|NCT05001776|Fondaparinux|fondaparinux|mesh-list
110732419|NCT05001776|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110732420|NCT05001776|Antithrombins|antithrombins|mesh-ancestor
110732421|NCT05001776|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110732422|NCT05001776|Protease Inhibitors|protease inhibitors|mesh-ancestor
110732423|NCT05001776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110732424|NCT05001776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110732425|NCT05001776|Anticoagulants|anticoagulants|mesh-ancestor
110732426|NCT05001776|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110732427|NCT05001776|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110732428|NCT04991974|Buprenorphine|buprenorphine|mesh-list
110864101|NCT02452450|Ibuprofen|ibuprofen|mesh-list
110732429|NCT04991974|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
110732430|NCT04991974|Naloxone|naloxone|mesh-list
110732431|NCT04991974|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110732432|NCT04991974|Narcotics|narcotics|mesh-ancestor
110732433|NCT04991974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110732434|NCT04991974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110732435|NCT04991974|Analgesics|analgesics|mesh-ancestor
110732436|NCT04991974|Sensory System Agents|sensory system agents|mesh-ancestor
110732437|NCT04991974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110732438|NCT04991974|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110732439|NCT04977479|Vaccines|vaccines|mesh-list
110732440|NCT04977479|Immunologic Factors|immunologic factors|mesh-ancestor
110732441|NCT04977479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110732442|NCT04971473|Hormones|hormones|mesh-list
110732443|NCT04971473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110732444|NCT04971473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110732445|NCT04917692|Empagliflozin|empagliflozin|mesh-list
110732446|NCT04917692|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110732447|NCT04917692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110732448|NCT04917692|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110732449|NCT04917692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110732450|NCT04915248|Dexamethasone|dexamethasone|mesh-list
110732451|NCT04915248|Dexamethasone acetate|dexamethasone acetate|mesh-list
110732452|NCT04915248|Bortezomib|bortezomib|mesh-list
110732453|NCT04915248|Daratumumab|daratumumab|mesh-list
110732455|NCT04915248|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110732456|NCT04915248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110732457|NCT04915248|Antiemetics|antiemetics|mesh-ancestor
110732458|NCT04915248|Autonomic Agents|autonomic agents|mesh-ancestor
110732459|NCT04915248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110732460|NCT04915248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110732461|NCT04915248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110732462|NCT04915248|Glucocorticoids|glucocorticoids|mesh-ancestor
110732463|NCT04915248|Hormones|hormones|mesh-ancestor
110444537|NCT05273710|Hematinics|hematinics|mesh-ancestor
110732464|NCT04915248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110732465|NCT04915248|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110732466|NCT04915248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110732467|NCT04915248|Protease Inhibitors|protease inhibitors|mesh-ancestor
110732468|NCT04915248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110732469|NCT04915248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110732470|NCT04915248|Immunologic Factors|immunologic factors|mesh-ancestor
110732472|NCT04893785|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110732473|NCT04893785|Alkylating Agents|alkylating agents|mesh-ancestor
110732474|NCT04893785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110732475|NCT04893785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110732476|NCT04881747|Lasmiditan|lasmiditan|mesh-list
110732478|NCT04881747|Serotonin Agents|serotonin agents|mesh-ancestor
110732479|NCT04881747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110732480|NCT04881747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110732481|NCT04881747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110732482|NCT04862949|Bevacizumab|bevacizumab|mesh-list
110732483|NCT04862949|Atezolizumab|atezolizumab|mesh-list
110732484|NCT04862949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110732485|NCT04862949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110732486|NCT04862949|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110732487|NCT04862949|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110732488|NCT04862949|Growth Substances|growth substances|mesh-ancestor
110732489|NCT04862949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110732490|NCT04862949|Growth Inhibitors|growth inhibitors|mesh-ancestor
110732491|NCT04862949|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110732492|NCT04862949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110732493|NCT04840823|Enoxacin|enoxacin|mesh-list
110732494|NCT04840823|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110732495|NCT04840823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110732496|NCT04840823|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110732497|NCT04840823|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110732498|NCT04840823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110732499|NCT04840823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110732500|NCT04840823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110732501|NCT04840823|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110732502|NCT04840823|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110732503|NCT04781959|Lenograstim|lenograstim|mesh-list
110732504|NCT04781959|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110732505|NCT04781959|Immunologic Factors|immunologic factors|mesh-ancestor
110864308|NCT03119116|Rivaroxaban|rivaroxaban|mesh-list
110732506|NCT04781959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110732507|NCT04729608|Paclitaxel|paclitaxel|mesh-list
110732508|NCT04729608|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110732509|NCT04729608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110732510|NCT04729608|Tubulin Modulators|tubulin modulators|mesh-ancestor
110732511|NCT04729608|Antimitotic Agents|antimitotic agents|mesh-ancestor
110732512|NCT04729608|Mitosis Modulators|mitosis modulators|mesh-ancestor
110732513|NCT04729608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110732514|NCT04652245|Fluticasone|fluticasone|mesh-list
110732515|NCT04652245|Xhance|xhance|mesh-list
110732516|NCT04652245|Azelastine|azelastine|mesh-list
110732517|NCT04652245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110732518|NCT04652245|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110732519|NCT04652245|Autonomic Agents|autonomic agents|mesh-ancestor
110732520|NCT04652245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110732521|NCT04652245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110732522|NCT04652245|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110732523|NCT04652245|Respiratory System Agents|respiratory system agents|mesh-ancestor
110732524|NCT04652245|Dermatologic Agents|dermatologic agents|mesh-ancestor
110732525|NCT04652245|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110732526|NCT04652245|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
110732527|NCT04652245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110732528|NCT04652245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110732529|NCT04652245|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110732530|NCT04652245|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110732531|NCT04652245|Histamine Antagonists|histamine antagonists|mesh-ancestor
110444539|NCT05273710|Vitamins|vitamins|mesh-ancestor
110732532|NCT04652245|Histamine Agents|histamine agents|mesh-ancestor
110732533|NCT04652245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110732534|NCT04642287|Fluorouracil|fluorouracil|mesh-list
110732535|NCT04642287|Calcipotriene|calcipotriene|mesh-list
110732536|NCT04642287|Petrolatum|petrolatum|mesh-list
110732537|NCT04642287|Antimetabolites|antimetabolites|mesh-ancestor
110732538|NCT04642287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110732539|NCT04642287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110732540|NCT04642287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110732541|NCT04642287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110732542|NCT04642287|Immunologic Factors|immunologic factors|mesh-ancestor
110732543|NCT04642287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110732544|NCT04642287|Dermatologic Agents|dermatologic agents|mesh-ancestor
110732545|NCT04642287|Emollients|emollients|mesh-ancestor
110732546|NCT04635735|Ipilimumab|ipilimumab|mesh-list
110732547|NCT04635735|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110732548|NCT04635735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110732549|NCT04635735|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110450296|NCT01115855|Eplerenone|eplerenone|mesh-list
110732555|NCT04595513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110732556|NCT04595513|Antifungal Agents|antifungal agents|mesh-ancestor
110732557|NCT04595513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110732558|NCT04595513|Immunologic Factors|immunologic factors|mesh-ancestor
110732559|NCT04595513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110732560|NCT04564339|Ravulizumab|ravulizumab|mesh-list
110732561|NCT04564339|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
110732562|NCT04564339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110732563|NCT04564339|Immunologic Factors|immunologic factors|mesh-ancestor
110732564|NCT04564339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110732565|NCT04543110|Durvalumab|durvalumab|mesh-list
110732566|NCT04543110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110732567|NCT04543110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110732568|NCT04487652|Coenzyme Q10|coenzyme q10|mesh-list
110732569|NCT04487652|Vitamins|vitamins|mesh-ancestor
110732570|NCT04487652|Micronutrients|micronutrients|mesh-ancestor
110732571|NCT04487652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110732572|NCT04454489|Pembrolizumab|pembrolizumab|mesh-list
110732573|NCT04454489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110732574|NCT04454489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110732575|NCT04454489|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110732576|NCT04454489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110732578|NCT04447183|Hormones|hormones|mesh-list
110732579|NCT04447183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110732580|NCT04447183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110732581|NCT04447183|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110732582|NCT04447183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110732583|NCT04447183|Trace Elements|trace elements|mesh-ancestor
110732584|NCT04447183|Micronutrients|micronutrients|mesh-ancestor
110732585|NCT04429334|Nangibotide|nangibotide|mesh-list
110732586|NCT04429334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110732587|NCT04408443|Vitamin D|vitamin d|mesh-list
110732588|NCT04408443|Cholecalciferol|cholecalciferol|mesh-list
110732589|NCT04408443|Vitamins|vitamins|mesh-ancestor
110732590|NCT04408443|Micronutrients|micronutrients|mesh-ancestor
110732591|NCT04408443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110732592|NCT04408443|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110732593|NCT04408443|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110732594|NCT04405739|Molnupiravir|molnupiravir|mesh-list
110732595|NCT04405739|Antiviral Agents|antiviral agents|mesh-ancestor
110732596|NCT04405739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110732597|NCT04396457|Pembrolizumab|pembrolizumab|mesh-list
110732598|NCT04396457|Pemetrexed|pemetrexed|mesh-list
110732599|NCT04396457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110732600|NCT04396457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110732601|NCT04396457|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110732602|NCT04396457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110732603|NCT04396457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110732604|NCT04396457|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110732605|NCT04396457|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110732606|NCT04377204|Lidocaine|lidocaine|mesh-list
110732607|NCT04377204|Bupivacaine|bupivacaine|mesh-list
110732608|NCT04377204|Anesthetics, Local|anesthetics, local|mesh-ancestor
110732609|NCT04377204|Anesthetics|anesthetics|mesh-ancestor
110444546|NCT01100502|Brentuximab Vedotin|brentuximab vedotin|mesh-list
110732610|NCT04377204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110732611|NCT04377204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110732612|NCT04377204|Sensory System Agents|sensory system agents|mesh-ancestor
110732613|NCT04377204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110732614|NCT04377204|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110732615|NCT04377204|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110732616|NCT04377204|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110732617|NCT04377204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110732618|NCT04377204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110450383|NCT05244538|Propofol|propofol|mesh-list
110732627|NCT04346589|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110732628|NCT04346589|Immunologic Factors|immunologic factors|mesh-ancestor
110732629|NCT04346589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110732631|NCT05934110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110732632|NCT05934110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110732633|NCT05934110|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110732634|NCT05934110|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110732635|NCT05934097|Prednisone|prednisone|mesh-list
110732636|NCT05934097|Cyclophosphamide|cyclophosphamide|mesh-list
110732637|NCT05934097|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110732638|NCT05934097|Rituximab|rituximab|mesh-list
110732639|NCT05934097|Doxorubicin|doxorubicin|mesh-list
110732640|NCT05934097|Vincristine|vincristine|mesh-list
110732641|NCT05934097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110732642|NCT05934097|Immunologic Factors|immunologic factors|mesh-ancestor
110732643|NCT05934097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110732644|NCT05934097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110732645|NCT05934097|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110732646|NCT05934097|Alkylating Agents|alkylating agents|mesh-ancestor
110732647|NCT05934097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110732648|NCT05934097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110732649|NCT05934097|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110732650|NCT05934097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110732651|NCT05934097|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110732652|NCT05934097|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110732653|NCT05934097|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110732654|NCT05934097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110732655|NCT05934097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110732656|NCT05934097|Glucocorticoids|glucocorticoids|mesh-ancestor
110732657|NCT05934097|Hormones|hormones|mesh-ancestor
110732658|NCT05934097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110732659|NCT05934097|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110732660|NCT05934097|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110732661|NCT05934097|Tubulin Modulators|tubulin modulators|mesh-ancestor
110732662|NCT05934097|Antimitotic Agents|antimitotic agents|mesh-ancestor
110732663|NCT05934097|Mitosis Modulators|mitosis modulators|mesh-ancestor
110732664|NCT05934071|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
110732665|NCT05934071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110732666|NCT05934071|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110732667|NCT05934071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110732668|NCT05933863|Antibodies|antibodies|mesh-list
110732669|NCT05933863|Immunologic Factors|immunologic factors|mesh-ancestor
110732670|NCT05933863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110732671|NCT05933759|Insulin|insulin|mesh-list
110732672|NCT05933759|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110732673|NCT05933759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110732674|NCT05933486|Pregabalin|pregabalin|mesh-list
110732675|NCT05933486|Analgesics|analgesics|mesh-ancestor
110732676|NCT05933486|Sensory System Agents|sensory system agents|mesh-ancestor
110732677|NCT05933486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110732678|NCT05933486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110732679|NCT05933486|Anticonvulsants|anticonvulsants|mesh-ancestor
110732680|NCT05933486|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110732681|NCT05933486|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110732682|NCT05933486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110732683|NCT05933486|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110732684|NCT05933486|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110732685|NCT05933486|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110732686|NCT05933486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110732687|NCT05933486|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110732688|NCT05933447|Moxifloxacin|moxifloxacin|mesh-list
110732689|NCT05933447|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
110732690|NCT05933447|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110732691|NCT05933447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110732692|NCT05933447|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110732693|NCT05933447|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110732694|NCT05933447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110732695|NCT05933447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110732696|NCT05933447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110732697|NCT05933447|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110732698|NCT05933447|Contraceptive Agents|contraceptive agents|mesh-ancestor
110732699|NCT05933447|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110732700|NCT05933447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110732701|NCT05933447|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110732702|NCT05933447|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110732703|NCT05933447|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110732705|NCT05933213|Glucocorticoids|glucocorticoids|mesh-list
110732707|NCT05933213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110732708|NCT05933213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110732709|NCT05933213|Hallucinogens|hallucinogens|mesh-ancestor
110732710|NCT05933213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110732711|NCT05933213|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110732713|NCT05933213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110732714|NCT05933213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110732715|NCT05933031|Lansoprazole|lansoprazole|mesh-list
110732716|NCT05933031|Dexlansoprazole|dexlansoprazole|mesh-list
110732717|NCT05933031|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110732718|NCT05933031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110732719|NCT05933031|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110732720|NCT05933031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110732721|NCT05933031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110732722|NCT05932849|Benralizumab|benralizumab|mesh-list
110732723|NCT05932849|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110732724|NCT05932849|Respiratory System Agents|respiratory system agents|mesh-ancestor
110732725|NCT05932693|Menthol|menthol|mesh-list
110732726|NCT05932693|Antipruritics|antipruritics|mesh-ancestor
110732727|NCT05932693|Dermatologic Agents|dermatologic agents|mesh-ancestor
110732728|NCT05932667|Fulvestrant|fulvestrant|mesh-list
110732729|NCT05932667|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110732730|NCT05932667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110732731|NCT05932667|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110732732|NCT05932667|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110732733|NCT05932667|Hormone Antagonists|hormone antagonists|mesh-ancestor
110732734|NCT05932667|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110732735|NCT05932667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110732736|NCT05932550|Maraviroc|maraviroc|mesh-list
110732737|NCT05932550|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110732738|NCT05932550|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110732739|NCT05932550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110732740|NCT05932550|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110732741|NCT05932550|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110732742|NCT05932550|Antiviral Agents|antiviral agents|mesh-ancestor
110732743|NCT05932550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110732744|NCT05932550|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
110732745|NCT05932524|Dexamethasone|dexamethasone|mesh-list
110732746|NCT05932524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110732747|NCT05932524|Antiemetics|antiemetics|mesh-ancestor
110732748|NCT05932524|Autonomic Agents|autonomic agents|mesh-ancestor
110732749|NCT05932524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110732750|NCT05932524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110732751|NCT05932524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110732752|NCT05932524|Glucocorticoids|glucocorticoids|mesh-ancestor
110732753|NCT05932524|Hormones|hormones|mesh-ancestor
110732754|NCT05932524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110732755|NCT05932524|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110732756|NCT05932524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110732757|NCT05932472|Aspirin|aspirin|mesh-list
110732758|NCT05932472|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110732759|NCT05932472|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110732760|NCT05932472|Analgesics|analgesics|mesh-ancestor
110732761|NCT05932472|Sensory System Agents|sensory system agents|mesh-ancestor
110732762|NCT05932472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110732763|NCT05932472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110732764|NCT05932472|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110732765|NCT05932472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110732766|NCT05932472|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110732767|NCT05932472|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110732768|NCT05932472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110732769|NCT05932472|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110732770|NCT05932472|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110732771|NCT05932472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110732772|NCT05932472|Antipyretics|antipyretics|mesh-ancestor
110732773|NCT05932407|Vortioxetine|vortioxetine|mesh-list
110732774|NCT05932407|Antidepressive Agents|antidepressive agents|mesh-ancestor
110732775|NCT05932407|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110732776|NCT05932407|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110732777|NCT05932407|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110732778|NCT05932407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110732779|NCT05932407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110732780|NCT05932407|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110732781|NCT05932407|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110864379|NCT03747341|Buprenorphine|buprenorphine|mesh-list
110732782|NCT05932407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110732783|NCT05932407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110732784|NCT05932407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110732785|NCT05932407|Serotonin Agents|serotonin agents|mesh-ancestor
110732786|NCT05932407|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110732787|NCT05932407|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110732788|NCT05932407|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110732789|NCT05932407|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110732791|NCT05932316|Bronchodilator Agents|bronchodilator agents|mesh-list
110732792|NCT05932316|Autonomic Agents|autonomic agents|mesh-ancestor
110732793|NCT05932316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110732794|NCT05932316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110732795|NCT05932316|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110732796|NCT05932316|Respiratory System Agents|respiratory system agents|mesh-ancestor
110732797|NCT05932316|Tocolytic Agents|tocolytic agents|mesh-ancestor
110732798|NCT05932316|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110732799|NCT05932316|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110732800|NCT05932316|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110732801|NCT05932316|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110732802|NCT05932316|Adrenergic Agents|adrenergic agents|mesh-ancestor
110732803|NCT05932316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110732804|NCT05932316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110732805|NCT05932277|Fexofenadine|fexofenadine|mesh-list
110732806|NCT05932277|Flurbiprofen|flurbiprofen|mesh-list
110732807|NCT05932277|Midazolam|midazolam|mesh-list
110732808|NCT05932277|Caffeine|caffeine|mesh-list
110732809|NCT05932277|Bupropion|bupropion|mesh-list
110732810|NCT05932277|Omeprazole|omeprazole|mesh-list
110732811|NCT05932277|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110732812|NCT05932277|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110732813|NCT05932277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110732814|NCT05932277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110732815|NCT05932277|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110732816|NCT05932277|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110732817|NCT05932277|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110732818|NCT05932277|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110732819|NCT05932277|Anesthetics, General|anesthetics, general|mesh-ancestor
110732820|NCT05932277|Anesthetics|anesthetics|mesh-ancestor
110732821|NCT05932277|GABA Modulators|gaba modulators|mesh-ancestor
110732822|NCT05932277|GABA Agents|gaba agents|mesh-ancestor
110732823|NCT05932277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110732824|NCT05932277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110732825|NCT05932277|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110732826|NCT05932277|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110732827|NCT05932277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110732828|NCT05932277|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110732829|NCT05932277|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110732830|NCT05932277|Purinergic Agents|purinergic agents|mesh-ancestor
110732831|NCT05932277|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110732832|NCT05932277|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110732833|NCT05932277|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110732834|NCT05932277|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110143727|NCT02027220|Antiemetics|antiemetics|mesh-ancestor
110732835|NCT05932277|Antidepressive Agents|antidepressive agents|mesh-ancestor
110732836|NCT05932277|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110732837|NCT05932277|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110732838|NCT05932277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110732839|NCT05932277|Dopamine Agents|dopamine agents|mesh-ancestor
110732840|NCT05932277|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110732841|NCT05932277|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110732842|NCT05932277|Analgesics|analgesics|mesh-ancestor
110732843|NCT05932277|Sensory System Agents|sensory system agents|mesh-ancestor
110450595|NCT01052844|Gabapentin|gabapentin|mesh-list
110732844|NCT05932277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110732845|NCT05932277|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110732846|NCT05932277|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110732847|NCT05932277|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110732848|NCT05932277|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110732849|NCT05932277|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110732850|NCT05932277|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110732851|NCT05932277|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110732852|NCT05932277|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110732853|NCT05932277|Histamine Antagonists|histamine antagonists|mesh-ancestor
110732854|NCT05932277|Histamine Agents|histamine agents|mesh-ancestor
110732856|NCT05932264|Fluzoparib|fluzoparib|mesh-list
110732857|NCT05932264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110732858|NCT05932264|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110732859|NCT05932264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110732860|NCT05932264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110732861|NCT05932264|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110732862|NCT05932186|Anesthetics|anesthetics|mesh-list
110732863|NCT05932186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110732864|NCT05932186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110732865|NCT05931822|Fluorides|fluorides|mesh-list
110732866|NCT05931822|Fluorides, Topical|fluorides, topical|mesh-list
110732867|NCT05931822|Cariostatic Agents|cariostatic agents|mesh-ancestor
110732868|NCT05931822|Protective Agents|protective agents|mesh-ancestor
110732869|NCT05931822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110732870|NCT05931757|Blinatumomab|blinatumomab|mesh-list
110732871|NCT05931757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110732872|NCT05931744|Prednisone|prednisone|mesh-list
110732873|NCT05931744|Budesonide|budesonide|mesh-list
110732874|NCT05931744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110732875|NCT05931744|Glucocorticoids|glucocorticoids|mesh-ancestor
110732876|NCT05931744|Hormones|hormones|mesh-ancestor
110732877|NCT05931744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110143744|NCT02027324|Chlorhexidine|chlorhexidine|mesh-list
110732878|NCT05931744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110732879|NCT05931744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110732880|NCT05931744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110732881|NCT05931744|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110732882|NCT05931744|Autonomic Agents|autonomic agents|mesh-ancestor
110732883|NCT05931744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110732884|NCT05931744|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110732885|NCT05931744|Respiratory System Agents|respiratory system agents|mesh-ancestor
110732886|NCT05931718|Epoetin Alfa|epoetin alfa|mesh-list
110732887|NCT05931718|Luspatercept|luspatercept|mesh-list
110732888|NCT05931718|Hematinics|hematinics|mesh-ancestor
110732889|NCT05931601|Norepinephrine|norepinephrine|mesh-list
110732890|NCT05931601|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110732891|NCT05931601|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110732892|NCT05931601|Adrenergic Agents|adrenergic agents|mesh-ancestor
110732893|NCT05931601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110732894|NCT05931601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110732895|NCT05931601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110732896|NCT05931601|Sympathomimetics|sympathomimetics|mesh-ancestor
110732897|NCT05931601|Autonomic Agents|autonomic agents|mesh-ancestor
110732898|NCT05931601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110732899|NCT05931601|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110732900|NCT05931484|Gemfibrozil|gemfibrozil|mesh-list
110732901|NCT05931484|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110732902|NCT05931484|Antimetabolites|antimetabolites|mesh-ancestor
110732903|NCT05931484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110732904|NCT05931484|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110732905|NCT05931484|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
110732906|NCT05931484|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110732907|NCT05931484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110732908|NCT05931458|Infliximab|infliximab|mesh-list
110732909|NCT05931458|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110732910|NCT05931458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110732911|NCT05931458|Dermatologic Agents|dermatologic agents|mesh-ancestor
110732912|NCT05931458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110732913|NCT05931458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110732914|NCT05931393|Nivolumab|nivolumab|mesh-list
110732915|NCT05931393|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110732916|NCT05931393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110732917|NCT05931393|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110864389|NCT03747341|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110732918|NCT05931393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110732921|NCT05931328|Immunologic Factors|immunologic factors|mesh-ancestor
110732922|NCT05931328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110732923|NCT05931328|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110732924|NCT05931328|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110732925|NCT05931328|Growth Substances|growth substances|mesh-ancestor
110732926|NCT05931328|Growth Inhibitors|growth inhibitors|mesh-ancestor
110732927|NCT05931328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110732928|NCT05931328|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110732929|NCT05931328|Alkylating Agents|alkylating agents|mesh-ancestor
110732930|NCT05931328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110732931|NCT05931328|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110732932|NCT05931328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110732933|NCT05931302|FAPI-46|fapi-46|mesh-list
110732934|NCT05931302|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110732935|NCT05931302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110732936|NCT05931263|Cytarabine|cytarabine|mesh-list
110732937|NCT05931263|Carmustine|carmustine|mesh-list
110732938|NCT05931263|Melphalan|melphalan|mesh-list
110732939|NCT05931263|Etoposide|etoposide|mesh-list
110732940|NCT05931263|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110732941|NCT05931263|Alkylating Agents|alkylating agents|mesh-ancestor
110732942|NCT05931263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110732943|NCT05931263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110732944|NCT05931263|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110732945|NCT05931263|Antimetabolites|antimetabolites|mesh-ancestor
110732946|NCT05931263|Antiviral Agents|antiviral agents|mesh-ancestor
110732947|NCT05931263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110732948|NCT05931263|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110732949|NCT05931263|Immunologic Factors|immunologic factors|mesh-ancestor
110732950|NCT05931263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110732951|NCT05931263|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110732952|NCT05931263|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110732953|NCT05931263|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110732954|NCT05931263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110732955|NCT05931263|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110732956|NCT05931224|Antihypertensive Agents|antihypertensive agents|mesh-list
110732957|NCT05931042|Trastuzumab|trastuzumab|mesh-list
110732958|NCT05931042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110732959|NCT05931042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110732960|NCT05931029|Ubiquinone|ubiquinone|mesh-list
110732961|NCT05931029|Idebenone|idebenone|mesh-list
110732962|NCT05931029|Antioxidants|antioxidants|mesh-ancestor
110732963|NCT05931029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110732964|NCT05931029|Protective Agents|protective agents|mesh-ancestor
110732965|NCT05931029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110732966|NCT05931029|Micronutrients|micronutrients|mesh-ancestor
110732967|NCT05930938|Cetuximab|cetuximab|mesh-list
110732968|NCT05930938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110732969|NCT05930938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110732970|NCT05930912|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110732971|NCT05930912|Sertraline|sertraline|mesh-list
110732972|NCT05930912|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110732973|NCT05930912|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110732974|NCT05930912|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110732975|NCT05930912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110732976|NCT05930912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110732977|NCT05930912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110732978|NCT05930912|Analgesics|analgesics|mesh-ancestor
110732979|NCT05930912|Sensory System Agents|sensory system agents|mesh-ancestor
110732980|NCT05930912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110732981|NCT05930912|Antidepressive Agents|antidepressive agents|mesh-ancestor
110732982|NCT05930912|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110732983|NCT05930912|Dopamine Agents|dopamine agents|mesh-ancestor
110732984|NCT05930912|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110732985|NCT05930912|Serotonin Agents|serotonin agents|mesh-ancestor
110732986|NCT05930665|Bevacizumab|bevacizumab|mesh-list
110732987|NCT05930665|Carboplatin|carboplatin|mesh-list
110732988|NCT05930665|Pemetrexed|pemetrexed|mesh-list
110732989|NCT05930665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110732990|NCT05930665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110732991|NCT05930665|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110732992|NCT05930665|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110732993|NCT05930665|Growth Substances|growth substances|mesh-ancestor
110732994|NCT05930665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110732995|NCT05930665|Growth Inhibitors|growth inhibitors|mesh-ancestor
110732996|NCT05930665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110732997|NCT05930665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110732998|NCT05930665|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110143781|NCT02027454|Moxifloxacin|moxifloxacin|mesh-list
110732999|NCT05930665|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110733000|NCT05930613|Certolizumab Pegol|certolizumab pegol|mesh-list
110733001|NCT05930613|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110733002|NCT05930613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110733003|NCT05930613|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110733004|NCT05930613|Immunologic Factors|immunologic factors|mesh-ancestor
110733005|NCT05930613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110733006|NCT05930613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110733007|NCT05930405|Sufentanil|sufentanil|mesh-list
110733008|NCT05930405|Ropivacaine|ropivacaine|mesh-list
110733009|NCT05930405|Anesthetics, Local|anesthetics, local|mesh-ancestor
110733010|NCT05930405|Anesthetics|anesthetics|mesh-ancestor
110733011|NCT05930405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110733012|NCT05930405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110733013|NCT05930405|Sensory System Agents|sensory system agents|mesh-ancestor
110733014|NCT05930405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110733015|NCT05930405|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110733016|NCT05930405|Narcotics|narcotics|mesh-ancestor
110733017|NCT05930405|Analgesics|analgesics|mesh-ancestor
110733018|NCT05930405|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110733019|NCT05930405|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110733020|NCT05930405|Anesthetics, General|anesthetics, general|mesh-ancestor
110733021|NCT05930236|Methylprednisolone|methylprednisolone|mesh-list
110733022|NCT05930236|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110733023|NCT05930236|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110733024|NCT05930236|Prednisolone|prednisolone|mesh-list
110733025|NCT05930236|Prednisolone acetate|prednisolone acetate|mesh-list
110733026|NCT05930236|Lidocaine|lidocaine|mesh-list
110733027|NCT05930236|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110733028|NCT05930236|Prednisolone phosphate|prednisolone phosphate|mesh-list
110733029|NCT05930236|Anesthetics, Local|anesthetics, local|mesh-ancestor
110733030|NCT05930236|Anesthetics|anesthetics|mesh-ancestor
110733031|NCT05930236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110733032|NCT05930236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110733033|NCT05930236|Sensory System Agents|sensory system agents|mesh-ancestor
110733034|NCT05930236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110733035|NCT05930236|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110733036|NCT05930236|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110733037|NCT05930236|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110733038|NCT05930236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110733039|NCT05930236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110733040|NCT05930236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110733041|NCT05930236|Antiemetics|antiemetics|mesh-ancestor
110733042|NCT05930236|Autonomic Agents|autonomic agents|mesh-ancestor
110733043|NCT05930236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110733044|NCT05930236|Glucocorticoids|glucocorticoids|mesh-ancestor
110733045|NCT05930236|Hormones|hormones|mesh-ancestor
110733046|NCT05930236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110733047|NCT05930236|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110733048|NCT05930236|Protective Agents|protective agents|mesh-ancestor
110733049|NCT05930236|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110733050|NCT05930236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110733051|NCT05930171|Acetaminophen|acetaminophen|mesh-list
110733052|NCT05930171|Bupivacaine|bupivacaine|mesh-list
110733053|NCT05930171|Anesthetics, Local|anesthetics, local|mesh-ancestor
110733054|NCT05930171|Anesthetics|anesthetics|mesh-ancestor
110733055|NCT05930171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110733056|NCT05930171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110733058|NCT05930171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110733059|NCT05930171|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110733060|NCT05930171|Analgesics|analgesics|mesh-ancestor
110733061|NCT05930171|Antipyretics|antipyretics|mesh-ancestor
110733062|NCT05930080|Celecoxib|celecoxib|mesh-list
110733063|NCT05930080|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110733064|NCT05930080|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110733065|NCT05930080|Analgesics|analgesics|mesh-ancestor
110733066|NCT05930080|Sensory System Agents|sensory system agents|mesh-ancestor
110733067|NCT05930080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110733068|NCT05930080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110733069|NCT05930080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110733080|NCT05930002|Antimitotic Agents|antimitotic agents|mesh-ancestor
110733081|NCT05930002|Mitosis Modulators|mitosis modulators|mesh-ancestor
110733082|NCT05930002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110733083|NCT05930002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110733084|NCT05930002|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110733085|NCT05930002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110733086|NCT05929092|Cyclophosphamide|cyclophosphamide|mesh-list
110733087|NCT05929092|Busulfan|busulfan|mesh-list
110733088|NCT05929092|Fludarabine|fludarabine|mesh-list
110733089|NCT05929092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110733090|NCT05929092|Immunologic Factors|immunologic factors|mesh-ancestor
110733091|NCT05929092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110733092|NCT05929092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110733093|NCT05929092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110733094|NCT05929092|Alkylating Agents|alkylating agents|mesh-ancestor
110733095|NCT05929092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110733096|NCT05929092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110733097|NCT05929092|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110733098|NCT05928897|Disitamab vedotin|disitamab vedotin|mesh-list
110733099|NCT05928897|Immunoconjugates|immunoconjugates|mesh-ancestor
110733100|NCT05928897|Immunologic Factors|immunologic factors|mesh-ancestor
110733101|NCT05928897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110733112|NCT05925894|Anesthetics|anesthetics|mesh-list
110733113|NCT05925894|Mydriatics|mydriatics|mesh-list
110733114|NCT05925894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110733115|NCT05925894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110733116|NCT05925894|Autonomic Agents|autonomic agents|mesh-ancestor
110733117|NCT05925894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110733118|NCT05923086|Lidocaine|lidocaine|mesh-list
110733119|NCT05923086|Anesthetics, Local|anesthetics, local|mesh-ancestor
110733120|NCT05923086|Anesthetics|anesthetics|mesh-ancestor
110733121|NCT05923086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110733122|NCT05923086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110733123|NCT05923086|Sensory System Agents|sensory system agents|mesh-ancestor
110733124|NCT05923086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110733125|NCT05923086|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110733126|NCT05923086|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110733127|NCT05923086|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110733128|NCT05923086|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110733129|NCT05923086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110733130|NCT05909618|Nivolumab|nivolumab|mesh-list
110733131|NCT05909618|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110733132|NCT05909618|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110733134|NCT05909618|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110733135|NCT05909618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110733136|NCT05902117|Arginine Vasopressin|arginine vasopressin|mesh-list
110733137|NCT05902117|Hemostatics|hemostatics|mesh-ancestor
110733138|NCT05902117|Coagulants|coagulants|mesh-ancestor
110733139|NCT05902117|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110733140|NCT05902117|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
110864413|NCT03209908|Tenofovir|tenofovir|mesh-list
110733141|NCT05902117|Natriuretic Agents|natriuretic agents|mesh-ancestor
110143822|NCT02027792|Diclofenac|diclofenac|mesh-list
110733142|NCT05902117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110733143|NCT05899010|Progesterone|progesterone|mesh-list
110733144|NCT05899010|Progestins|progestins|mesh-ancestor
110733145|NCT05899010|Hormones|hormones|mesh-ancestor
110733148|NCT05894577|Montelukast|montelukast|mesh-list
110733149|NCT05894577|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110733150|NCT05894577|Respiratory System Agents|respiratory system agents|mesh-ancestor
110733151|NCT05894577|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110733152|NCT05894577|Hormone Antagonists|hormone antagonists|mesh-ancestor
110733153|NCT05894577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110733154|NCT05894577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110733155|NCT05894577|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110733156|NCT05894577|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110733157|NCT05894577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110733158|NCT05894564|Fluvoxamine|fluvoxamine|mesh-list
110733159|NCT05894564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110733160|NCT05894564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110733161|NCT05894564|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110733162|NCT05894564|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110733163|NCT05894564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110733164|NCT05894564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110733165|NCT05894564|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110733166|NCT05894564|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110733167|NCT05894564|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110733168|NCT05894564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110733169|NCT05894564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110733170|NCT05894564|Serotonin Agents|serotonin agents|mesh-ancestor
110733171|NCT05894564|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110733172|NCT05894564|Antidepressive Agents|antidepressive agents|mesh-ancestor
110733173|NCT05894564|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110733174|NCT05894564|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110733175|NCT05894564|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110733179|NCT05877573|Capecitabine|capecitabine|mesh-list
110733180|NCT05877573|Oxaliplatin|oxaliplatin|mesh-list
110733181|NCT05877573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110733182|NCT05877573|Antimetabolites|antimetabolites|mesh-ancestor
110733183|NCT05877573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110733184|NCT05877573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110733185|NCT05872542|Listerine|listerine|mesh-list
110733186|NCT05872542|Fluorides|fluorides|mesh-list
110733187|NCT05872542|Sodium Fluoride|sodium fluoride|mesh-list
110733188|NCT05872542|Fluorides, Topical|fluorides, topical|mesh-list
110733189|NCT05872542|Cariostatic Agents|cariostatic agents|mesh-ancestor
110733190|NCT05872542|Protective Agents|protective agents|mesh-ancestor
110733191|NCT05872542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110733192|NCT05872542|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110733193|NCT05872542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110733194|NCT05872425|Drospirenone|drospirenone|mesh-list
110733195|NCT05872425|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110733196|NCT05872425|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
110733197|NCT05872425|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110733198|NCT05872425|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110733199|NCT05872425|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110733200|NCT05872425|Contraceptive Agents|contraceptive agents|mesh-ancestor
110733201|NCT05872425|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110733202|NCT05872425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110733203|NCT05872425|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110733204|NCT05872425|Estrogens|estrogens|mesh-ancestor
110733205|NCT05872425|Hormones|hormones|mesh-ancestor
110143830|NCT02027792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110733206|NCT05872425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110733207|NCT05872425|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110733208|NCT05872425|Hormone Antagonists|hormone antagonists|mesh-ancestor
110733209|NCT05872425|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110733210|NCT05872425|Diuretics|diuretics|mesh-ancestor
110733211|NCT05872425|Natriuretic Agents|natriuretic agents|mesh-ancestor
110733212|NCT05870709|Valsartan|valsartan|mesh-list
110733213|NCT05870709|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
110733214|NCT05870709|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110733215|NCT05870709|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110733216|NCT05870709|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110733217|NCT05870709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110733218|NCT05870514|Propofol|propofol|mesh-list
110733219|NCT05870514|Fospropofol|fospropofol|mesh-list
110733220|NCT05870514|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110733221|NCT05870514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110733222|NCT05870514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110733223|NCT05870514|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110733224|NCT05870514|Anesthetics, General|anesthetics, general|mesh-ancestor
110733225|NCT05870514|Anesthetics|anesthetics|mesh-ancestor
110733226|NCT05851560|Hyaluronic Acid|hyaluronic acid|mesh-list
110733227|NCT05851560|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110733228|NCT05851560|Immunologic Factors|immunologic factors|mesh-ancestor
110733229|NCT05851560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110733230|NCT05851560|Viscosupplements|viscosupplements|mesh-ancestor
110733231|NCT05851560|Protective Agents|protective agents|mesh-ancestor
110733232|NCT05817240|Nintedanib|nintedanib|mesh-list
110733233|NCT05817240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110733234|NCT05817240|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110733235|NCT05817240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110733236|NCT05817240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110733237|NCT05810363|Propofol|propofol|mesh-list
110733238|NCT05810363|Etomidate|etomidate|mesh-list
110733239|NCT05810363|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110733240|NCT05810363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110733241|NCT05810363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110733242|NCT05810363|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110733243|NCT05810363|Anesthetics, General|anesthetics, general|mesh-ancestor
110733244|NCT05810363|Anesthetics|anesthetics|mesh-ancestor
110733245|NCT05804123|Acetylcysteine|acetylcysteine|mesh-list
110733246|NCT05804123|Ciprofloxacin|ciprofloxacin|mesh-list
110733247|NCT05804123|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
110733248|NCT05804123|Cefotaxime|cefotaxime|mesh-list
110733249|NCT05804123|Cefoxitin|cefoxitin|mesh-list
110733250|NCT05804123|Xylometazoline|xylometazoline|mesh-list
110733251|NCT05804123|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110733252|NCT05804123|Antiviral Agents|antiviral agents|mesh-ancestor
110733253|NCT05804123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110733254|NCT05804123|Expectorants|expectorants|mesh-ancestor
110733255|NCT05804123|Respiratory System Agents|respiratory system agents|mesh-ancestor
110733256|NCT05804123|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110733257|NCT05804123|Antioxidants|antioxidants|mesh-ancestor
110733258|NCT05804123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110733259|NCT05804123|Protective Agents|protective agents|mesh-ancestor
110733260|NCT05804123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110733261|NCT05804123|Antidotes|antidotes|mesh-ancestor
110733262|NCT05804123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110733263|NCT05804123|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110733264|NCT05804123|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110733265|NCT05804123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110733266|NCT05804123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110733267|NCT05804123|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110733268|NCT05804123|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110733269|NCT05804123|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110733270|NCT05804123|Nasal Decongestants|nasal decongestants|mesh-ancestor
110733271|NCT05804123|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110733272|NCT05803148|Midodrine|midodrine|mesh-list
110733273|NCT05803148|Sympathomimetics|sympathomimetics|mesh-ancestor
110733274|NCT05803148|Autonomic Agents|autonomic agents|mesh-ancestor
110733275|NCT05803148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110733276|NCT05803148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110733277|NCT05803148|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110733278|NCT05803148|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110733279|NCT05803148|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110733280|NCT05803148|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110733281|NCT05803148|Adrenergic Agents|adrenergic agents|mesh-ancestor
110733282|NCT05803148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110444573|NCT02784340|Anesthetics|anesthetics|mesh-ancestor
110733283|NCT05803148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110733284|NCT05802849|Acetazolamide|acetazolamide|mesh-list
110733285|NCT05802849|Anticonvulsants|anticonvulsants|mesh-ancestor
110733286|NCT05802849|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110733287|NCT05802849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110733288|NCT05802849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110733289|NCT05802849|Diuretics|diuretics|mesh-ancestor
110451044|NCT01107353|Imipramine|imipramine|mesh-list
110733290|NCT05802849|Natriuretic Agents|natriuretic agents|mesh-ancestor
110733291|NCT05802849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110733292|NCT05785832|Insulin|insulin|mesh-list
110733305|NCT05773664|Glucocorticoids|glucocorticoids|mesh-ancestor
110733306|NCT05773664|Hormones|hormones|mesh-ancestor
110733307|NCT05773664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110733308|NCT05773664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110733309|NCT05773664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110733310|NCT05773664|Protease Inhibitors|protease inhibitors|mesh-ancestor
110733311|NCT05773664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110733312|NCT05773664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110733313|NCT05773664|Dermatologic Agents|dermatologic agents|mesh-ancestor
110733326|NCT05748366|Analgesics|analgesics|mesh-list
110733327|NCT05748366|Sensory System Agents|sensory system agents|mesh-ancestor
110733328|NCT05748366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110733329|NCT05748366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110733330|NCT05738161|Cisplatin|cisplatin|mesh-list
110733331|NCT05738161|Gemcitabine|gemcitabine|mesh-list
110733332|NCT05738161|Magrolimab|magrolimab|mesh-list
110733333|NCT05738161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110733334|NCT05738161|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110733335|NCT05738161|Antimetabolites|antimetabolites|mesh-ancestor
110733336|NCT05738161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110733337|NCT05738161|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110733338|NCT05732701|Oxymetazoline|oxymetazoline|mesh-list
110733339|NCT05732701|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110733340|NCT05732701|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110733341|NCT05732701|Adrenergic Agents|adrenergic agents|mesh-ancestor
110733342|NCT05732701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110733343|NCT05732701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110733344|NCT05732701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110733345|NCT05732701|Sympathomimetics|sympathomimetics|mesh-ancestor
110733346|NCT05732701|Autonomic Agents|autonomic agents|mesh-ancestor
110733347|NCT05732701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110733348|NCT05732701|Nasal Decongestants|nasal decongestants|mesh-ancestor
110733349|NCT05732701|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110733350|NCT05732701|Respiratory System Agents|respiratory system agents|mesh-ancestor
110733351|NCT05723055|Nivolumab|nivolumab|mesh-list
110733352|NCT05723055|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110733353|NCT05723055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110733354|NCT05723055|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110733355|NCT05723055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110733356|NCT05709977|Histamine Antagonists|histamine antagonists|mesh-list
110733357|NCT05709977|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
110733358|NCT05709977|Histamine Agents|histamine agents|mesh-ancestor
110733359|NCT05709977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110733360|NCT05709977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110733361|NCT05709977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110733362|NCT05709821|Pembrolizumab|pembrolizumab|mesh-list
110733363|NCT05709821|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110733364|NCT05709821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110733365|NCT05709821|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110733366|NCT05709821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110451114|NCT01112267|Antipyretics|antipyretics|mesh-ancestor
110733367|NCT05705804|Atorvastatin|atorvastatin|mesh-list
110733368|NCT05705804|Pitavastatin|pitavastatin|mesh-list
110733369|NCT05705804|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110864435|NCT03224338|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110733370|NCT05705804|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110733371|NCT05705804|Antimetabolites|antimetabolites|mesh-ancestor
110733372|NCT05705804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110733373|NCT05705804|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110733374|NCT05705804|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110733375|NCT05705804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110733376|NCT05703659|Sulfalene|sulfalene|mesh-list
110733377|NCT05703659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110733378|NCT05703659|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110733379|NCT05703659|Antimalarials|antimalarials|mesh-ancestor
110733380|NCT05703659|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110733381|NCT05703659|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110733382|NCT05701189|Immunoglobulins|immunoglobulins|mesh-list
110733383|NCT05701189|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110733384|NCT05701189|Antibodies|antibodies|mesh-list
110733385|NCT05701189|gamma-Globulins|gamma-globulins|mesh-list
110733386|NCT05701189|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110733387|NCT05701189|Immunologic Factors|immunologic factors|mesh-ancestor
110733388|NCT05701189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110733389|NCT05649722|Treprostinil|treprostinil|mesh-list
110733390|NCT05649722|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110733391|NCT05636787|Melphalan|melphalan|mesh-list
110733392|NCT05636787|Treosulfan|treosulfan|mesh-list
110733393|NCT05636787|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110733394|NCT05636787|Alkylating Agents|alkylating agents|mesh-ancestor
110733395|NCT05636787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110733396|NCT05636787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110733397|NCT05636787|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110733398|NCT05636787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110733399|NCT05636787|Immunologic Factors|immunologic factors|mesh-ancestor
110733400|NCT05636787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110733401|NCT05635162|Rituximab|rituximab|mesh-list
110733402|NCT05635162|Zanubrutinib|zanubrutinib|mesh-list
110733403|NCT05635162|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110733404|NCT05635162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110733405|NCT05635162|Immunologic Factors|immunologic factors|mesh-ancestor
110733406|NCT05635162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110733407|NCT05635162|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110733408|NCT05635162|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110733409|NCT05635162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110733410|NCT05635162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110733411|NCT05631912|Cyclophosphamide|cyclophosphamide|mesh-list
110733412|NCT05631912|Fludarabine|fludarabine|mesh-list
110733413|NCT05631912|Fludarabine phosphate|fludarabine phosphate|mesh-list
110733414|NCT05631912|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110733415|NCT05631912|Immunologic Factors|immunologic factors|mesh-ancestor
110733416|NCT05631912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110733417|NCT05631912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110733418|NCT05631912|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110733419|NCT05631912|Alkylating Agents|alkylating agents|mesh-ancestor
110733420|NCT05631912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110733421|NCT05631912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110733422|NCT05631912|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110733423|NCT05631912|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110733424|NCT05631912|Antimetabolites|antimetabolites|mesh-ancestor
110733425|NCT05627557|Acetaminophen|acetaminophen|mesh-list
110733426|NCT05627557|Diphenhydramine|diphenhydramine|mesh-list
110733427|NCT05627557|Promethazine|promethazine|mesh-list
110733428|NCT05627557|Prednisone|prednisone|mesh-list
110733429|NCT05627557|Methylprednisolone|methylprednisolone|mesh-list
110733430|NCT05627557|Obinutuzumab|obinutuzumab|mesh-list
110733431|NCT05627557|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110733432|NCT05627557|Glucocorticoids|glucocorticoids|mesh-ancestor
110733433|NCT05627557|Hormones|hormones|mesh-ancestor
110733434|NCT05627557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110733435|NCT05627557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110733436|NCT05627557|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110733437|NCT05627557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110733438|NCT05627557|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110733439|NCT05627557|Analgesics|analgesics|mesh-ancestor
110733440|NCT05627557|Sensory System Agents|sensory system agents|mesh-ancestor
110733441|NCT05627557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110733442|NCT05627557|Antipyretics|antipyretics|mesh-ancestor
110451237|NCT02705872|Dsuvia|dsuvia|mesh-list
110733443|NCT05627557|Antiemetics|antiemetics|mesh-ancestor
110733445|NCT05627557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110733447|NCT05627557|Protective Agents|protective agents|mesh-ancestor
110733448|NCT05627557|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110733449|NCT05627557|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110733450|NCT05627557|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110733451|NCT05627557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110733452|NCT05627557|Anesthetics, Local|anesthetics, local|mesh-ancestor
110733453|NCT05627557|Anesthetics|anesthetics|mesh-ancestor
110733454|NCT05627557|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110733455|NCT05627557|Histamine Antagonists|histamine antagonists|mesh-ancestor
110143904|NCT02028403|BMS-936559|bms-936559|mesh-list
110733456|NCT05627557|Histamine Agents|histamine agents|mesh-ancestor
110733457|NCT05627557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110733458|NCT05627557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110733459|NCT05627557|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110733460|NCT05627557|Antipruritics|antipruritics|mesh-ancestor
110733461|NCT05627557|Dermatologic Agents|dermatologic agents|mesh-ancestor
110733466|NCT05615948|Ketamine|ketamine|mesh-list
110733467|NCT05615948|Analgesics|analgesics|mesh-ancestor
110733468|NCT05615948|Sensory System Agents|sensory system agents|mesh-ancestor
110733469|NCT05615948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110733470|NCT05615948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110733471|NCT05615948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110733472|NCT05615948|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110733473|NCT05615948|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110733474|NCT05615948|Anesthetics, General|anesthetics, general|mesh-ancestor
110733475|NCT05615948|Anesthetics|anesthetics|mesh-ancestor
110733476|NCT05615948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110733477|NCT05615948|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110733478|NCT05615948|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110733479|NCT05615948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110733480|NCT05614349|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
110733481|NCT05614349|Antiviral Agents|antiviral agents|mesh-ancestor
110733482|NCT05614349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110733483|NCT05595460|Carboplatin|carboplatin|mesh-list
110733484|NCT05595460|Etoposide|etoposide|mesh-list
110733485|NCT05595460|Atezolizumab|atezolizumab|mesh-list
110733486|NCT05595460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110733487|NCT05595460|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110733488|NCT05595460|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110733489|NCT05595460|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110733490|NCT05595460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110733491|NCT05595460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110733492|NCT05595460|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110733493|NCT05595460|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110733494|NCT05594667|Psilocybin|psilocybin|mesh-list
110733495|NCT05594667|Hallucinogens|hallucinogens|mesh-ancestor
110733496|NCT05594667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110733497|NCT05594667|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110733498|NCT05589818|Pembrolizumab|pembrolizumab|mesh-list
110733499|NCT05589818|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110733500|NCT05589818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110733501|NCT05589818|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110733502|NCT05589818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110733503|NCT05573360|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110733504|NCT05573360|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110733505|NCT05571319|Metformin|metformin|mesh-list
110733506|NCT05571319|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110733507|NCT05571319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110733508|NCT05545072|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110733509|NCT05545072|Immunologic Factors|immunologic factors|mesh-ancestor
110733510|NCT05545072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110733511|NCT05542615|Pirfenidone|pirfenidone|mesh-list
110733512|NCT05542615|Analgesics|analgesics|mesh-ancestor
110733513|NCT05542615|Sensory System Agents|sensory system agents|mesh-ancestor
110733514|NCT05542615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110733515|NCT05542615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110733516|NCT05542615|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110733522|NCT05532163|Immunologic Factors|immunologic factors|mesh-ancestor
110733523|NCT05532163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110733524|NCT05510141|Nitrous Oxide|nitrous oxide|mesh-list
110733525|NCT05510141|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110733526|NCT05510141|Anesthetics, General|anesthetics, general|mesh-ancestor
110733527|NCT05510141|Anesthetics|anesthetics|mesh-ancestor
110733528|NCT05510141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110143921|NCT02028494|Capecitabine|capecitabine|mesh-list
110733529|NCT05510141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110733530|NCT05510141|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110733531|NCT05510141|Analgesics|analgesics|mesh-ancestor
110733532|NCT05510141|Sensory System Agents|sensory system agents|mesh-ancestor
110733533|NCT05510141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110733539|NCT05501600|Lidocaine|lidocaine|mesh-list
110733540|NCT05501600|Anesthetics, Local|anesthetics, local|mesh-ancestor
110733541|NCT05501600|Anesthetics|anesthetics|mesh-ancestor
110733542|NCT05501600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110733543|NCT05501600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110733544|NCT05501600|Sensory System Agents|sensory system agents|mesh-ancestor
110733545|NCT05501600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110733546|NCT05501600|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110733547|NCT05501600|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110733548|NCT05501600|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110733549|NCT05501600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110733550|NCT05501600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110733551|NCT05501548|Ascorbic Acid|ascorbic acid|mesh-list
110733552|NCT05501548|Olaparib|olaparib|mesh-list
110733553|NCT05501548|Vitamins|vitamins|mesh-ancestor
110733554|NCT05501548|Micronutrients|micronutrients|mesh-ancestor
110733555|NCT05501548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110733556|NCT05501548|Antioxidants|antioxidants|mesh-ancestor
110733557|NCT05501548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110733558|NCT05501548|Protective Agents|protective agents|mesh-ancestor
110733559|NCT05501548|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110733560|NCT05501548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110733561|NCT05501548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110733562|NCT05498155|Durvalumab|durvalumab|mesh-list
110733563|NCT05498155|Olaparib|olaparib|mesh-list
110733564|NCT05498155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110733565|NCT05498155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110733566|NCT05498155|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110733567|NCT05498155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110733568|NCT05498155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110733569|NCT05457933|Dapagliflozin|dapagliflozin|mesh-list
110733570|NCT05457933|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110733571|NCT05457933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110733572|NCT05457933|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110733573|NCT05457933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110733574|NCT05455424|Niraparib|niraparib|mesh-list
110733575|NCT05455424|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110733576|NCT05455424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110733577|NCT05455424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110733578|NCT05455424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110733579|NCT05444543|Fluticasone|fluticasone|mesh-list
110733581|NCT05444543|Budesonide|budesonide|mesh-list
110733582|NCT05444543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110733583|NCT05444543|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110733584|NCT05444543|Autonomic Agents|autonomic agents|mesh-ancestor
110733585|NCT05444543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110733586|NCT05444543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110733587|NCT05444543|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110733588|NCT05444543|Respiratory System Agents|respiratory system agents|mesh-ancestor
110733589|NCT05444543|Dermatologic Agents|dermatologic agents|mesh-ancestor
110733590|NCT05444543|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110451353|NCT02700022|Hormones|hormones|mesh-ancestor
110733591|NCT05444543|Glucocorticoids|glucocorticoids|mesh-ancestor
110733593|NCT05444543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110733595|NCT05443971|Immunoglobulins|immunoglobulins|mesh-list
110733596|NCT05443971|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110733597|NCT05443971|Immunoglobulin G|immunoglobulin g|mesh-list
110733598|NCT05443971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110733599|NCT05443971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110733600|NCT05443971|Immunologic Factors|immunologic factors|mesh-ancestor
110733601|NCT05443971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110733602|NCT05431270|Antibodies|antibodies|mesh-list
110733603|NCT05431270|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110733604|NCT05431270|Immunologic Factors|immunologic factors|mesh-ancestor
110733605|NCT05431270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110733606|NCT05421741|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110733607|NCT05421741|Vancomycin|vancomycin|mesh-list
110733608|NCT05421741|Gentamicins|gentamicins|mesh-list
110733609|NCT05421741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110733610|NCT05421741|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110733611|NCT05421741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110733612|NCT05421741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110733613|NCT05416658|Antipsychotic Agents|antipsychotic agents|mesh-list
110733614|NCT05416658|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110733615|NCT05416658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110733616|NCT05416658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110733617|NCT05416658|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110733618|NCT05416021|Dapivirine|dapivirine|mesh-list
110733619|NCT05416021|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110733620|NCT05416021|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110733621|NCT05416021|Antiviral Agents|antiviral agents|mesh-ancestor
110733622|NCT05416021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110733623|NCT05393271|Midazolam|midazolam|mesh-list
110733624|NCT05393271|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110733625|NCT05393271|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110733626|NCT05393271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110733627|NCT05393271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110733628|NCT05393271|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110733629|NCT05393271|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110733630|NCT05393271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110733631|NCT05393271|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110733632|NCT05393271|Anesthetics, General|anesthetics, general|mesh-ancestor
110733633|NCT05393271|Anesthetics|anesthetics|mesh-ancestor
110733634|NCT05393271|GABA Modulators|gaba modulators|mesh-ancestor
110733635|NCT05393271|GABA Agents|gaba agents|mesh-ancestor
110733636|NCT05393271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110733637|NCT05393271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110733638|NCT05388487|Complement Factor H|complement factor h|mesh-list
110733639|NCT05388487|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
110733640|NCT05388487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110733641|NCT05388487|Immunologic Factors|immunologic factors|mesh-ancestor
110733642|NCT05388487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110733643|NCT05388058|Cannabidiol|cannabidiol|mesh-list
110733644|NCT05388058|Anticonvulsants|anticonvulsants|mesh-ancestor
110733645|NCT05374525|Cabotegravir|cabotegravir|mesh-list
110733646|NCT05374525|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110733647|NCT05374525|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110733648|NCT05374525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110733649|NCT05374525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110733650|NCT05374525|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110733651|NCT05374525|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110733652|NCT05374525|Antiviral Agents|antiviral agents|mesh-ancestor
110733653|NCT05374525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110733654|NCT05363553|Caseins|caseins|mesh-list
110733655|NCT05363553|Chelating Agents|chelating agents|mesh-ancestor
110733656|NCT05363553|Sequestering Agents|sequestering agents|mesh-ancestor
110733657|NCT05363553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110733658|NCT05332561|Trastuzumab|trastuzumab|mesh-list
110733659|NCT05332561|Atezolizumab|atezolizumab|mesh-list
110733660|NCT05332561|Pertuzumab|pertuzumab|mesh-list
110733661|NCT05332561|Olaparib|olaparib|mesh-list
110733662|NCT05332561|Ipatasertib|ipatasertib|mesh-list
110733663|NCT05332561|Inavolisib|inavolisib|mesh-list
110733664|NCT05332561|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
110733665|NCT05332561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110733666|NCT05332561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110733667|NCT05332561|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110733668|NCT05332561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110733669|NCT05332561|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110733670|NCT05332561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110733671|NCT05332561|Immunoconjugates|immunoconjugates|mesh-ancestor
110733672|NCT05332561|Immunologic Factors|immunologic factors|mesh-ancestor
110733673|NCT05332561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110733674|NCT05332561|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110733675|NCT05332561|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
110733676|NCT05303935|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110733677|NCT05303935|Antidepressive Agents|antidepressive agents|mesh-ancestor
110733678|NCT05303935|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110733679|NCT05303935|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110733680|NCT05303935|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110733681|NCT05303935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110733682|NCT05303935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110733683|NCT05298449|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
110733684|NCT05298449|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110733685|NCT05298449|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110733686|NCT05298449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110733687|NCT05298449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110733688|NCT05298449|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110733689|NCT05298449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110733690|NCT05298449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110733691|NCT05298449|Cholinergic Agents|cholinergic agents|mesh-ancestor
110733692|NCT05298449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110733694|NCT05296837|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110733695|NCT05296837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110733697|NCT05296837|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110733698|NCT05296837|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110733699|NCT05291130|Vitamin E|vitamin e|mesh-list
110733700|NCT05291130|Vitamins|vitamins|mesh-ancestor
110733701|NCT05291130|Micronutrients|micronutrients|mesh-ancestor
110733702|NCT05291130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110733703|NCT05291130|Antioxidants|antioxidants|mesh-ancestor
110733704|NCT05291130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110733705|NCT05291130|Protective Agents|protective agents|mesh-ancestor
110733706|NCT05280769|Lobeline|lobeline|mesh-list
110733707|NCT05280769|Nicotine|nicotine|mesh-list
110733708|NCT05280769|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110733709|NCT05280769|Autonomic Agents|autonomic agents|mesh-ancestor
110733710|NCT05280769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110733711|NCT05280769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110733712|NCT05280769|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110733713|NCT05280769|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110733714|NCT05280769|Cholinergic Agents|cholinergic agents|mesh-ancestor
110733715|NCT05280769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110733716|NCT05280769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110733717|NCT05280769|Respiratory System Agents|respiratory system agents|mesh-ancestor
110733718|NCT05252390|Olaparib|olaparib|mesh-list
110733719|NCT05252390|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110733720|NCT05252390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110733721|NCT05252390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110733722|NCT05252390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110733723|NCT05243797|Lenalidomide|lenalidomide|mesh-list
110733724|NCT05243797|Immunologic Factors|immunologic factors|mesh-ancestor
110733725|NCT05243797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110733726|NCT05243797|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110733727|NCT05243797|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110733728|NCT05243797|Growth Substances|growth substances|mesh-ancestor
110733729|NCT05243797|Growth Inhibitors|growth inhibitors|mesh-ancestor
110864467|NCT03206944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110733730|NCT05243797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110733731|NCT05206266|Turmeric extract|turmeric extract|mesh-list
110733732|NCT05206266|Antioxidants|antioxidants|mesh-ancestor
110733733|NCT05206266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110733734|NCT05206266|Protective Agents|protective agents|mesh-ancestor
110733735|NCT05206266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110733736|NCT05188898|Hyaluronic Acid|hyaluronic acid|mesh-list
110733737|NCT05188898|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110733738|NCT05188898|Immunologic Factors|immunologic factors|mesh-ancestor
110733739|NCT05188898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110733740|NCT05188898|Viscosupplements|viscosupplements|mesh-ancestor
110444587|NCT01094808|Pregabalin|pregabalin|mesh-list
110733741|NCT05188898|Protective Agents|protective agents|mesh-ancestor
110733742|NCT05169268|Aripiprazole|aripiprazole|mesh-list
110733743|NCT05169268|Brexpiprazole|brexpiprazole|mesh-list
110733744|NCT05169268|Antidepressive Agents|antidepressive agents|mesh-ancestor
110733745|NCT05169268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110733746|NCT05169268|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110733747|NCT05169268|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110733748|NCT05169268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110733749|NCT05169268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110733750|NCT05169268|Dopamine Agonists|dopamine agonists|mesh-ancestor
110733751|NCT05169268|Dopamine Agents|dopamine agents|mesh-ancestor
110733752|NCT05169268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110733753|NCT05169268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110733754|NCT05169268|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110733755|NCT05169268|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110733756|NCT05169268|Serotonin Agents|serotonin agents|mesh-ancestor
110733757|NCT05169268|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110733758|NCT05169268|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110733759|NCT05169268|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110733760|NCT05169268|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110733761|NCT05166746|Clindamycin|clindamycin|mesh-list
110733762|NCT05166746|Clindamycin palmitate|clindamycin palmitate|mesh-list
110733763|NCT05166746|Clindamycin phosphate|clindamycin phosphate|mesh-list
110733764|NCT05166746|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110733765|NCT05166746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110733766|NCT05166746|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110733767|NCT05166746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110733768|NCT05166746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110733769|NCT05160298|Ropivacaine|ropivacaine|mesh-list
110733770|NCT05160298|Anesthetics, Local|anesthetics, local|mesh-ancestor
110733771|NCT05160298|Anesthetics|anesthetics|mesh-ancestor
110733772|NCT05160298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110733773|NCT05160298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110733774|NCT05160298|Sensory System Agents|sensory system agents|mesh-ancestor
110733775|NCT05160298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110733776|NCT05155579|Vaccines|vaccines|mesh-list
110733777|NCT05155579|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110733778|NCT05155579|Immunologic Factors|immunologic factors|mesh-ancestor
110733779|NCT05155579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110733780|NCT05145400|Dexamethasone|dexamethasone|mesh-list
110733781|NCT05145400|Lenalidomide|lenalidomide|mesh-list
110733782|NCT05145400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110733783|NCT05145400|Antiemetics|antiemetics|mesh-ancestor
110733784|NCT05145400|Autonomic Agents|autonomic agents|mesh-ancestor
110733785|NCT05145400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110143969|NCT02028598|Serotonin Agents|serotonin agents|mesh-ancestor
110733786|NCT05145400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110733787|NCT05145400|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110733788|NCT05145400|Glucocorticoids|glucocorticoids|mesh-ancestor
110733789|NCT05145400|Hormones|hormones|mesh-ancestor
110733790|NCT05145400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110733791|NCT05145400|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110733792|NCT05145400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110733793|NCT05145400|Immunologic Factors|immunologic factors|mesh-ancestor
110733794|NCT05145400|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110733795|NCT05145400|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110733796|NCT05145400|Growth Substances|growth substances|mesh-ancestor
110733797|NCT05145400|Growth Inhibitors|growth inhibitors|mesh-ancestor
110733799|NCT05143281|Dexamethasone acetate|dexamethasone acetate|mesh-list
110733800|NCT05143281|BB 1101|bb 1101|mesh-list
110733801|NCT05143281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110733802|NCT05143281|Antiemetics|antiemetics|mesh-ancestor
110733803|NCT05143281|Autonomic Agents|autonomic agents|mesh-ancestor
110733804|NCT05143281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110733805|NCT05143281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110733806|NCT05143281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110733807|NCT05143281|Glucocorticoids|glucocorticoids|mesh-ancestor
110733808|NCT05143281|Hormones|hormones|mesh-ancestor
110733809|NCT05143281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110733810|NCT05143281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110733811|NCT05143281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110733812|NCT05143281|Protease Inhibitors|protease inhibitors|mesh-ancestor
110733813|NCT05143281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110733814|NCT05143281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110733816|NCT05117710|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110733817|NCT05117710|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110733818|NCT05117710|Analgesics|analgesics|mesh-ancestor
110733824|NCT05117710|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110733825|NCT05117710|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110733826|NCT05117710|Antioxidants|antioxidants|mesh-ancestor
110733827|NCT05117710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110733828|NCT05117710|Protective Agents|protective agents|mesh-ancestor
110733829|NCT05117710|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110733830|NCT05117710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110733831|NCT05117710|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110733832|NCT05114746|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
110733833|NCT05114746|177Lu-PSMA-617|177lu-psma-617|mesh-list
110733834|NCT05114746|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110733835|NCT05114746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110733836|NCT05106192|Triamcinolone|triamcinolone|mesh-list
110733837|NCT05106192|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110733838|NCT05106192|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110733839|NCT05106192|Mechlorethamine|mechlorethamine|mesh-list
110733840|NCT05106192|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
110733841|NCT05106192|Bexarotene|bexarotene|mesh-list
110733842|NCT05106192|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110733843|NCT05106192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110733844|NCT05106192|Glucocorticoids|glucocorticoids|mesh-ancestor
110733845|NCT05106192|Hormones|hormones|mesh-ancestor
110733846|NCT05106192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110733847|NCT05106192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110733848|NCT05106192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110733849|NCT05106192|Immunologic Factors|immunologic factors|mesh-ancestor
110733850|NCT05106192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110733851|NCT05106192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110733852|NCT05106192|Alkylating Agents|alkylating agents|mesh-ancestor
110733853|NCT05106192|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110733854|NCT05106192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110733855|NCT05105022|Propofol|propofol|mesh-list
110733856|NCT05105022|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110733857|NCT05105022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110733858|NCT05105022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110733859|NCT05105022|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110733860|NCT05105022|Anesthetics, General|anesthetics, general|mesh-ancestor
110733861|NCT05105022|Anesthetics|anesthetics|mesh-ancestor
110733867|NCT05099718|Hyaluronic Acid|hyaluronic acid|mesh-list
110733868|NCT05099718|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110733869|NCT05099718|Immunologic Factors|immunologic factors|mesh-ancestor
110733870|NCT05099718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110733871|NCT05099718|Viscosupplements|viscosupplements|mesh-ancestor
110733872|NCT05099718|Protective Agents|protective agents|mesh-ancestor
110733873|NCT05096468|Pregabalin|pregabalin|mesh-list
110733874|NCT05096468|Ketamine|ketamine|mesh-list
110733875|NCT05096468|Esketamine|esketamine|mesh-list
110733876|NCT05096468|Analgesics|analgesics|mesh-ancestor
110733877|NCT05096468|Sensory System Agents|sensory system agents|mesh-ancestor
110733878|NCT05096468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110733879|NCT05096468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110733880|NCT05096468|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110733881|NCT05096468|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110733882|NCT05096468|Anesthetics, General|anesthetics, general|mesh-ancestor
110733883|NCT05096468|Anesthetics|anesthetics|mesh-ancestor
110733884|NCT05096468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110733885|NCT05096468|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110733886|NCT05096468|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110733887|NCT05096468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110444600|NCT01094808|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110733888|NCT05096468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110733889|NCT05096468|Anticonvulsants|anticonvulsants|mesh-ancestor
110733890|NCT05096468|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110733891|NCT05096468|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110733892|NCT05096468|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110733893|NCT05096468|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110733894|NCT05096468|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110733895|NCT05096468|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110733896|NCT05096468|Antidepressive Agents|antidepressive agents|mesh-ancestor
110733898|NCT05085028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110733899|NCT05085028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110733900|NCT05085028|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110733901|NCT05085028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110733902|NCT05084365|Sulforaphane|sulforaphane|mesh-list
110733903|NCT05084365|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110733904|NCT05084365|Protective Agents|protective agents|mesh-ancestor
110733905|NCT05084365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110733906|NCT05084365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110733907|NCT05079789|Amiloride|amiloride|mesh-list
110733908|NCT05079789|Furosemide|furosemide|mesh-list
110733909|NCT05079789|Diuretics|diuretics|mesh-ancestor
110733910|NCT05079789|Natriuretic Agents|natriuretic agents|mesh-ancestor
110733911|NCT05079789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110733912|NCT05079789|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110733913|NCT05079789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110733914|NCT05079789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110733915|NCT05079789|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
110733916|NCT05079789|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110733917|NCT05079789|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
110733918|NCT05079789|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110733919|NCT05025423|Venetoclax|venetoclax|mesh-list
110733920|NCT05025423|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110733921|NCT05025423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110733922|NCT05025423|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110733923|NCT05025423|Alkylating Agents|alkylating agents|mesh-ancestor
110733924|NCT05025423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110733925|NCT05023993|Niacinamide|niacinamide|mesh-list
110733926|NCT05023993|Niacin|niacin|mesh-list
110733927|NCT05023993|Nicotinic Acids|nicotinic acids|mesh-list
110733928|NCT05023993|Vitamin B Complex|vitamin b complex|mesh-ancestor
110733929|NCT05023993|Vitamins|vitamins|mesh-ancestor
110733930|NCT05023993|Micronutrients|micronutrients|mesh-ancestor
110733931|NCT05023993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110733932|NCT05023993|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110733933|NCT05023993|Antimetabolites|antimetabolites|mesh-ancestor
110733934|NCT05023993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110733935|NCT05023993|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110733936|NCT05023993|Vasodilator Agents|vasodilator agents|mesh-ancestor
110733937|NCT05021926|Lidocaine|lidocaine|mesh-list
110733938|NCT05021926|Hyaluronic Acid|hyaluronic acid|mesh-list
110733939|NCT05021926|Anesthetics, Local|anesthetics, local|mesh-ancestor
110733940|NCT05021926|Anesthetics|anesthetics|mesh-ancestor
110733941|NCT05021926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110733942|NCT05021926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110733943|NCT05021926|Sensory System Agents|sensory system agents|mesh-ancestor
110864488|NCT03209206|Docetaxel|docetaxel|mesh-list
110733944|NCT05021926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110733945|NCT05021926|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110733946|NCT05021926|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110733947|NCT05021926|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110733948|NCT05021926|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110733949|NCT05021926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110733950|NCT05021926|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110733951|NCT05021926|Immunologic Factors|immunologic factors|mesh-ancestor
110733952|NCT05021926|Viscosupplements|viscosupplements|mesh-ancestor
110733953|NCT05021926|Protective Agents|protective agents|mesh-ancestor
110733955|NCT05021913|Hyaluronic Acid|hyaluronic acid|mesh-list
110733956|NCT05021913|Anesthetics, Local|anesthetics, local|mesh-ancestor
110733957|NCT05021913|Anesthetics|anesthetics|mesh-ancestor
110733958|NCT05021913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110733959|NCT05021913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110733960|NCT05021913|Sensory System Agents|sensory system agents|mesh-ancestor
110733961|NCT05021913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110733962|NCT05021913|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110733963|NCT05021913|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110733964|NCT05021913|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110733965|NCT05021913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110733966|NCT05021913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110451728|NCT02612545|Artenimol|artenimol|mesh-list
110733967|NCT05021913|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110733968|NCT05021913|Immunologic Factors|immunologic factors|mesh-ancestor
110733970|NCT05021913|Protective Agents|protective agents|mesh-ancestor
110733971|NCT04999241|Infliximab|infliximab|mesh-list
110733972|NCT04999241|Mesalamine|mesalamine|mesh-list
110733973|NCT04999241|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110733974|NCT04999241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110733975|NCT04999241|Dermatologic Agents|dermatologic agents|mesh-ancestor
110733976|NCT04999241|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110733977|NCT04999241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110733978|NCT04999241|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110733979|NCT04999241|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110733980|NCT04999241|Analgesics|analgesics|mesh-ancestor
110733981|NCT04999241|Sensory System Agents|sensory system agents|mesh-ancestor
110733982|NCT04999241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110733983|NCT04999241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110733984|NCT04992065|Evolocumab|evolocumab|mesh-list
110733985|NCT04992065|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
110733986|NCT04992065|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110733987|NCT04992065|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110733988|NCT04992065|Antimetabolites|antimetabolites|mesh-ancestor
110733989|NCT04992065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110733990|NCT04992065|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110733991|NCT04992065|Protease Inhibitors|protease inhibitors|mesh-ancestor
110733992|NCT04992065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110733993|NCT04992065|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110733994|NCT04965090|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
110733995|NCT04965090|Lazertinib|lazertinib|mesh-list
110733996|NCT04965090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110733997|NCT04965090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110733998|NCT04965090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110733999|NCT04965090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110734000|NCT04965090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110734001|NCT04906902|Acalabrutinib|acalabrutinib|mesh-list
110734002|NCT04906902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110734003|NCT04906096|GDC-0084|gdc-0084|mesh-list
110734004|NCT04906096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110734005|NCT04906096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110734006|NCT04901494|Serotonin|serotonin|mesh-list
110734007|NCT04901494|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
110734008|NCT04901494|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110734009|NCT04901494|Serotonin Agents|serotonin agents|mesh-ancestor
110734010|NCT04901494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110734011|NCT04901494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110734012|NCT04901494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110734013|NCT04901494|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110734014|NCT04901494|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110734015|NCT04898114|Magnesium Sulfate|magnesium sulfate|mesh-list
110734016|NCT04898114|Sildenafil Citrate|sildenafil citrate|mesh-list
110734017|NCT04898114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110734018|NCT04898114|Vasodilator Agents|vasodilator agents|mesh-ancestor
110734019|NCT04898114|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110734020|NCT04898114|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110734021|NCT04898114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110734022|NCT04898114|Urological Agents|urological agents|mesh-ancestor
110734023|NCT04898114|Analgesics|analgesics|mesh-ancestor
110734024|NCT04898114|Sensory System Agents|sensory system agents|mesh-ancestor
110734025|NCT04898114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110734026|NCT04898114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110734027|NCT04898114|Anesthetics|anesthetics|mesh-ancestor
110734028|NCT04898114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110734029|NCT04898114|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110734030|NCT04898114|Anticonvulsants|anticonvulsants|mesh-ancestor
110734031|NCT04898114|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110444614|NCT02782312|Glucocorticoids|glucocorticoids|mesh-ancestor
110734032|NCT04898114|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110734033|NCT04898114|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110734034|NCT04898114|Tocolytic Agents|tocolytic agents|mesh-ancestor
110734035|NCT04898114|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110734036|NCT04897217|Megestrol|megestrol|mesh-list
110734037|NCT04897217|Megestrol Acetate|megestrol acetate|mesh-list
110734038|NCT04897217|Levonorgestrel|levonorgestrel|mesh-list
110734039|NCT04897217|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110734040|NCT04897217|Contraceptive Agents|contraceptive agents|mesh-ancestor
110451794|NCT01014624|Clopidogrel|clopidogrel|mesh-list
110734041|NCT04897217|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110734042|NCT04897217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110734043|NCT04897217|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110734044|NCT04897217|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110734045|NCT04897217|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110734046|NCT04897217|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110734047|NCT04897217|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110734048|NCT04897217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110734049|NCT04897217|Appetite Stimulants|appetite stimulants|mesh-ancestor
110734050|NCT04897217|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110734051|NCT04897022|Pembrolizumab|pembrolizumab|mesh-list
110734052|NCT04897022|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110734053|NCT04897022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110734054|NCT04897022|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110734055|NCT04897022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110734056|NCT04870203|Adalimumab|adalimumab|mesh-list
110734057|NCT04870203|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110734058|NCT04870203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110734059|NCT04870203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110734060|NCT04867707|Zanamivir|zanamivir|mesh-list
110734061|NCT04867707|Antiviral Agents|antiviral agents|mesh-ancestor
110734062|NCT04867707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110734063|NCT04867707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110734064|NCT04867707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110734065|NCT04860661|Esketamine|esketamine|mesh-list
110734066|NCT04860661|Antidepressive Agents|antidepressive agents|mesh-ancestor
110734067|NCT04860661|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110734068|NCT04853199|Quercetin|quercetin|mesh-list
110734069|NCT04853199|Antioxidants|antioxidants|mesh-ancestor
110734070|NCT04853199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110734071|NCT04853199|Protective Agents|protective agents|mesh-ancestor
110734072|NCT04853199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110734073|NCT04804722|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110734074|NCT04804722|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110734075|NCT04804722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110734076|NCT04801485|Inositol|inositol|mesh-list
110734077|NCT04801485|Vitamin B Complex|vitamin b complex|mesh-ancestor
110734078|NCT04801485|Vitamins|vitamins|mesh-ancestor
110734079|NCT04801485|Micronutrients|micronutrients|mesh-ancestor
110734080|NCT04801485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110734081|NCT04753970|Cilostazol|cilostazol|mesh-list
110734082|NCT04753970|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110734083|NCT04753970|Autonomic Agents|autonomic agents|mesh-ancestor
110734084|NCT04753970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110734085|NCT04753970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110734086|NCT04753970|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110734087|NCT04753970|Respiratory System Agents|respiratory system agents|mesh-ancestor
110734088|NCT04753970|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110734089|NCT04753970|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110734090|NCT04753970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110734091|NCT04753970|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110734092|NCT04753970|Vasodilator Agents|vasodilator agents|mesh-ancestor
110734093|NCT04753970|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110734094|NCT04753970|Protective Agents|protective agents|mesh-ancestor
110734095|NCT04753970|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110734096|NCT04753970|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110734097|NCT04753970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110734098|NCT04741204|Metformin|metformin|mesh-list
110734099|NCT04741204|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110734100|NCT04741204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110734101|NCT04727723|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
110734102|NCT04727723|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110734103|NCT04727723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110734105|NCT04725188|Pembrolizumab|pembrolizumab|mesh-list
110734106|NCT04725188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110734107|NCT04725188|Tubulin Modulators|tubulin modulators|mesh-ancestor
110734108|NCT04725188|Antimitotic Agents|antimitotic agents|mesh-ancestor
110734109|NCT04725188|Mitosis Modulators|mitosis modulators|mesh-ancestor
110734110|NCT04725188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110734111|NCT04725188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110734112|NCT04725188|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110451870|NCT00704899|Amitriptyline|amitriptyline|mesh-list
110734113|NCT04723394|Cilgavimab and tixagevimab drug combination|cilgavimab and tixagevimab drug combination|mesh-list
110734114|NCT04723394|Antiviral Agents|antiviral agents|mesh-ancestor
110734115|NCT04723394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110734116|NCT04722523|Carboplatin|carboplatin|mesh-list
110734117|NCT04722523|Docetaxel|docetaxel|mesh-list
110734118|NCT04722523|Cetuximab|cetuximab|mesh-list
110734119|NCT04722523|Cemiplimab|cemiplimab|mesh-list
110734120|NCT04722523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110734121|NCT04722523|Tubulin Modulators|tubulin modulators|mesh-ancestor
110734122|NCT04722523|Antimitotic Agents|antimitotic agents|mesh-ancestor
110734123|NCT04722523|Mitosis Modulators|mitosis modulators|mesh-ancestor
110734124|NCT04722523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110734125|NCT04722523|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110734126|NCT04718792|Psilocybin|psilocybin|mesh-list
110734127|NCT04718792|Hallucinogens|hallucinogens|mesh-ancestor
110734128|NCT04718792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110734129|NCT04718792|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110734130|NCT04707196|Fulvestrant|fulvestrant|mesh-list
110734131|NCT04707196|Aromatase Inhibitors|aromatase inhibitors|mesh-list
110734132|NCT04707196|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110734133|NCT04707196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110734134|NCT04707196|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110734135|NCT04707196|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110734136|NCT04707196|Hormone Antagonists|hormone antagonists|mesh-ancestor
110734137|NCT04707196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110734138|NCT04707196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110734139|NCT04707196|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110734140|NCT04707196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110734141|NCT04707196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110734142|NCT04681144|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
110734143|NCT04681144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110734144|NCT04667585|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110734145|NCT04667585|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110864501|NCT03223402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110734146|NCT04667585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110734148|NCT04663750|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
110734149|NCT04663750|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110734150|NCT04663750|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110734151|NCT04663750|Growth Substances|growth substances|mesh-ancestor
110734152|NCT04663750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110734153|NCT04663750|Growth Inhibitors|growth inhibitors|mesh-ancestor
110734154|NCT04663750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110734155|NCT04663750|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110734156|NCT04663750|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110734157|NCT04663750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110734158|NCT04656145|Chlorhexidine|chlorhexidine|mesh-list
110734159|NCT04656145|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110734160|NCT04656145|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110734161|NCT04656145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110734162|NCT04656145|Disinfectants|disinfectants|mesh-ancestor
110734163|NCT04656145|Dermatologic Agents|dermatologic agents|mesh-ancestor
110734164|NCT04613206|Vaccines|vaccines|mesh-list
110734165|NCT04613206|Immunologic Factors|immunologic factors|mesh-ancestor
110734166|NCT04613206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110734167|NCT04590508|Xanthohumol|xanthohumol|mesh-list
110734168|NCT04590508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110734169|NCT04590508|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110734170|NCT04590508|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110734171|NCT04590508|Growth Substances|growth substances|mesh-ancestor
110734172|NCT04590508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110734173|NCT04590508|Growth Inhibitors|growth inhibitors|mesh-ancestor
110734174|NCT04572295|Fulvestrant|fulvestrant|mesh-list
110734175|NCT04572295|Exemestane|exemestane|mesh-list
110734176|NCT04572295|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110734177|NCT04572295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110734178|NCT04572295|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110734179|NCT04572295|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110734180|NCT04572295|Hormone Antagonists|hormone antagonists|mesh-ancestor
110734181|NCT04572295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110734182|NCT04572295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110734183|NCT04572295|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110734184|NCT04572295|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110734185|NCT04572295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110734186|NCT04572295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110734188|NCT04557527|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110734190|NCT04557527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110734191|NCT04557527|Viscosupplements|viscosupplements|mesh-ancestor
110734192|NCT04557527|Protective Agents|protective agents|mesh-ancestor
110734193|NCT04543383|Thrombin|thrombin|mesh-list
110734194|NCT04543383|Hemostatics|hemostatics|mesh-ancestor
110734195|NCT04543383|Coagulants|coagulants|mesh-ancestor
110734196|NCT04533880|Calcium|calcium|mesh-list
110734197|NCT04533880|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110734198|NCT04533880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110734199|NCT04532606|Anesthetics|anesthetics|mesh-list
110734200|NCT04532606|Propofol|propofol|mesh-list
110734201|NCT04532606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110734202|NCT04532606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110734203|NCT04532606|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110734204|NCT04532606|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110734205|NCT04532606|Anesthetics, General|anesthetics, general|mesh-ancestor
110734206|NCT04513145|Ropivacaine|ropivacaine|mesh-list
110734207|NCT04513145|Anesthetics, Local|anesthetics, local|mesh-ancestor
110734208|NCT04513145|Anesthetics|anesthetics|mesh-ancestor
110734209|NCT04513145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110734210|NCT04513145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110734211|NCT04513145|Sensory System Agents|sensory system agents|mesh-ancestor
110734212|NCT04513145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110734213|NCT04478266|Letrozole|letrozole|mesh-list
110734214|NCT04478266|Palbociclib|palbociclib|mesh-list
110734215|NCT04478266|Goserelin|goserelin|mesh-list
110734216|NCT04478266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110734217|NCT04478266|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110734218|NCT04478266|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110734219|NCT04478266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110734220|NCT04478266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110734221|NCT04478266|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110734222|NCT04478266|Hormone Antagonists|hormone antagonists|mesh-ancestor
110734223|NCT04478266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110144063|NCT02029118|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110734224|NCT04478266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110734225|NCT04478266|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110734226|NCT04478266|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110734227|NCT04460885|Insulin|insulin|mesh-list
110734228|NCT04460885|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110734229|NCT04460885|Insulin Glargine|insulin glargine|mesh-list
110734230|NCT04460885|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110734231|NCT04460885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110734232|NCT04459715|Cisplatin|cisplatin|mesh-list
110734233|NCT04459715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110734234|NCT04418154|Paclitaxel|paclitaxel|mesh-list
110734235|NCT04418154|Cyclophosphamide|cyclophosphamide|mesh-list
110734236|NCT04418154|Epirubicin|epirubicin|mesh-list
110734237|NCT04418154|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110734238|NCT04418154|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110734239|NCT04418154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110734240|NCT04418154|Tubulin Modulators|tubulin modulators|mesh-ancestor
110734241|NCT04418154|Antimitotic Agents|antimitotic agents|mesh-ancestor
110734242|NCT04418154|Mitosis Modulators|mitosis modulators|mesh-ancestor
110734243|NCT04418154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110734244|NCT04418154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110734245|NCT04418154|Immunologic Factors|immunologic factors|mesh-ancestor
110734246|NCT04418154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110734247|NCT04418154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110734248|NCT04418154|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110734249|NCT04418154|Alkylating Agents|alkylating agents|mesh-ancestor
110734250|NCT04418154|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110444618|NCT04229758|Anticoagulants|anticoagulants|mesh-list
110734251|NCT04418154|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110734252|NCT04418154|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110734253|NCT04418154|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110734254|NCT04418154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110734255|NCT04417192|Pembrolizumab|pembrolizumab|mesh-list
110734256|NCT04417192|Olaparib|olaparib|mesh-list
110734257|NCT04417192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110734258|NCT04417192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110734259|NCT04417192|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110734260|NCT04417192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110734261|NCT04417192|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110734262|NCT04417192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110734263|NCT04409002|Niraparib|niraparib|mesh-list
110734264|NCT04409002|Dostarlimab|dostarlimab|mesh-list
110734265|NCT04409002|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110734266|NCT04409002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110734267|NCT04409002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110734268|NCT04409002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110734269|NCT04404361|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
110734270|NCT04404361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110734271|NCT04404361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110734272|NCT04404361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110734273|NCT04343885|Docetaxel|docetaxel|mesh-list
110734274|NCT04343885|177Lu-PSMA-617|177lu-psma-617|mesh-list
110734275|NCT04343885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110734276|NCT04343885|Tubulin Modulators|tubulin modulators|mesh-ancestor
110734277|NCT04343885|Antimitotic Agents|antimitotic agents|mesh-ancestor
110734278|NCT04343885|Mitosis Modulators|mitosis modulators|mesh-ancestor
110734279|NCT04343885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110734280|NCT04343885|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110734281|NCT04338061|Teriflunomide|teriflunomide|mesh-list
110734282|NCT04338061|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110734283|NCT04338061|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110734284|NCT04338061|Analgesics|analgesics|mesh-ancestor
110734285|NCT04338061|Sensory System Agents|sensory system agents|mesh-ancestor
110734286|NCT04338061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110734287|NCT04338061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110734288|NCT04338061|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110734289|NCT04338061|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110734290|NCT04338061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110734291|NCT04338061|Immunologic Factors|immunologic factors|mesh-ancestor
110734292|NCT04338022|Teriflunomide|teriflunomide|mesh-list
110734293|NCT04338022|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110734294|NCT04338022|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110734295|NCT04338022|Analgesics|analgesics|mesh-ancestor
110734296|NCT04338022|Sensory System Agents|sensory system agents|mesh-ancestor
110734297|NCT04338022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110734298|NCT04338022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110734299|NCT04338022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110734300|NCT04338022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110734301|NCT04338022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110734302|NCT04338022|Immunologic Factors|immunologic factors|mesh-ancestor
110734304|NCT04310995|Diltiazem|diltiazem|mesh-list
110734305|NCT04310995|Isosorbide|isosorbide|mesh-list
110734306|NCT04310995|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
110734307|NCT04310995|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
110734308|NCT04310995|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110734309|NCT04310995|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110734310|NCT04310995|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110734311|NCT04310995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110734312|NCT04310995|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110734313|NCT04310995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110734314|NCT04310995|Vasodilator Agents|vasodilator agents|mesh-ancestor
110734315|NCT04310995|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110734316|NCT04310995|Diuretics|diuretics|mesh-ancestor
110734317|NCT04310995|Natriuretic Agents|natriuretic agents|mesh-ancestor
110734318|NCT04310995|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
110734319|NCT04310995|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110734320|NCT04310995|Vitamin B Complex|vitamin b complex|mesh-ancestor
110734321|NCT04310995|Vitamins|vitamins|mesh-ancestor
110734322|NCT04310995|Micronutrients|micronutrients|mesh-ancestor
110734323|NCT04302324|Clarithromycin|clarithromycin|mesh-list
110734324|NCT04302324|Dexamethasone|dexamethasone|mesh-list
110734325|NCT04302324|Daratumumab|daratumumab|mesh-list
110734326|NCT04302324|Pomalidomide|pomalidomide|mesh-list
110734327|NCT04302324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110734328|NCT04302324|Antiemetics|antiemetics|mesh-ancestor
110734329|NCT04302324|Autonomic Agents|autonomic agents|mesh-ancestor
110734330|NCT04302324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110734331|NCT04302324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110734332|NCT04302324|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110734333|NCT04302324|Glucocorticoids|glucocorticoids|mesh-ancestor
110734334|NCT04302324|Hormones|hormones|mesh-ancestor
110734335|NCT04302324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110734336|NCT04302324|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110734337|NCT04302324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110734338|NCT04302324|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110734339|NCT04302324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110734340|NCT04302324|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110734341|NCT04302324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110734342|NCT04302324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110734343|NCT04302324|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110734344|NCT04302324|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110734345|NCT04302324|Immunologic Factors|immunologic factors|mesh-ancestor
110734346|NCT04302324|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110734347|NCT04302324|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110734348|NCT04302324|Growth Substances|growth substances|mesh-ancestor
110734349|NCT04302324|Growth Inhibitors|growth inhibitors|mesh-ancestor
110734350|NCT04292743|Leucovorin|leucovorin|mesh-list
110734351|NCT04292743|Fluorouracil|fluorouracil|mesh-list
110734352|NCT04292743|Oxaliplatin|oxaliplatin|mesh-list
110734353|NCT04292743|Irinotecan|irinotecan|mesh-list
110734354|NCT04292743|Folfirinox|folfirinox|mesh-list
110734355|NCT04292743|Eryaspase|eryaspase|mesh-list
110734356|NCT04292743|Antimetabolites|antimetabolites|mesh-ancestor
110734357|NCT04292743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110864521|NCT02451748|Methotrexate|methotrexate|mesh-list
110734358|NCT04292743|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110734359|NCT04292743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110734360|NCT04292743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110734361|NCT04292743|Immunologic Factors|immunologic factors|mesh-ancestor
110734362|NCT04292743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110734363|NCT04292743|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110734364|NCT04292743|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110734365|NCT04292743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110734366|NCT04292743|Antidotes|antidotes|mesh-ancestor
110734367|NCT04292743|Protective Agents|protective agents|mesh-ancestor
110734368|NCT04292743|Vitamin B Complex|vitamin b complex|mesh-ancestor
110734369|NCT04292743|Vitamins|vitamins|mesh-ancestor
110734370|NCT04292743|Micronutrients|micronutrients|mesh-ancestor
110734371|NCT04270175|Dexamethasone|dexamethasone|mesh-list
110734372|NCT04270175|Daratumumab|daratumumab|mesh-list
110734373|NCT04270175|Pomalidomide|pomalidomide|mesh-list
110734374|NCT04270175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110734375|NCT04270175|Antiemetics|antiemetics|mesh-ancestor
110734376|NCT04270175|Autonomic Agents|autonomic agents|mesh-ancestor
110734377|NCT04270175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110734378|NCT04270175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110734379|NCT04270175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110734380|NCT04270175|Glucocorticoids|glucocorticoids|mesh-ancestor
110734381|NCT04270175|Hormones|hormones|mesh-ancestor
110734382|NCT04270175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110734383|NCT04270175|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110734384|NCT04270175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110734385|NCT04270175|Immunologic Factors|immunologic factors|mesh-ancestor
110734386|NCT04270175|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110734387|NCT04270175|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110734388|NCT04270175|Growth Substances|growth substances|mesh-ancestor
110734389|NCT04270175|Growth Inhibitors|growth inhibitors|mesh-ancestor
110734390|NCT04267549|Paclitaxel|paclitaxel|mesh-list
110734391|NCT04267549|Apatinib|apatinib|mesh-list
110734392|NCT04267549|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110734393|NCT04267549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110734394|NCT04267549|Tubulin Modulators|tubulin modulators|mesh-ancestor
110734395|NCT04267549|Antimitotic Agents|antimitotic agents|mesh-ancestor
110734396|NCT04267549|Mitosis Modulators|mitosis modulators|mesh-ancestor
110734397|NCT04267549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110444626|NCT05342272|Lactoferrin|lactoferrin|mesh-list
110734399|NCT04267549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110734400|NCT04262336|Sodium thiosulfate|sodium thiosulfate|mesh-list
110734401|NCT04262336|Hyaluronic Acid|hyaluronic acid|mesh-list
110734402|NCT04262336|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110734403|NCT04262336|Immunologic Factors|immunologic factors|mesh-ancestor
110734404|NCT04262336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110734405|NCT04262336|Viscosupplements|viscosupplements|mesh-ancestor
110734406|NCT04262336|Protective Agents|protective agents|mesh-ancestor
110734407|NCT04262336|Antidotes|antidotes|mesh-ancestor
110734408|NCT04262336|Antioxidants|antioxidants|mesh-ancestor
110734409|NCT04262336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110734410|NCT04262336|Antitubercular Agents|antitubercular agents|mesh-ancestor
110734411|NCT04262336|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110734412|NCT04262336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110734413|NCT04262336|Chelating Agents|chelating agents|mesh-ancestor
110734414|NCT04262336|Sequestering Agents|sequestering agents|mesh-ancestor
110734415|NCT04242238|Avelumab|avelumab|mesh-list
110682831|NCT00902915|Autonomic Agents|autonomic agents|mesh-ancestor
110734416|NCT04242238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110734417|NCT04242238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110734418|NCT04235959|Tirzepatide|tirzepatide|mesh-list
110734419|NCT04235959|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110734420|NCT04235959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110734421|NCT04235959|Incretins|incretins|mesh-ancestor
110734422|NCT04235959|Hormones|hormones|mesh-ancestor
110734423|NCT04235959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110734424|NCT04235101|Trastuzumab|trastuzumab|mesh-list
110734425|NCT04235101|Niraparib|niraparib|mesh-list
110734426|NCT04235101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110734427|NCT04235101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110734428|NCT04235101|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110734429|NCT04235101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110734430|NCT04235101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110734431|NCT04200534|Nicotine|nicotine|mesh-list
110734432|NCT04200534|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110734433|NCT04200534|Autonomic Agents|autonomic agents|mesh-ancestor
110734434|NCT04200534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110734435|NCT04200534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110734436|NCT04200534|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110734437|NCT04200534|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110734438|NCT04200534|Cholinergic Agents|cholinergic agents|mesh-ancestor
110734439|NCT04200534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110734440|NCT04200534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110734441|NCT04182360|Carbetocin|carbetocin|mesh-list
110734442|NCT04182360|Oxytocics|oxytocics|mesh-ancestor
110734443|NCT04182360|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110734444|NCT04182360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110734445|NCT04147533|Imatinib Mesylate|imatinib mesylate|mesh-list
110734446|NCT04147533|Dasatinib|dasatinib|mesh-list
110734447|NCT04147533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110734448|NCT04147533|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110734449|NCT04147533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110734450|NCT04147533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110734451|NCT04115384|Insulin|insulin|mesh-list
110734452|NCT04115384|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110734453|NCT04115384|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110734454|NCT04115384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110734455|NCT04112368|Estradiol|estradiol|mesh-list
110734456|NCT04112368|Progesterone|progesterone|mesh-list
110734457|NCT04112368|Estrogens|estrogens|mesh-ancestor
110734458|NCT04112368|Hormones|hormones|mesh-ancestor
110734459|NCT04112368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110734460|NCT04112368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110734461|NCT04112368|Progestins|progestins|mesh-ancestor
110734462|NCT04088188|Cisplatin|cisplatin|mesh-list
110734463|NCT04088188|Gemcitabine|gemcitabine|mesh-list
110734464|NCT04088188|Ivosidenib|ivosidenib|mesh-list
110734465|NCT04088188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110734466|NCT04088188|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110734467|NCT04088188|Antimetabolites|antimetabolites|mesh-ancestor
110734468|NCT04088188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110734469|NCT04088188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110734470|NCT04080804|Nivolumab|nivolumab|mesh-list
110734471|NCT04080804|Ipilimumab|ipilimumab|mesh-list
110734473|NCT04080804|Antibodies|antibodies|mesh-list
110734474|NCT04080804|Immunoglobulins|immunoglobulins|mesh-list
110734475|NCT04080804|Immunologic Factors|immunologic factors|mesh-ancestor
110734476|NCT04080804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110734477|NCT04080804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110734478|NCT04080804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110734479|NCT04080804|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110734480|NCT04080804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110734481|NCT04066192|Brexpiprazole|brexpiprazole|mesh-list
110734482|NCT04066192|Serotonin Agents|serotonin agents|mesh-ancestor
110734483|NCT04066192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110734484|NCT04066192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110734485|NCT04066192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110734486|NCT04066192|Dopamine Agonists|dopamine agonists|mesh-ancestor
110734487|NCT04066192|Dopamine Agents|dopamine agents|mesh-ancestor
110734488|NCT04062123|Fentanyl|fentanyl|mesh-list
110734489|NCT04062123|Dexmedetomidine|dexmedetomidine|mesh-list
110734490|NCT04062123|Propofol|propofol|mesh-list
110734491|NCT04062123|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110734492|NCT04062123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110734493|NCT04062123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110734494|NCT04062123|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110452237|NCT00705445|Zinc|zinc|mesh-list
110734495|NCT04062123|Analgesics|analgesics|mesh-ancestor
110734496|NCT04062123|Sensory System Agents|sensory system agents|mesh-ancestor
110734497|NCT04062123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110734498|NCT04062123|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110864534|NCT02451748|Antimetabolites|antimetabolites|mesh-ancestor
110734499|NCT04062123|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110734500|NCT04062123|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110734501|NCT04062123|Adrenergic Agents|adrenergic agents|mesh-ancestor
110734502|NCT04062123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110864537|NCT02451748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110734503|NCT04062123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110734504|NCT04062123|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110734505|NCT04062123|Anesthetics, General|anesthetics, general|mesh-ancestor
110734506|NCT04062123|Anesthetics|anesthetics|mesh-ancestor
110734507|NCT04062123|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110734508|NCT04062123|Narcotics|narcotics|mesh-ancestor
110734509|NCT04062123|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110734511|NCT04059562|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110734512|NCT04059562|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110734513|NCT04059562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110734514|NCT04059562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110734515|NCT04059562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110734516|NCT04040088|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
110734517|NCT04040088|Chelating Agents|chelating agents|mesh-ancestor
110734518|NCT04040088|Sequestering Agents|sequestering agents|mesh-ancestor
110734519|NCT04040088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110734520|NCT04009681|Antibodies|antibodies|mesh-list
110734521|NCT04009681|Immunologic Factors|immunologic factors|mesh-ancestor
110734522|NCT04009681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110734523|NCT03992261|Halobetasol|halobetasol|mesh-list
110734524|NCT03992261|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110734525|NCT03991884|Prednisone|prednisone|mesh-list
110734526|NCT03991884|Cortisone|cortisone|mesh-list
110734527|NCT03991884|Cyclophosphamide|cyclophosphamide|mesh-list
110734528|NCT03991884|Doxorubicin|doxorubicin|mesh-list
110734529|NCT03991884|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110734530|NCT03991884|Etoposide|etoposide|mesh-list
110734531|NCT03991884|Vincristine|vincristine|mesh-list
110734532|NCT03991884|Etoposide phosphate|etoposide phosphate|mesh-list
110734533|NCT03991884|Daunorubicin|daunorubicin|mesh-list
110734534|NCT03991884|Podophyllotoxin|podophyllotoxin|mesh-list
110734535|NCT03991884|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
110734536|NCT03991884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110734537|NCT03991884|Immunologic Factors|immunologic factors|mesh-ancestor
110734538|NCT03991884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110734539|NCT03991884|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110734540|NCT03991884|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110734541|NCT03991884|Alkylating Agents|alkylating agents|mesh-ancestor
110734542|NCT03991884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110734543|NCT03991884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110734544|NCT03991884|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110734546|NCT03991884|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110734547|NCT03991884|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110734548|NCT03991884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110734549|NCT03991884|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110734550|NCT03991884|Glucocorticoids|glucocorticoids|mesh-ancestor
110734551|NCT03991884|Hormones|hormones|mesh-ancestor
110734552|NCT03991884|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110734553|NCT03991884|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110734554|NCT03991884|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110734555|NCT03991884|Tubulin Modulators|tubulin modulators|mesh-ancestor
110734556|NCT03991884|Antimitotic Agents|antimitotic agents|mesh-ancestor
110734557|NCT03991884|Mitosis Modulators|mitosis modulators|mesh-ancestor
110734558|NCT03991884|Keratolytic Agents|keratolytic agents|mesh-ancestor
110734559|NCT03991884|Dermatologic Agents|dermatologic agents|mesh-ancestor
110734560|NCT03991884|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110734561|NCT03991884|Immunotoxins|immunotoxins|mesh-ancestor
110734562|NCT03991884|Immunoconjugates|immunoconjugates|mesh-ancestor
110734563|NCT03984565|Cannabidiol|cannabidiol|mesh-list
110734564|NCT03984565|Anticonvulsants|anticonvulsants|mesh-ancestor
110734565|NCT03980509|Curcumin|curcumin|mesh-list
110734566|NCT03980509|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110734567|NCT03980509|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110734568|NCT03980509|Analgesics|analgesics|mesh-ancestor
110734569|NCT03980509|Sensory System Agents|sensory system agents|mesh-ancestor
110734570|NCT03980509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110734572|NCT03980509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110734574|NCT03980509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110734575|NCT03980509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110734576|NCT03980509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110734577|NCT03978039|Immunomodulating Agents|immunomodulating agents|mesh-list
110734578|NCT03978039|Immunologic Factors|immunologic factors|mesh-ancestor
110734579|NCT03978039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110734580|NCT03961971|Spartalizumab|spartalizumab|mesh-list
110734581|NCT03961971|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110734582|NCT03961971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110734583|NCT03961971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110734584|NCT03961971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110734585|NCT03947385|Crizotinib|crizotinib|mesh-list
110734586|NCT03947385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110734587|NCT03947385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110734588|NCT03947385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110734589|NCT03947385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110734590|NCT03918798|Chloroprocaine|chloroprocaine|mesh-list
110734591|NCT03918798|Procaine|procaine|mesh-list
110734592|NCT03918798|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110734593|NCT03918798|Anesthetics, Local|anesthetics, local|mesh-ancestor
110734594|NCT03918798|Anesthetics|anesthetics|mesh-ancestor
110734595|NCT03918798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110734596|NCT03918798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110734597|NCT03918798|Sensory System Agents|sensory system agents|mesh-ancestor
110734598|NCT03918798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110734599|NCT03890289|Obinutuzumab|obinutuzumab|mesh-list
110734600|NCT03890289|Idelalisib|idelalisib|mesh-list
110734601|NCT03890289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110734602|NCT03890289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110734603|NCT03890289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110734604|NCT03890289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110734605|NCT03858322|Paclitaxel|paclitaxel|mesh-list
110734606|NCT03858322|Cyclophosphamide|cyclophosphamide|mesh-list
110734607|NCT03858322|Carboplatin|carboplatin|mesh-list
110734608|NCT03858322|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110734609|NCT03858322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110734610|NCT03858322|Tubulin Modulators|tubulin modulators|mesh-ancestor
110734611|NCT03858322|Antimitotic Agents|antimitotic agents|mesh-ancestor
110734612|NCT03858322|Mitosis Modulators|mitosis modulators|mesh-ancestor
110734613|NCT03858322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110734614|NCT03858322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110734615|NCT03858322|Immunologic Factors|immunologic factors|mesh-ancestor
110734616|NCT03858322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110734617|NCT03858322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110734618|NCT03858322|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110734619|NCT03858322|Alkylating Agents|alkylating agents|mesh-ancestor
110734620|NCT03858322|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110734623|NCT03825289|Hydroxychloroquine|hydroxychloroquine|mesh-list
110734624|NCT03825289|Trametinib|trametinib|mesh-list
110734625|NCT03825289|Antimalarials|antimalarials|mesh-ancestor
110734626|NCT03825289|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110734627|NCT03825289|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110734628|NCT03825289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110734629|NCT03825289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110734630|NCT03825289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110734631|NCT03825289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110734632|NCT03825289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110734633|NCT03825289|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110734634|NCT03800602|Metformin|metformin|mesh-list
110734635|NCT03800602|Nivolumab|nivolumab|mesh-list
110734636|NCT03800602|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110734637|NCT03800602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110734638|NCT03800602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110734639|NCT03800602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110734640|NCT03800602|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110734641|NCT03800602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110734642|NCT03779191|Bevacizumab|bevacizumab|mesh-list
110734643|NCT03779191|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110734644|NCT03779191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110452385|NCT04251741|Adalimumab|adalimumab|mesh-list
110734645|NCT03779191|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110734646|NCT03779191|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110734647|NCT03779191|Growth Substances|growth substances|mesh-ancestor
110734648|NCT03779191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110734649|NCT03779191|Growth Inhibitors|growth inhibitors|mesh-ancestor
110734650|NCT03775902|Nicorandil|nicorandil|mesh-list
110734651|NCT03775902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110734652|NCT03775902|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110734653|NCT03775902|Vasodilator Agents|vasodilator agents|mesh-ancestor
110734654|NCT03775902|Vitamin B Complex|vitamin b complex|mesh-ancestor
110734655|NCT03775902|Vitamins|vitamins|mesh-ancestor
110734656|NCT03775902|Micronutrients|micronutrients|mesh-ancestor
110734657|NCT03775902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110734658|NCT03753074|Tenofovir|tenofovir|mesh-list
110734659|NCT03753074|Antiviral Agents|antiviral agents|mesh-ancestor
110734660|NCT03753074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110734661|NCT03753074|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110734662|NCT03753074|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110734663|NCT03753074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110734664|NCT03753074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110734665|NCT03753074|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110734666|NCT03753074|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110734667|NCT03743662|Bevacizumab|bevacizumab|mesh-list
110734668|NCT03743662|Nivolumab|nivolumab|mesh-list
110734669|NCT03743662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110734670|NCT03743662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110734671|NCT03743662|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110734672|NCT03743662|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110734673|NCT03743662|Growth Substances|growth substances|mesh-ancestor
110734674|NCT03743662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110734675|NCT03743662|Growth Inhibitors|growth inhibitors|mesh-ancestor
110734676|NCT03743662|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110734677|NCT03743662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110734678|NCT03735121|Atezolizumab|atezolizumab|mesh-list
110734679|NCT03735121|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110734680|NCT03735121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110734681|NCT03735121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110734682|NCT03735121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110734683|NCT03715946|Nivolumab|nivolumab|mesh-list
110734684|NCT03715946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110734685|NCT03715946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110734686|NCT03715946|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110734687|NCT03715946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110734688|NCT03712878|Mycophenolic Acid|mycophenolic acid|mesh-list
110734689|NCT03712878|Cyclophosphamide|cyclophosphamide|mesh-list
110734690|NCT03712878|Tacrolimus|tacrolimus|mesh-list
110734691|NCT03712878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110734692|NCT03712878|Immunologic Factors|immunologic factors|mesh-ancestor
110734693|NCT03712878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110734694|NCT03712878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110734703|NCT03712878|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110734704|NCT03712878|Antitubercular Agents|antitubercular agents|mesh-ancestor
110734705|NCT03712878|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110734706|NCT03712878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110734707|NCT03651206|Niraparib|niraparib|mesh-list
110734708|NCT03651206|Dostarlimab|dostarlimab|mesh-list
110734709|NCT03651206|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110864629|NCT04297241|Isosorbide|isosorbide|mesh-list
110734710|NCT03651206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110734711|NCT03651206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110734712|NCT03651206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110734721|NCT03618537|Dexamethasone|dexamethasone|mesh-list
110734722|NCT03618537|Ixazomib|ixazomib|mesh-list
110734723|NCT03618537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110734724|NCT03618537|Antiemetics|antiemetics|mesh-ancestor
110734725|NCT03618537|Autonomic Agents|autonomic agents|mesh-ancestor
110734726|NCT03618537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110734727|NCT03618537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110734728|NCT03618537|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110734729|NCT03618537|Glucocorticoids|glucocorticoids|mesh-ancestor
110734730|NCT03618537|Hormones|hormones|mesh-ancestor
110734731|NCT03618537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110734732|NCT03618537|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110734733|NCT03618537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110734734|NCT03618537|Protease Inhibitors|protease inhibitors|mesh-ancestor
110734735|NCT03618537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110734736|NCT03618537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110734737|NCT03552692|Venetoclax|venetoclax|mesh-list
110734738|NCT03552692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110734739|NCT03485417|Aripiprazole|aripiprazole|mesh-list
110734740|NCT03485417|Paliperidone Palmitate|paliperidone palmitate|mesh-list
110734741|NCT03485417|Antidepressive Agents|antidepressive agents|mesh-ancestor
110734742|NCT03485417|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110734743|NCT03485417|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110734744|NCT03485417|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110734745|NCT03485417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110734746|NCT03485417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110734747|NCT03485417|Dopamine Agonists|dopamine agonists|mesh-ancestor
110734748|NCT03485417|Dopamine Agents|dopamine agents|mesh-ancestor
110734749|NCT03485417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110734750|NCT03485417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110734751|NCT03485417|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110734752|NCT03485417|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110734753|NCT03485417|Serotonin Agents|serotonin agents|mesh-ancestor
110734754|NCT03485417|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110734755|NCT03485417|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110734756|NCT03485417|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110734757|NCT03485417|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110734758|NCT03485274|Vortioxetine|vortioxetine|mesh-list
110734759|NCT03485274|Antidepressive Agents|antidepressive agents|mesh-ancestor
110734760|NCT03485274|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110734761|NCT03485274|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110734762|NCT03485274|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110734763|NCT03485274|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110734764|NCT03485274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110734765|NCT03485274|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110734766|NCT03485274|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110734767|NCT03485274|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110734768|NCT03485274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110734769|NCT03485274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110734770|NCT03485274|Serotonin Agents|serotonin agents|mesh-ancestor
110734771|NCT03485274|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110734772|NCT03485274|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110734773|NCT03485274|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110734774|NCT03485274|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110734775|NCT03434028|Norepinephrine|norepinephrine|mesh-list
110734776|NCT03434028|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
110734777|NCT03434028|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110734778|NCT03434028|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110734779|NCT03434028|Adrenergic Agents|adrenergic agents|mesh-ancestor
110734780|NCT03434028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110734781|NCT03434028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110734782|NCT03434028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110734783|NCT03434028|Sympathomimetics|sympathomimetics|mesh-ancestor
110734784|NCT03434028|Autonomic Agents|autonomic agents|mesh-ancestor
110144197|NCT02029950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110734785|NCT03434028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110734787|NCT03412773|Tislelizumab|tislelizumab|mesh-list
110734788|NCT03412773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110734789|NCT03412773|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110734790|NCT03412773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110734791|NCT03412773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110734793|NCT03404960|Nivolumab|nivolumab|mesh-list
110734794|NCT03404960|Ipilimumab|ipilimumab|mesh-list
110734795|NCT03404960|Niraparib|niraparib|mesh-list
110734796|NCT03404960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110734797|NCT03404960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110734798|NCT03404960|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110734799|NCT03404960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110734800|NCT03404960|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110734801|NCT03404960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110734802|NCT03393845|Pembrolizumab|pembrolizumab|mesh-list
110734803|NCT03393845|Fulvestrant|fulvestrant|mesh-list
110734804|NCT03393845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110734805|NCT03393845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110734806|NCT03393845|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110734807|NCT03393845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110734808|NCT03393845|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110734809|NCT03393845|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110734810|NCT03393845|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110734811|NCT03393845|Hormone Antagonists|hormone antagonists|mesh-ancestor
110734812|NCT03393845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110734813|NCT03393845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110734814|NCT03391466|Cyclophosphamide|cyclophosphamide|mesh-list
110734815|NCT03391466|Fludarabine|fludarabine|mesh-list
110734816|NCT03391466|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
110734817|NCT03391466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110734818|NCT03391466|Immunologic Factors|immunologic factors|mesh-ancestor
110734819|NCT03391466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110734820|NCT03391466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110734821|NCT03391466|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110734822|NCT03391466|Alkylating Agents|alkylating agents|mesh-ancestor
110734823|NCT03391466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110734824|NCT03391466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110734825|NCT03391466|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110734826|NCT03391466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110734827|NCT03391427|Lidocaine|lidocaine|mesh-list
110734828|NCT03391427|Ketamine|ketamine|mesh-list
110734829|NCT03391427|Anesthetics, Local|anesthetics, local|mesh-ancestor
110734830|NCT03391427|Anesthetics|anesthetics|mesh-ancestor
110734831|NCT03391427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110734832|NCT03391427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110734833|NCT03391427|Sensory System Agents|sensory system agents|mesh-ancestor
110734834|NCT03391427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110734835|NCT03391427|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110734836|NCT03391427|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110734837|NCT03391427|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110734838|NCT03391427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110734839|NCT03391427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110734840|NCT03391427|Analgesics|analgesics|mesh-ancestor
110734841|NCT03391427|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110734842|NCT03391427|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110734843|NCT03391427|Anesthetics, General|anesthetics, general|mesh-ancestor
110734844|NCT03391427|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110734845|NCT03391427|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110734846|NCT03391427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110734847|NCT03381274|Osimertinib|osimertinib|mesh-list
110144209|NCT02029950|Growth Substances|growth substances|mesh-ancestor
110734848|NCT03381274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110734849|NCT03381274|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110734850|NCT03381274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110734851|NCT03381274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110734853|NCT03290950|Dexamethasone acetate|dexamethasone acetate|mesh-list
110734854|NCT03290950|Lenalidomide|lenalidomide|mesh-list
110734855|NCT03290950|Daratumumab|daratumumab|mesh-list
110734856|NCT03290950|BB 1101|bb 1101|mesh-list
110734857|NCT03290950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110734858|NCT03290950|Antiemetics|antiemetics|mesh-ancestor
110734859|NCT03290950|Autonomic Agents|autonomic agents|mesh-ancestor
110734860|NCT03290950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110734861|NCT03290950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110734862|NCT03290950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110734863|NCT03290950|Glucocorticoids|glucocorticoids|mesh-ancestor
110734864|NCT03290950|Hormones|hormones|mesh-ancestor
110734865|NCT03290950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110734866|NCT03290950|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110734867|NCT03290950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110734868|NCT03290950|Protease Inhibitors|protease inhibitors|mesh-ancestor
110734869|NCT03290950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110734870|NCT03290950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110734871|NCT03290950|Immunologic Factors|immunologic factors|mesh-ancestor
110734872|NCT03290950|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110734873|NCT03290950|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110734874|NCT03290950|Growth Substances|growth substances|mesh-ancestor
110734875|NCT03290950|Growth Inhibitors|growth inhibitors|mesh-ancestor
110734877|NCT03264404|Azacitidine|azacitidine|mesh-list
110734878|NCT03264404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110734879|NCT03264404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110734880|NCT03264404|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110734881|NCT03264404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110734882|NCT03264404|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110734883|NCT03264404|Antimetabolites|antimetabolites|mesh-ancestor
110734884|NCT03264404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110734885|NCT03241745|Nivolumab|nivolumab|mesh-list
110734886|NCT03241745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110734887|NCT03241745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110734888|NCT03241745|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110734889|NCT03241745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110734890|NCT03188432|Carboplatin|carboplatin|mesh-list
110734891|NCT03188432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110734892|NCT03132532|Paclitaxel|paclitaxel|mesh-list
110734893|NCT03132532|Etoposide|etoposide|mesh-list
110734894|NCT03132532|Podophyllotoxin|podophyllotoxin|mesh-list
110734895|NCT03132532|Cisplatin|cisplatin|mesh-list
110734896|NCT03132532|Carboplatin|carboplatin|mesh-list
110734897|NCT03132532|Pemetrexed|pemetrexed|mesh-list
110734898|NCT03132532|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110734899|NCT03132532|Etoposide phosphate|etoposide phosphate|mesh-list
110734900|NCT03132532|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110734901|NCT03132532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110734902|NCT03132532|Tubulin Modulators|tubulin modulators|mesh-ancestor
110734903|NCT03132532|Antimitotic Agents|antimitotic agents|mesh-ancestor
110734904|NCT03132532|Mitosis Modulators|mitosis modulators|mesh-ancestor
110734905|NCT03132532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110734906|NCT03132532|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110734907|NCT03132532|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110734908|NCT03132532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110734909|NCT03132532|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110734910|NCT03132532|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110734911|NCT03132532|Keratolytic Agents|keratolytic agents|mesh-ancestor
110734912|NCT03132532|Dermatologic Agents|dermatologic agents|mesh-ancestor
110734913|NCT03129555|Rivaroxaban|rivaroxaban|mesh-list
110734914|NCT03129555|Apixaban|apixaban|mesh-list
110734915|NCT03129555|Edoxaban|edoxaban|mesh-list
110734916|NCT03129555|Dabigatran|dabigatran|mesh-list
110734917|NCT03129555|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110734918|NCT03129555|Antithrombins|antithrombins|mesh-ancestor
110734919|NCT03129555|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110734920|NCT03129555|Protease Inhibitors|protease inhibitors|mesh-ancestor
110734921|NCT03129555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110864651|NCT04292171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110734922|NCT03129555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110734923|NCT03129555|Anticoagulants|anticoagulants|mesh-ancestor
110734924|NCT03129490|Rivaroxaban|rivaroxaban|mesh-list
110734925|NCT03129490|Apixaban|apixaban|mesh-list
110734926|NCT03129490|Edoxaban|edoxaban|mesh-list
110734927|NCT03129490|Dabigatran|dabigatran|mesh-list
110734928|NCT03129490|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110734929|NCT03129490|Antithrombins|antithrombins|mesh-ancestor
110734930|NCT03129490|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110734931|NCT03129490|Protease Inhibitors|protease inhibitors|mesh-ancestor
110734932|NCT03129490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110734933|NCT03129490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110734934|NCT03129490|Anticoagulants|anticoagulants|mesh-ancestor
110734935|NCT03121014|Methotrexate|methotrexate|mesh-list
110734936|NCT03121014|Fludarabine|fludarabine|mesh-list
110734937|NCT03121014|Busulfan|busulfan|mesh-list
110734938|NCT03121014|Tacrolimus|tacrolimus|mesh-list
110734939|NCT03121014|Thymoglobulin|thymoglobulin|mesh-list
110452687|NCT02607904|Cannabidiol|cannabidiol|mesh-list
110734940|NCT03121014|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110734941|NCT03121014|Abortifacient Agents|abortifacient agents|mesh-ancestor
110734942|NCT03121014|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110734943|NCT03121014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110734944|NCT03121014|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110734945|NCT03121014|Antimetabolites|antimetabolites|mesh-ancestor
110734946|NCT03121014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110734947|NCT03121014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110734948|NCT03121014|Dermatologic Agents|dermatologic agents|mesh-ancestor
110734949|NCT03121014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110734950|NCT03121014|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110734951|NCT03121014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110734952|NCT03121014|Immunologic Factors|immunologic factors|mesh-ancestor
110734953|NCT03121014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110734954|NCT03121014|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110734955|NCT03121014|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110734956|NCT03121014|Alkylating Agents|alkylating agents|mesh-ancestor
110734957|NCT03121014|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110734958|NCT03121014|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110734959|NCT03118570|Vitamin D|vitamin d|mesh-list
110734960|NCT03118570|Zoledronic Acid|zoledronic acid|mesh-list
110734961|NCT03118570|Calcium|calcium|mesh-list
110734962|NCT03118570|Vitamins|vitamins|mesh-ancestor
110734963|NCT03118570|Micronutrients|micronutrients|mesh-ancestor
110734964|NCT03118570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110734965|NCT03118570|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110734966|NCT03118570|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110734967|NCT03114319|Nazartinib|nazartinib|mesh-list
110734968|NCT03114319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110734969|NCT03076320|Adapalene|adapalene|mesh-list
110734970|NCT03076320|Benzoyl Peroxide|benzoyl peroxide|mesh-list
110734971|NCT03076320|Dermatologic Agents|dermatologic agents|mesh-ancestor
110734972|NCT03076320|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110734973|NCT03076320|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110734974|NCT03076320|Analgesics|analgesics|mesh-ancestor
110734975|NCT03076320|Sensory System Agents|sensory system agents|mesh-ancestor
110734976|NCT03076320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110734977|NCT03076320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110734978|NCT03076320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110734979|NCT03076320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110734980|NCT03069937|Docetaxel|docetaxel|mesh-list
110734981|NCT03069937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110734982|NCT03069937|Tubulin Modulators|tubulin modulators|mesh-ancestor
110734983|NCT03069937|Antimitotic Agents|antimitotic agents|mesh-ancestor
110734984|NCT03069937|Mitosis Modulators|mitosis modulators|mesh-ancestor
110734985|NCT03069937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110734986|NCT03066739|Remifentanil|remifentanil|mesh-list
110734987|NCT03066739|Naloxone|naloxone|mesh-list
110734988|NCT03066739|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110734989|NCT03066739|Narcotics|narcotics|mesh-ancestor
110734990|NCT03066739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110864661|NCT02449954|Ketorolac|ketorolac|mesh-list
110734991|NCT03066739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110734992|NCT03066739|Analgesics|analgesics|mesh-ancestor
110734993|NCT03066739|Sensory System Agents|sensory system agents|mesh-ancestor
110734994|NCT03066739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110734995|NCT03066739|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110734996|NCT03054896|Venetoclax|venetoclax|mesh-list
110734997|NCT03054896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110734998|NCT03033303|Isotretinoin|isotretinoin|mesh-list
110734999|NCT03033303|Dermatologic Agents|dermatologic agents|mesh-ancestor
110735000|NCT03009981|Prednisone|prednisone|mesh-list
110735001|NCT03009981|Leuprolide|leuprolide|mesh-list
110735002|NCT03009981|Abiraterone Acetate|abiraterone acetate|mesh-list
110735003|NCT03009981|Bicalutamide|bicalutamide|mesh-list
110735004|NCT03009981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110735005|NCT03009981|Glucocorticoids|glucocorticoids|mesh-ancestor
110735006|NCT03009981|Hormones|hormones|mesh-ancestor
110735007|NCT03009981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110735008|NCT03009981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110735009|NCT03009981|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110735010|NCT03009981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110735011|NCT03009981|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110735012|NCT03009981|Fertility Agents|fertility agents|mesh-ancestor
110735013|NCT03009981|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110735014|NCT03009981|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110452759|NCT00631527|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110735015|NCT03009981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110735016|NCT03009981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110735017|NCT03009981|Hormone Antagonists|hormone antagonists|mesh-ancestor
110735018|NCT03009981|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110735019|NCT03009981|Androgen Antagonists|androgen antagonists|mesh-ancestor
110735020|NCT03009240|Decitabine|decitabine|mesh-list
110735021|NCT03009240|Enzyme Inhibitors|enzyme inhibitors|mesh-list
110735022|NCT03009240|Pevonedistat|pevonedistat|mesh-list
110735023|NCT03009240|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110735024|NCT03009240|Antimetabolites|antimetabolites|mesh-ancestor
110735025|NCT03009240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110735026|NCT03009240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110735027|NCT03006705|Capecitabine|capecitabine|mesh-list
110735028|NCT03006705|Tegafur|tegafur|mesh-list
110735029|NCT03006705|Oxaliplatin|oxaliplatin|mesh-list
110735030|NCT03006705|Nivolumab|nivolumab|mesh-list
110735031|NCT03006705|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110735032|NCT03006705|Antimetabolites|antimetabolites|mesh-ancestor
110735033|NCT03006705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110735034|NCT03006705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110735035|NCT03006705|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110735036|NCT03006705|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110735037|NCT02971683|Abatacept|abatacept|mesh-list
110735038|NCT02971683|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110735039|NCT02971683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110735040|NCT02971683|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110735041|NCT02971683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110735042|NCT02971683|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110735043|NCT02971683|Immunologic Factors|immunologic factors|mesh-ancestor
110735044|NCT02971683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110735045|NCT02971683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110735046|NCT02950051|Cyclophosphamide|cyclophosphamide|mesh-list
110735047|NCT02950051|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110735048|NCT02950051|Rituximab|rituximab|mesh-list
110735049|NCT02950051|Fludarabine|fludarabine|mesh-list
110735050|NCT02950051|Venetoclax|venetoclax|mesh-list
110735051|NCT02950051|Obinutuzumab|obinutuzumab|mesh-list
110735052|NCT02950051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110735053|NCT02950051|Immunologic Factors|immunologic factors|mesh-ancestor
110735054|NCT02950051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110735055|NCT02950051|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110735056|NCT02950051|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110735057|NCT02950051|Alkylating Agents|alkylating agents|mesh-ancestor
110735058|NCT02950051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110735059|NCT02950051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110735060|NCT02950051|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110735061|NCT02950051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110735062|NCT02949219|Pembrolizumab|pembrolizumab|mesh-list
110735063|NCT02949219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110735064|NCT02949219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110735065|NCT02949219|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110735066|NCT02949219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110735067|NCT02921022|Paclitaxel|paclitaxel|mesh-list
110735068|NCT02921022|Gemcitabine|gemcitabine|mesh-list
110735069|NCT02921022|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110144287|NCT02033733|Cisatracurium|cisatracurium|mesh-list
110735070|NCT02921022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110735071|NCT02921022|Tubulin Modulators|tubulin modulators|mesh-ancestor
110735072|NCT02921022|Antimitotic Agents|antimitotic agents|mesh-ancestor
110735073|NCT02921022|Mitosis Modulators|mitosis modulators|mesh-ancestor
110735074|NCT02921022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110735075|NCT02921022|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110735076|NCT02921022|Antimetabolites|antimetabolites|mesh-ancestor
110735077|NCT02918162|Pembrolizumab|pembrolizumab|mesh-list
110735078|NCT02918162|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110735079|NCT02918162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110735080|NCT02918162|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110735081|NCT02918162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110735082|NCT02899299|Carboplatin|carboplatin|mesh-list
110735083|NCT02899299|Nivolumab|nivolumab|mesh-list
110735084|NCT02899299|Pemetrexed|pemetrexed|mesh-list
110735085|NCT02899299|Ipilimumab|ipilimumab|mesh-list
110735086|NCT02899299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110735087|NCT02899299|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110735088|NCT02899299|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110735089|NCT02899299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110735090|NCT02899299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110735091|NCT02899299|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110452837|NCT00916149|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110735105|NCT02814916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110735106|NCT02804594|Acetylcysteine|acetylcysteine|mesh-list
110735107|NCT02804594|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110735108|NCT02804594|Antiviral Agents|antiviral agents|mesh-ancestor
110735109|NCT02804594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110735110|NCT02804594|Expectorants|expectorants|mesh-ancestor
110735111|NCT02804594|Respiratory System Agents|respiratory system agents|mesh-ancestor
110735112|NCT02804594|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110735113|NCT02804594|Antioxidants|antioxidants|mesh-ancestor
110735114|NCT02804594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110735115|NCT02804594|Protective Agents|protective agents|mesh-ancestor
110735116|NCT02804594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110735118|NCT02728050|Cytarabine|cytarabine|mesh-list
110735119|NCT02728050|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
110735120|NCT02728050|Sorafenib|sorafenib|mesh-list
110735121|NCT02728050|Mitoxantrone|mitoxantrone|mesh-list
110735122|NCT02728050|Cladribine|cladribine|mesh-list
110735123|NCT02728050|Lenograstim|lenograstim|mesh-list
110735124|NCT02728050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110735125|NCT02728050|Antimetabolites|antimetabolites|mesh-ancestor
110735126|NCT02728050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110735127|NCT02728050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110735128|NCT02728050|Antiviral Agents|antiviral agents|mesh-ancestor
110735129|NCT02728050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110735130|NCT02728050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110735131|NCT02728050|Immunologic Factors|immunologic factors|mesh-ancestor
110735132|NCT02728050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110735133|NCT02728050|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110735134|NCT02728050|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110735135|NCT02728050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110735136|NCT02728050|Analgesics|analgesics|mesh-ancestor
110735137|NCT02728050|Sensory System Agents|sensory system agents|mesh-ancestor
110735138|NCT02728050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110735139|NCT02728050|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110735140|NCT02728050|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110735141|NCT02698254|Bevacizumab|bevacizumab|mesh-list
110735142|NCT02698254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110735143|NCT02698254|Endothelial Growth Factors|endothelial growth factors|mesh-list
110735144|NCT02698254|Antibodies|antibodies|mesh-list
110735145|NCT02698254|Immunoglobulins|immunoglobulins|mesh-list
110735146|NCT02698254|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110735147|NCT02698254|Immunoglobulin G|immunoglobulin g|mesh-list
110735148|NCT02698254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110735149|NCT02698254|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110735150|NCT02698254|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110735151|NCT02698254|Growth Substances|growth substances|mesh-ancestor
110735152|NCT02698254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110735153|NCT02698254|Growth Inhibitors|growth inhibitors|mesh-ancestor
110735154|NCT02698254|Immunologic Factors|immunologic factors|mesh-ancestor
110452911|NCT04208854|Vinorelbine|vinorelbine|mesh-list
110735186|NCT02581943|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110735187|NCT02581943|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110735188|NCT02581943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110735190|NCT02581943|Antimitotic Agents|antimitotic agents|mesh-ancestor
110735191|NCT02581943|Mitosis Modulators|mitosis modulators|mesh-ancestor
110735192|NCT02581943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110735193|NCT02581943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110735194|NCT02581943|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110735195|NCT02527200|Liraglutide|liraglutide|mesh-list
110735196|NCT02527200|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110735197|NCT02527200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110735198|NCT02527200|Incretins|incretins|mesh-ancestor
110735199|NCT02527200|Hormones|hormones|mesh-ancestor
110735200|NCT02527200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110735205|NCT02510040|Botulinum Toxins|botulinum toxins|mesh-list
110735206|NCT02510040|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110735207|NCT02510040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110735208|NCT02510040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110735209|NCT02510040|Cholinergic Agents|cholinergic agents|mesh-ancestor
110735210|NCT02510040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110735211|NCT02510040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110735212|NCT02414269|Cyclophosphamide|cyclophosphamide|mesh-list
110735213|NCT02414269|Pembrolizumab|pembrolizumab|mesh-list
110735214|NCT02414269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110735215|NCT02414269|Immunologic Factors|immunologic factors|mesh-ancestor
110735216|NCT02414269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110735217|NCT02414269|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110735218|NCT02414269|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110735219|NCT02414269|Alkylating Agents|alkylating agents|mesh-ancestor
110735220|NCT02414269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110735221|NCT02414269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110735222|NCT02414269|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110735223|NCT02414269|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110735224|NCT02414269|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110735225|NCT02413736|Imatinib Mesylate|imatinib mesylate|mesh-list
110735226|NCT02413736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110735227|NCT02413736|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110735228|NCT02413736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110735229|NCT02413736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110735230|NCT02341989|Carboplatin|carboplatin|mesh-list
110735231|NCT02341989|Etoposide|etoposide|mesh-list
110735232|NCT02341989|Bleomycin|bleomycin|mesh-list
110735233|NCT02341989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110144312|NCT02035020|Interferon-gamma|interferon-gamma|mesh-list
110735234|NCT02341989|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110735235|NCT02341989|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110735236|NCT02341989|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110735237|NCT02341989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110735238|NCT02341989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110735239|NCT02341989|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110735240|NCT02296125|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110735241|NCT02296125|Gefitinib|gefitinib|mesh-list
110735242|NCT02296125|Osimertinib|osimertinib|mesh-list
110682832|NCT00902915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110735243|NCT02296125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110735244|NCT02296125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110735245|NCT02296125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110735246|NCT02296125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110735247|NCT02285192|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110735248|NCT02285192|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110735249|NCT02285192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110735251|NCT02267603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110735252|NCT02267603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110735253|NCT02267603|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110735254|NCT02267603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110735255|NCT02244125|Dexamethasone|dexamethasone|mesh-list
110735256|NCT02244125|Cyclophosphamide|cyclophosphamide|mesh-list
110735257|NCT02244125|Pomalidomide|pomalidomide|mesh-list
110735258|NCT02244125|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110735259|NCT02244125|Immunologic Factors|immunologic factors|mesh-ancestor
110735260|NCT02244125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110735261|NCT02244125|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110735262|NCT02244125|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110735263|NCT02244125|Alkylating Agents|alkylating agents|mesh-ancestor
110735264|NCT02244125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110735265|NCT02244125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110735266|NCT02244125|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110735267|NCT02244125|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110735268|NCT02244125|Antiemetics|antiemetics|mesh-ancestor
110735269|NCT02244125|Autonomic Agents|autonomic agents|mesh-ancestor
110735270|NCT02244125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110735271|NCT02244125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110735272|NCT02244125|Glucocorticoids|glucocorticoids|mesh-ancestor
110735273|NCT02244125|Hormones|hormones|mesh-ancestor
110735274|NCT02244125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110735275|NCT02244125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110735276|NCT02244125|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110735277|NCT02244125|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110735278|NCT02244125|Growth Substances|growth substances|mesh-ancestor
110735279|NCT02244125|Growth Inhibitors|growth inhibitors|mesh-ancestor
110735280|NCT02243878|Ranibizumab|ranibizumab|mesh-list
110735281|NCT02243878|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110735282|NCT02243878|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110735283|NCT02243878|Growth Substances|growth substances|mesh-ancestor
110735284|NCT02243878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110735285|NCT02243878|Growth Inhibitors|growth inhibitors|mesh-ancestor
110735286|NCT02243878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110735287|NCT02199236|Capecitabine|capecitabine|mesh-list
110735288|NCT02199236|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110735289|NCT02199236|Antimetabolites|antimetabolites|mesh-ancestor
110735290|NCT02199236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110735291|NCT02199236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110735292|NCT02157051|Vaccines|vaccines|mesh-list
110735293|NCT02157051|Immunologic Factors|immunologic factors|mesh-ancestor
110735294|NCT02157051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110735295|NCT02111941|Vaccines|vaccines|mesh-list
110735296|NCT02111941|Immunologic Factors|immunologic factors|mesh-ancestor
110735297|NCT02111941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110735299|NCT02037048|Paclitaxel|paclitaxel|mesh-list
110735300|NCT02037048|Carboplatin|carboplatin|mesh-list
110735301|NCT02037048|Fluorouracil|fluorouracil|mesh-list
110735302|NCT02037048|Oxaliplatin|oxaliplatin|mesh-list
110735303|NCT02037048|Calcium|calcium|mesh-list
110735304|NCT02037048|Levoleucovorin|levoleucovorin|mesh-list
110735305|NCT02037048|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110735306|NCT02037048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110735307|NCT02037048|Tubulin Modulators|tubulin modulators|mesh-ancestor
110735308|NCT02037048|Antimitotic Agents|antimitotic agents|mesh-ancestor
110735309|NCT02037048|Mitosis Modulators|mitosis modulators|mesh-ancestor
110735310|NCT02037048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110735311|NCT02037048|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110735312|NCT02037048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110735313|NCT02037048|Antimetabolites|antimetabolites|mesh-ancestor
110735314|NCT02037048|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110735315|NCT02037048|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110735316|NCT02037048|Immunologic Factors|immunologic factors|mesh-ancestor
110735317|NCT02037048|Antidotes|antidotes|mesh-ancestor
110735319|NCT02037048|Vitamin B Complex|vitamin b complex|mesh-ancestor
110735320|NCT02037048|Vitamins|vitamins|mesh-ancestor
110735321|NCT02037048|Micronutrients|micronutrients|mesh-ancestor
110735322|NCT01935089|Interferons|interferons|mesh-list
110735323|NCT01935089|Interferon-alpha|interferon-alpha|mesh-list
110735324|NCT01935089|Interferon alpha-2|interferon alpha-2|mesh-list
110735325|NCT01935089|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110735326|NCT01935089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110735327|NCT01935089|Antiviral Agents|antiviral agents|mesh-ancestor
110735328|NCT01935089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110735329|NCT01935089|Immunologic Factors|immunologic factors|mesh-ancestor
110735330|NCT01935089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110735331|NCT01803152|Gemcitabine|gemcitabine|mesh-list
110735332|NCT01803152|Imiquimod|imiquimod|mesh-list
110735333|NCT01803152|Vaccines|vaccines|mesh-list
110735334|NCT01803152|Immunologic Factors|immunologic factors|mesh-ancestor
110735335|NCT01803152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110735336|NCT01803152|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110735337|NCT01803152|Antimetabolites|antimetabolites|mesh-ancestor
110735338|NCT01803152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110735339|NCT01803152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110735340|NCT01803152|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110735341|NCT01803152|Interferon Inducers|interferon inducers|mesh-ancestor
110735342|NCT01787409|Vitamin D|vitamin d|mesh-list
110735343|NCT01787409|Cholecalciferol|cholecalciferol|mesh-list
110735344|NCT01787409|Vitamins|vitamins|mesh-ancestor
110735345|NCT01787409|Micronutrients|micronutrients|mesh-ancestor
110735346|NCT01787409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110735347|NCT01787409|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110735348|NCT01787409|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110735349|NCT01773707|Abatacept|abatacept|mesh-list
110735350|NCT01773707|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110735351|NCT01773707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110735352|NCT01773707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110735353|NCT01773707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110735354|NCT01773707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110735355|NCT01773707|Immunologic Factors|immunologic factors|mesh-ancestor
110735356|NCT01773707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110735357|NCT01773707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110735358|NCT01628640|Interferons|interferons|mesh-list
110735359|NCT01628640|Interferon-beta|interferon-beta|mesh-list
110735360|NCT01628640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110735361|NCT01628640|Antiviral Agents|antiviral agents|mesh-ancestor
110735362|NCT01628640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110735363|NCT01628640|Immunologic Factors|immunologic factors|mesh-ancestor
110735364|NCT01628640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110735366|NCT01504815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110735367|NCT01494662|Capecitabine|capecitabine|mesh-list
110735368|NCT01494662|Trastuzumab|trastuzumab|mesh-list
110735369|NCT01494662|Maytansine|maytansine|mesh-list
110735370|NCT01494662|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
110735371|NCT01494662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110735372|NCT01494662|Antimetabolites|antimetabolites|mesh-ancestor
110735373|NCT01494662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110735374|NCT01494662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110444679|NCT02782078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110735375|NCT01494662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110735376|NCT01494662|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110735378|NCT01494662|Antimitotic Agents|antimitotic agents|mesh-ancestor
110735379|NCT01494662|Mitosis Modulators|mitosis modulators|mesh-ancestor
110735380|NCT01494662|Immunotoxins|immunotoxins|mesh-ancestor
110735381|NCT01494662|Immunoconjugates|immunoconjugates|mesh-ancestor
110735382|NCT01494662|Immunologic Factors|immunologic factors|mesh-ancestor
110735383|NCT01494662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110735384|NCT01413100|Mycophenolic Acid|mycophenolic acid|mesh-list
110735385|NCT01413100|Plerixafor|plerixafor|mesh-list
110735386|NCT01413100|Cyclophosphamide|cyclophosphamide|mesh-list
110735387|NCT01413100|Thymoglobulin|thymoglobulin|mesh-list
110735388|NCT01413100|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110735389|NCT01413100|Lenograstim|lenograstim|mesh-list
110735390|NCT01413100|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110735391|NCT01413100|Immunologic Factors|immunologic factors|mesh-ancestor
110735392|NCT01413100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110735393|NCT01413100|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110735394|NCT01413100|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110735395|NCT01413100|Alkylating Agents|alkylating agents|mesh-ancestor
110144397|NCT02040142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110735396|NCT01413100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110735397|NCT01413100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110735398|NCT01413100|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110735399|NCT01413100|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110735400|NCT01413100|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110735401|NCT01413100|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110735402|NCT01413100|Antitubercular Agents|antitubercular agents|mesh-ancestor
110735403|NCT01413100|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110735404|NCT01413100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110735405|NCT01413100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110735407|NCT01413100|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110735408|NCT01413100|Antiviral Agents|antiviral agents|mesh-ancestor
110735409|NCT01334944|Ibuprofen|ibuprofen|mesh-list
110735410|NCT01334944|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110735411|NCT01334944|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110735412|NCT01334944|Analgesics|analgesics|mesh-ancestor
110735413|NCT01334944|Sensory System Agents|sensory system agents|mesh-ancestor
110735414|NCT01334944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110735415|NCT01334944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110735416|NCT01334944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110735417|NCT01334944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110735418|NCT01334944|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110735419|NCT01334944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110735420|NCT01334944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110735421|NCT01140373|Cyclophosphamide|cyclophosphamide|mesh-list
110735422|NCT01140373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110735423|NCT01140373|Immunologic Factors|immunologic factors|mesh-ancestor
110735424|NCT01140373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110735425|NCT01140373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110735426|NCT01140373|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110735427|NCT01140373|Alkylating Agents|alkylating agents|mesh-ancestor
110735428|NCT01140373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110735429|NCT01140373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110735430|NCT01140373|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110735431|NCT00810732|Nifedipine|nifedipine|mesh-list
110735432|NCT00810732|Sitaxsentan|sitaxsentan|mesh-list
110735433|NCT00810732|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110735434|NCT00810732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110735435|NCT00810732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110735436|NCT00810732|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110735437|NCT00810732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110735438|NCT00810732|Vasodilator Agents|vasodilator agents|mesh-ancestor
110735439|NCT00810732|Tocolytic Agents|tocolytic agents|mesh-ancestor
110735440|NCT00810732|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110735441|NCT00810732|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
110735442|NCT00770809|Paclitaxel|paclitaxel|mesh-list
110735443|NCT00770809|Trastuzumab|trastuzumab|mesh-list
110735444|NCT00770809|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110735445|NCT00770809|Lapatinib|lapatinib|mesh-list
110735446|NCT00770809|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
110735447|NCT00770809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110735448|NCT00770809|Antibodies|antibodies|mesh-list
110735449|NCT00770809|Immunoglobulins|immunoglobulins|mesh-list
110735450|NCT00770809|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110735451|NCT00770809|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110735452|NCT00770809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110735453|NCT00770809|Tubulin Modulators|tubulin modulators|mesh-ancestor
110735454|NCT00770809|Antimitotic Agents|antimitotic agents|mesh-ancestor
110735455|NCT00770809|Mitosis Modulators|mitosis modulators|mesh-ancestor
110735456|NCT00770809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110735457|NCT00770809|Immunologic Factors|immunologic factors|mesh-ancestor
110735458|NCT00770809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110735459|NCT00770809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110735460|NCT00770809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110735461|NCT00719888|Cyclosporine|cyclosporine|mesh-list
110735462|NCT00719888|Mycophenolic Acid|mycophenolic acid|mesh-list
110735463|NCT00719888|Cyclophosphamide|cyclophosphamide|mesh-list
110735464|NCT00719888|Thiotepa|thiotepa|mesh-list
110735465|NCT00719888|Fludarabine|fludarabine|mesh-list
110735466|NCT00719888|Cyclosporins|cyclosporins|mesh-list
110735467|NCT00719888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110735468|NCT00719888|Immunologic Factors|immunologic factors|mesh-ancestor
110735469|NCT00719888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110453216|NCT00626015|Daclizumab|daclizumab|mesh-list
110735470|NCT00719888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110735471|NCT00719888|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110735472|NCT00719888|Alkylating Agents|alkylating agents|mesh-ancestor
110735473|NCT00719888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110735474|NCT00719888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110735475|NCT00719888|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110735476|NCT00719888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110735477|NCT00719888|Antifungal Agents|antifungal agents|mesh-ancestor
110735478|NCT00719888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110735479|NCT00719888|Dermatologic Agents|dermatologic agents|mesh-ancestor
110735480|NCT00719888|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110735481|NCT00719888|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110735482|NCT00719888|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110735483|NCT00719888|Antitubercular Agents|antitubercular agents|mesh-ancestor
110735484|NCT00719888|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110735485|NCT00571727|Mecasermin|mecasermin|mesh-list
110735486|NCT00571727|Growth Substances|growth substances|mesh-ancestor
110735487|NCT00571727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110735488|NCT00489307|Dexamethasone|dexamethasone|mesh-list
110735489|NCT00489307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110735490|NCT00489307|Antiemetics|antiemetics|mesh-ancestor
110735491|NCT00489307|Autonomic Agents|autonomic agents|mesh-ancestor
110735492|NCT00489307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110735493|NCT00489307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110735494|NCT00489307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110735495|NCT00489307|Glucocorticoids|glucocorticoids|mesh-ancestor
110735496|NCT00489307|Hormones|hormones|mesh-ancestor
110735497|NCT00489307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110735498|NCT00489307|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110735499|NCT00489307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110735500|NCT00427349|Octreotide|octreotide|mesh-list
110735501|NCT00427349|Motesanib diphosphate|motesanib diphosphate|mesh-list
110735502|NCT00427349|Imetelstat|imetelstat|mesh-list
110735503|NCT00427349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110735504|NCT00427349|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110735505|NCT00427349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110735506|NCT00427349|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110735507|NCT00427349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110735508|NCT00427349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110735509|NCT00309985|Docetaxel|docetaxel|mesh-list
110735510|NCT00309985|Androgens|androgens|mesh-list
110735511|NCT00309985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110735512|NCT00309985|Tubulin Modulators|tubulin modulators|mesh-ancestor
110735513|NCT00309985|Antimitotic Agents|antimitotic agents|mesh-ancestor
110735514|NCT00309985|Mitosis Modulators|mitosis modulators|mesh-ancestor
110735515|NCT00309985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110735516|NCT00309985|Hormones|hormones|mesh-ancestor
110735517|NCT00309985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110735518|NCT00309985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110735519|NCT00295893|Paclitaxel|paclitaxel|mesh-list
110735520|NCT00295893|Docetaxel|docetaxel|mesh-list
110735521|NCT00295893|Cyclophosphamide|cyclophosphamide|mesh-list
110735522|NCT00295893|Carboplatin|carboplatin|mesh-list
110735523|NCT00295893|Doxorubicin|doxorubicin|mesh-list
110735524|NCT00295893|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110735525|NCT00295893|Trastuzumab|trastuzumab|mesh-list
110735526|NCT00295893|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110735527|NCT00295893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110735528|NCT00295893|Tubulin Modulators|tubulin modulators|mesh-ancestor
110735529|NCT00295893|Antimitotic Agents|antimitotic agents|mesh-ancestor
110735530|NCT00295893|Mitosis Modulators|mitosis modulators|mesh-ancestor
110735531|NCT00295893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110735532|NCT00295893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110735533|NCT00295893|Immunologic Factors|immunologic factors|mesh-ancestor
110735534|NCT00295893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110735535|NCT00295893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110735536|NCT00295893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110735537|NCT00295893|Alkylating Agents|alkylating agents|mesh-ancestor
110735538|NCT00295893|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110735539|NCT00295893|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110735540|NCT00295893|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110735541|NCT00295893|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110735542|NCT00295893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110735543|NCT00295893|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110735544|NCT00200174|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
110735545|NCT00200174|Exemestane|exemestane|mesh-list
110735546|NCT00200174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110735547|NCT00200174|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110735548|NCT00200174|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110735549|NCT00200174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110735550|NCT00200174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110735551|NCT00200174|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110735552|NCT00200174|Hormone Antagonists|hormone antagonists|mesh-ancestor
110735553|NCT00200174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110735554|NCT00200174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110735555|NCT00200174|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110735556|NCT00200174|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110735557|NCT00200174|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110735558|NCT00195091|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
110735559|NCT00195091|Chelating Agents|chelating agents|mesh-ancestor
110735560|NCT00195091|Sequestering Agents|sequestering agents|mesh-ancestor
110735561|NCT00195091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110735562|NCT00195091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110735563|NCT00195091|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110864736|NCT03204760|Hormones|hormones|mesh-ancestor
110735564|NCT00195091|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110735565|NCT00195091|Growth Substances|growth substances|mesh-ancestor
110735566|NCT00195091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110735567|NCT00195091|Growth Inhibitors|growth inhibitors|mesh-ancestor
110735568|NCT00195091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110735569|NCT00098787|Leucovorin|leucovorin|mesh-list
110735570|NCT00098787|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
110735571|NCT00098787|Tetrahydrofolates|tetrahydrofolates|mesh-list
110735572|NCT00098787|Bevacizumab|bevacizumab|mesh-list
110735573|NCT00098787|Fluorouracil|fluorouracil|mesh-list
110735574|NCT00098787|Oxaliplatin|oxaliplatin|mesh-list
110735575|NCT00098787|Irinotecan|irinotecan|mesh-list
110735576|NCT00098787|Camptothecin|camptothecin|mesh-list
110735577|NCT00098787|Levoleucovorin|levoleucovorin|mesh-list
110735578|NCT00098787|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110735579|NCT00098787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110735580|NCT00098787|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110735581|NCT00098787|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110735582|NCT00098787|Growth Substances|growth substances|mesh-ancestor
110735583|NCT00098787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110735584|NCT00098787|Growth Inhibitors|growth inhibitors|mesh-ancestor
110735585|NCT00098787|Antimetabolites|antimetabolites|mesh-ancestor
110735586|NCT00098787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110735587|NCT00098787|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110735588|NCT00098787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110735589|NCT00098787|Immunologic Factors|immunologic factors|mesh-ancestor
110735590|NCT00098787|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110735591|NCT00098787|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110735592|NCT00098787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110735593|NCT00098787|Antidotes|antidotes|mesh-ancestor
110735594|NCT00098787|Protective Agents|protective agents|mesh-ancestor
110735595|NCT00098787|Vitamin B Complex|vitamin b complex|mesh-ancestor
110735596|NCT00098787|Vitamins|vitamins|mesh-ancestor
110735597|NCT00098787|Micronutrients|micronutrients|mesh-ancestor
110735598|NCT00098787|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110735600|NCT00075946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110735601|NCT00075946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110735602|NCT00075946|Immunologic Factors|immunologic factors|mesh-ancestor
110735603|NCT00075946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110735604|NCT00075946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110735605|NCT00074165|Cytarabine|cytarabine|mesh-list
110735606|NCT00074165|Sodium thiosulfate|sodium thiosulfate|mesh-list
110735607|NCT00074165|Cyclophosphamide|cyclophosphamide|mesh-list
110735608|NCT00074165|Rituximab|rituximab|mesh-list
110735609|NCT00074165|Carboplatin|carboplatin|mesh-list
110735610|NCT00074165|Etoposide|etoposide|mesh-list
110735611|NCT00074165|Etoposide phosphate|etoposide phosphate|mesh-list
110735612|NCT00074165|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110735613|NCT00074165|Immunologic Factors|immunologic factors|mesh-ancestor
110735614|NCT00074165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110735615|NCT00074165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110735616|NCT00074165|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110735617|NCT00074165|Alkylating Agents|alkylating agents|mesh-ancestor
110735618|NCT00074165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110735619|NCT00074165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110735620|NCT00074165|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110735621|NCT00074165|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110735623|NCT00074165|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110735624|NCT00074165|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110735625|NCT00074165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110735626|NCT00074165|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110735627|NCT00074165|Antimetabolites|antimetabolites|mesh-ancestor
110735628|NCT00074165|Antiviral Agents|antiviral agents|mesh-ancestor
110735629|NCT00074165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110735630|NCT00074165|Antidotes|antidotes|mesh-ancestor
110735631|NCT00074165|Protective Agents|protective agents|mesh-ancestor
110735632|NCT00074165|Antioxidants|antioxidants|mesh-ancestor
110735633|NCT00074165|Antitubercular Agents|antitubercular agents|mesh-ancestor
110144460|NCT02040454|Paclitaxel|paclitaxel|mesh-list
110735634|NCT00074165|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110735635|NCT00074165|Chelating Agents|chelating agents|mesh-ancestor
110735636|NCT00074165|Sequestering Agents|sequestering agents|mesh-ancestor
110735637|NCT00059930|Leucovorin|leucovorin|mesh-list
110735638|NCT00059930|Dexamethasone|dexamethasone|mesh-list
110735639|NCT00059930|Fluorouracil|fluorouracil|mesh-list
110735640|NCT00059930|Oxaliplatin|oxaliplatin|mesh-list
110735641|NCT00059930|Floxuridine|floxuridine|mesh-list
110735642|NCT00059930|Calcium|calcium|mesh-list
110735643|NCT00059930|Levoleucovorin|levoleucovorin|mesh-list
110735644|NCT00059930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110735645|NCT00059930|Antiemetics|antiemetics|mesh-ancestor
110735646|NCT00059930|Autonomic Agents|autonomic agents|mesh-ancestor
110735647|NCT00059930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110735648|NCT00059930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110735649|NCT00059930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110735650|NCT00059930|Glucocorticoids|glucocorticoids|mesh-ancestor
110735651|NCT00059930|Hormones|hormones|mesh-ancestor
110735652|NCT00059930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110735653|NCT00059930|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110735654|NCT00059930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110735655|NCT00059930|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110735656|NCT00059930|Antimetabolites|antimetabolites|mesh-ancestor
110735657|NCT00059930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110735658|NCT00059930|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110735659|NCT00059930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110735660|NCT00059930|Immunologic Factors|immunologic factors|mesh-ancestor
110735661|NCT00059930|Antidotes|antidotes|mesh-ancestor
110735662|NCT00059930|Protective Agents|protective agents|mesh-ancestor
110735663|NCT00059930|Vitamin B Complex|vitamin b complex|mesh-ancestor
110735664|NCT00059930|Vitamins|vitamins|mesh-ancestor
110735665|NCT00059930|Micronutrients|micronutrients|mesh-ancestor
110735666|NCT00057876|Gemcitabine|gemcitabine|mesh-list
110735667|NCT00057876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110735668|NCT00057876|Antimetabolites|antimetabolites|mesh-ancestor
110735669|NCT00057876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110735670|NCT00057876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110735671|NCT00057837|Cisplatin|cisplatin|mesh-list
110735672|NCT00057837|Irinotecan|irinotecan|mesh-list
110735673|NCT00057837|Etoposide|etoposide|mesh-list
110735674|NCT00057837|Etoposide phosphate|etoposide phosphate|mesh-list
110735675|NCT00057837|Topotecan|topotecan|mesh-list
110735676|NCT00057837|Podophyllotoxin|podophyllotoxin|mesh-list
110735677|NCT00057837|Camptothecin|camptothecin|mesh-list
110735678|NCT00057837|Lenograstim|lenograstim|mesh-list
110735679|NCT00057837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110735680|NCT00057837|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110735681|NCT00057837|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110735682|NCT00057837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110735683|NCT00057837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110735684|NCT00057837|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110735685|NCT00057837|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110735686|NCT00057837|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110735687|NCT00057837|Immunologic Factors|immunologic factors|mesh-ancestor
110735688|NCT00057837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110735689|NCT00057837|Keratolytic Agents|keratolytic agents|mesh-ancestor
110735690|NCT00057837|Dermatologic Agents|dermatologic agents|mesh-ancestor
110735691|NCT00057837|Tubulin Modulators|tubulin modulators|mesh-ancestor
110735692|NCT00057837|Antimitotic Agents|antimitotic agents|mesh-ancestor
110735693|NCT00057837|Mitosis Modulators|mitosis modulators|mesh-ancestor
110735695|NCT00046930|Daunorubicin|daunorubicin|mesh-list
110735696|NCT00046930|Molgramostim|molgramostim|mesh-list
110735697|NCT00046930|Lenograstim|lenograstim|mesh-list
110735698|NCT00046930|Sargramostim|sargramostim|mesh-list
110735699|NCT00046930|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110735700|NCT00046930|Antimetabolites|antimetabolites|mesh-ancestor
110735701|NCT00046930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110735702|NCT00046930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110735704|NCT00046930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110735705|NCT00046930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110735706|NCT00046930|Immunologic Factors|immunologic factors|mesh-ancestor
110735707|NCT00046930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110735709|NCT00046930|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110735710|NCT00046930|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110735711|NCT00046930|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110735712|NCT00046930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110735713|NCT00042939|Docetaxel|docetaxel|mesh-list
110735714|NCT00042939|Irinotecan|irinotecan|mesh-list
110735715|NCT00042939|Cetuximab|cetuximab|mesh-list
110735716|NCT00042939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110735717|NCT00042939|Tubulin Modulators|tubulin modulators|mesh-ancestor
110735718|NCT00042939|Antimitotic Agents|antimitotic agents|mesh-ancestor
110735719|NCT00042939|Mitosis Modulators|mitosis modulators|mesh-ancestor
110735720|NCT00042939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110735721|NCT00042939|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110735722|NCT00042939|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110735723|NCT00042939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110735724|NCT00042939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110735725|NCT00008385|Selenium|selenium|mesh-list
110735726|NCT00008385|Antioxidants|antioxidants|mesh-ancestor
110735727|NCT00008385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110735728|NCT00008385|Protective Agents|protective agents|mesh-ancestor
110735729|NCT00008385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110735730|NCT00008385|Trace Elements|trace elements|mesh-ancestor
110735731|NCT00008385|Micronutrients|micronutrients|mesh-ancestor
110735732|NCT00003927|Paclitaxel|paclitaxel|mesh-list
110735733|NCT00003927|Cyclophosphamide|cyclophosphamide|mesh-list
110735734|NCT00003927|Doxorubicin|doxorubicin|mesh-list
110735735|NCT00003927|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110735736|NCT00003927|Amifostine|amifostine|mesh-list
110735737|NCT00003927|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110735738|NCT00003927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110735739|NCT00003927|Tubulin Modulators|tubulin modulators|mesh-ancestor
110735740|NCT00003927|Antimitotic Agents|antimitotic agents|mesh-ancestor
110735741|NCT00003927|Mitosis Modulators|mitosis modulators|mesh-ancestor
110735742|NCT00003927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110735743|NCT00003927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110735744|NCT00003927|Immunologic Factors|immunologic factors|mesh-ancestor
110735745|NCT00003927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110735746|NCT00003927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110735747|NCT00003927|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110735748|NCT00003927|Alkylating Agents|alkylating agents|mesh-ancestor
110735749|NCT00003927|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110735750|NCT00003927|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110735751|NCT00003927|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110735752|NCT00003927|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110735753|NCT00003927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110735754|NCT00003927|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110735755|NCT00003927|Protective Agents|protective agents|mesh-ancestor
110735756|NCT00003910|Prednisone|prednisone|mesh-list
110735757|NCT00003910|Cyclophosphamide|cyclophosphamide|mesh-list
110735758|NCT00003910|Methotrexate|methotrexate|mesh-list
110735759|NCT00003910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110735760|NCT00003910|Immunologic Factors|immunologic factors|mesh-ancestor
110735761|NCT00003910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110735762|NCT00003910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110735763|NCT00003910|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110735764|NCT00003910|Alkylating Agents|alkylating agents|mesh-ancestor
110735765|NCT00003910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110735766|NCT00003910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110735767|NCT00003910|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110735768|NCT00003910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110735769|NCT00003910|Glucocorticoids|glucocorticoids|mesh-ancestor
110735770|NCT00003910|Hormones|hormones|mesh-ancestor
110735771|NCT00003910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110735772|NCT00003910|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110735773|NCT00003910|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110735774|NCT00003910|Abortifacient Agents|abortifacient agents|mesh-ancestor
110735775|NCT00003910|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110735776|NCT00003910|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110735777|NCT00003910|Antimetabolites|antimetabolites|mesh-ancestor
110582267|NCT00732498|Hormones|hormones|mesh-ancestor
110735778|NCT00003910|Dermatologic Agents|dermatologic agents|mesh-ancestor
110735779|NCT00003910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110735780|NCT00003910|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110735781|NCT00003910|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110735782|NCT00003907|Cisplatin|cisplatin|mesh-list
110735783|NCT00003907|Doxorubicin|doxorubicin|mesh-list
110735784|NCT00003907|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110735785|NCT00003907|Mitomycins|mitomycins|mesh-list
110735786|NCT00003907|Mitomycin|mitomycin|mesh-list
110735787|NCT00003907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110735788|NCT00003907|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110735789|NCT00003907|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110735790|NCT00003907|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110735791|NCT00003907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110735792|NCT00003907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110735793|NCT00003907|Alkylating Agents|alkylating agents|mesh-ancestor
110735794|NCT00003907|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110735795|NCT04331067|Paclitaxel|paclitaxel|mesh-list
110735796|NCT04331067|Carboplatin|carboplatin|mesh-list
110735797|NCT04331067|Nivolumab|nivolumab|mesh-list
110735798|NCT04331067|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110735799|NCT04331067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110735800|NCT04331067|Tubulin Modulators|tubulin modulators|mesh-ancestor
110735801|NCT04331067|Antimitotic Agents|antimitotic agents|mesh-ancestor
110735802|NCT04331067|Mitosis Modulators|mitosis modulators|mesh-ancestor
110735803|NCT04331067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110735804|NCT04331067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110735805|NCT04331067|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110735806|NCT04329221|Calcitriol|calcitriol|mesh-list
110735807|NCT04329221|Fluorouracil|fluorouracil|mesh-list
110144512|NCT02040662|Morphine|morphine|mesh-list
110735808|NCT04329221|Calcipotriene|calcipotriene|mesh-list
110735809|NCT04329221|Petrolatum|petrolatum|mesh-list
110735810|NCT04329221|Antimetabolites|antimetabolites|mesh-ancestor
110735811|NCT04329221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110735812|NCT04329221|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110735813|NCT04329221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110735814|NCT04329221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110735815|NCT04329221|Immunologic Factors|immunologic factors|mesh-ancestor
110735816|NCT04329221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110735817|NCT04329221|Dermatologic Agents|dermatologic agents|mesh-ancestor
110735818|NCT04329221|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110735819|NCT04329221|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
110735820|NCT04329221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110735821|NCT04329221|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110735822|NCT04329221|Vitamins|vitamins|mesh-ancestor
110735823|NCT04329221|Micronutrients|micronutrients|mesh-ancestor
110735824|NCT04329221|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110735825|NCT04329221|Emollients|emollients|mesh-ancestor
110735826|NCT04324840|Temozolomide|temozolomide|mesh-list
110735827|NCT04324840|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110735828|NCT04324840|Alkylating Agents|alkylating agents|mesh-ancestor
110735829|NCT04324840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110735830|NCT04324840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110735831|NCT04316013|Lidocaine|lidocaine|mesh-list
110735832|NCT04316013|Propofol|propofol|mesh-list
110735833|NCT04316013|Sevoflurane|sevoflurane|mesh-list
110735834|NCT04316013|Anesthetics, Local|anesthetics, local|mesh-ancestor
110735835|NCT04316013|Anesthetics|anesthetics|mesh-ancestor
110735836|NCT04316013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110735837|NCT04316013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110735838|NCT04316013|Sensory System Agents|sensory system agents|mesh-ancestor
110735839|NCT04316013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110735840|NCT04316013|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110735841|NCT04316013|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110735842|NCT04316013|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110735843|NCT04316013|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110735844|NCT04316013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110735845|NCT04316013|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110735846|NCT04316013|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110735847|NCT04316013|Anesthetics, General|anesthetics, general|mesh-ancestor
110735848|NCT04316013|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110735849|NCT04316013|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110453586|NCT01193842|Vorinostat|vorinostat|mesh-list
110735850|NCT04312594|Acetylcysteine|acetylcysteine|mesh-list
110735851|NCT04312594|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110735852|NCT04312594|Antiviral Agents|antiviral agents|mesh-ancestor
110735853|NCT04312594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110735854|NCT04312594|Expectorants|expectorants|mesh-ancestor
110735855|NCT04312594|Respiratory System Agents|respiratory system agents|mesh-ancestor
110735856|NCT04312594|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110735857|NCT04312594|Antioxidants|antioxidants|mesh-ancestor
110735858|NCT04312594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110735859|NCT04312594|Protective Agents|protective agents|mesh-ancestor
110735860|NCT04312594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110735861|NCT04312594|Antidotes|antidotes|mesh-ancestor
110735862|NCT04270474|Cholinergic Antagonists|cholinergic antagonists|mesh-list
110735863|NCT04270474|Cholinergic Agents|cholinergic agents|mesh-ancestor
110735864|NCT04270474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110735865|NCT04270474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110735866|NCT04270474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110735868|NCT04264897|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110735869|NCT04264897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110735870|NCT04225026|Manganese|manganese|mesh-list
110735871|NCT04225026|Avasopasem manganese|avasopasem manganese|mesh-list
110735872|NCT04225026|Trace Elements|trace elements|mesh-ancestor
110735873|NCT04225026|Micronutrients|micronutrients|mesh-ancestor
110735874|NCT04225026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110735875|NCT04225026|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110735876|NCT04225026|Antioxidants|antioxidants|mesh-ancestor
110735877|NCT04225026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110735878|NCT04225026|Protective Agents|protective agents|mesh-ancestor
110735879|NCT04177108|Paclitaxel|paclitaxel|mesh-list
110735880|NCT04177108|Atezolizumab|atezolizumab|mesh-list
110735881|NCT04177108|Ipatasertib|ipatasertib|mesh-list
110735882|NCT04177108|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110735883|NCT04177108|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110735884|NCT04177108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110735885|NCT04177108|Tubulin Modulators|tubulin modulators|mesh-ancestor
110735886|NCT04177108|Antimitotic Agents|antimitotic agents|mesh-ancestor
110735887|NCT04177108|Mitosis Modulators|mitosis modulators|mesh-ancestor
110735888|NCT04177108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110735889|NCT04177108|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110735890|NCT04177108|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110735891|NCT04177108|Immunologic Factors|immunologic factors|mesh-ancestor
110735892|NCT04177108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110735893|NCT04177108|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110735894|NCT04177108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110735895|NCT04140513|Deoxyglucose|deoxyglucose|mesh-list
110735896|NCT04140513|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110735897|NCT04140513|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110444688|NCT02782078|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110735898|NCT04140513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110735899|NCT04140513|Antimetabolites|antimetabolites|mesh-ancestor
110735900|NCT04140513|Antiviral Agents|antiviral agents|mesh-ancestor
110735901|NCT04140513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110735902|NCT04111627|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110735903|NCT04111627|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110735904|NCT04111627|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110735905|NCT04111627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110735906|NCT04111627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110735907|NCT04111627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110735908|NCT04111627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110735909|NCT04111627|Analgesics|analgesics|mesh-ancestor
110735910|NCT04111627|Sensory System Agents|sensory system agents|mesh-ancestor
110735911|NCT04111627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110735912|NCT04111627|Antidepressive Agents|antidepressive agents|mesh-ancestor
110735913|NCT04111627|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110735914|NCT04111627|Dopamine Agents|dopamine agents|mesh-ancestor
110735916|NCT04090710|Ipilimumab|ipilimumab|mesh-list
110735917|NCT04090710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110735919|NCT04090710|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110735920|NCT04090710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110735921|NCT04069312|Azithromycin|azithromycin|mesh-list
110735922|NCT04069312|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110735923|NCT04069312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110735924|NCT03983954|Durvalumab|durvalumab|mesh-list
110735925|NCT03983954|Obinutuzumab|obinutuzumab|mesh-list
110735927|NCT03983954|Naptumomab estafenatox|naptumomab estafenatox|mesh-list
110735928|NCT03983954|Immunoconjugates|immunoconjugates|mesh-list
110735929|NCT03983954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110735930|NCT03983954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110735931|NCT03983954|Immunologic Factors|immunologic factors|mesh-ancestor
110735932|NCT03983954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110735933|NCT03982277|Rifampin|rifampin|mesh-list
110735934|NCT03982277|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110735935|NCT03982277|Antitubercular Agents|antitubercular agents|mesh-ancestor
110735936|NCT03982277|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110735937|NCT03982277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110735938|NCT03982277|Leprostatic Agents|leprostatic agents|mesh-ancestor
110735939|NCT03982277|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110735940|NCT03982277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110735941|NCT03982277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110735942|NCT03982277|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110735943|NCT03982277|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110735944|NCT03982277|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110735945|NCT03982277|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110735946|NCT03982277|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110735947|NCT03982277|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110735948|NCT03955978|Dostarlimab|dostarlimab|mesh-list
110735949|NCT03955978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110735950|NCT03940352|Venetoclax|venetoclax|mesh-list
110735951|NCT03940352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110735952|NCT03918499|Cyclophosphamide|cyclophosphamide|mesh-list
110735953|NCT03918499|Pembrolizumab|pembrolizumab|mesh-list
110735954|NCT03918499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110735955|NCT03918499|Immunologic Factors|immunologic factors|mesh-ancestor
110735956|NCT03918499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110735957|NCT03918499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110735958|NCT03918499|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110735959|NCT03918499|Alkylating Agents|alkylating agents|mesh-ancestor
110735960|NCT03918499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110735961|NCT03918499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110735962|NCT03918499|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110735963|NCT03918499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110735964|NCT03918499|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110735965|NCT03914443|Cisplatin|cisplatin|mesh-list
110735966|NCT03914443|Docetaxel|docetaxel|mesh-list
110735967|NCT03914443|Fluorouracil|fluorouracil|mesh-list
110735968|NCT03914443|Nivolumab|nivolumab|mesh-list
110735969|NCT03914443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110735970|NCT03914443|Tubulin Modulators|tubulin modulators|mesh-ancestor
110735971|NCT03914443|Antimitotic Agents|antimitotic agents|mesh-ancestor
110735972|NCT03914443|Mitosis Modulators|mitosis modulators|mesh-ancestor
110735973|NCT03914443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110735974|NCT03914443|Antimetabolites|antimetabolites|mesh-ancestor
110735975|NCT03914443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110735976|NCT03914443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110735977|NCT03914443|Immunologic Factors|immunologic factors|mesh-ancestor
110735978|NCT03914443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110735979|NCT03914443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110735980|NCT03914443|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110735982|NCT03815890|Ipilimumab|ipilimumab|mesh-list
110735983|NCT03815890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110735984|NCT03815890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110735985|NCT03815890|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110735986|NCT03815890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110735987|NCT03794583|Treprostinil|treprostinil|mesh-list
110735988|NCT03794583|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110735989|NCT03711474|Dexamethasone|dexamethasone|mesh-list
110735990|NCT03711474|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110735991|NCT03711474|Antiemetics|antiemetics|mesh-ancestor
110735992|NCT03711474|Autonomic Agents|autonomic agents|mesh-ancestor
110735993|NCT03711474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110735994|NCT03711474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110735995|NCT03711474|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110735996|NCT03711474|Glucocorticoids|glucocorticoids|mesh-ancestor
110735998|NCT03711474|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110682833|NCT00902915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110735999|NCT03711474|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110736000|NCT03711474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110736002|NCT03482024|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110736003|NCT03482024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110736004|NCT03482024|Incretins|incretins|mesh-ancestor
110736005|NCT03482024|Hormones|hormones|mesh-ancestor
110736006|NCT03482024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110736007|NCT03423199|Tamoxifen|tamoxifen|mesh-list
110736008|NCT03423199|Goserelin|goserelin|mesh-list
110736009|NCT03423199|Palbociclib|palbociclib|mesh-list
110736010|NCT03423199|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110736011|NCT03423199|Hormone Antagonists|hormone antagonists|mesh-ancestor
110736012|NCT03423199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110736013|NCT03423199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110736014|NCT03423199|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110736015|NCT03423199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110736016|NCT03423199|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110736017|NCT03423199|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110736018|NCT03423199|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110736019|NCT03423199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110736020|NCT03423199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110736021|NCT03423199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110736022|NCT03423147|Chlorhexidine|chlorhexidine|mesh-list
110736023|NCT03423147|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110736024|NCT03423147|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110736025|NCT03423147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110736026|NCT03423147|Disinfectants|disinfectants|mesh-ancestor
110736027|NCT03423147|Dermatologic Agents|dermatologic agents|mesh-ancestor
110736028|NCT03418532|Osimertinib|osimertinib|mesh-list
110736029|NCT03418532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110736030|NCT03418532|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110736031|NCT03418532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110736032|NCT03418532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110736033|NCT03417401|Plasminogen|plasminogen|mesh-list
110736034|NCT03417401|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
110736035|NCT03417401|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110736036|NCT03417401|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110736037|NCT03417401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110736038|NCT03322631|Tirzepatide|tirzepatide|mesh-list
110736039|NCT03322631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110736040|NCT03322631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110736041|NCT03322631|Incretins|incretins|mesh-ancestor
110736042|NCT03322631|Hormones|hormones|mesh-ancestor
110736043|NCT03322631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110736044|NCT03290612|Ascorbic Acid|ascorbic acid|mesh-list
110736045|NCT03290612|Vitamins|vitamins|mesh-ancestor
110736046|NCT03290612|Micronutrients|micronutrients|mesh-ancestor
110736047|NCT03290612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110736048|NCT03290612|Antioxidants|antioxidants|mesh-ancestor
110736049|NCT03290612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110736050|NCT03290612|Protective Agents|protective agents|mesh-ancestor
110736051|NCT03086642|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
110864786|NCT02447380|Docetaxel|docetaxel|mesh-list
110736052|NCT03086642|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110736053|NCT03086642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110736054|NCT03057795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110736055|NCT03057795|Nivolumab|nivolumab|mesh-list
110736056|NCT03057795|Brentuximab Vedotin|brentuximab vedotin|mesh-list
110736057|NCT03057795|Antibodies|antibodies|mesh-list
110736058|NCT03057795|Immunoglobulins|immunoglobulins|mesh-list
110736059|NCT03057795|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110736060|NCT03057795|Immunoconjugates|immunoconjugates|mesh-list
110736061|NCT03057795|Immunologic Factors|immunologic factors|mesh-ancestor
110736062|NCT03057795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110736063|NCT03057795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110736064|NCT03057795|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110736065|NCT03057795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110736066|NCT03057795|Immunotoxins|immunotoxins|mesh-ancestor
110736067|NCT03018704|Topiramate|topiramate|mesh-list
110736068|NCT03018704|Anticonvulsants|anticonvulsants|mesh-ancestor
110736069|NCT03018704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110736070|NCT03018704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110736071|NCT02978612|Capecitabine|capecitabine|mesh-list
110736072|NCT02978612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110736073|NCT02978612|Antimetabolites|antimetabolites|mesh-ancestor
110736074|NCT02978612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110736075|NCT02978612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110736076|NCT02970500|Methylphenidate|methylphenidate|mesh-list
110736077|NCT02970500|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110736078|NCT02970500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110736079|NCT02970500|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110736080|NCT02970500|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110736081|NCT02970500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110736082|NCT02970500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110736083|NCT02970500|Dopamine Agents|dopamine agents|mesh-ancestor
110736084|NCT02970500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110736085|NCT02951130|Milrinone|milrinone|mesh-list
110736086|NCT02951130|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110736087|NCT02951130|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110736088|NCT02951130|Vasodilator Agents|vasodilator agents|mesh-ancestor
110736089|NCT02951130|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110736090|NCT02951130|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110736091|NCT02951130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110736092|NCT02951130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110736093|NCT02951130|Protective Agents|protective agents|mesh-ancestor
110736094|NCT02951130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110736095|NCT02810743|Olaparib|olaparib|mesh-list
110736096|NCT02810743|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110736097|NCT02810743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110736098|NCT02810743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110736099|NCT02810743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110736100|NCT02617407|Listerine|listerine|mesh-list
110736101|NCT02617407|Sodium Fluoride|sodium fluoride|mesh-list
110736102|NCT02617407|Cariostatic Agents|cariostatic agents|mesh-ancestor
110736103|NCT02617407|Protective Agents|protective agents|mesh-ancestor
110736104|NCT02617407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110736105|NCT02617407|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110736106|NCT02617407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110736107|NCT02537509|Cholecalciferol|cholecalciferol|mesh-list
110736108|NCT02537509|Vitamin D|vitamin d|mesh-list
110144669|NCT02041650|Ticagrelor|ticagrelor|mesh-list
110736109|NCT02537509|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110736110|NCT02537509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110736111|NCT02537509|Vitamins|vitamins|mesh-ancestor
110736112|NCT02537509|Micronutrients|micronutrients|mesh-ancestor
110736113|NCT02537509|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110736114|NCT02490878|Bevacizumab|bevacizumab|mesh-list
110736115|NCT02490878|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110736116|NCT02490878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110736117|NCT02490878|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110736118|NCT02490878|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110736119|NCT02490878|Growth Substances|growth substances|mesh-ancestor
110736120|NCT02490878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110736121|NCT02490878|Growth Inhibitors|growth inhibitors|mesh-ancestor
110736122|NCT02332850|Dexamethasone|dexamethasone|mesh-list
110736123|NCT02332850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110736124|NCT02332850|Antiemetics|antiemetics|mesh-ancestor
110736125|NCT02332850|Autonomic Agents|autonomic agents|mesh-ancestor
110736126|NCT02332850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110736127|NCT02332850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110736128|NCT02332850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110736129|NCT02332850|Glucocorticoids|glucocorticoids|mesh-ancestor
110736130|NCT02332850|Hormones|hormones|mesh-ancestor
110736131|NCT02332850|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110736132|NCT02332850|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110736133|NCT02332850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110736134|NCT02262325|Etoposide|etoposide|mesh-list
110736135|NCT02262325|Etoposide phosphate|etoposide phosphate|mesh-list
110736136|NCT02262325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110736137|NCT02262325|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110736138|NCT02262325|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110736139|NCT02262325|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110736140|NCT02262325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110736141|NCT02262325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110736142|NCT02205762|Cytarabine|cytarabine|mesh-list
110736143|NCT02205762|Prednisone|prednisone|mesh-list
110736144|NCT02205762|Indomethacin|indomethacin|mesh-list
110736145|NCT02205762|Methotrexate|methotrexate|mesh-list
110736146|NCT02205762|Mercaptopurine|mercaptopurine|mesh-list
110736147|NCT02205762|Vinblastine|vinblastine|mesh-list
110736148|NCT02205762|Cladribine|cladribine|mesh-list
110736149|NCT02205762|Immunoglobulins|immunoglobulins|mesh-list
110736150|NCT02205762|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110736151|NCT02205762|gamma-Globulins|gamma-globulins|mesh-list
110736152|NCT02205762|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110736153|NCT02205762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110736154|NCT02205762|Glucocorticoids|glucocorticoids|mesh-ancestor
110736155|NCT02205762|Hormones|hormones|mesh-ancestor
110144677|NCT02041650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110736156|NCT02205762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110736157|NCT02205762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110736158|NCT02205762|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110736159|NCT02205762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110736160|NCT02205762|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110736161|NCT02205762|Abortifacient Agents|abortifacient agents|mesh-ancestor
110736162|NCT02205762|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110736163|NCT02205762|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110736164|NCT02205762|Antimetabolites|antimetabolites|mesh-ancestor
110736165|NCT02205762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110736166|NCT02205762|Dermatologic Agents|dermatologic agents|mesh-ancestor
110736167|NCT02205762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110736168|NCT02205762|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110736169|NCT02205762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110736170|NCT02205762|Immunologic Factors|immunologic factors|mesh-ancestor
110736171|NCT02205762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110736172|NCT02205762|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110736173|NCT02205762|Antiviral Agents|antiviral agents|mesh-ancestor
110736174|NCT02205762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110736175|NCT02205762|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110736176|NCT02205762|Tubulin Modulators|tubulin modulators|mesh-ancestor
110736177|NCT02205762|Antimitotic Agents|antimitotic agents|mesh-ancestor
110736178|NCT02205762|Mitosis Modulators|mitosis modulators|mesh-ancestor
110736179|NCT02205762|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110736180|NCT02205762|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110736181|NCT02205762|Analgesics|analgesics|mesh-ancestor
110736182|NCT02205762|Sensory System Agents|sensory system agents|mesh-ancestor
110736183|NCT02205762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110736184|NCT02205762|Gout Suppressants|gout suppressants|mesh-ancestor
110736185|NCT02205762|Tocolytic Agents|tocolytic agents|mesh-ancestor
110736186|NCT02205762|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110736187|NCT01996267|Paclitaxel|paclitaxel|mesh-list
110736188|NCT01996267|Cyclophosphamide|cyclophosphamide|mesh-list
110736189|NCT01996267|Carboplatin|carboplatin|mesh-list
110736190|NCT01996267|Fluorouracil|fluorouracil|mesh-list
110736191|NCT01996267|Trastuzumab|trastuzumab|mesh-list
110736192|NCT01996267|Pertuzumab|pertuzumab|mesh-list
110736193|NCT01996267|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110736194|NCT01996267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110736195|NCT01996267|Tubulin Modulators|tubulin modulators|mesh-ancestor
110736196|NCT01996267|Antimitotic Agents|antimitotic agents|mesh-ancestor
110736197|NCT01996267|Mitosis Modulators|mitosis modulators|mesh-ancestor
110736198|NCT01996267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110736199|NCT01996267|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110736200|NCT01996267|Immunologic Factors|immunologic factors|mesh-ancestor
110736201|NCT01996267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110736202|NCT01996267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110736203|NCT01996267|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110736204|NCT01996267|Alkylating Agents|alkylating agents|mesh-ancestor
110736205|NCT01996267|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110736206|NCT01996267|Antimetabolites|antimetabolites|mesh-ancestor
110736207|NCT01996267|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110736208|NCT01996267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110736209|NCT01934218|Hyaluronic Acid|hyaluronic acid|mesh-list
110736210|NCT01934218|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110736211|NCT01934218|Immunologic Factors|immunologic factors|mesh-ancestor
110736212|NCT01934218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110736213|NCT01934218|Viscosupplements|viscosupplements|mesh-ancestor
110736214|NCT01934218|Protective Agents|protective agents|mesh-ancestor
110736215|NCT01898117|Paclitaxel|paclitaxel|mesh-list
110736216|NCT01898117|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110736217|NCT01898117|Cyclophosphamide|cyclophosphamide|mesh-list
110736218|NCT01898117|Carboplatin|carboplatin|mesh-list
110736219|NCT01898117|Atezolizumab|atezolizumab|mesh-list
110736220|NCT01898117|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110736221|NCT01898117|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110736222|NCT01898117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110682834|NCT00902915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110736223|NCT01898117|Tubulin Modulators|tubulin modulators|mesh-ancestor
110736224|NCT01898117|Antimitotic Agents|antimitotic agents|mesh-ancestor
110736225|NCT01898117|Mitosis Modulators|mitosis modulators|mesh-ancestor
110736226|NCT01898117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110736227|NCT01898117|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110736228|NCT01898117|Immunologic Factors|immunologic factors|mesh-ancestor
110736229|NCT01898117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110736230|NCT01898117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110736231|NCT01898117|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110736232|NCT01898117|Alkylating Agents|alkylating agents|mesh-ancestor
110736233|NCT01898117|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110736234|NCT01898117|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110736235|NCT01898117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110736236|NCT01623167|Cyclosporine|cyclosporine|mesh-list
110736237|NCT01623167|Cyclosporins|cyclosporins|mesh-list
110736238|NCT01623167|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110736239|NCT01623167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110736240|NCT01623167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110736241|NCT01623167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110736242|NCT01623167|Immunologic Factors|immunologic factors|mesh-ancestor
110736243|NCT01623167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110736244|NCT01623167|Antifungal Agents|antifungal agents|mesh-ancestor
110736245|NCT01623167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110736246|NCT01623167|Dermatologic Agents|dermatologic agents|mesh-ancestor
110736247|NCT01623167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110736248|NCT01623167|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110736250|NCT01233635|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110736251|NCT01233635|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110736252|NCT01233635|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110736253|NCT01233635|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110736254|NCT01233635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110736255|NCT00385606|Rofecoxib|rofecoxib|mesh-list
110736256|NCT00385606|Gemcitabine|gemcitabine|mesh-list
110736257|NCT00385606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110736258|NCT00385606|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110365883|NCT05751629|Dostarlimab|dostarlimab|mesh-list
110736259|NCT00385606|Antimetabolites|antimetabolites|mesh-ancestor
110736260|NCT00385606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110736261|NCT00385606|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110736262|NCT00385606|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110736263|NCT00385606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110736264|NCT00385606|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110736265|NCT00385606|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110736266|NCT00385606|Analgesics|analgesics|mesh-ancestor
110736267|NCT00385606|Sensory System Agents|sensory system agents|mesh-ancestor
110736268|NCT00385606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110736269|NCT00385606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110736270|NCT00385606|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110736271|NCT00385606|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110736272|NCT03721744|Paclitaxel|paclitaxel|mesh-list
110736273|NCT03721744|Gemcitabine|gemcitabine|mesh-list
110736274|NCT03721744|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110736275|NCT03721744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110736276|NCT03721744|Tubulin Modulators|tubulin modulators|mesh-ancestor
110736277|NCT03721744|Antimitotic Agents|antimitotic agents|mesh-ancestor
110736278|NCT03721744|Mitosis Modulators|mitosis modulators|mesh-ancestor
110736279|NCT03721744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110736280|NCT03721744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110736281|NCT03721744|Antimetabolites|antimetabolites|mesh-ancestor
110736282|NCT01589354|Ropivacaine|ropivacaine|mesh-list
110736283|NCT01589354|Anesthetics, Local|anesthetics, local|mesh-ancestor
110736284|NCT01589354|Anesthetics|anesthetics|mesh-ancestor
110144764|NCT02042690|Hormones|hormones|mesh-ancestor
110736285|NCT01589354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110736286|NCT01589354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110736287|NCT01589354|Sensory System Agents|sensory system agents|mesh-ancestor
110736288|NCT01589354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110736289|NCT01583660|Acetaminophen|acetaminophen|mesh-list
110736290|NCT01583660|Celecoxib|celecoxib|mesh-list
110736291|NCT01583660|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
110736292|NCT01583660|Oxycodone|oxycodone|mesh-list
110736293|NCT01583660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110736294|NCT01583660|Analgesics|analgesics|mesh-ancestor
110736295|NCT01583660|Sensory System Agents|sensory system agents|mesh-ancestor
110736296|NCT01583660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110736297|NCT01583660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110736298|NCT01583660|Antipyretics|antipyretics|mesh-ancestor
110736299|NCT01583660|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110736300|NCT01583660|Narcotics|narcotics|mesh-ancestor
110736301|NCT01583660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110736302|NCT01583660|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110736303|NCT01583660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110736304|NCT01583660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110736305|NCT01583660|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110736306|NCT01583660|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110736307|NCT01583660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110736308|NCT01583660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110736309|NCT01089218|Amoxicillin|amoxicillin|mesh-list
110736310|NCT01089218|Clavulanic Acid|clavulanic acid|mesh-list
110736311|NCT01089218|Clavulanic Acids|clavulanic acids|mesh-list
110736312|NCT01089218|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
110736313|NCT01089218|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110736314|NCT01089218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110736315|NCT01089218|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110736316|NCT01089218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110736317|NCT01089218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110736318|NCT03957668|Lactulose|lactulose|mesh-list
110736319|NCT03957668|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
110736320|NCT03957668|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110736321|NCT03957668|Laxatives|laxatives|mesh-ancestor
110736322|NCT01089452|Amlodipine|amlodipine|mesh-list
110736323|NCT01089452|Olmesartan|olmesartan|mesh-list
110736324|NCT01089452|Perindopril|perindopril|mesh-list
110736325|NCT01089452|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110736326|NCT01089452|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110736327|NCT01089452|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110736328|NCT01089452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110736329|NCT01089452|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110736330|NCT01089452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110736331|NCT01089452|Vasodilator Agents|vasodilator agents|mesh-ancestor
110736332|NCT01089452|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110736333|NCT01089452|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110736334|NCT01089452|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110736335|NCT01089452|Protease Inhibitors|protease inhibitors|mesh-ancestor
110736336|NCT01089452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110736337|NCT04880980|Itraconazole|itraconazole|mesh-list
110736338|NCT04880980|Terbinafine|terbinafine|mesh-list
110736339|NCT04880980|Antifungal Agents|antifungal agents|mesh-ancestor
110144780|NCT02042742|Phenylethyl Alcohol|phenylethyl alcohol|mesh-list
110736340|NCT04880980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110736341|NCT04880980|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110736342|NCT04880980|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110736343|NCT04880980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110736344|NCT04880980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110736345|NCT04880980|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110736346|NCT04880980|Hormone Antagonists|hormone antagonists|mesh-ancestor
110736347|NCT04880980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110736348|NCT04880980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110736349|NCT04880980|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110736350|NCT01583504|Anesthetics|anesthetics|mesh-list
110736351|NCT01583504|Anesthetics, Local|anesthetics, local|mesh-list
110736352|NCT01583504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110736353|NCT01583504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110736354|NCT01583504|Sensory System Agents|sensory system agents|mesh-ancestor
110736355|NCT01583504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110736356|NCT01583036|Digoxin|digoxin|mesh-list
110736357|NCT01583036|Ezogabine|ezogabine|mesh-list
110736358|NCT01583036|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110736359|NCT01583036|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110736360|NCT01583036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110736361|NCT01583036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110736362|NCT01583036|Protective Agents|protective agents|mesh-ancestor
110736363|NCT01583036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110736364|NCT01583036|Anticonvulsants|anticonvulsants|mesh-ancestor
110736365|NCT01583036|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110736366|NCT01091792|Bevacizumab|bevacizumab|mesh-list
110736367|NCT01091792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110736368|NCT01091792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110736369|NCT01091792|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110736370|NCT01091792|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110736371|NCT01091792|Growth Substances|growth substances|mesh-ancestor
110736372|NCT01091792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110736373|NCT01091792|Growth Inhibitors|growth inhibitors|mesh-ancestor
110736374|NCT03510910|Acetaminophen|acetaminophen|mesh-list
110736375|NCT03510910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110736376|NCT03510910|Analgesics|analgesics|mesh-ancestor
110736377|NCT03510910|Sensory System Agents|sensory system agents|mesh-ancestor
110736378|NCT03510910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110736379|NCT03510910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110736380|NCT03510910|Antipyretics|antipyretics|mesh-ancestor
110736381|NCT01091870|Sildenafil Citrate|sildenafil citrate|mesh-list
110736382|NCT01091870|Citric Acid|citric acid|mesh-list
110736383|NCT01091870|Sodium Citrate|sodium citrate|mesh-list
110736384|NCT01091870|Anticoagulants|anticoagulants|mesh-ancestor
110736385|NCT01091870|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110736386|NCT01091870|Chelating Agents|chelating agents|mesh-ancestor
110736387|NCT01091870|Sequestering Agents|sequestering agents|mesh-ancestor
110736388|NCT01091870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110736389|NCT01091870|Vasodilator Agents|vasodilator agents|mesh-ancestor
110736390|NCT01091870|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110736391|NCT01091870|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110736392|NCT01091870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110736393|NCT01091870|Urological Agents|urological agents|mesh-ancestor
110736394|NCT03509350|Vitamins|vitamins|mesh-list
110736395|NCT03509350|Ascorbic Acid|ascorbic acid|mesh-list
110736396|NCT03509350|Thiamine|thiamine|mesh-list
110736397|NCT03509350|Hydrocortisone|hydrocortisone|mesh-list
110736398|NCT03509350|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
110736399|NCT03509350|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
110736400|NCT03509350|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
110736401|NCT03509350|Micronutrients|micronutrients|mesh-ancestor
110736402|NCT03509350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110736403|NCT03509350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110736405|NCT03509350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110736406|NCT03509350|Protective Agents|protective agents|mesh-ancestor
110736407|NCT03509350|Vitamin B Complex|vitamin b complex|mesh-ancestor
110736408|NCT00072410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110736409|NCT00072410|Antibodies|antibodies|mesh-list
110736410|NCT00072410|Immunoglobulins|immunoglobulins|mesh-list
110736411|NCT00072410|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110736412|NCT00072410|Immunologic Factors|immunologic factors|mesh-ancestor
110736413|NCT00072410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110736414|NCT00072410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110736415|NCT03478696|Budesonide|budesonide|mesh-list
110736416|NCT03478696|Albuterol|albuterol|mesh-list
110736417|NCT03478696|Formoterol Fumarate|formoterol fumarate|mesh-list
110736418|NCT03478696|Tiotropium Bromide|tiotropium bromide|mesh-list
110736419|NCT03478696|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
110736420|NCT03478696|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110736421|NCT03478696|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110736422|NCT03478696|Autonomic Agents|autonomic agents|mesh-ancestor
110736423|NCT03478696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110736424|NCT03478696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110736425|NCT03478696|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110736426|NCT03478696|Respiratory System Agents|respiratory system agents|mesh-ancestor
110736427|NCT03478696|Glucocorticoids|glucocorticoids|mesh-ancestor
110736428|NCT03478696|Hormones|hormones|mesh-ancestor
110736429|NCT03478696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110736430|NCT03478696|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110736431|NCT03478696|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110736432|NCT03478696|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110736433|NCT03478696|Adrenergic Agents|adrenergic agents|mesh-ancestor
110736434|NCT03478696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110736435|NCT03478696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110736436|NCT03478696|Parasympatholytics|parasympatholytics|mesh-ancestor
110736437|NCT03478696|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110736438|NCT03478696|Cholinergic Agents|cholinergic agents|mesh-ancestor
110736439|NCT03478696|Tocolytic Agents|tocolytic agents|mesh-ancestor
110736440|NCT03478696|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110736441|NCT00072176|Sirolimus|sirolimus|mesh-list
110736442|NCT00072176|Temsirolimus|temsirolimus|mesh-list
110736443|NCT00072176|MTOR Inhibitors|mtor inhibitors|mesh-list
110736444|NCT00072176|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110454191|NCT01160822|Analgesics|analgesics|mesh-ancestor
110736445|NCT00072176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110736446|NCT00072176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110736447|NCT00072176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110736448|NCT00072176|Immunologic Factors|immunologic factors|mesh-ancestor
110736449|NCT00072176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110736450|NCT00072176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110736451|NCT00072176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110736452|NCT00072176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110736453|NCT00072176|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110736454|NCT00072176|Antifungal Agents|antifungal agents|mesh-ancestor
110736456|NCT00071396|Alemtuzumab|alemtuzumab|mesh-list
110736457|NCT00071396|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110736458|NCT00071396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110736459|NCT00071396|Immunologic Factors|immunologic factors|mesh-ancestor
110736460|NCT00071396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110736461|NCT00071396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110736462|NCT03472534|Diacerein|diacerein|mesh-list
110736463|NCT03472534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110736464|NCT03725020|Fluorides|fluorides|mesh-list
110736465|NCT03725020|Fluorides, Topical|fluorides, topical|mesh-list
110736466|NCT03725020|Cariostatic Agents|cariostatic agents|mesh-ancestor
110736467|NCT03725020|Protective Agents|protective agents|mesh-ancestor
110736468|NCT03725020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110736469|NCT03721432|Pregabalin|pregabalin|mesh-list
110736470|NCT03721432|Analgesics|analgesics|mesh-ancestor
110736471|NCT03721432|Sensory System Agents|sensory system agents|mesh-ancestor
110736472|NCT03721432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110736473|NCT03721432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110736474|NCT03721432|Anticonvulsants|anticonvulsants|mesh-ancestor
110736475|NCT03721432|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110736476|NCT03721432|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110736477|NCT03721432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110736478|NCT03721432|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110736479|NCT03721432|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110736480|NCT03721432|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110736481|NCT03721432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110736482|NCT03721432|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110736483|NCT03469336|Betamethasone|betamethasone|mesh-list
110736484|NCT03469336|Calcipotriene|calcipotriene|mesh-list
110736485|NCT03469336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110736486|NCT03469336|Glucocorticoids|glucocorticoids|mesh-ancestor
110736487|NCT03469336|Hormones|hormones|mesh-ancestor
110736488|NCT03469336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110736489|NCT03469336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110736490|NCT03469336|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110736491|NCT03469336|Respiratory System Agents|respiratory system agents|mesh-ancestor
110736492|NCT03469336|Dermatologic Agents|dermatologic agents|mesh-ancestor
110736493|NCT03719560|Cytarabine|cytarabine|mesh-list
110736494|NCT03719560|Methotrexate|methotrexate|mesh-list
110736495|NCT03719560|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110736496|NCT03719560|Abortifacient Agents|abortifacient agents|mesh-ancestor
110736497|NCT03719560|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110736498|NCT03719560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110736499|NCT03719560|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110736500|NCT03719560|Antimetabolites|antimetabolites|mesh-ancestor
110736501|NCT03719560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110736502|NCT03719560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110736503|NCT03719560|Dermatologic Agents|dermatologic agents|mesh-ancestor
110736504|NCT03719560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110736505|NCT03719560|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110736506|NCT03719560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110736507|NCT03719560|Immunologic Factors|immunologic factors|mesh-ancestor
110736508|NCT03719560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110736509|NCT03719560|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110736510|NCT03719560|Antiviral Agents|antiviral agents|mesh-ancestor
110736511|NCT03719560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110736512|NCT03469258|Pancrelipase|pancrelipase|mesh-list
110736513|NCT03469258|Pancreatin|pancreatin|mesh-list
110736514|NCT03469258|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110736515|NCT00066170|Sodium Oxybate|sodium oxybate|mesh-list
110736516|NCT00066170|Modafinil|modafinil|mesh-list
110736517|NCT00066170|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110736518|NCT00066170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110736519|NCT00066170|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
110144826|NCT02043314|Isoniazid|isoniazid|mesh-list
110736520|NCT00066170|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110736521|NCT00066170|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110454276|NCT00641212|Budesonide|budesonide|mesh-list
110736522|NCT00066170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110736523|NCT00066170|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110736524|NCT00066170|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110736525|NCT00066170|Anesthetics, General|anesthetics, general|mesh-ancestor
110736526|NCT00066170|Anesthetics|anesthetics|mesh-ancestor
110736527|NCT00066170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110736528|NCT00065468|Interferons|interferons|mesh-list
110736529|NCT00065468|Interferon-alpha|interferon-alpha|mesh-list
110736531|NCT00065468|Temsirolimus|temsirolimus|mesh-list
110736532|NCT00065468|MTOR Inhibitors|mtor inhibitors|mesh-list
110736533|NCT00065468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110736534|NCT00065468|Antiviral Agents|antiviral agents|mesh-ancestor
110736535|NCT00065468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110736536|NCT00065468|Immunologic Factors|immunologic factors|mesh-ancestor
110736537|NCT00065468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110736538|NCT00065468|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110736539|NCT00065468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110736540|NCT00065468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110736541|NCT00065468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110736542|NCT00065468|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110736543|NCT00065468|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110736544|NCT00065468|Antifungal Agents|antifungal agents|mesh-ancestor
110736545|NCT00071006|Axitinib|axitinib|mesh-list
110736546|NCT00071006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110444712|NCT00864097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110736547|NCT00071006|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110736548|NCT00071006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110736549|NCT00071006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110736550|NCT01089998|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110736551|NCT01089998|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110736552|NCT01089998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110736553|NCT00094107|Axitinib|axitinib|mesh-list
110736554|NCT00094107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110736555|NCT00094107|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110736556|NCT00094107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110736557|NCT00094107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110736558|NCT00102063|Aripiprazole|aripiprazole|mesh-list
110736559|NCT00102063|Antidepressive Agents|antidepressive agents|mesh-ancestor
110736560|NCT00102063|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110736561|NCT00102063|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110736562|NCT00102063|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110736563|NCT00102063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110736564|NCT00102063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110736565|NCT00102063|Dopamine Agonists|dopamine agonists|mesh-ancestor
110736566|NCT00102063|Dopamine Agents|dopamine agents|mesh-ancestor
110736567|NCT00102063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110736568|NCT00102063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110736569|NCT00102063|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110736570|NCT00102063|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110736571|NCT00102063|Serotonin Agents|serotonin agents|mesh-ancestor
110736572|NCT00102063|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110736573|NCT00102063|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110736574|NCT00102063|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110736575|NCT00102063|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110736576|NCT00065156|Lenalidomide|lenalidomide|mesh-list
110736577|NCT00065156|Immunologic Factors|immunologic factors|mesh-ancestor
110736578|NCT00065156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110736579|NCT00065156|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110736580|NCT00065156|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110736581|NCT00065156|Growth Substances|growth substances|mesh-ancestor
110736582|NCT00065156|Growth Inhibitors|growth inhibitors|mesh-ancestor
110736583|NCT00065156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110736584|NCT01094210|Fluorides|fluorides|mesh-list
110736585|NCT01094210|Fluorides, Topical|fluorides, topical|mesh-list
110736586|NCT01094210|Cariostatic Agents|cariostatic agents|mesh-ancestor
110736587|NCT01094210|Protective Agents|protective agents|mesh-ancestor
110736588|NCT01094210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110736589|NCT01094444|Vitamin K|vitamin k|mesh-list
110736590|NCT01094444|Vitamin K 3|vitamin k 3|mesh-list
110736591|NCT01094444|Vitamins|vitamins|mesh-ancestor
110736592|NCT01094444|Micronutrients|micronutrients|mesh-ancestor
110736593|NCT01094444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110736594|NCT01094444|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110736595|NCT01094444|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110736596|NCT01094444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110736597|NCT01094444|Hemostatics|hemostatics|mesh-ancestor
110736598|NCT01094444|Coagulants|coagulants|mesh-ancestor
110736599|NCT00078819|Etanercept|etanercept|mesh-list
110736600|NCT00078819|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110736601|NCT00078819|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110736602|NCT00078819|Analgesics|analgesics|mesh-ancestor
110736603|NCT00078819|Sensory System Agents|sensory system agents|mesh-ancestor
110736604|NCT00078819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110736605|NCT00078819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110736606|NCT00078819|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110736607|NCT00078819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110736608|NCT00078819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110736609|NCT00078819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110736610|NCT00078819|Immunologic Factors|immunologic factors|mesh-ancestor
110736611|NCT01088607|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
110736612|NCT01088607|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
110736613|NCT01088607|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110736614|NCT00098865|Thalidomide|thalidomide|mesh-list
110736615|NCT00098865|Temozolomide|temozolomide|mesh-list
110736616|NCT00098865|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110736617|NCT00098865|Alkylating Agents|alkylating agents|mesh-ancestor
110736618|NCT00098865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110736619|NCT00098865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110736620|NCT00098865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110736621|NCT00098865|Immunologic Factors|immunologic factors|mesh-ancestor
110736622|NCT00098865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110736623|NCT00098865|Leprostatic Agents|leprostatic agents|mesh-ancestor
110736624|NCT00098865|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110736625|NCT00098865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110736626|NCT00098865|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110736627|NCT00098865|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110736628|NCT00098865|Growth Substances|growth substances|mesh-ancestor
110736629|NCT00098865|Growth Inhibitors|growth inhibitors|mesh-ancestor
110736630|NCT01084863|Paclitaxel|paclitaxel|mesh-list
110736631|NCT01084863|Trastuzumab|trastuzumab|mesh-list
110736632|NCT01084863|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110736633|NCT01084863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110736634|NCT01084863|Tubulin Modulators|tubulin modulators|mesh-ancestor
110736635|NCT01084863|Antimitotic Agents|antimitotic agents|mesh-ancestor
110736636|NCT01084863|Mitosis Modulators|mitosis modulators|mesh-ancestor
110736637|NCT01084863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110736638|NCT01084863|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110736639|NCT03719404|Chlorhexidine|chlorhexidine|mesh-list
110736640|NCT03719404|Sodium Hypochlorite|sodium hypochlorite|mesh-list
110736641|NCT03719404|Eusol|eusol|mesh-list
110736642|NCT03719404|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110736643|NCT03719404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110736644|NCT03719404|Disinfectants|disinfectants|mesh-ancestor
110736645|NCT03720886|Teriparatide|teriparatide|mesh-list
110736646|NCT03720886|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110736647|NCT03720886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110736648|NCT03720886|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110736649|NCT00077649|Ribavirin|ribavirin|mesh-list
110736650|NCT00077649|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110736651|NCT00077649|Interferon-alpha|interferon-alpha|mesh-list
110736652|NCT00077649|Interferon alpha-2|interferon alpha-2|mesh-list
110736653|NCT00077649|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
110736654|NCT00077649|Antimetabolites|antimetabolites|mesh-ancestor
110736655|NCT00077649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110736656|NCT00077649|Antiviral Agents|antiviral agents|mesh-ancestor
110736657|NCT00077649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110736658|NCT00077649|Immunologic Factors|immunologic factors|mesh-ancestor
110736659|NCT00077649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110736660|NCT00077649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110736661|NCT00038948|Cyclosporine|cyclosporine|mesh-list
110736662|NCT00038948|Sirolimus|sirolimus|mesh-list
110736663|NCT00038948|Tacrolimus|tacrolimus|mesh-list
110736664|NCT00038948|Cyclosporins|cyclosporins|mesh-list
110736665|NCT00038948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110736666|NCT00038948|Immunologic Factors|immunologic factors|mesh-ancestor
110736667|NCT00038948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110736668|NCT00038948|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110736669|NCT00038948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110736670|NCT00038948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110736671|NCT00038948|Antifungal Agents|antifungal agents|mesh-ancestor
110736672|NCT00038948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110736673|NCT00038948|Dermatologic Agents|dermatologic agents|mesh-ancestor
110736675|NCT00038948|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110736676|NCT00038948|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110736677|NCT00038948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110736678|NCT01096940|Simvastatin|simvastatin|mesh-list
110736679|NCT01096940|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110736680|NCT01096940|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110736681|NCT01096940|Antimetabolites|antimetabolites|mesh-ancestor
110736682|NCT01096940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110736683|NCT01096940|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110736684|NCT01096940|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110144873|NCT02043912|Haloperidol|haloperidol|mesh-list
110736685|NCT01096940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110736686|NCT02530424|Trastuzumab|trastuzumab|mesh-list
110736688|NCT02530424|Fulvestrant|fulvestrant|mesh-list
110736689|NCT02530424|Palbociclib|palbociclib|mesh-list
110736690|NCT02530424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110736691|NCT02530424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110736692|NCT02530424|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110736693|NCT02530424|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110736694|NCT02530424|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110736695|NCT02530424|Hormone Antagonists|hormone antagonists|mesh-ancestor
110736696|NCT02530424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110736697|NCT02530424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110736698|NCT02530424|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110736699|NCT02530424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110736700|NCT02530424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110736701|NCT01088763|Dexamethasone|dexamethasone|mesh-list
110736702|NCT01088763|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
110736703|NCT01088763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110736704|NCT01088763|Antiemetics|antiemetics|mesh-ancestor
110736705|NCT01088763|Autonomic Agents|autonomic agents|mesh-ancestor
110736706|NCT01088763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110736707|NCT01088763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110736708|NCT01088763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110736709|NCT01088763|Glucocorticoids|glucocorticoids|mesh-ancestor
110736710|NCT01088763|Hormones|hormones|mesh-ancestor
110736711|NCT01088763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110736712|NCT01088763|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110736713|NCT01088763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110736714|NCT01088763|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
110736715|NCT01088763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110736716|NCT01088763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110736717|NCT01094600|Secretin|secretin|mesh-list
110736718|NCT01094600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110736719|NCT01094600|Hormones|hormones|mesh-ancestor
110736720|NCT01094600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110736721|NCT01094600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110736722|NCT01097252|Cisplatin|cisplatin|mesh-list
110736723|NCT01097252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110736724|NCT02530502|Pembrolizumab|pembrolizumab|mesh-list
110736725|NCT02530502|Temozolomide|temozolomide|mesh-list
110736726|NCT02530502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110736727|NCT02530502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110736728|NCT02530502|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110736729|NCT02530502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110736730|NCT02530502|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110736731|NCT02530502|Alkylating Agents|alkylating agents|mesh-ancestor
110736732|NCT00054704|Riluzole|riluzole|mesh-list
110736733|NCT00054704|Anticonvulsants|anticonvulsants|mesh-ancestor
110736734|NCT00054704|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110736735|NCT00054704|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110736736|NCT00054704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110736737|NCT00054704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110736738|NCT00054704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110736739|NCT00054704|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110736740|NCT00054704|Protective Agents|protective agents|mesh-ancestor
110736741|NCT01092572|Simvastatin|simvastatin|mesh-list
110736742|NCT01092572|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110736743|NCT01092572|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110736744|NCT01092572|Antimetabolites|antimetabolites|mesh-ancestor
110736745|NCT01092572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110736746|NCT01092572|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110736747|NCT01092572|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110736748|NCT01092572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110736750|NCT00031694|Bryostatin 1|bryostatin 1|mesh-list
110736751|NCT00031694|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110736752|NCT00031694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110736753|NCT00031694|Tubulin Modulators|tubulin modulators|mesh-ancestor
110736754|NCT00031694|Antimitotic Agents|antimitotic agents|mesh-ancestor
110736755|NCT00031694|Mitosis Modulators|mitosis modulators|mesh-ancestor
110736756|NCT00031694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110736757|NCT00031694|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110736758|NCT00031694|Immunologic Factors|immunologic factors|mesh-ancestor
110736759|NCT00031694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110736760|NCT03953066|Melatonin|melatonin|mesh-list
110736761|NCT03953066|Antioxidants|antioxidants|mesh-ancestor
110736762|NCT03953066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110736763|NCT03953066|Protective Agents|protective agents|mesh-ancestor
110736764|NCT03953066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110736765|NCT03953066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110736766|NCT00093795|Paclitaxel|paclitaxel|mesh-list
110736767|NCT00093795|Docetaxel|docetaxel|mesh-list
110736768|NCT00093795|Cyclophosphamide|cyclophosphamide|mesh-list
110736769|NCT00093795|Gemcitabine|gemcitabine|mesh-list
110736770|NCT00093795|Doxorubicin|doxorubicin|mesh-list
110736771|NCT00093795|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110736772|NCT00093795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110736773|NCT00093795|Tubulin Modulators|tubulin modulators|mesh-ancestor
110736774|NCT00093795|Antimitotic Agents|antimitotic agents|mesh-ancestor
110736775|NCT00093795|Mitosis Modulators|mitosis modulators|mesh-ancestor
110736776|NCT00093795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110736777|NCT00093795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110736778|NCT00093795|Immunologic Factors|immunologic factors|mesh-ancestor
110736779|NCT00093795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110736780|NCT00093795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110736781|NCT00093795|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110736782|NCT00093795|Alkylating Agents|alkylating agents|mesh-ancestor
110736783|NCT00093795|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110736784|NCT00093795|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110736785|NCT00093795|Antimetabolites|antimetabolites|mesh-ancestor
110736786|NCT00093795|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110736787|NCT00093795|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110736788|NCT00093795|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110864859|NCT03203356|Hormones|hormones|mesh-list
110736789|NCT00093795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110736790|NCT01092806|Tacrolimus|tacrolimus|mesh-list
110736791|NCT01092806|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110736792|NCT01092806|Immunologic Factors|immunologic factors|mesh-ancestor
110736793|NCT01092806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110736794|NCT01092806|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110736795|NCT01092806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110736796|NCT01092806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110736797|NCT01094912|Analgesics, Opioid|analgesics, opioid|mesh-list
110736798|NCT01094912|Narcotics|narcotics|mesh-ancestor
110736799|NCT01094912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110736800|NCT01094912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110736801|NCT01094912|Analgesics|analgesics|mesh-ancestor
110736802|NCT01094912|Sensory System Agents|sensory system agents|mesh-ancestor
110736803|NCT01094912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110736804|NCT01092962|Mycophenolic Acid|mycophenolic acid|mesh-list
110736805|NCT01092962|Cyclophosphamide|cyclophosphamide|mesh-list
110736806|NCT01092962|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110736807|NCT01092962|Immunologic Factors|immunologic factors|mesh-ancestor
110736808|NCT01092962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110736809|NCT01092962|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110736810|NCT01092962|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110736811|NCT01092962|Alkylating Agents|alkylating agents|mesh-ancestor
110736812|NCT01092962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110736813|NCT01092962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110736814|NCT01092962|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110736815|NCT01092962|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110736816|NCT01092962|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110736817|NCT01092962|Antitubercular Agents|antitubercular agents|mesh-ancestor
110454570|NCT04178512|Hormones|hormones|mesh-ancestor
110736818|NCT01092962|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110736819|NCT01092962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110736820|NCT01092962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110736822|NCT03802994|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110736823|NCT03802994|Immunologic Factors|immunologic factors|mesh-ancestor
110144952|NCT02044250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110736824|NCT03802994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110736825|NCT01088919|Pioglitazone|pioglitazone|mesh-list
110736826|NCT01088919|Ipragliflozin|ipragliflozin|mesh-list
110736827|NCT01088919|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110736828|NCT01088919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110736829|NCT01088919|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110736830|NCT01088919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110736831|NCT03802916|Deferiprone|deferiprone|mesh-list
110736832|NCT03802916|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110736833|NCT03802916|Chelating Agents|chelating agents|mesh-ancestor
110736834|NCT03802916|Sequestering Agents|sequestering agents|mesh-ancestor
110736835|NCT03802916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110736836|NCT03720340|Oprelvekin|oprelvekin|mesh-list
110736837|NCT03720340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110736838|NCT01094990|Dexamethasone|dexamethasone|mesh-list
110736839|NCT01094990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110736840|NCT01094990|Antiemetics|antiemetics|mesh-ancestor
110736841|NCT01094990|Autonomic Agents|autonomic agents|mesh-ancestor
110736842|NCT01094990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110736843|NCT01094990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110736844|NCT01094990|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110736845|NCT01094990|Glucocorticoids|glucocorticoids|mesh-ancestor
110736846|NCT01094990|Hormones|hormones|mesh-ancestor
110736847|NCT01094990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110736848|NCT01094990|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110736849|NCT01094990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110736850|NCT01584050|Folic Acid|folic acid|mesh-list
110736851|NCT01584050|Hematinics|hematinics|mesh-ancestor
110736852|NCT01584050|Vitamin B Complex|vitamin b complex|mesh-ancestor
110736853|NCT01584050|Vitamins|vitamins|mesh-ancestor
110736854|NCT01584050|Micronutrients|micronutrients|mesh-ancestor
110736855|NCT01584050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110736856|NCT03952832|Leflunomide|leflunomide|mesh-list
110736857|NCT03952832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110736858|NCT03952832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110736859|NCT03952832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110736860|NCT03952832|Immunologic Factors|immunologic factors|mesh-ancestor
110736861|NCT03952832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110736863|NCT01311076|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110736864|NCT01311076|Insulin Lispro|insulin lispro|mesh-list
110736865|NCT01311076|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110736866|NCT01311076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110736867|NCT01098344|Gemcitabine|gemcitabine|mesh-list
110736868|NCT01098344|3-(4-((4-chlorophenyl)sulfonyl)-4-(2,5-difluorophenyl)cyclohexyl)propanoic acid|3-(4-((4-chlorophenyl)sulfonyl)-4-(2,5-difluorophenyl)cyclohexyl)propanoic acid|mesh-list
110736869|NCT01098344|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110736870|NCT01098344|Antimetabolites|antimetabolites|mesh-ancestor
110736871|NCT01098344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110736872|NCT01098344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110736873|NCT01098344|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
110736874|NCT01098344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110736875|NCT01098656|Lenalidomide|lenalidomide|mesh-list
110736876|NCT01098656|Immunologic Factors|immunologic factors|mesh-ancestor
110736877|NCT01098656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110736878|NCT01098656|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110736879|NCT01098656|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110736880|NCT01098656|Growth Substances|growth substances|mesh-ancestor
110736881|NCT01098656|Growth Inhibitors|growth inhibitors|mesh-ancestor
110736882|NCT01098656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110736883|NCT00076011|Mitogens|mitogens|mesh-list
110736884|NCT00076011|Endothelial Growth Factors|endothelial growth factors|mesh-list
110736885|NCT00076011|Mitosis Modulators|mitosis modulators|mesh-ancestor
110736886|NCT00076011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110736887|NCT00076011|Growth Substances|growth substances|mesh-ancestor
110736888|NCT00076011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110736889|NCT03465436|Moxifloxacin|moxifloxacin|mesh-list
110736890|NCT03465436|Lasmiditan|lasmiditan|mesh-list
110736891|NCT03465436|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110682835|NCT00902915|Glucocorticoids|glucocorticoids|mesh-ancestor
110736892|NCT03465436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110736893|NCT03465436|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110736894|NCT03465436|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110736895|NCT03465436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110736896|NCT03465436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110736897|NCT03465436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110736898|NCT03465436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110736899|NCT03465436|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110736900|NCT03465436|Serotonin Agents|serotonin agents|mesh-ancestor
110736901|NCT03465436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110736902|NCT01098890|Plasminogen|plasminogen|mesh-list
110736903|NCT01098890|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
110736904|NCT01098890|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110736905|NCT01098890|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110736906|NCT01098890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110736907|NCT00053846|Buspirone|buspirone|mesh-list
110736908|NCT00053846|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110145042|NCT02045017|Hormones|hormones|mesh-ancestor
110736909|NCT00053846|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110736910|NCT00053846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110736911|NCT00053846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110736912|NCT00053846|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110736913|NCT00053846|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110736914|NCT00053846|Serotonin Agents|serotonin agents|mesh-ancestor
110736915|NCT00053846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110736916|NCT00053846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110736917|NCT01089075|Hydrocortisone|hydrocortisone|mesh-list
110736918|NCT01089075|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
110736919|NCT01089075|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
110736920|NCT01089075|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
110736921|NCT01089075|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110736922|NCT00090987|Imatinib Mesylate|imatinib mesylate|mesh-list
110736923|NCT00090987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110736924|NCT00090987|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110736925|NCT00090987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110736926|NCT00090987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110736927|NCT03489304|Zaleplon|zaleplon|mesh-list
110736928|NCT03489304|Anticonvulsants|anticonvulsants|mesh-ancestor
110736929|NCT03489304|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110736930|NCT03489304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110736931|NCT03489304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110736932|NCT03489304|GABA Modulators|gaba modulators|mesh-ancestor
110736933|NCT03489304|GABA Agents|gaba agents|mesh-ancestor
110736934|NCT03489304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110736935|NCT03489304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110736936|NCT03718624|Paclitaxel|paclitaxel|mesh-list
110736937|NCT03718624|Apatinib|apatinib|mesh-list
110736938|NCT03718624|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110736939|NCT03718624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110736940|NCT03718624|Tubulin Modulators|tubulin modulators|mesh-ancestor
110736941|NCT03718624|Antimitotic Agents|antimitotic agents|mesh-ancestor
110736942|NCT03718624|Mitosis Modulators|mitosis modulators|mesh-ancestor
110736943|NCT03718624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110736944|NCT03718624|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110736945|NCT03718624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110736946|NCT03543358|Rovalpituzumab tesirine|rovalpituzumab tesirine|mesh-list
110736947|NCT03543358|Immunoconjugates|immunoconjugates|mesh-list
110736948|NCT03543358|Immunologic Factors|immunologic factors|mesh-ancestor
110736949|NCT03543358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110736950|NCT03485950|Meropenem|meropenem|mesh-list
110736951|NCT03485950|Tazobactam|tazobactam|mesh-list
110736952|NCT03485950|Piperacillin|piperacillin|mesh-list
110736953|NCT03485950|Cefepime|cefepime|mesh-list
110736954|NCT03485950|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
110736955|NCT03485950|Ceftolozane|ceftolozane|mesh-list
110736956|NCT03485950|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110736957|NCT03485950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110736958|NCT03485950|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110736959|NCT03485950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110736960|NCT03485950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110736961|NCT00060944|Dexamethasone|dexamethasone|mesh-list
110736962|NCT00060944|Dexamethasone acetate|dexamethasone acetate|mesh-list
110736963|NCT00060944|Trabectedin|trabectedin|mesh-list
110736964|NCT00060944|BB 1101|bb 1101|mesh-list
110736965|NCT00060944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110736966|NCT00060944|Antiemetics|antiemetics|mesh-ancestor
110736967|NCT00060944|Autonomic Agents|autonomic agents|mesh-ancestor
110736968|NCT00060944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110736969|NCT00060944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110736970|NCT00060944|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110736971|NCT00060944|Glucocorticoids|glucocorticoids|mesh-ancestor
110736972|NCT00060944|Hormones|hormones|mesh-ancestor
110736973|NCT00060944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110736974|NCT00060944|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110736975|NCT00060944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110736976|NCT00060944|Protease Inhibitors|protease inhibitors|mesh-ancestor
110736977|NCT00060944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110736978|NCT00060944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110736979|NCT00060944|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110736980|NCT00060944|Alkylating Agents|alkylating agents|mesh-ancestor
110736981|NCT03956732|Vitamin D|vitamin d|mesh-list
110736982|NCT03956732|Caseins|caseins|mesh-list
110736983|NCT03956732|Vitamins|vitamins|mesh-ancestor
110736984|NCT03956732|Micronutrients|micronutrients|mesh-ancestor
110736985|NCT03956732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110736986|NCT03956732|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110736987|NCT03956732|Chelating Agents|chelating agents|mesh-ancestor
110736988|NCT03956732|Sequestering Agents|sequestering agents|mesh-ancestor
110736989|NCT03956732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110736990|NCT01093274|Picosulfate sodium|picosulfate sodium|mesh-list
110736991|NCT01093274|Cathartics|cathartics|mesh-ancestor
110736992|NCT01093274|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110736993|NCT01584206|Ezetimibe|ezetimibe|mesh-list
110736994|NCT01584206|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110736995|NCT01584206|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110736996|NCT01584206|Antimetabolites|antimetabolites|mesh-ancestor
110736997|NCT01584206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110736998|NCT01584206|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110736999|NCT03541252|Cisplatin|cisplatin|mesh-list
110737000|NCT03541252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110737001|NCT00031460|Acyclovir|acyclovir|mesh-list
110737002|NCT00031460|Antiviral Agents|antiviral agents|mesh-ancestor
110737003|NCT00031460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110737004|NCT03540160|Serlopitant|serlopitant|mesh-list
110737005|NCT03540160|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110737006|NCT03540160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110737007|NCT03540160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110737008|NCT03540160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110737009|NCT01095302|Docetaxel|docetaxel|mesh-list
110737010|NCT01095302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110737011|NCT01095302|Tubulin Modulators|tubulin modulators|mesh-ancestor
110737012|NCT01095302|Antimitotic Agents|antimitotic agents|mesh-ancestor
110737013|NCT01095302|Mitosis Modulators|mitosis modulators|mesh-ancestor
110737014|NCT01095302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110737015|NCT03459040|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
110737016|NCT03459040|Protein C Inhibitor|protein c inhibitor|mesh-list
110737017|NCT03459040|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
110737018|NCT03459040|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110737019|NCT03459040|Protease Inhibitors|protease inhibitors|mesh-ancestor
110737020|NCT03459040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110737021|NCT03459040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110737022|NCT03457636|Doxycycline|doxycycline|mesh-list
110737023|NCT03457636|Adapalene|adapalene|mesh-list
110737024|NCT03457636|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
110737025|NCT03457636|Benzoyl Peroxide|benzoyl peroxide|mesh-list
110737026|NCT03457636|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110737027|NCT03457636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110737028|NCT03457636|Antimalarials|antimalarials|mesh-ancestor
110737029|NCT03457636|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110737030|NCT03457636|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110737031|NCT03457636|Dermatologic Agents|dermatologic agents|mesh-ancestor
110737032|NCT03457636|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110737033|NCT03457636|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110737034|NCT03457636|Analgesics|analgesics|mesh-ancestor
110737035|NCT03457636|Sensory System Agents|sensory system agents|mesh-ancestor
110737036|NCT03457636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110737037|NCT03457636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110737038|NCT03457636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110737039|NCT03457636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110737040|NCT01099436|Zoledronic Acid|zoledronic acid|mesh-list
110737041|NCT01099436|Cyclophosphamide|cyclophosphamide|mesh-list
110737042|NCT01099436|Docetaxel|docetaxel|mesh-list
110737043|NCT01099436|Doxorubicin|doxorubicin|mesh-list
110454792|NCT04180384|Paclitaxel|paclitaxel|mesh-list
110737044|NCT01099436|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110737045|NCT01099436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110737046|NCT01099436|Immunologic Factors|immunologic factors|mesh-ancestor
110737047|NCT01099436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110737048|NCT01099436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110737049|NCT01099436|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110737050|NCT01099436|Alkylating Agents|alkylating agents|mesh-ancestor
110737051|NCT01099436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110737052|NCT01099436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110737053|NCT01099436|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110737054|NCT01099436|Tubulin Modulators|tubulin modulators|mesh-ancestor
110737055|NCT01099436|Antimitotic Agents|antimitotic agents|mesh-ancestor
110737056|NCT01099436|Mitosis Modulators|mitosis modulators|mesh-ancestor
110737057|NCT01099436|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110737058|NCT01099436|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110737059|NCT01099436|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110737060|NCT01099436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110737061|NCT01099436|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110737062|NCT01099592|Citalopram|citalopram|mesh-list
110737063|NCT01099592|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110864890|NCT02450188|Vasodilator Agents|vasodilator agents|mesh-ancestor
110737064|NCT01099592|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110737065|NCT01099592|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110737066|NCT01099592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110737067|NCT01099592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110737068|NCT01099592|Serotonin Agents|serotonin agents|mesh-ancestor
110737069|NCT01099592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110737070|NCT01099592|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110737071|NCT01099592|Antidepressive Agents|antidepressive agents|mesh-ancestor
110737072|NCT01099592|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110737073|NCT01099748|Methadone|methadone|mesh-list
110737074|NCT01099748|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110737075|NCT01099748|Narcotics|narcotics|mesh-ancestor
110737076|NCT01099748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110737077|NCT01099748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110737078|NCT01099748|Analgesics|analgesics|mesh-ancestor
110737079|NCT01099748|Sensory System Agents|sensory system agents|mesh-ancestor
110737080|NCT01099748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110737081|NCT01099748|Antitussive Agents|antitussive agents|mesh-ancestor
110737082|NCT01099748|Respiratory System Agents|respiratory system agents|mesh-ancestor
110737083|NCT03481816|Vaccines|vaccines|mesh-list
110737084|NCT03481816|Immunologic Factors|immunologic factors|mesh-ancestor
110737085|NCT03481816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110737086|NCT03956888|Acetylcysteine|acetylcysteine|mesh-list
110737087|NCT03956888|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110737088|NCT03956888|Antiviral Agents|antiviral agents|mesh-ancestor
110737089|NCT03956888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110737090|NCT03956888|Expectorants|expectorants|mesh-ancestor
110737091|NCT03956888|Respiratory System Agents|respiratory system agents|mesh-ancestor
110737092|NCT03956888|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110737093|NCT03956888|Antioxidants|antioxidants|mesh-ancestor
110737094|NCT03956888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110737095|NCT03956888|Protective Agents|protective agents|mesh-ancestor
110737096|NCT03956888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110737097|NCT03956888|Antidotes|antidotes|mesh-ancestor
110737098|NCT03955406|Anesthetics|anesthetics|mesh-list
110737099|NCT03955406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110737100|NCT03955406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110737101|NCT03538054|Dextromethorphan|dextromethorphan|mesh-list
110737102|NCT03538054|Antitussive Agents|antitussive agents|mesh-ancestor
110737103|NCT03538054|Respiratory System Agents|respiratory system agents|mesh-ancestor
110737104|NCT03538054|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110737105|NCT03538054|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110737106|NCT03538054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110737107|NCT03538054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110737108|NCT03538054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110737109|NCT03480802|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110737110|NCT03480802|Immunologic Factors|immunologic factors|mesh-ancestor
110737111|NCT03480802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110737112|NCT00050960|Paclitaxel|paclitaxel|mesh-list
110737113|NCT00050960|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110737114|NCT00050960|Carboplatin|carboplatin|mesh-list
110737115|NCT00050960|Bexarotene|bexarotene|mesh-list
110737116|NCT00050960|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110737117|NCT00050960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110737118|NCT00050960|Tubulin Modulators|tubulin modulators|mesh-ancestor
110737119|NCT00050960|Antimitotic Agents|antimitotic agents|mesh-ancestor
110737120|NCT00050960|Mitosis Modulators|mitosis modulators|mesh-ancestor
110737121|NCT00050960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110737122|NCT00097773|Ciprofloxacin|ciprofloxacin|mesh-list
110737123|NCT00097773|Tobramycin|tobramycin|mesh-list
110737124|NCT00097773|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110737125|NCT00097773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110737126|NCT00097773|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110737127|NCT00097773|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110737128|NCT00097773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110737129|NCT00097773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110737130|NCT00097773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110737131|NCT00097773|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110737132|NCT00097773|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110737133|NCT03480022|Liraglutide|liraglutide|mesh-list
110737134|NCT03480022|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110737135|NCT03480022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110737136|NCT03480022|Incretins|incretins|mesh-ancestor
110737137|NCT03480022|Hormones|hormones|mesh-ancestor
110737138|NCT03480022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110737139|NCT01093820|Epoetin Alfa|epoetin alfa|mesh-list
110737140|NCT01093820|Hematinics|hematinics|mesh-ancestor
110737141|NCT00049322|Bevacizumab|bevacizumab|mesh-list
110737142|NCT00049322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110737143|NCT00049322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110737144|NCT00049322|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110737145|NCT00049322|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110737146|NCT00049322|Growth Substances|growth substances|mesh-ancestor
110737147|NCT00049322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110737148|NCT00049322|Growth Inhibitors|growth inhibitors|mesh-ancestor
110737149|NCT00008138|Paclitaxel|paclitaxel|mesh-list
110737150|NCT00008138|Carboplatin|carboplatin|mesh-list
110737151|NCT00008138|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110737152|NCT00008138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110737153|NCT00008138|Tubulin Modulators|tubulin modulators|mesh-ancestor
110737154|NCT00008138|Antimitotic Agents|antimitotic agents|mesh-ancestor
110737155|NCT00008138|Mitosis Modulators|mitosis modulators|mesh-ancestor
110737156|NCT00008138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110737157|NCT03436732|LMB-100|lmb-100|mesh-list
110737158|NCT03436732|Immunoconjugates|immunoconjugates|mesh-ancestor
110737159|NCT03436732|Immunologic Factors|immunologic factors|mesh-ancestor
110737160|NCT03436732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110737161|NCT01100060|Azithromycin|azithromycin|mesh-list
110737162|NCT01100060|Chloroquine|chloroquine|mesh-list
110737163|NCT01100060|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
110737164|NCT01100060|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110737165|NCT01100060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110737166|NCT01100060|Amebicides|amebicides|mesh-ancestor
110737167|NCT01100060|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110737168|NCT01100060|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110737169|NCT01100060|Antimalarials|antimalarials|mesh-ancestor
110737170|NCT01100060|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110737171|NCT01100060|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110737172|NCT01100060|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110737173|NCT01100060|Analgesics|analgesics|mesh-ancestor
110737174|NCT01100060|Sensory System Agents|sensory system agents|mesh-ancestor
110737175|NCT01100060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110737176|NCT01100060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110737177|NCT01100060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110737178|NCT01100060|Filaricides|filaricides|mesh-ancestor
110737179|NCT01100060|Antinematodal Agents|antinematodal agents|mesh-ancestor
110737180|NCT01100060|Anthelmintics|anthelmintics|mesh-ancestor
110737181|NCT01100216|Nicotine|nicotine|mesh-list
110737182|NCT01100216|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110737183|NCT01100216|Autonomic Agents|autonomic agents|mesh-ancestor
110737184|NCT01100216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110737185|NCT01100216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110737186|NCT01100216|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110737187|NCT01100216|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110737188|NCT01100216|Cholinergic Agents|cholinergic agents|mesh-ancestor
110737189|NCT01100216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110737190|NCT01100216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110737191|NCT01100294|Vaccines|vaccines|mesh-list
110737192|NCT01100294|Immunologic Factors|immunologic factors|mesh-ancestor
110737193|NCT01100294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110737194|NCT03436420|Calcium|calcium|mesh-list
110737195|NCT03436420|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110737196|NCT03436420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110737197|NCT01100372|Gemcitabine|gemcitabine|mesh-list
110737198|NCT01100372|Doxorubicin|doxorubicin|mesh-list
110737199|NCT01100372|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110737200|NCT01100372|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110737201|NCT01100372|Antimetabolites|antimetabolites|mesh-ancestor
110737202|NCT01100372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110737203|NCT01100372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110737204|NCT01100372|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110737205|NCT01100372|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110864902|NCT04484506|Prednisone|prednisone|mesh-list
110737206|NCT01100372|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110737207|NCT01100372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110737208|NCT00027560|Cyclosporine|cyclosporine|mesh-list
110737209|NCT00027560|Fludarabine|fludarabine|mesh-list
110737210|NCT00027560|Fludarabine phosphate|fludarabine phosphate|mesh-list
110737211|NCT00027560|Melphalan|melphalan|mesh-list
110737212|NCT00027560|Alemtuzumab|alemtuzumab|mesh-list
110737213|NCT00027560|Cyclosporins|cyclosporins|mesh-list
110737214|NCT00027560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110737215|NCT00027560|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110737216|NCT00027560|Antimetabolites|antimetabolites|mesh-ancestor
110737217|NCT00027560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110737218|NCT00027560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110737219|NCT00027560|Immunologic Factors|immunologic factors|mesh-ancestor
110737220|NCT00027560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110737221|NCT00027560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110737222|NCT00027560|Antifungal Agents|antifungal agents|mesh-ancestor
110737223|NCT00027560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110737224|NCT00027560|Dermatologic Agents|dermatologic agents|mesh-ancestor
110737225|NCT00027560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110737226|NCT00027560|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110737227|NCT00027560|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110737228|NCT00027560|Alkylating Agents|alkylating agents|mesh-ancestor
110737229|NCT00027560|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110737230|NCT00027560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110737231|NCT02529878|Paclitaxel|paclitaxel|mesh-list
110737232|NCT02529878|Apatinib|apatinib|mesh-list
110737233|NCT02529878|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110737234|NCT02529878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110737235|NCT02529878|Tubulin Modulators|tubulin modulators|mesh-ancestor
110737236|NCT02529878|Antimitotic Agents|antimitotic agents|mesh-ancestor
110737237|NCT02529878|Mitosis Modulators|mitosis modulators|mesh-ancestor
110737238|NCT02529878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110737239|NCT02529878|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110737240|NCT02529878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110737241|NCT03451006|Metformin|metformin|mesh-list
110737242|NCT03451006|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110737243|NCT03451006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110737244|NCT05625854|Cocaine|cocaine|mesh-list
110737245|NCT05625854|Anesthetics, Local|anesthetics, local|mesh-ancestor
110737246|NCT05625854|Anesthetics|anesthetics|mesh-ancestor
110737247|NCT05625854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110737248|NCT05625854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110737249|NCT05625854|Sensory System Agents|sensory system agents|mesh-ancestor
110737250|NCT05625854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110737251|NCT05625854|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110737252|NCT05625854|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110737253|NCT05625854|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110737254|NCT05625854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110737255|NCT05625854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110737256|NCT05625854|Dopamine Agents|dopamine agents|mesh-ancestor
110737257|NCT05625854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110737258|NCT01327118|Dinoprost|dinoprost|mesh-list
110737259|NCT01327118|Dinoprost tromethamine|dinoprost tromethamine|mesh-list
110737260|NCT01327118|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110737261|NCT01327118|Abortifacient Agents|abortifacient agents|mesh-ancestor
110737262|NCT01327118|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110737263|NCT01327118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110737264|NCT01327118|Oxytocics|oxytocics|mesh-ancestor
110737265|NCT03449758|Hydroxychloroquine|hydroxychloroquine|mesh-list
110737266|NCT03449758|Chloroquine|chloroquine|mesh-list
110737267|NCT03449758|Sulfasalazine|sulfasalazine|mesh-list
110737268|NCT03449758|Methotrexate|methotrexate|mesh-list
110737269|NCT03449758|Azathioprine|azathioprine|mesh-list
110682836|NCT00902915|Hormones|hormones|mesh-ancestor
110737270|NCT03449758|Leflunomide|leflunomide|mesh-list
110737271|NCT03449758|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110737272|NCT03449758|Abortifacient Agents|abortifacient agents|mesh-ancestor
110737273|NCT03449758|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110737274|NCT03449758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110737275|NCT03449758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110737276|NCT03449758|Antimetabolites|antimetabolites|mesh-ancestor
110864905|NCT04484506|Vincristine|vincristine|mesh-list
110737277|NCT03449758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110737278|NCT03449758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110737279|NCT03449758|Dermatologic Agents|dermatologic agents|mesh-ancestor
110737280|NCT03449758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110737281|NCT03449758|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110737282|NCT03449758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110737283|NCT03449758|Immunologic Factors|immunologic factors|mesh-ancestor
110737284|NCT03449758|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110737285|NCT03449758|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110737286|NCT03449758|Antimalarials|antimalarials|mesh-ancestor
110737287|NCT03449758|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110737288|NCT03449758|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110737289|NCT03449758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110737290|NCT03449758|Amebicides|amebicides|mesh-ancestor
110737291|NCT03449758|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110737292|NCT03449758|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110737293|NCT03449758|Analgesics|analgesics|mesh-ancestor
110737294|NCT03449758|Sensory System Agents|sensory system agents|mesh-ancestor
110737295|NCT03449758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110737296|NCT03449758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110737297|NCT03449758|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110737298|NCT03449446|Firsocostat|firsocostat|mesh-list
110737299|NCT03449446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110737300|NCT03449446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110737302|NCT03716596|Immunologic Factors|immunologic factors|mesh-ancestor
110737303|NCT03716596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110737304|NCT05650840|Calcium Carbonate|calcium carbonate|mesh-list
110737305|NCT05650840|Calcium|calcium|mesh-list
110737306|NCT05650840|Charcoal|charcoal|mesh-list
110737307|NCT05650840|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110737308|NCT05650840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110737309|NCT05650840|Antacids|antacids|mesh-ancestor
110737310|NCT05650840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110737311|NCT05650840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110737312|NCT05650840|Antidotes|antidotes|mesh-ancestor
110737313|NCT05650840|Protective Agents|protective agents|mesh-ancestor
110737314|NCT03722914|Benzonatate|benzonatate|mesh-list
110737315|NCT03722914|Antitussive Agents|antitussive agents|mesh-ancestor
110737316|NCT03722914|Respiratory System Agents|respiratory system agents|mesh-ancestor
110737317|NCT03429556|Botulinum Toxins|botulinum toxins|mesh-list
110737318|NCT03429556|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110737319|NCT03429556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110737320|NCT03429556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110737321|NCT03429556|Cholinergic Agents|cholinergic agents|mesh-ancestor
110737322|NCT03429556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110737323|NCT03429556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110737324|NCT03444766|Nivolumab|nivolumab|mesh-list
110737325|NCT03444766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110737326|NCT03444766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110737327|NCT03444766|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110737328|NCT03444766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110737329|NCT03526432|Bevacizumab|bevacizumab|mesh-list
110737330|NCT03526432|Atezolizumab|atezolizumab|mesh-list
110737331|NCT03526432|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110737332|NCT03526432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110737333|NCT03526432|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110737334|NCT03526432|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110737335|NCT03526432|Growth Substances|growth substances|mesh-ancestor
110737336|NCT03526432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110737337|NCT03526432|Growth Inhibitors|growth inhibitors|mesh-ancestor
110737338|NCT03526432|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110737339|NCT03526432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110737340|NCT01310842|Nicotine|nicotine|mesh-list
110737341|NCT01310842|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110737342|NCT01310842|Autonomic Agents|autonomic agents|mesh-ancestor
110737343|NCT01310842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110737344|NCT01310842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110737345|NCT01310842|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110737347|NCT01310842|Cholinergic Agents|cholinergic agents|mesh-ancestor
110737348|NCT01310842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110737349|NCT01310842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110737350|NCT03722290|Metformin|metformin|mesh-list
110737351|NCT03722290|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110737352|NCT03722290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110737353|NCT03717688|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110737354|NCT03717688|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
110737355|NCT03717688|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
110737356|NCT03717688|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110737357|NCT03717688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110737358|NCT03717688|Incretins|incretins|mesh-ancestor
110737359|NCT03717688|Hormones|hormones|mesh-ancestor
110737360|NCT03717688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110737361|NCT03717688|Protease Inhibitors|protease inhibitors|mesh-ancestor
110737362|NCT03717688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110737363|NCT03717688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110737364|NCT03717688|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110737365|NCT02953678|Prednisone|prednisone|mesh-list
110737366|NCT02953678|Methylprednisolone|methylprednisolone|mesh-list
110737367|NCT02953678|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110737368|NCT02953678|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110737369|NCT02953678|Prednisolone|prednisolone|mesh-list
110737370|NCT02953678|Prednisolone acetate|prednisolone acetate|mesh-list
110737371|NCT02953678|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110737372|NCT02953678|Prednisolone phosphate|prednisolone phosphate|mesh-list
110737373|NCT02953678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110737374|NCT02953678|Glucocorticoids|glucocorticoids|mesh-ancestor
110737375|NCT02953678|Hormones|hormones|mesh-ancestor
110737376|NCT02953678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110737377|NCT02953678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110737378|NCT02953678|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110737379|NCT02953678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110737380|NCT02953678|Antiemetics|antiemetics|mesh-ancestor
110737381|NCT02953678|Autonomic Agents|autonomic agents|mesh-ancestor
110737382|NCT02953678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110737383|NCT02953678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110737384|NCT02953678|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110737385|NCT02953678|Protective Agents|protective agents|mesh-ancestor
110737386|NCT00090753|Epoetin Alfa|epoetin alfa|mesh-list
110737387|NCT00090753|Darbepoetin alfa|darbepoetin alfa|mesh-list
110737388|NCT00090753|Hematinics|hematinics|mesh-ancestor
110737389|NCT00048932|Abatacept|abatacept|mesh-list
110737390|NCT00048932|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110737391|NCT00048932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110737392|NCT00048932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110737393|NCT00048932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110737394|NCT00048932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110737395|NCT00048932|Immunologic Factors|immunologic factors|mesh-ancestor
110737396|NCT00048932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110737397|NCT00048932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110737398|NCT00073983|Gemcitabine|gemcitabine|mesh-list
110737399|NCT00073983|Docetaxel|docetaxel|mesh-list
110737400|NCT00073983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110737401|NCT00073983|Antimetabolites|antimetabolites|mesh-ancestor
110737402|NCT00073983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110737403|NCT00073983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110737404|NCT00073983|Tubulin Modulators|tubulin modulators|mesh-ancestor
110737405|NCT00073983|Antimitotic Agents|antimitotic agents|mesh-ancestor
110737406|NCT00073983|Mitosis Modulators|mitosis modulators|mesh-ancestor
110737407|NCT02952820|Lemborexant|lemborexant|mesh-list
110737408|NCT02952820|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
110737409|NCT02952820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110737410|NCT02952820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110737411|NCT02952820|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110737412|NCT02952820|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110737413|NCT02952820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110737414|NCT02952820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110737415|NCT01583361|Oxaliplatin|oxaliplatin|mesh-list
110864917|NCT04484506|Glucocorticoids|glucocorticoids|mesh-ancestor
110737416|NCT01583361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110737417|NCT01085487|Antifibrinolytic Agents|antifibrinolytic agents|mesh-list
110455169|NCT00910390|Ethylene|ethylene|mesh-list
110737418|NCT01085487|Levonorgestrel|levonorgestrel|mesh-list
110737419|NCT01085487|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110737420|NCT01085487|Contraceptive Agents|contraceptive agents|mesh-ancestor
110737421|NCT01085487|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110737422|NCT01085487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110737423|NCT01085487|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110737424|NCT01085487|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110737425|NCT01085487|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110737426|NCT01085487|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110737427|NCT01085487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110737428|NCT01085487|Hemostatics|hemostatics|mesh-ancestor
110737429|NCT01085487|Coagulants|coagulants|mesh-ancestor
110737430|NCT01089309|Spironolactone|spironolactone|mesh-list
110737431|NCT01089309|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110737432|NCT01089309|Hormone Antagonists|hormone antagonists|mesh-ancestor
110737433|NCT01089309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110737434|NCT01089309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110737435|NCT01089309|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110737436|NCT01089309|Diuretics|diuretics|mesh-ancestor
110737437|NCT01089309|Natriuretic Agents|natriuretic agents|mesh-ancestor
110737438|NCT01085721|Chlorpheniramine|chlorpheniramine|mesh-list
110737439|NCT01085721|Phenylpropanolamine|phenylpropanolamine|mesh-list
110737440|NCT01085721|Pseudoephedrine|pseudoephedrine|mesh-list
110737441|NCT01085721|Ephedrine|ephedrine|mesh-list
110737442|NCT01085721|Guaifenesin|guaifenesin|mesh-list
110737443|NCT01085721|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
110737444|NCT01085721|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
110737445|NCT01085721|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110737446|NCT01085721|Autonomic Agents|autonomic agents|mesh-ancestor
110737447|NCT01085721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110737448|NCT01085721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110737449|NCT01085721|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110737450|NCT01085721|Respiratory System Agents|respiratory system agents|mesh-ancestor
110737451|NCT01085721|Nasal Decongestants|nasal decongestants|mesh-ancestor
110737452|NCT01085721|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110737453|NCT01085721|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110737454|NCT01085721|Sympathomimetics|sympathomimetics|mesh-ancestor
110737455|NCT01085721|Adrenergic Agents|adrenergic agents|mesh-ancestor
110737456|NCT01085721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110737457|NCT01085721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110737458|NCT01085721|Expectorants|expectorants|mesh-ancestor
110737459|NCT01085721|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110737460|NCT01085721|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110737461|NCT01085721|Appetite Depressants|appetite depressants|mesh-ancestor
110737462|NCT01085721|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110737463|NCT01085721|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110737464|NCT01085721|Histamine Antagonists|histamine antagonists|mesh-ancestor
110737465|NCT01085721|Histamine Agents|histamine agents|mesh-ancestor
110737466|NCT01085721|Antipruritics|antipruritics|mesh-ancestor
110737467|NCT01085721|Dermatologic Agents|dermatologic agents|mesh-ancestor
110737468|NCT01085721|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110737469|NCT01089465|Dermatologic Agents|dermatologic agents|mesh-list
110737470|NCT00006392|Vitamins|vitamins|mesh-list
110737471|NCT00006392|Vitamin E|vitamin e|mesh-list
110737472|NCT00006392|Tocopherols|tocopherols|mesh-list
110737473|NCT00006392|Tocotrienols|tocotrienols|mesh-list
110737474|NCT00006392|alpha-Tocopherol|alpha-tocopherol|mesh-list
110737475|NCT00006392|Selenium|selenium|mesh-list
110737476|NCT00006392|Micronutrients|micronutrients|mesh-ancestor
110737477|NCT00006392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110737478|NCT00006392|Antioxidants|antioxidants|mesh-ancestor
110737479|NCT00006392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110737480|NCT00006392|Protective Agents|protective agents|mesh-ancestor
110737481|NCT00006392|Trace Elements|trace elements|mesh-ancestor
110737482|NCT01089621|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110737483|NCT01089621|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110737484|NCT01089621|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110737485|NCT01089621|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110737486|NCT01089621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110737487|NCT01089621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110737488|NCT01089621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110737489|NCT01089621|Analgesics|analgesics|mesh-ancestor
110737490|NCT01089621|Sensory System Agents|sensory system agents|mesh-ancestor
110737491|NCT01089621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110737492|NCT01089621|Antidepressive Agents|antidepressive agents|mesh-ancestor
110737493|NCT01089621|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110737495|NCT01101152|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
110737496|NCT01101152|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110737497|NCT01101152|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110737498|NCT01101152|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110737499|NCT01101152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110737500|NCT01101152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110145320|NCT02046733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110737501|NCT01101152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110737502|NCT01101152|Antidepressive Agents|antidepressive agents|mesh-ancestor
110737503|NCT01101152|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110737504|NCT00379769|Metformin|metformin|mesh-list
110737505|NCT00379769|Rosiglitazone|rosiglitazone|mesh-list
110737506|NCT00379769|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110737507|NCT00379769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110737508|NCT00006164|Ribavirin|ribavirin|mesh-list
110737509|NCT00006164|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110737510|NCT00006164|Interferon-alpha|interferon-alpha|mesh-list
110737511|NCT00006164|Antimetabolites|antimetabolites|mesh-ancestor
110737512|NCT00006164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110737513|NCT00006164|Antiviral Agents|antiviral agents|mesh-ancestor
110737514|NCT00006164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110737515|NCT00006164|Immunologic Factors|immunologic factors|mesh-ancestor
110737516|NCT00006164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110737517|NCT00378599|Interferons|interferons|mesh-list
110737518|NCT00378599|Interferon-alpha|interferon-alpha|mesh-list
110737519|NCT00378599|Interferon alpha-2|interferon alpha-2|mesh-list
110737520|NCT00378599|Ribavirin|ribavirin|mesh-list
110737521|NCT00378599|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110737522|NCT00378599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110737523|NCT00378599|Antiviral Agents|antiviral agents|mesh-ancestor
110737524|NCT00378599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110737525|NCT00378599|Immunologic Factors|immunologic factors|mesh-ancestor
110737526|NCT00378599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110737527|NCT00378599|Antimetabolites|antimetabolites|mesh-ancestor
110737528|NCT00378599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110737529|NCT01046981|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110737530|NCT01046981|Metronidazole|metronidazole|mesh-list
110737531|NCT01046981|Cefazolin|cefazolin|mesh-list
110737532|NCT01046981|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
110737533|NCT01046981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110737534|NCT01046981|Antitubercular Agents|antitubercular agents|mesh-ancestor
110737535|NCT01046981|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110737536|NCT01046981|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110737537|NCT00378209|Dexamethasone|dexamethasone|mesh-list
110737538|NCT00378209|Lenalidomide|lenalidomide|mesh-list
110737539|NCT00378209|Bortezomib|bortezomib|mesh-list
110737540|NCT00378209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110737541|NCT00378209|Antiemetics|antiemetics|mesh-ancestor
110737542|NCT00378209|Autonomic Agents|autonomic agents|mesh-ancestor
110737543|NCT00378209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110737544|NCT00378209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110737545|NCT00378209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110737546|NCT00378209|Glucocorticoids|glucocorticoids|mesh-ancestor
110737547|NCT00378209|Hormones|hormones|mesh-ancestor
110737548|NCT00378209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110737549|NCT00378209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110737550|NCT00378209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110737551|NCT00378209|Immunologic Factors|immunologic factors|mesh-ancestor
110737552|NCT00378209|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110864928|NCT04332653|Pembrolizumab|pembrolizumab|mesh-list
110737553|NCT00378209|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110737555|NCT00378209|Growth Inhibitors|growth inhibitors|mesh-ancestor
110737556|NCT01047059|Bevacizumab|bevacizumab|mesh-list
110737557|NCT01047059|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110737558|NCT01047059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110737559|NCT01047059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110737560|NCT01047059|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110737561|NCT01047059|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110737562|NCT01047059|Growth Substances|growth substances|mesh-ancestor
110737563|NCT01047059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110737564|NCT01047059|Growth Inhibitors|growth inhibitors|mesh-ancestor
110737565|NCT01047059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110737566|NCT01047059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110737567|NCT01047059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110737568|NCT00377819|Denosumab|denosumab|mesh-list
110737569|NCT00377819|Alendronate|alendronate|mesh-list
110145405|NCT02047149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110737570|NCT00377819|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110737571|NCT00377819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110737572|NCT00377429|Catumaxomab|catumaxomab|mesh-list
110737573|NCT00377429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110737574|NCT01047215|Aripiprazole|aripiprazole|mesh-list
110737575|NCT01047215|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110737576|NCT01047215|Antidepressive Agents|antidepressive agents|mesh-ancestor
110737577|NCT01047215|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110737578|NCT01047215|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110737579|NCT01047215|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110737580|NCT01047215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110737581|NCT01047215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110737582|NCT01047215|Dopamine Agonists|dopamine agonists|mesh-ancestor
110737583|NCT01047215|Dopamine Agents|dopamine agents|mesh-ancestor
110737584|NCT01047215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110737585|NCT01047215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110737586|NCT01047215|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110737587|NCT01047215|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110737588|NCT01047215|Serotonin Agents|serotonin agents|mesh-ancestor
110737589|NCT01047215|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110737590|NCT01047215|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110737591|NCT01047215|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110737592|NCT01047215|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110737593|NCT03715582|Trimetazidine|trimetazidine|mesh-list
110737594|NCT03715582|Vasodilator Agents|vasodilator agents|mesh-ancestor
110737595|NCT00376961|Prednisone|prednisone|mesh-list
110737596|NCT00376961|Cyclophosphamide|cyclophosphamide|mesh-list
110737597|NCT00376961|Rituximab|rituximab|mesh-list
110737598|NCT00376961|Doxorubicin|doxorubicin|mesh-list
110737599|NCT00376961|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110737600|NCT00376961|Vincristine|vincristine|mesh-list
110737601|NCT00376961|Bortezomib|bortezomib|mesh-list
110737602|NCT00376961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110737603|NCT00376961|Immunologic Factors|immunologic factors|mesh-ancestor
110737604|NCT00376961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110737605|NCT00376961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110737606|NCT00376961|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110737607|NCT00376961|Alkylating Agents|alkylating agents|mesh-ancestor
110737608|NCT00376961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110737609|NCT00376961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110737610|NCT00376961|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110737611|NCT00376961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110737612|NCT00376961|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110737613|NCT00376961|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110737614|NCT00376961|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110737615|NCT00376961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110737616|NCT00376961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110737617|NCT00376961|Glucocorticoids|glucocorticoids|mesh-ancestor
110737618|NCT00376961|Hormones|hormones|mesh-ancestor
110737619|NCT00376961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110444767|NCT01183013|Hormones|hormones|mesh-ancestor
110737620|NCT00376961|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110737621|NCT00376961|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110737622|NCT00376961|Tubulin Modulators|tubulin modulators|mesh-ancestor
110737623|NCT00376961|Antimitotic Agents|antimitotic agents|mesh-ancestor
110737624|NCT00376961|Mitosis Modulators|mitosis modulators|mesh-ancestor
110737625|NCT00376259|Adefovir|adefovir|mesh-list
110737626|NCT00376259|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
110737627|NCT00376259|Telbivudine|telbivudine|mesh-list
110737628|NCT00376259|Antiviral Agents|antiviral agents|mesh-ancestor
110737629|NCT00376259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110737630|NCT00376259|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110737631|NCT00376259|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110737632|NCT00376259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110737633|NCT00376259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110737634|NCT03715348|Thrombin|thrombin|mesh-list
110737635|NCT03715348|Hemostatics|hemostatics|mesh-ancestor
110737636|NCT03715348|Coagulants|coagulants|mesh-ancestor
110737637|NCT01041755|N-Methylaspartate|n-methylaspartate|mesh-list
110737638|NCT01041755|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
110737639|NCT01041755|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110737640|NCT01041755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110737641|NCT01041755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110455389|NCT00994890|Tanezumab|tanezumab|mesh-list
110737642|NCT01041755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110737643|NCT00365105|Vitamin D|vitamin d|mesh-list
110737644|NCT00365105|Zoledronic Acid|zoledronic acid|mesh-list
110737646|NCT00365105|Vitamins|vitamins|mesh-ancestor
110737647|NCT00365105|Micronutrients|micronutrients|mesh-ancestor
110737648|NCT00365105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110737649|NCT00365105|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110737650|NCT00365105|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110737651|NCT01049633|Aspirin|aspirin|mesh-list
110737652|NCT01049633|Sirolimus|sirolimus|mesh-list
110737653|NCT01049633|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110737654|NCT01049633|Antifungal Agents|antifungal agents|mesh-list
110737655|NCT01049633|Clotrimazole|clotrimazole|mesh-list
110737656|NCT01049633|Miconazole|miconazole|mesh-list
110737657|NCT01049633|Trimethoprim|trimethoprim|mesh-list
110737658|NCT01049633|Sulfamethoxazole|sulfamethoxazole|mesh-list
110737659|NCT01049633|Valganciclovir|valganciclovir|mesh-list
110737660|NCT01049633|Antiviral Agents|antiviral agents|mesh-list
110737661|NCT01049633|Heparin|heparin|mesh-list
110737662|NCT01049633|Enoxaparin|enoxaparin|mesh-list
110737663|NCT01049633|Pentoxifylline|pentoxifylline|mesh-list
110737664|NCT01049633|Tacrolimus|tacrolimus|mesh-list
110737665|NCT01049633|Basiliximab|basiliximab|mesh-list
110737666|NCT01049633|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110737667|NCT01049633|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110737668|NCT01049633|Analgesics|analgesics|mesh-ancestor
110737669|NCT01049633|Sensory System Agents|sensory system agents|mesh-ancestor
110737670|NCT01049633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110737671|NCT01049633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110737672|NCT01049633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110737673|NCT01049633|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110737674|NCT01049633|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110737675|NCT01049633|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110737676|NCT01049633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110737677|NCT01049633|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110737678|NCT01049633|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110737679|NCT01049633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110737681|NCT01049633|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110737682|NCT01049633|Immunologic Factors|immunologic factors|mesh-ancestor
110737683|NCT01049633|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110145466|NCT00005823|Daunorubicin|daunorubicin|mesh-list
110737684|NCT01049633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110737685|NCT01049633|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110737686|NCT01049633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110737687|NCT01049633|Anticoagulants|anticoagulants|mesh-ancestor
110737688|NCT01049633|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110737689|NCT01049633|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110737690|NCT01049633|Protective Agents|protective agents|mesh-ancestor
110737691|NCT01049633|Vasodilator Agents|vasodilator agents|mesh-ancestor
110737692|NCT01049633|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110737693|NCT01049633|Antioxidants|antioxidants|mesh-ancestor
110737694|NCT01049633|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110737695|NCT01049633|Antimalarials|antimalarials|mesh-ancestor
110737696|NCT01049633|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110737697|NCT01049633|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110737698|NCT01049633|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110737699|NCT01049633|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110737700|NCT01049633|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
110737701|NCT01049633|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110737702|NCT01049633|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110737703|NCT01049633|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110737704|NCT01049633|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110737705|NCT01049633|Hormone Antagonists|hormone antagonists|mesh-ancestor
110737706|NCT01049633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110737707|NCT01049633|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110737708|NCT01049633|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110737709|NCT00399893|Octreotide|octreotide|mesh-list
110737710|NCT00399893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110737711|NCT00399893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110737712|NCT00399893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110737713|NCT01049711|Epoetin Alfa|epoetin alfa|mesh-list
110737714|NCT01049711|Hematinics|hematinics|mesh-ancestor
110737715|NCT00048542|Adalimumab|adalimumab|mesh-list
110737716|NCT00048542|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110737717|NCT00048542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110737718|NCT00048542|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110737719|NCT03814590|Vaccines|vaccines|mesh-list
110737720|NCT03814590|Immunologic Factors|immunologic factors|mesh-ancestor
110737721|NCT03814590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110737722|NCT01583244|Abatacept|abatacept|mesh-list
110737723|NCT01583244|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110737724|NCT01583244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110737725|NCT01583244|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110737726|NCT01583244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110737727|NCT01583244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110737728|NCT01583244|Immunologic Factors|immunologic factors|mesh-ancestor
110737729|NCT01583244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110737730|NCT01583244|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110737731|NCT01085526|Immunomodulating Agents|immunomodulating agents|mesh-list
110737732|NCT01085526|Immunologic Factors|immunologic factors|mesh-list
110737733|NCT01085526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110737735|NCT00048074|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110737736|NCT00048074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110737737|NCT01102946|Ranibizumab|ranibizumab|mesh-list
110737738|NCT01102946|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110737739|NCT01102946|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110737740|NCT01102946|Growth Substances|growth substances|mesh-ancestor
110737741|NCT01102946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110737742|NCT01102946|Growth Inhibitors|growth inhibitors|mesh-ancestor
110737743|NCT01102946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110737744|NCT01103024|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110737745|NCT01103024|Immunologic Factors|immunologic factors|mesh-ancestor
110737746|NCT01103024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110737747|NCT01101386|Voriconazole|voriconazole|mesh-list
110737748|NCT01101386|Antifungal Agents|antifungal agents|mesh-ancestor
110737749|NCT01101386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110737750|NCT01101386|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110737751|NCT01101386|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110737752|NCT01101386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110737753|NCT01101386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110737754|NCT01101386|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110737755|NCT01101386|Hormone Antagonists|hormone antagonists|mesh-ancestor
110737756|NCT01101386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110737757|NCT01101386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110737758|NCT01101386|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110737760|NCT00005906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110737761|NCT00005906|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110737762|NCT00005906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110737763|NCT01103336|Nicorandil|nicorandil|mesh-list
110737764|NCT01103336|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110737765|NCT01103336|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110737766|NCT01103336|Vasodilator Agents|vasodilator agents|mesh-ancestor
110737767|NCT01103336|Vitamin B Complex|vitamin b complex|mesh-ancestor
110737768|NCT01103336|Vitamins|vitamins|mesh-ancestor
110737769|NCT01103336|Micronutrients|micronutrients|mesh-ancestor
110737770|NCT01103336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110737771|NCT03950960|Itraconazole|itraconazole|mesh-list
110737772|NCT03950960|Antifungal Agents|antifungal agents|mesh-ancestor
110737773|NCT03950960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110737774|NCT03950960|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110737775|NCT03950960|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110737776|NCT03950960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110737777|NCT03950960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110737778|NCT03950960|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110737779|NCT03950960|Hormone Antagonists|hormone antagonists|mesh-ancestor
110737780|NCT03950960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110737781|NCT03950960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110737782|NCT03950960|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110737783|NCT03954860|Tranexamic Acid|tranexamic acid|mesh-list
110737784|NCT03954860|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110737785|NCT03954860|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110737786|NCT03954860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110737787|NCT03954860|Hemostatics|hemostatics|mesh-ancestor
110737788|NCT03954860|Coagulants|coagulants|mesh-ancestor
110737789|NCT00066690|Tamoxifen|tamoxifen|mesh-list
110737790|NCT00066690|Triptorelin Pamoate|triptorelin pamoate|mesh-list
110737791|NCT00066690|Exemestane|exemestane|mesh-list
110737792|NCT00066690|Tryptophan|tryptophan|mesh-list
110737793|NCT00066690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110737794|NCT00066690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110737795|NCT00066690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110737796|NCT00066690|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110737797|NCT00066690|Hormone Antagonists|hormone antagonists|mesh-ancestor
110737798|NCT00066690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110737799|NCT00066690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110737800|NCT00066690|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110737801|NCT00066690|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110737802|NCT00066690|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110737803|NCT00066690|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110737804|NCT00066690|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110737805|NCT00066690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110737806|NCT00066690|Luteolytic Agents|luteolytic agents|mesh-ancestor
110864968|NCT03194620|Chelating Agents|chelating agents|mesh-ancestor
110737807|NCT00066690|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110737808|NCT00066690|Contraceptive Agents|contraceptive agents|mesh-ancestor
110737809|NCT00066690|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110737810|NCT00066690|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110737811|NCT00066690|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110737812|NCT00066690|Antidepressive Agents|antidepressive agents|mesh-ancestor
110737813|NCT00066690|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110737815|NCT03409276|Immunologic Factors|immunologic factors|mesh-ancestor
110737816|NCT03409276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110737817|NCT00004562|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
110737818|NCT00004562|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
110737819|NCT00004562|Enzyme Inhibitors|enzyme inhibitors|mesh-list
110737820|NCT00004562|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
110737821|NCT00004562|Adrenergic Agents|adrenergic agents|mesh-list
110737822|NCT00004562|Adrenergic Antagonists|adrenergic antagonists|mesh-list
110737823|NCT00004562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110737824|NCT00004562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110737825|NCT00004562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110737826|NCT00004562|Protease Inhibitors|protease inhibitors|mesh-ancestor
110737827|NCT00004412|Arginine butyrate|arginine butyrate|mesh-list
110737828|NCT00004412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110737829|NCT00004088|Pamidronate|pamidronate|mesh-list
110737830|NCT00004088|Interferons|interferons|mesh-list
110737831|NCT00004088|Interferon-alpha|interferon-alpha|mesh-list
110737832|NCT00004088|Thalidomide|thalidomide|mesh-list
110737833|NCT00004088|Cyclophosphamide|cyclophosphamide|mesh-list
110737834|NCT00004088|Melphalan|melphalan|mesh-list
110737835|NCT00004088|Busulfan|busulfan|mesh-list
110737836|NCT00004088|Lenograstim|lenograstim|mesh-list
110737837|NCT00004088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110737838|NCT00004088|Immunologic Factors|immunologic factors|mesh-ancestor
110737839|NCT00004088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110737840|NCT00004088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110737841|NCT00004088|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110737842|NCT00004088|Alkylating Agents|alkylating agents|mesh-ancestor
110737843|NCT00004088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110737844|NCT00004088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110737845|NCT00004088|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110737846|NCT00004088|Antiviral Agents|antiviral agents|mesh-ancestor
110737847|NCT00004088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110737848|NCT00004088|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110737849|NCT00004088|Leprostatic Agents|leprostatic agents|mesh-ancestor
110737850|NCT00004088|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110737851|NCT00004088|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110737852|NCT00004088|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110737853|NCT00004088|Growth Substances|growth substances|mesh-ancestor
110737854|NCT00004088|Growth Inhibitors|growth inhibitors|mesh-ancestor
110737855|NCT00004088|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110737856|NCT03439072|Glucagon|glucagon|mesh-list
110737857|NCT03439072|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
110737858|NCT03439072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110737859|NCT03439072|Hormones|hormones|mesh-ancestor
110737860|NCT03439072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110737861|NCT03439072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110737862|NCT03439072|Incretins|incretins|mesh-ancestor
110737863|NCT00078312|Modafinil|modafinil|mesh-list
110737864|NCT00078312|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110737865|NCT00078312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110737866|NCT00078312|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
110737867|NCT00078312|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110737868|NCT00078312|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110455610|NCT02662894|Valsartan|valsartan|mesh-list
110737869|NCT00078312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110737870|NCT01085838|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110737871|NCT01085838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110737872|NCT01085838|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110737873|NCT01085838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110737874|NCT01085838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110737875|NCT00003896|Paclitaxel|paclitaxel|mesh-list
110737877|NCT00003896|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110737878|NCT00003896|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110737879|NCT00003896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110737880|NCT00003896|Tubulin Modulators|tubulin modulators|mesh-ancestor
110737881|NCT00003896|Antimitotic Agents|antimitotic agents|mesh-ancestor
110737882|NCT00003896|Mitosis Modulators|mitosis modulators|mesh-ancestor
110737883|NCT00003896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110737884|NCT00003896|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110737885|NCT00003896|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110737886|NCT00003896|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110737887|NCT00003896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110737888|NCT01091766|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110737889|NCT03712540|Rifampin|rifampin|mesh-list
110737890|NCT03712540|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110737891|NCT03712540|Antitubercular Agents|antitubercular agents|mesh-ancestor
110737892|NCT03712540|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110737893|NCT03712540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110737894|NCT03712540|Leprostatic Agents|leprostatic agents|mesh-ancestor
110737895|NCT03712540|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110145554|NCT00005859|Tipifarnib|tipifarnib|mesh-list
110737896|NCT03712540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110737897|NCT03712540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110737898|NCT03712540|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110737899|NCT03712540|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110737900|NCT03712540|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110737901|NCT03712540|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110737902|NCT03712540|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110737903|NCT03712540|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110737904|NCT05472220|Carboplatin|carboplatin|mesh-list
110737905|NCT05472220|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-list
110737906|NCT05472220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110737907|NCT05472220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110737908|NCT05472220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110737909|NCT00003782|Cyclophosphamide|cyclophosphamide|mesh-list
110737910|NCT00003782|Docetaxel|docetaxel|mesh-list
110737911|NCT00003782|Doxorubicin|doxorubicin|mesh-list
110737912|NCT00003782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110737913|NCT00003782|Immunologic Factors|immunologic factors|mesh-ancestor
110737914|NCT00003782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110737915|NCT00003782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110737916|NCT00003782|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110737917|NCT00003782|Alkylating Agents|alkylating agents|mesh-ancestor
110737918|NCT00003782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110737919|NCT00003782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110737920|NCT00003782|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110737921|NCT00003782|Tubulin Modulators|tubulin modulators|mesh-ancestor
110737922|NCT00003782|Antimitotic Agents|antimitotic agents|mesh-ancestor
110737923|NCT00003782|Mitosis Modulators|mitosis modulators|mesh-ancestor
110737924|NCT00003782|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110737925|NCT00003782|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110737926|NCT00003782|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110737927|NCT00003782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110737928|NCT03389308|Diacerein|diacerein|mesh-list
110737929|NCT03389308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110737930|NCT03714490|Capecitabine|capecitabine|mesh-list
110737931|NCT03714490|Oxaliplatin|oxaliplatin|mesh-list
110737932|NCT03714490|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110737933|NCT03714490|Antimetabolites|antimetabolites|mesh-ancestor
110737934|NCT03714490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110737935|NCT03714490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110737936|NCT03407170|Pembrolizumab|pembrolizumab|mesh-list
110737937|NCT03407170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110737938|NCT03407170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110737939|NCT03407170|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110737940|NCT03407170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110455686|NCT00702793|Varenicline|varenicline|mesh-list
110737942|NCT01103648|Ezetimibe|ezetimibe|mesh-list
110737943|NCT01103648|Hypolipidemic Agents|hypolipidemic agents|mesh-list
110737944|NCT01103648|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
110737945|NCT01103648|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110737946|NCT01103648|Antimetabolites|antimetabolites|mesh-ancestor
110737947|NCT01103648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110737948|NCT01103648|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110737949|NCT01103648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110737950|NCT03406858|Pembrolizumab|pembrolizumab|mesh-list
110737951|NCT03406858|Antibodies, Bispecific|antibodies, bispecific|mesh-list
110737952|NCT03406858|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110737953|NCT03406858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110145571|NCT00005865|Mitosis Modulators|mitosis modulators|mesh-ancestor
110737954|NCT03406858|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110737955|NCT03406858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110737956|NCT03406858|Immunologic Factors|immunologic factors|mesh-ancestor
110737957|NCT03406858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110737958|NCT01095848|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
110737959|NCT01095848|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110737960|NCT01095848|Immunologic Factors|immunologic factors|mesh-ancestor
110737961|NCT01095848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110737962|NCT01095926|Doxorubicin|doxorubicin|mesh-list
110737963|NCT01095926|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110737964|NCT01095926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110737965|NCT01095926|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110737966|NCT01095926|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110737967|NCT01095926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110737968|NCT01095926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110737969|NCT00003656|Interferons|interferons|mesh-list
110737970|NCT00003656|Interferon-alpha|interferon-alpha|mesh-list
110737971|NCT00003656|Tretinoin|tretinoin|mesh-list
110737972|NCT00003656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110737973|NCT00003656|Antiviral Agents|antiviral agents|mesh-ancestor
110737974|NCT00003656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110737975|NCT00003656|Immunologic Factors|immunologic factors|mesh-ancestor
110737976|NCT00003656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110737977|NCT00003656|Keratolytic Agents|keratolytic agents|mesh-ancestor
110737978|NCT00003656|Dermatologic Agents|dermatologic agents|mesh-ancestor
110737979|NCT00003590|Hydroxyurea|hydroxyurea|mesh-list
110737980|NCT00003590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110737981|NCT00003590|Antisickling Agents|antisickling agents|mesh-ancestor
110737982|NCT00003590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110737983|NCT00003590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110737984|NCT00003590|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110737986|NCT03948620|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110737987|NCT03948620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110737988|NCT03416374|Dexamethasone|dexamethasone|mesh-list
110737989|NCT03416374|Lenalidomide|lenalidomide|mesh-list
110737990|NCT03416374|Bortezomib|bortezomib|mesh-list
110737991|NCT03416374|Ixazomib|ixazomib|mesh-list
110737992|NCT03416374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110737993|NCT03416374|Antiemetics|antiemetics|mesh-ancestor
110737994|NCT03416374|Autonomic Agents|autonomic agents|mesh-ancestor
110737995|NCT03416374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110737996|NCT03416374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110737997|NCT03416374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110737999|NCT03416374|Hormones|hormones|mesh-ancestor
110738000|NCT03416374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110738001|NCT03416374|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110738002|NCT03416374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110738003|NCT03416374|Immunologic Factors|immunologic factors|mesh-ancestor
110738004|NCT03416374|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110738005|NCT03416374|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110738006|NCT03416374|Growth Substances|growth substances|mesh-ancestor
110738007|NCT03416374|Growth Inhibitors|growth inhibitors|mesh-ancestor
110738008|NCT03416374|Protease Inhibitors|protease inhibitors|mesh-ancestor
110738009|NCT03416374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110738010|NCT03416374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110738011|NCT00077766|Darbepoetin alfa|darbepoetin alfa|mesh-list
110738012|NCT00077766|Hematinics|hematinics|mesh-ancestor
110738013|NCT01096082|Lithium Carbonate|lithium carbonate|mesh-list
110738014|NCT01096082|Antidepressive Agents|antidepressive agents|mesh-ancestor
110738015|NCT01096082|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110738016|NCT01096082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110738017|NCT01096082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110738019|NCT01096082|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110738020|NCT01096082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110738021|NCT01096082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110738022|NCT03388138|Ketotifen|ketotifen|mesh-list
110738023|NCT03388138|Antipruritics|antipruritics|mesh-ancestor
110738024|NCT03388138|Dermatologic Agents|dermatologic agents|mesh-ancestor
110738025|NCT03388138|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110738026|NCT03388138|Histamine Antagonists|histamine antagonists|mesh-ancestor
110738027|NCT03388138|Histamine Agents|histamine agents|mesh-ancestor
110738028|NCT03388138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110738029|NCT03388138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110738030|NCT03388138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110738031|NCT03388138|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110738032|NCT01101620|Simendan|simendan|mesh-list
110738033|NCT01101620|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110738034|NCT01101620|Vasodilator Agents|vasodilator agents|mesh-ancestor
110738035|NCT01101620|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110738036|NCT01101620|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110738037|NCT01101620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110738038|NCT01101620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110738039|NCT01101620|Protective Agents|protective agents|mesh-ancestor
110738040|NCT01101620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110738041|NCT02952898|Diclofenac|diclofenac|mesh-list
110738042|NCT02952898|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110738043|NCT02952898|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110738044|NCT02952898|Analgesics|analgesics|mesh-ancestor
110738045|NCT02952898|Sensory System Agents|sensory system agents|mesh-ancestor
110738046|NCT02952898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110738047|NCT02952898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110738048|NCT02952898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110738049|NCT02952898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110738050|NCT02952898|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110738051|NCT02952898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110738052|NCT02952898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110738053|NCT01101698|Vitamin D|vitamin d|mesh-list
110738054|NCT01101698|Cholecalciferol|cholecalciferol|mesh-list
110738055|NCT01101698|Vitamins|vitamins|mesh-list
110738056|NCT01101698|Vitamin K|vitamin k|mesh-list
110738057|NCT01101698|Vitamin K 2|vitamin k 2|mesh-list
110738058|NCT01101698|Micronutrients|micronutrients|mesh-ancestor
110738059|NCT01101698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110738061|NCT01101698|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110738062|NCT01101698|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110738063|NCT01101698|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110865014|NCT01005056|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110738064|NCT01101698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110738065|NCT01101698|Hemostatics|hemostatics|mesh-ancestor
110738066|NCT01101698|Coagulants|coagulants|mesh-ancestor
110738067|NCT00045734|Imatinib Mesylate|imatinib mesylate|mesh-list
110738068|NCT00045734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110738069|NCT00045734|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110738070|NCT00045734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110738071|NCT00045734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110738072|NCT05513768|Protein C|protein c|mesh-list
110738073|NCT05513768|Anticoagulants|anticoagulants|mesh-ancestor
110738074|NCT05513768|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110738075|NCT05513768|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110738076|NCT05513768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110738077|NCT03387046|Methylprednisolone|methylprednisolone|mesh-list
110738078|NCT03387046|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110738079|NCT03387046|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110738080|NCT03387046|Prednisolone|prednisolone|mesh-list
110738081|NCT03387046|Prednisolone acetate|prednisolone acetate|mesh-list
110738082|NCT03387046|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110738083|NCT03387046|Prednisolone phosphate|prednisolone phosphate|mesh-list
110738084|NCT03387046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110738085|NCT03387046|Antiemetics|antiemetics|mesh-ancestor
110738086|NCT03387046|Autonomic Agents|autonomic agents|mesh-ancestor
110738087|NCT03387046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110738088|NCT03387046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110738089|NCT03387046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110738090|NCT03387046|Glucocorticoids|glucocorticoids|mesh-ancestor
110738091|NCT03387046|Hormones|hormones|mesh-ancestor
110738092|NCT03387046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110738093|NCT03387046|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110738094|NCT03387046|Protective Agents|protective agents|mesh-ancestor
110738095|NCT03387046|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110738096|NCT03387046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110738097|NCT01101776|Interferons|interferons|mesh-list
110738098|NCT01101776|Interferon-beta|interferon-beta|mesh-list
110738099|NCT01101776|Interferon beta-1a|interferon beta-1a|mesh-list
110738100|NCT01101776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110738101|NCT01101776|Antiviral Agents|antiviral agents|mesh-ancestor
110738102|NCT01101776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110738103|NCT01101776|Immunologic Factors|immunologic factors|mesh-ancestor
110738104|NCT01101776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110738105|NCT01101776|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110738106|NCT00045110|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110738107|NCT00045110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110738108|NCT00045110|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110738109|NCT00045110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110738110|NCT00045110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110738111|NCT03353740|Edetic Acid|edetic acid|mesh-list
110738112|NCT03353740|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
110738113|NCT03353740|Chelating Agents|chelating agents|mesh-ancestor
110738114|NCT03353740|Sequestering Agents|sequestering agents|mesh-ancestor
110738115|NCT03353740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110738116|NCT03353740|Anticoagulants|anticoagulants|mesh-ancestor
110738117|NCT03353740|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110738118|NCT03353740|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110738119|NCT04814602|Proglumide|proglumide|mesh-list
110738120|NCT04814602|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110738121|NCT04814602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110738122|NCT01104038|Chlorhexidine|chlorhexidine|mesh-list
110738123|NCT01104038|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110738124|NCT01104038|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110738125|NCT01104038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110738126|NCT01104038|Disinfectants|disinfectants|mesh-ancestor
110738127|NCT01104038|Dermatologic Agents|dermatologic agents|mesh-ancestor
110738128|NCT03386344|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
110865023|NCT04796714|Analgesics|analgesics|mesh-ancestor
110738129|NCT03386344|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110738130|NCT03386344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110738131|NCT03386344|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110738132|NCT03386344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110738133|NCT00399035|Leucovorin|leucovorin|mesh-list
110738134|NCT00399035|Fluorouracil|fluorouracil|mesh-list
110738135|NCT00399035|Capecitabine|capecitabine|mesh-list
110738136|NCT00399035|Oxaliplatin|oxaliplatin|mesh-list
110738137|NCT00399035|Cediranib|cediranib|mesh-list
110738138|NCT00399035|Levoleucovorin|levoleucovorin|mesh-list
110738139|NCT00399035|Antimetabolites|antimetabolites|mesh-ancestor
110738140|NCT00399035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110738141|NCT00399035|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110738142|NCT00399035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110738143|NCT00399035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110738144|NCT00399035|Immunologic Factors|immunologic factors|mesh-ancestor
110738145|NCT00399035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110738146|NCT00399035|Antidotes|antidotes|mesh-ancestor
110738147|NCT00399035|Protective Agents|protective agents|mesh-ancestor
110738148|NCT00399035|Vitamin B Complex|vitamin b complex|mesh-ancestor
110738149|NCT00399035|Vitamins|vitamins|mesh-ancestor
110738150|NCT00399035|Micronutrients|micronutrients|mesh-ancestor
110738151|NCT00399035|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110738152|NCT00399035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110738153|NCT00073749|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
110738154|NCT00073749|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110738155|NCT00073749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110738156|NCT00073749|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110738157|NCT00073749|Immunotoxins|immunotoxins|mesh-ancestor
110738158|NCT00073749|Immunoconjugates|immunoconjugates|mesh-ancestor
110738159|NCT00073749|Immunologic Factors|immunologic factors|mesh-ancestor
110738160|NCT00073749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110145675|NCT00005898|Hormones|hormones|mesh-ancestor
110738161|NCT03960801|Remifentanil|remifentanil|mesh-list
110738162|NCT03960801|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110738163|NCT03960801|Narcotics|narcotics|mesh-ancestor
110738164|NCT03960801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110738165|NCT03960801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110738166|NCT03960801|Analgesics|analgesics|mesh-ancestor
110738167|NCT03960801|Sensory System Agents|sensory system agents|mesh-ancestor
110738168|NCT03960801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110738169|NCT01583439|Ritonavir|ritonavir|mesh-list
110738170|NCT01583439|Lopinavir|lopinavir|mesh-list
110738171|NCT01583439|Tenofovir|tenofovir|mesh-list
110738172|NCT01583439|Lamivudine|lamivudine|mesh-list
110738173|NCT01583439|Emtricitabine|emtricitabine|mesh-list
110738174|NCT01583439|Zidovudine|zidovudine|mesh-list
110738175|NCT01583439|Efavirenz|efavirenz|mesh-list
110738176|NCT01583439|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
110738177|NCT01583439|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110738178|NCT01583439|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110738179|NCT01583439|Protease Inhibitors|protease inhibitors|mesh-ancestor
110738180|NCT01583439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110738181|NCT01583439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110738182|NCT01583439|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110738183|NCT01583439|Antiviral Agents|antiviral agents|mesh-ancestor
110738184|NCT01583439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110738185|NCT01583439|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110738186|NCT01583439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110738187|NCT01583439|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110738188|NCT01583439|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110738189|NCT01583439|Antimetabolites|antimetabolites|mesh-ancestor
110738190|NCT01583439|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110738191|NCT01583439|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110738192|NCT01583439|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110738193|NCT01583439|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110738194|NCT01583439|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110738195|NCT02530827|Hypolipidemic Agents|hypolipidemic agents|mesh-list
110738196|NCT02530827|Antimetabolites|antimetabolites|mesh-ancestor
110738197|NCT02530827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110738198|NCT02530827|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110738199|NCT00398567|Trastuzumab|trastuzumab|mesh-list
110738200|NCT00398567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110738201|NCT00398567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110738202|NCT01082289|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
110738203|NCT01082289|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110738204|NCT01082289|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110738205|NCT01082289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110738206|NCT01082289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110738208|NCT01082289|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
110738209|NCT01082289|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110738210|NCT01082289|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110738211|NCT01082289|Adrenergic Agents|adrenergic agents|mesh-ancestor
110738212|NCT01082289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110738213|NCT01082289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110738214|NCT01082289|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110738215|NCT01082289|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110738216|NCT01082289|Serotonin Agents|serotonin agents|mesh-ancestor
110738217|NCT01082289|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110738218|NCT01082289|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110738219|NCT01082289|Dopamine Agents|dopamine agents|mesh-ancestor
110738220|NCT05842174|Hydroxychloroquine|hydroxychloroquine|mesh-list
110738221|NCT05842174|Ethiodized Oil|ethiodized oil|mesh-list
110738222|NCT05842174|Antimalarials|antimalarials|mesh-ancestor
110738223|NCT05842174|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110738224|NCT05842174|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110738225|NCT05842174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110738226|NCT05842174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110738227|NCT05842174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110738228|NCT05842174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110738229|NCT05842174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110738230|NCT05842096|Antibodies|antibodies|mesh-list
110738231|NCT05842096|Immunologic Factors|immunologic factors|mesh-ancestor
110738232|NCT05842096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110738233|NCT05841992|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
110738234|NCT05841992|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110738235|NCT05841992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110738236|NCT05841849|Aprepitant|aprepitant|mesh-list
110738237|NCT05841849|Fosaprepitant|fosaprepitant|mesh-list
110738238|NCT05841849|Palonosetron|palonosetron|mesh-list
110738239|NCT05841849|Antiemetics|antiemetics|mesh-ancestor
110738240|NCT05841849|Autonomic Agents|autonomic agents|mesh-ancestor
110738241|NCT05841849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110738242|NCT05841849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110738243|NCT05841849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110738244|NCT05841849|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110738245|NCT05841849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110738246|NCT05841849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110738247|NCT05841849|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110738248|NCT05841849|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110738249|NCT05841849|Serotonin Agents|serotonin agents|mesh-ancestor
110738250|NCT05841771|Azacitidine|azacitidine|mesh-list
110738251|NCT05841771|Decitabine|decitabine|mesh-list
110738252|NCT05841771|Venetoclax|venetoclax|mesh-list
110738253|NCT05841771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110738254|NCT05841771|Antimetabolites|antimetabolites|mesh-ancestor
110738255|NCT05841771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110738256|NCT05841771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110738257|NCT05841771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110738258|NCT05841758|Hydroxychloroquine|hydroxychloroquine|mesh-list
110738259|NCT05841758|Antimalarials|antimalarials|mesh-ancestor
110738260|NCT05841758|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110738261|NCT05841758|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110738262|NCT05841758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110738263|NCT05841758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110738264|NCT05841758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110738265|NCT05841758|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110738266|NCT05841654|Antihypertensive Agents|antihypertensive agents|mesh-list
110738267|NCT05841654|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
110738268|NCT05841654|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110738269|NCT05841654|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110738270|NCT05841654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110738271|NCT05841641|Hemostatics|hemostatics|mesh-list
110738272|NCT05841641|Coagulants|coagulants|mesh-ancestor
110738273|NCT05841589|Chlorhexidine|chlorhexidine|mesh-list
110738274|NCT05841589|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110738275|NCT05841589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110738276|NCT05841589|Disinfectants|disinfectants|mesh-ancestor
110738277|NCT05841446|Apixaban|apixaban|mesh-list
110738278|NCT05841446|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110738279|NCT05841446|Antithrombins|antithrombins|mesh-ancestor
110738280|NCT05841446|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110738281|NCT05841446|Protease Inhibitors|protease inhibitors|mesh-ancestor
110738282|NCT05841446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110738283|NCT05841446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110738284|NCT05841446|Anticoagulants|anticoagulants|mesh-ancestor
110738285|NCT05841394|Esomeprazole|esomeprazole|mesh-list
110738286|NCT05841394|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110738287|NCT05841394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110738288|NCT05841394|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110738289|NCT05841394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110738290|NCT05841394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110738291|NCT05841381|Paclitaxel|paclitaxel|mesh-list
110738292|NCT05841381|Trastuzumab|trastuzumab|mesh-list
110738293|NCT05841381|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110738294|NCT05841381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110738295|NCT05841381|Tubulin Modulators|tubulin modulators|mesh-ancestor
110738296|NCT05841381|Antimitotic Agents|antimitotic agents|mesh-ancestor
110738297|NCT05841381|Mitosis Modulators|mitosis modulators|mesh-ancestor
110738298|NCT05841381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110738299|NCT05841381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110738300|NCT05841303|Ascorbic Acid|ascorbic acid|mesh-list
110738301|NCT05841303|Antioxidants|antioxidants|mesh-ancestor
110738302|NCT05841303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110738303|NCT05841303|Protective Agents|protective agents|mesh-ancestor
110738304|NCT05841303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110738305|NCT05841303|Vitamins|vitamins|mesh-ancestor
110738306|NCT05841303|Micronutrients|micronutrients|mesh-ancestor
110738307|NCT05841290|Anesthetics|anesthetics|mesh-list
110738308|NCT05841290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110738309|NCT05841290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110738310|NCT05841251|Phenylephrine|phenylephrine|mesh-list
110738311|NCT05841251|Oxymetazoline|oxymetazoline|mesh-list
110738312|NCT05841251|Tranexamic Acid|tranexamic acid|mesh-list
110738313|NCT05841251|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110738314|NCT05841251|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110738315|NCT05841251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110738316|NCT05841251|Hemostatics|hemostatics|mesh-ancestor
110738317|NCT05841251|Coagulants|coagulants|mesh-ancestor
110738318|NCT05841251|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110456063|NCT02612233|Dopamine Agents|dopamine agents|mesh-ancestor
110738319|NCT05841251|Mydriatics|mydriatics|mesh-ancestor
110738320|NCT05841251|Autonomic Agents|autonomic agents|mesh-ancestor
110738321|NCT05841251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110738322|NCT05841251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110738323|NCT05841251|Sympathomimetics|sympathomimetics|mesh-ancestor
110738324|NCT05841251|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110738325|NCT05841251|Nasal Decongestants|nasal decongestants|mesh-ancestor
110738326|NCT05841251|Respiratory System Agents|respiratory system agents|mesh-ancestor
110738327|NCT05841251|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110738328|NCT05841251|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110738329|NCT05841251|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110738330|NCT05841251|Adrenergic Agents|adrenergic agents|mesh-ancestor
110738331|NCT05841251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110738332|NCT05841251|Protective Agents|protective agents|mesh-ancestor
110738333|NCT05841147|Tirofiban|tirofiban|mesh-list
110738334|NCT05841147|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110738335|NCT05841147|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110738336|NCT05841147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110738337|NCT05841147|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110738338|NCT05841121|Dexamethasone|dexamethasone|mesh-list
110738339|NCT05841121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110738340|NCT05841121|Antiemetics|antiemetics|mesh-ancestor
110738341|NCT05841121|Autonomic Agents|autonomic agents|mesh-ancestor
110738342|NCT05841121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110738343|NCT05841121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110738344|NCT05841121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110738345|NCT05841121|Glucocorticoids|glucocorticoids|mesh-ancestor
110738346|NCT05841121|Hormones|hormones|mesh-ancestor
110444788|NCT04229602|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
110738347|NCT05841121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110738348|NCT05841121|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110738349|NCT05841121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110738351|NCT05841056|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110738352|NCT05841056|Vasodilator Agents|vasodilator agents|mesh-ancestor
110738353|NCT05841056|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
110738354|NCT05841056|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110738355|NCT05841056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110738356|NCT05841056|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110738357|NCT05841056|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110738358|NCT05841056|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110738359|NCT05841056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110738360|NCT05841056|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110738361|NCT05841056|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110738362|NCT05841056|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110738363|NCT05841043|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110738364|NCT05841043|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110738365|NCT05840952|Itraconazole|itraconazole|mesh-list
110738366|NCT05840952|Carbamazepine|carbamazepine|mesh-list
110738367|NCT05840952|Midazolam|midazolam|mesh-list
110738368|NCT05840952|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110738369|NCT05840952|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110738370|NCT05840952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110738371|NCT05840952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110738372|NCT05840952|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110738373|NCT05840952|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110738374|NCT05840952|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110738375|NCT05840952|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110738376|NCT05840952|Anesthetics, General|anesthetics, general|mesh-ancestor
110738377|NCT05840952|Anesthetics|anesthetics|mesh-ancestor
110738378|NCT05840952|GABA Modulators|gaba modulators|mesh-ancestor
110738379|NCT05840952|GABA Agents|gaba agents|mesh-ancestor
110738380|NCT05840952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110738381|NCT05840952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110738382|NCT05840952|Antifungal Agents|antifungal agents|mesh-ancestor
110738383|NCT05840952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110738384|NCT05840952|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110738385|NCT05840952|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110738386|NCT05840952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110738387|NCT05840952|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110738388|NCT05840952|Hormone Antagonists|hormone antagonists|mesh-ancestor
110738389|NCT05840952|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110738390|NCT05840952|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110738391|NCT05840952|Anticonvulsants|anticonvulsants|mesh-ancestor
110738392|NCT05840952|Antimanic Agents|antimanic agents|mesh-ancestor
110738393|NCT05840952|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110738395|NCT05840952|Sensory System Agents|sensory system agents|mesh-ancestor
110738396|NCT05840952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110738397|NCT05840952|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110738398|NCT05840952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110738399|NCT05840952|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110145724|NCT00005931|Semaxinib|semaxinib|mesh-list
110738400|NCT05840952|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110738401|NCT05840913|Epinephrine|epinephrine|mesh-list
110738402|NCT05840913|Carticaine|carticaine|mesh-list
110738403|NCT05840913|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110738404|NCT05840913|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110738405|NCT05840913|Adrenergic Agents|adrenergic agents|mesh-ancestor
110738406|NCT05840913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110738407|NCT05840913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110738408|NCT05840913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110738409|NCT05840913|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110738410|NCT05840913|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110738411|NCT05840913|Autonomic Agents|autonomic agents|mesh-ancestor
110738412|NCT05840913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110738413|NCT05840913|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110738414|NCT05840913|Respiratory System Agents|respiratory system agents|mesh-ancestor
110738415|NCT05840913|Mydriatics|mydriatics|mesh-ancestor
110738416|NCT05840913|Sympathomimetics|sympathomimetics|mesh-ancestor
110738417|NCT05840913|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110738419|NCT05840913|Anesthetics|anesthetics|mesh-ancestor
110738420|NCT05840913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110738421|NCT05840913|Sensory System Agents|sensory system agents|mesh-ancestor
110738422|NCT05840822|Cannabidiol|cannabidiol|mesh-list
110738423|NCT05840822|Anticonvulsants|anticonvulsants|mesh-ancestor
110738424|NCT05840796|Caseins|caseins|mesh-list
110738425|NCT05840796|Chelating Agents|chelating agents|mesh-ancestor
110738426|NCT05840796|Sequestering Agents|sequestering agents|mesh-ancestor
110738427|NCT05840796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110738428|NCT05840770|Cemiplimab|cemiplimab|mesh-list
110738429|NCT05840770|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110738430|NCT05840770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110738431|NCT05840068|Metformin|metformin|mesh-list
110738432|NCT05840068|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110738433|NCT05840068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110738434|NCT05834023|Lidocaine|lidocaine|mesh-list
110738435|NCT05834023|Bupivacaine|bupivacaine|mesh-list
110738436|NCT05834023|Anesthetics, Local|anesthetics, local|mesh-ancestor
110738437|NCT05834023|Anesthetics|anesthetics|mesh-ancestor
110738438|NCT05834023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110738439|NCT05834023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110738440|NCT05834023|Sensory System Agents|sensory system agents|mesh-ancestor
110738441|NCT05834023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110738442|NCT05834023|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110738443|NCT05834023|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110738444|NCT05834023|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110738445|NCT05834023|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110738446|NCT05834023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110738447|NCT05804708|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
110738448|NCT05804708|Hallucinogens|hallucinogens|mesh-ancestor
110738449|NCT05804708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110738450|NCT05804708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110738451|NCT05804708|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110738452|NCT05804708|Serotonin Agents|serotonin agents|mesh-ancestor
110738453|NCT05804708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110738454|NCT05804708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110738455|NCT05804708|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110738456|NCT05787600|Chlorhexidine|chlorhexidine|mesh-list
110738457|NCT05787600|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110738458|NCT05787600|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110738459|NCT05787600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110738460|NCT05787600|Disinfectants|disinfectants|mesh-ancestor
110738461|NCT05787600|Dermatologic Agents|dermatologic agents|mesh-ancestor
110738462|NCT05782816|Oxytocin|oxytocin|mesh-list
110738463|NCT05782816|Oxytocics|oxytocics|mesh-ancestor
110738464|NCT05782816|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110738465|NCT05782816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110456216|NCT04116931|Clopidogrel|clopidogrel|mesh-list
110738466|NCT05768932|Paclitaxel|paclitaxel|mesh-list
110738467|NCT05768932|Carboplatin|carboplatin|mesh-list
110738468|NCT05768932|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110738469|NCT05768932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110738470|NCT05768932|Tubulin Modulators|tubulin modulators|mesh-ancestor
110738471|NCT05768932|Antimitotic Agents|antimitotic agents|mesh-ancestor
110738472|NCT05768932|Mitosis Modulators|mitosis modulators|mesh-ancestor
110738473|NCT05768932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110738474|NCT05726318|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110738475|NCT05726318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110738476|NCT05653882|Pembrolizumab|pembrolizumab|mesh-list
110738477|NCT05653882|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110738478|NCT05653882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110738479|NCT05653882|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110738480|NCT05653882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110738481|NCT05637398|Colchicine|colchicine|mesh-list
110738482|NCT05637398|Gout Suppressants|gout suppressants|mesh-ancestor
110738483|NCT05637398|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110738484|NCT05637398|Tubulin Modulators|tubulin modulators|mesh-ancestor
110738485|NCT05637398|Antimitotic Agents|antimitotic agents|mesh-ancestor
110738486|NCT05637398|Mitosis Modulators|mitosis modulators|mesh-ancestor
110738487|NCT05637398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110738488|NCT05637398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110738489|NCT05604729|Botulinum Toxins|botulinum toxins|mesh-list
110738490|NCT05604729|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110738491|NCT05604729|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110738492|NCT05604729|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110738493|NCT05604729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110738494|NCT05604729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110738495|NCT05604729|Cholinergic Agents|cholinergic agents|mesh-ancestor
110738496|NCT05604729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110738497|NCT05604729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110738498|NCT05604729|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110738499|NCT05604729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110738501|NCT05583071|Methotrexate|methotrexate|mesh-list
110738502|NCT05583071|Lenalidomide|lenalidomide|mesh-list
110738503|NCT05583071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110738504|NCT05583071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110738505|NCT05583071|Immunologic Factors|immunologic factors|mesh-ancestor
110738506|NCT05583071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110738507|NCT05583071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110738508|NCT05583071|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110738509|NCT05583071|Abortifacient Agents|abortifacient agents|mesh-ancestor
110738510|NCT05583071|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110738511|NCT05583071|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110738512|NCT05583071|Antimetabolites|antimetabolites|mesh-ancestor
110738513|NCT05583071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110738514|NCT05583071|Dermatologic Agents|dermatologic agents|mesh-ancestor
110738515|NCT05583071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110738516|NCT05583071|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110738517|NCT05583071|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110738518|NCT05583071|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110738519|NCT05583071|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110738520|NCT05583071|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110738521|NCT05583071|Growth Substances|growth substances|mesh-ancestor
110738522|NCT05583071|Growth Inhibitors|growth inhibitors|mesh-ancestor
110738523|NCT05417113|Bupivacaine|bupivacaine|mesh-list
110738524|NCT05417113|Anesthetics, Local|anesthetics, local|mesh-ancestor
110738525|NCT05417113|Anesthetics|anesthetics|mesh-ancestor
110738526|NCT05417113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110738527|NCT05417113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110738528|NCT05417113|Sensory System Agents|sensory system agents|mesh-ancestor
110738529|NCT05417113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110738530|NCT05394298|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110738531|NCT05394298|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
110738532|NCT05394298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110738533|NCT05394298|Antitubercular Agents|antitubercular agents|mesh-ancestor
110738534|NCT05390359|Oxymetazoline|oxymetazoline|mesh-list
110738535|NCT05390359|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110738536|NCT05390359|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110738537|NCT05390359|Adrenergic Agents|adrenergic agents|mesh-ancestor
110738538|NCT05390359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110738539|NCT05390359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110738540|NCT05390359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110738541|NCT05390359|Sympathomimetics|sympathomimetics|mesh-ancestor
110738542|NCT05390359|Autonomic Agents|autonomic agents|mesh-ancestor
110738543|NCT05390359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110738544|NCT05390359|Nasal Decongestants|nasal decongestants|mesh-ancestor
110738545|NCT05390359|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110738546|NCT05390359|Respiratory System Agents|respiratory system agents|mesh-ancestor
110738547|NCT05330078|Botulinum Toxins|botulinum toxins|mesh-list
110738548|NCT05330078|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110738549|NCT05330078|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110738550|NCT05330078|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110738551|NCT05330078|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110738552|NCT05330078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110738553|NCT05330078|Cholinergic Agents|cholinergic agents|mesh-ancestor
110738554|NCT05330078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110738555|NCT05330078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110738556|NCT05330078|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110738557|NCT05330078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110738558|NCT05309564|Botulinum Toxins|botulinum toxins|mesh-list
110738559|NCT05309564|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110738560|NCT05309564|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110738561|NCT05309564|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110738562|NCT05309564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110738563|NCT05309564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110738564|NCT05309564|Cholinergic Agents|cholinergic agents|mesh-ancestor
110738565|NCT05309564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110738566|NCT05309564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110738567|NCT05309564|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110738568|NCT05309564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110738569|NCT05249569|Avelumab|avelumab|mesh-list
110738570|NCT05249569|Bavituximab|bavituximab|mesh-list
110738571|NCT05249569|Axitinib|axitinib|mesh-list
110738572|NCT05249569|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110738573|NCT05249569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110738574|NCT05249569|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110738575|NCT05249569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110738576|NCT05249569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110738577|NCT05212662|Cysteamine|cysteamine|mesh-list
110738578|NCT05212662|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
110738579|NCT05212662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110738580|NCT05182073|Cyclophosphamide|cyclophosphamide|mesh-list
110738581|NCT05182073|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110738582|NCT05182073|Fludarabine|fludarabine|mesh-list
110738583|NCT05182073|Daratumumab|daratumumab|mesh-list
110738584|NCT05182073|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110738585|NCT05182073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110738586|NCT05182073|Immunologic Factors|immunologic factors|mesh-ancestor
110738587|NCT05182073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110738588|NCT05182073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110738589|NCT05182073|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110738590|NCT05182073|Alkylating Agents|alkylating agents|mesh-ancestor
110738591|NCT05182073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110738592|NCT05182073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110738593|NCT05182073|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110738594|NCT05177822|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
110738595|NCT05177822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110738596|NCT05096663|Vitamins|vitamins|mesh-list
110738597|NCT05096663|Folic Acid|folic acid|mesh-list
110738598|NCT05096663|Hydroxocobalamin|hydroxocobalamin|mesh-list
110738599|NCT05096663|Vitamin B 12|vitamin b 12|mesh-list
110738600|NCT05096663|Vitamin B Complex|vitamin b complex|mesh-list
110738601|NCT05096663|Dexamethasone|dexamethasone|mesh-list
110738602|NCT05096663|Dexamethasone acetate|dexamethasone acetate|mesh-list
110738603|NCT05096663|Gemcitabine|gemcitabine|mesh-list
110738604|NCT05096663|Docetaxel|docetaxel|mesh-list
110738605|NCT05096663|Pembrolizumab|pembrolizumab|mesh-list
110738606|NCT05096663|Pemetrexed|pemetrexed|mesh-list
110738607|NCT05096663|Ramucirumab|ramucirumab|mesh-list
110738608|NCT05096663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110738609|NCT05096663|Antibodies|antibodies|mesh-list
110738610|NCT05096663|Immunoglobulins|immunoglobulins|mesh-list
110738611|NCT05096663|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110738612|NCT05096663|Lexatumumab|lexatumumab|mesh-list
110738613|NCT05096663|BB 1101|bb 1101|mesh-list
110738614|NCT05096663|Micronutrients|micronutrients|mesh-ancestor
110738615|NCT05096663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110738616|NCT05096663|Immunologic Factors|immunologic factors|mesh-ancestor
110738617|NCT05096663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110738618|NCT05096663|Antiemetics|antiemetics|mesh-ancestor
110738619|NCT05096663|Autonomic Agents|autonomic agents|mesh-ancestor
110738620|NCT05096663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110738621|NCT05096663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110738622|NCT05096663|Glucocorticoids|glucocorticoids|mesh-ancestor
110738623|NCT05096663|Hormones|hormones|mesh-ancestor
110738624|NCT05096663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110738625|NCT05096663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110738626|NCT05096663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110738627|NCT05096663|Protease Inhibitors|protease inhibitors|mesh-ancestor
110738628|NCT05096663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110738629|NCT05096663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110738630|NCT05096663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110738631|NCT05096663|Antimetabolites|antimetabolites|mesh-ancestor
110738632|NCT05096663|Tubulin Modulators|tubulin modulators|mesh-ancestor
110738633|NCT05096663|Antimitotic Agents|antimitotic agents|mesh-ancestor
110738634|NCT05096663|Mitosis Modulators|mitosis modulators|mesh-ancestor
110738635|NCT05096663|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110738636|NCT05096663|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110738637|NCT05096663|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110738638|NCT05096663|Hematinics|hematinics|mesh-ancestor
110738639|NCT05009082|Paclitaxel|paclitaxel|mesh-list
110738640|NCT05009082|Bevacizumab|bevacizumab|mesh-list
110738641|NCT05009082|Carboplatin|carboplatin|mesh-list
110738642|NCT05009082|Niraparib|niraparib|mesh-list
110738643|NCT05009082|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110738644|NCT05009082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110738645|NCT05009082|Tubulin Modulators|tubulin modulators|mesh-ancestor
110738646|NCT05009082|Antimitotic Agents|antimitotic agents|mesh-ancestor
110738647|NCT05009082|Mitosis Modulators|mitosis modulators|mesh-ancestor
110145789|NCT00005946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110738648|NCT05009082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110738649|NCT05009082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110738650|NCT05009082|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110738651|NCT05009082|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110738652|NCT05009082|Growth Substances|growth substances|mesh-ancestor
110738653|NCT05009082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110738654|NCT05009082|Growth Inhibitors|growth inhibitors|mesh-ancestor
110738655|NCT05009082|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110738656|NCT05009082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110738657|NCT05002413|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110738658|NCT05002413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110738659|NCT04982796|Psilocybin|psilocybin|mesh-list
110738660|NCT04982796|Hallucinogens|hallucinogens|mesh-ancestor
110738661|NCT04982796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110738662|NCT04982796|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110738663|NCT04970576|Warfarin|warfarin|mesh-list
110738664|NCT04970576|Rivaroxaban|rivaroxaban|mesh-list
110738665|NCT04970576|Anticoagulants|anticoagulants|mesh-ancestor
110738666|NCT04970576|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110738667|NCT04970576|Antithrombins|antithrombins|mesh-ancestor
110738668|NCT04970576|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110738669|NCT04970576|Protease Inhibitors|protease inhibitors|mesh-ancestor
110738670|NCT04970576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110738671|NCT04970576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110738672|NCT04941911|Octreotide|octreotide|mesh-list
110738673|NCT04941911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110738674|NCT04941911|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110738675|NCT04941911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110738676|NCT04858490|Diazepam|diazepam|mesh-list
110738677|NCT04858490|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110738678|NCT04858490|Anticonvulsants|anticonvulsants|mesh-ancestor
110738679|NCT04858490|Antiemetics|antiemetics|mesh-ancestor
110738680|NCT04858490|Autonomic Agents|autonomic agents|mesh-ancestor
110738681|NCT04858490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110738682|NCT04858490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110738683|NCT04858490|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110738684|NCT04858490|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110738685|NCT04858490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110738686|NCT04858490|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110738687|NCT04858490|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110738688|NCT04858490|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110738689|NCT04858490|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110738690|NCT04858490|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110738691|NCT04858490|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110738692|NCT04858490|Anesthetics, General|anesthetics, general|mesh-ancestor
110738693|NCT04858490|Anesthetics|anesthetics|mesh-ancestor
110738694|NCT04858490|GABA Modulators|gaba modulators|mesh-ancestor
110738695|NCT04858490|GABA Agents|gaba agents|mesh-ancestor
110738696|NCT04858490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110738697|NCT04858490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110738698|NCT04790032|Cangrelor|cangrelor|mesh-list
110738699|NCT04790032|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110738700|NCT04790032|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110738701|NCT04790032|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110738702|NCT04790032|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110738703|NCT04790032|Purinergic Agents|purinergic agents|mesh-ancestor
110738704|NCT04790032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110738705|NCT04790032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110738706|NCT04790032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110738707|NCT04779879|Sotrovimab|sotrovimab|mesh-list
110738708|NCT04779879|Antiviral Agents|antiviral agents|mesh-ancestor
110738709|NCT04779879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110738710|NCT04768101|Corticosterone|corticosterone|mesh-list
110738711|NCT04768101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110738712|NCT04681729|Histamine Antagonists|histamine antagonists|mesh-list
110738713|NCT04681729|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
110738714|NCT04681729|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-list
110738715|NCT04681729|Histamine Agents|histamine agents|mesh-ancestor
110738716|NCT04681729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110738717|NCT04681729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110145803|NCT00005949|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110738718|NCT04681729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110738719|NCT04629729|Cyclophosphamide|cyclophosphamide|mesh-list
110738720|NCT04629729|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110738721|NCT04629729|Fludarabine|fludarabine|mesh-list
110738722|NCT04629729|Interleukin-2|interleukin-2|mesh-list
110738723|NCT04629729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110738724|NCT04629729|Immunologic Factors|immunologic factors|mesh-ancestor
110738725|NCT04629729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110738726|NCT04629729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110738727|NCT04629729|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110738728|NCT04629729|Alkylating Agents|alkylating agents|mesh-ancestor
110738729|NCT04629729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110738730|NCT04629729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110738731|NCT04629729|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110738732|NCT04629729|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110738733|NCT04629729|Analgesics|analgesics|mesh-ancestor
110738734|NCT04629729|Sensory System Agents|sensory system agents|mesh-ancestor
110738735|NCT04629729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110738736|NCT04599075|Insulin|insulin|mesh-list
110738737|NCT04599075|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110738738|NCT04599075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110738739|NCT04599075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110738740|NCT04574583|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
110738741|NCT04574583|Antiviral Agents|antiviral agents|mesh-ancestor
110738742|NCT04574583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110738743|NCT04544202|Trametinib|trametinib|mesh-list
110738744|NCT04544202|Dabrafenib|dabrafenib|mesh-list
110738745|NCT04544202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110738746|NCT04544202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110738747|NCT04544202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110738748|NCT04544202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110738749|NCT04523363|Metformin|metformin|mesh-list
110738750|NCT04523363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110738751|NCT04523363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110738752|NCT04495894|Ketorolac|ketorolac|mesh-list
110738753|NCT04495894|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110738754|NCT04495894|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110738755|NCT04495894|Analgesics|analgesics|mesh-ancestor
110738756|NCT04495894|Sensory System Agents|sensory system agents|mesh-ancestor
110738757|NCT04495894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110738758|NCT04495894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110738759|NCT04495894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110738760|NCT04495894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110738761|NCT04495894|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110738762|NCT04495894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110738763|NCT04495894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110738764|NCT04489433|Trametinib|trametinib|mesh-list
110738765|NCT04489433|Dabrafenib|dabrafenib|mesh-list
110738766|NCT04489433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110738767|NCT04489433|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110738768|NCT04489433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110738769|NCT04489433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110456514|NCT04030663|Nitroglycerin|nitroglycerin|mesh-list
110738770|NCT04478721|Meropenem|meropenem|mesh-list
110738771|NCT04478721|Temocillin|temocillin|mesh-list
110738772|NCT04478721|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110738773|NCT04478721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110738774|NCT04283500|Buprenorphine|buprenorphine|mesh-list
110145818|NCT00005958|Docetaxel|docetaxel|mesh-list
110865128|NCT01562405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110738775|NCT04283500|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
110738777|NCT04283500|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110738778|NCT04283500|Narcotics|narcotics|mesh-ancestor
110738779|NCT04283500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110738780|NCT04283500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110738781|NCT04283500|Analgesics|analgesics|mesh-ancestor
110738782|NCT04283500|Sensory System Agents|sensory system agents|mesh-ancestor
110738783|NCT04283500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110738784|NCT04283500|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110738785|NCT04223791|Islatravir|islatravir|mesh-list
110738786|NCT04223791|Antiviral Agents|antiviral agents|mesh-ancestor
110738787|NCT04223791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110738788|NCT04223791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110738789|NCT04223791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110738790|NCT04223791|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110738791|NCT04223791|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110738792|NCT04223791|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110738793|NCT04205812|Paclitaxel|paclitaxel|mesh-list
110738794|NCT04205812|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110738795|NCT04205812|Carboplatin|carboplatin|mesh-list
110738796|NCT04205812|Pemetrexed|pemetrexed|mesh-list
110738797|NCT04205812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110738798|NCT04205812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110738799|NCT04205812|Tubulin Modulators|tubulin modulators|mesh-ancestor
110738800|NCT04205812|Antimitotic Agents|antimitotic agents|mesh-ancestor
110738801|NCT04205812|Mitosis Modulators|mitosis modulators|mesh-ancestor
110738802|NCT04205812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110738803|NCT04205812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110738804|NCT04205812|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110738805|NCT04205812|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110738806|NCT03982030|Dalbavancin|dalbavancin|mesh-list
110738807|NCT03982030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110738808|NCT03982030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110738809|NCT03917914|Bisoprolol|bisoprolol|mesh-list
110738810|NCT03917914|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110738811|NCT03917914|Sympatholytics|sympatholytics|mesh-ancestor
110738812|NCT03917914|Autonomic Agents|autonomic agents|mesh-ancestor
110738813|NCT03917914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110738814|NCT03917914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110738815|NCT03917914|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110738816|NCT03917914|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110738817|NCT03917914|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110738818|NCT03917914|Adrenergic Agents|adrenergic agents|mesh-ancestor
110738819|NCT03917914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110738820|NCT03917914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110738821|NCT03915067|Botulinum Toxins|botulinum toxins|mesh-list
110738822|NCT03915067|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110738823|NCT03915067|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110738824|NCT03915067|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110738825|NCT03915067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110738826|NCT03915067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110738827|NCT03915067|Cholinergic Agents|cholinergic agents|mesh-ancestor
110738828|NCT03915067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110738829|NCT03915067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110738830|NCT03915067|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110738831|NCT03915067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110738832|NCT03903133|Vitamin E|vitamin e|mesh-list
110738833|NCT03903133|Antioxidants|antioxidants|mesh-list
110738834|NCT03903133|Vitamins|vitamins|mesh-ancestor
110738835|NCT03903133|Micronutrients|micronutrients|mesh-ancestor
110738836|NCT03903133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110738837|NCT03903133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110738838|NCT03903133|Protective Agents|protective agents|mesh-ancestor
110738839|NCT03841305|Liver Extracts|liver extracts|mesh-list
110738840|NCT03841305|Hematinics|hematinics|mesh-ancestor
110738841|NCT03768414|Paclitaxel|paclitaxel|mesh-list
110738842|NCT03768414|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110738843|NCT03768414|Cisplatin|cisplatin|mesh-list
110738844|NCT03768414|Gemcitabine|gemcitabine|mesh-list
110738845|NCT03768414|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110738846|NCT03768414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110738848|NCT03768414|Antimitotic Agents|antimitotic agents|mesh-ancestor
110738849|NCT03768414|Mitosis Modulators|mitosis modulators|mesh-ancestor
110738850|NCT03768414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110738851|NCT03768414|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110738852|NCT03768414|Antimetabolites|antimetabolites|mesh-ancestor
110738853|NCT03727633|Idarubicin|idarubicin|mesh-list
110738854|NCT03727633|Ethiodized Oil|ethiodized oil|mesh-list
110738856|NCT03727633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110738857|NCT03727633|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110738858|NCT03727633|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110738859|NCT03727633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110738860|NCT03727633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110738861|NCT03698019|Pembrolizumab|pembrolizumab|mesh-list
110738862|NCT03698019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110738863|NCT03698019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110738864|NCT03698019|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110738865|NCT03698019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110738866|NCT03694002|Paclitaxel|paclitaxel|mesh-list
110738867|NCT03694002|Carboplatin|carboplatin|mesh-list
110738868|NCT03694002|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110738869|NCT03694002|Ramucirumab|ramucirumab|mesh-list
110738870|NCT03694002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110738871|NCT03694002|Antibodies|antibodies|mesh-list
110738872|NCT03694002|Immunoglobulins|immunoglobulins|mesh-list
110738873|NCT03694002|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110738874|NCT03694002|Lexatumumab|lexatumumab|mesh-list
110738875|NCT03694002|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110738876|NCT03694002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110738877|NCT03694002|Tubulin Modulators|tubulin modulators|mesh-ancestor
110738878|NCT03694002|Antimitotic Agents|antimitotic agents|mesh-ancestor
110738879|NCT03694002|Mitosis Modulators|mitosis modulators|mesh-ancestor
110738880|NCT03694002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110738881|NCT03694002|Immunologic Factors|immunologic factors|mesh-ancestor
110738882|NCT03694002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110738883|NCT03623321|Pimavanserin|pimavanserin|mesh-list
110738884|NCT03623321|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110738885|NCT03623321|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110738886|NCT03623321|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110738887|NCT03623321|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110738888|NCT03623321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110738889|NCT03623321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110738890|NCT03623321|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110738891|NCT03623321|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110738892|NCT03623321|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110738893|NCT03623321|Serotonin Agents|serotonin agents|mesh-ancestor
110738894|NCT03623321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110738895|NCT03623321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110738896|NCT03447314|Pembrolizumab|pembrolizumab|mesh-list
110738897|NCT03447314|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110738898|NCT03447314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110738899|NCT03447314|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110738900|NCT03447314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110738901|NCT03423121|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
110738902|NCT03423121|Antiviral Agents|antiviral agents|mesh-ancestor
110738903|NCT03423121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110738904|NCT03423121|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
110738905|NCT03423121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110738906|NCT03365882|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110738907|NCT03365882|Trastuzumab|trastuzumab|mesh-list
110738908|NCT03365882|Cetuximab|cetuximab|mesh-list
110738909|NCT03365882|Pertuzumab|pertuzumab|mesh-list
110738910|NCT03365882|Irinotecan|irinotecan|mesh-list
110738911|NCT03365882|Camptothecin|camptothecin|mesh-list
110738912|NCT03365882|Antibodies|antibodies|mesh-list
110738913|NCT03365882|Immunoglobulins|immunoglobulins|mesh-list
110738914|NCT03365882|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110738915|NCT03365882|Immunologic Factors|immunologic factors|mesh-ancestor
110738916|NCT03365882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110738917|NCT03365882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110738918|NCT03365882|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110738919|NCT03365882|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110738920|NCT03365882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110738921|NCT03365882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110738923|NCT03364530|Gemcitabine|gemcitabine|mesh-list
110738924|NCT03364530|Oxaliplatin|oxaliplatin|mesh-list
110738925|NCT03364530|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110738926|NCT03364530|Antimetabolites|antimetabolites|mesh-ancestor
110738927|NCT03364530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110738928|NCT03364530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110738929|NCT03289910|Carboplatin|carboplatin|mesh-list
110738930|NCT03289910|Topotecan|topotecan|mesh-list
110738931|NCT03289910|Veliparib|veliparib|mesh-list
110738932|NCT03289910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110738933|NCT03289910|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110738934|NCT03289910|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110738935|NCT03289910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110738936|NCT03289910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110738937|NCT03289910|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110738938|NCT03253133|Oxaliplatin|oxaliplatin|mesh-list
110738939|NCT03253133|Oxycodone|oxycodone|mesh-list
110738940|NCT03253133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110738941|NCT03253133|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110738942|NCT03253133|Narcotics|narcotics|mesh-ancestor
110738943|NCT03253133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110738944|NCT03253133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110738945|NCT03253133|Analgesics|analgesics|mesh-ancestor
110738946|NCT03253133|Sensory System Agents|sensory system agents|mesh-ancestor
110738947|NCT03253133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110738948|NCT03252756|Cannabidiol|cannabidiol|mesh-list
110738949|NCT03252756|Anticonvulsants|anticonvulsants|mesh-ancestor
110738950|NCT03225417|Sirolimus|sirolimus|mesh-list
110738951|NCT03225417|Cyclophosphamide|cyclophosphamide|mesh-list
110738952|NCT03225417|Ixazomib|ixazomib|mesh-list
110738953|NCT03225417|Tacrolimus|tacrolimus|mesh-list
110738954|NCT03225417|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110738955|NCT03225417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110738956|NCT03225417|Immunologic Factors|immunologic factors|mesh-ancestor
110738957|NCT03225417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110738958|NCT03225417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110738959|NCT03225417|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110738960|NCT03225417|Alkylating Agents|alkylating agents|mesh-ancestor
110738961|NCT03225417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110145858|NCT00005964|Tubulin Modulators|tubulin modulators|mesh-ancestor
110738962|NCT03225417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110738963|NCT03225417|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110738964|NCT03225417|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110738965|NCT03225417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110738966|NCT03225417|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110738967|NCT03225417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110738968|NCT03225417|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110738969|NCT03225417|Antifungal Agents|antifungal agents|mesh-ancestor
110738970|NCT03225417|Protease Inhibitors|protease inhibitors|mesh-ancestor
110738971|NCT03091660|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110738972|NCT03091660|Vaccines|vaccines|mesh-list
110738973|NCT03091660|BCG Vaccine|bcg vaccine|mesh-list
110738974|NCT03091660|Immunologic Factors|immunologic factors|mesh-ancestor
110738975|NCT03091660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110738976|NCT03091660|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110738977|NCT03091595|Drospirenone|drospirenone|mesh-list
110738978|NCT03091595|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110738979|NCT03091595|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110738980|NCT03091595|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110738981|NCT03091595|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110738982|NCT03091595|Contraceptive Agents|contraceptive agents|mesh-ancestor
110738983|NCT03091595|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110738984|NCT03091595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110738985|NCT03091595|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110738986|NCT03091595|Estrogens|estrogens|mesh-ancestor
110738987|NCT03091595|Hormones|hormones|mesh-ancestor
110738988|NCT03091595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110738989|NCT03091595|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110738990|NCT03091595|Hormone Antagonists|hormone antagonists|mesh-ancestor
110738991|NCT03091595|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110738992|NCT03091595|Diuretics|diuretics|mesh-ancestor
110738993|NCT03091595|Natriuretic Agents|natriuretic agents|mesh-ancestor
110738994|NCT02822378|Vitamin D|vitamin d|mesh-list
110738995|NCT02822378|Calcium|calcium|mesh-list
110738996|NCT02822378|Vitamins|vitamins|mesh-ancestor
110738997|NCT02822378|Micronutrients|micronutrients|mesh-ancestor
110738998|NCT02822378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110738999|NCT02822378|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110739000|NCT02822378|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110739001|NCT02577406|Cytarabine|cytarabine|mesh-list
110739002|NCT02577406|Azacitidine|azacitidine|mesh-list
110739003|NCT02577406|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110739004|NCT02577406|Antimetabolites|antimetabolites|mesh-ancestor
110739005|NCT02577406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110739007|NCT02577406|Antiviral Agents|antiviral agents|mesh-ancestor
110739008|NCT02577406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110739009|NCT02577406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110739010|NCT02577406|Immunologic Factors|immunologic factors|mesh-ancestor
110739011|NCT02577406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110739012|NCT02577406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110739013|NCT02498600|Nivolumab|nivolumab|mesh-list
110739014|NCT02498600|Ipilimumab|ipilimumab|mesh-list
110739015|NCT02498600|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110739016|NCT02498600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110739017|NCT02498600|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110739018|NCT02498600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110739019|NCT01925131|Prednisone|prednisone|mesh-list
110739020|NCT01925131|Cyclophosphamide|cyclophosphamide|mesh-list
110739021|NCT01925131|Vincristine|vincristine|mesh-list
110739022|NCT01925131|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
110739023|NCT01925131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110739024|NCT01925131|Immunologic Factors|immunologic factors|mesh-ancestor
110739025|NCT01925131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110739026|NCT01925131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110739027|NCT01925131|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110739028|NCT01925131|Alkylating Agents|alkylating agents|mesh-ancestor
110739029|NCT01925131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110739030|NCT01925131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110739031|NCT01925131|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110739032|NCT01925131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110739033|NCT01925131|Glucocorticoids|glucocorticoids|mesh-ancestor
110739034|NCT01925131|Hormones|hormones|mesh-ancestor
110739035|NCT01925131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110739036|NCT01925131|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110739037|NCT01925131|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110739038|NCT01925131|Tubulin Modulators|tubulin modulators|mesh-ancestor
110739039|NCT01925131|Antimitotic Agents|antimitotic agents|mesh-ancestor
110739040|NCT01925131|Mitosis Modulators|mitosis modulators|mesh-ancestor
110739041|NCT01925131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110739042|NCT01925131|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110739043|NCT01925131|Immunotoxins|immunotoxins|mesh-ancestor
110739044|NCT01925131|Immunoconjugates|immunoconjugates|mesh-ancestor
110739045|NCT01809691|Bicalutamide|bicalutamide|mesh-list
110739046|NCT01809691|Androgen Antagonists|androgen antagonists|mesh-ancestor
110739047|NCT01809691|Hormone Antagonists|hormone antagonists|mesh-ancestor
110739048|NCT01809691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110739049|NCT01809691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110739050|NCT01809691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110739051|NCT01698918|Dexamethasone|dexamethasone|mesh-list
110739052|NCT01698918|Everolimus|everolimus|mesh-list
110739053|NCT01698918|Letrozole|letrozole|mesh-list
110739054|NCT01698918|Exemestane|exemestane|mesh-list
110739055|NCT01698918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110739056|NCT01698918|Antiemetics|antiemetics|mesh-ancestor
110739057|NCT01698918|Autonomic Agents|autonomic agents|mesh-ancestor
110739058|NCT01698918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110739059|NCT01698918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110739060|NCT01698918|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110739061|NCT01698918|Glucocorticoids|glucocorticoids|mesh-ancestor
110739062|NCT01698918|Hormones|hormones|mesh-ancestor
110739063|NCT01698918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110739064|NCT01698918|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110739065|NCT01698918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110739066|NCT01698918|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110739067|NCT01698918|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110739068|NCT01698918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110739069|NCT01698918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110739070|NCT01698918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110739071|NCT01698918|Immunologic Factors|immunologic factors|mesh-ancestor
110739072|NCT01698918|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110456808|NCT02641210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110739074|NCT01698918|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110739075|NCT01698918|Hormone Antagonists|hormone antagonists|mesh-ancestor
110739076|NCT01674140|Tamoxifen|tamoxifen|mesh-list
110739077|NCT01674140|Everolimus|everolimus|mesh-list
110739078|NCT01674140|Letrozole|letrozole|mesh-list
110739079|NCT01674140|Anastrozole|anastrozole|mesh-list
110739080|NCT01674140|Leuprolide|leuprolide|mesh-list
110739081|NCT01674140|Exemestane|exemestane|mesh-list
110739082|NCT01674140|Goserelin|goserelin|mesh-list
110739083|NCT01674140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110739084|NCT01674140|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110739085|NCT01674140|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110739086|NCT01674140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110739087|NCT01674140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110739088|NCT01674140|Immunologic Factors|immunologic factors|mesh-ancestor
110739089|NCT01674140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110739090|NCT01674140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110739091|NCT01674140|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110739092|NCT01674140|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110739093|NCT01674140|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110739094|NCT01674140|Hormone Antagonists|hormone antagonists|mesh-ancestor
110739095|NCT01674140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110739096|NCT01674140|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110739097|NCT01674140|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110739098|NCT01674140|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110739099|NCT01674140|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110739100|NCT01674140|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110739101|NCT01674140|Fertility Agents|fertility agents|mesh-ancestor
110739102|NCT01674140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110739103|NCT01574274|Pegaspargase|pegaspargase|mesh-list
110739104|NCT01574274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110739105|NCT01495403|Hydroxychloroquine|hydroxychloroquine|mesh-list
110739106|NCT01495403|Antimalarials|antimalarials|mesh-ancestor
110739107|NCT01495403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110739108|NCT01495403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110739109|NCT01495403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110739110|NCT01495403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110739111|NCT01495403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110739112|NCT01495403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110739113|NCT00840177|Cytarabine|cytarabine|mesh-list
110739114|NCT00840177|Idarubicin|idarubicin|mesh-list
110739115|NCT00840177|Pravastatin|pravastatin|mesh-list
110739116|NCT00840177|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110739117|NCT00840177|Antimetabolites|antimetabolites|mesh-ancestor
110739118|NCT00840177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110739119|NCT00840177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110739120|NCT00840177|Antiviral Agents|antiviral agents|mesh-ancestor
110739121|NCT00840177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110739122|NCT00840177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110739123|NCT00840177|Immunologic Factors|immunologic factors|mesh-ancestor
110739124|NCT00840177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110739125|NCT00840177|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110739126|NCT00840177|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110739127|NCT00840177|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110739128|NCT00840177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110739129|NCT00840177|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110739130|NCT00840177|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110739131|NCT00840177|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110739132|NCT00840177|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110739133|NCT01347580|Ticagrelor|ticagrelor|mesh-list
110739134|NCT01347580|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110739135|NCT01347580|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110739136|NCT01347580|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110739137|NCT01347580|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110739138|NCT01347580|Purinergic Agents|purinergic agents|mesh-ancestor
110739139|NCT01347580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110145900|NCT00005970|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110739140|NCT01347580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110739141|NCT01347580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110739142|NCT00398411|Moxifloxacin|moxifloxacin|mesh-list
110739143|NCT00398411|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110739144|NCT00398411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110739145|NCT00398411|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110739146|NCT00398411|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110739147|NCT00398411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110739148|NCT00398411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110739149|NCT00398411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110739150|NCT03352414|Alvimopan|alvimopan|mesh-list
110739151|NCT03352414|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110739152|NCT00364793|Emtricitabine|emtricitabine|mesh-list
110739153|NCT00364793|Efavirenz|efavirenz|mesh-list
110739154|NCT00364793|Didanosine|didanosine|mesh-list
110739155|NCT00364793|Antiviral Agents|antiviral agents|mesh-ancestor
110739156|NCT00364793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110739157|NCT00364793|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110739158|NCT00364793|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110739159|NCT00364793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110739160|NCT00364793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110739161|NCT00364793|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110739162|NCT00364793|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110739163|NCT00364793|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110739164|NCT00364793|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110739165|NCT00364793|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110739166|NCT00364793|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110739167|NCT00364793|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110739168|NCT00364793|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110739169|NCT00364793|Antimetabolites|antimetabolites|mesh-ancestor
110739170|NCT03351478|Empagliflozin|empagliflozin|mesh-list
110739171|NCT03351478|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
110739172|NCT03351478|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110739173|NCT03351478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110739174|NCT03351478|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110739175|NCT03351478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110739176|NCT00363545|Vaccines|vaccines|mesh-list
110739177|NCT00363545|Immunologic Factors|immunologic factors|mesh-ancestor
110739178|NCT00363545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110739179|NCT03351244|BI 409306|bi 409306|mesh-list
110739180|NCT03351244|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110739181|NCT03351244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110739182|NCT03351244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110739183|NCT03386032|Desonide|desonide|mesh-list
110739184|NCT03386032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110739185|NCT00077610|Epoetin Alfa|epoetin alfa|mesh-list
110739186|NCT00077610|Hematinics|hematinics|mesh-ancestor
110739187|NCT00066222|Etoposide|etoposide|mesh-list
110739188|NCT00066222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110739189|NCT00066222|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110739190|NCT00066222|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110739191|NCT00066222|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110739192|NCT00066222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110739193|NCT00066222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110739194|NCT00397943|Vaccines|vaccines|mesh-list
110739195|NCT00397943|Immunologic Factors|immunologic factors|mesh-ancestor
110739196|NCT00397943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110739197|NCT00066066|Amoxicillin|amoxicillin|mesh-list
110739198|NCT00066066|Metronidazole|metronidazole|mesh-list
110739199|NCT00066066|Doxycycline|doxycycline|mesh-list
110865163|NCT02445508|Sevelamer|sevelamer|mesh-list
110739200|NCT00066066|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110739201|NCT00066066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110739202|NCT00066066|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110739203|NCT00066066|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110739204|NCT00066066|Antimalarials|antimalarials|mesh-ancestor
110739205|NCT00363467|Busulfan|busulfan|mesh-list
110739206|NCT00363467|Alkylating Agents|alkylating agents|mesh-ancestor
110739207|NCT00363467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110739208|NCT00363467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110739209|NCT00363467|Immunologic Factors|immunologic factors|mesh-ancestor
110739210|NCT00363467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110739211|NCT00363467|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110739212|NCT00363467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110739213|NCT00363467|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110739214|NCT00397631|Pioglitazone|pioglitazone|mesh-list
110739215|NCT00397631|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110739216|NCT00397631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110739217|NCT00397631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110739218|NCT00397631|Incretins|incretins|mesh-ancestor
110739219|NCT00397631|Hormones|hormones|mesh-ancestor
110739220|NCT00397631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110456958|NCT00849901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110739221|NCT00397631|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110739222|NCT00397631|Protease Inhibitors|protease inhibitors|mesh-ancestor
110739223|NCT00397631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110444811|NCT01141283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110739224|NCT00397631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110739226|NCT00077376|Trastuzumab|trastuzumab|mesh-list
110739227|NCT00077376|Epothilone B|epothilone b|mesh-list
110739228|NCT00077376|Epothilones|epothilones|mesh-list
110739229|NCT00077376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110739230|NCT00077376|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110739231|NCT00077376|Tubulin Modulators|tubulin modulators|mesh-ancestor
110739232|NCT00077376|Antimitotic Agents|antimitotic agents|mesh-ancestor
110739233|NCT00077376|Mitosis Modulators|mitosis modulators|mesh-ancestor
110739234|NCT00077376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110739235|NCT01088724|Cyclophosphamide|cyclophosphamide|mesh-list
110739236|NCT01088724|Rituximab|rituximab|mesh-list
110739237|NCT01088724|Doxorubicin|doxorubicin|mesh-list
110739238|NCT01088724|Fludarabine|fludarabine|mesh-list
110739239|NCT01088724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110739240|NCT01088724|Immunologic Factors|immunologic factors|mesh-ancestor
110739241|NCT01088724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110739242|NCT01088724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110739243|NCT01088724|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110739244|NCT01088724|Alkylating Agents|alkylating agents|mesh-ancestor
110739245|NCT01088724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110739246|NCT01088724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110739247|NCT01088724|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110739248|NCT01088724|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110739249|NCT01088724|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110739250|NCT01088724|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110739251|NCT01088724|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110739252|NCT01088724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110739253|NCT03957174|Rivastigmine|rivastigmine|mesh-list
110739254|NCT03957174|Reboxetine|reboxetine|mesh-list
110739255|NCT03957174|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110739256|NCT03957174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110739257|NCT03957174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110739258|NCT03957174|Cholinergic Agents|cholinergic agents|mesh-ancestor
110739259|NCT03957174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110739260|NCT03957174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110739261|NCT03957174|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110739262|NCT03957174|Protective Agents|protective agents|mesh-ancestor
110145929|NCT00005985|Etoposide|etoposide|mesh-list
110739263|NCT03957174|Antidepressive Agents|antidepressive agents|mesh-ancestor
110739264|NCT03957174|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110739265|NCT03957174|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110739266|NCT03957174|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110739267|NCT03957174|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110739268|NCT03957174|Adrenergic Agents|adrenergic agents|mesh-ancestor
110739269|NCT00363311|Dutasteride|dutasteride|mesh-list
110739270|NCT00363311|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
110739271|NCT00363311|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110739272|NCT00363311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110739273|NCT00363311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110739274|NCT00363311|Hormone Antagonists|hormone antagonists|mesh-ancestor
110739275|NCT00363311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110739276|NCT00363311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110739277|NCT00362609|Pantoprazole|pantoprazole|mesh-list
110739278|NCT00362609|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110739279|NCT00362609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110739280|NCT00362609|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110739281|NCT00362609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110739282|NCT00362609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110739283|NCT02534753|Ascorbic Acid|ascorbic acid|mesh-list
110739284|NCT02534753|Antioxidants|antioxidants|mesh-ancestor
110739285|NCT02534753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110739286|NCT02534753|Protective Agents|protective agents|mesh-ancestor
110739287|NCT02534753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110739288|NCT02534753|Vitamins|vitamins|mesh-ancestor
110739289|NCT02534753|Micronutrients|micronutrients|mesh-ancestor
110739290|NCT01042457|Mycophenolic Acid|mycophenolic acid|mesh-list
110739291|NCT01042457|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110739292|NCT01042457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110739293|NCT01042457|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110739294|NCT01042457|Antitubercular Agents|antitubercular agents|mesh-ancestor
110739295|NCT01042457|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110064338|NCT01527032|Melphalan|melphalan|mesh-list
110739296|NCT01042457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110739297|NCT01042457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110739298|NCT01042457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110739300|NCT00362297|Acyclovir|acyclovir|mesh-list
110739301|NCT00362297|Antiviral Agents|antiviral agents|mesh-ancestor
110739302|NCT00362297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110739303|NCT01042691|Oxaliplatin|oxaliplatin|mesh-list
110739304|NCT01042691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110739305|NCT00090402|Thioctic Acid|thioctic acid|mesh-list
110739306|NCT00090402|Antioxidants|antioxidants|mesh-ancestor
110739307|NCT00090402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110739308|NCT00090402|Protective Agents|protective agents|mesh-ancestor
110739309|NCT00090402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110739310|NCT00090402|Vitamin B Complex|vitamin b complex|mesh-ancestor
110739311|NCT00090402|Vitamins|vitamins|mesh-ancestor
110739312|NCT00090402|Micronutrients|micronutrients|mesh-ancestor
110739313|NCT00361283|Atorvastatin|atorvastatin|mesh-list
110739314|NCT00361283|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110739315|NCT00361283|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110739316|NCT00361283|Antimetabolites|antimetabolites|mesh-ancestor
110739317|NCT00361283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110739318|NCT00361283|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110739319|NCT00361283|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110739320|NCT00361283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110739321|NCT00077064|Captopril|captopril|mesh-list
110739322|NCT00077064|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110739323|NCT00077064|Protease Inhibitors|protease inhibitors|mesh-ancestor
110739324|NCT00077064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110739325|NCT00077064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110739326|NCT00077064|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110739327|NCT00396383|Plerixafor|plerixafor|mesh-list
110739328|NCT00396383|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110739329|NCT00396383|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110739330|NCT00396383|Antiviral Agents|antiviral agents|mesh-ancestor
110739331|NCT00396383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110739332|NCT02534363|Aripiprazole|aripiprazole|mesh-list
110739333|NCT02534363|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110739334|NCT02534363|Ziprasidone|ziprasidone|mesh-list
110739335|NCT02534363|Antidepressive Agents|antidepressive agents|mesh-ancestor
110739336|NCT02534363|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110739337|NCT02534363|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110739338|NCT02534363|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110739339|NCT02534363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110739340|NCT02534363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110739341|NCT02534363|Dopamine Agonists|dopamine agonists|mesh-ancestor
110739342|NCT02534363|Dopamine Agents|dopamine agents|mesh-ancestor
110739343|NCT02534363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110739344|NCT02534363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110739345|NCT02534363|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110739346|NCT02534363|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110739347|NCT02534363|Serotonin Agents|serotonin agents|mesh-ancestor
110739348|NCT02534363|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110739349|NCT02534363|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110739350|NCT02534363|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110739351|NCT02534363|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110739352|NCT01050491|Sitaxsentan|sitaxsentan|mesh-list
110739353|NCT01050491|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
110739354|NCT01050491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110739355|NCT01088958|Micronutrients|micronutrients|mesh-list
110739356|NCT01088958|Trace Elements|trace elements|mesh-list
110739357|NCT01088958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110739358|NCT03404518|Acetaminophen|acetaminophen|mesh-list
110739359|NCT03404518|Ibuprofen|ibuprofen|mesh-list
110739360|NCT03404518|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
110739361|NCT03404518|Hydrocodone|hydrocodone|mesh-list
110739362|NCT03404518|Narcotics|narcotics|mesh-list
110739363|NCT03404518|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110739364|NCT03404518|Analgesics|analgesics|mesh-ancestor
110739365|NCT03404518|Sensory System Agents|sensory system agents|mesh-ancestor
110739366|NCT03404518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110739367|NCT03404518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110739368|NCT03404518|Antipyretics|antipyretics|mesh-ancestor
110739369|NCT03404518|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110457164|NCT00848965|Xhance|xhance|mesh-list
110739370|NCT03404518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110739371|NCT03404518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110739372|NCT03404518|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110739373|NCT03404518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110739374|NCT03404518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110739375|NCT03404518|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110739376|NCT03404518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110739377|NCT03404518|Antitussive Agents|antitussive agents|mesh-ancestor
110739378|NCT03404518|Respiratory System Agents|respiratory system agents|mesh-ancestor
110739379|NCT03404206|Ibuprofen|ibuprofen|mesh-list
110739380|NCT03404206|Naproxen|naproxen|mesh-list
110739381|NCT03404206|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110739382|NCT03404206|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110739383|NCT03404206|Analgesics|analgesics|mesh-ancestor
110739384|NCT03404206|Sensory System Agents|sensory system agents|mesh-ancestor
110739385|NCT03404206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110739386|NCT03404206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110739387|NCT03404206|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110739388|NCT03404206|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110739389|NCT03404206|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110739390|NCT03404206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110739391|NCT03404206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110739392|NCT03404206|Gout Suppressants|gout suppressants|mesh-ancestor
110739393|NCT00394901|Pregabalin|pregabalin|mesh-list
110739394|NCT00394901|Analgesics|analgesics|mesh-ancestor
110739395|NCT00394901|Sensory System Agents|sensory system agents|mesh-ancestor
110739396|NCT00394901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110739397|NCT00394901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110739398|NCT00394901|Anticonvulsants|anticonvulsants|mesh-ancestor
110739399|NCT00394901|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110739400|NCT00394901|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110739401|NCT00394901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110739402|NCT00394901|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110739403|NCT00394901|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110739404|NCT00394901|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110739405|NCT00394901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110739406|NCT00394901|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110739407|NCT03349060|Abrocitinib|abrocitinib|mesh-list
110739408|NCT03349060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110739409|NCT03349060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110739410|NCT03349060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110739411|NCT03348904|Paclitaxel|paclitaxel|mesh-list
110739412|NCT03348904|Carboplatin|carboplatin|mesh-list
110739413|NCT03348904|Gemcitabine|gemcitabine|mesh-list
110739414|NCT03348904|Nivolumab|nivolumab|mesh-list
110739415|NCT03348904|Pemetrexed|pemetrexed|mesh-list
110739416|NCT03348904|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110739417|NCT03348904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110739418|NCT03348904|Tubulin Modulators|tubulin modulators|mesh-ancestor
110739419|NCT03348904|Antimitotic Agents|antimitotic agents|mesh-ancestor
110739420|NCT03348904|Mitosis Modulators|mitosis modulators|mesh-ancestor
110739421|NCT03348904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110739422|NCT03348904|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110739423|NCT03348904|Antimetabolites|antimetabolites|mesh-ancestor
110739424|NCT03348904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110739425|NCT03348904|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110739426|NCT03348904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110739427|NCT03348904|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110739428|NCT03348904|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110739429|NCT00359021|Etravirine|etravirine|mesh-list
110739430|NCT00359021|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110739431|NCT00359021|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110739432|NCT00359021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110739433|NCT00359021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110739434|NCT00359021|Antiviral Agents|antiviral agents|mesh-ancestor
110739435|NCT00359021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110739436|NCT00360269|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
110739437|NCT00360269|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110739438|NCT00360269|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110739439|NCT00360269|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110739440|NCT00360269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110739441|NCT00360269|Adrenergic Agents|adrenergic agents|mesh-ancestor
110739442|NCT00360269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110739443|NCT00360269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110739445|NCT01052597|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110739446|NCT01052597|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110739448|NCT01052597|Sensory System Agents|sensory system agents|mesh-ancestor
110739449|NCT01052597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110739450|NCT01052597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110739451|NCT01052597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110739452|NCT01052597|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110739453|NCT01052597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110739454|NCT01052597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110739455|NCT01052597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110739456|NCT01051115|Dasatinib|dasatinib|mesh-list
110739457|NCT01051115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110739458|NCT01051115|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110739459|NCT01051115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110739460|NCT01051115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110739461|NCT00076752|Diphenhydramine|diphenhydramine|mesh-list
110739462|NCT00076752|Promethazine|promethazine|mesh-list
110739463|NCT00076752|Methylprednisolone|methylprednisolone|mesh-list
110739464|NCT00076752|Cyclophosphamide|cyclophosphamide|mesh-list
110739465|NCT00076752|Rituximab|rituximab|mesh-list
110739466|NCT00076752|Fludarabine|fludarabine|mesh-list
110739467|NCT00076752|Fludarabine phosphate|fludarabine phosphate|mesh-list
110739468|NCT00076752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110739469|NCT00076752|Immunologic Factors|immunologic factors|mesh-ancestor
110739470|NCT00076752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110739471|NCT00076752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110739472|NCT00076752|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110739473|NCT00076752|Alkylating Agents|alkylating agents|mesh-ancestor
110865184|NCT03197584|Alkylating Agents|alkylating agents|mesh-ancestor
110739474|NCT00076752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110739475|NCT00076752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110739476|NCT00076752|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110739477|NCT00076752|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110739478|NCT00076752|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110739479|NCT00076752|Antimetabolites|antimetabolites|mesh-ancestor
110739480|NCT00076752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110739481|NCT00076752|Antiemetics|antiemetics|mesh-ancestor
110739482|NCT00076752|Autonomic Agents|autonomic agents|mesh-ancestor
110739483|NCT00076752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110739484|NCT00076752|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110739485|NCT00076752|Glucocorticoids|glucocorticoids|mesh-ancestor
110739487|NCT00076752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110739488|NCT00076752|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110739489|NCT00076752|Protective Agents|protective agents|mesh-ancestor
110739490|NCT00076752|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110739491|NCT00076752|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110739492|NCT00076752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110739493|NCT00076752|Anesthetics, Local|anesthetics, local|mesh-ancestor
110739494|NCT00076752|Anesthetics|anesthetics|mesh-ancestor
110739495|NCT00076752|Sensory System Agents|sensory system agents|mesh-ancestor
110739496|NCT00076752|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110739497|NCT00076752|Histamine Antagonists|histamine antagonists|mesh-ancestor
110739498|NCT00076752|Histamine Agents|histamine agents|mesh-ancestor
110739499|NCT00076752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110739500|NCT00076752|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110739501|NCT00076752|Antipruritics|antipruritics|mesh-ancestor
110739502|NCT00076752|Dermatologic Agents|dermatologic agents|mesh-ancestor
110739503|NCT03384940|Trastuzumab|trastuzumab|mesh-list
110739504|NCT03384940|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
110739505|NCT03384940|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110739506|NCT03384940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110739507|NCT03384940|Immunoconjugates|immunoconjugates|mesh-ancestor
110739508|NCT03384940|Immunologic Factors|immunologic factors|mesh-ancestor
110739509|NCT03384940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110739510|NCT00075582|Dactinomycin|dactinomycin|mesh-list
110739511|NCT00075582|Cactinomycin|cactinomycin|mesh-list
110739512|NCT00075582|Cyclophosphamide|cyclophosphamide|mesh-list
110739513|NCT00075582|Vincristine|vincristine|mesh-list
110739514|NCT00075582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110739515|NCT00075582|Immunologic Factors|immunologic factors|mesh-ancestor
110739516|NCT00075582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110739517|NCT00075582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110064561|NCT01528137|Lactoferrin|lactoferrin|mesh-list
110739518|NCT00075582|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110739519|NCT00075582|Alkylating Agents|alkylating agents|mesh-ancestor
110739520|NCT00075582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110739521|NCT00075582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110739522|NCT00075582|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110739523|NCT00075582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110739524|NCT00075582|Tubulin Modulators|tubulin modulators|mesh-ancestor
110739525|NCT00075582|Antimitotic Agents|antimitotic agents|mesh-ancestor
110739526|NCT00075582|Mitosis Modulators|mitosis modulators|mesh-ancestor
110739527|NCT00075582|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110739528|NCT00075582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110739529|NCT00075582|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110739530|NCT00075582|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110739531|NCT00075582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110739532|NCT00075582|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110739534|NCT00063258|Carboplatin|carboplatin|mesh-list
110739535|NCT00063258|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110739536|NCT00063258|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110739537|NCT00063258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110739538|NCT00063258|Tubulin Modulators|tubulin modulators|mesh-ancestor
110739539|NCT00063258|Antimitotic Agents|antimitotic agents|mesh-ancestor
110739540|NCT00063258|Mitosis Modulators|mitosis modulators|mesh-ancestor
110739541|NCT00063258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110739542|NCT00063258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110739543|NCT00063258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110739544|NCT00088530|Prednisone|prednisone|mesh-list
110739545|NCT00088530|Cyclophosphamide|cyclophosphamide|mesh-list
110739546|NCT00088530|Rituximab|rituximab|mesh-list
110739547|NCT00088530|Gemcitabine|gemcitabine|mesh-list
110739548|NCT00088530|Etoposide|etoposide|mesh-list
110739549|NCT00088530|Vincristine|vincristine|mesh-list
110739550|NCT00088530|Vinorelbine|vinorelbine|mesh-list
110739551|NCT00088530|Pixantrone|pixantrone|mesh-list
110739552|NCT00088530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110739553|NCT00088530|Immunologic Factors|immunologic factors|mesh-ancestor
110739554|NCT00088530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110739555|NCT00088530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110739556|NCT00088530|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110739557|NCT00088530|Alkylating Agents|alkylating agents|mesh-ancestor
110739558|NCT00088530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110739559|NCT00088530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110739560|NCT00088530|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110739561|NCT00088530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110739562|NCT00088530|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110739563|NCT00088530|Antimetabolites|antimetabolites|mesh-ancestor
110739564|NCT00088530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110739565|NCT00088530|Glucocorticoids|glucocorticoids|mesh-ancestor
110739566|NCT00088530|Hormones|hormones|mesh-ancestor
110739567|NCT00088530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110739568|NCT00088530|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110739569|NCT00088530|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110739570|NCT00088530|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110739571|NCT00088530|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110739572|NCT00088530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110739573|NCT00088530|Tubulin Modulators|tubulin modulators|mesh-ancestor
110739574|NCT00088530|Antimitotic Agents|antimitotic agents|mesh-ancestor
110739575|NCT00088530|Mitosis Modulators|mitosis modulators|mesh-ancestor
110739576|NCT00359801|Insulin|insulin|mesh-list
110739577|NCT00359801|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110739578|NCT00359801|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110739579|NCT00359801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110739580|NCT03990701|Metomidate|metomidate|mesh-list
110739581|NCT03990701|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110739582|NCT03990701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110739583|NCT03990701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110739584|NCT01051193|Oxcarbazepine|oxcarbazepine|mesh-list
110739585|NCT01051193|Anticonvulsants|anticonvulsants|mesh-ancestor
110739586|NCT01051193|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110739587|NCT01051193|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110739588|NCT01051193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110739589|NCT01051193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110444817|NCT05340946|Anesthetics|anesthetics|mesh-list
110739590|NCT01051193|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110739591|NCT01051193|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110739593|NCT01051271|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110457337|NCT02641990|Exenatide|exenatide|mesh-list
110739594|NCT01051271|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110739595|NCT01051271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110739596|NCT01051271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110739597|NCT01051271|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110739598|NCT01051271|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110739599|NCT01051271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110739600|NCT01051271|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110739601|NCT01051271|Anesthetics, General|anesthetics, general|mesh-ancestor
110739602|NCT01051271|Anesthetics|anesthetics|mesh-ancestor
110739603|NCT01051271|GABA Modulators|gaba modulators|mesh-ancestor
110739604|NCT01051271|GABA Agents|gaba agents|mesh-ancestor
110739605|NCT01051271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110146041|NCT00006006|Interferons|interferons|mesh-list
110739606|NCT01051271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110739607|NCT01051427|Hemostatics|hemostatics|mesh-list
110739608|NCT01051427|Surgiflo|surgiflo|mesh-list
110739609|NCT01051427|Coagulants|coagulants|mesh-ancestor
110739610|NCT01052909|Glimepiride|glimepiride|mesh-list
110739611|NCT01052909|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110739612|NCT01052909|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110739613|NCT01052909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110739614|NCT01052909|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110739615|NCT01052909|Immunologic Factors|immunologic factors|mesh-ancestor
110739616|NCT00045032|Trastuzumab|trastuzumab|mesh-list
110739617|NCT00045032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110739618|NCT00045032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110739619|NCT01052987|Tranilast|tranilast|mesh-list
110739620|NCT01052987|Allopurinol|allopurinol|mesh-list
110739621|NCT01052987|Antimetabolites|antimetabolites|mesh-ancestor
110739622|NCT01052987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110739623|NCT01052987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110739624|NCT01052987|Gout Suppressants|gout suppressants|mesh-ancestor
110739625|NCT01052987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110739626|NCT01052987|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110739627|NCT01052987|Antioxidants|antioxidants|mesh-ancestor
110739628|NCT01052987|Protective Agents|protective agents|mesh-ancestor
110739629|NCT01052987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110739630|NCT01052987|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110739631|NCT01052987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110739632|NCT01052987|Analgesics|analgesics|mesh-ancestor
110739633|NCT01052987|Sensory System Agents|sensory system agents|mesh-ancestor
110739634|NCT01052987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110739635|NCT01052987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110739636|NCT01052987|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110739637|NCT01052987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110739638|NCT01052987|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110739639|NCT01052987|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110739640|NCT01052987|Histamine Antagonists|histamine antagonists|mesh-ancestor
110739641|NCT01052987|Histamine Agents|histamine agents|mesh-ancestor
110739642|NCT01052987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110739643|NCT01052987|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110739644|NCT01052987|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110739645|NCT02533973|Calcipotriene|calcipotriene|mesh-list
110739646|NCT02533973|Dermatologic Agents|dermatologic agents|mesh-ancestor
110739647|NCT01053065|Atorvastatin|atorvastatin|mesh-list
110739648|NCT01053065|Cholestyramine Resin|cholestyramine resin|mesh-list
110739649|NCT01053065|Gamma-sitosterol|gamma-sitosterol|mesh-list
110739650|NCT01053065|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110739651|NCT01053065|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110739652|NCT01053065|Antimetabolites|antimetabolites|mesh-ancestor
110739653|NCT01053065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110739654|NCT01053065|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110739655|NCT01053065|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110739656|NCT01053065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110739657|NCT01051583|Bevacizumab|bevacizumab|mesh-list
110739658|NCT01051583|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110739659|NCT01051583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110739660|NCT01051583|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110739661|NCT01051583|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110739662|NCT01051583|Growth Substances|growth substances|mesh-ancestor
110739663|NCT01051583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110739664|NCT01051583|Growth Inhibitors|growth inhibitors|mesh-ancestor
110739666|NCT05386706|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110739667|NCT05386706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110457409|NCT01152788|Dacarbazine|dacarbazine|mesh-list
110739668|NCT03950804|Eculizumab|eculizumab|mesh-list
110739669|NCT03950804|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
110739670|NCT03950804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110739671|NCT03950804|Immunologic Factors|immunologic factors|mesh-ancestor
110865211|NCT03236012|Botulinum Toxins|botulinum toxins|mesh-list
110739672|NCT03950804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110739673|NCT00356915|Itraconazole|itraconazole|mesh-list
110739674|NCT00356915|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
110739675|NCT00356915|Antifungal Agents|antifungal agents|mesh-ancestor
110739676|NCT00356915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110739677|NCT00356915|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110739678|NCT00356915|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110739679|NCT00356915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110739680|NCT00356915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110739681|NCT00356915|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110739682|NCT00356915|Hormone Antagonists|hormone antagonists|mesh-ancestor
110739683|NCT00356915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110739684|NCT00356915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110739685|NCT00356915|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110739686|NCT00356759|Warfarin|warfarin|mesh-list
110739687|NCT00356759|Anticoagulants|anticoagulants|mesh-ancestor
110739688|NCT00356603|Sumatriptan|sumatriptan|mesh-list
110739689|NCT00356603|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110739690|NCT00356603|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110739691|NCT00356603|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110739692|NCT00356603|Serotonin Agents|serotonin agents|mesh-ancestor
110739693|NCT00356603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110739694|NCT00356603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110739695|NCT00356603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110739696|NCT01052051|Vitamin D|vitamin d|mesh-list
110739697|NCT01052051|Cholecalciferol|cholecalciferol|mesh-list
110739698|NCT01052051|Calcium Carbonate|calcium carbonate|mesh-list
110739699|NCT01052051|Calcium|calcium|mesh-list
110739700|NCT01052051|Vitamins|vitamins|mesh-ancestor
110739701|NCT01052051|Micronutrients|micronutrients|mesh-ancestor
110739702|NCT01052051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110739703|NCT01052051|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110739704|NCT01052051|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110739705|NCT01052051|Antacids|antacids|mesh-ancestor
110739706|NCT01052051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110739707|NCT01052051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110739708|NCT00002558|Paclitaxel|paclitaxel|mesh-list
110739709|NCT00002558|Etoposide|etoposide|mesh-list
110739710|NCT00002558|Carboplatin|carboplatin|mesh-list
110739711|NCT00002558|Ifosfamide|ifosfamide|mesh-list
110739712|NCT00002558|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110739713|NCT00002558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110739714|NCT00002558|Tubulin Modulators|tubulin modulators|mesh-ancestor
110739715|NCT00002558|Antimitotic Agents|antimitotic agents|mesh-ancestor
110739716|NCT00002558|Mitosis Modulators|mitosis modulators|mesh-ancestor
110739717|NCT00002558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110739718|NCT00002558|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110739719|NCT00002558|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110739720|NCT00002558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110739721|NCT00002558|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110739722|NCT00002558|Alkylating Agents|alkylating agents|mesh-ancestor
110739723|NCT00001880|Cyclosporine|cyclosporine|mesh-list
110739724|NCT00001880|Methotrexate|methotrexate|mesh-list
110739725|NCT00001880|Cyclosporins|cyclosporins|mesh-list
110739726|NCT00001880|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110739727|NCT00001880|Abortifacient Agents|abortifacient agents|mesh-ancestor
110739728|NCT00001880|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110739729|NCT00001880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110739730|NCT00001880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110739731|NCT00001880|Antimetabolites|antimetabolites|mesh-ancestor
110739732|NCT00001880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110739733|NCT00001880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110739734|NCT00001880|Dermatologic Agents|dermatologic agents|mesh-ancestor
110739735|NCT00001880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110343217|NCT02916420|Hormones|hormones|mesh-ancestor
110739736|NCT00001880|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110739737|NCT00001880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110739739|NCT00001880|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110739740|NCT00001880|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110739741|NCT00001880|Antifungal Agents|antifungal agents|mesh-ancestor
110739742|NCT00001880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110739743|NCT00001880|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110739744|NCT01096472|Octenidine|octenidine|mesh-list
110739745|NCT01096472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110739746|NCT01096472|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110739748|NCT05627648|Mitosis Modulators|mitosis modulators|mesh-ancestor
110739749|NCT05627648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110739750|NCT03947528|Sarpogrelate|sarpogrelate|mesh-list
110739751|NCT03947528|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110739752|NCT03947528|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110739753|NCT03947528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110739754|NCT03947528|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110739755|NCT03947528|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110739756|NCT03947528|Serotonin Agents|serotonin agents|mesh-ancestor
110739757|NCT03947528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110739758|NCT03947528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110739759|NCT01104896|Nicotine|nicotine|mesh-list
110739760|NCT01104896|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110739761|NCT01104896|Autonomic Agents|autonomic agents|mesh-ancestor
110739762|NCT01104896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110739763|NCT01104896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110739764|NCT01104896|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110739765|NCT01104896|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110739766|NCT01104896|Cholinergic Agents|cholinergic agents|mesh-ancestor
110739767|NCT01104896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110739768|NCT01104896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110739769|NCT00043550|Sertraline|sertraline|mesh-list
110739770|NCT00043550|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
110739771|NCT00043550|Antidepressive Agents|antidepressive agents|mesh-ancestor
110739772|NCT00043550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110739773|NCT00043550|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110739774|NCT00043550|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110739775|NCT00043550|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110739776|NCT00043550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110739777|NCT00043550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110739778|NCT00043550|Serotonin Agents|serotonin agents|mesh-ancestor
110739779|NCT00043550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110739780|NCT00043550|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110739781|NCT00043550|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110739782|NCT01102244|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
110739783|NCT01102244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110739784|NCT01102244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110739785|NCT01102244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110739786|NCT01102244|Glucocorticoids|glucocorticoids|mesh-ancestor
110739787|NCT01102244|Hormones|hormones|mesh-ancestor
110739788|NCT01102244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110739789|NCT01102244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110739790|NCT01102244|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110739791|NCT01102244|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110739792|NCT01105208|Cephalexin|cephalexin|mesh-list
110739793|NCT01105208|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110739794|NCT01105208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110739795|NCT01105286|Vitamin D|vitamin d|mesh-list
110739796|NCT01105286|Calcipotriene|calcipotriene|mesh-list
110739797|NCT01105286|Vitamins|vitamins|mesh-ancestor
110739798|NCT01105286|Micronutrients|micronutrients|mesh-ancestor
110739799|NCT01105286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110739800|NCT01105286|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110739801|NCT01105286|Dermatologic Agents|dermatologic agents|mesh-ancestor
110739802|NCT00041132|Leucovorin|leucovorin|mesh-list
110739803|NCT00041132|Cytarabine|cytarabine|mesh-list
110739804|NCT00041132|Dexamethasone|dexamethasone|mesh-list
110739805|NCT00041132|Cyclophosphamide|cyclophosphamide|mesh-list
110739806|NCT00041132|Rituximab|rituximab|mesh-list
110739807|NCT00041132|Doxorubicin|doxorubicin|mesh-list
110739808|NCT00041132|Methotrexate|methotrexate|mesh-list
110739809|NCT00041132|Vincristine|vincristine|mesh-list
110739810|NCT00041132|Levoleucovorin|levoleucovorin|mesh-list
110739811|NCT00041132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110739812|NCT00041132|Immunologic Factors|immunologic factors|mesh-ancestor
110739813|NCT00041132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110739814|NCT00041132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110739815|NCT00041132|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110739816|NCT00041132|Alkylating Agents|alkylating agents|mesh-ancestor
110739817|NCT00041132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110739818|NCT00041132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110739819|NCT00041132|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110739820|NCT00041132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110739821|NCT00041132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110739823|NCT00041132|Autonomic Agents|autonomic agents|mesh-ancestor
110739824|NCT00041132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110739825|NCT00041132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110739826|NCT00041132|Glucocorticoids|glucocorticoids|mesh-ancestor
110739827|NCT00041132|Hormones|hormones|mesh-ancestor
110739828|NCT00041132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110739829|NCT00041132|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110739830|NCT00041132|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110739831|NCT00041132|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110739832|NCT00041132|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110739833|NCT00041132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110739834|NCT00041132|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110739835|NCT00041132|Abortifacient Agents|abortifacient agents|mesh-ancestor
110739836|NCT00041132|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110739837|NCT00041132|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110739838|NCT00041132|Antimetabolites|antimetabolites|mesh-ancestor
110739839|NCT00041132|Dermatologic Agents|dermatologic agents|mesh-ancestor
110739840|NCT00041132|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110739841|NCT00041132|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110739842|NCT00041132|Antiviral Agents|antiviral agents|mesh-ancestor
110739843|NCT00041132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110739844|NCT00041132|Antidotes|antidotes|mesh-ancestor
110739845|NCT00041132|Protective Agents|protective agents|mesh-ancestor
110739846|NCT00041132|Vitamin B Complex|vitamin b complex|mesh-ancestor
110739847|NCT00041132|Vitamins|vitamins|mesh-ancestor
110739848|NCT00041132|Micronutrients|micronutrients|mesh-ancestor
110739849|NCT00041132|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110739850|NCT00041132|Tubulin Modulators|tubulin modulators|mesh-ancestor
110739851|NCT00041132|Antimitotic Agents|antimitotic agents|mesh-ancestor
110739852|NCT00041132|Mitosis Modulators|mitosis modulators|mesh-ancestor
110739853|NCT00040664|Ritonavir|ritonavir|mesh-list
110739854|NCT00040664|Fosamprenavir|fosamprenavir|mesh-list
110739855|NCT00040664|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110739856|NCT00040664|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110739857|NCT00040664|Protease Inhibitors|protease inhibitors|mesh-ancestor
110739858|NCT00040664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110739859|NCT00040664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110739860|NCT00040664|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110739861|NCT00040664|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110739862|NCT00040664|Antiviral Agents|antiviral agents|mesh-ancestor
110739863|NCT00040664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110739864|NCT00040664|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110739865|NCT00040664|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110739866|NCT02952586|Avelumab|avelumab|mesh-list
110739867|NCT02952586|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110739868|NCT02952586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110739869|NCT01096706|Aspirin|aspirin|mesh-list
110739870|NCT01096706|Fluconazole|fluconazole|mesh-list
110739871|NCT01096706|Substance P|substance p|mesh-list
110739872|NCT01096706|Neurokinin A|neurokinin a|mesh-list
110739873|NCT01096706|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110739874|NCT01096706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110739875|NCT01096706|Analgesics|analgesics|mesh-ancestor
110739876|NCT01096706|Sensory System Agents|sensory system agents|mesh-ancestor
110739877|NCT01096706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110739878|NCT01096706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110739879|NCT01096706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110739880|NCT01096706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110739881|NCT01096706|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110739882|NCT01096706|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110739883|NCT01096706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110739884|NCT01096706|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110739885|NCT01096706|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110739886|NCT01096706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110739887|NCT01096706|Antipyretics|antipyretics|mesh-ancestor
110739888|NCT01096706|Antifungal Agents|antifungal agents|mesh-ancestor
110739889|NCT01096706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110739890|NCT01096706|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110739891|NCT01096706|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110739892|NCT01096706|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110739893|NCT01096706|Hormone Antagonists|hormone antagonists|mesh-ancestor
110739894|NCT01096706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110739895|NCT01096706|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110739896|NCT01096706|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110739897|NCT01096706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110739899|NCT01102478|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110739900|NCT01102478|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110739901|NCT01102478|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110146105|NCT00006021|Antioxidants|antioxidants|mesh-ancestor
110739902|NCT01102478|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110739903|NCT01102478|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110739904|NCT01102478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110739905|NCT01102478|Diuretics|diuretics|mesh-ancestor
110739906|NCT01102478|Natriuretic Agents|natriuretic agents|mesh-ancestor
110739907|NCT01102478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110739908|NCT01102478|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110739909|NCT01102478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110739910|NCT01105598|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
110739911|NCT01105598|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110739912|NCT01105598|Antimetabolites|antimetabolites|mesh-ancestor
110739913|NCT01105598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110739914|NCT01105598|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110739915|NCT01105598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110739916|NCT01105598|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110739917|NCT01105598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110739918|NCT03384316|Vaccines|vaccines|mesh-list
110739919|NCT03384316|Immunologic Factors|immunologic factors|mesh-ancestor
110739920|NCT03384316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110739921|NCT01105832|Teriparatide|teriparatide|mesh-list
110739922|NCT01105832|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110739923|NCT01105832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110739924|NCT01105832|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110739925|NCT01105910|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110739926|NCT01105910|Lubricant Eye Drops|lubricant eye drops|mesh-list
110739927|NCT01105910|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110739928|NCT00356525|Carboplatin|carboplatin|mesh-list
110739929|NCT00356525|Gemcitabine|gemcitabine|mesh-list
110739930|NCT00356525|Pemetrexed|pemetrexed|mesh-list
110739931|NCT00356525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110739932|NCT00356525|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110739933|NCT00356525|Antimetabolites|antimetabolites|mesh-ancestor
110739934|NCT00356525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110739935|NCT00356525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110739936|NCT00356525|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110739937|NCT00356525|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110739938|NCT01106066|Oxaliplatin|oxaliplatin|mesh-list
110739939|NCT01106066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110739940|NCT01052129|Naproxen|naproxen|mesh-list
110739941|NCT01052129|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110739942|NCT01052129|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110739943|NCT01052129|Analgesics|analgesics|mesh-ancestor
110739944|NCT01052129|Sensory System Agents|sensory system agents|mesh-ancestor
110739945|NCT01052129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110739946|NCT01052129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110739947|NCT01052129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110739948|NCT01052129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110739949|NCT01052129|Gout Suppressants|gout suppressants|mesh-ancestor
110739950|NCT01052129|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110739951|NCT01052129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110739952|NCT01052129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110739953|NCT01053377|Oseltamivir|oseltamivir|mesh-list
110739954|NCT01053377|Antiviral Agents|antiviral agents|mesh-ancestor
110739955|NCT01053377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110739956|NCT01053377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110739957|NCT01053377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110739958|NCT03991559|Manganese|manganese|mesh-list
110146142|NCT00006033|Methotrexate|methotrexate|mesh-list
110739959|NCT03991559|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
110739961|NCT03991559|Immunoglobulins|immunoglobulins|mesh-list
110739962|NCT03991559|Immunologic Factors|immunologic factors|mesh-ancestor
110739963|NCT03991559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110739964|NCT03991559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110739965|NCT03991559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110739966|NCT03991559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110457703|NCT00814801|Galantamine|galantamine|mesh-list
110739967|NCT03991559|Trace Elements|trace elements|mesh-ancestor
110739968|NCT03991559|Micronutrients|micronutrients|mesh-ancestor
110739969|NCT03949634|Paclitaxel|paclitaxel|mesh-list
110739970|NCT03949634|Docetaxel|docetaxel|mesh-list
110739971|NCT03949634|Doxorubicin|doxorubicin|mesh-list
110739972|NCT03949634|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110739973|NCT03949634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110739974|NCT03949634|Tubulin Modulators|tubulin modulators|mesh-ancestor
110739975|NCT03949634|Antimitotic Agents|antimitotic agents|mesh-ancestor
110739976|NCT03949634|Mitosis Modulators|mitosis modulators|mesh-ancestor
110739977|NCT03949634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110739978|NCT03949634|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110739979|NCT03949634|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110739980|NCT03949634|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110739981|NCT03949634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110739982|NCT01108874|Metaraminol|metaraminol|mesh-list
110739983|NCT01108874|Sympathomimetics|sympathomimetics|mesh-ancestor
110739984|NCT01108874|Autonomic Agents|autonomic agents|mesh-ancestor
110739985|NCT01108874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110739986|NCT01108874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110739987|NCT01108874|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110739988|NCT01108874|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110739989|NCT01108874|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110739990|NCT01108874|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110739991|NCT01108874|Adrenergic Agents|adrenergic agents|mesh-ancestor
110739992|NCT01108874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110739993|NCT01108874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110739994|NCT03383614|Emodepside|emodepside|mesh-list
110739995|NCT03383614|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110739996|NCT03383614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110739997|NCT03403036|Brodalumab|brodalumab|mesh-list
110739998|NCT03403036|Dermatologic Agents|dermatologic agents|mesh-ancestor
110739999|NCT00356135|Clopidogrel|clopidogrel|mesh-list
110740000|NCT00356135|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
110740001|NCT00356135|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110740002|NCT00356135|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110740003|NCT00356135|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110740004|NCT00356135|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110740005|NCT00356135|Purinergic Agents|purinergic agents|mesh-ancestor
110740006|NCT00356135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110740007|NCT00356135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110740008|NCT00356135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110740009|NCT01052363|Bevacizumab|bevacizumab|mesh-list
110740010|NCT01052363|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110740011|NCT01052363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110740012|NCT01052363|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110146149|NCT00006033|Antimetabolites|antimetabolites|mesh-ancestor
110740013|NCT01052363|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110740014|NCT01052363|Growth Substances|growth substances|mesh-ancestor
110740015|NCT01052363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110740016|NCT01052363|Growth Inhibitors|growth inhibitors|mesh-ancestor
110740017|NCT01053611|Remifentanil|remifentanil|mesh-list
110740018|NCT01053611|Propofol|propofol|mesh-list
110740019|NCT01053611|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110740020|NCT01053611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110740021|NCT01053611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110740022|NCT01053611|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110740023|NCT01053611|Anesthetics, General|anesthetics, general|mesh-ancestor
110740024|NCT01053611|Anesthetics|anesthetics|mesh-ancestor
110740025|NCT01053611|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110740026|NCT01053611|Narcotics|narcotics|mesh-ancestor
110740027|NCT01053611|Analgesics|analgesics|mesh-ancestor
110740028|NCT01053611|Sensory System Agents|sensory system agents|mesh-ancestor
110740029|NCT01053611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110740030|NCT00350519|Epoetin Alfa|epoetin alfa|mesh-list
110740031|NCT00350519|Hematinics|hematinics|mesh-ancestor
110740032|NCT01053689|Glimepiride|glimepiride|mesh-list
110740033|NCT01053689|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110740034|NCT01053689|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110740035|NCT01053689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110740036|NCT01053689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110740037|NCT01053689|Immunologic Factors|immunologic factors|mesh-ancestor
110740038|NCT01111448|Sirolimus|sirolimus|mesh-list
110740039|NCT01111448|Temsirolimus|temsirolimus|mesh-list
110740040|NCT01111448|MTOR Inhibitors|mtor inhibitors|mesh-list
110740041|NCT01111448|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110740042|NCT01111448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110740043|NCT01111448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110740044|NCT01111448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110740045|NCT01111448|Immunologic Factors|immunologic factors|mesh-ancestor
110740046|NCT01111448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110740047|NCT01111448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110740048|NCT01111448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110740049|NCT01111448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110740050|NCT01111448|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110740051|NCT01111448|Antifungal Agents|antifungal agents|mesh-ancestor
110740052|NCT03382912|Nivolumab|nivolumab|mesh-list
110740053|NCT03382912|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110740054|NCT03382912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110740055|NCT03382912|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110740056|NCT03382912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110740057|NCT03942926|Sirolimus|sirolimus|mesh-list
110740058|NCT03942926|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110740059|NCT03942926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110740060|NCT03942926|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110740061|NCT03942926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110740062|NCT03942926|Antifungal Agents|antifungal agents|mesh-ancestor
110740063|NCT03942926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110740064|NCT03942926|Immunologic Factors|immunologic factors|mesh-ancestor
110740065|NCT03942926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110740066|NCT00350207|Bromides|bromides|mesh-list
110740067|NCT00350207|Tiotropium Bromide|tiotropium bromide|mesh-list
110740068|NCT00350207|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110740069|NCT00350207|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110740070|NCT00350207|Autonomic Agents|autonomic agents|mesh-ancestor
110740071|NCT00350207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110740072|NCT00350207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110740073|NCT00350207|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110740074|NCT00350207|Respiratory System Agents|respiratory system agents|mesh-ancestor
110740075|NCT00350207|Parasympatholytics|parasympatholytics|mesh-ancestor
110740076|NCT00350207|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110146172|NCT00006042|Mycophenolic Acid|mycophenolic acid|mesh-list
110740077|NCT00350207|Cholinergic Agents|cholinergic agents|mesh-ancestor
110740078|NCT00350207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110740079|NCT00350207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110740080|NCT00350207|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110740081|NCT00350207|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110740082|NCT00350207|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110740083|NCT00350207|Adrenergic Agents|adrenergic agents|mesh-ancestor
110740084|NCT00350207|Anticonvulsants|anticonvulsants|mesh-ancestor
110740086|NCT03946826|Petrolatum|petrolatum|mesh-list
110740087|NCT03946826|Emollients|emollients|mesh-ancestor
110740088|NCT03946826|Dermatologic Agents|dermatologic agents|mesh-ancestor
110740089|NCT03946826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110740090|NCT03946826|Glucocorticoids|glucocorticoids|mesh-ancestor
110740091|NCT03946826|Hormones|hormones|mesh-ancestor
110740092|NCT03946826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110740093|NCT03946826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110740094|NCT01311622|Warfarin|warfarin|mesh-list
110740095|NCT01311622|Anticoagulants|anticoagulants|mesh-ancestor
110740096|NCT00349973|Dipyridamole|dipyridamole|mesh-list
110740097|NCT00349973|Olanzapine|olanzapine|mesh-list
110740098|NCT00349973|Antiemetics|antiemetics|mesh-ancestor
110740099|NCT00349973|Autonomic Agents|autonomic agents|mesh-ancestor
110740100|NCT00349973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110740101|NCT00349973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110740102|NCT00349973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110740103|NCT00349973|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110740104|NCT00349973|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110740105|NCT00349973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110740106|NCT00349973|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110740107|NCT00349973|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110740108|NCT00349973|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110740109|NCT00349973|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110740110|NCT00349973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110740111|NCT00349973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110740112|NCT00349973|Serotonin Agents|serotonin agents|mesh-ancestor
110740113|NCT00349973|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110740114|NCT00349973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110740115|NCT00349973|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110740116|NCT00349973|Vasodilator Agents|vasodilator agents|mesh-ancestor
110740117|NCT01111682|Mannitol|mannitol|mesh-list
110740118|NCT01111682|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110740119|NCT01111682|Diuretics|diuretics|mesh-ancestor
110740120|NCT01111682|Natriuretic Agents|natriuretic agents|mesh-ancestor
110740121|NCT01111682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110740122|NCT04464122|Somatostatin|somatostatin|mesh-list
110740123|NCT04464122|Hormones|hormones|mesh-ancestor
110740124|NCT04464122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110740125|NCT04464122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110740126|NCT01111994|Clindamycin|clindamycin|mesh-list
110740127|NCT01111994|Clindamycin palmitate|clindamycin palmitate|mesh-list
110740128|NCT01111994|Clindamycin phosphate|clindamycin phosphate|mesh-list
110740129|NCT01111994|Tretinoin|tretinoin|mesh-list
110740130|NCT01111994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110740131|NCT01111994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110740132|NCT01111994|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110740133|NCT01111994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110740134|NCT01111994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110740135|NCT01111994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110740136|NCT01111994|Keratolytic Agents|keratolytic agents|mesh-ancestor
110740137|NCT01111994|Dermatologic Agents|dermatologic agents|mesh-ancestor
110740138|NCT03187262|Daratumumab|daratumumab|mesh-list
110740139|NCT03187262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110740140|NCT03944252|Cetuximab|cetuximab|mesh-list
110740141|NCT03944252|Avelumab|avelumab|mesh-list
110740142|NCT03944252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110740143|NCT03944252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110740144|NCT01209026|Fluticasone|fluticasone|mesh-list
110740146|NCT01209026|Moxifloxacin|moxifloxacin|mesh-list
110740147|NCT01209026|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
110740148|NCT01209026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110740149|NCT01209026|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110740150|NCT01209026|Autonomic Agents|autonomic agents|mesh-ancestor
110740151|NCT01209026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110740152|NCT01209026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110740153|NCT01209026|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110740154|NCT01209026|Respiratory System Agents|respiratory system agents|mesh-ancestor
110740155|NCT01209026|Dermatologic Agents|dermatologic agents|mesh-ancestor
110740156|NCT01209026|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110740157|NCT01209026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110740158|NCT01209026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110740159|NCT01209026|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110740160|NCT01209026|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110740161|NCT01209026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110740162|NCT01209026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110740163|NCT01209026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110740164|NCT01209026|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110740165|NCT01209026|Contraceptive Agents|contraceptive agents|mesh-ancestor
110740166|NCT01209026|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110740167|NCT01209026|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110740168|NCT01209026|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110740169|NCT01209026|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110740170|NCT01107470|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
110740171|NCT01107470|Hormones|hormones|mesh-ancestor
110740172|NCT01107470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110740173|NCT01107470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110444835|NCT04187807|Melatonin|melatonin|mesh-list
110740175|NCT01109264|Chlorambucil|chlorambucil|mesh-list
110740176|NCT01109264|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110740177|NCT01109264|Alkylating Agents|alkylating agents|mesh-ancestor
110740178|NCT01109264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110740179|NCT01109264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110740180|NCT01311700|Metoprolol|metoprolol|mesh-list
110740181|NCT01311700|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110740182|NCT01311700|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110740183|NCT01311700|Sympatholytics|sympatholytics|mesh-ancestor
110740184|NCT01311700|Autonomic Agents|autonomic agents|mesh-ancestor
110740185|NCT01311700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110740186|NCT01311700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110740187|NCT01311700|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110740188|NCT01311700|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110740189|NCT01311700|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110740190|NCT01311700|Adrenergic Agents|adrenergic agents|mesh-ancestor
110740191|NCT01311700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110740192|NCT01311700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110740193|NCT01107782|Sildenafil Citrate|sildenafil citrate|mesh-list
110146201|NCT00386763|Antimalarials|antimalarials|mesh-ancestor
110740195|NCT01107782|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110740196|NCT01107782|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110740197|NCT01107782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110740198|NCT01107782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110740199|NCT01107782|Urological Agents|urological agents|mesh-ancestor
110740200|NCT01107938|Esomeprazole|esomeprazole|mesh-list
110740201|NCT01107938|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110740202|NCT01107938|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110740203|NCT01107938|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110740204|NCT01107938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110740205|NCT01107938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110740206|NCT02950558|Ropivacaine|ropivacaine|mesh-list
110740207|NCT02950558|Anesthetics, Local|anesthetics, local|mesh-ancestor
110740208|NCT02950558|Anesthetics|anesthetics|mesh-ancestor
110740209|NCT02950558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110740210|NCT02950558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110740211|NCT02950558|Sensory System Agents|sensory system agents|mesh-ancestor
110740212|NCT02950558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110740213|NCT02791334|Ramucirumab|ramucirumab|mesh-list
110740214|NCT02791334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110740215|NCT03945344|Tiotropium Bromide|tiotropium bromide|mesh-list
110740216|NCT03945344|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110740217|NCT03945344|Autonomic Agents|autonomic agents|mesh-ancestor
110740218|NCT03945344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110740219|NCT03945344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110740220|NCT03945344|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110740221|NCT03945344|Respiratory System Agents|respiratory system agents|mesh-ancestor
110740222|NCT03945344|Parasympatholytics|parasympatholytics|mesh-ancestor
110865259|NCT02445352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110740223|NCT03945344|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110740224|NCT03945344|Cholinergic Agents|cholinergic agents|mesh-ancestor
110740225|NCT03945344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110740226|NCT03945344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110740228|NCT01209416|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110740229|NCT01209416|Antimetabolites|antimetabolites|mesh-ancestor
110740230|NCT01209416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110740231|NCT01209416|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110740232|NCT00349349|Ofatumumab|ofatumumab|mesh-list
110740233|NCT00349349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110740234|NCT01112462|Acetaminophen|acetaminophen|mesh-list
110740235|NCT01112462|Phenylephrine|phenylephrine|mesh-list
110740236|NCT01112462|Oxymetazoline|oxymetazoline|mesh-list
110740237|NCT01112462|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110740238|NCT01112462|Analgesics|analgesics|mesh-ancestor
110740239|NCT01112462|Sensory System Agents|sensory system agents|mesh-ancestor
110740240|NCT01112462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110740241|NCT01112462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110740242|NCT01112462|Antipyretics|antipyretics|mesh-ancestor
110740243|NCT01112462|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110740244|NCT01112462|Mydriatics|mydriatics|mesh-ancestor
110740245|NCT01112462|Autonomic Agents|autonomic agents|mesh-ancestor
110740246|NCT01112462|Sympathomimetics|sympathomimetics|mesh-ancestor
110740247|NCT01112462|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110444836|NCT04187807|Antioxidants|antioxidants|mesh-ancestor
110740248|NCT01112462|Nasal Decongestants|nasal decongestants|mesh-ancestor
110740249|NCT01112462|Respiratory System Agents|respiratory system agents|mesh-ancestor
110740250|NCT01112462|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110740251|NCT01112462|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110740252|NCT01112462|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110740253|NCT01112462|Adrenergic Agents|adrenergic agents|mesh-ancestor
110740254|NCT01112462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110740255|NCT01112462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110740256|NCT01112462|Protective Agents|protective agents|mesh-ancestor
110740257|NCT02950480|Zafirlukast|zafirlukast|mesh-list
110740258|NCT02950480|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110740259|NCT02950480|Respiratory System Agents|respiratory system agents|mesh-ancestor
110740260|NCT02950480|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110740261|NCT02950480|Hormone Antagonists|hormone antagonists|mesh-ancestor
110146218|NCT05680545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110740262|NCT02950480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110740263|NCT02950480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110740264|NCT01109030|Pioglitazone|pioglitazone|mesh-list
110740265|NCT01109030|Chlordiazepoxide|chlordiazepoxide|mesh-list
110740266|NCT01109030|Dexetimide|dexetimide|mesh-list
110740267|NCT01109030|Citalopram|citalopram|mesh-list
110740268|NCT01109030|Escitalopram|escitalopram|mesh-list
110740269|NCT01109030|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110740270|NCT01109030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110740271|NCT01109030|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110740272|NCT01109030|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110740273|NCT01109030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110740274|NCT01109030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110740275|NCT01109030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110740276|NCT01109030|Serotonin Agents|serotonin agents|mesh-ancestor
110740277|NCT01109030|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110740278|NCT01109030|Antidepressive Agents|antidepressive agents|mesh-ancestor
110740279|NCT01109030|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110740280|NCT01109030|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110740281|NCT01109030|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110740282|NCT01109030|Parasympatholytics|parasympatholytics|mesh-ancestor
110740283|NCT01109030|Autonomic Agents|autonomic agents|mesh-ancestor
110740284|NCT01109030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110740285|NCT01109030|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110740286|NCT01109030|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110740287|NCT01109030|Cholinergic Agents|cholinergic agents|mesh-ancestor
110740288|NCT01109030|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110740289|NCT01109030|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110740290|NCT01109030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110740291|NCT01109030|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110740292|NCT01109030|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110740293|NCT01109030|GABA Modulators|gaba modulators|mesh-ancestor
110740294|NCT01109030|GABA Agents|gaba agents|mesh-ancestor
110740295|NCT05494528|Entecavir|entecavir|mesh-list
110740296|NCT05494528|Antiviral Agents|antiviral agents|mesh-ancestor
110740297|NCT05494528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110740298|NCT03987815|Nivolumab|nivolumab|mesh-list
110740299|NCT03987815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110740300|NCT03987815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110740301|NCT03987815|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110740302|NCT03987815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110740303|NCT00348881|Vaccines|vaccines|mesh-list
110740304|NCT00348881|Immunologic Factors|immunologic factors|mesh-ancestor
110740305|NCT00348881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110740306|NCT02257580|Aminocaproic Acid|aminocaproic acid|mesh-list
110740307|NCT02257580|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110740308|NCT02257580|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110740309|NCT02257580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110740310|NCT02257580|Hemostatics|hemostatics|mesh-ancestor
110740311|NCT02257580|Coagulants|coagulants|mesh-ancestor
110740312|NCT01055795|Bevacizumab|bevacizumab|mesh-list
110740313|NCT01055795|Everolimus|everolimus|mesh-list
110740314|NCT01055795|Panobinostat|panobinostat|mesh-list
110740315|NCT01055795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110740316|NCT01055795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110740317|NCT01055795|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110740318|NCT01055795|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110740319|NCT01055795|Growth Substances|growth substances|mesh-ancestor
110740320|NCT01055795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110740321|NCT01055795|Growth Inhibitors|growth inhibitors|mesh-ancestor
110740322|NCT01055795|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110740323|NCT01055795|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110740324|NCT01055795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110740325|NCT01055795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110740326|NCT01055795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110740327|NCT01055795|Immunologic Factors|immunologic factors|mesh-ancestor
110740328|NCT01055795|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110740329|NCT03943784|Propranolol|propranolol|mesh-list
110740330|NCT03943784|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
110740331|NCT03943784|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110740332|NCT03943784|Adrenergic Agents|adrenergic agents|mesh-ancestor
110740333|NCT03943784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110740334|NCT03943784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110740335|NCT03943784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110740336|NCT03943784|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110740337|NCT03943784|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110740338|NCT03943784|Vasodilator Agents|vasodilator agents|mesh-ancestor
110740339|NCT00347009|Adefovir|adefovir|mesh-list
110740340|NCT00347009|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
110740341|NCT00347009|Antiviral Agents|antiviral agents|mesh-ancestor
110740342|NCT00347009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110740343|NCT00347009|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110740344|NCT00347009|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110740345|NCT00347009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110740346|NCT00347009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110740347|NCT01209650|Afatinib|afatinib|mesh-list
110740348|NCT01209650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110740349|NCT01209650|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110740350|NCT01209650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110740351|NCT01209650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110740352|NCT01947140|Romidepsin|romidepsin|mesh-list
110740353|NCT01947140|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110740354|NCT01947140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110740355|NCT01947140|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110740356|NCT01947140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110740357|NCT01947140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110740358|NCT00346775|Beclomethasone|beclomethasone|mesh-list
110740359|NCT00346775|Flunisolide|flunisolide|mesh-list
110740360|NCT00346775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110740361|NCT00346775|Glucocorticoids|glucocorticoids|mesh-ancestor
110740363|NCT00346775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110740364|NCT00346775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110740365|NCT00346775|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110740366|NCT00346775|Respiratory System Agents|respiratory system agents|mesh-ancestor
110740367|NCT01108562|Lidocaine|lidocaine|mesh-list
110740368|NCT01108562|Anesthetics, Local|anesthetics, local|mesh-ancestor
110740369|NCT01108562|Anesthetics|anesthetics|mesh-ancestor
110740370|NCT01108562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110740371|NCT01108562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110740372|NCT01108562|Sensory System Agents|sensory system agents|mesh-ancestor
110740373|NCT01108562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110740374|NCT01108562|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110740375|NCT01108562|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110740376|NCT01108562|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110740377|NCT01108562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110740378|NCT01108562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110740379|NCT01112540|Morphine|morphine|mesh-list
110740380|NCT01112540|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110740381|NCT01112540|Narcotics|narcotics|mesh-ancestor
110740382|NCT01112540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110740383|NCT01112540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110740384|NCT01112540|Analgesics|analgesics|mesh-ancestor
110740385|NCT01112540|Sensory System Agents|sensory system agents|mesh-ancestor
110740386|NCT01112540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110740387|NCT03400852|Cosyntropin|cosyntropin|mesh-list
110740388|NCT03400852|Hormones|hormones|mesh-ancestor
110740389|NCT03400852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110740390|NCT03400852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110740391|NCT01056419|Propylthiouracil|propylthiouracil|mesh-list
110740392|NCT01056419|Antimetabolites|antimetabolites|mesh-ancestor
110065430|NCT01532856|Growth Substances|growth substances|mesh-ancestor
110740393|NCT01056419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110740394|NCT01056419|Antithyroid Agents|antithyroid agents|mesh-ancestor
110740395|NCT01056419|Hormone Antagonists|hormone antagonists|mesh-ancestor
110740396|NCT01056419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110740397|NCT01056419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110740399|NCT01056497|Antioxidants|antioxidants|mesh-ancestor
110740400|NCT01056497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110740401|NCT01056497|Protective Agents|protective agents|mesh-ancestor
110740402|NCT01056497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110740403|NCT01056497|Vitamin B Complex|vitamin b complex|mesh-ancestor
110740404|NCT01056497|Vitamins|vitamins|mesh-ancestor
110740405|NCT01056497|Micronutrients|micronutrients|mesh-ancestor
110740406|NCT03398356|Metformin|metformin|mesh-list
110740407|NCT03398356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110740408|NCT03398356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110740409|NCT00346151|Sirolimus|sirolimus|mesh-list
110740410|NCT00346151|Methylprednisolone|methylprednisolone|mesh-list
110740411|NCT00346151|Abatacept|abatacept|mesh-list
110740412|NCT00346151|Thymoglobulin|thymoglobulin|mesh-list
110740413|NCT00346151|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110740414|NCT00346151|Immunoglobulins|immunoglobulins|mesh-list
110740415|NCT00346151|Glucocorticoids|glucocorticoids|mesh-list
110740416|NCT00346151|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110740417|NCT00346151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110740418|NCT00346151|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110740419|NCT00346151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110740420|NCT00346151|Antifungal Agents|antifungal agents|mesh-ancestor
110740421|NCT00346151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110740422|NCT00346151|Immunologic Factors|immunologic factors|mesh-ancestor
110740423|NCT00346151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110740424|NCT00346151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110740425|NCT00346151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110740426|NCT00346151|Antiemetics|antiemetics|mesh-ancestor
110740427|NCT00346151|Autonomic Agents|autonomic agents|mesh-ancestor
110740428|NCT00346151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110740429|NCT00346151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110740431|NCT00346151|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110740432|NCT00346151|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110740433|NCT00346151|Protective Agents|protective agents|mesh-ancestor
110740434|NCT00346151|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110740435|NCT00346151|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110740436|NCT00346151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110740437|NCT03940976|Afatinib|afatinib|mesh-list
110740438|NCT03940976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110740439|NCT03940976|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110740440|NCT03940976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110146251|NCT05679453|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110740441|NCT03940976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110740442|NCT01109498|Cyclosporine|cyclosporine|mesh-list
110740443|NCT01109498|Mycophenolic Acid|mycophenolic acid|mesh-list
110740444|NCT01109498|Cyclosporins|cyclosporins|mesh-list
110740445|NCT01109498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110740446|NCT01109498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110740447|NCT01109498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110740448|NCT01109498|Immunologic Factors|immunologic factors|mesh-ancestor
110740449|NCT01109498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110740450|NCT01109498|Antifungal Agents|antifungal agents|mesh-ancestor
110740451|NCT01109498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110740452|NCT01109498|Dermatologic Agents|dermatologic agents|mesh-ancestor
110740453|NCT01109498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110740454|NCT01109498|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110740455|NCT01109498|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110740456|NCT01109498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110740457|NCT01109498|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110740458|NCT01109498|Antitubercular Agents|antitubercular agents|mesh-ancestor
110740459|NCT01109498|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110740460|NCT00130286|Rosiglitazone|rosiglitazone|mesh-list
110740461|NCT00130286|Hormones|hormones|mesh-list
110740462|NCT00130286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110740463|NCT00130286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110740464|NCT00130286|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110740465|NCT03940664|Formaldehyde|formaldehyde|mesh-list
110740466|NCT03940664|Disinfectants|disinfectants|mesh-ancestor
110740467|NCT03940664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110740468|NCT01211834|Antirheumatic Agents|antirheumatic agents|mesh-list
110740470|NCT03941990|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110740471|NCT03941990|Anesthetics, General|anesthetics, general|mesh-ancestor
110740472|NCT03941990|Anesthetics|anesthetics|mesh-ancestor
110740473|NCT03941990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110740474|NCT03941990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110740475|NCT03941990|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110740476|NCT03941990|Analgesics|analgesics|mesh-ancestor
110740477|NCT03941990|Sensory System Agents|sensory system agents|mesh-ancestor
110740478|NCT03941990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110740479|NCT03374488|Pembrolizumab|pembrolizumab|mesh-list
110740480|NCT03374488|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110740481|NCT03374488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110740482|NCT03374488|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110740483|NCT03374488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110740484|NCT01209728|Ethanol|ethanol|mesh-list
110740485|NCT01209728|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110740486|NCT01209728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110740487|NCT01209728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110740488|NCT01209728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110740489|NCT00345683|Vaccines|vaccines|mesh-list
110740490|NCT00345683|Immunologic Factors|immunologic factors|mesh-ancestor
110740491|NCT00345683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110740492|NCT01211912|Acetaminophen|acetaminophen|mesh-list
110740493|NCT01211912|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110740494|NCT01211912|Analgesics|analgesics|mesh-ancestor
110740495|NCT01211912|Sensory System Agents|sensory system agents|mesh-ancestor
110740496|NCT01211912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110740497|NCT01211912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110740498|NCT01211912|Antipyretics|antipyretics|mesh-ancestor
110740499|NCT03943472|Cyclophosphamide|cyclophosphamide|mesh-list
110740500|NCT03943472|Fludarabine|fludarabine|mesh-list
110740501|NCT03943472|Idecabtagene vicleucel|idecabtagene vicleucel|mesh-list
110740502|NCT03943472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110074431|NCT01592981|Rituximab|rituximab|mesh-list
110740503|NCT03943472|Immunologic Factors|immunologic factors|mesh-ancestor
110740504|NCT03943472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110740505|NCT03943472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110740506|NCT03943472|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110740507|NCT03943472|Alkylating Agents|alkylating agents|mesh-ancestor
110740508|NCT03943472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110740509|NCT03943472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110740510|NCT03943472|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110740511|NCT03943472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110740512|NCT01114490|Anacetrapib|anacetrapib|mesh-list
110740513|NCT01114490|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110740514|NCT01114490|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110740515|NCT01114490|Antimetabolites|antimetabolites|mesh-ancestor
110740516|NCT01114490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110740517|NCT01114490|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110740518|NCT01209806|Simethicone|simethicone|mesh-list
110740519|NCT01209806|Aluminum hydroxide, magnesium hydroxide, drug combination|aluminum hydroxide, magnesium hydroxide, drug combination|mesh-list
110740520|NCT01209806|Aluminum Hydroxide|aluminum hydroxide|mesh-list
110740521|NCT01209806|Magnesium Hydroxide|magnesium hydroxide|mesh-list
110740522|NCT01209806|Aluminum hydroxide, magnesium hydroxide, simethicone drug combination|aluminum hydroxide, magnesium hydroxide, simethicone drug combination|mesh-list
110740524|NCT01209806|Antifoaming Agents|antifoaming agents|mesh-ancestor
110740525|NCT01209806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110740526|NCT01209806|Emollients|emollients|mesh-ancestor
110740527|NCT01209806|Dermatologic Agents|dermatologic agents|mesh-ancestor
110740528|NCT01209806|Antacids|antacids|mesh-ancestor
110740529|NCT01209806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110740530|NCT01209806|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110740531|NCT01209806|Immunologic Factors|immunologic factors|mesh-ancestor
110740532|NCT01209806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110740533|NCT01209806|Antioxidants|antioxidants|mesh-ancestor
110740534|NCT01209806|Protective Agents|protective agents|mesh-ancestor
110740535|NCT01114568|Ertugliflozin|ertugliflozin|mesh-list
110740536|NCT01114568|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110740537|NCT01114568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110740538|NCT01114568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110740539|NCT01114568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110740540|NCT01109654|Cetrorelix|cetrorelix|mesh-list
110740541|NCT01109654|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
110740542|NCT01109654|Hormones|hormones|mesh-ancestor
110740543|NCT01109654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110740544|NCT01109654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110740545|NCT01109654|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110740546|NCT01109654|Fertility Agents|fertility agents|mesh-ancestor
110740547|NCT01109654|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110740548|NCT01109654|Hormone Antagonists|hormone antagonists|mesh-ancestor
110740549|NCT01054001|Sildenafil Citrate|sildenafil citrate|mesh-list
110740550|NCT01054001|Vasodilator Agents|vasodilator agents|mesh-ancestor
110740551|NCT01054001|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110740552|NCT01054001|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110740553|NCT01054001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110740554|NCT01054001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110740555|NCT01054001|Urological Agents|urological agents|mesh-ancestor
110740556|NCT01057355|Ethanol|ethanol|mesh-list
110740557|NCT01057355|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110740558|NCT01057355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110740559|NCT01057355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110740560|NCT01057355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110740561|NCT01057511|Progesterone|progesterone|mesh-list
110740562|NCT01057511|Progestins|progestins|mesh-ancestor
110740563|NCT01057511|Hormones|hormones|mesh-ancestor
110740564|NCT01057511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110740566|NCT00345605|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
110740567|NCT00345605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110458311|NCT00657904|Bicalutamide|bicalutamide|mesh-list
110740568|NCT01210040|Folic Acid|folic acid|mesh-list
110740569|NCT01210040|Vitamin B Complex|vitamin b complex|mesh-list
110740570|NCT01210040|Hematinics|hematinics|mesh-ancestor
110740571|NCT01210040|Vitamins|vitamins|mesh-ancestor
110740572|NCT01210040|Micronutrients|micronutrients|mesh-ancestor
110740573|NCT01210040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110740574|NCT01054313|Sirolimus|sirolimus|mesh-list
110740575|NCT01054313|Prednisone|prednisone|mesh-list
110740576|NCT01054313|Docetaxel|docetaxel|mesh-list
110740577|NCT01054313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110740578|NCT01054313|Tubulin Modulators|tubulin modulators|mesh-ancestor
110740579|NCT01054313|Antimitotic Agents|antimitotic agents|mesh-ancestor
110740580|NCT01054313|Mitosis Modulators|mitosis modulators|mesh-ancestor
110740581|NCT01054313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110740582|NCT01054313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110740583|NCT01054313|Glucocorticoids|glucocorticoids|mesh-ancestor
110740584|NCT01054313|Hormones|hormones|mesh-ancestor
110740585|NCT01054313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110740586|NCT01054313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110740587|NCT01054313|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110740588|NCT01054313|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110740589|NCT01054313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110740590|NCT01054313|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110740591|NCT01054313|Antifungal Agents|antifungal agents|mesh-ancestor
110740592|NCT01054313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110740593|NCT01054313|Immunologic Factors|immunologic factors|mesh-ancestor
110740594|NCT01114958|Cisplatin|cisplatin|mesh-list
110740595|NCT01114958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110740596|NCT03742115|Dexamethasone|dexamethasone|mesh-list
110740597|NCT03742115|Etoposide|etoposide|mesh-list
110740598|NCT03742115|Etoposide phosphate|etoposide phosphate|mesh-list
110740599|NCT03742115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110740600|NCT03742115|Antiemetics|antiemetics|mesh-ancestor
110740601|NCT03742115|Autonomic Agents|autonomic agents|mesh-ancestor
110740602|NCT03742115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110740603|NCT03742115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110740604|NCT03742115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110740605|NCT03742115|Glucocorticoids|glucocorticoids|mesh-ancestor
110740606|NCT03742115|Hormones|hormones|mesh-ancestor
110740607|NCT03742115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110740608|NCT03742115|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110740609|NCT03742115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110740610|NCT03742115|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110740611|NCT03742115|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110740612|NCT03742115|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110740613|NCT03742115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110740614|NCT03742115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110740615|NCT01115036|Panobinostat|panobinostat|mesh-list
110740616|NCT01115036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110740617|NCT01115036|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110740618|NCT01115036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110740619|NCT01115036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110740620|NCT01207622|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
110740621|NCT01207622|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110740622|NCT01207622|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110740623|NCT01207622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110740624|NCT01207622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110740625|NCT01207622|Adrenergic Agents|adrenergic agents|mesh-ancestor
110740626|NCT01207622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110740627|NCT01207622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110740628|NCT03942068|Paclitaxel|paclitaxel|mesh-list
110740629|NCT03942068|Apatinib|apatinib|mesh-list
110740630|NCT03942068|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110740631|NCT03942068|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110740632|NCT03942068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110740633|NCT03942068|Tubulin Modulators|tubulin modulators|mesh-ancestor
110740634|NCT03942068|Antimitotic Agents|antimitotic agents|mesh-ancestor
110740635|NCT03942068|Mitosis Modulators|mitosis modulators|mesh-ancestor
110865295|NCT02727998|Sensory System Agents|sensory system agents|mesh-ancestor
110740636|NCT03942068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110740637|NCT03942068|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110740638|NCT03942068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110740639|NCT01112852|Terlipressin|terlipressin|mesh-list
110740640|NCT01112852|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
110740641|NCT01112852|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
110740642|NCT01112852|Somatostatin|somatostatin|mesh-list
110740643|NCT01112852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110740644|NCT01112852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110740645|NCT01112852|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110740646|NCT01112852|Hormones|hormones|mesh-ancestor
110740647|NCT01112852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110740648|NCT01112852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110740649|NCT01054469|Ropivacaine|ropivacaine|mesh-list
110740650|NCT01054469|Anesthetics, Local|anesthetics, local|mesh-ancestor
110740651|NCT01054469|Anesthetics|anesthetics|mesh-ancestor
110740652|NCT01054469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110740653|NCT01054469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110740654|NCT01054469|Sensory System Agents|sensory system agents|mesh-ancestor
110740655|NCT01054469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110740656|NCT03940430|Lactoferrin|lactoferrin|mesh-list
110740657|NCT03940430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110740658|NCT00355121|Vaccines|vaccines|mesh-list
110740659|NCT00355121|Immunologic Factors|immunologic factors|mesh-ancestor
110740660|NCT00355121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110740661|NCT02533349|Pantoprazole|pantoprazole|mesh-list
110740662|NCT02533349|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110740663|NCT02533349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110740664|NCT02533349|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110740665|NCT02533349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110740666|NCT02533349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110740667|NCT01115426|Losartan|losartan|mesh-list
110740668|NCT01115426|Ramipril|ramipril|mesh-list
110740669|NCT01115426|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110740670|NCT01115426|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110740671|NCT01115426|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110740672|NCT01115426|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110740673|NCT01115426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110740674|NCT01115426|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110740675|NCT01115426|Protease Inhibitors|protease inhibitors|mesh-ancestor
110740676|NCT01115426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110740677|NCT03942458|Clopidogrel|clopidogrel|mesh-list
110740678|NCT03942458|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110740679|NCT03942458|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110740680|NCT03942458|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110740681|NCT03942458|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110740682|NCT03942458|Purinergic Agents|purinergic agents|mesh-ancestor
110740683|NCT03942458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110740684|NCT03942458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110740685|NCT03942458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110740686|NCT01115504|Thiamine|thiamine|mesh-list
110740687|NCT01115504|Vitamin B Complex|vitamin b complex|mesh-ancestor
110740688|NCT01115504|Vitamins|vitamins|mesh-ancestor
110740689|NCT01115504|Micronutrients|micronutrients|mesh-ancestor
110740690|NCT01115504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110740691|NCT00343889|Vaccines|vaccines|mesh-list
110740692|NCT00343889|Immunologic Factors|immunologic factors|mesh-ancestor
110740693|NCT00343889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110740694|NCT03939884|Diclofenac|diclofenac|mesh-list
110740695|NCT03939884|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110740696|NCT03939884|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110740697|NCT03939884|Analgesics|analgesics|mesh-ancestor
110740698|NCT03939884|Sensory System Agents|sensory system agents|mesh-ancestor
110740699|NCT03939884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110740700|NCT03939884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110740701|NCT03939884|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110740702|NCT03939884|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110740703|NCT03939884|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110740704|NCT03939884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110740705|NCT03939884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110740706|NCT01054547|Anesthetics|anesthetics|mesh-list
110740707|NCT01054547|Ropivacaine|ropivacaine|mesh-list
110740708|NCT01054547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110740709|NCT01054547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110740710|NCT01054547|Anesthetics, Local|anesthetics, local|mesh-ancestor
110740711|NCT01054547|Sensory System Agents|sensory system agents|mesh-ancestor
110740712|NCT01054547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110740713|NCT01115894|Naltrexone|naltrexone|mesh-list
110740714|NCT01115894|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110740715|NCT01115894|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110740716|NCT01115894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110740717|NCT01115894|Sensory System Agents|sensory system agents|mesh-ancestor
110740718|NCT01115894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110740719|NCT01115972|Valsartan|valsartan|mesh-list
110740720|NCT01115972|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110740721|NCT01115972|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110740722|NCT01115972|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110740723|NCT01115972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110740724|NCT01116050|Misoprostol|misoprostol|mesh-list
110740725|NCT01116050|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110740726|NCT01116050|Abortifacient Agents|abortifacient agents|mesh-ancestor
110740727|NCT01116050|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110740728|NCT01116050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110740729|NCT01116050|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110740730|NCT01116050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110740731|NCT01116050|Oxytocics|oxytocics|mesh-ancestor
110740732|NCT01054781|Rituximab|rituximab|mesh-list
110740733|NCT01054781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110740734|NCT01054781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110740735|NCT01054781|Immunologic Factors|immunologic factors|mesh-ancestor
110740736|NCT01054781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110740737|NCT01054781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110740738|NCT05282290|Antihypertensive Agents|antihypertensive agents|mesh-list
110740739|NCT01311778|Fentanyl|fentanyl|mesh-list
110740740|NCT01311778|Cannabidiol|cannabidiol|mesh-list
110740741|NCT01311778|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110740742|NCT01311778|Narcotics|narcotics|mesh-ancestor
110740743|NCT01311778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110865317|NCT02108990|Acetaminophen|acetaminophen|mesh-list
110740744|NCT01311778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110740745|NCT01311778|Analgesics|analgesics|mesh-ancestor
110740746|NCT01311778|Sensory System Agents|sensory system agents|mesh-ancestor
110740747|NCT01311778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110740748|NCT01311778|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110740749|NCT01311778|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110740750|NCT01311778|Anesthetics, General|anesthetics, general|mesh-ancestor
110740751|NCT01311778|Anesthetics|anesthetics|mesh-ancestor
110740752|NCT01311778|Anticonvulsants|anticonvulsants|mesh-ancestor
110740753|NCT00354341|Epoetin Alfa|epoetin alfa|mesh-list
110740754|NCT00354341|Hematinics|hematinics|mesh-ancestor
110740755|NCT03708718|Prednisolone|prednisolone|mesh-list
110740756|NCT03708718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110740757|NCT03708718|Glucocorticoids|glucocorticoids|mesh-ancestor
110740758|NCT03708718|Hormones|hormones|mesh-ancestor
110740759|NCT03708718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110740760|NCT03708718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110740761|NCT03708718|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110740762|NCT03708718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110740763|NCT00354107|Cytarabine|cytarabine|mesh-list
110740764|NCT00354107|Hydrocortisone|hydrocortisone|mesh-list
110740765|NCT00354107|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
110740766|NCT00354107|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
110740767|NCT00354107|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
110740768|NCT00354107|Carboplatin|carboplatin|mesh-list
110740769|NCT00354107|Methotrexate|methotrexate|mesh-list
110740770|NCT00354107|Etoposide|etoposide|mesh-list
110740771|NCT00354107|Etoposide phosphate|etoposide phosphate|mesh-list
110740772|NCT00354107|Ifosfamide|ifosfamide|mesh-list
110740773|NCT00354107|Brentuximab Vedotin|brentuximab vedotin|mesh-list
110740774|NCT00354107|Antibodies|antibodies|mesh-list
110740775|NCT00354107|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110740776|NCT00354107|Immunologic Factors|immunologic factors|mesh-ancestor
110740777|NCT00354107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110740778|NCT00354107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110740779|NCT00354107|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110740780|NCT00354107|Abortifacient Agents|abortifacient agents|mesh-ancestor
110740781|NCT00354107|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110740782|NCT00354107|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110740783|NCT00354107|Antimetabolites|antimetabolites|mesh-ancestor
110740784|NCT00354107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110740785|NCT00354107|Dermatologic Agents|dermatologic agents|mesh-ancestor
110740786|NCT00354107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110740787|NCT00354107|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110740788|NCT00354107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110740789|NCT00354107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110740790|NCT00354107|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110740791|NCT00354107|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110740792|NCT00354107|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110740793|NCT00354107|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110740794|NCT00354107|Antiviral Agents|antiviral agents|mesh-ancestor
110740795|NCT00354107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110740796|NCT00354107|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110740797|NCT00354107|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110740798|NCT00354107|Alkylating Agents|alkylating agents|mesh-ancestor
110740799|NCT00354107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110740801|NCT00354107|Immunoconjugates|immunoconjugates|mesh-ancestor
110740802|NCT00354029|Ketamine|ketamine|mesh-list
110740803|NCT00354029|Analgesics|analgesics|mesh-ancestor
110740804|NCT00354029|Sensory System Agents|sensory system agents|mesh-ancestor
110740805|NCT00354029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110740806|NCT00354029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110740807|NCT00354029|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110740808|NCT00354029|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110740809|NCT00354029|Anesthetics, General|anesthetics, general|mesh-ancestor
110740810|NCT00354029|Anesthetics|anesthetics|mesh-ancestor
110740811|NCT00354029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110740812|NCT00354029|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110740813|NCT00354029|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110740814|NCT00354029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110740815|NCT00354029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110740816|NCT00353873|Fluticasone|fluticasone|mesh-list
110740817|NCT00353873|Xhance|xhance|mesh-list
110740818|NCT00353873|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110740819|NCT00353873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110740820|NCT00353873|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110740821|NCT00353873|Autonomic Agents|autonomic agents|mesh-ancestor
110146394|NCT04360473|Ketamine|ketamine|mesh-list
110740822|NCT00353873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110740823|NCT00353873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110740824|NCT00353873|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110740825|NCT00353873|Respiratory System Agents|respiratory system agents|mesh-ancestor
110740826|NCT00353873|Dermatologic Agents|dermatologic agents|mesh-ancestor
110740827|NCT00353873|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110740828|NCT00353873|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110740829|NCT00353873|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110740830|NCT00353873|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110740831|NCT00353873|Adrenergic Agents|adrenergic agents|mesh-ancestor
110740832|NCT00353873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110740833|NCT00353873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110740834|NCT01058057|Atorvastatin|atorvastatin|mesh-list
110740835|NCT01058057|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110740836|NCT01058057|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110740837|NCT01058057|Antimetabolites|antimetabolites|mesh-ancestor
110740838|NCT01058057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110740839|NCT01058057|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110740840|NCT01058057|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110740841|NCT01058057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110740842|NCT03796676|Abrocitinib|abrocitinib|mesh-list
110740843|NCT03796676|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110740844|NCT03796676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110740845|NCT03796676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110740846|NCT00339833|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
110740847|NCT00339833|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110740848|NCT00339833|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110740849|NCT00339833|Analgesics|analgesics|mesh-ancestor
110740850|NCT00339833|Sensory System Agents|sensory system agents|mesh-ancestor
110740851|NCT00339833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110740852|NCT00339833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110740853|NCT00339833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110740854|NCT00339833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110740855|NCT01058291|Apomorphine|apomorphine|mesh-list
110740856|NCT01058291|Emetics|emetics|mesh-ancestor
110740857|NCT01058291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110740858|NCT01058291|Autonomic Agents|autonomic agents|mesh-ancestor
110740859|NCT01058291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110740860|NCT01058291|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110740861|NCT01058291|Dopamine Agonists|dopamine agonists|mesh-ancestor
110740862|NCT01058291|Dopamine Agents|dopamine agents|mesh-ancestor
110740863|NCT01058291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110740864|NCT01058291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110740865|NCT01055249|Ibuprofen|ibuprofen|mesh-list
110740866|NCT01055249|Hydrocortisone|hydrocortisone|mesh-list
110740867|NCT01055249|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
110740868|NCT01055249|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
110740869|NCT01055249|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
110740870|NCT01055249|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110740871|NCT01055249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110740873|NCT01055249|Sensory System Agents|sensory system agents|mesh-ancestor
110740874|NCT01055249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110740875|NCT01055249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110740876|NCT01055249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110444873|NCT04132063|Levetiracetam|levetiracetam|mesh-list
110740877|NCT01055249|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110740878|NCT01055249|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110740879|NCT01055249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110740880|NCT01055249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110740881|NCT01055327|Lamotrigine|lamotrigine|mesh-list
110740882|NCT01055327|Anticonvulsants|anticonvulsants|mesh-list
110740883|NCT01055327|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110740884|NCT01055327|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110740885|NCT01055327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110740886|NCT01055327|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110740887|NCT01055327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110740888|NCT01055327|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110740889|NCT01055327|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110740890|NCT01055327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110740891|NCT01055327|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110740892|NCT01055327|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110740893|NCT03793556|Omeprazole|omeprazole|mesh-list
110740894|NCT03793556|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110740895|NCT03793556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110740896|NCT03793556|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110740897|NCT03793556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110740898|NCT03793556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110740899|NCT01113164|Ondansetron|ondansetron|mesh-list
110740900|NCT01113164|Sertraline|sertraline|mesh-list
110740901|NCT01113164|Antiemetics|antiemetics|mesh-ancestor
110740902|NCT01113164|Autonomic Agents|autonomic agents|mesh-ancestor
110740903|NCT01113164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110740904|NCT01113164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110740905|NCT01113164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110740906|NCT01113164|Antipruritics|antipruritics|mesh-ancestor
110740907|NCT01113164|Dermatologic Agents|dermatologic agents|mesh-ancestor
110740908|NCT01113164|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110740909|NCT01113164|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110740910|NCT01113164|Serotonin Agents|serotonin agents|mesh-ancestor
110740911|NCT01113164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110740912|NCT01113164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110740913|NCT01113164|Antidepressive Agents|antidepressive agents|mesh-ancestor
110740914|NCT01113164|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110740915|NCT01113164|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110146502|NCT02936505|Cyclosporins|cyclosporins|mesh-list
110740916|NCT01113164|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110740917|NCT01113164|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110740918|NCT01210430|Vitamins|vitamins|mesh-list
110740919|NCT01210430|Ascorbic Acid|ascorbic acid|mesh-list
110740920|NCT01210430|Losartan|losartan|mesh-list
110740921|NCT01210430|Micronutrients|micronutrients|mesh-ancestor
110740922|NCT01210430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110740923|NCT01210430|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110740924|NCT01210430|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110740925|NCT01210430|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110740926|NCT01210430|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110740927|NCT01210430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110740928|NCT01210430|Antioxidants|antioxidants|mesh-ancestor
110740929|NCT01210430|Protective Agents|protective agents|mesh-ancestor
110740930|NCT01210742|Hylan|hylan|mesh-list
110740931|NCT01210742|Viscosupplements|viscosupplements|mesh-ancestor
110740932|NCT01210742|Protective Agents|protective agents|mesh-ancestor
110740933|NCT01210742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110740934|NCT01116128|Prednisone|prednisone|mesh-list
110740935|NCT01116128|Melphalan|melphalan|mesh-list
110740936|NCT01116128|Dasatinib|dasatinib|mesh-list
110740937|NCT01116128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110740938|NCT01116128|Glucocorticoids|glucocorticoids|mesh-ancestor
110740939|NCT01116128|Hormones|hormones|mesh-ancestor
110740940|NCT01116128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110740941|NCT01116128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110740942|NCT01116128|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110740943|NCT01116128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110740944|NCT01116128|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110740945|NCT01116128|Alkylating Agents|alkylating agents|mesh-ancestor
110740946|NCT01116128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110740947|NCT01116128|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110740948|NCT01116128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110066002|NCT01536158|Acetaminophen|acetaminophen|mesh-list
110740949|NCT01116128|Immunologic Factors|immunologic factors|mesh-ancestor
110740950|NCT01116128|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110740951|NCT01116128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110740953|NCT03390166|Immunologic Factors|immunologic factors|mesh-ancestor
110740954|NCT03390166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110740955|NCT01116206|Prucalopride|prucalopride|mesh-list
110740956|NCT01116206|Laxatives|laxatives|mesh-ancestor
110740957|NCT01116206|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110740958|NCT01116206|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
110740959|NCT01116206|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110740960|NCT01116206|Serotonin Agents|serotonin agents|mesh-ancestor
110740961|NCT01116206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110146540|NCT02373813|Folic Acid|folic acid|mesh-list
110740962|NCT01116206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110740963|NCT01116206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110740964|NCT01210976|Simendan|simendan|mesh-list
110740965|NCT01210976|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110740966|NCT01210976|Vasodilator Agents|vasodilator agents|mesh-ancestor
110740967|NCT01210976|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110740968|NCT01210976|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110740969|NCT01210976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110740970|NCT01210976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110740971|NCT01210976|Protective Agents|protective agents|mesh-ancestor
110740972|NCT01210976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110740973|NCT03828539|Topiramate|topiramate|mesh-list
110740974|NCT03828539|Erenumab|erenumab|mesh-list
110740975|NCT03828539|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110740976|NCT03828539|Anticonvulsants|anticonvulsants|mesh-ancestor
110740977|NCT03828539|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110740978|NCT03828539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110740979|NCT03828539|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
110740980|NCT03828539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110740981|NCT03828539|Analgesics|analgesics|mesh-ancestor
110740982|NCT03828539|Sensory System Agents|sensory system agents|mesh-ancestor
110740983|NCT03828539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110740984|NCT03828539|Immunologic Factors|immunologic factors|mesh-ancestor
110740985|NCT01109888|Cetrorelix|cetrorelix|mesh-list
110740986|NCT01109888|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110740987|NCT01109888|Fertility Agents|fertility agents|mesh-ancestor
110740988|NCT01109888|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110740989|NCT01109888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110740990|NCT01109888|Hormone Antagonists|hormone antagonists|mesh-ancestor
110740991|NCT01109888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110740992|NCT03336502|Posaconazole|posaconazole|mesh-list
110740993|NCT03336502|Antifungal Agents|antifungal agents|mesh-ancestor
110865385|NCT04844528|Niacin|niacin|mesh-list
110740994|NCT03336502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110740995|NCT03336502|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
110740996|NCT03336502|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110740997|NCT03336502|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110740998|NCT03336502|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110740999|NCT03336502|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110741000|NCT03336502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110741001|NCT03336502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110741002|NCT03336502|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110741003|NCT03336502|Hormone Antagonists|hormone antagonists|mesh-ancestor
110741004|NCT03336502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110741005|NCT03336502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110741006|NCT01325051|Raltegravir Potassium|raltegravir potassium|mesh-list
110741007|NCT01325051|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110741008|NCT01325051|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110741009|NCT01325051|Antiviral Agents|antiviral agents|mesh-ancestor
110741010|NCT01325051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110741011|NCT01325051|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110741012|NCT01325051|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110741013|NCT01325051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110741014|NCT01325051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110741015|NCT01055405|Sildenafil Citrate|sildenafil citrate|mesh-list
110741016|NCT01055405|Vasodilator Agents|vasodilator agents|mesh-ancestor
110741017|NCT01055405|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110741018|NCT01055405|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110741019|NCT01055405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110741020|NCT01055405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110741021|NCT01055405|Urological Agents|urological agents|mesh-ancestor
110741022|NCT01055483|Panobinostat|panobinostat|mesh-list
110741023|NCT01055483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110741024|NCT01055483|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110741025|NCT01055483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110741026|NCT01055483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110741027|NCT03370510|Oxytocin|oxytocin|mesh-list
110741028|NCT03370510|Oxytocics|oxytocics|mesh-ancestor
110741029|NCT03370510|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110741030|NCT03370510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110741031|NCT03985865|Quinine|quinine|mesh-list
110741032|NCT03985865|Denatonium|denatonium|mesh-list
110741033|NCT03985865|Antimalarials|antimalarials|mesh-ancestor
110741034|NCT03985865|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110741035|NCT03985865|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110741036|NCT03985865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110741037|NCT03985865|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110741038|NCT03985865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110741039|NCT03985865|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110741040|NCT03985865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110741041|NCT03985865|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110741042|NCT03985865|Analgesics|analgesics|mesh-ancestor
110741043|NCT03985865|Sensory System Agents|sensory system agents|mesh-ancestor
110741044|NCT03985865|Aversive Agents|aversive agents|mesh-ancestor
110741045|NCT03985865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110741046|NCT03985865|Abuse-Deterrent Formulations|abuse-deterrent formulations|mesh-ancestor
110741047|NCT01116596|Acetaminophen|acetaminophen|mesh-list
110741048|NCT01116596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110741049|NCT01116596|Analgesics|analgesics|mesh-ancestor
110741050|NCT01116596|Sensory System Agents|sensory system agents|mesh-ancestor
110741051|NCT01116596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110741052|NCT01116596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110741053|NCT01116596|Antipyretics|antipyretics|mesh-ancestor
110741054|NCT00351611|Pregabalin|pregabalin|mesh-list
110741055|NCT00351611|Analgesics|analgesics|mesh-ancestor
110741056|NCT00351611|Sensory System Agents|sensory system agents|mesh-ancestor
110741057|NCT00351611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110741058|NCT00351611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110741059|NCT00351611|Anticonvulsants|anticonvulsants|mesh-ancestor
110741060|NCT00351611|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110741061|NCT00351611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110741062|NCT00351611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110741063|NCT00351611|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110741064|NCT00351611|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110741065|NCT00351611|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110741066|NCT00351611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110741067|NCT00351611|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110741068|NCT01211210|Fluorouracil|fluorouracil|mesh-list
110741069|NCT01211210|Oxaliplatin|oxaliplatin|mesh-list
110741070|NCT01211210|Antimetabolites|antimetabolites|mesh-ancestor
110741071|NCT01211210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110741072|NCT01211210|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110741073|NCT01211210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110741074|NCT01211210|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110741075|NCT01211210|Immunologic Factors|immunologic factors|mesh-ancestor
110741076|NCT01211210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110741077|NCT01116830|Antipsychotic Agents|antipsychotic agents|mesh-list
110741078|NCT01116830|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110741079|NCT01116830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110741080|NCT01116830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110741081|NCT01116830|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110741082|NCT01208012|Liraglutide|liraglutide|mesh-list
110741083|NCT01208012|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110741084|NCT01208012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110741085|NCT01208012|Incretins|incretins|mesh-ancestor
110741086|NCT01208012|Hormones|hormones|mesh-ancestor
110741087|NCT01208012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110741088|NCT03939806|Oxytocin|oxytocin|mesh-list
110741089|NCT03939806|Carbetocin|carbetocin|mesh-list
110741090|NCT03939806|Oxytocics|oxytocics|mesh-ancestor
110741091|NCT03939806|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110741092|NCT03939806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110741093|NCT00351377|Mycophenolic Acid|mycophenolic acid|mesh-list
110741094|NCT00351377|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110444884|NCT01140503|Apremilast|apremilast|mesh-list
110741095|NCT00351377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110741096|NCT00351377|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110741097|NCT00351377|Antitubercular Agents|antitubercular agents|mesh-ancestor
110741098|NCT00351377|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110741099|NCT00351377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110741100|NCT00351377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110741101|NCT00351377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110741102|NCT00337727|Dexamethasone|dexamethasone|mesh-list
110741103|NCT00337727|Dexamethasone acetate|dexamethasone acetate|mesh-list
110741104|NCT00337727|Ondansetron|ondansetron|mesh-list
110741105|NCT00337727|Aprepitant|aprepitant|mesh-list
110741106|NCT00337727|Fosaprepitant|fosaprepitant|mesh-list
110741107|NCT00337727|BB 1101|bb 1101|mesh-list
110741108|NCT00337727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110741109|NCT00337727|Antiemetics|antiemetics|mesh-ancestor
110741110|NCT00337727|Autonomic Agents|autonomic agents|mesh-ancestor
110741111|NCT00337727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110741112|NCT00337727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110741113|NCT00337727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110741114|NCT00337727|Glucocorticoids|glucocorticoids|mesh-ancestor
110741115|NCT00337727|Hormones|hormones|mesh-ancestor
110741116|NCT00337727|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110741117|NCT00337727|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110741118|NCT00337727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110741119|NCT00337727|Protease Inhibitors|protease inhibitors|mesh-ancestor
110741120|NCT00337727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110741121|NCT00337727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110741122|NCT00337727|Antipruritics|antipruritics|mesh-ancestor
110741123|NCT00337727|Dermatologic Agents|dermatologic agents|mesh-ancestor
110741124|NCT00337727|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110741125|NCT00337727|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110741126|NCT00337727|Serotonin Agents|serotonin agents|mesh-ancestor
110741127|NCT00337727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110741128|NCT00337727|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110741130|NCT03987893|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
110741131|NCT03987893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110741132|NCT03987893|Laxatives|laxatives|mesh-ancestor
110741133|NCT01208480|Carboplatin|carboplatin|mesh-list
110741134|NCT01208480|Docetaxel|docetaxel|mesh-list
110741135|NCT01208480|Bevacizumab|bevacizumab|mesh-list
110741136|NCT01208480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110741137|NCT01208480|Tubulin Modulators|tubulin modulators|mesh-ancestor
110741138|NCT01208480|Antimitotic Agents|antimitotic agents|mesh-ancestor
110741139|NCT01208480|Mitosis Modulators|mitosis modulators|mesh-ancestor
110741140|NCT01208480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110741141|NCT01208480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110741142|NCT01208480|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110741143|NCT01208480|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110741144|NCT01208480|Growth Substances|growth substances|mesh-ancestor
110741145|NCT01208480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110741146|NCT01208480|Growth Inhibitors|growth inhibitors|mesh-ancestor
110741147|NCT04774120|Propofol|propofol|mesh-list
110741148|NCT04774120|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110741149|NCT04774120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110741150|NCT04774120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110741151|NCT04774120|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110741152|NCT04774120|Anesthetics, General|anesthetics, general|mesh-ancestor
110741153|NCT04774120|Anesthetics|anesthetics|mesh-ancestor
110741154|NCT01117220|Ziprasidone|ziprasidone|mesh-list
110741155|NCT01117220|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110741156|NCT01117220|Serotonin Agents|serotonin agents|mesh-ancestor
110741157|NCT01117220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110741158|NCT01117220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110741159|NCT01117220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110741160|NCT01117220|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110741161|NCT01117220|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110741162|NCT01117220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110741163|NCT01117220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110741164|NCT01117220|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110741165|NCT01117220|Dopamine Agents|dopamine agents|mesh-ancestor
110741166|NCT05236972|Capecitabine|capecitabine|mesh-list
110458910|NCT00878800|Doxorubicin|doxorubicin|mesh-list
110741167|NCT05236972|Oxaliplatin|oxaliplatin|mesh-list
110741168|NCT05236972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110741169|NCT05236972|Antimetabolites|antimetabolites|mesh-ancestor
110741170|NCT05236972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110741171|NCT05236972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110741173|NCT01114100|Antidepressive Agents|antidepressive agents|mesh-ancestor
110741174|NCT01114100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110741175|NCT01114100|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110741176|NCT01114100|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110741177|NCT01114100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110741178|NCT01114100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110741179|NCT01114100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110741180|NCT01114100|Serotonin Agents|serotonin agents|mesh-ancestor
110741181|NCT01114100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110741182|NCT01110590|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
110741183|NCT01110590|Vasodilator Agents|vasodilator agents|mesh-ancestor
110146703|NCT00006081|Paclitaxel|paclitaxel|mesh-list
110741184|NCT01110590|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110741185|NCT01110590|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110741186|NCT01110590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110741187|NCT01110590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110741188|NCT01110590|Urological Agents|urological agents|mesh-ancestor
110741189|NCT01117298|Tadalafil|tadalafil|mesh-list
110741190|NCT01117298|Vasodilator Agents|vasodilator agents|mesh-ancestor
110741191|NCT01117298|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110741192|NCT01117298|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110741193|NCT01117298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110741194|NCT01117298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110741195|NCT01117298|Urological Agents|urological agents|mesh-ancestor
110741196|NCT01117376|Erythromycin|erythromycin|mesh-list
110741197|NCT01117376|Erythromycin Estolate|erythromycin estolate|mesh-list
110741198|NCT01117376|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
110741199|NCT01117376|Erythromycin stearate|erythromycin stearate|mesh-list
110741200|NCT01117376|Methylnaltrexone|methylnaltrexone|mesh-list
110741201|NCT01117376|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110741202|NCT01117376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110741203|NCT01117376|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110741204|NCT01117376|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110741205|NCT01117376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110741206|NCT01117376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110741207|NCT01117376|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110741208|NCT01117376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110741209|NCT01117376|Sensory System Agents|sensory system agents|mesh-ancestor
110741210|NCT01117376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110741211|NCT01213238|Bevacizumab|bevacizumab|mesh-list
110741212|NCT01213238|Capecitabine|capecitabine|mesh-list
110741213|NCT01213238|Oxaliplatin|oxaliplatin|mesh-list
110741214|NCT01213238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110741215|NCT01213238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110741216|NCT01213238|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110741217|NCT01213238|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110741218|NCT01213238|Growth Substances|growth substances|mesh-ancestor
110741219|NCT01213238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110741220|NCT01213238|Growth Inhibitors|growth inhibitors|mesh-ancestor
110741221|NCT01213238|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110741222|NCT01213238|Antimetabolites|antimetabolites|mesh-ancestor
110741223|NCT01213238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110741224|NCT01110824|Carvedilol|carvedilol|mesh-list
110741225|NCT01110824|Enalapril|enalapril|mesh-list
110741226|NCT01110824|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110741227|NCT01110824|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110741228|NCT01110824|Adrenergic Agents|adrenergic agents|mesh-ancestor
110741229|NCT01110824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110741230|NCT01110824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110741231|NCT01110824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110741232|NCT01110824|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110741233|NCT01110824|Antioxidants|antioxidants|mesh-ancestor
110741234|NCT01110824|Protective Agents|protective agents|mesh-ancestor
110741235|NCT01110824|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110741236|NCT01110824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110741237|NCT01110824|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110741238|NCT01110824|Vasodilator Agents|vasodilator agents|mesh-ancestor
110741239|NCT01110824|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110741240|NCT01110824|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110741241|NCT01110824|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110741242|NCT01110824|Protease Inhibitors|protease inhibitors|mesh-ancestor
110741243|NCT01110824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110741244|NCT03936140|Iloprost|iloprost|mesh-list
110741245|NCT03936140|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110741246|NCT03936140|Vasodilator Agents|vasodilator agents|mesh-ancestor
110741247|NCT01117610|Ropivacaine|ropivacaine|mesh-list
110741248|NCT01117610|Anesthetics, Local|anesthetics, local|mesh-ancestor
110741249|NCT01117610|Anesthetics|anesthetics|mesh-ancestor
110741250|NCT01117610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110741251|NCT01117610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110741252|NCT01117610|Sensory System Agents|sensory system agents|mesh-ancestor
110741253|NCT01117610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110741254|NCT01215890|Risedronic Acid|risedronic acid|mesh-list
110741255|NCT01215890|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110741256|NCT01215890|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110741257|NCT01215890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110741258|NCT01215890|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110741259|NCT01215890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110741260|NCT01215890|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110741261|NCT01213394|Mycophenolic Acid|mycophenolic acid|mesh-list
110741262|NCT01213394|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110741263|NCT01213394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110741264|NCT01213394|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110741265|NCT01213394|Antitubercular Agents|antitubercular agents|mesh-ancestor
110741266|NCT01213394|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110741267|NCT01213394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110741268|NCT01213394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110741269|NCT01213394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110741270|NCT03368170|Mesdopetam|mesdopetam|mesh-list
110741271|NCT03368170|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110741272|NCT03368170|Dopamine Agents|dopamine agents|mesh-ancestor
110741273|NCT03368170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110741274|NCT03368170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110741275|NCT03368170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110741276|NCT01121744|Sirolimus|sirolimus|mesh-list
110741277|NCT01121744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110146754|NCT00006114|Tubulin Modulators|tubulin modulators|mesh-ancestor
110741278|NCT01121744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110741279|NCT01121744|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110741280|NCT01121744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110741281|NCT01121744|Antifungal Agents|antifungal agents|mesh-ancestor
110741282|NCT01121744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110741283|NCT01121744|Immunologic Factors|immunologic factors|mesh-ancestor
110741284|NCT01121744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110741285|NCT01121822|Vaccines|vaccines|mesh-list
110741286|NCT01121822|Immunologic Factors|immunologic factors|mesh-ancestor
110741287|NCT01121822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110741288|NCT01213550|Chlorhexidine|chlorhexidine|mesh-list
110741289|NCT01213550|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110741290|NCT01213550|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110741291|NCT01213550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110741292|NCT01213550|Disinfectants|disinfectants|mesh-ancestor
110741293|NCT01213550|Dermatologic Agents|dermatologic agents|mesh-ancestor
110741294|NCT01213784|Hypoglycemic Agents|hypoglycemic agents|mesh-list
110741295|NCT01213784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110741296|NCT01216046|Ivacaftor|ivacaftor|mesh-list
110741297|NCT01216046|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
110741298|NCT01216046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110741299|NCT01216046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110741300|NCT01216124|Docetaxel|docetaxel|mesh-list
110741301|NCT01216124|Oxaliplatin|oxaliplatin|mesh-list
110741302|NCT01216124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110741303|NCT01216124|Tubulin Modulators|tubulin modulators|mesh-ancestor
110741304|NCT01216124|Antimitotic Agents|antimitotic agents|mesh-ancestor
110741305|NCT01216124|Mitosis Modulators|mitosis modulators|mesh-ancestor
110741306|NCT01216124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110741307|NCT01219010|Siltuximab|siltuximab|mesh-list
110741308|NCT01219010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110741309|NCT01118234|Rituximab|rituximab|mesh-list
110741310|NCT01118234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110741311|NCT01118234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110741312|NCT01118234|Immunologic Factors|immunologic factors|mesh-ancestor
110741313|NCT01118234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110741314|NCT01118234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110741315|NCT00324155|Ipilimumab|ipilimumab|mesh-list
110741316|NCT00324155|Dacarbazine|dacarbazine|mesh-list
110741317|NCT00324155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110741318|NCT00324155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110741319|NCT00324155|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110741320|NCT00324155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110741321|NCT00324155|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110741322|NCT00324155|Alkylating Agents|alkylating agents|mesh-ancestor
110741323|NCT03937544|Cyclophosphamide|cyclophosphamide|mesh-list
110741324|NCT03937544|Fludarabine|fludarabine|mesh-list
110741325|NCT03937544|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110741326|NCT03937544|Immunologic Factors|immunologic factors|mesh-ancestor
110741327|NCT03937544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110741328|NCT03937544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110741329|NCT03937544|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110741330|NCT03937544|Alkylating Agents|alkylating agents|mesh-ancestor
110741331|NCT03937544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110741332|NCT03937544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110741333|NCT03937544|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110741334|NCT01122056|Interferons|interferons|mesh-list
110741335|NCT01122056|Interferon beta-1b|interferon beta-1b|mesh-list
110741336|NCT01122056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110741337|NCT01122056|Antiviral Agents|antiviral agents|mesh-ancestor
110741338|NCT01122056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110741339|NCT01122056|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110741340|NCT01122056|Immunologic Factors|immunologic factors|mesh-ancestor
110741341|NCT01122056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110741343|NCT01219088|Bupivacaine|bupivacaine|mesh-list
110741344|NCT01219088|Anesthetics, Local|anesthetics, local|mesh-ancestor
110741345|NCT01219088|Anesthetics|anesthetics|mesh-ancestor
110741346|NCT01219088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110741347|NCT01219088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110741348|NCT01219088|Sensory System Agents|sensory system agents|mesh-ancestor
110741349|NCT01219088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110741350|NCT01219088|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110741351|NCT01219088|Narcotics|narcotics|mesh-ancestor
110741352|NCT01219088|Analgesics|analgesics|mesh-ancestor
110741353|NCT01122134|Artesunate|artesunate|mesh-list
110741354|NCT01122134|Antimalarials|antimalarials|mesh-ancestor
110741355|NCT01122134|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110741356|NCT01122134|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110741357|NCT01122134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110741358|NCT01122134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110741359|NCT01122134|Antiviral Agents|antiviral agents|mesh-ancestor
110741360|NCT01122134|Schistosomicides|schistosomicides|mesh-ancestor
110741361|NCT01122134|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110741362|NCT01122134|Anthelmintics|anthelmintics|mesh-ancestor
110741363|NCT01118702|Methylphenidate|methylphenidate|mesh-list
110741364|NCT01118702|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110741365|NCT01118702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110741366|NCT01118702|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110741367|NCT01118702|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110741368|NCT01118702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110741369|NCT01118702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110741370|NCT01118702|Dopamine Agents|dopamine agents|mesh-ancestor
110741371|NCT01118702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110741372|NCT01118936|Magnesium Hydroxide|magnesium hydroxide|mesh-list
110741373|NCT01118936|Antacids|antacids|mesh-ancestor
110741374|NCT01118936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110741375|NCT01118936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110741376|NCT01119014|Aripiprazole|aripiprazole|mesh-list
110741377|NCT01119014|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110741378|NCT01119014|Antidepressive Agents|antidepressive agents|mesh-ancestor
110741379|NCT01119014|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110741380|NCT01119014|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110741381|NCT01119014|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110741382|NCT01119014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110741383|NCT01119014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110741384|NCT01119014|Dopamine Agonists|dopamine agonists|mesh-ancestor
110741385|NCT01119014|Dopamine Agents|dopamine agents|mesh-ancestor
110741386|NCT01119014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110741387|NCT01119014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110741388|NCT01119014|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110741389|NCT01119014|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110741390|NCT01119014|Serotonin Agents|serotonin agents|mesh-ancestor
110741391|NCT01119014|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110741392|NCT01119014|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110741393|NCT01119014|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110741394|NCT01119014|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110741395|NCT01219244|Resveratrol|resveratrol|mesh-list
110741396|NCT01219244|Antioxidants|antioxidants|mesh-ancestor
110741397|NCT01219244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110741398|NCT01219244|Protective Agents|protective agents|mesh-ancestor
110741399|NCT01219244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110741400|NCT01219244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110741401|NCT01219244|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110741403|NCT01119482|Immunologic Factors|immunologic factors|mesh-ancestor
110741404|NCT01119482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110741405|NCT01119638|Risperidone|risperidone|mesh-list
110741406|NCT01119638|Escitalopram|escitalopram|mesh-list
110741407|NCT01119638|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110741408|NCT01119638|Serotonin Agents|serotonin agents|mesh-ancestor
110741409|NCT01119638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110741410|NCT01119638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110741411|NCT01119638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110741412|NCT01119638|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110741413|NCT01119638|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110741414|NCT01119638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110741415|NCT01119638|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110741416|NCT01119638|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110741417|NCT01119638|Dopamine Agents|dopamine agents|mesh-ancestor
110741418|NCT01119638|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110741419|NCT01119638|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110741420|NCT01119638|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110741421|NCT03338998|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110741422|NCT03338998|Siponimod|siponimod|mesh-list
110741423|NCT03338998|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
110741424|NCT03338998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110741425|NCT03338998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110741426|NCT03338998|Immunologic Factors|immunologic factors|mesh-ancestor
110741427|NCT03338998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110741428|NCT03935984|Calcitonin|calcitonin|mesh-list
110741429|NCT03935984|Salmon calcitonin|salmon calcitonin|mesh-list
110741430|NCT03935984|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
110741431|NCT03935984|Katacalcin|katacalcin|mesh-list
110741432|NCT03935984|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110741433|NCT03935984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110741434|NCT03935984|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110741435|NCT03935984|Vasodilator Agents|vasodilator agents|mesh-ancestor
110741436|NCT01219400|Vildagliptin|vildagliptin|mesh-list
110741437|NCT01219400|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110741438|NCT01219400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110741439|NCT01219400|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110741440|NCT01219400|Protease Inhibitors|protease inhibitors|mesh-ancestor
110741441|NCT01219400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110741442|NCT01219400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110741443|NCT01124630|Leucovorin|leucovorin|mesh-list
110741444|NCT01124630|Fluorouracil|fluorouracil|mesh-list
110741445|NCT01124630|Irinotecan|irinotecan|mesh-list
110741446|NCT01124630|Antimetabolites|antimetabolites|mesh-ancestor
110741447|NCT01124630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110741448|NCT01124630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110741450|NCT01124630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110741451|NCT01124630|Immunologic Factors|immunologic factors|mesh-ancestor
110741452|NCT01124630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110741453|NCT01124630|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110741454|NCT01124630|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110741455|NCT01124630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110741456|NCT01124630|Antidotes|antidotes|mesh-ancestor
110741457|NCT01124630|Protective Agents|protective agents|mesh-ancestor
110741458|NCT01124630|Vitamin B Complex|vitamin b complex|mesh-ancestor
110741459|NCT01124630|Vitamins|vitamins|mesh-ancestor
110741460|NCT01124630|Micronutrients|micronutrients|mesh-ancestor
110741461|NCT05683054|Adalimumab|adalimumab|mesh-list
110741462|NCT05683054|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110741464|NCT05683054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110741465|NCT01120106|Simendan|simendan|mesh-list
110741466|NCT01120106|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110741467|NCT01120106|Vasodilator Agents|vasodilator agents|mesh-ancestor
110741468|NCT01120106|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110741469|NCT01120106|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110741470|NCT01120106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110741471|NCT01120106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110741472|NCT01120106|Protective Agents|protective agents|mesh-ancestor
110741473|NCT01120106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110741474|NCT01122368|Micafungin|micafungin|mesh-list
110741475|NCT01122368|Antifungal Agents|antifungal agents|mesh-ancestor
110741476|NCT01122368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110741477|NCT03338062|Iminodiacetic acid|iminodiacetic acid|mesh-list
110741478|NCT03338062|Chelating Agents|chelating agents|mesh-ancestor
110741479|NCT03338062|Sequestering Agents|sequestering agents|mesh-ancestor
110741480|NCT03338062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110741481|NCT01216826|Everolimus|everolimus|mesh-list
110741482|NCT01216826|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110741483|NCT01216826|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110741484|NCT01216826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110741485|NCT01216826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110741486|NCT01216826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110741487|NCT01216826|Immunologic Factors|immunologic factors|mesh-ancestor
110741488|NCT01216826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110741489|NCT01216826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110741490|NCT01120340|Mesalamine|mesalamine|mesh-list
110741491|NCT01120340|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110741492|NCT01120340|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110741493|NCT01120340|Analgesics|analgesics|mesh-ancestor
110741494|NCT01120340|Sensory System Agents|sensory system agents|mesh-ancestor
110146859|NCT00006174|Letrozole|letrozole|mesh-list
110741495|NCT01120340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110741496|NCT01120340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110865453|NCT05058404|Glucocorticoids|glucocorticoids|mesh-ancestor
110741497|NCT01120340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110741498|NCT01120340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110741500|NCT01214408|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110741501|NCT01214408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110741502|NCT01214408|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110741503|NCT01214408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110741504|NCT01214408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110741505|NCT01214486|Raltegravir Potassium|raltegravir potassium|mesh-list
110741506|NCT01214486|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110741507|NCT01214486|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110741508|NCT01214486|Antiviral Agents|antiviral agents|mesh-ancestor
110741509|NCT01214486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110741510|NCT01214486|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110741511|NCT01214486|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110741512|NCT01214486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110741513|NCT01214486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110741514|NCT01216904|Nicotine|nicotine|mesh-list
110741515|NCT01216904|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110741516|NCT01216904|Autonomic Agents|autonomic agents|mesh-ancestor
110741517|NCT01216904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110741518|NCT01216904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110741519|NCT01216904|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110741520|NCT01216904|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110741521|NCT01216904|Cholinergic Agents|cholinergic agents|mesh-ancestor
110741522|NCT01216904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110741523|NCT01216904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110741524|NCT01125020|Gemcitabine|gemcitabine|mesh-list
110741525|NCT01125020|Doxorubicin|doxorubicin|mesh-list
110741526|NCT01125020|Oxaliplatin|oxaliplatin|mesh-list
110741527|NCT01125020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110741528|NCT01125020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110741529|NCT01125020|Antimetabolites|antimetabolites|mesh-ancestor
110741530|NCT01125020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110741531|NCT01125020|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110741532|NCT01125020|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110741533|NCT01125020|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110741534|NCT01125020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110741535|NCT01312012|Antiviral Agents|antiviral agents|mesh-list
110741536|NCT01312012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110741537|NCT01125254|Amlodipine|amlodipine|mesh-list
110741538|NCT01125254|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110741539|NCT01125254|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110741540|NCT01125254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110741541|NCT01125254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110741542|NCT01125254|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110741543|NCT01125254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110741544|NCT01125254|Vasodilator Agents|vasodilator agents|mesh-ancestor
110741545|NCT03710434|Lansoprazole|lansoprazole|mesh-list
110741546|NCT03710434|Dexlansoprazole|dexlansoprazole|mesh-list
110741547|NCT03710434|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110741548|NCT03710434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110741549|NCT03710434|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110741550|NCT03710434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110741551|NCT03710434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110146872|NCT00006195|Olanzapine|olanzapine|mesh-list
110741552|NCT03706924|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110741553|NCT03706924|Elsulfavirine|elsulfavirine|mesh-list
110741554|NCT03706924|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110741555|NCT03706924|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110741556|NCT03706924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110741557|NCT03706924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110741558|NCT03706924|Antiviral Agents|antiviral agents|mesh-ancestor
110741559|NCT03706924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110741560|NCT03706924|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110741561|NCT03706924|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110741562|NCT05682586|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
110741563|NCT05682586|Antiviral Agents|antiviral agents|mesh-ancestor
110741564|NCT05682586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110741565|NCT01217138|Epinephrine|epinephrine|mesh-list
110741566|NCT01217138|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110741567|NCT01217138|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110741568|NCT01217138|Adrenergic Agents|adrenergic agents|mesh-ancestor
110741569|NCT01217138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110741570|NCT01217138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110741571|NCT01217138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110741572|NCT01217138|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110741573|NCT01217138|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110741574|NCT01217138|Autonomic Agents|autonomic agents|mesh-ancestor
110741575|NCT01217138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110741576|NCT01217138|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110741577|NCT01217138|Respiratory System Agents|respiratory system agents|mesh-ancestor
110741578|NCT01217138|Mydriatics|mydriatics|mesh-ancestor
110741579|NCT01217138|Sympathomimetics|sympathomimetics|mesh-ancestor
110741580|NCT01217138|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110741582|NCT03710356|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110741583|NCT03710356|Hormone Antagonists|hormone antagonists|mesh-ancestor
110741584|NCT03710356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110741585|NCT03710356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110741586|NCT01217294|Morphine|morphine|mesh-list
110741587|NCT01217294|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110741589|NCT01217294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110741590|NCT01217294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110741591|NCT01217294|Analgesics|analgesics|mesh-ancestor
110741592|NCT01217294|Sensory System Agents|sensory system agents|mesh-ancestor
110741593|NCT01217294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110741594|NCT03361228|Pembrolizumab|pembrolizumab|mesh-list
110741595|NCT03361228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110741596|NCT03361228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110741597|NCT03361228|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110741598|NCT03361228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110741599|NCT01121042|Ondansetron|ondansetron|mesh-list
110741600|NCT01121042|Antiemetics|antiemetics|mesh-ancestor
110741601|NCT01121042|Autonomic Agents|autonomic agents|mesh-ancestor
110741602|NCT01121042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110741603|NCT01121042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110741604|NCT01121042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110741605|NCT01121042|Antipruritics|antipruritics|mesh-ancestor
110741606|NCT01121042|Dermatologic Agents|dermatologic agents|mesh-ancestor
110741607|NCT01121042|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110741608|NCT01121042|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110741609|NCT01121042|Serotonin Agents|serotonin agents|mesh-ancestor
110741610|NCT01121042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110741611|NCT01121042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110741612|NCT01121120|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
110741613|NCT01121120|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110741615|NCT01217450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110741616|NCT01217450|Cetuximab|cetuximab|mesh-list
110741617|NCT01217450|Antibodies|antibodies|mesh-list
110741618|NCT01217450|Immunoglobulins|immunoglobulins|mesh-list
110741619|NCT01217450|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110741620|NCT01217450|Immunologic Factors|immunologic factors|mesh-ancestor
110741621|NCT01217450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110741622|NCT01217450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110741623|NCT01219556|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110741624|NCT01219556|Olmesartan|olmesartan|mesh-list
110741625|NCT01219556|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110741626|NCT01219556|Diuretics|diuretics|mesh-ancestor
110741627|NCT01219556|Natriuretic Agents|natriuretic agents|mesh-ancestor
110741628|NCT01219556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110741629|NCT01219556|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110741630|NCT01219556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110741631|NCT01219556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110741632|NCT01219556|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110741633|NCT01219556|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110741634|NCT01121198|Ipragliflozin|ipragliflozin|mesh-list
110741635|NCT01121198|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110741636|NCT01121198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110741637|NCT01121198|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110741638|NCT01121198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110741639|NCT01121276|Insulin|insulin|mesh-list
110865607|NCT02449252|Glucocorticoids|glucocorticoids|mesh-ancestor
110741640|NCT01121276|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110741641|NCT01121276|Insulin Aspart|insulin aspart|mesh-list
110741642|NCT01121276|Insulin, Long-Acting|insulin, long-acting|mesh-list
110741643|NCT01121276|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
110741644|NCT01121276|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110741645|NCT01121276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110741646|NCT05175508|Azacitidine|azacitidine|mesh-list
110741647|NCT05175508|Tretinoin|tretinoin|mesh-list
110741648|NCT05175508|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110741649|NCT05175508|Antimetabolites|antimetabolites|mesh-ancestor
110741650|NCT05175508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110741651|NCT05175508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110741652|NCT05175508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110741653|NCT05175508|Keratolytic Agents|keratolytic agents|mesh-ancestor
110741654|NCT05175508|Dermatologic Agents|dermatologic agents|mesh-ancestor
110741655|NCT01125410|Clindamycin|clindamycin|mesh-list
110741656|NCT01125410|Clindamycin palmitate|clindamycin palmitate|mesh-list
110741657|NCT01125410|Clindamycin phosphate|clindamycin phosphate|mesh-list
110741658|NCT01125410|Dequalinium|dequalinium|mesh-list
110741659|NCT01125410|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110741660|NCT01125410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110741661|NCT01125410|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110741662|NCT01125410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110146902|NCT00006198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110741663|NCT01125410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110741664|NCT01125410|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110741665|NCT01328834|Tacrolimus|tacrolimus|mesh-list
110741666|NCT01328834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110741667|NCT01328834|Immunologic Factors|immunologic factors|mesh-ancestor
110741668|NCT01328834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110741669|NCT01328834|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110741670|NCT01328834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110865626|NCT02444260|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110741671|NCT01328834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110741672|NCT01121354|Cefazolin|cefazolin|mesh-list
110741673|NCT01121354|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110741674|NCT01121354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110741675|NCT01122602|Aspirin|aspirin|mesh-list
110741676|NCT01122602|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110741677|NCT01122602|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110741678|NCT01122602|Analgesics|analgesics|mesh-ancestor
110741679|NCT01122602|Sensory System Agents|sensory system agents|mesh-ancestor
110741680|NCT01122602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110741681|NCT01122602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110741682|NCT01122602|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110741683|NCT01122602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110741684|NCT01122602|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110741685|NCT01122602|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110741686|NCT01122602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110741687|NCT01122602|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110741688|NCT01122602|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110741689|NCT01122602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110741690|NCT01122602|Antipyretics|antipyretics|mesh-ancestor
110741691|NCT03359590|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110741692|NCT03359590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110741693|NCT03359590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110741694|NCT03359590|Incretins|incretins|mesh-ancestor
110741695|NCT03359590|Hormones|hormones|mesh-ancestor
110741696|NCT03359590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110741697|NCT03359590|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110741698|NCT03359590|Protease Inhibitors|protease inhibitors|mesh-ancestor
110741699|NCT03359590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110865669|NCT02448550|Antithrombins|antithrombins|mesh-ancestor
110741700|NCT03359590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110741702|NCT01219712|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110741703|NCT01219712|Vasodilator Agents|vasodilator agents|mesh-ancestor
110741704|NCT01219712|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110741705|NCT01219712|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110741706|NCT01219712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110741707|NCT01219712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110741708|NCT01219712|Protective Agents|protective agents|mesh-ancestor
110146925|NCT00006204|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110741709|NCT01219712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110741710|NCT01215266|Sorafenib|sorafenib|mesh-list
110741711|NCT01215266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110741712|NCT01215266|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110741713|NCT01215266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110741714|NCT01215266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110741715|NCT05682196|Rituximab|rituximab|mesh-list
110741716|NCT05682196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110741717|NCT05682196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110741718|NCT05682196|Immunologic Factors|immunologic factors|mesh-ancestor
110741719|NCT05682196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110741720|NCT05682196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110741721|NCT03936374|Omeprazole|omeprazole|mesh-list
110741722|NCT03936374|Linrodostat|linrodostat|mesh-list
110741723|NCT03936374|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110741724|NCT03936374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110741725|NCT03936374|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110741726|NCT03936374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110741727|NCT03936374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110741728|NCT01125488|Triptorelin Pamoate|triptorelin pamoate|mesh-list
110741729|NCT01125488|Luteolytic Agents|luteolytic agents|mesh-ancestor
110741730|NCT01125488|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110741731|NCT01125488|Contraceptive Agents|contraceptive agents|mesh-ancestor
110865715|NCT03698474|Magnesium Sulfate|magnesium sulfate|mesh-list
110741732|NCT01125488|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110741733|NCT01125488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110741734|NCT01125488|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110741735|NCT01125488|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110741736|NCT01125488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110741737|NCT01215578|Sunitinib|sunitinib|mesh-list
110741738|NCT01215578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110741739|NCT01215578|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110741740|NCT01215578|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110741741|NCT01215578|Growth Substances|growth substances|mesh-ancestor
110741742|NCT01215578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110741743|NCT01215578|Growth Inhibitors|growth inhibitors|mesh-ancestor
110741744|NCT01215578|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110741745|NCT01215578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110741746|NCT01215578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110741747|NCT01120418|Besifloxacin|besifloxacin|mesh-list
110741748|NCT01120418|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110741749|NCT01120418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110741750|NCT01120418|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110741751|NCT01120418|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110741752|NCT01120418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110741753|NCT01120418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110741754|NCT01120418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110741755|NCT05577988|Aspirin|aspirin|mesh-list
110741756|NCT05577988|Clopidogrel|clopidogrel|mesh-list
110741757|NCT05577988|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110741758|NCT05577988|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110741759|NCT05577988|Analgesics|analgesics|mesh-ancestor
110741760|NCT05577988|Sensory System Agents|sensory system agents|mesh-ancestor
110741761|NCT05577988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110741762|NCT05577988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110741763|NCT05577988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110741764|NCT05577988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110741765|NCT05577988|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110741766|NCT05577988|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110741767|NCT05577988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110741768|NCT05577988|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110741769|NCT05577988|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110741770|NCT05577988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110741771|NCT05577988|Antipyretics|antipyretics|mesh-ancestor
110741772|NCT05577988|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110741773|NCT05577988|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110741774|NCT05577988|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110741775|NCT05577988|Purinergic Agents|purinergic agents|mesh-ancestor
110741776|NCT05577988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110741777|NCT01222052|Cyclophosphamide|cyclophosphamide|mesh-list
110741778|NCT01222052|Docetaxel|docetaxel|mesh-list
110741779|NCT01222052|Fluorouracil|fluorouracil|mesh-list
110741780|NCT01222052|Epirubicin|epirubicin|mesh-list
110741781|NCT01222052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110741782|NCT01222052|Immunologic Factors|immunologic factors|mesh-ancestor
110741783|NCT01222052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110741784|NCT01222052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110741785|NCT01222052|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110741786|NCT01222052|Alkylating Agents|alkylating agents|mesh-ancestor
110741787|NCT01222052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110741788|NCT01222052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110741789|NCT01222052|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110741790|NCT01222052|Tubulin Modulators|tubulin modulators|mesh-ancestor
110741791|NCT01222052|Antimitotic Agents|antimitotic agents|mesh-ancestor
110741792|NCT01222052|Mitosis Modulators|mitosis modulators|mesh-ancestor
110741793|NCT01222052|Antimetabolites|antimetabolites|mesh-ancestor
110741794|NCT01222052|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110741795|NCT01222052|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110741796|NCT01222052|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110741797|NCT01222052|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110741798|NCT01222052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110741799|NCT03710044|Cyclosporine|cyclosporine|mesh-list
110741800|NCT03710044|Cyclosporins|cyclosporins|mesh-list
110741801|NCT03710044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110741802|NCT03710044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110741803|NCT03710044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110741804|NCT03710044|Immunologic Factors|immunologic factors|mesh-ancestor
110741805|NCT03710044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110741806|NCT03710044|Antifungal Agents|antifungal agents|mesh-ancestor
110741807|NCT03710044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110741808|NCT03710044|Dermatologic Agents|dermatologic agents|mesh-ancestor
110741809|NCT03710044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110146993|NCT00006240|Hormones|hormones|mesh-ancestor
110741810|NCT03710044|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110741811|NCT03706300|Phenylpropanolamine|phenylpropanolamine|mesh-list
110741812|NCT03706300|Pseudoephedrine|pseudoephedrine|mesh-list
110741813|NCT03706300|Ephedrine|ephedrine|mesh-list
110741814|NCT03706300|Guaifenesin|guaifenesin|mesh-list
110741815|NCT03706300|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
110741816|NCT03706300|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110741817|NCT03706300|Autonomic Agents|autonomic agents|mesh-ancestor
110741818|NCT03706300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110741819|NCT03706300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110741820|NCT03706300|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110741821|NCT03706300|Respiratory System Agents|respiratory system agents|mesh-ancestor
110741822|NCT03706300|Nasal Decongestants|nasal decongestants|mesh-ancestor
110741823|NCT03706300|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110741824|NCT03706300|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110741825|NCT03706300|Sympathomimetics|sympathomimetics|mesh-ancestor
110741826|NCT03706300|Adrenergic Agents|adrenergic agents|mesh-ancestor
110741827|NCT03706300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110741828|NCT03706300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110741829|NCT03706300|Expectorants|expectorants|mesh-ancestor
110741830|NCT03706300|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110741831|NCT03706300|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110741832|NCT03706300|Appetite Depressants|appetite depressants|mesh-ancestor
110741833|NCT03706300|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110741834|NCT05155540|Plasminogen|plasminogen|mesh-list
110741835|NCT05155540|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
110741836|NCT05155540|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110741837|NCT05155540|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110741838|NCT05155540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110741839|NCT01122914|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
110741840|NCT01122914|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110741842|NCT01222442|AZD-3199|azd-3199|mesh-list
110741843|NCT01222442|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110741844|NCT01222442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110741845|NCT01222442|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110741846|NCT01222442|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110741847|NCT01222442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110741848|NCT01222442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110741849|NCT01222442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110741850|NCT01222442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110741851|NCT01222442|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110741852|NCT01222442|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110741853|NCT01222442|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110741854|NCT01222442|Adrenergic Agents|adrenergic agents|mesh-ancestor
110741855|NCT01222442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110741856|NCT03706222|Grazoprevir|grazoprevir|mesh-list
110741857|NCT03706222|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
110741858|NCT03706222|Antiviral Agents|antiviral agents|mesh-ancestor
110741859|NCT03706222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110741860|NCT01222676|Gemcitabine|gemcitabine|mesh-list
110741861|NCT01222676|Sorafenib|sorafenib|mesh-list
110741862|NCT01222676|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110741863|NCT01222676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110741864|NCT01222676|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110741865|NCT01222676|Antimetabolites|antimetabolites|mesh-ancestor
110741866|NCT01222676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110741867|NCT01222676|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110741868|NCT01222676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110741869|NCT01222676|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110741870|NCT05681728|Paclitaxel|paclitaxel|mesh-list
110741871|NCT05681728|Cyclophosphamide|cyclophosphamide|mesh-list
110741872|NCT05681728|Pembrolizumab|pembrolizumab|mesh-list
110741873|NCT05681728|Epirubicin|epirubicin|mesh-list
110741874|NCT05681728|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110741875|NCT05681728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110741876|NCT05681728|Tubulin Modulators|tubulin modulators|mesh-ancestor
110741877|NCT05681728|Antimitotic Agents|antimitotic agents|mesh-ancestor
110741878|NCT05681728|Mitosis Modulators|mitosis modulators|mesh-ancestor
110741879|NCT05681728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110741880|NCT05681728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110741881|NCT05681728|Immunologic Factors|immunologic factors|mesh-ancestor
110741882|NCT05681728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110741883|NCT05681728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110741884|NCT05681728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110741885|NCT05681728|Alkylating Agents|alkylating agents|mesh-ancestor
110741886|NCT05681728|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110741887|NCT05681728|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110865872|NCT03187912|Riboflavin|riboflavin|mesh-list
110741888|NCT05681728|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110741889|NCT05681728|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110741890|NCT05681728|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110741891|NCT05681728|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110741892|NCT05681728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110741893|NCT03931928|Tamoxifen|tamoxifen|mesh-list
110741894|NCT03931928|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110741895|NCT03931928|Hormone Antagonists|hormone antagonists|mesh-ancestor
110741896|NCT03931928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110741897|NCT03931928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110741898|NCT03931928|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110741899|NCT03931928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110741900|NCT03931928|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110741901|NCT03931928|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110741902|NCT03931928|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110741903|NCT01220102|Adapalene|adapalene|mesh-list
110741904|NCT01220102|Benzoyl Peroxide|benzoyl peroxide|mesh-list
110741905|NCT01220102|Dermatologic Agents|dermatologic agents|mesh-ancestor
110741906|NCT01220102|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110741907|NCT01220102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110741908|NCT01220102|Analgesics|analgesics|mesh-ancestor
110741909|NCT01220102|Sensory System Agents|sensory system agents|mesh-ancestor
110459661|NCT03867188|Bupivacaine|bupivacaine|mesh-list
110741910|NCT01220102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110741911|NCT01220102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110741912|NCT01220102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110741914|NCT05133310|Simvastatin|simvastatin|mesh-list
110741915|NCT05133310|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110741916|NCT05133310|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110741917|NCT05133310|Antimetabolites|antimetabolites|mesh-ancestor
110741918|NCT05133310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110741919|NCT05133310|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110741920|NCT05133310|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110741921|NCT05133310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110741922|NCT04576000|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
110147025|NCT00006252|Fludarabine|fludarabine|mesh-list
110741923|NCT04576000|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110741924|NCT04576000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110741925|NCT04576000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110741926|NCT01222910|Valacyclovir|valacyclovir|mesh-list
110741927|NCT01222910|Antiviral Agents|antiviral agents|mesh-ancestor
110741928|NCT01222910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110741929|NCT04533568|Ibuprofen|ibuprofen|mesh-list
110741930|NCT04533568|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
110741931|NCT04533568|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110741932|NCT04533568|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110741933|NCT04533568|Analgesics|analgesics|mesh-ancestor
110741934|NCT04533568|Sensory System Agents|sensory system agents|mesh-ancestor
110741935|NCT04533568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110741936|NCT04533568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110741937|NCT04533568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110741938|NCT04533568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110741939|NCT04533568|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110741940|NCT04533568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110741941|NCT04533568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110741943|NCT03932864|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110741944|NCT03932864|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110741945|NCT03932864|Antiviral Agents|antiviral agents|mesh-ancestor
110741946|NCT03932864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110741947|NCT05268562|Ketamine|ketamine|mesh-list
110741948|NCT05268562|Propofol|propofol|mesh-list
110741949|NCT05268562|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110741950|NCT05268562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110741951|NCT05268562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110741952|NCT05268562|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110741953|NCT05268562|Anesthetics, General|anesthetics, general|mesh-ancestor
110741954|NCT05268562|Anesthetics|anesthetics|mesh-ancestor
110741955|NCT05268562|Analgesics|analgesics|mesh-ancestor
110741956|NCT05268562|Sensory System Agents|sensory system agents|mesh-ancestor
110741957|NCT05268562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110741958|NCT05268562|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110741959|NCT05268562|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110741960|NCT05268562|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110741961|NCT05268562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110741962|NCT05268562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110741963|NCT05245552|Vaccines|vaccines|mesh-list
110741964|NCT05245552|Immunologic Factors|immunologic factors|mesh-ancestor
110741965|NCT05245552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110741966|NCT01312324|Docetaxel|docetaxel|mesh-list
110741967|NCT01312324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110741968|NCT01312324|Tubulin Modulators|tubulin modulators|mesh-ancestor
110741969|NCT01312324|Antimitotic Agents|antimitotic agents|mesh-ancestor
110741970|NCT01312324|Mitosis Modulators|mitosis modulators|mesh-ancestor
110741971|NCT01312324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110741972|NCT05482516|Bevacizumab|bevacizumab|mesh-list
110741974|NCT05482516|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110741975|NCT05482516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110741976|NCT05482516|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110741977|NCT05482516|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110741978|NCT05482516|Growth Substances|growth substances|mesh-ancestor
110741979|NCT05482516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110741980|NCT05482516|Growth Inhibitors|growth inhibitors|mesh-ancestor
110741981|NCT05482516|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110741982|NCT05482516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110741983|NCT01127594|Temozolomide|temozolomide|mesh-list
110741984|NCT01127594|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110741986|NCT01127594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110741987|NCT01127594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110741988|NCT01127672|Betamethasone|betamethasone|mesh-list
110741989|NCT01127672|Lidocaine|lidocaine|mesh-list
110741990|NCT01127672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110741991|NCT01127672|Glucocorticoids|glucocorticoids|mesh-ancestor
110741992|NCT01127672|Hormones|hormones|mesh-ancestor
110741993|NCT01127672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110741994|NCT01127672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110741995|NCT01127672|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110741996|NCT01127672|Respiratory System Agents|respiratory system agents|mesh-ancestor
110741997|NCT01127672|Anesthetics, Local|anesthetics, local|mesh-ancestor
110741998|NCT01127672|Anesthetics|anesthetics|mesh-ancestor
110741999|NCT01127672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110742000|NCT01127672|Sensory System Agents|sensory system agents|mesh-ancestor
110742001|NCT01127672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110742002|NCT01127672|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110742003|NCT01127672|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110742004|NCT01127672|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110742005|NCT01127672|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110742006|NCT01127672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110742007|NCT01220258|Azithromycin|azithromycin|mesh-list
110742008|NCT01220258|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110742009|NCT01220258|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110742010|NCT01220258|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110742011|NCT01220258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110742012|NCT01223534|Isoniazid|isoniazid|mesh-list
110742013|NCT01223534|Antitubercular Agents|antitubercular agents|mesh-ancestor
110742014|NCT01223534|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110742015|NCT01223534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110742016|NCT01223534|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
110742017|NCT01223534|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110742018|NCT01223534|Antimetabolites|antimetabolites|mesh-ancestor
110742019|NCT01223534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110147064|NCT00006258|Antimitotic Agents|antimitotic agents|mesh-ancestor
110742020|NCT01223534|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110742021|NCT01223612|Ranibizumab|ranibizumab|mesh-list
110742022|NCT01223612|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110742023|NCT01223612|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110742024|NCT01223612|Growth Substances|growth substances|mesh-ancestor
110742025|NCT01223612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110742026|NCT01223612|Growth Inhibitors|growth inhibitors|mesh-ancestor
110742027|NCT01223612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110742028|NCT01127750|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
110742029|NCT01127750|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
110742030|NCT01127750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110742031|NCT01127750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110742032|NCT01127750|Immunologic Factors|immunologic factors|mesh-ancestor
110742033|NCT01127750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110742034|NCT02946580|Naloxegol|naloxegol|mesh-list
110742035|NCT02946580|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110742036|NCT02946580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110742037|NCT02946580|Sensory System Agents|sensory system agents|mesh-ancestor
110865928|NCT03701984|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110742038|NCT02946580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110742039|NCT01223690|Clarithromycin|clarithromycin|mesh-list
110742040|NCT01223690|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110742041|NCT01223690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110742042|NCT01223690|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110742043|NCT01223690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110742044|NCT01223690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110742045|NCT01223690|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110742046|NCT01223690|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110742047|NCT05381350|Vaccines|vaccines|mesh-list
110742048|NCT05381350|Immunologic Factors|immunologic factors|mesh-ancestor
110742049|NCT05381350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110742050|NCT01223768|Acetylcarnitine|acetylcarnitine|mesh-list
110742051|NCT01223768|Vitamin B Complex|vitamin b complex|mesh-ancestor
110742052|NCT01223768|Vitamins|vitamins|mesh-ancestor
110742053|NCT01223768|Micronutrients|micronutrients|mesh-ancestor
110742054|NCT01223768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110742055|NCT01223768|Nootropic Agents|nootropic agents|mesh-ancestor
110742056|NCT01126112|Panitumumab|panitumumab|mesh-list
110742057|NCT01126112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110742059|NCT05024032|Tirzepatide|tirzepatide|mesh-list
110742060|NCT05024032|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110742061|NCT05024032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110742062|NCT05024032|Incretins|incretins|mesh-ancestor
110742063|NCT05024032|Hormones|hormones|mesh-ancestor
110742064|NCT05024032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110742065|NCT01123538|Chlormadinone Acetate|chlormadinone acetate|mesh-list
110742066|NCT01123538|Progesterone|progesterone|mesh-list
110742067|NCT01123538|Progestins|progestins|mesh-ancestor
110742068|NCT01123538|Hormones|hormones|mesh-ancestor
110742069|NCT01123538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110742070|NCT01123538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110742071|NCT01123538|Androgen Antagonists|androgen antagonists|mesh-ancestor
110742072|NCT01123538|Hormone Antagonists|hormone antagonists|mesh-ancestor
110742073|NCT01123538|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110742074|NCT01123538|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110742075|NCT01123538|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110742076|NCT01123538|Contraceptive Agents|contraceptive agents|mesh-ancestor
110742077|NCT01123538|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110742078|NCT01123538|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110742079|NCT01123538|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110742080|NCT03930992|Zoledronic Acid|zoledronic acid|mesh-list
110742081|NCT03930992|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110742082|NCT03930992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110742083|NCT01220570|Sirolimus|sirolimus|mesh-list
110742084|NCT01220570|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110742085|NCT01220570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110742086|NCT01220570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110742087|NCT01220570|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110742088|NCT01220570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110742089|NCT01220570|Antifungal Agents|antifungal agents|mesh-ancestor
110742090|NCT01220570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110742091|NCT01220570|Immunologic Factors|immunologic factors|mesh-ancestor
110742092|NCT01220570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110742093|NCT04682860|Scopolamine|scopolamine|mesh-list
110742094|NCT04682860|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
110742095|NCT04682860|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110742096|NCT04682860|Antiemetics|antiemetics|mesh-ancestor
110742097|NCT04682860|Autonomic Agents|autonomic agents|mesh-ancestor
110742098|NCT04682860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110742099|NCT04682860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110742100|NCT04682860|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110742101|NCT04682860|Mydriatics|mydriatics|mesh-ancestor
110742102|NCT04682860|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110742103|NCT04682860|Cholinergic Agents|cholinergic agents|mesh-ancestor
110742104|NCT04682860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110742105|NCT04682860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110865966|NCT02439034|Acetaminophen|acetaminophen|mesh-list
110742106|NCT04682860|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110742107|NCT04682860|Parasympatholytics|parasympatholytics|mesh-ancestor
110742108|NCT01127906|Oxycodone|oxycodone|mesh-list
110742109|NCT01127906|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110742110|NCT01127906|Narcotics|narcotics|mesh-ancestor
110742111|NCT01127906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110742112|NCT01127906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110742113|NCT01127906|Analgesics|analgesics|mesh-ancestor
110742114|NCT01127906|Sensory System Agents|sensory system agents|mesh-ancestor
110742115|NCT01127906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110742116|NCT01127984|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
110742117|NCT01127984|Hemostatics|hemostatics|mesh-ancestor
110742118|NCT01127984|Coagulants|coagulants|mesh-ancestor
110742119|NCT01220648|Interferons|interferons|mesh-list
110742121|NCT01220648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110742122|NCT01220648|Antiviral Agents|antiviral agents|mesh-ancestor
110742123|NCT01220648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110742124|NCT01220648|Immunologic Factors|immunologic factors|mesh-ancestor
110742125|NCT01220648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110742126|NCT01218386|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110742127|NCT01218386|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110742128|NCT01218386|Estradiol|estradiol|mesh-list
110742129|NCT01218386|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110742130|NCT01218386|Estrogens|estrogens|mesh-ancestor
110742131|NCT01218386|Hormones|hormones|mesh-ancestor
110742132|NCT01218386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110742133|NCT01218386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110742134|NCT01218386|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110742135|NCT01218386|Contraceptive Agents|contraceptive agents|mesh-ancestor
110147104|NCT00006267|Rubitecan|rubitecan|mesh-list
110742136|NCT01218386|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110742137|NCT01218386|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110742138|NCT03933098|Vaccines|vaccines|mesh-list
110742139|NCT03933098|Immunologic Factors|immunologic factors|mesh-ancestor
110742140|NCT03933098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110742141|NCT05111314|Edetic Acid|edetic acid|mesh-list
110742142|NCT05111314|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
110742143|NCT05111314|Chelating Agents|chelating agents|mesh-ancestor
110742144|NCT05111314|Sequestering Agents|sequestering agents|mesh-ancestor
110742145|NCT05111314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110742146|NCT05111314|Anticoagulants|anticoagulants|mesh-ancestor
110742147|NCT05111314|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110742148|NCT05111314|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110742149|NCT01224314|Dialysis Solutions|dialysis solutions|mesh-list
110742150|NCT01224314|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110742151|NCT01224392|Capecitabine|capecitabine|mesh-list
110742152|NCT01224392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110742153|NCT01224392|Antimetabolites|antimetabolites|mesh-ancestor
110742154|NCT01224392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110742155|NCT01224392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110742156|NCT01224470|Dexmedetomidine|dexmedetomidine|mesh-list
110742157|NCT01224470|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110742158|NCT01224470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110742159|NCT01224470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110742160|NCT01224470|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110742161|NCT01224470|Analgesics|analgesics|mesh-ancestor
110742162|NCT01224470|Sensory System Agents|sensory system agents|mesh-ancestor
110742163|NCT01224470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110742164|NCT01224470|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110742165|NCT01224470|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110742166|NCT01224470|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110742167|NCT01224470|Adrenergic Agents|adrenergic agents|mesh-ancestor
110742168|NCT01224470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110865970|NCT02439034|Analgesics|analgesics|mesh-ancestor
110742169|NCT01224470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110742170|NCT01128218|Aminolevulinic Acid|aminolevulinic acid|mesh-list
110742171|NCT01128218|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110742172|NCT01128218|Dermatologic Agents|dermatologic agents|mesh-ancestor
110742173|NCT03740516|Apremilast|apremilast|mesh-list
110742174|NCT03740516|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110742175|NCT03740516|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110742176|NCT03740516|Analgesics|analgesics|mesh-ancestor
110742177|NCT03740516|Sensory System Agents|sensory system agents|mesh-ancestor
110742178|NCT03740516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110742179|NCT03740516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110742180|NCT03740516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110742181|NCT03740516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110742182|NCT03740516|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
110742183|NCT03740516|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110742184|NCT03740516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110742185|NCT03740516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110742186|NCT03933956|Empagliflozin|empagliflozin|mesh-list
110742187|NCT03933956|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110742188|NCT03933956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110742189|NCT03933956|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110742190|NCT03933956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110742191|NCT01218620|Tolbutamide|tolbutamide|mesh-list
110742192|NCT01218620|Rifampin|rifampin|mesh-list
110742193|NCT01218620|Ketoconazole|ketoconazole|mesh-list
110742194|NCT01218620|Midazolam|midazolam|mesh-list
110742195|NCT01218620|Dextromethorphan|dextromethorphan|mesh-list
110742196|NCT01218620|Omeprazole|omeprazole|mesh-list
110742197|NCT01218620|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
110742198|NCT01218620|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-list
110742199|NCT01218620|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110742200|NCT01218620|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110742201|NCT01218620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110742202|NCT01218620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110742203|NCT01218620|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110742204|NCT01218620|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110742205|NCT01218620|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110742206|NCT01218620|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110742207|NCT01218620|Anesthetics, General|anesthetics, general|mesh-ancestor
110742209|NCT01218620|GABA Modulators|gaba modulators|mesh-ancestor
110742210|NCT01218620|GABA Agents|gaba agents|mesh-ancestor
110742211|NCT01218620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110742212|NCT01218620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110742213|NCT01218620|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110742214|NCT01218620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110742215|NCT01218620|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110742216|NCT01218620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110742217|NCT01218620|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110742218|NCT01218620|Antitubercular Agents|antitubercular agents|mesh-ancestor
110742219|NCT01218620|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110742220|NCT01218620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110742221|NCT01218620|Leprostatic Agents|leprostatic agents|mesh-ancestor
110742222|NCT01218620|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110742223|NCT01218620|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110742224|NCT01218620|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110742225|NCT01218620|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110742226|NCT01218620|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110742227|NCT01218620|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110742228|NCT01218620|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110742229|NCT01218620|Antifungal Agents|antifungal agents|mesh-ancestor
110742230|NCT01218620|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110742231|NCT01218620|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110865982|NCT02439034|Narcotics|narcotics|mesh-ancestor
110742232|NCT01218620|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110742233|NCT01218620|Hormone Antagonists|hormone antagonists|mesh-ancestor
110742234|NCT01218620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110742235|NCT01218620|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110742236|NCT01218620|Antitussive Agents|antitussive agents|mesh-ancestor
110742237|NCT01218620|Respiratory System Agents|respiratory system agents|mesh-ancestor
110742238|NCT01218620|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110742239|NCT01218620|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110742240|NCT01218620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110742241|NCT00323297|Bosentan|bosentan|mesh-list
110742242|NCT00323297|Sildenafil Citrate|sildenafil citrate|mesh-list
110742243|NCT00323297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110742244|NCT00323297|Vasodilator Agents|vasodilator agents|mesh-ancestor
110742245|NCT00323297|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110742246|NCT00323297|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110742247|NCT00323297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110742248|NCT00323297|Urological Agents|urological agents|mesh-ancestor
110742249|NCT00323297|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110742250|NCT00323297|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
110742251|NCT01218698|Losartan|losartan|mesh-list
110742252|NCT01218698|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110742253|NCT01218698|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110742254|NCT01218698|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110742255|NCT01218698|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110742256|NCT01218698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110742257|NCT01224860|Losartan|losartan|mesh-list
110742258|NCT01224860|Telmisartan|telmisartan|mesh-list
110742259|NCT01224860|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110742260|NCT01224860|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110742261|NCT01224860|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110742262|NCT01224860|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110742263|NCT01224860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110742264|NCT00323063|Gemcitabine|gemcitabine|mesh-list
110742265|NCT00323063|Imatinib Mesylate|imatinib mesylate|mesh-list
110742266|NCT00323063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110742267|NCT00323063|Antimetabolites|antimetabolites|mesh-ancestor
110742268|NCT00323063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110742269|NCT00323063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110742270|NCT00323063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110742271|NCT00323063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110742272|NCT01328990|Pyrimethamine|pyrimethamine|mesh-list
110742273|NCT01328990|Sulfadoxine|sulfadoxine|mesh-list
110742274|NCT01328990|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
110742275|NCT01328990|Amodiaquine|amodiaquine|mesh-list
110742276|NCT01328990|Antimalarials|antimalarials|mesh-ancestor
110742277|NCT01328990|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110742278|NCT01328990|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110742279|NCT01328990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110742280|NCT01328990|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110742281|NCT01328990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110742282|NCT01328990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110742283|NCT01328990|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110742285|NCT01225094|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110742286|NCT01225094|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110742287|NCT01225094|Analgesics|analgesics|mesh-ancestor
110742288|NCT01225094|Sensory System Agents|sensory system agents|mesh-ancestor
110742289|NCT01225094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110742290|NCT01225094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110742291|NCT01225094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110742292|NCT01225094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110742293|NCT01225094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110742294|NCT01225094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110742295|NCT01225094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110742296|NCT00322049|Vaccines|vaccines|mesh-list
110742297|NCT00322049|Immunologic Factors|immunologic factors|mesh-ancestor
110742298|NCT00322049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110742299|NCT01124240|Temozolomide|temozolomide|mesh-list
110742300|NCT01124240|Procarbazine|procarbazine|mesh-list
110742301|NCT01124240|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110742302|NCT01124240|Alkylating Agents|alkylating agents|mesh-ancestor
110742303|NCT01124240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110742304|NCT01124240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110742305|NCT01124318|Lactulose|lactulose|mesh-list
110742306|NCT01124318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110742307|NCT01221116|Simendan|simendan|mesh-list
110742308|NCT01221116|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110742309|NCT01221116|Vasodilator Agents|vasodilator agents|mesh-ancestor
110742310|NCT01221116|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110742311|NCT01221116|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110742312|NCT01221116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110742313|NCT01221116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110866036|NCT02433652|Vaccines|vaccines|mesh-list
110742314|NCT01221116|Protective Agents|protective agents|mesh-ancestor
110742315|NCT01221116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110742316|NCT03929744|Midazolam|midazolam|mesh-list
110742317|NCT03929744|Atorvastatin|atorvastatin|mesh-list
110742318|NCT03929744|Simvastatin|simvastatin|mesh-list
110742319|NCT03929744|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110742320|NCT03929744|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110742321|NCT03929744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110742322|NCT03929744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110742323|NCT03929744|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110742324|NCT03929744|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110742325|NCT03929744|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110742326|NCT03929744|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110742327|NCT03929744|Anesthetics, General|anesthetics, general|mesh-ancestor
110742328|NCT03929744|Anesthetics|anesthetics|mesh-ancestor
110742329|NCT03929744|GABA Modulators|gaba modulators|mesh-ancestor
110742330|NCT03929744|GABA Agents|gaba agents|mesh-ancestor
110742331|NCT03929744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110742332|NCT03929744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110147194|NCT00005824|Busulfan|busulfan|mesh-list
110742333|NCT03929744|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110742334|NCT03929744|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110742335|NCT03929744|Antimetabolites|antimetabolites|mesh-ancestor
110742336|NCT03929744|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110742337|NCT03929744|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110742338|NCT03929744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110742339|NCT01225406|Tenofovir|tenofovir|mesh-list
110742340|NCT01225406|Antiviral Agents|antiviral agents|mesh-ancestor
110742341|NCT01225406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110742342|NCT01225406|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110742343|NCT01225406|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110742344|NCT01225406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110742345|NCT01225406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110742346|NCT01225406|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110742347|NCT01225406|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110742348|NCT01126814|Imatinib Mesylate|imatinib mesylate|mesh-list
110742349|NCT01126814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110742350|NCT01126814|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110460103|NCT03262116|Pancrelipase|pancrelipase|mesh-list
110742351|NCT01126814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110742352|NCT01126814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110742353|NCT01225484|Ropivacaine|ropivacaine|mesh-list
110742354|NCT01225484|Anesthetics, Local|anesthetics, local|mesh-ancestor
110742355|NCT01225484|Anesthetics|anesthetics|mesh-ancestor
110742356|NCT01225484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110742357|NCT01225484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110742358|NCT01225484|Sensory System Agents|sensory system agents|mesh-ancestor
110742359|NCT01225484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110742360|NCT03928496|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110742361|NCT03928496|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110742362|NCT03928496|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110742363|NCT03928496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110742364|NCT03928496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110742365|NCT03928496|Cholinergic Agents|cholinergic agents|mesh-ancestor
110742366|NCT03928496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110742367|NCT03928496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110742368|NCT03928496|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110742369|NCT03928496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110742370|NCT01128998|Sorafenib|sorafenib|mesh-list
110742371|NCT01128998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110742372|NCT01128998|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110742373|NCT01128998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110742374|NCT01128998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110742375|NCT00321893|Budesonide|budesonide|mesh-list
110742376|NCT00321893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110742377|NCT00321893|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110742378|NCT00321893|Autonomic Agents|autonomic agents|mesh-ancestor
110742379|NCT00321893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110742380|NCT00321893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110742381|NCT00321893|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110742382|NCT00321893|Respiratory System Agents|respiratory system agents|mesh-ancestor
110742383|NCT00321893|Glucocorticoids|glucocorticoids|mesh-ancestor
110742384|NCT00321893|Hormones|hormones|mesh-ancestor
110742385|NCT00321893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110742386|NCT01225874|Cytarabine|cytarabine|mesh-list
110742387|NCT01225874|Dexamethasone|dexamethasone|mesh-list
110742388|NCT01225874|Prednisone|prednisone|mesh-list
110742389|NCT01225874|Methotrexate|methotrexate|mesh-list
110742390|NCT01225874|Vincristine|vincristine|mesh-list
110742391|NCT01225874|Daunorubicin|daunorubicin|mesh-list
110742392|NCT01225874|Asparaginase|asparaginase|mesh-list
110742393|NCT01225874|Pegaspargase|pegaspargase|mesh-list
110742394|NCT01225874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110742395|NCT01225874|Antiemetics|antiemetics|mesh-ancestor
110742396|NCT01225874|Autonomic Agents|autonomic agents|mesh-ancestor
110742397|NCT01225874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110742398|NCT01225874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110742399|NCT01225874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110742400|NCT01225874|Glucocorticoids|glucocorticoids|mesh-ancestor
110742401|NCT01225874|Hormones|hormones|mesh-ancestor
110742402|NCT01225874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110742403|NCT01225874|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110742404|NCT01225874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110742405|NCT01225874|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110742406|NCT01225874|Abortifacient Agents|abortifacient agents|mesh-ancestor
110742407|NCT01225874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110742408|NCT01225874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110742409|NCT01225874|Antimetabolites|antimetabolites|mesh-ancestor
110742410|NCT01225874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110742411|NCT01225874|Dermatologic Agents|dermatologic agents|mesh-ancestor
110742412|NCT01225874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110742413|NCT01225874|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110742414|NCT01225874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110742415|NCT01225874|Immunologic Factors|immunologic factors|mesh-ancestor
110742416|NCT01225874|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110742417|NCT01225874|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110742419|NCT01225874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110742420|NCT01225874|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110742421|NCT01225874|Tubulin Modulators|tubulin modulators|mesh-ancestor
110742422|NCT01225874|Antimitotic Agents|antimitotic agents|mesh-ancestor
110742423|NCT01225874|Mitosis Modulators|mitosis modulators|mesh-ancestor
110742424|NCT01225874|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110460180|NCT01129622|Letrozole|letrozole|mesh-list
110742425|NCT01225874|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110742426|NCT01225874|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110742427|NCT03928340|Metformin|metformin|mesh-list
110742428|NCT03928340|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110742429|NCT03928340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110742430|NCT00371345|Dasatinib|dasatinib|mesh-list
110742431|NCT00371345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110742432|NCT00371345|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110742433|NCT00371345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110742434|NCT00371345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110742435|NCT01226186|Morphine|morphine|mesh-list
110742436|NCT01226186|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110742437|NCT01226186|Narcotics|narcotics|mesh-ancestor
110742438|NCT01226186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110742439|NCT01226186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110742440|NCT01226186|Analgesics|analgesics|mesh-ancestor
110742441|NCT01226186|Sensory System Agents|sensory system agents|mesh-ancestor
110742442|NCT01226186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110742443|NCT01228214|Aspirin|aspirin|mesh-list
110742444|NCT01228214|Amiloride|amiloride|mesh-list
110742445|NCT01228214|Clopidogrel|clopidogrel|mesh-list
110742446|NCT01228214|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110742447|NCT01228214|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110742448|NCT01228214|Analgesics|analgesics|mesh-ancestor
110742449|NCT01228214|Sensory System Agents|sensory system agents|mesh-ancestor
110742450|NCT01228214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110742451|NCT01228214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110742452|NCT01228214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110742453|NCT01228214|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110742454|NCT01228214|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110742455|NCT01228214|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110742456|NCT01228214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110742457|NCT01228214|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110742458|NCT01228214|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110742459|NCT01228214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110742460|NCT01228214|Antipyretics|antipyretics|mesh-ancestor
110742461|NCT01228214|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110742462|NCT01228214|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110742463|NCT01228214|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110742464|NCT01228214|Purinergic Agents|purinergic agents|mesh-ancestor
110742465|NCT01228214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110742466|NCT01228214|Diuretics|diuretics|mesh-ancestor
110742467|NCT01228214|Natriuretic Agents|natriuretic agents|mesh-ancestor
110742468|NCT01228214|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
110742469|NCT01228214|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110742470|NCT01228214|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110742471|NCT01228214|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
110742472|NCT01228214|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110742473|NCT00321737|Dexlansoprazole|dexlansoprazole|mesh-list
110742474|NCT00321737|Lansoprazole|lansoprazole|mesh-list
110742475|NCT00321737|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110866087|NCT02441530|Antioxidants|antioxidants|mesh-ancestor
110742476|NCT00321737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110742477|NCT00321737|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110742479|NCT00321737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110742480|NCT03928262|Benralizumab|benralizumab|mesh-list
110742481|NCT03928262|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110742482|NCT03928262|Respiratory System Agents|respiratory system agents|mesh-ancestor
110742483|NCT03740438|Chrysarobin|chrysarobin|mesh-list
110742484|NCT03740438|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110742485|NCT03740438|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110742486|NCT03740438|Analgesics|analgesics|mesh-ancestor
110742487|NCT03740438|Sensory System Agents|sensory system agents|mesh-ancestor
110742488|NCT03740438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110742489|NCT03740438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110742490|NCT03740438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110742491|NCT03740438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110742492|NCT01129154|Panitumumab|panitumumab|mesh-list
110742493|NCT01129154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110742494|NCT01129154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110742495|NCT01047995|Ritonavir|ritonavir|mesh-list
110742496|NCT01047995|Darunavir|darunavir|mesh-list
110742497|NCT01047995|Raltegravir Potassium|raltegravir potassium|mesh-list
110742498|NCT01047995|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110742499|NCT01047995|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110742500|NCT01047995|Protease Inhibitors|protease inhibitors|mesh-ancestor
110742501|NCT01047995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110742502|NCT01047995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110742503|NCT01047995|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110742504|NCT01047995|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110742505|NCT01047995|Antiviral Agents|antiviral agents|mesh-ancestor
110742506|NCT01047995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110742507|NCT01047995|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110742508|NCT01047995|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110742509|NCT01047995|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110742510|NCT01047995|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110742511|NCT01129310|Capecitabine|capecitabine|mesh-list
110742512|NCT01129310|Oxaliplatin|oxaliplatin|mesh-list
110742513|NCT01129310|Irinotecan|irinotecan|mesh-list
110742514|NCT01129310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110742515|NCT01129310|Antimetabolites|antimetabolites|mesh-ancestor
110866097|NCT02433184|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110742516|NCT01129310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110742517|NCT01129310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110742518|NCT01129310|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110742519|NCT01129310|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110742520|NCT01129310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110742521|NCT01129388|Omeprazole|omeprazole|mesh-list
110742522|NCT01129388|Clopidogrel|clopidogrel|mesh-list
110742523|NCT01129388|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110742524|NCT01129388|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110742525|NCT01129388|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110742526|NCT01129388|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110742527|NCT01129388|Purinergic Agents|purinergic agents|mesh-ancestor
110742528|NCT01129388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110742529|NCT01129388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110742530|NCT01129388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110742531|NCT01129388|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110742532|NCT01129388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110742533|NCT01129388|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110742534|NCT01129388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110742535|NCT01228292|Heparin|heparin|mesh-list
110742536|NCT01228292|Calcium heparin|calcium heparin|mesh-list
110742537|NCT01228292|Anticoagulants|anticoagulants|mesh-ancestor
110742538|NCT01228292|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110742539|NCT01228292|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110742540|NCT01228292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110742541|NCT03924596|Boswellic acid|boswellic acid|mesh-list
110742542|NCT03924596|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110742543|NCT03924596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110742544|NCT03924596|Analgesics|analgesics|mesh-ancestor
110742545|NCT03924596|Sensory System Agents|sensory system agents|mesh-ancestor
110742546|NCT03924596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110742547|NCT03924596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110742548|NCT03924596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110742549|NCT03924596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110742550|NCT00320801|Buprenorphine|buprenorphine|mesh-list
110742551|NCT00320801|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110742552|NCT00320801|Narcotics|narcotics|mesh-ancestor
110742553|NCT00320801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110742554|NCT00320801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110742555|NCT00320801|Analgesics|analgesics|mesh-ancestor
110742556|NCT00320801|Sensory System Agents|sensory system agents|mesh-ancestor
110742557|NCT00320801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110742558|NCT00320801|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110742559|NCT01127204|Lamivudine|lamivudine|mesh-list
110742560|NCT01127204|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110742561|NCT01127204|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110742562|NCT01127204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110742563|NCT01127204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110742564|NCT01127204|Antiviral Agents|antiviral agents|mesh-ancestor
110866164|NCT02436694|BB 1101|bb 1101|mesh-list
110742565|NCT01127204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110742566|NCT01127204|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110742567|NCT01127204|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110742568|NCT01228370|Silodosin|silodosin|mesh-list
110742569|NCT01228370|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110742570|NCT01228370|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110742571|NCT01228370|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110742572|NCT01228370|Adrenergic Agents|adrenergic agents|mesh-ancestor
110742573|NCT01228370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110742574|NCT01228370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110742575|NCT01228370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110742576|NCT01228370|Urological Agents|urological agents|mesh-ancestor
110742577|NCT01221740|Milnacipran|milnacipran|mesh-list
110742578|NCT01221740|Levomilnacipran|levomilnacipran|mesh-list
110742579|NCT01221740|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110742580|NCT01221740|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110742581|NCT01221740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110742582|NCT01221740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110742583|NCT01221740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110147325|NCT00005863|Daunorubicin|daunorubicin|mesh-list
110742584|NCT01221740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110742585|NCT01221740|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110742586|NCT01221740|Analgesics|analgesics|mesh-ancestor
110742587|NCT01221740|Sensory System Agents|sensory system agents|mesh-ancestor
110742588|NCT01221740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110742589|NCT01221740|Antidepressive Agents|antidepressive agents|mesh-ancestor
110742590|NCT01221740|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110742591|NCT00320489|Olanzapine|olanzapine|mesh-list
110742592|NCT00320489|Antiemetics|antiemetics|mesh-ancestor
110742593|NCT00320489|Autonomic Agents|autonomic agents|mesh-ancestor
110742594|NCT00320489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110742595|NCT00320489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110742596|NCT00320489|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110742597|NCT00320489|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110742598|NCT00320489|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110742599|NCT00320489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110742600|NCT00320489|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110742601|NCT00320489|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110742602|NCT00320489|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110742603|NCT00320489|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110742604|NCT00320489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110742605|NCT00320489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110742606|NCT00320489|Serotonin Agents|serotonin agents|mesh-ancestor
110742607|NCT01127282|Vitamins|vitamins|mesh-list
110742608|NCT01127282|Vitamin A|vitamin a|mesh-list
110742609|NCT01127282|Micronutrients|micronutrients|mesh-ancestor
110742610|NCT01127282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110742611|NCT01127360|Bevacizumab|bevacizumab|mesh-list
110742612|NCT01127360|Ranibizumab|ranibizumab|mesh-list
110742613|NCT01127360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110742614|NCT01127360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110742615|NCT01127360|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110742616|NCT01127360|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110742617|NCT01127360|Growth Substances|growth substances|mesh-ancestor
110742618|NCT01127360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110742619|NCT01127360|Growth Inhibitors|growth inhibitors|mesh-ancestor
110742620|NCT01228604|Methylphenidate|methylphenidate|mesh-list
110742621|NCT01228604|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110742622|NCT01228604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110742623|NCT01228604|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110742624|NCT01228604|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110742625|NCT01228604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110742626|NCT01228604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110742627|NCT01228604|Dopamine Agents|dopamine agents|mesh-ancestor
110742628|NCT01228604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110742629|NCT01228682|Tolvaptan|tolvaptan|mesh-list
110742630|NCT01228682|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
110742631|NCT01228682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110742632|NCT01228682|Natriuretic Agents|natriuretic agents|mesh-ancestor
110742633|NCT01228682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110742634|NCT01221896|Choline|choline|mesh-list
110742635|NCT01221896|Lipotropic Agents|lipotropic agents|mesh-ancestor
110742636|NCT01221896|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110742637|NCT01221896|Antimetabolites|antimetabolites|mesh-ancestor
110742638|NCT01221896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110742639|NCT01221896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110742640|NCT01221896|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110742641|NCT01221896|Nootropic Agents|nootropic agents|mesh-ancestor
110742642|NCT03923114|Exenatide|exenatide|mesh-list
110742643|NCT03923114|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110742644|NCT03923114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110742645|NCT03923114|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110742646|NCT03923114|Incretins|incretins|mesh-ancestor
110742647|NCT03923114|Hormones|hormones|mesh-ancestor
110742648|NCT03923114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110742649|NCT00320411|Lapatinib|lapatinib|mesh-list
110742650|NCT00320411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110742651|NCT00320411|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110742652|NCT00320411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110742653|NCT00320411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110742654|NCT01132040|Primidone|primidone|mesh-list
110742655|NCT01132040|Anticonvulsants|anticonvulsants|mesh-ancestor
110742656|NCT01132040|GABA Modulators|gaba modulators|mesh-ancestor
110742657|NCT01132040|GABA Agents|gaba agents|mesh-ancestor
110742658|NCT01132040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110742659|NCT01132040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110742660|NCT01132040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110742661|NCT01226966|Liraglutide|liraglutide|mesh-list
110742662|NCT01226966|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110742663|NCT01226966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110742664|NCT01226966|Incretins|incretins|mesh-ancestor
110742665|NCT01226966|Hormones|hormones|mesh-ancestor
110742666|NCT01226966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110742667|NCT03923036|Cetuximab|cetuximab|mesh-list
110742668|NCT03923036|Panitumumab|panitumumab|mesh-list
110742669|NCT03923036|Aflibercept|aflibercept|mesh-list
110742670|NCT03923036|Capecitabine|capecitabine|mesh-list
110742671|NCT03923036|Irinotecan|irinotecan|mesh-list
110742672|NCT03923036|Antineoplastic Agents|antineoplastic agents|mesh-list
110742673|NCT03923036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110742674|NCT03923036|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110742675|NCT03923036|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110742676|NCT03923036|Growth Substances|growth substances|mesh-ancestor
110742677|NCT03923036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110742678|NCT03923036|Growth Inhibitors|growth inhibitors|mesh-ancestor
110742679|NCT03923036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110742680|NCT03923036|Antimetabolites|antimetabolites|mesh-ancestor
110742681|NCT03923036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110742682|NCT03923036|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110742683|NCT03923036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110742684|NCT03923036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110742685|NCT01129856|Dexamethasone|dexamethasone|mesh-list
110742686|NCT01129856|Citric Acid|citric acid|mesh-list
110742687|NCT01129856|Sodium Citrate|sodium citrate|mesh-list
110742688|NCT01129856|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110742689|NCT01129856|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110742690|NCT01129856|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
110742691|NCT01129856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110742692|NCT01129856|Antiemetics|antiemetics|mesh-ancestor
110742693|NCT01129856|Autonomic Agents|autonomic agents|mesh-ancestor
110742694|NCT01129856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110444920|NCT02744092|Edoxaban|edoxaban|mesh-list
110742695|NCT01129856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110742696|NCT01129856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110742697|NCT01129856|Glucocorticoids|glucocorticoids|mesh-ancestor
110742698|NCT01129856|Hormones|hormones|mesh-ancestor
110742699|NCT01129856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110742700|NCT01129856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110742701|NCT01129856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110742702|NCT01129856|Anticoagulants|anticoagulants|mesh-ancestor
110742703|NCT01129856|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110742704|NCT01129856|Chelating Agents|chelating agents|mesh-ancestor
110742705|NCT01129856|Sequestering Agents|sequestering agents|mesh-ancestor
110742706|NCT01129856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110742707|NCT01129934|Promethazine|promethazine|mesh-list
110742708|NCT01129934|Diphenhydramine|diphenhydramine|mesh-list
110742709|NCT01129934|Morphine|morphine|mesh-list
110742710|NCT01129934|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110742711|NCT01129934|Narcotics|narcotics|mesh-ancestor
110742712|NCT01129934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110742713|NCT01129934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110742714|NCT01129934|Analgesics|analgesics|mesh-ancestor
110742715|NCT01129934|Sensory System Agents|sensory system agents|mesh-ancestor
110742716|NCT01129934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110742717|NCT01129934|Antipruritics|antipruritics|mesh-ancestor
110742718|NCT01129934|Dermatologic Agents|dermatologic agents|mesh-ancestor
110742719|NCT01129934|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110742720|NCT01129934|Histamine Antagonists|histamine antagonists|mesh-ancestor
110742721|NCT01129934|Histamine Agents|histamine agents|mesh-ancestor
110742722|NCT01129934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110742723|NCT01129934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110742724|NCT01129934|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110742725|NCT01129934|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110742726|NCT01129934|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110742727|NCT01129934|Anesthetics, Local|anesthetics, local|mesh-ancestor
110742728|NCT01129934|Anesthetics|anesthetics|mesh-ancestor
110742729|NCT01129934|Antiemetics|antiemetics|mesh-ancestor
110742730|NCT01129934|Autonomic Agents|autonomic agents|mesh-ancestor
110742731|NCT01129934|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110742732|NCT01131572|Acetylcysteine|acetylcysteine|mesh-list
110742733|NCT01131572|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110742734|NCT01131572|Antiviral Agents|antiviral agents|mesh-ancestor
110742735|NCT01131572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110742736|NCT01131572|Expectorants|expectorants|mesh-ancestor
110866291|NCT02435368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110742737|NCT01131572|Respiratory System Agents|respiratory system agents|mesh-ancestor
110742738|NCT01131572|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110742739|NCT01131572|Antioxidants|antioxidants|mesh-ancestor
110742740|NCT01131572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110742741|NCT01131572|Protective Agents|protective agents|mesh-ancestor
110742742|NCT01131572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110742743|NCT01131572|Antidotes|antidotes|mesh-ancestor
110742744|NCT01132196|Valproic Acid|valproic acid|mesh-list
110742745|NCT01132196|Anticonvulsants|anticonvulsants|mesh-ancestor
110742746|NCT01132196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110742747|NCT01132196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110742748|NCT01132196|GABA Agents|gaba agents|mesh-ancestor
110742749|NCT01132196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110742750|NCT01132196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110742751|NCT01132196|Antimanic Agents|antimanic agents|mesh-ancestor
110742752|NCT01132196|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110742753|NCT01132196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110742754|NCT01132196|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110742755|NCT01228994|Baclofen|baclofen|mesh-list
110742756|NCT01228994|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110742757|NCT01228994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110742758|NCT01228994|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110742759|NCT01228994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110742760|NCT01228994|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
110742761|NCT01228994|GABA Agonists|gaba agonists|mesh-ancestor
110742762|NCT01228994|GABA Agents|gaba agents|mesh-ancestor
110742763|NCT01228994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110742764|NCT01228994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110742765|NCT03927170|Metformin|metformin|mesh-list
110742766|NCT03927170|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110742767|NCT03927170|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110742768|NCT03927170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110742769|NCT03927170|Incretins|incretins|mesh-ancestor
110742770|NCT03927170|Hormones|hormones|mesh-ancestor
110742771|NCT03927170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110742772|NCT03927170|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110742773|NCT03927170|Protease Inhibitors|protease inhibitors|mesh-ancestor
110742774|NCT03927170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110742775|NCT03927170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110742777|NCT01227200|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110742778|NCT01227200|Narcotics|narcotics|mesh-ancestor
110742779|NCT01227200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110866338|NCT05103228|Menotropins|menotropins|mesh-list
110742780|NCT01227200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110742781|NCT01227200|Analgesics|analgesics|mesh-ancestor
110742782|NCT01227200|Sensory System Agents|sensory system agents|mesh-ancestor
110742783|NCT01227200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110742784|NCT01227356|Interferons|interferons|mesh-list
110742785|NCT01227356|Imatinib Mesylate|imatinib mesylate|mesh-list
110742786|NCT01227356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110742787|NCT01227356|Antiviral Agents|antiviral agents|mesh-ancestor
110742788|NCT01227356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110742789|NCT01227356|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110742790|NCT01227356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110742791|NCT01227356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110742792|NCT01132352|Levetiracetam|levetiracetam|mesh-list
110742793|NCT01132352|Anticonvulsants|anticonvulsants|mesh-ancestor
110742794|NCT01132352|Nootropic Agents|nootropic agents|mesh-ancestor
110742795|NCT01131728|Naproxen|naproxen|mesh-list
110742796|NCT01131728|Pseudoephedrine|pseudoephedrine|mesh-list
110742797|NCT01131728|Ephedrine|ephedrine|mesh-list
110742798|NCT01131728|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110460548|NCT00666484|Vincristine|vincristine|mesh-list
110742799|NCT01131728|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110742800|NCT01131728|Analgesics|analgesics|mesh-ancestor
110742801|NCT01131728|Sensory System Agents|sensory system agents|mesh-ancestor
110742802|NCT01131728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110742803|NCT01131728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110742804|NCT01131728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110742805|NCT01131728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110742806|NCT01131728|Gout Suppressants|gout suppressants|mesh-ancestor
110742807|NCT01131728|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110742808|NCT01131728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110742809|NCT01131728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110742810|NCT01131728|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110742811|NCT01131728|Autonomic Agents|autonomic agents|mesh-ancestor
110742812|NCT01131728|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110742813|NCT01131728|Respiratory System Agents|respiratory system agents|mesh-ancestor
110742814|NCT01131728|Nasal Decongestants|nasal decongestants|mesh-ancestor
110742815|NCT01131728|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110742816|NCT01131728|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110742817|NCT01131728|Sympathomimetics|sympathomimetics|mesh-ancestor
110742818|NCT01131728|Adrenergic Agents|adrenergic agents|mesh-ancestor
110742819|NCT01131728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110742820|NCT01132586|Cytarabine|cytarabine|mesh-list
110742821|NCT01132586|Lenalidomide|lenalidomide|mesh-list
110742822|NCT01132586|Idarubicin|idarubicin|mesh-list
110742823|NCT01132586|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110742824|NCT01132586|Antimetabolites|antimetabolites|mesh-ancestor
110742825|NCT01132586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110742826|NCT01132586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110742827|NCT01132586|Antiviral Agents|antiviral agents|mesh-ancestor
110742828|NCT01132586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110742829|NCT01132586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110742830|NCT01132586|Immunologic Factors|immunologic factors|mesh-ancestor
110742831|NCT01132586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110742832|NCT01132586|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110742833|NCT01132586|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110742834|NCT01132586|Growth Substances|growth substances|mesh-ancestor
110742835|NCT01132586|Growth Inhibitors|growth inhibitors|mesh-ancestor
110742836|NCT01132586|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110742837|NCT01132586|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110742838|NCT01132586|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110742839|NCT01132586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110742840|NCT01130246|Varespladib methyl|varespladib methyl|mesh-list
110742841|NCT01130246|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
110742842|NCT01130246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110742843|NCT01130246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110742844|NCT03921086|Antihypertensive Agents|antihypertensive agents|mesh-list
110742846|NCT01227590|Lopinavir|lopinavir|mesh-list
110742847|NCT01227590|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110742848|NCT01227590|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110742849|NCT01227590|Protease Inhibitors|protease inhibitors|mesh-ancestor
110742850|NCT01227590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110742851|NCT01227590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110742852|NCT01227590|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110742853|NCT01227590|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110742854|NCT01227590|Antiviral Agents|antiviral agents|mesh-ancestor
110742855|NCT01227590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110742856|NCT01227590|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110742857|NCT01227590|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110742858|NCT03927248|Nivolumab|nivolumab|mesh-list
110742859|NCT03927248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110742860|NCT03927248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110742861|NCT03927248|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110742862|NCT03927248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110742863|NCT03926780|Warfarin|warfarin|mesh-list
110742864|NCT03926780|Rivaroxaban|rivaroxaban|mesh-list
110742865|NCT03926780|Anticoagulants|anticoagulants|mesh-ancestor
110742866|NCT03926780|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110742867|NCT03926780|Antithrombins|antithrombins|mesh-ancestor
110742868|NCT03926780|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110742869|NCT03926780|Protease Inhibitors|protease inhibitors|mesh-ancestor
110742870|NCT03926780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110742871|NCT03926780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110742872|NCT03926936|Fulvestrant|fulvestrant|mesh-list
110742873|NCT03926936|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110742874|NCT03926936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110742875|NCT03926936|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110742876|NCT03926936|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110742877|NCT03926936|Hormone Antagonists|hormone antagonists|mesh-ancestor
110742878|NCT03926936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110742879|NCT03926936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110742880|NCT03920618|Tenofovir|tenofovir|mesh-list
110742881|NCT03920618|Entecavir|entecavir|mesh-list
110742882|NCT03920618|Antiviral Agents|antiviral agents|mesh-ancestor
110742883|NCT03920618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110742884|NCT03920618|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110742885|NCT03920618|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110742886|NCT03920618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110742887|NCT03920618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110742888|NCT03920618|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110742889|NCT03920618|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110742890|NCT01131806|Fluticasone|fluticasone|mesh-list
110742891|NCT01131806|Xhance|xhance|mesh-list
110742892|NCT01131806|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110742893|NCT01131806|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
110742894|NCT01131806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110742895|NCT01131806|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110742896|NCT01131806|Autonomic Agents|autonomic agents|mesh-ancestor
110742898|NCT01131806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110742899|NCT01131806|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110742900|NCT01131806|Respiratory System Agents|respiratory system agents|mesh-ancestor
110742901|NCT01131806|Dermatologic Agents|dermatologic agents|mesh-ancestor
110742902|NCT01131806|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110742903|NCT01131806|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110742904|NCT01131806|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110742905|NCT01131806|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110742906|NCT01131806|Adrenergic Agents|adrenergic agents|mesh-ancestor
110742907|NCT01131806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110742908|NCT01131806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110742909|NCT01131806|Glucocorticoids|glucocorticoids|mesh-ancestor
110742910|NCT01131806|Hormones|hormones|mesh-ancestor
110742911|NCT01131806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110742912|NCT01131806|Sympathomimetics|sympathomimetics|mesh-ancestor
110742914|NCT01229930|Carboplatin|carboplatin|mesh-list
110742915|NCT01229930|Cediranib|cediranib|mesh-list
110742916|NCT01229930|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110742917|NCT01229930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110742918|NCT01229930|Tubulin Modulators|tubulin modulators|mesh-ancestor
110742919|NCT01229930|Antimitotic Agents|antimitotic agents|mesh-ancestor
110742920|NCT01229930|Mitosis Modulators|mitosis modulators|mesh-ancestor
110742921|NCT01229930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110742922|NCT01229930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110742923|NCT01229930|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110742924|NCT03805100|Ranibizumab|ranibizumab|mesh-list
110742925|NCT03805100|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110742926|NCT03805100|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110742927|NCT03805100|Growth Substances|growth substances|mesh-ancestor
110742928|NCT03805100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110742929|NCT03805100|Growth Inhibitors|growth inhibitors|mesh-ancestor
110742930|NCT03805100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110742931|NCT03920150|Vitamin D|vitamin d|mesh-list
110742932|NCT03920150|Ergocalciferols|ergocalciferols|mesh-list
110742933|NCT03920150|Cholecalciferol|cholecalciferol|mesh-list
110742934|NCT03920150|Vitamins|vitamins|mesh-list
110742935|NCT03920150|Micronutrients|micronutrients|mesh-ancestor
110742936|NCT03920150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110742937|NCT03920150|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110742938|NCT03920150|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110742939|NCT01131962|Sclerosing Solutions|sclerosing solutions|mesh-list
110742940|NCT01131962|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110742941|NCT01130324|Telavancin|telavancin|mesh-list
110742942|NCT01130324|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110742943|NCT01130324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110742944|NCT01229774|Diclofenac|diclofenac|mesh-list
110742945|NCT01229774|Etoricoxib|etoricoxib|mesh-list
110742946|NCT01229774|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110742947|NCT01229774|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110742948|NCT01229774|Analgesics|analgesics|mesh-ancestor
110742949|NCT01229774|Sensory System Agents|sensory system agents|mesh-ancestor
110742950|NCT01229774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110742951|NCT01229774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110742952|NCT01229774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110742953|NCT01229774|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110742954|NCT01229774|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110460698|NCT00667108|Antimanic Agents|antimanic agents|mesh-ancestor
110742955|NCT01229774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110742956|NCT01229774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110742957|NCT01229774|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110742959|NCT03918590|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
110742960|NCT03918590|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110742961|NCT03918590|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110742962|NCT03918590|Analgesics|analgesics|mesh-ancestor
110742963|NCT03918590|Sensory System Agents|sensory system agents|mesh-ancestor
110742964|NCT03918590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110742965|NCT03918590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110742966|NCT03918590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110742967|NCT03918590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110742968|NCT03918590|Laxatives|laxatives|mesh-ancestor
110742969|NCT03918590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110742970|NCT00320255|Apixaban|apixaban|mesh-list
110742971|NCT00320255|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110742972|NCT00320255|Antithrombins|antithrombins|mesh-ancestor
110742973|NCT00320255|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110742974|NCT00320255|Protease Inhibitors|protease inhibitors|mesh-ancestor
110742975|NCT00320255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110742976|NCT00320255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110742977|NCT00320255|Anticoagulants|anticoagulants|mesh-ancestor
110742979|NCT01231802|Fluorouracil|fluorouracil|mesh-list
110742980|NCT01231802|Capecitabine|capecitabine|mesh-list
110742981|NCT01231802|Eniluracil|eniluracil|mesh-list
110742982|NCT01231802|Antimetabolites|antimetabolites|mesh-ancestor
110742983|NCT01231802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110742984|NCT01231802|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110742985|NCT01231802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110742986|NCT01231802|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110742987|NCT01231802|Immunologic Factors|immunologic factors|mesh-ancestor
110742988|NCT01231802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110742989|NCT01231802|Antidotes|antidotes|mesh-ancestor
110742990|NCT01231802|Protective Agents|protective agents|mesh-ancestor
110742991|NCT01231802|Vitamin B Complex|vitamin b complex|mesh-ancestor
110742993|NCT01231802|Micronutrients|micronutrients|mesh-ancestor
110742994|NCT01231802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110742995|NCT01329614|Nicotine|nicotine|mesh-list
110742996|NCT01329614|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110742997|NCT01329614|Autonomic Agents|autonomic agents|mesh-ancestor
110742998|NCT01329614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110742999|NCT01329614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110743000|NCT01329614|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110743001|NCT01329614|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110743002|NCT01329614|Cholinergic Agents|cholinergic agents|mesh-ancestor
110743003|NCT01329614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110743004|NCT01329614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110743005|NCT01231880|Piperaquine|piperaquine|mesh-list
110743006|NCT01231880|Artenimol|artenimol|mesh-list
110743007|NCT01231880|Antimalarials|antimalarials|mesh-ancestor
110743008|NCT01231880|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110743009|NCT01231880|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110743010|NCT01231880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110743011|NCT01232036|Metformin|metformin|mesh-list
110743012|NCT01232036|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110743013|NCT01232036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110743014|NCT01130636|Oseltamivir|oseltamivir|mesh-list
110743015|NCT01130636|Antiviral Agents|antiviral agents|mesh-ancestor
110743016|NCT01130636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110743017|NCT01130636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110743018|NCT01130636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110743019|NCT03926156|Warfarin|warfarin|mesh-list
110743020|NCT03926156|Rivaroxaban|rivaroxaban|mesh-list
110743021|NCT03926156|Anticoagulants|anticoagulants|mesh-ancestor
110743022|NCT03926156|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110743023|NCT03926156|Antithrombins|antithrombins|mesh-ancestor
110866472|NCT03691922|Mydriatics|mydriatics|mesh-ancestor
110743024|NCT03926156|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110743025|NCT03926156|Protease Inhibitors|protease inhibitors|mesh-ancestor
110743026|NCT03926156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110743027|NCT03926156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110743028|NCT01134536|Tapentadol|tapentadol|mesh-list
110743029|NCT01134536|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110743030|NCT01134536|Narcotics|narcotics|mesh-ancestor
110743031|NCT01134536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110743032|NCT01134536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110743033|NCT01134536|Analgesics|analgesics|mesh-ancestor
110743034|NCT01134536|Sensory System Agents|sensory system agents|mesh-ancestor
110743035|NCT01134536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110743036|NCT01134536|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110743037|NCT01134536|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110743038|NCT01134536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110743039|NCT01134536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110743040|NCT01134536|Adrenergic Agents|adrenergic agents|mesh-ancestor
110743041|NCT01134536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110743042|NCT01134692|Norfloxacin|norfloxacin|mesh-list
110743043|NCT01134692|Propranolol|propranolol|mesh-list
110743044|NCT01134692|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110743045|NCT01134692|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110743046|NCT01134692|Adrenergic Agents|adrenergic agents|mesh-ancestor
110743047|NCT01134692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110743048|NCT01134692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110743049|NCT01134692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110743050|NCT01134692|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110743051|NCT01134692|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110743052|NCT01134692|Vasodilator Agents|vasodilator agents|mesh-ancestor
110743053|NCT01134692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110743054|NCT01134692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110743055|NCT01134692|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110743056|NCT01134692|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110743057|NCT01134692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110743058|NCT01134692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110743059|NCT01134692|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110743060|NCT01134692|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110743061|NCT01134848|Morphine|morphine|mesh-list
110743062|NCT01134848|Secretin|secretin|mesh-list
110743063|NCT01134848|Neostigmine|neostigmine|mesh-list
110743064|NCT01134848|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110743065|NCT01134848|Narcotics|narcotics|mesh-ancestor
110743066|NCT01134848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110743067|NCT01134848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110743068|NCT01134848|Analgesics|analgesics|mesh-ancestor
110743069|NCT01134848|Sensory System Agents|sensory system agents|mesh-ancestor
110743070|NCT01134848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110743071|NCT01134848|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110743072|NCT01134848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110743073|NCT01134848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110743074|NCT01134848|Cholinergic Agents|cholinergic agents|mesh-ancestor
110743075|NCT01134848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110743076|NCT01134848|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110743077|NCT01134848|Autonomic Agents|autonomic agents|mesh-ancestor
110743078|NCT01134848|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110743079|NCT01134848|Hormones|hormones|mesh-ancestor
110743080|NCT01134848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110743081|NCT03926000|Pregabalin|pregabalin|mesh-list
110743082|NCT03926000|Analgesics|analgesics|mesh-ancestor
110743083|NCT03926000|Sensory System Agents|sensory system agents|mesh-ancestor
110743084|NCT03926000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110743085|NCT03926000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110743086|NCT03926000|Anticonvulsants|anticonvulsants|mesh-ancestor
110743087|NCT03926000|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110743088|NCT03926000|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110743089|NCT03926000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110743090|NCT03926000|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110743091|NCT03926000|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110743092|NCT03926000|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110743093|NCT03926000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110743094|NCT03926000|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110743095|NCT01134926|Misoprostol|misoprostol|mesh-list
110743096|NCT01134926|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110743097|NCT01134926|Abortifacient Agents|abortifacient agents|mesh-ancestor
110743098|NCT01134926|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110743099|NCT01134926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110743100|NCT01134926|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110743101|NCT01134926|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110743102|NCT01134926|Oxytocics|oxytocics|mesh-ancestor
110743103|NCT01228136|Tranexamic Acid|tranexamic acid|mesh-list
110743104|NCT01228136|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110743105|NCT01228136|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110743106|NCT01228136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110743108|NCT01228136|Coagulants|coagulants|mesh-ancestor
110743109|NCT03140176|Sunitinib|sunitinib|mesh-list
110743110|NCT03140176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110743111|NCT03140176|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110743112|NCT03140176|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110743113|NCT03140176|Growth Substances|growth substances|mesh-ancestor
110743114|NCT03140176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110743115|NCT03140176|Growth Inhibitors|growth inhibitors|mesh-ancestor
110743116|NCT03140176|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110743117|NCT03140176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110743118|NCT03140176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110743119|NCT04259164|Mometasone Furoate|mometasone furoate|mesh-list
110743120|NCT04259164|Glycopyrrolate|glycopyrrolate|mesh-list
110743121|NCT04259164|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110743122|NCT04259164|Dermatologic Agents|dermatologic agents|mesh-ancestor
110743123|NCT04259164|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110743124|NCT04259164|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110743125|NCT04259164|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110743126|NCT04259164|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110743127|NCT04259164|Cholinergic Agents|cholinergic agents|mesh-ancestor
110743128|NCT04259164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110743129|NCT04259164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110743130|NCT04259164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110743131|NCT01230476|Cetuximab|cetuximab|mesh-list
110743132|NCT01230476|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110743133|NCT01230476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110743134|NCT01135472|Esomeprazole|esomeprazole|mesh-list
110743135|NCT01135472|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110743136|NCT01135472|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110743137|NCT01135472|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110743138|NCT01135472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110743139|NCT01135472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110743140|NCT01133210|Maraviroc|maraviroc|mesh-list
110743141|NCT01133210|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110743142|NCT01133210|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110743143|NCT01133210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110743144|NCT01133210|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110743145|NCT01133210|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110743146|NCT01133210|Antiviral Agents|antiviral agents|mesh-ancestor
110743147|NCT01133210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110743148|NCT01133210|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
110743149|NCT01135550|Dexamethasone|dexamethasone|mesh-list
110743150|NCT01135550|Dexamethasone acetate|dexamethasone acetate|mesh-list
110743151|NCT01135550|BB 1101|bb 1101|mesh-list
110743152|NCT01135550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110743153|NCT01135550|Antiemetics|antiemetics|mesh-ancestor
110743154|NCT01135550|Autonomic Agents|autonomic agents|mesh-ancestor
110743155|NCT01135550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110743156|NCT01135550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110743157|NCT01135550|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110743158|NCT01135550|Glucocorticoids|glucocorticoids|mesh-ancestor
110743159|NCT01135550|Hormones|hormones|mesh-ancestor
110743160|NCT01135550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110743161|NCT01135550|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110743162|NCT01135550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110147657|NCT00005974|Alvocidib|alvocidib|mesh-list
110743163|NCT01135550|Protease Inhibitors|protease inhibitors|mesh-ancestor
110743164|NCT01135550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110743165|NCT01135550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110743166|NCT05401370|Methylene Blue|methylene blue|mesh-list
110743167|NCT05401370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110743168|NCT05401370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110743169|NCT01131026|Amoxicillin|amoxicillin|mesh-list
110743170|NCT01131026|Levofloxacin|levofloxacin|mesh-list
110743171|NCT01131026|Lansoprazole|lansoprazole|mesh-list
110743172|NCT01131026|Dexlansoprazole|dexlansoprazole|mesh-list
110743173|NCT01131026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110743174|NCT01131026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110743175|NCT01131026|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110743176|NCT01131026|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110743177|NCT01131026|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110460924|NCT04282200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110743178|NCT01131026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110743179|NCT01131026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110743180|NCT01131026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110743182|NCT01131026|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110743183|NCT01131026|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110743184|NCT01131026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110743185|NCT01131026|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110743186|NCT01135628|Nitazoxanide|nitazoxanide|mesh-list
110743187|NCT01135628|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110743188|NCT01135628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110743189|NCT01133366|Warfarin|warfarin|mesh-list
110743190|NCT01133366|Mipomersen|mipomersen|mesh-list
110743191|NCT01133366|Anticoagulants|anticoagulants|mesh-ancestor
110743192|NCT01133366|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110743193|NCT01133366|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110743194|NCT01133366|Antimetabolites|antimetabolites|mesh-ancestor
110743195|NCT01133366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110743196|NCT01133366|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110743197|NCT01232270|Propofol|propofol|mesh-list
110743198|NCT01232270|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110743199|NCT01232270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110743200|NCT01232270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110743201|NCT01232270|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110743202|NCT01232270|Anesthetics, General|anesthetics, general|mesh-ancestor
110743203|NCT01232270|Anesthetics|anesthetics|mesh-ancestor
110743204|NCT05400902|Apatinib|apatinib|mesh-list
110743205|NCT05400902|Tislelizumab|tislelizumab|mesh-list
110743206|NCT05400902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110743207|NCT05400902|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110743208|NCT05400902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110743209|NCT05400902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110743210|NCT05400902|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110743211|NCT01233206|Metformin|metformin|mesh-list
110743212|NCT01233206|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110743213|NCT01233206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110743214|NCT00369941|Tenofovir|tenofovir|mesh-list
110743215|NCT00369941|Emtricitabine|emtricitabine|mesh-list
110743216|NCT00369941|Efavirenz|efavirenz|mesh-list
110743217|NCT00369941|Raltegravir Potassium|raltegravir potassium|mesh-list
110743218|NCT00369941|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110743219|NCT00369941|Antiviral Agents|antiviral agents|mesh-ancestor
110743220|NCT00369941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110743221|NCT00369941|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110743222|NCT00369941|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110743223|NCT00369941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110743224|NCT00369941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110743225|NCT00369941|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110743226|NCT00369941|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110743227|NCT00369941|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110743228|NCT00369941|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110743229|NCT00369941|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110743230|NCT00369941|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110743231|NCT00369941|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110743232|NCT00369941|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110743233|NCT00369941|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110743234|NCT00369941|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110743235|NCT01133444|Finasteride|finasteride|mesh-list
110743236|NCT01133444|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
110743237|NCT01133444|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110743238|NCT01133444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110743239|NCT01133444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110743240|NCT01133444|Hormone Antagonists|hormone antagonists|mesh-ancestor
110743241|NCT01133444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110743242|NCT01133444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110743243|NCT01133444|Urological Agents|urological agents|mesh-ancestor
110743244|NCT01137656|Acetylcholine|acetylcholine|mesh-list
110743245|NCT01137656|Vasodilator Agents|vasodilator agents|mesh-ancestor
110743246|NCT01137656|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110743247|NCT01137656|Cholinergic Agents|cholinergic agents|mesh-ancestor
110743248|NCT01137656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110743249|NCT01137656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110743250|NCT01137656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110743251|NCT00369785|Donepezil|donepezil|mesh-list
110743252|NCT00369785|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110743253|NCT00369785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110743254|NCT00369785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110743255|NCT00369785|Cholinergic Agents|cholinergic agents|mesh-ancestor
110743256|NCT00369785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110743257|NCT00369785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110743258|NCT00369785|Nootropic Agents|nootropic agents|mesh-ancestor
110743259|NCT05476562|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
110743260|NCT05476562|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110743261|NCT05476562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110743262|NCT05476562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110743264|NCT01136252|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110743265|NCT01136252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110743266|NCT01136252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110743267|NCT00369707|Rituximab|rituximab|mesh-list
110743268|NCT00369707|Bortezomib|bortezomib|mesh-list
110743269|NCT00369707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110743270|NCT00369707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110743271|NCT00369707|Immunologic Factors|immunologic factors|mesh-ancestor
110743272|NCT00369707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110743273|NCT00369707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110743274|NCT01232660|Hydroxychloroquine|hydroxychloroquine|mesh-list
110743275|NCT01232660|Antimalarials|antimalarials|mesh-ancestor
110743276|NCT01232660|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110743277|NCT01232660|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110743278|NCT01232660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110743279|NCT01232660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110743280|NCT01232660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110743281|NCT01232660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110743282|NCT01233362|Vaccines|vaccines|mesh-list
110743283|NCT01233362|Immunologic Factors|immunologic factors|mesh-ancestor
110743284|NCT01233362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110743285|NCT01136642|Nicotine|nicotine|mesh-list
110743286|NCT01136642|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110743287|NCT01136642|Autonomic Agents|autonomic agents|mesh-ancestor
110743288|NCT01136642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110068344|NCT01550146|BB 1101|bb 1101|mesh-list
110743289|NCT01136642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110743290|NCT01136642|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110743291|NCT01136642|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110743292|NCT01136642|Cholinergic Agents|cholinergic agents|mesh-ancestor
110743293|NCT01136642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110743294|NCT01136642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110743295|NCT00369629|Gemcitabine|gemcitabine|mesh-list
110743296|NCT00369629|Pemetrexed|pemetrexed|mesh-list
110743297|NCT00369629|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110743298|NCT00369629|Antimetabolites|antimetabolites|mesh-ancestor
110743299|NCT00369629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110743300|NCT00369629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110743301|NCT00369629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110743302|NCT00369629|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110743303|NCT00369629|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110743304|NCT01133600|Vancomycin|vancomycin|mesh-list
110743305|NCT01133600|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110743306|NCT01133600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110743307|NCT01133912|Paclitaxel|paclitaxel|mesh-list
110743308|NCT01133912|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110743309|NCT01133912|Gemcitabine|gemcitabine|mesh-list
110743310|NCT01133912|Lapatinib|lapatinib|mesh-list
110743311|NCT01133912|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110743312|NCT01133912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110743313|NCT01133912|Tubulin Modulators|tubulin modulators|mesh-ancestor
110743314|NCT01133912|Antimitotic Agents|antimitotic agents|mesh-ancestor
110743315|NCT01133912|Mitosis Modulators|mitosis modulators|mesh-ancestor
110743316|NCT01133912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110743317|NCT01133912|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110743318|NCT01133912|Antimetabolites|antimetabolites|mesh-ancestor
110743319|NCT01133912|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110743320|NCT01133912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110743321|NCT05320094|Sorbitol|sorbitol|mesh-list
110743322|NCT05320094|Charcoal|charcoal|mesh-list
110743323|NCT05320094|Antidotes|antidotes|mesh-ancestor
110743324|NCT05320094|Protective Agents|protective agents|mesh-ancestor
110743325|NCT05320094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110743326|NCT05320094|Cathartics|cathartics|mesh-ancestor
110743327|NCT05320094|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110743328|NCT01233752|Morphine|morphine|mesh-list
110743329|NCT01233752|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110743330|NCT01233752|Narcotics|narcotics|mesh-ancestor
110743333|NCT01233752|Analgesics|analgesics|mesh-ancestor
110743334|NCT01233752|Sensory System Agents|sensory system agents|mesh-ancestor
110743335|NCT01233752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110743336|NCT01140620|Ketamine|ketamine|mesh-list
110743337|NCT01140620|Risperidone|risperidone|mesh-list
110743338|NCT01140620|Analgesics|analgesics|mesh-ancestor
110743339|NCT01140620|Sensory System Agents|sensory system agents|mesh-ancestor
110743340|NCT01140620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110743341|NCT01140620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110743342|NCT01140620|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110743343|NCT01140620|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110743344|NCT01140620|Anesthetics, General|anesthetics, general|mesh-ancestor
110743345|NCT01140620|Anesthetics|anesthetics|mesh-ancestor
110743346|NCT01140620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110743347|NCT01140620|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110743348|NCT01140620|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110743349|NCT01140620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110743350|NCT01140620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110743351|NCT01140620|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110743352|NCT01140620|Serotonin Agents|serotonin agents|mesh-ancestor
110743353|NCT01140620|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110743354|NCT01140620|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110743355|NCT01140620|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110743356|NCT01140620|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110743357|NCT01140620|Dopamine Agents|dopamine agents|mesh-ancestor
110743358|NCT03917186|Sevoflurane|sevoflurane|mesh-list
110743359|NCT03917186|Desflurane|desflurane|mesh-list
110743360|NCT03917186|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110743361|NCT03917186|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110743362|NCT03917186|Anesthetics, General|anesthetics, general|mesh-ancestor
110743363|NCT03917186|Anesthetics|anesthetics|mesh-ancestor
110743364|NCT03917186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110743365|NCT03917186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110743369|NCT01140932|Prednisolone|prednisolone|mesh-list
110743370|NCT01140932|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110743371|NCT01140932|Methylprednisolone|methylprednisolone|mesh-list
110743372|NCT01140932|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110743373|NCT01140932|Prednisolone acetate|prednisolone acetate|mesh-list
110743374|NCT01140932|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110743375|NCT01140932|Prednisolone phosphate|prednisolone phosphate|mesh-list
110743376|NCT01140932|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110743377|NCT01140932|Glucocorticoids|glucocorticoids|mesh-ancestor
110743378|NCT01140932|Hormones|hormones|mesh-ancestor
110743379|NCT01140932|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110743380|NCT01140932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110743381|NCT01140932|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110743382|NCT01140932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110743383|NCT01140932|Antiemetics|antiemetics|mesh-ancestor
110743384|NCT01140932|Autonomic Agents|autonomic agents|mesh-ancestor
110743385|NCT01140932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110743386|NCT01140932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110743387|NCT01140932|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110743388|NCT01140932|Protective Agents|protective agents|mesh-ancestor
110743389|NCT01138904|Oxaliplatin|oxaliplatin|mesh-list
110743390|NCT01138904|Irinotecan|irinotecan|mesh-list
110743391|NCT01138904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110743392|NCT01138904|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110743393|NCT01138904|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110743394|NCT01138904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110743395|NCT01138904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110743396|NCT04582448|Insulin|insulin|mesh-list
110743397|NCT04582448|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110743398|NCT04582448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110743399|NCT05280314|Pembrolizumab|pembrolizumab|mesh-list
110743400|NCT05280314|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110743401|NCT05280314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110743402|NCT05280314|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110743403|NCT05280314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110461142|NCT02819856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110743404|NCT01139138|Irinotecan|irinotecan|mesh-list
110743405|NCT01139138|Everolimus|everolimus|mesh-list
110743406|NCT01139138|Panitumumab|panitumumab|mesh-list
110743407|NCT01139138|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110743408|NCT01139138|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110743409|NCT01139138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110743410|NCT01139138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110743411|NCT01139138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110743412|NCT01139138|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110743413|NCT01139138|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110743414|NCT01139138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110743415|NCT01139138|Immunologic Factors|immunologic factors|mesh-ancestor
110743416|NCT01139138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110743417|NCT01139138|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110743418|NCT01134224|Insulin|insulin|mesh-list
110743419|NCT01134224|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110743420|NCT01134224|Insulin Aspart|insulin aspart|mesh-list
110743421|NCT01134224|Insulin, Long-Acting|insulin, long-acting|mesh-list
110743422|NCT01134224|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
110743423|NCT01134224|Biphasic Insulins|biphasic insulins|mesh-list
110743424|NCT01134224|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
110743425|NCT01134224|Insulin, Isophane|insulin, isophane|mesh-list
110743426|NCT01134224|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110743427|NCT01134224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110743428|NCT05308888|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110743429|NCT05308888|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110743430|NCT05308888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110743431|NCT01231490|Naproxen|naproxen|mesh-list
110743432|NCT01231490|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110743433|NCT01231490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110743434|NCT01231490|Analgesics|analgesics|mesh-ancestor
110743435|NCT01231490|Sensory System Agents|sensory system agents|mesh-ancestor
110743436|NCT01231490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110743437|NCT01231490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110743438|NCT01231490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110743440|NCT01231490|Gout Suppressants|gout suppressants|mesh-ancestor
110743441|NCT01231490|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110743442|NCT01231490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110444935|NCT04125121|Propofol|propofol|mesh-list
110743443|NCT01231490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110743445|NCT01141244|Irinotecan|irinotecan|mesh-list
110743446|NCT01141244|Temozolomide|temozolomide|mesh-list
110743447|NCT01141244|Temsirolimus|temsirolimus|mesh-list
110743448|NCT01141244|MTOR Inhibitors|mtor inhibitors|mesh-list
110743449|NCT01141244|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110743450|NCT01141244|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110743451|NCT01141244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110743452|NCT01141244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110743453|NCT01141244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110743454|NCT01141244|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110743455|NCT01141244|Alkylating Agents|alkylating agents|mesh-ancestor
110743456|NCT01141244|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110743457|NCT01141244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110743458|NCT01141244|Immunologic Factors|immunologic factors|mesh-ancestor
110743459|NCT01141244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110743460|NCT01141244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110743461|NCT01141244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110743462|NCT01141244|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110743463|NCT01141244|Antifungal Agents|antifungal agents|mesh-ancestor
110743464|NCT01141322|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
110743465|NCT01141322|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
110743466|NCT01141322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110743467|NCT01141556|Selenium|selenium|mesh-list
110743468|NCT01141556|Antioxidants|antioxidants|mesh-ancestor
110743469|NCT01141556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110743470|NCT01141556|Protective Agents|protective agents|mesh-ancestor
110743471|NCT01141556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110743472|NCT01141556|Trace Elements|trace elements|mesh-ancestor
110743473|NCT01141556|Micronutrients|micronutrients|mesh-ancestor
110743474|NCT01139372|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110743475|NCT01139372|Lubricant Eye Drops|lubricant eye drops|mesh-list
110743476|NCT01139372|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110743477|NCT03638440|Naloxegol|naloxegol|mesh-list
110743478|NCT03638440|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110743479|NCT03638440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110743480|NCT03638440|Sensory System Agents|sensory system agents|mesh-ancestor
110461219|NCT00911859|Immunologic Factors|immunologic factors|mesh-ancestor
110743481|NCT03638440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110743482|NCT01719640|Insulin|insulin|mesh-list
110743483|NCT01719640|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110743484|NCT01719640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110743485|NCT02439658|Sotalol|sotalol|mesh-list
110743486|NCT02439658|Dofetilide|dofetilide|mesh-list
110743487|NCT02439658|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110743488|NCT02439658|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110743489|NCT02439658|Adrenergic Agents|adrenergic agents|mesh-ancestor
110743490|NCT02439658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110743491|NCT02439658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110743492|NCT02439658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110743493|NCT02439658|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110743494|NCT02439658|Sympatholytics|sympatholytics|mesh-ancestor
110743495|NCT02439658|Autonomic Agents|autonomic agents|mesh-ancestor
110743496|NCT02439658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110743497|NCT02439658|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
110743498|NCT02439658|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110743499|NCT05191394|Antibodies|antibodies|mesh-list
110743500|NCT05191394|Immunologic Factors|immunologic factors|mesh-ancestor
110743501|NCT05191394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110743502|NCT04895098|Ezetimibe|ezetimibe|mesh-list
110743503|NCT04895098|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
110743504|NCT04895098|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110743505|NCT04895098|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110743506|NCT04895098|Antimetabolites|antimetabolites|mesh-ancestor
110743507|NCT04895098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110743508|NCT04895098|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110743509|NCT04895098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110743510|NCT00318461|Metformin|metformin|mesh-list
110743511|NCT00318461|Liraglutide|liraglutide|mesh-list
110743512|NCT00318461|Glimepiride|glimepiride|mesh-list
110743513|NCT00318461|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110743514|NCT00318461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110743515|NCT00318461|Incretins|incretins|mesh-ancestor
110743516|NCT00318461|Hormones|hormones|mesh-ancestor
110444936|NCT04125121|Sevoflurane|sevoflurane|mesh-list
110743517|NCT00318461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110743518|NCT00318461|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110743519|NCT00318461|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110743520|NCT00318461|Immunologic Factors|immunologic factors|mesh-ancestor
110743521|NCT01142258|Trazodone|trazodone|mesh-list
110743522|NCT01142258|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110743523|NCT01142258|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110743524|NCT01142258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110743525|NCT01142258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110743526|NCT01142258|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110743527|NCT01142258|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110743528|NCT01142258|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110743529|NCT01142258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110743530|NCT01142258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110743531|NCT01142258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110743532|NCT01142258|Serotonin Agents|serotonin agents|mesh-ancestor
110743533|NCT01142258|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110743534|NCT01142258|Antidepressive Agents|antidepressive agents|mesh-ancestor
110743535|NCT05152940|Ertugliflozin|ertugliflozin|mesh-list
110743536|NCT05152940|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110743537|NCT05152940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110743538|NCT05152940|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110866633|NCT02429596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110743539|NCT05152940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110743541|NCT01139840|Ergocalciferols|ergocalciferols|mesh-list
110743542|NCT01139840|Cholecalciferol|cholecalciferol|mesh-list
110743543|NCT01139840|Vitamins|vitamins|mesh-list
110743544|NCT01139840|Micronutrients|micronutrients|mesh-ancestor
110743545|NCT01139840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110743546|NCT01139840|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110743547|NCT01139840|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110743548|NCT02945410|Vitamin D|vitamin d|mesh-list
110743549|NCT02945410|Calcium|calcium|mesh-list
110743550|NCT02945410|Vitamins|vitamins|mesh-ancestor
110743551|NCT02945410|Micronutrients|micronutrients|mesh-ancestor
110743552|NCT02945410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110743553|NCT02945410|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110743554|NCT02945410|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110743555|NCT03727724|Cetuximab|cetuximab|mesh-list
110743556|NCT03727724|Afatinib|afatinib|mesh-list
110743564|NCT05032508|Anesthetics|anesthetics|mesh-ancestor
110743565|NCT05032508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110743566|NCT05032508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110743567|NCT05032508|Sensory System Agents|sensory system agents|mesh-ancestor
110743568|NCT05032508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110743569|NCT05032508|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110743570|NCT05032508|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110743571|NCT05032508|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110743572|NCT05032508|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110743573|NCT05032508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110743574|NCT01140074|Zinc Sulfate|zinc sulfate|mesh-list
110743575|NCT01140074|Astringents|astringents|mesh-ancestor
110743576|NCT01140074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110743577|NCT01140074|Dermatologic Agents|dermatologic agents|mesh-ancestor
110743586|NCT01142414|Fluorouracil|fluorouracil|mesh-list
110743587|NCT01142414|Panitumumab|panitumumab|mesh-list
110743588|NCT01142414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110743589|NCT01142414|Antimetabolites|antimetabolites|mesh-ancestor
110743590|NCT01142414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110743591|NCT01142414|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110743592|NCT01142414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110743593|NCT01142414|Immunologic Factors|immunologic factors|mesh-ancestor
110743594|NCT01142414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110743595|NCT01142414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110743596|NCT01236482|Oxytocin|oxytocin|mesh-list
110743597|NCT01236482|Ergonovine|ergonovine|mesh-list
110743598|NCT01236482|Oxytocics|oxytocics|mesh-ancestor
110743599|NCT01236482|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110743600|NCT01236482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110743601|NCT01142492|Interferons|interferons|mesh-list
110743602|NCT01142492|Interferon-beta|interferon-beta|mesh-list
110743603|NCT01142492|Interferon beta-1a|interferon beta-1a|mesh-list
110743604|NCT01142492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110743605|NCT01142492|Antiviral Agents|antiviral agents|mesh-ancestor
110743606|NCT01142492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110743607|NCT01142492|Immunologic Factors|immunologic factors|mesh-ancestor
110743608|NCT01142492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110743609|NCT01142492|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110743610|NCT03958474|Remifentanil|remifentanil|mesh-list
110743611|NCT03958474|Oxycodone|oxycodone|mesh-list
110743612|NCT03958474|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110743613|NCT03958474|Narcotics|narcotics|mesh-ancestor
110743614|NCT03958474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110743615|NCT03958474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110743616|NCT03958474|Analgesics|analgesics|mesh-ancestor
110743617|NCT03958474|Sensory System Agents|sensory system agents|mesh-ancestor
110743618|NCT03958474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110743619|NCT01234142|Varenicline|varenicline|mesh-list
110743620|NCT01234142|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110743621|NCT01234142|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110743622|NCT01234142|Cholinergic Agents|cholinergic agents|mesh-ancestor
110743623|NCT01234142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110743624|NCT01234142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110743625|NCT01234142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110743626|NCT01140308|Ubiquinone|ubiquinone|mesh-list
110743627|NCT01140308|Coenzyme Q10|coenzyme q10|mesh-list
110743628|NCT01140308|Micronutrients|micronutrients|mesh-ancestor
110743629|NCT01140308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110743630|NCT01140308|Vitamins|vitamins|mesh-ancestor
110743631|NCT01142648|Glycopyrrolate|glycopyrrolate|mesh-list
110743632|NCT01142648|Neostigmine|neostigmine|mesh-list
110743633|NCT01142648|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110743634|NCT01142648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110743635|NCT01142648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110743636|NCT01142648|Cholinergic Agents|cholinergic agents|mesh-ancestor
110743637|NCT01142648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110743638|NCT01142648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110743639|NCT01142648|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110743640|NCT01142648|Autonomic Agents|autonomic agents|mesh-ancestor
110743641|NCT01142648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110743642|NCT01142648|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110743643|NCT01142648|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110743644|NCT01142648|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110743645|NCT02143726|Everolimus|everolimus|mesh-list
110743646|NCT02143726|Sorafenib|sorafenib|mesh-list
110743647|NCT02143726|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110743648|NCT02143726|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110743649|NCT02143726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110743650|NCT02143726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110743651|NCT02143726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110743652|NCT02143726|Immunologic Factors|immunologic factors|mesh-ancestor
110743653|NCT02143726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110743654|NCT02143726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110743655|NCT03503864|Arsenic Trioxide|arsenic trioxide|mesh-list
110743656|NCT03503864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110743657|NCT02088112|Durvalumab|durvalumab|mesh-list
110743658|NCT02088112|Gefitinib|gefitinib|mesh-list
110743659|NCT02088112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110743660|NCT02088112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110743661|NCT02088112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110743662|NCT02088112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110743663|NCT02088112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110743664|NCT01144910|Methacholine Chloride|methacholine chloride|mesh-list
110743665|NCT01144910|Miotics|miotics|mesh-ancestor
110743666|NCT01144910|Autonomic Agents|autonomic agents|mesh-ancestor
110743667|NCT01144910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110743668|NCT01144910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110743669|NCT01144910|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110743670|NCT01144910|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
110743671|NCT01144910|Respiratory System Agents|respiratory system agents|mesh-ancestor
110147925|NCT00006037|Irinotecan|irinotecan|mesh-list
110743672|NCT01144910|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
110743673|NCT01144910|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110743674|NCT01144910|Cholinergic Agents|cholinergic agents|mesh-ancestor
110743675|NCT01144910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110743676|NCT01144910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110743677|NCT01234298|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
110743678|NCT01234298|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110743679|NCT01234298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110743680|NCT01234298|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110743681|NCT01234298|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110743682|NCT01234298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110743683|NCT01234298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110743684|NCT01234298|Dopamine Agents|dopamine agents|mesh-ancestor
110743685|NCT01234298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110743686|NCT05308342|Hormones|hormones|mesh-list
110743687|NCT05308342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110743688|NCT05308342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110743689|NCT03332212|Empagliflozin|empagliflozin|mesh-list
110743690|NCT03332212|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110743691|NCT03332212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110743692|NCT03332212|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110743693|NCT03332212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110743694|NCT01144988|Bevacizumab|bevacizumab|mesh-list
110743695|NCT01144988|Irinotecan|irinotecan|mesh-list
110743696|NCT01144988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110743697|NCT01144988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110743698|NCT01144988|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110743699|NCT01144988|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110743700|NCT01144988|Growth Substances|growth substances|mesh-ancestor
110743701|NCT01144988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110743702|NCT01144988|Growth Inhibitors|growth inhibitors|mesh-ancestor
110743703|NCT01144988|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110743704|NCT01144988|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110743705|NCT01144988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110461443|NCT00811057|Vasodilator Agents|vasodilator agents|mesh-ancestor
110743706|NCT01144988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110743707|NCT03331666|Evolocumab|evolocumab|mesh-list
110743708|NCT03331666|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
110743709|NCT03331666|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110743710|NCT03331666|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110743711|NCT03331666|Antimetabolites|antimetabolites|mesh-ancestor
110743712|NCT03331666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110743713|NCT03331666|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110743714|NCT03331666|Protease Inhibitors|protease inhibitors|mesh-ancestor
110743715|NCT03331666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110743716|NCT03331666|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110743717|NCT04828538|Vitamin D|vitamin d|mesh-list
110743718|NCT04828538|Vitamins|vitamins|mesh-list
110743719|NCT04828538|Folic Acid|folic acid|mesh-list
110743720|NCT04828538|Vitamin B Complex|vitamin b complex|mesh-list
110743721|NCT04828538|Micronutrients|micronutrients|mesh-ancestor
110147942|NCT00006040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110743722|NCT04828538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110743723|NCT04828538|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110743724|NCT04828538|Hematinics|hematinics|mesh-ancestor
110743725|NCT01145144|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
110743726|NCT01145144|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110743727|NCT01145144|Immunologic Factors|immunologic factors|mesh-ancestor
110743728|NCT01145144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110743729|NCT03638206|Immunomodulating Agents|immunomodulating agents|mesh-list
110743730|NCT03638206|Immunologic Factors|immunologic factors|mesh-ancestor
110743731|NCT03638206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110743732|NCT00566488|Parathyroid Hormone|parathyroid hormone|mesh-list
110743733|NCT00566488|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110743734|NCT00566488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110743735|NCT04943302|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110743736|NCT04943302|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110743737|NCT04943302|Alkylating Agents|alkylating agents|mesh-ancestor
110743738|NCT04943302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110743739|NCT04943302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110743740|NCT01234454|Olanzapine|olanzapine|mesh-list
110743741|NCT01234454|Risperidone|risperidone|mesh-list
110743742|NCT01234454|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110743743|NCT01234454|Serotonin Agents|serotonin agents|mesh-ancestor
110743744|NCT01234454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110743745|NCT01234454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110743746|NCT01234454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110743747|NCT01234454|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110743748|NCT01234454|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110743749|NCT01234454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110743750|NCT01234454|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110743751|NCT01234454|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110743752|NCT01234454|Dopamine Agents|dopamine agents|mesh-ancestor
110743753|NCT01234454|Antiemetics|antiemetics|mesh-ancestor
110743754|NCT01234454|Autonomic Agents|autonomic agents|mesh-ancestor
110743755|NCT01234454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110743756|NCT01234454|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110743757|NCT01234454|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110743758|NCT01234454|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110743759|NCT01234454|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110743760|NCT01145456|Gemcitabine|gemcitabine|mesh-list
110743761|NCT01145456|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
110743762|NCT01145456|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110743763|NCT01145456|Antimetabolites|antimetabolites|mesh-ancestor
110743764|NCT01145456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110743765|NCT01145456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110743766|NCT01145456|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
110743767|NCT01145456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110743768|NCT04939636|Vitamin D|vitamin d|mesh-list
110743769|NCT04939636|Ergocalciferols|ergocalciferols|mesh-list
110743770|NCT04939636|Cholecalciferol|cholecalciferol|mesh-list
110743771|NCT04939636|Vitamins|vitamins|mesh-list
110743772|NCT04939636|Micronutrients|micronutrients|mesh-ancestor
110743773|NCT04939636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110743774|NCT04939636|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110743775|NCT04939636|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110743776|NCT01238276|Cefazolin|cefazolin|mesh-list
110743777|NCT01238276|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110743778|NCT01238276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110743779|NCT01145534|Glyburide|glyburide|mesh-list
110743780|NCT01145534|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110743781|NCT01145534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110743782|NCT01145612|Losartan|losartan|mesh-list
110743783|NCT01145612|Atenolol|atenolol|mesh-list
110743784|NCT01145612|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110743785|NCT01145612|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110743786|NCT01145612|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110743787|NCT01145612|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110743788|NCT01145612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110743789|NCT01145612|Sympatholytics|sympatholytics|mesh-ancestor
110743790|NCT01145612|Autonomic Agents|autonomic agents|mesh-ancestor
110743791|NCT01145612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110743792|NCT01145612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110743793|NCT01145612|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110743794|NCT01145612|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110743795|NCT01145612|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110743796|NCT01145612|Adrenergic Agents|adrenergic agents|mesh-ancestor
110743797|NCT01145612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110743798|NCT05293366|Dermatologic Agents|dermatologic agents|mesh-list
110743799|NCT03621670|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110743800|NCT03621670|Immunologic Factors|immunologic factors|mesh-ancestor
110866776|NCT02452554|Immunotoxins|immunotoxins|mesh-ancestor
110743801|NCT03621670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110743803|NCT01143584|Cabergoline|cabergoline|mesh-list
110743804|NCT01143584|Dopamine Agonists|dopamine agonists|mesh-list
110743805|NCT01143584|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110743806|NCT01143584|Sympathomimetics|sympathomimetics|mesh-ancestor
110743807|NCT01143584|Autonomic Agents|autonomic agents|mesh-ancestor
110743808|NCT01143584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110743809|NCT01143584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110743810|NCT01143584|Dopamine Agents|dopamine agents|mesh-ancestor
110743811|NCT01143584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110743812|NCT01143584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110743813|NCT01143584|Protective Agents|protective agents|mesh-ancestor
110743814|NCT01143584|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110743815|NCT01143584|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110743816|NCT01145846|Cytarabine|cytarabine|mesh-list
110743817|NCT01145846|Daunorubicin|daunorubicin|mesh-list
110743818|NCT01145846|Idarubicin|idarubicin|mesh-list
110743819|NCT01145846|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110743820|NCT01145846|Antimetabolites|antimetabolites|mesh-ancestor
110743821|NCT01145846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110743822|NCT01145846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110743823|NCT01145846|Antiviral Agents|antiviral agents|mesh-ancestor
110743824|NCT01145846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110743825|NCT01145846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110743826|NCT01145846|Immunologic Factors|immunologic factors|mesh-ancestor
110743827|NCT01145846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110743828|NCT01145846|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110743829|NCT01145846|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110743830|NCT01145846|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110743831|NCT01145846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110743832|NCT03134456|Pembrolizumab|pembrolizumab|mesh-list
110743833|NCT03134456|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110743834|NCT03134456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110743835|NCT03134456|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110743836|NCT03134456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110743837|NCT01143662|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110743838|NCT01143662|Antiviral Agents|antiviral agents|mesh-ancestor
110743839|NCT01143662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110743840|NCT05173688|Propofol|propofol|mesh-list
110743841|NCT05173688|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110743842|NCT05173688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110743843|NCT05173688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110743844|NCT05173688|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110743845|NCT05173688|Anesthetics, General|anesthetics, general|mesh-ancestor
110743846|NCT05173688|Anesthetics|anesthetics|mesh-ancestor
110743847|NCT01146548|Fluoxetine|fluoxetine|mesh-list
110743848|NCT01146548|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110743849|NCT01146548|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110743850|NCT01146548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110743851|NCT01146548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110743852|NCT01146548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110743853|NCT01146548|Serotonin Agents|serotonin agents|mesh-ancestor
110461590|NCT00676702|Pancreatin|pancreatin|mesh-list
110743854|NCT01146548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110743855|NCT01146548|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110743856|NCT01146548|Antidepressive Agents|antidepressive agents|mesh-ancestor
110743857|NCT01146548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110743858|NCT01146548|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110743859|NCT01146548|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110743860|NCT01146548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110743861|NCT03478930|Omalizumab|omalizumab|mesh-list
110743862|NCT03478930|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110743863|NCT03478930|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110743864|NCT03478930|Respiratory System Agents|respiratory system agents|mesh-ancestor
110743865|NCT01312714|Vitamin D|vitamin d|mesh-list
110743866|NCT01312714|Cholecalciferol|cholecalciferol|mesh-list
110743867|NCT01312714|Vitamins|vitamins|mesh-ancestor
110743868|NCT01312714|Micronutrients|micronutrients|mesh-ancestor
110743869|NCT01312714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110743870|NCT01312714|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110743871|NCT01312714|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110743872|NCT04188028|Dextromethorphan|dextromethorphan|mesh-list
110743873|NCT04188028|Paroxetine|paroxetine|mesh-list
110743874|NCT04188028|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110743875|NCT04188028|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110743876|NCT04188028|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110743877|NCT04188028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110743878|NCT04188028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110743879|NCT04188028|Serotonin Agents|serotonin agents|mesh-ancestor
110743880|NCT04188028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110743881|NCT04188028|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110743882|NCT04188028|Antidepressive Agents|antidepressive agents|mesh-ancestor
110743883|NCT04188028|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110743884|NCT04188028|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110743885|NCT04188028|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110743886|NCT04188028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110743887|NCT04188028|Antitussive Agents|antitussive agents|mesh-ancestor
110743888|NCT04188028|Respiratory System Agents|respiratory system agents|mesh-ancestor
110743889|NCT04188028|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110743890|NCT04188028|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110743891|NCT01312792|Ampicillin|ampicillin|mesh-list
110743892|NCT01312792|Cephradine|cephradine|mesh-list
110743893|NCT01312792|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110743894|NCT01312792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110743895|NCT03523000|Fentanyl|fentanyl|mesh-list
110743896|NCT03523000|Bupivacaine|bupivacaine|mesh-list
110743897|NCT03523000|Anesthetics, Local|anesthetics, local|mesh-ancestor
110743898|NCT03523000|Anesthetics|anesthetics|mesh-ancestor
110743899|NCT03523000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110743900|NCT03523000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110743901|NCT03523000|Sensory System Agents|sensory system agents|mesh-ancestor
110743902|NCT03523000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110743903|NCT03523000|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110743904|NCT03523000|Narcotics|narcotics|mesh-ancestor
110743905|NCT03523000|Analgesics|analgesics|mesh-ancestor
110148070|NCT05678296|Analgesics|analgesics|mesh-list
110743906|NCT03523000|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110743907|NCT03523000|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110743908|NCT03523000|Anesthetics, General|anesthetics, general|mesh-ancestor
110743909|NCT04705480|Pregabalin|pregabalin|mesh-list
110743911|NCT04705480|Analgesics|analgesics|mesh-ancestor
110743912|NCT04705480|Sensory System Agents|sensory system agents|mesh-ancestor
110743913|NCT04705480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110743914|NCT04705480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110743915|NCT04705480|Anticonvulsants|anticonvulsants|mesh-ancestor
110743916|NCT04705480|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110743917|NCT04705480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110743918|NCT04705480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110743919|NCT04705480|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110743920|NCT04705480|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110743921|NCT04705480|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110743922|NCT04705480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110743923|NCT04705480|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110743924|NCT04705480|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110743925|NCT04705480|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110743926|NCT04705480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110743927|NCT04705480|Antimanic Agents|antimanic agents|mesh-ancestor
110743928|NCT01238978|Vildagliptin|vildagliptin|mesh-list
110743930|NCT01238978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110743931|NCT01238978|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110743932|NCT01238978|Protease Inhibitors|protease inhibitors|mesh-ancestor
110743933|NCT01238978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110743934|NCT01238978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110743935|NCT00318149|Vaccines|vaccines|mesh-list
110743936|NCT00318149|Immunologic Factors|immunologic factors|mesh-ancestor
110743937|NCT00318149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110743938|NCT04648696|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110743939|NCT04648696|Vancomycin|vancomycin|mesh-list
110743940|NCT04648696|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
110743941|NCT04648696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110743942|NCT04648696|Antitubercular Agents|antitubercular agents|mesh-ancestor
110743943|NCT01236716|Paclitaxel|paclitaxel|mesh-list
110743944|NCT01236716|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110743945|NCT01236716|Carboplatin|carboplatin|mesh-list
110743946|NCT01236716|Gemcitabine|gemcitabine|mesh-list
110743947|NCT01236716|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110743948|NCT01236716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110743949|NCT01236716|Tubulin Modulators|tubulin modulators|mesh-ancestor
110743950|NCT01236716|Antimitotic Agents|antimitotic agents|mesh-ancestor
110743951|NCT01236716|Mitosis Modulators|mitosis modulators|mesh-ancestor
110743952|NCT01236716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110743953|NCT01236716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110743954|NCT01236716|Antimetabolites|antimetabolites|mesh-ancestor
110743955|NCT04154800|Itraconazole|itraconazole|mesh-list
110743956|NCT04154800|Diltiazem|diltiazem|mesh-list
110743957|NCT04154800|Antifungal Agents|antifungal agents|mesh-ancestor
110743958|NCT04154800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110743959|NCT04154800|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110743960|NCT04154800|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110743961|NCT04154800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110148078|NCT00006396|Nevirapine|nevirapine|mesh-list
110743962|NCT04154800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110743963|NCT04154800|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110743964|NCT04154800|Hormone Antagonists|hormone antagonists|mesh-ancestor
110743965|NCT04154800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110743966|NCT04154800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110743967|NCT04154800|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110743968|NCT04154800|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110743969|NCT04154800|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110743970|NCT04154800|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110743971|NCT04154800|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110743972|NCT04154800|Vasodilator Agents|vasodilator agents|mesh-ancestor
110743973|NCT01048229|Pramipexole|pramipexole|mesh-list
110743975|NCT01048229|Antioxidants|antioxidants|mesh-ancestor
110743976|NCT01048229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110743977|NCT01048229|Protective Agents|protective agents|mesh-ancestor
110743978|NCT01048229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110743979|NCT01048229|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110743980|NCT01048229|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110743981|NCT01048229|Dopamine Agonists|dopamine agonists|mesh-ancestor
110743982|NCT01048229|Dopamine Agents|dopamine agents|mesh-ancestor
110743983|NCT01048229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110743984|NCT01048229|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
110743985|NCT01048229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110743986|NCT01048229|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110743987|NCT01048307|Polihexanide|polihexanide|mesh-list
110743988|NCT01048307|Betaine|betaine|mesh-list
110743989|NCT01048307|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110743990|NCT01048307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110743991|NCT01048307|Lipotropic Agents|lipotropic agents|mesh-ancestor
110743992|NCT01048307|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110743993|NCT01048307|Antimetabolites|antimetabolites|mesh-ancestor
110743994|NCT01048307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110743995|NCT01048307|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110743996|NCT01048307|Disinfectants|disinfectants|mesh-ancestor
110743997|NCT01048307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110461755|NCT00595582|Curcumin|curcumin|mesh-list
110744008|NCT02049905|Gemcitabine|gemcitabine|mesh-list
110744010|NCT02049905|Doxorubicin|doxorubicin|mesh-list
110744011|NCT02049905|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110744012|NCT02049905|Ifosfamide|ifosfamide|mesh-list
110744013|NCT02049905|Isophosphamide mustard|isophosphamide mustard|mesh-list
110744014|NCT02049905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110744015|NCT02049905|Antimetabolites|antimetabolites|mesh-ancestor
110744016|NCT02049905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110744017|NCT02049905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110744018|NCT02049905|Tubulin Modulators|tubulin modulators|mesh-ancestor
110744019|NCT02049905|Antimitotic Agents|antimitotic agents|mesh-ancestor
110444967|NCT01078974|Antiemetics|antiemetics|mesh-ancestor
110744020|NCT02049905|Mitosis Modulators|mitosis modulators|mesh-ancestor
110744021|NCT02049905|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110744022|NCT02049905|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110744023|NCT02049905|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110744024|NCT02049905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110744025|NCT02049905|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110744026|NCT02049905|Alkylating Agents|alkylating agents|mesh-ancestor
110744027|NCT01062191|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
110744028|NCT01062191|Laxatives|laxatives|mesh-ancestor
110744029|NCT01062191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110744030|NCT01058759|Enoxaparin|enoxaparin|mesh-list
110744031|NCT01058759|Enoxaparin sodium|enoxaparin sodium|mesh-list
110744032|NCT01058759|Anticoagulants|anticoagulants|mesh-ancestor
110744033|NCT01058759|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110744034|NCT01058759|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110744035|NCT01058759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110744036|NCT01239368|Sirolimus|sirolimus|mesh-list
110744037|NCT01239368|Immunologic Factors|immunologic factors|mesh-ancestor
110744038|NCT01239368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110744039|NCT01239368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110744040|NCT01239368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110744041|NCT01239368|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110744042|NCT01239368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110744043|NCT01239368|Antifungal Agents|antifungal agents|mesh-ancestor
110744044|NCT01239368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110744045|NCT01146002|Guanfacine|guanfacine|mesh-list
110744046|NCT01146002|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110744047|NCT01146002|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110744048|NCT01146002|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110744049|NCT01146002|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110744050|NCT01146002|Adrenergic Agents|adrenergic agents|mesh-ancestor
110744051|NCT01146002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110744052|NCT01146002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110744053|NCT01146002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110744054|NCT01146626|Vitamin D|vitamin d|mesh-list
110744055|NCT01146626|Ribavirin|ribavirin|mesh-list
110744056|NCT01146626|Vitamins|vitamins|mesh-ancestor
110744057|NCT01146626|Micronutrients|micronutrients|mesh-ancestor
110744058|NCT01146626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110744059|NCT01146626|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110744060|NCT01146626|Antimetabolites|antimetabolites|mesh-ancestor
110744061|NCT01146626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110744062|NCT01146626|Antiviral Agents|antiviral agents|mesh-ancestor
110744063|NCT01146626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110744064|NCT02924324|Propofol|propofol|mesh-list
110744065|NCT02924324|Ropivacaine|ropivacaine|mesh-list
110744066|NCT02924324|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110744067|NCT02924324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110744068|NCT02924324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110744069|NCT02924324|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110744070|NCT02924324|Anesthetics, General|anesthetics, general|mesh-ancestor
110744071|NCT02924324|Anesthetics|anesthetics|mesh-ancestor
110744072|NCT02924324|Anesthetics, Local|anesthetics, local|mesh-ancestor
110744073|NCT02924324|Sensory System Agents|sensory system agents|mesh-ancestor
110744074|NCT02924324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110744075|NCT05137574|Ketamine|ketamine|mesh-list
110744076|NCT05137574|Propofol|propofol|mesh-list
110744077|NCT05137574|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110744078|NCT05137574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110744079|NCT05137574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110744080|NCT05137574|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110744081|NCT05137574|Anesthetics, General|anesthetics, general|mesh-ancestor
110744082|NCT05137574|Anesthetics|anesthetics|mesh-ancestor
110744083|NCT05137574|Analgesics|analgesics|mesh-ancestor
110744084|NCT05137574|Sensory System Agents|sensory system agents|mesh-ancestor
110744085|NCT05137574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110744086|NCT05137574|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110744087|NCT05137574|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110744088|NCT05137574|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110744089|NCT05137574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110744090|NCT05137574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110744091|NCT02842424|Ramipril|ramipril|mesh-list
110744092|NCT02842424|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110744093|NCT02842424|Protease Inhibitors|protease inhibitors|mesh-ancestor
110744094|NCT02842424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110744095|NCT02842424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110744096|NCT02842424|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110744097|NCT01236950|Listerine|listerine|mesh-list
110744098|NCT01236950|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110744099|NCT01236950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110744100|NCT04971746|Pirfenidone|pirfenidone|mesh-list
110744101|NCT04971746|Nintedanib|nintedanib|mesh-list
110744102|NCT04971746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110744103|NCT04971746|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110744104|NCT04971746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110744105|NCT04971746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110744106|NCT04971746|Analgesics|analgesics|mesh-ancestor
110744107|NCT04971746|Sensory System Agents|sensory system agents|mesh-ancestor
110744108|NCT04971746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110744109|NCT04971746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110744110|NCT04971746|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110744111|NCT04971746|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110744112|NCT04971746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110744113|NCT04971746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110744114|NCT00369161|Everolimus|everolimus|mesh-list
110744115|NCT00369161|Tacrolimus|tacrolimus|mesh-list
110744116|NCT00369161|Basiliximab|basiliximab|mesh-list
110744117|NCT00369161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110744118|NCT00369161|Immunologic Factors|immunologic factors|mesh-ancestor
110744119|NCT00369161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110744120|NCT00369161|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110744121|NCT00369161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110744122|NCT00369161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110744123|NCT00369161|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110744124|NCT00369161|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110744125|NCT00369161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110744127|NCT01143974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110744128|NCT01143974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110744129|NCT01143974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110744130|NCT01143974|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110744131|NCT01143974|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110744132|NCT00337571|Aripiprazole|aripiprazole|mesh-list
110744133|NCT00337571|Antidepressive Agents|antidepressive agents|mesh-ancestor
110744134|NCT00337571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110744135|NCT00337571|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110744136|NCT00337571|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110744137|NCT00337571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110744138|NCT00337571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110744139|NCT00337571|Dopamine Agonists|dopamine agonists|mesh-ancestor
110744140|NCT00337571|Dopamine Agents|dopamine agents|mesh-ancestor
110744141|NCT00337571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110148139|NCT05552404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110744142|NCT00337571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110744143|NCT00337571|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110744144|NCT00337571|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110744145|NCT00337571|Serotonin Agents|serotonin agents|mesh-ancestor
110744146|NCT00337571|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110744147|NCT00337571|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110744148|NCT00337571|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110744149|NCT00337571|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110744150|NCT01247870|Metformin|metformin|mesh-list
110744151|NCT01247870|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110744152|NCT01247870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110744154|NCT02528396|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110744155|NCT02528396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110744156|NCT03985319|Esomeprazole|esomeprazole|mesh-list
110744157|NCT03985319|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110744158|NCT03985319|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110744159|NCT03985319|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110744160|NCT03985319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110744161|NCT03985319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110744162|NCT01237028|Calcitriol|calcitriol|mesh-list
110744163|NCT01237028|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110744164|NCT01237028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110744165|NCT01237028|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
110744166|NCT01237028|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110744167|NCT01237028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110744168|NCT01237028|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110744169|NCT01237028|Vitamins|vitamins|mesh-ancestor
110744170|NCT01237028|Micronutrients|micronutrients|mesh-ancestor
110744171|NCT01237028|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110744172|NCT01240850|Prednisone|prednisone|mesh-list
110744173|NCT01240850|Methotrexate|methotrexate|mesh-list
110744174|NCT01240850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110744175|NCT01240850|Glucocorticoids|glucocorticoids|mesh-ancestor
110744176|NCT01240850|Hormones|hormones|mesh-ancestor
110744177|NCT01240850|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110744178|NCT01240850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110744179|NCT01240850|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110744180|NCT01240850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110744181|NCT01240850|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110744182|NCT01240850|Abortifacient Agents|abortifacient agents|mesh-ancestor
110744183|NCT01240850|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110744184|NCT01240850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110744185|NCT01240850|Antimetabolites|antimetabolites|mesh-ancestor
110744186|NCT01240850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110744187|NCT01240850|Dermatologic Agents|dermatologic agents|mesh-ancestor
110744188|NCT01240850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110744189|NCT01240850|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110744190|NCT01240850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110744191|NCT01240850|Immunologic Factors|immunologic factors|mesh-ancestor
110744192|NCT01240850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110744193|NCT01240850|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110744194|NCT04813016|Dexmedetomidine|dexmedetomidine|mesh-list
110744195|NCT04813016|Tramadol|tramadol|mesh-list
110744196|NCT04813016|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110744197|NCT04813016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110744198|NCT04813016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110744199|NCT04813016|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110744200|NCT04813016|Analgesics|analgesics|mesh-ancestor
110744201|NCT04813016|Sensory System Agents|sensory system agents|mesh-ancestor
110744202|NCT04813016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110744203|NCT04813016|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110744204|NCT04813016|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110744205|NCT04813016|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110744206|NCT04813016|Adrenergic Agents|adrenergic agents|mesh-ancestor
110744207|NCT04813016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110744208|NCT04813016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110744209|NCT04813016|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110744210|NCT04813016|Narcotics|narcotics|mesh-ancestor
110744211|NCT00368927|Sulindac|sulindac|mesh-list
110744212|NCT00368927|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110744213|NCT00368927|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110744214|NCT00368927|Analgesics|analgesics|mesh-ancestor
110744215|NCT00368927|Sensory System Agents|sensory system agents|mesh-ancestor
110744216|NCT00368927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110744217|NCT00368927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110744218|NCT00368927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110744219|NCT00368927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110744220|NCT00368927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110744221|NCT00368927|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110744222|NCT00368927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110744223|NCT00368927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110744224|NCT01242410|Silicon|silicon|mesh-list
110744225|NCT01242410|Trace Elements|trace elements|mesh-ancestor
110461975|NCT03993535|Serotonin|serotonin|mesh-list
110744227|NCT01242410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110744228|NCT02655692|Ketamine|ketamine|mesh-list
110744229|NCT02655692|Analgesics|analgesics|mesh-ancestor
110744230|NCT02655692|Sensory System Agents|sensory system agents|mesh-ancestor
110744231|NCT02655692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110744232|NCT02655692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110744233|NCT02655692|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110744234|NCT02655692|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110744235|NCT02655692|Anesthetics, General|anesthetics, general|mesh-ancestor
110744236|NCT02655692|Anesthetics|anesthetics|mesh-ancestor
110744237|NCT02655692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110744238|NCT02655692|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110744239|NCT02655692|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110744240|NCT02655692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110744241|NCT02655692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110744242|NCT01237262|Adalimumab|adalimumab|mesh-list
110744243|NCT01237262|Infliximab|infliximab|mesh-list
110744244|NCT01237262|Etanercept|etanercept|mesh-list
110744245|NCT01237262|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110744246|NCT01237262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110744247|NCT01237262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110744248|NCT01237262|Dermatologic Agents|dermatologic agents|mesh-ancestor
110744249|NCT01237262|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110744250|NCT01237262|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110744251|NCT01237262|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110744252|NCT01237262|Analgesics|analgesics|mesh-ancestor
110866853|NCT05602675|Midazolam|midazolam|mesh-list
110744253|NCT01237262|Sensory System Agents|sensory system agents|mesh-ancestor
110744254|NCT01237262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110744255|NCT01237262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110744256|NCT01237262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110744257|NCT01237262|Immunologic Factors|immunologic factors|mesh-ancestor
110744258|NCT01329770|Vitamins|vitamins|mesh-list
110744259|NCT01329770|Ascorbic Acid|ascorbic acid|mesh-list
110744260|NCT01329770|Vitamin E|vitamin e|mesh-list
110744261|NCT01329770|Tocopherols|tocopherols|mesh-list
110744262|NCT01329770|alpha-Tocopherol|alpha-tocopherol|mesh-list
110744263|NCT01329770|Micronutrients|micronutrients|mesh-ancestor
110744264|NCT01329770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110744265|NCT01329770|Antioxidants|antioxidants|mesh-ancestor
110744266|NCT01329770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110744267|NCT01329770|Protective Agents|protective agents|mesh-ancestor
110744268|NCT00316589|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
110744269|NCT00316589|Antiviral Agents|antiviral agents|mesh-ancestor
110744270|NCT00316589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110744271|NCT01048385|Ubiquinone|ubiquinone|mesh-list
110744272|NCT01048385|Coenzyme Q10|coenzyme q10|mesh-list
110744273|NCT01048385|Micronutrients|micronutrients|mesh-ancestor
110744274|NCT01048385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110744275|NCT01048385|Vitamins|vitamins|mesh-ancestor
110744276|NCT03916640|Insulin Lispro|insulin lispro|mesh-list
110744277|NCT03916640|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110744278|NCT03916640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110744279|NCT03916250|Petrolatum|petrolatum|mesh-list
110744280|NCT03916250|PF-06700841|pf-06700841|mesh-list
110744281|NCT03916250|Emollients|emollients|mesh-ancestor
110744282|NCT03916250|Dermatologic Agents|dermatologic agents|mesh-ancestor
110744283|NCT03916250|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110744284|NCT03916250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110744285|NCT03916250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110744286|NCT01062503|Zoledronic Acid|zoledronic acid|mesh-list
110744287|NCT01062503|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110744288|NCT01062503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110744289|NCT03916406|Midazolam|midazolam|mesh-list
110744290|NCT03916406|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110744291|NCT03916406|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110744292|NCT03916406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110744293|NCT03916406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110744294|NCT03916406|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110744295|NCT03916406|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110744296|NCT03916406|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110744297|NCT03916406|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110744298|NCT03916406|Anesthetics, General|anesthetics, general|mesh-ancestor
110744299|NCT03916406|Anesthetics|anesthetics|mesh-ancestor
110744300|NCT03916406|GABA Modulators|gaba modulators|mesh-ancestor
110744301|NCT03916406|GABA Agents|gaba agents|mesh-ancestor
110744302|NCT03916406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110744303|NCT03916406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110744304|NCT00316277|Opiate Alkaloids|opiate alkaloids|mesh-list
110744305|NCT00316277|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110744306|NCT00316277|Narcotics|narcotics|mesh-ancestor
110744307|NCT00316277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110744308|NCT00316277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110744309|NCT00316277|Analgesics|analgesics|mesh-ancestor
110744310|NCT00316277|Sensory System Agents|sensory system agents|mesh-ancestor
110744311|NCT00316277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110744312|NCT01249352|Fluorouracil|fluorouracil|mesh-list
110744313|NCT01249352|Nimotuzumab|nimotuzumab|mesh-list
110744314|NCT01249352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110744316|NCT01249352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110744317|NCT01249352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110744318|NCT01249352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110744319|NCT01249352|Immunologic Factors|immunologic factors|mesh-ancestor
110744320|NCT01249352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110744321|NCT01249352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110744322|NCT03912974|Escitalopram|escitalopram|mesh-list
110744323|NCT03912974|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110744324|NCT03912974|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110744325|NCT03912974|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110866855|NCT05602675|Warfarin|warfarin|mesh-list
110744326|NCT03912974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110744327|NCT03912974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110744329|NCT03912974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110744330|NCT00368849|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
110744331|NCT00368849|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110744332|NCT00368849|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110744333|NCT00368849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110744334|NCT00368849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110744335|NCT00368849|Adrenergic Agents|adrenergic agents|mesh-ancestor
110744336|NCT00368849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110744337|NCT00368849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110744338|NCT01144676|Dapivirine|dapivirine|mesh-list
110744339|NCT01144676|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110744340|NCT01144676|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110744341|NCT01144676|Antiviral Agents|antiviral agents|mesh-ancestor
110744342|NCT01144676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110744343|NCT00316199|Paclitaxel|paclitaxel|mesh-list
110744344|NCT00316199|Gemcitabine|gemcitabine|mesh-list
110744345|NCT00316199|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110744346|NCT00316199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110744347|NCT00316199|Tubulin Modulators|tubulin modulators|mesh-ancestor
110744348|NCT00316199|Antimitotic Agents|antimitotic agents|mesh-ancestor
110744349|NCT00316199|Mitosis Modulators|mitosis modulators|mesh-ancestor
110744350|NCT00316199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110744351|NCT00316199|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110744352|NCT00316199|Antimetabolites|antimetabolites|mesh-ancestor
110744353|NCT01147718|Digoxin|digoxin|mesh-list
110744354|NCT01147718|rGLP-1 protein|rglp-1 protein|mesh-list
110744355|NCT01147718|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110744356|NCT01147718|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110744357|NCT01147718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110744358|NCT01147718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110744359|NCT01147718|Protective Agents|protective agents|mesh-ancestor
110744360|NCT01147718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110744361|NCT01147718|Incretins|incretins|mesh-ancestor
110744362|NCT01147718|Hormones|hormones|mesh-ancestor
110744363|NCT01147718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110744364|NCT03913052|Viscosupplements|viscosupplements|mesh-list
110744365|NCT03913052|Protective Agents|protective agents|mesh-ancestor
110744366|NCT03913052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110744367|NCT03915938|Ketamine|ketamine|mesh-list
110744368|NCT03915938|Analgesics|analgesics|mesh-ancestor
110744369|NCT03915938|Sensory System Agents|sensory system agents|mesh-ancestor
110744370|NCT03915938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110744371|NCT03915938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110744372|NCT03915938|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110744373|NCT03915938|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110744374|NCT03915938|Anesthetics, General|anesthetics, general|mesh-ancestor
110744375|NCT03915938|Anesthetics|anesthetics|mesh-ancestor
110462114|NCT02606773|Protective Agents|protective agents|mesh-ancestor
110744376|NCT03915938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110744377|NCT03915938|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110744378|NCT03915938|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110744379|NCT03915938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110444979|NCT04307082|Ibrexafungerp|ibrexafungerp|mesh-list
110744380|NCT03915938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110744381|NCT01237496|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110744382|NCT01237496|Antiviral Agents|antiviral agents|mesh-ancestor
110744383|NCT01237496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110744385|NCT01251458|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110744386|NCT01251458|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110744387|NCT01251458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110744388|NCT01251458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110744389|NCT01251458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110744390|NCT01251458|Immunologic Factors|immunologic factors|mesh-ancestor
110744391|NCT01251458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110744392|NCT01251458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110744393|NCT03912740|Dexmedetomidine|dexmedetomidine|mesh-list
110744395|NCT03912740|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110744396|NCT03912740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110744397|NCT03912740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110744398|NCT03912740|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110744399|NCT03912740|Analgesics|analgesics|mesh-ancestor
110744400|NCT03912740|Sensory System Agents|sensory system agents|mesh-ancestor
110744401|NCT03912740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110744402|NCT03912740|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110744403|NCT03912740|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110744404|NCT03912740|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110744405|NCT03912740|Adrenergic Agents|adrenergic agents|mesh-ancestor
110744406|NCT03912740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110744407|NCT03912740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110744408|NCT03912740|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110744409|NCT03912740|Narcotics|narcotics|mesh-ancestor
110744410|NCT01058915|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110744411|NCT01058915|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110744412|NCT01058915|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110744413|NCT01058915|Antimetabolites|antimetabolites|mesh-ancestor
110744414|NCT01058915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110744415|NCT01058915|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110744416|NCT01058915|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110744417|NCT01058915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110744418|NCT01144754|Rituximab|rituximab|mesh-list
110744419|NCT01144754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110744420|NCT01144754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110744421|NCT01144754|Immunologic Factors|immunologic factors|mesh-ancestor
110744422|NCT01144754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110744423|NCT01144754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110744424|NCT01144832|Ebastine|ebastine|mesh-list
110744425|NCT01144832|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110744426|NCT01144832|Histamine Antagonists|histamine antagonists|mesh-ancestor
110744427|NCT01144832|Histamine Agents|histamine agents|mesh-ancestor
110744428|NCT01144832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110744429|NCT01144832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110744430|NCT01144832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110744431|NCT01251848|Ritonavir|ritonavir|mesh-list
110744432|NCT01251848|Sitaxsentan|sitaxsentan|mesh-list
110744433|NCT01251848|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110744434|NCT01251848|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110744435|NCT01251848|Protease Inhibitors|protease inhibitors|mesh-ancestor
110744436|NCT01251848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110744437|NCT01251848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110744438|NCT01251848|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110744439|NCT01251848|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110744440|NCT01251848|Antiviral Agents|antiviral agents|mesh-ancestor
110744441|NCT01251848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110744442|NCT01251848|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110744443|NCT01251848|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110744444|NCT01251848|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
110744445|NCT01251926|Bevacizumab|bevacizumab|mesh-list
110744446|NCT01251926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110744447|NCT01251926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110744448|NCT01251926|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110744449|NCT01251926|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110744450|NCT01251926|Growth Substances|growth substances|mesh-ancestor
110744451|NCT01251926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110744452|NCT01251926|Growth Inhibitors|growth inhibitors|mesh-ancestor
110744453|NCT03911648|Lidocaine|lidocaine|mesh-list
110744454|NCT03911648|Bupivacaine|bupivacaine|mesh-list
110744455|NCT03911648|Anesthetics, Local|anesthetics, local|mesh-ancestor
110744456|NCT03911648|Anesthetics|anesthetics|mesh-ancestor
110744457|NCT03911648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110744458|NCT03911648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110744459|NCT03911648|Sensory System Agents|sensory system agents|mesh-ancestor
110744460|NCT03911648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110866868|NCT05602675|Immunologic Factors|immunologic factors|mesh-ancestor
110744461|NCT03911648|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110744462|NCT03911648|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110744463|NCT03911648|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110744464|NCT03911648|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110744465|NCT03911648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110744466|NCT01237730|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110744467|NCT01237730|Cefuroxime|cefuroxime|mesh-list
110744468|NCT01237730|Cefuroxime axetil|cefuroxime axetil|mesh-list
110744469|NCT01237730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110744470|NCT01148030|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
110744471|NCT01148030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110744472|NCT01252160|Capsaicin|capsaicin|mesh-list
110744473|NCT01252160|Antipruritics|antipruritics|mesh-ancestor
110744474|NCT01252160|Dermatologic Agents|dermatologic agents|mesh-ancestor
110744475|NCT01252160|Sensory System Agents|sensory system agents|mesh-ancestor
110744476|NCT01252160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110744477|NCT01252160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110744478|NCT00337103|Capecitabine|capecitabine|mesh-list
110744479|NCT00337103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110744480|NCT00337103|Antimetabolites|antimetabolites|mesh-ancestor
110744481|NCT00337103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110744482|NCT00337103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110744483|NCT03911570|Acetaminophen|acetaminophen|mesh-list
110744484|NCT03911570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
110744485|NCT03911570|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
110744486|NCT03911570|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110744487|NCT03911570|Analgesics|analgesics|mesh-ancestor
110744488|NCT03911570|Sensory System Agents|sensory system agents|mesh-ancestor
110744489|NCT03911570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110744490|NCT03911570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110744491|NCT03911570|Antipyretics|antipyretics|mesh-ancestor
110744492|NCT03911570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110744493|NCT01250366|Ribavirin|ribavirin|mesh-list
110744494|NCT01250366|Antimetabolites|antimetabolites|mesh-ancestor
110744495|NCT01250366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110744496|NCT01250366|Antiviral Agents|antiviral agents|mesh-ancestor
110744497|NCT01250366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110744498|NCT00075504|Gemcitabine|gemcitabine|mesh-list
110744499|NCT00075504|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110744500|NCT00075504|Antimetabolites|antimetabolites|mesh-ancestor
110744501|NCT00075504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110744502|NCT00075504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110744503|NCT01092624|Solifenacin Succinate|solifenacin succinate|mesh-list
110744504|NCT01092624|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110744505|NCT01092624|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110744506|NCT01092624|Cholinergic Agents|cholinergic agents|mesh-ancestor
110744507|NCT01092624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110744508|NCT01092624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110744509|NCT01092624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110744510|NCT01092624|Urological Agents|urological agents|mesh-ancestor
110744511|NCT00321464|Zoledronic Acid|zoledronic acid|mesh-list
110744512|NCT00321464|Denosumab|denosumab|mesh-list
110744513|NCT00321464|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110744514|NCT00321464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110744515|NCT02889796|Adalimumab|adalimumab|mesh-list
110744516|NCT02889796|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110744517|NCT02889796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110744518|NCT02889796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110744519|NCT01237808|Cytarabine|cytarabine|mesh-list
110744520|NCT01237808|Etoposide|etoposide|mesh-list
110744521|NCT01237808|Tretinoin|tretinoin|mesh-list
110744522|NCT01237808|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110744523|NCT01237808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110744524|NCT01237808|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110744525|NCT01237808|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110744526|NCT01237808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110744527|NCT01237808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110744528|NCT01237808|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110744529|NCT01237808|Antimetabolites|antimetabolites|mesh-ancestor
110744530|NCT01237808|Antiviral Agents|antiviral agents|mesh-ancestor
110744531|NCT01237808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110744532|NCT01237808|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110744533|NCT01237808|Immunologic Factors|immunologic factors|mesh-ancestor
110744534|NCT01237808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110744535|NCT01237808|Keratolytic Agents|keratolytic agents|mesh-ancestor
110744536|NCT01237808|Dermatologic Agents|dermatologic agents|mesh-ancestor
110744537|NCT03910634|Carboplatin|carboplatin|mesh-list
110744538|NCT03910634|Fluorouracil|fluorouracil|mesh-list
110744539|NCT03910634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110744540|NCT03910634|Antimetabolites|antimetabolites|mesh-ancestor
110744541|NCT03910634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110744542|NCT03910634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110744543|NCT03910634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110744544|NCT03910634|Immunologic Factors|immunologic factors|mesh-ancestor
110744545|NCT03910634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110744546|NCT03910712|Trastuzumab|trastuzumab|mesh-list
110744547|NCT03910712|Letrozole|letrozole|mesh-list
110744548|NCT03910712|Anastrozole|anastrozole|mesh-list
110744549|NCT03910712|Exemestane|exemestane|mesh-list
110744550|NCT03910712|Aromatase Inhibitors|aromatase inhibitors|mesh-list
110744551|NCT03910712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110744552|NCT03910712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110744553|NCT03910712|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110744554|NCT03910712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110744555|NCT03910712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110744556|NCT03910712|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110744557|NCT03910712|Hormone Antagonists|hormone antagonists|mesh-ancestor
110744558|NCT03910712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110744559|NCT03910712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110744560|NCT03910712|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110744561|NCT03910556|Propofol|propofol|mesh-list
110744562|NCT03910556|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110744563|NCT03910556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110744564|NCT03910556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110744565|NCT03910556|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110744566|NCT03910556|Anesthetics, General|anesthetics, general|mesh-ancestor
110744567|NCT03910556|Anesthetics|anesthetics|mesh-ancestor
110744568|NCT03659578|Thymalfasin|thymalfasin|mesh-list
110744569|NCT03659578|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110744570|NCT03659578|Immunologic Factors|immunologic factors|mesh-ancestor
110744571|NCT03659578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110744572|NCT02889562|Warfarin|warfarin|mesh-list
110744573|NCT02889562|Apixaban|apixaban|mesh-list
110744574|NCT02889562|Anticoagulants|anticoagulants|mesh-ancestor
110744575|NCT02889562|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110744576|NCT02889562|Antithrombins|antithrombins|mesh-ancestor
110744577|NCT02889562|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110744578|NCT02889562|Protease Inhibitors|protease inhibitors|mesh-ancestor
110744579|NCT02889562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110744580|NCT02889562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110744581|NCT03323164|Timolol|timolol|mesh-list
110744582|NCT03323164|Brimonidine Tartrate|brimonidine tartrate|mesh-list
110744583|NCT03323164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110744584|NCT03323164|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110744585|NCT03323164|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110744586|NCT03323164|Adrenergic Agents|adrenergic agents|mesh-ancestor
110744587|NCT03323164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110744588|NCT03323164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110744589|NCT03323164|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110744590|NCT03323164|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110744591|NCT03323164|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110744592|NCT03323164|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110744593|NCT03323164|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110744594|NCT03914690|Epoetin Alfa|epoetin alfa|mesh-list
110744595|NCT03914690|Hematinics|hematinics|mesh-ancestor
110744597|NCT03914534|Anticonvulsants|anticonvulsants|mesh-ancestor
110744598|NCT03914534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110744599|NCT03914534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110744600|NCT03914534|GABA Agents|gaba agents|mesh-ancestor
110744602|NCT03914534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110744603|NCT03914534|Antimanic Agents|antimanic agents|mesh-ancestor
110744604|NCT03914534|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110744605|NCT03914534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110744606|NCT03914534|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110744607|NCT03910088|Acetaminophen|acetaminophen|mesh-list
110744608|NCT03910088|Hydrocortisone|hydrocortisone|mesh-list
110744609|NCT03910088|Diclofenac|diclofenac|mesh-list
110744610|NCT03910088|Pregabalin|pregabalin|mesh-list
110744611|NCT03910088|Caffeine|caffeine|mesh-list
110744612|NCT03910088|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110744613|NCT03910088|Analgesics|analgesics|mesh-ancestor
110744614|NCT03910088|Sensory System Agents|sensory system agents|mesh-ancestor
110744615|NCT03910088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110744616|NCT03910088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110744617|NCT03910088|Antipyretics|antipyretics|mesh-ancestor
110744618|NCT03910088|Anticonvulsants|anticonvulsants|mesh-ancestor
110744619|NCT03910088|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110744620|NCT03910088|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110744621|NCT03910088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110744622|NCT03910088|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110744623|NCT03910088|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110744624|NCT03910088|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110744625|NCT03910088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110744626|NCT03910088|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110744627|NCT03910088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110744628|NCT03910088|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110744629|NCT03910088|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110744630|NCT03910088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110744631|NCT03910088|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110744632|NCT03910088|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110148246|NCT05247970|Anesthetics|anesthetics|mesh-ancestor
110744633|NCT03910088|Purinergic Agents|purinergic agents|mesh-ancestor
110744634|NCT03910088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110744635|NCT03910088|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110744636|NCT03910088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110744637|NCT03910088|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110744638|NCT03610438|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
110744639|NCT03610438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110744640|NCT03610438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110744641|NCT03610438|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110744642|NCT03610438|Immunotoxins|immunotoxins|mesh-ancestor
110744643|NCT03610438|Immunoconjugates|immunoconjugates|mesh-ancestor
110744644|NCT03610438|Immunologic Factors|immunologic factors|mesh-ancestor
110744645|NCT03610438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110744646|NCT03908372|Docetaxel|docetaxel|mesh-list
110744647|NCT03908372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110744648|NCT03908372|Tubulin Modulators|tubulin modulators|mesh-ancestor
110744649|NCT03908372|Antimitotic Agents|antimitotic agents|mesh-ancestor
110744650|NCT03908372|Mitosis Modulators|mitosis modulators|mesh-ancestor
110744651|NCT03908372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110744652|NCT05617664|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
110744653|NCT05617664|Mirabegron|mirabegron|mesh-list
110744654|NCT05617664|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
110744655|NCT05617664|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110744656|NCT05617664|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110744657|NCT05617664|Adrenergic Agents|adrenergic agents|mesh-ancestor
110744658|NCT05617664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110744659|NCT05617664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110744660|NCT05617664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110744661|NCT05617664|Urological Agents|urological agents|mesh-ancestor
110744662|NCT05617664|Hemostatics|hemostatics|mesh-ancestor
110744663|NCT05617664|Coagulants|coagulants|mesh-ancestor
110744664|NCT05617664|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
110744665|NCT05617664|Natriuretic Agents|natriuretic agents|mesh-ancestor
110744666|NCT03909776|Cisplatin|cisplatin|mesh-list
110744667|NCT03909776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110744668|NCT01148264|Olanzapine|olanzapine|mesh-list
110744669|NCT01148264|Metoclopramide|metoclopramide|mesh-list
110744670|NCT01148264|Antiemetics|antiemetics|mesh-ancestor
110744671|NCT01148264|Autonomic Agents|autonomic agents|mesh-ancestor
110744672|NCT01148264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110744673|NCT01148264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110744674|NCT01148264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110744675|NCT01148264|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110744676|NCT01148264|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110744677|NCT01148264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110744679|NCT01148264|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110744680|NCT01148264|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110744681|NCT01148264|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110744682|NCT01148264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110744683|NCT01148264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110744684|NCT01148264|Serotonin Agents|serotonin agents|mesh-ancestor
110744685|NCT01148264|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110744686|NCT01148264|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110744687|NCT01148264|Dopamine Agents|dopamine agents|mesh-ancestor
110744688|NCT01253252|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110744689|NCT01253252|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110744690|NCT01253252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110744691|NCT00086580|Vidarabine|vidarabine|mesh-list
110744692|NCT00086580|Fludarabine|fludarabine|mesh-list
110744693|NCT00086580|Fludarabine phosphate|fludarabine phosphate|mesh-list
110744694|NCT00086580|Alemtuzumab|alemtuzumab|mesh-list
110744695|NCT00086580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110744696|NCT00086580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110744697|NCT00086580|Antimetabolites|antimetabolites|mesh-ancestor
110744698|NCT00086580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110744699|NCT00086580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110744700|NCT00086580|Immunologic Factors|immunologic factors|mesh-ancestor
110744701|NCT00086580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110744702|NCT00086580|Antiviral Agents|antiviral agents|mesh-ancestor
110744703|NCT00086580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110744704|NCT00086580|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110744705|NCT03908528|Thioctic Acid|thioctic acid|mesh-list
110744706|NCT03908528|Cyclophosphamide|cyclophosphamide|mesh-list
110744707|NCT03908528|Doxorubicin|doxorubicin|mesh-list
110744708|NCT03908528|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110744709|NCT03908528|Paclitaxel|paclitaxel|mesh-list
110744710|NCT03908528|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110744711|NCT03908528|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110744712|NCT03908528|Immunologic Factors|immunologic factors|mesh-ancestor
110744713|NCT03908528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110744714|NCT03908528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110744715|NCT03908528|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110744716|NCT03908528|Alkylating Agents|alkylating agents|mesh-ancestor
110744717|NCT03908528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110744718|NCT03908528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110744719|NCT03908528|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110744720|NCT03908528|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110744721|NCT03908528|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110744722|NCT03908528|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110744723|NCT03908528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110744724|NCT03908528|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110744725|NCT03908528|Tubulin Modulators|tubulin modulators|mesh-ancestor
110744726|NCT03908528|Antimitotic Agents|antimitotic agents|mesh-ancestor
110744727|NCT03908528|Mitosis Modulators|mitosis modulators|mesh-ancestor
110744728|NCT03908528|Antioxidants|antioxidants|mesh-ancestor
110744729|NCT03908528|Protective Agents|protective agents|mesh-ancestor
110744730|NCT03908528|Vitamin B Complex|vitamin b complex|mesh-ancestor
110744731|NCT03908528|Vitamins|vitamins|mesh-ancestor
110744732|NCT03908528|Micronutrients|micronutrients|mesh-ancestor
110744733|NCT03903458|Nivolumab|nivolumab|mesh-list
110744734|NCT03903458|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110744735|NCT03903458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110744736|NCT03903458|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110744737|NCT03903458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110744739|NCT00086502|Pioglitazone|pioglitazone|mesh-list
110744740|NCT00086502|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110744741|NCT00086502|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110866889|NCT03714685|Firibastat|firibastat|mesh-list
110744742|NCT00086502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110744743|NCT00086502|Incretins|incretins|mesh-ancestor
110744744|NCT00086502|Hormones|hormones|mesh-ancestor
110744745|NCT00086502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110744746|NCT00086502|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110744747|NCT00086502|Protease Inhibitors|protease inhibitors|mesh-ancestor
110744748|NCT00086502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110744749|NCT00086502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110744750|NCT03903302|Valproic Acid|valproic acid|mesh-list
110744751|NCT03903302|Anticonvulsants|anticonvulsants|mesh-ancestor
110744752|NCT03903302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110744753|NCT03903302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110744754|NCT03903302|GABA Agents|gaba agents|mesh-ancestor
110744755|NCT03903302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110744756|NCT03903302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110744757|NCT03903302|Antimanic Agents|antimanic agents|mesh-ancestor
110744758|NCT03903302|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110744759|NCT03903302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110744760|NCT03903302|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110744761|NCT03636542|Bupivacaine|bupivacaine|mesh-list
110744762|NCT03636542|Anesthetics, Local|anesthetics, local|mesh-ancestor
110744763|NCT03636542|Anesthetics|anesthetics|mesh-ancestor
110744764|NCT03636542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110744765|NCT03636542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110744766|NCT03636542|Sensory System Agents|sensory system agents|mesh-ancestor
110744767|NCT03636542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110744768|NCT00086190|Paroxetine|paroxetine|mesh-list
110744769|NCT00086190|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
110744770|NCT00086190|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110744771|NCT00086190|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110744772|NCT00086190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110744773|NCT00086190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110744774|NCT00086190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110744775|NCT00086190|Serotonin Agents|serotonin agents|mesh-ancestor
110744776|NCT00086190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110744777|NCT00086190|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110744778|NCT00086190|Antidepressive Agents|antidepressive agents|mesh-ancestor
110744779|NCT00086190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110744780|NCT00086190|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110744781|NCT00086190|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110744782|NCT00086190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110744783|NCT00086190|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110744784|NCT03275350|Naltrexone|naltrexone|mesh-list
110744785|NCT03275350|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110744786|NCT03275350|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110148310|NCT03876106|LUT014|lut014|mesh-list
110744787|NCT03275350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110744788|NCT03275350|Sensory System Agents|sensory system agents|mesh-ancestor
110744789|NCT03275350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110744790|NCT01148342|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
110744791|NCT01148342|Hallucinogens|hallucinogens|mesh-ancestor
110744792|NCT01148342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110744793|NCT01148342|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110744794|NCT01148342|Serotonin Agents|serotonin agents|mesh-ancestor
110744795|NCT01148342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110744796|NCT01148342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110744797|NCT01148342|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110744798|NCT01148342|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110445007|NCT02781064|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110744799|NCT01148342|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110744800|NCT01148342|Adrenergic Agents|adrenergic agents|mesh-ancestor
110744801|NCT03557242|Aspirin|aspirin|mesh-list
110744802|NCT03557242|Warfarin|warfarin|mesh-list
110744803|NCT03557242|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110744804|NCT03557242|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110744805|NCT03557242|Analgesics|analgesics|mesh-ancestor
110744806|NCT03557242|Sensory System Agents|sensory system agents|mesh-ancestor
110744807|NCT03557242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110744808|NCT03557242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110744809|NCT03557242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110744810|NCT03557242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110744811|NCT03557242|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110744812|NCT03557242|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110744813|NCT03557242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110744814|NCT03557242|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110744815|NCT03557242|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110744816|NCT03557242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110744817|NCT03557242|Antipyretics|antipyretics|mesh-ancestor
110744818|NCT03557242|Anticoagulants|anticoagulants|mesh-ancestor
110744819|NCT04774666|Antibodies|antibodies|mesh-list
110744820|NCT04774666|Immunologic Factors|immunologic factors|mesh-ancestor
110744821|NCT04774666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110744822|NCT01150448|Paliperidone Palmitate|paliperidone palmitate|mesh-list
110744823|NCT01150448|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110744824|NCT01150448|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110744825|NCT01150448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110744826|NCT01150448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110744827|NCT01150448|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110744828|NCT01150448|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110744829|NCT01150448|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110744830|NCT01150448|Serotonin Agents|serotonin agents|mesh-ancestor
110744831|NCT01150448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110744832|NCT01150448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110744833|NCT01150448|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110744834|NCT01150448|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110744835|NCT01150448|Dopamine Agents|dopamine agents|mesh-ancestor
110744836|NCT03898466|Fluticasone|fluticasone|mesh-list
110744837|NCT03898466|Xhance|xhance|mesh-list
110744838|NCT03898466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110744839|NCT03898466|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110744840|NCT03898466|Autonomic Agents|autonomic agents|mesh-ancestor
110744841|NCT03898466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110744842|NCT03898466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110744843|NCT03898466|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110744844|NCT03898466|Respiratory System Agents|respiratory system agents|mesh-ancestor
110744845|NCT03898466|Dermatologic Agents|dermatologic agents|mesh-ancestor
110744846|NCT03898466|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110744847|NCT02527772|Leucovorin|leucovorin|mesh-list
110744848|NCT02527772|Gemcitabine|gemcitabine|mesh-list
110744849|NCT02527772|Fluorouracil|fluorouracil|mesh-list
110744850|NCT02527772|Doxorubicin|doxorubicin|mesh-list
110744851|NCT02527772|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110744852|NCT02527772|Oxaliplatin|oxaliplatin|mesh-list
110744853|NCT02527772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110744854|NCT02527772|Antimetabolites|antimetabolites|mesh-ancestor
110744855|NCT02527772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110744856|NCT02527772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110744857|NCT02527772|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110744858|NCT02527772|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110744859|NCT02527772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110744860|NCT02527772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110744861|NCT02527772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110744862|NCT02527772|Immunologic Factors|immunologic factors|mesh-ancestor
110744863|NCT02527772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110744864|NCT02527772|Antidotes|antidotes|mesh-ancestor
110744865|NCT02527772|Protective Agents|protective agents|mesh-ancestor
110744866|NCT02527772|Vitamin B Complex|vitamin b complex|mesh-ancestor
110744867|NCT02527772|Vitamins|vitamins|mesh-ancestor
110744868|NCT02527772|Micronutrients|micronutrients|mesh-ancestor
110744869|NCT03273946|Fluticasone|fluticasone|mesh-list
110744870|NCT03273946|Xhance|xhance|mesh-list
110744871|NCT03273946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110744872|NCT03273946|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110744873|NCT03273946|Autonomic Agents|autonomic agents|mesh-ancestor
110744874|NCT03273946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110744875|NCT03273946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110744876|NCT03273946|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110866899|NCT02429050|Narcotics|narcotics|mesh-ancestor
110744877|NCT03273946|Respiratory System Agents|respiratory system agents|mesh-ancestor
110744878|NCT03273946|Dermatologic Agents|dermatologic agents|mesh-ancestor
110744879|NCT03273946|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110744880|NCT00660218|Paclitaxel|paclitaxel|mesh-list
110744881|NCT00660218|Cetuximab|cetuximab|mesh-list
110744882|NCT00660218|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
110744883|NCT00660218|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110744884|NCT00660218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110744885|NCT00660218|Tubulin Modulators|tubulin modulators|mesh-ancestor
110744886|NCT00660218|Antimitotic Agents|antimitotic agents|mesh-ancestor
110744887|NCT00660218|Mitosis Modulators|mitosis modulators|mesh-ancestor
110744888|NCT00660218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110744889|NCT00660218|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110744890|NCT00314951|Vancomycin|vancomycin|mesh-list
110744891|NCT00314951|Fidaxomicin|fidaxomicin|mesh-list
110744892|NCT00314951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110744893|NCT00314951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110744894|NCT00085644|Adalimumab|adalimumab|mesh-list
110744895|NCT00085644|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110744896|NCT00085644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110744897|NCT00085644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110744898|NCT01257074|Acyclovir|acyclovir|mesh-list
110744899|NCT01257074|Penciclovir|penciclovir|mesh-list
110744900|NCT01257074|Antiviral Agents|antiviral agents|mesh-ancestor
110744901|NCT01257074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110744902|NCT04597918|Faricimab|faricimab|mesh-list
110744903|NCT04597918|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110744904|NCT04597918|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110744905|NCT04597918|Growth Substances|growth substances|mesh-ancestor
110744906|NCT04597918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110744907|NCT04597918|Growth Inhibitors|growth inhibitors|mesh-ancestor
110744908|NCT04597918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110744909|NCT01149278|Benzocaine|benzocaine|mesh-list
110744910|NCT01149278|Anesthetics, Local|anesthetics, local|mesh-ancestor
110744911|NCT01149278|Anesthetics|anesthetics|mesh-ancestor
110744912|NCT01149278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110744913|NCT01149278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110744914|NCT01149278|Sensory System Agents|sensory system agents|mesh-ancestor
110744915|NCT01149278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110744916|NCT01086774|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110744917|NCT01086774|Lubricant Eye Drops|lubricant eye drops|mesh-list
110744918|NCT01086774|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110744919|NCT03902522|Leronlimab|leronlimab|mesh-list
110744920|NCT03902522|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110744921|NCT03902522|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110744922|NCT03902522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110744923|NCT03902522|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110744924|NCT03902522|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110744925|NCT03902522|Antiviral Agents|antiviral agents|mesh-ancestor
110744926|NCT03902522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110744927|NCT01092858|Methyltestosterone|methyltestosterone|mesh-list
110744928|NCT01092858|Testosterone|testosterone|mesh-list
110744929|NCT01092858|Testosterone undecanoate|testosterone undecanoate|mesh-list
110744930|NCT01092858|Testosterone enanthate|testosterone enanthate|mesh-list
110744931|NCT01092858|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
110744932|NCT01092858|Androgens|androgens|mesh-ancestor
110744933|NCT01092858|Hormones|hormones|mesh-ancestor
110744934|NCT01092858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110744935|NCT01092858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110744936|NCT01092858|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110744937|NCT01092858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110744938|NCT01092858|Anabolic Agents|anabolic agents|mesh-ancestor
110744939|NCT00314327|Risperidone|risperidone|mesh-list
110744940|NCT00314327|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110744941|NCT00314327|Serotonin Agents|serotonin agents|mesh-ancestor
110744942|NCT00314327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110744943|NCT00314327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110744944|NCT00314327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110744945|NCT00314327|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110744946|NCT00314327|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110744947|NCT00314327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110744948|NCT00314327|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110744949|NCT00314327|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110744950|NCT00314327|Dopamine Agents|dopamine agents|mesh-ancestor
110744951|NCT03897452|Fentanyl|fentanyl|mesh-list
110744952|NCT03897452|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110744953|NCT03897452|Narcotics|narcotics|mesh-ancestor
110744954|NCT03897452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110744955|NCT03897452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110744956|NCT03897452|Analgesics|analgesics|mesh-ancestor
110744957|NCT03897452|Sensory System Agents|sensory system agents|mesh-ancestor
110744958|NCT03897452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110744959|NCT03897452|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110744960|NCT03897452|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110744961|NCT03897452|Anesthetics, General|anesthetics, general|mesh-ancestor
110744962|NCT03897452|Anesthetics|anesthetics|mesh-ancestor
110744963|NCT01151072|Insulin|insulin|mesh-list
110744964|NCT01151072|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110744965|NCT01151072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110744966|NCT01257386|Mesalamine|mesalamine|mesh-list
110744967|NCT01257386|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110744968|NCT01257386|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110744969|NCT01257386|Analgesics|analgesics|mesh-ancestor
110744970|NCT01257386|Sensory System Agents|sensory system agents|mesh-ancestor
110744971|NCT01257386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110744972|NCT01257386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110744973|NCT01257386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110744974|NCT01257386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110744975|NCT01257464|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110744976|NCT01257464|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
110744977|NCT01257464|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110744978|NCT01257464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110744979|NCT01257464|Incretins|incretins|mesh-ancestor
110462734|NCT02855502|Hormones|hormones|mesh-ancestor
110744980|NCT01257464|Hormones|hormones|mesh-ancestor
110744981|NCT01257464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110744982|NCT01257464|Protease Inhibitors|protease inhibitors|mesh-ancestor
110744983|NCT01257464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110744984|NCT01257464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110744985|NCT01255046|Donepezil|donepezil|mesh-list
110744986|NCT01255046|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110744987|NCT01255046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110744988|NCT01255046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110744989|NCT01255046|Cholinergic Agents|cholinergic agents|mesh-ancestor
110744990|NCT01255046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110744991|NCT01255046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110744992|NCT01255046|Nootropic Agents|nootropic agents|mesh-ancestor
110744993|NCT01149356|Exemestane|exemestane|mesh-list
110744994|NCT01149356|Goserelin|goserelin|mesh-list
110744995|NCT01149356|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
110744996|NCT01149356|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-list
110744997|NCT01149356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110744998|NCT01149356|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110744999|NCT01149356|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110745000|NCT01149356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110745001|NCT01149356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110745002|NCT01149356|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110745003|NCT01149356|Hormone Antagonists|hormone antagonists|mesh-ancestor
110745004|NCT01149356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110745005|NCT01149356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110745006|NCT01149356|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110745007|NCT01148576|Vitamin E|vitamin e|mesh-list
110745008|NCT01148576|Entecavir|entecavir|mesh-list
110745009|NCT01148576|Essential 303 forte|essential 303 forte|mesh-list
110745010|NCT01148576|Vitamins|vitamins|mesh-ancestor
110745011|NCT01148576|Micronutrients|micronutrients|mesh-ancestor
110745012|NCT01148576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110307610|NCT00296361|Tacrolimus|tacrolimus|mesh-list
110745013|NCT01148576|Antioxidants|antioxidants|mesh-ancestor
110745014|NCT01148576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110745015|NCT01148576|Protective Agents|protective agents|mesh-ancestor
110745017|NCT01148576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110745018|NCT01148576|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110745019|NCT01148576|Immunologic Factors|immunologic factors|mesh-ancestor
110745020|NCT01148576|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110745021|NCT01148576|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110745022|NCT01148576|Antimetabolites|antimetabolites|mesh-ancestor
110745023|NCT01148576|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110745024|NCT01148576|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110745025|NCT01148576|Antitubercular Agents|antitubercular agents|mesh-ancestor
110745026|NCT01148576|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110745027|NCT01148576|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110745029|NCT03905486|Analgesics|analgesics|mesh-ancestor
110745030|NCT03905486|Sensory System Agents|sensory system agents|mesh-ancestor
110745031|NCT03905486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110745032|NCT03905486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110745033|NCT03905486|Anticonvulsants|anticonvulsants|mesh-ancestor
110745034|NCT03905486|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110745035|NCT03905486|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110745036|NCT03905486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110745037|NCT03905486|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110745038|NCT03905486|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110745039|NCT03905486|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110745040|NCT03905486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110745041|NCT03905486|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110745042|NCT03901118|Paclitaxel|paclitaxel|mesh-list
110745043|NCT03901118|Etoposide|etoposide|mesh-list
110745044|NCT03901118|Chiauranib|chiauranib|mesh-list
110745045|NCT03901118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110745046|NCT03901118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110745047|NCT03901118|Tubulin Modulators|tubulin modulators|mesh-ancestor
110745048|NCT03901118|Antimitotic Agents|antimitotic agents|mesh-ancestor
110745049|NCT03901118|Mitosis Modulators|mitosis modulators|mesh-ancestor
110745050|NCT03901118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110745051|NCT03901118|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110745052|NCT03901118|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110745054|NCT03901118|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110745055|NCT03895892|Caffeine|caffeine|mesh-list
110745056|NCT03895892|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110745057|NCT03895892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110745058|NCT03895892|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110745059|NCT03895892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110745060|NCT03895892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110745061|NCT03895892|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110745062|NCT03895892|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110745063|NCT03895892|Purinergic Agents|purinergic agents|mesh-ancestor
110745064|NCT03895892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110745065|NCT01151306|Simvastatin|simvastatin|mesh-list
110745066|NCT01151306|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110745067|NCT01151306|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110745069|NCT01151306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110745070|NCT01151306|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110745071|NCT01151306|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110745072|NCT01151306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110745073|NCT05570786|Gestrinone|gestrinone|mesh-list
110745074|NCT05570786|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110745075|NCT05570786|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110745076|NCT05570786|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110745077|NCT05570786|Contraceptive Agents|contraceptive agents|mesh-ancestor
110745078|NCT05570786|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110745079|NCT05570786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110745080|NCT05570786|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110745081|NCT05570786|Progestins|progestins|mesh-ancestor
110745082|NCT05570786|Hormones|hormones|mesh-ancestor
110745083|NCT05570786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110745084|NCT03895970|Pembrolizumab|pembrolizumab|mesh-list
110745085|NCT03895970|Lenvatinib|lenvatinib|mesh-list
110745086|NCT03895970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110745087|NCT03895970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110745088|NCT03895970|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110745089|NCT03895970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110745090|NCT03895970|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110745091|NCT03895970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110745092|NCT00336479|Interferons|interferons|mesh-list
110745093|NCT00336479|Ribavirin|ribavirin|mesh-list
110745094|NCT00336479|Interferon-alpha|interferon-alpha|mesh-list
110745095|NCT00336479|Interferon alpha-2|interferon alpha-2|mesh-list
110745096|NCT00336479|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110745097|NCT00336479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110745098|NCT00336479|Antiviral Agents|antiviral agents|mesh-ancestor
110745099|NCT00336479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110745100|NCT00336479|Antimetabolites|antimetabolites|mesh-ancestor
110745101|NCT00336479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110745102|NCT00336479|Immunologic Factors|immunologic factors|mesh-ancestor
110745103|NCT00336479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110745104|NCT03905564|Pyridoxine|pyridoxine|mesh-list
110745105|NCT03905564|Vitamin B 6|vitamin b 6|mesh-list
110745106|NCT03905564|Doxylamine|doxylamine|mesh-list
110745107|NCT03905564|Dicyclomine, doxylamine, pyridoxine drug combination|dicyclomine, doxylamine, pyridoxine drug combination|mesh-list
110745108|NCT03905564|Doxylamine succinate|doxylamine succinate|mesh-list
110745109|NCT03905564|Vitamin B Complex|vitamin b complex|mesh-ancestor
110745110|NCT03905564|Vitamins|vitamins|mesh-ancestor
110745111|NCT03905564|Micronutrients|micronutrients|mesh-ancestor
110745112|NCT03905564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110745113|NCT03905564|Antiemetics|antiemetics|mesh-ancestor
110745114|NCT03905564|Autonomic Agents|autonomic agents|mesh-ancestor
110745115|NCT03905564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110745116|NCT03905564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110745117|NCT03905564|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110745118|NCT03905564|Histamine Antagonists|histamine antagonists|mesh-ancestor
110745119|NCT03905564|Histamine Agents|histamine agents|mesh-ancestor
110745120|NCT03905564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110745121|NCT03905564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110745122|NCT01151384|Docetaxel|docetaxel|mesh-list
110745123|NCT01151384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110745124|NCT01151384|Tubulin Modulators|tubulin modulators|mesh-ancestor
110745125|NCT01151384|Antimitotic Agents|antimitotic agents|mesh-ancestor
110745126|NCT01151384|Mitosis Modulators|mitosis modulators|mesh-ancestor
110462858|NCT00681928|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110745127|NCT01151384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110745128|NCT01258010|Tranexamic Acid|tranexamic acid|mesh-list
110745129|NCT01258010|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110745130|NCT01258010|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110745131|NCT01258010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110745132|NCT01258010|Hemostatics|hemostatics|mesh-ancestor
110745133|NCT01258010|Coagulants|coagulants|mesh-ancestor
110745134|NCT00314249|Milnacipran|milnacipran|mesh-list
110745135|NCT00314249|Levomilnacipran|levomilnacipran|mesh-list
110745136|NCT00314249|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110745137|NCT00314249|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110745138|NCT00314249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110745139|NCT00314249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110745140|NCT00314249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110745141|NCT00314249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110745142|NCT00314249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110745143|NCT00314249|Analgesics|analgesics|mesh-ancestor
110745144|NCT00314249|Sensory System Agents|sensory system agents|mesh-ancestor
110745145|NCT00314249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110745146|NCT00314249|Antidepressive Agents|antidepressive agents|mesh-ancestor
110745147|NCT00314249|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110745149|NCT03905018|Vasodilator Agents|vasodilator agents|mesh-ancestor
110745150|NCT03905018|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110745151|NCT03905018|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110745152|NCT03905018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110745153|NCT03905018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110745154|NCT03905018|Urological Agents|urological agents|mesh-ancestor
110745155|NCT03894722|Povidone-Iodine|povidone-iodine|mesh-list
110745156|NCT03894722|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110745157|NCT03894722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110745158|NCT03894800|Fentanyl|fentanyl|mesh-list
110745159|NCT03894800|Methoxyflurane|methoxyflurane|mesh-list
110745160|NCT03894800|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110745161|NCT03894800|Narcotics|narcotics|mesh-ancestor
110745162|NCT03894800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110745163|NCT03894800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110745164|NCT03894800|Analgesics|analgesics|mesh-ancestor
110745165|NCT03894800|Sensory System Agents|sensory system agents|mesh-ancestor
110745166|NCT03894800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110745167|NCT03894800|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110745168|NCT03894800|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110745169|NCT03894800|Anesthetics, General|anesthetics, general|mesh-ancestor
110745171|NCT03894800|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110745172|NCT03900026|Evolocumab|evolocumab|mesh-list
110745173|NCT03900026|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
110745174|NCT03900026|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110745175|NCT03900026|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110745176|NCT03900026|Antimetabolites|antimetabolites|mesh-ancestor
110745177|NCT03900026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110745178|NCT03900026|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110745179|NCT03900026|Protease Inhibitors|protease inhibitors|mesh-ancestor
110745180|NCT03900026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110745181|NCT03900026|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110745182|NCT01149668|Abexinostat|abexinostat|mesh-list
110745183|NCT01149668|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110745184|NCT01149668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110745185|NCT01149668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110745186|NCT01149746|Tamsulosin|tamsulosin|mesh-list
110745187|NCT01149746|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110745188|NCT01149746|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110745189|NCT01149746|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110745190|NCT01149746|Adrenergic Agents|adrenergic agents|mesh-ancestor
110745191|NCT01149746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110745192|NCT01149746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110745193|NCT01149746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110745194|NCT01149746|Urological Agents|urological agents|mesh-ancestor
110745195|NCT01149824|Salvinorin A|salvinorin a|mesh-list
110745196|NCT01149824|Hallucinogens|hallucinogens|mesh-ancestor
110745197|NCT01149824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110745198|NCT01149824|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110745199|NCT01149902|Cyclophosphamide|cyclophosphamide|mesh-list
110745200|NCT01149902|Docetaxel|docetaxel|mesh-list
110462957|NCT02881346|Hormones|hormones|mesh-ancestor
110745201|NCT01149902|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110745202|NCT01149902|Immunologic Factors|immunologic factors|mesh-ancestor
110745203|NCT01149902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110745204|NCT01149902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110745205|NCT01149902|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110745206|NCT01149902|Alkylating Agents|alkylating agents|mesh-ancestor
110745207|NCT01149902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110745208|NCT01149902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110745209|NCT01149902|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110745210|NCT01149902|Tubulin Modulators|tubulin modulators|mesh-ancestor
110745211|NCT01149902|Antimitotic Agents|antimitotic agents|mesh-ancestor
110745212|NCT01149902|Mitosis Modulators|mitosis modulators|mesh-ancestor
110745213|NCT01151696|Hydroxyzine|hydroxyzine|mesh-list
110745214|NCT01151696|Antipruritics|antipruritics|mesh-ancestor
110745215|NCT01151696|Dermatologic Agents|dermatologic agents|mesh-ancestor
110745216|NCT01151696|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110745217|NCT01151696|Histamine Antagonists|histamine antagonists|mesh-ancestor
110745218|NCT01151696|Histamine Agents|histamine agents|mesh-ancestor
110745219|NCT01151696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110745220|NCT01151696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110745221|NCT01151696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110745222|NCT01149980|Dexetimide|dexetimide|mesh-list
110745223|NCT01149980|Citalopram|citalopram|mesh-list
110745224|NCT01149980|Escitalopram|escitalopram|mesh-list
110745225|NCT01149980|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110745226|NCT01149980|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110745227|NCT01149980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110745228|NCT01149980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110745229|NCT01149980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110745230|NCT01149980|Serotonin Agents|serotonin agents|mesh-ancestor
110745231|NCT01149980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110745232|NCT01149980|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110745233|NCT01149980|Antidepressive Agents|antidepressive agents|mesh-ancestor
110745234|NCT01149980|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110745235|NCT01149980|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110745236|NCT01149980|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110745237|NCT01149980|Parasympatholytics|parasympatholytics|mesh-ancestor
110745238|NCT01149980|Autonomic Agents|autonomic agents|mesh-ancestor
110745239|NCT01149980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110745240|NCT01149980|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110745241|NCT01149980|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110745242|NCT01149980|Cholinergic Agents|cholinergic agents|mesh-ancestor
110745243|NCT01258322|Pioglitazone|pioglitazone|mesh-list
110745244|NCT01258322|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110745245|NCT01258322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110745246|NCT01255358|Dexamethasone|dexamethasone|mesh-list
110745247|NCT01255358|Dexamethasone acetate|dexamethasone acetate|mesh-list
110745248|NCT01255358|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
110745249|NCT01255358|BB 1101|bb 1101|mesh-list
110745250|NCT01255358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110745251|NCT01255358|Antiemetics|antiemetics|mesh-ancestor
110745252|NCT01255358|Autonomic Agents|autonomic agents|mesh-ancestor
110745253|NCT01255358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110745254|NCT01255358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110745255|NCT01255358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110745256|NCT01255358|Glucocorticoids|glucocorticoids|mesh-ancestor
110745257|NCT01255358|Hormones|hormones|mesh-ancestor
110745258|NCT01255358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110745259|NCT01255358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110745260|NCT01255358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110745261|NCT01255358|Protease Inhibitors|protease inhibitors|mesh-ancestor
110745262|NCT01255358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110745263|NCT01255358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110745264|NCT03899246|Capsaicin|capsaicin|mesh-list
110745265|NCT03899246|Antipruritics|antipruritics|mesh-ancestor
110745266|NCT03899246|Dermatologic Agents|dermatologic agents|mesh-ancestor
110745267|NCT03899246|Sensory System Agents|sensory system agents|mesh-ancestor
110745268|NCT03899246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110745269|NCT03899246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110745270|NCT03893864|Ubiquinone|ubiquinone|mesh-list
110745271|NCT03893864|Coenzyme Q10|coenzyme q10|mesh-list
110745272|NCT03893864|Antioxidants|antioxidants|mesh-list
110745273|NCT03893864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110745274|NCT03893864|Protective Agents|protective agents|mesh-ancestor
110745275|NCT03893864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110745276|NCT03893864|Micronutrients|micronutrients|mesh-ancestor
110745278|NCT03899324|Bumetanide|bumetanide|mesh-list
110745279|NCT03899324|Diuretics|diuretics|mesh-ancestor
110745280|NCT03899324|Natriuretic Agents|natriuretic agents|mesh-ancestor
110745281|NCT03899324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110745282|NCT03899324|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110745283|NCT03899324|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110745284|NCT03899324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110745285|NCT01148966|Aminolevulinic Acid|aminolevulinic acid|mesh-list
110745286|NCT01148966|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110745287|NCT01148966|Dermatologic Agents|dermatologic agents|mesh-ancestor
110745288|NCT01258634|Leucovorin|leucovorin|mesh-list
110745289|NCT01258634|Doxorubicin|doxorubicin|mesh-list
110745290|NCT01258634|Etoposide|etoposide|mesh-list
110745291|NCT01258634|Ifosfamide|ifosfamide|mesh-list
110745292|NCT01258634|Dexrazoxane|dexrazoxane|mesh-list
110745293|NCT01258634|Razoxane|razoxane|mesh-list
110745294|NCT01258634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110745295|NCT01258634|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110745296|NCT01258634|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110745297|NCT01258634|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110745298|NCT01258634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110745299|NCT01258634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110745300|NCT01258634|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110745302|NCT01258634|Protective Agents|protective agents|mesh-ancestor
110745303|NCT01258634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110745304|NCT01258634|Vitamin B Complex|vitamin b complex|mesh-ancestor
110745305|NCT01258634|Vitamins|vitamins|mesh-ancestor
110745306|NCT01258634|Micronutrients|micronutrients|mesh-ancestor
110745307|NCT01258634|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110745308|NCT01258634|Alkylating Agents|alkylating agents|mesh-ancestor
110745309|NCT01258634|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110745310|NCT01258634|Antimitotic Agents|antimitotic agents|mesh-ancestor
110745311|NCT01258634|Mitosis Modulators|mitosis modulators|mesh-ancestor
110745312|NCT01258712|Methotrexate|methotrexate|mesh-list
110745313|NCT01258712|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110745314|NCT01258712|Abortifacient Agents|abortifacient agents|mesh-ancestor
110745315|NCT01258712|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110745316|NCT01258712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110745317|NCT01258712|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110745318|NCT01258712|Antimetabolites|antimetabolites|mesh-ancestor
110745319|NCT01258712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110745320|NCT01258712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110745321|NCT01258712|Dermatologic Agents|dermatologic agents|mesh-ancestor
110745322|NCT01258712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110745323|NCT01258712|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110745324|NCT01258712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110745325|NCT01258712|Immunologic Factors|immunologic factors|mesh-ancestor
110745326|NCT01258712|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110307769|NCT00296790|Zolpidem|zolpidem|mesh-list
110745327|NCT01258712|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110745328|NCT01258868|Celecoxib|celecoxib|mesh-list
110745329|NCT01258868|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110745330|NCT01258868|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110745331|NCT01258868|Analgesics|analgesics|mesh-ancestor
110745332|NCT01258868|Sensory System Agents|sensory system agents|mesh-ancestor
110745333|NCT01258868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110745334|NCT01258868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110745335|NCT01258868|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110745336|NCT01258868|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110745337|NCT01258868|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110745338|NCT01258868|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110745339|NCT01258868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110745340|NCT01258868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110745341|NCT01254578|Lenalidomide|lenalidomide|mesh-list
110745342|NCT01254578|Immunologic Factors|immunologic factors|mesh-ancestor
110745343|NCT01254578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110745344|NCT01254578|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110745345|NCT01254578|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110745346|NCT01254578|Growth Substances|growth substances|mesh-ancestor
110745347|NCT01254578|Growth Inhibitors|growth inhibitors|mesh-ancestor
110745348|NCT01254578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110745367|NCT01152242|Insulin Glargine|insulin glargine|mesh-list
110745368|NCT01152242|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110745369|NCT01152242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110745371|NCT03341806|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110745372|NCT03341806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110745373|NCT03904004|Botulinum Toxins|botulinum toxins|mesh-list
110745374|NCT03904004|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110745375|NCT03904004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110745376|NCT03904004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110745377|NCT03904004|Cholinergic Agents|cholinergic agents|mesh-ancestor
110745378|NCT03904004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110745379|NCT03904004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110745380|NCT01149122|Gemcitabine|gemcitabine|mesh-list
110745381|NCT01149122|Oxaliplatin|oxaliplatin|mesh-list
110745382|NCT01149122|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110745383|NCT01149122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110745384|NCT01149122|Antimetabolites|antimetabolites|mesh-ancestor
110745385|NCT01149122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110745386|NCT01149122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110745387|NCT01149122|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110745388|NCT01149122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110745389|NCT01152398|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
110307776|NCT00296790|GABA Agents|gaba agents|mesh-ancestor
110745390|NCT01152398|Antiviral Agents|antiviral agents|mesh-ancestor
110745391|NCT01152398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110745392|NCT03892148|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110745393|NCT03892148|Furosemide|furosemide|mesh-list
110745394|NCT03892148|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110745395|NCT03892148|Diuretics|diuretics|mesh-ancestor
110745396|NCT03892148|Natriuretic Agents|natriuretic agents|mesh-ancestor
110745397|NCT03892148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110745398|NCT03892148|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110745399|NCT03892148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110745400|NCT03892148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110745401|NCT03892148|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110745402|NCT01152476|Remifentanil|remifentanil|mesh-list
110745403|NCT01152476|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110745404|NCT01152476|Narcotics|narcotics|mesh-ancestor
110745405|NCT01152476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110745406|NCT01152476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110745407|NCT01152476|Analgesics|analgesics|mesh-ancestor
110745408|NCT01152476|Sensory System Agents|sensory system agents|mesh-ancestor
110745409|NCT01152476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110745410|NCT03892070|Mannitol|mannitol|mesh-list
110745411|NCT03892070|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110745412|NCT03892070|Diuretics|diuretics|mesh-ancestor
110745413|NCT03892070|Natriuretic Agents|natriuretic agents|mesh-ancestor
110745414|NCT03892070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110745415|NCT01155440|Lidocaine|lidocaine|mesh-list
110745416|NCT01155440|Anesthetics, Local|anesthetics, local|mesh-ancestor
110745417|NCT01155440|Anesthetics|anesthetics|mesh-ancestor
110745418|NCT01155440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110745419|NCT01155440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110745420|NCT01155440|Sensory System Agents|sensory system agents|mesh-ancestor
110745421|NCT01155440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110745422|NCT01155440|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110745423|NCT01155440|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110745424|NCT01155440|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110745425|NCT01155440|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110745426|NCT01155440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110745427|NCT01259336|Itraconazole|itraconazole|mesh-list
110745428|NCT01259336|Antifungal Agents|antifungal agents|mesh-ancestor
110745429|NCT01259336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110745430|NCT01259336|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110745431|NCT01259336|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110745432|NCT01259336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110745433|NCT01259336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110745434|NCT01259336|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110745435|NCT01259336|Hormone Antagonists|hormone antagonists|mesh-ancestor
110745436|NCT01259336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110745437|NCT01259336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110745438|NCT01259336|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110745439|NCT01259414|Ethiodized Oil|ethiodized oil|mesh-list
110745440|NCT01259414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110745441|NCT03314662|Vaccines|vaccines|mesh-list
110745442|NCT03314662|MF59 oil emulsion|mf59 oil emulsion|mesh-list
110745443|NCT03314662|Immunologic Factors|immunologic factors|mesh-ancestor
110745444|NCT03314662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110745445|NCT03314662|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110745446|NCT01152710|Capecitabine|capecitabine|mesh-list
110745447|NCT01152710|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110745448|NCT01152710|Antimetabolites|antimetabolites|mesh-ancestor
110745449|NCT01152710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110745450|NCT01152710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110745451|NCT03271528|Lacosamide|lacosamide|mesh-list
110745452|NCT03271528|Anticonvulsants|anticonvulsants|mesh-ancestor
110745453|NCT03271528|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110745454|NCT03271528|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110745455|NCT03271528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110745456|NCT03271528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110745457|NCT04480372|Gemcitabine|gemcitabine|mesh-list
110745458|NCT04480372|Atezolizumab|atezolizumab|mesh-list
110745459|NCT04480372|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110745460|NCT04480372|Antimetabolites|antimetabolites|mesh-ancestor
110745461|NCT04480372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110745462|NCT04480372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110745463|NCT04480372|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110745464|NCT04480372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110745465|NCT04462276|Atezolizumab|atezolizumab|mesh-list
110745466|NCT04462276|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110745467|NCT04462276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110745468|NCT04462276|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110745469|NCT04462276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110745470|NCT03890510|Anesthetics|anesthetics|mesh-list
110745471|NCT03890510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110745472|NCT03890510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110745473|NCT01152866|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
110745474|NCT01152866|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110745475|NCT01152866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110745476|NCT01153568|Vitamin D|vitamin d|mesh-list
110745477|NCT01153568|Cholecalciferol|cholecalciferol|mesh-list
110745478|NCT01153568|Vitamins|vitamins|mesh-ancestor
110745479|NCT01153568|Micronutrients|micronutrients|mesh-ancestor
110745480|NCT01153568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110745481|NCT01153568|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110745482|NCT01153568|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110745483|NCT03889808|Antitoxins|antitoxins|mesh-list
110745484|NCT03889808|Immunologic Factors|immunologic factors|mesh-ancestor
110745485|NCT03889808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110745486|NCT03890042|Dienogest|dienogest|mesh-list
110745487|NCT03890042|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110745488|NCT03890042|Gestodene|gestodene|mesh-list
110745489|NCT03890042|Femovan|femovan|mesh-list
110745490|NCT03890042|Estradiol|estradiol|mesh-list
110745491|NCT03890042|Estrogens|estrogens|mesh-ancestor
110745492|NCT03890042|Hormones|hormones|mesh-ancestor
110745493|NCT03890042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110745494|NCT03890042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110745495|NCT03890042|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110745496|NCT03890042|Contraceptive Agents|contraceptive agents|mesh-ancestor
110745497|NCT03890042|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110463228|NCT01730313|GABA Agents|gaba agents|mesh-ancestor
110745498|NCT03890042|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110745499|NCT03890042|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110745500|NCT03890042|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110745501|NCT03890042|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110745502|NCT03890042|Hormone Antagonists|hormone antagonists|mesh-ancestor
110745503|NCT03890042|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110745504|NCT03890042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110745505|NCT03890042|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110745506|NCT03890042|Progestins|progestins|mesh-ancestor
110745507|NCT03890042|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110745508|NCT01153802|Dopamine|dopamine|mesh-list
110745509|NCT01153802|Norepinephrine|norepinephrine|mesh-list
110745510|NCT01153802|Serotonin|serotonin|mesh-list
110745511|NCT01153802|Neurotransmitter Agents|neurotransmitter agents|mesh-list
110745512|NCT01153802|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110745513|NCT01153802|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110745514|NCT01153802|Adrenergic Agents|adrenergic agents|mesh-ancestor
110745515|NCT01153802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110745516|NCT01153802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110745518|NCT01153802|Autonomic Agents|autonomic agents|mesh-ancestor
110745519|NCT01153802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110745520|NCT01153802|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110745521|NCT01153802|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110745522|NCT01153802|Dopamine Agents|dopamine agents|mesh-ancestor
110745523|NCT01153802|Protective Agents|protective agents|mesh-ancestor
110745524|NCT01153802|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110745525|NCT01153802|Serotonin Agents|serotonin agents|mesh-ancestor
110745526|NCT01153100|Insulin Glargine|insulin glargine|mesh-list
110745527|NCT01153100|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110745528|NCT01153100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110745529|NCT01153256|Magnesium Sulfate|magnesium sulfate|mesh-list
110745530|NCT01153256|Analgesics|analgesics|mesh-ancestor
110745531|NCT01153256|Sensory System Agents|sensory system agents|mesh-ancestor
110745532|NCT01153256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110745533|NCT01153256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110745534|NCT01153256|Anesthetics|anesthetics|mesh-ancestor
110745535|NCT01153256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110745536|NCT01153256|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110745537|NCT01153256|Anticonvulsants|anticonvulsants|mesh-ancestor
110745538|NCT01153256|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110745539|NCT01153256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110745540|NCT01153256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110745541|NCT01153256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110745542|NCT01153256|Tocolytic Agents|tocolytic agents|mesh-ancestor
110745543|NCT01153256|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110745544|NCT01153334|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110745545|NCT01153334|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110745546|NCT01153334|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110745547|NCT01153334|Antimetabolites|antimetabolites|mesh-ancestor
110745548|NCT01153334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110745549|NCT01153334|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110745550|NCT01153334|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110745551|NCT01153334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110745552|NCT01259804|Immunomodulating Agents|immunomodulating agents|mesh-list
110745553|NCT01259804|Immunologic Factors|immunologic factors|mesh-ancestor
110745554|NCT01259804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110745555|NCT01153880|Mupirocin|mupirocin|mesh-list
110745556|NCT01153880|Retapamulin|retapamulin|mesh-list
110745557|NCT01153880|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110745558|NCT01153880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110745559|NCT01153880|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110745560|NCT01153880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110745561|NCT01153880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110745562|NCT01260506|Bevacizumab|bevacizumab|mesh-list
110745563|NCT01260506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110745564|NCT01260506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110745565|NCT01260506|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110745566|NCT01260506|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110745567|NCT01260506|Growth Substances|growth substances|mesh-ancestor
110745568|NCT01260506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110745569|NCT01260506|Growth Inhibitors|growth inhibitors|mesh-ancestor
110745570|NCT01154114|Darapladib|darapladib|mesh-list
110745571|NCT01154114|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
110745572|NCT01154114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110745573|NCT01154114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110745574|NCT01157312|Citric Acid|citric acid|mesh-list
110745575|NCT01157312|Sodium Citrate|sodium citrate|mesh-list
110745577|NCT01157312|Enclomiphene|enclomiphene|mesh-list
110745578|NCT01157312|Zuclomiphene|zuclomiphene|mesh-list
110745579|NCT01157312|Anticoagulants|anticoagulants|mesh-ancestor
110745580|NCT01157312|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110745581|NCT01157312|Chelating Agents|chelating agents|mesh-ancestor
110745582|NCT01157312|Sequestering Agents|sequestering agents|mesh-ancestor
110866954|NCT03744767|Spironolactone|spironolactone|mesh-list
110745583|NCT01157312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110745584|NCT01157312|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110745585|NCT01157312|Hormone Antagonists|hormone antagonists|mesh-ancestor
110745586|NCT01157312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110745587|NCT01157312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110745588|NCT01157312|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110745589|NCT01157312|Fertility Agents|fertility agents|mesh-ancestor
110745590|NCT01157312|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110745591|NCT01157312|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110745592|NCT01157312|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110745593|NCT01157546|Lidocaine|lidocaine|mesh-list
110745594|NCT01157546|Anesthetics, Local|anesthetics, local|mesh-ancestor
110745595|NCT01157546|Anesthetics|anesthetics|mesh-ancestor
110745596|NCT01157546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110745597|NCT01157546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110745598|NCT01157546|Sensory System Agents|sensory system agents|mesh-ancestor
110745599|NCT01157546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110745600|NCT01157546|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110745601|NCT01157546|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110745602|NCT01157546|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110745603|NCT01157546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110745604|NCT01157546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110745605|NCT02527460|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
110745606|NCT02527460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110745607|NCT01263860|Ribavirin|ribavirin|mesh-list
110745608|NCT01263860|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110745609|NCT01263860|Interferon-alpha|interferon-alpha|mesh-list
110745610|NCT01263860|Antimetabolites|antimetabolites|mesh-ancestor
110745611|NCT01263860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110745612|NCT01263860|Antiviral Agents|antiviral agents|mesh-ancestor
110745613|NCT01263860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110745614|NCT01263860|Immunologic Factors|immunologic factors|mesh-ancestor
110745615|NCT01263860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110745616|NCT03881306|Oxaliplatin|oxaliplatin|mesh-list
110745617|NCT03881306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110745618|NCT01154348|Metformin|metformin|mesh-list
110745619|NCT01154348|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110745620|NCT01154348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110745621|NCT00075270|Paclitaxel|paclitaxel|mesh-list
110745622|NCT00075270|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110745623|NCT00075270|Lapatinib|lapatinib|mesh-list
110745624|NCT00075270|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110745625|NCT00075270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110745626|NCT00075270|Tubulin Modulators|tubulin modulators|mesh-ancestor
110745627|NCT00075270|Antimitotic Agents|antimitotic agents|mesh-ancestor
110745628|NCT00075270|Mitosis Modulators|mitosis modulators|mesh-ancestor
110745629|NCT00075270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110745630|NCT00075270|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110745631|NCT00075270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110745632|NCT01264094|Clevudine|clevudine|mesh-list
110745633|NCT01264094|Antiviral Agents|antiviral agents|mesh-ancestor
110745634|NCT01264094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110745635|NCT03884348|Amoxicillin|amoxicillin|mesh-list
110745636|NCT03884348|Metronidazole|metronidazole|mesh-list
110745637|NCT03884348|Clarithromycin|clarithromycin|mesh-list
110745638|NCT03884348|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
110745639|NCT03884348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110745640|NCT03884348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110745641|NCT03884348|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110745642|NCT03884348|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110745643|NCT03884348|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110745644|NCT03884348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110745645|NCT03884348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110745646|NCT03884348|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110745647|NCT03884348|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110745648|NCT01154426|Gemcitabine|gemcitabine|mesh-list
110745649|NCT01154426|Veliparib|veliparib|mesh-list
110745650|NCT01154426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110745651|NCT01154426|Antimetabolites|antimetabolites|mesh-ancestor
110745652|NCT01154426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110745653|NCT01154426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110745654|NCT01154426|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110745655|NCT01154426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110745656|NCT01589744|Hemostatics|hemostatics|mesh-list
110745657|NCT01589744|Coagulants|coagulants|mesh-ancestor
110745658|NCT01154504|Adrenomedullin|adrenomedullin|mesh-list
110745659|NCT01154504|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110745660|NCT01154504|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110745661|NCT01154504|Autonomic Agents|autonomic agents|mesh-ancestor
110745662|NCT01154504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110745663|NCT01154504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110745664|NCT01154504|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110745665|NCT01154504|Respiratory System Agents|respiratory system agents|mesh-ancestor
110745666|NCT01154504|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110745667|NCT01154504|Vasodilator Agents|vasodilator agents|mesh-ancestor
110745668|NCT01154504|Protective Agents|protective agents|mesh-ancestor
110745669|NCT03880916|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110745670|NCT03880916|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110745671|NCT03880916|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110745672|NCT03880916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110745673|NCT03880916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110745674|NCT03880916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110745675|NCT03880916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110745676|NCT03880916|Analgesics|analgesics|mesh-ancestor
110745677|NCT03880916|Sensory System Agents|sensory system agents|mesh-ancestor
110745678|NCT03880916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110745679|NCT03880916|Antidepressive Agents|antidepressive agents|mesh-ancestor
110745680|NCT03880916|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110745681|NCT03880916|Dopamine Agents|dopamine agents|mesh-ancestor
110745682|NCT01155908|Amlodipine|amlodipine|mesh-list
110745683|NCT01155908|Benazepril|benazepril|mesh-list
110745684|NCT01155908|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110745685|NCT01155908|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110745686|NCT01155908|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110745687|NCT01155908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110745688|NCT01155908|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110307868|NCT00269126|Hormones|hormones|mesh-ancestor
110745689|NCT01155908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110745690|NCT01155908|Vasodilator Agents|vasodilator agents|mesh-ancestor
110745691|NCT01155908|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110745692|NCT01155908|Protease Inhibitors|protease inhibitors|mesh-ancestor
110745693|NCT01155908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110745694|NCT03880448|Metronidazole|metronidazole|mesh-list
110745695|NCT03880448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110745696|NCT03880448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110745697|NCT03880448|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110745698|NCT03880448|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110745699|NCT03298984|Cytarabine|cytarabine|mesh-list
110745700|NCT03298984|Daunorubicin|daunorubicin|mesh-list
110745701|NCT03298984|Alvocidib|alvocidib|mesh-list
110745702|NCT03298984|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110745703|NCT03298984|Antimetabolites|antimetabolites|mesh-ancestor
110745704|NCT03298984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110745705|NCT03298984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110745706|NCT03298984|Antiviral Agents|antiviral agents|mesh-ancestor
110745707|NCT03298984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110745708|NCT03298984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110745709|NCT03298984|Immunologic Factors|immunologic factors|mesh-ancestor
110745710|NCT03298984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110745711|NCT03298984|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110745712|NCT03298984|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110745713|NCT03298984|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110745714|NCT03298984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110745715|NCT03298984|Growth Inhibitors|growth inhibitors|mesh-ancestor
110745716|NCT03298984|Growth Substances|growth substances|mesh-ancestor
110745717|NCT03298984|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110745719|NCT03887858|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110745720|NCT03887858|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110745721|NCT03887858|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110745722|NCT03887858|Adrenergic Agents|adrenergic agents|mesh-ancestor
110745723|NCT03887858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110745724|NCT03887858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110745725|NCT03887858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110745726|NCT03887858|Urological Agents|urological agents|mesh-ancestor
110745727|NCT02940574|Oxytocin|oxytocin|mesh-list
110745728|NCT02940574|Oxytocics|oxytocics|mesh-ancestor
110307880|NCT00269204|Vitamins|vitamins|mesh-ancestor
110745729|NCT02940574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110745730|NCT02940574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110745731|NCT01264328|Paclitaxel|paclitaxel|mesh-list
110745732|NCT01264328|Panitumumab|panitumumab|mesh-list
110745733|NCT01264328|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110745734|NCT01264328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110745735|NCT01264328|Tubulin Modulators|tubulin modulators|mesh-ancestor
110745736|NCT01264328|Antimitotic Agents|antimitotic agents|mesh-ancestor
110745737|NCT01264328|Mitosis Modulators|mitosis modulators|mesh-ancestor
110745738|NCT01264328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110745739|NCT01264328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110745740|NCT01157858|Everolimus|everolimus|mesh-list
110745741|NCT01157858|Octreotide|octreotide|mesh-list
110745742|NCT01157858|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110745743|NCT01157858|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110745744|NCT01157858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110745745|NCT01157858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110745746|NCT01157858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110745747|NCT01157858|Immunologic Factors|immunologic factors|mesh-ancestor
110745748|NCT01157858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110745749|NCT01157858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110745750|NCT01157858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110745751|NCT01157858|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110745752|NCT01157936|Allopurinol|allopurinol|mesh-list
110745753|NCT01157936|Antimetabolites|antimetabolites|mesh-ancestor
110745754|NCT01157936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110745755|NCT01157936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110745756|NCT01157936|Gout Suppressants|gout suppressants|mesh-ancestor
110745757|NCT01157936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110745758|NCT01157936|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110745759|NCT01157936|Antioxidants|antioxidants|mesh-ancestor
110745760|NCT01157936|Protective Agents|protective agents|mesh-ancestor
110745761|NCT01157936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110745762|NCT01264484|Imidacloprid|imidacloprid|mesh-list
110745763|NCT01264484|Cholinergic Agents|cholinergic agents|mesh-ancestor
110745764|NCT01264484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110745765|NCT01264484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110745766|NCT01264484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110745767|NCT01260818|Tranexamic Acid|tranexamic acid|mesh-list
110745768|NCT01260818|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110745769|NCT01260818|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110745770|NCT01260818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110745771|NCT01260818|Hemostatics|hemostatics|mesh-ancestor
110745772|NCT01260818|Coagulants|coagulants|mesh-ancestor
110745773|NCT01262612|Cediranib|cediranib|mesh-list
110745774|NCT01262612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110745775|NCT01262612|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110745776|NCT01262612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110745777|NCT01262612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110745778|NCT01158014|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
110745779|NCT01158014|Hemostatics|hemostatics|mesh-ancestor
110745780|NCT01158014|Coagulants|coagulants|mesh-ancestor
110745781|NCT03884036|Vitamin D|vitamin d|mesh-list
110745782|NCT03884036|Vitamins|vitamins|mesh-ancestor
110745783|NCT03884036|Micronutrients|micronutrients|mesh-ancestor
110745784|NCT03884036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110745785|NCT03884036|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110745786|NCT01158170|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110745787|NCT01158170|Gefitinib|gefitinib|mesh-list
110745788|NCT01158170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110745789|NCT01158170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110745790|NCT01158170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110866969|NCT02428972|Anesthetics|anesthetics|mesh-ancestor
110745791|NCT01158170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110745792|NCT01260974|Caspofungin|caspofungin|mesh-list
110745793|NCT01260974|Antifungal Agents|antifungal agents|mesh-ancestor
110745794|NCT01260974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110745795|NCT01260974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110745796|NCT01260974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110745797|NCT01264640|Aspirin|aspirin|mesh-list
110745798|NCT01264640|Clopidogrel|clopidogrel|mesh-list
110745799|NCT01264640|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110745800|NCT01264640|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110745801|NCT01264640|Analgesics|analgesics|mesh-ancestor
110745802|NCT01264640|Sensory System Agents|sensory system agents|mesh-ancestor
110745803|NCT01264640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110745804|NCT01264640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110745805|NCT01264640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110745806|NCT01264640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110745807|NCT01264640|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110745808|NCT01264640|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110745809|NCT01264640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110745810|NCT01264640|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110745811|NCT01264640|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110745812|NCT01264640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110745813|NCT01264640|Antipyretics|antipyretics|mesh-ancestor
110745814|NCT01264640|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110745815|NCT01264640|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110745816|NCT01264640|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110745817|NCT01264640|Purinergic Agents|purinergic agents|mesh-ancestor
110745818|NCT01264640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110745819|NCT01155986|Lidocaine|lidocaine|mesh-list
110745820|NCT01155986|Anesthetics, Local|anesthetics, local|mesh-ancestor
110745821|NCT01155986|Anesthetics|anesthetics|mesh-ancestor
110745822|NCT01155986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110745823|NCT01155986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110745824|NCT01155986|Sensory System Agents|sensory system agents|mesh-ancestor
110745825|NCT01155986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110745826|NCT01155986|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110745827|NCT01155986|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110745828|NCT01155986|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110745829|NCT01155986|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110745830|NCT01155986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110745831|NCT01261130|Aluminum Hydroxide|aluminum hydroxide|mesh-list
110745832|NCT01261130|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110745833|NCT01261130|Immunologic Factors|immunologic factors|mesh-ancestor
110745834|NCT01261130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110745835|NCT01261130|Antacids|antacids|mesh-ancestor
110745836|NCT01261130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110745837|NCT01261130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110745838|NCT01158248|Panitumumab|panitumumab|mesh-list
110745839|NCT01158248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110745840|NCT01158248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110745841|NCT01264874|Vitamin D|vitamin d|mesh-list
110745842|NCT01264874|Cholecalciferol|cholecalciferol|mesh-list
110745843|NCT01264874|Vitamins|vitamins|mesh-ancestor
110745844|NCT01264874|Micronutrients|micronutrients|mesh-ancestor
110745845|NCT01264874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110745846|NCT01264874|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110745847|NCT01264874|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110745848|NCT01262924|Vaccines|vaccines|mesh-list
110745849|NCT01262924|Immunologic Factors|immunologic factors|mesh-ancestor
110745850|NCT01262924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110745851|NCT01158560|Vitamin D|vitamin d|mesh-list
110745852|NCT01158560|Cholecalciferol|cholecalciferol|mesh-list
110745853|NCT01158560|Vitamins|vitamins|mesh-ancestor
110745854|NCT01158560|Micronutrients|micronutrients|mesh-ancestor
110745855|NCT01158560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110745856|NCT01158560|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110745857|NCT01158560|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110745858|NCT03879746|Paroxetine|paroxetine|mesh-list
110745859|NCT03879746|Tamsulosin|tamsulosin|mesh-list
110745860|NCT03879746|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110745861|NCT03879746|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110745862|NCT03879746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110745863|NCT03879746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110745864|NCT03879746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110745865|NCT03879746|Serotonin Agents|serotonin agents|mesh-ancestor
110745866|NCT03879746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110745867|NCT03879746|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110745869|NCT03879746|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110745870|NCT03879746|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110745871|NCT03879746|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110745872|NCT03879746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110745873|NCT03879746|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110745874|NCT03879746|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110745875|NCT03879746|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110745876|NCT03879746|Adrenergic Agents|adrenergic agents|mesh-ancestor
110745877|NCT03879746|Urological Agents|urological agents|mesh-ancestor
110745878|NCT03879590|Budesonide|budesonide|mesh-list
110745879|NCT03879590|Doxofylline|doxofylline|mesh-list
110745880|NCT03879590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110745881|NCT03879590|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110745882|NCT03879590|Autonomic Agents|autonomic agents|mesh-ancestor
110745883|NCT03879590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110745884|NCT03879590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110745885|NCT03879590|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110745886|NCT03879590|Respiratory System Agents|respiratory system agents|mesh-ancestor
110745887|NCT03879590|Glucocorticoids|glucocorticoids|mesh-ancestor
110745888|NCT03879590|Hormones|hormones|mesh-ancestor
110745889|NCT03879590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110745890|NCT03879590|Antitussive Agents|antitussive agents|mesh-ancestor
110745891|NCT03879590|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110745892|NCT03879590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110745893|NCT03879590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110745894|NCT01265108|Iron|iron|mesh-list
110745895|NCT01265108|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
110745896|NCT01265108|Trace Elements|trace elements|mesh-ancestor
110745897|NCT01265108|Micronutrients|micronutrients|mesh-ancestor
110745898|NCT01265108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110745899|NCT01265108|Hematinics|hematinics|mesh-ancestor
110745900|NCT01154738|Lidocaine|lidocaine|mesh-list
110745901|NCT01154738|Anesthetics, Local|anesthetics, local|mesh-ancestor
110745902|NCT01154738|Anesthetics|anesthetics|mesh-ancestor
110745903|NCT01154738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110307939|NCT00269555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110745904|NCT01154738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110745905|NCT01154738|Sensory System Agents|sensory system agents|mesh-ancestor
110745906|NCT01154738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110745907|NCT01154738|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110745908|NCT01154738|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110745909|NCT01154738|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110745910|NCT01154738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110745911|NCT01154738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110745912|NCT01263002|Adefovir|adefovir|mesh-list
110745913|NCT01263002|Clevudine|clevudine|mesh-list
110745914|NCT01263002|Antiviral Agents|antiviral agents|mesh-ancestor
110745915|NCT01263002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110745916|NCT01263002|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110745917|NCT01263002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110745918|NCT01263002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110745919|NCT01263002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110745920|NCT01261286|Verapamil|verapamil|mesh-list
110745921|NCT01261286|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110745922|NCT01261286|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110745923|NCT01261286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110745924|NCT01261286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110745925|NCT01261286|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110745926|NCT01261286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110745927|NCT01261286|Vasodilator Agents|vasodilator agents|mesh-ancestor
110745928|NCT01263080|Folic Acid|folic acid|mesh-list
110745929|NCT01263080|Vitamin B Complex|vitamin b complex|mesh-list
110745930|NCT01263080|Mirtazapine|mirtazapine|mesh-list
110745931|NCT01263080|Vitamins|vitamins|mesh-ancestor
110745932|NCT01263080|Micronutrients|micronutrients|mesh-ancestor
110745933|NCT01263080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110745934|NCT01263080|Hematinics|hematinics|mesh-ancestor
110745935|NCT01263080|Antidepressive Agents|antidepressive agents|mesh-ancestor
110745936|NCT01263080|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110745937|NCT01263080|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110745938|NCT01263080|Histamine Antagonists|histamine antagonists|mesh-ancestor
110745939|NCT01263080|Histamine Agents|histamine agents|mesh-ancestor
110745940|NCT01263080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110745941|NCT01263080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110745942|NCT01263080|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110745943|NCT01263080|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110745944|NCT01263080|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110745945|NCT01263080|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
110745946|NCT01263080|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110307975|NCT00302835|Analgesics|analgesics|mesh-list
110745947|NCT01263080|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110745948|NCT01263080|Adrenergic Agents|adrenergic agents|mesh-ancestor
110745949|NCT01263080|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110745950|NCT01263080|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110745951|NCT01263080|Serotonin Agents|serotonin agents|mesh-ancestor
110745952|NCT01263080|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110745954|NCT01263158|Oxytocics|oxytocics|mesh-ancestor
110745955|NCT01263158|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110745956|NCT01263158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110745957|NCT03879356|Acetylcysteine|acetylcysteine|mesh-list
110745958|NCT03879356|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110745959|NCT03879356|Antiviral Agents|antiviral agents|mesh-ancestor
110745960|NCT03879356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110745961|NCT03879356|Expectorants|expectorants|mesh-ancestor
110745962|NCT03879356|Respiratory System Agents|respiratory system agents|mesh-ancestor
110745963|NCT03879356|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110745964|NCT03879356|Antioxidants|antioxidants|mesh-ancestor
110745965|NCT03879356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110745966|NCT03879356|Protective Agents|protective agents|mesh-ancestor
110745967|NCT03879356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110745968|NCT03879356|Antidotes|antidotes|mesh-ancestor
110745969|NCT01159418|Paclitaxel|paclitaxel|mesh-list
110745970|NCT01159418|Carboplatin|carboplatin|mesh-list
110745971|NCT01159418|Panobinostat|panobinostat|mesh-list
110745972|NCT01159418|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110745973|NCT01159418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110745974|NCT01159418|Tubulin Modulators|tubulin modulators|mesh-ancestor
110745975|NCT01159418|Antimitotic Agents|antimitotic agents|mesh-ancestor
110745976|NCT01159418|Mitosis Modulators|mitosis modulators|mesh-ancestor
110745977|NCT01159418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110745978|NCT01159418|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110745979|NCT01159418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110745980|NCT03886766|Efavirenz|efavirenz|mesh-list
110745981|NCT03886766|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110745982|NCT03886766|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110745983|NCT03886766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110745984|NCT03886766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110745985|NCT03886766|Antiviral Agents|antiviral agents|mesh-ancestor
110745986|NCT03886766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110745987|NCT03886766|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110745988|NCT03886766|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110745989|NCT03886766|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110745990|NCT03886766|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110745991|NCT03886766|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110745992|NCT03886766|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110745993|NCT01265342|Beclomethasone|beclomethasone|mesh-list
110745994|NCT01265342|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110745995|NCT01265342|Glucocorticoids|glucocorticoids|mesh-ancestor
110745996|NCT01265342|Hormones|hormones|mesh-ancestor
110745997|NCT01265342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110745998|NCT01265342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110745999|NCT01265342|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110746000|NCT01265342|Respiratory System Agents|respiratory system agents|mesh-ancestor
110746001|NCT03883334|Inosine Pranobex|inosine pranobex|mesh-list
110746002|NCT03883334|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110746003|NCT03883334|Immunologic Factors|immunologic factors|mesh-ancestor
110746004|NCT03883334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110746005|NCT03883334|Antiviral Agents|antiviral agents|mesh-ancestor
110746006|NCT03883334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110746007|NCT01265576|Etodolac|etodolac|mesh-list
110746008|NCT01265576|Sorafenib|sorafenib|mesh-list
110746009|NCT01265576|Propranolol|propranolol|mesh-list
110746010|NCT01265576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110307989|NCT00269750|Urological Agents|urological agents|mesh-ancestor
110746011|NCT01265576|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110746012|NCT01265576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110746013|NCT01265576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110746014|NCT01265576|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110746015|NCT01265576|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110746016|NCT01265576|Adrenergic Agents|adrenergic agents|mesh-ancestor
110746017|NCT01265576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110746018|NCT01265576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110746019|NCT01265576|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110746020|NCT01265576|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110746021|NCT01265576|Vasodilator Agents|vasodilator agents|mesh-ancestor
110746022|NCT01265576|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110746023|NCT01265576|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110746024|NCT01265576|Analgesics|analgesics|mesh-ancestor
110746025|NCT01265576|Sensory System Agents|sensory system agents|mesh-ancestor
110746026|NCT01265576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110746027|NCT01265576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110746028|NCT01265576|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110746029|NCT01265576|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110746030|NCT01265576|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110746031|NCT03883022|Vancomycin|vancomycin|mesh-list
110746032|NCT03883022|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110746033|NCT03883022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110746034|NCT01159652|Zaleplon|zaleplon|mesh-list
110746035|NCT01159652|Zolpidem|zolpidem|mesh-list
110746036|NCT01159652|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110746037|NCT01159652|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110746038|NCT01159652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110746039|NCT01159652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110746040|NCT01159652|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
110746041|NCT01159652|GABA Agonists|gaba agonists|mesh-ancestor
110746042|NCT01159652|GABA Agents|gaba agents|mesh-ancestor
110746043|NCT01159652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110746044|NCT01159652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110746045|NCT01159652|Anticonvulsants|anticonvulsants|mesh-ancestor
110746047|NCT01261832|Cilostazol|cilostazol|mesh-list
110746048|NCT01261832|Clopidogrel|clopidogrel|mesh-list
110746049|NCT01261832|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110746050|NCT01261832|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110746051|NCT01261832|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110746052|NCT01261832|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110746053|NCT01261832|Purinergic Agents|purinergic agents|mesh-ancestor
110746054|NCT01261832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110746055|NCT01261832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110746056|NCT01261832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110746057|NCT01261832|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110746058|NCT01261832|Autonomic Agents|autonomic agents|mesh-ancestor
110746059|NCT01261832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110746060|NCT01261832|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110746061|NCT01261832|Respiratory System Agents|respiratory system agents|mesh-ancestor
110746062|NCT01261832|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110746063|NCT01261832|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110746064|NCT01261832|Vasodilator Agents|vasodilator agents|mesh-ancestor
110746065|NCT01261832|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110746066|NCT01261832|Protective Agents|protective agents|mesh-ancestor
110746067|NCT01261832|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110746068|NCT01261832|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110746069|NCT01261832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110746070|NCT01265810|Calcium|calcium|mesh-list
110746071|NCT01265810|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110308008|NCT00269828|Paclitaxel|paclitaxel|mesh-list
110746072|NCT01265810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110746073|NCT01265888|Nitric Oxide|nitric oxide|mesh-list
110746074|NCT01265888|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110746075|NCT01265888|Autonomic Agents|autonomic agents|mesh-ancestor
110746076|NCT01265888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110746077|NCT01265888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110746078|NCT01265888|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110746079|NCT01265888|Respiratory System Agents|respiratory system agents|mesh-ancestor
110746080|NCT01265888|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110746081|NCT01265888|Antioxidants|antioxidants|mesh-ancestor
110746082|NCT01265888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110746083|NCT01265888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110746084|NCT01265888|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
110746085|NCT01265888|Vasodilator Agents|vasodilator agents|mesh-ancestor
110746086|NCT01265888|Gasotransmitters|gasotransmitters|mesh-ancestor
110746087|NCT01265888|Protective Agents|protective agents|mesh-ancestor
110746088|NCT01155206|Glucagon|glucagon|mesh-list
110746089|NCT01155206|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
110746090|NCT01155206|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110746091|NCT01155206|Hormones|hormones|mesh-ancestor
110746092|NCT01155206|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110746093|NCT01155206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110746094|NCT01155206|Incretins|incretins|mesh-ancestor
110463832|NCT00132717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110746095|NCT03879278|Immunoglobulins|immunoglobulins|mesh-list
110746096|NCT03879278|Immunoglobulin G|immunoglobulin g|mesh-list
110746097|NCT03879278|Immunologic Factors|immunologic factors|mesh-ancestor
110746098|NCT03879278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110746099|NCT03878888|Bupivacaine|bupivacaine|mesh-list
110746100|NCT03878888|Anesthetics, Local|anesthetics, local|mesh-ancestor
110746101|NCT03878888|Anesthetics|anesthetics|mesh-ancestor
110746102|NCT03878888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110746103|NCT03878888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110746104|NCT03878888|Sensory System Agents|sensory system agents|mesh-ancestor
110746105|NCT03878888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110746106|NCT03882710|Metoprolol|metoprolol|mesh-list
110746107|NCT03882710|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110746108|NCT03882710|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110746109|NCT03882710|Sympatholytics|sympatholytics|mesh-ancestor
110746110|NCT03882710|Autonomic Agents|autonomic agents|mesh-ancestor
110746111|NCT03882710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110746112|NCT03882710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110746113|NCT03882710|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110746114|NCT03882710|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110746115|NCT03882710|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110746116|NCT03882710|Adrenergic Agents|adrenergic agents|mesh-ancestor
110746117|NCT03882710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110746118|NCT03882710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110746119|NCT01161836|Iniparib|iniparib|mesh-list
110746120|NCT01161836|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110746121|NCT01161836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110746122|NCT01161836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110746123|NCT01161836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110746124|NCT01266434|Simvastatin|simvastatin|mesh-list
110746125|NCT01266434|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110746126|NCT01266434|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110746127|NCT01266434|Antimetabolites|antimetabolites|mesh-ancestor
110746128|NCT01266434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110746129|NCT01266434|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110746130|NCT01266434|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110746131|NCT01266434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110746132|NCT01266512|Docetaxel|docetaxel|mesh-list
110746133|NCT01266512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110746134|NCT01266512|Tubulin Modulators|tubulin modulators|mesh-ancestor
110746135|NCT01266512|Antimitotic Agents|antimitotic agents|mesh-ancestor
110746136|NCT01266512|Mitosis Modulators|mitosis modulators|mesh-ancestor
110746137|NCT01266512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110746138|NCT01160042|Metformin|metformin|mesh-list
110746139|NCT01160042|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110746140|NCT01160042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110746141|NCT03882788|Fentanyl|fentanyl|mesh-list
110746142|NCT03882788|Isoflurane|isoflurane|mesh-list
110746143|NCT03882788|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110746144|NCT03882788|Narcotics|narcotics|mesh-ancestor
110746145|NCT03882788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110746146|NCT03882788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110746147|NCT03882788|Analgesics|analgesics|mesh-ancestor
110746148|NCT03882788|Sensory System Agents|sensory system agents|mesh-ancestor
110746149|NCT03882788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110746150|NCT03882788|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110746151|NCT03882788|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110746152|NCT03882788|Anesthetics, General|anesthetics, general|mesh-ancestor
110746153|NCT03882788|Anesthetics|anesthetics|mesh-ancestor
110746154|NCT03882788|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110746155|NCT01156688|Misoprostol|misoprostol|mesh-list
110746156|NCT01156688|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110746157|NCT01156688|Abortifacient Agents|abortifacient agents|mesh-ancestor
110071215|NCT01557907|Insulin|insulin|mesh-list
110746158|NCT01156688|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110746159|NCT01156688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110746160|NCT01156688|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110746161|NCT01156688|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110746162|NCT01156688|Oxytocics|oxytocics|mesh-ancestor
110746163|NCT03876704|Vitamins|vitamins|mesh-list
110746164|NCT03876704|Micronutrients|micronutrients|mesh-ancestor
110746165|NCT03876704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110746166|NCT03878654|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
110746167|NCT03878654|Antiviral Agents|antiviral agents|mesh-ancestor
110746168|NCT03878654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110746169|NCT03878654|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
110463905|NCT00938964|Lidocaine|lidocaine|mesh-list
110746170|NCT03878654|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110746171|NCT03878264|Cortisone|cortisone|mesh-list
110746172|NCT03878264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110746173|NCT03882164|Tacrolimus|tacrolimus|mesh-list
110746174|NCT03882164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110746175|NCT03882164|Immunologic Factors|immunologic factors|mesh-ancestor
110746176|NCT03882164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110746177|NCT03882164|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110746178|NCT03882164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110746179|NCT03882164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110746180|NCT01160276|Cyclosporine|cyclosporine|mesh-list
110746181|NCT01160276|Colchicine|colchicine|mesh-list
110746182|NCT01160276|Tacrolimus|tacrolimus|mesh-list
110746183|NCT01160276|Cyclosporins|cyclosporins|mesh-list
110746184|NCT01160276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110746185|NCT01160276|Immunologic Factors|immunologic factors|mesh-ancestor
110746186|NCT01160276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110746187|NCT01160276|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110746188|NCT01160276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110746189|NCT01160276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110746190|NCT01160276|Antifungal Agents|antifungal agents|mesh-ancestor
110746191|NCT01160276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110746192|NCT01160276|Dermatologic Agents|dermatologic agents|mesh-ancestor
110746193|NCT01160276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110746194|NCT01160276|Gout Suppressants|gout suppressants|mesh-ancestor
110746195|NCT01160276|Tubulin Modulators|tubulin modulators|mesh-ancestor
110746196|NCT01160276|Antimitotic Agents|antimitotic agents|mesh-ancestor
110746197|NCT01160276|Mitosis Modulators|mitosis modulators|mesh-ancestor
110746198|NCT01160276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110746199|NCT01263548|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
110746200|NCT01263548|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110746201|NCT01263548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110746202|NCT01263548|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110746203|NCT01263548|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110746204|NCT01263548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110746205|NCT01263548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110746206|NCT01263548|Dopamine Agents|dopamine agents|mesh-ancestor
110746207|NCT01263548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110746208|NCT01160432|Methadone|methadone|mesh-list
110746209|NCT01160432|Naloxone|naloxone|mesh-list
110746210|NCT01160432|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110746211|NCT01160432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110746212|NCT01160432|Sensory System Agents|sensory system agents|mesh-ancestor
110746213|NCT01160432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110746214|NCT01160432|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110746215|NCT01160432|Narcotics|narcotics|mesh-ancestor
110746216|NCT01160432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110746217|NCT01160432|Analgesics|analgesics|mesh-ancestor
110746218|NCT01160432|Antitussive Agents|antitussive agents|mesh-ancestor
110746219|NCT01160432|Respiratory System Agents|respiratory system agents|mesh-ancestor
110746220|NCT03877718|Promethazine|promethazine|mesh-list
110746221|NCT03877718|Diphenhydramine|diphenhydramine|mesh-list
110746222|NCT03877718|Sumatriptan|sumatriptan|mesh-list
110746223|NCT03877718|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110746224|NCT03877718|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110746225|NCT03877718|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110746226|NCT03877718|Serotonin Agents|serotonin agents|mesh-ancestor
110746227|NCT03877718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110746228|NCT03877718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110746229|NCT03877718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110746230|NCT03877718|Antipruritics|antipruritics|mesh-ancestor
110746231|NCT03877718|Dermatologic Agents|dermatologic agents|mesh-ancestor
110746232|NCT03877718|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110746233|NCT03877718|Histamine Antagonists|histamine antagonists|mesh-ancestor
110746234|NCT03877718|Histamine Agents|histamine agents|mesh-ancestor
110746235|NCT03877718|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110746236|NCT03877718|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110746237|NCT03877718|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110746238|NCT03877718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110746239|NCT03877718|Anesthetics, Local|anesthetics, local|mesh-ancestor
110746240|NCT03877718|Anesthetics|anesthetics|mesh-ancestor
110746241|NCT03877718|Sensory System Agents|sensory system agents|mesh-ancestor
110746242|NCT03877718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110746243|NCT03877718|Antiemetics|antiemetics|mesh-ancestor
110746244|NCT03877718|Autonomic Agents|autonomic agents|mesh-ancestor
110867036|NCT03717415|Carboplatin|carboplatin|mesh-list
110746245|NCT03877718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110746247|NCT01267058|Immunologic Factors|immunologic factors|mesh-ancestor
110746248|NCT01267058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110746249|NCT02526914|Vasopressins|vasopressins|mesh-list
110746250|NCT02526914|Arginine Vasopressin|arginine vasopressin|mesh-list
110746251|NCT02526914|Oxytocin|oxytocin|mesh-list
110746252|NCT02526914|Oxytocics|oxytocics|mesh-ancestor
110746253|NCT02526914|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110746254|NCT02526914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110746255|NCT02526914|Hemostatics|hemostatics|mesh-ancestor
110746256|NCT02526914|Coagulants|coagulants|mesh-ancestor
110746257|NCT02526914|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110746258|NCT02526914|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
110746259|NCT02526914|Natriuretic Agents|natriuretic agents|mesh-ancestor
110746260|NCT03876938|Olanzapine|olanzapine|mesh-list
110746261|NCT03876938|Aprepitant|aprepitant|mesh-list
110746262|NCT03876938|Antiemetics|antiemetics|mesh-ancestor
110746263|NCT03876938|Autonomic Agents|autonomic agents|mesh-ancestor
110746264|NCT03876938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110746265|NCT03876938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110746266|NCT03876938|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110746267|NCT03876938|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110308033|NCT00269945|Epoetin Alfa|epoetin alfa|mesh-list
110746268|NCT03876938|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110746269|NCT03876938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110746270|NCT03876938|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110746271|NCT03876938|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110746272|NCT03876938|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110746273|NCT03876938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110746274|NCT03876938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110746275|NCT03876938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110746276|NCT03876938|Serotonin Agents|serotonin agents|mesh-ancestor
110746277|NCT03876938|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110746278|NCT01162460|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
110746279|NCT01162460|Anticonvulsants|anticonvulsants|mesh-ancestor
110746280|NCT01162460|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110746281|NCT01162460|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110746282|NCT01162460|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110746283|NCT01162460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110746284|NCT03882008|Abatacept|abatacept|mesh-list
110746285|NCT03882008|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110746286|NCT03882008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110746287|NCT03882008|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110746288|NCT03882008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110746289|NCT03882008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110746290|NCT03882008|Immunologic Factors|immunologic factors|mesh-ancestor
110746291|NCT03882008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110746292|NCT03882008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110746293|NCT01267214|Hyaluronic Acid|hyaluronic acid|mesh-list
110746294|NCT01267214|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110746295|NCT01267214|Immunologic Factors|immunologic factors|mesh-ancestor
110746296|NCT01267214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110746297|NCT01267214|Viscosupplements|viscosupplements|mesh-ancestor
110746298|NCT01267214|Protective Agents|protective agents|mesh-ancestor
110746299|NCT01156922|Rituximab|rituximab|mesh-list
110746300|NCT01156922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110746301|NCT01156922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110746302|NCT01156922|Immunologic Factors|immunologic factors|mesh-ancestor
110746303|NCT01156922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110746304|NCT01156922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110746305|NCT03877874|Terbutaline|terbutaline|mesh-list
110746306|NCT03877874|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110746307|NCT03877874|Autonomic Agents|autonomic agents|mesh-ancestor
110746308|NCT03877874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110746309|NCT03877874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110746310|NCT03877874|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110746311|NCT03877874|Respiratory System Agents|respiratory system agents|mesh-ancestor
110746313|NCT03877874|Tocolytic Agents|tocolytic agents|mesh-ancestor
110746314|NCT03877874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110746315|NCT03877874|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110746316|NCT03877874|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110746317|NCT03877874|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110746318|NCT03877874|Adrenergic Agents|adrenergic agents|mesh-ancestor
110746319|NCT03877874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110746320|NCT03877874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110746321|NCT01160588|Sertraline|sertraline|mesh-list
110746322|NCT01160588|Antidepressive Agents|antidepressive agents|mesh-ancestor
110746323|NCT01160588|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110746324|NCT01160588|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110746325|NCT01160588|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110746326|NCT01160588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110746327|NCT01160588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110308050|NCT00297375|Antipyretics|antipyretics|mesh-ancestor
110746328|NCT01160588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110746329|NCT01160588|Serotonin Agents|serotonin agents|mesh-ancestor
110746330|NCT01160588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110746331|NCT03877562|Olanzapine|olanzapine|mesh-list
110746332|NCT03877562|Antiemetics|antiemetics|mesh-ancestor
110746333|NCT03877562|Autonomic Agents|autonomic agents|mesh-ancestor
110746334|NCT03877562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110746335|NCT03877562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110746336|NCT03877562|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110746337|NCT03877562|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110746338|NCT03877562|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110746339|NCT03877562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110746340|NCT03877562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110746341|NCT03877562|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110746342|NCT03877562|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110746343|NCT03877562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110746344|NCT03877562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110746345|NCT03877562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110746346|NCT03877562|Serotonin Agents|serotonin agents|mesh-ancestor
110746347|NCT01160666|Belimumab|belimumab|mesh-list
110746348|NCT01160666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110746349|NCT01160666|Immunologic Factors|immunologic factors|mesh-ancestor
110746350|NCT01160666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110746351|NCT03876548|Iodine|iodine|mesh-list
110746352|NCT03876548|Cadexomer iodine|cadexomer iodine|mesh-list
110746353|NCT03876548|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110746354|NCT03876548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110746355|NCT03876548|Trace Elements|trace elements|mesh-ancestor
110746356|NCT03876548|Micronutrients|micronutrients|mesh-ancestor
110746357|NCT03876548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110746358|NCT03760250|Imiquimod|imiquimod|mesh-list
110746359|NCT03760250|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110746360|NCT03760250|Immunologic Factors|immunologic factors|mesh-ancestor
110746361|NCT03760250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110746362|NCT03760250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110746363|NCT03760250|Interferon Inducers|interferon inducers|mesh-ancestor
110746364|NCT01157000|Canagliflozin|canagliflozin|mesh-list
110746365|NCT01157000|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110746366|NCT01157000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110746367|NCT01157000|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110746368|NCT01157000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110746369|NCT01160900|Bivalirudin|bivalirudin|mesh-list
110746370|NCT01160900|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
110746371|NCT01160900|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110746372|NCT01160900|Antithrombins|antithrombins|mesh-ancestor
110746373|NCT01160900|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110746374|NCT01160900|Protease Inhibitors|protease inhibitors|mesh-ancestor
110746375|NCT01160900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110746376|NCT01160900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110746377|NCT01160900|Anticoagulants|anticoagulants|mesh-ancestor
110746378|NCT01160978|Simvastatin|simvastatin|mesh-list
110746379|NCT01160978|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110746380|NCT01160978|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110746381|NCT01160978|Antimetabolites|antimetabolites|mesh-ancestor
110746382|NCT01160978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110746383|NCT01160978|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110746384|NCT01160978|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110746385|NCT01160978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110746386|NCT01161134|Meloxicam|meloxicam|mesh-list
110746387|NCT01161134|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110746388|NCT01161134|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110746389|NCT01161134|Analgesics|analgesics|mesh-ancestor
110746390|NCT01161134|Sensory System Agents|sensory system agents|mesh-ancestor
110746391|NCT01161134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110746392|NCT01161134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110746393|NCT01161134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110746394|NCT01161134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110746395|NCT01161134|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110746396|NCT01161134|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110746397|NCT01161134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110746398|NCT01161134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110746399|NCT01268384|Gemcitabine|gemcitabine|mesh-list
110746400|NCT01268384|Capecitabine|capecitabine|mesh-list
110746401|NCT01268384|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110746402|NCT01268384|Antimetabolites|antimetabolites|mesh-ancestor
110746403|NCT01268384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110746404|NCT01268384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110746405|NCT01269476|Fluorides|fluorides|mesh-list
110746406|NCT01269476|Methanesulfonyl fluoride|methanesulfonyl fluoride|mesh-list
110746407|NCT01269476|Cariostatic Agents|cariostatic agents|mesh-ancestor
110746408|NCT01269476|Protective Agents|protective agents|mesh-ancestor
110746409|NCT01269476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110746410|NCT01269476|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110746411|NCT01269476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110746412|NCT01269476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110746413|NCT01269476|Cholinergic Agents|cholinergic agents|mesh-ancestor
110746414|NCT01269476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110746415|NCT01161368|Vinorelbine|vinorelbine|mesh-list
110746416|NCT01161368|Lapatinib|lapatinib|mesh-list
110746417|NCT01161368|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110746418|NCT01161368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110746419|NCT01161368|Tubulin Modulators|tubulin modulators|mesh-ancestor
110746420|NCT01161368|Antimitotic Agents|antimitotic agents|mesh-ancestor
110746421|NCT01161368|Mitosis Modulators|mitosis modulators|mesh-ancestor
110746422|NCT01161368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110746423|NCT01161368|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110746424|NCT01161368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110746425|NCT01267760|Dialysis Solutions|dialysis solutions|mesh-list
110746426|NCT01267760|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110746427|NCT01280162|Piperaquine|piperaquine|mesh-list
110746428|NCT01280162|Artenimol|artenimol|mesh-list
110746429|NCT01280162|Antimalarials|antimalarials|mesh-ancestor
110746430|NCT01280162|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110746431|NCT01280162|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110746432|NCT01280162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110746433|NCT01167062|Tamsulosin|tamsulosin|mesh-list
110746434|NCT01167062|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110746435|NCT01167062|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110746436|NCT01167062|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110746437|NCT01167062|Adrenergic Agents|adrenergic agents|mesh-ancestor
110746438|NCT01167062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110746439|NCT01167062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110746440|NCT01167062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110746441|NCT01167062|Urological Agents|urological agents|mesh-ancestor
110746442|NCT01280240|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
110746443|NCT01280240|Hematinics|hematinics|mesh-ancestor
110746444|NCT01165268|Dapagliflozin|dapagliflozin|mesh-list
110867059|NCT04207710|Anesthetics, Local|anesthetics, local|mesh-ancestor
110746445|NCT01165268|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110746446|NCT01165268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110746447|NCT01165268|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110746448|NCT01165268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110746450|NCT03874364|Anesthetics, Local|anesthetics, local|mesh-ancestor
110746451|NCT03874364|Anesthetics|anesthetics|mesh-ancestor
110746452|NCT03874364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110746453|NCT03874364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110746454|NCT03874364|Sensory System Agents|sensory system agents|mesh-ancestor
110746455|NCT03874364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110746456|NCT03874364|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110746457|NCT03874364|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110746458|NCT03874364|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110746459|NCT03874364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110746460|NCT03874364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110746461|NCT01163396|Leucovorin|leucovorin|mesh-list
110746462|NCT01163396|Bevacizumab|bevacizumab|mesh-list
110746463|NCT01163396|Fluorouracil|fluorouracil|mesh-list
110746464|NCT01163396|Oxaliplatin|oxaliplatin|mesh-list
110746465|NCT01163396|Irinotecan|irinotecan|mesh-list
110746466|NCT01163396|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110746467|NCT01163396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110746468|NCT01163396|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110746469|NCT01163396|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110746470|NCT01163396|Growth Substances|growth substances|mesh-ancestor
110746471|NCT01163396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110746472|NCT01163396|Growth Inhibitors|growth inhibitors|mesh-ancestor
110746473|NCT01163396|Antimetabolites|antimetabolites|mesh-ancestor
110746474|NCT01163396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110746475|NCT01163396|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110746476|NCT01163396|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110746477|NCT01163396|Immunologic Factors|immunologic factors|mesh-ancestor
110746478|NCT01163396|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110746479|NCT01163396|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110746480|NCT01163396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110746481|NCT01163396|Antidotes|antidotes|mesh-ancestor
110746482|NCT01163396|Protective Agents|protective agents|mesh-ancestor
110746483|NCT01163396|Vitamin B Complex|vitamin b complex|mesh-ancestor
110746484|NCT01163396|Vitamins|vitamins|mesh-ancestor
110746485|NCT01163396|Micronutrients|micronutrients|mesh-ancestor
110746486|NCT01269788|Fluoxetine|fluoxetine|mesh-list
110746487|NCT01269788|Omeprazole|omeprazole|mesh-list
110746488|NCT01269788|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110746489|NCT01269788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110746490|NCT01269788|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110746491|NCT01269788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110746492|NCT01269788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110746493|NCT01269788|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110746494|NCT01269788|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110746495|NCT01269788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110746496|NCT01269788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110746497|NCT01269788|Serotonin Agents|serotonin agents|mesh-ancestor
110746498|NCT01269788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110746499|NCT01269788|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110746500|NCT01269788|Antidepressive Agents|antidepressive agents|mesh-ancestor
110746501|NCT01269788|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110746502|NCT01269788|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110746503|NCT01269788|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110746504|NCT01163630|Esomeprazole|esomeprazole|mesh-list
110746505|NCT01163630|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110746506|NCT01163630|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110746507|NCT01163630|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110746508|NCT01163630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110308089|NCT00270491|Antimetabolites|antimetabolites|mesh-ancestor
110746509|NCT01163630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110746510|NCT03874130|Scopolamine|scopolamine|mesh-list
110746511|NCT03874130|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
110746512|NCT03874130|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110746513|NCT03874130|Antiemetics|antiemetics|mesh-ancestor
110746514|NCT03874130|Autonomic Agents|autonomic agents|mesh-ancestor
110746515|NCT03874130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110746516|NCT03874130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110746517|NCT03874130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110746518|NCT03874130|Mydriatics|mydriatics|mesh-ancestor
110746519|NCT03874130|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110746520|NCT03874130|Cholinergic Agents|cholinergic agents|mesh-ancestor
110746521|NCT03874130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110746522|NCT03874130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110746523|NCT03874130|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110746524|NCT03874130|Parasympatholytics|parasympatholytics|mesh-ancestor
110746525|NCT01269866|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110746526|NCT01269866|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110746527|NCT01269866|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110746528|NCT01269866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110746529|NCT01269866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110746530|NCT01269866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110746531|NCT01269866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110746533|NCT01269866|Sensory System Agents|sensory system agents|mesh-ancestor
110746534|NCT01269866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110746535|NCT01269866|Antidepressive Agents|antidepressive agents|mesh-ancestor
110746536|NCT01269866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110746537|NCT01269866|Dopamine Agents|dopamine agents|mesh-ancestor
110746538|NCT05387642|Pramoxine|pramoxine|mesh-list
110746539|NCT05387642|Anesthetics, Local|anesthetics, local|mesh-ancestor
110746540|NCT05387642|Anesthetics|anesthetics|mesh-ancestor
110746541|NCT05387642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110746542|NCT05387642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110746543|NCT05387642|Sensory System Agents|sensory system agents|mesh-ancestor
110746544|NCT05387642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110746545|NCT03871322|Vitamin D|vitamin d|mesh-list
110746546|NCT03871322|Ergocalciferols|ergocalciferols|mesh-list
110746547|NCT03871322|Cholecalciferol|cholecalciferol|mesh-list
110746548|NCT03871322|Vitamins|vitamins|mesh-list
110746549|NCT03871322|Micronutrients|micronutrients|mesh-ancestor
110746550|NCT03871322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110746551|NCT03871322|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110746552|NCT03871322|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110746553|NCT00313781|Prednisone|prednisone|mesh-list
110746554|NCT00313781|Docetaxel|docetaxel|mesh-list
110746555|NCT00313781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110746556|NCT00313781|Tubulin Modulators|tubulin modulators|mesh-ancestor
110746557|NCT00313781|Antimitotic Agents|antimitotic agents|mesh-ancestor
110746558|NCT00313781|Mitosis Modulators|mitosis modulators|mesh-ancestor
110746559|NCT00313781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110867074|NCT03401749|Chlorhexidine|chlorhexidine|mesh-list
110746560|NCT00313781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110746561|NCT00313781|Glucocorticoids|glucocorticoids|mesh-ancestor
110746562|NCT00313781|Hormones|hormones|mesh-ancestor
110746563|NCT00313781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110746564|NCT00313781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110746565|NCT00313781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110746566|NCT03871478|Lidocaine|lidocaine|mesh-list
110746567|NCT03871478|Bupivacaine|bupivacaine|mesh-list
110746568|NCT03871478|Anesthetics, Local|anesthetics, local|mesh-ancestor
110746569|NCT03871478|Anesthetics|anesthetics|mesh-ancestor
110746570|NCT03871478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110746571|NCT03871478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110746572|NCT03871478|Sensory System Agents|sensory system agents|mesh-ancestor
110746573|NCT03871478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110746574|NCT03871478|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110746575|NCT03871478|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110746576|NCT03871478|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110746577|NCT03871478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110746578|NCT03871478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110746579|NCT01281566|Cisapride|cisapride|mesh-list
110746580|NCT01281566|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110746581|NCT01281566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110746582|NCT01281566|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110746583|NCT01281566|Serotonin Agents|serotonin agents|mesh-ancestor
110746584|NCT01281566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110746585|NCT01281566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110746586|NCT01281566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110746587|NCT00368537|Ampicillin|ampicillin|mesh-list
110746588|NCT00368537|Tigecycline|tigecycline|mesh-list
110746589|NCT00368537|Sulbactam|sulbactam|mesh-list
110746590|NCT00368537|Sultamicillin|sultamicillin|mesh-list
110746591|NCT00368537|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110746592|NCT00368537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110746593|NCT00368537|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110746594|NCT00368537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110746595|NCT00368537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110746596|NCT00368537|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110746597|NCT01165580|Valganciclovir|valganciclovir|mesh-list
110746598|NCT01165580|Antiviral Agents|antiviral agents|mesh-ancestor
110746599|NCT01165580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110746600|NCT01048619|ON 01910|on 01910|mesh-list
110746601|NCT01048619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110746602|NCT01048619|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110746603|NCT01048619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110746604|NCT01048619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110746605|NCT01281800|Gemcitabine|gemcitabine|mesh-list
110746606|NCT01281800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110746607|NCT01281800|Antimetabolites|antimetabolites|mesh-ancestor
110746608|NCT01281800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110746609|NCT01281800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110746610|NCT03982121|Nivolumab|nivolumab|mesh-list
110746611|NCT03982121|Ipilimumab|ipilimumab|mesh-list
110746612|NCT03982121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110746613|NCT03982121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110746614|NCT03982121|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110746615|NCT03982121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110746616|NCT01167530|Everolimus|everolimus|mesh-list
110746617|NCT01167530|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110746618|NCT01167530|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110746619|NCT01167530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110746620|NCT01167530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110746621|NCT01167530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110746622|NCT01167530|Immunologic Factors|immunologic factors|mesh-ancestor
110746623|NCT01167530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110746624|NCT01167530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110746625|NCT01167764|Tranexamic Acid|tranexamic acid|mesh-list
110746626|NCT01167764|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110350182|NCT02912676|Methotrexate|methotrexate|mesh-list
110746628|NCT01167764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110746629|NCT01167764|Hemostatics|hemostatics|mesh-ancestor
110746630|NCT01167764|Coagulants|coagulants|mesh-ancestor
110746631|NCT01164176|Everolimus|everolimus|mesh-list
110746632|NCT01164176|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110746633|NCT01164176|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110746634|NCT01164176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110746635|NCT01164176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110746636|NCT01164176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110746637|NCT01164176|Immunologic Factors|immunologic factors|mesh-ancestor
110746638|NCT01164176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110746639|NCT01164176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110746640|NCT00313313|Metformin|metformin|mesh-list
110746641|NCT00313313|Saxagliptin|saxagliptin|mesh-list
110746642|NCT00313313|Glyburide|glyburide|mesh-list
110746643|NCT00313313|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110746644|NCT00313313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110746645|NCT00313313|Incretins|incretins|mesh-ancestor
110746646|NCT00313313|Hormones|hormones|mesh-ancestor
110746647|NCT00313313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110746648|NCT00313313|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110746649|NCT00313313|Protease Inhibitors|protease inhibitors|mesh-ancestor
110746650|NCT00313313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110746651|NCT00313313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110746652|NCT01167920|Calcium Channel Blockers|calcium channel blockers|mesh-list
110746653|NCT01167920|Angiotensin II|angiotensin ii|mesh-list
110746654|NCT01167920|Diuretics|diuretics|mesh-list
110746655|NCT01167920|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
110746656|NCT01167920|Renin Inhibitors|renin inhibitors|mesh-list
110746657|NCT01167920|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110746658|NCT01167920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110746659|NCT01167920|Natriuretic Agents|natriuretic agents|mesh-ancestor
110746660|NCT01167920|Protease Inhibitors|protease inhibitors|mesh-ancestor
110746661|NCT01167920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110746662|NCT01167920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110746663|NCT01167920|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110746664|NCT01167920|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110746665|NCT03873974|Immunoglobulin G|immunoglobulin g|mesh-list
110746666|NCT03873974|Immunoglobulin M|immunoglobulin m|mesh-list
110746667|NCT03873974|Immunologic Factors|immunologic factors|mesh-ancestor
110746668|NCT03873974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110746669|NCT01268930|Hemostatics|hemostatics|mesh-list
110746670|NCT01268930|Coagulants|coagulants|mesh-ancestor
110746671|NCT02526758|Budesonide|budesonide|mesh-list
110746672|NCT02526758|Beclomethasone|beclomethasone|mesh-list
110746673|NCT02526758|Formoterol Fumarate|formoterol fumarate|mesh-list
110746674|NCT02526758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110746675|NCT02526758|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110746676|NCT02526758|Autonomic Agents|autonomic agents|mesh-ancestor
110746677|NCT02526758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110746678|NCT02526758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110746679|NCT02526758|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110746680|NCT02526758|Respiratory System Agents|respiratory system agents|mesh-ancestor
110746681|NCT02526758|Glucocorticoids|glucocorticoids|mesh-ancestor
110746683|NCT02526758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110746684|NCT02526758|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110746685|NCT02526758|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110746686|NCT02526758|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110746687|NCT02526758|Adrenergic Agents|adrenergic agents|mesh-ancestor
110746688|NCT02526758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110746689|NCT02526758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110746690|NCT01281878|Vitamin B 6|vitamin b 6|mesh-list
110746691|NCT01281878|Pyridoxal|pyridoxal|mesh-list
110746692|NCT01281878|Pyridoxine|pyridoxine|mesh-list
110746693|NCT01281878|Vitamins|vitamins|mesh-ancestor
110746694|NCT01281878|Micronutrients|micronutrients|mesh-ancestor
110746695|NCT01281878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110746696|NCT01281878|Vitamin B Complex|vitamin b complex|mesh-ancestor
110464421|NCT00935532|Incretins|incretins|mesh-ancestor
110746697|NCT01164488|Ritonavir|ritonavir|mesh-list
110746698|NCT01164488|Ketoconazole|ketoconazole|mesh-list
110746699|NCT01164488|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110746700|NCT01164488|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110746701|NCT01164488|Protease Inhibitors|protease inhibitors|mesh-ancestor
110746702|NCT01164488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110746703|NCT01164488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110746704|NCT01164488|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110746705|NCT01164488|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110746706|NCT01164488|Antiviral Agents|antiviral agents|mesh-ancestor
110746707|NCT01164488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110746708|NCT01164488|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110746709|NCT01164488|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110746710|NCT01164488|Antifungal Agents|antifungal agents|mesh-ancestor
110746711|NCT01164488|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110746712|NCT01164488|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110746713|NCT01164488|Hormone Antagonists|hormone antagonists|mesh-ancestor
110746714|NCT01164488|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110746715|NCT01164488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110746716|NCT00312845|Rituximab|rituximab|mesh-list
110746717|NCT00312845|Bortezomib|bortezomib|mesh-list
110746718|NCT00312845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110746719|NCT00312845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110746720|NCT00312845|Immunologic Factors|immunologic factors|mesh-ancestor
110746721|NCT00312845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110746722|NCT00312845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110746723|NCT01168544|Vitamin D|vitamin d|mesh-list
110746724|NCT01168544|Ergocalciferols|ergocalciferols|mesh-list
110746725|NCT01168544|Cholecalciferol|cholecalciferol|mesh-list
110746726|NCT01168544|Vitamins|vitamins|mesh-list
110746727|NCT01168544|Micronutrients|micronutrients|mesh-ancestor
110746728|NCT01168544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110746729|NCT01168544|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110746730|NCT01168544|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110746731|NCT00368069|Levetiracetam|levetiracetam|mesh-list
110746732|NCT00368069|Anticonvulsants|anticonvulsants|mesh-ancestor
110746733|NCT00368069|Nootropic Agents|nootropic agents|mesh-ancestor
110746734|NCT01165814|Naproxen|naproxen|mesh-list
110746735|NCT01165814|Tramadol|tramadol|mesh-list
110746736|NCT01165814|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110746737|NCT01165814|Narcotics|narcotics|mesh-ancestor
110746738|NCT01165814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110746739|NCT01165814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110746740|NCT01165814|Analgesics|analgesics|mesh-ancestor
110746741|NCT01165814|Sensory System Agents|sensory system agents|mesh-ancestor
110746742|NCT01165814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110746743|NCT01165814|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110746744|NCT01165814|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110746745|NCT01165814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110746746|NCT01165814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110746747|NCT01165814|Gout Suppressants|gout suppressants|mesh-ancestor
110746748|NCT01165814|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110746749|NCT01165814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110746750|NCT01165814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110746752|NCT00367991|Hematinics|hematinics|mesh-ancestor
110746753|NCT00367835|Guanfacine|guanfacine|mesh-list
110746754|NCT00367835|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110746755|NCT00367835|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110746756|NCT00367835|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110746757|NCT00367835|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110746758|NCT00367835|Adrenergic Agents|adrenergic agents|mesh-ancestor
110746759|NCT00367835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110746760|NCT00367835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110746761|NCT00367835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110746762|NCT03874832|Dihydroergotamine|dihydroergotamine|mesh-list
110746763|NCT03874832|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110746764|NCT03874832|Dopamine Agonists|dopamine agonists|mesh-ancestor
110746765|NCT03874832|Dopamine Agents|dopamine agents|mesh-ancestor
110746766|NCT03874832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110867112|NCT03689114|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110746767|NCT03874832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110746768|NCT03874832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110746769|NCT03874832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110746770|NCT03874832|Analgesics|analgesics|mesh-ancestor
110746771|NCT03874832|Sensory System Agents|sensory system agents|mesh-ancestor
110464498|NCT00606450|Analgesics|analgesics|mesh-ancestor
110746772|NCT03874832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110746773|NCT01164800|Trandolapril|trandolapril|mesh-list
110746774|NCT01164800|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110746775|NCT01164800|Protease Inhibitors|protease inhibitors|mesh-ancestor
110746776|NCT01164800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110746777|NCT01164800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110746778|NCT01164800|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110746779|NCT01169012|Clofarabine|clofarabine|mesh-list
110746780|NCT01169012|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110746781|NCT01169012|Antimetabolites|antimetabolites|mesh-ancestor
110746782|NCT01169012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110746783|NCT01169012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110746784|NCT01169090|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110746785|NCT01169090|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110746786|NCT01169090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110746787|NCT01169090|Incretins|incretins|mesh-ancestor
110746788|NCT01169090|Hormones|hormones|mesh-ancestor
110746789|NCT01169090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110746790|NCT01169090|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110746791|NCT01169090|Protease Inhibitors|protease inhibitors|mesh-ancestor
110746792|NCT01169090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110746793|NCT01169090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110746794|NCT01282502|Midostaurin|midostaurin|mesh-list
110746795|NCT01282502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110746796|NCT01282502|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110746797|NCT01282502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110746798|NCT01282502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110746799|NCT01269242|Bindarit|bindarit|mesh-list
110746800|NCT01269242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110746801|NCT01269242|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110746802|NCT01269242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110746803|NCT01269242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110746804|NCT01169792|Tamoxifen|tamoxifen|mesh-list
110746805|NCT01169792|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110746806|NCT01169792|Hormone Antagonists|hormone antagonists|mesh-ancestor
110746807|NCT01169792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110746808|NCT01169792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110746809|NCT01169792|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110746810|NCT01169792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110746811|NCT01169792|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110746812|NCT01169792|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110746813|NCT01169792|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110746814|NCT01169402|Fluconazole|fluconazole|mesh-list
110746815|NCT01169402|Antifungal Agents|antifungal agents|mesh-ancestor
110746816|NCT01169402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110746817|NCT01169402|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110746818|NCT01169402|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110746819|NCT01169402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110746820|NCT01169402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110746821|NCT01169402|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110746822|NCT01169402|Hormone Antagonists|hormone antagonists|mesh-ancestor
110746823|NCT01169402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110746824|NCT01169402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110746825|NCT01169402|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110746826|NCT01169402|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110746828|NCT01274780|Atazanavir Sulfate|atazanavir sulfate|mesh-list
110746829|NCT01274780|Darunavir|darunavir|mesh-list
110746830|NCT01274780|Tenofovir|tenofovir|mesh-list
110746831|NCT01274780|Emtricitabine|emtricitabine|mesh-list
110746832|NCT01274780|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110746833|NCT01274780|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110746834|NCT01274780|Protease Inhibitors|protease inhibitors|mesh-ancestor
110746835|NCT01274780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110746836|NCT01274780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110746837|NCT01274780|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110746838|NCT01274780|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110746839|NCT01274780|Antiviral Agents|antiviral agents|mesh-ancestor
110746840|NCT01274780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110746841|NCT01274780|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110746842|NCT01274780|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110464587|NCT00688948|Alfuzosin|alfuzosin|mesh-list
110746843|NCT01274780|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110746844|NCT01274780|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110746845|NCT01169870|Paclitaxel|paclitaxel|mesh-list
110746846|NCT01169870|genexol-PM|genexol-pm|mesh-list
110746847|NCT01169870|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110746848|NCT01169870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110746849|NCT01169870|Tubulin Modulators|tubulin modulators|mesh-ancestor
110746850|NCT01169870|Antimitotic Agents|antimitotic agents|mesh-ancestor
110746851|NCT01169870|Mitosis Modulators|mitosis modulators|mesh-ancestor
110746852|NCT01169870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110746853|NCT01165970|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
110746854|NCT01165970|Laxatives|laxatives|mesh-ancestor
110746855|NCT01165970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110746856|NCT01166048|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110746857|NCT01166048|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110746858|NCT01166048|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110746859|NCT01166048|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110746860|NCT01166048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110746861|NCT01166048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110746862|NCT01166048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110746863|NCT01166048|Analgesics|analgesics|mesh-ancestor
110746864|NCT01166048|Sensory System Agents|sensory system agents|mesh-ancestor
110746865|NCT01166048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110746866|NCT01166048|Antidepressive Agents|antidepressive agents|mesh-ancestor
110746867|NCT01166048|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110746868|NCT01166048|Dopamine Agents|dopamine agents|mesh-ancestor
110746869|NCT03869762|Denosumab|denosumab|mesh-list
110746870|NCT03869762|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110746871|NCT03869762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110746872|NCT01283126|Hypoglycemic Agents|hypoglycemic agents|mesh-list
110746873|NCT01283126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110746874|NCT01283048|Bevacizumab|bevacizumab|mesh-list
110746875|NCT01283048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110746876|NCT01283048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110746877|NCT01283048|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110746878|NCT01283048|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110746879|NCT01283048|Growth Substances|growth substances|mesh-ancestor
110746880|NCT01283048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110746881|NCT01283048|Growth Inhibitors|growth inhibitors|mesh-ancestor
110746882|NCT03873740|Vaccines|vaccines|mesh-list
110746883|NCT03873740|Immunologic Factors|immunologic factors|mesh-ancestor
110746884|NCT03873740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110746885|NCT01172756|Riociguat|riociguat|mesh-list
110746886|NCT01172756|Enzyme Activators|enzyme activators|mesh-ancestor
110746887|NCT01172756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110746888|NCT02525822|Tazarotene|tazarotene|mesh-list
110746889|NCT02525822|Dermatologic Agents|dermatologic agents|mesh-ancestor
110746890|NCT02525822|Keratolytic Agents|keratolytic agents|mesh-ancestor
110746892|NCT01172912|Carboplatin|carboplatin|mesh-list
110746893|NCT01172912|Etoposide|etoposide|mesh-list
110746894|NCT01172912|Ifosfamide|ifosfamide|mesh-list
110746895|NCT01172912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110746896|NCT01172912|Antiemetics|antiemetics|mesh-ancestor
110746897|NCT01172912|Autonomic Agents|autonomic agents|mesh-ancestor
110746898|NCT01172912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110746899|NCT01172912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110746901|NCT01172912|Glucocorticoids|glucocorticoids|mesh-ancestor
110746902|NCT01172912|Hormones|hormones|mesh-ancestor
110746903|NCT01172912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110746904|NCT01172912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110746905|NCT01172912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110746906|NCT01172912|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110746907|NCT01172912|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110746908|NCT01172912|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110746909|NCT01172912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110746910|NCT01172912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110746911|NCT01172912|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110746912|NCT01172912|Alkylating Agents|alkylating agents|mesh-ancestor
110746913|NCT01283204|Leucovorin|leucovorin|mesh-list
110746914|NCT01283204|Paclitaxel|paclitaxel|mesh-list
110746915|NCT01283204|Docetaxel|docetaxel|mesh-list
110746916|NCT01283204|Cisplatin|cisplatin|mesh-list
110746917|NCT01283204|Oxaliplatin|oxaliplatin|mesh-list
110746918|NCT01283204|Levoleucovorin|levoleucovorin|mesh-list
110746919|NCT01283204|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110746920|NCT01283204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110746921|NCT01283204|Tubulin Modulators|tubulin modulators|mesh-ancestor
110746922|NCT01283204|Antimitotic Agents|antimitotic agents|mesh-ancestor
110746923|NCT01283204|Mitosis Modulators|mitosis modulators|mesh-ancestor
110746924|NCT01283204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110746925|NCT01283204|Antidotes|antidotes|mesh-ancestor
110746926|NCT01283204|Protective Agents|protective agents|mesh-ancestor
110746927|NCT01283204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110746928|NCT01283204|Vitamin B Complex|vitamin b complex|mesh-ancestor
110746929|NCT01283204|Vitamins|vitamins|mesh-ancestor
110746930|NCT01283204|Micronutrients|micronutrients|mesh-ancestor
110746931|NCT03869528|Lidocaine|lidocaine|mesh-list
110746932|NCT03869528|Anesthetics, Local|anesthetics, local|mesh-ancestor
110746933|NCT03869528|Anesthetics|anesthetics|mesh-ancestor
110746934|NCT03869528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110746935|NCT03869528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110746936|NCT03869528|Sensory System Agents|sensory system agents|mesh-ancestor
110746937|NCT03869528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110746938|NCT03869528|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110746939|NCT03869528|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110746940|NCT03869528|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110746941|NCT03869528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110746942|NCT03869528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110746943|NCT01283360|Tenofovir|tenofovir|mesh-list
110746944|NCT01283360|Antiviral Agents|antiviral agents|mesh-ancestor
110746945|NCT01283360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110746946|NCT01283360|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110746947|NCT01283360|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110746948|NCT01283360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110746949|NCT01283360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110746950|NCT01283360|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110746951|NCT01283360|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110746952|NCT01173068|Ertapenem|ertapenem|mesh-list
110746953|NCT01173068|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110746954|NCT01173068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110746955|NCT03267940|Atezolizumab|atezolizumab|mesh-list
110746956|NCT03267940|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110746957|NCT03267940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110746958|NCT03267940|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110746959|NCT03267940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110746960|NCT01284452|Hydrocortisone|hydrocortisone|mesh-list
110746961|NCT01284452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110746962|NCT01170104|Sorafenib|sorafenib|mesh-list
110746963|NCT01170104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110746964|NCT01170104|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110746965|NCT01170104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110746966|NCT01170104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110746967|NCT01284764|Mosapride|mosapride|mesh-list
110746968|NCT01284764|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110746969|NCT01284764|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110746971|NCT01284764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110746972|NCT01284764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110746973|NCT01284764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110746974|NCT01170182|Omeprazole|omeprazole|mesh-list
110746975|NCT01170182|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110746976|NCT01170182|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110746977|NCT01170182|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110746978|NCT01170182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110746979|NCT01170182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110746980|NCT01170260|Ethanol|ethanol|mesh-list
110746981|NCT01170260|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110746982|NCT01170260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110746983|NCT01170260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110746984|NCT01170260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110746985|NCT00312377|Docetaxel|docetaxel|mesh-list
110746986|NCT00312377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110746987|NCT00312377|Tubulin Modulators|tubulin modulators|mesh-ancestor
110746988|NCT00312377|Antimitotic Agents|antimitotic agents|mesh-ancestor
110746989|NCT00312377|Mitosis Modulators|mitosis modulators|mesh-ancestor
110746990|NCT00312377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110746991|NCT01173536|Moxifloxacin|moxifloxacin|mesh-list
110746992|NCT01173536|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110746993|NCT01173536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110746994|NCT01173536|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110746995|NCT01173536|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110746996|NCT01173536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110746997|NCT01173536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110746998|NCT01173536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110746999|NCT01580891|Naftifine|naftifine|mesh-list
110747000|NCT01580891|Antifungal Agents|antifungal agents|mesh-ancestor
110747001|NCT01580891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110747002|NCT01059383|Esomeprazole|esomeprazole|mesh-list
110747003|NCT01059383|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110747004|NCT01059383|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110747005|NCT01059383|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110747006|NCT01059383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110747007|NCT01059383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110747008|NCT01285232|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
110747009|NCT01285232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110747010|NCT01170338|Varenicline|varenicline|mesh-list
110747011|NCT01170338|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110747012|NCT01170338|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110747013|NCT01170338|Cholinergic Agents|cholinergic agents|mesh-ancestor
110747014|NCT01170338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110747015|NCT01170338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110747016|NCT01170338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110747017|NCT00312221|Oxycodone|oxycodone|mesh-list
110747018|NCT00312221|Buprenorphine|buprenorphine|mesh-list
110747019|NCT00312221|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110747020|NCT00312221|Narcotics|narcotics|mesh-ancestor
110747021|NCT00312221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110747022|NCT00312221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110747023|NCT00312221|Analgesics|analgesics|mesh-ancestor
110747024|NCT00312221|Sensory System Agents|sensory system agents|mesh-ancestor
110747025|NCT00312221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110747026|NCT00312221|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110747027|NCT03872570|Phenylephrine|phenylephrine|mesh-list
110747028|NCT03872570|Oxymetazoline|oxymetazoline|mesh-list
110747029|NCT03872570|Norepinephrine|norepinephrine|mesh-list
110747030|NCT03872570|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110747031|NCT03872570|Mydriatics|mydriatics|mesh-ancestor
110747032|NCT03872570|Autonomic Agents|autonomic agents|mesh-ancestor
110747033|NCT03872570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110747034|NCT03872570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110747035|NCT03872570|Sympathomimetics|sympathomimetics|mesh-ancestor
110747036|NCT03872570|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110747037|NCT03872570|Nasal Decongestants|nasal decongestants|mesh-ancestor
110747038|NCT03872570|Respiratory System Agents|respiratory system agents|mesh-ancestor
110747039|NCT03872570|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110747040|NCT03872570|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110747041|NCT03872570|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110747042|NCT03872570|Adrenergic Agents|adrenergic agents|mesh-ancestor
110747043|NCT03872570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110747044|NCT03872570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110747045|NCT03872570|Protective Agents|protective agents|mesh-ancestor
110747047|NCT01173926|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110747048|NCT01173926|Insulin Aspart|insulin aspart|mesh-list
110747049|NCT01173926|Insulin, Long-Acting|insulin, long-acting|mesh-list
110747050|NCT01173926|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
110747051|NCT01173926|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110747052|NCT01173926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110747053|NCT03349268|Xenon|xenon|mesh-list
110747054|NCT03349268|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110747055|NCT03349268|Anesthetics, General|anesthetics, general|mesh-ancestor
110747056|NCT03349268|Anesthetics|anesthetics|mesh-ancestor
110747057|NCT03349268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110747058|NCT03349268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110747059|NCT01170494|Cholecalciferol|cholecalciferol|mesh-list
110747060|NCT01170494|Vitamin D|vitamin d|mesh-list
110747061|NCT01170494|Ergocalciferols|ergocalciferols|mesh-list
110747062|NCT01170494|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110747063|NCT01170494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110747064|NCT01170494|Vitamins|vitamins|mesh-ancestor
110747065|NCT01170494|Micronutrients|micronutrients|mesh-ancestor
110747066|NCT01170494|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110464814|NCT02624830|Glyburide|glyburide|mesh-list
110747067|NCT01587326|Escitalopram|escitalopram|mesh-list
110747068|NCT01587326|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110747069|NCT01587326|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110747070|NCT01587326|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110747071|NCT01587326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110747072|NCT01587326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110747073|NCT01587326|Serotonin Agents|serotonin agents|mesh-ancestor
110747074|NCT01587326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110747075|NCT03294538|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110747076|NCT03294538|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110747077|NCT03294538|Estradiol|estradiol|mesh-list
110747078|NCT03294538|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110747079|NCT03294538|Estrogens|estrogens|mesh-ancestor
110747080|NCT03294538|Hormones|hormones|mesh-ancestor
110747081|NCT03294538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110747082|NCT03294538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110747083|NCT03294538|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110747084|NCT03294538|Contraceptive Agents|contraceptive agents|mesh-ancestor
110747085|NCT03294538|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110747086|NCT03294538|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110747087|NCT03872336|Labetalol|labetalol|mesh-list
110747088|NCT03872336|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110747089|NCT03872336|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110747090|NCT03872336|Adrenergic Agents|adrenergic agents|mesh-ancestor
110747091|NCT03872336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110747092|NCT03872336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110747093|NCT03872336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110747094|NCT03872336|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110747095|NCT03872336|Sympathomimetics|sympathomimetics|mesh-ancestor
110747096|NCT03872336|Autonomic Agents|autonomic agents|mesh-ancestor
110747097|NCT03872336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110747098|NCT03872336|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110747099|NCT03872336|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110747100|NCT02987530|Tenofovir|tenofovir|mesh-list
110747101|NCT02987530|Emtricitabine|emtricitabine|mesh-list
110747102|NCT02987530|Dolutegravir|dolutegravir|mesh-list
110747103|NCT02987530|Darunavir|darunavir|mesh-list
110747105|NCT02987530|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
110747106|NCT02987530|Antiviral Agents|antiviral agents|mesh-ancestor
110747107|NCT02987530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110747108|NCT02987530|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110747109|NCT02987530|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110747110|NCT02987530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110747111|NCT02987530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110747112|NCT02987530|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110747113|NCT02987530|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110747114|NCT02987530|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110747115|NCT02987530|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110747116|NCT02987530|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110747117|NCT02987530|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110747118|NCT02987530|Protease Inhibitors|protease inhibitors|mesh-ancestor
110747119|NCT02987530|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110747120|NCT02987530|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110747121|NCT03865550|Ketamine|ketamine|mesh-list
110747122|NCT03865550|Analgesics|analgesics|mesh-ancestor
110747123|NCT03865550|Sensory System Agents|sensory system agents|mesh-ancestor
110747124|NCT03865550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110747125|NCT03865550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110747126|NCT03865550|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110747127|NCT03865550|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110747128|NCT03865550|Anesthetics, General|anesthetics, general|mesh-ancestor
110747129|NCT03865550|Anesthetics|anesthetics|mesh-ancestor
110747130|NCT03865550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110747131|NCT03865550|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110747132|NCT03865550|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110747133|NCT03865550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110747134|NCT03865550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110747135|NCT02965690|Cimetidine|cimetidine|mesh-list
110747136|NCT02965690|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110747137|NCT02965690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110747138|NCT02965690|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110747139|NCT02965690|Histamine Antagonists|histamine antagonists|mesh-ancestor
110747140|NCT02965690|Histamine Agents|histamine agents|mesh-ancestor
110747141|NCT02965690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110464874|NCT00912574|Freund's Adjuvant|freund's adjuvant|mesh-list
110747142|NCT02965690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110747143|NCT02965690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110747144|NCT02965690|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110747145|NCT02965690|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110747146|NCT02965690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110747147|NCT01285388|Beta-lapachone|beta-lapachone|mesh-list
110747148|NCT01285388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110747149|NCT01285388|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110867155|NCT03688958|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110747150|NCT01285388|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110747151|NCT01285388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110747152|NCT01285388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110747153|NCT01285388|Antiviral Agents|antiviral agents|mesh-ancestor
110747154|NCT01285466|Paclitaxel|paclitaxel|mesh-list
110747155|NCT01285466|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110747156|NCT01285466|Trastuzumab|trastuzumab|mesh-list
110747157|NCT01285466|Dactolisib|dactolisib|mesh-list
110747158|NCT01285466|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110747159|NCT01285466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110747160|NCT01285466|Tubulin Modulators|tubulin modulators|mesh-ancestor
110747161|NCT01285466|Antimitotic Agents|antimitotic agents|mesh-ancestor
110747162|NCT01285466|Mitosis Modulators|mitosis modulators|mesh-ancestor
110747163|NCT01285466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110747164|NCT01285466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110747165|NCT01285544|Atorvastatin|atorvastatin|mesh-list
110747166|NCT01285544|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110747167|NCT01285544|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110747168|NCT01285544|Antimetabolites|antimetabolites|mesh-ancestor
110747169|NCT01285544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110747170|NCT01285544|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110747171|NCT01285544|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110747172|NCT01285544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110747173|NCT01174394|Fluoxetine|fluoxetine|mesh-list
110747174|NCT01174394|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110747175|NCT01174394|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110747176|NCT01174394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110747177|NCT01174394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110747178|NCT01174394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110747179|NCT01174394|Serotonin Agents|serotonin agents|mesh-ancestor
110747180|NCT01174394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110747181|NCT01174394|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110747182|NCT01174394|Antidepressive Agents|antidepressive agents|mesh-ancestor
110747183|NCT01174394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110747184|NCT01174394|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110747185|NCT01174394|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110747186|NCT01174394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110747187|NCT01174472|Paclitaxel|paclitaxel|mesh-list
110747188|NCT01174472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110747189|NCT01174472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110747190|NCT01174472|Tubulin Modulators|tubulin modulators|mesh-ancestor
110747191|NCT01174472|Antimitotic Agents|antimitotic agents|mesh-ancestor
110747192|NCT01174472|Mitosis Modulators|mitosis modulators|mesh-ancestor
110747193|NCT01174472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110747194|NCT00335153|Levodopa|levodopa|mesh-list
110747195|NCT00335153|Carbidopa|carbidopa|mesh-list
110747196|NCT00335153|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
110747197|NCT00335153|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110747198|NCT00335153|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110747199|NCT00335153|Dopamine Agents|dopamine agents|mesh-ancestor
110747200|NCT00335153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110747201|NCT00335153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110747202|NCT00335153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110747203|NCT00335153|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
110747204|NCT00335153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110747205|NCT00335153|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110747206|NCT00335153|Immunologic Factors|immunologic factors|mesh-ancestor
110747207|NCT00335153|Dopamine Agonists|dopamine agonists|mesh-ancestor
110747208|NCT01170806|Orlistat|orlistat|mesh-list
110747209|NCT01170806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110747210|NCT01170806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110747211|NCT01170806|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110747212|NCT01170806|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110464959|NCT00693862|Levodopa|levodopa|mesh-list
110747213|NCT03868436|Methoxyflurane|methoxyflurane|mesh-list
110747214|NCT03868436|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110747215|NCT03868436|Anesthetics, General|anesthetics, general|mesh-ancestor
110747216|NCT03868436|Anesthetics|anesthetics|mesh-ancestor
110747217|NCT03868436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110747218|NCT03868436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110747219|NCT01280006|Celecoxib|celecoxib|mesh-list
110747220|NCT01280006|Indomethacin|indomethacin|mesh-list
110747221|NCT01280006|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110747222|NCT01280006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110747223|NCT01280006|Analgesics|analgesics|mesh-ancestor
110747224|NCT01280006|Sensory System Agents|sensory system agents|mesh-ancestor
110747225|NCT01280006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110747226|NCT01280006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110747227|NCT01280006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110747228|NCT01280006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110747229|NCT01280006|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110747230|NCT01280006|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110747231|NCT01280006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110747232|NCT01280006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110747233|NCT01280006|Gout Suppressants|gout suppressants|mesh-ancestor
110747234|NCT01280006|Tocolytic Agents|tocolytic agents|mesh-ancestor
110747235|NCT01280006|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110747236|NCT03265132|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
110747237|NCT03265132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110747238|NCT03865160|Atropine|atropine|mesh-list
110747239|NCT03865160|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110747240|NCT03865160|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110747241|NCT03865160|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110747242|NCT03865160|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110747243|NCT03865160|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110747244|NCT03865160|Autonomic Agents|autonomic agents|mesh-ancestor
110747245|NCT03865160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110747246|NCT03865160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110747247|NCT03865160|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110747248|NCT03865160|Respiratory System Agents|respiratory system agents|mesh-ancestor
110747249|NCT03865160|Mydriatics|mydriatics|mesh-ancestor
110747250|NCT03865160|Parasympatholytics|parasympatholytics|mesh-ancestor
110747251|NCT03865160|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110747252|NCT03865160|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110747253|NCT03865160|Cholinergic Agents|cholinergic agents|mesh-ancestor
110747254|NCT03865160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110747255|NCT03865160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110747256|NCT01059461|Cerebrolysin|cerebrolysin|mesh-list
110747257|NCT01059461|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110747258|NCT01059461|Protective Agents|protective agents|mesh-ancestor
110747259|NCT01059461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110747260|NCT01059461|Nootropic Agents|nootropic agents|mesh-ancestor
110747261|NCT01324739|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
110747262|NCT01324739|Natriuretic Agents|natriuretic agents|mesh-ancestor
110747263|NCT01324739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110747264|NCT01286246|Progesterone|progesterone|mesh-list
110747265|NCT01286246|Progestins|progestins|mesh-ancestor
110747266|NCT01286246|Hormones|hormones|mesh-ancestor
110747267|NCT01286246|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110747268|NCT01286246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110747269|NCT03981887|Nafithromycin|nafithromycin|mesh-list
110747270|NCT03981887|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110747271|NCT03981887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110747272|NCT03981887|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110747273|NCT03981887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110747274|NCT03981887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110747275|NCT01063127|Insulin|insulin|mesh-list
110747276|NCT01063127|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110747277|NCT01063127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110747278|NCT03865004|Acetaminophen|acetaminophen|mesh-list
110747279|NCT03865004|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
110747280|NCT03865004|Morphine|morphine|mesh-list
110747281|NCT03865004|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110747282|NCT03865004|Narcotics|narcotics|mesh-ancestor
110747283|NCT03865004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110747284|NCT03865004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110747285|NCT03865004|Analgesics|analgesics|mesh-ancestor
110747286|NCT03865004|Sensory System Agents|sensory system agents|mesh-ancestor
110747287|NCT03865004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110465022|NCT00674596|Ramipril|ramipril|mesh-list
110867185|NCT03693638|Fentanyl|fentanyl|mesh-list
110747288|NCT03865004|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110747289|NCT03865004|Antipyretics|antipyretics|mesh-ancestor
110747290|NCT03865004|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110747291|NCT03865004|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110747292|NCT03865004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110747293|NCT00334295|Fulvestrant|fulvestrant|mesh-list
110747294|NCT00334295|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110747295|NCT00334295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110747296|NCT00334295|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110747297|NCT00334295|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110747298|NCT00334295|Hormone Antagonists|hormone antagonists|mesh-ancestor
110747299|NCT00334295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110747300|NCT00334295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110747301|NCT01285778|Panitumumab|panitumumab|mesh-list
110747302|NCT01285778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110747303|NCT01285778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110747304|NCT01063205|Acetylcysteine|acetylcysteine|mesh-list
110747305|NCT01063205|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110747306|NCT01063205|Antiviral Agents|antiviral agents|mesh-ancestor
110747307|NCT01063205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110747308|NCT01063205|Expectorants|expectorants|mesh-ancestor
110747309|NCT01063205|Respiratory System Agents|respiratory system agents|mesh-ancestor
110747310|NCT01063205|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110747311|NCT01063205|Antioxidants|antioxidants|mesh-ancestor
110747312|NCT01063205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110747313|NCT01063205|Protective Agents|protective agents|mesh-ancestor
110747314|NCT01063205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110747315|NCT01063205|Antidotes|antidotes|mesh-ancestor
110747316|NCT01175096|Everolimus|everolimus|mesh-list
110747317|NCT01175096|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110747318|NCT01175096|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110747319|NCT01175096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110747320|NCT01175096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110747321|NCT01175096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110747322|NCT01175096|Immunologic Factors|immunologic factors|mesh-ancestor
110747323|NCT01175096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110747324|NCT01175096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110747325|NCT01285934|Insulin|insulin|mesh-list
110747326|NCT01285934|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110747327|NCT01285934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110747328|NCT01060163|Tranexamic Acid|tranexamic acid|mesh-list
110747329|NCT01060163|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110747330|NCT01060163|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110747331|NCT01060163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110747332|NCT01060163|Hemostatics|hemostatics|mesh-ancestor
110747333|NCT01060163|Coagulants|coagulants|mesh-ancestor
110747334|NCT01063439|Cytarabine|cytarabine|mesh-list
110747335|NCT01063439|Etoposide|etoposide|mesh-list
110747336|NCT01063439|Melphalan|melphalan|mesh-list
110747337|NCT01063439|Busulfan|busulfan|mesh-list
110747338|NCT01063439|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110747339|NCT01063439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110747340|NCT01063439|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110747341|NCT01063439|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110747342|NCT01063439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110747343|NCT01063439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110747344|NCT01063439|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110747345|NCT01063439|Antimetabolites|antimetabolites|mesh-ancestor
110747346|NCT01063439|Antiviral Agents|antiviral agents|mesh-ancestor
110747347|NCT01063439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110747348|NCT01063439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110747349|NCT01063439|Immunologic Factors|immunologic factors|mesh-ancestor
110747350|NCT01063439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110747351|NCT01063439|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110747352|NCT01063439|Alkylating Agents|alkylating agents|mesh-ancestor
110747353|NCT01063439|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110747354|NCT05275270|Oxytocin|oxytocin|mesh-list
110747355|NCT05275270|Oxytocics|oxytocics|mesh-ancestor
110747356|NCT05275270|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110747357|NCT05275270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110747358|NCT03868202|Estradiol|estradiol|mesh-list
110747359|NCT03868202|Progesterone|progesterone|mesh-list
110747360|NCT03868202|Estrogens|estrogens|mesh-ancestor
110747361|NCT03868202|Hormones|hormones|mesh-ancestor
110747362|NCT03868202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110747363|NCT03868202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110747364|NCT03868202|Progestins|progestins|mesh-ancestor
110747365|NCT00311363|Gabapentin|gabapentin|mesh-list
110747366|NCT00311363|Analgesics|analgesics|mesh-ancestor
110747367|NCT00311363|Sensory System Agents|sensory system agents|mesh-ancestor
110747368|NCT00311363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110747369|NCT00311363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110747370|NCT00311363|Anticonvulsants|anticonvulsants|mesh-ancestor
110747371|NCT00311363|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110747372|NCT00311363|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110747373|NCT00311363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110747374|NCT00311363|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110747375|NCT00311363|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110747376|NCT00311363|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110747377|NCT00311363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110747378|NCT00311363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110747379|NCT00311363|Antimanic Agents|antimanic agents|mesh-ancestor
110747380|NCT01175330|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
110747381|NCT01175330|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
110747382|NCT01175330|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
110747383|NCT01175330|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110747384|NCT03262012|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
110747385|NCT03262012|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110747386|NCT03262012|Respiratory System Agents|respiratory system agents|mesh-ancestor
110747387|NCT01286090|Cisapride|cisapride|mesh-list
110747388|NCT01286090|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110747389|NCT01286090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110747390|NCT01286090|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110747391|NCT01286090|Serotonin Agents|serotonin agents|mesh-ancestor
110747392|NCT01286090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110747393|NCT01286090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110747394|NCT01286090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110747395|NCT00310817|Vaccines|vaccines|mesh-list
110747396|NCT00310817|Immunologic Factors|immunologic factors|mesh-ancestor
110747397|NCT00310817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110747398|NCT03783286|Ivacaftor|ivacaftor|mesh-list
110747399|NCT03783286|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
110747400|NCT03783286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110747401|NCT03783286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110747402|NCT03863366|Prucalopride|prucalopride|mesh-list
110747403|NCT03863366|Laxatives|laxatives|mesh-ancestor
110747404|NCT03863366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110747405|NCT03863366|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
110747406|NCT03863366|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110747407|NCT03863366|Serotonin Agents|serotonin agents|mesh-ancestor
110747408|NCT03863366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110747409|NCT03863366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110747410|NCT03863366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110747411|NCT01175486|Pioglitazone|pioglitazone|mesh-list
110747413|NCT01175486|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110747414|NCT01175486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110747415|NCT01175486|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
110747416|NCT01175486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110867206|NCT05191914|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110747417|NCT01175486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110747418|NCT01177904|Progesterone|progesterone|mesh-list
110747419|NCT01177904|Progestins|progestins|mesh-ancestor
110747420|NCT01177904|Hormones|hormones|mesh-ancestor
110747421|NCT01177904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110747422|NCT01177904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110747423|NCT02940886|Iron|iron|mesh-list
110747424|NCT02940886|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
110747425|NCT02940886|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
110747426|NCT02940886|Trace Elements|trace elements|mesh-ancestor
110747427|NCT02940886|Micronutrients|micronutrients|mesh-ancestor
110747428|NCT02940886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110747429|NCT02940886|Hematinics|hematinics|mesh-ancestor
110747430|NCT05216614|Fluvoxamine|fluvoxamine|mesh-list
110747431|NCT05216614|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110747432|NCT05216614|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110747433|NCT05216614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110747434|NCT05216614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110747435|NCT05216614|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110747436|NCT05216614|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110465172|NCT01092182|Glucocorticoids|glucocorticoids|mesh-ancestor
110747437|NCT05216614|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110747438|NCT05216614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110747439|NCT05216614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110747441|NCT05216614|Serotonin Agents|serotonin agents|mesh-ancestor
110747442|NCT05216614|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110747443|NCT05216614|Antidepressive Agents|antidepressive agents|mesh-ancestor
110747444|NCT05216614|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110747445|NCT05216614|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110747446|NCT05216614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110747447|NCT05216614|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110747448|NCT03860636|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110747449|NCT03860636|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110747450|NCT03860636|Estradiol|estradiol|mesh-list
110747451|NCT03860636|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110747452|NCT03860636|Progesterone|progesterone|mesh-list
110747453|NCT03860636|Estrogens|estrogens|mesh-ancestor
110747454|NCT03860636|Hormones|hormones|mesh-ancestor
110747455|NCT03860636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110747456|NCT03860636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110747457|NCT03860636|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110747458|NCT03860636|Contraceptive Agents|contraceptive agents|mesh-ancestor
110747459|NCT03860636|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110747460|NCT03860636|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110747461|NCT03860636|Progestins|progestins|mesh-ancestor
110747462|NCT03860480|Bupivacaine|bupivacaine|mesh-list
110747463|NCT03860480|Anesthetics, Local|anesthetics, local|mesh-ancestor
110747464|NCT03860480|Anesthetics|anesthetics|mesh-ancestor
110747465|NCT03860480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110747466|NCT03860480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110747467|NCT03860480|Sensory System Agents|sensory system agents|mesh-ancestor
110747468|NCT03860480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110747469|NCT03285646|Fasinumab|fasinumab|mesh-list
110747470|NCT03285646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110308392|NCT00272207|Nabilone|nabilone|mesh-list
110747471|NCT03285646|Analgesics|analgesics|mesh-ancestor
110747472|NCT03285646|Sensory System Agents|sensory system agents|mesh-ancestor
110747473|NCT03285646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110747474|NCT03285646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110747475|NCT03860012|Folic Acid|folic acid|mesh-list
110747476|NCT03860012|Hematinics|hematinics|mesh-ancestor
110747477|NCT03860012|Vitamin B Complex|vitamin b complex|mesh-ancestor
110747478|NCT03860012|Vitamins|vitamins|mesh-ancestor
110747479|NCT03860012|Micronutrients|micronutrients|mesh-ancestor
110747480|NCT03860012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110747481|NCT03859934|Melatonin|melatonin|mesh-list
110747482|NCT03859934|Antioxidants|antioxidants|mesh-ancestor
110747483|NCT03859934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110747484|NCT03859934|Protective Agents|protective agents|mesh-ancestor
110747485|NCT03859934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110747486|NCT03859934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110747487|NCT01178372|Lactulose|lactulose|mesh-list
110747488|NCT01178372|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110747489|NCT01178450|Cinacalcet|cinacalcet|mesh-list
110747490|NCT01178450|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110747491|NCT01178450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110747492|NCT01178450|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
110747493|NCT01178450|Hormone Antagonists|hormone antagonists|mesh-ancestor
110747494|NCT01178450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110747495|NCT00074490|Prednisone|prednisone|mesh-list
110747496|NCT00074490|Cyclophosphamide|cyclophosphamide|mesh-list
110747497|NCT00074490|Rituximab|rituximab|mesh-list
110747498|NCT00074490|Doxorubicin|doxorubicin|mesh-list
110747499|NCT00074490|Fludarabine|fludarabine|mesh-list
110747500|NCT00074490|Etoposide|etoposide|mesh-list
110747501|NCT00074490|Vincristine|vincristine|mesh-list
110747502|NCT00074490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110747503|NCT00074490|Immunologic Factors|immunologic factors|mesh-ancestor
110747504|NCT00074490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110747505|NCT00074490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110747506|NCT00074490|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110747507|NCT00074490|Alkylating Agents|alkylating agents|mesh-ancestor
110747508|NCT00074490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110747509|NCT00074490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110747510|NCT00074490|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110747511|NCT00074490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110747512|NCT00074490|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110747513|NCT00074490|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110747514|NCT00074490|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110747515|NCT00074490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110747516|NCT00074490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110747517|NCT00074490|Glucocorticoids|glucocorticoids|mesh-ancestor
110747518|NCT00074490|Hormones|hormones|mesh-ancestor
110308417|NCT00272324|Aspirin|aspirin|mesh-list
110747519|NCT00074490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110747520|NCT00074490|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110747521|NCT00074490|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110747522|NCT00074490|Tubulin Modulators|tubulin modulators|mesh-ancestor
110747523|NCT00074490|Antimitotic Agents|antimitotic agents|mesh-ancestor
110747524|NCT00074490|Mitosis Modulators|mitosis modulators|mesh-ancestor
110747525|NCT03859856|Hormones|hormones|mesh-list
110747526|NCT03859856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110747527|NCT03859856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110747528|NCT01094028|Oxytocin|oxytocin|mesh-list
110747529|NCT01094028|Oxytocics|oxytocics|mesh-ancestor
110747530|NCT01094028|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110747531|NCT01094028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110747532|NCT01288508|Psyllium|psyllium|mesh-list
110747533|NCT01288508|Cathartics|cathartics|mesh-ancestor
110747534|NCT01288508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110747535|NCT01175954|Lacosamide|lacosamide|mesh-list
110747536|NCT01175954|Anticonvulsants|anticonvulsants|mesh-ancestor
110747537|NCT01175954|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110747538|NCT01175954|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110747539|NCT01175954|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110747540|NCT01175954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110747541|NCT01288664|Tacrolimus|tacrolimus|mesh-list
110747542|NCT01288664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110747543|NCT01288664|Immunologic Factors|immunologic factors|mesh-ancestor
110747544|NCT01288664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110747545|NCT01288664|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110747546|NCT01288664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110747547|NCT01288664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110747548|NCT03285490|Tirbanibulin|tirbanibulin|mesh-list
110747549|NCT03285490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110747550|NCT03285490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110747551|NCT02525276|Hormones|hormones|mesh-list
110747552|NCT02525276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110747553|NCT02525276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110747554|NCT01172444|Mesalamine|mesalamine|mesh-list
110747555|NCT01172444|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110747556|NCT01172444|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110747558|NCT01172444|Sensory System Agents|sensory system agents|mesh-ancestor
110747559|NCT01172444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110747560|NCT01172444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110747561|NCT01172444|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110445101|NCT02779582|Hormones|hormones|mesh-ancestor
110747562|NCT01172444|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110747563|NCT01288742|Simeprevir|simeprevir|mesh-list
110747564|NCT01288742|Digoxin|digoxin|mesh-list
110747565|NCT01288742|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110747566|NCT01288742|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110747567|NCT01288742|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110747568|NCT01288742|Antimetabolites|antimetabolites|mesh-ancestor
110747569|NCT01288742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110747570|NCT01288742|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110747571|NCT01288742|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110747572|NCT01288742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110747573|NCT01288742|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110747574|NCT01288742|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110747575|NCT01288742|Protective Agents|protective agents|mesh-ancestor
110747576|NCT01288742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110747577|NCT01288742|Antiviral Agents|antiviral agents|mesh-ancestor
110747578|NCT01288742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110747579|NCT01288742|Protease Inhibitors|protease inhibitors|mesh-ancestor
110747580|NCT01178996|Ribavirin|ribavirin|mesh-list
110747581|NCT01178996|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110747582|NCT01178996|Thymalfasin|thymalfasin|mesh-list
110747583|NCT01178996|Antimetabolites|antimetabolites|mesh-ancestor
110747584|NCT01178996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110747585|NCT01178996|Antiviral Agents|antiviral agents|mesh-ancestor
110747586|NCT01178996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110168923|NCT00036556|Atrasentan|atrasentan|mesh-list
110747587|NCT01178996|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110747588|NCT01178996|Immunologic Factors|immunologic factors|mesh-ancestor
110747589|NCT01178996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110747590|NCT03862586|Acetylcysteine|acetylcysteine|mesh-list
110747591|NCT03862586|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110747592|NCT03862586|Antiviral Agents|antiviral agents|mesh-ancestor
110747593|NCT03862586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110747594|NCT03862586|Expectorants|expectorants|mesh-ancestor
110747595|NCT03862586|Respiratory System Agents|respiratory system agents|mesh-ancestor
110747596|NCT03862586|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110747597|NCT03862586|Antioxidants|antioxidants|mesh-ancestor
110747598|NCT03862586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110747599|NCT03862586|Protective Agents|protective agents|mesh-ancestor
110747600|NCT03862586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110747601|NCT03862586|Antidotes|antidotes|mesh-ancestor
110747602|NCT01180946|Vitamin D|vitamin d|mesh-list
110747603|NCT01180946|Ergocalciferols|ergocalciferols|mesh-list
110747604|NCT01180946|Vitamins|vitamins|mesh-ancestor
110747605|NCT01180946|Micronutrients|micronutrients|mesh-ancestor
110747606|NCT01180946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110747607|NCT01180946|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110747608|NCT01180946|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110747609|NCT01179152|Budesonide|budesonide|mesh-list
110747610|NCT01179152|Formoterol Fumarate|formoterol fumarate|mesh-list
110747611|NCT01179152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110747612|NCT01179152|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110747613|NCT01179152|Autonomic Agents|autonomic agents|mesh-ancestor
110747614|NCT01179152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110747615|NCT01179152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110747616|NCT01179152|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110747617|NCT01179152|Respiratory System Agents|respiratory system agents|mesh-ancestor
110747618|NCT01179152|Glucocorticoids|glucocorticoids|mesh-ancestor
110747619|NCT01179152|Hormones|hormones|mesh-ancestor
110747620|NCT01179152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110747621|NCT01179152|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110747622|NCT01179152|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110747623|NCT01179152|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110747624|NCT01179152|Adrenergic Agents|adrenergic agents|mesh-ancestor
110747625|NCT01179152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110747626|NCT01179152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110747627|NCT01179230|Dipyridamole|dipyridamole|mesh-list
110747628|NCT01179230|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110747629|NCT01179230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110747630|NCT01179230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110747631|NCT01179230|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110747632|NCT01179230|Vasodilator Agents|vasodilator agents|mesh-ancestor
110747633|NCT01286948|Levonorgestrel|levonorgestrel|mesh-list
110747634|NCT01286948|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110747635|NCT01286948|Contraceptive Agents|contraceptive agents|mesh-ancestor
110747636|NCT01286948|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110747637|NCT01286948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110747638|NCT01286948|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110747639|NCT01286948|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110747640|NCT01286948|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110747642|NCT01179308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110747643|NCT01179308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110747644|NCT03088826|Acetaminophen|acetaminophen|mesh-list
110747646|NCT03088826|Oxycodone|oxycodone|mesh-list
110747647|NCT03088826|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110747648|NCT03088826|Narcotics|narcotics|mesh-ancestor
110747649|NCT03088826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110747650|NCT03088826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110747651|NCT03088826|Analgesics|analgesics|mesh-ancestor
110747652|NCT03088826|Sensory System Agents|sensory system agents|mesh-ancestor
110747653|NCT03088826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110747654|NCT03088826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110747655|NCT03088826|Antipyretics|antipyretics|mesh-ancestor
110747656|NCT00367133|Triamcinolone|triamcinolone|mesh-list
110747657|NCT00367133|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110747658|NCT00367133|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110747659|NCT00367133|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110747660|NCT00367133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110747661|NCT00367133|Glucocorticoids|glucocorticoids|mesh-ancestor
110747662|NCT00367133|Hormones|hormones|mesh-ancestor
110747663|NCT00367133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110747664|NCT00367133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110747665|NCT00367133|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110747666|NCT00367133|Immunologic Factors|immunologic factors|mesh-ancestor
110747667|NCT00367133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110747668|NCT00367133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110747669|NCT01179464|Simvastatin|simvastatin|mesh-list
110747670|NCT01179464|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110747671|NCT01179464|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110747672|NCT01179464|Antimetabolites|antimetabolites|mesh-ancestor
110747673|NCT01179464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110747674|NCT01179464|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110747675|NCT01179464|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110747676|NCT01179464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110747677|NCT01179620|Certoparin|certoparin|mesh-list
110747678|NCT01179620|Anticoagulants|anticoagulants|mesh-ancestor
110747679|NCT01288820|Artesunate|artesunate|mesh-list
110747680|NCT01288820|Primaquine|primaquine|mesh-list
110747681|NCT01288820|Piperaquine|piperaquine|mesh-list
110747682|NCT01288820|Amodiaquine|amodiaquine|mesh-list
110747683|NCT01288820|Artenimol|artenimol|mesh-list
110747684|NCT01288820|Antimalarials|antimalarials|mesh-ancestor
110747685|NCT01288820|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110747686|NCT01288820|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110747687|NCT01288820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110747688|NCT01288820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110747689|NCT01288820|Antiviral Agents|antiviral agents|mesh-ancestor
110747690|NCT01288820|Schistosomicides|schistosomicides|mesh-ancestor
110747691|NCT01288820|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110747692|NCT01288820|Anthelmintics|anthelmintics|mesh-ancestor
110747693|NCT00367055|Metformin|metformin|mesh-list
110747694|NCT00367055|Rosiglitazone|rosiglitazone|mesh-list
110747695|NCT00367055|Gliclazide|gliclazide|mesh-list
110747696|NCT00367055|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110747697|NCT00367055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110747698|NCT00057330|polysaccharide-K|polysaccharide-k|mesh-list
110747699|NCT00057330|Vaccines|vaccines|mesh-list
110747700|NCT00057330|Monophosphoryl lipid A|monophosphoryl lipid a|mesh-list
110747701|NCT00057330|Immunologic Factors|immunologic factors|mesh-ancestor
110747702|NCT00057330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110747703|NCT00057330|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110308468|NCT00307671|Prednisone|prednisone|mesh-list
110747704|NCT00057330|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110747705|NCT00057330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110747706|NCT00057330|Antiviral Agents|antiviral agents|mesh-ancestor
110747707|NCT00057330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110747708|NCT00057330|Interferon Inducers|interferon inducers|mesh-ancestor
110747709|NCT00057330|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110747710|NCT00057330|Protective Agents|protective agents|mesh-ancestor
110747711|NCT03857672|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
110747712|NCT03857672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110747713|NCT03857672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110747714|NCT03283696|Doxorubicin|doxorubicin|mesh-list
110747715|NCT03283696|Ifosfamide|ifosfamide|mesh-list
110747716|NCT03283696|Olaratumab|olaratumab|mesh-list
110747717|NCT03283696|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110747718|NCT03283696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110747719|NCT03283696|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110747720|NCT03283696|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110747721|NCT03283696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110747722|NCT03283696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110747723|NCT03283696|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110747724|NCT03283696|Alkylating Agents|alkylating agents|mesh-ancestor
110747725|NCT01176344|Vitamin D|vitamin d|mesh-list
110747726|NCT01176344|Vitamins|vitamins|mesh-ancestor
110747727|NCT01176344|Micronutrients|micronutrients|mesh-ancestor
110747728|NCT01176344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110747729|NCT01176344|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110747730|NCT02530788|Selenium|selenium|mesh-list
110747731|NCT02530788|Selenious Acid|selenious acid|mesh-list
110747732|NCT02530788|Sodium Selenite|sodium selenite|mesh-list
110747733|NCT02530788|Antioxidants|antioxidants|mesh-ancestor
110747734|NCT02530788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110747735|NCT02530788|Protective Agents|protective agents|mesh-ancestor
110747736|NCT02530788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110465472|NCT02614456|Interferons|interferons|mesh-list
110747737|NCT02530788|Trace Elements|trace elements|mesh-ancestor
110747738|NCT02530788|Micronutrients|micronutrients|mesh-ancestor
110747739|NCT01288898|Ipragliflozin|ipragliflozin|mesh-list
110747740|NCT01288898|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110747741|NCT01288898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110747742|NCT01288898|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110747743|NCT01288898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110747744|NCT01089192|Metformin|metformin|mesh-list
110747745|NCT01089192|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110747746|NCT01089192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110747747|NCT02564380|Pembrolizumab|pembrolizumab|mesh-list
110747748|NCT02564380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110747749|NCT02564380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110747750|NCT02564380|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110747751|NCT02564380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110747752|NCT01093092|Calcitriol|calcitriol|mesh-list
110747753|NCT01093092|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
110747754|NCT01093092|Gemcitabine|gemcitabine|mesh-list
110747755|NCT01093092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110747756|NCT01093092|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110747757|NCT01093092|Antimetabolites|antimetabolites|mesh-ancestor
110747758|NCT01093092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110747759|NCT01093092|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110308486|NCT00307671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110747760|NCT01093092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110747761|NCT01093092|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
110747762|NCT01093092|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110747763|NCT01093092|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110747765|NCT01093092|Micronutrients|micronutrients|mesh-ancestor
110747766|NCT01093092|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110747767|NCT01289054|Imatinib Mesylate|imatinib mesylate|mesh-list
110747768|NCT01289054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110747769|NCT01289054|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110747770|NCT01289054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110747771|NCT01289054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110747772|NCT01179776|Iloprost|iloprost|mesh-list
110747773|NCT01179776|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110747774|NCT01179776|Vasodilator Agents|vasodilator agents|mesh-ancestor
110747775|NCT01181414|Amiodarone|amiodarone|mesh-list
110747776|NCT01181414|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
110747777|NCT01181414|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110747778|NCT01181414|Adrenergic Agents|adrenergic agents|mesh-ancestor
110747779|NCT01181414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110747780|NCT01181414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110747781|NCT01181414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110747782|NCT01181414|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110747783|NCT01181414|Vasodilator Agents|vasodilator agents|mesh-ancestor
110747784|NCT01181414|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
110747785|NCT01181414|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110747787|NCT01181414|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110747788|NCT01181414|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110747789|NCT01181414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110747790|NCT01181414|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110747791|NCT01181414|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110747792|NCT01181414|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110747793|NCT01094340|Thalidomide|thalidomide|mesh-list
110747794|NCT01094340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110747795|NCT01094340|Immunologic Factors|immunologic factors|mesh-ancestor
110747796|NCT01094340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110747797|NCT01094340|Leprostatic Agents|leprostatic agents|mesh-ancestor
110747798|NCT01094340|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110747799|NCT01094340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110747800|NCT01094340|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110747801|NCT01094340|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110747802|NCT01094340|Growth Substances|growth substances|mesh-ancestor
110747803|NCT01094340|Growth Inhibitors|growth inhibitors|mesh-ancestor
110747804|NCT01094340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110747805|NCT00056862|Ribavirin|ribavirin|mesh-list
110747806|NCT00056862|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110747807|NCT00056862|Interferon-alpha|interferon-alpha|mesh-list
110747808|NCT00056862|Antimetabolites|antimetabolites|mesh-ancestor
110747809|NCT00056862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110747810|NCT00056862|Antiviral Agents|antiviral agents|mesh-ancestor
110747811|NCT00056862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110747812|NCT00056862|Immunologic Factors|immunologic factors|mesh-ancestor
110747813|NCT00056862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110465546|NCT04872218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110747814|NCT01289132|Candesartan|candesartan|mesh-list
110747815|NCT01289132|Candesartan cilexetil|candesartan cilexetil|mesh-list
110747816|NCT01289132|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
110747817|NCT01289132|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110747818|NCT01289132|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110747819|NCT01289132|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110747820|NCT01289132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110747822|NCT01287260|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110747823|NCT01287260|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110747824|NCT01287260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110747825|NCT01287260|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110747826|NCT01287260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110747827|NCT01287260|Vasodilator Agents|vasodilator agents|mesh-ancestor
110747828|NCT01287260|Tocolytic Agents|tocolytic agents|mesh-ancestor
110747829|NCT01287260|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110747830|NCT01181570|Adalimumab|adalimumab|mesh-list
110747831|NCT01181570|Mannitol|mannitol|mesh-list
110747832|NCT01181570|Citric Acid|citric acid|mesh-list
110747833|NCT01181570|Sodium Citrate|sodium citrate|mesh-list
110747834|NCT01181570|Anticoagulants|anticoagulants|mesh-ancestor
110747835|NCT01181570|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110747836|NCT01181570|Chelating Agents|chelating agents|mesh-ancestor
110747837|NCT01181570|Sequestering Agents|sequestering agents|mesh-ancestor
110747838|NCT01181570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110747839|NCT01181570|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110747840|NCT01181570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110747841|NCT01181570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110747842|NCT01181570|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110747843|NCT01181570|Diuretics|diuretics|mesh-ancestor
110747844|NCT01181570|Natriuretic Agents|natriuretic agents|mesh-ancestor
110747845|NCT01181570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110747846|NCT05200312|Prednisone|prednisone|mesh-list
110747847|NCT05200312|Cyclophosphamide|cyclophosphamide|mesh-list
110747848|NCT05200312|Rituximab|rituximab|mesh-list
110747849|NCT05200312|Doxorubicin|doxorubicin|mesh-list
110747850|NCT05200312|Vincristine|vincristine|mesh-list
110747851|NCT05200312|Lenalidomide|lenalidomide|mesh-list
110747852|NCT05200312|Zanubrutinib|zanubrutinib|mesh-list
110747853|NCT05200312|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110747854|NCT05200312|Immunologic Factors|immunologic factors|mesh-ancestor
110747855|NCT05200312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110747856|NCT05200312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110747857|NCT05200312|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110747858|NCT05200312|Alkylating Agents|alkylating agents|mesh-ancestor
110747859|NCT05200312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110747860|NCT05200312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110747861|NCT05200312|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110747862|NCT05200312|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110747863|NCT05200312|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110747864|NCT05200312|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110747865|NCT05200312|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110747866|NCT05200312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110747867|NCT05200312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110747868|NCT05200312|Glucocorticoids|glucocorticoids|mesh-ancestor
110747869|NCT05200312|Hormones|hormones|mesh-ancestor
110747870|NCT05200312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110747871|NCT05200312|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110747872|NCT05200312|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110747873|NCT05200312|Tubulin Modulators|tubulin modulators|mesh-ancestor
110747874|NCT05200312|Antimitotic Agents|antimitotic agents|mesh-ancestor
110747875|NCT05200312|Mitosis Modulators|mitosis modulators|mesh-ancestor
110747876|NCT05200312|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110747877|NCT05200312|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110747878|NCT05200312|Growth Substances|growth substances|mesh-ancestor
110747879|NCT05200312|Growth Inhibitors|growth inhibitors|mesh-ancestor
110747880|NCT05200312|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110747881|NCT01180166|Nimotuzumab|nimotuzumab|mesh-list
110747882|NCT01180166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110747883|NCT01180166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110747884|NCT02940730|Dalbavancin|dalbavancin|mesh-list
110747885|NCT02940730|Teicoplanin|teicoplanin|mesh-list
110747886|NCT02940730|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110747887|NCT02940730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110747889|NCT01587638|Atenolol|atenolol|mesh-list
110465618|NCT00696982|Hormones|hormones|mesh-ancestor
110747890|NCT01587638|Carvedilol|carvedilol|mesh-list
110747891|NCT01587638|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-list
110747892|NCT01587638|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110747893|NCT01587638|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110747894|NCT01587638|Sympatholytics|sympatholytics|mesh-ancestor
110747895|NCT01587638|Autonomic Agents|autonomic agents|mesh-ancestor
110747896|NCT01587638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110747897|NCT01587638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110747898|NCT01587638|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110747899|NCT01587638|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110747900|NCT01587638|Adrenergic Agents|adrenergic agents|mesh-ancestor
110747901|NCT01587638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110747902|NCT01587638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110747903|NCT01587638|Antioxidants|antioxidants|mesh-ancestor
110747904|NCT01587638|Protective Agents|protective agents|mesh-ancestor
110747905|NCT01587638|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110747906|NCT01587638|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110747907|NCT01587638|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110747908|NCT01587638|Vasodilator Agents|vasodilator agents|mesh-ancestor
110747909|NCT01587638|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110747910|NCT01587638|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110747911|NCT01287338|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
110747912|NCT01287338|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110747913|NCT01287338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110747914|NCT01287338|Analgesics|analgesics|mesh-ancestor
110747915|NCT01287338|Sensory System Agents|sensory system agents|mesh-ancestor
110747916|NCT01287338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110747917|NCT01287338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110747918|NCT01287338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110747919|NCT01287338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110747920|NCT01287338|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110747921|NCT01287338|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110747922|NCT01287338|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110747923|NCT01287338|Histamine Antagonists|histamine antagonists|mesh-ancestor
110747924|NCT01287338|Histamine Agents|histamine agents|mesh-ancestor
110747925|NCT01287338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110747926|NCT01287338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110747928|NCT01180322|Etoposide|etoposide|mesh-list
110747929|NCT01180322|Idarubicin|idarubicin|mesh-list
110747930|NCT01180322|Azacitidine|azacitidine|mesh-list
110747931|NCT01180322|Lenograstim|lenograstim|mesh-list
110747932|NCT01180322|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110072981|NCT01575405|Tenofovir|tenofovir|mesh-list
110747933|NCT01180322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110747934|NCT01180322|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110747935|NCT01180322|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110747937|NCT01180322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110747938|NCT01180322|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110747939|NCT01180322|Antimetabolites|antimetabolites|mesh-ancestor
110747940|NCT01180322|Antiviral Agents|antiviral agents|mesh-ancestor
110747941|NCT01180322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110747942|NCT01180322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110747943|NCT01180322|Immunologic Factors|immunologic factors|mesh-ancestor
110747944|NCT01180322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110747945|NCT01180322|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110747946|NCT01180322|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110747947|NCT01287494|Sertraline|sertraline|mesh-list
110747948|NCT01287494|Antidepressive Agents|antidepressive agents|mesh-ancestor
110747949|NCT01287494|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110747950|NCT01287494|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110747951|NCT01287494|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110747952|NCT01287494|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110747953|NCT01287494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110867268|NCT01373970|Pantoprazole|pantoprazole|mesh-list
110747954|NCT01287494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110747955|NCT01287494|Serotonin Agents|serotonin agents|mesh-ancestor
110747956|NCT01287494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110747957|NCT02524964|Tanshinone|tanshinone|mesh-list
110747958|NCT02524964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110747959|NCT02524964|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110747960|NCT02524964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110747961|NCT02524964|Analgesics|analgesics|mesh-ancestor
110747962|NCT02524964|Sensory System Agents|sensory system agents|mesh-ancestor
110747963|NCT02524964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110747964|NCT02524964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110747965|NCT02524964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110747966|NCT02524964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110747967|NCT02524964|Anticoagulants|anticoagulants|mesh-ancestor
110747968|NCT02524964|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110747969|NCT02524964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110747970|NCT02524964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110747971|NCT02524964|Immunologic Factors|immunologic factors|mesh-ancestor
110747972|NCT01289756|Clarithromycin|clarithromycin|mesh-list
110747973|NCT01289756|Paroxetine|paroxetine|mesh-list
110747974|NCT01289756|Clomiphene|clomiphene|mesh-list
110747975|NCT01289756|Enclomiphene|enclomiphene|mesh-list
110747976|NCT01289756|Zuclomiphene|zuclomiphene|mesh-list
110747977|NCT01289756|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110747978|NCT01289756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110747979|NCT01289756|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110747980|NCT01289756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110747981|NCT01289756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110747982|NCT01289756|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110747983|NCT01289756|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110747984|NCT01289756|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110747985|NCT01289756|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110747986|NCT01289756|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110747987|NCT01289756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110747988|NCT01289756|Serotonin Agents|serotonin agents|mesh-ancestor
110747989|NCT01289756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110747990|NCT01289756|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110747991|NCT01289756|Antidepressive Agents|antidepressive agents|mesh-ancestor
110747992|NCT01289756|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110747993|NCT01289756|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110747994|NCT01289756|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110747995|NCT01289756|Hormone Antagonists|hormone antagonists|mesh-ancestor
110747996|NCT01289756|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110747997|NCT01289756|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110747998|NCT01289756|Fertility Agents|fertility agents|mesh-ancestor
110747999|NCT01289756|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110748000|NCT01289756|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110748001|NCT01289756|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110748002|NCT01181882|Aspirin|aspirin|mesh-list
110748003|NCT01181882|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110748004|NCT01181882|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110748005|NCT01181882|Analgesics|analgesics|mesh-ancestor
110748006|NCT01181882|Sensory System Agents|sensory system agents|mesh-ancestor
110748007|NCT01181882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110748008|NCT01181882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110748009|NCT01181882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110748010|NCT01181882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110748011|NCT01181882|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110748012|NCT01181882|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110748013|NCT01181882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110748014|NCT01181882|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110748015|NCT01181882|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110748016|NCT01181882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110748017|NCT01181882|Antipyretics|antipyretics|mesh-ancestor
110748018|NCT01181960|Risperidone|risperidone|mesh-list
110867274|NCT04050098|Metformin|metformin|mesh-list
110748019|NCT01181960|Paliperidone Palmitate|paliperidone palmitate|mesh-list
110748020|NCT01181960|Antipsychotic Agents|antipsychotic agents|mesh-list
110748021|NCT01181960|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110748022|NCT01181960|Serotonin Agents|serotonin agents|mesh-ancestor
110748023|NCT01181960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110748024|NCT01181960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110748025|NCT01181960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110748026|NCT01181960|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110748027|NCT01181960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110748028|NCT01181960|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110748029|NCT01181960|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110748030|NCT01181960|Dopamine Agents|dopamine agents|mesh-ancestor
110748031|NCT01181960|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110748032|NCT01181960|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110748033|NCT03858062|Insulin|insulin|mesh-list
110748034|NCT03858062|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110748035|NCT03858062|Pancrelipase|pancrelipase|mesh-list
110748036|NCT03858062|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110748037|NCT03858062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110748038|NCT03858062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110748039|NCT03307252|Metformin|metformin|mesh-list
110748040|NCT03307252|Rifampin|rifampin|mesh-list
110748041|NCT03307252|Probenecid|probenecid|mesh-list
110748042|NCT03307252|Digoxin|digoxin|mesh-list
110748043|NCT03307252|Verapamil|verapamil|mesh-list
110748044|NCT03307252|Furosemide|furosemide|mesh-list
110748045|NCT03307252|Cimetidine|cimetidine|mesh-list
110748046|NCT03307252|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110748047|NCT03307252|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110748048|NCT03307252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110748049|NCT03307252|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110748050|NCT03307252|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110748051|NCT03307252|Antimetabolites|antimetabolites|mesh-ancestor
110748052|NCT03307252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110748053|NCT03307252|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110748054|NCT03307252|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110748055|NCT03307252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110748056|NCT03307252|Diuretics|diuretics|mesh-ancestor
110748057|NCT03307252|Natriuretic Agents|natriuretic agents|mesh-ancestor
110748058|NCT03307252|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110748059|NCT03307252|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110748060|NCT03307252|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110748061|NCT03307252|Antitubercular Agents|antitubercular agents|mesh-ancestor
110748062|NCT03307252|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110748063|NCT03307252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110748064|NCT03307252|Leprostatic Agents|leprostatic agents|mesh-ancestor
110748065|NCT03307252|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110748066|NCT03307252|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110748067|NCT03307252|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110748068|NCT03307252|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110748069|NCT03307252|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110748070|NCT03307252|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110748071|NCT03307252|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110748072|NCT03307252|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110748073|NCT03307252|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110748074|NCT03307252|Protective Agents|protective agents|mesh-ancestor
110748075|NCT03307252|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110748076|NCT03307252|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110748077|NCT03307252|Vasodilator Agents|vasodilator agents|mesh-ancestor
110748078|NCT03307252|Uricosuric Agents|uricosuric agents|mesh-ancestor
110748079|NCT03307252|Gout Suppressants|gout suppressants|mesh-ancestor
110748080|NCT03307252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110748081|NCT03307252|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110748082|NCT03307252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110748083|NCT03307252|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110748084|NCT03307252|Histamine Antagonists|histamine antagonists|mesh-ancestor
110748085|NCT03307252|Histamine Agents|histamine agents|mesh-ancestor
110748086|NCT03307252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110748087|NCT03307252|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110748088|NCT03307252|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110748089|NCT03307174|Fentanyl|fentanyl|mesh-list
110748090|NCT03307174|Bupivacaine|bupivacaine|mesh-list
110748091|NCT03307174|Anesthetics, Local|anesthetics, local|mesh-ancestor
110748092|NCT03307174|Anesthetics|anesthetics|mesh-ancestor
110748093|NCT03307174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110748094|NCT03307174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110748095|NCT03307174|Sensory System Agents|sensory system agents|mesh-ancestor
110748096|NCT03307174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110748097|NCT03307174|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110748098|NCT03307174|Narcotics|narcotics|mesh-ancestor
110748099|NCT03307174|Analgesics|analgesics|mesh-ancestor
110748100|NCT03307174|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110748101|NCT03307174|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110748102|NCT03307174|Anesthetics, General|anesthetics, general|mesh-ancestor
110748103|NCT03448978|Cyclophosphamide|cyclophosphamide|mesh-list
110748104|NCT03448978|Fludarabine|fludarabine|mesh-list
110748105|NCT03448978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110748106|NCT03448978|Immunologic Factors|immunologic factors|mesh-ancestor
110748107|NCT03448978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110748108|NCT03448978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110748109|NCT03448978|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110748110|NCT03448978|Alkylating Agents|alkylating agents|mesh-ancestor
110748111|NCT03448978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110748112|NCT03448978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110748113|NCT03448978|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110748115|NCT01290926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110748116|NCT01290926|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110748117|NCT01290926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110748118|NCT01290926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110748119|NCT01185158|Gefitinib|gefitinib|mesh-list
110867315|NCT03046836|Oxytocin|oxytocin|mesh-list
110748121|NCT01185158|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110748122|NCT01185158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110748123|NCT01185158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110748124|NCT01185236|Atorvastatin|atorvastatin|mesh-list
110748125|NCT01185236|Simvastatin|simvastatin|mesh-list
110748126|NCT01185236|Ezetimibe|ezetimibe|mesh-list
110748127|NCT01185236|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110748128|NCT01185236|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110748129|NCT01185236|Antimetabolites|antimetabolites|mesh-ancestor
110748130|NCT01185236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110748131|NCT01185236|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110748132|NCT01185236|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110748133|NCT01185236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110748134|NCT02524652|Ropivacaine|ropivacaine|mesh-list
110748135|NCT02524652|Anesthetics, Local|anesthetics, local|mesh-ancestor
110748136|NCT02524652|Anesthetics|anesthetics|mesh-ancestor
110748137|NCT02524652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110748138|NCT02524652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110748139|NCT02524652|Sensory System Agents|sensory system agents|mesh-ancestor
110748140|NCT02524652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110748141|NCT01182272|Sorafenib|sorafenib|mesh-list
110748142|NCT01182272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110748143|NCT01182272|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110748144|NCT01182272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110748145|NCT01182272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110308610|NCT00416507|Gemcitabine|gemcitabine|mesh-list
110748146|NCT03861416|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110748147|NCT01185470|Morphine|morphine|mesh-list
110748148|NCT01185470|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110748149|NCT01185470|Narcotics|narcotics|mesh-ancestor
110748150|NCT01185470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110748151|NCT01185470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110748152|NCT01185470|Analgesics|analgesics|mesh-ancestor
110748153|NCT01185470|Sensory System Agents|sensory system agents|mesh-ancestor
110748154|NCT01185470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110748155|NCT00056160|Dexamethasone|dexamethasone|mesh-list
110748156|NCT00056160|Lenalidomide|lenalidomide|mesh-list
110748157|NCT00056160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110748158|NCT00056160|Antiemetics|antiemetics|mesh-ancestor
110748159|NCT00056160|Autonomic Agents|autonomic agents|mesh-ancestor
110748160|NCT00056160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110748161|NCT00056160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110748162|NCT00056160|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110748163|NCT00056160|Glucocorticoids|glucocorticoids|mesh-ancestor
110748164|NCT00056160|Hormones|hormones|mesh-ancestor
110748165|NCT00056160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110748166|NCT00056160|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110748167|NCT00056160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110748168|NCT00056160|Immunologic Factors|immunologic factors|mesh-ancestor
110748169|NCT00056160|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110748170|NCT00056160|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110748171|NCT00056160|Growth Substances|growth substances|mesh-ancestor
110748172|NCT00056160|Growth Inhibitors|growth inhibitors|mesh-ancestor
110748173|NCT01290146|Simendan|simendan|mesh-list
110748174|NCT01290146|Diuretics|diuretics|mesh-list
110748175|NCT01290146|Natriuretic Agents|natriuretic agents|mesh-ancestor
110748176|NCT01290146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110748177|NCT01290146|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110748178|NCT01290146|Vasodilator Agents|vasodilator agents|mesh-ancestor
110748179|NCT01290146|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110748180|NCT01290146|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110748181|NCT01290146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110748182|NCT01290146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110748183|NCT01290146|Protective Agents|protective agents|mesh-ancestor
110748184|NCT00061932|Irinotecan|irinotecan|mesh-list
110748185|NCT00061932|Bortezomib|bortezomib|mesh-list
110748186|NCT00061932|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110748187|NCT00061932|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110748188|NCT00061932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110465918|NCT00925704|Calcitriol|calcitriol|mesh-list
110748189|NCT00061932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110748191|NCT03856970|Glyburide|glyburide|mesh-list
110748192|NCT03856970|Digoxin|digoxin|mesh-list
110748193|NCT03856970|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110748194|NCT03856970|Norethindrone|norethindrone|mesh-list
110748195|NCT03856970|Estradiol|estradiol|mesh-list
110748196|NCT03856970|Estrogens|estrogens|mesh-ancestor
110748197|NCT03856970|Hormones|hormones|mesh-ancestor
110748198|NCT03856970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110748199|NCT03856970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110748200|NCT03856970|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110748201|NCT03856970|Contraceptive Agents|contraceptive agents|mesh-ancestor
110748202|NCT03856970|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110748203|NCT03856970|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110748204|NCT03856970|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110748205|NCT03856970|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110748206|NCT03856970|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110748207|NCT03856970|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110748208|NCT03856970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110748209|NCT03856970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110748210|NCT03856970|Protective Agents|protective agents|mesh-ancestor
110308644|NCT00272948|Defibrotide|defibrotide|mesh-list
110748211|NCT03856970|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110748212|NCT03856970|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110748213|NCT01089348|Metronidazole|metronidazole|mesh-list
110748214|NCT01089348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110748215|NCT01089348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110748216|NCT01089348|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110748217|NCT01089348|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110748218|NCT01291316|Clonazepam|clonazepam|mesh-list
110748219|NCT01291316|Clobazam|clobazam|mesh-list
110748220|NCT01291316|Tolterodine Tartrate|tolterodine tartrate|mesh-list
110748221|NCT01291316|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110748222|NCT01291316|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110748223|NCT01291316|Cholinergic Agents|cholinergic agents|mesh-ancestor
110748224|NCT01291316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110748225|NCT01291316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110748226|NCT01291316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110748227|NCT01291316|Urological Agents|urological agents|mesh-ancestor
110748228|NCT01291316|Anticonvulsants|anticonvulsants|mesh-ancestor
110748229|NCT01291316|GABA Modulators|gaba modulators|mesh-ancestor
110748230|NCT01291316|GABA Agents|gaba agents|mesh-ancestor
110748231|NCT01291316|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110748232|NCT01291316|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110748233|NCT01291316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110748234|NCT01291316|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110748235|NCT01291316|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
110748236|NCT01291316|GABA Agonists|gaba agonists|mesh-ancestor
110748237|NCT00060840|Nitric Oxide|nitric oxide|mesh-list
110748238|NCT00060840|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110748239|NCT00060840|Autonomic Agents|autonomic agents|mesh-ancestor
110748240|NCT00060840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110748241|NCT00060840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110748242|NCT00060840|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110748243|NCT00060840|Respiratory System Agents|respiratory system agents|mesh-ancestor
110748244|NCT00060840|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110748245|NCT00060840|Antioxidants|antioxidants|mesh-ancestor
110748246|NCT00060840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110748247|NCT00060840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110748248|NCT00060840|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
110748249|NCT00060840|Vasodilator Agents|vasodilator agents|mesh-ancestor
110748250|NCT00060840|Gasotransmitters|gasotransmitters|mesh-ancestor
110748251|NCT00060840|Protective Agents|protective agents|mesh-ancestor
110748252|NCT01185860|Ritonavir|ritonavir|mesh-list
110748253|NCT01185860|Ribavirin|ribavirin|mesh-list
110748254|NCT01185860|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110748255|NCT01185860|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110748256|NCT01185860|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110748257|NCT01185860|Protease Inhibitors|protease inhibitors|mesh-ancestor
110748258|NCT01185860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110748259|NCT01185860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110748260|NCT01185860|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110748261|NCT01185860|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110748262|NCT01185860|Antiviral Agents|antiviral agents|mesh-ancestor
110748263|NCT01185860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110748264|NCT01185860|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110748265|NCT01185860|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110748266|NCT01185860|Antimetabolites|antimetabolites|mesh-ancestor
110748267|NCT01290302|Azacitidine|azacitidine|mesh-list
110748268|NCT01290302|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110748269|NCT01290302|Antimetabolites|antimetabolites|mesh-ancestor
110748270|NCT01290302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110748271|NCT01290302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110748272|NCT01290302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110748273|NCT01089660|Vaccines|vaccines|mesh-list
110748274|NCT01089660|Immunologic Factors|immunologic factors|mesh-ancestor
110748275|NCT01089660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110748276|NCT01182662|Cyclosporine|cyclosporine|mesh-list
110748277|NCT01182662|Cyclosporins|cyclosporins|mesh-list
110748278|NCT01182662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110748279|NCT01182662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110748280|NCT01182662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110748281|NCT01182662|Immunologic Factors|immunologic factors|mesh-ancestor
110748282|NCT01182662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110748283|NCT01182662|Antifungal Agents|antifungal agents|mesh-ancestor
110748284|NCT01182662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110748285|NCT01182662|Dermatologic Agents|dermatologic agents|mesh-ancestor
110748286|NCT01182662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110748287|NCT01182662|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110748288|NCT01185938|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110748289|NCT01185938|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110748290|NCT01185938|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110748291|NCT01185938|Antimetabolites|antimetabolites|mesh-ancestor
110748292|NCT01185938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110748293|NCT01185938|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110748294|NCT01185938|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110748295|NCT01185938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110748296|NCT00059202|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
110748297|NCT00059202|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
110748298|NCT00059202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110748299|NCT01177358|Botulinum Toxins|botulinum toxins|mesh-list
110748300|NCT01177358|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110748301|NCT01177358|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110748302|NCT01177358|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110748303|NCT01177358|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110748304|NCT01177358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110748305|NCT01177358|Cholinergic Agents|cholinergic agents|mesh-ancestor
110748306|NCT01177358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110748307|NCT01177358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110748308|NCT01177358|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110748309|NCT01177358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110748311|NCT03854942|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110748312|NCT03854942|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110748313|NCT03854942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110748314|NCT03854942|Sensory System Agents|sensory system agents|mesh-ancestor
110748315|NCT03854942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110748316|NCT03278626|Paclitaxel|paclitaxel|mesh-list
110748317|NCT03278626|Carboplatin|carboplatin|mesh-list
110748318|NCT03278626|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110748319|NCT03278626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110748320|NCT03278626|Tubulin Modulators|tubulin modulators|mesh-ancestor
110748321|NCT03278626|Antimitotic Agents|antimitotic agents|mesh-ancestor
110748322|NCT03278626|Mitosis Modulators|mitosis modulators|mesh-ancestor
110748323|NCT03278626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110748324|NCT01186094|Sirolimus|sirolimus|mesh-list
110748325|NCT01186094|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110748326|NCT01186094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110748327|NCT01186094|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110748328|NCT01186094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110748329|NCT01186094|Antifungal Agents|antifungal agents|mesh-ancestor
110748330|NCT01186094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110748331|NCT01186094|Immunologic Factors|immunologic factors|mesh-ancestor
110748332|NCT01186094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110748333|NCT01287806|Urinastatin|urinastatin|mesh-list
110748334|NCT01287806|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
110748335|NCT01287806|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110748336|NCT01287806|Protease Inhibitors|protease inhibitors|mesh-ancestor
110748337|NCT01287806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110748338|NCT01287806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110748339|NCT01186172|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110748340|NCT01186172|Ethanol|ethanol|mesh-list
110748341|NCT01186172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110748342|NCT01186172|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110748343|NCT01186172|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110748344|NCT01186172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110748345|NCT03854708|Pancreatic Polypeptide|pancreatic polypeptide|mesh-list
110748346|NCT03854708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110748347|NCT03854708|Hormones|hormones|mesh-ancestor
110748348|NCT03854708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110748349|NCT03854708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110748350|NCT03860870|Clenbuterol|clenbuterol|mesh-list
110748351|NCT03860870|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110748352|NCT03860870|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110748353|NCT03860870|Adrenergic Agents|adrenergic agents|mesh-ancestor
110748354|NCT03860870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110748355|NCT03860870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110748356|NCT03860870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110748357|NCT03860870|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110748358|NCT03860870|Autonomic Agents|autonomic agents|mesh-ancestor
110748359|NCT03860870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110748360|NCT03860870|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110748361|NCT03860870|Respiratory System Agents|respiratory system agents|mesh-ancestor
110748362|NCT03860870|Sympathomimetics|sympathomimetics|mesh-ancestor
110748363|NCT01177514|Gabapentin|gabapentin|mesh-list
110748364|NCT01177514|Analgesics|analgesics|mesh-ancestor
110748365|NCT01177514|Sensory System Agents|sensory system agents|mesh-ancestor
110748366|NCT01177514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110748367|NCT01177514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110748368|NCT01177514|Anticonvulsants|anticonvulsants|mesh-ancestor
110748369|NCT01177514|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110748370|NCT01177514|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110748371|NCT01177514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110748372|NCT01177514|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110748373|NCT01177514|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110748374|NCT01177514|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110748375|NCT01177514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110748376|NCT01177514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110748378|NCT00073008|Lapatinib|lapatinib|mesh-list
110748379|NCT00073008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110748380|NCT00073008|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110748381|NCT00073008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110748382|NCT00073008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110748383|NCT01182974|Acetaminophen|acetaminophen|mesh-list
110748384|NCT01182974|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110748385|NCT01182974|Analgesics|analgesics|mesh-ancestor
110748386|NCT01182974|Sensory System Agents|sensory system agents|mesh-ancestor
110748387|NCT01182974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110748388|NCT01182974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110748389|NCT01182974|Antipyretics|antipyretics|mesh-ancestor
110748390|NCT03856502|Dexamethasone|dexamethasone|mesh-list
110748391|NCT03856502|Dexamethasone acetate|dexamethasone acetate|mesh-list
110748392|NCT03856502|Levobupivacaine|levobupivacaine|mesh-list
110748393|NCT03856502|BB 1101|bb 1101|mesh-list
110748394|NCT03856502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110748395|NCT03856502|Antiemetics|antiemetics|mesh-ancestor
110748396|NCT03856502|Autonomic Agents|autonomic agents|mesh-ancestor
110748397|NCT03856502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110748398|NCT03856502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110748399|NCT03856502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110748400|NCT03856502|Glucocorticoids|glucocorticoids|mesh-ancestor
110748401|NCT03856502|Hormones|hormones|mesh-ancestor
110748402|NCT03856502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110748403|NCT03856502|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110748404|NCT03856502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110748405|NCT03856502|Protease Inhibitors|protease inhibitors|mesh-ancestor
110748406|NCT03856502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110748407|NCT03856502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110748408|NCT03856502|Anesthetics, Local|anesthetics, local|mesh-ancestor
110748409|NCT03856502|Anesthetics|anesthetics|mesh-ancestor
110748410|NCT03856502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110748411|NCT03856502|Sensory System Agents|sensory system agents|mesh-ancestor
110748412|NCT01583478|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
110748413|NCT01583478|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110748414|NCT01583478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110748415|NCT01583478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110748416|NCT01583478|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110748417|NCT01583478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110748418|NCT01583478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110748419|NCT01583478|Cholinergic Agents|cholinergic agents|mesh-ancestor
110748420|NCT01583478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110748421|NCT03854396|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
110748422|NCT03854396|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110748423|NCT03854396|Immunologic Factors|immunologic factors|mesh-ancestor
110748424|NCT03854396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110748426|NCT01093638|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110748427|NCT01093638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110748428|NCT01287962|Apatinib|apatinib|mesh-list
110748429|NCT01287962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110748430|NCT01287962|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110748431|NCT01287962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110748432|NCT01287962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110748433|NCT00058422|Prednisone|prednisone|mesh-list
110748434|NCT00058422|Cyclophosphamide|cyclophosphamide|mesh-list
110748435|NCT00058422|Rituximab|rituximab|mesh-list
110748436|NCT00058422|Doxorubicin|doxorubicin|mesh-list
110748437|NCT00058422|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110748438|NCT00058422|Vincristine|vincristine|mesh-list
110748439|NCT00058422|Darbepoetin alfa|darbepoetin alfa|mesh-list
110748440|NCT00058422|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110748441|NCT00058422|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110748442|NCT00058422|Immunologic Factors|immunologic factors|mesh-ancestor
110748443|NCT00058422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110748444|NCT00058422|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110748445|NCT00058422|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110748446|NCT00058422|Alkylating Agents|alkylating agents|mesh-ancestor
110748447|NCT00058422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110748448|NCT00058422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110748449|NCT00058422|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110073490|NCT01578447|Contraceptive Agents|contraceptive agents|mesh-ancestor
110748450|NCT00058422|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110748451|NCT00058422|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110748452|NCT00058422|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110748453|NCT00058422|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110748454|NCT00058422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110748455|NCT00058422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110748457|NCT00058422|Hormones|hormones|mesh-ancestor
110748458|NCT00058422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110748459|NCT00058422|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110748460|NCT00058422|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110748461|NCT00058422|Tubulin Modulators|tubulin modulators|mesh-ancestor
110748462|NCT00058422|Antimitotic Agents|antimitotic agents|mesh-ancestor
110748463|NCT00058422|Mitosis Modulators|mitosis modulators|mesh-ancestor
110748464|NCT00058422|Hematinics|hematinics|mesh-ancestor
110748465|NCT01094964|Interferons|interferons|mesh-list
110748466|NCT01094964|Interferon-alpha|interferon-alpha|mesh-list
110748467|NCT01094964|Epirubicin|epirubicin|mesh-list
110748468|NCT01094964|Mitomycins|mitomycins|mesh-list
110748469|NCT01094964|Mitomycin|mitomycin|mesh-list
110748470|NCT01094964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110748471|NCT01094964|Antiviral Agents|antiviral agents|mesh-ancestor
110748472|NCT01094964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110748473|NCT01094964|Immunologic Factors|immunologic factors|mesh-ancestor
110748474|NCT01094964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110748475|NCT01094964|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110748476|NCT01094964|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110748477|NCT01094964|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110748478|NCT01094964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110748479|NCT01094964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110748480|NCT01094964|Alkylating Agents|alkylating agents|mesh-ancestor
110748481|NCT01094964|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110748482|NCT01291472|Ketorolac|ketorolac|mesh-list
110748483|NCT01291472|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
110748484|NCT01291472|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110748485|NCT01291472|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110748486|NCT01291472|Analgesics|analgesics|mesh-ancestor
110748487|NCT01291472|Sensory System Agents|sensory system agents|mesh-ancestor
110748488|NCT01291472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110748489|NCT01291472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110748490|NCT01291472|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110748491|NCT01291472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110748492|NCT01291472|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110748493|NCT01291472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110308730|NCT00273377|Dexamethasone|dexamethasone|mesh-list
110748494|NCT01291472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110748495|NCT02530632|Propofol|propofol|mesh-list
110748496|NCT02530632|Sevoflurane|sevoflurane|mesh-list
110748497|NCT02530632|Anesthetics|anesthetics|mesh-ancestor
110748498|NCT02530632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110748499|NCT02530632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110748500|NCT02530632|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110748501|NCT02530632|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110748502|NCT02530632|Anesthetics, General|anesthetics, general|mesh-ancestor
110748503|NCT02530632|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110748504|NCT02530632|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110748505|NCT01183364|Docetaxel|docetaxel|mesh-list
110748506|NCT01183364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110748507|NCT01183364|Tubulin Modulators|tubulin modulators|mesh-ancestor
110748508|NCT01183364|Antimitotic Agents|antimitotic agents|mesh-ancestor
110748509|NCT01183364|Mitosis Modulators|mitosis modulators|mesh-ancestor
110748510|NCT01183364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110748511|NCT00072384|Carboplatin|carboplatin|mesh-list
110748512|NCT00072384|Etoposide|etoposide|mesh-list
110748513|NCT00072384|Vincristine|vincristine|mesh-list
110748514|NCT00072384|Etoposide phosphate|etoposide phosphate|mesh-list
110748515|NCT00072384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110748516|NCT00072384|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110748517|NCT00072384|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110748518|NCT00072384|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110748519|NCT00072384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110748520|NCT00072384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110748521|NCT00072384|Tubulin Modulators|tubulin modulators|mesh-ancestor
110748522|NCT00072384|Antimitotic Agents|antimitotic agents|mesh-ancestor
110748523|NCT00072384|Mitosis Modulators|mitosis modulators|mesh-ancestor
110748524|NCT01183442|Vitamin D|vitamin d|mesh-list
110748525|NCT01183442|Ergocalciferols|ergocalciferols|mesh-list
110748526|NCT01183442|Cholecalciferol|cholecalciferol|mesh-list
110748527|NCT01183442|Vitamins|vitamins|mesh-list
110748528|NCT01183442|Micronutrients|micronutrients|mesh-ancestor
110748529|NCT01183442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110748530|NCT01183442|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110748531|NCT01183442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110748532|NCT01187108|Acetylcysteine|acetylcysteine|mesh-list
110748533|NCT01187108|Acetazolamide|acetazolamide|mesh-list
110748534|NCT01187108|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110748535|NCT01187108|Antiviral Agents|antiviral agents|mesh-ancestor
110748536|NCT01187108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110748537|NCT01187108|Expectorants|expectorants|mesh-ancestor
110748538|NCT01187108|Respiratory System Agents|respiratory system agents|mesh-ancestor
110748539|NCT01187108|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110748540|NCT01187108|Antioxidants|antioxidants|mesh-ancestor
110748541|NCT01187108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110748542|NCT01187108|Protective Agents|protective agents|mesh-ancestor
110748543|NCT01187108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110748544|NCT01187108|Antidotes|antidotes|mesh-ancestor
110748545|NCT01187108|Anticonvulsants|anticonvulsants|mesh-ancestor
110748546|NCT01187108|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110748547|NCT01187108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110748548|NCT01187108|Diuretics|diuretics|mesh-ancestor
110748549|NCT01187108|Natriuretic Agents|natriuretic agents|mesh-ancestor
110748550|NCT01187888|Rasagiline|rasagiline|mesh-list
110748551|NCT01187888|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
110748552|NCT01187888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110748553|NCT01187888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110748554|NCT01187888|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110748555|NCT01187888|Protective Agents|protective agents|mesh-ancestor
110748556|NCT01187888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110748557|NCT01187186|Ipragliflozin|ipragliflozin|mesh-list
110748558|NCT01187186|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110748559|NCT01187186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110748560|NCT01187186|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110748561|NCT01187186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110748562|NCT00054132|Bevacizumab|bevacizumab|mesh-list
110748563|NCT00054132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110748564|NCT00054132|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110748565|NCT00054132|Endothelial Growth Factors|endothelial growth factors|mesh-list
110748566|NCT00054132|Antibodies|antibodies|mesh-list
110748567|NCT00054132|Immunoglobulins|immunoglobulins|mesh-list
110748569|NCT00054132|Immunoglobulin G|immunoglobulin g|mesh-list
110748570|NCT00054132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110748571|NCT00054132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110748572|NCT00054132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110748573|NCT00054132|Growth Substances|growth substances|mesh-ancestor
110748574|NCT00054132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110748575|NCT00054132|Growth Inhibitors|growth inhibitors|mesh-ancestor
110748576|NCT00054132|Immunologic Factors|immunologic factors|mesh-ancestor
110748577|NCT00054132|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110748578|NCT00054132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110748579|NCT00054132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110748580|NCT01187264|Methotrexate|methotrexate|mesh-list
110748581|NCT01187264|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110748582|NCT01187264|Abortifacient Agents|abortifacient agents|mesh-ancestor
110748583|NCT01187264|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110748584|NCT01187264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110748585|NCT01187264|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110748586|NCT01187264|Antimetabolites|antimetabolites|mesh-ancestor
110748587|NCT01187264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110748588|NCT01187264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110748589|NCT01187264|Dermatologic Agents|dermatologic agents|mesh-ancestor
110748590|NCT01187264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110748591|NCT01187264|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110748592|NCT01187264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110748593|NCT01187264|Immunologic Factors|immunologic factors|mesh-ancestor
110748594|NCT01187264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110748595|NCT01187264|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110748596|NCT01183676|Valproic Acid|valproic acid|mesh-list
110748597|NCT01183676|Anticonvulsants|anticonvulsants|mesh-ancestor
110748598|NCT01183676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110748599|NCT01183676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110748600|NCT01183676|GABA Agents|gaba agents|mesh-ancestor
110748601|NCT01183676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110748602|NCT01183676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110748603|NCT01183676|Antimanic Agents|antimanic agents|mesh-ancestor
110748604|NCT01183676|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110748605|NCT01183676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110748606|NCT01183676|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110748607|NCT03856112|Dexamethasone|dexamethasone|mesh-list
110748608|NCT03856112|Dexamethasone acetate|dexamethasone acetate|mesh-list
110748609|NCT03856112|Venetoclax|venetoclax|mesh-list
110748610|NCT03856112|Ixazomib|ixazomib|mesh-list
110748611|NCT03856112|Ichthammol|ichthammol|mesh-list
110748612|NCT03856112|BB 1101|bb 1101|mesh-list
110748613|NCT03856112|Glycine|glycine|mesh-list
110748614|NCT03856112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110748615|NCT03856112|Antiemetics|antiemetics|mesh-ancestor
110748616|NCT03856112|Autonomic Agents|autonomic agents|mesh-ancestor
110748617|NCT03856112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110748618|NCT03856112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110748619|NCT03856112|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110748620|NCT03856112|Glucocorticoids|glucocorticoids|mesh-ancestor
110748621|NCT03856112|Hormones|hormones|mesh-ancestor
110748622|NCT03856112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110748623|NCT03856112|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110748624|NCT03856112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110748625|NCT03856112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110748626|NCT03856112|Protease Inhibitors|protease inhibitors|mesh-ancestor
110748627|NCT03856112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110748628|NCT03856112|Glycine Agents|glycine agents|mesh-ancestor
110748629|NCT03856112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110748630|NCT03856112|Dermatologic Agents|dermatologic agents|mesh-ancestor
110748631|NCT01290380|Vadimezan|vadimezan|mesh-list
110748632|NCT01290380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110748633|NCT00071760|Ritonavir|ritonavir|mesh-list
110748634|NCT00071760|Fosamprenavir|fosamprenavir|mesh-list
110748635|NCT00071760|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110748636|NCT00071760|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110748637|NCT00071760|Protease Inhibitors|protease inhibitors|mesh-ancestor
110748638|NCT00071760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110748639|NCT00071760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110748640|NCT00071760|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110748641|NCT00071760|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110748642|NCT00071760|Antiviral Agents|antiviral agents|mesh-ancestor
110748643|NCT00071760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110748644|NCT00071760|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110748645|NCT00071760|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110748646|NCT01183910|Calcium Carbonate|calcium carbonate|mesh-list
110748648|NCT01183910|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110748649|NCT01183910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110748650|NCT01183910|Antacids|antacids|mesh-ancestor
110748651|NCT01183910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110748652|NCT01183910|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110748653|NCT03852914|Hyaluronic Acid|hyaluronic acid|mesh-list
110748654|NCT03852914|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110748655|NCT03852914|Immunologic Factors|immunologic factors|mesh-ancestor
110748656|NCT03852914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110748657|NCT03852914|Viscosupplements|viscosupplements|mesh-ancestor
110748658|NCT03852914|Protective Agents|protective agents|mesh-ancestor
110748659|NCT05234684|Prednisone|prednisone|mesh-list
110748660|NCT05234684|Cyclophosphamide|cyclophosphamide|mesh-list
110748661|NCT05234684|Vincristine|vincristine|mesh-list
110748662|NCT05234684|Rituximab|rituximab|mesh-list
110748663|NCT05234684|Doxorubicin|doxorubicin|mesh-list
110748664|NCT05234684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110748665|NCT05234684|Immunologic Factors|immunologic factors|mesh-ancestor
110748666|NCT05234684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110748667|NCT05234684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110748668|NCT05234684|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110748669|NCT05234684|Alkylating Agents|alkylating agents|mesh-ancestor
110748670|NCT05234684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110748671|NCT05234684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110748672|NCT05234684|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110748673|NCT05234684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110748674|NCT05234684|Glucocorticoids|glucocorticoids|mesh-ancestor
110748675|NCT05234684|Hormones|hormones|mesh-ancestor
110748676|NCT05234684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110748677|NCT05234684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110748678|NCT05234684|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110748679|NCT05234684|Tubulin Modulators|tubulin modulators|mesh-ancestor
110748680|NCT05234684|Antimitotic Agents|antimitotic agents|mesh-ancestor
110748681|NCT05234684|Mitosis Modulators|mitosis modulators|mesh-ancestor
110748682|NCT05234684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110748683|NCT05234684|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110748684|NCT05234684|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110748685|NCT05234684|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110748686|NCT05234684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110748687|NCT03853538|Petrolatum|petrolatum|mesh-list
110748688|NCT03853538|Emollients|emollients|mesh-ancestor
110748689|NCT03853538|Dermatologic Agents|dermatologic agents|mesh-ancestor
110748690|NCT03853304|Folic Acid|folic acid|mesh-list
110748691|NCT03853304|Vitamin B 12|vitamin b 12|mesh-list
110748692|NCT03853304|Hydroxocobalamin|hydroxocobalamin|mesh-list
110748693|NCT03853304|Vitamins|vitamins|mesh-ancestor
110748694|NCT03853304|Micronutrients|micronutrients|mesh-ancestor
110748695|NCT03853304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110748696|NCT03853304|Hematinics|hematinics|mesh-ancestor
110748697|NCT03853304|Vitamin B Complex|vitamin b complex|mesh-ancestor
110748698|NCT01290458|Vitamins|vitamins|mesh-list
110748699|NCT01290458|Ascorbic Acid|ascorbic acid|mesh-list
110748700|NCT01290458|Vitamin E|vitamin e|mesh-list
110308837|NCT00273962|Albuterol|albuterol|mesh-list
110748701|NCT01290458|Tocopherols|tocopherols|mesh-list
110748702|NCT01290458|alpha-Tocopherol|alpha-tocopherol|mesh-list
110748703|NCT01290458|Antioxidants|antioxidants|mesh-list
110748704|NCT01290458|Micronutrients|micronutrients|mesh-ancestor
110748705|NCT01290458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110748706|NCT01290458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110748707|NCT01290458|Protective Agents|protective agents|mesh-ancestor
110748708|NCT01184144|Pioglitazone|pioglitazone|mesh-list
110748709|NCT01184144|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110748710|NCT01184144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110748711|NCT01291628|Copper|copper|mesh-list
110748712|NCT01291628|Trace Elements|trace elements|mesh-ancestor
110748713|NCT01291628|Micronutrients|micronutrients|mesh-ancestor
110748714|NCT01291628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110748715|NCT00053898|Tamoxifen|tamoxifen|mesh-list
110466448|NCT02618668|Ketamine|ketamine|mesh-list
110748716|NCT00053898|Anastrozole|anastrozole|mesh-list
110748717|NCT00053898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110748718|NCT00053898|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110748719|NCT00053898|Hormone Antagonists|hormone antagonists|mesh-ancestor
110748720|NCT00053898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110748721|NCT00053898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110308845|NCT00273962|Tocolytic Agents|tocolytic agents|mesh-ancestor
110748722|NCT00053898|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110748723|NCT00053898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110748724|NCT00053898|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110748725|NCT00053898|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110748726|NCT00053898|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110748727|NCT00053898|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110748728|NCT00053898|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110748729|NCT00053898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110748730|NCT01293734|Budesonide|budesonide|mesh-list
110748731|NCT01293734|Theophylline|theophylline|mesh-list
110748732|NCT01293734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110748733|NCT01293734|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110748735|NCT01293734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110748736|NCT01293734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110748737|NCT01293734|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110748738|NCT01293734|Respiratory System Agents|respiratory system agents|mesh-ancestor
110748739|NCT01293734|Glucocorticoids|glucocorticoids|mesh-ancestor
110748740|NCT01293734|Hormones|hormones|mesh-ancestor
110748741|NCT01293734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110748742|NCT01293734|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110748743|NCT01293734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110748744|NCT01293734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110748745|NCT01293734|Vasodilator Agents|vasodilator agents|mesh-ancestor
110748746|NCT01293734|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110748747|NCT01293734|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110748748|NCT01293734|Purinergic Agents|purinergic agents|mesh-ancestor
110748749|NCT01293734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110748750|NCT01184300|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
110748751|NCT01184300|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110748752|NCT01188278|Imatinib Mesylate|imatinib mesylate|mesh-list
110748753|NCT01188278|Dasatinib|dasatinib|mesh-list
110748754|NCT01188278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110748755|NCT01188278|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110748756|NCT01188278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110748757|NCT01188278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110748758|NCT01184378|Caseins|caseins|mesh-list
110748759|NCT01184378|Chelating Agents|chelating agents|mesh-ancestor
110748760|NCT01184378|Sequestering Agents|sequestering agents|mesh-ancestor
110748761|NCT01184378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110748762|NCT03852602|Analgesics|analgesics|mesh-list
110748763|NCT03852602|Sensory System Agents|sensory system agents|mesh-ancestor
110748764|NCT03852602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110748765|NCT03852602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110748766|NCT02459392|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110748767|NCT02459392|Methylprednisolone|methylprednisolone|mesh-list
110748768|NCT02459392|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110748769|NCT02459392|Prednisolone|prednisolone|mesh-list
110748770|NCT02459392|Prednisolone acetate|prednisolone acetate|mesh-list
110748771|NCT02459392|Hyaluronic Acid|hyaluronic acid|mesh-list
110748772|NCT02459392|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110748773|NCT02459392|Prednisolone phosphate|prednisolone phosphate|mesh-list
110748774|NCT02459392|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110748775|NCT02459392|Immunologic Factors|immunologic factors|mesh-ancestor
110748776|NCT02459392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110748777|NCT02459392|Viscosupplements|viscosupplements|mesh-ancestor
110748778|NCT02459392|Protective Agents|protective agents|mesh-ancestor
110748779|NCT02459392|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110748780|NCT02459392|Antiemetics|antiemetics|mesh-ancestor
110748781|NCT02459392|Autonomic Agents|autonomic agents|mesh-ancestor
110748782|NCT02459392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110748783|NCT02459392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110748784|NCT02459392|Glucocorticoids|glucocorticoids|mesh-ancestor
110748785|NCT02459392|Hormones|hormones|mesh-ancestor
110748786|NCT02459392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110748787|NCT02459392|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110748788|NCT02459392|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110748789|NCT02459392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110748790|NCT03256552|Glycopyrrolate|glycopyrrolate|mesh-list
110748791|NCT03256552|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110748792|NCT03256552|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110748793|NCT03256552|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110748794|NCT03256552|Cholinergic Agents|cholinergic agents|mesh-ancestor
110748795|NCT03256552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110748796|NCT03256552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110748797|NCT03256552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110748798|NCT03852446|Tryptophan|tryptophan|mesh-list
110748799|NCT03852446|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110748800|NCT03852446|Antidepressive Agents|antidepressive agents|mesh-ancestor
110748801|NCT03852446|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110748802|NCT03637582|Lidocaine|lidocaine|mesh-list
110748803|NCT03637582|Anesthetics, Local|anesthetics, local|mesh-ancestor
110748804|NCT03637582|Anesthetics|anesthetics|mesh-ancestor
110748805|NCT03637582|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110748806|NCT03637582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110748807|NCT03637582|Sensory System Agents|sensory system agents|mesh-ancestor
110748808|NCT03637582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110748809|NCT03637582|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110748810|NCT03637582|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110748811|NCT03637582|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110748812|NCT03637582|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110748813|NCT03637582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110748814|NCT00053352|Etoposide|etoposide|mesh-list
110748815|NCT00053352|Etoposide phosphate|etoposide phosphate|mesh-list
110748816|NCT00053352|Bleomycin|bleomycin|mesh-list
110748817|NCT00053352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110748818|NCT00053352|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110748819|NCT00053352|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110748820|NCT00053352|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110748821|NCT00053352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110748822|NCT00053352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110748823|NCT00053352|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110748824|NCT01193816|Loxapine|loxapine|mesh-list
110748826|NCT01193816|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110748827|NCT01193816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110748828|NCT01193816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110748829|NCT01193816|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110748830|NCT01193816|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110748831|NCT01193816|Dopamine Agents|dopamine agents|mesh-ancestor
110748832|NCT01193816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110748833|NCT01193816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110748834|NCT05571202|Anesthetics|anesthetics|mesh-list
110748835|NCT05571202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110748836|NCT05571202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110748837|NCT03245398|Mebendazole|mebendazole|mesh-list
110748838|NCT03245398|Piperazine|piperazine|mesh-list
110748839|NCT03245398|Piperazine citrate|piperazine citrate|mesh-list
110748840|NCT03245398|DMP 777|dmp 777|mesh-list
110748841|NCT03245398|Antinematodal Agents|antinematodal agents|mesh-ancestor
110748842|NCT03245398|Anthelmintics|anthelmintics|mesh-ancestor
110748843|NCT03245398|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110748844|NCT03245398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110748845|NCT03245398|Tubulin Modulators|tubulin modulators|mesh-ancestor
110748846|NCT03245398|Antimitotic Agents|antimitotic agents|mesh-ancestor
110748847|NCT03245398|Mitosis Modulators|mitosis modulators|mesh-ancestor
110748848|NCT03245398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110748849|NCT03245398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110748850|NCT03245398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110748851|NCT01291940|Petrolatum|petrolatum|mesh-list
110748852|NCT01291940|Emollients|emollients|mesh-ancestor
110748853|NCT01291940|Dermatologic Agents|dermatologic agents|mesh-ancestor
110748854|NCT03244618|Fluorides|fluorides|mesh-list
110748855|NCT03244618|Cariostatic Agents|cariostatic agents|mesh-ancestor
110748856|NCT03244618|Protective Agents|protective agents|mesh-ancestor
110748857|NCT03244618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110748858|NCT05571046|Betamethasone dipropionate, betamethasone sodium phosphate drug combination|betamethasone dipropionate, betamethasone sodium phosphate drug combination|mesh-list
110748859|NCT05571046|Glucocorticoids|glucocorticoids|mesh-list
110748860|NCT05571046|Hormones|hormones|mesh-ancestor
110748861|NCT05571046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110748862|NCT05571046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110748863|NCT05571046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110748864|NCT03849404|Adalimumab|adalimumab|mesh-list
110748865|NCT03849404|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110748866|NCT03849404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110748867|NCT03849404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110748868|NCT00051636|Vitamin D|vitamin d|mesh-list
110748869|NCT00051636|Zoledronic Acid|zoledronic acid|mesh-list
110748870|NCT00051636|Risedronic Acid|risedronic acid|mesh-list
110748871|NCT00051636|Etidronic Acid|etidronic acid|mesh-list
110748872|NCT00051636|Calcium|calcium|mesh-list
110748873|NCT00051636|Vitamins|vitamins|mesh-ancestor
110748874|NCT00051636|Micronutrients|micronutrients|mesh-ancestor
110748875|NCT00051636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110748876|NCT00051636|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110748877|NCT00051636|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110748878|NCT00051636|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110748879|NCT00051636|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110748880|NCT00051636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110748882|NCT01294826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110748883|NCT01294826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110748884|NCT03847922|Lidocaine|lidocaine|mesh-list
110748885|NCT03847922|Nitrous Oxide|nitrous oxide|mesh-list
110748886|NCT03847922|Anesthetics, Local|anesthetics, local|mesh-ancestor
110748887|NCT03847922|Anesthetics|anesthetics|mesh-ancestor
110748888|NCT03847922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110748889|NCT03847922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110748890|NCT03847922|Sensory System Agents|sensory system agents|mesh-ancestor
110748891|NCT03847922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110748892|NCT03847922|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110748893|NCT03847922|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110748894|NCT03847922|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110748895|NCT03847922|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110748896|NCT03847922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110748897|NCT03847922|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110748898|NCT03847922|Anesthetics, General|anesthetics, general|mesh-ancestor
110748899|NCT03847922|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110748900|NCT03847922|Analgesics|analgesics|mesh-ancestor
110748901|NCT01194284|Mifamurtide|mifamurtide|mesh-list
110748902|NCT01194284|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110748903|NCT01194284|Immunologic Factors|immunologic factors|mesh-ancestor
110748904|NCT01194284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110748905|NCT03255382|Dimethyl Fumarate|dimethyl fumarate|mesh-list
110748906|NCT03255382|Dermatologic Agents|dermatologic agents|mesh-ancestor
110748907|NCT03255382|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110748908|NCT03255382|Immunologic Factors|immunologic factors|mesh-ancestor
110748909|NCT03255382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110748910|NCT01191554|Tranexamic Acid|tranexamic acid|mesh-list
110748911|NCT01191554|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110748912|NCT01191554|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110748913|NCT01191554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110748914|NCT01191554|Hemostatics|hemostatics|mesh-ancestor
110748915|NCT01191554|Coagulants|coagulants|mesh-ancestor
110748916|NCT01296464|Carbidopa|carbidopa|mesh-list
110748917|NCT01296464|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110748918|NCT01296464|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110748919|NCT01296464|Dopamine Agents|dopamine agents|mesh-ancestor
110748920|NCT01296464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110748921|NCT01296464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110748922|NCT01296464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110748923|NCT01296464|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
110748924|NCT01296464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110748925|NCT00038142|Cyclophosphamide|cyclophosphamide|mesh-list
110748926|NCT00038142|Doxorubicin|doxorubicin|mesh-list
110748927|NCT00038142|Vincristine|vincristine|mesh-list
110748928|NCT00038142|Dexrazoxane|dexrazoxane|mesh-list
110748929|NCT00038142|Razoxane|razoxane|mesh-list
110748930|NCT00038142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110748931|NCT00038142|Immunologic Factors|immunologic factors|mesh-ancestor
110748932|NCT00038142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110748933|NCT00038142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110748934|NCT00038142|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110748935|NCT00038142|Alkylating Agents|alkylating agents|mesh-ancestor
110748936|NCT00038142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110748937|NCT00038142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110748938|NCT00038142|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110748939|NCT00038142|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110748940|NCT00038142|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110748941|NCT00038142|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110748942|NCT00038142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110748943|NCT00038142|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110748944|NCT00038142|Tubulin Modulators|tubulin modulators|mesh-ancestor
110748945|NCT00038142|Antimitotic Agents|antimitotic agents|mesh-ancestor
110748946|NCT00038142|Mitosis Modulators|mitosis modulators|mesh-ancestor
110748947|NCT00038142|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110748948|NCT00038142|Protective Agents|protective agents|mesh-ancestor
110748949|NCT00366899|Vaccines|vaccines|mesh-list
110748950|NCT00366899|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110748951|NCT00366899|Immunologic Factors|immunologic factors|mesh-ancestor
110748952|NCT00366899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110748953|NCT03847376|Rilpivirine|rilpivirine|mesh-list
110748954|NCT03847376|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110748955|NCT03847376|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110748956|NCT03847376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110748957|NCT03847376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110748958|NCT03847376|Antiviral Agents|antiviral agents|mesh-ancestor
110748959|NCT03847376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110748960|NCT03847376|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110748961|NCT03847376|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110748962|NCT01090128|Paclitaxel|paclitaxel|mesh-list
110748963|NCT01090128|Cyclophosphamide|cyclophosphamide|mesh-list
110748964|NCT01090128|Doxorubicin|doxorubicin|mesh-list
110748965|NCT01090128|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110748966|NCT01090128|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110748967|NCT01090128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110748968|NCT01090128|Tubulin Modulators|tubulin modulators|mesh-ancestor
110748969|NCT01090128|Antimitotic Agents|antimitotic agents|mesh-ancestor
110748970|NCT01090128|Mitosis Modulators|mitosis modulators|mesh-ancestor
110748971|NCT01090128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110748972|NCT01090128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110748973|NCT01090128|Immunologic Factors|immunologic factors|mesh-ancestor
110748974|NCT01090128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110748975|NCT01090128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110748976|NCT01090128|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110748977|NCT01090128|Alkylating Agents|alkylating agents|mesh-ancestor
110748978|NCT01090128|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110748979|NCT01090128|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110748980|NCT01090128|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110748981|NCT01090128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110748982|NCT01090128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110748984|NCT01292174|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110748985|NCT01292174|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110748986|NCT01292174|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110748987|NCT01292174|Antiviral Agents|antiviral agents|mesh-ancestor
110748988|NCT01292174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110748989|NCT01292174|Immunologic Factors|immunologic factors|mesh-ancestor
110748990|NCT01292174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110748991|NCT01090206|Vitamin D|vitamin d|mesh-list
110748992|NCT01090206|Calcium|calcium|mesh-list
110748993|NCT01090206|Vitamins|vitamins|mesh-ancestor
110748994|NCT01090206|Micronutrients|micronutrients|mesh-ancestor
110748995|NCT01090206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110748996|NCT01090206|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110748997|NCT01090206|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110748998|NCT04728646|Dexamethasone|dexamethasone|mesh-list
110748999|NCT04728646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110749000|NCT04728646|Antiemetics|antiemetics|mesh-ancestor
110749001|NCT04728646|Autonomic Agents|autonomic agents|mesh-ancestor
110749002|NCT04728646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110749003|NCT04728646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110749004|NCT04728646|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110749005|NCT04728646|Glucocorticoids|glucocorticoids|mesh-ancestor
110749006|NCT04728646|Hormones|hormones|mesh-ancestor
110749007|NCT04728646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110749008|NCT04728646|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110749009|NCT04728646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110749010|NCT04674826|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110749011|NCT04674826|Immunologic Factors|immunologic factors|mesh-ancestor
110749012|NCT04674826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110749013|NCT01295138|Lactulose|lactulose|mesh-list
110749014|NCT01295138|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110749015|NCT01188824|Cilostazol|cilostazol|mesh-list
110749016|NCT01188824|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110749017|NCT01188824|Autonomic Agents|autonomic agents|mesh-ancestor
110749018|NCT01188824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110749019|NCT01188824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110749020|NCT01188824|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110749021|NCT01188824|Respiratory System Agents|respiratory system agents|mesh-ancestor
110749022|NCT01188824|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110749023|NCT01188824|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110749024|NCT01188824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110749025|NCT01188824|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110749026|NCT01188824|Vasodilator Agents|vasodilator agents|mesh-ancestor
110749027|NCT01188824|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110749028|NCT01188824|Protective Agents|protective agents|mesh-ancestor
110749029|NCT01188824|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110749030|NCT01188824|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110749031|NCT01188824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110749032|NCT01060475|Tacrolimus|tacrolimus|mesh-list
110749033|NCT01060475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110749034|NCT01060475|Immunologic Factors|immunologic factors|mesh-ancestor
110749035|NCT01060475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110749036|NCT01060475|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110749037|NCT01060475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110749038|NCT01060475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110749039|NCT01060631|Propofol|propofol|mesh-list
110749040|NCT01060631|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110749041|NCT01060631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110749042|NCT01060631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110749043|NCT01060631|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110749044|NCT01060631|Anesthetics, General|anesthetics, general|mesh-ancestor
110749045|NCT01060631|Anesthetics|anesthetics|mesh-ancestor
110749046|NCT03254134|Warfarin|warfarin|mesh-list
110749047|NCT03254134|Dabigatran|dabigatran|mesh-list
110749048|NCT03254134|Anticoagulants|anticoagulants|mesh-ancestor
110749049|NCT03254134|Antithrombins|antithrombins|mesh-ancestor
110749050|NCT03254134|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110749051|NCT03254134|Protease Inhibitors|protease inhibitors|mesh-ancestor
110749052|NCT03254134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110749053|NCT03254134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110749054|NCT03953196|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
110749055|NCT03953196|Antiviral Agents|antiviral agents|mesh-ancestor
110749056|NCT03953196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110749057|NCT01295294|Mefenamic Acid|mefenamic acid|mesh-list
110749058|NCT01295294|Tranexamic Acid|tranexamic acid|mesh-list
110749059|NCT01295294|Levonorgestrel|levonorgestrel|mesh-list
110749060|NCT01295294|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110749061|NCT01295294|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110749062|NCT01295294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110749063|NCT01295294|Hemostatics|hemostatics|mesh-ancestor
110749064|NCT01295294|Coagulants|coagulants|mesh-ancestor
110749065|NCT01295294|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110749066|NCT01295294|Contraceptive Agents|contraceptive agents|mesh-ancestor
110749067|NCT01295294|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110749068|NCT01295294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110749069|NCT01295294|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110749070|NCT01295294|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110749071|NCT01295294|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110749072|NCT01295294|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110749073|NCT01295294|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110749074|NCT01295294|Analgesics|analgesics|mesh-ancestor
110749075|NCT01295294|Sensory System Agents|sensory system agents|mesh-ancestor
110749076|NCT01295294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110749077|NCT01295294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110867430|NCT01376154|Lamivudine|lamivudine|mesh-list
110749078|NCT01295294|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110749079|NCT01295294|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110749080|NCT01295294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110749082|NCT01191710|Progestins|progestins|mesh-ancestor
110749083|NCT01191710|Hormones|hormones|mesh-ancestor
110749084|NCT01191710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110749085|NCT01191710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110749086|NCT04367740|Antibodies|antibodies|mesh-list
110749087|NCT04367740|Immunoglobulin G|immunoglobulin g|mesh-list
110749088|NCT04367740|Immunologic Factors|immunologic factors|mesh-ancestor
110749089|NCT04367740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110749090|NCT03852056|Fluorides|fluorides|mesh-list
110749091|NCT03852056|Tin Fluorides|tin fluorides|mesh-list
110749092|NCT03852056|Cariostatic Agents|cariostatic agents|mesh-ancestor
110749093|NCT03852056|Protective Agents|protective agents|mesh-ancestor
110749094|NCT03852056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110749095|NCT03242434|Mannitol|mannitol|mesh-list
110749096|NCT03242434|Lactulose|lactulose|mesh-list
110749097|NCT03242434|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110749098|NCT03242434|Diuretics|diuretics|mesh-ancestor
110749099|NCT03242434|Natriuretic Agents|natriuretic agents|mesh-ancestor
110749100|NCT03242434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110749101|NCT03242434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110749102|NCT04222426|Atezolizumab|atezolizumab|mesh-list
110749103|NCT04222426|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110749104|NCT04222426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110749105|NCT04222426|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110749106|NCT04222426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110749107|NCT01292408|Hydroxychloroquine|hydroxychloroquine|mesh-list
110749108|NCT01292408|Antimalarials|antimalarials|mesh-ancestor
110749109|NCT01292408|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110749110|NCT01292408|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110749111|NCT01292408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110749112|NCT01292408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110749113|NCT01292408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110749114|NCT01292408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110749115|NCT01295372|Risperidone|risperidone|mesh-list
110749116|NCT01295372|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110749117|NCT01295372|Serotonin Agents|serotonin agents|mesh-ancestor
110749118|NCT01295372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110749119|NCT01295372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110749120|NCT01295372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110749121|NCT01295372|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110749122|NCT01295372|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110749123|NCT01295372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110749124|NCT01295372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110749125|NCT01295372|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110749126|NCT01295372|Dopamine Agents|dopamine agents|mesh-ancestor
110749127|NCT05283278|Lactoferrin|lactoferrin|mesh-list
110749128|NCT05283278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110749129|NCT05179018|Autoantibodies|autoantibodies|mesh-list
110749130|NCT05179018|Immunologic Factors|immunologic factors|mesh-ancestor
110749131|NCT05179018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110749132|NCT01295450|Vitamins|vitamins|mesh-list
110749133|NCT01295450|Micronutrients|micronutrients|mesh-ancestor
110309059|NCT00308763|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110749134|NCT01295450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110749135|NCT01297010|Dexamethasone|dexamethasone|mesh-list
110749136|NCT01297010|Dexamethasone acetate|dexamethasone acetate|mesh-list
110749137|NCT01297010|BB 1101|bb 1101|mesh-list
110749138|NCT01297010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110749139|NCT01297010|Antiemetics|antiemetics|mesh-ancestor
110749140|NCT01297010|Autonomic Agents|autonomic agents|mesh-ancestor
110749141|NCT01297010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110749142|NCT01297010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110749143|NCT01297010|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110749144|NCT01297010|Glucocorticoids|glucocorticoids|mesh-ancestor
110749145|NCT01297010|Hormones|hormones|mesh-ancestor
110749146|NCT01297010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110749147|NCT01297010|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110749148|NCT01297010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110749149|NCT01297010|Protease Inhibitors|protease inhibitors|mesh-ancestor
110749150|NCT01297010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110749151|NCT01297010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110749152|NCT03851432|Metformin|metformin|mesh-list
110749153|NCT03851432|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110749154|NCT03851432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110749155|NCT01192490|Lidocaine|lidocaine|mesh-list
110749156|NCT01192490|Anesthetics, Local|anesthetics, local|mesh-ancestor
110749157|NCT01192490|Anesthetics|anesthetics|mesh-ancestor
110749158|NCT01192490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110749159|NCT01192490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110749160|NCT01192490|Sensory System Agents|sensory system agents|mesh-ancestor
110749161|NCT01192490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110749162|NCT01192490|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110749163|NCT01192490|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110749164|NCT01192490|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110749165|NCT01192490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110749166|NCT01192490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110749167|NCT01295606|Cefazolin|cefazolin|mesh-list
110749168|NCT01295606|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110749169|NCT01295606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110749170|NCT01192724|Aspirin|aspirin|mesh-list
110749171|NCT01192724|Cilostazol|cilostazol|mesh-list
110749172|NCT01192724|Clopidogrel|clopidogrel|mesh-list
110749173|NCT01192724|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110749174|NCT01192724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110749176|NCT01192724|Sensory System Agents|sensory system agents|mesh-ancestor
110749177|NCT01192724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110749178|NCT01192724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110749179|NCT01192724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110749180|NCT01192724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110749181|NCT01192724|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110749182|NCT01192724|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110749183|NCT01192724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110749184|NCT01192724|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110749185|NCT01192724|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110749186|NCT01192724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110749187|NCT01192724|Antipyretics|antipyretics|mesh-ancestor
110749188|NCT01192724|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110749189|NCT01192724|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110749190|NCT01192724|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110749191|NCT01192724|Purinergic Agents|purinergic agents|mesh-ancestor
110749192|NCT01192724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110749193|NCT01192724|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110749194|NCT01192724|Autonomic Agents|autonomic agents|mesh-ancestor
110749195|NCT01192724|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110309093|NCT00274820|Antioxidants|antioxidants|mesh-ancestor
110749196|NCT01192724|Respiratory System Agents|respiratory system agents|mesh-ancestor
110749197|NCT01192724|Vasodilator Agents|vasodilator agents|mesh-ancestor
110749198|NCT01192724|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110749199|NCT01192724|Protective Agents|protective agents|mesh-ancestor
110749200|NCT01192724|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110749201|NCT01192724|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110749202|NCT01192802|Albendazole|albendazole|mesh-list
110749203|NCT01192802|Anthelmintics|anthelmintics|mesh-ancestor
110749204|NCT01192802|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110749205|NCT01192802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110749206|NCT01192802|Anticestodal Agents|anticestodal agents|mesh-ancestor
110749207|NCT01192802|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110749208|NCT01192802|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110749209|NCT01192802|Tubulin Modulators|tubulin modulators|mesh-ancestor
110749210|NCT01192802|Antimitotic Agents|antimitotic agents|mesh-ancestor
110749211|NCT01192802|Mitosis Modulators|mitosis modulators|mesh-ancestor
110749212|NCT01192802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110749213|NCT01192802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110749214|NCT01292720|Vitamin D|vitamin d|mesh-list
110749215|NCT01292720|Cholecalciferol|cholecalciferol|mesh-list
110749216|NCT01292720|Vitamins|vitamins|mesh-ancestor
110749217|NCT01292720|Micronutrients|micronutrients|mesh-ancestor
110749218|NCT01292720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110749219|NCT01292720|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110749220|NCT01292720|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110749221|NCT02939014|Brentuximab Vedotin|brentuximab vedotin|mesh-list
110749222|NCT02939014|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110749223|NCT02939014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110749224|NCT02939014|Immunotoxins|immunotoxins|mesh-ancestor
110749225|NCT02939014|Immunoconjugates|immunoconjugates|mesh-ancestor
110749226|NCT02939014|Immunologic Factors|immunologic factors|mesh-ancestor
110749227|NCT02939014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110749228|NCT05177926|Tenofovir|tenofovir|mesh-list
110749229|NCT05177926|Antiviral Agents|antiviral agents|mesh-list
110749230|NCT05177926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110749231|NCT05177926|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110749232|NCT05177926|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110749233|NCT05177926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110749234|NCT05177926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110749235|NCT05177926|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110749236|NCT05177926|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110749237|NCT01193192|Vitamins|vitamins|mesh-list
110749238|NCT01193192|Micronutrients|micronutrients|mesh-ancestor
110749239|NCT01193192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110749240|NCT01193270|Vitamin E|vitamin e|mesh-list
110749241|NCT01193270|Vitamins|vitamins|mesh-ancestor
110749242|NCT01193270|Micronutrients|micronutrients|mesh-ancestor
110749243|NCT01193270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110749244|NCT01193270|Antioxidants|antioxidants|mesh-ancestor
110749245|NCT01193270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110749246|NCT01193270|Protective Agents|protective agents|mesh-ancestor
110749247|NCT01189214|Memantine|memantine|mesh-list
110749248|NCT01189214|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110749249|NCT01189214|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110466966|NCT00592852|Serotonin Agents|serotonin agents|mesh-ancestor
110749250|NCT01189214|Dopamine Agents|dopamine agents|mesh-ancestor
110749251|NCT01189214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110749252|NCT01189214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110749253|NCT01189214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110749254|NCT01189214|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110749255|NCT01189214|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110749256|NCT01193504|Loteprednol Etabonate|loteprednol etabonate|mesh-list
110749257|NCT01193504|Prednisolone acetate|prednisolone acetate|mesh-list
110749258|NCT01193504|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110749259|NCT01193504|Methylprednisolone|methylprednisolone|mesh-list
110749260|NCT01193504|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110749261|NCT01193504|Prednisolone|prednisolone|mesh-list
110749262|NCT01193504|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110749263|NCT01193504|Prednisolone phosphate|prednisolone phosphate|mesh-list
110749264|NCT01193504|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110749265|NCT01193504|Antiemetics|antiemetics|mesh-ancestor
110749266|NCT01193504|Autonomic Agents|autonomic agents|mesh-ancestor
110445184|NCT04227808|Lenvatinib|lenvatinib|mesh-list
110749267|NCT01193504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110749268|NCT01193504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110749269|NCT01193504|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110749270|NCT01193504|Glucocorticoids|glucocorticoids|mesh-ancestor
110749272|NCT01193504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110749273|NCT01193504|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110749274|NCT01193504|Protective Agents|protective agents|mesh-ancestor
110749275|NCT01193504|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110749276|NCT01193504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110749277|NCT01193504|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110749278|NCT03848780|Desflurane|desflurane|mesh-list
110749279|NCT03848780|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110749280|NCT03848780|Anesthetics, General|anesthetics, general|mesh-ancestor
110749281|NCT03848780|Anesthetics|anesthetics|mesh-ancestor
110749282|NCT03848780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110749283|NCT03848780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110749284|NCT05599802|Vaccines|vaccines|mesh-list
110749285|NCT05599802|Immunologic Factors|immunologic factors|mesh-ancestor
110749286|NCT05599802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110749287|NCT00051558|Alendronate|alendronate|mesh-list
110749288|NCT00051558|Teriparatide|teriparatide|mesh-list
110749289|NCT00051558|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110749290|NCT00051558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110749291|NCT00051558|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110749292|NCT03848234|Estradiol|estradiol|mesh-list
110749293|NCT03848234|Estrogens|estrogens|mesh-ancestor
110749294|NCT03848234|Hormones|hormones|mesh-ancestor
110749295|NCT03848234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110749296|NCT03848234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110749297|NCT01295918|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110749298|NCT01295918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110749299|NCT01195298|Bevacizumab|bevacizumab|mesh-list
110749300|NCT01195298|Capecitabine|capecitabine|mesh-list
110749301|NCT01195298|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110749302|NCT01195298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110749303|NCT01195298|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110749304|NCT01195298|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110749305|NCT01195298|Growth Substances|growth substances|mesh-ancestor
110749306|NCT01195298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110749307|NCT01195298|Growth Inhibitors|growth inhibitors|mesh-ancestor
110749308|NCT01195298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110749309|NCT01195298|Antimetabolites|antimetabolites|mesh-ancestor
110749310|NCT01195298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110749311|NCT01296074|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110749312|NCT01296074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110749313|NCT01296074|Glucocorticoids|glucocorticoids|mesh-ancestor
110749314|NCT01296074|Hormones|hormones|mesh-ancestor
110749315|NCT01296074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110749316|NCT01296074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110749317|NCT01296074|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110749318|NCT01296074|Protective Agents|protective agents|mesh-ancestor
110749319|NCT01296074|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110749320|NCT01296074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110749321|NCT01189448|Pyrimethamine|pyrimethamine|mesh-list
110749322|NCT01189448|Sulfadiazine|sulfadiazine|mesh-list
110749323|NCT01189448|Spiramycin|spiramycin|mesh-list
110467041|NCT04025203|Ibuprofen|ibuprofen|mesh-list
110749324|NCT01189448|Antimalarials|antimalarials|mesh-ancestor
110749325|NCT01189448|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110749326|NCT01189448|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110749327|NCT01189448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110749328|NCT01189448|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110749329|NCT01189448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110749330|NCT01189448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110749331|NCT01189448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110749332|NCT01189448|Coccidiostats|coccidiostats|mesh-ancestor
110749333|NCT01195376|Dactolisib|dactolisib|mesh-list
110749334|NCT01195376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110749335|NCT01189526|Ranibizumab|ranibizumab|mesh-list
110749336|NCT01189526|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110749337|NCT01189526|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110749338|NCT01189526|Growth Substances|growth substances|mesh-ancestor
110749339|NCT01189526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110749340|NCT01189526|Growth Inhibitors|growth inhibitors|mesh-ancestor
110074373|NCT01592253|Antifungal Agents|antifungal agents|mesh-ancestor
110749341|NCT01189526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110749343|NCT01296230|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110749344|NCT01296230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110749345|NCT01580696|Molgramostim|molgramostim|mesh-list
110749346|NCT01580696|Vaccines|vaccines|mesh-list
110749347|NCT01580696|Sargramostim|sargramostim|mesh-list
110749348|NCT01580696|Immunologic Factors|immunologic factors|mesh-ancestor
110749349|NCT01580696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110749350|NCT01580696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110749351|NCT01197014|Losartan|losartan|mesh-list
110749352|NCT01197014|Amlodipine|amlodipine|mesh-list
110749353|NCT01197014|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110749354|NCT01197014|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110749355|NCT01197014|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110749356|NCT01197014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110749357|NCT01197014|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110749358|NCT01197014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110749359|NCT01197014|Vasodilator Agents|vasodilator agents|mesh-ancestor
110749360|NCT01197014|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110749361|NCT01197014|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110749362|NCT01197014|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110749363|NCT01195454|Insulin|insulin|mesh-list
110749364|NCT01195454|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110749365|NCT01195454|Insulin Glargine|insulin glargine|mesh-list
110749366|NCT01195454|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110749367|NCT01195454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110749368|NCT01197170|Bevacizumab|bevacizumab|mesh-list
110749369|NCT01197170|Everolimus|everolimus|mesh-list
110749370|NCT01197170|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110749371|NCT01197170|Sorafenib|sorafenib|mesh-list
110749372|NCT01197170|Anastrozole|anastrozole|mesh-list
110749373|NCT01197170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110749374|NCT01197170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110749375|NCT01197170|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110749376|NCT01197170|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110749377|NCT01197170|Growth Substances|growth substances|mesh-ancestor
110749378|NCT01197170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110749379|NCT01197170|Growth Inhibitors|growth inhibitors|mesh-ancestor
110749380|NCT01197170|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110749381|NCT01197170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110749382|NCT01197170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110749383|NCT01197170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110749384|NCT01197170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110749385|NCT01197170|Immunologic Factors|immunologic factors|mesh-ancestor
110309191|NCT00277589|Trace Elements|trace elements|mesh-ancestor
110749386|NCT01197170|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110749387|NCT01197170|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110749388|NCT01197170|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110749389|NCT01197170|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110749390|NCT01197170|Hormone Antagonists|hormone antagonists|mesh-ancestor
110749391|NCT01197170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110749392|NCT05516966|Dulaglutide|dulaglutide|mesh-list
110749393|NCT05516966|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110749394|NCT05516966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110749395|NCT01195766|Ofatumumab|ofatumumab|mesh-list
110749396|NCT01195766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110749397|NCT03850886|Niacinamide|niacinamide|mesh-list
110749398|NCT03850886|Niacin|niacin|mesh-list
110749399|NCT03850886|Nicotinic Acids|nicotinic acids|mesh-list
110445189|NCT01091454|Cisplatin|cisplatin|mesh-list
110749400|NCT03850886|Hypoglycemic Agents|hypoglycemic agents|mesh-list
110749401|NCT03850886|Vitamins|vitamins|mesh-ancestor
110749402|NCT03850886|Micronutrients|micronutrients|mesh-ancestor
110749403|NCT03850886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110749404|NCT03850886|Vitamin B Complex|vitamin b complex|mesh-ancestor
110749405|NCT03850886|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110749406|NCT03850886|Antimetabolites|antimetabolites|mesh-ancestor
110749407|NCT03850886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110749408|NCT03850886|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110749409|NCT03850886|Vasodilator Agents|vasodilator agents|mesh-ancestor
110749410|NCT03251482|Apixaban|apixaban|mesh-list
110749411|NCT03251482|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110749412|NCT03251482|Antithrombins|antithrombins|mesh-ancestor
110749413|NCT03251482|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110749414|NCT03251482|Protease Inhibitors|protease inhibitors|mesh-ancestor
110749415|NCT03251482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110749416|NCT03251482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110749417|NCT03251482|Anticoagulants|anticoagulants|mesh-ancestor
110749418|NCT03732248|Sirolimus|sirolimus|mesh-list
110749419|NCT03732248|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110749420|NCT03732248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110749421|NCT03732248|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110749422|NCT03732248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110749423|NCT03732248|Antifungal Agents|antifungal agents|mesh-ancestor
110749424|NCT03732248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110749425|NCT03732248|Immunologic Factors|immunologic factors|mesh-ancestor
110749426|NCT03732248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110749427|NCT00310037|Bortezomib|bortezomib|mesh-list
110749428|NCT00310037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110749429|NCT01196234|Paclitaxel|paclitaxel|mesh-list
110749430|NCT01196234|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110749431|NCT01196234|Carboplatin|carboplatin|mesh-list
110749432|NCT01196234|Gefitinib|gefitinib|mesh-list
110749433|NCT01196234|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110749434|NCT01196234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110749435|NCT01196234|Tubulin Modulators|tubulin modulators|mesh-ancestor
110749436|NCT01196234|Antimitotic Agents|antimitotic agents|mesh-ancestor
110749437|NCT01196234|Mitosis Modulators|mitosis modulators|mesh-ancestor
110309216|NCT00277706|Calcium|calcium|mesh-list
110749438|NCT01196234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110749439|NCT01196234|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110749440|NCT01196234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110749441|NCT05292404|Alirocumab|alirocumab|mesh-list
110749442|NCT05292404|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
110749443|NCT05292404|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110749444|NCT05292404|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110749445|NCT05292404|Antimetabolites|antimetabolites|mesh-ancestor
110749446|NCT05292404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110749447|NCT05292404|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110749448|NCT05292404|Protease Inhibitors|protease inhibitors|mesh-ancestor
110749449|NCT05292404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110749450|NCT05292404|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110749451|NCT00309959|Paclitaxel|paclitaxel|mesh-list
110749452|NCT00309959|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110749453|NCT00309959|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110749454|NCT00309959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110749455|NCT00309959|Tubulin Modulators|tubulin modulators|mesh-ancestor
110749456|NCT00309959|Antimitotic Agents|antimitotic agents|mesh-ancestor
110749457|NCT00309959|Mitosis Modulators|mitosis modulators|mesh-ancestor
110749458|NCT00309959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110749459|NCT03238924|Oxytocin|oxytocin|mesh-list
110749460|NCT03238924|Oxytocics|oxytocics|mesh-ancestor
110749461|NCT03238924|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110749462|NCT03238924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110749463|NCT01190384|Grape Seed Extract|grape seed extract|mesh-list
110749464|NCT01190384|Antioxidants|antioxidants|mesh-list
110749465|NCT01190384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110749466|NCT01190384|Protective Agents|protective agents|mesh-ancestor
110749467|NCT01190384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110749468|NCT01190384|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110749469|NCT01190384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110749470|NCT02532413|Entecavir|entecavir|mesh-list
110749471|NCT02532413|Poly I-C|poly i-c|mesh-list
110749472|NCT02532413|Antiviral Agents|antiviral agents|mesh-ancestor
110749473|NCT02532413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110467209|NCT02839941|Tacrolimus|tacrolimus|mesh-list
110749474|NCT02532413|Interferon Inducers|interferon inducers|mesh-ancestor
110749475|NCT02532413|Immunologic Factors|immunologic factors|mesh-ancestor
110749476|NCT02532413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110749477|NCT01190462|Cetuximab|cetuximab|mesh-list
110749479|NCT01190462|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110749480|NCT01190462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110749481|NCT01190462|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110749482|NCT01190462|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110749483|NCT01190462|Antimetabolites|antimetabolites|mesh-ancestor
110749484|NCT01190462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110749485|NCT01190462|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110749486|NCT01190462|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110749487|NCT01190462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110749488|NCT01198106|Cinnarizine|cinnarizine|mesh-list
110749489|NCT01198106|Scopolamine|scopolamine|mesh-list
110749490|NCT01198106|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
110749491|NCT01198106|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110749492|NCT01198106|Antiemetics|antiemetics|mesh-ancestor
110749493|NCT01198106|Autonomic Agents|autonomic agents|mesh-ancestor
110749494|NCT01198106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110749495|NCT01198106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110749496|NCT01198106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110749497|NCT01198106|Mydriatics|mydriatics|mesh-ancestor
110749498|NCT01198106|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110749499|NCT01198106|Cholinergic Agents|cholinergic agents|mesh-ancestor
110749500|NCT01198106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110749501|NCT01198106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110749502|NCT01198106|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110749503|NCT01198106|Parasympatholytics|parasympatholytics|mesh-ancestor
110749504|NCT01198106|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110749505|NCT01198106|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110749506|NCT01198106|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110749507|NCT01198106|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110749508|NCT01198106|Histamine Antagonists|histamine antagonists|mesh-ancestor
110749509|NCT01198106|Histamine Agents|histamine agents|mesh-ancestor
110749510|NCT02918500|Nicotine|nicotine|mesh-list
110749511|NCT02918500|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110749512|NCT02918500|Autonomic Agents|autonomic agents|mesh-ancestor
110749513|NCT02918500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110749514|NCT02918500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110749515|NCT02918500|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110749516|NCT02918500|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110749517|NCT02918500|Cholinergic Agents|cholinergic agents|mesh-ancestor
110749518|NCT02918500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110309295|NCT00278330|Vorinostat|vorinostat|mesh-list
110749519|NCT02918500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110749520|NCT03850652|Iron|iron|mesh-list
110749521|NCT03850652|Trace Elements|trace elements|mesh-ancestor
110749522|NCT03850652|Micronutrients|micronutrients|mesh-ancestor
110749523|NCT03850652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110749524|NCT01198184|Sirolimus|sirolimus|mesh-list
110749525|NCT01198184|Temsirolimus|temsirolimus|mesh-list
110749526|NCT01198184|MTOR Inhibitors|mtor inhibitors|mesh-list
110749527|NCT01198184|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
110749528|NCT01198184|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110749529|NCT01198184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110749530|NCT01198184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110749531|NCT01198184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110749532|NCT01198184|Immunologic Factors|immunologic factors|mesh-ancestor
110749533|NCT01198184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110749534|NCT01198184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110749535|NCT01198184|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110749536|NCT01198184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110749537|NCT01198184|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110749538|NCT01198184|Antifungal Agents|antifungal agents|mesh-ancestor
110749539|NCT01198184|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
110749540|NCT00333359|Gabapentin|gabapentin|mesh-list
110749541|NCT00333359|Analgesics|analgesics|mesh-ancestor
110749542|NCT00333359|Sensory System Agents|sensory system agents|mesh-ancestor
110749543|NCT00333359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110749544|NCT00333359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110749545|NCT00333359|Anticonvulsants|anticonvulsants|mesh-ancestor
110749546|NCT00333359|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110749547|NCT00333359|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110749548|NCT00333359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110749549|NCT00333359|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110749550|NCT00333359|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110749551|NCT00333359|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110749552|NCT00333359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110749553|NCT00333359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110749555|NCT03246724|Midazolam|midazolam|mesh-list
110749556|NCT03246724|Triazolam|triazolam|mesh-list
110749557|NCT03246724|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110749558|NCT03246724|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110749559|NCT03246724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110749560|NCT03246724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110749561|NCT03246724|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110749562|NCT03246724|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110749563|NCT03246724|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110749564|NCT03246724|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110749565|NCT03246724|Anesthetics, General|anesthetics, general|mesh-ancestor
110749566|NCT03246724|Anesthetics|anesthetics|mesh-ancestor
110749567|NCT03246724|GABA Modulators|gaba modulators|mesh-ancestor
110749568|NCT03246724|GABA Agents|gaba agents|mesh-ancestor
110749569|NCT03246724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110749570|NCT03246724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110749571|NCT01196546|Metformin|metformin|mesh-list
110749572|NCT01196546|Vildagliptin|vildagliptin|mesh-list
110749573|NCT01196546|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110749574|NCT01196546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110749575|NCT01196546|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110749576|NCT01196546|Protease Inhibitors|protease inhibitors|mesh-ancestor
110749577|NCT01196546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110749578|NCT01196546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110749579|NCT01293266|Propofol|propofol|mesh-list
110749580|NCT01293266|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110749581|NCT01293266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110749582|NCT01293266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110749583|NCT01293266|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110749584|NCT01293266|Anesthetics, General|anesthetics, general|mesh-ancestor
110749585|NCT01293266|Anesthetics|anesthetics|mesh-ancestor
110749586|NCT03948646|Bromides|bromides|mesh-list
110749587|NCT03948646|Anticonvulsants|anticonvulsants|mesh-ancestor
110749588|NCT01198340|Ropivacaine|ropivacaine|mesh-list
110749589|NCT01198340|Anesthetics, Local|anesthetics, local|mesh-list
110749590|NCT01198340|Anesthetics|anesthetics|mesh-list
110749591|NCT01198340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110749592|NCT01198340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110749593|NCT01198340|Sensory System Agents|sensory system agents|mesh-ancestor
110749594|NCT01198340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110749596|NCT01347112|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110749597|NCT01347112|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110749598|NCT01347112|Cholinergic Agents|cholinergic agents|mesh-ancestor
110749599|NCT01347112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110749600|NCT01347112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110749601|NCT01347112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110749602|NCT00308711|Misoprostol|misoprostol|mesh-list
110749603|NCT00308711|Dinoprostone|dinoprostone|mesh-list
110749604|NCT00308711|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110749605|NCT00308711|Abortifacient Agents|abortifacient agents|mesh-ancestor
110749606|NCT00308711|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110749607|NCT00308711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110749608|NCT00308711|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110749609|NCT00308711|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110749610|NCT00308711|Oxytocics|oxytocics|mesh-ancestor
110749611|NCT04057456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
110749612|NCT04057456|Nabilone|nabilone|mesh-list
110749613|NCT04057456|Antiemetics|antiemetics|mesh-ancestor
110749614|NCT04057456|Autonomic Agents|autonomic agents|mesh-ancestor
110749615|NCT04057456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110749616|NCT04057456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110749617|NCT04057456|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110749618|NCT04057456|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110749619|NCT04057456|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110749620|NCT04057456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110749621|NCT04057456|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110749622|NCT01198496|Losartan|losartan|mesh-list
110749623|NCT01198496|Amlodipine|amlodipine|mesh-list
110749624|NCT01198496|Valsartan|valsartan|mesh-list
110749625|NCT01198496|Telmisartan|telmisartan|mesh-list
110749626|NCT01198496|Candesartan|candesartan|mesh-list
110749627|NCT01198496|Candesartan cilexetil|candesartan cilexetil|mesh-list
110749628|NCT01198496|Olmesartan|olmesartan|mesh-list
110749629|NCT01198496|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
110749630|NCT01198496|Spironolactone|spironolactone|mesh-list
110749631|NCT01198496|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110749632|NCT01198496|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110749633|NCT01198496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110749634|NCT01198496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110749635|NCT01198496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110749636|NCT01198496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110749637|NCT01198496|Vasodilator Agents|vasodilator agents|mesh-ancestor
110749638|NCT01198496|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110749639|NCT01198496|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110749640|NCT01198496|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110749641|NCT01198496|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110749642|NCT01198496|Hormone Antagonists|hormone antagonists|mesh-ancestor
110749643|NCT01198496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110749644|NCT01198496|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110749645|NCT01198496|Diuretics|diuretics|mesh-ancestor
110749646|NCT01198496|Natriuretic Agents|natriuretic agents|mesh-ancestor
110749647|NCT01066013|Anti-Infective Agents|anti-infective agents|mesh-list
110749648|NCT01066013|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110749649|NCT01066091|Palmitic Acid|palmitic acid|mesh-list
110749650|NCT01066091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110749651|NCT01066091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110749652|NCT03846284|Magnesium Sulfate|magnesium sulfate|mesh-list
110749653|NCT03846284|Bupivacaine|bupivacaine|mesh-list
110749654|NCT03846284|Anesthetics, Local|anesthetics, local|mesh-list
110749655|NCT03846284|Anesthetics|anesthetics|mesh-list
110749656|NCT03846284|N-Methylaspartate|n-methylaspartate|mesh-list
110749657|NCT03846284|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110749658|NCT03846284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110749659|NCT03846284|Sensory System Agents|sensory system agents|mesh-ancestor
110749660|NCT03846284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110749661|NCT03846284|Analgesics|analgesics|mesh-ancestor
110749662|NCT03846284|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110749663|NCT03846284|Anticonvulsants|anticonvulsants|mesh-ancestor
110749664|NCT03846284|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110749665|NCT03846284|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110749666|NCT03846284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110749667|NCT03846284|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110749668|NCT03846284|Tocolytic Agents|tocolytic agents|mesh-ancestor
110749669|NCT03846284|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110749670|NCT03846284|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
110749671|NCT03846284|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110749672|NCT03846284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110749674|NCT01066169|Cathartics|cathartics|mesh-ancestor
110749675|NCT01066169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110749676|NCT05572060|Metformin|metformin|mesh-list
110749677|NCT05572060|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110749678|NCT05572060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110749679|NCT05431244|Antiviral Agents|antiviral agents|mesh-list
110749680|NCT05431244|Gemcitabine|gemcitabine|mesh-list
110749681|NCT05431244|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110749682|NCT05431244|Antimetabolites|antimetabolites|mesh-ancestor
110749683|NCT05431244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110749684|NCT05431244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110749685|NCT05431244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110749686|NCT01199432|Cyclophosphamide|cyclophosphamide|mesh-list
110749687|NCT01199432|Fluorouracil|fluorouracil|mesh-list
110749688|NCT01199432|Epirubicin|epirubicin|mesh-list
110749689|NCT01199432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110749690|NCT01199432|Immunologic Factors|immunologic factors|mesh-ancestor
110749691|NCT01199432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110749692|NCT01199432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110749693|NCT01199432|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110749694|NCT01199432|Alkylating Agents|alkylating agents|mesh-ancestor
110749695|NCT01199432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110749696|NCT01199432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110749697|NCT01199432|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110749698|NCT01199432|Antimetabolites|antimetabolites|mesh-ancestor
110445205|NCT02883569|Ibuprofen|ibuprofen|mesh-list
110749700|NCT01199432|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110749701|NCT01199432|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110467417|NCT00928668|Olodaterol|olodaterol|mesh-list
110749702|NCT01199432|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110749703|NCT01199432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110749704|NCT05064020|Tenofovir|tenofovir|mesh-list
110749705|NCT05064020|Emtricitabine|emtricitabine|mesh-list
110749706|NCT05064020|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
110749707|NCT05064020|Antiviral Agents|antiviral agents|mesh-ancestor
110749708|NCT05064020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110749709|NCT05064020|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110749710|NCT05064020|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110749711|NCT05064020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110749712|NCT05064020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110749713|NCT05064020|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110749714|NCT05064020|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110749715|NCT05058560|Tislelizumab|tislelizumab|mesh-list
110749716|NCT05058560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110749717|NCT05058560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110749718|NCT01293422|Rifampin|rifampin|mesh-list
110749719|NCT01293422|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110749720|NCT01293422|Antitubercular Agents|antitubercular agents|mesh-ancestor
110749721|NCT01293422|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110749722|NCT01293422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110749723|NCT01293422|Leprostatic Agents|leprostatic agents|mesh-ancestor
110749724|NCT01293422|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110749725|NCT01293422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110749726|NCT01293422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110749727|NCT01293422|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110749728|NCT01293422|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110749729|NCT01293422|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110749730|NCT01293422|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110749731|NCT01293422|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110749732|NCT01293422|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110749733|NCT01566656|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110749734|NCT01566656|Immunologic Factors|immunologic factors|mesh-ancestor
110749735|NCT01566656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110749736|NCT01566656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110749737|NCT01566734|Cefazolin|cefazolin|mesh-list
110749738|NCT01566734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110749739|NCT01566734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110749740|NCT00050778|Interferons|interferons|mesh-list
110749741|NCT00050778|Interferon-beta|interferon-beta|mesh-list
110749742|NCT00050778|Interferon beta-1a|interferon beta-1a|mesh-list
110749743|NCT00050778|Alemtuzumab|alemtuzumab|mesh-list
110749744|NCT00050778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110749745|NCT00050778|Antiviral Agents|antiviral agents|mesh-ancestor
110749746|NCT00050778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110749747|NCT00050778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110749748|NCT00050778|Immunologic Factors|immunologic factors|mesh-ancestor
110749749|NCT00050778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110749750|NCT00050778|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110749751|NCT01199510|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110749752|NCT01199510|Lubricant Eye Drops|lubricant eye drops|mesh-list
110749753|NCT01199510|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110749754|NCT04153682|Anti-Infective Agents|anti-infective agents|mesh-list
110749755|NCT04153682|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110749756|NCT00050622|Methylphenidate|methylphenidate|mesh-list
110749757|NCT00050622|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110749758|NCT00050622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110749759|NCT00050622|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110749760|NCT00050622|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110749761|NCT00050622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110749762|NCT00050622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110749763|NCT00050622|Dopamine Agents|dopamine agents|mesh-ancestor
110749764|NCT00050622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110749765|NCT00308087|Rituximab|rituximab|mesh-list
110749766|NCT00308087|Molgramostim|molgramostim|mesh-list
110749767|NCT00308087|Sargramostim|sargramostim|mesh-list
110749768|NCT00308087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110445206|NCT02883569|Aceclofenac|aceclofenac|mesh-list
110749769|NCT00308087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110749770|NCT00308087|Immunologic Factors|immunologic factors|mesh-ancestor
110749771|NCT00308087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110749772|NCT00308087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110749773|NCT04942184|Complement Factor H|complement factor h|mesh-list
110749774|NCT04942184|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
110749775|NCT04942184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110467494|NCT00789373|Pemetrexed|pemetrexed|mesh-list
110749776|NCT04942184|Immunologic Factors|immunologic factors|mesh-ancestor
110749777|NCT04942184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110749778|NCT00307931|Certolizumab Pegol|certolizumab pegol|mesh-list
110749779|NCT00307931|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110749780|NCT00307931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110749781|NCT00307931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110749782|NCT00307931|Immunologic Factors|immunologic factors|mesh-ancestor
110749783|NCT00307931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110749784|NCT00307931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110749786|NCT01097148|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110749787|NCT01097148|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110749788|NCT01097148|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110749789|NCT01097148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110749790|NCT01097148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110749791|NCT01097148|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
110749792|NCT01097148|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110749793|NCT01097148|Cholinergic Agents|cholinergic agents|mesh-ancestor
110749794|NCT01097148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110749795|NCT01097148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110749796|NCT01199276|Sevoflurane|sevoflurane|mesh-list
110749797|NCT01199276|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110749798|NCT01199276|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110749799|NCT01199276|Anesthetics, General|anesthetics, general|mesh-ancestor
110749800|NCT01199276|Anesthetics|anesthetics|mesh-ancestor
110749801|NCT01199276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110749802|NCT01199276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110749803|NCT01202084|Fluticasone|fluticasone|mesh-list
110749804|NCT01202084|Xhance|xhance|mesh-list
110749805|NCT01202084|Formoterol Fumarate|formoterol fumarate|mesh-list
110749806|NCT01202084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110749807|NCT01202084|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110749808|NCT01202084|Autonomic Agents|autonomic agents|mesh-ancestor
110749809|NCT01202084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110749810|NCT01202084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110749811|NCT01202084|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110749812|NCT01202084|Respiratory System Agents|respiratory system agents|mesh-ancestor
110749813|NCT01202084|Dermatologic Agents|dermatologic agents|mesh-ancestor
110749814|NCT01202084|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110749815|NCT01202084|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110749816|NCT01202084|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110749817|NCT01202084|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110749818|NCT01202084|Adrenergic Agents|adrenergic agents|mesh-ancestor
110749819|NCT01202084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110749820|NCT01202084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110749821|NCT04133792|Simvastatin|simvastatin|mesh-list
110749822|NCT04133792|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110749823|NCT04133792|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110749824|NCT04133792|Antimetabolites|antimetabolites|mesh-ancestor
110749825|NCT04133792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110749826|NCT04133792|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110749827|NCT04133792|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110749828|NCT04133792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110749829|NCT01202240|Ketoconazole|ketoconazole|mesh-list
110749830|NCT01202240|Tofacitinib|tofacitinib|mesh-list
110749831|NCT01202240|Antifungal Agents|antifungal agents|mesh-ancestor
110749832|NCT01202240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110749833|NCT01202240|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110749834|NCT01202240|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110749835|NCT01202240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110749836|NCT01202240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110749837|NCT01202240|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110749838|NCT01202240|Hormone Antagonists|hormone antagonists|mesh-ancestor
110749839|NCT01202240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110749840|NCT01202240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110749841|NCT01202240|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110749842|NCT01202240|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
110749843|NCT01202240|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110749844|NCT01204112|Rifampin|rifampin|mesh-list
110749845|NCT01204112|Tofacitinib|tofacitinib|mesh-list
110749846|NCT01204112|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110749847|NCT01204112|Antitubercular Agents|antitubercular agents|mesh-ancestor
110749848|NCT01204112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110749849|NCT01204112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110749850|NCT01204112|Leprostatic Agents|leprostatic agents|mesh-ancestor
110749851|NCT01204112|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110749852|NCT01204112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110749853|NCT01204112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110749854|NCT01204112|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110749855|NCT01204112|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110749856|NCT01204112|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110749857|NCT01204112|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110749858|NCT01204112|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110749859|NCT01204112|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110749860|NCT01204112|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
110749861|NCT01204112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110749862|NCT01204190|Gestodene|gestodene|mesh-list
110749863|NCT01204190|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110749864|NCT01204190|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110749865|NCT01204190|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110749866|NCT01204190|Contraceptive Agents|contraceptive agents|mesh-ancestor
110749867|NCT01204190|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110749868|NCT01204190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110353432|NCT03795701|Hormones|hormones|mesh-ancestor
110749869|NCT01204190|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110749870|NCT01204190|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110749871|NCT01204190|Progestins|progestins|mesh-ancestor
110749872|NCT01204190|Hormones|hormones|mesh-ancestor
110749873|NCT01204190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110749874|NCT01204268|Sevoflurane|sevoflurane|mesh-list
110749875|NCT01204268|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110749876|NCT01204268|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110749877|NCT01204268|Anesthetics, General|anesthetics, general|mesh-ancestor
110749878|NCT01204268|Anesthetics|anesthetics|mesh-ancestor
110749879|NCT01204268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110749880|NCT01204268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110749881|NCT02965898|Vitamin D|vitamin d|mesh-list
110749882|NCT02965898|Ergocalciferols|ergocalciferols|mesh-list
110749883|NCT02965898|Cholecalciferol|cholecalciferol|mesh-list
110749884|NCT02965898|Vitamins|vitamins|mesh-list
110749885|NCT02965898|Micronutrients|micronutrients|mesh-ancestor
110749886|NCT02965898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110749887|NCT02965898|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110749888|NCT02965898|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110749889|NCT01204346|Psychotropic Drugs|psychotropic drugs|mesh-list
110749890|NCT02796170|Dapagliflozin|dapagliflozin|mesh-list
110749891|NCT02796170|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110749892|NCT02796170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110749893|NCT02796170|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110749894|NCT02796170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110749895|NCT03844178|Tetracaine|tetracaine|mesh-list
110749896|NCT03844178|Anesthetics, Local|anesthetics, local|mesh-ancestor
110749897|NCT03844178|Anesthetics|anesthetics|mesh-ancestor
110749898|NCT03844178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110749899|NCT03844178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110749900|NCT03844178|Sensory System Agents|sensory system agents|mesh-ancestor
110749901|NCT03844178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110749902|NCT00049842|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110749903|NCT00049842|Antiviral Agents|antiviral agents|mesh-ancestor
110749904|NCT00049842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110749905|NCT00307151|Ritonavir|ritonavir|mesh-list
110749906|NCT00307151|Lopinavir|lopinavir|mesh-list
110749907|NCT00307151|Lamivudine|lamivudine|mesh-list
110749908|NCT00307151|Zidovudine|zidovudine|mesh-list
110749909|NCT00307151|Nevirapine|nevirapine|mesh-list
110749910|NCT00307151|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110749911|NCT00307151|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110074952|NCT01595737|Simendan|simendan|mesh-list
110749912|NCT00307151|Protease Inhibitors|protease inhibitors|mesh-ancestor
110749913|NCT00307151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110309472|NCT00279344|Fentanyl|fentanyl|mesh-list
110749914|NCT00307151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110749916|NCT00307151|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110749917|NCT00307151|Antiviral Agents|antiviral agents|mesh-ancestor
110749918|NCT00307151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110749919|NCT00307151|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110749920|NCT00307151|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110749921|NCT00307151|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110749922|NCT00307151|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110749923|NCT00307151|Antimetabolites|antimetabolites|mesh-ancestor
110749924|NCT00307151|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110749925|NCT00307151|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110749926|NCT03981029|Folic Acid|folic acid|mesh-list
110749927|NCT03981029|Hematinics|hematinics|mesh-ancestor
110749928|NCT03981029|Vitamin B Complex|vitamin b complex|mesh-ancestor
110749929|NCT03981029|Vitamins|vitamins|mesh-ancestor
110749930|NCT03981029|Micronutrients|micronutrients|mesh-ancestor
110749931|NCT03981029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110749932|NCT02654132|Dexamethasone|dexamethasone|mesh-list
110749933|NCT02654132|Dexamethasone acetate|dexamethasone acetate|mesh-list
110749934|NCT02654132|Pomalidomide|pomalidomide|mesh-list
110749935|NCT02654132|Elotuzumab|elotuzumab|mesh-list
110749936|NCT02654132|BB 1101|bb 1101|mesh-list
110749937|NCT02654132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110749938|NCT02654132|Antiemetics|antiemetics|mesh-ancestor
110749939|NCT02654132|Autonomic Agents|autonomic agents|mesh-ancestor
110749940|NCT02654132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110749941|NCT02654132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110749942|NCT02654132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110749943|NCT02654132|Glucocorticoids|glucocorticoids|mesh-ancestor
110749944|NCT02654132|Hormones|hormones|mesh-ancestor
110749945|NCT02654132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110749946|NCT02654132|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110749947|NCT02654132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110749948|NCT02654132|Protease Inhibitors|protease inhibitors|mesh-ancestor
110749949|NCT02654132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110749950|NCT02654132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110749951|NCT02654132|Immunologic Factors|immunologic factors|mesh-ancestor
110749952|NCT02654132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110749953|NCT02654132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110749954|NCT02654132|Growth Substances|growth substances|mesh-ancestor
110749955|NCT02654132|Growth Inhibitors|growth inhibitors|mesh-ancestor
110749956|NCT01064141|Vaccines|vaccines|mesh-list
110749957|NCT01064141|Immunologic Factors|immunologic factors|mesh-ancestor
110749958|NCT01064141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110749959|NCT03837470|Furosemide|furosemide|mesh-list
110749960|NCT03837470|Diuretics|diuretics|mesh-ancestor
110749961|NCT03837470|Natriuretic Agents|natriuretic agents|mesh-ancestor
110749962|NCT03837470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110749963|NCT03837470|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110749964|NCT03837470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110749965|NCT03837470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110749966|NCT01199900|Prednisone|prednisone|mesh-list
110749967|NCT01199900|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110749968|NCT01199900|Glucocorticoids|glucocorticoids|mesh-ancestor
110749969|NCT01199900|Hormones|hormones|mesh-ancestor
110309513|NCT00309855|Anastrozole|anastrozole|mesh-list
110749970|NCT01199900|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110749971|NCT01199900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110749972|NCT01199900|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110749973|NCT01199900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110749974|NCT01200056|Atorvastatin|atorvastatin|mesh-list
110749975|NCT01200056|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110749976|NCT01200056|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110749977|NCT01200056|Antimetabolites|antimetabolites|mesh-ancestor
110749978|NCT01200056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110749979|NCT01200056|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110749980|NCT01200056|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110749981|NCT01200056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110749982|NCT01200212|Bevacizumab|bevacizumab|mesh-list
110749983|NCT01200212|Taxane|taxane|mesh-list
110749984|NCT01200212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110749985|NCT01200212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110075009|NCT01595958|Cyclosporine|cyclosporine|mesh-list
110749986|NCT01200212|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110749987|NCT01200212|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110749988|NCT01200212|Growth Substances|growth substances|mesh-ancestor
110749989|NCT01200212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110749990|NCT01200212|Growth Inhibitors|growth inhibitors|mesh-ancestor
110749991|NCT03978845|Lidocaine|lidocaine|mesh-list
110749992|NCT03978845|Anesthetics, Local|anesthetics, local|mesh-list
110749993|NCT03978845|Anesthetics|anesthetics|mesh-list
110749994|NCT03978845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110749995|NCT03978845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110749996|NCT03978845|Sensory System Agents|sensory system agents|mesh-ancestor
110749997|NCT03978845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110749998|NCT03978845|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110749999|NCT03978845|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110750000|NCT03978845|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110750001|NCT03978845|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110750002|NCT03978845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110750003|NCT02387996|Nivolumab|nivolumab|mesh-list
110750004|NCT02387996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110750005|NCT02387996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110750006|NCT02387996|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110750007|NCT02387996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110750008|NCT01204580|Metformin|metformin|mesh-list
110750009|NCT01204580|Glimepiride|glimepiride|mesh-list
110750010|NCT01204580|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110750011|NCT01204580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110750012|NCT01204580|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110750013|NCT01204580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110750014|NCT01204580|Immunologic Factors|immunologic factors|mesh-ancestor
110750015|NCT03850366|Cyclophosphamide|cyclophosphamide|mesh-list
110750016|NCT03850366|Bortezomib|bortezomib|mesh-list
110750017|NCT03850366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110750018|NCT03850366|Immunologic Factors|immunologic factors|mesh-ancestor
110750019|NCT03850366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110750020|NCT03850366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110750021|NCT03850366|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110750022|NCT03850366|Alkylating Agents|alkylating agents|mesh-ancestor
110750023|NCT03850366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110750024|NCT03850366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110750025|NCT03850366|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110750026|NCT05181592|Luspatercept|luspatercept|mesh-list
110750027|NCT05181592|Hematinics|hematinics|mesh-ancestor
110750028|NCT05181514|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
110750029|NCT05181514|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
110750030|NCT05181514|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
110750031|NCT05181514|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110750032|NCT03229486|Glycopyrrolate|glycopyrrolate|mesh-list
110750033|NCT03229486|Neostigmine|neostigmine|mesh-list
110750034|NCT03229486|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110750035|NCT03229486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110750036|NCT03229486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110750037|NCT03229486|Cholinergic Agents|cholinergic agents|mesh-ancestor
110750038|NCT03229486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110750039|NCT03229486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110750040|NCT03229486|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110750041|NCT03229486|Autonomic Agents|autonomic agents|mesh-ancestor
110750042|NCT03229486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110750043|NCT03229486|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110750044|NCT03229486|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110750045|NCT03229486|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110750046|NCT05153668|Everolimus|everolimus|mesh-list
110750047|NCT05153668|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110750048|NCT05153668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110750049|NCT05153668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110750050|NCT05153668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110750051|NCT05153668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110750053|NCT05153668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110750054|NCT05153668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110750055|NCT03833570|Melatonin|melatonin|mesh-list
110750056|NCT03833570|Antioxidants|antioxidants|mesh-ancestor
110750057|NCT03833570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110750058|NCT03833570|Protective Agents|protective agents|mesh-ancestor
110750059|NCT03833570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110750060|NCT03833570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110750061|NCT01779050|Paclitaxel|paclitaxel|mesh-list
110750062|NCT01779050|Docetaxel|docetaxel|mesh-list
110750063|NCT01779050|Cyclophosphamide|cyclophosphamide|mesh-list
110750064|NCT01779050|Carboplatin|carboplatin|mesh-list
110750065|NCT01779050|Doxorubicin|doxorubicin|mesh-list
110750066|NCT01779050|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110750067|NCT01779050|Fluorouracil|fluorouracil|mesh-list
110750068|NCT01779050|Trastuzumab|trastuzumab|mesh-list
110750069|NCT01779050|Epirubicin|epirubicin|mesh-list
110750070|NCT01779050|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110750071|NCT01779050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110750072|NCT01779050|Tubulin Modulators|tubulin modulators|mesh-ancestor
110750073|NCT01779050|Antimitotic Agents|antimitotic agents|mesh-ancestor
110750074|NCT01779050|Mitosis Modulators|mitosis modulators|mesh-ancestor
110750075|NCT01779050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110750076|NCT01779050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110309562|NCT00316329|Artesunate|artesunate|mesh-list
110750077|NCT01779050|Immunologic Factors|immunologic factors|mesh-ancestor
110750078|NCT01779050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110750079|NCT01779050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110750080|NCT01779050|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110750081|NCT01779050|Alkylating Agents|alkylating agents|mesh-ancestor
110750082|NCT01779050|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110750083|NCT01779050|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110750084|NCT01779050|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110750085|NCT01779050|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110750086|NCT01779050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110750087|NCT01779050|Antimetabolites|antimetabolites|mesh-ancestor
110750088|NCT01779050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110750089|NCT01779050|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110750090|NCT03841136|Etoposide|etoposide|mesh-list
110750091|NCT03841136|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110750092|NCT03841136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110750093|NCT03841136|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110750094|NCT03841136|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110750095|NCT03841136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110750096|NCT03841136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110750097|NCT05669768|Tamoxifen|tamoxifen|mesh-list
110750098|NCT05669768|Pamiparib|pamiparib|mesh-list
110750099|NCT05669768|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110750100|NCT05669768|Hormone Antagonists|hormone antagonists|mesh-ancestor
110750101|NCT05669768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110750102|NCT05669768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110750103|NCT05669768|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110750104|NCT05669768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110750105|NCT05669768|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110750106|NCT05669768|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110750107|NCT05669768|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110750108|NCT05669768|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110309579|NCT00279578|Tranexamic Acid|tranexamic acid|mesh-list
110750109|NCT05669768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110750110|NCT05669768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110750111|NCT00306527|Vaccines|vaccines|mesh-list
110750112|NCT00306527|Immunologic Factors|immunologic factors|mesh-ancestor
110750113|NCT00306527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110750114|NCT01066247|Midazolam|midazolam|mesh-list
110750115|NCT01066247|Morphine|morphine|mesh-list
110750116|NCT01066247|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110750117|NCT01066247|Narcotics|narcotics|mesh-ancestor
110750118|NCT01066247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110750119|NCT01066247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110750120|NCT01066247|Analgesics|analgesics|mesh-ancestor
110750121|NCT01066247|Sensory System Agents|sensory system agents|mesh-ancestor
110750122|NCT01066247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110750123|NCT01066247|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110750124|NCT01066247|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110750125|NCT01066247|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110750126|NCT01066247|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110750127|NCT01066247|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110750128|NCT01066247|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110750129|NCT01066247|Anesthetics, General|anesthetics, general|mesh-ancestor
110750130|NCT01066247|Anesthetics|anesthetics|mesh-ancestor
110750131|NCT01066247|GABA Modulators|gaba modulators|mesh-ancestor
110750132|NCT01066247|GABA Agents|gaba agents|mesh-ancestor
110750133|NCT01066247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110750134|NCT01066247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110750135|NCT00306293|Valacyclovir|valacyclovir|mesh-list
110750136|NCT00306293|Antiviral Agents|antiviral agents|mesh-ancestor
110750137|NCT00306293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110750138|NCT03980951|Analgesics, Opioid|analgesics, opioid|mesh-list
110750139|NCT03980951|Narcotics|narcotics|mesh-ancestor
110750140|NCT03980951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110750141|NCT03980951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110867566|NCT01442649|Irinotecan|irinotecan|mesh-list
110750142|NCT03980951|Analgesics|analgesics|mesh-ancestor
110750143|NCT03980951|Sensory System Agents|sensory system agents|mesh-ancestor
110750144|NCT03980951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110750145|NCT02532491|Risperidone|risperidone|mesh-list
110750146|NCT02532491|Aripiprazole|aripiprazole|mesh-list
110750147|NCT02532491|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110750148|NCT02532491|Serotonin Agents|serotonin agents|mesh-ancestor
110467861|NCT00784459|Abatacept|abatacept|mesh-list
110750149|NCT02532491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110750150|NCT02532491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110750151|NCT02532491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110750152|NCT02532491|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110750153|NCT02532491|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110750154|NCT02532491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110750155|NCT02532491|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110750156|NCT02532491|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110750157|NCT02532491|Dopamine Agents|dopamine agents|mesh-ancestor
110750158|NCT02532491|Antidepressive Agents|antidepressive agents|mesh-ancestor
110750159|NCT02532491|Dopamine Agonists|dopamine agonists|mesh-ancestor
110750160|NCT02532491|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110750161|NCT02532491|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110750162|NCT02532491|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110750163|NCT02532491|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110750164|NCT01066403|Pergolide|pergolide|mesh-list
110750165|NCT01066403|Dopamine Agonists|dopamine agonists|mesh-ancestor
110750166|NCT01066403|Dopamine Agents|dopamine agents|mesh-ancestor
110750167|NCT01066403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110750168|NCT01066403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110750169|NCT01066403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110750170|NCT01064219|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
110750171|NCT01064219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110750172|NCT01064219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110750173|NCT00294671|Diflunisal|diflunisal|mesh-list
110750174|NCT00294671|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110750175|NCT00294671|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110750176|NCT00294671|Analgesics|analgesics|mesh-ancestor
110750177|NCT00294671|Sensory System Agents|sensory system agents|mesh-ancestor
110750178|NCT00294671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110750179|NCT00294671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110750180|NCT00294671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110750181|NCT00294671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110750182|NCT00294671|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110750183|NCT00294671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110750184|NCT00294671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110750185|NCT01064453|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
110750186|NCT01064453|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110750187|NCT01064453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110750188|NCT03980249|Carvedilol|carvedilol|mesh-list
110750189|NCT03980249|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110750190|NCT03980249|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110750191|NCT03980249|Adrenergic Agents|adrenergic agents|mesh-ancestor
110750192|NCT03980249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110750193|NCT03980249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110750194|NCT03980249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110750195|NCT03980249|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110750196|NCT03980249|Antioxidants|antioxidants|mesh-ancestor
110750197|NCT03980249|Protective Agents|protective agents|mesh-ancestor
110750198|NCT03980249|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110750199|NCT03980249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110750200|NCT03980249|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110750201|NCT03980249|Vasodilator Agents|vasodilator agents|mesh-ancestor
110750202|NCT03980249|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110750203|NCT03980249|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110750204|NCT01495598|Pomalidomide|pomalidomide|mesh-list
110750205|NCT01495598|Immunologic Factors|immunologic factors|mesh-ancestor
110750206|NCT01495598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110750207|NCT01495598|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110750208|NCT01495598|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110750209|NCT01495598|Growth Substances|growth substances|mesh-ancestor
110750210|NCT01495598|Growth Inhibitors|growth inhibitors|mesh-ancestor
110750211|NCT01495598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110750212|NCT01297166|Calcitriol|calcitriol|mesh-list
110750213|NCT01297166|Calcipotriene|calcipotriene|mesh-list
110750214|NCT01297166|Dermatologic Agents|dermatologic agents|mesh-ancestor
110750215|NCT01297166|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110750216|NCT01297166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110750217|NCT01297166|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
110750218|NCT01297166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110750219|NCT01297166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110467950|NCT04254744|Sevoflurane|sevoflurane|mesh-list
110750220|NCT01297166|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110750221|NCT01297166|Vitamins|vitamins|mesh-ancestor
110750222|NCT01297166|Micronutrients|micronutrients|mesh-ancestor
110750223|NCT01297166|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110750224|NCT01202474|Insulin|insulin|mesh-list
110750225|NCT01202474|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110750226|NCT01202474|Insulin Glargine|insulin glargine|mesh-list
110750227|NCT01202474|Insulin glulisine|insulin glulisine|mesh-list
110750228|NCT01202474|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110750229|NCT01202474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110750230|NCT05667818|Norfloxacin|norfloxacin|mesh-list
110750231|NCT05667818|Amlodipine|amlodipine|mesh-list
110750232|NCT05667818|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110750233|NCT05667818|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110750234|NCT05667818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110750235|NCT05667818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110750236|NCT05667818|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110750237|NCT05667818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110750238|NCT05667818|Vasodilator Agents|vasodilator agents|mesh-ancestor
110750239|NCT05667818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110750240|NCT05667818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110750241|NCT05667818|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110750242|NCT05667818|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110750243|NCT05667818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110750244|NCT05667818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110750245|NCT05667818|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110750246|NCT05667818|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110750247|NCT01205204|Clonidine|clonidine|mesh-list
110750248|NCT01205204|Fentanyl|fentanyl|mesh-list
110750249|NCT01205204|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110750250|NCT01205204|Narcotics|narcotics|mesh-ancestor
110750251|NCT01205204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110750252|NCT01205204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110750253|NCT01205204|Analgesics|analgesics|mesh-ancestor
110750254|NCT01205204|Sensory System Agents|sensory system agents|mesh-ancestor
110750255|NCT01205204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110750256|NCT01205204|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110750257|NCT01205204|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110750258|NCT01205204|Anesthetics, General|anesthetics, general|mesh-ancestor
110750259|NCT01205204|Anesthetics|anesthetics|mesh-ancestor
110750260|NCT01205204|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110750261|NCT01205204|Sympatholytics|sympatholytics|mesh-ancestor
110750262|NCT01205204|Autonomic Agents|autonomic agents|mesh-ancestor
110750263|NCT01205204|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110750264|NCT01205204|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110750265|NCT01205204|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110750266|NCT01205204|Adrenergic Agents|adrenergic agents|mesh-ancestor
110750267|NCT01205204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110750268|NCT01205204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110750269|NCT01205282|Pioglitazone|pioglitazone|mesh-list
110750270|NCT01205282|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110750271|NCT01205282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110750272|NCT03902912|Prednisolone|prednisolone|mesh-list
110750273|NCT03902912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110750274|NCT03902912|Glucocorticoids|glucocorticoids|mesh-ancestor
110750275|NCT03902912|Hormones|hormones|mesh-ancestor
110750276|NCT03902912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110750277|NCT03902912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110750278|NCT03902912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110750279|NCT03902912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110750280|NCT01205360|Fentanyl|fentanyl|mesh-list
110750281|NCT01205360|Bupivacaine|bupivacaine|mesh-list
110750282|NCT01205360|Anesthetics, Local|anesthetics, local|mesh-ancestor
110750283|NCT01205360|Anesthetics|anesthetics|mesh-ancestor
110750284|NCT01205360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110750285|NCT01205360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110750286|NCT01205360|Sensory System Agents|sensory system agents|mesh-ancestor
110750287|NCT01205360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110750288|NCT01205360|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110750289|NCT01205360|Narcotics|narcotics|mesh-ancestor
110750290|NCT01205360|Analgesics|analgesics|mesh-ancestor
110750291|NCT01205360|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110750292|NCT01205360|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110750293|NCT01205360|Anesthetics, General|anesthetics, general|mesh-ancestor
110750294|NCT01200914|Heparin|heparin|mesh-list
110750295|NCT01200914|Anticoagulants|anticoagulants|mesh-ancestor
110750296|NCT01200914|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110750297|NCT01200914|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110750298|NCT01200914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110750299|NCT01205516|Morphine|morphine|mesh-list
110750300|NCT01205516|Methadone|methadone|mesh-list
110750301|NCT01205516|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110750302|NCT01205516|Narcotics|narcotics|mesh-ancestor
110750303|NCT01205516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110750304|NCT01205516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110750305|NCT01205516|Analgesics|analgesics|mesh-ancestor
110750306|NCT01205516|Sensory System Agents|sensory system agents|mesh-ancestor
110750307|NCT01205516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110750308|NCT01205516|Antitussive Agents|antitussive agents|mesh-ancestor
110750309|NCT01205516|Respiratory System Agents|respiratory system agents|mesh-ancestor
110750310|NCT01297634|Botulinum Toxins|botulinum toxins|mesh-list
110750311|NCT01297634|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110750312|NCT01297634|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110750313|NCT01297634|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110750314|NCT01297634|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110750315|NCT01297634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110750316|NCT01297634|Cholinergic Agents|cholinergic agents|mesh-ancestor
110750317|NCT01297634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110750318|NCT01297634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110750319|NCT01297634|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110750320|NCT01297634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110750321|NCT01201070|Antithrombins|antithrombins|mesh-list
110750322|NCT01201070|Antithrombin III|antithrombin iii|mesh-list
110750323|NCT01201070|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110750324|NCT01201070|Protease Inhibitors|protease inhibitors|mesh-ancestor
110750325|NCT01201070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110750326|NCT01201070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110750327|NCT01201070|Anticoagulants|anticoagulants|mesh-ancestor
110750328|NCT01205672|Metformin|metformin|mesh-list
110750329|NCT01205672|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110750330|NCT01205672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110750331|NCT03817970|Ondansetron|ondansetron|mesh-list
110750332|NCT03817970|Palonosetron|palonosetron|mesh-list
110750333|NCT03817970|Granisetron|granisetron|mesh-list
110750334|NCT03817970|Antiemetics|antiemetics|mesh-ancestor
110750335|NCT03817970|Autonomic Agents|autonomic agents|mesh-ancestor
110750336|NCT03817970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110750337|NCT03817970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110750338|NCT03817970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110750339|NCT03817970|Antipruritics|antipruritics|mesh-ancestor
110750340|NCT03817970|Dermatologic Agents|dermatologic agents|mesh-ancestor
110750341|NCT03817970|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110750342|NCT03817970|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110750343|NCT03817970|Serotonin Agents|serotonin agents|mesh-ancestor
110750344|NCT03817970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110750345|NCT03817970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110750346|NCT01205750|Insulin|insulin|mesh-list
110750347|NCT01205750|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110750348|NCT01205750|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110750349|NCT01205750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110750350|NCT03012386|Sildenafil Citrate|sildenafil citrate|mesh-list
110750351|NCT03012386|Citric Acid|citric acid|mesh-list
110750352|NCT03012386|Sodium Citrate|sodium citrate|mesh-list
110750353|NCT03012386|Anticoagulants|anticoagulants|mesh-ancestor
110750354|NCT03012386|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110750355|NCT03012386|Chelating Agents|chelating agents|mesh-ancestor
110309788|NCT00310518|Beta-lapachone|beta-lapachone|mesh-list
110750356|NCT03012386|Sequestering Agents|sequestering agents|mesh-ancestor
110750357|NCT03012386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110750358|NCT03012386|Vasodilator Agents|vasodilator agents|mesh-ancestor
110750359|NCT03012386|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110750360|NCT03012386|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110750361|NCT03012386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110750362|NCT03012386|Urological Agents|urological agents|mesh-ancestor
110750363|NCT01202552|Vaccines|vaccines|mesh-list
110750364|NCT01202552|Immunologic Factors|immunologic factors|mesh-ancestor
110750365|NCT01202552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110750366|NCT01205984|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
110750367|NCT01205984|Methylprednisolone|methylprednisolone|mesh-list
110750368|NCT01205984|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110750369|NCT01205984|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110750370|NCT01205984|Prednisolone|prednisolone|mesh-list
110750371|NCT01205984|Prednisolone acetate|prednisolone acetate|mesh-list
110468089|NCT00701428|Losartan|losartan|mesh-list
110750372|NCT01205984|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110750373|NCT01205984|Prednisolone phosphate|prednisolone phosphate|mesh-list
110750374|NCT01205984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110750376|NCT01205984|Autonomic Agents|autonomic agents|mesh-ancestor
110750377|NCT01205984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110750378|NCT01205984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110750379|NCT01205984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110750380|NCT01205984|Glucocorticoids|glucocorticoids|mesh-ancestor
110750381|NCT01205984|Hormones|hormones|mesh-ancestor
110750382|NCT01205984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110750383|NCT01205984|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110750384|NCT01205984|Protective Agents|protective agents|mesh-ancestor
110750385|NCT01205984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110750386|NCT01205984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110750387|NCT01205984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110750388|NCT01205984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110750389|NCT01205984|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110750390|NCT01205984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110750391|NCT01205984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110750392|NCT01297946|Hormones|hormones|mesh-list
110750393|NCT01297946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110750394|NCT01297946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110750395|NCT03211858|Insulin|insulin|mesh-list
110750396|NCT03211858|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110750397|NCT03211858|Insulin Glargine|insulin glargine|mesh-list
110750398|NCT03211858|Insulin Aspart|insulin aspart|mesh-list
110750399|NCT03211858|Insulin, Long-Acting|insulin, long-acting|mesh-list
110750400|NCT03211858|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
110750401|NCT03211858|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110309829|NCT00316953|Dasatinib|dasatinib|mesh-list
110750402|NCT03211858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110750403|NCT01298180|Hormones|hormones|mesh-list
110750404|NCT01298180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110750405|NCT01298180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110750406|NCT03211156|Amoxicillin|amoxicillin|mesh-list
110750407|NCT03211156|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110750408|NCT03211156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110750409|NCT01298336|Moxifloxacin|moxifloxacin|mesh-list
110750410|NCT01298336|Clarithromycin|clarithromycin|mesh-list
110750411|NCT01298336|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110750412|NCT01298336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110750413|NCT01298336|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110750414|NCT01298336|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110750415|NCT01298336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110750416|NCT01298336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110750417|NCT01298336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110750418|NCT01298336|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110750419|NCT01298336|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110750420|NCT01298336|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110750422|NCT04472494|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110750423|NCT04472494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110750424|NCT04472494|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110750425|NCT04472494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110750426|NCT04472494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110750427|NCT04472494|Immunologic Factors|immunologic factors|mesh-ancestor
110750428|NCT04472494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110750429|NCT04472494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110750430|NCT04568200|Paclitaxel|paclitaxel|mesh-list
110750431|NCT04568200|Carboplatin|carboplatin|mesh-list
110750432|NCT04568200|Durvalumab|durvalumab|mesh-list
110750433|NCT04568200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110750434|NCT04568200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110750435|NCT04568200|Tubulin Modulators|tubulin modulators|mesh-ancestor
110750436|NCT04568200|Antimitotic Agents|antimitotic agents|mesh-ancestor
110750437|NCT04568200|Mitosis Modulators|mitosis modulators|mesh-ancestor
110750438|NCT04568200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110750439|NCT04568200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110750440|NCT03236506|Sofosbuvir|sofosbuvir|mesh-list
110750441|NCT03236506|Grazoprevir|grazoprevir|mesh-list
110750442|NCT03236506|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
110750443|NCT03236506|Antiviral Agents|antiviral agents|mesh-ancestor
110750444|NCT03236506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110750445|NCT01298882|Diacerein|diacerein|mesh-list
110468161|NCT00791557|Infliximab|infliximab|mesh-list
110750446|NCT01298882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110750447|NCT01206530|Leucovorin|leucovorin|mesh-list
110750448|NCT01206530|Hydroxychloroquine|hydroxychloroquine|mesh-list
110750449|NCT01206530|Bevacizumab|bevacizumab|mesh-list
110750450|NCT01206530|Fluorouracil|fluorouracil|mesh-list
110750451|NCT01206530|Oxaliplatin|oxaliplatin|mesh-list
110750452|NCT01206530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110750453|NCT01206530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110750454|NCT01206530|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110750455|NCT01206530|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110750456|NCT01206530|Growth Substances|growth substances|mesh-ancestor
110750457|NCT01206530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110750458|NCT01206530|Growth Inhibitors|growth inhibitors|mesh-ancestor
110750459|NCT01206530|Antimetabolites|antimetabolites|mesh-ancestor
110750460|NCT01206530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110750461|NCT01206530|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110750462|NCT01206530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110750463|NCT01206530|Immunologic Factors|immunologic factors|mesh-ancestor
110750464|NCT01206530|Antidotes|antidotes|mesh-ancestor
110750465|NCT01206530|Protective Agents|protective agents|mesh-ancestor
110750466|NCT01206530|Vitamin B Complex|vitamin b complex|mesh-ancestor
110750467|NCT01206530|Vitamins|vitamins|mesh-ancestor
110750468|NCT01206530|Micronutrients|micronutrients|mesh-ancestor
110750469|NCT01206530|Antimalarials|antimalarials|mesh-ancestor
110750470|NCT01206530|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110750471|NCT01206530|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110750472|NCT01206530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110750473|NCT01206530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110750474|NCT01206530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110750475|NCT03209518|Leuprolide|leuprolide|mesh-list
110750476|NCT03209518|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110750477|NCT03209518|Fertility Agents|fertility agents|mesh-ancestor
110750478|NCT03209518|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110750479|NCT03209518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110750480|NCT03209518|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110750481|NCT03209518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110750482|NCT05282420|Ranibizumab|ranibizumab|mesh-list
110750483|NCT05282420|Aflibercept|aflibercept|mesh-list
110750484|NCT05282420|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110750485|NCT05282420|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110750486|NCT05282420|Growth Substances|growth substances|mesh-ancestor
110750487|NCT05282420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110750488|NCT05282420|Growth Inhibitors|growth inhibitors|mesh-ancestor
110750489|NCT05282420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110750490|NCT00304031|Temozolomide|temozolomide|mesh-list
110750491|NCT00304031|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110750492|NCT00304031|Alkylating Agents|alkylating agents|mesh-ancestor
110750493|NCT00304031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110075531|NCT01597986|Norinyl|norinyl|mesh-list
110750495|NCT01567124|Moxonidine|moxonidine|mesh-list
110750496|NCT01567124|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110750497|NCT03617666|Avelumab|avelumab|mesh-list
110750498|NCT03617666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110750499|NCT03617666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110750500|NCT01299194|Atorvastatin|atorvastatin|mesh-list
110750501|NCT01299194|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110750502|NCT01299194|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110750503|NCT01299194|Antimetabolites|antimetabolites|mesh-ancestor
110750504|NCT01299194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110750505|NCT01299194|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110750506|NCT01299194|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110750507|NCT01299194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110750508|NCT03827408|Midazolam|midazolam|mesh-list
110750509|NCT03827408|Dexmedetomidine|dexmedetomidine|mesh-list
110750510|NCT03827408|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110750511|NCT03827408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110750512|NCT03827408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110750513|NCT03827408|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110750514|NCT03827408|Analgesics|analgesics|mesh-ancestor
110750515|NCT03827408|Sensory System Agents|sensory system agents|mesh-ancestor
110750516|NCT03827408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110750517|NCT03827408|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110750518|NCT03827408|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110750519|NCT03827408|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110750520|NCT03827408|Adrenergic Agents|adrenergic agents|mesh-ancestor
110750521|NCT03827408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110468239|NCT04252248|Decitabine|decitabine|mesh-list
110750522|NCT03827408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110750523|NCT03827408|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110750524|NCT03827408|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110750525|NCT03827408|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110750526|NCT03827408|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110750527|NCT03827408|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110750528|NCT03827408|Anesthetics, General|anesthetics, general|mesh-ancestor
110750529|NCT03827408|Anesthetics|anesthetics|mesh-ancestor
110750530|NCT03827408|GABA Modulators|gaba modulators|mesh-ancestor
110750531|NCT03827408|GABA Agents|gaba agents|mesh-ancestor
110750532|NCT03556904|Docetaxel|docetaxel|mesh-list
110750533|NCT03556904|Hormones|hormones|mesh-list
110750534|NCT03556904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110750535|NCT03556904|Tubulin Modulators|tubulin modulators|mesh-ancestor
110750536|NCT03556904|Antimitotic Agents|antimitotic agents|mesh-ancestor
110750537|NCT03556904|Mitosis Modulators|mitosis modulators|mesh-ancestor
110750538|NCT03556904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110750539|NCT03556904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110750540|NCT03556904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110750541|NCT00332189|Verapamil|verapamil|mesh-list
110750542|NCT00332189|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110750543|NCT00332189|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110750544|NCT00332189|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110309918|NCT00317187|Vaccines|vaccines|mesh-list
110750545|NCT00332189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110750546|NCT00332189|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110750547|NCT00332189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110750548|NCT00332189|Vasodilator Agents|vasodilator agents|mesh-ancestor
110750549|NCT01206998|Progesterone|progesterone|mesh-list
110750550|NCT01206998|Progestins|progestins|mesh-ancestor
110750551|NCT01206998|Hormones|hormones|mesh-ancestor
110750552|NCT01206998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110750553|NCT01206998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110750554|NCT00331799|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110750555|NCT00331799|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110750556|NCT00331799|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110750557|NCT00331799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110750558|NCT00331799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110750559|NCT00331799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110750560|NCT00331799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110750561|NCT00331799|Analgesics|analgesics|mesh-ancestor
110750562|NCT00331799|Sensory System Agents|sensory system agents|mesh-ancestor
110750563|NCT00331799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110750564|NCT00331799|Antidepressive Agents|antidepressive agents|mesh-ancestor
110750565|NCT00331799|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110750566|NCT00331799|Dopamine Agents|dopamine agents|mesh-ancestor
110750567|NCT03826940|Lovastatin|lovastatin|mesh-list
110750568|NCT03826940|L 647318|l 647318|mesh-list
110750569|NCT03826940|Dihydromevinolin|dihydromevinolin|mesh-list
110750570|NCT03826940|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110750571|NCT03826940|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110750572|NCT03826940|Antimetabolites|antimetabolites|mesh-ancestor
110750573|NCT03826940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110750574|NCT03826940|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110750575|NCT03826940|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110750576|NCT03826940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110750577|NCT01201694|Curcumin|curcumin|mesh-list
110750578|NCT01201694|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110750579|NCT01201694|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110750580|NCT01201694|Analgesics|analgesics|mesh-ancestor
110750581|NCT01201694|Sensory System Agents|sensory system agents|mesh-ancestor
110750582|NCT01201694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110750583|NCT01201694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110750584|NCT01201694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110750585|NCT01201694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110750586|NCT01201694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110750587|NCT01201694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110750588|NCT01201694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110750589|NCT01201928|Insulin|insulin|mesh-list
110750590|NCT01201928|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110750591|NCT01201928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110750592|NCT00303719|Cyclosporine|cyclosporine|mesh-list
110750593|NCT00303719|Mycophenolic Acid|mycophenolic acid|mesh-list
110750594|NCT00303719|Cyclophosphamide|cyclophosphamide|mesh-list
110750595|NCT00303719|Fludarabine|fludarabine|mesh-list
110750596|NCT00303719|Cyclosporins|cyclosporins|mesh-list
110750597|NCT00303719|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110750598|NCT00303719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110750599|NCT00303719|Immunologic Factors|immunologic factors|mesh-ancestor
110750600|NCT00303719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110750601|NCT00303719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110750602|NCT00303719|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110750603|NCT00303719|Alkylating Agents|alkylating agents|mesh-ancestor
110750604|NCT00303719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110750605|NCT00303719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110750606|NCT00303719|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110750607|NCT00303719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110750608|NCT00303719|Antifungal Agents|antifungal agents|mesh-ancestor
110750609|NCT00303719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110750610|NCT00303719|Dermatologic Agents|dermatologic agents|mesh-ancestor
110750611|NCT00303719|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110750612|NCT00303719|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110750613|NCT00303719|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110750614|NCT00303719|Antitubercular Agents|antitubercular agents|mesh-ancestor
110750615|NCT00303719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110750617|NCT01207310|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110750618|NCT01207310|Autonomic Agents|autonomic agents|mesh-ancestor
110750619|NCT01207310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110750620|NCT01207310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110750621|NCT01207310|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110750622|NCT01207310|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110750623|NCT01207310|Cholinergic Agents|cholinergic agents|mesh-ancestor
110750624|NCT01207310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110750625|NCT01207310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110750626|NCT00331409|Everolimus|everolimus|mesh-list
110750627|NCT00331409|Imatinib Mesylate|imatinib mesylate|mesh-list
110750628|NCT00331409|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110750629|NCT00331409|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110750630|NCT00331409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110750631|NCT00331409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110750632|NCT00331409|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110750633|NCT00331409|Immunologic Factors|immunologic factors|mesh-ancestor
110750634|NCT00331409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110750635|NCT00331409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110750636|NCT01203254|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
110750637|NCT01203254|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110750638|NCT01203254|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110750639|NCT01203254|Antimetabolites|antimetabolites|mesh-ancestor
110445228|NCT02883023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110750640|NCT01203254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110750641|NCT01203254|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110750643|NCT01064921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110750644|NCT01064921|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110750645|NCT01064921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110750646|NCT01064921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110750647|NCT01299662|Poly ICLC|poly iclc|mesh-list
110750648|NCT01299662|Interferon Inducers|interferon inducers|mesh-ancestor
110750649|NCT01299662|Immunologic Factors|immunologic factors|mesh-ancestor
110750650|NCT01299662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110750651|NCT00303485|Vitamin D|vitamin d|mesh-list
110750652|NCT00303485|Ibandronic Acid|ibandronic acid|mesh-list
110750653|NCT00303485|Calcium|calcium|mesh-list
110750654|NCT00303485|Vitamins|vitamins|mesh-ancestor
110750655|NCT00303485|Micronutrients|micronutrients|mesh-ancestor
110750656|NCT00303485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110750657|NCT00303485|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110750658|NCT00303485|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110750659|NCT03983915|Dexmedetomidine|dexmedetomidine|mesh-list
110750660|NCT03983915|Remifentanil|remifentanil|mesh-list
110750661|NCT03983915|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110750662|NCT03983915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110750663|NCT03983915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110750664|NCT03983915|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110750665|NCT03983915|Analgesics|analgesics|mesh-ancestor
110750666|NCT03983915|Sensory System Agents|sensory system agents|mesh-ancestor
110750667|NCT03983915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110750668|NCT03983915|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110750669|NCT03983915|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110750670|NCT03983915|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110867639|NCT03111108|Grazoprevir|grazoprevir|mesh-list
110750671|NCT03983915|Adrenergic Agents|adrenergic agents|mesh-ancestor
110750672|NCT03983915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110750673|NCT03983915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110750674|NCT03983915|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110750675|NCT03983915|Narcotics|narcotics|mesh-ancestor
110750676|NCT01300754|Lidocaine|lidocaine|mesh-list
110750677|NCT01300754|Anesthetics, Local|anesthetics, local|mesh-ancestor
110750678|NCT01300754|Anesthetics|anesthetics|mesh-ancestor
110750679|NCT01300754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110750680|NCT01300754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110750681|NCT01300754|Sensory System Agents|sensory system agents|mesh-ancestor
110750682|NCT01300754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110750683|NCT01300754|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110750684|NCT01300754|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110750685|NCT01300754|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110750686|NCT01300754|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110750687|NCT01300754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110750688|NCT00303953|Belinostat|belinostat|mesh-list
110750689|NCT00303953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110750690|NCT00303953|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110750691|NCT00303953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110750692|NCT00303953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110750693|NCT03840122|Anesthetics|anesthetics|mesh-list
110750694|NCT03840122|Anesthetics, Local|anesthetics, local|mesh-list
110750695|NCT03840122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110750696|NCT03840122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110750697|NCT03840122|Sensory System Agents|sensory system agents|mesh-ancestor
110750698|NCT03840122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110750699|NCT04343872|Metformin|metformin|mesh-list
110750700|NCT04343872|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110750701|NCT04343872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110750702|NCT01314274|Bevacizumab|bevacizumab|mesh-list
110750703|NCT01314274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110750704|NCT01314274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110750705|NCT01314274|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110750706|NCT01314274|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110750707|NCT01314274|Growth Substances|growth substances|mesh-ancestor
110750708|NCT01314274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110750709|NCT01314274|Growth Inhibitors|growth inhibitors|mesh-ancestor
110750710|NCT02935894|Ibuprofen|ibuprofen|mesh-list
110750711|NCT02935894|Pilocarpine|pilocarpine|mesh-list
110750712|NCT02935894|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110075757|NCT01599338|Incretins|incretins|mesh-ancestor
110750713|NCT02935894|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110750714|NCT02935894|Analgesics|analgesics|mesh-ancestor
110750715|NCT02935894|Sensory System Agents|sensory system agents|mesh-ancestor
110750716|NCT02935894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110750717|NCT02935894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110750718|NCT02935894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110750719|NCT02935894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110750720|NCT02935894|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110750721|NCT02935894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110750722|NCT02935894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110750723|NCT02935894|Miotics|miotics|mesh-ancestor
110750724|NCT02935894|Autonomic Agents|autonomic agents|mesh-ancestor
110750725|NCT02935894|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
110750726|NCT02935894|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110750727|NCT02935894|Cholinergic Agents|cholinergic agents|mesh-ancestor
110750728|NCT02935894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110750729|NCT03224182|Apaziquone|apaziquone|mesh-list
110750730|NCT03224182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110750731|NCT03821480|Fluconazole|fluconazole|mesh-list
110750732|NCT03821480|Antifungal Agents|antifungal agents|mesh-ancestor
110750733|NCT03821480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110750734|NCT03821480|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110750735|NCT03821480|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110750736|NCT03821480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110750737|NCT03821480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110750738|NCT03821480|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110750739|NCT03821480|Hormone Antagonists|hormone antagonists|mesh-ancestor
110867644|NCT00702520|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
110750740|NCT03821480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110750741|NCT03821480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110750742|NCT03821480|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110750743|NCT03821480|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110750744|NCT01203488|Vitamin A|vitamin a|mesh-list
110750745|NCT01203488|Vitamins|vitamins|mesh-ancestor
110750746|NCT01203488|Micronutrients|micronutrients|mesh-ancestor
110750747|NCT01203488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110750748|NCT03697720|Naproxen|naproxen|mesh-list
110750749|NCT03697720|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110750750|NCT03697720|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110750751|NCT03697720|Analgesics|analgesics|mesh-ancestor
110750752|NCT03697720|Sensory System Agents|sensory system agents|mesh-ancestor
110750753|NCT03697720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110750754|NCT03697720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110750755|NCT03697720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110750756|NCT03697720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110750757|NCT03697720|Gout Suppressants|gout suppressants|mesh-ancestor
110309993|NCT00417053|Etoposide|etoposide|mesh-list
110750758|NCT03697720|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110750759|NCT03697720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110750760|NCT03697720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110750761|NCT01314352|Desloratadine|desloratadine|mesh-list
110750762|NCT01314352|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110750763|NCT01314352|Cholinergic Agents|cholinergic agents|mesh-ancestor
110750764|NCT01314352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110750765|NCT01314352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110750766|NCT01314352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110750767|NCT01314352|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110750768|NCT01314352|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110750769|NCT01314352|Histamine Antagonists|histamine antagonists|mesh-ancestor
110750770|NCT01314352|Histamine Agents|histamine agents|mesh-ancestor
110750771|NCT03818282|Paclitaxel|paclitaxel|mesh-list
110750772|NCT03818282|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110750773|NCT03818282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110750774|NCT03818282|Tubulin Modulators|tubulin modulators|mesh-ancestor
110750775|NCT03818282|Antimitotic Agents|antimitotic agents|mesh-ancestor
110750776|NCT03818282|Mitosis Modulators|mitosis modulators|mesh-ancestor
110750777|NCT03818282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110750778|NCT01300364|Citalopram|citalopram|mesh-list
110750779|NCT01300364|Reboxetine|reboxetine|mesh-list
110750780|NCT01300364|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110750781|NCT01300364|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110750782|NCT01300364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110750783|NCT01300364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110750784|NCT01300364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110750785|NCT01300364|Serotonin Agents|serotonin agents|mesh-ancestor
110750786|NCT01300364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110750787|NCT01300364|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110750788|NCT01300364|Antidepressive Agents|antidepressive agents|mesh-ancestor
110750789|NCT01300364|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110750790|NCT01300364|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110750791|NCT01300364|Adrenergic Agents|adrenergic agents|mesh-ancestor
110750792|NCT03221842|Complement C1s|complement c1s|mesh-list
110750793|NCT03221842|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
110750794|NCT03221842|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
110750795|NCT03221842|Immunologic Factors|immunologic factors|mesh-ancestor
110750796|NCT03221842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110750797|NCT03221842|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
110750798|NCT03221842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110750799|NCT05622890|Maytansine|maytansine|mesh-list
110750800|NCT05622890|Mirvetuximab soravtansine|mirvetuximab soravtansine|mesh-list
110750801|NCT05622890|Immunoconjugates|immunoconjugates|mesh-ancestor
110750802|NCT05622890|Immunologic Factors|immunologic factors|mesh-ancestor
110750803|NCT05622890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110750804|NCT05622890|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110750805|NCT05622890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110750806|NCT05622890|Tubulin Modulators|tubulin modulators|mesh-ancestor
110750807|NCT05622890|Antimitotic Agents|antimitotic agents|mesh-ancestor
110750808|NCT05622890|Mitosis Modulators|mitosis modulators|mesh-ancestor
110750809|NCT05622890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110750811|NCT00303329|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110750812|NCT00303329|Chelating Agents|chelating agents|mesh-ancestor
110750813|NCT00303329|Sequestering Agents|sequestering agents|mesh-ancestor
110750814|NCT00303329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110750815|NCT01300988|Aprepitant|aprepitant|mesh-list
110750816|NCT01300988|Fosaprepitant|fosaprepitant|mesh-list
110468541|NCT00626600|Oxycodone|oxycodone|mesh-list
110750817|NCT01300988|Antiemetics|antiemetics|mesh-ancestor
110750818|NCT01300988|Autonomic Agents|autonomic agents|mesh-ancestor
110750819|NCT01300988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110750820|NCT01300988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110750821|NCT01300988|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110750822|NCT01300988|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110750823|NCT01300988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110750824|NCT01300988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110750825|NCT01064999|Capecitabine|capecitabine|mesh-list
110750826|NCT01064999|Oxaliplatin|oxaliplatin|mesh-list
110750827|NCT01064999|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110750828|NCT01064999|Antimetabolites|antimetabolites|mesh-ancestor
110750829|NCT01064999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110750830|NCT01064999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110750831|NCT03818048|Propofol|propofol|mesh-list
110750832|NCT03818048|Sevoflurane|sevoflurane|mesh-list
110750833|NCT03818048|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110750834|NCT03818048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110750835|NCT03818048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110750836|NCT03818048|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110750837|NCT03818048|Anesthetics, General|anesthetics, general|mesh-ancestor
110750838|NCT03818048|Anesthetics|anesthetics|mesh-ancestor
110750839|NCT03818048|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110750840|NCT03818048|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110750841|NCT01301924|Meglumine Antimoniate|meglumine antimoniate|mesh-list
110750842|NCT01301924|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110750843|NCT01301924|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110750844|NCT01301924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110750845|NCT00329849|Vaccines|vaccines|mesh-list
110750846|NCT00329849|Immunologic Factors|immunologic factors|mesh-ancestor
110750847|NCT00329849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110750848|NCT05655806|Aminophylline|aminophylline|mesh-list
110750849|NCT05655806|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110750850|NCT05655806|Autonomic Agents|autonomic agents|mesh-ancestor
110750851|NCT05655806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110750852|NCT05655806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110750853|NCT05655806|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110750854|NCT05655806|Respiratory System Agents|respiratory system agents|mesh-ancestor
110750855|NCT05655806|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110750856|NCT05655806|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110750857|NCT05655806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110750858|NCT05655806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110750859|NCT05655806|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110750860|NCT05655806|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110750861|NCT05655806|Purinergic Agents|purinergic agents|mesh-ancestor
110750862|NCT05655806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110750863|NCT05655806|Protective Agents|protective agents|mesh-ancestor
110750864|NCT01300676|Estradiol|estradiol|mesh-list
110750865|NCT01300676|Dydrogesterone|dydrogesterone|mesh-list
110750866|NCT01300676|Estrogens|estrogens|mesh-ancestor
110750867|NCT01300676|Hormones|hormones|mesh-ancestor
110750868|NCT01300676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110750869|NCT01300676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110750870|NCT01300676|Progestins|progestins|mesh-ancestor
110750871|NCT00329303|Certolizumab Pegol|certolizumab pegol|mesh-list
110750872|NCT00329303|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110750873|NCT00329303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110750874|NCT00329303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110750875|NCT00329303|Immunologic Factors|immunologic factors|mesh-ancestor
110750876|NCT00329303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110750877|NCT00329303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110750878|NCT03806816|Melatonin|melatonin|mesh-list
110750879|NCT03806816|Antioxidants|antioxidants|mesh-ancestor
110750880|NCT03806816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110750881|NCT03806816|Protective Agents|protective agents|mesh-ancestor
110750882|NCT03806816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110750883|NCT03806816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110750884|NCT01301222|Octreotide|octreotide|mesh-list
110750885|NCT01301222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110750886|NCT01301222|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110750887|NCT01301222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110750888|NCT02532569|Vaccines|vaccines|mesh-list
110750889|NCT02532569|Immunologic Factors|immunologic factors|mesh-ancestor
110750890|NCT02532569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110750891|NCT01302002|Metformin|metformin|mesh-list
110750892|NCT01302002|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110750893|NCT01302002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110750894|NCT01303250|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
110750895|NCT01303250|Plasma Substitutes|plasma substitutes|mesh-ancestor
110750896|NCT01303250|Blood Substitutes|blood substitutes|mesh-ancestor
110750897|NCT03814616|Artesunate|artesunate|mesh-list
110750898|NCT03814616|Pyronaridine|pyronaridine|mesh-list
110750899|NCT03814616|Antimalarials|antimalarials|mesh-ancestor
110750900|NCT03814616|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110750901|NCT03814616|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110750902|NCT03814616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110750903|NCT03814616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110750904|NCT03814616|Antiviral Agents|antiviral agents|mesh-ancestor
110750905|NCT03814616|Schistosomicides|schistosomicides|mesh-ancestor
110750906|NCT03814616|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110750907|NCT03814616|Anthelmintics|anthelmintics|mesh-ancestor
110750908|NCT00302159|Temozolomide|temozolomide|mesh-list
110750909|NCT00302159|Valproic Acid|valproic acid|mesh-list
110750910|NCT00302159|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110750911|NCT00302159|Alkylating Agents|alkylating agents|mesh-ancestor
110750912|NCT00302159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110750913|NCT00302159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110750914|NCT00302159|Anticonvulsants|anticonvulsants|mesh-ancestor
110750915|NCT00302159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110750916|NCT00302159|GABA Agents|gaba agents|mesh-ancestor
110867671|NCT04059536|Aspirin|aspirin|mesh-list
110750917|NCT00302159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110750918|NCT00302159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110750919|NCT00302159|Antimanic Agents|antimanic agents|mesh-ancestor
110750920|NCT00302159|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110750921|NCT00302159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110750922|NCT00302159|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110750923|NCT03814226|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
110750924|NCT03814226|Growth Substances|growth substances|mesh-ancestor
110750925|NCT03814226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110750926|NCT03814226|Vasodilator Agents|vasodilator agents|mesh-ancestor
110750927|NCT03814226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110750928|NCT03814226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110750929|NCT00302081|Ribavirin|ribavirin|mesh-list
110750930|NCT00302081|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110750931|NCT00302081|Interferon-alpha|interferon-alpha|mesh-list
110750932|NCT00302081|Antimetabolites|antimetabolites|mesh-ancestor
110750933|NCT00302081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110750934|NCT00302081|Antiviral Agents|antiviral agents|mesh-ancestor
110750935|NCT00302081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110750936|NCT00302081|Immunologic Factors|immunologic factors|mesh-ancestor
110750937|NCT00302081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110750938|NCT00302003|Cytarabine|cytarabine|mesh-list
110750939|NCT00302003|Dexamethasone|dexamethasone|mesh-list
110750940|NCT00302003|Prednisone|prednisone|mesh-list
110750941|NCT00302003|Cyclophosphamide|cyclophosphamide|mesh-list
110750942|NCT00302003|Ifosfamide|ifosfamide|mesh-list
110750943|NCT00302003|Doxorubicin|doxorubicin|mesh-list
110750944|NCT00302003|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110750945|NCT00302003|Etoposide|etoposide|mesh-list
110750946|NCT00302003|Vincristine|vincristine|mesh-list
110750947|NCT00302003|Vinorelbine|vinorelbine|mesh-list
110750948|NCT00302003|Etoposide phosphate|etoposide phosphate|mesh-list
110750949|NCT00302003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110750950|NCT00302003|Immunologic Factors|immunologic factors|mesh-ancestor
110750951|NCT00302003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110750952|NCT00302003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110750953|NCT00302003|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110750954|NCT00302003|Alkylating Agents|alkylating agents|mesh-ancestor
110750955|NCT00302003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110750956|NCT00302003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110750957|NCT00302003|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110750958|NCT00302003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110750959|NCT00302003|Antiemetics|antiemetics|mesh-ancestor
110750960|NCT00302003|Autonomic Agents|autonomic agents|mesh-ancestor
110750961|NCT00302003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110750962|NCT00302003|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110750963|NCT00302003|Glucocorticoids|glucocorticoids|mesh-ancestor
110750964|NCT00302003|Hormones|hormones|mesh-ancestor
110750965|NCT00302003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110750966|NCT00302003|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110750967|NCT00302003|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110468683|NCT04244097|Anesthetics|anesthetics|mesh-ancestor
110750968|NCT00302003|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110750969|NCT00302003|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110750970|NCT00302003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110750971|NCT00302003|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110750972|NCT00302003|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110750974|NCT00302003|Antiviral Agents|antiviral agents|mesh-ancestor
110750975|NCT00302003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110750976|NCT00302003|Tubulin Modulators|tubulin modulators|mesh-ancestor
110750977|NCT00302003|Antimitotic Agents|antimitotic agents|mesh-ancestor
110750978|NCT00302003|Mitosis Modulators|mitosis modulators|mesh-ancestor
110750979|NCT00036270|Tamoxifen|tamoxifen|mesh-list
110750980|NCT00036270|Exemestane|exemestane|mesh-list
110750981|NCT00036270|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110750982|NCT00036270|Hormone Antagonists|hormone antagonists|mesh-ancestor
110750983|NCT00036270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110750984|NCT00036270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110750985|NCT00036270|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110750986|NCT00036270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110750987|NCT00036270|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110750988|NCT00036270|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110750989|NCT00036270|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110750990|NCT00036270|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110750991|NCT00036270|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110750992|NCT00036270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110750993|NCT00036270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110750995|NCT01097382|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110750996|NCT01097382|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110750997|NCT01097382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110750998|NCT01097382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110750999|NCT01097382|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
110751000|NCT01097382|GABA Agonists|gaba agonists|mesh-ancestor
110751001|NCT01097382|GABA Agents|gaba agents|mesh-ancestor
110751002|NCT01097382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110751003|NCT01097382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110751004|NCT00301067|Calcitriol|calcitriol|mesh-list
110751005|NCT00301067|Temozolomide|temozolomide|mesh-list
110751006|NCT00301067|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110751008|NCT00301067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110751009|NCT00301067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110751010|NCT00301067|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110751011|NCT00301067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110751012|NCT00301067|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
110751013|NCT00301067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110751014|NCT00301067|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110751015|NCT00301067|Vitamins|vitamins|mesh-ancestor
110751016|NCT00301067|Micronutrients|micronutrients|mesh-ancestor
110751017|NCT00301067|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110751018|NCT03979859|Nafithromycin|nafithromycin|mesh-list
110751019|NCT03979859|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110751020|NCT03979859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110751021|NCT03979859|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110751022|NCT03979859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110751023|NCT03979859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110751024|NCT03955458|Bupivacaine|bupivacaine|mesh-list
110751025|NCT03955458|Ropivacaine|ropivacaine|mesh-list
110751026|NCT03955458|Anesthetics, Local|anesthetics, local|mesh-ancestor
110751027|NCT03955458|Anesthetics|anesthetics|mesh-ancestor
110751028|NCT03955458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110751029|NCT03955458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110751030|NCT03955458|Sensory System Agents|sensory system agents|mesh-ancestor
110751031|NCT03955458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110751032|NCT00007020|Cholic Acids|cholic acids|mesh-list
110751033|NCT00007020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110751034|NCT00300755|Pantoprazole|pantoprazole|mesh-list
110751035|NCT00300755|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110751036|NCT00300755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110751037|NCT00300755|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110751038|NCT00300755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110751039|NCT00300755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110751040|NCT00033540|Gemcitabine|gemcitabine|mesh-list
110751041|NCT00033540|Capecitabine|capecitabine|mesh-list
110751042|NCT00033540|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110468761|NCT00784927|Rituximab|rituximab|mesh-list
110751043|NCT00033540|Antimetabolites|antimetabolites|mesh-ancestor
110751044|NCT00033540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110751046|NCT00300365|Aspirin|aspirin|mesh-list
110751047|NCT00300365|Niacin|niacin|mesh-list
110751048|NCT00300365|Pioglitazone|pioglitazone|mesh-list
110751049|NCT00300365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110751050|NCT00300365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110751051|NCT00300365|Analgesics|analgesics|mesh-ancestor
110751052|NCT00300365|Sensory System Agents|sensory system agents|mesh-ancestor
110751053|NCT00300365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110751054|NCT00300365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110867701|NCT01361763|Dabigatran|dabigatran|mesh-list
110751055|NCT00300365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110751057|NCT00300365|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110751058|NCT00300365|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110751059|NCT00300365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110751060|NCT00300365|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110751061|NCT00300365|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110751062|NCT00300365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110751063|NCT00300365|Antipyretics|antipyretics|mesh-ancestor
110751064|NCT00300365|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110751065|NCT00300365|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110751066|NCT00300365|Antimetabolites|antimetabolites|mesh-ancestor
110751067|NCT00300365|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110751068|NCT00300365|Vasodilator Agents|vasodilator agents|mesh-ancestor
110751069|NCT00300365|Vitamin B Complex|vitamin b complex|mesh-ancestor
110751070|NCT00300365|Vitamins|vitamins|mesh-ancestor
110751071|NCT00300365|Micronutrients|micronutrients|mesh-ancestor
110751072|NCT03980015|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110751073|NCT03980015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110751074|NCT00048048|Epoetin Alfa|epoetin alfa|mesh-list
110751075|NCT00048048|Hematinics|hematinics|mesh-ancestor
110751076|NCT03953118|Azithromycin|azithromycin|mesh-list
110751077|NCT03953118|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110751078|NCT03953118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110751079|NCT01101204|Metformin|metformin|mesh-list
110751080|NCT01101204|Simvastatin|simvastatin|mesh-list
110751081|NCT01101204|Fenofibrate|fenofibrate|mesh-list
110751082|NCT01101204|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110751083|NCT01101204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110751084|NCT01101204|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110751085|NCT01101204|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110751086|NCT01101204|Antimetabolites|antimetabolites|mesh-ancestor
110751087|NCT01101204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110751088|NCT01101204|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110751089|NCT01101204|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110751090|NCT01101204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110751091|NCT01095822|Valsartan|valsartan|mesh-list
110751092|NCT01095822|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110751093|NCT01095822|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110751094|NCT01095822|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110751095|NCT01095822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110751096|NCT01095900|Botulinum Toxins|botulinum toxins|mesh-list
110751097|NCT01095900|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110751098|NCT01095900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110751099|NCT01095900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110751100|NCT01095900|Cholinergic Agents|cholinergic agents|mesh-ancestor
110751101|NCT01095900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110751102|NCT01095900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110751103|NCT00300053|Lenograstim|lenograstim|mesh-list
110751104|NCT00300053|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110751105|NCT00300053|Immunologic Factors|immunologic factors|mesh-ancestor
110751106|NCT00300053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110751107|NCT01098084|Decitabine|decitabine|mesh-list
110751108|NCT01098084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110751109|NCT01098084|Antimetabolites|antimetabolites|mesh-ancestor
110751110|NCT01098084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110751111|NCT01098084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110751112|NCT01098084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110751113|NCT03952572|Prednisone|prednisone|mesh-list
110751114|NCT03952572|Cyclophosphamide|cyclophosphamide|mesh-list
110751115|NCT03952572|Doxorubicin|doxorubicin|mesh-list
110751116|NCT03952572|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110751117|NCT03952572|Vincristine|vincristine|mesh-list
110751118|NCT03952572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110751119|NCT03952572|Immunologic Factors|immunologic factors|mesh-ancestor
110751120|NCT03952572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110751121|NCT03952572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110751122|NCT03952572|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110751123|NCT03952572|Alkylating Agents|alkylating agents|mesh-ancestor
110751124|NCT03952572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110867709|NCT02420782|Midazolam|midazolam|mesh-list
110751125|NCT03952572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110751126|NCT03952572|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110751127|NCT03952572|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110751128|NCT03952572|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110751129|NCT03952572|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110751130|NCT03952572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110751131|NCT03952572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110751132|NCT03952572|Glucocorticoids|glucocorticoids|mesh-ancestor
110751133|NCT03952572|Hormones|hormones|mesh-ancestor
110751134|NCT03952572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110751135|NCT03952572|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110751136|NCT03952572|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110751137|NCT03952572|Tubulin Modulators|tubulin modulators|mesh-ancestor
110751138|NCT03952572|Antimitotic Agents|antimitotic agents|mesh-ancestor
110751139|NCT03952572|Mitosis Modulators|mitosis modulators|mesh-ancestor
110751140|NCT03954756|Apatinib|apatinib|mesh-list
110751141|NCT03954756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110751142|NCT03954756|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110751143|NCT03954756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110751144|NCT03954756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110751145|NCT00326963|Enfuvirtide|enfuvirtide|mesh-list
110751146|NCT00326963|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110751147|NCT00326963|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110751148|NCT00326963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110751149|NCT00326963|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110751150|NCT00326963|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110751151|NCT00326963|Antiviral Agents|antiviral agents|mesh-ancestor
110751152|NCT00326963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110751153|NCT00326885|Catumaxomab|catumaxomab|mesh-list
110751154|NCT00326885|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110751155|NCT00326495|Cetuximab|cetuximab|mesh-list
110751156|NCT00326495|Sorafenib|sorafenib|mesh-list
110751157|NCT00326495|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110751158|NCT00326495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110751159|NCT00326495|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110751160|NCT00326495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110751161|NCT00326495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110751162|NCT00326417|Cyclophosphamide|cyclophosphamide|mesh-list
110751163|NCT00326417|Fludarabine|fludarabine|mesh-list
110751164|NCT00326417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110751165|NCT00326417|Immunologic Factors|immunologic factors|mesh-ancestor
110751166|NCT00326417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110751167|NCT00326417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110751168|NCT00326417|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110751169|NCT00326417|Alkylating Agents|alkylating agents|mesh-ancestor
110751170|NCT00326417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110751171|NCT00326417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110751172|NCT00326417|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110751173|NCT01060787|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
110751174|NCT01060787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110751175|NCT01060787|Glucocorticoids|glucocorticoids|mesh-ancestor
110751176|NCT01060787|Hormones|hormones|mesh-ancestor
110751177|NCT01060787|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110751178|NCT01060787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110751179|NCT01065467|Panobinostat|panobinostat|mesh-list
110751180|NCT01065467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110751181|NCT01065467|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110751182|NCT01065467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110751183|NCT01065467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110751184|NCT01065545|Clofarabine|clofarabine|mesh-list
110751185|NCT01065545|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110751186|NCT01065545|Antimetabolites|antimetabolites|mesh-ancestor
110751187|NCT01065545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110751188|NCT01065545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110751189|NCT03979469|Fentanyl|fentanyl|mesh-list
110751190|NCT03979469|Dexmedetomidine|dexmedetomidine|mesh-list
110751192|NCT03979469|Remifentanil|remifentanil|mesh-list
110751193|NCT03979469|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110751194|NCT03979469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110751195|NCT03979469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110751197|NCT03979469|Analgesics|analgesics|mesh-ancestor
110751198|NCT03979469|Sensory System Agents|sensory system agents|mesh-ancestor
110751199|NCT03979469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110751200|NCT03979469|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110751201|NCT03979469|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110751202|NCT03979469|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110751203|NCT03979469|Adrenergic Agents|adrenergic agents|mesh-ancestor
110751204|NCT03979469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110751205|NCT03979469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110751206|NCT03979469|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110751207|NCT03979469|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110751208|NCT03979469|Anesthetics, General|anesthetics, general|mesh-ancestor
110751209|NCT03979469|Anesthetics|anesthetics|mesh-ancestor
110751210|NCT03979469|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110751211|NCT03979469|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110751212|NCT03979469|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110751213|NCT03979469|Narcotics|narcotics|mesh-ancestor
110751214|NCT03979469|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110751215|NCT01065701|Dexmedetomidine|dexmedetomidine|mesh-list
110751216|NCT01065701|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110751217|NCT01065701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110751218|NCT01065701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110751219|NCT01065701|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110751220|NCT01065701|Analgesics|analgesics|mesh-ancestor
110751221|NCT01065701|Sensory System Agents|sensory system agents|mesh-ancestor
110751222|NCT01065701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110751223|NCT01065701|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110751224|NCT01065701|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110751225|NCT01065701|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110751226|NCT01065701|Adrenergic Agents|adrenergic agents|mesh-ancestor
110751227|NCT01065701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110751228|NCT01065701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110751229|NCT03825341|Hydroxyurea|hydroxyurea|mesh-list
110751230|NCT03825341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110751231|NCT03825341|Antisickling Agents|antisickling agents|mesh-ancestor
110751232|NCT03825341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110751233|NCT03825341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110751234|NCT03825341|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110751235|NCT01065857|Picosulfate sodium|picosulfate sodium|mesh-list
110751236|NCT01065857|Sodium sulfate|sodium sulfate|mesh-list
110751237|NCT01065857|Magnesium Oxide|magnesium oxide|mesh-list
110751238|NCT01065857|Citric Acid|citric acid|mesh-list
110751239|NCT01065857|Sodium Citrate|sodium citrate|mesh-list
110751240|NCT01065857|Anticoagulants|anticoagulants|mesh-ancestor
110751241|NCT01065857|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110751242|NCT01065857|Chelating Agents|chelating agents|mesh-ancestor
110751243|NCT01065857|Sequestering Agents|sequestering agents|mesh-ancestor
110751244|NCT01065857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110751245|NCT01065857|Cathartics|cathartics|mesh-ancestor
110751246|NCT01065857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110751247|NCT01065857|Antacids|antacids|mesh-ancestor
110751248|NCT00297479|Nicotine|nicotine|mesh-list
110751249|NCT00297479|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110751250|NCT00297479|Autonomic Agents|autonomic agents|mesh-ancestor
110751251|NCT00297479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110751252|NCT00297479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110751253|NCT00297479|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110751254|NCT00297479|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110751255|NCT00297479|Cholinergic Agents|cholinergic agents|mesh-ancestor
110751256|NCT00297479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110310187|NCT00282503|Dermatologic Agents|dermatologic agents|mesh-ancestor
110751257|NCT00297479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110751258|NCT00688870|Vaccines|vaccines|mesh-list
110751259|NCT00688870|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110751260|NCT00688870|Immunologic Factors|immunologic factors|mesh-ancestor
110751261|NCT00688870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110751262|NCT02532335|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
110751263|NCT02532335|Cathartics|cathartics|mesh-ancestor
110751264|NCT02532335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110751265|NCT03216226|Glucagon|glucagon|mesh-list
110751266|NCT03216226|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110751267|NCT03216226|Hormones|hormones|mesh-ancestor
110468962|NCT00704860|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110751268|NCT03216226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110751269|NCT03216226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110751270|NCT00290771|Imatinib Mesylate|imatinib mesylate|mesh-list
110751271|NCT00290771|Hydroxyurea|hydroxyurea|mesh-list
110751272|NCT00290771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110751273|NCT00290771|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110751274|NCT00290771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110751275|NCT00290771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110751276|NCT00290771|Antisickling Agents|antisickling agents|mesh-ancestor
110751277|NCT00290771|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110751278|NCT00290693|Docetaxel|docetaxel|mesh-list
110751279|NCT00290693|Capecitabine|capecitabine|mesh-list
110751280|NCT00290693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110751281|NCT00290693|Tubulin Modulators|tubulin modulators|mesh-ancestor
110751282|NCT00290693|Antimitotic Agents|antimitotic agents|mesh-ancestor
110751283|NCT00290693|Mitosis Modulators|mitosis modulators|mesh-ancestor
110751284|NCT00290693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110751285|NCT00290693|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110751286|NCT00290693|Antimetabolites|antimetabolites|mesh-ancestor
110751287|NCT00274469|Fulvestrant|fulvestrant|mesh-list
110751288|NCT00274469|Anastrozole|anastrozole|mesh-list
110751289|NCT00274469|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110751290|NCT00274469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110751291|NCT00274469|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110445243|NCT01197560|Rituximab|rituximab|mesh-list
110751292|NCT00274469|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110751293|NCT00274469|Hormone Antagonists|hormone antagonists|mesh-ancestor
110751294|NCT00274469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110751295|NCT00274469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110751296|NCT00274469|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110751297|NCT00274469|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110751298|NCT00274469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110751299|NCT00274469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110751300|NCT01556776|Lenalidomide|lenalidomide|mesh-list
110751301|NCT01556776|Immunologic Factors|immunologic factors|mesh-ancestor
110751302|NCT01556776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110751303|NCT01556776|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110751304|NCT01556776|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110751305|NCT01556776|Growth Substances|growth substances|mesh-ancestor
110751306|NCT01556776|Growth Inhibitors|growth inhibitors|mesh-ancestor
110751307|NCT01556776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110751308|NCT05180422|Sotorasib|sotorasib|mesh-list
110751309|NCT05180422|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110751310|NCT05180422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110751311|NCT05180422|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110751312|NCT05180422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110751313|NCT02422498|Cisplatin|cisplatin|mesh-list
110751314|NCT02422498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110751315|NCT01314976|Metronidazole|metronidazole|mesh-list
110751316|NCT01314976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110751317|NCT01314976|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110751318|NCT01314976|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110751319|NCT01314976|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110751320|NCT02379520|Cyclophosphamide|cyclophosphamide|mesh-list
110751321|NCT02379520|Nivolumab|nivolumab|mesh-list
110751323|NCT02379520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110751324|NCT02379520|Immunologic Factors|immunologic factors|mesh-ancestor
110751325|NCT02379520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110751326|NCT02379520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110751327|NCT02379520|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110751328|NCT02379520|Alkylating Agents|alkylating agents|mesh-ancestor
110751329|NCT02379520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110751330|NCT02379520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110751331|NCT02379520|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110751332|NCT02379520|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110751333|NCT02379520|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110751334|NCT01973452|Dexmedetomidine|dexmedetomidine|mesh-list
110751335|NCT01973452|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110751336|NCT01973452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110751337|NCT01973452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110751338|NCT01973452|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110751339|NCT01973452|Analgesics|analgesics|mesh-ancestor
110751340|NCT01973452|Sensory System Agents|sensory system agents|mesh-ancestor
110469055|NCT00916123|Prednisone|prednisone|mesh-list
110751341|NCT01973452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110751342|NCT01973452|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110751343|NCT01973452|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110751344|NCT01973452|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110751345|NCT01973452|Adrenergic Agents|adrenergic agents|mesh-ancestor
110751346|NCT01973452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110751347|NCT01973452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110751348|NCT04504942|Leronlimab|leronlimab|mesh-list
110751349|NCT04504942|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110751350|NCT04504942|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110751351|NCT04504942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110751352|NCT04504942|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110751353|NCT04504942|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110751354|NCT04504942|Antiviral Agents|antiviral agents|mesh-ancestor
110751355|NCT04504942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110751356|NCT01882816|Doxorubicin|doxorubicin|mesh-list
110751357|NCT01882816|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110751358|NCT01882816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110751359|NCT01882816|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110751360|NCT01882816|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110751361|NCT01882816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110751362|NCT01882816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110751363|NCT00272987|Paclitaxel|paclitaxel|mesh-list
110751364|NCT00272987|Trastuzumab|trastuzumab|mesh-list
110751365|NCT00272987|Lapatinib|lapatinib|mesh-list
110751366|NCT00272987|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110751367|NCT00272987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110751368|NCT00272987|Tubulin Modulators|tubulin modulators|mesh-ancestor
110751369|NCT00272987|Antimitotic Agents|antimitotic agents|mesh-ancestor
110751370|NCT00272987|Mitosis Modulators|mitosis modulators|mesh-ancestor
110751371|NCT00272987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110751372|NCT00272987|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110751373|NCT00272987|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110751374|NCT00272987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110751375|NCT01069757|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110751376|NCT01069757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110751377|NCT01069757|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110310267|NCT00311883|Antimalarials|antimalarials|mesh-ancestor
110751378|NCT01069757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110751379|NCT01069757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110751380|NCT01070927|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
110751381|NCT01070927|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
110751382|NCT01070927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110751383|NCT01070927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110751384|NCT03976271|Hypoglycemic Agents|hypoglycemic agents|mesh-list
110751385|NCT03976271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110751386|NCT01069913|Dimethyl Fumarate|dimethyl fumarate|mesh-list
110751387|NCT01069913|Dermatologic Agents|dermatologic agents|mesh-ancestor
110751388|NCT01069913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110751389|NCT01069913|Immunologic Factors|immunologic factors|mesh-ancestor
110751390|NCT01069913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110751391|NCT01730950|Bevacizumab|bevacizumab|mesh-list
110751392|NCT01730950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110751393|NCT01730950|Antibodies|antibodies|mesh-list
110751394|NCT01730950|Immunoglobulins|immunoglobulins|mesh-list
110751395|NCT01730950|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110751396|NCT01730950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110751397|NCT01730950|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110751398|NCT01730950|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110751399|NCT01730950|Growth Substances|growth substances|mesh-ancestor
110751400|NCT01730950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110751401|NCT01730950|Growth Inhibitors|growth inhibitors|mesh-ancestor
110751402|NCT01730950|Immunologic Factors|immunologic factors|mesh-ancestor
110751403|NCT00271505|Bevacizumab|bevacizumab|mesh-list
110751404|NCT00271505|Carboplatin|carboplatin|mesh-list
110751405|NCT00271505|Docetaxel|docetaxel|mesh-list
110751406|NCT00271505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110751407|NCT00271505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110751408|NCT00271505|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110751409|NCT00271505|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110751410|NCT00271505|Growth Substances|growth substances|mesh-ancestor
110751411|NCT00271505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110751412|NCT00271505|Growth Inhibitors|growth inhibitors|mesh-ancestor
110310303|NCT00318630|Rosiglitazone|rosiglitazone|mesh-list
110751413|NCT00271505|Tubulin Modulators|tubulin modulators|mesh-ancestor
110751414|NCT00271505|Antimitotic Agents|antimitotic agents|mesh-ancestor
110751415|NCT00271505|Mitosis Modulators|mitosis modulators|mesh-ancestor
110751416|NCT00271505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110751417|NCT01642186|Everolimus|everolimus|mesh-list
110751418|NCT01642186|Letrozole|letrozole|mesh-list
110751419|NCT01642186|Leuprolide|leuprolide|mesh-list
110751420|NCT01642186|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110751421|NCT01642186|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110751422|NCT01642186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110751423|NCT01642186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110751424|NCT01642186|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110751425|NCT01642186|Immunologic Factors|immunologic factors|mesh-ancestor
110751426|NCT01642186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110751427|NCT01642186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110751428|NCT01642186|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110751429|NCT01642186|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110751430|NCT01642186|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110751431|NCT01642186|Hormone Antagonists|hormone antagonists|mesh-ancestor
110751432|NCT01642186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110751433|NCT01642186|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110751434|NCT01642186|Fertility Agents|fertility agents|mesh-ancestor
110751435|NCT01642186|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110751436|NCT01642186|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110751437|NCT00423514|Mycophenolic Acid|mycophenolic acid|mesh-list
110751438|NCT00423514|Melphalan|melphalan|mesh-list
110751439|NCT00423514|Thiotepa|thiotepa|mesh-list
110751440|NCT00423514|Clofarabine|clofarabine|mesh-list
110751441|NCT00423514|Tacrolimus|tacrolimus|mesh-list
110751442|NCT00423514|Immunologic Factors|immunologic factors|mesh-ancestor
110751443|NCT00423514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110751444|NCT00423514|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110751445|NCT00423514|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110751446|NCT00423514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110751447|NCT00423514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110751448|NCT00423514|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110751449|NCT00423514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110751450|NCT00423514|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110751451|NCT00423514|Antitubercular Agents|antitubercular agents|mesh-ancestor
110751452|NCT00423514|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110751453|NCT00423514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110751454|NCT00423514|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110751455|NCT00423514|Alkylating Agents|alkylating agents|mesh-ancestor
110751456|NCT00423514|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110751457|NCT00423514|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110751458|NCT00423514|Antimetabolites|antimetabolites|mesh-ancestor
110751460|NCT00120952|Chromium|chromium|mesh-list
110751461|NCT00120952|Trace Elements|trace elements|mesh-ancestor
110751462|NCT00120952|Micronutrients|micronutrients|mesh-ancestor
110751463|NCT00120952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110751464|NCT00289991|Itraconazole|itraconazole|mesh-list
110751465|NCT00289991|Voriconazole|voriconazole|mesh-list
110751466|NCT00289991|Antifungal Agents|antifungal agents|mesh-ancestor
110751467|NCT00289991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110751468|NCT00289991|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110751469|NCT00289991|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110751470|NCT00289991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110751471|NCT00289991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110751472|NCT00289991|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110751473|NCT00289991|Hormone Antagonists|hormone antagonists|mesh-ancestor
110751474|NCT00289991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110751475|NCT00289991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110751476|NCT00289991|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110751477|NCT00270413|Sunitinib|sunitinib|mesh-list
110751478|NCT00270413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110751479|NCT00270413|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110751480|NCT00270413|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110751481|NCT00270413|Growth Substances|growth substances|mesh-ancestor
110751482|NCT00270413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110751483|NCT00270413|Growth Inhibitors|growth inhibitors|mesh-ancestor
110751484|NCT00270413|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110751485|NCT00270413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110751486|NCT00270413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110751487|NCT00270257|Buprenorphine|buprenorphine|mesh-list
110751488|NCT00270257|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
110751489|NCT00270257|Naloxone|naloxone|mesh-list
110751490|NCT00270257|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110751491|NCT00270257|Narcotics|narcotics|mesh-ancestor
110751492|NCT00270257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110751493|NCT00270257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110751494|NCT00270257|Analgesics|analgesics|mesh-ancestor
110751495|NCT00270257|Sensory System Agents|sensory system agents|mesh-ancestor
110751496|NCT00270257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110751497|NCT00270257|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110751498|NCT00269399|Vancomycin|vancomycin|mesh-list
110751499|NCT00269399|Rifaximin|rifaximin|mesh-list
110751500|NCT00269399|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110751501|NCT00269399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110751502|NCT00269399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110751503|NCT00269087|Fluticasone|fluticasone|mesh-list
110751504|NCT00269087|Xhance|xhance|mesh-list
110751505|NCT00269087|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110751506|NCT00269087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110751507|NCT00269087|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110751508|NCT00269087|Autonomic Agents|autonomic agents|mesh-ancestor
110751509|NCT00269087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110751510|NCT00269087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110751511|NCT00269087|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110751512|NCT00269087|Respiratory System Agents|respiratory system agents|mesh-ancestor
110751513|NCT00269087|Dermatologic Agents|dermatologic agents|mesh-ancestor
110751514|NCT00269087|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110751515|NCT00269087|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110751516|NCT00269087|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110751517|NCT00269087|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110751518|NCT00269087|Adrenergic Agents|adrenergic agents|mesh-ancestor
110751519|NCT00269087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110751520|NCT00269087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110751521|NCT00288587|Diuretics|diuretics|mesh-list
110751522|NCT00288587|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
110751523|NCT00288587|Natriuretic Agents|natriuretic agents|mesh-ancestor
110751524|NCT00288587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110751525|NCT00288587|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110751526|NCT00288587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110751527|NCT00268463|Capecitabine|capecitabine|mesh-list
110751528|NCT00268463|Floxuridine|floxuridine|mesh-list
110751529|NCT00268463|Oxaliplatin|oxaliplatin|mesh-list
110751530|NCT00268463|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110751531|NCT00268463|Antimetabolites|antimetabolites|mesh-ancestor
110751532|NCT00268463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110751533|NCT00268463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110751534|NCT00288509|Botulinum Toxins|botulinum toxins|mesh-list
110751535|NCT00288509|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110751536|NCT00288509|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110751537|NCT00288509|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110751538|NCT00288509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110751539|NCT00288509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110751540|NCT00288509|Cholinergic Agents|cholinergic agents|mesh-ancestor
110751541|NCT00288509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110751542|NCT00288509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110751543|NCT00288509|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110751544|NCT00288509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110751545|NCT01071005|Leuprolide|leuprolide|mesh-list
110751546|NCT01071005|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110751547|NCT01071005|Fertility Agents|fertility agents|mesh-ancestor
110751548|NCT01071005|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110751549|NCT01071005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110751550|NCT01071005|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110751551|NCT01071005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110751552|NCT03976037|Misoprostol|misoprostol|mesh-list
110751553|NCT03976037|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110751554|NCT03976037|Abortifacient Agents|abortifacient agents|mesh-ancestor
110751555|NCT03976037|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110751556|NCT03976037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110751557|NCT03976037|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110751558|NCT03976037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110751559|NCT03976037|Oxytocics|oxytocics|mesh-ancestor
110751560|NCT00265889|Cyclophosphamide|cyclophosphamide|mesh-list
110751561|NCT00265889|Melphalan|melphalan|mesh-list
110469272|NCT02612272|Hormones|hormones|mesh-ancestor
110751562|NCT00265889|Busulfan|busulfan|mesh-list
110751563|NCT00265889|Etoposide|etoposide|mesh-list
110310402|NCT00419250|Lenalidomide|lenalidomide|mesh-list
110751564|NCT00265889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110751565|NCT00265889|Immunologic Factors|immunologic factors|mesh-ancestor
110751566|NCT00265889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110751567|NCT00265889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110751568|NCT00265889|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110751569|NCT00265889|Alkylating Agents|alkylating agents|mesh-ancestor
110751570|NCT00265889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110751571|NCT00265889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110751572|NCT00265889|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110751573|NCT00265889|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110751574|NCT00265889|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110751575|NCT00265889|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110751576|NCT00265889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110751577|NCT01333696|Pemetrexed|pemetrexed|mesh-list
110867773|NCT03184480|Autonomic Agents|autonomic agents|mesh-ancestor
110751578|NCT01333696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110751580|NCT01333696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110751581|NCT01333696|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110751582|NCT01333696|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110751584|NCT01333774|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
110751585|NCT01333774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110751586|NCT01333774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110751587|NCT01333774|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110751588|NCT01333774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110751589|NCT01333852|Metformin|metformin|mesh-list
110751590|NCT01333852|Paclitaxel|paclitaxel|mesh-list
110751591|NCT01333852|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110751592|NCT01333852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110751593|NCT01333852|Tubulin Modulators|tubulin modulators|mesh-ancestor
110751594|NCT01333852|Antimitotic Agents|antimitotic agents|mesh-ancestor
110751595|NCT01333852|Mitosis Modulators|mitosis modulators|mesh-ancestor
110751596|NCT01333852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110751597|NCT01333852|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110751598|NCT01333852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110751599|NCT03365362|Varenicline|varenicline|mesh-list
110751600|NCT03365362|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110751601|NCT03365362|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110751602|NCT03365362|Cholinergic Agents|cholinergic agents|mesh-ancestor
110751603|NCT03365362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110751604|NCT03365362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110751605|NCT03365362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110751606|NCT03206788|Losartan|losartan|mesh-list
110751607|NCT03206788|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110751608|NCT03206788|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110751609|NCT03206788|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110751610|NCT03206788|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110751611|NCT03206788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110751612|NCT03205150|Licogliflozin|licogliflozin|mesh-list
110751613|NCT03205150|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110751614|NCT03205150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110751615|NCT03205150|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110751616|NCT03205150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110751617|NCT04936984|Abaloparatide|abaloparatide|mesh-list
110751618|NCT04936984|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
110310420|NCT00284258|Irinotecan|irinotecan|mesh-list
110751619|NCT04936984|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110751620|NCT04936984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110751621|NCT04936984|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110751622|NCT02931838|Deucravacitinib|deucravacitinib|mesh-list
110751623|NCT02931838|Dermatologic Agents|dermatologic agents|mesh-ancestor
110751624|NCT02931838|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110751625|NCT02931838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110751626|NCT02931838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110751627|NCT03201562|Tropicamide|tropicamide|mesh-list
110751628|NCT03201562|Aceclidine|aceclidine|mesh-list
110751629|NCT03201562|Mydriatics|mydriatics|mesh-ancestor
110751630|NCT03201562|Autonomic Agents|autonomic agents|mesh-ancestor
110751631|NCT03201562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110751632|NCT03201562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110751633|NCT03201562|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110751634|NCT03201562|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110751635|NCT03201562|Cholinergic Agents|cholinergic agents|mesh-ancestor
110469337|NCT04099771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110751636|NCT03201562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110751637|NCT03201562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110751638|NCT03201562|Miotics|miotics|mesh-ancestor
110751639|NCT03201562|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110751640|NCT03200860|Empagliflozin|empagliflozin|mesh-list
110751641|NCT03200860|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110751642|NCT03200860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110751643|NCT03200860|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110751644|NCT03200860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110751645|NCT01314508|Mecasermin|mecasermin|mesh-list
110751646|NCT01314508|Growth Substances|growth substances|mesh-ancestor
110751647|NCT01314508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110751648|NCT01314586|Secoisolariciresinol|secoisolariciresinol|mesh-list
110751649|NCT01314586|Phytoestrogens|phytoestrogens|mesh-ancestor
110751650|NCT01314586|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
110751651|NCT01314586|Estrogens|estrogens|mesh-ancestor
110751652|NCT01314586|Hormones|hormones|mesh-ancestor
110751653|NCT01314586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110751654|NCT01314586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110751655|NCT03187756|Cyclophosphamide|cyclophosphamide|mesh-list
110751656|NCT03187756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110751657|NCT03187756|Immunologic Factors|immunologic factors|mesh-ancestor
110751658|NCT03187756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110751659|NCT03187756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110751660|NCT03187756|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110751661|NCT03187756|Alkylating Agents|alkylating agents|mesh-ancestor
110751662|NCT03187756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110751663|NCT03187756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110751664|NCT03187756|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110751665|NCT03184558|Pembrolizumab|pembrolizumab|mesh-list
110751666|NCT03184558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110751667|NCT03184558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110751668|NCT03184558|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110751669|NCT03184558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110751670|NCT03180736|Dexamethasone|dexamethasone|mesh-list
110751671|NCT03180736|Daratumumab|daratumumab|mesh-list
110751672|NCT03180736|Pomalidomide|pomalidomide|mesh-list
110751673|NCT03180736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110751674|NCT03180736|Antiemetics|antiemetics|mesh-ancestor
110751675|NCT03180736|Autonomic Agents|autonomic agents|mesh-ancestor
110751676|NCT03180736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110751677|NCT03180736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110751678|NCT03180736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110751679|NCT03180736|Glucocorticoids|glucocorticoids|mesh-ancestor
110751680|NCT03180736|Hormones|hormones|mesh-ancestor
110751681|NCT03180736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110751682|NCT03180736|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110751683|NCT03180736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110751684|NCT03180736|Immunologic Factors|immunologic factors|mesh-ancestor
110751685|NCT03180736|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110751686|NCT03180736|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110751687|NCT03180736|Growth Substances|growth substances|mesh-ancestor
110751688|NCT03180736|Growth Inhibitors|growth inhibitors|mesh-ancestor
110751689|NCT03178942|Permethrin|permethrin|mesh-list
110751690|NCT03178942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110751691|NCT03178942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110751692|NCT03093922|Gemcitabine|gemcitabine|mesh-list
110751693|NCT03093922|Atezolizumab|atezolizumab|mesh-list
110751694|NCT03093922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110751695|NCT03093922|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110751696|NCT03093922|Antimetabolites|antimetabolites|mesh-ancestor
110751697|NCT03093922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110751698|NCT03093922|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110751699|NCT03093922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110751700|NCT03175198|Dabigatran|dabigatran|mesh-list
110751701|NCT03175198|Antithrombins|antithrombins|mesh-ancestor
110751702|NCT03175198|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110751703|NCT03175198|Protease Inhibitors|protease inhibitors|mesh-ancestor
110751704|NCT03175198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110751705|NCT03175198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110751706|NCT03175198|Anticoagulants|anticoagulants|mesh-ancestor
110751707|NCT03087448|Trametinib|trametinib|mesh-list
110751708|NCT03087448|Ceritinib|ceritinib|mesh-list
110751709|NCT03087448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110751710|NCT03087448|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110751711|NCT03087448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110751712|NCT03087448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110751714|NCT03175120|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110751716|NCT03175120|Insulin, Long-Acting|insulin, long-acting|mesh-list
110751717|NCT03175120|Xultophy|xultophy|mesh-list
110751718|NCT03175120|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110751719|NCT03175120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110751720|NCT03175120|Incretins|incretins|mesh-ancestor
110751721|NCT03175120|Hormones|hormones|mesh-ancestor
110751722|NCT03175120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110751723|NCT02795182|Tislelizumab|tislelizumab|mesh-list
110751724|NCT02795182|Zanubrutinib|zanubrutinib|mesh-list
110751725|NCT02795182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110751726|NCT02795182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110751727|NCT02795182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110751728|NCT02795182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110751729|NCT02795182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110751730|NCT03054766|Ranibizumab|ranibizumab|mesh-list
110751731|NCT03054766|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110751732|NCT03054766|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110751733|NCT03054766|Growth Substances|growth substances|mesh-ancestor
110751734|NCT03054766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110751735|NCT03054766|Growth Inhibitors|growth inhibitors|mesh-ancestor
110751736|NCT03054766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110751737|NCT05118724|Atezolizumab|atezolizumab|mesh-list
110751738|NCT05118724|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110751739|NCT05118724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110751740|NCT05118724|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110751741|NCT05118724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110751742|NCT03036748|Amiloride|amiloride|mesh-list
110751743|NCT03036748|Diuretics|diuretics|mesh-ancestor
110751744|NCT03036748|Natriuretic Agents|natriuretic agents|mesh-ancestor
110751745|NCT03036748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110751746|NCT03036748|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
110751747|NCT03036748|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110751748|NCT03036748|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110751749|NCT03036748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110751750|NCT03036748|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
110751751|NCT03036748|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110751752|NCT03167242|Lumefantrine|lumefantrine|mesh-list
110751753|NCT03167242|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
110751754|NCT03167242|Antimalarials|antimalarials|mesh-ancestor
110751755|NCT03167242|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110751756|NCT03167242|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110751757|NCT03167242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110751758|NCT03636178|Daminozide|daminozide|mesh-list
110751759|NCT03636178|Plant Growth Regulators|plant growth regulators|mesh-ancestor
110751760|NCT03636178|Growth Substances|growth substances|mesh-ancestor
110751761|NCT03636178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110751762|NCT01330654|Metoprolol|metoprolol|mesh-list
110751763|NCT01330654|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110751764|NCT01330654|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110751765|NCT01330654|Sympatholytics|sympatholytics|mesh-ancestor
110751766|NCT01330654|Autonomic Agents|autonomic agents|mesh-ancestor
110751767|NCT01330654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110751768|NCT01330654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110751769|NCT01330654|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110751770|NCT01330654|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110310488|NCT00284687|Artesunate|artesunate|mesh-list
110751771|NCT01330654|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110751772|NCT01330654|Adrenergic Agents|adrenergic agents|mesh-ancestor
110751773|NCT01330654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110751774|NCT01330654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110751775|NCT01330810|Curcumin|curcumin|mesh-list
110751776|NCT01330810|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110751777|NCT01330810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110751778|NCT01330810|Analgesics|analgesics|mesh-ancestor
110751779|NCT01330810|Sensory System Agents|sensory system agents|mesh-ancestor
110751780|NCT01330810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110751781|NCT01330810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110751782|NCT01330810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110751783|NCT01330810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110469492|NCT02822937|Dopamine Agents|dopamine agents|mesh-ancestor
110751784|NCT01330810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110751785|NCT01330810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110751786|NCT01330810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110751788|NCT01331122|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110751789|NCT01331122|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110751791|NCT01320280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110751792|NCT01320280|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110751793|NCT01320280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110751794|NCT01320280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110751795|NCT01331434|Exemestane|exemestane|mesh-list
110751796|NCT01331434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110751797|NCT01331434|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110751798|NCT01331434|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110751800|NCT01331434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110751801|NCT01331434|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110751802|NCT01331434|Hormone Antagonists|hormone antagonists|mesh-ancestor
110751803|NCT01331434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110751804|NCT01331434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110751805|NCT01331590|Dexamethasone|dexamethasone|mesh-list
110751806|NCT01331590|Etoposide|etoposide|mesh-list
110751807|NCT01331590|Ifosfamide|ifosfamide|mesh-list
110751808|NCT01331590|Lenograstim|lenograstim|mesh-list
110751809|NCT01331590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110751810|NCT01331590|Antiemetics|antiemetics|mesh-ancestor
110751811|NCT01331590|Autonomic Agents|autonomic agents|mesh-ancestor
110751812|NCT01331590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110751813|NCT01331590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110751814|NCT01331590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110751815|NCT01331590|Glucocorticoids|glucocorticoids|mesh-ancestor
110751816|NCT01331590|Hormones|hormones|mesh-ancestor
110751817|NCT01331590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110751818|NCT01331590|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110751819|NCT01331590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110751820|NCT01331590|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110751821|NCT01331590|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110751822|NCT01331590|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110310514|NCT00318981|Dopamine Agents|dopamine agents|mesh-ancestor
110751823|NCT01331590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110751824|NCT01331590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110751825|NCT01331590|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110751826|NCT01331590|Immunologic Factors|immunologic factors|mesh-ancestor
110751827|NCT01331590|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110751828|NCT01331590|Alkylating Agents|alkylating agents|mesh-ancestor
110751829|NCT01331902|Nicorandil|nicorandil|mesh-list
110751830|NCT01331902|Adenosine|adenosine|mesh-list
110751831|NCT01331902|Analgesics|analgesics|mesh-ancestor
110751832|NCT01331902|Sensory System Agents|sensory system agents|mesh-ancestor
110751833|NCT01331902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110751834|NCT01331902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110751835|NCT01331902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110751836|NCT01331902|Vasodilator Agents|vasodilator agents|mesh-ancestor
110751837|NCT01331902|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
110751838|NCT01331902|Purinergic Agonists|purinergic agonists|mesh-ancestor
110751839|NCT01331902|Purinergic Agents|purinergic agents|mesh-ancestor
110751840|NCT01331902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110751841|NCT01331902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110751842|NCT01331902|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110751843|NCT01331902|Vitamin B Complex|vitamin b complex|mesh-ancestor
110751844|NCT01331902|Vitamins|vitamins|mesh-ancestor
110751845|NCT01331902|Micronutrients|micronutrients|mesh-ancestor
110751846|NCT01332370|Metformin|metformin|mesh-list
110867794|NCT02420392|Dapagliflozin|dapagliflozin|mesh-list
110751848|NCT01332370|Rosiglitazone|rosiglitazone|mesh-list
110751849|NCT01332370|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110751850|NCT01332370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110751851|NCT01332370|Incretins|incretins|mesh-ancestor
110751852|NCT01332370|Hormones|hormones|mesh-ancestor
110751853|NCT01332370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110751854|NCT01332370|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110751855|NCT01332370|Protease Inhibitors|protease inhibitors|mesh-ancestor
110751856|NCT01332370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110751857|NCT01332370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110751858|NCT01332448|Orlistat|orlistat|mesh-list
110751859|NCT01332448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110751860|NCT01332448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110751861|NCT01332448|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110751862|NCT01332448|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110751863|NCT04484428|Menthol|menthol|mesh-list
110751864|NCT04484428|Antipruritics|antipruritics|mesh-ancestor
110751865|NCT04484428|Dermatologic Agents|dermatologic agents|mesh-ancestor
110751866|NCT01332604|Bevacizumab|bevacizumab|mesh-list
110751867|NCT01332604|Capecitabine|capecitabine|mesh-list
110751868|NCT01332604|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110751869|NCT01332604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110751870|NCT01332604|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110751871|NCT01332604|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110751872|NCT01332604|Growth Substances|growth substances|mesh-ancestor
110751873|NCT01332604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110751874|NCT01332604|Growth Inhibitors|growth inhibitors|mesh-ancestor
110751875|NCT01332604|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110751876|NCT01332604|Antimetabolites|antimetabolites|mesh-ancestor
110751877|NCT01332604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110751878|NCT03445858|Pembrolizumab|pembrolizumab|mesh-list
110751879|NCT03445858|Decitabine|decitabine|mesh-list
110751880|NCT03445858|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110751881|NCT03445858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110751882|NCT03445858|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110751883|NCT03445858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110751884|NCT03445858|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110751885|NCT03445858|Antimetabolites|antimetabolites|mesh-ancestor
110751886|NCT03445858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110751887|NCT01333150|Propranolol|propranolol|mesh-list
110751888|NCT01333150|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110751889|NCT01333150|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110751890|NCT01333150|Adrenergic Agents|adrenergic agents|mesh-ancestor
110751891|NCT01333150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110751892|NCT01333150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110751893|NCT01333150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110751894|NCT01333150|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110751895|NCT01333150|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110751896|NCT01333150|Vasodilator Agents|vasodilator agents|mesh-ancestor
110751897|NCT02913664|Losartan|losartan|mesh-list
110751898|NCT02913664|Amlodipine|amlodipine|mesh-list
110751899|NCT02913664|Calcium Channel Blockers|calcium channel blockers|mesh-list
110751900|NCT02913664|Angiotensin II|angiotensin ii|mesh-list
110751901|NCT02913664|Giapreza|giapreza|mesh-list
110751902|NCT02913664|Calcium|calcium|mesh-list
110751903|NCT02913664|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
110751904|NCT02913664|Angiotensinogen|angiotensinogen|mesh-list
110751905|NCT02913664|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110751906|NCT02913664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110751907|NCT02913664|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110751908|NCT02913664|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110751909|NCT02913664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110751910|NCT02913664|Vasodilator Agents|vasodilator agents|mesh-ancestor
110751911|NCT02913664|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110751912|NCT02913664|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110751913|NCT02913664|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110751914|NCT02913664|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110751915|NCT02913664|Protease Inhibitors|protease inhibitors|mesh-ancestor
110751916|NCT02913664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110751917|NCT02818582|Remdesivir|remdesivir|mesh-list
110751918|NCT02818582|Antimetabolites|antimetabolites|mesh-ancestor
110751919|NCT02818582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110751920|NCT02818582|Antiviral Agents|antiviral agents|mesh-ancestor
110751921|NCT02818582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110751922|NCT01337440|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110751923|NCT01337440|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
110751924|NCT01337440|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110751925|NCT01337440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110751926|NCT01337440|Incretins|incretins|mesh-ancestor
110751927|NCT01337440|Hormones|hormones|mesh-ancestor
110751928|NCT01337440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110751929|NCT01337440|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110751930|NCT01337440|Protease Inhibitors|protease inhibitors|mesh-ancestor
110751931|NCT01337440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110751932|NCT01337440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110469654|NCT02820051|Lidocaine|lidocaine|mesh-list
110751933|NCT01337440|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
110751934|NCT01337440|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110751935|NCT01337518|Androgens|androgens|mesh-list
110751936|NCT01337518|Hormones|hormones|mesh-ancestor
110445264|NCT04940572|Valproic Acid|valproic acid|mesh-list
110751937|NCT01337518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110751938|NCT01337518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110751939|NCT05186194|Vitamin D|vitamin d|mesh-list
110751940|NCT05186194|Calcium|calcium|mesh-list
110751941|NCT05186194|Vitamins|vitamins|mesh-ancestor
110751942|NCT05186194|Micronutrients|micronutrients|mesh-ancestor
110751943|NCT05186194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110751944|NCT05186194|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110751945|NCT05186194|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110751946|NCT01338454|Tranexamic Acid|tranexamic acid|mesh-list
110751947|NCT01338454|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110751948|NCT01338454|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110751949|NCT01338454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110751950|NCT01338454|Hemostatics|hemostatics|mesh-ancestor
110751951|NCT01338454|Coagulants|coagulants|mesh-ancestor
110751952|NCT02882152|Morphine|morphine|mesh-list
110751953|NCT02882152|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110751954|NCT02882152|Narcotics|narcotics|mesh-ancestor
110751955|NCT02882152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110751956|NCT02882152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110751957|NCT02882152|Analgesics|analgesics|mesh-ancestor
110751958|NCT02882152|Sensory System Agents|sensory system agents|mesh-ancestor
110751959|NCT02882152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110751960|NCT05185804|Enoxaparin|enoxaparin|mesh-list
110751961|NCT05185804|Enoxaparin sodium|enoxaparin sodium|mesh-list
110751962|NCT05185804|Anticoagulants|anticoagulants|mesh-ancestor
110751963|NCT05185804|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110751964|NCT05185804|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110751965|NCT05185804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110751966|NCT01338844|Inositol|inositol|mesh-list
110751967|NCT01338844|Vitamin B Complex|vitamin b complex|mesh-ancestor
110751968|NCT01338844|Vitamins|vitamins|mesh-ancestor
110751969|NCT01338844|Micronutrients|micronutrients|mesh-ancestor
110751970|NCT01338844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110751971|NCT01338922|Insulin|insulin|mesh-list
110751972|NCT01338922|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110751973|NCT01338922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110751974|NCT01339312|Vaccines|vaccines|mesh-list
110751975|NCT01339312|Immunologic Factors|immunologic factors|mesh-ancestor
110751976|NCT01339312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110751977|NCT01339468|Tacrolimus|tacrolimus|mesh-list
110751978|NCT01339468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110751979|NCT01339468|Immunologic Factors|immunologic factors|mesh-ancestor
110751980|NCT01339468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110751981|NCT01339468|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110751982|NCT01339468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110751983|NCT01339468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110751984|NCT01339624|Ketorolac|ketorolac|mesh-list
110751985|NCT01339624|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
110751986|NCT01339624|Fentanyl|fentanyl|mesh-list
110751987|NCT01339624|Morphine|morphine|mesh-list
110751988|NCT01339624|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110751989|NCT01339624|Narcotics|narcotics|mesh-ancestor
110751990|NCT01339624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110751991|NCT01339624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110751992|NCT01339624|Analgesics|analgesics|mesh-ancestor
110751993|NCT01339624|Sensory System Agents|sensory system agents|mesh-ancestor
110310627|NCT00285428|Veltuzumab|veltuzumab|mesh-list
110751994|NCT01339624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110751995|NCT01339624|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110751996|NCT01339624|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110751997|NCT01339624|Anesthetics, General|anesthetics, general|mesh-ancestor
110751998|NCT01339624|Anesthetics|anesthetics|mesh-ancestor
110751999|NCT01339624|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110752000|NCT01339624|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110752001|NCT01339624|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110752002|NCT01339624|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110752003|NCT01339624|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110752004|NCT01339624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110752005|NCT01339624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110469711|NCT00765817|Exenatide|exenatide|mesh-list
110752007|NCT01340248|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110752008|NCT01340248|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110752009|NCT01340248|Adrenergic Agents|adrenergic agents|mesh-ancestor
110752010|NCT01340248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110752011|NCT01340248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110752012|NCT01340248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110752013|NCT01340248|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110752014|NCT01340248|Antioxidants|antioxidants|mesh-ancestor
110752015|NCT01340248|Protective Agents|protective agents|mesh-ancestor
110752016|NCT01340248|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110752017|NCT01340248|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110752018|NCT01340248|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110752019|NCT01340248|Vasodilator Agents|vasodilator agents|mesh-ancestor
110752020|NCT01340248|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110752021|NCT01340248|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110752022|NCT01340326|Valsartan|valsartan|mesh-list
110752023|NCT01340326|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110752024|NCT01340326|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110752025|NCT01340326|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110752026|NCT01340326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110752027|NCT00286091|Denosumab|denosumab|mesh-list
110752028|NCT00286091|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110752029|NCT00286091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110752030|NCT01340950|Tenofovir|tenofovir|mesh-list
110752031|NCT01340950|Lamivudine|lamivudine|mesh-list
110752032|NCT01340950|Zidovudine|zidovudine|mesh-list
110752033|NCT01340950|Efavirenz|efavirenz|mesh-list
110752034|NCT01340950|Nevirapine|nevirapine|mesh-list
110752035|NCT01340950|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
110752036|NCT01340950|Antiviral Agents|antiviral agents|mesh-ancestor
110752037|NCT01340950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110752038|NCT01340950|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110752039|NCT01340950|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110752040|NCT01340950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110752041|NCT01340950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110752042|NCT01340950|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110752043|NCT01340950|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110752044|NCT01340950|Antimetabolites|antimetabolites|mesh-ancestor
110752045|NCT01340950|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110752046|NCT01340950|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110752047|NCT01340950|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110752048|NCT01340950|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110752049|NCT01340950|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110752050|NCT01340950|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110752051|NCT01341106|Entecavir|entecavir|mesh-list
110752052|NCT01341106|Antiviral Agents|antiviral agents|mesh-ancestor
110752053|NCT01341106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110752054|NCT01341184|Rifampin|rifampin|mesh-list
110752055|NCT01341184|Rifabutin|rifabutin|mesh-list
110752056|NCT01341184|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110752057|NCT01341184|Antitubercular Agents|antitubercular agents|mesh-ancestor
110752058|NCT01341184|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110752059|NCT01341184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110752060|NCT01341184|Leprostatic Agents|leprostatic agents|mesh-ancestor
110752061|NCT01341184|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110752062|NCT01341184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110752063|NCT01341184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110752064|NCT01341184|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110752065|NCT01341184|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110752066|NCT01341184|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110752067|NCT01341184|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110752068|NCT01341184|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110752069|NCT01341184|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110752070|NCT00285857|Lovastatin|lovastatin|mesh-list
110752071|NCT00285857|L 647318|l 647318|mesh-list
110752072|NCT00285857|Dihydromevinolin|dihydromevinolin|mesh-list
110752073|NCT00285857|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110752074|NCT00285857|Antimetabolites|antimetabolites|mesh-ancestor
110752075|NCT00285857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110752076|NCT00285857|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110752077|NCT00285857|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110752078|NCT00285857|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110752079|NCT00285857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110752080|NCT01341262|Zoledronic Acid|zoledronic acid|mesh-list
110469805|NCT02817477|Ketamine|ketamine|mesh-list
110752081|NCT01341262|Thalidomide|thalidomide|mesh-list
110752082|NCT01341262|Dexamethasone|dexamethasone|mesh-list
110752084|NCT01341262|Melphalan|melphalan|mesh-list
110752085|NCT01341262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110752086|NCT01341262|Immunologic Factors|immunologic factors|mesh-ancestor
110752087|NCT01341262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110752088|NCT01341262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110752089|NCT01341262|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110752090|NCT01341262|Alkylating Agents|alkylating agents|mesh-ancestor
110752091|NCT01341262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110752092|NCT01341262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110752093|NCT01341262|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110752094|NCT01341262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110752095|NCT01341262|Antiemetics|antiemetics|mesh-ancestor
110752096|NCT01341262|Autonomic Agents|autonomic agents|mesh-ancestor
110752097|NCT01341262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110752098|NCT01341262|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110752099|NCT01341262|Glucocorticoids|glucocorticoids|mesh-ancestor
110752100|NCT01341262|Hormones|hormones|mesh-ancestor
110752101|NCT01341262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110752102|NCT01341262|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110752103|NCT01341262|Leprostatic Agents|leprostatic agents|mesh-ancestor
110752104|NCT01341262|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110752105|NCT01341262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110752106|NCT01341262|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110752107|NCT01341262|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110752108|NCT01341262|Growth Substances|growth substances|mesh-ancestor
110752109|NCT01341262|Growth Inhibitors|growth inhibitors|mesh-ancestor
110752110|NCT01341262|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110752111|NCT01341340|Everolimus|everolimus|mesh-list
110752112|NCT01341340|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110752113|NCT01341340|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110752114|NCT01341340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110752115|NCT01341340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110752116|NCT01341340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110752117|NCT01341340|Immunologic Factors|immunologic factors|mesh-ancestor
110752118|NCT01341340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110752119|NCT01341340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110752120|NCT01341496|Celecoxib|celecoxib|mesh-list
110752121|NCT01341496|Cyclophosphamide|cyclophosphamide|mesh-list
110752122|NCT01341496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110867821|NCT02424136|Antioxidants|antioxidants|mesh-ancestor
110752123|NCT01341496|Immunologic Factors|immunologic factors|mesh-ancestor
110752124|NCT01341496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110752125|NCT01341496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110752126|NCT01341496|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110752127|NCT01341496|Alkylating Agents|alkylating agents|mesh-ancestor
110752128|NCT01341496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110752129|NCT01341496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110752130|NCT01341496|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110752131|NCT01341496|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110752132|NCT01341496|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110752134|NCT01341496|Sensory System Agents|sensory system agents|mesh-ancestor
110752135|NCT01341496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110752136|NCT01341496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110752137|NCT01341496|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110752138|NCT01341496|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110752139|NCT01341496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110752140|NCT00284141|Aflibercept|aflibercept|mesh-list
110752141|NCT00284141|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110752142|NCT00284141|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110752143|NCT00284141|Growth Substances|growth substances|mesh-ancestor
110752144|NCT00284141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110752145|NCT00284141|Growth Inhibitors|growth inhibitors|mesh-ancestor
110752146|NCT00284141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110752148|NCT05182138|Trace Elements|trace elements|mesh-ancestor
110752149|NCT05182138|Micronutrients|micronutrients|mesh-ancestor
110752150|NCT05182138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110752151|NCT01315990|Cetuximab|cetuximab|mesh-list
110752152|NCT01315990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110752153|NCT01315990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110752154|NCT00265343|Olanzapine|olanzapine|mesh-list
110752155|NCT00265343|Asenapine|asenapine|mesh-list
110752156|NCT00265343|Antiemetics|antiemetics|mesh-ancestor
110752157|NCT00265343|Autonomic Agents|autonomic agents|mesh-ancestor
110469856|NCT02817321|Analgesics|analgesics|mesh-ancestor
110752158|NCT00265343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110752159|NCT00265343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110752161|NCT00265343|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110752162|NCT00265343|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110752163|NCT00265343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110752164|NCT00265343|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110752165|NCT00265343|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110752166|NCT00265343|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110752167|NCT00265343|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110752168|NCT00265343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110752169|NCT00265343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110752170|NCT00265343|Serotonin Agents|serotonin agents|mesh-ancestor
110752171|NCT01341886|Metformin|metformin|mesh-list
110752172|NCT01341886|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110752173|NCT01341886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110752174|NCT00283595|Hormones|hormones|mesh-list
110752175|NCT00283595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110752176|NCT00283595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110752177|NCT00265109|Levetiracetam|levetiracetam|mesh-list
110752178|NCT00265109|Anticonvulsants|anticonvulsants|mesh-ancestor
110752179|NCT00265109|Nootropic Agents|nootropic agents|mesh-ancestor
110752180|NCT01342198|Erythromycin|erythromycin|mesh-list
110752181|NCT01342198|Erythromycin Estolate|erythromycin estolate|mesh-list
110752182|NCT01342198|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
110752183|NCT01342198|Erythromycin stearate|erythromycin stearate|mesh-list
110752184|NCT01342198|Pregabalin|pregabalin|mesh-list
110752185|NCT01342198|Analgesics|analgesics|mesh-ancestor
110752186|NCT01342198|Sensory System Agents|sensory system agents|mesh-ancestor
110752187|NCT01342198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110752188|NCT01342198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110752189|NCT01342198|Anticonvulsants|anticonvulsants|mesh-ancestor
110752190|NCT01342198|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110752191|NCT01342198|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110310829|NCT00286364|Hormone Antagonists|hormone antagonists|mesh-ancestor
110752192|NCT01342198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110752193|NCT01342198|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110752195|NCT01342198|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110752196|NCT01342198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110752197|NCT01342198|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110752198|NCT01342198|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110752199|NCT01342198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110752200|NCT01342198|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110752201|NCT01342198|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110752202|NCT01342198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110752203|NCT01342744|Metformin|metformin|mesh-list
110752204|NCT01342744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110752205|NCT01342744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110752206|NCT05150782|Ascorbic Acid|ascorbic acid|mesh-list
110752207|NCT05150782|Curcumin|curcumin|mesh-list
110752208|NCT05150782|Antioxidants|antioxidants|mesh-ancestor
110752209|NCT05150782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110752210|NCT05150782|Protective Agents|protective agents|mesh-ancestor
110752211|NCT05150782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110752212|NCT05150782|Vitamins|vitamins|mesh-ancestor
110752213|NCT05150782|Micronutrients|micronutrients|mesh-ancestor
110752214|NCT05150782|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110752215|NCT05150782|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110752216|NCT05150782|Analgesics|analgesics|mesh-ancestor
110752217|NCT05150782|Sensory System Agents|sensory system agents|mesh-ancestor
110752218|NCT05150782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110752219|NCT05150782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110752220|NCT05150782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110752221|NCT05150782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110752222|NCT05150782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110752223|NCT01316068|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
110752224|NCT01316068|Anticoagulants|anticoagulants|mesh-ancestor
110752225|NCT01316068|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110752226|NCT01316068|Antimetabolites|antimetabolites|mesh-ancestor
110752227|NCT01316068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110752228|NCT01316068|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110752229|NCT01316068|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110310842|NCT00286403|Dopamine Agents|dopamine agents|mesh-ancestor
110752230|NCT01316068|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110752232|NCT01316068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110752234|NCT03233308|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110752235|NCT00283049|Insulin|insulin|mesh-list
110752236|NCT00283049|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110752237|NCT00283049|Insulin Glargine|insulin glargine|mesh-list
110752238|NCT00283049|Insulin glulisine|insulin glulisine|mesh-list
110752239|NCT00283049|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110752240|NCT00283049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110752241|NCT00264875|Pregabalin|pregabalin|mesh-list
110752242|NCT00264875|Analgesics|analgesics|mesh-ancestor
110752243|NCT00264875|Sensory System Agents|sensory system agents|mesh-ancestor
110752244|NCT00264875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110752245|NCT00264875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110752246|NCT00264875|Anticonvulsants|anticonvulsants|mesh-ancestor
110752247|NCT00264875|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110752248|NCT00264875|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110752249|NCT00264875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110752250|NCT00264875|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110752251|NCT00264875|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110752252|NCT00264875|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110752253|NCT00264875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110752254|NCT00264875|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110752255|NCT03635398|Midazolam|midazolam|mesh-list
110752256|NCT03635398|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110752257|NCT03635398|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110752258|NCT03635398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110752259|NCT03635398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110752261|NCT03635398|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110752262|NCT03635398|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110752263|NCT03635398|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110752264|NCT03635398|Anesthetics, General|anesthetics, general|mesh-ancestor
110752265|NCT03635398|Anesthetics|anesthetics|mesh-ancestor
110752266|NCT03635398|GABA Modulators|gaba modulators|mesh-ancestor
110752267|NCT03635398|GABA Agents|gaba agents|mesh-ancestor
110752268|NCT03635398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110752269|NCT03635398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110752270|NCT03151408|Azacitidine|azacitidine|mesh-list
110752271|NCT03151408|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110752272|NCT03151408|Antimetabolites|antimetabolites|mesh-ancestor
110752273|NCT03151408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110752274|NCT03151408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110752275|NCT03151408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110752276|NCT05226442|Heparin|heparin|mesh-list
110752277|NCT05226442|Calcium heparin|calcium heparin|mesh-list
110752278|NCT05226442|Argatroban|argatroban|mesh-list
110752279|NCT05226442|Anticoagulants|anticoagulants|mesh-ancestor
110752280|NCT05226442|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110752281|NCT05226442|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110752282|NCT05226442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110752283|NCT05226442|Antithrombins|antithrombins|mesh-ancestor
110752284|NCT05226442|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110752285|NCT05226442|Protease Inhibitors|protease inhibitors|mesh-ancestor
110752286|NCT05226442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110752287|NCT05226442|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110752288|NCT01316458|Imatinib Mesylate|imatinib mesylate|mesh-list
110752289|NCT01316458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110752290|NCT01316458|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110752291|NCT01316458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110752292|NCT01316458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110752293|NCT05198128|Calcium|calcium|mesh-list
110752294|NCT05198128|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110752295|NCT05198128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110752296|NCT01316848|Tivozanib|tivozanib|mesh-list
110752297|NCT01316848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110752298|NCT01316848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110752299|NCT01316848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110752300|NCT02121184|Oxytocin|oxytocin|mesh-list
110752301|NCT02121184|Oxytocics|oxytocics|mesh-ancestor
110752302|NCT02121184|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110752303|NCT02121184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110752304|NCT01485874|Doxorubicin|doxorubicin|mesh-list
110752305|NCT01485874|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110752306|NCT01485874|Nintedanib|nintedanib|mesh-list
110470009|NCT00909480|Insulin|insulin|mesh-list
110752307|NCT01485874|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110752308|NCT01485874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110752309|NCT01485874|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110752310|NCT01485874|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110752311|NCT01485874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110752312|NCT01485874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110752313|NCT01485874|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110752315|NCT05000710|Tremelimumab|tremelimumab|mesh-list
110752316|NCT05000710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110752317|NCT05000710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110752318|NCT04786756|Bupivacaine|bupivacaine|mesh-list
110752319|NCT04786756|Anesthetics, Local|anesthetics, local|mesh-ancestor
110752320|NCT04786756|Anesthetics|anesthetics|mesh-ancestor
110752321|NCT04786756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110752322|NCT04786756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110752323|NCT04786756|Sensory System Agents|sensory system agents|mesh-ancestor
110752324|NCT04786756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110752326|NCT00546754|Valsartan|valsartan|mesh-list
110752327|NCT00546754|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110752328|NCT00546754|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110752329|NCT00546754|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110752330|NCT00546754|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110752331|NCT00546754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110752332|NCT00546754|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110752333|NCT00546754|Diuretics|diuretics|mesh-ancestor
110752334|NCT00546754|Natriuretic Agents|natriuretic agents|mesh-ancestor
110752335|NCT00546754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110752336|NCT00546754|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110752337|NCT00546754|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110752338|NCT04768426|Capecitabine|capecitabine|mesh-list
110752339|NCT04768426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110752340|NCT04768426|Antimetabolites|antimetabolites|mesh-ancestor
110752341|NCT04768426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110752342|NCT04768426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110752343|NCT04473508|Ropivacaine|ropivacaine|mesh-list
110752344|NCT04473508|Anesthetics, Local|anesthetics, local|mesh-ancestor
110752345|NCT04473508|Anesthetics|anesthetics|mesh-ancestor
110752346|NCT04473508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110752347|NCT04473508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110752348|NCT04473508|Sensory System Agents|sensory system agents|mesh-ancestor
110752349|NCT04473508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110752350|NCT04471402|Dexmedetomidine|dexmedetomidine|mesh-list
110752351|NCT04471402|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110752352|NCT04471402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110752353|NCT04471402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110752354|NCT04471402|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110752355|NCT04471402|Analgesics|analgesics|mesh-ancestor
110752356|NCT04471402|Sensory System Agents|sensory system agents|mesh-ancestor
110752357|NCT04471402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110752358|NCT04471402|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110752359|NCT04471402|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110752360|NCT04471402|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110752361|NCT04471402|Adrenergic Agents|adrenergic agents|mesh-ancestor
110752362|NCT04471402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110752363|NCT04471402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110752364|NCT00282347|Acetaminophen|acetaminophen|mesh-list
110752365|NCT00282347|Diphenhydramine|diphenhydramine|mesh-list
110752366|NCT00282347|Promethazine|promethazine|mesh-list
110752367|NCT00282347|Mycophenolic Acid|mycophenolic acid|mesh-list
110752368|NCT00282347|Prednisone|prednisone|mesh-list
110752369|NCT00282347|Methylprednisolone|methylprednisolone|mesh-list
110752370|NCT00282347|Rituximab|rituximab|mesh-list
110752371|NCT00282347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110752372|NCT00282347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110752373|NCT00282347|Immunologic Factors|immunologic factors|mesh-ancestor
110752374|NCT00282347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110752375|NCT00282347|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110752376|NCT00282347|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110752377|NCT00282347|Glucocorticoids|glucocorticoids|mesh-ancestor
110752378|NCT00282347|Hormones|hormones|mesh-ancestor
110752379|NCT00282347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110752380|NCT00282347|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110077468|NCT01610401|Metformin|metformin|mesh-list
110752382|NCT00282347|Analgesics|analgesics|mesh-ancestor
110752383|NCT00282347|Sensory System Agents|sensory system agents|mesh-ancestor
110752384|NCT00282347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110752385|NCT00282347|Antipyretics|antipyretics|mesh-ancestor
110752386|NCT00282347|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110867866|NCT02427880|Anticonvulsants|anticonvulsants|mesh-ancestor
110752387|NCT00282347|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110752388|NCT00282347|Antitubercular Agents|antitubercular agents|mesh-ancestor
110752389|NCT00282347|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110752390|NCT00282347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110752391|NCT00282347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110752392|NCT00282347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110752393|NCT00282347|Antiemetics|antiemetics|mesh-ancestor
110752394|NCT00282347|Autonomic Agents|autonomic agents|mesh-ancestor
110752395|NCT00282347|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110752396|NCT00282347|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110752397|NCT00282347|Protective Agents|protective agents|mesh-ancestor
110752398|NCT00282347|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110752399|NCT00282347|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110752400|NCT00282347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110752401|NCT00282347|Anesthetics, Local|anesthetics, local|mesh-ancestor
110752402|NCT00282347|Anesthetics|anesthetics|mesh-ancestor
110752403|NCT00282347|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110752404|NCT00282347|Histamine Antagonists|histamine antagonists|mesh-ancestor
110752405|NCT00282347|Histamine Agents|histamine agents|mesh-ancestor
110752406|NCT00282347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110752407|NCT00282347|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110752408|NCT00282347|Antipruritics|antipruritics|mesh-ancestor
110752409|NCT00282347|Dermatologic Agents|dermatologic agents|mesh-ancestor
110752410|NCT01334632|Morphine|morphine|mesh-list
110752411|NCT01334632|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110752412|NCT01334632|Narcotics|narcotics|mesh-ancestor
110752413|NCT01334632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110752414|NCT01334632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110752415|NCT01334632|Analgesics|analgesics|mesh-ancestor
110752416|NCT01334632|Sensory System Agents|sensory system agents|mesh-ancestor
110752417|NCT01334632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110752418|NCT00405964|Desloratadine|desloratadine|mesh-list
110752419|NCT00405964|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110752420|NCT00405964|Cholinergic Agents|cholinergic agents|mesh-ancestor
110752421|NCT00405964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110752422|NCT00405964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110752423|NCT00405964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110752424|NCT00405964|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110752425|NCT00405964|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110752426|NCT00405964|Histamine Antagonists|histamine antagonists|mesh-ancestor
110752427|NCT00405964|Histamine Agents|histamine agents|mesh-ancestor
110752428|NCT00264797|Methylphenidate|methylphenidate|mesh-list
110752429|NCT00264797|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110752430|NCT00264797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110752431|NCT00264797|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110752432|NCT00264797|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110752433|NCT00264797|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110752434|NCT00264797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110752435|NCT00264797|Dopamine Agents|dopamine agents|mesh-ancestor
110752436|NCT00264797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110752437|NCT03148756|Dalbavancin|dalbavancin|mesh-list
110752438|NCT03148756|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110752439|NCT03148756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110752440|NCT01343680|Heparin|heparin|mesh-list
110752441|NCT01343680|Anticoagulants|anticoagulants|mesh-ancestor
110752442|NCT01343680|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110752443|NCT01343680|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110752444|NCT01343680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110752445|NCT00281957|Sirolimus|sirolimus|mesh-list
110752446|NCT00281957|Sorafenib|sorafenib|mesh-list
110752447|NCT00281957|Temsirolimus|temsirolimus|mesh-list
110752448|NCT00281957|Tipifarnib|tipifarnib|mesh-list
110752449|NCT00281957|MTOR Inhibitors|mtor inhibitors|mesh-list
110752450|NCT00281957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110752451|NCT00281957|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110752452|NCT00281957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110752453|NCT00281957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110867868|NCT02427880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110752455|NCT00281957|Immunologic Factors|immunologic factors|mesh-ancestor
110752456|NCT00281957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110752457|NCT00281957|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110752458|NCT00281957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110752459|NCT00281957|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110752460|NCT00281957|Antifungal Agents|antifungal agents|mesh-ancestor
110752461|NCT01071161|Azithromycin|azithromycin|mesh-list
110752462|NCT01071161|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110752463|NCT01071161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110752464|NCT01070225|Hydrocortisone|hydrocortisone|mesh-list
110752465|NCT01070225|Propranolol|propranolol|mesh-list
110752466|NCT01070225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110752467|NCT01070225|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110752468|NCT01070225|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110752469|NCT01070225|Adrenergic Agents|adrenergic agents|mesh-ancestor
110752470|NCT01070225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110752471|NCT01070225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110752472|NCT01070225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110752473|NCT01070225|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110752474|NCT01070225|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110752475|NCT01070225|Vasodilator Agents|vasodilator agents|mesh-ancestor
110752476|NCT01070615|Prucalopride|prucalopride|mesh-list
110752477|NCT01070615|Laxatives|laxatives|mesh-ancestor
110752478|NCT01070615|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110752479|NCT01070615|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
110752480|NCT01070615|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110752481|NCT01070615|Serotonin Agents|serotonin agents|mesh-ancestor
110752482|NCT01070615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110752483|NCT01070615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110752484|NCT01070615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110752485|NCT00262925|Leucovorin|leucovorin|mesh-list
110752486|NCT00262925|Dexamethasone|dexamethasone|mesh-list
110752487|NCT00262925|Methotrexate|methotrexate|mesh-list
110752488|NCT00262925|Vincristine|vincristine|mesh-list
110752489|NCT00262925|Asparaginase|asparaginase|mesh-list
110752490|NCT00262925|Mercaptopurine|mercaptopurine|mesh-list
110752491|NCT00262925|Alemtuzumab|alemtuzumab|mesh-list
110752492|NCT00262925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110752493|NCT00262925|Antibodies|antibodies|mesh-list
110752494|NCT00262925|Immunoglobulins|immunoglobulins|mesh-list
110752495|NCT00262925|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110752496|NCT00262925|Levoleucovorin|levoleucovorin|mesh-list
110752497|NCT00262925|Immunologic Factors|immunologic factors|mesh-ancestor
110752498|NCT00262925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110752499|NCT00262925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110752500|NCT00262925|Antiemetics|antiemetics|mesh-ancestor
110752501|NCT00262925|Autonomic Agents|autonomic agents|mesh-ancestor
110752502|NCT00262925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110752503|NCT00262925|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110752504|NCT00262925|Glucocorticoids|glucocorticoids|mesh-ancestor
110752505|NCT00262925|Hormones|hormones|mesh-ancestor
110752506|NCT00262925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110752507|NCT00262925|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110752508|NCT00262925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110752509|NCT00262925|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110752510|NCT00262925|Abortifacient Agents|abortifacient agents|mesh-ancestor
110752511|NCT00262925|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110752512|NCT00262925|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110752513|NCT00262925|Antimetabolites|antimetabolites|mesh-ancestor
110752514|NCT00262925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110752515|NCT00262925|Dermatologic Agents|dermatologic agents|mesh-ancestor
110752516|NCT00262925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110752517|NCT00262925|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110752518|NCT00262925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110752519|NCT00262925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110752520|NCT00262925|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110752521|NCT00262925|Antidotes|antidotes|mesh-ancestor
110752522|NCT00262925|Protective Agents|protective agents|mesh-ancestor
110752523|NCT00262925|Vitamin B Complex|vitamin b complex|mesh-ancestor
110752524|NCT00262925|Vitamins|vitamins|mesh-ancestor
110752525|NCT00262925|Micronutrients|micronutrients|mesh-ancestor
110752526|NCT00262925|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110752527|NCT00262925|Tubulin Modulators|tubulin modulators|mesh-ancestor
110752528|NCT00262925|Antimitotic Agents|antimitotic agents|mesh-ancestor
110752529|NCT00262925|Mitosis Modulators|mitosis modulators|mesh-ancestor
110752530|NCT01581515|Everolimus|everolimus|mesh-list
110470226|NCT03893175|Acetaminophen|acetaminophen|mesh-list
110752531|NCT01581515|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110752532|NCT01581515|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110752533|NCT01581515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110752534|NCT01581515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110752535|NCT01581515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110752536|NCT01581515|Immunologic Factors|immunologic factors|mesh-ancestor
110752537|NCT01581515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110752538|NCT01581515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110752539|NCT03720470|Abrocitinib|abrocitinib|mesh-list
110752540|NCT03720470|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110752541|NCT03720470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110310937|NCT00313482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110752542|NCT03720470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110752543|NCT00262847|Paclitaxel|paclitaxel|mesh-list
110752544|NCT00262847|Bevacizumab|bevacizumab|mesh-list
110752545|NCT00262847|Carboplatin|carboplatin|mesh-list
110752546|NCT00262847|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110752547|NCT00262847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110752548|NCT00262847|Endothelial Growth Factors|endothelial growth factors|mesh-list
110752549|NCT00262847|Antibodies|antibodies|mesh-list
110752550|NCT00262847|Immunoglobulins|immunoglobulins|mesh-list
110752551|NCT00262847|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110752552|NCT00262847|Immunoglobulin G|immunoglobulin g|mesh-list
110752553|NCT00262847|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110752554|NCT00262847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110752555|NCT00262847|Tubulin Modulators|tubulin modulators|mesh-ancestor
110752556|NCT00262847|Antimitotic Agents|antimitotic agents|mesh-ancestor
110752557|NCT00262847|Mitosis Modulators|mitosis modulators|mesh-ancestor
110752558|NCT00262847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110752559|NCT00262847|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110752560|NCT00262847|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110752561|NCT00262847|Growth Substances|growth substances|mesh-ancestor
110752562|NCT00262847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110752563|NCT00262847|Growth Inhibitors|growth inhibitors|mesh-ancestor
110752564|NCT00262847|Immunologic Factors|immunologic factors|mesh-ancestor
110752565|NCT05329532|Pembrolizumab|pembrolizumab|mesh-list
110752566|NCT05329532|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110752567|NCT05329532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110752568|NCT05329532|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110752569|NCT05329532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110752570|NCT01303640|Everolimus|everolimus|mesh-list
110752571|NCT01303640|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110752572|NCT01303640|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110752573|NCT01303640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110752574|NCT01303640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110752575|NCT01303640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110752576|NCT01303640|Immunologic Factors|immunologic factors|mesh-ancestor
110752577|NCT01303640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110752578|NCT01303640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110752579|NCT03817268|Capecitabine|capecitabine|mesh-list
110752580|NCT03817268|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110752581|NCT03817268|Antimetabolites|antimetabolites|mesh-ancestor
110752582|NCT03817268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110752583|NCT03817268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110752584|NCT00280397|Lenvatinib|lenvatinib|mesh-list
110752585|NCT00280397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110752586|NCT00280397|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110752587|NCT00280397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110752588|NCT00280397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110752589|NCT03817112|Dexmedetomidine|dexmedetomidine|mesh-list
110752590|NCT03817112|Propofol|propofol|mesh-list
110752591|NCT03817112|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110752592|NCT03817112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110752593|NCT03817112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110752594|NCT03817112|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110752595|NCT03817112|Analgesics|analgesics|mesh-ancestor
110752596|NCT03817112|Sensory System Agents|sensory system agents|mesh-ancestor
110752597|NCT03817112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110752598|NCT03817112|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110310953|NCT00320307|Antiviral Agents|antiviral agents|mesh-ancestor
110752599|NCT03817112|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110752600|NCT03817112|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110752601|NCT03817112|Adrenergic Agents|adrenergic agents|mesh-ancestor
110752602|NCT03817112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110752603|NCT03817112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110752604|NCT03817112|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110752605|NCT03817112|Anesthetics, General|anesthetics, general|mesh-ancestor
110752606|NCT03817112|Anesthetics|anesthetics|mesh-ancestor
110470301|NCT00763321|Acetaminophen|acetaminophen|mesh-list
110752607|NCT00262301|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
110752608|NCT00262301|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
110752609|NCT00262301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110752610|NCT00262301|Immunologic Factors|immunologic factors|mesh-ancestor
110752611|NCT00262301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110752612|NCT03814148|Indapamide|indapamide|mesh-list
110752613|NCT03814148|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110752614|NCT03814148|Diuretics|diuretics|mesh-ancestor
110752615|NCT03814148|Natriuretic Agents|natriuretic agents|mesh-ancestor
110752616|NCT03814148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110752617|NCT03814148|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110752618|NCT03814148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110752619|NCT03814148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110752620|NCT00279305|Rituximab|rituximab|mesh-list
110752621|NCT00279305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110752622|NCT00279305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110752623|NCT00279305|Immunologic Factors|immunologic factors|mesh-ancestor
110752624|NCT00279305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110752625|NCT00279305|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110752626|NCT03800810|Hyaluronic Acid|hyaluronic acid|mesh-list
110752627|NCT03800810|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110752628|NCT03800810|Immunologic Factors|immunologic factors|mesh-ancestor
110752629|NCT03800810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110752630|NCT03800810|Viscosupplements|viscosupplements|mesh-ancestor
110752631|NCT03800810|Protective Agents|protective agents|mesh-ancestor
110752632|NCT03974867|Prednisone|prednisone|mesh-list
110752633|NCT03974867|Methylprednisolone|methylprednisolone|mesh-list
110752634|NCT03974867|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110752635|NCT03974867|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110752636|NCT03974867|Prednisolone|prednisolone|mesh-list
110752637|NCT03974867|Prednisolone acetate|prednisolone acetate|mesh-list
110752638|NCT03974867|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110752639|NCT03974867|Prednisolone phosphate|prednisolone phosphate|mesh-list
110752640|NCT03974867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110752641|NCT03974867|Glucocorticoids|glucocorticoids|mesh-ancestor
110752642|NCT03974867|Hormones|hormones|mesh-ancestor
110752643|NCT03974867|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110752644|NCT03974867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110752645|NCT03974867|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110752646|NCT03974867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110752647|NCT03974867|Antiemetics|antiemetics|mesh-ancestor
110752648|NCT03974867|Autonomic Agents|autonomic agents|mesh-ancestor
110752649|NCT03974867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110356218|NCT02465606|Hormones|hormones|mesh-ancestor
110752651|NCT03974867|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110752652|NCT03974867|Protective Agents|protective agents|mesh-ancestor
110752653|NCT03799406|Vitamin D|vitamin d|mesh-list
110752654|NCT03799406|Cholecalciferol|cholecalciferol|mesh-list
110752655|NCT03799406|Vitamins|vitamins|mesh-ancestor
110752656|NCT03799406|Micronutrients|micronutrients|mesh-ancestor
110310976|NCT00287066|Insulin|insulin|mesh-list
110752657|NCT03799406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110752658|NCT03799406|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110752659|NCT03799406|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110752660|NCT03799172|Echinocandins|echinocandins|mesh-list
110752661|NCT03799172|Antifungal Agents|antifungal agents|mesh-ancestor
110752662|NCT03799172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110752663|NCT03799094|Ascorbic Acid|ascorbic acid|mesh-list
110752664|NCT03799094|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
110752665|NCT03799094|Vitamins|vitamins|mesh-ancestor
110752666|NCT03799094|Micronutrients|micronutrients|mesh-ancestor
110752667|NCT03799094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110752668|NCT03799094|Antioxidants|antioxidants|mesh-ancestor
110752669|NCT03799094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110752670|NCT03799094|Protective Agents|protective agents|mesh-ancestor
110752671|NCT03799094|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110752672|NCT03799094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110752673|NCT00277355|Minocycline|minocycline|mesh-list
110752674|NCT00277355|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110752675|NCT00277355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110752676|NCT00262223|Sertraline|sertraline|mesh-list
110752677|NCT00262223|Antidepressive Agents|antidepressive agents|mesh-ancestor
110752678|NCT00262223|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110752679|NCT00262223|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110752680|NCT00262223|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110752681|NCT00262223|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110752682|NCT00262223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110752683|NCT00262223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110752684|NCT00262223|Serotonin Agents|serotonin agents|mesh-ancestor
110752685|NCT00262223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110752687|NCT05575700|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110752688|NCT05575700|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110752689|NCT05575700|Analgesics|analgesics|mesh-ancestor
110752690|NCT05575700|Sensory System Agents|sensory system agents|mesh-ancestor
110752691|NCT05575700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110752692|NCT05575700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110752693|NCT05575700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110752694|NCT05575700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110752695|NCT05575700|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110752696|NCT05575700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110752697|NCT05575700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110752698|NCT00276419|Diclofenac|diclofenac|mesh-list
110752699|NCT00276419|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110752700|NCT00276419|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110752701|NCT00276419|Analgesics|analgesics|mesh-ancestor
110752702|NCT00276419|Sensory System Agents|sensory system agents|mesh-ancestor
110752703|NCT00276419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110752704|NCT00276419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110752705|NCT00276419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110752706|NCT00276419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110752707|NCT00276419|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110752708|NCT00276419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110752709|NCT00276419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110752711|NCT03798392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110752712|NCT03798392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110752713|NCT03816020|Niacinamide|niacinamide|mesh-list
110752714|NCT03816020|Niacin|niacin|mesh-list
110752715|NCT03816020|Nicotinic Acids|nicotinic acids|mesh-list
110752716|NCT03816020|Vitamin B Complex|vitamin b complex|mesh-ancestor
110752717|NCT03816020|Vitamins|vitamins|mesh-ancestor
110752718|NCT03816020|Micronutrients|micronutrients|mesh-ancestor
110752719|NCT03816020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110752720|NCT03816020|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110752721|NCT03816020|Antimetabolites|antimetabolites|mesh-ancestor
110752722|NCT03816020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110752723|NCT03816020|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110752724|NCT03816020|Vasodilator Agents|vasodilator agents|mesh-ancestor
110752725|NCT03815864|Antibodies|antibodies|mesh-list
110752726|NCT03815864|Immunoglobulins|immunoglobulins|mesh-list
110752727|NCT03815864|Immunologic Factors|immunologic factors|mesh-ancestor
110752728|NCT03815864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110752729|NCT04151342|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
110752730|NCT04151342|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110752731|NCT04151342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110752732|NCT04151342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110752733|NCT03815942|Nivolumab|nivolumab|mesh-list
110752734|NCT03815942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110752735|NCT03815942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110752736|NCT03815942|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110752737|NCT03815942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110752738|NCT01303874|Etanercept|etanercept|mesh-list
110752739|NCT01303874|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110752740|NCT01303874|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110752741|NCT01303874|Analgesics|analgesics|mesh-ancestor
110752742|NCT01303874|Sensory System Agents|sensory system agents|mesh-ancestor
110752743|NCT01303874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110752744|NCT01303874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110752745|NCT01303874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110752746|NCT01303874|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110752747|NCT01303874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110752748|NCT01303874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110752749|NCT01303874|Immunologic Factors|immunologic factors|mesh-ancestor
110752750|NCT03813056|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110752751|NCT03813056|Lubricant Eye Drops|lubricant eye drops|mesh-list
110752752|NCT03813056|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110752754|NCT04070768|Gemtuzumab|gemtuzumab|mesh-list
110752755|NCT04070768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110752756|NCT04070768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110752757|NCT04070768|Immunotoxins|immunotoxins|mesh-ancestor
110752758|NCT04070768|Immunoconjugates|immunoconjugates|mesh-ancestor
110752759|NCT04070768|Immunologic Factors|immunologic factors|mesh-ancestor
110752760|NCT04070768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110752761|NCT01301612|Cisplatin|cisplatin|mesh-list
110752762|NCT01301612|Nimotuzumab|nimotuzumab|mesh-list
110752763|NCT01301612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110752764|NCT01301612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110752765|NCT01303952|Eculizumab|eculizumab|mesh-list
110752766|NCT01303952|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
110752767|NCT01303952|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110752768|NCT01303952|Immunologic Factors|immunologic factors|mesh-ancestor
110752769|NCT01303952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110752770|NCT03970616|Durvalumab|durvalumab|mesh-list
110752771|NCT03970616|Tivozanib|tivozanib|mesh-list
110752772|NCT03970616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110752773|NCT03970616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110752774|NCT03970616|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110752775|NCT03970616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110752776|NCT03970616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110752777|NCT03815474|Epirubicin|epirubicin|mesh-list
110752778|NCT03815474|Ifosfamide|ifosfamide|mesh-list
110752779|NCT03815474|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110752780|NCT03815474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110752781|NCT03815474|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110752782|NCT03815474|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110752783|NCT03815474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110752784|NCT03815474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110752785|NCT03815474|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110752786|NCT03815474|Alkylating Agents|alkylating agents|mesh-ancestor
110752787|NCT01302158|Glimepiride|glimepiride|mesh-list
110752788|NCT01302158|Ipragliflozin|ipragliflozin|mesh-list
110752789|NCT01302158|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110752790|NCT01302158|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110752791|NCT01302158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110752792|NCT01302158|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110752793|NCT01302158|Immunologic Factors|immunologic factors|mesh-ancestor
110752794|NCT01302158|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110752795|NCT01302158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110752796|NCT01302236|Eplerenone|eplerenone|mesh-list
110752797|NCT01302236|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110752798|NCT01302236|Hormone Antagonists|hormone antagonists|mesh-ancestor
110752799|NCT01302236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110752800|NCT01302236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110752801|NCT01302236|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110752802|NCT01302236|Diuretics|diuretics|mesh-ancestor
110752803|NCT01302236|Natriuretic Agents|natriuretic agents|mesh-ancestor
110752804|NCT01302236|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110752805|NCT01304264|Maleic acid|maleic acid|mesh-list
110752806|NCT01304264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110752807|NCT01304264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110752808|NCT01304342|Fentanyl|fentanyl|mesh-list
110752809|NCT01304342|Remifentanil|remifentanil|mesh-list
110752810|NCT01304342|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110752811|NCT01304342|Narcotics|narcotics|mesh-ancestor
110752812|NCT01304342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110752813|NCT01304342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110752814|NCT01304342|Analgesics|analgesics|mesh-ancestor
110752815|NCT01304342|Sensory System Agents|sensory system agents|mesh-ancestor
110752816|NCT01304342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110752817|NCT01304342|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110752818|NCT01304342|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110752819|NCT01304342|Anesthetics, General|anesthetics, general|mesh-ancestor
110752820|NCT01304342|Anesthetics|anesthetics|mesh-ancestor
110752821|NCT03653546|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110752822|NCT03653546|Gefitinib|gefitinib|mesh-list
110445279|NCT01196078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110752823|NCT03653546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110752824|NCT03653546|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110752825|NCT03653546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110752826|NCT03653546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110752827|NCT03812354|Nicotine|nicotine|mesh-list
110752828|NCT03812354|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110752829|NCT03812354|Autonomic Agents|autonomic agents|mesh-ancestor
110752830|NCT03812354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110752831|NCT03812354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110752832|NCT03812354|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110752833|NCT03812354|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110752834|NCT03812354|Cholinergic Agents|cholinergic agents|mesh-ancestor
110752835|NCT03812354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110752836|NCT03812354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110752837|NCT03812120|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
110752838|NCT03812120|Hemostatics|hemostatics|mesh-ancestor
110752839|NCT03812120|Coagulants|coagulants|mesh-ancestor
110752840|NCT03796364|Endostar protein|endostar protein|mesh-list
110752841|NCT03796364|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110752842|NCT03796364|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110752843|NCT03796364|Growth Substances|growth substances|mesh-ancestor
110752844|NCT03796364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110752845|NCT03796364|Growth Inhibitors|growth inhibitors|mesh-ancestor
110752846|NCT03796364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110752847|NCT03795584|Hemostatics|hemostatics|mesh-list
110752848|NCT03795584|Coagulants|coagulants|mesh-ancestor
110752849|NCT03792776|Lidocaine|lidocaine|mesh-list
110752850|NCT03792776|Anesthetics|anesthetics|mesh-list
110752851|NCT03792776|Anesthetics, Local|anesthetics, local|mesh-ancestor
110752852|NCT03792776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110752853|NCT03792776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110752854|NCT03792776|Sensory System Agents|sensory system agents|mesh-ancestor
110752855|NCT03792776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110752856|NCT03792776|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110752857|NCT03792776|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110752858|NCT03792776|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110752859|NCT03792776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110752860|NCT03792776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110752861|NCT03795272|Rucaparib|rucaparib|mesh-list
110752862|NCT03795272|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110752863|NCT03795272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110752864|NCT03795272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110752865|NCT03795272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110752866|NCT00956930|Doxorubicin|doxorubicin|mesh-list
110752867|NCT00956930|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110752868|NCT00956930|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110752869|NCT00956930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110752870|NCT00956930|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110752871|NCT00956930|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110752872|NCT00956930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110752873|NCT00956930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110752874|NCT03792620|Daratumumab|daratumumab|mesh-list
110752875|NCT03792620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110752876|NCT05027594|Dexamethasone|dexamethasone|mesh-list
110752877|NCT05027594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110752878|NCT05027594|Antiemetics|antiemetics|mesh-ancestor
110752879|NCT05027594|Autonomic Agents|autonomic agents|mesh-ancestor
110752880|NCT05027594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110752881|NCT05027594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110752882|NCT05027594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110752883|NCT05027594|Glucocorticoids|glucocorticoids|mesh-ancestor
110752884|NCT05027594|Hormones|hormones|mesh-ancestor
110752885|NCT05027594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110752886|NCT05027594|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110752887|NCT05027594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110752888|NCT03811418|Docetaxel|docetaxel|mesh-list
110752889|NCT03811418|Trastuzumab|trastuzumab|mesh-list
110752890|NCT03811418|Vinorelbine|vinorelbine|mesh-list
110752891|NCT03811418|Pertuzumab|pertuzumab|mesh-list
110752892|NCT03811418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110752893|NCT03811418|Tubulin Modulators|tubulin modulators|mesh-ancestor
110752894|NCT03811418|Antimitotic Agents|antimitotic agents|mesh-ancestor
110752895|NCT03811418|Mitosis Modulators|mitosis modulators|mesh-ancestor
110752896|NCT03811418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110077975|NCT01613846|Sorafenib|sorafenib|mesh-list
110752897|NCT03811418|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110752898|NCT03811418|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110752900|NCT03794492|Methylprednisolone|methylprednisolone|mesh-list
110752901|NCT03794492|Prednisolone|prednisolone|mesh-list
110752902|NCT03794492|Tacrolimus|tacrolimus|mesh-list
110752903|NCT03794492|Basiliximab|basiliximab|mesh-list
110752904|NCT03794492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110752905|NCT03794492|Immunologic Factors|immunologic factors|mesh-ancestor
110752906|NCT03794492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110752907|NCT03794492|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110752908|NCT03794492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110752909|NCT03794492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110752910|NCT03794492|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110752911|NCT03794492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110752912|NCT03794492|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110752913|NCT03794492|Antitubercular Agents|antitubercular agents|mesh-ancestor
110752914|NCT03794492|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110752915|NCT03794492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110752916|NCT03794492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110752918|NCT03794492|Autonomic Agents|autonomic agents|mesh-ancestor
110752919|NCT03794492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110752920|NCT03794492|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110752921|NCT03794492|Glucocorticoids|glucocorticoids|mesh-ancestor
110752922|NCT03794492|Hormones|hormones|mesh-ancestor
110752923|NCT03794492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110752924|NCT03794492|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110752925|NCT03794492|Protective Agents|protective agents|mesh-ancestor
110752926|NCT03794492|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110752927|NCT03792152|Warfarin|warfarin|mesh-list
110752928|NCT03792152|Rivaroxaban|rivaroxaban|mesh-list
110752929|NCT03792152|Anticoagulants|anticoagulants|mesh-ancestor
110752930|NCT03792152|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110752931|NCT03792152|Antithrombins|antithrombins|mesh-ancestor
110752932|NCT03792152|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110752933|NCT03792152|Protease Inhibitors|protease inhibitors|mesh-ancestor
110752934|NCT03792152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110752935|NCT03792152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110752936|NCT00262067|Bevacizumab|bevacizumab|mesh-list
110752937|NCT00262067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110752938|NCT00262067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110752939|NCT00262067|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110752940|NCT00262067|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110752941|NCT00262067|Growth Substances|growth substances|mesh-ancestor
110752942|NCT00262067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110752943|NCT00262067|Growth Inhibitors|growth inhibitors|mesh-ancestor
110752944|NCT00275561|Fluticasone|fluticasone|mesh-list
110752945|NCT00275561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110752946|NCT00275561|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110752947|NCT00275561|Autonomic Agents|autonomic agents|mesh-ancestor
110752948|NCT00275561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110752949|NCT00275561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110752950|NCT00275561|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110752951|NCT00275561|Respiratory System Agents|respiratory system agents|mesh-ancestor
110752952|NCT00275561|Dermatologic Agents|dermatologic agents|mesh-ancestor
110752953|NCT00275561|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110752954|NCT03810872|Paclitaxel|paclitaxel|mesh-list
110752955|NCT03810872|Afatinib|afatinib|mesh-list
110752956|NCT03810872|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110752957|NCT03810872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110752958|NCT03810872|Tubulin Modulators|tubulin modulators|mesh-ancestor
110752959|NCT03810872|Antimitotic Agents|antimitotic agents|mesh-ancestor
110752960|NCT03810872|Mitosis Modulators|mitosis modulators|mesh-ancestor
110752961|NCT03810872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110752962|NCT03810872|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110752963|NCT03810872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110752964|NCT05569148|Faricimab|faricimab|mesh-list
110752965|NCT05569148|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110752966|NCT05569148|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110752967|NCT05569148|Growth Substances|growth substances|mesh-ancestor
110752968|NCT05569148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110752969|NCT05569148|Growth Inhibitors|growth inhibitors|mesh-ancestor
110752970|NCT05569148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110752971|NCT03794180|Plonmarlimab|plonmarlimab|mesh-list
110752972|NCT03794180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110752973|NCT03794180|Antiviral Agents|antiviral agents|mesh-ancestor
110752974|NCT03794180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110752976|NCT00274937|Fluorouracil|fluorouracil|mesh-list
110752977|NCT00274937|Amifostine|amifostine|mesh-list
110752978|NCT00274937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110752979|NCT00274937|Antimetabolites|antimetabolites|mesh-ancestor
110752980|NCT00274937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110752981|NCT00274937|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110752982|NCT00274937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110752983|NCT00274937|Immunologic Factors|immunologic factors|mesh-ancestor
110752984|NCT00274937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110752985|NCT00274937|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110752986|NCT00274937|Protective Agents|protective agents|mesh-ancestor
110752987|NCT03792074|Paclitaxel|paclitaxel|mesh-list
110752988|NCT03792074|Bevacizumab|bevacizumab|mesh-list
110752989|NCT03792074|Carboplatin|carboplatin|mesh-list
110752990|NCT03792074|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110752991|NCT03792074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110752992|NCT03792074|Tubulin Modulators|tubulin modulators|mesh-ancestor
110752993|NCT03792074|Antimitotic Agents|antimitotic agents|mesh-ancestor
110752994|NCT03792074|Mitosis Modulators|mitosis modulators|mesh-ancestor
110752995|NCT03792074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110752996|NCT03792074|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110752997|NCT03792074|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110752998|NCT03792074|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110752999|NCT03792074|Growth Substances|growth substances|mesh-ancestor
110753000|NCT03792074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110753001|NCT03792074|Growth Inhibitors|growth inhibitors|mesh-ancestor
110753002|NCT00251693|Lansoprazole|lansoprazole|mesh-list
110753003|NCT00251693|Dexlansoprazole|dexlansoprazole|mesh-list
110753004|NCT00251693|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110753005|NCT00251693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110753006|NCT00251693|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110753007|NCT00251693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110753008|NCT00251693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110753009|NCT03791918|Lenvatinib|lenvatinib|mesh-list
110753010|NCT03791918|Chlorotrianisene|chlorotrianisene|mesh-list
110753011|NCT03791918|Antibodies|antibodies|mesh-list
110753012|NCT03791918|Immunoglobulins|immunoglobulins|mesh-list
110753013|NCT03791918|Immunologic Factors|immunologic factors|mesh-ancestor
110753014|NCT03791918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110753015|NCT03791918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110753016|NCT03791918|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110753017|NCT03791918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110753018|NCT03791918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110753019|NCT03791918|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
110753020|NCT03791918|Estrogens|estrogens|mesh-ancestor
110753021|NCT03791918|Hormones|hormones|mesh-ancestor
110753022|NCT03791918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110753023|NCT03791918|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110753024|NCT00250835|Celecoxib|celecoxib|mesh-list
110753025|NCT00250835|Capecitabine|capecitabine|mesh-list
110753026|NCT00250835|Oxaliplatin|oxaliplatin|mesh-list
110753027|NCT00250835|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110753028|NCT00250835|Antimetabolites|antimetabolites|mesh-ancestor
110753029|NCT00250835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110753030|NCT00250835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110753031|NCT00250835|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110753032|NCT00250835|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110753033|NCT00250835|Analgesics|analgesics|mesh-ancestor
110753034|NCT00250835|Sensory System Agents|sensory system agents|mesh-ancestor
110753035|NCT00250835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110753036|NCT00250835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110753037|NCT00250835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110753038|NCT00250835|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110753039|NCT00250835|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110753040|NCT00250835|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110753041|NCT00250835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110753042|NCT01303094|Trabectedin|trabectedin|mesh-list
110753043|NCT01303094|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110753044|NCT01303094|Alkylating Agents|alkylating agents|mesh-ancestor
110753045|NCT01303094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110753046|NCT01303094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110753047|NCT04785326|Ustekinumab|ustekinumab|mesh-list
110753048|NCT04785326|Dermatologic Agents|dermatologic agents|mesh-ancestor
110753049|NCT03791762|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
110753050|NCT03791762|Vasodilator Agents|vasodilator agents|mesh-ancestor
110753051|NCT03791762|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
110753052|NCT03791762|Protective Agents|protective agents|mesh-ancestor
110753053|NCT03791762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110753054|NCT04663568|Levonorgestrel|levonorgestrel|mesh-list
110753055|NCT04663568|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110753056|NCT04663568|Contraceptive Agents|contraceptive agents|mesh-ancestor
110753057|NCT04663568|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110753058|NCT04663568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110169254|NCT00000926|Nonoxynol|nonoxynol|mesh-list
110753059|NCT04663568|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110753060|NCT04663568|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110753061|NCT04663568|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110753062|NCT03789032|Rabeprazole|rabeprazole|mesh-list
110753063|NCT03789032|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110753064|NCT03789032|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110753065|NCT03789032|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110753066|NCT03789032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110753067|NCT03789032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110753068|NCT01306370|Tranexamic Acid|tranexamic acid|mesh-list
110753069|NCT01306370|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
110753070|NCT01306370|Hemostatics|hemostatics|mesh-list
110753071|NCT01306370|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110753072|NCT01306370|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110753073|NCT01306370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110753074|NCT01306370|Coagulants|coagulants|mesh-ancestor
110753075|NCT03716024|Linezolid|linezolid|mesh-list
110753076|NCT03716024|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110753077|NCT03716024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110753078|NCT03716024|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110753079|NCT03716024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110753080|NCT03716024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110753081|NCT00250679|Formoterol Fumarate|formoterol fumarate|mesh-list
110753082|NCT00250679|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110753083|NCT00250679|Autonomic Agents|autonomic agents|mesh-ancestor
110753084|NCT00250679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110753085|NCT00250679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110753086|NCT00250679|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110753087|NCT00250679|Respiratory System Agents|respiratory system agents|mesh-ancestor
110867985|NCT02427334|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110753088|NCT00250679|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110753089|NCT00250679|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110753090|NCT00250679|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110753091|NCT00250679|Adrenergic Agents|adrenergic agents|mesh-ancestor
110753092|NCT00250679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110753093|NCT00250679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110753094|NCT03791294|Titanium dioxide|titanium dioxide|mesh-list
110753095|NCT03791294|Hyaluronic Acid|hyaluronic acid|mesh-list
110753096|NCT03791294|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110753097|NCT03791294|Immunologic Factors|immunologic factors|mesh-ancestor
110753098|NCT03791294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110753099|NCT03791294|Viscosupplements|viscosupplements|mesh-ancestor
110753100|NCT03791294|Protective Agents|protective agents|mesh-ancestor
110753101|NCT03791294|Sunscreening Agents|sunscreening agents|mesh-ancestor
110753102|NCT03791294|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110753103|NCT03791294|Dermatologic Agents|dermatologic agents|mesh-ancestor
110753104|NCT03791294|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110753105|NCT01567358|Infliximab|infliximab|mesh-list
110753106|NCT01567358|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110753107|NCT01567358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110753108|NCT01567358|Dermatologic Agents|dermatologic agents|mesh-ancestor
110753109|NCT01567358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110753110|NCT01567358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110753111|NCT00261833|Protease Inhibitors|protease inhibitors|mesh-list
110753112|NCT00261833|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
110753113|NCT00261833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110753114|NCT00261833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110753115|NCT00261833|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
110753116|NCT00261833|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110753117|NCT01308242|Sevelamer|sevelamer|mesh-list
110753118|NCT01308242|Chelating Agents|chelating agents|mesh-ancestor
110753119|NCT01308242|Sequestering Agents|sequestering agents|mesh-ancestor
110753120|NCT01308242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110753121|NCT01308320|Fentanyl|fentanyl|mesh-list
110753122|NCT01308320|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110753123|NCT01308320|Narcotics|narcotics|mesh-ancestor
110753124|NCT01308320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110753125|NCT01308320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110753126|NCT01308320|Analgesics|analgesics|mesh-ancestor
110753127|NCT01308320|Sensory System Agents|sensory system agents|mesh-ancestor
110753128|NCT01308320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110753129|NCT01308320|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110753130|NCT01308320|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110753131|NCT01308320|Anesthetics, General|anesthetics, general|mesh-ancestor
110753132|NCT01308320|Anesthetics|anesthetics|mesh-ancestor
110753133|NCT01306760|Ketamine|ketamine|mesh-list
110753134|NCT01306760|Propofol|propofol|mesh-list
110753135|NCT01306760|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110753136|NCT01306760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110753137|NCT01306760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110753138|NCT01306760|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110753139|NCT01306760|Anesthetics, General|anesthetics, general|mesh-ancestor
110753141|NCT01306760|Analgesics|analgesics|mesh-ancestor
110753142|NCT01306760|Sensory System Agents|sensory system agents|mesh-ancestor
110753143|NCT01306760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110753144|NCT01306760|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110753145|NCT01306760|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110753146|NCT01306760|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110753147|NCT01306760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110753148|NCT01306760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110753149|NCT03787940|Isoniazid|isoniazid|mesh-list
110753150|NCT03787940|Antitubercular Agents|antitubercular agents|mesh-ancestor
110753151|NCT03787940|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110753152|NCT03787940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110753153|NCT03787940|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
110753154|NCT03787940|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110753155|NCT03787940|Antimetabolites|antimetabolites|mesh-ancestor
110753156|NCT03787940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110753157|NCT03787940|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110753158|NCT03788018|Lidocaine|lidocaine|mesh-list
110753159|NCT03788018|Dexmedetomidine|dexmedetomidine|mesh-list
110753160|NCT03788018|Anesthetics, Local|anesthetics, local|mesh-ancestor
110753161|NCT03788018|Anesthetics|anesthetics|mesh-ancestor
110753162|NCT03788018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110311130|NCT00320775|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110753163|NCT03788018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110753164|NCT03788018|Sensory System Agents|sensory system agents|mesh-ancestor
110753165|NCT03788018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110753166|NCT03788018|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110753167|NCT03788018|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110753168|NCT03788018|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110753169|NCT03788018|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110753170|NCT03788018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110753171|NCT03788018|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110753172|NCT03788018|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110753173|NCT03788018|Analgesics|analgesics|mesh-ancestor
110753174|NCT03788018|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110753175|NCT03788018|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110753176|NCT03788018|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110753177|NCT03788018|Adrenergic Agents|adrenergic agents|mesh-ancestor
110753178|NCT03788018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110753179|NCT03785756|Ibuprofen|ibuprofen|mesh-list
110753180|NCT03785756|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110753181|NCT03785756|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110753182|NCT03785756|Analgesics|analgesics|mesh-ancestor
110753183|NCT03785756|Sensory System Agents|sensory system agents|mesh-ancestor
110753184|NCT03785756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110753185|NCT03785756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110753186|NCT03785756|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110753187|NCT03785756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110753188|NCT03785756|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110753189|NCT03785756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110753190|NCT03785756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110753191|NCT03788174|Apatinib|apatinib|mesh-list
110753192|NCT03788174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110078266|NCT01615601|Darunavir|darunavir|mesh-list
110753193|NCT03788174|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110753194|NCT03788174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110753195|NCT03788174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110753196|NCT03787550|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110753197|NCT03787550|Analgesics|analgesics|mesh-list
110753198|NCT03787550|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
110753199|NCT03787550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110753200|NCT03787550|Sensory System Agents|sensory system agents|mesh-ancestor
110753201|NCT03787550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110753202|NCT03787550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110753203|NCT03787550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110753204|NCT03790358|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
110753205|NCT03790358|Hallucinogens|hallucinogens|mesh-ancestor
110753206|NCT03790358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110753207|NCT03790358|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110753208|NCT03790358|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110753209|NCT03790358|Serotonin Agents|serotonin agents|mesh-ancestor
110753210|NCT03790358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110753211|NCT03790358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110753212|NCT03790358|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110753213|NCT03789890|Itraconazole|itraconazole|mesh-list
110753214|NCT03789890|Antifungal Agents|antifungal agents|mesh-ancestor
110753215|NCT03789890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110753216|NCT03789890|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110753217|NCT03789890|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110311161|NCT00287924|Methotrexate|methotrexate|mesh-list
110753218|NCT03789890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110753219|NCT03789890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110753220|NCT03789890|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110753221|NCT03789890|Hormone Antagonists|hormone antagonists|mesh-ancestor
110753222|NCT03789890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110753223|NCT03789890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110753224|NCT03789890|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110753225|NCT01308554|Bupivacaine|bupivacaine|mesh-list
110753226|NCT01308554|Anesthetics, Local|anesthetics, local|mesh-ancestor
110753227|NCT01308554|Anesthetics|anesthetics|mesh-ancestor
110753228|NCT01308554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110753229|NCT01308554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110753230|NCT01308554|Sensory System Agents|sensory system agents|mesh-ancestor
110753231|NCT01308554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110753232|NCT05693402|Analgesics, Opioid|analgesics, opioid|mesh-list
110753233|NCT05693402|Anesthetics|anesthetics|mesh-list
110753234|NCT05693402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110753235|NCT05693402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110753236|NCT05693402|Narcotics|narcotics|mesh-ancestor
110753237|NCT05693402|Analgesics|analgesics|mesh-ancestor
110753238|NCT05693402|Sensory System Agents|sensory system agents|mesh-ancestor
110753239|NCT05693402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110753240|NCT05694728|Vaccines|vaccines|mesh-list
110753241|NCT05694728|Immunologic Factors|immunologic factors|mesh-ancestor
110753242|NCT05694728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110753243|NCT01308632|Irinotecan|irinotecan|mesh-list
110753244|NCT01308632|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110753245|NCT01308632|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110753246|NCT01308632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110753247|NCT01308632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110753248|NCT01308632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110753249|NCT03713684|Efpeglenatide|efpeglenatide|mesh-list
110753250|NCT03713684|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110753251|NCT03713684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110753252|NCT03785522|Insulin|insulin|mesh-list
110868018|NCT01358253|Cytarabine|cytarabine|mesh-list
110753253|NCT03785522|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110753254|NCT03785522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110753256|NCT05694416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110753257|NCT05694416|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110753258|NCT05694416|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110753259|NCT05694416|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110753260|NCT05694416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110753261|NCT05694416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110753262|NCT03789422|Cetirizine|cetirizine|mesh-list
110753263|NCT03789422|Tranexamic Acid|tranexamic acid|mesh-list
110753264|NCT03789422|Levocetirizine|levocetirizine|mesh-list
110753265|NCT03789422|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110753266|NCT03789422|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110753267|NCT03789422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110753268|NCT03789422|Hemostatics|hemostatics|mesh-ancestor
110753269|NCT03789422|Coagulants|coagulants|mesh-ancestor
110753270|NCT03789422|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110753271|NCT03789422|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110753272|NCT03789422|Histamine Antagonists|histamine antagonists|mesh-ancestor
110753273|NCT03789422|Histamine Agents|histamine agents|mesh-ancestor
110753274|NCT03789422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110753275|NCT03789422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110753276|NCT03789422|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110753277|NCT04751084|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
110753278|NCT04751084|Parasympatholytics|parasympatholytics|mesh-ancestor
110753279|NCT04751084|Autonomic Agents|autonomic agents|mesh-ancestor
110753280|NCT04751084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110753281|NCT04751084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110753282|NCT04751084|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110753283|NCT04751084|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110753284|NCT04751084|Cholinergic Agents|cholinergic agents|mesh-ancestor
110753285|NCT04751084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110753286|NCT04751084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110753288|NCT05690048|Bevacizumab|bevacizumab|mesh-list
110753289|NCT05690048|Atezolizumab|atezolizumab|mesh-list
110753290|NCT05690048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110753291|NCT05690048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110753292|NCT05690048|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110753293|NCT05690048|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110753294|NCT05690048|Growth Substances|growth substances|mesh-ancestor
110753295|NCT05690048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110753296|NCT05690048|Growth Inhibitors|growth inhibitors|mesh-ancestor
110753297|NCT05690048|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110753298|NCT05690048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110753299|NCT05690048|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110753300|NCT05690048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110753301|NCT01308086|Leucovorin|leucovorin|mesh-list
110753302|NCT01308086|Fluorouracil|fluorouracil|mesh-list
110753303|NCT01308086|Capecitabine|capecitabine|mesh-list
110753304|NCT01308086|Oxaliplatin|oxaliplatin|mesh-list
110753305|NCT01308086|Levoleucovorin|levoleucovorin|mesh-list
110753306|NCT01308086|Antimetabolites|antimetabolites|mesh-ancestor
110753307|NCT01308086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110753308|NCT01308086|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110753309|NCT01308086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110753310|NCT01308086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110753311|NCT01308086|Immunologic Factors|immunologic factors|mesh-ancestor
110753312|NCT01308086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110753313|NCT01308086|Antidotes|antidotes|mesh-ancestor
110753314|NCT01308086|Protective Agents|protective agents|mesh-ancestor
110753315|NCT01308086|Vitamin B Complex|vitamin b complex|mesh-ancestor
110753316|NCT01308086|Vitamins|vitamins|mesh-ancestor
110753317|NCT01308086|Micronutrients|micronutrients|mesh-ancestor
110753318|NCT05443802|Insulin|insulin|mesh-list
110753319|NCT05443802|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110753320|NCT05443802|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110753321|NCT05443802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110753322|NCT01308944|Propranolol|propranolol|mesh-list
110753323|NCT01308944|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110753324|NCT01308944|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110753325|NCT01308944|Adrenergic Agents|adrenergic agents|mesh-ancestor
110753326|NCT01308944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110753327|NCT01308944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110753328|NCT01308944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110753329|NCT01308944|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110753330|NCT01308944|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110753331|NCT01308944|Vasodilator Agents|vasodilator agents|mesh-ancestor
110753332|NCT03777488|Tranexamic Acid|tranexamic acid|mesh-list
110753333|NCT03777488|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110753334|NCT03777488|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110753335|NCT03777488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110753336|NCT03777488|Hemostatics|hemostatics|mesh-ancestor
110753337|NCT03777488|Coagulants|coagulants|mesh-ancestor
110753338|NCT03777254|RC28-E protein|rc28-e protein|mesh-list
110753339|NCT03777254|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110753340|NCT03777254|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110753341|NCT03777254|Growth Substances|growth substances|mesh-ancestor
110753342|NCT03777254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110753343|NCT03777254|Growth Inhibitors|growth inhibitors|mesh-ancestor
110311198|NCT00320892|Mydriatics|mydriatics|mesh-ancestor
110753344|NCT03777254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110753346|NCT01312298|Anesthetics|anesthetics|mesh-list
110753347|NCT01312298|Propofol|propofol|mesh-list
110753348|NCT01312298|Succinylcholine|succinylcholine|mesh-list
110753349|NCT01312298|Anesthetics, Local|anesthetics, local|mesh-ancestor
110753350|NCT01312298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110753351|NCT01312298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110753352|NCT01312298|Sensory System Agents|sensory system agents|mesh-ancestor
110753353|NCT01312298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110753354|NCT01312298|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110753355|NCT01312298|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110753356|NCT01312298|Anesthetics, General|anesthetics, general|mesh-ancestor
110753357|NCT01312298|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
110471051|NCT05601817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110753358|NCT01312298|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110753359|NCT01312298|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110753360|NCT01309022|Mycophenolic Acid|mycophenolic acid|mesh-list
110753361|NCT01309022|Sirolimus|sirolimus|mesh-list
110753362|NCT01309022|Tacrolimus|tacrolimus|mesh-list
110753363|NCT01309022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110753364|NCT01309022|Immunologic Factors|immunologic factors|mesh-ancestor
110753365|NCT01309022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110753366|NCT01309022|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110753367|NCT01309022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110753368|NCT01309022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110753369|NCT01309022|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110753370|NCT01309022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110753371|NCT01309022|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110753372|NCT01309022|Antitubercular Agents|antitubercular agents|mesh-ancestor
110753373|NCT01309022|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110753374|NCT01309022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110753375|NCT01309022|Antifungal Agents|antifungal agents|mesh-ancestor
110753376|NCT01560962|Azithromycin|azithromycin|mesh-list
110753377|NCT01560962|Tobramycin|tobramycin|mesh-list
110753378|NCT01560962|Povidone-Iodine|povidone-iodine|mesh-list
110753379|NCT01560962|Povidone|povidone|mesh-list
110753380|NCT01560962|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110753381|NCT01560962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110753382|NCT01560962|Plasma Substitutes|plasma substitutes|mesh-ancestor
110753383|NCT01560962|Blood Substitutes|blood substitutes|mesh-ancestor
110753384|NCT01560962|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110753385|NCT05401058|Droperidol|droperidol|mesh-list
110753386|NCT05401058|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110753387|NCT05401058|Antiemetics|antiemetics|mesh-ancestor
110753388|NCT05401058|Autonomic Agents|autonomic agents|mesh-ancestor
110753389|NCT05401058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110753390|NCT05401058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110753391|NCT05401058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110753392|NCT05401058|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110753393|NCT05401058|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110753394|NCT05401058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110753395|NCT05401058|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110753396|NCT05401058|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110753397|NCT05401058|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110753398|NCT05401058|Dopamine Agents|dopamine agents|mesh-ancestor
110753399|NCT05401058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110753400|NCT05401058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110753401|NCT03781466|Progesterone|progesterone|mesh-list
110753402|NCT03781466|Progestins|progestins|mesh-ancestor
110753403|NCT03781466|Hormones|hormones|mesh-ancestor
110753404|NCT03781466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110753405|NCT03781466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110753406|NCT03150862|Pamiparib|pamiparib|mesh-list
110753407|NCT03150862|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110753408|NCT03150862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110753409|NCT03150862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110753410|NCT03150862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110753411|NCT01318928|Metronidazole|metronidazole|mesh-list
110753412|NCT01318928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110753413|NCT01318928|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110078489|NCT01616966|Narcotics|narcotics|mesh-ancestor
110753414|NCT01318928|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110753415|NCT01318928|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110753416|NCT01309178|Mannitol|mannitol|mesh-list
110753417|NCT01309178|Amitriptyline|amitriptyline|mesh-list
110753418|NCT01309178|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110753419|NCT01309178|Antidepressive Agents|antidepressive agents|mesh-ancestor
110753420|NCT01309178|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110753421|NCT01309178|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110753422|NCT01309178|Analgesics|analgesics|mesh-ancestor
110753423|NCT01309178|Sensory System Agents|sensory system agents|mesh-ancestor
110753424|NCT01309178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110753425|NCT01309178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110753426|NCT01309178|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110753427|NCT01309178|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110753428|NCT01309178|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110753429|NCT01309178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110753430|NCT01309178|Adrenergic Agents|adrenergic agents|mesh-ancestor
110753431|NCT01309178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110753432|NCT01309178|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110753433|NCT01309178|Diuretics|diuretics|mesh-ancestor
110471127|NCT05350085|Midazolam|midazolam|mesh-list
110753434|NCT01309178|Natriuretic Agents|natriuretic agents|mesh-ancestor
110753435|NCT01335334|Metronidazole|metronidazole|mesh-list
110753436|NCT01335334|Tetracycline|tetracycline|mesh-list
110753437|NCT01335334|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
110753438|NCT01335334|Omeprazole|omeprazole|mesh-list
110753439|NCT01335334|Bismuth|bismuth|mesh-list
110753440|NCT01335334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110753441|NCT01335334|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110753442|NCT01335334|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110753443|NCT01335334|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110311231|NCT00322569|Paclitaxel|paclitaxel|mesh-list
110753444|NCT01335334|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110753445|NCT01335334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110753446|NCT01335334|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110753447|NCT01335334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110753448|NCT01335334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110753449|NCT01335334|Antacids|antacids|mesh-ancestor
110753450|NCT01335334|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110753451|NCT01344304|Aprepitant|aprepitant|mesh-list
110753452|NCT01344304|Fosaprepitant|fosaprepitant|mesh-list
110753453|NCT01344304|Antiemetics|antiemetics|mesh-ancestor
110753454|NCT01344304|Autonomic Agents|autonomic agents|mesh-ancestor
110753455|NCT01344304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110753456|NCT01344304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110753457|NCT01344304|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110753458|NCT01344304|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110753459|NCT01344304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110753460|NCT01344304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110753461|NCT01320020|Catumaxomab|catumaxomab|mesh-list
110753462|NCT01320020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110753463|NCT05312762|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
110753464|NCT05312762|Chitosan|chitosan|mesh-list
110753465|NCT05312762|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110753466|NCT05312762|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110753467|NCT05312762|Antimetabolites|antimetabolites|mesh-ancestor
110753468|NCT05312762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110753469|NCT05312762|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110753470|NCT05312762|Chelating Agents|chelating agents|mesh-ancestor
110753471|NCT05312762|Sequestering Agents|sequestering agents|mesh-ancestor
110753472|NCT05312762|Hemostatics|hemostatics|mesh-ancestor
110753473|NCT05312762|Coagulants|coagulants|mesh-ancestor
110753474|NCT05312762|Laxatives|laxatives|mesh-ancestor
110753475|NCT05312762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110753476|NCT00379288|Fluticasone|fluticasone|mesh-list
110753478|NCT00379288|Mometasone Furoate|mometasone furoate|mesh-list
110753479|NCT00379288|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110753480|NCT00379288|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
110753481|NCT00379288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110753482|NCT00379288|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110753483|NCT00379288|Autonomic Agents|autonomic agents|mesh-ancestor
110753484|NCT00379288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110753485|NCT00379288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110753486|NCT00379288|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110753487|NCT00379288|Respiratory System Agents|respiratory system agents|mesh-ancestor
110753488|NCT00379288|Dermatologic Agents|dermatologic agents|mesh-ancestor
110753489|NCT00379288|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110753490|NCT00379288|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110753491|NCT00379288|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110753492|NCT00379288|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110753493|NCT00379288|Adrenergic Agents|adrenergic agents|mesh-ancestor
110753494|NCT00379288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110753495|NCT00379288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110753496|NCT00379288|Glucocorticoids|glucocorticoids|mesh-ancestor
110753497|NCT00379288|Hormones|hormones|mesh-ancestor
110753498|NCT00379288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110753499|NCT00379288|Sympathomimetics|sympathomimetics|mesh-ancestor
110753500|NCT03784040|Nivolumab|nivolumab|mesh-list
110753501|NCT03784040|Ipilimumab|ipilimumab|mesh-list
110753502|NCT03784040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110753503|NCT03784040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110753504|NCT03784040|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110753505|NCT03784040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110753506|NCT00243503|Trastuzumab|trastuzumab|mesh-list
110753507|NCT00243503|Sunitinib|sunitinib|mesh-list
110753508|NCT00243503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110753509|NCT00243503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110753510|NCT00243503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110753511|NCT00243503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110753512|NCT00243503|Growth Substances|growth substances|mesh-ancestor
110753513|NCT00243503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110753514|NCT00243503|Growth Inhibitors|growth inhibitors|mesh-ancestor
110753515|NCT00243503|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110753516|NCT00243503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110753517|NCT00243503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110753518|NCT03780686|Dopamine|dopamine|mesh-list
110753519|NCT03780686|Norepinephrine|norepinephrine|mesh-list
110753520|NCT03780686|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110753521|NCT03780686|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110753522|NCT03780686|Adrenergic Agents|adrenergic agents|mesh-ancestor
110753523|NCT03780686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110753524|NCT03780686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110753525|NCT03780686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110753526|NCT03780686|Sympathomimetics|sympathomimetics|mesh-ancestor
110753527|NCT03780686|Autonomic Agents|autonomic agents|mesh-ancestor
110753528|NCT03780686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110753529|NCT03780686|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110753530|NCT03780686|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110753531|NCT03780686|Dopamine Agents|dopamine agents|mesh-ancestor
110753532|NCT03780686|Protective Agents|protective agents|mesh-ancestor
110753533|NCT00338260|Atenolol|atenolol|mesh-list
110753534|NCT00338260|Adrenergic Agents|adrenergic agents|mesh-ancestor
110753535|NCT00338260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110753536|NCT00338260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110753537|NCT00338260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110753538|NCT00338260|Autonomic Agents|autonomic agents|mesh-ancestor
110753539|NCT00338260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110753540|NCT00338260|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110753541|NCT00338260|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110753542|NCT00338260|Sympatholytics|sympatholytics|mesh-ancestor
110753543|NCT00338260|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110753544|NCT00338260|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110753545|NCT00338260|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110753546|NCT03775928|Capecitabine|capecitabine|mesh-list
110753547|NCT03775928|Apatinib|apatinib|mesh-list
110753548|NCT03775928|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110753549|NCT03775928|Antimetabolites|antimetabolites|mesh-ancestor
110753550|NCT03775928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110753551|NCT03775928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110753552|NCT03775928|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110753553|NCT03775928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110753554|NCT03775538|Dopamine|dopamine|mesh-list
110753555|NCT03775538|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110753556|NCT03775538|Sympathomimetics|sympathomimetics|mesh-ancestor
110753557|NCT03775538|Autonomic Agents|autonomic agents|mesh-ancestor
110753558|NCT03775538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110753559|NCT03775538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110753560|NCT03775538|Dopamine Agents|dopamine agents|mesh-ancestor
110753561|NCT03775538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110445289|NCT04920292|Oxfendazole|oxfendazole|mesh-list
110753562|NCT03775538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110753563|NCT03775538|Protective Agents|protective agents|mesh-ancestor
110753564|NCT00259649|Eletriptan|eletriptan|mesh-list
110753565|NCT00259649|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110753566|NCT00259649|Serotonin Agents|serotonin agents|mesh-ancestor
110753567|NCT00259649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110753568|NCT00259649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110753569|NCT00259649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110753570|NCT01320176|Vaccines|vaccines|mesh-list
110753571|NCT01320176|Immunologic Factors|immunologic factors|mesh-ancestor
110753572|NCT01320176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110753573|NCT01335646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
110753574|NCT01335646|Analgesics|analgesics|mesh-list
110753575|NCT01335646|Sensory System Agents|sensory system agents|mesh-ancestor
110753576|NCT01335646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110753577|NCT01335646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110753578|NCT01309412|Siltuximab|siltuximab|mesh-list
110753579|NCT01309412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110753580|NCT00307060|Losartan|losartan|mesh-list
110753581|NCT00307060|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110753582|NCT00307060|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110753583|NCT00307060|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110753584|NCT00307060|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110753585|NCT00307060|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110753586|NCT00307060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110753587|NCT00307060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110753588|NCT00307060|Diuretics|diuretics|mesh-ancestor
110753589|NCT00307060|Natriuretic Agents|natriuretic agents|mesh-ancestor
110753590|NCT00307060|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110753591|NCT00307060|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110753592|NCT01320254|Cisplatin|cisplatin|mesh-list
110753593|NCT01320254|Gemcitabine|gemcitabine|mesh-list
110753594|NCT01320254|Panitumumab|panitumumab|mesh-list
110753595|NCT01320254|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110753596|NCT01320254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110753597|NCT01320254|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110753598|NCT01320254|Antimetabolites|antimetabolites|mesh-ancestor
110753599|NCT01320254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110753600|NCT01320254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110753601|NCT00092638|Ezetimibe|ezetimibe|mesh-list
110753602|NCT00092638|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110753603|NCT00092638|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110753604|NCT00092638|Antimetabolites|antimetabolites|mesh-ancestor
110753605|NCT00092638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110753606|NCT00092638|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110753607|NCT03783728|Pyridoxine|pyridoxine|mesh-list
110753608|NCT03783728|Vitamin B 6|vitamin b 6|mesh-list
110753609|NCT03783728|Isoniazid|isoniazid|mesh-list
110753610|NCT03783728|Rifapentine|rifapentine|mesh-list
110753611|NCT03783728|Vitamins|vitamins|mesh-ancestor
110753612|NCT03783728|Micronutrients|micronutrients|mesh-ancestor
110753613|NCT03783728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110753614|NCT03783728|Vitamin B Complex|vitamin b complex|mesh-ancestor
110753615|NCT03783728|Antitubercular Agents|antitubercular agents|mesh-ancestor
110753616|NCT03783728|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110753617|NCT03783728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110753618|NCT03783728|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
110753619|NCT03783728|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110753620|NCT03783728|Antimetabolites|antimetabolites|mesh-ancestor
110753621|NCT03783728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110753622|NCT03783728|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110753623|NCT03783728|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110753624|NCT03783728|Leprostatic Agents|leprostatic agents|mesh-ancestor
110753625|NCT03620422|Mannitol|mannitol|mesh-list
110753626|NCT03620422|Albuterol|albuterol|mesh-list
110753627|NCT03620422|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110753628|NCT03620422|Autonomic Agents|autonomic agents|mesh-ancestor
110753629|NCT03620422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110753630|NCT03620422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110753631|NCT03620422|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110311283|NCT00288197|Voriconazole|voriconazole|mesh-list
110753632|NCT03620422|Respiratory System Agents|respiratory system agents|mesh-ancestor
110753633|NCT03620422|Tocolytic Agents|tocolytic agents|mesh-ancestor
110753634|NCT03620422|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110753635|NCT03620422|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110753636|NCT03620422|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110753637|NCT03620422|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110753638|NCT03620422|Adrenergic Agents|adrenergic agents|mesh-ancestor
110753639|NCT03620422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110753640|NCT03620422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110753641|NCT03620422|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110753642|NCT03620422|Diuretics|diuretics|mesh-ancestor
110753643|NCT03620422|Natriuretic Agents|natriuretic agents|mesh-ancestor
110753644|NCT01309490|Ribavirin|ribavirin|mesh-list
110753645|NCT01309490|Antimetabolites|antimetabolites|mesh-ancestor
110753646|NCT01309490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110753647|NCT01309490|Antiviral Agents|antiviral agents|mesh-ancestor
110753648|NCT01309490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110753649|NCT04883840|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110753650|NCT04883840|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110753651|NCT04883840|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110753652|NCT04883840|Antimetabolites|antimetabolites|mesh-ancestor
110753653|NCT04883840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110753654|NCT04883840|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110753655|NCT04883840|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110753656|NCT04883840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110753657|NCT01345084|Nimotuzumab|nimotuzumab|mesh-list
110753658|NCT01345084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110753659|NCT01345084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110753660|NCT03783494|Propofol|propofol|mesh-list
110753661|NCT03783494|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110753662|NCT03783494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110753663|NCT03783494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110753664|NCT03783494|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110753665|NCT03783494|Anesthetics, General|anesthetics, general|mesh-ancestor
110753666|NCT03783494|Anesthetics|anesthetics|mesh-ancestor
110753667|NCT03774836|Morphine|morphine|mesh-list
110753668|NCT03774836|Tramadol|tramadol|mesh-list
110753669|NCT03774836|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110753670|NCT03774836|Narcotics|narcotics|mesh-ancestor
110753671|NCT03774836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110753672|NCT03774836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110753673|NCT03774836|Analgesics|analgesics|mesh-ancestor
110753674|NCT03774836|Sensory System Agents|sensory system agents|mesh-ancestor
110753675|NCT03774836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110753676|NCT03774680|Cetuximab|cetuximab|mesh-list
110753677|NCT03774680|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110753678|NCT03774680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110753679|NCT03783338|Vitamin D|vitamin d|mesh-list
110753680|NCT03783338|Vitamins|vitamins|mesh-ancestor
110753681|NCT03783338|Micronutrients|micronutrients|mesh-ancestor
110753682|NCT03783338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110753683|NCT03783338|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110753684|NCT03774524|Misoprostol|misoprostol|mesh-list
110753685|NCT03774524|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110753686|NCT03774524|Abortifacient Agents|abortifacient agents|mesh-ancestor
110753687|NCT03774524|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110753688|NCT03774524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110753689|NCT03774524|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110753690|NCT03774524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110753691|NCT03774524|Oxytocics|oxytocics|mesh-ancestor
110753692|NCT03773744|Cyclophosphamide|cyclophosphamide|mesh-list
110753693|NCT03773744|Pembrolizumab|pembrolizumab|mesh-list
110753694|NCT03773744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110753695|NCT03773744|Immunologic Factors|immunologic factors|mesh-ancestor
110753696|NCT03773744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110753697|NCT03773744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110753698|NCT03773744|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110753699|NCT03773744|Alkylating Agents|alkylating agents|mesh-ancestor
110753700|NCT03773744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110753701|NCT03773744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110753702|NCT03773744|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110753703|NCT03773744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110753704|NCT03773744|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110753705|NCT03779516|Lidocaine|lidocaine|mesh-list
110753706|NCT03779516|Anesthetics, Local|anesthetics, local|mesh-ancestor
110753707|NCT03779516|Anesthetics|anesthetics|mesh-ancestor
110753708|NCT03779516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110753709|NCT03779516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110753711|NCT03779516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110753712|NCT03779516|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110753713|NCT03779516|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110753714|NCT03779516|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110753715|NCT03779516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110753716|NCT03779516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110753717|NCT03779594|Acetazolamide|acetazolamide|mesh-list
110753718|NCT03779594|Anticonvulsants|anticonvulsants|mesh-ancestor
110753719|NCT03779594|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110753720|NCT03779594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110753721|NCT03779594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110753722|NCT03779594|Diuretics|diuretics|mesh-ancestor
110753723|NCT03779594|Natriuretic Agents|natriuretic agents|mesh-ancestor
110753724|NCT03779594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110753725|NCT03779672|Memantine|memantine|mesh-list
110753726|NCT03779672|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110753727|NCT03779672|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110753728|NCT03779672|Dopamine Agents|dopamine agents|mesh-ancestor
110753729|NCT03779672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110753730|NCT03779672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110753731|NCT03779672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110753732|NCT03779672|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110753733|NCT03779672|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110753734|NCT03779282|Dexmedetomidine|dexmedetomidine|mesh-list
110753735|NCT03779282|Ketamine|ketamine|mesh-list
110753736|NCT03779282|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110753737|NCT03779282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110753738|NCT03779282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110753739|NCT03779282|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110753740|NCT03779282|Analgesics|analgesics|mesh-ancestor
110753741|NCT03779282|Sensory System Agents|sensory system agents|mesh-ancestor
110753742|NCT03779282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110753743|NCT03779282|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110753744|NCT03779282|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110753745|NCT03779282|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110753746|NCT03779282|Adrenergic Agents|adrenergic agents|mesh-ancestor
110753747|NCT03779282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110753748|NCT03779282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110753749|NCT03779282|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110753750|NCT03779282|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110753751|NCT03779282|Anesthetics, General|anesthetics, general|mesh-ancestor
110753752|NCT03779282|Anesthetics|anesthetics|mesh-ancestor
110753753|NCT03779282|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110753754|NCT03779282|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110753755|NCT03773588|Propofol|propofol|mesh-list
110753756|NCT03773588|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110753757|NCT03773588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110753758|NCT03773588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110753759|NCT03773588|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110753760|NCT03773588|Anesthetics, General|anesthetics, general|mesh-ancestor
110753761|NCT03773588|Anesthetics|anesthetics|mesh-ancestor
110753762|NCT03773510|Trabectedin|trabectedin|mesh-list
110753763|NCT03773510|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110753764|NCT03773510|Alkylating Agents|alkylating agents|mesh-ancestor
110753765|NCT03773510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110753766|NCT03773510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110753767|NCT03779360|Clindamycin|clindamycin|mesh-list
110753768|NCT03779360|Clindamycin palmitate|clindamycin palmitate|mesh-list
110753769|NCT03779360|Clindamycin phosphate|clindamycin phosphate|mesh-list
110753770|NCT03779360|Erythromycin|erythromycin|mesh-list
110753771|NCT03779360|Erythromycin Estolate|erythromycin estolate|mesh-list
110753772|NCT03779360|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
110753773|NCT03779360|Erythromycin stearate|erythromycin stearate|mesh-list
110753774|NCT03779360|Prednisolone|prednisolone|mesh-list
110753775|NCT03779360|Clobetasol|clobetasol|mesh-list
110753776|NCT03779360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110753777|NCT03779360|Glucocorticoids|glucocorticoids|mesh-ancestor
110753779|NCT03779360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110753780|NCT03779360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110753781|NCT03779360|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110753782|NCT03779360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110753783|NCT03779360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110753784|NCT03779360|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110753785|NCT03779360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110753786|NCT03779360|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110753787|NCT03779360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110753788|NCT03779360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110753789|NCT01320878|Iloprost|iloprost|mesh-list
110753790|NCT01320878|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110753791|NCT01320878|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110753792|NCT01320878|Vasodilator Agents|vasodilator agents|mesh-ancestor
110753793|NCT01321034|Niacin|niacin|mesh-list
110753794|NCT01321034|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110753795|NCT01321034|Antimetabolites|antimetabolites|mesh-ancestor
110753796|NCT01321034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110753797|NCT01321034|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110753798|NCT01321034|Vasodilator Agents|vasodilator agents|mesh-ancestor
110753799|NCT01321034|Vitamin B Complex|vitamin b complex|mesh-ancestor
110753800|NCT01321034|Vitamins|vitamins|mesh-ancestor
110753801|NCT01321034|Micronutrients|micronutrients|mesh-ancestor
110753802|NCT01321034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110753803|NCT05254184|Nivolumab|nivolumab|mesh-list
110753804|NCT05254184|Ipilimumab|ipilimumab|mesh-list
110753805|NCT05254184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110753806|NCT05254184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110753807|NCT05254184|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110753808|NCT05254184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110753809|NCT03773042|Propofol|propofol|mesh-list
110471500|NCT03729401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110753810|NCT03773042|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110753811|NCT03773042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110753812|NCT03773042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110753813|NCT03773042|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110753814|NCT03773042|Anesthetics, General|anesthetics, general|mesh-ancestor
110753815|NCT03773042|Anesthetics|anesthetics|mesh-ancestor
110753816|NCT03782480|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
110753817|NCT03782480|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110753818|NCT03782480|Immunologic Factors|immunologic factors|mesh-ancestor
110753819|NCT03782480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110753820|NCT03712280|Rifaximin|rifaximin|mesh-list
110753821|NCT03712280|Phenylacetic acid|phenylacetic acid|mesh-list
110753822|NCT03712280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110753823|NCT03712280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110753824|NCT03712280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110753825|NCT03712280|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110753826|NCT03712280|Antimetabolites|antimetabolites|mesh-ancestor
110753827|NCT03712280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110753828|NCT03712280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110753829|NCT01561508|Butyric Acid|butyric acid|mesh-list
110753830|NCT01561508|Histamine Antagonists|histamine antagonists|mesh-ancestor
110753831|NCT01561508|Histamine Agents|histamine agents|mesh-ancestor
110753832|NCT01561508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110753833|NCT01561508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110753834|NCT01561508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110753835|NCT03772262|Metformin|metformin|mesh-list
110753836|NCT03772262|Furosemide|furosemide|mesh-list
110753837|NCT03772262|Midazolam|midazolam|mesh-list
110753838|NCT03772262|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110753839|NCT03772262|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110753840|NCT03772262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110753841|NCT03772262|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110753842|NCT03772262|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110753843|NCT03772262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110753844|NCT03772262|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110753845|NCT03772262|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110753846|NCT03772262|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110753847|NCT03772262|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110753848|NCT03772262|Anesthetics, General|anesthetics, general|mesh-ancestor
110753849|NCT03772262|Anesthetics|anesthetics|mesh-ancestor
110753850|NCT03772262|GABA Modulators|gaba modulators|mesh-ancestor
110753851|NCT03772262|GABA Agents|gaba agents|mesh-ancestor
110753852|NCT03772262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110753853|NCT03772262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110753854|NCT03772262|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110753855|NCT03772262|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110753856|NCT03772262|Antimetabolites|antimetabolites|mesh-ancestor
110753857|NCT03772262|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110753858|NCT03772262|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110753859|NCT03772262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110753860|NCT03772262|Diuretics|diuretics|mesh-ancestor
110753861|NCT03772262|Natriuretic Agents|natriuretic agents|mesh-ancestor
110753862|NCT03772262|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110753863|NCT03772262|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110753864|NCT03772106|Propofol|propofol|mesh-list
110753865|NCT03772106|Sevoflurane|sevoflurane|mesh-list
110753866|NCT03772106|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110753867|NCT03772106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110753868|NCT03772106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110753869|NCT03772106|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110753870|NCT03772106|Anesthetics, General|anesthetics, general|mesh-ancestor
110753871|NCT03772106|Anesthetics|anesthetics|mesh-ancestor
110753872|NCT03772106|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110753873|NCT03772106|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110753874|NCT01345240|Vaccines|vaccines|mesh-list
110753875|NCT01345240|Immunologic Factors|immunologic factors|mesh-ancestor
110753876|NCT01345240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110753877|NCT03771638|Tenofovir|tenofovir|mesh-list
110753878|NCT03771638|Emtricitabine|emtricitabine|mesh-list
110753879|NCT03771638|Antiviral Agents|antiviral agents|mesh-ancestor
110753880|NCT03771638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110753881|NCT03771638|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110753882|NCT03771638|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110868172|NCT01356381|Vildagliptin|vildagliptin|mesh-list
110753883|NCT03771638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110753884|NCT03771638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110753885|NCT03771638|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110753886|NCT03771638|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110753887|NCT00092560|Ezetimibe|ezetimibe|mesh-list
110753888|NCT00092560|Fenofibrate|fenofibrate|mesh-list
110753889|NCT00092560|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110753890|NCT00092560|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110753891|NCT00092560|Antimetabolites|antimetabolites|mesh-ancestor
110753892|NCT00092560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110753893|NCT00092560|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110753894|NCT03769064|Methylphenidate|methylphenidate|mesh-list
110753895|NCT03769064|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110753896|NCT03769064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110753897|NCT03769064|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110753898|NCT03769064|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110753899|NCT03769064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110753900|NCT03769064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110753901|NCT03769064|Dopamine Agents|dopamine agents|mesh-ancestor
110753902|NCT03769064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110753903|NCT00090298|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110753904|NCT00090298|Simvastatin|simvastatin|mesh-list
110753905|NCT00090298|Ezetimibe|ezetimibe|mesh-list
110753906|NCT00090298|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110753907|NCT00090298|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110753908|NCT00090298|Antimetabolites|antimetabolites|mesh-ancestor
110753909|NCT00090298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110753910|NCT00090298|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110753911|NCT00090298|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110753912|NCT00090298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110753913|NCT03771092|Ferric gluconate|ferric gluconate|mesh-list
110753914|NCT03771092|Hematinics|hematinics|mesh-ancestor
110753915|NCT03768908|Artesunate|artesunate|mesh-list
110753916|NCT03768908|Lumefantrine|lumefantrine|mesh-list
110753917|NCT03768908|Artemether|artemether|mesh-list
110753918|NCT03768908|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
110753919|NCT03768908|Amodiaquine|amodiaquine|mesh-list
110753920|NCT03768908|Antimalarials|antimalarials|mesh-ancestor
110753921|NCT03768908|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110753922|NCT03768908|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110753923|NCT03768908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110753924|NCT03768908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110753925|NCT03768908|Antiviral Agents|antiviral agents|mesh-ancestor
110753926|NCT03768908|Schistosomicides|schistosomicides|mesh-ancestor
110753927|NCT03768908|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110753928|NCT03768908|Anthelmintics|anthelmintics|mesh-ancestor
110753929|NCT03777878|Oxytocin|oxytocin|mesh-list
110753930|NCT03777878|Carbetocin|carbetocin|mesh-list
110753931|NCT03777878|Oxytocics|oxytocics|mesh-ancestor
110753932|NCT03777878|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110753933|NCT03777878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110753934|NCT03246958|Nivolumab|nivolumab|mesh-list
110753935|NCT03246958|Ipilimumab|ipilimumab|mesh-list
110753936|NCT03246958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110753937|NCT03246958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110753938|NCT03246958|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110753939|NCT03246958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110753940|NCT01321268|Beta Carotene|beta carotene|mesh-list
110753941|NCT01321268|Lycopene|lycopene|mesh-list
110753942|NCT01321268|Resveratrol|resveratrol|mesh-list
110753943|NCT01321268|Carotenoids|carotenoids|mesh-list
110753944|NCT01321268|Antioxidants|antioxidants|mesh-ancestor
110753945|NCT01321268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110753946|NCT01321268|Protective Agents|protective agents|mesh-ancestor
110753947|NCT01321268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110753948|NCT01321268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110753949|NCT01321268|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110753950|NCT01321268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110753951|NCT01321268|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110753952|NCT01321268|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110753953|NCT01321268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110753954|NCT01321268|Provitamins|provitamins|mesh-ancestor
110753955|NCT01321268|Vitamins|vitamins|mesh-ancestor
110753956|NCT01321268|Micronutrients|micronutrients|mesh-ancestor
110753957|NCT01335958|DMUC5754A|dmuc5754a|mesh-list
110753958|NCT01335958|Immunoconjugates|immunoconjugates|mesh-ancestor
110753959|NCT01335958|Immunologic Factors|immunologic factors|mesh-ancestor
110753960|NCT01335958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110753961|NCT01561274|Bupivacaine|bupivacaine|mesh-list
110753962|NCT01561274|Anesthetics, Local|anesthetics, local|mesh-ancestor
110753963|NCT01561274|Anesthetics|anesthetics|mesh-ancestor
110471647|NCT02910414|Ethanol|ethanol|mesh-list
110753964|NCT01561274|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110753965|NCT01561274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110753966|NCT01561274|Sensory System Agents|sensory system agents|mesh-ancestor
110753967|NCT01561274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110753968|NCT02882854|Guanfacine|guanfacine|mesh-list
110753969|NCT02882854|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110753970|NCT02882854|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110753971|NCT02882854|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110753972|NCT02882854|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110753973|NCT02882854|Adrenergic Agents|adrenergic agents|mesh-ancestor
110753974|NCT02882854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110753975|NCT02882854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110753976|NCT02882854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110753977|NCT03770936|Candesartan|candesartan|mesh-list
110753978|NCT03770936|Candesartan cilexetil|candesartan cilexetil|mesh-list
110753979|NCT03770936|Ramipril|ramipril|mesh-list
110753980|NCT03770936|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110753981|NCT03770936|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110753982|NCT03770936|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110753983|NCT03770936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110753984|NCT03770936|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110753985|NCT03770936|Protease Inhibitors|protease inhibitors|mesh-ancestor
110753986|NCT03770936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110753987|NCT03150082|Ciprofloxacin|ciprofloxacin|mesh-list
110753988|NCT03150082|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110753989|NCT03150082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110753990|NCT03150082|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110753991|NCT03150082|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110753992|NCT03150082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110753993|NCT03150082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110753994|NCT03150082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110753995|NCT03150082|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110753996|NCT03150082|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110753997|NCT01321346|Cytarabine|cytarabine|mesh-list
110753998|NCT01321346|Panobinostat|panobinostat|mesh-list
110753999|NCT01321346|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110754000|NCT01321346|Antimetabolites|antimetabolites|mesh-ancestor
110754001|NCT01321346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110754002|NCT01321346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110754003|NCT01321346|Antiviral Agents|antiviral agents|mesh-ancestor
110754004|NCT01321346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110754005|NCT01321346|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110754006|NCT01321346|Immunologic Factors|immunologic factors|mesh-ancestor
110754007|NCT01321346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110754008|NCT01321346|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110754009|NCT01321346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110754010|NCT04058366|Ivacaftor|ivacaftor|mesh-list
110754011|NCT04058366|Elexacaftor|elexacaftor|mesh-list
110754012|NCT04058366|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
110754013|NCT04058366|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110754014|NCT04058366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110754015|NCT02118610|Tetrahydropalmatine|tetrahydropalmatine|mesh-list
110754016|NCT02118610|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110754017|NCT02118610|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110754018|NCT02118610|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110754019|NCT02118610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110754020|NCT02118610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110754021|NCT02118610|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110754022|NCT02118610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110754023|NCT02118610|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110754024|NCT02118610|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110754025|NCT02118610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110754026|NCT02118610|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110754027|NCT02118610|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110754028|NCT02118610|Dopamine Agents|dopamine agents|mesh-ancestor
110754029|NCT02118610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110754030|NCT02118610|Adrenergic Agents|adrenergic agents|mesh-ancestor
110754031|NCT02118610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110754032|NCT02118610|Analgesics|analgesics|mesh-ancestor
110754033|NCT02118610|Sensory System Agents|sensory system agents|mesh-ancestor
110754034|NCT02118610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110754035|NCT01561742|Minocycline|minocycline|mesh-list
110754036|NCT01561742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110754037|NCT01561742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110754038|NCT03770702|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
110754039|NCT03770702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110754040|NCT01345708|Prednisone|prednisone|mesh-list
110754041|NCT01345708|Rituximab|rituximab|mesh-list
110754042|NCT01345708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110754043|NCT01345708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110754044|NCT01345708|Immunologic Factors|immunologic factors|mesh-ancestor
110754045|NCT01345708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110754046|NCT01345708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110754047|NCT01345708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110754048|NCT01345708|Glucocorticoids|glucocorticoids|mesh-ancestor
110754049|NCT01345708|Hormones|hormones|mesh-ancestor
110754050|NCT01345708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110754051|NCT01345708|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110754052|NCT01345864|Scopolamine|scopolamine|mesh-list
110754053|NCT01345864|Donepezil|donepezil|mesh-list
110754054|NCT01345864|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
110754055|NCT01345864|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110754056|NCT01345864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110754057|NCT01345864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110754058|NCT01345864|Cholinergic Agents|cholinergic agents|mesh-ancestor
110754059|NCT01345864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110754060|NCT01345864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110754061|NCT01345864|Nootropic Agents|nootropic agents|mesh-ancestor
110754062|NCT01345864|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110754063|NCT01345864|Antiemetics|antiemetics|mesh-ancestor
110754064|NCT01345864|Autonomic Agents|autonomic agents|mesh-ancestor
110754065|NCT01345864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110754066|NCT01345864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110754067|NCT01345864|Mydriatics|mydriatics|mesh-ancestor
110754068|NCT01345864|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110754069|NCT01345864|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110754070|NCT01345864|Parasympatholytics|parasympatholytics|mesh-ancestor
110754071|NCT04320602|Eculizumab|eculizumab|mesh-list
110754072|NCT04320602|Ravulizumab|ravulizumab|mesh-list
110754073|NCT04320602|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
110754074|NCT04320602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110754075|NCT04320602|Immunologic Factors|immunologic factors|mesh-ancestor
110754076|NCT04320602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110754077|NCT03948022|Progesterone|progesterone|mesh-list
110754078|NCT03948022|Dydrogesterone|dydrogesterone|mesh-list
110754079|NCT03948022|Progestins|progestins|mesh-ancestor
110754081|NCT03948022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110754082|NCT03948022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110754083|NCT03777644|Morphine|morphine|mesh-list
110754084|NCT03777644|Ropivacaine|ropivacaine|mesh-list
110754085|NCT03777644|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110754086|NCT03777644|Narcotics|narcotics|mesh-ancestor
110754087|NCT03777644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110754088|NCT03777644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110754089|NCT03777644|Analgesics|analgesics|mesh-ancestor
110754090|NCT03777644|Sensory System Agents|sensory system agents|mesh-ancestor
110754091|NCT03777644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110754092|NCT03777644|Anesthetics, Local|anesthetics, local|mesh-ancestor
110754093|NCT03777644|Anesthetics|anesthetics|mesh-ancestor
110754094|NCT04345666|Methyltestosterone|methyltestosterone|mesh-list
110754095|NCT04345666|Testosterone|testosterone|mesh-list
110754096|NCT04345666|Testosterone undecanoate|testosterone undecanoate|mesh-list
110754097|NCT04345666|Testosterone enanthate|testosterone enanthate|mesh-list
110754098|NCT04345666|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
110754099|NCT04345666|Androgens|androgens|mesh-ancestor
110754101|NCT04345666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110754102|NCT04345666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110754103|NCT04345666|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110754104|NCT04345666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110754105|NCT04345666|Anabolic Agents|anabolic agents|mesh-ancestor
110754106|NCT01336192|Gemcitabine|gemcitabine|mesh-list
110754107|NCT01336192|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110754108|NCT01336192|Antimetabolites|antimetabolites|mesh-ancestor
110754109|NCT01336192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110754110|NCT01336192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110754111|NCT01336348|Tirofiban|tirofiban|mesh-list
110754112|NCT01336348|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
110754113|NCT01336348|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110754114|NCT01336348|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110754115|NCT01336348|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110754116|NCT01336348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110754117|NCT01346254|Pioglitazone|pioglitazone|mesh-list
110754118|NCT01346254|Vildagliptin|vildagliptin|mesh-list
110754119|NCT01346254|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110754120|NCT01346254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110754121|NCT01346254|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110754122|NCT01346254|Protease Inhibitors|protease inhibitors|mesh-ancestor
110754123|NCT01346254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110754124|NCT01346254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110754125|NCT04592536|Alprazolam|alprazolam|mesh-list
110754126|NCT04592536|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110754127|NCT04592536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110754128|NCT04592536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110754129|NCT04592536|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110754130|NCT04592536|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110754131|NCT04592536|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110754132|NCT04592536|GABA Modulators|gaba modulators|mesh-ancestor
110754133|NCT04592536|GABA Agents|gaba agents|mesh-ancestor
110754134|NCT04592536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110754135|NCT04592536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110754136|NCT01336582|Docetaxel|docetaxel|mesh-list
110754137|NCT01336582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110754138|NCT01336582|Tubulin Modulators|tubulin modulators|mesh-ancestor
110754139|NCT01336582|Antimitotic Agents|antimitotic agents|mesh-ancestor
110754140|NCT01336582|Mitosis Modulators|mitosis modulators|mesh-ancestor
110754141|NCT01336582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110754142|NCT03149848|Rifabutin|rifabutin|mesh-list
110754143|NCT03149848|Cabotegravir|cabotegravir|mesh-list
110754144|NCT03149848|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110754145|NCT03149848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110754146|NCT03149848|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110754147|NCT03149848|Antitubercular Agents|antitubercular agents|mesh-ancestor
110754148|NCT03149848|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110754149|NCT03149848|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110754150|NCT03149848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110754151|NCT03149848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110754152|NCT03149848|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110754153|NCT03149848|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110754154|NCT03149848|Antiviral Agents|antiviral agents|mesh-ancestor
110754163|NCT01346800|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110754164|NCT01346800|Antiviral Agents|antiviral agents|mesh-ancestor
110754165|NCT01346800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110754166|NCT01346800|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110754167|NCT01346800|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110754168|NCT01346800|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110754169|NCT03902314|Lidocaine|lidocaine|mesh-list
110754170|NCT03902314|Anesthetics, Local|anesthetics, local|mesh-ancestor
110754171|NCT03902314|Anesthetics|anesthetics|mesh-ancestor
110754172|NCT03902314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110754173|NCT03902314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110754174|NCT03902314|Sensory System Agents|sensory system agents|mesh-ancestor
110754175|NCT03902314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110754176|NCT03902314|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110754177|NCT03902314|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110754178|NCT03902314|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110754179|NCT03902314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110754180|NCT03902314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110754181|NCT01336660|Antivenins|antivenins|mesh-list
110754182|NCT01336660|Immunologic Factors|immunologic factors|mesh-ancestor
110754183|NCT01336660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110754184|NCT03768518|Exenatide|exenatide|mesh-list
110754185|NCT03768518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110311405|NCT00321360|Anesthetics|anesthetics|mesh-ancestor
110754186|NCT03768518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110754187|NCT03768518|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110754188|NCT03768518|Incretins|incretins|mesh-ancestor
110754189|NCT03768518|Hormones|hormones|mesh-ancestor
110471875|NCT00760669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110754190|NCT03768518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110754191|NCT04276376|Atezolizumab|atezolizumab|mesh-list
110754192|NCT04276376|Rucaparib|rucaparib|mesh-list
110754193|NCT04276376|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110754194|NCT04276376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110754195|NCT04276376|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110754196|NCT04276376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110754197|NCT04276376|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110754198|NCT04276376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110754206|NCT03770000|Romidepsin|romidepsin|mesh-list
110754207|NCT03770000|Tenalisib|tenalisib|mesh-list
110754208|NCT03770000|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110754209|NCT03770000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110754210|NCT03770000|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110754211|NCT03770000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110754212|NCT03770000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110754213|NCT03770000|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
110868223|NCT04583592|Anticoagulants|anticoagulants|mesh-ancestor
110754214|NCT03770312|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
110754215|NCT03770312|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110754216|NCT03770312|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110754217|NCT03770312|Antimetabolites|antimetabolites|mesh-ancestor
110754218|NCT03770312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110754219|NCT03770312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110754220|NCT03770312|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110754221|NCT03158272|Nivolumab|nivolumab|mesh-list
110754222|NCT03158272|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110754223|NCT03158272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110754224|NCT03158272|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110754225|NCT03158272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110754226|NCT01431508|Losartan|losartan|mesh-list
110754227|NCT01431508|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110754228|NCT01431508|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110754229|NCT01431508|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110754230|NCT01431508|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110754231|NCT01431508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110754232|NCT01321502|Famciclovir|famciclovir|mesh-list
110754233|NCT01321502|Antiviral Agents|antiviral agents|mesh-ancestor
110754234|NCT01321502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110754235|NCT01321502|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110754236|NCT01321502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110754237|NCT01321502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110754238|NCT01347268|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
110754239|NCT01347268|Hormones|hormones|mesh-ancestor
110754240|NCT01347268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110754241|NCT01347268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110754242|NCT01347424|Paclitaxel|paclitaxel|mesh-list
110754243|NCT01347424|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110754244|NCT01347424|Carboplatin|carboplatin|mesh-list
110754245|NCT01347424|Endostatins|endostatins|mesh-list
110754246|NCT01347424|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110754247|NCT01347424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110754248|NCT01347424|Tubulin Modulators|tubulin modulators|mesh-ancestor
110754249|NCT01347424|Antimitotic Agents|antimitotic agents|mesh-ancestor
110754250|NCT01347424|Mitosis Modulators|mitosis modulators|mesh-ancestor
110754251|NCT01347424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110754252|NCT01347424|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110754253|NCT01347424|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110754254|NCT01347424|Growth Substances|growth substances|mesh-ancestor
110754255|NCT01347424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110754256|NCT01347424|Growth Inhibitors|growth inhibitors|mesh-ancestor
110754257|NCT01322438|Rifampin|rifampin|mesh-list
110754258|NCT01322438|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110754259|NCT01322438|Antitubercular Agents|antitubercular agents|mesh-ancestor
110754260|NCT01322438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110754261|NCT01322438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110754262|NCT01322438|Leprostatic Agents|leprostatic agents|mesh-ancestor
110754263|NCT01322438|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110754264|NCT01322438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110754265|NCT01322438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110754266|NCT01322438|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110754267|NCT01322438|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110754268|NCT01322438|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110754269|NCT01322438|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110754270|NCT01322438|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110754271|NCT01322438|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110754272|NCT00654628|Simvastatin|simvastatin|mesh-list
110754273|NCT00654628|Ezetimibe|ezetimibe|mesh-list
110754274|NCT00654628|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110754275|NCT00654628|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110754276|NCT00654628|Antimetabolites|antimetabolites|mesh-ancestor
110754277|NCT00654628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110754278|NCT00654628|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110868230|NCT02418988|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110754279|NCT00654628|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110754280|NCT00654628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110754281|NCT00536380|Loratadine|loratadine|mesh-list
110754282|NCT00536380|Desloratadine|desloratadine|mesh-list
110754283|NCT00536380|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110754284|NCT00536380|Cholinergic Agents|cholinergic agents|mesh-ancestor
110754285|NCT00536380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110754286|NCT00536380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110754287|NCT00536380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110754288|NCT00536380|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110754289|NCT00536380|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110754290|NCT00536380|Histamine Antagonists|histamine antagonists|mesh-ancestor
110754291|NCT00536380|Histamine Agents|histamine agents|mesh-ancestor
110754292|NCT00536380|Antipruritics|antipruritics|mesh-ancestor
110754293|NCT00536380|Dermatologic Agents|dermatologic agents|mesh-ancestor
110754294|NCT00536380|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110754295|NCT01337362|Insulin|insulin|mesh-list
110754296|NCT01337362|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110754297|NCT01337362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110754298|NCT01337362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110754299|NCT03762824|Vaccines|vaccines|mesh-list
110754300|NCT03762824|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110754301|NCT03762824|Immunologic Factors|immunologic factors|mesh-ancestor
110754302|NCT03762824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110754303|NCT00496834|Losartan|losartan|mesh-list
110754304|NCT00496834|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110754305|NCT00496834|Carvedilol|carvedilol|mesh-list
110754306|NCT00496834|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110754307|NCT00496834|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110754308|NCT00496834|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110754309|NCT00496834|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110311436|NCT00321516|Dopamine Agents|dopamine agents|mesh-ancestor
110754310|NCT00496834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110754311|NCT00496834|Diuretics|diuretics|mesh-ancestor
110754312|NCT00496834|Natriuretic Agents|natriuretic agents|mesh-ancestor
110754313|NCT00496834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110754314|NCT00496834|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110754315|NCT00496834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110754316|NCT00496834|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110754317|NCT00496834|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110754318|NCT00496834|Adrenergic Agents|adrenergic agents|mesh-ancestor
110754319|NCT00496834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110754320|NCT00496834|Antioxidants|antioxidants|mesh-ancestor
110754321|NCT00496834|Protective Agents|protective agents|mesh-ancestor
110754322|NCT00496834|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110754323|NCT00496834|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110754324|NCT00496834|Vasodilator Agents|vasodilator agents|mesh-ancestor
110754325|NCT00496834|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110754326|NCT00496834|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110754327|NCT00189280|Imiquimod|imiquimod|mesh-list
110754328|NCT00189280|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110754329|NCT00189280|Immunologic Factors|immunologic factors|mesh-ancestor
110754330|NCT00189280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110754331|NCT00189280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110754332|NCT00189280|Interferon Inducers|interferon inducers|mesh-ancestor
110754333|NCT01352494|Gemcitabine|gemcitabine|mesh-list
110754334|NCT01352494|Docetaxel|docetaxel|mesh-list
110754335|NCT01352494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110754336|NCT01352494|Antimetabolites|antimetabolites|mesh-ancestor
110754337|NCT01352494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110754338|NCT01352494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110754339|NCT01352494|Tubulin Modulators|tubulin modulators|mesh-ancestor
110754340|NCT01352494|Antimitotic Agents|antimitotic agents|mesh-ancestor
110754341|NCT01352494|Mitosis Modulators|mitosis modulators|mesh-ancestor
110754342|NCT01347814|Domperidone|domperidone|mesh-list
110754343|NCT01347814|Antiemetics|antiemetics|mesh-ancestor
110754344|NCT01347814|Autonomic Agents|autonomic agents|mesh-ancestor
110754345|NCT01347814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110754346|NCT01347814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110754347|NCT01347814|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110754349|NCT01347814|Dopamine Agents|dopamine agents|mesh-ancestor
110754350|NCT01347814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110754351|NCT01347814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110754352|NCT01348126|Docetaxel|docetaxel|mesh-list
110754353|NCT01348126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110754354|NCT01348126|Tubulin Modulators|tubulin modulators|mesh-ancestor
110754355|NCT01348126|Antimitotic Agents|antimitotic agents|mesh-ancestor
110754356|NCT01348126|Mitosis Modulators|mitosis modulators|mesh-ancestor
110754357|NCT01348126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110754358|NCT01348204|Quercetin|quercetin|mesh-list
110754359|NCT01348204|Antioxidants|antioxidants|mesh-ancestor
110754360|NCT01348204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110754361|NCT01348204|Protective Agents|protective agents|mesh-ancestor
110754362|NCT01348204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110754363|NCT00166504|Atorvastatin|atorvastatin|mesh-list
110754364|NCT00166504|Simvastatin|simvastatin|mesh-list
110754365|NCT00166504|Ezetimibe|ezetimibe|mesh-list
110754366|NCT00166504|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110754367|NCT00166504|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110754368|NCT00166504|Antimetabolites|antimetabolites|mesh-ancestor
110754369|NCT00166504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110754370|NCT00166504|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110445303|NCT04317872|Glucocorticoids|glucocorticoids|mesh-ancestor
110754371|NCT00166504|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110754373|NCT01348282|Rivastigmine|rivastigmine|mesh-list
110754374|NCT01348282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110754375|NCT01348282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110754376|NCT01348282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110754377|NCT01348282|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110754378|NCT01348282|Cholinergic Agents|cholinergic agents|mesh-ancestor
110754379|NCT01348282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110754380|NCT01348282|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110754381|NCT01348282|Protective Agents|protective agents|mesh-ancestor
110754382|NCT03137992|Bromides|bromides|mesh-list
110754383|NCT03137992|Tiotropium Bromide|tiotropium bromide|mesh-list
110754384|NCT03137992|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110754385|NCT03137992|Autonomic Agents|autonomic agents|mesh-ancestor
110754386|NCT03137992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110754387|NCT03137992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110754388|NCT03137992|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110754389|NCT03137992|Respiratory System Agents|respiratory system agents|mesh-ancestor
110754390|NCT03137992|Parasympatholytics|parasympatholytics|mesh-ancestor
110754391|NCT03137992|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110754392|NCT03137992|Cholinergic Agents|cholinergic agents|mesh-ancestor
110754393|NCT03137992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110754394|NCT03137992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110754395|NCT03137992|Anticonvulsants|anticonvulsants|mesh-ancestor
110754396|NCT04470778|Famotidine|famotidine|mesh-list
110754397|NCT04470778|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110754398|NCT04470778|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110754399|NCT04470778|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110754400|NCT04470778|Histamine Antagonists|histamine antagonists|mesh-ancestor
110754401|NCT04470778|Histamine Agents|histamine agents|mesh-ancestor
110754402|NCT04470778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110754403|NCT04470778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110754404|NCT04470778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110754405|NCT01352572|Milnacipran|milnacipran|mesh-list
110754406|NCT01352572|Mirtazapine|mirtazapine|mesh-list
110754407|NCT01352572|Sertraline|sertraline|mesh-list
110754408|NCT01352572|Fluoxetine|fluoxetine|mesh-list
110754409|NCT01352572|Paroxetine|paroxetine|mesh-list
110754410|NCT01352572|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
110754411|NCT01352572|Antidepressive Agents|antidepressive agents|mesh-list
110754412|NCT01352572|Levomilnacipran|levomilnacipran|mesh-list
110754414|NCT01352572|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110754415|NCT01352572|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110754416|NCT01352572|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110754417|NCT01352572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110754418|NCT01352572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110754419|NCT01352572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110754420|NCT01352572|Serotonin Agents|serotonin agents|mesh-ancestor
110754421|NCT01352572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110754422|NCT01352572|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110754423|NCT01352572|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110754424|NCT01352572|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110754425|NCT01352572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110754426|NCT01352572|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110754427|NCT01352572|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110754428|NCT01352572|Histamine Antagonists|histamine antagonists|mesh-ancestor
110754429|NCT01352572|Histamine Agents|histamine agents|mesh-ancestor
110754430|NCT01352572|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110754431|NCT01352572|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110754432|NCT01352572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110754433|NCT01352572|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
110754434|NCT01352572|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110754435|NCT01352572|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110754436|NCT01352572|Adrenergic Agents|adrenergic agents|mesh-ancestor
110754437|NCT01352572|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110754438|NCT01352572|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110754439|NCT01352572|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110754440|NCT01352572|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110754441|NCT01352572|Analgesics|analgesics|mesh-ancestor
110754442|NCT01352572|Sensory System Agents|sensory system agents|mesh-ancestor
110754443|NCT01352572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110079514|NCT01622946|Coagulants|coagulants|mesh-ancestor
110754444|NCT01352572|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110754445|NCT01352572|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110754447|NCT01352650|Decitabine|decitabine|mesh-list
110754448|NCT01352650|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110754449|NCT01352650|Antimetabolites|antimetabolites|mesh-ancestor
110754450|NCT01352650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110754451|NCT01352650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110754452|NCT01352650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110754453|NCT01352650|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110754454|NCT01352650|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110754455|NCT01352650|Antiviral Agents|antiviral agents|mesh-ancestor
110754456|NCT01352650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110754457|NCT01352728|Axitinib|axitinib|mesh-list
110754458|NCT01352728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110754459|NCT01352728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110754460|NCT01352728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110754461|NCT01352728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110754462|NCT03997448|Pembrolizumab|pembrolizumab|mesh-list
110754463|NCT03997448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110754464|NCT03997448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110754465|NCT03997448|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110754466|NCT03997448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110754467|NCT03767660|Sirolimus|sirolimus|mesh-list
110754468|NCT03767660|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110754469|NCT03767660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110754470|NCT03767660|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110754471|NCT03767660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110754472|NCT03767660|Antifungal Agents|antifungal agents|mesh-ancestor
110754473|NCT03767660|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110754474|NCT03767660|Immunologic Factors|immunologic factors|mesh-ancestor
110754475|NCT03767660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110754476|NCT03767504|Thymol|thymol|mesh-list
110754477|NCT03767504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110754478|NCT03767504|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110754479|NCT03767504|Antifungal Agents|antifungal agents|mesh-ancestor
110754480|NCT01343290|Canagliflozin|canagliflozin|mesh-list
110754481|NCT01343290|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110754482|NCT01343290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110754483|NCT01343290|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110472193|NCT02791035|Ipragliflozin|ipragliflozin|mesh-list
110754484|NCT01343290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110754485|NCT03761264|Amoxicillin|amoxicillin|mesh-list
110754486|NCT03761264|Zinc Oxide|zinc oxide|mesh-list
110754487|NCT03761264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110754488|NCT03761264|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110754489|NCT03761264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110754490|NCT03761264|Dermatologic Agents|dermatologic agents|mesh-ancestor
110754491|NCT03761264|Sunscreening Agents|sunscreening agents|mesh-ancestor
110754492|NCT03761264|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110754493|NCT03761264|Protective Agents|protective agents|mesh-ancestor
110754494|NCT05096312|Zinc|zinc|mesh-list
110754495|NCT05096312|Adapalene|adapalene|mesh-list
110754496|NCT05096312|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
110754497|NCT05096312|Benzoyl Peroxide|benzoyl peroxide|mesh-list
110754498|NCT05096312|Trace Elements|trace elements|mesh-ancestor
110754499|NCT05096312|Micronutrients|micronutrients|mesh-ancestor
110754500|NCT05096312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110754501|NCT05096312|Dermatologic Agents|dermatologic agents|mesh-ancestor
110754502|NCT05096312|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110754503|NCT05096312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110754504|NCT05096312|Analgesics|analgesics|mesh-ancestor
110754505|NCT05096312|Sensory System Agents|sensory system agents|mesh-ancestor
110754506|NCT05096312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110754507|NCT05096312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110754508|NCT05096312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110754509|NCT03767036|Ketorolac|ketorolac|mesh-list
110754510|NCT03767036|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
110754511|NCT03767036|Tramadol|tramadol|mesh-list
110754512|NCT03767036|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110754513|NCT03767036|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110754514|NCT03767036|Analgesics|analgesics|mesh-ancestor
110754515|NCT03767036|Sensory System Agents|sensory system agents|mesh-ancestor
110754516|NCT03767036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110754518|NCT03767036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110754519|NCT03767036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110754520|NCT03767036|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110754521|NCT03767036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110754522|NCT03767036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110754523|NCT03767036|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110754524|NCT03767036|Narcotics|narcotics|mesh-ancestor
110754525|NCT03767036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110754526|NCT03758144|Rifaximin|rifaximin|mesh-list
110754527|NCT03758144|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110754528|NCT03758144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110754529|NCT03758144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110754530|NCT03766724|Dapagliflozin|dapagliflozin|mesh-list
110754531|NCT03766724|Empagliflozin|empagliflozin|mesh-list
110754532|NCT03766724|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110754533|NCT03766724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110754534|NCT03766724|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110754535|NCT03766724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110754536|NCT04860518|Dexamethasone|dexamethasone|mesh-list
110754537|NCT04860518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110754538|NCT04860518|Antiemetics|antiemetics|mesh-ancestor
110754539|NCT04860518|Autonomic Agents|autonomic agents|mesh-ancestor
110754540|NCT04860518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110754541|NCT04860518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110754542|NCT04860518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110754543|NCT04860518|Glucocorticoids|glucocorticoids|mesh-ancestor
110754544|NCT04860518|Hormones|hormones|mesh-ancestor
110754545|NCT04860518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110754546|NCT04860518|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110754547|NCT04860518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110754548|NCT03110380|Dolutegravir|dolutegravir|mesh-list
110754549|NCT03110380|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
110754550|NCT03110380|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110754551|NCT03110380|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110754552|NCT03110380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110754553|NCT03110380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110754554|NCT03110380|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110754555|NCT03110380|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110754556|NCT03110380|Antiviral Agents|antiviral agents|mesh-ancestor
110754557|NCT03110380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110754558|NCT03110380|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110472254|NCT02788851|Methylphenidate|methylphenidate|mesh-list
110754559|NCT03110380|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110754560|NCT03757910|Corticosterone|corticosterone|mesh-list
110754561|NCT03757910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110754562|NCT01322204|Codeine|codeine|mesh-list
110754563|NCT01322204|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110754564|NCT01322204|Narcotics|narcotics|mesh-ancestor
110754565|NCT01322204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110754566|NCT01322204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110754567|NCT01322204|Analgesics|analgesics|mesh-ancestor
110754568|NCT01322204|Sensory System Agents|sensory system agents|mesh-ancestor
110754569|NCT01322204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110754570|NCT01322204|Antitussive Agents|antitussive agents|mesh-ancestor
110754571|NCT01322204|Respiratory System Agents|respiratory system agents|mesh-ancestor
110754572|NCT03766490|Gefitinib|gefitinib|mesh-list
110754573|NCT03766490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110754574|NCT03766490|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110754575|NCT03766490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110754576|NCT03766490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110754577|NCT01348984|Fentanyl|fentanyl|mesh-list
110754578|NCT01348984|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110754579|NCT01348984|Narcotics|narcotics|mesh-ancestor
110754580|NCT01348984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110754581|NCT01348984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110754582|NCT01348984|Analgesics|analgesics|mesh-ancestor
110754583|NCT01348984|Sensory System Agents|sensory system agents|mesh-ancestor
110754584|NCT01348984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110754585|NCT01348984|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110754586|NCT01348984|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110754587|NCT01348984|Anesthetics, General|anesthetics, general|mesh-ancestor
110754588|NCT01348984|Anesthetics|anesthetics|mesh-ancestor
110754589|NCT01567670|Naloxone|naloxone|mesh-list
110754590|NCT01567670|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110754591|NCT01567670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110754592|NCT01567670|Sensory System Agents|sensory system agents|mesh-ancestor
110754593|NCT01567670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110754594|NCT01349062|Immunomodulating Agents|immunomodulating agents|mesh-list
110754595|NCT01349062|Immunologic Factors|immunologic factors|mesh-ancestor
110754596|NCT01349062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110754597|NCT04848662|Budesonide|budesonide|mesh-list
110754598|NCT04848662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110754599|NCT04848662|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110754600|NCT04848662|Autonomic Agents|autonomic agents|mesh-ancestor
110754601|NCT04848662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110754602|NCT04848662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110754603|NCT04848662|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110754604|NCT04848662|Respiratory System Agents|respiratory system agents|mesh-ancestor
110754605|NCT04848662|Glucocorticoids|glucocorticoids|mesh-ancestor
110754606|NCT04848662|Hormones|hormones|mesh-ancestor
110754607|NCT04848662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110754608|NCT04351256|Durvalumab|durvalumab|mesh-list
110754609|NCT04351256|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110754610|NCT04351256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110754611|NCT03700892|Cinnamaldehyde|cinnamaldehyde|mesh-list
110754612|NCT03700892|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110754613|NCT03700892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110754614|NCT03700892|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
110754615|NCT03700892|Protective Agents|protective agents|mesh-ancestor
110754616|NCT03700892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110754617|NCT01322282|Cetirizine|cetirizine|mesh-list
110754618|NCT01322282|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110754619|NCT01322282|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110754620|NCT01322282|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110754621|NCT01322282|Histamine Antagonists|histamine antagonists|mesh-ancestor
110754622|NCT01322282|Histamine Agents|histamine agents|mesh-ancestor
110754623|NCT01322282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110754624|NCT01322282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110754625|NCT01322282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110754626|NCT03757364|Methotrexate|methotrexate|mesh-list
110754627|NCT03757364|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110754628|NCT03757364|Abortifacient Agents|abortifacient agents|mesh-ancestor
110754629|NCT03757364|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110754630|NCT03757364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110754631|NCT03757364|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110754632|NCT03757364|Antimetabolites|antimetabolites|mesh-ancestor
110754633|NCT03757364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110754634|NCT03757364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110754635|NCT03757364|Dermatologic Agents|dermatologic agents|mesh-ancestor
110754636|NCT03757364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110754637|NCT03757364|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110754638|NCT03757364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110754639|NCT03757364|Immunologic Factors|immunologic factors|mesh-ancestor
110754640|NCT03757364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110754641|NCT03757364|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110754642|NCT03766178|Nimotuzumab|nimotuzumab|mesh-list
110754643|NCT03766178|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110754644|NCT03766178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110754645|NCT04737278|Nicotinic Acids|nicotinic acids|mesh-list
110754647|NCT04737278|Vitamin B Complex|vitamin b complex|mesh-ancestor
110754648|NCT04737278|Vitamins|vitamins|mesh-ancestor
110754649|NCT04737278|Micronutrients|micronutrients|mesh-ancestor
110754650|NCT04737278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110754651|NCT04737278|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110754652|NCT04737278|Antimetabolites|antimetabolites|mesh-ancestor
110754653|NCT04737278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110754654|NCT04737278|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110754655|NCT04737278|Vasodilator Agents|vasodilator agents|mesh-ancestor
110754656|NCT03759860|Ranibizumab|ranibizumab|mesh-list
110754657|NCT03759860|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110754658|NCT03759860|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110754659|NCT03759860|Growth Substances|growth substances|mesh-ancestor
110754660|NCT03759860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110754661|NCT03759860|Growth Inhibitors|growth inhibitors|mesh-ancestor
110754662|NCT03759860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110754663|NCT03759782|Tenofovir|tenofovir|mesh-list
110754664|NCT03759782|Ribavirin|ribavirin|mesh-list
110754665|NCT03759782|Antiviral Agents|antiviral agents|mesh-ancestor
110754666|NCT03759782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110754667|NCT03759782|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110754668|NCT03759782|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110754669|NCT03759782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110754670|NCT03759782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110754671|NCT03759782|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110754672|NCT03759782|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110754673|NCT03759782|Antimetabolites|antimetabolites|mesh-ancestor
110754674|NCT03757052|Amoxicillin|amoxicillin|mesh-list
110754675|NCT03757052|Penicillins|penicillins|mesh-list
110754676|NCT03757052|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110754677|NCT03757052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110754678|NCT03765944|Sirolimus|sirolimus|mesh-list
110754679|NCT03765944|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110754680|NCT03765944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110754681|NCT03765944|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110754682|NCT03765944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110754683|NCT03765944|Antifungal Agents|antifungal agents|mesh-ancestor
110754684|NCT03765944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110754685|NCT03765944|Immunologic Factors|immunologic factors|mesh-ancestor
110754686|NCT03765944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110754687|NCT04684394|Aflibercept|aflibercept|mesh-list
110754688|NCT04684394|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110754689|NCT04684394|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110754690|NCT04684394|Growth Substances|growth substances|mesh-ancestor
110754691|NCT04684394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110754692|NCT04684394|Growth Inhibitors|growth inhibitors|mesh-ancestor
110754693|NCT04684394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110754694|NCT03765554|PF-06700841|pf-06700841|mesh-list
110754695|NCT03765554|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110754696|NCT03765554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110754697|NCT03765554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110754698|NCT04668950|Fluvoxamine|fluvoxamine|mesh-list
110754699|NCT04668950|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110754700|NCT04668950|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110754701|NCT04668950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110754702|NCT04668950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110754703|NCT04668950|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110754704|NCT04668950|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110754705|NCT04668950|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110754706|NCT04668950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110754707|NCT04668950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110754708|NCT04668950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110472414|NCT00706576|Mitogens|mitogens|mesh-list
110754709|NCT04668950|Serotonin Agents|serotonin agents|mesh-ancestor
110754710|NCT04668950|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110754711|NCT04668950|Antidepressive Agents|antidepressive agents|mesh-ancestor
110754712|NCT04668950|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110754713|NCT04668950|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110754714|NCT04668950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110754715|NCT04668950|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110754717|NCT03078478|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110754718|NCT03078478|Insulin Glargine|insulin glargine|mesh-list
110754719|NCT03078478|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110754720|NCT03078478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110754721|NCT01349296|Everolimus|everolimus|mesh-list
110754722|NCT01349296|Nintedanib|nintedanib|mesh-list
110754723|NCT01349296|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110754724|NCT01349296|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110754725|NCT01349296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110754726|NCT01349296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110754727|NCT01349296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110754728|NCT01349296|Immunologic Factors|immunologic factors|mesh-ancestor
110754729|NCT01349296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110754730|NCT01349296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110754731|NCT03522844|Escitalopram|escitalopram|mesh-list
110754732|NCT03522844|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110754733|NCT03522844|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110754734|NCT03522844|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110754735|NCT03522844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110754736|NCT03522844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110754738|NCT03522844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110754739|NCT00045942|Itraconazole|itraconazole|mesh-list
110754740|NCT00045942|Midostaurin|midostaurin|mesh-list
110754741|NCT00045942|Antifungal Agents|antifungal agents|mesh-ancestor
110754742|NCT00045942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110754743|NCT00045942|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110754744|NCT00045942|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110754745|NCT00045942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110754746|NCT00045942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110754747|NCT00045942|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110754748|NCT00045942|Hormone Antagonists|hormone antagonists|mesh-ancestor
110754749|NCT00045942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110754750|NCT00045942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110754751|NCT00045942|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110754752|NCT00045942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110754753|NCT00045942|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110754755|NCT04386616|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110754756|NCT04386616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110754757|NCT04386616|Antiviral Agents|antiviral agents|mesh-ancestor
110754758|NCT04386616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110754759|NCT00045708|Epothilones|epothilones|mesh-list
110754760|NCT00045708|Epothilone B|epothilone b|mesh-list
110754761|NCT00045708|Anticonvulsants|anticonvulsants|mesh-list
110754762|NCT00045708|Tubulin Modulators|tubulin modulators|mesh-ancestor
110754763|NCT00045708|Antimitotic Agents|antimitotic agents|mesh-ancestor
110754764|NCT00045708|Mitosis Modulators|mitosis modulators|mesh-ancestor
110754765|NCT00045708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110754766|NCT00045708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110754767|NCT01349452|Ganciclovir|ganciclovir|mesh-list
110754768|NCT01349452|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
110754769|NCT01349452|Lubricant Eye Drops|lubricant eye drops|mesh-list
110754770|NCT01349452|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110754771|NCT01349452|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110754772|NCT01349452|Antiviral Agents|antiviral agents|mesh-ancestor
110754773|NCT01349452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110754774|NCT01349452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110754775|NCT01349452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110754776|NCT01349452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110754777|NCT00045630|Paclitaxel|paclitaxel|mesh-list
110754778|NCT00045630|Carboplatin|carboplatin|mesh-list
110754779|NCT00045630|Gemcitabine|gemcitabine|mesh-list
110754780|NCT00045630|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110754781|NCT00045630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110472494|NCT03105843|Miotics|miotics|mesh-ancestor
110754782|NCT00045630|Tubulin Modulators|tubulin modulators|mesh-ancestor
110754783|NCT00045630|Antimitotic Agents|antimitotic agents|mesh-ancestor
110754784|NCT00045630|Mitosis Modulators|mitosis modulators|mesh-ancestor
110754785|NCT00045630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110754786|NCT00045630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110754787|NCT00045630|Antimetabolites|antimetabolites|mesh-ancestor
110754789|NCT01357252|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110754790|NCT01357252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110754791|NCT01357252|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110754792|NCT01357252|Protease Inhibitors|protease inhibitors|mesh-ancestor
110754793|NCT01357252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110754794|NCT01357252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110754795|NCT03465280|Interferons|interferons|mesh-list
110754796|NCT03465280|Acyclovir|acyclovir|mesh-list
110754797|NCT03465280|Cidofovir|cidofovir|mesh-list
110754798|NCT03465280|Interferon-alpha|interferon-alpha|mesh-list
110754799|NCT03465280|Artemisinins|artemisinins|mesh-list
110754800|NCT03465280|Artemisinin|artemisinin|mesh-list
110754801|NCT03465280|Celecoxib|celecoxib|mesh-list
110754802|NCT03465280|Methotrexate|methotrexate|mesh-list
110754803|NCT03465280|Indole-3-carbinol|indole-3-carbinol|mesh-list
110754804|NCT03465280|Isotretinoin|isotretinoin|mesh-list
110754805|NCT03465280|Cimetidine|cimetidine|mesh-list
110754806|NCT03465280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110754807|NCT03465280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110754808|NCT03465280|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110754809|NCT03465280|Abortifacient Agents|abortifacient agents|mesh-ancestor
110754810|NCT03465280|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110754811|NCT03465280|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110754812|NCT03465280|Antimetabolites|antimetabolites|mesh-ancestor
110311545|NCT00289406|Amlodipine|amlodipine|mesh-list
110754813|NCT03465280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110754814|NCT03465280|Dermatologic Agents|dermatologic agents|mesh-ancestor
110754815|NCT03465280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110754816|NCT03465280|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110754817|NCT03465280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110754818|NCT03465280|Immunologic Factors|immunologic factors|mesh-ancestor
110754819|NCT03465280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110754820|NCT03465280|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110754821|NCT03465280|Antiviral Agents|antiviral agents|mesh-ancestor
110754822|NCT03465280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110754823|NCT03465280|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110754824|NCT03465280|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110754825|NCT03465280|Analgesics|analgesics|mesh-ancestor
110754826|NCT03465280|Sensory System Agents|sensory system agents|mesh-ancestor
110754827|NCT03465280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110754828|NCT03465280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110754829|NCT03465280|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110754830|NCT03465280|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110754831|NCT03465280|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110754832|NCT03465280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110754833|NCT03465280|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110754834|NCT03465280|Histamine Antagonists|histamine antagonists|mesh-ancestor
110754835|NCT03465280|Histamine Agents|histamine agents|mesh-ancestor
110754836|NCT03465280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110754837|NCT03465280|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110754838|NCT03465280|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110754839|NCT03465280|Antimalarials|antimalarials|mesh-ancestor
110754840|NCT03465280|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110754841|NCT03465280|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110754842|NCT03465280|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110754843|NCT03465280|Protective Agents|protective agents|mesh-ancestor
110754845|NCT01349764|Cholecalciferol|cholecalciferol|mesh-list
110754846|NCT01349764|Vitamins|vitamins|mesh-ancestor
110754847|NCT01349764|Micronutrients|micronutrients|mesh-ancestor
110754848|NCT01349764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110754849|NCT01349764|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110754850|NCT01349764|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110754851|NCT02924272|Ixazomib|ixazomib|mesh-list
110754852|NCT02924272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110754853|NCT02924272|Protease Inhibitors|protease inhibitors|mesh-ancestor
110754854|NCT02924272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110754855|NCT02924272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110754856|NCT01353742|Lamivudine|lamivudine|mesh-list
110754857|NCT01353742|Adefovir|adefovir|mesh-list
110472556|NCT04302116|Prednisolone acetate|prednisolone acetate|mesh-list
110754859|NCT01353742|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110754860|NCT01353742|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110754861|NCT01353742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110754862|NCT01353742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110754863|NCT01353742|Antiviral Agents|antiviral agents|mesh-ancestor
110754864|NCT01353742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110754865|NCT01353742|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110754866|NCT01353742|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110754867|NCT00003702|Dactinomycin|dactinomycin|mesh-list
110754868|NCT00003702|Cactinomycin|cactinomycin|mesh-list
110754869|NCT00003702|Methotrexate|methotrexate|mesh-list
110754870|NCT00003702|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110754871|NCT00003702|Abortifacient Agents|abortifacient agents|mesh-ancestor
110754872|NCT00003702|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110311552|NCT00289406|Vasodilator Agents|vasodilator agents|mesh-ancestor
110754873|NCT00003702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110754874|NCT00003702|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110754875|NCT00003702|Antimetabolites|antimetabolites|mesh-ancestor
110754876|NCT00003702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110754877|NCT00003702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110754878|NCT00003702|Dermatologic Agents|dermatologic agents|mesh-ancestor
110754879|NCT00003702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110754880|NCT00003702|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110754881|NCT00003702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110754883|NCT00003702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110754884|NCT00003702|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110754885|NCT00003702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110754886|NCT00003702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110868290|NCT03686618|Secretin|secretin|mesh-list
110754887|NCT00003702|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110754888|NCT00003702|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110754889|NCT01350154|Sildenafil Citrate|sildenafil citrate|mesh-list
110754890|NCT01350154|Vasodilator Agents|vasodilator agents|mesh-ancestor
110754891|NCT01350154|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110754892|NCT01350154|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110754893|NCT01350154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110754894|NCT01350154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110754895|NCT01350154|Urological Agents|urological agents|mesh-ancestor
110754896|NCT00031590|Cyclophosphamide|cyclophosphamide|mesh-list
110754898|NCT00031590|Etoposide|etoposide|mesh-list
110754899|NCT00031590|Vincristine|vincristine|mesh-list
110754900|NCT00031590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110754901|NCT00031590|Immunologic Factors|immunologic factors|mesh-ancestor
110754902|NCT00031590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110754903|NCT00031590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110754904|NCT00031590|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110754905|NCT00031590|Alkylating Agents|alkylating agents|mesh-ancestor
110754906|NCT00031590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110754907|NCT00031590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110754908|NCT00031590|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110754909|NCT00031590|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110754910|NCT00031590|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110754911|NCT00031590|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110754912|NCT00031590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110754913|NCT00031590|Tubulin Modulators|tubulin modulators|mesh-ancestor
110754914|NCT00031590|Antimitotic Agents|antimitotic agents|mesh-ancestor
110754915|NCT00031590|Mitosis Modulators|mitosis modulators|mesh-ancestor
110754916|NCT01318096|Tenofovir|tenofovir|mesh-list
110754917|NCT01318096|Lamivudine|lamivudine|mesh-list
110754918|NCT01318096|Efavirenz|efavirenz|mesh-list
110754919|NCT01318096|Raltegravir Potassium|raltegravir potassium|mesh-list
110754920|NCT01318096|Antiviral Agents|antiviral agents|mesh-ancestor
110754921|NCT01318096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110754922|NCT01318096|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110754923|NCT01318096|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110754924|NCT01318096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110754925|NCT01318096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110754926|NCT01318096|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110754927|NCT01318096|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110754928|NCT01318096|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110754929|NCT01318096|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110754930|NCT01318096|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110754931|NCT01318096|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110754932|NCT01318096|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110754933|NCT01318096|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110754934|NCT01318096|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110754935|NCT01318096|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110754936|NCT02530320|Palbociclib|palbociclib|mesh-list
110754937|NCT02530320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110754938|NCT02530320|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110754939|NCT02530320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110754940|NCT02530320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110754941|NCT00239681|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110754942|NCT00239681|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110754943|NCT00239681|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110754944|NCT00239681|Antimetabolites|antimetabolites|mesh-ancestor
110754945|NCT00239681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110754946|NCT00239681|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110754947|NCT00239681|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110754948|NCT00239681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110754949|NCT00238433|Melphalan|melphalan|mesh-list
110754950|NCT00238433|Busulfan|busulfan|mesh-list
110754951|NCT00238433|Thiotepa|thiotepa|mesh-list
110754952|NCT00238433|Immunologic Factors|immunologic factors|mesh-ancestor
110754953|NCT00238433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110445315|NCT01132547|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110754955|NCT00238433|Alkylating Agents|alkylating agents|mesh-ancestor
110754956|NCT00238433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110754957|NCT00238433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110754958|NCT00238433|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110754959|NCT00238433|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110754960|NCT02532023|Curcumin|curcumin|mesh-list
110754961|NCT02532023|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110754962|NCT02532023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110754963|NCT02532023|Analgesics|analgesics|mesh-ancestor
110754964|NCT02532023|Sensory System Agents|sensory system agents|mesh-ancestor
110754965|NCT02532023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110754966|NCT02532023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110754967|NCT02532023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110754968|NCT02532023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110754969|NCT02532023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110754970|NCT02532023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110754971|NCT02532023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110754972|NCT01354522|Cyclophosphamide|cyclophosphamide|mesh-list
110754973|NCT01354522|Docetaxel|docetaxel|mesh-list
110754974|NCT01354522|Doxorubicin|doxorubicin|mesh-list
110754975|NCT01354522|Capecitabine|capecitabine|mesh-list
110754976|NCT01354522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110754977|NCT01354522|Immunologic Factors|immunologic factors|mesh-ancestor
110754978|NCT01354522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110754979|NCT01354522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110754980|NCT01354522|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110754981|NCT01354522|Alkylating Agents|alkylating agents|mesh-ancestor
110754982|NCT01354522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110754983|NCT01354522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110754984|NCT01354522|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110754985|NCT01354522|Tubulin Modulators|tubulin modulators|mesh-ancestor
110754986|NCT01354522|Antimitotic Agents|antimitotic agents|mesh-ancestor
110754987|NCT01354522|Mitosis Modulators|mitosis modulators|mesh-ancestor
110754988|NCT01354522|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110754989|NCT01354522|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110754990|NCT01354522|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110754991|NCT01354522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110754992|NCT01354522|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110754993|NCT01354522|Antimetabolites|antimetabolites|mesh-ancestor
110754994|NCT00045162|Irinotecan|irinotecan|mesh-list
110754995|NCT00045162|Etoposide|etoposide|mesh-list
110754996|NCT00045162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110754997|NCT00045162|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110754998|NCT00045162|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110754999|NCT00045162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110755000|NCT00045162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110755001|NCT00045162|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110755002|NCT00045162|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110755003|NCT02748616|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
110755004|NCT02748616|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
110755005|NCT02748616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110755006|NCT00238121|Sorafenib|sorafenib|mesh-list
110755007|NCT00238121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110755008|NCT00238121|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110755009|NCT00238121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110755010|NCT00238121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110755011|NCT01350622|Diclofenac|diclofenac|mesh-list
110755012|NCT01350622|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
110755013|NCT01350622|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110755014|NCT01350622|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110755015|NCT01350622|Analgesics|analgesics|mesh-ancestor
110755016|NCT01350622|Sensory System Agents|sensory system agents|mesh-ancestor
110755017|NCT01350622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110755018|NCT01350622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110868308|NCT02423824|Liraglutide|liraglutide|mesh-list
110755019|NCT01350622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110755020|NCT01350622|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110755021|NCT01350622|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110755022|NCT01350622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110755023|NCT01350622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110755024|NCT01096212|Sevoflurane|sevoflurane|mesh-list
110755025|NCT01096212|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110755026|NCT01096212|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110755028|NCT01096212|Anesthetics|anesthetics|mesh-ancestor
110755029|NCT01096212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110755030|NCT01096212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110755031|NCT03139240|Oxycodone|oxycodone|mesh-list
110755032|NCT03139240|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110755033|NCT03139240|Narcotics|narcotics|mesh-ancestor
110755034|NCT03139240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110755035|NCT03139240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110755036|NCT03139240|Analgesics|analgesics|mesh-ancestor
110755037|NCT03139240|Sensory System Agents|sensory system agents|mesh-ancestor
110755038|NCT03139240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110755039|NCT01350856|Artesunate|artesunate|mesh-list
110755040|NCT01350856|Antimalarials|antimalarials|mesh-ancestor
110755041|NCT01350856|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110755042|NCT01350856|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110755043|NCT01350856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110755044|NCT01350856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110755045|NCT01350856|Antiviral Agents|antiviral agents|mesh-ancestor
110755046|NCT01350856|Schistosomicides|schistosomicides|mesh-ancestor
110755047|NCT01350856|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110755048|NCT01350856|Anthelmintics|anthelmintics|mesh-ancestor
110755049|NCT03973775|Permethrin|permethrin|mesh-list
110755050|NCT03973775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110755051|NCT03973775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110755052|NCT01351168|Levodopa|levodopa|mesh-list
110755053|NCT01351168|Zolpidem|zolpidem|mesh-list
110755054|NCT01351168|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110755055|NCT01351168|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110755056|NCT01351168|Dopamine Agents|dopamine agents|mesh-ancestor
110755057|NCT01351168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110755058|NCT01351168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110755059|NCT01351168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110755060|NCT01351168|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110755061|NCT01351168|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110755062|NCT01351168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110755063|NCT01351168|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
110755064|NCT01351168|GABA Agonists|gaba agonists|mesh-ancestor
110755065|NCT01351168|GABA Agents|gaba agents|mesh-ancestor
110755066|NCT01351636|Arotinolol|arotinolol|mesh-list
110755067|NCT01351636|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110755068|NCT01351636|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110755069|NCT01351636|Adrenergic Agents|adrenergic agents|mesh-ancestor
110755070|NCT01351636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110755071|NCT01351636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110755072|NCT01351636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110755073|NCT01351636|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110755074|NCT01351792|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
110755075|NCT01351792|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110755076|NCT01351792|Respiratory System Agents|respiratory system agents|mesh-ancestor
110755077|NCT03952260|Anesthetics|anesthetics|mesh-list
110755078|NCT03952260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110755079|NCT03952260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110755080|NCT01351948|Aluminum Hydroxide|aluminum hydroxide|mesh-list
110755081|NCT01351948|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110755082|NCT01351948|Immunologic Factors|immunologic factors|mesh-ancestor
110755083|NCT01351948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110755084|NCT01351948|Antacids|antacids|mesh-ancestor
110755085|NCT01351948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110868312|NCT02423824|Hormones|hormones|mesh-ancestor
110755086|NCT01351948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110755087|NCT01352026|Metformin|metformin|mesh-list
110755088|NCT01352026|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110755089|NCT01352026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110755090|NCT03136198|Vasodilator Agents|vasodilator agents|mesh-list
110755091|NCT03136198|Diuretics|diuretics|mesh-list
110755092|NCT03136198|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
110755093|NCT03136198|Natriuretic Agents|natriuretic agents|mesh-ancestor
110755094|NCT03136198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110755095|NCT03136198|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110755096|NCT03136198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110755097|NCT01357486|Sorafenib|sorafenib|mesh-list
110755098|NCT01357486|Pravastatin|pravastatin|mesh-list
110755099|NCT01357486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110755100|NCT01357486|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110755101|NCT01357486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110755102|NCT01357486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110755104|NCT01357486|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110755105|NCT01357486|Antimetabolites|antimetabolites|mesh-ancestor
110755106|NCT01357486|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110755107|NCT01357486|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110755108|NCT01318564|Metformin|metformin|mesh-list
110755109|NCT01318564|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110755110|NCT01318564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110755111|NCT00042432|Cinacalcet|cinacalcet|mesh-list
110755112|NCT00042432|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110755113|NCT00042432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110755114|NCT00042432|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
110755115|NCT00042432|Hormone Antagonists|hormone antagonists|mesh-ancestor
110755116|NCT00042432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110755117|NCT01352338|Prednisone|prednisone|mesh-list
110755118|NCT01352338|Cyclophosphamide|cyclophosphamide|mesh-list
110755119|NCT01352338|Lenalidomide|lenalidomide|mesh-list
110755120|NCT01352338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110755121|NCT01352338|Immunologic Factors|immunologic factors|mesh-ancestor
110755122|NCT01352338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110755123|NCT01352338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110755124|NCT01352338|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110755125|NCT01352338|Alkylating Agents|alkylating agents|mesh-ancestor
110755126|NCT01352338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110755127|NCT01352338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110755128|NCT01352338|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110755129|NCT01352338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110755130|NCT01352338|Glucocorticoids|glucocorticoids|mesh-ancestor
110755131|NCT01352338|Hormones|hormones|mesh-ancestor
110755132|NCT01352338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110755133|NCT01352338|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110755134|NCT01352338|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110755135|NCT01352338|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110755136|NCT01352338|Growth Substances|growth substances|mesh-ancestor
110755137|NCT01352338|Growth Inhibitors|growth inhibitors|mesh-ancestor
110755138|NCT01542736|Carboplatin|carboplatin|mesh-list
110755139|NCT01542736|Vincristine|vincristine|mesh-list
110755140|NCT01542736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110755141|NCT01542736|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110755142|NCT01542736|Tubulin Modulators|tubulin modulators|mesh-ancestor
110755143|NCT01542736|Antimitotic Agents|antimitotic agents|mesh-ancestor
110755144|NCT01542736|Mitosis Modulators|mitosis modulators|mesh-ancestor
110755145|NCT01542736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110755146|NCT01099566|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
110755147|NCT01099566|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110755148|NCT01099722|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
110755149|NCT01099722|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110755150|NCT01099722|Respiratory System Agents|respiratory system agents|mesh-ancestor
110755151|NCT01361542|Infliximab|infliximab|mesh-list
110755152|NCT01361542|Etanercept|etanercept|mesh-list
110755153|NCT01361542|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110755154|NCT01361542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110755155|NCT01361542|Dermatologic Agents|dermatologic agents|mesh-ancestor
110755156|NCT01361542|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110755157|NCT01361542|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110755158|NCT01361542|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110755159|NCT01361542|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110755160|NCT01361542|Analgesics|analgesics|mesh-ancestor
110755161|NCT01361542|Sensory System Agents|sensory system agents|mesh-ancestor
110755162|NCT01361542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110755163|NCT01361542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110755164|NCT01361542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110755165|NCT01361542|Immunologic Factors|immunologic factors|mesh-ancestor
110755166|NCT03950700|Epinephrine|epinephrine|mesh-list
110755167|NCT03950700|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
110755168|NCT03950700|Bupivacaine|bupivacaine|mesh-list
110755169|NCT03950700|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110755170|NCT03950700|Anesthetics, Local|anesthetics, local|mesh-ancestor
110755171|NCT03950700|Anesthetics|anesthetics|mesh-ancestor
110755172|NCT03950700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110755173|NCT03950700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110755174|NCT03950700|Sensory System Agents|sensory system agents|mesh-ancestor
110755175|NCT03950700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110755176|NCT03950700|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110755177|NCT03950700|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110755178|NCT03950700|Adrenergic Agents|adrenergic agents|mesh-ancestor
110755179|NCT03950700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110755180|NCT03950700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110755181|NCT03950700|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110755182|NCT03950700|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110755183|NCT03950700|Autonomic Agents|autonomic agents|mesh-ancestor
110755184|NCT03950700|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110755185|NCT03950700|Respiratory System Agents|respiratory system agents|mesh-ancestor
110755186|NCT03950700|Mydriatics|mydriatics|mesh-ancestor
110755187|NCT03950700|Sympathomimetics|sympathomimetics|mesh-ancestor
110755188|NCT00237185|Imatinib Mesylate|imatinib mesylate|mesh-list
110755189|NCT00237185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110755190|NCT00237185|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110755191|NCT00237185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110755192|NCT00237185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110755193|NCT01357798|Botulinum Toxins|botulinum toxins|mesh-list
110755194|NCT01357798|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110755195|NCT01357798|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110755196|NCT01357798|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110755197|NCT01357798|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110755198|NCT01357798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110755199|NCT01357798|Cholinergic Agents|cholinergic agents|mesh-ancestor
110755200|NCT01357798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110755201|NCT01357798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110755202|NCT01357798|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110755203|NCT01357798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110755204|NCT00003222|Aldesleukin|aldesleukin|mesh-list
110755205|NCT00003222|Interleukin-2|interleukin-2|mesh-list
110755206|NCT00003222|Sargramostim|sargramostim|mesh-list
110755207|NCT00003222|Freund's Adjuvant|freund's adjuvant|mesh-list
110755208|NCT00003222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110755209|NCT00003222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110755210|NCT00003222|Analgesics|analgesics|mesh-ancestor
110755211|NCT00003222|Sensory System Agents|sensory system agents|mesh-ancestor
110755212|NCT00003222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110755213|NCT00003222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110755214|NCT00003222|Immunologic Factors|immunologic factors|mesh-ancestor
110755215|NCT00003222|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110755216|NCT00003222|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110755217|NCT00003222|Antiviral Agents|antiviral agents|mesh-ancestor
110755218|NCT00003222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110755219|NCT00003222|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110755220|NCT01357876|Metformin|metformin|mesh-list
110755221|NCT01357876|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110755222|NCT01357876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110755223|NCT02877082|Bortezomib|bortezomib|mesh-list
110755224|NCT02877082|Tacrolimus|tacrolimus|mesh-list
110755225|NCT02877082|Thymoglobulin|thymoglobulin|mesh-list
110755226|NCT02877082|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110755227|NCT02877082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110755228|NCT02877082|Immunologic Factors|immunologic factors|mesh-ancestor
110755229|NCT02877082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110472934|NCT02784717|Anticoagulants|anticoagulants|mesh-ancestor
110755230|NCT02877082|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110755231|NCT02877082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110755232|NCT02877082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110755233|NCT02877082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110311653|NCT00290069|Sirolimus|sirolimus|mesh-list
110755235|NCT03951558|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110755236|NCT03951558|Diuretics|diuretics|mesh-ancestor
110755237|NCT03951558|Natriuretic Agents|natriuretic agents|mesh-ancestor
110755238|NCT03951558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110755239|NCT03951558|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110755240|NCT03951558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110755241|NCT03951558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110755242|NCT01362010|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110755243|NCT01362010|Minocycline|minocycline|mesh-list
110755244|NCT01362010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110755245|NCT02875366|Ivacaftor|ivacaftor|mesh-list
110755246|NCT02875366|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
110755247|NCT02875366|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110868370|NCT05760456|Metformin|metformin|mesh-list
110445320|NCT01132547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110755248|NCT02875366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110755250|NCT01362400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110755251|NCT01362400|Tubulin Modulators|tubulin modulators|mesh-ancestor
110755252|NCT01362400|Antimitotic Agents|antimitotic agents|mesh-ancestor
110755253|NCT01362400|Mitosis Modulators|mitosis modulators|mesh-ancestor
110755254|NCT01362400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110755256|NCT00003102|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110755257|NCT00003102|Immunologic Factors|immunologic factors|mesh-ancestor
110755258|NCT00003102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110755259|NCT00002850|Ciprofloxacin|ciprofloxacin|mesh-list
110755260|NCT00002850|Ofloxacin|ofloxacin|mesh-list
110755261|NCT00002850|Trimethoprim|trimethoprim|mesh-list
110755262|NCT00002850|Sulfamethoxazole|sulfamethoxazole|mesh-list
110755263|NCT00002850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110755264|NCT00002850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110755265|NCT00002850|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110755266|NCT00002850|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110755267|NCT00002850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110755268|NCT00002850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110755269|NCT00002850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110755270|NCT00002850|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110755271|NCT00002850|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110755272|NCT00002850|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110755273|NCT00002850|Antimalarials|antimalarials|mesh-ancestor
110755274|NCT00002850|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110755275|NCT00002850|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110755276|NCT00002850|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110755277|NCT00002850|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110755278|NCT00002850|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
110755279|NCT04234906|Magnesium Sulfate|magnesium sulfate|mesh-list
110755280|NCT04234906|Amiodarone|amiodarone|mesh-list
110755281|NCT04234906|Procainamide|procainamide|mesh-list
110755282|NCT04234906|Dexmedetomidine|dexmedetomidine|mesh-list
110755283|NCT04234906|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110755284|NCT04234906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110755285|NCT04234906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110755286|NCT04234906|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110755287|NCT04234906|Analgesics|analgesics|mesh-ancestor
110755288|NCT04234906|Sensory System Agents|sensory system agents|mesh-ancestor
110755289|NCT04234906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110755290|NCT04234906|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110755291|NCT04234906|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110755292|NCT04234906|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110755293|NCT04234906|Adrenergic Agents|adrenergic agents|mesh-ancestor
110311666|NCT04718259|Midazolam|midazolam|mesh-list
110755294|NCT04234906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110755295|NCT04234906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110755296|NCT04234906|Anesthetics|anesthetics|mesh-ancestor
110755297|NCT04234906|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110755298|NCT04234906|Anticonvulsants|anticonvulsants|mesh-ancestor
110755299|NCT04234906|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110755300|NCT04234906|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110755301|NCT04234906|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110755302|NCT04234906|Tocolytic Agents|tocolytic agents|mesh-ancestor
110755303|NCT04234906|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110473014|NCT00759031|Listerine|listerine|mesh-list
110755305|NCT04234906|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
110755306|NCT04234906|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110755307|NCT04234906|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110755308|NCT04234906|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110755309|NCT04234906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110755310|NCT04234906|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110755311|NCT04234906|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110755312|NCT04234906|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110755313|NCT04234906|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110755314|NCT00002766|Cytarabine|cytarabine|mesh-list
110755315|NCT00002766|Dactinomycin|dactinomycin|mesh-list
110755316|NCT00002766|Prednisone|prednisone|mesh-list
110755317|NCT00002766|Cyclophosphamide|cyclophosphamide|mesh-list
110755318|NCT00002766|Carmustine|carmustine|mesh-list
110755319|NCT00002766|Doxorubicin|doxorubicin|mesh-list
110755320|NCT00002766|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110755321|NCT00002766|Methotrexate|methotrexate|mesh-list
110755322|NCT00002766|Etoposide|etoposide|mesh-list
110755323|NCT00002766|Vincristine|vincristine|mesh-list
110755324|NCT00002766|Daunorubicin|daunorubicin|mesh-list
110755325|NCT00002766|Mitoxantrone|mitoxantrone|mesh-list
110755326|NCT00002766|Mercaptopurine|mercaptopurine|mesh-list
110755327|NCT00002766|Pegaspargase|pegaspargase|mesh-list
110755328|NCT00002766|Sargramostim|sargramostim|mesh-list
110755329|NCT00002766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110755330|NCT00002766|Immunologic Factors|immunologic factors|mesh-ancestor
110755331|NCT00002766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110755332|NCT00002766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110755333|NCT00002766|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110755334|NCT00002766|Alkylating Agents|alkylating agents|mesh-ancestor
110755335|NCT00002766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110755336|NCT00002766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110755337|NCT00002766|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110755338|NCT00002766|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110755339|NCT00002766|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110755340|NCT00002766|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110755341|NCT00002766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110755342|NCT00002766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110755343|NCT00002766|Glucocorticoids|glucocorticoids|mesh-ancestor
110755344|NCT00002766|Hormones|hormones|mesh-ancestor
110755345|NCT00002766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110755346|NCT00002766|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110755347|NCT00002766|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110755348|NCT00002766|Abortifacient Agents|abortifacient agents|mesh-ancestor
110755349|NCT00002766|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110755350|NCT00002766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110755351|NCT00002766|Antimetabolites|antimetabolites|mesh-ancestor
110755352|NCT00002766|Dermatologic Agents|dermatologic agents|mesh-ancestor
110755353|NCT00002766|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110755354|NCT00002766|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110755355|NCT00002766|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110755356|NCT00002766|Antiviral Agents|antiviral agents|mesh-ancestor
110755357|NCT00002766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110755358|NCT00002766|Tubulin Modulators|tubulin modulators|mesh-ancestor
110755359|NCT00002766|Antimitotic Agents|antimitotic agents|mesh-ancestor
110755360|NCT00002766|Mitosis Modulators|mitosis modulators|mesh-ancestor
110755361|NCT00002766|Analgesics|analgesics|mesh-ancestor
110755362|NCT00002766|Sensory System Agents|sensory system agents|mesh-ancestor
110755363|NCT00002766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110755364|NCT00002766|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110755365|NCT00002766|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110755366|NCT01355380|Iloprost|iloprost|mesh-list
110868398|NCT02675790|Hydroxyurea|hydroxyurea|mesh-list
110755367|NCT01355380|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110755368|NCT01355380|Vasodilator Agents|vasodilator agents|mesh-ancestor
110755370|NCT01355614|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110755371|NCT01355614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110755372|NCT01355614|Dermatologic Agents|dermatologic agents|mesh-ancestor
110755373|NCT01355614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110755374|NCT01355614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110755375|NCT01584492|Beclomethasone|beclomethasone|mesh-list
110755376|NCT01584492|Albuterol|albuterol|mesh-list
110755377|NCT01584492|Formoterol Fumarate|formoterol fumarate|mesh-list
110755378|NCT01584492|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110755379|NCT01584492|Autonomic Agents|autonomic agents|mesh-ancestor
110755380|NCT01584492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110755381|NCT01584492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110755382|NCT01584492|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110755383|NCT01584492|Respiratory System Agents|respiratory system agents|mesh-ancestor
110755384|NCT01584492|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110755385|NCT01584492|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110755386|NCT01584492|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110755387|NCT01584492|Adrenergic Agents|adrenergic agents|mesh-ancestor
110755388|NCT01584492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110755389|NCT01584492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110755390|NCT01584492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110755392|NCT01584492|Hormones|hormones|mesh-ancestor
110755393|NCT01584492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110755394|NCT01584492|Tocolytic Agents|tocolytic agents|mesh-ancestor
110755395|NCT01584492|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110755396|NCT00001962|Daclizumab|daclizumab|mesh-list
110755397|NCT00001962|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110755398|NCT00001962|Immunologic Factors|immunologic factors|mesh-ancestor
110755399|NCT00001962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110755400|NCT01101984|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110755401|NCT01101984|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110755402|NCT01101984|Hyaluronic Acid|hyaluronic acid|mesh-list
110755403|NCT01101984|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110755404|NCT01101984|Immunologic Factors|immunologic factors|mesh-ancestor
110755405|NCT01101984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110755406|NCT01101984|Viscosupplements|viscosupplements|mesh-ancestor
110755407|NCT01101984|Protective Agents|protective agents|mesh-ancestor
110755408|NCT01103154|Nadolol|nadolol|mesh-list
110755409|NCT01103154|Carvedilol|carvedilol|mesh-list
110755410|NCT01103154|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110755411|NCT01103154|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110755412|NCT01103154|Adrenergic Agents|adrenergic agents|mesh-ancestor
110755413|NCT01103154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110755414|NCT01103154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110755415|NCT01103154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110755416|NCT01103154|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110755417|NCT01103154|Antioxidants|antioxidants|mesh-ancestor
110755418|NCT01103154|Protective Agents|protective agents|mesh-ancestor
110755419|NCT01103154|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110755420|NCT01103154|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110755421|NCT01103154|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110755422|NCT01103154|Vasodilator Agents|vasodilator agents|mesh-ancestor
110311681|NCT04718259|GABA Modulators|gaba modulators|mesh-ancestor
110755423|NCT01103154|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110755424|NCT01103154|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110755425|NCT01103154|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110755426|NCT01103154|Sympatholytics|sympatholytics|mesh-ancestor
110755427|NCT01103154|Autonomic Agents|autonomic agents|mesh-ancestor
110755428|NCT01103154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110755429|NCT01100346|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
110755430|NCT01100346|Hormones|hormones|mesh-ancestor
110755431|NCT01100346|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110755432|NCT01100346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110755433|NCT01103388|Rituximab|rituximab|mesh-list
110755434|NCT01103388|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110755435|NCT01103388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110755436|NCT01103388|Immunologic Factors|immunologic factors|mesh-ancestor
110755437|NCT01103388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110755438|NCT01103388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110755439|NCT01327326|Naltrexone|naltrexone|mesh-list
110755440|NCT01327326|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110755441|NCT01327326|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110755442|NCT01327326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110755443|NCT01327326|Sensory System Agents|sensory system agents|mesh-ancestor
110755444|NCT01327326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110755445|NCT03950544|Meropenem|meropenem|mesh-list
110755446|NCT03950544|Fosfomycin|fosfomycin|mesh-list
110755447|NCT03950544|Tigecycline|tigecycline|mesh-list
110755448|NCT03950544|Polymyxins|polymyxins|mesh-list
110755449|NCT03950544|Polymyxin B|polymyxin b|mesh-list
110755450|NCT03950544|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110755451|NCT03950544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110755452|NCT03950544|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110755453|NCT03950544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110755454|NCT03950544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110755455|NCT00028002|Imatinib Mesylate|imatinib mesylate|mesh-list
110473163|NCT02782221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110755456|NCT00028002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110755457|NCT00028002|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110755458|NCT00028002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110755459|NCT00028002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110755460|NCT00256997|Risperidone|risperidone|mesh-list
110755461|NCT00256997|Antipsychotic Agents|antipsychotic agents|mesh-list
110755462|NCT00256997|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110755463|NCT00256997|Serotonin Agents|serotonin agents|mesh-ancestor
110755464|NCT00256997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110755465|NCT00256997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110755466|NCT00256997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110755467|NCT00256997|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110755468|NCT00256997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110755469|NCT00256997|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110755470|NCT00256997|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110755471|NCT00256997|Dopamine Agents|dopamine agents|mesh-ancestor
110755472|NCT00027846|Cyclophosphamide|cyclophosphamide|mesh-list
110755474|NCT00027846|Etoposide|etoposide|mesh-list
110755475|NCT00027846|Vincristine|vincristine|mesh-list
110755476|NCT00027846|Podophyllotoxin|podophyllotoxin|mesh-list
110755477|NCT00027846|Lenograstim|lenograstim|mesh-list
110755478|NCT00027846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110755479|NCT00027846|Immunologic Factors|immunologic factors|mesh-ancestor
110755480|NCT00027846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110755481|NCT00027846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110755482|NCT00027846|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110755483|NCT00027846|Alkylating Agents|alkylating agents|mesh-ancestor
110755484|NCT00027846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110755485|NCT00027846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110755486|NCT00027846|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110755487|NCT00027846|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110755488|NCT00027846|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110755489|NCT00027846|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110755490|NCT00027846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110755491|NCT00027846|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110755492|NCT00027846|Tubulin Modulators|tubulin modulators|mesh-ancestor
110755493|NCT00027846|Antimitotic Agents|antimitotic agents|mesh-ancestor
110755494|NCT00027846|Mitosis Modulators|mitosis modulators|mesh-ancestor
110755495|NCT00027846|Keratolytic Agents|keratolytic agents|mesh-ancestor
110755496|NCT00027846|Dermatologic Agents|dermatologic agents|mesh-ancestor
110755497|NCT00027378|Fluoxetine|fluoxetine|mesh-list
110755498|NCT00027378|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110755499|NCT00027378|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110755500|NCT00027378|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110755501|NCT00027378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110755502|NCT00027378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110755503|NCT00027378|Serotonin Agents|serotonin agents|mesh-ancestor
110755504|NCT00027378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110755505|NCT00027378|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110755506|NCT00027378|Antidepressive Agents|antidepressive agents|mesh-ancestor
110755507|NCT00027378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110755508|NCT00027378|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110755509|NCT00027378|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110755510|NCT00027378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110755511|NCT03949062|Rituximab|rituximab|mesh-list
110755512|NCT03949062|Lenalidomide|lenalidomide|mesh-list
110755513|NCT03949062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110755514|NCT03949062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110755515|NCT03949062|Immunologic Factors|immunologic factors|mesh-ancestor
110755516|NCT03949062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110755517|NCT03949062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110755518|NCT03949062|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110755519|NCT03949062|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110755520|NCT03949062|Growth Substances|growth substances|mesh-ancestor
110755521|NCT03949062|Growth Inhibitors|growth inhibitors|mesh-ancestor
110755522|NCT00235391|Deferasirox|deferasirox|mesh-list
110755523|NCT00235391|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110755524|NCT00235391|Chelating Agents|chelating agents|mesh-ancestor
110755525|NCT00235391|Sequestering Agents|sequestering agents|mesh-ancestor
110755526|NCT00235391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110755527|NCT01103622|Digoxin|digoxin|mesh-list
110755528|NCT01103622|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110755529|NCT01103622|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110755530|NCT01103622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110755531|NCT01103622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110755532|NCT01103622|Protective Agents|protective agents|mesh-ancestor
110755533|NCT01103622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110755534|NCT01072955|Heparin|heparin|mesh-list
110755535|NCT01072955|Calcium heparin|calcium heparin|mesh-list
110755536|NCT01072955|Anticoagulants|anticoagulants|mesh-ancestor
110755537|NCT01072955|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110755538|NCT01072955|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110755539|NCT01072955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110755540|NCT00026208|Prednisone|prednisone|mesh-list
110755541|NCT00026208|Cyclophosphamide|cyclophosphamide|mesh-list
110755542|NCT00026208|Doxorubicin|doxorubicin|mesh-list
110755543|NCT00026208|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110755544|NCT00026208|Etoposide|etoposide|mesh-list
110755545|NCT00026208|Etoposide phosphate|etoposide phosphate|mesh-list
110755546|NCT00026208|Vincristine|vincristine|mesh-list
110755547|NCT00026208|Bleomycin|bleomycin|mesh-list
110755548|NCT00026208|Vinblastine|vinblastine|mesh-list
110755549|NCT00026208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110755550|NCT00026208|Immunologic Factors|immunologic factors|mesh-ancestor
110755551|NCT00026208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110755552|NCT00026208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110755553|NCT00026208|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110755554|NCT00026208|Alkylating Agents|alkylating agents|mesh-ancestor
110755555|NCT00026208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110755556|NCT00026208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110755557|NCT00026208|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110755558|NCT00026208|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110755559|NCT00026208|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110755560|NCT00026208|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110755561|NCT00026208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110755562|NCT00026208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110755563|NCT00026208|Glucocorticoids|glucocorticoids|mesh-ancestor
110755564|NCT00026208|Hormones|hormones|mesh-ancestor
110755565|NCT00026208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110755566|NCT00026208|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110755567|NCT00026208|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110755568|NCT00026208|Tubulin Modulators|tubulin modulators|mesh-ancestor
110755569|NCT00026208|Antimitotic Agents|antimitotic agents|mesh-ancestor
110755570|NCT00026208|Mitosis Modulators|mitosis modulators|mesh-ancestor
110755571|NCT00025662|Interleukin-2|interleukin-2|mesh-list
110755572|NCT00025662|Immunotoxins|immunotoxins|mesh-list
110755573|NCT00025662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110755574|NCT00025662|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110755575|NCT00025662|Analgesics|analgesics|mesh-ancestor
110755576|NCT00025662|Sensory System Agents|sensory system agents|mesh-ancestor
110755577|NCT00025662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110755578|NCT00025662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110755579|NCT00025662|Immunoconjugates|immunoconjugates|mesh-ancestor
110755580|NCT00025662|Immunologic Factors|immunologic factors|mesh-ancestor
110755581|NCT03759158|Acetylcysteine|acetylcysteine|mesh-list
110755582|NCT03759158|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110755583|NCT03759158|Antiviral Agents|antiviral agents|mesh-ancestor
110755584|NCT03759158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110755585|NCT03759158|Expectorants|expectorants|mesh-ancestor
110755586|NCT03759158|Respiratory System Agents|respiratory system agents|mesh-ancestor
110755587|NCT03759158|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110755588|NCT03759158|Antioxidants|antioxidants|mesh-ancestor
110755589|NCT03759158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110755590|NCT03759158|Protective Agents|protective agents|mesh-ancestor
110755591|NCT03759158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110755592|NCT03759158|Antidotes|antidotes|mesh-ancestor
110755593|NCT00025506|Thalidomide|thalidomide|mesh-list
110755594|NCT00025506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110755595|NCT00025506|Immunologic Factors|immunologic factors|mesh-ancestor
110755596|NCT00025506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110755597|NCT00025506|Leprostatic Agents|leprostatic agents|mesh-ancestor
110755598|NCT00025506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110755599|NCT00025506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110755600|NCT00025506|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110755601|NCT00025506|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110755602|NCT00025506|Growth Substances|growth substances|mesh-ancestor
110755603|NCT00025506|Growth Inhibitors|growth inhibitors|mesh-ancestor
110755604|NCT00025506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110755605|NCT00024258|Arsenic Trioxide|arsenic trioxide|mesh-list
110755606|NCT00024258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110755607|NCT03756272|Bupivacaine|bupivacaine|mesh-list
110755608|NCT03756272|Anesthetics, Local|anesthetics, local|mesh-ancestor
110755609|NCT03756272|Anesthetics|anesthetics|mesh-ancestor
110755610|NCT03756272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110755611|NCT03756272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110755612|NCT03756272|Sensory System Agents|sensory system agents|mesh-ancestor
110755613|NCT03756272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110755614|NCT03756194|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110755615|NCT03756116|Epinephrine|epinephrine|mesh-list
110755616|NCT03756116|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110755617|NCT03756116|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110755618|NCT03756116|Adrenergic Agents|adrenergic agents|mesh-ancestor
110755619|NCT03756116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110445327|NCT01194830|Incretins|incretins|mesh-ancestor
110755620|NCT03756116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110755621|NCT03756116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110755622|NCT03756116|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110755623|NCT03756116|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110755625|NCT03756116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110755626|NCT03756116|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110755627|NCT03756116|Respiratory System Agents|respiratory system agents|mesh-ancestor
110755628|NCT03756116|Mydriatics|mydriatics|mesh-ancestor
110755629|NCT03756116|Sympathomimetics|sympathomimetics|mesh-ancestor
110755630|NCT03756116|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110755631|NCT00023712|Bortezomib|bortezomib|mesh-list
110755632|NCT00023712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110755633|NCT00023322|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110755634|NCT00023322|Antiviral Agents|antiviral agents|mesh-ancestor
110755635|NCT00023322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110755636|NCT04640168|Remdesivir|remdesivir|mesh-list
110755637|NCT04640168|Dexamethasone|dexamethasone|mesh-list
110868427|NCT02505204|Analgesics|analgesics|mesh-ancestor
110755638|NCT04640168|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110755639|NCT04640168|Antiemetics|antiemetics|mesh-ancestor
110755640|NCT04640168|Autonomic Agents|autonomic agents|mesh-ancestor
110755641|NCT04640168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110755642|NCT04640168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110755643|NCT04640168|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110755644|NCT04640168|Glucocorticoids|glucocorticoids|mesh-ancestor
110755645|NCT04640168|Hormones|hormones|mesh-ancestor
110755646|NCT04640168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110755647|NCT04640168|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110755648|NCT04640168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110755649|NCT04640168|Antimetabolites|antimetabolites|mesh-ancestor
110755650|NCT04640168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110755651|NCT04640168|Antiviral Agents|antiviral agents|mesh-ancestor
110755652|NCT04640168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110755653|NCT00022698|Capecitabine|capecitabine|mesh-list
110755654|NCT00022698|Irinotecan|irinotecan|mesh-list
110755655|NCT00022698|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110755656|NCT00022698|Antimetabolites|antimetabolites|mesh-ancestor
110755657|NCT00022698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110755658|NCT00022698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110755659|NCT00022698|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110755660|NCT00022698|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110755661|NCT00022698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110755662|NCT03951402|Moxifloxacin|moxifloxacin|mesh-list
110755663|NCT03951402|Tapentadol|tapentadol|mesh-list
110755664|NCT03951402|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
110755665|NCT03951402|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110755666|NCT03951402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110755667|NCT03951402|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110755668|NCT03951402|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110755669|NCT03951402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110755670|NCT03951402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110755671|NCT03951402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110755672|NCT03951402|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110755673|NCT03951402|Contraceptive Agents|contraceptive agents|mesh-ancestor
110755674|NCT03951402|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110755675|NCT03951402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110755676|NCT03951402|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110755677|NCT03951402|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110755678|NCT03951402|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110755679|NCT03951402|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110755680|NCT03951402|Narcotics|narcotics|mesh-ancestor
110755681|NCT03951402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110755682|NCT03951402|Analgesics|analgesics|mesh-ancestor
110755683|NCT03951402|Sensory System Agents|sensory system agents|mesh-ancestor
110755684|NCT03951402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110755685|NCT03951402|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110755686|NCT03951402|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110755687|NCT03951402|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110755688|NCT03951402|Adrenergic Agents|adrenergic agents|mesh-ancestor
110755689|NCT03951402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110755690|NCT01100736|Bosentan|bosentan|mesh-list
110755691|NCT01100736|Sitaxsentan|sitaxsentan|mesh-list
110755692|NCT01100736|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110755693|NCT01100736|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
110755694|NCT01100736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110755695|NCT01584726|Magnesium Sulfate|magnesium sulfate|mesh-list
110755697|NCT01584726|Sensory System Agents|sensory system agents|mesh-ancestor
110755698|NCT01584726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110755699|NCT01584726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110755700|NCT01584726|Anesthetics|anesthetics|mesh-ancestor
110755701|NCT01584726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110755702|NCT01584726|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110755703|NCT01584726|Anticonvulsants|anticonvulsants|mesh-ancestor
110868440|NCT04351698|Montelukast|montelukast|mesh-list
110755704|NCT01584726|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110755705|NCT01584726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110755706|NCT01584726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110755707|NCT01584726|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110755708|NCT01584726|Tocolytic Agents|tocolytic agents|mesh-ancestor
110755709|NCT01584726|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110755710|NCT01584804|Antitussive Agents|antitussive agents|mesh-list
110755711|NCT01584804|Respiratory System Agents|respiratory system agents|mesh-ancestor
110755712|NCT01105494|Epoetin Alfa|epoetin alfa|mesh-list
110755713|NCT01105494|Hematinics|hematinics|mesh-ancestor
110755714|NCT03949686|Bupivacaine|bupivacaine|mesh-list
110755715|NCT03949686|Anesthetics, Local|anesthetics, local|mesh-ancestor
110755716|NCT03949686|Anesthetics|anesthetics|mesh-ancestor
110755717|NCT03949686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110755718|NCT03949686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110755719|NCT03949686|Sensory System Agents|sensory system agents|mesh-ancestor
110755720|NCT03949686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110755721|NCT03949842|Fluticasone|fluticasone|mesh-list
110755722|NCT03949842|Xhance|xhance|mesh-list
110755723|NCT03949842|Adrenergic Agents|adrenergic agents|mesh-list
110755724|NCT03949842|Cholinergic Agents|cholinergic agents|mesh-list
110755725|NCT03949842|Muscarinic Antagonists|muscarinic antagonists|mesh-list
110755726|NCT03949842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110755727|NCT03949842|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110755728|NCT03949842|Autonomic Agents|autonomic agents|mesh-ancestor
110755729|NCT03949842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110755730|NCT03949842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110755731|NCT03949842|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110755732|NCT03949842|Respiratory System Agents|respiratory system agents|mesh-ancestor
110755733|NCT03949842|Dermatologic Agents|dermatologic agents|mesh-ancestor
110755734|NCT03949842|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110755735|NCT03949842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110755736|NCT03949842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110755737|NCT03949842|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110755738|NCT01102608|Ifosfamide|ifosfamide|mesh-list
110755739|NCT01102608|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110755740|NCT01102608|Alkylating Agents|alkylating agents|mesh-ancestor
110755741|NCT01102608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110755742|NCT01102608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110755743|NCT01102686|Leucovorin|leucovorin|mesh-list
110755744|NCT01102686|Pyrimethamine|pyrimethamine|mesh-list
110755745|NCT01102686|Antidotes|antidotes|mesh-ancestor
110755746|NCT01102686|Protective Agents|protective agents|mesh-ancestor
110755747|NCT01102686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110755748|NCT01102686|Vitamin B Complex|vitamin b complex|mesh-ancestor
110755749|NCT01102686|Vitamins|vitamins|mesh-ancestor
110755750|NCT01102686|Micronutrients|micronutrients|mesh-ancestor
110755751|NCT01102686|Antimalarials|antimalarials|mesh-ancestor
110755752|NCT01102686|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110755753|NCT01102686|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110755754|NCT01102686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110755755|NCT01102686|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110755756|NCT01102686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110755757|NCT01102686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110755758|NCT03949374|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110755759|NCT03949374|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110755760|NCT03949374|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110755761|NCT03949374|Antimetabolites|antimetabolites|mesh-ancestor
110755762|NCT03949374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110755763|NCT03949374|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110755764|NCT03949374|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110755765|NCT03949374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110755766|NCT04625972|Cilgavimab and tixagevimab drug combination|cilgavimab and tixagevimab drug combination|mesh-list
110755768|NCT04625972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110755770|NCT05626140|Lacosamide|lacosamide|mesh-list
110755771|NCT05626140|Codeine|codeine|mesh-list
110755772|NCT05626140|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110755774|NCT05626140|Analgesics|analgesics|mesh-ancestor
110755775|NCT05626140|Sensory System Agents|sensory system agents|mesh-ancestor
110755776|NCT05626140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110755777|NCT05626140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110755778|NCT05626140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110755779|NCT05626140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110755780|NCT05626140|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110755781|NCT05626140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110755782|NCT05626140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110755783|NCT05626140|Anticonvulsants|anticonvulsants|mesh-ancestor
110755784|NCT05626140|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110755785|NCT05626140|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110755786|NCT05626140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110755787|NCT05626140|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110755788|NCT05626140|Narcotics|narcotics|mesh-ancestor
110755789|NCT05626140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110755790|NCT05626140|Antitussive Agents|antitussive agents|mesh-ancestor
110755791|NCT05626140|Respiratory System Agents|respiratory system agents|mesh-ancestor
110755792|NCT04878042|Hydrogen Peroxide|hydrogen peroxide|mesh-list
110755793|NCT04878042|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110755794|NCT04878042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110755795|NCT04813614|Lidocaine|lidocaine|mesh-list
110755796|NCT04813614|Anesthetics, Local|anesthetics, local|mesh-ancestor
110755797|NCT04813614|Anesthetics|anesthetics|mesh-ancestor
110755798|NCT04813614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110755799|NCT04813614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110755800|NCT04813614|Sensory System Agents|sensory system agents|mesh-ancestor
110755801|NCT04813614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110755802|NCT04813614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110755803|NCT04813614|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110755804|NCT04813614|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110755805|NCT04813614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110755806|NCT04813614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110755807|NCT01106118|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
110755808|NCT01106118|Vasodilator Agents|vasodilator agents|mesh-ancestor
110755809|NCT01106118|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110755810|NCT01106118|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110755811|NCT01106118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110755812|NCT01106118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110755813|NCT01106118|Urological Agents|urological agents|mesh-ancestor
110755814|NCT00234065|Aspirin|aspirin|mesh-list
110755815|NCT00234065|Cilostazol|cilostazol|mesh-list
110755816|NCT00234065|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110755817|NCT00234065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110755818|NCT00234065|Analgesics|analgesics|mesh-ancestor
110755819|NCT00234065|Sensory System Agents|sensory system agents|mesh-ancestor
110755820|NCT00234065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110755821|NCT00234065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110755822|NCT00234065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110755823|NCT00234065|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110755824|NCT00234065|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110755825|NCT00234065|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110755826|NCT00234065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110755827|NCT00234065|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110755828|NCT00234065|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110755829|NCT00234065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110755830|NCT00234065|Antipyretics|antipyretics|mesh-ancestor
110755831|NCT00234065|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110755832|NCT00234065|Autonomic Agents|autonomic agents|mesh-ancestor
110755833|NCT00234065|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110755834|NCT00234065|Respiratory System Agents|respiratory system agents|mesh-ancestor
110755835|NCT00234065|Vasodilator Agents|vasodilator agents|mesh-ancestor
110755836|NCT00234065|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110755837|NCT00234065|Protective Agents|protective agents|mesh-ancestor
110755838|NCT00234065|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110755839|NCT00234065|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110755841|NCT01108848|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
110755842|NCT01108848|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
110755843|NCT01108848|Immunologic Factors|immunologic factors|mesh-ancestor
110755844|NCT01108848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110311793|NCT00303615|Fluoxymesterone|fluoxymesterone|mesh-list
110755845|NCT01108848|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
110755846|NCT01108848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110755847|NCT00233987|Cyclophosphamide|cyclophosphamide|mesh-list
110755848|NCT00233987|Melphalan|melphalan|mesh-list
110755849|NCT00233987|Carmustine|carmustine|mesh-list
110755850|NCT00233987|Etoposide|etoposide|mesh-list
110755851|NCT00233987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110755852|NCT00233987|Immunologic Factors|immunologic factors|mesh-ancestor
110755853|NCT00233987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110755854|NCT00233987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110755855|NCT00233987|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110755856|NCT00233987|Alkylating Agents|alkylating agents|mesh-ancestor
110755857|NCT00233987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110755858|NCT00233987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110755859|NCT00233987|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110755860|NCT00233987|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110755861|NCT00233987|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110755862|NCT00233987|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110755863|NCT00233987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110755864|NCT01108926|Tenofovir|tenofovir|mesh-list
110755865|NCT01108926|Emtricitabine|emtricitabine|mesh-list
110755866|NCT01108926|Efavirenz|efavirenz|mesh-list
110755867|NCT01108926|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110755868|NCT01108926|Antiviral Agents|antiviral agents|mesh-ancestor
110755869|NCT01108926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110755870|NCT01108926|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110755871|NCT01108926|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110755872|NCT01108926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110755873|NCT01108926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110755874|NCT01108926|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110755875|NCT01108926|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110755876|NCT01108926|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110755877|NCT01108926|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110755878|NCT01108926|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110755879|NCT01108926|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110755880|NCT01108926|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110755881|NCT01108926|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110755882|NCT04623242|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110755883|NCT04623242|Immunologic Factors|immunologic factors|mesh-ancestor
110755884|NCT04623242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110755885|NCT00233363|Rebamipide|rebamipide|mesh-list
110755886|NCT00233363|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110755887|NCT00233363|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110755888|NCT00233363|Antioxidants|antioxidants|mesh-ancestor
110755889|NCT00233363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110755890|NCT00233363|Protective Agents|protective agents|mesh-ancestor
110755891|NCT00233363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110755892|NCT00233363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110755893|NCT01147666|Epoetin Alfa|epoetin alfa|mesh-list
110755894|NCT01147666|Hematinics|hematinics|mesh-ancestor
110755895|NCT01073111|Sirolimus|sirolimus|mesh-list
110755896|NCT01073111|Everolimus|everolimus|mesh-list
110755897|NCT01073111|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110755898|NCT01073111|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110755899|NCT01073111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110755900|NCT01073111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110755901|NCT01073111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110755903|NCT01073111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110755904|NCT01073111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110755905|NCT01073111|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110755906|NCT01073111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110755907|NCT01073111|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110755908|NCT01073111|Antifungal Agents|antifungal agents|mesh-ancestor
110755909|NCT01325987|Vitamin D|vitamin d|mesh-list
110755910|NCT01325987|Ergocalciferols|ergocalciferols|mesh-list
110755912|NCT01325987|Vitamins|vitamins|mesh-list
110755913|NCT01325987|Micronutrients|micronutrients|mesh-ancestor
110755914|NCT01325987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110755915|NCT01325987|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110755916|NCT01325987|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110755917|NCT05321394|Ritonavir|ritonavir|mesh-list
110755918|NCT05321394|Nirmatrelvir|nirmatrelvir|mesh-list
110755919|NCT05321394|Sotrovimab|sotrovimab|mesh-list
110755920|NCT05321394|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
110755921|NCT05321394|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110755922|NCT05321394|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110755923|NCT05321394|Protease Inhibitors|protease inhibitors|mesh-ancestor
110755924|NCT05321394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110755925|NCT05321394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110755926|NCT05321394|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110755927|NCT05321394|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110755928|NCT05321394|Antiviral Agents|antiviral agents|mesh-ancestor
110755929|NCT05321394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110755930|NCT05321394|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110755931|NCT05321394|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110755932|NCT00256295|Gemcitabine|gemcitabine|mesh-list
110755933|NCT00256295|Oxaliplatin|oxaliplatin|mesh-list
110755934|NCT00256295|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110755935|NCT00256295|Antimetabolites|antimetabolites|mesh-ancestor
110755936|NCT00256295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110755937|NCT00256295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110755938|NCT04410562|Hydroxychloroquine|hydroxychloroquine|mesh-list
110755939|NCT04410562|Antimalarials|antimalarials|mesh-ancestor
110755940|NCT04410562|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110755941|NCT04410562|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110755942|NCT04410562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110755943|NCT04410562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110755944|NCT04410562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110755945|NCT04410562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110755946|NCT01109160|Azithromycin|azithromycin|mesh-list
110755947|NCT01109160|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110755948|NCT01109160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110755949|NCT01363336|Nifedipine|nifedipine|mesh-list
110755950|NCT01363336|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110311835|NCT00324363|Exenatide|exenatide|mesh-list
110755951|NCT01363336|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110755952|NCT01363336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110755953|NCT01363336|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110755954|NCT01363336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110755955|NCT01363336|Vasodilator Agents|vasodilator agents|mesh-ancestor
110755956|NCT01363336|Tocolytic Agents|tocolytic agents|mesh-ancestor
110755957|NCT01363336|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110755958|NCT01363414|Hyaluronic Acid|hyaluronic acid|mesh-list
110755959|NCT01363414|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110755960|NCT01363414|Immunologic Factors|immunologic factors|mesh-ancestor
110755961|NCT01363414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110755962|NCT01363414|Viscosupplements|viscosupplements|mesh-ancestor
110755963|NCT01363414|Protective Agents|protective agents|mesh-ancestor
110755964|NCT02223520|Chlorhexidine|chlorhexidine|mesh-list
110755965|NCT02223520|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110755966|NCT02223520|Mupirocin|mupirocin|mesh-list
110755967|NCT02223520|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110755968|NCT02223520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110755969|NCT02223520|Disinfectants|disinfectants|mesh-ancestor
110755970|NCT02223520|Dermatologic Agents|dermatologic agents|mesh-ancestor
110755971|NCT02223520|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110755972|NCT02223520|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110755973|NCT02223520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110868465|NCT01359423|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110755974|NCT02223520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110755975|NCT01356472|Imipenem|imipenem|mesh-list
110755976|NCT01356472|Cilastatin|cilastatin|mesh-list
110755977|NCT01356472|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110755978|NCT01356472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110755979|NCT01356472|Protease Inhibitors|protease inhibitors|mesh-ancestor
110755980|NCT01356472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110473691|NCT02778789|Adalimumab|adalimumab|mesh-list
110755981|NCT01356472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110755982|NCT02122198|Leuprolide|leuprolide|mesh-list
110755983|NCT02122198|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
110755984|NCT02122198|Medroxyprogesterone|medroxyprogesterone|mesh-list
110755985|NCT02122198|Estradiol|estradiol|mesh-list
110755986|NCT02122198|Estrogens|estrogens|mesh-ancestor
110755987|NCT02122198|Hormones|hormones|mesh-ancestor
110755988|NCT02122198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110755989|NCT02122198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110755990|NCT02122198|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110755991|NCT02122198|Contraceptive Agents|contraceptive agents|mesh-ancestor
110755992|NCT02122198|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110755993|NCT02122198|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110755994|NCT02122198|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110755995|NCT02122198|Fertility Agents|fertility agents|mesh-ancestor
110755996|NCT02122198|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110755997|NCT02122198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110755998|NCT02122198|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110755999|NCT02122198|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110756000|NCT02122198|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110756001|NCT02122198|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110756002|NCT01363570|Ranibizumab|ranibizumab|mesh-list
110756003|NCT01363570|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110756004|NCT01363570|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110756005|NCT01363570|Growth Substances|growth substances|mesh-ancestor
110756006|NCT01363570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110756007|NCT01363570|Growth Inhibitors|growth inhibitors|mesh-ancestor
110756008|NCT01363570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110756009|NCT04608500|Minocycline|minocycline|mesh-list
110756010|NCT04608500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110756011|NCT04608500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110756012|NCT01363648|Choline|choline|mesh-list
110756013|NCT01363648|Lipotropic Agents|lipotropic agents|mesh-ancestor
110756014|NCT01363648|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110756015|NCT01363648|Antimetabolites|antimetabolites|mesh-ancestor
110756016|NCT01363648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110756017|NCT01363648|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110756018|NCT01363648|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110756019|NCT01363648|Nootropic Agents|nootropic agents|mesh-ancestor
110756020|NCT01107054|Moxifloxacin|moxifloxacin|mesh-list
110756021|NCT01107054|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110756022|NCT01107054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110756023|NCT01107054|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110756024|NCT01107054|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110756025|NCT01107054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110756026|NCT01107054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110756027|NCT01107054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110756028|NCT03944070|Ranibizumab|ranibizumab|mesh-list
110756029|NCT03944070|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110756030|NCT03944070|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110756031|NCT03944070|Growth Substances|growth substances|mesh-ancestor
110756032|NCT03944070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110756033|NCT03944070|Growth Inhibitors|growth inhibitors|mesh-ancestor
110756034|NCT03944070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110756035|NCT01363804|Tivozanib|tivozanib|mesh-list
110868470|NCT01363089|Oxymetazoline|oxymetazoline|mesh-list
110756036|NCT01363804|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110756037|NCT01363804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110756038|NCT01363804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110756039|NCT03764462|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
110756040|NCT03764462|AD 101|ad 101|mesh-list
110756041|NCT03764462|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110756042|NCT03764462|Hormone Antagonists|hormone antagonists|mesh-ancestor
110756043|NCT03764462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110756044|NCT03764462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110756045|NCT03764462|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110311905|NCT00324480|Vorinostat|vorinostat|mesh-list
110756046|NCT03764462|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110756047|NCT03764462|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110756048|NCT03764462|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
110756049|NCT03764462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110756050|NCT03764462|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110756051|NCT03764462|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110756052|NCT03764462|Antiviral Agents|antiviral agents|mesh-ancestor
110756053|NCT03764462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110756054|NCT05460416|Aspirin|aspirin|mesh-list
110756055|NCT05460416|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110756056|NCT05460416|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110756057|NCT05460416|Analgesics|analgesics|mesh-ancestor
110756058|NCT05460416|Sensory System Agents|sensory system agents|mesh-ancestor
110756059|NCT05460416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110756060|NCT05460416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110756061|NCT05460416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110756062|NCT05460416|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110756063|NCT05460416|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110756064|NCT05460416|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110756065|NCT05460416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110756066|NCT05460416|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110756067|NCT05460416|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110756068|NCT05460416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110756069|NCT05460416|Antipyretics|antipyretics|mesh-ancestor
110756070|NCT01364194|Bupivacaine|bupivacaine|mesh-list
110756071|NCT01364194|Anesthetics, Local|anesthetics, local|mesh-ancestor
110756072|NCT01364194|Anesthetics|anesthetics|mesh-ancestor
110756073|NCT01364194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110756074|NCT01364194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110756075|NCT01364194|Sensory System Agents|sensory system agents|mesh-ancestor
110756076|NCT01364194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110756077|NCT04575038|Brequinar|brequinar|mesh-list
110756078|NCT04575038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110756079|NCT04575038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110756080|NCT04575038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110756081|NCT04575038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110756082|NCT04575038|Immunologic Factors|immunologic factors|mesh-ancestor
110756083|NCT04575038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110756084|NCT03066622|Olanzapine|olanzapine|mesh-list
110756085|NCT03066622|Antiemetics|antiemetics|mesh-ancestor
110756086|NCT03066622|Autonomic Agents|autonomic agents|mesh-ancestor
110756087|NCT03066622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110756088|NCT03066622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110756089|NCT03066622|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110756090|NCT03066622|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110756091|NCT03066622|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110756092|NCT03066622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110756093|NCT03066622|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110756094|NCT03066622|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110756095|NCT03066622|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110756096|NCT03066622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110756097|NCT03066622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110756098|NCT03066622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110756099|NCT03066622|Serotonin Agents|serotonin agents|mesh-ancestor
110756101|NCT01364974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110756102|NCT01364974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110756103|NCT01364974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110756104|NCT01364974|Immunologic Factors|immunologic factors|mesh-ancestor
110756105|NCT01364974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110756106|NCT05323214|Fentanyl|fentanyl|mesh-list
110756107|NCT05323214|Dexmedetomidine|dexmedetomidine|mesh-list
110756108|NCT05323214|Analgesics|analgesics|mesh-list
110756109|NCT05323214|Bupivacaine|bupivacaine|mesh-list
110756110|NCT05323214|Anesthetics, Local|anesthetics, local|mesh-ancestor
110756111|NCT05323214|Anesthetics|anesthetics|mesh-ancestor
110756112|NCT05323214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110756113|NCT05323214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110756114|NCT05323214|Sensory System Agents|sensory system agents|mesh-ancestor
110756115|NCT05323214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110756116|NCT05323214|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110756117|NCT05323214|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110756118|NCT05323214|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110756119|NCT05323214|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110756120|NCT05323214|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110756121|NCT05323214|Adrenergic Agents|adrenergic agents|mesh-ancestor
110756122|NCT05323214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110756123|NCT05323214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110756124|NCT05323214|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110756125|NCT05323214|Narcotics|narcotics|mesh-ancestor
110756126|NCT05323214|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110756127|NCT05323214|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110756128|NCT05323214|Anesthetics, General|anesthetics, general|mesh-ancestor
110756129|NCT01936480|Moxifloxacin|moxifloxacin|mesh-list
110756130|NCT01936480|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110756131|NCT01936480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110756132|NCT01936480|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110756133|NCT01936480|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110756134|NCT01936480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110756135|NCT01936480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110756136|NCT01936480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110756137|NCT01356862|Pasireotide|pasireotide|mesh-list
110756138|NCT01356862|Hormones|hormones|mesh-ancestor
110756139|NCT01356862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110756140|NCT01356862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110756141|NCT03763760|Dexamethasone|dexamethasone|mesh-list
110756142|NCT03763760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110756143|NCT03763760|Antiemetics|antiemetics|mesh-ancestor
110756144|NCT03763760|Autonomic Agents|autonomic agents|mesh-ancestor
110756145|NCT03763760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110756146|NCT03763760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110756147|NCT03763760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110756148|NCT03763760|Glucocorticoids|glucocorticoids|mesh-ancestor
110756149|NCT03763760|Hormones|hormones|mesh-ancestor
110756150|NCT03763760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110756151|NCT03763760|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110756152|NCT03763760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110756153|NCT04501952|Remdesivir|remdesivir|mesh-list
110756154|NCT04501952|Antimetabolites|antimetabolites|mesh-ancestor
110756155|NCT04501952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110756156|NCT04501952|Antiviral Agents|antiviral agents|mesh-ancestor
110756157|NCT04501952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110756158|NCT00321100|Bevacizumab|bevacizumab|mesh-list
110756159|NCT00321100|Cetuximab|cetuximab|mesh-list
110756160|NCT00321100|Capecitabine|capecitabine|mesh-list
110756161|NCT00321100|Oxaliplatin|oxaliplatin|mesh-list
110756162|NCT00321100|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110756163|NCT00321100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110756164|NCT00321100|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110756165|NCT00321100|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110756166|NCT00321100|Growth Substances|growth substances|mesh-ancestor
110756167|NCT00321100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110756168|NCT00321100|Growth Inhibitors|growth inhibitors|mesh-ancestor
110756169|NCT00321100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110756170|NCT00321100|Antimetabolites|antimetabolites|mesh-ancestor
110756171|NCT00321100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110756172|NCT02930122|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
110756173|NCT02930122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110756174|NCT01365598|Primaquine|primaquine|mesh-list
110756175|NCT01365598|Antimalarials|antimalarials|mesh-ancestor
110756176|NCT01365598|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110756177|NCT01365598|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110756178|NCT01365598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110756179|NCT01365676|Hypericin|hypericin|mesh-list
110756180|NCT01365676|Antidepressive Agents|antidepressive agents|mesh-ancestor
110756181|NCT01365676|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110756182|NCT01365676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110756183|NCT01365676|Antiviral Agents|antiviral agents|mesh-ancestor
110756184|NCT01365676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110756185|NCT01365676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110756186|NCT01365676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110756187|NCT01365676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110756188|NCT01365676|Immunologic Factors|immunologic factors|mesh-ancestor
110756189|NCT01365676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110756190|NCT03754712|Vitamin D|vitamin d|mesh-list
110756191|NCT03754712|Cholecalciferol|cholecalciferol|mesh-list
110756192|NCT03754712|Vitamins|vitamins|mesh-ancestor
110756193|NCT03754712|Micronutrients|micronutrients|mesh-ancestor
110756194|NCT03754712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110756195|NCT03754712|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110756196|NCT03754712|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110756197|NCT01318954|Immunomodulating Agents|immunomodulating agents|mesh-list
110756198|NCT01318954|Immunologic Factors|immunologic factors|mesh-ancestor
110756199|NCT01318954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110756200|NCT00070018|Prednisone|prednisone|mesh-list
110756201|NCT00070018|Cyclophosphamide|cyclophosphamide|mesh-list
110756202|NCT00070018|Rituximab|rituximab|mesh-list
110756203|NCT00070018|Doxorubicin|doxorubicin|mesh-list
110756204|NCT00070018|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110756205|NCT00070018|Vincristine|vincristine|mesh-list
110756206|NCT00070018|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110756207|NCT00070018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110756208|NCT00070018|Immunologic Factors|immunologic factors|mesh-ancestor
110756209|NCT00070018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110756210|NCT00070018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110756211|NCT00070018|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110756212|NCT00070018|Alkylating Agents|alkylating agents|mesh-ancestor
110756213|NCT00070018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110756214|NCT00070018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110756215|NCT00070018|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110756216|NCT00070018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110756217|NCT00070018|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110756218|NCT00070018|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110756219|NCT00070018|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110756220|NCT00070018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110756221|NCT00070018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110756222|NCT00070018|Glucocorticoids|glucocorticoids|mesh-ancestor
110756223|NCT00070018|Hormones|hormones|mesh-ancestor
110756224|NCT00070018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110756225|NCT00070018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110756226|NCT00070018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110756227|NCT00070018|Tubulin Modulators|tubulin modulators|mesh-ancestor
110756228|NCT00070018|Antimitotic Agents|antimitotic agents|mesh-ancestor
110756229|NCT00070018|Mitosis Modulators|mitosis modulators|mesh-ancestor
110756230|NCT03991988|Montelukast|montelukast|mesh-list
110756231|NCT03991988|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110756232|NCT03991988|Respiratory System Agents|respiratory system agents|mesh-ancestor
110756233|NCT03991988|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110756234|NCT03991988|Hormone Antagonists|hormone antagonists|mesh-ancestor
110756235|NCT03991988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110756236|NCT03991988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110756237|NCT03991988|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110756238|NCT03991988|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110756239|NCT03991988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110756240|NCT01073189|Fenoldopam|fenoldopam|mesh-list
110756241|NCT01073189|Furosemide|furosemide|mesh-list
110756242|NCT01073189|Diuretics|diuretics|mesh-ancestor
110756243|NCT01073189|Natriuretic Agents|natriuretic agents|mesh-ancestor
110756244|NCT01073189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110756245|NCT01073189|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110756246|NCT01073189|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110756247|NCT01073189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110756248|NCT01073189|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110756249|NCT01073189|Vasodilator Agents|vasodilator agents|mesh-ancestor
110756250|NCT01073189|Dopamine Agonists|dopamine agonists|mesh-ancestor
110756251|NCT01073189|Dopamine Agents|dopamine agents|mesh-ancestor
110756252|NCT01073189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110756253|NCT05191186|Immunomodulating Agents|immunomodulating agents|mesh-list
110756254|NCT05191186|Immunologic Factors|immunologic factors|mesh-ancestor
110756255|NCT05191186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110756256|NCT03750656|Hyoscyamine|hyoscyamine|mesh-list
110756257|NCT03750656|Tamsulosin|tamsulosin|mesh-list
110756258|NCT03750656|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110756259|NCT03750656|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110756260|NCT03750656|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110756261|NCT03750656|Adrenergic Agents|adrenergic agents|mesh-ancestor
110756262|NCT03750656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110756263|NCT03750656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110756264|NCT03750656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110756265|NCT03750656|Urological Agents|urological agents|mesh-ancestor
110756266|NCT03750656|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110756267|NCT03750656|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110756268|NCT03750656|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110756269|NCT03750656|Autonomic Agents|autonomic agents|mesh-ancestor
110756270|NCT03750656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110756271|NCT03750656|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110756272|NCT03750656|Respiratory System Agents|respiratory system agents|mesh-ancestor
110756273|NCT03750656|Mydriatics|mydriatics|mesh-ancestor
110756274|NCT03750656|Parasympatholytics|parasympatholytics|mesh-ancestor
110756275|NCT03750656|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110756276|NCT03750656|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110756277|NCT03750656|Cholinergic Agents|cholinergic agents|mesh-ancestor
110756278|NCT00229931|Triamcinolone|triamcinolone|mesh-list
110756279|NCT00229931|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110756280|NCT00229931|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110473989|NCT02771379|Protective Agents|protective agents|mesh-ancestor
110756281|NCT00229931|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110756282|NCT00229931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110756284|NCT00229931|Hormones|hormones|mesh-ancestor
110756285|NCT00229931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110756286|NCT00229931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110756287|NCT00229931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110756288|NCT00229931|Immunologic Factors|immunologic factors|mesh-ancestor
110756289|NCT00229931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110756290|NCT00229931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110756291|NCT03752294|Dabigatran|dabigatran|mesh-list
110756292|NCT03752294|Antithrombins|antithrombins|mesh-ancestor
110756293|NCT03752294|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110756294|NCT03752294|Protease Inhibitors|protease inhibitors|mesh-ancestor
110756295|NCT03752294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110756296|NCT03752294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110756297|NCT03752294|Anticoagulants|anticoagulants|mesh-ancestor
110756298|NCT03135028|Cytarabine|cytarabine|mesh-list
110756299|NCT03135028|Daunorubicin|daunorubicin|mesh-list
110756300|NCT03135028|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110756301|NCT03135028|Antimetabolites|antimetabolites|mesh-ancestor
110756302|NCT03135028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110756303|NCT03135028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110756304|NCT03135028|Antiviral Agents|antiviral agents|mesh-ancestor
110756305|NCT03135028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110756306|NCT03135028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110756307|NCT03135028|Immunologic Factors|immunologic factors|mesh-ancestor
110756308|NCT03135028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110756309|NCT03135028|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110756310|NCT03135028|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110756311|NCT03135028|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110756312|NCT03135028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110756313|NCT03752138|Decitabine|decitabine|mesh-list
110756314|NCT03752138|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110756315|NCT03752138|Antimetabolites|antimetabolites|mesh-ancestor
110756316|NCT03752138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110756317|NCT03752138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110756318|NCT03752138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110756319|NCT01370434|Dexamethasone|dexamethasone|mesh-list
110756320|NCT01370434|Doxorubicin|doxorubicin|mesh-list
110756321|NCT01370434|Vincristine|vincristine|mesh-list
110756322|NCT01370434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110756323|NCT01370434|Antiemetics|antiemetics|mesh-ancestor
110756324|NCT01370434|Autonomic Agents|autonomic agents|mesh-ancestor
110756325|NCT01370434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110756326|NCT01370434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110756327|NCT01370434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110756328|NCT01370434|Glucocorticoids|glucocorticoids|mesh-ancestor
110756329|NCT01370434|Hormones|hormones|mesh-ancestor
110756330|NCT01370434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110756331|NCT01370434|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110756332|NCT01370434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110756333|NCT01370434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110756334|NCT01370434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110756335|NCT01370434|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110756336|NCT01370434|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110756337|NCT01370434|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110756338|NCT01370434|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110756339|NCT01370434|Tubulin Modulators|tubulin modulators|mesh-ancestor
110756340|NCT01370434|Antimitotic Agents|antimitotic agents|mesh-ancestor
110756341|NCT01370434|Mitosis Modulators|mitosis modulators|mesh-ancestor
110756342|NCT05190952|Dexamethasone|dexamethasone|mesh-list
110756343|NCT05190952|Ketamine|ketamine|mesh-list
110756344|NCT05190952|Bupivacaine|bupivacaine|mesh-list
110756345|NCT05190952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110756346|NCT05190952|Antiemetics|antiemetics|mesh-ancestor
110756347|NCT05190952|Autonomic Agents|autonomic agents|mesh-ancestor
110756348|NCT05190952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110756349|NCT05190952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110756350|NCT05190952|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110756351|NCT05190952|Glucocorticoids|glucocorticoids|mesh-ancestor
110756352|NCT05190952|Hormones|hormones|mesh-ancestor
110756353|NCT05190952|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110756354|NCT05190952|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110474062|NCT00816972|Loratadine|loratadine|mesh-list
110756355|NCT05190952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110756356|NCT05190952|Anesthetics, Local|anesthetics, local|mesh-ancestor
110756357|NCT05190952|Anesthetics|anesthetics|mesh-ancestor
110756358|NCT05190952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110756359|NCT05190952|Sensory System Agents|sensory system agents|mesh-ancestor
110756360|NCT05190952|Analgesics|analgesics|mesh-ancestor
110756361|NCT05190952|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110756362|NCT05190952|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110756363|NCT05190952|Anesthetics, General|anesthetics, general|mesh-ancestor
110756364|NCT05190952|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110756365|NCT05190952|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110756366|NCT05190952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110756367|NCT05190952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110756368|NCT03972683|Atropine|atropine|mesh-list
110756369|NCT03972683|Adenosine|adenosine|mesh-list
110756370|NCT03972683|Nitroprusside|nitroprusside|mesh-list
110756371|NCT03972683|Phenylephrine|phenylephrine|mesh-list
110756372|NCT03972683|Oxymetazoline|oxymetazoline|mesh-list
110756373|NCT03972683|Acetylcholine|acetylcholine|mesh-list
110756374|NCT03972683|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110756375|NCT03972683|Mydriatics|mydriatics|mesh-ancestor
110756376|NCT03972683|Autonomic Agents|autonomic agents|mesh-ancestor
110756377|NCT03972683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110756378|NCT03972683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110756379|NCT03972683|Sympathomimetics|sympathomimetics|mesh-ancestor
110756380|NCT03972683|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110756381|NCT03972683|Nasal Decongestants|nasal decongestants|mesh-ancestor
110756382|NCT03972683|Respiratory System Agents|respiratory system agents|mesh-ancestor
110756383|NCT03972683|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110756384|NCT03972683|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110756385|NCT03972683|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110756386|NCT03972683|Adrenergic Agents|adrenergic agents|mesh-ancestor
110756387|NCT03972683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110756388|NCT03972683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110756389|NCT03972683|Protective Agents|protective agents|mesh-ancestor
110756390|NCT03972683|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110756391|NCT03972683|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110756392|NCT03972683|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110756393|NCT03972683|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110756394|NCT03972683|Parasympatholytics|parasympatholytics|mesh-ancestor
110756395|NCT03972683|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110756396|NCT03972683|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110756397|NCT03972683|Cholinergic Agents|cholinergic agents|mesh-ancestor
110756398|NCT03972683|Analgesics|analgesics|mesh-ancestor
110756399|NCT03972683|Sensory System Agents|sensory system agents|mesh-ancestor
110756400|NCT03972683|Vasodilator Agents|vasodilator agents|mesh-ancestor
110756401|NCT03972683|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
110756402|NCT03972683|Purinergic Agonists|purinergic agonists|mesh-ancestor
110756403|NCT03972683|Purinergic Agents|purinergic agents|mesh-ancestor
110756404|NCT03972683|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110756405|NCT03972683|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
110756406|NCT03972683|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110756407|NCT04411628|Bamlanivimab|bamlanivimab|mesh-list
110756408|NCT04411628|Antiviral Agents|antiviral agents|mesh-ancestor
110756409|NCT04411628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110756410|NCT03754010|Hyaluronic Acid|hyaluronic acid|mesh-list
110756411|NCT03754010|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110756412|NCT03754010|Immunologic Factors|immunologic factors|mesh-ancestor
110756413|NCT03754010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110756414|NCT03754010|Viscosupplements|viscosupplements|mesh-ancestor
110756415|NCT03754010|Protective Agents|protective agents|mesh-ancestor
110756416|NCT00227591|Prednisone|prednisone|mesh-list
110756417|NCT00227591|Lenalidomide|lenalidomide|mesh-list
110756418|NCT00227591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110756419|NCT00227591|Glucocorticoids|glucocorticoids|mesh-ancestor
110756420|NCT00227591|Hormones|hormones|mesh-ancestor
110756421|NCT00227591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110756422|NCT00227591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110756423|NCT00227591|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110756424|NCT00227591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110756425|NCT00227591|Immunologic Factors|immunologic factors|mesh-ancestor
110756426|NCT00227591|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110756427|NCT00227591|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110756428|NCT00227591|Growth Substances|growth substances|mesh-ancestor
110756429|NCT00227591|Growth Inhibitors|growth inhibitors|mesh-ancestor
110756430|NCT01358344|Pantoprazole|pantoprazole|mesh-list
110756431|NCT01358344|Vorapaxar|vorapaxar|mesh-list
110756432|NCT01358344|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110756433|NCT01358344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110756434|NCT01358344|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110756435|NCT01358344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110756436|NCT01358344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110756437|NCT01358344|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110756438|NCT01366300|Lidocaine|lidocaine|mesh-list
110756439|NCT01366300|Propofol|propofol|mesh-list
110756440|NCT01366300|Anesthetics, Local|anesthetics, local|mesh-ancestor
110756441|NCT01366300|Anesthetics|anesthetics|mesh-ancestor
110756442|NCT01366300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110756443|NCT01366300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110756444|NCT01366300|Sensory System Agents|sensory system agents|mesh-ancestor
110756445|NCT01366300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110756446|NCT01366300|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110756447|NCT01366300|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110756448|NCT01366300|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110756449|NCT01366300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110756450|NCT01366300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110756451|NCT01366300|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110756452|NCT01366300|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110756453|NCT01366300|Anesthetics, General|anesthetics, general|mesh-ancestor
110756454|NCT00226811|Sunitinib|sunitinib|mesh-list
110756455|NCT00226811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110756456|NCT00226811|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110756457|NCT00226811|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110756458|NCT00226811|Growth Substances|growth substances|mesh-ancestor
110756459|NCT00226811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110756460|NCT00226811|Growth Inhibitors|growth inhibitors|mesh-ancestor
110756461|NCT00226811|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110756462|NCT00226811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110756463|NCT00226811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110756464|NCT02951052|Rilpivirine|rilpivirine|mesh-list
110756465|NCT02951052|Cabotegravir|cabotegravir|mesh-list
110756466|NCT02951052|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110756467|NCT02951052|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110756468|NCT02951052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110756469|NCT02951052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110756470|NCT02951052|Antiviral Agents|antiviral agents|mesh-ancestor
110756471|NCT02951052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110756472|NCT02951052|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110756473|NCT02951052|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110756474|NCT02951052|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110756475|NCT02951052|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110756476|NCT05261516|Magnesium Sulfate|magnesium sulfate|mesh-list
110756477|NCT05261516|Analgesics|analgesics|mesh-ancestor
110756478|NCT05261516|Sensory System Agents|sensory system agents|mesh-ancestor
110756479|NCT05261516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110756480|NCT05261516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110756481|NCT05261516|Anesthetics|anesthetics|mesh-ancestor
110756482|NCT05261516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110756483|NCT05261516|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110312076|NCT00304434|Oseltamivir|oseltamivir|mesh-list
110756484|NCT05261516|Anticonvulsants|anticonvulsants|mesh-ancestor
110756485|NCT05261516|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110868545|NCT01359579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110756486|NCT05261516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110756487|NCT05261516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110756488|NCT05261516|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110756490|NCT05261516|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110756491|NCT00226655|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
110756492|NCT00226655|Hormones|hormones|mesh-ancestor
110756493|NCT00226655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110756494|NCT00226655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110756495|NCT01371058|Clopidogrel|clopidogrel|mesh-list
110756496|NCT01371058|Policosanol|policosanol|mesh-list
110756497|NCT01371058|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110756498|NCT01371058|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110756499|NCT01371058|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110756500|NCT01371058|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110756501|NCT01371058|Purinergic Agents|purinergic agents|mesh-ancestor
110756502|NCT01371058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110756503|NCT01371058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110756504|NCT01371058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110756505|NCT01371058|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110756506|NCT01371058|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110756507|NCT01371058|Antimetabolites|antimetabolites|mesh-ancestor
110756508|NCT01371058|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110756509|NCT01105338|Lycopene|lycopene|mesh-list
110756510|NCT01105338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110756511|NCT01105338|Antioxidants|antioxidants|mesh-ancestor
110756512|NCT01105338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110756513|NCT01105338|Protective Agents|protective agents|mesh-ancestor
110756514|NCT01105338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110756515|NCT01105338|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110756516|NCT01105338|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110756517|NCT01105338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110756518|NCT03747614|Fluorometholone|fluorometholone|mesh-list
110756519|NCT03747614|Tacrolimus|tacrolimus|mesh-list
110756520|NCT03747614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110756521|NCT03747614|Immunologic Factors|immunologic factors|mesh-ancestor
110756522|NCT03747614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110756523|NCT03747614|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110756524|NCT03747614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110756525|NCT03747614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110756526|NCT03747614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110756527|NCT03747614|Glucocorticoids|glucocorticoids|mesh-ancestor
110756528|NCT03747614|Hormones|hormones|mesh-ancestor
110756529|NCT03747614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110756530|NCT03747614|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110756531|NCT05347004|BI 425809|bi 425809|mesh-list
110756532|NCT05347004|Nootropic Agents|nootropic agents|mesh-ancestor
110756533|NCT04353596|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
110756534|NCT04353596|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
110756535|NCT04353596|Protease Inhibitors|protease inhibitors|mesh-ancestor
110756536|NCT04353596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110756537|NCT04353596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110756538|NCT01366378|Methylnaltrexone|methylnaltrexone|mesh-list
110756539|NCT01366378|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110756540|NCT01366378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110756541|NCT01366378|Sensory System Agents|sensory system agents|mesh-ancestor
110756542|NCT01366378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110756543|NCT03747536|Bromides|bromides|mesh-list
110756544|NCT03747536|Ipratropium|ipratropium|mesh-list
110756545|NCT03747536|Anticonvulsants|anticonvulsants|mesh-ancestor
110756546|NCT03747536|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110756547|NCT03747536|Autonomic Agents|autonomic agents|mesh-ancestor
110756548|NCT03747536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110756549|NCT03747536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110756550|NCT03747536|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110756551|NCT03747536|Respiratory System Agents|respiratory system agents|mesh-ancestor
110756552|NCT03747536|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110756553|NCT03747536|Cholinergic Agents|cholinergic agents|mesh-ancestor
110756554|NCT03747536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110756555|NCT03747536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110756556|NCT01358500|Fentanyl|fentanyl|mesh-list
110756557|NCT01358500|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110756558|NCT01358500|Narcotics|narcotics|mesh-ancestor
110756559|NCT01358500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110756560|NCT01358500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110756562|NCT01358500|Sensory System Agents|sensory system agents|mesh-ancestor
110756563|NCT01358500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110756564|NCT01358500|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110756565|NCT01358500|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110756566|NCT01358500|Anesthetics, General|anesthetics, general|mesh-ancestor
110756567|NCT01358500|Anesthetics|anesthetics|mesh-ancestor
110756568|NCT03724942|Brexpiprazole|brexpiprazole|mesh-list
110756569|NCT03724942|Serotonin Agents|serotonin agents|mesh-ancestor
110756570|NCT03724942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110756571|NCT03724942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110756572|NCT03724942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110756573|NCT03724942|Dopamine Agonists|dopamine agonists|mesh-ancestor
110756574|NCT03724942|Dopamine Agents|dopamine agents|mesh-ancestor
110756575|NCT03751514|Azithromycin|azithromycin|mesh-list
110756576|NCT03751514|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110756577|NCT03751514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110756578|NCT03615664|Dexamethasone|dexamethasone|mesh-list
110756579|NCT03615664|Gemcitabine|gemcitabine|mesh-list
110756580|NCT03615664|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110756581|NCT03615664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110756582|NCT03615664|Antiemetics|antiemetics|mesh-ancestor
110756583|NCT03615664|Autonomic Agents|autonomic agents|mesh-ancestor
110756584|NCT03615664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110756585|NCT03615664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110756586|NCT03615664|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110756587|NCT03615664|Glucocorticoids|glucocorticoids|mesh-ancestor
110756589|NCT03615664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110756590|NCT03615664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110756591|NCT03615664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110756592|NCT03615664|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110756593|NCT03615664|Antimetabolites|antimetabolites|mesh-ancestor
110756594|NCT03615664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110756595|NCT03615664|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110756596|NCT03615664|Alkylating Agents|alkylating agents|mesh-ancestor
110756597|NCT03513250|Scopolamine|scopolamine|mesh-list
110756598|NCT03513250|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
110756599|NCT03513250|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110756600|NCT03513250|Antiemetics|antiemetics|mesh-ancestor
110756601|NCT03513250|Autonomic Agents|autonomic agents|mesh-ancestor
110756602|NCT03513250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110756603|NCT03513250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110756604|NCT03513250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110756605|NCT03513250|Mydriatics|mydriatics|mesh-ancestor
110756606|NCT03513250|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110312158|NCT00418509|Autonomic Agents|autonomic agents|mesh-ancestor
110756607|NCT03513250|Cholinergic Agents|cholinergic agents|mesh-ancestor
110756608|NCT03513250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110756609|NCT03513250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110756610|NCT03513250|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110756611|NCT03513250|Parasympatholytics|parasympatholytics|mesh-ancestor
110756612|NCT01358812|Panitumumab|panitumumab|mesh-list
110756613|NCT01358812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110756614|NCT01358812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110756615|NCT01371448|Paroxetine|paroxetine|mesh-list
110756616|NCT01371448|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110756617|NCT01371448|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110756618|NCT01371448|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110756619|NCT01371448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110756620|NCT01371448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110756621|NCT01371448|Serotonin Agents|serotonin agents|mesh-ancestor
110756622|NCT01371448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110756623|NCT01371448|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110756624|NCT01371448|Antidepressive Agents|antidepressive agents|mesh-ancestor
110756625|NCT01371448|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110756626|NCT01371448|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110756627|NCT01371448|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110756628|NCT01371448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110756629|NCT01371526|Cosyntropin|cosyntropin|mesh-list
110756630|NCT01371526|Hormones|hormones|mesh-ancestor
110756631|NCT01371526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110756632|NCT01371526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110756633|NCT03943992|Esomeprazole|esomeprazole|mesh-list
110756634|NCT03943992|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110756635|NCT03943992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110756636|NCT03943992|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110756637|NCT03943992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110756638|NCT03943992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110756639|NCT01371604|Ribavirin|ribavirin|mesh-list
110756640|NCT01371604|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110756641|NCT01371604|Antimetabolites|antimetabolites|mesh-ancestor
110756642|NCT01371604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110756643|NCT01371604|Antiviral Agents|antiviral agents|mesh-ancestor
110756644|NCT01371604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110756645|NCT01371682|Ropinirole|ropinirole|mesh-list
110756646|NCT01371682|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110756647|NCT01371682|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110756648|NCT01371682|Dopamine Agonists|dopamine agonists|mesh-ancestor
110756649|NCT01371682|Dopamine Agents|dopamine agents|mesh-ancestor
110756650|NCT01371682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110756651|NCT01371682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110756652|NCT01371682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110756653|NCT01107756|Lenograstim|lenograstim|mesh-list
110756654|NCT01107756|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110756655|NCT01107756|Immunologic Factors|immunologic factors|mesh-ancestor
110756656|NCT01107756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110756658|NCT03127384|Anesthetics, Local|anesthetics, local|mesh-ancestor
110756659|NCT03127384|Anesthetics|anesthetics|mesh-ancestor
110756660|NCT03127384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110756661|NCT03127384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110756662|NCT03127384|Sensory System Agents|sensory system agents|mesh-ancestor
110756663|NCT03127384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110756664|NCT03127384|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110756665|NCT03127384|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110756666|NCT03127384|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110756667|NCT03127384|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110756668|NCT03127384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110756669|NCT01111656|Interferons|interferons|mesh-list
110756670|NCT01111656|Interferon-beta|interferon-beta|mesh-list
110756671|NCT01111656|Atorvastatin|atorvastatin|mesh-list
110756672|NCT01111656|Interferon beta-1b|interferon beta-1b|mesh-list
110756673|NCT01111656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110756674|NCT01111656|Antiviral Agents|antiviral agents|mesh-ancestor
110756675|NCT01111656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110756676|NCT01111656|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110756677|NCT01111656|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110756678|NCT01111656|Antimetabolites|antimetabolites|mesh-ancestor
110756679|NCT01111656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110756680|NCT01111656|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110756681|NCT01111656|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110756682|NCT01111656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110756683|NCT01111656|Immunologic Factors|immunologic factors|mesh-ancestor
110868566|NCT02426164|Morphine|morphine|mesh-list
110756684|NCT01111656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110756685|NCT01111656|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110756686|NCT02819752|Pembrolizumab|pembrolizumab|mesh-list
110756687|NCT02819752|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110756688|NCT02819752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110756689|NCT02819752|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110756690|NCT02819752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110756691|NCT02567578|YH12852|yh12852|mesh-list
110756692|NCT02567578|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
110756693|NCT02567578|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110756694|NCT02567578|Serotonin Agents|serotonin agents|mesh-ancestor
110756695|NCT02567578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110756696|NCT02567578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110312228|NCT00293072|Rituximab|rituximab|mesh-list
110756697|NCT02567578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110756698|NCT02523274|Resveratrol|resveratrol|mesh-list
110756699|NCT02523274|Antioxidants|antioxidants|mesh-ancestor
110756700|NCT02523274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110756701|NCT02523274|Protective Agents|protective agents|mesh-ancestor
110756702|NCT02523274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110756703|NCT02523274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110756704|NCT02523274|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110756705|NCT02432560|Sirolimus|sirolimus|mesh-list
110756706|NCT02432560|Everolimus|everolimus|mesh-list
110756707|NCT02432560|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110756708|NCT02432560|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110756709|NCT02432560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110756710|NCT02432560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110756711|NCT02432560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110756712|NCT02432560|Immunologic Factors|immunologic factors|mesh-ancestor
110756713|NCT02432560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110756714|NCT02432560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110756715|NCT02432560|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110756716|NCT02432560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110756717|NCT02432560|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110756718|NCT02432560|Antifungal Agents|antifungal agents|mesh-ancestor
110756719|NCT01111734|Acetylcysteine|acetylcysteine|mesh-list
110756720|NCT01111734|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110756721|NCT01111734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110756722|NCT01111734|Antiviral Agents|antiviral agents|mesh-ancestor
110756723|NCT01111734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110756724|NCT01111734|Expectorants|expectorants|mesh-ancestor
110756725|NCT01111734|Respiratory System Agents|respiratory system agents|mesh-ancestor
110312268|NCT00293345|Gemcitabine|gemcitabine|mesh-list
110756726|NCT01111734|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110756727|NCT01111734|Antioxidants|antioxidants|mesh-ancestor
110756742|NCT01111890|Dorzolamide|dorzolamide|mesh-list
110756743|NCT01111890|Brinzolamide|brinzolamide|mesh-list
110756744|NCT01111890|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110756745|NCT01111890|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110756746|NCT01111890|Adrenergic Agents|adrenergic agents|mesh-ancestor
110756747|NCT01111890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110756748|NCT01111890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110756749|NCT01111890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110756750|NCT01111890|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110756751|NCT01111890|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110756752|NCT01111890|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110756753|NCT01111890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110756769|NCT01111968|Vaccines|vaccines|mesh-list
110756770|NCT01111968|Immunologic Factors|immunologic factors|mesh-ancestor
110756771|NCT01111968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110756772|NCT04398134|Entecavir|entecavir|mesh-list
110756773|NCT04398134|Antiviral Agents|antiviral agents|mesh-ancestor
110756774|NCT04398134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110756775|NCT04281342|Moxifloxacin|moxifloxacin|mesh-list
110756776|NCT04281342|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110756777|NCT04281342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110756778|NCT04281342|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110756779|NCT04281342|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110756780|NCT04281342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110756781|NCT04281342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110756782|NCT04281342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110756783|NCT01108146|Hydrocortisone|hydrocortisone|mesh-list
110756784|NCT01108146|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
110756785|NCT01108146|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
110756786|NCT01108146|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
110756787|NCT01108146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110756788|NCT01108302|Oxytocin|oxytocin|mesh-list
110756789|NCT01108302|Oxytocics|oxytocics|mesh-ancestor
110756790|NCT01108302|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110756791|NCT01108302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110312321|NCT00304980|Artemether|artemether|mesh-list
110756792|NCT03122860|Lorecivivint|lorecivivint|mesh-list
110756793|NCT03122860|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110756794|NCT01319188|Ranibizumab|ranibizumab|mesh-list
110756795|NCT01319188|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110756796|NCT01319188|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110756797|NCT01319188|Growth Substances|growth substances|mesh-ancestor
110756798|NCT01319188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110756799|NCT01319188|Growth Inhibitors|growth inhibitors|mesh-ancestor
110756800|NCT01319188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110756801|NCT05167084|Hydrocortisone|hydrocortisone|mesh-list
110756802|NCT05167084|Metyrapone|metyrapone|mesh-list
110756803|NCT05167084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110756804|NCT05167084|Antimetabolites|antimetabolites|mesh-ancestor
110756805|NCT05167084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110756806|NCT05167084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110756807|NCT00867178|Vitamin A|vitamin a|mesh-list
110756808|NCT00867178|Cyclophosphamide|cyclophosphamide|mesh-list
110756809|NCT00867178|Thiotepa|thiotepa|mesh-list
110756810|NCT00867178|Cisplatin|cisplatin|mesh-list
110756811|NCT00867178|Carboplatin|carboplatin|mesh-list
110756812|NCT00867178|Etoposide|etoposide|mesh-list
110756813|NCT00867178|Vincristine|vincristine|mesh-list
110756814|NCT00867178|Vorinostat|vorinostat|mesh-list
110756815|NCT00867178|Tretinoin|tretinoin|mesh-list
110756816|NCT00867178|Etoposide phosphate|etoposide phosphate|mesh-list
110756817|NCT00867178|Isotretinoin|isotretinoin|mesh-list
110756818|NCT00867178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110756819|NCT00867178|Immunologic Factors|immunologic factors|mesh-ancestor
110756820|NCT00867178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110756821|NCT00867178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110756822|NCT00867178|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110756823|NCT00867178|Alkylating Agents|alkylating agents|mesh-ancestor
110756824|NCT00867178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110756825|NCT00867178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110756826|NCT00867178|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110756827|NCT00867178|Vitamins|vitamins|mesh-ancestor
110756828|NCT00867178|Micronutrients|micronutrients|mesh-ancestor
110756829|NCT00867178|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110756830|NCT00867178|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110756831|NCT00867178|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110756832|NCT00867178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110756833|NCT00867178|Tubulin Modulators|tubulin modulators|mesh-ancestor
110756834|NCT00867178|Antimitotic Agents|antimitotic agents|mesh-ancestor
110756835|NCT00867178|Mitosis Modulators|mitosis modulators|mesh-ancestor
110756836|NCT00867178|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110756837|NCT00867178|Keratolytic Agents|keratolytic agents|mesh-ancestor
110756838|NCT00867178|Dermatologic Agents|dermatologic agents|mesh-ancestor
110756839|NCT03945396|Calcium Carbonate|calcium carbonate|mesh-list
110756840|NCT03945396|Antacids|antacids|mesh-ancestor
110756841|NCT03945396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110756842|NCT03945396|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110756843|NCT01109784|Clopidogrel|clopidogrel|mesh-list
110756844|NCT01109784|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
110756845|NCT01109784|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110756846|NCT01109784|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110756847|NCT01109784|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110756848|NCT01109784|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110756849|NCT01109784|Purinergic Agents|purinergic agents|mesh-ancestor
110756850|NCT01109784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110756851|NCT01109784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110756852|NCT01109784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110756853|NCT01328340|Methamphetamine|methamphetamine|mesh-list
110868587|NCT02426164|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110756854|NCT01328340|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110756855|NCT01328340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110756856|NCT01328340|Sympathomimetics|sympathomimetics|mesh-ancestor
110756857|NCT01328340|Autonomic Agents|autonomic agents|mesh-ancestor
110756858|NCT01328340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110756859|NCT01328340|Dopamine Agents|dopamine agents|mesh-ancestor
110756860|NCT01328340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110756861|NCT01328340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110756862|NCT01328340|Adrenergic Agents|adrenergic agents|mesh-ancestor
110756863|NCT01328340|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110756864|NCT01328340|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110756865|NCT01328340|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110756866|NCT01328340|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110756867|NCT03796728|Lidocaine|lidocaine|mesh-list
110756868|NCT03796728|Anesthetics, Local|anesthetics, local|mesh-ancestor
110756869|NCT03796728|Anesthetics|anesthetics|mesh-ancestor
110756870|NCT03796728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110756871|NCT03796728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110756872|NCT03796728|Sensory System Agents|sensory system agents|mesh-ancestor
110756873|NCT03796728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110756874|NCT03796728|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110756875|NCT03796728|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110312447|NCT00325767|Tocolytic Agents|tocolytic agents|mesh-ancestor
110756876|NCT03796728|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110756877|NCT03796728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110756878|NCT03796728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110756879|NCT00352534|Dactinomycin|dactinomycin|mesh-list
110756880|NCT00352534|Cactinomycin|cactinomycin|mesh-list
110756881|NCT00352534|Doxorubicin|doxorubicin|mesh-list
110756882|NCT00352534|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110756883|NCT00352534|Vincristine|vincristine|mesh-list
110756884|NCT00352534|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110756885|NCT00352534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110756886|NCT00352534|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110756887|NCT00352534|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110756889|NCT00352534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110756890|NCT00352534|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110756891|NCT00352534|Tubulin Modulators|tubulin modulators|mesh-ancestor
110756892|NCT00352534|Antimitotic Agents|antimitotic agents|mesh-ancestor
110756893|NCT00352534|Mitosis Modulators|mitosis modulators|mesh-ancestor
110756894|NCT00352534|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110756895|NCT00352534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110756896|NCT00352534|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110756897|NCT00352534|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110756898|NCT01328106|Trametinib|trametinib|mesh-list
110756899|NCT01328106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110756900|NCT01328106|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110756901|NCT01328106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110756902|NCT01328106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110756903|NCT03122548|Pembrolizumab|pembrolizumab|mesh-list
110756904|NCT03122548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110756905|NCT03122548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110756906|NCT03122548|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110756907|NCT03122548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110756908|NCT03749642|Gabapentin|gabapentin|mesh-list
110756909|NCT03749642|Trazodone|trazodone|mesh-list
110756910|NCT03749642|Analgesics|analgesics|mesh-ancestor
110756911|NCT03749642|Sensory System Agents|sensory system agents|mesh-ancestor
110756912|NCT03749642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110756913|NCT03749642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110756914|NCT03749642|Anticonvulsants|anticonvulsants|mesh-ancestor
110756915|NCT03749642|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110756916|NCT03749642|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110756917|NCT03749642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110756918|NCT03749642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110756919|NCT03749642|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110756920|NCT03749642|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110756921|NCT03749642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110756922|NCT03749642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110756923|NCT03749642|Antimanic Agents|antimanic agents|mesh-ancestor
110756924|NCT03749642|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110312585|NCT00305838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110756925|NCT03749642|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110756926|NCT03749642|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110756927|NCT03749642|Serotonin Agents|serotonin agents|mesh-ancestor
110756928|NCT03749642|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110756929|NCT03749642|Antidepressive Agents|antidepressive agents|mesh-ancestor
110756930|NCT03751358|Anesthetics|anesthetics|mesh-list
110756931|NCT03751358|Anesthetics, Local|anesthetics, local|mesh-list
110756932|NCT03751358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110756933|NCT03751358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110756934|NCT03751358|Sensory System Agents|sensory system agents|mesh-ancestor
110756935|NCT03751358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110756936|NCT05193292|Trastuzumab|trastuzumab|mesh-list
110756937|NCT05193292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110756938|NCT05193292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110756939|NCT05193214|Antibodies|antibodies|mesh-list
110756940|NCT05193214|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110756941|NCT05193214|Immunologic Factors|immunologic factors|mesh-ancestor
110756942|NCT05193214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110756943|NCT02529774|Leucovorin|leucovorin|mesh-list
110756944|NCT02529774|Dexamethasone|dexamethasone|mesh-list
110756945|NCT02529774|Capecitabine|capecitabine|mesh-list
110756946|NCT02529774|Oxaliplatin|oxaliplatin|mesh-list
110756947|NCT02529774|Fluorouracil|fluorouracil|mesh-list
110756948|NCT02529774|Floxuridine|floxuridine|mesh-list
110756949|NCT02529774|Heparin|heparin|mesh-list
110756950|NCT02529774|Levoleucovorin|levoleucovorin|mesh-list
110756951|NCT02529774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110756952|NCT02529774|Antiemetics|antiemetics|mesh-ancestor
110756953|NCT02529774|Autonomic Agents|autonomic agents|mesh-ancestor
110756954|NCT02529774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110756955|NCT02529774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110756956|NCT02529774|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110756957|NCT02529774|Glucocorticoids|glucocorticoids|mesh-ancestor
110756958|NCT02529774|Hormones|hormones|mesh-ancestor
110756959|NCT02529774|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110756961|NCT02529774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110756962|NCT02529774|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110756963|NCT02529774|Antimetabolites|antimetabolites|mesh-ancestor
110756964|NCT02529774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110756965|NCT02529774|Antidotes|antidotes|mesh-ancestor
110756966|NCT02529774|Protective Agents|protective agents|mesh-ancestor
110756967|NCT02529774|Vitamin B Complex|vitamin b complex|mesh-ancestor
110756968|NCT02529774|Vitamins|vitamins|mesh-ancestor
110756969|NCT02529774|Micronutrients|micronutrients|mesh-ancestor
110756970|NCT02529774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110756971|NCT02529774|Immunologic Factors|immunologic factors|mesh-ancestor
110756972|NCT02529774|Anticoagulants|anticoagulants|mesh-ancestor
110756973|NCT02529774|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110756974|NCT02529774|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110756975|NCT04459598|Efavirenz|efavirenz|mesh-list
110756976|NCT04459598|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110756977|NCT04459598|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110756978|NCT04459598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110756979|NCT04459598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110756980|NCT04459598|Antiviral Agents|antiviral agents|mesh-ancestor
110756981|NCT04459598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110756982|NCT04459598|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110756983|NCT04459598|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110756984|NCT04459598|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110756985|NCT04459598|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110756986|NCT04459598|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110756987|NCT04459598|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110756988|NCT03942354|Moxifloxacin|moxifloxacin|mesh-list
110756989|NCT03942354|Linezolid|linezolid|mesh-list
110756990|NCT03942354|Bedaquiline|bedaquiline|mesh-list
110756992|NCT03942354|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110756993|NCT03942354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110756994|NCT03942354|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110756995|NCT03942354|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110756996|NCT03942354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110756997|NCT03942354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110756998|NCT03942354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110756999|NCT03942354|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110757000|NCT03942354|Antitubercular Agents|antitubercular agents|mesh-ancestor
110757001|NCT03942354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110757002|NCT03942354|Leprostatic Agents|leprostatic agents|mesh-ancestor
110757003|NCT05165992|Fentanyl|fentanyl|mesh-list
110757004|NCT05165992|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110757005|NCT05165992|Narcotics|narcotics|mesh-ancestor
110757006|NCT05165992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110757007|NCT05165992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110757008|NCT05165992|Analgesics|analgesics|mesh-ancestor
110757009|NCT05165992|Sensory System Agents|sensory system agents|mesh-ancestor
110757010|NCT05165992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110757011|NCT05165992|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110757012|NCT05165992|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110757013|NCT05165992|Anesthetics, General|anesthetics, general|mesh-ancestor
110757014|NCT05165992|Anesthetics|anesthetics|mesh-ancestor
110757015|NCT01359202|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110757016|NCT01367548|Methylnaltrexone|methylnaltrexone|mesh-list
110757017|NCT01367548|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110757018|NCT01367548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110757019|NCT01367548|Sensory System Agents|sensory system agents|mesh-ancestor
110757020|NCT01367548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110757021|NCT01367626|Letrozole|letrozole|mesh-list
110757022|NCT01367626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110757023|NCT01367626|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110757024|NCT01367626|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110757025|NCT01367626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110757026|NCT01367626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110757027|NCT01367626|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110757028|NCT01367626|Hormone Antagonists|hormone antagonists|mesh-ancestor
110474738|NCT02764281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110757029|NCT01367626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110757030|NCT01367626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110757032|NCT01112748|Anesthetics, Local|anesthetics, local|mesh-ancestor
110757033|NCT01112748|Anesthetics|anesthetics|mesh-ancestor
110757034|NCT01112748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110757035|NCT01112748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110757036|NCT01112748|Sensory System Agents|sensory system agents|mesh-ancestor
110757037|NCT01112748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110757038|NCT01112748|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110757039|NCT01112748|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110757040|NCT01112748|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110757041|NCT01112748|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110757042|NCT01112748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110757043|NCT05192902|Anesthetics|anesthetics|mesh-list
110757044|NCT05192902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110757045|NCT05192902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110757046|NCT01211808|Diltiazem|diltiazem|mesh-list
110757047|NCT01211808|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110757048|NCT01211808|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110757049|NCT01211808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110757050|NCT01211808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110757051|NCT01211808|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110757052|NCT01211808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110757053|NCT01211808|Vasodilator Agents|vasodilator agents|mesh-ancestor
110757054|NCT01209858|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
110757055|NCT01209858|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
110757056|NCT01209858|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110757057|NCT01209858|Contraceptive Agents|contraceptive agents|mesh-ancestor
110757058|NCT01209858|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110757059|NCT01209858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110757060|NCT01209858|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110757061|NCT01209858|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110757062|NCT01209858|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110757063|NCT01209858|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110757064|NCT01209858|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110757065|NCT01209858|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
110757066|NCT01209858|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
110757067|NCT01209858|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
110757068|NCT05191888|Amoxicillin|amoxicillin|mesh-list
110757069|NCT05191888|Metronidazole|metronidazole|mesh-list
110757070|NCT05191888|Clarithromycin|clarithromycin|mesh-list
110757071|NCT05191888|Rabeprazole|rabeprazole|mesh-list
110757072|NCT05191888|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110757073|NCT05191888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110757074|NCT05191888|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110757075|NCT05191888|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110757076|NCT05191888|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110757077|NCT05191888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110757078|NCT05191888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110757079|NCT05191888|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110757080|NCT05191888|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110757081|NCT05191888|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110757082|NCT05191888|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110757083|NCT05191888|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110757084|NCT01112826|Capecitabine|capecitabine|mesh-list
110757085|NCT01112826|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110757086|NCT01112826|Antimetabolites|antimetabolites|mesh-ancestor
110757087|NCT01112826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110757088|NCT01112826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110757089|NCT01210014|Zinc Sulfate|zinc sulfate|mesh-list
110757090|NCT01210014|Astringents|astringents|mesh-ancestor
110757091|NCT01210014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110757092|NCT01210014|Dermatologic Agents|dermatologic agents|mesh-ancestor
110757093|NCT05118256|Pirfenidone|pirfenidone|mesh-list
110757094|NCT05118256|Analgesics|analgesics|mesh-ancestor
110757095|NCT05118256|Sensory System Agents|sensory system agents|mesh-ancestor
110757096|NCT05118256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110757097|NCT05118256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110757098|NCT05118256|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110757099|NCT05118256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110757100|NCT05118256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110757101|NCT05118256|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110757102|NCT05118256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110757103|NCT01114542|Insulin|insulin|mesh-list
110757104|NCT01114542|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110757105|NCT01114542|Insulin Glargine|insulin glargine|mesh-list
110757106|NCT01114542|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110757107|NCT01114542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110757108|NCT02529540|Methamphetamine|methamphetamine|mesh-list
110757109|NCT02529540|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110757110|NCT02529540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110757111|NCT02529540|Sympathomimetics|sympathomimetics|mesh-ancestor
110757112|NCT02529540|Autonomic Agents|autonomic agents|mesh-ancestor
110757113|NCT02529540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110757114|NCT02529540|Dopamine Agents|dopamine agents|mesh-ancestor
110757115|NCT02529540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110757116|NCT02529540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110757118|NCT02529540|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110757119|NCT02529540|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110757120|NCT02529540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110757121|NCT02529540|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110757122|NCT01359436|Antibodies|antibodies|mesh-list
110757123|NCT01359436|Immunologic Factors|immunologic factors|mesh-ancestor
110757124|NCT01359436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110757125|NCT01359514|Pregabalin|pregabalin|mesh-list
110757126|NCT01359514|Calcium Channel Blockers|calcium channel blockers|mesh-list
110757127|NCT01359514|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110757128|NCT01359514|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110757129|NCT01359514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110757130|NCT01359514|Analgesics|analgesics|mesh-ancestor
110757131|NCT01359514|Sensory System Agents|sensory system agents|mesh-ancestor
110757132|NCT01359514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110757133|NCT01359514|Anticonvulsants|anticonvulsants|mesh-ancestor
110757134|NCT01359514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110757135|NCT01359514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110757136|NCT01359514|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110757137|NCT01359514|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110757138|NCT01359514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110757139|NCT01359514|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110757140|NCT01359514|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110757141|NCT01359514|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110757142|NCT01359514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110757143|NCT01359514|Antidepressive Agents|antidepressive agents|mesh-ancestor
110757144|NCT01359514|Dopamine Agents|dopamine agents|mesh-ancestor
110757145|NCT01368016|Nicotine|nicotine|mesh-list
110757146|NCT01368016|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110757147|NCT01368016|Autonomic Agents|autonomic agents|mesh-ancestor
110757148|NCT01368016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110757149|NCT01368016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110757150|NCT01368016|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110757151|NCT01368016|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110757152|NCT01368016|Cholinergic Agents|cholinergic agents|mesh-ancestor
110757153|NCT01368016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110757154|NCT01368016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110757155|NCT01208454|Vitamin A|vitamin a|mesh-list
110757156|NCT01208454|Vorinostat|vorinostat|mesh-list
110757157|NCT01208454|Tretinoin|tretinoin|mesh-list
110757158|NCT01208454|Isotretinoin|isotretinoin|mesh-list
110757159|NCT01208454|Vitamins|vitamins|mesh-ancestor
110757160|NCT01208454|Micronutrients|micronutrients|mesh-ancestor
110757161|NCT01208454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110757162|NCT01208454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110757163|NCT01208454|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110757164|NCT01208454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110757165|NCT01208454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110757166|NCT01208454|Keratolytic Agents|keratolytic agents|mesh-ancestor
110757167|NCT01208454|Dermatologic Agents|dermatologic agents|mesh-ancestor
110757168|NCT01110486|Carboplatin|carboplatin|mesh-list
110757169|NCT01110486|Docetaxel|docetaxel|mesh-list
110757170|NCT01110486|Ilorasertib|ilorasertib|mesh-list
110757171|NCT01110486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110757172|NCT01110486|Tubulin Modulators|tubulin modulators|mesh-ancestor
110757173|NCT01110486|Antimitotic Agents|antimitotic agents|mesh-ancestor
110090787|NCT03785106|Pyridoxine|pyridoxine|mesh-list
110757174|NCT01110486|Mitosis Modulators|mitosis modulators|mesh-ancestor
110757175|NCT01110486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110757176|NCT01110486|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110757177|NCT01110486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110757178|NCT01372306|Galantamine|galantamine|mesh-list
110757179|NCT01372306|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110757180|NCT01372306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110757181|NCT01372306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110757182|NCT01372306|Cholinergic Agents|cholinergic agents|mesh-ancestor
110757183|NCT01372306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110757184|NCT01372306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110757186|NCT01372306|Autonomic Agents|autonomic agents|mesh-ancestor
110757187|NCT01372306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110757188|NCT01372306|Nootropic Agents|nootropic agents|mesh-ancestor
110757189|NCT01114854|Topiramate|topiramate|mesh-list
110757190|NCT01114854|Anticonvulsants|anticonvulsants|mesh-ancestor
110757191|NCT01114854|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110757192|NCT01114854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110757193|NCT01359670|Sildenafil Citrate|sildenafil citrate|mesh-list
110757194|NCT01359670|Tadalafil|tadalafil|mesh-list
110757195|NCT01359670|Vasodilator Agents|vasodilator agents|mesh-ancestor
110757196|NCT01359670|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110757197|NCT01359670|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110757198|NCT01359670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110757199|NCT01359670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110757200|NCT01359670|Urological Agents|urological agents|mesh-ancestor
110757201|NCT05188768|Mitogens|mitogens|mesh-list
110757202|NCT05188768|Mitosis Modulators|mitosis modulators|mesh-ancestor
110757203|NCT05188768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110757204|NCT01368328|Chromium|chromium|mesh-list
110757205|NCT01368328|Niacin|niacin|mesh-list
110757206|NCT01368328|Trace Elements|trace elements|mesh-ancestor
110757207|NCT01368328|Micronutrients|micronutrients|mesh-ancestor
110757208|NCT01368328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110757209|NCT01368328|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110757210|NCT01368328|Antimetabolites|antimetabolites|mesh-ancestor
110757211|NCT01368328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110757212|NCT01368328|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110757213|NCT01368328|Vasodilator Agents|vasodilator agents|mesh-ancestor
110757214|NCT01368328|Vitamin B Complex|vitamin b complex|mesh-ancestor
110757215|NCT01368328|Vitamins|vitamins|mesh-ancestor
110757216|NCT01110642|Lovastatin|lovastatin|mesh-list
110757217|NCT01110642|L 647318|l 647318|mesh-list
110757218|NCT01110642|Dihydromevinolin|dihydromevinolin|mesh-list
110757219|NCT01110642|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110757220|NCT01110642|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110757221|NCT01110642|Antimetabolites|antimetabolites|mesh-ancestor
110757222|NCT01110642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110757223|NCT01110642|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110757224|NCT01110642|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110757225|NCT01110642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110757226|NCT02929498|Azacitidine|azacitidine|mesh-list
110757227|NCT02929498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110757228|NCT02929498|Antimetabolites|antimetabolites|mesh-ancestor
110757229|NCT02929498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110757230|NCT02929498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110757231|NCT02929498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110757232|NCT01359826|Milnacipran|milnacipran|mesh-list
110757233|NCT01359826|Levomilnacipran|levomilnacipran|mesh-list
110757234|NCT01359826|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110757235|NCT01359826|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110757236|NCT01359826|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110757237|NCT01359826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110757238|NCT01359826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110757239|NCT01359826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110757240|NCT01359826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110757241|NCT01359826|Analgesics|analgesics|mesh-ancestor
110757242|NCT01359826|Sensory System Agents|sensory system agents|mesh-ancestor
110757243|NCT01359826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110757244|NCT01359826|Antidepressive Agents|antidepressive agents|mesh-ancestor
110757245|NCT01359826|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110757246|NCT03792672|Ketamine|ketamine|mesh-list
110757247|NCT03792672|Analgesics|analgesics|mesh-ancestor
110445365|NCT04823052|Gaboxadol|gaboxadol|mesh-list
110757248|NCT03792672|Sensory System Agents|sensory system agents|mesh-ancestor
110757249|NCT03792672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110757250|NCT03792672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110757251|NCT03792672|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110757252|NCT03792672|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110757253|NCT03792672|Anesthetics, General|anesthetics, general|mesh-ancestor
110757255|NCT03792672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110757256|NCT03792672|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110757257|NCT03792672|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110757258|NCT03792672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110757259|NCT03792672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110757261|NCT01372540|Antimitotic Agents|antimitotic agents|mesh-ancestor
110757262|NCT01372540|Mitosis Modulators|mitosis modulators|mesh-ancestor
110757263|NCT01372540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110757264|NCT01372540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110757265|NCT01113138|Magnesium Sulfate|magnesium sulfate|mesh-list
110757266|NCT01113138|Analgesics|analgesics|mesh-ancestor
110757267|NCT01113138|Sensory System Agents|sensory system agents|mesh-ancestor
110757268|NCT01113138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110757269|NCT01113138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110757270|NCT01113138|Anesthetics|anesthetics|mesh-ancestor
110757271|NCT01113138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110757272|NCT01113138|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110757273|NCT01113138|Anticonvulsants|anticonvulsants|mesh-ancestor
110757274|NCT01113138|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110757275|NCT01113138|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110757276|NCT01113138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110757277|NCT01113138|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110757278|NCT01113138|Tocolytic Agents|tocolytic agents|mesh-ancestor
110757279|NCT01113138|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110757280|NCT01115322|Nicotinic Acids|nicotinic acids|mesh-list
110757281|NCT01115322|Tazarotene|tazarotene|mesh-list
110757282|NCT01115322|Dermatologic Agents|dermatologic agents|mesh-ancestor
110757283|NCT01115322|Keratolytic Agents|keratolytic agents|mesh-ancestor
110757284|NCT01115322|Vitamin B Complex|vitamin b complex|mesh-ancestor
110757285|NCT01115322|Vitamins|vitamins|mesh-ancestor
110757286|NCT01115322|Micronutrients|micronutrients|mesh-ancestor
110757287|NCT01115322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110757288|NCT01111188|Bortezomib|bortezomib|mesh-list
110757289|NCT01111188|Palbociclib|palbociclib|mesh-list
110757290|NCT01111188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110757291|NCT01111188|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110757292|NCT01111188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110757293|NCT01111188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110757294|NCT01210482|Sirolimus|sirolimus|mesh-list
110757295|NCT01210482|Temsirolimus|temsirolimus|mesh-list
110757296|NCT01210482|MTOR Inhibitors|mtor inhibitors|mesh-list
110757297|NCT01210482|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110757298|NCT01210482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110757299|NCT01210482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110757300|NCT01210482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110757301|NCT01210482|Immunologic Factors|immunologic factors|mesh-ancestor
110757302|NCT01210482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110757303|NCT01210482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110757304|NCT01210482|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110757305|NCT01210482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110757306|NCT01210482|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110757307|NCT01210482|Antifungal Agents|antifungal agents|mesh-ancestor
110757308|NCT01360060|Magnesium Sulfate|magnesium sulfate|mesh-list
110757309|NCT01360060|Analgesics|analgesics|mesh-ancestor
110757310|NCT01360060|Sensory System Agents|sensory system agents|mesh-ancestor
110757311|NCT01360060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110757312|NCT01360060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110757313|NCT01360060|Anesthetics|anesthetics|mesh-ancestor
110757314|NCT01360060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110757315|NCT01360060|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110757316|NCT01360060|Anticonvulsants|anticonvulsants|mesh-ancestor
110757317|NCT01360060|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110757318|NCT01360060|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110757319|NCT01360060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110757320|NCT01360060|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110082384|NCT01645839|Cytarabine|cytarabine|mesh-list
110757321|NCT01360060|Tocolytic Agents|tocolytic agents|mesh-ancestor
110757322|NCT01360060|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110757323|NCT01210638|Oxymorphone|oxymorphone|mesh-list
110757324|NCT01210638|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110757325|NCT01210638|Narcotics|narcotics|mesh-ancestor
110757326|NCT01210638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110757327|NCT01210638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110757328|NCT01210638|Analgesics|analgesics|mesh-ancestor
110757329|NCT01210638|Sensory System Agents|sensory system agents|mesh-ancestor
110757330|NCT01210638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110757331|NCT01210638|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110757332|NCT03120676|Atezolizumab|atezolizumab|mesh-list
110757333|NCT03120676|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110757334|NCT03120676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110757335|NCT03120676|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110757336|NCT03120676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110757338|NCT01115478|Vitamins|vitamins|mesh-ancestor
110757339|NCT01115478|Micronutrients|micronutrients|mesh-ancestor
110757340|NCT01115478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110757341|NCT01111422|Acetylcysteine|acetylcysteine|mesh-list
110757342|NCT01111422|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110757343|NCT01111422|Antiviral Agents|antiviral agents|mesh-ancestor
110757344|NCT01111422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110757345|NCT01111422|Expectorants|expectorants|mesh-ancestor
110757346|NCT01111422|Respiratory System Agents|respiratory system agents|mesh-ancestor
110757347|NCT01111422|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110757348|NCT01111422|Antioxidants|antioxidants|mesh-ancestor
110757349|NCT01111422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110757350|NCT01111422|Protective Agents|protective agents|mesh-ancestor
110757351|NCT01111422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110757352|NCT01111422|Antidotes|antidotes|mesh-ancestor
110757353|NCT01212432|Daptomycin|daptomycin|mesh-list
110757354|NCT01212432|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110757355|NCT01212432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110757356|NCT01213368|Dronedarone|dronedarone|mesh-list
110757357|NCT01213368|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110757358|NCT01369186|Morphine|morphine|mesh-list
110757359|NCT01369186|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110757360|NCT01369186|Narcotics|narcotics|mesh-ancestor
110757361|NCT01369186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110757362|NCT01369186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110757363|NCT01369186|Analgesics|analgesics|mesh-ancestor
110757364|NCT01369186|Sensory System Agents|sensory system agents|mesh-ancestor
110757365|NCT01369186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110757366|NCT01115712|Pioglitazone|pioglitazone|mesh-list
110757367|NCT01115712|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110757368|NCT01115712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110757369|NCT01117662|Rituximab|rituximab|mesh-list
110757370|NCT01117662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110757371|NCT01117662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110757372|NCT01117662|Immunologic Factors|immunologic factors|mesh-ancestor
110757373|NCT01117662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110757374|NCT01117662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110757375|NCT01319266|Hydrocodone|hydrocodone|mesh-list
110757376|NCT01319266|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110757377|NCT01319266|Narcotics|narcotics|mesh-ancestor
110757378|NCT01319266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110757379|NCT01319266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110757380|NCT01319266|Analgesics|analgesics|mesh-ancestor
110757381|NCT01319266|Sensory System Agents|sensory system agents|mesh-ancestor
110757382|NCT01319266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110757383|NCT01319266|Antitussive Agents|antitussive agents|mesh-ancestor
110757384|NCT01319266|Respiratory System Agents|respiratory system agents|mesh-ancestor
110757385|NCT01115790|Prexasertib|prexasertib|mesh-list
110757386|NCT01115790|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110757387|NCT01115790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110757388|NCT01115790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110757389|NCT01115946|Enalapril|enalapril|mesh-list
110757390|NCT01115946|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110757391|NCT01115946|Protease Inhibitors|protease inhibitors|mesh-ancestor
110757392|NCT01115946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110757393|NCT01115946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110757394|NCT01115946|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110757395|NCT01113372|Clopidogrel|clopidogrel|mesh-list
110757396|NCT01113372|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110757397|NCT01113372|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110757398|NCT01113372|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110757399|NCT01113372|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110757400|NCT01113372|Purinergic Agents|purinergic agents|mesh-ancestor
110757401|NCT01113372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110757402|NCT01113372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110757403|NCT01113372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110757405|NCT03120520|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
110757406|NCT03120520|Enzyme Activators|enzyme activators|mesh-ancestor
110757407|NCT03120520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110757408|NCT03120520|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110757409|NCT03941340|Aflutinib|aflutinib|mesh-list
110757410|NCT03941340|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110757411|NCT03941340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110757412|NCT03941340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110757413|NCT01372930|Etanercept|etanercept|mesh-list
110757414|NCT01372930|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110757415|NCT01372930|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110757416|NCT01372930|Analgesics|analgesics|mesh-ancestor
110757417|NCT01372930|Sensory System Agents|sensory system agents|mesh-ancestor
110757418|NCT01372930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110757419|NCT01372930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110757420|NCT01372930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110757421|NCT01372930|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110757422|NCT01372930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110757423|NCT01372930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110757424|NCT01372930|Immunologic Factors|immunologic factors|mesh-ancestor
110757425|NCT01328652|Dexlansoprazole|dexlansoprazole|mesh-list
110757426|NCT01328652|Lansoprazole|lansoprazole|mesh-list
110757427|NCT01328652|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
110757428|NCT01328652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110757429|NCT01328652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110757430|NCT01328652|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110757431|NCT01328652|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110757432|NCT01373008|Beclomethasone|beclomethasone|mesh-list
110757433|NCT01373008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110757434|NCT01373008|Glucocorticoids|glucocorticoids|mesh-ancestor
110757435|NCT01373008|Hormones|hormones|mesh-ancestor
110757436|NCT01373008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110757437|NCT01373008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110757438|NCT01373008|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110757439|NCT01373008|Respiratory System Agents|respiratory system agents|mesh-ancestor
110757440|NCT01116180|Candesartan|candesartan|mesh-list
110757441|NCT01116180|Candesartan cilexetil|candesartan cilexetil|mesh-list
110757442|NCT01116180|Angiotensin II|angiotensin ii|mesh-list
110757443|NCT01116180|Giapreza|giapreza|mesh-list
110757444|NCT01116180|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
110757445|NCT01116180|Angiotensinogen|angiotensinogen|mesh-list
110757446|NCT01116180|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110757447|NCT01116180|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110757448|NCT01116180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110757449|NCT01116180|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110757450|NCT01116180|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110757451|NCT01116180|Protease Inhibitors|protease inhibitors|mesh-ancestor
110757452|NCT01116180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110757453|NCT05067166|Ansuvimab|ansuvimab|mesh-list
110757454|NCT05067166|Antiviral Agents|antiviral agents|mesh-ancestor
110757455|NCT05067166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110757456|NCT01113528|Aspirin|aspirin|mesh-list
110757457|NCT01113528|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110757458|NCT01113528|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110757459|NCT01113528|Analgesics|analgesics|mesh-ancestor
110757460|NCT01113528|Sensory System Agents|sensory system agents|mesh-ancestor
110757461|NCT01113528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110757462|NCT01113528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110757463|NCT01113528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110757464|NCT01113528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110757465|NCT01113528|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110757466|NCT01113528|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110757467|NCT01113528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110757468|NCT01113528|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110757469|NCT01113528|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110757470|NCT01113528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110757471|NCT01113528|Antipyretics|antipyretics|mesh-ancestor
110757472|NCT01369576|Zopiclone|zopiclone|mesh-list
110757473|NCT01369576|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110757474|NCT01369576|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110757475|NCT01369576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110757476|NCT01113762|Cimetidine|cimetidine|mesh-list
110475186|NCT02747511|Haloperidol|haloperidol|mesh-list
110757477|NCT01113762|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110757478|NCT01113762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110757479|NCT01113762|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110757480|NCT01113762|Histamine Antagonists|histamine antagonists|mesh-ancestor
110757481|NCT01113762|Histamine Agents|histamine agents|mesh-ancestor
110757482|NCT01113762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110757483|NCT01113762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110757484|NCT01113762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110757485|NCT01113762|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110757486|NCT01113762|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110757487|NCT01113762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110757488|NCT01212666|Ropivacaine|ropivacaine|mesh-list
110757489|NCT01212666|Anesthetics, Local|anesthetics, local|mesh-ancestor
110757490|NCT01212666|Anesthetics|anesthetics|mesh-ancestor
110757491|NCT01212666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110757492|NCT01212666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110757493|NCT01212666|Sensory System Agents|sensory system agents|mesh-ancestor
110757494|NCT01212666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110757495|NCT01116336|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110757496|NCT01116336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110757497|NCT01116336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110757498|NCT01116336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110757499|NCT01116336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110757500|NCT01213680|Ferric Compounds|ferric compounds|mesh-list
110757501|NCT01213680|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
110757502|NCT01213680|Hematinics|hematinics|mesh-ancestor
110757503|NCT03937518|Strontium ranelate|strontium ranelate|mesh-list
110757504|NCT03937518|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110757505|NCT03937518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110757506|NCT01211496|Methamphetamine|methamphetamine|mesh-list
110757507|NCT01211496|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110757508|NCT01211496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110757509|NCT01211496|Sympathomimetics|sympathomimetics|mesh-ancestor
110757510|NCT01211496|Autonomic Agents|autonomic agents|mesh-ancestor
110757511|NCT01211496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110757512|NCT01211496|Dopamine Agents|dopamine agents|mesh-ancestor
110757513|NCT01211496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110757514|NCT01211496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110757515|NCT01211496|Adrenergic Agents|adrenergic agents|mesh-ancestor
110757516|NCT01211496|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110757517|NCT01211496|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110757518|NCT01211496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110757519|NCT01211496|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110757520|NCT01118286|Nifedipine|nifedipine|mesh-list
110757521|NCT01118286|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110757522|NCT01118286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110868663|NCT01365897|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110757523|NCT01118286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110757524|NCT01118286|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110757525|NCT01118286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110757526|NCT01118286|Vasodilator Agents|vasodilator agents|mesh-ancestor
110757527|NCT01118286|Tocolytic Agents|tocolytic agents|mesh-ancestor
110757528|NCT01118286|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110757529|NCT01585350|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
110757530|NCT01585350|Freund's Adjuvant|freund's adjuvant|mesh-list
110757531|NCT01585350|Poly ICLC|poly iclc|mesh-list
110757532|NCT01585350|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110757533|NCT01585350|Immunologic Factors|immunologic factors|mesh-ancestor
110757534|NCT01585350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110757535|NCT01585350|Interferon Inducers|interferon inducers|mesh-ancestor
110757536|NCT01118598|Nicotinic Acids|nicotinic acids|mesh-list
110757537|NCT01118598|Niacin|niacin|mesh-list
110757538|NCT01118598|Niacinamide|niacinamide|mesh-list
110757539|NCT01118598|Vitamin B Complex|vitamin b complex|mesh-ancestor
110757541|NCT01118598|Micronutrients|micronutrients|mesh-ancestor
110757542|NCT01118598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110757543|NCT01118598|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110757544|NCT01118598|Antimetabolites|antimetabolites|mesh-ancestor
110757545|NCT01118598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110757546|NCT01118598|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110757547|NCT01118598|Vasodilator Agents|vasodilator agents|mesh-ancestor
110757548|NCT01216020|Cisplatin|cisplatin|mesh-list
110757549|NCT01216020|Cetuximab|cetuximab|mesh-list
110757550|NCT01216020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110475269|NCT02741817|Antipyretics|antipyretics|mesh-ancestor
110757551|NCT01216020|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110757553|NCT01121796|Ergocalciferols|ergocalciferols|mesh-list
110757554|NCT01121796|Cholecalciferol|cholecalciferol|mesh-list
110757555|NCT01121796|Vitamins|vitamins|mesh-list
110757556|NCT01121796|Micronutrients|micronutrients|mesh-ancestor
110757557|NCT01121796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110757558|NCT01121796|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110757559|NCT01121796|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110757560|NCT03939624|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
110757561|NCT03939624|Protease Inhibitors|protease inhibitors|mesh-ancestor
110757562|NCT03939624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110757563|NCT03939624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110757564|NCT03939624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110757565|NCT03939624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110757566|NCT01119144|Calcium, Dietary|calcium, dietary|mesh-list
110757567|NCT01119144|Calcium|calcium|mesh-list
110757568|NCT01119144|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110757569|NCT01119144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110757570|NCT01119144|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110757571|NCT01117038|Amlodipine|amlodipine|mesh-list
110757572|NCT01117038|Enalapril|enalapril|mesh-list
110757573|NCT01117038|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110757574|NCT01117038|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110757575|NCT01117038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110757576|NCT01117038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110757577|NCT01117038|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110757578|NCT01117038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110757579|NCT01117038|Vasodilator Agents|vasodilator agents|mesh-ancestor
110757580|NCT01117038|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110757581|NCT01117038|Protease Inhibitors|protease inhibitors|mesh-ancestor
110757582|NCT01117038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110757583|NCT01119534|Camphor|camphor|mesh-list
110757584|NCT01119534|Eucalyptol|eucalyptol|mesh-list
110757585|NCT01119534|Phenylpropanolamine|phenylpropanolamine|mesh-list
110757586|NCT01119534|Menthol|menthol|mesh-list
110757587|NCT01119534|Guaifenesin|guaifenesin|mesh-list
110757588|NCT01119534|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
110757589|NCT01119534|Antipruritics|antipruritics|mesh-ancestor
110757590|NCT01119534|Dermatologic Agents|dermatologic agents|mesh-ancestor
110757591|NCT01119534|Expectorants|expectorants|mesh-ancestor
110757592|NCT01119534|Respiratory System Agents|respiratory system agents|mesh-ancestor
110868668|NCT01359657|Dexamethasone|dexamethasone|mesh-list
110757593|NCT01119534|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110757595|NCT01119534|Adrenergic Agents|adrenergic agents|mesh-ancestor
110757596|NCT01119534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110757597|NCT01119534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110757598|NCT01119534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110757599|NCT01119534|Appetite Depressants|appetite depressants|mesh-ancestor
110757600|NCT01119534|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110757601|NCT01119534|Sympathomimetics|sympathomimetics|mesh-ancestor
110757602|NCT01119534|Autonomic Agents|autonomic agents|mesh-ancestor
110757603|NCT01119534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110757604|NCT01119534|Nasal Decongestants|nasal decongestants|mesh-ancestor
110757605|NCT01119534|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110757606|NCT01119534|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110757607|NCT01119534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110757608|NCT01119534|Antitussive Agents|antitussive agents|mesh-ancestor
110757609|NCT01119534|Insect Repellents|insect repellents|mesh-ancestor
110757610|NCT01119534|Protective Agents|protective agents|mesh-ancestor
110757611|NCT01117116|Fluticasone|fluticasone|mesh-list
110757612|NCT01117116|Xhance|xhance|mesh-list
110757613|NCT01117116|Budesonide|budesonide|mesh-list
110082685|NCT01651325|Isavuconazole|isavuconazole|mesh-list
110757614|NCT01117116|Formoterol Fumarate|formoterol fumarate|mesh-list
110757615|NCT01117116|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110757616|NCT01117116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110757617|NCT01117116|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110757618|NCT01117116|Autonomic Agents|autonomic agents|mesh-ancestor
110757619|NCT01117116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110757620|NCT01117116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110757621|NCT01117116|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110757622|NCT01117116|Respiratory System Agents|respiratory system agents|mesh-ancestor
110757623|NCT01117116|Dermatologic Agents|dermatologic agents|mesh-ancestor
110757624|NCT01117116|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110757625|NCT01117116|Glucocorticoids|glucocorticoids|mesh-ancestor
110757626|NCT01117116|Hormones|hormones|mesh-ancestor
110312974|NCT00327288|Docetaxel|docetaxel|mesh-list
110757627|NCT01117116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110757628|NCT01117116|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110757629|NCT01117116|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110757630|NCT01117116|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110757631|NCT01117116|Adrenergic Agents|adrenergic agents|mesh-ancestor
110757632|NCT01117116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110757633|NCT01117116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110757635|NCT01216488|Anesthetics, Local|anesthetics, local|mesh-ancestor
110757636|NCT01216488|Anesthetics|anesthetics|mesh-ancestor
110757637|NCT01216488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110757638|NCT01216488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110757639|NCT01216488|Sensory System Agents|sensory system agents|mesh-ancestor
110757640|NCT01216488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110757641|NCT01216488|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110757642|NCT01216488|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110757643|NCT01216488|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110757644|NCT01216488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110757645|NCT01216488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110757646|NCT01122342|Methyltestosterone|methyltestosterone|mesh-list
110757647|NCT01122342|Testosterone|testosterone|mesh-list
110757648|NCT01122342|Testosterone undecanoate|testosterone undecanoate|mesh-list
110757649|NCT01122342|Testosterone enanthate|testosterone enanthate|mesh-list
110757650|NCT01122342|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
110757651|NCT01122342|Androgens|androgens|mesh-ancestor
110757652|NCT01122342|Hormones|hormones|mesh-ancestor
110757653|NCT01122342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110757654|NCT01122342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110757655|NCT01122342|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110757656|NCT01122342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110757657|NCT01122342|Anabolic Agents|anabolic agents|mesh-ancestor
110757658|NCT01213992|Iron|iron|mesh-list
110757659|NCT01213992|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
110757660|NCT01213992|Ferric Compounds|ferric compounds|mesh-list
110757661|NCT01213992|Trace Elements|trace elements|mesh-ancestor
110757662|NCT01213992|Micronutrients|micronutrients|mesh-ancestor
110757663|NCT01213992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110757664|NCT01213992|Hematinics|hematinics|mesh-ancestor
110757665|NCT01216644|Leucovorin|leucovorin|mesh-list
110757666|NCT01216644|Docetaxel|docetaxel|mesh-list
110757667|NCT01216644|Fluorouracil|fluorouracil|mesh-list
110757668|NCT01216644|Oxaliplatin|oxaliplatin|mesh-list
110757669|NCT01216644|Epirubicin|epirubicin|mesh-list
110757670|NCT01216644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110757671|NCT01216644|Tubulin Modulators|tubulin modulators|mesh-ancestor
110757672|NCT01216644|Antimitotic Agents|antimitotic agents|mesh-ancestor
110757673|NCT01216644|Mitosis Modulators|mitosis modulators|mesh-ancestor
110757674|NCT01216644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110757675|NCT01216644|Antimetabolites|antimetabolites|mesh-ancestor
110757676|NCT01216644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110757677|NCT01216644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110757678|NCT01216644|Immunologic Factors|immunologic factors|mesh-ancestor
110757679|NCT01216644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110757680|NCT01216644|Antidotes|antidotes|mesh-ancestor
110757681|NCT01216644|Protective Agents|protective agents|mesh-ancestor
110757682|NCT01216644|Vitamin B Complex|vitamin b complex|mesh-ancestor
110757683|NCT01216644|Vitamins|vitamins|mesh-ancestor
110757684|NCT01216644|Micronutrients|micronutrients|mesh-ancestor
110757685|NCT01216644|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110757686|NCT01216644|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110757687|NCT01216644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110757688|NCT01216644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110757689|NCT04959760|Antibodies|antibodies|mesh-list
110757690|NCT04959760|Immunoglobulins|immunoglobulins|mesh-list
110757692|NCT04959760|Immunologic Factors|immunologic factors|mesh-ancestor
110757693|NCT04959760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110757694|NCT01214226|Pentoxifylline|pentoxifylline|mesh-list
110757695|NCT01214226|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110757696|NCT01214226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110757697|NCT01214226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110757698|NCT01214226|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110757699|NCT01214226|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110757700|NCT01214226|Protective Agents|protective agents|mesh-ancestor
110757701|NCT01214226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110475414|NCT02612116|Ticagrelor|ticagrelor|mesh-list
110757702|NCT01214226|Vasodilator Agents|vasodilator agents|mesh-ancestor
110757703|NCT01214226|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110757704|NCT01214226|Antioxidants|antioxidants|mesh-ancestor
110757705|NCT01360372|Methylnaltrexone|methylnaltrexone|mesh-list
110757706|NCT01360372|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110757707|NCT01360372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110757708|NCT01360372|Sensory System Agents|sensory system agents|mesh-ancestor
110757709|NCT01360372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110757710|NCT01219062|Morphine|morphine|mesh-list
110757711|NCT01219062|Bupivacaine|bupivacaine|mesh-list
110757712|NCT01219062|Anesthetics, Local|anesthetics, local|mesh-ancestor
110757713|NCT01219062|Anesthetics|anesthetics|mesh-ancestor
110757714|NCT01219062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110757715|NCT01219062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110757716|NCT01219062|Sensory System Agents|sensory system agents|mesh-ancestor
110757717|NCT01219062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110757718|NCT01219062|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110757719|NCT01219062|Narcotics|narcotics|mesh-ancestor
110757720|NCT01219062|Analgesics|analgesics|mesh-ancestor
110757721|NCT01120158|Paclitaxel|paclitaxel|mesh-list
110757722|NCT01120158|Bevacizumab|bevacizumab|mesh-list
110757723|NCT01120158|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110757724|NCT01120158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110757725|NCT01120158|Tubulin Modulators|tubulin modulators|mesh-ancestor
110757726|NCT01120158|Antimitotic Agents|antimitotic agents|mesh-ancestor
110757727|NCT01120158|Mitosis Modulators|mitosis modulators|mesh-ancestor
110757728|NCT01120158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110757729|NCT01120158|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110757730|NCT01120158|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110757731|NCT01120158|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110757732|NCT01120158|Growth Substances|growth substances|mesh-ancestor
110757733|NCT01120158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110757734|NCT01120158|Growth Inhibitors|growth inhibitors|mesh-ancestor
110757735|NCT01373398|Apaziquone|apaziquone|mesh-list
110757736|NCT01373398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110757737|NCT01124526|Cyclophosphamide|cyclophosphamide|mesh-list
110757738|NCT01124526|Rituximab|rituximab|mesh-list
110757739|NCT01124526|Fludarabine|fludarabine|mesh-list
110757740|NCT01124526|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110757741|NCT01124526|Immunologic Factors|immunologic factors|mesh-ancestor
110757742|NCT01124526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110757743|NCT01124526|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110757744|NCT01124526|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110757745|NCT01124526|Alkylating Agents|alkylating agents|mesh-ancestor
110757746|NCT01124526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110757747|NCT01124526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110757748|NCT01124526|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110757749|NCT01124526|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110757750|NCT01120314|Otamixaban|otamixaban|mesh-list
110757751|NCT01120314|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110757752|NCT01120314|Antithrombins|antithrombins|mesh-ancestor
110757753|NCT01120314|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110757754|NCT01120314|Protease Inhibitors|protease inhibitors|mesh-ancestor
110757755|NCT01120314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110757756|NCT01120314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110757757|NCT01120314|Anticoagulants|anticoagulants|mesh-ancestor
110757758|NCT03633994|Heparin|heparin|mesh-list
110757759|NCT03633994|Anticoagulants|anticoagulants|mesh-ancestor
110757760|NCT03633994|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110757761|NCT03633994|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110757762|NCT03633994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110757763|NCT01328886|Omalizumab|omalizumab|mesh-list
110757764|NCT01328886|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110757765|NCT01328886|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110757766|NCT01328886|Respiratory System Agents|respiratory system agents|mesh-ancestor
110757767|NCT01216878|Losartan|losartan|mesh-list
110757768|NCT01216878|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110757769|NCT01216878|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110757770|NCT01216878|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110757771|NCT01216878|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110757772|NCT01216878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110757773|NCT04624984|Gemcitabine|gemcitabine|mesh-list
110757774|NCT04624984|Doxorubicin|doxorubicin|mesh-list
110757775|NCT04624984|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110757776|NCT04624984|Vinorelbine|vinorelbine|mesh-list
110757777|NCT04624984|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
110757778|NCT04624984|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110757779|NCT04624984|Antimetabolites|antimetabolites|mesh-ancestor
110757780|NCT04624984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110757781|NCT04624984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110757782|NCT04624984|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110757783|NCT04624984|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110757784|NCT04624984|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110757785|NCT04624984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110757786|NCT04624984|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110757787|NCT04624984|Tubulin Modulators|tubulin modulators|mesh-ancestor
110757788|NCT04624984|Antimitotic Agents|antimitotic agents|mesh-ancestor
110757789|NCT04624984|Mitosis Modulators|mitosis modulators|mesh-ancestor
110757790|NCT04624984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110757791|NCT01214382|Sertraline|sertraline|mesh-list
110757792|NCT01214382|Antidepressive Agents|antidepressive agents|mesh-ancestor
110757793|NCT01214382|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110757794|NCT01214382|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110757795|NCT01214382|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110757796|NCT01214382|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110757797|NCT01214382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110757798|NCT01214382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110757799|NCT01214382|Serotonin Agents|serotonin agents|mesh-ancestor
110757800|NCT01214382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110757801|NCT01216956|Nicotinic Acids|nicotinic acids|mesh-list
110757802|NCT01216956|Niacin|niacin|mesh-list
110757803|NCT01216956|Niacinamide|niacinamide|mesh-list
110757804|NCT01216956|Vitamin B Complex|vitamin b complex|mesh-ancestor
110757805|NCT01216956|Vitamins|vitamins|mesh-ancestor
110757806|NCT01216956|Micronutrients|micronutrients|mesh-ancestor
110757807|NCT01216956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110757808|NCT01216956|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110757809|NCT01216956|Antimetabolites|antimetabolites|mesh-ancestor
110757810|NCT01216956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110757811|NCT01216956|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110757812|NCT01216956|Vasodilator Agents|vasodilator agents|mesh-ancestor
110757813|NCT01217034|Sorafenib|sorafenib|mesh-list
110757814|NCT01217034|Chlorotrianisene|chlorotrianisene|mesh-list
110757815|NCT01217034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110757816|NCT01217034|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110757817|NCT01217034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110757818|NCT01217034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110757819|NCT01217034|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
110757820|NCT01217034|Estrogens|estrogens|mesh-ancestor
110757821|NCT01217034|Hormones|hormones|mesh-ancestor
110757822|NCT01217034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110757823|NCT01217034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110757824|NCT01217034|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110757825|NCT01373554|Oltipraz|oltipraz|mesh-list
110757826|NCT01373554|Antiviral Agents|antiviral agents|mesh-ancestor
110757827|NCT01373554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110757828|NCT01373554|Schistosomicides|schistosomicides|mesh-ancestor
110757829|NCT01373554|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110757830|NCT01373554|Anthelmintics|anthelmintics|mesh-ancestor
110757831|NCT01373554|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110757832|NCT01373554|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110757833|NCT01373554|Protective Agents|protective agents|mesh-ancestor
110757834|NCT01373554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110757835|NCT01373554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110757836|NCT01373554|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110757837|NCT01373554|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110757838|NCT01373554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110757839|NCT01373554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110757840|NCT01319344|Eplerenone|eplerenone|mesh-list
110757841|NCT01319344|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110757842|NCT01319344|Hormone Antagonists|hormone antagonists|mesh-ancestor
110757843|NCT01319344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110757844|NCT01319344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110757845|NCT01319344|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110757846|NCT01319344|Diuretics|diuretics|mesh-ancestor
110757847|NCT01319344|Natriuretic Agents|natriuretic agents|mesh-ancestor
110757848|NCT01319344|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110757849|NCT01373632|Sirolimus|sirolimus|mesh-list
110757850|NCT01373632|Temsirolimus|temsirolimus|mesh-list
110757851|NCT01373632|MTOR Inhibitors|mtor inhibitors|mesh-list
110757852|NCT01373632|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110757853|NCT01373632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110757854|NCT01373632|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110757855|NCT01373632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110757856|NCT01373632|Antifungal Agents|antifungal agents|mesh-ancestor
110757857|NCT01373632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110757858|NCT01373632|Immunologic Factors|immunologic factors|mesh-ancestor
110757859|NCT01373632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110757860|NCT01373632|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110757861|NCT01373632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110757862|NCT01373632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110757863|NCT01124760|Ketoconazole|ketoconazole|mesh-list
110757864|NCT01124760|Diltiazem|diltiazem|mesh-list
110757865|NCT01124760|Antifungal Agents|antifungal agents|mesh-ancestor
110757866|NCT01124760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110757867|NCT01124760|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110757868|NCT01124760|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110757869|NCT01124760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110757870|NCT01124760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110757871|NCT01124760|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110757872|NCT01124760|Hormone Antagonists|hormone antagonists|mesh-ancestor
110757873|NCT01124760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110757874|NCT01124760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110757875|NCT01124760|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110757876|NCT01124760|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110757877|NCT01124760|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110757878|NCT01124760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110757879|NCT01124760|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110757880|NCT01124760|Vasodilator Agents|vasodilator agents|mesh-ancestor
110757881|NCT01214772|Heparin|heparin|mesh-list
110757882|NCT01214772|Anticoagulants|anticoagulants|mesh-ancestor
110757883|NCT01214772|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110757884|NCT01214772|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110757885|NCT01214772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110757886|NCT01125150|Metformin|metformin|mesh-list
110757887|NCT01125150|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110757888|NCT01125150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110757889|NCT01373710|Trastuzumab|trastuzumab|mesh-list
110757890|NCT01373710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110757891|NCT01373710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110757892|NCT03935256|Paclitaxel|paclitaxel|mesh-list
110757893|NCT03935256|Carboplatin|carboplatin|mesh-list
110757894|NCT03935256|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110757895|NCT03935256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110757896|NCT03935256|Tubulin Modulators|tubulin modulators|mesh-ancestor
110757897|NCT03935256|Antimitotic Agents|antimitotic agents|mesh-ancestor
110757898|NCT03935256|Mitosis Modulators|mitosis modulators|mesh-ancestor
110757899|NCT03935256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110757900|NCT03869866|Vaccines|vaccines|mesh-list
110757901|NCT03869866|Immunologic Factors|immunologic factors|mesh-ancestor
110757902|NCT03869866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110757903|NCT03783702|Acetaminophen|acetaminophen|mesh-list
110757904|NCT03783702|Ibuprofen|ibuprofen|mesh-list
110757905|NCT03783702|Oxycodone|oxycodone|mesh-list
110757906|NCT03783702|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110757907|NCT03783702|Analgesics|analgesics|mesh-ancestor
110757908|NCT03783702|Sensory System Agents|sensory system agents|mesh-ancestor
110757909|NCT03783702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110757910|NCT03783702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110757911|NCT03783702|Antipyretics|antipyretics|mesh-ancestor
110757912|NCT03783702|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110757913|NCT03783702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110757914|NCT03783702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110757915|NCT03783702|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110757916|NCT03783702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110868704|NCT03183310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110757917|NCT03783702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110757918|NCT03783702|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110757919|NCT03783702|Narcotics|narcotics|mesh-ancestor
110757920|NCT03783702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110757921|NCT01319734|Glyburide|glyburide|mesh-list
110757922|NCT01319734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110757923|NCT01319734|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110757924|NCT01121016|Montelukast|montelukast|mesh-list
110757925|NCT01121016|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110757926|NCT01121016|Respiratory System Agents|respiratory system agents|mesh-ancestor
110757927|NCT01121016|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110757928|NCT01121016|Hormone Antagonists|hormone antagonists|mesh-ancestor
110757929|NCT01121016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110757930|NCT01121016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110757931|NCT01121016|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110757932|NCT01121016|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110757933|NCT01121016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110757934|NCT03575572|Colchicine|colchicine|mesh-list
110757935|NCT03575572|Gout Suppressants|gout suppressants|mesh-ancestor
110757936|NCT03575572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110757937|NCT03575572|Tubulin Modulators|tubulin modulators|mesh-ancestor
110757938|NCT03575572|Antimitotic Agents|antimitotic agents|mesh-ancestor
110757939|NCT03575572|Mitosis Modulators|mitosis modulators|mesh-ancestor
110757940|NCT03575572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110757941|NCT03575572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110757942|NCT01214928|Vitamin D|vitamin d|mesh-list
110757943|NCT01214928|Cholecalciferol|cholecalciferol|mesh-list
110757944|NCT01214928|Vitamins|vitamins|mesh-ancestor
110757945|NCT01214928|Micronutrients|micronutrients|mesh-ancestor
110757946|NCT01214928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110757947|NCT01214928|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110757948|NCT01214928|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110757949|NCT01122966|Bevacizumab|bevacizumab|mesh-list
110757950|NCT01122966|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110757951|NCT01122966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110757952|NCT01122966|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110757953|NCT01122966|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110757954|NCT01122966|Growth Substances|growth substances|mesh-ancestor
110757955|NCT01122966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110757956|NCT01122966|Growth Inhibitors|growth inhibitors|mesh-ancestor
110757957|NCT01219686|Pindolol|pindolol|mesh-list
110757958|NCT01219686|Dexetimide|dexetimide|mesh-list
110757959|NCT01219686|Citalopram|citalopram|mesh-list
110757960|NCT01219686|Escitalopram|escitalopram|mesh-list
110757961|NCT01219686|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110757962|NCT01219686|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110757963|NCT01219686|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110757964|NCT01219686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110757965|NCT01219686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110757966|NCT01219686|Serotonin Agents|serotonin agents|mesh-ancestor
110757967|NCT01219686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110757968|NCT01219686|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110757969|NCT01219686|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110757970|NCT01219686|Parasympatholytics|parasympatholytics|mesh-ancestor
110757971|NCT01219686|Autonomic Agents|autonomic agents|mesh-ancestor
110757972|NCT01219686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110757973|NCT01219686|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110757974|NCT01219686|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110757975|NCT01219686|Cholinergic Agents|cholinergic agents|mesh-ancestor
110757976|NCT01219686|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110757977|NCT01219686|Antidepressive Agents|antidepressive agents|mesh-ancestor
110757978|NCT01219686|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110757979|NCT01219686|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110757980|NCT01219686|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110757981|NCT01219686|Adrenergic Agents|adrenergic agents|mesh-ancestor
110757982|NCT01219686|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110757983|NCT01219686|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110757984|NCT01219686|Vasodilator Agents|vasodilator agents|mesh-ancestor
110757985|NCT01219764|Amoxicillin|amoxicillin|mesh-list
110757986|NCT01219764|Metronidazole|metronidazole|mesh-list
110757987|NCT01219764|Clarithromycin|clarithromycin|mesh-list
110757988|NCT01219764|Rabeprazole|rabeprazole|mesh-list
110757989|NCT01219764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110757990|NCT01219764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110757991|NCT01219764|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110757992|NCT01219764|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110757993|NCT01219764|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110757994|NCT01219764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110757995|NCT01219764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110757996|NCT01219764|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110757997|NCT01219764|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110757998|NCT01219764|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110757999|NCT01219764|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110758000|NCT01219764|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110758001|NCT03936426|Copper|copper|mesh-list
110758002|NCT03936426|Trace Elements|trace elements|mesh-ancestor
110758003|NCT03936426|Micronutrients|micronutrients|mesh-ancestor
110758004|NCT03936426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110758006|NCT01215084|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
110758007|NCT01215084|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110758008|NCT01215084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110758009|NCT01125696|Ritonavir|ritonavir|mesh-list
110758010|NCT01125696|Lopinavir|lopinavir|mesh-list
110758011|NCT01125696|Tenofovir|tenofovir|mesh-list
110758012|NCT01125696|Lamivudine|lamivudine|mesh-list
110758013|NCT01125696|Zidovudine|zidovudine|mesh-list
110758014|NCT01125696|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110758015|NCT01125696|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110758016|NCT01125696|Protease Inhibitors|protease inhibitors|mesh-ancestor
110758017|NCT01125696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110758018|NCT01125696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110758019|NCT01125696|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110758020|NCT01125696|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110758021|NCT01125696|Antiviral Agents|antiviral agents|mesh-ancestor
110758022|NCT01125696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110758023|NCT01125696|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110758024|NCT01125696|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110758025|NCT01125696|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110758026|NCT01125696|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110758027|NCT01125696|Antimetabolites|antimetabolites|mesh-ancestor
110758028|NCT03932916|Donepezil|donepezil|mesh-list
110758029|NCT03932916|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110758030|NCT03932916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110758031|NCT03932916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110758032|NCT03932916|Cholinergic Agents|cholinergic agents|mesh-ancestor
110758033|NCT03932916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110758034|NCT03932916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110758035|NCT03932916|Nootropic Agents|nootropic agents|mesh-ancestor
110758036|NCT03116152|Paclitaxel|paclitaxel|mesh-list
110758037|NCT03116152|Irinotecan|irinotecan|mesh-list
110758038|NCT03116152|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110758039|NCT03116152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110758040|NCT03116152|Tubulin Modulators|tubulin modulators|mesh-ancestor
110758041|NCT03116152|Antimitotic Agents|antimitotic agents|mesh-ancestor
110758042|NCT03116152|Mitosis Modulators|mitosis modulators|mesh-ancestor
110758043|NCT03116152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110758044|NCT03116152|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110758045|NCT03116152|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110758046|NCT03116152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110758047|NCT01123278|Testosterone|testosterone|mesh-list
110758048|NCT01123278|Androgens|androgens|mesh-ancestor
110758049|NCT01123278|Hormones|hormones|mesh-ancestor
110758050|NCT01123278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110758051|NCT01123278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110758052|NCT01219920|Leucovorin|leucovorin|mesh-list
110758053|NCT01219920|Irinotecan|irinotecan|mesh-list
110758054|NCT01219920|Antidotes|antidotes|mesh-ancestor
110758055|NCT01219920|Protective Agents|protective agents|mesh-ancestor
110758056|NCT01219920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110586244|NCT00709917|Repaglinide|repaglinide|mesh-list
110758057|NCT01219920|Vitamin B Complex|vitamin b complex|mesh-ancestor
110758059|NCT01219920|Micronutrients|micronutrients|mesh-ancestor
110758060|NCT01219920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110758061|NCT01219920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110758062|NCT01219920|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110758063|NCT01219920|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110758064|NCT01219920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110758065|NCT01400776|Estradiol|estradiol|mesh-list
110758066|NCT01400776|Estrogens|estrogens|mesh-ancestor
110758067|NCT01400776|Hormones|hormones|mesh-ancestor
110758068|NCT01400776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110758069|NCT01400776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110758070|NCT01220076|Tamoxifen|tamoxifen|mesh-list
110758071|NCT01220076|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110758072|NCT01220076|Hormone Antagonists|hormone antagonists|mesh-ancestor
110758073|NCT01220076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110758074|NCT01220076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110758075|NCT01220076|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110758076|NCT01220076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110758077|NCT01220076|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110758078|NCT01220076|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110758079|NCT01220076|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110758081|NCT01220154|Bevacizumab|bevacizumab|mesh-list
110758082|NCT01220154|Carboplatin|carboplatin|mesh-list
110758083|NCT01220154|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110758084|NCT01220154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110758085|NCT01220154|Tubulin Modulators|tubulin modulators|mesh-ancestor
110758086|NCT01220154|Antimitotic Agents|antimitotic agents|mesh-ancestor
110758087|NCT01220154|Mitosis Modulators|mitosis modulators|mesh-ancestor
110758088|NCT01220154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110758089|NCT01220154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110758090|NCT01220154|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110758091|NCT01220154|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110758092|NCT01220154|Growth Substances|growth substances|mesh-ancestor
110758093|NCT01220154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110758094|NCT01220154|Growth Inhibitors|growth inhibitors|mesh-ancestor
110758095|NCT01182766|Topiramate|topiramate|mesh-list
110758096|NCT01182766|Anticonvulsants|anticonvulsants|mesh-ancestor
110758097|NCT01182766|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110758098|NCT01182766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110758099|NCT01220232|Lamivudine|lamivudine|mesh-list
110758100|NCT01220232|Abacavir|abacavir|mesh-list
110758101|NCT01220232|Dideoxynucleosides|dideoxynucleosides|mesh-list
110758102|NCT01220232|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110758103|NCT01220232|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110758104|NCT01220232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110758105|NCT01220232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110758106|NCT01220232|Antiviral Agents|antiviral agents|mesh-ancestor
110758107|NCT01220232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110758108|NCT01220232|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110758109|NCT01220232|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110758110|NCT01220232|Antimetabolites|antimetabolites|mesh-ancestor
110758111|NCT01126008|Docetaxel|docetaxel|mesh-list
110758112|NCT01126008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110758113|NCT01126008|Tubulin Modulators|tubulin modulators|mesh-ancestor
110758114|NCT01126008|Antimitotic Agents|antimitotic agents|mesh-ancestor
110758115|NCT01126008|Mitosis Modulators|mitosis modulators|mesh-ancestor
110758116|NCT01126008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110758117|NCT03934710|Serotonin|serotonin|mesh-list
110758118|NCT03934710|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-list
110758119|NCT03934710|Serotonin Agents|serotonin agents|mesh-ancestor
110758120|NCT03934710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110758121|NCT03934710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110758122|NCT03934710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110758123|NCT05169424|Fluticasone|fluticasone|mesh-list
110758124|NCT05169424|Xhance|xhance|mesh-list
110758125|NCT05169424|Tiotropium Bromide|tiotropium bromide|mesh-list
110758126|NCT05169424|Olodaterol|olodaterol|mesh-list
110758127|NCT05169424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110758128|NCT05169424|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110758129|NCT05169424|Autonomic Agents|autonomic agents|mesh-ancestor
110758130|NCT05169424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110758131|NCT05169424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110758132|NCT05169424|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110758133|NCT05169424|Respiratory System Agents|respiratory system agents|mesh-ancestor
110758134|NCT05169424|Dermatologic Agents|dermatologic agents|mesh-ancestor
110758135|NCT05169424|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110758136|NCT05169424|Parasympatholytics|parasympatholytics|mesh-ancestor
110758137|NCT05169424|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110758138|NCT05169424|Cholinergic Agents|cholinergic agents|mesh-ancestor
110758139|NCT05169424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110758140|NCT05169424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110758143|NCT03117010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110758144|NCT03117010|Antiemetics|antiemetics|mesh-ancestor
110758145|NCT03117010|Autonomic Agents|autonomic agents|mesh-ancestor
110758146|NCT03117010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110758147|NCT03117010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110758148|NCT03117010|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110758149|NCT03117010|Glucocorticoids|glucocorticoids|mesh-ancestor
110758150|NCT03117010|Hormones|hormones|mesh-ancestor
110758151|NCT03117010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110758152|NCT03117010|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110758153|NCT03117010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110758154|NCT03117010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110758155|NCT03117010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110758156|NCT03117010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110758157|NCT03117010|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110758158|NCT03117010|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110758160|NCT01123824|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110758161|NCT01123824|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110758162|NCT01123824|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110758163|NCT01123824|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110758164|NCT01123824|Purinergic Agents|purinergic agents|mesh-ancestor
110758165|NCT01123824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110758166|NCT01123824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110758167|NCT01123824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110758168|NCT01126086|Otamixaban|otamixaban|mesh-list
110758169|NCT01126086|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110758170|NCT01126086|Antithrombins|antithrombins|mesh-ancestor
110758171|NCT01126086|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110758172|NCT01126086|Protease Inhibitors|protease inhibitors|mesh-ancestor
110758173|NCT01126086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110758174|NCT01126086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110758175|NCT01126086|Anticoagulants|anticoagulants|mesh-ancestor
110758176|NCT03009838|Letrozole|letrozole|mesh-list
110758177|NCT03009838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110758178|NCT03009838|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110758179|NCT03009838|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110758180|NCT03009838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110758181|NCT03009838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110758182|NCT03009838|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110758183|NCT03009838|Hormone Antagonists|hormone antagonists|mesh-ancestor
110758184|NCT03009838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110758185|NCT03009838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110758186|NCT01124058|Heparin|heparin|mesh-list
110758187|NCT01124058|Calcium heparin|calcium heparin|mesh-list
110758188|NCT01124058|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
110758189|NCT01124058|Tinzaparin|tinzaparin|mesh-list
110758190|NCT01124058|Dalteparin|dalteparin|mesh-list
110758191|NCT01124058|Warfarin|warfarin|mesh-list
110758192|NCT01124058|Anticoagulants|anticoagulants|mesh-ancestor
110758193|NCT01124058|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110758194|NCT01124058|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110758195|NCT01124058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110758196|NCT01375972|Cisplatin|cisplatin|mesh-list
110758197|NCT01375972|Gemcitabine|gemcitabine|mesh-list
110758198|NCT01375972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110758199|NCT01375972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110758201|NCT01375972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110758202|NCT05129644|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110758203|NCT05129644|Antiviral Agents|antiviral agents|mesh-ancestor
110758204|NCT05129644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110758205|NCT01220622|Nimodipine|nimodipine|mesh-list
110758206|NCT01220622|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110758207|NCT01220622|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110758208|NCT01220622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110758209|NCT01220622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110758210|NCT01220622|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110758211|NCT01220622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110758212|NCT01220622|Vasodilator Agents|vasodilator agents|mesh-ancestor
110758213|NCT05123170|Lidocaine|lidocaine|mesh-list
110758214|NCT05123170|Dexmedetomidine|dexmedetomidine|mesh-list
110758215|NCT05123170|Anesthetics, Local|anesthetics, local|mesh-ancestor
110758216|NCT05123170|Anesthetics|anesthetics|mesh-ancestor
110758217|NCT05123170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110758218|NCT05123170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110758219|NCT05123170|Sensory System Agents|sensory system agents|mesh-ancestor
110758220|NCT05123170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110758221|NCT05123170|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110758222|NCT05123170|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110758223|NCT05123170|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110758224|NCT05123170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110758225|NCT05123170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110758226|NCT05123170|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110475935|NCT05430243|Empagliflozin|empagliflozin|mesh-list
110758227|NCT05123170|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110758229|NCT05123170|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110758230|NCT05123170|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110758231|NCT05123170|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110758232|NCT05123170|Adrenergic Agents|adrenergic agents|mesh-ancestor
110758233|NCT05123170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110758234|NCT01215708|Tamsulosin|tamsulosin|mesh-list
110758235|NCT01215708|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110758236|NCT01215708|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110758237|NCT01215708|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110758238|NCT01215708|Adrenergic Agents|adrenergic agents|mesh-ancestor
110758239|NCT01215708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110758240|NCT01215708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110758241|NCT01215708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110758242|NCT01215708|Urological Agents|urological agents|mesh-ancestor
110758243|NCT01222026|Vitamin D|vitamin d|mesh-list
110758244|NCT01222026|Strontium ranelate|strontium ranelate|mesh-list
110758245|NCT01222026|Vitamins|vitamins|mesh-ancestor
110758246|NCT01222026|Micronutrients|micronutrients|mesh-ancestor
110758247|NCT01222026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110758248|NCT01222026|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110758249|NCT00225251|Bupropion|bupropion|mesh-list
110758250|NCT00225251|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110758251|NCT00225251|Antidepressive Agents|antidepressive agents|mesh-ancestor
110758252|NCT00225251|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110758253|NCT00225251|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110758254|NCT00225251|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110758255|NCT00225251|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110758256|NCT00225251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110758257|NCT00225251|Dopamine Agents|dopamine agents|mesh-ancestor
110758258|NCT00225251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110758259|NCT00225251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110758260|NCT00225251|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110758261|NCT00225251|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110758262|NCT00225251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110758263|NCT01376128|Paroxetine|paroxetine|mesh-list
110758264|NCT01376128|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110758265|NCT01376128|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110758266|NCT01376128|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110758267|NCT01376128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110758268|NCT01376128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110758269|NCT01376128|Serotonin Agents|serotonin agents|mesh-ancestor
110758270|NCT01376128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110758271|NCT01376128|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110758272|NCT01376128|Antidepressive Agents|antidepressive agents|mesh-ancestor
110758273|NCT01376128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110758274|NCT01376128|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110758275|NCT01376128|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110758276|NCT01376128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110758277|NCT01376206|Fluticasone|fluticasone|mesh-list
110758278|NCT01376206|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110758279|NCT01376206|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110758280|NCT01376206|Autonomic Agents|autonomic agents|mesh-ancestor
110758281|NCT01376206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110758282|NCT01376206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110758283|NCT01376206|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110758284|NCT01376206|Respiratory System Agents|respiratory system agents|mesh-ancestor
110758285|NCT01376206|Dermatologic Agents|dermatologic agents|mesh-ancestor
110758286|NCT01376206|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110758287|NCT01073501|Pregabalin|pregabalin|mesh-list
110758288|NCT01073501|Analgesics|analgesics|mesh-ancestor
110758289|NCT01073501|Sensory System Agents|sensory system agents|mesh-ancestor
110758290|NCT01073501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110758291|NCT01073501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110758292|NCT01073501|Anticonvulsants|anticonvulsants|mesh-ancestor
110758293|NCT01073501|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110758294|NCT01073501|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110758295|NCT01073501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110758296|NCT01073501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110758297|NCT01073501|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110313208|NCT05455944|Pregabalin|pregabalin|mesh-list
110758298|NCT01073501|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110758299|NCT01073501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110758300|NCT01073501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110758301|NCT01222182|Atorvastatin|atorvastatin|mesh-list
110758302|NCT01222182|Simvastatin|simvastatin|mesh-list
110758303|NCT01222182|Pravastatin|pravastatin|mesh-list
110758304|NCT01222182|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110758305|NCT01222182|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110758306|NCT01222182|Antimetabolites|antimetabolites|mesh-ancestor
110758307|NCT01222182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110758308|NCT01222182|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110758309|NCT01222182|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110758310|NCT01222182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110758311|NCT01218750|Bevacizumab|bevacizumab|mesh-list
110758312|NCT01218750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110758313|NCT01218750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110758314|NCT01218750|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110758315|NCT01218750|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110758316|NCT01218750|Growth Substances|growth substances|mesh-ancestor
110758317|NCT01218750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110758318|NCT01218750|Growth Inhibitors|growth inhibitors|mesh-ancestor
110758319|NCT01376284|Dutasteride|dutasteride|mesh-list
110758320|NCT01376284|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
110758321|NCT01376284|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110758322|NCT01376284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110758323|NCT01376284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110758324|NCT01376284|Hormone Antagonists|hormone antagonists|mesh-ancestor
110758325|NCT01376284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110758326|NCT01376284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110758327|NCT01376440|Sodium Hypochlorite|sodium hypochlorite|mesh-list
110758329|NCT01376440|Disinfectants|disinfectants|mesh-ancestor
110758330|NCT01376440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110758331|NCT01329042|Citric Acid|citric acid|mesh-list
110758332|NCT01329042|Sodium Citrate|sodium citrate|mesh-list
110758333|NCT01329042|Anticoagulants|anticoagulants|mesh-ancestor
110758334|NCT01329042|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110758335|NCT01329042|Chelating Agents|chelating agents|mesh-ancestor
110758336|NCT01329042|Sequestering Agents|sequestering agents|mesh-ancestor
110758337|NCT01329042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110758338|NCT00253643|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
110758339|NCT00253643|Antioxidants|antioxidants|mesh-ancestor
110758340|NCT00253643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110758341|NCT00253643|Protective Agents|protective agents|mesh-ancestor
110758342|NCT00253643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110758343|NCT00253643|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
110758344|NCT00253643|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110758345|NCT00253643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110758346|NCT00253643|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110758347|NCT01222650|Silodosin|silodosin|mesh-list
110758348|NCT01222650|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110758349|NCT01222650|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110758350|NCT01222650|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110758351|NCT01222650|Adrenergic Agents|adrenergic agents|mesh-ancestor
110758352|NCT01222650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110758353|NCT01222650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110758354|NCT01222650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110758355|NCT01222650|Urological Agents|urological agents|mesh-ancestor
110758356|NCT04856488|Lugol's solution|lugol's solution|mesh-list
110758357|NCT04856488|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110758358|NCT04856488|Hemostatics|hemostatics|mesh-ancestor
110758359|NCT04856488|Coagulants|coagulants|mesh-ancestor
110758360|NCT01073579|Vigabatrin|vigabatrin|mesh-list
110758361|NCT01073579|Anticonvulsants|anticonvulsants|mesh-ancestor
110758362|NCT01073579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110758363|NCT01073579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110758364|NCT01073579|GABA Agents|gaba agents|mesh-ancestor
110758365|NCT01073579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110758366|NCT01073579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110758367|NCT00221195|Thrombin|thrombin|mesh-list
110758368|NCT00221195|Hemostatics|hemostatics|mesh-ancestor
110758369|NCT00221195|Coagulants|coagulants|mesh-ancestor
110758370|NCT04646590|Vaccines|vaccines|mesh-list
110758371|NCT04646590|Immunologic Factors|immunologic factors|mesh-ancestor
110758372|NCT04646590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110758373|NCT03931668|Maleic acid|maleic acid|mesh-list
110758374|NCT03931668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110758375|NCT03931668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110758376|NCT00220805|Immunoglobulins|immunoglobulins|mesh-list
110758377|NCT00220805|Antibodies|antibodies|mesh-list
110758378|NCT00220805|gamma-Globulins|gamma-globulins|mesh-list
110758379|NCT00220805|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110758380|NCT00220805|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110758381|NCT00220805|Immunoglobulin G|immunoglobulin g|mesh-list
110758382|NCT00220805|Immunologic Factors|immunologic factors|mesh-ancestor
110758383|NCT00220805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110758384|NCT00220727|Immunoglobulins|immunoglobulins|mesh-list
110758385|NCT00220727|Antibodies|antibodies|mesh-list
110758386|NCT00220727|gamma-Globulins|gamma-globulins|mesh-list
110758387|NCT00220727|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110758388|NCT00220727|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110758389|NCT00220727|Immunoglobulin G|immunoglobulin g|mesh-list
110758390|NCT00220727|Immunologic Factors|immunologic factors|mesh-ancestor
110758391|NCT00220727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110758392|NCT01072097|Atorvastatin|atorvastatin|mesh-list
110758393|NCT01072097|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110758394|NCT01072097|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110758395|NCT01072097|Antimetabolites|antimetabolites|mesh-ancestor
110758396|NCT01072097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110758397|NCT01072097|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110758398|NCT01072097|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110758399|NCT01072097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110758400|NCT05760430|Bevacizumab|bevacizumab|mesh-list
110758401|NCT05760430|Apatinib|apatinib|mesh-list
110758402|NCT05760430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110758403|NCT05760430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110758404|NCT05760430|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110758405|NCT05760430|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110758406|NCT05760430|Growth Substances|growth substances|mesh-ancestor
110758407|NCT05760430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110758408|NCT05760430|Growth Inhibitors|growth inhibitors|mesh-ancestor
110758409|NCT05760430|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110758410|NCT05760430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110758411|NCT05760430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110758413|NCT01221402|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110758414|NCT01221402|Antimetabolites|antimetabolites|mesh-ancestor
110758415|NCT01221402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110758416|NCT01221402|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110758417|NCT01221402|Vasodilator Agents|vasodilator agents|mesh-ancestor
110758418|NCT01221402|Vitamin B Complex|vitamin b complex|mesh-ancestor
110758419|NCT01221402|Vitamins|vitamins|mesh-ancestor
110758420|NCT01221402|Micronutrients|micronutrients|mesh-ancestor
110758421|NCT01221402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110758422|NCT04214860|Azacitidine|azacitidine|mesh-list
110758423|NCT04214860|Venetoclax|venetoclax|mesh-list
110758424|NCT04214860|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110758425|NCT04214860|Antimetabolites|antimetabolites|mesh-ancestor
110758426|NCT04214860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110758427|NCT04214860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110758428|NCT04214860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110758429|NCT01127490|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110758430|NCT01127490|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110758431|NCT01127490|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110758432|NCT01127490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110758433|NCT01127490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110758434|NCT01127490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110758435|NCT01127490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110758436|NCT01127490|Analgesics|analgesics|mesh-ancestor
110758437|NCT01127490|Sensory System Agents|sensory system agents|mesh-ancestor
110758438|NCT01127490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110758439|NCT01127490|Antidepressive Agents|antidepressive agents|mesh-ancestor
110758440|NCT01127490|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110758441|NCT01127490|Dopamine Agents|dopamine agents|mesh-ancestor
110758442|NCT01223040|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110758443|NCT01223040|Lubricant Eye Drops|lubricant eye drops|mesh-list
110758444|NCT01223040|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110758445|NCT01126866|Bevacizumab|bevacizumab|mesh-list
110758446|NCT01126866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110758447|NCT01126866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110758448|NCT01126866|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110758449|NCT01126866|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110758450|NCT01126866|Growth Substances|growth substances|mesh-ancestor
110758451|NCT01126866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110758452|NCT01126866|Growth Inhibitors|growth inhibitors|mesh-ancestor
110758453|NCT04103554|Valsartan|valsartan|mesh-list
110758454|NCT04103554|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
110758455|NCT04103554|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110758456|NCT04103554|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110758457|NCT04103554|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110758458|NCT04103554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110758459|NCT03740568|Progesterone|progesterone|mesh-list
110758460|NCT03740568|Progestins|progestins|mesh-ancestor
110758461|NCT03740568|Hormones|hormones|mesh-ancestor
110758462|NCT03740568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110758463|NCT03740568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110758464|NCT00252239|Plasminogen|plasminogen|mesh-list
110758465|NCT00252239|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
110758466|NCT00252239|Tenecteplase|tenecteplase|mesh-list
110758467|NCT00252239|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110758468|NCT00252239|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110758469|NCT00252239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110758470|NCT01127022|Choline|choline|mesh-list
110758471|NCT01127022|Lipotropic Agents|lipotropic agents|mesh-ancestor
110758472|NCT01127022|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110758473|NCT01127022|Antimetabolites|antimetabolites|mesh-ancestor
110758474|NCT01127022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110758475|NCT01127022|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110758476|NCT01127022|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110758477|NCT01127022|Nootropic Agents|nootropic agents|mesh-ancestor
110758478|NCT01221558|Lycopene|lycopene|mesh-list
110758479|NCT01221558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110758480|NCT01221558|Antioxidants|antioxidants|mesh-ancestor
110758481|NCT01221558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110758482|NCT01221558|Protective Agents|protective agents|mesh-ancestor
110758483|NCT01221558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110758484|NCT01221558|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110758485|NCT01221558|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110758486|NCT01221558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110758487|NCT01221636|Abatacept|abatacept|mesh-list
110758488|NCT01221636|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110758489|NCT01221636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110758490|NCT01221636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110758491|NCT01221636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110758492|NCT01221636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110758493|NCT01221636|Immunologic Factors|immunologic factors|mesh-ancestor
110758494|NCT01221636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110758495|NCT01221636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110758496|NCT05731804|Ritonavir|ritonavir|mesh-list
110758497|NCT05731804|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110758498|NCT05731804|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110758499|NCT05731804|Protease Inhibitors|protease inhibitors|mesh-ancestor
110758500|NCT05731804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110758501|NCT05731804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110758502|NCT05731804|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110758503|NCT05731804|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110758504|NCT05731804|Antiviral Agents|antiviral agents|mesh-ancestor
110758505|NCT05731804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110758506|NCT05731804|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110758507|NCT05731804|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110758508|NCT01127568|Propranolol|propranolol|mesh-list
110758509|NCT01127568|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110758510|NCT01127568|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110758511|NCT01127568|Adrenergic Agents|adrenergic agents|mesh-ancestor
110758512|NCT01127568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110758513|NCT01127568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110758514|NCT01127568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110758515|NCT01127568|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110758516|NCT01127568|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110758517|NCT01127568|Vasodilator Agents|vasodilator agents|mesh-ancestor
110758518|NCT03932292|Calcium|calcium|mesh-list
110758519|NCT03932292|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110758520|NCT03932292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110758521|NCT01127100|Fentanyl|fentanyl|mesh-list
110758522|NCT01127100|Gabapentin|gabapentin|mesh-list
110758523|NCT01127100|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110758524|NCT01127100|Narcotics|narcotics|mesh-ancestor
110758525|NCT01127100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110758526|NCT01127100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110758527|NCT01127100|Analgesics|analgesics|mesh-ancestor
110758528|NCT01127100|Sensory System Agents|sensory system agents|mesh-ancestor
110758529|NCT01127100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110758530|NCT01127100|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110758531|NCT01127100|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110758532|NCT01127100|Anesthetics, General|anesthetics, general|mesh-ancestor
110758533|NCT01127100|Anesthetics|anesthetics|mesh-ancestor
110758534|NCT01127100|Anticonvulsants|anticonvulsants|mesh-ancestor
110758535|NCT01127100|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110758536|NCT01127100|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110758537|NCT01127100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110758538|NCT01127100|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110758539|NCT01127100|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110758540|NCT01127100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110313273|NCT00300287|Vildagliptin|vildagliptin|mesh-list
110758541|NCT01127100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110758542|NCT01127100|Antimanic Agents|antimanic agents|mesh-ancestor
110758543|NCT01127178|10-((4-hydroxypiperidin-1-yl)methyl)chromeno(4,3,2-de)phthalazin-3(2H)-one|10-((4-hydroxypiperidin-1-yl)methyl)chromeno(4,3,2-de)phthalazin-3(2h)-one|mesh-list
110758544|NCT01127178|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110758545|NCT01127178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110758546|NCT01127178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110758547|NCT01127178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110758549|NCT01221792|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110758550|NCT01221792|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110758551|NCT01221792|Adrenergic Agents|adrenergic agents|mesh-ancestor
110758552|NCT01221792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110758553|NCT01221792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110758554|NCT01221792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110758555|NCT01221792|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110758556|NCT01221792|Antioxidants|antioxidants|mesh-ancestor
110758557|NCT01221792|Protective Agents|protective agents|mesh-ancestor
110758558|NCT01221792|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110758559|NCT01221792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110758560|NCT01221792|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110758561|NCT01221792|Vasodilator Agents|vasodilator agents|mesh-ancestor
110758562|NCT01221792|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110758563|NCT01221792|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110758564|NCT03932526|Apatinib|apatinib|mesh-list
110758565|NCT03932526|Vinorelbine|vinorelbine|mesh-list
110758566|NCT03932526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110758567|NCT03932526|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110758568|NCT03932526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110758569|NCT03932526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110758570|NCT03932526|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110758571|NCT03932526|Tubulin Modulators|tubulin modulators|mesh-ancestor
110758572|NCT03932526|Antimitotic Agents|antimitotic agents|mesh-ancestor
110758573|NCT03932526|Mitosis Modulators|mitosis modulators|mesh-ancestor
110758574|NCT01127724|Vitamins|vitamins|mesh-list
110758575|NCT01127724|Vitamin B 12|vitamin b 12|mesh-list
110758576|NCT01127724|Hydroxocobalamin|hydroxocobalamin|mesh-list
110758577|NCT01127724|Vitamin B Complex|vitamin b complex|mesh-list
110758578|NCT01127724|Micronutrients|micronutrients|mesh-ancestor
110868780|NCT03106948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110758579|NCT01127724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110758581|NCT03103906|Sunscreening Agents|sunscreening agents|mesh-list
110758582|NCT03103906|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110758583|NCT03103906|Protective Agents|protective agents|mesh-ancestor
110758584|NCT03103906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110758585|NCT03103906|Dermatologic Agents|dermatologic agents|mesh-ancestor
110758586|NCT05675098|Methylphenidate|methylphenidate|mesh-list
110758587|NCT05675098|Modafinil|modafinil|mesh-list
110758588|NCT05675098|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110758589|NCT05675098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110758590|NCT05675098|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110758591|NCT05675098|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110758592|NCT05675098|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110758593|NCT05675098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110758594|NCT05675098|Dopamine Agents|dopamine agents|mesh-ancestor
110758595|NCT05675098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110758596|NCT05675098|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
110758597|NCT05675098|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110758598|NCT05675098|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110758599|NCT01223742|Acetylcarnitine|acetylcarnitine|mesh-list
110758600|NCT01223742|Vitamin B Complex|vitamin b complex|mesh-ancestor
110758601|NCT01223742|Vitamins|vitamins|mesh-ancestor
110758602|NCT01223742|Micronutrients|micronutrients|mesh-ancestor
110758603|NCT01223742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110758604|NCT01223742|Nootropic Agents|nootropic agents|mesh-ancestor
110758605|NCT01129518|Vaccines|vaccines|mesh-list
110758606|NCT01129518|Immunologic Factors|immunologic factors|mesh-ancestor
110758607|NCT01129518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110758608|NCT01223820|Capsaicin|capsaicin|mesh-list
110758609|NCT01223820|Antipruritics|antipruritics|mesh-ancestor
110758610|NCT01223820|Dermatologic Agents|dermatologic agents|mesh-ancestor
110758611|NCT01223820|Sensory System Agents|sensory system agents|mesh-ancestor
110758612|NCT01223820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110758613|NCT01223820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110758614|NCT01131234|Cediranib|cediranib|mesh-list
110758615|NCT01131234|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
110758616|NCT01131234|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-list
110758617|NCT01131234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110758618|NCT01131234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110758619|NCT01131234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110758620|NCT01131234|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110758621|NCT01129596|Donepezil|donepezil|mesh-list
110758622|NCT01129596|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110758623|NCT01129596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110758624|NCT01129596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110758625|NCT01129596|Cholinergic Agents|cholinergic agents|mesh-ancestor
110758626|NCT01129596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110758627|NCT01129596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110758628|NCT01129596|Nootropic Agents|nootropic agents|mesh-ancestor
110758629|NCT01127880|Clindamycin|clindamycin|mesh-list
110758630|NCT01127880|Clindamycin palmitate|clindamycin palmitate|mesh-list
110758631|NCT01127880|Clindamycin phosphate|clindamycin phosphate|mesh-list
110758632|NCT01127880|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110758633|NCT01127880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110758634|NCT01127880|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110758635|NCT01127880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110758636|NCT01127880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110758637|NCT01228344|Lumefantrine|lumefantrine|mesh-list
110758638|NCT01228344|Artemether|artemether|mesh-list
110758639|NCT01228344|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
110758640|NCT01228344|Antimalarials|antimalarials|mesh-ancestor
110758641|NCT01228344|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110758642|NCT01228344|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110758643|NCT01228344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110758644|NCT03927456|Fulvestrant|fulvestrant|mesh-list
110758645|NCT03927456|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110758646|NCT03927456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110758647|NCT03927456|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110758648|NCT03927456|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110758649|NCT03927456|Hormone Antagonists|hormone antagonists|mesh-ancestor
110758650|NCT03927456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110362191|NCT03993132|Empagliflozin|empagliflozin|mesh-list
110758651|NCT03927456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110758653|NCT01129830|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110758654|NCT01129830|Immunologic Factors|immunologic factors|mesh-ancestor
110758655|NCT01129830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110758656|NCT01228422|Interferons|interferons|mesh-list
110758657|NCT01228422|Interferon-alpha|interferon-alpha|mesh-list
110758658|NCT01228422|Interferon alpha-2|interferon alpha-2|mesh-list
110758659|NCT01228422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110758660|NCT01228422|Antiviral Agents|antiviral agents|mesh-ancestor
110758661|NCT01228422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110758662|NCT01228422|Immunologic Factors|immunologic factors|mesh-ancestor
110758663|NCT01228422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110758664|NCT01319422|Pomalidomide|pomalidomide|mesh-list
110758665|NCT01319422|Immunologic Factors|immunologic factors|mesh-ancestor
110758666|NCT01319422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110758667|NCT01319422|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110758668|NCT01319422|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110758669|NCT01319422|Growth Substances|growth substances|mesh-ancestor
110758670|NCT01319422|Growth Inhibitors|growth inhibitors|mesh-ancestor
110476371|NCT02609932|Antiviral Agents|antiviral agents|mesh-ancestor
110758671|NCT01319422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110758673|NCT01227174|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110758674|NCT01227174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110758675|NCT01227174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110758676|NCT01227174|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110758677|NCT01227174|Anesthetics, General|anesthetics, general|mesh-ancestor
110758678|NCT01227174|Anesthetics|anesthetics|mesh-ancestor
110758679|NCT03924492|Pregnanolone|pregnanolone|mesh-list
110758680|NCT03924492|Brexanolone|brexanolone|mesh-list
110758681|NCT03924492|Neurosteroids|neurosteroids|mesh-ancestor
110758682|NCT03924492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110758683|NCT03924492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110758684|NCT03924492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110758685|NCT03924492|GABA Modulators|gaba modulators|mesh-ancestor
110758686|NCT03924492|GABA Agents|gaba agents|mesh-ancestor
110758687|NCT03924492|Anesthetics|anesthetics|mesh-ancestor
110758688|NCT03924492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110758689|NCT01329276|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
110758690|NCT01329276|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110758691|NCT01329276|Respiratory System Agents|respiratory system agents|mesh-ancestor
110758692|NCT01224366|Vildagliptin|vildagliptin|mesh-list
110758693|NCT01224366|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110758694|NCT01224366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110758695|NCT01224366|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110758696|NCT01224366|Protease Inhibitors|protease inhibitors|mesh-ancestor
110758697|NCT01224366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110313311|NCT00300443|Bimatoprost|bimatoprost|mesh-list
110758698|NCT01224366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110758699|NCT05415826|Dexamethasone|dexamethasone|mesh-list
110758700|NCT05415826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110758701|NCT05415826|Antiemetics|antiemetics|mesh-ancestor
110758702|NCT05415826|Autonomic Agents|autonomic agents|mesh-ancestor
110758703|NCT05415826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110758704|NCT05415826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110758705|NCT05415826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110758706|NCT05415826|Glucocorticoids|glucocorticoids|mesh-ancestor
110758707|NCT05415826|Hormones|hormones|mesh-ancestor
110758708|NCT05415826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110758709|NCT05415826|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110758710|NCT05415826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110758711|NCT05415748|Tamsulosin|tamsulosin|mesh-list
110758712|NCT05415748|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110758713|NCT05415748|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110758714|NCT05415748|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110758715|NCT05415748|Adrenergic Agents|adrenergic agents|mesh-ancestor
110758716|NCT05415748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110758717|NCT05415748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110758718|NCT05415748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110758719|NCT05415748|Urological Agents|urological agents|mesh-ancestor
110758720|NCT03774576|Itraconazole|itraconazole|mesh-list
110758721|NCT03774576|Antifungal Agents|antifungal agents|mesh-ancestor
110758722|NCT03774576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110868815|NCT02416258|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110758723|NCT03774576|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110758724|NCT03774576|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110758725|NCT03774576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110758726|NCT03774576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110758727|NCT03774576|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110758728|NCT03774576|Hormone Antagonists|hormone antagonists|mesh-ancestor
110758729|NCT03774576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110758730|NCT03774576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110758731|NCT03774576|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110758732|NCT05415436|Propofol|propofol|mesh-list
110758733|NCT05415436|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110758734|NCT05415436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110758735|NCT05415436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110758736|NCT05415436|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110758737|NCT05415436|Anesthetics, General|anesthetics, general|mesh-ancestor
110758738|NCT05415436|Anesthetics|anesthetics|mesh-ancestor
110758739|NCT01227408|Paclitaxel|paclitaxel|mesh-list
110758740|NCT01227408|Cyclophosphamide|cyclophosphamide|mesh-list
110758741|NCT01227408|Doxorubicin|doxorubicin|mesh-list
110758742|NCT01227408|Capecitabine|capecitabine|mesh-list
110758743|NCT01227408|Methotrexate|methotrexate|mesh-list
110758744|NCT01227408|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
110758745|NCT01227408|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110758746|NCT01227408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110758747|NCT01227408|Tubulin Modulators|tubulin modulators|mesh-ancestor
110758748|NCT01227408|Antimitotic Agents|antimitotic agents|mesh-ancestor
110758749|NCT01227408|Mitosis Modulators|mitosis modulators|mesh-ancestor
110758750|NCT01227408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110758751|NCT01227408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110758752|NCT01227408|Immunologic Factors|immunologic factors|mesh-ancestor
110758753|NCT01227408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110758754|NCT01227408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110758755|NCT01227408|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110758756|NCT01227408|Alkylating Agents|alkylating agents|mesh-ancestor
110758757|NCT01227408|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110758758|NCT01227408|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110758759|NCT01227408|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110758760|NCT01227408|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110758761|NCT01227408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110758762|NCT01227408|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110758763|NCT01227408|Antimetabolites|antimetabolites|mesh-ancestor
110758764|NCT01227408|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110758765|NCT01227408|Abortifacient Agents|abortifacient agents|mesh-ancestor
110758766|NCT01227408|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110758767|NCT01227408|Dermatologic Agents|dermatologic agents|mesh-ancestor
110758768|NCT01227408|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110758769|NCT01227408|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110758770|NCT03773796|Nabilone|nabilone|mesh-list
110758771|NCT03773796|Antiemetics|antiemetics|mesh-ancestor
110758772|NCT03773796|Autonomic Agents|autonomic agents|mesh-ancestor
110758773|NCT03773796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110758774|NCT03773796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110758775|NCT03773796|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110758776|NCT03773796|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110758777|NCT03773796|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110758778|NCT03773796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110758779|NCT03773796|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110758780|NCT02927938|Cytarabine|cytarabine|mesh-list
110758781|NCT02927938|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110758782|NCT02927938|Antimetabolites|antimetabolites|mesh-ancestor
110758783|NCT02927938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110758784|NCT02927938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110758785|NCT02927938|Antiviral Agents|antiviral agents|mesh-ancestor
110758786|NCT02927938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110758787|NCT02927938|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110758788|NCT02927938|Immunologic Factors|immunologic factors|mesh-ancestor
110758789|NCT02927938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110758791|NCT05370820|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110758792|NCT05370820|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110758793|NCT05370820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110758794|NCT05370820|Hemostatics|hemostatics|mesh-ancestor
110758795|NCT05370820|Coagulants|coagulants|mesh-ancestor
110758796|NCT03863860|Fluzoparib|fluzoparib|mesh-list
110758797|NCT03863860|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110758798|NCT03863860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110758799|NCT03863860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110758800|NCT03863860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110758801|NCT03923166|Capecitabine|capecitabine|mesh-list
110758802|NCT03923166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110758803|NCT03923166|Antimetabolites|antimetabolites|mesh-ancestor
110758804|NCT03923166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110758805|NCT03923166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110758806|NCT01224756|Tinoridine|tinoridine|mesh-list
110758807|NCT01224756|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110758808|NCT01224756|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110758809|NCT01224756|Analgesics|analgesics|mesh-ancestor
110758810|NCT01224756|Sensory System Agents|sensory system agents|mesh-ancestor
110758811|NCT01224756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110758812|NCT01224756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110758813|NCT01224756|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110758814|NCT01224756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110758815|NCT03392428|177Lu-PSMA-617|177lu-psma-617|mesh-list
110758816|NCT03392428|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110758817|NCT03392428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110758818|NCT03222856|Pembrolizumab|pembrolizumab|mesh-list
110758819|NCT03222856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110758820|NCT03222856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110758821|NCT03222856|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110758822|NCT03222856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110758824|NCT01130298|Androgens|androgens|mesh-ancestor
110758825|NCT01130298|Hormones|hormones|mesh-ancestor
110758826|NCT01130298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110758827|NCT01130298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110758828|NCT01227720|Nicotine|nicotine|mesh-list
110758829|NCT01227720|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110758830|NCT01227720|Autonomic Agents|autonomic agents|mesh-ancestor
110758831|NCT01227720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110758832|NCT01227720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110758833|NCT01227720|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110758834|NCT01227720|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110758835|NCT01227720|Cholinergic Agents|cholinergic agents|mesh-ancestor
110758836|NCT01227720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110758837|NCT01227720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110758838|NCT03175978|Methotrexate|methotrexate|mesh-list
110758839|NCT03175978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110758840|NCT03175978|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110758841|NCT03175978|Abortifacient Agents|abortifacient agents|mesh-ancestor
110758842|NCT03175978|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110758843|NCT03175978|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110758844|NCT03175978|Antimetabolites|antimetabolites|mesh-ancestor
110758845|NCT03175978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110758846|NCT03175978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110758848|NCT03175978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110758849|NCT03175978|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110758850|NCT03175978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110758851|NCT03175978|Immunologic Factors|immunologic factors|mesh-ancestor
110758852|NCT03175978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110758853|NCT03175978|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110758854|NCT03923010|Itraconazole|itraconazole|mesh-list
110758855|NCT03923010|Antifungal Agents|antifungal agents|mesh-ancestor
110758856|NCT03923010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110758857|NCT03923010|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110758858|NCT03923010|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110758859|NCT03923010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110758860|NCT03923010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110758861|NCT03923010|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110758862|NCT03923010|Hormone Antagonists|hormone antagonists|mesh-ancestor
110758863|NCT03923010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110758864|NCT03923010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110758865|NCT03923010|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110758866|NCT01227798|Interferons|interferons|mesh-list
110758867|NCT01227798|Interferon alfacon-1|interferon alfacon-1|mesh-list
110758868|NCT01227798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110758869|NCT01227798|Antiviral Agents|antiviral agents|mesh-ancestor
110758870|NCT01227798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110758871|NCT01130376|Aldesleukin|aldesleukin|mesh-list
110758872|NCT01130376|Interleukin-2|interleukin-2|mesh-list
110758873|NCT01130376|Hormones|hormones|mesh-list
110758874|NCT01130376|Sargramostim|sargramostim|mesh-list
110758875|NCT01130376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110758876|NCT01130376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110758877|NCT01130376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110758878|NCT01130376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110758879|NCT01130376|Analgesics|analgesics|mesh-ancestor
110758880|NCT01130376|Sensory System Agents|sensory system agents|mesh-ancestor
110758881|NCT01130376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110758882|NCT01130376|Immunologic Factors|immunologic factors|mesh-ancestor
110758883|NCT01130376|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110758884|NCT01130376|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110758885|NCT01130376|Antiviral Agents|antiviral agents|mesh-ancestor
110758886|NCT01130376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110758887|NCT03740178|Donepezil|donepezil|mesh-list
110758888|NCT03740178|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110758889|NCT03740178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110758890|NCT03740178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110758891|NCT03740178|Cholinergic Agents|cholinergic agents|mesh-ancestor
110758892|NCT03740178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110758893|NCT03740178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110758894|NCT03740178|Nootropic Agents|nootropic agents|mesh-ancestor
110758895|NCT01131468|Acetylcysteine|acetylcysteine|mesh-list
110758896|NCT01131468|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110758897|NCT01131468|Antiviral Agents|antiviral agents|mesh-ancestor
110758898|NCT01131468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110758899|NCT01131468|Expectorants|expectorants|mesh-ancestor
110758900|NCT01131468|Respiratory System Agents|respiratory system agents|mesh-ancestor
110758901|NCT01131468|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110758902|NCT01131468|Antioxidants|antioxidants|mesh-ancestor
110758903|NCT01131468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110758904|NCT01131468|Protective Agents|protective agents|mesh-ancestor
110758905|NCT01131468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110758906|NCT01131468|Antidotes|antidotes|mesh-ancestor
110758907|NCT01225224|Peficitinib|peficitinib|mesh-list
110758908|NCT01225224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110758909|NCT01225224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110758910|NCT01225224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110758911|NCT01225224|Immunologic Factors|immunologic factors|mesh-ancestor
110758912|NCT01225224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110758913|NCT01131546|Amlodipine|amlodipine|mesh-list
110758914|NCT01131546|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110758915|NCT01131546|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110758916|NCT01131546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110758917|NCT01131546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110758918|NCT01131546|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110758919|NCT01131546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110758920|NCT01131546|Vasodilator Agents|vasodilator agents|mesh-ancestor
110758922|NCT01225302|Carboplatin|carboplatin|mesh-list
110758923|NCT01225302|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110758924|NCT01225302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110758925|NCT01225302|Tubulin Modulators|tubulin modulators|mesh-ancestor
110758926|NCT01225302|Antimitotic Agents|antimitotic agents|mesh-ancestor
110758927|NCT01225302|Mitosis Modulators|mitosis modulators|mesh-ancestor
110758928|NCT01225302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110758929|NCT01229046|Clavulanic Acids|clavulanic acids|mesh-list
110758930|NCT01229046|Clavulanic Acid|clavulanic acid|mesh-list
110758931|NCT01229046|Ticarcillin|ticarcillin|mesh-list
110758932|NCT01229046|Ticarcillin-clavulanic acid|ticarcillin-clavulanic acid|mesh-list
110758933|NCT01229046|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110758934|NCT01229046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110758935|NCT01229046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110758936|NCT01229046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110758937|NCT01229046|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110758938|NCT03921684|Capecitabine|capecitabine|mesh-list
110758939|NCT03921684|Nivolumab|nivolumab|mesh-list
110758940|NCT03921684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110758941|NCT03921684|Antimetabolites|antimetabolites|mesh-ancestor
110758942|NCT03921684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110758943|NCT03921684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110758944|NCT03921684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110758945|NCT03921684|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110758946|NCT03929094|Paclitaxel|paclitaxel|mesh-list
110758947|NCT03929094|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110758948|NCT03929094|Gemcitabine|gemcitabine|mesh-list
110758949|NCT03929094|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110758950|NCT03929094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110758951|NCT03929094|Tubulin Modulators|tubulin modulators|mesh-ancestor
110758952|NCT03929094|Antimitotic Agents|antimitotic agents|mesh-ancestor
110758953|NCT03929094|Mitosis Modulators|mitosis modulators|mesh-ancestor
110758954|NCT03929094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110758955|NCT03929094|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110758956|NCT03929094|Antimetabolites|antimetabolites|mesh-ancestor
110758957|NCT01131702|Ranitidine|ranitidine|mesh-list
110758958|NCT01131702|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
110758959|NCT01131702|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110758960|NCT01131702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110758961|NCT01131702|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110758962|NCT01131702|Histamine Antagonists|histamine antagonists|mesh-ancestor
110758963|NCT01131702|Histamine Agents|histamine agents|mesh-ancestor
110758964|NCT01131702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110758965|NCT01131702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110758966|NCT01131702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110758967|NCT01228110|Hydrocortisone|hydrocortisone|mesh-list
110758968|NCT01228110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110758969|NCT03925818|Metronidazole|metronidazole|mesh-list
110758970|NCT03925818|Tetracycline|tetracycline|mesh-list
110758971|NCT03925818|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
110758972|NCT03925818|Pantoprazole|pantoprazole|mesh-list
110758973|NCT03925818|Bismuth|bismuth|mesh-list
110758974|NCT03925818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110758975|NCT03925818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110758976|NCT03925818|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110758977|NCT03925818|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110758978|NCT03925818|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110758979|NCT03925818|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110758980|NCT03925818|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110758981|NCT03925818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110758982|NCT03925818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110758983|NCT03925818|Antacids|antacids|mesh-ancestor
110758984|NCT03925818|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110758985|NCT03925740|Listerine|listerine|mesh-list
110758986|NCT03925740|Fluorides|fluorides|mesh-list
110758987|NCT03925740|Sodium Fluoride|sodium fluoride|mesh-list
110758988|NCT03925740|Cariostatic Agents|cariostatic agents|mesh-ancestor
110758989|NCT03925740|Protective Agents|protective agents|mesh-ancestor
110758990|NCT03925740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110758991|NCT03925740|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110758992|NCT03925740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110758993|NCT01130688|Zileuton|zileuton|mesh-list
110758994|NCT01130688|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110758995|NCT01130688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110758996|NCT01130688|Analgesics|analgesics|mesh-ancestor
110084064|NCT01657513|Analgesics|analgesics|mesh-ancestor
110758997|NCT01130688|Sensory System Agents|sensory system agents|mesh-ancestor
110758998|NCT01130688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110758999|NCT01130688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110759000|NCT01130688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110759001|NCT01130688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110759002|NCT01130688|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
110759003|NCT01130688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110759004|NCT01130688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110759005|NCT01130688|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110759006|NCT01130688|Hormone Antagonists|hormone antagonists|mesh-ancestor
110759007|NCT01130688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110759008|NCT03925662|Mebendazole|mebendazole|mesh-list
110759009|NCT03925662|Piperazine|piperazine|mesh-list
110759010|NCT03925662|Piperazine citrate|piperazine citrate|mesh-list
110759011|NCT03925662|Bevacizumab|bevacizumab|mesh-list
110759012|NCT03925662|DMP 777|dmp 777|mesh-list
110759013|NCT03925662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110759014|NCT03925662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110759015|NCT03925662|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110759016|NCT03925662|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110759017|NCT03925662|Growth Substances|growth substances|mesh-ancestor
110759018|NCT03925662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110759019|NCT03925662|Growth Inhibitors|growth inhibitors|mesh-ancestor
110759020|NCT03925662|Antinematodal Agents|antinematodal agents|mesh-ancestor
110759021|NCT03925662|Anthelmintics|anthelmintics|mesh-ancestor
110759022|NCT03925662|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110759023|NCT03925662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110759024|NCT03925662|Tubulin Modulators|tubulin modulators|mesh-ancestor
110759025|NCT03925662|Antimitotic Agents|antimitotic agents|mesh-ancestor
110759026|NCT03925662|Mitosis Modulators|mitosis modulators|mesh-ancestor
110759027|NCT03925662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110759028|NCT03925662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110759029|NCT01229202|Bevacizumab|bevacizumab|mesh-list
110759030|NCT01229202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110759031|NCT01229202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110759032|NCT01229202|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110759033|NCT01229202|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110759034|NCT01229202|Growth Substances|growth substances|mesh-ancestor
110759035|NCT01229202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110759036|NCT01229202|Growth Inhibitors|growth inhibitors|mesh-ancestor
110759037|NCT01229280|Darifenacin|darifenacin|mesh-list
110759038|NCT01229280|Muscarinic Antagonists|muscarinic antagonists|mesh-list
110759039|NCT01229280|Cholinergic Agents|cholinergic agents|mesh-list
110759040|NCT01229280|Cholinergic Antagonists|cholinergic antagonists|mesh-list
110476746|NCT02715687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110759041|NCT01229280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110759042|NCT01229280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110759043|NCT01229280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110759044|NCT01229280|Urological Agents|urological agents|mesh-ancestor
110759045|NCT01131780|Ibuprofen|ibuprofen|mesh-list
110759046|NCT01131780|Pseudoephedrine|pseudoephedrine|mesh-list
110759047|NCT01131780|Ephedrine|ephedrine|mesh-list
110759048|NCT01131780|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110759049|NCT01131780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110759050|NCT01131780|Analgesics|analgesics|mesh-ancestor
110759051|NCT01131780|Sensory System Agents|sensory system agents|mesh-ancestor
110759052|NCT01131780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110759053|NCT01131780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110759054|NCT01131780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110759055|NCT01131780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110759056|NCT01131780|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110759057|NCT01131780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110759058|NCT01131780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110759059|NCT01131780|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110759060|NCT01131780|Autonomic Agents|autonomic agents|mesh-ancestor
110759061|NCT01131780|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110759062|NCT01131780|Respiratory System Agents|respiratory system agents|mesh-ancestor
110759063|NCT01131780|Nasal Decongestants|nasal decongestants|mesh-ancestor
110759064|NCT01131780|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110759065|NCT01131780|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110759066|NCT01131780|Sympathomimetics|sympathomimetics|mesh-ancestor
110759067|NCT01131780|Adrenergic Agents|adrenergic agents|mesh-ancestor
110759068|NCT01131780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110759070|NCT01130922|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
110759071|NCT01130922|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110759072|NCT01130922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110759073|NCT01130922|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110759074|NCT01130922|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110759075|NCT01130922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110759076|NCT01130922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110759077|NCT01130922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110759078|NCT01130922|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110759079|NCT01130922|Contraceptive Agents|contraceptive agents|mesh-ancestor
110759080|NCT01130922|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110759081|NCT01130922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110759082|NCT01130922|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110759083|NCT01130922|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110759084|NCT01130922|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110759085|NCT01131000|Ibuprofen|ibuprofen|mesh-list
110759086|NCT01131000|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110759087|NCT01131000|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110759088|NCT01131000|Analgesics|analgesics|mesh-ancestor
110759089|NCT01131000|Sensory System Agents|sensory system agents|mesh-ancestor
110759090|NCT01131000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110759091|NCT01131000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110759092|NCT01131000|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110759093|NCT01131000|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110759094|NCT01131000|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110759095|NCT01131000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110759096|NCT01131000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110759097|NCT01132170|Valproic Acid|valproic acid|mesh-list
110759098|NCT01132170|Anticonvulsants|anticonvulsants|mesh-ancestor
110759099|NCT01132170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110759100|NCT01132170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110759101|NCT01132170|GABA Agents|gaba agents|mesh-ancestor
110759102|NCT01132170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110759103|NCT01132170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110759104|NCT01132170|Antimanic Agents|antimanic agents|mesh-ancestor
110759105|NCT01132170|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110759106|NCT01132170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110759107|NCT01132170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110759108|NCT03925428|Entinostat|entinostat|mesh-list
110759109|NCT03925428|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
110759110|NCT03925428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110759111|NCT03925428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110759112|NCT03925428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110759113|NCT03920514|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
110759114|NCT03920514|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110759115|NCT03920514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110759116|NCT03919812|Cholecalciferol|cholecalciferol|mesh-list
110759118|NCT03919812|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110759119|NCT03919812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110759121|NCT03919812|Micronutrients|micronutrients|mesh-ancestor
110759122|NCT03919812|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110759123|NCT03919656|Dapagliflozin|dapagliflozin|mesh-list
110759124|NCT03919656|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110759125|NCT03919656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110759126|NCT03919656|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110759127|NCT03919656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110759128|NCT01132248|Mefloquine|mefloquine|mesh-list
110759129|NCT01132248|Antimalarials|antimalarials|mesh-ancestor
110759130|NCT01132248|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110759131|NCT01132248|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110759132|NCT01132248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110759133|NCT01229592|Ethanol|ethanol|mesh-list
110759134|NCT01229592|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110759135|NCT01229592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110759136|NCT01229592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110759137|NCT01229592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110759138|NCT01131936|Amlodipine|amlodipine|mesh-list
110759139|NCT01131936|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110759140|NCT01131936|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110759141|NCT01131936|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110759142|NCT01131936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110759143|NCT01131936|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110759144|NCT01131936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110759145|NCT01131936|Vasodilator Agents|vasodilator agents|mesh-ancestor
110759146|NCT01132404|Leuprolide|leuprolide|mesh-list
110759147|NCT01132404|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110759148|NCT01132404|Fertility Agents|fertility agents|mesh-ancestor
110759149|NCT01132404|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110759150|NCT01132404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110759151|NCT01132404|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110759152|NCT01132404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110759153|NCT01231854|Cyclosporine|cyclosporine|mesh-list
110759154|NCT01231854|Alitretinoin|alitretinoin|mesh-list
110759155|NCT01231854|Cyclosporins|cyclosporins|mesh-list
110759156|NCT01231854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110759157|NCT01231854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110759158|NCT01231854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110759159|NCT01231854|Immunologic Factors|immunologic factors|mesh-ancestor
110759160|NCT01231854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110759161|NCT01231854|Antifungal Agents|antifungal agents|mesh-ancestor
110759162|NCT01231854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110759163|NCT01231854|Dermatologic Agents|dermatologic agents|mesh-ancestor
110759164|NCT01231854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110759165|NCT01231854|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110759166|NCT01231854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110759167|NCT01132638|Esomeprazole|esomeprazole|mesh-list
110759168|NCT01132638|Pantoprazole|pantoprazole|mesh-list
110759169|NCT01132638|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110759170|NCT01132638|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110759171|NCT01132638|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110759172|NCT01132638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110759173|NCT01132638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110759174|NCT05402124|Aspirin|aspirin|mesh-list
110759175|NCT05402124|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110759176|NCT05402124|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110759178|NCT05402124|Sensory System Agents|sensory system agents|mesh-ancestor
110759179|NCT05402124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110759180|NCT05402124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110759181|NCT05402124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110759182|NCT05402124|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110759183|NCT05402124|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110759184|NCT05402124|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110759185|NCT05402124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110759186|NCT05402124|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110759187|NCT05402124|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110759188|NCT05402124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110759189|NCT05402124|Antipyretics|antipyretics|mesh-ancestor
110759190|NCT01134432|Prednisolone|prednisolone|mesh-list
110476901|NCT00729937|Antimalarials|antimalarials|mesh-ancestor
110759191|NCT01134432|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110759192|NCT01134432|Methylprednisolone|methylprednisolone|mesh-list
110759193|NCT01134432|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110759194|NCT01134432|Prednisolone acetate|prednisolone acetate|mesh-list
110759195|NCT01134432|Rituximab|rituximab|mesh-list
110759196|NCT01134432|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110759197|NCT01134432|Prednisolone phosphate|prednisolone phosphate|mesh-list
110759198|NCT01134432|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110759199|NCT01134432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110759200|NCT01134432|Immunologic Factors|immunologic factors|mesh-ancestor
110759201|NCT01134432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110759202|NCT01134432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110759203|NCT01134432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110759204|NCT01134432|Glucocorticoids|glucocorticoids|mesh-ancestor
110759205|NCT01134432|Hormones|hormones|mesh-ancestor
110313492|NCT00301925|Epirubicin|epirubicin|mesh-list
110759206|NCT01134432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110759207|NCT01134432|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110759208|NCT01134432|Antiemetics|antiemetics|mesh-ancestor
110759209|NCT01134432|Autonomic Agents|autonomic agents|mesh-ancestor
110759210|NCT01134432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110759211|NCT01134432|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110759212|NCT01134432|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110759213|NCT01134432|Protective Agents|protective agents|mesh-ancestor
110759214|NCT01232010|Mirodenafil|mirodenafil|mesh-list
110759215|NCT01232010|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110759216|NCT01232010|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110759217|NCT01232010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110759218|NCT01232010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110759219|NCT01132716|Valacyclovir|valacyclovir|mesh-list
110759220|NCT01132716|Antiviral Agents|antiviral agents|mesh-ancestor
110759221|NCT01132716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110759222|NCT05401812|Glucocorticoids|glucocorticoids|mesh-list
110759223|NCT05401812|Hormones|hormones|mesh-ancestor
110759224|NCT05401812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110759225|NCT05401812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110759226|NCT01137708|Levonorgestrel|levonorgestrel|mesh-list
110759227|NCT01137708|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110759228|NCT01137708|Tofacitinib|tofacitinib|mesh-list
110759229|NCT01137708|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110759230|NCT01137708|Contraceptive Agents|contraceptive agents|mesh-ancestor
110759231|NCT01137708|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110759232|NCT01137708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110759233|NCT01137708|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110759234|NCT01137708|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110759235|NCT01137708|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110759236|NCT01137708|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
110759237|NCT01137708|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110759238|NCT01137708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110759239|NCT01137708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110759240|NCT01137708|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110759241|NCT01137708|Estrogens|estrogens|mesh-ancestor
110759242|NCT01137708|Hormones|hormones|mesh-ancestor
110759243|NCT01137708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110759244|NCT03765138|Pramipexole|pramipexole|mesh-list
110759245|NCT03765138|Antioxidants|antioxidants|mesh-ancestor
110759246|NCT03765138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110759247|NCT03765138|Protective Agents|protective agents|mesh-ancestor
110759248|NCT03765138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110759249|NCT03765138|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110759250|NCT03765138|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110759251|NCT03765138|Dopamine Agonists|dopamine agonists|mesh-ancestor
110759252|NCT03765138|Dopamine Agents|dopamine agents|mesh-ancestor
110759253|NCT03765138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110759254|NCT01134666|Cetuximab|cetuximab|mesh-list
110759255|NCT01134666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110759256|NCT01134666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110759257|NCT03739788|Deucravacitinib|deucravacitinib|mesh-list
110759258|NCT03739788|Dermatologic Agents|dermatologic agents|mesh-ancestor
110759259|NCT03739788|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110759260|NCT03739788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110759261|NCT03739788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110759262|NCT01137942|Metronidazole|metronidazole|mesh-list
110759263|NCT01137942|Clarithromycin|clarithromycin|mesh-list
110759264|NCT01137942|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
110759265|NCT01137942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110759266|NCT01137942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110759267|NCT01137942|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110759268|NCT01137942|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110759269|NCT01137942|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110759270|NCT01137942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110759271|NCT01137942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110759272|NCT01137942|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110759273|NCT01137942|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110759275|NCT01233492|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110759276|NCT01233492|Diuretics|diuretics|mesh-ancestor
110759277|NCT01233492|Natriuretic Agents|natriuretic agents|mesh-ancestor
110759278|NCT01233492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110759279|NCT01135056|Sorafenib|sorafenib|mesh-list
110759280|NCT01135056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110759281|NCT01135056|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110759282|NCT01135056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110759283|NCT01135056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110759284|NCT01132794|Dexmedetomidine|dexmedetomidine|mesh-list
110759285|NCT01132794|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110445417|NCT01193660|Hematinics|hematinics|mesh-ancestor
110759286|NCT01132794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110759287|NCT01132794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110759288|NCT01132794|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110759289|NCT01132794|Analgesics|analgesics|mesh-ancestor
110759290|NCT01132794|Sensory System Agents|sensory system agents|mesh-ancestor
110759291|NCT01132794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110759292|NCT01132794|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110759293|NCT01132794|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110759294|NCT01132794|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110759295|NCT01132794|Adrenergic Agents|adrenergic agents|mesh-ancestor
110759296|NCT01132794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110759297|NCT01132794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110759298|NCT01135212|Candesartan|candesartan|mesh-list
110759299|NCT01135212|Candesartan cilexetil|candesartan cilexetil|mesh-list
110759300|NCT01135212|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110759301|NCT01135212|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110759302|NCT01135212|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110759303|NCT01135212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110759305|NCT01233570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110759306|NCT01233570|Immunologic Factors|immunologic factors|mesh-ancestor
110759307|NCT01233570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110759308|NCT01233570|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110759309|NCT01233570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110759310|NCT01233570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110759312|NCT01135290|Emollients|emollients|mesh-ancestor
110759313|NCT01135290|Dermatologic Agents|dermatologic agents|mesh-ancestor
110759314|NCT01135446|Dapagliflozin|dapagliflozin|mesh-list
110313539|NCT00302393|Dopamine Agents|dopamine agents|mesh-ancestor
110759315|NCT01135446|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110759316|NCT01135446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110759317|NCT01135446|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110759318|NCT01135446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110759319|NCT01135602|Topiramate|topiramate|mesh-list
110759320|NCT01135602|Anticonvulsants|anticonvulsants|mesh-ancestor
110759321|NCT01135602|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110759322|NCT01135602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110759323|NCT05308212|Vaccines|vaccines|mesh-list
110759324|NCT05308212|Immunologic Factors|immunologic factors|mesh-ancestor
110759325|NCT05308212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110759326|NCT01138488|Insulin|insulin|mesh-list
110759327|NCT01138488|Insulin Aspart|insulin aspart|mesh-list
110759328|NCT01138488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110759329|NCT01138488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110759330|NCT01135680|Moxifloxacin|moxifloxacin|mesh-list
110759331|NCT01135680|Glycerol|glycerol|mesh-list
110759332|NCT01135680|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110759333|NCT01135680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110759334|NCT01135680|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110759335|NCT01135680|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110759336|NCT01135680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110759337|NCT01135680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110759338|NCT01135680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110759339|NCT01135680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110759340|NCT01135680|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
110759341|NCT01135680|Protective Agents|protective agents|mesh-ancestor
110759342|NCT01135758|Ketamine|ketamine|mesh-list
110759343|NCT01135758|Analgesics|analgesics|mesh-ancestor
110759344|NCT01135758|Sensory System Agents|sensory system agents|mesh-ancestor
110759345|NCT01135758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110759346|NCT01135758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110759347|NCT01135758|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110759348|NCT01135758|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110759349|NCT01135758|Anesthetics, General|anesthetics, general|mesh-ancestor
110759350|NCT01135758|Anesthetics|anesthetics|mesh-ancestor
110759351|NCT01135758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110759352|NCT01135758|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110759353|NCT01135758|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110759354|NCT01135758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110759355|NCT01135758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110759356|NCT05401032|Tamsulosin|tamsulosin|mesh-list
110759357|NCT05401032|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110445421|NCT02777788|Carboplatin|carboplatin|mesh-list
110759358|NCT05401032|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110759359|NCT05401032|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110759360|NCT05401032|Adrenergic Agents|adrenergic agents|mesh-ancestor
110759361|NCT05401032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110759362|NCT05401032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110759363|NCT05401032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110759364|NCT05401032|Urological Agents|urological agents|mesh-ancestor
110759365|NCT03768726|Ziprasidone|ziprasidone|mesh-list
110759366|NCT03768726|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110759367|NCT03768726|Serotonin Agents|serotonin agents|mesh-ancestor
110759368|NCT03768726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110759369|NCT03768726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110759370|NCT03768726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110759371|NCT03768726|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110759372|NCT03768726|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110759373|NCT03768726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110759374|NCT03768726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110759375|NCT03768726|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110759376|NCT03768726|Dopamine Agents|dopamine agents|mesh-ancestor
110759377|NCT01138956|Acetylcysteine|acetylcysteine|mesh-list
110759379|NCT01138956|Antiviral Agents|antiviral agents|mesh-ancestor
110759380|NCT01138956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110759381|NCT01138956|Expectorants|expectorants|mesh-ancestor
110759382|NCT01138956|Respiratory System Agents|respiratory system agents|mesh-ancestor
110759383|NCT01138956|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110759384|NCT01138956|Antioxidants|antioxidants|mesh-ancestor
110759385|NCT01138956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110759386|NCT01138956|Protective Agents|protective agents|mesh-ancestor
110759387|NCT01138956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110759388|NCT01138956|Antidotes|antidotes|mesh-ancestor
110759389|NCT03917940|Glimepiride|glimepiride|mesh-list
110759390|NCT03917940|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110759391|NCT03917940|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110759392|NCT03917940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110759393|NCT03917940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110759394|NCT03917940|Immunologic Factors|immunologic factors|mesh-ancestor
110759395|NCT05287542|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
110759396|NCT05287542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110759397|NCT05287542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110759398|NCT01232244|Glucagon|glucagon|mesh-list
110759399|NCT01232244|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
110759400|NCT01232244|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110759401|NCT01232244|Hormones|hormones|mesh-ancestor
110759402|NCT01232244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110759403|NCT01232244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110759404|NCT01232244|Incretins|incretins|mesh-ancestor
110759405|NCT03917784|Curcumin|curcumin|mesh-list
110759406|NCT03917784|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110759407|NCT03917784|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110759408|NCT03917784|Analgesics|analgesics|mesh-ancestor
110759409|NCT03917784|Sensory System Agents|sensory system agents|mesh-ancestor
110759410|NCT03917784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110759411|NCT03917784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110759412|NCT03917784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110477122|NCT00808210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110759413|NCT03917784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110759414|NCT03917784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110759415|NCT03917784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110759416|NCT03917784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110759417|NCT01133496|Alendronate|alendronate|mesh-list
110759418|NCT01133496|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110759419|NCT01133496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110759420|NCT01232400|Esmolol|esmolol|mesh-list
110759421|NCT01232400|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110759422|NCT01232400|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110759423|NCT01232400|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110759424|NCT01232400|Adrenergic Agents|adrenergic agents|mesh-ancestor
110759425|NCT01232400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110759426|NCT01232400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110759427|NCT01232400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110759428|NCT02528760|Erythromycin|erythromycin|mesh-list
110759429|NCT02528760|Erythromycin Estolate|erythromycin estolate|mesh-list
110759430|NCT02528760|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
110759431|NCT02528760|Erythromycin stearate|erythromycin stearate|mesh-list
110759432|NCT02528760|Metoclopramide|metoclopramide|mesh-list
110759433|NCT02528760|Antiemetics|antiemetics|mesh-ancestor
110759434|NCT02528760|Autonomic Agents|autonomic agents|mesh-ancestor
110759435|NCT02528760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110759436|NCT02528760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110759437|NCT02528760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110759438|NCT02528760|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110759439|NCT02528760|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110759440|NCT02528760|Dopamine Agents|dopamine agents|mesh-ancestor
110759441|NCT02528760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110759442|NCT02528760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110868913|NCT04046939|Pramipexole|pramipexole|mesh-list
110759443|NCT02528760|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110759444|NCT02528760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110759445|NCT02528760|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110759446|NCT02528760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110759447|NCT05594472|Gentamicins|gentamicins|mesh-list
110759448|NCT05594472|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110759449|NCT05594472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110759450|NCT05594472|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110759451|NCT05594472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110759452|NCT05594472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110759453|NCT01136538|Valacyclovir|valacyclovir|mesh-list
110759454|NCT01136538|Antiviral Agents|antiviral agents|mesh-ancestor
110759455|NCT01136538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110759456|NCT03917628|Adalimumab|adalimumab|mesh-list
110759457|NCT03917628|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110759458|NCT03917628|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110759459|NCT03917628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110759460|NCT01329588|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110759461|NCT01329588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110759462|NCT01136850|Azithromycin|azithromycin|mesh-list
110759463|NCT01136850|Chloroquine|chloroquine|mesh-list
110759464|NCT01136850|Pyrimethamine|pyrimethamine|mesh-list
110759465|NCT01136850|Sulfadoxine|sulfadoxine|mesh-list
110759466|NCT01136850|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
110759467|NCT01136850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110759468|NCT01136850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110759469|NCT01136850|Amebicides|amebicides|mesh-ancestor
110759470|NCT01136850|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110759471|NCT01136850|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110759472|NCT01136850|Antimalarials|antimalarials|mesh-ancestor
110759473|NCT01136850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110759474|NCT01136850|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110759475|NCT01136850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110759476|NCT01136850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110759477|NCT01136850|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110759478|NCT01234116|Tenofovir|tenofovir|mesh-list
110759479|NCT01234116|Emtricitabine|emtricitabine|mesh-list
110759480|NCT01234116|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110759481|NCT01234116|Antiviral Agents|antiviral agents|mesh-ancestor
110759482|NCT01234116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110759483|NCT01234116|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110759484|NCT01234116|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110759485|NCT01234116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110759486|NCT01234116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110477198|NCT02776761|Vaccines|vaccines|mesh-list
110759487|NCT01234116|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110759488|NCT01234116|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110759489|NCT03917004|Nitroglycerin|nitroglycerin|mesh-list
110759490|NCT03917004|Vasodilator Agents|vasodilator agents|mesh-ancestor
110759491|NCT01230996|Cisplatin|cisplatin|mesh-list
110759492|NCT01230996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110759493|NCT01137084|Methylprednisolone|methylprednisolone|mesh-list
110759494|NCT01137084|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110759495|NCT01137084|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110759496|NCT01137084|Prednisolone|prednisolone|mesh-list
110759497|NCT01137084|Prednisolone acetate|prednisolone acetate|mesh-list
110759498|NCT01137084|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110759499|NCT01137084|Prednisolone phosphate|prednisolone phosphate|mesh-list
110759500|NCT01137084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110759501|NCT01137084|Antiemetics|antiemetics|mesh-ancestor
110759502|NCT01137084|Autonomic Agents|autonomic agents|mesh-ancestor
110445425|NCT02777788|Nedaplatin|nedaplatin|mesh-list
110759503|NCT01137084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110759504|NCT01137084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110759505|NCT01137084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110759506|NCT01137084|Glucocorticoids|glucocorticoids|mesh-ancestor
110759507|NCT01137084|Hormones|hormones|mesh-ancestor
110759508|NCT01137084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110759509|NCT01137084|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110759510|NCT01137084|Protective Agents|protective agents|mesh-ancestor
110759511|NCT01137084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110759512|NCT01137084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110759513|NCT01133886|Decitabine|decitabine|mesh-list
110759514|NCT01133886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110759515|NCT01133886|Antimetabolites|antimetabolites|mesh-ancestor
110759516|NCT01133886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110759517|NCT01133886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110759518|NCT01133886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110759520|NCT01140126|Antibodies|antibodies|mesh-list
110759521|NCT01140126|Immunologic Factors|immunologic factors|mesh-ancestor
110759522|NCT01140126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110759523|NCT01140126|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110759524|NCT01140126|Antiviral Agents|antiviral agents|mesh-ancestor
110759525|NCT01140126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110759526|NCT01231074|Metformin|metformin|mesh-list
110759527|NCT01231074|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110759528|NCT01231074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110759530|NCT03917394|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
110759531|NCT03917394|Trace Elements|trace elements|mesh-ancestor
110759532|NCT03917394|Micronutrients|micronutrients|mesh-ancestor
110759533|NCT03917394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110759534|NCT03917394|Hematinics|hematinics|mesh-ancestor
110759535|NCT03769896|Nabilone|nabilone|mesh-list
110759536|NCT03769896|Antiemetics|antiemetics|mesh-ancestor
110759537|NCT03769896|Autonomic Agents|autonomic agents|mesh-ancestor
110759538|NCT03769896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110759539|NCT03769896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110759540|NCT03769896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110759541|NCT03769896|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110759542|NCT03769896|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110759543|NCT03769896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110759544|NCT03769896|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110759545|NCT01234194|Remifentanil|remifentanil|mesh-list
110759546|NCT01234194|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110759547|NCT01234194|Narcotics|narcotics|mesh-ancestor
110759548|NCT01234194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110759549|NCT01234194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110759550|NCT01234194|Analgesics|analgesics|mesh-ancestor
110759551|NCT01234194|Sensory System Agents|sensory system agents|mesh-ancestor
110759552|NCT01234194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110759553|NCT04913922|Nivolumab|nivolumab|mesh-list
110759554|NCT04913922|Relatlimab|relatlimab|mesh-list
110759555|NCT04913922|Azacitidine|azacitidine|mesh-list
110759556|NCT04913922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110759557|NCT04913922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110759558|NCT04913922|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110759559|NCT04913922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110759560|NCT04913922|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110759561|NCT04913922|Antimetabolites|antimetabolites|mesh-ancestor
110759562|NCT04913922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110759563|NCT05485662|Listerine|listerine|mesh-list
110759564|NCT05485662|Fluorides|fluorides|mesh-list
110759565|NCT05485662|Sodium Fluoride|sodium fluoride|mesh-list
110477275|NCT00729157|Antimetabolites|antimetabolites|mesh-ancestor
110759566|NCT05485662|Cariostatic Agents|cariostatic agents|mesh-ancestor
110759567|NCT05485662|Protective Agents|protective agents|mesh-ancestor
110759568|NCT05485662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110759569|NCT05485662|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110759570|NCT05485662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110759571|NCT01234272|Morphine|morphine|mesh-list
110759572|NCT01234272|Ropivacaine|ropivacaine|mesh-list
110759573|NCT01234272|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110759574|NCT01234272|Narcotics|narcotics|mesh-ancestor
110759575|NCT01234272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110759576|NCT01234272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110759577|NCT01234272|Analgesics|analgesics|mesh-ancestor
110759578|NCT01234272|Sensory System Agents|sensory system agents|mesh-ancestor
110759579|NCT01234272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110759580|NCT01234272|Anesthetics, Local|anesthetics, local|mesh-ancestor
110759582|NCT01140438|Metformin|metformin|mesh-list
110759583|NCT01140438|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110759584|NCT01140438|Repaglinide|repaglinide|mesh-list
110759585|NCT01140438|Insulin, Isophane|insulin, isophane|mesh-list
110759586|NCT01140438|Isophane Insulin, Human|isophane insulin, human|mesh-list
110759587|NCT01140438|Isophane insulin, beef|isophane insulin, beef|mesh-list
110759588|NCT01140438|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110759589|NCT01140438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110759590|NCT01140438|Incretins|incretins|mesh-ancestor
110759591|NCT01140438|Hormones|hormones|mesh-ancestor
110759592|NCT01140438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110759593|NCT01140438|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110759594|NCT01140438|Protease Inhibitors|protease inhibitors|mesh-ancestor
110759595|NCT01140438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110759596|NCT01140438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110759597|NCT01234506|Vitamin D|vitamin d|mesh-list
110759598|NCT01234506|Secoisolariciresinol|secoisolariciresinol|mesh-list
110759599|NCT01234506|Vitamins|vitamins|mesh-ancestor
110759600|NCT01234506|Micronutrients|micronutrients|mesh-ancestor
110759601|NCT01234506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110759602|NCT01234506|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110759603|NCT01234506|Phytoestrogens|phytoestrogens|mesh-ancestor
110759604|NCT01234506|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
110759605|NCT01234506|Estrogens|estrogens|mesh-ancestor
110759606|NCT01234506|Hormones|hormones|mesh-ancestor
110759607|NCT01234506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110759608|NCT04751604|Niacinamide|niacinamide|mesh-list
110759610|NCT04751604|Nicotinic Acids|nicotinic acids|mesh-list
110759611|NCT04751604|Vitamin B Complex|vitamin b complex|mesh-ancestor
110759612|NCT04751604|Vitamins|vitamins|mesh-ancestor
110759613|NCT04751604|Micronutrients|micronutrients|mesh-ancestor
110759614|NCT04751604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110759615|NCT04751604|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110759616|NCT04751604|Antimetabolites|antimetabolites|mesh-ancestor
110759617|NCT04751604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110759618|NCT04751604|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110759619|NCT04751604|Vasodilator Agents|vasodilator agents|mesh-ancestor
110759620|NCT01231542|Rifampin|rifampin|mesh-list
110759621|NCT01231542|Rifabutin|rifabutin|mesh-list
110759622|NCT01231542|Dolutegravir|dolutegravir|mesh-list
110759623|NCT01231542|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110759624|NCT01231542|Antitubercular Agents|antitubercular agents|mesh-ancestor
110759625|NCT01231542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110759626|NCT01231542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110759627|NCT01231542|Leprostatic Agents|leprostatic agents|mesh-ancestor
110759628|NCT01231542|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110759629|NCT01231542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110759630|NCT01231542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110759631|NCT01231542|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110759632|NCT01231542|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110759633|NCT01231542|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110759634|NCT01231542|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110759635|NCT01231542|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110759636|NCT01231542|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110759637|NCT01231542|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110759638|NCT01231542|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110477344|NCT02707809|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110759639|NCT01231542|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110759640|NCT01231542|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110759641|NCT01231542|Antiviral Agents|antiviral agents|mesh-ancestor
110759642|NCT01231698|Esmolol|esmolol|mesh-list
110759643|NCT01231698|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110759644|NCT01231698|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110759645|NCT01231698|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110759646|NCT01231698|Adrenergic Agents|adrenergic agents|mesh-ancestor
110759647|NCT01231698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110759648|NCT01231698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110868933|NCT05188131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110759649|NCT01231698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110759650|NCT01142778|Bevacizumab|bevacizumab|mesh-list
110759651|NCT01142778|Trastuzumab|trastuzumab|mesh-list
110759652|NCT01142778|Docetaxel|docetaxel|mesh-list
110084720|NCT01661530|Vitamin E|vitamin e|mesh-list
110759654|NCT01142778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110759655|NCT01142778|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110759656|NCT01142778|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110759657|NCT01142778|Growth Substances|growth substances|mesh-ancestor
110759658|NCT01142778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110759659|NCT01142778|Growth Inhibitors|growth inhibitors|mesh-ancestor
110759660|NCT01142778|Tubulin Modulators|tubulin modulators|mesh-ancestor
110759661|NCT01142778|Antimitotic Agents|antimitotic agents|mesh-ancestor
110759662|NCT01142778|Mitosis Modulators|mitosis modulators|mesh-ancestor
110759663|NCT01142778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110759664|NCT01142934|Chlorhexidine|chlorhexidine|mesh-list
110759665|NCT01142934|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110759666|NCT01142934|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110759667|NCT01142934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110759668|NCT01142934|Disinfectants|disinfectants|mesh-ancestor
110759669|NCT01142934|Dermatologic Agents|dermatologic agents|mesh-ancestor
110759670|NCT04722978|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110759671|NCT04722978|Moxifloxacin|moxifloxacin|mesh-list
110759672|NCT04722978|Carboplatin|carboplatin|mesh-list
110759673|NCT04722978|Gemcitabine|gemcitabine|mesh-list
110759674|NCT04722978|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
110759675|NCT04722978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110759676|NCT04722978|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110759677|NCT04722978|Antimetabolites|antimetabolites|mesh-ancestor
110759678|NCT04722978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110759679|NCT04722978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110759680|NCT04722978|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110759681|NCT04722978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110759682|NCT04722978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110759683|NCT04722978|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110759684|NCT04722978|Contraceptive Agents|contraceptive agents|mesh-ancestor
110759685|NCT04722978|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110759686|NCT04722978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110759687|NCT04722978|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110759688|NCT04722978|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110759689|NCT04722978|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110759690|NCT01140828|Rabeprazole|rabeprazole|mesh-list
110759691|NCT01140828|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110759692|NCT01140828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110759693|NCT01140828|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110759694|NCT01140828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110759695|NCT01140828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110759696|NCT01234740|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
110759697|NCT01234740|Bafetinib|bafetinib|mesh-list
110759698|NCT01234740|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110759699|NCT01234740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110759700|NCT01234740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110759701|NCT01234818|Levonorgestrel|levonorgestrel|mesh-list
110759702|NCT01234818|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110759703|NCT01234818|Contraceptive Agents|contraceptive agents|mesh-ancestor
110759704|NCT01234818|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110759705|NCT01234818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110759706|NCT01234818|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110759707|NCT01234818|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110759708|NCT01234818|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110759709|NCT03714594|Dapagliflozin|dapagliflozin|mesh-list
110759710|NCT03714594|Saxagliptin|saxagliptin|mesh-list
110759711|NCT03714594|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110759712|NCT03714594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110759713|NCT03714594|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110759714|NCT03714594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110759715|NCT03714594|Incretins|incretins|mesh-ancestor
110759716|NCT03714594|Hormones|hormones|mesh-ancestor
110868940|NCT01360437|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110759717|NCT03714594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110313655|NCT00328458|Antimitotic Agents|antimitotic agents|mesh-ancestor
110759718|NCT03714594|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110759719|NCT03714594|Protease Inhibitors|protease inhibitors|mesh-ancestor
110759720|NCT03714594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110759721|NCT04624776|Methylprednisolone|methylprednisolone|mesh-list
110759722|NCT04624776|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110759723|NCT04624776|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110759724|NCT04624776|Prednisolone|prednisolone|mesh-list
110759725|NCT04624776|Prednisolone acetate|prednisolone acetate|mesh-list
110759726|NCT04624776|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110759727|NCT04624776|Prednisolone phosphate|prednisolone phosphate|mesh-list
110759728|NCT04624776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110759729|NCT04624776|Antiemetics|antiemetics|mesh-ancestor
110759730|NCT04624776|Autonomic Agents|autonomic agents|mesh-ancestor
110759731|NCT04624776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110759732|NCT04624776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110759733|NCT04624776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110759734|NCT04624776|Glucocorticoids|glucocorticoids|mesh-ancestor
110759735|NCT04624776|Hormones|hormones|mesh-ancestor
110759736|NCT04624776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110759737|NCT04624776|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110759738|NCT04624776|Protective Agents|protective agents|mesh-ancestor
110759739|NCT04624776|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110759740|NCT04624776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110759741|NCT01234896|Nicotine|nicotine|mesh-list
110759742|NCT01234896|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110759743|NCT01234896|Autonomic Agents|autonomic agents|mesh-ancestor
110759744|NCT01234896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110759745|NCT01234896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110759746|NCT01234896|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110759747|NCT01234896|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110759748|NCT01234896|Cholinergic Agents|cholinergic agents|mesh-ancestor
110759749|NCT01234896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110759750|NCT01234896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110759751|NCT01238094|Simvastatin|simvastatin|mesh-list
110759752|NCT01238094|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110759753|NCT01238094|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110759754|NCT01238094|Antimetabolites|antimetabolites|mesh-ancestor
110759755|NCT01238094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110759756|NCT01238094|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110759757|NCT01238094|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110759758|NCT01238094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110759759|NCT01236612|Chloroquine|chloroquine|mesh-list
110759760|NCT01236612|Proguanil|proguanil|mesh-list
110759761|NCT01236612|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
110759762|NCT01236612|Amebicides|amebicides|mesh-ancestor
110759763|NCT01236612|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110759764|NCT01236612|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110759765|NCT01236612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110759766|NCT01236612|Antimalarials|antimalarials|mesh-ancestor
110759767|NCT01236612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110759768|NCT01236612|Antimetabolites|antimetabolites|mesh-ancestor
110759769|NCT01236612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110759770|NCT03633630|Magnesium Oxide|magnesium oxide|mesh-list
110759771|NCT03633630|Antacids|antacids|mesh-ancestor
110759772|NCT03633630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110759773|NCT03633630|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110759774|NCT01234974|Everolimus|everolimus|mesh-list
110759775|NCT01234974|Pasireotide|pasireotide|mesh-list
110759776|NCT01234974|Somatostatin|somatostatin|mesh-list
110759777|NCT01234974|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110759778|NCT01234974|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110759779|NCT01234974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110759780|NCT01234974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110759781|NCT01234974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110759782|NCT01234974|Immunologic Factors|immunologic factors|mesh-ancestor
110759783|NCT01234974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110759784|NCT01234974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110759785|NCT01234974|Hormones|hormones|mesh-ancestor
110868945|NCT02409862|Oxytocin|oxytocin|mesh-list
110759786|NCT01234974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110759787|NCT01140984|Methylprednisolone|methylprednisolone|mesh-list
110759788|NCT01140984|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110759789|NCT01140984|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110477493|NCT00808132|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110759791|NCT01140984|Prednisolone acetate|prednisolone acetate|mesh-list
110759792|NCT01140984|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110759793|NCT01140984|Prednisolone phosphate|prednisolone phosphate|mesh-list
110759794|NCT01140984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110759795|NCT01140984|Antiemetics|antiemetics|mesh-ancestor
110759796|NCT01140984|Autonomic Agents|autonomic agents|mesh-ancestor
110759797|NCT01140984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110759798|NCT01140984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110759800|NCT01140984|Glucocorticoids|glucocorticoids|mesh-ancestor
110759801|NCT01140984|Hormones|hormones|mesh-ancestor
110759802|NCT01140984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110759803|NCT01140984|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110759804|NCT01140984|Protective Agents|protective agents|mesh-ancestor
110759805|NCT01140984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110759806|NCT01140984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110759807|NCT01145430|Doxorubicin|doxorubicin|mesh-list
110759808|NCT01145430|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110759809|NCT01145430|Veliparib|veliparib|mesh-list
110759810|NCT01145430|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110759811|NCT01145430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110759812|NCT01145430|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110759813|NCT01145430|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110759814|NCT01145430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110759815|NCT01145430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110759816|NCT01145430|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110759817|NCT03389724|Captopril|captopril|mesh-list
110759818|NCT03389724|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110759819|NCT03389724|Protease Inhibitors|protease inhibitors|mesh-ancestor
110759820|NCT03389724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110759821|NCT03389724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110759822|NCT03389724|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110759823|NCT01586052|Epoetin Alfa|epoetin alfa|mesh-list
110759824|NCT01586052|Hematinics|hematinics|mesh-ancestor
110759825|NCT03684564|Warfarin|warfarin|mesh-list
110759826|NCT03684564|Rivaroxaban|rivaroxaban|mesh-list
110759827|NCT03684564|Anticoagulants|anticoagulants|mesh-ancestor
110759828|NCT03684564|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110759829|NCT03684564|Antithrombins|antithrombins|mesh-ancestor
110759830|NCT03684564|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110759831|NCT03684564|Protease Inhibitors|protease inhibitors|mesh-ancestor
110759832|NCT03684564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110759833|NCT03684564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110759834|NCT05796635|Allantoin|allantoin|mesh-list
110759835|NCT05796635|Dermatologic Agents|dermatologic agents|mesh-ancestor
110759836|NCT05796362|Azithromycin|azithromycin|mesh-list
110759837|NCT05796362|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110759838|NCT05796362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110759839|NCT05796115|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110759840|NCT05796115|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
110759841|NCT05796115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110759842|NCT05796115|Antitubercular Agents|antitubercular agents|mesh-ancestor
110759843|NCT05795946|Vitamin D|vitamin d|mesh-list
110759844|NCT05795946|Vitamins|vitamins|mesh-ancestor
110759845|NCT05795946|Micronutrients|micronutrients|mesh-ancestor
110759846|NCT05795946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110759847|NCT05795946|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110759848|NCT05795920|Gemcitabine|gemcitabine|mesh-list
110759849|NCT05795920|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110759850|NCT05795920|Antimetabolites|antimetabolites|mesh-ancestor
110759851|NCT05795920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110759852|NCT05795920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110759853|NCT05849246|Cisplatin|cisplatin|mesh-list
110759854|NCT05849246|Carboplatin|carboplatin|mesh-list
110759855|NCT05849246|Pemetrexed|pemetrexed|mesh-list
110759856|NCT05849246|Maytansine|maytansine|mesh-list
110759857|NCT05849246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110759858|NCT05849246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110759859|NCT05849246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110759860|NCT05849246|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110759861|NCT05849246|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110759862|NCT05849246|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110759863|NCT05849246|Tubulin Modulators|tubulin modulators|mesh-ancestor
110759864|NCT05849246|Antimitotic Agents|antimitotic agents|mesh-ancestor
110759865|NCT05849246|Mitosis Modulators|mitosis modulators|mesh-ancestor
110759866|NCT05849220|Dapagliflozin|dapagliflozin|mesh-list
110759867|NCT05849220|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110759868|NCT05849220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110759870|NCT05849220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110759871|NCT05849090|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110759872|NCT05849090|Vancomycin|vancomycin|mesh-list
110759873|NCT05849090|Clindamycin|clindamycin|mesh-list
110759874|NCT05849090|Clindamycin palmitate|clindamycin palmitate|mesh-list
110759876|NCT05849090|Cefazolin|cefazolin|mesh-list
110759877|NCT05849090|Ceftriaxone|ceftriaxone|mesh-list
110759878|NCT05849090|Tobramycin|tobramycin|mesh-list
110759879|NCT05849090|Cephalosporins|cephalosporins|mesh-list
110759880|NCT05849090|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
110759881|NCT05849090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110759882|NCT05849090|Antitubercular Agents|antitubercular agents|mesh-ancestor
110759883|NCT05849090|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110759884|NCT05849090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110759885|NCT05849090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110759886|NCT05848869|Misoprostol|misoprostol|mesh-list
110759887|NCT05848869|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110759888|NCT05848869|Abortifacient Agents|abortifacient agents|mesh-ancestor
110759889|NCT05848869|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110759890|NCT05848869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110759891|NCT05848869|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110759892|NCT05848869|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110759893|NCT05848869|Oxytocics|oxytocics|mesh-ancestor
110759894|NCT05848713|Heparin|heparin|mesh-list
110759895|NCT05848713|Anticoagulants|anticoagulants|mesh-ancestor
110759896|NCT05848713|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110759897|NCT05848713|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110313704|NCT00303290|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110759898|NCT05848713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110759899|NCT05848635|Morphine|morphine|mesh-list
110759900|NCT05848635|Hydromorphone|hydromorphone|mesh-list
110759901|NCT05848635|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110759902|NCT05848635|Narcotics|narcotics|mesh-ancestor
110759903|NCT05848635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110759904|NCT05848635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110759905|NCT05848635|Analgesics|analgesics|mesh-ancestor
110759906|NCT05848635|Sensory System Agents|sensory system agents|mesh-ancestor
110759907|NCT05848635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110759908|NCT05848531|Clonidine|clonidine|mesh-list
110759909|NCT05848531|Analgesics|analgesics|mesh-ancestor
110759910|NCT05848531|Sensory System Agents|sensory system agents|mesh-ancestor
110759911|NCT05848531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110759912|NCT05848531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110759913|NCT05848531|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110759914|NCT05848531|Sympatholytics|sympatholytics|mesh-ancestor
110759915|NCT05848531|Autonomic Agents|autonomic agents|mesh-ancestor
110759916|NCT05848531|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110759917|NCT05848531|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110759918|NCT05848531|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110759919|NCT05848531|Adrenergic Agents|adrenergic agents|mesh-ancestor
110759920|NCT05848531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110759921|NCT05848531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110759922|NCT05848505|Dexmedetomidine|dexmedetomidine|mesh-list
110759923|NCT05848505|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110759924|NCT05848505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110759925|NCT05848505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110759926|NCT05848505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110759927|NCT05848505|Analgesics|analgesics|mesh-ancestor
110759928|NCT05848505|Sensory System Agents|sensory system agents|mesh-ancestor
110759929|NCT05848505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110759930|NCT05848505|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110759931|NCT05848505|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110759933|NCT05848505|Adrenergic Agents|adrenergic agents|mesh-ancestor
110759934|NCT05848505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110759935|NCT05848505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110759936|NCT05848492|Fluconazole|fluconazole|mesh-list
110759937|NCT05848492|Antifungal Agents|antifungal agents|mesh-ancestor
110759938|NCT05848492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110759939|NCT05848492|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110759940|NCT05848492|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110759941|NCT05848492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110759945|NCT05848492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110759946|NCT05848492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110759947|NCT05848492|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110759948|NCT05848492|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110759950|NCT05848336|Chelating Agents|chelating agents|mesh-ancestor
110759951|NCT05848336|Sequestering Agents|sequestering agents|mesh-ancestor
110759952|NCT05848336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110759954|NCT05848102|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110313718|NCT00419718|Insulin|insulin|mesh-list
110759955|NCT05848102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110759956|NCT05848102|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110759957|NCT05848102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110759958|NCT05847764|Carboplatin|carboplatin|mesh-list
110759959|NCT05847764|Tislelizumab|tislelizumab|mesh-list
110759960|NCT05847764|Aflutinib|aflutinib|mesh-list
110759961|NCT05847764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110759962|NCT05847764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110759963|NCT05847764|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110759964|NCT05847764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110759965|NCT05847764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110759966|NCT05846373|Niacin|niacin|mesh-list
110759967|NCT05846373|Niacinamide|niacinamide|mesh-list
110759968|NCT05846373|Nicotinic Acids|nicotinic acids|mesh-list
110759969|NCT05846373|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110759970|NCT05846373|Antimetabolites|antimetabolites|mesh-ancestor
110759971|NCT05846373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110759972|NCT05846373|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110759973|NCT05846373|Vasodilator Agents|vasodilator agents|mesh-ancestor
110759974|NCT05846373|Vitamin B Complex|vitamin b complex|mesh-ancestor
110759975|NCT05846373|Vitamins|vitamins|mesh-ancestor
110759976|NCT05846373|Micronutrients|micronutrients|mesh-ancestor
110759977|NCT05846373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110759978|NCT05846243|Vaccines|vaccines|mesh-list
110759979|NCT05846243|Immunologic Factors|immunologic factors|mesh-ancestor
110759980|NCT05846243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110759981|NCT05846139|Chlorhexidine|chlorhexidine|mesh-list
110759982|NCT05846139|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110759983|NCT05846139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110759984|NCT05846139|Disinfectants|disinfectants|mesh-ancestor
110759989|NCT05845723|Cyclophosphamide|cyclophosphamide|mesh-list
110759990|NCT05845723|Tofacitinib|tofacitinib|mesh-list
110759991|NCT05845723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110759992|NCT05845723|Immunologic Factors|immunologic factors|mesh-ancestor
110759993|NCT05845723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110759994|NCT05845723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110759995|NCT05845723|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110759996|NCT05845723|Alkylating Agents|alkylating agents|mesh-ancestor
110759997|NCT05845723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110759998|NCT05845723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110759999|NCT05845723|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110760000|NCT05845723|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
110760001|NCT05845723|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110760002|NCT05845723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110760009|NCT05845567|Clarithromycin|clarithromycin|mesh-list
110760010|NCT05845567|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110760011|NCT05845567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110760012|NCT05845567|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110760013|NCT05845567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110760014|NCT05845567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110477723|NCT02607436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110760027|NCT05845385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110760028|NCT05845385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110760029|NCT05845268|Tislelizumab|tislelizumab|mesh-list
110760030|NCT05845268|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
110760031|NCT05845268|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110760032|NCT05845268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110760033|NCT05845268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110760034|NCT05845125|Triamcinolone|triamcinolone|mesh-list
110760035|NCT05845125|Bupivacaine|bupivacaine|mesh-list
110760036|NCT05845125|Anesthetics, Local|anesthetics, local|mesh-ancestor
110760037|NCT05845125|Anesthetics|anesthetics|mesh-ancestor
110760038|NCT05845125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110760039|NCT05845125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110760040|NCT05845125|Sensory System Agents|sensory system agents|mesh-ancestor
110760041|NCT05845125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110760042|NCT05845125|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110760043|NCT05845125|Glucocorticoids|glucocorticoids|mesh-ancestor
110760044|NCT05845125|Hormones|hormones|mesh-ancestor
110760045|NCT05845125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110760058|NCT05844930|Triamcinolone|triamcinolone|mesh-list
110760059|NCT05844930|Lidocaine|lidocaine|mesh-list
110760060|NCT05844930|Anesthetics, Local|anesthetics, local|mesh-ancestor
110760061|NCT05844930|Anesthetics|anesthetics|mesh-ancestor
110760062|NCT05844930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110760063|NCT05844930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110760064|NCT05844930|Sensory System Agents|sensory system agents|mesh-ancestor
110760065|NCT05844930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110760066|NCT05844930|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110760067|NCT05844930|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110760068|NCT05844930|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110760069|NCT05844930|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110760070|NCT05844930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110760071|NCT05844930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110760072|NCT05844930|Glucocorticoids|glucocorticoids|mesh-ancestor
110760073|NCT05844930|Hormones|hormones|mesh-ancestor
110760074|NCT05844930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110760075|NCT05844800|Bupivacaine|bupivacaine|mesh-list
110760076|NCT05844800|Anesthetics, Local|anesthetics, local|mesh-ancestor
110760077|NCT05844800|Anesthetics|anesthetics|mesh-ancestor
110760078|NCT05844800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110760079|NCT05844800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110760080|NCT05844800|Sensory System Agents|sensory system agents|mesh-ancestor
110760081|NCT05844800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110760082|NCT05844683|Chlorhexidine|chlorhexidine|mesh-list
110760083|NCT05844683|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110760084|NCT05844683|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110760085|NCT05844683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110477795|NCT00588952|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110760086|NCT05844683|Disinfectants|disinfectants|mesh-ancestor
110760088|NCT05844670|Vincristine|vincristine|mesh-list
110760089|NCT05844670|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110760090|NCT05844670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110760091|NCT05844670|Tubulin Modulators|tubulin modulators|mesh-ancestor
110760092|NCT05844670|Antimitotic Agents|antimitotic agents|mesh-ancestor
110760093|NCT05844670|Mitosis Modulators|mitosis modulators|mesh-ancestor
110760094|NCT05844670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110760095|NCT05844657|Ferrous fumarate|ferrous fumarate|mesh-list
110760096|NCT05844657|Trace Elements|trace elements|mesh-ancestor
110760097|NCT05844657|Micronutrients|micronutrients|mesh-ancestor
110760098|NCT05844657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110760099|NCT05844553|Hydrogen Peroxide|hydrogen peroxide|mesh-list
110760100|NCT05844553|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110760101|NCT05844553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110760102|NCT05844436|Pritelivir|pritelivir|mesh-list
110760103|NCT05844436|Antiviral Agents|antiviral agents|mesh-ancestor
110760104|NCT05844436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110760105|NCT05844436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110760106|NCT05844436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110760107|NCT05844371|Oxaliplatin|oxaliplatin|mesh-list
110760108|NCT05844371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110760109|NCT05844306|Deoxyglucose|deoxyglucose|mesh-list
110760110|NCT05844306|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110760111|NCT05844306|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110760112|NCT05844306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110760113|NCT05844306|Antimetabolites|antimetabolites|mesh-ancestor
110760114|NCT05844306|Antiviral Agents|antiviral agents|mesh-ancestor
110760115|NCT05844306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110760116|NCT05844150|Etoposide|etoposide|mesh-list
110760117|NCT05844150|Atezolizumab|atezolizumab|mesh-list
110760118|NCT05844150|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110760119|NCT05844150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110760120|NCT05844150|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110760121|NCT05844150|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110760122|NCT05844150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110085159|NCT01665235|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110760123|NCT05844150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110760124|NCT05844150|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110760125|NCT05844150|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110760126|NCT05844046|Bevacizumab|bevacizumab|mesh-list
110760127|NCT05844046|Durvalumab|durvalumab|mesh-list
110760128|NCT05844046|Tremelimumab|tremelimumab|mesh-list
110760129|NCT05844046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110760130|NCT05844046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110760131|NCT05844046|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110760132|NCT05844046|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110760133|NCT05844046|Growth Substances|growth substances|mesh-ancestor
110760134|NCT05844046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110760135|NCT05844046|Growth Inhibitors|growth inhibitors|mesh-ancestor
110760136|NCT05843812|Magnesium Sulfate|magnesium sulfate|mesh-list
110760137|NCT05843812|Analgesics|analgesics|mesh-ancestor
110760138|NCT05843812|Sensory System Agents|sensory system agents|mesh-ancestor
110760139|NCT05843812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110760140|NCT05843812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110760141|NCT05843812|Anesthetics|anesthetics|mesh-ancestor
110760142|NCT05843812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110760143|NCT05843812|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110760144|NCT05843812|Anticonvulsants|anticonvulsants|mesh-ancestor
110760145|NCT05843812|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110760146|NCT05843812|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110760147|NCT05843812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110760148|NCT05843812|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110760149|NCT05843812|Tocolytic Agents|tocolytic agents|mesh-ancestor
110760150|NCT05843812|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110760151|NCT05843617|Vitamins|vitamins|mesh-list
110760152|NCT05843617|Ascorbic Acid|ascorbic acid|mesh-list
110760153|NCT05843617|Micronutrients|micronutrients|mesh-ancestor
110760154|NCT05843617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110760155|NCT05843617|Antioxidants|antioxidants|mesh-ancestor
110760156|NCT05843617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110760157|NCT05843617|Protective Agents|protective agents|mesh-ancestor
110760158|NCT05843344|Dexmedetomidine|dexmedetomidine|mesh-list
110760159|NCT05843344|Morphine|morphine|mesh-list
110760160|NCT05843344|Ropivacaine|ropivacaine|mesh-list
110313780|NCT00303758|Vitamins|vitamins|mesh-ancestor
110760161|NCT05843344|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110477870|NCT02692599|Vaccines|vaccines|mesh-list
110760170|NCT05843344|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110760171|NCT05843344|Adrenergic Agents|adrenergic agents|mesh-ancestor
110760172|NCT05843344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110760173|NCT05843344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110760174|NCT05843344|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110760176|NCT05843344|Anesthetics, Local|anesthetics, local|mesh-ancestor
110760177|NCT05843344|Anesthetics|anesthetics|mesh-ancestor
110760178|NCT05843292|Carboplatin|carboplatin|mesh-list
110760179|NCT05843292|Taxane|taxane|mesh-list
110760180|NCT05843292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110760191|NCT05843162|Telmisartan|telmisartan|mesh-list
110760192|NCT05843162|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110760193|NCT05843162|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110760194|NCT05843162|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110760195|NCT05843162|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110760196|NCT05843162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110760197|NCT05842681|Azithromycin|azithromycin|mesh-list
110760198|NCT05842681|Methylprednisolone|methylprednisolone|mesh-list
110760199|NCT05842681|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110760200|NCT05842681|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110760201|NCT05842681|Prednisolone|prednisolone|mesh-list
110760202|NCT05842681|Prednisolone acetate|prednisolone acetate|mesh-list
110760203|NCT05842681|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110760204|NCT05842681|Prednisolone phosphate|prednisolone phosphate|mesh-list
110760205|NCT05842681|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110760206|NCT05842681|Antiemetics|antiemetics|mesh-ancestor
110760207|NCT05842681|Autonomic Agents|autonomic agents|mesh-ancestor
110760208|NCT05842681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110760209|NCT05842681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110760210|NCT05842681|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110760211|NCT05842681|Glucocorticoids|glucocorticoids|mesh-ancestor
110760212|NCT05842681|Hormones|hormones|mesh-ancestor
110760213|NCT05842681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110760214|NCT05842681|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110760215|NCT05842681|Protective Agents|protective agents|mesh-ancestor
110760216|NCT05842681|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110760217|NCT05842681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110760218|NCT05842681|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110760219|NCT05842681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110760220|NCT05842486|Antibodies|antibodies|mesh-list
110760221|NCT05842486|Immunologic Factors|immunologic factors|mesh-ancestor
110760222|NCT05842486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110760223|NCT05842330|Methylphenidate|methylphenidate|mesh-list
110760224|NCT05842330|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110760225|NCT05842330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110760226|NCT05842330|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110760227|NCT05842330|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110760228|NCT05842330|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110760229|NCT05842330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110760230|NCT05842330|Dopamine Agents|dopamine agents|mesh-ancestor
110760231|NCT05842330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110760232|NCT05842317|Lenvatinib|lenvatinib|mesh-list
110760233|NCT05842317|Tislelizumab|tislelizumab|mesh-list
110760234|NCT05842317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110760235|NCT05842317|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110760236|NCT05842317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110760237|NCT05842317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110760238|NCT05842317|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110760240|NCT05840848|Carotenoids|carotenoids|mesh-list
110760241|NCT05840848|Antioxidants|antioxidants|mesh-ancestor
110760242|NCT05840848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110760243|NCT05840848|Protective Agents|protective agents|mesh-ancestor
110760244|NCT05840848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110760245|NCT05840848|Provitamins|provitamins|mesh-ancestor
110760246|NCT05840848|Vitamins|vitamins|mesh-ancestor
110760247|NCT05840848|Micronutrients|micronutrients|mesh-ancestor
110760248|NCT05840835|Tislelizumab|tislelizumab|mesh-list
110760249|NCT05840835|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110760250|NCT05840835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110760251|NCT05840562|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110760252|NCT05840562|Capsaicin|capsaicin|mesh-list
110760253|NCT05840562|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110760254|NCT05840562|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110760255|NCT05840562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110760256|NCT05840562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110760257|NCT05840562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110760258|NCT05840562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110760259|NCT05840562|Analgesics|analgesics|mesh-ancestor
110760260|NCT05840562|Sensory System Agents|sensory system agents|mesh-ancestor
110868980|NCT03176524|Incretins|incretins|mesh-ancestor
110760261|NCT05840562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110760262|NCT05840562|Antidepressive Agents|antidepressive agents|mesh-ancestor
110760264|NCT05840562|Dopamine Agents|dopamine agents|mesh-ancestor
110760265|NCT05840562|Antipruritics|antipruritics|mesh-ancestor
110760266|NCT05840562|Dermatologic Agents|dermatologic agents|mesh-ancestor
110760267|NCT05840471|Tranexamic Acid|tranexamic acid|mesh-list
110760268|NCT05840471|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110760269|NCT05840471|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110760270|NCT05840471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110760271|NCT05840471|Hemostatics|hemostatics|mesh-ancestor
110760272|NCT05840471|Coagulants|coagulants|mesh-ancestor
110760273|NCT05840289|Rituximab|rituximab|mesh-list
110760274|NCT05840289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110760275|NCT05840289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110760276|NCT05840289|Immunologic Factors|immunologic factors|mesh-ancestor
110760277|NCT05840289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110760278|NCT05840289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110760279|NCT05839938|Vitamin D|vitamin d|mesh-list
110760280|NCT05839938|Vitamins|vitamins|mesh-ancestor
110760281|NCT05839938|Micronutrients|micronutrients|mesh-ancestor
110760282|NCT05839938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110760283|NCT05839938|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110760284|NCT05839756|Budesonide|budesonide|mesh-list
110760285|NCT05839756|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110760286|NCT05839756|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110760287|NCT05839756|Autonomic Agents|autonomic agents|mesh-ancestor
110313823|NCT00304226|Valsartan|valsartan|mesh-list
110760288|NCT05839756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110760289|NCT05839756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110760290|NCT05839756|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110760291|NCT05839756|Respiratory System Agents|respiratory system agents|mesh-ancestor
110760292|NCT05839756|Glucocorticoids|glucocorticoids|mesh-ancestor
110760293|NCT05839756|Hormones|hormones|mesh-ancestor
110760294|NCT05839756|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110760295|NCT05839314|Cyclosporine|cyclosporine|mesh-list
110760296|NCT05839314|Cyclosporins|cyclosporins|mesh-list
110760297|NCT05839314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110760298|NCT05839314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110760299|NCT05839314|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110760300|NCT05839314|Immunologic Factors|immunologic factors|mesh-ancestor
110760301|NCT05839314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110760302|NCT05839314|Antifungal Agents|antifungal agents|mesh-ancestor
110760303|NCT05839314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110760304|NCT05839314|Dermatologic Agents|dermatologic agents|mesh-ancestor
110760305|NCT05839314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110760306|NCT05839314|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110760307|NCT05829499|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110760308|NCT05829499|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110760310|NCT05825573|Anticoagulants|anticoagulants|mesh-list
110760311|NCT05825573|Vitamins|vitamins|mesh-ancestor
110760312|NCT05825573|Micronutrients|micronutrients|mesh-ancestor
110760313|NCT05825573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110760314|NCT05825573|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110760315|NCT05825573|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110760316|NCT05825573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110760318|NCT05825573|Coagulants|coagulants|mesh-ancestor
110760319|NCT05825352|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110760320|NCT05825352|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110760321|NCT05824494|Paclitaxel|paclitaxel|mesh-list
110760322|NCT05824494|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110760323|NCT05824494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110760324|NCT05824494|Tubulin Modulators|tubulin modulators|mesh-ancestor
110760325|NCT05824494|Antimitotic Agents|antimitotic agents|mesh-ancestor
110760326|NCT05824494|Mitosis Modulators|mitosis modulators|mesh-ancestor
110760327|NCT05824494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110760328|NCT05824000|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110760329|NCT05824000|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110760330|NCT05823961|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110760331|NCT05823961|Hyaluronic Acid|hyaluronic acid|mesh-list
110760332|NCT05823961|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110760333|NCT05823961|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110760334|NCT05823961|Immunologic Factors|immunologic factors|mesh-ancestor
110760335|NCT05823961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110760336|NCT05823961|Viscosupplements|viscosupplements|mesh-ancestor
110760337|NCT05823961|Protective Agents|protective agents|mesh-ancestor
110760338|NCT05823506|Tadalafil|tadalafil|mesh-list
110760339|NCT05823506|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
110760340|NCT05823506|Vasodilator Agents|vasodilator agents|mesh-ancestor
110760341|NCT05823506|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110760342|NCT05823506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110760343|NCT05823506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110760344|NCT05823506|Urological Agents|urological agents|mesh-ancestor
110760345|NCT05822817|Propofol|propofol|mesh-list
110760346|NCT05822817|Sevoflurane|sevoflurane|mesh-list
110760347|NCT05822817|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110760348|NCT05822817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110760349|NCT05822817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110760350|NCT05822817|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110760351|NCT05822817|Anesthetics, General|anesthetics, general|mesh-ancestor
110760352|NCT05822817|Anesthetics|anesthetics|mesh-ancestor
110760353|NCT05822817|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110760354|NCT05822817|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110760355|NCT05821075|Prednisolone|prednisolone|mesh-list
110760356|NCT05821075|Cerebrolysin|cerebrolysin|mesh-list
110760357|NCT05821075|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110760358|NCT05821075|Glucocorticoids|glucocorticoids|mesh-ancestor
110760359|NCT05821075|Hormones|hormones|mesh-ancestor
110760360|NCT05821075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110760361|NCT05821075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110760362|NCT05821075|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110760363|NCT05821075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110760364|NCT05821075|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110760365|NCT05821075|Protective Agents|protective agents|mesh-ancestor
110760366|NCT05821075|Nootropic Agents|nootropic agents|mesh-ancestor
110760367|NCT05817903|Nivolumab|nivolumab|mesh-list
110760368|NCT05817903|Axitinib|axitinib|mesh-list
110760369|NCT05817903|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110760370|NCT05817903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110760371|NCT05817903|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110760372|NCT05817903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110760373|NCT05817903|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110760374|NCT05817903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110760375|NCT05806021|Triamcinolone|triamcinolone|mesh-list
110760376|NCT05806021|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110760377|NCT05806021|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110760378|NCT05806021|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110760379|NCT05806021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110760380|NCT05806021|Glucocorticoids|glucocorticoids|mesh-ancestor
110760381|NCT05806021|Hormones|hormones|mesh-ancestor
110760382|NCT05806021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110760383|NCT05806021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110760384|NCT05806021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110760385|NCT05806021|Immunologic Factors|immunologic factors|mesh-ancestor
110760386|NCT05806021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110760387|NCT05806021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110760389|NCT05805605|Sirolimus|sirolimus|mesh-list
110760390|NCT05805605|Cyclophosphamide|cyclophosphamide|mesh-list
110760391|NCT05805605|Fludarabine|fludarabine|mesh-list
110760392|NCT05805605|Allopurinol|allopurinol|mesh-list
110760393|NCT05805605|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110760394|NCT05805605|Immunologic Factors|immunologic factors|mesh-ancestor
110760395|NCT05805605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110760396|NCT05805605|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110760397|NCT05805605|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110760398|NCT05805605|Alkylating Agents|alkylating agents|mesh-ancestor
110760399|NCT05805605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110760400|NCT05805605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110760401|NCT05805605|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110760402|NCT05805605|Antimetabolites|antimetabolites|mesh-ancestor
110760403|NCT05805605|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110760404|NCT05805605|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110760405|NCT05805605|Antitubercular Agents|antitubercular agents|mesh-ancestor
110760406|NCT05805605|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110760407|NCT05805605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110760408|NCT05805605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110760409|NCT05805605|Antifungal Agents|antifungal agents|mesh-ancestor
110760410|NCT05805605|Gout Suppressants|gout suppressants|mesh-ancestor
110760411|NCT05805605|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110760412|NCT05805605|Antioxidants|antioxidants|mesh-ancestor
110760413|NCT05805605|Protective Agents|protective agents|mesh-ancestor
110760414|NCT05805436|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
110760415|NCT05805436|Laxatives|laxatives|mesh-ancestor
110760416|NCT05805436|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110760417|NCT05805072|Cytarabine|cytarabine|mesh-list
110760418|NCT05805072|Azacitidine|azacitidine|mesh-list
110760419|NCT05805072|Decitabine|decitabine|mesh-list
110760420|NCT05805072|Homoharringtonine|homoharringtonine|mesh-list
110760421|NCT05805072|Aclacinomycins|aclacinomycins|mesh-list
110760422|NCT05805072|Lenograstim|lenograstim|mesh-list
110760423|NCT05805072|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110760424|NCT05805072|Antimetabolites|antimetabolites|mesh-ancestor
110760425|NCT05805072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110760426|NCT05805072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110760427|NCT05805072|Antiviral Agents|antiviral agents|mesh-ancestor
110760428|NCT05805072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110760429|NCT05805072|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110760430|NCT05805072|Immunologic Factors|immunologic factors|mesh-ancestor
110760431|NCT05805072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110760432|NCT05805072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110760433|NCT05805072|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110760434|NCT05805072|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110760435|NCT05805072|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110760436|NCT05805072|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110760437|NCT05804032|Dexamethasone|dexamethasone|mesh-list
110760438|NCT05804032|Lenalidomide|lenalidomide|mesh-list
110760439|NCT05804032|Bortezomib|bortezomib|mesh-list
110760440|NCT05804032|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110760441|NCT05804032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110760442|NCT05804032|Antiemetics|antiemetics|mesh-ancestor
110760443|NCT05804032|Autonomic Agents|autonomic agents|mesh-ancestor
110760444|NCT05804032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110760445|NCT05804032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110760446|NCT05804032|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110760447|NCT05804032|Glucocorticoids|glucocorticoids|mesh-ancestor
110760448|NCT05804032|Hormones|hormones|mesh-ancestor
110760449|NCT05804032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110760450|NCT05804032|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110760451|NCT05804032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110760452|NCT05804032|Immunologic Factors|immunologic factors|mesh-ancestor
110760453|NCT05804032|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110760454|NCT05804032|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110760455|NCT05804032|Growth Substances|growth substances|mesh-ancestor
110760456|NCT05804032|Growth Inhibitors|growth inhibitors|mesh-ancestor
110760457|NCT05801913|Vaccines|vaccines|mesh-list
110760458|NCT05801913|Immunologic Factors|immunologic factors|mesh-ancestor
110760459|NCT05801913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110760460|NCT05797090|Cardioplegic Solutions|cardioplegic solutions|mesh-list
110760461|NCT05797090|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110760462|NCT05795101|Trastuzumab|trastuzumab|mesh-list
110760463|NCT05795101|Durvalumab|durvalumab|mesh-list
110760464|NCT05795101|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
110760465|NCT05795101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110760466|NCT05795101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110760467|NCT05795101|Immunoconjugates|immunoconjugates|mesh-ancestor
110760468|NCT05795101|Immunologic Factors|immunologic factors|mesh-ancestor
110760469|NCT05795101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110760470|NCT05772364|Calcium|calcium|mesh-list
110760471|NCT05772364|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110760472|NCT05772364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110760473|NCT05770180|Vaccines|vaccines|mesh-list
110760474|NCT05770180|Immunologic Factors|immunologic factors|mesh-ancestor
110760475|NCT05770180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110760476|NCT05767749|Lidocaine|lidocaine|mesh-list
110760477|NCT05767749|Epinephrine|epinephrine|mesh-list
110760478|NCT05767749|Racepinephrine|racepinephrine|mesh-list
110760479|NCT05767749|Bupivacaine|bupivacaine|mesh-list
110760480|NCT05767749|Ropivacaine|ropivacaine|mesh-list
110760481|NCT05767749|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110760482|NCT05767749|Epinephryl borate|epinephryl borate|mesh-list
110760483|NCT05767749|Anesthetics, Local|anesthetics, local|mesh-ancestor
110760484|NCT05767749|Anesthetics|anesthetics|mesh-ancestor
110760485|NCT05767749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110760486|NCT05767749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110760487|NCT05767749|Sensory System Agents|sensory system agents|mesh-ancestor
110760488|NCT05767749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110760489|NCT05767749|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110760490|NCT05767749|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110760491|NCT05767749|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110760492|NCT05767749|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110760493|NCT05767749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110760494|NCT05767749|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110760495|NCT05767749|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110760496|NCT05767749|Adrenergic Agents|adrenergic agents|mesh-ancestor
110760497|NCT05767749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110760498|NCT05767749|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110760499|NCT05767749|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110760500|NCT05767749|Autonomic Agents|autonomic agents|mesh-ancestor
110760501|NCT05767749|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110760502|NCT05767749|Respiratory System Agents|respiratory system agents|mesh-ancestor
110760503|NCT05767749|Mydriatics|mydriatics|mesh-ancestor
110760504|NCT05767749|Sympathomimetics|sympathomimetics|mesh-ancestor
110760505|NCT05767749|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110760506|NCT05765682|Bupivacaine|bupivacaine|mesh-list
110760507|NCT05765682|Mepivacaine|mepivacaine|mesh-list
110760508|NCT05765682|Anesthetics, Local|anesthetics, local|mesh-ancestor
110760509|NCT05765682|Anesthetics|anesthetics|mesh-ancestor
110760510|NCT05765682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110760511|NCT05765682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110760512|NCT05765682|Sensory System Agents|sensory system agents|mesh-ancestor
110760513|NCT05765682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110760514|NCT05765604|Vaccines|vaccines|mesh-list
110760515|NCT05765604|Immunologic Factors|immunologic factors|mesh-ancestor
110760516|NCT05765604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110760517|NCT05753592|Remibrutinib|remibrutinib|mesh-list
110760518|NCT05753592|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110760519|NCT05753592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110760520|NCT05753592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110760521|NCT05735431|Fluticasone|fluticasone|mesh-list
110760522|NCT05735431|Formoterol Fumarate|formoterol fumarate|mesh-list
110760523|NCT05735431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110760524|NCT05735431|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110760525|NCT05735431|Autonomic Agents|autonomic agents|mesh-ancestor
110760526|NCT05735431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110760527|NCT05735431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110760528|NCT05735431|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110760529|NCT05735431|Respiratory System Agents|respiratory system agents|mesh-ancestor
110760530|NCT05735431|Dermatologic Agents|dermatologic agents|mesh-ancestor
110760531|NCT05735431|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110760532|NCT05735431|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110760533|NCT05735431|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110760534|NCT05735431|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110760535|NCT05735431|Adrenergic Agents|adrenergic agents|mesh-ancestor
110760536|NCT05735431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110760537|NCT05735431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110760538|NCT05704673|Morphine|morphine|mesh-list
110760539|NCT05704673|Nalbuphine|nalbuphine|mesh-list
110760540|NCT05704673|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110760541|NCT05704673|Narcotics|narcotics|mesh-ancestor
110478231|NCT00724243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110760542|NCT05704673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110760543|NCT05704673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110760544|NCT05704673|Analgesics|analgesics|mesh-ancestor
110760545|NCT05704673|Sensory System Agents|sensory system agents|mesh-ancestor
110760546|NCT05704673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110760547|NCT05702671|Immunoglobulins|immunoglobulins|mesh-list
110760548|NCT05702671|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110760549|NCT05702671|Antibodies|antibodies|mesh-list
110760550|NCT05702671|Immunologic Factors|immunologic factors|mesh-ancestor
110760551|NCT05702671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110760552|NCT05693545|Penicillins|penicillins|mesh-list
110760553|NCT05693545|Penicillin G|penicillin g|mesh-list
110760554|NCT05693545|Penicillin G Benzathine|penicillin g benzathine|mesh-list
110760555|NCT05693545|Penicillin G Procaine|penicillin g procaine|mesh-list
110760556|NCT05693545|Penicillin V|penicillin v|mesh-list
110760557|NCT05693545|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110760558|NCT05693545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110760559|NCT05683574|Etoricoxib|etoricoxib|mesh-list
110760560|NCT05683574|Amitriptyline|amitriptyline|mesh-list
110760561|NCT05683574|Cyclobenzaprine|cyclobenzaprine|mesh-list
110760562|NCT05683574|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110760563|NCT05683574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110760564|NCT05683574|Analgesics|analgesics|mesh-ancestor
110760565|NCT05683574|Sensory System Agents|sensory system agents|mesh-ancestor
110760566|NCT05683574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110760567|NCT05683574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110760568|NCT05683574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110760569|NCT05683574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110760570|NCT05683574|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110760571|NCT05683574|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110760572|NCT05683574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110760573|NCT05683574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110760574|NCT05683574|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110760575|NCT05683574|Antidepressive Agents|antidepressive agents|mesh-ancestor
110760576|NCT05683574|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110760577|NCT05683574|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110760578|NCT05683574|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110760579|NCT05683574|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110760580|NCT05683574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110760581|NCT05683574|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110760582|NCT05683574|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110760583|NCT05683574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110760584|NCT05683574|Adrenergic Agents|adrenergic agents|mesh-ancestor
110760585|NCT05683574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110760605|NCT05678205|Cyclophosphamide|cyclophosphamide|mesh-list
110760606|NCT05678205|Fludarabine|fludarabine|mesh-list
110760607|NCT05678205|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110760608|NCT05678205|Immunologic Factors|immunologic factors|mesh-ancestor
110760609|NCT05678205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110760610|NCT05678205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110760611|NCT05678205|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110760612|NCT05678205|Alkylating Agents|alkylating agents|mesh-ancestor
110760613|NCT05678205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110760614|NCT05678205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110760615|NCT05678205|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110760616|NCT05673811|Paclitaxel|paclitaxel|mesh-list
110760617|NCT05673811|Gemcitabine|gemcitabine|mesh-list
110760618|NCT05673811|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110760619|NCT05673811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110760620|NCT05673811|Tubulin Modulators|tubulin modulators|mesh-ancestor
110760621|NCT05673811|Antimitotic Agents|antimitotic agents|mesh-ancestor
110760622|NCT05673811|Mitosis Modulators|mitosis modulators|mesh-ancestor
110760623|NCT05673811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110760624|NCT05673811|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110760625|NCT05673811|Antimetabolites|antimetabolites|mesh-ancestor
110760626|NCT05671562|Lycopene|lycopene|mesh-list
110760627|NCT05671562|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110760628|NCT05671562|Antioxidants|antioxidants|mesh-ancestor
110760629|NCT05671562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110760630|NCT05671562|Protective Agents|protective agents|mesh-ancestor
110760631|NCT05671562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110760632|NCT05671562|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110760633|NCT05671562|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110760634|NCT05671562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110760636|NCT05654818|Vitamins|vitamins|mesh-ancestor
110760637|NCT05654818|Micronutrients|micronutrients|mesh-ancestor
110760638|NCT05654818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110760639|NCT05654818|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110760640|NCT05634525|Adagrasib|adagrasib|mesh-list
110760641|NCT05634525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110760642|NCT05634369|Dexamethasone|dexamethasone|mesh-list
110760643|NCT05634369|Gemcitabine|gemcitabine|mesh-list
110760644|NCT05634369|Docetaxel|docetaxel|mesh-list
110760645|NCT05634369|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110760646|NCT05634369|Antiemetics|antiemetics|mesh-ancestor
110760647|NCT05634369|Autonomic Agents|autonomic agents|mesh-ancestor
110760648|NCT05634369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110760649|NCT05634369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110760650|NCT05634369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110760651|NCT05634369|Glucocorticoids|glucocorticoids|mesh-ancestor
110760652|NCT05634369|Hormones|hormones|mesh-ancestor
110760653|NCT05634369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110760654|NCT05634369|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110760655|NCT05634369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110760656|NCT05634369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110760657|NCT05634369|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110760658|NCT05634369|Antimetabolites|antimetabolites|mesh-ancestor
110760659|NCT05634369|Tubulin Modulators|tubulin modulators|mesh-ancestor
110760660|NCT05634369|Antimitotic Agents|antimitotic agents|mesh-ancestor
110760661|NCT05634369|Mitosis Modulators|mitosis modulators|mesh-ancestor
110760662|NCT05613205|Vaccines|vaccines|mesh-list
110760663|NCT05613205|Adjuvants, Vaccine|adjuvants, vaccine|mesh-list
110760664|NCT05613205|Immunologic Factors|immunologic factors|mesh-ancestor
110760665|NCT05613205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110760666|NCT05613205|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110760668|NCT05589181|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110760669|NCT05589181|Narcotics|narcotics|mesh-ancestor
110760670|NCT05589181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110760671|NCT05589181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110760672|NCT05589181|Analgesics|analgesics|mesh-ancestor
110760673|NCT05589181|Sensory System Agents|sensory system agents|mesh-ancestor
110760674|NCT05589181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110760675|NCT05589181|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110760676|NCT05562349|Clavulanic Acids|clavulanic acids|mesh-list
110760677|NCT05562349|Clavulanic Acid|clavulanic acid|mesh-list
110760678|NCT05562349|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110760679|NCT05562349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110760680|NCT05562349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110760681|NCT05562349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110760682|NCT05562349|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110760683|NCT05561673|Aluminum Hydroxide|aluminum hydroxide|mesh-list
110760684|NCT05561673|Vaccines|vaccines|mesh-list
110760685|NCT05561673|Immunologic Factors|immunologic factors|mesh-ancestor
110760686|NCT05561673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110760687|NCT05561673|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110760688|NCT05561673|Antacids|antacids|mesh-ancestor
110760689|NCT05561673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110760690|NCT05561673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110760691|NCT05550714|Anesthetics|anesthetics|mesh-list
110760692|NCT05550714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110760693|NCT05550714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110760694|NCT05542264|Olanzapine|olanzapine|mesh-list
110760696|NCT05542264|Aripiprazole|aripiprazole|mesh-list
110760697|NCT05542264|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110760698|NCT05542264|Antipsychotic Agents|antipsychotic agents|mesh-list
110760699|NCT05542264|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110760700|NCT05542264|Serotonin Agents|serotonin agents|mesh-ancestor
110760701|NCT05542264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110760702|NCT05542264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110760703|NCT05542264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110760704|NCT05542264|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110760705|NCT05542264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110760706|NCT05542264|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110760707|NCT05542264|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110760708|NCT05542264|Dopamine Agents|dopamine agents|mesh-ancestor
110760709|NCT05542264|Antiemetics|antiemetics|mesh-ancestor
110760710|NCT05542264|Autonomic Agents|autonomic agents|mesh-ancestor
110760711|NCT05542264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110760712|NCT05542264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110760713|NCT05542264|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110760714|NCT05542264|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110760715|NCT05542264|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110760716|NCT05542264|Antidepressive Agents|antidepressive agents|mesh-ancestor
110760717|NCT05542264|Dopamine Agonists|dopamine agonists|mesh-ancestor
110760718|NCT05542264|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110760719|NCT05542264|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110760720|NCT05542264|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110760721|NCT05542264|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110760722|NCT05523323|Pembrolizumab|pembrolizumab|mesh-list
110760723|NCT05523323|Lenvatinib|lenvatinib|mesh-list
110760724|NCT05523323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110760725|NCT05523323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110760726|NCT05523323|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110760727|NCT05523323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110760728|NCT05523323|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110760729|NCT05523323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110760730|NCT05505617|Nitric Oxide|nitric oxide|mesh-list
110760731|NCT05505617|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110760732|NCT05505617|Autonomic Agents|autonomic agents|mesh-ancestor
110760733|NCT05505617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110760734|NCT05505617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110760735|NCT05505617|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110760736|NCT05505617|Respiratory System Agents|respiratory system agents|mesh-ancestor
110760737|NCT05505617|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110760738|NCT05505617|Antioxidants|antioxidants|mesh-ancestor
110760739|NCT05505617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110760740|NCT05505617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110760741|NCT05505617|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
110760742|NCT05505617|Vasodilator Agents|vasodilator agents|mesh-ancestor
110760743|NCT05505617|Gasotransmitters|gasotransmitters|mesh-ancestor
110760744|NCT05505617|Protective Agents|protective agents|mesh-ancestor
110760745|NCT05487040|Ritonavir|ritonavir|mesh-list
110760746|NCT05487040|Nirmatrelvir|nirmatrelvir|mesh-list
110760747|NCT05487040|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110760748|NCT05487040|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110760749|NCT05487040|Protease Inhibitors|protease inhibitors|mesh-ancestor
110760750|NCT05487040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110760751|NCT05487040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110760752|NCT05487040|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110760753|NCT05487040|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110760754|NCT05487040|Antiviral Agents|antiviral agents|mesh-ancestor
110760755|NCT05487040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110760756|NCT05487040|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110760757|NCT05487040|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110760758|NCT05484466|Entecavir|entecavir|mesh-list
110760759|NCT05484466|Antiviral Agents|antiviral agents|mesh-ancestor
110760760|NCT05484466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110760761|NCT05466747|Protease Inhibitors|protease inhibitors|mesh-list
110760762|NCT05466747|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
110760763|NCT05466747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110760764|NCT05466747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110760765|NCT05466747|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
110760766|NCT05466747|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110760767|NCT05408988|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
110478473|NCT00722761|Diuretics|diuretics|mesh-ancestor
110760768|NCT05408988|Natriuretic Agents|natriuretic agents|mesh-ancestor
110760769|NCT05408988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110760770|NCT05402111|Olanzapine|olanzapine|mesh-list
110760771|NCT05402111|Risperidone|risperidone|mesh-list
110760772|NCT05402111|Aripiprazole|aripiprazole|mesh-list
110760773|NCT05402111|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110760774|NCT05402111|Antipsychotic Agents|antipsychotic agents|mesh-list
110760775|NCT05402111|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110760776|NCT05402111|Serotonin Agents|serotonin agents|mesh-ancestor
110760777|NCT05402111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110760778|NCT05402111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110760779|NCT05402111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110760780|NCT05402111|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110760781|NCT05402111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110760782|NCT05402111|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110760783|NCT05402111|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110760784|NCT05402111|Dopamine Agents|dopamine agents|mesh-ancestor
110760785|NCT05402111|Antiemetics|antiemetics|mesh-ancestor
110760786|NCT05402111|Autonomic Agents|autonomic agents|mesh-ancestor
110760787|NCT05402111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110760788|NCT05402111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110760789|NCT05402111|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110760790|NCT05402111|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110760791|NCT05402111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110760792|NCT05402111|Antidepressive Agents|antidepressive agents|mesh-ancestor
110760793|NCT05402111|Dopamine Agonists|dopamine agonists|mesh-ancestor
110760794|NCT05402111|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110760795|NCT05402111|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110760796|NCT05402111|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110760797|NCT05402111|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110760798|NCT05393791|Abiraterone Acetate|abiraterone acetate|mesh-list
110760799|NCT05393791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110760800|NCT05393791|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110760801|NCT05393791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110760802|NCT05393791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110760803|NCT05393791|Hormone Antagonists|hormone antagonists|mesh-ancestor
110760804|NCT05393791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110760805|NCT05393791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110760806|NCT05393791|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110760807|NCT05388773|Carboplatin|carboplatin|mesh-list
110760808|NCT05388773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110760810|NCT05383521|Alkylating Agents|alkylating agents|mesh-ancestor
110760811|NCT05383521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110760812|NCT05383521|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110760813|NCT05383521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110760814|NCT05383521|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
110760815|NCT05383521|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110760816|NCT05383521|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110760817|NCT05361382|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
110760818|NCT05361382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110760819|NCT05359211|Cyclophosphamide|cyclophosphamide|mesh-list
110760820|NCT05359211|Fludarabine|fludarabine|mesh-list
110760821|NCT05359211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110760822|NCT05359211|Immunologic Factors|immunologic factors|mesh-ancestor
110760823|NCT05359211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110760824|NCT05359211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110760825|NCT05359211|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110760826|NCT05359211|Alkylating Agents|alkylating agents|mesh-ancestor
110760827|NCT05359211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110760828|NCT05359211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110760829|NCT05359211|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110760830|NCT05358938|Pembrolizumab|pembrolizumab|mesh-list
110760831|NCT05358938|Nivolumab|nivolumab|mesh-list
110760832|NCT05358938|Ipilimumab|ipilimumab|mesh-list
110760833|NCT05358938|Avelumab|avelumab|mesh-list
110760834|NCT05358938|Cemiplimab|cemiplimab|mesh-list
110760835|NCT05358938|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
110760836|NCT05358938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110760837|NCT05358938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110760838|NCT05358938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110760839|NCT05349474|Metformin|metformin|mesh-list
110760840|NCT05349474|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110760841|NCT05349474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110760842|NCT05343481|Nivolumab|nivolumab|mesh-list
110760843|NCT05343481|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110760844|NCT05343481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110760845|NCT05343481|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110760846|NCT05343481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110760847|NCT05340764|Infliximab|infliximab|mesh-list
110760848|NCT05340764|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110760849|NCT05340764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110760850|NCT05340764|Dermatologic Agents|dermatologic agents|mesh-ancestor
110760851|NCT05340764|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110760852|NCT05340764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110760853|NCT05327361|Sunscreening Agents|sunscreening agents|mesh-list
110760854|NCT05327361|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110760855|NCT05327361|Protective Agents|protective agents|mesh-ancestor
110760856|NCT05327361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110760857|NCT05327361|Dermatologic Agents|dermatologic agents|mesh-ancestor
110760858|NCT05305014|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
110760859|NCT05305014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110760860|NCT05302986|Tranexamic Acid|tranexamic acid|mesh-list
110314015|NCT00304811|Vancomycin|vancomycin|mesh-list
110760861|NCT05302986|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110760862|NCT05302986|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110760863|NCT05302986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110760864|NCT05302986|Hemostatics|hemostatics|mesh-ancestor
110760865|NCT05302986|Coagulants|coagulants|mesh-ancestor
110760866|NCT05301192|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
110760867|NCT05301192|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110760868|NCT05301192|Vasodilator Agents|vasodilator agents|mesh-ancestor
110760869|NCT05300451|Daratumumab|daratumumab|mesh-list
110760870|NCT05300451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110760871|NCT05287321|Hydroxychloroquine|hydroxychloroquine|mesh-list
110760872|NCT05287321|Antimalarials|antimalarials|mesh-ancestor
110760873|NCT05287321|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110760874|NCT05287321|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110760875|NCT05287321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110760876|NCT05287321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110760877|NCT05287321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110760878|NCT05287321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110760879|NCT05285904|Ofatumumab|ofatumumab|mesh-list
110760880|NCT05285904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110760881|NCT05283083|Dexmedetomidine|dexmedetomidine|mesh-list
110760882|NCT05283083|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110760883|NCT05283083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110760884|NCT05283083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110760885|NCT05283083|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110760886|NCT05283083|Analgesics|analgesics|mesh-ancestor
110760887|NCT05283083|Sensory System Agents|sensory system agents|mesh-ancestor
110760888|NCT05283083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110760889|NCT05283083|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110760890|NCT05283083|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110760891|NCT05283083|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110760892|NCT05283083|Adrenergic Agents|adrenergic agents|mesh-ancestor
110760893|NCT05283083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110760894|NCT05283083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110760895|NCT05262777|Lidocaine|lidocaine|mesh-list
110760896|NCT05262777|Anesthetics, Local|anesthetics, local|mesh-ancestor
110760897|NCT05262777|Anesthetics|anesthetics|mesh-ancestor
110760898|NCT05262777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110760899|NCT05262777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110760900|NCT05262777|Sensory System Agents|sensory system agents|mesh-ancestor
110760901|NCT05262777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110760902|NCT05262777|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110760903|NCT05262777|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110760904|NCT05262777|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110760905|NCT05262777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110760906|NCT05262777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110760907|NCT05248321|Tranexamic Acid|tranexamic acid|mesh-list
110760908|NCT05248321|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110760909|NCT05248321|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110760910|NCT05248321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110760911|NCT05248321|Hemostatics|hemostatics|mesh-ancestor
110760912|NCT05248321|Coagulants|coagulants|mesh-ancestor
110760913|NCT05241093|Cytarabine|cytarabine|mesh-list
110314039|NCT00332787|Serotonin Agents|serotonin agents|mesh-ancestor
110760914|NCT05241093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110760915|NCT05241093|Antimetabolites|antimetabolites|mesh-ancestor
110478617|NCT01017146|Tazarotene|tazarotene|mesh-list
110760916|NCT05241093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110760917|NCT05241093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110760918|NCT05241093|Antiviral Agents|antiviral agents|mesh-ancestor
110760919|NCT05241093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110760920|NCT05241093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110760921|NCT05241093|Immunologic Factors|immunologic factors|mesh-ancestor
110760922|NCT05241093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110760923|NCT05233163|Empagliflozin|empagliflozin|mesh-list
110760924|NCT05233163|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110760925|NCT05233163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110760926|NCT05233163|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110760927|NCT05233163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110760928|NCT05229991|Ritonavir|ritonavir|mesh-list
110760929|NCT05229991|Lonafarnib|lonafarnib|mesh-list
110760930|NCT05229991|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110760931|NCT05229991|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110760932|NCT05229991|Protease Inhibitors|protease inhibitors|mesh-ancestor
110760933|NCT05229991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110760934|NCT05229991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110760935|NCT05229991|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110760936|NCT05229991|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110760937|NCT05229991|Antiviral Agents|antiviral agents|mesh-ancestor
110760938|NCT05229991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110760939|NCT05229991|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110760940|NCT05229991|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110760941|NCT05214911|Loratadine|loratadine|mesh-list
110760942|NCT05214911|Prednisolone|prednisolone|mesh-list
110760943|NCT05214911|Desloratadine|desloratadine|mesh-list
110760944|NCT05214911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110760945|NCT05214911|Glucocorticoids|glucocorticoids|mesh-ancestor
110760946|NCT05214911|Hormones|hormones|mesh-ancestor
110760947|NCT05214911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110760948|NCT05214911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110760949|NCT05214911|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110760950|NCT05214911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110760951|NCT05214911|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110760952|NCT05214911|Cholinergic Agents|cholinergic agents|mesh-ancestor
110760953|NCT05214911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110760954|NCT05214911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110760955|NCT05214911|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110760956|NCT05214911|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110760957|NCT05214911|Histamine Antagonists|histamine antagonists|mesh-ancestor
110760958|NCT05214911|Histamine Agents|histamine agents|mesh-ancestor
110760959|NCT05214911|Antipruritics|antipruritics|mesh-ancestor
110760960|NCT05214911|Dermatologic Agents|dermatologic agents|mesh-ancestor
110760961|NCT05214911|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110760962|NCT05213884|Cisplatin|cisplatin|mesh-list
110760963|NCT05213884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110760964|NCT05211024|Penicillins|penicillins|mesh-list
110760965|NCT05211024|Penicillin G|penicillin g|mesh-list
110760966|NCT05211024|Penicillin G Benzathine|penicillin g benzathine|mesh-list
110760967|NCT05211024|Penicillin G Procaine|penicillin g procaine|mesh-list
110760968|NCT05211024|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110760969|NCT05211024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110760970|NCT05210439|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110760971|NCT05210439|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
110760972|NCT05210439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110760973|NCT05210439|Antitubercular Agents|antitubercular agents|mesh-ancestor
110760974|NCT05209984|Topiramate|topiramate|mesh-list
110760975|NCT05209984|Sibutramine|sibutramine|mesh-list
110760976|NCT05209984|Anticonvulsants|anticonvulsants|mesh-ancestor
110760977|NCT05209984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110760978|NCT05209984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110760979|NCT05209984|Antidepressive Agents|antidepressive agents|mesh-ancestor
110760980|NCT05209984|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110760981|NCT05209984|Appetite Depressants|appetite depressants|mesh-ancestor
110760982|NCT05209984|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110760983|NCT05204290|Pembrolizumab|pembrolizumab|mesh-list
110760984|NCT05204290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110760985|NCT05204290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110760986|NCT05204290|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110760987|NCT05204290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110760988|NCT05199311|Dexamethasone|dexamethasone|mesh-list
110760989|NCT05199311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110760990|NCT05199311|Antiemetics|antiemetics|mesh-ancestor
110760991|NCT05199311|Autonomic Agents|autonomic agents|mesh-ancestor
110760992|NCT05199311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110760993|NCT05199311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110760994|NCT05199311|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110760995|NCT05199311|Glucocorticoids|glucocorticoids|mesh-ancestor
110760997|NCT05199311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110760998|NCT05199311|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110760999|NCT05199311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110761000|NCT05179005|Imidacloprid|imidacloprid|mesh-list
110761001|NCT05179005|Cholinergic Agents|cholinergic agents|mesh-ancestor
110761002|NCT05179005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110761003|NCT05179005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110761004|NCT05179005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110761005|NCT05176080|Fulvestrant|fulvestrant|mesh-list
110761006|NCT05176080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110761007|NCT05176080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110761008|NCT05176080|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110761009|NCT05176080|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110761010|NCT05176080|Hormone Antagonists|hormone antagonists|mesh-ancestor
110761011|NCT05176080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110761012|NCT05176080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110761013|NCT05165082|Timolol|timolol|mesh-list
110761014|NCT05165082|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110761015|NCT05165082|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110761016|NCT05165082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110761017|NCT05165082|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110761018|NCT05165082|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110761019|NCT05165082|Adrenergic Agents|adrenergic agents|mesh-ancestor
110761020|NCT05165082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110761021|NCT05165082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110761022|NCT05165082|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110761023|NCT05165082|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110761024|NCT05159531|Tenofovir|tenofovir|mesh-list
110761025|NCT05159531|Emtricitabine|emtricitabine|mesh-list
110761026|NCT05159531|Antiviral Agents|antiviral agents|mesh-ancestor
110761028|NCT05159531|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110761029|NCT05159531|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110761030|NCT05159531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110761031|NCT05159531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110761032|NCT05159531|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110761033|NCT05159531|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110761034|NCT05128071|Progesterone|progesterone|mesh-list
110761035|NCT05128071|Progestins|progestins|mesh-ancestor
110761036|NCT05128071|Hormones|hormones|mesh-ancestor
110761037|NCT05128071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110761038|NCT05128071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110761039|NCT05121324|Midazolam|midazolam|mesh-list
110761040|NCT05121324|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110761041|NCT05121324|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110761042|NCT05121324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110761043|NCT05121324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110761044|NCT05121324|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110761045|NCT05121324|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110761046|NCT05121324|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110761047|NCT05121324|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110761048|NCT05121324|Anesthetics, General|anesthetics, general|mesh-ancestor
110761049|NCT05121324|Anesthetics|anesthetics|mesh-ancestor
110761051|NCT05121324|GABA Agents|gaba agents|mesh-ancestor
110761052|NCT05121324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110761053|NCT05121324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110761054|NCT05118672|Acetaminophen|acetaminophen|mesh-list
110761055|NCT05118672|Fexofenadine|fexofenadine|mesh-list
110761056|NCT05118672|Phenylephrine|phenylephrine|mesh-list
110761057|NCT05118672|Oxymetazoline|oxymetazoline|mesh-list
110761058|NCT05118672|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110761059|NCT05118672|Analgesics|analgesics|mesh-ancestor
110761060|NCT05118672|Sensory System Agents|sensory system agents|mesh-ancestor
110761061|NCT05118672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110761062|NCT05118672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110761063|NCT05118672|Antipyretics|antipyretics|mesh-ancestor
110761064|NCT05118672|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110761065|NCT05118672|Mydriatics|mydriatics|mesh-ancestor
110761066|NCT05118672|Autonomic Agents|autonomic agents|mesh-ancestor
110761067|NCT05118672|Sympathomimetics|sympathomimetics|mesh-ancestor
110761068|NCT05118672|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110761069|NCT05118672|Nasal Decongestants|nasal decongestants|mesh-ancestor
110761070|NCT05118672|Respiratory System Agents|respiratory system agents|mesh-ancestor
110761071|NCT05118672|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110761072|NCT05118672|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110761073|NCT05118672|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110761074|NCT05118672|Adrenergic Agents|adrenergic agents|mesh-ancestor
110761075|NCT05118672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110761076|NCT05118672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110761077|NCT05118672|Protective Agents|protective agents|mesh-ancestor
110761078|NCT05118672|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110761079|NCT05118672|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110761080|NCT05118672|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110761081|NCT05118672|Histamine Antagonists|histamine antagonists|mesh-ancestor
110761082|NCT05118672|Histamine Agents|histamine agents|mesh-ancestor
110761083|NCT05114096|Betamethasone|betamethasone|mesh-list
110761084|NCT05114096|Betamethasone Valerate|betamethasone valerate|mesh-list
110761085|NCT05114096|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
110761086|NCT05114096|Betamethasone benzoate|betamethasone benzoate|mesh-list
110761087|NCT05114096|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
110761088|NCT05114096|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110761089|NCT05114096|Glucocorticoids|glucocorticoids|mesh-ancestor
110761090|NCT05114096|Hormones|hormones|mesh-ancestor
110761091|NCT05114096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110761092|NCT05114096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110761093|NCT05114096|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110761094|NCT05114096|Respiratory System Agents|respiratory system agents|mesh-ancestor
110761095|NCT05109611|Nitric Oxide|nitric oxide|mesh-list
110761096|NCT05109611|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110761097|NCT05109611|Autonomic Agents|autonomic agents|mesh-ancestor
110761098|NCT05109611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110761099|NCT05109611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110761100|NCT05109611|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110761101|NCT05109611|Respiratory System Agents|respiratory system agents|mesh-ancestor
110761102|NCT05109611|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110761103|NCT05109611|Antioxidants|antioxidants|mesh-ancestor
110761104|NCT05109611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110761105|NCT05109611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110761106|NCT05109611|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
110761107|NCT05109611|Vasodilator Agents|vasodilator agents|mesh-ancestor
110761108|NCT05109611|Gasotransmitters|gasotransmitters|mesh-ancestor
110761109|NCT05109611|Protective Agents|protective agents|mesh-ancestor
110761110|NCT05106153|Zolpidem|zolpidem|mesh-list
110761111|NCT05106153|Suvorexant|suvorexant|mesh-list
110761112|NCT05106153|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110761113|NCT05106153|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110761114|NCT05106153|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110761115|NCT05106153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110761116|NCT05106153|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
110761117|NCT05106153|GABA Agonists|gaba agonists|mesh-ancestor
110761118|NCT05106153|GABA Agents|gaba agents|mesh-ancestor
110761119|NCT05106153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110761120|NCT05106153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110761121|NCT05106153|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
110761122|NCT05102591|Ketorolac|ketorolac|mesh-list
110761123|NCT05102591|Metoclopramide|metoclopramide|mesh-list
110761124|NCT05102591|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110761125|NCT05102591|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110761126|NCT05102591|Analgesics|analgesics|mesh-ancestor
110761127|NCT05102591|Sensory System Agents|sensory system agents|mesh-ancestor
110761128|NCT05102591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110761129|NCT05102591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110761130|NCT05102591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110761131|NCT05102591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110761132|NCT05102591|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110761133|NCT05102591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110761134|NCT05102591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110761135|NCT05102591|Antiemetics|antiemetics|mesh-ancestor
110761136|NCT05102591|Autonomic Agents|autonomic agents|mesh-ancestor
110761137|NCT05102591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110761138|NCT05102591|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110761139|NCT05102591|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110761140|NCT05102591|Dopamine Agents|dopamine agents|mesh-ancestor
110478843|NCT02604784|Cisplatin|cisplatin|mesh-list
110761141|NCT05102591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110761142|NCT05097326|Misoprostol|misoprostol|mesh-list
110761143|NCT05097326|Mifepristone|mifepristone|mesh-list
110761144|NCT05097326|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110761145|NCT05097326|Abortifacient Agents|abortifacient agents|mesh-ancestor
110761146|NCT05097326|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110761147|NCT05097326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110761148|NCT05097326|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110761149|NCT05097326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110761150|NCT05097326|Oxytocics|oxytocics|mesh-ancestor
110761151|NCT05097326|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
110761152|NCT05097326|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110761153|NCT05097326|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110761154|NCT05097326|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110761155|NCT05097326|Contraceptive Agents|contraceptive agents|mesh-ancestor
110761156|NCT05097326|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
110761157|NCT05097326|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
110761158|NCT05097326|Hormone Antagonists|hormone antagonists|mesh-ancestor
110761159|NCT05097326|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110761160|NCT05097326|Luteolytic Agents|luteolytic agents|mesh-ancestor
110761161|NCT05097326|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110761162|NCT05097326|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
110761163|NCT05081492|Antibodies|antibodies|mesh-list
110761164|NCT05081492|Immunoglobulins|immunoglobulins|mesh-list
110761165|NCT05081492|Immunologic Factors|immunologic factors|mesh-ancestor
110761166|NCT05081492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110761167|NCT05081102|Ibuprofen|ibuprofen|mesh-list
110761168|NCT05081102|Oxycodone|oxycodone|mesh-list
110761169|NCT05081102|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110761170|NCT05081102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110761171|NCT05081102|Analgesics|analgesics|mesh-ancestor
110761172|NCT05081102|Sensory System Agents|sensory system agents|mesh-ancestor
110761173|NCT05081102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110761174|NCT05081102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110761175|NCT05081102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110869135|NCT03171610|Fentanyl|fentanyl|mesh-list
110761176|NCT05081102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110761177|NCT05081102|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110761178|NCT05081102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110761179|NCT05081102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110761180|NCT05081102|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110761181|NCT05081102|Narcotics|narcotics|mesh-ancestor
110761182|NCT05081102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110761184|NCT05074992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110761185|NCT05074992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110761186|NCT05074992|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110761187|NCT05074992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110761188|NCT05070403|Afatinib|afatinib|mesh-list
110761189|NCT05070403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110761190|NCT05070403|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110761191|NCT05070403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110761192|NCT05070403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110761193|NCT05063656|Gabapentin|gabapentin|mesh-list
110761194|NCT05063656|Analgesics|analgesics|mesh-ancestor
110761195|NCT05063656|Sensory System Agents|sensory system agents|mesh-ancestor
110761196|NCT05063656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110761197|NCT05063656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110761198|NCT05063656|Anticonvulsants|anticonvulsants|mesh-ancestor
110761199|NCT05063656|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110761200|NCT05063656|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110761201|NCT05063656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110314127|NCT00305396|Sirolimus|sirolimus|mesh-list
110761202|NCT05063656|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110761203|NCT05063656|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110761204|NCT05063656|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110761205|NCT05063656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110761206|NCT05063656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110761207|NCT05063656|Antimanic Agents|antimanic agents|mesh-ancestor
110761208|NCT05060237|Aminolevulinic Acid|aminolevulinic acid|mesh-list
110761209|NCT05060237|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110761210|NCT05060237|Dermatologic Agents|dermatologic agents|mesh-ancestor
110761211|NCT05047601|Ritonavir|ritonavir|mesh-list
110761212|NCT05047601|Nirmatrelvir|nirmatrelvir|mesh-list
110761213|NCT05047601|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110761214|NCT05047601|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110478923|NCT05257213|Heparin|heparin|mesh-list
110761215|NCT05047601|Protease Inhibitors|protease inhibitors|mesh-ancestor
110761216|NCT05047601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110445489|NCT01193348|Eculizumab|eculizumab|mesh-list
110761217|NCT05047601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110761218|NCT05047601|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110761219|NCT05047601|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110761220|NCT05047601|Antiviral Agents|antiviral agents|mesh-ancestor
110761221|NCT05047601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110761222|NCT05047601|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110761223|NCT05047601|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110761224|NCT05043506|Palbociclib|palbociclib|mesh-list
110761225|NCT05043506|Aromatase Inhibitors|aromatase inhibitors|mesh-list
110761226|NCT05043506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110761227|NCT05043506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110761228|NCT05043506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110761229|NCT05043506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110761230|NCT05043506|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110761231|NCT05043506|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110761232|NCT05043506|Hormone Antagonists|hormone antagonists|mesh-ancestor
110761233|NCT05043506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110761234|NCT05043506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110761235|NCT05022329|Vaccines|vaccines|mesh-list
110761236|NCT05022329|Immunologic Factors|immunologic factors|mesh-ancestor
110761237|NCT05022329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110761238|NCT05012371|Everolimus|everolimus|mesh-list
110761239|NCT05012371|Lenvatinib|lenvatinib|mesh-list
110761240|NCT05012371|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110761241|NCT05012371|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110869148|NCT01364181|Udenafil|udenafil|mesh-list
110761242|NCT05012371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110761243|NCT05012371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110761244|NCT05012371|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110761245|NCT05012371|Immunologic Factors|immunologic factors|mesh-ancestor
110761246|NCT05012371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110761247|NCT05012371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110761248|NCT05011760|Amphetamine|amphetamine|mesh-list
110761249|NCT05011760|Dextroamphetamine|dextroamphetamine|mesh-list
110761250|NCT05011760|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110761251|NCT05011760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110761252|NCT05011760|Sympathomimetics|sympathomimetics|mesh-ancestor
110761253|NCT05011760|Autonomic Agents|autonomic agents|mesh-ancestor
110761254|NCT05011760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110761255|NCT05011760|Dopamine Agents|dopamine agents|mesh-ancestor
110761256|NCT05011760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110761257|NCT05011760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110761258|NCT05011760|Adrenergic Agents|adrenergic agents|mesh-ancestor
110761259|NCT05011760|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110761260|NCT05011760|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110314153|NCT00329511|Clonidine|clonidine|mesh-list
110761261|NCT05011760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110761262|NCT05011760|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110761263|NCT05008146|Hydrocortisone|hydrocortisone|mesh-list
110761264|NCT05008146|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
110761265|NCT05008146|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
110761266|NCT05008146|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
110761267|NCT05008146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110761269|NCT05006599|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110761270|NCT05006599|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110761271|NCT05006599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110761272|NCT04998669|Rituximab|rituximab|mesh-list
110761273|NCT04998669|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
110761274|NCT04998669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110761275|NCT04998669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110761276|NCT04998669|Immunologic Factors|immunologic factors|mesh-ancestor
110761277|NCT04998669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110761278|NCT04998669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110761279|NCT04998604|Omalizumab|omalizumab|mesh-list
110761280|NCT04998604|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110761281|NCT04998604|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110761282|NCT04998604|Respiratory System Agents|respiratory system agents|mesh-ancestor
110761283|NCT04996030|Arsenic Trioxide|arsenic trioxide|mesh-list
110761284|NCT04996030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110478994|NCT00793624|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110761285|NCT04978545|Chlorhexidine|chlorhexidine|mesh-list
110761286|NCT04978545|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110761287|NCT04978545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110761289|NCT04972292|Dipyrone|dipyrone|mesh-list
110761290|NCT04972292|Codeine|codeine|mesh-list
110761291|NCT04972292|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110761292|NCT04972292|Narcotics|narcotics|mesh-ancestor
110761293|NCT04972292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110761294|NCT04972292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110761295|NCT04972292|Analgesics|analgesics|mesh-ancestor
110761296|NCT04972292|Sensory System Agents|sensory system agents|mesh-ancestor
110761297|NCT04972292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110761298|NCT04972292|Antitussive Agents|antitussive agents|mesh-ancestor
110761299|NCT04972292|Respiratory System Agents|respiratory system agents|mesh-ancestor
110761300|NCT04972292|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110761301|NCT04972292|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110761302|NCT04972292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110761303|NCT04972292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110761304|NCT04972292|Antipyretics|antipyretics|mesh-ancestor
110761305|NCT04958811|Bevacizumab|bevacizumab|mesh-list
110761306|NCT04958811|Atezolizumab|atezolizumab|mesh-list
110761307|NCT04958811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110761308|NCT04958811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110761309|NCT04958811|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110761310|NCT04958811|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110761311|NCT04958811|Growth Substances|growth substances|mesh-ancestor
110761312|NCT04958811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110761313|NCT04958811|Growth Inhibitors|growth inhibitors|mesh-ancestor
110761314|NCT04958811|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110761315|NCT04958811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110761316|NCT04950530|Emtricitabine|emtricitabine|mesh-list
110761317|NCT04950530|Antiviral Agents|antiviral agents|mesh-ancestor
110761318|NCT04950530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110761319|NCT04950530|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110761320|NCT04950530|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110761321|NCT04950530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110761322|NCT04950530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110761323|NCT04950530|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110761324|NCT04950530|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110761325|NCT04937699|Aspirin|aspirin|mesh-list
110761326|NCT04937699|Clopidogrel|clopidogrel|mesh-list
110761327|NCT04937699|Ticagrelor|ticagrelor|mesh-list
110761328|NCT04937699|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110761329|NCT04937699|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110761330|NCT04937699|Analgesics|analgesics|mesh-ancestor
110761331|NCT04937699|Sensory System Agents|sensory system agents|mesh-ancestor
110761332|NCT04937699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110761333|NCT04937699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110761334|NCT04937699|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110761335|NCT04937699|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110761336|NCT04937699|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110761337|NCT04937699|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110761338|NCT04937699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110761339|NCT04937699|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110761340|NCT04937699|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110761341|NCT04937699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110761342|NCT04937699|Antipyretics|antipyretics|mesh-ancestor
110761343|NCT04937699|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110761344|NCT04937699|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110761345|NCT04937699|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110761346|NCT04937699|Purinergic Agents|purinergic agents|mesh-ancestor
110761347|NCT04937699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110761348|NCT04925375|Abatacept|abatacept|mesh-list
110761349|NCT04925375|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110761350|NCT04925375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110761351|NCT04925375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110761352|NCT04925375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110761353|NCT04925375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110761354|NCT04925375|Immunologic Factors|immunologic factors|mesh-ancestor
110761355|NCT04925375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110761356|NCT04925375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110761357|NCT04920708|Fulvestrant|fulvestrant|mesh-list
110761358|NCT04920708|Palbociclib|palbociclib|mesh-list
110761359|NCT04920708|Ipatasertib|ipatasertib|mesh-list
110479072|NCT00798304|Vaccines|vaccines|mesh-list
110761360|NCT04920708|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110761361|NCT04920708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110761362|NCT04920708|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110761363|NCT04920708|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110761364|NCT04920708|Hormone Antagonists|hormone antagonists|mesh-ancestor
110761365|NCT04920708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110761366|NCT04920708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110761367|NCT04920708|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110761368|NCT04920708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110761369|NCT04920708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110761371|NCT04908956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110761372|NCT04908956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110761373|NCT04908956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110761374|NCT04908956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110761375|NCT04891068|Azacitidine|azacitidine|mesh-list
110314172|NCT00305513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110761376|NCT04891068|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110761377|NCT04891068|Antimetabolites|antimetabolites|mesh-ancestor
110761378|NCT04891068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110761379|NCT04891068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110761380|NCT04891068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110761381|NCT04889716|Obinutuzumab|obinutuzumab|mesh-list
110761382|NCT04889716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110761383|NCT04889716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110761384|NCT04880499|Folic Acid|folic acid|mesh-list
110761385|NCT04880499|Riboflavin|riboflavin|mesh-list
110761386|NCT04880499|Vitamins|vitamins|mesh-ancestor
110761387|NCT04880499|Micronutrients|micronutrients|mesh-ancestor
110761388|NCT04880499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110761389|NCT04880499|Hematinics|hematinics|mesh-ancestor
110761390|NCT04880499|Vitamin B Complex|vitamin b complex|mesh-ancestor
110761391|NCT04880499|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110761392|NCT04880499|Dermatologic Agents|dermatologic agents|mesh-ancestor
110761393|NCT04853719|Rivaroxaban|rivaroxaban|mesh-list
110761394|NCT04853719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110761395|NCT04853719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110761396|NCT04853719|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110761397|NCT04853719|Antithrombins|antithrombins|mesh-ancestor
110761398|NCT04853719|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110761399|NCT04853719|Protease Inhibitors|protease inhibitors|mesh-ancestor
110761400|NCT04853719|Anticoagulants|anticoagulants|mesh-ancestor
110761401|NCT04852484|Ketamine|ketamine|mesh-list
110761402|NCT04852484|Morphine|morphine|mesh-list
110761403|NCT04852484|Anesthetics|anesthetics|mesh-list
110761404|NCT04852484|Anesthetics, Local|anesthetics, local|mesh-list
110761405|NCT04852484|Analgesics|analgesics|mesh-ancestor
110761406|NCT04852484|Sensory System Agents|sensory system agents|mesh-ancestor
110761407|NCT04852484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110761408|NCT04852484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110761409|NCT04852484|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110761410|NCT04852484|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110761411|NCT04852484|Anesthetics, General|anesthetics, general|mesh-ancestor
110761412|NCT04852484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110761413|NCT04852484|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110761414|NCT04852484|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110761415|NCT04852484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110761416|NCT04852484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110761417|NCT04852484|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110761418|NCT04852484|Narcotics|narcotics|mesh-ancestor
110761419|NCT04838223|Proxymetacaine|proxymetacaine|mesh-list
110761420|NCT04838223|Anesthetics, Local|anesthetics, local|mesh-ancestor
110761421|NCT04838223|Anesthetics|anesthetics|mesh-ancestor
110761422|NCT04838223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110761423|NCT04838223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110761424|NCT04838223|Sensory System Agents|sensory system agents|mesh-ancestor
110761425|NCT04838223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110761426|NCT04829604|Immunoconjugates|immunoconjugates|mesh-list
110761427|NCT04829604|Immunologic Factors|immunologic factors|mesh-ancestor
110869185|NCT02414776|Hydroxychloroquine|hydroxychloroquine|mesh-list
110761428|NCT04829604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110761429|NCT04827147|Methamphetamine|methamphetamine|mesh-list
110761430|NCT04827147|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110761431|NCT04827147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110761432|NCT04827147|Sympathomimetics|sympathomimetics|mesh-ancestor
110761433|NCT04827147|Autonomic Agents|autonomic agents|mesh-ancestor
110761434|NCT04827147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110761435|NCT04827147|Dopamine Agents|dopamine agents|mesh-ancestor
110761437|NCT04827147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110761438|NCT04827147|Adrenergic Agents|adrenergic agents|mesh-ancestor
110761439|NCT04827147|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110761440|NCT04827147|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110761441|NCT04827147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110761442|NCT04827147|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110761443|NCT04786873|Clonidine|clonidine|mesh-list
110761444|NCT04786873|Analgesics|analgesics|mesh-ancestor
110761445|NCT04786873|Sensory System Agents|sensory system agents|mesh-ancestor
110761446|NCT04786873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110761447|NCT04786873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110761448|NCT04786873|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110761449|NCT04786873|Sympatholytics|sympatholytics|mesh-ancestor
110761450|NCT04786873|Autonomic Agents|autonomic agents|mesh-ancestor
110761451|NCT04786873|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110761452|NCT04786873|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110761453|NCT04786873|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110761454|NCT04786873|Adrenergic Agents|adrenergic agents|mesh-ancestor
110761455|NCT04786873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110761456|NCT04786873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110761457|NCT04781881|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
110761458|NCT04781881|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110761459|NCT04781881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110761460|NCT04771728|Metronidazole|metronidazole|mesh-list
110761461|NCT04771728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110761462|NCT04771728|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110761463|NCT04771728|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110761464|NCT04771728|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110761465|NCT04767074|Phenylpropanolamine|phenylpropanolamine|mesh-list
110761466|NCT04767074|Guaifenesin|guaifenesin|mesh-list
110761467|NCT04767074|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
110761468|NCT04767074|Expectorants|expectorants|mesh-ancestor
110761469|NCT04767074|Respiratory System Agents|respiratory system agents|mesh-ancestor
110761470|NCT04767074|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110761471|NCT04767074|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110761472|NCT04767074|Adrenergic Agents|adrenergic agents|mesh-ancestor
110761473|NCT04767074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110761474|NCT04767074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110761475|NCT04767074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110761476|NCT04767074|Appetite Depressants|appetite depressants|mesh-ancestor
110761477|NCT04767074|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110761478|NCT04767074|Sympathomimetics|sympathomimetics|mesh-ancestor
110761479|NCT04767074|Autonomic Agents|autonomic agents|mesh-ancestor
110761480|NCT04767074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110314217|NCT00305630|Hormones|hormones|mesh-ancestor
110761481|NCT04767074|Nasal Decongestants|nasal decongestants|mesh-ancestor
110761482|NCT04767074|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110761483|NCT04764942|Dexamethasone|dexamethasone|mesh-list
110761484|NCT04764942|Dexamethasone acetate|dexamethasone acetate|mesh-list
110761485|NCT04764942|Pomalidomide|pomalidomide|mesh-list
110761486|NCT04764942|Ichthammol|ichthammol|mesh-list
110761487|NCT04764942|BB 1101|bb 1101|mesh-list
110761488|NCT04764942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110761489|NCT04764942|Antiemetics|antiemetics|mesh-ancestor
110761490|NCT04764942|Autonomic Agents|autonomic agents|mesh-ancestor
110761491|NCT04764942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110761492|NCT04764942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110761493|NCT04764942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110761494|NCT04764942|Glucocorticoids|glucocorticoids|mesh-ancestor
110761495|NCT04764942|Hormones|hormones|mesh-ancestor
110761496|NCT04764942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110761497|NCT04764942|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110761498|NCT04764942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110761499|NCT04764942|Protease Inhibitors|protease inhibitors|mesh-ancestor
110761500|NCT04764942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110761501|NCT04764942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110761502|NCT04764942|Immunologic Factors|immunologic factors|mesh-ancestor
110761503|NCT04764942|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110761504|NCT04764942|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110761505|NCT04764942|Growth Substances|growth substances|mesh-ancestor
110761506|NCT04764942|Growth Inhibitors|growth inhibitors|mesh-ancestor
110761507|NCT04764942|Dermatologic Agents|dermatologic agents|mesh-ancestor
110761508|NCT04761614|Calcium, Dietary|calcium, dietary|mesh-list
110761509|NCT04761614|Leucovorin|leucovorin|mesh-list
110761510|NCT04761614|Folic Acid|folic acid|mesh-list
110761511|NCT04761614|Bevacizumab|bevacizumab|mesh-list
110761512|NCT04761614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110761513|NCT04761614|Fluorouracil|fluorouracil|mesh-list
110761514|NCT04761614|Oxaliplatin|oxaliplatin|mesh-list
110761515|NCT04761614|Riluzole|riluzole|mesh-list
110761516|NCT04761614|Endothelial Growth Factors|endothelial growth factors|mesh-list
110761517|NCT04761614|Antibodies|antibodies|mesh-list
110761518|NCT04761614|Immunoglobulins|immunoglobulins|mesh-list
110761519|NCT04761614|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110761520|NCT04761614|Immunoglobulin G|immunoglobulin g|mesh-list
110761521|NCT04761614|Calcium|calcium|mesh-list
110682837|NCT00902915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110682838|NCT00902915|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110682839|NCT00902915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110682840|NCT00902915|Immunologic Factors|immunologic factors|mesh-ancestor
110682841|NCT00902915|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110682842|NCT00902915|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110682843|NCT00902915|Growth Substances|growth substances|mesh-ancestor
110682844|NCT00902915|Growth Inhibitors|growth inhibitors|mesh-ancestor
110682845|NCT04034771|Propofol|propofol|mesh-list
110682846|NCT04034771|Melatonin|melatonin|mesh-list
110682847|NCT04034771|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110682848|NCT04034771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110682849|NCT04034771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110682850|NCT04034771|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110682851|NCT04034771|Anesthetics, General|anesthetics, general|mesh-ancestor
110682852|NCT04034771|Anesthetics|anesthetics|mesh-ancestor
110682853|NCT04034771|Antioxidants|antioxidants|mesh-ancestor
110682854|NCT04034771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110682855|NCT04034771|Protective Agents|protective agents|mesh-ancestor
110682856|NCT00899483|Insulin|insulin|mesh-list
110682857|NCT00899483|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110682858|NCT00899483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110682859|NCT02539199|Misoprostol|misoprostol|mesh-list
110682860|NCT02539199|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110682861|NCT02539199|Abortifacient Agents|abortifacient agents|mesh-ancestor
110682862|NCT02539199|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110682863|NCT02539199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110682864|NCT02539199|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110682865|NCT02539199|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110682866|NCT02539199|Oxytocics|oxytocics|mesh-ancestor
110682867|NCT00903227|Fluticasone|fluticasone|mesh-list
110682868|NCT00903227|Xhance|xhance|mesh-list
110682869|NCT00903227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110682870|NCT00903227|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110869197|NCT04482712|Sirolimus|sirolimus|mesh-list
110682871|NCT00903227|Autonomic Agents|autonomic agents|mesh-ancestor
110682872|NCT00903227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110682873|NCT00903227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110682874|NCT00903227|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110682875|NCT00903227|Respiratory System Agents|respiratory system agents|mesh-ancestor
110682876|NCT00903227|Dermatologic Agents|dermatologic agents|mesh-ancestor
110682877|NCT00903227|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110682878|NCT00605657|Valproic Acid|valproic acid|mesh-list
110682879|NCT00605657|Anticonvulsants|anticonvulsants|mesh-ancestor
110682880|NCT00605657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110682881|NCT00605657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110682882|NCT00605657|GABA Agents|gaba agents|mesh-ancestor
110682883|NCT00605657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110682884|NCT00605657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110682885|NCT00605657|Antimanic Agents|antimanic agents|mesh-ancestor
110682886|NCT00605657|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110682887|NCT00605657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110682888|NCT00605657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110682889|NCT00899951|Fentanyl|fentanyl|mesh-list
110682890|NCT00899951|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110682891|NCT00899951|Narcotics|narcotics|mesh-ancestor
110682892|NCT00899951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110682893|NCT00899951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110682894|NCT00899951|Analgesics|analgesics|mesh-ancestor
110682895|NCT00899951|Sensory System Agents|sensory system agents|mesh-ancestor
110682896|NCT00899951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110682897|NCT00899951|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110682898|NCT00899951|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110479289|NCT04083625|Oxytocics|oxytocics|mesh-ancestor
110761522|NCT04761614|Levoleucovorin|levoleucovorin|mesh-list
110445496|NCT00945321|Antiemetics|antiemetics|mesh-ancestor
110761524|NCT04761614|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110761525|NCT04761614|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110761526|NCT04761614|Growth Substances|growth substances|mesh-ancestor
110761527|NCT04761614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110761528|NCT04761614|Growth Inhibitors|growth inhibitors|mesh-ancestor
110761529|NCT04761614|Immunologic Factors|immunologic factors|mesh-ancestor
110761530|NCT04761614|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110761531|NCT04761614|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110761532|NCT04761614|Antimetabolites|antimetabolites|mesh-ancestor
110761533|NCT04761614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110761534|NCT04761614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110761535|NCT04761614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110761536|NCT04761614|Antidotes|antidotes|mesh-ancestor
110761537|NCT04761614|Protective Agents|protective agents|mesh-ancestor
110761538|NCT04761614|Vitamin B Complex|vitamin b complex|mesh-ancestor
110761539|NCT04761614|Vitamins|vitamins|mesh-ancestor
110761540|NCT04761614|Micronutrients|micronutrients|mesh-ancestor
110761541|NCT04761614|Hematinics|hematinics|mesh-ancestor
110761542|NCT04761614|Anticonvulsants|anticonvulsants|mesh-ancestor
110761543|NCT04761614|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110761544|NCT04761614|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110761545|NCT04761614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110761546|NCT04761614|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110761547|NCT04760860|Prazosin|prazosin|mesh-list
110761548|NCT04760860|Terazosin|terazosin|mesh-list
110761549|NCT04760860|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110761550|NCT04760860|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110761551|NCT04760860|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110761552|NCT04760860|Adrenergic Agents|adrenergic agents|mesh-ancestor
110761553|NCT04760860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110761554|NCT04760860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110761555|NCT04760860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110761556|NCT04760860|Urological Agents|urological agents|mesh-ancestor
110761557|NCT04760860|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110761558|NCT04710199|Maraviroc|maraviroc|mesh-list
110761559|NCT04710199|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110761560|NCT04710199|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110761561|NCT04710199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110761562|NCT04710199|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110761563|NCT04710199|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110761564|NCT04710199|Antiviral Agents|antiviral agents|mesh-ancestor
110761565|NCT04710199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110761566|NCT04710199|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
110761567|NCT04700176|Dexamethasone|dexamethasone|mesh-list
110761568|NCT04700176|Daratumumab|daratumumab|mesh-list
110761569|NCT04700176|Pomalidomide|pomalidomide|mesh-list
110761570|NCT04700176|Tretinoin|tretinoin|mesh-list
110761571|NCT04700176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110761572|NCT04700176|Antiemetics|antiemetics|mesh-ancestor
110761573|NCT04700176|Autonomic Agents|autonomic agents|mesh-ancestor
110761574|NCT04700176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110761575|NCT04700176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110761576|NCT04700176|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110761577|NCT04700176|Glucocorticoids|glucocorticoids|mesh-ancestor
110761578|NCT04700176|Hormones|hormones|mesh-ancestor
110761579|NCT04700176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110761580|NCT04700176|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110761581|NCT04700176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110761582|NCT04700176|Immunologic Factors|immunologic factors|mesh-ancestor
110761583|NCT04700176|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110761584|NCT04700176|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110761585|NCT04700176|Growth Substances|growth substances|mesh-ancestor
110761586|NCT04700176|Growth Inhibitors|growth inhibitors|mesh-ancestor
110761587|NCT04700176|Keratolytic Agents|keratolytic agents|mesh-ancestor
110761588|NCT04700176|Dermatologic Agents|dermatologic agents|mesh-ancestor
110761589|NCT04699240|Clotrimazole|clotrimazole|mesh-list
110761590|NCT04699240|Miconazole|miconazole|mesh-list
110761591|NCT04699240|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110761592|NCT04699240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110761593|NCT04699240|Antifungal Agents|antifungal agents|mesh-ancestor
110761594|NCT04699240|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110761595|NCT04699240|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110761596|NCT04699240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110761597|NCT04699240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110761609|NCT04688658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110761610|NCT04688658|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110761611|NCT04688658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110761612|NCT04666454|Adenosine|adenosine|mesh-list
110761613|NCT04666454|Dipyridamole|dipyridamole|mesh-list
110761614|NCT04666454|Apixaban|apixaban|mesh-list
110761615|NCT04666454|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110761616|NCT04666454|Antithrombins|antithrombins|mesh-ancestor
110761617|NCT04666454|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110761618|NCT04666454|Protease Inhibitors|protease inhibitors|mesh-ancestor
110761619|NCT04666454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110761620|NCT04666454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110761621|NCT04666454|Anticoagulants|anticoagulants|mesh-ancestor
110761622|NCT04666454|Analgesics|analgesics|mesh-ancestor
110761623|NCT04666454|Sensory System Agents|sensory system agents|mesh-ancestor
110761624|NCT04666454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110761625|NCT04666454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110761626|NCT04666454|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110761627|NCT04666454|Vasodilator Agents|vasodilator agents|mesh-ancestor
110761628|NCT04666454|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
110761629|NCT04666454|Purinergic Agonists|purinergic agonists|mesh-ancestor
110761630|NCT04666454|Purinergic Agents|purinergic agents|mesh-ancestor
110761631|NCT04666454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110761632|NCT04666454|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110761633|NCT04666454|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110761645|NCT04658784|Cyclopropane|cyclopropane|mesh-list
110761646|NCT04658784|Anesthetics|anesthetics|mesh-ancestor
110761647|NCT04658784|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110761648|NCT04658784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110761649|NCT04657640|Iron|iron|mesh-list
110761650|NCT04657640|Trace Elements|trace elements|mesh-list
110761651|NCT04657640|Folic Acid|folic acid|mesh-list
110761652|NCT04657640|Micronutrients|micronutrients|mesh-list
110761653|NCT04657640|Vitamin B Complex|vitamin b complex|mesh-list
110761654|NCT04657640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110761655|NCT04657640|Hematinics|hematinics|mesh-ancestor
110761656|NCT04657640|Vitamins|vitamins|mesh-ancestor
110761657|NCT04622813|Acetaminophen|acetaminophen|mesh-list
110761658|NCT04622813|Ketoprofen|ketoprofen|mesh-list
110761659|NCT04622813|Nefopam|nefopam|mesh-list
110761660|NCT04622813|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110761661|NCT04622813|Analgesics|analgesics|mesh-ancestor
110314289|NCT00333294|Gefitinib|gefitinib|mesh-list
110761662|NCT04622813|Sensory System Agents|sensory system agents|mesh-ancestor
110761663|NCT04622813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110761664|NCT04622813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110761665|NCT04622813|Antipyretics|antipyretics|mesh-ancestor
110761666|NCT04622813|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110761667|NCT04622813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110761668|NCT04622813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110761669|NCT04622813|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110761670|NCT04622813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110761671|NCT04622813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110761672|NCT04616963|Tenofovir|tenofovir|mesh-list
110761673|NCT04616963|Emtricitabine|emtricitabine|mesh-list
110761674|NCT04616963|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
110761675|NCT04616963|Antiviral Agents|antiviral agents|mesh-ancestor
110761676|NCT04616963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110761677|NCT04616963|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110761678|NCT04616963|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110761679|NCT04616963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110761680|NCT04616963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110761681|NCT04616963|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110761682|NCT04616963|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110761683|NCT04606394|Albuterol|albuterol|mesh-list
110761684|NCT04606394|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110761685|NCT04606394|Autonomic Agents|autonomic agents|mesh-ancestor
110761686|NCT04606394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110761687|NCT04606394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110761688|NCT04606394|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110761689|NCT04606394|Respiratory System Agents|respiratory system agents|mesh-ancestor
110761690|NCT04606394|Tocolytic Agents|tocolytic agents|mesh-ancestor
110761691|NCT04606394|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110761692|NCT04606394|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110761693|NCT04606394|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110761694|NCT04606394|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110761695|NCT04606394|Adrenergic Agents|adrenergic agents|mesh-ancestor
110761696|NCT04606394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110761697|NCT04606394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110761698|NCT04588545|Trastuzumab|trastuzumab|mesh-list
110761699|NCT04588545|Pertuzumab|pertuzumab|mesh-list
110761700|NCT04588545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110761701|NCT04588545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110761702|NCT04586088|Apatinib|apatinib|mesh-list
110761703|NCT04586088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110761704|NCT04586088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110761705|NCT04586088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110761706|NCT04586088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110761707|NCT04579523|Cyclophosphamide|cyclophosphamide|mesh-list
110761708|NCT04579523|Fludarabine|fludarabine|mesh-list
110761709|NCT04579523|Fludarabine phosphate|fludarabine phosphate|mesh-list
110761710|NCT04579523|Daratumumab|daratumumab|mesh-list
110761711|NCT04579523|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110761712|NCT04579523|Antibodies|antibodies|mesh-list
110761713|NCT04579523|Immunoglobulins|immunoglobulins|mesh-list
110761714|NCT04579523|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110761715|NCT04579523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110761716|NCT04579523|Immunologic Factors|immunologic factors|mesh-ancestor
110761717|NCT04579523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110761718|NCT04579523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110761719|NCT04579523|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110761720|NCT04579523|Alkylating Agents|alkylating agents|mesh-ancestor
110761721|NCT04579523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110761722|NCT04579523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110761723|NCT04579523|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110761724|NCT04579523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110761725|NCT04579523|Antimetabolites|antimetabolites|mesh-ancestor
110761726|NCT04579510|Vaccines|vaccines|mesh-list
110761727|NCT04579510|Immunologic Factors|immunologic factors|mesh-ancestor
110761728|NCT04579510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110761730|NCT04579120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110761731|NCT04564547|Islatravir|islatravir|mesh-list
110761732|NCT04564547|Antiviral Agents|antiviral agents|mesh-ancestor
110761733|NCT04564547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110761734|NCT04564547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110761735|NCT04564547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110761736|NCT04564547|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110761737|NCT04564547|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110761738|NCT04564547|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110761739|NCT04557735|Ravulizumab|ravulizumab|mesh-list
110761740|NCT04557735|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
110761741|NCT04557735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110761742|NCT04557735|Immunologic Factors|immunologic factors|mesh-ancestor
110761743|NCT04557735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110761744|NCT04552223|Nivolumab|nivolumab|mesh-list
110761745|NCT04552223|Relatlimab|relatlimab|mesh-list
110761746|NCT04552223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110761748|NCT04552223|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110761749|NCT04552223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110479452|NCT02604004|Lamivudine|lamivudine|mesh-list
110761750|NCT04550442|Azacitidine|azacitidine|mesh-list
110761751|NCT04550442|Venetoclax|venetoclax|mesh-list
110761752|NCT04550442|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110761753|NCT04550442|Antimetabolites|antimetabolites|mesh-ancestor
110761754|NCT04550442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110761755|NCT04550442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110761756|NCT04550442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110761757|NCT04527900|Paclitaxel|paclitaxel|mesh-list
110761758|NCT04527900|Carboplatin|carboplatin|mesh-list
110761759|NCT04527900|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110761760|NCT04527900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110761761|NCT04527900|Tubulin Modulators|tubulin modulators|mesh-ancestor
110761762|NCT04527900|Antimitotic Agents|antimitotic agents|mesh-ancestor
110761763|NCT04527900|Mitosis Modulators|mitosis modulators|mesh-ancestor
110761764|NCT04527900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110761765|NCT04549168|Lemborexant|lemborexant|mesh-list
110761766|NCT04549168|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
110761767|NCT04549168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110761768|NCT04549168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110761769|NCT04549168|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110761770|NCT04549168|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110761771|NCT04549168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110761772|NCT04549168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110761773|NCT04509050|Ivacaftor|ivacaftor|mesh-list
110761774|NCT04509050|Elexacaftor|elexacaftor|mesh-list
110761775|NCT04509050|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
110761776|NCT04509050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110761777|NCT04509050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110761778|NCT04478734|Thiamine|thiamine|mesh-list
110761779|NCT04478734|Biotin|biotin|mesh-list
110761780|NCT04478734|Vitamin B Complex|vitamin b complex|mesh-ancestor
110761781|NCT04478734|Vitamins|vitamins|mesh-ancestor
110761782|NCT04478734|Micronutrients|micronutrients|mesh-ancestor
110761783|NCT04478734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110761784|NCT04459117|Acetaminophen|acetaminophen|mesh-list
110761785|NCT04459117|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110761786|NCT04459117|Analgesics|analgesics|mesh-ancestor
110761787|NCT04459117|Sensory System Agents|sensory system agents|mesh-ancestor
110761788|NCT04459117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110761789|NCT04459117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110761790|NCT04459117|Antipyretics|antipyretics|mesh-ancestor
110761791|NCT04456439|Diphenhydramine|diphenhydramine|mesh-list
110761792|NCT04456439|Promethazine|promethazine|mesh-list
110761793|NCT04456439|Remestemcel-l|remestemcel-l|mesh-list
110761794|NCT04456439|Hydrocortisone|hydrocortisone|mesh-list
110761795|NCT04456439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110761796|NCT04456439|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110761797|NCT04456439|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110761798|NCT04456439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110761799|NCT04456439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110761800|NCT04456439|Anesthetics, Local|anesthetics, local|mesh-ancestor
110761801|NCT04456439|Anesthetics|anesthetics|mesh-ancestor
110761802|NCT04456439|Sensory System Agents|sensory system agents|mesh-ancestor
110761803|NCT04456439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110761805|NCT04456439|Autonomic Agents|autonomic agents|mesh-ancestor
110761806|NCT04456439|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110761807|NCT04456439|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110761808|NCT04456439|Histamine Antagonists|histamine antagonists|mesh-ancestor
110761809|NCT04456439|Histamine Agents|histamine agents|mesh-ancestor
110761810|NCT04456439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110761811|NCT04456439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110761812|NCT04456439|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110761813|NCT04456439|Antipruritics|antipruritics|mesh-ancestor
110761814|NCT04456439|Dermatologic Agents|dermatologic agents|mesh-ancestor
110761815|NCT04456439|Antiviral Agents|antiviral agents|mesh-ancestor
110761816|NCT04456439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110761817|NCT04445714|Dapagliflozin|dapagliflozin|mesh-list
110761818|NCT04445714|Saxagliptin|saxagliptin|mesh-list
110761819|NCT04445714|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110761820|NCT04445714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110761821|NCT04445714|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110761822|NCT04445714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110761823|NCT04445714|Incretins|incretins|mesh-ancestor
110761824|NCT04445714|Hormones|hormones|mesh-ancestor
110761825|NCT04445714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110761826|NCT04445714|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110479529|NCT02587273|Anesthetics|anesthetics|mesh-ancestor
110761827|NCT04445714|Protease Inhibitors|protease inhibitors|mesh-ancestor
110761828|NCT04445714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110761829|NCT04435704|Oxytocin|oxytocin|mesh-list
110761830|NCT04435704|Oxytocics|oxytocics|mesh-ancestor
110761831|NCT04435704|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110761832|NCT04435704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110761833|NCT04433741|Oxytocin|oxytocin|mesh-list
110761834|NCT04433741|Oxytocics|oxytocics|mesh-ancestor
110761835|NCT04433741|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110761836|NCT04433741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110761837|NCT04431700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
110761838|NCT04431206|Oxytocin|oxytocin|mesh-list
110761839|NCT04431206|Oxytocics|oxytocics|mesh-ancestor
110761840|NCT04431206|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110314351|NCT00306176|Rosiglitazone|rosiglitazone|mesh-list
110761841|NCT04431206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110761842|NCT04427709|Oxytocin|oxytocin|mesh-list
110761843|NCT04427709|Oxytocics|oxytocics|mesh-ancestor
110761844|NCT04427709|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110761845|NCT04427709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110761846|NCT04415476|Mycophenolic Acid|mycophenolic acid|mesh-list
110761847|NCT04415476|Sirolimus|sirolimus|mesh-list
110761848|NCT04415476|Prednisone|prednisone|mesh-list
110761849|NCT04415476|Tacrolimus|tacrolimus|mesh-list
110761850|NCT04415476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110761851|NCT04415476|Glucocorticoids|glucocorticoids|mesh-ancestor
110761852|NCT04415476|Hormones|hormones|mesh-ancestor
110761853|NCT04415476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110761854|NCT04415476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110761855|NCT04415476|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110761856|NCT04415476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110761857|NCT04415476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110761858|NCT04415476|Immunologic Factors|immunologic factors|mesh-ancestor
110761859|NCT04415476|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110761860|NCT04415476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110761861|NCT04415476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110761862|NCT04415476|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110761863|NCT04415476|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110761864|NCT04415476|Antitubercular Agents|antitubercular agents|mesh-ancestor
110761865|NCT04415476|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110761866|NCT04415476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110761867|NCT04415476|Antifungal Agents|antifungal agents|mesh-ancestor
110761868|NCT04389567|Famotidine|famotidine|mesh-list
110761869|NCT04389567|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110761870|NCT04389567|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110761871|NCT04389567|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110761872|NCT04389567|Histamine Antagonists|histamine antagonists|mesh-ancestor
110761873|NCT04389567|Histamine Agents|histamine agents|mesh-ancestor
110761874|NCT04389567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110761875|NCT04389567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110761876|NCT04389567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110761877|NCT04386967|Pembrolizumab|pembrolizumab|mesh-list
110761878|NCT04386967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110761879|NCT04386967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110761880|NCT04386967|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110761881|NCT04386967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110761882|NCT04384367|Naproxen|naproxen|mesh-list
110761883|NCT04384367|Rizatriptan|rizatriptan|mesh-list
110761884|NCT04384367|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110761885|NCT04384367|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110761886|NCT04384367|Analgesics|analgesics|mesh-ancestor
110761887|NCT04384367|Sensory System Agents|sensory system agents|mesh-ancestor
110761888|NCT04384367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110761889|NCT04384367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110761890|NCT04384367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110761891|NCT04384367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110761892|NCT04384367|Gout Suppressants|gout suppressants|mesh-ancestor
110761893|NCT04384367|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110761894|NCT04384367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110761895|NCT04384367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110761896|NCT04384367|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110761897|NCT04384367|Serotonin Agents|serotonin agents|mesh-ancestor
110761898|NCT04384367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110761899|NCT04378933|Methamphetamine|methamphetamine|mesh-list
110761900|NCT04378933|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110761901|NCT04378933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110761902|NCT04378933|Sympathomimetics|sympathomimetics|mesh-ancestor
110761911|NCT04378933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110761912|NCT04378933|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110761913|NCT04341259|Ipatasertib|ipatasertib|mesh-list
110761914|NCT04341259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110761915|NCT04341259|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110761916|NCT04341259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110761917|NCT04341259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110761918|NCT04341116|Plonmarlimab|plonmarlimab|mesh-list
110761919|NCT04341116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110761920|NCT04341116|Antiviral Agents|antiviral agents|mesh-ancestor
110761921|NCT04341116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110761922|NCT04335006|Paclitaxel|paclitaxel|mesh-list
110761923|NCT04335006|Apatinib|apatinib|mesh-list
110761924|NCT04335006|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110761925|NCT04335006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110761926|NCT04335006|Tubulin Modulators|tubulin modulators|mesh-ancestor
110761927|NCT04335006|Antimitotic Agents|antimitotic agents|mesh-ancestor
110761928|NCT04335006|Mitosis Modulators|mitosis modulators|mesh-ancestor
110761929|NCT04335006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110761930|NCT04335006|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110761931|NCT04335006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110761932|NCT04318548|Vaccines|vaccines|mesh-list
110761933|NCT04318548|Immunologic Factors|immunologic factors|mesh-ancestor
110761934|NCT04318548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110761935|NCT04315233|Belinostat|belinostat|mesh-list
110761936|NCT04315233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110761937|NCT04315233|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110761938|NCT04315233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110761939|NCT04315233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110761940|NCT04313088|Eluxadoline|eluxadoline|mesh-list
110761941|NCT04313088|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110761951|NCT04299373|Ethanol|ethanol|mesh-list
110761952|NCT04299373|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110761953|NCT04299373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110761954|NCT04299373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110761955|NCT04299373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110761956|NCT04292808|Methoxyflurane|methoxyflurane|mesh-list
110761957|NCT04292808|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110761958|NCT04292808|Anesthetics, General|anesthetics, general|mesh-ancestor
110761959|NCT04292808|Anesthetics|anesthetics|mesh-ancestor
110761960|NCT04292808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110761961|NCT04292808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110761962|NCT04250805|Lidocaine|lidocaine|mesh-list
110761963|NCT04250805|Ropivacaine|ropivacaine|mesh-list
110761964|NCT04250805|Anesthetics, Local|anesthetics, local|mesh-ancestor
110761965|NCT04250805|Anesthetics|anesthetics|mesh-ancestor
110761966|NCT04250805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110761967|NCT04250805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110761968|NCT04250805|Sensory System Agents|sensory system agents|mesh-ancestor
110761969|NCT04250805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110761970|NCT04250805|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110761971|NCT04250805|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110761972|NCT04250805|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110761973|NCT04250805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110761974|NCT04250805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110761975|NCT04233190|Budesonide|budesonide|mesh-list
110761976|NCT04233190|Formoterol Fumarate|formoterol fumarate|mesh-list
110479680|NCT02602444|Ticagrelor|ticagrelor|mesh-list
110761977|NCT04233190|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110761978|NCT04233190|Autonomic Agents|autonomic agents|mesh-ancestor
110761979|NCT04233190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110761980|NCT04233190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110761981|NCT04233190|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110761982|NCT04233190|Respiratory System Agents|respiratory system agents|mesh-ancestor
110761983|NCT04233190|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110761984|NCT04233190|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110761985|NCT04233190|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110761986|NCT04233190|Adrenergic Agents|adrenergic agents|mesh-ancestor
110761987|NCT04233190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110761988|NCT04233190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110761989|NCT04233190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110761990|NCT04233190|Glucocorticoids|glucocorticoids|mesh-ancestor
110761991|NCT04233190|Hormones|hormones|mesh-ancestor
110761992|NCT04233190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110761993|NCT04214834|Morphine|morphine|mesh-list
110761994|NCT04214834|Methadone|methadone|mesh-list
110761995|NCT04214834|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110761996|NCT04214834|Narcotics|narcotics|mesh-ancestor
110761997|NCT04214834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110761998|NCT04214834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110761999|NCT04214834|Analgesics|analgesics|mesh-ancestor
110762000|NCT04214834|Sensory System Agents|sensory system agents|mesh-ancestor
110762001|NCT04214834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110762002|NCT04214834|Antitussive Agents|antitussive agents|mesh-ancestor
110762003|NCT04214834|Respiratory System Agents|respiratory system agents|mesh-ancestor
110762004|NCT04161118|Tisagenlecleucel|tisagenlecleucel|mesh-list
110762005|NCT04161118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110762006|NCT04161118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110762007|NCT04134884|Talazoparib|talazoparib|mesh-list
110762008|NCT04134884|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
110762009|NCT04134884|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110762010|NCT04134884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110762011|NCT04134884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110762012|NCT04134884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110762013|NCT04134884|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110762014|NCT04134884|Antimetabolites|antimetabolites|mesh-ancestor
110762015|NCT04119037|Morphine|morphine|mesh-list
110762016|NCT04119037|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110762017|NCT04119037|Narcotics|narcotics|mesh-ancestor
110762018|NCT04119037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110762019|NCT04119037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110762020|NCT04119037|Analgesics|analgesics|mesh-ancestor
110762021|NCT04119037|Sensory System Agents|sensory system agents|mesh-ancestor
110762022|NCT04119037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110762024|NCT04071769|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110762025|NCT04071769|Anesthetics, General|anesthetics, general|mesh-ancestor
110762026|NCT04071769|Anesthetics|anesthetics|mesh-ancestor
110762027|NCT04071769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110762028|NCT04071769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110762029|NCT04052568|Psilocybin|psilocybin|mesh-list
110762030|NCT04052568|Hallucinogens|hallucinogens|mesh-ancestor
110762031|NCT04052568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110762032|NCT04052568|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110762033|NCT04050670|Tirzepatide|tirzepatide|mesh-list
110762034|NCT04050670|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110762035|NCT04050670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110762036|NCT04050670|Incretins|incretins|mesh-ancestor
110762037|NCT04050670|Hormones|hormones|mesh-ancestor
110762038|NCT04050670|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110762039|NCT04049084|Adenosine|adenosine|mesh-list
110762040|NCT04049084|Analgesics|analgesics|mesh-ancestor
110762041|NCT04049084|Sensory System Agents|sensory system agents|mesh-ancestor
110762042|NCT04049084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110762043|NCT04049084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110762044|NCT04049084|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110762045|NCT04049084|Vasodilator Agents|vasodilator agents|mesh-ancestor
110314385|NCT00330135|Hyaluronic Acid|hyaluronic acid|mesh-list
110762046|NCT04049084|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
110762047|NCT04049084|Purinergic Agonists|purinergic agonists|mesh-ancestor
110762048|NCT04049084|Purinergic Agents|purinergic agents|mesh-ancestor
110762049|NCT04049084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110762050|NCT04049084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110762051|NCT04016714|Vaccines|vaccines|mesh-list
110762095|NCT03980769|Treosulfan|treosulfan|mesh-list
110762096|NCT03980769|Busulfan|busulfan|mesh-list
110762097|NCT03980769|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110762098|NCT03980769|Thymoglobulin|thymoglobulin|mesh-list
110762099|NCT03980769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110762100|NCT03980769|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110762101|NCT03980769|Antimetabolites|antimetabolites|mesh-ancestor
110762102|NCT03980769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110762103|NCT03980769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110762104|NCT03980769|Immunologic Factors|immunologic factors|mesh-ancestor
110762105|NCT03980769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110762106|NCT03980769|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110762107|NCT03980769|Alkylating Agents|alkylating agents|mesh-ancestor
110762108|NCT03980769|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110762109|NCT03972657|Cemiplimab|cemiplimab|mesh-list
110762110|NCT03972657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110762111|NCT03972657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110762112|NCT03948243|Tolbutamide|tolbutamide|mesh-list
110762113|NCT03948243|Dextromethorphan|dextromethorphan|mesh-list
110762114|NCT03948243|Alprazolam|alprazolam|mesh-list
110762115|NCT03948243|Caffeine|caffeine|mesh-list
110762116|NCT03948243|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110762117|NCT03948243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110762118|NCT03948243|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110762119|NCT03948243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110762120|NCT03948243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110762121|NCT03948243|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110762122|NCT03948243|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110762123|NCT03948243|Purinergic Agents|purinergic agents|mesh-ancestor
110762124|NCT03948243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110762125|NCT03948243|Antitussive Agents|antitussive agents|mesh-ancestor
110762126|NCT03948243|Respiratory System Agents|respiratory system agents|mesh-ancestor
110762127|NCT03948243|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110762128|NCT03948243|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110762129|NCT03948243|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110762130|NCT03948243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110762131|NCT03948243|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110762132|NCT03948243|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110762133|NCT03948243|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110762134|NCT03948243|GABA Modulators|gaba modulators|mesh-ancestor
110762135|NCT03948243|GABA Agents|gaba agents|mesh-ancestor
110762136|NCT03948243|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110762137|NCT03948035|Dexamethasone|dexamethasone|mesh-list
110762138|NCT03948035|Dexamethasone acetate|dexamethasone acetate|mesh-list
110762139|NCT03948035|Lenalidomide|lenalidomide|mesh-list
110762141|NCT03948035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110762142|NCT03948035|Antiemetics|antiemetics|mesh-ancestor
110762143|NCT03948035|Autonomic Agents|autonomic agents|mesh-ancestor
110762144|NCT03948035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110762145|NCT03948035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110762147|NCT03948035|Glucocorticoids|glucocorticoids|mesh-ancestor
110762148|NCT03948035|Hormones|hormones|mesh-ancestor
110762149|NCT03948035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110762150|NCT03948035|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110762151|NCT03948035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110762152|NCT03948035|Immunologic Factors|immunologic factors|mesh-ancestor
110762153|NCT03948035|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110762154|NCT03948035|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110762155|NCT03948035|Growth Substances|growth substances|mesh-ancestor
110762156|NCT03948035|Growth Inhibitors|growth inhibitors|mesh-ancestor
110762157|NCT03946124|Fesoterodine|fesoterodine|mesh-list
110762158|NCT03946124|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110762159|NCT03946124|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110762160|NCT03946124|Cholinergic Agents|cholinergic agents|mesh-ancestor
110762161|NCT03946124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110762162|NCT03946124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110762163|NCT03946124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110762164|NCT03946124|Urological Agents|urological agents|mesh-ancestor
110762165|NCT03942224|Dexamethasone|dexamethasone|mesh-list
110762166|NCT03942224|Bortezomib|bortezomib|mesh-list
110762167|NCT03942224|Daratumumab|daratumumab|mesh-list
110762168|NCT03942224|Ixazomib|ixazomib|mesh-list
110762169|NCT03942224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110762170|NCT03942224|Antiemetics|antiemetics|mesh-ancestor
110762171|NCT03942224|Autonomic Agents|autonomic agents|mesh-ancestor
110762172|NCT03942224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110762173|NCT03942224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110762174|NCT03942224|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110762175|NCT03942224|Glucocorticoids|glucocorticoids|mesh-ancestor
110762176|NCT03942224|Hormones|hormones|mesh-ancestor
110445504|NCT02776228|Brotizolam|brotizolam|mesh-list
110314447|NCT00420537|Everolimus|everolimus|mesh-list
110762177|NCT03942224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110762178|NCT03942224|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110762179|NCT03942224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110762180|NCT03942224|Protease Inhibitors|protease inhibitors|mesh-ancestor
110762181|NCT03942224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110762182|NCT03942224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110762183|NCT03938701|Adalimumab|adalimumab|mesh-list
110762184|NCT03938701|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110762185|NCT03938701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110762186|NCT03938701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110762187|NCT03936933|Goserelin|goserelin|mesh-list
110762188|NCT03936933|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110762189|NCT03936933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110762190|NCT03936218|Goserelin|goserelin|mesh-list
110762191|NCT03936218|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110762192|NCT03936218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110762193|NCT03879798|Irinotecan|irinotecan|mesh-list
110762194|NCT03879798|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110762195|NCT03879798|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110762196|NCT03879798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110762197|NCT03879798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110762198|NCT03879798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110762199|NCT03818685|Capecitabine|capecitabine|mesh-list
110762200|NCT03818685|Nivolumab|nivolumab|mesh-list
110762201|NCT03818685|Ipilimumab|ipilimumab|mesh-list
110762202|NCT03818685|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110762203|NCT03818685|Antimetabolites|antimetabolites|mesh-ancestor
110762204|NCT03818685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110762205|NCT03818685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110762206|NCT03818685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110762207|NCT03818685|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110762208|NCT03815058|Pembrolizumab|pembrolizumab|mesh-list
110762209|NCT03815058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110762210|NCT03815058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110762211|NCT03815058|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110762212|NCT03815058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110762213|NCT03801122|Tranexamic Acid|tranexamic acid|mesh-list
110762214|NCT03801122|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110762215|NCT03801122|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110762216|NCT03801122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110762217|NCT03801122|Hemostatics|hemostatics|mesh-ancestor
110762218|NCT03801122|Coagulants|coagulants|mesh-ancestor
110762219|NCT03797066|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
110762220|NCT03797066|Antiviral Agents|antiviral agents|mesh-ancestor
110762221|NCT03797066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110762222|NCT03771677|Interferons|interferons|mesh-list
110762223|NCT03771677|Interferon-alpha|interferon-alpha|mesh-list
110762224|NCT03771677|Interferon alpha-2|interferon alpha-2|mesh-list
110762225|NCT03771677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110762226|NCT03771677|Antiviral Agents|antiviral agents|mesh-ancestor
110762227|NCT03771677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110762228|NCT03771677|Immunologic Factors|immunologic factors|mesh-ancestor
110762229|NCT03771677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110762230|NCT03771651|Aspirin|aspirin|mesh-list
110762231|NCT03771651|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110762232|NCT03771651|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110762233|NCT03771651|Analgesics|analgesics|mesh-ancestor
110762234|NCT03771651|Sensory System Agents|sensory system agents|mesh-ancestor
110762235|NCT03771651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110762236|NCT03771651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110762237|NCT03771651|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110314467|NCT00451139|Artemether|artemether|mesh-list
110762238|NCT03771651|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110762239|NCT03771651|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110762240|NCT03771651|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110762241|NCT03771651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110762242|NCT03771651|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110762243|NCT03771651|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110762244|NCT03771651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110762245|NCT03771651|Antipyretics|antipyretics|mesh-ancestor
110762246|NCT03770767|Insulin|insulin|mesh-list
110762247|NCT03770767|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110762248|NCT03770767|Insulin Aspart|insulin aspart|mesh-list
110762249|NCT03770767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110762250|NCT03770767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110762252|NCT03769155|Ipilimumab|ipilimumab|mesh-list
110762253|NCT03769155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110762254|NCT03769155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110762255|NCT03769155|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110762256|NCT03769155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110762257|NCT03756896|Dexamethasone|dexamethasone|mesh-list
110762258|NCT03756896|Pomalidomide|pomalidomide|mesh-list
110762259|NCT03756896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110762260|NCT03756896|Antiemetics|antiemetics|mesh-ancestor
110762261|NCT03756896|Autonomic Agents|autonomic agents|mesh-ancestor
110762262|NCT03756896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110762263|NCT03756896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110762264|NCT03756896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110762265|NCT03756896|Glucocorticoids|glucocorticoids|mesh-ancestor
110762266|NCT03756896|Hormones|hormones|mesh-ancestor
110762267|NCT03756896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110762268|NCT03756896|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110762269|NCT03756896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110762270|NCT03756896|Immunologic Factors|immunologic factors|mesh-ancestor
110762271|NCT03756896|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110762272|NCT03756896|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110762273|NCT03756896|Growth Substances|growth substances|mesh-ancestor
110762274|NCT03756896|Growth Inhibitors|growth inhibitors|mesh-ancestor
110762275|NCT03747575|Astegolimab|astegolimab|mesh-list
110762276|NCT03747575|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110762277|NCT03747575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110762278|NCT03747575|Antiviral Agents|antiviral agents|mesh-ancestor
110762279|NCT03747575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110479977|NCT04215159|Irinotecan|irinotecan|mesh-list
110762280|NCT03747419|Avelumab|avelumab|mesh-list
110762281|NCT03747419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110762282|NCT03747419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110762283|NCT03733145|Angiotensin II|angiotensin ii|mesh-list
110762284|NCT03733145|Giapreza|giapreza|mesh-list
110762285|NCT03733145|Angiotensinogen|angiotensinogen|mesh-list
110762286|NCT03733145|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110762287|NCT03733145|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110762288|NCT03733145|Protease Inhibitors|protease inhibitors|mesh-ancestor
110762289|NCT03733145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110762290|NCT03733145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110762292|NCT03715972|Acetazolamide|acetazolamide|mesh-list
110762293|NCT03715972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110762294|NCT03715972|Antisickling Agents|antisickling agents|mesh-ancestor
110762295|NCT03715972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110762296|NCT03715972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110762297|NCT03715972|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110762298|NCT03715972|Anticonvulsants|anticonvulsants|mesh-ancestor
110762299|NCT03715972|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110762300|NCT03715972|Diuretics|diuretics|mesh-ancestor
110762301|NCT03715972|Natriuretic Agents|natriuretic agents|mesh-ancestor
110762302|NCT03715972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110762303|NCT03702218|Antiviral Agents|antiviral agents|mesh-list
110762304|NCT03702218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110762305|NCT03691714|Cetuximab|cetuximab|mesh-list
110762306|NCT03691714|Durvalumab|durvalumab|mesh-list
110762307|NCT03691714|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110762308|NCT03691714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110762309|NCT03691493|Tamoxifen|tamoxifen|mesh-list
110762310|NCT03691493|Letrozole|letrozole|mesh-list
110762311|NCT03691493|Fulvestrant|fulvestrant|mesh-list
110762312|NCT03691493|Palbociclib|palbociclib|mesh-list
110762313|NCT03691493|Anastrozole|anastrozole|mesh-list
110762314|NCT03691493|Exemestane|exemestane|mesh-list
110762315|NCT03691493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110762316|NCT03691493|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110762317|NCT03691493|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110762318|NCT03691493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110762319|NCT03691493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110762320|NCT03691493|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110762321|NCT03691493|Hormone Antagonists|hormone antagonists|mesh-ancestor
110762322|NCT03691493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110762323|NCT03691493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110762324|NCT03691493|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110445508|NCT05382728|Osimertinib|osimertinib|mesh-list
110762325|NCT03691493|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110762326|NCT03691493|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110762327|NCT03691493|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110762328|NCT03691493|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110762329|NCT03691493|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110762330|NCT03657043|Tisotumab vedotin|tisotumab vedotin|mesh-list
110762331|NCT03657043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110762332|NCT03657043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110762333|NCT03634540|Belzutifan|belzutifan|mesh-list
110762334|NCT03634540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110762335|NCT03631706|Pembrolizumab|pembrolizumab|mesh-list
110762336|NCT03631706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110762337|NCT03631706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110762338|NCT03631706|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110762339|NCT03631706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110762340|NCT03619876|Adalimumab|adalimumab|mesh-list
110762341|NCT03619876|Abatacept|abatacept|mesh-list
110762342|NCT03619876|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110762343|NCT03619876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110762344|NCT03619876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110762345|NCT03619876|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110762346|NCT03619876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110762347|NCT03619876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110762348|NCT03619876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110762349|NCT03619876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110762350|NCT03619876|Immunologic Factors|immunologic factors|mesh-ancestor
110762351|NCT03619876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110762352|NCT03605901|Methadone|methadone|mesh-list
110762353|NCT03605901|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110762354|NCT03605901|Narcotics|narcotics|mesh-ancestor
110762355|NCT03605901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110762356|NCT03605901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110762357|NCT03605901|Analgesics|analgesics|mesh-ancestor
110762358|NCT03605901|Sensory System Agents|sensory system agents|mesh-ancestor
110762359|NCT03605901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110762360|NCT03605901|Antitussive Agents|antitussive agents|mesh-ancestor
110762361|NCT03605901|Respiratory System Agents|respiratory system agents|mesh-ancestor
110762362|NCT03583255|Dexamethasone|dexamethasone|mesh-list
110762363|NCT03583255|Dexamethasone acetate|dexamethasone acetate|mesh-list
110762364|NCT03583255|Ichthammol|ichthammol|mesh-list
110762365|NCT03583255|BB 1101|bb 1101|mesh-list
110762366|NCT03583255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110762367|NCT03583255|Antiemetics|antiemetics|mesh-ancestor
110762368|NCT03583255|Autonomic Agents|autonomic agents|mesh-ancestor
110762369|NCT03583255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110762370|NCT03583255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110762371|NCT03583255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110762372|NCT03583255|Glucocorticoids|glucocorticoids|mesh-ancestor
110762373|NCT03583255|Hormones|hormones|mesh-ancestor
110762374|NCT03583255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110762375|NCT03583255|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110762376|NCT03583255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110762377|NCT03583255|Protease Inhibitors|protease inhibitors|mesh-ancestor
110762378|NCT03583255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110762379|NCT03583255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110762380|NCT03583255|Dermatologic Agents|dermatologic agents|mesh-ancestor
110762381|NCT03579771|Paclitaxel|paclitaxel|mesh-list
110762382|NCT03579771|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110762383|NCT03579771|Gemcitabine|gemcitabine|mesh-list
110762384|NCT03579771|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110762385|NCT03579771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110762386|NCT03579771|Tubulin Modulators|tubulin modulators|mesh-ancestor
110762387|NCT03579771|Antimitotic Agents|antimitotic agents|mesh-ancestor
110762388|NCT03579771|Mitosis Modulators|mitosis modulators|mesh-ancestor
110762389|NCT03579771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110762390|NCT03579771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110762391|NCT03579771|Antimetabolites|antimetabolites|mesh-ancestor
110762392|NCT03578081|Dexamethasone|dexamethasone|mesh-list
110762393|NCT03578081|Ondansetron|ondansetron|mesh-list
110762394|NCT03578081|Olanzapine|olanzapine|mesh-list
110762395|NCT03578081|Palonosetron|palonosetron|mesh-list
110762396|NCT03578081|Fosaprepitant|fosaprepitant|mesh-list
110762397|NCT03578081|Aprepitant|aprepitant|mesh-list
110762398|NCT03578081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110762399|NCT03578081|Antiemetics|antiemetics|mesh-ancestor
110762401|NCT03578081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110762402|NCT03578081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110762403|NCT03578081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110762404|NCT03578081|Glucocorticoids|glucocorticoids|mesh-ancestor
110762405|NCT03578081|Hormones|hormones|mesh-ancestor
110762406|NCT03578081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110762407|NCT03578081|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110762408|NCT03578081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110762409|NCT03578081|Antipruritics|antipruritics|mesh-ancestor
110762410|NCT03578081|Dermatologic Agents|dermatologic agents|mesh-ancestor
110762411|NCT03578081|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110762412|NCT03578081|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110762413|NCT03578081|Serotonin Agents|serotonin agents|mesh-ancestor
110762414|NCT03578081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110762415|NCT03578081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110762416|NCT03578081|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110762417|NCT03578081|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110762418|NCT03578081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110762419|NCT03578081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110762420|NCT03578081|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110762421|NCT03578081|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110762422|NCT03578081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110869268|NCT03738527|Tranexamic Acid|tranexamic acid|mesh-list
110762423|NCT03578081|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110762424|NCT03540420|Atezolizumab|atezolizumab|mesh-list
110762425|NCT03540420|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110762426|NCT03540420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110762427|NCT03540420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110762428|NCT03540420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110762429|NCT03510884|Nicotinic Acids|nicotinic acids|mesh-list
110762430|NCT03510884|Niacin|niacin|mesh-list
110762431|NCT03510884|Niacinamide|niacinamide|mesh-list
110762432|NCT03510884|Atorvastatin|atorvastatin|mesh-list
110762433|NCT03510884|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110762434|NCT03510884|Simvastatin|simvastatin|mesh-list
110762435|NCT03510884|Ezetimibe|ezetimibe|mesh-list
110762436|NCT03510884|Pravastatin|pravastatin|mesh-list
110762437|NCT03510884|Alirocumab|alirocumab|mesh-list
110762438|NCT03510884|Lovastatin|lovastatin|mesh-list
110762439|NCT03510884|Cholestyramine Resin|cholestyramine resin|mesh-list
110762440|NCT03510884|Fenofibrate|fenofibrate|mesh-list
110762441|NCT03510884|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110762442|NCT03510884|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110762443|NCT03510884|Antimetabolites|antimetabolites|mesh-ancestor
110762444|NCT03510884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110762445|NCT03510884|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110762446|NCT03510884|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110762447|NCT03510884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110762448|NCT03510884|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
110762449|NCT03510884|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110762450|NCT03510884|Protease Inhibitors|protease inhibitors|mesh-ancestor
110762451|NCT03510884|Vitamin B Complex|vitamin b complex|mesh-ancestor
110762452|NCT03510884|Vitamins|vitamins|mesh-ancestor
110762453|NCT03510884|Micronutrients|micronutrients|mesh-ancestor
110762454|NCT03510884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110762455|NCT03510884|Vasodilator Agents|vasodilator agents|mesh-ancestor
110762456|NCT03506360|Dexamethasone|dexamethasone|mesh-list
110762457|NCT03506360|Dexamethasone acetate|dexamethasone acetate|mesh-list
110762458|NCT03506360|Pembrolizumab|pembrolizumab|mesh-list
110762459|NCT03506360|Ixazomib|ixazomib|mesh-list
110762460|NCT03506360|Ichthammol|ichthammol|mesh-list
110762461|NCT03506360|BB 1101|bb 1101|mesh-list
110762462|NCT03506360|Glycine|glycine|mesh-list
110762463|NCT03506360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110762464|NCT03506360|Antiemetics|antiemetics|mesh-ancestor
110762465|NCT03506360|Autonomic Agents|autonomic agents|mesh-ancestor
110762466|NCT03506360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110762467|NCT03506360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110762468|NCT03506360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110762469|NCT03506360|Glucocorticoids|glucocorticoids|mesh-ancestor
110762470|NCT03506360|Hormones|hormones|mesh-ancestor
110762471|NCT03506360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110762472|NCT03506360|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110762473|NCT03506360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110762474|NCT03506360|Protease Inhibitors|protease inhibitors|mesh-ancestor
110762475|NCT03506360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110762476|NCT03506360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110762477|NCT03506360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110762478|NCT03506360|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110762479|NCT03506360|Dermatologic Agents|dermatologic agents|mesh-ancestor
110762480|NCT03506360|Glycine Agents|glycine agents|mesh-ancestor
110762481|NCT03506360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110762483|NCT03497975|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110762484|NCT03497975|Narcotics|narcotics|mesh-ancestor
110762485|NCT03497975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110762486|NCT03497975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110762487|NCT03497975|Analgesics|analgesics|mesh-ancestor
110762488|NCT03497975|Sensory System Agents|sensory system agents|mesh-ancestor
110762489|NCT03497975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110762490|NCT03497169|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
110762491|NCT03497169|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110762492|NCT03497169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110762493|NCT03497169|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110762494|NCT03497169|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110762495|NCT03497169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110762496|NCT03497169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110762497|NCT03497169|Dopamine Agents|dopamine agents|mesh-ancestor
110762498|NCT03497169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110762499|NCT03497143|Lamotrigine|lamotrigine|mesh-list
110762500|NCT03497143|Anticonvulsants|anticonvulsants|mesh-ancestor
110762501|NCT03497143|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110762502|NCT03497143|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110762503|NCT03497143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110762504|NCT03497143|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110762505|NCT03497143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110762506|NCT03497143|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110762507|NCT03497143|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110762508|NCT03497143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110762509|NCT03497143|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110762510|NCT03497143|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110762511|NCT03478514|Palbociclib|palbociclib|mesh-list
110762512|NCT03478514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110762513|NCT03478514|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110762514|NCT03478514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110762515|NCT03478514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110762516|NCT03456843|Ascorbic Acid|ascorbic acid|mesh-list
110762517|NCT03456843|Docetaxel|docetaxel|mesh-list
110762518|NCT03456843|Methyltestosterone|methyltestosterone|mesh-list
110762519|NCT03456843|Hormones|hormones|mesh-list
110762520|NCT03456843|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
110762521|NCT03456843|Androgens|androgens|mesh-list
110762522|NCT03456843|Androgen Antagonists|androgen antagonists|mesh-list
110762523|NCT03456843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110762524|NCT03456843|Tubulin Modulators|tubulin modulators|mesh-ancestor
110762525|NCT03456843|Antimitotic Agents|antimitotic agents|mesh-ancestor
110762526|NCT03456843|Mitosis Modulators|mitosis modulators|mesh-ancestor
110762527|NCT03456843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110762528|NCT03456843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110762529|NCT03456843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110762530|NCT03456843|Antioxidants|antioxidants|mesh-ancestor
110762531|NCT03456843|Protective Agents|protective agents|mesh-ancestor
110762532|NCT03456843|Vitamins|vitamins|mesh-ancestor
110762533|NCT03456843|Micronutrients|micronutrients|mesh-ancestor
110762534|NCT03456843|Estrogens|estrogens|mesh-ancestor
110762535|NCT03456843|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110762536|NCT03456843|Anabolic Agents|anabolic agents|mesh-ancestor
110762537|NCT03456843|Hormone Antagonists|hormone antagonists|mesh-ancestor
110762538|NCT03455829|Osimertinib|osimertinib|mesh-list
110762539|NCT03455829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110762540|NCT03455829|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110762541|NCT03455829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110762542|NCT03455829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110762543|NCT03453489|Tryptophan|tryptophan|mesh-list
110762544|NCT03453489|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110762545|NCT03453489|Antidepressive Agents|antidepressive agents|mesh-ancestor
110762546|NCT03453489|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110762547|NCT03440190|Methylphenidate|methylphenidate|mesh-list
110762548|NCT03440190|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110762549|NCT03440190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110762550|NCT03440190|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110762551|NCT03440190|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110762552|NCT03440190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110762553|NCT03440190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110762555|NCT03440190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110762556|NCT03434262|Gemcitabine|gemcitabine|mesh-list
110762557|NCT03434262|Trametinib|trametinib|mesh-list
110762558|NCT03434262|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110762559|NCT03434262|Antimetabolites|antimetabolites|mesh-ancestor
110762560|NCT03434262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110762561|NCT03434262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110762562|NCT03434262|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110762563|NCT03434262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110762564|NCT03429244|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
110762565|NCT03429244|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110762566|NCT03429244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110762567|NCT03408587|Ipilimumab|ipilimumab|mesh-list
110762568|NCT03408587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110762569|NCT03408587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110762570|NCT03408587|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110762571|NCT03408587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110762572|NCT03370276|Nivolumab|nivolumab|mesh-list
110762573|NCT03370276|Cetuximab|cetuximab|mesh-list
110762574|NCT03370276|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110762575|NCT03370276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110762576|NCT03370276|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110762577|NCT03370276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110762578|NCT03331341|Doxorubicin|doxorubicin|mesh-list
110762579|NCT03331341|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110762580|NCT03331341|Pembrolizumab|pembrolizumab|mesh-list
110762581|NCT03331341|Dacarbazine|dacarbazine|mesh-list
110762582|NCT03331341|Vinblastine|vinblastine|mesh-list
110762583|NCT03331341|Imidazole|imidazole|mesh-list
110762584|NCT03331341|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110762585|NCT03331341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110762586|NCT03331341|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110762587|NCT03331341|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110762588|NCT03331341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110762589|NCT03331341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110762590|NCT03331341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110762591|NCT03331341|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110762592|NCT03331341|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110762593|NCT03331341|Alkylating Agents|alkylating agents|mesh-ancestor
110762594|NCT03331341|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110762595|NCT03331341|Tubulin Modulators|tubulin modulators|mesh-ancestor
110762596|NCT03331341|Antimitotic Agents|antimitotic agents|mesh-ancestor
110762597|NCT03331341|Mitosis Modulators|mitosis modulators|mesh-ancestor
110762598|NCT03319745|Pembrolizumab|pembrolizumab|mesh-list
110762599|NCT03319745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110762600|NCT03319745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110762601|NCT03319745|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110762602|NCT03319745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110762603|NCT03314636|Dexamethasone|dexamethasone|mesh-list
110762604|NCT03314636|Lenalidomide|lenalidomide|mesh-list
110762605|NCT03314636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110762606|NCT03314636|Antiemetics|antiemetics|mesh-ancestor
110762607|NCT03314636|Autonomic Agents|autonomic agents|mesh-ancestor
110762608|NCT03314636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110762609|NCT03314636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110762610|NCT03314636|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110762611|NCT03314636|Glucocorticoids|glucocorticoids|mesh-ancestor
110762612|NCT03314636|Hormones|hormones|mesh-ancestor
110762613|NCT03314636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110762614|NCT03314636|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110762615|NCT03314636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110762616|NCT03314636|Immunologic Factors|immunologic factors|mesh-ancestor
110762617|NCT03314636|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110762618|NCT03314636|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110762619|NCT03314636|Growth Substances|growth substances|mesh-ancestor
110762620|NCT03314636|Growth Inhibitors|growth inhibitors|mesh-ancestor
110762621|NCT03310541|Fulvestrant|fulvestrant|mesh-list
110762622|NCT03310541|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110762623|NCT03310541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110762624|NCT03310541|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110762625|NCT03310541|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110762626|NCT03310541|Hormone Antagonists|hormone antagonists|mesh-ancestor
110762627|NCT03310541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110762628|NCT03310541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110762629|NCT03279861|Valsartan|valsartan|mesh-list
110762630|NCT03279861|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
110762631|NCT03279861|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110762632|NCT03279861|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110762633|NCT03279861|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110762634|NCT03279861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110762635|NCT03277729|Cyclophosphamide|cyclophosphamide|mesh-list
110762636|NCT03277729|Fludarabine|fludarabine|mesh-list
110762637|NCT03277729|Fludarabine phosphate|fludarabine phosphate|mesh-list
110762638|NCT03277729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110762639|NCT03277729|Immunologic Factors|immunologic factors|mesh-ancestor
110762640|NCT03277729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110762641|NCT03277729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110762642|NCT03277729|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110314665|NCT00334308|Caseins|caseins|mesh-list
110762643|NCT03277729|Alkylating Agents|alkylating agents|mesh-ancestor
110762644|NCT03277729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110762645|NCT03277729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110762646|NCT03277729|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110762647|NCT03277729|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110762648|NCT03277729|Antimetabolites|antimetabolites|mesh-ancestor
110762649|NCT03250832|Bevacizumab|bevacizumab|mesh-list
110762650|NCT03250832|Dostarlimab|dostarlimab|mesh-list
110762651|NCT03250832|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110762652|NCT03250832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110762653|NCT03250832|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110762654|NCT03250832|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110762655|NCT03250832|Growth Substances|growth substances|mesh-ancestor
110762656|NCT03250832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110762657|NCT03250832|Growth Inhibitors|growth inhibitors|mesh-ancestor
110762658|NCT03250117|Ropinirole|ropinirole|mesh-list
110762659|NCT03250117|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110762660|NCT03250117|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110762661|NCT03250117|Dopamine Agonists|dopamine agonists|mesh-ancestor
110762662|NCT03250117|Dopamine Agents|dopamine agents|mesh-ancestor
110762663|NCT03250117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110762664|NCT03250117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110762665|NCT03250117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110762666|NCT03236935|Pembrolizumab|pembrolizumab|mesh-list
110762667|NCT03236935|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
110762668|NCT03236935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110762669|NCT03236935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110762670|NCT03236935|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110762671|NCT03236935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110762672|NCT03236935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110762673|NCT03230838|Meropenem|meropenem|mesh-list
110762674|NCT03230838|Tazobactam|tazobactam|mesh-list
110762675|NCT03230838|Ceftolozane|ceftolozane|mesh-list
110762676|NCT03230838|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
110762677|NCT03230838|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110762678|NCT03230838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110762679|NCT03230838|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110869314|NCT02408146|Analgesics|analgesics|mesh-ancestor
110762680|NCT03230838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110762681|NCT03230838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110762682|NCT03230838|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110762683|NCT03217136|Metronidazole|metronidazole|mesh-list
110762684|NCT03217136|Meropenem|meropenem|mesh-list
110762685|NCT03217136|Tazobactam|tazobactam|mesh-list
110762686|NCT03217136|Ceftolozane|ceftolozane|mesh-list
110762687|NCT03217136|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
110762688|NCT03217136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110762689|NCT03217136|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110762690|NCT03217136|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110762691|NCT03217136|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110762692|NCT03217136|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110762693|NCT03217136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110762694|NCT03217136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110762695|NCT03217136|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110762696|NCT03201939|Lisinopril|lisinopril|mesh-list
110762697|NCT03201939|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110762698|NCT03201939|Protease Inhibitors|protease inhibitors|mesh-ancestor
110762699|NCT03201939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110762700|NCT03201939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110762701|NCT03201939|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110762702|NCT03201939|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110762703|NCT03201939|Protective Agents|protective agents|mesh-ancestor
110762704|NCT03201939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110762705|NCT03179761|Vaccines|vaccines|mesh-list
110762706|NCT03179761|Immunologic Factors|immunologic factors|mesh-ancestor
110762707|NCT03179761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110762708|NCT03173248|Azacitidine|azacitidine|mesh-list
110762709|NCT03173248|Ivosidenib|ivosidenib|mesh-list
110762710|NCT03173248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110762711|NCT03173248|Antimetabolites|antimetabolites|mesh-ancestor
110762712|NCT03173248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110762713|NCT03173248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110762714|NCT03173248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110762715|NCT03158064|Durvalumab|durvalumab|mesh-list
110762716|NCT03158064|Tremelimumab|tremelimumab|mesh-list
110762717|NCT03158064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110762718|NCT03158064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110762719|NCT03122886|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
110762720|NCT03122886|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
110762721|NCT03122886|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
110762722|NCT03122886|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110762723|NCT03090165|Bicalutamide|bicalutamide|mesh-list
110762724|NCT03090165|Androgen Antagonists|androgen antagonists|mesh-ancestor
110762725|NCT03090165|Hormone Antagonists|hormone antagonists|mesh-ancestor
110762726|NCT03090165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110762727|NCT03090165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110762728|NCT03090165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110762729|NCT03087708|Naloxegol|naloxegol|mesh-list
110762730|NCT03087708|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110682899|NCT00899951|Anesthetics, General|anesthetics, general|mesh-ancestor
110762731|NCT03087708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110762732|NCT03087708|Sensory System Agents|sensory system agents|mesh-ancestor
110762733|NCT03087708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110762734|NCT03059563|Varenicline|varenicline|mesh-list
110762735|NCT03059563|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110762736|NCT03059563|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110762737|NCT03059563|Cholinergic Agents|cholinergic agents|mesh-ancestor
110762738|NCT03059563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110762739|NCT03059563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110762740|NCT03059563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110762741|NCT03057847|Sofosbuvir|sofosbuvir|mesh-list
110762742|NCT03057847|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
110762743|NCT03057847|Velpatasvir|velpatasvir|mesh-list
110762744|NCT03057847|Antiviral Agents|antiviral agents|mesh-ancestor
110762745|NCT03057847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110762746|NCT03043599|Nivolumab|nivolumab|mesh-list
110762747|NCT03043599|Ipilimumab|ipilimumab|mesh-list
110762748|NCT03043599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110762749|NCT03043599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110762750|NCT03043599|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110762751|NCT03043599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110762752|NCT03042143|Plasma-lyte 148|plasma-lyte 148|mesh-list
110762753|NCT03042143|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110762754|NCT03042143|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110762755|NCT03040973|Gefitinib|gefitinib|mesh-list
110762756|NCT03040973|Osimertinib|osimertinib|mesh-list
110762757|NCT03040973|Nazartinib|nazartinib|mesh-list
110762758|NCT03040973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110762759|NCT03040973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110762760|NCT03040973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110762761|NCT03040973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110762762|NCT03022773|Carotenoids|carotenoids|mesh-list
110762763|NCT03022773|Antioxidants|antioxidants|mesh-ancestor
110762764|NCT03022773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110762765|NCT03022773|Protective Agents|protective agents|mesh-ancestor
110762766|NCT03022773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110762767|NCT02946463|Eculizumab|eculizumab|mesh-list
110762768|NCT02946463|Ravulizumab|ravulizumab|mesh-list
110762769|NCT02946463|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
110762770|NCT02946463|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110762771|NCT02946463|Immunologic Factors|immunologic factors|mesh-ancestor
110762772|NCT02946463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110762773|NCT02928224|Leucovorin|leucovorin|mesh-list
110762774|NCT02928224|Folic Acid|folic acid|mesh-list
110762775|NCT02928224|Fluorouracil|fluorouracil|mesh-list
110762776|NCT02928224|Irinotecan|irinotecan|mesh-list
110762777|NCT02928224|Cetuximab|cetuximab|mesh-list
110762778|NCT02928224|Levoleucovorin|levoleucovorin|mesh-list
110762779|NCT02928224|Antimetabolites|antimetabolites|mesh-ancestor
110762780|NCT02928224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110762781|NCT02928224|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110762782|NCT02928224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110762783|NCT02928224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110762784|NCT02928224|Immunologic Factors|immunologic factors|mesh-ancestor
110762785|NCT02928224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110762786|NCT02928224|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110762787|NCT02928224|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110762788|NCT02928224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110762789|NCT02928224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110762790|NCT02928224|Antidotes|antidotes|mesh-ancestor
110762791|NCT02928224|Protective Agents|protective agents|mesh-ancestor
110762792|NCT02928224|Vitamin B Complex|vitamin b complex|mesh-ancestor
110762793|NCT02928224|Vitamins|vitamins|mesh-ancestor
110762794|NCT02928224|Micronutrients|micronutrients|mesh-ancestor
110762795|NCT02928224|Hematinics|hematinics|mesh-ancestor
110762796|NCT02897375|Carboplatin|carboplatin|mesh-list
110762797|NCT02897375|Palbociclib|palbociclib|mesh-list
110762798|NCT02897375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110762799|NCT02897375|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110762800|NCT02897375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110762801|NCT02897375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110762802|NCT02891603|Sirolimus|sirolimus|mesh-list
110762803|NCT02891603|Tacrolimus|tacrolimus|mesh-list
110762804|NCT02891603|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
110762805|NCT02891603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110762806|NCT02891603|Immunologic Factors|immunologic factors|mesh-ancestor
110762807|NCT02891603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110762808|NCT02891603|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110762809|NCT02891603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110762810|NCT02891603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110762811|NCT02891603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110762812|NCT02891603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110762813|NCT02891603|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110762814|NCT02891603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110762815|NCT02891603|Antifungal Agents|antifungal agents|mesh-ancestor
110762816|NCT02891603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110762817|NCT02875314|Cyclophosphamide|cyclophosphamide|mesh-list
110762818|NCT02875314|Thiotepa|thiotepa|mesh-list
110762819|NCT02875314|Cisplatin|cisplatin|mesh-list
110762820|NCT02875314|Carboplatin|carboplatin|mesh-list
110762821|NCT02875314|Methotrexate|methotrexate|mesh-list
110762822|NCT02875314|Etoposide|etoposide|mesh-list
110762823|NCT02875314|Etoposide phosphate|etoposide phosphate|mesh-list
110762824|NCT02875314|Vincristine|vincristine|mesh-list
110762825|NCT02875314|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110762826|NCT02875314|Immunologic Factors|immunologic factors|mesh-ancestor
110762827|NCT02875314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110762828|NCT02875314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110762829|NCT02875314|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110762830|NCT02875314|Alkylating Agents|alkylating agents|mesh-ancestor
110762831|NCT02875314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110762832|NCT02875314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110762833|NCT02875314|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110762834|NCT02875314|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110762835|NCT02875314|Abortifacient Agents|abortifacient agents|mesh-ancestor
110762836|NCT02875314|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110762837|NCT02875314|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110762839|NCT02875314|Dermatologic Agents|dermatologic agents|mesh-ancestor
110762840|NCT02875314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110762841|NCT02875314|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110762842|NCT02875314|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110762843|NCT02875314|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110762844|NCT02875314|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110762845|NCT02875314|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110762846|NCT02875314|Tubulin Modulators|tubulin modulators|mesh-ancestor
110762847|NCT02875314|Antimitotic Agents|antimitotic agents|mesh-ancestor
110762848|NCT02875314|Mitosis Modulators|mitosis modulators|mesh-ancestor
110762849|NCT02860039|Vaccines|vaccines|mesh-list
110762850|NCT02860039|Immunologic Factors|immunologic factors|mesh-ancestor
110762851|NCT02860039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110762852|NCT02819024|Alovudine|alovudine|mesh-list
110762853|NCT02819024|Dideoxynucleosides|dideoxynucleosides|mesh-list
110762854|NCT02819024|Dexamethasone|dexamethasone|mesh-list
110762855|NCT02819024|Dexamethasone acetate|dexamethasone acetate|mesh-list
110762856|NCT02819024|Ichthammol|ichthammol|mesh-list
110762857|NCT02819024|BB 1101|bb 1101|mesh-list
110762858|NCT02819024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110762859|NCT02819024|Antiemetics|antiemetics|mesh-ancestor
110762860|NCT02819024|Autonomic Agents|autonomic agents|mesh-ancestor
110762861|NCT02819024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110762862|NCT02819024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110762863|NCT02819024|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110762864|NCT02819024|Glucocorticoids|glucocorticoids|mesh-ancestor
110762865|NCT02819024|Hormones|hormones|mesh-ancestor
110762866|NCT02819024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110762867|NCT02819024|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110762868|NCT02819024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110762869|NCT02819024|Protease Inhibitors|protease inhibitors|mesh-ancestor
110762870|NCT02819024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110762871|NCT02819024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110762872|NCT02819024|Dermatologic Agents|dermatologic agents|mesh-ancestor
110762873|NCT02819024|Antiviral Agents|antiviral agents|mesh-ancestor
110762874|NCT02819024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110762875|NCT02819024|Antimetabolites|antimetabolites|mesh-ancestor
110762876|NCT02819024|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110762877|NCT02819024|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110762878|NCT02800785|Moxifloxacin|moxifloxacin|mesh-list
110762879|NCT02800785|Metronidazole|metronidazole|mesh-list
110762880|NCT02800785|Ciprofloxacin|ciprofloxacin|mesh-list
110762881|NCT02800785|Levofloxacin|levofloxacin|mesh-list
110762882|NCT02800785|Cefazolin|cefazolin|mesh-list
110762883|NCT02800785|Ceftriaxone|ceftriaxone|mesh-list
110762884|NCT02800785|Clavulanic Acids|clavulanic acids|mesh-list
110480587|NCT02583217|Ketamine|ketamine|mesh-list
110762885|NCT02800785|Clavulanic Acid|clavulanic acid|mesh-list
110762886|NCT02800785|Ertapenem|ertapenem|mesh-list
110762888|NCT02800785|Tigecycline|tigecycline|mesh-list
110762889|NCT02800785|Cefotaxime|cefotaxime|mesh-list
110762890|NCT02800785|Cefoxitin|cefoxitin|mesh-list
110762891|NCT02800785|Ticarcillin|ticarcillin|mesh-list
110762892|NCT02800785|Ticarcillin-clavulanic acid|ticarcillin-clavulanic acid|mesh-list
110762893|NCT02800785|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110762894|NCT02800785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110762895|NCT02800785|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110762896|NCT02800785|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110762897|NCT02800785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110762898|NCT02800785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110762899|NCT02800785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110762900|NCT02800785|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110762901|NCT02800785|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110762902|NCT02800785|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110762903|NCT02800785|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110762904|NCT02800785|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110762905|NCT02800785|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110762906|NCT02800785|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110762907|NCT02796937|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
110762908|NCT02796937|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
110762909|NCT02796937|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110762910|NCT02796937|Protease Inhibitors|protease inhibitors|mesh-ancestor
110762911|NCT02796937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110762912|NCT02796937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110762913|NCT02792257|Dronabinol|dronabinol|mesh-list
110762915|NCT02792257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110762916|NCT02792257|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110762917|NCT02792257|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110762918|NCT02792257|Analgesics|analgesics|mesh-ancestor
110762919|NCT02792257|Sensory System Agents|sensory system agents|mesh-ancestor
110762920|NCT02792257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110762921|NCT02792257|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
110762922|NCT02792257|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110762923|NCT02792257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110762924|NCT02792257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110762925|NCT02792257|Hormones|hormones|mesh-ancestor
110762926|NCT02792257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110762927|NCT02782663|Upadacitinib|upadacitinib|mesh-list
110762928|NCT02782663|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
110762929|NCT02782663|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110762930|NCT02782663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110762931|NCT02782663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110762932|NCT02782663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110762933|NCT02765854|Dexamethasone|dexamethasone|mesh-list
110762934|NCT02765854|Lenalidomide|lenalidomide|mesh-list
110762935|NCT02765854|Ixazomib|ixazomib|mesh-list
110762936|NCT02765854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110762937|NCT02765854|Antiemetics|antiemetics|mesh-ancestor
110762938|NCT02765854|Autonomic Agents|autonomic agents|mesh-ancestor
110762939|NCT02765854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110762940|NCT02765854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110762941|NCT02765854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110762942|NCT02765854|Glucocorticoids|glucocorticoids|mesh-ancestor
110762943|NCT02765854|Hormones|hormones|mesh-ancestor
110762944|NCT02765854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110762945|NCT02765854|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110762946|NCT02765854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110762947|NCT02765854|Immunologic Factors|immunologic factors|mesh-ancestor
110762948|NCT02765854|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110762949|NCT02765854|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110762950|NCT02765854|Growth Substances|growth substances|mesh-ancestor
110762951|NCT02765854|Growth Inhibitors|growth inhibitors|mesh-ancestor
110762952|NCT02765854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110762953|NCT02765854|Protease Inhibitors|protease inhibitors|mesh-ancestor
110762954|NCT02765854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110762955|NCT02761694|Paclitaxel|paclitaxel|mesh-list
110762956|NCT02761694|Fulvestrant|fulvestrant|mesh-list
110762957|NCT02761694|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110762958|NCT02761694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110762959|NCT02761694|Tubulin Modulators|tubulin modulators|mesh-ancestor
110762960|NCT02761694|Antimitotic Agents|antimitotic agents|mesh-ancestor
110762961|NCT02761694|Mitosis Modulators|mitosis modulators|mesh-ancestor
110762962|NCT02761694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110762963|NCT02761694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110762964|NCT02761694|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110762965|NCT02761694|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110762966|NCT02761694|Hormone Antagonists|hormone antagonists|mesh-ancestor
110762967|NCT02761694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110762968|NCT02761694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110762969|NCT02760030|Fulvestrant|fulvestrant|mesh-list
110762970|NCT02760030|Palbociclib|palbociclib|mesh-list
110762971|NCT02760030|Aromatase Inhibitors|aromatase inhibitors|mesh-list
110762972|NCT02760030|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110762973|NCT02760030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110762974|NCT02760030|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110762975|NCT02760030|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110762976|NCT02760030|Hormone Antagonists|hormone antagonists|mesh-ancestor
110762977|NCT02760030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110762978|NCT02760030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110762979|NCT02760030|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110762980|NCT02760030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110762981|NCT02760030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110762982|NCT02760030|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110762983|NCT02641093|Pembrolizumab|pembrolizumab|mesh-list
110762984|NCT02641093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110762985|NCT02641093|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110762986|NCT02641093|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110762987|NCT02641093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110762988|NCT02584309|Doxorubicin|doxorubicin|mesh-list
110762989|NCT02584309|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110762990|NCT02584309|Dexrazoxane|dexrazoxane|mesh-list
110762991|NCT02584309|Razoxane|razoxane|mesh-list
110762992|NCT02584309|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110762993|NCT02584309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110762994|NCT02584309|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110762995|NCT02584309|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110762996|NCT02584309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110762997|NCT02584309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110762998|NCT02584309|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110762999|NCT02584309|Protective Agents|protective agents|mesh-ancestor
110763000|NCT02584309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110763001|NCT02584309|Antimitotic Agents|antimitotic agents|mesh-ancestor
110763002|NCT02584309|Mitosis Modulators|mitosis modulators|mesh-ancestor
110763003|NCT02578732|Leucovorin|leucovorin|mesh-list
110763004|NCT02578732|Oxaliplatin|oxaliplatin|mesh-list
110763005|NCT02578732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110763006|NCT02578732|Antidotes|antidotes|mesh-ancestor
110763007|NCT02578732|Protective Agents|protective agents|mesh-ancestor
110763008|NCT02578732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110763009|NCT02578732|Vitamin B Complex|vitamin b complex|mesh-ancestor
110763010|NCT02578732|Vitamins|vitamins|mesh-ancestor
110763011|NCT02578732|Micronutrients|micronutrients|mesh-ancestor
110763012|NCT02525757|Paclitaxel|paclitaxel|mesh-list
110763013|NCT02525757|Carboplatin|carboplatin|mesh-list
110763014|NCT02525757|Atezolizumab|atezolizumab|mesh-list
110869341|NCT03175666|Bevacizumab|bevacizumab|mesh-list
110763015|NCT02525757|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110763016|NCT02525757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110763017|NCT02525757|Tubulin Modulators|tubulin modulators|mesh-ancestor
110763018|NCT02525757|Antimitotic Agents|antimitotic agents|mesh-ancestor
110314825|NCT00335088|Iodine|iodine|mesh-list
110763019|NCT02525757|Mitosis Modulators|mitosis modulators|mesh-ancestor
110763020|NCT02525757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110763021|NCT02525757|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110763022|NCT02525757|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110763023|NCT02519452|Daratumumab|daratumumab|mesh-list
110763024|NCT02519452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110763025|NCT02505984|Oxytocin|oxytocin|mesh-list
110763026|NCT02505984|Oxytocics|oxytocics|mesh-ancestor
110763027|NCT02505984|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110763028|NCT02505984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110763029|NCT02477280|Methylphenidate|methylphenidate|mesh-list
110763030|NCT02477280|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110763031|NCT02477280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110763032|NCT02477280|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110763033|NCT02477280|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110763034|NCT02477280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110763035|NCT02477280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110763036|NCT02477280|Dopamine Agents|dopamine agents|mesh-ancestor
110763037|NCT02477280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110763038|NCT02438722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110763039|NCT02438722|Cetuximab|cetuximab|mesh-list
110763040|NCT02438722|Afatinib|afatinib|mesh-list
110763041|NCT02438722|Antibodies|antibodies|mesh-list
110763042|NCT02438722|Immunoglobulins|immunoglobulins|mesh-list
110763043|NCT02438722|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110763044|NCT02438722|Immunologic Factors|immunologic factors|mesh-ancestor
110763045|NCT02438722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110763046|NCT02438722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110763047|NCT02438722|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110763048|NCT02438722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110763049|NCT02438722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110763050|NCT02435212|Deferasirox|deferasirox|mesh-list
110763051|NCT02435212|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110763052|NCT02435212|Chelating Agents|chelating agents|mesh-ancestor
110763053|NCT02435212|Sequestering Agents|sequestering agents|mesh-ancestor
110763054|NCT02435212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110763055|NCT02408770|Ulipristal acetate|ulipristal acetate|mesh-list
110763056|NCT02408770|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110763057|NCT02408770|Contraceptive Agents|contraceptive agents|mesh-ancestor
110763058|NCT02408770|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110445524|NCT01192178|Dermatologic Agents|dermatologic agents|mesh-ancestor
110763059|NCT02408770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110763060|NCT02408770|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110763062|NCT02403323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110763063|NCT02403323|Immunologic Factors|immunologic factors|mesh-ancestor
110763064|NCT02403323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110763065|NCT02368665|Amlodipine|amlodipine|mesh-list
110763066|NCT02368665|Candesartan|candesartan|mesh-list
110763067|NCT02368665|Candesartan cilexetil|candesartan cilexetil|mesh-list
110763068|NCT02368665|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110763069|NCT02368665|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110763070|NCT02368665|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110763071|NCT02368665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110763072|NCT02368665|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110763073|NCT02368665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110763074|NCT02368665|Vasodilator Agents|vasodilator agents|mesh-ancestor
110763075|NCT02368665|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110763076|NCT02368665|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110763077|NCT02368652|Amlodipine|amlodipine|mesh-list
110763078|NCT02368652|Candesartan|candesartan|mesh-list
110763079|NCT02368652|Candesartan cilexetil|candesartan cilexetil|mesh-list
110763080|NCT02368652|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110763081|NCT02368652|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110763082|NCT02368652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110763083|NCT02368652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110763084|NCT02368652|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110763085|NCT02368652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110763086|NCT02368652|Vasodilator Agents|vasodilator agents|mesh-ancestor
110763087|NCT02368652|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110763088|NCT02368652|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110763090|NCT02339922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110763091|NCT02339922|Ixazomib|ixazomib|mesh-list
110763092|NCT02339922|Antibodies|antibodies|mesh-list
110763093|NCT02339922|Immunoglobulins|immunoglobulins|mesh-list
110763094|NCT02339922|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110763095|NCT02339922|Glycine|glycine|mesh-list
110763096|NCT02339922|Immunologic Factors|immunologic factors|mesh-ancestor
110763097|NCT02339922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110763098|NCT02339922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110763099|NCT02339922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110763100|NCT02339922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110763101|NCT02339922|Protease Inhibitors|protease inhibitors|mesh-ancestor
110763102|NCT02339922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110763103|NCT02339922|Glycine Agents|glycine agents|mesh-ancestor
110763104|NCT02339922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110763105|NCT02332577|Amoxicillin|amoxicillin|mesh-list
110763106|NCT02332577|Pristinamycin|pristinamycin|mesh-list
110763107|NCT02332577|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110480810|NCT03879577|Tamoxifen|tamoxifen|mesh-list
110763108|NCT02332577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110763109|NCT02330926|Ibuprofen|ibuprofen|mesh-list
110763110|NCT02330926|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110763111|NCT02330926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110763112|NCT02330926|Analgesics|analgesics|mesh-ancestor
110763113|NCT02330926|Sensory System Agents|sensory system agents|mesh-ancestor
110763114|NCT02330926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110763115|NCT02330926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110763116|NCT02330926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110763117|NCT02330926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110763118|NCT02330926|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110763119|NCT02330926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110763120|NCT02330926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110763121|NCT02312245|Paclitaxel|paclitaxel|mesh-list
110763122|NCT02312245|Bevacizumab|bevacizumab|mesh-list
110763123|NCT02312245|Gemcitabine|gemcitabine|mesh-list
110763124|NCT02312245|Doxorubicin|doxorubicin|mesh-list
110763125|NCT02312245|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110763126|NCT02312245|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110763127|NCT02312245|Topotecan|topotecan|mesh-list
110763128|NCT02312245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110763129|NCT02312245|Endothelial Growth Factors|endothelial growth factors|mesh-list
110763130|NCT02312245|Antibodies|antibodies|mesh-list
110763131|NCT02312245|Immunoglobulins|immunoglobulins|mesh-list
110763132|NCT02312245|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110763133|NCT02312245|Immunoglobulin G|immunoglobulin g|mesh-list
110763134|NCT02312245|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110763135|NCT02312245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110763136|NCT02312245|Tubulin Modulators|tubulin modulators|mesh-ancestor
110763137|NCT02312245|Antimitotic Agents|antimitotic agents|mesh-ancestor
110763138|NCT02312245|Mitosis Modulators|mitosis modulators|mesh-ancestor
110763139|NCT02312245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110763140|NCT02312245|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110763141|NCT02312245|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110763142|NCT02312245|Growth Substances|growth substances|mesh-ancestor
110763143|NCT02312245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110763144|NCT02312245|Growth Inhibitors|growth inhibitors|mesh-ancestor
110763145|NCT02312245|Immunologic Factors|immunologic factors|mesh-ancestor
110763146|NCT02312245|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110763147|NCT02312245|Antimetabolites|antimetabolites|mesh-ancestor
110763148|NCT02312245|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110763149|NCT02312245|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110763150|NCT02312245|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110763151|NCT02312245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110763152|NCT02312245|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110763153|NCT02297438|Letrozole|letrozole|mesh-list
110763154|NCT02297438|Palbociclib|palbociclib|mesh-list
110763155|NCT02297438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110763156|NCT02297438|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110763157|NCT02297438|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110763158|NCT02297438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110763159|NCT02297438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110763160|NCT02297438|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110763161|NCT02297438|Hormone Antagonists|hormone antagonists|mesh-ancestor
110763162|NCT02297438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110763163|NCT02297438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110763164|NCT02297438|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110763166|NCT02297139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110763167|NCT02297139|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110763168|NCT02297139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110763169|NCT02297139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110763170|NCT02137759|Temozolomide|temozolomide|mesh-list
110763171|NCT02137759|Belinostat|belinostat|mesh-list
110763172|NCT02137759|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110763173|NCT02137759|Alkylating Agents|alkylating agents|mesh-ancestor
110763174|NCT02137759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110763175|NCT02137759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110763176|NCT02137759|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110763177|NCT02137759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110763178|NCT02115295|Cytarabine|cytarabine|mesh-list
110763179|NCT02115295|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
110763180|NCT02115295|Venetoclax|venetoclax|mesh-list
110763181|NCT02115295|Idarubicin|idarubicin|mesh-list
110763182|NCT02115295|Cladribine|cladribine|mesh-list
110763183|NCT02115295|Midostaurin|midostaurin|mesh-list
110763184|NCT02115295|Staurosporine|staurosporine|mesh-list
110763185|NCT02115295|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110763186|NCT02115295|Antimetabolites|antimetabolites|mesh-ancestor
110763187|NCT02115295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110763188|NCT02115295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110763189|NCT02115295|Antiviral Agents|antiviral agents|mesh-ancestor
110763190|NCT02115295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110763191|NCT02115295|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110763192|NCT02115295|Immunologic Factors|immunologic factors|mesh-ancestor
110763193|NCT02115295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110763194|NCT02115295|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110763195|NCT02115295|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110763196|NCT02115295|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110763197|NCT02115295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110763198|NCT02115295|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110763199|NCT02090998|Lidocaine|lidocaine|mesh-list
110763200|NCT02090998|Amitriptyline|amitriptyline|mesh-list
110763201|NCT02090998|Anesthetics, Local|anesthetics, local|mesh-ancestor
110763202|NCT02090998|Anesthetics|anesthetics|mesh-ancestor
110763203|NCT02090998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110763204|NCT02090998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110763205|NCT02090998|Sensory System Agents|sensory system agents|mesh-ancestor
110763206|NCT02090998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110763207|NCT02090998|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110763208|NCT02090998|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110763209|NCT02090998|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110763210|NCT02090998|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110763211|NCT02090998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110763212|NCT02090998|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110763213|NCT02090998|Antidepressive Agents|antidepressive agents|mesh-ancestor
110763215|NCT02090998|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110763216|NCT02090998|Analgesics|analgesics|mesh-ancestor
110763217|NCT02090998|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110763218|NCT02090998|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110763219|NCT02090998|Adrenergic Agents|adrenergic agents|mesh-ancestor
110763220|NCT02090998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110763221|NCT02043665|Pembrolizumab|pembrolizumab|mesh-list
110763222|NCT02043665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110763223|NCT02043665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110763224|NCT02043665|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110763225|NCT02043665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110763226|NCT01912651|Cephalexin|cephalexin|mesh-list
110763227|NCT01912651|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110763228|NCT01912651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110763229|NCT01912625|Paclitaxel|paclitaxel|mesh-list
110763230|NCT01912625|Carboplatin|carboplatin|mesh-list
110763231|NCT01912625|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110763232|NCT01912625|Trametinib|trametinib|mesh-list
110763233|NCT01912625|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110763234|NCT01912625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110763235|NCT01912625|Tubulin Modulators|tubulin modulators|mesh-ancestor
110763236|NCT01912625|Antimitotic Agents|antimitotic agents|mesh-ancestor
110763237|NCT01912625|Mitosis Modulators|mitosis modulators|mesh-ancestor
110763238|NCT01912625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110763239|NCT01912625|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110763240|NCT01912625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110763241|NCT01817166|Vitamin D|vitamin d|mesh-list
110763242|NCT01817166|Cholecalciferol|cholecalciferol|mesh-list
110763243|NCT01817166|Vitamins|vitamins|mesh-ancestor
110763244|NCT01817166|Micronutrients|micronutrients|mesh-ancestor
110763245|NCT01817166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110763246|NCT01817166|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110763247|NCT01817166|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110763248|NCT01814813|Bevacizumab|bevacizumab|mesh-list
110763249|NCT01814813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110763250|NCT01814813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110763251|NCT01814813|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110763252|NCT01814813|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110763253|NCT01814813|Growth Substances|growth substances|mesh-ancestor
110763254|NCT01814813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110763255|NCT01814813|Growth Inhibitors|growth inhibitors|mesh-ancestor
110763256|NCT01720836|Poly ICLC|poly iclc|mesh-list
110763257|NCT01720836|Interferon Inducers|interferon inducers|mesh-ancestor
110763258|NCT01720836|Immunologic Factors|immunologic factors|mesh-ancestor
110763259|NCT01720836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110480952|NCT04297202|Apatinib|apatinib|mesh-list
110763260|NCT01667120|Ketorolac|ketorolac|mesh-list
110763261|NCT01667120|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110763262|NCT01667120|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110763263|NCT01667120|Analgesics|analgesics|mesh-ancestor
110763264|NCT01667120|Sensory System Agents|sensory system agents|mesh-ancestor
110763265|NCT01667120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110763266|NCT01667120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110763267|NCT01667120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110763268|NCT01667120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110763269|NCT01667120|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110763270|NCT01667120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110763271|NCT01667120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110763272|NCT01642251|Cisplatin|cisplatin|mesh-list
110763273|NCT01642251|Etoposide|etoposide|mesh-list
110763274|NCT01642251|Etoposide phosphate|etoposide phosphate|mesh-list
110763275|NCT01642251|Veliparib|veliparib|mesh-list
110763276|NCT01642251|Podophyllotoxin|podophyllotoxin|mesh-list
110763277|NCT01642251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110763278|NCT01642251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110763279|NCT01642251|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110763280|NCT01642251|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110763281|NCT01642251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110763282|NCT01642251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110763283|NCT01642251|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110763284|NCT01642251|Keratolytic Agents|keratolytic agents|mesh-ancestor
110763285|NCT01642251|Dermatologic Agents|dermatologic agents|mesh-ancestor
110763286|NCT01642251|Tubulin Modulators|tubulin modulators|mesh-ancestor
110763287|NCT01642251|Antimitotic Agents|antimitotic agents|mesh-ancestor
110763288|NCT01642251|Mitosis Modulators|mitosis modulators|mesh-ancestor
110763290|NCT01606137|Analgesics|analgesics|mesh-ancestor
110763291|NCT01606137|Sensory System Agents|sensory system agents|mesh-ancestor
110763292|NCT01606137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110763293|NCT01606137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110763294|NCT01532518|MEN 11420|men 11420|mesh-list
110763295|NCT01532518|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110763296|NCT01532518|Autonomic Agents|autonomic agents|mesh-ancestor
110763297|NCT01532518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110763298|NCT01532518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110763299|NCT01532518|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110763300|NCT01532518|Respiratory System Agents|respiratory system agents|mesh-ancestor
110763301|NCT01489813|Genistein|genistein|mesh-list
110763302|NCT01489813|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110763303|NCT01489813|Protective Agents|protective agents|mesh-ancestor
110763304|NCT01489813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110763305|NCT01489813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110763306|NCT01489813|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110763307|NCT01489813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110763308|NCT01489813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110763309|NCT01489813|Phytoestrogens|phytoestrogens|mesh-ancestor
110763310|NCT01489813|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
110763311|NCT01489813|Estrogens|estrogens|mesh-ancestor
110763312|NCT01489813|Hormones|hormones|mesh-ancestor
110763313|NCT01489813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110763314|NCT01420874|Leucovorin|leucovorin|mesh-list
110763315|NCT01420874|Fluorouracil|fluorouracil|mesh-list
110763316|NCT01420874|Oxaliplatin|oxaliplatin|mesh-list
110763317|NCT01420874|Antimetabolites|antimetabolites|mesh-ancestor
110763318|NCT01420874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110763319|NCT01420874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110763320|NCT01420874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110763321|NCT01420874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110763322|NCT01420874|Immunologic Factors|immunologic factors|mesh-ancestor
110763323|NCT01420874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110763324|NCT01420874|Antidotes|antidotes|mesh-ancestor
110763325|NCT01420874|Protective Agents|protective agents|mesh-ancestor
110763326|NCT01420874|Vitamin B Complex|vitamin b complex|mesh-ancestor
110763327|NCT01420874|Vitamins|vitamins|mesh-ancestor
110763328|NCT01420874|Micronutrients|micronutrients|mesh-ancestor
110763329|NCT01405521|Vaccines|vaccines|mesh-list
110763330|NCT01405521|Immunologic Factors|immunologic factors|mesh-ancestor
110763331|NCT01405521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110763332|NCT01027000|Sirolimus|sirolimus|mesh-list
110763333|NCT01027000|Cyclophosphamide|cyclophosphamide|mesh-list
110763334|NCT01027000|Busulfan|busulfan|mesh-list
110763335|NCT01027000|Rituximab|rituximab|mesh-list
110763336|NCT01027000|Methotrexate|methotrexate|mesh-list
110481024|NCT02601898|Thioctic Acid|thioctic acid|mesh-list
110763338|NCT01027000|Fludarabine phosphate|fludarabine phosphate|mesh-list
110763339|NCT01027000|Tacrolimus|tacrolimus|mesh-list
110763340|NCT01027000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110763341|NCT01027000|Immunologic Factors|immunologic factors|mesh-ancestor
110763342|NCT01027000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110763343|NCT01027000|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110763344|NCT01027000|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110763345|NCT01027000|Alkylating Agents|alkylating agents|mesh-ancestor
110763346|NCT01027000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110763347|NCT01027000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110763348|NCT01027000|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110763349|NCT01027000|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110763350|NCT01027000|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110763351|NCT01027000|Abortifacient Agents|abortifacient agents|mesh-ancestor
110763352|NCT01027000|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110763353|NCT01027000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110763354|NCT01027000|Antimetabolites|antimetabolites|mesh-ancestor
110763355|NCT01027000|Dermatologic Agents|dermatologic agents|mesh-ancestor
110763356|NCT01027000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110763357|NCT01027000|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110763358|NCT01027000|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110763359|NCT01027000|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110763360|NCT01027000|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110763361|NCT01027000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110763362|NCT01027000|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110763363|NCT01027000|Antifungal Agents|antifungal agents|mesh-ancestor
110763364|NCT00861068|Lacosamide|lacosamide|mesh-list
110763365|NCT00861068|Anticonvulsants|anticonvulsants|mesh-ancestor
110763366|NCT00861068|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110763367|NCT00861068|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110763368|NCT00861068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110763369|NCT00861068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110763370|NCT00844285|Certolizumab Pegol|certolizumab pegol|mesh-list
110763371|NCT00844285|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110763372|NCT00844285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110763373|NCT00844285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110763374|NCT00844285|Immunologic Factors|immunologic factors|mesh-ancestor
110763375|NCT00844285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110763376|NCT00844285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110763377|NCT00841789|Etanercept|etanercept|mesh-list
110763378|NCT00841789|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110763379|NCT00841789|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110763380|NCT00841789|Analgesics|analgesics|mesh-ancestor
110763381|NCT00841789|Sensory System Agents|sensory system agents|mesh-ancestor
110763382|NCT00841789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110763383|NCT00841789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110763384|NCT00841789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110763385|NCT00841789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110763386|NCT00841789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110763387|NCT00841789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110763388|NCT00841789|Immunologic Factors|immunologic factors|mesh-ancestor
110763389|NCT00711646|Nabiximols|nabiximols|mesh-list
110763390|NCT00711646|Analgesics|analgesics|mesh-ancestor
110763391|NCT00711646|Sensory System Agents|sensory system agents|mesh-ancestor
110763392|NCT00711646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110763393|NCT00711646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110763394|NCT00702468|Nabiximols|nabiximols|mesh-list
110763395|NCT00702468|Analgesics|analgesics|mesh-ancestor
110763396|NCT00702468|Sensory System Agents|sensory system agents|mesh-ancestor
110763397|NCT00702468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110763398|NCT00702468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110763399|NCT00681538|Nabiximols|nabiximols|mesh-list
110763400|NCT00681538|Analgesics|analgesics|mesh-ancestor
110763401|NCT00681538|Sensory System Agents|sensory system agents|mesh-ancestor
110763402|NCT00681538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110763403|NCT00681538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110763404|NCT00634634|Sorafenib|sorafenib|mesh-list
110763405|NCT00634634|Letrozole|letrozole|mesh-list
110763406|NCT00634634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110763407|NCT00634634|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110763408|NCT00634634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110869405|NCT03173326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110763409|NCT00634634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110763410|NCT00634634|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110481106|NCT01068665|Insulin|insulin|mesh-list
110763411|NCT00634634|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110763412|NCT00634634|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110763413|NCT00634634|Hormone Antagonists|hormone antagonists|mesh-ancestor
110763414|NCT00634634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110763415|NCT00634634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110763417|NCT00497029|Fluorides, Topical|fluorides, topical|mesh-list
110763418|NCT00497029|Cariostatic Agents|cariostatic agents|mesh-ancestor
110763419|NCT00497029|Protective Agents|protective agents|mesh-ancestor
110763420|NCT00497029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110763421|NCT00455351|Vorinostat|vorinostat|mesh-list
110763422|NCT00455351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110763423|NCT00455351|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110763424|NCT00455351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110763425|NCT00455351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110763426|NCT00379340|Dactinomycin|dactinomycin|mesh-list
110763427|NCT00379340|Cactinomycin|cactinomycin|mesh-list
110763428|NCT00379340|Cyclophosphamide|cyclophosphamide|mesh-list
110763429|NCT00379340|Doxorubicin|doxorubicin|mesh-list
110763430|NCT00379340|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110763431|NCT00379340|Etoposide|etoposide|mesh-list
110763432|NCT00379340|Vincristine|vincristine|mesh-list
110763433|NCT00379340|Etoposide phosphate|etoposide phosphate|mesh-list
110763434|NCT00379340|Podophyllotoxin|podophyllotoxin|mesh-list
110763435|NCT00379340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110763436|NCT00379340|Immunologic Factors|immunologic factors|mesh-ancestor
110763437|NCT00379340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110763438|NCT00379340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110763439|NCT00379340|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110763440|NCT00379340|Alkylating Agents|alkylating agents|mesh-ancestor
110315050|NCT00336648|Growth Inhibitors|growth inhibitors|mesh-ancestor
110763441|NCT00379340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110763442|NCT00379340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110763443|NCT00379340|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110763444|NCT00379340|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110763445|NCT00379340|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110763446|NCT00379340|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110763447|NCT00379340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110763448|NCT00379340|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110763449|NCT00379340|Tubulin Modulators|tubulin modulators|mesh-ancestor
110763450|NCT00379340|Antimitotic Agents|antimitotic agents|mesh-ancestor
110763451|NCT00379340|Mitosis Modulators|mitosis modulators|mesh-ancestor
110763452|NCT00379340|Keratolytic Agents|keratolytic agents|mesh-ancestor
110763453|NCT00379340|Dermatologic Agents|dermatologic agents|mesh-ancestor
110763454|NCT00379340|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110763455|NCT00379340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110763456|NCT00379340|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110763457|NCT00379340|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110763458|NCT00301808|Docetaxel|docetaxel|mesh-list
110763459|NCT00301808|Pemetrexed|pemetrexed|mesh-list
110763460|NCT00301808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110763461|NCT00301808|Tubulin Modulators|tubulin modulators|mesh-ancestor
110763462|NCT00301808|Antimitotic Agents|antimitotic agents|mesh-ancestor
110763463|NCT00301808|Mitosis Modulators|mitosis modulators|mesh-ancestor
110763464|NCT00301808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110763465|NCT00301808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110763466|NCT00301808|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110763467|NCT00301808|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110763468|NCT00254670|Naltrexone|naltrexone|mesh-list
110763469|NCT00254670|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110763470|NCT00254670|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110763471|NCT00254670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110763472|NCT00254670|Sensory System Agents|sensory system agents|mesh-ancestor
110763473|NCT00254670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110763474|NCT00138801|Doxycycline|doxycycline|mesh-list
110763475|NCT00138801|Ceftriaxone|ceftriaxone|mesh-list
110763476|NCT00138801|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110763477|NCT00138801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110763478|NCT00138801|Antimalarials|antimalarials|mesh-ancestor
110763479|NCT00138801|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110763480|NCT00138801|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110763481|NCT05795478|Pregabalin|pregabalin|mesh-list
110763482|NCT05795478|Oxycodone|oxycodone|mesh-list
110763483|NCT05795478|Analgesics|analgesics|mesh-ancestor
110763484|NCT05795478|Sensory System Agents|sensory system agents|mesh-ancestor
110763485|NCT05795478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110763486|NCT05795478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110763487|NCT05795478|Anticonvulsants|anticonvulsants|mesh-ancestor
110763488|NCT05795478|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110763489|NCT05795478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110763490|NCT05795478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110763491|NCT05795478|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110763492|NCT05795478|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110763493|NCT05795478|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110763494|NCT05795478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110315097|NCT00230477|Lamivudine|lamivudine|mesh-list
110763495|NCT05795478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110763496|NCT05795478|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110763497|NCT05795478|Narcotics|narcotics|mesh-ancestor
110763498|NCT05795413|Bupivacaine|bupivacaine|mesh-list
110763499|NCT05795413|Anesthetics, Local|anesthetics, local|mesh-ancestor
110763500|NCT05795413|Anesthetics|anesthetics|mesh-ancestor
110763501|NCT05795413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110763502|NCT05795413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110763503|NCT05795413|Sensory System Agents|sensory system agents|mesh-ancestor
110763504|NCT05795413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110763505|NCT05795400|Dapagliflozin|dapagliflozin|mesh-list
110763506|NCT05795400|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110763507|NCT05795400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110763508|NCT05795400|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110763509|NCT05795400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110763510|NCT05795283|Dexetimide|dexetimide|mesh-list
110763511|NCT05795283|Citalopram|citalopram|mesh-list
110763512|NCT05795283|Escitalopram|escitalopram|mesh-list
110763513|NCT05795283|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110763514|NCT05795283|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110763515|NCT05795283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110763516|NCT05795283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110763517|NCT05795283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110763518|NCT05795283|Serotonin Agents|serotonin agents|mesh-ancestor
110763519|NCT05795283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110763520|NCT05795283|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110763521|NCT05795283|Antidepressive Agents|antidepressive agents|mesh-ancestor
110763522|NCT05795283|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110763523|NCT05795283|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110763524|NCT05795283|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110763525|NCT05795283|Parasympatholytics|parasympatholytics|mesh-ancestor
110763526|NCT05795283|Autonomic Agents|autonomic agents|mesh-ancestor
110763527|NCT05795283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110763528|NCT05795283|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110763529|NCT05795283|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110763530|NCT05795283|Cholinergic Agents|cholinergic agents|mesh-ancestor
110763531|NCT05795244|Nivolumab|nivolumab|mesh-list
110763532|NCT05795244|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110763533|NCT05795244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110763534|NCT05795244|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110763535|NCT05795244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110763536|NCT05794919|Calcium, Dietary|calcium, dietary|mesh-list
110763537|NCT05794919|Phenol|phenol|mesh-list
110763538|NCT05794919|Calcium|calcium|mesh-list
110763539|NCT05794919|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110763540|NCT05794919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110763541|NCT05794919|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110763542|NCT05794919|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110763543|NCT05794919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110763544|NCT05794919|Disinfectants|disinfectants|mesh-ancestor
110763545|NCT05794919|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
110763546|NCT05794919|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110763547|NCT05794425|Cyclosporine|cyclosporine|mesh-list
110763548|NCT05794425|Cyclosporins|cyclosporins|mesh-list
110763549|NCT05794425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110763550|NCT05794425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110763551|NCT05794425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110763552|NCT05794425|Immunologic Factors|immunologic factors|mesh-ancestor
110763553|NCT05794425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110763554|NCT05794425|Antifungal Agents|antifungal agents|mesh-ancestor
110763555|NCT05794425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110763556|NCT05794425|Dermatologic Agents|dermatologic agents|mesh-ancestor
110763557|NCT05794425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110763558|NCT05794425|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110763559|NCT05726097|Ascorbic Acid|ascorbic acid|mesh-list
110763560|NCT05726097|Prucalopride|prucalopride|mesh-list
110763561|NCT05726097|Picosulfate sodium|picosulfate sodium|mesh-list
110763562|NCT05726097|Antioxidants|antioxidants|mesh-ancestor
110763563|NCT05726097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110763564|NCT05726097|Protective Agents|protective agents|mesh-ancestor
110763565|NCT05726097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110763566|NCT05726097|Vitamins|vitamins|mesh-ancestor
110763567|NCT05726097|Micronutrients|micronutrients|mesh-ancestor
110763568|NCT05726097|Laxatives|laxatives|mesh-ancestor
110763569|NCT05726097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110763570|NCT05726097|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
110763571|NCT05726097|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110763572|NCT05726097|Serotonin Agents|serotonin agents|mesh-ancestor
110763573|NCT05726097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110763574|NCT05726097|Cathartics|cathartics|mesh-ancestor
110763575|NCT05712343|Valacyclovir|valacyclovir|mesh-list
110763576|NCT05712343|Antiviral Agents|antiviral agents|mesh-ancestor
110763577|NCT05712343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110763579|NCT05703425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110763580|NCT05703425|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110763581|NCT05703425|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110763582|NCT05703425|Analgesics|analgesics|mesh-ancestor
110763583|NCT05703425|Sensory System Agents|sensory system agents|mesh-ancestor
110763584|NCT05703425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110763585|NCT05703425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110763586|NCT05703425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110763587|NCT05703425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110763588|NCT05703425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110763589|NCT05690503|Ketamine|ketamine|mesh-list
110763590|NCT05690503|Analgesics|analgesics|mesh-ancestor
110763591|NCT05690503|Sensory System Agents|sensory system agents|mesh-ancestor
110763592|NCT05690503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110763593|NCT05690503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110763594|NCT05690503|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110763595|NCT05690503|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110763596|NCT05690503|Anesthetics, General|anesthetics, general|mesh-ancestor
110763597|NCT05690503|Anesthetics|anesthetics|mesh-ancestor
110763598|NCT05690503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110763599|NCT05690503|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110763600|NCT05690503|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110763601|NCT05690503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110763602|NCT05690503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110763603|NCT05624606|Vaccines|vaccines|mesh-list
110763604|NCT05624606|Immunologic Factors|immunologic factors|mesh-ancestor
110763605|NCT05624606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110763606|NCT05588648|Vactosertib|vactosertib|mesh-list
110763607|NCT05588648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110763608|NCT05588648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110763609|NCT05588648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110763610|NCT05571267|Bevacizumab|bevacizumab|mesh-list
110763611|NCT05571267|Ranibizumab|ranibizumab|mesh-list
110763612|NCT05571267|Aflibercept|aflibercept|mesh-list
110763613|NCT05571267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110763614|NCT05571267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110763615|NCT05571267|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110315126|NCT00336882|GABA Modulators|gaba modulators|mesh-ancestor
110763616|NCT05571267|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110763617|NCT05571267|Growth Substances|growth substances|mesh-ancestor
110763618|NCT05571267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110763619|NCT05571267|Growth Inhibitors|growth inhibitors|mesh-ancestor
110763620|NCT05550194|Valacyclovir|valacyclovir|mesh-list
110763621|NCT05550194|Antiviral Agents|antiviral agents|mesh-ancestor
110763622|NCT05550194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110763623|NCT05477459|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
110763624|NCT05477459|Hallucinogens|hallucinogens|mesh-ancestor
110869433|NCT03170284|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110763625|NCT05477459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110763626|NCT05477459|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110763627|NCT05477459|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110763628|NCT05477459|Serotonin Agents|serotonin agents|mesh-ancestor
110763629|NCT05477459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110763630|NCT05477459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110763631|NCT05477459|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110763632|NCT05426486|Carboplatin|carboplatin|mesh-list
110763633|NCT05426486|Docetaxel|docetaxel|mesh-list
110763634|NCT05426486|Trastuzumab|trastuzumab|mesh-list
110763635|NCT05426486|Pertuzumab|pertuzumab|mesh-list
110763636|NCT05426486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110763637|NCT05426486|Tubulin Modulators|tubulin modulators|mesh-ancestor
110763638|NCT05426486|Antimitotic Agents|antimitotic agents|mesh-ancestor
110763639|NCT05426486|Mitosis Modulators|mitosis modulators|mesh-ancestor
110763640|NCT05426486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110763641|NCT05426486|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110763642|NCT05399290|Doxycycline|doxycycline|mesh-list
110763643|NCT05399290|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110763644|NCT05399290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110763645|NCT05399290|Antimalarials|antimalarials|mesh-ancestor
110763646|NCT05399290|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110763647|NCT05399290|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110763648|NCT05389852|Dexmedetomidine|dexmedetomidine|mesh-list
110763649|NCT05389852|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110763650|NCT05389852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110088680|NCT05294640|Mydriatics|mydriatics|mesh-ancestor
110763651|NCT05389852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110763652|NCT05389852|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110763654|NCT05389852|Sensory System Agents|sensory system agents|mesh-ancestor
110763655|NCT05389852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110763656|NCT05389852|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110763657|NCT05389852|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110763658|NCT05389852|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110763659|NCT05389852|Adrenergic Agents|adrenergic agents|mesh-ancestor
110763660|NCT05389852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110763661|NCT05389852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110763662|NCT05386914|Sirolimus|sirolimus|mesh-list
110763663|NCT05386914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110763664|NCT05386914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110763665|NCT05386914|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110763666|NCT05386914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110763667|NCT05386914|Antifungal Agents|antifungal agents|mesh-ancestor
110763668|NCT05386914|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110763669|NCT05386914|Immunologic Factors|immunologic factors|mesh-ancestor
110763670|NCT05386914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110763671|NCT05352828|Nivolumab|nivolumab|mesh-list
110763672|NCT05352828|Fludarabine|fludarabine|mesh-list
110763673|NCT05352828|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110763674|NCT05352828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110763675|NCT05352828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110763676|NCT05352828|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110763677|NCT05352828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110763678|NCT05352828|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110763679|NCT05352828|Alkylating Agents|alkylating agents|mesh-ancestor
110763680|NCT05318469|Ivermectin|ivermectin|mesh-list
110763681|NCT05318469|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110763682|NCT05318469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110763683|NCT05318248|Clonidine|clonidine|mesh-list
110763684|NCT05318248|Analgesics|analgesics|mesh-ancestor
110763685|NCT05318248|Sensory System Agents|sensory system agents|mesh-ancestor
110763686|NCT05318248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110763687|NCT05318248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110763688|NCT05318248|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110763689|NCT05318248|Sympatholytics|sympatholytics|mesh-ancestor
110763690|NCT05318248|Autonomic Agents|autonomic agents|mesh-ancestor
110763691|NCT05318248|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110763692|NCT05318248|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110763693|NCT05318248|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110763694|NCT05318248|Adrenergic Agents|adrenergic agents|mesh-ancestor
110763695|NCT05318248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110763696|NCT05318248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110869437|NCT03170284|Growth Inhibitors|growth inhibitors|mesh-ancestor
110763697|NCT05290493|5-((2-(6-Amino-9H-purin-9-yl) ethyl) amino)-1-pentanol|5-((2-(6-amino-9h-purin-9-yl) ethyl) amino)-1-pentanol|mesh-list
110763698|NCT05290493|Adenylyl Cyclase Inhibitors|adenylyl cyclase inhibitors|mesh-ancestor
110763699|NCT05290493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110763700|NCT05290493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110763701|NCT05287256|Dronabinol|dronabinol|mesh-list
110763702|NCT05287256|Hallucinogens|hallucinogens|mesh-ancestor
110763703|NCT05287256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110763704|NCT05287256|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110763705|NCT05287256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110763706|NCT05287256|Analgesics|analgesics|mesh-ancestor
110763707|NCT05287256|Sensory System Agents|sensory system agents|mesh-ancestor
110763708|NCT05287256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110763709|NCT05287256|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
110763710|NCT05287256|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110763711|NCT05287256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110763712|NCT05287256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110763713|NCT05287256|Hormones|hormones|mesh-ancestor
110763714|NCT05287256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110763715|NCT05219266|Midostaurin|midostaurin|mesh-list
110763716|NCT05219266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110763717|NCT05219266|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110763718|NCT05219266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110763719|NCT05219266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110763720|NCT05204862|Antibodies|antibodies|mesh-list
110763721|NCT05204862|Immunologic Factors|immunologic factors|mesh-ancestor
110315226|NCT00337506|Bortezomib|bortezomib|mesh-list
110763722|NCT05204862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110763723|NCT05193851|Ricolinostat|ricolinostat|mesh-list
110763724|NCT05193851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110763725|NCT05193851|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110763726|NCT05193851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110763727|NCT05193851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110763728|NCT05193318|Ketamine|ketamine|mesh-list
110763729|NCT05193318|Analgesics|analgesics|mesh-ancestor
110763730|NCT05193318|Sensory System Agents|sensory system agents|mesh-ancestor
110763731|NCT05193318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110763732|NCT05193318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110763733|NCT05193318|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110763734|NCT05193318|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110763735|NCT05193318|Anesthetics, General|anesthetics, general|mesh-ancestor
110763736|NCT05193318|Anesthetics|anesthetics|mesh-ancestor
110763737|NCT05193318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110763738|NCT05193318|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110763739|NCT05193318|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110763740|NCT05193318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110763741|NCT05193318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110763742|NCT05163041|Nivolumab|nivolumab|mesh-list
110763743|NCT05163041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110763744|NCT05163041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110763745|NCT05163041|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110763746|NCT05163041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110763747|NCT05138575|Empagliflozin|empagliflozin|mesh-list
110763748|NCT05138575|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110763749|NCT05138575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110763750|NCT05138575|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110763751|NCT05138575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110763752|NCT05122559|Acetylcysteine|acetylcysteine|mesh-list
110763753|NCT05122559|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110763754|NCT05122559|Antiviral Agents|antiviral agents|mesh-ancestor
110763755|NCT05122559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110763756|NCT05122559|Expectorants|expectorants|mesh-ancestor
110763757|NCT05122559|Respiratory System Agents|respiratory system agents|mesh-ancestor
110763758|NCT05122559|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110763759|NCT05122559|Antioxidants|antioxidants|mesh-ancestor
110763760|NCT05122559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110763761|NCT05122559|Protective Agents|protective agents|mesh-ancestor
110869440|NCT03170050|Lidocaine|lidocaine|mesh-list
110763762|NCT05122559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110763763|NCT05122559|Antidotes|antidotes|mesh-ancestor
110763764|NCT05112666|Rivaroxaban|rivaroxaban|mesh-list
110763765|NCT05112666|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110763766|NCT05112666|Antithrombins|antithrombins|mesh-ancestor
110763767|NCT05112666|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110763768|NCT05112666|Protease Inhibitors|protease inhibitors|mesh-ancestor
110763769|NCT05112666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110763770|NCT05112666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110763771|NCT05112666|Anticoagulants|anticoagulants|mesh-ancestor
110763772|NCT05080764|Aminolevulinic Acid|aminolevulinic acid|mesh-list
110763773|NCT05080764|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110763774|NCT05080764|Dermatologic Agents|dermatologic agents|mesh-ancestor
110763775|NCT05054725|Sotorasib|sotorasib|mesh-list
110763776|NCT05054725|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110763777|NCT05054725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110763778|NCT05054725|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110763779|NCT05054725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110763780|NCT05046522|Palmidrol|palmidrol|mesh-list
110763781|NCT05046522|Analgesics|analgesics|mesh-ancestor
110763782|NCT05046522|Sensory System Agents|sensory system agents|mesh-ancestor
110763783|NCT05046522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110763784|NCT05046522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110763785|NCT05046522|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110682900|NCT00899951|Anesthetics|anesthetics|mesh-ancestor
110763786|NCT05046522|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110763787|NCT05046522|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110763788|NCT05046522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110763789|NCT05046522|Antiviral Agents|antiviral agents|mesh-ancestor
110763790|NCT05046522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110763791|NCT05046522|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
110763792|NCT05046522|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110763793|NCT05046522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110763794|NCT05046522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110763795|NCT05046522|Hormones|hormones|mesh-ancestor
110763796|NCT05046522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110763797|NCT05046132|Moxifloxacin|moxifloxacin|mesh-list
110763798|NCT05046132|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110763799|NCT05046132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110763800|NCT05046132|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110763801|NCT05046132|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110763802|NCT05046132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110763803|NCT05046132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110763804|NCT05046132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110763805|NCT04915482|Antibodies|antibodies|mesh-list
110763806|NCT04915482|Immunologic Factors|immunologic factors|mesh-ancestor
110763807|NCT04915482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110763808|NCT04897971|Antibodies|antibodies|mesh-list
110763809|NCT04897971|Immunologic Factors|immunologic factors|mesh-ancestor
110763810|NCT04897971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110763811|NCT04857827|Timolol|timolol|mesh-list
110763812|NCT04857827|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110763813|NCT04857827|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110763814|NCT04857827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110763815|NCT04857827|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110763816|NCT04857827|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110763817|NCT04857827|Adrenergic Agents|adrenergic agents|mesh-ancestor
110763818|NCT04857827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110763819|NCT04857827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110763820|NCT04857827|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110763821|NCT04857827|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110763822|NCT04796584|Antibodies|antibodies|mesh-list
110763823|NCT04796584|Immunologic Factors|immunologic factors|mesh-ancestor
110763824|NCT04796584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110763825|NCT04725149|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110763826|NCT04716075|Acalabrutinib|acalabrutinib|mesh-list
110763827|NCT04716075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110763828|NCT04712539|Oseltamivir|oseltamivir|mesh-list
110763829|NCT04712539|Baloxavir|baloxavir|mesh-list
110763830|NCT04712539|Antiviral Agents|antiviral agents|mesh-ancestor
110763831|NCT04712539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110763832|NCT04712539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110763833|NCT04712539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110763834|NCT04688931|Mitomycins|mitomycins|mesh-list
110763835|NCT04688931|Mitomycin|mitomycin|mesh-list
110763836|NCT04688931|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110763837|NCT04688931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110763838|NCT04688931|Alkylating Agents|alkylating agents|mesh-ancestor
110763839|NCT04688931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110763840|NCT04688931|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110763841|NCT04688931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110763842|NCT04630769|Interleukin-2|interleukin-2|mesh-list
110763843|NCT04630769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110763844|NCT04630769|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110763845|NCT04630769|Analgesics|analgesics|mesh-ancestor
110763846|NCT04630769|Sensory System Agents|sensory system agents|mesh-ancestor
110763847|NCT04630769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110763848|NCT04630769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110763849|NCT04543188|Midazolam|midazolam|mesh-list
110763850|NCT04543188|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110763851|NCT04543188|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110763852|NCT04543188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110763853|NCT04543188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110763854|NCT04543188|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110763855|NCT04543188|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110763856|NCT04543188|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110763857|NCT04543188|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110763858|NCT04543188|Anesthetics, General|anesthetics, general|mesh-ancestor
110763859|NCT04543188|Anesthetics|anesthetics|mesh-ancestor
110682901|NCT02539979|Acetaminophen|acetaminophen|mesh-list
110481556|NCT02539537|Leucovorin|leucovorin|mesh-list
110763860|NCT04543188|GABA Modulators|gaba modulators|mesh-ancestor
110763861|NCT04543188|GABA Agents|gaba agents|mesh-ancestor
110763862|NCT04543188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110763863|NCT04543188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110763864|NCT04477512|Prednisone|prednisone|mesh-list
110763865|NCT04477512|Nivolumab|nivolumab|mesh-list
110763866|NCT04477512|Abiraterone Acetate|abiraterone acetate|mesh-list
110763867|NCT04477512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110763868|NCT04477512|Glucocorticoids|glucocorticoids|mesh-ancestor
110763869|NCT04477512|Hormones|hormones|mesh-ancestor
110763870|NCT04477512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110763871|NCT04477512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110763872|NCT04477512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110763873|NCT04477512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110763874|NCT04477512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110763875|NCT04477512|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110763876|NCT04477512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110763877|NCT04477512|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110315361|NCT00338091|Losartan|losartan|mesh-list
110763878|NCT04477512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110763879|NCT04477512|Hormone Antagonists|hormone antagonists|mesh-ancestor
110763880|NCT04477512|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110763881|NCT04459273|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110763882|NCT04459273|FAPI-46|fapi-46|mesh-list
110763883|NCT04459273|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110763884|NCT04459273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110763885|NCT04457232|FAPI-46|fapi-46|mesh-list
110763886|NCT04457232|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110763887|NCT04457232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110763888|NCT04407247|Infliximab|infliximab|mesh-list
110763889|NCT04407247|Vedolizumab|vedolizumab|mesh-list
110763890|NCT04407247|Immunoglobulins|immunoglobulins|mesh-list
110763891|NCT04407247|Immunoglobulin G|immunoglobulin g|mesh-list
110763892|NCT04407247|Immunologic Factors|immunologic factors|mesh-ancestor
110763893|NCT04407247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110763894|NCT04407247|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110763895|NCT04407247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110763896|NCT04407247|Dermatologic Agents|dermatologic agents|mesh-ancestor
110763897|NCT04407247|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110763898|NCT04407247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110763899|NCT04349124|Nifedipine|nifedipine|mesh-list
110869453|NCT02407834|Eusol|eusol|mesh-list
110763900|NCT04349124|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110763901|NCT04349124|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110763902|NCT04349124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110763903|NCT04349124|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110763904|NCT04349124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110763905|NCT04349124|Vasodilator Agents|vasodilator agents|mesh-ancestor
110763907|NCT04349124|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110763908|NCT04348292|Sirolimus|sirolimus|mesh-list
110763909|NCT04348292|Durvalumab|durvalumab|mesh-list
110763910|NCT04348292|Immunoglobulins|immunoglobulins|mesh-list
110315406|NCT00308321|Prednisolone|prednisolone|mesh-list
110763911|NCT04348292|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110763912|NCT04348292|Immunoglobulin G|immunoglobulin g|mesh-list
110763913|NCT04348292|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110763914|NCT04348292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110763915|NCT04348292|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110763916|NCT04348292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110763917|NCT04348292|Antifungal Agents|antifungal agents|mesh-ancestor
110763918|NCT04348292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110763919|NCT04348292|Immunologic Factors|immunologic factors|mesh-ancestor
110763920|NCT04348292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110763921|NCT04348292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110763922|NCT04316676|Regadenoson|regadenoson|mesh-list
110763923|NCT04316676|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
110763924|NCT04316676|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
110763925|NCT04316676|Purinergic Agonists|purinergic agonists|mesh-ancestor
110763926|NCT04316676|Purinergic Agents|purinergic agents|mesh-ancestor
110763927|NCT04316676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110763928|NCT04316676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110763929|NCT04316676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110763930|NCT04147494|Edetic Acid|edetic acid|mesh-list
110763931|NCT04147494|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
110763932|NCT04147494|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110763933|NCT04147494|FAPI-46|fapi-46|mesh-list
110763934|NCT04147494|Chelating Agents|chelating agents|mesh-ancestor
110763935|NCT04147494|Sequestering Agents|sequestering agents|mesh-ancestor
110763936|NCT04147494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110763938|NCT04147494|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110763939|NCT04147494|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110763940|NCT04138706|Vancomycin|vancomycin|mesh-list
110763941|NCT04138706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110763942|NCT04138706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110763943|NCT03991403|Paclitaxel|paclitaxel|mesh-list
110763944|NCT03991403|Bevacizumab|bevacizumab|mesh-list
110763945|NCT03991403|Carboplatin|carboplatin|mesh-list
110763946|NCT03991403|Pemetrexed|pemetrexed|mesh-list
110763947|NCT03991403|Atezolizumab|atezolizumab|mesh-list
110763948|NCT03991403|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110763949|NCT03991403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110763950|NCT03991403|Tubulin Modulators|tubulin modulators|mesh-ancestor
110763951|NCT03991403|Antimitotic Agents|antimitotic agents|mesh-ancestor
110763952|NCT03991403|Mitosis Modulators|mitosis modulators|mesh-ancestor
110763953|NCT03991403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110763954|NCT03991403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110763955|NCT03991403|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110763956|NCT03991403|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110763957|NCT03991403|Growth Substances|growth substances|mesh-ancestor
110763958|NCT03991403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110763959|NCT03991403|Growth Inhibitors|growth inhibitors|mesh-ancestor
110763960|NCT03991403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110763961|NCT03991403|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110763962|NCT03991403|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110763963|NCT03991403|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110763964|NCT03930680|Dexrazoxane|dexrazoxane|mesh-list
110763965|NCT03930680|Razoxane|razoxane|mesh-list
110763966|NCT03930680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110763967|NCT03930680|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110763968|NCT03930680|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110763969|NCT03930680|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110763970|NCT03930680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110763971|NCT03930680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110763972|NCT03930680|Protective Agents|protective agents|mesh-ancestor
110763973|NCT03930680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110763974|NCT03930680|Antimitotic Agents|antimitotic agents|mesh-ancestor
110763975|NCT03930680|Mitosis Modulators|mitosis modulators|mesh-ancestor
110763977|NCT03897439|Nicotine|nicotine|mesh-list
110763978|NCT03897439|Varenicline|varenicline|mesh-list
110763979|NCT03897439|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110763980|NCT03897439|Autonomic Agents|autonomic agents|mesh-ancestor
110763981|NCT03897439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110763982|NCT03897439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110763983|NCT03897439|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110763984|NCT03897439|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110763985|NCT03897439|Cholinergic Agents|cholinergic agents|mesh-ancestor
110763986|NCT03897439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110763987|NCT03897439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110763988|NCT03897439|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110763989|NCT03897439|Antidepressive Agents|antidepressive agents|mesh-ancestor
110763990|NCT03897439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110763991|NCT03897439|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110763992|NCT03897439|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110315545|NCT00309491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110763993|NCT03897439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110763994|NCT03897439|Dopamine Agents|dopamine agents|mesh-ancestor
110763995|NCT03897439|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110763996|NCT03897439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110763997|NCT03897439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110763998|NCT03830164|Vitamins|vitamins|mesh-list
110763999|NCT03830164|Vitamin E|vitamin e|mesh-list
110764000|NCT03830164|Tocopherols|tocopherols|mesh-list
110764001|NCT03830164|Tocotrienols|tocotrienols|mesh-list
110764002|NCT03830164|alpha-Tocopherol|alpha-tocopherol|mesh-list
110764003|NCT03830164|Pentoxifylline|pentoxifylline|mesh-list
110764004|NCT03830164|Atorvastatin|atorvastatin|mesh-list
110764005|NCT03830164|Micronutrients|micronutrients|mesh-ancestor
110764006|NCT03830164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110764007|NCT03830164|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110764008|NCT03830164|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110764009|NCT03830164|Antimetabolites|antimetabolites|mesh-ancestor
110764010|NCT03830164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110764011|NCT03830164|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110764012|NCT03830164|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110764013|NCT03830164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110764014|NCT03830164|Antioxidants|antioxidants|mesh-ancestor
110764015|NCT03830164|Protective Agents|protective agents|mesh-ancestor
110764016|NCT03830164|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110764017|NCT03830164|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110764018|NCT03830164|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110764019|NCT03830164|Vasodilator Agents|vasodilator agents|mesh-ancestor
110764020|NCT03830164|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110764021|NCT03777436|Apremilast|apremilast|mesh-list
110764022|NCT03777436|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110764023|NCT03777436|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110764024|NCT03777436|Analgesics|analgesics|mesh-ancestor
110764025|NCT03777436|Sensory System Agents|sensory system agents|mesh-ancestor
110869468|NCT03169738|Immunologic Factors|immunologic factors|mesh-ancestor
110764026|NCT03777436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110764027|NCT03777436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110764028|NCT03777436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110764029|NCT03777436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110764030|NCT03777436|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
110764031|NCT03777436|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110764032|NCT03777436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110764033|NCT03777436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110764034|NCT03773302|Gemcitabine|gemcitabine|mesh-list
110764035|NCT03773302|Infigratinib|infigratinib|mesh-list
110764036|NCT03773302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110764037|NCT03773302|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110764038|NCT03773302|Antimetabolites|antimetabolites|mesh-ancestor
110764039|NCT03773302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110764040|NCT03701763|Apremilast|apremilast|mesh-list
110764041|NCT03701763|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110764042|NCT03701763|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110764043|NCT03701763|Analgesics|analgesics|mesh-ancestor
110764044|NCT03701763|Sensory System Agents|sensory system agents|mesh-ancestor
110764045|NCT03701763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110764046|NCT03701763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110764047|NCT03701763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110764048|NCT03701763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110315594|NCT00309686|Paliperidone Palmitate|paliperidone palmitate|mesh-list
110764049|NCT03701763|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
110764050|NCT03701763|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110764051|NCT03701763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110764052|NCT03701763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110764053|NCT03673462|Vaccines|vaccines|mesh-list
110764054|NCT03673462|Immunologic Factors|immunologic factors|mesh-ancestor
110764055|NCT03673462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110764056|NCT03592992|Morphine|morphine|mesh-list
110764057|NCT03592992|Hydromorphone|hydromorphone|mesh-list
110764058|NCT03592992|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110764059|NCT03592992|Narcotics|narcotics|mesh-ancestor
110764060|NCT03592992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110764061|NCT03592992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110764062|NCT03592992|Analgesics|analgesics|mesh-ancestor
110764063|NCT03592992|Sensory System Agents|sensory system agents|mesh-ancestor
110764064|NCT03592992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110764065|NCT03447808|Daratumumab|daratumumab|mesh-list
110764066|NCT03447808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110764067|NCT03366766|Cisplatin|cisplatin|mesh-list
110764068|NCT03366766|Gemcitabine|gemcitabine|mesh-list
110764069|NCT03366766|Nivolumab|nivolumab|mesh-list
110764070|NCT03366766|Pemetrexed|pemetrexed|mesh-list
110764071|NCT03366766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110764072|NCT03366766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110764073|NCT03366766|Antimetabolites|antimetabolites|mesh-ancestor
110764074|NCT03366766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110764075|NCT03366766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110764076|NCT03366766|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110764077|NCT03366766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110764078|NCT03366766|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110764079|NCT03366766|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110764080|NCT03308448|Epoetin Alfa|epoetin alfa|mesh-list
110764081|NCT03308448|Hematinics|hematinics|mesh-ancestor
110764082|NCT03299309|Vaccines|vaccines|mesh-list
110764083|NCT03299309|Immunologic Factors|immunologic factors|mesh-ancestor
110764084|NCT03299309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110764085|NCT03254927|Cetuximab|cetuximab|mesh-list
110764086|NCT03254927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110481772|NCT00999908|Autonomic Agents|autonomic agents|mesh-ancestor
110764087|NCT03254927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110764088|NCT03039036|Misoprostol|misoprostol|mesh-list
110764089|NCT03039036|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110764090|NCT03039036|Abortifacient Agents|abortifacient agents|mesh-ancestor
110764091|NCT03039036|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110764092|NCT03039036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110869485|NCT03169738|Vitamins|vitamins|mesh-ancestor
110764093|NCT03039036|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110764094|NCT03039036|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110764095|NCT03039036|Oxytocics|oxytocics|mesh-ancestor
110764096|NCT03025880|Gemcitabine|gemcitabine|mesh-list
110764097|NCT03025880|Pembrolizumab|pembrolizumab|mesh-list
110764098|NCT03025880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110764099|NCT03025880|Antimetabolites|antimetabolites|mesh-ancestor
110764100|NCT03025880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110764101|NCT03025880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110764102|NCT03025880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110315612|NCT00309725|Cholinergic Agents|cholinergic agents|mesh-ancestor
110764103|NCT03025880|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110764104|NCT02962297|Vitamin E|vitamin e|mesh-list
110764105|NCT02962297|Vitamins|vitamins|mesh-ancestor
110764106|NCT02962297|Micronutrients|micronutrients|mesh-ancestor
110764107|NCT02962297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110764108|NCT02962297|Antioxidants|antioxidants|mesh-ancestor
110764109|NCT02962297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110764110|NCT02962297|Protective Agents|protective agents|mesh-ancestor
110764111|NCT02678572|Melphalan|melphalan|mesh-list
110764112|NCT02678572|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110764113|NCT02678572|Alkylating Agents|alkylating agents|mesh-ancestor
110764114|NCT02678572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110764115|NCT02678572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110764116|NCT02678572|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110764117|NCT02678572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110764118|NCT02678572|Immunologic Factors|immunologic factors|mesh-ancestor
110764119|NCT02678572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110764120|NCT02518555|Vaccines|vaccines|mesh-list
110764121|NCT02518555|Immunologic Factors|immunologic factors|mesh-ancestor
110764122|NCT02518555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110764123|NCT02027376|Docetaxel|docetaxel|mesh-list
110764124|NCT02027376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110764125|NCT02027376|Tubulin Modulators|tubulin modulators|mesh-ancestor
110764126|NCT02027376|Antimitotic Agents|antimitotic agents|mesh-ancestor
110764127|NCT02027376|Mitosis Modulators|mitosis modulators|mesh-ancestor
110764128|NCT02027376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110764129|NCT02005289|Lenalidomide|lenalidomide|mesh-list
110764130|NCT02005289|Immunologic Factors|immunologic factors|mesh-ancestor
110764131|NCT02005289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110764132|NCT02005289|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110764133|NCT02005289|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110764134|NCT02005289|Growth Substances|growth substances|mesh-ancestor
110764135|NCT02005289|Growth Inhibitors|growth inhibitors|mesh-ancestor
110764136|NCT02005289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110764137|NCT01924533|Paclitaxel|paclitaxel|mesh-list
110764138|NCT01924533|Olaparib|olaparib|mesh-list
110764139|NCT01924533|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110764140|NCT01924533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110764141|NCT01924533|Tubulin Modulators|tubulin modulators|mesh-ancestor
110764142|NCT01924533|Antimitotic Agents|antimitotic agents|mesh-ancestor
110764143|NCT01924533|Mitosis Modulators|mitosis modulators|mesh-ancestor
110764144|NCT01924533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110764145|NCT01924533|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110764146|NCT01924533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110764147|NCT01683955|Tranexamic Acid|tranexamic acid|mesh-list
110764148|NCT01683955|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110764149|NCT01683955|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110764150|NCT01683955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110764151|NCT01683955|Hemostatics|hemostatics|mesh-ancestor
110764152|NCT01683955|Coagulants|coagulants|mesh-ancestor
110764153|NCT01606436|Moxifloxacin|moxifloxacin|mesh-list
110764154|NCT01606436|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110764155|NCT01606436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110764156|NCT01606436|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110764157|NCT01606436|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110764158|NCT01606436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110764159|NCT01606436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110764160|NCT01606436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110764161|NCT01453088|Bortezomib|bortezomib|mesh-list
110764162|NCT01453088|Melphalan|melphalan|mesh-list
110764163|NCT01453088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110764164|NCT01453088|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110764165|NCT01453088|Alkylating Agents|alkylating agents|mesh-ancestor
110764166|NCT01453088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110764167|NCT01453088|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110764168|NCT01453088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110764169|NCT01453088|Immunologic Factors|immunologic factors|mesh-ancestor
110764170|NCT01453088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110764171|NCT01345175|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110764173|NCT01345175|Rifaximin|rifaximin|mesh-list
110764174|NCT01345175|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
110764175|NCT01345175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110764176|NCT01345175|Antitubercular Agents|antitubercular agents|mesh-ancestor
110764177|NCT01345175|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110764178|NCT01345175|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110764179|NCT01345175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110764180|NCT01295645|Cidofovir|cidofovir|mesh-list
110764181|NCT01295645|Antiviral Agents|antiviral agents|mesh-ancestor
110764182|NCT01295645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110764183|NCT01295645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110764184|NCT01295645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110764185|NCT01257139|Docetaxel|docetaxel|mesh-list
110764186|NCT01257139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110764187|NCT01257139|Tubulin Modulators|tubulin modulators|mesh-ancestor
110764188|NCT01257139|Antimitotic Agents|antimitotic agents|mesh-ancestor
110764189|NCT01257139|Mitosis Modulators|mitosis modulators|mesh-ancestor
110764190|NCT01257139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110764191|NCT01243190|Ofatumumab|ofatumumab|mesh-list
110764192|NCT01243190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110764193|NCT00936936|Carboplatin|carboplatin|mesh-list
110764194|NCT00936936|Gemcitabine|gemcitabine|mesh-list
110764195|NCT00936936|Docetaxel|docetaxel|mesh-list
110764196|NCT00936936|Etoposide|etoposide|mesh-list
110764197|NCT00936936|Melphalan|melphalan|mesh-list
110764198|NCT00936936|Ifosfamide|ifosfamide|mesh-list
110764199|NCT00936936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110315666|NCT00309881|Glucocorticoids|glucocorticoids|mesh-ancestor
110764200|NCT00936936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110764201|NCT00936936|Antimetabolites|antimetabolites|mesh-ancestor
110764202|NCT00936936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110764203|NCT00936936|Tubulin Modulators|tubulin modulators|mesh-ancestor
110764204|NCT00936936|Antimitotic Agents|antimitotic agents|mesh-ancestor
110764205|NCT00936936|Mitosis Modulators|mitosis modulators|mesh-ancestor
110764206|NCT00936936|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110764207|NCT00936936|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110764208|NCT00936936|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110764209|NCT00936936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110764210|NCT00936936|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110764211|NCT00936936|Alkylating Agents|alkylating agents|mesh-ancestor
110764212|NCT00936936|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110764213|NCT00936936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110764214|NCT00936936|Immunologic Factors|immunologic factors|mesh-ancestor
110764215|NCT00936936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110764216|NCT01141296|Fenofibrate|fenofibrate|mesh-list
110764217|NCT01141296|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110764218|NCT01141296|Antimetabolites|antimetabolites|mesh-ancestor
110764219|NCT01141296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110764220|NCT01141296|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110764221|NCT01238328|Thymoglobulin|thymoglobulin|mesh-list
110764222|NCT01238328|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110764223|NCT01238328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110764224|NCT01238328|Immunologic Factors|immunologic factors|mesh-ancestor
110764225|NCT01238328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110764226|NCT01238406|Pancrelipase|pancrelipase|mesh-list
110764227|NCT01238406|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110764228|NCT03724890|Avelumab|avelumab|mesh-list
110764229|NCT03724890|Peposertib|peposertib|mesh-list
110764230|NCT03724890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110764231|NCT03724890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110764232|NCT03724890|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110764233|NCT03724890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110764234|NCT03724890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110764235|NCT01141452|Fluticasone|fluticasone|mesh-list
110764236|NCT01141452|Xhance|xhance|mesh-list
110764237|NCT01141452|Beclomethasone|beclomethasone|mesh-list
110764238|NCT01141452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110764239|NCT01141452|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110445542|NCT00869401|Dasatinib|dasatinib|mesh-list
110764240|NCT01141452|Autonomic Agents|autonomic agents|mesh-ancestor
110764241|NCT01141452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110764242|NCT01141452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110764243|NCT01141452|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110764244|NCT01141452|Respiratory System Agents|respiratory system agents|mesh-ancestor
110764245|NCT01141452|Dermatologic Agents|dermatologic agents|mesh-ancestor
110764246|NCT01141452|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110764247|NCT01141452|Glucocorticoids|glucocorticoids|mesh-ancestor
110764249|NCT01141452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110764250|NCT00219557|Gemcitabine|gemcitabine|mesh-list
110764252|NCT00219557|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110764253|NCT00219557|Antimetabolites|antimetabolites|mesh-ancestor
110764254|NCT00219557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110764255|NCT00219557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110764256|NCT00219557|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110764257|NCT00219557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110764258|NCT05282940|Levonorgestrel|levonorgestrel|mesh-list
110764259|NCT05282940|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110764260|NCT05282940|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
110764261|NCT05282940|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
110764262|NCT05282940|Estradiol|estradiol|mesh-list
110764263|NCT05282940|Estrogens|estrogens|mesh-ancestor
110764264|NCT05282940|Hormones|hormones|mesh-ancestor
110764265|NCT05282940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110764266|NCT05282940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110764267|NCT05282940|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110764268|NCT05282940|Contraceptive Agents|contraceptive agents|mesh-ancestor
110764269|NCT05282940|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110764270|NCT05282940|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110764271|NCT05282940|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110764272|NCT05282940|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110764273|NCT05282940|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110764274|NCT05282940|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110869504|NCT02403544|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110764275|NCT05282940|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
110764276|NCT05282940|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
110764277|NCT05282940|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
110764278|NCT01238562|Lenograstim|lenograstim|mesh-list
110764279|NCT01238562|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110764280|NCT01238562|Immunologic Factors|immunologic factors|mesh-ancestor
110764281|NCT01238562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110764282|NCT01329666|Vitamin D|vitamin d|mesh-list
110764283|NCT01329666|Cholecalciferol|cholecalciferol|mesh-list
110764284|NCT01329666|Vitamins|vitamins|mesh-ancestor
110764285|NCT01329666|Micronutrients|micronutrients|mesh-ancestor
110764286|NCT01329666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110764287|NCT01329666|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110764288|NCT01329666|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110764289|NCT05255484|Antibodies|antibodies|mesh-list
110764290|NCT05255484|Immunologic Factors|immunologic factors|mesh-ancestor
110764291|NCT05255484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110764292|NCT01141998|Cholecalciferol|cholecalciferol|mesh-list
110764293|NCT01141998|Vitamin D|vitamin d|mesh-list
110764294|NCT01141998|Calcium, Dietary|calcium, dietary|mesh-list
110764295|NCT01141998|Calcium|calcium|mesh-list
110764296|NCT01141998|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110764297|NCT01141998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110764298|NCT01141998|Vitamins|vitamins|mesh-ancestor
110764299|NCT01141998|Micronutrients|micronutrients|mesh-ancestor
110764300|NCT01141998|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110764301|NCT01238718|Lidocaine|lidocaine|mesh-list
110764302|NCT01238718|Anesthetics, Local|anesthetics, local|mesh-ancestor
110764303|NCT01238718|Anesthetics|anesthetics|mesh-ancestor
110315710|NCT00309998|Tubulin Modulators|tubulin modulators|mesh-ancestor
110764304|NCT01238718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110764305|NCT01238718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110764306|NCT01238718|Sensory System Agents|sensory system agents|mesh-ancestor
110764307|NCT01238718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110764308|NCT01238718|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110764309|NCT01238718|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110764310|NCT01238718|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110764311|NCT01238718|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110764312|NCT01238718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110764313|NCT01238796|Telavancin|telavancin|mesh-list
110764314|NCT01238796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110764315|NCT01238796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110764316|NCT01143948|Insulin|insulin|mesh-list
110764317|NCT01143948|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110764318|NCT01143948|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110764319|NCT01143948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110764320|NCT01145976|Cyclophosphamide|cyclophosphamide|mesh-list
110764321|NCT01145976|Fludarabine|fludarabine|mesh-list
110764322|NCT01145976|Thymoglobulin|thymoglobulin|mesh-list
110764323|NCT01145976|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110764324|NCT01145976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110764325|NCT01145976|Immunologic Factors|immunologic factors|mesh-ancestor
110764326|NCT01145976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110764327|NCT01145976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110764328|NCT01145976|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110764329|NCT01145976|Alkylating Agents|alkylating agents|mesh-ancestor
110764330|NCT01145976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110764331|NCT01145976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110764332|NCT01145976|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110764333|NCT01238952|Carboplatin|carboplatin|mesh-list
110764334|NCT01238952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110764335|NCT05158998|Propofol|propofol|mesh-list
110764336|NCT05158998|Sevoflurane|sevoflurane|mesh-list
110764337|NCT05158998|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110764338|NCT05158998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110764339|NCT05158998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110764340|NCT05158998|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110764341|NCT05158998|Anesthetics, General|anesthetics, general|mesh-ancestor
110764342|NCT05158998|Anesthetics|anesthetics|mesh-ancestor
110764343|NCT05158998|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110764344|NCT05158998|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110764345|NCT01144260|Bafetinib|bafetinib|mesh-list
110764346|NCT01144260|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110764347|NCT01144260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110764348|NCT01144260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110764349|NCT01239498|Lidocaine|lidocaine|mesh-list
110764350|NCT01239498|Epinephrine|epinephrine|mesh-list
110764351|NCT01239498|Racepinephrine|racepinephrine|mesh-list
110764352|NCT01239498|Anesthetics|anesthetics|mesh-list
110764353|NCT01239498|Epinephryl borate|epinephryl borate|mesh-list
110764354|NCT01239498|Anesthetics, Local|anesthetics, local|mesh-ancestor
110764355|NCT01239498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110764356|NCT01239498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110764357|NCT01239498|Sensory System Agents|sensory system agents|mesh-ancestor
110764358|NCT01239498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110764359|NCT01239498|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110764360|NCT01239498|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110764361|NCT01239498|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110764362|NCT01239498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110764363|NCT01239498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110764364|NCT01239498|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110764365|NCT01239498|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110764366|NCT01239498|Adrenergic Agents|adrenergic agents|mesh-ancestor
110764367|NCT01239498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110764368|NCT01239498|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110764369|NCT01239498|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110764370|NCT01239498|Autonomic Agents|autonomic agents|mesh-ancestor
110764371|NCT01239498|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110764372|NCT01239498|Respiratory System Agents|respiratory system agents|mesh-ancestor
110764373|NCT01239498|Mydriatics|mydriatics|mesh-ancestor
110764374|NCT01239498|Sympathomimetics|sympathomimetics|mesh-ancestor
110764375|NCT01239498|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110764376|NCT00251927|Esomeprazole|esomeprazole|mesh-list
110764377|NCT00251927|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110764378|NCT00251927|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110764379|NCT00251927|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110764380|NCT00251927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110764381|NCT00251927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110764382|NCT03790800|Urapidil|urapidil|mesh-list
110764383|NCT03790800|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110764384|NCT03790800|Vasodilator Agents|vasodilator agents|mesh-ancestor
110764385|NCT03790800|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110764386|NCT03790800|Serotonin Agents|serotonin agents|mesh-ancestor
110764387|NCT03790800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110764388|NCT03790800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110764389|NCT03790800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110764390|NCT03790800|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110764391|NCT03790800|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110764392|NCT03790800|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110764393|NCT03790800|Adrenergic Agents|adrenergic agents|mesh-ancestor
110764394|NCT03971201|Sorafenib|sorafenib|mesh-list
110764395|NCT03971201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110764396|NCT03971201|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110764397|NCT03971201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110764398|NCT03971201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110764399|NCT01236144|Plerixafor|plerixafor|mesh-list
110764400|NCT01236144|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110764401|NCT01236144|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110764402|NCT01236144|Antiviral Agents|antiviral agents|mesh-ancestor
110764403|NCT01236144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110764404|NCT02528526|Inositol|inositol|mesh-list
110764405|NCT02528526|Vitamin B Complex|vitamin b complex|mesh-ancestor
110764406|NCT02528526|Vitamins|vitamins|mesh-ancestor
110764407|NCT02528526|Micronutrients|micronutrients|mesh-ancestor
110764408|NCT02528526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110764409|NCT03971279|Dexamethasone|dexamethasone|mesh-list
110315770|NCT00339066|Sertraline|sertraline|mesh-list
110764410|NCT03971279|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110764411|NCT03971279|Antiemetics|antiemetics|mesh-ancestor
110764412|NCT03971279|Autonomic Agents|autonomic agents|mesh-ancestor
110764413|NCT03971279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110764414|NCT03971279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110764415|NCT03971279|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110764416|NCT03971279|Glucocorticoids|glucocorticoids|mesh-ancestor
110764417|NCT03971279|Hormones|hormones|mesh-ancestor
110764418|NCT03971279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110764419|NCT03971279|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110764420|NCT03971279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110764421|NCT01329744|Mecasermin|mecasermin|mesh-list
110764422|NCT01329744|Growth Substances|growth substances|mesh-ancestor
110764423|NCT01329744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110764424|NCT00165503|Sodium thiosulfate|sodium thiosulfate|mesh-list
110764425|NCT00165503|Pemetrexed|pemetrexed|mesh-list
110764426|NCT00165503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110764427|NCT00165503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110764428|NCT00165503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110764429|NCT00165503|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110764430|NCT00165503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110764431|NCT00165503|Antidotes|antidotes|mesh-ancestor
110764432|NCT00165503|Protective Agents|protective agents|mesh-ancestor
110764433|NCT00165503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110764434|NCT00165503|Antioxidants|antioxidants|mesh-ancestor
110764435|NCT00165503|Antitubercular Agents|antitubercular agents|mesh-ancestor
110764436|NCT00165503|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110764437|NCT00165503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110764438|NCT00165503|Chelating Agents|chelating agents|mesh-ancestor
110764439|NCT00165503|Sequestering Agents|sequestering agents|mesh-ancestor
110764440|NCT01144650|Dapsone|dapsone|mesh-list
110764441|NCT01144650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110764442|NCT01144650|Antimalarials|antimalarials|mesh-ancestor
110764443|NCT01144650|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110764444|NCT01144650|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110764445|NCT01144650|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110764446|NCT01144650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110764447|NCT01144650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110764448|NCT01144650|Leprostatic Agents|leprostatic agents|mesh-ancestor
110764449|NCT01144650|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110764450|NCT00162773|Omalizumab|omalizumab|mesh-list
110764451|NCT00162773|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110764452|NCT00162773|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110764453|NCT00162773|Respiratory System Agents|respiratory system agents|mesh-ancestor
110764454|NCT03970577|Prednisone|prednisone|mesh-list
110764455|NCT03970577|Rituximab|rituximab|mesh-list
110764456|NCT03970577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110764457|NCT03970577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110764458|NCT03970577|Immunologic Factors|immunologic factors|mesh-ancestor
110764459|NCT03970577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110764460|NCT03970577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110764461|NCT03970577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110764462|NCT03970577|Glucocorticoids|glucocorticoids|mesh-ancestor
110764463|NCT03970577|Hormones|hormones|mesh-ancestor
110764464|NCT03970577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110764465|NCT03970577|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110764466|NCT01073813|Minocycline|minocycline|mesh-list
110764467|NCT01073813|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110764468|NCT01073813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110764469|NCT03823391|Adalimumab|adalimumab|mesh-list
110764470|NCT03823391|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110764471|NCT03823391|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110764472|NCT03823391|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110764473|NCT01075529|Fluoxetine|fluoxetine|mesh-list
110764474|NCT01075529|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110764475|NCT01075529|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110764476|NCT01075529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110764477|NCT01075529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110764478|NCT01075529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110764479|NCT01075529|Serotonin Agents|serotonin agents|mesh-ancestor
110764480|NCT01075529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110764481|NCT01075529|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110764482|NCT01075529|Antidepressive Agents|antidepressive agents|mesh-ancestor
110764483|NCT01075529|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110764484|NCT01075529|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110764485|NCT01075529|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110315828|NCT00421083|Tadalafil|tadalafil|mesh-list
110764486|NCT01075529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110764487|NCT01073891|Moxifloxacin|moxifloxacin|mesh-list
110764488|NCT01073891|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
110764489|NCT01073891|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110764490|NCT01073891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110764491|NCT01073891|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110764492|NCT01073891|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110764493|NCT01073891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110764494|NCT01073891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110764495|NCT01073891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110764496|NCT01073891|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110764497|NCT01073891|Contraceptive Agents|contraceptive agents|mesh-ancestor
110764498|NCT01073891|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110764499|NCT01073891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110764500|NCT01073891|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110764501|NCT01073891|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110764502|NCT01073891|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110764503|NCT00209027|Aripiprazole|aripiprazole|mesh-list
110764504|NCT00209027|Antidepressive Agents|antidepressive agents|mesh-ancestor
110764505|NCT00209027|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110764506|NCT00209027|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110764507|NCT00209027|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110764508|NCT00209027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110764509|NCT00209027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110764510|NCT00209027|Dopamine Agonists|dopamine agonists|mesh-ancestor
110764511|NCT00209027|Dopamine Agents|dopamine agents|mesh-ancestor
110764512|NCT00209027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110764513|NCT00209027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110764514|NCT00209027|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110764515|NCT00209027|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110764516|NCT00209027|Serotonin Agents|serotonin agents|mesh-ancestor
110764517|NCT00209027|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110764518|NCT00209027|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110764519|NCT00209027|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110764520|NCT00209027|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110764521|NCT00160667|Brivaracetam|brivaracetam|mesh-list
110764522|NCT00160667|Anticonvulsants|anticonvulsants|mesh-ancestor
110764523|NCT00206375|Hormones|hormones|mesh-list
110764524|NCT00206375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110764525|NCT00206375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110764526|NCT00160199|Progesterone|progesterone|mesh-list
110764527|NCT00160199|Progestins|progestins|mesh-ancestor
110764528|NCT00160199|Hormones|hormones|mesh-ancestor
110764529|NCT00160199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110764530|NCT00160199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110764531|NCT00157157|Factor VIII|factor viii|mesh-list
110764532|NCT00157157|Coagulants|coagulants|mesh-ancestor
110764533|NCT00203411|Bevacizumab|bevacizumab|mesh-list
110764534|NCT00203411|Capecitabine|capecitabine|mesh-list
110764535|NCT00203411|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110764536|NCT00203411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110764537|NCT00203411|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110764538|NCT00203411|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110764539|NCT00203411|Growth Substances|growth substances|mesh-ancestor
110764540|NCT00203411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110482227|NCT04138641|Cangrelor|cangrelor|mesh-list
110315864|NCT00421122|Hormones|hormones|mesh-ancestor
110764542|NCT00203411|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110764543|NCT00203411|Antimetabolites|antimetabolites|mesh-ancestor
110764544|NCT00203411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110764545|NCT00203021|Glatiramer Acetate|glatiramer acetate|mesh-list
110764546|NCT00203021|(T,G)-A-L|(t,g)-a-l|mesh-list
110764547|NCT00203021|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110764548|NCT00203021|Immunologic Factors|immunologic factors|mesh-ancestor
110764549|NCT00203021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110764550|NCT00203021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110764552|NCT00201851|Tamoxifen|tamoxifen|mesh-list
110764553|NCT00201851|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110764554|NCT00201851|Hormone Antagonists|hormone antagonists|mesh-ancestor
110764555|NCT00201851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110764556|NCT00201851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110764557|NCT00201851|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110764558|NCT00201851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110764559|NCT00201851|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110764560|NCT00201851|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110764561|NCT00201851|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110764562|NCT01074203|Nitazoxanide|nitazoxanide|mesh-list
110764563|NCT01074203|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110764564|NCT01074203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110764565|NCT01074281|Enalapril|enalapril|mesh-list
110764566|NCT01074281|Enalaprilat|enalaprilat|mesh-list
110764567|NCT01074281|Nitrendipine|nitrendipine|mesh-list
110764568|NCT01074281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110764569|NCT01074281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110764570|NCT01074281|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110764571|NCT01074281|Protease Inhibitors|protease inhibitors|mesh-ancestor
110764572|NCT01074281|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110764573|NCT01074281|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110764574|NCT01074281|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110764575|NCT01074281|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110764576|NCT01074281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110764577|NCT01074281|Vasodilator Agents|vasodilator agents|mesh-ancestor
110764578|NCT03129100|Ixekizumab|ixekizumab|mesh-list
110764579|NCT03129100|Dermatologic Agents|dermatologic agents|mesh-ancestor
110764580|NCT03100006|Nivolumab|nivolumab|mesh-list
110764581|NCT03100006|Oregovomab|oregovomab|mesh-list
110764582|NCT03100006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110764583|NCT03100006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110764584|NCT03100006|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110764585|NCT03100006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110764587|NCT03099538|Dermatologic Agents|dermatologic agents|mesh-ancestor
110764588|NCT00883480|Gemcitabine|gemcitabine|mesh-list
110764589|NCT00883480|Docetaxel|docetaxel|mesh-list
110764590|NCT00883480|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110764591|NCT00883480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110764592|NCT00883480|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110764593|NCT00883480|Antimetabolites|antimetabolites|mesh-ancestor
110764594|NCT00883480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110764595|NCT00883480|Tubulin Modulators|tubulin modulators|mesh-ancestor
110764596|NCT00883480|Antimitotic Agents|antimitotic agents|mesh-ancestor
110764597|NCT00883480|Mitosis Modulators|mitosis modulators|mesh-ancestor
110764598|NCT00883480|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110764599|NCT00883480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110764600|NCT05418946|Dapagliflozin|dapagliflozin|mesh-list
110764601|NCT05418946|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110764602|NCT05418946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110764603|NCT05418946|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110764604|NCT05418946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110764605|NCT03097588|Palonosetron|palonosetron|mesh-list
110764606|NCT03097588|Antiemetics|antiemetics|mesh-ancestor
110764607|NCT03097588|Autonomic Agents|autonomic agents|mesh-ancestor
110764608|NCT03097588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110764609|NCT03097588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110764610|NCT03097588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110764611|NCT03097588|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110764612|NCT03097588|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110764613|NCT03097588|Serotonin Agents|serotonin agents|mesh-ancestor
110764614|NCT03097588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110764615|NCT03097588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110764616|NCT05418166|Evolocumab|evolocumab|mesh-list
110764617|NCT05418166|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
110764618|NCT05418166|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110764619|NCT05418166|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110764620|NCT05418166|Antimetabolites|antimetabolites|mesh-ancestor
110764621|NCT05418166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110764622|NCT05418166|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110764623|NCT05418166|Protease Inhibitors|protease inhibitors|mesh-ancestor
110764624|NCT05418166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110764625|NCT05418166|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110764626|NCT01631214|Alendronate|alendronate|mesh-list
110764627|NCT01631214|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110764628|NCT01631214|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110764629|NCT01631214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110764630|NCT01631214|Immunologic Factors|immunologic factors|mesh-ancestor
110764631|NCT01567774|Atorvastatin|atorvastatin|mesh-list
110764632|NCT01567774|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110764633|NCT01567774|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110764634|NCT01567774|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110764635|NCT01567774|Antimetabolites|antimetabolites|mesh-ancestor
110764636|NCT01567774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110764637|NCT01567774|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110764638|NCT01567774|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110764639|NCT01567774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110764640|NCT01567930|Sirolimus|sirolimus|mesh-list
110764641|NCT01567930|Temsirolimus|temsirolimus|mesh-list
110764642|NCT01567930|MTOR Inhibitors|mtor inhibitors|mesh-list
110764643|NCT01567930|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110764644|NCT01567930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110764645|NCT01567930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110764646|NCT01567930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110764647|NCT01567930|Immunologic Factors|immunologic factors|mesh-ancestor
110764648|NCT01567930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110764649|NCT01567930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110764650|NCT01567930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110764651|NCT01567930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110764652|NCT01567930|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110764653|NCT01567930|Antifungal Agents|antifungal agents|mesh-ancestor
110764654|NCT04604548|6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid|6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid|mesh-list
110764655|NCT04604548|Antioxidants|antioxidants|mesh-ancestor
110764656|NCT04604548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110764657|NCT04604548|Protective Agents|protective agents|mesh-ancestor
110764658|NCT04604548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110764659|NCT01142622|Ropivacaine|ropivacaine|mesh-list
110764660|NCT01142622|Anesthetics, Local|anesthetics, local|mesh-ancestor
110764661|NCT01142622|Anesthetics|anesthetics|mesh-ancestor
110764662|NCT01142622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110764663|NCT01142622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110764664|NCT01142622|Sensory System Agents|sensory system agents|mesh-ancestor
110764665|NCT01142622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110764666|NCT01142700|Ribavirin|ribavirin|mesh-list
110764667|NCT01142700|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110764668|NCT01142700|Antimetabolites|antimetabolites|mesh-ancestor
110315956|NCT00311636|Epirubicin|epirubicin|mesh-list
110764669|NCT01142700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110764670|NCT01142700|Antiviral Agents|antiviral agents|mesh-ancestor
110764671|NCT01142700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110764672|NCT01144728|Metformin|metformin|mesh-list
110764673|NCT01144728|Glimepiride|glimepiride|mesh-list
110764674|NCT01144728|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110764675|NCT01144728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110764676|NCT01144728|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110764677|NCT01144728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110764678|NCT01144728|Immunologic Factors|immunologic factors|mesh-ancestor
110764679|NCT01239810|Hyaluronic Acid|hyaluronic acid|mesh-list
110764680|NCT01239810|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110764681|NCT01239810|Immunologic Factors|immunologic factors|mesh-ancestor
110764682|NCT01239810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110764683|NCT01239810|Viscosupplements|viscosupplements|mesh-ancestor
110764684|NCT01239810|Protective Agents|protective agents|mesh-ancestor
110764685|NCT01239888|Tibolone|tibolone|mesh-list
110764686|NCT01239888|Oxytocin|oxytocin|mesh-list
110764687|NCT01239888|Oxytocics|oxytocics|mesh-ancestor
110764688|NCT01239888|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110764689|NCT01239888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110764690|NCT01239888|Androgen Antagonists|androgen antagonists|mesh-ancestor
110764691|NCT01239888|Hormone Antagonists|hormone antagonists|mesh-ancestor
110764692|NCT01239888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110764693|NCT01239888|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110764694|NCT01239888|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110764695|NCT01239888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110764696|NCT01239888|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110764697|NCT01239888|Anabolic Agents|anabolic agents|mesh-ancestor
110764698|NCT01239888|Hormones|hormones|mesh-ancestor
110764699|NCT01318486|Heparin|heparin|mesh-list
110764700|NCT01318486|Anticoagulants|anticoagulants|mesh-ancestor
110764701|NCT01318486|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110764702|NCT01318486|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110764703|NCT01318486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110764704|NCT03436108|Bisphenol A|bisphenol a|mesh-list
110764705|NCT03436108|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
110764706|NCT03436108|Estrogens|estrogens|mesh-ancestor
110764707|NCT03436108|Hormones|hormones|mesh-ancestor
110764708|NCT03436108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110764709|NCT03436108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110764710|NCT03436108|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110764711|NCT03436108|Antioxidants|antioxidants|mesh-ancestor
110764712|NCT03436108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110764713|NCT03436108|Protective Agents|protective agents|mesh-ancestor
110764714|NCT02870218|Nicotine|nicotine|mesh-list
110764715|NCT02870218|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110764716|NCT02870218|Autonomic Agents|autonomic agents|mesh-ancestor
110764717|NCT02870218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110764718|NCT02870218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110764719|NCT02870218|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110764720|NCT02870218|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110764721|NCT02870218|Cholinergic Agents|cholinergic agents|mesh-ancestor
110764722|NCT02870218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110764723|NCT02870218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110764724|NCT02614690|Calpastatin|calpastatin|mesh-list
110764725|NCT02614690|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
110764726|NCT02614690|Protease Inhibitors|protease inhibitors|mesh-ancestor
110764727|NCT02614690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110764728|NCT02614690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110764729|NCT01442194|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
110764730|NCT01442194|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
110764731|NCT01442194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110764732|NCT01442194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110764733|NCT01442194|Immunologic Factors|immunologic factors|mesh-ancestor
110764734|NCT01442194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110764735|NCT00468130|Aripiprazole|aripiprazole|mesh-list
110764736|NCT00468130|Antidepressive Agents|antidepressive agents|mesh-ancestor
110764738|NCT00468130|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110764739|NCT00468130|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110764740|NCT00468130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110764741|NCT00468130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110764742|NCT00468130|Dopamine Agonists|dopamine agonists|mesh-ancestor
110764743|NCT00468130|Dopamine Agents|dopamine agents|mesh-ancestor
110764744|NCT00468130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110764745|NCT00468130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110764746|NCT00468130|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110764747|NCT00468130|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110764748|NCT00468130|Serotonin Agents|serotonin agents|mesh-ancestor
110764749|NCT00468130|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110764750|NCT00468130|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110764751|NCT00468130|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110764752|NCT00468130|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110764753|NCT05196256|Sufentanil|sufentanil|mesh-list
110764754|NCT05196256|Levobupivacaine|levobupivacaine|mesh-list
110764755|NCT05196256|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110764756|NCT05196256|Narcotics|narcotics|mesh-ancestor
110764757|NCT05196256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110764758|NCT05196256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110764759|NCT05196256|Analgesics|analgesics|mesh-ancestor
110764760|NCT05196256|Sensory System Agents|sensory system agents|mesh-ancestor
110764761|NCT05196256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110764762|NCT05196256|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110764763|NCT05196256|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110764764|NCT05196256|Anesthetics, General|anesthetics, general|mesh-ancestor
110764765|NCT05196256|Anesthetics|anesthetics|mesh-ancestor
110764766|NCT05196256|Anesthetics, Local|anesthetics, local|mesh-ancestor
110764767|NCT01375348|Remifentanil|remifentanil|mesh-list
110764768|NCT01375348|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110764769|NCT01375348|Narcotics|narcotics|mesh-ancestor
110764770|NCT01375348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110764771|NCT01375348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110764772|NCT01375348|Analgesics|analgesics|mesh-ancestor
110764773|NCT01375348|Sensory System Agents|sensory system agents|mesh-ancestor
110764774|NCT01375348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110764775|NCT05195086|Mycophenolic Acid|mycophenolic acid|mesh-list
110764776|NCT05195086|Cyclophosphamide|cyclophosphamide|mesh-list
110764777|NCT05195086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110764778|NCT05195086|Immunologic Factors|immunologic factors|mesh-ancestor
110764779|NCT05195086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110764780|NCT05195086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110764781|NCT05195086|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110764782|NCT05195086|Alkylating Agents|alkylating agents|mesh-ancestor
110764783|NCT05195086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110764784|NCT05195086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110764785|NCT05195086|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110764786|NCT05195086|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110764787|NCT05195086|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110764788|NCT05195086|Antitubercular Agents|antitubercular agents|mesh-ancestor
110764789|NCT05195086|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110764790|NCT05195086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110764791|NCT05195086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110764792|NCT05194852|Anesthetics|anesthetics|mesh-list
110764793|NCT05194852|Anesthetics, Local|anesthetics, local|mesh-list
110764794|NCT05194852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110764795|NCT05194852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110764796|NCT05194852|Sensory System Agents|sensory system agents|mesh-ancestor
110764797|NCT05194852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110764798|NCT01375426|Amoxicillin|amoxicillin|mesh-list
110764799|NCT01375426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110764800|NCT01375426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110764801|NCT05193838|Allopurinol|allopurinol|mesh-list
110764802|NCT05193838|Antimetabolites|antimetabolites|mesh-ancestor
110764803|NCT05193838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110764804|NCT05193838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110764805|NCT05193838|Gout Suppressants|gout suppressants|mesh-ancestor
110764806|NCT05193838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110764807|NCT05193838|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110764808|NCT05193838|Antioxidants|antioxidants|mesh-ancestor
110764809|NCT05193838|Protective Agents|protective agents|mesh-ancestor
110764810|NCT05193838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110764812|NCT05193604|Gemcitabine|gemcitabine|mesh-list
110764813|NCT05193604|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110764814|NCT05193604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110764815|NCT05193604|Tubulin Modulators|tubulin modulators|mesh-ancestor
110764816|NCT05193604|Antimitotic Agents|antimitotic agents|mesh-ancestor
110764817|NCT05193604|Mitosis Modulators|mitosis modulators|mesh-ancestor
110764818|NCT05193604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110764819|NCT05193604|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110764820|NCT05193604|Antimetabolites|antimetabolites|mesh-ancestor
110764822|NCT01375816|Bevacizumab|bevacizumab|mesh-list
110764823|NCT01375816|Fluorouracil|fluorouracil|mesh-list
110764824|NCT01375816|Irinotecan|irinotecan|mesh-list
110764825|NCT01375816|Calcium|calcium|mesh-list
110764826|NCT01375816|Levoleucovorin|levoleucovorin|mesh-list
110764827|NCT01375816|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110764828|NCT01375816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110764829|NCT01375816|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110764830|NCT01375816|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110764831|NCT01375816|Growth Substances|growth substances|mesh-ancestor
110764832|NCT01375816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110764833|NCT01375816|Growth Inhibitors|growth inhibitors|mesh-ancestor
110764834|NCT01375816|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110764835|NCT01375816|Antimetabolites|antimetabolites|mesh-ancestor
110764836|NCT01375816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110764837|NCT01375816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110764838|NCT01375816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110482524|NCT00998738|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110764839|NCT01375816|Immunologic Factors|immunologic factors|mesh-ancestor
110764840|NCT01375816|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110764841|NCT01375816|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110764842|NCT01375816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110764843|NCT01375816|Antidotes|antidotes|mesh-ancestor
110764844|NCT01375816|Protective Agents|protective agents|mesh-ancestor
110764845|NCT01375816|Vitamin B Complex|vitamin b complex|mesh-ancestor
110764846|NCT01375816|Vitamins|vitamins|mesh-ancestor
110764847|NCT01375816|Micronutrients|micronutrients|mesh-ancestor
110764848|NCT03632824|Tranexamic Acid|tranexamic acid|mesh-list
110764849|NCT03632824|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110764850|NCT03632824|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110764851|NCT03632824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110764852|NCT03632824|Hemostatics|hemostatics|mesh-ancestor
110764853|NCT03632824|Coagulants|coagulants|mesh-ancestor
110764854|NCT00911820|Bevacizumab|bevacizumab|mesh-list
110764855|NCT00911820|Cisplatin|cisplatin|mesh-list
110764856|NCT00911820|Docetaxel|docetaxel|mesh-list
110764857|NCT00911820|Irinotecan|irinotecan|mesh-list
110764858|NCT00911820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110764859|NCT00911820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110764860|NCT00911820|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110764861|NCT00911820|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110764862|NCT00911820|Growth Substances|growth substances|mesh-ancestor
110764863|NCT00911820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110764864|NCT00911820|Growth Inhibitors|growth inhibitors|mesh-ancestor
110764865|NCT00911820|Tubulin Modulators|tubulin modulators|mesh-ancestor
110764866|NCT00911820|Antimitotic Agents|antimitotic agents|mesh-ancestor
110764867|NCT00911820|Mitosis Modulators|mitosis modulators|mesh-ancestor
110764868|NCT00911820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110764869|NCT00911820|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110869604|NCT02288832|Azithromycin|azithromycin|mesh-list
110764870|NCT00911820|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110764871|NCT00911820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110764872|NCT05348122|Dulaglutide|dulaglutide|mesh-list
110764873|NCT05348122|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
110764874|NCT05348122|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110764875|NCT05348122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110764876|NCT05348122|Immunologic Factors|immunologic factors|mesh-ancestor
110764877|NCT05038618|Somatomedin B|somatomedin b|mesh-list
110764878|NCT05038618|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
110764879|NCT05038618|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110764880|NCT05038618|Protease Inhibitors|protease inhibitors|mesh-ancestor
110764881|NCT05038618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110764882|NCT05038618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110764884|NCT01244880|Analgesics|analgesics|mesh-ancestor
110764885|NCT01244880|Sensory System Agents|sensory system agents|mesh-ancestor
110764886|NCT01244880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110316043|NCT00312182|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110764887|NCT01244880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110764888|NCT01244880|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110764889|NCT01244880|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110764890|NCT01244880|Anesthetics, General|anesthetics, general|mesh-ancestor
110764891|NCT01244880|Anesthetics|anesthetics|mesh-ancestor
110764892|NCT01244880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110764893|NCT01244880|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110764894|NCT01244880|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110764895|NCT01244880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110764896|NCT01244880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110764897|NCT01244958|Rituximab|rituximab|mesh-list
110764898|NCT01244958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110764899|NCT01244958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110764900|NCT01244958|Immunologic Factors|immunologic factors|mesh-ancestor
110764901|NCT01244958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110764902|NCT01244958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110764903|NCT00246324|Interferons|interferons|mesh-list
110764904|NCT00246324|Interferon-beta|interferon-beta|mesh-list
110764905|NCT00246324|Interferon beta-1a|interferon beta-1a|mesh-list
110764906|NCT00246324|Doxycycline|doxycycline|mesh-list
110764907|NCT00246324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110764908|NCT00246324|Antiviral Agents|antiviral agents|mesh-ancestor
110764909|NCT00246324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110764910|NCT00246324|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110764911|NCT00246324|Antimalarials|antimalarials|mesh-ancestor
110764912|NCT00246324|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110764913|NCT00246324|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110764914|NCT00246324|Immunologic Factors|immunologic factors|mesh-ancestor
110764915|NCT00246324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110764916|NCT00246324|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110764917|NCT01237782|Propolis|propolis|mesh-list
110764918|NCT01237782|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110764919|NCT01237782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110764920|NCT01245660|Lapatinib|lapatinib|mesh-list
110764921|NCT01245660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110764922|NCT01245660|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110764923|NCT01245660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110764924|NCT01245660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110764925|NCT03686904|Benzalkonium Compounds|benzalkonium compounds|mesh-list
110764926|NCT03686904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110764927|NCT03686904|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110764928|NCT03913806|Bevacizumab|bevacizumab|mesh-list
110764929|NCT03913806|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110764930|NCT03913806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110764931|NCT03913806|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110764932|NCT03913806|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110764933|NCT03913806|Growth Substances|growth substances|mesh-ancestor
110764934|NCT03913806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110764935|NCT03913806|Growth Inhibitors|growth inhibitors|mesh-ancestor
110764936|NCT01250808|Dexamethasone|dexamethasone|mesh-list
110764937|NCT01250808|Bortezomib|bortezomib|mesh-list
110764938|NCT01250808|Melphalan|melphalan|mesh-list
110764939|NCT01250808|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110764940|NCT01250808|Antiemetics|antiemetics|mesh-ancestor
110764941|NCT01250808|Autonomic Agents|autonomic agents|mesh-ancestor
110764942|NCT01250808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110764943|NCT01250808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110764944|NCT01250808|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110764945|NCT01250808|Glucocorticoids|glucocorticoids|mesh-ancestor
110764946|NCT01250808|Hormones|hormones|mesh-ancestor
110764947|NCT01250808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110764948|NCT01250808|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110764949|NCT01250808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110764950|NCT01250808|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110764951|NCT01250808|Alkylating Agents|alkylating agents|mesh-ancestor
110764952|NCT01250808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110764953|NCT01250808|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110764954|NCT01250808|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110764955|NCT01250808|Immunologic Factors|immunologic factors|mesh-ancestor
110764956|NCT01146678|Insulin Glargine|insulin glargine|mesh-list
110764957|NCT01146678|Lixisenatide|lixisenatide|mesh-list
110764958|NCT01146678|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110764959|NCT01146678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110764960|NCT05429866|Nivolumab|nivolumab|mesh-list
110764961|NCT05429866|Atezolizumab|atezolizumab|mesh-list
110764962|NCT05429866|Durvalumab|durvalumab|mesh-list
110764963|NCT05429866|Avelumab|avelumab|mesh-list
110764964|NCT05429866|Cemiplimab|cemiplimab|mesh-list
110764965|NCT05429866|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
110764966|NCT05429866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110764967|NCT05429866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110764968|NCT05429866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110764969|NCT01250886|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110764970|NCT03632590|Magnesium Sulfate|magnesium sulfate|mesh-list
110764971|NCT03632590|Magnesium citrate|magnesium citrate|mesh-list
110764972|NCT03632590|Magnesium Oxide|magnesium oxide|mesh-list
110764973|NCT03632590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110764974|NCT03632590|Analgesics|analgesics|mesh-ancestor
110764975|NCT03632590|Sensory System Agents|sensory system agents|mesh-ancestor
110764976|NCT03632590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110764977|NCT03632590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110764978|NCT03632590|Anesthetics|anesthetics|mesh-ancestor
110764979|NCT03632590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110764980|NCT03632590|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110764981|NCT03632590|Anticonvulsants|anticonvulsants|mesh-ancestor
110764982|NCT03632590|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110764983|NCT03632590|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110764984|NCT03632590|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110764985|NCT03632590|Tocolytic Agents|tocolytic agents|mesh-ancestor
110764986|NCT03632590|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110764987|NCT03632590|Cathartics|cathartics|mesh-ancestor
110764988|NCT03632590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110764989|NCT03632590|Antacids|antacids|mesh-ancestor
110764990|NCT05376670|Gentamicins|gentamicins|mesh-list
110764991|NCT05376670|Tobramycin|tobramycin|mesh-list
110764992|NCT05376670|Amikacin|amikacin|mesh-list
110764993|NCT05376670|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110764994|NCT05376670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110764995|NCT05376670|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110764996|NCT05376670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110764997|NCT05376670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110764998|NCT01242774|Panobinostat|panobinostat|mesh-list
110764999|NCT01242774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110765000|NCT01242774|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110765001|NCT01242774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110765002|NCT01242774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110765003|NCT01243086|Dexamethasone|dexamethasone|mesh-list
110765004|NCT01243086|Ranibizumab|ranibizumab|mesh-list
110765005|NCT01243086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110765006|NCT01243086|Antiemetics|antiemetics|mesh-ancestor
110765007|NCT01243086|Autonomic Agents|autonomic agents|mesh-ancestor
110765008|NCT01243086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110765009|NCT01243086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110765010|NCT01243086|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110765011|NCT01243086|Glucocorticoids|glucocorticoids|mesh-ancestor
110765012|NCT01243086|Hormones|hormones|mesh-ancestor
110765013|NCT01243086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110765014|NCT01243086|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110765015|NCT01243086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110765016|NCT01243086|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110765017|NCT01243086|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110765018|NCT01243086|Growth Substances|growth substances|mesh-ancestor
110765019|NCT01243086|Growth Inhibitors|growth inhibitors|mesh-ancestor
110765020|NCT03908814|Antibodies|antibodies|mesh-list
110765021|NCT03908814|Immunologic Factors|immunologic factors|mesh-ancestor
110765022|NCT03908814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110765023|NCT01253382|Ecallantide|ecallantide|mesh-list
110765024|NCT01253382|Analgesics|analgesics|mesh-ancestor
110765025|NCT01253382|Sensory System Agents|sensory system agents|mesh-ancestor
110765026|NCT01253382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110765027|NCT01253382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110765028|NCT01253382|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110765029|NCT01253382|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110765030|NCT01253382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110765031|NCT01253382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110765032|NCT01148160|Voriconazole|voriconazole|mesh-list
110765033|NCT01148160|Antifungal Agents|antifungal agents|mesh-ancestor
110765034|NCT01148160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110765035|NCT01148160|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110765036|NCT01148160|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110765037|NCT01148160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110765038|NCT01148160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110765039|NCT01148160|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110765040|NCT01148160|Hormone Antagonists|hormone antagonists|mesh-ancestor
110765041|NCT01148160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110765042|NCT01148160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110765043|NCT01148160|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110765044|NCT01147692|Simvastatin|simvastatin|mesh-list
110765045|NCT01147692|rGLP-1 protein|rglp-1 protein|mesh-list
110765046|NCT01147692|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110316114|NCT00312650|Gemcitabine|gemcitabine|mesh-list
110765047|NCT01147692|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110765048|NCT01147692|Antimetabolites|antimetabolites|mesh-ancestor
110765049|NCT01147692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110765050|NCT01147692|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110765051|NCT01147692|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110765052|NCT01147692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110765053|NCT01147692|Incretins|incretins|mesh-ancestor
110765054|NCT01147692|Hormones|hormones|mesh-ancestor
110765055|NCT01147692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110765056|NCT01147692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110765057|NCT03913182|Apatinib|apatinib|mesh-list
110765058|NCT03913182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110765059|NCT03913182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110765060|NCT03913182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110765061|NCT03913182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110765062|NCT02713386|Paclitaxel|paclitaxel|mesh-list
110765063|NCT02713386|Carboplatin|carboplatin|mesh-list
110765064|NCT02713386|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110765065|NCT02713386|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110765066|NCT02713386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110482744|NCT02269267|Cariostatic Agents|cariostatic agents|mesh-ancestor
110765067|NCT02713386|Tubulin Modulators|tubulin modulators|mesh-ancestor
110765068|NCT02713386|Antimitotic Agents|antimitotic agents|mesh-ancestor
110765069|NCT02713386|Mitosis Modulators|mitosis modulators|mesh-ancestor
110765070|NCT02713386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110765072|NCT01967238|Immunologic Factors|immunologic factors|mesh-ancestor
110765073|NCT01967238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110765074|NCT05616000|Folic Acid|folic acid|mesh-list
110765075|NCT05616000|Acetylcarnitine|acetylcarnitine|mesh-list
110765076|NCT05616000|Hematinics|hematinics|mesh-ancestor
110765077|NCT05616000|Vitamin B Complex|vitamin b complex|mesh-ancestor
110765078|NCT05616000|Vitamins|vitamins|mesh-ancestor
110765079|NCT05616000|Micronutrients|micronutrients|mesh-ancestor
110765080|NCT05616000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110765081|NCT05616000|Nootropic Agents|nootropic agents|mesh-ancestor
110765082|NCT03912402|Paclitaxel|paclitaxel|mesh-list
110765083|NCT03912402|Bevacizumab|bevacizumab|mesh-list
110765084|NCT03912402|Carboplatin|carboplatin|mesh-list
110765085|NCT03912402|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110765086|NCT03912402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110765087|NCT03912402|Tubulin Modulators|tubulin modulators|mesh-ancestor
110765088|NCT03912402|Antimitotic Agents|antimitotic agents|mesh-ancestor
110765089|NCT03912402|Mitosis Modulators|mitosis modulators|mesh-ancestor
110765090|NCT03912402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110765091|NCT03912402|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110765092|NCT03912402|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110765093|NCT03912402|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110765094|NCT03912402|Growth Substances|growth substances|mesh-ancestor
110765095|NCT03912402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110765096|NCT03912402|Growth Inhibitors|growth inhibitors|mesh-ancestor
110765097|NCT01147770|Progesterone|progesterone|mesh-list
110765098|NCT01147770|Progestins|progestins|mesh-ancestor
110765099|NCT01147770|Hormones|hormones|mesh-ancestor
110765100|NCT01147770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110765101|NCT01147770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110765102|NCT01148316|Fluoxetine|fluoxetine|mesh-list
110765103|NCT01148316|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110765104|NCT01148316|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110765105|NCT01148316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110765106|NCT01148316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110765107|NCT01148316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110765108|NCT01148316|Serotonin Agents|serotonin agents|mesh-ancestor
110765109|NCT01148316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110765110|NCT01148316|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110765111|NCT01148316|Antidepressive Agents|antidepressive agents|mesh-ancestor
110765112|NCT01148316|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110765113|NCT01148316|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110765114|NCT01148316|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110765115|NCT01148316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110765116|NCT01249638|Bevacizumab|bevacizumab|mesh-list
110765117|NCT01249638|Capecitabine|capecitabine|mesh-list
110765118|NCT01249638|Irinotecan|irinotecan|mesh-list
110765119|NCT01249638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110765120|NCT01249638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110765121|NCT01249638|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110765122|NCT01249638|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110765123|NCT01249638|Growth Substances|growth substances|mesh-ancestor
110765124|NCT01249638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110765125|NCT01249638|Growth Inhibitors|growth inhibitors|mesh-ancestor
110765126|NCT01249638|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110765127|NCT01249638|Antimetabolites|antimetabolites|mesh-ancestor
110765128|NCT01249638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110765129|NCT01249638|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110765130|NCT01249638|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110765131|NCT01249638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110765132|NCT03907098|Endostar protein|endostar protein|mesh-list
110765133|NCT03907098|Endostatins|endostatins|mesh-list
110765134|NCT03907098|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110765135|NCT03907098|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110765136|NCT03907098|Growth Substances|growth substances|mesh-ancestor
110765137|NCT03907098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110765138|NCT03907098|Growth Inhibitors|growth inhibitors|mesh-ancestor
110765139|NCT03907098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110765140|NCT01251822|Prucalopride|prucalopride|mesh-list
110482821|NCT04070755|Minocycline|minocycline|mesh-list
110765141|NCT01251822|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
110765142|NCT01251822|Laxatives|laxatives|mesh-ancestor
110765143|NCT01251822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110765144|NCT01251822|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
110765145|NCT01251822|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110765146|NCT01251822|Serotonin Agents|serotonin agents|mesh-ancestor
110765147|NCT01251822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110765148|NCT01251822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110765149|NCT01251822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110765150|NCT01253694|Ranibizumab|ranibizumab|mesh-list
110765151|NCT01253694|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110765152|NCT01253694|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110765153|NCT01253694|Growth Substances|growth substances|mesh-ancestor
110765154|NCT01253694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110765155|NCT01253694|Growth Inhibitors|growth inhibitors|mesh-ancestor
110765156|NCT01253694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110765157|NCT01148004|Ritonavir|ritonavir|mesh-list
110765158|NCT01148004|Lopinavir|lopinavir|mesh-list
110765159|NCT01148004|Fenofibrate|fenofibrate|mesh-list
110765160|NCT01148004|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110765161|NCT01148004|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110765162|NCT01148004|Protease Inhibitors|protease inhibitors|mesh-ancestor
110765163|NCT01148004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110765164|NCT01148004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110765165|NCT01148004|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110765166|NCT01148004|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110765167|NCT01148004|Antiviral Agents|antiviral agents|mesh-ancestor
110765168|NCT01148004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110445588|NCT04134637|Bupivacaine|bupivacaine|mesh-list
110765169|NCT01148004|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110765170|NCT01148004|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110765171|NCT01148004|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110765173|NCT01148004|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110765174|NCT01252056|Cilostazol|cilostazol|mesh-list
110765175|NCT01252056|Probucol|probucol|mesh-list
110765176|NCT01252056|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110765177|NCT01252056|Autonomic Agents|autonomic agents|mesh-ancestor
110765178|NCT01252056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110765179|NCT01252056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110765180|NCT01252056|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110765181|NCT01252056|Respiratory System Agents|respiratory system agents|mesh-ancestor
110765182|NCT01252056|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110765183|NCT01252056|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110765184|NCT01252056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110765185|NCT01252056|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110765186|NCT01252056|Vasodilator Agents|vasodilator agents|mesh-ancestor
110765187|NCT01252056|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110765188|NCT01252056|Protective Agents|protective agents|mesh-ancestor
110765189|NCT01252056|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110765190|NCT01252056|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110765191|NCT01252056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110765192|NCT01252056|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110765193|NCT01252056|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110765194|NCT01252056|Antimetabolites|antimetabolites|mesh-ancestor
110765195|NCT01252056|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110765196|NCT01252056|Antioxidants|antioxidants|mesh-ancestor
110765197|NCT02528448|Plasma-lyte 148|plasma-lyte 148|mesh-list
110765198|NCT02528448|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110765199|NCT02528448|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110765200|NCT01148472|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110765201|NCT01148472|Escitalopram|escitalopram|mesh-list
110765202|NCT01148472|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110765203|NCT01148472|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110765204|NCT01148472|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110765205|NCT01148472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110765207|NCT01148472|Serotonin Agents|serotonin agents|mesh-ancestor
110765208|NCT01148472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110765209|NCT01148472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110765210|NCT01148472|Antidepressive Agents|antidepressive agents|mesh-ancestor
110765211|NCT01148472|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110765212|NCT01148472|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110765213|NCT01148472|Analgesics|analgesics|mesh-ancestor
110765214|NCT01148472|Sensory System Agents|sensory system agents|mesh-ancestor
110765215|NCT01148472|Dopamine Agents|dopamine agents|mesh-ancestor
110765216|NCT01147146|Fentanyl|fentanyl|mesh-list
110765217|NCT01147146|Midazolam|midazolam|mesh-list
110765218|NCT01147146|Bupivacaine|bupivacaine|mesh-list
110765219|NCT01147146|Propofol|propofol|mesh-list
110765220|NCT01147146|Atracurium|atracurium|mesh-list
110765221|NCT01147146|Anesthetics, Local|anesthetics, local|mesh-ancestor
110765222|NCT01147146|Anesthetics|anesthetics|mesh-ancestor
110765223|NCT01147146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110765224|NCT01147146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110765225|NCT01147146|Sensory System Agents|sensory system agents|mesh-ancestor
110765226|NCT01147146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110765227|NCT01147146|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110765228|NCT01147146|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110765229|NCT01147146|Anesthetics, General|anesthetics, general|mesh-ancestor
110765230|NCT01147146|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110765231|NCT01147146|Narcotics|narcotics|mesh-ancestor
110765232|NCT01147146|Analgesics|analgesics|mesh-ancestor
110765233|NCT01147146|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110765234|NCT01147146|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110765235|NCT01147146|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110765236|NCT01147146|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110765237|NCT01147146|GABA Modulators|gaba modulators|mesh-ancestor
110765238|NCT01147146|GABA Agents|gaba agents|mesh-ancestor
110765239|NCT01147146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110765240|NCT01147146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110765241|NCT01147146|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110765242|NCT01147146|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110765243|NCT01147146|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110765244|NCT01147146|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
110765245|NCT01147146|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110765246|NCT01147146|Cholinergic Agents|cholinergic agents|mesh-ancestor
110765247|NCT01250340|Aspirin|aspirin|mesh-list
110765248|NCT01250340|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110765249|NCT01250340|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110765250|NCT01250340|Analgesics|analgesics|mesh-ancestor
110765251|NCT01250340|Sensory System Agents|sensory system agents|mesh-ancestor
110765252|NCT01250340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110765253|NCT01250340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110765254|NCT01250340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110765255|NCT01250340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110765256|NCT01250340|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110765257|NCT01250340|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110765258|NCT01250340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110765259|NCT01250340|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110765260|NCT01250340|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110765261|NCT01250340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110765262|NCT01250340|Antipyretics|antipyretics|mesh-ancestor
110765263|NCT03915132|Nimotuzumab|nimotuzumab|mesh-list
110765264|NCT03915132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110765265|NCT03915132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110765266|NCT01250652|Cetirizine|cetirizine|mesh-list
110765267|NCT01250652|Hydroxyzine|hydroxyzine|mesh-list
110765268|NCT01250652|Levocetirizine|levocetirizine|mesh-list
110765269|NCT01250652|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110765270|NCT01250652|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110765271|NCT01250652|Histamine Antagonists|histamine antagonists|mesh-ancestor
110765272|NCT01250652|Histamine Agents|histamine agents|mesh-ancestor
110765273|NCT01250652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110765274|NCT01250652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110765275|NCT01250652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110765276|NCT01250652|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110765277|NCT01250652|Antipruritics|antipruritics|mesh-ancestor
110765278|NCT01250652|Dermatologic Agents|dermatologic agents|mesh-ancestor
110765279|NCT01253928|Pioglitazone|pioglitazone|mesh-list
110765280|NCT01253928|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110765281|NCT01253928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110765282|NCT01252524|Calcium polycarbophil|calcium polycarbophil|mesh-list
110765283|NCT01252524|Psyllium|psyllium|mesh-list
110765284|NCT01252524|Calcium|calcium|mesh-list
110765285|NCT01252524|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110765286|NCT01252524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110765287|NCT01252524|Antidiarrheals|antidiarrheals|mesh-ancestor
110765288|NCT01252524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110765289|NCT01252524|Cathartics|cathartics|mesh-ancestor
110765290|NCT03914352|Antibodies|antibodies|mesh-list
110482977|NCT00628043|Epoetin Alfa|epoetin alfa|mesh-list
110765291|NCT03914352|Immunologic Factors|immunologic factors|mesh-ancestor
110765292|NCT03914352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110765293|NCT01254006|Thiamine|thiamine|mesh-list
110765294|NCT01254006|Vitamins|vitamins|mesh-ancestor
110765295|NCT01254006|Micronutrients|micronutrients|mesh-ancestor
110765296|NCT01254006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110765297|NCT01254006|Vitamin B Complex|vitamin b complex|mesh-ancestor
110765305|NCT02528136|Oxytocin|oxytocin|mesh-list
110765306|NCT02528136|Carbetocin|carbetocin|mesh-list
110765307|NCT02528136|Oxytocics|oxytocics|mesh-ancestor
110765308|NCT02528136|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110765309|NCT02528136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110765310|NCT01252680|Vaccines|vaccines|mesh-list
110765311|NCT01252680|Immunologic Factors|immunologic factors|mesh-ancestor
110765312|NCT01252680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110765313|NCT01252758|Albuterol|albuterol|mesh-list
110765314|NCT01252758|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110765315|NCT01252758|Autonomic Agents|autonomic agents|mesh-ancestor
110765316|NCT01252758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110090388|NCT03961360|Aspirin|aspirin|mesh-list
110765317|NCT01252758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110765318|NCT01252758|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110765319|NCT01252758|Respiratory System Agents|respiratory system agents|mesh-ancestor
110765320|NCT01252758|Tocolytic Agents|tocolytic agents|mesh-ancestor
110765321|NCT01252758|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110765322|NCT01252758|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110765323|NCT01252758|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110765324|NCT01252758|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110765325|NCT01252758|Adrenergic Agents|adrenergic agents|mesh-ancestor
110765326|NCT01252758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110765327|NCT01252758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110765329|NCT03913884|Mitosis Modulators|mitosis modulators|mesh-ancestor
110765330|NCT03913884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110765331|NCT01147224|Ciclesonide|ciclesonide|mesh-list
110765332|NCT01147224|Glucocorticoids|glucocorticoids|mesh-ancestor
110765333|NCT01147224|Hormones|hormones|mesh-ancestor
110765334|NCT01147224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110765335|NCT01147224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110765336|NCT01147224|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110765337|NCT03913650|Bupivacaine|bupivacaine|mesh-list
110765338|NCT03913650|Anesthetics, Local|anesthetics, local|mesh-ancestor
110765339|NCT03913650|Anesthetics|anesthetics|mesh-ancestor
110765340|NCT03913650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110765341|NCT03913650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110765342|NCT03913650|Sensory System Agents|sensory system agents|mesh-ancestor
110765343|NCT03913650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110765344|NCT01149174|Mitomycins|mitomycins|mesh-list
110765345|NCT01149174|Mitomycin|mitomycin|mesh-list
110765346|NCT01149174|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110765347|NCT01149174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110765348|NCT01149174|Alkylating Agents|alkylating agents|mesh-ancestor
110765349|NCT01149174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110765350|NCT01149174|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110765351|NCT01149174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110765352|NCT04353778|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
110765353|NCT04353778|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110765354|NCT04353778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110765355|NCT04353778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110765356|NCT04353778|Cholinergic Agents|cholinergic agents|mesh-ancestor
110765357|NCT04353778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110765358|NCT04353778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110765359|NCT01148628|Everolimus|everolimus|mesh-list
110765360|NCT01148628|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110765361|NCT01148628|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110765362|NCT01148628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110765363|NCT01148628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110765364|NCT01148628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110765365|NCT01148628|Immunologic Factors|immunologic factors|mesh-ancestor
110765366|NCT01148628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110483046|NCT00710359|Vitamins|vitamins|mesh-list
110765367|NCT01148628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110765368|NCT01254708|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
110765369|NCT01254708|Antifungal Agents|antifungal agents|mesh-ancestor
110765370|NCT01254708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110765371|NCT01254708|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110765372|NCT01254708|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110765373|NCT03909594|Ketamine|ketamine|mesh-list
110765374|NCT03909594|Bupivacaine|bupivacaine|mesh-list
110765375|NCT03909594|Anesthetics, Local|anesthetics, local|mesh-ancestor
110765376|NCT03909594|Anesthetics|anesthetics|mesh-ancestor
110765377|NCT03909594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110765378|NCT03909594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110765379|NCT03909594|Sensory System Agents|sensory system agents|mesh-ancestor
110765380|NCT03909594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110765381|NCT03909594|Analgesics|analgesics|mesh-ancestor
110765382|NCT03909594|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110765383|NCT03909594|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110765384|NCT03909594|Anesthetics, General|anesthetics, general|mesh-ancestor
110765385|NCT03909594|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110765386|NCT03909594|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110765387|NCT03909594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110765388|NCT03909594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110765389|NCT04492072|Misoprostol|misoprostol|mesh-list
110765390|NCT04492072|Oxytocin|oxytocin|mesh-list
110765391|NCT04492072|Oxytocics|oxytocics|mesh-ancestor
110765392|NCT04492072|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110765393|NCT04492072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110765394|NCT04492072|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110765395|NCT04492072|Abortifacient Agents|abortifacient agents|mesh-ancestor
110765396|NCT04492072|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110765397|NCT04492072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110765398|NCT04181008|Amiloride|amiloride|mesh-list
110765399|NCT04181008|Diuretics|diuretics|mesh-ancestor
110765400|NCT04181008|Natriuretic Agents|natriuretic agents|mesh-ancestor
110765401|NCT04181008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110765402|NCT04181008|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
110765403|NCT04181008|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110765404|NCT04181008|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110765405|NCT04181008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110765406|NCT04181008|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
110765407|NCT04181008|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110765408|NCT03629340|Metformin|metformin|mesh-list
110765409|NCT03629340|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110765410|NCT03629340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110765411|NCT03904836|Tobramycin|tobramycin|mesh-list
110765412|NCT03904836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110765413|NCT03904836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110316273|NCT00343707|Serotonin Agents|serotonin agents|mesh-ancestor
110765414|NCT03908580|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110765415|NCT03908580|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110765416|NCT03908580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110765417|NCT03908580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110765418|NCT03908580|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110765419|NCT03908580|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110765420|NCT03908580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110765421|NCT03908580|Cholinergic Agents|cholinergic agents|mesh-ancestor
110765422|NCT03908580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110765423|NCT03904680|Vitamin D|vitamin d|mesh-list
110765424|NCT03904680|Methotrexate|methotrexate|mesh-list
110765425|NCT03904680|Vitamins|vitamins|mesh-ancestor
110765426|NCT03904680|Micronutrients|micronutrients|mesh-ancestor
110765427|NCT03904680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110765428|NCT03904680|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110765429|NCT03904680|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110765430|NCT03904680|Abortifacient Agents|abortifacient agents|mesh-ancestor
110765431|NCT03904680|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110765432|NCT03904680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110765433|NCT03904680|Antimetabolites|antimetabolites|mesh-ancestor
110765434|NCT03904680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110765435|NCT03904680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110765436|NCT03904680|Dermatologic Agents|dermatologic agents|mesh-ancestor
110765437|NCT03904680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110765438|NCT03904680|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110765439|NCT03904680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110765440|NCT03904680|Immunologic Factors|immunologic factors|mesh-ancestor
110483140|NCT01014767|Antidotes|antidotes|mesh-ancestor
110765441|NCT03904680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110765442|NCT03904680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110765443|NCT01150266|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
110765444|NCT01150266|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110765445|NCT01150266|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110765446|NCT01150266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110765447|NCT01256268|Paclitaxel|paclitaxel|mesh-list
110765448|NCT01256268|Carboplatin|carboplatin|mesh-list
110765449|NCT01256268|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110765450|NCT01256268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110765451|NCT01256268|Tubulin Modulators|tubulin modulators|mesh-ancestor
110765452|NCT01256268|Antimitotic Agents|antimitotic agents|mesh-ancestor
110765453|NCT01256268|Mitosis Modulators|mitosis modulators|mesh-ancestor
110765454|NCT01256268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110765455|NCT03902106|Albuterol|albuterol|mesh-list
110765456|NCT03902106|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110765457|NCT03902106|Autonomic Agents|autonomic agents|mesh-ancestor
110765458|NCT03902106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110765459|NCT03902106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110765460|NCT03902106|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110765461|NCT03902106|Respiratory System Agents|respiratory system agents|mesh-ancestor
110765462|NCT03902106|Tocolytic Agents|tocolytic agents|mesh-ancestor
110765463|NCT03902106|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110765464|NCT03902106|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110765465|NCT03902106|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110765466|NCT03902106|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110765467|NCT03902106|Adrenergic Agents|adrenergic agents|mesh-ancestor
110765468|NCT03902106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110765469|NCT03902106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110765470|NCT03902340|Analgesics|analgesics|mesh-list
110765471|NCT03902340|Sensory System Agents|sensory system agents|mesh-ancestor
110765472|NCT03902340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110765473|NCT03902340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110765474|NCT01149330|Adapalene|adapalene|mesh-list
110765475|NCT01149330|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110765476|NCT01149330|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110765477|NCT01149330|Analgesics|analgesics|mesh-ancestor
110765478|NCT01149330|Sensory System Agents|sensory system agents|mesh-ancestor
110765479|NCT01149330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110765480|NCT01149330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110765481|NCT01149330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110765482|NCT01149330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110765483|NCT01149330|Dermatologic Agents|dermatologic agents|mesh-ancestor
110765484|NCT01150344|Artemether|artemether|mesh-list
110765485|NCT01150344|Atovaquone|atovaquone|mesh-list
110765486|NCT01150344|Proguanil|proguanil|mesh-list
110765487|NCT01150344|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
110765488|NCT01150344|Antimalarials|antimalarials|mesh-ancestor
110765489|NCT01150344|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110765490|NCT01150344|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110765491|NCT01150344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110765492|NCT01150344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110765493|NCT01150344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110765494|NCT01150344|Antimetabolites|antimetabolites|mesh-ancestor
110765495|NCT01256580|Dexamethasone|dexamethasone|mesh-list
110765496|NCT01256580|Bevacizumab|bevacizumab|mesh-list
110765497|NCT01256580|Verteporfin|verteporfin|mesh-list
110765498|NCT01256580|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110765499|NCT01256580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110765500|NCT01256580|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110765501|NCT01256580|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110765502|NCT01256580|Growth Substances|growth substances|mesh-ancestor
110316329|NCT00348192|Nootropic Agents|nootropic agents|mesh-ancestor
110765503|NCT01256580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110765504|NCT01256580|Growth Inhibitors|growth inhibitors|mesh-ancestor
110765505|NCT01256580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110765506|NCT01256580|Antiemetics|antiemetics|mesh-ancestor
110765507|NCT01256580|Autonomic Agents|autonomic agents|mesh-ancestor
110765508|NCT01256580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110765509|NCT01256580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110765510|NCT01256580|Glucocorticoids|glucocorticoids|mesh-ancestor
110765511|NCT01256580|Hormones|hormones|mesh-ancestor
110765512|NCT01256580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110765513|NCT01256580|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110765514|NCT01256580|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110765515|NCT01256580|Dermatologic Agents|dermatologic agents|mesh-ancestor
110765516|NCT03901716|Fentanyl|fentanyl|mesh-list
110765517|NCT03901716|Midazolam|midazolam|mesh-list
110765518|NCT03901716|Sufentanil|sufentanil|mesh-list
110765519|NCT03901716|Remifentanil|remifentanil|mesh-list
110765520|NCT03901716|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110765521|NCT03901716|Narcotics|narcotics|mesh-ancestor
110765522|NCT03901716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110765523|NCT03901716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110765524|NCT03901716|Analgesics|analgesics|mesh-ancestor
110765525|NCT03901716|Sensory System Agents|sensory system agents|mesh-ancestor
110765526|NCT03901716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110765527|NCT03901716|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110765528|NCT03901716|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110765529|NCT03901716|Anesthetics, General|anesthetics, general|mesh-ancestor
110765530|NCT03901716|Anesthetics|anesthetics|mesh-ancestor
110765531|NCT03901716|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110765532|NCT03901716|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110765533|NCT03901716|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110765534|NCT03901716|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110765535|NCT03901716|GABA Modulators|gaba modulators|mesh-ancestor
110765536|NCT03901716|GABA Agents|gaba agents|mesh-ancestor
110765537|NCT03901716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110765538|NCT03901716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110765539|NCT04113538|Aflibercept|aflibercept|mesh-list
110765540|NCT04113538|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110765541|NCT04113538|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110765542|NCT04113538|Growth Substances|growth substances|mesh-ancestor
110765543|NCT04113538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110765544|NCT04113538|Growth Inhibitors|growth inhibitors|mesh-ancestor
110765545|NCT04113538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110765546|NCT03904368|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
110316379|NCT00348231|Insulin|insulin|mesh-list
110765547|NCT03904368|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110765548|NCT03904368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110765550|NCT03922750|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110765551|NCT03922750|Insulin Glargine|insulin glargine|mesh-list
110765552|NCT03922750|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110765553|NCT03922750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110765554|NCT03898128|Immunotoxins|immunotoxins|mesh-list
110765556|NCT03898128|Immunologic Factors|immunologic factors|mesh-ancestor
110765557|NCT03898128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110765558|NCT01149408|Decitabine|decitabine|mesh-list
110765559|NCT01149408|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110765560|NCT01149408|Antimetabolites|antimetabolites|mesh-ancestor
110765561|NCT01149408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110765562|NCT01149408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110765563|NCT01149408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110765564|NCT03631966|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110765565|NCT03631966|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110765566|NCT03631966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110765567|NCT03631966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110765568|NCT03631966|Cholinergic Agents|cholinergic agents|mesh-ancestor
110765569|NCT03631966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110765570|NCT03631966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110765571|NCT01149018|Dronabinol|dronabinol|mesh-list
110765572|NCT01149018|Hallucinogens|hallucinogens|mesh-ancestor
110765573|NCT01149018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110765574|NCT01149018|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110765575|NCT01149018|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110765576|NCT01149018|Analgesics|analgesics|mesh-ancestor
110765577|NCT01149018|Sensory System Agents|sensory system agents|mesh-ancestor
110765578|NCT01149018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110765579|NCT01149018|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
110765580|NCT01149018|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110765581|NCT01149018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110765582|NCT01149018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110765583|NCT01149018|Hormones|hormones|mesh-ancestor
110765584|NCT01149018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110765585|NCT03904056|Ranibizumab|ranibizumab|mesh-list
110765586|NCT03904056|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110765587|NCT03904056|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110765588|NCT03904056|Growth Substances|growth substances|mesh-ancestor
110765589|NCT03904056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110765590|NCT03904056|Growth Inhibitors|growth inhibitors|mesh-ancestor
110765591|NCT03904056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110483272|NCT02871869|Rituximab|rituximab|mesh-list
110765593|NCT03897660|Vitamin K|vitamin k|mesh-list
110765594|NCT03897660|Vitamin K 2|vitamin k 2|mesh-list
110765595|NCT03897660|Micronutrients|micronutrients|mesh-ancestor
110765596|NCT03897660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110765597|NCT03897660|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110765598|NCT03897660|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110765599|NCT03897660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110765600|NCT03897660|Hemostatics|hemostatics|mesh-ancestor
110765601|NCT03897660|Coagulants|coagulants|mesh-ancestor
110765602|NCT03901170|Letrozole|letrozole|mesh-list
110765603|NCT03901170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110765604|NCT03901170|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110765605|NCT03901170|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110765606|NCT03901170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110765607|NCT03901170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110765608|NCT03901170|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110765609|NCT03901170|Hormone Antagonists|hormone antagonists|mesh-ancestor
110445595|NCT02617849|Paclitaxel|paclitaxel|mesh-list
110765610|NCT03901170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110765611|NCT03901170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110765612|NCT03900858|Isoniazid|isoniazid|mesh-list
110765613|NCT03900858|Rifapentine|rifapentine|mesh-list
110765614|NCT03900858|Rifampin|rifampin|mesh-list
110765615|NCT03900858|Antitubercular Agents|antitubercular agents|mesh-ancestor
110765616|NCT03900858|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110765617|NCT03900858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110765618|NCT03900858|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
110765619|NCT03900858|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110765620|NCT03900858|Antimetabolites|antimetabolites|mesh-ancestor
110765621|NCT03900858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110765622|NCT03900858|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110765623|NCT03900858|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110765624|NCT03900858|Leprostatic Agents|leprostatic agents|mesh-ancestor
110765625|NCT03900858|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110765626|NCT03900858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110765627|NCT03900858|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110765628|NCT03900858|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110765629|NCT03900858|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110765630|NCT03900858|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110316419|NCT00314171|Timolol|timolol|mesh-list
110765631|NCT03900858|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110765632|NCT03900858|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110765633|NCT01149564|Ibuprofen|ibuprofen|mesh-list
110765634|NCT01149564|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110765635|NCT01149564|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110765636|NCT01149564|Analgesics|analgesics|mesh-ancestor
110765637|NCT01149564|Sensory System Agents|sensory system agents|mesh-ancestor
110765638|NCT01149564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110765639|NCT01149564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110765640|NCT01149564|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110765641|NCT01149564|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110765642|NCT01149564|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110765643|NCT01149564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110765644|NCT01149564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110765645|NCT02527746|Cyclophosphamide|cyclophosphamide|mesh-list
110765646|NCT02527746|Epirubicin|epirubicin|mesh-list
110765647|NCT02527746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110765648|NCT02527746|Immunologic Factors|immunologic factors|mesh-ancestor
110765649|NCT02527746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110765650|NCT02527746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110765651|NCT02527746|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110765652|NCT02527746|Alkylating Agents|alkylating agents|mesh-ancestor
110765653|NCT02527746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110765654|NCT02527746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110765655|NCT02527746|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110765656|NCT02527746|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110765657|NCT02527746|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110765658|NCT02527746|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110765659|NCT02527746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110765660|NCT01586286|Nifedipine|nifedipine|mesh-list
110765661|NCT01586286|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110765662|NCT01586286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110765663|NCT01586286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110765664|NCT01586286|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110765665|NCT01586286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110765666|NCT01586286|Vasodilator Agents|vasodilator agents|mesh-ancestor
110765668|NCT01586286|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110765669|NCT01257048|Budesonide|budesonide|mesh-list
110765670|NCT01257048|Formoterol Fumarate|formoterol fumarate|mesh-list
110765671|NCT01257048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110765672|NCT01257048|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110765673|NCT01257048|Autonomic Agents|autonomic agents|mesh-ancestor
110765674|NCT01257048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110316463|NCT00344253|Antiviral Agents|antiviral agents|mesh-ancestor
110765675|NCT01257048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110765676|NCT01257048|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110765677|NCT01257048|Respiratory System Agents|respiratory system agents|mesh-ancestor
110765678|NCT01257048|Glucocorticoids|glucocorticoids|mesh-ancestor
110765679|NCT01257048|Hormones|hormones|mesh-ancestor
110765680|NCT01257048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110445597|NCT02617849|Pembrolizumab|pembrolizumab|mesh-list
110765681|NCT01257048|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110765682|NCT01257048|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110765683|NCT01257048|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110765684|NCT01257048|Adrenergic Agents|adrenergic agents|mesh-ancestor
110765685|NCT01257048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110765686|NCT01257048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110765687|NCT01258296|Fentanyl|fentanyl|mesh-list
110765688|NCT01258296|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110765689|NCT01258296|Narcotics|narcotics|mesh-ancestor
110765690|NCT01258296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110765691|NCT01258296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110765692|NCT01258296|Analgesics|analgesics|mesh-ancestor
110765693|NCT01258296|Sensory System Agents|sensory system agents|mesh-ancestor
110765694|NCT01258296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110765695|NCT01258296|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110765696|NCT01258296|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110765697|NCT01258296|Anesthetics, General|anesthetics, general|mesh-ancestor
110765698|NCT01258296|Anesthetics|anesthetics|mesh-ancestor
110765699|NCT01257126|Diclofenac|diclofenac|mesh-list
110765700|NCT01257126|Nimesulide|nimesulide|mesh-list
110765701|NCT01257126|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110765702|NCT01257126|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110765703|NCT01257126|Analgesics|analgesics|mesh-ancestor
110765704|NCT01257126|Sensory System Agents|sensory system agents|mesh-ancestor
110765705|NCT01257126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110765706|NCT01257126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110765707|NCT01257126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110765708|NCT01257126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110765709|NCT01257126|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110765710|NCT01257126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110765711|NCT01257126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110765712|NCT02527824|Oxaliplatin|oxaliplatin|mesh-list
110765713|NCT02527824|Irinotecan|irinotecan|mesh-list
110765714|NCT02527824|Tegafur|tegafur|mesh-list
110765715|NCT02527824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110765716|NCT02527824|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110765717|NCT02527824|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110765718|NCT02527824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110765719|NCT02527824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110765720|NCT02527824|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110765721|NCT02527824|Antimetabolites|antimetabolites|mesh-ancestor
110765722|NCT01586208|Phenytoin|phenytoin|mesh-list
110765723|NCT01586208|Valproic Acid|valproic acid|mesh-list
110765724|NCT01586208|Anticonvulsants|anticonvulsants|mesh-ancestor
110765725|NCT01586208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110765726|NCT01586208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110765727|NCT01586208|GABA Agents|gaba agents|mesh-ancestor
110765728|NCT01586208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110765729|NCT01586208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110765730|NCT01586208|Antimanic Agents|antimanic agents|mesh-ancestor
110765731|NCT01586208|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110765732|NCT01586208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110765733|NCT01586208|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110765734|NCT01586208|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110765735|NCT01586208|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110765736|NCT01586208|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110765737|NCT01586208|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110765738|NCT01586208|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110483439|NCT00712855|Sorafenib|sorafenib|mesh-list
110765739|NCT03893526|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110765740|NCT03893526|Valsartan|valsartan|mesh-list
110765741|NCT03893526|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
110765742|NCT03893526|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110765743|NCT03893526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110765744|NCT03893526|Incretins|incretins|mesh-ancestor
110765745|NCT03893526|Hormones|hormones|mesh-ancestor
110765746|NCT03893526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110765747|NCT03893526|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110765748|NCT03893526|Protease Inhibitors|protease inhibitors|mesh-ancestor
110765749|NCT03893526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110765750|NCT03893526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110765751|NCT03893526|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110090831|NCT03770299|Paclitaxel|paclitaxel|mesh-list
110765752|NCT03893526|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110765753|NCT03893526|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110765754|NCT01149798|Cisplatin|cisplatin|mesh-list
110765755|NCT01149798|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110765756|NCT01149798|Paclitaxel|paclitaxel|mesh-list
110765757|NCT01149798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110765758|NCT01149798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110765759|NCT01149798|Tubulin Modulators|tubulin modulators|mesh-ancestor
110765760|NCT01149798|Antimitotic Agents|antimitotic agents|mesh-ancestor
110765761|NCT01149798|Mitosis Modulators|mitosis modulators|mesh-ancestor
110765762|NCT01149798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110765763|NCT01257360|Panitumumab|panitumumab|mesh-list
110765764|NCT01257360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110765765|NCT01257360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110765766|NCT01258452|1-(3',4'-dichloro-2-fluoro(1,1'-biphenyl)-4-yl)cyclopropanecarboxylic acid|1-(3',4'-dichloro-2-fluoro(1,1'-biphenyl)-4-yl)cyclopropanecarboxylic acid|mesh-list
110765767|NCT01258452|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
110765768|NCT01258452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110765769|NCT01258452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110765770|NCT05943028|Esketamine|esketamine|mesh-list
110765771|NCT05943028|Antidepressive Agents|antidepressive agents|mesh-ancestor
110765772|NCT05943028|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110765773|NCT05942963|Metformin|metformin|mesh-list
110765774|NCT05942963|Pioglitazone|pioglitazone|mesh-list
110765775|NCT05942963|Empagliflozin|empagliflozin|mesh-list
110765776|NCT05942963|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110765777|NCT05942963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110765778|NCT05942963|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110765779|NCT05942963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110765780|NCT05942911|Hydroxychloroquine|hydroxychloroquine|mesh-list
110765781|NCT05942911|Cannabidiol|cannabidiol|mesh-list
110765782|NCT05942911|Antimalarials|antimalarials|mesh-ancestor
110765783|NCT05942911|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110765784|NCT05942911|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110765785|NCT05942911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110765786|NCT05942911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110765787|NCT05942911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110765788|NCT05942911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110765789|NCT05942911|Anticonvulsants|anticonvulsants|mesh-ancestor
110765790|NCT05942768|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
110765791|NCT05942768|Antibodies|antibodies|mesh-list
110316559|NCT00344565|Modafinil|modafinil|mesh-list
110765792|NCT05942768|Immunologic Factors|immunologic factors|mesh-ancestor
110765793|NCT05942768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110765794|NCT05942768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110765795|NCT05942768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110765796|NCT05942768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110765797|NCT05942573|Paclitaxel|paclitaxel|mesh-list
110765798|NCT05942573|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110765799|NCT05942573|Apatinib|apatinib|mesh-list
110765800|NCT05942573|Ramucirumab|ramucirumab|mesh-list
110765801|NCT05942573|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110765802|NCT05942573|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110765803|NCT05942573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110765804|NCT05942573|Tubulin Modulators|tubulin modulators|mesh-ancestor
110765805|NCT05942573|Antimitotic Agents|antimitotic agents|mesh-ancestor
110765806|NCT05942573|Mitosis Modulators|mitosis modulators|mesh-ancestor
110765807|NCT05942573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110765808|NCT05942573|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110765809|NCT05942573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110765810|NCT05942573|Immunologic Factors|immunologic factors|mesh-ancestor
110765811|NCT05942573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110765812|NCT05942378|Vaccines|vaccines|mesh-list
110765813|NCT05942378|Immunologic Factors|immunologic factors|mesh-ancestor
110765814|NCT05942378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110765815|NCT05942352|Tetramethylpyrazine|tetramethylpyrazine|mesh-list
110765816|NCT05942352|Vasodilator Agents|vasodilator agents|mesh-ancestor
110765817|NCT05942300|Carboplatin|carboplatin|mesh-list
110869706|NCT03169504|Tiotropium Bromide|tiotropium bromide|mesh-list
110765818|NCT05942300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110765819|NCT05942053|Vitamin K|vitamin k|mesh-list
110765820|NCT05942053|Vitamin K 2|vitamin k 2|mesh-list
110765821|NCT05942053|Menaquinone 7|menaquinone 7|mesh-list
110765822|NCT05942053|Vitamins|vitamins|mesh-ancestor
110765823|NCT05942053|Micronutrients|micronutrients|mesh-ancestor
110765824|NCT05942053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110765825|NCT05942053|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110765826|NCT05942053|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110765827|NCT05942053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110765828|NCT05942053|Hemostatics|hemostatics|mesh-ancestor
110765829|NCT05942053|Coagulants|coagulants|mesh-ancestor
110765830|NCT05942027|Coenzyme Q10|coenzyme q10|mesh-list
110765831|NCT05942027|Ubiquinone|ubiquinone|mesh-list
110765832|NCT05942027|Vitamins|vitamins|mesh-ancestor
110765833|NCT05942027|Micronutrients|micronutrients|mesh-ancestor
110765834|NCT05942027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110765835|NCT05941845|Interferons|interferons|mesh-list
110765836|NCT05941845|Interferon-alpha|interferon-alpha|mesh-list
110765837|NCT05941845|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110765838|NCT05941845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110765839|NCT05941845|Antiviral Agents|antiviral agents|mesh-ancestor
110765840|NCT05941845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110765841|NCT05941845|Immunologic Factors|immunologic factors|mesh-ancestor
110316597|NCT02960126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110765842|NCT05941845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110765843|NCT05941806|Tamsulosin|tamsulosin|mesh-list
110765844|NCT05941806|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110765845|NCT05941806|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110765846|NCT05941806|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110765847|NCT05941806|Adrenergic Agents|adrenergic agents|mesh-ancestor
110765848|NCT05941806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110765849|NCT05941806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110765850|NCT05941806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110765851|NCT05941806|Urological Agents|urological agents|mesh-ancestor
110765852|NCT05941741|Cisplatin|cisplatin|mesh-list
110765853|NCT05941741|Gemcitabine|gemcitabine|mesh-list
110765854|NCT05941741|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
110765855|NCT05941741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110765856|NCT05941741|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110765857|NCT05941741|Antimetabolites|antimetabolites|mesh-ancestor
110765858|NCT05941741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110765859|NCT05941741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110765860|NCT05941637|Axitinib|axitinib|mesh-list
110765861|NCT05941637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110765862|NCT05941637|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110765863|NCT05941637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110765864|NCT05941637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110765865|NCT05941585|Cytarabine|cytarabine|mesh-list
110765866|NCT05941585|Venetoclax|venetoclax|mesh-list
110765867|NCT05941585|Mitoxantrone|mitoxantrone|mesh-list
110765868|NCT05941585|Homoharringtonine|homoharringtonine|mesh-list
110765869|NCT05941585|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110765870|NCT05941585|Antimetabolites|antimetabolites|mesh-ancestor
110765871|NCT05941585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110765872|NCT05941585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110765873|NCT05941585|Antiviral Agents|antiviral agents|mesh-ancestor
110869725|NCT03169426|Adrenergic Agents|adrenergic agents|mesh-ancestor
110765874|NCT05941585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110765875|NCT05941585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110765876|NCT05941585|Immunologic Factors|immunologic factors|mesh-ancestor
110765877|NCT05941585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110765879|NCT05941585|Sensory System Agents|sensory system agents|mesh-ancestor
110765880|NCT05941585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110765881|NCT05941585|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110765882|NCT05941585|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110765883|NCT05941585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110765884|NCT05941585|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110765885|NCT05941585|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110765886|NCT05941507|Antibodies|antibodies|mesh-list
110765887|NCT05941507|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110765888|NCT05941507|Immunologic Factors|immunologic factors|mesh-ancestor
110765889|NCT05941507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110765891|NCT05941494|Oxymetazoline|oxymetazoline|mesh-list
110765892|NCT05941494|Ephedrine|ephedrine|mesh-list
110765893|NCT05941494|Pseudoephedrine|pseudoephedrine|mesh-list
110765894|NCT05941494|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
110765895|NCT05941494|Anesthetics|anesthetics|mesh-list
110765896|NCT05941494|Propofol|propofol|mesh-list
110765897|NCT05941494|Sevoflurane|sevoflurane|mesh-list
110765898|NCT05941494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110765899|NCT05941494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110765900|NCT05941494|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110765901|NCT05941494|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110765903|NCT05941494|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110765904|NCT05941494|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110765905|NCT05941494|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110765906|NCT05941494|Mydriatics|mydriatics|mesh-ancestor
110765907|NCT05941494|Autonomic Agents|autonomic agents|mesh-ancestor
110765908|NCT05941494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110765909|NCT05941494|Sympathomimetics|sympathomimetics|mesh-ancestor
110765910|NCT05941494|Nasal Decongestants|nasal decongestants|mesh-ancestor
110765911|NCT05941494|Respiratory System Agents|respiratory system agents|mesh-ancestor
110765912|NCT05941494|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110765913|NCT05941494|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110765914|NCT05941494|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110765915|NCT05941494|Adrenergic Agents|adrenergic agents|mesh-ancestor
110765916|NCT05941494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110765917|NCT05941494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110765918|NCT05941494|Protective Agents|protective agents|mesh-ancestor
110765919|NCT05941494|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110765920|NCT05941494|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110765921|NCT05941494|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110765922|NCT05941481|Tislelizumab|tislelizumab|mesh-list
110765923|NCT05941481|Antibodies|antibodies|mesh-list
110765924|NCT05941481|Immunologic Factors|immunologic factors|mesh-ancestor
110765925|NCT05941481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110765926|NCT05941481|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110765927|NCT05941481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110765928|NCT05941429|Fluorides|fluorides|mesh-list
110765929|NCT05941429|Cariostatic Agents|cariostatic agents|mesh-ancestor
110765930|NCT05941429|Protective Agents|protective agents|mesh-ancestor
110765931|NCT05941429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110765932|NCT05941338|Paclitaxel|paclitaxel|mesh-list
110765933|NCT05941338|Carboplatin|carboplatin|mesh-list
110765934|NCT05941338|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110765935|NCT05941338|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110765936|NCT05941338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110765937|NCT05941338|Tubulin Modulators|tubulin modulators|mesh-ancestor
110765938|NCT05941338|Antimitotic Agents|antimitotic agents|mesh-ancestor
110765939|NCT05941338|Mitosis Modulators|mitosis modulators|mesh-ancestor
110765940|NCT05941338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110765941|NCT05941130|Ibuprofen|ibuprofen|mesh-list
110765942|NCT05941130|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
110765943|NCT05941130|Methylprednisolone|methylprednisolone|mesh-list
110765944|NCT05941130|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
110765945|NCT05941130|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110765946|NCT05941130|Analgesics|analgesics|mesh-ancestor
110765947|NCT05941130|Sensory System Agents|sensory system agents|mesh-ancestor
110765948|NCT05941130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110765949|NCT05941130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110765950|NCT05941130|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110765951|NCT05941130|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110765952|NCT05941130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110765953|NCT05941130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110765954|NCT05941130|Antiemetics|antiemetics|mesh-ancestor
110765955|NCT05941130|Autonomic Agents|autonomic agents|mesh-ancestor
110765956|NCT05941130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110765957|NCT05941130|Glucocorticoids|glucocorticoids|mesh-ancestor
110765958|NCT05941130|Hormones|hormones|mesh-ancestor
110765959|NCT05941130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110765960|NCT05941130|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110765961|NCT05941130|Protective Agents|protective agents|mesh-ancestor
110765962|NCT05939921|Metformin|metformin|mesh-list
110765963|NCT05939921|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110483652|NCT02572375|Codeine|codeine|mesh-list
110765964|NCT05939921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110765965|NCT05939219|Vaccines|vaccines|mesh-list
110765966|NCT05939219|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110765968|NCT05939219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110765969|NCT05938517|Betahistine|betahistine|mesh-list
110765970|NCT05938517|Selegiline|selegiline|mesh-list
110765971|NCT05938517|Antidepressive Agents|antidepressive agents|mesh-ancestor
110765972|NCT05938517|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110765973|NCT05938517|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110765974|NCT05938517|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110765975|NCT05938517|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
110765976|NCT05938517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110765977|NCT05938517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110765978|NCT05938517|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110765979|NCT05938517|Protective Agents|protective agents|mesh-ancestor
110765980|NCT05938517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110765981|NCT05938517|Vasodilator Agents|vasodilator agents|mesh-ancestor
110765982|NCT05938517|Histamine Agonists|histamine agonists|mesh-ancestor
110765983|NCT05938517|Histamine Agents|histamine agents|mesh-ancestor
110765984|NCT05938517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110765985|NCT05935657|Dexmedetomidine|dexmedetomidine|mesh-list
110765986|NCT05935657|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110765987|NCT05935657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110765988|NCT05935657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110765989|NCT05935657|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110765990|NCT05935657|Analgesics|analgesics|mesh-ancestor
110765991|NCT05935657|Sensory System Agents|sensory system agents|mesh-ancestor
110765992|NCT05935657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110765993|NCT05935657|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110765994|NCT05935657|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110765995|NCT05935657|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110765996|NCT05935657|Adrenergic Agents|adrenergic agents|mesh-ancestor
110765997|NCT05935657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110765998|NCT05935657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110765999|NCT05922982|Norepinephrine|norepinephrine|mesh-list
110766000|NCT05922982|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110766001|NCT05922982|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110766002|NCT05922982|Adrenergic Agents|adrenergic agents|mesh-ancestor
110766003|NCT05922982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110766004|NCT05922982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110766005|NCT05922982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110766006|NCT05922982|Sympathomimetics|sympathomimetics|mesh-ancestor
110766007|NCT05922982|Autonomic Agents|autonomic agents|mesh-ancestor
110766008|NCT05922982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110766009|NCT05922982|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110766010|NCT05907850|Riboflavin|riboflavin|mesh-list
110766011|NCT05907850|Vitamin B Complex|vitamin b complex|mesh-ancestor
110766012|NCT05907850|Vitamins|vitamins|mesh-ancestor
110766013|NCT05907850|Micronutrients|micronutrients|mesh-ancestor
110766014|NCT05907850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110766015|NCT05907850|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110766016|NCT05907850|Dermatologic Agents|dermatologic agents|mesh-ancestor
110766017|NCT05904730|Axitinib|axitinib|mesh-list
110766018|NCT05904730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110766019|NCT05904730|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110766020|NCT05904730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110766021|NCT05904730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110766023|NCT05903859|Uricosuric Agents|uricosuric agents|mesh-ancestor
110766024|NCT05903859|Gout Suppressants|gout suppressants|mesh-ancestor
110766025|NCT05903859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110766026|NCT05896384|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
110766027|NCT05896384|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
110766028|NCT05896384|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110766029|NCT05896384|Contraceptive Agents|contraceptive agents|mesh-ancestor
110766030|NCT05896384|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110766031|NCT05896384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110766032|NCT05896384|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110766033|NCT05896384|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110766034|NCT05896384|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110766035|NCT05896384|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110766036|NCT05896384|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110766037|NCT05896384|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
110766038|NCT05896384|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
110766039|NCT05896384|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
110766041|NCT05889793|Amebicides|amebicides|mesh-ancestor
110766042|NCT05889793|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110766043|NCT05889793|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110766044|NCT05889793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110766045|NCT05889793|Antinematodal Agents|antinematodal agents|mesh-ancestor
110766046|NCT05889793|Anthelmintics|anthelmintics|mesh-ancestor
110766047|NCT05889793|Cathartics|cathartics|mesh-ancestor
110445606|NCT00950859|Dolutegravir|dolutegravir|mesh-list
110766048|NCT05889793|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110766049|NCT05889793|Emetics|emetics|mesh-ancestor
110766050|NCT05889793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110766051|NCT05889793|Autonomic Agents|autonomic agents|mesh-ancestor
110766052|NCT05889793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110766053|NCT05889793|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110766054|NCT05889793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110766055|NCT05889793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110766056|NCT05860270|Vitamin D|vitamin d|mesh-list
110766057|NCT05860270|Cholecalciferol|cholecalciferol|mesh-list
110766058|NCT05860270|Vitamins|vitamins|mesh-ancestor
110766059|NCT05860270|Micronutrients|micronutrients|mesh-ancestor
110766060|NCT05860270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110766061|NCT05860270|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110766062|NCT05860270|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110766063|NCT05855395|Dexamethasone|dexamethasone|mesh-list
110766064|NCT05855395|Prednisone|prednisone|mesh-list
110766065|NCT05855395|Methylprednisolone|methylprednisolone|mesh-list
110766066|NCT05855395|Glucocorticoids|glucocorticoids|mesh-list
110766067|NCT05855395|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110766068|NCT05855395|Antiemetics|antiemetics|mesh-ancestor
110766069|NCT05855395|Autonomic Agents|autonomic agents|mesh-ancestor
110766070|NCT05855395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110766071|NCT05855395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110766072|NCT05855395|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110766073|NCT05855395|Hormones|hormones|mesh-ancestor
110316743|NCT00315965|Antioxidants|antioxidants|mesh-ancestor
110766074|NCT05855395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110766075|NCT05855395|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110766076|NCT05855395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110766077|NCT05855395|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110766078|NCT05855395|Protective Agents|protective agents|mesh-ancestor
110766079|NCT05853354|Denosumab|denosumab|mesh-list
110766080|NCT05853354|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110766081|NCT05853354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110766082|NCT05833867|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
110766083|NCT05833867|Immunoconjugates|immunoconjugates|mesh-ancestor
110766084|NCT05833867|Immunologic Factors|immunologic factors|mesh-ancestor
110766085|NCT05833867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110766086|NCT05818826|Hydrocortisone|hydrocortisone|mesh-list
110766087|NCT05818826|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110766088|NCT05818826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110766089|NCT05808881|Naloxone|naloxone|mesh-list
110766090|NCT05808881|Nalmefene|nalmefene|mesh-list
110869753|NCT03631355|Coagulants|coagulants|mesh-ancestor
110766091|NCT05808881|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110766092|NCT05808881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110766093|NCT05808881|Sensory System Agents|sensory system agents|mesh-ancestor
110766094|NCT05808881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110766095|NCT05802628|Cetylpyridinium|cetylpyridinium|mesh-list
110766096|NCT05802628|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110766097|NCT05802628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110766098|NCT05751187|Folic Acid|folic acid|mesh-list
110766099|NCT05751187|Vitamin B 12|vitamin b 12|mesh-list
110766100|NCT05751187|Dexamethasone|dexamethasone|mesh-list
110766101|NCT05751187|Bevacizumab|bevacizumab|mesh-list
110766102|NCT05751187|Pembrolizumab|pembrolizumab|mesh-list
110766103|NCT05751187|Carboplatin|carboplatin|mesh-list
110766104|NCT05751187|Pemetrexed|pemetrexed|mesh-list
110766105|NCT05751187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110766106|NCT05751187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110766107|NCT05751187|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110766108|NCT05751187|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110766109|NCT05751187|Growth Substances|growth substances|mesh-ancestor
110766110|NCT05751187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110766111|NCT05751187|Growth Inhibitors|growth inhibitors|mesh-ancestor
110766112|NCT05751187|Vitamins|vitamins|mesh-ancestor
110766113|NCT05751187|Micronutrients|micronutrients|mesh-ancestor
110766114|NCT05751187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110766115|NCT05751187|Antiemetics|antiemetics|mesh-ancestor
110766116|NCT05751187|Autonomic Agents|autonomic agents|mesh-ancestor
110766117|NCT05751187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110766118|NCT05751187|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110766119|NCT05751187|Glucocorticoids|glucocorticoids|mesh-ancestor
110766120|NCT05751187|Hormones|hormones|mesh-ancestor
110766121|NCT05751187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110766122|NCT05751187|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110766123|NCT05751187|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110091191|NCT05357859|Vitamin D|vitamin d|mesh-list
110766124|NCT05751187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110766125|NCT05751187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110766126|NCT05751187|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110766127|NCT05751187|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110766129|NCT05751187|Vitamin B Complex|vitamin b complex|mesh-ancestor
110766130|NCT05701241|Octreotide|octreotide|mesh-list
110766131|NCT05701241|Lanreotide|lanreotide|mesh-list
110766132|NCT05701241|Somatostatin|somatostatin|mesh-list
110766133|NCT05701241|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110766134|NCT05701241|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110766135|NCT05701241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110766136|NCT05701241|Hormones|hormones|mesh-ancestor
110766137|NCT05701241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110766138|NCT05701241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110766139|NCT05698979|Botulinum Toxins|botulinum toxins|mesh-list
110766140|NCT05698979|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110766141|NCT05698979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110766142|NCT05698979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110766143|NCT05698979|Cholinergic Agents|cholinergic agents|mesh-ancestor
110766144|NCT05698979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110766145|NCT05698979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110766146|NCT05676216|Diphenhydramine|diphenhydramine|mesh-list
110766147|NCT05676216|Promethazine|promethazine|mesh-list
110766148|NCT05676216|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110766149|NCT05676216|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110316813|NCT00349401|Morphine|morphine|mesh-list
110766150|NCT05676216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110766151|NCT05676216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110316847|NCT00349518|Dasatinib|dasatinib|mesh-list
110766152|NCT05676216|Anesthetics, Local|anesthetics, local|mesh-ancestor
110766153|NCT05676216|Anesthetics|anesthetics|mesh-ancestor
110766154|NCT05676216|Sensory System Agents|sensory system agents|mesh-ancestor
110766155|NCT05676216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110766156|NCT05676216|Antiemetics|antiemetics|mesh-ancestor
110766157|NCT05676216|Autonomic Agents|autonomic agents|mesh-ancestor
110316942|NCT00316940|Bortezomib|bortezomib|mesh-list
110766158|NCT05676216|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110766159|NCT05676216|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110766160|NCT05676216|Histamine Antagonists|histamine antagonists|mesh-ancestor
110766161|NCT05676216|Histamine Agents|histamine agents|mesh-ancestor
110766162|NCT05676216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110766163|NCT05676216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110317225|NCT00350415|Mesalamine|mesalamine|mesh-list
110766164|NCT05676216|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110766165|NCT05676216|Antipruritics|antipruritics|mesh-ancestor
110766166|NCT05676216|Dermatologic Agents|dermatologic agents|mesh-ancestor
110766167|NCT05647889|Lidocaine|lidocaine|mesh-list
110766168|NCT05647889|Anesthetics, Local|anesthetics, local|mesh-ancestor
110766169|NCT05647889|Anesthetics|anesthetics|mesh-ancestor
110766170|NCT05647889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110766171|NCT05647889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110766172|NCT05647889|Sensory System Agents|sensory system agents|mesh-ancestor
110766173|NCT05647889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110766174|NCT05647889|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110766175|NCT05647889|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110766176|NCT05647889|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110766177|NCT05647889|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110766178|NCT05647889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110766179|NCT05571592|Cannabidiol|cannabidiol|mesh-list
110766180|NCT05571592|Anticonvulsants|anticonvulsants|mesh-ancestor
110766181|NCT05559905|Molnupiravir|molnupiravir|mesh-list
110766182|NCT05559905|Antiviral Agents|antiviral agents|mesh-ancestor
110766183|NCT05559905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110766184|NCT05538663|Gemcitabine|gemcitabine|mesh-list
110766185|NCT05538663|Docetaxel|docetaxel|mesh-list
110766186|NCT05538663|BCG Vaccine|bcg vaccine|mesh-list
110766187|NCT05538663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110766188|NCT05538663|Antimetabolites|antimetabolites|mesh-ancestor
110766189|NCT05538663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110766190|NCT05538663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110766191|NCT05538663|Tubulin Modulators|tubulin modulators|mesh-ancestor
110317814|NCT00322400|Paclitaxel|paclitaxel|mesh-list
110766192|NCT05538663|Antimitotic Agents|antimitotic agents|mesh-ancestor
110766193|NCT05538663|Mitosis Modulators|mitosis modulators|mesh-ancestor
110766194|NCT05538663|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110766195|NCT05538663|Immunologic Factors|immunologic factors|mesh-ancestor
110766196|NCT05538663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110766198|NCT05536791|Antithrombins|antithrombins|mesh-ancestor
110445608|NCT00950859|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110766199|NCT05536791|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110766200|NCT05536791|Protease Inhibitors|protease inhibitors|mesh-ancestor
110766201|NCT05536791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110766202|NCT05536791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110766203|NCT05536791|Anticoagulants|anticoagulants|mesh-ancestor
110766204|NCT05522231|Everolimus|everolimus|mesh-list
110766205|NCT05522231|Axitinib|axitinib|mesh-list
110766206|NCT05522231|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110766207|NCT05522231|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110766208|NCT05522231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110318008|NCT00353184|Respiratory System Agents|respiratory system agents|mesh-ancestor
110766209|NCT05522231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110766210|NCT05522231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110766211|NCT05522231|Immunologic Factors|immunologic factors|mesh-ancestor
110766212|NCT05522231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110766213|NCT05522231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110766214|NCT05484154|Protein C|protein c|mesh-list
110766215|NCT05484154|Anticoagulants|anticoagulants|mesh-ancestor
110766216|NCT05484154|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110766217|NCT05484154|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110766218|NCT05484154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110766219|NCT05481736|Psilocybin|psilocybin|mesh-list
110766220|NCT05481736|Hallucinogens|hallucinogens|mesh-ancestor
110766221|NCT05481736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110766222|NCT05481736|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110766223|NCT05446298|Pembrolizumab|pembrolizumab|mesh-list
110766224|NCT05446298|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110766225|NCT05446298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110766226|NCT05446298|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110766227|NCT05446298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110766228|NCT05377424|Istradefylline|istradefylline|mesh-list
110766229|NCT05377424|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
110766230|NCT05377424|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110869764|NCT03679052|Mirtazapine|mirtazapine|mesh-list
110318439|NCT00426621|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110766231|NCT05377424|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110766232|NCT05377424|Purinergic Agents|purinergic agents|mesh-ancestor
110766233|NCT05377424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110766234|NCT05377424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110766235|NCT05377424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110766236|NCT05371964|Imetelstat|imetelstat|mesh-list
110766237|NCT05371964|Motesanib diphosphate|motesanib diphosphate|mesh-list
110766238|NCT05371964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110766239|NCT05371964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110766240|NCT05371964|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110766241|NCT05321043|Riboflavin|riboflavin|mesh-list
110766242|NCT05321043|Vitamins|vitamins|mesh-ancestor
110766243|NCT05321043|Micronutrients|micronutrients|mesh-ancestor
110766244|NCT05321043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110766245|NCT05321043|Vitamin B Complex|vitamin b complex|mesh-ancestor
110766246|NCT05321043|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110766247|NCT05321043|Dermatologic Agents|dermatologic agents|mesh-ancestor
110766248|NCT05318105|Diuretics|diuretics|mesh-list
110766249|NCT05318105|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
110766250|NCT05318105|Natriuretic Agents|natriuretic agents|mesh-ancestor
110766251|NCT05318105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110766252|NCT05318105|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110766253|NCT05318105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110766254|NCT05303311|Dexamethasone|dexamethasone|mesh-list
110766255|NCT05303311|Meperidine|meperidine|mesh-list
110766256|NCT05303311|Bupivacaine|bupivacaine|mesh-list
110766257|NCT05303311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110766258|NCT05303311|Antiemetics|antiemetics|mesh-ancestor
110766259|NCT05303311|Autonomic Agents|autonomic agents|mesh-ancestor
110766260|NCT05303311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110766261|NCT05303311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110766262|NCT05303311|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110766263|NCT05303311|Glucocorticoids|glucocorticoids|mesh-ancestor
110766264|NCT05303311|Hormones|hormones|mesh-ancestor
110766265|NCT05303311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110318934|NCT02273505|Aspirin|aspirin|mesh-list
110766266|NCT05303311|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110766267|NCT05303311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110766268|NCT05303311|Anesthetics, Local|anesthetics, local|mesh-ancestor
110766269|NCT05303311|Anesthetics|anesthetics|mesh-ancestor
110766270|NCT05303311|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110766271|NCT05303311|Sensory System Agents|sensory system agents|mesh-ancestor
110766272|NCT05303311|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110766274|NCT05303311|Analgesics|analgesics|mesh-ancestor
110766275|NCT05303311|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110766276|NCT05285982|Nintedanib|nintedanib|mesh-list
110766277|NCT05285982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110766278|NCT05285982|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110766279|NCT05285982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110766280|NCT05285982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110766281|NCT05275374|Trametinib|trametinib|mesh-list
110766282|NCT05275374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110766283|NCT05275374|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110766284|NCT05275374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110766285|NCT05275374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110766286|NCT05262764|Empagliflozin|empagliflozin|mesh-list
110766287|NCT05262764|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110766288|NCT05262764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110766289|NCT05262764|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110766290|NCT05262764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110766291|NCT05233579|Sulforaphane|sulforaphane|mesh-list
110766292|NCT05233579|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110766293|NCT05233579|Protective Agents|protective agents|mesh-ancestor
110766294|NCT05233579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110766295|NCT05233579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110766296|NCT05227612|Psilocybin|psilocybin|mesh-list
110766297|NCT05227612|Hallucinogens|hallucinogens|mesh-ancestor
110766298|NCT05227612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110766299|NCT05227612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110766300|NCT05208892|Dexmedetomidine|dexmedetomidine|mesh-list
110766301|NCT05208892|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110319274|NCT00327587|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110766302|NCT05208892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110766303|NCT05208892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110766304|NCT05208892|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110766305|NCT05208892|Analgesics|analgesics|mesh-ancestor
110766306|NCT05208892|Sensory System Agents|sensory system agents|mesh-ancestor
110319387|NCT00328718|Xhance|xhance|mesh-list
110766307|NCT05208892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110766308|NCT05208892|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110766309|NCT05208892|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110766310|NCT05208892|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110766311|NCT05208892|Adrenergic Agents|adrenergic agents|mesh-ancestor
110766312|NCT05208892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110766313|NCT05208892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110766314|NCT05154955|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110766315|NCT05147402|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
110766316|NCT05147402|Hallucinogens|hallucinogens|mesh-ancestor
110319558|NCT00329264|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110766317|NCT05147402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110766318|NCT05147402|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110766319|NCT05147402|Serotonin Agents|serotonin agents|mesh-ancestor
110766320|NCT05147402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110766321|NCT05147402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110766322|NCT05147402|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110766323|NCT05147402|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110766324|NCT05147402|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110766325|NCT05147402|Adrenergic Agents|adrenergic agents|mesh-ancestor
110766326|NCT05130463|Empagliflozin|empagliflozin|mesh-list
110766327|NCT05130463|Linagliptin|linagliptin|mesh-list
110319845|NCT00330902|Pyrimethamine|pyrimethamine|mesh-list
110766328|NCT05130463|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110766329|NCT05130463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110766330|NCT05130463|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110319918|NCT00331097|Abortifacient Agents|abortifacient agents|mesh-ancestor
110766331|NCT05130463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110766333|NCT05130463|Hormones|hormones|mesh-ancestor
110766334|NCT05130463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110766335|NCT05130463|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110766336|NCT05130463|Protease Inhibitors|protease inhibitors|mesh-ancestor
110766337|NCT05130463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110766338|NCT05119920|Pilocarpine|pilocarpine|mesh-list
110766339|NCT05119920|Miotics|miotics|mesh-ancestor
110320138|NCT00435435|Disulfiram|disulfiram|mesh-list
110766340|NCT05119920|Autonomic Agents|autonomic agents|mesh-ancestor
110484026|NCT04291118|Hormones|hormones|mesh-ancestor
110766341|NCT05119920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110766342|NCT05119920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110766344|NCT05119920|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110766345|NCT05119920|Cholinergic Agents|cholinergic agents|mesh-ancestor
110766346|NCT05119920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110766347|NCT05119920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110766348|NCT05090371|Ofatumumab|ofatumumab|mesh-list
110766349|NCT05090371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110766350|NCT05084638|Ofatumumab|ofatumumab|mesh-list
110766351|NCT05084638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110766352|NCT05065736|Clofarabine|clofarabine|mesh-list
110766353|NCT05065736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110766354|NCT05065736|Antimetabolites|antimetabolites|mesh-ancestor
110320498|NCT00438048|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
110766355|NCT05065736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110766356|NCT05065736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110766357|NCT05054868|Ketorolac|ketorolac|mesh-list
110766358|NCT05054868|Oxycodone|oxycodone|mesh-list
110766359|NCT05054868|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110766360|NCT05054868|Narcotics|narcotics|mesh-ancestor
110766361|NCT05054868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110766362|NCT05054868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110766363|NCT05054868|Analgesics|analgesics|mesh-ancestor
110766364|NCT05054868|Sensory System Agents|sensory system agents|mesh-ancestor
110766365|NCT05054868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110766366|NCT05054868|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110766367|NCT05054868|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110766368|NCT05054868|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110170630|NCT00041275|Megestrol|megestrol|mesh-list
110766369|NCT05054868|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110766370|NCT05054868|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110766371|NCT05054868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110766372|NCT05054868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110766373|NCT05046535|Nicotine|nicotine|mesh-list
110766374|NCT05046535|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110766375|NCT05046535|Autonomic Agents|autonomic agents|mesh-ancestor
110320926|NCT00335621|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110766376|NCT05046535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110766377|NCT05046535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110766378|NCT05046535|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110766379|NCT05046535|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110766380|NCT05046535|Cholinergic Agents|cholinergic agents|mesh-ancestor
110766381|NCT05046535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110766382|NCT05046535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110766383|NCT05009342|Calpastatin|calpastatin|mesh-list
110766384|NCT05009342|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
110766385|NCT05009342|Protease Inhibitors|protease inhibitors|mesh-ancestor
110766386|NCT05009342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110766387|NCT05009342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110766388|NCT04987775|Acetylcysteine|acetylcysteine|mesh-list
110766389|NCT04987775|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110766390|NCT04987775|Antiviral Agents|antiviral agents|mesh-ancestor
110321206|NCT00451113|Incretins|incretins|mesh-ancestor
110766391|NCT04987775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110766392|NCT04987775|Expectorants|expectorants|mesh-ancestor
110766393|NCT04987775|Respiratory System Agents|respiratory system agents|mesh-ancestor
110766394|NCT04987775|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110766395|NCT04987775|Antioxidants|antioxidants|mesh-ancestor
110766396|NCT04987775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110766397|NCT04987775|Protective Agents|protective agents|mesh-ancestor
110766398|NCT04987775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110766399|NCT04987775|Antidotes|antidotes|mesh-ancestor
110766400|NCT04922827|Infliximab|infliximab|mesh-list
110766401|NCT04922827|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110766402|NCT04922827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110766403|NCT04922827|Dermatologic Agents|dermatologic agents|mesh-ancestor
110766404|NCT04922827|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110766405|NCT04922827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110766406|NCT04921930|Artesunate|artesunate|mesh-list
110766407|NCT04921930|Antimalarials|antimalarials|mesh-ancestor
110766408|NCT04921930|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110766409|NCT04921930|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110766410|NCT04921930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110766411|NCT04921930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110321563|NCT00446667|Mannitol|mannitol|mesh-list
110766412|NCT04921930|Antiviral Agents|antiviral agents|mesh-ancestor
110766413|NCT04921930|Schistosomicides|schistosomicides|mesh-ancestor
110766414|NCT04921930|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110766415|NCT04921930|Anthelmintics|anthelmintics|mesh-ancestor
110766416|NCT04909684|Pembrolizumab|pembrolizumab|mesh-list
110766418|NCT04909684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110766419|NCT04909684|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110766420|NCT04909684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110766421|NCT04877457|Ocrelizumab|ocrelizumab|mesh-list
110766422|NCT04877457|Immunologic Factors|immunologic factors|mesh-ancestor
110766423|NCT04877457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110766426|NCT04719273|Anastrozole|anastrozole|mesh-list
110766427|NCT04719273|Onapristone|onapristone|mesh-list
110766428|NCT04719273|Progesterone|progesterone|mesh-list
110766429|NCT04719273|Estrogens|estrogens|mesh-list
110766430|NCT04719273|Progestins|progestins|mesh-ancestor
110766431|NCT04719273|Hormones|hormones|mesh-ancestor
110766432|NCT04719273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110766433|NCT04719273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110766434|NCT04719273|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110321849|NCT00343733|Fentanyl|fentanyl|mesh-list
110766435|NCT04719273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110766436|NCT04719273|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110766437|NCT04719273|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110766438|NCT04719273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110321923|NCT00344123|Antiviral Agents|antiviral agents|mesh-ancestor
110766439|NCT04719273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110766440|NCT04719273|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110766441|NCT04719273|Hormone Antagonists|hormone antagonists|mesh-ancestor
110321994|NCT00447915|Calcium|calcium|mesh-list
110766442|NCT04719273|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110766443|NCT04719273|Fertility Agents|fertility agents|mesh-ancestor
110322070|NCT00344942|Triamcinolone|triamcinolone|mesh-list
110766444|NCT04719273|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110766445|NCT04631510|Gabapentin|gabapentin|mesh-list
110766446|NCT04631510|Analgesics|analgesics|mesh-ancestor
110766447|NCT04631510|Sensory System Agents|sensory system agents|mesh-ancestor
110766448|NCT04631510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110766449|NCT04631510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110766451|NCT04631510|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110766452|NCT04631510|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110766453|NCT04631510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110766454|NCT04631510|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110322279|NCT00448578|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110766455|NCT04631510|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110766456|NCT04631510|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110766457|NCT04631510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110766458|NCT04631510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110766459|NCT04631510|Antimanic Agents|antimanic agents|mesh-ancestor
110766460|NCT04612257|Insulin|insulin|mesh-list
110766461|NCT04612257|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110322425|NCT00455286|Immunologic Factors|immunologic factors|mesh-ancestor
110766462|NCT04612257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110766463|NCT04571619|Buprenorphine|buprenorphine|mesh-list
110766464|NCT04571619|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110766465|NCT04571619|Narcotics|narcotics|mesh-ancestor
110766466|NCT04571619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110766467|NCT04571619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110766468|NCT04571619|Analgesics|analgesics|mesh-ancestor
110766469|NCT04571619|Sensory System Agents|sensory system agents|mesh-ancestor
110766470|NCT04571619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110766471|NCT04571619|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110766472|NCT04559581|Nintedanib|nintedanib|mesh-list
110766473|NCT04559581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110766474|NCT04559581|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110766475|NCT04559581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110766476|NCT04559581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110766477|NCT04522050|Gemcitabine|gemcitabine|mesh-list
110766478|NCT04522050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110766479|NCT04522050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110766480|NCT04522050|Antimetabolites|antimetabolites|mesh-ancestor
110322718|NCT03274323|Travoprost|travoprost|mesh-list
110766481|NCT04522050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110766483|NCT04485013|Cetuximab|cetuximab|mesh-list
110766484|NCT04485013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110766485|NCT04485013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110766486|NCT04485013|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110322781|NCT00449514|Tamoxifen|tamoxifen|mesh-list
110766487|NCT04485013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110766488|NCT04481048|Acetylcysteine|acetylcysteine|mesh-list
110766489|NCT04481048|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110766490|NCT04481048|Antiviral Agents|antiviral agents|mesh-ancestor
110766491|NCT04481048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110766492|NCT04481048|Expectorants|expectorants|mesh-ancestor
110766493|NCT04481048|Respiratory System Agents|respiratory system agents|mesh-ancestor
110766494|NCT04481048|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110766496|NCT04481048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110766497|NCT04481048|Protective Agents|protective agents|mesh-ancestor
110766498|NCT04481048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110766499|NCT04481048|Antidotes|antidotes|mesh-ancestor
110766500|NCT04472429|Paclitaxel|paclitaxel|mesh-list
110766501|NCT04472429|Carboplatin|carboplatin|mesh-list
110766502|NCT04472429|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110766503|NCT04472429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110766504|NCT04472429|Tubulin Modulators|tubulin modulators|mesh-ancestor
110766505|NCT04472429|Antimitotic Agents|antimitotic agents|mesh-ancestor
110766506|NCT04472429|Mitosis Modulators|mitosis modulators|mesh-ancestor
110323058|NCT00351026|Methadone|methadone|mesh-list
110766507|NCT04472429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110766508|NCT04471597|Bupivacaine|bupivacaine|mesh-list
110766509|NCT04471597|Anesthetics, Local|anesthetics, local|mesh-ancestor
110766510|NCT04471597|Anesthetics|anesthetics|mesh-ancestor
110766511|NCT04471597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110766512|NCT04471597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110766513|NCT04471597|Sensory System Agents|sensory system agents|mesh-ancestor
110766514|NCT04471597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110766515|NCT04464798|Rituximab|rituximab|mesh-list
110766516|NCT04464798|Obinutuzumab|obinutuzumab|mesh-list
110766517|NCT04464798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110766518|NCT04464798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110766519|NCT04464798|Immunologic Factors|immunologic factors|mesh-ancestor
110766520|NCT04464798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110766521|NCT04464798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110766522|NCT04375631|Cytarabine|cytarabine|mesh-list
110766523|NCT04375631|Cyclosporine|cyclosporine|mesh-list
110766524|NCT04375631|Mycophenolic Acid|mycophenolic acid|mesh-list
110766525|NCT04375631|Cyclophosphamide|cyclophosphamide|mesh-list
110766526|NCT04375631|Fludarabine|fludarabine|mesh-list
110766527|NCT04375631|Fludarabine phosphate|fludarabine phosphate|mesh-list
110766528|NCT04375631|Mitoxantrone|mitoxantrone|mesh-list
110766529|NCT04375631|Idarubicin|idarubicin|mesh-list
110766530|NCT04375631|Cladribine|cladribine|mesh-list
110766531|NCT04375631|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
110766532|NCT04375631|Cyclosporins|cyclosporins|mesh-list
110766533|NCT04375631|Lenograstim|lenograstim|mesh-list
110766534|NCT04375631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110766535|NCT04375631|Immunologic Factors|immunologic factors|mesh-ancestor
110766536|NCT04375631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110766537|NCT04375631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110766538|NCT04375631|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110766539|NCT04375631|Alkylating Agents|alkylating agents|mesh-ancestor
110766540|NCT04375631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110766541|NCT04375631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110323200|NCT00352430|Autonomic Agents|autonomic agents|mesh-ancestor
110766542|NCT04375631|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110766543|NCT04375631|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110766544|NCT04375631|Antimetabolites|antimetabolites|mesh-ancestor
110766545|NCT04375631|Antiviral Agents|antiviral agents|mesh-ancestor
110766546|NCT04375631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110323253|NCT00352859|Interferons|interferons|mesh-list
110766547|NCT04375631|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110766548|NCT04375631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110766549|NCT04375631|Antifungal Agents|antifungal agents|mesh-ancestor
110766550|NCT04375631|Dermatologic Agents|dermatologic agents|mesh-ancestor
110766551|NCT04375631|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110766552|NCT04375631|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110766553|NCT04375631|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110766554|NCT04375631|Antitubercular Agents|antitubercular agents|mesh-ancestor
110766555|NCT04375631|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110766556|NCT04375631|Analgesics|analgesics|mesh-ancestor
110766557|NCT04375631|Sensory System Agents|sensory system agents|mesh-ancestor
110766558|NCT04375631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110766559|NCT04375631|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110766560|NCT04375631|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110766562|NCT04357587|Capecitabine|capecitabine|mesh-list
110766563|NCT04357587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110766564|NCT04357587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110766565|NCT04357587|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110766566|NCT04357587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110766567|NCT04357587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110766568|NCT04357587|Antimetabolites|antimetabolites|mesh-ancestor
110766569|NCT04325217|Nintedanib|nintedanib|mesh-list
110766570|NCT04325217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110766571|NCT04325217|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110766572|NCT04325217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110766573|NCT04325217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110766575|NCT04269408|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110766576|NCT04269408|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110766577|NCT04269408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110323448|NCT00354068|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110766578|NCT04269408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110766579|NCT04269408|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110766580|NCT04269408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110766581|NCT04269408|Vasodilator Agents|vasodilator agents|mesh-ancestor
110766582|NCT04187833|Nivolumab|nivolumab|mesh-list
110766583|NCT04187833|Talazoparib|talazoparib|mesh-list
110766584|NCT04187833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110766585|NCT04187833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110766586|NCT04187833|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110766587|NCT04187833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110323517|NCT00354419|Cyclosporins|cyclosporins|mesh-list
110766588|NCT04187833|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110766589|NCT04187833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110766590|NCT04184401|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110766591|NCT04122170|Aspirin|aspirin|mesh-list
110766592|NCT04122170|Ticagrelor|ticagrelor|mesh-list
110766593|NCT04122170|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110766594|NCT04122170|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110766595|NCT04122170|Analgesics|analgesics|mesh-ancestor
110766596|NCT04122170|Sensory System Agents|sensory system agents|mesh-ancestor
110766597|NCT04122170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110766598|NCT04122170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110766599|NCT04122170|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110766600|NCT04122170|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110766601|NCT04122170|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110766602|NCT04122170|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110323727|NCT03271905|Tocolytic Agents|tocolytic agents|mesh-ancestor
110766603|NCT04122170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110766604|NCT04122170|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110766605|NCT04122170|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110766606|NCT04122170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110766607|NCT04122170|Antipyretics|antipyretics|mesh-ancestor
110766608|NCT04122170|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110766609|NCT04122170|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110766610|NCT04122170|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110766611|NCT04122170|Purinergic Agents|purinergic agents|mesh-ancestor
110766612|NCT04122170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110766613|NCT04073433|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
110766614|NCT04073433|Hallucinogens|hallucinogens|mesh-ancestor
110766615|NCT04073433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110766616|NCT04073433|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110766617|NCT04073433|Serotonin Agents|serotonin agents|mesh-ancestor
110766618|NCT04073433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110766619|NCT04073433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110766620|NCT04073433|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110766621|NCT04073433|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110766622|NCT04073433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110766623|NCT04073433|Adrenergic Agents|adrenergic agents|mesh-ancestor
110766624|NCT04038515|Menthol|menthol|mesh-list
110766625|NCT04038515|Nicotine|nicotine|mesh-list
110766626|NCT04038515|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110766627|NCT04038515|Autonomic Agents|autonomic agents|mesh-ancestor
110766628|NCT04038515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110766629|NCT04038515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110766630|NCT04038515|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110766631|NCT04038515|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110766632|NCT04038515|Cholinergic Agents|cholinergic agents|mesh-ancestor
110766633|NCT04038515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110766634|NCT04038515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110766635|NCT04038515|Antipruritics|antipruritics|mesh-ancestor
110766636|NCT04038515|Dermatologic Agents|dermatologic agents|mesh-ancestor
110766637|NCT03997266|Gentamicins|gentamicins|mesh-list
110766638|NCT03997266|Ampicillin|ampicillin|mesh-list
110766639|NCT03997266|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110766640|NCT03997266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110766641|NCT03997266|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110766642|NCT03997266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110766643|NCT03997266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110766645|NCT03959293|Tremelimumab|tremelimumab|mesh-list
110766646|NCT03959293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110766647|NCT03959293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110766648|NCT03936153|Abexinostat|abexinostat|mesh-list
110766649|NCT03936153|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110766650|NCT03936153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110766651|NCT03936153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110766652|NCT03792841|Etanercept|etanercept|mesh-list
110766653|NCT03792841|Pembrolizumab|pembrolizumab|mesh-list
110766654|NCT03792841|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
110766655|NCT03792841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110766656|NCT03792841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110766657|NCT03792841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110766658|NCT03792841|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110766659|NCT03792841|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110766660|NCT03792841|Analgesics|analgesics|mesh-ancestor
110766661|NCT03792841|Sensory System Agents|sensory system agents|mesh-ancestor
110766662|NCT03792841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110766663|NCT03792841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110324441|NCT00430586|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
110766664|NCT03792841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110766665|NCT03792841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110766666|NCT03792841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110766667|NCT03792841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110766668|NCT03792841|Immunologic Factors|immunologic factors|mesh-ancestor
110766669|NCT03782987|Itraconazole|itraconazole|mesh-list
110766670|NCT03782987|Antifungal Agents|antifungal agents|mesh-ancestor
110766671|NCT03782987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110766672|NCT03782987|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110766673|NCT03782987|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110766674|NCT03782987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110324645|NCT00462540|Anticonvulsants|anticonvulsants|mesh-ancestor
110766675|NCT03782987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110766676|NCT03782987|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110766677|NCT03782987|Hormone Antagonists|hormone antagonists|mesh-ancestor
110766678|NCT03782987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110766679|NCT03782987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110766680|NCT03782987|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110766681|NCT03755791|Sorafenib|sorafenib|mesh-list
110766682|NCT03755791|Atezolizumab|atezolizumab|mesh-list
110766683|NCT03755791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110766684|NCT03755791|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110766685|NCT03755791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110766686|NCT03755791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110324867|NCT00432653|Rituximab|rituximab|mesh-list
110766687|NCT03755791|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110324947|NCT03273075|Cangrelor|cangrelor|mesh-list
110766688|NCT03755791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110766689|NCT03755102|Osimertinib|osimertinib|mesh-list
110766690|NCT03755102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110766691|NCT03755102|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110325014|NCT00433121|Antiemetics|antiemetics|mesh-ancestor
110766692|NCT03755102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110766693|NCT03755102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110766694|NCT03742986|Paclitaxel|paclitaxel|mesh-list
110766695|NCT03742986|Docetaxel|docetaxel|mesh-list
110766696|NCT03742986|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110766697|NCT03742986|Cyclophosphamide|cyclophosphamide|mesh-list
110766698|NCT03742986|Doxorubicin|doxorubicin|mesh-list
110766699|NCT03742986|Nivolumab|nivolumab|mesh-list
110766700|NCT03742986|Trastuzumab|trastuzumab|mesh-list
110766701|NCT03742986|Pertuzumab|pertuzumab|mesh-list
110766702|NCT03742986|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110766703|NCT03742986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110766704|NCT03742986|Tubulin Modulators|tubulin modulators|mesh-ancestor
110325217|NCT01050764|Antiviral Agents|antiviral agents|mesh-ancestor
110766705|NCT03742986|Antimitotic Agents|antimitotic agents|mesh-ancestor
110766706|NCT03742986|Mitosis Modulators|mitosis modulators|mesh-ancestor
110766707|NCT03742986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110766708|NCT03742986|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110766709|NCT03742986|Immunologic Factors|immunologic factors|mesh-ancestor
110766710|NCT03742986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110766711|NCT03742986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110766712|NCT03742986|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110766713|NCT03742986|Alkylating Agents|alkylating agents|mesh-ancestor
110766714|NCT03742986|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110766715|NCT03742986|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110325431|NCT00465192|Hormones|hormones|mesh-ancestor
110766719|NCT03742986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110766720|NCT03742986|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110766721|NCT03713580|Venetoclax|venetoclax|mesh-list
110325507|NCT00465543|Analgesics|analgesics|mesh-ancestor
110766722|NCT03713580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110766726|NCT03594747|Paclitaxel|paclitaxel|mesh-list
110766727|NCT03594747|Carboplatin|carboplatin|mesh-list
110766728|NCT03594747|Tislelizumab|tislelizumab|mesh-list
110766729|NCT03594747|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110766730|NCT03594747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110766731|NCT03594747|Tubulin Modulators|tubulin modulators|mesh-ancestor
110766732|NCT03594747|Antimitotic Agents|antimitotic agents|mesh-ancestor
110766733|NCT03594747|Mitosis Modulators|mitosis modulators|mesh-ancestor
110766734|NCT03594747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110766735|NCT03594747|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110766736|NCT03575403|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110766737|NCT03575403|Methylphenidate|methylphenidate|mesh-list
110766738|NCT03575403|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110766739|NCT03575403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110766740|NCT03575403|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110766741|NCT03575403|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110766742|NCT03575403|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110325791|NCT00437723|Epoetin Alfa|epoetin alfa|mesh-list
110766743|NCT03575403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110766744|NCT03575403|Dopamine Agents|dopamine agents|mesh-ancestor
110766745|NCT03575403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110766746|NCT03575403|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110766747|NCT03575403|Analgesics|analgesics|mesh-ancestor
110766748|NCT03575403|Sensory System Agents|sensory system agents|mesh-ancestor
110766749|NCT03575403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110766750|NCT03575403|Antidepressive Agents|antidepressive agents|mesh-ancestor
110766751|NCT03575403|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110766752|NCT03485287|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
110766753|NCT03485287|Hallucinogens|hallucinogens|mesh-ancestor
110766754|NCT03485287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110766755|NCT03485287|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110766756|NCT03485287|Serotonin Agents|serotonin agents|mesh-ancestor
110766757|NCT03485287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110766758|NCT03485287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110766759|NCT03485287|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110325946|NCT00438230|Warfarin|warfarin|mesh-list
110766760|NCT03485287|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110766761|NCT03485287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110766762|NCT03485287|Adrenergic Agents|adrenergic agents|mesh-ancestor
110766763|NCT03474029|Rifampin|rifampin|mesh-list
110766764|NCT03474029|Rifapentine|rifapentine|mesh-list
110766765|NCT03474029|Isoniazid|isoniazid|mesh-list
110766766|NCT03474029|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110766767|NCT03474029|Antitubercular Agents|antitubercular agents|mesh-ancestor
110766768|NCT03474029|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110766769|NCT03474029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110326002|NCT00438386|Dopamine Agents|dopamine agents|mesh-ancestor
110766770|NCT03474029|Leprostatic Agents|leprostatic agents|mesh-ancestor
110766771|NCT03474029|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110766772|NCT03474029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110326062|NCT00438737|Growth Inhibitors|growth inhibitors|mesh-ancestor
110766773|NCT03474029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110766774|NCT03474029|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110766775|NCT03474029|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110326138|NCT00475566|Immunologic Factors|immunologic factors|mesh-ancestor
110766776|NCT03474029|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110766777|NCT03474029|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110766778|NCT03474029|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110766779|NCT03474029|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110766780|NCT03474029|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
110766781|NCT03474029|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110766782|NCT03474029|Antimetabolites|antimetabolites|mesh-ancestor
110326274|NCT00476268|Glucocorticoids|glucocorticoids|mesh-ancestor
110766783|NCT03474029|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110766784|NCT03395080|Paclitaxel|paclitaxel|mesh-list
110766785|NCT03395080|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110766786|NCT03395080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110766787|NCT03395080|Tubulin Modulators|tubulin modulators|mesh-ancestor
110766788|NCT03395080|Antimitotic Agents|antimitotic agents|mesh-ancestor
110869816|NCT03671174|Hormones|hormones|mesh-ancestor
110766789|NCT03395080|Mitosis Modulators|mitosis modulators|mesh-ancestor
110326420|NCT03279536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110766790|NCT03395080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110766791|NCT03356860|Paclitaxel|paclitaxel|mesh-list
110766792|NCT03356860|Cyclophosphamide|cyclophosphamide|mesh-list
110766793|NCT03356860|Durvalumab|durvalumab|mesh-list
110766794|NCT03356860|Epirubicin|epirubicin|mesh-list
110766795|NCT03356860|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110766796|NCT03356860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110766797|NCT03356860|Tubulin Modulators|tubulin modulators|mesh-ancestor
110766798|NCT03356860|Antimitotic Agents|antimitotic agents|mesh-ancestor
110766799|NCT03356860|Mitosis Modulators|mitosis modulators|mesh-ancestor
110766800|NCT03356860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110766801|NCT03356860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110766802|NCT03356860|Immunologic Factors|immunologic factors|mesh-ancestor
110766803|NCT03356860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110766804|NCT03356860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110766805|NCT03356860|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110766806|NCT03356860|Alkylating Agents|alkylating agents|mesh-ancestor
110766807|NCT03356860|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110766808|NCT03356860|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110766809|NCT03356860|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110326566|NCT00438828|Hormones|hormones|mesh-ancestor
110766810|NCT03356860|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110766811|NCT03356860|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110766812|NCT03356860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110766813|NCT03313778|Pembrolizumab|pembrolizumab|mesh-list
110766814|NCT03313778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110766815|NCT03313778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110766816|NCT03313778|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110766817|NCT03313778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110766818|NCT03282123|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
110766819|NCT03282123|Hallucinogens|hallucinogens|mesh-ancestor
110766820|NCT03282123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110766821|NCT03282123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110766822|NCT03282123|Serotonin Agents|serotonin agents|mesh-ancestor
110766823|NCT03282123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110766824|NCT03282123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110326839|NCT00478101|Fentanyl|fentanyl|mesh-list
110766825|NCT03282123|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110766826|NCT03282123|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110766827|NCT03282123|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110766828|NCT03282123|Adrenergic Agents|adrenergic agents|mesh-ancestor
110766829|NCT03245437|Oxytocin|oxytocin|mesh-list
110766830|NCT03245437|Oxytocics|oxytocics|mesh-ancestor
110766831|NCT03245437|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110766832|NCT03245437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110766833|NCT03217643|Brentuximab Vedotin|brentuximab vedotin|mesh-list
110766834|NCT03217643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110766835|NCT03217643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110766836|NCT03217643|Immunotoxins|immunotoxins|mesh-ancestor
110766837|NCT03217643|Immunoconjugates|immunoconjugates|mesh-ancestor
110766838|NCT03217643|Immunologic Factors|immunologic factors|mesh-ancestor
110766839|NCT03217643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110766840|NCT03207529|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-list
110766841|NCT03207529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110766842|NCT03207529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110766843|NCT03181763|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
110766844|NCT03181763|Hallucinogens|hallucinogens|mesh-ancestor
110766845|NCT03181763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110766846|NCT03181763|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110766848|NCT03181763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110766849|NCT03181763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110766850|NCT03181763|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110766851|NCT03181763|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110766852|NCT03181763|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110766853|NCT03181763|Adrenergic Agents|adrenergic agents|mesh-ancestor
110766854|NCT03175432|Bevacizumab|bevacizumab|mesh-list
110766855|NCT03175432|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110327281|NCT00479739|Xhance|xhance|mesh-list
110766856|NCT03175432|Atezolizumab|atezolizumab|mesh-list
110766857|NCT03175432|Endothelial Growth Factors|endothelial growth factors|mesh-list
110766858|NCT03175432|Antibodies|antibodies|mesh-list
110766859|NCT03175432|Immunoglobulins|immunoglobulins|mesh-list
110766860|NCT03175432|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110766861|NCT03175432|Immunoglobulin G|immunoglobulin g|mesh-list
110766862|NCT03175432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110327413|NCT03278808|Azithromycin|azithromycin|mesh-list
110766863|NCT03175432|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110766864|NCT03175432|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110766865|NCT03175432|Growth Substances|growth substances|mesh-ancestor
110766866|NCT03175432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110766867|NCT03175432|Growth Inhibitors|growth inhibitors|mesh-ancestor
110766868|NCT03175432|Immunologic Factors|immunologic factors|mesh-ancestor
110766869|NCT03175432|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110766870|NCT03175432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110766871|NCT03092323|Pembrolizumab|pembrolizumab|mesh-list
110766872|NCT03092323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110766873|NCT03092323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110766874|NCT03092323|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110766875|NCT03092323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110766876|NCT03006432|Leucovorin|leucovorin|mesh-list
110766877|NCT03006432|Folic Acid|folic acid|mesh-list
110766878|NCT03006432|Docetaxel|docetaxel|mesh-list
110766879|NCT03006432|Fluorouracil|fluorouracil|mesh-list
110766880|NCT03006432|Oxaliplatin|oxaliplatin|mesh-list
110766881|NCT03006432|Levoleucovorin|levoleucovorin|mesh-list
110766882|NCT03006432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110766883|NCT03006432|Tubulin Modulators|tubulin modulators|mesh-ancestor
110766884|NCT03006432|Antimitotic Agents|antimitotic agents|mesh-ancestor
110766885|NCT03006432|Mitosis Modulators|mitosis modulators|mesh-ancestor
110766886|NCT03006432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110766887|NCT03006432|Antimetabolites|antimetabolites|mesh-ancestor
110766888|NCT03006432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110766889|NCT03006432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110766890|NCT03006432|Immunologic Factors|immunologic factors|mesh-ancestor
110766891|NCT03006432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110766892|NCT03006432|Antidotes|antidotes|mesh-ancestor
110766893|NCT03006432|Protective Agents|protective agents|mesh-ancestor
110766894|NCT03006432|Vitamin B Complex|vitamin b complex|mesh-ancestor
110766895|NCT03006432|Vitamins|vitamins|mesh-ancestor
110766896|NCT03006432|Micronutrients|micronutrients|mesh-ancestor
110766897|NCT03006432|Hematinics|hematinics|mesh-ancestor
110766898|NCT02759185|Dronabinol|dronabinol|mesh-list
110766899|NCT02759185|Cannabidiol|cannabidiol|mesh-list
110766900|NCT02759185|Anticonvulsants|anticonvulsants|mesh-ancestor
110766901|NCT02759185|Hallucinogens|hallucinogens|mesh-ancestor
110766902|NCT02759185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110766903|NCT02759185|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110766904|NCT02759185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110766905|NCT02759185|Analgesics|analgesics|mesh-ancestor
110327837|NCT00443508|Everolimus|everolimus|mesh-list
110766906|NCT02759185|Sensory System Agents|sensory system agents|mesh-ancestor
110766907|NCT02759185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110766908|NCT02759185|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
110766909|NCT02759185|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110766910|NCT02759185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110766911|NCT02759185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110766912|NCT02759185|Hormones|hormones|mesh-ancestor
110327903|NCT00457964|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110766913|NCT02759185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110766914|NCT02619253|Pembrolizumab|pembrolizumab|mesh-list
110766915|NCT02619253|Vorinostat|vorinostat|mesh-list
110766916|NCT02619253|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110766917|NCT02619253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110766918|NCT02619253|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110766919|NCT02619253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110766920|NCT02619253|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110766922|NCT02584478|Paclitaxel|paclitaxel|mesh-list
110766923|NCT02584478|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110766924|NCT02584478|Carboplatin|carboplatin|mesh-list
110766925|NCT02584478|Doxorubicin|doxorubicin|mesh-list
110766926|NCT02584478|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110766927|NCT02584478|Topotecan|topotecan|mesh-list
110766928|NCT02584478|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110766929|NCT02584478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110766930|NCT02584478|Tubulin Modulators|tubulin modulators|mesh-ancestor
110065797|NCT01534949|Rituximab|rituximab|mesh-list
110766931|NCT02584478|Antimitotic Agents|antimitotic agents|mesh-ancestor
110766932|NCT02584478|Mitosis Modulators|mitosis modulators|mesh-ancestor
110766933|NCT02584478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110766934|NCT02584478|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110766935|NCT02584478|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110766936|NCT02584478|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110328112|NCT00488670|Escitalopram|escitalopram|mesh-list
110766937|NCT02584478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110766938|NCT02584478|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110766939|NCT02502786|Antibodies|antibodies|mesh-list
110766940|NCT02502786|Immunologic Factors|immunologic factors|mesh-ancestor
110766941|NCT02502786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110766942|NCT02436993|Paclitaxel|paclitaxel|mesh-list
110766943|NCT02436993|Bevacizumab|bevacizumab|mesh-list
110766944|NCT02436993|Carboplatin|carboplatin|mesh-list
110766945|NCT02436993|Trastuzumab|trastuzumab|mesh-list
110766946|NCT02436993|Pertuzumab|pertuzumab|mesh-list
110766947|NCT02436993|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110766948|NCT02436993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110766949|NCT02436993|Tubulin Modulators|tubulin modulators|mesh-ancestor
110766950|NCT02436993|Antimitotic Agents|antimitotic agents|mesh-ancestor
110766951|NCT02436993|Mitosis Modulators|mitosis modulators|mesh-ancestor
110766952|NCT02436993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110766953|NCT02436993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110766954|NCT02436993|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110766955|NCT02436993|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110766956|NCT02436993|Growth Substances|growth substances|mesh-ancestor
110766957|NCT02436993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110766958|NCT02436993|Growth Inhibitors|growth inhibitors|mesh-ancestor
110328252|NCT00495651|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
110766959|NCT02427568|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
110766961|NCT02427568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110766962|NCT02427568|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110766963|NCT02427568|Serotonin Agents|serotonin agents|mesh-ancestor
110766964|NCT02427568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110766965|NCT02427568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110766966|NCT02427568|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110766967|NCT02427568|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110766968|NCT02427568|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110766969|NCT02427568|Adrenergic Agents|adrenergic agents|mesh-ancestor
110766970|NCT02193841|Calcium|calcium|mesh-list
110766971|NCT02193841|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110766972|NCT02193841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110766973|NCT02102802|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
110766974|NCT02102802|Hallucinogens|hallucinogens|mesh-ancestor
110766975|NCT02102802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110766976|NCT02102802|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110766977|NCT02102802|Serotonin Agents|serotonin agents|mesh-ancestor
110766978|NCT02102802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110766979|NCT02102802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110766980|NCT02102802|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110766981|NCT02102802|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110766982|NCT02102802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110766983|NCT02102802|Adrenergic Agents|adrenergic agents|mesh-ancestor
110766984|NCT02011971|Vinpocetine|vinpocetine|mesh-list
110766985|NCT02011971|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110766986|NCT02011971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110766987|NCT02011971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110766988|NCT02011971|Vasodilator Agents|vasodilator agents|mesh-ancestor
110766989|NCT02011971|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110766990|NCT02011971|Protective Agents|protective agents|mesh-ancestor
110766991|NCT02011971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110766992|NCT02011971|Nootropic Agents|nootropic agents|mesh-ancestor
110766993|NCT02008396|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
110766994|NCT02008396|Hallucinogens|hallucinogens|mesh-ancestor
110766995|NCT02008396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110766996|NCT02008396|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110766998|NCT02008396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110766999|NCT02008396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110767000|NCT02008396|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110767001|NCT02008396|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110328524|NCT00497016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110767002|NCT02008396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110767003|NCT02008396|Adrenergic Agents|adrenergic agents|mesh-ancestor
110767004|NCT01951339|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110767005|NCT01951339|Glimepiride|glimepiride|mesh-list
110767006|NCT01951339|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110767007|NCT01951339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110767008|NCT01951339|Incretins|incretins|mesh-ancestor
110767009|NCT01951339|Hormones|hormones|mesh-ancestor
110767010|NCT01951339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110767011|NCT01951339|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110767012|NCT01951339|Protease Inhibitors|protease inhibitors|mesh-ancestor
110767013|NCT01951339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110767014|NCT01951339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110767015|NCT01951339|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110767016|NCT01951339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110767018|NCT01856478|Methotrexate|methotrexate|mesh-list
110767019|NCT01856478|Afatinib|afatinib|mesh-list
110767020|NCT01856478|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110767021|NCT01856478|Abortifacient Agents|abortifacient agents|mesh-ancestor
110767022|NCT01856478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110767023|NCT01856478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110767024|NCT01856478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110767025|NCT01856478|Antimetabolites|antimetabolites|mesh-ancestor
110767026|NCT01856478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110767027|NCT01856478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110767028|NCT01856478|Dermatologic Agents|dermatologic agents|mesh-ancestor
110767029|NCT01856478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110767030|NCT01856478|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110767031|NCT01856478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110767032|NCT01856478|Immunologic Factors|immunologic factors|mesh-ancestor
110767033|NCT01856478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110767034|NCT01856478|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110767035|NCT01856478|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110767036|NCT01853826|Afatinib|afatinib|mesh-list
110767037|NCT01853826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110767038|NCT01853826|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110767039|NCT01853826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110767040|NCT01853826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110767041|NCT01844518|Abatacept|abatacept|mesh-list
110767042|NCT01844518|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110767043|NCT01844518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110767044|NCT01844518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110767045|NCT01844518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110767046|NCT01844518|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110767047|NCT01844518|Immunologic Factors|immunologic factors|mesh-ancestor
110767048|NCT01844518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110767049|NCT01844518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110767050|NCT01835041|Leucovorin|leucovorin|mesh-list
110767051|NCT01835041|Thioctic Acid|thioctic acid|mesh-list
110767052|NCT01835041|Fluorouracil|fluorouracil|mesh-list
110767053|NCT01835041|Oxaliplatin|oxaliplatin|mesh-list
110767054|NCT01835041|Irinotecan|irinotecan|mesh-list
110767055|NCT01835041|Calcium|calcium|mesh-list
110767056|NCT01835041|Levoleucovorin|levoleucovorin|mesh-list
110767057|NCT01835041|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110767058|NCT01835041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110767059|NCT01835041|Antimetabolites|antimetabolites|mesh-ancestor
110767060|NCT01835041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110767061|NCT01835041|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110767062|NCT01835041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110767063|NCT01835041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110767064|NCT01835041|Immunologic Factors|immunologic factors|mesh-ancestor
110767065|NCT01835041|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110767066|NCT01835041|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110767067|NCT01835041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110767068|NCT01835041|Antidotes|antidotes|mesh-ancestor
110767069|NCT01835041|Protective Agents|protective agents|mesh-ancestor
110767070|NCT01835041|Vitamin B Complex|vitamin b complex|mesh-ancestor
110767071|NCT01835041|Vitamins|vitamins|mesh-ancestor
110767072|NCT01835041|Micronutrients|micronutrients|mesh-ancestor
110767073|NCT01835041|Antioxidants|antioxidants|mesh-ancestor
110767074|NCT01833572|Gefitinib|gefitinib|mesh-list
110767075|NCT01833572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110767076|NCT01833572|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110767077|NCT01833572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110767078|NCT01833572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110767079|NCT01793610|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
110767081|NCT01793610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110767082|NCT01793610|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110767083|NCT01793610|Serotonin Agents|serotonin agents|mesh-ancestor
110767084|NCT01793610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110767085|NCT01793610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110767086|NCT01793610|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110767087|NCT01793610|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110767088|NCT01793610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110767089|NCT01793610|Adrenergic Agents|adrenergic agents|mesh-ancestor
110767090|NCT01639690|Busulfan|busulfan|mesh-list
110767091|NCT01639690|Alkylating Agents|alkylating agents|mesh-ancestor
110767092|NCT01639690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110767093|NCT01639690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110329017|NCT01243437|Ciprofloxacin|ciprofloxacin|mesh-list
110767094|NCT01639690|Immunologic Factors|immunologic factors|mesh-ancestor
110767095|NCT01639690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110767096|NCT01639690|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110767097|NCT01639690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110767098|NCT01639690|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110767099|NCT01591577|Temozolomide|temozolomide|mesh-list
110767100|NCT01591577|Lapatinib|lapatinib|mesh-list
110767101|NCT01591577|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110767102|NCT01591577|Alkylating Agents|alkylating agents|mesh-ancestor
110767103|NCT01591577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110767104|NCT01591577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110767105|NCT01591577|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110767106|NCT01591577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110767107|NCT01509586|Lobeline|lobeline|mesh-list
110767108|NCT01509586|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110767109|NCT01509586|Autonomic Agents|autonomic agents|mesh-ancestor
110767110|NCT01509586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110767111|NCT01509586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110767112|NCT01509586|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110767113|NCT01509586|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110767114|NCT01509586|Cholinergic Agents|cholinergic agents|mesh-ancestor
110767115|NCT01509586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110767116|NCT01509586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110767117|NCT01509586|Respiratory System Agents|respiratory system agents|mesh-ancestor
110767118|NCT01364584|Exenatide|exenatide|mesh-list
110767119|NCT01364584|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110767120|NCT01364584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110767121|NCT01364584|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110767122|NCT01364584|Incretins|incretins|mesh-ancestor
110767123|NCT01364584|Hormones|hormones|mesh-ancestor
110767124|NCT01364584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110767126|NCT01163383|Cadexomer iodine|cadexomer iodine|mesh-list
110767127|NCT01163383|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
110767128|NCT01163383|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110767129|NCT01163383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110767130|NCT01163383|Trace Elements|trace elements|mesh-ancestor
110767131|NCT01163383|Micronutrients|micronutrients|mesh-ancestor
110767132|NCT01163383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110767133|NCT01163383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110767134|NCT01163383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110767135|NCT01163383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110767136|NCT01163383|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110767137|NCT01044264|Clindamycin|clindamycin|mesh-list
110767138|NCT01044264|Clindamycin palmitate|clindamycin palmitate|mesh-list
110767139|NCT01044264|Clindamycin phosphate|clindamycin phosphate|mesh-list
110767140|NCT01044264|Benzoyl Peroxide|benzoyl peroxide|mesh-list
110767141|NCT01044264|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110767142|NCT01044264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110767143|NCT01044264|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110767144|NCT01044264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110767145|NCT01044264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110767146|NCT01044264|Dermatologic Agents|dermatologic agents|mesh-ancestor
110767148|NCT01039584|Antifungal Agents|antifungal agents|mesh-ancestor
110767149|NCT01039584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110767150|NCT00979693|Psilocybin|psilocybin|mesh-list
110767151|NCT00979693|Hallucinogens|hallucinogens|mesh-ancestor
110767152|NCT00979693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110767153|NCT00979693|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110767154|NCT00920387|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
110767155|NCT00920387|Hallucinogens|hallucinogens|mesh-ancestor
110767156|NCT00920387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110767157|NCT00920387|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110767158|NCT00920387|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110767159|NCT00920387|Serotonin Agents|serotonin agents|mesh-ancestor
110767160|NCT00920387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110767161|NCT00920387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110484855|NCT00722293|Epirubicin|epirubicin|mesh-list
110767162|NCT00920387|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110767167|NCT00786019|Antioxidants|antioxidants|mesh-ancestor
110767168|NCT00786019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110767169|NCT00786019|Protective Agents|protective agents|mesh-ancestor
110767170|NCT00692484|Chlorhexidine|chlorhexidine|mesh-list
110767171|NCT00692484|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110767172|NCT00692484|Povidone-Iodine|povidone-iodine|mesh-list
110767174|NCT00692484|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110767175|NCT00692484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110767176|NCT00692484|Disinfectants|disinfectants|mesh-ancestor
110767177|NCT00692484|Dermatologic Agents|dermatologic agents|mesh-ancestor
110767178|NCT00692484|Plasma Substitutes|plasma substitutes|mesh-ancestor
110767179|NCT00692484|Blood Substitutes|blood substitutes|mesh-ancestor
110767180|NCT00679783|Olaparib|olaparib|mesh-list
110767181|NCT00679783|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110329386|NCT00465257|Artesunate|artesunate|mesh-list
110767182|NCT00679783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110767183|NCT00679783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110767184|NCT00679783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110767185|NCT00152698|Irbesartan|irbesartan|mesh-list
110767186|NCT00152698|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110767187|NCT00152698|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110767188|NCT00152698|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110329431|NCT00465296|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110767189|NCT00152698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110767190|NCT01257516|Pregabalin|pregabalin|mesh-list
110767191|NCT01257516|Analgesics|analgesics|mesh-ancestor
110767192|NCT01257516|Sensory System Agents|sensory system agents|mesh-ancestor
110767193|NCT01257516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110767194|NCT01257516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110767195|NCT01257516|Anticonvulsants|anticonvulsants|mesh-ancestor
110767196|NCT01257516|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110767197|NCT01257516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110767198|NCT01257516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110767199|NCT01257516|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110767200|NCT01257516|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110767201|NCT01257516|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110767202|NCT01257516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110767203|NCT01257516|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110767204|NCT01149954|Ibuprofen|ibuprofen|mesh-list
110767205|NCT01149954|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110767206|NCT01149954|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110767207|NCT01149954|Analgesics|analgesics|mesh-ancestor
110767208|NCT01149954|Sensory System Agents|sensory system agents|mesh-ancestor
110767209|NCT01149954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110767210|NCT01149954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110767211|NCT01149954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110767212|NCT01149954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110767213|NCT01149954|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110767214|NCT01149954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110767215|NCT01149954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110767216|NCT03899610|Durvalumab|durvalumab|mesh-list
110767217|NCT03899610|Tremelimumab|tremelimumab|mesh-list
110767218|NCT03899610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110092282|NCT01694797|Sympatholytics|sympatholytics|mesh-ancestor
110767220|NCT02527668|Vitamin D|vitamin d|mesh-list
110767221|NCT02527668|Cholecalciferol|cholecalciferol|mesh-list
110767222|NCT02527668|Calcifediol|calcifediol|mesh-list
110767223|NCT02527668|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
110767224|NCT02527668|Vitamins|vitamins|mesh-ancestor
110330002|NCT01243788|Xhance|xhance|mesh-list
110767225|NCT02527668|Micronutrients|micronutrients|mesh-ancestor
110767226|NCT02527668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110330005|NCT01243788|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110767227|NCT02527668|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110330154|NCT01606345|Valrubicin|valrubicin|mesh-list
110767228|NCT02527668|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110767233|NCT03896256|Ketamine|ketamine|mesh-list
110767234|NCT03896256|Analgesics|analgesics|mesh-ancestor
110330233|NCT00474695|Ranibizumab|ranibizumab|mesh-list
110767235|NCT03896256|Sensory System Agents|sensory system agents|mesh-ancestor
110767236|NCT03896256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110330301|NCT01246089|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110767237|NCT03896256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110484949|NCT02571517|Hormones|hormones|mesh-ancestor
110767238|NCT03896256|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110767239|NCT03896256|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110330373|NCT04326166|Metformin|metformin|mesh-list
110767240|NCT03896256|Anesthetics, General|anesthetics, general|mesh-ancestor
110767242|NCT03896256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110767243|NCT03896256|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110767244|NCT03896256|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110767245|NCT03896256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110767246|NCT03896256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110767247|NCT03893136|Leflunomide|leflunomide|mesh-list
110767248|NCT03893136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110767249|NCT03893136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110767250|NCT03893136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110767251|NCT03893136|Immunologic Factors|immunologic factors|mesh-ancestor
110767252|NCT03893136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110767253|NCT01258530|Oseltamivir|oseltamivir|mesh-list
110767254|NCT01258530|Antiviral Agents|antiviral agents|mesh-ancestor
110767255|NCT01258530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110767256|NCT01258530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110767257|NCT01258530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110767258|NCT01255410|Vaccines|vaccines|mesh-list
110767259|NCT01255410|Immunologic Factors|immunologic factors|mesh-ancestor
110767260|NCT01255410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110767261|NCT01150110|Salicylic Acid|salicylic acid|mesh-list
110767262|NCT01150110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110767263|NCT01150110|Antifungal Agents|antifungal agents|mesh-ancestor
110767264|NCT01150110|Keratolytic Agents|keratolytic agents|mesh-ancestor
110767265|NCT01150110|Dermatologic Agents|dermatologic agents|mesh-ancestor
110767266|NCT01257672|Ondansetron|ondansetron|mesh-list
110767267|NCT01257672|Domperidone|domperidone|mesh-list
110767268|NCT01257672|Antiemetics|antiemetics|mesh-ancestor
110767269|NCT01257672|Autonomic Agents|autonomic agents|mesh-ancestor
110767270|NCT01257672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110767271|NCT01257672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110767272|NCT01257672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110767273|NCT01257672|Antipruritics|antipruritics|mesh-ancestor
110330723|NCT00601432|Levofloxacin|levofloxacin|mesh-list
110767274|NCT01257672|Dermatologic Agents|dermatologic agents|mesh-ancestor
110767275|NCT01257672|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110767276|NCT01257672|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110767277|NCT01257672|Serotonin Agents|serotonin agents|mesh-ancestor
110767278|NCT01257672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110767279|NCT01257672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110767280|NCT01257672|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110767281|NCT01257672|Dopamine Agents|dopamine agents|mesh-ancestor
110767282|NCT01258686|Silymarin|silymarin|mesh-list
110767283|NCT01258686|Antioxidants|antioxidants|mesh-ancestor
110767284|NCT01258686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110767285|NCT01258686|Protective Agents|protective agents|mesh-ancestor
110767286|NCT01258686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110767287|NCT01258764|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110767288|NCT01258764|Lisinopril|lisinopril|mesh-list
110331072|NCT00471419|Rimexolone|rimexolone|mesh-list
110767289|NCT01258764|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
110767290|NCT01258764|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110767291|NCT01258764|Diuretics|diuretics|mesh-ancestor
110331147|NCT01244217|Histamine Agents|histamine agents|mesh-ancestor
110767292|NCT01258764|Natriuretic Agents|natriuretic agents|mesh-ancestor
110767293|NCT01258764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110331236|NCT00471965|Vitamins|vitamins|mesh-ancestor
110767294|NCT01258764|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110767295|NCT01258764|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110767296|NCT01258764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110767297|NCT01258764|Protease Inhibitors|protease inhibitors|mesh-ancestor
110767298|NCT01258764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110767299|NCT01258764|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110767300|NCT01258764|Protective Agents|protective agents|mesh-ancestor
110767301|NCT03895788|Niraparib|niraparib|mesh-list
110767302|NCT03895788|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110767303|NCT03895788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110767304|NCT03895788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110767305|NCT03895788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110767306|NCT01257828|Riluzole|riluzole|mesh-list
110767307|NCT01257828|Anticonvulsants|anticonvulsants|mesh-ancestor
110767308|NCT01257828|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110767309|NCT01257828|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110767310|NCT01257828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110767311|NCT01257828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110767312|NCT01257828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110767313|NCT01257828|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110767314|NCT01257828|Protective Agents|protective agents|mesh-ancestor
110767315|NCT03899142|Immunoglobulins|immunoglobulins|mesh-list
110331658|NCT00478634|Irinotecan|irinotecan|mesh-list
110767316|NCT03899142|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110767318|NCT03899142|Immunologic Factors|immunologic factors|mesh-ancestor
110331727|NCT01248078|Cephalexin|cephalexin|mesh-list
110767319|NCT03899142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110767320|NCT03892902|Zopiclone|zopiclone|mesh-list
110767321|NCT03892902|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110767322|NCT03892902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110767323|NCT03892902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110767324|NCT03892668|Tranexamic Acid|tranexamic acid|mesh-list
110767325|NCT03892668|Oxytocin|oxytocin|mesh-list
110767326|NCT03892668|Oxytocics|oxytocics|mesh-ancestor
110331945|NCT00473486|Carboplatin|carboplatin|mesh-list
110767327|NCT03892668|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110767328|NCT03892668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110767329|NCT03892668|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110767330|NCT03892668|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110767331|NCT03892668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110767332|NCT03892668|Hemostatics|hemostatics|mesh-ancestor
110767333|NCT03892668|Coagulants|coagulants|mesh-ancestor
110767334|NCT01258920|Paliperidone Palmitate|paliperidone palmitate|mesh-list
110767335|NCT01258920|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110767336|NCT01258920|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110767337|NCT01258920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110767338|NCT01258920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110767339|NCT01258920|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110767340|NCT01258920|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110767341|NCT01258920|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110767342|NCT01258920|Serotonin Agents|serotonin agents|mesh-ancestor
110767343|NCT01258920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110767344|NCT01258920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110767345|NCT01258920|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110767346|NCT01258920|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110767347|NCT01258920|Dopamine Agents|dopamine agents|mesh-ancestor
110767348|NCT03898752|Coenzyme Q10|coenzyme q10|mesh-list
110767349|NCT03898752|Vitamins|vitamins|mesh-ancestor
110767350|NCT03898752|Micronutrients|micronutrients|mesh-ancestor
110767351|NCT03898752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110767352|NCT01255644|Valganciclovir|valganciclovir|mesh-list
110767353|NCT01255644|Antiviral Agents|antiviral agents|mesh-ancestor
110767354|NCT01255644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110767355|NCT01255800|Cetuximab|cetuximab|mesh-list
110767356|NCT01255800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110767357|NCT01255800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110767358|NCT01257906|Tretinoin|tretinoin|mesh-list
110767359|NCT01257906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110767360|NCT01257906|Keratolytic Agents|keratolytic agents|mesh-ancestor
110767361|NCT01257906|Dermatologic Agents|dermatologic agents|mesh-ancestor
110767362|NCT03892512|Dexmedetomidine|dexmedetomidine|mesh-list
110767363|NCT03892512|Esmolol|esmolol|mesh-list
110767364|NCT03892512|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110767365|NCT03892512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110767366|NCT03892512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110767367|NCT03892512|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110767368|NCT03892512|Analgesics|analgesics|mesh-ancestor
110767369|NCT03892512|Sensory System Agents|sensory system agents|mesh-ancestor
110767370|NCT03892512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110767371|NCT03892512|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110767372|NCT03892512|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110767374|NCT03892512|Adrenergic Agents|adrenergic agents|mesh-ancestor
110767375|NCT03892512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110767376|NCT03892512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110767377|NCT03892512|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110767378|NCT03892512|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110767379|NCT03892512|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110767380|NCT01255878|Gabapentin|gabapentin|mesh-list
110767381|NCT01255878|Analgesics|analgesics|mesh-ancestor
110767382|NCT01255878|Sensory System Agents|sensory system agents|mesh-ancestor
110767383|NCT01255878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110767384|NCT01255878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110767385|NCT01255878|Anticonvulsants|anticonvulsants|mesh-ancestor
110767386|NCT01255878|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110767387|NCT01255878|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110767388|NCT01255878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110767389|NCT01255878|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110767390|NCT01255878|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110767391|NCT01255878|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110767392|NCT01255878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110767393|NCT01255878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110767394|NCT01255878|Antimanic Agents|antimanic agents|mesh-ancestor
110767395|NCT01255956|Sirolimus|sirolimus|mesh-list
110767396|NCT01255956|Paclitaxel|paclitaxel|mesh-list
110767397|NCT01255956|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110767398|NCT01255956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110767399|NCT01255956|Tubulin Modulators|tubulin modulators|mesh-ancestor
110767400|NCT01255956|Antimitotic Agents|antimitotic agents|mesh-ancestor
110767401|NCT01255956|Mitosis Modulators|mitosis modulators|mesh-ancestor
110767402|NCT01255956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110767403|NCT01255956|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110767404|NCT01255956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110767405|NCT01255956|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110767406|NCT01255956|Antifungal Agents|antifungal agents|mesh-ancestor
110767407|NCT01255956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110767408|NCT01255956|Immunologic Factors|immunologic factors|mesh-ancestor
110767409|NCT01255956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110767410|NCT03892434|Dexamethasone|dexamethasone|mesh-list
110767411|NCT03892434|Dexamethasone acetate|dexamethasone acetate|mesh-list
110767412|NCT03892434|Bevacizumab|bevacizumab|mesh-list
110767413|NCT03892434|BB 1101|bb 1101|mesh-list
110767414|NCT03892434|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110767415|NCT03892434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110767416|NCT03892434|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110767417|NCT03892434|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110767418|NCT03892434|Growth Substances|growth substances|mesh-ancestor
110767419|NCT03892434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110767420|NCT03892434|Growth Inhibitors|growth inhibitors|mesh-ancestor
110767421|NCT03892434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110767422|NCT03892434|Antiemetics|antiemetics|mesh-ancestor
110767423|NCT03892434|Autonomic Agents|autonomic agents|mesh-ancestor
110767424|NCT03892434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110767425|NCT03892434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110767426|NCT03892434|Glucocorticoids|glucocorticoids|mesh-ancestor
110767427|NCT03892434|Hormones|hormones|mesh-ancestor
110767428|NCT03892434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110767429|NCT03892434|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110767430|NCT03892434|Protease Inhibitors|protease inhibitors|mesh-ancestor
110767431|NCT03892434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110767432|NCT03892434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110767433|NCT03889626|Capecitabine|capecitabine|mesh-list
110767434|NCT03889626|Apatinib|apatinib|mesh-list
110767435|NCT03889626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110767436|NCT03889626|Antimetabolites|antimetabolites|mesh-ancestor
110767437|NCT03889626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110767438|NCT03889626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110767439|NCT03889626|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110767440|NCT03889626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110767441|NCT03892122|Dexmedetomidine|dexmedetomidine|mesh-list
110767442|NCT03892122|Propofol|propofol|mesh-list
110767443|NCT03892122|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110767444|NCT03892122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110767445|NCT03892122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110767446|NCT03892122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110767447|NCT03892122|Analgesics|analgesics|mesh-ancestor
110767448|NCT03892122|Sensory System Agents|sensory system agents|mesh-ancestor
110767449|NCT03892122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110767450|NCT03892122|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110767451|NCT03892122|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110767452|NCT03892122|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110767453|NCT03892122|Adrenergic Agents|adrenergic agents|mesh-ancestor
110767454|NCT03892122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110767455|NCT03892122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110767456|NCT03892122|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110767457|NCT03892122|Anesthetics, General|anesthetics, general|mesh-ancestor
110767458|NCT03892122|Anesthetics|anesthetics|mesh-ancestor
110767459|NCT01589562|Megestrol|megestrol|mesh-list
110767460|NCT01589562|Megestrol Acetate|megestrol acetate|mesh-list
110767461|NCT01589562|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110767462|NCT01589562|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110767463|NCT01589562|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110767464|NCT01589562|Contraceptive Agents|contraceptive agents|mesh-ancestor
110767465|NCT01589562|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110767466|NCT01589562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110767467|NCT01589562|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110767468|NCT01589562|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110767469|NCT01589562|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110767471|NCT01589562|Appetite Stimulants|appetite stimulants|mesh-ancestor
110767472|NCT01589562|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110767473|NCT01152372|Insulin|insulin|mesh-list
110767474|NCT01152372|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110767475|NCT01152372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110767476|NCT01589640|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110767477|NCT01589640|Lubricant Eye Drops|lubricant eye drops|mesh-list
110767478|NCT01589640|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110767479|NCT01259934|Interferons|interferons|mesh-list
110767480|NCT01259934|Interferon-alpha|interferon-alpha|mesh-list
110767481|NCT01259934|Interferon alpha-2|interferon alpha-2|mesh-list
110767482|NCT01259934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110767483|NCT01259934|Antiviral Agents|antiviral agents|mesh-ancestor
110767484|NCT01259934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110767485|NCT01259934|Immunologic Factors|immunologic factors|mesh-ancestor
110767486|NCT01259934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110767487|NCT01153386|Treprostinil|treprostinil|mesh-list
110767488|NCT01153386|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110767489|NCT01260012|Praziquantel|praziquantel|mesh-list
110767490|NCT01260012|Antioxidants|antioxidants|mesh-list
110767491|NCT01260012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110767492|NCT01260012|Protective Agents|protective agents|mesh-ancestor
110767493|NCT01260012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110767494|NCT01260012|Anthelmintics|anthelmintics|mesh-ancestor
110767495|NCT01260012|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110767496|NCT01260012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110767497|NCT03888924|Vaccines|vaccines|mesh-list
110767498|NCT03888924|BCG Vaccine|bcg vaccine|mesh-list
110767499|NCT03888924|Immunologic Factors|immunologic factors|mesh-ancestor
110767500|NCT03888924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110767501|NCT03888924|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110767502|NCT01151592|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
110767503|NCT01151592|Hematinics|hematinics|mesh-ancestor
110767504|NCT01151670|Pioglitazone|pioglitazone|mesh-list
110767505|NCT01151670|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110767506|NCT01151670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110767507|NCT03888846|Colchicine|colchicine|mesh-list
110767508|NCT03888846|Pentoxifylline|pentoxifylline|mesh-list
110767509|NCT03888846|Gout Suppressants|gout suppressants|mesh-ancestor
110767510|NCT03888846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110767511|NCT03888846|Tubulin Modulators|tubulin modulators|mesh-ancestor
110767512|NCT03888846|Antimitotic Agents|antimitotic agents|mesh-ancestor
110767513|NCT03888846|Mitosis Modulators|mitosis modulators|mesh-ancestor
110767514|NCT03888846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110767516|NCT03888846|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110767517|NCT03888846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110767518|NCT03888846|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110767519|NCT03888846|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110767520|NCT03888846|Protective Agents|protective agents|mesh-ancestor
110767521|NCT03888846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110767522|NCT03888846|Vasodilator Agents|vasodilator agents|mesh-ancestor
110767523|NCT03888846|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110767524|NCT03888846|Antioxidants|antioxidants|mesh-ancestor
110767525|NCT03891420|Galidesivir|galidesivir|mesh-list
110767526|NCT03891420|Antiviral Agents|antiviral agents|mesh-ancestor
110767527|NCT03891420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110767528|NCT01153542|Ivacaftor|ivacaftor|mesh-list
110767529|NCT01153542|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
110767530|NCT01153542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110767531|NCT01153542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110767532|NCT01152606|Trastuzumab|trastuzumab|mesh-list
110767533|NCT01152606|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110767534|NCT01152606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110767535|NCT01153854|Racecadotril|racecadotril|mesh-list
110767537|NCT01153854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110767538|NCT01153854|Protease Inhibitors|protease inhibitors|mesh-ancestor
110485254|NCT00727831|Leucovorin|leucovorin|mesh-list
110767539|NCT01153854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110767540|NCT01153854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110767542|NCT01260246|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110767543|NCT01260246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110767544|NCT01260246|Incretins|incretins|mesh-ancestor
110767545|NCT01260246|Hormones|hormones|mesh-ancestor
110332400|NCT00482456|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110767546|NCT01260246|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110767547|NCT01260246|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110767548|NCT01260246|Protease Inhibitors|protease inhibitors|mesh-ancestor
110767549|NCT01260246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110767550|NCT01260246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110767551|NCT03888534|Ixazomib|ixazomib|mesh-list
110767552|NCT03888534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110767553|NCT03888534|Protease Inhibitors|protease inhibitors|mesh-ancestor
110767554|NCT03888534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110767555|NCT03888534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110767556|NCT03885804|Dexmedetomidine|dexmedetomidine|mesh-list
110767557|NCT03885804|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110767558|NCT03885804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110767559|NCT03885804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110767560|NCT03885804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110767561|NCT03885804|Analgesics|analgesics|mesh-ancestor
110767562|NCT03885804|Sensory System Agents|sensory system agents|mesh-ancestor
110767563|NCT03885804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110767564|NCT03885804|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110767565|NCT03885804|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110767566|NCT03885804|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110767567|NCT03885804|Adrenergic Agents|adrenergic agents|mesh-ancestor
110767568|NCT03885804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110767569|NCT03885804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110767570|NCT03885258|Melatonin|melatonin|mesh-list
110767571|NCT03885258|Antioxidants|antioxidants|mesh-ancestor
110767572|NCT03885258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110767573|NCT03885258|Protective Agents|protective agents|mesh-ancestor
110767574|NCT03885258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110767575|NCT03885258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110767576|NCT01262196|Chrysarobin|chrysarobin|mesh-list
110767577|NCT01262196|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110445667|NCT02775370|Apatinib|apatinib|mesh-list
110767578|NCT01262196|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110767579|NCT01262196|Analgesics|analgesics|mesh-ancestor
110767580|NCT01262196|Sensory System Agents|sensory system agents|mesh-ancestor
110767581|NCT01262196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110767582|NCT01262196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110767583|NCT01262196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110767584|NCT01262196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110767586|NCT03885180|Anticoagulants|anticoagulants|mesh-ancestor
110767587|NCT03888144|Ketorolac|ketorolac|mesh-list
110767588|NCT03888144|Oxycodone|oxycodone|mesh-list
110767589|NCT03888144|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110767590|NCT03888144|Narcotics|narcotics|mesh-ancestor
110767591|NCT03888144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110767592|NCT03888144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110767593|NCT03888144|Analgesics|analgesics|mesh-ancestor
110767594|NCT03888144|Sensory System Agents|sensory system agents|mesh-ancestor
110767595|NCT03888144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110767596|NCT03888144|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110767597|NCT03888144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110767598|NCT03888144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110767599|NCT03888144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110767600|NCT03888144|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110767601|NCT03888144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110767602|NCT03888144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110767603|NCT03890406|Rocuronium|rocuronium|mesh-list
110767604|NCT03890406|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110767605|NCT03890406|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110767606|NCT03890406|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110767607|NCT03890406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110767608|NCT03890406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110767609|NCT01154400|Caseins|caseins|mesh-list
110767610|NCT01154400|Chelating Agents|chelating agents|mesh-ancestor
110767611|NCT01154400|Sequestering Agents|sequestering agents|mesh-ancestor
110485303|NCT02681913|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110767612|NCT01154400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110767613|NCT01152840|Everolimus|everolimus|mesh-list
110767614|NCT01152840|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110767615|NCT01152840|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110767616|NCT01152840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110767617|NCT01152840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110767618|NCT01152840|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110767619|NCT01152840|Immunologic Factors|immunologic factors|mesh-ancestor
110767620|NCT01152840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110767621|NCT01152840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110767622|NCT01262274|Anastrozole|anastrozole|mesh-list
110767623|NCT01262274|Tegafur|tegafur|mesh-list
110767624|NCT01262274|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110767625|NCT01262274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110767626|NCT01262274|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110767627|NCT01262274|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110767628|NCT01262274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110767629|NCT01262274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110767630|NCT01262274|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110767631|NCT01262274|Hormone Antagonists|hormone antagonists|mesh-ancestor
110767632|NCT01262274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110767633|NCT01262274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110767634|NCT01262274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110767635|NCT01262274|Antimetabolites|antimetabolites|mesh-ancestor
110767636|NCT01260558|Sirolimus|sirolimus|mesh-list
110767637|NCT01260558|Temsirolimus|temsirolimus|mesh-list
110767638|NCT01260558|MTOR Inhibitors|mtor inhibitors|mesh-list
110767639|NCT01260558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110767640|NCT01260558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110767641|NCT01260558|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110767642|NCT01260558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110767643|NCT01260558|Antifungal Agents|antifungal agents|mesh-ancestor
110767644|NCT01260558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110767645|NCT01260558|Immunologic Factors|immunologic factors|mesh-ancestor
110767646|NCT01260558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110767647|NCT01260558|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110767648|NCT01260558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110767649|NCT01260558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110767650|NCT01260714|Etoposide|etoposide|mesh-list
110767651|NCT01260714|Podophyllotoxin|podophyllotoxin|mesh-list
110767652|NCT01260714|Mitoxantrone|mitoxantrone|mesh-list
110767653|NCT01260714|Azacitidine|azacitidine|mesh-list
110767654|NCT01260714|Etoposide phosphate|etoposide phosphate|mesh-list
110767655|NCT01260714|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110767656|NCT01260714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110767657|NCT01260714|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110767658|NCT01260714|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110767659|NCT01260714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110767660|NCT01260714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110767661|NCT01260714|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110767662|NCT01260714|Antimetabolites|antimetabolites|mesh-ancestor
110767663|NCT01260714|Analgesics|analgesics|mesh-ancestor
110767664|NCT01260714|Sensory System Agents|sensory system agents|mesh-ancestor
110767665|NCT01260714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110767666|NCT01260714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110767667|NCT01260714|Keratolytic Agents|keratolytic agents|mesh-ancestor
110767668|NCT01260714|Dermatologic Agents|dermatologic agents|mesh-ancestor
110767669|NCT01260714|Tubulin Modulators|tubulin modulators|mesh-ancestor
110767670|NCT01260714|Antimitotic Agents|antimitotic agents|mesh-ancestor
110767671|NCT01260714|Mitosis Modulators|mitosis modulators|mesh-ancestor
110767672|NCT03890094|Sufentanil|sufentanil|mesh-list
110767673|NCT03890094|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110767674|NCT03890094|Narcotics|narcotics|mesh-ancestor
110767675|NCT03890094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110767676|NCT03890094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110767677|NCT03890094|Analgesics|analgesics|mesh-ancestor
110767678|NCT03890094|Sensory System Agents|sensory system agents|mesh-ancestor
110767679|NCT03890094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110767680|NCT03890094|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110767681|NCT03890094|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110767682|NCT03890094|Anesthetics, General|anesthetics, general|mesh-ancestor
110767683|NCT03890094|Anesthetics|anesthetics|mesh-ancestor
110767684|NCT03887754|Risperidone|risperidone|mesh-list
110767685|NCT03887754|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110767686|NCT03887754|Serotonin Agents|serotonin agents|mesh-ancestor
110767687|NCT03887754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110767688|NCT03887754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110767689|NCT03887754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110767690|NCT03887754|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110767691|NCT03887754|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110767692|NCT03887754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110767693|NCT03887754|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110767694|NCT03887754|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110767695|NCT03887754|Dopamine Agents|dopamine agents|mesh-ancestor
110767696|NCT03889470|Nitroglycerin|nitroglycerin|mesh-list
110767697|NCT03889470|Vasodilator Agents|vasodilator agents|mesh-ancestor
110767698|NCT01262586|Glimepiride|glimepiride|mesh-list
110767699|NCT01262586|Vildagliptin|vildagliptin|mesh-list
110767700|NCT01262586|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110767701|NCT01262586|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110767702|NCT01262586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110767703|NCT01262586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110767704|NCT01262586|Immunologic Factors|immunologic factors|mesh-ancestor
110332464|NCT00482573|Mydriatics|mydriatics|mesh-ancestor
110767705|NCT01262586|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110767706|NCT01262586|Protease Inhibitors|protease inhibitors|mesh-ancestor
110767707|NCT01262586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110767708|NCT01262586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110767709|NCT01157052|Capecitabine|capecitabine|mesh-list
110767710|NCT01157052|Oxaliplatin|oxaliplatin|mesh-list
110767711|NCT01157052|Calcium|calcium|mesh-list
110767712|NCT01157052|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110767713|NCT01157052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110767714|NCT01157052|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110767715|NCT01157052|Antimetabolites|antimetabolites|mesh-ancestor
110767716|NCT01157052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110767717|NCT01157052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110767718|NCT03887130|Paclitaxel|paclitaxel|mesh-list
110767719|NCT03887130|Vinorelbine|vinorelbine|mesh-list
110767720|NCT03887130|Docetaxel|docetaxel|mesh-list
110767721|NCT03887130|Gemcitabine|gemcitabine|mesh-list
110767722|NCT03887130|Capecitabine|capecitabine|mesh-list
110767723|NCT03887130|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110767724|NCT03887130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110767725|NCT03887130|Tubulin Modulators|tubulin modulators|mesh-ancestor
110767726|NCT03887130|Antimitotic Agents|antimitotic agents|mesh-ancestor
110767727|NCT03887130|Mitosis Modulators|mitosis modulators|mesh-ancestor
110767728|NCT03887130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110767729|NCT03887130|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110767730|NCT03887130|Antimetabolites|antimetabolites|mesh-ancestor
110767731|NCT01155960|Anastrozole|anastrozole|mesh-list
110767732|NCT01155960|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110767733|NCT01155960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110767734|NCT01155960|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110767735|NCT01155960|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110767736|NCT01155960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110767737|NCT01155960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110767738|NCT01155960|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110767739|NCT01155960|Hormone Antagonists|hormone antagonists|mesh-ancestor
110767740|NCT01155960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110767741|NCT01155960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110767742|NCT03883776|Octreotide|octreotide|mesh-list
110767743|NCT03883776|Al18F-NOTA-octreotide|al18f-nota-octreotide|mesh-list
110767744|NCT03883776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110767745|NCT03883776|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110767746|NCT03883776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110767747|NCT03883776|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110767748|NCT03883776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110767749|NCT03886896|Lidocaine|lidocaine|mesh-list
110767750|NCT03886896|Anesthetics, Local|anesthetics, local|mesh-ancestor
110767751|NCT03886896|Anesthetics|anesthetics|mesh-ancestor
110767752|NCT03886896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110767753|NCT03886896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110767754|NCT03886896|Sensory System Agents|sensory system agents|mesh-ancestor
110767755|NCT03886896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110767756|NCT03886896|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110767757|NCT03886896|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110767758|NCT03886896|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110767759|NCT03886896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110767760|NCT03886896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110767761|NCT03881904|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110767762|NCT03881904|Gestodene|gestodene|mesh-list
110767763|NCT03881904|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110767764|NCT03881904|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110767765|NCT03881904|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110767766|NCT03881904|Contraceptive Agents|contraceptive agents|mesh-ancestor
110767767|NCT03881904|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110767768|NCT03881904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110767769|NCT03881904|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110767770|NCT03881904|Estrogens|estrogens|mesh-ancestor
110767771|NCT03881904|Hormones|hormones|mesh-ancestor
110767772|NCT03881904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110767773|NCT03881904|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110767774|NCT03881904|Progestins|progestins|mesh-ancestor
110767775|NCT01262742|Carbetocin|carbetocin|mesh-list
110767776|NCT01262742|Oxytocin|oxytocin|mesh-list
110767777|NCT01262742|Oxytocics|oxytocics|mesh-ancestor
110767778|NCT01262742|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110767779|NCT01262742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110767780|NCT01261416|Levetiracetam|levetiracetam|mesh-list
110767781|NCT01261416|Anticonvulsants|anticonvulsants|mesh-ancestor
110767782|NCT01261416|Nootropic Agents|nootropic agents|mesh-ancestor
110767783|NCT03617172|Misoprostol|misoprostol|mesh-list
110767784|NCT03617172|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110767785|NCT03617172|Abortifacient Agents|abortifacient agents|mesh-ancestor
110767786|NCT03617172|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110767787|NCT03617172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110767788|NCT03617172|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110767789|NCT03617172|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110767790|NCT03617172|Oxytocics|oxytocics|mesh-ancestor
110767791|NCT01154790|Naproxen|naproxen|mesh-list
110767792|NCT01154790|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110767793|NCT01154790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110767794|NCT01154790|Analgesics|analgesics|mesh-ancestor
110767795|NCT01154790|Sensory System Agents|sensory system agents|mesh-ancestor
110767796|NCT01154790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110767797|NCT01154790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110767798|NCT01154790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110767799|NCT01154790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110767800|NCT01154790|Gout Suppressants|gout suppressants|mesh-ancestor
110767801|NCT01154790|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110767802|NCT01154790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110767803|NCT01154790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110767804|NCT03883698|Sofosbuvir|sofosbuvir|mesh-list
110767805|NCT03883698|Antiviral Agents|antiviral agents|mesh-ancestor
110767806|NCT03883698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110767807|NCT01263210|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110767808|NCT01263210|Immunologic Factors|immunologic factors|mesh-ancestor
110767809|NCT01263210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110767810|NCT01263288|Cholecalciferol|cholecalciferol|mesh-list
110767811|NCT01263288|Vitamin D|vitamin d|mesh-list
110767812|NCT01263288|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110767813|NCT01263288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110767814|NCT01263288|Vitamins|vitamins|mesh-ancestor
110767815|NCT01263288|Micronutrients|micronutrients|mesh-ancestor
110767816|NCT01263288|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110767817|NCT01263834|Bevacizumab|bevacizumab|mesh-list
110767818|NCT01263834|Mitomycins|mitomycins|mesh-list
110767819|NCT01263834|Mitomycin|mitomycin|mesh-list
110767820|NCT01263834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110767821|NCT01263834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110767822|NCT01263834|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110767823|NCT01263834|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110767824|NCT01263834|Growth Substances|growth substances|mesh-ancestor
110767825|NCT01263834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110767826|NCT01263834|Growth Inhibitors|growth inhibitors|mesh-ancestor
110767827|NCT01263834|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110767828|NCT01263834|Alkylating Agents|alkylating agents|mesh-ancestor
110767829|NCT01263834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110767830|NCT01263834|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110767831|NCT01263834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110767832|NCT01263366|Norepinephrine|norepinephrine|mesh-list
110767833|NCT01263366|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110767834|NCT01263366|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110767835|NCT01263366|Adrenergic Agents|adrenergic agents|mesh-ancestor
110767836|NCT01263366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110767837|NCT01263366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110767838|NCT01263366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110767839|NCT01263366|Sympathomimetics|sympathomimetics|mesh-ancestor
110767840|NCT01263366|Autonomic Agents|autonomic agents|mesh-ancestor
110767841|NCT01263366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110767842|NCT01263366|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110767843|NCT01155102|Anastrozole|anastrozole|mesh-list
110767844|NCT01155102|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110767845|NCT01155102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110767846|NCT01155102|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110767847|NCT01155102|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110767848|NCT01155102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110767849|NCT01155102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110767850|NCT01155102|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110767851|NCT01155102|Hormone Antagonists|hormone antagonists|mesh-ancestor
110767852|NCT01155102|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110767853|NCT01155102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110767854|NCT01156350|Fludarabine|fludarabine|mesh-list
110767855|NCT01156350|Busulfan|busulfan|mesh-list
110767856|NCT01156350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110767857|NCT01156350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110767858|NCT01156350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110767859|NCT01156350|Immunologic Factors|immunologic factors|mesh-ancestor
110767860|NCT01156350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110767861|NCT01156350|Alkylating Agents|alkylating agents|mesh-ancestor
110767862|NCT01156350|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110767863|NCT01156350|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110767864|NCT03886662|LB100|lb100|mesh-list
110767865|NCT03886662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110767866|NCT03886662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110767867|NCT03886662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110767868|NCT01155258|Sirolimus|sirolimus|mesh-list
110767869|NCT01155258|Vinorelbine|vinorelbine|mesh-list
110767870|NCT01155258|Temsirolimus|temsirolimus|mesh-list
110767871|NCT01155258|MTOR Inhibitors|mtor inhibitors|mesh-list
110767872|NCT01155258|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110767873|NCT01155258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110767874|NCT01155258|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110767875|NCT01155258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110767876|NCT01155258|Antifungal Agents|antifungal agents|mesh-ancestor
110767877|NCT01155258|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110767878|NCT01155258|Immunologic Factors|immunologic factors|mesh-ancestor
110767879|NCT01155258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110767880|NCT01155258|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110767881|NCT01155258|Tubulin Modulators|tubulin modulators|mesh-ancestor
110767882|NCT01155258|Antimitotic Agents|antimitotic agents|mesh-ancestor
110767883|NCT01155258|Mitosis Modulators|mitosis modulators|mesh-ancestor
110767884|NCT01155258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110767885|NCT01155258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110767886|NCT01155258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110767887|NCT01156584|Flucytosine|flucytosine|mesh-list
110767888|NCT01156584|Antifungal Agents|antifungal agents|mesh-ancestor
110767889|NCT01156584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110767890|NCT01156584|Antimetabolites|antimetabolites|mesh-ancestor
110332503|NCT04517526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110767891|NCT01156584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110767892|NCT03879174|Tamoxifen|tamoxifen|mesh-list
110767893|NCT03879174|Pembrolizumab|pembrolizumab|mesh-list
110767894|NCT03879174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110767895|NCT03879174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110767896|NCT03879174|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110767897|NCT03879174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110767898|NCT03879174|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110767899|NCT03879174|Hormone Antagonists|hormone antagonists|mesh-ancestor
110767900|NCT03879174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110767901|NCT03879174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110767902|NCT03879174|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110767903|NCT03879174|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110767904|NCT03879174|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110767905|NCT03879174|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110767906|NCT01159548|Promethazine|promethazine|mesh-list
110767907|NCT01159548|Diphenhydramine|diphenhydramine|mesh-list
110767908|NCT01159548|Antipruritics|antipruritics|mesh-ancestor
110767909|NCT01159548|Dermatologic Agents|dermatologic agents|mesh-ancestor
110767910|NCT01159548|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110485612|NCT04204772|Charcoal|charcoal|mesh-list
110767911|NCT01159548|Histamine Antagonists|histamine antagonists|mesh-ancestor
110767912|NCT01159548|Histamine Agents|histamine agents|mesh-ancestor
110767913|NCT01159548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110767914|NCT01159548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110767915|NCT01159548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110767916|NCT01159548|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110767917|NCT01159548|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110767918|NCT01159548|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110767919|NCT01159548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110767920|NCT01159548|Anesthetics, Local|anesthetics, local|mesh-ancestor
110767921|NCT01159548|Anesthetics|anesthetics|mesh-ancestor
110767922|NCT01159548|Sensory System Agents|sensory system agents|mesh-ancestor
110767923|NCT01159548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110767924|NCT01159548|Antiemetics|antiemetics|mesh-ancestor
110767925|NCT01159548|Autonomic Agents|autonomic agents|mesh-ancestor
110767926|NCT01159548|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110767927|NCT01156740|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110767928|NCT01156740|Amoxicillin|amoxicillin|mesh-list
110767929|NCT01156740|Penicillins|penicillins|mesh-list
110767930|NCT01156740|beta-Lactams|beta-lactams|mesh-list
110767931|NCT01156740|Penicillin G|penicillin g|mesh-list
110870037|NCT03731429|Lidocaine|lidocaine|mesh-list
110767932|NCT01156740|Penicillin G Benzathine|penicillin g benzathine|mesh-list
110767933|NCT01156740|Penicillin G Procaine|penicillin g procaine|mesh-list
110767934|NCT01156740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110767936|NCT03880968|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110767937|NCT03880968|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110767938|NCT03880968|Analgesics|analgesics|mesh-ancestor
110767939|NCT03880968|Sensory System Agents|sensory system agents|mesh-ancestor
110767940|NCT03880968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110767941|NCT03880968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110767942|NCT03880968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110767943|NCT03880968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110767944|NCT03880968|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110767945|NCT03880968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110767946|NCT03880968|Immunologic Factors|immunologic factors|mesh-ancestor
110767947|NCT03880734|Cholecalciferol|cholecalciferol|mesh-list
110767948|NCT03880734|Vitamin D|vitamin d|mesh-list
110767949|NCT03880734|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110767950|NCT03880734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110767951|NCT03880734|Vitamins|vitamins|mesh-ancestor
110767952|NCT03880734|Micronutrients|micronutrients|mesh-ancestor
110767953|NCT03880734|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110767954|NCT01157754|Levonorgestrel|levonorgestrel|mesh-list
110767955|NCT01157754|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110767956|NCT01157754|Contraceptive Agents|contraceptive agents|mesh-ancestor
110767957|NCT01157754|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110767958|NCT01157754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110767959|NCT01157754|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110767960|NCT01157754|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110767961|NCT01157754|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110767962|NCT01265940|Vinblastine|vinblastine|mesh-list
110767963|NCT01265940|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110767964|NCT01265940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110767965|NCT01265940|Tubulin Modulators|tubulin modulators|mesh-ancestor
110767966|NCT01265940|Antimitotic Agents|antimitotic agents|mesh-ancestor
110767967|NCT01265940|Mitosis Modulators|mitosis modulators|mesh-ancestor
110767968|NCT01265940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110767969|NCT01264302|Finasteride|finasteride|mesh-list
110767970|NCT01264302|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
110767971|NCT01264302|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110767972|NCT01264302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110767973|NCT01264302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110767974|NCT01264302|Hormone Antagonists|hormone antagonists|mesh-ancestor
110767975|NCT01264302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110767976|NCT01264302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110767977|NCT01264302|Urological Agents|urological agents|mesh-ancestor
110767978|NCT03760146|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110767979|NCT03760146|Immunologic Factors|immunologic factors|mesh-ancestor
110767980|NCT03760146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110767981|NCT01161654|Naratriptan|naratriptan|mesh-list
110767982|NCT01161654|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110767983|NCT01161654|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110485685|NCT02601040|Vaccines|vaccines|mesh-list
110767984|NCT01161654|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110767985|NCT01161654|Serotonin Agents|serotonin agents|mesh-ancestor
110767986|NCT01161654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110767987|NCT01161654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110767988|NCT01161654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110767989|NCT01266174|Eltoprazine|eltoprazine|mesh-list
110767990|NCT01266174|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110767991|NCT01266174|Serotonin Agents|serotonin agents|mesh-ancestor
110767992|NCT01266174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110767993|NCT01266174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110767994|NCT01266174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110767995|NCT01266252|Dexmedetomidine|dexmedetomidine|mesh-list
110767996|NCT01266252|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110767997|NCT01266252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110767998|NCT01266252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110767999|NCT01266252|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110768000|NCT01266252|Analgesics|analgesics|mesh-ancestor
110768001|NCT01266252|Sensory System Agents|sensory system agents|mesh-ancestor
110768002|NCT01266252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110768003|NCT01266252|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110768004|NCT01266252|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110768005|NCT01266252|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110768006|NCT01266252|Adrenergic Agents|adrenergic agents|mesh-ancestor
110768007|NCT01266252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110768008|NCT01266252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110768010|NCT01266486|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110768011|NCT01266486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110768012|NCT01161888|Imiquimod|imiquimod|mesh-list
110768013|NCT01161888|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110768014|NCT01161888|Immunologic Factors|immunologic factors|mesh-ancestor
110768015|NCT01161888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110768016|NCT01161888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110768017|NCT01161888|Interferon Inducers|interferon inducers|mesh-ancestor
110768018|NCT03760068|Insulin Aspart|insulin aspart|mesh-list
110768019|NCT03760068|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110768020|NCT03760068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110768021|NCT03759600|Niraparib|niraparib|mesh-list
110768022|NCT03759600|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110768023|NCT03759600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110768024|NCT03759600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110768025|NCT03759600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110768026|NCT01161966|Zonisamide|zonisamide|mesh-list
110768027|NCT01161966|Anticonvulsants|anticonvulsants|mesh-ancestor
110768028|NCT01161966|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110768029|NCT01161966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110768030|NCT01161966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110768031|NCT01161966|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110768032|NCT01161966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110768033|NCT01158144|Paclitaxel|paclitaxel|mesh-list
110768034|NCT01158144|Carboplatin|carboplatin|mesh-list
110768035|NCT01158144|Endostar protein|endostar protein|mesh-list
110768036|NCT01158144|Endostatins|endostatins|mesh-list
110768037|NCT01158144|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110768038|NCT01158144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110768039|NCT01158144|Tubulin Modulators|tubulin modulators|mesh-ancestor
110768040|NCT01158144|Antimitotic Agents|antimitotic agents|mesh-ancestor
110768041|NCT01158144|Mitosis Modulators|mitosis modulators|mesh-ancestor
110768042|NCT01158144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110768043|NCT01158144|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110768044|NCT01158144|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110768045|NCT01158144|Growth Substances|growth substances|mesh-ancestor
110768046|NCT01158144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110768047|NCT01158144|Growth Inhibitors|growth inhibitors|mesh-ancestor
110768048|NCT01264536|Lactoferrin|lactoferrin|mesh-list
110768049|NCT01264536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110768050|NCT01160172|Vaccines|vaccines|mesh-list
110768051|NCT01160172|Immunologic Factors|immunologic factors|mesh-ancestor
110768052|NCT01160172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110768054|NCT03878784|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110768055|NCT03878784|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110768056|NCT03878784|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110768057|NCT03878784|Serotonin Agents|serotonin agents|mesh-ancestor
110768058|NCT03878784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110768059|NCT03878784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110768060|NCT03878784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110768061|NCT01266720|Gemcitabine|gemcitabine|mesh-list
110768062|NCT01266720|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110768063|NCT01266720|Antimetabolites|antimetabolites|mesh-ancestor
110768064|NCT01266720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110768065|NCT01266720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110768066|NCT01589952|Interferons|interferons|mesh-list
110768067|NCT01589952|Entecavir|entecavir|mesh-list
110768068|NCT01589952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110768069|NCT01589952|Antiviral Agents|antiviral agents|mesh-ancestor
110768070|NCT01589952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110768071|NCT03876444|Methylprednisolone|methylprednisolone|mesh-list
110768072|NCT03876444|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110768073|NCT03876444|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110768074|NCT03876444|Prednisolone|prednisolone|mesh-list
110768075|NCT03876444|Prednisolone acetate|prednisolone acetate|mesh-list
110768076|NCT03876444|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110768077|NCT03876444|Prednisolone phosphate|prednisolone phosphate|mesh-list
110768078|NCT03876444|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110768079|NCT03876444|Antiemetics|antiemetics|mesh-ancestor
110768080|NCT03876444|Autonomic Agents|autonomic agents|mesh-ancestor
110768081|NCT03876444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110768082|NCT03876444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110768083|NCT03876444|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110768084|NCT03876444|Glucocorticoids|glucocorticoids|mesh-ancestor
110768085|NCT03876444|Hormones|hormones|mesh-ancestor
110768086|NCT03876444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110768087|NCT03876444|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110768088|NCT03876444|Protective Agents|protective agents|mesh-ancestor
110768089|NCT03876444|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110768090|NCT03876444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110768091|NCT01264692|Amlodipine|amlodipine|mesh-list
110768092|NCT01264692|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110768093|NCT01264692|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110768094|NCT01264692|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110768095|NCT01264692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110768096|NCT01264692|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110768097|NCT01264692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110768098|NCT01264692|Vasodilator Agents|vasodilator agents|mesh-ancestor
110768099|NCT01160328|Leuprolide|leuprolide|mesh-list
110768100|NCT01160328|Testosterone|testosterone|mesh-list
110768101|NCT01160328|Androgens|androgens|mesh-ancestor
110768102|NCT01160328|Hormones|hormones|mesh-ancestor
110768103|NCT01160328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110768104|NCT01160328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110768105|NCT01160328|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110768106|NCT01160328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110768107|NCT01160328|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110768108|NCT01160328|Fertility Agents|fertility agents|mesh-ancestor
110768109|NCT01160328|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110768110|NCT01162746|Dexamethasone|dexamethasone|mesh-list
110768111|NCT01162746|Ranibizumab|ranibizumab|mesh-list
110768112|NCT01162746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110768113|NCT01162746|Antiemetics|antiemetics|mesh-ancestor
110768114|NCT01162746|Autonomic Agents|autonomic agents|mesh-ancestor
110768115|NCT01162746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110768116|NCT01162746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110870066|NCT03735251|Metoprolol|metoprolol|mesh-list
110768117|NCT01162746|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110768118|NCT01162746|Glucocorticoids|glucocorticoids|mesh-ancestor
110768119|NCT01162746|Hormones|hormones|mesh-ancestor
110768120|NCT01162746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110768121|NCT01162746|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110768122|NCT01162746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110768123|NCT01162746|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110768124|NCT01162746|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110768125|NCT01162746|Growth Substances|growth substances|mesh-ancestor
110768126|NCT01162746|Growth Inhibitors|growth inhibitors|mesh-ancestor
110768127|NCT01268202|Pravastatin|pravastatin|mesh-list
110768128|NCT01268202|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110768129|NCT01268202|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110768130|NCT01268202|Antimetabolites|antimetabolites|mesh-ancestor
110768131|NCT01268202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110768132|NCT01268202|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110768133|NCT01268202|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110768134|NCT01268202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110768135|NCT01162824|Adenosine|adenosine|mesh-list
110768136|NCT01162824|Acetylcholine|acetylcholine|mesh-list
110768137|NCT01162824|Analgesics|analgesics|mesh-ancestor
110768138|NCT01162824|Sensory System Agents|sensory system agents|mesh-ancestor
110768139|NCT01162824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110768140|NCT01162824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110768141|NCT01162824|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110768142|NCT01162824|Vasodilator Agents|vasodilator agents|mesh-ancestor
110768143|NCT01162824|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
110768144|NCT01162824|Purinergic Agonists|purinergic agonists|mesh-ancestor
110768145|NCT01162824|Purinergic Agents|purinergic agents|mesh-ancestor
110768146|NCT01162824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110768147|NCT01162824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110768149|NCT01162824|Cholinergic Agents|cholinergic agents|mesh-ancestor
110768150|NCT01265004|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
110768151|NCT01265004|Hemostatics|hemostatics|mesh-ancestor
110768152|NCT01265004|Coagulants|coagulants|mesh-ancestor
110768153|NCT01162902|Candesartan|candesartan|mesh-list
110768154|NCT01162902|Candesartan cilexetil|candesartan cilexetil|mesh-list
110768155|NCT01162902|Bisoprolol|bisoprolol|mesh-list
110768156|NCT01162902|Diltiazem|diltiazem|mesh-list
110768157|NCT01162902|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110768158|NCT01162902|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110768159|NCT01162902|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110768160|NCT01162902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110768161|NCT01162902|Sympatholytics|sympatholytics|mesh-ancestor
110768162|NCT01162902|Autonomic Agents|autonomic agents|mesh-ancestor
110768163|NCT01162902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110768164|NCT01162902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110768165|NCT01162902|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110768166|NCT01162902|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110768167|NCT01162902|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110768168|NCT01162902|Adrenergic Agents|adrenergic agents|mesh-ancestor
110768169|NCT01162902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110768170|NCT01162902|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110768171|NCT01162902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110768172|NCT01162902|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110768173|NCT01162902|Vasodilator Agents|vasodilator agents|mesh-ancestor
110870077|NCT03735251|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110332589|NCT00483054|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110768174|NCT03877536|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110768175|NCT03877536|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110768176|NCT03877536|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110768177|NCT03877536|Antiviral Agents|antiviral agents|mesh-ancestor
110768178|NCT03877536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110768179|NCT02526888|Diltiazem|diltiazem|mesh-list
110768180|NCT02526888|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110768181|NCT02526888|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110768182|NCT02526888|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110768183|NCT02526888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110768184|NCT02526888|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110768185|NCT02526888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110768186|NCT02526888|Vasodilator Agents|vasodilator agents|mesh-ancestor
110768187|NCT01158612|Hormones|hormones|mesh-list
110768188|NCT01158612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110768189|NCT01158612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110768190|NCT03877692|Labetalol|labetalol|mesh-list
110768191|NCT03877692|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110768192|NCT03877692|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110768193|NCT03877692|Adrenergic Agents|adrenergic agents|mesh-ancestor
110768194|NCT03877692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110768195|NCT03877692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110768196|NCT03877692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110768197|NCT03877692|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110768198|NCT03877692|Sympathomimetics|sympathomimetics|mesh-ancestor
110768199|NCT03877692|Autonomic Agents|autonomic agents|mesh-ancestor
110768200|NCT03877692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110768201|NCT03877692|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110768202|NCT03877692|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110768203|NCT01158846|Bivalirudin|bivalirudin|mesh-list
110768204|NCT01158846|Abciximab|abciximab|mesh-list
110768205|NCT01158846|Clopidogrel|clopidogrel|mesh-list
110768206|NCT01158846|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
110485911|NCT05273775|Anesthetics|anesthetics|mesh-ancestor
110768207|NCT01158846|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110768208|NCT01158846|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110768209|NCT01158846|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110768210|NCT01158846|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110768211|NCT01158846|Purinergic Agents|purinergic agents|mesh-ancestor
110768212|NCT01158846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110768213|NCT01158846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110768214|NCT01158846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110768215|NCT01158846|Antithrombins|antithrombins|mesh-ancestor
110768216|NCT01158846|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110768217|NCT01158846|Protease Inhibitors|protease inhibitors|mesh-ancestor
110768218|NCT01158846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110768220|NCT01268670|Ibuprofen|ibuprofen|mesh-list
110768221|NCT01268670|Oxycodone|oxycodone|mesh-list
110768222|NCT01268670|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110768223|NCT01268670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110768224|NCT01268670|Analgesics|analgesics|mesh-ancestor
110768225|NCT01268670|Sensory System Agents|sensory system agents|mesh-ancestor
110768226|NCT01268670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110768227|NCT01268670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110768228|NCT01268670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110768229|NCT01268670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110768230|NCT01268670|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110768231|NCT01268670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110768232|NCT01268670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110768233|NCT01268670|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110768234|NCT01268670|Narcotics|narcotics|mesh-ancestor
110768235|NCT01268670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110768236|NCT01160718|Fulvestrant|fulvestrant|mesh-list
110768237|NCT01160718|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110768238|NCT01160718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110768239|NCT01160718|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110768240|NCT01160718|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110768241|NCT01160718|Hormone Antagonists|hormone antagonists|mesh-ancestor
110768242|NCT01160718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110768243|NCT01160718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110768244|NCT01159080|Mycophenolic Acid|mycophenolic acid|mesh-list
110768245|NCT01159080|Tacrolimus|tacrolimus|mesh-list
110768246|NCT01159080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110768247|NCT01159080|Immunologic Factors|immunologic factors|mesh-ancestor
110768248|NCT01159080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110768249|NCT01159080|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110768250|NCT01159080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110768251|NCT01159080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110768252|NCT01159080|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110768253|NCT01159080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110768254|NCT01159080|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110768255|NCT01159080|Antitubercular Agents|antitubercular agents|mesh-ancestor
110768256|NCT01159080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110768257|NCT01159080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110768258|NCT01160952|Itraconazole|itraconazole|mesh-list
110768259|NCT01160952|Antifungal Agents|antifungal agents|mesh-ancestor
110768260|NCT01160952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110768261|NCT01160952|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110768262|NCT01160952|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110768263|NCT01160952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110768264|NCT01160952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110768265|NCT01160952|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110768266|NCT01160952|Hormone Antagonists|hormone antagonists|mesh-ancestor
110768267|NCT01160952|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110768268|NCT01160952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110768269|NCT01160952|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110768270|NCT01159158|Nateglinide|nateglinide|mesh-list
110768271|NCT01159158|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110768272|NCT01159158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110768273|NCT01161108|Melatonin|melatonin|mesh-list
110768274|NCT01161108|Antioxidants|antioxidants|mesh-ancestor
110768275|NCT01161108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110332630|NCT01240941|Exemestane|exemestane|mesh-list
110768276|NCT01161108|Protective Agents|protective agents|mesh-ancestor
110768277|NCT01161108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110768278|NCT01161108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110768279|NCT01161186|Paclitaxel|paclitaxel|mesh-list
110768280|NCT01161186|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110768281|NCT01161186|Gemcitabine|gemcitabine|mesh-list
110768282|NCT01161186|Capecitabine|capecitabine|mesh-list
110768283|NCT01161186|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110768284|NCT01161186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110768285|NCT01161186|Tubulin Modulators|tubulin modulators|mesh-ancestor
110768286|NCT01161186|Antimitotic Agents|antimitotic agents|mesh-ancestor
110768287|NCT01161186|Mitosis Modulators|mitosis modulators|mesh-ancestor
110768288|NCT01161186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110768289|NCT01161186|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110768290|NCT01161186|Antimetabolites|antimetabolites|mesh-ancestor
110768291|NCT01159236|Paclitaxel|paclitaxel|mesh-list
110768292|NCT01159236|Cyclophosphamide|cyclophosphamide|mesh-list
110768293|NCT01159236|Bevacizumab|bevacizumab|mesh-list
110768294|NCT01159236|Doxorubicin|doxorubicin|mesh-list
110768295|NCT01159236|Fluorouracil|fluorouracil|mesh-list
110768296|NCT01159236|Epirubicin|epirubicin|mesh-list
110768297|NCT01159236|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110768298|NCT01159236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110768299|NCT01159236|Tubulin Modulators|tubulin modulators|mesh-ancestor
110768300|NCT01159236|Antimitotic Agents|antimitotic agents|mesh-ancestor
110768301|NCT01159236|Mitosis Modulators|mitosis modulators|mesh-ancestor
110768302|NCT01159236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110768303|NCT01159236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110768304|NCT01159236|Immunologic Factors|immunologic factors|mesh-ancestor
110768305|NCT01159236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110768306|NCT01159236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110768307|NCT01159236|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110768308|NCT01159236|Alkylating Agents|alkylating agents|mesh-ancestor
110768309|NCT01159236|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110768310|NCT01159236|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110768311|NCT01159236|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110768312|NCT01159236|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110768313|NCT01159236|Growth Substances|growth substances|mesh-ancestor
110768314|NCT01159236|Growth Inhibitors|growth inhibitors|mesh-ancestor
110870134|NCT05418660|Nivolumab|nivolumab|mesh-list
110768315|NCT01159236|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110768316|NCT01159236|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110768317|NCT01159236|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110768318|NCT01159236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110768319|NCT01159236|Antimetabolites|antimetabolites|mesh-ancestor
110768320|NCT01159236|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110768321|NCT01267344|Gemcitabine|gemcitabine|mesh-list
110768322|NCT01267344|Oxaliplatin|oxaliplatin|mesh-list
110768323|NCT01267344|Cetuximab|cetuximab|mesh-list
110768324|NCT01267344|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110768325|NCT01267344|Antimetabolites|antimetabolites|mesh-ancestor
110768326|NCT01267344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110768327|NCT01267344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110768328|NCT01267344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110768329|NCT03879564|Ketamine|ketamine|mesh-list
110768330|NCT03879564|Analgesics|analgesics|mesh-ancestor
110768331|NCT03879564|Sensory System Agents|sensory system agents|mesh-ancestor
110768332|NCT03879564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110768333|NCT03879564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110768334|NCT03879564|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110768335|NCT03879564|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110768336|NCT03879564|Anesthetics, General|anesthetics, general|mesh-ancestor
110768337|NCT03879564|Anesthetics|anesthetics|mesh-ancestor
110768338|NCT03879564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110768339|NCT03879564|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110768340|NCT03879564|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110768341|NCT03879564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110768342|NCT03879564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110768343|NCT01581840|Panitumumab|panitumumab|mesh-list
110768344|NCT01581840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110768345|NCT01581840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110768346|NCT03879486|Povidone-Iodine|povidone-iodine|mesh-list
110768347|NCT03879486|Formaldehyde|formaldehyde|mesh-list
110768348|NCT03879486|Povidone|povidone|mesh-list
110768349|NCT03879486|Plasma Substitutes|plasma substitutes|mesh-ancestor
110768350|NCT03879486|Blood Substitutes|blood substitutes|mesh-ancestor
110768351|NCT03879486|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110768352|NCT03879486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110768353|NCT03879486|Disinfectants|disinfectants|mesh-ancestor
110768354|NCT01269294|Moxifloxacin|moxifloxacin|mesh-list
110768355|NCT01269294|Simeprevir|simeprevir|mesh-list
110768356|NCT01269294|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
110768357|NCT01269294|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110768358|NCT01269294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110768359|NCT01269294|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110768360|NCT01269294|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110768361|NCT01269294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110768362|NCT01269294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110768363|NCT01269294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110768364|NCT01269294|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110768365|NCT01269294|Contraceptive Agents|contraceptive agents|mesh-ancestor
110768366|NCT01269294|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110768367|NCT01269294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110768368|NCT01269294|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110768369|NCT01269294|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110768370|NCT01269294|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110768371|NCT01269294|Antiviral Agents|antiviral agents|mesh-ancestor
110768372|NCT01269294|Protease Inhibitors|protease inhibitors|mesh-ancestor
110768373|NCT01163994|Doxycycline|doxycycline|mesh-list
110768374|NCT01163994|Ceftriaxone|ceftriaxone|mesh-list
110768375|NCT01163994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110768376|NCT01163994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110768377|NCT01163994|Antimalarials|antimalarials|mesh-ancestor
110768378|NCT01163994|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110768379|NCT01163994|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110768380|NCT01267734|Everolimus|everolimus|mesh-list
110768381|NCT01267734|Clopidogrel|clopidogrel|mesh-list
110768382|NCT01267734|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110768383|NCT01267734|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110768384|NCT01267734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110768385|NCT01267734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110768386|NCT01267734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110768387|NCT01267734|Immunologic Factors|immunologic factors|mesh-ancestor
110768388|NCT01267734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110768389|NCT01267734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110768390|NCT01267734|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110768391|NCT01267734|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110332662|NCT00482963|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110768392|NCT01267734|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110768393|NCT01267734|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110768394|NCT01267734|Purinergic Agents|purinergic agents|mesh-ancestor
110768395|NCT01267734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110768396|NCT01164306|Nicotine|nicotine|mesh-list
110768397|NCT01164306|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110768398|NCT01164306|Autonomic Agents|autonomic agents|mesh-ancestor
110768399|NCT01164306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110768400|NCT01164306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110768401|NCT01164306|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110768402|NCT01164306|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110768403|NCT01164306|Cholinergic Agents|cholinergic agents|mesh-ancestor
110768404|NCT01164306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110768405|NCT01164306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110768406|NCT01269450|Progesterone|progesterone|mesh-list
110768407|NCT01269450|Progestins|progestins|mesh-ancestor
110768408|NCT01269450|Hormones|hormones|mesh-ancestor
110768409|NCT01269450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110768410|NCT01269450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110768411|NCT01269528|Nitric Oxide|nitric oxide|mesh-list
110768412|NCT01269528|Methacholine Chloride|methacholine chloride|mesh-list
110768413|NCT01269528|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110768414|NCT01269528|Autonomic Agents|autonomic agents|mesh-ancestor
110768415|NCT01269528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110768416|NCT01269528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110768417|NCT01269528|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110768418|NCT01269528|Respiratory System Agents|respiratory system agents|mesh-ancestor
110768419|NCT01269528|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110768420|NCT01269528|Antioxidants|antioxidants|mesh-ancestor
110768421|NCT01269528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110768422|NCT01269528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110768423|NCT01269528|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
110768424|NCT01269528|Vasodilator Agents|vasodilator agents|mesh-ancestor
110768425|NCT01269528|Gasotransmitters|gasotransmitters|mesh-ancestor
110768426|NCT01269528|Protective Agents|protective agents|mesh-ancestor
110768427|NCT01269528|Miotics|miotics|mesh-ancestor
110768428|NCT01269528|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110768429|NCT01269528|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
110768430|NCT01269528|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
110768431|NCT01269528|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110768432|NCT01269528|Cholinergic Agents|cholinergic agents|mesh-ancestor
110768433|NCT01268904|Valproic Acid|valproic acid|mesh-list
110768434|NCT01268904|Anticonvulsants|anticonvulsants|mesh-ancestor
110768435|NCT01268904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110768436|NCT01268904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110768437|NCT01268904|GABA Agents|gaba agents|mesh-ancestor
110768438|NCT01268904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110445697|NCT02776540|Clopidogrel|clopidogrel|mesh-list
110768439|NCT01268904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110768440|NCT01268904|Antimanic Agents|antimanic agents|mesh-ancestor
110768441|NCT01268904|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110768442|NCT01268904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110768443|NCT01268904|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110768444|NCT01269606|Insulin|insulin|mesh-list
110768445|NCT01269606|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110768446|NCT01269606|Insulin Aspart|insulin aspart|mesh-list
110768447|NCT01269606|Insulin, Long-Acting|insulin, long-acting|mesh-list
110768448|NCT01269606|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
110768449|NCT01269606|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110768450|NCT01269606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110768451|NCT03872232|Telmisartan|telmisartan|mesh-list
110768452|NCT03872232|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110768453|NCT03872232|Ezetimibe|ezetimibe|mesh-list
110768454|NCT03872232|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110768455|NCT03872232|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110768456|NCT03872232|Antimetabolites|antimetabolites|mesh-ancestor
110768457|NCT03872232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110768458|NCT03872232|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110768459|NCT03872232|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110768460|NCT03872232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110768461|NCT03872232|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110768462|NCT03872232|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110768463|NCT03872232|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110768464|NCT01280214|Triamcinolone|triamcinolone|mesh-list
110768465|NCT01280214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110768466|NCT01280214|Glucocorticoids|glucocorticoids|mesh-ancestor
110768467|NCT01280214|Hormones|hormones|mesh-ancestor
110768468|NCT01280214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110768469|NCT01280214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110768470|NCT01165008|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
110768471|NCT01165008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110768472|NCT01164540|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110768473|NCT01164540|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110768474|NCT01164540|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110768475|NCT01164540|Antimetabolites|antimetabolites|mesh-ancestor
110768476|NCT01164540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110768477|NCT01164540|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110768478|NCT01164540|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110768479|NCT01164540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110768480|NCT01269684|Everolimus|everolimus|mesh-list
110768481|NCT01269684|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110768482|NCT01269684|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110768483|NCT01269684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110768484|NCT01269684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110768485|NCT01269684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110768486|NCT01269684|Immunologic Factors|immunologic factors|mesh-ancestor
110768487|NCT01269684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110768488|NCT01269684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110768489|NCT01165164|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110768490|NCT01165164|Lubricant Eye Drops|lubricant eye drops|mesh-list
110768491|NCT01165164|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110768493|NCT01280526|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110768494|NCT01280526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110768495|NCT01280526|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110768496|NCT01280526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110768497|NCT01280526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110768498|NCT01164774|Ramipril|ramipril|mesh-list
110768499|NCT01164774|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110768500|NCT01164774|Protease Inhibitors|protease inhibitors|mesh-ancestor
110768501|NCT01164774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110768502|NCT01164774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110768503|NCT01164774|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110768504|NCT01269138|Thrombin|thrombin|mesh-list
110768506|NCT01269138|Coagulants|coagulants|mesh-ancestor
110768507|NCT02526810|Insulin|insulin|mesh-list
110768508|NCT02526810|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110768509|NCT02526810|Insulin Glargine|insulin glargine|mesh-list
110768510|NCT02526810|Insulin Lispro|insulin lispro|mesh-list
110768511|NCT02526810|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110332688|NCT00483132|Interferons|interferons|mesh-list
110768512|NCT02526810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110768513|NCT01280682|Rituximab|rituximab|mesh-list
110768514|NCT01280682|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110768515|NCT01280682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110768516|NCT01280682|Immunologic Factors|immunologic factors|mesh-ancestor
110768517|NCT01280682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110768518|NCT01280682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110768519|NCT01269216|Leucovorin|leucovorin|mesh-list
110768520|NCT01269216|Irinotecan|irinotecan|mesh-list
110768521|NCT01269216|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110768522|NCT01269216|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110768523|NCT01269216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110768524|NCT01269216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110768525|NCT01269216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110768526|NCT01269216|Antidotes|antidotes|mesh-ancestor
110768527|NCT01269216|Protective Agents|protective agents|mesh-ancestor
110768528|NCT01269216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110768529|NCT01269216|Vitamin B Complex|vitamin b complex|mesh-ancestor
110768530|NCT01269216|Vitamins|vitamins|mesh-ancestor
110768531|NCT01269216|Micronutrients|micronutrients|mesh-ancestor
110768532|NCT03874806|Ropivacaine|ropivacaine|mesh-list
110768533|NCT03874806|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110768534|NCT03874806|Anesthetics, Local|anesthetics, local|mesh-ancestor
110768535|NCT03874806|Anesthetics|anesthetics|mesh-ancestor
110768536|NCT03874806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110768537|NCT03874806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110768538|NCT03874806|Sensory System Agents|sensory system agents|mesh-ancestor
110768539|NCT03874806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110768540|NCT01165476|Treprostinil|treprostinil|mesh-list
110768541|NCT01165476|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110768542|NCT01169922|Ethanol|ethanol|mesh-list
110768543|NCT01169922|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110768544|NCT01169922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110768545|NCT01169922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110768546|NCT01169922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110768547|NCT01283100|Dolutegravir|dolutegravir|mesh-list
110768548|NCT01283100|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110768549|NCT01283100|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110768550|NCT01283100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110768551|NCT01283100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110768552|NCT01283100|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110768553|NCT01283100|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110768554|NCT01283100|Antiviral Agents|antiviral agents|mesh-ancestor
110768555|NCT01283100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110768556|NCT01269996|Metformin|metformin|mesh-list
110768557|NCT01269996|Gliclazide|gliclazide|mesh-list
110768558|NCT01269996|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110768559|NCT01269996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110768560|NCT01283178|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110768561|NCT01283178|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110768562|NCT01283178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110768563|NCT01281150|Paclitaxel|paclitaxel|mesh-list
110768564|NCT01281150|Carboplatin|carboplatin|mesh-list
110768565|NCT01281150|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110768566|NCT01281150|Veliparib|veliparib|mesh-list
110768567|NCT01281150|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110768568|NCT01281150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110768569|NCT01281150|Tubulin Modulators|tubulin modulators|mesh-ancestor
110768570|NCT01281150|Antimitotic Agents|antimitotic agents|mesh-ancestor
110768571|NCT01281150|Mitosis Modulators|mitosis modulators|mesh-ancestor
110768572|NCT01281150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110768573|NCT01281150|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110768574|NCT01281150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110768575|NCT03871218|Hyaluronic Acid|hyaluronic acid|mesh-list
110768576|NCT03871218|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110768577|NCT03871218|Immunologic Factors|immunologic factors|mesh-ancestor
110768578|NCT03871218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110768579|NCT03871218|Viscosupplements|viscosupplements|mesh-ancestor
110768580|NCT03871218|Protective Agents|protective agents|mesh-ancestor
110768581|NCT01281228|Exenatide|exenatide|mesh-list
110768582|NCT01281228|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110768583|NCT01281228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110768584|NCT01281228|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110768585|NCT01281228|Incretins|incretins|mesh-ancestor
110768586|NCT01281228|Hormones|hormones|mesh-ancestor
110768587|NCT01281228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110768588|NCT01283256|Zonisamide|zonisamide|mesh-list
110768589|NCT01283256|Anticonvulsants|anticonvulsants|mesh-ancestor
110768590|NCT01283256|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110768591|NCT01283256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110768592|NCT01283256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110768593|NCT01283256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110768594|NCT01283256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110768595|NCT01270776|Chlorhexidine|chlorhexidine|mesh-list
110768596|NCT01270776|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110768597|NCT01270776|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110768598|NCT01270776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110768600|NCT01270776|Dermatologic Agents|dermatologic agents|mesh-ancestor
110768601|NCT03874260|Fenofibrate|fenofibrate|mesh-list
110768602|NCT03874260|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110768603|NCT03874260|Antimetabolites|antimetabolites|mesh-ancestor
110768604|NCT03874260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110768605|NCT03874260|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110768607|NCT01281540|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110768608|NCT01281540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110768609|NCT01281540|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110768610|NCT01281540|Serotonin Agents|serotonin agents|mesh-ancestor
110768611|NCT01281540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110768612|NCT01281540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110768613|NCT01281540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110768614|NCT03874026|Cetuximab|cetuximab|mesh-list
110768615|NCT03874026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110768616|NCT03874026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110768617|NCT01283412|Dexmedetomidine|dexmedetomidine|mesh-list
110768618|NCT01283412|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110768619|NCT01283412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110768620|NCT01283412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110768621|NCT01283412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110768622|NCT01283412|Analgesics|analgesics|mesh-ancestor
110768623|NCT01283412|Sensory System Agents|sensory system agents|mesh-ancestor
110768624|NCT01283412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110768625|NCT01283412|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110768626|NCT01283412|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110768627|NCT01283412|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110768628|NCT01283412|Adrenergic Agents|adrenergic agents|mesh-ancestor
110768629|NCT01283412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110768630|NCT01283412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110768631|NCT01271478|Telmisartan|telmisartan|mesh-list
110768632|NCT01271478|Captopril|captopril|mesh-list
110768633|NCT01271478|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110768634|NCT01271478|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110768635|NCT01271478|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110768636|NCT01271478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110768637|NCT01271478|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110768638|NCT01271478|Protease Inhibitors|protease inhibitors|mesh-ancestor
110768639|NCT01271478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110768640|NCT03871062|Anesthetics|anesthetics|mesh-list
110768641|NCT03871062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110768642|NCT03871062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110768643|NCT01281696|Bevacizumab|bevacizumab|mesh-list
110768644|NCT01281696|Methotrexate|methotrexate|mesh-list
110768645|NCT01281696|Etoposide|etoposide|mesh-list
110768646|NCT01281696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110768647|NCT01281696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110768648|NCT01281696|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110768649|NCT01281696|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110768650|NCT01281696|Growth Substances|growth substances|mesh-ancestor
110768651|NCT01281696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110768652|NCT01281696|Growth Inhibitors|growth inhibitors|mesh-ancestor
110768653|NCT01281696|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110768654|NCT01281696|Abortifacient Agents|abortifacient agents|mesh-ancestor
110768655|NCT01281696|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110486356|NCT04837209|Niraparib|niraparib|mesh-list
110768656|NCT01281696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110768658|NCT01281696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110768659|NCT01281696|Dermatologic Agents|dermatologic agents|mesh-ancestor
110768660|NCT01281696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110768661|NCT01281696|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110768662|NCT01281696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110768664|NCT01281696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110768665|NCT01281696|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110768666|NCT01281696|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110768667|NCT01281696|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110768668|NCT01281696|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110768669|NCT05835713|Propofol|propofol|mesh-list
110768670|NCT05835713|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110768671|NCT05835713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110768672|NCT05835713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110768673|NCT05835713|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110768674|NCT05835713|Anesthetics, General|anesthetics, general|mesh-ancestor
110768675|NCT05835713|Anesthetics|anesthetics|mesh-ancestor
110768676|NCT05835479|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
110768677|NCT05835479|Rezafungin|rezafungin|mesh-list
110768678|NCT05835479|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110768679|NCT05835479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110768680|NCT05835479|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110768681|NCT05835479|Antimalarials|antimalarials|mesh-ancestor
110768682|NCT05835479|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110768683|NCT05835479|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110768684|NCT05835479|Antifungal Agents|antifungal agents|mesh-ancestor
110768685|NCT05835089|Estradiol|estradiol|mesh-list
110768686|NCT05835089|Testosterone|testosterone|mesh-list
110768687|NCT05835089|Estrogens|estrogens|mesh-ancestor
110768688|NCT05835089|Hormones|hormones|mesh-ancestor
110768689|NCT05835089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110768690|NCT05835089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110768691|NCT05835089|Androgens|androgens|mesh-ancestor
110768692|NCT05834868|Insulin Lispro|insulin lispro|mesh-list
110768693|NCT05834868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110768694|NCT05834868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110768695|NCT05834855|Rituximab|rituximab|mesh-list
110768696|NCT05834855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110768697|NCT05834855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110768698|NCT05834855|Immunologic Factors|immunologic factors|mesh-ancestor
110768699|NCT05834855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110768700|NCT05834855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110768701|NCT05834764|Maleic acid|maleic acid|mesh-list
110768702|NCT05834764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110768703|NCT05834764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110768704|NCT05834647|Lidocaine|lidocaine|mesh-list
110768705|NCT05834647|Prilocaine|prilocaine|mesh-list
110768706|NCT05834647|Anesthetics, Local|anesthetics, local|mesh-ancestor
110768707|NCT05834647|Anesthetics|anesthetics|mesh-ancestor
110768708|NCT05834647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110768709|NCT05834647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110768710|NCT05834647|Sensory System Agents|sensory system agents|mesh-ancestor
110768711|NCT05834647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110768712|NCT05834647|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110768713|NCT05834647|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110768714|NCT05834647|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110768715|NCT05834647|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110768716|NCT05834647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110768717|NCT05834582|Paclitaxel|paclitaxel|mesh-list
110768718|NCT05834582|Cyclophosphamide|cyclophosphamide|mesh-list
110768719|NCT05834582|Epirubicin|epirubicin|mesh-list
110768720|NCT05834582|Fluzoparib|fluzoparib|mesh-list
110768721|NCT05834582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110768722|NCT05834582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110768723|NCT05834582|Tubulin Modulators|tubulin modulators|mesh-ancestor
110768724|NCT05834582|Antimitotic Agents|antimitotic agents|mesh-ancestor
110768725|NCT05834582|Mitosis Modulators|mitosis modulators|mesh-ancestor
110768726|NCT05834582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110067602|NCT01544972|Ibuprofen|ibuprofen|mesh-list
110768727|NCT05834582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110768728|NCT05834582|Immunologic Factors|immunologic factors|mesh-ancestor
110768729|NCT05834582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110768730|NCT05834582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110768731|NCT05834582|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110768732|NCT05834582|Alkylating Agents|alkylating agents|mesh-ancestor
110768733|NCT05834582|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110768734|NCT05834582|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110768735|NCT05834582|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110768737|NCT05834582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110768738|NCT05834582|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110768740|NCT05834543|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110768741|NCT05834543|Cisplatin|cisplatin|mesh-list
110768742|NCT05834543|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110768743|NCT05834543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110768744|NCT05834543|Tubulin Modulators|tubulin modulators|mesh-ancestor
110768745|NCT05834543|Antimitotic Agents|antimitotic agents|mesh-ancestor
110768746|NCT05834543|Mitosis Modulators|mitosis modulators|mesh-ancestor
110768747|NCT05834543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110768748|NCT05834517|Hyaluronic Acid|hyaluronic acid|mesh-list
110768749|NCT05834517|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110768750|NCT05834517|Immunologic Factors|immunologic factors|mesh-ancestor
110768751|NCT05834517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110768752|NCT05834517|Viscosupplements|viscosupplements|mesh-ancestor
110768753|NCT05834517|Protective Agents|protective agents|mesh-ancestor
110768754|NCT05834478|Fallypride|fallypride|mesh-list
110768755|NCT05834478|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110768756|NCT05834478|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110768757|NCT05834478|Dopamine Agents|dopamine agents|mesh-ancestor
110768758|NCT05834478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110768759|NCT05834478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110768760|NCT05834478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110768761|NCT05834361|Carboprost|carboprost|mesh-list
110768762|NCT05834361|Carboprost tromethamine|carboprost tromethamine|mesh-list
110768763|NCT05834361|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110768764|NCT05834361|Abortifacient Agents|abortifacient agents|mesh-ancestor
110768765|NCT05834361|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110768766|NCT05834361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110768767|NCT05834361|Oxytocics|oxytocics|mesh-ancestor
110768768|NCT05834348|Docetaxel|docetaxel|mesh-list
110768769|NCT05834348|Bevacizumab|bevacizumab|mesh-list
110768770|NCT05834348|Carboplatin|carboplatin|mesh-list
110768771|NCT05834348|Pembrolizumab|pembrolizumab|mesh-list
110768772|NCT05834348|Nivolumab|nivolumab|mesh-list
110768773|NCT05834348|Atezolizumab|atezolizumab|mesh-list
110768774|NCT05834348|Gefitinib|gefitinib|mesh-list
110768775|NCT05834348|Osimertinib|osimertinib|mesh-list
110768776|NCT05834348|Afatinib|afatinib|mesh-list
110768777|NCT05834348|Crizotinib|crizotinib|mesh-list
110768778|NCT05834348|Ceritinib|ceritinib|mesh-list
110768779|NCT05834348|Entrectinib|entrectinib|mesh-list
110768780|NCT05834348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110768781|NCT05834348|Tubulin Modulators|tubulin modulators|mesh-ancestor
110768782|NCT05834348|Antimitotic Agents|antimitotic agents|mesh-ancestor
110768783|NCT05834348|Mitosis Modulators|mitosis modulators|mesh-ancestor
110768784|NCT05834348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110768785|NCT05834348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110768786|NCT05834348|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110768787|NCT05834348|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110768788|NCT05834348|Growth Substances|growth substances|mesh-ancestor
110768789|NCT05834348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110768790|NCT05834348|Growth Inhibitors|growth inhibitors|mesh-ancestor
110768791|NCT05834348|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110768792|NCT05834348|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110768793|NCT05834348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110768794|NCT05834270|Tamsulosin|tamsulosin|mesh-list
110768795|NCT05834270|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110768796|NCT05834270|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110768797|NCT05834270|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110768798|NCT05834270|Adrenergic Agents|adrenergic agents|mesh-ancestor
110768799|NCT05834270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110768800|NCT05834270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110768801|NCT05834270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110768802|NCT05834270|Urological Agents|urological agents|mesh-ancestor
110768803|NCT05834244|Azacitidine|azacitidine|mesh-list
110768804|NCT05834244|Venetoclax|venetoclax|mesh-list
110768805|NCT05834244|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110768806|NCT05834244|Antimetabolites|antimetabolites|mesh-ancestor
110768807|NCT05834244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110768808|NCT05834244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110768809|NCT05834244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110768811|NCT05834231|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110768812|NCT05834231|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110768813|NCT05834231|Dopamine Agents|dopamine agents|mesh-ancestor
110768814|NCT05834231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110768815|NCT05834231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110768816|NCT05834231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110768817|NCT05834231|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110768818|NCT05834231|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110768820|NCT05833958|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110768821|NCT05833958|Dapagliflozin|dapagliflozin|mesh-list
110768822|NCT05833958|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110768823|NCT05833958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110768824|NCT05833958|Incretins|incretins|mesh-ancestor
110768825|NCT05833958|Hormones|hormones|mesh-ancestor
110768826|NCT05833958|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110768827|NCT05833958|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110768828|NCT05833958|Protease Inhibitors|protease inhibitors|mesh-ancestor
110768829|NCT05833958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110768830|NCT05833958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110768831|NCT05833958|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110768832|NCT05830162|Amoxicillin|amoxicillin|mesh-list
110768833|NCT05830162|Clavulanic Acids|clavulanic acids|mesh-list
110768834|NCT05830162|Clavulanic Acid|clavulanic acid|mesh-list
110768835|NCT05830162|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110768836|NCT05830162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110768837|NCT05830162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110768838|NCT05830162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110768839|NCT05830162|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110768840|NCT05829707|Diclofenac|diclofenac|mesh-list
110768841|NCT05829707|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
110768842|NCT05829707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
110768843|NCT05829707|Anesthetics|anesthetics|mesh-list
110768844|NCT05829707|Levobupivacaine|levobupivacaine|mesh-list
110768845|NCT05829707|Anesthetics, Local|anesthetics, local|mesh-list
110768846|NCT05829707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110768847|NCT05829707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110768848|NCT05829707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110768849|NCT05829707|Analgesics|analgesics|mesh-ancestor
110768850|NCT05829707|Sensory System Agents|sensory system agents|mesh-ancestor
110768851|NCT05829707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110768852|NCT05829707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110768853|NCT05829707|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110768854|NCT05829707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110768855|NCT05829707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110768856|NCT05823948|Insulin|insulin|mesh-list
110768857|NCT05823948|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110768858|NCT05823948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110768860|NCT05819918|Vitamins|vitamins|mesh-ancestor
110768861|NCT05819918|Micronutrients|micronutrients|mesh-ancestor
110768862|NCT05819918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110768863|NCT05819918|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110768864|NCT05810883|Insulin|insulin|mesh-list
110768865|NCT05810883|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110768866|NCT05810883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110768867|NCT05807074|Tranexamic Acid|tranexamic acid|mesh-list
110768868|NCT05807074|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110768869|NCT05807074|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110768870|NCT05807074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110768871|NCT05807074|Hemostatics|hemostatics|mesh-ancestor
110768872|NCT05807074|Coagulants|coagulants|mesh-ancestor
110768873|NCT05789303|Dexamethasone|dexamethasone|mesh-list
110768874|NCT05789303|Pomalidomide|pomalidomide|mesh-list
110768875|NCT05789303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110768876|NCT05789303|Antiemetics|antiemetics|mesh-ancestor
110768877|NCT05789303|Autonomic Agents|autonomic agents|mesh-ancestor
110768878|NCT05789303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110768879|NCT05789303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110768880|NCT05789303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110768881|NCT05789303|Glucocorticoids|glucocorticoids|mesh-ancestor
110486582|NCT02655471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110768882|NCT05789303|Hormones|hormones|mesh-ancestor
110768883|NCT05789303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110332790|NCT00483795|Citric Acid|citric acid|mesh-list
110768884|NCT05789303|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110768886|NCT05789303|Immunologic Factors|immunologic factors|mesh-ancestor
110768887|NCT05789303|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110093967|NCT01705808|Protein C|protein c|mesh-list
110768888|NCT05789303|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110768889|NCT05789303|Growth Substances|growth substances|mesh-ancestor
110768890|NCT05789303|Growth Inhibitors|growth inhibitors|mesh-ancestor
110768891|NCT05772273|Azacitidine|azacitidine|mesh-list
110768892|NCT05772273|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110768893|NCT05772273|Antimetabolites|antimetabolites|mesh-ancestor
110768894|NCT05772273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110768895|NCT05772273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110768896|NCT05772273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110768897|NCT05753098|Sildenafil Citrate|sildenafil citrate|mesh-list
110768899|NCT05753098|Enclomiphene|enclomiphene|mesh-list
110768900|NCT05753098|Zuclomiphene|zuclomiphene|mesh-list
110768901|NCT05753098|Estrogens|estrogens|mesh-list
110768902|NCT05753098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110768903|NCT05753098|Vasodilator Agents|vasodilator agents|mesh-ancestor
110768904|NCT05753098|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110768905|NCT05753098|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110768906|NCT05753098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110768907|NCT05753098|Urological Agents|urological agents|mesh-ancestor
110768908|NCT05753098|Hormones|hormones|mesh-ancestor
110768909|NCT05753098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110768910|NCT05753098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110768911|NCT05753098|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110768912|NCT05753098|Hormone Antagonists|hormone antagonists|mesh-ancestor
110768913|NCT05753098|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110768914|NCT05753098|Fertility Agents|fertility agents|mesh-ancestor
110768915|NCT05753098|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110768916|NCT05753098|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110768917|NCT05753098|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110768918|NCT05726292|Androgens|androgens|mesh-list
110768919|NCT05726292|Hormones|hormones|mesh-ancestor
110768920|NCT05726292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110768921|NCT05726292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110768922|NCT05699811|Paclitaxel|paclitaxel|mesh-list
110768923|NCT05699811|Cyclophosphamide|cyclophosphamide|mesh-list
110768924|NCT05699811|Tislelizumab|tislelizumab|mesh-list
110768925|NCT05699811|Antibodies|antibodies|mesh-list
110768927|NCT05699811|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110768928|NCT05699811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110768929|NCT05699811|Tubulin Modulators|tubulin modulators|mesh-ancestor
110768930|NCT05699811|Antimitotic Agents|antimitotic agents|mesh-ancestor
110768931|NCT05699811|Mitosis Modulators|mitosis modulators|mesh-ancestor
110768932|NCT05699811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110768933|NCT05699811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110768934|NCT05699811|Immunologic Factors|immunologic factors|mesh-ancestor
110768935|NCT05699811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110768936|NCT05699811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110768937|NCT05699811|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110768938|NCT05699811|Alkylating Agents|alkylating agents|mesh-ancestor
110768939|NCT05699811|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110768940|NCT05699811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110768941|NCT05692908|Immunoconjugates|immunoconjugates|mesh-list
110768942|NCT05692908|Immunologic Factors|immunologic factors|mesh-ancestor
110332797|NCT05644210|Aspirin|aspirin|mesh-list
110768943|NCT05692908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110768944|NCT05692843|Cyclosporine|cyclosporine|mesh-list
110768945|NCT05692843|Cyclosporins|cyclosporins|mesh-list
110768946|NCT05692843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110768947|NCT05692843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110768948|NCT05692843|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110768949|NCT05692843|Immunologic Factors|immunologic factors|mesh-ancestor
110768950|NCT05692843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110768951|NCT05692843|Antifungal Agents|antifungal agents|mesh-ancestor
110768952|NCT05692843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110768953|NCT05692843|Dermatologic Agents|dermatologic agents|mesh-ancestor
110768954|NCT05692843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110768955|NCT05692843|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110768956|NCT05662865|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
110768957|NCT05662865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110768959|NCT05662865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110768960|NCT05660616|Gemcitabine|gemcitabine|mesh-list
110768961|NCT05660616|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110768962|NCT05660616|Antimetabolites|antimetabolites|mesh-ancestor
110768963|NCT05660616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110768964|NCT05660616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110768965|NCT05659810|Gabapentin|gabapentin|mesh-list
110768966|NCT05659810|Analgesics|analgesics|mesh-ancestor
110768967|NCT05659810|Sensory System Agents|sensory system agents|mesh-ancestor
110768968|NCT05659810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110768969|NCT05659810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110768970|NCT05659810|Anticonvulsants|anticonvulsants|mesh-ancestor
110768971|NCT05659810|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110768972|NCT05659810|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110768973|NCT05659810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110768974|NCT05659810|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110768975|NCT05659810|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110768976|NCT05659810|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110768977|NCT05659810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110768978|NCT05659810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110768979|NCT05659810|Antimanic Agents|antimanic agents|mesh-ancestor
110768980|NCT05658497|Interferons|interferons|mesh-list
110768981|NCT05658497|Interferon-beta|interferon-beta|mesh-list
110768982|NCT05658497|Interferon beta-1a|interferon beta-1a|mesh-list
110768983|NCT05658497|Dimethyl Fumarate|dimethyl fumarate|mesh-list
110768984|NCT05658497|Natalizumab|natalizumab|mesh-list
110768985|NCT05658497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110768986|NCT05658497|Antiviral Agents|antiviral agents|mesh-ancestor
110768987|NCT05658497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110768988|NCT05658497|Immunologic Factors|immunologic factors|mesh-ancestor
110768989|NCT05658497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110768990|NCT05658497|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110768991|NCT05658497|Dermatologic Agents|dermatologic agents|mesh-ancestor
110768992|NCT05658497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110768993|NCT05645757|Ertapenem|ertapenem|mesh-list
110768994|NCT05645757|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110768995|NCT05645757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110768996|NCT05625347|Aspirin|aspirin|mesh-list
110768997|NCT05625347|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110768998|NCT05625347|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110768999|NCT05625347|Analgesics|analgesics|mesh-ancestor
110769000|NCT05625347|Sensory System Agents|sensory system agents|mesh-ancestor
110769001|NCT05625347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110769002|NCT05625347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110769003|NCT05625347|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110332814|NCT05644210|Analgesics|analgesics|mesh-ancestor
110769004|NCT05625347|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110769005|NCT05625347|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110769006|NCT05625347|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110769007|NCT05625347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110769008|NCT05625347|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110769009|NCT05625347|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110769010|NCT05625347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110769011|NCT05625347|Antipyretics|antipyretics|mesh-ancestor
110769012|NCT05619913|Pembrolizumab|pembrolizumab|mesh-list
110769013|NCT05619913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110769014|NCT05619913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110769015|NCT05619913|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110769016|NCT05619913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110769017|NCT05594680|Methotrexate|methotrexate|mesh-list
110769018|NCT05594680|Cilostazol|cilostazol|mesh-list
110769019|NCT05594680|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110769020|NCT05594680|Abortifacient Agents|abortifacient agents|mesh-ancestor
110769021|NCT05594680|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110769022|NCT05594680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110769023|NCT05594680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110769024|NCT05594680|Antimetabolites|antimetabolites|mesh-ancestor
110769025|NCT05594680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110769026|NCT05594680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110769027|NCT05594680|Dermatologic Agents|dermatologic agents|mesh-ancestor
110769028|NCT05594680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110486731|NCT00650247|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110769029|NCT05594680|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110769030|NCT05594680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110769031|NCT05594680|Immunologic Factors|immunologic factors|mesh-ancestor
110769032|NCT05594680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110769033|NCT05594680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110769034|NCT05594680|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110769035|NCT05594680|Autonomic Agents|autonomic agents|mesh-ancestor
110769036|NCT05594680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110769037|NCT05594680|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110769038|NCT05594680|Respiratory System Agents|respiratory system agents|mesh-ancestor
110769039|NCT05594680|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110769040|NCT05594680|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110769041|NCT05594680|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110769042|NCT05594680|Vasodilator Agents|vasodilator agents|mesh-ancestor
110769043|NCT05594680|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110769044|NCT05594680|Protective Agents|protective agents|mesh-ancestor
110769045|NCT05594680|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110769046|NCT05594680|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110769047|NCT05567029|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110769048|NCT05567029|Immunologic Factors|immunologic factors|mesh-ancestor
110769049|NCT05567029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110769050|NCT05557643|Psilocybin|psilocybin|mesh-list
110769051|NCT05557643|Hallucinogens|hallucinogens|mesh-ancestor
110769052|NCT05557643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110769053|NCT05557643|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110769054|NCT05526443|Antineoplastic Agents|antineoplastic agents|mesh-list
110769055|NCT05325593|Dexamethasone|dexamethasone|mesh-list
110769056|NCT05325593|Dexamethasone acetate|dexamethasone acetate|mesh-list
110769057|NCT05325593|BB 1101|bb 1101|mesh-list
110769058|NCT05325593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110769059|NCT05325593|Antiemetics|antiemetics|mesh-ancestor
110769060|NCT05325593|Autonomic Agents|autonomic agents|mesh-ancestor
110769061|NCT05325593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110769062|NCT05325593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110769063|NCT05325593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110769064|NCT05325593|Glucocorticoids|glucocorticoids|mesh-ancestor
110769065|NCT05325593|Hormones|hormones|mesh-ancestor
110769066|NCT05325593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110769067|NCT05325593|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110769068|NCT05325593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110769069|NCT05325593|Protease Inhibitors|protease inhibitors|mesh-ancestor
110769070|NCT05325593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110769071|NCT05325593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110769072|NCT05322967|Antihypertensive Agents|antihypertensive agents|mesh-list
110769073|NCT05321121|Dexmedetomidine|dexmedetomidine|mesh-list
110769074|NCT05321121|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110769075|NCT05321121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110769076|NCT05321121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110769077|NCT05321121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110769078|NCT05321121|Analgesics|analgesics|mesh-ancestor
110769079|NCT05321121|Sensory System Agents|sensory system agents|mesh-ancestor
110769080|NCT05321121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110769081|NCT05321121|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110769082|NCT05321121|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110769083|NCT05321121|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110769084|NCT05321121|Adrenergic Agents|adrenergic agents|mesh-ancestor
110769085|NCT05321121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110769086|NCT05321121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110769087|NCT05310734|Benzyl Alcohol|benzyl alcohol|mesh-list
110769088|NCT05310734|Anesthetics, Local|anesthetics, local|mesh-ancestor
110769089|NCT05310734|Anesthetics|anesthetics|mesh-ancestor
110769090|NCT05310734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110769091|NCT05310734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110769092|NCT05310734|Sensory System Agents|sensory system agents|mesh-ancestor
110769093|NCT05310734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110769095|NCT05284552|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
110769096|NCT05284552|Dalteparin|dalteparin|mesh-list
110769097|NCT05284552|Anticoagulants|anticoagulants|mesh-ancestor
110769098|NCT05284552|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110769099|NCT05284552|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110769100|NCT05284552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110769101|NCT05281614|Etanercept|etanercept|mesh-list
110769102|NCT05281614|Vedolizumab|vedolizumab|mesh-list
110769103|NCT05281614|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110769104|NCT05281614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110769105|NCT05281614|Analgesics|analgesics|mesh-ancestor
110769106|NCT05281614|Sensory System Agents|sensory system agents|mesh-ancestor
110769107|NCT05281614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110769108|NCT05281614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110769109|NCT05281614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110769110|NCT05281614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110769111|NCT05281614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110769112|NCT05281614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110769113|NCT05281614|Immunologic Factors|immunologic factors|mesh-ancestor
110769114|NCT05228288|Pyrithione zinc|pyrithione zinc|mesh-list
110769115|NCT05228288|Keratolytic Agents|keratolytic agents|mesh-ancestor
110769116|NCT05228288|Dermatologic Agents|dermatologic agents|mesh-ancestor
110769117|NCT05215574|Pembrolizumab|pembrolizumab|mesh-list
110769118|NCT05215574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110769119|NCT05215574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110769120|NCT05215574|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110769121|NCT05215574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110769122|NCT05041153|Pembrolizumab|pembrolizumab|mesh-list
110769123|NCT05041153|Lenvatinib|lenvatinib|mesh-list
110769124|NCT05041153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110769125|NCT05041153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110769126|NCT05041153|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110769127|NCT05041153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110769128|NCT05041153|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110769129|NCT05041153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110769130|NCT04955938|Ivosidenib|ivosidenib|mesh-list
110769131|NCT04955938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110769132|NCT04955938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110769133|NCT04955938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110769134|NCT04879589|Abiraterone Acetate|abiraterone acetate|mesh-list
110769135|NCT04879589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110769136|NCT04879589|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110769137|NCT04879589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110769138|NCT04879589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110769139|NCT04879589|Hormone Antagonists|hormone antagonists|mesh-ancestor
110769140|NCT04879589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110769141|NCT04879589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110769142|NCT04879589|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110769143|NCT04872608|Letrozole|letrozole|mesh-list
110769144|NCT04872608|Palbociclib|palbociclib|mesh-list
110769145|NCT04872608|Onapristone|onapristone|mesh-list
110769146|NCT04872608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110769147|NCT04872608|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110769148|NCT04872608|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110769149|NCT04872608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110769150|NCT04872608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110769151|NCT04872608|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110769152|NCT04872608|Hormone Antagonists|hormone antagonists|mesh-ancestor
110769153|NCT04872608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110769154|NCT04872608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110769155|NCT04872608|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110769156|NCT04872608|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110769157|NCT04872608|Fertility Agents|fertility agents|mesh-ancestor
110769158|NCT04872608|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110769160|NCT04869501|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110769161|NCT04869501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110769162|NCT04869501|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110769163|NCT04869501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110769164|NCT04831398|Melatonin|melatonin|mesh-list
110769165|NCT04831398|Antioxidants|antioxidants|mesh-ancestor
110769166|NCT04831398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110769167|NCT04831398|Protective Agents|protective agents|mesh-ancestor
110769168|NCT04831398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110769169|NCT04831398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110769170|NCT04826484|Bupivacaine|bupivacaine|mesh-list
110769171|NCT04826484|Anesthetics, Local|anesthetics, local|mesh-ancestor
110769172|NCT04826484|Anesthetics|anesthetics|mesh-ancestor
110769173|NCT04826484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110769174|NCT04826484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110769175|NCT04826484|Sensory System Agents|sensory system agents|mesh-ancestor
110769176|NCT04826484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110769177|NCT04801849|Vitamin E|vitamin e|mesh-list
110769178|NCT04801849|Tocopherols|tocopherols|mesh-list
110769179|NCT04801849|alpha-Tocopherol|alpha-tocopherol|mesh-list
110769180|NCT04801849|Vitamins|vitamins|mesh-ancestor
110769181|NCT04801849|Micronutrients|micronutrients|mesh-ancestor
110769182|NCT04801849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110769183|NCT04801849|Antioxidants|antioxidants|mesh-ancestor
110769184|NCT04801849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110769185|NCT04801849|Protective Agents|protective agents|mesh-ancestor
110769186|NCT04635839|Heparin|heparin|mesh-list
110769187|NCT04635839|Calcium heparin|calcium heparin|mesh-list
110769188|NCT04635839|Anticoagulants|anticoagulants|mesh-ancestor
110769189|NCT04635839|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110769190|NCT04635839|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110769191|NCT04635839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110769192|NCT04591275|Denosumab|denosumab|mesh-list
110769193|NCT04591275|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110769194|NCT04591275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110769195|NCT04560179|Tobramycin|tobramycin|mesh-list
110769196|NCT04560179|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110769197|NCT04560179|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110769198|NCT04560179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110769199|NCT04543591|Ravulizumab|ravulizumab|mesh-list
110769200|NCT04543591|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
110769201|NCT04543591|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110769202|NCT04543591|Immunologic Factors|immunologic factors|mesh-ancestor
110769203|NCT04543591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110769204|NCT04536337|Entecavir|entecavir|mesh-list
110769205|NCT04536337|Antiviral Agents|antiviral agents|mesh-ancestor
110769206|NCT04536337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110769207|NCT04515836|Olaparib|olaparib|mesh-list
110769208|NCT04515836|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110769209|NCT04515836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110769210|NCT04515836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110769211|NCT04515836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110769212|NCT04441034|Anticonvulsants|anticonvulsants|mesh-list
110769213|NCT04441034|Convulsants|convulsants|mesh-list
110769214|NCT04441034|Antidepressive Agents|antidepressive agents|mesh-list
110769215|NCT04441034|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110769216|NCT04441034|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110769217|NCT04441034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110769218|NCT04438824|Palbociclib|palbociclib|mesh-list
110769219|NCT04438824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110769220|NCT04438824|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110769221|NCT04438824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110769222|NCT04438824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110769223|NCT04348006|Dexamethasone|dexamethasone|mesh-list
110769224|NCT04348006|Cyclophosphamide|cyclophosphamide|mesh-list
110769225|NCT04348006|Lenalidomide|lenalidomide|mesh-list
110769227|NCT04348006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110769228|NCT04348006|Immunologic Factors|immunologic factors|mesh-ancestor
110769229|NCT04348006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110769230|NCT04348006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110769231|NCT04348006|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110769232|NCT04348006|Alkylating Agents|alkylating agents|mesh-ancestor
110769233|NCT04348006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110769234|NCT04348006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110769235|NCT04348006|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110769236|NCT04348006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110769237|NCT04348006|Antiemetics|antiemetics|mesh-ancestor
110769238|NCT04348006|Autonomic Agents|autonomic agents|mesh-ancestor
110769239|NCT04348006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110769240|NCT04348006|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110769241|NCT04348006|Glucocorticoids|glucocorticoids|mesh-ancestor
110769242|NCT04348006|Hormones|hormones|mesh-ancestor
110769243|NCT04348006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110769244|NCT04348006|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110332881|NCT00483782|Paclitaxel|paclitaxel|mesh-list
110769245|NCT04348006|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110769246|NCT04348006|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110769247|NCT04348006|Growth Substances|growth substances|mesh-ancestor
110769248|NCT04348006|Growth Inhibitors|growth inhibitors|mesh-ancestor
110769249|NCT04313972|Naltrexone|naltrexone|mesh-list
110769250|NCT04313972|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110769251|NCT04313972|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110769252|NCT04313972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110769253|NCT04313972|Sensory System Agents|sensory system agents|mesh-ancestor
110769254|NCT04313972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110769255|NCT04304625|Tranexamic Acid|tranexamic acid|mesh-list
110769256|NCT04304625|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110769257|NCT04304625|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110769258|NCT04304625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110769259|NCT04304625|Hemostatics|hemostatics|mesh-ancestor
110769260|NCT04304625|Coagulants|coagulants|mesh-ancestor
110769261|NCT04295863|Pembrolizumab|pembrolizumab|mesh-list
110769262|NCT04295863|Nivolumab|nivolumab|mesh-list
110769263|NCT04295863|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110769264|NCT04295863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110769265|NCT04295863|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110769266|NCT04295863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110769267|NCT04231526|Pembrolizumab|pembrolizumab|mesh-list
110769268|NCT04231526|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110769269|NCT04231526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110769270|NCT04231526|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110769271|NCT04231526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110769272|NCT04201873|Poly I-C|poly i-c|mesh-list
110769273|NCT04201873|Pembrolizumab|pembrolizumab|mesh-list
110769274|NCT04201873|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
110769275|NCT04201873|Vaccines|vaccines|mesh-list
110769276|NCT04201873|Poly ICLC|poly iclc|mesh-list
110769277|NCT04201873|Immunologic Factors|immunologic factors|mesh-ancestor
110769278|NCT04201873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110769279|NCT04201873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110769280|NCT04201873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110769281|NCT04201873|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110769282|NCT04201873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110769283|NCT04201873|Interferon Inducers|interferon inducers|mesh-ancestor
110769284|NCT04201873|Laxatives|laxatives|mesh-ancestor
110769285|NCT04201873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110769286|NCT04201873|Antiviral Agents|antiviral agents|mesh-ancestor
110769287|NCT04201873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110769293|NCT03785678|Tenecteplase|tenecteplase|mesh-list
110769294|NCT03785678|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110769295|NCT03785678|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110769296|NCT03785678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110769297|NCT03729804|Dexamethasone|dexamethasone|mesh-list
110769298|NCT03729804|Lenalidomide|lenalidomide|mesh-list
110769299|NCT03729804|Bortezomib|bortezomib|mesh-list
110769300|NCT03729804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110769301|NCT03729804|Antiemetics|antiemetics|mesh-ancestor
110769302|NCT03729804|Autonomic Agents|autonomic agents|mesh-ancestor
110769303|NCT03729804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110769304|NCT03729804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110769305|NCT03729804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110769306|NCT03729804|Glucocorticoids|glucocorticoids|mesh-ancestor
110769307|NCT03729804|Hormones|hormones|mesh-ancestor
110769308|NCT03729804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110769309|NCT03729804|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110769310|NCT03729804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110769311|NCT03729804|Immunologic Factors|immunologic factors|mesh-ancestor
110769312|NCT03729804|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110769313|NCT03729804|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110769314|NCT03729804|Growth Substances|growth substances|mesh-ancestor
110769315|NCT03729804|Growth Inhibitors|growth inhibitors|mesh-ancestor
110769316|NCT03697564|Gemcitabine|gemcitabine|mesh-list
110769317|NCT03697564|Nivolumab|nivolumab|mesh-list
110769318|NCT03697564|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110769319|NCT03697564|Antimetabolites|antimetabolites|mesh-ancestor
110769320|NCT03697564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110769321|NCT03697564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110769322|NCT03697564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110769323|NCT03697564|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110769324|NCT03595683|Pembrolizumab|pembrolizumab|mesh-list
110769325|NCT03595683|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110769326|NCT03595683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110769327|NCT03595683|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110769328|NCT03595683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110769329|NCT03571321|Cytarabine|cytarabine|mesh-list
110769331|NCT03571321|Cyclophosphamide|cyclophosphamide|mesh-list
110769332|NCT03571321|Rituximab|rituximab|mesh-list
110769333|NCT03571321|Doxorubicin|doxorubicin|mesh-list
110769334|NCT03571321|Methotrexate|methotrexate|mesh-list
110769335|NCT03571321|Vincristine|vincristine|mesh-list
110769336|NCT03571321|Mercaptopurine|mercaptopurine|mesh-list
110769337|NCT03571321|Pegaspargase|pegaspargase|mesh-list
110769338|NCT03571321|Thioguanine|thioguanine|mesh-list
110769339|NCT03571321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110769340|NCT03571321|Immunologic Factors|immunologic factors|mesh-ancestor
110769341|NCT03571321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110769342|NCT03571321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110769343|NCT03571321|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110769344|NCT03571321|Alkylating Agents|alkylating agents|mesh-ancestor
110769345|NCT03571321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110769346|NCT03571321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110769347|NCT03571321|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110769348|NCT03571321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110769349|NCT03571321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110769350|NCT03571321|Antiemetics|antiemetics|mesh-ancestor
110769351|NCT03571321|Autonomic Agents|autonomic agents|mesh-ancestor
110769352|NCT03571321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110769353|NCT03571321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110769354|NCT03571321|Glucocorticoids|glucocorticoids|mesh-ancestor
110769355|NCT03571321|Hormones|hormones|mesh-ancestor
110769356|NCT03571321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110769357|NCT03571321|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110769358|NCT03571321|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110769359|NCT03571321|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110769360|NCT03571321|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110769361|NCT03571321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110769362|NCT03571321|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110769363|NCT03571321|Abortifacient Agents|abortifacient agents|mesh-ancestor
110769364|NCT03571321|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110769365|NCT03571321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110769366|NCT03571321|Antimetabolites|antimetabolites|mesh-ancestor
110769367|NCT03571321|Dermatologic Agents|dermatologic agents|mesh-ancestor
110769368|NCT03571321|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110769369|NCT03571321|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110769370|NCT03571321|Antiviral Agents|antiviral agents|mesh-ancestor
110769371|NCT03571321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110769372|NCT03571321|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110769373|NCT03571321|Tubulin Modulators|tubulin modulators|mesh-ancestor
110769374|NCT03571321|Antimitotic Agents|antimitotic agents|mesh-ancestor
110769375|NCT03571321|Mitosis Modulators|mitosis modulators|mesh-ancestor
110769376|NCT03565445|Pembrolizumab|pembrolizumab|mesh-list
110769377|NCT03565445|Nivolumab|nivolumab|mesh-list
110769378|NCT03565445|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110769379|NCT03565445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110769380|NCT03565445|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110769381|NCT03565445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110769382|NCT03516812|Methyltestosterone|methyltestosterone|mesh-list
110769384|NCT03516812|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
110769385|NCT03516812|Testosterone|testosterone|mesh-list
110769386|NCT03516812|Testosterone undecanoate|testosterone undecanoate|mesh-list
110769387|NCT03516812|Testosterone enanthate|testosterone enanthate|mesh-list
110769388|NCT03516812|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
110769389|NCT03516812|Androgens|androgens|mesh-ancestor
110769390|NCT03516812|Hormones|hormones|mesh-ancestor
110769391|NCT03516812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110769392|NCT03516812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110769393|NCT03516812|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110769394|NCT03516812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110769395|NCT03516812|Anabolic Agents|anabolic agents|mesh-ancestor
110769396|NCT03516812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110769397|NCT03516812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110769398|NCT03500445|Dexamethasone|dexamethasone|mesh-list
110769399|NCT03500445|Lenalidomide|lenalidomide|mesh-list
110769400|NCT03500445|Daratumumab|daratumumab|mesh-list
110769401|NCT03500445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110769402|NCT03500445|Antiemetics|antiemetics|mesh-ancestor
110332946|NCT04515420|Norepinephrine|norepinephrine|mesh-list
110769403|NCT03500445|Autonomic Agents|autonomic agents|mesh-ancestor
110487101|NCT02646267|Anticoagulants|anticoagulants|mesh-ancestor
110769404|NCT03500445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110769405|NCT03500445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110769406|NCT03500445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110769407|NCT03500445|Glucocorticoids|glucocorticoids|mesh-ancestor
110769408|NCT03500445|Hormones|hormones|mesh-ancestor
110769409|NCT03500445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110769410|NCT03500445|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110769411|NCT03500445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110769412|NCT03500445|Immunologic Factors|immunologic factors|mesh-ancestor
110769413|NCT03500445|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110769414|NCT03500445|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110769415|NCT03500445|Growth Substances|growth substances|mesh-ancestor
110769416|NCT03500445|Growth Inhibitors|growth inhibitors|mesh-ancestor
110769417|NCT03494530|Edoxaban|edoxaban|mesh-list
110769418|NCT03494530|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110769419|NCT03494530|Antithrombins|antithrombins|mesh-ancestor
110769420|NCT03494530|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110769421|NCT03494530|Protease Inhibitors|protease inhibitors|mesh-ancestor
110769422|NCT03494530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110769423|NCT03494530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110769424|NCT03494530|Anticoagulants|anticoagulants|mesh-ancestor
110769425|NCT03466736|Flutemetamol|flutemetamol|mesh-list
110769426|NCT03466736|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110769427|NCT03466736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110769428|NCT03423264|Gabapentin|gabapentin|mesh-list
110769429|NCT03423264|Analgesics|analgesics|mesh-ancestor
110769430|NCT03423264|Sensory System Agents|sensory system agents|mesh-ancestor
110769431|NCT03423264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110769432|NCT03423264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110769433|NCT03423264|Anticonvulsants|anticonvulsants|mesh-ancestor
110769434|NCT03423264|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110769435|NCT03423264|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110769436|NCT03423264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110769437|NCT03423264|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110769438|NCT03423264|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110769439|NCT03423264|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110769440|NCT03423264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110769441|NCT03423264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110769442|NCT03423264|Antimanic Agents|antimanic agents|mesh-ancestor
110769443|NCT03225547|Pembrolizumab|pembrolizumab|mesh-list
110769444|NCT03225547|Mifepristone|mifepristone|mesh-list
110769445|NCT03225547|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110769446|NCT03225547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110769447|NCT03225547|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110769448|NCT03225547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110769449|NCT03225547|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
110769450|NCT03225547|Abortifacient Agents|abortifacient agents|mesh-ancestor
110769451|NCT03225547|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110769452|NCT03225547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110769453|NCT03225547|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110769454|NCT03225547|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110769455|NCT03225547|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110769456|NCT03225547|Contraceptive Agents|contraceptive agents|mesh-ancestor
110769457|NCT03225547|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
110769458|NCT03225547|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
110769459|NCT03225547|Hormone Antagonists|hormone antagonists|mesh-ancestor
110769460|NCT03225547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110769461|NCT03225547|Luteolytic Agents|luteolytic agents|mesh-ancestor
110769462|NCT03225547|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110769463|NCT03225547|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
110769464|NCT02990533|Methyltestosterone|methyltestosterone|mesh-list
110769465|NCT02990533|Testosterone|testosterone|mesh-list
110332963|NCT00488540|Antipyretics|antipyretics|mesh-ancestor
110769466|NCT02990533|Testosterone undecanoate|testosterone undecanoate|mesh-list
110769467|NCT02990533|Testosterone enanthate|testosterone enanthate|mesh-list
110769468|NCT02990533|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
110769469|NCT02990533|Androgens|androgens|mesh-ancestor
110769470|NCT02990533|Hormones|hormones|mesh-ancestor
110769471|NCT02990533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110769472|NCT02990533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110769473|NCT02990533|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110769474|NCT02990533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110769475|NCT02990533|Anabolic Agents|anabolic agents|mesh-ancestor
110769476|NCT02969837|Dexamethasone|dexamethasone|mesh-list
110769477|NCT02969837|Lenalidomide|lenalidomide|mesh-list
110769478|NCT02969837|Elotuzumab|elotuzumab|mesh-list
110769479|NCT02969837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110769481|NCT02969837|Autonomic Agents|autonomic agents|mesh-ancestor
110769482|NCT02969837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110769483|NCT02969837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110769484|NCT02969837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110769485|NCT02969837|Glucocorticoids|glucocorticoids|mesh-ancestor
110769486|NCT02969837|Hormones|hormones|mesh-ancestor
110769487|NCT02969837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110769488|NCT02969837|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110769489|NCT02969837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110769490|NCT02969837|Immunologic Factors|immunologic factors|mesh-ancestor
110769491|NCT02969837|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110769492|NCT02969837|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110769493|NCT02969837|Growth Substances|growth substances|mesh-ancestor
110769494|NCT02969837|Growth Inhibitors|growth inhibitors|mesh-ancestor
110769495|NCT02776917|Paclitaxel|paclitaxel|mesh-list
110769496|NCT02776917|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110769497|NCT02776917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110769498|NCT02776917|Tubulin Modulators|tubulin modulators|mesh-ancestor
110769499|NCT02776917|Antimitotic Agents|antimitotic agents|mesh-ancestor
110769500|NCT02776917|Mitosis Modulators|mitosis modulators|mesh-ancestor
110769501|NCT02776917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110769502|NCT02751255|Tretinoin|tretinoin|mesh-list
110769503|NCT02751255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110769504|NCT02751255|Keratolytic Agents|keratolytic agents|mesh-ancestor
110769505|NCT02751255|Dermatologic Agents|dermatologic agents|mesh-ancestor
110769506|NCT02707666|Pembrolizumab|pembrolizumab|mesh-list
110769507|NCT02707666|Pemetrexed|pemetrexed|mesh-list
110769508|NCT02707666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110769509|NCT02707666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110769510|NCT02707666|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110769511|NCT02707666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110769512|NCT02707666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110769513|NCT02707666|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110769514|NCT02707666|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110769515|NCT02668770|Ipilimumab|ipilimumab|mesh-list
110769516|NCT02668770|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110445744|NCT04224922|Immunologic Factors|immunologic factors|mesh-ancestor
110769517|NCT02668770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110769518|NCT02668770|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110769519|NCT02668770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110769520|NCT02659293|Dexamethasone|dexamethasone|mesh-list
110769521|NCT02659293|Lenalidomide|lenalidomide|mesh-list
110769522|NCT02659293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110769523|NCT02659293|Antiemetics|antiemetics|mesh-ancestor
110769524|NCT02659293|Autonomic Agents|autonomic agents|mesh-ancestor
110769525|NCT02659293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110769526|NCT02659293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110769527|NCT02659293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110769528|NCT02659293|Glucocorticoids|glucocorticoids|mesh-ancestor
110769529|NCT02659293|Hormones|hormones|mesh-ancestor
110769530|NCT02659293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110769531|NCT02659293|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110769532|NCT02659293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110769533|NCT02659293|Immunologic Factors|immunologic factors|mesh-ancestor
110769534|NCT02659293|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110769535|NCT02659293|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110769536|NCT02659293|Growth Substances|growth substances|mesh-ancestor
110769537|NCT02659293|Growth Inhibitors|growth inhibitors|mesh-ancestor
110769538|NCT02656511|Tenofovir|tenofovir|mesh-list
110769539|NCT02656511|Emtricitabine|emtricitabine|mesh-list
110769540|NCT02656511|Dolutegravir|dolutegravir|mesh-list
110769541|NCT02656511|Antiviral Agents|antiviral agents|mesh-ancestor
110769542|NCT02656511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110769543|NCT02656511|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110769544|NCT02656511|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110769545|NCT02656511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110769546|NCT02656511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110769547|NCT02656511|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110769548|NCT02656511|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110769549|NCT02656511|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110769550|NCT02656511|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110769551|NCT02613169|Isoniazid|isoniazid|mesh-list
110769552|NCT02613169|Antitubercular Agents|antitubercular agents|mesh-ancestor
110769553|NCT02613169|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110769554|NCT02613169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110769555|NCT02613169|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
110769556|NCT02613169|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110769557|NCT02613169|Antimetabolites|antimetabolites|mesh-ancestor
110769558|NCT02613169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110769559|NCT02613169|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110769560|NCT02572323|Tesamorelin|tesamorelin|mesh-list
110769561|NCT02572323|Growth Substances|growth substances|mesh-ancestor
110769562|NCT02572323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110769563|NCT02513186|Dexamethasone|dexamethasone|mesh-list
110769564|NCT02513186|Cyclophosphamide|cyclophosphamide|mesh-list
110769565|NCT02513186|Lenalidomide|lenalidomide|mesh-list
110769566|NCT02513186|Bortezomib|bortezomib|mesh-list
110769567|NCT02513186|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110769568|NCT02513186|Immunologic Factors|immunologic factors|mesh-ancestor
110769569|NCT02513186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110769570|NCT02513186|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110769571|NCT02513186|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110769572|NCT02513186|Alkylating Agents|alkylating agents|mesh-ancestor
110769573|NCT02513186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110769574|NCT02513186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110769575|NCT02513186|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110769576|NCT02513186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110769577|NCT02513186|Antiemetics|antiemetics|mesh-ancestor
110769578|NCT02513186|Autonomic Agents|autonomic agents|mesh-ancestor
110769579|NCT02513186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110769580|NCT02513186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110769581|NCT02513186|Glucocorticoids|glucocorticoids|mesh-ancestor
110769582|NCT02513186|Hormones|hormones|mesh-ancestor
110332985|NCT01303861|Bupropion|bupropion|mesh-list
110769583|NCT02513186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110769584|NCT02513186|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110769585|NCT02513186|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110769586|NCT02513186|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110769587|NCT02513186|Growth Substances|growth substances|mesh-ancestor
110769588|NCT02513186|Growth Inhibitors|growth inhibitors|mesh-ancestor
110769589|NCT02441491|Cyclophosphamide|cyclophosphamide|mesh-list
110769590|NCT02441491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110769591|NCT02441491|Immunologic Factors|immunologic factors|mesh-ancestor
110769592|NCT02441491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110769593|NCT02441491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110769594|NCT02441491|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110769595|NCT02441491|Alkylating Agents|alkylating agents|mesh-ancestor
110769596|NCT02441491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110769597|NCT02441491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110769598|NCT02441491|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110769599|NCT02431988|Cyclophosphamide|cyclophosphamide|mesh-list
110769600|NCT02431988|Fludarabine|fludarabine|mesh-list
110769601|NCT02431988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110769602|NCT02431988|Immunologic Factors|immunologic factors|mesh-ancestor
110769603|NCT02431988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110769604|NCT02431988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110769605|NCT02431988|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110769606|NCT02431988|Alkylating Agents|alkylating agents|mesh-ancestor
110769607|NCT02431988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110769608|NCT02431988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110769609|NCT02431988|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110769610|NCT02399371|Pembrolizumab|pembrolizumab|mesh-list
110769611|NCT02399371|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110769612|NCT02399371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110769613|NCT02399371|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110769614|NCT02399371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110769615|NCT02389517|Dexamethasone|dexamethasone|mesh-list
110769616|NCT02389517|Lenalidomide|lenalidomide|mesh-list
110769617|NCT02389517|Ixazomib|ixazomib|mesh-list
110769618|NCT02389517|Glycine|glycine|mesh-list
110769619|NCT02389517|Proteasome Inhibitors|proteasome inhibitors|mesh-list
110769620|NCT02389517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110769621|NCT02389517|Antiemetics|antiemetics|mesh-ancestor
110769622|NCT02389517|Autonomic Agents|autonomic agents|mesh-ancestor
110769623|NCT02389517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110769624|NCT02389517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110769625|NCT02389517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110769626|NCT02389517|Glucocorticoids|glucocorticoids|mesh-ancestor
110769627|NCT02389517|Hormones|hormones|mesh-ancestor
110487347|NCT02639091|Pemetrexed|pemetrexed|mesh-list
110769628|NCT02389517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110769629|NCT02389517|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110769630|NCT02389517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110769631|NCT02389517|Immunologic Factors|immunologic factors|mesh-ancestor
110769632|NCT02389517|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110769633|NCT02389517|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110769634|NCT02389517|Growth Substances|growth substances|mesh-ancestor
110769635|NCT02389517|Growth Inhibitors|growth inhibitors|mesh-ancestor
110769636|NCT02389517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110769637|NCT02389517|Protease Inhibitors|protease inhibitors|mesh-ancestor
110769638|NCT02389517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110769639|NCT02389517|Glycine Agents|glycine agents|mesh-ancestor
110769640|NCT02389517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110769641|NCT02366819|Leucovorin|leucovorin|mesh-list
110769642|NCT02366819|Fluorouracil|fluorouracil|mesh-list
110769643|NCT02366819|Oxaliplatin|oxaliplatin|mesh-list
110769644|NCT02366819|Irinotecan|irinotecan|mesh-list
110769645|NCT02366819|Calcium|calcium|mesh-list
110769646|NCT02366819|Levoleucovorin|levoleucovorin|mesh-list
110769647|NCT02366819|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110769648|NCT02366819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110769649|NCT02366819|Antimetabolites|antimetabolites|mesh-ancestor
110769650|NCT02366819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110769651|NCT02366819|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110769652|NCT02366819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110769653|NCT02366819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110769654|NCT02366819|Immunologic Factors|immunologic factors|mesh-ancestor
110769655|NCT02366819|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110769656|NCT02366819|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110769658|NCT02366819|Antidotes|antidotes|mesh-ancestor
110769659|NCT02366819|Protective Agents|protective agents|mesh-ancestor
110769660|NCT02366819|Vitamin B Complex|vitamin b complex|mesh-ancestor
110769661|NCT02366819|Vitamins|vitamins|mesh-ancestor
110769662|NCT02366819|Micronutrients|micronutrients|mesh-ancestor
110769663|NCT02352948|Gemcitabine|gemcitabine|mesh-list
110769664|NCT02352948|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110769665|NCT02352948|Durvalumab|durvalumab|mesh-list
110769666|NCT02352948|Vinorelbine|vinorelbine|mesh-list
110769667|NCT02352948|Tremelimumab|tremelimumab|mesh-list
110769668|NCT02352948|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110769669|NCT02352948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110769670|NCT02352948|Antimetabolites|antimetabolites|mesh-ancestor
110769671|NCT02352948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110769672|NCT02352948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110769673|NCT02352948|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110769674|NCT02352948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110769675|NCT02352948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110769676|NCT02352948|Immunologic Factors|immunologic factors|mesh-ancestor
110769677|NCT02352948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110769678|NCT02352948|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110769679|NCT02352948|Tubulin Modulators|tubulin modulators|mesh-ancestor
110870443|NCT02393482|Tibolone|tibolone|mesh-list
110769680|NCT02352948|Antimitotic Agents|antimitotic agents|mesh-ancestor
110769681|NCT02352948|Mitosis Modulators|mitosis modulators|mesh-ancestor
110769682|NCT02333162|Mycophenolic Acid|mycophenolic acid|mesh-list
110769683|NCT02333162|Fludarabine|fludarabine|mesh-list
110769684|NCT02333162|Fludarabine phosphate|fludarabine phosphate|mesh-list
110769685|NCT02333162|Melphalan|melphalan|mesh-list
110769686|NCT02333162|Tacrolimus|tacrolimus|mesh-list
110769687|NCT02333162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110769688|NCT02333162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110769689|NCT02333162|Antimetabolites|antimetabolites|mesh-ancestor
110769690|NCT02333162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110769691|NCT02333162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110769692|NCT02333162|Immunologic Factors|immunologic factors|mesh-ancestor
110769693|NCT02333162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110769694|NCT02333162|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110769695|NCT02333162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110769696|NCT02333162|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110769697|NCT02333162|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110769698|NCT02333162|Antitubercular Agents|antitubercular agents|mesh-ancestor
110769699|NCT02333162|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110769700|NCT02333162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110769701|NCT02333162|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110769702|NCT02333162|Alkylating Agents|alkylating agents|mesh-ancestor
110769703|NCT02333162|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110769704|NCT02281838|Enalapril|enalapril|mesh-list
110769705|NCT02281838|Labetalol|labetalol|mesh-list
110769706|NCT02281838|Hydralazine|hydralazine|mesh-list
110769707|NCT02281838|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110769708|NCT02281838|Protease Inhibitors|protease inhibitors|mesh-ancestor
110769709|NCT02281838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110769710|NCT02281838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110769711|NCT02281838|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110769712|NCT02281838|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110769713|NCT02281838|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110769714|NCT02281838|Adrenergic Agents|adrenergic agents|mesh-ancestor
110769715|NCT02281838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110769716|NCT02281838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110769717|NCT02281838|Sympathomimetics|sympathomimetics|mesh-ancestor
110769718|NCT02281838|Autonomic Agents|autonomic agents|mesh-ancestor
110769719|NCT02281838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110769720|NCT02281838|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110769721|NCT02281838|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110769722|NCT02281838|Vasodilator Agents|vasodilator agents|mesh-ancestor
110769723|NCT02213913|Prednisone|prednisone|mesh-list
110769724|NCT02213913|Cyclophosphamide|cyclophosphamide|mesh-list
110769725|NCT02213913|Rituximab|rituximab|mesh-list
110769726|NCT02213913|Doxorubicin|doxorubicin|mesh-list
110769727|NCT02213913|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110769728|NCT02213913|Etoposide|etoposide|mesh-list
110769729|NCT02213913|Vincristine|vincristine|mesh-list
110769730|NCT02213913|Lenalidomide|lenalidomide|mesh-list
110769731|NCT02213913|Etoposide phosphate|etoposide phosphate|mesh-list
110769732|NCT02213913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110769733|NCT02213913|Immunologic Factors|immunologic factors|mesh-ancestor
110445756|NCT02877888|Cariostatic Agents|cariostatic agents|mesh-ancestor
110769734|NCT02213913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110769735|NCT02213913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110769736|NCT02213913|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110769737|NCT02213913|Alkylating Agents|alkylating agents|mesh-ancestor
110333051|NCT01302964|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110769738|NCT02213913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110769739|NCT02213913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110769740|NCT02213913|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110769741|NCT02213913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110769742|NCT02213913|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110769743|NCT02213913|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110769744|NCT02213913|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110769745|NCT02213913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110769746|NCT02213913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110769747|NCT02213913|Glucocorticoids|glucocorticoids|mesh-ancestor
110769749|NCT02213913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110769750|NCT02213913|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110769751|NCT02213913|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110769752|NCT02213913|Tubulin Modulators|tubulin modulators|mesh-ancestor
110769753|NCT02213913|Antimitotic Agents|antimitotic agents|mesh-ancestor
110769754|NCT02213913|Mitosis Modulators|mitosis modulators|mesh-ancestor
110769755|NCT02213913|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110769756|NCT02213913|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110769757|NCT02213913|Growth Substances|growth substances|mesh-ancestor
110769758|NCT02213913|Growth Inhibitors|growth inhibitors|mesh-ancestor
110769759|NCT01847326|Paclitaxel|paclitaxel|mesh-list
110769760|NCT01847326|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110769761|NCT01847326|Carboplatin|carboplatin|mesh-list
110769762|NCT01847326|Fluorouracil|fluorouracil|mesh-list
110769763|NCT01847326|Hydroxyurea|hydroxyurea|mesh-list
110769764|NCT01847326|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110769765|NCT01847326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110769766|NCT01847326|Tubulin Modulators|tubulin modulators|mesh-ancestor
110769767|NCT01847326|Antimitotic Agents|antimitotic agents|mesh-ancestor
110769768|NCT01847326|Mitosis Modulators|mitosis modulators|mesh-ancestor
110769769|NCT01847326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110769770|NCT01847326|Antimetabolites|antimetabolites|mesh-ancestor
110769771|NCT01847326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110769772|NCT01847326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110769773|NCT01847326|Immunologic Factors|immunologic factors|mesh-ancestor
110769774|NCT01847326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110769775|NCT01847326|Antisickling Agents|antisickling agents|mesh-ancestor
110769776|NCT01847326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110769777|NCT01847326|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110769778|NCT01665794|Dexamethasone|dexamethasone|mesh-list
110769779|NCT01665794|Daratumumab|daratumumab|mesh-list
110487485|NCT00964886|Benztropine|benztropine|mesh-list
110769780|NCT01665794|Pomalidomide|pomalidomide|mesh-list
110769781|NCT01665794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110769782|NCT01665794|Antiemetics|antiemetics|mesh-ancestor
110769783|NCT01665794|Autonomic Agents|autonomic agents|mesh-ancestor
110333074|NCT01302691|Diuretics|diuretics|mesh-ancestor
110769784|NCT01665794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110769785|NCT01665794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110769786|NCT01665794|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110769787|NCT01665794|Glucocorticoids|glucocorticoids|mesh-ancestor
110769788|NCT01665794|Hormones|hormones|mesh-ancestor
110769789|NCT01665794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110769790|NCT01665794|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110769791|NCT01665794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110769792|NCT01665794|Immunologic Factors|immunologic factors|mesh-ancestor
110769793|NCT01665794|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110769794|NCT01665794|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110769795|NCT01665794|Growth Substances|growth substances|mesh-ancestor
110769796|NCT01665794|Growth Inhibitors|growth inhibitors|mesh-ancestor
110769797|NCT01526096|Plerixafor|plerixafor|mesh-list
110769798|NCT01526096|Melphalan|melphalan|mesh-list
110769799|NCT01526096|Basiliximab|basiliximab|mesh-list
110769800|NCT01526096|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110769801|NCT01526096|Alkylating Agents|alkylating agents|mesh-ancestor
110769802|NCT01526096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110769803|NCT01526096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110769804|NCT01526096|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110769805|NCT01526096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110769806|NCT01526096|Immunologic Factors|immunologic factors|mesh-ancestor
110769807|NCT01526096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110769808|NCT01526096|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110769809|NCT01526096|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110769810|NCT01526096|Antiviral Agents|antiviral agents|mesh-ancestor
110769811|NCT01526096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110769812|NCT01369212|Tenofovir|tenofovir|mesh-list
110769813|NCT01369212|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110769814|NCT01369212|Antiviral Agents|antiviral agents|mesh-ancestor
110769815|NCT01369212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110769816|NCT01369212|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110769817|NCT01369212|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110769818|NCT01369212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110769819|NCT01369212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110769820|NCT01369212|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110769821|NCT01369212|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110769822|NCT00800215|Lacosamide|lacosamide|mesh-list
110769823|NCT00800215|Anticonvulsants|anticonvulsants|mesh-ancestor
110769824|NCT00800215|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110769825|NCT00800215|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110769826|NCT00800215|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110769827|NCT00800215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110769828|NCT00669734|Metronidazole|metronidazole|mesh-list
110769829|NCT00669734|Tricyclodecane-9-yl-xanthogenate|tricyclodecane-9-yl-xanthogenate|mesh-list
110769830|NCT00669734|Vaccines|vaccines|mesh-list
110769831|NCT00669734|Sargramostim|sargramostim|mesh-list
110769832|NCT00669734|Immunologic Factors|immunologic factors|mesh-ancestor
110769833|NCT00669734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110769834|NCT00669734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110769835|NCT00669734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110769836|NCT00669734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110769837|NCT00669734|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110769838|NCT00669734|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110769839|NCT00669734|Antioxidants|antioxidants|mesh-ancestor
110769840|NCT00669734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110769841|NCT00669734|Protective Agents|protective agents|mesh-ancestor
110769842|NCT00669734|Antiviral Agents|antiviral agents|mesh-ancestor
110769843|NCT00669734|Growth Inhibitors|growth inhibitors|mesh-ancestor
110769844|NCT00669734|Growth Substances|growth substances|mesh-ancestor
110769845|NCT00669734|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110769846|NCT00669734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110769847|NCT00337649|Trastuzumab|trastuzumab|mesh-list
110769848|NCT00337649|Epothilones|epothilones|mesh-list
110333104|NCT00484133|Dobutamine|dobutamine|mesh-list
110769849|NCT00337649|Desoxyepothilone B|desoxyepothilone b|mesh-list
110769850|NCT00337649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110769851|NCT00337649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110769852|NCT00337649|Tubulin Modulators|tubulin modulators|mesh-ancestor
110769853|NCT00337649|Antimitotic Agents|antimitotic agents|mesh-ancestor
110769854|NCT00337649|Mitosis Modulators|mitosis modulators|mesh-ancestor
110769855|NCT00337649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110769856|NCT00071084|Zanolimumab|zanolimumab|mesh-list
110769857|NCT00071084|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110769858|NCT00071084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110769859|NCT00071084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110769860|NCT00071084|Immunologic Factors|immunologic factors|mesh-ancestor
110769861|NCT00071084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110769862|NCT00042406|Zanolimumab|zanolimumab|mesh-list
110769863|NCT00042406|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110769864|NCT00042406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110769865|NCT00042406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110769866|NCT00042406|Immunologic Factors|immunologic factors|mesh-ancestor
110769867|NCT00042406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110769868|NCT01170078|Epoetin Alfa|epoetin alfa|mesh-list
110769869|NCT01170078|Hematinics|hematinics|mesh-ancestor
110769870|NCT01283646|Vitamins|vitamins|mesh-list
110769871|NCT01283646|Folic Acid|folic acid|mesh-list
110769872|NCT01283646|Vitamin B Complex|vitamin b complex|mesh-list
110769873|NCT01283646|Micronutrients|micronutrients|mesh-ancestor
110769874|NCT01283646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110769875|NCT01283646|Hematinics|hematinics|mesh-ancestor
110769876|NCT01283724|Dienogest|dienogest|mesh-list
110769877|NCT01283724|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110769878|NCT01283724|Contraceptive Agents|contraceptive agents|mesh-ancestor
110769879|NCT01283724|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110769880|NCT01283724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110769881|NCT01283724|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110769882|NCT01283724|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110870523|NCT03345979|Serotonin Agents|serotonin agents|mesh-ancestor
110769883|NCT01283724|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110769884|NCT01283724|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110769885|NCT01283724|Hormone Antagonists|hormone antagonists|mesh-ancestor
110769886|NCT01283724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110769887|NCT01283724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110769888|NCT01283724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110769889|NCT01586442|Eplerenone|eplerenone|mesh-list
110769890|NCT01586442|Spironolactone|spironolactone|mesh-list
110769891|NCT01586442|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110333128|NCT00484341|Doxorubicin|doxorubicin|mesh-list
110769892|NCT01586442|Hormone Antagonists|hormone antagonists|mesh-ancestor
110769893|NCT01586442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110769894|NCT01586442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110769895|NCT01586442|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110769896|NCT01586442|Diuretics|diuretics|mesh-ancestor
110769897|NCT01586442|Natriuretic Agents|natriuretic agents|mesh-ancestor
110769898|NCT01586442|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110769899|NCT01587066|Valproic Acid|valproic acid|mesh-list
110769900|NCT01587066|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110769901|NCT01587066|Antidepressive Agents|antidepressive agents|mesh-ancestor
110769902|NCT01587066|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110769903|NCT01587066|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110769904|NCT01587066|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110769905|NCT01587066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110769906|NCT01587066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110769907|NCT01587066|Anticonvulsants|anticonvulsants|mesh-ancestor
110769908|NCT01587066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110769909|NCT01587066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110769910|NCT01587066|GABA Agents|gaba agents|mesh-ancestor
110769911|NCT01587066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110769912|NCT01587066|Antimanic Agents|antimanic agents|mesh-ancestor
110769913|NCT01587144|Lucanthone|lucanthone|mesh-list
110769914|NCT01587144|Temozolomide|temozolomide|mesh-list
110769915|NCT01587144|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110769916|NCT01587144|Alkylating Agents|alkylating agents|mesh-ancestor
110769917|NCT01587144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110769918|NCT01587144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110769919|NCT01587144|Schistosomicides|schistosomicides|mesh-ancestor
110769920|NCT01587144|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110769921|NCT01587144|Anthelmintics|anthelmintics|mesh-ancestor
110769922|NCT01587144|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110769923|NCT01587144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110769924|NCT01587222|Octreotide|octreotide|mesh-list
110769925|NCT01587222|Midodrine|midodrine|mesh-list
110769926|NCT01587222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110769927|NCT01587222|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110769928|NCT01587222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110769929|NCT01587222|Sympathomimetics|sympathomimetics|mesh-ancestor
110769930|NCT01587222|Autonomic Agents|autonomic agents|mesh-ancestor
110769931|NCT01587222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110769932|NCT01587222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110769933|NCT01587222|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110769934|NCT01587222|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110769935|NCT01587222|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110769936|NCT01587222|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110769937|NCT01587222|Adrenergic Agents|adrenergic agents|mesh-ancestor
110769938|NCT01587222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110769939|NCT01587222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110769941|NCT01167738|Gemcitabine|gemcitabine|mesh-list
110769942|NCT01167738|Capecitabine|capecitabine|mesh-list
110769944|NCT01167738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110769945|NCT01167738|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110769946|NCT01167738|Antimetabolites|antimetabolites|mesh-ancestor
110769947|NCT01167738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110769948|NCT01167738|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110445760|NCT02772640|Ezetimibe|ezetimibe|mesh-list
110769949|NCT01167738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110769950|NCT01167738|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110769951|NCT01167738|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110769952|NCT01167738|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110769953|NCT01167738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110769954|NCT01167816|Azacitidine|azacitidine|mesh-list
110769955|NCT01167816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110769956|NCT01167816|Antimetabolites|antimetabolites|mesh-ancestor
110769957|NCT01167816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110769958|NCT01167816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110333143|NCT04514835|Antimetabolites|antimetabolites|mesh-ancestor
110769959|NCT01167816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110769960|NCT01167894|Simvastatin|simvastatin|mesh-list
110769961|NCT01167894|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110769962|NCT01167894|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110769963|NCT01167894|Antimetabolites|antimetabolites|mesh-ancestor
110769964|NCT01167894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110769965|NCT01167894|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110769966|NCT01167894|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110769967|NCT01167894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110769968|NCT03870828|Dimercaprol|dimercaprol|mesh-list
110769969|NCT03870828|Chelating Agents|chelating agents|mesh-ancestor
110769970|NCT03870828|Sequestering Agents|sequestering agents|mesh-ancestor
110769971|NCT03870828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110769972|NCT03870594|Chrysarobin|chrysarobin|mesh-list
110769973|NCT03870594|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110769974|NCT03870594|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110769975|NCT03870594|Analgesics|analgesics|mesh-ancestor
110769976|NCT03870594|Sensory System Agents|sensory system agents|mesh-ancestor
110769977|NCT03870594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110769978|NCT03870594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110769979|NCT03870594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110769980|NCT03870594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110769981|NCT01165866|Ondansetron|ondansetron|mesh-list
110769982|NCT01165866|Metoclopramide|metoclopramide|mesh-list
110769983|NCT01165866|Antiemetics|antiemetics|mesh-ancestor
110769984|NCT01165866|Autonomic Agents|autonomic agents|mesh-ancestor
110769985|NCT01165866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110769986|NCT01165866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110769987|NCT01165866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110769988|NCT01165866|Antipruritics|antipruritics|mesh-ancestor
110769989|NCT01165866|Dermatologic Agents|dermatologic agents|mesh-ancestor
110769990|NCT01165866|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110769991|NCT01165866|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110769992|NCT01165866|Serotonin Agents|serotonin agents|mesh-ancestor
110769993|NCT01165866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110769994|NCT01165866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110769995|NCT01165866|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110769996|NCT01165866|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110769997|NCT01165866|Dopamine Agents|dopamine agents|mesh-ancestor
110769998|NCT01170468|Vitamin D|vitamin d|mesh-list
110769999|NCT01170468|Cholecalciferol|cholecalciferol|mesh-list
110770000|NCT01170468|Vitamins|vitamins|mesh-ancestor
110770001|NCT01170468|Micronutrients|micronutrients|mesh-ancestor
110770002|NCT01170468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110770003|NCT01170468|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110770004|NCT01170468|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110770005|NCT01273584|Metformin|metformin|mesh-list
110487699|NCT02598466|Immunologic Factors|immunologic factors|mesh-ancestor
110770006|NCT01273584|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110770007|NCT01273584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110770008|NCT01281852|Paclitaxel|paclitaxel|mesh-list
110770009|NCT01281852|Cisplatin|cisplatin|mesh-list
110770010|NCT01281852|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110770011|NCT01281852|Veliparib|veliparib|mesh-list
110770012|NCT01281852|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110770013|NCT01281852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110770014|NCT01281852|Tubulin Modulators|tubulin modulators|mesh-ancestor
110770015|NCT01281852|Antimitotic Agents|antimitotic agents|mesh-ancestor
110770016|NCT01281852|Mitosis Modulators|mitosis modulators|mesh-ancestor
110770017|NCT01281852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110770018|NCT01281852|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110770019|NCT01281852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110770021|NCT01168440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110770022|NCT01168440|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110770023|NCT01168440|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110770024|NCT01168440|Growth Substances|growth substances|mesh-ancestor
110770025|NCT01168440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110770026|NCT01168440|Growth Inhibitors|growth inhibitors|mesh-ancestor
110770027|NCT01168440|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110770028|NCT01168440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110770029|NCT01168440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110770030|NCT01170780|Dexamethasone|dexamethasone|mesh-list
110770031|NCT01170780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110770032|NCT01170780|Antiemetics|antiemetics|mesh-ancestor
110770033|NCT01170780|Autonomic Agents|autonomic agents|mesh-ancestor
110770034|NCT01170780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110770035|NCT01170780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110770036|NCT01170780|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110770037|NCT01170780|Glucocorticoids|glucocorticoids|mesh-ancestor
110770038|NCT01170780|Hormones|hormones|mesh-ancestor
110770039|NCT01170780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110770040|NCT01170780|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110770041|NCT01170780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110770042|NCT01165944|Pramlintide|pramlintide|mesh-list
110770043|NCT01165944|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110770044|NCT01165944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110770045|NCT01170858|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110770046|NCT01170858|Icodextrin|icodextrin|mesh-list
110770047|NCT01170858|Dialysis Solutions|dialysis solutions|mesh-ancestor
110770048|NCT01171092|Bortezomib|bortezomib|mesh-list
110770049|NCT01171092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110770050|NCT03753204|Furosemide|furosemide|mesh-list
110770051|NCT03753204|Diuretics|diuretics|mesh-ancestor
110770052|NCT03753204|Natriuretic Agents|natriuretic agents|mesh-ancestor
110770053|NCT03753204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110770054|NCT03753204|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110770055|NCT03753204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110770056|NCT03753204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110770057|NCT01171170|Paclitaxel|paclitaxel|mesh-list
110770058|NCT01171170|Bevacizumab|bevacizumab|mesh-list
110770059|NCT01171170|Carboplatin|carboplatin|mesh-list
110770060|NCT01171170|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110770061|NCT01171170|Nitroglycerin|nitroglycerin|mesh-list
110770062|NCT01171170|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110770063|NCT01171170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110770064|NCT01171170|Tubulin Modulators|tubulin modulators|mesh-ancestor
110770065|NCT01171170|Antimitotic Agents|antimitotic agents|mesh-ancestor
110770066|NCT01171170|Mitosis Modulators|mitosis modulators|mesh-ancestor
110770067|NCT01171170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110770068|NCT01171170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110770069|NCT01171170|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110770070|NCT01171170|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110770071|NCT01171170|Growth Substances|growth substances|mesh-ancestor
110770072|NCT01171170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110770073|NCT01171170|Growth Inhibitors|growth inhibitors|mesh-ancestor
110770074|NCT01171170|Vasodilator Agents|vasodilator agents|mesh-ancestor
110770075|NCT01166100|Fluoxetine|fluoxetine|mesh-list
110770076|NCT01166100|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110770077|NCT01166100|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110770078|NCT01166100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110770079|NCT01166100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110770080|NCT01166100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110770081|NCT01166100|Serotonin Agents|serotonin agents|mesh-ancestor
110770082|NCT01166100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110770083|NCT01166100|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110333163|NCT00488891|Serotonin Agents|serotonin agents|mesh-ancestor
110770084|NCT01166100|Antidepressive Agents|antidepressive agents|mesh-ancestor
110770085|NCT01166100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110770086|NCT01166100|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110770087|NCT01166100|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110770088|NCT01166100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110770089|NCT01277016|Melphalan|melphalan|mesh-list
110770090|NCT01277016|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110770091|NCT01277016|Alkylating Agents|alkylating agents|mesh-ancestor
110770092|NCT01277016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110770093|NCT01277016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110770094|NCT01277016|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110770095|NCT01277016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110770096|NCT01277016|Immunologic Factors|immunologic factors|mesh-ancestor
110770097|NCT01277016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110770098|NCT01171326|Minocycline|minocycline|mesh-list
110770099|NCT01171326|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110770100|NCT01171326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110770101|NCT01171482|Fluorouracil|fluorouracil|mesh-list
110770102|NCT01171482|Sorafenib|sorafenib|mesh-list
110770103|NCT01171482|Mitomycins|mitomycins|mesh-list
110770104|NCT01171482|Mitomycin|mitomycin|mesh-list
110770105|NCT01171482|Antimetabolites|antimetabolites|mesh-ancestor
110770106|NCT01171482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110770107|NCT01171482|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110770108|NCT01171482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110770109|NCT01171482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110770110|NCT01171482|Immunologic Factors|immunologic factors|mesh-ancestor
110770111|NCT01171482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110770112|NCT01171482|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110770113|NCT01171482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110770114|NCT01171482|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110770115|NCT01171482|Alkylating Agents|alkylating agents|mesh-ancestor
110770116|NCT01171482|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110770117|NCT01282398|Simvastatin|simvastatin|mesh-list
110770118|NCT01282398|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110770119|NCT01282398|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110770120|NCT01282398|Antimetabolites|antimetabolites|mesh-ancestor
110770121|NCT01282398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110870610|NCT04053478|Sympathomimetics|sympathomimetics|mesh-ancestor
110770122|NCT01282398|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110770123|NCT01282398|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110770124|NCT01282398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110770125|NCT01169142|Vitamin D|vitamin d|mesh-list
110770126|NCT01169142|Ergocalciferols|ergocalciferols|mesh-list
110770127|NCT01169142|Cholecalciferol|cholecalciferol|mesh-list
110770128|NCT01169142|Vitamins|vitamins|mesh-list
110770129|NCT01169142|Micronutrients|micronutrients|mesh-ancestor
110770130|NCT01169142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110770131|NCT01169142|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110333184|NCT04514796|Adalimumab|adalimumab|mesh-list
110770132|NCT01169142|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110770133|NCT01169298|Lenalidomide|lenalidomide|mesh-list
110770134|NCT01169298|Immunologic Factors|immunologic factors|mesh-ancestor
110770135|NCT01169298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110770136|NCT01169298|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110770137|NCT01169298|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110770138|NCT01169298|Growth Substances|growth substances|mesh-ancestor
110770139|NCT01169298|Growth Inhibitors|growth inhibitors|mesh-ancestor
110770140|NCT01169298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110770141|NCT01277484|Decitabine|decitabine|mesh-list
110770142|NCT01277484|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110770143|NCT01277484|Antimetabolites|antimetabolites|mesh-ancestor
110770144|NCT01277484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110770145|NCT01277484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110770146|NCT01277484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110770147|NCT01282632|Olanzapine|olanzapine|mesh-list
110770148|NCT01282632|Risperidone|risperidone|mesh-list
110770149|NCT01282632|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110770150|NCT01282632|Serotonin Agents|serotonin agents|mesh-ancestor
110770151|NCT01282632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110770152|NCT01282632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110770153|NCT01282632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110770154|NCT01282632|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110770155|NCT01282632|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110770156|NCT01282632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110770157|NCT01282632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110770158|NCT01282632|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110770159|NCT01282632|Dopamine Agents|dopamine agents|mesh-ancestor
110770160|NCT01282632|Antiemetics|antiemetics|mesh-ancestor
110770161|NCT01282632|Autonomic Agents|autonomic agents|mesh-ancestor
110770162|NCT01282632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110770163|NCT01282632|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110770164|NCT01282632|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110770165|NCT01282632|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110770166|NCT01282632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110770167|NCT01172028|Docetaxel|docetaxel|mesh-list
110770169|NCT01172028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110770170|NCT01172028|Tubulin Modulators|tubulin modulators|mesh-ancestor
110770171|NCT01172028|Antimitotic Agents|antimitotic agents|mesh-ancestor
110770172|NCT01172028|Mitosis Modulators|mitosis modulators|mesh-ancestor
110770173|NCT01172028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110770174|NCT01172028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110770175|NCT01172028|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110770176|NCT01172028|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110770177|NCT01278186|Paclitaxel|paclitaxel|mesh-list
110770178|NCT01278186|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110770179|NCT01278186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110770180|NCT01278186|Tubulin Modulators|tubulin modulators|mesh-ancestor
110770181|NCT01278186|Antimitotic Agents|antimitotic agents|mesh-ancestor
110770182|NCT01278186|Mitosis Modulators|mitosis modulators|mesh-ancestor
110770183|NCT01278186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110770184|NCT01169688|Phenylephrine|phenylephrine|mesh-list
110770185|NCT01169688|Oxymetazoline|oxymetazoline|mesh-list
110770186|NCT01169688|Cyclopentolate|cyclopentolate|mesh-list
110770187|NCT01169688|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110770188|NCT01169688|Mydriatics|mydriatics|mesh-ancestor
110770189|NCT01169688|Autonomic Agents|autonomic agents|mesh-ancestor
110770190|NCT01169688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110770191|NCT01169688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110770192|NCT01169688|Sympathomimetics|sympathomimetics|mesh-ancestor
110770193|NCT01169688|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110770194|NCT01169688|Nasal Decongestants|nasal decongestants|mesh-ancestor
110770195|NCT01169688|Respiratory System Agents|respiratory system agents|mesh-ancestor
110770196|NCT01169688|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110770197|NCT01169688|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110770198|NCT01169688|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110770199|NCT01169688|Adrenergic Agents|adrenergic agents|mesh-ancestor
110770200|NCT01169688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110770201|NCT01169688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110770202|NCT01169688|Protective Agents|protective agents|mesh-ancestor
110770203|NCT01169688|Parasympatholytics|parasympatholytics|mesh-ancestor
110770204|NCT01169688|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110770205|NCT01169688|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110770206|NCT01169688|Cholinergic Agents|cholinergic agents|mesh-ancestor
110770207|NCT01278264|Ropivacaine|ropivacaine|mesh-list
110770208|NCT01278264|Anesthetics, Local|anesthetics, local|mesh-ancestor
110770209|NCT01278264|Anesthetics|anesthetics|mesh-ancestor
110770210|NCT01278264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110770211|NCT01278264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110770212|NCT01278264|Sensory System Agents|sensory system agents|mesh-ancestor
110770213|NCT01278264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110770214|NCT01172652|Ziprasidone|ziprasidone|mesh-list
110770215|NCT01172652|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110770216|NCT01172652|Serotonin Agents|serotonin agents|mesh-ancestor
110770217|NCT01172652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110770218|NCT01172652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110770219|NCT01172652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110770220|NCT01172652|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110770221|NCT01172652|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110770222|NCT01172652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110770223|NCT01172652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110770224|NCT01172652|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110770225|NCT01172652|Dopamine Agents|dopamine agents|mesh-ancestor
110770226|NCT02526030|Aripiprazole|aripiprazole|mesh-list
110770227|NCT02526030|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110770228|NCT02526030|Ziprasidone|ziprasidone|mesh-list
110770229|NCT02526030|Antidepressive Agents|antidepressive agents|mesh-ancestor
110770230|NCT02526030|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110487928|NCT05967052|Anticonvulsants|anticonvulsants|mesh-ancestor
110770231|NCT02526030|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110770232|NCT02526030|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110770233|NCT02526030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110770234|NCT02526030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110770235|NCT02526030|Dopamine Agonists|dopamine agonists|mesh-ancestor
110770237|NCT02526030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110770238|NCT02526030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110770239|NCT02526030|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110770240|NCT02526030|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110770241|NCT02526030|Serotonin Agents|serotonin agents|mesh-ancestor
110770242|NCT02526030|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110770243|NCT02526030|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110770244|NCT02526030|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110770245|NCT02526030|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110770246|NCT03867240|Gabapentin|gabapentin|mesh-list
110770247|NCT03867240|Analgesics|analgesics|mesh-ancestor
110770248|NCT03867240|Sensory System Agents|sensory system agents|mesh-ancestor
110770249|NCT03867240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110870641|NCT02392702|Ivacaftor|ivacaftor|mesh-list
110770250|NCT03867240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110770251|NCT03867240|Anticonvulsants|anticonvulsants|mesh-ancestor
110770252|NCT03867240|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110770253|NCT03867240|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110770254|NCT03867240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110770255|NCT03867240|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110770256|NCT03867240|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110770257|NCT03867240|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110770258|NCT03867240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110770259|NCT03867240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110770260|NCT03867240|Antimanic Agents|antimanic agents|mesh-ancestor
110770261|NCT01172964|Flucytosine|flucytosine|mesh-list
110770262|NCT01172964|Antifungal Agents|antifungal agents|mesh-ancestor
110770263|NCT01172964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110770264|NCT01172964|Antimetabolites|antimetabolites|mesh-ancestor
110770265|NCT01172964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110770266|NCT03866928|Stiripentol|stiripentol|mesh-list
110770267|NCT03866928|Anticonvulsants|anticonvulsants|mesh-ancestor
110770268|NCT01172496|Treprostinil|treprostinil|mesh-list
110770269|NCT01172496|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110770270|NCT01178034|Warfarin|warfarin|mesh-list
110770271|NCT01178034|Anticoagulants|anticoagulants|mesh-ancestor
110770272|NCT01288170|Tobramycin|tobramycin|mesh-list
110770273|NCT01288170|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110770274|NCT01288170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110770275|NCT01178112|Carboplatin|carboplatin|mesh-list
110770276|NCT01178112|Trientine|trientine|mesh-list
110770277|NCT01178112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110770278|NCT01178112|Chelating Agents|chelating agents|mesh-ancestor
110770279|NCT01178112|Sequestering Agents|sequestering agents|mesh-ancestor
110770280|NCT01178112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110770281|NCT01175460|Nedaplatin|nedaplatin|mesh-list
110770282|NCT01175460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110770283|NCT01175538|Lactulose|lactulose|mesh-list
110770284|NCT01175538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110770285|NCT01288326|Liraglutide|liraglutide|mesh-list
110770286|NCT01288326|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110770287|NCT01288326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110770288|NCT01288326|Incretins|incretins|mesh-ancestor
110770289|NCT01288326|Hormones|hormones|mesh-ancestor
110770290|NCT01288326|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110770291|NCT01173510|Raltegravir Potassium|raltegravir potassium|mesh-list
110770292|NCT01173510|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110770293|NCT01173510|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110770294|NCT01173510|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110770295|NCT01173510|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110770296|NCT01173510|Antiviral Agents|antiviral agents|mesh-ancestor
110770297|NCT01173510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110770298|NCT01173510|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110770299|NCT01173510|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110770300|NCT01173510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110770301|NCT01173510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110770302|NCT01173510|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110770303|NCT01173510|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110770304|NCT03435640|Nivolumab|nivolumab|mesh-list
110770305|NCT03435640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110770306|NCT03435640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110770307|NCT03435640|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110770308|NCT03435640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110770310|NCT01175772|Methotrexate|methotrexate|mesh-list
110770311|NCT01175772|Cyclophosphamide|cyclophosphamide|mesh-list
110770312|NCT01175772|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110770313|NCT01175772|Abortifacient Agents|abortifacient agents|mesh-ancestor
110770314|NCT01175772|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110870649|NCT02397928|Carboplatin|carboplatin|mesh-list
110770315|NCT01175772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110770316|NCT01175772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110770317|NCT01175772|Antimetabolites|antimetabolites|mesh-ancestor
110770318|NCT01175772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110770319|NCT01175772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110770320|NCT01175772|Dermatologic Agents|dermatologic agents|mesh-ancestor
110770321|NCT01175772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110770322|NCT01175772|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110770323|NCT01175772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110770324|NCT01175772|Immunologic Factors|immunologic factors|mesh-ancestor
110770325|NCT01175772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110770326|NCT01175772|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110770327|NCT01175772|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110770328|NCT01175772|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110770329|NCT01175772|Analgesics|analgesics|mesh-ancestor
110770330|NCT01175772|Sensory System Agents|sensory system agents|mesh-ancestor
110770331|NCT01175772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110770332|NCT01175772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110770333|NCT01175772|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110770334|NCT01175772|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110770335|NCT01175772|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110770336|NCT01175772|Alkylating Agents|alkylating agents|mesh-ancestor
110770337|NCT01175772|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110770338|NCT03395392|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
110770339|NCT03395392|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110770340|NCT03395392|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110770341|NCT03395392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110770342|NCT03395392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110770343|NCT03395392|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110770344|NCT03395392|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
110770345|NCT03395392|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110770346|NCT03395392|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110770347|NCT03395392|Adrenergic Agents|adrenergic agents|mesh-ancestor
110770348|NCT03395392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110770349|NCT03395392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110770350|NCT03395392|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110770351|NCT03395392|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110770352|NCT03395392|Serotonin Agents|serotonin agents|mesh-ancestor
110770353|NCT03395392|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110770354|NCT03395392|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110770355|NCT03395392|Dopamine Agents|dopamine agents|mesh-ancestor
110770356|NCT01536964|Morphine|morphine|mesh-list
110770357|NCT01536964|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110770358|NCT01536964|Narcotics|narcotics|mesh-ancestor
110770359|NCT01536964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110770360|NCT01536964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110770361|NCT01536964|Analgesics|analgesics|mesh-ancestor
110770362|NCT01536964|Sensory System Agents|sensory system agents|mesh-ancestor
110770363|NCT01536964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110770364|NCT01288404|Fluorometholone|fluorometholone|mesh-list
110770365|NCT01288404|Bevacizumab|bevacizumab|mesh-list
110770366|NCT01288404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110770367|NCT01288404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110770368|NCT01288404|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110770369|NCT01288404|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110770370|NCT01288404|Growth Substances|growth substances|mesh-ancestor
110770371|NCT01288404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110770372|NCT01288404|Growth Inhibitors|growth inhibitors|mesh-ancestor
110770373|NCT01288404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110770374|NCT01288404|Glucocorticoids|glucocorticoids|mesh-ancestor
110770375|NCT01288404|Hormones|hormones|mesh-ancestor
110770376|NCT01288404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110770377|NCT01288404|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110770378|NCT03860220|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
110488076|NCT05741060|Equol|equol|mesh-list
110770379|NCT03860220|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110770380|NCT03860220|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110770381|NCT03860220|Antimetabolites|antimetabolites|mesh-ancestor
110770382|NCT03860220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110770383|NCT03860220|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110770384|NCT03860220|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110770385|NCT03860220|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110770386|NCT03860220|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110770387|NCT03860220|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110770388|NCT03860220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110770389|NCT03860220|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110770390|NCT03860220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110770391|NCT01286688|Terbinafine|terbinafine|mesh-list
110770392|NCT01286688|Antifungal Agents|antifungal agents|mesh-ancestor
110770393|NCT01286688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110770394|NCT01286688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110770395|NCT01286688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110770396|NCT01286766|Cisplatin|cisplatin|mesh-list
110770397|NCT01286766|Docetaxel|docetaxel|mesh-list
110770398|NCT01286766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110770399|NCT01286766|Tubulin Modulators|tubulin modulators|mesh-ancestor
110770400|NCT01286766|Antimitotic Agents|antimitotic agents|mesh-ancestor
110770401|NCT01286766|Mitosis Modulators|mitosis modulators|mesh-ancestor
110770402|NCT01286766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110770403|NCT02525484|Pirfenidone|pirfenidone|mesh-list
110770404|NCT02525484|Analgesics|analgesics|mesh-ancestor
110770405|NCT02525484|Sensory System Agents|sensory system agents|mesh-ancestor
110770406|NCT02525484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110770407|NCT02525484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110770408|NCT02525484|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110770409|NCT02525484|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110770410|NCT02525484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110770411|NCT02525484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110770412|NCT02525484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110770413|NCT01173978|Prednisolone|prednisolone|mesh-list
110770414|NCT01173978|Hormones|hormones|mesh-list
110770415|NCT01173978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110770416|NCT01173978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110770417|NCT01173978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110770418|NCT01173978|Glucocorticoids|glucocorticoids|mesh-ancestor
110770419|NCT01173978|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110770420|NCT01173978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110770421|NCT01174056|Pioglitazone|pioglitazone|mesh-list
110770422|NCT01174056|Zileuton|zileuton|mesh-list
110770423|NCT01174056|Hydroxyurea|hydroxyurea|mesh-list
110770424|NCT01174056|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110770425|NCT01174056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110770426|NCT01174056|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110770427|NCT01174056|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110770428|NCT01174056|Analgesics|analgesics|mesh-ancestor
110770429|NCT01174056|Sensory System Agents|sensory system agents|mesh-ancestor
110770430|NCT01174056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110770431|NCT01174056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110770432|NCT01174056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110770433|NCT01174056|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
110770434|NCT01174056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110770435|NCT01174056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110770436|NCT01174056|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110770437|NCT01174056|Hormone Antagonists|hormone antagonists|mesh-ancestor
110770438|NCT01174056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110770439|NCT01174056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110770440|NCT01174056|Antisickling Agents|antisickling agents|mesh-ancestor
110770441|NCT01174056|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110770442|NCT01174212|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110770443|NCT01174212|Vancomycin|vancomycin|mesh-list
110770444|NCT01174212|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
110770445|NCT01174212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110770446|NCT01174212|Antitubercular Agents|antitubercular agents|mesh-ancestor
110770447|NCT01174290|Haloperidol|haloperidol|mesh-list
110770448|NCT01174290|Haloperidol decanoate|haloperidol decanoate|mesh-list
110770449|NCT01174290|Antiemetics|antiemetics|mesh-ancestor
110770450|NCT01174290|Autonomic Agents|autonomic agents|mesh-ancestor
110770451|NCT01174290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110770452|NCT01174290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110770453|NCT01174290|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110770454|NCT01174290|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110770455|NCT01174290|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110770456|NCT01174290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110770457|NCT01174290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110770458|NCT01174290|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110770459|NCT01174290|Dopamine Agents|dopamine agents|mesh-ancestor
110770460|NCT01174290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110770461|NCT01174290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110770462|NCT01174290|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110770463|NCT03862404|Epinephrine|epinephrine|mesh-list
110770464|NCT03862404|Bupivacaine|bupivacaine|mesh-list
110770465|NCT03862404|Anesthetics, Local|anesthetics, local|mesh-ancestor
110770466|NCT03862404|Anesthetics|anesthetics|mesh-ancestor
110770467|NCT03862404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110770468|NCT03862404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110770469|NCT03862404|Sensory System Agents|sensory system agents|mesh-ancestor
110770470|NCT03862404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110770471|NCT03862404|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110770472|NCT03862404|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110770473|NCT03862404|Adrenergic Agents|adrenergic agents|mesh-ancestor
110770474|NCT03862404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110770475|NCT03862404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110770476|NCT03862404|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110770477|NCT03862404|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110770478|NCT03862404|Autonomic Agents|autonomic agents|mesh-ancestor
110770479|NCT03862404|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110770480|NCT03862404|Respiratory System Agents|respiratory system agents|mesh-ancestor
110770481|NCT03862404|Mydriatics|mydriatics|mesh-ancestor
110770482|NCT03862404|Sympathomimetics|sympathomimetics|mesh-ancestor
110770483|NCT03862404|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110770484|NCT03865680|Fluorides|fluorides|mesh-list
110770485|NCT03865680|Sodium Fluoride|sodium fluoride|mesh-list
110770486|NCT03865680|Fluorides, Topical|fluorides, topical|mesh-list
110770487|NCT03865680|Sodium fluoride topical preparation|sodium fluoride topical preparation|mesh-list
110770488|NCT03865680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110770489|NCT03865680|Cariostatic Agents|cariostatic agents|mesh-ancestor
110770490|NCT03865680|Protective Agents|protective agents|mesh-ancestor
110770491|NCT01288716|Baclofen|baclofen|mesh-list
110770492|NCT01288716|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110770493|NCT01288716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110770494|NCT01288716|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110770495|NCT01288716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110770496|NCT01288716|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
110770497|NCT01288716|GABA Agonists|gaba agonists|mesh-ancestor
110770498|NCT01288716|GABA Agents|gaba agents|mesh-ancestor
110770499|NCT01288716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110770500|NCT01288716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110770501|NCT01285596|Mirabegron|mirabegron|mesh-list
110770502|NCT01285596|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
110770503|NCT01285596|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110770504|NCT01285596|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110770505|NCT01285596|Adrenergic Agents|adrenergic agents|mesh-ancestor
110770506|NCT01285596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110445785|NCT04121611|Analgesics|analgesics|mesh-ancestor
110333332|NCT00485004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110770507|NCT01285596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110770509|NCT01285596|Urological Agents|urological agents|mesh-ancestor
110770510|NCT00655876|Paclitaxel|paclitaxel|mesh-list
110770511|NCT00655876|Cetuximab|cetuximab|mesh-list
110870672|NCT02397772|Albendazole|albendazole|mesh-list
110770512|NCT00655876|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110770513|NCT00655876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110770514|NCT00655876|Tubulin Modulators|tubulin modulators|mesh-ancestor
110770515|NCT00655876|Antimitotic Agents|antimitotic agents|mesh-ancestor
110770516|NCT00655876|Mitosis Modulators|mitosis modulators|mesh-ancestor
110770517|NCT00655876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110770518|NCT00655876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110770519|NCT01176318|Erdosteine|erdosteine|mesh-list
110770520|NCT01176318|Expectorants|expectorants|mesh-ancestor
110770521|NCT01176318|Respiratory System Agents|respiratory system agents|mesh-ancestor
110770522|NCT01178658|Cytarabine|cytarabine|mesh-list
110770523|NCT01178658|Etoposide|etoposide|mesh-list
110770524|NCT01178658|Melphalan|melphalan|mesh-list
110770525|NCT01178658|Busulfan|busulfan|mesh-list
110770526|NCT01178658|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110770527|NCT01178658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110770528|NCT01178658|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110770529|NCT01178658|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110770530|NCT01178658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110770531|NCT01178658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110770532|NCT01178658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110770533|NCT01178658|Antimetabolites|antimetabolites|mesh-ancestor
110770534|NCT01178658|Antiviral Agents|antiviral agents|mesh-ancestor
110770535|NCT01178658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110770536|NCT01178658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110770537|NCT01178658|Immunologic Factors|immunologic factors|mesh-ancestor
110770538|NCT01178658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110770539|NCT01178658|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110770540|NCT01178658|Alkylating Agents|alkylating agents|mesh-ancestor
110770541|NCT01178658|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110770542|NCT03092752|Hypoglycemic Agents|hypoglycemic agents|mesh-list
110770543|NCT03092752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110770544|NCT01174524|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110770545|NCT01174524|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110770546|NCT01174524|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110770547|NCT01174524|Gestodene|gestodene|mesh-list
110770548|NCT01174524|Femovan|femovan|mesh-list
110770549|NCT01174524|Contraceptive Agents|contraceptive agents|mesh-list
110770550|NCT01174524|Contraceptives, Oral|contraceptives, oral|mesh-list
110770551|NCT01174524|Estradiol|estradiol|mesh-list
110770552|NCT01174524|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110770553|NCT01174524|Estrogens|estrogens|mesh-ancestor
110770554|NCT01174524|Hormones|hormones|mesh-ancestor
110770555|NCT01174524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110770556|NCT01174524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110770557|NCT01174524|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110770558|NCT01174524|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110770559|NCT01174524|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110770560|NCT01174524|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110770561|NCT01174524|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110770562|NCT01174524|Progestins|progestins|mesh-ancestor
110770563|NCT01174524|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110770564|NCT02525172|Rituximab|rituximab|mesh-list
110770565|NCT02525172|Methotrexate|methotrexate|mesh-list
110770566|NCT02525172|Bortezomib|bortezomib|mesh-list
110770567|NCT02525172|Immunoglobulins|immunoglobulins|mesh-list
110770568|NCT02525172|Antibodies|antibodies|mesh-list
110770569|NCT02525172|gamma-Globulins|gamma-globulins|mesh-list
110770570|NCT02525172|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110770571|NCT02525172|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110770572|NCT02525172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110770573|NCT02525172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110770574|NCT02525172|Immunologic Factors|immunologic factors|mesh-ancestor
110770575|NCT02525172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110770576|NCT02525172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110870684|NCT03592277|Vitamins|vitamins|mesh-list
110770577|NCT02525172|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110770578|NCT02525172|Abortifacient Agents|abortifacient agents|mesh-ancestor
110770579|NCT02525172|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110770580|NCT02525172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110445805|NCT02771392|Tetracaine|tetracaine|mesh-list
110770582|NCT02525172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110770583|NCT02525172|Dermatologic Agents|dermatologic agents|mesh-ancestor
110770584|NCT02525172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110770585|NCT02525172|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110770586|NCT02525172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110770587|NCT02525172|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110770588|NCT01285674|Cisplatin|cisplatin|mesh-list
110770589|NCT01285674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110770590|NCT03859362|Ertapenem|ertapenem|mesh-list
110770591|NCT03859362|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110770592|NCT03859362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110770593|NCT01287546|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110770594|NCT01287546|Trametinib|trametinib|mesh-list
110770595|NCT01287546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110770596|NCT01287546|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110770597|NCT01287546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110770598|NCT01287546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110770599|NCT03182166|Golimumab|golimumab|mesh-list
110770600|NCT03182166|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110770601|NCT03182166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110770602|NCT03182166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110770603|NCT03182166|Immunologic Factors|immunologic factors|mesh-ancestor
110770604|NCT03182166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110770605|NCT03193216|Alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|mesh-list
110770606|NCT03193216|Antacids|antacids|mesh-ancestor
110770607|NCT03193216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110770608|NCT03193216|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110770609|NCT03864978|Rifaximin|rifaximin|mesh-list
110770610|NCT03864978|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110770611|NCT03864978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110770612|NCT03864978|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110770613|NCT01568788|Vaccines|vaccines|mesh-list
110770614|NCT01568788|Immunologic Factors|immunologic factors|mesh-ancestor
110770615|NCT01568788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110770616|NCT01287624|Paclitaxel|paclitaxel|mesh-list
110770617|NCT01287624|Gemcitabine|gemcitabine|mesh-list
110770618|NCT01287624|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110770619|NCT01287624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110770620|NCT01287624|Tubulin Modulators|tubulin modulators|mesh-ancestor
110770621|NCT01287624|Antimitotic Agents|antimitotic agents|mesh-ancestor
110770622|NCT01287624|Mitosis Modulators|mitosis modulators|mesh-ancestor
110770623|NCT01287624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110770624|NCT01287624|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110770625|NCT01287624|Antimetabolites|antimetabolites|mesh-ancestor
110770626|NCT05597800|Nivolumab|nivolumab|mesh-list
110770627|NCT05597800|Ipilimumab|ipilimumab|mesh-list
110770628|NCT05597800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110770629|NCT05597800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110770630|NCT05597800|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110770631|NCT05597800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110770632|NCT01176552|Interferon-alpha|interferon-alpha|mesh-list
110770633|NCT01176552|Interferon alpha-2|interferon alpha-2|mesh-list
110770634|NCT01176552|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
110770635|NCT01176552|Antiviral Agents|antiviral agents|mesh-ancestor
110770636|NCT01176552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110770637|NCT01176552|Immunologic Factors|immunologic factors|mesh-ancestor
110770638|NCT01176552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110770639|NCT01176552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110770640|NCT01179438|Dexmedetomidine|dexmedetomidine|mesh-list
110770641|NCT01179438|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110770642|NCT01179438|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110770643|NCT01179438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110770644|NCT01179438|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110770645|NCT01179438|Analgesics|analgesics|mesh-ancestor
110770646|NCT01179438|Sensory System Agents|sensory system agents|mesh-ancestor
110770647|NCT01179438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110770648|NCT01179438|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110770649|NCT01179438|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110770650|NCT01179438|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110770651|NCT01179438|Adrenergic Agents|adrenergic agents|mesh-ancestor
110770652|NCT01179438|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110770653|NCT01179438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110770654|NCT03864666|Cilostazol|cilostazol|mesh-list
110770655|NCT03864666|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110770656|NCT03864666|Autonomic Agents|autonomic agents|mesh-ancestor
110770657|NCT03864666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110770658|NCT03864666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110770659|NCT03864666|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110770660|NCT03864666|Respiratory System Agents|respiratory system agents|mesh-ancestor
110770661|NCT03864666|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110770662|NCT03864666|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110770663|NCT03864666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110770664|NCT03864666|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110770665|NCT03864666|Vasodilator Agents|vasodilator agents|mesh-ancestor
110770666|NCT03864666|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110770667|NCT03864666|Protective Agents|protective agents|mesh-ancestor
110770668|NCT03864666|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110770669|NCT03864666|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110770670|NCT03864666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110770671|NCT03858972|Capecitabine|capecitabine|mesh-list
110770672|NCT03858972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110770673|NCT03858972|Antimetabolites|antimetabolites|mesh-ancestor
110770674|NCT03858972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110770675|NCT03858972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110770676|NCT03091348|Methyltestosterone|methyltestosterone|mesh-list
110770677|NCT03091348|Testosterone|testosterone|mesh-list
110770678|NCT03091348|Testosterone undecanoate|testosterone undecanoate|mesh-list
110770679|NCT03091348|Testosterone enanthate|testosterone enanthate|mesh-list
110870718|NCT02397382|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110770680|NCT03091348|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
110770681|NCT03091348|Androgens|androgens|mesh-ancestor
110770682|NCT03091348|Hormones|hormones|mesh-ancestor
110770683|NCT03091348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110770684|NCT03091348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110770685|NCT03091348|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110770686|NCT03091348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110770687|NCT03091348|Anabolic Agents|anabolic agents|mesh-ancestor
110770688|NCT02525016|Lidocaine|lidocaine|mesh-list
110770689|NCT02525016|Anesthetics, Local|anesthetics, local|mesh-ancestor
110770690|NCT02525016|Anesthetics|anesthetics|mesh-ancestor
110770691|NCT02525016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110770692|NCT02525016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110770693|NCT02525016|Sensory System Agents|sensory system agents|mesh-ancestor
110770694|NCT02525016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110770695|NCT02525016|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110770696|NCT02525016|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110770697|NCT02525016|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110770698|NCT02525016|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110770699|NCT02525016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110770700|NCT01179594|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110770701|NCT01179594|Interferon-alpha|interferon-alpha|mesh-list
110770702|NCT01179594|Entecavir|entecavir|mesh-list
110770703|NCT01179594|Antiviral Agents|antiviral agents|mesh-ancestor
110770704|NCT01179594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110770705|NCT01179594|Immunologic Factors|immunologic factors|mesh-ancestor
110770706|NCT01179594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110770707|NCT03751098|Phenylephrine|phenylephrine|mesh-list
110770708|NCT03751098|Oxymetazoline|oxymetazoline|mesh-list
110770709|NCT03751098|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110770710|NCT03751098|Tropicamide|tropicamide|mesh-list
110770711|NCT03751098|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110770712|NCT03751098|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110770713|NCT03751098|Mydriatics|mydriatics|mesh-ancestor
110770714|NCT03751098|Autonomic Agents|autonomic agents|mesh-ancestor
110770715|NCT03751098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110770716|NCT03751098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110770717|NCT03751098|Sympathomimetics|sympathomimetics|mesh-ancestor
110770718|NCT03751098|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110770719|NCT03751098|Nasal Decongestants|nasal decongestants|mesh-ancestor
110770720|NCT03751098|Respiratory System Agents|respiratory system agents|mesh-ancestor
110770721|NCT03751098|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110770722|NCT03751098|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110770723|NCT03751098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110770724|NCT03751098|Adrenergic Agents|adrenergic agents|mesh-ancestor
110770725|NCT03751098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110770726|NCT03751098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110770727|NCT03751098|Protective Agents|protective agents|mesh-ancestor
110770728|NCT03751098|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110770729|NCT03751098|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110770730|NCT03751098|Cholinergic Agents|cholinergic agents|mesh-ancestor
110770731|NCT01176708|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
110770732|NCT01176708|Protease Inhibitors|protease inhibitors|mesh-ancestor
110770733|NCT01176708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110770734|NCT01176708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110770735|NCT01176708|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110770736|NCT01176708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110770737|NCT01288794|Furosemide|furosemide|mesh-list
110770738|NCT01288794|Diuretics|diuretics|mesh-list
110770739|NCT01288794|Natriuretic Agents|natriuretic agents|mesh-ancestor
110770740|NCT01288794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110770741|NCT01288794|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110770742|NCT01288794|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110770743|NCT01288794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110770744|NCT01288872|Praziquantel|praziquantel|mesh-list
110770745|NCT01288872|Anthelmintics|anthelmintics|mesh-ancestor
110770746|NCT01288872|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110770747|NCT01288872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110770748|NCT03864588|Ropivacaine|ropivacaine|mesh-list
110770749|NCT03864588|Anesthetics, Local|anesthetics, local|mesh-ancestor
110770750|NCT03864588|Anesthetics|anesthetics|mesh-ancestor
110770751|NCT03864588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110770752|NCT03864588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110770753|NCT03864588|Sensory System Agents|sensory system agents|mesh-ancestor
110770754|NCT03864588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110770755|NCT01288950|Vitamin D|vitamin d|mesh-list
110770756|NCT01288950|Ergocalciferols|ergocalciferols|mesh-list
110770757|NCT01288950|Cholecalciferol|cholecalciferol|mesh-list
110770758|NCT01288950|Vitamins|vitamins|mesh-list
110770759|NCT01288950|Micronutrients|micronutrients|mesh-ancestor
110770760|NCT01288950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110770761|NCT01288950|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110770762|NCT01288950|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110770763|NCT01174914|Tenofovir|tenofovir|mesh-list
110770764|NCT01174914|Lamivudine|lamivudine|mesh-list
110770765|NCT01174914|Emtricitabine|emtricitabine|mesh-list
110770766|NCT01174914|Efavirenz|efavirenz|mesh-list
110770767|NCT01174914|Lopinavir|lopinavir|mesh-list
110770768|NCT01174914|Nevirapine|nevirapine|mesh-list
110770769|NCT01174914|Stavudine|stavudine|mesh-list
110770770|NCT01174914|Stavudine, lamivudine, nevirapine drug combination|stavudine, lamivudine, nevirapine drug combination|mesh-list
110770771|NCT01174914|Naltrexone|naltrexone|mesh-list
110770772|NCT01174914|Antiviral Agents|antiviral agents|mesh-ancestor
110770773|NCT01174914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110770774|NCT01174914|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110770775|NCT01174914|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110770776|NCT01174914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110770777|NCT01174914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110770778|NCT01174914|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110770779|NCT01174914|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110770780|NCT01174914|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110770781|NCT01174914|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110770782|NCT01174914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110770783|NCT01174914|Sensory System Agents|sensory system agents|mesh-ancestor
110770784|NCT01174914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110770785|NCT01174914|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110770786|NCT01174914|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110770787|NCT01174914|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110770788|NCT01174914|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110770789|NCT01174914|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110770790|NCT01174914|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110770791|NCT01174914|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110770792|NCT01174914|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110770793|NCT01174914|Protease Inhibitors|protease inhibitors|mesh-ancestor
110770794|NCT01174914|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110770795|NCT01174914|Antimetabolites|antimetabolites|mesh-ancestor
110770796|NCT05548426|Linezolid|linezolid|mesh-list
110770797|NCT05548426|Penicillins|penicillins|mesh-list
110770798|NCT05548426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110770799|NCT05548426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110770800|NCT05548426|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110333493|NCT01241487|Valsartan|valsartan|mesh-list
110770801|NCT05548426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110770802|NCT05548426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110770803|NCT03102892|Anti-Infective Agents|anti-infective agents|mesh-list
110770804|NCT03102892|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110770805|NCT01177176|Bupropion|bupropion|mesh-list
110770806|NCT01177176|Nicotine|nicotine|mesh-list
110770807|NCT01177176|Varenicline|varenicline|mesh-list
110770808|NCT01177176|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110770809|NCT01177176|Autonomic Agents|autonomic agents|mesh-ancestor
110770810|NCT01177176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110770811|NCT01177176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110770812|NCT01177176|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110770813|NCT01177176|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110770814|NCT01177176|Cholinergic Agents|cholinergic agents|mesh-ancestor
110770815|NCT01177176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110770816|NCT01177176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110770817|NCT01177176|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110770818|NCT01177176|Antidepressive Agents|antidepressive agents|mesh-ancestor
110770819|NCT01177176|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110770820|NCT01177176|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110770821|NCT01177176|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110770822|NCT01177176|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110770823|NCT01177176|Dopamine Agents|dopamine agents|mesh-ancestor
110770824|NCT01177176|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110770825|NCT01177176|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110770826|NCT01177176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110770827|NCT01287780|Gentamicins|gentamicins|mesh-list
110770828|NCT01287780|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110770829|NCT01287780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110770830|NCT01287780|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110770831|NCT01287780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110770832|NCT01287780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110770834|NCT01179828|Clobazam|clobazam|mesh-list
110770835|NCT01179828|Imipramine|imipramine|mesh-list
110770836|NCT01179828|Tolterodine Tartrate|tolterodine tartrate|mesh-list
110770837|NCT01179828|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110770838|NCT01179828|Narcotics|narcotics|mesh-ancestor
110770839|NCT01179828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110770840|NCT01179828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110770841|NCT01179828|Analgesics|analgesics|mesh-ancestor
110770842|NCT01179828|Sensory System Agents|sensory system agents|mesh-ancestor
110770843|NCT01179828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110770844|NCT01179828|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110770845|NCT01179828|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110770846|NCT01179828|Cholinergic Agents|cholinergic agents|mesh-ancestor
110770847|NCT01179828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110770848|NCT01179828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110770849|NCT01179828|Urological Agents|urological agents|mesh-ancestor
110770850|NCT01179828|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110770851|NCT01179828|Antidepressive Agents|antidepressive agents|mesh-ancestor
110770852|NCT01179828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110770853|NCT01179828|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110770854|NCT01179828|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110770855|NCT01179828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110770856|NCT01179828|Adrenergic Agents|adrenergic agents|mesh-ancestor
110770857|NCT01179828|Anticonvulsants|anticonvulsants|mesh-ancestor
110770858|NCT01179828|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110770859|NCT01179828|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110770860|NCT01179828|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
110770861|NCT01179828|GABA Agonists|gaba agonists|mesh-ancestor
110770862|NCT01179828|GABA Agents|gaba agents|mesh-ancestor
110770863|NCT01180062|Latanoprost|latanoprost|mesh-list
110770864|NCT01180062|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110770865|NCT01180062|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110770866|NCT03858582|Pembrolizumab|pembrolizumab|mesh-list
110770867|NCT03858582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110770868|NCT03858582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110770869|NCT03858582|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110770870|NCT03858582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110770871|NCT01177566|Pimecrolimus|pimecrolimus|mesh-list
110770872|NCT01177566|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110770873|NCT01177566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110770874|NCT01177566|Analgesics|analgesics|mesh-ancestor
110770875|NCT01177566|Sensory System Agents|sensory system agents|mesh-ancestor
110770876|NCT01177566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110770877|NCT01177566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110770878|NCT01177566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110770879|NCT01177566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110770880|NCT01177566|Dermatologic Agents|dermatologic agents|mesh-ancestor
110770881|NCT01177566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110770882|NCT01177566|Immunologic Factors|immunologic factors|mesh-ancestor
110770883|NCT01177566|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110770884|NCT01177566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110770885|NCT01177566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110770886|NCT01181154|Rituximab|rituximab|mesh-list
110770887|NCT01181154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110770888|NCT01181154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110770889|NCT01181154|Immunologic Factors|immunologic factors|mesh-ancestor
110770890|NCT01181154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110770891|NCT01181154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110770892|NCT03101566|Gemcitabine|gemcitabine|mesh-list
110770893|NCT03101566|Nivolumab|nivolumab|mesh-list
110770894|NCT03101566|Ipilimumab|ipilimumab|mesh-list
110770895|NCT03101566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110770896|NCT03101566|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110770897|NCT03101566|Antimetabolites|antimetabolites|mesh-ancestor
110770898|NCT03101566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110770899|NCT03101566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110770900|NCT03101566|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110770901|NCT01289496|Interferons|interferons|mesh-list
110770902|NCT01289496|Ribavirin|ribavirin|mesh-list
110770903|NCT01289496|Interferon-alpha|interferon-alpha|mesh-list
110488605|NCT03662074|Gemcitabine|gemcitabine|mesh-list
110770904|NCT01289496|Interferon alpha-2|interferon alpha-2|mesh-list
110770905|NCT01289496|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110770906|NCT01289496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110770907|NCT01289496|Antiviral Agents|antiviral agents|mesh-ancestor
110770908|NCT01289496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110770909|NCT01289496|Antimetabolites|antimetabolites|mesh-ancestor
110770910|NCT01289496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110770911|NCT01289496|Immunologic Factors|immunologic factors|mesh-ancestor
110770912|NCT01289496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110770913|NCT01181232|Zolpidem|zolpidem|mesh-list
110770914|NCT01181232|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110770915|NCT01181232|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110770916|NCT01181232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110770917|NCT01181232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110770918|NCT01181232|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
110770919|NCT01181232|GABA Agonists|gaba agonists|mesh-ancestor
110770920|NCT01181232|GABA Agents|gaba agents|mesh-ancestor
110770921|NCT01181232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110770922|NCT01181232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110770923|NCT01181310|Scopolamine|scopolamine|mesh-list
110770924|NCT01181310|Donepezil|donepezil|mesh-list
110770925|NCT01181310|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
110770926|NCT01181310|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110770927|NCT01181310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110770928|NCT01181310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110770929|NCT01181310|Cholinergic Agents|cholinergic agents|mesh-ancestor
110770930|NCT01181310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110770931|NCT01181310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110770932|NCT01181310|Nootropic Agents|nootropic agents|mesh-ancestor
110770933|NCT01181310|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110770934|NCT01181310|Antiemetics|antiemetics|mesh-ancestor
110770935|NCT01181310|Autonomic Agents|autonomic agents|mesh-ancestor
110770936|NCT01181310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110770937|NCT01181310|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110770938|NCT01181310|Mydriatics|mydriatics|mesh-ancestor
110770939|NCT01181310|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110770940|NCT01181310|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110770941|NCT01181310|Parasympatholytics|parasympatholytics|mesh-ancestor
110770942|NCT02525250|Lenalidomide|lenalidomide|mesh-list
110770943|NCT02525250|Immunologic Factors|immunologic factors|mesh-ancestor
110770944|NCT02525250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110770945|NCT02525250|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110770946|NCT02525250|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110770947|NCT02525250|Growth Substances|growth substances|mesh-ancestor
110770948|NCT02525250|Growth Inhibitors|growth inhibitors|mesh-ancestor
110770949|NCT02525250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110770950|NCT01288092|Dactolisib|dactolisib|mesh-list
110770951|NCT01288092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110770952|NCT01290744|Clofazimine|clofazimine|mesh-list
110770953|NCT01290744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110770954|NCT01290744|Leprostatic Agents|leprostatic agents|mesh-ancestor
110770955|NCT01290744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110770956|NCT01290744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110770957|NCT01181388|Tirofiban|tirofiban|mesh-list
110770958|NCT01181388|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110770959|NCT01181388|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110770960|NCT01181388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110770961|NCT01181388|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110770962|NCT01181544|Heparin|heparin|mesh-list
110770963|NCT01181544|Anticoagulants|anticoagulants|mesh-ancestor
110770964|NCT01181544|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110770965|NCT01181544|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110770966|NCT01181544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110770967|NCT01184664|Nicotine|nicotine|mesh-list
110770968|NCT01184664|Varenicline|varenicline|mesh-list
110770969|NCT01184664|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110333544|NCT00485498|Olanzapine|olanzapine|mesh-list
110770970|NCT01184664|Autonomic Agents|autonomic agents|mesh-ancestor
110770971|NCT01184664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110770972|NCT01184664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110770973|NCT01184664|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110770974|NCT01184664|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110770975|NCT01184664|Cholinergic Agents|cholinergic agents|mesh-ancestor
110770976|NCT01184664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110770977|NCT01184664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110770978|NCT03858192|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110770979|NCT03858192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110770980|NCT01184820|Factor VIII|factor viii|mesh-list
110770981|NCT01184820|Coagulants|coagulants|mesh-ancestor
110770982|NCT03858270|Memantine|memantine|mesh-list
110770983|NCT03858270|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110770984|NCT03858270|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110770985|NCT03858270|Dopamine Agents|dopamine agents|mesh-ancestor
110770986|NCT03858270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110770987|NCT03858270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110770988|NCT03858270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110770989|NCT03858270|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110770990|NCT03858270|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110770991|NCT01289730|Etanercept|etanercept|mesh-list
110770992|NCT01289730|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110770993|NCT01289730|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110770994|NCT01289730|Analgesics|analgesics|mesh-ancestor
110770995|NCT01289730|Sensory System Agents|sensory system agents|mesh-ancestor
110770996|NCT01289730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110770997|NCT01289730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110770998|NCT01289730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110770999|NCT01289730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110771000|NCT01289730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110771001|NCT01289730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110771002|NCT01289730|Immunologic Factors|immunologic factors|mesh-ancestor
110771003|NCT01290900|Moxifloxacin|moxifloxacin|mesh-list
110771004|NCT01290900|Ceftazidime|ceftazidime|mesh-list
110771005|NCT01290900|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
110771006|NCT01290900|Avibactam|avibactam|mesh-list
110771007|NCT01290900|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110771008|NCT01290900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110771009|NCT01290900|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110771010|NCT01290900|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110771011|NCT01290900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110771012|NCT01290900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110771013|NCT01290900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110771014|NCT01290900|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110771015|NCT03855306|Glyburide|glyburide|mesh-list
110771016|NCT03855306|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110771017|NCT03855306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110771018|NCT03855384|Cisplatin|cisplatin|mesh-list
110771019|NCT03855384|Carboplatin|carboplatin|mesh-list
110771020|NCT03855384|Fluorouracil|fluorouracil|mesh-list
110771021|NCT03855384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110771022|NCT03855384|Antimetabolites|antimetabolites|mesh-ancestor
110771023|NCT03855384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110771024|NCT03855384|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110771025|NCT03855384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110771026|NCT03855384|Immunologic Factors|immunologic factors|mesh-ancestor
110771027|NCT03855384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110771028|NCT01181934|Nicotine|nicotine|mesh-list
110771029|NCT01181934|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110771030|NCT01181934|Autonomic Agents|autonomic agents|mesh-ancestor
110771031|NCT01181934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110771032|NCT01181934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110771033|NCT01181934|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110771034|NCT01181934|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110771035|NCT01181934|Cholinergic Agents|cholinergic agents|mesh-ancestor
110771036|NCT01181934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110771037|NCT01181934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110771038|NCT01187862|Efavirenz|efavirenz|mesh-list
110771039|NCT01187862|Losartan|losartan|mesh-list
110771040|NCT01187862|Metoprolol|metoprolol|mesh-list
110771041|NCT01187862|Midazolam|midazolam|mesh-list
110771042|NCT01187862|Caffeine|caffeine|mesh-list
110771043|NCT01187862|Chlorzoxazone|chlorzoxazone|mesh-list
110771044|NCT01187862|Omeprazole|omeprazole|mesh-list
110771045|NCT01187862|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110771046|NCT01187862|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110771047|NCT01187862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110771048|NCT01187862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110771049|NCT01187862|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110771050|NCT01187862|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110771051|NCT01187862|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110771052|NCT01187862|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110771053|NCT01187862|Anesthetics, General|anesthetics, general|mesh-ancestor
110771054|NCT01187862|Anesthetics|anesthetics|mesh-ancestor
110771055|NCT01187862|GABA Modulators|gaba modulators|mesh-ancestor
110488747|NCT03131908|GSK2636771|gsk2636771|mesh-list
110771056|NCT01187862|GABA Agents|gaba agents|mesh-ancestor
110771057|NCT01187862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110771058|NCT01187862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110771060|NCT01187862|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110771061|NCT01187862|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110771062|NCT01187862|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110771063|NCT01187862|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110771064|NCT01187862|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110771065|NCT01187862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110771066|NCT01187862|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110771067|NCT01187862|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110771068|NCT01187862|Purinergic Agents|purinergic agents|mesh-ancestor
110771069|NCT01187862|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110771070|NCT01187862|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110771071|NCT01187862|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110771072|NCT01187862|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110771073|NCT01187862|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110771074|NCT01187862|Antiviral Agents|antiviral agents|mesh-ancestor
110771075|NCT01187862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110771076|NCT01187862|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110771077|NCT01187862|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110771078|NCT01187862|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110771079|NCT01187862|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110771080|NCT01187862|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110771081|NCT01187862|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110771082|NCT01187862|Sympatholytics|sympatholytics|mesh-ancestor
110771083|NCT01187862|Autonomic Agents|autonomic agents|mesh-ancestor
110771084|NCT01187862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110771085|NCT01187862|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110771086|NCT01187862|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110771087|NCT01187862|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110771088|NCT01187862|Adrenergic Agents|adrenergic agents|mesh-ancestor
110771089|NCT01187862|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110771090|NCT01187862|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110771091|NCT01290042|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110771092|NCT01290042|Immunologic Factors|immunologic factors|mesh-ancestor
110771093|NCT01290042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110771094|NCT01185444|Hyaluronic Acid|hyaluronic acid|mesh-list
110771095|NCT01185444|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110771096|NCT01185444|Immunologic Factors|immunologic factors|mesh-ancestor
110771097|NCT01185444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110771098|NCT01185444|Viscosupplements|viscosupplements|mesh-ancestor
110771099|NCT01185444|Protective Agents|protective agents|mesh-ancestor
110771100|NCT03857334|Cortivazol|cortivazol|mesh-list
110771101|NCT03857334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110771102|NCT01185678|Contraceptive Agents|contraceptive agents|mesh-list
110771103|NCT01185678|Desogestrel|desogestrel|mesh-list
110771104|NCT01185678|Contraceptives, Oral|contraceptives, oral|mesh-list
110771105|NCT01185678|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
110771106|NCT01185678|Progestins|progestins|mesh-list
110771107|NCT01185678|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110771108|NCT01185678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110771109|NCT01185678|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110771110|NCT01185678|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110771111|NCT01185678|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110771112|NCT01185678|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110771113|NCT01185678|Hormones|hormones|mesh-ancestor
110771114|NCT01185678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110771115|NCT01188174|Clofarabine|clofarabine|mesh-list
110771116|NCT01188174|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110771117|NCT01188174|Antimetabolites|antimetabolites|mesh-ancestor
110771118|NCT01188174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110771119|NCT01188174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110771120|NCT01588002|Ritonavir|ritonavir|mesh-list
110771121|NCT01588002|Efavirenz|efavirenz|mesh-list
110771122|NCT01588002|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110771123|NCT01588002|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110771124|NCT01588002|Protease Inhibitors|protease inhibitors|mesh-ancestor
110771125|NCT01588002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110771126|NCT01588002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110771127|NCT01588002|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110771128|NCT01588002|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110771129|NCT01588002|Antiviral Agents|antiviral agents|mesh-ancestor
110771130|NCT01588002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110488830|NCT02914405|Nivolumab|nivolumab|mesh-list
110771131|NCT01588002|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110771132|NCT01588002|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110771133|NCT01588002|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110771134|NCT01588002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110771135|NCT01588002|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110771136|NCT01588002|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110771137|NCT01588002|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110771138|NCT01588002|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110771139|NCT01588002|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110771141|NCT01291212|Testosterone|testosterone|mesh-list
110771142|NCT01291212|Testosterone undecanoate|testosterone undecanoate|mesh-list
110771143|NCT01291212|Testosterone enanthate|testosterone enanthate|mesh-list
110771144|NCT01291212|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
110771145|NCT01291212|Androgens|androgens|mesh-ancestor
110771146|NCT01291212|Hormones|hormones|mesh-ancestor
110771147|NCT01291212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110771148|NCT01291212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110771149|NCT01291212|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110771150|NCT01291212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110771151|NCT01291212|Anabolic Agents|anabolic agents|mesh-ancestor
110771152|NCT01182168|Gemcitabine|gemcitabine|mesh-list
110771153|NCT01182168|Everolimus|everolimus|mesh-list
110771154|NCT01182168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110771155|NCT01182168|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110771156|NCT01182168|Antimetabolites|antimetabolites|mesh-ancestor
110771157|NCT01182168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110771158|NCT01182168|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110771159|NCT01182168|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110771160|NCT01182168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110771161|NCT01182168|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110771162|NCT01182168|Immunologic Factors|immunologic factors|mesh-ancestor
110771163|NCT01182168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110771164|NCT01182246|Genistein|genistein|mesh-list
110771165|NCT01182246|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110771166|NCT01182246|Protective Agents|protective agents|mesh-ancestor
110771167|NCT01182246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110771168|NCT01182246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110771169|NCT01182246|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110771170|NCT01182246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110771171|NCT01182246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110771172|NCT01182246|Phytoestrogens|phytoestrogens|mesh-ancestor
110771173|NCT01182246|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
110445813|NCT02771704|Iodine|iodine|mesh-list
110771175|NCT01182246|Hormones|hormones|mesh-ancestor
110771176|NCT01182246|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110771177|NCT01588626|Ticagrelor|ticagrelor|mesh-list
110771178|NCT01588626|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110771179|NCT01588626|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110771180|NCT01588626|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110771181|NCT01588626|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110771182|NCT01588626|Purinergic Agents|purinergic agents|mesh-ancestor
110771183|NCT01588626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110771184|NCT01588626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110771185|NCT01588626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110771186|NCT01290120|Rituximab|rituximab|mesh-list
110771187|NCT01290120|Doxorubicin|doxorubicin|mesh-list
110771188|NCT01290120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110771189|NCT01290120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110771190|NCT01290120|Immunologic Factors|immunologic factors|mesh-ancestor
110771191|NCT01290120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110070076|NCT04239040|Nivolumab|nivolumab|mesh-list
110771192|NCT01290120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110771193|NCT01290120|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110771194|NCT01290120|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110771195|NCT01290120|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110771196|NCT01290120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110771197|NCT01290120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110771198|NCT01290198|Fluconazole|fluconazole|mesh-list
110771199|NCT01290198|NG-Nitroarginine Methyl Ester|ng-nitroarginine methyl ester|mesh-list
110771200|NCT01290198|Antifungal Agents|antifungal agents|mesh-ancestor
110771201|NCT01290198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110771202|NCT01290198|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110771203|NCT01290198|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110771204|NCT01290198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110771205|NCT01290198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110771206|NCT01290198|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110771207|NCT01290198|Hormone Antagonists|hormone antagonists|mesh-ancestor
110771208|NCT01290198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110771209|NCT01290198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110771210|NCT01290198|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110771211|NCT01290198|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110771212|NCT01290276|Ondansetron|ondansetron|mesh-list
110771213|NCT01290276|Methylphenidate|methylphenidate|mesh-list
110771214|NCT01290276|Antiemetics|antiemetics|mesh-ancestor
110771215|NCT01290276|Autonomic Agents|autonomic agents|mesh-ancestor
110771216|NCT01290276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110771217|NCT01290276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110771218|NCT01290276|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110771219|NCT01290276|Antipruritics|antipruritics|mesh-ancestor
110771220|NCT01290276|Dermatologic Agents|dermatologic agents|mesh-ancestor
110771221|NCT01290276|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110771222|NCT01290276|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110771223|NCT01290276|Serotonin Agents|serotonin agents|mesh-ancestor
110771224|NCT01290276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110771225|NCT01290276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110771226|NCT01290276|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110771227|NCT01290276|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110771228|NCT01290276|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110771229|NCT01290276|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110771230|NCT01290276|Dopamine Agents|dopamine agents|mesh-ancestor
110771231|NCT03856866|Hydroxychloroquine|hydroxychloroquine|mesh-list
110771232|NCT03856866|Antimalarials|antimalarials|mesh-ancestor
110771233|NCT03856866|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110771234|NCT03856866|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110771235|NCT03856866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110771236|NCT03856866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110771237|NCT03856866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110771238|NCT03856866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110771239|NCT01587768|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110771240|NCT01587768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110771241|NCT01182636|Adapalene|adapalene|mesh-list
110771242|NCT01182636|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110771243|NCT01182636|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110771244|NCT01182636|Analgesics|analgesics|mesh-ancestor
110771245|NCT01182636|Sensory System Agents|sensory system agents|mesh-ancestor
110771246|NCT01182636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110771247|NCT01182636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110771248|NCT01182636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110771249|NCT01182636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110771250|NCT01182636|Dermatologic Agents|dermatologic agents|mesh-ancestor
110771252|NCT01290354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110771253|NCT01290354|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110771254|NCT01290354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110771255|NCT01290354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110771256|NCT01188408|Docetaxel|docetaxel|mesh-list
110771257|NCT01188408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110771258|NCT01188408|Tubulin Modulators|tubulin modulators|mesh-ancestor
110771259|NCT01188408|Antimitotic Agents|antimitotic agents|mesh-ancestor
110771260|NCT01188408|Mitosis Modulators|mitosis modulators|mesh-ancestor
110771261|NCT01188408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110771262|NCT01186146|Aspirin|aspirin|mesh-list
110771263|NCT01186146|Clopidogrel|clopidogrel|mesh-list
110771264|NCT01186146|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110771265|NCT01186146|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110771266|NCT01186146|Analgesics|analgesics|mesh-ancestor
110771267|NCT01186146|Sensory System Agents|sensory system agents|mesh-ancestor
110771268|NCT01186146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110771269|NCT01186146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110771270|NCT01186146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110771271|NCT01186146|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110771272|NCT01186146|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110771273|NCT01186146|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110771274|NCT01186146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110771275|NCT01186146|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110771277|NCT01186146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110771278|NCT01186146|Antipyretics|antipyretics|mesh-ancestor
110771279|NCT01186146|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110771280|NCT01186146|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110771281|NCT01186146|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110771282|NCT01186146|Purinergic Agents|purinergic agents|mesh-ancestor
110771283|NCT01186146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110771284|NCT01186224|Plerixafor|plerixafor|mesh-list
110771285|NCT01186224|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110771286|NCT01186224|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110771287|NCT01186224|Antiviral Agents|antiviral agents|mesh-ancestor
110771288|NCT01186224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110771289|NCT01183494|Irinotecan|irinotecan|mesh-list
110771290|NCT01183494|Bevacizumab|bevacizumab|mesh-list
110771291|NCT01183494|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110771292|NCT01183494|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110771293|NCT01183494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110771294|NCT01183494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110771295|NCT01183494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110771296|NCT01183494|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110771297|NCT01183494|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110771298|NCT01183494|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110771299|NCT01183494|Growth Substances|growth substances|mesh-ancestor
110771300|NCT01183494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110771301|NCT01183494|Growth Inhibitors|growth inhibitors|mesh-ancestor
110771302|NCT01183572|Iron|iron|mesh-list
110771303|NCT01183572|Folic Acid|folic acid|mesh-list
110771304|NCT01183572|Vitamin B Complex|vitamin b complex|mesh-list
110771305|NCT01183572|Trace Elements|trace elements|mesh-ancestor
110771306|NCT01183572|Micronutrients|micronutrients|mesh-ancestor
110771307|NCT01183572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110771308|NCT01183572|Hematinics|hematinics|mesh-ancestor
110771309|NCT01183572|Vitamins|vitamins|mesh-ancestor
110771310|NCT03856242|Tamsulosin|tamsulosin|mesh-list
110771311|NCT03856242|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110771312|NCT03856242|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110771313|NCT03856242|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110771314|NCT03856242|Adrenergic Agents|adrenergic agents|mesh-ancestor
110771315|NCT03856242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110771316|NCT03856242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110771317|NCT03856242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110771318|NCT03856242|Urological Agents|urological agents|mesh-ancestor
110771319|NCT01291524|Pregabalin|pregabalin|mesh-list
110771320|NCT01291524|Analgesics|analgesics|mesh-ancestor
110771321|NCT01291524|Sensory System Agents|sensory system agents|mesh-ancestor
110771322|NCT01291524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110771323|NCT01291524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110771324|NCT01291524|Anticonvulsants|anticonvulsants|mesh-ancestor
110771325|NCT01291524|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110771326|NCT01291524|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110771327|NCT01291524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110771328|NCT01291524|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110771329|NCT01291524|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110771330|NCT01291524|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110771331|NCT01291524|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110771332|NCT01291524|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110771333|NCT01183806|Rivastigmine|rivastigmine|mesh-list
110771334|NCT01183806|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110771335|NCT01183806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110771336|NCT01183806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110771337|NCT01183806|Cholinergic Agents|cholinergic agents|mesh-ancestor
110771338|NCT01183806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110771339|NCT01183806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110771340|NCT01183806|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110771341|NCT01183806|Protective Agents|protective agents|mesh-ancestor
110771342|NCT01188954|Doxycycline|doxycycline|mesh-list
110771343|NCT01188954|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110771344|NCT01188954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110771345|NCT01188954|Antimalarials|antimalarials|mesh-ancestor
110771346|NCT01188954|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110771347|NCT01188954|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110771349|NCT01183962|Vitamins|vitamins|mesh-ancestor
110771350|NCT01183962|Micronutrients|micronutrients|mesh-ancestor
110771351|NCT01183962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110771352|NCT01183962|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110771353|NCT01187238|Cisplatin|cisplatin|mesh-list
110771354|NCT01187238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110771355|NCT01588314|Gabapentin|gabapentin|mesh-list
110771356|NCT01588314|Analgesics|analgesics|mesh-ancestor
110771357|NCT01588314|Sensory System Agents|sensory system agents|mesh-ancestor
110771358|NCT01588314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110771359|NCT01588314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110771360|NCT01588314|Anticonvulsants|anticonvulsants|mesh-ancestor
110771361|NCT01588314|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110771362|NCT01588314|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110771363|NCT01588314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110771364|NCT01588314|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110771365|NCT01588314|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110771366|NCT01588314|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110771367|NCT01588314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110771368|NCT01588314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110771369|NCT01588314|Antimanic Agents|antimanic agents|mesh-ancestor
110771370|NCT01290432|Folic Acid|folic acid|mesh-list
110771371|NCT01290432|Melatonin|melatonin|mesh-list
110771372|NCT01290432|Antioxidants|antioxidants|mesh-ancestor
110771373|NCT01290432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110771374|NCT01290432|Protective Agents|protective agents|mesh-ancestor
110771375|NCT01290432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110771376|NCT01290432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110771377|NCT01290432|Hematinics|hematinics|mesh-ancestor
110771378|NCT01290432|Vitamin B Complex|vitamin b complex|mesh-ancestor
110771379|NCT01290432|Vitamins|vitamins|mesh-ancestor
110771380|NCT01290432|Micronutrients|micronutrients|mesh-ancestor
110771381|NCT01290510|Hyaluronic Acid|hyaluronic acid|mesh-list
110771382|NCT01290510|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110771383|NCT01290510|Immunologic Factors|immunologic factors|mesh-ancestor
110771384|NCT01290510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110771385|NCT01290510|Viscosupplements|viscosupplements|mesh-ancestor
110771386|NCT01290510|Protective Agents|protective agents|mesh-ancestor
110771387|NCT01184196|Povidone-Iodine|povidone-iodine|mesh-list
110771388|NCT01184196|Povidone|povidone|mesh-list
110771389|NCT01184196|Plasma Substitutes|plasma substitutes|mesh-ancestor
110771390|NCT01184196|Blood Substitutes|blood substitutes|mesh-ancestor
110771391|NCT01184196|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110771392|NCT01184196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110771393|NCT01292460|Timolol|timolol|mesh-list
110771394|NCT01292460|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110870845|NCT03093402|Hormones|hormones|mesh-ancestor
110771395|NCT01292460|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110771396|NCT01292460|Adrenergic Agents|adrenergic agents|mesh-ancestor
110771397|NCT01292460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110771398|NCT01292460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110771399|NCT01292460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110771400|NCT01292460|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110771401|NCT01292460|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110771402|NCT01292616|Antirheumatic Agents|antirheumatic agents|mesh-list
110771404|NCT01292694|Captopril|captopril|mesh-list
110771405|NCT01292694|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110771406|NCT01292694|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110771407|NCT01292694|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110771408|NCT01292694|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110771409|NCT01292694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110771410|NCT01292694|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110771411|NCT01292694|Protease Inhibitors|protease inhibitors|mesh-ancestor
110771412|NCT01292694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110771413|NCT03851562|Alprostadil|alprostadil|mesh-list
110771414|NCT03851562|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110771415|NCT03851562|Vasodilator Agents|vasodilator agents|mesh-ancestor
110771416|NCT03851562|Urological Agents|urological agents|mesh-ancestor
110771417|NCT01293630|Paclitaxel|paclitaxel|mesh-list
110771418|NCT01293630|Carboplatin|carboplatin|mesh-list
110771419|NCT01293630|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110771420|NCT01293630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110771421|NCT01293630|Tubulin Modulators|tubulin modulators|mesh-ancestor
110771422|NCT01293630|Antimitotic Agents|antimitotic agents|mesh-ancestor
110771423|NCT01293630|Mitosis Modulators|mitosis modulators|mesh-ancestor
110771424|NCT01293630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110771425|NCT01191060|Lenalidomide|lenalidomide|mesh-list
110771426|NCT01191060|Bortezomib|bortezomib|mesh-list
110771427|NCT01191060|Immunologic Factors|immunologic factors|mesh-ancestor
110771428|NCT01191060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110771429|NCT01191060|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110771430|NCT01191060|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110771431|NCT01191060|Growth Substances|growth substances|mesh-ancestor
110771432|NCT01191060|Growth Inhibitors|growth inhibitors|mesh-ancestor
110771433|NCT01191060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110771434|NCT01291602|Avibactam|avibactam|mesh-list
110771435|NCT01291602|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110771436|NCT01291602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110771437|NCT01291602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110771438|NCT01291602|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110771439|NCT01291602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110771440|NCT03851172|Ketorolac|ketorolac|mesh-list
110771441|NCT03851172|Nepafenac|nepafenac|mesh-list
110771442|NCT03851172|Cyclopentolate|cyclopentolate|mesh-list
110771443|NCT03851172|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110771444|NCT03851172|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110771445|NCT03851172|Analgesics|analgesics|mesh-ancestor
110771446|NCT03851172|Sensory System Agents|sensory system agents|mesh-ancestor
110771447|NCT03851172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110771448|NCT03851172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110771449|NCT03851172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110771450|NCT03851172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110771451|NCT03851172|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110771452|NCT03851172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110771453|NCT03851172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110771454|NCT03851172|Mydriatics|mydriatics|mesh-ancestor
110771455|NCT03851172|Autonomic Agents|autonomic agents|mesh-ancestor
110771456|NCT03851172|Parasympatholytics|parasympatholytics|mesh-ancestor
110771457|NCT03851172|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110771458|NCT03851172|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110771459|NCT03851172|Cholinergic Agents|cholinergic agents|mesh-ancestor
110771460|NCT03851172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110771461|NCT03853512|Petrolatum|petrolatum|mesh-list
110771462|NCT03853512|Emollients|emollients|mesh-ancestor
110771463|NCT03853512|Dermatologic Agents|dermatologic agents|mesh-ancestor
110771464|NCT03849612|Insulin Lispro|insulin lispro|mesh-list
110771465|NCT03849612|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110771466|NCT03849612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110771467|NCT03853200|Chlorhexidine|chlorhexidine|mesh-list
110771468|NCT03853200|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110771469|NCT03853200|Acetic Acid|acetic acid|mesh-list
110771470|NCT03853200|Root Canal Irrigants|root canal irrigants|mesh-list
110771471|NCT03853200|Edetic Acid|edetic acid|mesh-list
110771472|NCT03853200|Pentetic Acid|pentetic acid|mesh-list
110771473|NCT03853200|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110771474|NCT03853200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110771475|NCT03853200|Disinfectants|disinfectants|mesh-ancestor
110771476|NCT03853200|Dermatologic Agents|dermatologic agents|mesh-ancestor
110771477|NCT03853200|Anticoagulants|anticoagulants|mesh-ancestor
110771478|NCT03853200|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110771479|NCT03853200|Chelating Agents|chelating agents|mesh-ancestor
110771480|NCT03853200|Sequestering Agents|sequestering agents|mesh-ancestor
110771481|NCT03853200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110771482|NCT03853200|Antidotes|antidotes|mesh-ancestor
110771483|NCT03853200|Protective Agents|protective agents|mesh-ancestor
110771484|NCT03853200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110771485|NCT03853200|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110771486|NCT03853200|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110771487|NCT03853200|Dental Disinfectants|dental disinfectants|mesh-ancestor
110771488|NCT01293942|Bevacizumab|bevacizumab|mesh-list
110771489|NCT01293942|Capecitabine|capecitabine|mesh-list
110771490|NCT01293942|Oxaliplatin|oxaliplatin|mesh-list
110771492|NCT01293942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110771493|NCT01293942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110771494|NCT01293942|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110771495|NCT01293942|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110771496|NCT01293942|Growth Substances|growth substances|mesh-ancestor
110771497|NCT01293942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110771498|NCT01293942|Growth Inhibitors|growth inhibitors|mesh-ancestor
110771499|NCT01293942|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110771500|NCT01293942|Antimetabolites|antimetabolites|mesh-ancestor
110771501|NCT01293942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110771502|NCT01293942|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110771503|NCT01293942|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110771504|NCT01293942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110771505|NCT01189656|Vaccines|vaccines|mesh-list
110771506|NCT01189656|Immunologic Factors|immunologic factors|mesh-ancestor
110771507|NCT01189656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110771508|NCT01581138|Ribavirin|ribavirin|mesh-list
110771509|NCT01581138|Antimetabolites|antimetabolites|mesh-ancestor
110771510|NCT01581138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110771511|NCT01581138|Antiviral Agents|antiviral agents|mesh-ancestor
110771512|NCT01581138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110771513|NCT01191216|Docetaxel|docetaxel|mesh-list
110771514|NCT01191216|Tryptophan|tryptophan|mesh-list
110771515|NCT01191216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110771516|NCT01191216|Tubulin Modulators|tubulin modulators|mesh-ancestor
110771517|NCT01191216|Antimitotic Agents|antimitotic agents|mesh-ancestor
110870865|NCT05733676|Calcium|calcium|mesh-list
110771518|NCT01191216|Mitosis Modulators|mitosis modulators|mesh-ancestor
110771519|NCT01191216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110771520|NCT01191216|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110771521|NCT01191216|Antidepressive Agents|antidepressive agents|mesh-ancestor
110771522|NCT01191216|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110771523|NCT01294176|Thioctic Acid|thioctic acid|mesh-list
110771524|NCT01294176|Antioxidants|antioxidants|mesh-ancestor
110771525|NCT01294176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110771526|NCT01294176|Protective Agents|protective agents|mesh-ancestor
110771527|NCT01294176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110771528|NCT01294176|Vitamin B Complex|vitamin b complex|mesh-ancestor
110771529|NCT01294176|Vitamins|vitamins|mesh-ancestor
110771530|NCT01294176|Micronutrients|micronutrients|mesh-ancestor
110771531|NCT03847818|Carboplatin|carboplatin|mesh-list
110771532|NCT03847818|Docetaxel|docetaxel|mesh-list
110771533|NCT03847818|Trastuzumab|trastuzumab|mesh-list
110771534|NCT03847818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110771535|NCT03847818|Tubulin Modulators|tubulin modulators|mesh-ancestor
110771536|NCT03847818|Antimitotic Agents|antimitotic agents|mesh-ancestor
110771537|NCT03847818|Mitosis Modulators|mitosis modulators|mesh-ancestor
110771538|NCT03847818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110771539|NCT03847818|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110771540|NCT01294410|Antibodies|antibodies|mesh-list
110771541|NCT01294410|Immunoglobulins|immunoglobulins|mesh-list
110771542|NCT01294410|Immunologic Factors|immunologic factors|mesh-ancestor
110771543|NCT01294410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110771544|NCT01191450|Chlorthalidone|chlorthalidone|mesh-list
110771545|NCT01191450|Amiloride|amiloride|mesh-list
110771546|NCT01191450|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110771547|NCT01191450|Diuretics|diuretics|mesh-ancestor
110771548|NCT01191450|Natriuretic Agents|natriuretic agents|mesh-ancestor
110771549|NCT01191450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110771550|NCT01191450|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110771551|NCT01191450|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110771552|NCT01191450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110771553|NCT01191450|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
110771554|NCT01191450|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110771555|NCT01191450|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
110771556|NCT01191450|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110771558|NCT01194336|Donepezil|donepezil|mesh-list
110771559|NCT01194336|Galantamine|galantamine|mesh-list
110771560|NCT01194336|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110771561|NCT01194336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110771562|NCT01194336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110771563|NCT01194336|Cholinergic Agents|cholinergic agents|mesh-ancestor
110771564|NCT01194336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110771565|NCT01194336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110771566|NCT01194336|Nootropic Agents|nootropic agents|mesh-ancestor
110771567|NCT01194336|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110771568|NCT01194336|Autonomic Agents|autonomic agents|mesh-ancestor
110771569|NCT01194336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110771570|NCT01194336|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110771571|NCT01194336|Protective Agents|protective agents|mesh-ancestor
110771572|NCT02660710|Rituximab|rituximab|mesh-list
110771573|NCT02660710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110771574|NCT02660710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110771575|NCT02660710|Immunologic Factors|immunologic factors|mesh-ancestor
110771576|NCT02660710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110771577|NCT02660710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110771578|NCT01294878|Omalizumab|omalizumab|mesh-list
110771579|NCT01294878|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110771580|NCT01294878|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110771581|NCT01294878|Respiratory System Agents|respiratory system agents|mesh-ancestor
110771582|NCT01296438|Insulin|insulin|mesh-list
110771583|NCT01296438|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110771585|NCT01296438|Insulin, Long-Acting|insulin, long-acting|mesh-list
110771586|NCT01296438|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
110771587|NCT01296438|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110771588|NCT01296438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110771589|NCT03847272|Prednisone|prednisone|mesh-list
110771590|NCT03847272|Ustekinumab|ustekinumab|mesh-list
110771591|NCT03847272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110771592|NCT03847272|Glucocorticoids|glucocorticoids|mesh-ancestor
110771593|NCT03847272|Hormones|hormones|mesh-ancestor
110771594|NCT03847272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110771595|NCT03847272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110771596|NCT03847272|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110771597|NCT03847272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110771598|NCT03847272|Dermatologic Agents|dermatologic agents|mesh-ancestor
110771599|NCT03850626|Immunomodulating Agents|immunomodulating agents|mesh-list
110771600|NCT03850626|Immunologic Factors|immunologic factors|mesh-ancestor
110771601|NCT03850626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110771602|NCT01294956|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
110771603|NCT01294956|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110771604|NCT01294956|Lubricant Eye Drops|lubricant eye drops|mesh-list
110771605|NCT01294956|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110771606|NCT01294956|Laxatives|laxatives|mesh-ancestor
110771607|NCT01294956|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110771608|NCT01190358|Grape Seed Extract|grape seed extract|mesh-list
110771609|NCT01190358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110771610|NCT01190358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110771611|NCT01190358|Antioxidants|antioxidants|mesh-ancestor
110771612|NCT01190358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110771613|NCT01190358|Protective Agents|protective agents|mesh-ancestor
110771614|NCT01190358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110771615|NCT01293162|Folic Acid|folic acid|mesh-list
110771616|NCT01293162|Policosanol|policosanol|mesh-list
110771617|NCT01293162|Hematinics|hematinics|mesh-ancestor
110771618|NCT01293162|Vitamin B Complex|vitamin b complex|mesh-ancestor
110771619|NCT01293162|Vitamins|vitamins|mesh-ancestor
110771620|NCT01293162|Micronutrients|micronutrients|mesh-ancestor
110771621|NCT01293162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110771622|NCT01293162|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110771623|NCT01293162|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110771624|NCT01293162|Antimetabolites|antimetabolites|mesh-ancestor
110870886|NCT04479748|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110771625|NCT01293162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110771626|NCT01293162|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110771627|NCT01293162|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110771628|NCT01190670|Tacrolimus|tacrolimus|mesh-list
110771629|NCT01190670|Peficitinib|peficitinib|mesh-list
110771630|NCT01190670|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110771631|NCT01190670|Immunologic Factors|immunologic factors|mesh-ancestor
110771632|NCT01190670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110771633|NCT01190670|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110771634|NCT01190670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110771635|NCT01190670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110771636|NCT01194882|Insulin|insulin|mesh-list
110771637|NCT01194882|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110771638|NCT01194882|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110771639|NCT01194882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110771640|NCT01191684|Vaccines|vaccines|mesh-list
110771641|NCT01191684|Immunologic Factors|immunologic factors|mesh-ancestor
110771642|NCT01191684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110771643|NCT02659540|Nivolumab|nivolumab|mesh-list
110771644|NCT02659540|Ipilimumab|ipilimumab|mesh-list
110771645|NCT02659540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110771646|NCT02659540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110771647|NCT02659540|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110771648|NCT02659540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110771649|NCT01295268|Emu Oil|emu oil|mesh-list
110771650|NCT01295268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110771651|NCT01295268|Dermatologic Agents|dermatologic agents|mesh-ancestor
110771652|NCT01383694|Piperine|piperine|mesh-list
110771653|NCT01383694|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110771654|NCT01383694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110771655|NCT01383694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110771656|NCT01191918|Lithium Carbonate|lithium carbonate|mesh-list
110771657|NCT01191918|Donepezil|donepezil|mesh-list
110771658|NCT01191918|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110771659|NCT01191918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110771660|NCT01191918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110771662|NCT01191918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110771663|NCT01191918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110771664|NCT01191918|Nootropic Agents|nootropic agents|mesh-ancestor
110771665|NCT01191918|Antidepressive Agents|antidepressive agents|mesh-ancestor
110771666|NCT01191918|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110771667|NCT01191918|Antimanic Agents|antimanic agents|mesh-ancestor
110771668|NCT01191918|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110771669|NCT01191918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110771670|NCT03850314|Glycine|glycine|mesh-list
110771671|NCT03850314|Glycine Agents|glycine agents|mesh-ancestor
110771672|NCT03850314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110771673|NCT03850314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110771674|NCT03850314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110771675|NCT01097746|Paclitaxel|paclitaxel|mesh-list
110771676|NCT01097746|Bevacizumab|bevacizumab|mesh-list
110771677|NCT01097746|Carboplatin|carboplatin|mesh-list
110771678|NCT01097746|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110771679|NCT01097746|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110771680|NCT01097746|Endothelial Growth Factors|endothelial growth factors|mesh-list
110771681|NCT01097746|Antibodies|antibodies|mesh-list
110771682|NCT01097746|Immunoglobulins|immunoglobulins|mesh-list
110771683|NCT01097746|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110771684|NCT01097746|Immunoglobulin G|immunoglobulin g|mesh-list
110771685|NCT01097746|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110771686|NCT01097746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110771687|NCT01097746|Tubulin Modulators|tubulin modulators|mesh-ancestor
110771688|NCT01097746|Antimitotic Agents|antimitotic agents|mesh-ancestor
110771689|NCT01097746|Mitosis Modulators|mitosis modulators|mesh-ancestor
110771690|NCT01097746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110771691|NCT01097746|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110771692|NCT01097746|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110771693|NCT01097746|Growth Substances|growth substances|mesh-ancestor
110771694|NCT01097746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110771695|NCT01097746|Growth Inhibitors|growth inhibitors|mesh-ancestor
110870895|NCT04479748|Hormones|hormones|mesh-ancestor
110771696|NCT01097746|Immunologic Factors|immunologic factors|mesh-ancestor
110771697|NCT01190748|Galantamine|galantamine|mesh-list
110445823|NCT02771704|Micronutrients|micronutrients|mesh-ancestor
110771698|NCT01190748|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110771699|NCT01190748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110771700|NCT01190748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110771701|NCT01190748|Cholinergic Agents|cholinergic agents|mesh-ancestor
110771702|NCT01190748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110771703|NCT01190748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110771704|NCT01190748|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110771705|NCT01190748|Autonomic Agents|autonomic agents|mesh-ancestor
110771706|NCT01190748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110771707|NCT01190748|Nootropic Agents|nootropic agents|mesh-ancestor
110771708|NCT01383538|Leucovorin|leucovorin|mesh-list
110771709|NCT01383538|Oxaliplatin|oxaliplatin|mesh-list
110771710|NCT01383538|Irinotecan|irinotecan|mesh-list
110771711|NCT01383538|Folfirinox|folfirinox|mesh-list
110333789|NCT00485940|Serotonin Agents|serotonin agents|mesh-ancestor
110771712|NCT01383538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110771713|NCT01383538|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110771714|NCT01383538|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110771715|NCT01383538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110771716|NCT01383538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110771717|NCT01383538|Antidotes|antidotes|mesh-ancestor
110771718|NCT01383538|Protective Agents|protective agents|mesh-ancestor
110771719|NCT01383538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110771720|NCT01383538|Vitamin B Complex|vitamin b complex|mesh-ancestor
110771721|NCT01383538|Vitamins|vitamins|mesh-ancestor
110771722|NCT01383538|Micronutrients|micronutrients|mesh-ancestor
110771723|NCT01383460|Epoetin Alfa|epoetin alfa|mesh-list
110771724|NCT01383460|Lenograstim|lenograstim|mesh-list
110771725|NCT01383460|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110771726|NCT01383460|Immunologic Factors|immunologic factors|mesh-ancestor
110771727|NCT01383460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110771728|NCT01383460|Hematinics|hematinics|mesh-ancestor
110771729|NCT01192230|Docetaxel|docetaxel|mesh-list
110771730|NCT01192230|Endostatins|endostatins|mesh-list
110771731|NCT01192230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110771732|NCT01192230|Tubulin Modulators|tubulin modulators|mesh-ancestor
110771733|NCT01192230|Antimitotic Agents|antimitotic agents|mesh-ancestor
110771734|NCT01192230|Mitosis Modulators|mitosis modulators|mesh-ancestor
110771735|NCT01192230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110771736|NCT01192230|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110771737|NCT01192230|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110771738|NCT01192230|Growth Substances|growth substances|mesh-ancestor
110771739|NCT01192230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110771740|NCT01192230|Growth Inhibitors|growth inhibitors|mesh-ancestor
110771741|NCT05416840|Amlodipine|amlodipine|mesh-list
110771742|NCT05416840|Clonidine|clonidine|mesh-list
110771743|NCT05416840|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110771744|NCT05416840|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110771745|NCT05416840|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110771746|NCT05416840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110771747|NCT05416840|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110771748|NCT05416840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110771749|NCT05416840|Vasodilator Agents|vasodilator agents|mesh-ancestor
110771750|NCT05416840|Analgesics|analgesics|mesh-ancestor
110771751|NCT05416840|Sensory System Agents|sensory system agents|mesh-ancestor
110771752|NCT05416840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110771753|NCT05416840|Sympatholytics|sympatholytics|mesh-ancestor
110771754|NCT05416840|Autonomic Agents|autonomic agents|mesh-ancestor
110771755|NCT05416840|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110771756|NCT05416840|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110771757|NCT05416840|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110771758|NCT05416840|Adrenergic Agents|adrenergic agents|mesh-ancestor
110771759|NCT05416840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110771760|NCT01192308|Tamoxifen|tamoxifen|mesh-list
110771761|NCT01192308|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110771762|NCT01192308|Hormone Antagonists|hormone antagonists|mesh-ancestor
110771763|NCT01192308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110771764|NCT01192308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110771765|NCT01192308|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110771766|NCT01192308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110771767|NCT01192308|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110771768|NCT01192308|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110771769|NCT01192308|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110771770|NCT01190982|Paclitaxel|paclitaxel|mesh-list
110771771|NCT01190982|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110771772|NCT01190982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110771773|NCT01190982|Tubulin Modulators|tubulin modulators|mesh-ancestor
110771774|NCT01190982|Antimitotic Agents|antimitotic agents|mesh-ancestor
110771775|NCT01190982|Mitosis Modulators|mitosis modulators|mesh-ancestor
110771776|NCT01190982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110771777|NCT04170556|Nivolumab|nivolumab|mesh-list
110771778|NCT04170556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110771779|NCT04170556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110771780|NCT04170556|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110771781|NCT04170556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110771782|NCT03846960|Pulmonary Surfactants|pulmonary surfactants|mesh-list
110771783|NCT03846960|Respiratory System Agents|respiratory system agents|mesh-ancestor
110771784|NCT01196754|Sevoflurane|sevoflurane|mesh-list
110771785|NCT01196754|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110771786|NCT01196754|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110771787|NCT01196754|Anesthetics, General|anesthetics, general|mesh-ancestor
110771788|NCT01196754|Anesthetics|anesthetics|mesh-ancestor
110771789|NCT01196754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110771790|NCT01196754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110771791|NCT01295502|Paclitaxel|paclitaxel|mesh-list
110771792|NCT01295502|Cisplatin|cisplatin|mesh-list
110771793|NCT01295502|Carboplatin|carboplatin|mesh-list
110771794|NCT01295502|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110771795|NCT01295502|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110771796|NCT01295502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110771797|NCT01295502|Tubulin Modulators|tubulin modulators|mesh-ancestor
110771799|NCT01295502|Mitosis Modulators|mitosis modulators|mesh-ancestor
110771800|NCT01295502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110771801|NCT05207644|Letrozole|letrozole|mesh-list
110771802|NCT05207644|Misoprostol|misoprostol|mesh-list
110771803|NCT05207644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110771804|NCT05207644|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110771805|NCT05207644|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110771806|NCT05207644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110771807|NCT05207644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110771808|NCT05207644|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110771809|NCT05207644|Hormone Antagonists|hormone antagonists|mesh-ancestor
110771810|NCT05207644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110771811|NCT05207644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110771812|NCT05207644|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110771813|NCT05207644|Abortifacient Agents|abortifacient agents|mesh-ancestor
110771814|NCT05207644|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110771815|NCT05207644|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110771816|NCT05207644|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110771817|NCT05207644|Oxytocics|oxytocics|mesh-ancestor
110771818|NCT03846102|Acetaminophen|acetaminophen|mesh-list
110771819|NCT03846102|Morphine|morphine|mesh-list
110771820|NCT03846102|Levobupivacaine|levobupivacaine|mesh-list
110771821|NCT03846102|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110771822|NCT03846102|Narcotics|narcotics|mesh-ancestor
110771823|NCT03846102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110771824|NCT03846102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110771825|NCT03846102|Analgesics|analgesics|mesh-ancestor
110771826|NCT03846102|Sensory System Agents|sensory system agents|mesh-ancestor
110771827|NCT03846102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110771828|NCT03846102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110771829|NCT03846102|Antipyretics|antipyretics|mesh-ancestor
110771830|NCT03846102|Anesthetics, Local|anesthetics, local|mesh-ancestor
110771831|NCT03846102|Anesthetics|anesthetics|mesh-ancestor
110771832|NCT01383148|Paclitaxel|paclitaxel|mesh-list
110771833|NCT01383148|Cisplatin|cisplatin|mesh-list
110771834|NCT01383148|Carboplatin|carboplatin|mesh-list
110771835|NCT01383148|Gemcitabine|gemcitabine|mesh-list
110771836|NCT01383148|Pemetrexed|pemetrexed|mesh-list
110771837|NCT01383148|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110771838|NCT01383148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110771839|NCT01383148|Tubulin Modulators|tubulin modulators|mesh-ancestor
110771840|NCT01383148|Antimitotic Agents|antimitotic agents|mesh-ancestor
110771841|NCT01383148|Mitosis Modulators|mitosis modulators|mesh-ancestor
110771842|NCT01383148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110771843|NCT01383148|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110771844|NCT01383148|Antimetabolites|antimetabolites|mesh-ancestor
110870950|NCT04160520|Dopamine Agents|dopamine agents|mesh-ancestor
110771845|NCT01383148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110771846|NCT01383148|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110771847|NCT01383148|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110771848|NCT01382914|Chlorhexidine|chlorhexidine|mesh-list
110771849|NCT01382914|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110771850|NCT01382914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110771851|NCT01382914|Disinfectants|disinfectants|mesh-ancestor
110771852|NCT01195428|Simvastatin|simvastatin|mesh-list
110771853|NCT01195428|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110771854|NCT01195428|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110771855|NCT01195428|Antimetabolites|antimetabolites|mesh-ancestor
110771856|NCT01195428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110771857|NCT01195428|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110771858|NCT01195428|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110771859|NCT01195428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110771860|NCT03439462|Sirolimus|sirolimus|mesh-list
110771861|NCT03439462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110771862|NCT03439462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110771863|NCT03439462|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110771864|NCT03439462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110771865|NCT03439462|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110771866|NCT03439462|Antifungal Agents|antifungal agents|mesh-ancestor
110771867|NCT03439462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110771868|NCT03439462|Immunologic Factors|immunologic factors|mesh-ancestor
110771869|NCT01193166|Olanzapine|olanzapine|mesh-list
110771870|NCT01193166|Risperidone|risperidone|mesh-list
110771871|NCT01193166|Aripiprazole|aripiprazole|mesh-list
110771872|NCT01193166|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110771873|NCT01193166|Paliperidone Palmitate|paliperidone palmitate|mesh-list
110771874|NCT01193166|Perphenazine|perphenazine|mesh-list
110771875|NCT01193166|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110771876|NCT01193166|Serotonin Agents|serotonin agents|mesh-ancestor
110771877|NCT01193166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110771878|NCT01193166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110771879|NCT01193166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110771880|NCT01193166|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110771881|NCT01193166|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110771882|NCT01193166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110771883|NCT01193166|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110771884|NCT01193166|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110771885|NCT01193166|Dopamine Agents|dopamine agents|mesh-ancestor
110771886|NCT01193166|Antiemetics|antiemetics|mesh-ancestor
110771887|NCT01193166|Autonomic Agents|autonomic agents|mesh-ancestor
110771888|NCT01193166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110771889|NCT01193166|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110771890|NCT01193166|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110771891|NCT01193166|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110771892|NCT01193166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110771893|NCT01193166|Antidepressive Agents|antidepressive agents|mesh-ancestor
110771894|NCT01193166|Dopamine Agonists|dopamine agonists|mesh-ancestor
110771895|NCT01193166|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110771896|NCT01193166|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110771897|NCT01193166|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110771898|NCT01193166|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110771899|NCT01197144|Adalimumab|adalimumab|mesh-list
110771900|NCT01197144|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110771901|NCT01197144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110771902|NCT01197144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110771903|NCT01193400|Cytarabine|cytarabine|mesh-list
110771904|NCT01193400|Clofarabine|clofarabine|mesh-list
110771905|NCT01193400|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110771906|NCT01193400|Antimetabolites|antimetabolites|mesh-ancestor
110588508|NCT00921063|Alprazolam|alprazolam|mesh-list
110771907|NCT01193400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110771908|NCT01193400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110771909|NCT01193400|Antiviral Agents|antiviral agents|mesh-ancestor
110771910|NCT01193400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110771911|NCT01193400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110771912|NCT01193400|Immunologic Factors|immunologic factors|mesh-ancestor
110771913|NCT01193400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110771914|NCT03904888|Anesthetics|anesthetics|mesh-list
110771915|NCT03904888|Anesthetics, Local|anesthetics, local|mesh-list
110771916|NCT03904888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110771917|NCT03904888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110771918|NCT03904888|Sensory System Agents|sensory system agents|mesh-ancestor
110445831|NCT02771158|Autonomic Agents|autonomic agents|mesh-ancestor
110871131|NCT05666219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110771919|NCT03904888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110771920|NCT03846258|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110771921|NCT01193478|Ledipasvir|ledipasvir|mesh-list
110771922|NCT01193478|Antiviral Agents|antiviral agents|mesh-ancestor
110771923|NCT01193478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110771924|NCT01295736|Sildenafil Citrate|sildenafil citrate|mesh-list
110771925|NCT01295736|Vasodilator Agents|vasodilator agents|mesh-ancestor
110871274|NCT03639558|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110771926|NCT01295736|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110771927|NCT01295736|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110771928|NCT01295736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110771929|NCT01295736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110771930|NCT01295736|Urological Agents|urological agents|mesh-ancestor
110771932|NCT03733470|Vasodilator Agents|vasodilator agents|mesh-ancestor
110771933|NCT03733470|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110771934|NCT03733470|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110771935|NCT03733470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110771936|NCT03733470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110771937|NCT03733470|Urological Agents|urological agents|mesh-ancestor
110771938|NCT01195974|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
110771939|NCT01195974|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110771940|NCT01195974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110771941|NCT04731376|Methyltestosterone|methyltestosterone|mesh-list
110771942|NCT04731376|Testosterone|testosterone|mesh-list
110771943|NCT04731376|Testosterone undecanoate|testosterone undecanoate|mesh-list
110771944|NCT04731376|Testosterone enanthate|testosterone enanthate|mesh-list
110771945|NCT04731376|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
110771946|NCT04731376|Androgens|androgens|mesh-ancestor
110771948|NCT04731376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110771949|NCT04731376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110771950|NCT04731376|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110771951|NCT04731376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110771952|NCT04731376|Anabolic Agents|anabolic agents|mesh-ancestor
110771953|NCT01196208|Brentuximab Vedotin|brentuximab vedotin|mesh-list
110771954|NCT01196208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110771955|NCT01196208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110771956|NCT01196208|Immunotoxins|immunotoxins|mesh-ancestor
110771957|NCT01196208|Immunoconjugates|immunoconjugates|mesh-ancestor
110771958|NCT01196208|Immunologic Factors|immunologic factors|mesh-ancestor
110771959|NCT01196208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110771960|NCT01295892|Estrogens|estrogens|mesh-list
110771961|NCT01295892|Hormones|hormones|mesh-ancestor
110771962|NCT01295892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110771963|NCT01295892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110771964|NCT03018418|Mitomycins|mitomycins|mesh-list
110771965|NCT03018418|Mitomycin|mitomycin|mesh-list
110771966|NCT03018418|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110771967|NCT03018418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110771968|NCT03018418|Alkylating Agents|alkylating agents|mesh-ancestor
110771969|NCT03018418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110771970|NCT03018418|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110771971|NCT03018418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110771973|NCT01296204|Immunologic Factors|immunologic factors|mesh-ancestor
110771974|NCT01296204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110771975|NCT01197846|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110771976|NCT01197846|Antidepressive Agents|antidepressive agents|mesh-ancestor
110771977|NCT01197846|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110771978|NCT01197846|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110771979|NCT01197846|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110771980|NCT01197846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110771981|NCT01197846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110771982|NCT01192854|Adefovir|adefovir|mesh-list
110771983|NCT01192854|Clevudine|clevudine|mesh-list
110771984|NCT01192854|Antiviral Agents|antiviral agents|mesh-ancestor
110771985|NCT01192854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110771986|NCT01192854|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110771987|NCT01192854|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110771988|NCT01192854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110771989|NCT01192854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110771990|NCT05670678|Lactoferrin|lactoferrin|mesh-list
110771991|NCT05670678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110771992|NCT02914366|Ambroxol|ambroxol|mesh-list
110771994|NCT02914366|Respiratory System Agents|respiratory system agents|mesh-ancestor
110771995|NCT03846180|Octreotide|octreotide|mesh-list
110771996|NCT03846180|Terlipressin|terlipressin|mesh-list
110771997|NCT03846180|Somatostatin|somatostatin|mesh-list
110771998|NCT03846180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110771999|NCT03846180|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110772000|NCT03846180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110772001|NCT03846180|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110772002|NCT03846180|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110772003|NCT03846180|Hormones|hormones|mesh-ancestor
110772004|NCT03846180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110772005|NCT03846180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110772006|NCT01199406|Levobupivacaine|levobupivacaine|mesh-list
110772007|NCT01199406|Anesthetics, Local|anesthetics, local|mesh-ancestor
110772008|NCT01199406|Anesthetics|anesthetics|mesh-ancestor
110772009|NCT01199406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110772010|NCT01199406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110772011|NCT01199406|Sensory System Agents|sensory system agents|mesh-ancestor
110772012|NCT01199406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110772013|NCT02729116|Ertapenem|ertapenem|mesh-list
110772014|NCT02729116|Sitafloxacin|sitafloxacin|mesh-list
110772015|NCT02729116|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110772016|NCT02729116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110772017|NCT02729116|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110772018|NCT02729116|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110772019|NCT02729116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110772020|NCT02729116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110772021|NCT02729116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110772022|NCT02627092|Copper|copper|mesh-list
110772023|NCT02627092|Trace Elements|trace elements|mesh-ancestor
110772024|NCT02627092|Micronutrients|micronutrients|mesh-ancestor
110772025|NCT02627092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110772026|NCT05289648|Niraparib|niraparib|mesh-list
110871524|NCT03620929|Hormones|hormones|mesh-ancestor
110772027|NCT05289648|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110772028|NCT05289648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110772029|NCT05289648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110772030|NCT05289648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110772031|NCT01199562|Valganciclovir|valganciclovir|mesh-list
110772032|NCT01199562|Ganciclovir|ganciclovir|mesh-list
110772033|NCT01199562|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
110772034|NCT01199562|Antiviral Agents|antiviral agents|mesh-list
110489742|NCT01012037|Linagliptin|linagliptin|mesh-list
110772035|NCT01199562|Foscarnet|foscarnet|mesh-list
110772036|NCT01199562|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
110772037|NCT01199562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110772038|NCT01199562|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110772039|NCT01199562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110772040|NCT01199562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110772041|NCT01199562|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110772042|NCT03845322|Curcumin|curcumin|mesh-list
110772043|NCT03845322|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110772044|NCT03845322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110772045|NCT03845322|Analgesics|analgesics|mesh-ancestor
110772046|NCT03845322|Sensory System Agents|sensory system agents|mesh-ancestor
110772047|NCT03845322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110772048|NCT03845322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110772049|NCT03845322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110871624|NCT03674606|Antipyretics|antipyretics|mesh-ancestor
110772050|NCT03845322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110772051|NCT03845322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110772052|NCT03845322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110772053|NCT03845322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110772055|NCT03844932|Cyclosporins|cyclosporins|mesh-list
110772056|NCT03844932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110772057|NCT03844932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110772058|NCT03844932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110772059|NCT03844932|Immunologic Factors|immunologic factors|mesh-ancestor
110772060|NCT03844932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110772061|NCT03844932|Antifungal Agents|antifungal agents|mesh-ancestor
110772062|NCT03844932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110772063|NCT03844932|Dermatologic Agents|dermatologic agents|mesh-ancestor
110772064|NCT03844932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110772065|NCT03844932|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110772066|NCT03726996|Desipramine|desipramine|mesh-list
110097142|NCT01733589|Etoposide|etoposide|mesh-list
110772067|NCT03726996|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110772068|NCT03726996|Antidepressive Agents|antidepressive agents|mesh-ancestor
110772070|NCT03726996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110772071|NCT03726996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110772072|NCT03726996|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110772073|NCT03726996|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110772074|NCT03726996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110772075|NCT03726996|Adrenergic Agents|adrenergic agents|mesh-ancestor
110772076|NCT03726996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110772077|NCT03726996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110772078|NCT01202058|Sirolimus|sirolimus|mesh-list
110772079|NCT01202058|Everolimus|everolimus|mesh-list
110772080|NCT01202058|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110871670|NCT03163420|Sensory System Agents|sensory system agents|mesh-ancestor
110772081|NCT01202058|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110772082|NCT01202058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110772083|NCT01202058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110772084|NCT01202058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110772085|NCT01202058|Immunologic Factors|immunologic factors|mesh-ancestor
110772086|NCT01202058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110772087|NCT01202058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110772088|NCT01202058|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110772089|NCT01202058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110772090|NCT01202058|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110772091|NCT01202058|Antifungal Agents|antifungal agents|mesh-ancestor
110772092|NCT03844854|Salicylic Acid|salicylic acid|mesh-list
110772093|NCT03844854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110772094|NCT03844854|Antifungal Agents|antifungal agents|mesh-ancestor
110772095|NCT03844854|Keratolytic Agents|keratolytic agents|mesh-ancestor
110772096|NCT03844854|Dermatologic Agents|dermatologic agents|mesh-ancestor
110772097|NCT03842046|Phenylephrine|phenylephrine|mesh-list
110772098|NCT03842046|Oxymetazoline|oxymetazoline|mesh-list
110772099|NCT03842046|Norepinephrine|norepinephrine|mesh-list
110772100|NCT03842046|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110772101|NCT03842046|Mydriatics|mydriatics|mesh-ancestor
110772102|NCT03842046|Autonomic Agents|autonomic agents|mesh-ancestor
110772103|NCT03842046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110772104|NCT03842046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110772105|NCT03842046|Sympathomimetics|sympathomimetics|mesh-ancestor
110772106|NCT03842046|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110772107|NCT03842046|Nasal Decongestants|nasal decongestants|mesh-ancestor
110772108|NCT03842046|Respiratory System Agents|respiratory system agents|mesh-ancestor
110772109|NCT03842046|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110772110|NCT03842046|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110772111|NCT03842046|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110772112|NCT03842046|Adrenergic Agents|adrenergic agents|mesh-ancestor
110772113|NCT03842046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110772114|NCT03842046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110772115|NCT03842046|Protective Agents|protective agents|mesh-ancestor
110772117|NCT01198236|Antifungal Agents|antifungal agents|mesh-ancestor
110772118|NCT01198236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110772119|NCT01198236|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110772120|NCT01198236|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110772121|NCT01198236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110772122|NCT01198236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110772123|NCT01198236|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110828224|NCT01105481|Amisulpride|amisulpride|mesh-list
110772124|NCT01198236|Hormone Antagonists|hormone antagonists|mesh-ancestor
110772125|NCT01198236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110772126|NCT01198236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110772127|NCT01198236|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110772128|NCT01198314|Immunosuppressive Agents|immunosuppressive agents|mesh-list
110772129|NCT01198314|Immunologic Factors|immunologic factors|mesh-ancestor
110772130|NCT01198314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110772131|NCT05184816|Deferoxamine|deferoxamine|mesh-list
110772132|NCT05184816|Siderophores|siderophores|mesh-ancestor
110772133|NCT05184816|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110333887|NCT00486213|Pyridoxine|pyridoxine|mesh-list
110772134|NCT05184816|Chelating Agents|chelating agents|mesh-ancestor
110772135|NCT05184816|Sequestering Agents|sequestering agents|mesh-ancestor
110772136|NCT05184816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110772137|NCT03841890|Tolnaftate|tolnaftate|mesh-list
110772138|NCT03841890|Antifungal Agents|antifungal agents|mesh-ancestor
110772139|NCT03841890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110772140|NCT01200108|Budesonide|budesonide|mesh-list
110772141|NCT01200108|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110772142|NCT01200108|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110772144|NCT01200108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110772145|NCT01200108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110772146|NCT01200108|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110772147|NCT01200108|Respiratory System Agents|respiratory system agents|mesh-ancestor
110772148|NCT01200108|Glucocorticoids|glucocorticoids|mesh-ancestor
110772149|NCT01200108|Hormones|hormones|mesh-ancestor
110772150|NCT01200108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110772151|NCT01200186|Progestins|progestins|mesh-list
110772152|NCT01200186|Hormones|hormones|mesh-ancestor
110772153|NCT01200186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110772154|NCT01200186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110772155|NCT03841812|Propofol|propofol|mesh-list
110772156|NCT03841812|Sevoflurane|sevoflurane|mesh-list
110772157|NCT03841812|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110772158|NCT03841812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110772159|NCT03841812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110772160|NCT03841812|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110772161|NCT03841812|Anesthetics, General|anesthetics, general|mesh-ancestor
110772162|NCT03841812|Anesthetics|anesthetics|mesh-ancestor
110772163|NCT03841812|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110772164|NCT03841812|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110772165|NCT03882970|Tirzepatide|tirzepatide|mesh-list
110772166|NCT03882970|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110772167|NCT03882970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110772168|NCT03882970|Incretins|incretins|mesh-ancestor
110772170|NCT03882970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110772171|NCT05111808|Methylene Blue|methylene blue|mesh-list
110772172|NCT05111808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110772173|NCT05111808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110772174|NCT01198392|Cisplatin|cisplatin|mesh-list
110772175|NCT01198392|Tegafur|tegafur|mesh-list
110772176|NCT01198392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110772177|NCT01198392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110772178|NCT01198392|Antimetabolites|antimetabolites|mesh-ancestor
110772179|NCT01198392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110772180|NCT01200264|Apremilast|apremilast|mesh-list
110772181|NCT01200264|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110772182|NCT01200264|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110772183|NCT01200264|Analgesics|analgesics|mesh-ancestor
110772184|NCT01200264|Sensory System Agents|sensory system agents|mesh-ancestor
110772185|NCT01200264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110489877|NCT00576823|Alfuzosin|alfuzosin|mesh-list
110772186|NCT01200264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110772187|NCT01200264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110772188|NCT01200264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110772189|NCT01200264|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
110772190|NCT01200264|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110772191|NCT01200264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110772192|NCT01200264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110772193|NCT04799236|Amphotericin B|amphotericin b|mesh-list
110772194|NCT04799236|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
110772195|NCT04799236|Miltefosine|miltefosine|mesh-list
110772196|NCT04799236|Amebicides|amebicides|mesh-ancestor
110772197|NCT04799236|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110772198|NCT04799236|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110772199|NCT04799236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110772200|NCT04799236|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110772201|NCT04799236|Antifungal Agents|antifungal agents|mesh-ancestor
110772202|NCT04799236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110772203|NCT01202370|10-hydroxycamptothecin|10-hydroxycamptothecin|mesh-list
110772204|NCT01202370|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110772205|NCT01202370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110772206|NCT03630952|Aflibercept|aflibercept|mesh-list
110772207|NCT03630952|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110772208|NCT03630952|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110772209|NCT03630952|Growth Substances|growth substances|mesh-ancestor
110772210|NCT03630952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110772211|NCT03630952|Growth Inhibitors|growth inhibitors|mesh-ancestor
110772212|NCT03630952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110772213|NCT01198782|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110772214|NCT01198782|Lubricant Eye Drops|lubricant eye drops|mesh-list
110772215|NCT01198782|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110772216|NCT01200654|Linezolid|linezolid|mesh-list
110772217|NCT01200654|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110772218|NCT01200654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110772219|NCT01200654|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110772220|NCT01200654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110772221|NCT01200654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110772222|NCT01200732|Tadalafil|tadalafil|mesh-list
110772223|NCT01200732|Vasodilator Agents|vasodilator agents|mesh-ancestor
110772224|NCT01200732|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110772225|NCT01200732|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110772226|NCT01200732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110828593|NCT01310751|Iloprost|iloprost|mesh-list
110772227|NCT01200732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110772228|NCT01200732|Urological Agents|urological agents|mesh-ancestor
110772229|NCT01198860|Ascorbic Acid|ascorbic acid|mesh-list
110772230|NCT01198860|Tenofovir|tenofovir|mesh-list
110772231|NCT01198860|Antiviral Agents|antiviral agents|mesh-ancestor
110772232|NCT01198860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110772233|NCT01198860|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110772234|NCT01198860|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110772235|NCT01198860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110772236|NCT01198860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110772237|NCT01198860|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110772238|NCT01198860|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110772239|NCT01198860|Antioxidants|antioxidants|mesh-ancestor
110772240|NCT01198860|Protective Agents|protective agents|mesh-ancestor
110772241|NCT01198860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110772242|NCT01198860|Vitamins|vitamins|mesh-ancestor
110772243|NCT01198860|Micronutrients|micronutrients|mesh-ancestor
110772244|NCT01198938|Melatonin|melatonin|mesh-list
110772245|NCT01198938|Antioxidants|antioxidants|mesh-ancestor
110772246|NCT01198938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110772247|NCT01198938|Protective Agents|protective agents|mesh-ancestor
110772248|NCT01198938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110772249|NCT01198938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110772250|NCT01201044|Gemcitabine|gemcitabine|mesh-list
110772251|NCT01201044|Nedaplatin|nedaplatin|mesh-list
110772252|NCT01201044|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110772253|NCT01201044|Antimetabolites|antimetabolites|mesh-ancestor
110772254|NCT01201044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110772255|NCT01201044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110772256|NCT03843060|Itraconazole|itraconazole|mesh-list
110772257|NCT03843060|Antifungal Agents|antifungal agents|mesh-ancestor
110772258|NCT03843060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110772259|NCT03843060|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110828657|NCT03348930|Tolcapone|tolcapone|mesh-list
110772260|NCT03843060|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110772261|NCT03843060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110772262|NCT03843060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110772263|NCT03843060|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110772264|NCT03843060|Hormone Antagonists|hormone antagonists|mesh-ancestor
110772265|NCT03843060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110772266|NCT03843060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110772267|NCT03843060|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110772268|NCT04427904|Lidocaine|lidocaine|mesh-list
110772269|NCT04427904|Epinephrine|epinephrine|mesh-list
110772270|NCT04427904|Racepinephrine|racepinephrine|mesh-list
110772271|NCT04427904|Bupivacaine|bupivacaine|mesh-list
110772272|NCT04427904|Epinephryl borate|epinephryl borate|mesh-list
110772273|NCT04427904|Anesthetics, Local|anesthetics, local|mesh-ancestor
110772274|NCT04427904|Anesthetics|anesthetics|mesh-ancestor
110772275|NCT04427904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110772276|NCT04427904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110772277|NCT04427904|Sensory System Agents|sensory system agents|mesh-ancestor
110772278|NCT04427904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110772279|NCT04427904|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110772280|NCT04427904|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110772281|NCT04427904|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110772282|NCT04427904|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110772283|NCT04427904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110772284|NCT04427904|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110772285|NCT04427904|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110772286|NCT04427904|Adrenergic Agents|adrenergic agents|mesh-ancestor
110772287|NCT04427904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110772288|NCT04427904|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110772289|NCT04427904|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110772290|NCT04427904|Autonomic Agents|autonomic agents|mesh-ancestor
110772291|NCT04427904|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110772292|NCT04427904|Respiratory System Agents|respiratory system agents|mesh-ancestor
110772293|NCT04427904|Mydriatics|mydriatics|mesh-ancestor
110772294|NCT04427904|Sympathomimetics|sympathomimetics|mesh-ancestor
110772295|NCT04427904|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110772297|NCT03792516|Antimalarials|antimalarials|mesh-ancestor
110772298|NCT03792516|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110772299|NCT03792516|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110772300|NCT03792516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110772301|NCT03792516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110772302|NCT03792516|Antiviral Agents|antiviral agents|mesh-ancestor
110772303|NCT03792516|Schistosomicides|schistosomicides|mesh-ancestor
110772304|NCT03792516|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110772305|NCT03792516|Anthelmintics|anthelmintics|mesh-ancestor
110772306|NCT01201122|Mesalamine|mesalamine|mesh-list
110772307|NCT01201122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110772308|NCT01201122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110772309|NCT01201122|Analgesics|analgesics|mesh-ancestor
110772310|NCT01201122|Sensory System Agents|sensory system agents|mesh-ancestor
110772311|NCT01201122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110772312|NCT01201122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110772313|NCT01201122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110772314|NCT01201122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110772315|NCT03674112|Trastuzumab|trastuzumab|mesh-list
110772316|NCT03674112|Pertuzumab|pertuzumab|mesh-list
110772317|NCT03674112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110772318|NCT03674112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110772319|NCT03668808|Insulin|insulin|mesh-list
110772320|NCT03668808|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110772321|NCT03668808|Insulin Glargine|insulin glargine|mesh-list
110772322|NCT03668808|Insulin, Long-Acting|insulin, long-acting|mesh-list
110772323|NCT03668808|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110772324|NCT03668808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110772325|NCT05281926|Nivolumab|nivolumab|mesh-list
110772326|NCT05281926|Poly ICLC|poly iclc|mesh-list
110772327|NCT05281926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110772328|NCT05281926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110772329|NCT05281926|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110772330|NCT05281926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110772331|NCT05281926|Interferon Inducers|interferon inducers|mesh-ancestor
110772332|NCT05281926|Immunologic Factors|immunologic factors|mesh-ancestor
110772333|NCT05281926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110772334|NCT03844776|Acetaminophen|acetaminophen|mesh-list
110772335|NCT03844776|Amoxicillin|amoxicillin|mesh-list
110772336|NCT03844776|Metronidazole|metronidazole|mesh-list
110772337|NCT03844776|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
110772338|NCT03844776|Chlorhexidine|chlorhexidine|mesh-list
110772339|NCT03844776|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110772340|NCT03844776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110772341|NCT03844776|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110772342|NCT03844776|Disinfectants|disinfectants|mesh-ancestor
110772343|NCT03844776|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110772344|NCT03844776|Analgesics|analgesics|mesh-ancestor
110772345|NCT03844776|Sensory System Agents|sensory system agents|mesh-ancestor
110772346|NCT03844776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110772347|NCT03844776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110772348|NCT03844776|Antipyretics|antipyretics|mesh-ancestor
110772349|NCT03844776|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110772350|NCT03844776|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110772351|NCT03844776|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110772352|NCT03844776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110772353|NCT03844776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110772354|NCT01566942|Oxaliplatin|oxaliplatin|mesh-list
110772355|NCT01566942|Irinotecan|irinotecan|mesh-list
110772356|NCT01566942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110772357|NCT01566942|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110772358|NCT01566942|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110772359|NCT01566942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110772360|NCT01566942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110772361|NCT01201278|Insulin|insulin|mesh-list
110772362|NCT01201278|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110772364|NCT01201278|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110772365|NCT01201278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110772366|NCT05667948|Immunomodulating Agents|immunomodulating agents|mesh-list
110772367|NCT05667948|Immunologic Factors|immunologic factors|mesh-ancestor
110772368|NCT05667948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110772369|NCT01199328|Aspirin|aspirin|mesh-list
110772370|NCT01199328|Esomeprazole|esomeprazole|mesh-list
110772371|NCT01199328|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110772372|NCT01199328|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110772373|NCT01199328|Analgesics|analgesics|mesh-ancestor
110772374|NCT01199328|Sensory System Agents|sensory system agents|mesh-ancestor
110772375|NCT01199328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110772376|NCT01199328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110772377|NCT01199328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110772378|NCT01199328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110772379|NCT01199328|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110772380|NCT01199328|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110772381|NCT01199328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110772382|NCT01199328|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110772383|NCT01199328|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110772384|NCT01199328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110772385|NCT01199328|Antipyretics|antipyretics|mesh-ancestor
110828748|NCT03477903|Metoclopramide|metoclopramide|mesh-list
110772386|NCT01199328|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110772387|NCT01199328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110772388|NCT01199328|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110772389|NCT02982954|Nivolumab|nivolumab|mesh-list
110772390|NCT02982954|Ipilimumab|ipilimumab|mesh-list
110772391|NCT02982954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110772392|NCT02982954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110772393|NCT02982954|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110772394|NCT02982954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110772395|NCT01203228|Cyclophosphamide|cyclophosphamide|mesh-list
110772396|NCT01203228|Busulfan|busulfan|mesh-list
110772397|NCT01203228|Fludarabine phosphate|fludarabine phosphate|mesh-list
110772398|NCT01203228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110772399|NCT01203228|Immunologic Factors|immunologic factors|mesh-ancestor
110772400|NCT01203228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110772401|NCT01203228|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110772402|NCT01203228|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110772403|NCT01203228|Alkylating Agents|alkylating agents|mesh-ancestor
110772404|NCT01203228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110772405|NCT01203228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110772406|NCT01203228|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110772407|NCT01203228|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110772408|NCT01203228|Antimetabolites|antimetabolites|mesh-ancestor
110772409|NCT01203696|Amlodipine|amlodipine|mesh-list
110772410|NCT01203696|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110772411|NCT01203696|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110772412|NCT01203696|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110772413|NCT01203696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110772414|NCT01203696|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110772415|NCT01203696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110772416|NCT01203696|Vasodilator Agents|vasodilator agents|mesh-ancestor
110772417|NCT01203306|Bevacizumab|bevacizumab|mesh-list
110772418|NCT01203306|Capecitabine|capecitabine|mesh-list
110772419|NCT01203306|Octreotide|octreotide|mesh-list
110772420|NCT01203306|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110772421|NCT01203306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110772422|NCT01203306|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110772423|NCT01203306|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110772424|NCT01203306|Growth Substances|growth substances|mesh-ancestor
110772425|NCT01203306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110772426|NCT01203306|Growth Inhibitors|growth inhibitors|mesh-ancestor
110772427|NCT01203306|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110772428|NCT01203306|Antimetabolites|antimetabolites|mesh-ancestor
110772429|NCT01203306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110772430|NCT01203306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110772431|NCT01203306|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110772432|NCT01203384|1-(3',4'-dichloro-2-fluoro(1,1'-biphenyl)-4-yl)cyclopropanecarboxylic acid|1-(3',4'-dichloro-2-fluoro(1,1'-biphenyl)-4-yl)cyclopropanecarboxylic acid|mesh-list
110772433|NCT01203384|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
110772434|NCT01203384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110772435|NCT01203384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110772436|NCT03724968|Nivolumab|nivolumab|mesh-list
110772437|NCT03724968|Ipilimumab|ipilimumab|mesh-list
110772438|NCT03724968|Relatlimab|relatlimab|mesh-list
110772439|NCT03724968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110772440|NCT03724968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110772441|NCT03724968|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110772442|NCT03724968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110772443|NCT01204086|Fluoxetine|fluoxetine|mesh-list
110772444|NCT01204086|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
110772445|NCT01204086|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110772446|NCT01204086|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110772447|NCT01204086|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110772448|NCT01204086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110772449|NCT01204086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110772450|NCT01204086|Serotonin Agents|serotonin agents|mesh-ancestor
110772451|NCT01204086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110772452|NCT01204086|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110772453|NCT01204086|Antidepressive Agents|antidepressive agents|mesh-ancestor
110772454|NCT01204086|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110772455|NCT01204086|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110772456|NCT01204086|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110772457|NCT01204086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110772458|NCT01204086|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110772459|NCT01201902|Vaccines|vaccines|mesh-list
110772460|NCT01201902|Immunologic Factors|immunologic factors|mesh-ancestor
110772461|NCT01201902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110772462|NCT01204164|Dexamethasone|dexamethasone|mesh-list
110772463|NCT01204164|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110772464|NCT01204164|Antiemetics|antiemetics|mesh-ancestor
110772465|NCT01204164|Autonomic Agents|autonomic agents|mesh-ancestor
110772466|NCT01204164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110772467|NCT01204164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110772468|NCT01204164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110772469|NCT01204164|Glucocorticoids|glucocorticoids|mesh-ancestor
110772470|NCT01204164|Hormones|hormones|mesh-ancestor
110772471|NCT01204164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110772472|NCT01204164|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110772473|NCT01204164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110772474|NCT01206036|Sirolimus|sirolimus|mesh-list
110772475|NCT01206036|Docetaxel|docetaxel|mesh-list
110772476|NCT01206036|Temsirolimus|temsirolimus|mesh-list
110772477|NCT01206036|MTOR Inhibitors|mtor inhibitors|mesh-list
110772478|NCT01206036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110772479|NCT01206036|Tubulin Modulators|tubulin modulators|mesh-ancestor
110772480|NCT01206036|Antimitotic Agents|antimitotic agents|mesh-ancestor
110772481|NCT01206036|Mitosis Modulators|mitosis modulators|mesh-ancestor
110772482|NCT01206036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110772483|NCT01206036|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110772484|NCT01206036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110772485|NCT01206036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110772486|NCT01206036|Immunologic Factors|immunologic factors|mesh-ancestor
110828798|NCT03474081|Cholinergic Agents|cholinergic agents|mesh-ancestor
110772487|NCT01206036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110772488|NCT01206036|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110772489|NCT01206036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110772490|NCT01206036|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110772491|NCT01206036|Antifungal Agents|antifungal agents|mesh-ancestor
110772492|NCT01204320|Paclitaxel|paclitaxel|mesh-list
110772493|NCT01204320|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110772494|NCT01204320|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110772495|NCT01204320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110772496|NCT01204320|Tubulin Modulators|tubulin modulators|mesh-ancestor
110772497|NCT01204320|Antimitotic Agents|antimitotic agents|mesh-ancestor
110772498|NCT01204320|Mitosis Modulators|mitosis modulators|mesh-ancestor
110772499|NCT01204320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110772500|NCT03722238|Ibuprofen|ibuprofen|mesh-list
110772501|NCT03722238|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110772502|NCT03722238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110772503|NCT03722238|Analgesics|analgesics|mesh-ancestor
110772504|NCT03722238|Sensory System Agents|sensory system agents|mesh-ancestor
110772505|NCT03722238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110772506|NCT03722238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110772507|NCT03722238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110772508|NCT03722238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110772509|NCT03722238|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110772510|NCT03722238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110772511|NCT03722238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110772512|NCT01203540|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110772513|NCT01203540|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110772514|NCT01203618|Farletuzumab|farletuzumab|mesh-list
110772515|NCT01203618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110772516|NCT01206270|Methyltestosterone|methyltestosterone|mesh-list
110772517|NCT01206270|Castor Oil|castor oil|mesh-list
110772518|NCT01206270|Testosterone|testosterone|mesh-list
110772519|NCT01206270|Testosterone undecanoate|testosterone undecanoate|mesh-list
110772520|NCT01206270|Testosterone enanthate|testosterone enanthate|mesh-list
110772521|NCT01206270|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
110772522|NCT01206270|Androgens|androgens|mesh-ancestor
110772523|NCT01206270|Hormones|hormones|mesh-ancestor
110772524|NCT01206270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110772525|NCT01206270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110772526|NCT01206270|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110772527|NCT01206270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110772528|NCT01206270|Anabolic Agents|anabolic agents|mesh-ancestor
110772529|NCT01206270|Cathartics|cathartics|mesh-ancestor
110772530|NCT01206270|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110772531|NCT01298310|Lidocaine|lidocaine|mesh-list
110772532|NCT01298310|Anesthetics, Local|anesthetics, local|mesh-ancestor
110772533|NCT01298310|Anesthetics|anesthetics|mesh-ancestor
110772534|NCT01298310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110772535|NCT01298310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110772536|NCT01298310|Sensory System Agents|sensory system agents|mesh-ancestor
110772537|NCT01298310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110772538|NCT01298310|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110772539|NCT01298310|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110772540|NCT01298310|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110772541|NCT01298310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110334006|NCT04324411|Sirolimus|sirolimus|mesh-list
110772542|NCT01298310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110772543|NCT01298466|Pregabalin|pregabalin|mesh-list
110772544|NCT01298466|Analgesics|analgesics|mesh-ancestor
110772545|NCT01298466|Sensory System Agents|sensory system agents|mesh-ancestor
110772546|NCT01298466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110772547|NCT01298466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110772548|NCT01298466|Anticonvulsants|anticonvulsants|mesh-ancestor
110772549|NCT01298466|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110772550|NCT01298466|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110772551|NCT01298466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110772552|NCT01298466|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110772553|NCT01298466|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110772554|NCT01298466|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110772555|NCT01298466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110772556|NCT01298466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110772557|NCT01206348|Minocycline|minocycline|mesh-list
110772558|NCT01206348|Clindamycin|clindamycin|mesh-list
110772559|NCT01206348|Clindamycin palmitate|clindamycin palmitate|mesh-list
110772560|NCT01206348|Clindamycin phosphate|clindamycin phosphate|mesh-list
110772561|NCT01206348|Tretinoin|tretinoin|mesh-list
110772562|NCT01206348|Benzoyl Peroxide|benzoyl peroxide|mesh-list
110772563|NCT01206348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110772564|NCT01206348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110772565|NCT01206348|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110772566|NCT01206348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110828852|NCT01180075|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110772567|NCT01206348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110772568|NCT01206348|Dermatologic Agents|dermatologic agents|mesh-ancestor
110772569|NCT01206348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110772570|NCT01206348|Keratolytic Agents|keratolytic agents|mesh-ancestor
110772571|NCT01204476|Everolimus|everolimus|mesh-list
110772572|NCT01204476|Octreotide|octreotide|mesh-list
110772573|NCT01204476|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110772574|NCT01204476|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110772575|NCT01204476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110772576|NCT01204476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110772577|NCT01204476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110772578|NCT01204476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110772579|NCT01204476|Immunologic Factors|immunologic factors|mesh-ancestor
110772580|NCT01204476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110772581|NCT01204476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110772582|NCT01204476|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110772583|NCT01204476|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110772584|NCT03633292|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
110772585|NCT03633292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110772586|NCT04630210|Atezolizumab|atezolizumab|mesh-list
110772587|NCT04630210|Letrozole|letrozole|mesh-list
110772588|NCT04630210|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110772589|NCT04630210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110772590|NCT04630210|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110334029|NCT01242072|Ifosfamide|ifosfamide|mesh-list
110772591|NCT04630210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110772592|NCT04630210|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110772593|NCT04630210|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110772594|NCT04630210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110772595|NCT04630210|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110772596|NCT04630210|Hormone Antagonists|hormone antagonists|mesh-ancestor
110772597|NCT04630210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110772598|NCT04630210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110772599|NCT01382368|Sildenafil Citrate|sildenafil citrate|mesh-list
110772600|NCT01382368|Vasodilator Agents|vasodilator agents|mesh-ancestor
110772601|NCT01382368|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110772602|NCT01382368|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110772603|NCT01382368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110772604|NCT01382368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110772605|NCT01382368|Urological Agents|urological agents|mesh-ancestor
110772606|NCT04546828|Gemcitabine|gemcitabine|mesh-list
110772607|NCT04546828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110772608|NCT04546828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110772609|NCT04546828|Antimetabolites|antimetabolites|mesh-ancestor
110772610|NCT04546828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110772611|NCT01382134|Aspirin|aspirin|mesh-list
110772612|NCT01382134|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
110772613|NCT01382134|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110772614|NCT01382134|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110772615|NCT01382134|Analgesics|analgesics|mesh-ancestor
110772616|NCT01382134|Sensory System Agents|sensory system agents|mesh-ancestor
110772617|NCT01382134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110772618|NCT01382134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110772619|NCT01382134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110772620|NCT01382134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110772621|NCT01382134|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110772622|NCT01382134|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110772623|NCT01382134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110772624|NCT01382134|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110772625|NCT01382134|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110772626|NCT01382134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110772627|NCT01382134|Antipyretics|antipyretics|mesh-ancestor
110772628|NCT01382134|Hemostatics|hemostatics|mesh-ancestor
110772629|NCT01382134|Coagulants|coagulants|mesh-ancestor
110772630|NCT01382134|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
110772631|NCT01382134|Natriuretic Agents|natriuretic agents|mesh-ancestor
110772633|NCT05077488|Anesthetics, Local|anesthetics, local|mesh-ancestor
110772634|NCT05077488|Anesthetics|anesthetics|mesh-ancestor
110772635|NCT05077488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110772636|NCT05077488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110772637|NCT05077488|Sensory System Agents|sensory system agents|mesh-ancestor
110772638|NCT05077488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110772639|NCT05077488|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110772640|NCT05077488|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110772641|NCT05077488|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110772642|NCT05077488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110772643|NCT05077488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110772644|NCT05668572|Vaccines|vaccines|mesh-list
110772645|NCT05668572|Immunologic Factors|immunologic factors|mesh-ancestor
110772646|NCT05668572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110772647|NCT02410980|Tretinoin|tretinoin|mesh-list
110772648|NCT02410980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110772649|NCT02410980|Keratolytic Agents|keratolytic agents|mesh-ancestor
110772650|NCT02410980|Dermatologic Agents|dermatologic agents|mesh-ancestor
110772651|NCT01298934|Panobinostat|panobinostat|mesh-list
110772652|NCT01298934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110772653|NCT01298934|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110772654|NCT01298934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110772655|NCT01298934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110772666|NCT01299012|Liraglutide|liraglutide|mesh-list
110772667|NCT01299012|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110772668|NCT01299012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110772669|NCT01299012|Incretins|incretins|mesh-ancestor
110772670|NCT01299012|Hormones|hormones|mesh-ancestor
110772671|NCT01299012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110772672|NCT02155920|Everolimus|everolimus|mesh-list
110772673|NCT02155920|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110772674|NCT02155920|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110772675|NCT02155920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110772676|NCT02155920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110828933|NCT03472521|Antimanic Agents|antimanic agents|mesh-ancestor
110772677|NCT02155920|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110772678|NCT02155920|Immunologic Factors|immunologic factors|mesh-ancestor
110772679|NCT02155920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110772680|NCT02155920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110772681|NCT01301040|Cyclophosphamide|cyclophosphamide|mesh-list
110772682|NCT01301040|Docetaxel|docetaxel|mesh-list
110772683|NCT01301040|Epirubicin|epirubicin|mesh-list
110772684|NCT01301040|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110772685|NCT01301040|Immunologic Factors|immunologic factors|mesh-ancestor
110772686|NCT01301040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110772687|NCT01301040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110772688|NCT01301040|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110772689|NCT01301040|Alkylating Agents|alkylating agents|mesh-ancestor
110772690|NCT01301040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110772691|NCT01301040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110772692|NCT01301040|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110772693|NCT01301040|Tubulin Modulators|tubulin modulators|mesh-ancestor
110772694|NCT01301040|Antimitotic Agents|antimitotic agents|mesh-ancestor
110772695|NCT01301040|Mitosis Modulators|mitosis modulators|mesh-ancestor
110772696|NCT01301040|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110772697|NCT01301040|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110772698|NCT01301040|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110772699|NCT01301040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110772700|NCT03818334|Cyclophosphamide|cyclophosphamide|mesh-list
110772701|NCT03818334|Thymoglobulin|thymoglobulin|mesh-list
110772702|NCT03818334|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110772703|NCT03818334|Immunologic Factors|immunologic factors|mesh-ancestor
110772704|NCT03818334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110772705|NCT03818334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110772706|NCT03818334|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110772707|NCT03818334|Alkylating Agents|alkylating agents|mesh-ancestor
110772708|NCT03818334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110490406|NCT04281680|Octreotide|octreotide|mesh-list
110772709|NCT03818334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110772710|NCT03818334|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110772711|NCT01206972|Enoxaparin|enoxaparin|mesh-list
110772712|NCT01206972|Rivaroxaban|rivaroxaban|mesh-list
110772713|NCT01206972|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110772714|NCT01206972|Antithrombins|antithrombins|mesh-ancestor
110772715|NCT01206972|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110772716|NCT01206972|Protease Inhibitors|protease inhibitors|mesh-ancestor
110772717|NCT01206972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110772718|NCT01206972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110772719|NCT01206972|Anticoagulants|anticoagulants|mesh-ancestor
110772720|NCT01206972|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110828945|NCT01177501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110772722|NCT03817476|BI 425809|bi 425809|mesh-list
110772723|NCT03817476|Nootropic Agents|nootropic agents|mesh-ancestor
110772724|NCT02918292|Mycophenolic Acid|mycophenolic acid|mesh-list
110772725|NCT02918292|Cyclophosphamide|cyclophosphamide|mesh-list
110772726|NCT02918292|Fludarabine|fludarabine|mesh-list
110772727|NCT02918292|Tacrolimus|tacrolimus|mesh-list
110772729|NCT02918292|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110772730|NCT02918292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110772731|NCT02918292|Immunologic Factors|immunologic factors|mesh-ancestor
110772732|NCT02918292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110772733|NCT02918292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110772734|NCT02918292|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110772735|NCT02918292|Alkylating Agents|alkylating agents|mesh-ancestor
110772736|NCT02918292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110772737|NCT02918292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110772738|NCT02918292|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110772739|NCT02918292|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110772740|NCT02918292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110772741|NCT02918292|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110772742|NCT02918292|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110772743|NCT02918292|Antitubercular Agents|antitubercular agents|mesh-ancestor
110772744|NCT02918292|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110772745|NCT02918292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110772746|NCT01207128|Voriconazole|voriconazole|mesh-list
110772747|NCT01207128|Micafungin|micafungin|mesh-list
110772748|NCT01207128|Antifungal Agents|antifungal agents|mesh-ancestor
110772749|NCT01207128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110772750|NCT01207128|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110772751|NCT01207128|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110772752|NCT01207128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110772753|NCT01207128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110772754|NCT01207128|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110772755|NCT01207128|Hormone Antagonists|hormone antagonists|mesh-ancestor
110772756|NCT01207128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110772757|NCT01207128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110772758|NCT01207128|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110772759|NCT01299558|Fluticasone|fluticasone|mesh-list
110772760|NCT01299558|Xhance|xhance|mesh-list
110772761|NCT01299558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110772762|NCT01299558|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110772763|NCT01299558|Autonomic Agents|autonomic agents|mesh-ancestor
110772764|NCT01299558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110772765|NCT01299558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110772766|NCT01299558|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110772767|NCT01299558|Respiratory System Agents|respiratory system agents|mesh-ancestor
110772768|NCT01299558|Dermatologic Agents|dermatologic agents|mesh-ancestor
110772769|NCT01299558|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110772770|NCT01207206|Ketamine|ketamine|mesh-list
110772771|NCT01207206|Analgesics|analgesics|mesh-ancestor
110772772|NCT01207206|Sensory System Agents|sensory system agents|mesh-ancestor
110772773|NCT01207206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110772774|NCT01207206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110772775|NCT01207206|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110772776|NCT01207206|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110772777|NCT01207206|Anesthetics, General|anesthetics, general|mesh-ancestor
110772778|NCT01207206|Anesthetics|anesthetics|mesh-ancestor
110829010|NCT04668131|Immunologic Factors|immunologic factors|mesh-ancestor
110772779|NCT01207206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110772780|NCT01207206|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110772781|NCT01207206|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110772782|NCT01207206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110772783|NCT01207206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110772784|NCT03719586|Remdesivir|remdesivir|mesh-list
110772785|NCT03719586|Atoltivimab, maftivimab, and odesivimab-ebgn drug combination|atoltivimab, maftivimab, and odesivimab-ebgn drug combination|mesh-list
110772786|NCT03719586|Antimetabolites|antimetabolites|mesh-ancestor
110772787|NCT03719586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110772788|NCT03719586|Antiviral Agents|antiviral agents|mesh-ancestor
110772789|NCT03719586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110772790|NCT01205022|Calcium, Dietary|calcium, dietary|mesh-list
110772791|NCT01205022|Leucovorin|leucovorin|mesh-list
110772792|NCT01205022|Bevacizumab|bevacizumab|mesh-list
110772793|NCT01205022|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110772794|NCT01205022|Fluorouracil|fluorouracil|mesh-list
110772795|NCT01205022|Irinotecan|irinotecan|mesh-list
110772796|NCT01205022|Camptothecin|camptothecin|mesh-list
110772797|NCT01205022|Antibodies|antibodies|mesh-list
110772798|NCT01205022|Immunoglobulins|immunoglobulins|mesh-list
110772799|NCT01205022|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110772801|NCT01205022|Levoleucovorin|levoleucovorin|mesh-list
110772802|NCT01205022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110772803|NCT01205022|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110772804|NCT01205022|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110772805|NCT01205022|Growth Substances|growth substances|mesh-ancestor
110772806|NCT01205022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110772807|NCT01205022|Growth Inhibitors|growth inhibitors|mesh-ancestor
110772808|NCT01205022|Immunologic Factors|immunologic factors|mesh-ancestor
110772809|NCT01205022|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110772810|NCT01205022|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110772811|NCT01205022|Antimetabolites|antimetabolites|mesh-ancestor
110772812|NCT01205022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110772813|NCT01205022|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110772814|NCT01205022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110772815|NCT01205022|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110772816|NCT01205022|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110772817|NCT01205022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110772818|NCT01205022|Antidotes|antidotes|mesh-ancestor
110772819|NCT01205022|Protective Agents|protective agents|mesh-ancestor
110772820|NCT01205022|Vitamin B Complex|vitamin b complex|mesh-ancestor
110772821|NCT01205022|Vitamins|vitamins|mesh-ancestor
110772822|NCT01205022|Micronutrients|micronutrients|mesh-ancestor
110772823|NCT01205022|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110772824|NCT01205178|Chloroquine|chloroquine|mesh-list
110772825|NCT01205178|Primaquine|primaquine|mesh-list
110772826|NCT01205178|Tafenoquine|tafenoquine|mesh-list
110772827|NCT01205178|Amebicides|amebicides|mesh-ancestor
110772828|NCT01205178|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110772829|NCT01205178|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110772830|NCT01205178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110772831|NCT01205178|Antimalarials|antimalarials|mesh-ancestor
110772832|NCT01205178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110772833|NCT01205256|Methadone|methadone|mesh-list
110772834|NCT01205256|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110772835|NCT01205256|Narcotics|narcotics|mesh-ancestor
110772836|NCT01205256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110772837|NCT01205256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110772838|NCT01205256|Analgesics|analgesics|mesh-ancestor
110772839|NCT01205256|Sensory System Agents|sensory system agents|mesh-ancestor
110772840|NCT01205256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110772841|NCT01205256|Antitussive Agents|antitussive agents|mesh-ancestor
110772842|NCT01205256|Respiratory System Agents|respiratory system agents|mesh-ancestor
110772843|NCT03823482|Lidocaine|lidocaine|mesh-list
110772844|NCT03823482|Anesthetics, Local|anesthetics, local|mesh-ancestor
110772845|NCT03823482|Anesthetics|anesthetics|mesh-ancestor
110772846|NCT03823482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110772847|NCT03823482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110772848|NCT03823482|Sensory System Agents|sensory system agents|mesh-ancestor
110772849|NCT03823482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110772850|NCT03823482|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110772851|NCT03823482|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110772852|NCT03823482|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110772853|NCT03823482|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110772854|NCT03823482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110772855|NCT03816306|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
110772856|NCT03816306|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110772857|NCT03816306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110772858|NCT03816072|Phenylephrine|phenylephrine|mesh-list
110772859|NCT03816072|Oxymetazoline|oxymetazoline|mesh-list
110772860|NCT03816072|Propofol|propofol|mesh-list
110772861|NCT03816072|Sevoflurane|sevoflurane|mesh-list
110772862|NCT03816072|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110772863|NCT03816072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110772864|NCT03816072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110772865|NCT03816072|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110772866|NCT03816072|Anesthetics, General|anesthetics, general|mesh-ancestor
110772867|NCT03816072|Anesthetics|anesthetics|mesh-ancestor
110772868|NCT03816072|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110772869|NCT03816072|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110772870|NCT03816072|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110772871|NCT03816072|Mydriatics|mydriatics|mesh-ancestor
110772872|NCT03816072|Autonomic Agents|autonomic agents|mesh-ancestor
110097959|NCT01739218|Paclitaxel|paclitaxel|mesh-list
110772873|NCT03816072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110772874|NCT03816072|Sympathomimetics|sympathomimetics|mesh-ancestor
110772875|NCT03816072|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110772876|NCT03816072|Nasal Decongestants|nasal decongestants|mesh-ancestor
110772877|NCT03816072|Respiratory System Agents|respiratory system agents|mesh-ancestor
110772878|NCT03816072|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110772879|NCT03816072|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110772880|NCT03816072|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110772881|NCT03816072|Adrenergic Agents|adrenergic agents|mesh-ancestor
110829151|NCT00003875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110772882|NCT03816072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110772883|NCT03816072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110772884|NCT03816072|Protective Agents|protective agents|mesh-ancestor
110772885|NCT01299948|Prednisolone|prednisolone|mesh-list
110772886|NCT01299948|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110772887|NCT01299948|Glucocorticoids|glucocorticoids|mesh-ancestor
110772888|NCT01299948|Hormones|hormones|mesh-ancestor
110772889|NCT01299948|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110772890|NCT01299948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110772891|NCT01299948|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110772892|NCT01299948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110772893|NCT01300026|N-(1-(7-fluoro-2-(pyridin-2-yl)quinolin-3-yl)ethyl)-9H-purin-6-amine|n-(1-(7-fluoro-2-(pyridin-2-yl)quinolin-3-yl)ethyl)-9h-purin-6-amine|mesh-list
110772894|NCT01300026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110772895|NCT01300026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110772896|NCT01297452|Paclitaxel|paclitaxel|mesh-list
110772897|NCT01297452|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110772898|NCT01297452|Carboplatin|carboplatin|mesh-list
110772899|NCT01297452|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110772900|NCT01297452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110772901|NCT01297452|Tubulin Modulators|tubulin modulators|mesh-ancestor
110772902|NCT01297452|Antimitotic Agents|antimitotic agents|mesh-ancestor
110772903|NCT01297452|Mitosis Modulators|mitosis modulators|mesh-ancestor
110772904|NCT01297452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110772905|NCT01301586|Doxycycline|doxycycline|mesh-list
110772906|NCT01301586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110772907|NCT01301586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110772908|NCT01301586|Antimalarials|antimalarials|mesh-ancestor
110772909|NCT01301586|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110772910|NCT01301586|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110772911|NCT03815838|Fallypride|fallypride|mesh-list
110772912|NCT03815838|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110772913|NCT03815838|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110772914|NCT03815838|Dopamine Agents|dopamine agents|mesh-ancestor
110772915|NCT03815838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110772916|NCT03815838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110772917|NCT03815838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110772918|NCT01205724|Factor VIII|factor viii|mesh-list
110772919|NCT01205724|Coagulants|coagulants|mesh-ancestor
110772920|NCT01301820|Lenalidomide|lenalidomide|mesh-list
110772921|NCT01301820|Azacitidine|azacitidine|mesh-list
110772922|NCT01301820|Immunologic Factors|immunologic factors|mesh-ancestor
110772923|NCT01301820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110772924|NCT01301820|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110772925|NCT01301820|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110772926|NCT01301820|Growth Substances|growth substances|mesh-ancestor
110772927|NCT01301820|Growth Inhibitors|growth inhibitors|mesh-ancestor
110772928|NCT01301820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110772929|NCT01301820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110772930|NCT01301820|Antimetabolites|antimetabolites|mesh-ancestor
110772931|NCT01301820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110772932|NCT01301820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110772933|NCT01297686|Dexamethasone|dexamethasone|mesh-list
110772934|NCT01297686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110772935|NCT01297686|Antiemetics|antiemetics|mesh-ancestor
110772936|NCT01297686|Autonomic Agents|autonomic agents|mesh-ancestor
110772937|NCT01297686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110772938|NCT01297686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110772939|NCT01297686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110772940|NCT01297686|Glucocorticoids|glucocorticoids|mesh-ancestor
110772941|NCT01297686|Hormones|hormones|mesh-ancestor
110772942|NCT01297686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110772943|NCT01297686|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110772944|NCT01297686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110772946|NCT01205880|Clobetasol|clobetasol|mesh-list
110772947|NCT01205880|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110772948|NCT01205880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110772949|NCT01205880|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
110772950|NCT01205880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110772951|NCT01205880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110772952|NCT01205880|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110772953|NCT01205880|Vitamins|vitamins|mesh-ancestor
110772954|NCT01205880|Micronutrients|micronutrients|mesh-ancestor
110772955|NCT01205880|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110772956|NCT01205880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110772957|NCT01205880|Glucocorticoids|glucocorticoids|mesh-ancestor
110772958|NCT01205880|Hormones|hormones|mesh-ancestor
110772959|NCT01205880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110772960|NCT01205958|Pyranoprofen|pyranoprofen|mesh-list
110772961|NCT01205958|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110772962|NCT01205958|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110772963|NCT01205958|Analgesics|analgesics|mesh-ancestor
110772964|NCT01205958|Sensory System Agents|sensory system agents|mesh-ancestor
110772965|NCT01205958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110772966|NCT01205958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110772967|NCT01205958|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110772968|NCT01205958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110772969|NCT01205958|Gout Suppressants|gout suppressants|mesh-ancestor
110772970|NCT01297842|Meropenem|meropenem|mesh-list
110772971|NCT01297842|Imipenem|imipenem|mesh-list
110772972|NCT01297842|Ertapenem|ertapenem|mesh-list
110772973|NCT01297842|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110772974|NCT01297842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110772975|NCT01297998|Cisplatin|cisplatin|mesh-list
110772976|NCT01297998|Gemcitabine|gemcitabine|mesh-list
110772977|NCT01297998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110772978|NCT01297998|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110772979|NCT01297998|Antimetabolites|antimetabolites|mesh-ancestor
110772980|NCT01297998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110772981|NCT01298076|Dexamethasone|dexamethasone|mesh-list
110772982|NCT01298076|Bevacizumab|bevacizumab|mesh-list
110772983|NCT01298076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110829203|NCT03709056|Propofol|propofol|mesh-list
110772984|NCT01298076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110772985|NCT01298076|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110772986|NCT01298076|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110772987|NCT01298076|Growth Substances|growth substances|mesh-ancestor
110772988|NCT01298076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110772989|NCT01298076|Growth Inhibitors|growth inhibitors|mesh-ancestor
110772990|NCT01298076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110772991|NCT01298076|Antiemetics|antiemetics|mesh-ancestor
110772992|NCT01298076|Autonomic Agents|autonomic agents|mesh-ancestor
110772993|NCT01298076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110772994|NCT01298076|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110772995|NCT01298076|Glucocorticoids|glucocorticoids|mesh-ancestor
110772996|NCT01298076|Hormones|hormones|mesh-ancestor
110772997|NCT01298076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110772998|NCT01298076|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110772999|NCT03819348|Antifungal Agents|antifungal agents|mesh-list
110773000|NCT03819348|Clotrimazole|clotrimazole|mesh-list
110773001|NCT03819348|Miconazole|miconazole|mesh-list
110773002|NCT03819348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110773003|NCT03819348|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110773004|NCT03819348|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110773005|NCT03819348|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110773006|NCT03819348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110773007|NCT03819348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110773008|NCT03819348|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110773009|NCT03819348|Hormone Antagonists|hormone antagonists|mesh-ancestor
110773010|NCT03819348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110490702|NCT00694369|Analgesics|analgesics|mesh-ancestor
110773011|NCT03819348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110773012|NCT03819348|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110773013|NCT03819348|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110773014|NCT01560390|Ketamine|ketamine|mesh-list
110773015|NCT01560390|Analgesics|analgesics|mesh-ancestor
110773016|NCT01560390|Sensory System Agents|sensory system agents|mesh-ancestor
110773017|NCT01560390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110773018|NCT01560390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110773019|NCT01560390|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110773020|NCT01560390|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110773021|NCT01560390|Anesthetics, General|anesthetics, general|mesh-ancestor
110773022|NCT01560390|Anesthetics|anesthetics|mesh-ancestor
110773023|NCT01560390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110773024|NCT01560390|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110773025|NCT01560390|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110773026|NCT01560390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110829233|NCT01106495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110773027|NCT01560390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110773028|NCT03807882|Clozapine|clozapine|mesh-list
110773029|NCT03807882|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110773030|NCT03807882|Serotonin Agents|serotonin agents|mesh-ancestor
110773031|NCT03807882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110773032|NCT03807882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110773033|NCT03807882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110773034|NCT03807882|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110773035|NCT03807882|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110773036|NCT03807882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110773037|NCT03807882|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110773038|NCT03807882|GABA Antagonists|gaba antagonists|mesh-ancestor
110773039|NCT03807882|GABA Agents|gaba agents|mesh-ancestor
110773040|NCT03796572|Ropivacaine|ropivacaine|mesh-list
110773041|NCT03796572|Anesthetics, Local|anesthetics, local|mesh-ancestor
110773042|NCT03796572|Anesthetics|anesthetics|mesh-ancestor
110773043|NCT03796572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110773044|NCT03796572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110773045|NCT03796572|Sensory System Agents|sensory system agents|mesh-ancestor
110773046|NCT03796572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110773047|NCT01304472|Clopidogrel|clopidogrel|mesh-list
110773048|NCT01304472|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
110773049|NCT01304472|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110773050|NCT01304472|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110334178|NCT01300546|Sumatriptan|sumatriptan|mesh-list
110773051|NCT01304472|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110773052|NCT01304472|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110773053|NCT01304472|Purinergic Agents|purinergic agents|mesh-ancestor
110773054|NCT01304472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110773055|NCT01304472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110773056|NCT01304472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110773057|NCT03795792|Curcumin|curcumin|mesh-list
110773058|NCT03795792|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110773059|NCT03795792|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110773060|NCT03795792|Analgesics|analgesics|mesh-ancestor
110773061|NCT03795792|Sensory System Agents|sensory system agents|mesh-ancestor
110773062|NCT03795792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110773063|NCT03795792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110773064|NCT03795792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110773065|NCT03795792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110773066|NCT03795792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110773067|NCT03795792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110829265|NCT03364686|Biotin|biotin|mesh-list
110773068|NCT03795792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110773069|NCT01303536|Ondansetron|ondansetron|mesh-list
110773070|NCT01303536|Antiemetics|antiemetics|mesh-ancestor
110773071|NCT01303536|Autonomic Agents|autonomic agents|mesh-ancestor
110773072|NCT01303536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110773073|NCT01303536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110773074|NCT01303536|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110773075|NCT01303536|Antipruritics|antipruritics|mesh-ancestor
110773076|NCT01303536|Dermatologic Agents|dermatologic agents|mesh-ancestor
110773077|NCT01303536|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110773078|NCT01303536|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110773079|NCT01303536|Serotonin Agents|serotonin agents|mesh-ancestor
110773080|NCT01303536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110773081|NCT01303536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110773082|NCT01303614|Lidocaine|lidocaine|mesh-list
110773083|NCT01303614|Prilocaine|prilocaine|mesh-list
110490791|NCT00954512|Vitamins|vitamins|mesh-ancestor
110773084|NCT01303614|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
110445854|NCT02770378|Ritonavir|ritonavir|mesh-list
110773086|NCT01303614|Anesthetics|anesthetics|mesh-ancestor
110773087|NCT01303614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110773088|NCT01303614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110773089|NCT01303614|Sensory System Agents|sensory system agents|mesh-ancestor
110773090|NCT01303614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110773091|NCT01303614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110773092|NCT01303614|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110773093|NCT01303614|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110773094|NCT01303614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110773095|NCT01303614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110773096|NCT01303614|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
110773098|NCT03347838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110773099|NCT03347838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110773100|NCT03347838|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110773101|NCT03347838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110773102|NCT03795090|Anti-Infective Agents|anti-infective agents|mesh-list
110773103|NCT03795090|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110773104|NCT03802422|Vitamin B 12|vitamin b 12|mesh-list
110773105|NCT03802422|Hydroxocobalamin|hydroxocobalamin|mesh-list
110773106|NCT03802422|Vitamins|vitamins|mesh-ancestor
110773107|NCT03802422|Micronutrients|micronutrients|mesh-ancestor
110773108|NCT03802422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110773109|NCT03802422|Vitamin B Complex|vitamin b complex|mesh-ancestor
110773110|NCT03802422|Hematinics|hematinics|mesh-ancestor
110773111|NCT03801564|Hyaluronic Acid|hyaluronic acid|mesh-list
110773112|NCT03801564|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110773113|NCT03801564|Immunologic Factors|immunologic factors|mesh-ancestor
110773114|NCT03801564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110773115|NCT03801564|Viscosupplements|viscosupplements|mesh-ancestor
110773116|NCT03801564|Protective Agents|protective agents|mesh-ancestor
110773117|NCT03813186|Decitabine|decitabine|mesh-list
110773118|NCT03813186|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
110773119|NCT03813186|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110773120|NCT03813186|Antimetabolites|antimetabolites|mesh-ancestor
110773121|NCT03813186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110773122|NCT03813186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110773123|NCT03813186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110773124|NCT03353350|Efpeglenatide|efpeglenatide|mesh-list
110773125|NCT03353350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110773126|NCT03353350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110773127|NCT01302132|Ipragliflozin|ipragliflozin|mesh-list
110773128|NCT01302132|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110773129|NCT01302132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110773130|NCT01302132|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110773131|NCT01302132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110773132|NCT03799536|Sotalol|sotalol|mesh-list
110773133|NCT03799536|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110773134|NCT03799536|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110773135|NCT03799536|Adrenergic Agents|adrenergic agents|mesh-ancestor
110773136|NCT03799536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110773137|NCT03799536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110773138|NCT03799536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110773139|NCT03799536|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110773140|NCT03799536|Sympatholytics|sympatholytics|mesh-ancestor
110773141|NCT03799536|Autonomic Agents|autonomic agents|mesh-ancestor
110773142|NCT03799536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110773143|NCT03229278|Pembrolizumab|pembrolizumab|mesh-list
110773144|NCT03229278|Nivolumab|nivolumab|mesh-list
110773145|NCT03229278|Enzyme Inhibitors|enzyme inhibitors|mesh-list
110773146|NCT03229278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110773147|NCT03229278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110773148|NCT03229278|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110773149|NCT03229278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110773150|NCT03812796|Avelumab|avelumab|mesh-list
110773151|NCT03812796|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110773152|NCT03812796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110773153|NCT05759104|Adalimumab|adalimumab|mesh-list
110773154|NCT05759104|Infliximab|infliximab|mesh-list
110773155|NCT05759104|Ustekinumab|ustekinumab|mesh-list
110773156|NCT05759104|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110490855|NCT00949988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110773157|NCT05759104|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110773158|NCT05759104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110773159|NCT05759104|Dermatologic Agents|dermatologic agents|mesh-ancestor
110773160|NCT05759104|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110773162|NCT01384240|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110773163|NCT01384240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110773164|NCT01381510|Finasteride|finasteride|mesh-list
110773165|NCT01381510|Dutasteride|dutasteride|mesh-list
110773166|NCT01381510|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-list
110773167|NCT01381510|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110773168|NCT01381510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110773169|NCT01381510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110773170|NCT01381510|Hormone Antagonists|hormone antagonists|mesh-ancestor
110334206|NCT00487110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110773171|NCT01381510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110773172|NCT01381510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110773173|NCT01381510|Urological Agents|urological agents|mesh-ancestor
110773174|NCT04258072|Vactosertib|vactosertib|mesh-list
110773175|NCT04258072|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110773176|NCT04258072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110773177|NCT04258072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110773178|NCT02984800|Anesthetics|anesthetics|mesh-list
110773179|NCT02984800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110773180|NCT02984800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110773181|NCT04188730|Lofexidine|lofexidine|mesh-list
110773182|NCT04188730|Clonidine|clonidine|mesh-list
110773183|NCT04188730|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110773184|NCT04188730|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110773185|NCT04188730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110773186|NCT04188730|Sensory System Agents|sensory system agents|mesh-ancestor
110773187|NCT04188730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110773188|NCT04188730|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110773189|NCT04188730|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110773190|NCT04188730|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110773191|NCT04188730|Adrenergic Agents|adrenergic agents|mesh-ancestor
110773192|NCT04188730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110773193|NCT04188730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110773194|NCT04188730|Analgesics|analgesics|mesh-ancestor
110773195|NCT04188730|Sympatholytics|sympatholytics|mesh-ancestor
110773196|NCT04188730|Autonomic Agents|autonomic agents|mesh-ancestor
110773197|NCT01381432|Azathioprine|azathioprine|mesh-list
110773198|NCT01381432|Antimetabolites|antimetabolites|mesh-ancestor
110773199|NCT01381432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110773200|NCT01381432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110773201|NCT01381432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110773202|NCT01381432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110773203|NCT01381432|Immunologic Factors|immunologic factors|mesh-ancestor
110773204|NCT01381432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110773205|NCT01381432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110773206|NCT01381354|Thioctic Acid|thioctic acid|mesh-list
110773207|NCT01381354|Riboflavin|riboflavin|mesh-list
110773208|NCT01381354|Thiamine|thiamine|mesh-list
110773209|NCT01381354|Niacinamide|niacinamide|mesh-list
110773210|NCT01381354|Niacin|niacin|mesh-list
110773211|NCT01381354|Nicotinic Acids|nicotinic acids|mesh-list
110773212|NCT01381354|Acetylcarnitine|acetylcarnitine|mesh-list
110773213|NCT01381354|Ubiquinone|ubiquinone|mesh-list
110773214|NCT01381354|Acetylcysteine|acetylcysteine|mesh-list
110773215|NCT01381354|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
110773216|NCT01381354|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110773217|NCT01381354|Vitamins|vitamins|mesh-ancestor
110773218|NCT01381354|Micronutrients|micronutrients|mesh-ancestor
110773219|NCT01381354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110773220|NCT01381354|Antiviral Agents|antiviral agents|mesh-ancestor
110773221|NCT01381354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110773222|NCT01381354|Expectorants|expectorants|mesh-ancestor
110773223|NCT01381354|Respiratory System Agents|respiratory system agents|mesh-ancestor
110773224|NCT01381354|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110773225|NCT01381354|Antioxidants|antioxidants|mesh-ancestor
110445863|NCT02770378|Sertraline|sertraline|mesh-list
110773226|NCT01381354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110773228|NCT01381354|Antidotes|antidotes|mesh-ancestor
110773229|NCT01381354|Vitamin B Complex|vitamin b complex|mesh-ancestor
110773230|NCT01381354|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110773231|NCT01381354|Dermatologic Agents|dermatologic agents|mesh-ancestor
110773232|NCT01381354|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110773233|NCT01381354|Antimetabolites|antimetabolites|mesh-ancestor
110334224|NCT02276001|Cyclosporine|cyclosporine|mesh-list
110773234|NCT01381354|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110773236|NCT01381354|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110773237|NCT01381354|Nootropic Agents|nootropic agents|mesh-ancestor
110773238|NCT01381276|Beta Carotene|beta carotene|mesh-list
110773239|NCT01381276|Vitamin A|vitamin a|mesh-list
110773240|NCT01381276|Retinol palmitate|retinol palmitate|mesh-list
110773241|NCT01381276|Carotenoids|carotenoids|mesh-list
110773242|NCT01381276|Antioxidants|antioxidants|mesh-ancestor
110773243|NCT01381276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110773244|NCT01381276|Protective Agents|protective agents|mesh-ancestor
110773245|NCT01381276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110773246|NCT01381276|Provitamins|provitamins|mesh-ancestor
110773247|NCT01381276|Vitamins|vitamins|mesh-ancestor
110773248|NCT01381276|Micronutrients|micronutrients|mesh-ancestor
110773249|NCT01381276|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110773250|NCT01381276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110773251|NCT02661022|Dexamethasone|dexamethasone|mesh-list
110773252|NCT02661022|Pomalidomide|pomalidomide|mesh-list
110773253|NCT02661022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110773254|NCT02661022|Antiemetics|antiemetics|mesh-ancestor
110773255|NCT02661022|Autonomic Agents|autonomic agents|mesh-ancestor
110773256|NCT02661022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110773257|NCT02661022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110773258|NCT02661022|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110773259|NCT02661022|Glucocorticoids|glucocorticoids|mesh-ancestor
110773260|NCT02661022|Hormones|hormones|mesh-ancestor
110773261|NCT02661022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110773262|NCT02661022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110773263|NCT02661022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110773264|NCT02661022|Immunologic Factors|immunologic factors|mesh-ancestor
110773265|NCT02661022|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110773266|NCT02661022|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110773267|NCT02661022|Growth Substances|growth substances|mesh-ancestor
110773268|NCT02661022|Growth Inhibitors|growth inhibitors|mesh-ancestor
110773269|NCT01569256|Cabergoline|cabergoline|mesh-list
110773270|NCT01569256|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110773271|NCT01569256|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110773272|NCT01569256|Dopamine Agonists|dopamine agonists|mesh-ancestor
110773273|NCT01569256|Dopamine Agents|dopamine agents|mesh-ancestor
110773274|NCT01569256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110773275|NCT01569256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110773276|NCT01569256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110773277|NCT03794544|Durvalumab|durvalumab|mesh-list
110773278|NCT03794544|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110773279|NCT03794544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110773280|NCT01380808|Capecitabine|capecitabine|mesh-list
110773281|NCT01380808|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110773282|NCT01380808|Antimetabolites|antimetabolites|mesh-ancestor
110773283|NCT01380808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110773284|NCT01380808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110773285|NCT03799224|Decitabine|decitabine|mesh-list
110773286|NCT03799224|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110773287|NCT03799224|Antimetabolites|antimetabolites|mesh-ancestor
110773288|NCT03799224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110773289|NCT03799224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110773290|NCT03799224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110773291|NCT03798912|Octreotide|octreotide|mesh-list
110773292|NCT03798912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110773293|NCT03798912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110773294|NCT03798912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110773295|NCT03798834|Anesthetics|anesthetics|mesh-list
110773296|NCT03798834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110773297|NCT03798834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110773298|NCT03812562|Nivolumab|nivolumab|mesh-list
110773299|NCT03812562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110773300|NCT03812562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110773301|NCT03812562|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110445870|NCT02770378|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110773302|NCT03812562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110773303|NCT01304784|Paclitaxel|paclitaxel|mesh-list
110773304|NCT01304784|Docetaxel|docetaxel|mesh-list
110773305|NCT01304784|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110773306|NCT01304784|Capecitabine|capecitabine|mesh-list
110773307|NCT01304784|Trastuzumab|trastuzumab|mesh-list
110773308|NCT01304784|Lapatinib|lapatinib|mesh-list
110773309|NCT01304784|Antibodies, Bispecific|antibodies, bispecific|mesh-list
110490999|NCT05311579|Niraparib|niraparib|mesh-list
110773310|NCT01304784|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110773311|NCT01304784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110773312|NCT01304784|Tubulin Modulators|tubulin modulators|mesh-ancestor
110773313|NCT01304784|Antimitotic Agents|antimitotic agents|mesh-ancestor
110773314|NCT01304784|Mitosis Modulators|mitosis modulators|mesh-ancestor
110773315|NCT01304784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110773316|NCT01304784|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110773317|NCT01304784|Antimetabolites|antimetabolites|mesh-ancestor
110773318|NCT01304784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110773319|NCT01304784|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110773320|NCT01304784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110773321|NCT01304784|Immunologic Factors|immunologic factors|mesh-ancestor
110773322|NCT01304784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110773323|NCT03798600|Caspofungin|caspofungin|mesh-list
110773324|NCT03798600|Antifungal Agents|antifungal agents|mesh-ancestor
110773325|NCT03798600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110773326|NCT03798600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110773327|NCT03798600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110773328|NCT03798522|Nalbuphine|nalbuphine|mesh-list
110773329|NCT03798522|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110773330|NCT03798522|Narcotics|narcotics|mesh-ancestor
110773331|NCT03798522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110773332|NCT03798522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110773333|NCT03798522|Analgesics|analgesics|mesh-ancestor
110773334|NCT03798522|Sensory System Agents|sensory system agents|mesh-ancestor
110773335|NCT03798522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110773336|NCT01308034|Sunitinib|sunitinib|mesh-list
110773337|NCT01308034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110773338|NCT01308034|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110773339|NCT01308034|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110773340|NCT01308034|Growth Substances|growth substances|mesh-ancestor
110773341|NCT01308034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110773342|NCT01308034|Growth Inhibitors|growth inhibitors|mesh-ancestor
110773343|NCT01308034|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110773344|NCT01308034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110773345|NCT01308034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110773346|NCT01302210|Mupirocin|mupirocin|mesh-list
110773347|NCT01302210|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110773348|NCT01302210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110773349|NCT01302210|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110773350|NCT01302210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110773351|NCT01302210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110773352|NCT00005044|Bicalutamide|bicalutamide|mesh-list
110773353|NCT00005044|Flutamide|flutamide|mesh-list
110773354|NCT00005044|Hormones|hormones|mesh-list
110773355|NCT00005044|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
110773356|NCT00005044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110773357|NCT00005044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110773358|NCT00005044|Androgen Antagonists|androgen antagonists|mesh-ancestor
110773359|NCT00005044|Hormone Antagonists|hormone antagonists|mesh-ancestor
110773360|NCT00005044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110773361|NCT00005044|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110773362|NCT03794154|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110773363|NCT03794154|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110773364|NCT03794154|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110773365|NCT03794154|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110773366|NCT03794154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110773367|NCT03794154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110773368|NCT03794154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110773369|NCT03794154|Analgesics|analgesics|mesh-ancestor
110773370|NCT03794154|Sensory System Agents|sensory system agents|mesh-ancestor
110773371|NCT03794154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110773372|NCT03794154|Antidepressive Agents|antidepressive agents|mesh-ancestor
110773373|NCT03794154|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110773374|NCT03794154|Dopamine Agents|dopamine agents|mesh-ancestor
110773375|NCT03811860|Lithium Carbonate|lithium carbonate|mesh-list
110773376|NCT03811860|Antidepressive Agents|antidepressive agents|mesh-ancestor
110773377|NCT03811860|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110773378|NCT03811860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110773379|NCT03811860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110773380|NCT03811860|Antimanic Agents|antimanic agents|mesh-ancestor
110773381|NCT03811860|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110773382|NCT03811860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110682902|NCT02539979|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110773383|NCT03811860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110773384|NCT02722668|Mycophenolic Acid|mycophenolic acid|mesh-list
110773386|NCT02722668|Cyclophosphamide|cyclophosphamide|mesh-list
110773387|NCT02722668|Fludarabine|fludarabine|mesh-list
110773388|NCT02722668|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110773389|NCT02722668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110773390|NCT02722668|Immunologic Factors|immunologic factors|mesh-ancestor
110773391|NCT02722668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110773392|NCT02722668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110773393|NCT02722668|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110773394|NCT02722668|Alkylating Agents|alkylating agents|mesh-ancestor
110773395|NCT02722668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110773396|NCT02722668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110773397|NCT02722668|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110773398|NCT02722668|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110773399|NCT02722668|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110773400|NCT02722668|Antitubercular Agents|antitubercular agents|mesh-ancestor
110773401|NCT02722668|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110773402|NCT02722668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110773403|NCT02722668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110773404|NCT02722668|Antifungal Agents|antifungal agents|mesh-ancestor
110773405|NCT01303926|Paclitaxel|paclitaxel|mesh-list
110773406|NCT01303926|Bevacizumab|bevacizumab|mesh-list
110773407|NCT01303926|Carboplatin|carboplatin|mesh-list
110773408|NCT01303926|Pemetrexed|pemetrexed|mesh-list
110773409|NCT01303926|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110773410|NCT01303926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110773411|NCT01303926|Tubulin Modulators|tubulin modulators|mesh-ancestor
110773412|NCT01303926|Antimitotic Agents|antimitotic agents|mesh-ancestor
110773413|NCT01303926|Mitosis Modulators|mitosis modulators|mesh-ancestor
110773414|NCT01303926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110773415|NCT01303926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110773416|NCT01303926|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110773417|NCT01303926|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110773418|NCT01303926|Growth Substances|growth substances|mesh-ancestor
110773419|NCT01303926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110773420|NCT01303926|Growth Inhibitors|growth inhibitors|mesh-ancestor
110773421|NCT01303926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110773422|NCT01303926|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110773423|NCT01303926|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110773424|NCT03084796|Bromides|bromides|mesh-list
110773425|NCT03084796|Tiotropium Bromide|tiotropium bromide|mesh-list
110773426|NCT03084796|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110773427|NCT03084796|Autonomic Agents|autonomic agents|mesh-ancestor
110773428|NCT03084796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110773429|NCT03084796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110773430|NCT03084796|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110773431|NCT03084796|Respiratory System Agents|respiratory system agents|mesh-ancestor
110773432|NCT03084796|Parasympatholytics|parasympatholytics|mesh-ancestor
110773433|NCT03084796|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110773434|NCT03084796|Cholinergic Agents|cholinergic agents|mesh-ancestor
110773435|NCT03084796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110773436|NCT03084796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110773437|NCT03084796|Anticonvulsants|anticonvulsants|mesh-ancestor
110773438|NCT03717012|Nintedanib|nintedanib|mesh-list
110773439|NCT03717012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110773440|NCT03717012|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110773441|NCT03717012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110773442|NCT03717012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110773443|NCT01302756|Folic Acid|folic acid|mesh-list
110773444|NCT01302756|Hematinics|hematinics|mesh-ancestor
110773445|NCT01302756|Vitamin B Complex|vitamin b complex|mesh-ancestor
110773447|NCT01302756|Micronutrients|micronutrients|mesh-ancestor
110839428|NCT03764527|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110839429|NCT03764527|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110839430|NCT03764527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110839431|NCT03764527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110839432|NCT03764527|Antiviral Agents|antiviral agents|mesh-ancestor
110839433|NCT03764527|Schistosomicides|schistosomicides|mesh-ancestor
110839434|NCT03764527|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110839436|NCT01321801|Pregabalin|pregabalin|mesh-list
110839437|NCT01321801|Analgesics|analgesics|mesh-ancestor
110839438|NCT01321801|Sensory System Agents|sensory system agents|mesh-ancestor
110839439|NCT01321801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110839440|NCT01321801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110839441|NCT01321801|Anticonvulsants|anticonvulsants|mesh-ancestor
110839442|NCT01321801|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110839443|NCT01321801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110839444|NCT01321801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110571487|NCT01023139|Antidepressive Agents|antidepressive agents|mesh-ancestor
110839445|NCT01321801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110839446|NCT01321801|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110839447|NCT01321801|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110839448|NCT01321801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110839449|NCT01321801|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110839450|NCT01155375|Ferrous fumarate|ferrous fumarate|mesh-list
110839451|NCT01155375|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
110839452|NCT01155375|Hematinics|hematinics|mesh-ancestor
110839453|NCT01155375|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
110839454|NCT01155375|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110839455|NCT01155375|Trace Elements|trace elements|mesh-ancestor
110839456|NCT01155375|Micronutrients|micronutrients|mesh-ancestor
110839457|NCT01155375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110839458|NCT03759301|Cetrorelix|cetrorelix|mesh-list
110557055|NCT02325011|Analgesics|analgesics|mesh-ancestor
110839459|NCT03759301|Hormones|hormones|mesh-list
110839460|NCT03759301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110839461|NCT03759301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110839462|NCT03759301|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110839463|NCT03759301|Fertility Agents|fertility agents|mesh-ancestor
110839464|NCT03759301|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110839465|NCT03759301|Hormone Antagonists|hormone antagonists|mesh-ancestor
110839466|NCT03764059|Chlorhexidine|chlorhexidine|mesh-list
110839467|NCT03764059|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110839468|NCT03764059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110839469|NCT03764059|Disinfectants|disinfectants|mesh-ancestor
110839470|NCT02260102|Temocillin|temocillin|mesh-list
110839471|NCT02260102|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110839472|NCT02260102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110839473|NCT03425734|Dexmedetomidine|dexmedetomidine|mesh-list
110839474|NCT03425734|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110839475|NCT03425734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110571906|NCT02555488|Methylene Blue|methylene blue|mesh-list
110839476|NCT03425734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110839477|NCT03425734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110839478|NCT03425734|Analgesics|analgesics|mesh-ancestor
110839479|NCT03425734|Sensory System Agents|sensory system agents|mesh-ancestor
110839480|NCT03425734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110839481|NCT03425734|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110572042|NCT00851084|Leucovorin|leucovorin|mesh-list
110839482|NCT03425734|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110839483|NCT03425734|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110839484|NCT03425734|Adrenergic Agents|adrenergic agents|mesh-ancestor
110839485|NCT03425734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110839486|NCT03425734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110839487|NCT03420586|Nitrous Oxide|nitrous oxide|mesh-list
110839488|NCT03420586|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110839489|NCT03420586|Anesthetics, General|anesthetics, general|mesh-ancestor
110839490|NCT03420586|Anesthetics|anesthetics|mesh-ancestor
110572261|NCT02616497|Analgesics|analgesics|mesh-ancestor
110839491|NCT03420586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110839492|NCT03420586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110839493|NCT03420586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110839494|NCT03420586|Analgesics|analgesics|mesh-ancestor
110572332|NCT00809328|Azithromycin|azithromycin|mesh-list
110839495|NCT03420586|Sensory System Agents|sensory system agents|mesh-ancestor
110839496|NCT03420586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110839497|NCT03759067|Clopidogrel|clopidogrel|mesh-list
110839498|NCT03759067|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110839499|NCT03759067|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110839500|NCT03759067|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110839501|NCT03759067|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110839502|NCT03759067|Purinergic Agents|purinergic agents|mesh-ancestor
110839503|NCT03759067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110839504|NCT03759067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110839505|NCT03759067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110839506|NCT03425656|Cyclophosphamide|cyclophosphamide|mesh-list
110839507|NCT03425656|Docetaxel|docetaxel|mesh-list
110839508|NCT03425656|Doxorubicin|doxorubicin|mesh-list
110839509|NCT03425656|Trastuzumab|trastuzumab|mesh-list
110839510|NCT03425656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110839511|NCT03425656|Immunologic Factors|immunologic factors|mesh-ancestor
110839512|NCT03425656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110839513|NCT03425656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110839514|NCT03425656|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110839515|NCT03425656|Alkylating Agents|alkylating agents|mesh-ancestor
110572401|NCT00814164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110839516|NCT03425656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110839517|NCT03425656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110839518|NCT03425656|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110839519|NCT03425656|Tubulin Modulators|tubulin modulators|mesh-ancestor
110839520|NCT03425656|Antimitotic Agents|antimitotic agents|mesh-ancestor
110839521|NCT03425656|Mitosis Modulators|mitosis modulators|mesh-ancestor
110839522|NCT03425656|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110839523|NCT03425656|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110839524|NCT03425656|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110839525|NCT03425656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110839526|NCT03425656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110839527|NCT03413722|Everolimus|everolimus|mesh-list
110839528|NCT03413722|Tacrolimus|tacrolimus|mesh-list
110839529|NCT03413722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110839530|NCT03413722|Immunologic Factors|immunologic factors|mesh-ancestor
110839531|NCT03413722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110839532|NCT03413722|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110839533|NCT03413722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110839534|NCT03413722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110839535|NCT03413722|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110839536|NCT03413722|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110839537|NCT03413722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110839539|NCT04843462|Antidepressive Agents|antidepressive agents|mesh-ancestor
110839540|NCT04843462|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110839541|NCT03420040|Insulin Glargine|insulin glargine|mesh-list
110839543|NCT03420040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110839544|NCT03413410|Metoprolol|metoprolol|mesh-list
110839545|NCT03413410|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110839546|NCT03413410|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110572579|NCT02609646|Tazobactam|tazobactam|mesh-list
110839547|NCT03413410|Sympatholytics|sympatholytics|mesh-ancestor
110839548|NCT03413410|Autonomic Agents|autonomic agents|mesh-ancestor
110839549|NCT03413410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110839550|NCT03413410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110839551|NCT03413410|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110839554|NCT03413410|Adrenergic Agents|adrenergic agents|mesh-ancestor
110839555|NCT03413410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110839556|NCT03413410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110839557|NCT03419806|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
110839558|NCT03419806|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110839559|NCT03419806|Immunologic Factors|immunologic factors|mesh-ancestor
110839560|NCT03419806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110839561|NCT03419806|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110839562|NCT03419806|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110839563|NCT03419806|Dopamine Agonists|dopamine agonists|mesh-ancestor
110839565|NCT03419806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110839566|NCT03419806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110839567|NCT03424876|Sunitinib|sunitinib|mesh-list
110839568|NCT03424876|Imatinib Mesylate|imatinib mesylate|mesh-list
110572863|NCT00837434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110839569|NCT03424876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110839570|NCT03424876|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110839571|NCT03424876|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110839572|NCT03424876|Growth Substances|growth substances|mesh-ancestor
110839573|NCT03424876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110839574|NCT03424876|Growth Inhibitors|growth inhibitors|mesh-ancestor
110839575|NCT03424876|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110839576|NCT03424876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110839577|NCT03424876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110839578|NCT03476577|Ibuprofen|ibuprofen|mesh-list
110839579|NCT03476577|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110839580|NCT03476577|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110839581|NCT03476577|Analgesics|analgesics|mesh-ancestor
110839582|NCT03476577|Sensory System Agents|sensory system agents|mesh-ancestor
110839583|NCT03476577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110839584|NCT03476577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110839585|NCT03476577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110839586|NCT03476577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110839587|NCT03476577|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110839588|NCT03476577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110839589|NCT03476577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110839590|NCT03419650|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
110839591|NCT03419650|Hormones|hormones|mesh-ancestor
110839592|NCT03419650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110839593|NCT03419650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110839594|NCT04893915|Cyclophosphamide|cyclophosphamide|mesh-list
110839596|NCT04893915|Interleukin-2|interleukin-2|mesh-list
110334287|NCT05641909|Anesthetics|anesthetics|mesh-ancestor
110839597|NCT04893915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110839598|NCT04893915|Immunologic Factors|immunologic factors|mesh-ancestor
110839599|NCT04893915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110839600|NCT04893915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110839601|NCT04893915|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110839602|NCT04893915|Alkylating Agents|alkylating agents|mesh-ancestor
110839603|NCT04893915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110839605|NCT04893915|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110839606|NCT04893915|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110839607|NCT04893915|Analgesics|analgesics|mesh-ancestor
110839608|NCT04893915|Sensory System Agents|sensory system agents|mesh-ancestor
110839609|NCT04893915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110839611|NCT03419494|Daunorubicin|daunorubicin|mesh-list
110839612|NCT03419494|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110839613|NCT03419494|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110839614|NCT03419494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110839615|NCT03419494|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110839616|NCT03419494|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110839617|NCT03419494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110839618|NCT03419494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110839619|NCT03413020|Amoxicillin|amoxicillin|mesh-list
110839620|NCT03413020|Metronidazole|metronidazole|mesh-list
110839621|NCT03413020|Clarithromycin|clarithromycin|mesh-list
110839622|NCT03413020|Levofloxacin|levofloxacin|mesh-list
110839623|NCT03413020|Potassium Citrate|potassium citrate|mesh-list
110839624|NCT03413020|Esomeprazole|esomeprazole|mesh-list
110839625|NCT03413020|Bismuth|bismuth|mesh-list
110839626|NCT03413020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110839627|NCT03413020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110839628|NCT03413020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110839629|NCT03413020|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110839630|NCT03413020|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110839631|NCT03413020|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110839632|NCT03413020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110839633|NCT03413020|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110839634|NCT03413020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110839635|NCT03413020|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110839636|NCT03413020|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110839637|NCT03413020|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110829630|NCT01186159|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110839638|NCT03413020|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110839639|NCT03413020|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110839641|NCT03413020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110839642|NCT03413020|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110839643|NCT03413020|Antacids|antacids|mesh-ancestor
110839644|NCT03413020|Diuretics|diuretics|mesh-ancestor
110839645|NCT03413020|Natriuretic Agents|natriuretic agents|mesh-ancestor
110839646|NCT03413020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110839647|NCT03413020|Expectorants|expectorants|mesh-ancestor
110839648|NCT03413020|Respiratory System Agents|respiratory system agents|mesh-ancestor
110839649|NCT03424408|Aspirin|aspirin|mesh-list
110839650|NCT03424408|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110839651|NCT03424408|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110839652|NCT03424408|Analgesics|analgesics|mesh-ancestor
110839653|NCT03424408|Sensory System Agents|sensory system agents|mesh-ancestor
110839654|NCT03424408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110839655|NCT03424408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110839656|NCT03424408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110839657|NCT03424408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110839658|NCT03424408|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110839659|NCT03424408|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110839660|NCT03424408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110839661|NCT03424408|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110839662|NCT03424408|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110839663|NCT03424408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110839664|NCT03424408|Antipyretics|antipyretics|mesh-ancestor
110839665|NCT03305055|Fentanyl|fentanyl|mesh-list
110839666|NCT03305055|Ketamine|ketamine|mesh-list
110839667|NCT03305055|Analgesics|analgesics|mesh-ancestor
110839668|NCT03305055|Sensory System Agents|sensory system agents|mesh-ancestor
110839669|NCT03305055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110839670|NCT03305055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110839671|NCT03305055|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110839672|NCT03305055|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110829675|NCT01293643|Amebicides|amebicides|mesh-ancestor
110839673|NCT03305055|Anesthetics, General|anesthetics, general|mesh-ancestor
110839674|NCT03305055|Anesthetics|anesthetics|mesh-ancestor
110839675|NCT03305055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110839676|NCT03305055|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110574106|NCT00705692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110839677|NCT03305055|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110839678|NCT03305055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110839679|NCT03305055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110839680|NCT03305055|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110839681|NCT03305055|Narcotics|narcotics|mesh-ancestor
110839682|NCT03305055|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110839684|NCT04547985|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110839685|NCT04547985|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110839686|NCT04547985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110839687|NCT04547985|Sensory System Agents|sensory system agents|mesh-ancestor
110839688|NCT04547985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110839689|NCT03412552|Magnesium Sulfate|magnesium sulfate|mesh-list
110839690|NCT03412552|Analgesics|analgesics|mesh-ancestor
110574253|NCT00795639|Sitaxsentan|sitaxsentan|mesh-list
110839691|NCT03412552|Sensory System Agents|sensory system agents|mesh-ancestor
110839692|NCT03412552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110839693|NCT03412552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110839694|NCT03412552|Anesthetics|anesthetics|mesh-ancestor
110839695|NCT03412552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110839696|NCT03412552|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110839697|NCT03412552|Anticonvulsants|anticonvulsants|mesh-ancestor
110839698|NCT03412552|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110839699|NCT03412552|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110839700|NCT03412552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110839701|NCT03412552|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110839702|NCT03412552|Tocolytic Agents|tocolytic agents|mesh-ancestor
110574383|NCT01026337|Growth Substances|growth substances|mesh-ancestor
110839703|NCT03412552|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110839704|NCT03412474|Acetaminophen|acetaminophen|mesh-list
110839705|NCT03412474|Dexmedetomidine|dexmedetomidine|mesh-list
110839706|NCT03412474|Bupivacaine|bupivacaine|mesh-list
110839707|NCT03412474|Anesthetics, Local|anesthetics, local|mesh-ancestor
110839708|NCT03412474|Anesthetics|anesthetics|mesh-ancestor
110839709|NCT03412474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110839710|NCT03412474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110839711|NCT03412474|Sensory System Agents|sensory system agents|mesh-ancestor
110839712|NCT03412474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110839713|NCT03412474|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110839714|NCT03412474|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110839715|NCT03412474|Analgesics|analgesics|mesh-ancestor
110839716|NCT03412474|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110839717|NCT03412474|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110839718|NCT03412474|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110839719|NCT03412474|Adrenergic Agents|adrenergic agents|mesh-ancestor
110839720|NCT03412474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110829706|NCT03707652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110839721|NCT03412474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110839722|NCT03412474|Antipyretics|antipyretics|mesh-ancestor
110839723|NCT03273387|Trimetazidine|trimetazidine|mesh-list
110839724|NCT03273387|Vasodilator Agents|vasodilator agents|mesh-ancestor
110839725|NCT04527003|Cannabidiol|cannabidiol|mesh-list
110839726|NCT04527003|Norethindrone|norethindrone|mesh-list
110839727|NCT04527003|Norethindrone Acetate|norethindrone acetate|mesh-list
110839728|NCT04527003|Anticonvulsants|anticonvulsants|mesh-ancestor
110839729|NCT04527003|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110839730|NCT04527003|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110839731|NCT04527003|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110839732|NCT04527003|Contraceptive Agents|contraceptive agents|mesh-ancestor
110839733|NCT04527003|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110839734|NCT04527003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110839735|NCT04527003|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110839736|NCT04527003|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110839737|NCT04447612|Gemcitabine|gemcitabine|mesh-list
110839738|NCT04447612|Durvalumab|durvalumab|mesh-list
110839739|NCT04447612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110839740|NCT04447612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110839741|NCT04447612|Antimetabolites|antimetabolites|mesh-ancestor
110839742|NCT04447612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110839743|NCT04447612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110839744|NCT03418558|Trastuzumab|trastuzumab|mesh-list
110839745|NCT03418558|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
110839746|NCT03418558|Maytansine|maytansine|mesh-list
110574558|NCT00588354|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110839747|NCT03418558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110839748|NCT03418558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110839749|NCT03418558|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110839750|NCT03418558|Tubulin Modulators|tubulin modulators|mesh-ancestor
110839751|NCT03418558|Antimitotic Agents|antimitotic agents|mesh-ancestor
110839752|NCT03418558|Mitosis Modulators|mitosis modulators|mesh-ancestor
110839753|NCT03418558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110839754|NCT03418558|Immunotoxins|immunotoxins|mesh-ancestor
110839755|NCT03418558|Immunoconjugates|immunoconjugates|mesh-ancestor
110574713|NCT01024075|Hormones|hormones|mesh-ancestor
110839756|NCT03418558|Immunologic Factors|immunologic factors|mesh-ancestor
110839757|NCT03418558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110839759|NCT05170828|Sirolimus|sirolimus|mesh-list
110839760|NCT05170828|Cyclophosphamide|cyclophosphamide|mesh-list
110839761|NCT05170828|Busulfan|busulfan|mesh-list
110839762|NCT05170828|Fludarabine|fludarabine|mesh-list
110839763|NCT05170828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110839764|NCT05170828|Immunologic Factors|immunologic factors|mesh-ancestor
110839765|NCT05170828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110839766|NCT05170828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110839767|NCT05170828|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110839768|NCT05170828|Alkylating Agents|alkylating agents|mesh-ancestor
110839769|NCT05170828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110839770|NCT05170828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110839771|NCT05170828|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110839772|NCT05170828|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110839773|NCT05170828|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110839774|NCT05170828|Antitubercular Agents|antitubercular agents|mesh-ancestor
110839775|NCT05170828|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110839776|NCT05170828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110839777|NCT05170828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110839778|NCT05170828|Antifungal Agents|antifungal agents|mesh-ancestor
110839779|NCT03412006|Fulacimstat|fulacimstat|mesh-list
110839780|NCT03412006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110839781|NCT03412006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110839782|NCT03418246|Calcium|calcium|mesh-list
110839783|NCT03418246|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110839784|NCT03418246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110839786|NCT03411850|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110839787|NCT03411850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110839788|NCT03411850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110839789|NCT03411850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110839790|NCT03411850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110839791|NCT03411850|Immunologic Factors|immunologic factors|mesh-ancestor
110839792|NCT03411850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110839793|NCT03411850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110334321|NCT00491855|Paclitaxel|paclitaxel|mesh-list
110839795|NCT05170594|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
110839796|NCT05170594|Fluzoparib|fluzoparib|mesh-list
110839797|NCT05170594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110839798|NCT05170594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110839799|NCT05170594|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110839800|NCT05170594|Growth Substances|growth substances|mesh-ancestor
110839801|NCT05170594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110839802|NCT05170594|Growth Inhibitors|growth inhibitors|mesh-ancestor
110839803|NCT05170594|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110839804|NCT05170594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110839805|NCT05170594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110839807|NCT03410836|Anesthetics, Local|anesthetics, local|mesh-ancestor
110839808|NCT03410836|Anesthetics|anesthetics|mesh-ancestor
110839809|NCT03410836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110839810|NCT03410836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110839811|NCT03410836|Sensory System Agents|sensory system agents|mesh-ancestor
110839812|NCT03410836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110839813|NCT03410836|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110839814|NCT03410836|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110839815|NCT03410836|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110839816|NCT03410836|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110839817|NCT03410836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110839818|NCT03273153|Pembrolizumab|pembrolizumab|mesh-list
110839819|NCT03273153|Atezolizumab|atezolizumab|mesh-list
110839820|NCT03273153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110839821|NCT03273153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110839822|NCT03273153|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110839823|NCT03273153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110839824|NCT03418090|Xenon|xenon|mesh-list
110839825|NCT03418090|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110839826|NCT03418090|Anesthetics, General|anesthetics, general|mesh-ancestor
110839827|NCT03418090|Anesthetics|anesthetics|mesh-ancestor
110839828|NCT03418090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110829821|NCT00003377|Paclitaxel|paclitaxel|mesh-list
110839829|NCT03418090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110839830|NCT03323034|Irinotecan|irinotecan|mesh-list
110839831|NCT03323034|Temozolomide|temozolomide|mesh-list
110839832|NCT03323034|Enzyme Inhibitors|enzyme inhibitors|mesh-list
110839833|NCT03323034|Pevonedistat|pevonedistat|mesh-list
110839834|NCT03323034|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110839835|NCT03323034|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110839836|NCT03323034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110839837|NCT03323034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110575143|NCT00448123|Adrenergic Agents|adrenergic agents|mesh-ancestor
110839838|NCT03323034|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110839839|NCT03323034|Alkylating Agents|alkylating agents|mesh-ancestor
110839840|NCT02520934|Miglustat|miglustat|mesh-list
110839841|NCT02520934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110839842|NCT02520934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110575221|NCT00651118|Xhance|xhance|mesh-list
110839843|NCT02520934|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110839844|NCT02520934|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110839845|NCT02520934|Antiviral Agents|antiviral agents|mesh-ancestor
110839846|NCT02520934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110839847|NCT02520934|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
110575291|NCT00811096|Tinidazole|tinidazole|mesh-list
110839848|NCT02520934|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110839849|NCT02520934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110839850|NCT02749968|Bupivacaine|bupivacaine|mesh-list
110839851|NCT02749968|Anesthetics, Local|anesthetics, local|mesh-ancestor
110839852|NCT02749968|Anesthetics|anesthetics|mesh-ancestor
110839853|NCT02749968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110839854|NCT02749968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110839855|NCT02749968|Sensory System Agents|sensory system agents|mesh-ancestor
110839856|NCT02749968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110839857|NCT04787250|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110839858|NCT04787250|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
110839859|NCT04787250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110839860|NCT04787250|Antitubercular Agents|antitubercular agents|mesh-ancestor
110839861|NCT03417700|Vitamin D|vitamin d|mesh-list
110839862|NCT03417700|Vitamins|vitamins|mesh-ancestor
110839863|NCT03417700|Micronutrients|micronutrients|mesh-ancestor
110839864|NCT03417700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110839865|NCT03417700|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110839866|NCT03410524|Simethicone|simethicone|mesh-list
110839867|NCT03410524|Antifoaming Agents|antifoaming agents|mesh-ancestor
110839868|NCT03410524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110839870|NCT03410524|Dermatologic Agents|dermatologic agents|mesh-ancestor
110839871|NCT02713776|Pasireotide|pasireotide|mesh-list
110839872|NCT02713776|Somatostatin|somatostatin|mesh-list
110839874|NCT02713776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110839875|NCT02713776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110839876|NCT05215990|Metformin|metformin|mesh-list
110839877|NCT05215990|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110839878|NCT05215990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110839879|NCT03268941|Metoclopramide|metoclopramide|mesh-list
110839880|NCT03268941|Maleic acid|maleic acid|mesh-list
110839881|NCT03268941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110839882|NCT03268941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110839883|NCT03268941|Antiemetics|antiemetics|mesh-ancestor
110839884|NCT03268941|Autonomic Agents|autonomic agents|mesh-ancestor
110839885|NCT03268941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110839886|NCT03268941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110839887|NCT03268941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110839888|NCT03268941|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110839890|NCT03268941|Dopamine Agents|dopamine agents|mesh-ancestor
110839891|NCT03268941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110839892|NCT05215834|Remifentanil|remifentanil|mesh-list
110839893|NCT05215834|Propofol|propofol|mesh-list
110839894|NCT05215834|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110839895|NCT05215834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110839896|NCT05215834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110839897|NCT05215834|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110839898|NCT05215834|Anesthetics, General|anesthetics, general|mesh-ancestor
110839899|NCT05215834|Anesthetics|anesthetics|mesh-ancestor
110839900|NCT05215834|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110839901|NCT05215834|Narcotics|narcotics|mesh-ancestor
110839902|NCT05215834|Analgesics|analgesics|mesh-ancestor
110839903|NCT05215834|Sensory System Agents|sensory system agents|mesh-ancestor
110839904|NCT05215834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110839905|NCT03394144|Durvalumab|durvalumab|mesh-list
110839906|NCT03394144|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110682917|NCT00903851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110839907|NCT03394144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110839908|NCT05011149|Ibuprofen|ibuprofen|mesh-list
110839909|NCT05011149|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110839910|NCT05011149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110839912|NCT05011149|Sensory System Agents|sensory system agents|mesh-ancestor
110839913|NCT05011149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110839914|NCT05011149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110839915|NCT05011149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110839916|NCT05011149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110839917|NCT05011149|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110839918|NCT05011149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110839919|NCT05011149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110839920|NCT03393988|Fentanyl|fentanyl|mesh-list
110334338|NCT00487448|Cytarabine|cytarabine|mesh-list
110839921|NCT03393988|Dexmedetomidine|dexmedetomidine|mesh-list
110839922|NCT03393988|Sympathomimetics|sympathomimetics|mesh-list
110839923|NCT03393988|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110839924|NCT03393988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110839925|NCT03393988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110839926|NCT03393988|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110839927|NCT03393988|Analgesics|analgesics|mesh-ancestor
110839928|NCT03393988|Sensory System Agents|sensory system agents|mesh-ancestor
110839929|NCT03393988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110839930|NCT03393988|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110839931|NCT03393988|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110839932|NCT03393988|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110839933|NCT03393988|Adrenergic Agents|adrenergic agents|mesh-ancestor
110839934|NCT03393988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110839935|NCT03393988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110839936|NCT03393988|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110839937|NCT03393988|Narcotics|narcotics|mesh-ancestor
110839938|NCT03393988|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110839939|NCT03393988|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110839940|NCT03393988|Anesthetics, General|anesthetics, general|mesh-ancestor
110839942|NCT03393988|Autonomic Agents|autonomic agents|mesh-ancestor
110839943|NCT03410212|Ketorolac|ketorolac|mesh-list
110839944|NCT03410212|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
110839945|NCT03410212|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110839946|NCT03410212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110839947|NCT03410212|Analgesics|analgesics|mesh-ancestor
110839948|NCT03410212|Sensory System Agents|sensory system agents|mesh-ancestor
110839949|NCT03410212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110839950|NCT03410212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110839951|NCT03410212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110839952|NCT03410212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110839954|NCT03410212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110839955|NCT03410212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110839957|NCT03397264|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110839958|NCT03397264|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110839959|NCT03397264|Growth Substances|growth substances|mesh-ancestor
110839960|NCT03397264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110839961|NCT03397264|Growth Inhibitors|growth inhibitors|mesh-ancestor
110839962|NCT03397264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110839963|NCT03397186|Trabectedin|trabectedin|mesh-list
110839964|NCT03397186|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110839965|NCT03397186|Alkylating Agents|alkylating agents|mesh-ancestor
110839966|NCT03397186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110839967|NCT03397186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110839968|NCT03393364|Ketorolac|ketorolac|mesh-list
110839969|NCT03393364|Oxycodone|oxycodone|mesh-list
110839970|NCT03393364|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110839971|NCT03393364|Narcotics|narcotics|mesh-ancestor
110839972|NCT03393364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110839973|NCT03393364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110839974|NCT03393364|Analgesics|analgesics|mesh-ancestor
110839975|NCT03393364|Sensory System Agents|sensory system agents|mesh-ancestor
110575996|NCT00646906|Aspirin|aspirin|mesh-list
110839976|NCT03393364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110839977|NCT03393364|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110839978|NCT03393364|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110839979|NCT03393364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110839980|NCT03393364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110839981|NCT03393364|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110839982|NCT03393364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110839983|NCT03393364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110839984|NCT04632706|Ivermectin|ivermectin|mesh-list
110839985|NCT04632706|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110829955|NCT03853525|Petrolatum|petrolatum|mesh-list
110839986|NCT04632706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110334354|NCT00506259|Melatonin|melatonin|mesh-list
110839988|NCT03405454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110839990|NCT05168176|Dolutegravir|dolutegravir|mesh-list
110839991|NCT05168176|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110839992|NCT05168176|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110839993|NCT05168176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110839994|NCT05168176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110839995|NCT05168176|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110839997|NCT05168176|Antiviral Agents|antiviral agents|mesh-ancestor
110839998|NCT05168176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110839999|NCT04539730|Bupivacaine|bupivacaine|mesh-list
110840000|NCT04539730|Ropivacaine|ropivacaine|mesh-list
110840001|NCT04539730|Anesthetics, Local|anesthetics, local|mesh-ancestor
110840002|NCT04539730|Anesthetics|anesthetics|mesh-ancestor
110840003|NCT04539730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110840004|NCT04539730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110840005|NCT04539730|Sensory System Agents|sensory system agents|mesh-ancestor
110840006|NCT04539730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110840007|NCT03396484|Methyldopa|methyldopa|mesh-list
110840008|NCT03396484|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110840009|NCT03396484|Sympatholytics|sympatholytics|mesh-ancestor
110840010|NCT03396484|Autonomic Agents|autonomic agents|mesh-ancestor
110840011|NCT03396484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110840012|NCT03396484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110840013|NCT03396484|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110840014|NCT03396484|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110840015|NCT03396484|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110840016|NCT03396484|Adrenergic Agents|adrenergic agents|mesh-ancestor
110829992|NCT03720249|Antimetabolites|antimetabolites|mesh-ancestor
110840017|NCT03396484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110840018|NCT03396484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110840019|NCT03321396|Calcium|calcium|mesh-list
110840020|NCT03321396|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110840021|NCT03321396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110576304|NCT00814502|Zolpidem|zolpidem|mesh-list
110840022|NCT04809376|Pentosan Sulfuric Polyester|pentosan sulfuric polyester|mesh-list
110840023|NCT04809376|Anticoagulants|anticoagulants|mesh-ancestor
110840024|NCT03321006|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110840025|NCT03321006|Escitalopram|escitalopram|mesh-list
110840026|NCT03321006|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110840027|NCT03321006|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110840028|NCT03321006|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110840029|NCT03321006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110840030|NCT03321006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110840031|NCT03321006|Serotonin Agents|serotonin agents|mesh-ancestor
110840032|NCT03321006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110840033|NCT03321006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110840034|NCT03321006|Antidepressive Agents|antidepressive agents|mesh-ancestor
110840035|NCT03321006|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110840036|NCT03321006|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110840038|NCT03321006|Sensory System Agents|sensory system agents|mesh-ancestor
110840039|NCT03321006|Dopamine Agents|dopamine agents|mesh-ancestor
110840040|NCT01974609|Acetaminophen|acetaminophen|mesh-list
110840041|NCT01974609|Ibuprofen|ibuprofen|mesh-list
110840042|NCT01974609|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
110840043|NCT01974609|Hydrocodone|hydrocodone|mesh-list
110840044|NCT01974609|Narcotics|narcotics|mesh-list
110840045|NCT01974609|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110840046|NCT01974609|Analgesics|analgesics|mesh-ancestor
110840047|NCT01974609|Sensory System Agents|sensory system agents|mesh-ancestor
110840048|NCT01974609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110840049|NCT01974609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110840050|NCT01974609|Antipyretics|antipyretics|mesh-ancestor
110840051|NCT01974609|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110840052|NCT01974609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110840053|NCT01974609|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110840054|NCT01974609|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110840055|NCT01974609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110840056|NCT01974609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110840057|NCT01974609|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110576568|NCT00640510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110840058|NCT01974609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110840059|NCT01974609|Antitussive Agents|antitussive agents|mesh-ancestor
110840060|NCT01974609|Respiratory System Agents|respiratory system agents|mesh-ancestor
110840061|NCT02593123|Mycophenolic Acid|mycophenolic acid|mesh-list
110840063|NCT02593123|Lenograstim|lenograstim|mesh-list
110840064|NCT02593123|Sargramostim|sargramostim|mesh-list
110576652|NCT00807092|Insulin|insulin|mesh-list
110840065|NCT02593123|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110840066|NCT02593123|Immunologic Factors|immunologic factors|mesh-ancestor
110840067|NCT02593123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110840068|NCT02593123|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110840069|NCT02593123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110840070|NCT02593123|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110840071|NCT02593123|Antitubercular Agents|antitubercular agents|mesh-ancestor
110840072|NCT02593123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110840073|NCT02593123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110840074|NCT02593123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110840075|NCT02593123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110840076|NCT03396250|Diphenhydramine|diphenhydramine|mesh-list
110840077|NCT03396250|Promethazine|promethazine|mesh-list
110840078|NCT03396250|Naproxen|naproxen|mesh-list
110840079|NCT03396250|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110840080|NCT03396250|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110840081|NCT03396250|Analgesics|analgesics|mesh-ancestor
110840082|NCT03396250|Sensory System Agents|sensory system agents|mesh-ancestor
110840083|NCT03396250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110840084|NCT03396250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110840085|NCT03396250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110840086|NCT03396250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110840087|NCT03396250|Gout Suppressants|gout suppressants|mesh-ancestor
110840088|NCT03396250|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110840089|NCT03396250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110840090|NCT03396250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110840091|NCT03396250|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110840092|NCT03396250|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110840093|NCT03396250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110840094|NCT03396250|Anesthetics, Local|anesthetics, local|mesh-ancestor
110840096|NCT03396250|Antiemetics|antiemetics|mesh-ancestor
110840097|NCT03396250|Autonomic Agents|autonomic agents|mesh-ancestor
110840098|NCT03396250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110840099|NCT03396250|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110840100|NCT03396250|Histamine Antagonists|histamine antagonists|mesh-ancestor
110840101|NCT03396250|Histamine Agents|histamine agents|mesh-ancestor
110840102|NCT03396250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110840103|NCT03396250|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110840104|NCT03396250|Antipruritics|antipruritics|mesh-ancestor
110840105|NCT03396250|Dermatologic Agents|dermatologic agents|mesh-ancestor
110840106|NCT03302559|Vitamin A|vitamin a|mesh-list
110840107|NCT03302559|Retinol palmitate|retinol palmitate|mesh-list
110840108|NCT03302559|Sunscreening Agents|sunscreening agents|mesh-list
110840109|NCT03302559|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110840110|NCT03302559|Protective Agents|protective agents|mesh-ancestor
110840111|NCT03302559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110840112|NCT03302559|Dermatologic Agents|dermatologic agents|mesh-ancestor
110840113|NCT03302559|Vitamins|vitamins|mesh-ancestor
110840114|NCT03302559|Micronutrients|micronutrients|mesh-ancestor
110840115|NCT03302559|Antioxidants|antioxidants|mesh-ancestor
110577032|NCT05572476|Carboplatin|carboplatin|mesh-list
110840116|NCT03302559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110840117|NCT03302559|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110577104|NCT00626392|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110840118|NCT03302559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110840119|NCT03763669|Folic Acid|folic acid|mesh-list
110840120|NCT03763669|Vitamin B Complex|vitamin b complex|mesh-list
110840121|NCT03763669|Inositol|inositol|mesh-list
110840122|NCT03763669|Hematinics|hematinics|mesh-ancestor
110840123|NCT03763669|Vitamins|vitamins|mesh-ancestor
110577175|NCT02548936|Simvastatin|simvastatin|mesh-list
110840125|NCT03763669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110840126|NCT03302247|Gemcitabine|gemcitabine|mesh-list
110840127|NCT03302247|Nivolumab|nivolumab|mesh-list
110840128|NCT03302247|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110840129|NCT03302247|Antimetabolites|antimetabolites|mesh-ancestor
110840130|NCT03302247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110840131|NCT03302247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110840132|NCT03302247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110557728|NCT00618527|Interferons|interferons|mesh-list
110840133|NCT03302247|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110840134|NCT04363840|Aspirin|aspirin|mesh-list
110840135|NCT04363840|Vitamin D|vitamin d|mesh-list
110840136|NCT04363840|Vitamins|vitamins|mesh-ancestor
110840137|NCT04363840|Micronutrients|micronutrients|mesh-ancestor
110840138|NCT04363840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110840139|NCT04363840|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110840140|NCT04363840|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110840141|NCT04363840|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110840142|NCT04363840|Analgesics|analgesics|mesh-ancestor
110840143|NCT04363840|Sensory System Agents|sensory system agents|mesh-ancestor
110840144|NCT04363840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110840145|NCT04363840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110840146|NCT04363840|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110840147|NCT04363840|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110577451|NCT00623428|Ribavirin|ribavirin|mesh-list
110840148|NCT04363840|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110840149|NCT04363840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110840150|NCT04363840|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110840151|NCT04363840|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110840152|NCT04363840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110840153|NCT04363840|Antipyretics|antipyretics|mesh-ancestor
110840154|NCT04981665|Tislelizumab|tislelizumab|mesh-list
110840155|NCT04981665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110840156|NCT04981665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110840157|NCT03392740|Lisinopril|lisinopril|mesh-list
110840158|NCT03392740|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110840159|NCT03392740|Protease Inhibitors|protease inhibitors|mesh-ancestor
110840160|NCT03392740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110840161|NCT03392740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110840162|NCT03392740|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110577674|NCT02602938|Aspirin|aspirin|mesh-list
110840163|NCT03392740|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110840164|NCT03392740|Protective Agents|protective agents|mesh-ancestor
110840165|NCT03392740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110334390|NCT01242228|Alogliptin|alogliptin|mesh-list
110840166|NCT04919317|Dexamethasone|dexamethasone|mesh-list
110577745|NCT00838396|Baclofen|baclofen|mesh-list
110840167|NCT04919317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110840169|NCT04919317|Autonomic Agents|autonomic agents|mesh-ancestor
110840170|NCT04919317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110840171|NCT04919317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110840172|NCT04919317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110840173|NCT04919317|Glucocorticoids|glucocorticoids|mesh-ancestor
110840174|NCT04919317|Hormones|hormones|mesh-ancestor
110840175|NCT04919317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110840176|NCT04919317|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110840177|NCT04919317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110840178|NCT02818023|Pembrolizumab|pembrolizumab|mesh-list
110840179|NCT02818023|Vemurafenib|vemurafenib|mesh-list
110840180|NCT02818023|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110840181|NCT02818023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110840182|NCT02818023|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110840183|NCT02818023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110840184|NCT02818023|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110840185|NCT02818023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110840186|NCT03262389|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110840187|NCT03262389|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110840188|NCT03262389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110840189|NCT04631536|Folic Acid|folic acid|mesh-list
110840190|NCT04631536|Vitamin B Complex|vitamin b complex|mesh-list
110840191|NCT04631536|Nicorandil|nicorandil|mesh-list
110840192|NCT04631536|Nebivolol|nebivolol|mesh-list
110840193|NCT04631536|Atorvastatin|atorvastatin|mesh-list
110840194|NCT04631536|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110840195|NCT04631536|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110840196|NCT04631536|Antimetabolites|antimetabolites|mesh-ancestor
110840197|NCT04631536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110840198|NCT04631536|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110840199|NCT04631536|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110840200|NCT04631536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110840201|NCT04631536|Hematinics|hematinics|mesh-ancestor
110840202|NCT04631536|Vitamins|vitamins|mesh-ancestor
110840203|NCT04631536|Micronutrients|micronutrients|mesh-ancestor
110840204|NCT04631536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110840205|NCT04631536|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110840206|NCT04631536|Vasodilator Agents|vasodilator agents|mesh-ancestor
110578156|NCT00845429|Vaccines|vaccines|mesh-list
110840207|NCT04631536|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
110840208|NCT04631536|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110840209|NCT04631536|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110840210|NCT04631536|Adrenergic Agents|adrenergic agents|mesh-ancestor
110840211|NCT04631536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110840212|NCT04631536|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110840213|NCT03262233|Nicotine|nicotine|mesh-list
110840214|NCT03262233|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110840215|NCT03262233|Autonomic Agents|autonomic agents|mesh-ancestor
110840216|NCT03262233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110840217|NCT03262233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110840218|NCT03262233|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110840219|NCT03262233|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110840220|NCT03262233|Cholinergic Agents|cholinergic agents|mesh-ancestor
110578360|NCT00763035|Dobutamine|dobutamine|mesh-list
110840221|NCT03262233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110840222|NCT03262233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110840223|NCT05166538|Clopidogrel|clopidogrel|mesh-list
110840224|NCT05166538|Ticagrelor|ticagrelor|mesh-list
110840225|NCT05166538|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110840226|NCT05166538|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110840227|NCT05166538|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110840228|NCT05166538|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110840229|NCT05166538|Purinergic Agents|purinergic agents|mesh-ancestor
110840230|NCT05166538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110334409|NCT00492128|Losartan|losartan|mesh-list
110840231|NCT05166538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110840232|NCT05166538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110840233|NCT03260205|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
110840234|NCT03260205|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110840235|NCT03260205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110840236|NCT03260205|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110840237|NCT03260205|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110840238|NCT03260205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110840239|NCT03260205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110840240|NCT03260205|Dopamine Agents|dopamine agents|mesh-ancestor
110840241|NCT03260205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110840242|NCT04666441|Casirivimab and imdevimab drug combination|casirivimab and imdevimab drug combination|mesh-list
110578693|NCT00784836|Interferons|interferons|mesh-list
110840243|NCT04666441|Antiviral Agents|antiviral agents|mesh-ancestor
110840244|NCT04666441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110840245|NCT03320850|Botulinum Toxins|botulinum toxins|mesh-list
110840246|NCT03320850|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110840248|NCT03320850|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110840249|NCT03320850|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110840250|NCT03320850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110840251|NCT03320850|Cholinergic Agents|cholinergic agents|mesh-ancestor
110840252|NCT03320850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110840253|NCT03320850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110840254|NCT03320850|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110840255|NCT03320850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110840256|NCT04447378|PENTA|penta|mesh-list
110840257|NCT04447378|Fondaparinux|fondaparinux|mesh-list
110840258|NCT04447378|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110840259|NCT04447378|Antithrombins|antithrombins|mesh-ancestor
110840260|NCT04447378|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110840261|NCT04447378|Protease Inhibitors|protease inhibitors|mesh-ancestor
110840262|NCT04447378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110840263|NCT04447378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110840264|NCT04447378|Anticoagulants|anticoagulants|mesh-ancestor
110840265|NCT04447378|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110579056|NCT00752856|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110840266|NCT04447378|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110840267|NCT03125980|Capecitabine|capecitabine|mesh-list
110840268|NCT03125980|Oxaliplatin|oxaliplatin|mesh-list
110579121|NCT00759915|Morphine|morphine|mesh-list
110840269|NCT03125980|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110840270|NCT03125980|Antimetabolites|antimetabolites|mesh-ancestor
110840271|NCT03125980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110840272|NCT03125980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110840273|NCT03399604|Treprostinil|treprostinil|mesh-list
110840274|NCT03399604|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110840275|NCT03399526|Calcitriol|calcitriol|mesh-list
110840276|NCT03399526|Betamethasone|betamethasone|mesh-list
110840277|NCT03399526|Betamethasone Valerate|betamethasone valerate|mesh-list
110579190|NCT00833027|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110840278|NCT03399526|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
110840279|NCT03399526|Betamethasone benzoate|betamethasone benzoate|mesh-list
110840280|NCT03399526|Clobetasol|clobetasol|mesh-list
110840281|NCT03399526|Prednicarbate|prednicarbate|mesh-list
110840282|NCT03399526|Calcipotriene|calcipotriene|mesh-list
110840283|NCT03399526|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
110840284|NCT03399526|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110840285|NCT03399526|Glucocorticoids|glucocorticoids|mesh-ancestor
110840286|NCT03399526|Hormones|hormones|mesh-ancestor
110840287|NCT03399526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110840288|NCT03399526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110840289|NCT03399526|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110840290|NCT03399526|Respiratory System Agents|respiratory system agents|mesh-ancestor
110840291|NCT03399526|Dermatologic Agents|dermatologic agents|mesh-ancestor
110840292|NCT03399526|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110840293|NCT03399526|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
110840294|NCT03399526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110840295|NCT03399526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110840296|NCT03399526|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110840297|NCT03399526|Vitamins|vitamins|mesh-ancestor
110840298|NCT03399526|Micronutrients|micronutrients|mesh-ancestor
110579333|NCT05438277|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110840299|NCT03399526|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110840300|NCT03392272|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
110840301|NCT03392272|Hemostatics|hemostatics|mesh-ancestor
110840302|NCT03392272|Coagulants|coagulants|mesh-ancestor
110840303|NCT03905902|Vaccines|vaccines|mesh-list
110840304|NCT03905902|Immunologic Factors|immunologic factors|mesh-ancestor
110579458|NCT00589784|Sunitinib|sunitinib|mesh-list
110840305|NCT03905902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110840306|NCT03638310|Gentamicins|gentamicins|mesh-list
110840307|NCT03638310|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110840308|NCT03638310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110840309|NCT03638310|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110840310|NCT03638310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110840311|NCT03638310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110840312|NCT04656691|Bamlanivimab|bamlanivimab|mesh-list
110840313|NCT04656691|Antiviral Agents|antiviral agents|mesh-ancestor
110840314|NCT04656691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110840315|NCT03399448|Cyclophosphamide|cyclophosphamide|mesh-list
110840316|NCT03399448|Fludarabine|fludarabine|mesh-list
110840317|NCT03399448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110840318|NCT03399448|Immunologic Factors|immunologic factors|mesh-ancestor
110840319|NCT03399448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110840320|NCT03399448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110840321|NCT03399448|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110840322|NCT03399448|Alkylating Agents|alkylating agents|mesh-ancestor
110840323|NCT03399448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110840324|NCT03399448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110840325|NCT03399448|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110840326|NCT03755947|Venetoclax|venetoclax|mesh-list
110840327|NCT03755947|Obinutuzumab|obinutuzumab|mesh-list
110840328|NCT03755947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110840329|NCT03755947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110840330|NCT03395470|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110840331|NCT03395470|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110840332|NCT03395470|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110840333|NCT03395470|Antimetabolites|antimetabolites|mesh-ancestor
110840334|NCT03395470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110840335|NCT03395470|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110840336|NCT03395470|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110840337|NCT03395470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110840338|NCT03257865|Brexpiprazole|brexpiprazole|mesh-list
110840339|NCT03257865|Serotonin Agents|serotonin agents|mesh-ancestor
110840340|NCT03257865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110579653|NCT02606552|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110840341|NCT03257865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110840342|NCT03257865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110840343|NCT03257865|Dopamine Agonists|dopamine agonists|mesh-ancestor
110840344|NCT03257865|Dopamine Agents|dopamine agents|mesh-ancestor
110840345|NCT01610700|Nabiximols|nabiximols|mesh-list
110840346|NCT01610700|Analgesics|analgesics|mesh-ancestor
110840347|NCT01610700|Sensory System Agents|sensory system agents|mesh-ancestor
110840348|NCT01610700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110579792|NCT05406726|Antiviral Agents|antiviral agents|mesh-ancestor
110334425|NCT00487734|Methyltestosterone|methyltestosterone|mesh-list
110840349|NCT01610700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110840350|NCT04632459|Pembrolizumab|pembrolizumab|mesh-list
110840351|NCT04632459|Ramucirumab|ramucirumab|mesh-list
110840352|NCT04632459|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110840353|NCT04632459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110840354|NCT04632459|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110840355|NCT04632459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110579857|NCT04020003|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110579858|NCT04020003|Vasodilator Agents|vasodilator agents|mesh-ancestor
110579859|NCT04020003|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110579860|NCT04020003|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110579861|NCT04020003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110579862|NCT04020003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110579863|NCT04020003|Protective Agents|protective agents|mesh-ancestor
110579865|NCT03977142|Chrysarobin|chrysarobin|mesh-list
110840356|NCT03985371|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110840357|NCT03985371|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110840358|NCT03316872|Pembrolizumab|pembrolizumab|mesh-list
110840359|NCT03316872|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110579926|NCT00829829|Rilonacept|rilonacept|mesh-list
110840360|NCT03316872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110840361|NCT03316872|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110840362|NCT03316872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110840364|NCT03256695|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110840365|NCT03256695|Autonomic Agents|autonomic agents|mesh-ancestor
110840366|NCT03256695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110840367|NCT03256695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110840368|NCT03256695|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110840369|NCT03256695|Respiratory System Agents|respiratory system agents|mesh-ancestor
110840370|NCT03256695|Tocolytic Agents|tocolytic agents|mesh-ancestor
110840371|NCT03256695|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110840372|NCT03256695|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110840373|NCT03256695|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110840374|NCT03256695|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110840375|NCT03256695|Adrenergic Agents|adrenergic agents|mesh-ancestor
110840376|NCT03256695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110840377|NCT03256695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110840378|NCT04623684|Phenylephrine|phenylephrine|mesh-list
110840379|NCT04623684|Oxymetazoline|oxymetazoline|mesh-list
110840380|NCT04623684|Tropicamide|tropicamide|mesh-list
110840381|NCT04623684|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110840382|NCT04623684|Mydriatics|mydriatics|mesh-ancestor
110840383|NCT04623684|Autonomic Agents|autonomic agents|mesh-ancestor
110840384|NCT04623684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110840385|NCT04623684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110830215|NCT01584791|Aspirin|aspirin|mesh-list
110840386|NCT04623684|Sympathomimetics|sympathomimetics|mesh-ancestor
110840387|NCT04623684|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110840388|NCT04623684|Nasal Decongestants|nasal decongestants|mesh-ancestor
110840389|NCT04623684|Respiratory System Agents|respiratory system agents|mesh-ancestor
110580281|NCT00585585|Betahistine|betahistine|mesh-list
110580338|NCT05756621|Propofol|propofol|mesh-list
110840390|NCT04623684|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110840391|NCT04623684|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110840392|NCT04623684|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110840393|NCT04623684|Adrenergic Agents|adrenergic agents|mesh-ancestor
110840394|NCT04623684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110840395|NCT04623684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110840396|NCT04623684|Protective Agents|protective agents|mesh-ancestor
110840397|NCT04623684|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110840398|NCT04623684|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110580495|NCT00728481|Budesonide|budesonide|mesh-list
110840399|NCT04623684|Cholinergic Agents|cholinergic agents|mesh-ancestor
110840400|NCT03297021|Ondansetron|ondansetron|mesh-list
110840401|NCT03297021|Antiemetics|antiemetics|mesh-ancestor
110840402|NCT03297021|Autonomic Agents|autonomic agents|mesh-ancestor
110840403|NCT03297021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110840404|NCT03297021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110580552|NCT00726999|Gabapentin|gabapentin|mesh-list
110840405|NCT03297021|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110840407|NCT03297021|Dermatologic Agents|dermatologic agents|mesh-ancestor
110840408|NCT03297021|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110840409|NCT03297021|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110840410|NCT03297021|Serotonin Agents|serotonin agents|mesh-ancestor
110840411|NCT03297021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110840412|NCT03297021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110840413|NCT03752749|Prednisolone|prednisolone|mesh-list
110840414|NCT03752749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110840415|NCT03752749|Glucocorticoids|glucocorticoids|mesh-ancestor
110840416|NCT03752749|Hormones|hormones|mesh-ancestor
110840417|NCT03752749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110840418|NCT03752749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110840419|NCT03752749|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110840420|NCT03752749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110840421|NCT01988571|Atorvastatin|atorvastatin|mesh-list
110840422|NCT01988571|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110840423|NCT01988571|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110840424|NCT01988571|Antimetabolites|antimetabolites|mesh-ancestor
110840425|NCT01988571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110840426|NCT01988571|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110580831|NCT00589472|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110840427|NCT01988571|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110840428|NCT01988571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110840429|NCT03755557|Budesonide|budesonide|mesh-list
110840430|NCT03755557|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110580899|NCT02597868|Capecitabine|capecitabine|mesh-list
110840431|NCT03755557|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110840432|NCT03755557|Autonomic Agents|autonomic agents|mesh-ancestor
110840433|NCT03755557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110840434|NCT03755557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110840435|NCT03755557|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110840436|NCT03755557|Respiratory System Agents|respiratory system agents|mesh-ancestor
110580967|NCT00801632|Prednisone|prednisone|mesh-list
110840437|NCT03755557|Glucocorticoids|glucocorticoids|mesh-ancestor
110840438|NCT03755557|Hormones|hormones|mesh-ancestor
110840439|NCT03755557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110840440|NCT03511599|Cycloserine|cycloserine|mesh-list
110547829|NCT04138836|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110840441|NCT03511599|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110840442|NCT03511599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110840443|NCT03511599|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110840444|NCT03511599|Antitubercular Agents|antitubercular agents|mesh-ancestor
110840445|NCT03511599|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110840446|NCT03511599|Antimetabolites|antimetabolites|mesh-ancestor
110840447|NCT03511599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110840448|NCT01140867|Zonisamide|zonisamide|mesh-list
110840449|NCT01140867|Anticonvulsants|anticonvulsants|mesh-ancestor
110840450|NCT01140867|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110581108|NCT00800540|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110840451|NCT01140867|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110840452|NCT01140867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110840453|NCT01140867|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110334463|NCT00487773|Budesonide|budesonide|mesh-list
110840454|NCT01140867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110840455|NCT04572997|Apremilast|apremilast|mesh-list
110840456|NCT04572997|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110840457|NCT04572997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110840458|NCT04572997|Analgesics|analgesics|mesh-ancestor
110840459|NCT04572997|Sensory System Agents|sensory system agents|mesh-ancestor
110840460|NCT04572997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110840461|NCT04572997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110840462|NCT04572997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110840463|NCT04572997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110840464|NCT04572997|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
110840465|NCT04572997|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110840466|NCT04572997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110840467|NCT04572997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110840468|NCT03292653|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
110840469|NCT03292653|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110840470|NCT03292653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110840471|NCT03292653|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110840472|NCT03292653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110581243|NCT04107896|Tamsulosin|tamsulosin|mesh-list
110840473|NCT02891070|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
110840474|NCT02891070|Hemostatics|hemostatics|mesh-ancestor
110840475|NCT02891070|Coagulants|coagulants|mesh-ancestor
110840476|NCT00381381|Donepezil|donepezil|mesh-list
110840477|NCT00381381|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110840478|NCT00381381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110840479|NCT00381381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110840480|NCT00381381|Cholinergic Agents|cholinergic agents|mesh-ancestor
110840481|NCT00381381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110840482|NCT00381381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110840483|NCT00381381|Nootropic Agents|nootropic agents|mesh-ancestor
110840484|NCT03637335|Carboplatin|carboplatin|mesh-list
110830348|NCT01190371|Artesunate|artesunate|mesh-list
110840485|NCT03637335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110840486|NCT02939937|Phenytoin|phenytoin|mesh-list
110840487|NCT02939937|Anticonvulsants|anticonvulsants|mesh-ancestor
110840488|NCT02939937|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110840489|NCT02939937|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110840490|NCT02939937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110840491|NCT02939937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110840492|NCT02939937|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110840493|NCT02939937|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110840494|NCT02939079|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
110840495|NCT02939079|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
110840496|NCT02939079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110840497|NCT02939079|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110840498|NCT02939079|Immunologic Factors|immunologic factors|mesh-ancestor
110840499|NCT02939079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110840500|NCT02774265|Aspirin|aspirin|mesh-list
110840501|NCT02774265|Heparin|heparin|mesh-list
110840502|NCT02774265|Enoxaparin|enoxaparin|mesh-list
110840503|NCT02774265|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
110840504|NCT02774265|Tinzaparin|tinzaparin|mesh-list
110840505|NCT02774265|Dalteparin|dalteparin|mesh-list
110840506|NCT02774265|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110840507|NCT02774265|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110840508|NCT02774265|Analgesics|analgesics|mesh-ancestor
110840509|NCT02774265|Sensory System Agents|sensory system agents|mesh-ancestor
110840510|NCT02774265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110840511|NCT02774265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110840512|NCT02774265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110840513|NCT02774265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110840514|NCT02774265|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110840515|NCT02774265|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110840516|NCT02774265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110840517|NCT02774265|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110840518|NCT02774265|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110840519|NCT02774265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110840520|NCT02774265|Antipyretics|antipyretics|mesh-ancestor
110840521|NCT02774265|Anticoagulants|anticoagulants|mesh-ancestor
110840522|NCT04755595|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110840523|NCT04755595|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110840524|NCT04755595|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110840525|NCT04755595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110840526|NCT04755595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110840527|NCT04755595|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110840528|NCT04755595|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110840529|NCT04755595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110840530|NCT04755595|Cholinergic Agents|cholinergic agents|mesh-ancestor
110840531|NCT04755595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110840533|NCT03755479|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110830364|NCT05158426|Anesthetics|anesthetics|mesh-ancestor
110840534|NCT03755479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110840537|NCT05239390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110840538|NCT05239390|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110840539|NCT05239390|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110840540|NCT05239390|Analgesics|analgesics|mesh-ancestor
110840541|NCT05239390|Sensory System Agents|sensory system agents|mesh-ancestor
110840542|NCT05239390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110840543|NCT05239390|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
110840544|NCT05239390|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110840545|NCT05239390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110840546|NCT05239390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110840547|NCT05239390|Hormones|hormones|mesh-ancestor
110840548|NCT05239390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110840549|NCT03752437|Heparin|heparin|mesh-list
110840550|NCT03752437|Anticoagulants|anticoagulants|mesh-ancestor
110840551|NCT03752437|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110840552|NCT03752437|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110840553|NCT03752437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110840554|NCT05239312|Anti-Infective Agents|anti-infective agents|mesh-list
110840555|NCT05239312|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110840556|NCT04748341|Benzocaine|benzocaine|mesh-list
110840557|NCT04748341|Anesthetics, Local|anesthetics, local|mesh-ancestor
110840558|NCT04748341|Anesthetics|anesthetics|mesh-ancestor
110840559|NCT04748341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110840560|NCT04748341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110840561|NCT04748341|Sensory System Agents|sensory system agents|mesh-ancestor
110840562|NCT04748341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110840563|NCT01328002|Milnacipran|milnacipran|mesh-list
110840564|NCT01328002|Levomilnacipran|levomilnacipran|mesh-list
110840565|NCT01328002|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110840566|NCT01328002|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110840567|NCT01328002|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110840568|NCT01328002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110840569|NCT01328002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110840570|NCT01328002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110840571|NCT01328002|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110840572|NCT01328002|Analgesics|analgesics|mesh-ancestor
110840573|NCT01328002|Sensory System Agents|sensory system agents|mesh-ancestor
110840574|NCT01328002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110840575|NCT01328002|Antidepressive Agents|antidepressive agents|mesh-ancestor
110840576|NCT01328002|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110558183|NCT04187417|Sensory System Agents|sensory system agents|mesh-ancestor
110840578|NCT05239078|Anesthetics, Local|anesthetics, local|mesh-list
110840579|NCT05239078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110840580|NCT05239078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110840581|NCT05239078|Sensory System Agents|sensory system agents|mesh-ancestor
110840582|NCT05239078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110840583|NCT02579265|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
110840584|NCT02579265|SMOFlipid|smoflipid|mesh-list
110840585|NCT02579265|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
110840586|NCT02579265|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
110840587|NCT02579265|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110840588|NCT05238220|Valganciclovir|valganciclovir|mesh-list
110840589|NCT05238220|Antiviral Agents|antiviral agents|mesh-ancestor
110840590|NCT05238220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110840591|NCT04446598|Tadalafil|tadalafil|mesh-list
110840592|NCT04446598|Vasodilator Agents|vasodilator agents|mesh-ancestor
110581707|NCT00807599|Hormones|hormones|mesh-ancestor
110840593|NCT04446598|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110840594|NCT04446598|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110840595|NCT04446598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110830412|NCT03949517|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110840596|NCT04446598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110840597|NCT04446598|Urological Agents|urological agents|mesh-ancestor
110840598|NCT03391570|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
110840599|NCT03391570|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110840600|NCT03391570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110840601|NCT03391570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110581844|NCT00590681|Temozolomide|temozolomide|mesh-list
110840602|NCT03391570|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110840603|NCT03391570|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110840604|NCT03391570|Analgesics|analgesics|mesh-ancestor
110840605|NCT03391570|Sensory System Agents|sensory system agents|mesh-ancestor
110840606|NCT03391570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110840607|NCT03391570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110840608|NCT03391570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110840609|NCT03391570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110840611|NCT03755089|Anesthetics, Local|anesthetics, local|mesh-ancestor
110840612|NCT03755089|Anesthetics|anesthetics|mesh-ancestor
110840613|NCT03755089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110840614|NCT03755089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110840615|NCT03755089|Sensory System Agents|sensory system agents|mesh-ancestor
110840616|NCT03755089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110581986|NCT02603198|Epinephrine|epinephrine|mesh-list
110840618|NCT03755089|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110840619|NCT03755089|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110840620|NCT03755089|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110840621|NCT03755089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110840622|NCT03757117|Hormones|hormones|mesh-list
110840623|NCT03757117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110840624|NCT03757117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110840625|NCT03752125|Caffeine|caffeine|mesh-list
110582121|NCT05728151|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110840626|NCT03752125|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110840627|NCT03752125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110840628|NCT03752125|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110840629|NCT03752125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110840630|NCT03752125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110582192|NCT00590135|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110840631|NCT03752125|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110840632|NCT03752125|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110840633|NCT03752125|Purinergic Agents|purinergic agents|mesh-ancestor
110840634|NCT03752125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110840636|NCT03289533|Axitinib|axitinib|mesh-list
110840637|NCT03289533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110840638|NCT03289533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110840639|NCT03289533|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110840640|NCT03289533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110840641|NCT03289533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110840644|NCT03395002|Tiotropium Bromide|tiotropium bromide|mesh-list
110840645|NCT03395002|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110840646|NCT03395002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110840647|NCT03395002|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110840648|NCT03395002|Autonomic Agents|autonomic agents|mesh-ancestor
110840649|NCT03395002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110558253|NCT00500149|Dopamine Agents|dopamine agents|mesh-ancestor
110840650|NCT03395002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110840651|NCT03395002|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110840652|NCT03395002|Respiratory System Agents|respiratory system agents|mesh-ancestor
110840653|NCT03395002|Dermatologic Agents|dermatologic agents|mesh-ancestor
110840654|NCT03395002|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110840655|NCT03395002|Parasympatholytics|parasympatholytics|mesh-ancestor
110840656|NCT03395002|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110582464|NCT02604992|Hormones|hormones|mesh-ancestor
110840657|NCT03395002|Cholinergic Agents|cholinergic agents|mesh-ancestor
110840658|NCT03395002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110582539|NCT00730158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110840659|NCT03395002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110840660|NCT03395002|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110840661|NCT03395002|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110840662|NCT03395002|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110840663|NCT03395002|Adrenergic Agents|adrenergic agents|mesh-ancestor
110840664|NCT05238064|Cyclophosphamide|cyclophosphamide|mesh-list
110840665|NCT05238064|Doxorubicin|doxorubicin|mesh-list
110840666|NCT05238064|Vincristine|vincristine|mesh-list
110840667|NCT05238064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110840668|NCT05238064|Immunologic Factors|immunologic factors|mesh-ancestor
110840669|NCT05238064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110840670|NCT05238064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110582609|NCT04027829|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110840671|NCT05238064|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110840672|NCT05238064|Alkylating Agents|alkylating agents|mesh-ancestor
110840673|NCT05238064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110582671|NCT04103684|Dexamethasone|dexamethasone|mesh-list
110840674|NCT05238064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110840675|NCT05238064|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110840676|NCT05238064|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110840677|NCT05238064|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110840678|NCT05238064|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110840679|NCT05238064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110840680|NCT05238064|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110840681|NCT05238064|Tubulin Modulators|tubulin modulators|mesh-ancestor
110840682|NCT05238064|Antimitotic Agents|antimitotic agents|mesh-ancestor
110840683|NCT05238064|Mitosis Modulators|mitosis modulators|mesh-ancestor
110840684|NCT03390790|Lidocaine|lidocaine|mesh-list
110840685|NCT03390790|Anesthetics, Local|anesthetics, local|mesh-ancestor
110840686|NCT03390790|Anesthetics|anesthetics|mesh-ancestor
110582814|NCT00766532|Hormone Antagonists|hormone antagonists|mesh-ancestor
110840687|NCT03390790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110840688|NCT03390790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110840689|NCT03390790|Sensory System Agents|sensory system agents|mesh-ancestor
110840690|NCT03390790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110840691|NCT03390790|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110840692|NCT03390790|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110840693|NCT03390790|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110840694|NCT03390790|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110840695|NCT03390790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110840696|NCT03697993|Levofloxacin|levofloxacin|mesh-list
110840697|NCT03697993|Fosfomycin|fosfomycin|mesh-list
110840698|NCT03697993|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110830556|NCT01209455|Acetaminophen|acetaminophen|mesh-list
110840699|NCT03697993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110840700|NCT03697993|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110840701|NCT03697993|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110840702|NCT03697993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110583107|NCT00586898|Estrogens|estrogens|mesh-list
110840704|NCT03697993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110840705|NCT03697993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110840706|NCT03697993|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110583171|NCT02587533|Dopamine Agents|dopamine agents|mesh-ancestor
110840707|NCT03697993|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110840708|NCT05393245|Tiotropium Bromide|tiotropium bromide|mesh-list
110840709|NCT05393245|Olodaterol|olodaterol|mesh-list
110840710|NCT05393245|Cholinergic Agents|cholinergic agents|mesh-list
110840711|NCT05393245|Muscarinic Antagonists|muscarinic antagonists|mesh-list
110840712|NCT05393245|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110840713|NCT05393245|Autonomic Agents|autonomic agents|mesh-ancestor
110840714|NCT05393245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110840715|NCT05393245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110840716|NCT05393245|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110840717|NCT05393245|Respiratory System Agents|respiratory system agents|mesh-ancestor
110840718|NCT05393245|Parasympatholytics|parasympatholytics|mesh-ancestor
110840719|NCT05393245|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110840720|NCT05393245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110840721|NCT05393245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110840722|NCT03390712|Risperidone|risperidone|mesh-list
110840723|NCT03390712|Paliperidone Palmitate|paliperidone palmitate|mesh-list
110840724|NCT03390712|Antipsychotic Agents|antipsychotic agents|mesh-list
110840725|NCT03390712|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110840726|NCT03390712|Serotonin Agents|serotonin agents|mesh-ancestor
110840727|NCT03390712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110840728|NCT03390712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110840729|NCT03390712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110840730|NCT03390712|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110840731|NCT03390712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110840732|NCT03390712|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110840733|NCT03390712|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110840734|NCT03390712|Dopamine Agents|dopamine agents|mesh-ancestor
110830583|NCT01209533|Iloprost|iloprost|mesh-list
110840735|NCT03390712|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110840736|NCT03390712|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110840737|NCT03756727|Ascorbic Acid|ascorbic acid|mesh-list
110840738|NCT03756727|Vitamins|vitamins|mesh-ancestor
110840739|NCT03756727|Micronutrients|micronutrients|mesh-ancestor
110583456|NCT00583947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110840740|NCT03756727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110840742|NCT03756727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110840743|NCT03756727|Protective Agents|protective agents|mesh-ancestor
110583528|NCT00761306|Serotonin Agents|serotonin agents|mesh-ancestor
110840744|NCT04962724|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110840746|NCT03398434|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110840747|NCT03398434|Antithrombins|antithrombins|mesh-ancestor
110840748|NCT03398434|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110840749|NCT03398434|Protease Inhibitors|protease inhibitors|mesh-ancestor
110840750|NCT03398434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110840751|NCT03398434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110840752|NCT03398434|Anticoagulants|anticoagulants|mesh-ancestor
110840753|NCT03398122|Apatinib|apatinib|mesh-list
110840754|NCT03398122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110840755|NCT03398122|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110840756|NCT03398122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110840757|NCT03398122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110840758|NCT05459857|Menthol|menthol|mesh-list
110840759|NCT05459857|Antipruritics|antipruritics|mesh-ancestor
110840760|NCT05459857|Dermatologic Agents|dermatologic agents|mesh-ancestor
110840761|NCT03394222|Budesonide|budesonide|mesh-list
110583737|NCT04078425|Diuretics|diuretics|mesh-ancestor
110840762|NCT03394222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110840763|NCT03394222|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110840765|NCT03394222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110840766|NCT03394222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110840767|NCT03394222|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110840768|NCT03394222|Respiratory System Agents|respiratory system agents|mesh-ancestor
110840769|NCT03394222|Glucocorticoids|glucocorticoids|mesh-ancestor
110840770|NCT03394222|Hormones|hormones|mesh-ancestor
110840771|NCT03394222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110840772|NCT03398044|Dexamethasone|dexamethasone|mesh-list
110840773|NCT03398044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110840774|NCT03398044|Antiemetics|antiemetics|mesh-ancestor
110840775|NCT03398044|Autonomic Agents|autonomic agents|mesh-ancestor
110840776|NCT03398044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110840777|NCT03398044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110840778|NCT03398044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110840779|NCT03398044|Glucocorticoids|glucocorticoids|mesh-ancestor
110840780|NCT03398044|Hormones|hormones|mesh-ancestor
110840781|NCT03398044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110840782|NCT03398044|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110840783|NCT03398044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110840784|NCT03389776|Anesthetics|anesthetics|mesh-list
110840785|NCT03389776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110840786|NCT03389776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110840787|NCT02813200|Tiotropium Bromide|tiotropium bromide|mesh-list
110583863|NCT04114097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110840788|NCT02813200|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
110840790|NCT02813200|Autonomic Agents|autonomic agents|mesh-ancestor
110840791|NCT02813200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110840792|NCT02813200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110840793|NCT02813200|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110840794|NCT02813200|Respiratory System Agents|respiratory system agents|mesh-ancestor
110840795|NCT02813200|Parasympatholytics|parasympatholytics|mesh-ancestor
110840796|NCT02813200|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110840797|NCT02813200|Cholinergic Agents|cholinergic agents|mesh-ancestor
110840798|NCT02813200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110830629|NCT01192165|Paclitaxel|paclitaxel|mesh-list
110840799|NCT02813200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110840801|NCT02813200|Hormones|hormones|mesh-ancestor
110840802|NCT02813200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110840803|NCT02813200|Sympathomimetics|sympathomimetics|mesh-ancestor
110840804|NCT04535947|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110840805|NCT04535947|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110840807|NCT03750721|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110840808|NCT03750721|Antitubercular Agents|antitubercular agents|mesh-ancestor
110840809|NCT03750721|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110840810|NCT03750721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110840811|NCT03750721|Leprostatic Agents|leprostatic agents|mesh-ancestor
110584144|NCT00914693|Gestodene|gestodene|mesh-list
110840812|NCT03750721|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110840813|NCT03750721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110840814|NCT03750721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110840815|NCT03750721|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110840816|NCT03750721|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110840817|NCT03750721|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110840818|NCT03750721|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110840819|NCT03750721|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110840820|NCT03750721|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110840821|NCT01481272|Leucovorin|leucovorin|mesh-list
110840822|NCT01481272|Cytarabine|cytarabine|mesh-list
110840823|NCT01481272|Methotrexate|methotrexate|mesh-list
110840824|NCT01481272|Etoposide|etoposide|mesh-list
110840825|NCT01481272|Ofatumumab|ofatumumab|mesh-list
110840826|NCT01481272|Lenograstim|lenograstim|mesh-list
110840827|NCT01481272|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110840828|NCT01481272|Abortifacient Agents|abortifacient agents|mesh-ancestor
110840829|NCT01481272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110840830|NCT01481272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110840831|NCT01481272|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110840832|NCT01481272|Antimetabolites|antimetabolites|mesh-ancestor
110840833|NCT01481272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110840834|NCT01481272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110840835|NCT01481272|Dermatologic Agents|dermatologic agents|mesh-ancestor
110840836|NCT01481272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110840837|NCT01481272|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110840838|NCT01481272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110840839|NCT01481272|Immunologic Factors|immunologic factors|mesh-ancestor
110840840|NCT01481272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110840841|NCT01481272|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110840842|NCT01481272|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110840843|NCT01481272|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110840844|NCT01481272|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110584642|NCT00721110|Lidocaine|lidocaine|mesh-list
110840846|NCT01481272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110840848|NCT01481272|Protective Agents|protective agents|mesh-ancestor
110840849|NCT01481272|Vitamin B Complex|vitamin b complex|mesh-ancestor
110840850|NCT01481272|Vitamins|vitamins|mesh-ancestor
110840851|NCT01481272|Micronutrients|micronutrients|mesh-ancestor
110840852|NCT01481272|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110840853|NCT04478695|Pembrolizumab|pembrolizumab|mesh-list
110840854|NCT04478695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110840855|NCT04478695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110840856|NCT04478695|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110840857|NCT04478695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110840858|NCT02687386|Mitoxantrone|mitoxantrone|mesh-list
110840859|NCT02687386|Analgesics|analgesics|mesh-ancestor
110840860|NCT02687386|Sensory System Agents|sensory system agents|mesh-ancestor
110840861|NCT02687386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110584833|NCT00789191|Hormones|hormones|mesh-ancestor
110840862|NCT02687386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110840863|NCT02687386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110840864|NCT02687386|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110840865|NCT02687386|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110840866|NCT02687386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110840867|NCT02687386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110840868|NCT04531813|Butenafine|butenafine|mesh-list
110840869|NCT04531813|Antifungal Agents|antifungal agents|mesh-ancestor
110840870|NCT04531813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110840871|NCT01380028|Prednisone|prednisone|mesh-list
110840872|NCT01380028|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110840873|NCT01380028|Glucocorticoids|glucocorticoids|mesh-ancestor
110840874|NCT01380028|Hormones|hormones|mesh-ancestor
110840875|NCT01380028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110584968|NCT03249831|Mycophenolic Acid|mycophenolic acid|mesh-list
110840876|NCT01380028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110840877|NCT01380028|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110840878|NCT01380028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110840879|NCT01305460|Azacitidine|azacitidine|mesh-list
110585036|NCT01028443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110840880|NCT01305460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110840881|NCT01305460|Antimetabolites|antimetabolites|mesh-ancestor
110840882|NCT01305460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110840883|NCT01305460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110840884|NCT01305460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110840885|NCT03754543|Iron|iron|mesh-list
110840886|NCT03754543|Trace Elements|trace elements|mesh-ancestor
110840887|NCT03754543|Micronutrients|micronutrients|mesh-ancestor
110840888|NCT03754543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110840889|NCT01199302|Brodalumab|brodalumab|mesh-list
110840890|NCT01199302|Dermatologic Agents|dermatologic agents|mesh-ancestor
110840891|NCT03754387|Ceftazidime|ceftazidime|mesh-list
110840892|NCT03754387|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110840893|NCT03754387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110840894|NCT03171480|Isosorbide|isosorbide|mesh-list
110840895|NCT03171480|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
110840896|NCT03171480|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
110840897|NCT03171480|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110840898|NCT03171480|Diuretics|diuretics|mesh-ancestor
110840899|NCT03171480|Natriuretic Agents|natriuretic agents|mesh-ancestor
110840900|NCT03171480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110840901|NCT03171480|Vasodilator Agents|vasodilator agents|mesh-ancestor
110840902|NCT03171480|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
110840903|NCT03171480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110840904|NCT04465357|Erenumab|erenumab|mesh-list
110840905|NCT04465357|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
110585388|NCT04095182|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110840906|NCT04465357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110840907|NCT04465357|Analgesics|analgesics|mesh-ancestor
110585461|NCT02599532|Apixaban|apixaban|mesh-list
110840908|NCT04465357|Sensory System Agents|sensory system agents|mesh-ancestor
110840909|NCT04465357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110840910|NCT04465357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110840911|NCT05396690|Sevoflurane|sevoflurane|mesh-list
110840912|NCT05396690|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110840913|NCT05396690|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110840914|NCT05396690|Anesthetics, General|anesthetics, general|mesh-ancestor
110840915|NCT05396690|Anesthetics|anesthetics|mesh-ancestor
110840916|NCT05396690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110585603|NCT02597114|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110840917|NCT05396690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110840918|NCT01384058|Simvastatin|simvastatin|mesh-list
110840919|NCT01384058|Ezetimibe|ezetimibe|mesh-list
110840920|NCT01384058|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110840921|NCT01384058|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110840922|NCT01384058|Antimetabolites|antimetabolites|mesh-ancestor
110585673|NCT00743288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110840923|NCT01384058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110840924|NCT01384058|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110840925|NCT01384058|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110840926|NCT01384058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110840927|NCT04401384|Pyridoxine|pyridoxine|mesh-list
110840928|NCT04401384|Dicyclomine, doxylamine, pyridoxine drug combination|dicyclomine, doxylamine, pyridoxine drug combination|mesh-list
110840929|NCT04401384|Doxylamine|doxylamine|mesh-list
110840930|NCT04401384|Dicyclomine|dicyclomine|mesh-list
110840931|NCT04401384|Antiemetics|antiemetics|mesh-ancestor
110840932|NCT04401384|Autonomic Agents|autonomic agents|mesh-ancestor
110840933|NCT04401384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110840934|NCT04401384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110830697|NCT03847441|Vitamin D|vitamin d|mesh-list
110840935|NCT04401384|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110840936|NCT04401384|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110840937|NCT04401384|Histamine Antagonists|histamine antagonists|mesh-ancestor
110840938|NCT04401384|Histamine Agents|histamine agents|mesh-ancestor
110840939|NCT04401384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110585881|NCT02596334|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110840940|NCT04401384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110840941|NCT04401384|Parasympatholytics|parasympatholytics|mesh-ancestor
110840942|NCT04401384|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110840943|NCT04401384|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110840944|NCT04401384|Cholinergic Agents|cholinergic agents|mesh-ancestor
110840945|NCT04401384|Vitamin B Complex|vitamin b complex|mesh-ancestor
110840947|NCT04401384|Micronutrients|micronutrients|mesh-ancestor
110840948|NCT03312114|Avelumab|avelumab|mesh-list
110840949|NCT03312114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110840950|NCT03312114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110840951|NCT04239222|Ibuprofen|ibuprofen|mesh-list
110840952|NCT04239222|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110840953|NCT04239222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110840954|NCT04239222|Analgesics|analgesics|mesh-ancestor
110840955|NCT04239222|Sensory System Agents|sensory system agents|mesh-ancestor
110840956|NCT04239222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110840957|NCT04239222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110840958|NCT04239222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110840959|NCT04239222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110840960|NCT04239222|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110840961|NCT04239222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110585954|NCT00719472|Mitosis Modulators|mitosis modulators|mesh-ancestor
110840962|NCT04239222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110840963|NCT04732260|Letermovir|letermovir|mesh-list
110840964|NCT04732260|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110840965|NCT04732260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110586013|NCT02598830|Vitamin D|vitamin d|mesh-list
110840966|NCT04732260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110840967|NCT04732260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110840968|NCT04732260|Antiviral Agents|antiviral agents|mesh-ancestor
110840969|NCT04732260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110840970|NCT03084536|Acetaminophen|acetaminophen|mesh-list
110840971|NCT03084536|Celecoxib|celecoxib|mesh-list
110840972|NCT03084536|Fentanyl|fentanyl|mesh-list
110840973|NCT03084536|Midazolam|midazolam|mesh-list
110840974|NCT03084536|Gabapentin|gabapentin|mesh-list
110840975|NCT03084536|Bupivacaine|bupivacaine|mesh-list
110840976|NCT03084536|Anesthetics, Local|anesthetics, local|mesh-ancestor
110840977|NCT03084536|Anesthetics|anesthetics|mesh-ancestor
110840978|NCT03084536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110840979|NCT03084536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110840980|NCT03084536|Sensory System Agents|sensory system agents|mesh-ancestor
110840981|NCT03084536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110840982|NCT03084536|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110840983|NCT03084536|Narcotics|narcotics|mesh-ancestor
110840984|NCT03084536|Analgesics|analgesics|mesh-ancestor
110840985|NCT03084536|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110840986|NCT03084536|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110840987|NCT03084536|Anesthetics, General|anesthetics, general|mesh-ancestor
110840988|NCT03084536|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110840989|NCT03084536|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110840990|NCT03084536|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110840991|NCT03084536|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110840992|NCT03084536|GABA Modulators|gaba modulators|mesh-ancestor
110840993|NCT03084536|GABA Agents|gaba agents|mesh-ancestor
110840994|NCT03084536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110840995|NCT03084536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110840996|NCT03084536|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110840997|NCT03084536|Antipyretics|antipyretics|mesh-ancestor
110840998|NCT03084536|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110840999|NCT03084536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110841000|NCT03084536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110841001|NCT03084536|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110830761|NCT03424239|Vitamins|vitamins|mesh-list
110841002|NCT03084536|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110841003|NCT03084536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110841004|NCT03084536|Anticonvulsants|anticonvulsants|mesh-ancestor
110586197|NCT00709683|Insulin Aspart|insulin aspart|mesh-list
110841005|NCT03084536|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110841006|NCT03084536|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110841007|NCT03084536|Antimanic Agents|antimanic agents|mesh-ancestor
110841008|NCT03311724|Tirzepatide|tirzepatide|mesh-list
110841009|NCT03311724|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110841010|NCT03311724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110841011|NCT03311724|Incretins|incretins|mesh-ancestor
110841012|NCT03311724|Hormones|hormones|mesh-ancestor
110586335|NCT04085562|Vasodilator Agents|vasodilator agents|mesh-ancestor
110841013|NCT03311724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110841015|NCT05213312|Fluorouracil|fluorouracil|mesh-list
110841016|NCT05213312|Nivolumab|nivolumab|mesh-list
110841017|NCT05213312|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110841018|NCT05213312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110841019|NCT05213312|Tubulin Modulators|tubulin modulators|mesh-ancestor
110841020|NCT05213312|Antimitotic Agents|antimitotic agents|mesh-ancestor
110841021|NCT05213312|Mitosis Modulators|mitosis modulators|mesh-ancestor
110586481|NCT00719199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110841022|NCT05213312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110841023|NCT05213312|Antimetabolites|antimetabolites|mesh-ancestor
110841024|NCT05213312|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110841025|NCT05213312|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110841026|NCT05213312|Immunologic Factors|immunologic factors|mesh-ancestor
110841027|NCT05213312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110841028|NCT05213312|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110841029|NCT05213312|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110841030|NCT03311646|Nicotine|nicotine|mesh-list
110841031|NCT03311646|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110841032|NCT03311646|Autonomic Agents|autonomic agents|mesh-ancestor
110841033|NCT03311646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110586695|NCT02573025|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110830797|NCT01210391|Caseins|caseins|mesh-list
110841034|NCT03311646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110841035|NCT03311646|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110841036|NCT03311646|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110841037|NCT03311646|Cholinergic Agents|cholinergic agents|mesh-ancestor
110841038|NCT03311646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110841039|NCT03311646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110841040|NCT03680274|Ascorbic Acid|ascorbic acid|mesh-list
110841041|NCT03680274|Vitamins|vitamins|mesh-ancestor
110841042|NCT03680274|Micronutrients|micronutrients|mesh-ancestor
110586839|NCT00741260|Antimetabolites|antimetabolites|mesh-ancestor
110841043|NCT03680274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110841044|NCT03680274|Antioxidants|antioxidants|mesh-ancestor
110841045|NCT03680274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110841046|NCT03680274|Protective Agents|protective agents|mesh-ancestor
110841047|NCT03288987|Leucovorin|leucovorin|mesh-list
110841048|NCT03288987|Bevacizumab|bevacizumab|mesh-list
110841049|NCT03288987|Fluorouracil|fluorouracil|mesh-list
110841050|NCT03288987|Irinotecan|irinotecan|mesh-list
110841051|NCT03288987|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110841052|NCT03288987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110841053|NCT03288987|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110841054|NCT03288987|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110841055|NCT03288987|Growth Substances|growth substances|mesh-ancestor
110841056|NCT03288987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110841057|NCT03288987|Growth Inhibitors|growth inhibitors|mesh-ancestor
110841058|NCT03288987|Antimetabolites|antimetabolites|mesh-ancestor
110586984|NCT04083066|Hormones|hormones|mesh-ancestor
110841059|NCT03288987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110841060|NCT03288987|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110841061|NCT03288987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110841062|NCT03288987|Immunologic Factors|immunologic factors|mesh-ancestor
110841063|NCT03288987|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110841064|NCT03288987|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110841065|NCT03288987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110841066|NCT03288987|Antidotes|antidotes|mesh-ancestor
110841067|NCT03288987|Protective Agents|protective agents|mesh-ancestor
110841068|NCT03288987|Vitamin B Complex|vitamin b complex|mesh-ancestor
110841070|NCT03288987|Micronutrients|micronutrients|mesh-ancestor
110841071|NCT01379846|Vaccines|vaccines|mesh-list
110841072|NCT01379846|Immunologic Factors|immunologic factors|mesh-ancestor
110587120|NCT00795509|Urological Agents|urological agents|mesh-ancestor
110841074|NCT01379300|Rivaroxaban|rivaroxaban|mesh-list
110841075|NCT01379300|Dabigatran|dabigatran|mesh-list
110841076|NCT01379300|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110841077|NCT01379300|Antithrombins|antithrombins|mesh-ancestor
110841078|NCT01379300|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110841079|NCT01379300|Protease Inhibitors|protease inhibitors|mesh-ancestor
110841080|NCT01379300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110841081|NCT01379300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110841082|NCT01379300|Anticoagulants|anticoagulants|mesh-ancestor
110841083|NCT03682224|Epinephrine|epinephrine|mesh-list
110841084|NCT03682224|Bupivacaine|bupivacaine|mesh-list
110841085|NCT03682224|Anesthetics, Local|anesthetics, local|mesh-ancestor
110841086|NCT03682224|Anesthetics|anesthetics|mesh-ancestor
110841087|NCT03682224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110841088|NCT03682224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110841089|NCT03682224|Sensory System Agents|sensory system agents|mesh-ancestor
110841090|NCT03682224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110841091|NCT03682224|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110841092|NCT03682224|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110841093|NCT03682224|Adrenergic Agents|adrenergic agents|mesh-ancestor
110841094|NCT03682224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110841095|NCT03682224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110841096|NCT03682224|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110841097|NCT03682224|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110587408|NCT00723879|Ribavirin|ribavirin|mesh-list
110841098|NCT03682224|Autonomic Agents|autonomic agents|mesh-ancestor
110841099|NCT03682224|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110841100|NCT03682224|Respiratory System Agents|respiratory system agents|mesh-ancestor
110841101|NCT03682224|Mydriatics|mydriatics|mesh-ancestor
110558696|NCT00809835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110841102|NCT03682224|Sympathomimetics|sympathomimetics|mesh-ancestor
110841103|NCT03682224|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110841105|NCT01383044|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110841106|NCT01383044|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110841107|NCT01383044|Adrenergic Agents|adrenergic agents|mesh-ancestor
110841108|NCT01383044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110334599|NCT00495326|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110841109|NCT01383044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110841110|NCT01383044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110841111|NCT01383044|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110841112|NCT01383044|Antioxidants|antioxidants|mesh-ancestor
110841113|NCT01383044|Protective Agents|protective agents|mesh-ancestor
110841114|NCT01383044|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110841115|NCT01383044|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110841116|NCT01383044|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110841117|NCT01383044|Vasodilator Agents|vasodilator agents|mesh-ancestor
110841118|NCT01383044|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110841119|NCT01383044|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110841120|NCT01377428|Formoterol Fumarate|formoterol fumarate|mesh-list
110841121|NCT01377428|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110841122|NCT01377428|Autonomic Agents|autonomic agents|mesh-ancestor
110841123|NCT01377428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110841124|NCT01377428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110587605|NCT00725439|R 115866|r 115866|mesh-list
110587606|NCT00725439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110587609|NCT03205761|Olaparib|olaparib|mesh-list
110841125|NCT01377428|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110841126|NCT01377428|Respiratory System Agents|respiratory system agents|mesh-ancestor
110841127|NCT01377428|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110587664|NCT02603861|Modafinil|modafinil|mesh-list
110841129|NCT01377428|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110841130|NCT01377428|Adrenergic Agents|adrenergic agents|mesh-ancestor
110841131|NCT01377428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110841132|NCT01377428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110841133|NCT03083990|Bevacizumab|bevacizumab|mesh-list
110841134|NCT03083990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110841135|NCT03083990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110841136|NCT03083990|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110841137|NCT03083990|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110841138|NCT03083990|Growth Substances|growth substances|mesh-ancestor
110841139|NCT03083990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110841140|NCT03083990|Growth Inhibitors|growth inhibitors|mesh-ancestor
110841142|NCT03252015|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110841143|NCT03252015|Serotonin Agents|serotonin agents|mesh-ancestor
110841144|NCT03252015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110841145|NCT03252015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110841146|NCT03252015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110841147|NCT01314027|Gemcitabine|gemcitabine|mesh-list
110841148|NCT01314027|Oxaliplatin|oxaliplatin|mesh-list
110841149|NCT01314027|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110841150|NCT01314027|Antimetabolites|antimetabolites|mesh-ancestor
110841151|NCT01314027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110841152|NCT01314027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110841153|NCT03708003|Venetoclax|venetoclax|mesh-list
110841154|NCT03708003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110841156|NCT03083132|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110841157|NCT03083132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110841158|NCT03083132|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
110587951|NCT00735345|Docetaxel|docetaxel|mesh-list
110841159|NCT03083132|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110841160|NCT03083132|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110841161|NCT03083132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110841162|NCT04121468|Metformin|metformin|mesh-list
110841163|NCT04121468|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110841164|NCT04121468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110841165|NCT03648489|Paclitaxel|paclitaxel|mesh-list
110841166|NCT03648489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110841167|NCT03648489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110841168|NCT03648489|Tubulin Modulators|tubulin modulators|mesh-ancestor
110841169|NCT03648489|Antimitotic Agents|antimitotic agents|mesh-ancestor
110841170|NCT03648489|Mitosis Modulators|mitosis modulators|mesh-ancestor
110841171|NCT03648489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110841172|NCT01382888|Heparin|heparin|mesh-list
110841173|NCT01382888|Anticoagulants|anticoagulants|mesh-ancestor
110841174|NCT01382888|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110841176|NCT01382888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110841177|NCT03249909|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
110841178|NCT03249909|Laxatives|laxatives|mesh-ancestor
110841179|NCT03249909|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110841180|NCT04809116|Pimavanserin|pimavanserin|mesh-list
110841181|NCT04809116|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110841182|NCT04809116|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110841183|NCT04809116|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110841184|NCT04809116|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110588294|NCT00712335|Dermatologic Agents|dermatologic agents|mesh-ancestor
110841185|NCT04809116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110841186|NCT04809116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110841187|NCT04809116|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110841188|NCT04809116|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110841189|NCT04809116|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110841190|NCT04809116|Serotonin Agents|serotonin agents|mesh-ancestor
110841191|NCT04809116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110841192|NCT04809116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110841194|NCT03077438|Immunologic Factors|immunologic factors|mesh-ancestor
110841195|NCT03077438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110841196|NCT01382732|Oxytocin|oxytocin|mesh-list
110841197|NCT01382732|Carbetocin|carbetocin|mesh-list
110841198|NCT01382732|Oxytocics|oxytocics|mesh-ancestor
110841199|NCT01382732|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110841200|NCT01382732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110841201|NCT02183870|Crizotinib|crizotinib|mesh-list
110830930|NCT03943043|Antimetabolites|antimetabolites|mesh-ancestor
110841203|NCT02183870|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110841204|NCT02183870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110841205|NCT02183870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110841206|NCT03076970|Sumatriptan|sumatriptan|mesh-list
110841207|NCT03076970|Lasmiditan|lasmiditan|mesh-list
110841208|NCT03076970|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110841209|NCT03076970|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110841210|NCT03076970|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110841211|NCT03076970|Serotonin Agents|serotonin agents|mesh-ancestor
110841212|NCT03076970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110588491|NCT05512767|Antimetabolites|antimetabolites|mesh-ancestor
110841213|NCT03076970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110841214|NCT03076970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110841215|NCT00726596|Hydroxychloroquine|hydroxychloroquine|mesh-list
110841216|NCT00726596|Antimalarials|antimalarials|mesh-ancestor
110841217|NCT00726596|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110841218|NCT00726596|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110841219|NCT00726596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110841220|NCT00726596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110841221|NCT00726596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110841222|NCT00726596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110841223|NCT04897880|Panobinostat|panobinostat|mesh-list
110841224|NCT04897880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110841225|NCT04897880|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110841226|NCT04897880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110841227|NCT04897880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110841228|NCT02890992|Nicotinic Acids|nicotinic acids|mesh-list
110841230|NCT02890992|Niacinamide|niacinamide|mesh-list
110841231|NCT02890992|Ezetimibe|ezetimibe|mesh-list
110841232|NCT02890992|Alirocumab|alirocumab|mesh-list
110841233|NCT02890992|Cholestyramine Resin|cholestyramine resin|mesh-list
110841234|NCT02890992|Fenofibrate|fenofibrate|mesh-list
110841235|NCT02890992|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110841236|NCT02890992|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110841238|NCT02890992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110841239|NCT02890992|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110841240|NCT02890992|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
110841241|NCT02890992|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110841242|NCT02890992|Protease Inhibitors|protease inhibitors|mesh-ancestor
110841243|NCT02890992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110841244|NCT02890992|Vitamin B Complex|vitamin b complex|mesh-ancestor
110841245|NCT02890992|Vitamins|vitamins|mesh-ancestor
110841246|NCT02890992|Micronutrients|micronutrients|mesh-ancestor
110841247|NCT02890992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110841248|NCT02890992|Vasodilator Agents|vasodilator agents|mesh-ancestor
110841249|NCT03603912|Metformin|metformin|mesh-list
110841250|NCT03603912|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110841251|NCT03603912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110841252|NCT04357730|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
110841253|NCT04357730|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110841254|NCT04357730|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110841255|NCT04357730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110841256|NCT05274984|Lidocaine|lidocaine|mesh-list
110841257|NCT05274984|Anesthetics, Local|anesthetics, local|mesh-ancestor
110841258|NCT05274984|Anesthetics|anesthetics|mesh-ancestor
110841259|NCT05274984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110841260|NCT05274984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110841261|NCT05274984|Sensory System Agents|sensory system agents|mesh-ancestor
110841262|NCT05274984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110841264|NCT05274984|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110841265|NCT05274984|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110841266|NCT05274984|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110588736|NCT00734162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110841267|NCT05274984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110841269|NCT05274672|Cephalexin|cephalexin|mesh-list
110841270|NCT05274672|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
110841271|NCT05274672|Nitrofurantoin|nitrofurantoin|mesh-list
110841272|NCT05274672|Trimethoprim|trimethoprim|mesh-list
110841273|NCT05274672|Sulfamethoxazole|sulfamethoxazole|mesh-list
110841274|NCT05274672|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110841275|NCT05274672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110841276|NCT05274672|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110841277|NCT05274672|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110841278|NCT05274672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110841279|NCT05274672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110841280|NCT05274672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110588870|NCT00711243|Tubulin Modulators|tubulin modulators|mesh-ancestor
110841281|NCT05274672|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110841282|NCT05274672|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110841283|NCT05274672|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110841284|NCT05274672|Antimalarials|antimalarials|mesh-ancestor
110841285|NCT05274672|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110841286|NCT05274672|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110841287|NCT05274672|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110841288|NCT05274672|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110841289|NCT05274672|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
110841290|NCT01379144|Latanoprost|latanoprost|mesh-list
110841291|NCT01379144|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110841292|NCT01379144|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110841293|NCT01376882|Caffeine|caffeine|mesh-list
110841294|NCT01376882|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110841295|NCT01376882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110841296|NCT01376882|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110841297|NCT01376882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110841298|NCT01376882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110841299|NCT01376882|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110841300|NCT01376882|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110841301|NCT01376882|Purinergic Agents|purinergic agents|mesh-ancestor
110841302|NCT01376882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110841303|NCT03329196|Darbepoetin alfa|darbepoetin alfa|mesh-list
110841304|NCT03329196|Hematinics|hematinics|mesh-ancestor
110841305|NCT04656002|Vactosertib|vactosertib|mesh-list
110841306|NCT04656002|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110841307|NCT04656002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110841308|NCT04656002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110841309|NCT01382498|Calcium Dobesilate|calcium dobesilate|mesh-list
110841310|NCT01382498|Calcium|calcium|mesh-list
110589086|NCT02567799|Paclitaxel|paclitaxel|mesh-list
110841311|NCT01382498|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110841312|NCT01382498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110841313|NCT01382498|Hemostatics|hemostatics|mesh-ancestor
110841314|NCT01382498|Coagulants|coagulants|mesh-ancestor
110841315|NCT03476538|Gabapentin|gabapentin|mesh-list
110841316|NCT03476538|Analgesics|analgesics|mesh-ancestor
110841317|NCT03476538|Sensory System Agents|sensory system agents|mesh-ancestor
110841318|NCT03476538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110841319|NCT03476538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110841320|NCT03476538|Anticonvulsants|anticonvulsants|mesh-ancestor
110841321|NCT03476538|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110841322|NCT03476538|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110841323|NCT03476538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110841324|NCT03476538|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110841325|NCT03476538|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110841326|NCT03476538|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110841327|NCT03476538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110841328|NCT03476538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110841329|NCT03476538|Antimanic Agents|antimanic agents|mesh-ancestor
110841330|NCT03326856|Botulinum Toxins|botulinum toxins|mesh-list
110841331|NCT03326856|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110841332|NCT03326856|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110841333|NCT03326856|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110841334|NCT03326856|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110841335|NCT03326856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110841336|NCT03326856|Cholinergic Agents|cholinergic agents|mesh-ancestor
110841337|NCT03326856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110589150|NCT04062357|Lidocaine|lidocaine|mesh-list
110830973|NCT01208363|Fe(III)-EDTA|fe(iii)-edta|mesh-list
110841338|NCT03326856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110841339|NCT03326856|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110841340|NCT03326856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110841342|NCT00000116|Vitamins|vitamins|mesh-ancestor
110841343|NCT00000116|Micronutrients|micronutrients|mesh-ancestor
110841344|NCT00000116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110841345|NCT05232396|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110841346|NCT05232396|Antibodies|antibodies|mesh-list
110841347|NCT05232396|Immunoglobulins|immunoglobulins|mesh-list
110841348|NCT05232396|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110841349|NCT05232396|Immunologic Factors|immunologic factors|mesh-ancestor
110841350|NCT05232396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110841351|NCT05232396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110841352|NCT05222724|Ibuprofen|ibuprofen|mesh-list
110334656|NCT00506844|Irinotecan|irinotecan|mesh-list
110841353|NCT05222724|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110841354|NCT05222724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110841355|NCT05222724|Analgesics|analgesics|mesh-ancestor
110841356|NCT05222724|Sensory System Agents|sensory system agents|mesh-ancestor
110841357|NCT05222724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110841358|NCT05222724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110841359|NCT05222724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110841360|NCT05222724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110841361|NCT05222724|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110841362|NCT05222724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110841363|NCT05222724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110841364|NCT01382342|Rasagiline|rasagiline|mesh-list
110841365|NCT01382342|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
110841366|NCT01382342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110841367|NCT01382342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110841368|NCT01382342|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110841369|NCT01382342|Protective Agents|protective agents|mesh-ancestor
110841370|NCT01382342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110841371|NCT03471728|Linaclotide|linaclotide|mesh-list
110841372|NCT03471728|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
110841373|NCT03471728|Enzyme Activators|enzyme activators|mesh-ancestor
110841374|NCT03471728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110841375|NCT03471728|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110841376|NCT03630614|Nicotine|nicotine|mesh-list
110841377|NCT03630614|Varenicline|varenicline|mesh-list
110841378|NCT03630614|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110841379|NCT03630614|Autonomic Agents|autonomic agents|mesh-ancestor
110841380|NCT03630614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110841381|NCT03630614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110841382|NCT03630614|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110841383|NCT03630614|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110841384|NCT03630614|Cholinergic Agents|cholinergic agents|mesh-ancestor
110841385|NCT03630614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110841386|NCT03630614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110841387|NCT01378832|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110841388|NCT01378832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110841390|NCT01378754|Propofol|propofol|mesh-list
110841391|NCT01378754|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110841392|NCT01378754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110841393|NCT01378754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110841394|NCT01378754|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110841395|NCT01378754|Anesthetics, General|anesthetics, general|mesh-ancestor
110841396|NCT01378754|Anesthetics|anesthetics|mesh-ancestor
110841397|NCT05764304|Sinomenine|sinomenine|mesh-list
110841398|NCT05764304|Glucocorticoids|glucocorticoids|mesh-list
110841399|NCT05764304|Hormones|hormones|mesh-ancestor
110841400|NCT05764304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110841401|NCT05764304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110841403|NCT03075410|GSK656|gsk656|mesh-list
110841404|NCT03075410|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110841405|NCT03075410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110841406|NCT05764226|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110841407|NCT02826512|Niraparib|niraparib|mesh-list
110841408|NCT02826512|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110841410|NCT02826512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110841411|NCT02826512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110841412|NCT05391230|Permethrin|permethrin|mesh-list
110841413|NCT05391230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110589647|NCT02565693|Anticoagulants|anticoagulants|mesh-ancestor
110841414|NCT05391230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110841415|NCT02731352|Apatinib|apatinib|mesh-list
110841416|NCT02731352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110841417|NCT02731352|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110841418|NCT02731352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110841419|NCT02731352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110841420|NCT05132660|Levodopa|levodopa|mesh-list
110841421|NCT05132660|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
110841422|NCT05132660|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110841423|NCT05132660|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110841424|NCT05132660|Dopamine Agents|dopamine agents|mesh-ancestor
110841425|NCT05132660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110589721|NCT00724958|Infliximab|infliximab|mesh-list
110841426|NCT05132660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110841428|NCT05132660|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110589788|NCT00742911|Disulfiram|disulfiram|mesh-list
110841429|NCT05132660|Immunologic Factors|immunologic factors|mesh-ancestor
110841430|NCT05132660|Dopamine Agonists|dopamine agonists|mesh-ancestor
110841431|NCT05762744|Exenatide|exenatide|mesh-list
110841432|NCT05762744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110841433|NCT05762744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110841434|NCT05762744|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110841435|NCT05762744|Incretins|incretins|mesh-ancestor
110841436|NCT05762744|Hormones|hormones|mesh-ancestor
110841437|NCT05762744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110841438|NCT02257424|Hydroxychloroquine|hydroxychloroquine|mesh-list
110841439|NCT02257424|Trametinib|trametinib|mesh-list
110841440|NCT02257424|Dabrafenib|dabrafenib|mesh-list
110841441|NCT02257424|Antimalarials|antimalarials|mesh-ancestor
110841442|NCT02257424|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110841443|NCT02257424|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110841444|NCT02257424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110841445|NCT02257424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110841446|NCT02257424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110841447|NCT02257424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110841448|NCT02257424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110841449|NCT02257424|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110841450|NCT01858922|Cytarabine|cytarabine|mesh-list
110841451|NCT01858922|Dexamethasone|dexamethasone|mesh-list
110841452|NCT01858922|Prednisone|prednisone|mesh-list
110841453|NCT01858922|Cyclophosphamide|cyclophosphamide|mesh-list
110841454|NCT01858922|Cisplatin|cisplatin|mesh-list
110841455|NCT01858922|Doxorubicin|doxorubicin|mesh-list
110841456|NCT01858922|Etoposide|etoposide|mesh-list
110841457|NCT01858922|Etoposide phosphate|etoposide phosphate|mesh-list
110841458|NCT01858922|Vincristine|vincristine|mesh-list
110841459|NCT01858922|Bleomycin|bleomycin|mesh-list
110589979|NCT00923637|Pemetrexed|pemetrexed|mesh-list
110841461|NCT01858922|Immunologic Factors|immunologic factors|mesh-ancestor
110841462|NCT01858922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110841463|NCT01858922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110841464|NCT01858922|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110590057|NCT00746655|Cisplatin|cisplatin|mesh-list
110841465|NCT01858922|Alkylating Agents|alkylating agents|mesh-ancestor
110841466|NCT01858922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110841467|NCT01858922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110841468|NCT01858922|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110841469|NCT01858922|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110841470|NCT01858922|Antiemetics|antiemetics|mesh-ancestor
110841471|NCT01858922|Autonomic Agents|autonomic agents|mesh-ancestor
110841472|NCT01858922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110841473|NCT01858922|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110841474|NCT01858922|Glucocorticoids|glucocorticoids|mesh-ancestor
110841475|NCT01858922|Hormones|hormones|mesh-ancestor
110841476|NCT01858922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110841477|NCT01858922|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110841479|NCT01858922|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110334679|NCT00492635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110841480|NCT01858922|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110841481|NCT01858922|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110841482|NCT01858922|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110841483|NCT01858922|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110841484|NCT01858922|Antimetabolites|antimetabolites|mesh-ancestor
110841485|NCT01858922|Antiviral Agents|antiviral agents|mesh-ancestor
110841486|NCT01858922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110841487|NCT01858922|Tubulin Modulators|tubulin modulators|mesh-ancestor
110841488|NCT01858922|Antimitotic Agents|antimitotic agents|mesh-ancestor
110841489|NCT01858922|Mitosis Modulators|mitosis modulators|mesh-ancestor
110841490|NCT01378286|Artesunate|artesunate|mesh-list
110841491|NCT01378286|Chloroquine|chloroquine|mesh-list
110841492|NCT01378286|Amodiaquine|amodiaquine|mesh-list
110841493|NCT01378286|Antimalarials|antimalarials|mesh-ancestor
110841494|NCT01378286|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110841495|NCT01378286|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110841496|NCT01378286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110841497|NCT01378286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110841498|NCT01378286|Antiviral Agents|antiviral agents|mesh-ancestor
110841499|NCT01378286|Schistosomicides|schistosomicides|mesh-ancestor
110841500|NCT01378286|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110841501|NCT01378286|Anthelmintics|anthelmintics|mesh-ancestor
110841502|NCT01378286|Amebicides|amebicides|mesh-ancestor
110841503|NCT01378286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110841504|NCT01377974|Miltefosine|miltefosine|mesh-list
110841505|NCT01377974|Meglumine Antimoniate|meglumine antimoniate|mesh-list
110841506|NCT01377974|Antifungal Agents|antifungal agents|mesh-ancestor
110841507|NCT01377974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110841508|NCT01377974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110841509|NCT01377974|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110841510|NCT01377974|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110841511|NCT03071276|Cytarabine|cytarabine|mesh-list
110841512|NCT03071276|Hydrocortisone|hydrocortisone|mesh-list
110841513|NCT03071276|Methotrexate|methotrexate|mesh-list
110841514|NCT03071276|Fludarabine phosphate|fludarabine phosphate|mesh-list
110841515|NCT03071276|Fludarabine|fludarabine|mesh-list
110841516|NCT03071276|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110841517|NCT03071276|Abortifacient Agents|abortifacient agents|mesh-ancestor
110841518|NCT03071276|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110841519|NCT03071276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110841520|NCT03071276|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110841521|NCT03071276|Antimetabolites|antimetabolites|mesh-ancestor
110841522|NCT03071276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110841523|NCT03071276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110841524|NCT03071276|Dermatologic Agents|dermatologic agents|mesh-ancestor
110841525|NCT03071276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110841526|NCT03071276|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110841527|NCT03071276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110841528|NCT03071276|Immunologic Factors|immunologic factors|mesh-ancestor
110841529|NCT03071276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110841530|NCT03071276|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110841531|NCT03071276|Antiviral Agents|antiviral agents|mesh-ancestor
110841532|NCT03071276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110841533|NCT03071276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110841534|NCT03629600|Indomethacin|indomethacin|mesh-list
110841535|NCT03629600|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110841536|NCT03629600|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110841537|NCT03629600|Analgesics|analgesics|mesh-ancestor
110841538|NCT03629600|Sensory System Agents|sensory system agents|mesh-ancestor
110841539|NCT03629600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110841540|NCT03629600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110841541|NCT03629600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110841542|NCT03629600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110841543|NCT03629600|Gout Suppressants|gout suppressants|mesh-ancestor
110841544|NCT03629600|Tocolytic Agents|tocolytic agents|mesh-ancestor
110830997|NCT01197469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110841545|NCT03629600|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110334690|NCT00495872|Sunitinib|sunitinib|mesh-list
110841546|NCT03629600|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110841547|NCT03629600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110841548|NCT03629600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110841549|NCT03074162|Diclofenac|diclofenac|mesh-list
110841550|NCT03074162|Capsaicin|capsaicin|mesh-list
110841551|NCT03074162|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110841552|NCT03074162|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110841553|NCT03074162|Analgesics|analgesics|mesh-ancestor
110841554|NCT03074162|Sensory System Agents|sensory system agents|mesh-ancestor
110841555|NCT03074162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110841556|NCT03074162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110841557|NCT03074162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110841558|NCT03074162|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110841559|NCT03074162|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110841560|NCT03074162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110841561|NCT03074162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110841562|NCT03074162|Antipruritics|antipruritics|mesh-ancestor
110841563|NCT03074162|Dermatologic Agents|dermatologic agents|mesh-ancestor
110841564|NCT05069012|Morphine|morphine|mesh-list
110841565|NCT05069012|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110841566|NCT05069012|Narcotics|narcotics|mesh-ancestor
110841567|NCT05069012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110841568|NCT05069012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110841569|NCT05069012|Analgesics|analgesics|mesh-ancestor
110841570|NCT05069012|Sensory System Agents|sensory system agents|mesh-ancestor
110841572|NCT04065074|FX006|fx006|mesh-list
110841573|NCT04065074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110841574|NCT04065074|Glucocorticoids|glucocorticoids|mesh-ancestor
110841575|NCT04065074|Hormones|hormones|mesh-ancestor
110841576|NCT04065074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110841577|NCT04065074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110841578|NCT04065074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110841579|NCT04065074|Immunologic Factors|immunologic factors|mesh-ancestor
110841580|NCT03920306|Silver Nitrate|silver nitrate|mesh-list
110841581|NCT03920306|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110841582|NCT03920306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110841583|NCT02888106|Tenofovir|tenofovir|mesh-list
110590702|NCT00571701|Analgesics|analgesics|mesh-ancestor
110841584|NCT02888106|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110841585|NCT02888106|Interferon alpha-2|interferon alpha-2|mesh-list
110841586|NCT02888106|Antiviral Agents|antiviral agents|mesh-ancestor
110841587|NCT02888106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110841588|NCT02888106|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110841589|NCT02888106|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110841591|NCT02888106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110841592|NCT02888106|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110841593|NCT02888106|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110841594|NCT02888106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110841595|NCT03793010|FX006|fx006|mesh-list
110841596|NCT03793010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110841597|NCT03793010|Glucocorticoids|glucocorticoids|mesh-ancestor
110841599|NCT03793010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110841600|NCT03793010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110841601|NCT03793010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110841602|NCT03793010|Immunologic Factors|immunologic factors|mesh-ancestor
110841603|NCT03055026|Rivaroxaban|rivaroxaban|mesh-list
110841604|NCT03055026|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110841605|NCT03055026|Antithrombins|antithrombins|mesh-ancestor
110841606|NCT03055026|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110841607|NCT03055026|Protease Inhibitors|protease inhibitors|mesh-ancestor
110841608|NCT03055026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110841609|NCT03055026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110841610|NCT03055026|Anticoagulants|anticoagulants|mesh-ancestor
110841611|NCT03304626|Prednisone|prednisone|mesh-list
110841612|NCT03304626|Budesonide|budesonide|mesh-list
110841613|NCT03304626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110591129|NCT00753909|Paclitaxel|paclitaxel|mesh-list
110841614|NCT03304626|Glucocorticoids|glucocorticoids|mesh-ancestor
110841615|NCT03304626|Hormones|hormones|mesh-ancestor
110841616|NCT03304626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110841617|NCT03304626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110841618|NCT03304626|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110841619|NCT03304626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110841620|NCT03304626|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110841621|NCT03304626|Autonomic Agents|autonomic agents|mesh-ancestor
110841622|NCT03304626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110841623|NCT03304626|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110841624|NCT03304626|Respiratory System Agents|respiratory system agents|mesh-ancestor
110841626|NCT05121714|Caffeine|caffeine|mesh-list
110841627|NCT05121714|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110841628|NCT05121714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110841629|NCT05121714|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110841630|NCT05121714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110559234|NCT00746746|Interferons|interferons|mesh-list
110841631|NCT05121714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110841632|NCT05121714|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110841633|NCT05121714|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110841634|NCT05121714|Purinergic Agents|purinergic agents|mesh-ancestor
110841635|NCT05121714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110841636|NCT05121714|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110841637|NCT05121714|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110841638|NCT05121714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110841639|NCT05121714|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110841640|NCT05121714|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110841641|NCT05121714|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110841642|NCT05121714|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110841643|NCT05121714|Serotonin Agents|serotonin agents|mesh-ancestor
110841644|NCT05121714|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110841645|NCT05121714|Antidepressive Agents|antidepressive agents|mesh-ancestor
110841646|NCT05121714|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110841647|NCT05121714|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110841648|NCT05121714|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110841649|NCT02958150|Dexmedetomidine|dexmedetomidine|mesh-list
110841650|NCT02958150|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110841651|NCT02958150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110841652|NCT02958150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110841653|NCT02958150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110841654|NCT02958150|Analgesics|analgesics|mesh-ancestor
110841655|NCT02958150|Sensory System Agents|sensory system agents|mesh-ancestor
110841656|NCT02958150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110841657|NCT02958150|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110841658|NCT02958150|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110841659|NCT02958150|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110841660|NCT02958150|Adrenergic Agents|adrenergic agents|mesh-ancestor
110841661|NCT02958150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110591300|NCT00754689|Metformin|metformin|mesh-list
110841662|NCT02958150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110841663|NCT04250142|Methamphetamine|methamphetamine|mesh-list
110841664|NCT04250142|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110841665|NCT04250142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110841666|NCT04250142|Sympathomimetics|sympathomimetics|mesh-ancestor
110841667|NCT04250142|Autonomic Agents|autonomic agents|mesh-ancestor
110841668|NCT04250142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110841669|NCT04250142|Dopamine Agents|dopamine agents|mesh-ancestor
110841670|NCT04250142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110841671|NCT04250142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110841672|NCT04250142|Adrenergic Agents|adrenergic agents|mesh-ancestor
110841673|NCT04250142|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110841674|NCT04250142|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110841675|NCT04250142|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110841676|NCT04250142|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110841677|NCT02714322|Adalimumab|adalimumab|mesh-list
110841678|NCT02714322|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110841680|NCT02714322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110841681|NCT03267576|Metformin|metformin|mesh-list
110841682|NCT03267576|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110841683|NCT03267576|Canagliflozin|canagliflozin|mesh-list
110841684|NCT03267576|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110841685|NCT03267576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110841686|NCT03267576|Incretins|incretins|mesh-ancestor
110841687|NCT03267576|Hormones|hormones|mesh-ancestor
110841688|NCT03267576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110841689|NCT03267576|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110841690|NCT03267576|Protease Inhibitors|protease inhibitors|mesh-ancestor
110841691|NCT03267576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110841692|NCT03267576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110841693|NCT03267576|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110841694|NCT02472912|Adalimumab|adalimumab|mesh-list
110841695|NCT02472912|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110841696|NCT02472912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110841697|NCT02472912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110841698|NCT02356458|Bortezomib|bortezomib|mesh-list
110841699|NCT02356458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110841700|NCT03243630|Menthol|menthol|mesh-list
110841701|NCT03243630|Nicotine|nicotine|mesh-list
110841702|NCT03243630|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110841703|NCT03243630|Autonomic Agents|autonomic agents|mesh-ancestor
110841704|NCT03243630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110841706|NCT03243630|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110841707|NCT03243630|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110841708|NCT03243630|Cholinergic Agents|cholinergic agents|mesh-ancestor
110841709|NCT03243630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110841710|NCT03243630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110841711|NCT03243630|Antipruritics|antipruritics|mesh-ancestor
110841712|NCT03243630|Dermatologic Agents|dermatologic agents|mesh-ancestor
110841713|NCT04725331|Pembrolizumab|pembrolizumab|mesh-list
110841714|NCT04725331|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110841715|NCT04725331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110841716|NCT04725331|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110841717|NCT04725331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110841719|NCT03753685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110841720|NCT03753685|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110841721|NCT03753685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110591757|NCT02677545|Antipyretics|antipyretics|mesh-ancestor
110841722|NCT03753685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110841723|NCT05172050|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
110841725|NCT05172050|Hormone Antagonists|hormone antagonists|mesh-ancestor
110591820|NCT00673179|Immunologic Factors|immunologic factors|mesh-ancestor
110841726|NCT05172050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110841727|NCT05172050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110841728|NCT05172050|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110841729|NCT05172050|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110841730|NCT05172050|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110841731|NCT02787044|Vaccines|vaccines|mesh-list
110841732|NCT02787044|Immunologic Factors|immunologic factors|mesh-ancestor
110841733|NCT02787044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110841734|NCT01345019|Zoledronic Acid|zoledronic acid|mesh-list
110841736|NCT01345019|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110841737|NCT01345019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110841738|NCT03629522|Ondansetron|ondansetron|mesh-list
110841739|NCT03629522|Antiemetics|antiemetics|mesh-ancestor
110841740|NCT03629522|Autonomic Agents|autonomic agents|mesh-ancestor
110841741|NCT03629522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110841742|NCT03629522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110841743|NCT03629522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110841744|NCT03629522|Antipruritics|antipruritics|mesh-ancestor
110841745|NCT03629522|Dermatologic Agents|dermatologic agents|mesh-ancestor
110841746|NCT03629522|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110841747|NCT03629522|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110841748|NCT03629522|Serotonin Agents|serotonin agents|mesh-ancestor
110841749|NCT03629522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110841750|NCT03629522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110841751|NCT03751111|Naloxone|naloxone|mesh-list
110841752|NCT03751111|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110841753|NCT03751111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110841754|NCT03751111|Sensory System Agents|sensory system agents|mesh-ancestor
110841755|NCT03751111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110841756|NCT05167370|Amifostine|amifostine|mesh-list
110841757|NCT05167370|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110841758|NCT05167370|Protective Agents|protective agents|mesh-ancestor
110591954|NCT00764907|Antiemetics|antiemetics|mesh-ancestor
110841759|NCT05167370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110841761|NCT01265537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110841762|NCT01265537|Immunologic Factors|immunologic factors|mesh-ancestor
110841763|NCT01265537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110841764|NCT01265537|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110841765|NCT01265537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110841766|NCT01265537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110841767|NCT05763836|Ibuprofen|ibuprofen|mesh-list
110841768|NCT05763836|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110841769|NCT05763836|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110841770|NCT05763836|Analgesics|analgesics|mesh-ancestor
110841771|NCT05763836|Sensory System Agents|sensory system agents|mesh-ancestor
110841772|NCT05763836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110841773|NCT05763836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110841774|NCT05763836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110841775|NCT05763836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110841776|NCT05763836|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110841777|NCT05763836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110841778|NCT05763836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110841779|NCT01237535|Progesterone|progesterone|mesh-list
110841780|NCT01237535|Estrogens|estrogens|mesh-list
110841781|NCT01237535|Progestins|progestins|mesh-ancestor
110841782|NCT01237535|Hormones|hormones|mesh-ancestor
110841783|NCT01237535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110841784|NCT01237535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110841785|NCT04396639|Factor VIII|factor viii|mesh-list
110841786|NCT04396639|Coagulants|coagulants|mesh-ancestor
110841787|NCT01146431|Anesthetics|anesthetics|mesh-list
110841788|NCT01146431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110841789|NCT01146431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110841790|NCT01250249|Vaccines|vaccines|mesh-list
110841791|NCT01250249|BCG Vaccine|bcg vaccine|mesh-list
110841792|NCT01250249|Immunologic Factors|immunologic factors|mesh-ancestor
110841793|NCT01250249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110841794|NCT01250249|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110841795|NCT03747679|Mannitol|mannitol|mesh-list
110841796|NCT03747679|Sorbitol|sorbitol|mesh-list
110841797|NCT03747679|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110841798|NCT03747679|Diuretics|diuretics|mesh-ancestor
110841799|NCT03747679|Natriuretic Agents|natriuretic agents|mesh-ancestor
110841800|NCT03747679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110841801|NCT03747679|Cathartics|cathartics|mesh-ancestor
110841802|NCT03747679|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110841803|NCT01243385|Metformin|metformin|mesh-list
110841804|NCT01243385|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110831036|NCT01110473|Azacitidine|azacitidine|mesh-list
110841805|NCT01243385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110841806|NCT01147133|Clopidogrel|clopidogrel|mesh-list
110841807|NCT01147133|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110841808|NCT01147133|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110841809|NCT01147133|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110841810|NCT01147133|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110841811|NCT01147133|Purinergic Agents|purinergic agents|mesh-ancestor
110841812|NCT01147133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110592340|NCT02557581|Clenbuterol|clenbuterol|mesh-list
110841813|NCT01147133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110592411|NCT02582372|Bupivacaine|bupivacaine|mesh-list
110841814|NCT01147133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110841815|NCT02162420|Cyclophosphamide|cyclophosphamide|mesh-list
110841816|NCT02162420|Fludarabine|fludarabine|mesh-list
110841817|NCT02162420|Alemtuzumab|alemtuzumab|mesh-list
110841818|NCT02162420|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110841819|NCT02162420|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110841820|NCT02162420|Immunologic Factors|immunologic factors|mesh-ancestor
110841821|NCT02162420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110841822|NCT02162420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110841823|NCT02162420|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110841824|NCT02162420|Alkylating Agents|alkylating agents|mesh-ancestor
110841825|NCT02162420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110841827|NCT02162420|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110841828|NCT02162420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110841829|NCT04167085|Doxycycline|doxycycline|mesh-list
110841830|NCT04167085|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110334780|NCT00493415|Nitroglycerin|nitroglycerin|mesh-list
110841831|NCT04167085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110841832|NCT04167085|Antimalarials|antimalarials|mesh-ancestor
110841833|NCT04167085|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110841834|NCT04167085|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110841835|NCT01147289|Meloxicam|meloxicam|mesh-list
110841836|NCT01147289|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110841837|NCT01147289|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110841838|NCT01147289|Analgesics|analgesics|mesh-ancestor
110841839|NCT01147289|Sensory System Agents|sensory system agents|mesh-ancestor
110841840|NCT01147289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110841841|NCT01147289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110841842|NCT01147289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110841843|NCT01147289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110841844|NCT01147289|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110841845|NCT01147289|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110841846|NCT01147289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110841847|NCT01147289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110841849|NCT01237769|Ergocalciferols|ergocalciferols|mesh-list
110841850|NCT01237769|Cholecalciferol|cholecalciferol|mesh-list
110841851|NCT01237769|Vitamins|vitamins|mesh-list
110841852|NCT01237769|Micronutrients|micronutrients|mesh-ancestor
110559453|NCT01018225|Darifenacin|darifenacin|mesh-list
110841853|NCT01237769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110841854|NCT01237769|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110841855|NCT01237769|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110841856|NCT03914963|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
110841857|NCT03914963|Hemostatics|hemostatics|mesh-ancestor
110841858|NCT03914963|Coagulants|coagulants|mesh-ancestor
110841859|NCT04162795|Loratadine|loratadine|mesh-list
110841860|NCT04162795|Antipruritics|antipruritics|mesh-ancestor
110841861|NCT04162795|Dermatologic Agents|dermatologic agents|mesh-ancestor
110841862|NCT04162795|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110841863|NCT04162795|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110841864|NCT04162795|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110841865|NCT04162795|Histamine Antagonists|histamine antagonists|mesh-ancestor
110841866|NCT04162795|Histamine Agents|histamine agents|mesh-ancestor
110841867|NCT04162795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110841868|NCT04162795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110841869|NCT04162795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110841870|NCT01250951|Deferasirox|deferasirox|mesh-list
110841871|NCT01250951|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110841872|NCT01250951|Chelating Agents|chelating agents|mesh-ancestor
110841873|NCT01250951|Sequestering Agents|sequestering agents|mesh-ancestor
110841874|NCT01250951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110841875|NCT03069482|Nicotine|nicotine|mesh-list
110841876|NCT03069482|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110841877|NCT03069482|Autonomic Agents|autonomic agents|mesh-ancestor
110841878|NCT03069482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110841879|NCT03069482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110841880|NCT03069482|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110593037|NCT03410654|Tacrolimus|tacrolimus|mesh-list
110841881|NCT03069482|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110841882|NCT03069482|Cholinergic Agents|cholinergic agents|mesh-ancestor
110841883|NCT03069482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110841884|NCT03069482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110841885|NCT01250405|Cinacalcet|cinacalcet|mesh-list
110841886|NCT01250405|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110841887|NCT01250405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110841888|NCT01250405|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
110841889|NCT01250405|Hormone Antagonists|hormone antagonists|mesh-ancestor
110841890|NCT01250405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110841891|NCT05083910|Misoprostol|misoprostol|mesh-list
110841892|NCT05083910|Oxytocin|oxytocin|mesh-list
110841893|NCT05083910|Carbetocin|carbetocin|mesh-list
110841894|NCT05083910|Oxytocics|oxytocics|mesh-ancestor
110841895|NCT05083910|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110334799|NCT01244204|Vitamin D|vitamin d|mesh-list
110841896|NCT05083910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110841897|NCT05083910|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110841898|NCT05083910|Abortifacient Agents|abortifacient agents|mesh-ancestor
110841899|NCT05083910|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110841900|NCT05083910|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110841901|NCT01250561|Valacyclovir|valacyclovir|mesh-list
110841902|NCT01250561|Gabapentin|gabapentin|mesh-list
110841903|NCT01250561|Analgesics|analgesics|mesh-ancestor
110841904|NCT01250561|Sensory System Agents|sensory system agents|mesh-ancestor
110841905|NCT01250561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110841906|NCT01250561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110841907|NCT01250561|Anticonvulsants|anticonvulsants|mesh-ancestor
110841908|NCT01250561|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110841909|NCT01250561|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110841910|NCT01250561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110841911|NCT01250561|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110841912|NCT01250561|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110841913|NCT01250561|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110841914|NCT01250561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110841915|NCT01250561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110841916|NCT01250561|Antimanic Agents|antimanic agents|mesh-ancestor
110841917|NCT01250561|Antiviral Agents|antiviral agents|mesh-ancestor
110841918|NCT01250561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110841919|NCT05055908|Atezolizumab|atezolizumab|mesh-list
110841920|NCT05055908|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110841921|NCT05055908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110841922|NCT05055908|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110841923|NCT05055908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110841924|NCT01147523|Vitamin E|vitamin e|mesh-list
110841925|NCT01147523|Spironolactone|spironolactone|mesh-list
110841926|NCT01147523|Vitamins|vitamins|mesh-ancestor
110841927|NCT01147523|Micronutrients|micronutrients|mesh-ancestor
110841928|NCT01147523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110841929|NCT01147523|Antioxidants|antioxidants|mesh-ancestor
110841930|NCT01147523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110841931|NCT01147523|Protective Agents|protective agents|mesh-ancestor
110841932|NCT01147523|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110841933|NCT01147523|Hormone Antagonists|hormone antagonists|mesh-ancestor
110841934|NCT01147523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110841935|NCT01147523|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110841937|NCT01147523|Natriuretic Agents|natriuretic agents|mesh-ancestor
110841938|NCT01251029|Acetylcysteine|acetylcysteine|mesh-list
110841939|NCT01251029|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110841940|NCT01251029|Antiviral Agents|antiviral agents|mesh-ancestor
110841941|NCT01251029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110841942|NCT01251029|Expectorants|expectorants|mesh-ancestor
110074916|NCT01595594|Doxycycline|doxycycline|mesh-list
110841943|NCT01251029|Respiratory System Agents|respiratory system agents|mesh-ancestor
110841944|NCT01251029|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110841945|NCT01251029|Antioxidants|antioxidants|mesh-ancestor
110841946|NCT01251029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110841947|NCT01251029|Protective Agents|protective agents|mesh-ancestor
110841948|NCT01251029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110841949|NCT01251029|Antidotes|antidotes|mesh-ancestor
110841951|NCT01251107|Cyclophosphamide|cyclophosphamide|mesh-list
110841952|NCT01251107|Dacarbazine|dacarbazine|mesh-list
110841953|NCT01251107|Doxorubicin|doxorubicin|mesh-list
110841954|NCT01251107|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110841956|NCT01251107|Etoposide phosphate|etoposide phosphate|mesh-list
110841957|NCT01251107|Vincristine|vincristine|mesh-list
110841958|NCT01251107|Bleomycin|bleomycin|mesh-list
110841959|NCT01251107|Vinblastine|vinblastine|mesh-list
110841960|NCT01251107|Procarbazine|procarbazine|mesh-list
110841961|NCT01251107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110841962|NCT01251107|Immunologic Factors|immunologic factors|mesh-ancestor
110841963|NCT01251107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110841964|NCT01251107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110841965|NCT01251107|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110841966|NCT01251107|Alkylating Agents|alkylating agents|mesh-ancestor
110841967|NCT01251107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110841968|NCT01251107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110841969|NCT01251107|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110841970|NCT01251107|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110841971|NCT01251107|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110841972|NCT01251107|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110841973|NCT01251107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110841974|NCT01251107|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110841975|NCT01251107|Glucocorticoids|glucocorticoids|mesh-ancestor
110841977|NCT01251107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110841978|NCT01251107|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110594055|NCT00783081|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110841979|NCT01251107|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110841980|NCT01251107|Tubulin Modulators|tubulin modulators|mesh-ancestor
110841981|NCT01251107|Antimitotic Agents|antimitotic agents|mesh-ancestor
110841982|NCT01251107|Mitosis Modulators|mitosis modulators|mesh-ancestor
110841983|NCT01125176|Thalidomide|thalidomide|mesh-list
110841984|NCT01125176|Rituximab|rituximab|mesh-list
110841985|NCT01125176|Lenalidomide|lenalidomide|mesh-list
110841986|NCT01125176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110841987|NCT01125176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110594133|NCT00791739|Serotonin Agents|serotonin agents|mesh-ancestor
110841988|NCT01125176|Immunologic Factors|immunologic factors|mesh-ancestor
110841989|NCT01125176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110841990|NCT01125176|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110841991|NCT01125176|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110841992|NCT01125176|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110841993|NCT01125176|Growth Substances|growth substances|mesh-ancestor
110841994|NCT01125176|Growth Inhibitors|growth inhibitors|mesh-ancestor
110841995|NCT01125176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110841996|NCT01125176|Leprostatic Agents|leprostatic agents|mesh-ancestor
110841997|NCT01125176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110841998|NCT01125176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110841999|NCT00882050|Exenatide|exenatide|mesh-list
110842000|NCT00882050|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110842001|NCT00882050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110842002|NCT00882050|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110842003|NCT00882050|Incretins|incretins|mesh-ancestor
110559615|NCT01012141|Docetaxel|docetaxel|mesh-list
110842004|NCT00882050|Hormones|hormones|mesh-ancestor
110870379|NCT02394418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110842005|NCT00882050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110842006|NCT03912857|Apatinib|apatinib|mesh-list
110842007|NCT03912857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110842008|NCT03912857|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110842009|NCT03912857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110842010|NCT03912857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110842011|NCT04892420|Dexamethasone|dexamethasone|mesh-list
110842012|NCT04892420|Magnesium Sulfate|magnesium sulfate|mesh-list
110842013|NCT04892420|Dexmedetomidine|dexmedetomidine|mesh-list
110842014|NCT04892420|Bupivacaine|bupivacaine|mesh-list
110842015|NCT04892420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110842016|NCT04892420|Antiemetics|antiemetics|mesh-ancestor
110842017|NCT04892420|Autonomic Agents|autonomic agents|mesh-ancestor
110594390|NCT00788931|Trastuzumab|trastuzumab|mesh-list
110842018|NCT04892420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110842019|NCT04892420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110842020|NCT04892420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110842021|NCT04892420|Glucocorticoids|glucocorticoids|mesh-ancestor
110842022|NCT04892420|Hormones|hormones|mesh-ancestor
110842023|NCT04892420|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110842024|NCT04892420|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110842025|NCT04892420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110842026|NCT04892420|Anesthetics, Local|anesthetics, local|mesh-ancestor
110842027|NCT04892420|Anesthetics|anesthetics|mesh-ancestor
110842028|NCT04892420|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110842029|NCT04892420|Sensory System Agents|sensory system agents|mesh-ancestor
110842030|NCT04892420|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110842031|NCT04892420|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110842032|NCT04892420|Analgesics|analgesics|mesh-ancestor
110842033|NCT04892420|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110842034|NCT04892420|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110842035|NCT04892420|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110842036|NCT04892420|Adrenergic Agents|adrenergic agents|mesh-ancestor
110842037|NCT04892420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110842038|NCT04892420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110842039|NCT04892420|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110842040|NCT04892420|Anticonvulsants|anticonvulsants|mesh-ancestor
110842041|NCT04892420|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110842042|NCT04892420|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110842043|NCT04892420|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110842044|NCT04892420|Tocolytic Agents|tocolytic agents|mesh-ancestor
110594735|NCT00660699|Antimetabolites|antimetabolites|mesh-ancestor
110842046|NCT01251263|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110842047|NCT01251263|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110842048|NCT01251263|Estradiol|estradiol|mesh-list
110842049|NCT01251263|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110842050|NCT01251263|Estrogens|estrogens|mesh-ancestor
110842051|NCT01251263|Hormones|hormones|mesh-ancestor
110842052|NCT01251263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110842053|NCT01251263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110842054|NCT01251263|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110842055|NCT01251263|Contraceptive Agents|contraceptive agents|mesh-ancestor
110842056|NCT01251263|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110842057|NCT01251263|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110842059|NCT04707534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110842060|NCT04707534|Antiemetics|antiemetics|mesh-ancestor
110842061|NCT04707534|Autonomic Agents|autonomic agents|mesh-ancestor
110842062|NCT04707534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110842063|NCT04707534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110842064|NCT04707534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110842065|NCT04707534|Glucocorticoids|glucocorticoids|mesh-ancestor
110842066|NCT04707534|Hormones|hormones|mesh-ancestor
110842067|NCT04707534|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110842068|NCT04707534|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110842069|NCT04707534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110842070|NCT05761730|Dexamethasone|dexamethasone|mesh-list
110842071|NCT05761730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110842072|NCT05761730|Antiemetics|antiemetics|mesh-ancestor
110842073|NCT05761730|Autonomic Agents|autonomic agents|mesh-ancestor
110842074|NCT05761730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110842075|NCT05761730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110831066|NCT03940391|Anesthetics|anesthetics|mesh-ancestor
110842076|NCT05761730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110842077|NCT05761730|Glucocorticoids|glucocorticoids|mesh-ancestor
110842078|NCT05761730|Hormones|hormones|mesh-ancestor
110842079|NCT05761730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110842080|NCT05761730|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110595159|NCT00772031|Topiramate|topiramate|mesh-list
110842082|NCT04353817|Ivacaftor|ivacaftor|mesh-list
110842083|NCT04353817|Elexacaftor|elexacaftor|mesh-list
110842084|NCT04353817|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
110842085|NCT04353817|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110842086|NCT04353817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110842087|NCT00159588|Angiotensin II|angiotensin ii|mesh-list
110842088|NCT00159588|Gabapentin|gabapentin|mesh-list
110842089|NCT00159588|Valproic Acid|valproic acid|mesh-list
110842090|NCT00159588|Antidepressive Agents|antidepressive agents|mesh-list
110842091|NCT00159588|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-list
110842092|NCT00159588|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
110842093|NCT00159588|Analgesics|analgesics|mesh-ancestor
110842094|NCT00159588|Sensory System Agents|sensory system agents|mesh-ancestor
110595288|NCT00805701|Dutasteride|dutasteride|mesh-list
110842096|NCT00159588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110842097|NCT00159588|Anticonvulsants|anticonvulsants|mesh-ancestor
110842098|NCT00159588|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110842099|NCT00159588|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110842100|NCT00159588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110842101|NCT00159588|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110842102|NCT00159588|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110842103|NCT00159588|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110842104|NCT00159588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110842105|NCT00159588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110842106|NCT00159588|Antimanic Agents|antimanic agents|mesh-ancestor
110842107|NCT00159588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110842108|NCT00159588|GABA Agents|gaba agents|mesh-ancestor
110842109|NCT00159588|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110842110|NCT00159588|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110842111|NCT00159588|Adrenergic Agents|adrenergic agents|mesh-ancestor
110842112|NCT04166942|Belumosudil|belumosudil|mesh-list
110842113|NCT04166942|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110842114|NCT04166942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110842115|NCT04166942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110842134|NCT04349917|Dopamine Agents|dopamine agents|mesh-ancestor
110842135|NCT04349917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110842136|NCT03903029|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110842137|NCT03903029|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110842138|NCT03903029|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110842139|NCT03903029|Antimetabolites|antimetabolites|mesh-ancestor
110842140|NCT03903029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110842141|NCT03903029|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110842142|NCT03903029|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110842143|NCT03903029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110842144|NCT04691856|Acetaminophen|acetaminophen|mesh-list
110842145|NCT04691856|Ibuprofen|ibuprofen|mesh-list
110842146|NCT04691856|Morphine|morphine|mesh-list
110842147|NCT04691856|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110842148|NCT04691856|Narcotics|narcotics|mesh-ancestor
110842149|NCT04691856|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110842150|NCT04691856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110842152|NCT04691856|Sensory System Agents|sensory system agents|mesh-ancestor
110842153|NCT04691856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110842154|NCT04691856|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110842155|NCT04691856|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110842156|NCT04691856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110842157|NCT04691856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110842158|NCT04691856|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110842159|NCT04691856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110334846|NCT00496184|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110842160|NCT04691856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110842162|NCT01254929|Frovatriptan|frovatriptan|mesh-list
110842163|NCT01254929|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110842164|NCT01254929|Serotonin Agents|serotonin agents|mesh-ancestor
110842165|NCT01254929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110842166|NCT01254929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110842167|NCT01254929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110842169|NCT03300570|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
110842170|NCT03300570|Enzyme Activators|enzyme activators|mesh-ancestor
110842171|NCT03300570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110842172|NCT03300570|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110842173|NCT03853694|Morphine|morphine|mesh-list
110842174|NCT03853694|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110842175|NCT03853694|Narcotics|narcotics|mesh-ancestor
110842176|NCT03853694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110842177|NCT03853694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110842178|NCT03853694|Analgesics|analgesics|mesh-ancestor
110842179|NCT03853694|Sensory System Agents|sensory system agents|mesh-ancestor
110842180|NCT03853694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110842181|NCT04154293|Isotretinoin|isotretinoin|mesh-list
110842182|NCT04154293|Dermatologic Agents|dermatologic agents|mesh-ancestor
110842183|NCT01148147|Adenosine|adenosine|mesh-list
110842184|NCT01148147|Analgesics|analgesics|mesh-ancestor
110842185|NCT01148147|Sensory System Agents|sensory system agents|mesh-ancestor
110842186|NCT01148147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110842187|NCT01148147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110842188|NCT01148147|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110842189|NCT01148147|Vasodilator Agents|vasodilator agents|mesh-ancestor
110842190|NCT01148147|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
110842191|NCT01148147|Purinergic Agonists|purinergic agonists|mesh-ancestor
110842192|NCT01148147|Purinergic Agents|purinergic agents|mesh-ancestor
110842193|NCT01148147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110842194|NCT01148147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110842195|NCT03902249|Dexamethasone|dexamethasone|mesh-list
110842196|NCT03902249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110842197|NCT03902249|Antiemetics|antiemetics|mesh-ancestor
110842198|NCT03902249|Autonomic Agents|autonomic agents|mesh-ancestor
110842199|NCT03902249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110842200|NCT03902249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110842201|NCT03902249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110842202|NCT03902249|Glucocorticoids|glucocorticoids|mesh-ancestor
110842203|NCT03902249|Hormones|hormones|mesh-ancestor
110842204|NCT03902249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110842205|NCT03902249|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110842206|NCT03902249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110842207|NCT03908489|Allyl sulfide|allyl sulfide|mesh-list
110842208|NCT03908489|Antioxidants|antioxidants|mesh-ancestor
110842209|NCT03908489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110842210|NCT03908489|Protective Agents|protective agents|mesh-ancestor
110842211|NCT03908489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110595624|NCT00806169|Triamcinolone|triamcinolone|mesh-list
110842212|NCT03908489|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110842213|NCT03908489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110842214|NCT03908489|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110842215|NCT03908489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110842216|NCT04342897|Zansecimab|zansecimab|mesh-list
110842217|NCT04342897|Antiviral Agents|antiviral agents|mesh-ancestor
110842218|NCT04342897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110842219|NCT03263767|Cyclophosphamide|cyclophosphamide|mesh-list
110842220|NCT03263767|Fludarabine|fludarabine|mesh-list
110842221|NCT03263767|Clofarabine|clofarabine|mesh-list
110842222|NCT03263767|Thymoglobulin|thymoglobulin|mesh-list
110842223|NCT03263767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110842224|NCT03263767|Immunologic Factors|immunologic factors|mesh-ancestor
110842225|NCT03263767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110842226|NCT03263767|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110842227|NCT03263767|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110842228|NCT03263767|Alkylating Agents|alkylating agents|mesh-ancestor
110842229|NCT03263767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110842231|NCT03263767|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110842232|NCT03263767|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110842233|NCT03263767|Antimetabolites|antimetabolites|mesh-ancestor
110842234|NCT04603742|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
110842235|NCT04603742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110842236|NCT03908333|Ascorbic Acid|ascorbic acid|mesh-list
110842237|NCT03908333|Paclitaxel|paclitaxel|mesh-list
110842238|NCT03908333|Gemcitabine|gemcitabine|mesh-list
110842239|NCT03908333|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110842240|NCT03908333|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110842241|NCT03908333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110842242|NCT03908333|Tubulin Modulators|tubulin modulators|mesh-ancestor
110842243|NCT03908333|Antimitotic Agents|antimitotic agents|mesh-ancestor
110842244|NCT03908333|Mitosis Modulators|mitosis modulators|mesh-ancestor
110842245|NCT03908333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110842246|NCT03908333|Vitamins|vitamins|mesh-ancestor
110842247|NCT03908333|Micronutrients|micronutrients|mesh-ancestor
110842248|NCT03908333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110842249|NCT03908333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110842250|NCT03908333|Antimetabolites|antimetabolites|mesh-ancestor
110842251|NCT03908333|Antioxidants|antioxidants|mesh-ancestor
110842252|NCT03908333|Protective Agents|protective agents|mesh-ancestor
110842253|NCT04340557|Losartan|losartan|mesh-list
110842254|NCT04340557|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110842255|NCT04340557|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110842256|NCT04340557|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110842257|NCT04340557|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110842258|NCT04340557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110842259|NCT04549376|Iodine|iodine|mesh-list
110842260|NCT04549376|Cadexomer iodine|cadexomer iodine|mesh-list
110842261|NCT04549376|Povidone-Iodine|povidone-iodine|mesh-list
110842262|NCT04549376|Povidone|povidone|mesh-list
110842263|NCT04549376|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110842264|NCT04549376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110842265|NCT04549376|Trace Elements|trace elements|mesh-ancestor
110842266|NCT04549376|Micronutrients|micronutrients|mesh-ancestor
110842267|NCT04549376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110842268|NCT04549376|Plasma Substitutes|plasma substitutes|mesh-ancestor
110842269|NCT04549376|Blood Substitutes|blood substitutes|mesh-ancestor
110842270|NCT01149395|Dexlansoprazole|dexlansoprazole|mesh-list
110842271|NCT01149395|Lansoprazole|lansoprazole|mesh-list
110842272|NCT01149395|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110842273|NCT01149395|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110842274|NCT01149395|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110842275|NCT01149395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110842276|NCT01149395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110842277|NCT02527733|Ranibizumab|ranibizumab|mesh-list
110842278|NCT02527733|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110842279|NCT02527733|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110842281|NCT02527733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110842282|NCT02527733|Growth Inhibitors|growth inhibitors|mesh-ancestor
110842283|NCT02527733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110842284|NCT04135495|Ivacaftor|ivacaftor|mesh-list
110842285|NCT04135495|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
110842286|NCT04135495|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110842287|NCT04135495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110842288|NCT01148303|Etoricoxib|etoricoxib|mesh-list
110842289|NCT01148303|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110842290|NCT01148303|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110842291|NCT01148303|Analgesics|analgesics|mesh-ancestor
110842292|NCT01148303|Sensory System Agents|sensory system agents|mesh-ancestor
110842293|NCT01148303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110842294|NCT01148303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110842295|NCT01148303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110842296|NCT01148303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110842297|NCT01148303|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110596211|NCT02576808|Loratadine|loratadine|mesh-list
110842298|NCT01148303|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110842299|NCT01148303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110842300|NCT01148303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110842301|NCT03066830|Metformin|metformin|mesh-list
110842302|NCT03066830|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
110842303|NCT03066830|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110842304|NCT03066830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110842305|NCT03066830|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110842306|NCT03066830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110842307|NCT05205200|Paclitaxel|paclitaxel|mesh-list
110842308|NCT05205200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110842309|NCT05205200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110842310|NCT05205200|Tubulin Modulators|tubulin modulators|mesh-ancestor
110842311|NCT05205200|Antimitotic Agents|antimitotic agents|mesh-ancestor
110842312|NCT05205200|Mitosis Modulators|mitosis modulators|mesh-ancestor
110596343|NCT00709488|Talaporfin|talaporfin|mesh-list
110842313|NCT05205200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110842315|NCT01149629|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110842316|NCT01149629|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110842317|NCT05205122|Mitomycins|mitomycins|mesh-list
110842318|NCT05205122|Mitomycin|mitomycin|mesh-list
110842319|NCT05205122|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110842320|NCT05205122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110842321|NCT05205122|Alkylating Agents|alkylating agents|mesh-ancestor
110842322|NCT05205122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110842323|NCT05205122|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110842324|NCT05205122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110842325|NCT03907163|Dronabinol|dronabinol|mesh-list
110842326|NCT03907163|Hallucinogens|hallucinogens|mesh-ancestor
110842327|NCT03907163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110842328|NCT03907163|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110842329|NCT03907163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110842330|NCT03907163|Analgesics|analgesics|mesh-ancestor
110842331|NCT03907163|Sensory System Agents|sensory system agents|mesh-ancestor
110596505|NCT00851344|Cetirizine|cetirizine|mesh-list
110842332|NCT03907163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110842333|NCT03907163|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
110842334|NCT03907163|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110842335|NCT03907163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110842336|NCT03907163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110842338|NCT03907163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110842340|NCT01253681|Carboplatin|carboplatin|mesh-list
110842341|NCT01253681|Trebananib|trebananib|mesh-list
110842342|NCT01253681|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110842343|NCT01253681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110842344|NCT01253681|Tubulin Modulators|tubulin modulators|mesh-ancestor
110842345|NCT01253681|Antimitotic Agents|antimitotic agents|mesh-ancestor
110842346|NCT01253681|Mitosis Modulators|mitosis modulators|mesh-ancestor
110842347|NCT01253681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110842348|NCT01253681|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110842349|NCT01253681|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110842350|NCT01253681|Growth Substances|growth substances|mesh-ancestor
110842351|NCT01253681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110842352|NCT01253681|Growth Inhibitors|growth inhibitors|mesh-ancestor
110842353|NCT01149941|Ibuprofen|ibuprofen|mesh-list
110842354|NCT01149941|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110842355|NCT01149941|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110842356|NCT01149941|Analgesics|analgesics|mesh-ancestor
110842357|NCT01149941|Sensory System Agents|sensory system agents|mesh-ancestor
110596548|NCT05810558|Glycine|glycine|mesh-list
110842358|NCT01149941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110842359|NCT01149941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110842360|NCT01149941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110842361|NCT01149941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110842362|NCT01149941|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110842363|NCT01149941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110842364|NCT01149941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110842365|NCT01589549|Methylprednisolone|methylprednisolone|mesh-list
110842366|NCT01589549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110842367|NCT01589549|Antiemetics|antiemetics|mesh-ancestor
110842368|NCT01589549|Autonomic Agents|autonomic agents|mesh-ancestor
110842369|NCT01589549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110596666|NCT05737576|Insulin Aspart|insulin aspart|mesh-list
110842370|NCT01589549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110842371|NCT01589549|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110842372|NCT01589549|Glucocorticoids|glucocorticoids|mesh-ancestor
110842373|NCT01589549|Hormones|hormones|mesh-ancestor
110842374|NCT01589549|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110842375|NCT01589549|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110842376|NCT01589549|Protective Agents|protective agents|mesh-ancestor
110842377|NCT03899675|Caffeine|caffeine|mesh-list
110842378|NCT03899675|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110842379|NCT03899675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110596807|NCT05532215|Misoprostol|misoprostol|mesh-list
110842380|NCT03899675|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110842381|NCT03899675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110842382|NCT03899675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110596879|NCT05366764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110842383|NCT03899675|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110842384|NCT03899675|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110842385|NCT03899675|Purinergic Agents|purinergic agents|mesh-ancestor
110842386|NCT03899675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110842387|NCT01562197|Axitinib|axitinib|mesh-list
110842388|NCT01562197|Lomustine|lomustine|mesh-list
110842389|NCT01562197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110842390|NCT01562197|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110842391|NCT01562197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110842392|NCT01562197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110842393|NCT01562197|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110842394|NCT01562197|Alkylating Agents|alkylating agents|mesh-ancestor
110597153|NCT04586348|Iodine|iodine|mesh-list
110842396|NCT03905837|Piperidine|piperidine|mesh-list
110842397|NCT03905837|Remifentanil|remifentanil|mesh-list
110842398|NCT03905837|Anesthetics, Local|anesthetics, local|mesh-ancestor
110842399|NCT03905837|Anesthetics|anesthetics|mesh-ancestor
110842400|NCT03905837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110842401|NCT03905837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110842402|NCT03905837|Sensory System Agents|sensory system agents|mesh-ancestor
110842403|NCT03905837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110842404|NCT03905837|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110842405|NCT03905837|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110842406|NCT03905837|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110842407|NCT03905837|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110842408|NCT03905837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110842409|NCT03905837|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110842410|NCT03905837|Narcotics|narcotics|mesh-ancestor
110842411|NCT03905837|Analgesics|analgesics|mesh-ancestor
110842412|NCT03905837|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110842413|NCT03905837|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110842414|NCT03063632|Interferons|interferons|mesh-list
110842415|NCT03063632|Interferon-gamma|interferon-gamma|mesh-list
110842416|NCT03063632|Pembrolizumab|pembrolizumab|mesh-list
110842417|NCT03063632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110842418|NCT03063632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110842419|NCT03063632|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110842420|NCT03063632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110842421|NCT03063632|Antiviral Agents|antiviral agents|mesh-ancestor
110842422|NCT03063632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110842423|NCT04328467|Hydroxychloroquine|hydroxychloroquine|mesh-list
110842424|NCT04328467|Antimalarials|antimalarials|mesh-ancestor
110842425|NCT04328467|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110842426|NCT04328467|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110842427|NCT04328467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110842428|NCT04328467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110842429|NCT04328467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110842430|NCT04328467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110842431|NCT01148615|Docetaxel|docetaxel|mesh-list
110842432|NCT01148615|Aflibercept|aflibercept|mesh-list
110842433|NCT01148615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110842434|NCT01148615|Tubulin Modulators|tubulin modulators|mesh-ancestor
110842435|NCT01148615|Antimitotic Agents|antimitotic agents|mesh-ancestor
110842436|NCT01148615|Mitosis Modulators|mitosis modulators|mesh-ancestor
110597219|NCT04489771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110842437|NCT01148615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110842438|NCT01148615|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110842439|NCT01148615|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110842440|NCT01148615|Growth Substances|growth substances|mesh-ancestor
110842441|NCT01148615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110842442|NCT01148615|Growth Inhibitors|growth inhibitors|mesh-ancestor
110842444|NCT03905759|Amiodarone|amiodarone|mesh-list
110842445|NCT03905759|Dronedarone|dronedarone|mesh-list
110842446|NCT03905759|Gout Suppressants|gout suppressants|mesh-ancestor
110842447|NCT03905759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110842448|NCT03905759|Tubulin Modulators|tubulin modulators|mesh-ancestor
110842449|NCT03905759|Antimitotic Agents|antimitotic agents|mesh-ancestor
110842450|NCT03905759|Mitosis Modulators|mitosis modulators|mesh-ancestor
110842451|NCT03905759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110842452|NCT03905759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110842454|NCT03905759|Vasodilator Agents|vasodilator agents|mesh-ancestor
110842455|NCT03905759|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
110842456|NCT03905759|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110842457|NCT03905759|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110842458|NCT03905759|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110842459|NCT03905759|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110842460|NCT03905759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110842461|NCT03905759|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110842462|NCT03905759|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110842463|NCT03905759|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110842464|NCT01255475|Amlodipine|amlodipine|mesh-list
110842465|NCT01255475|Hydralazine|hydralazine|mesh-list
110842466|NCT01255475|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110842467|NCT01255475|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110831138|NCT03846271|Oxytocin|oxytocin|mesh-list
110842468|NCT01255475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110842469|NCT01255475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110842470|NCT01255475|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110842471|NCT01255475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110842472|NCT01255475|Vasodilator Agents|vasodilator agents|mesh-ancestor
110842475|NCT05208398|Anticoagulants|anticoagulants|mesh-ancestor
110842476|NCT05208398|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110842477|NCT05208398|Antithrombins|antithrombins|mesh-ancestor
110842478|NCT05208398|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110842479|NCT05208398|Protease Inhibitors|protease inhibitors|mesh-ancestor
110842480|NCT05208398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110842481|NCT05208398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110842482|NCT05593601|Neomycin|neomycin|mesh-list
110842483|NCT05593601|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110842484|NCT05593601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110842485|NCT05593601|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110842486|NCT05593601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110597390|NCT04177758|Vitamins|vitamins|mesh-ancestor
110842487|NCT05593601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110842488|NCT03629210|Dexamethasone|dexamethasone|mesh-list
110842489|NCT03629210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110842490|NCT03629210|Antiemetics|antiemetics|mesh-ancestor
110842491|NCT03629210|Autonomic Agents|autonomic agents|mesh-ancestor
110842492|NCT03629210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110842493|NCT03629210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110842494|NCT03629210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110842495|NCT03629210|Glucocorticoids|glucocorticoids|mesh-ancestor
110842496|NCT03629210|Hormones|hormones|mesh-ancestor
110842497|NCT03629210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110842498|NCT03629210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110842499|NCT03629210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110842500|NCT03899285|Citalopram|citalopram|mesh-list
110842501|NCT03899285|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110842502|NCT03899285|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110842503|NCT03899285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110842504|NCT03899285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110842505|NCT03899285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110842506|NCT03899285|Serotonin Agents|serotonin agents|mesh-ancestor
110842507|NCT03899285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110842508|NCT03899285|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110842509|NCT03899285|Antidepressive Agents|antidepressive agents|mesh-ancestor
110842510|NCT03899285|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110842511|NCT01254071|Tamsulosin|tamsulosin|mesh-list
110842512|NCT01254071|Dutasteride|dutasteride|mesh-list
110842513|NCT01254071|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110842514|NCT01254071|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110842515|NCT01254071|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110842517|NCT01254071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110842518|NCT01254071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110842519|NCT01254071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110842520|NCT01254071|Urological Agents|urological agents|mesh-ancestor
110842521|NCT01254071|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
110842522|NCT01254071|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110842523|NCT01254071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110842524|NCT01254071|Hormone Antagonists|hormone antagonists|mesh-ancestor
110842525|NCT01254071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110842526|NCT05761418|Misoprostol|misoprostol|mesh-list
110842527|NCT05761418|Dinoprostone|dinoprostone|mesh-list
110842528|NCT05761418|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110842529|NCT05761418|Abortifacient Agents|abortifacient agents|mesh-ancestor
110842530|NCT05761418|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110842531|NCT05761418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110842532|NCT05761418|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110842533|NCT05761418|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110842534|NCT05761418|Oxytocics|oxytocics|mesh-ancestor
110842535|NCT05207774|Oxytocin|oxytocin|mesh-list
110842536|NCT05207774|Oxytocics|oxytocics|mesh-ancestor
110842537|NCT05207774|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110831142|NCT01110941|Leucovorin|leucovorin|mesh-list
110842538|NCT05207774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110842539|NCT02528123|Tobramycin|tobramycin|mesh-list
110842540|NCT02528123|Ofloxacin|ofloxacin|mesh-list
110842541|NCT02528123|Dexamethasone|dexamethasone|mesh-list
110842542|NCT02528123|Benoxinate|benoxinate|mesh-list
110842543|NCT02528123|Proxymetacaine|proxymetacaine|mesh-list
110842544|NCT02528123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110842545|NCT02528123|Antiemetics|antiemetics|mesh-ancestor
110842546|NCT02528123|Autonomic Agents|autonomic agents|mesh-ancestor
110842547|NCT02528123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110597551|NCT03642990|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110842549|NCT02528123|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110842550|NCT02528123|Glucocorticoids|glucocorticoids|mesh-ancestor
110842551|NCT02528123|Hormones|hormones|mesh-ancestor
110597627|NCT03465540|Dexamethasone|dexamethasone|mesh-list
110842552|NCT02528123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110842553|NCT02528123|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110842554|NCT02528123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110842555|NCT02528123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110842556|NCT02528123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110842557|NCT02528123|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110842558|NCT02528123|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110842559|NCT02528123|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110842560|NCT02528123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110842561|NCT02528123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110842562|NCT02528123|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110842563|NCT02528123|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110842564|NCT02528123|Anesthetics, Local|anesthetics, local|mesh-ancestor
110842565|NCT02528123|Anesthetics|anesthetics|mesh-ancestor
110842566|NCT02528123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110842567|NCT02528123|Sensory System Agents|sensory system agents|mesh-ancestor
110842568|NCT02527811|Urinastatin|urinastatin|mesh-list
110842569|NCT02527811|Trypsin Inhibitors|trypsin inhibitors|mesh-list
110842570|NCT02527811|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110842571|NCT02527811|Protease Inhibitors|protease inhibitors|mesh-ancestor
110842572|NCT02527811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110842573|NCT02527811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110842574|NCT03691831|Hydrogen Peroxide|hydrogen peroxide|mesh-list
110842575|NCT03691831|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110842576|NCT03691831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110842577|NCT01254383|Sildenafil Citrate|sildenafil citrate|mesh-list
110842578|NCT01254383|Vasodilator Agents|vasodilator agents|mesh-ancestor
110842579|NCT01254383|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110842580|NCT01254383|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110842581|NCT01254383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110842582|NCT01254383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110842583|NCT01254383|Urological Agents|urological agents|mesh-ancestor
110842585|NCT03700970|Anesthetics, Local|anesthetics, local|mesh-ancestor
110842586|NCT03700970|Anesthetics|anesthetics|mesh-ancestor
110842587|NCT03700970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110842588|NCT03700970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110842589|NCT03700970|Sensory System Agents|sensory system agents|mesh-ancestor
110842590|NCT03700970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110842591|NCT01256021|Botulinum Toxins|botulinum toxins|mesh-list
110842592|NCT01256021|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110842593|NCT01256021|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110842594|NCT01256021|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110842595|NCT01256021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110597758|NCT02366494|Luteolytic Agents|luteolytic agents|mesh-ancestor
110842596|NCT01256021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110842598|NCT01256021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110842599|NCT01256021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110842600|NCT01256021|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110842601|NCT01256021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110842602|NCT04320745|Testosterone|testosterone|mesh-list
110842603|NCT04320745|Androgens|androgens|mesh-ancestor
110842605|NCT04320745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110842606|NCT04320745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110842607|NCT01254461|Pravastatin|pravastatin|mesh-list
110842609|NCT01254461|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110842610|NCT01254461|Antimetabolites|antimetabolites|mesh-ancestor
110842611|NCT01254461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110842612|NCT01254461|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110597935|NCT00845338|Darifenacin|darifenacin|mesh-list
110842613|NCT01254461|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110842614|NCT01254461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110842615|NCT03747523|Vitamin D|vitamin d|mesh-list
110842616|NCT03747523|Ergocalciferols|ergocalciferols|mesh-list
110842617|NCT03747523|Vitamins|vitamins|mesh-ancestor
110842618|NCT03747523|Micronutrients|micronutrients|mesh-ancestor
110842619|NCT03747523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110842620|NCT03747523|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110842621|NCT03747523|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110842622|NCT05293171|Moxifloxacin|moxifloxacin|mesh-list
110842623|NCT05293171|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110842624|NCT05293171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110842625|NCT05293171|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110842626|NCT05293171|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110842627|NCT05293171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110842628|NCT05293171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110842629|NCT05293171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110842630|NCT03063086|Fluticasone|fluticasone|mesh-list
110842631|NCT03063086|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110842632|NCT03063086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110598083|NCT00845884|Antimetabolites|antimetabolites|mesh-ancestor
110842633|NCT03063086|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110598142|NCT00712374|Pyrimethamine|pyrimethamine|mesh-list
110842635|NCT03063086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110842636|NCT03063086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110842637|NCT03063086|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110842638|NCT03063086|Respiratory System Agents|respiratory system agents|mesh-ancestor
110842639|NCT03063086|Dermatologic Agents|dermatologic agents|mesh-ancestor
110842640|NCT03063086|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110842641|NCT03063086|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110842642|NCT03063086|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110842643|NCT03063086|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110842644|NCT03063086|Adrenergic Agents|adrenergic agents|mesh-ancestor
110842645|NCT03063086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110842646|NCT03063086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110842647|NCT03904745|Atosiban|atosiban|mesh-list
110598422|NCT02573922|Naloxone|naloxone|mesh-list
110842649|NCT03904745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110842650|NCT03904745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110842651|NCT03904745|Tocolytic Agents|tocolytic agents|mesh-ancestor
110842652|NCT03904745|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110842653|NCT05187338|Pembrolizumab|pembrolizumab|mesh-list
110842654|NCT05187338|Ipilimumab|ipilimumab|mesh-list
110842655|NCT05187338|Durvalumab|durvalumab|mesh-list
110842656|NCT05187338|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110842657|NCT05187338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110842658|NCT05187338|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110598641|NCT00849316|Insulin Aspart|insulin aspart|mesh-list
110842659|NCT05187338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110842661|NCT03898583|Betamethasone|betamethasone|mesh-list
110246033|NCT00475189|Hormones|hormones|mesh-ancestor
110842662|NCT03898583|Betamethasone Valerate|betamethasone valerate|mesh-list
110842663|NCT03898583|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
110842664|NCT03898583|Betamethasone benzoate|betamethasone benzoate|mesh-list
110842665|NCT03898583|Calcipotriene|calcipotriene|mesh-list
110842666|NCT03898583|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
110842667|NCT03898583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110842668|NCT03898583|Glucocorticoids|glucocorticoids|mesh-ancestor
110842669|NCT03898583|Hormones|hormones|mesh-ancestor
110842670|NCT03898583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110842671|NCT03898583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110842672|NCT03898583|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110842673|NCT03898583|Respiratory System Agents|respiratory system agents|mesh-ancestor
110842674|NCT03898583|Dermatologic Agents|dermatologic agents|mesh-ancestor
110842675|NCT03898583|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110842676|NCT03898583|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
110842677|NCT03898583|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110842678|NCT03898583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110842679|NCT03898583|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110842680|NCT03898583|Vitamins|vitamins|mesh-ancestor
110842681|NCT03898583|Micronutrients|micronutrients|mesh-ancestor
110842682|NCT03898583|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110842684|NCT03898193|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110842685|NCT03898193|Respiratory System Agents|respiratory system agents|mesh-ancestor
110842686|NCT03898193|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110842687|NCT03898193|Hormone Antagonists|hormone antagonists|mesh-ancestor
110842688|NCT03898193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110842689|NCT03898193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110842690|NCT03898193|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110842691|NCT03898193|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110842692|NCT03898193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110842693|NCT03321188|Paclitaxel|paclitaxel|mesh-list
110842694|NCT03321188|Carboplatin|carboplatin|mesh-list
110599283|NCT00865384|Mirtazapine|mirtazapine|mesh-list
110842695|NCT03321188|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110842696|NCT03321188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110842697|NCT03321188|Tubulin Modulators|tubulin modulators|mesh-ancestor
110842698|NCT03321188|Antimitotic Agents|antimitotic agents|mesh-ancestor
110842699|NCT03321188|Mitosis Modulators|mitosis modulators|mesh-ancestor
110842700|NCT03321188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110842701|NCT03904355|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
110842702|NCT03904355|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110842703|NCT03904355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110842704|NCT01254617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110842705|NCT01254617|Cetuximab|cetuximab|mesh-list
110842706|NCT01254617|Lenalidomide|lenalidomide|mesh-list
110842707|NCT01254617|Antibodies|antibodies|mesh-list
110842708|NCT01254617|Immunoglobulins|immunoglobulins|mesh-list
110842709|NCT01254617|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110842711|NCT01254617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110842712|NCT01254617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110842713|NCT01254617|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110842714|NCT01254617|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110842715|NCT01254617|Growth Substances|growth substances|mesh-ancestor
110842716|NCT01254617|Growth Inhibitors|growth inhibitors|mesh-ancestor
110842717|NCT01150331|Levetiracetam|levetiracetam|mesh-list
110842718|NCT01150331|Clonazepam|clonazepam|mesh-list
110842719|NCT01150331|Anticonvulsants|anticonvulsants|mesh-list
110842720|NCT01150331|Nootropic Agents|nootropic agents|mesh-ancestor
110842721|NCT01150331|GABA Modulators|gaba modulators|mesh-ancestor
110842722|NCT01150331|GABA Agents|gaba agents|mesh-ancestor
110599555|NCT03491540|Laxatives|laxatives|mesh-ancestor
110842724|NCT01150331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110842725|NCT01150331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110842726|NCT01256489|Infliximab|infliximab|mesh-list
110842727|NCT01256489|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110842728|NCT01256489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110842729|NCT01256489|Dermatologic Agents|dermatologic agents|mesh-ancestor
110842730|NCT01256489|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110842731|NCT01256489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110842732|NCT03746119|Nicotine|nicotine|mesh-list
110842733|NCT03746119|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110842734|NCT03746119|Autonomic Agents|autonomic agents|mesh-ancestor
110842735|NCT03746119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110842736|NCT03746119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110842737|NCT03746119|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110599705|NCT00804921|Bevacizumab|bevacizumab|mesh-list
110842738|NCT03746119|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110842739|NCT03746119|Cholinergic Agents|cholinergic agents|mesh-ancestor
110842740|NCT03746119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110842741|NCT03746119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110842742|NCT01149005|Insulin|insulin|mesh-list
110842743|NCT01149005|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110842744|NCT01149005|Insulin Lispro|insulin lispro|mesh-list
110842745|NCT01149005|Insulin Aspart|insulin aspart|mesh-list
110842746|NCT01149005|Insulin, Short-Acting|insulin, short-acting|mesh-list
110842747|NCT01149005|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110560355|NCT00697892|Lumefantrine|lumefantrine|mesh-list
110842748|NCT01149005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110842749|NCT03903887|Antibodies|antibodies|mesh-list
110842750|NCT03903887|Immunologic Factors|immunologic factors|mesh-ancestor
110842751|NCT03903887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110842752|NCT03903419|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
110842753|NCT03903419|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110842754|NCT03903419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110842755|NCT05122130|Melatonin|melatonin|mesh-list
110842756|NCT05122130|Antioxidants|antioxidants|mesh-ancestor
110842757|NCT05122130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110842758|NCT05122130|Protective Agents|protective agents|mesh-ancestor
110842759|NCT05122130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110842760|NCT05122130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110842762|NCT02898506|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110842763|NCT02898506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110842764|NCT02898506|Incretins|incretins|mesh-ancestor
110842765|NCT02898506|Hormones|hormones|mesh-ancestor
110831210|NCT05258773|Azasetron|azasetron|mesh-list
110842766|NCT02898506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110842767|NCT04123405|Acetylcysteine|acetylcysteine|mesh-list
110842768|NCT04123405|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110842769|NCT04123405|Antiviral Agents|antiviral agents|mesh-ancestor
110842770|NCT04123405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110842771|NCT04123405|Expectorants|expectorants|mesh-ancestor
110842772|NCT04123405|Respiratory System Agents|respiratory system agents|mesh-ancestor
110842773|NCT04123405|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110842774|NCT04123405|Antioxidants|antioxidants|mesh-ancestor
110842775|NCT04123405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110842776|NCT04123405|Protective Agents|protective agents|mesh-ancestor
110842777|NCT04123405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110842778|NCT04123405|Antidotes|antidotes|mesh-ancestor
110842779|NCT02611232|Liraglutide|liraglutide|mesh-list
110842780|NCT02611232|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110842781|NCT02611232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110842782|NCT02611232|Incretins|incretins|mesh-ancestor
110842783|NCT02611232|Hormones|hormones|mesh-ancestor
110842784|NCT02611232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110842785|NCT01150877|Vitamin D|vitamin d|mesh-list
110842786|NCT01150877|Vitamins|vitamins|mesh-ancestor
110842787|NCT01150877|Micronutrients|micronutrients|mesh-ancestor
110334967|NCT02597634|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110842788|NCT01150877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110842789|NCT01150877|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110842790|NCT03893591|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
110842791|NCT03893591|Dalteparin|dalteparin|mesh-list
110600011|NCT02569346|Lamivudine|lamivudine|mesh-list
110842793|NCT03893591|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110842794|NCT03893591|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110842795|NCT03893591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110842796|NCT01256801|Interleukin-2|interleukin-2|mesh-list
110842797|NCT01256801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110842798|NCT01256801|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110842799|NCT01256801|Analgesics|analgesics|mesh-ancestor
110842800|NCT01256801|Sensory System Agents|sensory system agents|mesh-ancestor
110842801|NCT01256801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110842802|NCT01256801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110842803|NCT02519738|Silver Nitrate|silver nitrate|mesh-list
110842804|NCT02519738|Triamcinolone|triamcinolone|mesh-list
110842805|NCT02519738|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110842806|NCT02519738|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110842807|NCT02519738|Glucocorticoids|glucocorticoids|mesh-ancestor
110842809|NCT02519738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110842810|NCT02519738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110842811|NCT02519738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110842812|NCT02519738|Immunologic Factors|immunologic factors|mesh-ancestor
110842813|NCT02519738|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110842814|NCT02519738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110842815|NCT03893747|Vaccines|vaccines|mesh-list
110842816|NCT03893747|Immunologic Factors|immunologic factors|mesh-ancestor
110842817|NCT03893747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110842818|NCT02343224|Interferons|interferons|mesh-list
110842819|NCT02343224|Interferon-alpha|interferon-alpha|mesh-list
110842820|NCT02343224|Interferon alpha-2|interferon alpha-2|mesh-list
110842821|NCT02343224|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110842822|NCT02343224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110842823|NCT02343224|Antiviral Agents|antiviral agents|mesh-ancestor
110842824|NCT02343224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110842825|NCT02343224|Immunologic Factors|immunologic factors|mesh-ancestor
110842826|NCT02343224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110842827|NCT01257035|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
110842828|NCT01257035|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110842829|NCT01257035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110842830|NCT04314037|Praziquantel|praziquantel|mesh-list
110842831|NCT04314037|Anthelmintics|anthelmintics|mesh-ancestor
110842832|NCT04314037|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110842833|NCT04314037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110842834|NCT05737862|Folic Acid|folic acid|mesh-list
110842835|NCT05737862|Hematinics|hematinics|mesh-ancestor
110842836|NCT05737862|Vitamin B Complex|vitamin b complex|mesh-ancestor
110842837|NCT05737862|Vitamins|vitamins|mesh-ancestor
110842838|NCT05737862|Micronutrients|micronutrients|mesh-ancestor
110842839|NCT05737862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110842840|NCT02097680|Letrozole|letrozole|mesh-list
110842841|NCT02097680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110842842|NCT02097680|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110842843|NCT02097680|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110842844|NCT02097680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110842845|NCT02097680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110842846|NCT02097680|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110842847|NCT02097680|Hormone Antagonists|hormone antagonists|mesh-ancestor
110842848|NCT02097680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110842849|NCT02097680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110842850|NCT01150955|Resveratrol|resveratrol|mesh-list
110842851|NCT01150955|Antioxidants|antioxidants|mesh-ancestor
110842852|NCT01150955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110842853|NCT01150955|Protective Agents|protective agents|mesh-ancestor
110842854|NCT01150955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110842855|NCT01150955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110842856|NCT01150955|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110842858|NCT03897413|Calcium Carbonate|calcium carbonate|mesh-list
110842859|NCT03897413|Calcium|calcium|mesh-list
110842860|NCT03897413|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110842861|NCT03897413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110842862|NCT03897413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110842863|NCT03897413|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110842864|NCT01258439|Ritonavir|ritonavir|mesh-list
110842865|NCT01258439|Darunavir|darunavir|mesh-list
110842866|NCT01258439|Tenofovir|tenofovir|mesh-list
110842867|NCT01258439|Emtricitabine|emtricitabine|mesh-list
110842868|NCT01258439|Raltegravir Potassium|raltegravir potassium|mesh-list
110831255|NCT03846583|Aromatase Inhibitors|aromatase inhibitors|mesh-list
110842869|NCT01258439|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110842870|NCT01258439|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110842871|NCT01258439|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110842872|NCT01258439|Protease Inhibitors|protease inhibitors|mesh-ancestor
110842873|NCT01258439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110600307|NCT00799149|Antimanic Agents|antimanic agents|mesh-ancestor
110842874|NCT01258439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110842875|NCT01258439|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110842876|NCT01258439|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110842877|NCT01258439|Antiviral Agents|antiviral agents|mesh-ancestor
110842878|NCT01258439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110842879|NCT01258439|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110842880|NCT01258439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110842881|NCT01258439|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110842882|NCT01258439|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110842883|NCT01258439|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110842884|NCT01258439|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110842885|NCT01850888|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
110842886|NCT01850888|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110842887|NCT01850888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110842888|NCT01850888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110842889|NCT01850888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110842890|NCT01850888|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110842891|NCT01560572|Mycophenolic Acid|mycophenolic acid|mesh-list
110842892|NCT01560572|Prednisolone|prednisolone|mesh-list
110842893|NCT01560572|Tacrolimus|tacrolimus|mesh-list
110842894|NCT01560572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110842895|NCT01560572|Immunologic Factors|immunologic factors|mesh-ancestor
110842896|NCT01560572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110842897|NCT01560572|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110842898|NCT01560572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110842899|NCT01560572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110842900|NCT01560572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110842901|NCT01560572|Glucocorticoids|glucocorticoids|mesh-ancestor
110842902|NCT01560572|Hormones|hormones|mesh-ancestor
110842903|NCT01560572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110842904|NCT01560572|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110842905|NCT01560572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110842906|NCT01560572|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110842907|NCT01560572|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110842908|NCT01560572|Antitubercular Agents|antitubercular agents|mesh-ancestor
110600527|NCT00728546|Isoniazid|isoniazid|mesh-list
110842909|NCT01560572|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110842910|NCT01560572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110842911|NCT05209256|Pemetrexed|pemetrexed|mesh-list
110842912|NCT05209256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110842913|NCT05209256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110842914|NCT05209256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110842915|NCT05209256|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110842916|NCT05209256|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110842917|NCT03896321|Anticoagulants|anticoagulants|mesh-list
110842918|NCT03896321|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
110842919|NCT05211050|Cromakalim|cromakalim|mesh-list
110842920|NCT05211050|Sumatriptan|sumatriptan|mesh-list
110842921|NCT05211050|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110842922|NCT05211050|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110842923|NCT05211050|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110842924|NCT05211050|Serotonin Agents|serotonin agents|mesh-ancestor
110842925|NCT05211050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110842926|NCT05211050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110600567|NCT00868426|Budesonide|budesonide|mesh-list
110842927|NCT05211050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110842928|NCT05211050|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110842929|NCT05211050|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110842930|NCT05211050|Autonomic Agents|autonomic agents|mesh-ancestor
110842931|NCT05211050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110842932|NCT05211050|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110842933|NCT05211050|Respiratory System Agents|respiratory system agents|mesh-ancestor
110842934|NCT05211050|Parasympatholytics|parasympatholytics|mesh-ancestor
110842935|NCT05211050|Vasodilator Agents|vasodilator agents|mesh-ancestor
110842936|NCT03892499|Itraconazole|itraconazole|mesh-list
110842937|NCT03892499|Antifungal Agents|antifungal agents|mesh-ancestor
110842938|NCT03892499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110842939|NCT03892499|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110842940|NCT03892499|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110842941|NCT03892499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110842942|NCT03892499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110842943|NCT03892499|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110842944|NCT03892499|Hormone Antagonists|hormone antagonists|mesh-ancestor
110600689|NCT00869596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110842945|NCT03892499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110842946|NCT03892499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110842947|NCT03892499|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110842948|NCT01152047|Oxytocin|oxytocin|mesh-list
110842949|NCT01152047|Oxytocics|oxytocics|mesh-ancestor
110842950|NCT01152047|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110842951|NCT01152047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110842952|NCT01151267|Anesthetics|anesthetics|mesh-list
110842953|NCT01151267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110842954|NCT01151267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110842955|NCT01259141|Azithromycin|azithromycin|mesh-list
110842956|NCT01259141|Moxifloxacin|moxifloxacin|mesh-list
110842957|NCT01259141|Cephalosporins|cephalosporins|mesh-list
110842958|NCT01259141|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110842959|NCT01259141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110842960|NCT01259141|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110842961|NCT01259141|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110842962|NCT01259141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110600768|NCT00739388|Azacitidine|azacitidine|mesh-list
110842963|NCT01259141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110842964|NCT01259141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110842965|NCT05210192|Lidocaine|lidocaine|mesh-list
110842966|NCT05210192|Anesthetics, Local|anesthetics, local|mesh-ancestor
110842967|NCT05210192|Anesthetics|anesthetics|mesh-ancestor
110842968|NCT05210192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110842969|NCT05210192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110842970|NCT05210192|Sensory System Agents|sensory system agents|mesh-ancestor
110842971|NCT05210192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110842972|NCT05210192|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110842973|NCT05210192|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110842974|NCT05210192|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110842975|NCT05210192|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110601023|NCT00876616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110842976|NCT05210192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110842978|NCT01152203|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110842979|NCT01152203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110842980|NCT01152203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110842981|NCT01152203|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110842982|NCT01152203|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110842983|NCT01152203|Growth Substances|growth substances|mesh-ancestor
110842984|NCT01152203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110842985|NCT01152203|Growth Inhibitors|growth inhibitors|mesh-ancestor
110842986|NCT01152203|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110842987|NCT01152203|Alkylating Agents|alkylating agents|mesh-ancestor
110842988|NCT01152203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110842989|NCT01257815|Ranibizumab|ranibizumab|mesh-list
110842990|NCT01257815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110842991|NCT01257815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110842992|NCT01257815|Growth Substances|growth substances|mesh-ancestor
110842993|NCT01257815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110601251|NCT00735930|Alvocidib|alvocidib|mesh-list
110842994|NCT01257815|Growth Inhibitors|growth inhibitors|mesh-ancestor
110831278|NCT01216007|Propofol|propofol|mesh-list
110842995|NCT01257815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110842997|NCT03892421|Dexamethasone|dexamethasone|mesh-list
110842998|NCT03892421|Rituximab|rituximab|mesh-list
110842999|NCT03892421|Carboplatin|carboplatin|mesh-list
110843000|NCT03892421|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110843001|NCT03892421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110843002|NCT03892421|Immunologic Factors|immunologic factors|mesh-ancestor
110843003|NCT03892421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110843004|NCT03892421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110843005|NCT03892421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110843006|NCT03892421|Antiemetics|antiemetics|mesh-ancestor
110843007|NCT03892421|Autonomic Agents|autonomic agents|mesh-ancestor
110843008|NCT03892421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110843009|NCT03892421|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110843010|NCT03892421|Glucocorticoids|glucocorticoids|mesh-ancestor
110843011|NCT03892421|Hormones|hormones|mesh-ancestor
110843012|NCT03892421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110843014|NCT03892421|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110843015|NCT03892421|Antimetabolites|antimetabolites|mesh-ancestor
110843016|NCT03892421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110843017|NCT03892421|Antiviral Agents|antiviral agents|mesh-ancestor
110843018|NCT03892421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110843019|NCT03892421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110843020|NCT05546567|Niacinamide|niacinamide|mesh-list
110843021|NCT05546567|Niacin|niacin|mesh-list
110843022|NCT05546567|Nicotinic Acids|nicotinic acids|mesh-list
110843023|NCT05546567|Vitamin B Complex|vitamin b complex|mesh-ancestor
110843024|NCT05546567|Vitamins|vitamins|mesh-ancestor
110843025|NCT05546567|Micronutrients|micronutrients|mesh-ancestor
110843026|NCT05546567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110843027|NCT05546567|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110843028|NCT05546567|Antimetabolites|antimetabolites|mesh-ancestor
110843029|NCT05546567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110843030|NCT05546567|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110843031|NCT05546567|Vasodilator Agents|vasodilator agents|mesh-ancestor
110843032|NCT03895229|Empagliflozin|empagliflozin|mesh-list
110843033|NCT03895229|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110843034|NCT03895229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110601498|NCT00736814|Docetaxel|docetaxel|mesh-list
110843035|NCT03895229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110843036|NCT03895229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110843037|NCT01257893|Aspirin|aspirin|mesh-list
110843038|NCT01257893|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110843039|NCT01257893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110843040|NCT01257893|Analgesics|analgesics|mesh-ancestor
110843041|NCT01257893|Sensory System Agents|sensory system agents|mesh-ancestor
110843042|NCT01257893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110843043|NCT01257893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110843044|NCT01257893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110843045|NCT01257893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110335002|NCT00494156|Analgesics|analgesics|mesh-ancestor
110843046|NCT01257893|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110843047|NCT01257893|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110843048|NCT01257893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110843049|NCT01257893|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110843050|NCT01257893|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110843051|NCT01257893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110843053|NCT01152593|Mupirocin|mupirocin|mesh-list
110843054|NCT01152593|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110843055|NCT01152593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110843056|NCT01152593|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110843058|NCT01152593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110843059|NCT01259219|Rifabutin|rifabutin|mesh-list
110601841|NCT00736866|Antioxidants|antioxidants|mesh-ancestor
110843060|NCT01259219|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110843061|NCT01259219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110843062|NCT01259219|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110843063|NCT01259219|Antitubercular Agents|antitubercular agents|mesh-ancestor
110843064|NCT03891095|Oxytocin|oxytocin|mesh-list
110843065|NCT03891095|Oxytocics|oxytocics|mesh-ancestor
110601913|NCT05529056|Mydriatics|mydriatics|mesh-ancestor
110843066|NCT03891095|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110843067|NCT03891095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110843069|NCT05667077|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110843070|NCT05667077|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110843071|NCT05667077|Antiviral Agents|antiviral agents|mesh-ancestor
110843072|NCT05667077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110843073|NCT05667077|Dopamine Agents|dopamine agents|mesh-ancestor
110843074|NCT05667077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110843075|NCT05667077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110601979|NCT02567942|Anesthetics|anesthetics|mesh-ancestor
110843076|NCT05667077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110843077|NCT05667077|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110843079|NCT05667077|Sensory System Agents|sensory system agents|mesh-ancestor
110843080|NCT05667077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110843081|NCT03894839|Chlorhexidine|chlorhexidine|mesh-list
110602048|NCT00404755|Dopamine Agents|dopamine agents|mesh-ancestor
110843082|NCT03894839|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110843083|NCT03894839|Sodium Hypochlorite|sodium hypochlorite|mesh-list
110843084|NCT03894839|Glutaral|glutaral|mesh-list
110843085|NCT03894839|Eusol|eusol|mesh-list
110843086|NCT03894839|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110843087|NCT03894839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110843088|NCT03894839|Disinfectants|disinfectants|mesh-ancestor
110843089|NCT03894839|Dermatologic Agents|dermatologic agents|mesh-ancestor
110843090|NCT01152749|Nicotine|nicotine|mesh-list
110843091|NCT01152749|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110843092|NCT01152749|Autonomic Agents|autonomic agents|mesh-ancestor
110843093|NCT01152749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110843094|NCT01152749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110602274|NCT05733078|Vitamins|vitamins|mesh-list
110843096|NCT01152749|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110843097|NCT01152749|Cholinergic Agents|cholinergic agents|mesh-ancestor
110843098|NCT01152749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110843099|NCT01152749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110843100|NCT03894683|Melatonin|melatonin|mesh-list
110843101|NCT03894683|Antioxidants|antioxidants|mesh-ancestor
110602323|NCT00883870|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110843102|NCT03894683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110843103|NCT03894683|Protective Agents|protective agents|mesh-ancestor
110843104|NCT03894683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110843105|NCT03894683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110843106|NCT01259531|Silodosin|silodosin|mesh-list
110843107|NCT01259531|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110843108|NCT01259531|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110843109|NCT01259531|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110843111|NCT01259531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110843112|NCT01259531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110843113|NCT01259531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110843114|NCT01259531|Urological Agents|urological agents|mesh-ancestor
110843115|NCT01151735|Complement C1s|complement c1s|mesh-list
110843116|NCT01151735|Immunologic Factors|immunologic factors|mesh-ancestor
110843117|NCT01151735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110602530|NCT00651261|Dexamethasone|dexamethasone|mesh-list
110843119|NCT03061214|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110843120|NCT03061214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110843121|NCT03061214|Incretins|incretins|mesh-ancestor
110843122|NCT03061214|Hormones|hormones|mesh-ancestor
110843123|NCT03061214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110560736|NCT02678195|Amoxicillin|amoxicillin|mesh-list
110843124|NCT03061214|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110843125|NCT03061214|Protease Inhibitors|protease inhibitors|mesh-ancestor
110843126|NCT03061214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110602600|NCT00651183|Dopamine Agents|dopamine agents|mesh-ancestor
110843127|NCT03061214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110843128|NCT01152827|Everolimus|everolimus|mesh-list
110843129|NCT01152827|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110831285|NCT01216007|Anesthetics|anesthetics|mesh-ancestor
110843130|NCT01152827|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110843131|NCT01152827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110843132|NCT01152827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110843133|NCT01152827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110843134|NCT01152827|Immunologic Factors|immunologic factors|mesh-ancestor
110843135|NCT01152827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110843136|NCT01152827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110843137|NCT01153373|Ethanol|ethanol|mesh-list
110843138|NCT01153373|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110843139|NCT01153373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110843140|NCT01153373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110843141|NCT01153373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110843142|NCT03889145|Amlodipine|amlodipine|mesh-list
110843143|NCT03889145|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110843144|NCT03889145|Telmisartan|telmisartan|mesh-list
110843145|NCT03889145|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110843146|NCT03889145|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110843147|NCT03889145|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110843148|NCT03889145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110843149|NCT03889145|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110843150|NCT03889145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110843151|NCT03889145|Vasodilator Agents|vasodilator agents|mesh-ancestor
110843152|NCT03889145|Diuretics|diuretics|mesh-ancestor
110843153|NCT03889145|Natriuretic Agents|natriuretic agents|mesh-ancestor
110843154|NCT03889145|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110603058|NCT00886678|Pemetrexed|pemetrexed|mesh-list
110843155|NCT03889145|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110843156|NCT03889145|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110843157|NCT03888677|Cyclophosphamide|cyclophosphamide|mesh-list
110843158|NCT03888677|Epirubicin|epirubicin|mesh-list
110843159|NCT03888677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110843160|NCT03888677|Immunologic Factors|immunologic factors|mesh-ancestor
110843161|NCT03888677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110843162|NCT03888677|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110843163|NCT03888677|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110843164|NCT03888677|Alkylating Agents|alkylating agents|mesh-ancestor
110843165|NCT03888677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110843166|NCT03888677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110843168|NCT03888677|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110843169|NCT03888677|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110843170|NCT03888677|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110843172|NCT04655690|Insulin Aspart|insulin aspart|mesh-list
110843173|NCT04655690|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110843174|NCT04655690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110843175|NCT01260233|Nicotine|nicotine|mesh-list
110335021|NCT02595489|Vitamin D|vitamin d|mesh-list
110843176|NCT01260233|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110843177|NCT01260233|Autonomic Agents|autonomic agents|mesh-ancestor
110843178|NCT01260233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110843179|NCT01260233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110843180|NCT01260233|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110843181|NCT01260233|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110843182|NCT01260233|Cholinergic Agents|cholinergic agents|mesh-ancestor
110843183|NCT01260233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110843184|NCT01260233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110843185|NCT04435964|Immunomodulating Agents|immunomodulating agents|mesh-list
110843186|NCT04435964|Immunologic Factors|immunologic factors|mesh-ancestor
110843187|NCT04435964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110843188|NCT01153919|Interferons|interferons|mesh-list
110843189|NCT01153919|Ribavirin|ribavirin|mesh-list
110843190|NCT01153919|Interferon-alpha|interferon-alpha|mesh-list
110843191|NCT01153919|Interferon alpha-2|interferon alpha-2|mesh-list
110843192|NCT01153919|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110843193|NCT01153919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110843194|NCT01153919|Antiviral Agents|antiviral agents|mesh-ancestor
110843195|NCT01153919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110843196|NCT01153919|Antimetabolites|antimetabolites|mesh-ancestor
110843197|NCT01153919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110843198|NCT01153919|Immunologic Factors|immunologic factors|mesh-ancestor
110843199|NCT01153919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110843201|NCT03912389|Pemetrexed|pemetrexed|mesh-list
110843202|NCT03912389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110843203|NCT03912389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110843204|NCT03912389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110603502|NCT00890110|Sunitinib|sunitinib|mesh-list
110843205|NCT03912389|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110843206|NCT03912389|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110843208|NCT01147757|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110843209|NCT01147757|Narcotics|narcotics|mesh-ancestor
110843210|NCT01147757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110843211|NCT01147757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110843212|NCT01147757|Analgesics|analgesics|mesh-ancestor
110843213|NCT01147757|Sensory System Agents|sensory system agents|mesh-ancestor
110843214|NCT01147757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110843215|NCT01251809|Pegaspargase|pegaspargase|mesh-list
110843216|NCT01251809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110843217|NCT01154387|Mycophenolic Acid|mycophenolic acid|mesh-list
110843218|NCT01154387|Tacrolimus|tacrolimus|mesh-list
110843219|NCT01154387|Thymoglobulin|thymoglobulin|mesh-list
110843220|NCT01154387|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110843221|NCT01154387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110603700|NCT00821535|Maraviroc|maraviroc|mesh-list
110843222|NCT01154387|Immunologic Factors|immunologic factors|mesh-ancestor
110843223|NCT01154387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110843224|NCT01154387|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110843225|NCT01154387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110843226|NCT01154387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110843227|NCT01154387|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110843228|NCT01154387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110843229|NCT01154387|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110843230|NCT01154387|Antitubercular Agents|antitubercular agents|mesh-ancestor
110843231|NCT01154387|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110843232|NCT01154387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110843234|NCT01154465|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110843235|NCT01154465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110843236|NCT01260623|Prednisone|prednisone|mesh-list
110843237|NCT01260623|Prednisolone|prednisolone|mesh-list
110843238|NCT01260623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110603919|NCT00819195|(T,G)-A-L|(t,g)-a-l|mesh-list
110843240|NCT01260623|Hormones|hormones|mesh-ancestor
110843241|NCT01260623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110603981|NCT00891670|Autonomic Agents|autonomic agents|mesh-ancestor
110843242|NCT01260623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110843243|NCT01260623|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110843244|NCT01260623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110843245|NCT01252121|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110843246|NCT01252121|Lubricant Eye Drops|lubricant eye drops|mesh-list
110843247|NCT01252121|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110843248|NCT01260857|Hydroflumethiazide|hydroflumethiazide|mesh-list
110843249|NCT01260857|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110843250|NCT01260857|Diuretics|diuretics|mesh-ancestor
110843251|NCT01260857|Natriuretic Agents|natriuretic agents|mesh-ancestor
110843252|NCT01260857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110843253|NCT01260857|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110843254|NCT01260857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110843255|NCT01260857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110843256|NCT03890003|Insulin Lispro|insulin lispro|mesh-list
110843257|NCT03890003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110843258|NCT03890003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110843259|NCT01153217|Tenofovir|tenofovir|mesh-list
110843260|NCT01153217|Abacavir|abacavir|mesh-list
110843261|NCT01153217|Antiviral Agents|antiviral agents|mesh-ancestor
110843263|NCT01153217|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110604329|NCT00631917|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110843264|NCT01153217|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110843265|NCT01153217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110604399|NCT02085265|Protease Inhibitors|protease inhibitors|mesh-ancestor
110843266|NCT01153217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110843267|NCT01153217|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110831304|NCT02529761|Sorafenib|sorafenib|mesh-list
110843268|NCT01153217|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110843270|NCT01261169|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110843271|NCT01261169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110843272|NCT01261169|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110843273|NCT01261169|Antitubercular Agents|antitubercular agents|mesh-ancestor
110843274|NCT01261169|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110843275|NCT01261169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110843276|NCT01261169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110843277|NCT01261169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110843279|NCT03889379|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110843280|NCT03889379|Autonomic Agents|autonomic agents|mesh-ancestor
110843281|NCT03889379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110843282|NCT03889379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110843283|NCT03889379|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110843284|NCT03889379|Respiratory System Agents|respiratory system agents|mesh-ancestor
110843285|NCT03889379|Tocolytic Agents|tocolytic agents|mesh-ancestor
110843286|NCT03889379|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110843287|NCT03889379|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110843288|NCT03889379|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110843289|NCT03889379|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110843290|NCT03889379|Adrenergic Agents|adrenergic agents|mesh-ancestor
110843291|NCT03889379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110604825|NCT04044417|Simvastatin|simvastatin|mesh-list
110843292|NCT03889379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110843293|NCT01586507|Tramadol|tramadol|mesh-list
110843294|NCT01586507|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110843295|NCT01586507|Narcotics|narcotics|mesh-ancestor
110843296|NCT01586507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110843297|NCT01586507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110843298|NCT01586507|Analgesics|analgesics|mesh-ancestor
110843299|NCT01586507|Sensory System Agents|sensory system agents|mesh-ancestor
110843300|NCT01586507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110843301|NCT03910361|Pioglitazone|pioglitazone|mesh-list
110843302|NCT03910361|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110843303|NCT03910361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110604966|NCT02550249|Nivolumab|nivolumab|mesh-list
110843304|NCT03700658|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
110843305|NCT03700658|Medroxyprogesterone|medroxyprogesterone|mesh-list
110843306|NCT03700658|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110843307|NCT03700658|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110843308|NCT03700658|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110843309|NCT03700658|Contraceptive Agents|contraceptive agents|mesh-ancestor
110843310|NCT03700658|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110843311|NCT03700658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110843312|NCT03700658|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110843313|NCT03700658|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110843314|NCT03700658|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110843315|NCT03700658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110843316|NCT03700658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110843317|NCT03885947|Fludarabine|fludarabine|mesh-list
110843318|NCT03885947|Cyclophosphamide|cyclophosphamide|mesh-list
110843319|NCT03885947|Thiotepa|thiotepa|mesh-list
110843320|NCT03885947|Valproic Acid|valproic acid|mesh-list
110843321|NCT03885947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110843322|NCT03885947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110843323|NCT03885947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110843324|NCT03885947|Immunologic Factors|immunologic factors|mesh-ancestor
110843325|NCT03885947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110843326|NCT03885947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110843327|NCT03885947|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110605166|NCT00882388|Aspirin|aspirin|mesh-list
110843328|NCT03885947|Alkylating Agents|alkylating agents|mesh-ancestor
110843329|NCT03885947|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110843330|NCT03885947|Anticonvulsants|anticonvulsants|mesh-ancestor
110843331|NCT03885947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110605292|NCT00908362|Xhance|xhance|mesh-list
110843333|NCT03885947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110843334|NCT03885947|Antimanic Agents|antimanic agents|mesh-ancestor
110843335|NCT03885947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110843336|NCT03885947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110843337|NCT03885947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110843338|NCT01261481|Tolvaptan|tolvaptan|mesh-list
110843339|NCT01261481|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
110843340|NCT01261481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110843341|NCT01261481|Natriuretic Agents|natriuretic agents|mesh-ancestor
110843342|NCT01261481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110843343|NCT01261637|Ropivacaine|ropivacaine|mesh-list
110843344|NCT01261637|Anesthetics, Local|anesthetics, local|mesh-ancestor
110843345|NCT01261637|Anesthetics|anesthetics|mesh-ancestor
110843346|NCT01261637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110843347|NCT01261637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110843348|NCT01261637|Sensory System Agents|sensory system agents|mesh-ancestor
110843349|NCT01261637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110843350|NCT01262183|Panitumumab|panitumumab|mesh-list
110605508|NCT01042873|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110843351|NCT01262183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110843352|NCT01262183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110843353|NCT01154933|Exenatide|exenatide|mesh-list
110843354|NCT01154933|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110843355|NCT01154933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110843356|NCT01154933|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110843357|NCT01154933|Incretins|incretins|mesh-ancestor
110843358|NCT01154933|Hormones|hormones|mesh-ancestor
110843359|NCT01154933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110843360|NCT01155635|Carvedilol|carvedilol|mesh-list
110605647|NCT01037101|Antitubercular Agents|antitubercular agents|mesh-ancestor
110843361|NCT01155635|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110843362|NCT01155635|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110843363|NCT01155635|Adrenergic Agents|adrenergic agents|mesh-ancestor
110843364|NCT01155635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110605721|NCT00396565|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110870380|NCT02394418|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110843365|NCT01155635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110843366|NCT01155635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110843367|NCT01155635|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110843368|NCT01155635|Antioxidants|antioxidants|mesh-ancestor
110843369|NCT01155635|Protective Agents|protective agents|mesh-ancestor
110843370|NCT01155635|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110843371|NCT01155635|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110843372|NCT01155635|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110843373|NCT01155635|Vasodilator Agents|vasodilator agents|mesh-ancestor
110843374|NCT01155635|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110843375|NCT01155635|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110843376|NCT01155089|Anastrozole|anastrozole|mesh-list
110843377|NCT01155089|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110606004|NCT00932386|Dexmedetomidine|dexmedetomidine|mesh-list
110843378|NCT01155089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110843379|NCT01155089|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110843380|NCT01155089|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110843381|NCT01155089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110606072|NCT01045837|Glucocorticoids|glucocorticoids|mesh-ancestor
110843382|NCT01155089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110843383|NCT01155089|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110843384|NCT01155089|Hormone Antagonists|hormone antagonists|mesh-ancestor
110843385|NCT01155089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110843386|NCT01155089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110843387|NCT01155245|Teriparatide|teriparatide|mesh-list
110843388|NCT01155245|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110843389|NCT01155245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110843390|NCT01155245|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110843391|NCT01262417|Hyaluronic Acid|hyaluronic acid|mesh-list
110843392|NCT01262417|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110843393|NCT01262417|Immunologic Factors|immunologic factors|mesh-ancestor
110843394|NCT01262417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110843395|NCT01262417|Viscosupplements|viscosupplements|mesh-ancestor
110843396|NCT01262417|Protective Agents|protective agents|mesh-ancestor
110843397|NCT01155791|Prednisone|prednisone|mesh-list
110843398|NCT01155791|Docetaxel|docetaxel|mesh-list
110843399|NCT01155791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110843401|NCT01155791|Antimitotic Agents|antimitotic agents|mesh-ancestor
110843402|NCT01155791|Mitosis Modulators|mitosis modulators|mesh-ancestor
110843403|NCT01155791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110843404|NCT01155791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110843405|NCT01155791|Glucocorticoids|glucocorticoids|mesh-ancestor
110843407|NCT01155791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110843408|NCT01155791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110843409|NCT01155791|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110843410|NCT01157507|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110843411|NCT01157507|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110843412|NCT01157507|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110606487|NCT02548923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110843413|NCT01157507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110843414|NCT01157507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110843415|NCT01157507|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110843416|NCT01157507|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110843417|NCT01157507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110843418|NCT01157507|Cholinergic Agents|cholinergic agents|mesh-ancestor
110843419|NCT01157507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110843420|NCT03881423|Bromides|bromides|mesh-list
110843421|NCT03881423|Rocuronium|rocuronium|mesh-list
110843422|NCT03881423|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
110843423|NCT03881423|Anticonvulsants|anticonvulsants|mesh-ancestor
110843424|NCT03881423|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110843425|NCT03881423|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110843426|NCT03881423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110076477|NCT05274243|Phenol|phenol|mesh-list
110843427|NCT03881423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110843428|NCT03884465|Treprostinil|treprostinil|mesh-list
110843429|NCT03884465|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110843430|NCT01155947|Anastrozole|anastrozole|mesh-list
110843431|NCT01155947|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110843432|NCT01155947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110843433|NCT01155947|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110843434|NCT01155947|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110843435|NCT01155947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110843436|NCT01155947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110843437|NCT01155947|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110843438|NCT01155947|Hormone Antagonists|hormone antagonists|mesh-ancestor
110843439|NCT01155947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110843440|NCT01155947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110843441|NCT01157585|Paliperidone Palmitate|paliperidone palmitate|mesh-list
110843442|NCT01157585|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110843443|NCT01157585|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110843444|NCT01157585|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110843445|NCT01157585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110843446|NCT01157585|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110843447|NCT01157585|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110843448|NCT01157585|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110843449|NCT01157585|Serotonin Agents|serotonin agents|mesh-ancestor
110843450|NCT01157585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110606840|NCT00690378|Protease Inhibitors|protease inhibitors|mesh-ancestor
110843451|NCT01157585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110843452|NCT01157585|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110843453|NCT01157585|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110843454|NCT01157585|Dopamine Agents|dopamine agents|mesh-ancestor
110843456|NCT01264133|Clevudine|clevudine|mesh-list
110843457|NCT01264133|Antiviral Agents|antiviral agents|mesh-ancestor
110843458|NCT01264133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110606968|NCT00840489|Ribavirin|ribavirin|mesh-list
110843459|NCT01264133|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110843460|NCT01264133|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110843461|NCT01264133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110843462|NCT01264133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110843463|NCT02527577|Ropivacaine|ropivacaine|mesh-list
110843464|NCT02527577|Anesthetics, Local|anesthetics, local|mesh-ancestor
110843465|NCT02527577|Anesthetics|anesthetics|mesh-ancestor
110843466|NCT02527577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110843467|NCT02527577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110843468|NCT02527577|Sensory System Agents|sensory system agents|mesh-ancestor
110843469|NCT02527577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110843470|NCT03883841|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
110843472|NCT03881111|Pembrolizumab|pembrolizumab|mesh-list
110843473|NCT03881111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110843474|NCT03881111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110843475|NCT03881111|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110843476|NCT03881111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110843477|NCT01264211|Diacerein|diacerein|mesh-list
110843478|NCT01264211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110843479|NCT03880877|Leucovorin|leucovorin|mesh-list
110843480|NCT03880877|Antidotes|antidotes|mesh-ancestor
110843481|NCT03880877|Protective Agents|protective agents|mesh-ancestor
110843482|NCT03880877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110843483|NCT03880877|Vitamin B Complex|vitamin b complex|mesh-ancestor
110843485|NCT03880877|Micronutrients|micronutrients|mesh-ancestor
110843486|NCT05666999|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
110843487|NCT05666999|Laxatives|laxatives|mesh-ancestor
110843488|NCT05666999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110843489|NCT01262729|Xenon|xenon|mesh-list
110843490|NCT01262729|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110843491|NCT01262729|Anesthetics, General|anesthetics, general|mesh-ancestor
110843492|NCT01262729|Anesthetics|anesthetics|mesh-ancestor
110561109|NCT04181957|Dopamine Agents|dopamine agents|mesh-ancestor
110843493|NCT01262729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110843494|NCT01262729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110843495|NCT01264289|Finasteride|finasteride|mesh-list
110843496|NCT01264289|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
110843497|NCT01264289|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110843499|NCT01264289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110843501|NCT01264289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110843502|NCT01264289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110843503|NCT01264289|Urological Agents|urological agents|mesh-ancestor
110843504|NCT03880487|Oxycodone|oxycodone|mesh-list
110843505|NCT03880487|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110843506|NCT03880487|Narcotics|narcotics|mesh-ancestor
110843507|NCT03880487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110843508|NCT03880487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110843509|NCT03880487|Analgesics|analgesics|mesh-ancestor
110843510|NCT03880487|Sensory System Agents|sensory system agents|mesh-ancestor
110843511|NCT03880487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110843512|NCT03880409|Lidocaine|lidocaine|mesh-list
110843513|NCT03880409|Epinephrine|epinephrine|mesh-list
110843514|NCT03880409|Racepinephrine|racepinephrine|mesh-list
110843515|NCT03880409|Carticaine|carticaine|mesh-list
110843516|NCT03880409|Epinephryl borate|epinephryl borate|mesh-list
110607730|NCT00851175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110607731|NCT00851175|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110607732|NCT00851175|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110607733|NCT00851175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110607734|NCT00851175|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110607735|NCT00851175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110843517|NCT03880409|Anesthetics, Local|anesthetics, local|mesh-ancestor
110843519|NCT03880409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110843520|NCT03880409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110843521|NCT03880409|Sensory System Agents|sensory system agents|mesh-ancestor
110607797|NCT00851487|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110843522|NCT03880409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110843523|NCT03880409|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110831389|NCT05156437|Ceftriaxone|ceftriaxone|mesh-list
110843524|NCT03880409|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110843525|NCT03880409|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110843526|NCT03880409|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110843527|NCT03880409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110843528|NCT03880409|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110843529|NCT03880409|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110843530|NCT03880409|Adrenergic Agents|adrenergic agents|mesh-ancestor
110843531|NCT03880409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110843532|NCT03880409|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110843533|NCT03880409|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110843534|NCT03880409|Autonomic Agents|autonomic agents|mesh-ancestor
110843535|NCT03880409|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110843536|NCT03880409|Respiratory System Agents|respiratory system agents|mesh-ancestor
110843537|NCT03880409|Mydriatics|mydriatics|mesh-ancestor
110843538|NCT03880409|Sympathomimetics|sympathomimetics|mesh-ancestor
110843539|NCT03880409|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110843540|NCT01157819|Ciprofloxacin|ciprofloxacin|mesh-list
110843541|NCT01157819|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110843542|NCT01157819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110843543|NCT01157819|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110335090|NCT00494468|Zolpidem|zolpidem|mesh-list
110843544|NCT01157819|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110843545|NCT01157819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110843546|NCT01157819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110843547|NCT01157819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110843548|NCT01157819|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110843549|NCT01157819|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110843550|NCT01264367|Interferons|interferons|mesh-list
110843551|NCT01264367|Clevudine|clevudine|mesh-list
110843552|NCT01264367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110843553|NCT01264367|Antiviral Agents|antiviral agents|mesh-ancestor
110843554|NCT01264367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110843555|NCT05097716|Tolbutamide|tolbutamide|mesh-list
110843556|NCT05097716|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110843557|NCT05097716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110843558|NCT01262963|Dabrafenib|dabrafenib|mesh-list
110608131|NCT00576758|Obinutuzumab|obinutuzumab|mesh-list
110843559|NCT01262963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110843560|NCT01262963|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110843561|NCT01262963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110843562|NCT01262963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110843563|NCT01264445|Vaccines|vaccines|mesh-list
110843564|NCT01264445|Immunologic Factors|immunologic factors|mesh-ancestor
110843565|NCT01264445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110843566|NCT01157975|Pioglitazone|pioglitazone|mesh-list
110843567|NCT01157975|Prednisone|prednisone|mesh-list
110843568|NCT01157975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110843569|NCT01157975|Glucocorticoids|glucocorticoids|mesh-ancestor
110843570|NCT01157975|Hormones|hormones|mesh-ancestor
110843571|NCT01157975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110843572|NCT01157975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110843573|NCT01157975|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110843574|NCT01157975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110843575|NCT01157975|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110843576|NCT03060512|Naloxegol|naloxegol|mesh-list
110843577|NCT03060512|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
110843578|NCT03060512|Laxatives|laxatives|mesh-ancestor
110843579|NCT03060512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110843580|NCT03060512|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110843581|NCT03060512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110843582|NCT03060512|Sensory System Agents|sensory system agents|mesh-ancestor
110843583|NCT03060512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110843585|NCT01263353|Pasireotide|pasireotide|mesh-list
110843586|NCT01263353|Somatostatin|somatostatin|mesh-list
110843587|NCT01263353|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110843588|NCT01263353|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110843589|NCT01263353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110843590|NCT01263353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110843591|NCT01263353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110843592|NCT01263353|Immunologic Factors|immunologic factors|mesh-ancestor
110843593|NCT01263353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110843594|NCT01263353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110843595|NCT01263353|Hormones|hormones|mesh-ancestor
110843596|NCT01263353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110843597|NCT01158287|Sorafenib|sorafenib|mesh-list
110843598|NCT01158287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110843599|NCT01158287|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110843600|NCT01158287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110843601|NCT01158287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110843602|NCT01158365|Glycerol|glycerol|mesh-list
110843603|NCT01158365|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
110843604|NCT01158365|Protective Agents|protective agents|mesh-ancestor
110843605|NCT01158365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110843607|NCT01156649|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110843608|NCT01156649|Analgesics|analgesics|mesh-ancestor
110608691|NCT00755976|Analgesics|analgesics|mesh-ancestor
110843609|NCT01156649|Sensory System Agents|sensory system agents|mesh-ancestor
110843610|NCT01156649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110843611|NCT01156649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110843612|NCT01156649|Antipyretics|antipyretics|mesh-ancestor
110843613|NCT01158755|Moxifloxacin|moxifloxacin|mesh-list
110843614|NCT01158755|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110843615|NCT01158755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110608772|NCT00861627|Paclitaxel|paclitaxel|mesh-list
110843616|NCT01158755|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110843617|NCT01158755|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110843618|NCT01158755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110843619|NCT01158755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110843620|NCT01158755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110843621|NCT03879707|Melatonin|melatonin|mesh-list
110843622|NCT03879707|Antioxidants|antioxidants|mesh-ancestor
110843623|NCT03879707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110843624|NCT03879707|Protective Agents|protective agents|mesh-ancestor
110843625|NCT03879707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110843626|NCT03879707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110843627|NCT01265147|Nedaplatin|nedaplatin|mesh-list
110843628|NCT01265147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110843629|NCT01159145|Omeprazole|omeprazole|mesh-list
110843630|NCT01159145|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110843631|NCT01159145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110843632|NCT01159145|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110843633|NCT01159145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110843634|NCT01159145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110843635|NCT01156883|Cytarabine|cytarabine|mesh-list
110608897|NCT00952978|Omeprazole|omeprazole|mesh-list
110843637|NCT01156883|Prednisone|prednisone|mesh-list
110843638|NCT01156883|Methylprednisolone|methylprednisolone|mesh-list
110843639|NCT01156883|Cyclophosphamide|cyclophosphamide|mesh-list
110843640|NCT01156883|Ifosfamide|ifosfamide|mesh-list
110843641|NCT01156883|Doxorubicin|doxorubicin|mesh-list
110843642|NCT01156883|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110843643|NCT01156883|Methotrexate|methotrexate|mesh-list
110843644|NCT01156883|Vincristine|vincristine|mesh-list
110843645|NCT01156883|Daunorubicin|daunorubicin|mesh-list
110843646|NCT01156883|Asparaginase|asparaginase|mesh-list
110561257|NCT02674997|Coagulants|coagulants|mesh-ancestor
110843647|NCT01156883|Mercaptopurine|mercaptopurine|mesh-list
110843648|NCT01156883|Thioguanine|thioguanine|mesh-list
110843650|NCT01156883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110843651|NCT01156883|Immunologic Factors|immunologic factors|mesh-ancestor
110843652|NCT01156883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110843653|NCT01156883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110843654|NCT01156883|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110843655|NCT01156883|Alkylating Agents|alkylating agents|mesh-ancestor
110843656|NCT01156883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110843657|NCT01156883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110843658|NCT01156883|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110843659|NCT01156883|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110843660|NCT01156883|Antiemetics|antiemetics|mesh-ancestor
110843661|NCT01156883|Autonomic Agents|autonomic agents|mesh-ancestor
110609164|NCT02565836|Thrombin|thrombin|mesh-list
110843662|NCT01156883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110843663|NCT01156883|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110843664|NCT01156883|Glucocorticoids|glucocorticoids|mesh-ancestor
110843665|NCT01156883|Hormones|hormones|mesh-ancestor
110843666|NCT01156883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110843667|NCT01156883|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110843668|NCT01156883|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110843669|NCT01156883|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110843670|NCT01156883|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110843671|NCT01156883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110843672|NCT01156883|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110843673|NCT01156883|Abortifacient Agents|abortifacient agents|mesh-ancestor
110843674|NCT01156883|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110843675|NCT01156883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110843676|NCT01156883|Antimetabolites|antimetabolites|mesh-ancestor
110843677|NCT01156883|Dermatologic Agents|dermatologic agents|mesh-ancestor
110843678|NCT01156883|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110843679|NCT01156883|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110843680|NCT01156883|Antiviral Agents|antiviral agents|mesh-ancestor
110843681|NCT01156883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110843682|NCT01156883|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110843683|NCT01156883|Tubulin Modulators|tubulin modulators|mesh-ancestor
110843684|NCT01156883|Antimitotic Agents|antimitotic agents|mesh-ancestor
110843685|NCT01156883|Mitosis Modulators|mitosis modulators|mesh-ancestor
110843686|NCT01156883|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110843687|NCT01156883|Protective Agents|protective agents|mesh-ancestor
110843689|NCT01156961|Bevacizumab|bevacizumab|mesh-list
110843690|NCT01156961|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110843691|NCT01156961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110843692|NCT01156961|Tubulin Modulators|tubulin modulators|mesh-ancestor
110843693|NCT01156961|Antimitotic Agents|antimitotic agents|mesh-ancestor
110843694|NCT01156961|Mitosis Modulators|mitosis modulators|mesh-ancestor
110843695|NCT01156961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110843696|NCT01156961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110843697|NCT01156961|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110843698|NCT01156961|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110843699|NCT01156961|Growth Substances|growth substances|mesh-ancestor
110843700|NCT01156961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110843701|NCT01156961|Growth Inhibitors|growth inhibitors|mesh-ancestor
110843703|NCT01159301|Entinostat|entinostat|mesh-list
110843704|NCT01159301|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
110843705|NCT01159301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110843706|NCT01159301|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110843707|NCT01159301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110843708|NCT01159301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110843710|NCT01159379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110843711|NCT01159379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110843712|NCT01159847|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110843714|NCT01159847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110843716|NCT01159847|Hormones|hormones|mesh-ancestor
110843717|NCT01159847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110843718|NCT01159847|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110843719|NCT01159847|Protease Inhibitors|protease inhibitors|mesh-ancestor
110843720|NCT01159847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110843721|NCT01159847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110843723|NCT02539160|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110843724|NCT02539160|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110843725|NCT02539160|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110843726|NCT02539160|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110843727|NCT02539160|Purinergic Agents|purinergic agents|mesh-ancestor
110843728|NCT02539160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110843729|NCT02539160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110843730|NCT02539160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110843731|NCT01265927|Trastuzumab|trastuzumab|mesh-list
110843732|NCT01265927|Imetelstat|imetelstat|mesh-list
110843733|NCT01265927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110843734|NCT01265927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110843735|NCT01265927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110843736|NCT01265927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110843738|NCT01266005|Clevudine|clevudine|mesh-list
110843739|NCT01266005|Antiviral Agents|antiviral agents|mesh-ancestor
110843740|NCT01266005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110843741|NCT04292899|Remdesivir|remdesivir|mesh-list
110843742|NCT04292899|Antimetabolites|antimetabolites|mesh-ancestor
110843743|NCT04292899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110335120|NCT00497237|Hormones|hormones|mesh-ancestor
110843744|NCT04292899|Antiviral Agents|antiviral agents|mesh-ancestor
110843745|NCT04292899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110843746|NCT03876899|Evening primrose oil|evening primrose oil|mesh-list
110843747|NCT03876899|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110843748|NCT03876899|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110843749|NCT03876899|Analgesics|analgesics|mesh-ancestor
110843750|NCT03876899|Sensory System Agents|sensory system agents|mesh-ancestor
110843751|NCT03876899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110843752|NCT03876899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110843753|NCT03876899|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110843754|NCT03876899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110843755|NCT03876899|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110843756|NCT03876899|Antimetabolites|antimetabolites|mesh-ancestor
110843757|NCT03876899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110843758|NCT03876899|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110843759|NCT03876899|Dermatologic Agents|dermatologic agents|mesh-ancestor
110843760|NCT03241173|Nivolumab|nivolumab|mesh-list
110843761|NCT03241173|Ipilimumab|ipilimumab|mesh-list
110843762|NCT03241173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110843763|NCT03241173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110843764|NCT03241173|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110843765|NCT03241173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110843766|NCT03264066|Atezolizumab|atezolizumab|mesh-list
110843767|NCT03264066|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110843768|NCT03264066|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110843769|NCT03264066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110843770|NCT03264066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110609912|NCT00742976|Insulin|insulin|mesh-list
110843771|NCT03264066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110843772|NCT03264066|Immunologic Factors|immunologic factors|mesh-ancestor
110843773|NCT03264066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110843774|NCT03759041|Vancomycin|vancomycin|mesh-list
110843775|NCT03759041|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110843776|NCT03759041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110843777|NCT04110145|Linaclotide|linaclotide|mesh-list
110843778|NCT04110145|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
110843779|NCT04110145|Enzyme Activators|enzyme activators|mesh-ancestor
110843780|NCT04110145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110610124|NCT00755118|Immunologic Factors|immunologic factors|mesh-ancestor
110843781|NCT04110145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110843782|NCT02477618|Brexanolone|brexanolone|mesh-list
110843783|NCT02477618|Neurosteroids|neurosteroids|mesh-ancestor
110843784|NCT02477618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110843785|NCT02477618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110610269|NCT00863889|Methylprednisolone|methylprednisolone|mesh-list
110843786|NCT02477618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110843787|NCT02477618|GABA Modulators|gaba modulators|mesh-ancestor
110843788|NCT02477618|GABA Agents|gaba agents|mesh-ancestor
110843789|NCT01268033|Rituximab|rituximab|mesh-list
110843790|NCT01268033|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110843791|NCT01268033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110843792|NCT01268033|Immunologic Factors|immunologic factors|mesh-ancestor
110843793|NCT01268033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110843794|NCT01268033|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110843795|NCT01162031|Bortezomib|bortezomib|mesh-list
110843796|NCT01162031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110843797|NCT02879162|Durvalumab|durvalumab|mesh-list
110843798|NCT02879162|Tremelimumab|tremelimumab|mesh-list
110610420|NCT00864591|Adenosine|adenosine|mesh-list
110843799|NCT02879162|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110843800|NCT02879162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110843801|NCT03285477|Tirbanibulin|tirbanibulin|mesh-list
110843802|NCT03285477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110843803|NCT03285477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110843804|NCT02285504|Brexanolone|brexanolone|mesh-list
110843805|NCT02285504|Neurosteroids|neurosteroids|mesh-ancestor
110843806|NCT02285504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110843807|NCT02285504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110843808|NCT02285504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110843809|NCT02285504|GABA Modulators|gaba modulators|mesh-ancestor
110843810|NCT02285504|GABA Agents|gaba agents|mesh-ancestor
110843811|NCT02227394|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
110843812|NCT02227394|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110843813|NCT02227394|Respiratory System Agents|respiratory system agents|mesh-ancestor
110843814|NCT05158491|Irinotecan|irinotecan|mesh-list
110843815|NCT05158491|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110843816|NCT05158491|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110843817|NCT05158491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110843818|NCT05158491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110843819|NCT05158491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110843820|NCT04276207|Insulin Lispro|insulin lispro|mesh-list
110843821|NCT04276207|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110843822|NCT04276207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110843823|NCT03876587|Docetaxel|docetaxel|mesh-list
110843824|NCT03876587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110843825|NCT03876587|Tubulin Modulators|tubulin modulators|mesh-ancestor
110843826|NCT03876587|Antimitotic Agents|antimitotic agents|mesh-ancestor
110610531|NCT00371683|Enoxaparin|enoxaparin|mesh-list
110843827|NCT03876587|Mitosis Modulators|mitosis modulators|mesh-ancestor
110843828|NCT03876587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110843829|NCT01162889|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110843830|NCT01162889|Immunologic Factors|immunologic factors|mesh-ancestor
110610597|NCT00547534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110843831|NCT01162889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110843832|NCT04635423|Vaccines|vaccines|mesh-list
110843833|NCT04635423|Immunologic Factors|immunologic factors|mesh-ancestor
110843834|NCT04635423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110843835|NCT03282357|Hyaluronic Acid|hyaluronic acid|mesh-list
110843836|NCT03282357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110843837|NCT03282357|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110843838|NCT03282357|Immunologic Factors|immunologic factors|mesh-ancestor
110843839|NCT03282357|Viscosupplements|viscosupplements|mesh-ancestor
110843840|NCT03282357|Protective Agents|protective agents|mesh-ancestor
110843841|NCT01162967|Posaconazole|posaconazole|mesh-list
110843842|NCT01162967|Benzonidazole|benzonidazole|mesh-list
110843843|NCT01162967|Antifungal Agents|antifungal agents|mesh-ancestor
110843844|NCT01162967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110843845|NCT01162967|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
110831443|NCT01213979|Iron|iron|mesh-list
110843846|NCT01162967|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110843847|NCT01162967|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110843848|NCT01162967|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110843849|NCT01162967|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110843850|NCT01162967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110843851|NCT01162967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110843852|NCT01162967|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110843853|NCT01162967|Hormone Antagonists|hormone antagonists|mesh-ancestor
110843854|NCT01162967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110843855|NCT01162967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110843856|NCT01162967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110843857|NCT01162967|Immunologic Factors|immunologic factors|mesh-ancestor
110843858|NCT01268735|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110843859|NCT01268735|Lubricant Eye Drops|lubricant eye drops|mesh-list
110843860|NCT01268735|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110843861|NCT04272775|Dexamethasone|dexamethasone|mesh-list
110843862|NCT04272775|Lenalidomide|lenalidomide|mesh-list
110843863|NCT04272775|Ixazomib|ixazomib|mesh-list
110843864|NCT04272775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110843865|NCT04272775|Antiemetics|antiemetics|mesh-ancestor
110843866|NCT04272775|Autonomic Agents|autonomic agents|mesh-ancestor
110843867|NCT04272775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110843868|NCT04272775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110843869|NCT04272775|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110843870|NCT04272775|Glucocorticoids|glucocorticoids|mesh-ancestor
110843871|NCT04272775|Hormones|hormones|mesh-ancestor
110843872|NCT04272775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110843873|NCT04272775|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110843874|NCT04272775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110843875|NCT04272775|Immunologic Factors|immunologic factors|mesh-ancestor
110843876|NCT04272775|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110843877|NCT04272775|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110843878|NCT04272775|Growth Substances|growth substances|mesh-ancestor
110843879|NCT04272775|Growth Inhibitors|growth inhibitors|mesh-ancestor
110843880|NCT04272775|Protease Inhibitors|protease inhibitors|mesh-ancestor
110843881|NCT04272775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110843882|NCT04272775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110843884|NCT03232983|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110843885|NCT03232983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110611000|NCT00874107|Paclitaxel|paclitaxel|mesh-list
110843886|NCT01163201|Cyclophosphamide|cyclophosphamide|mesh-list
110843887|NCT01163201|Fludarabine|fludarabine|mesh-list
110843888|NCT01163201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110843889|NCT01163201|Immunologic Factors|immunologic factors|mesh-ancestor
110843890|NCT01163201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110843891|NCT01163201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110843892|NCT01163201|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110843893|NCT01163201|Alkylating Agents|alkylating agents|mesh-ancestor
110843894|NCT01163201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110843895|NCT01163201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110843896|NCT01163201|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110843897|NCT03876041|Dexamethasone|dexamethasone|mesh-list
110843898|NCT03876041|Dexamethasone acetate|dexamethasone acetate|mesh-list
110843899|NCT03876041|Methylprednisolone|methylprednisolone|mesh-list
110843900|NCT03876041|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110843901|NCT03876041|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
110843902|NCT03876041|BB 1101|bb 1101|mesh-list
110843903|NCT03876041|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110843904|NCT03876041|Antiemetics|antiemetics|mesh-ancestor
110843905|NCT03876041|Autonomic Agents|autonomic agents|mesh-ancestor
110843906|NCT03876041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110843907|NCT03876041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110843908|NCT03876041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110843909|NCT03876041|Glucocorticoids|glucocorticoids|mesh-ancestor
110843910|NCT03876041|Hormones|hormones|mesh-ancestor
110843911|NCT03876041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110843912|NCT03876041|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110843913|NCT03876041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110843914|NCT03876041|Protease Inhibitors|protease inhibitors|mesh-ancestor
110843915|NCT03876041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110843916|NCT03876041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110843917|NCT03876041|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110843918|NCT03876041|Protective Agents|protective agents|mesh-ancestor
110843920|NCT04102345|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110843921|NCT04102345|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110843922|NCT04102345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110843923|NCT04102345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110843924|NCT04102345|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
110843925|NCT04102345|GABA Agonists|gaba agonists|mesh-ancestor
110843926|NCT04102345|GABA Agents|gaba agents|mesh-ancestor
110843927|NCT04102345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110843928|NCT04102345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110843929|NCT01163435|Clarithromycin|clarithromycin|mesh-list
110843930|NCT01163435|Levofloxacin|levofloxacin|mesh-list
110843931|NCT01163435|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110843932|NCT01163435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110843933|NCT01163435|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110843934|NCT01163435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110843935|NCT01163435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110843936|NCT01163435|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110843937|NCT01163435|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110843938|NCT01163435|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110843939|NCT01163435|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110611467|NCT00611715|Letrozole|letrozole|mesh-list
110843940|NCT01163435|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110843941|NCT01163435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110843942|NCT01163435|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110843943|NCT03299244|Cinacalcet|cinacalcet|mesh-list
110843944|NCT03299244|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110843945|NCT03299244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110843946|NCT03299244|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
110843947|NCT03299244|Hormone Antagonists|hormone antagonists|mesh-ancestor
110843948|NCT03299244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110843949|NCT03875963|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110843950|NCT03875963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110843951|NCT03757715|Dexamethasone|dexamethasone|mesh-list
110843952|NCT03757715|Bupivacaine|bupivacaine|mesh-list
110843953|NCT03757715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110843955|NCT03757715|Autonomic Agents|autonomic agents|mesh-ancestor
110843956|NCT03757715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110843957|NCT03757715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110843958|NCT03757715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110843959|NCT03757715|Glucocorticoids|glucocorticoids|mesh-ancestor
110843960|NCT03757715|Hormones|hormones|mesh-ancestor
110843961|NCT03757715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110843962|NCT03757715|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110843963|NCT03757715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110843964|NCT03757715|Anesthetics, Local|anesthetics, local|mesh-ancestor
110843965|NCT03757715|Anesthetics|anesthetics|mesh-ancestor
110843966|NCT03757715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110843967|NCT03757715|Sensory System Agents|sensory system agents|mesh-ancestor
110843968|NCT01163825|Mitogens|mitogens|mesh-list
110843969|NCT01163825|Mitosis Modulators|mitosis modulators|mesh-ancestor
110843970|NCT01163825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110843971|NCT01163903|Doxorubicin|doxorubicin|mesh-list
110843972|NCT01163903|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110843973|NCT01163903|Pantoprazole|pantoprazole|mesh-list
110843974|NCT01163903|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110843975|NCT01163903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110843976|NCT01163903|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110843977|NCT01163903|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110843979|NCT01163903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110843980|NCT01163903|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110843981|NCT01163903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110843982|NCT01163903|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110843983|NCT03759587|Niraparib|niraparib|mesh-list
110843984|NCT03759587|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110843985|NCT03759587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110843986|NCT03759587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110843987|NCT03759587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110843988|NCT03745807|Nivolumab|nivolumab|mesh-list
110843989|NCT03745807|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110843990|NCT03745807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110843991|NCT03745807|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110843992|NCT03745807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110843993|NCT01164059|Haloperidol|haloperidol|mesh-list
110843994|NCT01164059|Olanzapine|olanzapine|mesh-list
110843995|NCT01164059|Aripiprazole|aripiprazole|mesh-list
110843996|NCT01164059|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110843997|NCT01164059|Haloperidol decanoate|haloperidol decanoate|mesh-list
110843998|NCT01164059|Flupenthixol|flupenthixol|mesh-list
110843999|NCT01164059|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
110844001|NCT01164059|Autonomic Agents|autonomic agents|mesh-ancestor
110844002|NCT01164059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110844003|NCT01164059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110844004|NCT01164059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110844005|NCT01164059|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110844006|NCT01164059|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110844007|NCT01164059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110844008|NCT01164059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110844009|NCT01164059|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110844010|NCT01164059|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110844011|NCT01164059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110844012|NCT01164059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110844013|NCT01164059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110844014|NCT01164059|Serotonin Agents|serotonin agents|mesh-ancestor
110844015|NCT01164059|Antidepressive Agents|antidepressive agents|mesh-ancestor
110844016|NCT01164059|Dopamine Agonists|dopamine agonists|mesh-ancestor
110844017|NCT01164059|Dopamine Agents|dopamine agents|mesh-ancestor
110611775|NCT05955040|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110844018|NCT01164059|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110844019|NCT01164059|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110844020|NCT01164059|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110844021|NCT01164059|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110844022|NCT01164059|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110844023|NCT01164059|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110844024|NCT01164059|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110844025|NCT03879005|Technetium Tc 99m Dimercaptosuccinic Acid|technetium tc 99m dimercaptosuccinic acid|mesh-list
110844026|NCT03879005|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110844027|NCT03879005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110844028|NCT03878771|Clobetasol|clobetasol|mesh-list
110844029|NCT03878771|Benzocaine|benzocaine|mesh-list
110844030|NCT03878771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110844031|NCT03878771|Glucocorticoids|glucocorticoids|mesh-ancestor
110844032|NCT03878771|Hormones|hormones|mesh-ancestor
110844033|NCT03878771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110844034|NCT03878771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110844035|NCT03878771|Anesthetics, Local|anesthetics, local|mesh-ancestor
110844036|NCT03878771|Anesthetics|anesthetics|mesh-ancestor
110844037|NCT03878771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110844038|NCT03878771|Sensory System Agents|sensory system agents|mesh-ancestor
110844039|NCT03878771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110844040|NCT02959918|Sirolimus|sirolimus|mesh-list
110844041|NCT02959918|Temsirolimus|temsirolimus|mesh-list
110844042|NCT02959918|MTOR Inhibitors|mtor inhibitors|mesh-list
110844043|NCT02959918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110844044|NCT02959918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110844045|NCT02959918|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110844046|NCT02959918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110844047|NCT02959918|Antifungal Agents|antifungal agents|mesh-ancestor
110844048|NCT02959918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110844049|NCT02959918|Immunologic Factors|immunologic factors|mesh-ancestor
110844050|NCT02959918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110844051|NCT02959918|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110844052|NCT02959918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110844053|NCT02959918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110844055|NCT01266707|Vaccines|vaccines|mesh-list
110844056|NCT01266707|Immunologic Factors|immunologic factors|mesh-ancestor
110844057|NCT01266707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110844058|NCT01266707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110844059|NCT01266707|Growth Substances|growth substances|mesh-ancestor
110844060|NCT01266707|Growth Inhibitors|growth inhibitors|mesh-ancestor
110844061|NCT01266707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110844063|NCT03263442|Vitamin B Complex|vitamin b complex|mesh-ancestor
110844064|NCT03263442|Vitamins|vitamins|mesh-ancestor
110844065|NCT03263442|Micronutrients|micronutrients|mesh-ancestor
110844066|NCT03263442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110844067|NCT01164215|Leucovorin|leucovorin|mesh-list
110844068|NCT01164215|Fluorouracil|fluorouracil|mesh-list
110844069|NCT01164215|Oxaliplatin|oxaliplatin|mesh-list
110844070|NCT01164215|Levoleucovorin|levoleucovorin|mesh-list
110844071|NCT01164215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110844072|NCT01164215|Antimetabolites|antimetabolites|mesh-ancestor
110844073|NCT01164215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110844074|NCT01164215|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110844075|NCT01164215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110844076|NCT01164215|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110844077|NCT01164215|Immunologic Factors|immunologic factors|mesh-ancestor
110844078|NCT01164215|Antidotes|antidotes|mesh-ancestor
110844079|NCT01164215|Protective Agents|protective agents|mesh-ancestor
110844080|NCT01164215|Vitamin B Complex|vitamin b complex|mesh-ancestor
110844081|NCT01164215|Vitamins|vitamins|mesh-ancestor
110844082|NCT01164215|Micronutrients|micronutrients|mesh-ancestor
110844083|NCT04245709|Clenbuterol|clenbuterol|mesh-list
110844084|NCT04245709|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110844085|NCT04245709|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110844086|NCT04245709|Adrenergic Agents|adrenergic agents|mesh-ancestor
110844087|NCT04245709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110844088|NCT04245709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110844089|NCT04245709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110844090|NCT04245709|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110844091|NCT04245709|Autonomic Agents|autonomic agents|mesh-ancestor
110844092|NCT04245709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110844093|NCT04245709|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110844094|NCT04245709|Respiratory System Agents|respiratory system agents|mesh-ancestor
110844095|NCT04245709|Sympathomimetics|sympathomimetics|mesh-ancestor
110844096|NCT03878693|Fomepizole|fomepizole|mesh-list
110844097|NCT03878693|Antidotes|antidotes|mesh-ancestor
110844098|NCT03878693|Protective Agents|protective agents|mesh-ancestor
110844099|NCT03878693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110844100|NCT03878693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110844101|NCT03878693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110844102|NCT05305495|Empagliflozin|empagliflozin|mesh-list
110844103|NCT05305495|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110844104|NCT05305495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110844105|NCT05305495|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110844106|NCT05305495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110844107|NCT03748537|Hydrocortisone|hydrocortisone|mesh-list
110844108|NCT03748537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110844110|NCT02527109|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110844111|NCT02527109|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110844112|NCT02527109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110844113|NCT02527109|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110844114|NCT02527109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110844116|NCT02527109|Tocolytic Agents|tocolytic agents|mesh-ancestor
110077149|NCT01953926|Trastuzumab|trastuzumab|mesh-list
110844117|NCT02527109|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110844118|NCT02940522|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
110844119|NCT02940522|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
110844120|NCT02940522|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110844121|NCT02940522|Hormone Antagonists|hormone antagonists|mesh-ancestor
110844122|NCT02940522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110844123|NCT02940522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110844124|NCT02940522|Progestins|progestins|mesh-ancestor
110844125|NCT02940522|Hormones|hormones|mesh-ancestor
110844126|NCT01266785|Infliximab|infliximab|mesh-list
110844127|NCT01266785|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110844128|NCT01266785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110844129|NCT01266785|Dermatologic Agents|dermatologic agents|mesh-ancestor
110844130|NCT01266785|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110844131|NCT01266785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110844132|NCT03262038|Ondansetron|ondansetron|mesh-list
110844133|NCT03262038|Antiemetics|antiemetics|mesh-ancestor
110844134|NCT03262038|Autonomic Agents|autonomic agents|mesh-ancestor
110844135|NCT03262038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110844136|NCT03262038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110844137|NCT03262038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110844138|NCT03262038|Antipruritics|antipruritics|mesh-ancestor
110844139|NCT03262038|Dermatologic Agents|dermatologic agents|mesh-ancestor
110844140|NCT03262038|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110844141|NCT03262038|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110844142|NCT03262038|Serotonin Agents|serotonin agents|mesh-ancestor
110844143|NCT03262038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110844144|NCT03262038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110844145|NCT03746821|Biotin|biotin|mesh-list
110844146|NCT03746821|Vitamin B Complex|vitamin b complex|mesh-ancestor
110844147|NCT03746821|Vitamins|vitamins|mesh-ancestor
110844148|NCT03746821|Micronutrients|micronutrients|mesh-ancestor
110844149|NCT03746821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110844150|NCT02472964|Paclitaxel|paclitaxel|mesh-list
110844151|NCT02472964|Docetaxel|docetaxel|mesh-list
110844152|NCT02472964|Trastuzumab|trastuzumab|mesh-list
110844153|NCT02472964|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110612282|NCT05387811|Diuretics|diuretics|mesh-list
110844155|NCT02472964|Tubulin Modulators|tubulin modulators|mesh-ancestor
110844156|NCT02472964|Antimitotic Agents|antimitotic agents|mesh-ancestor
110844157|NCT02472964|Mitosis Modulators|mitosis modulators|mesh-ancestor
110844158|NCT02472964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110844159|NCT02472964|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110844160|NCT01160315|Triptorelin Pamoate|triptorelin pamoate|mesh-list
110844161|NCT01160315|Norethindrone|norethindrone|mesh-list
110844162|NCT01160315|Norethindrone Acetate|norethindrone acetate|mesh-list
110844163|NCT01160315|Luteolytic Agents|luteolytic agents|mesh-ancestor
110844164|NCT01160315|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110844165|NCT01160315|Contraceptive Agents|contraceptive agents|mesh-ancestor
110844166|NCT01160315|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110844167|NCT01160315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110844168|NCT01160315|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110831482|NCT01200121|Bevacizumab|bevacizumab|mesh-list
110844169|NCT01160315|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110682918|NCT00903851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110844170|NCT01160315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110844171|NCT01160315|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110844172|NCT01160315|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110844173|NCT01160315|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110844174|NCT03385174|Carbon Monoxide|carbon monoxide|mesh-list
110844175|NCT03385174|Antimetabolites|antimetabolites|mesh-ancestor
110844176|NCT03385174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110844177|NCT03385174|Gasotransmitters|gasotransmitters|mesh-ancestor
110844178|NCT03385174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110844179|NCT03385174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110844180|NCT01164605|Raltegravir Potassium|raltegravir potassium|mesh-list
110844181|NCT01164605|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110844182|NCT01164605|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110844183|NCT01164605|Antiviral Agents|antiviral agents|mesh-ancestor
110844184|NCT01164605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110844185|NCT01164605|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110844186|NCT01164605|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110844187|NCT01164605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110844188|NCT01164605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110844190|NCT03380728|Hallucinogens|hallucinogens|mesh-ancestor
110844191|NCT03380728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110844192|NCT03380728|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110844193|NCT03380728|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110844194|NCT03380728|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110844195|NCT03380728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110844196|NCT03380728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110844197|NCT01104922|Cetuximab|cetuximab|mesh-list
110844198|NCT01104922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110844199|NCT01104922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110844200|NCT01164761|Ramipril|ramipril|mesh-list
110844201|NCT01164761|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110844203|NCT01164761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110844204|NCT01164761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110844205|NCT01164761|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110844206|NCT03385096|Cyclophosphamide|cyclophosphamide|mesh-list
110844207|NCT03385096|Melphalan|melphalan|mesh-list
110844208|NCT03385096|Busulfan|busulfan|mesh-list
110844209|NCT03385096|Etoposide|etoposide|mesh-list
110844210|NCT03385096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110844211|NCT03385096|Immunologic Factors|immunologic factors|mesh-ancestor
110844212|NCT03385096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110844213|NCT03385096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110844214|NCT03385096|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110844215|NCT03385096|Alkylating Agents|alkylating agents|mesh-ancestor
110844216|NCT03385096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110612631|NCT04551521|Trastuzumab|trastuzumab|mesh-list
110844218|NCT03385096|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110844219|NCT03385096|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110844220|NCT03385096|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110844221|NCT03385096|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110844222|NCT03385096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110844223|NCT02526875|Amlodipine|amlodipine|mesh-list
110844224|NCT02526875|Telmisartan|telmisartan|mesh-list
110844225|NCT02526875|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110844226|NCT02526875|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110844227|NCT02526875|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110844228|NCT02526875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110844229|NCT02526875|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110844230|NCT02526875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110844231|NCT02526875|Vasodilator Agents|vasodilator agents|mesh-ancestor
110844232|NCT02526875|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110612702|NCT04271189|Protease Inhibitors|protease inhibitors|mesh-ancestor
110844233|NCT02526875|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110844234|NCT04222699|Chlorhexidine|chlorhexidine|mesh-list
110844235|NCT04222699|Mupirocin|mupirocin|mesh-list
110844236|NCT04222699|Calcium|calcium|mesh-list
110844237|NCT04222699|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110612764|NCT04101721|Aflibercept|aflibercept|mesh-list
110844238|NCT04222699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110844239|NCT04222699|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110844240|NCT04222699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110844242|NCT04222699|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110844243|NCT04222699|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110844244|NCT04222699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110561855|NCT00646529|Autonomic Agents|autonomic agents|mesh-ancestor
110844245|NCT04222699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110844246|NCT01269203|Curcumin|curcumin|mesh-list
110844247|NCT01269203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110844248|NCT01269203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110844249|NCT01269203|Analgesics|analgesics|mesh-ancestor
110844250|NCT01269203|Sensory System Agents|sensory system agents|mesh-ancestor
110844251|NCT01269203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110844252|NCT01269203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110844253|NCT01269203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110844254|NCT01269203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110844255|NCT01269203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110844256|NCT01269203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110844257|NCT01269203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110844258|NCT01160627|Acetylcysteine|acetylcysteine|mesh-list
110844259|NCT01160627|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110844260|NCT01160627|Antiviral Agents|antiviral agents|mesh-ancestor
110844261|NCT01160627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110844263|NCT01160627|Respiratory System Agents|respiratory system agents|mesh-ancestor
110844264|NCT01160627|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110844265|NCT01160627|Antioxidants|antioxidants|mesh-ancestor
110844266|NCT01160627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110844267|NCT01160627|Protective Agents|protective agents|mesh-ancestor
110844268|NCT01160627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110844269|NCT01160627|Antidotes|antidotes|mesh-ancestor
110844270|NCT04075513|Insulin|insulin|mesh-list
110844271|NCT04075513|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110844272|NCT04075513|Insulin Glargine|insulin glargine|mesh-list
110844273|NCT04075513|Insulin, Short-Acting|insulin, short-acting|mesh-list
110844274|NCT04075513|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110844275|NCT04075513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110844276|NCT03877679|Triamcinolone|triamcinolone|mesh-list
110844277|NCT03877679|Curcumin|curcumin|mesh-list
110844278|NCT03877679|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110844279|NCT03877679|Glucocorticoids|glucocorticoids|mesh-ancestor
110844280|NCT03877679|Hormones|hormones|mesh-ancestor
110844281|NCT03877679|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110844282|NCT03877679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110844284|NCT03877679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110844285|NCT03877679|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110844286|NCT03877679|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110844287|NCT03877679|Analgesics|analgesics|mesh-ancestor
110844288|NCT03877679|Sensory System Agents|sensory system agents|mesh-ancestor
110844289|NCT03877679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110844290|NCT03877679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110844291|NCT03877679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110844292|NCT03330249|Cisplatin|cisplatin|mesh-list
110844293|NCT03330249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110844294|NCT04652206|Paclitaxel|paclitaxel|mesh-list
110844295|NCT04652206|Gemcitabine|gemcitabine|mesh-list
110844296|NCT04652206|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110844297|NCT04652206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110844299|NCT04652206|Antimitotic Agents|antimitotic agents|mesh-ancestor
110844300|NCT04652206|Mitosis Modulators|mitosis modulators|mesh-ancestor
110844301|NCT04652206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110844302|NCT04652206|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110844303|NCT04652206|Antimetabolites|antimetabolites|mesh-ancestor
110844304|NCT01269281|Sumatriptan|sumatriptan|mesh-list
110844305|NCT01269281|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110844306|NCT01269281|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110844307|NCT01269281|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110844309|NCT01269281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110844310|NCT01269281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110870381|NCT02394418|Anesthetics, General|anesthetics, general|mesh-ancestor
110844311|NCT01269281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110844313|NCT02778204|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110844314|NCT02778204|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110613519|NCT04588948|Growth Substances|growth substances|mesh-ancestor
110844315|NCT02778204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110844316|NCT02778204|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110561925|NCT02663999|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110844317|NCT02778204|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110844318|NCT02778204|Antiviral Agents|antiviral agents|mesh-ancestor
110844319|NCT02778204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110613593|NCT04488952|Anesthetics|anesthetics|mesh-list
110844320|NCT02778204|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
110844322|NCT01160705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110844323|NCT01160705|Tubulin Modulators|tubulin modulators|mesh-ancestor
110844324|NCT01160705|Antimitotic Agents|antimitotic agents|mesh-ancestor
110844325|NCT01160705|Mitosis Modulators|mitosis modulators|mesh-ancestor
110844326|NCT01160705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110844327|NCT03232281|Triptorelin Pamoate|triptorelin pamoate|mesh-list
110844328|NCT03232281|Luteolytic Agents|luteolytic agents|mesh-ancestor
110844329|NCT03232281|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110613731|NCT00760032|Ciprofloxacin|ciprofloxacin|mesh-list
110844330|NCT03232281|Contraceptive Agents|contraceptive agents|mesh-ancestor
110844331|NCT03232281|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110844332|NCT03232281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110844333|NCT03232281|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110844334|NCT03232281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110844335|NCT03232281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110844336|NCT03261336|Vitamin D|vitamin d|mesh-list
110844337|NCT03261336|Calcitriol|calcitriol|mesh-list
110844338|NCT03261336|Ketoconazole|ketoconazole|mesh-list
110844339|NCT03261336|Hydrocortisone|hydrocortisone|mesh-list
110844340|NCT03261336|Vitamins|vitamins|mesh-ancestor
110844341|NCT03261336|Micronutrients|micronutrients|mesh-ancestor
110844342|NCT03261336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110844343|NCT03261336|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110844344|NCT03261336|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110844345|NCT03261336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110844346|NCT03261336|Antifungal Agents|antifungal agents|mesh-ancestor
110844347|NCT03261336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110844348|NCT03261336|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110613930|NCT05279482|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110844349|NCT03261336|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110844350|NCT03261336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110844351|NCT03261336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110844352|NCT03261336|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110844353|NCT03261336|Hormone Antagonists|hormone antagonists|mesh-ancestor
110844354|NCT03261336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110844355|NCT03261336|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110844356|NCT03261336|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
110844357|NCT03261336|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110844358|NCT03261336|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110844359|NCT03384862|Folic Acid|folic acid|mesh-list
110844360|NCT03384862|Vitamin B 12|vitamin b 12|mesh-list
110844361|NCT03384862|Hydroxocobalamin|hydroxocobalamin|mesh-list
110844363|NCT03384862|Micronutrients|micronutrients|mesh-ancestor
110844364|NCT03384862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110844365|NCT03384862|Hematinics|hematinics|mesh-ancestor
110844366|NCT03384862|Vitamin B Complex|vitamin b complex|mesh-ancestor
110844368|NCT01269437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110844369|NCT01269437|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110844370|NCT01269437|Autonomic Agents|autonomic agents|mesh-ancestor
110844371|NCT01269437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110844372|NCT01269437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110844373|NCT01269437|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110844374|NCT01269437|Respiratory System Agents|respiratory system agents|mesh-ancestor
110844375|NCT01269437|Glucocorticoids|glucocorticoids|mesh-ancestor
110844376|NCT01269437|Hormones|hormones|mesh-ancestor
110844377|NCT01269437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110844378|NCT03909269|Carbon Monoxide|carbon monoxide|mesh-list
110844379|NCT03909269|Antimetabolites|antimetabolites|mesh-ancestor
110844380|NCT03909269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110844381|NCT03909269|Gasotransmitters|gasotransmitters|mesh-ancestor
110844382|NCT03909269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110844383|NCT03909269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110844385|NCT00462748|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110844386|NCT00462748|Simvastatin|simvastatin|mesh-list
110844388|NCT00462748|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110844389|NCT00462748|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110844390|NCT00462748|Antimetabolites|antimetabolites|mesh-ancestor
110844391|NCT00462748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110844392|NCT00462748|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110844393|NCT00462748|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110844394|NCT00462748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110844395|NCT01161017|Topiramate|topiramate|mesh-list
110844396|NCT01161017|Amitriptyline|amitriptyline|mesh-list
110844397|NCT01161017|Anticonvulsants|anticonvulsants|mesh-ancestor
110844398|NCT01161017|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110844399|NCT01161017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110614412|NCT00891267|Vasodilator Agents|vasodilator agents|mesh-ancestor
110844400|NCT01161017|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110844401|NCT01161017|Antidepressive Agents|antidepressive agents|mesh-ancestor
110844402|NCT01161017|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110844403|NCT01161017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110844404|NCT01161017|Analgesics|analgesics|mesh-ancestor
110844405|NCT01161017|Sensory System Agents|sensory system agents|mesh-ancestor
110844406|NCT01161017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110844407|NCT01161017|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110844408|NCT01161017|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110844409|NCT01161017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110844410|NCT01161017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110844411|NCT01161017|Adrenergic Agents|adrenergic agents|mesh-ancestor
110844412|NCT01161017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110844414|NCT03935685|Antidepressive Agents|antidepressive agents|mesh-ancestor
110614702|NCT00608985|Zolpidem|zolpidem|mesh-list
110844415|NCT03935685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110844416|NCT03935685|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110844417|NCT03935685|Histamine Antagonists|histamine antagonists|mesh-ancestor
110844418|NCT03935685|Histamine Agents|histamine agents|mesh-ancestor
110844419|NCT03935685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110844420|NCT03935685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110844421|NCT03935685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110844422|NCT03935685|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110844423|NCT03935685|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110844424|NCT03935685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110844425|NCT03935685|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
110844426|NCT03935685|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110844427|NCT03935685|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110844428|NCT03935685|Adrenergic Agents|adrenergic agents|mesh-ancestor
110614918|NCT00869271|Leucovorin|leucovorin|mesh-list
110844429|NCT03935685|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110844430|NCT03935685|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110844432|NCT03935685|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110844433|NCT01164917|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110844434|NCT01164917|Immunologic Factors|immunologic factors|mesh-ancestor
110614974|NCT01051531|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110844435|NCT01164917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110844436|NCT03238911|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
110844437|NCT03238911|Hematinics|hematinics|mesh-ancestor
110844438|NCT01269515|Etoricoxib|etoricoxib|mesh-list
110844439|NCT01269515|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110844440|NCT01269515|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110844441|NCT01269515|Analgesics|analgesics|mesh-ancestor
110844442|NCT01269515|Sensory System Agents|sensory system agents|mesh-ancestor
110844443|NCT01269515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110844444|NCT01269515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110844445|NCT01269515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110615106|NCT00894621|Autonomic Agents|autonomic agents|mesh-ancestor
110844446|NCT01269515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110844447|NCT01269515|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110844448|NCT01269515|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110844449|NCT01269515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110844450|NCT01269515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110844451|NCT00418834|Atorvastatin|atorvastatin|mesh-list
110844453|NCT00418834|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110844454|NCT00418834|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110844455|NCT00418834|Antimetabolites|antimetabolites|mesh-ancestor
110844456|NCT00418834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110844457|NCT00418834|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110844458|NCT00418834|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110844459|NCT00418834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110844460|NCT01269671|Peppermint oil|peppermint oil|mesh-list
110844461|NCT01269671|Melatonin|melatonin|mesh-list
110844462|NCT01269671|Simethicone|simethicone|mesh-list
110844463|NCT01269671|Antioxidants|antioxidants|mesh-ancestor
110844464|NCT01269671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110844465|NCT01269671|Protective Agents|protective agents|mesh-ancestor
110844466|NCT01269671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110844467|NCT01269671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110844468|NCT01269671|Antifoaming Agents|antifoaming agents|mesh-ancestor
110844469|NCT01269671|Emollients|emollients|mesh-ancestor
110844470|NCT01269671|Dermatologic Agents|dermatologic agents|mesh-ancestor
110844471|NCT01269671|Antiemetics|antiemetics|mesh-ancestor
110844472|NCT01269671|Autonomic Agents|autonomic agents|mesh-ancestor
110844473|NCT01269671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110844474|NCT01269671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110844475|NCT01269671|Parasympatholytics|parasympatholytics|mesh-ancestor
110844476|NCT04407286|Vitamin D|vitamin d|mesh-list
110844477|NCT04407286|Cholecalciferol|cholecalciferol|mesh-list
110844478|NCT04407286|Vitamins|vitamins|mesh-ancestor
110844479|NCT04407286|Micronutrients|micronutrients|mesh-ancestor
110844480|NCT04407286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110615404|NCT00982540|Miconazole|miconazole|mesh-list
110844481|NCT04407286|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110844482|NCT04407286|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110844483|NCT03276975|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
110844484|NCT03276975|Hemostatics|hemostatics|mesh-ancestor
110844485|NCT03276975|Coagulants|coagulants|mesh-ancestor
110844486|NCT03125746|Exemestane|exemestane|mesh-list
110844487|NCT03125746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110844488|NCT03125746|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110844489|NCT03125746|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110844490|NCT03125746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110844491|NCT03125746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110844492|NCT03125746|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110844493|NCT03125746|Hormone Antagonists|hormone antagonists|mesh-ancestor
110615518|NCT04006054|Anesthetics|anesthetics|mesh-ancestor
110844494|NCT03125746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110844495|NCT03125746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110844496|NCT03877601|Bevacizumab|bevacizumab|mesh-list
110615579|NCT00349921|Vasodilator Agents|vasodilator agents|mesh-ancestor
110844497|NCT03877601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110844498|NCT03877601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110844499|NCT03877601|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110844500|NCT03877601|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110844501|NCT03877601|Growth Substances|growth substances|mesh-ancestor
110844502|NCT03877601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110844503|NCT03877601|Growth Inhibitors|growth inhibitors|mesh-ancestor
110844504|NCT03297216|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
110844505|NCT03297216|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
110844506|NCT03297216|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110831528|NCT01198639|Narcotics|narcotics|mesh-ancestor
110844507|NCT03297216|Hormone Antagonists|hormone antagonists|mesh-ancestor
110844508|NCT03297216|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110844509|NCT03297216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110844510|NCT03297216|Progestins|progestins|mesh-ancestor
110844511|NCT03297216|Hormones|hormones|mesh-ancestor
110844512|NCT03260868|Insulin|insulin|mesh-list
110844513|NCT03260868|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110844514|NCT03260868|Insulin Glargine|insulin glargine|mesh-list
110844515|NCT03260868|Insulin Lispro|insulin lispro|mesh-list
110844516|NCT03260868|Insulin Aspart|insulin aspart|mesh-list
110844517|NCT03260868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110844518|NCT03260868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110844519|NCT01165385|Cisplatin|cisplatin|mesh-list
110844520|NCT01165385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110844521|NCT01267487|Heparin|heparin|mesh-list
110844522|NCT01267487|Calcium heparin|calcium heparin|mesh-list
110844523|NCT01267487|Protamines|protamines|mesh-list
110844524|NCT01267487|Anticoagulants|anticoagulants|mesh-ancestor
110844525|NCT01267487|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110844526|NCT01267487|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110844527|NCT01267487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110844528|NCT01267487|Heparin Antagonists|heparin antagonists|mesh-ancestor
110844529|NCT01267487|Coagulants|coagulants|mesh-ancestor
110844530|NCT01267643|Alefacept|alefacept|mesh-list
110844531|NCT01267643|Dermatologic Agents|dermatologic agents|mesh-ancestor
110844532|NCT01267643|Immunologic Factors|immunologic factors|mesh-ancestor
110844533|NCT01267643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110844534|NCT01269827|Pentoxifylline|pentoxifylline|mesh-list
110844535|NCT01269827|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110844536|NCT01269827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110844537|NCT01269827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110844538|NCT01269827|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110844539|NCT01269827|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110844540|NCT01269827|Protective Agents|protective agents|mesh-ancestor
110844541|NCT01269827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110844542|NCT01269827|Vasodilator Agents|vasodilator agents|mesh-ancestor
110844543|NCT01269827|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110844544|NCT01269827|Antioxidants|antioxidants|mesh-ancestor
110844545|NCT03388372|Temozolomide|temozolomide|mesh-list
110844546|NCT03388372|Nimotuzumab|nimotuzumab|mesh-list
110844547|NCT03388372|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110844548|NCT03388372|Alkylating Agents|alkylating agents|mesh-ancestor
110844549|NCT03388372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110844550|NCT03388372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110844551|NCT03388372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110844553|NCT05173246|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110844554|NCT05173246|Cisplatin|cisplatin|mesh-list
110844555|NCT05173246|Carboplatin|carboplatin|mesh-list
110844556|NCT05173246|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110844558|NCT05173246|Tubulin Modulators|tubulin modulators|mesh-ancestor
110844559|NCT05173246|Antimitotic Agents|antimitotic agents|mesh-ancestor
110844560|NCT05173246|Mitosis Modulators|mitosis modulators|mesh-ancestor
110844561|NCT05173246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110844562|NCT01167101|Pantoprazole|pantoprazole|mesh-list
110844563|NCT01167101|Rebamipide|rebamipide|mesh-list
110844564|NCT01167101|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110844565|NCT01167101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110844566|NCT01167101|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110844567|NCT01167101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110844568|NCT01167101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110844569|NCT01167101|Antioxidants|antioxidants|mesh-ancestor
110844570|NCT01167101|Protective Agents|protective agents|mesh-ancestor
110844571|NCT01167101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110844572|NCT05173090|Ropivacaine|ropivacaine|mesh-list
110844573|NCT05173090|Anesthetics, Local|anesthetics, local|mesh-ancestor
110844574|NCT05173090|Anesthetics|anesthetics|mesh-ancestor
110844575|NCT05173090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110844576|NCT05173090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110870382|NCT02394418|Anesthetics|anesthetics|mesh-ancestor
110844577|NCT05173090|Sensory System Agents|sensory system agents|mesh-ancestor
110844578|NCT05173090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110844579|NCT02526953|Paclitaxel|paclitaxel|mesh-list
110844580|NCT02526953|Capecitabine|capecitabine|mesh-list
110844581|NCT02526953|Mitomycins|mitomycins|mesh-list
110844582|NCT02526953|Mitomycin|mitomycin|mesh-list
110844583|NCT02526953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110844584|NCT02526953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110844585|NCT02526953|Tubulin Modulators|tubulin modulators|mesh-ancestor
110844586|NCT02526953|Antimitotic Agents|antimitotic agents|mesh-ancestor
110615811|NCT00904449|Analgesics|analgesics|mesh-ancestor
110844587|NCT02526953|Mitosis Modulators|mitosis modulators|mesh-ancestor
110844588|NCT02526953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110615868|NCT00905229|Vitamins|vitamins|mesh-list
110844589|NCT02526953|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110844590|NCT02526953|Antimetabolites|antimetabolites|mesh-ancestor
110844591|NCT02526953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110844592|NCT02526953|Alkylating Agents|alkylating agents|mesh-ancestor
110844593|NCT02526953|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110844594|NCT02526953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110844595|NCT03258762|Leucovorin|leucovorin|mesh-list
110844596|NCT03258762|Pyrimethamine|pyrimethamine|mesh-list
110844597|NCT03258762|Calcium|calcium|mesh-list
110844598|NCT03258762|Levoleucovorin|levoleucovorin|mesh-list
110844599|NCT03258762|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110844600|NCT03258762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110844602|NCT03258762|Protective Agents|protective agents|mesh-ancestor
110844603|NCT03258762|Vitamin B Complex|vitamin b complex|mesh-ancestor
110844604|NCT03258762|Vitamins|vitamins|mesh-ancestor
110844605|NCT03258762|Micronutrients|micronutrients|mesh-ancestor
110844606|NCT03258762|Antimalarials|antimalarials|mesh-ancestor
110844607|NCT03258762|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110844608|NCT03258762|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110844609|NCT03258762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110844610|NCT03258762|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110844611|NCT03258762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110844612|NCT03258762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110844613|NCT05427669|Leucovorin|leucovorin|mesh-list
110844614|NCT05427669|Fluorouracil|fluorouracil|mesh-list
110844615|NCT05427669|Oxaliplatin|oxaliplatin|mesh-list
110844616|NCT05427669|Irinotecan|irinotecan|mesh-list
110844617|NCT05427669|Levoleucovorin|levoleucovorin|mesh-list
110844618|NCT05427669|Antimetabolites|antimetabolites|mesh-ancestor
110844619|NCT05427669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110844620|NCT05427669|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110844621|NCT05427669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110844622|NCT05427669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110844623|NCT05427669|Immunologic Factors|immunologic factors|mesh-ancestor
110844624|NCT05427669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110844625|NCT05427669|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110844626|NCT05427669|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110844627|NCT05427669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110844628|NCT05427669|Antidotes|antidotes|mesh-ancestor
110844629|NCT05427669|Protective Agents|protective agents|mesh-ancestor
110844630|NCT05427669|Vitamin B Complex|vitamin b complex|mesh-ancestor
110844631|NCT05427669|Vitamins|vitamins|mesh-ancestor
110844632|NCT05427669|Micronutrients|micronutrients|mesh-ancestor
110844633|NCT01270373|Docetaxel|docetaxel|mesh-list
110844634|NCT01270373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110844635|NCT01270373|Tubulin Modulators|tubulin modulators|mesh-ancestor
110844636|NCT01270373|Antimitotic Agents|antimitotic agents|mesh-ancestor
110844637|NCT01270373|Mitosis Modulators|mitosis modulators|mesh-ancestor
110844638|NCT01270373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110844639|NCT03713086|Vaccines|vaccines|mesh-list
110844640|NCT03713086|Immunologic Factors|immunologic factors|mesh-ancestor
110844641|NCT03713086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110844642|NCT01271231|Azithromycin|azithromycin|mesh-list
110844644|NCT01271231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110844645|NCT03697876|Hyaluronic Acid|hyaluronic acid|mesh-list
110844646|NCT03697876|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110844648|NCT03697876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110844649|NCT03697876|Viscosupplements|viscosupplements|mesh-ancestor
110844650|NCT03697876|Protective Agents|protective agents|mesh-ancestor
110844651|NCT04526691|Carboplatin|carboplatin|mesh-list
110844652|NCT04526691|Pembrolizumab|pembrolizumab|mesh-list
110844653|NCT04526691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110844654|NCT04526691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110844655|NCT04526691|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110616559|NCT00357097|Ropinirole|ropinirole|mesh-list
110616572|NCT00983944|Prednisone|prednisone|mesh-list
110844656|NCT04526691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110844657|NCT01280669|Sirolimus|sirolimus|mesh-list
110844658|NCT01280669|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110844659|NCT01280669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110844660|NCT01280669|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110844661|NCT01280669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110844662|NCT01280669|Antifungal Agents|antifungal agents|mesh-ancestor
110844663|NCT01280669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110844664|NCT01280669|Immunologic Factors|immunologic factors|mesh-ancestor
110844665|NCT01280669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110844666|NCT03379558|Alirocumab|alirocumab|mesh-list
110844667|NCT03379558|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
110616700|NCT01053481|Vitamin D|vitamin d|mesh-list
110844668|NCT03379558|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110844669|NCT03379558|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110844670|NCT03379558|Antimetabolites|antimetabolites|mesh-ancestor
110844671|NCT03379558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110844672|NCT03379558|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110844673|NCT03379558|Protease Inhibitors|protease inhibitors|mesh-ancestor
110844674|NCT03379558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110616834|NCT00987454|Epoetin Alfa|epoetin alfa|mesh-list
110844675|NCT03379558|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110844677|NCT01169909|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110844678|NCT01169909|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110844679|NCT01169909|Growth Substances|growth substances|mesh-ancestor
110844680|NCT01169909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110844681|NCT01169909|Growth Inhibitors|growth inhibitors|mesh-ancestor
110844682|NCT01169909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110844683|NCT04502589|Disulfiram|disulfiram|mesh-list
110844684|NCT04502589|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110335269|NCT00494897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110844685|NCT04502589|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
110844686|NCT04502589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110844687|NCT04502589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110844688|NCT03387904|Irinotecan|irinotecan|mesh-list
110844689|NCT03387904|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110617038|NCT00540046|Copper|copper|mesh-list
110844690|NCT03387904|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110844691|NCT03387904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110844692|NCT03387904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110844693|NCT03387904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110844694|NCT03291288|Tolbutamide|tolbutamide|mesh-list
110844695|NCT03291288|Midazolam|midazolam|mesh-list
110844696|NCT03291288|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110844697|NCT03291288|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110844698|NCT03291288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110682919|NCT00903851|Sensory System Agents|sensory system agents|mesh-ancestor
110617115|NCT00671034|Mercaptopurine|mercaptopurine|mesh-list
110844699|NCT03291288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110844700|NCT03291288|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110844701|NCT03291288|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110844702|NCT03291288|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110844703|NCT03291288|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110844704|NCT03291288|Anesthetics, General|anesthetics, general|mesh-ancestor
110844705|NCT03291288|Anesthetics|anesthetics|mesh-ancestor
110844706|NCT03291288|GABA Modulators|gaba modulators|mesh-ancestor
110844707|NCT03291288|GABA Agents|gaba agents|mesh-ancestor
110844708|NCT03291288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110844709|NCT03291288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110844711|NCT05172310|FAPI-46|fapi-46|mesh-list
110844712|NCT05172310|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110844713|NCT05172310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110617329|NCT00743912|Rifaximin|rifaximin|mesh-list
110844714|NCT03636711|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110844715|NCT03636711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110844716|NCT04084626|Lenalidomide|lenalidomide|mesh-list
110844717|NCT04084626|Antibodies|antibodies|mesh-list
110844718|NCT04084626|Immunologic Factors|immunologic factors|mesh-ancestor
110617405|NCT00669864|Metformin|metformin|mesh-list
110844719|NCT04084626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110844720|NCT04084626|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110844721|NCT04084626|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110844722|NCT04084626|Growth Substances|growth substances|mesh-ancestor
110844723|NCT04084626|Growth Inhibitors|growth inhibitors|mesh-ancestor
110844724|NCT04084626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110844725|NCT03387826|Ticagrelor|ticagrelor|mesh-list
110844726|NCT03387826|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
110844727|NCT03387826|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110844728|NCT03387826|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110844729|NCT03387826|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110844730|NCT03387826|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110844731|NCT03387826|Purinergic Agents|purinergic agents|mesh-ancestor
110844732|NCT03387826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110335290|NCT00494897|Mitosis Modulators|mitosis modulators|mesh-ancestor
110844733|NCT03387826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110844734|NCT03387826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110844735|NCT03871517|Aspirin|aspirin|mesh-list
110844736|NCT03871517|Indobufen|indobufen|mesh-list
110844737|NCT03871517|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110617672|NCT00400946|Cytarabine|cytarabine|mesh-list
110844738|NCT03871517|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110844739|NCT03871517|Analgesics|analgesics|mesh-ancestor
110844740|NCT03871517|Sensory System Agents|sensory system agents|mesh-ancestor
110844741|NCT03871517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110844742|NCT03871517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110844743|NCT03871517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110844744|NCT03871517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110844745|NCT03871517|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110844746|NCT03871517|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110844747|NCT03871517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110844748|NCT03871517|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110844749|NCT03871517|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110844750|NCT03871517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110844751|NCT03871517|Antipyretics|antipyretics|mesh-ancestor
110844753|NCT03387592|Fluorouracil|fluorouracil|mesh-list
110844754|NCT03387592|Capecitabine|capecitabine|mesh-list
110844755|NCT03387592|Temozolomide|temozolomide|mesh-list
110844756|NCT03387592|Levoleucovorin|levoleucovorin|mesh-list
110844757|NCT03387592|Antimetabolites|antimetabolites|mesh-ancestor
110844758|NCT03387592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110844759|NCT03387592|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110844760|NCT03387592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110844761|NCT03387592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110844762|NCT03387592|Immunologic Factors|immunologic factors|mesh-ancestor
110844763|NCT03387592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110844764|NCT03387592|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110844765|NCT03387592|Alkylating Agents|alkylating agents|mesh-ancestor
110844766|NCT03387592|Antidotes|antidotes|mesh-ancestor
110844767|NCT03387592|Protective Agents|protective agents|mesh-ancestor
110844768|NCT03387592|Vitamin B Complex|vitamin b complex|mesh-ancestor
110844769|NCT03387592|Vitamins|vitamins|mesh-ancestor
110844770|NCT03387592|Micronutrients|micronutrients|mesh-ancestor
110844771|NCT04445506|Dexamethasone|dexamethasone|mesh-list
110844772|NCT04445506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110844773|NCT04445506|Antiemetics|antiemetics|mesh-ancestor
110844774|NCT04445506|Autonomic Agents|autonomic agents|mesh-ancestor
110844775|NCT04445506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110844776|NCT04445506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110844777|NCT04445506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110844778|NCT04445506|Glucocorticoids|glucocorticoids|mesh-ancestor
110870383|NCT02394418|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110844780|NCT04445506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110844781|NCT04445506|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110844782|NCT04445506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110844784|NCT03379012|Methyltestosterone|methyltestosterone|mesh-list
110844785|NCT03379012|Testosterone|testosterone|mesh-list
110844786|NCT03379012|Testosterone undecanoate|testosterone undecanoate|mesh-list
110844787|NCT03379012|Testosterone enanthate|testosterone enanthate|mesh-list
110844788|NCT03379012|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
110844789|NCT03379012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110844791|NCT03379012|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110844792|NCT03379012|Growth Substances|growth substances|mesh-ancestor
110844793|NCT03379012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110844794|NCT03379012|Growth Inhibitors|growth inhibitors|mesh-ancestor
110844795|NCT03379012|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110844796|NCT03379012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110844797|NCT03379012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110844798|NCT03379012|Androgens|androgens|mesh-ancestor
110844799|NCT03379012|Hormones|hormones|mesh-ancestor
110844800|NCT03379012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110844801|NCT03379012|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110844802|NCT03379012|Anabolic Agents|anabolic agents|mesh-ancestor
110844803|NCT03383302|Nivolumab|nivolumab|mesh-list
110844804|NCT03383302|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110844805|NCT03383302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110844806|NCT03383302|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110844807|NCT03383302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110844808|NCT03493126|Estradiol|estradiol|mesh-list
110844809|NCT03493126|Estrogens|estrogens|mesh-ancestor
110844810|NCT03493126|Hormones|hormones|mesh-ancestor
110844811|NCT03493126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110844812|NCT03493126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110844813|NCT03257358|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
110844814|NCT03257358|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
110844815|NCT03257358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110844817|NCT03257358|Immunologic Factors|immunologic factors|mesh-ancestor
110844818|NCT03257358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110844819|NCT03386656|Tranexamic Acid|tranexamic acid|mesh-list
110844820|NCT03386656|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110844821|NCT03386656|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110844822|NCT03386656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110844823|NCT03386656|Hemostatics|hemostatics|mesh-ancestor
110844824|NCT03386656|Coagulants|coagulants|mesh-ancestor
110844825|NCT01281527|Paliperidone Palmitate|paliperidone palmitate|mesh-list
110844826|NCT01281527|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110844827|NCT01281527|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110844828|NCT01281527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110844829|NCT01281527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110618724|NCT00931281|Ritonavir|ritonavir|mesh-list
110844830|NCT01281527|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110844831|NCT01281527|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110844832|NCT01281527|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110844833|NCT01281527|Serotonin Agents|serotonin agents|mesh-ancestor
110844834|NCT01281527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110844835|NCT01281527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110844836|NCT01281527|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110844837|NCT01281527|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110844838|NCT01281527|Dopamine Agents|dopamine agents|mesh-ancestor
110844839|NCT01281605|Insulin|insulin|mesh-list
110844840|NCT01281605|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110844841|NCT01281605|Insulin Detemir|insulin detemir|mesh-list
110844842|NCT01281605|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110844843|NCT01281605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110844844|NCT01170143|Trastuzumab|trastuzumab|mesh-list
110831563|NCT03940001|Carboplatin|carboplatin|mesh-list
110844845|NCT01170143|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110844846|NCT01170143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110844848|NCT05171530|Taxane|taxane|mesh-list
110844849|NCT05171530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110844850|NCT05171530|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110844851|NCT05171530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110844852|NCT05171530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110844854|NCT02936037|Vitamin B Complex|vitamin b complex|mesh-ancestor
110844855|NCT02936037|Vitamins|vitamins|mesh-ancestor
110844856|NCT02936037|Micronutrients|micronutrients|mesh-ancestor
110844857|NCT02936037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110844858|NCT04068181|Pembrolizumab|pembrolizumab|mesh-list
110844859|NCT04068181|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
110844860|NCT04068181|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110844861|NCT04068181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110844862|NCT04068181|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110844863|NCT04068181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110844864|NCT01283789|Everolimus|everolimus|mesh-list
110844865|NCT01283789|Lapatinib|lapatinib|mesh-list
110844866|NCT01283789|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110844867|NCT01283789|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110844868|NCT01283789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110844869|NCT01283789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110844870|NCT01283789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110844871|NCT01283789|Immunologic Factors|immunologic factors|mesh-ancestor
110844872|NCT01283789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110844873|NCT01283789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110844874|NCT03383068|Metformin|metformin|mesh-list
110844875|NCT03383068|Exenatide|exenatide|mesh-list
110844876|NCT03383068|Acarbose|acarbose|mesh-list
110844877|NCT03383068|Orlistat|orlistat|mesh-list
110844878|NCT03383068|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110844879|NCT03383068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110844880|NCT03383068|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110844881|NCT03383068|Incretins|incretins|mesh-ancestor
110844882|NCT03383068|Hormones|hormones|mesh-ancestor
110844883|NCT03383068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110844884|NCT03383068|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
110844885|NCT03383068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110844886|NCT03383068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110844887|NCT03383068|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110844888|NCT03378310|Linrodostat|linrodostat|mesh-list
110844889|NCT03378310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110844890|NCT03378310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110844891|NCT01283867|Mycophenolic Acid|mycophenolic acid|mesh-list
110844892|NCT01283867|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110844893|NCT01283867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110844894|NCT01283867|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110844895|NCT01283867|Antitubercular Agents|antitubercular agents|mesh-ancestor
110619117|NCT04004884|Contraceptive Agents|contraceptive agents|mesh-ancestor
110619118|NCT04004884|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110844896|NCT01283867|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110844897|NCT01283867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110844898|NCT01283867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110844899|NCT01283867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110844901|NCT04094298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110844902|NCT04094298|Glucocorticoids|glucocorticoids|mesh-ancestor
110844903|NCT04094298|Hormones|hormones|mesh-ancestor
110844904|NCT04094298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110844905|NCT04094298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110844906|NCT04094298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110844907|NCT04094298|Immunologic Factors|immunologic factors|mesh-ancestor
110844908|NCT04194151|Propofol|propofol|mesh-list
110844909|NCT04194151|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110844910|NCT04194151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110844911|NCT04194151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110844912|NCT04194151|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110844913|NCT04194151|Anesthetics, General|anesthetics, general|mesh-ancestor
110844915|NCT01281761|Irinotecan|irinotecan|mesh-list
110844916|NCT01281761|Cetuximab|cetuximab|mesh-list
110844917|NCT01281761|Simvastatin|simvastatin|mesh-list
110844918|NCT01281761|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110844919|NCT01281761|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110844920|NCT01281761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110844921|NCT01281761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110844922|NCT01281761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110844923|NCT01281761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110844924|NCT01281761|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110844925|NCT01281761|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110844926|NCT01281761|Antimetabolites|antimetabolites|mesh-ancestor
110844927|NCT01281761|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110844928|NCT01281761|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110844930|NCT04280328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110844931|NCT03748147|Misoprostol|misoprostol|mesh-list
110844932|NCT03748147|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110844933|NCT03748147|Abortifacient Agents|abortifacient agents|mesh-ancestor
110844934|NCT03748147|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110844935|NCT03748147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110844936|NCT03748147|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110844937|NCT03748147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110844938|NCT03748147|Oxytocics|oxytocics|mesh-ancestor
110844939|NCT01580813|Acipimox|acipimox|mesh-list
110844940|NCT01580813|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110844941|NCT01580813|Antimetabolites|antimetabolites|mesh-ancestor
110619352|NCT02562950|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110844942|NCT01580813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110844943|NCT01580813|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110844945|NCT04446364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110844946|NCT01588535|Benzocaine|benzocaine|mesh-list
110844947|NCT01588535|Anesthetics, Local|anesthetics, local|mesh-ancestor
110844948|NCT01588535|Anesthetics|anesthetics|mesh-ancestor
110844949|NCT01588535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110844950|NCT01588535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110844951|NCT01588535|Sensory System Agents|sensory system agents|mesh-ancestor
110844952|NCT01588535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110844953|NCT01165931|Riociguat|riociguat|mesh-list
110844954|NCT01165931|Enzyme Activators|enzyme activators|mesh-ancestor
110844955|NCT01165931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110844956|NCT03441282|Fentanyl|fentanyl|mesh-list
110844957|NCT03441282|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110844958|NCT03441282|Narcotics|narcotics|mesh-ancestor
110619497|NCT00797160|Anesthetics|anesthetics|mesh-ancestor
110844959|NCT03441282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110844960|NCT03441282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110844961|NCT03441282|Analgesics|analgesics|mesh-ancestor
110619564|NCT00681590|Vitamin D|vitamin d|mesh-list
110844963|NCT03441282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110844964|NCT03441282|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110844965|NCT03441282|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110844966|NCT03441282|Anesthetics, General|anesthetics, general|mesh-ancestor
110844967|NCT03441282|Anesthetics|anesthetics|mesh-ancestor
110844968|NCT01274273|Interferons|interferons|mesh-list
110844969|NCT01274273|Interferon-alpha|interferon-alpha|mesh-list
110844970|NCT01274273|Interferon alpha-2|interferon alpha-2|mesh-list
110844971|NCT01274273|Aldesleukin|aldesleukin|mesh-list
110844972|NCT01274273|Bevacizumab|bevacizumab|mesh-list
110844973|NCT01274273|Interleukin-2|interleukin-2|mesh-list
110844974|NCT01274273|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110844975|NCT01274273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110844976|NCT01274273|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110619771|NCT00326209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110844977|NCT01274273|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110844979|NCT01274273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110844980|NCT01274273|Growth Inhibitors|growth inhibitors|mesh-ancestor
110844981|NCT01274273|Antiviral Agents|antiviral agents|mesh-ancestor
110844982|NCT01274273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110844983|NCT01274273|Immunologic Factors|immunologic factors|mesh-ancestor
110844984|NCT01274273|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110844985|NCT01274273|Analgesics|analgesics|mesh-ancestor
110844986|NCT01274273|Sensory System Agents|sensory system agents|mesh-ancestor
110844987|NCT01274273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110844989|NCT01274273|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110844990|NCT04058353|Ivacaftor|ivacaftor|mesh-list
110844991|NCT04058353|Elexacaftor|elexacaftor|mesh-list
110844992|NCT04058353|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
110844993|NCT04058353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110844994|NCT04058353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110844995|NCT01167725|Leucovorin|leucovorin|mesh-list
110844996|NCT01167725|Bevacizumab|bevacizumab|mesh-list
110844997|NCT01167725|Cetuximab|cetuximab|mesh-list
110844998|NCT01167725|Fluorouracil|fluorouracil|mesh-list
110844999|NCT01167725|Capecitabine|capecitabine|mesh-list
110845000|NCT01167725|Oxaliplatin|oxaliplatin|mesh-list
110845001|NCT01167725|Irinotecan|irinotecan|mesh-list
110845002|NCT01167725|Mitomycins|mitomycins|mesh-list
110845003|NCT01167725|Mitomycin|mitomycin|mesh-list
110845004|NCT01167725|Levoleucovorin|levoleucovorin|mesh-list
110845005|NCT01167725|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110845006|NCT01167725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110845007|NCT01167725|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110845008|NCT01167725|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110845009|NCT01167725|Growth Substances|growth substances|mesh-ancestor
110845010|NCT01167725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110845011|NCT01167725|Growth Inhibitors|growth inhibitors|mesh-ancestor
110845012|NCT01167725|Antimetabolites|antimetabolites|mesh-ancestor
110845013|NCT01167725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110845014|NCT01167725|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110845015|NCT01167725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110845016|NCT01167725|Immunologic Factors|immunologic factors|mesh-ancestor
110845017|NCT01167725|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110831600|NCT01199029|Prednisone|prednisone|mesh-list
110845019|NCT01167725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110845020|NCT01167725|Antidotes|antidotes|mesh-ancestor
110845021|NCT01167725|Protective Agents|protective agents|mesh-ancestor
110845022|NCT01167725|Vitamin B Complex|vitamin b complex|mesh-ancestor
110845023|NCT01167725|Vitamins|vitamins|mesh-ancestor
110845024|NCT01167725|Micronutrients|micronutrients|mesh-ancestor
110620186|NCT00991744|Antimetabolites|antimetabolites|mesh-ancestor
110845025|NCT01167725|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110845026|NCT01167725|Alkylating Agents|alkylating agents|mesh-ancestor
110845027|NCT01167725|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110845028|NCT04446130|Decitabine|decitabine|mesh-list
110845029|NCT04446130|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110845030|NCT04446130|Antimetabolites|antimetabolites|mesh-ancestor
110620316|NCT00658632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110845031|NCT04446130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110845032|NCT04446130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110845033|NCT04446130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110845034|NCT03226275|Amlodipine|amlodipine|mesh-list
110845035|NCT03226275|Bisoprolol|bisoprolol|mesh-list
110845036|NCT03226275|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110845037|NCT03226275|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110845038|NCT03226275|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110845039|NCT03226275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110845040|NCT03226275|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110845041|NCT03226275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110845042|NCT03226275|Vasodilator Agents|vasodilator agents|mesh-ancestor
110845043|NCT03226275|Sympatholytics|sympatholytics|mesh-ancestor
110845044|NCT03226275|Autonomic Agents|autonomic agents|mesh-ancestor
110845045|NCT03226275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110845046|NCT03226275|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110845047|NCT03226275|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110845048|NCT03226275|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110845049|NCT03226275|Adrenergic Agents|adrenergic agents|mesh-ancestor
110845050|NCT03226275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110845052|NCT03382756|Atorvastatin|atorvastatin|mesh-list
110845053|NCT03382756|Fenofibrate|fenofibrate|mesh-list
110845054|NCT03382756|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110845055|NCT03382756|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110845056|NCT03382756|Antimetabolites|antimetabolites|mesh-ancestor
110845057|NCT03382756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110845058|NCT03382756|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110620516|NCT00562965|Alkylating Agents|alkylating agents|mesh-ancestor
110845059|NCT03382756|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110845060|NCT03382756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110845061|NCT03382756|Lipotropic Agents|lipotropic agents|mesh-ancestor
110845062|NCT03382756|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110845063|NCT03382756|Nootropic Agents|nootropic agents|mesh-ancestor
110620586|NCT01057849|Olanzapine|olanzapine|mesh-list
110845065|NCT01166087|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110335349|NCT00498134|Analgesics|analgesics|mesh-ancestor
110845066|NCT01166087|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110845067|NCT01166087|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110845068|NCT01166087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110845069|NCT01166087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110620654|NCT04978012|Fluzoparib|fluzoparib|mesh-list
110845070|NCT01166087|Serotonin Agents|serotonin agents|mesh-ancestor
110845071|NCT01166087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110845072|NCT01166087|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110845073|NCT01166087|Antidepressive Agents|antidepressive agents|mesh-ancestor
110620738|NCT00935805|Insulin|insulin|mesh-list
110845074|NCT01166087|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110845075|NCT01166087|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110845076|NCT01166087|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110845077|NCT01166087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110845079|NCT01170767|Ranibizumab|ranibizumab|mesh-list
110845080|NCT01170767|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110845081|NCT01170767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110845082|NCT01170767|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110620860|NCT00323869|Bevacizumab|bevacizumab|mesh-list
110845083|NCT01170767|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110845084|NCT01170767|Growth Substances|growth substances|mesh-ancestor
110845085|NCT01170767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110845086|NCT01170767|Growth Inhibitors|growth inhibitors|mesh-ancestor
110845087|NCT01170845|Sivelestat|sivelestat|mesh-list
110845088|NCT01170845|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110845089|NCT01170845|Protease Inhibitors|protease inhibitors|mesh-ancestor
110845090|NCT01170845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110845091|NCT01170845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110845092|NCT01150890|Brodalumab|brodalumab|mesh-list
110845093|NCT01150890|Dermatologic Agents|dermatologic agents|mesh-ancestor
110845094|NCT01167803|Desflurane|desflurane|mesh-list
110845095|NCT01167803|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110845096|NCT01167803|Anesthetics, General|anesthetics, general|mesh-ancestor
110845097|NCT01167803|Anesthetics|anesthetics|mesh-ancestor
110845098|NCT01167803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110621071|NCT01063621|Dopamine Agonists|dopamine agonists|mesh-ancestor
110845099|NCT01167803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110845100|NCT01275521|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
110845101|NCT01275521|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110845102|NCT01275521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110845103|NCT01275521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110845104|NCT01275521|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110845105|NCT01275521|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110845106|NCT01275521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110845107|NCT01275521|Cholinergic Agents|cholinergic agents|mesh-ancestor
110845108|NCT01275521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110845109|NCT01275911|Remifentanil|remifentanil|mesh-list
110845110|NCT01275911|Esmolol|esmolol|mesh-list
110845111|NCT01275911|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110845112|NCT01275911|Narcotics|narcotics|mesh-ancestor
110845113|NCT01275911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110845114|NCT01275911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110845116|NCT01275911|Sensory System Agents|sensory system agents|mesh-ancestor
110845117|NCT01275911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110845118|NCT01275911|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110845119|NCT01275911|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110845120|NCT01275911|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110845121|NCT01275911|Adrenergic Agents|adrenergic agents|mesh-ancestor
110845122|NCT01275911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110845123|NCT01275911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110845125|NCT01166165|Vitamin D|vitamin d|mesh-list
110845126|NCT01166165|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110845127|NCT01166165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110845128|NCT01166165|Vitamins|vitamins|mesh-ancestor
110845129|NCT01166165|Micronutrients|micronutrients|mesh-ancestor
110845130|NCT01166165|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110845131|NCT03286218|Alprazolam|alprazolam|mesh-list
110845132|NCT03286218|Lasmiditan|lasmiditan|mesh-list
110845133|NCT03286218|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110845134|NCT03286218|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110845135|NCT03286218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110845136|NCT03286218|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110845137|NCT03286218|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110845138|NCT03286218|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110845139|NCT03286218|GABA Modulators|gaba modulators|mesh-ancestor
110845140|NCT03286218|GABA Agents|gaba agents|mesh-ancestor
110845141|NCT03286218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110845142|NCT03286218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110845143|NCT03286218|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110845144|NCT03286218|Serotonin Agents|serotonin agents|mesh-ancestor
110845145|NCT03745261|Fluticasone|fluticasone|mesh-list
110845146|NCT03745261|Xhance|xhance|mesh-list
110845147|NCT03745261|Bromides|bromides|mesh-list
110845148|NCT03745261|Albuterol|albuterol|mesh-list
110845149|NCT03745261|Tiotropium Bromide|tiotropium bromide|mesh-list
110845150|NCT03745261|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110845151|NCT03745261|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
110845152|NCT03745261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110845153|NCT03745261|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110845154|NCT03745261|Autonomic Agents|autonomic agents|mesh-ancestor
110845155|NCT03745261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110845156|NCT03745261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110845158|NCT03745261|Respiratory System Agents|respiratory system agents|mesh-ancestor
110845159|NCT03745261|Dermatologic Agents|dermatologic agents|mesh-ancestor
110845160|NCT03745261|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110845161|NCT03745261|Parasympatholytics|parasympatholytics|mesh-ancestor
110845162|NCT03745261|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110845163|NCT03745261|Cholinergic Agents|cholinergic agents|mesh-ancestor
110845164|NCT03745261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110845165|NCT03745261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110845166|NCT03745261|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110845167|NCT03745261|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110845168|NCT03745261|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110845169|NCT03745261|Adrenergic Agents|adrenergic agents|mesh-ancestor
110845170|NCT03745261|Anticonvulsants|anticonvulsants|mesh-ancestor
110845171|NCT03745261|Tocolytic Agents|tocolytic agents|mesh-ancestor
110845172|NCT03745261|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110845173|NCT03745261|Glucocorticoids|glucocorticoids|mesh-ancestor
110845174|NCT03745261|Hormones|hormones|mesh-ancestor
110845175|NCT03745261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110845176|NCT03745261|Sympathomimetics|sympathomimetics|mesh-ancestor
110845177|NCT03744949|Remifentanil|remifentanil|mesh-list
110845178|NCT03744949|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110845179|NCT03744949|Narcotics|narcotics|mesh-ancestor
110845180|NCT03744949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110845181|NCT03744949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110845182|NCT03744949|Analgesics|analgesics|mesh-ancestor
110845183|NCT03744949|Sensory System Agents|sensory system agents|mesh-ancestor
110845184|NCT03744949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110845185|NCT03870581|Warfarin|warfarin|mesh-list
110845186|NCT03870581|Anticoagulants|anticoagulants|mesh-ancestor
110845187|NCT01277315|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
110845188|NCT01277315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110845189|NCT04016779|Viloxazine|viloxazine|mesh-list
110845190|NCT04016779|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110845191|NCT04016779|Antidepressive Agents|antidepressive agents|mesh-ancestor
110845192|NCT04016779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110845193|NCT04016779|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110845194|NCT04016779|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110845195|NCT04016779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110845196|NCT04016779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110845197|NCT04016779|Adrenergic Agents|adrenergic agents|mesh-ancestor
110845198|NCT04016779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110845199|NCT04016779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110845200|NCT03870503|Misoprostol|misoprostol|mesh-list
110845201|NCT03870503|Oxytocin|oxytocin|mesh-list
110845202|NCT03870503|Carbetocin|carbetocin|mesh-list
110845204|NCT03870503|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110845205|NCT03870503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110845206|NCT03870503|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110845207|NCT03870503|Abortifacient Agents|abortifacient agents|mesh-ancestor
110845208|NCT03870503|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110845209|NCT03870503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110845210|NCT02857426|Nivolumab|nivolumab|mesh-list
110845211|NCT02857426|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110845212|NCT02857426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110845213|NCT02857426|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110845214|NCT02857426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110845215|NCT05181033|Letrozole|letrozole|mesh-list
110845216|NCT05181033|Lenvatinib|lenvatinib|mesh-list
110845217|NCT05181033|Fulvestrant|fulvestrant|mesh-list
110845218|NCT05181033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110845219|NCT05181033|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110845220|NCT05181033|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110845221|NCT05181033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110845222|NCT05181033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110845223|NCT05181033|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110845224|NCT05181033|Hormone Antagonists|hormone antagonists|mesh-ancestor
110845225|NCT05181033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110845226|NCT05181033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110845227|NCT05181033|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110845228|NCT05181033|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110845229|NCT05181033|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110845232|NCT05666765|Dermatologic Agents|dermatologic agents|mesh-ancestor
110845233|NCT05666765|Antioxidants|antioxidants|mesh-ancestor
110845234|NCT05666765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110845235|NCT05666765|Protective Agents|protective agents|mesh-ancestor
110845236|NCT05666765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110845237|NCT01127256|Carbamazepine|carbamazepine|mesh-list
110845238|NCT01127256|Zonisamide|zonisamide|mesh-list
110845239|NCT01127256|Anticonvulsants|anticonvulsants|mesh-ancestor
110845240|NCT01127256|Antimanic Agents|antimanic agents|mesh-ancestor
110845241|NCT01127256|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110845242|NCT01127256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110845243|NCT01127256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110845244|NCT01127256|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110845245|NCT01127256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110845247|NCT01127256|Sensory System Agents|sensory system agents|mesh-ancestor
110622147|NCT00770744|Olanzapine|olanzapine|mesh-list
110845248|NCT01127256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110845249|NCT01127256|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110845250|NCT01127256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110845251|NCT01127256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110845252|NCT01127256|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110845253|NCT01127256|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110845254|NCT01127256|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110845255|NCT01127256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110845256|NCT03377842|Leucovorin|leucovorin|mesh-list
110845257|NCT03377842|Apatinib|apatinib|mesh-list
110845258|NCT03377842|Fluorouracil|fluorouracil|mesh-list
110845259|NCT03377842|Oxaliplatin|oxaliplatin|mesh-list
110845260|NCT03377842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110845261|NCT03377842|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110845262|NCT03377842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110845263|NCT03377842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110845264|NCT03377842|Antimetabolites|antimetabolites|mesh-ancestor
110845265|NCT03377842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110335368|NCT00498251|Adrenergic Agents|adrenergic agents|mesh-ancestor
110845266|NCT03377842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110845267|NCT03377842|Immunologic Factors|immunologic factors|mesh-ancestor
110845268|NCT03377842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110845269|NCT03377842|Antidotes|antidotes|mesh-ancestor
110845270|NCT03377842|Protective Agents|protective agents|mesh-ancestor
110845271|NCT03377842|Vitamin B Complex|vitamin b complex|mesh-ancestor
110845273|NCT03377842|Micronutrients|micronutrients|mesh-ancestor
110845274|NCT01277705|Vaccines|vaccines|mesh-list
110845275|NCT01277705|Immunologic Factors|immunologic factors|mesh-ancestor
110845276|NCT01277705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110845277|NCT04757337|Cyclophosphamide|cyclophosphamide|mesh-list
110845278|NCT04757337|Doxorubicin|doxorubicin|mesh-list
110845279|NCT04757337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110845281|NCT04757337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110845282|NCT04757337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110845283|NCT04757337|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110845284|NCT04757337|Alkylating Agents|alkylating agents|mesh-ancestor
110845285|NCT04757337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110845286|NCT04757337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110845287|NCT04757337|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110845288|NCT04757337|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110845289|NCT04757337|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110845290|NCT04757337|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110845291|NCT04757337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110845292|NCT03946527|Lanreotide|lanreotide|mesh-list
110845293|NCT03946527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110845294|NCT03377608|Tenofovir|tenofovir|mesh-list
110845295|NCT03377608|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
110845296|NCT03377608|Medroxyprogesterone|medroxyprogesterone|mesh-list
110845297|NCT03377608|Antiviral Agents|antiviral agents|mesh-ancestor
110845298|NCT03377608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110845299|NCT03377608|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110845300|NCT03377608|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110845301|NCT03377608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110845302|NCT03377608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110622406|NCT00771680|Insulin|insulin|mesh-list
110562896|NCT00651599|Drospirenone|drospirenone|mesh-list
110845303|NCT03377608|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110845304|NCT03377608|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110622431|NCT00775580|Autonomic Agents|autonomic agents|mesh-ancestor
110845305|NCT03377608|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110845306|NCT03377608|Contraceptive Agents|contraceptive agents|mesh-ancestor
110845307|NCT03377608|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110845308|NCT03377608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110845309|NCT03377608|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110845310|NCT03377608|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110845311|NCT03377608|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110845312|NCT03377608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110845313|NCT03377608|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110845314|NCT03377608|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110845315|NCT03377608|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110845316|NCT01282073|Cyclosporine|cyclosporine|mesh-list
110845317|NCT01282073|Mycophenolic Acid|mycophenolic acid|mesh-list
110845318|NCT01282073|Cyclosporins|cyclosporins|mesh-list
110845319|NCT01282073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110845320|NCT01282073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110845321|NCT01282073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110845322|NCT01282073|Immunologic Factors|immunologic factors|mesh-ancestor
110845323|NCT01282073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110845324|NCT01282073|Antifungal Agents|antifungal agents|mesh-ancestor
110845325|NCT01282073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110845326|NCT01282073|Dermatologic Agents|dermatologic agents|mesh-ancestor
110845327|NCT01282073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110622630|NCT00772616|Analgesics|analgesics|mesh-ancestor
110845328|NCT01282073|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110845329|NCT01282073|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110622706|NCT00776438|Vaccines|vaccines|mesh-list
110845330|NCT01282073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110845331|NCT01282073|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110845332|NCT01282073|Antitubercular Agents|antitubercular agents|mesh-ancestor
110845333|NCT01282073|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110845334|NCT01166477|Ritonavir|ritonavir|mesh-list
110845335|NCT01166477|Lopinavir|lopinavir|mesh-list
110845336|NCT01166477|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110845337|NCT01166477|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110845338|NCT01166477|Protease Inhibitors|protease inhibitors|mesh-ancestor
110845339|NCT01166477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110845340|NCT01166477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110845341|NCT01166477|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110845342|NCT01166477|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110845343|NCT01166477|Antiviral Agents|antiviral agents|mesh-ancestor
110845344|NCT01166477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110845345|NCT01166477|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110845346|NCT01166477|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110845347|NCT01282151|Cisplatin|cisplatin|mesh-list
110845348|NCT01282151|Pemetrexed|pemetrexed|mesh-list
110845349|NCT01282151|Docetaxel|docetaxel|mesh-list
110845350|NCT01282151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110845351|NCT01282151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110845352|NCT01282151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110845353|NCT01282151|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110845354|NCT01282151|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110845355|NCT01282151|Tubulin Modulators|tubulin modulators|mesh-ancestor
110845356|NCT01282151|Antimitotic Agents|antimitotic agents|mesh-ancestor
110845357|NCT01282151|Mitosis Modulators|mitosis modulators|mesh-ancestor
110845358|NCT03377218|Iodine|iodine|mesh-list
110845359|NCT03377218|Selenium|selenium|mesh-list
110845360|NCT03377218|Cadexomer iodine|cadexomer iodine|mesh-list
110845361|NCT03377218|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110845362|NCT03377218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110845363|NCT03377218|Trace Elements|trace elements|mesh-ancestor
110845364|NCT03377218|Micronutrients|micronutrients|mesh-ancestor
110845365|NCT03377218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110845366|NCT03377218|Antioxidants|antioxidants|mesh-ancestor
110845367|NCT03377218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110845368|NCT03377218|Protective Agents|protective agents|mesh-ancestor
110845369|NCT01168505|Teferrol|teferrol|mesh-list
110845370|NCT01168505|Hematinics|hematinics|mesh-ancestor
110845371|NCT03382600|Pembrolizumab|pembrolizumab|mesh-list
110845372|NCT03382600|Oxaliplatin|oxaliplatin|mesh-list
110845373|NCT03382600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110845374|NCT03382600|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110845375|NCT03382600|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110845376|NCT03382600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110845377|NCT04013191|Padsevonil|padsevonil|mesh-list
110845378|NCT04013191|Anticonvulsants|anticonvulsants|mesh-ancestor
110845379|NCT03867929|Vitamin D|vitamin d|mesh-list
110845380|NCT03867929|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
110845381|NCT03867929|Calcifediol|calcifediol|mesh-list
110845383|NCT03867929|Micronutrients|micronutrients|mesh-ancestor
110845384|NCT03867929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110845385|NCT03867929|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110845386|NCT03285594|Insulin Glargine|insulin glargine|mesh-list
110845387|NCT03285594|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
110845388|NCT03285594|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110845389|NCT03285594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110845390|NCT03285594|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110845391|NCT03285594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110845392|NCT01171469|Imiquimod|imiquimod|mesh-list
110845393|NCT01171469|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110845394|NCT01171469|Immunologic Factors|immunologic factors|mesh-ancestor
110845395|NCT01171469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110845396|NCT01171469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110845397|NCT01171469|Interferon Inducers|interferon inducers|mesh-ancestor
110845399|NCT02695992|Diltiazem|diltiazem|mesh-list
110845400|NCT02695992|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110845401|NCT02695992|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110845402|NCT02695992|Sympatholytics|sympatholytics|mesh-ancestor
110845404|NCT02695992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110845405|NCT02695992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110845406|NCT02695992|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110845407|NCT02695992|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110845408|NCT02695992|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110845409|NCT02695992|Adrenergic Agents|adrenergic agents|mesh-ancestor
110845410|NCT02695992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110845411|NCT02695992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110845412|NCT02695992|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110845413|NCT02695992|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110845414|NCT02695992|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110845415|NCT02695992|Vasodilator Agents|vasodilator agents|mesh-ancestor
110845416|NCT04050865|Dexamethasone|dexamethasone|mesh-list
110623073|NCT00307489|Tenofovir|tenofovir|mesh-list
110845417|NCT04050865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110845418|NCT04050865|Antiemetics|antiemetics|mesh-ancestor
110845419|NCT04050865|Autonomic Agents|autonomic agents|mesh-ancestor
110845420|NCT04050865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110845421|NCT04050865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110845422|NCT04050865|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110845423|NCT04050865|Glucocorticoids|glucocorticoids|mesh-ancestor
110845424|NCT04050865|Hormones|hormones|mesh-ancestor
110845425|NCT04050865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110845426|NCT04050865|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110623210|NCT00321685|Leucovorin|leucovorin|mesh-list
110845427|NCT04050865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110845428|NCT03283566|Hydroxychloroquine|hydroxychloroquine|mesh-list
110845429|NCT03283566|Antimalarials|antimalarials|mesh-ancestor
110845430|NCT03283566|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110845431|NCT03283566|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110845432|NCT03283566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110845433|NCT03283566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110845434|NCT03283566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110845435|NCT03283566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110845437|NCT01171547|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110845438|NCT01171547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110845439|NCT04048681|Cocaine|cocaine|mesh-list
110845440|NCT04048681|Anesthetics, Local|anesthetics, local|mesh-ancestor
110845441|NCT04048681|Anesthetics|anesthetics|mesh-ancestor
110845442|NCT04048681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110845443|NCT04048681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110845444|NCT04048681|Sensory System Agents|sensory system agents|mesh-ancestor
110845445|NCT04048681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110845446|NCT04048681|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110845447|NCT04048681|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110845448|NCT04048681|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110845449|NCT04048681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110845450|NCT04048681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110845451|NCT04048681|Dopamine Agents|dopamine agents|mesh-ancestor
110270683|NCT04723940|Cefadroxil|cefadroxil|mesh-list
110845452|NCT04048681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110845453|NCT01282385|Simvastatin|simvastatin|mesh-list
110845454|NCT01282385|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110845455|NCT01282385|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110845456|NCT01282385|Antimetabolites|antimetabolites|mesh-ancestor
110845457|NCT01282385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110845458|NCT01282385|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110845459|NCT01282385|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110845460|NCT01282385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110845461|NCT01166711|Chromium|chromium|mesh-list
110845462|NCT01166711|Paclitaxel|paclitaxel|mesh-list
110845463|NCT01166711|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110845464|NCT01166711|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110845465|NCT01166711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110845466|NCT01166711|Tubulin Modulators|tubulin modulators|mesh-ancestor
110845467|NCT01166711|Antimitotic Agents|antimitotic agents|mesh-ancestor
110845468|NCT01166711|Mitosis Modulators|mitosis modulators|mesh-ancestor
110623618|NCT00808392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110845469|NCT01166711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110845470|NCT01166711|Trace Elements|trace elements|mesh-ancestor
110845471|NCT01166711|Micronutrients|micronutrients|mesh-ancestor
110845472|NCT01166711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110845474|NCT01168739|Antioxidants|antioxidants|mesh-ancestor
110845475|NCT01168739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110845476|NCT01168739|Protective Agents|protective agents|mesh-ancestor
110845477|NCT01168739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110845478|NCT01171781|Cisplatin|cisplatin|mesh-list
110845479|NCT01171781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110845480|NCT04006171|Natriuretic Peptide, C-Type|natriuretic peptide, c-type|mesh-list
110845481|NCT04006171|Natriuretic Agents|natriuretic agents|mesh-ancestor
110845482|NCT04006171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110845483|NCT01171859|Doxycycline|doxycycline|mesh-list
110845484|NCT01171859|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
110845485|NCT01171859|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110845486|NCT01171859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110845487|NCT01171859|Antimalarials|antimalarials|mesh-ancestor
110845488|NCT01171859|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110845489|NCT01171859|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110845490|NCT01171859|Antiviral Agents|antiviral agents|mesh-ancestor
110335428|NCT00498953|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110845491|NCT01171859|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
110845492|NCT01171859|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110845494|NCT02652468|Cyclophosphamide|cyclophosphamide|mesh-list
110845495|NCT02652468|Rituximab|rituximab|mesh-list
110845496|NCT02652468|Fludarabine|fludarabine|mesh-list
110845497|NCT02652468|Fludarabine phosphate|fludarabine phosphate|mesh-list
110845499|NCT02652468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110845500|NCT02652468|Immunologic Factors|immunologic factors|mesh-ancestor
110845501|NCT02652468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110845502|NCT02652468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110845503|NCT02652468|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110845504|NCT02652468|Alkylating Agents|alkylating agents|mesh-ancestor
110845505|NCT02652468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110845506|NCT02652468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110845507|NCT02652468|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110845508|NCT02652468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110845509|NCT02652468|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110845511|NCT02652468|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110845512|NCT02652468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110845513|NCT02652468|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110845514|NCT02652468|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110845515|NCT02652468|Antitubercular Agents|antitubercular agents|mesh-ancestor
110845516|NCT02652468|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110845517|NCT02652468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110845518|NCT04673877|Vancomycin|vancomycin|mesh-list
110845519|NCT04673877|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110845520|NCT04673877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110845521|NCT01166789|Lubiprostone|lubiprostone|mesh-list
110845522|NCT01166789|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
110845523|NCT01166789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110845524|NCT01166789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110845525|NCT01314339|Desloratadine|desloratadine|mesh-list
110845526|NCT01314339|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110845527|NCT01314339|Cholinergic Agents|cholinergic agents|mesh-ancestor
110563113|NCT02642939|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
110845529|NCT01314339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110845530|NCT01314339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110845531|NCT01314339|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110845532|NCT01314339|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110845533|NCT01314339|Histamine Antagonists|histamine antagonists|mesh-ancestor
110845534|NCT01314339|Histamine Agents|histamine agents|mesh-ancestor
110845535|NCT01168817|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
110845536|NCT01168817|Vasodilator Agents|vasodilator agents|mesh-ancestor
110845537|NCT01168817|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110845538|NCT01168817|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110845539|NCT01168817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110845540|NCT01168817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110845541|NCT01168817|Urological Agents|urological agents|mesh-ancestor
110845542|NCT01279811|Dopamine|dopamine|mesh-list
110845543|NCT01279811|Norepinephrine|norepinephrine|mesh-list
110845544|NCT01279811|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
110845545|NCT01279811|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110845546|NCT01279811|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110845547|NCT01279811|Adrenergic Agents|adrenergic agents|mesh-ancestor
110845548|NCT01279811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110845549|NCT01279811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110845550|NCT01279811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110845551|NCT01279811|Sympathomimetics|sympathomimetics|mesh-ancestor
110845552|NCT01279811|Autonomic Agents|autonomic agents|mesh-ancestor
110845553|NCT01279811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110845554|NCT01279811|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110845556|NCT01279811|Protective Agents|protective agents|mesh-ancestor
110845557|NCT01168895|Ciprofloxacin|ciprofloxacin|mesh-list
110845558|NCT01168895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110845559|NCT01168895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110845560|NCT01168895|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110845561|NCT01168895|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110845562|NCT01168895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110845563|NCT01168895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110845564|NCT01168895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110845565|NCT01168895|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110845566|NCT01168895|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110845567|NCT03745105|Dexamethasone|dexamethasone|mesh-list
110845568|NCT03745105|Dexamethasone acetate|dexamethasone acetate|mesh-list
110845569|NCT03745105|Piroxicam|piroxicam|mesh-list
110845570|NCT03745105|Mepivacaine|mepivacaine|mesh-list
110845571|NCT03745105|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
110845572|NCT03745105|BB 1101|bb 1101|mesh-list
110845573|NCT03745105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110845574|NCT03745105|Antiemetics|antiemetics|mesh-ancestor
110845575|NCT03745105|Autonomic Agents|autonomic agents|mesh-ancestor
110845576|NCT03745105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110845577|NCT03745105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110845578|NCT03745105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110845579|NCT03745105|Glucocorticoids|glucocorticoids|mesh-ancestor
110845580|NCT03745105|Hormones|hormones|mesh-ancestor
110624785|NCT00642954|Growth Substances|growth substances|mesh-ancestor
110845581|NCT03745105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110845582|NCT03745105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110845583|NCT03745105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110845584|NCT03745105|Anesthetics, Local|anesthetics, local|mesh-ancestor
110845585|NCT03745105|Anesthetics|anesthetics|mesh-ancestor
110845586|NCT03745105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110845587|NCT03745105|Sensory System Agents|sensory system agents|mesh-ancestor
110624931|NCT00302731|Estradiol|estradiol|mesh-list
110845588|NCT03745105|Protease Inhibitors|protease inhibitors|mesh-ancestor
110845589|NCT03745105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110845590|NCT03745105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110845591|NCT03745105|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110625067|NCT00293293|Taxane|taxane|mesh-list
110845592|NCT03745105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110845593|NCT03745105|Analgesics|analgesics|mesh-ancestor
110845594|NCT03745105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110845595|NCT03745105|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110845596|NCT01282541|Botulinum Toxins|botulinum toxins|mesh-list
110845597|NCT01282541|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110845598|NCT01282541|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110845599|NCT01282541|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110831715|NCT01212887|Antimetabolites|antimetabolites|mesh-ancestor
110845600|NCT01282541|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110845601|NCT01282541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110845602|NCT01282541|Cholinergic Agents|cholinergic agents|mesh-ancestor
110845603|NCT01282541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110845604|NCT01282541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110845605|NCT01282541|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110845606|NCT01282541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110845607|NCT03744247|Lenvatinib|lenvatinib|mesh-list
110845608|NCT03744247|Antibodies|antibodies|mesh-list
110845609|NCT03744247|Immunoglobulins|immunoglobulins|mesh-list
110845610|NCT03744247|Immunologic Factors|immunologic factors|mesh-ancestor
110845611|NCT03744247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110625151|NCT05732051|Vitamins|vitamins|mesh-ancestor
110845612|NCT03744247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110845613|NCT03744247|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110845614|NCT03744247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110845615|NCT03744247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110845616|NCT01282619|Huperzine A|huperzine a|mesh-list
110845617|NCT01282619|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110845618|NCT01282619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110845619|NCT01282619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110845620|NCT01282619|Cholinergic Agents|cholinergic agents|mesh-ancestor
110845621|NCT01282619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110845622|NCT01282619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110845623|NCT01282619|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110845624|NCT01282619|Protective Agents|protective agents|mesh-ancestor
110845625|NCT01282697|Sirolimus|sirolimus|mesh-list
110845626|NCT01282697|Irinotecan|irinotecan|mesh-list
110272632|NCT04859946|Busulfan|busulfan|mesh-list
110845627|NCT01282697|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110845628|NCT01282697|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110845629|NCT01282697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110625413|NCT05073484|Antibodies|antibodies|mesh-list
110845630|NCT01282697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110845631|NCT01282697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110845632|NCT01282697|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110845633|NCT01282697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110845634|NCT01282697|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110845635|NCT01282697|Antifungal Agents|antifungal agents|mesh-ancestor
110845636|NCT01282697|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110845637|NCT01282697|Immunologic Factors|immunologic factors|mesh-ancestor
110845638|NCT01282697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110845639|NCT01169597|Prednisone|prednisone|mesh-list
110845640|NCT01169597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110845641|NCT01169597|Glucocorticoids|glucocorticoids|mesh-ancestor
110845642|NCT01169597|Hormones|hormones|mesh-ancestor
110845643|NCT01169597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110845644|NCT01169597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110845645|NCT01169597|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110845646|NCT01169597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110845647|NCT02527798|Furosemide|furosemide|mesh-list
110845648|NCT02527798|Diuretics|diuretics|mesh-ancestor
110625489|NCT04877288|Cyclosporine|cyclosporine|mesh-list
110845649|NCT02527798|Natriuretic Agents|natriuretic agents|mesh-ancestor
110845650|NCT02527798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110845651|NCT02527798|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110845652|NCT02527798|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110845653|NCT02527798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110845655|NCT05331911|Sevoflurane|sevoflurane|mesh-list
110845657|NCT05331911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110845659|NCT05331911|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110845660|NCT05331911|Anesthetics, General|anesthetics, general|mesh-ancestor
110845661|NCT05331911|Anesthetics|anesthetics|mesh-ancestor
110845662|NCT05331911|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110845663|NCT05331911|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110845664|NCT03857542|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110845665|NCT03857542|Pilocarpine|pilocarpine|mesh-list
110845666|NCT03857542|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110845669|NCT03857542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110845670|NCT03857542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110831720|NCT01215149|Vaccines|vaccines|mesh-list
110845671|NCT03857542|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
110845672|NCT03857542|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110845673|NCT03857542|Cholinergic Agents|cholinergic agents|mesh-ancestor
110845674|NCT03857542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110845675|NCT03857542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110845676|NCT01172717|Panitumumab|panitumumab|mesh-list
110845677|NCT01172717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110845678|NCT01172717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110625966|NCT02889523|Prednisolone|prednisolone|mesh-list
110845680|NCT03209973|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110845681|NCT03209973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110845682|NCT03751631|Phenylephrine|phenylephrine|mesh-list
110845683|NCT03751631|Oxymetazoline|oxymetazoline|mesh-list
110845684|NCT03751631|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110845685|NCT03751631|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110845686|NCT03751631|Tropicamide|tropicamide|mesh-list
110845687|NCT03751631|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110845688|NCT03751631|Mydriatics|mydriatics|mesh-ancestor
110845689|NCT03751631|Autonomic Agents|autonomic agents|mesh-ancestor
110845690|NCT03751631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110845691|NCT03751631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110845692|NCT03751631|Sympathomimetics|sympathomimetics|mesh-ancestor
110845693|NCT03751631|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110845694|NCT03751631|Nasal Decongestants|nasal decongestants|mesh-ancestor
110845695|NCT03751631|Respiratory System Agents|respiratory system agents|mesh-ancestor
110845696|NCT03751631|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110845697|NCT03751631|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110845698|NCT03751631|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110845699|NCT03751631|Adrenergic Agents|adrenergic agents|mesh-ancestor
110845700|NCT03751631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110845701|NCT03751631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110845702|NCT03751631|Protective Agents|protective agents|mesh-ancestor
110845703|NCT03751631|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110845704|NCT03751631|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110845705|NCT03751631|Cholinergic Agents|cholinergic agents|mesh-ancestor
110845706|NCT03866681|Sirolimus|sirolimus|mesh-list
110845707|NCT03866681|Warfarin|warfarin|mesh-list
110845708|NCT03866681|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110845709|NCT03866681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110845710|NCT03866681|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110845711|NCT03866681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110845712|NCT03866681|Antifungal Agents|antifungal agents|mesh-ancestor
110845713|NCT03866681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110845714|NCT03866681|Immunologic Factors|immunologic factors|mesh-ancestor
110845715|NCT03866681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110845717|NCT03736369|Esomeprazole|esomeprazole|mesh-list
110845718|NCT03736369|Fexuprazan|fexuprazan|mesh-list
110845719|NCT03736369|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110845720|NCT03736369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110845721|NCT03736369|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110845722|NCT03736369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110845723|NCT03736369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110845724|NCT03867695|Ropivacaine|ropivacaine|mesh-list
110845725|NCT03867695|Anesthetics, Local|anesthetics, local|mesh-ancestor
110845726|NCT03867695|Anesthetics|anesthetics|mesh-ancestor
110845727|NCT03867695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110845728|NCT03867695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110845729|NCT03867695|Sensory System Agents|sensory system agents|mesh-ancestor
110845730|NCT03867695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110845731|NCT01172171|Melatonin|melatonin|mesh-list
110845732|NCT01172171|Antioxidants|antioxidants|mesh-ancestor
110845733|NCT01172171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110845734|NCT01172171|Protective Agents|protective agents|mesh-ancestor
110845735|NCT01172171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110845736|NCT01172171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110845737|NCT03655717|Ethanol|ethanol|mesh-list
110845738|NCT03655717|Dronabinol|dronabinol|mesh-list
110845739|NCT03655717|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110845740|NCT03655717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110626508|NCT01065727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110845741|NCT03655717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110845742|NCT03655717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110845743|NCT03655717|Hallucinogens|hallucinogens|mesh-ancestor
110845744|NCT03655717|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110845745|NCT03655717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110845746|NCT03655717|Analgesics|analgesics|mesh-ancestor
110845747|NCT03655717|Sensory System Agents|sensory system agents|mesh-ancestor
110845748|NCT03655717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110845749|NCT03655717|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
110626652|NCT00817284|Alkylating Agents|alkylating agents|mesh-ancestor
110845750|NCT03655717|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110845751|NCT03655717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110845752|NCT03655717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110845753|NCT03655717|Hormones|hormones|mesh-ancestor
110626718|NCT00825942|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110845754|NCT03655717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110845756|NCT03867071|Hematinics|hematinics|mesh-ancestor
110845757|NCT01284413|Cisplatin|cisplatin|mesh-list
110845758|NCT01284413|Gemcitabine|gemcitabine|mesh-list
110845759|NCT01284413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110845760|NCT01284413|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110845762|NCT01284413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110845763|NCT05152017|Vaccines|vaccines|mesh-list
110845764|NCT05152017|Immunologic Factors|immunologic factors|mesh-ancestor
110845765|NCT05152017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110845766|NCT03866993|Paclitaxel|paclitaxel|mesh-list
110626863|NCT05244694|Insulin|insulin|mesh-list
110845768|NCT03866993|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110845769|NCT03866993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110845770|NCT03866993|Tubulin Modulators|tubulin modulators|mesh-ancestor
110845771|NCT03866993|Antimitotic Agents|antimitotic agents|mesh-ancestor
110845772|NCT03866993|Mitosis Modulators|mitosis modulators|mesh-ancestor
110845773|NCT03866993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110845774|NCT01172405|Ibuprofen|ibuprofen|mesh-list
110845775|NCT01172405|Caffeine|caffeine|mesh-list
110626925|NCT00821028|Paclitaxel|paclitaxel|mesh-list
110845776|NCT01172405|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110845777|NCT01172405|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110845778|NCT01172405|Analgesics|analgesics|mesh-ancestor
110845779|NCT01172405|Sensory System Agents|sensory system agents|mesh-ancestor
110845780|NCT01172405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110845781|NCT01172405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110845782|NCT01172405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110845783|NCT01172405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110845784|NCT01172405|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110627001|NCT00777101|Lapatinib|lapatinib|mesh-list
110845785|NCT01172405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110845786|NCT01172405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110845787|NCT01172405|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110845788|NCT01172405|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110845789|NCT01172405|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110845790|NCT01172405|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110845791|NCT01172405|Purinergic Agents|purinergic agents|mesh-ancestor
110845792|NCT01172405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110845793|NCT04000165|Mitapivat|mitapivat|mesh-list
110845794|NCT04000165|Enzyme Activators|enzyme activators|mesh-ancestor
110845795|NCT04000165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110845796|NCT03375424|Vedolizumab|vedolizumab|mesh-list
110845797|NCT03375424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110845798|NCT03187197|Dabigatran|dabigatran|mesh-list
110845799|NCT03187197|Antithrombins|antithrombins|mesh-ancestor
110845800|NCT03187197|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110845801|NCT03187197|Protease Inhibitors|protease inhibitors|mesh-ancestor
110845802|NCT03187197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110845803|NCT03187197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110845804|NCT03187197|Anticoagulants|anticoagulants|mesh-ancestor
110627116|NCT04095455|Anesthetics|anesthetics|mesh-ancestor
110845805|NCT01284647|Geranylgeranylacetone|geranylgeranylacetone|mesh-list
110845806|NCT01284647|Sucralfate|sucralfate|mesh-list
110845807|NCT01284647|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110845808|NCT01284647|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110845809|NCT01284647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110845811|NCT04000009|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110845812|NCT04000009|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110845813|NCT04000009|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110845814|NCT04000009|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110845815|NCT04000009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110845816|NCT04000009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110845817|NCT04000009|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110845818|NCT04000009|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110845819|NCT04000009|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110845820|NCT04000009|Serotonin Agents|serotonin agents|mesh-ancestor
110845821|NCT04000009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110845822|NCT04000009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110845823|NCT03282240|Vaccines|vaccines|mesh-list
110845824|NCT03282240|Immunologic Factors|immunologic factors|mesh-ancestor
110845825|NCT03282240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110845826|NCT01284725|Mycophenolic Acid|mycophenolic acid|mesh-list
110845828|NCT01284725|Immunosuppressive Agents|immunosuppressive agents|mesh-list
110845829|NCT01284725|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110845831|NCT01284725|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110845832|NCT01284725|Antitubercular Agents|antitubercular agents|mesh-ancestor
110845833|NCT01284725|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110845834|NCT01284725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110845835|NCT01284725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110845836|NCT01284725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110845837|NCT01284725|Antimetabolites|antimetabolites|mesh-ancestor
110845838|NCT01284725|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110845839|NCT01284725|Immunologic Factors|immunologic factors|mesh-ancestor
110845840|NCT01284725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110845841|NCT01284725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110845842|NCT03510598|Deoxycholic Acid|deoxycholic acid|mesh-list
110845843|NCT03510598|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
110845844|NCT03510598|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110845845|NCT01173107|Colchicine|colchicine|mesh-list
110845846|NCT01173107|Gout Suppressants|gout suppressants|mesh-ancestor
110845847|NCT01173107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110845848|NCT01173107|Tubulin Modulators|tubulin modulators|mesh-ancestor
110845849|NCT01173107|Antimitotic Agents|antimitotic agents|mesh-ancestor
110845850|NCT01173107|Mitosis Modulators|mitosis modulators|mesh-ancestor
110845851|NCT01173107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110845852|NCT01173107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110845854|NCT03744091|Hallucinogens|hallucinogens|mesh-ancestor
110845855|NCT03744091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110845856|NCT03744091|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110845857|NCT03744091|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110845859|NCT03744091|Sensory System Agents|sensory system agents|mesh-ancestor
110845860|NCT03744091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110845861|NCT03744091|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
110845862|NCT03744091|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110845863|NCT03744091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110845864|NCT03744091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110845865|NCT03744091|Hormones|hormones|mesh-ancestor
110845866|NCT03744091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110845867|NCT03376594|Loratadine|loratadine|mesh-list
110845868|NCT03376594|Antipruritics|antipruritics|mesh-ancestor
110845869|NCT03376594|Dermatologic Agents|dermatologic agents|mesh-ancestor
110845870|NCT03376594|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110845871|NCT03376594|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110845872|NCT03376594|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110845873|NCT03376594|Histamine Antagonists|histamine antagonists|mesh-ancestor
110845874|NCT03376594|Histamine Agents|histamine agents|mesh-ancestor
110845875|NCT03376594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110845876|NCT03376594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110845877|NCT03376594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110845878|NCT03381664|Quinidine|quinidine|mesh-list
110845879|NCT03381664|Dextromethorphan|dextromethorphan|mesh-list
110845880|NCT03381664|Antitussive Agents|antitussive agents|mesh-ancestor
110845881|NCT03381664|Respiratory System Agents|respiratory system agents|mesh-ancestor
110845882|NCT03381664|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110845883|NCT03381664|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110845884|NCT03381664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110845885|NCT03381664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110845887|NCT03381664|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110845888|NCT03381664|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110845889|NCT03381664|Adrenergic Agents|adrenergic agents|mesh-ancestor
110845890|NCT03381664|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110845891|NCT03381664|Antimalarials|antimalarials|mesh-ancestor
110845892|NCT03381664|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110845893|NCT03381664|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110845894|NCT03381664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110845895|NCT03381664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110845896|NCT03381664|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110845897|NCT03381664|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110845898|NCT03381664|Cholinergic Agents|cholinergic agents|mesh-ancestor
110845899|NCT03381664|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110628527|NCT01325779|Heparin|heparin|mesh-list
110845900|NCT03381664|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110845901|NCT03381664|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110845902|NCT03381664|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110845903|NCT03381664|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110845905|NCT04060758|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110845906|NCT04060758|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110845907|NCT03376438|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
110845909|NCT03863405|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110845910|NCT03863405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110845911|NCT03866369|Moxifloxacin|moxifloxacin|mesh-list
110845912|NCT03866369|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110845913|NCT03866369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110845914|NCT03866369|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110845915|NCT03866369|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110845916|NCT03866369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110845917|NCT03866369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110845918|NCT03866369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110845919|NCT04024891|Phentolamine|phentolamine|mesh-list
110628793|NCT04678089|Bortezomib|bortezomib|mesh-list
110845920|NCT04024891|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110845921|NCT04024891|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110845922|NCT04024891|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110845923|NCT04024891|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110845924|NCT04024891|Adrenergic Agents|adrenergic agents|mesh-ancestor
110628955|NCT00574080|Hormones|hormones|mesh-ancestor
110845926|NCT04024891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110845927|NCT04024891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110276375|NCT00176618|Curcumin|curcumin|mesh-list
110845928|NCT04024891|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110845929|NCT01178021|Chloroquine|chloroquine|mesh-list
110845930|NCT01178021|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
110845931|NCT01178021|Primaquine|primaquine|mesh-list
110845932|NCT01178021|Amebicides|amebicides|mesh-ancestor
110845933|NCT01178021|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110845934|NCT01178021|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110845935|NCT01178021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110845936|NCT01178021|Antimalarials|antimalarials|mesh-ancestor
110845937|NCT01178021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110845938|NCT01178021|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110845939|NCT01178021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110845940|NCT01178021|Analgesics|analgesics|mesh-ancestor
110845941|NCT01178021|Sensory System Agents|sensory system agents|mesh-ancestor
110845942|NCT01178021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110845943|NCT01178021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110845944|NCT01178021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110845946|NCT01178021|Antinematodal Agents|antinematodal agents|mesh-ancestor
110845947|NCT01178021|Anthelmintics|anthelmintics|mesh-ancestor
110845948|NCT03250182|Budesonide|budesonide|mesh-list
110845949|NCT03250182|Glycopyrrolate|glycopyrrolate|mesh-list
110845950|NCT03250182|Formoterol Fumarate|formoterol fumarate|mesh-list
110845951|NCT03250182|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110845952|NCT03250182|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110845953|NCT03250182|Autonomic Agents|autonomic agents|mesh-ancestor
110845954|NCT03250182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110845955|NCT03250182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110845956|NCT03250182|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110845957|NCT03250182|Respiratory System Agents|respiratory system agents|mesh-ancestor
110845959|NCT03250182|Hormones|hormones|mesh-ancestor
110845960|NCT03250182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110845961|NCT03250182|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110845962|NCT03250182|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110845963|NCT03250182|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110845964|NCT03250182|Adrenergic Agents|adrenergic agents|mesh-ancestor
110845965|NCT03250182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110845966|NCT03250182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110845967|NCT03250182|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110845968|NCT03250182|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110845970|NCT03250182|Cholinergic Agents|cholinergic agents|mesh-ancestor
110845971|NCT01173263|Propofol|propofol|mesh-list
110845972|NCT01173263|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110845973|NCT01173263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110845974|NCT01173263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110845975|NCT01173263|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110845976|NCT01173263|Anesthetics, General|anesthetics, general|mesh-ancestor
110845978|NCT03381430|Gefitinib|gefitinib|mesh-list
110845979|NCT03381430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110845980|NCT03381430|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110845981|NCT03381430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110845982|NCT03381430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110845983|NCT01288157|Golimumab|golimumab|mesh-list
110845984|NCT01288157|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110845985|NCT01288157|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110845986|NCT01288157|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110845987|NCT01288157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110845988|NCT01288157|Immunologic Factors|immunologic factors|mesh-ancestor
110845989|NCT01288157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110845990|NCT03993379|Ipilimumab|ipilimumab|mesh-list
110845991|NCT03993379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110845992|NCT03993379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110629630|NCT00861510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110845993|NCT03993379|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110845994|NCT03993379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110845995|NCT03866447|Vitamin D|vitamin d|mesh-list
110845996|NCT03866447|Adapalene|adapalene|mesh-list
110845997|NCT03866447|Vitamins|vitamins|mesh-ancestor
110845998|NCT03866447|Micronutrients|micronutrients|mesh-ancestor
110629697|NCT04119024|Sensory System Agents|sensory system agents|mesh-ancestor
110845999|NCT03866447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110846000|NCT03866447|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110846001|NCT03866447|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110846002|NCT03866447|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110846003|NCT03866447|Analgesics|analgesics|mesh-ancestor
110846004|NCT03866447|Sensory System Agents|sensory system agents|mesh-ancestor
110846005|NCT03866447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110846006|NCT03866447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110846008|NCT03866447|Dermatologic Agents|dermatologic agents|mesh-ancestor
110846009|NCT03370120|Padsevonil|padsevonil|mesh-list
110846010|NCT03370120|Anticonvulsants|anticonvulsants|mesh-ancestor
110846011|NCT01175291|Leucovorin|leucovorin|mesh-list
110846012|NCT01175291|Bevacizumab|bevacizumab|mesh-list
110846013|NCT01175291|Fluorouracil|fluorouracil|mesh-list
110846014|NCT01175291|Oxaliplatin|oxaliplatin|mesh-list
110846015|NCT01175291|Levoleucovorin|levoleucovorin|mesh-list
110629910|NCT00971685|Immunologic Factors|immunologic factors|mesh-ancestor
110846016|NCT01175291|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110846017|NCT01175291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110629981|NCT00790946|Valsartan|valsartan|mesh-list
110846018|NCT01175291|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110846019|NCT01175291|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110846020|NCT01175291|Growth Substances|growth substances|mesh-ancestor
110846021|NCT01175291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110846022|NCT01175291|Growth Inhibitors|growth inhibitors|mesh-ancestor
110846023|NCT01175291|Antimetabolites|antimetabolites|mesh-ancestor
110846024|NCT01175291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110846025|NCT01175291|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110846026|NCT01175291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110846027|NCT01175291|Immunologic Factors|immunologic factors|mesh-ancestor
110630050|NCT03897244|Antacids|antacids|mesh-ancestor
110846028|NCT01175291|Antidotes|antidotes|mesh-ancestor
110846029|NCT01175291|Protective Agents|protective agents|mesh-ancestor
110846030|NCT01175291|Vitamin B Complex|vitamin b complex|mesh-ancestor
110846031|NCT01175291|Vitamins|vitamins|mesh-ancestor
110846032|NCT01175291|Micronutrients|micronutrients|mesh-ancestor
110846033|NCT03230266|Insulin|insulin|mesh-list
110846034|NCT03230266|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110846035|NCT03230266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110846036|NCT03732469|Acetaminophen|acetaminophen|mesh-list
110846037|NCT03732469|Fentanyl|fentanyl|mesh-list
110846038|NCT03732469|Propofol|propofol|mesh-list
110846039|NCT03732469|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110846040|NCT03732469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110630188|NCT00792584|Efavirenz|efavirenz|mesh-list
110846041|NCT03732469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110846042|NCT03732469|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110846043|NCT03732469|Anesthetics, General|anesthetics, general|mesh-ancestor
110846044|NCT03732469|Anesthetics|anesthetics|mesh-ancestor
110846045|NCT03732469|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110846047|NCT03732469|Analgesics|analgesics|mesh-ancestor
110846048|NCT03732469|Sensory System Agents|sensory system agents|mesh-ancestor
110846049|NCT03732469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110846050|NCT03732469|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110846051|NCT03732469|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110846052|NCT03732469|Antipyretics|antipyretics|mesh-ancestor
110846053|NCT03381352|Capecitabine|capecitabine|mesh-list
110846054|NCT03381352|Mitomycins|mitomycins|mesh-list
110846055|NCT03381352|Mitomycin|mitomycin|mesh-list
110846056|NCT03381352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110846057|NCT03381352|Antimetabolites|antimetabolites|mesh-ancestor
110846058|NCT03381352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110846059|NCT03381352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110846060|NCT03381352|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110846061|NCT03381352|Alkylating Agents|alkylating agents|mesh-ancestor
110846062|NCT03381352|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110846063|NCT03381352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110630536|NCT00972933|Ipilimumab|ipilimumab|mesh-list
110846065|NCT01175525|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
110846066|NCT01175525|Immunologic Factors|immunologic factors|mesh-ancestor
110846067|NCT01175525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110846068|NCT01175525|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110846069|NCT01175525|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110846070|NCT01175525|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110846071|NCT01175525|Respiratory System Agents|respiratory system agents|mesh-ancestor
110846072|NCT03863249|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110846073|NCT03863249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110846074|NCT03381118|Cytarabine|cytarabine|mesh-list
110846075|NCT03381118|Nivolumab|nivolumab|mesh-list
110846076|NCT03381118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110846077|NCT03381118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110846078|NCT03381118|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110846079|NCT03381118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110846080|NCT03381118|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110846081|NCT03381118|Antimetabolites|antimetabolites|mesh-ancestor
110846082|NCT03381118|Antiviral Agents|antiviral agents|mesh-ancestor
110846083|NCT03381118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110846084|NCT03381118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110846085|NCT03381118|Immunologic Factors|immunologic factors|mesh-ancestor
110846086|NCT03381118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110846087|NCT03375112|Bupivacaine|bupivacaine|mesh-list
110846088|NCT03375112|Anesthetics, Local|anesthetics, local|mesh-ancestor
110846089|NCT03375112|Anesthetics|anesthetics|mesh-ancestor
110846090|NCT03375112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110846091|NCT03375112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110846092|NCT03375112|Sensory System Agents|sensory system agents|mesh-ancestor
110846093|NCT03375112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110846094|NCT02954575|Factor VIII|factor viii|mesh-list
110846095|NCT02954575|Coagulants|coagulants|mesh-ancestor
110846096|NCT02997358|Doxorubicin|doxorubicin|mesh-list
110846097|NCT02997358|Trabectedin|trabectedin|mesh-list
110846098|NCT02997358|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110846099|NCT02997358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110846100|NCT02997358|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110846101|NCT02997358|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110846102|NCT02997358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110630747|NCT00975897|Vitamins|vitamins|mesh-ancestor
110846103|NCT02997358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110846104|NCT02997358|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110846105|NCT02997358|Alkylating Agents|alkylating agents|mesh-ancestor
110846106|NCT03375034|Clonazepam|clonazepam|mesh-list
110846107|NCT03375034|Anticonvulsants|anticonvulsants|mesh-ancestor
110846108|NCT03375034|GABA Modulators|gaba modulators|mesh-ancestor
110846109|NCT03375034|GABA Agents|gaba agents|mesh-ancestor
110846110|NCT03375034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110846111|NCT03375034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110846112|NCT03375034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110846113|NCT03381040|Hyaluronic Acid|hyaluronic acid|mesh-list
110846114|NCT03381040|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110846115|NCT03381040|Immunologic Factors|immunologic factors|mesh-ancestor
110846116|NCT03381040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110846117|NCT03381040|Viscosupplements|viscosupplements|mesh-ancestor
110846118|NCT03381040|Protective Agents|protective agents|mesh-ancestor
110846119|NCT03376048|Ropivacaine|ropivacaine|mesh-list
110846120|NCT03376048|Anesthetics, Local|anesthetics, local|mesh-ancestor
110846121|NCT03376048|Anesthetics|anesthetics|mesh-ancestor
110846122|NCT03376048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110846123|NCT03376048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110846124|NCT03376048|Sensory System Agents|sensory system agents|mesh-ancestor
110846125|NCT03376048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110846126|NCT03374878|Contraceptive Agents|contraceptive agents|mesh-list
110846127|NCT03374878|Contraceptives, Oral|contraceptives, oral|mesh-list
110846128|NCT03374878|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110846129|NCT03374878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110846130|NCT03374878|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110846131|NCT01285037|Gemcitabine|gemcitabine|mesh-list
110846132|NCT01285037|Cetuximab|cetuximab|mesh-list
110563738|NCT00686686|Infliximab|infliximab|mesh-list
110846133|NCT01285037|Ramucirumab|ramucirumab|mesh-list
110846134|NCT01285037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110846135|NCT01285037|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110846136|NCT01285037|Antimetabolites|antimetabolites|mesh-ancestor
110846137|NCT01285037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110846138|NCT01285037|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110846139|NCT03732391|Carboplatin|carboplatin|mesh-list
110846140|NCT03732391|Pembrolizumab|pembrolizumab|mesh-list
110846141|NCT03732391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110846142|NCT03732391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110846143|NCT03732391|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110846144|NCT03732391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110846145|NCT03374722|Analgesics, Opioid|analgesics, opioid|mesh-list
110846146|NCT03374722|Narcotics|narcotics|mesh-ancestor
110846147|NCT03374722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110631134|NCT00961467|Glucocorticoids|glucocorticoids|mesh-ancestor
110846148|NCT03374722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110846149|NCT03374722|Analgesics|analgesics|mesh-ancestor
110846150|NCT03374722|Sensory System Agents|sensory system agents|mesh-ancestor
110846151|NCT03374722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110846152|NCT03207243|Fluticasone|fluticasone|mesh-list
110846154|NCT03207243|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110846155|NCT03207243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110846156|NCT03207243|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110846157|NCT03207243|Autonomic Agents|autonomic agents|mesh-ancestor
110846159|NCT03207243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110846160|NCT03207243|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110846161|NCT03207243|Respiratory System Agents|respiratory system agents|mesh-ancestor
110846162|NCT03207243|Dermatologic Agents|dermatologic agents|mesh-ancestor
110846163|NCT03207243|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110846164|NCT03207243|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110846165|NCT03207243|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110846166|NCT03207243|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110846167|NCT03207243|Adrenergic Agents|adrenergic agents|mesh-ancestor
110846168|NCT03207243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110846169|NCT03207243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110846170|NCT01285271|Sevoflurane|sevoflurane|mesh-list
110846171|NCT01285271|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110631419|NCT00796250|Infliximab|infliximab|mesh-list
110846172|NCT01285271|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110846173|NCT01285271|Anesthetics, General|anesthetics, general|mesh-ancestor
110846174|NCT01285271|Anesthetics|anesthetics|mesh-ancestor
110846175|NCT01285271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110846176|NCT01285271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110846177|NCT03982069|Vaccines|vaccines|mesh-list
110846178|NCT03982069|Immunologic Factors|immunologic factors|mesh-ancestor
110846179|NCT03982069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110846180|NCT03219723|Amoxicillin|amoxicillin|mesh-list
110846181|NCT03219723|Metronidazole|metronidazole|mesh-list
110846182|NCT03219723|Clarithromycin|clarithromycin|mesh-list
110846183|NCT03219723|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110631547|NCT00864942|Rituximab|rituximab|mesh-list
110846184|NCT03219723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110846185|NCT03219723|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110846186|NCT03219723|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110846187|NCT03219723|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110846188|NCT03219723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110631619|NCT00870480|Urological Agents|urological agents|mesh-ancestor
110846189|NCT03219723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110846190|NCT03219723|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110846191|NCT03219723|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110846192|NCT03628417|Bleomycin|bleomycin|mesh-list
110846193|NCT03628417|Calcium|calcium|mesh-list
110846194|NCT03628417|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110846195|NCT03628417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110846196|NCT03628417|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110846197|NCT03628417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110846198|NCT03369964|Atezolizumab|atezolizumab|mesh-list
110846199|NCT03369964|Obinutuzumab|obinutuzumab|mesh-list
110846200|NCT03369964|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110846201|NCT03369964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110846202|NCT03369964|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110846203|NCT03369964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110846204|NCT03245736|Tisotumab vedotin|tisotumab vedotin|mesh-list
110846205|NCT03245736|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110846206|NCT03245736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110846207|NCT01173809|Amiodarone|amiodarone|mesh-list
110846208|NCT01173809|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110846209|NCT01173809|Vasodilator Agents|vasodilator agents|mesh-ancestor
110846210|NCT01173809|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
110846211|NCT01173809|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110631814|NCT00802802|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110846212|NCT01173809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110846213|NCT01173809|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110846214|NCT01173809|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110846215|NCT01173809|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110846216|NCT01173809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110846217|NCT01173809|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110846218|NCT01173809|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110846219|NCT01173809|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110846220|NCT03375580|Metformin|metformin|mesh-list
110631893|NCT00518284|Paclitaxel|paclitaxel|mesh-list
110846222|NCT03375580|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110846223|NCT03375580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110846224|NCT03375580|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110846225|NCT03375580|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110846226|NCT03375580|Antimetabolites|antimetabolites|mesh-ancestor
110846227|NCT03375580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110846228|NCT03375580|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110846229|NCT03375580|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110846230|NCT03375580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110846231|NCT01286909|Lycopene|lycopene|mesh-list
110846232|NCT01286909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110846233|NCT01286909|Antioxidants|antioxidants|mesh-ancestor
110846234|NCT01286909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110846235|NCT01286909|Protective Agents|protective agents|mesh-ancestor
110846236|NCT01286909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110846237|NCT01286909|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110846238|NCT01286909|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110846239|NCT01286909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110846240|NCT02954887|Cannabidiol|cannabidiol|mesh-list
110846241|NCT02954887|Anticonvulsants|anticonvulsants|mesh-ancestor
110846242|NCT03860129|Sevoflurane|sevoflurane|mesh-list
110846243|NCT03860129|Desflurane|desflurane|mesh-list
110846244|NCT03860129|Isoflurane|isoflurane|mesh-list
110846245|NCT03860129|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110846246|NCT03860129|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110846247|NCT03860129|Anesthetics, General|anesthetics, general|mesh-ancestor
110846248|NCT03860129|Anesthetics|anesthetics|mesh-ancestor
110846249|NCT03860129|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110846250|NCT03860129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110846251|NCT03369808|Aluminum Hydroxide|aluminum hydroxide|mesh-list
110846252|NCT03369808|Vaccines|vaccines|mesh-list
110846253|NCT03369808|Immunologic Factors|immunologic factors|mesh-ancestor
110846254|NCT03369808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110846255|NCT03369808|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110846256|NCT03369808|Antacids|antacids|mesh-ancestor
110846257|NCT03369808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110846258|NCT03369808|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110846260|NCT02525237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110632067|NCT04039854|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110846261|NCT02525237|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110846262|NCT02525237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110846263|NCT02525237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110846264|NCT01173887|Mogamulizumab|mogamulizumab|mesh-list
110846265|NCT01173887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110846266|NCT03369574|Reslizumab|reslizumab|mesh-list
110846267|NCT03369574|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110846268|NCT03369574|Respiratory System Agents|respiratory system agents|mesh-ancestor
110846269|NCT03278028|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110846270|NCT02651740|Rifaximin|rifaximin|mesh-list
110846271|NCT02651740|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110846272|NCT02651740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110846273|NCT02651740|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110846274|NCT03862391|Analgesics|analgesics|mesh-list
110846275|NCT03862391|Antiemetics|antiemetics|mesh-list
110846276|NCT03862391|Sensory System Agents|sensory system agents|mesh-ancestor
110846277|NCT03862391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110632300|NCT00981513|Vaccines|vaccines|mesh-list
110846278|NCT03862391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110846279|NCT03862391|Autonomic Agents|autonomic agents|mesh-ancestor
110846280|NCT03862391|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110846281|NCT03859583|Capsaicin|capsaicin|mesh-list
110846282|NCT03859583|Antipruritics|antipruritics|mesh-ancestor
110846283|NCT03859583|Dermatologic Agents|dermatologic agents|mesh-ancestor
110846284|NCT03859583|Sensory System Agents|sensory system agents|mesh-ancestor
110846285|NCT03859583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110846286|NCT03859583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110846287|NCT03369262|Atosiban|atosiban|mesh-list
110846288|NCT03369262|Hormone Antagonists|hormone antagonists|mesh-ancestor
110846289|NCT03369262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110846290|NCT03369262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110846291|NCT03369262|Tocolytic Agents|tocolytic agents|mesh-ancestor
110846292|NCT03369262|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110846293|NCT03276078|Bromides|bromides|mesh-list
110846294|NCT03276078|Formoterol Fumarate|formoterol fumarate|mesh-list
110846295|NCT03276078|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110846296|NCT03276078|Autonomic Agents|autonomic agents|mesh-ancestor
110831765|NCT05282251|Bupivacaine|bupivacaine|mesh-list
110846297|NCT03276078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110846298|NCT03276078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110846299|NCT03276078|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110846300|NCT03276078|Respiratory System Agents|respiratory system agents|mesh-ancestor
110846301|NCT03276078|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110846302|NCT03276078|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110846304|NCT03276078|Adrenergic Agents|adrenergic agents|mesh-ancestor
110846305|NCT03276078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110846306|NCT03276078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110846307|NCT03276078|Anticonvulsants|anticonvulsants|mesh-ancestor
110846308|NCT01288547|Theobromine|theobromine|mesh-list
110846309|NCT01288547|Caffeine|caffeine|mesh-list
110335573|NCT01245452|Antimetabolites|antimetabolites|mesh-ancestor
110846310|NCT01288547|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110846311|NCT01288547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110846312|NCT01288547|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110846313|NCT01288547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110846314|NCT01288547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110846315|NCT01288547|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110846316|NCT01288547|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110846317|NCT01288547|Purinergic Agents|purinergic agents|mesh-ancestor
110846318|NCT01288547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110632759|NCT00874068|Palmitic Acid|palmitic acid|mesh-list
110846319|NCT01288547|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110846320|NCT01288547|Autonomic Agents|autonomic agents|mesh-ancestor
110846321|NCT01288547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110846322|NCT01288547|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110632826|NCT00586157|Dopamine Agents|dopamine agents|mesh-ancestor
110846323|NCT01288547|Respiratory System Agents|respiratory system agents|mesh-ancestor
110846324|NCT01288547|Vasodilator Agents|vasodilator agents|mesh-ancestor
110846325|NCT03373864|Anesthetics|anesthetics|mesh-list
110846326|NCT03373864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110846327|NCT03373864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110846328|NCT04597320|Fentanyl|fentanyl|mesh-list
110846329|NCT04597320|Midazolam|midazolam|mesh-list
110846330|NCT04597320|Esketamine|esketamine|mesh-list
110846331|NCT04597320|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110846332|NCT04597320|Narcotics|narcotics|mesh-ancestor
110846333|NCT04597320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110632964|NCT00652340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110846334|NCT04597320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110846335|NCT04597320|Analgesics|analgesics|mesh-ancestor
110846336|NCT04597320|Sensory System Agents|sensory system agents|mesh-ancestor
110846337|NCT04597320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110846338|NCT04597320|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110846339|NCT04597320|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110846340|NCT04597320|Anesthetics, General|anesthetics, general|mesh-ancestor
110846341|NCT04597320|Anesthetics|anesthetics|mesh-ancestor
110846342|NCT04597320|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110846343|NCT04597320|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110846344|NCT04597320|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110846345|NCT04597320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110846346|NCT04597320|GABA Modulators|gaba modulators|mesh-ancestor
110846347|NCT04597320|GABA Agents|gaba agents|mesh-ancestor
110846348|NCT04597320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110846349|NCT04597320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110846350|NCT04597320|Antidepressive Agents|antidepressive agents|mesh-ancestor
110846352|NCT03373708|Cyclophosphamide|cyclophosphamide|mesh-list
110846353|NCT03373708|Docetaxel|docetaxel|mesh-list
110846354|NCT03373708|Letrozole|letrozole|mesh-list
110846355|NCT03373708|Epirubicin|epirubicin|mesh-list
110846356|NCT03373708|Goserelin|goserelin|mesh-list
110846357|NCT03373708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110846358|NCT03373708|Immunologic Factors|immunologic factors|mesh-ancestor
110846359|NCT03373708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110846360|NCT03373708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110846361|NCT03373708|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110846362|NCT03373708|Alkylating Agents|alkylating agents|mesh-ancestor
110846363|NCT03373708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110846365|NCT03373708|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110846366|NCT03373708|Tubulin Modulators|tubulin modulators|mesh-ancestor
110846367|NCT03373708|Antimitotic Agents|antimitotic agents|mesh-ancestor
110846368|NCT03373708|Mitosis Modulators|mitosis modulators|mesh-ancestor
110846369|NCT03373708|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110846370|NCT03373708|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110846371|NCT03373708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110846372|NCT03373708|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110846373|NCT03373708|Hormone Antagonists|hormone antagonists|mesh-ancestor
110633536|NCT02594423|Bevacizumab|bevacizumab|mesh-list
110846374|NCT03373708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110846375|NCT03373708|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110846376|NCT03373708|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110846377|NCT03373708|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110846378|NCT03373708|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110846379|NCT03373708|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110846380|NCT03373708|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110846381|NCT03373708|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110846382|NCT03123952|ABT-414|abt-414|mesh-list
110846383|NCT03123952|Immunoconjugates|immunoconjugates|mesh-ancestor
110846384|NCT03123952|Immunologic Factors|immunologic factors|mesh-ancestor
110846385|NCT03123952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110846386|NCT02519608|Aspirin|aspirin|mesh-list
110846387|NCT02519608|Clopidogrel|clopidogrel|mesh-list
110846388|NCT02519608|Ticagrelor|ticagrelor|mesh-list
110846389|NCT02519608|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110633605|NCT00888732|Insulin|insulin|mesh-list
110846390|NCT02519608|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110846392|NCT02519608|Sensory System Agents|sensory system agents|mesh-ancestor
110846393|NCT02519608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110846394|NCT02519608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110846395|NCT02519608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110846396|NCT02519608|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110846397|NCT02519608|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110846398|NCT02519608|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110633658|NCT00888810|Lapatinib|lapatinib|mesh-list
110846399|NCT02519608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110846400|NCT02519608|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110846401|NCT02519608|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110846402|NCT02519608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110846403|NCT02519608|Antipyretics|antipyretics|mesh-ancestor
110846404|NCT02519608|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110846405|NCT02519608|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110846406|NCT02519608|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110846407|NCT02519608|Purinergic Agents|purinergic agents|mesh-ancestor
110846408|NCT02519608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110846409|NCT05181852|Pregabalin|pregabalin|mesh-list
110846411|NCT05181852|Sensory System Agents|sensory system agents|mesh-ancestor
110846412|NCT05181852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110846413|NCT05181852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110846414|NCT05181852|Anticonvulsants|anticonvulsants|mesh-ancestor
110846415|NCT05181852|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110846416|NCT05181852|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110846417|NCT05181852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110846418|NCT05181852|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110846419|NCT05181852|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110846420|NCT05181852|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110846421|NCT05181852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110846422|NCT05181852|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110846423|NCT04584684|Ethanol|ethanol|mesh-list
110846424|NCT04584684|Hydrogen Peroxide|hydrogen peroxide|mesh-list
110846425|NCT04584684|Cetylpyridinium|cetylpyridinium|mesh-list
110846426|NCT04584684|Povidone|povidone|mesh-list
110846427|NCT04584684|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110846428|NCT04584684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110846429|NCT04584684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110846430|NCT04584684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110846431|NCT04584684|Plasma Substitutes|plasma substitutes|mesh-ancestor
110846432|NCT04584684|Blood Substitutes|blood substitutes|mesh-ancestor
110846433|NCT03373318|Plasma-lyte 148|plasma-lyte 148|mesh-list
110846434|NCT03373318|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110846435|NCT03373318|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110846436|NCT03124420|Amoxicillin|amoxicillin|mesh-list
110846437|NCT03124420|Clarithromycin|clarithromycin|mesh-list
110846438|NCT03124420|Lansoprazole|lansoprazole|mesh-list
110846439|NCT03124420|Dexlansoprazole|dexlansoprazole|mesh-list
110846440|NCT03124420|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110846441|NCT03124420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110846442|NCT03124420|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110846443|NCT03124420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110846444|NCT03124420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110846445|NCT03124420|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110846446|NCT03124420|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110846447|NCT03124420|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110846448|NCT03124420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110846449|NCT03124420|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110846451|NCT03231228|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110846453|NCT03510468|Pyridoxine|pyridoxine|mesh-list
110846454|NCT03510468|Isoniazid|isoniazid|mesh-list
110846455|NCT03510468|Rifapentine|rifapentine|mesh-list
110846456|NCT03510468|Antitubercular Agents|antitubercular agents|mesh-ancestor
110846457|NCT03510468|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110846458|NCT03510468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110846459|NCT03510468|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
110846460|NCT03510468|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110846461|NCT03510468|Antimetabolites|antimetabolites|mesh-ancestor
110633914|NCT00886314|Midazolam|midazolam|mesh-list
110846462|NCT03510468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110846463|NCT03510468|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110846464|NCT03510468|Vitamin B Complex|vitamin b complex|mesh-ancestor
110846465|NCT03510468|Vitamins|vitamins|mesh-ancestor
110846466|NCT03510468|Micronutrients|micronutrients|mesh-ancestor
110846467|NCT03510468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110846468|NCT03510468|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110846469|NCT03510468|Leprostatic Agents|leprostatic agents|mesh-ancestor
110846470|NCT01178645|Cytarabine|cytarabine|mesh-list
110846471|NCT01178645|Etoposide|etoposide|mesh-list
110846472|NCT01178645|Melphalan|melphalan|mesh-list
110846473|NCT01178645|Busulfan|busulfan|mesh-list
110846474|NCT01178645|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110846475|NCT01178645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110846476|NCT01178645|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110846477|NCT01178645|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110846478|NCT01178645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110846479|NCT01178645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110846480|NCT01178645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110846481|NCT01178645|Antimetabolites|antimetabolites|mesh-ancestor
110846482|NCT01178645|Antiviral Agents|antiviral agents|mesh-ancestor
110846483|NCT01178645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110846484|NCT01178645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110846485|NCT01178645|Immunologic Factors|immunologic factors|mesh-ancestor
110846486|NCT01178645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110846487|NCT01178645|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110846488|NCT01178645|Alkylating Agents|alkylating agents|mesh-ancestor
110846489|NCT01178645|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110846490|NCT01285505|Alprazolam|alprazolam|mesh-list
110846491|NCT01285505|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110846492|NCT01285505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110846493|NCT01285505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110846494|NCT01285505|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110846495|NCT01285505|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110846496|NCT01285505|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110846497|NCT01285505|GABA Modulators|gaba modulators|mesh-ancestor
110846498|NCT01285505|GABA Agents|gaba agents|mesh-ancestor
110846499|NCT01285505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110846500|NCT01285505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110846501|NCT03372850|Esomeprazole|esomeprazole|mesh-list
110846502|NCT03372850|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110846503|NCT03372850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110846504|NCT03372850|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110846505|NCT03372850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110564091|NCT00880607|Analgesics|analgesics|mesh-ancestor
110846506|NCT03372850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110846508|NCT04525066|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110846509|NCT04525066|Immunologic Factors|immunologic factors|mesh-ancestor
110846510|NCT04525066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110846511|NCT04525066|Viscosupplements|viscosupplements|mesh-ancestor
110846512|NCT04525066|Protective Agents|protective agents|mesh-ancestor
110846513|NCT03362788|Vitamin K|vitamin k|mesh-list
110846514|NCT03362788|Anticoagulants|anticoagulants|mesh-list
110846515|NCT03362788|Vitamins|vitamins|mesh-ancestor
110846516|NCT03362788|Micronutrients|micronutrients|mesh-ancestor
110846517|NCT03362788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110846518|NCT03362788|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110846519|NCT03362788|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110846520|NCT03362788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110846521|NCT03362788|Hemostatics|hemostatics|mesh-ancestor
110846522|NCT03362788|Coagulants|coagulants|mesh-ancestor
110846523|NCT03368794|Analgesics, Opioid|analgesics, opioid|mesh-list
110846524|NCT03368794|Narcotics|narcotics|mesh-ancestor
110846525|NCT03368794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110846526|NCT03368794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110846527|NCT03368794|Analgesics|analgesics|mesh-ancestor
110846528|NCT03368794|Sensory System Agents|sensory system agents|mesh-ancestor
110846529|NCT03368794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110846530|NCT03862079|Tazobactam|tazobactam|mesh-list
110846531|NCT03862079|Piperacillin|piperacillin|mesh-list
110846532|NCT03862079|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
110846533|NCT03862079|Nystatin|nystatin|mesh-list
110846534|NCT03862079|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110846535|NCT03862079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110846536|NCT03862079|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110846537|NCT03862079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110846538|NCT03862079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110846539|NCT03862079|Antifungal Agents|antifungal agents|mesh-ancestor
110846540|NCT03862079|Ionophores|ionophores|mesh-ancestor
110846541|NCT03862079|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110846542|NCT03362632|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110846543|NCT03362632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110846544|NCT01179269|Paclitaxel|paclitaxel|mesh-list
110846545|NCT01179269|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110846546|NCT01179269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110846547|NCT01179269|Tubulin Modulators|tubulin modulators|mesh-ancestor
110846548|NCT01179269|Antimitotic Agents|antimitotic agents|mesh-ancestor
110846549|NCT01179269|Mitosis Modulators|mitosis modulators|mesh-ancestor
110846550|NCT01179269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110846551|NCT00165724|Donepezil|donepezil|mesh-list
110846552|NCT00165724|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110846553|NCT00165724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110846554|NCT00165724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110846555|NCT00165724|Cholinergic Agents|cholinergic agents|mesh-ancestor
110846556|NCT00165724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110846557|NCT00165724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110846558|NCT00165724|Nootropic Agents|nootropic agents|mesh-ancestor
110846559|NCT01287455|Vitamin D|vitamin d|mesh-list
110846560|NCT01287455|Cholecalciferol|cholecalciferol|mesh-list
110846561|NCT01287455|Vitamins|vitamins|mesh-ancestor
110846562|NCT01287455|Micronutrients|micronutrients|mesh-ancestor
110846563|NCT01287455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110846564|NCT01287455|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110846565|NCT01287455|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110846566|NCT03865511|Osimertinib|osimertinib|mesh-list
110846567|NCT03865511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110846568|NCT03865511|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110846569|NCT03865511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110846570|NCT03865511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110846571|NCT01287533|Ibandronic Acid|ibandronic acid|mesh-list
110846572|NCT01287533|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110846573|NCT01287533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110846574|NCT03368404|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110846575|NCT03368404|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110335615|NCT05148195|Vitamins|vitamins|mesh-ancestor
110846576|NCT01287689|Immunoglobulins|immunoglobulins|mesh-list
110846577|NCT01287689|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110846578|NCT01287689|Antibodies|antibodies|mesh-list
110846579|NCT01287689|Immunoglobulin G|immunoglobulin g|mesh-list
110846580|NCT01287689|Immunologic Factors|immunologic factors|mesh-ancestor
110846581|NCT01287689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110846582|NCT01179503|Calcium, Dietary|calcium, dietary|mesh-list
110846583|NCT01179503|Vitamin D|vitamin d|mesh-list
110846584|NCT01179503|Calcium|calcium|mesh-list
110682920|NCT00903851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110846585|NCT01179503|Vitamins|vitamins|mesh-ancestor
110846586|NCT01179503|Micronutrients|micronutrients|mesh-ancestor
110846587|NCT01179503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110846588|NCT01179503|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110846589|NCT01179503|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110846591|NCT03117049|Bevacizumab|bevacizumab|mesh-list
110846592|NCT03117049|Carboplatin|carboplatin|mesh-list
110846593|NCT03117049|Nivolumab|nivolumab|mesh-list
110846594|NCT03117049|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110846595|NCT03117049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110846596|NCT03117049|Tubulin Modulators|tubulin modulators|mesh-ancestor
110846597|NCT03117049|Antimitotic Agents|antimitotic agents|mesh-ancestor
110846598|NCT03117049|Mitosis Modulators|mitosis modulators|mesh-ancestor
110846599|NCT03117049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110846600|NCT03117049|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110846601|NCT03117049|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110846602|NCT03117049|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110846603|NCT03117049|Growth Substances|growth substances|mesh-ancestor
110846604|NCT03117049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110846605|NCT03117049|Growth Inhibitors|growth inhibitors|mesh-ancestor
110846606|NCT03117049|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110846607|NCT03372304|Ropivacaine|ropivacaine|mesh-list
110846608|NCT03372304|Anesthetics, Local|anesthetics, local|mesh-ancestor
110846609|NCT03372304|Anesthetics|anesthetics|mesh-ancestor
110846610|NCT03372304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110846611|NCT03372304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110846612|NCT03372304|Sensory System Agents|sensory system agents|mesh-ancestor
110846613|NCT03372304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110846614|NCT02525081|Ramipril|ramipril|mesh-list
110846615|NCT02525081|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
110846616|NCT02525081|Protease Inhibitors|protease inhibitors|mesh-ancestor
110846617|NCT02525081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110846618|NCT02525081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110846619|NCT02525081|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110846620|NCT05566548|Bilirubin|bilirubin|mesh-list
110846621|NCT05566548|Antioxidants|antioxidants|mesh-ancestor
110846622|NCT05566548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110846623|NCT05566548|Protective Agents|protective agents|mesh-ancestor
110846624|NCT05566548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110846625|NCT02525003|Vitamin D|vitamin d|mesh-list
110846626|NCT02525003|Ergocalciferols|ergocalciferols|mesh-list
110846627|NCT02525003|Cholecalciferol|cholecalciferol|mesh-list
110846628|NCT02525003|Vitamins|vitamins|mesh-list
110846629|NCT02525003|Micronutrients|micronutrients|mesh-ancestor
110846630|NCT02525003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110846631|NCT02525003|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110846632|NCT02525003|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110846633|NCT03464448|Teriflunomide|teriflunomide|mesh-list
110846634|NCT03464448|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110846635|NCT03464448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110846636|NCT03464448|Analgesics|analgesics|mesh-ancestor
110846637|NCT03464448|Sensory System Agents|sensory system agents|mesh-ancestor
110846638|NCT03464448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110846639|NCT03464448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110846640|NCT03464448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110846641|NCT03464448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110846642|NCT03464448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110846643|NCT03464448|Immunologic Factors|immunologic factors|mesh-ancestor
110846644|NCT03362008|Varenicline|varenicline|mesh-list
110846645|NCT03362008|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110846646|NCT03362008|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110846647|NCT03362008|Cholinergic Agents|cholinergic agents|mesh-ancestor
110846648|NCT03362008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110846649|NCT03362008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110846650|NCT03362008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110846651|NCT03123406|Cinacalcet|cinacalcet|mesh-list
110846652|NCT03123406|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110846653|NCT03123406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110846654|NCT03123406|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
110846655|NCT03123406|Hormone Antagonists|hormone antagonists|mesh-ancestor
110846656|NCT03123406|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110846657|NCT01179659|Pantoprazole|pantoprazole|mesh-list
110846658|NCT01179659|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110846659|NCT01179659|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110846660|NCT01179659|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110846661|NCT01179659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110846662|NCT01179659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110846663|NCT03361774|Fluorides|fluorides|mesh-list
110846664|NCT03361774|Cariostatic Agents|cariostatic agents|mesh-ancestor
110846665|NCT03361774|Protective Agents|protective agents|mesh-ancestor
110846666|NCT03361774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110846667|NCT04523740|Acetaminophen|acetaminophen|mesh-list
110846668|NCT04523740|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110846669|NCT04523740|Analgesics|analgesics|mesh-ancestor
110846670|NCT04523740|Sensory System Agents|sensory system agents|mesh-ancestor
110846671|NCT04523740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110846672|NCT04523740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110846673|NCT04523740|Antipyretics|antipyretics|mesh-ancestor
110846674|NCT03410706|Rivaroxaban|rivaroxaban|mesh-list
110846675|NCT03410706|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110846676|NCT03410706|Antithrombins|antithrombins|mesh-ancestor
110846677|NCT03410706|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110846678|NCT03410706|Protease Inhibitors|protease inhibitors|mesh-ancestor
110846679|NCT03410706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110846680|NCT03410706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110846681|NCT03410706|Anticoagulants|anticoagulants|mesh-ancestor
110846682|NCT04523662|Apatinib|apatinib|mesh-list
110846683|NCT04523662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110846684|NCT04523662|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110846685|NCT04523662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110846686|NCT04523662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110846687|NCT03371992|Pembrolizumab|pembrolizumab|mesh-list
110846688|NCT03371992|Nivolumab|nivolumab|mesh-list
110846689|NCT03371992|Atezolizumab|atezolizumab|mesh-list
110846690|NCT03371992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110846691|NCT03371992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110846692|NCT03371992|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110846693|NCT03371992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110846694|NCT03682705|Upadacitinib|upadacitinib|mesh-list
110846695|NCT03682705|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
110846696|NCT03682705|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110846697|NCT03682705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110846698|NCT03682705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110846699|NCT03682705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110846700|NCT03361618|Zinc Sulfate|zinc sulfate|mesh-list
110846701|NCT03361618|Astringents|astringents|mesh-ancestor
110846702|NCT03361618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110846703|NCT03361618|Dermatologic Agents|dermatologic agents|mesh-ancestor
110846704|NCT01314495|Abatacept|abatacept|mesh-list
110846705|NCT01314495|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110846706|NCT01314495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110846707|NCT01314495|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110846708|NCT01314495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110846709|NCT01314495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110846710|NCT01314495|Immunologic Factors|immunologic factors|mesh-ancestor
110846711|NCT01314495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110846712|NCT01314495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110846713|NCT03123484|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110846714|NCT03123484|Gefitinib|gefitinib|mesh-list
110846715|NCT03123484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110846716|NCT03123484|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110846717|NCT03123484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110846718|NCT03123484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110846720|NCT03179787|Antidepressive Agents|antidepressive agents|mesh-ancestor
110846721|NCT03179787|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110846722|NCT03179787|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110846723|NCT03179787|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110846724|NCT03179787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110846725|NCT03179787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110846726|NCT03179787|Dopamine Agonists|dopamine agonists|mesh-ancestor
110846727|NCT03179787|Dopamine Agents|dopamine agents|mesh-ancestor
110846728|NCT03179787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110846729|NCT03179787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110846730|NCT03179787|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110846731|NCT03179787|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110846732|NCT03179787|Serotonin Agents|serotonin agents|mesh-ancestor
110846733|NCT03179787|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110846734|NCT03179787|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110846735|NCT03179787|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110564317|NCT05862701|Permethrin|permethrin|mesh-list
110846736|NCT03179787|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110846737|NCT02956057|Ascorbic Acid|ascorbic acid|mesh-list
110846738|NCT02956057|Magnesium citrate|magnesium citrate|mesh-list
110846739|NCT02956057|Picosulfate sodium|picosulfate sodium|mesh-list
110846740|NCT02956057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110846741|NCT02956057|Antioxidants|antioxidants|mesh-ancestor
110846742|NCT02956057|Protective Agents|protective agents|mesh-ancestor
110846743|NCT02956057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110846744|NCT02956057|Vitamins|vitamins|mesh-ancestor
110846745|NCT02956057|Micronutrients|micronutrients|mesh-ancestor
110846746|NCT02956057|Cathartics|cathartics|mesh-ancestor
110846747|NCT02956057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110846748|NCT04526470|Paclitaxel|paclitaxel|mesh-list
110846749|NCT04526470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110846750|NCT04526470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110846751|NCT04526470|Tubulin Modulators|tubulin modulators|mesh-ancestor
110846752|NCT04526470|Antimitotic Agents|antimitotic agents|mesh-ancestor
110846753|NCT04526470|Mitosis Modulators|mitosis modulators|mesh-ancestor
110846754|NCT04526470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110846755|NCT03367390|Insulin Lispro|insulin lispro|mesh-list
110846756|NCT03367390|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110846757|NCT03367390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110846759|NCT01176851|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110846760|NCT01176851|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110846761|NCT01176851|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110846762|NCT01176851|Cholinergic Agents|cholinergic agents|mesh-ancestor
110846763|NCT01176851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110846764|NCT01176851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110846765|NCT01176851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110846766|NCT04526236|Methadone|methadone|mesh-list
110846767|NCT04526236|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110846768|NCT04526236|Narcotics|narcotics|mesh-ancestor
110846769|NCT04526236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110846770|NCT04526236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110846771|NCT04526236|Analgesics|analgesics|mesh-ancestor
110335648|NCT05148312|Budesonide|budesonide|mesh-list
110846772|NCT04526236|Sensory System Agents|sensory system agents|mesh-ancestor
110846773|NCT04526236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110846774|NCT04526236|Antitussive Agents|antitussive agents|mesh-ancestor
110846775|NCT04526236|Respiratory System Agents|respiratory system agents|mesh-ancestor
110846776|NCT01179971|Evening primrose oil|evening primrose oil|mesh-list
110846777|NCT01179971|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110846778|NCT01179971|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110846779|NCT01179971|Analgesics|analgesics|mesh-ancestor
110846780|NCT01179971|Sensory System Agents|sensory system agents|mesh-ancestor
110831812|NCT01124435|Celecoxib|celecoxib|mesh-list
110846781|NCT01179971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110846782|NCT01179971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110846783|NCT01179971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110846784|NCT01179971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110846785|NCT01179971|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110846786|NCT01179971|Antimetabolites|antimetabolites|mesh-ancestor
110846787|NCT01179971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110846788|NCT01179971|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110846790|NCT04237584|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
110846791|NCT04237584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110846792|NCT03681691|Estradiol|estradiol|mesh-list
110846793|NCT03681691|Estrogens|estrogens|mesh-ancestor
110846794|NCT03681691|Hormones|hormones|mesh-ancestor
110846795|NCT03681691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110846796|NCT03681691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110846797|NCT03360760|Doxorubicin|doxorubicin|mesh-list
110846798|NCT03360760|Methotrexate|methotrexate|mesh-list
110846799|NCT03360760|Ifosfamide|ifosfamide|mesh-list
110846800|NCT03360760|Isophosphamide mustard|isophosphamide mustard|mesh-list
110846801|NCT03360760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110846802|NCT03360760|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110846803|NCT03360760|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110846804|NCT03360760|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110846805|NCT03360760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110846806|NCT03360760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110846807|NCT03360760|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110846808|NCT03360760|Abortifacient Agents|abortifacient agents|mesh-ancestor
110846809|NCT03360760|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110846810|NCT03360760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110846811|NCT03360760|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110846812|NCT03360760|Antimetabolites|antimetabolites|mesh-ancestor
110846813|NCT03360760|Dermatologic Agents|dermatologic agents|mesh-ancestor
110846814|NCT03360760|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110846815|NCT03360760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110846816|NCT03360760|Immunologic Factors|immunologic factors|mesh-ancestor
110846817|NCT03360760|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110846818|NCT03360760|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110846819|NCT03360760|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110846820|NCT03360760|Alkylating Agents|alkylating agents|mesh-ancestor
110846821|NCT01285661|Vitamin K|vitamin k|mesh-list
110846823|NCT01285661|Anticoagulants|anticoagulants|mesh-list
110846824|NCT01285661|Vitamins|vitamins|mesh-ancestor
110846825|NCT01285661|Micronutrients|micronutrients|mesh-ancestor
110846826|NCT01285661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110846827|NCT01285661|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110846828|NCT01285661|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110846829|NCT01285661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110846830|NCT01285661|Hemostatics|hemostatics|mesh-ancestor
110846831|NCT01285661|Coagulants|coagulants|mesh-ancestor
110846832|NCT03360682|Tenofovir|tenofovir|mesh-list
110846833|NCT03360682|Lamivudine|lamivudine|mesh-list
110846834|NCT03360682|Emtricitabine|emtricitabine|mesh-list
110846835|NCT03360682|Dolutegravir|dolutegravir|mesh-list
110846836|NCT03360682|Abacavir|abacavir|mesh-list
110846837|NCT03360682|Antiviral Agents|antiviral agents|mesh-ancestor
110846838|NCT03360682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110846839|NCT03360682|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110846840|NCT03360682|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110846841|NCT03360682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110846842|NCT03360682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110846843|NCT03360682|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110846844|NCT03360682|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110846845|NCT03360682|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110846846|NCT03360682|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110846847|NCT01180205|Amlodipine|amlodipine|mesh-list
110846848|NCT01180205|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110846849|NCT01180205|Telmisartan|telmisartan|mesh-list
110846850|NCT01180205|Olmesartan|olmesartan|mesh-list
110846851|NCT01180205|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
110846852|NCT01180205|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110846853|NCT01180205|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110846854|NCT01180205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110846855|NCT01180205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110846856|NCT01180205|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110846857|NCT01180205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110846858|NCT01180205|Vasodilator Agents|vasodilator agents|mesh-ancestor
110846859|NCT01180205|Diuretics|diuretics|mesh-ancestor
110846860|NCT01180205|Natriuretic Agents|natriuretic agents|mesh-ancestor
110846861|NCT01180205|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110846862|NCT01180205|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110846863|NCT01180205|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110846864|NCT04523506|Botulinum Toxins|botulinum toxins|mesh-list
110846865|NCT04523506|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110634515|NCT02551796|BB 1101|bb 1101|mesh-list
110846866|NCT04523506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110846867|NCT04523506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110846869|NCT04523506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110846870|NCT04523506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110846871|NCT03867084|Pembrolizumab|pembrolizumab|mesh-list
110846872|NCT03867084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110846873|NCT03867084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110846874|NCT03867084|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110846875|NCT03867084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110846876|NCT03860831|Midazolam|midazolam|mesh-list
110846877|NCT03860831|Ketamine|ketamine|mesh-list
110846878|NCT03860831|Analgesics|analgesics|mesh-ancestor
110846879|NCT03860831|Sensory System Agents|sensory system agents|mesh-ancestor
110846880|NCT03860831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110846881|NCT03860831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110846882|NCT03860831|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110846883|NCT03860831|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110846884|NCT03860831|Anesthetics, General|anesthetics, general|mesh-ancestor
110846885|NCT03860831|Anesthetics|anesthetics|mesh-ancestor
110846886|NCT03860831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110846887|NCT03860831|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110846888|NCT03860831|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110846889|NCT03860831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110846890|NCT03860831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110846891|NCT03860831|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110846892|NCT03860831|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110846893|NCT03860831|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110846894|NCT03860831|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110846895|NCT03860831|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110846896|NCT03860831|GABA Modulators|gaba modulators|mesh-ancestor
110846897|NCT03860831|GABA Agents|gaba agents|mesh-ancestor
110846899|NCT01064479|Carboplatin|carboplatin|mesh-list
110846900|NCT01064479|Docetaxel|docetaxel|mesh-list
110846901|NCT01064479|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110846902|NCT01064479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110846903|NCT01064479|Tubulin Modulators|tubulin modulators|mesh-ancestor
110846904|NCT01064479|Antimitotic Agents|antimitotic agents|mesh-ancestor
110846905|NCT01064479|Mitosis Modulators|mitosis modulators|mesh-ancestor
110846906|NCT01064479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110846907|NCT01064479|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110846908|NCT01064479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110846909|NCT04218708|Nicotine|nicotine|mesh-list
110846910|NCT04218708|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110846911|NCT04218708|Autonomic Agents|autonomic agents|mesh-ancestor
110846912|NCT04218708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110846913|NCT04218708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110846914|NCT04218708|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110846915|NCT04218708|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110846916|NCT04218708|Cholinergic Agents|cholinergic agents|mesh-ancestor
110846917|NCT04218708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110846918|NCT04218708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110846919|NCT03667326|Aspirin|aspirin|mesh-list
110846920|NCT03667326|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110846921|NCT03667326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110846923|NCT03667326|Sensory System Agents|sensory system agents|mesh-ancestor
110846924|NCT03667326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110846925|NCT03667326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110846926|NCT03667326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110846927|NCT03667326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110634605|NCT00585689|Antimetabolites|antimetabolites|mesh-ancestor
110846928|NCT03667326|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110846929|NCT03667326|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110846930|NCT03667326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110846931|NCT03667326|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110846932|NCT03667326|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110846933|NCT03667326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110846934|NCT03667326|Antipyretics|antipyretics|mesh-ancestor
110846935|NCT04525300|Liraglutide|liraglutide|mesh-list
110846936|NCT04525300|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110846937|NCT04525300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110846938|NCT04525300|Incretins|incretins|mesh-ancestor
110846939|NCT04525300|Hormones|hormones|mesh-ancestor
110846940|NCT04525300|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110846941|NCT03865121|Nicotine|nicotine|mesh-list
110846942|NCT03865121|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110846943|NCT03865121|Autonomic Agents|autonomic agents|mesh-ancestor
110846944|NCT03865121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110846945|NCT03865121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110846946|NCT03865121|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110846947|NCT03865121|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110846948|NCT03865121|Cholinergic Agents|cholinergic agents|mesh-ancestor
110846949|NCT03865121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110846950|NCT03865121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110846951|NCT03680911|Acetylcysteine|acetylcysteine|mesh-list
110846952|NCT03680911|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110846953|NCT03680911|Antiviral Agents|antiviral agents|mesh-ancestor
110846954|NCT03680911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110846955|NCT03680911|Expectorants|expectorants|mesh-ancestor
110846956|NCT03680911|Respiratory System Agents|respiratory system agents|mesh-ancestor
110846957|NCT03680911|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110846958|NCT03680911|Antioxidants|antioxidants|mesh-ancestor
110846959|NCT03680911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110846960|NCT03680911|Protective Agents|protective agents|mesh-ancestor
110846961|NCT03680911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110634635|NCT00736385|Metformin|metformin|mesh-list
110846962|NCT03680911|Antidotes|antidotes|mesh-ancestor
110846963|NCT03370588|Dexmedetomidine|dexmedetomidine|mesh-list
110846964|NCT03370588|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110846965|NCT03370588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110846966|NCT03370588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110846967|NCT03370588|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110846968|NCT03370588|Analgesics|analgesics|mesh-ancestor
110846969|NCT03370588|Sensory System Agents|sensory system agents|mesh-ancestor
110846970|NCT03370588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110846971|NCT03370588|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110846972|NCT03370588|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110846973|NCT03370588|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110846974|NCT03370588|Adrenergic Agents|adrenergic agents|mesh-ancestor
110846975|NCT03370588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110846976|NCT03370588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110846977|NCT05156814|Dydrogesterone|dydrogesterone|mesh-list
110846978|NCT05156814|Progestins|progestins|mesh-ancestor
110846979|NCT05156814|Hormones|hormones|mesh-ancestor
110846980|NCT05156814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110846981|NCT05156814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110846982|NCT01289483|Fospropofol|fospropofol|mesh-list
110846983|NCT01289483|Propofol|propofol|mesh-list
110846984|NCT01289483|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110846985|NCT01289483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110846986|NCT01289483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110846987|NCT01289483|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110846988|NCT01289483|Anesthetics, General|anesthetics, general|mesh-ancestor
110846989|NCT01289483|Anesthetics|anesthetics|mesh-ancestor
110846990|NCT03680521|Nivolumab|nivolumab|mesh-list
110846991|NCT03680521|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110846992|NCT03680521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110846993|NCT03680521|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110846994|NCT03680521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110846995|NCT01289327|Midazolam|midazolam|mesh-list
110846996|NCT01289327|Alfentanil|alfentanil|mesh-list
110846997|NCT01289327|Propofol|propofol|mesh-list
110846998|NCT01289327|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110846999|NCT01289327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110847000|NCT01289327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110847001|NCT01289327|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110847002|NCT01289327|Anesthetics, General|anesthetics, general|mesh-ancestor
110847003|NCT01289327|Anesthetics|anesthetics|mesh-ancestor
110847004|NCT01289327|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110847005|NCT01289327|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110847006|NCT01289327|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110847007|NCT01289327|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110847008|NCT01289327|GABA Modulators|gaba modulators|mesh-ancestor
110847009|NCT01289327|GABA Agents|gaba agents|mesh-ancestor
110847010|NCT01289327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110847011|NCT01289327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110847012|NCT01289327|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110847013|NCT01289327|Narcotics|narcotics|mesh-ancestor
110847014|NCT01289327|Analgesics|analgesics|mesh-ancestor
110847015|NCT01289327|Sensory System Agents|sensory system agents|mesh-ancestor
110847016|NCT01289327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110847017|NCT01181063|Budesonide|budesonide|mesh-list
110847018|NCT01181063|Formoterol Fumarate|formoterol fumarate|mesh-list
110847019|NCT01181063|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110847020|NCT01181063|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110847021|NCT01181063|Autonomic Agents|autonomic agents|mesh-ancestor
110847022|NCT01181063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110847023|NCT01181063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110847024|NCT01181063|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110847025|NCT01181063|Respiratory System Agents|respiratory system agents|mesh-ancestor
110847026|NCT01181063|Glucocorticoids|glucocorticoids|mesh-ancestor
110847027|NCT01181063|Hormones|hormones|mesh-ancestor
110847028|NCT01181063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110847029|NCT01181063|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110847030|NCT01181063|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110847031|NCT01181063|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110847032|NCT01181063|Adrenergic Agents|adrenergic agents|mesh-ancestor
110847033|NCT01181063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110847034|NCT01181063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110847035|NCT02596997|Brincidofovir|brincidofovir|mesh-list
110847036|NCT02596997|Antiviral Agents|antiviral agents|mesh-ancestor
110847037|NCT02596997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110847038|NCT03649477|Carbetocin|carbetocin|mesh-list
110847039|NCT03649477|Oxytocin|oxytocin|mesh-list
110847040|NCT03649477|Oxytocics|oxytocics|mesh-ancestor
110847041|NCT03649477|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110847042|NCT03649477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110847043|NCT03359746|Grazoprevir|grazoprevir|mesh-list
110847044|NCT03359746|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
110847045|NCT03359746|Antiviral Agents|antiviral agents|mesh-ancestor
110847046|NCT03359746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110847047|NCT01310101|Dexamethasone|dexamethasone|mesh-list
110847048|NCT01310101|Ofatumumab|ofatumumab|mesh-list
110847049|NCT01310101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110847050|NCT01310101|Antiemetics|antiemetics|mesh-ancestor
110847051|NCT01310101|Autonomic Agents|autonomic agents|mesh-ancestor
110847052|NCT01310101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110847053|NCT01310101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110847054|NCT01310101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110847055|NCT01310101|Glucocorticoids|glucocorticoids|mesh-ancestor
110847056|NCT01310101|Hormones|hormones|mesh-ancestor
110847057|NCT01310101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110847058|NCT01310101|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110847059|NCT01310101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110847060|NCT03639727|Mannitol|mannitol|mesh-list
110847061|NCT03639727|Citric Acid|citric acid|mesh-list
110847062|NCT03639727|Sodium Citrate|sodium citrate|mesh-list
110847063|NCT03639727|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110847064|NCT03639727|Diuretics|diuretics|mesh-ancestor
110847065|NCT03639727|Natriuretic Agents|natriuretic agents|mesh-ancestor
110847066|NCT03639727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110847067|NCT03639727|Anticoagulants|anticoagulants|mesh-ancestor
110847068|NCT03639727|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110847069|NCT03639727|Chelating Agents|chelating agents|mesh-ancestor
110847070|NCT03639727|Sequestering Agents|sequestering agents|mesh-ancestor
110847071|NCT03639727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110847072|NCT01180751|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110847073|NCT01180751|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110847074|NCT01180751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110847075|NCT04523272|Sunitinib|sunitinib|mesh-list
110847076|NCT04523272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110847077|NCT04523272|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110847078|NCT04523272|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110847079|NCT04523272|Growth Substances|growth substances|mesh-ancestor
110847080|NCT04523272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110847081|NCT04523272|Growth Inhibitors|growth inhibitors|mesh-ancestor
110847082|NCT04523272|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110847083|NCT04523272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110847084|NCT04523272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110847085|NCT01289561|Ethanol|ethanol|mesh-list
110847086|NCT01289561|Quinine|quinine|mesh-list
110847087|NCT01289561|Caffeine|caffeine|mesh-list
110847088|NCT01289561|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110847089|NCT01289561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110847090|NCT01289561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110847091|NCT01289561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110634745|NCT00252499|Rosiglitazone|rosiglitazone|mesh-list
110847092|NCT01289561|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110847093|NCT01289561|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110847094|NCT01289561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110847095|NCT01289561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110847096|NCT01289561|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110847097|NCT01289561|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110847098|NCT01289561|Purinergic Agents|purinergic agents|mesh-ancestor
110847099|NCT01289561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110847100|NCT01289561|Antimalarials|antimalarials|mesh-ancestor
110847101|NCT01289561|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110847102|NCT01289561|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110847103|NCT01289561|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110847104|NCT01289561|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110847105|NCT01289561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110847106|NCT01289561|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110847107|NCT01289561|Analgesics|analgesics|mesh-ancestor
110847108|NCT01289561|Sensory System Agents|sensory system agents|mesh-ancestor
110847109|NCT03855527|Chlorhexidine|chlorhexidine|mesh-list
110847110|NCT03855527|Fluorides|fluorides|mesh-list
110847111|NCT03855527|Cariostatic Agents|cariostatic agents|mesh-ancestor
110847112|NCT03855527|Protective Agents|protective agents|mesh-ancestor
110847113|NCT03855527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110847114|NCT03855527|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110564703|NCT04857398|Insulin|insulin|mesh-list
110847115|NCT03855527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110847116|NCT03855527|Disinfectants|disinfectants|mesh-ancestor
110847117|NCT03366064|Pemetrexed|pemetrexed|mesh-list
110847118|NCT03366064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110847119|NCT03366064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110847120|NCT03366064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110847121|NCT03366064|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110847122|NCT03366064|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110847123|NCT03677401|Serlopitant|serlopitant|mesh-list
110847124|NCT03677401|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110847125|NCT03677401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110847126|NCT03677401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110847127|NCT03677401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110847128|NCT03357874|Clopidogrel|clopidogrel|mesh-list
110847129|NCT03357874|Ticagrelor|ticagrelor|mesh-list
110634770|NCT00163657|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110847130|NCT03357874|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110847131|NCT03357874|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110847132|NCT03357874|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110847133|NCT03357874|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110847134|NCT03357874|Purinergic Agents|purinergic agents|mesh-ancestor
110847135|NCT03357874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110847136|NCT03357874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110847137|NCT03357874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110847138|NCT01286051|Ganirelix|ganirelix|mesh-list
110847139|NCT01286051|Hormone Antagonists|hormone antagonists|mesh-ancestor
110847140|NCT01286051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110847141|NCT01286051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110847142|NCT03357796|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
110847143|NCT03357796|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110847144|NCT03357796|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110847145|NCT03357796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110847146|NCT03357796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110847147|NCT03357796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110847148|NCT03357796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110847149|NCT03357796|Antidepressive Agents|antidepressive agents|mesh-ancestor
110847150|NCT03357796|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110847151|NCT02359513|Fluoxetine|fluoxetine|mesh-list
110847152|NCT02359513|Antidepressive Agents|antidepressive agents|mesh-list
110847153|NCT02359513|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110847154|NCT02359513|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110847155|NCT02359513|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110847156|NCT02359513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110847157|NCT02359513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110847158|NCT02359513|Serotonin Agents|serotonin agents|mesh-ancestor
110847159|NCT02359513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110847160|NCT02359513|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110847161|NCT02359513|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110847162|NCT02359513|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110847163|NCT02359513|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110847164|NCT02359513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110847165|NCT01184495|Epoetin Alfa|epoetin alfa|mesh-list
110847166|NCT01184495|Hematinics|hematinics|mesh-ancestor
110847167|NCT03864575|Celecoxib|celecoxib|mesh-list
110847168|NCT03864575|Nivolumab|nivolumab|mesh-list
110847169|NCT03864575|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110847170|NCT03864575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110847171|NCT03864575|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110847172|NCT03864575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110847173|NCT03864575|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110847174|NCT03864575|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110847175|NCT03864575|Analgesics|analgesics|mesh-ancestor
110847176|NCT03864575|Sensory System Agents|sensory system agents|mesh-ancestor
110335728|NCT00503594|Mitosis Modulators|mitosis modulators|mesh-ancestor
110847177|NCT03864575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110847178|NCT03864575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110847179|NCT03864575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110847180|NCT03864575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110847181|NCT03864575|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110847182|NCT03864575|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110847183|NCT03864575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110847185|NCT03357718|Dexmedetomidine|dexmedetomidine|mesh-list
110847186|NCT03357718|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110847187|NCT03357718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110847188|NCT03357718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110847189|NCT03357718|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110847190|NCT03357718|Analgesics|analgesics|mesh-ancestor
110847191|NCT03357718|Sensory System Agents|sensory system agents|mesh-ancestor
110847192|NCT03357718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110847193|NCT03357718|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110847194|NCT03357718|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110847195|NCT03357718|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110847196|NCT03357718|Adrenergic Agents|adrenergic agents|mesh-ancestor
110847197|NCT03357718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110847198|NCT03357718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110847199|NCT03357718|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110847200|NCT03357718|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110847201|NCT03357718|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110847202|NCT03357718|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110847203|NCT03357718|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110847204|NCT03357718|Anesthetics, General|anesthetics, general|mesh-ancestor
110847205|NCT03357718|Anesthetics|anesthetics|mesh-ancestor
110847206|NCT03357718|GABA Modulators|gaba modulators|mesh-ancestor
110847207|NCT03357718|GABA Agents|gaba agents|mesh-ancestor
110847208|NCT04521400|Interferons|interferons|mesh-list
110847209|NCT04521400|Ritonavir|ritonavir|mesh-list
110847210|NCT04521400|Lopinavir|lopinavir|mesh-list
110847211|NCT04521400|Interferon-beta|interferon-beta|mesh-list
110847212|NCT04521400|Interferon beta-1a|interferon beta-1a|mesh-list
110847213|NCT04521400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110847214|NCT04521400|Antiviral Agents|antiviral agents|mesh-ancestor
110847215|NCT04521400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110847216|NCT04521400|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110847217|NCT04521400|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110847218|NCT04521400|Protease Inhibitors|protease inhibitors|mesh-ancestor
110847219|NCT04521400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110847220|NCT04521400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110847221|NCT04521400|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110847222|NCT04521400|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110847223|NCT04521400|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110847224|NCT04521400|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110847225|NCT04521400|Immunologic Factors|immunologic factors|mesh-ancestor
110847226|NCT04521400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110847227|NCT04521400|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110847228|NCT03864185|Rituximab|rituximab|mesh-list
110847229|NCT03864185|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110847230|NCT03864185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110847231|NCT03864185|Immunologic Factors|immunologic factors|mesh-ancestor
110847232|NCT03864185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110847233|NCT03864185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110847234|NCT01185119|Glucagon|glucagon|mesh-list
110847235|NCT01185119|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
110847236|NCT01185119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110847237|NCT01185119|Hormones|hormones|mesh-ancestor
110847238|NCT01185119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110847239|NCT01185119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110847240|NCT01185119|Incretins|incretins|mesh-ancestor
110847241|NCT03357640|Contraceptive Agents|contraceptive agents|mesh-list
110847242|NCT03357640|Contraceptives, Oral|contraceptives, oral|mesh-list
110847243|NCT03357640|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
110847244|NCT03357640|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110847245|NCT03357640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110847246|NCT03357640|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110847247|NCT01185197|Mycophenolic Acid|mycophenolic acid|mesh-list
110847248|NCT01185197|Prednisolone|prednisolone|mesh-list
110847249|NCT01185197|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110847250|NCT01185197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110847251|NCT01185197|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110847252|NCT01185197|Antitubercular Agents|antitubercular agents|mesh-ancestor
110635086|NCT04035330|Etidronic Acid|etidronic acid|mesh-list
110847253|NCT01185197|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110847254|NCT01185197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110847255|NCT01185197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110847256|NCT01185197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110847257|NCT01185197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110847258|NCT01185197|Glucocorticoids|glucocorticoids|mesh-ancestor
110847259|NCT01185197|Hormones|hormones|mesh-ancestor
110847260|NCT01185197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110847261|NCT01185197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110847262|NCT01185197|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110847263|NCT03733873|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
110847264|NCT03733873|Hemostatics|hemostatics|mesh-ancestor
110847265|NCT03733873|Coagulants|coagulants|mesh-ancestor
110847266|NCT03733873|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
110847267|NCT03733873|Natriuretic Agents|natriuretic agents|mesh-ancestor
110847268|NCT03733873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110847269|NCT03733639|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
110847270|NCT03733639|Hemostatics|hemostatics|mesh-ancestor
110847271|NCT03733639|Coagulants|coagulants|mesh-ancestor
110847272|NCT03733561|Rotigotine|rotigotine|mesh-list
110847273|NCT03733561|Dopamine Agonists|dopamine agonists|mesh-ancestor
110847274|NCT03733561|Dopamine Agents|dopamine agents|mesh-ancestor
110847275|NCT03733561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110847276|NCT03733561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110847277|NCT03733561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110847278|NCT03358888|Analgesics, Opioid|analgesics, opioid|mesh-list
110847279|NCT03358888|Narcotics|narcotics|mesh-ancestor
110847280|NCT03358888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110847281|NCT03358888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110847282|NCT03358888|Analgesics|analgesics|mesh-ancestor
110847283|NCT03358888|Sensory System Agents|sensory system agents|mesh-ancestor
110847284|NCT03358888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110847285|NCT01291121|Ranibizumab|ranibizumab|mesh-list
110847286|NCT01291121|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110847287|NCT01291121|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110847288|NCT01291121|Growth Substances|growth substances|mesh-ancestor
110847289|NCT01291121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110847290|NCT01291121|Growth Inhibitors|growth inhibitors|mesh-ancestor
110847291|NCT01291121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110847292|NCT01187849|Metformin|metformin|mesh-list
110847293|NCT01187849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110847294|NCT01187849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110847295|NCT04522882|Insulin|insulin|mesh-list
110847296|NCT04522882|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110847297|NCT04522882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110847298|NCT03123718|Methotrexate|methotrexate|mesh-list
110847299|NCT03123718|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110847300|NCT03123718|Abortifacient Agents|abortifacient agents|mesh-ancestor
110847301|NCT03123718|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110847302|NCT03123718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110847303|NCT03123718|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110847304|NCT03123718|Antimetabolites|antimetabolites|mesh-ancestor
110847305|NCT03123718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110847306|NCT03123718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110847307|NCT03123718|Dermatologic Agents|dermatologic agents|mesh-ancestor
110847308|NCT03123718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110847309|NCT03123718|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110847310|NCT03123718|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110847311|NCT03123718|Immunologic Factors|immunologic factors|mesh-ancestor
110847312|NCT03123718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110847313|NCT03123718|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110847315|NCT01185743|Ziprasidone|ziprasidone|mesh-list
110847316|NCT01185743|Antiemetics|antiemetics|mesh-ancestor
110847317|NCT01185743|Autonomic Agents|autonomic agents|mesh-ancestor
110847318|NCT01185743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110847319|NCT01185743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110847320|NCT01185743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110847321|NCT01185743|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110847322|NCT01185743|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110847323|NCT01185743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110847324|NCT01185743|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110847325|NCT01185743|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110847326|NCT01185743|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110847327|NCT01185743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110847328|NCT01185743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110847329|NCT01185743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110847330|NCT01185743|Serotonin Agents|serotonin agents|mesh-ancestor
110847331|NCT01185743|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110847332|NCT01185743|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110847333|NCT01185743|Dopamine Agents|dopamine agents|mesh-ancestor
110847334|NCT01188005|Vitamins|vitamins|mesh-list
110847335|NCT01188005|Vitamin E|vitamin e|mesh-list
110847336|NCT01188005|Vitamin A|vitamin a|mesh-list
110847337|NCT01188005|Acetylcysteine|acetylcysteine|mesh-list
110847338|NCT01188005|Allopurinol|allopurinol|mesh-list
110847339|NCT01188005|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110847340|NCT01188005|Micronutrients|micronutrients|mesh-ancestor
110847341|NCT01188005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110847343|NCT01188005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110847344|NCT01188005|Protective Agents|protective agents|mesh-ancestor
110847345|NCT01188005|Antiviral Agents|antiviral agents|mesh-ancestor
110847346|NCT01188005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110847347|NCT01188005|Expectorants|expectorants|mesh-ancestor
110847348|NCT01188005|Respiratory System Agents|respiratory system agents|mesh-ancestor
110847349|NCT01188005|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110847350|NCT01188005|Antidotes|antidotes|mesh-ancestor
110847351|NCT01188005|Antimetabolites|antimetabolites|mesh-ancestor
110847352|NCT01188005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110847353|NCT01188005|Gout Suppressants|gout suppressants|mesh-ancestor
110847354|NCT01188005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110847355|NCT04445194|Vaccines|vaccines|mesh-list
110847356|NCT04445194|Immunologic Factors|immunologic factors|mesh-ancestor
110847357|NCT04445194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110847358|NCT01291199|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
110847359|NCT01291199|Vasodilator Agents|vasodilator agents|mesh-ancestor
110847360|NCT01291199|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110847361|NCT01291199|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110847362|NCT01291199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110847363|NCT01291199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110847364|NCT01291199|Urological Agents|urological agents|mesh-ancestor
110847365|NCT04444726|Betamethasone|betamethasone|mesh-list
110847366|NCT04444726|Betamethasone Valerate|betamethasone valerate|mesh-list
110847367|NCT04444726|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
110847368|NCT04444726|Betamethasone benzoate|betamethasone benzoate|mesh-list
110847369|NCT04444726|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
110847371|NCT04444726|Glucocorticoids|glucocorticoids|mesh-ancestor
110847372|NCT04444726|Hormones|hormones|mesh-ancestor
110847373|NCT04444726|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110847374|NCT04444726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110847375|NCT04444726|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110847376|NCT04444726|Respiratory System Agents|respiratory system agents|mesh-ancestor
110847377|NCT03733327|Cyclophosphamide|cyclophosphamide|mesh-list
110847378|NCT03733327|Busulfan|busulfan|mesh-list
110847379|NCT03733327|Etoposide|etoposide|mesh-list
110847380|NCT03733327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110847381|NCT03733327|Immunologic Factors|immunologic factors|mesh-ancestor
110847382|NCT03733327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110847383|NCT03733327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110847384|NCT03733327|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110847385|NCT03733327|Alkylating Agents|alkylating agents|mesh-ancestor
110847386|NCT03733327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110847387|NCT03733327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110847388|NCT03733327|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110847389|NCT03733327|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110847390|NCT03733327|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110847391|NCT03733327|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110847392|NCT03733327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110847393|NCT03733171|Epinephrine|epinephrine|mesh-list
110847394|NCT03733171|Hemostatics|hemostatics|mesh-list
110847395|NCT03733171|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110847397|NCT03733171|Adrenergic Agents|adrenergic agents|mesh-ancestor
110847398|NCT03733171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110635323|NCT00809042|Hydroxyurea|hydroxyurea|mesh-list
110847399|NCT03733171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110847400|NCT03733171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110847401|NCT03733171|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110847402|NCT03733171|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110847403|NCT03733171|Autonomic Agents|autonomic agents|mesh-ancestor
110847404|NCT03733171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110847405|NCT03733171|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110847406|NCT03733171|Respiratory System Agents|respiratory system agents|mesh-ancestor
110847407|NCT03733171|Mydriatics|mydriatics|mesh-ancestor
110847408|NCT03733171|Sympathomimetics|sympathomimetics|mesh-ancestor
110847409|NCT03733171|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110847410|NCT03733171|Coagulants|coagulants|mesh-ancestor
110847411|NCT03207750|Vaccines|vaccines|mesh-list
110847412|NCT03207750|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110847413|NCT03207750|Immunologic Factors|immunologic factors|mesh-ancestor
110847414|NCT03207750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110847415|NCT01185977|Fluoxetine|fluoxetine|mesh-list
110847416|NCT01185977|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110847417|NCT01185977|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110847418|NCT01185977|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110335803|NCT00500279|Analgesics|analgesics|mesh-ancestor
110847419|NCT01185977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110847420|NCT01185977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110847421|NCT01185977|Serotonin Agents|serotonin agents|mesh-ancestor
110847422|NCT01185977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110847423|NCT01185977|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110847424|NCT01185977|Antidepressive Agents|antidepressive agents|mesh-ancestor
110847426|NCT01185977|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110847427|NCT01185977|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110847428|NCT01185977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110847429|NCT03857399|Caspofungin|caspofungin|mesh-list
110847430|NCT03857399|Antifungal Agents|antifungal agents|mesh-ancestor
110847431|NCT03857399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110847432|NCT03857399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110847433|NCT03857399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110847434|NCT04520620|Enoxaparin|enoxaparin|mesh-list
110847435|NCT04520620|Anticoagulants|anticoagulants|mesh-ancestor
110847436|NCT04520620|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110847437|NCT04520620|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110847438|NCT04520620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110847439|NCT03857711|Amiodarone|amiodarone|mesh-list
110847440|NCT03857711|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110847441|NCT03857711|Vasodilator Agents|vasodilator agents|mesh-ancestor
110847442|NCT03857711|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
110847443|NCT03857711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110847444|NCT03857711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110847445|NCT03857711|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110847446|NCT03857711|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110847447|NCT03857711|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110847448|NCT03857711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110847449|NCT03857711|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110847450|NCT03857711|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110847451|NCT03857711|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110847452|NCT03672097|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
110847453|NCT03672097|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110847454|NCT03847896|Budesonide|budesonide|mesh-list
110847455|NCT03847896|Albuterol|albuterol|mesh-list
110847456|NCT03847896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110847457|NCT03847896|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110847458|NCT03847896|Autonomic Agents|autonomic agents|mesh-ancestor
110847459|NCT03847896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110847460|NCT03847896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110847461|NCT03847896|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110831875|NCT03715101|Antimetabolites|antimetabolites|mesh-ancestor
110847462|NCT03847896|Respiratory System Agents|respiratory system agents|mesh-ancestor
110847463|NCT03847896|Glucocorticoids|glucocorticoids|mesh-ancestor
110847464|NCT03847896|Hormones|hormones|mesh-ancestor
110847465|NCT03847896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110847466|NCT03847896|Tocolytic Agents|tocolytic agents|mesh-ancestor
110847467|NCT03847896|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110847468|NCT03847896|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110847469|NCT03847896|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110847470|NCT03847896|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110847471|NCT03847896|Adrenergic Agents|adrenergic agents|mesh-ancestor
110847472|NCT03847896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110847473|NCT03847896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110847474|NCT01186289|Atorvastatin|atorvastatin|mesh-list
110847475|NCT01186289|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110847476|NCT01186289|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110847477|NCT01186289|Antimetabolites|antimetabolites|mesh-ancestor
110847478|NCT01186289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110847479|NCT01186289|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110847480|NCT01186289|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110847481|NCT01186289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110847482|NCT01291823|Gefitinib|gefitinib|mesh-list
110847483|NCT01291823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110847484|NCT01291823|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110847485|NCT01291823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110565073|NCT03260894|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110847486|NCT01291823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110847488|NCT01181765|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110847489|NCT01181765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110847490|NCT01181765|Dermatologic Agents|dermatologic agents|mesh-ancestor
110847491|NCT01181765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110847492|NCT01181765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110847493|NCT01186445|Morphine|morphine|mesh-list
110847494|NCT01186445|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110847495|NCT01186445|Narcotics|narcotics|mesh-ancestor
110847496|NCT01186445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110847497|NCT01186445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110847498|NCT01186445|Analgesics|analgesics|mesh-ancestor
110847499|NCT01186445|Sensory System Agents|sensory system agents|mesh-ancestor
110847500|NCT01186445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110847501|NCT03739333|Carbon-11 methionine|carbon-11 methionine|mesh-list
110847502|NCT03739333|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110847503|NCT03739333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110847504|NCT04520230|Budesonide|budesonide|mesh-list
110847505|NCT04520230|Formoterol Fumarate|formoterol fumarate|mesh-list
110847506|NCT04520230|Tiotropium Bromide|tiotropium bromide|mesh-list
110847507|NCT04520230|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
110847508|NCT04520230|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110847509|NCT04520230|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110847510|NCT04520230|Autonomic Agents|autonomic agents|mesh-ancestor
110847511|NCT04520230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110847512|NCT04520230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110847513|NCT04520230|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110847514|NCT04520230|Respiratory System Agents|respiratory system agents|mesh-ancestor
110847515|NCT04520230|Glucocorticoids|glucocorticoids|mesh-ancestor
110847516|NCT04520230|Hormones|hormones|mesh-ancestor
110847517|NCT04520230|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110847518|NCT04520230|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110847519|NCT04520230|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110847520|NCT04520230|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110847521|NCT04520230|Adrenergic Agents|adrenergic agents|mesh-ancestor
110847522|NCT04520230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110847523|NCT04520230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110847524|NCT04520230|Parasympatholytics|parasympatholytics|mesh-ancestor
110847525|NCT04520230|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110847526|NCT04520230|Cholinergic Agents|cholinergic agents|mesh-ancestor
110847527|NCT03619837|Sofosbuvir|sofosbuvir|mesh-list
110847528|NCT03619837|Velpatasvir|velpatasvir|mesh-list
110847529|NCT03619837|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
110831883|NCT03780959|Analgesics|analgesics|mesh-ancestor
110847531|NCT03619837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110847532|NCT03852563|Petrolatum|petrolatum|mesh-list
110847533|NCT03852563|Emollients|emollients|mesh-ancestor
110847534|NCT03852563|Dermatologic Agents|dermatologic agents|mesh-ancestor
110847535|NCT01188317|Ibuprofen|ibuprofen|mesh-list
110847536|NCT01188317|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110847537|NCT01188317|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110847538|NCT01188317|Analgesics|analgesics|mesh-ancestor
110847539|NCT01188317|Sensory System Agents|sensory system agents|mesh-ancestor
110847540|NCT01188317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110847541|NCT01188317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110847542|NCT01188317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110847543|NCT01188317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110847544|NCT01188317|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110847545|NCT01188317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110847546|NCT01188317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110847547|NCT03206970|Zanubrutinib|zanubrutinib|mesh-list
110847548|NCT03206970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110847549|NCT03206970|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110847550|NCT03206970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110847551|NCT03206970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110847552|NCT03739021|Ropivacaine|ropivacaine|mesh-list
110847553|NCT03739021|Anesthetics, Local|anesthetics, local|mesh-ancestor
110847554|NCT03739021|Anesthetics|anesthetics|mesh-ancestor
110847555|NCT03739021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110847556|NCT03739021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110847557|NCT03739021|Sensory System Agents|sensory system agents|mesh-ancestor
110847558|NCT03739021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110847560|NCT03738943|Pyridoxal|pyridoxal|mesh-list
110847561|NCT03738943|Vitamin B 6|vitamin b 6|mesh-list
110847562|NCT03738943|Pyridoxal Phosphate|pyridoxal phosphate|mesh-list
110847563|NCT03738943|Adenosine|adenosine|mesh-list
110847564|NCT03738943|Nitroprusside|nitroprusside|mesh-list
110847565|NCT03738943|Acetylcholine|acetylcholine|mesh-list
110847566|NCT03738943|Vitamins|vitamins|mesh-ancestor
110847567|NCT03738943|Micronutrients|micronutrients|mesh-ancestor
110847568|NCT03738943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110847569|NCT03738943|Vitamin B Complex|vitamin b complex|mesh-ancestor
110847570|NCT03738943|Analgesics|analgesics|mesh-ancestor
110847571|NCT03738943|Sensory System Agents|sensory system agents|mesh-ancestor
110847572|NCT03738943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110847573|NCT03738943|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110847574|NCT03738943|Vasodilator Agents|vasodilator agents|mesh-ancestor
110847575|NCT03738943|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
110847576|NCT03738943|Purinergic Agonists|purinergic agonists|mesh-ancestor
110847577|NCT03738943|Purinergic Agents|purinergic agents|mesh-ancestor
110847578|NCT03738943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110847579|NCT03738943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110847580|NCT03738943|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110847581|NCT03738943|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
110847582|NCT03738943|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110847583|NCT03738943|Cholinergic Agents|cholinergic agents|mesh-ancestor
110847584|NCT03178851|Atezolizumab|atezolizumab|mesh-list
110847585|NCT03178851|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110847586|NCT03178851|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110847587|NCT03178851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110847588|NCT03178851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110847589|NCT03178851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110847590|NCT03178851|Immunologic Factors|immunologic factors|mesh-ancestor
110847591|NCT03178851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110847592|NCT01291979|Lidocaine|lidocaine|mesh-list
110847593|NCT01291979|Anesthetics, Local|anesthetics, local|mesh-ancestor
110847594|NCT01291979|Anesthetics|anesthetics|mesh-ancestor
110847595|NCT01291979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110635621|NCT00229723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110847596|NCT01291979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110847597|NCT01291979|Sensory System Agents|sensory system agents|mesh-ancestor
110847598|NCT01291979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110847599|NCT01291979|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110847600|NCT01291979|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110847601|NCT01291979|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110847602|NCT01291979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110870384|NCT02394418|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110847603|NCT01291979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110847604|NCT04443634|Bupivacaine|bupivacaine|mesh-list
110847605|NCT04443634|Anesthetics, Local|anesthetics, local|mesh-ancestor
110847606|NCT04443634|Anesthetics|anesthetics|mesh-ancestor
110847607|NCT04443634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110847608|NCT04443634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110847609|NCT04443634|Sensory System Agents|sensory system agents|mesh-ancestor
110847610|NCT04443634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110847611|NCT03643159|Aripiprazole|aripiprazole|mesh-list
110847612|NCT03643159|Antipsychotic Agents|antipsychotic agents|mesh-list
110847613|NCT03643159|Antidepressive Agents|antidepressive agents|mesh-ancestor
110847614|NCT03643159|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110847615|NCT03643159|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110847616|NCT03643159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110847617|NCT03643159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110847618|NCT03643159|Dopamine Agonists|dopamine agonists|mesh-ancestor
110847619|NCT03643159|Dopamine Agents|dopamine agents|mesh-ancestor
110847620|NCT03643159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110847621|NCT03643159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110847622|NCT03643159|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110847623|NCT03643159|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110847624|NCT03643159|Serotonin Agents|serotonin agents|mesh-ancestor
110847625|NCT03643159|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110847626|NCT03643159|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110847627|NCT03643159|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110847628|NCT03643159|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110847629|NCT03205566|Lamivudine|lamivudine|mesh-list
110847630|NCT03205566|Raltegravir Potassium|raltegravir potassium|mesh-list
110847631|NCT03205566|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110847632|NCT03205566|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110847633|NCT03205566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110847634|NCT03205566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110847636|NCT03205566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110847637|NCT03205566|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110847638|NCT03205566|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110847639|NCT03205566|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110847640|NCT03205566|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110847641|NCT01181999|Rituximab|rituximab|mesh-list
110847642|NCT01181999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110847643|NCT01181999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110847644|NCT01181999|Immunologic Factors|immunologic factors|mesh-ancestor
110847645|NCT01181999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110847646|NCT01181999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110847647|NCT04509232|Fluorides|fluorides|mesh-list
110847648|NCT04509232|Cariostatic Agents|cariostatic agents|mesh-ancestor
110847649|NCT04509232|Protective Agents|protective agents|mesh-ancestor
110847650|NCT04509232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110847651|NCT03732235|Bevacizumab|bevacizumab|mesh-list
110847652|NCT03732235|Chlorotrianisene|chlorotrianisene|mesh-list
110847653|NCT03732235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110847654|NCT03732235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110847655|NCT03732235|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110847656|NCT03732235|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110847657|NCT03732235|Growth Substances|growth substances|mesh-ancestor
110847658|NCT03732235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110847659|NCT03732235|Growth Inhibitors|growth inhibitors|mesh-ancestor
110847660|NCT03732235|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
110847661|NCT03732235|Estrogens|estrogens|mesh-ancestor
110847662|NCT03732235|Hormones|hormones|mesh-ancestor
110847663|NCT03732235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110847664|NCT03732235|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110847665|NCT01289951|Raltegravir Potassium|raltegravir potassium|mesh-list
110847666|NCT01289951|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110847667|NCT01289951|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110847668|NCT01289951|Antiviral Agents|antiviral agents|mesh-ancestor
110847669|NCT01289951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110847670|NCT01289951|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110847671|NCT01289951|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110847672|NCT01289951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110870385|NCT02693002|Norethindrone|norethindrone|mesh-list
110847673|NCT01289951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110847674|NCT01182077|Midazolam|midazolam|mesh-list
110847675|NCT01182077|Peficitinib|peficitinib|mesh-list
110847676|NCT01182077|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110847677|NCT01182077|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110847678|NCT01182077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110847679|NCT01182077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110847680|NCT01182077|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110847681|NCT01182077|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110847682|NCT01182077|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110847683|NCT01182077|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110847684|NCT01182077|Anesthetics, General|anesthetics, general|mesh-ancestor
110847685|NCT01182077|Anesthetics|anesthetics|mesh-ancestor
110847686|NCT01182077|GABA Modulators|gaba modulators|mesh-ancestor
110847687|NCT01182077|GABA Agents|gaba agents|mesh-ancestor
110847688|NCT01182077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110847689|NCT01182077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110847690|NCT01182077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110847691|NCT01182077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110847692|NCT01182077|Immunologic Factors|immunologic factors|mesh-ancestor
110847693|NCT03618823|Acetaminophen|acetaminophen|mesh-list
110847694|NCT03618823|Ibuprofen|ibuprofen|mesh-list
110847695|NCT03618823|Oxycodone|oxycodone|mesh-list
110847696|NCT03618823|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110847697|NCT03618823|Analgesics|analgesics|mesh-ancestor
110847698|NCT03618823|Sensory System Agents|sensory system agents|mesh-ancestor
110847699|NCT03618823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110847700|NCT03618823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110847701|NCT03618823|Antipyretics|antipyretics|mesh-ancestor
110847702|NCT03618823|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110847703|NCT03618823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110847704|NCT03618823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110847705|NCT03618823|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110847706|NCT03618823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110847707|NCT03618823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110847708|NCT03618823|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110847709|NCT03618823|Narcotics|narcotics|mesh-ancestor
110847710|NCT03618823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110847711|NCT01188707|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110847712|NCT01188707|Belinostat|belinostat|mesh-list
110635777|NCT00905814|Axitinib|axitinib|mesh-list
110847713|NCT01188707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110847714|NCT01188707|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110847715|NCT01188707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110847716|NCT01188707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110847717|NCT01188707|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110847718|NCT03356158|Cetuximab|cetuximab|mesh-list
110847719|NCT03356158|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110847720|NCT03356158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110847721|NCT03356080|Cytarabine|cytarabine|mesh-list
110847722|NCT03356080|Decitabine|decitabine|mesh-list
110847723|NCT03356080|Tretinoin|tretinoin|mesh-list
110847724|NCT03356080|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110847725|NCT03356080|Antimetabolites|antimetabolites|mesh-ancestor
110847726|NCT03356080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110847727|NCT03356080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110847728|NCT03356080|Antiviral Agents|antiviral agents|mesh-ancestor
110635791|NCT00900510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110847729|NCT03356080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110847730|NCT03356080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110847731|NCT03356080|Immunologic Factors|immunologic factors|mesh-ancestor
110847732|NCT03356080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110847733|NCT03356080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110847734|NCT03356080|Keratolytic Agents|keratolytic agents|mesh-ancestor
110847735|NCT03356080|Dermatologic Agents|dermatologic agents|mesh-ancestor
110847736|NCT03640507|Chlorhexidine|chlorhexidine|mesh-list
110847737|NCT03640507|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110847738|NCT03640507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110847739|NCT03640507|Disinfectants|disinfectants|mesh-ancestor
110847740|NCT02937636|Fluorides|fluorides|mesh-list
110847741|NCT02937636|Tin Fluorides|tin fluorides|mesh-list
110847742|NCT02937636|Fluorophosphate|fluorophosphate|mesh-list
110847743|NCT02937636|Cariostatic Agents|cariostatic agents|mesh-ancestor
110847744|NCT02937636|Protective Agents|protective agents|mesh-ancestor
110847745|NCT02937636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110847746|NCT03638635|Bupivacaine|bupivacaine|mesh-list
110847747|NCT03638635|Anesthetics, Local|anesthetics, local|mesh-ancestor
110847748|NCT03638635|Anesthetics|anesthetics|mesh-ancestor
110847749|NCT03638635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110847750|NCT03638635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110847751|NCT03638635|Sensory System Agents|sensory system agents|mesh-ancestor
110847752|NCT03638635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110847753|NCT02518516|Atorvastatin|atorvastatin|mesh-list
110847754|NCT02518516|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110847755|NCT02518516|Simvastatin|simvastatin|mesh-list
110847756|NCT02518516|Pravastatin|pravastatin|mesh-list
110847757|NCT02518516|Lovastatin|lovastatin|mesh-list
110847758|NCT02518516|L 647318|l 647318|mesh-list
110335912|NCT00507858|Hormones|hormones|mesh-ancestor
110847759|NCT02518516|Dihydromevinolin|dihydromevinolin|mesh-list
110847760|NCT02518516|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110847761|NCT02518516|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110847762|NCT02518516|Antimetabolites|antimetabolites|mesh-ancestor
110635850|NCT00643760|Anticonvulsants|anticonvulsants|mesh-ancestor
110847763|NCT02518516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110847765|NCT02518516|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110847766|NCT02518516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110847767|NCT04508686|Capecitabine|capecitabine|mesh-list
110847768|NCT04508686|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110847769|NCT04508686|Antimetabolites|antimetabolites|mesh-ancestor
110847770|NCT04508686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110847771|NCT04508686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110847772|NCT02518438|Tramadol|tramadol|mesh-list
110847773|NCT02518438|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110847774|NCT02518438|Narcotics|narcotics|mesh-ancestor
110847775|NCT02518438|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110847776|NCT02518438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110847777|NCT02518438|Analgesics|analgesics|mesh-ancestor
110847778|NCT02518438|Sensory System Agents|sensory system agents|mesh-ancestor
110847779|NCT02518438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110847780|NCT04521556|Morphine|morphine|mesh-list
110847781|NCT04521556|Tramadol|tramadol|mesh-list
110847782|NCT04521556|Anesthetics|anesthetics|mesh-list
110847783|NCT04521556|Ropivacaine|ropivacaine|mesh-list
110870386|NCT02693002|Norethindrone Acetate|norethindrone acetate|mesh-list
110847784|NCT04521556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110565376|NCT02611596|Ranolazine|ranolazine|mesh-list
110847785|NCT04521556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110635890|NCT00603798|Imiquimod|imiquimod|mesh-list
110847786|NCT04521556|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110847787|NCT04521556|Narcotics|narcotics|mesh-ancestor
110847788|NCT04521556|Analgesics|analgesics|mesh-ancestor
110847789|NCT04521556|Sensory System Agents|sensory system agents|mesh-ancestor
110847790|NCT04521556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110847791|NCT04521556|Anesthetics, Local|anesthetics, local|mesh-ancestor
110847792|NCT03204279|Palonosetron|palonosetron|mesh-list
110847793|NCT03204279|Antiemetics|antiemetics|mesh-ancestor
110847794|NCT03204279|Autonomic Agents|autonomic agents|mesh-ancestor
110847795|NCT03204279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110847796|NCT03204279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110847797|NCT03204279|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110847798|NCT03204279|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110847799|NCT03204279|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110847800|NCT03204279|Serotonin Agents|serotonin agents|mesh-ancestor
110847801|NCT03204279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110847802|NCT03204279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110847803|NCT02524301|Diprenorphine|diprenorphine|mesh-list
110847804|NCT02524301|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110847805|NCT02524301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110847806|NCT02524301|Sensory System Agents|sensory system agents|mesh-ancestor
110847807|NCT02524301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110847808|NCT03122782|Tranexamic Acid|tranexamic acid|mesh-list
110847809|NCT03122782|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110847810|NCT03122782|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110847811|NCT03122782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110847812|NCT03122782|Hemostatics|hemostatics|mesh-ancestor
110847813|NCT03122782|Coagulants|coagulants|mesh-ancestor
110847814|NCT01291433|Clodronic Acid|clodronic acid|mesh-list
110847815|NCT01291433|Tocopherols|tocopherols|mesh-list
110847816|NCT01291433|Vitamin E|vitamin e|mesh-list
110847817|NCT01291433|Tocotrienols|tocotrienols|mesh-list
110847818|NCT01291433|alpha-Tocopherol|alpha-tocopherol|mesh-list
110847819|NCT01291433|Pentoxifylline|pentoxifylline|mesh-list
110847820|NCT01291433|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110847821|NCT01291433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110847822|NCT01291433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110847823|NCT01291433|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110847824|NCT01291433|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110847825|NCT01291433|Protective Agents|protective agents|mesh-ancestor
110635945|NCT00905190|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110847826|NCT01291433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110847828|NCT01291433|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110847829|NCT01291433|Antioxidants|antioxidants|mesh-ancestor
110847830|NCT01291433|Vitamins|vitamins|mesh-ancestor
110847831|NCT01291433|Micronutrients|micronutrients|mesh-ancestor
110847832|NCT01291433|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110635980|NCT00819728|Docetaxel|docetaxel|mesh-list
110847834|NCT01314144|Anesthetics, Local|anesthetics, local|mesh-ancestor
110847835|NCT01314144|Anesthetics|anesthetics|mesh-ancestor
110847836|NCT01314144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110847837|NCT01314144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110847838|NCT01314144|Sensory System Agents|sensory system agents|mesh-ancestor
110847839|NCT01314144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110847840|NCT02954653|Cytarabine|cytarabine|mesh-list
110847841|NCT02954653|Azacitidine|azacitidine|mesh-list
110847842|NCT02954653|Decitabine|decitabine|mesh-list
110847843|NCT02954653|Daunorubicin|daunorubicin|mesh-list
110847844|NCT02954653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110847845|NCT02954653|Antimetabolites|antimetabolites|mesh-ancestor
110847846|NCT02954653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110847847|NCT02954653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110847848|NCT02954653|Antiviral Agents|antiviral agents|mesh-ancestor
110847849|NCT02954653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110847850|NCT02954653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110847851|NCT02954653|Immunologic Factors|immunologic factors|mesh-ancestor
110847852|NCT02954653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110847853|NCT02954653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110847854|NCT02954653|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110847855|NCT02954653|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110847856|NCT02954653|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110847859|NCT04508452|Oxaliplatin|oxaliplatin|mesh-list
110847860|NCT04508452|Irinotecan|irinotecan|mesh-list
110847861|NCT04508452|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110847862|NCT04508452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110847863|NCT04508452|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110565444|NCT00843492|PENTA|penta|mesh-list
110847864|NCT04508452|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110847865|NCT04508452|Growth Substances|growth substances|mesh-ancestor
110847866|NCT04508452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110847867|NCT04508452|Growth Inhibitors|growth inhibitors|mesh-ancestor
110847868|NCT04508452|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110847869|NCT04508452|Antimetabolites|antimetabolites|mesh-ancestor
110847870|NCT04508452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110847871|NCT04508452|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110847872|NCT04508452|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110847873|NCT04508452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110847875|NCT03856853|Analgesics|analgesics|mesh-ancestor
110847876|NCT03856853|Sensory System Agents|sensory system agents|mesh-ancestor
110847877|NCT03856853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110847878|NCT03856853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110847879|NCT03856853|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110847880|NCT03856853|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110847881|NCT03856853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110847882|NCT03856853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110847883|NCT03856853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110847884|NCT03732703|Thalidomide|thalidomide|mesh-list
110847885|NCT03732703|Dexamethasone|dexamethasone|mesh-list
110847886|NCT03732703|Dexamethasone acetate|dexamethasone acetate|mesh-list
110847888|NCT03732703|Daratumumab|daratumumab|mesh-list
110847889|NCT03732703|Pomalidomide|pomalidomide|mesh-list
110847890|NCT03732703|Ixazomib|ixazomib|mesh-list
110847891|NCT03732703|BB 1101|bb 1101|mesh-list
110847892|NCT03732703|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110847893|NCT03732703|Glycine|glycine|mesh-list
110847894|NCT03732703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110847895|NCT03732703|Antiemetics|antiemetics|mesh-ancestor
110847896|NCT03732703|Autonomic Agents|autonomic agents|mesh-ancestor
110847897|NCT03732703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110847898|NCT03732703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110847899|NCT03732703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110847900|NCT03732703|Glucocorticoids|glucocorticoids|mesh-ancestor
110847901|NCT03732703|Hormones|hormones|mesh-ancestor
110847902|NCT03732703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110847903|NCT03732703|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110847904|NCT03732703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110847905|NCT03732703|Protease Inhibitors|protease inhibitors|mesh-ancestor
110847906|NCT03732703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110847907|NCT03732703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110847908|NCT03732703|Immunologic Factors|immunologic factors|mesh-ancestor
110847909|NCT03732703|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110847910|NCT03732703|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110847911|NCT03732703|Growth Substances|growth substances|mesh-ancestor
110847912|NCT03732703|Growth Inhibitors|growth inhibitors|mesh-ancestor
110847913|NCT03732703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110847914|NCT03732703|Leprostatic Agents|leprostatic agents|mesh-ancestor
110847915|NCT03732703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110847916|NCT03732703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110847917|NCT03732703|Glycine Agents|glycine agents|mesh-ancestor
110847918|NCT03732703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110847919|NCT03636555|Oxytocin|oxytocin|mesh-list
110847920|NCT03636555|Oxytocics|oxytocics|mesh-ancestor
110847921|NCT03636555|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110847922|NCT03636555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110847923|NCT03123016|Apremilast|apremilast|mesh-list
110831939|NCT03408483|Autonomic Agents|autonomic agents|mesh-ancestor
110847924|NCT03123016|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110847925|NCT03123016|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110847926|NCT03123016|Analgesics|analgesics|mesh-ancestor
110847927|NCT03123016|Sensory System Agents|sensory system agents|mesh-ancestor
110847928|NCT03123016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110847929|NCT03123016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110847930|NCT03123016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110847931|NCT03123016|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110847932|NCT03123016|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
110847933|NCT03123016|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110847934|NCT03123016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110847935|NCT03123016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110847936|NCT03636477|Nivolumab|nivolumab|mesh-list
110847937|NCT03636477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110847938|NCT03636477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110847939|NCT03636477|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110847940|NCT03636477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110847941|NCT03732001|Docetaxel|docetaxel|mesh-list
110847942|NCT03732001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110847943|NCT03732001|Tubulin Modulators|tubulin modulators|mesh-ancestor
110847944|NCT03732001|Antimitotic Agents|antimitotic agents|mesh-ancestor
110847945|NCT03732001|Mitosis Modulators|mitosis modulators|mesh-ancestor
110847946|NCT03732001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110847947|NCT01186835|Botulinum Toxins|botulinum toxins|mesh-list
110847948|NCT01186835|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110847949|NCT01186835|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110847950|NCT01186835|Hyaluronic Acid|hyaluronic acid|mesh-list
110847951|NCT01186835|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110847952|NCT01186835|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110847953|NCT01186835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110847954|NCT01186835|Cholinergic Agents|cholinergic agents|mesh-ancestor
110847955|NCT01186835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110847956|NCT01186835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110847957|NCT01186835|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110847958|NCT01186835|Immunologic Factors|immunologic factors|mesh-ancestor
110847959|NCT01186835|Viscosupplements|viscosupplements|mesh-ancestor
110847960|NCT01186835|Protective Agents|protective agents|mesh-ancestor
110847961|NCT01186835|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110847962|NCT01186835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110847963|NCT03649464|Antineoplastic Agents|antineoplastic agents|mesh-list
110847964|NCT04812951|Cyclosporine|cyclosporine|mesh-list
110847965|NCT04812951|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110847966|NCT04812951|Cyclosporins|cyclosporins|mesh-list
110847967|NCT04812951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110847968|NCT04812951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110847969|NCT04812951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110847970|NCT04812951|Immunologic Factors|immunologic factors|mesh-ancestor
110847971|NCT04812951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110847972|NCT04812951|Antifungal Agents|antifungal agents|mesh-ancestor
110847973|NCT04812951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110636329|NCT00821912|Docetaxel|docetaxel|mesh-list
110847974|NCT04812951|Dermatologic Agents|dermatologic agents|mesh-ancestor
110847975|NCT04812951|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110847976|NCT04812951|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110847977|NCT04812951|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110847978|NCT05666089|Acetylcysteine|acetylcysteine|mesh-list
110847979|NCT05666089|Calcium|calcium|mesh-list
110847980|NCT05666089|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110847981|NCT05666089|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110847982|NCT05666089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110847983|NCT05666089|Antiviral Agents|antiviral agents|mesh-ancestor
110847984|NCT05666089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110847985|NCT05666089|Expectorants|expectorants|mesh-ancestor
110847986|NCT05666089|Respiratory System Agents|respiratory system agents|mesh-ancestor
110847987|NCT05666089|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110847988|NCT05666089|Antioxidants|antioxidants|mesh-ancestor
110847989|NCT05666089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110847990|NCT05666089|Protective Agents|protective agents|mesh-ancestor
110847991|NCT05666089|Antidotes|antidotes|mesh-ancestor
110847992|NCT03732625|Raltegravir Potassium|raltegravir potassium|mesh-list
110847993|NCT03732625|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110847994|NCT03732625|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110847995|NCT03732625|Antiviral Agents|antiviral agents|mesh-ancestor
110847996|NCT03732625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110847997|NCT03732625|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110847998|NCT03732625|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110847999|NCT03732625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110848000|NCT03732625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110848001|NCT04597476|Fucoidan|fucoidan|mesh-list
110848002|NCT04597476|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110848003|NCT04597476|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110848004|NCT04597476|Anticoagulants|anticoagulants|mesh-ancestor
110848005|NCT04597476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110848006|NCT01188863|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
110636365|NCT00567996|Autonomic Agents|autonomic agents|mesh-ancestor
110848007|NCT01188863|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110848008|NCT01188863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110848009|NCT01188863|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110848010|NCT01188863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110848011|NCT02730208|Ivacaftor|ivacaftor|mesh-list
110848012|NCT02730208|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
110848013|NCT02730208|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110848014|NCT02730208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110565594|NCT00911573|Tigecycline|tigecycline|mesh-list
110848015|NCT01291511|Iloperidone|iloperidone|mesh-list
110848016|NCT01291511|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110848017|NCT01291511|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110848018|NCT01291511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110848019|NCT01291511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110848020|NCT01291511|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110848021|NCT01292213|Dimercaprol|dimercaprol|mesh-list
110848022|NCT01292213|Chelating Agents|chelating agents|mesh-ancestor
110848023|NCT01292213|Sequestering Agents|sequestering agents|mesh-ancestor
110848024|NCT01292213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110848025|NCT03122938|Lactoferrin|lactoferrin|mesh-list
110848026|NCT03122938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110848027|NCT04971005|Alemtuzumab|alemtuzumab|mesh-list
110848028|NCT04971005|Ocrelizumab|ocrelizumab|mesh-list
110636403|NCT04085627|Vasodilator Agents|vasodilator agents|mesh-ancestor
110848029|NCT04971005|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110848030|NCT04971005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110848031|NCT04971005|Immunologic Factors|immunologic factors|mesh-ancestor
110848032|NCT04971005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110848033|NCT03782532|Prednisone|prednisone|mesh-list
110848034|NCT03782532|Prednisolone|prednisolone|mesh-list
110848035|NCT03782532|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110848036|NCT03782532|Glucocorticoids|glucocorticoids|mesh-ancestor
110848037|NCT03782532|Hormones|hormones|mesh-ancestor
110848038|NCT03782532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110848039|NCT03782532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110848040|NCT03782532|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110848041|NCT03782532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110848042|NCT03355768|Romidepsin|romidepsin|mesh-list
110831972|NCT01204177|Sorafenib|sorafenib|mesh-list
110848043|NCT03355768|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110848044|NCT03355768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110848045|NCT03355768|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110848046|NCT03355768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110848047|NCT03355768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110848048|NCT03349840|Insulin|insulin|mesh-list
110848049|NCT03349840|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110848050|NCT03349840|Insulin Glargine|insulin glargine|mesh-list
110848051|NCT03349840|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110848052|NCT03349840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110848053|NCT03170271|Benralizumab|benralizumab|mesh-list
110848054|NCT03170271|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110848055|NCT03170271|Respiratory System Agents|respiratory system agents|mesh-ancestor
110848056|NCT03355612|Capecitabine|capecitabine|mesh-list
110848057|NCT03355612|Oxaliplatin|oxaliplatin|mesh-list
110848058|NCT03355612|Apatinib|apatinib|mesh-list
110848059|NCT03355612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110848060|NCT03355612|Antimetabolites|antimetabolites|mesh-ancestor
110848061|NCT03355612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110848062|NCT03355612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110848063|NCT03355612|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110636516|NCT00717197|Capecitabine|capecitabine|mesh-list
110848064|NCT03355612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110848065|NCT03732547|Poly I-C|poly i-c|mesh-list
110848066|NCT03732547|Antiviral Agents|antiviral agents|mesh-ancestor
110848067|NCT03732547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110848068|NCT03732547|Interferon Inducers|interferon inducers|mesh-ancestor
110848069|NCT03732547|Immunologic Factors|immunologic factors|mesh-ancestor
110848070|NCT03732547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110848071|NCT04503850|Mirabegron|mirabegron|mesh-list
110848072|NCT04503850|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
110848073|NCT04503850|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
110848074|NCT04503850|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110848075|NCT04503850|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110848076|NCT04503850|Adrenergic Agents|adrenergic agents|mesh-ancestor
110848077|NCT04503850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110848078|NCT04503850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110848079|NCT04503850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110848080|NCT04503850|Urological Agents|urological agents|mesh-ancestor
110336020|NCT00501137|Immunologic Factors|immunologic factors|mesh-ancestor
110848081|NCT04503850|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110848082|NCT03349684|Metformin|metformin|mesh-list
110848083|NCT03349684|Acarbose|acarbose|mesh-list
110848084|NCT03349684|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110848085|NCT03349684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110848086|NCT03349684|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
110848087|NCT03349684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110848088|NCT03349684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110848089|NCT03856697|Gefitinib|gefitinib|mesh-list
110848090|NCT03856697|Maleic acid|maleic acid|mesh-list
110848091|NCT03856697|Abivertinib|abivertinib|mesh-list
110848092|NCT03856697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110848093|NCT03856697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110848094|NCT03856697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110848095|NCT03856697|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110848096|NCT03349606|Amphetamine|amphetamine|mesh-list
110848097|NCT03349606|Dextroamphetamine|dextroamphetamine|mesh-list
110848098|NCT03349606|FLB 457|flb 457|mesh-list
110848099|NCT03349606|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110848100|NCT03349606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110848101|NCT03349606|Sympathomimetics|sympathomimetics|mesh-ancestor
110848102|NCT03349606|Autonomic Agents|autonomic agents|mesh-ancestor
110848103|NCT03349606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110848104|NCT03349606|Dopamine Agents|dopamine agents|mesh-ancestor
110848105|NCT03349606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110848106|NCT03349606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110848107|NCT03349606|Adrenergic Agents|adrenergic agents|mesh-ancestor
110848108|NCT03349606|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110848109|NCT03349606|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110848110|NCT03349606|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110848111|NCT03349606|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110848112|NCT03349606|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110848113|NCT02843451|Silymarin|silymarin|mesh-list
110848114|NCT02843451|Antioxidants|antioxidants|mesh-ancestor
110848115|NCT02843451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110848116|NCT02843451|Protective Agents|protective agents|mesh-ancestor
110848117|NCT02843451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110848118|NCT01292525|Tacrolimus|tacrolimus|mesh-list
110848119|NCT01292525|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110848120|NCT01292525|Immunologic Factors|immunologic factors|mesh-ancestor
110848121|NCT01292525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110848122|NCT01292525|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110848123|NCT01292525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110848124|NCT01292525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110848125|NCT01189019|Ranibizumab|ranibizumab|mesh-list
110848126|NCT01189019|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110848127|NCT01189019|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110848128|NCT01189019|Growth Substances|growth substances|mesh-ancestor
110848129|NCT01189019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110848130|NCT01189019|Growth Inhibitors|growth inhibitors|mesh-ancestor
110848131|NCT01189019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110848132|NCT01183247|Sirolimus|sirolimus|mesh-list
110848133|NCT01183247|Prednisone|prednisone|mesh-list
110848134|NCT01183247|Everolimus|everolimus|mesh-list
110848135|NCT01183247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110848136|NCT01183247|Glucocorticoids|glucocorticoids|mesh-ancestor
110848137|NCT01183247|Hormones|hormones|mesh-ancestor
110848138|NCT01183247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110848139|NCT01183247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110848140|NCT01183247|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110848141|NCT01183247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110848142|NCT01183247|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110848143|NCT01183247|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110848144|NCT01183247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110848145|NCT01183247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110848146|NCT01183247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110848147|NCT01183247|Immunologic Factors|immunologic factors|mesh-ancestor
110636614|NCT00822380|Vitamins|vitamins|mesh-ancestor
110848148|NCT01183247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110848149|NCT01183247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110848150|NCT01183247|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110848151|NCT01183247|Antifungal Agents|antifungal agents|mesh-ancestor
110848152|NCT03349216|Anesthetics|anesthetics|mesh-list
110848153|NCT03349216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110848154|NCT03349216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110848155|NCT04507750|Apatinib|apatinib|mesh-list
110848156|NCT04507750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110848157|NCT04507750|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110848158|NCT04507750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110848159|NCT04507750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110848160|NCT03633331|Letrozole|letrozole|mesh-list
110848161|NCT03633331|Fulvestrant|fulvestrant|mesh-list
110848162|NCT03633331|Palbociclib|palbociclib|mesh-list
110848163|NCT03633331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110848164|NCT03633331|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110848165|NCT03633331|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110848166|NCT03633331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110848167|NCT03633331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110848168|NCT03633331|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110848169|NCT03633331|Hormone Antagonists|hormone antagonists|mesh-ancestor
110848170|NCT03633331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110848171|NCT03633331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110848172|NCT03633331|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110848173|NCT03633331|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110848174|NCT03633331|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110848176|NCT01189097|Antitussive Agents|antitussive agents|mesh-ancestor
110848177|NCT01189097|Respiratory System Agents|respiratory system agents|mesh-ancestor
110848178|NCT01189097|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110848179|NCT01189097|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110848180|NCT01189097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110848181|NCT01189097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110848182|NCT01189097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110848183|NCT01187303|Ofatumumab|ofatumumab|mesh-list
110848184|NCT01187303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110848185|NCT01187459|Vitamin D|vitamin d|mesh-list
110848186|NCT01187459|Ergocalciferols|ergocalciferols|mesh-list
110848187|NCT01187459|Cholecalciferol|cholecalciferol|mesh-list
110848188|NCT01187459|Vitamins|vitamins|mesh-list
110848189|NCT01187459|Micronutrients|micronutrients|mesh-ancestor
110848190|NCT01187459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110848191|NCT01187459|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110848192|NCT01187459|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110848193|NCT01187537|Bupivacaine|bupivacaine|mesh-list
110848194|NCT01187537|Anesthetics, Local|anesthetics, local|mesh-ancestor
110848195|NCT01187537|Anesthetics|anesthetics|mesh-ancestor
110848196|NCT01187537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110848197|NCT01187537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110848198|NCT01187537|Sensory System Agents|sensory system agents|mesh-ancestor
110848199|NCT01187537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110848200|NCT03348826|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
110848201|NCT03348826|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110848202|NCT03348826|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110848203|NCT03348826|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110848204|NCT03348826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110848205|NCT01290419|Vaccines|vaccines|mesh-list
110848206|NCT01290419|Immunologic Factors|immunologic factors|mesh-ancestor
110848207|NCT01290419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110848208|NCT03737773|Methamphetamine|methamphetamine|mesh-list
110848209|NCT03737773|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110848210|NCT03737773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110848211|NCT03737773|Sympathomimetics|sympathomimetics|mesh-ancestor
110848212|NCT03737773|Autonomic Agents|autonomic agents|mesh-ancestor
110848213|NCT03737773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110848214|NCT03737773|Dopamine Agents|dopamine agents|mesh-ancestor
110848215|NCT03737773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110848216|NCT03737773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110848217|NCT03737773|Adrenergic Agents|adrenergic agents|mesh-ancestor
110848218|NCT03737773|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110848219|NCT03737773|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110848220|NCT03737773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110848221|NCT03737773|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110848222|NCT01060579|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110848223|NCT01060579|Latanoprost|latanoprost|mesh-list
110848224|NCT01060579|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110848225|NCT04443946|Sufentanil|sufentanil|mesh-list
110848226|NCT04443946|Propofol|propofol|mesh-list
110848227|NCT04443946|Sevoflurane|sevoflurane|mesh-list
110848228|NCT04443946|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110848229|NCT04443946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110848230|NCT04443946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110848231|NCT04443946|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110848232|NCT04443946|Anesthetics, General|anesthetics, general|mesh-ancestor
110848233|NCT04443946|Anesthetics|anesthetics|mesh-ancestor
110848234|NCT04443946|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110848235|NCT04443946|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110848236|NCT04443946|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110848238|NCT04443946|Analgesics|analgesics|mesh-ancestor
110848239|NCT04443946|Sensory System Agents|sensory system agents|mesh-ancestor
110848240|NCT04443946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110848241|NCT04443946|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110848242|NCT03729973|Lidocaine|lidocaine|mesh-list
110848243|NCT03729973|Magnesium Sulfate|magnesium sulfate|mesh-list
110848245|NCT03729973|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110848246|NCT03729973|Anesthetics, Local|anesthetics, local|mesh-ancestor
110848247|NCT03729973|Anesthetics|anesthetics|mesh-ancestor
110848248|NCT03729973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110848249|NCT03729973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110848250|NCT03729973|Sensory System Agents|sensory system agents|mesh-ancestor
110848251|NCT03729973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110848252|NCT03729973|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110848253|NCT03729973|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110848254|NCT03729973|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110848255|NCT03729973|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110848256|NCT03729973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110848257|NCT03729973|Analgesics|analgesics|mesh-ancestor
110848258|NCT03729973|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110848259|NCT03729973|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110848260|NCT03729973|Anesthetics, General|anesthetics, general|mesh-ancestor
110848261|NCT03729973|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110848262|NCT03729973|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110848263|NCT03729973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110848264|NCT03729973|Anticonvulsants|anticonvulsants|mesh-ancestor
110848265|NCT03729973|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110848266|NCT03729973|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110848267|NCT03729973|Tocolytic Agents|tocolytic agents|mesh-ancestor
110848268|NCT03729973|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110848269|NCT01189253|Doxorubicin|doxorubicin|mesh-list
110848270|NCT01189253|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110848271|NCT01189253|Trabectedin|trabectedin|mesh-list
110848272|NCT01189253|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110848273|NCT01189253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110848274|NCT01189253|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110848275|NCT01189253|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110848276|NCT01189253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110848277|NCT01189253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110848278|NCT01189253|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110848279|NCT01189253|Alkylating Agents|alkylating agents|mesh-ancestor
110848280|NCT04443868|Nitric Oxide|nitric oxide|mesh-list
110848281|NCT04443868|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110848282|NCT04443868|Autonomic Agents|autonomic agents|mesh-ancestor
110848283|NCT04443868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110848284|NCT04443868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110848285|NCT04443868|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110848286|NCT04443868|Respiratory System Agents|respiratory system agents|mesh-ancestor
110848287|NCT04443868|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110848288|NCT04443868|Antioxidants|antioxidants|mesh-ancestor
110848289|NCT04443868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110848290|NCT04443868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110848291|NCT04443868|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
110848292|NCT04443868|Vasodilator Agents|vasodilator agents|mesh-ancestor
110848293|NCT04443868|Gasotransmitters|gasotransmitters|mesh-ancestor
110848294|NCT04443868|Protective Agents|protective agents|mesh-ancestor
110848295|NCT03851393|Citric Acid|citric acid|mesh-list
110848296|NCT03851393|Sodium Citrate|sodium citrate|mesh-list
110848297|NCT03851393|Anticoagulants|anticoagulants|mesh-ancestor
110848298|NCT03851393|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110848299|NCT03851393|Chelating Agents|chelating agents|mesh-ancestor
110848300|NCT03851393|Sequestering Agents|sequestering agents|mesh-ancestor
110848301|NCT03851393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110848303|NCT04443556|Anesthetics|anesthetics|mesh-list
110848304|NCT04443556|Anesthetics, Local|anesthetics, local|mesh-list
110848305|NCT04443556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110848306|NCT04443556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110832008|NCT04305457|Antioxidants|antioxidants|mesh-ancestor
110848307|NCT04443556|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110848308|NCT04443556|Narcotics|narcotics|mesh-ancestor
110848309|NCT04443556|Analgesics|analgesics|mesh-ancestor
110848310|NCT04443556|Sensory System Agents|sensory system agents|mesh-ancestor
110848311|NCT04443556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110848314|NCT01187615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110336089|NCT02953743|Lenvatinib|lenvatinib|mesh-list
110848315|NCT01187615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110848316|NCT01187615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110848317|NCT01187615|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110848318|NCT01187615|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110848319|NCT05375097|Erenumab|erenumab|mesh-list
110848320|NCT05375097|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
110848321|NCT05375097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110848322|NCT05375097|Analgesics|analgesics|mesh-ancestor
110848323|NCT05375097|Sensory System Agents|sensory system agents|mesh-ancestor
110848324|NCT05375097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110848325|NCT05375097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110848326|NCT02752191|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
110848327|NCT02752191|Hematinics|hematinics|mesh-ancestor
110848328|NCT02752191|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
110848329|NCT02752191|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110848330|NCT01290497|Hyaluronic Acid|hyaluronic acid|mesh-list
110848331|NCT01290497|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110848332|NCT01290497|Immunologic Factors|immunologic factors|mesh-ancestor
110848333|NCT01290497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110848334|NCT01290497|Viscosupplements|viscosupplements|mesh-ancestor
110848335|NCT01290497|Protective Agents|protective agents|mesh-ancestor
110848336|NCT04509466|Mitoxantrone|mitoxantrone|mesh-list
110848337|NCT04509466|Pegaspargase|pegaspargase|mesh-list
110848338|NCT04509466|Asparaginase|asparaginase|mesh-list
110848339|NCT04509466|Analgesics|analgesics|mesh-ancestor
110848340|NCT04509466|Sensory System Agents|sensory system agents|mesh-ancestor
110848341|NCT04509466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110848342|NCT04509466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110848343|NCT04509466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110848344|NCT04509466|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110848345|NCT04509466|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110848346|NCT04509466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110848347|NCT04509466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110848348|NCT03738215|Cariprazine|cariprazine|mesh-list
110848349|NCT03738215|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110848350|NCT03738215|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110848351|NCT03738215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110636917|NCT00827450|Caffeine|caffeine|mesh-list
110848352|NCT03738215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110848353|NCT03738215|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110848355|NCT05352321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110848356|NCT05352321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110848357|NCT05352321|Antimetabolites|antimetabolites|mesh-ancestor
110848358|NCT05352321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110848359|NCT03199911|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110848360|NCT03199911|Erythromycin|erythromycin|mesh-list
110848361|NCT03199911|Bacitracin|bacitracin|mesh-list
110848362|NCT03199911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110848363|NCT03199911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110172784|NCT00053716|Alprostadil|alprostadil|mesh-list
110848364|NCT03199911|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110848365|NCT03199911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110848366|NCT03199911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110848367|NCT03199911|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110848368|NCT02517814|Vitamin D|vitamin d|mesh-list
110848369|NCT02517814|Vitamins|vitamins|mesh-ancestor
110848370|NCT02517814|Micronutrients|micronutrients|mesh-ancestor
110848371|NCT02517814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110848372|NCT02517814|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110848373|NCT05349201|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
110848374|NCT05349201|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110848375|NCT05349201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110848376|NCT05303727|Cyclosporine|cyclosporine|mesh-list
110848377|NCT05303727|Mycophenolic Acid|mycophenolic acid|mesh-list
110848378|NCT05303727|Cyclophosphamide|cyclophosphamide|mesh-list
110848379|NCT05303727|Melphalan|melphalan|mesh-list
110848380|NCT05303727|Busulfan|busulfan|mesh-list
110848381|NCT05303727|Thiotepa|thiotepa|mesh-list
110848382|NCT05303727|Methotrexate|methotrexate|mesh-list
110848383|NCT05303727|Fludarabine|fludarabine|mesh-list
110848384|NCT05303727|Topotecan|topotecan|mesh-list
110848385|NCT05303727|Tacrolimus|tacrolimus|mesh-list
110848386|NCT05303727|Cyclosporins|cyclosporins|mesh-list
110848387|NCT05303727|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110848388|NCT05303727|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110848389|NCT05303727|Immunologic Factors|immunologic factors|mesh-ancestor
110848390|NCT05303727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110848391|NCT05303727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110848392|NCT05303727|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110848393|NCT05303727|Alkylating Agents|alkylating agents|mesh-ancestor
110848394|NCT05303727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110848395|NCT05303727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110848396|NCT05303727|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110848397|NCT05303727|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110848398|NCT05303727|Abortifacient Agents|abortifacient agents|mesh-ancestor
110848399|NCT05303727|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110848400|NCT05303727|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110848401|NCT05303727|Antimetabolites|antimetabolites|mesh-ancestor
110848402|NCT05303727|Dermatologic Agents|dermatologic agents|mesh-ancestor
110848403|NCT05303727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110848404|NCT05303727|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110848405|NCT05303727|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110848406|NCT05303727|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110848407|NCT05303727|Antifungal Agents|antifungal agents|mesh-ancestor
110848408|NCT05303727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110848409|NCT05303727|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110848410|NCT05303727|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110848411|NCT05303727|Antitubercular Agents|antitubercular agents|mesh-ancestor
110336143|NCT00509613|Sirolimus|sirolimus|mesh-list
110848412|NCT05303727|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110848413|NCT05303727|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110848414|NCT05303727|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110848415|NCT04502368|Dimercaprol|dimercaprol|mesh-list
110848416|NCT04502368|Chelating Agents|chelating agents|mesh-ancestor
110848417|NCT04502368|Sequestering Agents|sequestering agents|mesh-ancestor
110848418|NCT04502368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110848419|NCT04984083|Vitamin K|vitamin k|mesh-list
110848420|NCT04984083|Vitamins|vitamins|mesh-ancestor
110848421|NCT04984083|Micronutrients|micronutrients|mesh-ancestor
110848422|NCT04984083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110848423|NCT04984083|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110848424|NCT04984083|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110848425|NCT04984083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110848426|NCT04984083|Hemostatics|hemostatics|mesh-ancestor
110848427|NCT04984083|Coagulants|coagulants|mesh-ancestor
110848428|NCT03736967|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110848429|NCT03736967|Immunologic Factors|immunologic factors|mesh-ancestor
110848430|NCT03736967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110848431|NCT01581203|Interferons|interferons|mesh-list
110848432|NCT01581203|Ribavirin|ribavirin|mesh-list
110848433|NCT01581203|Interferon-alpha|interferon-alpha|mesh-list
110848434|NCT01581203|Interferon alpha-2|interferon alpha-2|mesh-list
110848435|NCT01581203|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110848436|NCT01581203|Asunaprevir|asunaprevir|mesh-list
110848437|NCT01581203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110848438|NCT01581203|Antiviral Agents|antiviral agents|mesh-ancestor
110848439|NCT01581203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110848440|NCT01581203|Antimetabolites|antimetabolites|mesh-ancestor
110848441|NCT01581203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110848442|NCT01581203|Immunologic Factors|immunologic factors|mesh-ancestor
110848443|NCT01581203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110848444|NCT01581203|Protease Inhibitors|protease inhibitors|mesh-ancestor
110848445|NCT01581203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110832023|NCT01217177|Everolimus|everolimus|mesh-list
110848446|NCT03168555|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
110848447|NCT03168555|Cathartics|cathartics|mesh-ancestor
110848448|NCT03168555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110848449|NCT03235050|Liraglutide|liraglutide|mesh-list
110848450|NCT03235050|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110848451|NCT03235050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110848452|NCT03235050|Incretins|incretins|mesh-ancestor
110848453|NCT03235050|Hormones|hormones|mesh-ancestor
110848454|NCT03235050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110848455|NCT04933149|Ketamine|ketamine|mesh-list
110848456|NCT04933149|Analgesics|analgesics|mesh-ancestor
110848457|NCT04933149|Sensory System Agents|sensory system agents|mesh-ancestor
110848458|NCT04933149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110848459|NCT04933149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110848460|NCT04933149|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110848461|NCT04933149|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110848462|NCT04933149|Anesthetics, General|anesthetics, general|mesh-ancestor
110848463|NCT04933149|Anesthetics|anesthetics|mesh-ancestor
110848464|NCT04933149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110848465|NCT04933149|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110848466|NCT04933149|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110848467|NCT04933149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110566038|NCT00665093|Insulin Aspart|insulin aspart|mesh-list
110848468|NCT04933149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110848469|NCT01189721|Propofol|propofol|mesh-list
110848470|NCT01189721|Sevoflurane|sevoflurane|mesh-list
110848471|NCT01189721|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110848472|NCT01189721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110848473|NCT01189721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110848474|NCT01189721|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110848475|NCT01189721|Anesthetics, General|anesthetics, general|mesh-ancestor
110848476|NCT01189721|Anesthetics|anesthetics|mesh-ancestor
110848477|NCT01189721|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110848478|NCT01189721|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110848479|NCT03167619|Durvalumab|durvalumab|mesh-list
110848480|NCT03167619|Olaparib|olaparib|mesh-list
110848481|NCT03167619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110848482|NCT03167619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110848483|NCT03167619|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110848484|NCT03167619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110848485|NCT03167619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110848486|NCT03198507|Amoxicillin|amoxicillin|mesh-list
110848487|NCT03198507|Rifabutin|rifabutin|mesh-list
110848488|NCT03198507|Omeprazole|omeprazole|mesh-list
110848489|NCT03198507|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110848490|NCT03198507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110832032|NCT01204333|Heparin|heparin|mesh-list
110848491|NCT03198507|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110848492|NCT03198507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110848493|NCT03198507|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110848494|NCT03198507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110848495|NCT03198507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110848496|NCT03198507|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110848497|NCT03198507|Antitubercular Agents|antitubercular agents|mesh-ancestor
110848498|NCT03850769|Paclitaxel|paclitaxel|mesh-list
110848499|NCT03850769|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110848500|NCT03850769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110848501|NCT03850769|Tubulin Modulators|tubulin modulators|mesh-ancestor
110848502|NCT03850769|Antimitotic Agents|antimitotic agents|mesh-ancestor
110848503|NCT03850769|Mitosis Modulators|mitosis modulators|mesh-ancestor
110848504|NCT03850769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110848505|NCT04663464|Abaloparatide|abaloparatide|mesh-list
110848506|NCT04663464|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
110848507|NCT04663464|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110848508|NCT04663464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110848509|NCT04663464|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110848510|NCT01292993|Metformin|metformin|mesh-list
110848511|NCT01292993|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
110848512|NCT01292993|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110848513|NCT01292993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110848514|NCT01292993|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110848515|NCT01292993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110848516|NCT03849833|Vitamin D|vitamin d|mesh-list
110848517|NCT03849833|Cholecalciferol|cholecalciferol|mesh-list
110848518|NCT03849833|Vitamins|vitamins|mesh-ancestor
110848519|NCT03849833|Micronutrients|micronutrients|mesh-ancestor
110848520|NCT03849833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110848521|NCT03849833|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110848522|NCT03849833|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110848523|NCT03167151|Pembrolizumab|pembrolizumab|mesh-list
110848524|NCT03167151|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110848525|NCT03167151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110848526|NCT03167151|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110848527|NCT03167151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110848529|NCT01191203|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
110848530|NCT01191203|Medroxyprogesterone|medroxyprogesterone|mesh-list
110848531|NCT01191203|Trace Elements|trace elements|mesh-ancestor
110848532|NCT01191203|Micronutrients|micronutrients|mesh-ancestor
110848533|NCT01191203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110848534|NCT01191203|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110848535|NCT01191203|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110336236|NCT00501566|Satavaptan|satavaptan|mesh-list
110848536|NCT01191203|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110848537|NCT01191203|Contraceptive Agents|contraceptive agents|mesh-ancestor
110848538|NCT01191203|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110848539|NCT01191203|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110848540|NCT01191203|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110848541|NCT01191203|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110848542|NCT01191203|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110848543|NCT01191203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110848544|NCT03197883|Sunscreening Agents|sunscreening agents|mesh-list
110848545|NCT03197883|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110848546|NCT03197883|Protective Agents|protective agents|mesh-ancestor
110848547|NCT03197883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110848548|NCT03197883|Dermatologic Agents|dermatologic agents|mesh-ancestor
110848551|NCT03729505|Anesthetics, Local|anesthetics, local|mesh-ancestor
110848552|NCT03729505|Anesthetics|anesthetics|mesh-ancestor
110848553|NCT03729505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110848554|NCT03729505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110848555|NCT03729505|Sensory System Agents|sensory system agents|mesh-ancestor
110848556|NCT03729505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110848557|NCT03729505|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110848558|NCT03729505|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110848559|NCT03729505|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110848560|NCT03729505|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110848561|NCT03729505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110848563|NCT03729505|Anticonvulsants|anticonvulsants|mesh-ancestor
110848564|NCT03729505|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110848565|NCT03729505|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110848566|NCT03729505|Tocolytic Agents|tocolytic agents|mesh-ancestor
110848567|NCT03729505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110848568|NCT03234036|Ritonavir|ritonavir|mesh-list
110848569|NCT03234036|GSK-2838232|gsk-2838232|mesh-list
110848570|NCT03234036|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110848571|NCT03234036|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110848572|NCT03234036|Protease Inhibitors|protease inhibitors|mesh-ancestor
110848573|NCT03234036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110848574|NCT03234036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110848575|NCT03234036|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110848576|NCT03234036|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110848577|NCT03234036|Antiviral Agents|antiviral agents|mesh-ancestor
110848578|NCT03234036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110848579|NCT03234036|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110848580|NCT03234036|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110848581|NCT03606109|Tranexamic Acid|tranexamic acid|mesh-list
110848582|NCT03606109|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110336269|NCT02952573|Hormones|hormones|mesh-ancestor
110848583|NCT03606109|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110848584|NCT03606109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110848585|NCT03606109|Hemostatics|hemostatics|mesh-ancestor
110848586|NCT03606109|Coagulants|coagulants|mesh-ancestor
110848587|NCT01191359|Immunomodulating Agents|immunomodulating agents|mesh-list
110848588|NCT01191359|Immunologic Factors|immunologic factors|mesh-ancestor
110848589|NCT01191359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110848590|NCT01293071|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110848591|NCT01293071|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
110848592|NCT01293071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110848593|NCT01293071|Antitubercular Agents|antitubercular agents|mesh-ancestor
110848595|NCT01193855|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
110848596|NCT01193855|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110848597|NCT01193855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110848598|NCT01193855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110848599|NCT01193855|Hormone Antagonists|hormone antagonists|mesh-ancestor
110848600|NCT01193855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110848601|NCT01193855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110848602|NCT01190345|Bevacizumab|bevacizumab|mesh-list
110848603|NCT01190345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110848604|NCT01190345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110848605|NCT01190345|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110848606|NCT01190345|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110848607|NCT01190345|Growth Substances|growth substances|mesh-ancestor
110848608|NCT01190345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110848609|NCT01190345|Growth Inhibitors|growth inhibitors|mesh-ancestor
110848610|NCT02729896|Rituximab|rituximab|mesh-list
110848611|NCT02729896|Atezolizumab|atezolizumab|mesh-list
110848612|NCT02729896|Obinutuzumab|obinutuzumab|mesh-list
110848613|NCT02729896|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
110848614|NCT02729896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110848615|NCT02729896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110832059|NCT03932123|Meropenem|meropenem|mesh-list
110848616|NCT02729896|Immunologic Factors|immunologic factors|mesh-ancestor
110848617|NCT02729896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110848619|NCT02729896|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110637307|NCT00990405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110848620|NCT02729896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110848622|NCT04540380|Cyclophosphamide|cyclophosphamide|mesh-list
110848623|NCT04540380|Rituximab|rituximab|mesh-list
110848624|NCT04540380|Fludarabine|fludarabine|mesh-list
110848625|NCT04540380|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110848626|NCT04540380|Immunologic Factors|immunologic factors|mesh-ancestor
110848627|NCT04540380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110848628|NCT04540380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110848629|NCT04540380|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110848630|NCT04540380|Alkylating Agents|alkylating agents|mesh-ancestor
110848631|NCT04540380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110637355|NCT02842359|Antimetabolites|antimetabolites|mesh-ancestor
110848632|NCT04540380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110848633|NCT04540380|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110848634|NCT04540380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110848635|NCT04506034|Lidocaine|lidocaine|mesh-list
110848636|NCT04506034|Anesthetics, Local|anesthetics, local|mesh-ancestor
110848637|NCT04506034|Anesthetics|anesthetics|mesh-ancestor
110848638|NCT04506034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110848639|NCT04506034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110336299|NCT00510471|Immunoglobulins|immunoglobulins|mesh-list
110848640|NCT04506034|Sensory System Agents|sensory system agents|mesh-ancestor
110848641|NCT04506034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110848642|NCT04506034|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110848643|NCT04506034|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110848644|NCT04506034|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110848645|NCT04506034|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110848646|NCT04506034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110848647|NCT01294631|Canagliflozin|canagliflozin|mesh-list
110848648|NCT01294631|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110848649|NCT01294631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110848650|NCT01294631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110848651|NCT01294631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110848652|NCT03849209|Pancrelipase|pancrelipase|mesh-list
110848653|NCT03849209|Pancreatin|pancreatin|mesh-list
110848654|NCT03849209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110848655|NCT05342662|Methamphetamine|methamphetamine|mesh-list
110848656|NCT05342662|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110848657|NCT05342662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110848658|NCT05342662|Sympathomimetics|sympathomimetics|mesh-ancestor
110848659|NCT05342662|Autonomic Agents|autonomic agents|mesh-ancestor
110848660|NCT05342662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110848661|NCT05342662|Dopamine Agents|dopamine agents|mesh-ancestor
110848662|NCT05342662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110848663|NCT05342662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110848664|NCT05342662|Adrenergic Agents|adrenergic agents|mesh-ancestor
110848665|NCT05342662|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110848666|NCT05342662|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110848667|NCT05342662|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110848668|NCT05342662|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110848669|NCT03847571|Acetazolamide|acetazolamide|mesh-list
110848670|NCT03847571|Anticonvulsants|anticonvulsants|mesh-ancestor
110848671|NCT03847571|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110848672|NCT03847571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110848673|NCT03847571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110848674|NCT03847571|Diuretics|diuretics|mesh-ancestor
110848676|NCT03847571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110848677|NCT01293149|Clonidine|clonidine|mesh-list
110848678|NCT01293149|Ropivacaine|ropivacaine|mesh-list
110848679|NCT01293149|Anesthetics, Local|anesthetics, local|mesh-ancestor
110848680|NCT01293149|Anesthetics|anesthetics|mesh-ancestor
110848681|NCT01293149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110870387|NCT02693002|Estradiol|estradiol|mesh-list
110848682|NCT01293149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110848683|NCT01293149|Sensory System Agents|sensory system agents|mesh-ancestor
110848684|NCT01293149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110848685|NCT01293149|Analgesics|analgesics|mesh-ancestor
110848686|NCT01293149|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110848687|NCT01293149|Sympatholytics|sympatholytics|mesh-ancestor
110848688|NCT01293149|Autonomic Agents|autonomic agents|mesh-ancestor
110848689|NCT01293149|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110848690|NCT01293149|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110848691|NCT01293149|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110848692|NCT01293149|Adrenergic Agents|adrenergic agents|mesh-ancestor
110848693|NCT01293149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110848694|NCT01293149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110848695|NCT03575065|Pamiparib|pamiparib|mesh-list
110848696|NCT03575065|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110848697|NCT03575065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110848698|NCT03575065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110848699|NCT03575065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110848700|NCT04454424|Midazolam|midazolam|mesh-list
110848701|NCT04454424|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110848702|NCT04454424|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110848703|NCT04454424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110848704|NCT04454424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110848705|NCT04454424|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110848706|NCT04454424|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110848707|NCT04454424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110848708|NCT04454424|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110848709|NCT04454424|Anesthetics, General|anesthetics, general|mesh-ancestor
110848710|NCT04454424|Anesthetics|anesthetics|mesh-ancestor
110848711|NCT04454424|GABA Modulators|gaba modulators|mesh-ancestor
110848712|NCT04454424|GABA Agents|gaba agents|mesh-ancestor
110848713|NCT04454424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110848714|NCT04454424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110848715|NCT03348046|Infliximab|infliximab|mesh-list
110848716|NCT03348046|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110848717|NCT03348046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110848718|NCT03348046|Dermatologic Agents|dermatologic agents|mesh-ancestor
110848719|NCT03348046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110848720|NCT03348046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110848721|NCT04505644|Lidocaine|lidocaine|mesh-list
110848722|NCT04505644|Anesthetics, Local|anesthetics, local|mesh-ancestor
110848723|NCT04505644|Anesthetics|anesthetics|mesh-ancestor
110848724|NCT04505644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110848725|NCT04505644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110848726|NCT04505644|Sensory System Agents|sensory system agents|mesh-ancestor
110848727|NCT04505644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110848728|NCT04505644|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110848729|NCT04505644|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110848730|NCT04505644|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110848731|NCT04505644|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110848732|NCT04505644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110848733|NCT04505800|Tryptophan|tryptophan|mesh-list
110848734|NCT04505800|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110848735|NCT04505800|Antidepressive Agents|antidepressive agents|mesh-ancestor
110848736|NCT04505800|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110848737|NCT05200156|Choline|choline|mesh-list
110848738|NCT05200156|Lipotropic Agents|lipotropic agents|mesh-ancestor
110848739|NCT05200156|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110848740|NCT05200156|Antimetabolites|antimetabolites|mesh-ancestor
110848741|NCT05200156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110848742|NCT05200156|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110848743|NCT05200156|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110848744|NCT05200156|Nootropic Agents|nootropic agents|mesh-ancestor
110848745|NCT03347968|Warfarin|warfarin|mesh-list
110848746|NCT03347968|Esmolol|esmolol|mesh-list
110848747|NCT03347968|Anticoagulants|anticoagulants|mesh-ancestor
110848748|NCT03347968|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110848749|NCT03347968|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110848750|NCT03347968|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110848751|NCT03347968|Adrenergic Agents|adrenergic agents|mesh-ancestor
110848752|NCT03347968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110848753|NCT03347968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110848754|NCT03347968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110848755|NCT01191593|Ropivacaine|ropivacaine|mesh-list
110848756|NCT01191593|Anesthetics, Local|anesthetics, local|mesh-ancestor
110848757|NCT01191593|Anesthetics|anesthetics|mesh-ancestor
110848758|NCT01191593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110848759|NCT01191593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110848760|NCT01191593|Sensory System Agents|sensory system agents|mesh-ancestor
110848761|NCT01191593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110848762|NCT03347890|Liraglutide|liraglutide|mesh-list
110848763|NCT03347890|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110848764|NCT03347890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110848765|NCT03347890|Incretins|incretins|mesh-ancestor
110848766|NCT03347890|Hormones|hormones|mesh-ancestor
110848767|NCT03347890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110848768|NCT01296503|Thalidomide|thalidomide|mesh-list
110848769|NCT01296503|Dexamethasone|dexamethasone|mesh-list
110848770|NCT01296503|Dexamethasone acetate|dexamethasone acetate|mesh-list
110848771|NCT01296503|BB 1101|bb 1101|mesh-list
110848772|NCT01296503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110848773|NCT01296503|Antiemetics|antiemetics|mesh-ancestor
110848774|NCT01296503|Autonomic Agents|autonomic agents|mesh-ancestor
110848775|NCT01296503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110848776|NCT01296503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110848777|NCT01296503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110848779|NCT01296503|Hormones|hormones|mesh-ancestor
110848780|NCT01296503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110848781|NCT01296503|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110848782|NCT01296503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110848783|NCT01296503|Protease Inhibitors|protease inhibitors|mesh-ancestor
110848784|NCT01296503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110848785|NCT01296503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110848786|NCT01296503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110848787|NCT01296503|Immunologic Factors|immunologic factors|mesh-ancestor
110848788|NCT01296503|Leprostatic Agents|leprostatic agents|mesh-ancestor
110848789|NCT01296503|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110848790|NCT01296503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110848791|NCT01296503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110848792|NCT01296503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110848793|NCT01296503|Growth Substances|growth substances|mesh-ancestor
110848794|NCT01296503|Growth Inhibitors|growth inhibitors|mesh-ancestor
110848795|NCT01295099|Triamcinolone|triamcinolone|mesh-list
110848796|NCT01295099|Fluorouracil|fluorouracil|mesh-list
110848797|NCT01295099|Antimetabolites|antimetabolites|mesh-ancestor
110848798|NCT01295099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110848799|NCT01295099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110848800|NCT01295099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110848801|NCT01295099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110848802|NCT01295099|Immunologic Factors|immunologic factors|mesh-ancestor
110848803|NCT01295099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110848804|NCT01295099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110848805|NCT01295099|Glucocorticoids|glucocorticoids|mesh-ancestor
110848806|NCT01295099|Hormones|hormones|mesh-ancestor
110848807|NCT01295099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110848808|NCT01426529|Norepinephrine|norepinephrine|mesh-list
110848809|NCT01426529|Angiotensin II|angiotensin ii|mesh-list
110848811|NCT01426529|Angiotensinogen|angiotensinogen|mesh-list
110848812|NCT01426529|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110848813|NCT01426529|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110848814|NCT01426529|Adrenergic Agents|adrenergic agents|mesh-ancestor
110848816|NCT01426529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110848817|NCT01426529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110848818|NCT01426529|Sympathomimetics|sympathomimetics|mesh-ancestor
110848819|NCT01426529|Autonomic Agents|autonomic agents|mesh-ancestor
110848820|NCT01426529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110848821|NCT01426529|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110848822|NCT01426529|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110848823|NCT01426529|Protease Inhibitors|protease inhibitors|mesh-ancestor
110848824|NCT01426529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110848825|NCT03122158|Escitalopram|escitalopram|mesh-list
110848826|NCT03122158|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110848827|NCT03122158|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110848828|NCT03122158|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110848829|NCT03122158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110848830|NCT03122158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110848831|NCT03122158|Serotonin Agents|serotonin agents|mesh-ancestor
110848832|NCT03122158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110848833|NCT02668653|Cytarabine|cytarabine|mesh-list
110848834|NCT02668653|Daunorubicin|daunorubicin|mesh-list
110848835|NCT02668653|Idarubicin|idarubicin|mesh-list
110848836|NCT02668653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110848837|NCT02668653|Antimetabolites|antimetabolites|mesh-ancestor
110848838|NCT02668653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110848839|NCT02668653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110848840|NCT02668653|Antiviral Agents|antiviral agents|mesh-ancestor
110848841|NCT02668653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110848842|NCT02668653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110848843|NCT02668653|Immunologic Factors|immunologic factors|mesh-ancestor
110848844|NCT02668653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110848845|NCT02668653|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110848846|NCT02668653|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110848847|NCT02668653|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110848848|NCT02668653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110848849|NCT01190735|Caffeine|caffeine|mesh-list
110848850|NCT01190735|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110848851|NCT01190735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110848852|NCT01190735|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110848853|NCT01190735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110848854|NCT01190735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110848855|NCT01190735|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110848856|NCT01190735|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110848857|NCT01190735|Purinergic Agents|purinergic agents|mesh-ancestor
110848858|NCT01190735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110848859|NCT05097118|Ketamine|ketamine|mesh-list
110848860|NCT05097118|Bupivacaine|bupivacaine|mesh-list
110848861|NCT05097118|Anesthetics, Local|anesthetics, local|mesh-ancestor
110848862|NCT05097118|Anesthetics|anesthetics|mesh-ancestor
110848863|NCT05097118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110848864|NCT05097118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110848865|NCT05097118|Sensory System Agents|sensory system agents|mesh-ancestor
110848866|NCT05097118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110848867|NCT05097118|Analgesics|analgesics|mesh-ancestor
110848868|NCT05097118|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110848869|NCT05097118|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110848870|NCT05097118|Anesthetics, General|anesthetics, general|mesh-ancestor
110848871|NCT05097118|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110848872|NCT05097118|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110832108|NCT04199767|Insulin|insulin|mesh-list
110848873|NCT05097118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110848874|NCT05097118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110848875|NCT01194791|Dexamethasone|dexamethasone|mesh-list
110848876|NCT01194791|Cyclophosphamide|cyclophosphamide|mesh-list
110848877|NCT01194791|Lenalidomide|lenalidomide|mesh-list
110848878|NCT01194791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110848879|NCT01194791|Immunologic Factors|immunologic factors|mesh-ancestor
110848880|NCT01194791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110848881|NCT01194791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110848882|NCT01194791|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110848883|NCT01194791|Alkylating Agents|alkylating agents|mesh-ancestor
110848884|NCT01194791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110637726|NCT00833534|Rituximab|rituximab|mesh-list
110848885|NCT01194791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110848886|NCT01194791|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110848887|NCT01194791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110848888|NCT01194791|Antiemetics|antiemetics|mesh-ancestor
110848889|NCT01194791|Autonomic Agents|autonomic agents|mesh-ancestor
110848890|NCT01194791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110848891|NCT01194791|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110848892|NCT01194791|Glucocorticoids|glucocorticoids|mesh-ancestor
110848893|NCT01194791|Hormones|hormones|mesh-ancestor
110848894|NCT01194791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110848895|NCT01194791|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110848896|NCT01194791|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110848897|NCT01194791|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110848898|NCT01194791|Growth Substances|growth substances|mesh-ancestor
110848899|NCT01194791|Growth Inhibitors|growth inhibitors|mesh-ancestor
110848900|NCT03351322|Minoxidil|minoxidil|mesh-list
110848901|NCT03351322|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110848902|NCT03351322|Vasodilator Agents|vasodilator agents|mesh-ancestor
110848903|NCT01296971|Ribavirin|ribavirin|mesh-list
110848904|NCT01296971|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110848905|NCT01296971|Antimetabolites|antimetabolites|mesh-ancestor
110336406|NCT00502073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110848906|NCT01296971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110848907|NCT01296971|Antiviral Agents|antiviral agents|mesh-ancestor
110848908|NCT01296971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110848909|NCT01195181|Ribavirin|ribavirin|mesh-list
110848910|NCT01195181|Antimetabolites|antimetabolites|mesh-ancestor
110848911|NCT01195181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110848912|NCT01195181|Antiviral Agents|antiviral agents|mesh-ancestor
110848913|NCT01195181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110848914|NCT01197053|Immunomodulating Agents|immunomodulating agents|mesh-list
110848915|NCT01197053|Immunologic Factors|immunologic factors|mesh-ancestor
110848916|NCT01197053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110848917|NCT03845699|Fentanyl|fentanyl|mesh-list
110848918|NCT03845699|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110848919|NCT03845699|Narcotics|narcotics|mesh-ancestor
110848920|NCT03845699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110848921|NCT03845699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110848922|NCT03845699|Analgesics|analgesics|mesh-ancestor
110848923|NCT03845699|Sensory System Agents|sensory system agents|mesh-ancestor
110848924|NCT03845699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110848925|NCT03845699|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110848926|NCT03845699|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110848927|NCT03845699|Anesthetics, General|anesthetics, general|mesh-ancestor
110848928|NCT03845699|Anesthetics|anesthetics|mesh-ancestor
110848929|NCT03845777|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
110848930|NCT03845777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110848931|NCT00709618|Vinorelbine|vinorelbine|mesh-list
110848932|NCT00709618|Lapatinib|lapatinib|mesh-list
110336424|NCT01248923|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110848933|NCT00709618|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110848934|NCT00709618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110848935|NCT00709618|Tubulin Modulators|tubulin modulators|mesh-ancestor
110848936|NCT00709618|Antimitotic Agents|antimitotic agents|mesh-ancestor
110848937|NCT00709618|Mitosis Modulators|mitosis modulators|mesh-ancestor
110848938|NCT00709618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110848939|NCT00709618|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110848940|NCT00709618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110848941|NCT01195259|Metformin|metformin|mesh-list
110848942|NCT01195259|Rosiglitazone|rosiglitazone|mesh-list
110848943|NCT01195259|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110848944|NCT01195259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110848945|NCT05584228|Infliximab|infliximab|mesh-list
110848946|NCT05584228|Azathioprine|azathioprine|mesh-list
110848947|NCT05584228|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110848948|NCT05584228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110848949|NCT05584228|Dermatologic Agents|dermatologic agents|mesh-ancestor
110848950|NCT05584228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110848951|NCT05584228|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110848952|NCT05584228|Antimetabolites|antimetabolites|mesh-ancestor
110848953|NCT05584228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110848954|NCT05584228|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110848955|NCT05584228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110848956|NCT05584228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110848957|NCT05584228|Immunologic Factors|immunologic factors|mesh-ancestor
110848958|NCT05584228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110848959|NCT03193047|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
110848960|NCT03193047|Evolocumab|evolocumab|mesh-list
110848961|NCT03193047|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
110848962|NCT03193047|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110848963|NCT03193047|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110848964|NCT03193047|Antimetabolites|antimetabolites|mesh-ancestor
110848965|NCT03193047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110848966|NCT03193047|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110848967|NCT03193047|Protease Inhibitors|protease inhibitors|mesh-ancestor
110848968|NCT03193047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110848969|NCT03193047|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110848970|NCT03193047|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110848971|NCT03193047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110848972|NCT04504552|Avelumab|avelumab|mesh-list
110848973|NCT04504552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110848974|NCT04504552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110848975|NCT03845387|Pramipexole|pramipexole|mesh-list
110848976|NCT03845387|Antioxidants|antioxidants|mesh-ancestor
110848977|NCT03845387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110848978|NCT03845387|Protective Agents|protective agents|mesh-ancestor
110848979|NCT03845387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110848980|NCT03845387|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110848981|NCT03845387|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110848982|NCT03845387|Dopamine Agonists|dopamine agonists|mesh-ancestor
110848983|NCT03845387|Dopamine Agents|dopamine agents|mesh-ancestor
110848984|NCT03845387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110848985|NCT01295177|Insulin|insulin|mesh-list
110848986|NCT01295177|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110848987|NCT01295177|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110848988|NCT01295177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110848989|NCT02918019|Astegolimab|astegolimab|mesh-list
110848990|NCT02918019|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110848991|NCT02918019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110848992|NCT02918019|Antiviral Agents|antiviral agents|mesh-ancestor
110848993|NCT02918019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110848994|NCT04848454|Vinorelbine|vinorelbine|mesh-list
110848995|NCT04848454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110848996|NCT04848454|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110848997|NCT04848454|Tubulin Modulators|tubulin modulators|mesh-ancestor
110848998|NCT04848454|Antimitotic Agents|antimitotic agents|mesh-ancestor
110848999|NCT04848454|Mitosis Modulators|mitosis modulators|mesh-ancestor
110849000|NCT04848454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110849001|NCT04842292|Heparin|heparin|mesh-list
110849002|NCT04842292|Anticoagulants|anticoagulants|mesh-ancestor
110849003|NCT04842292|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110849004|NCT04842292|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110849005|NCT04842292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110849006|NCT01191983|Epoetin Alfa|epoetin alfa|mesh-list
110849007|NCT01191983|Hematinics|hematinics|mesh-ancestor
110849008|NCT03055988|Fluticasone|fluticasone|mesh-list
110849009|NCT03055988|Xhance|xhance|mesh-list
110849010|NCT03055988|Tiotropium Bromide|tiotropium bromide|mesh-list
110849011|NCT03055988|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110849012|NCT03055988|Olodaterol|olodaterol|mesh-list
110849013|NCT03055988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110637893|NCT00825188|Amlodipine|amlodipine|mesh-list
110849014|NCT03055988|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110849015|NCT03055988|Autonomic Agents|autonomic agents|mesh-ancestor
110849016|NCT03055988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110849017|NCT03055988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110849018|NCT03055988|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110849019|NCT03055988|Respiratory System Agents|respiratory system agents|mesh-ancestor
110849020|NCT03055988|Dermatologic Agents|dermatologic agents|mesh-ancestor
110849021|NCT03055988|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110849022|NCT03055988|Parasympatholytics|parasympatholytics|mesh-ancestor
110849023|NCT03055988|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110849024|NCT03055988|Cholinergic Agents|cholinergic agents|mesh-ancestor
110849025|NCT03055988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110849026|NCT03055988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110849027|NCT03055988|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110849028|NCT03055988|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110849029|NCT03055988|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110849030|NCT03055988|Adrenergic Agents|adrenergic agents|mesh-ancestor
110849031|NCT03346642|Decitabine|decitabine|mesh-list
110849032|NCT03346642|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
110849033|NCT03346642|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110849034|NCT03346642|Antimetabolites|antimetabolites|mesh-ancestor
110849035|NCT03346642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110849036|NCT03346642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110849037|NCT03346642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110849038|NCT03346642|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110849039|NCT02912949|Immunoglobulin G|immunoglobulin g|mesh-list
110849040|NCT02912949|Antibodies, Bispecific|antibodies, bispecific|mesh-list
110849041|NCT02912949|Immunologic Factors|immunologic factors|mesh-ancestor
110849042|NCT02912949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110849043|NCT01250912|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
110849044|NCT01250912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110849045|NCT01250912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110849046|NCT01250912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110849047|NCT01250912|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110849048|NCT04789304|Midazolam|midazolam|mesh-list
110849049|NCT04789304|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110849050|NCT04789304|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110637987|NCT00840242|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110849051|NCT04789304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110849052|NCT04789304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110849053|NCT04789304|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110849054|NCT04789304|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110849055|NCT04789304|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110849056|NCT04789304|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110849057|NCT04789304|Anesthetics, General|anesthetics, general|mesh-ancestor
110849058|NCT04789304|Anesthetics|anesthetics|mesh-ancestor
110849059|NCT04789304|GABA Modulators|gaba modulators|mesh-ancestor
110849060|NCT04789304|GABA Agents|gaba agents|mesh-ancestor
110849061|NCT04789304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110849062|NCT04789304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110849063|NCT04780724|Nitrox|nitrox|mesh-list
110849064|NCT04780724|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110849065|NCT04780724|Protective Agents|protective agents|mesh-ancestor
110849066|NCT04780724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110849067|NCT05583214|Dexamethasone|dexamethasone|mesh-list
110849068|NCT05583214|Ondansetron|ondansetron|mesh-list
110849069|NCT05583214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110849070|NCT05583214|Antiemetics|antiemetics|mesh-ancestor
110849071|NCT05583214|Autonomic Agents|autonomic agents|mesh-ancestor
110849072|NCT05583214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110849073|NCT05583214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110849074|NCT05583214|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110849075|NCT05583214|Glucocorticoids|glucocorticoids|mesh-ancestor
110849076|NCT05583214|Hormones|hormones|mesh-ancestor
110336522|NCT03459417|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110849077|NCT05583214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110849078|NCT05583214|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110849079|NCT05583214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110849080|NCT05583214|Antipruritics|antipruritics|mesh-ancestor
110849081|NCT05583214|Dermatologic Agents|dermatologic agents|mesh-ancestor
110849082|NCT05583214|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110849083|NCT05583214|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110849084|NCT05583214|Serotonin Agents|serotonin agents|mesh-ancestor
110849085|NCT05583214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110849086|NCT05583214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110849087|NCT02871297|Vortioxetine|vortioxetine|mesh-list
110849088|NCT02871297|Antidepressive Agents|antidepressive agents|mesh-ancestor
110849089|NCT02871297|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110849090|NCT02871297|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110849091|NCT02871297|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110849092|NCT02871297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110849093|NCT02871297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110849094|NCT02871297|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110849095|NCT02871297|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110849096|NCT02871297|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110849097|NCT02871297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110849098|NCT02871297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110849099|NCT02871297|Serotonin Agents|serotonin agents|mesh-ancestor
110849100|NCT02871297|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110849101|NCT02871297|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110849102|NCT02871297|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110849103|NCT02871297|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110849104|NCT03628430|Lidocaine|lidocaine|mesh-list
110849105|NCT03628430|Epinephrine|epinephrine|mesh-list
110849106|NCT03628430|Anesthetics, Local|anesthetics, local|mesh-ancestor
110849107|NCT03628430|Anesthetics|anesthetics|mesh-ancestor
110849108|NCT03628430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110849109|NCT03628430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110638086|NCT02549924|Resveratrol|resveratrol|mesh-list
110849110|NCT03628430|Sensory System Agents|sensory system agents|mesh-ancestor
110849111|NCT03628430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110849112|NCT03628430|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110849113|NCT03628430|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110849114|NCT03628430|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110849115|NCT03628430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110849116|NCT03628430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110849117|NCT03628430|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110849118|NCT03628430|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110849119|NCT03628430|Adrenergic Agents|adrenergic agents|mesh-ancestor
110849120|NCT03628430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110849121|NCT03628430|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110849122|NCT03628430|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110849123|NCT03628430|Autonomic Agents|autonomic agents|mesh-ancestor
110849124|NCT03628430|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110849125|NCT03628430|Respiratory System Agents|respiratory system agents|mesh-ancestor
110849126|NCT03628430|Mydriatics|mydriatics|mesh-ancestor
110849127|NCT03628430|Sympathomimetics|sympathomimetics|mesh-ancestor
110849128|NCT03628430|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110849129|NCT03121846|Apatinib|apatinib|mesh-list
110849130|NCT03121846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110849131|NCT03121846|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110849132|NCT03121846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110638130|NCT01010308|Autonomic Agents|autonomic agents|mesh-ancestor
110849133|NCT03121846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110849134|NCT03122314|Acetaminophen|acetaminophen|mesh-list
110849135|NCT03122314|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
110849136|NCT03122314|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110849137|NCT03122314|Analgesics|analgesics|mesh-ancestor
110849138|NCT03122314|Sensory System Agents|sensory system agents|mesh-ancestor
110849139|NCT03122314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110849140|NCT03122314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110849141|NCT03122314|Antipyretics|antipyretics|mesh-ancestor
110849142|NCT03122314|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110849143|NCT03122314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110849144|NCT03122314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110849145|NCT03554005|Acetaminophen|acetaminophen|mesh-list
110849146|NCT03554005|Interferons|interferons|mesh-list
110849147|NCT03554005|Interferon-alpha|interferon-alpha|mesh-list
110849148|NCT03554005|Interferon alpha-2|interferon alpha-2|mesh-list
110849149|NCT03554005|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110849150|NCT03554005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110849151|NCT03554005|Antiviral Agents|antiviral agents|mesh-ancestor
110849152|NCT03554005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110849153|NCT03554005|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110849154|NCT03554005|Analgesics|analgesics|mesh-ancestor
110849155|NCT03554005|Sensory System Agents|sensory system agents|mesh-ancestor
110849156|NCT03554005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110849157|NCT03554005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110849158|NCT03554005|Antipyretics|antipyretics|mesh-ancestor
110849159|NCT03554005|Immunologic Factors|immunologic factors|mesh-ancestor
110849160|NCT00709228|Ribavirin|ribavirin|mesh-list
110849161|NCT00709228|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110849162|NCT00709228|Antimetabolites|antimetabolites|mesh-ancestor
110849163|NCT00709228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110849164|NCT00709228|Antiviral Agents|antiviral agents|mesh-ancestor
110849165|NCT00709228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110849166|NCT01584557|Tolvaptan|tolvaptan|mesh-list
110849167|NCT01584557|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
110849168|NCT01584557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110849169|NCT01584557|Natriuretic Agents|natriuretic agents|mesh-ancestor
110849170|NCT01584557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110849171|NCT05214872|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
110849172|NCT05214872|Calcium|calcium|mesh-list
110849173|NCT05214872|Mitogens|mitogens|mesh-list
110849174|NCT05214872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110849175|NCT05214872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110849176|NCT05214872|Mitosis Modulators|mitosis modulators|mesh-ancestor
110849177|NCT05214872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110849178|NCT05214872|Natriuretic Agents|natriuretic agents|mesh-ancestor
110849179|NCT01195571|Vaccines|vaccines|mesh-list
110849180|NCT01195571|Immunologic Factors|immunologic factors|mesh-ancestor
110849181|NCT01195571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110849182|NCT03219372|Pravastatin|pravastatin|mesh-list
110849183|NCT03219372|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110849184|NCT03219372|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110849185|NCT03219372|Antimetabolites|antimetabolites|mesh-ancestor
110849186|NCT03219372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110849187|NCT03219372|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110849188|NCT03219372|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110849189|NCT03219372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110849190|NCT02422641|Methotrexate|methotrexate|mesh-list
110849191|NCT02422641|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110849192|NCT02422641|Abortifacient Agents|abortifacient agents|mesh-ancestor
110849193|NCT02422641|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110849194|NCT02422641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110849195|NCT02422641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110849196|NCT02422641|Antimetabolites|antimetabolites|mesh-ancestor
110849197|NCT02422641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110849198|NCT02422641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110849199|NCT02422641|Dermatologic Agents|dermatologic agents|mesh-ancestor
110849200|NCT02422641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110849201|NCT02422641|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110849202|NCT02422641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110849203|NCT02422641|Immunologic Factors|immunologic factors|mesh-ancestor
110849204|NCT02422641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110849205|NCT02422641|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110849206|NCT03628040|Ropivacaine|ropivacaine|mesh-list
110849207|NCT03628040|Anesthetics, Local|anesthetics, local|mesh-ancestor
110849208|NCT03628040|Anesthetics|anesthetics|mesh-ancestor
110638284|NCT00207727|Ustekinumab|ustekinumab|mesh-list
110849209|NCT03628040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110849210|NCT03628040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110849211|NCT03628040|Sensory System Agents|sensory system agents|mesh-ancestor
110849212|NCT03628040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110849213|NCT04715763|Telmisartan|telmisartan|mesh-list
110849214|NCT04715763|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110849215|NCT04715763|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110849216|NCT04715763|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110849217|NCT04715763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110849218|NCT04338828|Nitric Oxide|nitric oxide|mesh-list
110849219|NCT04338828|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110849220|NCT04338828|Autonomic Agents|autonomic agents|mesh-ancestor
110849221|NCT04338828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110849222|NCT04338828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110849223|NCT04338828|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110849224|NCT04338828|Respiratory System Agents|respiratory system agents|mesh-ancestor
110849225|NCT04338828|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110849226|NCT04338828|Antioxidants|antioxidants|mesh-ancestor
110849227|NCT04338828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110849228|NCT04338828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110849229|NCT04338828|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
110849230|NCT04338828|Vasodilator Agents|vasodilator agents|mesh-ancestor
110849231|NCT04338828|Gasotransmitters|gasotransmitters|mesh-ancestor
110849232|NCT04338828|Protective Agents|protective agents|mesh-ancestor
110849233|NCT01295567|Dipyridamole|dipyridamole|mesh-list
110849234|NCT01295567|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110849235|NCT01295567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110849236|NCT01295567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110849237|NCT01295567|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110849238|NCT01295567|Vasodilator Agents|vasodilator agents|mesh-ancestor
110849239|NCT01192529|Phentermine|phentermine|mesh-list
110849240|NCT01192529|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110849241|NCT01192529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110849242|NCT01192529|Appetite Depressants|appetite depressants|mesh-ancestor
110849243|NCT01192529|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110849244|NCT01192529|Sympathomimetics|sympathomimetics|mesh-ancestor
110849245|NCT01192529|Autonomic Agents|autonomic agents|mesh-ancestor
110849246|NCT01192529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110849247|NCT01192529|Adrenergic Agents|adrenergic agents|mesh-ancestor
110849248|NCT01192529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110849249|NCT01192529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110849250|NCT01195649|Sorafenib|sorafenib|mesh-list
110849251|NCT01195649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110849252|NCT01195649|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110849253|NCT01195649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110849254|NCT01195649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110849255|NCT01195727|Apixaban|apixaban|mesh-list
110849256|NCT01195727|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110849257|NCT01195727|Antithrombins|antithrombins|mesh-ancestor
110849258|NCT01195727|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110849259|NCT01195727|Protease Inhibitors|protease inhibitors|mesh-ancestor
110849260|NCT01195727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110849261|NCT01195727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110849262|NCT01195727|Anticoagulants|anticoagulants|mesh-ancestor
110849263|NCT04958876|Naltrexone|naltrexone|mesh-list
110849264|NCT04958876|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110849265|NCT04958876|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110849266|NCT04958876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110849267|NCT04958876|Sensory System Agents|sensory system agents|mesh-ancestor
110849268|NCT04958876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110849269|NCT01195805|Amiloride|amiloride|mesh-list
110849270|NCT01195805|Spironolactone|spironolactone|mesh-list
110849271|NCT01195805|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110849272|NCT01195805|Hormone Antagonists|hormone antagonists|mesh-ancestor
110849273|NCT01195805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110849274|NCT01195805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110849275|NCT01195805|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110849276|NCT01195805|Diuretics|diuretics|mesh-ancestor
110849277|NCT01195805|Natriuretic Agents|natriuretic agents|mesh-ancestor
110849278|NCT01195805|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
110849279|NCT01195805|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110849280|NCT01195805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110849281|NCT01195805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110849282|NCT01195805|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
110849283|NCT04899986|Chlorhexidine|chlorhexidine|mesh-list
110849284|NCT04899986|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110849285|NCT04899986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110849286|NCT04899986|Disinfectants|disinfectants|mesh-ancestor
110849287|NCT01791478|Letrozole|letrozole|mesh-list
110849288|NCT01791478|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-list
110849289|NCT01791478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110849290|NCT01791478|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110849291|NCT01791478|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110849293|NCT01791478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110849294|NCT01791478|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110849295|NCT01791478|Hormone Antagonists|hormone antagonists|mesh-ancestor
110849296|NCT01791478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110849297|NCT01791478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110849298|NCT03845153|Metformin|metformin|mesh-list
110849299|NCT03845153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110849300|NCT03845153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110849301|NCT00198718|Vitamin A|vitamin a|mesh-list
110849302|NCT00198718|Retinol palmitate|retinol palmitate|mesh-list
110849303|NCT00198718|Vitamins|vitamins|mesh-ancestor
110849304|NCT00198718|Micronutrients|micronutrients|mesh-ancestor
110849305|NCT00198718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110849306|NCT00198718|Antioxidants|antioxidants|mesh-ancestor
110849307|NCT00198718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110849308|NCT00198718|Protective Agents|protective agents|mesh-ancestor
110849309|NCT00198718|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110849310|NCT00198718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110849311|NCT04500808|Macitentan|macitentan|mesh-list
110849312|NCT04500808|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
110849313|NCT04500808|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
110849314|NCT04500808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110849315|NCT04500808|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
110870388|NCT02693002|Estrogens|estrogens|mesh-ancestor
110849316|NCT01192763|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
110849317|NCT01192763|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
110849318|NCT01192763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110849319|NCT01192763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110849320|NCT04539548|Prednisolone|prednisolone|mesh-list
110849321|NCT04539548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110849322|NCT04539548|Glucocorticoids|glucocorticoids|mesh-ancestor
110849324|NCT04539548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110849325|NCT04539548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110849326|NCT04539548|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110849327|NCT04539548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110849328|NCT00708916|Apremilast|apremilast|mesh-list
110849329|NCT00708916|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110849330|NCT00708916|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110849331|NCT00708916|Analgesics|analgesics|mesh-ancestor
110849332|NCT00708916|Sensory System Agents|sensory system agents|mesh-ancestor
110849333|NCT00708916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110849334|NCT00708916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110849335|NCT00708916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110849336|NCT00708916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110849337|NCT00708916|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
110849338|NCT00708916|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110849339|NCT00708916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110849340|NCT00708916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110849341|NCT02352753|Denosumab|denosumab|mesh-list
110849342|NCT02352753|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110849343|NCT02352753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110849344|NCT02517736|Sorafenib|sorafenib|mesh-list
110849345|NCT02517736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110849346|NCT02517736|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110849347|NCT02517736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110849348|NCT02517736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110849349|NCT03727971|Omalizumab|omalizumab|mesh-list
110849350|NCT03727971|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110849351|NCT03727971|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110849352|NCT03727971|Respiratory System Agents|respiratory system agents|mesh-ancestor
110849353|NCT03844841|Dexmedetomidine|dexmedetomidine|mesh-list
110849354|NCT03844841|Propofol|propofol|mesh-list
110849355|NCT03844841|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110849356|NCT03844841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110849357|NCT03844841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110849358|NCT03844841|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110849359|NCT03844841|Analgesics|analgesics|mesh-ancestor
110849360|NCT03844841|Sensory System Agents|sensory system agents|mesh-ancestor
110849361|NCT03844841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110566941|NCT05957653|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110849362|NCT03844841|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110849363|NCT03844841|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110849364|NCT03844841|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110849365|NCT03844841|Adrenergic Agents|adrenergic agents|mesh-ancestor
110849366|NCT03844841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110849367|NCT03844841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110849368|NCT03844841|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110849369|NCT03844841|Anesthetics, General|anesthetics, general|mesh-ancestor
110849370|NCT03844841|Anesthetics|anesthetics|mesh-ancestor
110849371|NCT03197766|Natriuretic Peptide, C-Type|natriuretic peptide, c-type|mesh-list
110849372|NCT03197766|Natriuretic Agents|natriuretic agents|mesh-ancestor
110849373|NCT03197766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110849374|NCT04501900|Clopidogrel|clopidogrel|mesh-list
110849375|NCT04501900|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110849376|NCT04501900|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110849377|NCT04501900|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110849378|NCT04501900|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110849379|NCT04501900|Purinergic Agents|purinergic agents|mesh-ancestor
110849380|NCT04501900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110849381|NCT04501900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110849382|NCT04501900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110849383|NCT03637556|Deferasirox|deferasirox|mesh-list
110849384|NCT03637556|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110849385|NCT03637556|Chelating Agents|chelating agents|mesh-ancestor
110849386|NCT03637556|Sequestering Agents|sequestering agents|mesh-ancestor
110849387|NCT03637556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110849388|NCT01193387|Insulin|insulin|mesh-list
110849389|NCT01193387|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110849390|NCT01193387|Insulin, Long-Acting|insulin, long-acting|mesh-list
110849391|NCT01193387|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110849392|NCT01193387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110849393|NCT01198223|Nystatin|nystatin|mesh-list
110849395|NCT01198223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110849396|NCT01198223|Antifungal Agents|antifungal agents|mesh-ancestor
110849397|NCT01198223|Ionophores|ionophores|mesh-ancestor
110849398|NCT01198223|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110849399|NCT01198223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110849400|NCT01193465|Anesthetics|anesthetics|mesh-list
110849401|NCT01193465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110849402|NCT01193465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110849403|NCT03347344|Riluzole|riluzole|mesh-list
110849404|NCT03347344|Anticonvulsants|anticonvulsants|mesh-ancestor
110638588|NCT03541486|Gemcitabine|gemcitabine|mesh-list
110849405|NCT03347344|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110849406|NCT03347344|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110849407|NCT03347344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110849408|NCT03347344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110849409|NCT03347344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110849410|NCT03347344|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110849411|NCT03347344|Protective Agents|protective agents|mesh-ancestor
110849413|NCT04220866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110849414|NCT04220866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110849415|NCT04220866|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110849416|NCT04220866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110849417|NCT03173456|Acetaminophen|acetaminophen|mesh-list
110849418|NCT03173456|Ibuprofen|ibuprofen|mesh-list
110849419|NCT03173456|Oxycodone|oxycodone|mesh-list
110849420|NCT03173456|Hydrocodone|hydrocodone|mesh-list
110849421|NCT03173456|Codeine|codeine|mesh-list
110849422|NCT03173456|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110849423|NCT03173456|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110849424|NCT03173456|Analgesics|analgesics|mesh-ancestor
110849425|NCT03173456|Sensory System Agents|sensory system agents|mesh-ancestor
110849426|NCT03173456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110849427|NCT03173456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110849428|NCT03173456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110849429|NCT03173456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110849430|NCT03173456|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110849431|NCT03173456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110849432|NCT03173456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110849433|NCT03173456|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110849434|NCT03173456|Narcotics|narcotics|mesh-ancestor
110849435|NCT03173456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110849436|NCT03173456|Antipyretics|antipyretics|mesh-ancestor
110849437|NCT03173456|Antitussive Agents|antitussive agents|mesh-ancestor
110849438|NCT03173456|Respiratory System Agents|respiratory system agents|mesh-ancestor
110849439|NCT01193621|Haloperidol|haloperidol|mesh-list
110849440|NCT01193621|Haloperidol decanoate|haloperidol decanoate|mesh-list
110849441|NCT01193621|Antiemetics|antiemetics|mesh-ancestor
110849442|NCT01193621|Autonomic Agents|autonomic agents|mesh-ancestor
110849443|NCT01193621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110849444|NCT01193621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110849445|NCT01193621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110849446|NCT01193621|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110849447|NCT01193621|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110849448|NCT01193621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110849449|NCT01193621|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110849450|NCT01193621|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110849451|NCT01193621|Dopamine Agents|dopamine agents|mesh-ancestor
110849452|NCT01193621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110849453|NCT01193621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110849454|NCT01193621|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110849456|NCT02517424|Hallucinogens|hallucinogens|mesh-ancestor
110849457|NCT02517424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110849458|NCT02517424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110849459|NCT02517424|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110849460|NCT02517424|Analgesics|analgesics|mesh-ancestor
110849461|NCT02517424|Sensory System Agents|sensory system agents|mesh-ancestor
110849462|NCT02517424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110849463|NCT02517424|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
110849464|NCT02517424|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110849465|NCT02517424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110849466|NCT02517424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110849467|NCT02517424|Hormones|hormones|mesh-ancestor
110849468|NCT02517424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110849469|NCT01567904|Semuloparin|semuloparin|mesh-list
110849470|NCT01567904|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110849471|NCT01567904|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110849472|NCT01567904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110849473|NCT01196507|Carvedilol|carvedilol|mesh-list
110849474|NCT01196507|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110849475|NCT01196507|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110849476|NCT01196507|Adrenergic Agents|adrenergic agents|mesh-ancestor
110849477|NCT01196507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110849478|NCT01196507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110849479|NCT01196507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110849480|NCT01196507|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110849481|NCT01196507|Antioxidants|antioxidants|mesh-ancestor
110849482|NCT01196507|Protective Agents|protective agents|mesh-ancestor
110849483|NCT01196507|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110849484|NCT01196507|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110849485|NCT01196507|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110849486|NCT01196507|Vasodilator Agents|vasodilator agents|mesh-ancestor
110849487|NCT01196507|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110849488|NCT01196507|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110849489|NCT05670509|Midazolam|midazolam|mesh-list
110849490|NCT05670509|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110849491|NCT05670509|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110849492|NCT05670509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110849493|NCT05670509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110849494|NCT05670509|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110849495|NCT05670509|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110849496|NCT05670509|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110849497|NCT05670509|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110849498|NCT05670509|Anesthetics, General|anesthetics, general|mesh-ancestor
110849499|NCT05670509|Anesthetics|anesthetics|mesh-ancestor
110849500|NCT05670509|GABA Modulators|gaba modulators|mesh-ancestor
110849501|NCT05670509|GABA Agents|gaba agents|mesh-ancestor
110849502|NCT05670509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110849503|NCT05670509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110849504|NCT05282771|Nicotinic Acids|nicotinic acids|mesh-list
110849505|NCT05282771|Clobetasol|clobetasol|mesh-list
110849506|NCT05282771|Halobetasol|halobetasol|mesh-list
110849507|NCT05282771|Tazarotene|tazarotene|mesh-list
110849508|NCT05282771|Dermatologic Agents|dermatologic agents|mesh-ancestor
110849509|NCT05282771|Keratolytic Agents|keratolytic agents|mesh-ancestor
110849510|NCT05282771|Vitamin B Complex|vitamin b complex|mesh-ancestor
110567093|NCT05936203|Insulin|insulin|mesh-list
110849511|NCT05282771|Vitamins|vitamins|mesh-ancestor
110849512|NCT05282771|Micronutrients|micronutrients|mesh-ancestor
110849513|NCT05282771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110849514|NCT05282771|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110849515|NCT05282771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110849516|NCT05282771|Glucocorticoids|glucocorticoids|mesh-ancestor
110849517|NCT05282771|Hormones|hormones|mesh-ancestor
110849518|NCT05282771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110849519|NCT05487833|Insulin|insulin|mesh-list
110849520|NCT05487833|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110849521|NCT05487833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110849522|NCT03600805|Prednisone|prednisone|mesh-list
110849523|NCT03600805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110849524|NCT03600805|Glucocorticoids|glucocorticoids|mesh-ancestor
110849525|NCT03600805|Hormones|hormones|mesh-ancestor
110849526|NCT03600805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110849527|NCT03600805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110849528|NCT03600805|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110849529|NCT03600805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110849530|NCT01198379|Aspirin|aspirin|mesh-list
110849531|NCT01198379|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110849532|NCT01198379|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110849533|NCT01198379|Analgesics|analgesics|mesh-ancestor
110849534|NCT01198379|Sensory System Agents|sensory system agents|mesh-ancestor
110849535|NCT01198379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110849536|NCT01198379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110849537|NCT01198379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110849538|NCT01198379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110849539|NCT01198379|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110638854|NCT00992199|Fluorouracil|fluorouracil|mesh-list
110849540|NCT01198379|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110849541|NCT01198379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110849542|NCT01198379|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110849543|NCT01198379|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110849544|NCT01198379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110849545|NCT01198379|Antipyretics|antipyretics|mesh-ancestor
110849546|NCT03848039|Vaccines|vaccines|mesh-list
110849547|NCT03848039|Immunologic Factors|immunologic factors|mesh-ancestor
110849548|NCT03848039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110849549|NCT01296269|Vasopressins|vasopressins|mesh-list
110849550|NCT01296269|Arginine Vasopressin|arginine vasopressin|mesh-list
110849551|NCT01296269|Oxytocin|oxytocin|mesh-list
110849552|NCT01296269|Oxytocics|oxytocics|mesh-ancestor
110849553|NCT01296269|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110849554|NCT01296269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110849555|NCT01296269|Hemostatics|hemostatics|mesh-ancestor
110849556|NCT01296269|Coagulants|coagulants|mesh-ancestor
110849557|NCT01296269|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110849558|NCT01296269|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
110849559|NCT01296269|Natriuretic Agents|natriuretic agents|mesh-ancestor
110849560|NCT05595772|Mitogens|mitogens|mesh-list
110849561|NCT05595772|Mitosis Modulators|mitosis modulators|mesh-ancestor
110849562|NCT05595772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110849563|NCT03844451|Epinephrine|epinephrine|mesh-list
110849564|NCT03844451|Bupivacaine|bupivacaine|mesh-list
110849565|NCT03844451|Anesthetics, Local|anesthetics, local|mesh-ancestor
110849566|NCT03844451|Anesthetics|anesthetics|mesh-ancestor
110849567|NCT03844451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110849568|NCT03844451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110849569|NCT03844451|Sensory System Agents|sensory system agents|mesh-ancestor
110849570|NCT03844451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110849571|NCT03844451|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110849572|NCT03844451|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110849573|NCT03844451|Adrenergic Agents|adrenergic agents|mesh-ancestor
110849574|NCT03844451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110849575|NCT03844451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110849576|NCT03844451|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110849577|NCT03844451|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110849578|NCT03844451|Autonomic Agents|autonomic agents|mesh-ancestor
110638937|NCT00618956|Analgesics|analgesics|mesh-ancestor
110849579|NCT03844451|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110849580|NCT03844451|Respiratory System Agents|respiratory system agents|mesh-ancestor
110849581|NCT03844451|Mydriatics|mydriatics|mesh-ancestor
110849582|NCT03844451|Sympathomimetics|sympathomimetics|mesh-ancestor
110849583|NCT03844451|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110849584|NCT03346096|Thiotepa|thiotepa|mesh-list
110849585|NCT03346096|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110849586|NCT03346096|Alkylating Agents|alkylating agents|mesh-ancestor
110849587|NCT03346096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110849589|NCT03346096|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110849590|NCT03346096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110849591|NCT03346096|Immunologic Factors|immunologic factors|mesh-ancestor
110849592|NCT03346096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110849593|NCT01198457|Clodronic Acid|clodronic acid|mesh-list
110849594|NCT01198457|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110639138|NCT00620282|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110849595|NCT01198457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110849596|NCT03386214|Pevonedistat|pevonedistat|mesh-list
110849597|NCT03386214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110849598|NCT03386214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110849599|NCT01198535|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110849600|NCT01198535|Cetuximab|cetuximab|mesh-list
110849601|NCT01198535|Antibodies|antibodies|mesh-list
110849602|NCT01198535|Immunoglobulins|immunoglobulins|mesh-list
110849603|NCT01198535|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110849604|NCT01198535|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
110849605|NCT01198535|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-list
110849606|NCT01198535|Immunologic Factors|immunologic factors|mesh-ancestor
110849607|NCT01198535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110849608|NCT01198535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110849609|NCT01198535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110849610|NCT01198535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110849611|NCT05081219|Insulin|insulin|mesh-list
110849612|NCT05081219|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110849613|NCT05081219|Empagliflozin|empagliflozin|mesh-list
110849614|NCT05081219|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110849615|NCT05081219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110849616|NCT05081219|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110849617|NCT05081219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110849618|NCT03844763|Cyclophosphamide|cyclophosphamide|mesh-list
110849619|NCT03844763|Avelumab|avelumab|mesh-list
110849620|NCT03844763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110849621|NCT03844763|Immunologic Factors|immunologic factors|mesh-ancestor
110849622|NCT03844763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110849623|NCT03844763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110849624|NCT03844763|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110849625|NCT03844763|Alkylating Agents|alkylating agents|mesh-ancestor
110639479|NCT00502996|Immunologic Factors|immunologic factors|mesh-ancestor
110849626|NCT03844763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110849628|NCT03844763|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110849629|NCT03844763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110849630|NCT01198925|Piperacillin|piperacillin|mesh-list
110849631|NCT01198925|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110849632|NCT01198925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110849633|NCT03844139|Glycerol|glycerol|mesh-list
110849634|NCT03844139|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
110849635|NCT03844139|Protective Agents|protective agents|mesh-ancestor
110639572|NCT00864812|Hormones|hormones|mesh-ancestor
110849636|NCT03844139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110849638|NCT04500496|Dinoprostone|dinoprostone|mesh-list
110849639|NCT04500496|Oxytocics|oxytocics|mesh-ancestor
110849640|NCT04500496|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110849641|NCT04500496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110849643|NCT04500496|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110849644|NCT04500496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110870389|NCT02693002|Hormones|hormones|mesh-ancestor
110849645|NCT04500496|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
110849646|NCT04500496|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110849648|NCT04500496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110849649|NCT04500496|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110849650|NCT01199081|Dronedarone|dronedarone|mesh-list
110849651|NCT01199081|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110849652|NCT04989335|Fludarabine|fludarabine|mesh-list
110849653|NCT04989335|Clofarabine|clofarabine|mesh-list
110849654|NCT04989335|Bisantrene|bisantrene|mesh-list
110849655|NCT04989335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110849656|NCT04989335|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110849657|NCT04989335|Antimetabolites|antimetabolites|mesh-ancestor
110849658|NCT04989335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110567246|NCT05647551|Lidocaine|lidocaine|mesh-list
110849659|NCT04989335|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110849660|NCT03345940|Dimethyl Fumarate|dimethyl fumarate|mesh-list
110849661|NCT03345940|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
110849662|NCT03345940|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
110849663|NCT03345940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110849664|NCT03345940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110849665|NCT03345940|Immunologic Factors|immunologic factors|mesh-ancestor
110849666|NCT03345940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110849667|NCT03345940|Dermatologic Agents|dermatologic agents|mesh-ancestor
110849668|NCT05670353|Contraceptive Agents|contraceptive agents|mesh-list
110849669|NCT05670353|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-list
110849670|NCT05670353|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110639822|NCT00871364|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110849671|NCT05670353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110849673|NCT01199159|Pyridoxal|pyridoxal|mesh-list
110849674|NCT01199159|Pyridoxine|pyridoxine|mesh-list
110849675|NCT01199159|Misoprostol|misoprostol|mesh-list
110849676|NCT01199159|Vitamins|vitamins|mesh-ancestor
110849677|NCT01199159|Micronutrients|micronutrients|mesh-ancestor
110849678|NCT01199159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110849679|NCT01199159|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110849680|NCT01199159|Abortifacient Agents|abortifacient agents|mesh-ancestor
110849681|NCT01199159|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110849682|NCT01199159|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110849683|NCT01199159|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110849684|NCT01199159|Oxytocics|oxytocics|mesh-ancestor
110849685|NCT01199159|Vitamin B Complex|vitamin b complex|mesh-ancestor
110849686|NCT05669963|Lactoferrin|lactoferrin|mesh-list
110849687|NCT05669963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110849689|NCT02507440|Propofol|propofol|mesh-list
110849690|NCT02507440|Anesthetics, Local|anesthetics, local|mesh-ancestor
110849691|NCT02507440|Anesthetics|anesthetics|mesh-ancestor
110849692|NCT02507440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110849693|NCT02507440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110849694|NCT02507440|Sensory System Agents|sensory system agents|mesh-ancestor
110849695|NCT02507440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110849696|NCT02507440|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110849697|NCT02507440|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110849698|NCT02507440|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110849699|NCT02507440|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110849700|NCT02507440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110849701|NCT02507440|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110849702|NCT02507440|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110849703|NCT02507440|Anesthetics, General|anesthetics, general|mesh-ancestor
110849704|NCT02507362|Riboflavin|riboflavin|mesh-list
110849705|NCT02507362|Dextrans|dextrans|mesh-list
110849706|NCT02507362|Vitamin B Complex|vitamin b complex|mesh-ancestor
110849707|NCT02507362|Vitamins|vitamins|mesh-ancestor
110849708|NCT02507362|Micronutrients|micronutrients|mesh-ancestor
110849709|NCT02507362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110849710|NCT02507362|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110849711|NCT02507362|Dermatologic Agents|dermatologic agents|mesh-ancestor
110849712|NCT02507362|Anticoagulants|anticoagulants|mesh-ancestor
110849713|NCT02507362|Plasma Substitutes|plasma substitutes|mesh-ancestor
110849714|NCT02507362|Blood Substitutes|blood substitutes|mesh-ancestor
110849715|NCT05640830|Paclitaxel|paclitaxel|mesh-list
110849716|NCT05640830|Bevacizumab|bevacizumab|mesh-list
110849717|NCT05640830|Trastuzumab|trastuzumab|mesh-list
110849718|NCT05640830|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110849719|NCT05640830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110082762|NCT01651520|Flumazenil|flumazenil|mesh-list
110849720|NCT05640830|Tubulin Modulators|tubulin modulators|mesh-ancestor
110849721|NCT05640830|Antimitotic Agents|antimitotic agents|mesh-ancestor
110849722|NCT05640830|Mitosis Modulators|mitosis modulators|mesh-ancestor
110849723|NCT05640830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110849724|NCT05640830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110849725|NCT05640830|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110849726|NCT05640830|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110849727|NCT05640830|Growth Substances|growth substances|mesh-ancestor
110849728|NCT05640830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110849729|NCT05640830|Growth Inhibitors|growth inhibitors|mesh-ancestor
110849731|NCT03730961|Diuretics|diuretics|mesh-ancestor
110849732|NCT03730961|Natriuretic Agents|natriuretic agents|mesh-ancestor
110849733|NCT03730961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110849734|NCT03730961|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110849735|NCT03730961|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110849736|NCT03730961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110849738|NCT01078454|Bortezomib|bortezomib|mesh-list
110849739|NCT01078454|Melphalan|melphalan|mesh-list
110849740|NCT01078454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110849741|NCT01078454|Antiemetics|antiemetics|mesh-ancestor
110849742|NCT01078454|Autonomic Agents|autonomic agents|mesh-ancestor
110849743|NCT01078454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110849744|NCT01078454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110849745|NCT01078454|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110849746|NCT01078454|Glucocorticoids|glucocorticoids|mesh-ancestor
110849747|NCT01078454|Hormones|hormones|mesh-ancestor
110849748|NCT01078454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110849749|NCT01078454|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110849750|NCT01078454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110849751|NCT01078454|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110849752|NCT01078454|Alkylating Agents|alkylating agents|mesh-ancestor
110849753|NCT01078454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110849754|NCT01078454|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110849755|NCT01078454|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110849756|NCT01078454|Immunologic Factors|immunologic factors|mesh-ancestor
110849757|NCT02968602|Minocycline|minocycline|mesh-list
110849758|NCT02968602|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110849759|NCT02968602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110849760|NCT03345004|Vitamin D|vitamin d|mesh-list
110849761|NCT03345004|Ergocalciferols|ergocalciferols|mesh-list
110849762|NCT03345004|Cholecalciferol|cholecalciferol|mesh-list
110849763|NCT03345004|Vitamins|vitamins|mesh-list
110849765|NCT03345004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110849766|NCT03345004|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110849767|NCT03345004|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110849768|NCT03034356|Levetiracetam|levetiracetam|mesh-list
110849769|NCT03034356|Anticonvulsants|anticonvulsants|mesh-ancestor
110849770|NCT03034356|Nootropic Agents|nootropic agents|mesh-ancestor
110849771|NCT03003468|Pembrolizumab|pembrolizumab|mesh-list
110849772|NCT03003468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110849773|NCT03003468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110849774|NCT03003468|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110849775|NCT03003468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110849776|NCT03345628|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
110849777|NCT03345628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110849778|NCT03345628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110849779|NCT03552523|Pancrelipase|pancrelipase|mesh-list
110849780|NCT03552523|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110849781|NCT03728101|Dabigatran|dabigatran|mesh-list
110849782|NCT03728101|Simvastatin|simvastatin|mesh-list
110849783|NCT03728101|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110849784|NCT03728101|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110849785|NCT03728101|Antimetabolites|antimetabolites|mesh-ancestor
110849786|NCT03728101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110849787|NCT03728101|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110849788|NCT03728101|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110849790|NCT03728101|Antithrombins|antithrombins|mesh-ancestor
110849791|NCT03728101|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110849792|NCT03728101|Protease Inhibitors|protease inhibitors|mesh-ancestor
110849793|NCT03728101|Anticoagulants|anticoagulants|mesh-ancestor
110849794|NCT03844217|Tryptophan|tryptophan|mesh-list
110849795|NCT03844217|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110849796|NCT03844217|Antidepressive Agents|antidepressive agents|mesh-ancestor
110849797|NCT03844217|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110849798|NCT04170972|Insulin|insulin|mesh-list
110849799|NCT04170972|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110849800|NCT04170972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110849801|NCT02515864|Moxifloxacin|moxifloxacin|mesh-list
110849802|NCT02515864|Dotinurad|dotinurad|mesh-list
110849803|NCT02515864|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
110849804|NCT02515864|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110849805|NCT02515864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110849806|NCT02515864|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110849807|NCT02515864|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110849808|NCT02515864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110849809|NCT02515864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110640223|NCT02588417|Glucocorticoids|glucocorticoids|mesh-ancestor
110849810|NCT02515864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110849811|NCT02515864|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110849813|NCT02515864|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110849814|NCT02515864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110849815|NCT02515864|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110849816|NCT02515864|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110849817|NCT02515864|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110849818|NCT02515864|Uricosuric Agents|uricosuric agents|mesh-ancestor
110849819|NCT02515864|Gout Suppressants|gout suppressants|mesh-ancestor
110849820|NCT02515864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110849821|NCT02507206|Dihydrexidine|dihydrexidine|mesh-list
110849822|NCT02507206|Dopamine Agonists|dopamine agonists|mesh-ancestor
110849823|NCT02507206|Dopamine Agents|dopamine agents|mesh-ancestor
110849824|NCT02507206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110849825|NCT02507206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110849826|NCT02507206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110849827|NCT02892409|Amoxicillin|amoxicillin|mesh-list
110849828|NCT02892409|Clarithromycin|clarithromycin|mesh-list
110849829|NCT02892409|Lansoprazole|lansoprazole|mesh-list
110849830|NCT02892409|Dexlansoprazole|dexlansoprazole|mesh-list
110849831|NCT02892409|Bismuth|bismuth|mesh-list
110849832|NCT02892409|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110849833|NCT02892409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110849834|NCT02892409|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110849835|NCT02892409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110849836|NCT02892409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110849837|NCT02892409|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110640283|NCT00994617|Diuretics|diuretics|mesh-ancestor
110849838|NCT02892409|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110849839|NCT02892409|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110849840|NCT02892409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110849841|NCT02892409|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110849843|NCT02507128|Liraglutide|liraglutide|mesh-list
110849844|NCT02507128|Glucagon|glucagon|mesh-list
110849845|NCT02507128|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
110849846|NCT02507128|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110849847|NCT02507128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110849848|NCT02507128|Incretins|incretins|mesh-ancestor
110849849|NCT02507128|Hormones|hormones|mesh-ancestor
110849850|NCT02507128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110849851|NCT02507128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110849852|NCT03844529|Lidocaine|lidocaine|mesh-list
110849853|NCT03844529|Anesthetics, Local|anesthetics, local|mesh-ancestor
110849854|NCT03844529|Anesthetics|anesthetics|mesh-ancestor
110849855|NCT03844529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110849856|NCT03844529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110849857|NCT03844529|Sensory System Agents|sensory system agents|mesh-ancestor
110849858|NCT03844529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110849859|NCT03844529|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110849860|NCT03844529|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110849861|NCT03844529|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110849862|NCT03844529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110849863|NCT03844529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110849864|NCT02292758|Bevacizumab|bevacizumab|mesh-list
110849865|NCT02292758|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110849866|NCT02292758|Cetuximab|cetuximab|mesh-list
110849867|NCT02292758|Irinotecan|irinotecan|mesh-list
110849868|NCT02292758|Endothelial Growth Factors|endothelial growth factors|mesh-list
110849869|NCT02292758|Antibodies|antibodies|mesh-list
110849870|NCT02292758|Immunoglobulins|immunoglobulins|mesh-list
110849871|NCT02292758|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110849872|NCT02292758|Immunoglobulin G|immunoglobulin g|mesh-list
110849873|NCT02292758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110849874|NCT02292758|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110849875|NCT02292758|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110849876|NCT02292758|Growth Substances|growth substances|mesh-ancestor
110849877|NCT02292758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110849878|NCT02292758|Growth Inhibitors|growth inhibitors|mesh-ancestor
110849879|NCT02292758|Immunologic Factors|immunologic factors|mesh-ancestor
110849880|NCT02292758|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110849881|NCT02292758|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110849882|NCT02292758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110849883|NCT02292758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110849884|NCT03727867|Mitogens|mitogens|mesh-list
110849885|NCT03727867|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
110849886|NCT03727867|Mitosis Modulators|mitosis modulators|mesh-ancestor
110849887|NCT03727867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110849888|NCT03727867|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110849889|NCT03727867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110849890|NCT02832648|Selenium|selenium|mesh-list
110849891|NCT02832648|Antioxidants|antioxidants|mesh-ancestor
110849892|NCT02832648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110849893|NCT02832648|Protective Agents|protective agents|mesh-ancestor
110849894|NCT02832648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110849895|NCT02832648|Trace Elements|trace elements|mesh-ancestor
110849896|NCT02832648|Micronutrients|micronutrients|mesh-ancestor
110849897|NCT04497766|Magnesium Sulfate|magnesium sulfate|mesh-list
110849898|NCT04497766|Analgesics|analgesics|mesh-ancestor
110849899|NCT04497766|Sensory System Agents|sensory system agents|mesh-ancestor
110849900|NCT04497766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110849901|NCT04497766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110849902|NCT04497766|Anesthetics|anesthetics|mesh-ancestor
110849903|NCT04497766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110849904|NCT04497766|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110849905|NCT04497766|Anticonvulsants|anticonvulsants|mesh-ancestor
110849906|NCT04497766|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110849907|NCT04497766|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110849908|NCT04497766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110849909|NCT04497766|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110336847|NCT00513552|Rifabutin|rifabutin|mesh-list
110849910|NCT04497766|Tocolytic Agents|tocolytic agents|mesh-ancestor
110849911|NCT04497766|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110849912|NCT03841721|Linezolid|linezolid|mesh-list
110849913|NCT03841721|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110849914|NCT03841721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110849915|NCT03841721|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110849916|NCT03841721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110849917|NCT03841721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110849918|NCT03620526|Iloprost|iloprost|mesh-list
110849919|NCT03620526|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110849920|NCT03620526|Vasodilator Agents|vasodilator agents|mesh-ancestor
110849921|NCT03843749|Trastuzumab|trastuzumab|mesh-list
110849922|NCT03843749|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110849923|NCT03843749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110849925|NCT01199783|Daptomycin|daptomycin|mesh-list
110849926|NCT01199783|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110849927|NCT01199783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110849928|NCT03192306|Ethanol|ethanol|mesh-list
110849929|NCT03192306|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110849930|NCT03192306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110849931|NCT03192306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110849932|NCT03192306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110640545|NCT00868010|Donepezil|donepezil|mesh-list
110849934|NCT03216954|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110849935|NCT03216954|Antiviral Agents|antiviral agents|mesh-ancestor
110849936|NCT03216954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110849937|NCT03216954|Expectorants|expectorants|mesh-ancestor
110849938|NCT03216954|Respiratory System Agents|respiratory system agents|mesh-ancestor
110849939|NCT03216954|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110849940|NCT03216954|Antioxidants|antioxidants|mesh-ancestor
110849941|NCT03216954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110849942|NCT03216954|Protective Agents|protective agents|mesh-ancestor
110849943|NCT03216954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110849944|NCT03216954|Antidotes|antidotes|mesh-ancestor
110849945|NCT05669807|Paclitaxel|paclitaxel|mesh-list
110849946|NCT05669807|Irinotecan|irinotecan|mesh-list
110849947|NCT05669807|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110849948|NCT05669807|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110849949|NCT05669807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110849950|NCT05669807|Tubulin Modulators|tubulin modulators|mesh-ancestor
110849951|NCT05669807|Antimitotic Agents|antimitotic agents|mesh-ancestor
110849952|NCT05669807|Mitosis Modulators|mitosis modulators|mesh-ancestor
110849953|NCT05669807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110849954|NCT05669807|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110849955|NCT05669807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110640670|NCT02585531|Hormones|hormones|mesh-ancestor
110849956|NCT05669807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110849957|NCT03599089|Acetaminophen|acetaminophen|mesh-list
110849958|NCT03599089|Ketorolac|ketorolac|mesh-list
110849959|NCT03599089|Oxycodone|oxycodone|mesh-list
110849960|NCT03599089|Bupivacaine|bupivacaine|mesh-list
110849961|NCT03599089|Anesthetics, Local|anesthetics, local|mesh-ancestor
110849962|NCT03599089|Anesthetics|anesthetics|mesh-ancestor
110849963|NCT03599089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110849964|NCT03599089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110849965|NCT03599089|Sensory System Agents|sensory system agents|mesh-ancestor
110849966|NCT03599089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110849967|NCT03599089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110849969|NCT03599089|Antipyretics|antipyretics|mesh-ancestor
110849970|NCT03599089|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110849971|NCT03599089|Narcotics|narcotics|mesh-ancestor
110849972|NCT03599089|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110849973|NCT03599089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110849974|NCT03599089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110849975|NCT03599089|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110640733|NCT04080713|Budesonide|budesonide|mesh-list
110849977|NCT03599089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110849978|NCT03597529|Melatonin|melatonin|mesh-list
110849979|NCT03597529|Antioxidants|antioxidants|mesh-ancestor
110849980|NCT03597529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110849981|NCT03597529|Protective Agents|protective agents|mesh-ancestor
110849982|NCT03597529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110849983|NCT03597529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110849984|NCT05420454|Paclitaxel|paclitaxel|mesh-list
110849985|NCT05420454|Docetaxel|docetaxel|mesh-list
110849986|NCT05420454|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110849987|NCT05420454|Cyclophosphamide|cyclophosphamide|mesh-list
110849988|NCT05420454|Carboplatin|carboplatin|mesh-list
110849989|NCT05420454|Trastuzumab|trastuzumab|mesh-list
110849990|NCT05420454|Epirubicin|epirubicin|mesh-list
110849991|NCT05420454|Pertuzumab|pertuzumab|mesh-list
110849992|NCT05420454|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110849993|NCT05420454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110849994|NCT05420454|Tubulin Modulators|tubulin modulators|mesh-ancestor
110849995|NCT05420454|Antimitotic Agents|antimitotic agents|mesh-ancestor
110849996|NCT05420454|Mitosis Modulators|mitosis modulators|mesh-ancestor
110849997|NCT05420454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110849998|NCT05420454|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110849999|NCT05420454|Immunologic Factors|immunologic factors|mesh-ancestor
110850000|NCT05420454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110850001|NCT05420454|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110850002|NCT05420454|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110850003|NCT05420454|Alkylating Agents|alkylating agents|mesh-ancestor
110850004|NCT05420454|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110850005|NCT05420454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110850006|NCT05420454|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110850007|NCT05420454|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110850008|NCT05420454|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110850009|NCT05420454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110850010|NCT03180528|Benzoic Acid|benzoic acid|mesh-list
110850011|NCT03180528|Antifungal Agents|antifungal agents|mesh-ancestor
110850012|NCT03180528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110850013|NCT04667507|Dexamethasone|dexamethasone|mesh-list
110850014|NCT04667507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110850015|NCT04667507|Antiemetics|antiemetics|mesh-ancestor
110850016|NCT04667507|Autonomic Agents|autonomic agents|mesh-ancestor
110850017|NCT04667507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110850018|NCT04667507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110850019|NCT04667507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110850020|NCT04667507|Glucocorticoids|glucocorticoids|mesh-ancestor
110850021|NCT04667507|Hormones|hormones|mesh-ancestor
110850022|NCT04667507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110850023|NCT04667507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110850024|NCT04667507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110850025|NCT01200251|Bimatoprost|bimatoprost|mesh-list
110850026|NCT01200251|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110850027|NCT03597139|Cyclosporine|cyclosporine|mesh-list
110850028|NCT03597139|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110850029|NCT03597139|Cyclosporins|cyclosporins|mesh-list
110850030|NCT03597139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110850031|NCT03597139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110850032|NCT03597139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110850033|NCT03597139|Immunologic Factors|immunologic factors|mesh-ancestor
110850034|NCT03597139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110850035|NCT03597139|Antifungal Agents|antifungal agents|mesh-ancestor
110850036|NCT03597139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110641043|NCT00534495|Rilonacept|rilonacept|mesh-list
110850038|NCT03597139|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110850039|NCT03597139|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110850040|NCT03597139|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110850042|NCT01202435|Analgesics|analgesics|mesh-ancestor
110850043|NCT01202435|Sensory System Agents|sensory system agents|mesh-ancestor
110850044|NCT01202435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110850045|NCT01202435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110850046|NCT01202435|Anticonvulsants|anticonvulsants|mesh-ancestor
110850047|NCT01202435|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110850048|NCT01202435|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110850049|NCT01202435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110850050|NCT01202435|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110850051|NCT01202435|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110850052|NCT01202435|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110850053|NCT01202435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110850054|NCT01202435|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110850055|NCT05406102|Propofol|propofol|mesh-list
110850056|NCT05406102|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110832277|NCT01125449|Protective Agents|protective agents|mesh-ancestor
110850057|NCT05406102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110850058|NCT05406102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110850059|NCT05406102|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110850060|NCT05406102|Anesthetics, General|anesthetics, general|mesh-ancestor
110850061|NCT05406102|Anesthetics|anesthetics|mesh-ancestor
110850062|NCT01204307|Cisplatin|cisplatin|mesh-list
110850063|NCT01204307|Docetaxel|docetaxel|mesh-list
110850064|NCT01204307|Pemetrexed|pemetrexed|mesh-list
110850065|NCT01204307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110850066|NCT01204307|Tubulin Modulators|tubulin modulators|mesh-ancestor
110850067|NCT01204307|Antimitotic Agents|antimitotic agents|mesh-ancestor
110850068|NCT01204307|Mitosis Modulators|mitosis modulators|mesh-ancestor
110850069|NCT01204307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110850070|NCT01204307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110850071|NCT01204307|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110850072|NCT01204307|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110850073|NCT00708214|Letrozole|letrozole|mesh-list
110850074|NCT00708214|Afatinib|afatinib|mesh-list
110850075|NCT00708214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110850076|NCT00708214|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110641153|NCT04099667|Cholinergic Agents|cholinergic agents|mesh-ancestor
110850077|NCT00708214|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110850078|NCT00708214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110850079|NCT00708214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110850080|NCT00708214|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110850081|NCT00708214|Hormone Antagonists|hormone antagonists|mesh-ancestor
110850082|NCT00708214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110850083|NCT00708214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110850084|NCT00708214|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110850085|NCT02506894|Magnesium Sulfate|magnesium sulfate|mesh-list
110850086|NCT02506894|Analgesics|analgesics|mesh-ancestor
110850087|NCT02506894|Sensory System Agents|sensory system agents|mesh-ancestor
110850088|NCT02506894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110850089|NCT02506894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110850090|NCT02506894|Anesthetics|anesthetics|mesh-ancestor
110850091|NCT02506894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110641213|NCT00997581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110850092|NCT02506894|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110850093|NCT02506894|Anticonvulsants|anticonvulsants|mesh-ancestor
110850094|NCT02506894|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110850095|NCT02506894|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110336887|NCT00513786|Growth Substances|growth substances|mesh-ancestor
110850096|NCT02506894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110850097|NCT02506894|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110850098|NCT02506894|Tocolytic Agents|tocolytic agents|mesh-ancestor
110850099|NCT02506894|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110850100|NCT03909737|Azithromycin|azithromycin|mesh-list
110850101|NCT03909737|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110850102|NCT03909737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110850103|NCT04891250|Ivermectin|ivermectin|mesh-list
110850104|NCT04891250|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110850105|NCT04891250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110850106|NCT03570697|Evolocumab|evolocumab|mesh-list
110850107|NCT03570697|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
110850108|NCT03570697|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110850109|NCT03570697|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110850110|NCT03570697|Antimetabolites|antimetabolites|mesh-ancestor
110850111|NCT03570697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110850112|NCT03570697|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110850113|NCT03570697|Protease Inhibitors|protease inhibitors|mesh-ancestor
110850114|NCT03570697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110850115|NCT03570697|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110850116|NCT02511574|Progesterone|progesterone|mesh-list
110850117|NCT02511574|Progestins|progestins|mesh-ancestor
110850118|NCT02511574|Hormones|hormones|mesh-ancestor
110850119|NCT02511574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110850120|NCT02511574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110850121|NCT01200641|Gabapentin|gabapentin|mesh-list
110850122|NCT01200641|Melatonin|melatonin|mesh-list
110850124|NCT01200641|Sensory System Agents|sensory system agents|mesh-ancestor
110850125|NCT01200641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110850126|NCT01200641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110850128|NCT01200641|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110850129|NCT01200641|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110850130|NCT01200641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110850131|NCT01200641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110850132|NCT01200641|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110850133|NCT01200641|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110850134|NCT01200641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110850135|NCT01200641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110850136|NCT01200641|Antimanic Agents|antimanic agents|mesh-ancestor
110850137|NCT01200641|Antioxidants|antioxidants|mesh-ancestor
110850138|NCT01200641|Protective Agents|protective agents|mesh-ancestor
110850139|NCT01856270|Amitriptyline|amitriptyline|mesh-list
110850140|NCT01856270|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110850141|NCT01856270|Antidepressive Agents|antidepressive agents|mesh-ancestor
110850142|NCT01856270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110850143|NCT01856270|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110850144|NCT01856270|Analgesics|analgesics|mesh-ancestor
110850145|NCT01856270|Sensory System Agents|sensory system agents|mesh-ancestor
110850146|NCT01856270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110850147|NCT01856270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110850148|NCT01856270|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110850149|NCT01856270|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110850150|NCT01856270|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110641767|NCT01002729|Oseltamivir|oseltamivir|mesh-list
110850151|NCT01856270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110850152|NCT01856270|Adrenergic Agents|adrenergic agents|mesh-ancestor
110850153|NCT01856270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110850154|NCT02511340|Flumatinib|flumatinib|mesh-list
110850155|NCT02511340|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110850156|NCT02511340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110850157|NCT02511340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110850158|NCT02506348|Diclofenac|diclofenac|mesh-list
110850159|NCT02506348|Nepafenac|nepafenac|mesh-list
110850160|NCT02506348|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110850161|NCT02506348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110850162|NCT02506348|Analgesics|analgesics|mesh-ancestor
110850163|NCT02506348|Sensory System Agents|sensory system agents|mesh-ancestor
110850164|NCT02506348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110850165|NCT02506348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110850166|NCT02506348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110850167|NCT02506348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110850168|NCT02506348|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110850169|NCT02506348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110641960|NCT00874328|Irinotecan|irinotecan|mesh-list
110850170|NCT02506348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110850172|NCT01318070|Alogliptin|alogliptin|mesh-list
110850173|NCT01318070|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110850174|NCT01318070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110850175|NCT01318070|Incretins|incretins|mesh-ancestor
110850176|NCT01318070|Hormones|hormones|mesh-ancestor
110850177|NCT01318070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110832293|NCT03931889|Vitamin D|vitamin d|mesh-list
110850178|NCT01318070|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110850179|NCT01318070|Protease Inhibitors|protease inhibitors|mesh-ancestor
110850180|NCT01318070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110850181|NCT01318070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110850182|NCT01202513|Bimatoprost|bimatoprost|mesh-list
110850183|NCT01202513|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110850184|NCT01202513|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110850185|NCT01202513|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110850186|NCT03835715|Vortioxetine|vortioxetine|mesh-list
110850187|NCT03835715|Antidepressive Agents|antidepressive agents|mesh-ancestor
110850188|NCT03835715|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110567770|NCT04201197|Analgesics|analgesics|mesh-ancestor
110850189|NCT03835715|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110850190|NCT03835715|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110850191|NCT03835715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110850192|NCT03835715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110850193|NCT03835715|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110850194|NCT03835715|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110850195|NCT03835715|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110850196|NCT03835715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110850197|NCT03835715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110850199|NCT03835715|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110850200|NCT03835715|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110850201|NCT03835715|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110850202|NCT03835715|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110850203|NCT02505802|Botulinum Toxins|botulinum toxins|mesh-list
110850204|NCT02505802|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110850205|NCT02505802|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110850206|NCT02505802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110850207|NCT02505802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110850208|NCT02505802|Cholinergic Agents|cholinergic agents|mesh-ancestor
110850209|NCT02505802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110850210|NCT02505802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110850211|NCT02505802|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110850212|NCT02505802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110850213|NCT03627884|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110850215|NCT03843281|Morphine|morphine|mesh-list
110850216|NCT03843281|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110850217|NCT03843281|Narcotics|narcotics|mesh-ancestor
110850218|NCT03843281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110850220|NCT03843281|Analgesics|analgesics|mesh-ancestor
110850221|NCT03843281|Sensory System Agents|sensory system agents|mesh-ancestor
110850222|NCT03843281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110850223|NCT03843281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110850224|NCT03843281|Antipyretics|antipyretics|mesh-ancestor
110850225|NCT02515240|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110850226|NCT02515240|Immunologic Factors|immunologic factors|mesh-ancestor
110850227|NCT02515240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110850228|NCT03843515|Nivolumab|nivolumab|mesh-list
110850229|NCT03843515|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110850230|NCT03843515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110850231|NCT03843515|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110850232|NCT03843515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110850233|NCT00245960|Etanercept|etanercept|mesh-list
110850234|NCT00245960|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110850235|NCT00245960|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110850236|NCT00245960|Analgesics|analgesics|mesh-ancestor
110850237|NCT00245960|Sensory System Agents|sensory system agents|mesh-ancestor
110850238|NCT00245960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110850239|NCT00245960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110850240|NCT00245960|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110850241|NCT00245960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110850242|NCT00245960|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110850243|NCT00245960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110850244|NCT00245960|Immunologic Factors|immunologic factors|mesh-ancestor
110850246|NCT04443322|Lenvatinib|lenvatinib|mesh-list
110850247|NCT04443322|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110850248|NCT04443322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110850249|NCT04443322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110850250|NCT04443322|Immunologic Factors|immunologic factors|mesh-ancestor
110850251|NCT04443322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110850252|NCT04443322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110850253|NCT04443322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110850254|NCT04443322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110850255|NCT01202825|Simeprevir|simeprevir|mesh-list
110850256|NCT01202825|Antiviral Agents|antiviral agents|mesh-ancestor
110850257|NCT01202825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110850258|NCT01202825|Protease Inhibitors|protease inhibitors|mesh-ancestor
110850259|NCT01202825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110850260|NCT01202825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110567845|NCT03941730|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110850261|NCT02510872|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110850262|NCT02510872|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110850263|NCT02510872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110850264|NCT05222204|Paclitaxel|paclitaxel|mesh-list
110850265|NCT05222204|Gemcitabine|gemcitabine|mesh-list
110850266|NCT05222204|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110850267|NCT05222204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110850268|NCT05222204|Tubulin Modulators|tubulin modulators|mesh-ancestor
110850269|NCT05222204|Antimitotic Agents|antimitotic agents|mesh-ancestor
110850270|NCT05222204|Mitosis Modulators|mitosis modulators|mesh-ancestor
110850271|NCT05222204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110850272|NCT05222204|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110850273|NCT05222204|Antimetabolites|antimetabolites|mesh-ancestor
110850274|NCT02558465|Rivaroxaban|rivaroxaban|mesh-list
110850275|NCT02558465|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110850276|NCT02558465|Antithrombins|antithrombins|mesh-ancestor
110850277|NCT02558465|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110850278|NCT02558465|Protease Inhibitors|protease inhibitors|mesh-ancestor
110850279|NCT02558465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110850280|NCT02558465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110850281|NCT02558465|Anticoagulants|anticoagulants|mesh-ancestor
110850283|NCT05218616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110850284|NCT05218616|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110850285|NCT05218616|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110850286|NCT05218616|Growth Substances|growth substances|mesh-ancestor
110850287|NCT05218616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110850289|NCT05218616|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110850290|NCT05218616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110850291|NCT05218616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110850292|NCT02505880|Anesthetics|anesthetics|mesh-list
110642813|NCT04387240|Artesunate|artesunate|mesh-list
110850294|NCT02505880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110850295|NCT02505880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110850296|NCT02505880|Sensory System Agents|sensory system agents|mesh-ancestor
110850297|NCT02505880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110850298|NCT02510950|Temozolomide|temozolomide|mesh-list
110850300|NCT02510950|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110850301|NCT02510950|Alkylating Agents|alkylating agents|mesh-ancestor
110850302|NCT02510950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110850303|NCT02510950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110850304|NCT02510950|Interferon Inducers|interferon inducers|mesh-ancestor
110850305|NCT02510950|Immunologic Factors|immunologic factors|mesh-ancestor
110850306|NCT02510950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110850307|NCT05221736|Ethanol|ethanol|mesh-list
110850308|NCT05221736|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110850309|NCT05221736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110850310|NCT05221736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110850311|NCT05221736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110850312|NCT02514850|Insulin Lispro|insulin lispro|mesh-list
110850313|NCT02514850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110850314|NCT02514850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110850315|NCT04454411|Naltrexone|naltrexone|mesh-list
110850316|NCT04454411|Buprenorphine|buprenorphine|mesh-list
110850317|NCT04454411|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110850318|NCT04454411|Narcotics|narcotics|mesh-ancestor
110850319|NCT04454411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110850320|NCT04454411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110850321|NCT04454411|Analgesics|analgesics|mesh-ancestor
110850322|NCT04454411|Sensory System Agents|sensory system agents|mesh-ancestor
110850323|NCT04454411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110850324|NCT04454411|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110850325|NCT04454411|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110850326|NCT02505568|Infliximab|infliximab|mesh-list
110850327|NCT02505568|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110643084|NCT00129961|Cyclosporine|cyclosporine|mesh-list
110850328|NCT02505568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110850329|NCT02505568|Dermatologic Agents|dermatologic agents|mesh-ancestor
110850330|NCT02505568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110850331|NCT02505568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110850332|NCT05356728|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110850333|NCT05356728|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110850335|NCT05217836|Chrysarobin|chrysarobin|mesh-list
110850336|NCT05217836|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110850337|NCT05217836|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110850338|NCT05217836|Analgesics|analgesics|mesh-ancestor
110850339|NCT05217836|Sensory System Agents|sensory system agents|mesh-ancestor
110850340|NCT05217836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110850341|NCT05217836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110850342|NCT05217836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110850343|NCT05217836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110850344|NCT05217836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110850345|NCT02510248|1-2-isopropoxy-2-oxidodihydro-4H,6H-spiro(furo(3,2-d)(1,3,2)dioxaphosphinine-7,2'-oxetan)-6-yl)pyrimidine-2,4(1H,3H)-dione|1-2-isopropoxy-2-oxidodihydro-4h,6h-spiro(furo(3,2-d)(1,3,2)dioxaphosphinine-7,2'-oxetan)-6-yl)pyrimidine-2,4(1h,3h)-dione|mesh-list
110850346|NCT02510248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110850347|NCT02510248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110850348|NCT02514538|Acetaminophen|acetaminophen|mesh-list
110643260|NCT04074317|Insulin|insulin|mesh-list
110850350|NCT02514538|Analgesics|analgesics|mesh-ancestor
110643279|NCT03263429|Irinotecan|irinotecan|mesh-list
110850351|NCT02514538|Sensory System Agents|sensory system agents|mesh-ancestor
110850352|NCT02514538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110850353|NCT02514538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110850355|NCT05669417|Magnesium Sulfate|magnesium sulfate|mesh-list
110850356|NCT05669417|Analgesics|analgesics|mesh-ancestor
110850357|NCT05669417|Sensory System Agents|sensory system agents|mesh-ancestor
110850358|NCT05669417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110850359|NCT05669417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110850360|NCT05669417|Anesthetics|anesthetics|mesh-ancestor
110850361|NCT05669417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110850362|NCT05669417|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110850363|NCT05669417|Anticonvulsants|anticonvulsants|mesh-ancestor
110850364|NCT05669417|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110850365|NCT05669417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110643425|NCT00890786|Bevacizumab|bevacizumab|mesh-list
110850366|NCT05669417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110850367|NCT05669417|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110850368|NCT05669417|Tocolytic Agents|tocolytic agents|mesh-ancestor
110850369|NCT05669417|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110850370|NCT03832673|Pembrolizumab|pembrolizumab|mesh-list
110850371|NCT03832673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110850372|NCT03832673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110850373|NCT03832673|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110643555|NCT04038008|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110850374|NCT03832673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110850375|NCT02504944|Propranolol|propranolol|mesh-list
110850376|NCT02504944|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110850377|NCT02504944|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110850378|NCT02504944|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110850379|NCT02504944|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110850380|NCT02504944|Adrenergic Agents|adrenergic agents|mesh-ancestor
110850381|NCT02504944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110850382|NCT02504944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110850383|NCT02504944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110850384|NCT02504944|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110643632|NCT00892112|Plasma Substitutes|plasma substitutes|mesh-list
110850385|NCT02504944|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110850386|NCT02504944|Vasodilator Agents|vasodilator agents|mesh-ancestor
110850388|NCT01201499|Remifentanil|remifentanil|mesh-list
110850389|NCT01201499|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110850390|NCT01201499|Narcotics|narcotics|mesh-ancestor
110850391|NCT01201499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110850392|NCT01201499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110850393|NCT01201499|Analgesics|analgesics|mesh-ancestor
110850394|NCT01201499|Sensory System Agents|sensory system agents|mesh-ancestor
110850395|NCT01201499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110643697|NCT00892346|Melphalan|melphalan|mesh-list
110850396|NCT03473639|Capecitabine|capecitabine|mesh-list
110850397|NCT03473639|Entinostat|entinostat|mesh-list
110850398|NCT03473639|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110850399|NCT03473639|Antimetabolites|antimetabolites|mesh-ancestor
110832434|NCT01219907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110850400|NCT03473639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110850401|NCT03473639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110850402|NCT03473639|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110850403|NCT03473639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110850404|NCT03121690|Prednisone|prednisone|mesh-list
110850405|NCT03121690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110850406|NCT03121690|Glucocorticoids|glucocorticoids|mesh-ancestor
110850407|NCT03121690|Hormones|hormones|mesh-ancestor
110643823|NCT00528411|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110850408|NCT03121690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110850409|NCT03121690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110850410|NCT03121690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110850411|NCT03121690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110850412|NCT03831269|Azithromycin|azithromycin|mesh-list
110850413|NCT03831269|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110850414|NCT03831269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110850415|NCT02504476|Midazolam|midazolam|mesh-list
110850416|NCT02504476|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110850417|NCT02504476|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110850418|NCT02504476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110850419|NCT02504476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110850420|NCT02504476|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110850421|NCT02504476|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110850422|NCT02504476|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110850423|NCT02504476|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110850424|NCT02504476|Anesthetics, General|anesthetics, general|mesh-ancestor
110850425|NCT02504476|Anesthetics|anesthetics|mesh-ancestor
110850426|NCT02504476|GABA Modulators|gaba modulators|mesh-ancestor
110850427|NCT02504476|GABA Agents|gaba agents|mesh-ancestor
110850428|NCT02504476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110850429|NCT02504476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110850430|NCT02504398|Methamphetamine|methamphetamine|mesh-list
110644038|NCT00897026|Paclitaxel|paclitaxel|mesh-list
110850431|NCT02504398|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110850432|NCT02504398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110850433|NCT02504398|Sympathomimetics|sympathomimetics|mesh-ancestor
110850434|NCT02504398|Autonomic Agents|autonomic agents|mesh-ancestor
110850435|NCT02504398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110850436|NCT02504398|Dopamine Agents|dopamine agents|mesh-ancestor
110850437|NCT02504398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110850438|NCT02504398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110850439|NCT02504398|Adrenergic Agents|adrenergic agents|mesh-ancestor
110850440|NCT02504398|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110644164|NCT00943566|Anesthetics|anesthetics|mesh-ancestor
110850441|NCT02504398|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110850442|NCT02504398|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110850443|NCT02504398|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110850444|NCT01205009|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
110850445|NCT01205009|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110850446|NCT01205009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110850448|NCT03830489|Antioxidants|antioxidants|mesh-ancestor
110850449|NCT03830489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110850450|NCT03830489|Protective Agents|protective agents|mesh-ancestor
110850451|NCT03830489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110850452|NCT03830489|Vitamins|vitamins|mesh-ancestor
110850453|NCT03830489|Micronutrients|micronutrients|mesh-ancestor
110850454|NCT02509468|Sirolimus|sirolimus|mesh-list
110850455|NCT02509468|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110850456|NCT02509468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110850457|NCT02509468|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110850458|NCT02509468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110850459|NCT02509468|Antifungal Agents|antifungal agents|mesh-ancestor
110850460|NCT02509468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110850461|NCT02509468|Immunologic Factors|immunologic factors|mesh-ancestor
110850462|NCT02509468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110850464|NCT03344614|Raltitrexed|raltitrexed|mesh-list
110850465|NCT03344614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110850466|NCT03344614|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110850467|NCT03344614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110850468|NCT03344614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110850469|NCT03344614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110850470|NCT03344614|Antimetabolites|antimetabolites|mesh-ancestor
110850471|NCT03344614|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110850472|NCT01205087|Omeprazole|omeprazole|mesh-list
110850473|NCT01205087|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110850474|NCT01205087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110850475|NCT01205087|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110850476|NCT01205087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110850477|NCT01205087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110850478|NCT01205243|Abacavir|abacavir|mesh-list
110850479|NCT01205243|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110850480|NCT01205243|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110850481|NCT01205243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110850482|NCT01205243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110850483|NCT01205243|Antiviral Agents|antiviral agents|mesh-ancestor
110850484|NCT01205243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110850485|NCT01205243|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110850486|NCT01205243|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110832491|NCT04249310|Olodaterol|olodaterol|mesh-list
110850488|NCT02504164|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110850489|NCT02504164|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110850490|NCT02504164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110850491|NCT02504164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110850492|NCT02504164|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110850493|NCT02504164|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110850494|NCT02504164|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110850495|NCT02504164|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110850496|NCT02504164|Anesthetics, General|anesthetics, general|mesh-ancestor
110850497|NCT02504164|Anesthetics|anesthetics|mesh-ancestor
110850498|NCT02504164|GABA Modulators|gaba modulators|mesh-ancestor
110850499|NCT02504164|GABA Agents|gaba agents|mesh-ancestor
110850500|NCT02504164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110850501|NCT02504164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110850502|NCT02509234|Irinotecan|irinotecan|mesh-list
110850503|NCT02509234|Trabectedin|trabectedin|mesh-list
110850504|NCT02509234|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110644929|NCT05892744|Antidepressive Agents|antidepressive agents|mesh-ancestor
110850505|NCT02509234|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110850506|NCT02509234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110850507|NCT02509234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110850508|NCT02509234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110850509|NCT02509234|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110850510|NCT02509234|Alkylating Agents|alkylating agents|mesh-ancestor
110850511|NCT01205321|Gastrin-Releasing Peptide|gastrin-releasing peptide|mesh-list
110850513|NCT01205321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110850514|NCT01205321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110850515|NCT01205321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110850516|NCT01205321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110850517|NCT02504008|Zoledronic Acid|zoledronic acid|mesh-list
110850518|NCT02504008|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110850519|NCT02504008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110850520|NCT03566485|Atezolizumab|atezolizumab|mesh-list
110850521|NCT03566485|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110850522|NCT03566485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110850523|NCT03566485|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110645005|NCT05796089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110645032|NCT05777993|Mitapivat|mitapivat|mesh-list
110850524|NCT03566485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110850526|NCT02513290|Antipruritics|antipruritics|mesh-ancestor
110850527|NCT02513290|Dermatologic Agents|dermatologic agents|mesh-ancestor
110850528|NCT02513290|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110850529|NCT02513290|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110850530|NCT02513290|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110850531|NCT02513290|Histamine Antagonists|histamine antagonists|mesh-ancestor
110850532|NCT02513290|Histamine Agents|histamine agents|mesh-ancestor
110850533|NCT02513290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110850534|NCT02513290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110850535|NCT02513290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110850536|NCT02501200|Ezetimibe|ezetimibe|mesh-list
110850537|NCT02501200|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110850538|NCT02501200|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110850539|NCT02501200|Antimetabolites|antimetabolites|mesh-ancestor
110850540|NCT02501200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110645145|NCT05669846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110645146|NCT05669846|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110832520|NCT03714165|alpha-Defensins|alpha-defensins|mesh-list
110645147|NCT05669846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110645148|NCT05650775|Methylphenidate|methylphenidate|mesh-list
110645149|NCT05650775|Adderall|adderall|mesh-list
110645150|NCT05650775|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110645151|NCT05650775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110645152|NCT05650775|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110645153|NCT05650775|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110645154|NCT05650775|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110645155|NCT05650775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110645156|NCT05650775|Dopamine Agents|dopamine agents|mesh-ancestor
110850541|NCT02501200|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110850542|NCT01205477|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110850543|NCT01205477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110850544|NCT02501278|Cisplatin|cisplatin|mesh-list
110850545|NCT02501278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110850546|NCT03176238|Everolimus|everolimus|mesh-list
110850547|NCT03176238|Exemestane|exemestane|mesh-list
110850548|NCT03176238|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110850549|NCT03176238|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110645285|NCT05488405|Mesalamine|mesalamine|mesh-list
110850550|NCT03176238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110850551|NCT03176238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110850552|NCT03176238|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110850553|NCT03176238|Immunologic Factors|immunologic factors|mesh-ancestor
110850554|NCT03176238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110850555|NCT03176238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110850556|NCT03176238|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110850557|NCT03176238|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110850558|NCT03176238|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110850559|NCT03176238|Hormone Antagonists|hormone antagonists|mesh-ancestor
110850560|NCT03176238|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110850562|NCT01957332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110850563|NCT01957332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110850564|NCT01205711|Leucovorin|leucovorin|mesh-list
110850565|NCT01205711|Fluorouracil|fluorouracil|mesh-list
110850566|NCT01205711|Irinotecan|irinotecan|mesh-list
110850567|NCT01205711|Calcium|calcium|mesh-list
110850568|NCT01205711|Levoleucovorin|levoleucovorin|mesh-list
110645492|NCT05123703|Ocrelizumab|ocrelizumab|mesh-list
110850569|NCT01205711|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110850570|NCT01205711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110850571|NCT01205711|Antimetabolites|antimetabolites|mesh-ancestor
110850572|NCT01205711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110850573|NCT01205711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110850574|NCT01205711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110850575|NCT01205711|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110850576|NCT01205711|Immunologic Factors|immunologic factors|mesh-ancestor
110850577|NCT01205711|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110850578|NCT01205711|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110850579|NCT01205711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110850580|NCT01205711|Antidotes|antidotes|mesh-ancestor
110850581|NCT01205711|Protective Agents|protective agents|mesh-ancestor
110850582|NCT01205711|Vitamin B Complex|vitamin b complex|mesh-ancestor
110850583|NCT01205711|Vitamins|vitamins|mesh-ancestor
110850584|NCT01205711|Micronutrients|micronutrients|mesh-ancestor
110850585|NCT02508922|Vitamin D|vitamin d|mesh-list
110850586|NCT02508922|Cholecalciferol|cholecalciferol|mesh-list
110850587|NCT02508922|Vitamins|vitamins|mesh-ancestor
110850588|NCT02508922|Micronutrients|micronutrients|mesh-ancestor
110850589|NCT02508922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110850590|NCT02508922|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110850591|NCT02508922|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110850592|NCT01860456|Imatinib Mesylate|imatinib mesylate|mesh-list
110850593|NCT01860456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110850595|NCT01860456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110645561|NCT05019885|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110850596|NCT01860456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110850597|NCT03730675|Sorafenib|sorafenib|mesh-list
110850598|NCT03730675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110850599|NCT03730675|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110850600|NCT03730675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110850601|NCT03730675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110850602|NCT01765140|Amifampridine|amifampridine|mesh-list
110645634|NCT04965155|Autonomic Agents|autonomic agents|mesh-ancestor
110645635|NCT04965155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110645636|NCT04965155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110645637|NCT04965155|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110645638|NCT04965155|Glucocorticoids|glucocorticoids|mesh-ancestor
110645639|NCT04965155|Hormones|hormones|mesh-ancestor
110645640|NCT04965155|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110645641|NCT04965155|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110850603|NCT01765140|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110850604|NCT01765140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110850605|NCT01765140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110850606|NCT01765140|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
110645705|NCT04899778|Estradiol|estradiol|mesh-list
110850607|NCT01765140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110850608|NCT01765140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110850610|NCT01345682|Afatinib|afatinib|mesh-list
110850611|NCT01345682|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110850612|NCT01345682|Abortifacient Agents|abortifacient agents|mesh-ancestor
110850613|NCT01345682|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110850614|NCT01345682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110850615|NCT01345682|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110850616|NCT01345682|Antimetabolites|antimetabolites|mesh-ancestor
110850617|NCT01345682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110850618|NCT01345682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110850619|NCT01345682|Dermatologic Agents|dermatologic agents|mesh-ancestor
110850620|NCT01345682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110850621|NCT01345682|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110850622|NCT01345682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110850623|NCT01345682|Immunologic Factors|immunologic factors|mesh-ancestor
110850624|NCT01345682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110645917|NCT04585750|Pembrolizumab|pembrolizumab|mesh-list
110850626|NCT01345682|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110850627|NCT03562117|Gepotidacin|gepotidacin|mesh-list
110850628|NCT03562117|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110850629|NCT03562117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110850630|NCT03562117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110568220|NCT01012817|Topotecan|topotecan|mesh-list
110850631|NCT03562117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110850632|NCT02503462|Ritonavir|ritonavir|mesh-list
110850633|NCT02503462|Darunavir|darunavir|mesh-list
110850634|NCT02503462|Cobicistat|cobicistat|mesh-list
110850635|NCT02503462|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110850636|NCT02503462|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110850637|NCT02503462|Protease Inhibitors|protease inhibitors|mesh-ancestor
110645980|NCT04461535|Hormones|hormones|mesh-list
110645981|NCT04461535|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
110645982|NCT04461535|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
110645983|NCT04461535|beta-Endorphin|beta-endorphin|mesh-list
110645984|NCT04461535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110645985|NCT04461535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110645986|NCT04461535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110645987|NCT04461535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110645988|NCT04432012|Dexamethasone|dexamethasone|mesh-list
110645989|NCT04432012|Dexamethasone acetate|dexamethasone acetate|mesh-list
110645990|NCT04432012|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
110645991|NCT04432012|BB 1101|bb 1101|mesh-list
110645992|NCT04432012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110645993|NCT04432012|Antiemetics|antiemetics|mesh-ancestor
110645994|NCT04432012|Autonomic Agents|autonomic agents|mesh-ancestor
110645995|NCT04432012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110645996|NCT04432012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110645998|NCT04432012|Glucocorticoids|glucocorticoids|mesh-ancestor
110850638|NCT02503462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110850639|NCT02503462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110850641|NCT02503462|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110850642|NCT02503462|Antiviral Agents|antiviral agents|mesh-ancestor
110850643|NCT02503462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110850644|NCT02503462|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110850645|NCT02503462|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110850646|NCT03343678|Venetoclax|venetoclax|mesh-list
110850647|NCT03343678|BI 836826|bi 836826|mesh-list
110850648|NCT03343678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110850649|NCT03343678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110850650|NCT05216822|Racecadotril|racecadotril|mesh-list
110850651|NCT05216822|Antidiarrheals|antidiarrheals|mesh-ancestor
110850652|NCT05216822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110850653|NCT05216822|Protease Inhibitors|protease inhibitors|mesh-ancestor
110850654|NCT05216822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110850655|NCT05216822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110850656|NCT04498936|Sofosbuvir|sofosbuvir|mesh-list
110850657|NCT04498936|Ledipasvir|ledipasvir|mesh-list
110850658|NCT04498936|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
110850659|NCT04498936|Nitazoxanide|nitazoxanide|mesh-list
110850660|NCT04498936|Antiviral Agents|antiviral agents|mesh-ancestor
110850661|NCT04498936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110850662|NCT04498936|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110850663|NCT03627260|Sunscreening Agents|sunscreening agents|mesh-list
110850664|NCT03627260|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110850665|NCT03627260|Protective Agents|protective agents|mesh-ancestor
110850666|NCT03627260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110850667|NCT03627260|Dermatologic Agents|dermatologic agents|mesh-ancestor
110850668|NCT05706038|Adalimumab|adalimumab|mesh-list
110646240|NCT03838159|Paclitaxel|paclitaxel|mesh-list
110850669|NCT05706038|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110850670|NCT05706038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110850671|NCT05706038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110850672|NCT03546907|Cholinergic Agents|cholinergic agents|mesh-list
110850673|NCT03546907|Muscarinic Agonists|muscarinic agonists|mesh-list
110850674|NCT03546907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110850675|NCT03546907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110850676|NCT03546907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110850677|NCT03546907|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110850678|NCT05126264|Ibuprofen|ibuprofen|mesh-list
110850679|NCT05126264|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110850680|NCT05126264|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110850681|NCT05126264|Analgesics|analgesics|mesh-ancestor
110850682|NCT05126264|Sensory System Agents|sensory system agents|mesh-ancestor
110850683|NCT05126264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110850684|NCT05126264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110850685|NCT05126264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110850686|NCT05126264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110850687|NCT05126264|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110850688|NCT05126264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110850689|NCT05126264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110850690|NCT03001817|Fenofibrate|fenofibrate|mesh-list
110850691|NCT03001817|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110850692|NCT03001817|Antimetabolites|antimetabolites|mesh-ancestor
110850693|NCT03001817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110850694|NCT03001817|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110850696|NCT02502682|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110850697|NCT02502682|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110850698|NCT02502682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110850699|NCT02502682|Disinfectants|disinfectants|mesh-ancestor
110646447|NCT03539614|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110850700|NCT02502682|Dermatologic Agents|dermatologic agents|mesh-ancestor
110850701|NCT03590743|Apixaban|apixaban|mesh-list
110850702|NCT03590743|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110850703|NCT03590743|Antithrombins|antithrombins|mesh-ancestor
110850704|NCT03590743|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110850705|NCT03590743|Protease Inhibitors|protease inhibitors|mesh-ancestor
110850706|NCT03590743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110850707|NCT03590743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110850708|NCT03590743|Anticoagulants|anticoagulants|mesh-ancestor
110850709|NCT03343600|Imatinib Mesylate|imatinib mesylate|mesh-list
110646510|NCT03443856|Nivolumab|nivolumab|mesh-list
110646511|NCT03443856|Ipilimumab|ipilimumab|mesh-list
110646512|NCT03443856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110646513|NCT03443856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110646514|NCT03443856|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110646515|NCT03443856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110646517|NCT03389750|Oxycodone|oxycodone|mesh-list
110832649|NCT01220375|Plerixafor|plerixafor|mesh-list
110646518|NCT03389750|Hydromorphone|hydromorphone|mesh-list
110646519|NCT03389750|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110646520|NCT03389750|Narcotics|narcotics|mesh-ancestor
110646521|NCT03389750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110568293|NCT00575380|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110850710|NCT03343600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110850711|NCT03343600|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110850712|NCT03343600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110850713|NCT03343600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110850714|NCT03589885|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110850715|NCT03589885|Immunologic Factors|immunologic factors|mesh-ancestor
110850716|NCT03589885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110850717|NCT03121222|Acetylcysteine|acetylcysteine|mesh-list
110850718|NCT03121222|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110850719|NCT03121222|Antiviral Agents|antiviral agents|mesh-ancestor
110850720|NCT03121222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110850721|NCT03121222|Expectorants|expectorants|mesh-ancestor
110646578|NCT03033225|Verteporfin|verteporfin|mesh-list
110646579|NCT03033225|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110646580|NCT03033225|Dermatologic Agents|dermatologic agents|mesh-ancestor
110646581|NCT02998528|Paclitaxel|paclitaxel|mesh-list
110646582|NCT02998528|Vinorelbine|vinorelbine|mesh-list
110646583|NCT02998528|Docetaxel|docetaxel|mesh-list
110646584|NCT02998528|Carboplatin|carboplatin|mesh-list
110646585|NCT02998528|Gemcitabine|gemcitabine|mesh-list
110646586|NCT02998528|Nivolumab|nivolumab|mesh-list
110646587|NCT02998528|Pemetrexed|pemetrexed|mesh-list
110646588|NCT02998528|Ipilimumab|ipilimumab|mesh-list
110293804|NCT00228488|Gefitinib|gefitinib|mesh-list
110337020|NCT01245062|Trametinib|trametinib|mesh-list
110646589|NCT02998528|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110646590|NCT02998528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110646591|NCT02998528|Tubulin Modulators|tubulin modulators|mesh-ancestor
110646592|NCT02998528|Antimitotic Agents|antimitotic agents|mesh-ancestor
110850722|NCT03121222|Respiratory System Agents|respiratory system agents|mesh-ancestor
110850723|NCT03121222|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110850724|NCT03121222|Antioxidants|antioxidants|mesh-ancestor
110850725|NCT03121222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110850726|NCT03121222|Protective Agents|protective agents|mesh-ancestor
110850728|NCT03121222|Antidotes|antidotes|mesh-ancestor
110850729|NCT03639493|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
110850730|NCT03639493|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110850731|NCT03639493|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110850732|NCT03639493|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110850733|NCT03639493|Antimetabolites|antimetabolites|mesh-ancestor
110850734|NCT03639493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110850735|NCT03639493|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110850736|NCT03639493|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110850737|NCT03639493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110850738|NCT03639493|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110646712|NCT02777385|Pembrolizumab|pembrolizumab|mesh-list
110646713|NCT02777385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110832711|NCT03819127|Metformin|metformin|mesh-list
110646714|NCT02777385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110850739|NCT03344302|Oxytocin|oxytocin|mesh-list
110850740|NCT03344302|Oxytocics|oxytocics|mesh-ancestor
110850741|NCT03344302|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110850742|NCT03344302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110850743|NCT03545503|Ketamine|ketamine|mesh-list
110850744|NCT03545503|Etomidate|etomidate|mesh-list
110850745|NCT03545503|Analgesics|analgesics|mesh-ancestor
110850746|NCT03545503|Sensory System Agents|sensory system agents|mesh-ancestor
110850747|NCT03545503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110646781|NCT02337686|Pembrolizumab|pembrolizumab|mesh-list
110646782|NCT02337686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110646783|NCT02337686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110646784|NCT02337686|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110646785|NCT02337686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110646786|NCT02231749|Nivolumab|nivolumab|mesh-list
110646787|NCT02231749|Ipilimumab|ipilimumab|mesh-list
110646788|NCT02231749|Sunitinib|sunitinib|mesh-list
110646789|NCT02231749|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110646790|NCT02231749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110850748|NCT03545503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110850749|NCT03545503|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110850750|NCT03545503|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110850751|NCT03545503|Anesthetics, General|anesthetics, general|mesh-ancestor
110850752|NCT03545503|Anesthetics|anesthetics|mesh-ancestor
110646849|NCT01915810|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110850753|NCT03545503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110850754|NCT03545503|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110850755|NCT03545503|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110850756|NCT03545503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110850757|NCT03545503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110850758|NCT03545503|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110850760|NCT01297829|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110850761|NCT01297829|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110850762|NCT01297829|Analgesics|analgesics|mesh-ancestor
110850763|NCT01297829|Sensory System Agents|sensory system agents|mesh-ancestor
110850764|NCT01297829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110850765|NCT01297829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110850766|NCT01297829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110850767|NCT01297829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110850768|NCT01297829|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110850769|NCT01297829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110850770|NCT01297829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110850771|NCT03829943|Vitamin D|vitamin d|mesh-list
110850772|NCT03829943|Vitamins|vitamins|mesh-ancestor
110850773|NCT03829943|Micronutrients|micronutrients|mesh-ancestor
110850774|NCT03829943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110850775|NCT03829943|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110850776|NCT02508142|Scopolamine|scopolamine|mesh-list
110850777|NCT02508142|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
110850778|NCT02508142|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110850779|NCT02508142|Antiemetics|antiemetics|mesh-ancestor
110850780|NCT02508142|Autonomic Agents|autonomic agents|mesh-ancestor
110850781|NCT02508142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110647207|NCT00183391|Dopamine Agents|dopamine agents|mesh-ancestor
110832723|NCT05607550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110568367|NCT00757198|Sensory System Agents|sensory system agents|mesh-ancestor
110850783|NCT02508142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110850785|NCT02508142|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110850786|NCT02508142|Cholinergic Agents|cholinergic agents|mesh-ancestor
110850787|NCT02508142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110294482|NCT00176488|Vinorelbine|vinorelbine|mesh-list
110850788|NCT02508142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110850789|NCT02508142|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110850790|NCT02508142|Parasympatholytics|parasympatholytics|mesh-ancestor
110850791|NCT02508220|Oxytocin|oxytocin|mesh-list
110850792|NCT02508220|Oxytocics|oxytocics|mesh-ancestor
110850793|NCT02508220|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110850794|NCT02508220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110850795|NCT01297907|Methacholine Chloride|methacholine chloride|mesh-list
110850797|NCT01297907|Autonomic Agents|autonomic agents|mesh-ancestor
110850798|NCT01297907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110850799|NCT01297907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110850800|NCT01297907|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110850801|NCT01297907|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
110850802|NCT01297907|Respiratory System Agents|respiratory system agents|mesh-ancestor
110850803|NCT01297907|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
110850804|NCT01297907|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110850805|NCT01297907|Cholinergic Agents|cholinergic agents|mesh-ancestor
110850806|NCT01297907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110850807|NCT01297907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110850809|NCT02508064|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110850810|NCT02508064|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110850811|NCT02508064|Antiviral Agents|antiviral agents|mesh-ancestor
110850812|NCT02508064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110850813|NCT02508064|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110850814|NCT02508064|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110850815|NCT02508064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110850817|NCT05705570|Fludarabine|fludarabine|mesh-list
110850818|NCT05705570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110850819|NCT05705570|Immunologic Factors|immunologic factors|mesh-ancestor
110832741|NCT03930875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110850820|NCT05705570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110850821|NCT05705570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110850822|NCT05705570|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110850823|NCT05705570|Alkylating Agents|alkylating agents|mesh-ancestor
110647832|NCT03958656|Alkylating Agents|alkylating agents|mesh-ancestor
110850824|NCT05705570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110850825|NCT05705570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110850826|NCT05705570|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110850827|NCT05670236|Lidocaine|lidocaine|mesh-list
110850828|NCT05670236|Anesthetics, Local|anesthetics, local|mesh-ancestor
110850830|NCT05670236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110850831|NCT05670236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110850832|NCT05670236|Sensory System Agents|sensory system agents|mesh-ancestor
110850833|NCT05670236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110850834|NCT05670236|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110850835|NCT05670236|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110850836|NCT05670236|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110850837|NCT05670236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110850838|NCT05670236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110850839|NCT03214380|Insulin|insulin|mesh-list
110850840|NCT03214380|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110850841|NCT03214380|Metformin|metformin|mesh-list
110850842|NCT03214380|Insulin Glargine|insulin glargine|mesh-list
110850843|NCT03214380|Insulin Lispro|insulin lispro|mesh-list
110648044|NCT00168805|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110850844|NCT03214380|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
110850845|NCT03214380|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110850846|NCT03214380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110648104|NCT00463060|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110850847|NCT03214380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110850848|NCT04498234|Bupivacaine|bupivacaine|mesh-list
110850849|NCT04498234|Anesthetics, Local|anesthetics, local|mesh-ancestor
110850850|NCT04498234|Anesthetics|anesthetics|mesh-ancestor
110850851|NCT04498234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110850852|NCT04498234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110850853|NCT04498234|Sensory System Agents|sensory system agents|mesh-ancestor
110850854|NCT04498234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110850855|NCT03343444|Sofosbuvir|sofosbuvir|mesh-list
110850856|NCT03343444|Ledipasvir|ledipasvir|mesh-list
110850857|NCT03343444|Antiviral Agents|antiviral agents|mesh-ancestor
110648316|NCT00957216|Vitamins|vitamins|mesh-ancestor
110850858|NCT03343444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110850859|NCT03819101|Aspirin|aspirin|mesh-list
110850860|NCT03819101|Atorvastatin|atorvastatin|mesh-list
110850861|NCT03819101|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110850862|NCT03819101|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110850863|NCT03819101|Antimetabolites|antimetabolites|mesh-ancestor
110850864|NCT03819101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110850865|NCT03819101|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110832778|NCT03474640|Antibodies|antibodies|mesh-list
110850866|NCT03819101|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110850867|NCT03819101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110850868|NCT03819101|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110648481|NCT00952302|Iron|iron|mesh-list
110850869|NCT03819101|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110850870|NCT03819101|Analgesics|analgesics|mesh-ancestor
110850871|NCT03819101|Sensory System Agents|sensory system agents|mesh-ancestor
110850872|NCT03819101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110850873|NCT03819101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110850874|NCT03819101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110850875|NCT03819101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110850876|NCT03819101|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110648544|NCT00719459|Iron|iron|mesh-list
110850877|NCT03819101|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110850878|NCT03819101|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110850879|NCT03819101|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110850881|NCT05199324|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110850882|NCT05199324|Ciprofloxacin|ciprofloxacin|mesh-list
110850883|NCT05199324|Cefazolin|cefazolin|mesh-list
110850884|NCT05199324|Ceftriaxone|ceftriaxone|mesh-list
110850885|NCT05199324|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
110850886|NCT05199324|Fluoroquinolones|fluoroquinolones|mesh-list
110850887|NCT05199324|Trimethoprim|trimethoprim|mesh-list
110850888|NCT05199324|Sulfamethoxazole|sulfamethoxazole|mesh-list
110850889|NCT05199324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110850890|NCT05199324|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110850891|NCT05199324|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110648740|NCT00712049|Vitamins|vitamins|mesh-ancestor
110850892|NCT05199324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110850893|NCT05199324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110850894|NCT05199324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110850895|NCT05199324|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110850896|NCT05199324|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110850897|NCT05199324|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110850899|NCT05199324|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110850900|NCT05199324|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110850901|NCT05199324|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110850902|NCT05199324|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110850903|NCT05199324|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
110850904|NCT05199324|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110850905|NCT03343366|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110850907|NCT03343366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110850908|NCT03343366|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110850909|NCT03343366|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110850910|NCT01298297|Morphine|morphine|mesh-list
110850911|NCT01298297|Buprenorphine|buprenorphine|mesh-list
110850912|NCT01298297|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110850913|NCT01298297|Narcotics|narcotics|mesh-ancestor
110850914|NCT01298297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110850915|NCT01298297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110850916|NCT01298297|Analgesics|analgesics|mesh-ancestor
110850917|NCT01298297|Sensory System Agents|sensory system agents|mesh-ancestor
110850918|NCT01298297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110850920|NCT03818945|Listerine|listerine|mesh-list
110850921|NCT03818945|Fluorides|fluorides|mesh-list
110850922|NCT03818945|Sodium Fluoride|sodium fluoride|mesh-list
110850923|NCT03818945|Fluorides, Topical|fluorides, topical|mesh-list
110649237|NCT00722579|Chromium|chromium|mesh-list
110850924|NCT03818945|Cariostatic Agents|cariostatic agents|mesh-ancestor
110850925|NCT03818945|Protective Agents|protective agents|mesh-ancestor
110850926|NCT03818945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110850927|NCT03818945|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110850928|NCT03818945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110850929|NCT04300751|Analgesics, Opioid|analgesics, opioid|mesh-list
110850930|NCT04300751|Narcotics|narcotics|mesh-ancestor
110850931|NCT04300751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110850932|NCT04300751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110649378|NCT02571491|Anesthetics, General|anesthetics, general|mesh-ancestor
110568516|NCT00755404|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110850933|NCT04300751|Analgesics|analgesics|mesh-ancestor
110850934|NCT04300751|Sensory System Agents|sensory system agents|mesh-ancestor
110850935|NCT04300751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110850936|NCT03842423|Anesthetics|anesthetics|mesh-list
110850937|NCT03842423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110850938|NCT03842423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110850939|NCT03172026|Maraviroc|maraviroc|mesh-list
110850940|NCT03172026|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110850941|NCT03172026|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110649444|NCT02572505|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110850942|NCT03172026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110850944|NCT03172026|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110850945|NCT03172026|Antiviral Agents|antiviral agents|mesh-ancestor
110850946|NCT03172026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110850947|NCT03172026|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
110850948|NCT01201577|Azithromycin|azithromycin|mesh-list
110850949|NCT01201577|Sulfalene|sulfalene|mesh-list
110850950|NCT01201577|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110850951|NCT01201577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110850952|NCT01201577|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110850954|NCT01201577|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110850955|NCT01201577|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110850956|NCT04496050|Alprostadil|alprostadil|mesh-list
110850957|NCT04496050|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110850958|NCT04496050|Vasodilator Agents|vasodilator agents|mesh-ancestor
110850959|NCT04496050|Urological Agents|urological agents|mesh-ancestor
110850960|NCT01300793|Rituximab|rituximab|mesh-list
110850961|NCT01300793|Carboplatin|carboplatin|mesh-list
110850962|NCT01300793|Etoposide|etoposide|mesh-list
110850963|NCT01300793|Bortezomib|bortezomib|mesh-list
110850964|NCT01300793|Ifosfamide|ifosfamide|mesh-list
110850965|NCT01300793|Isophosphamide mustard|isophosphamide mustard|mesh-list
110850966|NCT01300793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110850967|NCT01300793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110850968|NCT01300793|Immunologic Factors|immunologic factors|mesh-ancestor
110850969|NCT01300793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110850970|NCT01300793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110850971|NCT01300793|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110850972|NCT01300793|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110850973|NCT01300793|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110850974|NCT01300793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110850975|NCT01300793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110850976|NCT01300793|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110850977|NCT01300793|Alkylating Agents|alkylating agents|mesh-ancestor
110850978|NCT03342040|Bupivacaine|bupivacaine|mesh-list
110850979|NCT03342040|Ropivacaine|ropivacaine|mesh-list
110850980|NCT03342040|Anesthetics, Local|anesthetics, local|mesh-ancestor
110850981|NCT03342040|Anesthetics|anesthetics|mesh-ancestor
110850982|NCT03342040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110850983|NCT03342040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110850984|NCT03342040|Sensory System Agents|sensory system agents|mesh-ancestor
110850985|NCT03342040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110850986|NCT01298843|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
110850987|NCT01298843|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110850988|NCT01298843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110850990|NCT03336970|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110850991|NCT03336970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110850992|NCT03336814|Terlipressin|terlipressin|mesh-list
110650035|NCT02538146|Vitamins|vitamins|mesh-ancestor
110850993|NCT03336814|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110850994|NCT03336814|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110850996|NCT02495584|Ergocalciferols|ergocalciferols|mesh-list
110850997|NCT02495584|Cholecalciferol|cholecalciferol|mesh-list
110850998|NCT02495584|Vitamins|vitamins|mesh-list
110850999|NCT02495584|Micronutrients|micronutrients|mesh-ancestor
110851000|NCT02495584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110650141|NCT00728195|Serotonin Agents|serotonin agents|mesh-ancestor
110851001|NCT02495584|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110851002|NCT02495584|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110851004|NCT02495818|Anesthetics, Local|anesthetics, local|mesh-ancestor
110851005|NCT02495818|Anesthetics|anesthetics|mesh-ancestor
110851006|NCT02495818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110851007|NCT02495818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110851008|NCT02495818|Sensory System Agents|sensory system agents|mesh-ancestor
110851009|NCT02495818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110851010|NCT02495818|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110851011|NCT02495818|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110851012|NCT02495818|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110851013|NCT02495818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110851014|NCT02495818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110851016|NCT02495662|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110851017|NCT02495662|Methylprednisolone|methylprednisolone|mesh-list
110851018|NCT02495662|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110851019|NCT02495662|Prednisolone acetate|prednisolone acetate|mesh-list
110851020|NCT02495662|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110851021|NCT02495662|Prednisolone phosphate|prednisolone phosphate|mesh-list
110851022|NCT02495662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110650570|NCT00734123|Sensory System Agents|sensory system agents|mesh-ancestor
110650571|NCT00734123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110650572|NCT00734123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110650573|NCT00734123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110650581|NCT00734123|Antipyretics|antipyretics|mesh-ancestor
110851023|NCT02495662|Glucocorticoids|glucocorticoids|mesh-ancestor
110851024|NCT02495662|Hormones|hormones|mesh-ancestor
110851025|NCT02495662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110851026|NCT02495662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110851027|NCT02495662|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110851028|NCT02495662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110851029|NCT02495662|Antiemetics|antiemetics|mesh-ancestor
110650709|NCT00733265|Ticagrelor|ticagrelor|mesh-list
110851030|NCT02495662|Autonomic Agents|autonomic agents|mesh-ancestor
110851031|NCT02495662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110851032|NCT02495662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110851033|NCT02495662|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110851034|NCT02495662|Protective Agents|protective agents|mesh-ancestor
110851035|NCT02496052|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110851036|NCT02496052|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110851037|NCT02496052|Estradiol|estradiol|mesh-list
110650784|NCT00459706|Etanercept|etanercept|mesh-list
110851038|NCT02496052|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110851039|NCT02496052|Dydrogesterone|dydrogesterone|mesh-list
110851040|NCT02496052|Estrogens|estrogens|mesh-ancestor
110851041|NCT02496052|Hormones|hormones|mesh-ancestor
110851042|NCT02496052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110851043|NCT02496052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110851044|NCT02496052|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110851045|NCT02496052|Contraceptive Agents|contraceptive agents|mesh-ancestor
110851046|NCT02496052|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110851047|NCT02496052|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110851048|NCT02496052|Progestins|progestins|mesh-ancestor
110851049|NCT01206569|Tacrolimus|tacrolimus|mesh-list
110851050|NCT01206569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110851051|NCT01206569|Immunologic Factors|immunologic factors|mesh-ancestor
110851052|NCT01206569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110651063|NCT01079065|Histamine Agents|histamine agents|mesh-ancestor
110851053|NCT01206569|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110851054|NCT01206569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110851055|NCT01206569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110851056|NCT01206647|Metformin|metformin|mesh-list
110851057|NCT01206647|Saxagliptin|saxagliptin|mesh-list
110851058|NCT01206647|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110851059|NCT01206647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110851060|NCT01206647|Incretins|incretins|mesh-ancestor
110851061|NCT01206647|Hormones|hormones|mesh-ancestor
110651276|NCT00930566|Dermatologic Agents|dermatologic agents|mesh-ancestor
110851062|NCT01206647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110851063|NCT01206647|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110851064|NCT01206647|Protease Inhibitors|protease inhibitors|mesh-ancestor
110851065|NCT01206647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110851066|NCT01206647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110851068|NCT03341884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110851069|NCT03341884|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110851070|NCT03341884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110851071|NCT03341884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110851072|NCT03560245|Bryostatin 1|bryostatin 1|mesh-list
110651422|NCT00936650|Cinacalcet|cinacalcet|mesh-list
110851073|NCT03560245|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110851074|NCT03560245|Immunologic Factors|immunologic factors|mesh-ancestor
110851075|NCT03560245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110851076|NCT03560245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110851077|NCT02495272|Oxytocin|oxytocin|mesh-list
110851078|NCT02495272|Oxytocics|oxytocics|mesh-ancestor
110851079|NCT02495272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110851080|NCT02495272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110851081|NCT03336346|Efavirenz|efavirenz|mesh-list
110851082|NCT03336346|Dolutegravir|dolutegravir|mesh-list
110651567|NCT00938600|Vitamin D|vitamin d|mesh-list
110851083|NCT03336346|Etonogestrel|etonogestrel|mesh-list
110851084|NCT03336346|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110851085|NCT03336346|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110851086|NCT03336346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110568666|NCT00822120|Etoposide|etoposide|mesh-list
110851087|NCT03336346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110651625|NCT00933374|Tubulin Modulators|tubulin modulators|mesh-ancestor
110851089|NCT03336346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110851090|NCT03336346|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110851091|NCT03336346|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110851092|NCT03336346|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110851093|NCT03336346|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110651771|NCT00934154|Glucocorticoids|glucocorticoids|mesh-ancestor
110851094|NCT03336346|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110851095|NCT03336346|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110851096|NCT03336346|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110851097|NCT03336346|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110851098|NCT03336346|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110851099|NCT03336346|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110851100|NCT03336346|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110851101|NCT03336346|Contraceptive Agents|contraceptive agents|mesh-ancestor
110851102|NCT03336346|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110851103|NCT03336346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110851104|NCT03336346|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110851105|NCT03841292|Varenicline|varenicline|mesh-list
110851106|NCT03841292|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110851107|NCT03841292|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110851108|NCT03841292|Cholinergic Agents|cholinergic agents|mesh-ancestor
110851109|NCT03841292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110851110|NCT03841292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110851111|NCT03841292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110851112|NCT03814577|Antioxidants|antioxidants|mesh-list
110851113|NCT03814577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110851114|NCT03814577|Protective Agents|protective agents|mesh-ancestor
110851115|NCT03814577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110851117|NCT03730363|Antifungal Agents|antifungal agents|mesh-ancestor
110851118|NCT03730363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110851119|NCT03730363|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110851120|NCT03730363|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110851121|NCT03730363|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
110851122|NCT01206803|Ganirelix|ganirelix|mesh-list
110851123|NCT01206803|Hormone Antagonists|hormone antagonists|mesh-ancestor
110851124|NCT01206803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110851125|NCT01206803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110851126|NCT03335956|Pioglitazone|pioglitazone|mesh-list
110851127|NCT03335956|Prednisone|prednisone|mesh-list
110851128|NCT03335956|Cortisone|cortisone|mesh-list
110652196|NCT00445978|Verapamil|verapamil|mesh-list
110851129|NCT03335956|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110851130|NCT03335956|Glucocorticoids|glucocorticoids|mesh-ancestor
110851131|NCT03335956|Hormones|hormones|mesh-ancestor
110851132|NCT03335956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110851133|NCT03335956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110851134|NCT03335956|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110851135|NCT03335956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110851136|NCT03335956|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110851137|NCT03817931|Solifenacin Succinate|solifenacin succinate|mesh-list
110851138|NCT03817931|Mirabegron|mirabegron|mesh-list
110851139|NCT03817931|Cholinergic Antagonists|cholinergic antagonists|mesh-list
110851140|NCT03817931|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-list
110851141|NCT03817931|Adrenergic Agents|adrenergic agents|mesh-list
110851142|NCT03817931|Adrenergic Agonists|adrenergic agonists|mesh-list
110851143|NCT03817931|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110851144|NCT03817931|Cholinergic Agents|cholinergic agents|mesh-ancestor
110851145|NCT03817931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110851146|NCT03817931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110851147|NCT03817931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110851148|NCT03817931|Urological Agents|urological agents|mesh-ancestor
110851149|NCT03817931|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110851150|NCT01206881|Cyclophosphamide|cyclophosphamide|mesh-list
110851153|NCT01206881|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110851154|NCT01206881|Trastuzumab|trastuzumab|mesh-list
110851155|NCT01206881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110851156|NCT01206881|Immunologic Factors|immunologic factors|mesh-ancestor
110851157|NCT01206881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110851158|NCT01206881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110851159|NCT01206881|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110851160|NCT01206881|Alkylating Agents|alkylating agents|mesh-ancestor
110851161|NCT01206881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110851163|NCT01206881|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110652540|NCT00694109|Mipomersen|mipomersen|mesh-list
110851164|NCT01206881|Tubulin Modulators|tubulin modulators|mesh-ancestor
110851165|NCT01206881|Antimitotic Agents|antimitotic agents|mesh-ancestor
110851166|NCT01206881|Mitosis Modulators|mitosis modulators|mesh-ancestor
110851167|NCT01206881|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110851168|NCT01206881|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110851169|NCT01206881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110851170|NCT01206881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110851171|NCT01206881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110851172|NCT02494804|Temozolomide|temozolomide|mesh-list
110851173|NCT02494804|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110851174|NCT02494804|Alkylating Agents|alkylating agents|mesh-ancestor
110851175|NCT02494804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110851176|NCT02494804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110851177|NCT03558997|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110851178|NCT03558997|Immunologic Factors|immunologic factors|mesh-ancestor
110851179|NCT03558997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110851180|NCT03814343|Amphotericin B|amphotericin b|mesh-list
110851181|NCT03814343|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
110851182|NCT03814343|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
110851183|NCT03814343|Amebicides|amebicides|mesh-ancestor
110851184|NCT03814343|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110851185|NCT03814343|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110851186|NCT03814343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110851187|NCT03814343|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110851188|NCT03814343|Antifungal Agents|antifungal agents|mesh-ancestor
110851189|NCT03814343|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
110851190|NCT03814343|Protective Agents|protective agents|mesh-ancestor
110851191|NCT03814343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110851192|NCT03814343|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110851193|NCT03814343|Antioxidants|antioxidants|mesh-ancestor
110851194|NCT03814343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110851195|NCT03817541|Propofol|propofol|mesh-list
110851196|NCT03817541|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110851197|NCT03817541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110851198|NCT03817541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110851199|NCT03817541|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110851200|NCT03817541|Anesthetics, General|anesthetics, general|mesh-ancestor
110550382|NCT00534313|Abatacept|abatacept|mesh-list
110851202|NCT03341494|Thalidomide|thalidomide|mesh-list
110851203|NCT03341494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110851204|NCT03341494|Immunologic Factors|immunologic factors|mesh-ancestor
110851205|NCT03341494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110851206|NCT03341494|Leprostatic Agents|leprostatic agents|mesh-ancestor
110851207|NCT03341494|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110851208|NCT03341494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110851209|NCT03341494|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110851210|NCT03341494|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110851211|NCT03341494|Growth Substances|growth substances|mesh-ancestor
110851212|NCT03341494|Growth Inhibitors|growth inhibitors|mesh-ancestor
110851213|NCT03341494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110851215|NCT03586609|Azacitidine|azacitidine|mesh-list
110851216|NCT03586609|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
110851218|NCT03586609|Cladribine|cladribine|mesh-list
110851219|NCT03586609|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110851220|NCT03586609|Antimetabolites|antimetabolites|mesh-ancestor
110851221|NCT03586609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110652933|NCT02917564|Glucocorticoids|glucocorticoids|mesh-ancestor
110851222|NCT03586609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110851223|NCT03586609|Antiviral Agents|antiviral agents|mesh-ancestor
110851224|NCT03586609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110851225|NCT03586609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110851226|NCT03586609|Immunologic Factors|immunologic factors|mesh-ancestor
110851227|NCT03586609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110851228|NCT03586609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110653062|NCT00946790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110851229|NCT03817619|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
110851230|NCT03817619|Antiviral Agents|antiviral agents|mesh-ancestor
110851231|NCT03817619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110851232|NCT03725995|Lidocaine|lidocaine|mesh-list
110851233|NCT03725995|Midazolam|midazolam|mesh-list
110851234|NCT03725995|Anesthetics, Local|anesthetics, local|mesh-ancestor
110851235|NCT03725995|Anesthetics|anesthetics|mesh-ancestor
110851236|NCT03725995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110653207|NCT00550238|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110851237|NCT03725995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110851238|NCT03725995|Sensory System Agents|sensory system agents|mesh-ancestor
110851239|NCT03725995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110851240|NCT03725995|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110851241|NCT03725995|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110851242|NCT03725995|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110851243|NCT03725995|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110851244|NCT03725995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110851245|NCT03725995|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110851246|NCT03725995|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110851247|NCT03725995|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110851248|NCT03725995|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110851249|NCT03725995|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110851250|NCT03725995|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110851251|NCT03725995|Anesthetics, General|anesthetics, general|mesh-ancestor
110851252|NCT03725995|GABA Modulators|gaba modulators|mesh-ancestor
110851253|NCT03725995|GABA Agents|gaba agents|mesh-ancestor
110851254|NCT03725995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110851255|NCT03341260|Diclofenac|diclofenac|mesh-list
110851256|NCT03341260|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110851257|NCT03341260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110851258|NCT03341260|Analgesics|analgesics|mesh-ancestor
110851259|NCT03341260|Sensory System Agents|sensory system agents|mesh-ancestor
110851260|NCT03341260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110851261|NCT03341260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110851262|NCT03341260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110851263|NCT03341260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110851264|NCT03341260|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110851266|NCT03341260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110851267|NCT03052400|Mifepristone|mifepristone|mesh-list
110851268|NCT03052400|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
110851269|NCT03052400|Abortifacient Agents|abortifacient agents|mesh-ancestor
110851270|NCT03052400|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110851271|NCT03052400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110851272|NCT03052400|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110173044|NCT00055549|Lorazepam|lorazepam|mesh-list
110851273|NCT03052400|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110851274|NCT03052400|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110851275|NCT03052400|Contraceptive Agents|contraceptive agents|mesh-ancestor
110851276|NCT03052400|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
110851277|NCT03052400|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
110851278|NCT03052400|Hormone Antagonists|hormone antagonists|mesh-ancestor
110851279|NCT03052400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110851280|NCT03052400|Luteolytic Agents|luteolytic agents|mesh-ancestor
110851281|NCT03052400|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110851282|NCT03052400|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
110851283|NCT03341104|Bupivacaine|bupivacaine|mesh-list
110851284|NCT03341104|Anesthetics, Local|anesthetics, local|mesh-ancestor
110851285|NCT03341104|Anesthetics|anesthetics|mesh-ancestor
110851286|NCT03341104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110851287|NCT03341104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110851288|NCT03341104|Sensory System Agents|sensory system agents|mesh-ancestor
110851289|NCT03341104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110851290|NCT03335098|Thalidomide|thalidomide|mesh-list
110851291|NCT03335098|Dexamethasone|dexamethasone|mesh-list
110851292|NCT03335098|Bortezomib|bortezomib|mesh-list
110851293|NCT03335098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110851294|NCT03335098|Antiemetics|antiemetics|mesh-ancestor
110851295|NCT03335098|Autonomic Agents|autonomic agents|mesh-ancestor
110851296|NCT03335098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110851297|NCT03335098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110851298|NCT03335098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110851299|NCT03335098|Glucocorticoids|glucocorticoids|mesh-ancestor
110851300|NCT03335098|Hormones|hormones|mesh-ancestor
110851301|NCT03335098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110851302|NCT03335098|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110851303|NCT03335098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110851304|NCT03335098|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110851305|NCT03335098|Immunologic Factors|immunologic factors|mesh-ancestor
110851306|NCT03335098|Leprostatic Agents|leprostatic agents|mesh-ancestor
110851307|NCT03335098|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110851308|NCT03335098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110851309|NCT03335098|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110851310|NCT03335098|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110851311|NCT03335098|Growth Substances|growth substances|mesh-ancestor
110851312|NCT03335098|Growth Inhibitors|growth inhibitors|mesh-ancestor
110851313|NCT03639571|Ibuprofen|ibuprofen|mesh-list
110851314|NCT03639571|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110851315|NCT03639571|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110851316|NCT03639571|Analgesics|analgesics|mesh-ancestor
110653616|NCT00095173|Abatacept|abatacept|mesh-list
110851317|NCT03639571|Sensory System Agents|sensory system agents|mesh-ancestor
110851318|NCT03639571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110851319|NCT03639571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110851320|NCT03639571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110851321|NCT03639571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110851322|NCT03639571|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110653737|NCT04492956|Ecopipam|ecopipam|mesh-list
110851323|NCT03639571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110851324|NCT03639571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110851325|NCT03052322|Adalimumab|adalimumab|mesh-list
110851326|NCT03052322|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110851327|NCT03052322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110851328|NCT03052322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110851329|NCT03521791|Bromfenac|bromfenac|mesh-list
110851330|NCT03521791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110851331|NCT03521791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110851332|NCT03521791|Analgesics|analgesics|mesh-ancestor
110851333|NCT03521791|Sensory System Agents|sensory system agents|mesh-ancestor
110851334|NCT03521791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110851335|NCT03521791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110851336|NCT03521791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110851337|NCT03521791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110851339|NCT03521635|Antioxidants|antioxidants|mesh-ancestor
110653856|NCT00433966|Antithrombins|antithrombins|mesh-ancestor
110851340|NCT03521635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110851341|NCT03521635|Protective Agents|protective agents|mesh-ancestor
110851342|NCT03521635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110851343|NCT03521635|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110851344|NCT03521635|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110851345|NCT03521635|Dopamine Agonists|dopamine agonists|mesh-ancestor
110851346|NCT03521635|Dopamine Agents|dopamine agents|mesh-ancestor
110851347|NCT03521635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110851348|NCT03170544|Insulin Glargine|insulin glargine|mesh-list
110851349|NCT03170544|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110851350|NCT03170544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110851351|NCT03813641|Capecitabine|capecitabine|mesh-list
110851352|NCT03813641|Raltitrexed|raltitrexed|mesh-list
110851353|NCT03813641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110851354|NCT03813641|Antimetabolites|antimetabolites|mesh-ancestor
110851355|NCT03813641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110851356|NCT03813641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110851357|NCT03813641|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110851358|NCT03813641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110851359|NCT02492464|Red yeast rice|red yeast rice|mesh-list
110851360|NCT02492464|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110851361|NCT02492464|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110851362|NCT02492464|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110851363|NCT02492464|Antimetabolites|antimetabolites|mesh-ancestor
110851364|NCT02492464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110851365|NCT02492464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110851366|NCT02492464|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110851368|NCT05255159|Diuretics|diuretics|mesh-ancestor
110851369|NCT05255159|Natriuretic Agents|natriuretic agents|mesh-ancestor
110851370|NCT05255159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110851371|NCT05255159|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110851372|NCT05255159|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110851373|NCT05255159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110851374|NCT03340558|Atezolizumab|atezolizumab|mesh-list
110851375|NCT03340558|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110851376|NCT03340558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110851377|NCT03340558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110851378|NCT03340558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110851380|NCT04905108|Vitamin B Complex|vitamin b complex|mesh-ancestor
110851381|NCT04905108|Vitamins|vitamins|mesh-ancestor
110851382|NCT04905108|Micronutrients|micronutrients|mesh-ancestor
110851383|NCT04905108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110568965|NCT00763906|Norepinephrine|norepinephrine|mesh-list
110851384|NCT04905108|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110851385|NCT04905108|Dermatologic Agents|dermatologic agents|mesh-ancestor
110851386|NCT04443166|Hyaluronic Acid|hyaluronic acid|mesh-list
110851387|NCT04443166|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110851388|NCT04443166|Immunologic Factors|immunologic factors|mesh-ancestor
110851389|NCT04443166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110851390|NCT04443166|Viscosupplements|viscosupplements|mesh-ancestor
110851391|NCT04443166|Protective Agents|protective agents|mesh-ancestor
110851392|NCT01560221|Buprenorphine|buprenorphine|mesh-list
110851393|NCT01560221|Methadone|methadone|mesh-list
110851394|NCT01560221|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110851395|NCT01560221|Narcotics|narcotics|mesh-ancestor
110851396|NCT01560221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110851397|NCT01560221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110851398|NCT01560221|Analgesics|analgesics|mesh-ancestor
110851399|NCT01560221|Sensory System Agents|sensory system agents|mesh-ancestor
110654183|NCT00741845|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110851400|NCT01560221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110851402|NCT01560221|Antitussive Agents|antitussive agents|mesh-ancestor
110851403|NCT01560221|Respiratory System Agents|respiratory system agents|mesh-ancestor
110851404|NCT03813329|Calcium Carbonate|calcium carbonate|mesh-list
110851405|NCT03813329|Calcium|calcium|mesh-list
110851406|NCT03813329|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110851407|NCT03813329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110851408|NCT03813329|Antacids|antacids|mesh-ancestor
110851409|NCT03813329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110851410|NCT03813329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110851411|NCT03639415|Oxycodone|oxycodone|mesh-list
110851412|NCT03639415|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110851413|NCT03639415|Narcotics|narcotics|mesh-ancestor
110851414|NCT03639415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110851415|NCT03639415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110851416|NCT03639415|Analgesics|analgesics|mesh-ancestor
110851417|NCT03639415|Sensory System Agents|sensory system agents|mesh-ancestor
110851418|NCT03639415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110851419|NCT02492386|Everolimus|everolimus|mesh-list
110851420|NCT02492386|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110851421|NCT02492386|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110851422|NCT02492386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110851423|NCT02492386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110851424|NCT02492386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110851425|NCT02492386|Immunologic Factors|immunologic factors|mesh-ancestor
110851426|NCT02492386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110851427|NCT02492386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110851429|NCT03340168|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
110851430|NCT03340168|Estrogens|estrogens|mesh-ancestor
110851431|NCT03340168|Hormones|hormones|mesh-ancestor
110851432|NCT03340168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110851433|NCT03340168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110851434|NCT03340168|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110851435|NCT03340168|Antioxidants|antioxidants|mesh-ancestor
110851436|NCT03340168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110851437|NCT03340168|Protective Agents|protective agents|mesh-ancestor
110851438|NCT01299701|Vadimezan|vadimezan|mesh-list
110851439|NCT01299701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110851440|NCT01299779|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
110851441|NCT01299779|Laxatives|laxatives|mesh-ancestor
110851442|NCT01299779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110851443|NCT03812939|Octreotide|octreotide|mesh-list
110851444|NCT03812939|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110851445|NCT03812939|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110851446|NCT03812939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110851447|NCT03339700|Cyclophosphamide|cyclophosphamide|mesh-list
110851448|NCT03339700|Busulfan|busulfan|mesh-list
110851449|NCT03339700|Gemcitabine|gemcitabine|mesh-list
110851450|NCT03339700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110851451|NCT03339700|Immunologic Factors|immunologic factors|mesh-ancestor
110851452|NCT03339700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110851453|NCT03339700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110851454|NCT03339700|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110337173|NCT00516009|Dexamethasone|dexamethasone|mesh-list
110851455|NCT03339700|Alkylating Agents|alkylating agents|mesh-ancestor
110851456|NCT03339700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110851457|NCT03339700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110851458|NCT03339700|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110851459|NCT03339700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110851460|NCT03339700|Antimetabolites|antimetabolites|mesh-ancestor
110851461|NCT01299857|Rituximab|rituximab|mesh-list
110851462|NCT01299857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110851463|NCT01299857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110851464|NCT01299857|Immunologic Factors|immunologic factors|mesh-ancestor
110851465|NCT01299857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110851466|NCT01299857|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110851467|NCT03478969|Insulin|insulin|mesh-list
110851468|NCT03478969|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110851469|NCT03478969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110851470|NCT03812783|Sorafenib|sorafenib|mesh-list
110851471|NCT03812783|Folfirinox|folfirinox|mesh-list
110851472|NCT03812783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110851473|NCT03812783|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110851474|NCT03812783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110851475|NCT03812783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110851476|NCT02500498|Abatacept|abatacept|mesh-list
110851477|NCT02500498|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110851478|NCT02500498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110851479|NCT02500498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110851480|NCT02500498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110851481|NCT02500498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110851482|NCT02500498|Immunologic Factors|immunologic factors|mesh-ancestor
110851484|NCT02500498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110851485|NCT02500108|Domperidone|domperidone|mesh-list
110851486|NCT02500108|Antiemetics|antiemetics|mesh-ancestor
110851487|NCT02500108|Autonomic Agents|autonomic agents|mesh-ancestor
110851488|NCT02500108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110851489|NCT02500108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110851490|NCT02500108|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110851491|NCT02500108|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110851493|NCT02500108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110851494|NCT02500108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110851495|NCT02499874|Tenofovir|tenofovir|mesh-list
110851496|NCT02499874|Lamivudine|lamivudine|mesh-list
110851497|NCT02499874|Emtricitabine|emtricitabine|mesh-list
110851498|NCT02499874|Zidovudine|zidovudine|mesh-list
110851499|NCT02499874|Efavirenz|efavirenz|mesh-list
110851500|NCT02499874|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
110851501|NCT02499874|Antiviral Agents|antiviral agents|mesh-ancestor
110851502|NCT02499874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110851503|NCT02499874|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110851504|NCT02499874|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110851505|NCT02499874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110851506|NCT02499874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110851507|NCT02499874|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110851508|NCT02499874|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110851509|NCT02499874|Antimetabolites|antimetabolites|mesh-ancestor
110851510|NCT02499874|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110851511|NCT02499874|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110851512|NCT02499874|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110851513|NCT02499874|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110851514|NCT02499874|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110851515|NCT02499874|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110851516|NCT02492308|Basiliximab|basiliximab|mesh-list
110851517|NCT02492308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110851518|NCT02492308|Immunologic Factors|immunologic factors|mesh-ancestor
110851519|NCT02492308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110851520|NCT05865470|Dronabinol|dronabinol|mesh-list
110851521|NCT05865470|Hallucinogens|hallucinogens|mesh-ancestor
110851522|NCT05865470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110851523|NCT05865470|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110851524|NCT05865470|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110851525|NCT05865470|Analgesics|analgesics|mesh-ancestor
110851526|NCT05865470|Sensory System Agents|sensory system agents|mesh-ancestor
110851527|NCT05865470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110851528|NCT05865470|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
110851529|NCT05865470|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110851530|NCT05865470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110851531|NCT05865470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110851532|NCT05865470|Hormones|hormones|mesh-ancestor
110851533|NCT05865470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110851534|NCT05865431|Zinc Oxide|zinc oxide|mesh-list
110851535|NCT05865431|Avobenzone|avobenzone|mesh-list
110851536|NCT05865431|Dermatologic Agents|dermatologic agents|mesh-ancestor
110851537|NCT05865431|Sunscreening Agents|sunscreening agents|mesh-ancestor
110851538|NCT05865431|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110851539|NCT05865431|Protective Agents|protective agents|mesh-ancestor
110851540|NCT05865431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110851542|NCT05865288|Oxytocics|oxytocics|mesh-ancestor
110851543|NCT05865288|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110851544|NCT05865288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110851545|NCT05865132|Palbociclib|palbociclib|mesh-list
110851546|NCT05865132|Afatinib|afatinib|mesh-list
110851547|NCT05865132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110851548|NCT05865132|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110851549|NCT05865132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110851550|NCT05865132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110851551|NCT05864885|Minoxidil|minoxidil|mesh-list
110851552|NCT05864885|Latanoprost|latanoprost|mesh-list
110851553|NCT05864885|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110851554|NCT05864885|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110851555|NCT05864885|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110851556|NCT05864885|Vasodilator Agents|vasodilator agents|mesh-ancestor
110851557|NCT05864677|Cerebrolysin|cerebrolysin|mesh-list
110851558|NCT05864677|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110851559|NCT05864677|Protective Agents|protective agents|mesh-ancestor
110851560|NCT05864677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110851561|NCT05864677|Nootropic Agents|nootropic agents|mesh-ancestor
110851563|NCT05864664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110851564|NCT05864664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110851565|NCT05864508|Oxytocin|oxytocin|mesh-list
110851566|NCT05864508|Oxytocics|oxytocics|mesh-ancestor
110851567|NCT05864508|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110851568|NCT05864508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110851569|NCT05864053|Ketamine|ketamine|mesh-list
110851570|NCT05864053|Analgesics|analgesics|mesh-ancestor
110851571|NCT05864053|Sensory System Agents|sensory system agents|mesh-ancestor
110851572|NCT05864053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110851573|NCT05864053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110851575|NCT05864053|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110851576|NCT05864053|Anesthetics, General|anesthetics, general|mesh-ancestor
110851577|NCT05864053|Anesthetics|anesthetics|mesh-ancestor
110851578|NCT05864053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110851579|NCT05864053|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110851580|NCT05864053|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110851581|NCT05864053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110851582|NCT05864053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110851583|NCT05863975|Interferons|interferons|mesh-list
110851584|NCT05863975|Interferon-alpha|interferon-alpha|mesh-list
110851585|NCT05863975|Interferon alpha-2|interferon alpha-2|mesh-list
110851586|NCT05863975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110851587|NCT05863975|Antiviral Agents|antiviral agents|mesh-ancestor
110851588|NCT05863975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110851589|NCT05863975|Immunologic Factors|immunologic factors|mesh-ancestor
110851590|NCT05863975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110851591|NCT05863949|Vitamin D|vitamin d|mesh-list
110851592|NCT05863949|Calcium|calcium|mesh-list
110851593|NCT05863949|Vitamins|vitamins|mesh-ancestor
110851594|NCT05863949|Micronutrients|micronutrients|mesh-ancestor
110851595|NCT05863949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110655346|NCT00964106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110851596|NCT05863949|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110851598|NCT05863936|Methylprednisolone|methylprednisolone|mesh-list
110851599|NCT05863936|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110851600|NCT05863936|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110851601|NCT05863936|Prednisolone|prednisolone|mesh-list
110851602|NCT05863936|Prednisolone acetate|prednisolone acetate|mesh-list
110851603|NCT05863936|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110851604|NCT05863936|Prednisolone phosphate|prednisolone phosphate|mesh-list
110851605|NCT05863936|Belimumab|belimumab|mesh-list
110851606|NCT05863936|Immunosuppressive Agents|immunosuppressive agents|mesh-list
110851607|NCT05863936|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110851608|NCT05863936|Antiemetics|antiemetics|mesh-ancestor
110851609|NCT05863936|Autonomic Agents|autonomic agents|mesh-ancestor
110851610|NCT05863936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110851611|NCT05863936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110851612|NCT05863936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110851613|NCT05863936|Glucocorticoids|glucocorticoids|mesh-ancestor
110851614|NCT05863936|Hormones|hormones|mesh-ancestor
110851615|NCT05863936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110851616|NCT05863936|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110851617|NCT05863936|Protective Agents|protective agents|mesh-ancestor
110851618|NCT05863936|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110851619|NCT05863936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110851620|NCT05863936|Immunologic Factors|immunologic factors|mesh-ancestor
110851622|NCT05863858|Moxifloxacin|moxifloxacin|mesh-list
110851623|NCT05863858|Levofloxacin|levofloxacin|mesh-list
110851624|NCT05863858|Ofloxacin|ofloxacin|mesh-list
110851625|NCT05863858|Tinidazole|tinidazole|mesh-list
110851626|NCT05863858|Omeprazole|omeprazole|mesh-list
110851627|NCT05863858|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
110851628|NCT05863858|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110851629|NCT05863858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110851630|NCT05863858|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110851631|NCT05863858|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110655671|NCT00966576|Timolol|timolol|mesh-list
110851632|NCT05863858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110851633|NCT05863858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110851634|NCT05863858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110851635|NCT05863858|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110851636|NCT05863858|Contraceptive Agents|contraceptive agents|mesh-ancestor
110851637|NCT05863858|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110851638|NCT05863858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110851639|NCT05863858|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110851640|NCT05863858|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110851641|NCT05863858|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110851642|NCT05863858|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110851643|NCT05863858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110851644|NCT05863858|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110851645|NCT05863858|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110851646|NCT05863858|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110851647|NCT05863858|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110851648|NCT05863858|Alkylating Agents|alkylating agents|mesh-ancestor
110851649|NCT05863858|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
110851651|NCT05863858|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110851652|NCT05863845|Cytarabine|cytarabine|mesh-list
110851653|NCT05863845|Etoposide|etoposide|mesh-list
110851654|NCT05863845|Melphalan|melphalan|mesh-list
110851655|NCT05863845|Venetoclax|venetoclax|mesh-list
110851656|NCT05863845|Carmustine|carmustine|mesh-list
110851657|NCT05863845|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110851658|NCT05863845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110851659|NCT05863845|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110656008|NCT04974996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110851660|NCT05863845|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110851661|NCT05863845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110851662|NCT05863845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110851663|NCT05863845|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110851664|NCT05863845|Antimetabolites|antimetabolites|mesh-ancestor
110851665|NCT05863845|Antiviral Agents|antiviral agents|mesh-ancestor
110851666|NCT05863845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110851667|NCT05863845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110851668|NCT05863845|Immunologic Factors|immunologic factors|mesh-ancestor
110851669|NCT05863845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110851670|NCT05863845|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110851671|NCT05863845|Alkylating Agents|alkylating agents|mesh-ancestor
110851672|NCT05863845|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110851674|NCT05863832|Ciprofloxacin|ciprofloxacin|mesh-list
110851675|NCT05863832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110851676|NCT05863832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110851677|NCT05863832|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110851678|NCT05863832|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110851679|NCT05863832|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110851680|NCT05863832|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110851681|NCT05863832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110851682|NCT05863832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110851683|NCT05863832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110851684|NCT05863832|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110851685|NCT05863832|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110851687|NCT05863585|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110851688|NCT05863585|Immunologic Factors|immunologic factors|mesh-ancestor
110851689|NCT05863585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110851691|NCT05863455|Sufentanil|sufentanil|mesh-list
110851692|NCT05863455|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110851693|NCT05863455|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110851694|NCT05863455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110851695|NCT05863455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110851696|NCT05863455|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110851697|NCT05863455|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110851698|NCT05863455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110851699|NCT05863455|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110851700|NCT05863455|Anesthetics, General|anesthetics, general|mesh-ancestor
110851701|NCT05863455|Anesthetics|anesthetics|mesh-ancestor
110851702|NCT05863455|GABA Modulators|gaba modulators|mesh-ancestor
110851703|NCT05863455|GABA Agents|gaba agents|mesh-ancestor
110851704|NCT05863455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110851705|NCT05863455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110851706|NCT05863455|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110851707|NCT05863455|Narcotics|narcotics|mesh-ancestor
110851708|NCT05863455|Analgesics|analgesics|mesh-ancestor
110851709|NCT05863455|Sensory System Agents|sensory system agents|mesh-ancestor
110851710|NCT05863455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110851711|NCT05863442|Eculizumab|eculizumab|mesh-list
110851712|NCT05863442|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
110851713|NCT05863442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110851714|NCT05863442|Immunologic Factors|immunologic factors|mesh-ancestor
110656858|NCT05919797|Naltrexone|naltrexone|mesh-list
110851715|NCT05863442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110851716|NCT05863416|Dexmedetomidine|dexmedetomidine|mesh-list
110851717|NCT05863416|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110656939|NCT05919017|Naltrexone|naltrexone|mesh-list
110851718|NCT05863416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110851719|NCT05863416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110851720|NCT05863416|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110851721|NCT05863416|Analgesics|analgesics|mesh-ancestor
110851722|NCT05863416|Sensory System Agents|sensory system agents|mesh-ancestor
110851723|NCT05863416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110851724|NCT05863416|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110851725|NCT05863416|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110851726|NCT05863416|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110851727|NCT05863416|Adrenergic Agents|adrenergic agents|mesh-ancestor
110851728|NCT05863416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110851729|NCT05863416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110851730|NCT05863325|Docetaxel|docetaxel|mesh-list
110851731|NCT05863325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110851732|NCT05863325|Tubulin Modulators|tubulin modulators|mesh-ancestor
110851733|NCT05863325|Antimitotic Agents|antimitotic agents|mesh-ancestor
110851734|NCT05863325|Mitosis Modulators|mitosis modulators|mesh-ancestor
110851735|NCT05863325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110851736|NCT05863273|Apremilast|apremilast|mesh-list
110851737|NCT05863273|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110851738|NCT05863273|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110851739|NCT05863273|Analgesics|analgesics|mesh-ancestor
110851740|NCT05863273|Sensory System Agents|sensory system agents|mesh-ancestor
110851741|NCT05863273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110851742|NCT05863273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110851743|NCT05863273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110851744|NCT05863273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110657010|NCT05918211|Udenafil|udenafil|mesh-list
110851745|NCT05863273|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
110851746|NCT05863273|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110851747|NCT05863273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110851748|NCT05863273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110851749|NCT05862272|Relugolix|relugolix|mesh-list
110851750|NCT05862272|Androgen Antagonists|androgen antagonists|mesh-ancestor
110851751|NCT05862272|Hormone Antagonists|hormone antagonists|mesh-ancestor
110657108|NCT05874245|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110337247|NCT01249443|Tubulin Modulators|tubulin modulators|mesh-ancestor
110851752|NCT05862272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110851753|NCT05862272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110851754|NCT05860998|Antibodies|antibodies|mesh-list
110851755|NCT05860998|Immunoglobulin G|immunoglobulin g|mesh-list
110851756|NCT05860998|Immunologic Factors|immunologic factors|mesh-ancestor
110851757|NCT05860998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110851758|NCT05860452|Ropivacaine|ropivacaine|mesh-list
110851759|NCT05860452|Anesthetics, Local|anesthetics, local|mesh-ancestor
110851761|NCT05860452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110851762|NCT05860452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110851763|NCT05860452|Sensory System Agents|sensory system agents|mesh-ancestor
110851764|NCT05860452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110851766|NCT05856500|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110851767|NCT05856500|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110851768|NCT05856500|Analgesics|analgesics|mesh-ancestor
110851769|NCT05856500|Sensory System Agents|sensory system agents|mesh-ancestor
110851770|NCT05856500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110851771|NCT05856500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110851772|NCT05856500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110851773|NCT05856500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110851774|NCT05856500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110851775|NCT05856500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110851776|NCT05856500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110851777|NCT05849779|Sevoflurane|sevoflurane|mesh-list
110851778|NCT05849779|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110851779|NCT05849779|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110851780|NCT05849779|Anesthetics, General|anesthetics, general|mesh-ancestor
110851781|NCT05849779|Anesthetics|anesthetics|mesh-ancestor
110851782|NCT05849779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110851783|NCT05849779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110851784|NCT05828303|Metformin|metformin|mesh-list
110851785|NCT05828303|Digoxin|digoxin|mesh-list
110851786|NCT05828303|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110851787|NCT05828303|Calcium|calcium|mesh-list
110851788|NCT05828303|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110851789|NCT05828303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110851790|NCT05828303|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110851791|NCT05828303|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110851792|NCT05828303|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110851793|NCT05828303|Antimetabolites|antimetabolites|mesh-ancestor
110851794|NCT05828303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110851795|NCT05828303|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110851796|NCT05828303|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110851797|NCT05828303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110657320|NCT05312671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110832893|NCT01126697|Ubiquinone|ubiquinone|mesh-list
110851798|NCT05828303|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110851799|NCT05828303|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110851800|NCT05828303|Protective Agents|protective agents|mesh-ancestor
110851801|NCT05801705|Tamoxifen|tamoxifen|mesh-list
110851802|NCT05801705|Toremifene|toremifene|mesh-list
110851803|NCT05801705|Hormones|hormones|mesh-list
110851804|NCT05801705|Aromatase Inhibitors|aromatase inhibitors|mesh-list
110851805|NCT05801705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110851806|NCT05801705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110851807|NCT05801705|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110851808|NCT05801705|Hormone Antagonists|hormone antagonists|mesh-ancestor
110851809|NCT05801705|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110851810|NCT05801705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110851811|NCT05801705|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110851812|NCT05801705|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110851813|NCT05801705|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110851814|NCT05801705|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110851815|NCT05801705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110851816|NCT05801705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110851817|NCT05778617|Ambroxol|ambroxol|mesh-list
110851818|NCT05778617|Expectorants|expectorants|mesh-ancestor
110851819|NCT05778617|Respiratory System Agents|respiratory system agents|mesh-ancestor
110851820|NCT05766345|BCG Vaccine|bcg vaccine|mesh-list
110851821|NCT05766345|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110851822|NCT05766345|Immunologic Factors|immunologic factors|mesh-ancestor
110851823|NCT05766345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110851824|NCT05756153|Cetuximab|cetuximab|mesh-list
110851825|NCT05756153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110851826|NCT05756153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110851827|NCT05743777|Pembrolizumab|pembrolizumab|mesh-list
110851828|NCT05743777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110851829|NCT05743777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110851830|NCT05743777|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110851831|NCT05743777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110851832|NCT05701007|Docetaxel|docetaxel|mesh-list
110851833|NCT05701007|Goserelin|goserelin|mesh-list
110851834|NCT05701007|Triptorelin Pamoate|triptorelin pamoate|mesh-list
110851835|NCT05701007|Leuprolide|leuprolide|mesh-list
110851836|NCT05701007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110851837|NCT05701007|Tubulin Modulators|tubulin modulators|mesh-ancestor
110851838|NCT05701007|Antimitotic Agents|antimitotic agents|mesh-ancestor
110851839|NCT05701007|Mitosis Modulators|mitosis modulators|mesh-ancestor
110851840|NCT05701007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110657709|NCT04162873|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110657710|NCT04162873|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110657711|NCT04162873|Analgesics|analgesics|mesh-ancestor
110657712|NCT04162873|Sensory System Agents|sensory system agents|mesh-ancestor
110657713|NCT04162873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110657714|NCT04162873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110657715|NCT04162873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110657716|NCT04162873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110851841|NCT05701007|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110851842|NCT05701007|Luteolytic Agents|luteolytic agents|mesh-ancestor
110851843|NCT05701007|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110851844|NCT05701007|Contraceptive Agents|contraceptive agents|mesh-ancestor
110851845|NCT05701007|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110851846|NCT05701007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110851847|NCT05701007|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110851848|NCT05701007|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110851849|NCT05701007|Fertility Agents|fertility agents|mesh-ancestor
110851851|NCT05676203|Androgens|androgens|mesh-list
110851852|NCT05676203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110851853|NCT05676203|Tubulin Modulators|tubulin modulators|mesh-ancestor
110851854|NCT05676203|Antimitotic Agents|antimitotic agents|mesh-ancestor
110851855|NCT05676203|Mitosis Modulators|mitosis modulators|mesh-ancestor
110851856|NCT05676203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110851857|NCT05676203|Hormones|hormones|mesh-ancestor
110851858|NCT05676203|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110851859|NCT05676203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110851860|NCT05673928|Trastuzumab|trastuzumab|mesh-list
110851861|NCT05673928|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
110851862|NCT05673928|Maytansine|maytansine|mesh-list
110851863|NCT05673928|Tucatinib|tucatinib|mesh-list
110851864|NCT05673928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110851865|NCT05673928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110851866|NCT05673928|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110851867|NCT05673928|Tubulin Modulators|tubulin modulators|mesh-ancestor
110851868|NCT05673928|Antimitotic Agents|antimitotic agents|mesh-ancestor
110658123|NCT00004180|Rosiglitazone|rosiglitazone|mesh-list
110851869|NCT05673928|Mitosis Modulators|mitosis modulators|mesh-ancestor
110851870|NCT05673928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110851871|NCT05673928|Immunotoxins|immunotoxins|mesh-ancestor
110851872|NCT05673928|Immunoconjugates|immunoconjugates|mesh-ancestor
110851873|NCT05673928|Immunologic Factors|immunologic factors|mesh-ancestor
110851874|NCT05673928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110658198|NCT00098839|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110851875|NCT05673928|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110851876|NCT05673928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110851878|NCT05615779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110851879|NCT05591092|Iodine|iodine|mesh-list
110851880|NCT05591092|Cadexomer iodine|cadexomer iodine|mesh-list
110851881|NCT05591092|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110851882|NCT05591092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110851883|NCT05591092|Trace Elements|trace elements|mesh-ancestor
110851884|NCT05591092|Micronutrients|micronutrients|mesh-ancestor
110851885|NCT05591092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110851886|NCT05513560|Pentoxifylline|pentoxifylline|mesh-list
110851887|NCT05513560|Ibudilast|ibudilast|mesh-list
110851888|NCT05513560|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110851889|NCT05513560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110851890|NCT05513560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110851891|NCT05513560|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110851892|NCT05513560|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110851893|NCT05513560|Protective Agents|protective agents|mesh-ancestor
110851894|NCT05513560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110851895|NCT05513560|Vasodilator Agents|vasodilator agents|mesh-ancestor
110851896|NCT05513560|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110851897|NCT05513560|Antioxidants|antioxidants|mesh-ancestor
110851898|NCT05513560|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110851899|NCT05513560|Autonomic Agents|autonomic agents|mesh-ancestor
110851900|NCT05513560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110851901|NCT05513560|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110851902|NCT05513560|Respiratory System Agents|respiratory system agents|mesh-ancestor
110851903|NCT05489796|Ketorolac|ketorolac|mesh-list
110851904|NCT05489796|Fentanyl|fentanyl|mesh-list
110851905|NCT05489796|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110851906|NCT05489796|Narcotics|narcotics|mesh-ancestor
110851907|NCT05489796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110851908|NCT05489796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110851909|NCT05489796|Analgesics|analgesics|mesh-ancestor
110851910|NCT05489796|Sensory System Agents|sensory system agents|mesh-ancestor
110851911|NCT05489796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110851912|NCT05489796|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110337314|NCT04696848|Durvalumab|durvalumab|mesh-list
110569486|NCT00775996|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110851913|NCT05489796|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110851914|NCT05489796|Anesthetics, General|anesthetics, general|mesh-ancestor
110851915|NCT05489796|Anesthetics|anesthetics|mesh-ancestor
110851916|NCT05489796|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110851917|NCT05489796|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110851918|NCT05489796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110851919|NCT05489796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110658468|NCT01085617|Cytarabine|cytarabine|mesh-list
110851921|NCT05489796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110851922|NCT05489796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110851923|NCT05435547|Dexamethasone|dexamethasone|mesh-list
110851924|NCT05435547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110851925|NCT05435547|Antiemetics|antiemetics|mesh-ancestor
110851926|NCT05435547|Autonomic Agents|autonomic agents|mesh-ancestor
110851927|NCT05435547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110851928|NCT05435547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110851929|NCT05435547|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110851930|NCT05435547|Glucocorticoids|glucocorticoids|mesh-ancestor
110851931|NCT05435547|Hormones|hormones|mesh-ancestor
110851932|NCT05435547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110851933|NCT05435547|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110851934|NCT05435547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110851935|NCT05422131|Clozapine|clozapine|mesh-list
110851936|NCT05422131|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110851937|NCT05422131|Serotonin Agents|serotonin agents|mesh-ancestor
110851938|NCT05422131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110851939|NCT05422131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110851940|NCT05422131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110851941|NCT05422131|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110851942|NCT05422131|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110851943|NCT05422131|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110851944|NCT05422131|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110851945|NCT05422131|GABA Antagonists|gaba antagonists|mesh-ancestor
110851946|NCT05422131|GABA Agents|gaba agents|mesh-ancestor
110851947|NCT05415228|Edetic Acid|edetic acid|mesh-list
110851948|NCT05415228|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
110851949|NCT05415228|Chelating Agents|chelating agents|mesh-ancestor
110851950|NCT05415228|Sequestering Agents|sequestering agents|mesh-ancestor
110851951|NCT05415228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110851952|NCT05415228|Anticoagulants|anticoagulants|mesh-ancestor
110851953|NCT05415228|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110851954|NCT05415228|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110851955|NCT05357079|Tranexamic Acid|tranexamic acid|mesh-list
110658789|NCT00483405|Capecitabine|capecitabine|mesh-list
110851956|NCT05357079|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110851957|NCT05357079|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110851958|NCT05357079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110851960|NCT05357079|Coagulants|coagulants|mesh-ancestor
110851961|NCT05326997|Tranexamic Acid|tranexamic acid|mesh-list
110851962|NCT05326997|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110851963|NCT05326997|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110658865|NCT00752921|Etoricoxib|etoricoxib|mesh-list
110851964|NCT05326997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110851965|NCT05326997|Hemostatics|hemostatics|mesh-ancestor
110658931|NCT00482703|Dasatinib|dasatinib|mesh-list
110851966|NCT05326997|Coagulants|coagulants|mesh-ancestor
110851967|NCT05309629|Carboplatin|carboplatin|mesh-list
110851968|NCT05309629|Etoposide|etoposide|mesh-list
110851969|NCT05309629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110851970|NCT05309629|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110851971|NCT05309629|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110851972|NCT05309629|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110851973|NCT05309629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110851974|NCT05309629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110851975|NCT05209620|Pemetrexed|pemetrexed|mesh-list
110851976|NCT05209620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110337328|NCT01244256|Hormones|hormones|mesh-ancestor
110851977|NCT05209620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110851978|NCT05209620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110851979|NCT05209620|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110851980|NCT05209620|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110851981|NCT05204836|Zoledronic Acid|zoledronic acid|mesh-list
110851982|NCT05204836|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110851983|NCT05204836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110851984|NCT05184062|Cilgavimab and tixagevimab drug combination|cilgavimab and tixagevimab drug combination|mesh-list
110851985|NCT05184062|Antiviral Agents|antiviral agents|mesh-ancestor
110851986|NCT05184062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110851987|NCT05153304|Nivolumab|nivolumab|mesh-list
110851988|NCT05153304|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110851989|NCT05153304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110851990|NCT05153304|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110851991|NCT05153304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110851992|NCT05109728|Temozolomide|temozolomide|mesh-list
110851993|NCT05109728|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
110851994|NCT05109728|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
110851995|NCT05109728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110851996|NCT05109728|Alkylating Agents|alkylating agents|mesh-ancestor
110851997|NCT05109728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110851998|NCT05109728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110851999|NCT05109728|Chelating Agents|chelating agents|mesh-ancestor
110659019|NCT00757835|Timolol|timolol|mesh-list
110852000|NCT05109728|Sequestering Agents|sequestering agents|mesh-ancestor
110852001|NCT05109728|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110852002|NCT05071183|Trametinib|trametinib|mesh-list
110852003|NCT05071183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110852004|NCT05071183|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110852005|NCT05071183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110852006|NCT05071183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110852007|NCT05068726|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
110852008|NCT05068726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110852009|NCT05022901|Melphalan|melphalan|mesh-list
110852010|NCT05022901|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110852011|NCT05022901|Alkylating Agents|alkylating agents|mesh-ancestor
110852012|NCT05022901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110852013|NCT05022901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110852014|NCT05022901|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110852015|NCT05022901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110852016|NCT05022901|Immunologic Factors|immunologic factors|mesh-ancestor
110852017|NCT05022901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110852018|NCT05009862|Aspirin|aspirin|mesh-list
110852019|NCT05009862|Rivaroxaban|rivaroxaban|mesh-list
110832982|NCT03720847|Estradiol|estradiol|mesh-list
110852020|NCT05009862|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110852021|NCT05009862|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110852022|NCT05009862|Analgesics|analgesics|mesh-ancestor
110852023|NCT05009862|Sensory System Agents|sensory system agents|mesh-ancestor
110852024|NCT05009862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110852025|NCT05009862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110852026|NCT05009862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110852027|NCT05009862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110852028|NCT05009862|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110852029|NCT05009862|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110852030|NCT05009862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110852031|NCT05009862|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110852032|NCT05009862|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110852033|NCT05009862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110852034|NCT05009862|Antipyretics|antipyretics|mesh-ancestor
110852035|NCT05009862|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110852036|NCT05009862|Antithrombins|antithrombins|mesh-ancestor
110852037|NCT05009862|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110852038|NCT05009862|Protease Inhibitors|protease inhibitors|mesh-ancestor
110852039|NCT05009862|Anticoagulants|anticoagulants|mesh-ancestor
110852040|NCT04973748|Analgesics, Opioid|analgesics, opioid|mesh-list
110852041|NCT04973748|Narcotics|narcotics|mesh-ancestor
110852042|NCT04973748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110852043|NCT04973748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110852044|NCT04973748|Analgesics|analgesics|mesh-ancestor
110852045|NCT04973748|Sensory System Agents|sensory system agents|mesh-ancestor
110852046|NCT04973748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110852047|NCT04968054|Propofol|propofol|mesh-list
110852049|NCT04968054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110852050|NCT04968054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110852051|NCT04968054|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110852052|NCT04968054|Anesthetics, General|anesthetics, general|mesh-ancestor
110852053|NCT04968054|Anesthetics|anesthetics|mesh-ancestor
110852054|NCT04967495|Lenvatinib|lenvatinib|mesh-list
110852055|NCT04967495|Chlorotrianisene|chlorotrianisene|mesh-list
110852056|NCT04967495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110852057|NCT04967495|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110852058|NCT04967495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110852059|NCT04967495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110852060|NCT04967495|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
110852061|NCT04967495|Estrogens|estrogens|mesh-ancestor
110852062|NCT04967495|Hormones|hormones|mesh-ancestor
110852063|NCT04967495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110852064|NCT04967495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110852065|NCT04967495|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110852066|NCT04965766|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
110852067|NCT04965766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110852068|NCT04965766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110852069|NCT04933721|Berotralstat|berotralstat|mesh-list
110852070|NCT04933721|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110852071|NCT04933721|Protease Inhibitors|protease inhibitors|mesh-ancestor
110852072|NCT04933721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110852073|NCT04933721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110852075|NCT04828135|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110852076|NCT04828135|Anesthetics, General|anesthetics, general|mesh-ancestor
110852078|NCT04828135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110852079|NCT04828135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110659061|NCT01324180|Hormones|hormones|mesh-ancestor
110852080|NCT04815720|Pembrolizumab|pembrolizumab|mesh-list
110852081|NCT04815720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110852082|NCT04815720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110852083|NCT04815720|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110852084|NCT04815720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110852085|NCT04777851|Pembrolizumab|pembrolizumab|mesh-list
110852086|NCT04777851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110852087|NCT04777851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110852088|NCT04777851|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110852089|NCT04777851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110852090|NCT04765111|Rituximab|rituximab|mesh-list
110852091|NCT04765111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110852092|NCT04765111|Acalabrutinib|acalabrutinib|mesh-list
110852093|NCT04765111|Antibodies|antibodies|mesh-list
110852094|NCT04765111|Immunoglobulins|immunoglobulins|mesh-list
110852095|NCT04765111|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110852096|NCT04765111|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
110852097|NCT04765111|Immunologic Factors|immunologic factors|mesh-ancestor
110852098|NCT04765111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110659119|NCT00682643|Xhance|xhance|mesh-list
110852099|NCT04765111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110852100|NCT04765111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110659161|NCT01038388|Bortezomib|bortezomib|mesh-list
110852101|NCT04765111|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110852103|NCT04765111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110852104|NCT04737889|Rituximab|rituximab|mesh-list
110852105|NCT04737889|Methotrexate|methotrexate|mesh-list
110852106|NCT04737889|Lenalidomide|lenalidomide|mesh-list
110852107|NCT04737889|Temozolomide|temozolomide|mesh-list
110852108|NCT04737889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110852109|NCT04737889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110852110|NCT04737889|Immunologic Factors|immunologic factors|mesh-ancestor
110852111|NCT04737889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110852112|NCT04737889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110852113|NCT04737889|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110852114|NCT04737889|Abortifacient Agents|abortifacient agents|mesh-ancestor
110852115|NCT04737889|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110852116|NCT04737889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110852117|NCT04737889|Antimetabolites|antimetabolites|mesh-ancestor
110852118|NCT04737889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110852119|NCT04737889|Dermatologic Agents|dermatologic agents|mesh-ancestor
110852120|NCT04737889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110852121|NCT04737889|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110852122|NCT04737889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110852123|NCT04737889|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110852124|NCT04737889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110852125|NCT04737889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110852126|NCT04737889|Growth Substances|growth substances|mesh-ancestor
110852127|NCT04737889|Growth Inhibitors|growth inhibitors|mesh-ancestor
110852128|NCT04737889|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110852129|NCT04737889|Alkylating Agents|alkylating agents|mesh-ancestor
110852131|NCT04735354|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
110852132|NCT04735354|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110852133|NCT04735354|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110852134|NCT04735354|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110852135|NCT04735354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110852136|NCT04679740|Sirolimus|sirolimus|mesh-list
110569711|NCT02556970|Anesthetics|anesthetics|mesh-ancestor
110833011|NCT01218737|Hormones|hormones|mesh-ancestor
110852137|NCT04679740|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110852138|NCT04679740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110852139|NCT04679740|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110852140|NCT04679740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110852141|NCT04679740|Antifungal Agents|antifungal agents|mesh-ancestor
110852142|NCT04679740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110852143|NCT04679740|Immunologic Factors|immunologic factors|mesh-ancestor
110852144|NCT04679740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110852145|NCT04672291|Poly I-C|poly i-c|mesh-list
110852146|NCT04672291|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
110852147|NCT04672291|Poly ICLC|poly iclc|mesh-list
110852148|NCT04672291|Interferon Inducers|interferon inducers|mesh-ancestor
110852149|NCT04672291|Immunologic Factors|immunologic factors|mesh-ancestor
110852150|NCT04672291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110852151|NCT04672291|Laxatives|laxatives|mesh-ancestor
110852152|NCT04672291|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110852153|NCT04672291|Antiviral Agents|antiviral agents|mesh-ancestor
110852154|NCT04672291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110852155|NCT04668365|Prednisone|prednisone|mesh-list
110852156|NCT04668365|Cyclophosphamide|cyclophosphamide|mesh-list
110852157|NCT04668365|Rituximab|rituximab|mesh-list
110852158|NCT04668365|Vincristine|vincristine|mesh-list
110852159|NCT04668365|Epirubicin|epirubicin|mesh-list
110852160|NCT04668365|Zanubrutinib|zanubrutinib|mesh-list
110852161|NCT04668365|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110852162|NCT04668365|Immunologic Factors|immunologic factors|mesh-ancestor
110852163|NCT04668365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110852164|NCT04668365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110659700|NCT00964418|Insulin|insulin|mesh-list
110852165|NCT04668365|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110852166|NCT04668365|Alkylating Agents|alkylating agents|mesh-ancestor
110852167|NCT04668365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110852168|NCT04668365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110852169|NCT04668365|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110852170|NCT04668365|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110852171|NCT04668365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110852172|NCT04668365|Glucocorticoids|glucocorticoids|mesh-ancestor
110852173|NCT04668365|Hormones|hormones|mesh-ancestor
110852174|NCT04668365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110852175|NCT04668365|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110852176|NCT04668365|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110852177|NCT04668365|Tubulin Modulators|tubulin modulators|mesh-ancestor
110852178|NCT04668365|Antimitotic Agents|antimitotic agents|mesh-ancestor
110852179|NCT04668365|Mitosis Modulators|mitosis modulators|mesh-ancestor
110852180|NCT04668365|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110852181|NCT04668365|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110852182|NCT04668365|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110852183|NCT04668365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110852184|NCT04668365|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110852185|NCT04646395|Acalabrutinib|acalabrutinib|mesh-list
110852186|NCT04646395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110852187|NCT04616729|Triptorelin Pamoate|triptorelin pamoate|mesh-list
110852188|NCT04616729|Luteolytic Agents|luteolytic agents|mesh-ancestor
110852189|NCT04616729|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110852190|NCT04616729|Contraceptive Agents|contraceptive agents|mesh-ancestor
110852191|NCT04616729|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110852192|NCT04616729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110852193|NCT04616729|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110852194|NCT04616729|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110852195|NCT04616729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110852196|NCT04496401|Tacrolimus|tacrolimus|mesh-list
110852197|NCT04496401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110852198|NCT04496401|Immunologic Factors|immunologic factors|mesh-ancestor
110852199|NCT04496401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110852200|NCT04496401|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110852201|NCT04496401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110660045|NCT00975494|Urological Agents|urological agents|mesh-ancestor
110852202|NCT04496401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110852203|NCT04433156|Prednisone|prednisone|mesh-list
110852204|NCT04433156|Cyclophosphamide|cyclophosphamide|mesh-list
110852205|NCT04433156|Rituximab|rituximab|mesh-list
110852206|NCT04433156|Bortezomib|bortezomib|mesh-list
110852207|NCT04433156|Epirubicin|epirubicin|mesh-list
110852208|NCT04433156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110852209|NCT04433156|Immunologic Factors|immunologic factors|mesh-ancestor
110852210|NCT04433156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110852211|NCT04433156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110852212|NCT04433156|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110852213|NCT04433156|Alkylating Agents|alkylating agents|mesh-ancestor
110852214|NCT04433156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110852215|NCT04433156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110852216|NCT04433156|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110660243|NCT00990444|Blood Substitutes|blood substitutes|mesh-ancestor
110852217|NCT04433156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110852218|NCT04433156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110852219|NCT04433156|Glucocorticoids|glucocorticoids|mesh-ancestor
110852220|NCT04433156|Hormones|hormones|mesh-ancestor
110852221|NCT04433156|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110852222|NCT04433156|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110852223|NCT04433156|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110852224|NCT04433156|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110852225|NCT04433156|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110852226|NCT04433156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110852227|NCT04388176|Compound 21|compound 21|mesh-list
110852228|NCT04388176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110852229|NCT04354129|Immunoglobulins|immunoglobulins|mesh-list
110852230|NCT04354129|Immunologic Factors|immunologic factors|mesh-ancestor
110852231|NCT04354129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110852232|NCT04311489|Ularitide|ularitide|mesh-list
110852233|NCT04311489|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110852234|NCT04311489|Autonomic Agents|autonomic agents|mesh-ancestor
110852235|NCT04311489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110852236|NCT04311489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110852237|NCT04311489|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110852238|NCT04311489|Respiratory System Agents|respiratory system agents|mesh-ancestor
110852239|NCT04311489|Diuretics|diuretics|mesh-ancestor
110852240|NCT04311489|Natriuretic Agents|natriuretic agents|mesh-ancestor
110852241|NCT04305405|Benralizumab|benralizumab|mesh-list
110852242|NCT04305405|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110098832|NCT01744444|Anticonvulsants|anticonvulsants|mesh-ancestor
110852243|NCT04305405|Respiratory System Agents|respiratory system agents|mesh-ancestor
110852244|NCT04258488|Vitamin K|vitamin k|mesh-list
110852245|NCT04258488|Warfarin|warfarin|mesh-list
110852246|NCT04258488|Rivaroxaban|rivaroxaban|mesh-list
110852247|NCT04258488|Vitamins|vitamins|mesh-ancestor
110852248|NCT04258488|Micronutrients|micronutrients|mesh-ancestor
110852249|NCT04258488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110852250|NCT04258488|Anticoagulants|anticoagulants|mesh-ancestor
110852251|NCT04258488|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110852252|NCT04258488|Antithrombins|antithrombins|mesh-ancestor
110852253|NCT04258488|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110852254|NCT04258488|Protease Inhibitors|protease inhibitors|mesh-ancestor
110852255|NCT04258488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110852256|NCT04258488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110852257|NCT04258488|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110852258|NCT04258488|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110852259|NCT04258488|Hemostatics|hemostatics|mesh-ancestor
110852261|NCT04255134|Adalimumab|adalimumab|mesh-list
110852262|NCT04255134|Abatacept|abatacept|mesh-list
110852263|NCT04255134|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110852264|NCT04255134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110852265|NCT04255134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110852266|NCT04255134|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110099116|NCT01746641|Anesthetics|anesthetics|mesh-ancestor
110852267|NCT04255134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110852268|NCT04255134|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110852269|NCT04255134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110852270|NCT04255134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110852271|NCT04255134|Immunologic Factors|immunologic factors|mesh-ancestor
110852272|NCT04255134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110852274|NCT04214626|Cyclophosphamide|cyclophosphamide|mesh-list
110852275|NCT04214626|Rituximab|rituximab|mesh-list
110852276|NCT04214626|Methotrexate|methotrexate|mesh-list
110852277|NCT04214626|Vincristine|vincristine|mesh-list
110852278|NCT04214626|Lenalidomide|lenalidomide|mesh-list
110852279|NCT04214626|Epirubicin|epirubicin|mesh-list
110852280|NCT04214626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110852281|NCT04214626|Immunologic Factors|immunologic factors|mesh-ancestor
110099323|NCT01747616|Acetylcysteine|acetylcysteine|mesh-list
110852282|NCT04214626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110852283|NCT04214626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110852284|NCT04214626|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110852285|NCT04214626|Alkylating Agents|alkylating agents|mesh-ancestor
110852286|NCT04214626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110852287|NCT04214626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110852288|NCT04214626|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110852289|NCT04214626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110099465|NCT01748370|Vitamins|vitamins|mesh-list
110852290|NCT04214626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110852292|NCT04214626|Hormones|hormones|mesh-ancestor
110337379|NCT04519385|Hormones|hormones|mesh-ancestor
110852293|NCT04214626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110852294|NCT04214626|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110099538|NCT01748630|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110852295|NCT04214626|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110852296|NCT04214626|Abortifacient Agents|abortifacient agents|mesh-ancestor
110852297|NCT04214626|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110852298|NCT04214626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110852299|NCT04214626|Antimetabolites|antimetabolites|mesh-ancestor
110852300|NCT04214626|Dermatologic Agents|dermatologic agents|mesh-ancestor
110852301|NCT04214626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110852302|NCT04214626|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110852303|NCT04214626|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110852304|NCT04214626|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110852305|NCT04214626|Tubulin Modulators|tubulin modulators|mesh-ancestor
110852306|NCT04214626|Antimitotic Agents|antimitotic agents|mesh-ancestor
110852307|NCT04214626|Mitosis Modulators|mitosis modulators|mesh-ancestor
110852308|NCT04214626|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110852309|NCT04214626|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110852310|NCT04214626|Growth Substances|growth substances|mesh-ancestor
110852311|NCT04214626|Growth Inhibitors|growth inhibitors|mesh-ancestor
110852312|NCT04214626|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110852313|NCT04214626|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110852314|NCT04214626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110852315|NCT04192370|Cannabidiol|cannabidiol|mesh-list
110852316|NCT04192370|Anticonvulsants|anticonvulsants|mesh-ancestor
110852318|NCT04180371|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110852319|NCT04180371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110852320|NCT04180371|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110099966|NCT01750983|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110852321|NCT04180371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110100035|NCT01751373|Botulinum Toxins|botulinum toxins|mesh-list
110852323|NCT04160910|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110852324|NCT04160910|Antidepressive Agents|antidepressive agents|mesh-ancestor
110852325|NCT04160910|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110852326|NCT04125472|Lumasiran|lumasiran|mesh-list
110852327|NCT04125472|Renal Agents|renal agents|mesh-ancestor
110852328|NCT04067037|Vincristine|vincristine|mesh-list
110852329|NCT04067037|Epirubicin|epirubicin|mesh-list
110852331|NCT04067037|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110852332|NCT04067037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110852333|NCT04067037|Tubulin Modulators|tubulin modulators|mesh-ancestor
110852334|NCT04067037|Antimitotic Agents|antimitotic agents|mesh-ancestor
110852335|NCT04067037|Mitosis Modulators|mitosis modulators|mesh-ancestor
110852336|NCT04067037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110852337|NCT04067037|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110852338|NCT04067037|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110852339|NCT04067037|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110852340|NCT04067037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110852341|NCT04067037|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110852342|NCT04067037|Alkylating Agents|alkylating agents|mesh-ancestor
110852343|NCT03632941|Pembrolizumab|pembrolizumab|mesh-list
110852344|NCT03632941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110852345|NCT03632941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110852346|NCT03632941|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110852347|NCT03632941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110852348|NCT03601507|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-list
110852350|NCT03601507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110852351|NCT03568058|Pembrolizumab|pembrolizumab|mesh-list
110100458|NCT01755338|Glucocorticoids|glucocorticoids|mesh-ancestor
110852352|NCT03568058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110852353|NCT03568058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110852354|NCT03568058|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110100537|NCT01755572|Liraglutide|liraglutide|mesh-list
110852355|NCT03568058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110852356|NCT03502785|Atezolizumab|atezolizumab|mesh-list
110852357|NCT03502785|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110852358|NCT03502785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110852359|NCT03502785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110852360|NCT03502785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110852361|NCT03495960|Rituximab|rituximab|mesh-list
110852362|NCT03495960|Methotrexate|methotrexate|mesh-list
110852363|NCT03495960|Lenalidomide|lenalidomide|mesh-list
110852364|NCT03495960|Temozolomide|temozolomide|mesh-list
110852365|NCT03495960|Procarbazine|procarbazine|mesh-list
110852366|NCT03495960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110852367|NCT03495960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110852368|NCT03495960|Immunologic Factors|immunologic factors|mesh-ancestor
110852369|NCT03495960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110852370|NCT03495960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110852371|NCT03495960|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110852372|NCT03495960|Abortifacient Agents|abortifacient agents|mesh-ancestor
110852373|NCT03495960|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110852374|NCT03495960|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110852375|NCT03495960|Antimetabolites|antimetabolites|mesh-ancestor
110852376|NCT03495960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110852377|NCT03495960|Dermatologic Agents|dermatologic agents|mesh-ancestor
110852378|NCT03495960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110852379|NCT03495960|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110852380|NCT03495960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110852381|NCT03495960|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110852382|NCT03495960|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110852383|NCT03495960|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110852384|NCT03495960|Growth Substances|growth substances|mesh-ancestor
110852386|NCT03495960|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110852387|NCT03495960|Alkylating Agents|alkylating agents|mesh-ancestor
110852388|NCT03491683|Temozolomide|temozolomide|mesh-list
110852389|NCT03491683|Cemiplimab|cemiplimab|mesh-list
110852390|NCT03491683|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110852391|NCT03491683|Alkylating Agents|alkylating agents|mesh-ancestor
110101018|NCT01758120|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110852392|NCT03491683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110852393|NCT03491683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110852394|NCT03491683|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110852395|NCT03351296|Bevacizumab|bevacizumab|mesh-list
110852396|NCT03351296|Capecitabine|capecitabine|mesh-list
110852397|NCT03351296|Temozolomide|temozolomide|mesh-list
110852398|NCT03351296|Streptozocin|streptozocin|mesh-list
110852399|NCT03351296|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110101088|NCT01758380|Metformin|metformin|mesh-list
110852400|NCT03351296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110852401|NCT03351296|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110852402|NCT03351296|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110852403|NCT03351296|Growth Substances|growth substances|mesh-ancestor
110852404|NCT03351296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110852405|NCT03351296|Growth Inhibitors|growth inhibitors|mesh-ancestor
110852406|NCT03351296|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110852407|NCT03351296|Antimetabolites|antimetabolites|mesh-ancestor
110852408|NCT03351296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110852409|NCT03351296|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110852410|NCT03351296|Alkylating Agents|alkylating agents|mesh-ancestor
110852411|NCT03351296|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110337397|NCT04510649|Rifampin|rifampin|mesh-list
110852412|NCT03345823|Upadacitinib|upadacitinib|mesh-list
110852413|NCT03345823|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
110101297|NCT01759732|Immunologic Factors|immunologic factors|mesh-ancestor
110852414|NCT03345823|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110852415|NCT03345823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110852416|NCT03345823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110852417|NCT03345823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110852419|NCT03203850|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110852420|NCT03203850|Chelating Agents|chelating agents|mesh-ancestor
110852421|NCT03203850|Sequestering Agents|sequestering agents|mesh-ancestor
110101441|NCT01760226|Tubulin Modulators|tubulin modulators|mesh-ancestor
110852422|NCT03203850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110852423|NCT03138161|Nivolumab|nivolumab|mesh-list
110852424|NCT03138161|Ipilimumab|ipilimumab|mesh-list
110852425|NCT03138161|Trabectedin|trabectedin|mesh-list
110852426|NCT03138161|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110852427|NCT03138161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110852428|NCT03138161|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110101518|NCT01760642|Midazolam|midazolam|mesh-list
110852429|NCT03138161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110852430|NCT03138161|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110852431|NCT03138161|Alkylating Agents|alkylating agents|mesh-ancestor
110852432|NCT03091075|Oxandrolone|oxandrolone|mesh-list
110852433|NCT03091075|Androgens|androgens|mesh-ancestor
110852434|NCT03091075|Hormones|hormones|mesh-ancestor
110852435|NCT03091075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110852436|NCT03091075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110852437|NCT03091075|Anabolic Agents|anabolic agents|mesh-ancestor
110852438|NCT03031821|Metformin|metformin|mesh-list
110852439|NCT03031821|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110852440|NCT03031821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110852441|NCT02907359|Guadecitabine|guadecitabine|mesh-list
110852442|NCT02907359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110852443|NCT02714205|Nitroglycerin|nitroglycerin|mesh-list
110852444|NCT02714205|Vasodilator Agents|vasodilator agents|mesh-ancestor
110852445|NCT02669173|Bevacizumab|bevacizumab|mesh-list
110852446|NCT02669173|Capecitabine|capecitabine|mesh-list
110852447|NCT02669173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110101717|NCT01761526|Rotigotine|rotigotine|mesh-list
110852448|NCT02669173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110852449|NCT02669173|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110852450|NCT02669173|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110852451|NCT02669173|Growth Substances|growth substances|mesh-ancestor
110852452|NCT02669173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110852453|NCT02669173|Growth Inhibitors|growth inhibitors|mesh-ancestor
110852454|NCT02669173|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110852455|NCT02669173|Antimetabolites|antimetabolites|mesh-ancestor
110852456|NCT02669173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110852457|NCT02647437|Levetiracetam|levetiracetam|mesh-list
110852458|NCT02647437|Anticonvulsants|anticonvulsants|mesh-ancestor
110852459|NCT02647437|Nootropic Agents|nootropic agents|mesh-ancestor
110852461|NCT02329080|Rituximab|rituximab|mesh-list
110852462|NCT02329080|Methotrexate|methotrexate|mesh-list
110852463|NCT02329080|Etoposide|etoposide|mesh-list
110852464|NCT02329080|Ifosfamide|ifosfamide|mesh-list
110852465|NCT02329080|Thiotepa|thiotepa|mesh-list
110852466|NCT02329080|Carmustine|carmustine|mesh-list
110852467|NCT02329080|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110852468|NCT02329080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110852470|NCT02329080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110852471|NCT02329080|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110852472|NCT02329080|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110852473|NCT02329080|Abortifacient Agents|abortifacient agents|mesh-ancestor
110852474|NCT02329080|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110852475|NCT02329080|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110852476|NCT02329080|Antimetabolites|antimetabolites|mesh-ancestor
110852477|NCT02329080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110852478|NCT02329080|Dermatologic Agents|dermatologic agents|mesh-ancestor
110852479|NCT02329080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110852480|NCT02329080|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110852482|NCT02329080|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110852483|NCT02329080|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110101836|NCT01762306|Folic Acid|folic acid|mesh-list
110852484|NCT02329080|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110852485|NCT02329080|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110852486|NCT02329080|Antiviral Agents|antiviral agents|mesh-ancestor
110852487|NCT02329080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110852488|NCT02329080|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110852489|NCT02329080|Alkylating Agents|alkylating agents|mesh-ancestor
110852490|NCT02329080|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110852491|NCT02227927|Domperidone|domperidone|mesh-list
110852492|NCT02227927|Antiemetics|antiemetics|mesh-ancestor
110852493|NCT02227927|Autonomic Agents|autonomic agents|mesh-ancestor
110852494|NCT02227927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110852495|NCT02227927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110852496|NCT02227927|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110852497|NCT02227927|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110852498|NCT02227927|Dopamine Agents|dopamine agents|mesh-ancestor
110852499|NCT02227927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110852500|NCT02227927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110852501|NCT01820910|Doxycycline|doxycycline|mesh-list
110852502|NCT01820910|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110852503|NCT01820910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110852504|NCT01820910|Antimalarials|antimalarials|mesh-ancestor
110852505|NCT01820910|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110852506|NCT01820910|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110852507|NCT01808599|Rituximab|rituximab|mesh-list
110852508|NCT01808599|Chlorambucil|chlorambucil|mesh-list
110852509|NCT01808599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110852510|NCT01808599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110852511|NCT01808599|Immunologic Factors|immunologic factors|mesh-ancestor
110852512|NCT01808599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110852513|NCT01808599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110852514|NCT01808599|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110852515|NCT01808599|Alkylating Agents|alkylating agents|mesh-ancestor
110102251|NCT01764555|Acetaminophen|acetaminophen|mesh-list
110852516|NCT01808599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110852519|NCT00071071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110852520|NCT00071071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110852521|NCT00071071|Immunologic Factors|immunologic factors|mesh-ancestor
110852522|NCT00071071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110852523|NCT05465278|Alirocumab|alirocumab|mesh-list
110852524|NCT05465278|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
110852525|NCT05465278|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110852526|NCT05465278|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110852527|NCT05465278|Antimetabolites|antimetabolites|mesh-ancestor
110852528|NCT05465278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110852529|NCT05465278|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110852530|NCT05465278|Protease Inhibitors|protease inhibitors|mesh-ancestor
110852531|NCT05465278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110852532|NCT05465278|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110852534|NCT01302275|Anticonvulsants|anticonvulsants|mesh-ancestor
110852535|NCT01302275|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110102455|NCT01765829|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110852537|NCT01302275|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110852538|NCT01302275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110852539|NCT01302275|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110852540|NCT01302275|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110852542|NCT03339544|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110852543|NCT03339544|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110852544|NCT03339544|Analgesics|analgesics|mesh-ancestor
110852545|NCT03339544|Sensory System Agents|sensory system agents|mesh-ancestor
110337416|NCT01249092|Pentoxifylline|pentoxifylline|mesh-list
110852546|NCT03339544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110852547|NCT03339544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110852548|NCT03339544|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110852549|NCT03339544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110852550|NCT03339544|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110852551|NCT03339544|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110852552|NCT03339544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110852553|NCT03339544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110852554|NCT03332602|Vitamins|vitamins|mesh-list
110852555|NCT03332602|Folic Acid|folic acid|mesh-list
110852556|NCT03332602|Vitamin A|vitamin a|mesh-list
110852557|NCT03332602|Retinol palmitate|retinol palmitate|mesh-list
110852558|NCT03332602|Fesoterodine|fesoterodine|mesh-list
110852559|NCT03332602|Hyaluronic Acid|hyaluronic acid|mesh-list
110852560|NCT03332602|Micronutrients|micronutrients|mesh-ancestor
110852561|NCT03332602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110852562|NCT03332602|Hematinics|hematinics|mesh-ancestor
110852563|NCT03332602|Vitamin B Complex|vitamin b complex|mesh-ancestor
110852564|NCT03332602|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110852565|NCT03332602|Immunologic Factors|immunologic factors|mesh-ancestor
110852566|NCT03332602|Viscosupplements|viscosupplements|mesh-ancestor
110852567|NCT03332602|Protective Agents|protective agents|mesh-ancestor
110852569|NCT03332602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110852570|NCT03332602|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110852571|NCT03332602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110852572|NCT03332602|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110852573|NCT03332602|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110852574|NCT03332602|Cholinergic Agents|cholinergic agents|mesh-ancestor
110852575|NCT03332602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110852576|NCT03332602|Urological Agents|urological agents|mesh-ancestor
110852577|NCT01302353|Isoflurane|isoflurane|mesh-list
110852578|NCT01302353|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110852579|NCT01302353|Anesthetics, General|anesthetics, general|mesh-ancestor
110852580|NCT01302353|Anesthetics|anesthetics|mesh-ancestor
110852581|NCT01302353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110852582|NCT01302353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110852583|NCT03812315|Propolis|propolis|mesh-list
110852584|NCT03812315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110852585|NCT03332524|Chlorpheniramine|chlorpheniramine|mesh-list
110852586|NCT03332524|Ibuprofen|ibuprofen|mesh-list
110852587|NCT03332524|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110102902|NCT01768351|Calcitriol|calcitriol|mesh-list
110852588|NCT03332524|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110852590|NCT03332524|Sensory System Agents|sensory system agents|mesh-ancestor
110852591|NCT03332524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110102926|NCT01768377|Sensory System Agents|sensory system agents|mesh-ancestor
110852592|NCT03332524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110852593|NCT03332524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110852594|NCT03332524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110852595|NCT03332524|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110852596|NCT03332524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110852597|NCT03332524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110852599|NCT03332524|Dermatologic Agents|dermatologic agents|mesh-ancestor
110852600|NCT03332524|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110852601|NCT03332524|Histamine Antagonists|histamine antagonists|mesh-ancestor
110852602|NCT03332524|Histamine Agents|histamine agents|mesh-ancestor
110852603|NCT03332524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110852604|NCT03332524|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110852606|NCT02499484|Vasodilator Agents|vasodilator agents|mesh-ancestor
110852607|NCT03812003|Remifentanil|remifentanil|mesh-list
110852608|NCT03812003|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110852609|NCT03812003|Narcotics|narcotics|mesh-ancestor
110833064|NCT03825133|Hyaluronic Acid|hyaluronic acid|mesh-list
110852610|NCT03812003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110852611|NCT03812003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110103136|NCT01769625|Analgesics|analgesics|mesh-ancestor
110852613|NCT03812003|Sensory System Agents|sensory system agents|mesh-ancestor
110852614|NCT03812003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110852615|NCT04874610|Methylprednisolone|methylprednisolone|mesh-list
110852616|NCT04874610|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110852617|NCT04874610|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110852619|NCT04874610|Prednisolone acetate|prednisolone acetate|mesh-list
110852620|NCT04874610|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110852621|NCT04874610|Prednisolone phosphate|prednisolone phosphate|mesh-list
110852622|NCT04874610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110852623|NCT04874610|Antiemetics|antiemetics|mesh-ancestor
110852624|NCT04874610|Autonomic Agents|autonomic agents|mesh-ancestor
110852625|NCT04874610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110852626|NCT04874610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110852627|NCT04874610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110852628|NCT04874610|Glucocorticoids|glucocorticoids|mesh-ancestor
110852629|NCT04874610|Hormones|hormones|mesh-ancestor
110852630|NCT04874610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110852631|NCT04874610|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110852632|NCT04874610|Protective Agents|protective agents|mesh-ancestor
110852633|NCT04874610|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110852634|NCT04874610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110852635|NCT03518125|Vaccines|vaccines|mesh-list
110852636|NCT03518125|Immunologic Factors|immunologic factors|mesh-ancestor
110852637|NCT03518125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110852638|NCT02492230|Warfarin|warfarin|mesh-list
110852639|NCT02492230|Anticoagulants|anticoagulants|mesh-ancestor
110852640|NCT03169530|Ethanol|ethanol|mesh-list
110852641|NCT03169530|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110852642|NCT03169530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110852643|NCT03169530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110852644|NCT03169530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110852646|NCT02440230|Exemestane|exemestane|mesh-list
110852647|NCT02440230|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110852648|NCT02440230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110852649|NCT02440230|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110852650|NCT02440230|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110852651|NCT02440230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110852652|NCT02440230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110852653|NCT02440230|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110852654|NCT02440230|Hormone Antagonists|hormone antagonists|mesh-ancestor
110852655|NCT02440230|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110852656|NCT02440230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110852657|NCT03478891|Ansuvimab|ansuvimab|mesh-list
110852658|NCT03478891|Antiviral Agents|antiviral agents|mesh-ancestor
110852659|NCT03478891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110852660|NCT00706966|Dutasteride|dutasteride|mesh-list
110852661|NCT00706966|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
110852662|NCT00706966|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110852663|NCT00706966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110852664|NCT00706966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110852666|NCT00706966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110852667|NCT00706966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110852668|NCT01330524|Triamcinolone|triamcinolone|mesh-list
110852669|NCT01330524|Bevacizumab|bevacizumab|mesh-list
110852670|NCT01330524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110852671|NCT01330524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110852672|NCT01330524|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110852673|NCT01330524|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110852674|NCT01330524|Growth Substances|growth substances|mesh-ancestor
110852675|NCT01330524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110852676|NCT01330524|Growth Inhibitors|growth inhibitors|mesh-ancestor
110852677|NCT01330524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110852678|NCT01330524|Glucocorticoids|glucocorticoids|mesh-ancestor
110852679|NCT01330524|Hormones|hormones|mesh-ancestor
110852680|NCT01330524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110852682|NCT01560065|Vitamin B Complex|vitamin b complex|mesh-list
110852683|NCT01560065|Inositol|inositol|mesh-list
110852684|NCT01560065|Hematinics|hematinics|mesh-ancestor
110852685|NCT01560065|Vitamins|vitamins|mesh-ancestor
110852686|NCT01560065|Micronutrients|micronutrients|mesh-ancestor
110852687|NCT01560065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110852688|NCT01302587|Albuterol|albuterol|mesh-list
110852689|NCT01302587|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110103683|NCT01772953|Treosulfan|treosulfan|mesh-list
110852690|NCT01302587|Autonomic Agents|autonomic agents|mesh-ancestor
110852691|NCT01302587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110852692|NCT01302587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110852693|NCT01302587|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110852694|NCT01302587|Respiratory System Agents|respiratory system agents|mesh-ancestor
110852696|NCT01302587|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110852697|NCT01302587|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110852698|NCT01302587|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110852699|NCT01302587|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110852700|NCT01302587|Adrenergic Agents|adrenergic agents|mesh-ancestor
110852701|NCT01302587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110852702|NCT01302587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110852703|NCT03723109|Anesthetics|anesthetics|mesh-list
110852704|NCT03723109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110852705|NCT03723109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110852706|NCT03018288|Pembrolizumab|pembrolizumab|mesh-list
110852707|NCT03018288|Temozolomide|temozolomide|mesh-list
110103865|NCT01774474|Triamcinolone|triamcinolone|mesh-list
110852708|NCT03018288|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110852709|NCT03018288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110852710|NCT03018288|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110852711|NCT03018288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110852712|NCT03018288|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110103934|NCT01775098|Allopurinol|allopurinol|mesh-list
110852713|NCT03018288|Alkylating Agents|alkylating agents|mesh-ancestor
110852714|NCT03515941|Leucovorin|leucovorin|mesh-list
110852715|NCT03515941|Fluorouracil|fluorouracil|mesh-list
110852716|NCT03515941|Capecitabine|capecitabine|mesh-list
110852717|NCT03515941|Oxaliplatin|oxaliplatin|mesh-list
110852718|NCT03515941|Antimetabolites|antimetabolites|mesh-ancestor
110852719|NCT03515941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110852720|NCT03515941|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110852721|NCT03515941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110852722|NCT03515941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110852723|NCT03515941|Immunologic Factors|immunologic factors|mesh-ancestor
110852724|NCT03515941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110104067|NCT01776515|Narcotics|narcotics|mesh-ancestor
110852726|NCT03515941|Protective Agents|protective agents|mesh-ancestor
110852727|NCT03515941|Vitamin B Complex|vitamin b complex|mesh-ancestor
110852728|NCT03515941|Vitamins|vitamins|mesh-ancestor
110852729|NCT03515941|Micronutrients|micronutrients|mesh-ancestor
110852730|NCT02492074|Dronabinol|dronabinol|mesh-list
110852731|NCT02492074|Cannabidiol|cannabidiol|mesh-list
110852732|NCT02492074|Anticonvulsants|anticonvulsants|mesh-ancestor
110852733|NCT02492074|Hallucinogens|hallucinogens|mesh-ancestor
110852734|NCT02492074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110852735|NCT02492074|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110852736|NCT02492074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110852737|NCT02492074|Analgesics|analgesics|mesh-ancestor
110852738|NCT02492074|Sensory System Agents|sensory system agents|mesh-ancestor
110852739|NCT02492074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110852740|NCT02492074|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
110852741|NCT02492074|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110852742|NCT02492074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110104355|NCT01779284|Timolol|timolol|mesh-list
110682921|NCT00903851|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110852743|NCT02492074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110852744|NCT02492074|Hormones|hormones|mesh-ancestor
110104428|NCT01779492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110852745|NCT02492074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110852747|NCT03819647|Anticonvulsants|anticonvulsants|mesh-ancestor
110852748|NCT02498938|Protease Inhibitors|protease inhibitors|mesh-list
110852749|NCT02498938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110852750|NCT02498938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110852752|NCT02498860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110852753|NCT02498860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110852754|NCT02498860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110852755|NCT02498860|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110852756|NCT02498860|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110852757|NCT03011034|Daratumumab|daratumumab|mesh-list
110852758|NCT03011034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110852759|NCT05464966|Insulin|insulin|mesh-list
110852760|NCT05464966|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110852761|NCT05464966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110852762|NCT03515629|Pembrolizumab|pembrolizumab|mesh-list
110852763|NCT03515629|Cemiplimab|cemiplimab|mesh-list
110104501|NCT01779921|Thrombin|thrombin|mesh-list
110852764|NCT03515629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110852765|NCT03515629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110852766|NCT03515629|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110852767|NCT03515629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110852769|NCT01302821|Vaccines|vaccines|mesh-list
110852770|NCT01302821|Immunologic Factors|immunologic factors|mesh-ancestor
110852771|NCT01302821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110852772|NCT01302821|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110852773|NCT01302821|Antidepressive Agents|antidepressive agents|mesh-ancestor
110852774|NCT01302821|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110852775|NCT03331432|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
110852776|NCT03331432|Antiviral Agents|antiviral agents|mesh-ancestor
110104703|NCT01781442|Sirolimus|sirolimus|mesh-list
110852777|NCT03331432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110852778|NCT03331432|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
110852779|NCT03331432|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110852780|NCT03512353|Dexamethasone|dexamethasone|mesh-list
110852781|NCT03512353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110852782|NCT03512353|Antiemetics|antiemetics|mesh-ancestor
110852783|NCT03512353|Autonomic Agents|autonomic agents|mesh-ancestor
110852784|NCT03512353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110852785|NCT03512353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110852786|NCT03512353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110852787|NCT03512353|Glucocorticoids|glucocorticoids|mesh-ancestor
110852788|NCT03512353|Hormones|hormones|mesh-ancestor
110852789|NCT03512353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110852790|NCT03512353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110852791|NCT03512353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110852792|NCT04959006|Antioxidants|antioxidants|mesh-list
110852793|NCT04959006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110852794|NCT04959006|Protective Agents|protective agents|mesh-ancestor
110852795|NCT04959006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110852796|NCT01300637|Metformin|metformin|mesh-list
110852797|NCT01300637|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110852798|NCT01300637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110852799|NCT04851522|Sodium Hypochlorite|sodium hypochlorite|mesh-list
110852800|NCT04851522|Eusol|eusol|mesh-list
110852801|NCT04851522|Petrolatum|petrolatum|mesh-list
110852802|NCT04851522|Disinfectants|disinfectants|mesh-ancestor
110852803|NCT04851522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110852804|NCT04851522|Emollients|emollients|mesh-ancestor
110852805|NCT04851522|Dermatologic Agents|dermatologic agents|mesh-ancestor
110852806|NCT03512275|Antibodies|antibodies|mesh-list
110852807|NCT03512275|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110852808|NCT03512275|Immunologic Factors|immunologic factors|mesh-ancestor
110852809|NCT03512275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110852810|NCT03809897|Nicotine|nicotine|mesh-list
110852811|NCT03809897|Varenicline|varenicline|mesh-list
110852812|NCT03809897|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110852813|NCT03809897|Autonomic Agents|autonomic agents|mesh-ancestor
110852814|NCT03809897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110852815|NCT03809897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110852816|NCT03809897|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110852817|NCT03809897|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110852818|NCT03809897|Cholinergic Agents|cholinergic agents|mesh-ancestor
110852819|NCT03809897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110852820|NCT03809897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110852821|NCT03473197|Diacerein|diacerein|mesh-list
110852822|NCT03473197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110852823|NCT01560299|Methimazole|methimazole|mesh-list
110852824|NCT01560299|Antithyroid Agents|antithyroid agents|mesh-ancestor
110852825|NCT01560299|Hormone Antagonists|hormone antagonists|mesh-ancestor
110852826|NCT01560299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110852827|NCT01560299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110852829|NCT03337828|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110852830|NCT03337828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110852831|NCT03337828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110852832|NCT03337828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110852833|NCT03510715|Nicotinic Acids|nicotinic acids|mesh-list
110852834|NCT03510715|Niacin|niacin|mesh-list
110852835|NCT03510715|Niacinamide|niacinamide|mesh-list
110852836|NCT03510715|Atorvastatin|atorvastatin|mesh-list
110852837|NCT03510715|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110852838|NCT03510715|Simvastatin|simvastatin|mesh-list
110852839|NCT03510715|Ezetimibe|ezetimibe|mesh-list
110852841|NCT03510715|Alirocumab|alirocumab|mesh-list
110852842|NCT03510715|Lovastatin|lovastatin|mesh-list
110852843|NCT03510715|Cholestyramine Resin|cholestyramine resin|mesh-list
110852844|NCT03510715|Fenofibrate|fenofibrate|mesh-list
110852845|NCT03510715|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110852846|NCT03510715|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110852847|NCT03510715|Antimetabolites|antimetabolites|mesh-ancestor
110852848|NCT03510715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110852849|NCT03510715|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110852850|NCT03510715|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110852851|NCT03510715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110852852|NCT03510715|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
110852853|NCT03510715|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110852854|NCT03510715|Protease Inhibitors|protease inhibitors|mesh-ancestor
110852855|NCT03510715|Vitamin B Complex|vitamin b complex|mesh-ancestor
110852856|NCT03510715|Vitamins|vitamins|mesh-ancestor
110852857|NCT03510715|Micronutrients|micronutrients|mesh-ancestor
110852858|NCT03510715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110852859|NCT03510715|Vasodilator Agents|vasodilator agents|mesh-ancestor
110852860|NCT03815279|Dexamethasone|dexamethasone|mesh-list
110852861|NCT03815279|Lenalidomide|lenalidomide|mesh-list
110852862|NCT03815279|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110852863|NCT03815279|Antiemetics|antiemetics|mesh-ancestor
110852864|NCT03815279|Autonomic Agents|autonomic agents|mesh-ancestor
110105234|NCT01785446|Sufentanil|sufentanil|mesh-list
110852865|NCT03815279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110852866|NCT03815279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110852867|NCT03815279|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110852868|NCT03815279|Glucocorticoids|glucocorticoids|mesh-ancestor
110852869|NCT03815279|Hormones|hormones|mesh-ancestor
110852870|NCT03815279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110852871|NCT03815279|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110852873|NCT03815279|Immunologic Factors|immunologic factors|mesh-ancestor
110852874|NCT03815279|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110852875|NCT03815279|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110852876|NCT03815279|Growth Substances|growth substances|mesh-ancestor
110852877|NCT03815279|Growth Inhibitors|growth inhibitors|mesh-ancestor
110852880|NCT03814733|Analgesics|analgesics|mesh-ancestor
110852881|NCT03814733|Sensory System Agents|sensory system agents|mesh-ancestor
110852882|NCT03814733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110852883|NCT03814733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110852884|NCT03814733|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110852885|NCT03814733|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110852886|NCT03814733|Anesthetics, General|anesthetics, general|mesh-ancestor
110852887|NCT03814733|Anesthetics|anesthetics|mesh-ancestor
110852888|NCT03814733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110852889|NCT03814733|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110852890|NCT03814733|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110852891|NCT03814733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110852892|NCT03814733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110852893|NCT03814733|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110852894|NCT03814733|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110852895|NCT03814733|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110852896|NCT03814733|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110852897|NCT03814733|GABA Modulators|gaba modulators|mesh-ancestor
110852898|NCT03814733|GABA Agents|gaba agents|mesh-ancestor
110852899|NCT03721627|Sofosbuvir|sofosbuvir|mesh-list
110852900|NCT03721627|Ledipasvir|ledipasvir|mesh-list
110852901|NCT03721627|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
110852902|NCT03721627|Antiviral Agents|antiviral agents|mesh-ancestor
110105499|NCT01786655|Mydriatics|mydriatics|mesh-ancestor
110852903|NCT03721627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110852905|NCT03811223|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
110852906|NCT03811223|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110852907|NCT03811223|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110852908|NCT03811223|Antimetabolites|antimetabolites|mesh-ancestor
110852909|NCT03811223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110852910|NCT03811223|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110852912|NCT03811223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110105655|NCT01788332|Olaparib|olaparib|mesh-list
110852913|NCT03811223|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110852915|NCT03723031|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110852916|NCT03723031|Abortifacient Agents|abortifacient agents|mesh-ancestor
110852917|NCT03723031|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110852918|NCT03723031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110852919|NCT03723031|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110852920|NCT03723031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110852921|NCT03723031|Oxytocics|oxytocics|mesh-ancestor
110852922|NCT03722875|Apatinib|apatinib|mesh-list
110852923|NCT03722875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110852924|NCT03722875|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110852925|NCT03722875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110852926|NCT03722875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110852927|NCT04860713|Aspirin|aspirin|mesh-list
110852928|NCT04860713|Ketamine|ketamine|mesh-list
110852929|NCT04860713|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110852930|NCT04860713|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110852931|NCT04860713|Analgesics|analgesics|mesh-ancestor
110852932|NCT04860713|Sensory System Agents|sensory system agents|mesh-ancestor
110852933|NCT04860713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110852934|NCT04860713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110852935|NCT04860713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110852936|NCT04860713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110852937|NCT04860713|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110852938|NCT04860713|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110852939|NCT04860713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110852940|NCT04860713|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110105765|NCT01789086|Incretins|incretins|mesh-ancestor
110852941|NCT04860713|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110852942|NCT04860713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110852943|NCT04860713|Antipyretics|antipyretics|mesh-ancestor
110852944|NCT04860713|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110852945|NCT04860713|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110852946|NCT04860713|Anesthetics, General|anesthetics, general|mesh-ancestor
110852947|NCT04860713|Anesthetics|anesthetics|mesh-ancestor
110852948|NCT04860713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110852949|NCT04860713|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110852950|NCT04860713|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110852951|NCT04860713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110852952|NCT03528577|Albuterol|albuterol|mesh-list
110852953|NCT03528577|Procaterol|procaterol|mesh-list
110105897|NCT01789892|Prednisolone|prednisolone|mesh-list
110852954|NCT03528577|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110852955|NCT03528577|Autonomic Agents|autonomic agents|mesh-ancestor
110852956|NCT03528577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110852957|NCT03528577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110852958|NCT03528577|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110852959|NCT03528577|Respiratory System Agents|respiratory system agents|mesh-ancestor
110852960|NCT03528577|Tocolytic Agents|tocolytic agents|mesh-ancestor
110852961|NCT03528577|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110852962|NCT03528577|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110852963|NCT03528577|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110852964|NCT03528577|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110852965|NCT03528577|Adrenergic Agents|adrenergic agents|mesh-ancestor
110852967|NCT03528577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110852968|NCT03528577|Sympathomimetics|sympathomimetics|mesh-ancestor
110852969|NCT05432414|Dexamethasone|dexamethasone|mesh-list
110852970|NCT05432414|Bortezomib|bortezomib|mesh-list
110852971|NCT05432414|Pomalidomide|pomalidomide|mesh-list
110852972|NCT05432414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110852973|NCT05432414|Antiemetics|antiemetics|mesh-ancestor
110852974|NCT05432414|Autonomic Agents|autonomic agents|mesh-ancestor
110852975|NCT05432414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110852976|NCT05432414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110852977|NCT05432414|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110852978|NCT05432414|Glucocorticoids|glucocorticoids|mesh-ancestor
110852979|NCT05432414|Hormones|hormones|mesh-ancestor
110106179|NCT01799863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110852980|NCT05432414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110337513|NCT01246206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110852981|NCT05432414|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110852982|NCT05432414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110852984|NCT05432414|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110852985|NCT05432414|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110852986|NCT05432414|Growth Substances|growth substances|mesh-ancestor
110852987|NCT05432414|Growth Inhibitors|growth inhibitors|mesh-ancestor
110852988|NCT03796403|Diclofenac|diclofenac|mesh-list
110852989|NCT03796403|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110852990|NCT03796403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110852991|NCT03796403|Analgesics|analgesics|mesh-ancestor
110852992|NCT03796403|Sensory System Agents|sensory system agents|mesh-ancestor
110852993|NCT03796403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110852994|NCT03796403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110852995|NCT03796403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110852996|NCT03796403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110852997|NCT03796403|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110852998|NCT03796403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110852999|NCT03796403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110853000|NCT00706654|Aripiprazole|aripiprazole|mesh-list
110853001|NCT00706654|Antidepressive Agents|antidepressive agents|mesh-ancestor
110853002|NCT00706654|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110853003|NCT00706654|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110853004|NCT00706654|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110853005|NCT00706654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110853006|NCT00706654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110853007|NCT00706654|Dopamine Agonists|dopamine agonists|mesh-ancestor
110853008|NCT00706654|Dopamine Agents|dopamine agents|mesh-ancestor
110853009|NCT00706654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110853010|NCT00706654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110853011|NCT00706654|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110853012|NCT00706654|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110853013|NCT00706654|Serotonin Agents|serotonin agents|mesh-ancestor
110853014|NCT00706654|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110853015|NCT00706654|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110853016|NCT00706654|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110853017|NCT00706654|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110853018|NCT03471871|Lemborexant|lemborexant|mesh-list
110853019|NCT03471871|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
110853020|NCT03471871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110853021|NCT03471871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110853022|NCT03471871|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110853023|NCT03471871|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110853024|NCT03471871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110853025|NCT03471871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110853026|NCT04313153|Darbepoetin alfa|darbepoetin alfa|mesh-list
110853027|NCT04313153|Hematinics|hematinics|mesh-ancestor
110853028|NCT03337672|Midazolam|midazolam|mesh-list
110853029|NCT03337672|Dexmedetomidine|dexmedetomidine|mesh-list
110853030|NCT03337672|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110853031|NCT03337672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110853032|NCT03337672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110853033|NCT03337672|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110853034|NCT03337672|Analgesics|analgesics|mesh-ancestor
110853035|NCT03337672|Sensory System Agents|sensory system agents|mesh-ancestor
110853036|NCT03337672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110853037|NCT03337672|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110853038|NCT03337672|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110853039|NCT03337672|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110853040|NCT03337672|Adrenergic Agents|adrenergic agents|mesh-ancestor
110853041|NCT03337672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110853042|NCT03337672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110853043|NCT03337672|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110853044|NCT03337672|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110853045|NCT03337672|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110853046|NCT03337672|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110853047|NCT03337672|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110853048|NCT03337672|Anesthetics, General|anesthetics, general|mesh-ancestor
110853049|NCT03337672|Anesthetics|anesthetics|mesh-ancestor
110853050|NCT03337672|GABA Modulators|gaba modulators|mesh-ancestor
110853051|NCT03337672|GABA Agents|gaba agents|mesh-ancestor
110853052|NCT03330808|Anesthetics|anesthetics|mesh-list
110853053|NCT03330808|Ropivacaine|ropivacaine|mesh-list
110106327|NCT01800799|Analgesics|analgesics|mesh-ancestor
110853054|NCT03330808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110853055|NCT03330808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110853056|NCT03330808|Anesthetics, Local|anesthetics, local|mesh-ancestor
110853057|NCT03330808|Sensory System Agents|sensory system agents|mesh-ancestor
110853058|NCT03330808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110853059|NCT01303055|Metformin|metformin|mesh-list
110853060|NCT01303055|Alogliptin|alogliptin|mesh-list
110853061|NCT01303055|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110106390|NCT01801410|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110853062|NCT01303055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110853063|NCT01303055|Incretins|incretins|mesh-ancestor
110853064|NCT01303055|Hormones|hormones|mesh-ancestor
110853065|NCT01303055|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110853066|NCT01303055|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110853067|NCT01303055|Protease Inhibitors|protease inhibitors|mesh-ancestor
110853068|NCT01303055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110853069|NCT01303055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110853070|NCT03636048|Bupivacaine|bupivacaine|mesh-list
110853071|NCT03636048|Anesthetics|anesthetics|mesh-list
110853073|NCT03636048|Anesthetics, Local|anesthetics, local|mesh-ancestor
110853074|NCT03636048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110106456|NCT01802476|Palbociclib|palbociclib|mesh-list
110853075|NCT03636048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110853076|NCT03636048|Sensory System Agents|sensory system agents|mesh-ancestor
110853077|NCT03636048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110853078|NCT03636048|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110853079|NCT03636048|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110853080|NCT03636048|Anesthetics, General|anesthetics, general|mesh-ancestor
110853081|NCT03527173|Vaccines|vaccines|mesh-list
110853082|NCT03527173|Immunologic Factors|immunologic factors|mesh-ancestor
110853083|NCT03527173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110853084|NCT04718922|Chlorhexidine|chlorhexidine|mesh-list
110853085|NCT04718922|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110853086|NCT04718922|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110853087|NCT04718922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110853088|NCT04718922|Disinfectants|disinfectants|mesh-ancestor
110853089|NCT04718922|Dermatologic Agents|dermatologic agents|mesh-ancestor
110853090|NCT01303601|Olanzapine|olanzapine|mesh-list
110853091|NCT01303601|Antiemetics|antiemetics|mesh-ancestor
110853092|NCT01303601|Autonomic Agents|autonomic agents|mesh-ancestor
110853093|NCT01303601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110853094|NCT01303601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110853095|NCT01303601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110853096|NCT01303601|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110853097|NCT01303601|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110853098|NCT01303601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110853099|NCT01303601|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110853100|NCT01303601|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110853101|NCT01303601|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110853102|NCT01303601|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110853103|NCT01303601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110853104|NCT01303601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110853105|NCT01303601|Serotonin Agents|serotonin agents|mesh-ancestor
110853106|NCT00707980|Vortioxetine|vortioxetine|mesh-list
110853107|NCT00707980|Antidepressive Agents|antidepressive agents|mesh-ancestor
110853108|NCT00707980|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110853109|NCT00707980|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110853110|NCT00707980|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110853111|NCT00707980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110853112|NCT00707980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110853113|NCT00707980|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110853114|NCT00707980|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110853115|NCT00707980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110853116|NCT00707980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110853117|NCT00707980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110853118|NCT00707980|Serotonin Agents|serotonin agents|mesh-ancestor
110853119|NCT00707980|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110853120|NCT00707980|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110853121|NCT00707980|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110853122|NCT00707980|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110853123|NCT01304537|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
110106645|NCT01803503|Docetaxel|docetaxel|mesh-list
110853124|NCT01304537|Protein C Inhibitor|protein c inhibitor|mesh-list
110853125|NCT01304537|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
110853126|NCT01304537|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110853127|NCT01304537|Protease Inhibitors|protease inhibitors|mesh-ancestor
110833148|NCT01225913|Xhance|xhance|mesh-list
110853128|NCT01304537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110853129|NCT01304537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110853130|NCT03051620|Alendronate|alendronate|mesh-list
110853131|NCT03051620|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110853132|NCT03051620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110853133|NCT02861183|Hyaluronic Acid|hyaluronic acid|mesh-list
110853134|NCT02861183|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110853135|NCT02861183|Immunologic Factors|immunologic factors|mesh-ancestor
110853136|NCT02861183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110853138|NCT02861183|Protective Agents|protective agents|mesh-ancestor
110853139|NCT02498002|Lidocaine|lidocaine|mesh-list
110853140|NCT02498002|Anesthetics, Local|anesthetics, local|mesh-ancestor
110853141|NCT02498002|Anesthetics|anesthetics|mesh-ancestor
110853142|NCT02498002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110853143|NCT02498002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110853144|NCT02498002|Sensory System Agents|sensory system agents|mesh-ancestor
110853145|NCT02498002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110853146|NCT02498002|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110853147|NCT02498002|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110853148|NCT02498002|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110853149|NCT02498002|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110853150|NCT02498002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110853151|NCT03810209|Magnesium Sulfate|magnesium sulfate|mesh-list
110853152|NCT03810209|Analgesics|analgesics|mesh-ancestor
110853153|NCT03810209|Sensory System Agents|sensory system agents|mesh-ancestor
110853154|NCT03810209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110853155|NCT03810209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110853156|NCT03810209|Anesthetics|anesthetics|mesh-ancestor
110853157|NCT03810209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110853159|NCT03810209|Anticonvulsants|anticonvulsants|mesh-ancestor
110853160|NCT03810209|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110853161|NCT03810209|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110853162|NCT03810209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110853163|NCT03810209|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110853164|NCT03810209|Tocolytic Agents|tocolytic agents|mesh-ancestor
110853165|NCT03810209|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110853166|NCT04186988|9-arabinofuranosylguanine|9-arabinofuranosylguanine|mesh-list
110853167|NCT04186988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110853168|NCT03337282|Anesthetics|anesthetics|mesh-list
110853169|NCT03337282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110853170|NCT03337282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110853171|NCT03801707|Sofosbuvir|sofosbuvir|mesh-list
110853172|NCT03801707|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
110853173|NCT03801707|Velpatasvir|velpatasvir|mesh-list
110853175|NCT03801707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110853176|NCT04576871|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
110853177|NCT04576871|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110853178|NCT04576871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110853179|NCT04239872|Calcium, Dietary|calcium, dietary|mesh-list
110853180|NCT04239872|Calcium|calcium|mesh-list
110853181|NCT04239872|Fluorides|fluorides|mesh-list
110853182|NCT04239872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110853183|NCT04239872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110853184|NCT04239872|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110853185|NCT04239872|Cariostatic Agents|cariostatic agents|mesh-ancestor
110853186|NCT04239872|Protective Agents|protective agents|mesh-ancestor
110853187|NCT03164772|Durvalumab|durvalumab|mesh-list
110853188|NCT03164772|Tremelimumab|tremelimumab|mesh-list
110853189|NCT03164772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110853190|NCT03164772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110853191|NCT03801317|Micronutrients|micronutrients|mesh-list
110853192|NCT03801317|Trace Elements|trace elements|mesh-list
110853193|NCT03801317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110853194|NCT03337126|Metronidazole|metronidazole|mesh-list
110570759|NCT00688961|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110853195|NCT03337126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110853196|NCT03337126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110853197|NCT03337126|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110853198|NCT03337126|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110853200|NCT04710732|Enoxaparin sodium|enoxaparin sodium|mesh-list
110853201|NCT04710732|Anticoagulants|anticoagulants|mesh-ancestor
110853202|NCT04710732|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110853203|NCT04710732|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110853204|NCT04710732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110853205|NCT05014334|Amoxicillin|amoxicillin|mesh-list
110853206|NCT05014334|Clarithromycin|clarithromycin|mesh-list
110853207|NCT05014334|Rabeprazole|rabeprazole|mesh-list
110853208|NCT05014334|Bismuth|bismuth|mesh-list
110853209|NCT05014334|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110853210|NCT05014334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110853211|NCT05014334|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110853212|NCT05014334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110853213|NCT05014334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110853214|NCT05014334|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110853215|NCT05014334|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110853216|NCT05014334|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110853217|NCT05014334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110853218|NCT05014334|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110853220|NCT02497378|Dexamethasone|dexamethasone|mesh-list
110853221|NCT02497378|Bortezomib|bortezomib|mesh-list
110853222|NCT02497378|Daratumumab|daratumumab|mesh-list
110853223|NCT02497378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110853224|NCT02497378|Antiemetics|antiemetics|mesh-ancestor
110853225|NCT02497378|Autonomic Agents|autonomic agents|mesh-ancestor
110853226|NCT02497378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110853227|NCT02497378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110853228|NCT02497378|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110853229|NCT02497378|Glucocorticoids|glucocorticoids|mesh-ancestor
110853230|NCT02497378|Hormones|hormones|mesh-ancestor
110853231|NCT02497378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110853232|NCT02497378|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110853233|NCT02497378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110853234|NCT02497222|RNS60|rns60|mesh-list
110107214|NCT01810640|Hematinics|hematinics|mesh-ancestor
110853235|NCT02497222|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110853236|NCT02497222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110853237|NCT02497222|Analgesics|analgesics|mesh-ancestor
110853238|NCT02497222|Sensory System Agents|sensory system agents|mesh-ancestor
110853239|NCT02497222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110853240|NCT02497222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110853241|NCT02497222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110853242|NCT02497222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110853243|NCT02497222|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110853244|NCT02491606|Tafenoquine|tafenoquine|mesh-list
110853245|NCT02491606|Antimalarials|antimalarials|mesh-ancestor
110853246|NCT02491606|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110853247|NCT02491606|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110107415|NCT01812135|Vaccines|vaccines|mesh-list
110853248|NCT02491606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110853249|NCT03329638|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110853250|NCT03329638|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110853251|NCT03050450|Lenalidomide|lenalidomide|mesh-list
110853252|NCT03050450|Vorinostat|vorinostat|mesh-list
110853253|NCT03050450|Immunologic Factors|immunologic factors|mesh-ancestor
110853254|NCT03050450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110853255|NCT03050450|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110853256|NCT03050450|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110853258|NCT03050450|Growth Inhibitors|growth inhibitors|mesh-ancestor
110853259|NCT03050450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110853260|NCT03050450|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110853261|NCT03050450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110853262|NCT03050450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110853263|NCT03799679|Antineoplastic Agents|antineoplastic agents|mesh-list
110853265|NCT03505021|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110853266|NCT03505021|Vasodilator Agents|vasodilator agents|mesh-ancestor
110853267|NCT03505021|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110853268|NCT03505021|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110853269|NCT03505021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110853270|NCT03505021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110853271|NCT03505021|Protective Agents|protective agents|mesh-ancestor
110853272|NCT03505021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110853273|NCT03793283|Insulin|insulin|mesh-list
110853274|NCT03793283|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110853275|NCT03793283|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110853276|NCT03793283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110853277|NCT02496988|Temozolomide|temozolomide|mesh-list
110853278|NCT02496988|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110853279|NCT02496988|Alkylating Agents|alkylating agents|mesh-ancestor
110853280|NCT02496988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110853281|NCT02496988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110853282|NCT03793205|Lenograstim|lenograstim|mesh-list
110853283|NCT03793205|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110853284|NCT03793205|Immunologic Factors|immunologic factors|mesh-ancestor
110853285|NCT03793205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110853287|NCT03329248|Paclitaxel|paclitaxel|mesh-list
110853288|NCT03329248|Cyclophosphamide|cyclophosphamide|mesh-list
110853289|NCT03329248|Bevacizumab|bevacizumab|mesh-list
110853290|NCT03329248|Fluorouracil|fluorouracil|mesh-list
110853291|NCT03329248|Capecitabine|capecitabine|mesh-list
110853292|NCT03329248|Oxaliplatin|oxaliplatin|mesh-list
110853293|NCT03329248|Avelumab|avelumab|mesh-list
110853294|NCT03329248|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110853295|NCT03329248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110853296|NCT03329248|Tubulin Modulators|tubulin modulators|mesh-ancestor
110853297|NCT03329248|Antimitotic Agents|antimitotic agents|mesh-ancestor
110853298|NCT03329248|Mitosis Modulators|mitosis modulators|mesh-ancestor
110853299|NCT03329248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110853300|NCT03329248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110853301|NCT03329248|Immunologic Factors|immunologic factors|mesh-ancestor
110853302|NCT03329248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110853303|NCT03329248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110853304|NCT03329248|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110853305|NCT03329248|Alkylating Agents|alkylating agents|mesh-ancestor
110853306|NCT03329248|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110853307|NCT03329248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110853308|NCT03329248|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110853309|NCT03329248|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110853310|NCT03329248|Growth Substances|growth substances|mesh-ancestor
110853311|NCT03329248|Growth Inhibitors|growth inhibitors|mesh-ancestor
110853312|NCT03329248|Antimetabolites|antimetabolites|mesh-ancestor
110853313|NCT03329248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110853314|NCT03329248|Antidotes|antidotes|mesh-ancestor
110853315|NCT03329248|Protective Agents|protective agents|mesh-ancestor
110853316|NCT03329248|Vitamin B Complex|vitamin b complex|mesh-ancestor
110853317|NCT03329248|Vitamins|vitamins|mesh-ancestor
110853318|NCT03329248|Micronutrients|micronutrients|mesh-ancestor
110853319|NCT03795311|Bevacizumab|bevacizumab|mesh-list
110853320|NCT03795311|Folfirinox|folfirinox|mesh-list
110853321|NCT03795311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110853322|NCT03795311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110853323|NCT03795311|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110853324|NCT03795311|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110853325|NCT03795311|Growth Substances|growth substances|mesh-ancestor
110853326|NCT03795311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110853327|NCT03795311|Growth Inhibitors|growth inhibitors|mesh-ancestor
110853328|NCT03792971|Dextromethorphan|dextromethorphan|mesh-list
110853329|NCT03792971|Avasopasem manganese|avasopasem manganese|mesh-list
110853330|NCT03792971|Antitussive Agents|antitussive agents|mesh-ancestor
110853331|NCT03792971|Respiratory System Agents|respiratory system agents|mesh-ancestor
110853332|NCT03792971|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110853333|NCT03792971|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110853334|NCT03792971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110853335|NCT03792971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110853336|NCT03792971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110833168|NCT01225913|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110853337|NCT03792971|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110853339|NCT03792971|Protective Agents|protective agents|mesh-ancestor
110853340|NCT03328936|Melphalan|melphalan|mesh-list
110853341|NCT03328936|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110853342|NCT03328936|Alkylating Agents|alkylating agents|mesh-ancestor
110853343|NCT03328936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110853344|NCT03328936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110853345|NCT03328936|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110853346|NCT03328936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110853347|NCT03328936|Immunologic Factors|immunologic factors|mesh-ancestor
110853348|NCT03328936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110853349|NCT02496754|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
110853350|NCT02496754|Hormones|hormones|mesh-ancestor
110853351|NCT02496754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110853352|NCT02496754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110853353|NCT04887194|Nivolumab|nivolumab|mesh-list
110853354|NCT04887194|Digoxin|digoxin|mesh-list
110853355|NCT04887194|Midazolam|midazolam|mesh-list
110853356|NCT04887194|Dextromethorphan|dextromethorphan|mesh-list
110853357|NCT04887194|Warfarin|warfarin|mesh-list
110853358|NCT04887194|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110853359|NCT04887194|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110853360|NCT04887194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110853361|NCT04887194|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110853362|NCT04887194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110853363|NCT04887194|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110853364|NCT04887194|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110853365|NCT04887194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110853366|NCT04887194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110853367|NCT04887194|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110853368|NCT04887194|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110853369|NCT04887194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110853370|NCT04887194|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110853371|NCT04887194|Anesthetics, General|anesthetics, general|mesh-ancestor
110853373|NCT04887194|GABA Modulators|gaba modulators|mesh-ancestor
110853374|NCT04887194|GABA Agents|gaba agents|mesh-ancestor
110853375|NCT04887194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110853376|NCT04887194|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110853377|NCT04887194|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110853378|NCT04887194|Antimetabolites|antimetabolites|mesh-ancestor
110853379|NCT04887194|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110108107|NCT01816035|Immunotoxins|immunotoxins|mesh-ancestor
110853380|NCT04887194|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110853381|NCT04887194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110853382|NCT04887194|Anticoagulants|anticoagulants|mesh-ancestor
110853383|NCT04887194|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110853384|NCT04887194|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110853385|NCT04887194|Protective Agents|protective agents|mesh-ancestor
110853386|NCT04887194|Antitussive Agents|antitussive agents|mesh-ancestor
110853387|NCT04887194|Respiratory System Agents|respiratory system agents|mesh-ancestor
110853388|NCT04887194|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110853389|NCT04887194|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110853391|NCT02496910|Telmisartan|telmisartan|mesh-list
110853392|NCT02496910|Chlorthalidone|chlorthalidone|mesh-list
110853393|NCT02496910|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
110853394|NCT02496910|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110853395|NCT02496910|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110853396|NCT02496910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110853397|NCT02496910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110108389|NCT01817829|Antipyretics|antipyretics|mesh-ancestor
110853398|NCT02496910|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110853399|NCT02496910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110853400|NCT02496910|Vasodilator Agents|vasodilator agents|mesh-ancestor
110853401|NCT02496910|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110853402|NCT02496910|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110853403|NCT02496910|Diuretics|diuretics|mesh-ancestor
110853404|NCT02496910|Natriuretic Agents|natriuretic agents|mesh-ancestor
110853405|NCT02496910|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110853406|NCT03342352|Carboplatin|carboplatin|mesh-list
110853407|NCT03342352|Fluorouracil|fluorouracil|mesh-list
110853408|NCT03342352|Nivolumab|nivolumab|mesh-list
110853409|NCT03342352|Cetuximab|cetuximab|mesh-list
110853410|NCT03342352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110853411|NCT03342352|Antimetabolites|antimetabolites|mesh-ancestor
110853412|NCT03342352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110108521|NCT01819220|Amlodipine|amlodipine|mesh-list
110853413|NCT03342352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110853415|NCT03342352|Immunologic Factors|immunologic factors|mesh-ancestor
110853416|NCT03342352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110853417|NCT03342352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110853418|NCT03342352|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110853419|NCT03120442|Fentanyl|fentanyl|mesh-list
110853420|NCT03120442|Dexmedetomidine|dexmedetomidine|mesh-list
110853421|NCT03120442|Propofol|propofol|mesh-list
110853422|NCT03120442|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110853423|NCT03120442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110853424|NCT03120442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110570988|NCT02624531|Cisplatin|cisplatin|mesh-list
110853425|NCT03120442|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110853426|NCT03120442|Analgesics|analgesics|mesh-ancestor
110853427|NCT03120442|Sensory System Agents|sensory system agents|mesh-ancestor
110853428|NCT03120442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110853429|NCT03120442|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110853430|NCT03120442|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110853431|NCT03120442|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110853432|NCT03120442|Adrenergic Agents|adrenergic agents|mesh-ancestor
110853433|NCT03120442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110853434|NCT03120442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110853435|NCT03120442|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110853436|NCT03120442|Anesthetics, General|anesthetics, general|mesh-ancestor
110853437|NCT03120442|Anesthetics|anesthetics|mesh-ancestor
110853438|NCT03120442|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110853439|NCT03120442|Narcotics|narcotics|mesh-ancestor
110853440|NCT03120442|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110853441|NCT00852696|Solifenacin Succinate|solifenacin succinate|mesh-list
110853442|NCT00852696|Tolterodine Tartrate|tolterodine tartrate|mesh-list
110853443|NCT00852696|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110853444|NCT00852696|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110853445|NCT00852696|Cholinergic Agents|cholinergic agents|mesh-ancestor
110853446|NCT00852696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110853447|NCT00852696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110853448|NCT00852696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110853449|NCT00852696|Urological Agents|urological agents|mesh-ancestor
110853450|NCT02496832|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
110853451|NCT02496832|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110108781|NCT01820897|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110853452|NCT02496832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110853455|NCT03324490|Bupivacaine|bupivacaine|mesh-list
110853456|NCT03324490|Anesthetics|anesthetics|mesh-list
110853457|NCT03324490|Anesthetics, Local|anesthetics, local|mesh-ancestor
110853458|NCT03324490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110853459|NCT03324490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110853460|NCT03324490|Sensory System Agents|sensory system agents|mesh-ancestor
110086624|NCT03928093|Pregabalin|pregabalin|mesh-list
110853461|NCT03324490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110853462|NCT03324490|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110853463|NCT03324490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110853464|NCT03324490|Analgesics|analgesics|mesh-ancestor
110853465|NCT03324490|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110853466|NCT03324490|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110853467|NCT03324490|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110853468|NCT03324490|Adrenergic Agents|adrenergic agents|mesh-ancestor
110853469|NCT03324490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110853470|NCT03324490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110853471|NCT03324490|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110853472|NCT03324490|Narcotics|narcotics|mesh-ancestor
110853473|NCT03324490|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110853474|NCT03324490|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110853475|NCT03324490|Anesthetics, General|anesthetics, general|mesh-ancestor
110853476|NCT03798899|Methoxyflurane|methoxyflurane|mesh-list
110853477|NCT03798899|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110853478|NCT03798899|Anesthetics, General|anesthetics, general|mesh-ancestor
110853479|NCT03798899|Anesthetics|anesthetics|mesh-ancestor
110853480|NCT03798899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110853481|NCT03798899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110853482|NCT03274661|Pembrolizumab|pembrolizumab|mesh-list
110853483|NCT03274661|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110853484|NCT03274661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110853485|NCT03274661|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110853486|NCT03274661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110853487|NCT03798821|Sulfalene|sulfalene|mesh-list
110853488|NCT03798821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110853489|NCT03798821|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110853490|NCT03798821|Antimalarials|antimalarials|mesh-ancestor
110853491|NCT03798821|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110853492|NCT03798821|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110853493|NCT03324334|Antibodies|antibodies|mesh-list
110853494|NCT03324334|Immunologic Factors|immunologic factors|mesh-ancestor
110853495|NCT03324334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110853496|NCT03792815|Etoposide|etoposide|mesh-list
110853497|NCT03792815|Melphalan|melphalan|mesh-list
110853498|NCT03792815|Busulfan|busulfan|mesh-list
110853499|NCT03792815|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110571061|NCT00460603|Axitinib|axitinib|mesh-list
110853500|NCT03792815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110853501|NCT03792815|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110853502|NCT03792815|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110853503|NCT03792815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110853504|NCT03792815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110853505|NCT03792815|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110853506|NCT03792815|Alkylating Agents|alkylating agents|mesh-ancestor
110853507|NCT03792815|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110853508|NCT03792815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110853509|NCT03792815|Immunologic Factors|immunologic factors|mesh-ancestor
110853510|NCT03792815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110853511|NCT04381364|Ciclesonide|ciclesonide|mesh-list
110853512|NCT04381364|Glucocorticoids|glucocorticoids|mesh-ancestor
110853513|NCT04381364|Hormones|hormones|mesh-ancestor
110853514|NCT04381364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110853515|NCT04381364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110853516|NCT04381364|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110853517|NCT01331382|Resveratrol|resveratrol|mesh-list
110853518|NCT01331382|Antioxidants|antioxidants|mesh-ancestor
110853519|NCT01331382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110853520|NCT01331382|Protective Agents|protective agents|mesh-ancestor
110853521|NCT01331382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110853522|NCT01331382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110853523|NCT01331382|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110853524|NCT03794765|Metronidazole|metronidazole|mesh-list
110853525|NCT03794765|Ceftriaxone|ceftriaxone|mesh-list
110853526|NCT03794765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110853527|NCT03794765|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110853528|NCT03794765|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110853529|NCT03794765|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110853530|NCT02496286|Bevacizumab|bevacizumab|mesh-list
110853531|NCT02496286|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110853532|NCT02496286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110853533|NCT02496286|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110853534|NCT02496286|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110853535|NCT02496286|Growth Substances|growth substances|mesh-ancestor
110853536|NCT02496286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110853537|NCT02496286|Growth Inhibitors|growth inhibitors|mesh-ancestor
110853538|NCT01489176|Regadenoson|regadenoson|mesh-list
110853539|NCT01489176|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
110853540|NCT01489176|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
110853541|NCT01489176|Purinergic Agonists|purinergic agonists|mesh-ancestor
110853542|NCT01489176|Purinergic Agents|purinergic agents|mesh-ancestor
110853543|NCT01489176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110853544|NCT01489176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110853545|NCT01489176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110853546|NCT03792503|Pemetrexed|pemetrexed|mesh-list
110853547|NCT03792503|Apatinib|apatinib|mesh-list
110853548|NCT03792503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110853549|NCT03792503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110853550|NCT03792503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110853551|NCT03792503|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110853552|NCT03792503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110853553|NCT03792503|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110853554|NCT03794843|Nimodipine|nimodipine|mesh-list
110853555|NCT03794843|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110853556|NCT03794843|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110853557|NCT03794843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110109191|NCT01823744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110853558|NCT03794843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110853559|NCT03794843|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110853560|NCT03794843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110853561|NCT03794843|Vasodilator Agents|vasodilator agents|mesh-ancestor
110853562|NCT01333800|Ciclesonide|ciclesonide|mesh-list
110853563|NCT01333800|Beclomethasone|beclomethasone|mesh-list
110853564|NCT01333800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110853565|NCT01333800|Glucocorticoids|glucocorticoids|mesh-ancestor
110853567|NCT01333800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110853568|NCT01333800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110853569|NCT01333800|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110853570|NCT01333800|Respiratory System Agents|respiratory system agents|mesh-ancestor
110853571|NCT01333800|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110853574|NCT04494100|Ropivacaine|ropivacaine|mesh-list
110853575|NCT04494100|Anesthetics, Local|anesthetics, local|mesh-ancestor
110853576|NCT04494100|Anesthetics|anesthetics|mesh-ancestor
110853577|NCT04494100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110853578|NCT04494100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110853579|NCT04494100|Sensory System Agents|sensory system agents|mesh-ancestor
110853580|NCT04494100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110853581|NCT04494100|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110853582|NCT04494100|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110853583|NCT04494100|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110853584|NCT04494100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110853585|NCT04494100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110853586|NCT04494100|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110853587|NCT04494100|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110853588|NCT04494100|Adrenergic Agents|adrenergic agents|mesh-ancestor
110853589|NCT04494100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110853590|NCT04494100|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110853591|NCT04494100|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110853592|NCT04494100|Autonomic Agents|autonomic agents|mesh-ancestor
110853593|NCT04494100|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110853594|NCT04494100|Respiratory System Agents|respiratory system agents|mesh-ancestor
110853595|NCT04494100|Mydriatics|mydriatics|mesh-ancestor
110853596|NCT04494100|Sympathomimetics|sympathomimetics|mesh-ancestor
110853597|NCT04494100|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110853598|NCT01333878|Abatacept|abatacept|mesh-list
110853599|NCT01333878|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110853600|NCT01333878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110853601|NCT01333878|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110853602|NCT01333878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110853603|NCT01333878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110109676|NCT01827293|Anesthetics|anesthetics|mesh-ancestor
110853605|NCT01333878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110853606|NCT01333878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110853607|NCT03328312|Atropine|atropine|mesh-list
110853608|NCT03328312|Neostigmine|neostigmine|mesh-list
110853609|NCT03328312|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110853610|NCT03328312|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110853611|NCT03328312|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110853612|NCT03328312|Autonomic Agents|autonomic agents|mesh-ancestor
110853613|NCT03328312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110853614|NCT03328312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110853615|NCT03328312|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110853616|NCT03328312|Respiratory System Agents|respiratory system agents|mesh-ancestor
110853617|NCT03328312|Mydriatics|mydriatics|mesh-ancestor
110853618|NCT03328312|Parasympatholytics|parasympatholytics|mesh-ancestor
110853619|NCT03328312|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110853620|NCT03328312|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110853621|NCT03328312|Cholinergic Agents|cholinergic agents|mesh-ancestor
110853622|NCT03328312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110853623|NCT03328312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110109882|NCT01828788|Ropivacaine|ropivacaine|mesh-list
110853624|NCT03328312|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110853625|NCT03328312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110853626|NCT03328312|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110853627|NCT04051580|Plasma-lyte 148|plasma-lyte 148|mesh-list
110853628|NCT04051580|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110853629|NCT04051580|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110853630|NCT03328234|Paclitaxel|paclitaxel|mesh-list
110853631|NCT03328234|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110853632|NCT03328234|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110853633|NCT03328234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110853634|NCT03328234|Tubulin Modulators|tubulin modulators|mesh-ancestor
110853635|NCT03328234|Antimitotic Agents|antimitotic agents|mesh-ancestor
110853636|NCT03328234|Mitosis Modulators|mitosis modulators|mesh-ancestor
110853637|NCT03328234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110853638|NCT04781192|Durvalumab|durvalumab|mesh-list
110110083|NCT01832350|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110853639|NCT04781192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110853640|NCT04781192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110853641|NCT03323710|Sunitinib|sunitinib|mesh-list
110853642|NCT03323710|Propranolol|propranolol|mesh-list
110853643|NCT03323710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110853644|NCT03323710|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110853645|NCT03323710|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110853646|NCT03323710|Growth Substances|growth substances|mesh-ancestor
110853647|NCT03323710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110853649|NCT03323710|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110853650|NCT03323710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110853651|NCT03323710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110853652|NCT03323710|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110853653|NCT03323710|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110853654|NCT03323710|Adrenergic Agents|adrenergic agents|mesh-ancestor
110853655|NCT03323710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110853656|NCT03323710|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110853657|NCT03323710|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110853658|NCT03323710|Vasodilator Agents|vasodilator agents|mesh-ancestor
110853659|NCT03792269|Capecitabine|capecitabine|mesh-list
110853660|NCT03792269|Oxaliplatin|oxaliplatin|mesh-list
110853661|NCT03792269|Irinotecan|irinotecan|mesh-list
110853662|NCT03792269|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110853663|NCT03792269|Antimetabolites|antimetabolites|mesh-ancestor
110853664|NCT03792269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110853665|NCT03792269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110853666|NCT03792269|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110853667|NCT03792269|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110853668|NCT03792269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110853670|NCT02488564|Docetaxel|docetaxel|mesh-list
110853671|NCT02488564|Doxorubicin|doxorubicin|mesh-list
110853673|NCT02488564|Trastuzumab|trastuzumab|mesh-list
110853674|NCT02488564|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110853675|NCT02488564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110853676|NCT02488564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110853677|NCT02488564|Tubulin Modulators|tubulin modulators|mesh-ancestor
110853678|NCT02488564|Antimitotic Agents|antimitotic agents|mesh-ancestor
110853679|NCT02488564|Mitosis Modulators|mitosis modulators|mesh-ancestor
110853680|NCT02488564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110853681|NCT02488564|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110853682|NCT02488564|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110853683|NCT02488564|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110853684|NCT02488564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110853685|NCT02488564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110853687|NCT02966873|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110853688|NCT02966873|Antiviral Agents|antiviral agents|mesh-ancestor
110853689|NCT02966873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110853690|NCT02966873|Expectorants|expectorants|mesh-ancestor
110853691|NCT02966873|Respiratory System Agents|respiratory system agents|mesh-ancestor
110853692|NCT02966873|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110853693|NCT02966873|Antioxidants|antioxidants|mesh-ancestor
110853694|NCT02966873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110110865|NCT01843998|Sirolimus|sirolimus|mesh-list
110853695|NCT02966873|Protective Agents|protective agents|mesh-ancestor
110853696|NCT02966873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110853697|NCT02966873|Antidotes|antidotes|mesh-ancestor
110853698|NCT03792347|Pembrolizumab|pembrolizumab|mesh-list
110853699|NCT03792347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110853700|NCT03792347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110853701|NCT03792347|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110111006|NCT01845038|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110853702|NCT03792347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110853703|NCT04697186|Amoxicillin|amoxicillin|mesh-list
110853704|NCT04697186|Clarithromycin|clarithromycin|mesh-list
110853705|NCT04697186|Rabeprazole|rabeprazole|mesh-list
110853706|NCT04697186|Bismuth|bismuth|mesh-list
110853707|NCT04697186|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110853708|NCT04697186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110853709|NCT04697186|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110853710|NCT04697186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110853711|NCT04697186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110853712|NCT04697186|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110853713|NCT04697186|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110853714|NCT04697186|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110853715|NCT04697186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110853716|NCT04697186|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110853717|NCT04697186|Antacids|antacids|mesh-ancestor
110853718|NCT02488642|Isosorbide|isosorbide|mesh-list
110853719|NCT02488642|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
110853720|NCT02488642|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
110853721|NCT02488642|Misoprostol|misoprostol|mesh-list
110853722|NCT02488642|Oxytocin|oxytocin|mesh-list
110853723|NCT02488642|Oxytocics|oxytocics|mesh-ancestor
110571285|NCT02612480|Aspirin|aspirin|mesh-list
110853724|NCT02488642|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110853725|NCT02488642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110853726|NCT02488642|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110853727|NCT02488642|Abortifacient Agents|abortifacient agents|mesh-ancestor
110853728|NCT02488642|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110853729|NCT02488642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110853730|NCT02488642|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110853731|NCT02488642|Diuretics|diuretics|mesh-ancestor
110111147|NCT01845558|Wobenzym|wobenzym|mesh-list
110853732|NCT02488642|Natriuretic Agents|natriuretic agents|mesh-ancestor
110853733|NCT02488642|Vasodilator Agents|vasodilator agents|mesh-ancestor
110853734|NCT02488642|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
110853735|NCT02488642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110853736|NCT02488486|Remifentanil|remifentanil|mesh-list
110853737|NCT02488486|Propofol|propofol|mesh-list
110853738|NCT02488486|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110853739|NCT02488486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110853740|NCT02488486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110853741|NCT02488486|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110853742|NCT02488486|Anesthetics, General|anesthetics, general|mesh-ancestor
110853744|NCT02488486|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110853746|NCT02488486|Analgesics|analgesics|mesh-ancestor
110853747|NCT02488486|Sensory System Agents|sensory system agents|mesh-ancestor
110853748|NCT02488486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110853750|NCT04144517|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110853751|NCT04144517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110853752|NCT04144517|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110853753|NCT04144517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110853754|NCT01389024|Hydroxyurea|hydroxyurea|mesh-list
110853755|NCT01389024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110853756|NCT01389024|Antisickling Agents|antisickling agents|mesh-ancestor
110853757|NCT01389024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110853758|NCT01389024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110853759|NCT01389024|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110853761|NCT03327766|Vitamins|vitamins|mesh-ancestor
110853762|NCT03327766|Micronutrients|micronutrients|mesh-ancestor
110853763|NCT03327766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110853764|NCT03327766|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110853765|NCT03798119|Tenofovir|tenofovir|mesh-list
110853766|NCT03798119|Antiviral Agents|antiviral agents|mesh-ancestor
110111570|NCT01848769|Hormones|hormones|mesh-ancestor
110853767|NCT03798119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110853768|NCT03798119|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110853769|NCT03798119|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110853770|NCT03798119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110853771|NCT03798119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110853772|NCT03798119|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110853773|NCT03798119|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110853774|NCT03794219|Naproxen|naproxen|mesh-list
110853775|NCT03794219|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110853776|NCT03794219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110853777|NCT03794219|Analgesics|analgesics|mesh-ancestor
110111697|NCT01850095|Hormones|hormones|mesh-ancestor
110853778|NCT03794219|Sensory System Agents|sensory system agents|mesh-ancestor
110853779|NCT03794219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110853780|NCT03794219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110853781|NCT03794219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110853782|NCT03794219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110853783|NCT03794219|Gout Suppressants|gout suppressants|mesh-ancestor
110853784|NCT03794219|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110853785|NCT03794219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110111836|NCT01851005|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110853786|NCT03794219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110853787|NCT01297764|Dexamethasone|dexamethasone|mesh-list
110853788|NCT01297764|Dexamethasone acetate|dexamethasone acetate|mesh-list
110853789|NCT01297764|Lenalidomide|lenalidomide|mesh-list
110853791|NCT01297764|BB 1101|bb 1101|mesh-list
110853792|NCT01297764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110853793|NCT01297764|Antiemetics|antiemetics|mesh-ancestor
110853794|NCT01297764|Autonomic Agents|autonomic agents|mesh-ancestor
110853795|NCT01297764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110853796|NCT01297764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110853797|NCT01297764|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110853798|NCT01297764|Glucocorticoids|glucocorticoids|mesh-ancestor
110571397|NCT00696215|Rasagiline|rasagiline|mesh-list
110853799|NCT01297764|Hormones|hormones|mesh-ancestor
110111974|NCT01851850|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110853800|NCT01297764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110853801|NCT01297764|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110853802|NCT01297764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110853803|NCT01297764|Protease Inhibitors|protease inhibitors|mesh-ancestor
110853804|NCT01297764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110853805|NCT01297764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110853806|NCT01297764|Immunologic Factors|immunologic factors|mesh-ancestor
110337668|NCT02949648|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110853807|NCT01297764|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110853808|NCT01297764|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110853809|NCT01297764|Growth Substances|growth substances|mesh-ancestor
110853810|NCT01297764|Growth Inhibitors|growth inhibitors|mesh-ancestor
110853811|NCT01297764|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110853812|NCT01334034|Insulin Glargine|insulin glargine|mesh-list
110853813|NCT01334034|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110853814|NCT01334034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110853815|NCT03050060|Nelfinavir|nelfinavir|mesh-list
110853816|NCT03050060|Pembrolizumab|pembrolizumab|mesh-list
110853817|NCT03050060|Nivolumab|nivolumab|mesh-list
110853818|NCT03050060|Atezolizumab|atezolizumab|mesh-list
110853819|NCT03050060|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110853820|NCT03050060|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110853821|NCT03050060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110853822|NCT03050060|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110853823|NCT03050060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110853824|NCT03050060|Immunologic Factors|immunologic factors|mesh-ancestor
110853825|NCT03050060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110853826|NCT03050060|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110853827|NCT03050060|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110853828|NCT03050060|Protease Inhibitors|protease inhibitors|mesh-ancestor
110853829|NCT03050060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110853830|NCT03050060|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110853831|NCT03050060|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110853832|NCT03050060|Antiviral Agents|antiviral agents|mesh-ancestor
110853833|NCT03050060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110853834|NCT01334112|Axitinib|axitinib|mesh-list
110853835|NCT01334112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110853836|NCT01334112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110853837|NCT01334112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110112320|NCT01854502|Fluorides|fluorides|mesh-list
110853838|NCT01334112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110853839|NCT03791957|Chrysarobin|chrysarobin|mesh-list
110853840|NCT03791957|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110853841|NCT03791957|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110853842|NCT03791957|Analgesics|analgesics|mesh-ancestor
110853843|NCT03791957|Sensory System Agents|sensory system agents|mesh-ancestor
110853844|NCT03791957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110853845|NCT03791957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110853846|NCT03791957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110853848|NCT02491450|Sofosbuvir|sofosbuvir|mesh-list
110853849|NCT02491450|Antiviral Agents|antiviral agents|mesh-ancestor
110853850|NCT02491450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110853851|NCT03792113|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
110853852|NCT03792113|Hemostatics|hemostatics|mesh-ancestor
110853853|NCT03792113|Coagulants|coagulants|mesh-ancestor
110853854|NCT02491528|Insulin|insulin|mesh-list
110853855|NCT02491528|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110853856|NCT02491528|Insulin Aspart|insulin aspart|mesh-list
110853857|NCT02491528|Insulin, Long-Acting|insulin, long-acting|mesh-list
110853858|NCT02491528|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
110853859|NCT02491528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110853860|NCT02491528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110853861|NCT01304927|Vitamin D|vitamin d|mesh-list
110853862|NCT01304927|Cholecalciferol|cholecalciferol|mesh-list
110853863|NCT01304927|Calcium|calcium|mesh-list
110853864|NCT01304927|Vitamins|vitamins|mesh-ancestor
110853865|NCT01304927|Micronutrients|micronutrients|mesh-ancestor
110853866|NCT01304927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110853867|NCT01304927|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110853868|NCT01304927|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110853869|NCT05464940|Caffeine|caffeine|mesh-list
110853870|NCT05464940|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110853871|NCT05464940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110853872|NCT05464940|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110337676|NCT04510337|Sensory System Agents|sensory system agents|mesh-ancestor
110853874|NCT05464940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110853875|NCT05464940|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110853876|NCT05464940|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110112811|NCT01857154|Antacids|antacids|mesh-ancestor
110853877|NCT05464940|Purinergic Agents|purinergic agents|mesh-ancestor
110853878|NCT05464940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110853879|NCT01305551|Metformin|metformin|mesh-list
110853880|NCT01305551|Saxagliptin|saxagliptin|mesh-list
110853881|NCT01305551|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110853882|NCT01305551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110853883|NCT01305551|Incretins|incretins|mesh-ancestor
110853884|NCT01305551|Hormones|hormones|mesh-ancestor
110853885|NCT01305551|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110853886|NCT01305551|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110853887|NCT01305551|Protease Inhibitors|protease inhibitors|mesh-ancestor
110853888|NCT01305551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110853889|NCT01305551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110853891|NCT03799757|Anesthetics, Local|anesthetics, local|mesh-ancestor
110853892|NCT03799757|Anesthetics|anesthetics|mesh-ancestor
110853893|NCT03799757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110853894|NCT03799757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110853895|NCT03799757|Sensory System Agents|sensory system agents|mesh-ancestor
110853896|NCT03799757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110853898|NCT03327454|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110113096|NCT01858168|Irinotecan|irinotecan|mesh-list
110853899|NCT03327454|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110853900|NCT03327454|Analgesics|analgesics|mesh-ancestor
110853901|NCT03327454|Sensory System Agents|sensory system agents|mesh-ancestor
110853902|NCT03327454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110853903|NCT03327454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110853904|NCT03327454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110853905|NCT03327454|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110853906|NCT03327454|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110853907|NCT03327454|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110853908|NCT03327454|Immunologic Factors|immunologic factors|mesh-ancestor
110853910|NCT03799913|Fludarabine|fludarabine|mesh-list
110853911|NCT03799913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110853912|NCT03799913|Immunologic Factors|immunologic factors|mesh-ancestor
110853913|NCT03799913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110113228|NCT01858792|Belimumab|belimumab|mesh-list
110853914|NCT03799913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110853915|NCT03799913|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110113297|NCT01859468|Antacids|antacids|mesh-ancestor
110853916|NCT03799913|Alkylating Agents|alkylating agents|mesh-ancestor
110853917|NCT03799913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110853918|NCT03799913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110853919|NCT03799913|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110853920|NCT01304069|Etoricoxib|etoricoxib|mesh-list
110853921|NCT01304069|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110853922|NCT01304069|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110853924|NCT01304069|Sensory System Agents|sensory system agents|mesh-ancestor
110853925|NCT01304069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110853926|NCT01304069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110853927|NCT01304069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110853928|NCT01304069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110853929|NCT01304069|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110853930|NCT01304069|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110853931|NCT01304069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110853932|NCT01304069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110853933|NCT05459402|Methadone|methadone|mesh-list
110853934|NCT05459402|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110853935|NCT05459402|Narcotics|narcotics|mesh-ancestor
110853936|NCT05459402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110853937|NCT05459402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110853938|NCT05459402|Analgesics|analgesics|mesh-ancestor
110853939|NCT05459402|Sensory System Agents|sensory system agents|mesh-ancestor
110853940|NCT05459402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110853941|NCT05459402|Antitussive Agents|antitussive agents|mesh-ancestor
110853942|NCT05459402|Respiratory System Agents|respiratory system agents|mesh-ancestor
110113660|NCT01862003|Leucovorin|leucovorin|mesh-list
110853943|NCT03799601|Carboplatin|carboplatin|mesh-list
110853944|NCT03799601|Docetaxel|docetaxel|mesh-list
110853945|NCT03799601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110853946|NCT03799601|Tubulin Modulators|tubulin modulators|mesh-ancestor
110853947|NCT03799601|Antimitotic Agents|antimitotic agents|mesh-ancestor
110853948|NCT03799601|Mitosis Modulators|mitosis modulators|mesh-ancestor
110853949|NCT03799601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110853950|NCT03791801|Glycopyrrolate|glycopyrrolate|mesh-list
110853951|NCT03791801|Rocuronium|rocuronium|mesh-list
110853953|NCT03791801|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110853954|NCT03791801|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110853955|NCT03791801|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110853956|NCT03791801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110853957|NCT03791801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110113786|NCT01863004|Bortezomib|bortezomib|mesh-list
110853958|NCT03791801|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110853959|NCT03791801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110853960|NCT03791801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110853961|NCT03791801|Cholinergic Agents|cholinergic agents|mesh-ancestor
110853962|NCT03791801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110853963|NCT03791801|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110853964|NCT03791801|Autonomic Agents|autonomic agents|mesh-ancestor
110853965|NCT03791801|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110853966|NCT03791801|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110853967|NCT03791801|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110853968|NCT01305083|Udenafil|udenafil|mesh-list
110853969|NCT01305083|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110853970|NCT01305083|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110853971|NCT01305083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110113990|NCT01863888|Analgesics|analgesics|mesh-ancestor
110853972|NCT01305083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110853973|NCT03791723|Valsartan|valsartan|mesh-list
110853974|NCT03791723|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
110853975|NCT03791723|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110853976|NCT03791723|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110853977|NCT03791723|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110833247|NCT01221935|Antidepressive Agents|antidepressive agents|mesh-ancestor
110853978|NCT03791723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110853980|NCT05452070|Anesthetics, Local|anesthetics, local|mesh-ancestor
110853981|NCT05452070|Anesthetics|anesthetics|mesh-ancestor
110853982|NCT05452070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110853983|NCT05452070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110853984|NCT05452070|Sensory System Agents|sensory system agents|mesh-ancestor
110853985|NCT05452070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110853986|NCT05452070|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110853987|NCT05452070|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110853988|NCT05452070|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110853989|NCT05452070|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110853990|NCT05452070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110853991|NCT03920657|Deferasirox|deferasirox|mesh-list
110853992|NCT03920657|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110853993|NCT03920657|Chelating Agents|chelating agents|mesh-ancestor
110853994|NCT03920657|Sequestering Agents|sequestering agents|mesh-ancestor
110853995|NCT03920657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110853996|NCT03420950|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
110853997|NCT03420950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110853998|NCT03420950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110854000|NCT03501277|Alogliptin|alogliptin|mesh-list
110854001|NCT03501277|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110854002|NCT03501277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110854003|NCT03501277|Incretins|incretins|mesh-ancestor
110854004|NCT03501277|Hormones|hormones|mesh-ancestor
110854005|NCT03501277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110854006|NCT03501277|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110337696|NCT04518176|Oxytocin|oxytocin|mesh-list
110854007|NCT03501277|Protease Inhibitors|protease inhibitors|mesh-ancestor
110854008|NCT03501277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110114409|NCT01867645|Antibodies|antibodies|mesh-list
110854009|NCT03501277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110854010|NCT03797729|Tirofiban|tirofiban|mesh-list
110854011|NCT03797729|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110854012|NCT03797729|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110854013|NCT03797729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110114473|NCT01867892|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110854014|NCT03797729|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110854015|NCT02487940|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
110854016|NCT02487940|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
110854017|NCT02487940|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
110854018|NCT02487940|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110854019|NCT02487706|Dolutegravir|dolutegravir|mesh-list
110854020|NCT02487706|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110854021|NCT02487706|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110854022|NCT02487706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110854023|NCT02487706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110854024|NCT02487706|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110114618|NCT01869023|Gemcitabine|gemcitabine|mesh-list
110854025|NCT02487706|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110854027|NCT02487706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110854028|NCT04551950|Paclitaxel|paclitaxel|mesh-list
110854029|NCT04551950|Bevacizumab|bevacizumab|mesh-list
110854030|NCT04551950|Carboplatin|carboplatin|mesh-list
110854031|NCT04551950|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110854032|NCT04551950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110854033|NCT04551950|Tubulin Modulators|tubulin modulators|mesh-ancestor
110854034|NCT04551950|Antimitotic Agents|antimitotic agents|mesh-ancestor
110854035|NCT04551950|Mitosis Modulators|mitosis modulators|mesh-ancestor
110854036|NCT04551950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110854037|NCT04551950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110854038|NCT04551950|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110854039|NCT04551950|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110854040|NCT04551950|Growth Substances|growth substances|mesh-ancestor
110854041|NCT04551950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110854042|NCT04551950|Growth Inhibitors|growth inhibitors|mesh-ancestor
110854043|NCT03326752|Nivolumab|nivolumab|mesh-list
110854044|NCT03326752|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
110854045|NCT03326752|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110854046|NCT03326752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110854047|NCT03326752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110854048|NCT03326674|Capecitabine|capecitabine|mesh-list
110854049|NCT03326674|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110854050|NCT03326674|Antimetabolites|antimetabolites|mesh-ancestor
110854051|NCT03326674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110854052|NCT03326674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110854054|NCT01316900|Tiotropium Bromide|tiotropium bromide|mesh-list
110854055|NCT01316900|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110114886|NCT01870440|Hormones|hormones|mesh-ancestor
110854056|NCT01316900|Autonomic Agents|autonomic agents|mesh-ancestor
110854057|NCT01316900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110854058|NCT01316900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110854059|NCT01316900|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110854060|NCT01316900|Respiratory System Agents|respiratory system agents|mesh-ancestor
110854061|NCT01316900|Parasympatholytics|parasympatholytics|mesh-ancestor
110854062|NCT01316900|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110854063|NCT01316900|Cholinergic Agents|cholinergic agents|mesh-ancestor
110854064|NCT01316900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110854065|NCT01316900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110854066|NCT01316900|Anticonvulsants|anticonvulsants|mesh-ancestor
110854067|NCT02490982|Teriflunomide|teriflunomide|mesh-list
110854068|NCT02490982|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110854069|NCT02490982|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110854071|NCT02490982|Sensory System Agents|sensory system agents|mesh-ancestor
110854072|NCT02490982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110854073|NCT02490982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110854074|NCT02490982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110854075|NCT02490982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110854076|NCT02490982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110854077|NCT02490982|Immunologic Factors|immunologic factors|mesh-ancestor
110854078|NCT03322150|Atropine|atropine|mesh-list
110854079|NCT03322150|Glycopyrrolate|glycopyrrolate|mesh-list
110854080|NCT03322150|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110854081|NCT03322150|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110854082|NCT03322150|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110854083|NCT03322150|Autonomic Agents|autonomic agents|mesh-ancestor
110854084|NCT03322150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110854085|NCT03322150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110115105|NCT01871701|Serotonin Agents|serotonin agents|mesh-ancestor
110854086|NCT03322150|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110854087|NCT03322150|Respiratory System Agents|respiratory system agents|mesh-ancestor
110854088|NCT03322150|Mydriatics|mydriatics|mesh-ancestor
110854089|NCT03322150|Parasympatholytics|parasympatholytics|mesh-ancestor
110854090|NCT03322150|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110854091|NCT03322150|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110854092|NCT03322150|Cholinergic Agents|cholinergic agents|mesh-ancestor
110854093|NCT03322150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110854094|NCT03322150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110854095|NCT00936390|Leuprolide|leuprolide|mesh-list
110854096|NCT00936390|Goserelin|goserelin|mesh-list
110571660|NCT04030572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110854097|NCT00936390|Triptorelin Pamoate|triptorelin pamoate|mesh-list
110854098|NCT00936390|Flutamide|flutamide|mesh-list
110854099|NCT00936390|Bicalutamide|bicalutamide|mesh-list
110854100|NCT00936390|Buserelin|buserelin|mesh-list
110854101|NCT00936390|Androgens|androgens|mesh-list
110115292|NCT01872494|Flurbiprofen|flurbiprofen|mesh-list
110854102|NCT00936390|Androgen Antagonists|androgen antagonists|mesh-list
110854103|NCT00936390|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110854104|NCT00936390|Fertility Agents|fertility agents|mesh-ancestor
110854105|NCT00936390|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110854106|NCT00936390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110854107|NCT00936390|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110854108|NCT00936390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110854109|NCT00936390|Hormones|hormones|mesh-ancestor
110115364|NCT01872858|Aspirin|aspirin|mesh-list
110854110|NCT00936390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110854111|NCT00936390|Hormone Antagonists|hormone antagonists|mesh-ancestor
110854112|NCT00936390|Luteolytic Agents|luteolytic agents|mesh-ancestor
110854113|NCT00936390|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110833258|NCT05101018|Denosumab|denosumab|mesh-list
110854114|NCT00936390|Contraceptive Agents|contraceptive agents|mesh-ancestor
110854115|NCT00936390|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110854116|NCT03326596|Tranexamic Acid|tranexamic acid|mesh-list
110854117|NCT03326596|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110854118|NCT03326596|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110854119|NCT03326596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110854120|NCT03326596|Hemostatics|hemostatics|mesh-ancestor
110854121|NCT03326596|Coagulants|coagulants|mesh-ancestor
110854122|NCT03499873|Nepafenac|nepafenac|mesh-list
110854123|NCT03499873|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110854124|NCT03499873|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110854125|NCT03499873|Analgesics|analgesics|mesh-ancestor
110854126|NCT03499873|Sensory System Agents|sensory system agents|mesh-ancestor
110854127|NCT03499873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110854128|NCT03499873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110854129|NCT03499873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110854130|NCT03499873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110854131|NCT01305707|Diazepam|diazepam|mesh-list
110854132|NCT01305707|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110854133|NCT01305707|Lorazepam|lorazepam|mesh-list
110854134|NCT01305707|Clorazepate Dipotassium|clorazepate dipotassium|mesh-list
110854135|NCT01305707|Dexetimide|dexetimide|mesh-list
110854136|NCT01305707|Olanzapine|olanzapine|mesh-list
110854137|NCT01305707|Risperidone|risperidone|mesh-list
110854138|NCT01305707|Aripiprazole|aripiprazole|mesh-list
110854139|NCT01305707|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110854140|NCT01305707|Antipsychotic Agents|antipsychotic agents|mesh-list
110854141|NCT01305707|Lithium Carbonate|lithium carbonate|mesh-list
110854142|NCT01305707|Mirtazapine|mirtazapine|mesh-list
110854143|NCT01305707|Citalopram|citalopram|mesh-list
110854144|NCT01305707|Sertraline|sertraline|mesh-list
110854145|NCT01305707|Fluoxetine|fluoxetine|mesh-list
110854146|NCT01305707|Paroxetine|paroxetine|mesh-list
110854147|NCT01305707|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
110854148|NCT01305707|Nortriptyline|nortriptyline|mesh-list
110854149|NCT01305707|Imipramine|imipramine|mesh-list
110854150|NCT01305707|Clomipramine|clomipramine|mesh-list
110854151|NCT01305707|Mianserin|mianserin|mesh-list
110854152|NCT01305707|Antidepressive Agents|antidepressive agents|mesh-list
110854153|NCT01305707|Escitalopram|escitalopram|mesh-list
110854154|NCT01305707|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110854155|NCT01305707|Serotonin Agents|serotonin agents|mesh-ancestor
110115847|NCT05528718|Anesthetics|anesthetics|mesh-ancestor
110854156|NCT01305707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110854157|NCT01305707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110854158|NCT01305707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110854159|NCT01305707|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110854160|NCT01305707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110854161|NCT01305707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110854162|NCT01305707|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110854163|NCT01305707|Dopamine Agents|dopamine agents|mesh-ancestor
110854164|NCT01305707|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110116008|NCT05252585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110854165|NCT01305707|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110854166|NCT01305707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110854167|NCT01305707|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110854168|NCT01305707|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110854169|NCT01305707|Parasympatholytics|parasympatholytics|mesh-ancestor
110854170|NCT01305707|Autonomic Agents|autonomic agents|mesh-ancestor
110854171|NCT01305707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110854172|NCT01305707|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110854173|NCT01305707|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110854174|NCT01305707|Cholinergic Agents|cholinergic agents|mesh-ancestor
110854175|NCT01305707|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110116161|NCT04859322|Glucagon|glucagon|mesh-list
110854176|NCT01305707|Antiemetics|antiemetics|mesh-ancestor
110854177|NCT01305707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110854178|NCT01305707|Dopamine Agonists|dopamine agonists|mesh-ancestor
110854179|NCT01305707|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110854180|NCT01305707|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110854181|NCT01305707|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110854182|NCT01305707|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110854183|NCT01305707|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110854184|NCT01305707|Analgesics|analgesics|mesh-ancestor
110116287|NCT04700826|Rivaroxaban|rivaroxaban|mesh-list
110854185|NCT01305707|Sensory System Agents|sensory system agents|mesh-ancestor
110854186|NCT01305707|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110854187|NCT01305707|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110854188|NCT01305707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110854189|NCT01305707|Antimanic Agents|antimanic agents|mesh-ancestor
110854190|NCT01305707|Anticonvulsants|anticonvulsants|mesh-ancestor
110854191|NCT01305707|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110854192|NCT01305707|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110854193|NCT01305707|GABA Modulators|gaba modulators|mesh-ancestor
110854194|NCT01305707|GABA Agents|gaba agents|mesh-ancestor
110854195|NCT01305707|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110854196|NCT01305707|Histamine Antagonists|histamine antagonists|mesh-ancestor
110854197|NCT01305707|Histamine Agents|histamine agents|mesh-ancestor
110854198|NCT01305707|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
110116507|NCT03783429|Digoxin|digoxin|mesh-list
110854199|NCT01305707|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110854200|NCT01305707|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110854201|NCT01305707|Adrenergic Agents|adrenergic agents|mesh-ancestor
110854202|NCT01305707|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110854203|NCT01305707|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110854204|NCT01305707|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110854205|NCT01305707|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110854206|NCT01305707|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110854207|NCT01305707|Anesthetics, General|anesthetics, general|mesh-ancestor
110854208|NCT01305707|Anesthetics|anesthetics|mesh-ancestor
110854209|NCT01305707|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110116645|NCT03131219|Ravulizumab|ravulizumab|mesh-list
110854210|NCT01305707|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110854211|NCT04051970|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
110854212|NCT04051970|Antiviral Agents|antiviral agents|mesh-ancestor
110854213|NCT04051970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110854214|NCT03722329|Eculizumab|eculizumab|mesh-list
110854215|NCT03722329|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
110854216|NCT03722329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110854217|NCT03722329|Immunologic Factors|immunologic factors|mesh-ancestor
110854218|NCT03722329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110854219|NCT03467971|Metformin|metformin|mesh-list
110854220|NCT03467971|Gliclazide|gliclazide|mesh-list
110854221|NCT03467971|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110854222|NCT03467971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110854223|NCT03791099|Metronidazole|metronidazole|mesh-list
110854224|NCT03791099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110854225|NCT03791099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110854226|NCT03791099|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110854227|NCT03791099|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110116927|NCT01873339|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110854228|NCT03185000|Immunomodulating Agents|immunomodulating agents|mesh-list
110854229|NCT03185000|Immunologic Factors|immunologic factors|mesh-ancestor
110854230|NCT03185000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110854231|NCT03791255|Calcium, Dietary|calcium, dietary|mesh-list
110854232|NCT03791255|Calcium|calcium|mesh-list
110854233|NCT03791255|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110854234|NCT03791255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110854235|NCT03791255|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110854236|NCT03742349|Spartalizumab|spartalizumab|mesh-list
110854237|NCT03742349|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110854238|NCT03742349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110854239|NCT03742349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110854240|NCT03742349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110854241|NCT03319420|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110854242|NCT03319420|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110854243|NCT03794297|Trametinib|trametinib|mesh-list
110854244|NCT03794297|Dabrafenib|dabrafenib|mesh-list
110854245|NCT03794297|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
110854246|NCT03794297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110854247|NCT03794297|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110854248|NCT03794297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110854249|NCT03794297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110854250|NCT03794297|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
110854251|NCT03794297|Protective Agents|protective agents|mesh-ancestor
110854252|NCT03794297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110854253|NCT03794297|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110854254|NCT03794297|Antioxidants|antioxidants|mesh-ancestor
110854255|NCT03048500|Metformin|metformin|mesh-list
110854256|NCT03048500|Nivolumab|nivolumab|mesh-list
110854257|NCT03048500|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110854258|NCT03048500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110117069|NCT01874171|Cetuximab|cetuximab|mesh-list
110854259|NCT03048500|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110854260|NCT03048500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110854261|NCT03048500|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110337726|NCT00517218|Oblimersen|oblimersen|mesh-list
110854262|NCT03048500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110854264|NCT03790787|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110117122|NCT01874717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110854265|NCT03790787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110854266|NCT03790787|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110854267|NCT03790787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110854269|NCT01334268|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110854270|NCT01334268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110854271|NCT01334268|Tubulin Modulators|tubulin modulators|mesh-ancestor
110117194|NCT01875224|Abatacept|abatacept|mesh-list
110854272|NCT01334268|Antimitotic Agents|antimitotic agents|mesh-ancestor
110854273|NCT01334268|Mitosis Modulators|mitosis modulators|mesh-ancestor
110854274|NCT01334268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110854275|NCT04493398|Erythritol|erythritol|mesh-list
110854276|NCT04493398|Vasodilator Agents|vasodilator agents|mesh-ancestor
110854277|NCT00908076|Lubiprostone|lubiprostone|mesh-list
110854278|NCT00908076|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
110854279|NCT00908076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110854280|NCT00908076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110854281|NCT01305317|Atorvastatin|atorvastatin|mesh-list
110854282|NCT01305317|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110854283|NCT01305317|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110854284|NCT01305317|Antimetabolites|antimetabolites|mesh-ancestor
110854285|NCT01305317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110854286|NCT01305317|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110854287|NCT01305317|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110854288|NCT01305317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110854289|NCT02613416|Denosumab|denosumab|mesh-list
110854290|NCT02613416|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110854291|NCT02613416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110854292|NCT03326050|Ciprofloxacin|ciprofloxacin|mesh-list
110854293|NCT03326050|Rifampin|rifampin|mesh-list
110854295|NCT03326050|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110854296|NCT03326050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110854297|NCT03326050|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110854298|NCT03326050|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110854299|NCT03326050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110854300|NCT03326050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110854301|NCT03326050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110854302|NCT03326050|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110854303|NCT03326050|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110854304|NCT03326050|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110854305|NCT03326050|Antitubercular Agents|antitubercular agents|mesh-ancestor
110117448|NCT01877226|Tapentadol|tapentadol|mesh-list
110854306|NCT03326050|Leprostatic Agents|leprostatic agents|mesh-ancestor
110854307|NCT03326050|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110854308|NCT03326050|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110854309|NCT03326050|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110854310|NCT03326050|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110854311|NCT03326050|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110854312|NCT03326050|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110854313|NCT03326050|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110854315|NCT01334424|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110854316|NCT01334424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110854317|NCT01334424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110854318|NCT01334424|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110854319|NCT01334424|Anesthetics, General|anesthetics, general|mesh-ancestor
110854321|NCT05083637|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110854322|NCT05664685|Bismuth|bismuth|mesh-list
110854323|NCT05664685|Antacids|antacids|mesh-ancestor
110854324|NCT05664685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110854325|NCT05664685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110854326|NCT03793517|Decitabine|decitabine|mesh-list
110854327|NCT03793517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110854328|NCT03793517|Antimetabolites|antimetabolites|mesh-ancestor
110854329|NCT03793517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110854330|NCT03793517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110854331|NCT03793517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110854332|NCT02886702|Nicotinic Acids|nicotinic acids|mesh-list
110854333|NCT02886702|Tazarotene|tazarotene|mesh-list
110854334|NCT02886702|Dermatologic Agents|dermatologic agents|mesh-ancestor
110854335|NCT02886702|Keratolytic Agents|keratolytic agents|mesh-ancestor
110854336|NCT02886702|Vitamin B Complex|vitamin b complex|mesh-ancestor
110854337|NCT02886702|Vitamins|vitamins|mesh-ancestor
110854338|NCT02886702|Micronutrients|micronutrients|mesh-ancestor
110854339|NCT02886702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110854340|NCT03498313|Estradiol|estradiol|mesh-list
110854341|NCT03498313|Progesterone|progesterone|mesh-list
110854342|NCT03498313|Estrogens|estrogens|mesh-ancestor
110854344|NCT03498313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110854345|NCT03498313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110854346|NCT03498313|Progestins|progestins|mesh-ancestor
110854347|NCT03721081|Lidocaine|lidocaine|mesh-list
110854348|NCT03721081|Anesthetics, Local|anesthetics, local|mesh-ancestor
110854349|NCT03721081|Anesthetics|anesthetics|mesh-ancestor
110854350|NCT03721081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110854351|NCT03721081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110854352|NCT03721081|Sensory System Agents|sensory system agents|mesh-ancestor
110854353|NCT03721081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110117933|NCT01881100|Listerine|listerine|mesh-list
110854354|NCT03721081|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110854355|NCT03721081|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110854356|NCT03721081|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110854357|NCT03721081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110854358|NCT03721081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110854359|NCT04493554|Vasopressins|vasopressins|mesh-list
110854360|NCT04493554|Arginine Vasopressin|arginine vasopressin|mesh-list
110854361|NCT04493554|Hemostatics|hemostatics|mesh-ancestor
110854362|NCT04493554|Coagulants|coagulants|mesh-ancestor
110854363|NCT04493554|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110854364|NCT04493554|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
110854365|NCT04493554|Natriuretic Agents|natriuretic agents|mesh-ancestor
110854366|NCT04493554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110854368|NCT02601014|Ipilimumab|ipilimumab|mesh-list
110854369|NCT02601014|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110854370|NCT02601014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110854371|NCT02601014|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110854372|NCT02601014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110854373|NCT01307046|Losartan|losartan|mesh-list
110854374|NCT01307046|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110854375|NCT01307046|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110854376|NCT01307046|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110854377|NCT01307046|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110854378|NCT01307046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110854379|NCT05419115|Furosemide|furosemide|mesh-list
110854380|NCT05419115|Diuretics|diuretics|mesh-ancestor
110854381|NCT05419115|Natriuretic Agents|natriuretic agents|mesh-ancestor
110854382|NCT05419115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110337761|NCT00517725|Nebivolol|nebivolol|mesh-list
110854383|NCT05419115|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110833278|NCT03821623|Vitamins|vitamins|mesh-ancestor
110854384|NCT05419115|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110854385|NCT05419115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110854386|NCT02490592|Fluorides|fluorides|mesh-list
110854387|NCT02490592|Cariostatic Agents|cariostatic agents|mesh-ancestor
110854388|NCT02490592|Protective Agents|protective agents|mesh-ancestor
110854389|NCT02490592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110854390|NCT03075462|Apatinib|apatinib|mesh-list
110854391|NCT03075462|Fluzoparib|fluzoparib|mesh-list
110854392|NCT03075462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110854393|NCT03075462|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110854394|NCT03075462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110118363|NCT01884896|Metoprolol|metoprolol|mesh-list
110854395|NCT03075462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110854396|NCT03075462|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110571956|NCT00786370|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110854397|NCT01305395|Sirolimus|sirolimus|mesh-list
110854398|NCT01305395|Temsirolimus|temsirolimus|mesh-list
110854399|NCT01305395|MTOR Inhibitors|mtor inhibitors|mesh-list
110854400|NCT01305395|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110854401|NCT01305395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110854402|NCT01305395|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110854403|NCT01305395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110854404|NCT01305395|Antifungal Agents|antifungal agents|mesh-ancestor
110854405|NCT01305395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110854406|NCT01305395|Immunologic Factors|immunologic factors|mesh-ancestor
110854407|NCT01305395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110854408|NCT01305395|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110854409|NCT01305395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110854410|NCT01305395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110854411|NCT02886624|Grazoprevir|grazoprevir|mesh-list
110854412|NCT02886624|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
110854413|NCT02886624|Antiviral Agents|antiviral agents|mesh-ancestor
110854414|NCT02886624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110854415|NCT02487316|Crizotinib|crizotinib|mesh-list
110854416|NCT02487316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110854417|NCT02487316|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110854418|NCT02487316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110118627|NCT01886443|Anticoagulants|anticoagulants|mesh-ancestor
110854419|NCT02487316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110854421|NCT02490436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110854422|NCT02490436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110854423|NCT03318718|Rocuronium|rocuronium|mesh-list
110854424|NCT03318718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110854425|NCT03318718|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110854426|NCT03318718|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110854427|NCT03318718|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110854428|NCT03318718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110854429|NCT03325348|Labetalol|labetalol|mesh-list
110854430|NCT03325348|Nifedipine|nifedipine|mesh-list
110854431|NCT03325348|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110854432|NCT03325348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110854433|NCT03325348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110854434|NCT03325348|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110118693|NCT01887184|Analgesics|analgesics|mesh-ancestor
110854435|NCT03325348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110854436|NCT03325348|Vasodilator Agents|vasodilator agents|mesh-ancestor
110854437|NCT03325348|Tocolytic Agents|tocolytic agents|mesh-ancestor
110854438|NCT03325348|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110854439|NCT03325348|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110854440|NCT03325348|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110854441|NCT03325348|Adrenergic Agents|adrenergic agents|mesh-ancestor
110854442|NCT03325348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110854443|NCT03325348|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110854444|NCT03325348|Sympathomimetics|sympathomimetics|mesh-ancestor
110854445|NCT03325348|Autonomic Agents|autonomic agents|mesh-ancestor
110854446|NCT03325348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110854447|NCT03325348|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110854448|NCT03325348|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110854449|NCT03790163|Levobupivacaine|levobupivacaine|mesh-list
110854450|NCT03790163|Anesthetics, Local|anesthetics, local|mesh-ancestor
110854451|NCT03790163|Anesthetics|anesthetics|mesh-ancestor
110854452|NCT03790163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110854453|NCT03790163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110854454|NCT03790163|Sensory System Agents|sensory system agents|mesh-ancestor
110854455|NCT03790163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110854456|NCT03325270|Ferrous fumarate|ferrous fumarate|mesh-list
110854457|NCT03325270|Trace Elements|trace elements|mesh-ancestor
110854458|NCT03325270|Micronutrients|micronutrients|mesh-ancestor
110854459|NCT03325270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110854460|NCT02963766|Dulaglutide|dulaglutide|mesh-list
110854461|NCT02963766|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110854462|NCT02963766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110854463|NCT01334502|Prednisone|prednisone|mesh-list
110854464|NCT01334502|Cyclophosphamide|cyclophosphamide|mesh-list
110854465|NCT01334502|Rituximab|rituximab|mesh-list
110854466|NCT01334502|Doxorubicin|doxorubicin|mesh-list
110854467|NCT01334502|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110854468|NCT01334502|Vincristine|vincristine|mesh-list
110854469|NCT01334502|Everolimus|everolimus|mesh-list
110854470|NCT01334502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110854471|NCT01334502|Immunologic Factors|immunologic factors|mesh-ancestor
110854472|NCT01334502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110854473|NCT01334502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110854474|NCT01334502|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110854475|NCT01334502|Alkylating Agents|alkylating agents|mesh-ancestor
110854476|NCT01334502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110854477|NCT01334502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110854478|NCT01334502|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110854479|NCT01334502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110854480|NCT01334502|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110854481|NCT01334502|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110854482|NCT01334502|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110854483|NCT01334502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110854484|NCT01334502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110854485|NCT01334502|Glucocorticoids|glucocorticoids|mesh-ancestor
110854486|NCT01334502|Hormones|hormones|mesh-ancestor
110854487|NCT01334502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110854488|NCT01334502|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110854489|NCT01334502|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110854490|NCT01334502|Tubulin Modulators|tubulin modulators|mesh-ancestor
110854491|NCT01334502|Antimitotic Agents|antimitotic agents|mesh-ancestor
110854492|NCT01334502|Mitosis Modulators|mitosis modulators|mesh-ancestor
110854493|NCT01334502|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110854494|NCT01334502|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110854495|NCT02487082|Melatonin|melatonin|mesh-list
110854496|NCT02487082|Donepezil|donepezil|mesh-list
110854497|NCT02487082|Antioxidants|antioxidants|mesh-ancestor
110854498|NCT02487082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110118784|NCT01887561|Dasatinib|dasatinib|mesh-list
110854499|NCT02487082|Protective Agents|protective agents|mesh-ancestor
110854500|NCT02487082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110854501|NCT02487082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110854502|NCT02487082|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110854503|NCT02487082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110854504|NCT02487082|Cholinergic Agents|cholinergic agents|mesh-ancestor
110854505|NCT02487082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110854506|NCT02487082|Nootropic Agents|nootropic agents|mesh-ancestor
110854507|NCT03788681|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110854508|NCT03788681|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110854510|NCT03788681|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110854511|NCT03788681|Estrogens|estrogens|mesh-ancestor
110854512|NCT03788681|Hormones|hormones|mesh-ancestor
110854513|NCT03788681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110854514|NCT03788681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110854515|NCT03788681|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110854516|NCT03788681|Contraceptive Agents|contraceptive agents|mesh-ancestor
110854517|NCT03788681|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110854518|NCT03788681|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110854519|NCT03790085|Olanzapine|olanzapine|mesh-list
110854520|NCT03790085|Risperidone|risperidone|mesh-list
110854521|NCT03790085|Aripiprazole|aripiprazole|mesh-list
110854522|NCT03790085|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110854523|NCT03790085|Serotonin Agents|serotonin agents|mesh-ancestor
110854524|NCT03790085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110854525|NCT03790085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110854526|NCT03790085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110854527|NCT03790085|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110854528|NCT03790085|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110854529|NCT03790085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110854530|NCT03790085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110854531|NCT03790085|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110854532|NCT03790085|Dopamine Agents|dopamine agents|mesh-ancestor
110854533|NCT03790085|Antiemetics|antiemetics|mesh-ancestor
110854534|NCT03790085|Autonomic Agents|autonomic agents|mesh-ancestor
110854535|NCT03790085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110854536|NCT03790085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110854537|NCT03790085|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110118890|NCT01887873|Protective Agents|protective agents|mesh-ancestor
110854538|NCT03790085|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110854539|NCT03790085|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110854540|NCT03790085|Antidepressive Agents|antidepressive agents|mesh-ancestor
110854541|NCT03790085|Dopamine Agonists|dopamine agonists|mesh-ancestor
110118946|NCT01888263|Lamotrigine|lamotrigine|mesh-list
110854542|NCT03790085|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110854544|NCT03790085|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110854545|NCT03790085|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110854546|NCT01306097|Zinc|zinc|mesh-list
110854547|NCT01306097|Zinc Sulfate|zinc sulfate|mesh-list
110854548|NCT01306097|Trace Elements|trace elements|mesh-ancestor
110854549|NCT01306097|Micronutrients|micronutrients|mesh-ancestor
110572114|NCT00661492|Cetuximab|cetuximab|mesh-list
110854550|NCT01306097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110854551|NCT01306097|Astringents|astringents|mesh-ancestor
110854552|NCT01306097|Dermatologic Agents|dermatologic agents|mesh-ancestor
110854553|NCT03790007|Bupivacaine|bupivacaine|mesh-list
110854554|NCT03790007|Anesthetics, Local|anesthetics, local|mesh-ancestor
110854555|NCT03790007|Anesthetics|anesthetics|mesh-ancestor
110854556|NCT03790007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110854557|NCT03790007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110854558|NCT03790007|Sensory System Agents|sensory system agents|mesh-ancestor
110854559|NCT03790007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110854560|NCT03789695|Dabigatran|dabigatran|mesh-list
110854561|NCT03789695|Antithrombins|antithrombins|mesh-ancestor
110854562|NCT03789695|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110854563|NCT03789695|Protease Inhibitors|protease inhibitors|mesh-ancestor
110854564|NCT03789695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110854565|NCT03789695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110854566|NCT03789695|Anticoagulants|anticoagulants|mesh-ancestor
110854567|NCT00739674|Losartan|losartan|mesh-list
110854568|NCT00739674|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110854569|NCT00739674|Calcium Channel Blockers|calcium channel blockers|mesh-list
110854570|NCT00739674|Calcium|calcium|mesh-list
110854571|NCT00739674|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110854572|NCT00739674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110854573|NCT00739674|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110854574|NCT00739674|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110854575|NCT00739674|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110854576|NCT00739674|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110854577|NCT00739674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110854578|NCT00739674|Diuretics|diuretics|mesh-ancestor
110854579|NCT00739674|Natriuretic Agents|natriuretic agents|mesh-ancestor
110854580|NCT00739674|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110854581|NCT00739674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110854582|NCT01306409|Darbepoetin alfa|darbepoetin alfa|mesh-list
110854583|NCT01306409|Hematinics|hematinics|mesh-ancestor
110854584|NCT01331928|Docetaxel|docetaxel|mesh-list
110854585|NCT01331928|Capecitabine|capecitabine|mesh-list
110854586|NCT01331928|Oxaliplatin|oxaliplatin|mesh-list
110854587|NCT01331928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110854588|NCT01331928|Tubulin Modulators|tubulin modulators|mesh-ancestor
110854589|NCT01331928|Antimitotic Agents|antimitotic agents|mesh-ancestor
110854590|NCT01331928|Mitosis Modulators|mitosis modulators|mesh-ancestor
110854591|NCT01331928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110854592|NCT01331928|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110854593|NCT01331928|Antimetabolites|antimetabolites|mesh-ancestor
110854595|NCT01334580|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110854596|NCT01334580|Narcotics|narcotics|mesh-ancestor
110854597|NCT01334580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110119151|NCT01888978|Vitamins|vitamins|mesh-ancestor
110854598|NCT01334580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110854599|NCT01334580|Analgesics|analgesics|mesh-ancestor
110854600|NCT01334580|Sensory System Agents|sensory system agents|mesh-ancestor
110854601|NCT01334580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110854602|NCT01334580|Antitussive Agents|antitussive agents|mesh-ancestor
110854603|NCT01334580|Respiratory System Agents|respiratory system agents|mesh-ancestor
110854604|NCT02694588|Infliximab|infliximab|mesh-list
110854605|NCT02694588|Vedolizumab|vedolizumab|mesh-list
110854606|NCT02694588|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110854607|NCT02694588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110854608|NCT02694588|Dermatologic Agents|dermatologic agents|mesh-ancestor
110854609|NCT02694588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110854610|NCT02694588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110854611|NCT03789539|Vaccines|vaccines|mesh-list
110854612|NCT03789539|Immunologic Factors|immunologic factors|mesh-ancestor
110854613|NCT03789539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110854614|NCT00400218|Losartan|losartan|mesh-list
110854615|NCT00400218|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110854616|NCT00400218|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110854617|NCT00400218|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110854618|NCT00400218|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110854619|NCT00400218|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110854620|NCT00400218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110854621|NCT00400218|Diuretics|diuretics|mesh-ancestor
110854622|NCT00400218|Natriuretic Agents|natriuretic agents|mesh-ancestor
110854623|NCT00400218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110854624|NCT00400218|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110854625|NCT00400218|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110854626|NCT02486848|Minoxidil|minoxidil|mesh-list
110854628|NCT02486848|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110854629|NCT02486848|Vasodilator Agents|vasodilator agents|mesh-ancestor
110854630|NCT01306565|Atorvastatin|atorvastatin|mesh-list
110854631|NCT01306565|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110854632|NCT01306565|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110854633|NCT01306565|Antimetabolites|antimetabolites|mesh-ancestor
110854634|NCT01306565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110854635|NCT01306565|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110854636|NCT01306565|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110854637|NCT01306565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110854638|NCT03716791|Dimethyl sulfone|dimethyl sulfone|mesh-list
110854639|NCT03716791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110854640|NCT03786029|Acetaminophen|acetaminophen|mesh-list
110854641|NCT03786029|Ibuprofen|ibuprofen|mesh-list
110854642|NCT03786029|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110854643|NCT03786029|Analgesics|analgesics|mesh-ancestor
110854644|NCT03786029|Sensory System Agents|sensory system agents|mesh-ancestor
110854645|NCT03786029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110854646|NCT03786029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110854647|NCT03786029|Antipyretics|antipyretics|mesh-ancestor
110854648|NCT03786029|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110854649|NCT03786029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110854650|NCT03786029|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110854651|NCT03786029|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110854652|NCT03786029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110854653|NCT03786029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110854655|NCT01334892|Cyclosporins|cyclosporins|mesh-list
110854656|NCT01334892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110854657|NCT01334892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110854658|NCT01334892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110854659|NCT01334892|Immunologic Factors|immunologic factors|mesh-ancestor
110854660|NCT01334892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110854661|NCT01334892|Antifungal Agents|antifungal agents|mesh-ancestor
110854662|NCT01334892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110854663|NCT01334892|Dermatologic Agents|dermatologic agents|mesh-ancestor
110854664|NCT01334892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110854665|NCT01334892|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110854666|NCT04730219|Paclitaxel|paclitaxel|mesh-list
110854667|NCT04730219|Tislelizumab|tislelizumab|mesh-list
110854668|NCT04730219|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110854669|NCT04730219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110854670|NCT04730219|Tubulin Modulators|tubulin modulators|mesh-ancestor
110854671|NCT04730219|Antimitotic Agents|antimitotic agents|mesh-ancestor
110854672|NCT04730219|Mitosis Modulators|mitosis modulators|mesh-ancestor
110119433|NCT01895049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110854673|NCT04730219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110854674|NCT04730219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110854675|NCT04492774|Dexamethasone|dexamethasone|mesh-list
110854676|NCT04492774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110854677|NCT04492774|Antiemetics|antiemetics|mesh-ancestor
110854678|NCT04492774|Autonomic Agents|autonomic agents|mesh-ancestor
110854679|NCT04492774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110854680|NCT04492774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110854681|NCT04492774|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110854682|NCT04492774|Glucocorticoids|glucocorticoids|mesh-ancestor
110854683|NCT04492774|Hormones|hormones|mesh-ancestor
110854684|NCT04492774|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110854685|NCT04492774|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110854686|NCT04492774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110854687|NCT03321292|Aspirin|aspirin|mesh-list
110854688|NCT03321292|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110854689|NCT03321292|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110854690|NCT03321292|Analgesics|analgesics|mesh-ancestor
110854691|NCT03321292|Sensory System Agents|sensory system agents|mesh-ancestor
110854692|NCT03321292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110854693|NCT03321292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110854694|NCT03321292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110854696|NCT03321292|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110854697|NCT03321292|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110854698|NCT03321292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110854699|NCT03321292|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110854700|NCT03321292|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110854701|NCT03321292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110854702|NCT03321292|Antipyretics|antipyretics|mesh-ancestor
110854703|NCT01306721|Fexofenadine|fexofenadine|mesh-list
110854704|NCT01306721|Pseudoephedrine|pseudoephedrine|mesh-list
110854705|NCT01306721|Ephedrine|ephedrine|mesh-list
110854706|NCT01306721|Terfenadine|terfenadine|mesh-list
110854707|NCT01306721|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110854708|NCT01306721|Autonomic Agents|autonomic agents|mesh-ancestor
110854709|NCT01306721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110854710|NCT01306721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110854711|NCT01306721|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110854712|NCT01306721|Respiratory System Agents|respiratory system agents|mesh-ancestor
110119551|NCT01900158|Cisplatin|cisplatin|mesh-list
110854713|NCT01306721|Nasal Decongestants|nasal decongestants|mesh-ancestor
110854714|NCT01306721|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110854715|NCT01306721|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110854716|NCT01306721|Sympathomimetics|sympathomimetics|mesh-ancestor
110854717|NCT01306721|Adrenergic Agents|adrenergic agents|mesh-ancestor
110854718|NCT01306721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110854719|NCT01306721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110854720|NCT01306721|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110854721|NCT01306721|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110854722|NCT01306721|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110854723|NCT01306721|Histamine Antagonists|histamine antagonists|mesh-ancestor
110833314|NCT00741988|Bevacizumab|bevacizumab|mesh-list
110854724|NCT01306721|Histamine Agents|histamine agents|mesh-ancestor
110854725|NCT01337466|Fialuridine|fialuridine|mesh-list
110854726|NCT01337466|Antiviral Agents|antiviral agents|mesh-ancestor
110854727|NCT01337466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110119593|NCT01900496|Rituximab|rituximab|mesh-list
110854728|NCT01337466|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110854729|NCT01337466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110854730|NCT01337466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110854731|NCT02486926|Remifentanil|remifentanil|mesh-list
110854732|NCT02486926|Alfentanil|alfentanil|mesh-list
110854733|NCT02486926|Thiopental|thiopental|mesh-list
110854734|NCT02486926|Sevoflurane|sevoflurane|mesh-list
110854735|NCT02486926|Rocuronium|rocuronium|mesh-list
110854736|NCT02486926|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110854737|NCT02486926|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110854738|NCT02486926|Anesthetics, General|anesthetics, general|mesh-ancestor
110854739|NCT02486926|Anesthetics|anesthetics|mesh-ancestor
110854740|NCT02486926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110854741|NCT02486926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110854742|NCT02486926|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110854743|NCT02486926|Narcotics|narcotics|mesh-ancestor
110854744|NCT02486926|Analgesics|analgesics|mesh-ancestor
110854745|NCT02486926|Sensory System Agents|sensory system agents|mesh-ancestor
110854746|NCT02486926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110854747|NCT02486926|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110854748|NCT02486926|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110854749|NCT02486926|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110854750|NCT02486926|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110854751|NCT02486926|Anticonvulsants|anticonvulsants|mesh-ancestor
110854752|NCT02486926|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110854753|NCT02486926|GABA Modulators|gaba modulators|mesh-ancestor
110854755|NCT02486926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110854756|NCT02486926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110854757|NCT01335048|Clopidogrel|clopidogrel|mesh-list
110854758|NCT01335048|Atorvastatin|atorvastatin|mesh-list
110854759|NCT01335048|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110854760|NCT01335048|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110854761|NCT01335048|Antimetabolites|antimetabolites|mesh-ancestor
110854762|NCT01335048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110854763|NCT01335048|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110854764|NCT01335048|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110854765|NCT01335048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110854766|NCT01335048|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110854767|NCT01335048|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110854768|NCT01335048|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110854769|NCT01335048|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110854770|NCT01335048|Purinergic Agents|purinergic agents|mesh-ancestor
110119704|NCT01900938|Midazolam|midazolam|mesh-list
110854771|NCT01335048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110854772|NCT01335048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110854773|NCT01335126|Lubricant Eye Drops|lubricant eye drops|mesh-list
110854774|NCT01335126|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110854775|NCT01335126|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110854776|NCT01567475|Rituximab|rituximab|mesh-list
110854778|NCT01567475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110119761|NCT01901172|Hormone Antagonists|hormone antagonists|mesh-ancestor
110854779|NCT01567475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110854780|NCT01567475|Immunologic Factors|immunologic factors|mesh-ancestor
110854781|NCT01567475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110854782|NCT01567475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110854783|NCT01567475|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110854784|NCT01567475|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110854785|NCT01567475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110854786|NCT01567475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110854787|NCT01567475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110854788|NCT03435055|Nitrous Oxide|nitrous oxide|mesh-list
110854789|NCT03435055|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110854790|NCT03435055|Anesthetics, General|anesthetics, general|mesh-ancestor
110854791|NCT03435055|Anesthetics|anesthetics|mesh-ancestor
110854792|NCT03435055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110854793|NCT03435055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110854794|NCT03435055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110854795|NCT03435055|Analgesics|analgesics|mesh-ancestor
110854796|NCT03435055|Sensory System Agents|sensory system agents|mesh-ancestor
110854797|NCT03435055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110854799|NCT05693246|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110854800|NCT05693246|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110854801|NCT05693246|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110854802|NCT05693246|Cholinergic Agents|cholinergic agents|mesh-ancestor
110854803|NCT05693246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110854804|NCT05693246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110854805|NCT05693246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110119890|NCT01902186|Ritonavir|ritonavir|mesh-list
110854807|NCT03316066|Anesthetics, Local|anesthetics, local|mesh-ancestor
110854808|NCT03316066|Anesthetics|anesthetics|mesh-ancestor
110854809|NCT03316066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110854810|NCT03316066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110854811|NCT03316066|Sensory System Agents|sensory system agents|mesh-ancestor
110854812|NCT03316066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110854813|NCT03318016|Cyclophosphamide|cyclophosphamide|mesh-list
110854814|NCT03318016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110854815|NCT03318016|Immunologic Factors|immunologic factors|mesh-ancestor
110854816|NCT03318016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110854817|NCT03318016|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110854818|NCT03318016|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110854819|NCT03318016|Alkylating Agents|alkylating agents|mesh-ancestor
110854820|NCT03318016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110854821|NCT03318016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110854822|NCT03318016|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110854823|NCT03434977|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
110854824|NCT03434977|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110854825|NCT03434977|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110854826|NCT03434977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110854827|NCT01335360|Nevirapine|nevirapine|mesh-list
110854828|NCT01335360|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110854829|NCT01335360|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110854830|NCT01335360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110854831|NCT01335360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110854832|NCT01335360|Antiviral Agents|antiviral agents|mesh-ancestor
110854833|NCT01335360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110854834|NCT01335360|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110854835|NCT01335360|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110854836|NCT01335360|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110854837|NCT01335360|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110854838|NCT02489266|Aldesleukin|aldesleukin|mesh-list
110854839|NCT02489266|Cyclophosphamide|cyclophosphamide|mesh-list
110854840|NCT02489266|Fludarabine|fludarabine|mesh-list
110854841|NCT02489266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110854842|NCT02489266|Immunologic Factors|immunologic factors|mesh-ancestor
110854843|NCT02489266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110854844|NCT02489266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110854845|NCT02489266|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110854846|NCT02489266|Alkylating Agents|alkylating agents|mesh-ancestor
110854847|NCT02489266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110854848|NCT02489266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110572408|NCT02609334|Pemirolast|pemirolast|mesh-list
110854850|NCT02489266|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110854851|NCT02489266|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110854852|NCT02489266|Antiviral Agents|antiviral agents|mesh-ancestor
110854853|NCT02489266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110854855|NCT03434119|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110854856|NCT03434119|Insulin Glargine|insulin glargine|mesh-list
110854857|NCT03434119|Lixisenatide|lixisenatide|mesh-list
110854858|NCT03434119|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110854859|NCT03434119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110854860|NCT02484352|Oxycodone|oxycodone|mesh-list
110854861|NCT02484352|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110854862|NCT02484352|Narcotics|narcotics|mesh-ancestor
110854863|NCT02484352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110854864|NCT02484352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110854865|NCT02484352|Analgesics|analgesics|mesh-ancestor
110854866|NCT02484352|Sensory System Agents|sensory system agents|mesh-ancestor
110854867|NCT02484352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110854868|NCT01308671|Varenicline|varenicline|mesh-list
110854869|NCT01308671|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110854870|NCT01308671|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110854871|NCT01308671|Cholinergic Agents|cholinergic agents|mesh-ancestor
110854872|NCT01308671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110854873|NCT01308671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110854874|NCT01308671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110854875|NCT00378378|Mometasone Furoate|mometasone furoate|mesh-list
110854876|NCT00378378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110854877|NCT00378378|Dermatologic Agents|dermatologic agents|mesh-ancestor
110854878|NCT00378378|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110854879|NCT03315676|Esomeprazole|esomeprazole|mesh-list
110854880|NCT03315676|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110854881|NCT03315676|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110854882|NCT03315676|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110854883|NCT03315676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110854884|NCT03315676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110854885|NCT01307189|Tiotropium Bromide|tiotropium bromide|mesh-list
110854886|NCT01307189|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110854887|NCT01307189|Autonomic Agents|autonomic agents|mesh-ancestor
110854888|NCT01307189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110854889|NCT01307189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110854890|NCT01307189|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110854891|NCT01307189|Respiratory System Agents|respiratory system agents|mesh-ancestor
110854892|NCT01307189|Parasympatholytics|parasympatholytics|mesh-ancestor
110854893|NCT01307189|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110854894|NCT01307189|Cholinergic Agents|cholinergic agents|mesh-ancestor
110854895|NCT01307189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110854896|NCT01307189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110854898|NCT02486458|Fluorides|fluorides|mesh-list
110854899|NCT02486458|Sodium Fluoride|sodium fluoride|mesh-list
110854900|NCT02486458|Fluorides, Topical|fluorides, topical|mesh-list
110854901|NCT02486458|Cariostatic Agents|cariostatic agents|mesh-ancestor
110854902|NCT02486458|Protective Agents|protective agents|mesh-ancestor
110854903|NCT02486458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110854904|NCT02486458|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110854905|NCT02486458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110854906|NCT01335516|Terlipressin|terlipressin|mesh-list
110854907|NCT01335516|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110854908|NCT01335516|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110854909|NCT05694923|Empagliflozin|empagliflozin|mesh-list
110854910|NCT05694923|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110854911|NCT05694923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110854912|NCT05694923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110854913|NCT05694923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110854914|NCT01332396|Lapatinib|lapatinib|mesh-list
110854915|NCT01332396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110854916|NCT01332396|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110854917|NCT01332396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110854918|NCT01332396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110854919|NCT03719053|Tenofovir|tenofovir|mesh-list
110854920|NCT03719053|Antiviral Agents|antiviral agents|mesh-ancestor
110854921|NCT03719053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110833336|NCT04457050|Antiviral Agents|antiviral agents|mesh-ancestor
110854922|NCT03719053|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110854923|NCT03719053|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110854925|NCT03719053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110854927|NCT03719053|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110854928|NCT03526848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110854929|NCT03526848|Antibodies|antibodies|mesh-list
110854930|NCT03526848|Immunoglobulins|immunoglobulins|mesh-list
110854931|NCT03526848|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110120214|NCT01904214|Siponimod|siponimod|mesh-list
110854933|NCT03526848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110854934|NCT03526848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110854935|NCT03321136|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
110854936|NCT03321136|Hallucinogens|hallucinogens|mesh-ancestor
110854937|NCT03321136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110854938|NCT03321136|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110854939|NCT03321136|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110854940|NCT03321136|Serotonin Agents|serotonin agents|mesh-ancestor
110854941|NCT03321136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110854942|NCT03321136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110854943|NCT03321136|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110854944|NCT01332552|Ritonavir|ritonavir|mesh-list
110854945|NCT01332552|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110854946|NCT01332552|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110854947|NCT01332552|Protease Inhibitors|protease inhibitors|mesh-ancestor
110854948|NCT01332552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110854949|NCT01332552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110854950|NCT01332552|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110854951|NCT01332552|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110854952|NCT01332552|Antiviral Agents|antiviral agents|mesh-ancestor
110854953|NCT01332552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110854954|NCT01332552|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110854955|NCT01332552|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110854956|NCT03720223|Bupivacaine|bupivacaine|mesh-list
110854957|NCT03720223|Anesthetics, Local|anesthetics, local|mesh-ancestor
110854958|NCT03720223|Anesthetics|anesthetics|mesh-ancestor
110120412|NCT01905371|Adrenergic Agents|adrenergic agents|mesh-ancestor
110854959|NCT03720223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110854960|NCT03720223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110854961|NCT03720223|Sensory System Agents|sensory system agents|mesh-ancestor
110854962|NCT03720223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110854964|NCT03160716|Anesthetics, Local|anesthetics, local|mesh-ancestor
110854965|NCT03160716|Anesthetics|anesthetics|mesh-ancestor
110854966|NCT03160716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110854967|NCT03160716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110854968|NCT03160716|Sensory System Agents|sensory system agents|mesh-ancestor
110854969|NCT03160716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110854970|NCT03160716|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110854971|NCT03160716|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110854972|NCT03160716|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110854973|NCT03160716|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110854974|NCT03160716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110854975|NCT00092664|Simvastatin|simvastatin|mesh-list
110854976|NCT00092664|Ezetimibe|ezetimibe|mesh-list
110854977|NCT00092664|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110854978|NCT00092664|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110854979|NCT00092664|Antimetabolites|antimetabolites|mesh-ancestor
110854980|NCT00092664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110854981|NCT00092664|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110854982|NCT00092664|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110854984|NCT02483884|Bombesin|bombesin|mesh-list
110854985|NCT02483884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110854986|NCT02483884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110854987|NCT02483884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110854988|NCT03317548|Progesterone|progesterone|mesh-list
110854989|NCT03317548|Progestins|progestins|mesh-ancestor
110854990|NCT03317548|Hormones|hormones|mesh-ancestor
110854991|NCT03317548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110854992|NCT03317548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110854994|NCT00092586|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110854995|NCT00092586|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110854996|NCT00092586|Antimetabolites|antimetabolites|mesh-ancestor
110854997|NCT00092586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110854998|NCT00092586|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110855000|NCT03786887|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110855001|NCT03786887|Narcotics|narcotics|mesh-ancestor
110855002|NCT03786887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110855003|NCT03786887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110855004|NCT03786887|Analgesics|analgesics|mesh-ancestor
110855005|NCT03786887|Sensory System Agents|sensory system agents|mesh-ancestor
110855006|NCT03786887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110855007|NCT03787043|Metformin|metformin|mesh-list
110855008|NCT03787043|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110855009|NCT03787043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110855010|NCT00090168|Atorvastatin|atorvastatin|mesh-list
110855011|NCT00090168|Simvastatin|simvastatin|mesh-list
110855012|NCT00090168|Ezetimibe|ezetimibe|mesh-list
110855013|NCT00090168|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110855014|NCT00090168|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110855015|NCT00090168|Antimetabolites|antimetabolites|mesh-ancestor
110855016|NCT00090168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110855017|NCT00090168|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110855018|NCT00090168|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110855019|NCT00090168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110855020|NCT01332786|Tigecycline|tigecycline|mesh-list
110855021|NCT01332786|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110855022|NCT01332786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110855023|NCT01332786|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110855024|NCT01332786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110855025|NCT01332786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110855026|NCT01338090|Bevacizumab|bevacizumab|mesh-list
110855027|NCT01338090|Everolimus|everolimus|mesh-list
110855028|NCT01338090|89Zr-bevacizumab|89zr-bevacizumab|mesh-list
110855029|NCT01338090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110855030|NCT01338090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110855031|NCT01338090|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110855032|NCT01338090|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110855033|NCT01338090|Growth Substances|growth substances|mesh-ancestor
110855034|NCT01338090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110855035|NCT01338090|Growth Inhibitors|growth inhibitors|mesh-ancestor
110855036|NCT01338090|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110855037|NCT01338090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110855038|NCT01338090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110855039|NCT01338090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110855040|NCT01338090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110855041|NCT01338090|Immunologic Factors|immunologic factors|mesh-ancestor
110855042|NCT01338090|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110855043|NCT01307969|Lidocaine|lidocaine|mesh-list
110855044|NCT01307969|Epinephrine|epinephrine|mesh-list
110855045|NCT01307969|Racepinephrine|racepinephrine|mesh-list
110855046|NCT01307969|Ropivacaine|ropivacaine|mesh-list
110855047|NCT01307969|Epinephryl borate|epinephryl borate|mesh-list
110855048|NCT01307969|Anesthetics, Local|anesthetics, local|mesh-ancestor
110855049|NCT01307969|Anesthetics|anesthetics|mesh-ancestor
110855050|NCT01307969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110855051|NCT01307969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110855052|NCT01307969|Sensory System Agents|sensory system agents|mesh-ancestor
110833357|NCT05654233|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110855053|NCT01307969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110855054|NCT01307969|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110855055|NCT01307969|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110855056|NCT01307969|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110855057|NCT01307969|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110855058|NCT01307969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110855059|NCT01307969|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110855060|NCT01307969|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110855061|NCT01307969|Adrenergic Agents|adrenergic agents|mesh-ancestor
110855062|NCT01307969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110855063|NCT01307969|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110855064|NCT01307969|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110855065|NCT01307969|Autonomic Agents|autonomic agents|mesh-ancestor
110855066|NCT01307969|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110855067|NCT01307969|Respiratory System Agents|respiratory system agents|mesh-ancestor
110855069|NCT01307969|Sympathomimetics|sympathomimetics|mesh-ancestor
110855070|NCT01307969|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110855072|NCT03786419|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110572630|NCT00867113|Imatinib Mesylate|imatinib mesylate|mesh-list
110120894|NCT01908660|Antiviral Agents|antiviral agents|mesh-ancestor
110855073|NCT03786419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110855074|NCT03786419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110855075|NCT03786419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110855076|NCT01338324|Simvastatin|simvastatin|mesh-list
110855077|NCT01338324|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110855078|NCT01338324|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110855079|NCT01338324|Antimetabolites|antimetabolites|mesh-ancestor
110855080|NCT01338324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110855081|NCT01338324|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110855082|NCT01338324|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110855083|NCT01338324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110855084|NCT01336062|Paclitaxel|paclitaxel|mesh-list
110121034|NCT01910142|Hemostatics|hemostatics|mesh-ancestor
110855085|NCT01336062|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110855086|NCT01336062|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110855087|NCT01336062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110855088|NCT01336062|Tubulin Modulators|tubulin modulators|mesh-ancestor
110855089|NCT01336062|Antimitotic Agents|antimitotic agents|mesh-ancestor
110855090|NCT01336062|Mitosis Modulators|mitosis modulators|mesh-ancestor
110855091|NCT01336062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110855092|NCT05694221|Metformin|metformin|mesh-list
110855093|NCT05694221|Digoxin|digoxin|mesh-list
110855094|NCT05694221|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110855095|NCT05694221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110855096|NCT05694221|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110855097|NCT05694221|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110855098|NCT05694221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110121100|NCT01910285|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110855099|NCT05694221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110855100|NCT05694221|Protective Agents|protective agents|mesh-ancestor
110855101|NCT01308047|Bupivacaine|bupivacaine|mesh-list
110855102|NCT01308047|Anesthetics, Local|anesthetics, local|mesh-ancestor
110855103|NCT01308047|Anesthetics|anesthetics|mesh-ancestor
110855104|NCT01308047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110855105|NCT01308047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110855106|NCT01308047|Sensory System Agents|sensory system agents|mesh-ancestor
110855107|NCT01308047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110855108|NCT03777605|Nitroglycerin|nitroglycerin|mesh-list
110855109|NCT03777605|Vasodilator Agents|vasodilator agents|mesh-ancestor
110855110|NCT03777761|Moxifloxacin|moxifloxacin|mesh-list
110855111|NCT03777761|Tucatinib|tucatinib|mesh-list
110855112|NCT03777761|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110855113|NCT03777761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110855114|NCT03777761|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110855115|NCT03777761|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110855116|NCT03777761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110855117|NCT03777761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110855118|NCT03777761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110855119|NCT03777761|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110855120|NCT01316861|Acarbose|acarbose|mesh-list
110855121|NCT01316861|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
110855122|NCT01316861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110855123|NCT01316861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110855124|NCT01316861|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110855125|NCT01316861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110855126|NCT01336218|Rifampin|rifampin|mesh-list
110855127|NCT01336218|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110855128|NCT01336218|Antitubercular Agents|antitubercular agents|mesh-ancestor
110855129|NCT01336218|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110855130|NCT01336218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110855131|NCT01336218|Leprostatic Agents|leprostatic agents|mesh-ancestor
110855132|NCT01336218|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110855133|NCT01336218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110855134|NCT01336218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110855135|NCT01336218|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110855136|NCT01336218|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110855137|NCT01336218|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110855138|NCT01336218|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110121203|NCT01910870|Cyclophosphamide|cyclophosphamide|mesh-list
110855139|NCT01336218|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110855140|NCT01336218|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110855141|NCT05029115|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
110855142|NCT05029115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110855143|NCT05029115|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110855144|NCT05029115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110855145|NCT03776279|Mitoxantrone|mitoxantrone|mesh-list
110855146|NCT03776279|Analgesics|analgesics|mesh-ancestor
110855147|NCT03776279|Sensory System Agents|sensory system agents|mesh-ancestor
110855148|NCT03776279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110855149|NCT03776279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110855150|NCT03776279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110855151|NCT03776279|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110855152|NCT03776279|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110855153|NCT03776279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110121415|NCT01912066|Aceclofenac|aceclofenac|mesh-list
110855154|NCT03776279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110855155|NCT01561391|Factor VIII|factor viii|mesh-list
110855156|NCT01561391|Coagulants|coagulants|mesh-ancestor
110855157|NCT03775655|Dexmedetomidine|dexmedetomidine|mesh-list
110855158|NCT03775655|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110855159|NCT03775655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110855160|NCT03775655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110855161|NCT03775655|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110855162|NCT03775655|Analgesics|analgesics|mesh-ancestor
110121552|NCT01912898|Vitamin D|vitamin d|mesh-list
110855163|NCT03775655|Sensory System Agents|sensory system agents|mesh-ancestor
110855164|NCT03775655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110855165|NCT03775655|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110855166|NCT03775655|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110855167|NCT03775655|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110855168|NCT03775655|Adrenergic Agents|adrenergic agents|mesh-ancestor
110855169|NCT03775655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110855170|NCT03775655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110855171|NCT01310465|Zoledronic Acid|zoledronic acid|mesh-list
110855172|NCT01310465|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110855173|NCT01310465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110855174|NCT03781895|Cholecalciferol|cholecalciferol|mesh-list
110337930|NCT00518583|Paclitaxel|paclitaxel|mesh-list
110855176|NCT03781895|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110855177|NCT03781895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110855179|NCT03781895|Micronutrients|micronutrients|mesh-ancestor
110855180|NCT03781895|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110855181|NCT00706030|Vinorelbine|vinorelbine|mesh-list
110855182|NCT00706030|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110855183|NCT00706030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110855184|NCT00706030|Tubulin Modulators|tubulin modulators|mesh-ancestor
110855186|NCT00706030|Mitosis Modulators|mitosis modulators|mesh-ancestor
110855187|NCT00706030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110855189|NCT03781505|Ropivacaine|ropivacaine|mesh-list
110855190|NCT03781505|Anesthetics, Local|anesthetics, local|mesh-ancestor
110855191|NCT03781505|Anesthetics|anesthetics|mesh-ancestor
110855192|NCT03781505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110855193|NCT03781505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110855194|NCT03781505|Sensory System Agents|sensory system agents|mesh-ancestor
110855195|NCT03781505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110855196|NCT03781505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110855197|NCT03781505|Analgesics|analgesics|mesh-ancestor
110855198|NCT03781505|Antipyretics|antipyretics|mesh-ancestor
110855199|NCT03781115|Olanzapine|olanzapine|mesh-list
110855200|NCT03781115|Ziprasidone|ziprasidone|mesh-list
110855201|NCT03781115|Antiemetics|antiemetics|mesh-ancestor
110855202|NCT03781115|Autonomic Agents|autonomic agents|mesh-ancestor
110855203|NCT03781115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110855204|NCT03781115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110855205|NCT03781115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110855206|NCT03781115|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110855207|NCT03781115|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110855208|NCT03781115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110855209|NCT03781115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110855210|NCT03781115|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110855211|NCT03781115|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110855212|NCT03781115|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110855213|NCT03781115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110122029|NCT01916252|Glucocorticoids|glucocorticoids|mesh-ancestor
110855214|NCT03781115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110855215|NCT03781115|Serotonin Agents|serotonin agents|mesh-ancestor
110855216|NCT03781115|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110855217|NCT03781115|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110855218|NCT03781115|Dopamine Agents|dopamine agents|mesh-ancestor
110855219|NCT03317236|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110855220|NCT03317236|Antidepressive Agents|antidepressive agents|mesh-ancestor
110855221|NCT03317236|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110855222|NCT03317236|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110855223|NCT03317236|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110855224|NCT03317236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110855225|NCT03317236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110855226|NCT01313429|Celecoxib|celecoxib|mesh-list
110855227|NCT01313429|Cyclophosphamide|cyclophosphamide|mesh-list
110855228|NCT01313429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110855229|NCT01313429|Immunologic Factors|immunologic factors|mesh-ancestor
110855230|NCT01313429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110855231|NCT01313429|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110855232|NCT01313429|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110855234|NCT01313429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110855235|NCT01313429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110855236|NCT01313429|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110855237|NCT01313429|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110855238|NCT01313429|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110855239|NCT01313429|Analgesics|analgesics|mesh-ancestor
110855240|NCT01313429|Sensory System Agents|sensory system agents|mesh-ancestor
110337944|NCT00519753|Travoprost|travoprost|mesh-list
110855241|NCT01313429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110855242|NCT01313429|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110855243|NCT01313429|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110855244|NCT01313429|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110855245|NCT01313429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110855246|NCT03488251|Gemcitabine|gemcitabine|mesh-list
110855247|NCT03488251|Oxaliplatin|oxaliplatin|mesh-list
110855248|NCT03488251|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110855249|NCT03488251|Antimetabolites|antimetabolites|mesh-ancestor
110855250|NCT03488251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110855251|NCT03488251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110855252|NCT02727322|Nitrofurantoin|nitrofurantoin|mesh-list
110122520|NCT01918865|Metformin|metformin|mesh-list
110855253|NCT02727322|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110855254|NCT02727322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110855255|NCT02727322|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110855256|NCT03315520|Cytarabine|cytarabine|mesh-list
110855257|NCT03315520|Cyclophosphamide|cyclophosphamide|mesh-list
110855258|NCT03315520|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110855259|NCT03315520|Etoposide|etoposide|mesh-list
110855260|NCT03315520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110855261|NCT03315520|Immunologic Factors|immunologic factors|mesh-ancestor
110855262|NCT03315520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110855263|NCT03315520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110855264|NCT03315520|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110855265|NCT03315520|Alkylating Agents|alkylating agents|mesh-ancestor
110855266|NCT03315520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110855267|NCT03315520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110855268|NCT03315520|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110855269|NCT03315520|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110855270|NCT03315520|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110855271|NCT03315520|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110855272|NCT03315520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110122718|NCT01921374|Vitamin B 12|vitamin b 12|mesh-list
110855273|NCT03315520|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110855274|NCT03315520|Antimetabolites|antimetabolites|mesh-ancestor
110855275|NCT03315520|Antiviral Agents|antiviral agents|mesh-ancestor
110855276|NCT03315520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110855277|NCT02483182|Acyclovir|acyclovir|mesh-list
110855278|NCT02483182|Antiviral Agents|antiviral agents|mesh-ancestor
110855279|NCT02483182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110855280|NCT01338558|Bevacizumab|bevacizumab|mesh-list
110855281|NCT01338558|Cetuximab|cetuximab|mesh-list
110855282|NCT01338558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110855283|NCT01338558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110855284|NCT01338558|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110855285|NCT01338558|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110855286|NCT01338558|Growth Substances|growth substances|mesh-ancestor
110855287|NCT01338558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110855288|NCT01338558|Growth Inhibitors|growth inhibitors|mesh-ancestor
110855290|NCT03780569|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110855291|NCT03780569|Alkylating Agents|alkylating agents|mesh-ancestor
110855292|NCT03780569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110855293|NCT03780569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110123023|NCT01930812|Listerine|listerine|mesh-list
110572854|NCT02612714|Antimetabolites|antimetabolites|mesh-ancestor
110855294|NCT03487549|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110855295|NCT03487549|Cantharidin|cantharidin|mesh-list
110855296|NCT03487549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110855297|NCT03487549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110855298|NCT01313585|Beclomethasone|beclomethasone|mesh-list
110855299|NCT01313585|Albuterol|albuterol|mesh-list
110855300|NCT01313585|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110855301|NCT01313585|Autonomic Agents|autonomic agents|mesh-ancestor
110855302|NCT01313585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110855303|NCT01313585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110855304|NCT01313585|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110855305|NCT01313585|Respiratory System Agents|respiratory system agents|mesh-ancestor
110855307|NCT01313585|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110855308|NCT01313585|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110855309|NCT01313585|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110855310|NCT01313585|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110855311|NCT01313585|Adrenergic Agents|adrenergic agents|mesh-ancestor
110855312|NCT01313585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110855313|NCT01313585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110855314|NCT01313585|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110855315|NCT01313585|Glucocorticoids|glucocorticoids|mesh-ancestor
110855316|NCT01313585|Hormones|hormones|mesh-ancestor
110833387|NCT01129427|Purinergic Agents|purinergic agents|mesh-ancestor
110855317|NCT01313585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110855318|NCT01561235|Hormones|hormones|mesh-list
110855319|NCT01561235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110855320|NCT01561235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110855321|NCT02485990|Olaparib|olaparib|mesh-list
110855322|NCT02485990|Tremelimumab|tremelimumab|mesh-list
110855323|NCT02485990|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110855325|NCT02485990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110855326|NCT02485990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110855327|NCT01313819|Amantadine|amantadine|mesh-list
110855328|NCT01313819|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110855329|NCT01313819|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110855330|NCT01313819|Antiviral Agents|antiviral agents|mesh-ancestor
110855331|NCT01313819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110855332|NCT01313819|Dopamine Agents|dopamine agents|mesh-ancestor
110855333|NCT01313819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110855334|NCT01313819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110855335|NCT01313819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110855336|NCT01313819|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110855337|NCT01313819|Analgesics|analgesics|mesh-ancestor
110855338|NCT01313819|Sensory System Agents|sensory system agents|mesh-ancestor
110123485|NCT01933945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110855339|NCT01313819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110855341|NCT03315442|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110855342|NCT03315442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110855343|NCT03315442|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110855344|NCT03315442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110855345|NCT03315442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110855346|NCT03315442|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110855347|NCT03315442|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110855348|NCT03315442|Purinergic Agents|purinergic agents|mesh-ancestor
110855349|NCT03315442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110855350|NCT03464383|Escitalopram|escitalopram|mesh-list
110855351|NCT03464383|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110855352|NCT03464383|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110855353|NCT03464383|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110855354|NCT03464383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110855355|NCT03464383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110855356|NCT03464383|Serotonin Agents|serotonin agents|mesh-ancestor
110855357|NCT03464383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110855358|NCT03315364|Paclitaxel|paclitaxel|mesh-list
110855359|NCT03315364|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110855360|NCT03315364|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110855361|NCT03315364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110855362|NCT03315364|Tubulin Modulators|tubulin modulators|mesh-ancestor
110855363|NCT03315364|Antimitotic Agents|antimitotic agents|mesh-ancestor
110855364|NCT03315364|Mitosis Modulators|mitosis modulators|mesh-ancestor
110855365|NCT03315364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110572933|NCT00813150|Bortezomib|bortezomib|mesh-list
110855366|NCT03779633|Estradiol|estradiol|mesh-list
110855367|NCT03779633|Estrogens|estrogens|mesh-ancestor
110855368|NCT03779633|Hormones|hormones|mesh-ancestor
110855369|NCT03779633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110855370|NCT03779633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110855372|NCT03720067|Carvedilol|carvedilol|mesh-list
110855373|NCT03720067|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110855374|NCT03720067|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110855375|NCT03720067|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110855376|NCT03720067|Antimetabolites|antimetabolites|mesh-ancestor
110123752|NCT01935518|Fasudil|fasudil|mesh-list
110833390|NCT01129427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110855377|NCT03720067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110855379|NCT03720067|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110855380|NCT03720067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110855381|NCT03720067|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110855382|NCT03720067|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110855383|NCT03720067|Adrenergic Agents|adrenergic agents|mesh-ancestor
110855384|NCT03720067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110123824|NCT01935713|Nicotine|nicotine|mesh-list
110855385|NCT03720067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110855386|NCT03720067|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110855387|NCT03720067|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110855388|NCT03720067|Vasodilator Agents|vasodilator agents|mesh-ancestor
110855389|NCT03720067|Antioxidants|antioxidants|mesh-ancestor
110855390|NCT03720067|Protective Agents|protective agents|mesh-ancestor
110855391|NCT03720067|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110123885|NCT01935973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110855392|NCT03720067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110855393|NCT03720067|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110855394|NCT03720067|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110855395|NCT03720067|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110855396|NCT01444092|Budesonide|budesonide|mesh-list
110855397|NCT01444092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110855398|NCT01444092|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110855400|NCT01444092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110855401|NCT01444092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110855402|NCT01444092|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110124020|NCT01936805|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110855403|NCT01444092|Respiratory System Agents|respiratory system agents|mesh-ancestor
110855404|NCT01444092|Glucocorticoids|glucocorticoids|mesh-ancestor
110855405|NCT01444092|Hormones|hormones|mesh-ancestor
110855406|NCT01444092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110855407|NCT03719989|Azacitidine|azacitidine|mesh-list
110855408|NCT03719989|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110855409|NCT03719989|Antimetabolites|antimetabolites|mesh-ancestor
110855410|NCT03719989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110855411|NCT03719989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110855412|NCT03719989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110855413|NCT05462470|Liver Extracts|liver extracts|mesh-list
110855414|NCT05462470|Hematinics|hematinics|mesh-ancestor
110855415|NCT03779087|Amoxicillin|amoxicillin|mesh-list
110855416|NCT03779087|Levofloxacin|levofloxacin|mesh-list
110855417|NCT03779087|Ofloxacin|ofloxacin|mesh-list
110855418|NCT03779087|Tetracycline|tetracycline|mesh-list
110855419|NCT03779087|Esomeprazole|esomeprazole|mesh-list
110855420|NCT03779087|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110855421|NCT03779087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110855422|NCT03779087|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110855423|NCT03779087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110855424|NCT03779087|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110855425|NCT03779087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110124147|NCT01937728|Ribavirin|ribavirin|mesh-list
110855426|NCT03779087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110855427|NCT03779087|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110855428|NCT03779087|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110855429|NCT03779087|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110855430|NCT03779087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110855431|NCT03779087|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110855432|NCT03779087|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110855433|NCT03779087|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110855434|NCT01265784|Ertapenem|ertapenem|mesh-list
110855435|NCT01265784|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110855436|NCT01265784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110855437|NCT05692271|Propranolol|propranolol|mesh-list
110855438|NCT05692271|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110855439|NCT05692271|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110855440|NCT05692271|Adrenergic Agents|adrenergic agents|mesh-ancestor
110855441|NCT05692271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110124218|NCT01938092|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110855442|NCT05692271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110855443|NCT05692271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110855444|NCT05692271|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110855445|NCT05692271|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110855446|NCT05692271|Vasodilator Agents|vasodilator agents|mesh-ancestor
110855447|NCT03774953|Vitamins|vitamins|mesh-list
110855448|NCT03774953|Micronutrients|micronutrients|mesh-ancestor
110855449|NCT03774953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110855451|NCT02483026|Vitamins|vitamins|mesh-list
110855452|NCT02483026|Micronutrients|micronutrients|mesh-ancestor
110855453|NCT02483026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110855454|NCT02483026|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110855455|NCT02483104|Paclitaxel|paclitaxel|mesh-list
110855456|NCT02483104|Carboplatin|carboplatin|mesh-list
110855457|NCT02483104|Veliparib|veliparib|mesh-list
110124345|NCT01939054|Docetaxel|docetaxel|mesh-list
110855458|NCT02483104|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110855459|NCT02483104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110855460|NCT02483104|Tubulin Modulators|tubulin modulators|mesh-ancestor
110855461|NCT02483104|Antimitotic Agents|antimitotic agents|mesh-ancestor
110855462|NCT02483104|Mitosis Modulators|mitosis modulators|mesh-ancestor
110855463|NCT02483104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110855464|NCT02483104|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110855465|NCT02483104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110855466|NCT00116220|Goserelin|goserelin|mesh-list
110855467|NCT00116220|Flutamide|flutamide|mesh-list
110855468|NCT00116220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110855469|NCT00116220|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110855470|NCT00116220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110855471|NCT00116220|Androgen Antagonists|androgen antagonists|mesh-ancestor
110855472|NCT00116220|Hormone Antagonists|hormone antagonists|mesh-ancestor
110855473|NCT00116220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110855474|NCT03785015|Aspirin|aspirin|mesh-list
110855475|NCT03785015|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110855476|NCT03785015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110855477|NCT03785015|Analgesics|analgesics|mesh-ancestor
110855478|NCT03785015|Sensory System Agents|sensory system agents|mesh-ancestor
110855479|NCT03785015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110855480|NCT03785015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110855481|NCT03785015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110855482|NCT03785015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110855483|NCT03785015|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110855484|NCT03785015|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110855485|NCT03785015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110855486|NCT03785015|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110855487|NCT03785015|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110855488|NCT03785015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110855489|NCT03785015|Antipyretics|antipyretics|mesh-ancestor
110855490|NCT04867343|Fentanyl|fentanyl|mesh-list
110855491|NCT04867343|Remifentanil|remifentanil|mesh-list
110855492|NCT04867343|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110855493|NCT04867343|Narcotics|narcotics|mesh-ancestor
110855494|NCT04867343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110855496|NCT04867343|Analgesics|analgesics|mesh-ancestor
110855497|NCT04867343|Sensory System Agents|sensory system agents|mesh-ancestor
110124687|NCT01940718|Hormones|hormones|mesh-ancestor
110855498|NCT04867343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110855499|NCT04867343|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110855500|NCT04867343|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110855501|NCT04867343|Anesthetics, General|anesthetics, general|mesh-ancestor
110855502|NCT04867343|Anesthetics|anesthetics|mesh-ancestor
110855503|NCT05185518|Insulin|insulin|mesh-list
110855504|NCT05185518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110833417|NCT05164198|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110855505|NCT05185518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110855506|NCT03316690|Metformin|metformin|mesh-list
110855507|NCT03316690|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110855508|NCT03316690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110855509|NCT03315052|Mycophenolic Acid|mycophenolic acid|mesh-list
110855510|NCT03315052|Prednisone|prednisone|mesh-list
110855511|NCT03315052|Budesonide|budesonide|mesh-list
110855512|NCT03315052|Tacrolimus|tacrolimus|mesh-list
110855513|NCT03315052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110855514|NCT03315052|Glucocorticoids|glucocorticoids|mesh-ancestor
110855515|NCT03315052|Hormones|hormones|mesh-ancestor
110855516|NCT03315052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110855517|NCT03315052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110855518|NCT03315052|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110855519|NCT03315052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110855520|NCT03315052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110855521|NCT03315052|Immunologic Factors|immunologic factors|mesh-ancestor
110855522|NCT03315052|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110855523|NCT03315052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110855524|NCT03315052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110124819|NCT01941407|Growth Inhibitors|growth inhibitors|mesh-ancestor
110855525|NCT03315052|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110855526|NCT03315052|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110855527|NCT03315052|Antitubercular Agents|antitubercular agents|mesh-ancestor
110855528|NCT03315052|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110855529|NCT03315052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110855530|NCT03315052|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110855531|NCT03315052|Autonomic Agents|autonomic agents|mesh-ancestor
110855532|NCT03315052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110855533|NCT03315052|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110855534|NCT03315052|Respiratory System Agents|respiratory system agents|mesh-ancestor
110855535|NCT03778619|Cyclophosphamide|cyclophosphamide|mesh-list
110855536|NCT03778619|Rituximab|rituximab|mesh-list
110855537|NCT03778619|Fludarabine|fludarabine|mesh-list
110855538|NCT03778619|Interleukin-2|interleukin-2|mesh-list
110855539|NCT03778619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110855540|NCT03778619|Immunologic Factors|immunologic factors|mesh-ancestor
110855541|NCT03778619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110855542|NCT03778619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110855543|NCT03778619|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110855544|NCT03778619|Alkylating Agents|alkylating agents|mesh-ancestor
110855545|NCT03778619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110855546|NCT03778619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110855547|NCT03778619|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110855548|NCT03778619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110124883|NCT01941953|Metformin|metformin|mesh-list
110855549|NCT03778619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110855550|NCT03778619|Analgesics|analgesics|mesh-ancestor
110855551|NCT03778619|Sensory System Agents|sensory system agents|mesh-ancestor
110855552|NCT03778619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110855553|NCT05714176|Lactoferrin|lactoferrin|mesh-list
110855554|NCT05714176|Dextrans|dextrans|mesh-list
110855555|NCT05714176|Iron-Dextran Complex|iron-dextran complex|mesh-list
110124953|NCT01942187|Bupropion|bupropion|mesh-list
110855556|NCT05714176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110855557|NCT05714176|Anticoagulants|anticoagulants|mesh-ancestor
110855558|NCT05714176|Plasma Substitutes|plasma substitutes|mesh-ancestor
110855559|NCT05714176|Blood Substitutes|blood substitutes|mesh-ancestor
110855560|NCT05714176|Hematinics|hematinics|mesh-ancestor
110855561|NCT03156504|Ketamine|ketamine|mesh-list
110855562|NCT03156504|Analgesics|analgesics|mesh-ancestor
110855563|NCT03156504|Sensory System Agents|sensory system agents|mesh-ancestor
110855564|NCT03156504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110855565|NCT03156504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110855566|NCT03156504|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110855567|NCT03156504|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110855568|NCT03156504|Anesthetics, General|anesthetics, general|mesh-ancestor
110855569|NCT03156504|Anesthetics|anesthetics|mesh-ancestor
110125072|NCT01943019|Hormones|hormones|mesh-ancestor
110855570|NCT03156504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110855571|NCT03156504|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110855572|NCT03156504|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110855573|NCT03156504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110855574|NCT03156504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110855575|NCT01333332|Capecitabine|capecitabine|mesh-list
110855576|NCT01333332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110855577|NCT01333332|Antimetabolites|antimetabolites|mesh-ancestor
110855578|NCT01333332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110855579|NCT01333332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110855580|NCT03316534|Aspirin|aspirin|mesh-list
110855581|NCT03316534|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110855582|NCT03316534|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110855583|NCT03316534|Analgesics|analgesics|mesh-ancestor
110855584|NCT03316534|Sensory System Agents|sensory system agents|mesh-ancestor
110855585|NCT03316534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110855586|NCT03316534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110855587|NCT03316534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110338017|NCT00518895|Dacarbazine|dacarbazine|mesh-list
110855588|NCT03316534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110855589|NCT03316534|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110855590|NCT03316534|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110855591|NCT03316534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110855592|NCT03316534|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110855593|NCT03316534|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110855594|NCT03316534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110855595|NCT03316534|Antipyretics|antipyretics|mesh-ancestor
110855596|NCT04476420|Betamethasone|betamethasone|mesh-list
110855597|NCT04476420|Betamethasone Valerate|betamethasone valerate|mesh-list
110125350|NCT01945047|GABA Agents|gaba agents|mesh-ancestor
110855598|NCT04476420|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
110855599|NCT04476420|Betamethasone benzoate|betamethasone benzoate|mesh-list
110855600|NCT04476420|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
110855601|NCT04476420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110855602|NCT04476420|Glucocorticoids|glucocorticoids|mesh-ancestor
110855603|NCT04476420|Hormones|hormones|mesh-ancestor
110855604|NCT04476420|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110855605|NCT04476420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110855606|NCT04476420|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110855607|NCT04476420|Respiratory System Agents|respiratory system agents|mesh-ancestor
110855608|NCT03778541|Temozolomide|temozolomide|mesh-list
110855609|NCT03778541|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110855610|NCT03778541|Alkylating Agents|alkylating agents|mesh-ancestor
110855611|NCT03778541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110855612|NCT03778541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110855613|NCT02479828|Ropivacaine|ropivacaine|mesh-list
110855614|NCT02479828|Anesthetics, Local|anesthetics, local|mesh-ancestor
110855615|NCT02479828|Anesthetics|anesthetics|mesh-ancestor
110855616|NCT02479828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110855617|NCT02479828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110855618|NCT02479828|Sensory System Agents|sensory system agents|mesh-ancestor
110855619|NCT02479828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110855620|NCT01320449|Epoetin Alfa|epoetin alfa|mesh-list
110855621|NCT01320449|Hematinics|hematinics|mesh-ancestor
110855622|NCT03430063|Ipilimumab|ipilimumab|mesh-list
110855623|NCT03430063|Cemiplimab|cemiplimab|mesh-list
110855624|NCT03430063|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110855625|NCT03430063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110855626|NCT03430063|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110855627|NCT03430063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110855628|NCT03158220|Vaccines|vaccines|mesh-list
110855629|NCT03158220|Immunologic Factors|immunologic factors|mesh-ancestor
110855630|NCT03158220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110855632|NCT01308983|Diuretics|diuretics|mesh-ancestor
110855633|NCT01308983|Natriuretic Agents|natriuretic agents|mesh-ancestor
110855634|NCT01308983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110855635|NCT01308983|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
110855636|NCT01308983|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110855637|NCT01308983|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110855638|NCT01308983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110855639|NCT01308983|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
110855640|NCT01308983|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110855642|NCT01336842|Panobinostat|panobinostat|mesh-list
110855643|NCT01336842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110855644|NCT01336842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110855645|NCT01336842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110855646|NCT01336842|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110855647|NCT01336842|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110855648|NCT01336842|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110855649|NCT05178407|Micronutrients|micronutrients|mesh-list
110125802|NCT02335099|Ticagrelor|ticagrelor|mesh-list
110855650|NCT05178407|Trace Elements|trace elements|mesh-list
110855651|NCT05178407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110855652|NCT01339026|Clopidogrel|clopidogrel|mesh-list
110855653|NCT01339026|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
110855654|NCT01339026|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110855655|NCT01339026|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110855656|NCT01339026|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110855657|NCT01339026|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110855658|NCT01339026|Purinergic Agents|purinergic agents|mesh-ancestor
110855659|NCT01339026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110855660|NCT01339026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110855661|NCT01339026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110855662|NCT03314740|Paclitaxel|paclitaxel|mesh-list
110855663|NCT03314740|Olaparib|olaparib|mesh-list
110855664|NCT03314740|Cediranib|cediranib|mesh-list
110855665|NCT03314740|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110855666|NCT03314740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110855667|NCT03314740|Tubulin Modulators|tubulin modulators|mesh-ancestor
110855668|NCT03314740|Antimitotic Agents|antimitotic agents|mesh-ancestor
110855669|NCT03314740|Mitosis Modulators|mitosis modulators|mesh-ancestor
110855670|NCT03314740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110855671|NCT03314740|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110855672|NCT03314740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110855673|NCT03314740|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110855674|NCT02482636|Vaccines|vaccines|mesh-list
110855675|NCT02482636|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110855676|NCT02482636|Immunologic Factors|immunologic factors|mesh-ancestor
110855677|NCT02482636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110855678|NCT02482402|Iloprost|iloprost|mesh-list
110855679|NCT02482402|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110855680|NCT02482402|Vasodilator Agents|vasodilator agents|mesh-ancestor
110855681|NCT03774095|Pycnogenols|pycnogenols|mesh-list
110855682|NCT03774095|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110855683|NCT03774095|Immunologic Factors|immunologic factors|mesh-ancestor
110855684|NCT03774095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110855685|NCT03774095|Antioxidants|antioxidants|mesh-ancestor
110855686|NCT03774095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110855687|NCT03774095|Protective Agents|protective agents|mesh-ancestor
110855688|NCT03774095|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110855689|NCT01333410|Mometasone Furoate|mometasone furoate|mesh-list
110855690|NCT01333410|Tacrolimus|tacrolimus|mesh-list
110855691|NCT01333410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110855692|NCT01333410|Immunologic Factors|immunologic factors|mesh-ancestor
110855693|NCT01333410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110855694|NCT01333410|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110855695|NCT01333410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110855696|NCT01333410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110855697|NCT01333410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110855698|NCT01333410|Dermatologic Agents|dermatologic agents|mesh-ancestor
110855699|NCT01333410|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110855700|NCT02482090|Cyclophosphamide|cyclophosphamide|mesh-list
110855701|NCT02482090|Fludarabine|fludarabine|mesh-list
110855702|NCT02482090|Interleukin-2|interleukin-2|mesh-list
110855703|NCT02482090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110855704|NCT02482090|Immunologic Factors|immunologic factors|mesh-ancestor
110855705|NCT02482090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110855706|NCT02482090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110855707|NCT02482090|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110855708|NCT02482090|Alkylating Agents|alkylating agents|mesh-ancestor
110855709|NCT02482090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110855710|NCT02482090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110855711|NCT02482090|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110855712|NCT02482090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110855713|NCT02482090|Analgesics|analgesics|mesh-ancestor
110855714|NCT02482090|Sensory System Agents|sensory system agents|mesh-ancestor
110855715|NCT02482090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110855717|NCT02482324|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110855718|NCT02482324|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110855719|NCT02482324|Analgesics|analgesics|mesh-ancestor
110855720|NCT02482324|Sensory System Agents|sensory system agents|mesh-ancestor
110855721|NCT02482324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110855722|NCT02482324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110855723|NCT02482324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110855724|NCT02482324|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110855725|NCT02482324|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110855726|NCT02482324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110855727|NCT02482324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110855728|NCT05185284|Remdesivir|remdesivir|mesh-list
110855729|NCT05185284|Favipiravir|favipiravir|mesh-list
110855730|NCT05185284|Antimetabolites|antimetabolites|mesh-ancestor
110855731|NCT05185284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110855732|NCT05185284|Antiviral Agents|antiviral agents|mesh-ancestor
110855733|NCT05185284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110855734|NCT03784703|Atorvastatin|atorvastatin|mesh-list
110855735|NCT03784703|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110855736|NCT03784703|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110855737|NCT03784703|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110855738|NCT03784703|Antimetabolites|antimetabolites|mesh-ancestor
110855739|NCT03784703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110855740|NCT03784703|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110855741|NCT03784703|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110855742|NCT03784703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110855743|NCT02724592|Fluorides|fluorides|mesh-list
110855744|NCT02724592|Fluorides, Topical|fluorides, topical|mesh-list
110855745|NCT02724592|Sodium fluoride topical preparation|sodium fluoride topical preparation|mesh-list
110855746|NCT02724592|Cariostatic Agents|cariostatic agents|mesh-ancestor
110855747|NCT02724592|Protective Agents|protective agents|mesh-ancestor
110855748|NCT02724592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110855749|NCT02476864|Macitentan|macitentan|mesh-list
110855750|NCT02476864|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
110855751|NCT02476864|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
110855752|NCT02476864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110855753|NCT02476864|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
110855754|NCT05451550|Anesthetics|anesthetics|mesh-list
110855755|NCT05451550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110855756|NCT05451550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110855757|NCT02476708|Curcumin|curcumin|mesh-list
110855758|NCT02476708|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110855759|NCT02476708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110855760|NCT02476708|Analgesics|analgesics|mesh-ancestor
110855761|NCT02476708|Sensory System Agents|sensory system agents|mesh-ancestor
110855762|NCT02476708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110855763|NCT02476708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110855764|NCT02476708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110855765|NCT02476708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110855766|NCT02476708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110855767|NCT02476708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110855768|NCT02476708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110855769|NCT02479204|Atenolol|atenolol|mesh-list
110855770|NCT02479204|Diltiazem|diltiazem|mesh-list
110855771|NCT02479204|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110855772|NCT02479204|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110855773|NCT02479204|Sympatholytics|sympatholytics|mesh-ancestor
110855774|NCT02479204|Autonomic Agents|autonomic agents|mesh-ancestor
110855775|NCT02479204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110855776|NCT02479204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110855777|NCT02479204|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110855778|NCT02479204|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110855779|NCT02479204|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110855780|NCT02479204|Adrenergic Agents|adrenergic agents|mesh-ancestor
110855781|NCT02479204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110855782|NCT02479204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110855783|NCT02479204|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110855784|NCT02479204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110855785|NCT02479204|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110855786|NCT02479204|Vasodilator Agents|vasodilator agents|mesh-ancestor
110855787|NCT03784547|Ocrelizumab|ocrelizumab|mesh-list
110855788|NCT03784547|Immunologic Factors|immunologic factors|mesh-ancestor
110855789|NCT03784547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110855790|NCT01339572|Plerixafor|plerixafor|mesh-list
110855791|NCT01339572|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110855792|NCT01339572|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110855793|NCT01339572|Antiviral Agents|antiviral agents|mesh-ancestor
110855794|NCT01339572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110855795|NCT01309139|Tiotropium Bromide|tiotropium bromide|mesh-list
110855796|NCT01309139|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110855797|NCT01309139|Autonomic Agents|autonomic agents|mesh-ancestor
110855798|NCT01309139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110855799|NCT01309139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110855800|NCT01309139|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110855801|NCT01309139|Respiratory System Agents|respiratory system agents|mesh-ancestor
110855802|NCT01309139|Parasympatholytics|parasympatholytics|mesh-ancestor
110855803|NCT01309139|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110855804|NCT01309139|Cholinergic Agents|cholinergic agents|mesh-ancestor
110855805|NCT01309139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110855806|NCT01309139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110855807|NCT03154476|Sildenafil Citrate|sildenafil citrate|mesh-list
110855808|NCT03154476|Vasodilator Agents|vasodilator agents|mesh-ancestor
110855809|NCT03154476|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110855810|NCT03154476|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110855811|NCT03154476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110855812|NCT03154476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110855813|NCT03154476|Urological Agents|urological agents|mesh-ancestor
110855814|NCT03784391|Nifurtimox|nifurtimox|mesh-list
110855815|NCT03784391|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
110855816|NCT03784391|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110573376|NCT04046302|Dinoprostone|dinoprostone|mesh-list
110855817|NCT03784391|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110855818|NCT03784391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110855819|NCT02476552|Niraparib|niraparib|mesh-list
110855820|NCT02476552|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110855821|NCT02476552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110855822|NCT02476552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110855823|NCT02476552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110855824|NCT01316718|Mesalamine|mesalamine|mesh-list
110855825|NCT01316718|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110126339|NCT05413746|Antioxidants|antioxidants|mesh-list
110855826|NCT01316718|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110855827|NCT01316718|Analgesics|analgesics|mesh-ancestor
110855828|NCT01316718|Sensory System Agents|sensory system agents|mesh-ancestor
110855829|NCT01316718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110855830|NCT01316718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110126381|NCT05251493|Iron|iron|mesh-list
110855831|NCT01316718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110855832|NCT01316718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110855833|NCT01316952|Carvedilol|carvedilol|mesh-list
110855834|NCT01316952|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
110855835|NCT01316952|Adrenergic Agents|adrenergic agents|mesh-list
110855836|NCT01316952|Adrenergic Antagonists|adrenergic antagonists|mesh-list
110855837|NCT01316952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110855838|NCT01316952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110855839|NCT01316952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110855840|NCT01316952|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110855841|NCT01316952|Antioxidants|antioxidants|mesh-ancestor
110855842|NCT01316952|Protective Agents|protective agents|mesh-ancestor
110855843|NCT01316952|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110855844|NCT01316952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110126448|NCT04524663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110855845|NCT01316952|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110855846|NCT01316952|Vasodilator Agents|vasodilator agents|mesh-ancestor
110855847|NCT01316952|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110855848|NCT01316952|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110855849|NCT03768869|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110855850|NCT03768869|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
110855851|NCT03768869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110855852|NCT03768869|Antitubercular Agents|antitubercular agents|mesh-ancestor
110855854|NCT01320917|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110855855|NCT01320917|Contraceptive Agents|contraceptive agents|mesh-ancestor
110855856|NCT01320917|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110855857|NCT01320917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110855858|NCT01320917|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110855859|NCT01320917|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110855860|NCT01320917|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110855861|NCT03768713|Suvorexant|suvorexant|mesh-list
110855862|NCT03768713|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110855863|NCT03768713|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110855864|NCT03768713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110855865|NCT03768713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110855866|NCT03768713|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
110855867|NCT03768713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110855868|NCT03768713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110855869|NCT02481076|Monensin|monensin|mesh-list
110855870|NCT02481076|Antifungal Agents|antifungal agents|mesh-ancestor
110855871|NCT02481076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110855872|NCT02481076|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110855873|NCT02481076|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110855874|NCT02481076|Coccidiostats|coccidiostats|mesh-ancestor
110855875|NCT02481076|Proton Ionophores|proton ionophores|mesh-ancestor
110855876|NCT02481076|Uncoupling Agents|uncoupling agents|mesh-ancestor
110855877|NCT02481076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110855878|NCT02481076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110855879|NCT02481076|Ionophores|ionophores|mesh-ancestor
110855880|NCT02481076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110855881|NCT02481076|Sodium Ionophores|sodium ionophores|mesh-ancestor
110855883|NCT05713396|Quinapril|quinapril|mesh-list
110855884|NCT05713396|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110855885|NCT05713396|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110855886|NCT05713396|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110855887|NCT05713396|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110855888|NCT05713396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110855889|NCT05713396|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110573452|NCT00802282|Psilocybin|psilocybin|mesh-list
110855890|NCT05713396|Protease Inhibitors|protease inhibitors|mesh-ancestor
110855891|NCT05713396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110855892|NCT02480608|Imatinib Mesylate|imatinib mesylate|mesh-list
110855893|NCT02480608|Hydroxyurea|hydroxyurea|mesh-list
110855894|NCT02480608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110855895|NCT02480608|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110855896|NCT02480608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110855897|NCT02480608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110855898|NCT02480608|Antisickling Agents|antisickling agents|mesh-ancestor
110855899|NCT02480608|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110855900|NCT02480686|Sofosbuvir|sofosbuvir|mesh-list
110855901|NCT02480686|Antiviral Agents|antiviral agents|mesh-ancestor
110855902|NCT02480686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110855903|NCT02475382|Nivolumab|nivolumab|mesh-list
110126561|NCT03578276|Analgesics|analgesics|mesh-ancestor
110855904|NCT02475382|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110855905|NCT02475382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110855906|NCT02475382|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110855907|NCT02475382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110855908|NCT02475304|Dimethyl Fumarate|dimethyl fumarate|mesh-list
110855909|NCT02475304|Dermatologic Agents|dermatologic agents|mesh-ancestor
110855910|NCT02475304|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110855911|NCT02475304|Immunologic Factors|immunologic factors|mesh-ancestor
110855912|NCT02475304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110855914|NCT05371288|Acetylcysteine|acetylcysteine|mesh-list
110855915|NCT05371288|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110855916|NCT05371288|Antioxidants|antioxidants|mesh-ancestor
110855917|NCT05371288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110855918|NCT05371288|Protective Agents|protective agents|mesh-ancestor
110855919|NCT05371288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110855920|NCT05371288|Vitamin B Complex|vitamin b complex|mesh-ancestor
110855921|NCT05371288|Vitamins|vitamins|mesh-ancestor
110855922|NCT05371288|Micronutrients|micronutrients|mesh-ancestor
110855923|NCT05371288|Antiviral Agents|antiviral agents|mesh-ancestor
110855924|NCT05371288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110855925|NCT05371288|Expectorants|expectorants|mesh-ancestor
110855926|NCT05371288|Respiratory System Agents|respiratory system agents|mesh-ancestor
110855927|NCT05371288|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110855928|NCT05371288|Antidotes|antidotes|mesh-ancestor
110855929|NCT02478424|Cyclosporine|cyclosporine|mesh-list
110855930|NCT02478424|Methotrexate|methotrexate|mesh-list
110855931|NCT02478424|Cannabidiol|cannabidiol|mesh-list
110855932|NCT02478424|Cyclosporins|cyclosporins|mesh-list
110855933|NCT02478424|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110855934|NCT02478424|Abortifacient Agents|abortifacient agents|mesh-ancestor
110855935|NCT02478424|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110855936|NCT02478424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110855937|NCT02478424|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110855938|NCT02478424|Antimetabolites|antimetabolites|mesh-ancestor
110855939|NCT02478424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110855940|NCT02478424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110855941|NCT02478424|Dermatologic Agents|dermatologic agents|mesh-ancestor
110855942|NCT02478424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110855943|NCT02478424|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110855944|NCT02478424|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110855945|NCT02478424|Immunologic Factors|immunologic factors|mesh-ancestor
110855946|NCT02478424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110855947|NCT02478424|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110855948|NCT02478424|Antifungal Agents|antifungal agents|mesh-ancestor
110855949|NCT02478424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110855950|NCT02478424|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110855951|NCT02478424|Anticonvulsants|anticonvulsants|mesh-ancestor
110855952|NCT03712787|Tilavonemab|tilavonemab|mesh-list
110855953|NCT03712787|Nootropic Agents|nootropic agents|mesh-ancestor
110855954|NCT02478268|Xenon|xenon|mesh-list
110173135|NCT00055978|Analgesics|analgesics|mesh-ancestor
110855955|NCT02478268|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110855956|NCT02478268|Anesthetics, General|anesthetics, general|mesh-ancestor
110855957|NCT02478268|Anesthetics|anesthetics|mesh-ancestor
110855958|NCT02478268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110855959|NCT02478268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110855960|NCT04053881|Certolizumab Pegol|certolizumab pegol|mesh-list
110855961|NCT04053881|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110855962|NCT04053881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110855963|NCT04053881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110855964|NCT04053881|Immunologic Factors|immunologic factors|mesh-ancestor
110855965|NCT04053881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110855966|NCT04053881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110855967|NCT03768557|Minocycline|minocycline|mesh-list
110855968|NCT03768557|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110855969|NCT03768557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110855970|NCT03783845|Amoxicillin|amoxicillin|mesh-list
110855971|NCT03783845|Metronidazole|metronidazole|mesh-list
110855972|NCT03783845|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110855973|NCT03783845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110833463|NCT05390710|Paclitaxel|paclitaxel|mesh-list
110855974|NCT03783845|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110855975|NCT03783845|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110855976|NCT01560689|Budesonide|budesonide|mesh-list
110855977|NCT01560689|Formoterol Fumarate|formoterol fumarate|mesh-list
110855978|NCT01560689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110855979|NCT01560689|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110855980|NCT01560689|Autonomic Agents|autonomic agents|mesh-ancestor
110855981|NCT01560689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110855982|NCT01560689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110855983|NCT01560689|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110855984|NCT01560689|Respiratory System Agents|respiratory system agents|mesh-ancestor
110855985|NCT01560689|Glucocorticoids|glucocorticoids|mesh-ancestor
110855986|NCT01560689|Hormones|hormones|mesh-ancestor
110855987|NCT01560689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110126903|NCT01947114|Propofol|propofol|mesh-list
110855989|NCT01560689|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110855990|NCT01560689|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110855991|NCT01560689|Adrenergic Agents|adrenergic agents|mesh-ancestor
110855992|NCT01560689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110855993|NCT01560689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110855994|NCT02474914|Octreotide|octreotide|mesh-list
110855995|NCT02474914|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110855996|NCT02474914|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110855997|NCT02474914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110855998|NCT03769103|Osimertinib|osimertinib|mesh-list
110855999|NCT03769103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110856000|NCT03769103|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110856001|NCT03769103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110856002|NCT03769103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110856003|NCT04998214|Thrombin|thrombin|mesh-list
110856004|NCT04998214|Hemostatics|hemostatics|mesh-ancestor
110856005|NCT04998214|Coagulants|coagulants|mesh-ancestor
110856006|NCT01309607|Paclitaxel|paclitaxel|mesh-list
110856007|NCT01309607|Carboplatin|carboplatin|mesh-list
110856008|NCT01309607|Lapatinib|lapatinib|mesh-list
110856009|NCT01309607|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110856010|NCT01309607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110856011|NCT01309607|Tubulin Modulators|tubulin modulators|mesh-ancestor
110856012|NCT01309607|Antimitotic Agents|antimitotic agents|mesh-ancestor
110856013|NCT01309607|Mitosis Modulators|mitosis modulators|mesh-ancestor
110856014|NCT01309607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110856015|NCT01309607|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110856016|NCT01309607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110856017|NCT03783455|Hyaluronic Acid|hyaluronic acid|mesh-list
110856018|NCT03783455|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110856019|NCT03783455|Immunologic Factors|immunologic factors|mesh-ancestor
110856020|NCT03783455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110856021|NCT03783455|Viscosupplements|viscosupplements|mesh-ancestor
110856022|NCT03783455|Protective Agents|protective agents|mesh-ancestor
110856023|NCT05305066|Adalimumab|adalimumab|mesh-list
110856024|NCT05305066|Golimumab|golimumab|mesh-list
110856025|NCT05305066|Etanercept|etanercept|mesh-list
110856026|NCT05305066|Upadacitinib|upadacitinib|mesh-list
110856027|NCT05305066|Tofacitinib|tofacitinib|mesh-list
110856028|NCT05305066|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110856029|NCT05305066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110856030|NCT05305066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110856031|NCT05305066|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110856032|NCT05305066|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110856033|NCT05305066|Analgesics|analgesics|mesh-ancestor
110856034|NCT05305066|Sensory System Agents|sensory system agents|mesh-ancestor
110856035|NCT05305066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110856036|NCT05305066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110127162|NCT01948921|Meperidine|meperidine|mesh-list
110856037|NCT05305066|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110856038|NCT05305066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110856039|NCT05305066|Immunologic Factors|immunologic factors|mesh-ancestor
110856040|NCT05305066|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
110856041|NCT05305066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110573600|NCT05753280|Vitamin D|vitamin d|mesh-list
110856042|NCT05305066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110856043|NCT05305066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110856044|NCT05251714|Fulvestrant|fulvestrant|mesh-list
110856045|NCT05251714|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110856046|NCT05251714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110856047|NCT05251714|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110856048|NCT05251714|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110856049|NCT05251714|Hormone Antagonists|hormone antagonists|mesh-ancestor
110856050|NCT05251714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110856051|NCT05251714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110856053|NCT02478034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110856055|NCT02477956|Ergocalciferols|ergocalciferols|mesh-list
110127228|NCT01949233|Irbesartan|irbesartan|mesh-list
110856057|NCT02477956|Vitamins|vitamins|mesh-list
110856058|NCT02477956|Micronutrients|micronutrients|mesh-ancestor
110856059|NCT02477956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110856060|NCT02477956|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110856061|NCT02477956|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110856062|NCT02472574|Plasminogen|plasminogen|mesh-list
110856063|NCT02472574|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
110856064|NCT02472574|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110856065|NCT02472574|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110856066|NCT02472574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110856067|NCT05708248|Pentoxifylline|pentoxifylline|mesh-list
110856068|NCT05708248|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110856069|NCT05708248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110127344|NCT01949909|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110856070|NCT05708248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110856071|NCT05708248|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110856072|NCT05708248|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110856074|NCT05708248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110856075|NCT05708248|Vasodilator Agents|vasodilator agents|mesh-ancestor
110856076|NCT05708248|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110856078|NCT05685394|Dapagliflozin|dapagliflozin|mesh-list
110856079|NCT05685394|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110856080|NCT05685394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110856081|NCT05685394|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110856082|NCT05685394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110856083|NCT03772223|Budesonide|budesonide|mesh-list
110856084|NCT03772223|Albuterol|albuterol|mesh-list
110856085|NCT03772223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110856086|NCT03772223|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110856087|NCT03772223|Autonomic Agents|autonomic agents|mesh-ancestor
110856088|NCT03772223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110856089|NCT03772223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110856090|NCT03772223|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110856091|NCT03772223|Respiratory System Agents|respiratory system agents|mesh-ancestor
110856092|NCT03772223|Glucocorticoids|glucocorticoids|mesh-ancestor
110856093|NCT03772223|Hormones|hormones|mesh-ancestor
110856094|NCT03772223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110856095|NCT03772223|Tocolytic Agents|tocolytic agents|mesh-ancestor
110856096|NCT03772223|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110856097|NCT03772223|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110856098|NCT03772223|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110856099|NCT03772223|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110856100|NCT03772223|Adrenergic Agents|adrenergic agents|mesh-ancestor
110856101|NCT03772223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110856102|NCT03772223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110856103|NCT03783299|Lumefantrine|lumefantrine|mesh-list
110856104|NCT03783299|Artemether|artemether|mesh-list
110856105|NCT03783299|Primaquine|primaquine|mesh-list
110856106|NCT03783299|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
110856107|NCT03783299|Antimalarials|antimalarials|mesh-ancestor
110856108|NCT03783299|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110856109|NCT03783299|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110856110|NCT03783299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110856111|NCT03771755|Acetaminophen|acetaminophen|mesh-list
110856112|NCT03771755|Ibuprofen|ibuprofen|mesh-list
110856113|NCT03771755|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110856114|NCT03771755|Analgesics|analgesics|mesh-ancestor
110856115|NCT03771755|Sensory System Agents|sensory system agents|mesh-ancestor
110856116|NCT03771755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110856117|NCT03771755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110856118|NCT03771755|Antipyretics|antipyretics|mesh-ancestor
110856119|NCT03771755|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110856120|NCT03771755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110856121|NCT03771755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110856122|NCT03771755|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110856123|NCT03771755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110856124|NCT03771755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110856125|NCT02477566|Triptorelin Pamoate|triptorelin pamoate|mesh-list
110856126|NCT02477566|Luteolytic Agents|luteolytic agents|mesh-ancestor
110856127|NCT02477566|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110856128|NCT02477566|Contraceptive Agents|contraceptive agents|mesh-ancestor
110856129|NCT02477566|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110856130|NCT02477566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110856131|NCT02477566|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110856132|NCT02477566|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110856133|NCT02477566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110856134|NCT05432531|Cyclophosphamide|cyclophosphamide|mesh-list
110856135|NCT05432531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110856136|NCT05432531|Immunologic Factors|immunologic factors|mesh-ancestor
110856137|NCT05432531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110856138|NCT05432531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110127657|NCT01951898|Montelukast|montelukast|mesh-list
110856139|NCT05432531|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110856140|NCT05432531|Alkylating Agents|alkylating agents|mesh-ancestor
110856141|NCT05432531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110856142|NCT05432531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110856143|NCT05432531|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110856144|NCT01309685|Varenicline|varenicline|mesh-list
110856145|NCT01309685|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110856146|NCT01309685|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110856147|NCT01309685|Cholinergic Agents|cholinergic agents|mesh-ancestor
110856148|NCT01309685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110856149|NCT01309685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110856150|NCT01309685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110856151|NCT03772067|Insulin|insulin|mesh-list
110856152|NCT03772067|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110856153|NCT03772067|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
110856154|NCT03772067|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110856155|NCT03772067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110856156|NCT03772067|Incretins|incretins|mesh-ancestor
110856157|NCT03772067|Hormones|hormones|mesh-ancestor
110856158|NCT03772067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110856159|NCT03783065|Propranolol|propranolol|mesh-list
110856160|NCT03783065|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110856161|NCT03783065|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110856162|NCT03783065|Adrenergic Agents|adrenergic agents|mesh-ancestor
110856163|NCT03783065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110856164|NCT03783065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110856165|NCT03783065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110856166|NCT03783065|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110856167|NCT03783065|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110856168|NCT03783065|Vasodilator Agents|vasodilator agents|mesh-ancestor
110856169|NCT03766997|Hydrocortisone|hydrocortisone|mesh-list
110856170|NCT03766997|Betamethasone|betamethasone|mesh-list
110856171|NCT03766997|Hydrocortisone-17-butyrate|hydrocortisone-17-butyrate|mesh-list
110856172|NCT03766997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110856173|NCT03766997|Glucocorticoids|glucocorticoids|mesh-ancestor
110856174|NCT03766997|Hormones|hormones|mesh-ancestor
110856175|NCT03766997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110856176|NCT03766997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110856177|NCT03766997|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110856178|NCT03766997|Respiratory System Agents|respiratory system agents|mesh-ancestor
110856179|NCT03766997|Dermatologic Agents|dermatologic agents|mesh-ancestor
110856180|NCT03782831|Antibodies|antibodies|mesh-list
110856181|NCT03782831|Immunologic Factors|immunologic factors|mesh-ancestor
110856182|NCT03782831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110856183|NCT05539391|Rocuronium|rocuronium|mesh-list
110127856|NCT05875571|Analgesics|analgesics|mesh-ancestor
110856184|NCT05539391|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110856185|NCT05539391|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110856186|NCT05539391|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110856187|NCT05539391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110127893|NCT05875285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110856188|NCT05539391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110856189|NCT03766607|Paclitaxel|paclitaxel|mesh-list
110856190|NCT03766607|Trastuzumab|trastuzumab|mesh-list
110856191|NCT03766607|Ramucirumab|ramucirumab|mesh-list
110856192|NCT03766607|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110856193|NCT03766607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110856195|NCT03766607|Antimitotic Agents|antimitotic agents|mesh-ancestor
110856196|NCT03766607|Mitosis Modulators|mitosis modulators|mesh-ancestor
110856197|NCT03766607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110856198|NCT03766607|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110856199|NCT01567709|Vorinostat|vorinostat|mesh-list
110856200|NCT01567709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110856201|NCT01567709|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110856202|NCT01567709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110856203|NCT01567709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110856204|NCT03765827|Vitamins|vitamins|mesh-list
110856205|NCT03765827|Vitamin E|vitamin e|mesh-list
110128107|NCT05799820|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110128108|NCT05799820|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110128109|NCT05799820|Growth Substances|growth substances|mesh-ancestor
110128110|NCT05799820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110128111|NCT05799820|Growth Inhibitors|growth inhibitors|mesh-ancestor
110128112|NCT05799820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110128113|NCT05799820|Antimetabolites|antimetabolites|mesh-ancestor
110128114|NCT05799820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110128115|NCT05790161|Caffeine|caffeine|mesh-list
110338132|NCT02949258|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110128116|NCT05790161|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110128117|NCT05790161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110856206|NCT03765827|Tocopherols|tocopherols|mesh-list
110856207|NCT03765827|Tocotrienols|tocotrienols|mesh-list
110856208|NCT03765827|alpha-Tocopherol|alpha-tocopherol|mesh-list
110856209|NCT03765827|Micronutrients|micronutrients|mesh-ancestor
110856210|NCT03765827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110856211|NCT03765827|Antioxidants|antioxidants|mesh-ancestor
110856212|NCT03765827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110856213|NCT03765827|Protective Agents|protective agents|mesh-ancestor
110128206|NCT05574712|Leuprolide|leuprolide|mesh-list
110856214|NCT03771053|Simvastatin|simvastatin|mesh-list
110856215|NCT03771053|Ezetimibe|ezetimibe|mesh-list
110856216|NCT03771053|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110856217|NCT03771053|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110856218|NCT03771053|Antimetabolites|antimetabolites|mesh-ancestor
110128256|NCT05463861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110856219|NCT03771053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110856220|NCT03771053|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110856221|NCT03771053|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110856222|NCT03771053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110856223|NCT03770663|Cyclophosphamide|cyclophosphamide|mesh-list
110856224|NCT03770663|Azathioprine|azathioprine|mesh-list
110856225|NCT03770663|Tacrolimus|tacrolimus|mesh-list
110856226|NCT03770663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110856227|NCT03770663|Immunologic Factors|immunologic factors|mesh-ancestor
110856228|NCT03770663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110856229|NCT03770663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110856230|NCT03770663|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110856231|NCT03770663|Alkylating Agents|alkylating agents|mesh-ancestor
110856232|NCT03770663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110856233|NCT03770663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110128494|NCT04507217|Pemetrexed|pemetrexed|mesh-list
110856234|NCT03770663|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110856235|NCT03770663|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110856236|NCT03770663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110856237|NCT03770663|Antimetabolites|antimetabolites|mesh-ancestor
110856238|NCT03770663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110856239|NCT03048422|Tenofovir|tenofovir|mesh-list
110856240|NCT03048422|Emtricitabine|emtricitabine|mesh-list
110856241|NCT03048422|Efavirenz|efavirenz|mesh-list
110856242|NCT03048422|Dolutegravir|dolutegravir|mesh-list
110856243|NCT03048422|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110856244|NCT03048422|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
110128546|NCT04237103|Immunologic Factors|immunologic factors|mesh-ancestor
110856245|NCT03048422|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110856246|NCT03048422|Antiviral Agents|antiviral agents|mesh-ancestor
110856247|NCT03048422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110856248|NCT03048422|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110856249|NCT03048422|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110856250|NCT03048422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110856251|NCT03048422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110856252|NCT03048422|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110856253|NCT03048422|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110856254|NCT03048422|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110856255|NCT03048422|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110856256|NCT03048422|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110856257|NCT03048422|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110856258|NCT03048422|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110856259|NCT03048422|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110856260|NCT03048422|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110856261|NCT03048422|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110128753|NCT03337087|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110128754|NCT03337087|Immunologic Factors|immunologic factors|mesh-ancestor
110128755|NCT03337087|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110128756|NCT03337087|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110128757|NCT03337087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110128758|NCT03337087|Antidotes|antidotes|mesh-ancestor
110128759|NCT03337087|Protective Agents|protective agents|mesh-ancestor
110128760|NCT03337087|Vitamin B Complex|vitamin b complex|mesh-ancestor
110128761|NCT03337087|Vitamins|vitamins|mesh-ancestor
110128762|NCT03337087|Micronutrients|micronutrients|mesh-ancestor
110128763|NCT03337087|Hematinics|hematinics|mesh-ancestor
110128764|NCT03337087|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110128765|NCT03262935|Capecitabine|capecitabine|mesh-list
110128766|NCT03262935|Trastuzumab|trastuzumab|mesh-list
110128767|NCT03262935|Vinorelbine|vinorelbine|mesh-list
110856263|NCT01561781|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110856264|NCT01561781|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110856265|NCT01561781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110573820|NCT02607111|Dalteparin|dalteparin|mesh-list
110856266|NCT01561781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110856267|NCT01561781|Protective Agents|protective agents|mesh-ancestor
110856268|NCT01561781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110856270|NCT03770039|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110856271|NCT03770039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110128865|NCT03114865|Dexamethasone|dexamethasone|mesh-list
110128866|NCT03114865|Blinatumomab|blinatumomab|mesh-list
110128867|NCT03114865|Antibodies, Bispecific|antibodies, bispecific|mesh-list
110128868|NCT03114865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110128869|NCT03114865|Antiemetics|antiemetics|mesh-ancestor
110128870|NCT03114865|Autonomic Agents|autonomic agents|mesh-ancestor
110128871|NCT03114865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110128872|NCT03114865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110128873|NCT03114865|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110128874|NCT03114865|Glucocorticoids|glucocorticoids|mesh-ancestor
110128875|NCT03114865|Hormones|hormones|mesh-ancestor
110128876|NCT03114865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110128877|NCT03114865|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110128878|NCT03114865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110128879|NCT03114865|Immunologic Factors|immunologic factors|mesh-ancestor
110128880|NCT02920008|Guadecitabine|guadecitabine|mesh-list
110128881|NCT02920008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110128882|NCT02866747|Durvalumab|durvalumab|mesh-list
110128883|NCT02866747|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110128884|NCT02866747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110128885|NCT02766335|Docetaxel|docetaxel|mesh-list
110128886|NCT02766335|Durvalumab|durvalumab|mesh-list
110128887|NCT02766335|Immunoglobulins|immunoglobulins|mesh-list
110128888|NCT02766335|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110128889|NCT02766335|Immunoglobulin G|immunoglobulin g|mesh-list
110856272|NCT03770039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110856273|NCT01321775|Paclitaxel|paclitaxel|mesh-list
110856274|NCT01321775|Cyclophosphamide|cyclophosphamide|mesh-list
110856275|NCT01321775|Bevacizumab|bevacizumab|mesh-list
110856276|NCT01321775|Trastuzumab|trastuzumab|mesh-list
110856277|NCT01321775|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110856278|NCT01321775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110856279|NCT01321775|Tubulin Modulators|tubulin modulators|mesh-ancestor
110856280|NCT01321775|Antimitotic Agents|antimitotic agents|mesh-ancestor
110856281|NCT01321775|Mitosis Modulators|mitosis modulators|mesh-ancestor
110856282|NCT01321775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110856283|NCT01321775|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110856284|NCT01321775|Immunologic Factors|immunologic factors|mesh-ancestor
110856285|NCT01321775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110856286|NCT01321775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110856287|NCT01321775|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110856288|NCT01321775|Alkylating Agents|alkylating agents|mesh-ancestor
110856289|NCT01321775|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110856290|NCT01321775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110856291|NCT01321775|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110856292|NCT01321775|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110856293|NCT01321775|Growth Substances|growth substances|mesh-ancestor
110856294|NCT01321775|Growth Inhibitors|growth inhibitors|mesh-ancestor
110856295|NCT05514509|Cabotegravir|cabotegravir|mesh-list
110856296|NCT05514509|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110856297|NCT05514509|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110856298|NCT05514509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110856299|NCT05514509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110856300|NCT05514509|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110856301|NCT05514509|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110856302|NCT05514509|Antiviral Agents|antiviral agents|mesh-ancestor
110856303|NCT05514509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110856304|NCT03764267|Lidocaine|lidocaine|mesh-list
110856305|NCT03764267|Remifentanil|remifentanil|mesh-list
110856306|NCT03764267|Anesthetics|anesthetics|mesh-list
110856307|NCT03764267|Anesthetics, General|anesthetics, general|mesh-list
110856308|NCT03764267|Anesthetics, Local|anesthetics, local|mesh-ancestor
110128951|NCT02344810|Oxaliplatin|oxaliplatin|mesh-list
110128952|NCT02344810|Calcium|calcium|mesh-list
110128965|NCT02344810|Vitamins|vitamins|mesh-ancestor
110856309|NCT03764267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110856310|NCT03764267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110856311|NCT03764267|Sensory System Agents|sensory system agents|mesh-ancestor
110856312|NCT03764267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110856313|NCT03764267|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110856314|NCT03764267|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110856315|NCT03764267|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110856316|NCT03764267|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110856317|NCT03764267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110856318|NCT03764267|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110856319|NCT03764267|Narcotics|narcotics|mesh-ancestor
110856320|NCT03764267|Analgesics|analgesics|mesh-ancestor
110856321|NCT01321931|Nicotine|nicotine|mesh-list
110856322|NCT01321931|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110856323|NCT01321931|Autonomic Agents|autonomic agents|mesh-ancestor
110856324|NCT01321931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110129071|NCT01725802|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110856325|NCT01321931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110856326|NCT01321931|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110856327|NCT01321931|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110856328|NCT01321931|Cholinergic Agents|cholinergic agents|mesh-ancestor
110856329|NCT01321931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110856330|NCT01321931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110856332|NCT03763409|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110856333|NCT03763409|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110856334|NCT03763409|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110856335|NCT03763409|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110856336|NCT03763409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110856337|NCT01322477|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110856338|NCT01322477|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110573965|NCT00704990|Zinc|zinc|mesh-list
110856339|NCT01322477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110856341|NCT03762785|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110856342|NCT03762785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110856343|NCT03762785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110856344|NCT03762785|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110856345|NCT03762785|Analgesics|analgesics|mesh-ancestor
110856346|NCT03762785|Sensory System Agents|sensory system agents|mesh-ancestor
110856347|NCT03762785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110856348|NCT03762785|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110856349|NCT03762785|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110856350|NCT03762785|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110338162|NCT00519987|Anesthetics|anesthetics|mesh-ancestor
110856351|NCT03762785|Adrenergic Agents|adrenergic agents|mesh-ancestor
110856352|NCT03762785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110856353|NCT03762785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110856354|NCT03758729|Nivolumab|nivolumab|mesh-list
110856355|NCT03758729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110856356|NCT03758729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110856357|NCT03758729|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110856358|NCT03758729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110856360|NCT03756623|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110856361|NCT03756623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110856362|NCT03756233|Remifentanil|remifentanil|mesh-list
110856363|NCT03756233|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110856364|NCT03756233|Narcotics|narcotics|mesh-ancestor
110856365|NCT03756233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110856366|NCT03756233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110856367|NCT03756233|Analgesics|analgesics|mesh-ancestor
110856368|NCT03756233|Sensory System Agents|sensory system agents|mesh-ancestor
110856369|NCT03756233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110856370|NCT03758339|Tucatinib|tucatinib|mesh-list
110856371|NCT03758339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110856372|NCT03758339|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110856373|NCT03758339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110856374|NCT03758339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110856375|NCT03565913|Calcium, Dietary|calcium, dietary|mesh-list
110856376|NCT03565913|Magnesium citrate|magnesium citrate|mesh-list
110856377|NCT03565913|Calcium|calcium|mesh-list
110856378|NCT03565913|Calcium acetate|calcium acetate|mesh-list
110856379|NCT03565913|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110856380|NCT03565913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110856381|NCT03565913|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110856382|NCT03565913|Chelating Agents|chelating agents|mesh-ancestor
110856383|NCT03565913|Sequestering Agents|sequestering agents|mesh-ancestor
110856384|NCT03565913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110856385|NCT03565913|Cathartics|cathartics|mesh-ancestor
110856386|NCT03565913|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110856387|NCT05085665|Ivermectin|ivermectin|mesh-list
110856388|NCT05085665|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110856389|NCT05085665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110856390|NCT05004077|Amiodarone|amiodarone|mesh-list
110856391|NCT05004077|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110856392|NCT05004077|Vasodilator Agents|vasodilator agents|mesh-ancestor
110129552|NCT01955187|Rituximab|rituximab|mesh-list
110856393|NCT05004077|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
110856394|NCT05004077|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110856395|NCT05004077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110856396|NCT05004077|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110833506|NCT05159674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110856397|NCT05004077|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110856398|NCT05004077|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110856399|NCT05004077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110856400|NCT05004077|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110856401|NCT05004077|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110856402|NCT05004077|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110856404|NCT03755609|Oxycodone|oxycodone|mesh-list
110856405|NCT03755609|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110856407|NCT03755609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110856408|NCT03755609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110129809|NCT01956955|Heparin|heparin|mesh-list
110856409|NCT03755609|Analgesics|analgesics|mesh-ancestor
110856410|NCT03755609|Sensory System Agents|sensory system agents|mesh-ancestor
110573972|NCT00704990|Protective Agents|protective agents|mesh-ancestor
110856411|NCT03755609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110338177|NCT00520650|Aripiprazole|aripiprazole|mesh-list
110856412|NCT03755609|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110856413|NCT03755609|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110856414|NCT03755609|Anesthetics, General|anesthetics, general|mesh-ancestor
110856415|NCT03755609|Anesthetics|anesthetics|mesh-ancestor
110856417|NCT03760445|Posaconazole|posaconazole|mesh-list
110856419|NCT03760445|Idarubicin|idarubicin|mesh-list
110856420|NCT03760445|Midostaurin|midostaurin|mesh-list
110856421|NCT03760445|Midazolam|midazolam|mesh-list
110856422|NCT03760445|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110856423|NCT03760445|Antimetabolites|antimetabolites|mesh-ancestor
110130020|NCT01958775|Hormones|hormones|mesh-ancestor
110856424|NCT03760445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110856425|NCT03760445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110856426|NCT03760445|Antiviral Agents|antiviral agents|mesh-ancestor
110856427|NCT03760445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110856428|NCT03760445|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110856429|NCT03760445|Immunologic Factors|immunologic factors|mesh-ancestor
110856430|NCT03760445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110856431|NCT03760445|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110856432|NCT03760445|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110856433|NCT03760445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110856434|NCT03760445|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110856435|NCT03760445|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110856436|NCT03760445|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110856437|NCT03760445|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110856438|NCT03760445|Anesthetics, General|anesthetics, general|mesh-ancestor
110856439|NCT03760445|Anesthetics|anesthetics|mesh-ancestor
110856440|NCT03760445|GABA Modulators|gaba modulators|mesh-ancestor
110856442|NCT03760445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110856443|NCT03760445|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110856444|NCT03760445|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110856445|NCT03760445|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110856446|NCT03760445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110856447|NCT03760445|Antifungal Agents|antifungal agents|mesh-ancestor
110856448|NCT03760445|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
110856449|NCT03760445|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110856450|NCT03760445|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110856451|NCT03760445|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110856452|NCT03760445|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110856453|NCT03760445|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110856454|NCT03760445|Hormone Antagonists|hormone antagonists|mesh-ancestor
110856455|NCT03760445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110856457|NCT05460377|Vaccines|vaccines|mesh-list
110856458|NCT05460377|Immunologic Factors|immunologic factors|mesh-ancestor
110856459|NCT05460377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110856460|NCT04956575|Vaccines|vaccines|mesh-list
110856461|NCT04956575|Immunologic Factors|immunologic factors|mesh-ancestor
110856462|NCT04956575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110856463|NCT05692856|Clenbuterol|clenbuterol|mesh-list
110856464|NCT05692856|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110856465|NCT05692856|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110856466|NCT05692856|Adrenergic Agents|adrenergic agents|mesh-ancestor
110856467|NCT05692856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110856468|NCT05692856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110130574|NCT01963546|Dexmedetomidine|dexmedetomidine|mesh-list
110856469|NCT05692856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110856470|NCT05692856|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110856471|NCT05692856|Autonomic Agents|autonomic agents|mesh-ancestor
110130646|NCT01963832|Fluoxetine|fluoxetine|mesh-list
110856472|NCT05692856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110856473|NCT05692856|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110856474|NCT05692856|Respiratory System Agents|respiratory system agents|mesh-ancestor
110856476|NCT03755531|Oxytocin|oxytocin|mesh-list
110856477|NCT03755531|Carbetocin|carbetocin|mesh-list
110856478|NCT03755531|Oxytocics|oxytocics|mesh-ancestor
110856479|NCT03755531|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110856480|NCT03755531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110856481|NCT04854707|Menotropins|menotropins|mesh-list
110856482|NCT04854707|Hormones|hormones|mesh-list
110856483|NCT04854707|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
110856484|NCT04854707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110130782|NCT01964287|Micronutrients|micronutrients|mesh-ancestor
110856485|NCT04854707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110856486|NCT04854707|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110574050|NCT00914472|Heparin|heparin|mesh-list
110856487|NCT04854707|Fertility Agents|fertility agents|mesh-ancestor
110856488|NCT04854707|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110856489|NCT03215069|Empagliflozin|empagliflozin|mesh-list
110856490|NCT03215069|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110856491|NCT03215069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110856492|NCT03215069|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110856493|NCT03215069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110856494|NCT03759353|Lactoferrin|lactoferrin|mesh-list
110856495|NCT03759353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110856496|NCT03757559|Hydromorphone|hydromorphone|mesh-list
110856497|NCT03757559|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110856498|NCT03757559|Narcotics|narcotics|mesh-ancestor
110856499|NCT03757559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110856500|NCT03757559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110856501|NCT03757559|Analgesics|analgesics|mesh-ancestor
110856502|NCT03757559|Sensory System Agents|sensory system agents|mesh-ancestor
110856503|NCT03757559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110130858|NCT01964586|Analgesics|analgesics|mesh-ancestor
110856504|NCT02658929|Idecabtagene vicleucel|idecabtagene vicleucel|mesh-list
110856505|NCT02658929|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110856506|NCT02658929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110856507|NCT04784897|Brilacidin|brilacidin|mesh-list
110856508|NCT04784897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110856509|NCT02780804|Entinostat|entinostat|mesh-list
110856510|NCT02780804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110856511|NCT02780804|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110856512|NCT02780804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110856513|NCT02780804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110856514|NCT01322711|Atorvastatin|atorvastatin|mesh-list
110856515|NCT01322711|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110856516|NCT01322711|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110856517|NCT01322711|Antimetabolites|antimetabolites|mesh-ancestor
110856518|NCT01322711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110856519|NCT01322711|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110856520|NCT01322711|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110856521|NCT01322711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110856522|NCT04532099|Hydrogen Peroxide|hydrogen peroxide|mesh-list
110856523|NCT04532099|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110856524|NCT04532099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110856525|NCT03041792|Liraglutide|liraglutide|mesh-list
110856526|NCT03041792|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110856527|NCT03041792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110856528|NCT03041792|Incretins|incretins|mesh-ancestor
110856529|NCT03041792|Hormones|hormones|mesh-ancestor
110856530|NCT03041792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110856531|NCT03753581|Cytarabine|cytarabine|mesh-list
110856532|NCT03753581|Methotrexate|methotrexate|mesh-list
110856533|NCT03753581|Etoposide|etoposide|mesh-list
110856534|NCT03753581|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110856535|NCT03753581|Antimetabolites|antimetabolites|mesh-ancestor
110856536|NCT03753581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110856537|NCT03753581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110856538|NCT03753581|Antiviral Agents|antiviral agents|mesh-ancestor
110856539|NCT03753581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110856540|NCT03753581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110856541|NCT03753581|Immunologic Factors|immunologic factors|mesh-ancestor
110338195|NCT00519363|Atorvastatin|atorvastatin|mesh-list
110856542|NCT03753581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110856543|NCT03753581|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110856544|NCT03753581|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110856545|NCT03753581|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110856546|NCT03753581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110856547|NCT03753581|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110856548|NCT03753581|Abortifacient Agents|abortifacient agents|mesh-ancestor
110856549|NCT03753581|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110856550|NCT03753581|Dermatologic Agents|dermatologic agents|mesh-ancestor
110856551|NCT03753581|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110856552|NCT03753581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110856553|NCT03753581|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110856554|NCT04507763|Etanercept|etanercept|mesh-list
110856555|NCT04507763|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110856556|NCT04507763|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110856557|NCT04507763|Analgesics|analgesics|mesh-ancestor
110856558|NCT04507763|Sensory System Agents|sensory system agents|mesh-ancestor
110856559|NCT04507763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110856560|NCT04507763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110574130|NCT00806286|Paclitaxel|paclitaxel|mesh-list
110856561|NCT04507763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110856562|NCT04507763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110856563|NCT04507763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110856564|NCT04507763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110856565|NCT04507763|Immunologic Factors|immunologic factors|mesh-ancestor
110856566|NCT00705484|Infliximab|infliximab|mesh-list
110856567|NCT00705484|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110856568|NCT00705484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110856569|NCT00705484|Dermatologic Agents|dermatologic agents|mesh-ancestor
110130981|NCT01965353|Hormones|hormones|mesh-ancestor
110856570|NCT00705484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110856571|NCT00705484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110856572|NCT05459597|Anticonvulsants|anticonvulsants|mesh-list
110856573|NCT05358626|Antibodies|antibodies|mesh-list
110856574|NCT05358626|Immunoglobulin G|immunoglobulin g|mesh-list
110856575|NCT05358626|Immunologic Factors|immunologic factors|mesh-ancestor
110856576|NCT05358626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110856577|NCT03753269|Fasudil|fasudil|mesh-list
110856578|NCT03753269|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110856579|NCT03753269|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110856580|NCT03753269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110856581|NCT03753269|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110856582|NCT03753269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110856583|NCT03753269|Vasodilator Agents|vasodilator agents|mesh-ancestor
110856584|NCT03753269|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110856585|NCT03753269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110856586|NCT05459441|Pemetrexed|pemetrexed|mesh-list
110856587|NCT05459441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110856588|NCT05459441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110856589|NCT05459441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110856590|NCT05459441|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110856591|NCT05459441|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110856592|NCT04523831|Doxycycline|doxycycline|mesh-list
110856593|NCT04523831|Ivermectin|ivermectin|mesh-list
110131203|NCT01966822|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110856594|NCT04523831|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110856595|NCT04523831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110856596|NCT04523831|Antimalarials|antimalarials|mesh-ancestor
110856597|NCT04523831|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110856598|NCT04523831|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110856600|NCT05691764|Cyclosporins|cyclosporins|mesh-list
110856601|NCT05691764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110856602|NCT05691764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110856603|NCT05691764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110856604|NCT05691764|Immunologic Factors|immunologic factors|mesh-ancestor
110856605|NCT05691764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110856606|NCT05691764|Antifungal Agents|antifungal agents|mesh-ancestor
110856607|NCT05691764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110856608|NCT05691764|Dermatologic Agents|dermatologic agents|mesh-ancestor
110856609|NCT05691764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110856610|NCT05691764|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110856611|NCT04707664|Sargramostim|sargramostim|mesh-list
110856612|NCT04707664|Immunologic Factors|immunologic factors|mesh-ancestor
110856613|NCT04707664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110856614|NCT01316276|Amikacin|amikacin|mesh-list
110856615|NCT01316276|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110856616|NCT01316276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110856617|NCT02474290|Sorafenib|sorafenib|mesh-list
110856618|NCT02474290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110856619|NCT02474290|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110856620|NCT02474290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110856621|NCT02474290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110856622|NCT02474212|Enoxaparin|enoxaparin|mesh-list
110856623|NCT02474212|Anticoagulants|anticoagulants|mesh-ancestor
110856624|NCT02474212|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110856625|NCT02474212|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110856626|NCT02474212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110856627|NCT05200286|Olorofim|olorofim|mesh-list
110856628|NCT05200286|Antifungal Agents|antifungal agents|mesh-ancestor
110856629|NCT05200286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110856630|NCT02474446|Vitamin D|vitamin d|mesh-list
110856631|NCT02474446|Vitamins|vitamins|mesh-ancestor
110856632|NCT02474446|Micronutrients|micronutrients|mesh-ancestor
110131540|NCT01969019|Glucocorticoids|glucocorticoids|mesh-ancestor
110856633|NCT02474446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110856634|NCT02474446|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110574200|NCT00796419|Plasma Substitutes|plasma substitutes|mesh-ancestor
110856636|NCT05199818|Antiemetics|antiemetics|mesh-ancestor
110856637|NCT05199818|Autonomic Agents|autonomic agents|mesh-ancestor
110856638|NCT05199818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110856639|NCT05199818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110856641|NCT05199818|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110856642|NCT05199818|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110856643|NCT05199818|Serotonin Agents|serotonin agents|mesh-ancestor
110856644|NCT05199818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110856645|NCT05199818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110089980|NCT05601154|Listerine|listerine|mesh-list
110856646|NCT02474134|Interferons|interferons|mesh-list
110856647|NCT02474134|Interferon-beta|interferon-beta|mesh-list
110856648|NCT02474134|Interferon beta-1b|interferon beta-1b|mesh-list
110856649|NCT02474134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110856650|NCT02474134|Antiviral Agents|antiviral agents|mesh-ancestor
110856651|NCT02474134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110856652|NCT02474134|Immunologic Factors|immunologic factors|mesh-ancestor
110131673|NCT01969773|Cholinergic Agents|cholinergic agents|mesh-ancestor
110856654|NCT02474134|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110856655|NCT02473900|Oseltamivir|oseltamivir|mesh-list
110856656|NCT02473900|Antiviral Agents|antiviral agents|mesh-ancestor
110856657|NCT02473900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110856658|NCT02473900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110856659|NCT02473900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110856660|NCT02471950|Isoflurane|isoflurane|mesh-list
110856661|NCT02471950|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110856662|NCT02471950|Anesthetics, General|anesthetics, general|mesh-ancestor
110856663|NCT02471950|Anesthetics|anesthetics|mesh-ancestor
110856664|NCT02471950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110856665|NCT02471950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110856666|NCT01322867|Alprazolam|alprazolam|mesh-list
110856667|NCT01322867|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110856668|NCT01322867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110338213|NCT02954939|Hormones|hormones|mesh-ancestor
110856669|NCT01322867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110856670|NCT01322867|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110856671|NCT01322867|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110856672|NCT01322867|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110856673|NCT01322867|GABA Modulators|gaba modulators|mesh-ancestor
110856674|NCT01322867|GABA Agents|gaba agents|mesh-ancestor
110856675|NCT01322867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110856676|NCT01322867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110856677|NCT04624828|Androgens|androgens|mesh-list
110856678|NCT04624828|Hormones|hormones|mesh-ancestor
110856679|NCT04624828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110856680|NCT04624828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110856681|NCT02471560|Dimethyl Fumarate|dimethyl fumarate|mesh-list
110856682|NCT02471560|Dermatologic Agents|dermatologic agents|mesh-ancestor
110856683|NCT02471560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110856684|NCT02471560|Immunologic Factors|immunologic factors|mesh-ancestor
110856685|NCT02471560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110856686|NCT02477488|Allopurinol|allopurinol|mesh-list
110856687|NCT02477488|Antimetabolites|antimetabolites|mesh-ancestor
110131939|NCT01971658|Growth Inhibitors|growth inhibitors|mesh-ancestor
110856688|NCT02477488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110856689|NCT02477488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110856690|NCT02477488|Gout Suppressants|gout suppressants|mesh-ancestor
110856691|NCT02477488|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110856692|NCT02477488|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110856693|NCT02477488|Antioxidants|antioxidants|mesh-ancestor
110856694|NCT02477488|Protective Agents|protective agents|mesh-ancestor
110856695|NCT02477488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110856696|NCT05163106|Letrozole|letrozole|mesh-list
110856697|NCT05163106|Goserelin|goserelin|mesh-list
110856698|NCT05163106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110856699|NCT05163106|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110856700|NCT05163106|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110856701|NCT05163106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110856702|NCT05163106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110856703|NCT05163106|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110856704|NCT05163106|Hormone Antagonists|hormone antagonists|mesh-ancestor
110856705|NCT05163106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110856706|NCT05163106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110132138|NCT01973400|Antioxidants|antioxidants|mesh-ancestor
110856707|NCT05163106|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110856709|NCT02477098|Anesthetics, Local|anesthetics, local|mesh-ancestor
110856710|NCT02477098|Anesthetics|anesthetics|mesh-ancestor
110574280|NCT02604225|Methoxyflurane|methoxyflurane|mesh-list
110856711|NCT02477098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110856712|NCT02477098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110856713|NCT02477098|Sensory System Agents|sensory system agents|mesh-ancestor
110856714|NCT02477098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110856716|NCT04518046|Ipilimumab|ipilimumab|mesh-list
110856717|NCT04518046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110856718|NCT04518046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110132278|NCT01974167|Alfacalcidol|alfacalcidol|mesh-list
110856719|NCT04518046|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110856720|NCT04518046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110856722|NCT05571670|MTOR Inhibitors|mtor inhibitors|mesh-list
110856723|NCT05571670|Temsirolimus|temsirolimus|mesh-list
110856724|NCT05571670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110856725|NCT05571670|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110856726|NCT05571670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110856727|NCT05571670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110856728|NCT05571670|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110856729|NCT05571670|Immunologic Factors|immunologic factors|mesh-ancestor
110856730|NCT05571670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110856731|NCT05571670|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110856732|NCT05571670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110856733|NCT05571670|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110856734|NCT05571670|Antifungal Agents|antifungal agents|mesh-ancestor
110856735|NCT02473354|Remifentanil|remifentanil|mesh-list
110856736|NCT02473354|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110856737|NCT02473354|Narcotics|narcotics|mesh-ancestor
110856738|NCT02473354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110856739|NCT02473354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110856740|NCT02473354|Analgesics|analgesics|mesh-ancestor
110856741|NCT02473354|Sensory System Agents|sensory system agents|mesh-ancestor
110856742|NCT02473354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110856743|NCT02470858|Sofosbuvir|sofosbuvir|mesh-list
110856744|NCT02470858|Asunaprevir|asunaprevir|mesh-list
110856745|NCT02470858|Antiviral Agents|antiviral agents|mesh-ancestor
110856746|NCT02470858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110856747|NCT02470858|Protease Inhibitors|protease inhibitors|mesh-ancestor
110856748|NCT02470858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110856749|NCT02470858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110856750|NCT02473198|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
110856751|NCT02473198|Morphine|morphine|mesh-list
110856753|NCT02473198|Anesthetics, Local|anesthetics, local|mesh-ancestor
110856754|NCT02473198|Anesthetics|anesthetics|mesh-ancestor
110856755|NCT02473198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110856756|NCT02473198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110856757|NCT02473198|Sensory System Agents|sensory system agents|mesh-ancestor
110856758|NCT02473198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110856759|NCT02473198|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110856760|NCT02473198|Narcotics|narcotics|mesh-ancestor
110856761|NCT02473198|Analgesics|analgesics|mesh-ancestor
110856762|NCT02473198|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110856763|NCT02473198|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110856764|NCT02473198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110856765|NCT02473198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110856766|NCT02473198|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110856767|NCT02473198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110856768|NCT02473198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110856769|NCT03614728|Azacitidine|azacitidine|mesh-list
110856770|NCT03614728|GSK-3326595|gsk-3326595|mesh-list
110856771|NCT03614728|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110856772|NCT03614728|Antimetabolites|antimetabolites|mesh-ancestor
110856773|NCT03614728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110856774|NCT03614728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110856775|NCT03614728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110856776|NCT05069974|Linezolid|linezolid|mesh-list
110856777|NCT05069974|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110856778|NCT05069974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110856779|NCT05069974|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110856780|NCT05069974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110856781|NCT05069974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110856782|NCT05336266|Ketorolac|ketorolac|mesh-list
110856783|NCT05336266|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
110856784|NCT05336266|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110856785|NCT05336266|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110856786|NCT05336266|Analgesics|analgesics|mesh-ancestor
110856787|NCT05336266|Sensory System Agents|sensory system agents|mesh-ancestor
110856788|NCT05336266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110856789|NCT05336266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110856790|NCT05336266|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110856791|NCT05336266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110856792|NCT05336266|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110856793|NCT05336266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110856794|NCT05336266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110856796|NCT02470780|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110856797|NCT02470780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110856798|NCT02470780|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110856799|NCT05180292|Carvedilol|carvedilol|mesh-list
110856800|NCT05180292|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110856801|NCT05180292|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110856802|NCT05180292|Adrenergic Agents|adrenergic agents|mesh-ancestor
110856803|NCT05180292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110856804|NCT05180292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110856805|NCT05180292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110856806|NCT05180292|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110856807|NCT05180292|Antioxidants|antioxidants|mesh-ancestor
110856808|NCT05180292|Protective Agents|protective agents|mesh-ancestor
110856809|NCT05180292|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110856810|NCT05180292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110856811|NCT05180292|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110856812|NCT05180292|Vasodilator Agents|vasodilator agents|mesh-ancestor
110856813|NCT05180292|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110856814|NCT05180292|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110856815|NCT01315938|Abatacept|abatacept|mesh-list
110856816|NCT01315938|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110856817|NCT01315938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110856818|NCT01315938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110856819|NCT01315938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110856820|NCT01315938|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110856821|NCT01315938|Immunologic Factors|immunologic factors|mesh-ancestor
110856822|NCT01315938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110856823|NCT01315938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110856824|NCT01339884|Resveratrol|resveratrol|mesh-list
110856825|NCT01339884|Antioxidants|antioxidants|mesh-ancestor
110856826|NCT01339884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110856827|NCT01339884|Protective Agents|protective agents|mesh-ancestor
110856828|NCT01339884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110856829|NCT01339884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110856830|NCT01339884|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110856831|NCT04736394|Epirubicin|epirubicin|mesh-list
110856832|NCT04736394|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110132672|NCT01977300|Antimanic Agents|antimanic agents|mesh-ancestor
110856833|NCT04736394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110856834|NCT04736394|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110856835|NCT04736394|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110856836|NCT04736394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110856837|NCT04736394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110856838|NCT01341834|Everolimus|everolimus|mesh-list
110856839|NCT01341834|Panobinostat|panobinostat|mesh-list
110856840|NCT01341834|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110856841|NCT01341834|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110856842|NCT01341834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110856843|NCT01341834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110856844|NCT01341834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110856845|NCT01341834|Immunologic Factors|immunologic factors|mesh-ancestor
110856846|NCT01341834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110856847|NCT01341834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110856848|NCT01341834|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110856849|NCT01340118|Budesonide|budesonide|mesh-list
110856850|NCT01340118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110856851|NCT01340118|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110856852|NCT01340118|Autonomic Agents|autonomic agents|mesh-ancestor
110856853|NCT01340118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110856854|NCT01340118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110856855|NCT01340118|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110132824|NCT01978678|Hormones|hormones|mesh-ancestor
110856856|NCT01340118|Respiratory System Agents|respiratory system agents|mesh-ancestor
110856857|NCT01340118|Glucocorticoids|glucocorticoids|mesh-ancestor
110856859|NCT01340118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110856860|NCT03401398|Hydrocortisone|hydrocortisone|mesh-list
110856861|NCT03401398|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
110856863|NCT03401398|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
110856864|NCT03401398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110856866|NCT02470702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110856867|NCT02470702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110856868|NCT01375582|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110856869|NCT01375582|Lubricant Eye Drops|lubricant eye drops|mesh-list
110856870|NCT01375582|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110856871|NCT04409964|Lidocaine|lidocaine|mesh-list
110132958|NCT01980069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110856872|NCT04409964|Dexmedetomidine|dexmedetomidine|mesh-list
110856874|NCT04409964|Anesthetics, Local|anesthetics, local|mesh-ancestor
110856875|NCT04409964|Anesthetics|anesthetics|mesh-ancestor
110856876|NCT04409964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110856877|NCT04409964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110856878|NCT04409964|Sensory System Agents|sensory system agents|mesh-ancestor
110856879|NCT04409964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110856880|NCT04409964|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110856881|NCT04409964|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110856882|NCT04409964|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110856883|NCT04409964|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110856884|NCT04409964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110856885|NCT04409964|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110856886|NCT04409964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110856887|NCT04409964|Analgesics|analgesics|mesh-ancestor
110856888|NCT04409964|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110856889|NCT04409964|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110856890|NCT04409964|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110133166|NCT01981707|Choline|choline|mesh-list
110856891|NCT04409964|Adrenergic Agents|adrenergic agents|mesh-ancestor
110856892|NCT04409964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110856893|NCT04409964|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110856894|NCT04409964|Narcotics|narcotics|mesh-ancestor
110856896|NCT01342146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110856897|NCT01342146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110856898|NCT03212716|Oseltamivir|oseltamivir|mesh-list
110856899|NCT03212716|Diltiazem|diltiazem|mesh-list
110856900|NCT03212716|Antiviral Agents|antiviral agents|mesh-ancestor
110856901|NCT03212716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110133233|NCT01982201|Lesinurad|lesinurad|mesh-list
110856902|NCT03212716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110856903|NCT03212716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110856904|NCT03212716|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110856905|NCT03212716|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110856906|NCT03212716|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110856907|NCT03212716|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110856908|NCT03212716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110856909|NCT03212716|Vasodilator Agents|vasodilator agents|mesh-ancestor
110856910|NCT04762836|Cycloserine|cycloserine|mesh-list
110856911|NCT04762836|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110133304|NCT01982799|Narcotics|narcotics|mesh-ancestor
110856912|NCT04762836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110856913|NCT04762836|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110856914|NCT04762836|Antitubercular Agents|antitubercular agents|mesh-ancestor
110856915|NCT04762836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110856917|NCT04762836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110856918|NCT00705406|Peramivir|peramivir|mesh-list
110856919|NCT00705406|Antiviral Agents|antiviral agents|mesh-ancestor
110856920|NCT00705406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110133434|NCT01983761|Vidarabine|vidarabine|mesh-list
110856921|NCT00705406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110856922|NCT00705406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110856923|NCT01342224|Gemcitabine|gemcitabine|mesh-list
110856924|NCT01342224|Tadalafil|tadalafil|mesh-list
110856925|NCT01342224|Sargramostim|sargramostim|mesh-list
110856926|NCT01342224|Immunologic Factors|immunologic factors|mesh-ancestor
110856927|NCT01342224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110856928|NCT01342224|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110856929|NCT01342224|Antimetabolites|antimetabolites|mesh-ancestor
110856930|NCT01342224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110856931|NCT01342224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110856932|NCT01342224|Vasodilator Agents|vasodilator agents|mesh-ancestor
110856933|NCT01342224|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110856934|NCT01342224|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110133575|NCT01984567|Vitamin E|vitamin e|mesh-list
110856935|NCT01342224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110856936|NCT01342224|Urological Agents|urological agents|mesh-ancestor
110856937|NCT03155178|Ethanol|ethanol|mesh-list
110856938|NCT03155178|Chlorhexidine|chlorhexidine|mesh-list
110856939|NCT03155178|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110856940|NCT03155178|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110856941|NCT03155178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110856942|NCT03155178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110856943|NCT03155178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110856944|NCT03155178|Disinfectants|disinfectants|mesh-ancestor
110856945|NCT03155178|Dermatologic Agents|dermatologic agents|mesh-ancestor
110856946|NCT02470546|Metformin|metformin|mesh-list
110856947|NCT02470546|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110856948|NCT02470546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110856949|NCT03310762|Silicon|silicon|mesh-list
110856950|NCT03310762|Trace Elements|trace elements|mesh-ancestor
110856951|NCT03310762|Micronutrients|micronutrients|mesh-ancestor
110856952|NCT03310762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110856953|NCT03310606|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110856954|NCT03310606|Lactams|lactams|mesh-list
110856955|NCT03310606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110856956|NCT01315704|Vitamin D|vitamin d|mesh-list
110856957|NCT01315704|Vitamins|vitamins|mesh-ancestor
110856958|NCT01315704|Micronutrients|micronutrients|mesh-ancestor
110856959|NCT01315704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110856960|NCT01315704|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110856961|NCT05158608|Cyclophosphamide|cyclophosphamide|mesh-list
110856962|NCT05158608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110856963|NCT05158608|Immunologic Factors|immunologic factors|mesh-ancestor
110856964|NCT05158608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110856965|NCT05158608|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110856966|NCT05158608|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110856967|NCT05158608|Alkylating Agents|alkylating agents|mesh-ancestor
110856968|NCT05158608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110856970|NCT05158608|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110856971|NCT04702776|Hyaluronic Acid|hyaluronic acid|mesh-list
110856972|NCT04702776|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110856973|NCT04702776|Immunologic Factors|immunologic factors|mesh-ancestor
110856974|NCT04702776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110856975|NCT04702776|Viscosupplements|viscosupplements|mesh-ancestor
110856976|NCT04702776|Protective Agents|protective agents|mesh-ancestor
110856977|NCT03310372|Temozolomide|temozolomide|mesh-list
110856978|NCT03310372|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110133693|NCT01985477|Hormones|hormones|mesh-ancestor
110856979|NCT03310372|Alkylating Agents|alkylating agents|mesh-ancestor
110856980|NCT03310372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110833590|NCT05533281|Serotonin Agents|serotonin agents|mesh-ancestor
110856981|NCT03310372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110856982|NCT03108664|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110856983|NCT03108664|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110856985|NCT01342614|Fosinopril|fosinopril|mesh-list
110856986|NCT01342614|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110856987|NCT01342614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110856988|NCT01342614|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110856989|NCT01342614|Protease Inhibitors|protease inhibitors|mesh-ancestor
110856990|NCT01342614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110856991|NCT01342614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110856992|NCT01342614|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110856993|NCT01342692|Lenalidomide|lenalidomide|mesh-list
110856994|NCT01342692|Azacitidine|azacitidine|mesh-list
110856996|NCT01342692|Valproic Acid|valproic acid|mesh-list
110856997|NCT01342692|Immunologic Factors|immunologic factors|mesh-ancestor
110856998|NCT01342692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110856999|NCT01342692|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110857000|NCT01342692|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110857001|NCT01342692|Growth Substances|growth substances|mesh-ancestor
110857002|NCT01342692|Growth Inhibitors|growth inhibitors|mesh-ancestor
110857003|NCT01342692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110857004|NCT01342692|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110857005|NCT01342692|Antimetabolites|antimetabolites|mesh-ancestor
110857006|NCT01342692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110857007|NCT01342692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110857008|NCT01342692|Anticonvulsants|anticonvulsants|mesh-ancestor
110857009|NCT01342692|GABA Agents|gaba agents|mesh-ancestor
110857010|NCT01342692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110857011|NCT01342692|Antimanic Agents|antimanic agents|mesh-ancestor
110857012|NCT01342692|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110857013|NCT01342692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110857014|NCT01342692|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110857015|NCT01342692|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110857016|NCT01342692|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110857017|NCT01342692|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110857018|NCT05153772|Octreotide|octreotide|mesh-list
110857019|NCT05153772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110857020|NCT05153772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110857021|NCT05153772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110857022|NCT03310060|Tranexamic Acid|tranexamic acid|mesh-list
110857023|NCT03310060|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
110857024|NCT03310060|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110857025|NCT03310060|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110857026|NCT03310060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110857027|NCT03310060|Hemostatics|hemostatics|mesh-ancestor
110857028|NCT03310060|Coagulants|coagulants|mesh-ancestor
110857029|NCT03740958|Argatroban|argatroban|mesh-list
110857030|NCT03740958|Antithrombins|antithrombins|mesh-ancestor
110857031|NCT03740958|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110857032|NCT03740958|Protease Inhibitors|protease inhibitors|mesh-ancestor
110133940|NCT01986660|Ibuprofen|ibuprofen|mesh-list
110857033|NCT03740958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110857034|NCT03740958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110857035|NCT03740958|Anticoagulants|anticoagulants|mesh-ancestor
110857036|NCT03740958|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110857037|NCT01340820|BCG Vaccine|bcg vaccine|mesh-list
110857038|NCT01340820|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110857039|NCT01340820|Immunologic Factors|immunologic factors|mesh-ancestor
110857040|NCT01340820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110857041|NCT03685188|Sufentanil|sufentanil|mesh-list
110857042|NCT03685188|Oxycodone|oxycodone|mesh-list
110857044|NCT03685188|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110857045|NCT03685188|Narcotics|narcotics|mesh-ancestor
110857046|NCT03685188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110857047|NCT03685188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110857049|NCT03685188|Sensory System Agents|sensory system agents|mesh-ancestor
110857050|NCT03685188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110857051|NCT03685188|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110857052|NCT03685188|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110857053|NCT03685188|Anesthetics, General|anesthetics, general|mesh-ancestor
110857054|NCT03685188|Anesthetics|anesthetics|mesh-ancestor
110857055|NCT02305654|Paclitaxel|paclitaxel|mesh-list
110857056|NCT02305654|Ifosfamide|ifosfamide|mesh-list
110857057|NCT02305654|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110857058|NCT02305654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110857059|NCT02305654|Tubulin Modulators|tubulin modulators|mesh-ancestor
110857060|NCT02305654|Antimitotic Agents|antimitotic agents|mesh-ancestor
110857061|NCT02305654|Mitosis Modulators|mitosis modulators|mesh-ancestor
110857062|NCT02305654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110857063|NCT02305654|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110857064|NCT02305654|Alkylating Agents|alkylating agents|mesh-ancestor
110857066|NCT05251584|Mupirocin|mupirocin|mesh-list
110857067|NCT05251584|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110857068|NCT05251584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110857069|NCT05251584|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110857070|NCT05251584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110857071|NCT05251584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110857072|NCT03309748|Anti-Infective Agents|anti-infective agents|mesh-list
110857073|NCT03309748|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110857074|NCT00705250|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110857075|NCT00705250|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110857076|NCT00705250|Alkylating Agents|alkylating agents|mesh-ancestor
110857077|NCT00705250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110857078|NCT00705250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110857079|NCT03309592|Ambrisentan|ambrisentan|mesh-list
110857080|NCT03309592|Tadalafil|tadalafil|mesh-list
110857081|NCT03309592|Vasodilator Agents|vasodilator agents|mesh-ancestor
110857082|NCT03309592|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110857083|NCT03309592|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110857084|NCT03309592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110857085|NCT03309592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110857086|NCT03309592|Urological Agents|urological agents|mesh-ancestor
110857087|NCT03309592|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110574655|NCT03849313|Adalimumab|adalimumab|mesh-list
110857088|NCT04641312|Dulaglutide|dulaglutide|mesh-list
110857090|NCT04641312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110857091|NCT03078192|Xenon|xenon|mesh-list
110857092|NCT03078192|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110857093|NCT03078192|Anesthetics, General|anesthetics, general|mesh-ancestor
110857094|NCT03078192|Anesthetics|anesthetics|mesh-ancestor
110857095|NCT03078192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110857096|NCT03078192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110857097|NCT00703846|Ketoconazole|ketoconazole|mesh-list
110857098|NCT00703846|Antifungal Agents|antifungal agents|mesh-ancestor
110857099|NCT00703846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110857100|NCT00703846|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110857101|NCT00703846|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110857102|NCT00703846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110833618|NCT01227239|Oxaliplatin|oxaliplatin|mesh-list
110857103|NCT00703846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110857104|NCT00703846|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110857105|NCT00703846|Hormone Antagonists|hormone antagonists|mesh-ancestor
110857106|NCT00703846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110857107|NCT00703846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110857108|NCT00703846|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110857110|NCT03309436|Enclomiphene|enclomiphene|mesh-list
110857111|NCT03309436|Zuclomiphene|zuclomiphene|mesh-list
110857112|NCT03309436|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110857113|NCT03309436|Hormone Antagonists|hormone antagonists|mesh-ancestor
110857114|NCT03309436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110857115|NCT03309436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110857116|NCT03309436|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110857117|NCT03309436|Fertility Agents|fertility agents|mesh-ancestor
110857118|NCT03309436|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110857119|NCT03309436|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110857120|NCT03309436|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110857121|NCT05183334|Sildenafil Citrate|sildenafil citrate|mesh-list
110857122|NCT05183334|Tramadol|tramadol|mesh-list
110857123|NCT05183334|Vasodilator Agents|vasodilator agents|mesh-ancestor
110857124|NCT05183334|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110857125|NCT05183334|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110857126|NCT05183334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110857127|NCT05183334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110857128|NCT05183334|Urological Agents|urological agents|mesh-ancestor
110857129|NCT05183334|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110857130|NCT05183334|Narcotics|narcotics|mesh-ancestor
110857131|NCT05183334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110857132|NCT05183334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110857133|NCT05183334|Analgesics|analgesics|mesh-ancestor
110857134|NCT05183334|Sensory System Agents|sensory system agents|mesh-ancestor
110857135|NCT05183334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110857136|NCT03304444|Bupivacaine|bupivacaine|mesh-list
110857137|NCT03304444|Anesthetics, Local|anesthetics, local|mesh-ancestor
110857138|NCT03304444|Anesthetics|anesthetics|mesh-ancestor
110857139|NCT03304444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110857140|NCT03304444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110857141|NCT03304444|Sensory System Agents|sensory system agents|mesh-ancestor
110857142|NCT03304444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110857143|NCT03304288|Rituximab|rituximab|mesh-list
110857144|NCT03304288|Tretinoin|tretinoin|mesh-list
110857145|NCT03304288|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110857146|NCT03304288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110857147|NCT03304288|Immunologic Factors|immunologic factors|mesh-ancestor
110857148|NCT03304288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110857149|NCT03304288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110857150|NCT03304288|Keratolytic Agents|keratolytic agents|mesh-ancestor
110857151|NCT03304288|Dermatologic Agents|dermatologic agents|mesh-ancestor
110857152|NCT03304210|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110857153|NCT03304210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110857154|NCT03313960|Insulin|insulin|mesh-list
110857155|NCT03313960|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110857156|NCT03313960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110857157|NCT03308890|Entecavir|entecavir|mesh-list
110857158|NCT03308890|Antiviral Agents|antiviral agents|mesh-ancestor
110857159|NCT03308890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110857160|NCT03313726|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
110857161|NCT03313726|Hormones|hormones|mesh-ancestor
110857162|NCT03313726|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110857163|NCT03313726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110857164|NCT03303976|Vaccines|vaccines|mesh-list
110857165|NCT03303976|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110857166|NCT03303976|Immunologic Factors|immunologic factors|mesh-ancestor
110857167|NCT03303976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110857168|NCT03313414|Sofosbuvir|sofosbuvir|mesh-list
110857169|NCT03313414|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
110857170|NCT03313414|Velpatasvir|velpatasvir|mesh-list
110857171|NCT03313414|Antiviral Agents|antiviral agents|mesh-ancestor
110857172|NCT03313414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110857173|NCT02468518|Vitamin E|vitamin e|mesh-list
110857174|NCT02468518|Vitamins|vitamins|mesh-ancestor
110857175|NCT02468518|Micronutrients|micronutrients|mesh-ancestor
110857176|NCT02468518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110857177|NCT02468518|Antioxidants|antioxidants|mesh-ancestor
110857178|NCT02468518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110857179|NCT02468518|Protective Agents|protective agents|mesh-ancestor
110857180|NCT03313336|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
110857181|NCT03313336|Anesthetics, Local|anesthetics, local|mesh-ancestor
110857182|NCT03313336|Anesthetics|anesthetics|mesh-ancestor
110857183|NCT03313336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110857184|NCT03313336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110857185|NCT03313336|Sensory System Agents|sensory system agents|mesh-ancestor
110857186|NCT03313336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110857187|NCT03313336|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
110857188|NCT05262322|Rivaroxaban|rivaroxaban|mesh-list
110857189|NCT05262322|Apixaban|apixaban|mesh-list
110857190|NCT05262322|Edoxaban|edoxaban|mesh-list
110857191|NCT05262322|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110857192|NCT05262322|Antithrombins|antithrombins|mesh-ancestor
110857193|NCT05262322|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110857194|NCT05262322|Protease Inhibitors|protease inhibitors|mesh-ancestor
110857195|NCT05262322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110857196|NCT05262322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110857197|NCT05262322|Anticoagulants|anticoagulants|mesh-ancestor
110857198|NCT04490980|Butorphanol|butorphanol|mesh-list
110857199|NCT04490980|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110857200|NCT04490980|Narcotics|narcotics|mesh-ancestor
110857201|NCT04490980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110857202|NCT04490980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110857203|NCT04490980|Analgesics|analgesics|mesh-ancestor
110857204|NCT04490980|Sensory System Agents|sensory system agents|mesh-ancestor
110857205|NCT04490980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110857206|NCT04490980|Antitussive Agents|antitussive agents|mesh-ancestor
110857207|NCT04490980|Respiratory System Agents|respiratory system agents|mesh-ancestor
110857208|NCT04490980|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110857209|NCT03307720|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
110857210|NCT03307720|Hormones|hormones|mesh-list
110857211|NCT03307720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110857212|NCT03307720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110857213|NCT03307720|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110857214|NCT04608786|Capecitabine|capecitabine|mesh-list
110857215|NCT04608786|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110338332|NCT00521430|Hormones|hormones|mesh-ancestor
110857216|NCT04608786|Antimetabolites|antimetabolites|mesh-ancestor
110857217|NCT04608786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110857218|NCT04608786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110857219|NCT01314872|Tolterodine Tartrate|tolterodine tartrate|mesh-list
110857220|NCT01314872|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110857221|NCT01314872|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110857222|NCT01314872|Cholinergic Agents|cholinergic agents|mesh-ancestor
110857223|NCT01314872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110857224|NCT01314872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110857225|NCT01314872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110857226|NCT01314872|Urological Agents|urological agents|mesh-ancestor
110857227|NCT01343628|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
110134433|NCT01990755|Serotonin Agents|serotonin agents|mesh-ancestor
110857228|NCT01343628|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110857229|NCT01343628|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110857230|NCT01343628|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110857231|NCT01343628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110857232|NCT01343628|Adrenergic Agents|adrenergic agents|mesh-ancestor
110090576|NCT03082534|Pembrolizumab|pembrolizumab|mesh-list
110857233|NCT01343628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110857234|NCT01343628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110857235|NCT00703924|Paromomycin|paromomycin|mesh-list
110857236|NCT00703924|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110857237|NCT00703924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110857238|NCT00703924|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110857239|NCT00703924|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110857240|NCT03302650|Norepinephrine|norepinephrine|mesh-list
110857241|NCT03302650|Angiotensin II|angiotensin ii|mesh-list
110857243|NCT03302650|Angiotensinogen|angiotensinogen|mesh-list
110857244|NCT03302650|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110857245|NCT03302650|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110857246|NCT03302650|Adrenergic Agents|adrenergic agents|mesh-ancestor
110857247|NCT03302650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110857248|NCT03302650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110857249|NCT03302650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110857250|NCT03302650|Sympathomimetics|sympathomimetics|mesh-ancestor
110857251|NCT03302650|Autonomic Agents|autonomic agents|mesh-ancestor
110857252|NCT03302650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110857253|NCT03302650|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110857254|NCT03302650|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110857255|NCT03302650|Protease Inhibitors|protease inhibitors|mesh-ancestor
110857256|NCT03302650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110857257|NCT01343706|BI 409306|bi 409306|mesh-list
110857258|NCT01343706|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110857259|NCT01343706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110857260|NCT01343706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110857261|NCT03312478|Antibodies|antibodies|mesh-list
110857262|NCT03312478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110857263|NCT03312478|Immunologic Factors|immunologic factors|mesh-ancestor
110857264|NCT03312244|Bromides|bromides|mesh-list
110857265|NCT03312244|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
110857266|NCT03312244|Anticonvulsants|anticonvulsants|mesh-ancestor
110857267|NCT03312244|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110857268|NCT03312244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110857269|NCT03312244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110857270|NCT03312244|Cholinergic Agents|cholinergic agents|mesh-ancestor
110134564|NCT01991288|Mydriatics|mydriatics|mesh-ancestor
110857271|NCT03312244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110857272|NCT03312244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110857274|NCT03306940|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110857275|NCT03306940|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110857276|NCT03306940|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110857277|NCT03306940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110857278|NCT03306940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110857279|NCT03306940|Cholinergic Agents|cholinergic agents|mesh-ancestor
110857280|NCT03306940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110857281|NCT03306940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110857282|NCT03306940|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110857283|NCT03306940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110857284|NCT00739050|Simvastatin|simvastatin|mesh-list
110857285|NCT00739050|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110857286|NCT00739050|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110857287|NCT00739050|Antimetabolites|antimetabolites|mesh-ancestor
110857288|NCT00739050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110857289|NCT00739050|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110857290|NCT00739050|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110857291|NCT00739050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110857292|NCT03302182|Ritonavir|ritonavir|mesh-list
110857293|NCT03302182|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110857294|NCT03302182|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110857295|NCT03302182|Protease Inhibitors|protease inhibitors|mesh-ancestor
110857296|NCT03302182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110857297|NCT03302182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110857298|NCT03302182|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110857299|NCT03302182|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110857300|NCT03302182|Antiviral Agents|antiviral agents|mesh-ancestor
110857301|NCT03302182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110857302|NCT03302182|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110857303|NCT03302182|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110857304|NCT01343862|Cycloserine|cycloserine|mesh-list
110857305|NCT01343862|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110857306|NCT01343862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110857307|NCT01343862|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110857308|NCT01343862|Antitubercular Agents|antitubercular agents|mesh-ancestor
110857309|NCT01343862|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110857310|NCT01343862|Antimetabolites|antimetabolites|mesh-ancestor
110857311|NCT01343862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110857312|NCT03311932|Hydrocortisone|hydrocortisone|mesh-list
110857313|NCT03311932|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110857314|NCT00604812|Rizatriptan|rizatriptan|mesh-list
110857315|NCT00604812|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110857316|NCT00604812|Serotonin Agents|serotonin agents|mesh-ancestor
110857317|NCT00604812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110857318|NCT00604812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110857319|NCT00604812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110857320|NCT04347408|Antibodies|antibodies|mesh-list
110338388|NCT02948283|Metformin|metformin|mesh-list
110857321|NCT04347408|Immunologic Factors|immunologic factors|mesh-ancestor
110857322|NCT04347408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110857323|NCT03306550|Aspirin|aspirin|mesh-list
110857324|NCT03306550|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110857325|NCT03306550|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110857326|NCT03306550|Analgesics|analgesics|mesh-ancestor
110857327|NCT03306550|Sensory System Agents|sensory system agents|mesh-ancestor
110857328|NCT03306550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110857329|NCT03306550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110857330|NCT03306550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110857331|NCT03306550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110857332|NCT03306550|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110857333|NCT03306550|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110857334|NCT03306550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110857335|NCT03306550|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110857336|NCT03306550|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110857337|NCT03306550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110857338|NCT03306550|Antipyretics|antipyretics|mesh-ancestor
110857339|NCT03306472|Letrozole|letrozole|mesh-list
110857340|NCT03306472|Megestrol|megestrol|mesh-list
110857341|NCT03306472|Megestrol Acetate|megestrol acetate|mesh-list
110857342|NCT03306472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110857343|NCT03306472|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110857344|NCT03306472|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110857345|NCT03306472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110857346|NCT03306472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110857347|NCT03306472|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110857348|NCT03306472|Hormone Antagonists|hormone antagonists|mesh-ancestor
110857349|NCT03306472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110857350|NCT03306472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110857351|NCT03306472|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110857352|NCT03306472|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110857353|NCT03306472|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110857354|NCT03306472|Contraceptive Agents|contraceptive agents|mesh-ancestor
110857355|NCT03306472|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110857356|NCT03306472|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110857357|NCT03306472|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110857358|NCT03306472|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110857359|NCT03306472|Appetite Stimulants|appetite stimulants|mesh-ancestor
110134819|NCT01993472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110857360|NCT03306472|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110857361|NCT03311542|Pembrolizumab|pembrolizumab|mesh-list
110857362|NCT03311542|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110857363|NCT03311542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110857364|NCT03311542|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110857365|NCT03311542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110857366|NCT03311464|Adalimumab|adalimumab|mesh-list
110857367|NCT03311464|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110857368|NCT03311464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110857369|NCT03311464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110857370|NCT05214066|Thymoglobulin|thymoglobulin|mesh-list
110857371|NCT05214066|Immunologic Factors|immunologic factors|mesh-ancestor
110857372|NCT05214066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110857373|NCT05214066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110857374|NCT02468206|Polidocanol|polidocanol|mesh-list
110857375|NCT02468206|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
110857376|NCT02468206|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110857377|NCT01344174|Lamivudine|lamivudine|mesh-list
110857378|NCT01344174|Dexamethasone|dexamethasone|mesh-list
110857379|NCT01344174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110857380|NCT01344174|Antiemetics|antiemetics|mesh-ancestor
110857381|NCT01344174|Autonomic Agents|autonomic agents|mesh-ancestor
110134951|NCT01994759|Methylprednisolone|methylprednisolone|mesh-list
110857382|NCT01344174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110857383|NCT01344174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110857384|NCT01344174|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110857386|NCT01344174|Hormones|hormones|mesh-ancestor
110857387|NCT01344174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110857388|NCT01344174|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110857389|NCT01344174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110135014|NCT01995019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110135016|NCT01995019|Hormones|hormones|mesh-ancestor
110857390|NCT01344174|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110857391|NCT01344174|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110857392|NCT01344174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110857393|NCT01344174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110857394|NCT01344174|Antiviral Agents|antiviral agents|mesh-ancestor
110857395|NCT01344174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110857396|NCT01344174|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110857397|NCT01344174|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110857399|NCT05162274|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110857400|NCT05162274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110857401|NCT05162274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110857402|NCT03023566|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
110857403|NCT03023566|Chelating Agents|chelating agents|mesh-ancestor
110857404|NCT03023566|Sequestering Agents|sequestering agents|mesh-ancestor
110857405|NCT03023566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110857406|NCT03311386|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
110857407|NCT03311386|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110857408|NCT03311386|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110857409|NCT03311386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110857410|NCT02468908|Molgramostim|molgramostim|mesh-list
110857411|NCT02468908|Sargramostim|sargramostim|mesh-list
110857412|NCT02468908|Immunologic Factors|immunologic factors|mesh-ancestor
110857413|NCT02468908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110857414|NCT02468908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110857415|NCT02468128|Nalbuphine|nalbuphine|mesh-list
110857416|NCT02468128|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110857417|NCT02468128|Narcotics|narcotics|mesh-ancestor
110857418|NCT02468128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110857419|NCT02468128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110857420|NCT02468128|Analgesics|analgesics|mesh-ancestor
110857421|NCT02468128|Sensory System Agents|sensory system agents|mesh-ancestor
110857422|NCT02468128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110857423|NCT03305536|Vitamin D|vitamin d|mesh-list
110857424|NCT03305536|Vitamins|vitamins|mesh-list
110857425|NCT03305536|Vitamin K|vitamin k|mesh-list
110857426|NCT03305536|Vitamin K 2|vitamin k 2|mesh-list
110857427|NCT03305536|Menaquinone 7|menaquinone 7|mesh-list
110857428|NCT03305536|Micronutrients|micronutrients|mesh-ancestor
110857429|NCT03305536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110857430|NCT03305536|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110857431|NCT03305536|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110857432|NCT03305536|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110857433|NCT03305536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110857434|NCT03305536|Hemostatics|hemostatics|mesh-ancestor
110857435|NCT03305536|Coagulants|coagulants|mesh-ancestor
110857436|NCT02467426|Mitoxantrone|mitoxantrone|mesh-list
110857437|NCT02467426|Analgesics|analgesics|mesh-ancestor
110857438|NCT02467426|Sensory System Agents|sensory system agents|mesh-ancestor
110857439|NCT02467426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110857440|NCT02467426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110857441|NCT02467426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110857442|NCT02467426|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110857443|NCT02467426|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110857444|NCT02467426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110135187|NCT01996306|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110857445|NCT02467426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110857446|NCT04296942|Trastuzumab|trastuzumab|mesh-list
110857447|NCT04296942|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
110857448|NCT04296942|Maytansine|maytansine|mesh-list
110857449|NCT04296942|Entinostat|entinostat|mesh-list
110857450|NCT04296942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110857451|NCT04296942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110857452|NCT04296942|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110857453|NCT04296942|Tubulin Modulators|tubulin modulators|mesh-ancestor
110857454|NCT04296942|Antimitotic Agents|antimitotic agents|mesh-ancestor
110857455|NCT04296942|Mitosis Modulators|mitosis modulators|mesh-ancestor
110857456|NCT04296942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110857457|NCT04296942|Immunotoxins|immunotoxins|mesh-ancestor
110857458|NCT04296942|Immunoconjugates|immunoconjugates|mesh-ancestor
110857459|NCT04296942|Immunologic Factors|immunologic factors|mesh-ancestor
110857460|NCT04296942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110857461|NCT04296942|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110857462|NCT04296942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110857463|NCT01344564|Leuprolide|leuprolide|mesh-list
110857464|NCT01344564|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110857465|NCT01344564|Fertility Agents|fertility agents|mesh-ancestor
110857466|NCT01344564|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110857467|NCT01344564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110857468|NCT01344564|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110857469|NCT01344564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110857470|NCT01344720|Etoricoxib|etoricoxib|mesh-list
110857471|NCT01344720|Oxycodone|oxycodone|mesh-list
110857472|NCT01344720|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110857473|NCT01344720|Narcotics|narcotics|mesh-ancestor
110857474|NCT01344720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110857475|NCT01344720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110857476|NCT01344720|Analgesics|analgesics|mesh-ancestor
110857477|NCT01344720|Sensory System Agents|sensory system agents|mesh-ancestor
110857478|NCT01344720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110857479|NCT01344720|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110857480|NCT01344720|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110857481|NCT01344720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110857482|NCT01344720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110857483|NCT01344720|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110857484|NCT01344720|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110857485|NCT01344720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110857486|NCT01344720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110857487|NCT03220854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110857489|NCT03220854|Immunoglobulins|immunoglobulins|mesh-list
110833675|NCT03815461|Paclitaxel|paclitaxel|mesh-list
110857491|NCT03220854|Immunologic Factors|immunologic factors|mesh-ancestor
110857492|NCT03220854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110857493|NCT03220854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110857494|NCT03305068|Celecoxib|celecoxib|mesh-list
110857495|NCT03305068|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110857496|NCT03305068|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110857497|NCT03305068|Analgesics|analgesics|mesh-ancestor
110338436|NCT04693962|Mitogens|mitogens|mesh-list
110857498|NCT03305068|Sensory System Agents|sensory system agents|mesh-ancestor
110857499|NCT03305068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110857500|NCT03305068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110857501|NCT03305068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110857502|NCT03305068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110857503|NCT03305068|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110857504|NCT03305068|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110857505|NCT03305068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110857506|NCT03305068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110857507|NCT04490590|Etoposide|etoposide|mesh-list
110857508|NCT04490590|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110857509|NCT04490590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110857510|NCT04490590|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110857511|NCT04490590|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110857512|NCT04490590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110857513|NCT04490590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110857514|NCT03299998|Anesthetics|anesthetics|mesh-list
110857515|NCT03299998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110857516|NCT03299998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110857517|NCT03299842|Fenfluramine|fenfluramine|mesh-list
110135300|NCT01996618|Ranolazine|ranolazine|mesh-list
110857518|NCT03299842|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110857519|NCT03299842|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110857520|NCT03299842|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110857521|NCT03299842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110857522|NCT03299842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110857523|NCT03299842|Serotonin Agents|serotonin agents|mesh-ancestor
110857524|NCT03299842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110857525|NCT02720536|Deferasirox|deferasirox|mesh-list
110857526|NCT02720536|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110857527|NCT02720536|Chelating Agents|chelating agents|mesh-ancestor
110857528|NCT02720536|Sequestering Agents|sequestering agents|mesh-ancestor
110857529|NCT02720536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110857530|NCT03168438|Cyclophosphamide|cyclophosphamide|mesh-list
110857531|NCT03168438|Pembrolizumab|pembrolizumab|mesh-list
110857532|NCT03168438|Fludarabine|fludarabine|mesh-list
110857533|NCT03168438|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110857534|NCT03168438|Immunologic Factors|immunologic factors|mesh-ancestor
110857535|NCT03168438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110857536|NCT03168438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110857537|NCT03168438|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110857538|NCT03168438|Alkylating Agents|alkylating agents|mesh-ancestor
110857539|NCT03168438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110857540|NCT03168438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110857541|NCT03168438|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110857542|NCT03168438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110857543|NCT03168438|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110857545|NCT03299296|Rivaroxaban|rivaroxaban|mesh-list
110135332|NCT01997099|Diazepam|diazepam|mesh-list
110857546|NCT03299296|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110857548|NCT03299296|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110857549|NCT03299296|Protease Inhibitors|protease inhibitors|mesh-ancestor
110857550|NCT03299296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110857551|NCT03299296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110857552|NCT03299296|Anticoagulants|anticoagulants|mesh-ancestor
110857553|NCT03299296|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110857554|NCT03299296|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110857555|NCT03137784|Glycopyrrolate|glycopyrrolate|mesh-list
110857557|NCT03137784|Anticonvulsants|anticonvulsants|mesh-ancestor
110857558|NCT03137784|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110857559|NCT03137784|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110857560|NCT03137784|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110857561|NCT03137784|Cholinergic Agents|cholinergic agents|mesh-ancestor
110857562|NCT03137784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110857563|NCT03137784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110857564|NCT03137784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110857565|NCT01344954|Rivaroxaban|rivaroxaban|mesh-list
110857566|NCT01344954|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110857567|NCT01344954|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110857568|NCT01344954|Antithrombins|antithrombins|mesh-ancestor
110857569|NCT01344954|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110857570|NCT01344954|Protease Inhibitors|protease inhibitors|mesh-ancestor
110857571|NCT01344954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110857572|NCT01344954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110857573|NCT01344954|Anticoagulants|anticoagulants|mesh-ancestor
110857574|NCT01344954|Immunologic Factors|immunologic factors|mesh-ancestor
110857575|NCT01344954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110857576|NCT01347996|Interleukin-2|interleukin-2|mesh-list
110857577|NCT01347996|Histamine|histamine|mesh-list
110857578|NCT01347996|Histamine phosphate|histamine phosphate|mesh-list
110857579|NCT01347996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110857580|NCT01347996|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110857581|NCT01347996|Analgesics|analgesics|mesh-ancestor
110857582|NCT01347996|Sensory System Agents|sensory system agents|mesh-ancestor
110857583|NCT01347996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110857584|NCT01347996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110857585|NCT01347996|Histamine Agonists|histamine agonists|mesh-ancestor
110857586|NCT01347996|Histamine Agents|histamine agents|mesh-ancestor
110857587|NCT01347996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110857588|NCT01347996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110857589|NCT01352988|Dimethyl Fumarate|dimethyl fumarate|mesh-list
110857590|NCT01352988|Dermatologic Agents|dermatologic agents|mesh-ancestor
110857591|NCT01352988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110857592|NCT01352988|Immunologic Factors|immunologic factors|mesh-ancestor
110857593|NCT01352988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110857594|NCT02466802|Sildenafil Citrate|sildenafil citrate|mesh-list
110857595|NCT02466802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110857596|NCT02466802|Vasodilator Agents|vasodilator agents|mesh-ancestor
110857597|NCT02466802|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110857598|NCT02466802|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110857599|NCT02466802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110857600|NCT02466802|Urological Agents|urological agents|mesh-ancestor
110857602|NCT01348308|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110857603|NCT01348308|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110857604|NCT01348308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110857605|NCT01348308|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110857606|NCT01348308|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110857607|NCT01348308|Antiviral Agents|antiviral agents|mesh-ancestor
110857608|NCT01348308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110857609|NCT01348308|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
110857610|NCT04074174|Acetaminophen|acetaminophen|mesh-list
110857611|NCT04074174|Contraceptive Agents|contraceptive agents|mesh-list
110857612|NCT04074174|Contraceptives, Oral|contraceptives, oral|mesh-list
110857613|NCT04074174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110857614|NCT04074174|Analgesics|analgesics|mesh-ancestor
110857615|NCT04074174|Sensory System Agents|sensory system agents|mesh-ancestor
110857616|NCT04074174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110857617|NCT04074174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110857618|NCT04074174|Antipyretics|antipyretics|mesh-ancestor
110857619|NCT04074174|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110857620|NCT04074174|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110857621|NCT04752826|Pembrolizumab|pembrolizumab|mesh-list
110338454|NCT00521742|Glyburide|glyburide|mesh-list
110857622|NCT04752826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110857623|NCT04752826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110857624|NCT04752826|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110857625|NCT04752826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110857626|NCT03620292|Bevacizumab|bevacizumab|mesh-list
110857627|NCT03620292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110857628|NCT03620292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110857629|NCT03620292|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110857630|NCT03620292|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110857631|NCT03620292|Growth Substances|growth substances|mesh-ancestor
110857632|NCT03620292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110857633|NCT03620292|Growth Inhibitors|growth inhibitors|mesh-ancestor
110857634|NCT01353378|Dexmedetomidine|dexmedetomidine|mesh-list
110857635|NCT01353378|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110857636|NCT01353378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110857637|NCT01353378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110857638|NCT01353378|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110857639|NCT01353378|Analgesics|analgesics|mesh-ancestor
110857640|NCT01353378|Sensory System Agents|sensory system agents|mesh-ancestor
110857641|NCT01353378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110857642|NCT01353378|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110857643|NCT01353378|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110857644|NCT01353378|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110857645|NCT01353378|Adrenergic Agents|adrenergic agents|mesh-ancestor
110857646|NCT01353378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110857647|NCT01353378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110857648|NCT05245006|Antibodies|antibodies|mesh-list
110857649|NCT05245006|Immunoglobulins|immunoglobulins|mesh-list
110857650|NCT05245006|Immunologic Factors|immunologic factors|mesh-ancestor
110857651|NCT05245006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110857652|NCT01465334|Methylprednisolone|methylprednisolone|mesh-list
110857653|NCT01465334|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110857654|NCT01465334|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110857655|NCT01465334|Prednisolone|prednisolone|mesh-list
110857656|NCT01465334|Prednisolone acetate|prednisolone acetate|mesh-list
110857657|NCT01465334|Alemtuzumab|alemtuzumab|mesh-list
110857658|NCT01465334|Ofatumumab|ofatumumab|mesh-list
110857659|NCT01465334|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110857660|NCT01465334|Prednisolone phosphate|prednisolone phosphate|mesh-list
110857661|NCT01465334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110857662|NCT01465334|Antiemetics|antiemetics|mesh-ancestor
110857663|NCT01465334|Autonomic Agents|autonomic agents|mesh-ancestor
110857664|NCT01465334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110857665|NCT01465334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110857666|NCT01465334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110857667|NCT01465334|Glucocorticoids|glucocorticoids|mesh-ancestor
110857668|NCT01465334|Hormones|hormones|mesh-ancestor
110135673|NCT01999270|Growth Substances|growth substances|mesh-ancestor
110857669|NCT01465334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110857670|NCT01465334|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110857671|NCT01465334|Protective Agents|protective agents|mesh-ancestor
110857672|NCT01465334|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110857673|NCT01465334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110857674|NCT01465334|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110857676|NCT04019262|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110857677|NCT04019262|Alkylating Agents|alkylating agents|mesh-ancestor
110857678|NCT04019262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110857679|NCT04019262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110857680|NCT05549726|Cabotegravir|cabotegravir|mesh-list
110857681|NCT05549726|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110857682|NCT05549726|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110857683|NCT05549726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110857684|NCT05549726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110857685|NCT05549726|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110833709|NCT03813043|Anesthetics|anesthetics|mesh-ancestor
110857686|NCT05549726|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110857687|NCT05549726|Antiviral Agents|antiviral agents|mesh-ancestor
110857688|NCT05549726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110857689|NCT01353456|Dexmedetomidine|dexmedetomidine|mesh-list
110857690|NCT01353456|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110857691|NCT01353456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110857692|NCT01353456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110857693|NCT01353456|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110857694|NCT01353456|Analgesics|analgesics|mesh-ancestor
110857695|NCT01353456|Sensory System Agents|sensory system agents|mesh-ancestor
110857696|NCT01353456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110857697|NCT01353456|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110857698|NCT01353456|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110857699|NCT01353456|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110857700|NCT01353456|Adrenergic Agents|adrenergic agents|mesh-ancestor
110857701|NCT01353456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110857702|NCT01353456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110857703|NCT04289142|Dexmedetomidine|dexmedetomidine|mesh-list
110857704|NCT04289142|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110857705|NCT04289142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110857706|NCT04289142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110857707|NCT04289142|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110857708|NCT04289142|Analgesics|analgesics|mesh-ancestor
110857709|NCT04289142|Sensory System Agents|sensory system agents|mesh-ancestor
110857710|NCT04289142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110857711|NCT04289142|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110857712|NCT04289142|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110857713|NCT04289142|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110857715|NCT04289142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110857716|NCT04289142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110857717|NCT04948814|Vancomycin|vancomycin|mesh-list
110857718|NCT04948814|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110857719|NCT04948814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110857720|NCT02718898|Ixekizumab|ixekizumab|mesh-list
110857721|NCT02718898|Dermatologic Agents|dermatologic agents|mesh-ancestor
110857722|NCT05726734|Amoxicillin|amoxicillin|mesh-list
110857723|NCT05726734|Metronidazole|metronidazole|mesh-list
110857724|NCT05726734|Potassium Citrate|potassium citrate|mesh-list
110857725|NCT05726734|Esomeprazole|esomeprazole|mesh-list
110857726|NCT05726734|Bismuth|bismuth|mesh-list
110857727|NCT05726734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110857728|NCT05726734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110857729|NCT05726734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110857730|NCT05726734|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110857731|NCT05726734|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110857732|NCT05726734|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110857733|NCT05726734|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110857734|NCT05726734|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110857735|NCT05726734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110857737|NCT05726734|Diuretics|diuretics|mesh-ancestor
110857738|NCT05726734|Natriuretic Agents|natriuretic agents|mesh-ancestor
110857739|NCT05726734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110857740|NCT05726734|Expectorants|expectorants|mesh-ancestor
110857741|NCT05726734|Respiratory System Agents|respiratory system agents|mesh-ancestor
110857742|NCT01317966|Rituximab|rituximab|mesh-list
110857743|NCT01317966|Oprelvekin|oprelvekin|mesh-list
110857744|NCT01317966|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110857745|NCT01317966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110857746|NCT01317966|Immunologic Factors|immunologic factors|mesh-ancestor
110857747|NCT01317966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110857748|NCT01317966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110857749|NCT01345734|Liraglutide|liraglutide|mesh-list
110857750|NCT01345734|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110857751|NCT01345734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110857752|NCT01345734|Incretins|incretins|mesh-ancestor
110857753|NCT01345734|Hormones|hormones|mesh-ancestor
110857754|NCT01345734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110857755|NCT01318044|Thiopental|thiopental|mesh-list
110857756|NCT01318044|Propofol|propofol|mesh-list
110857757|NCT01318044|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110857758|NCT01318044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110857759|NCT01318044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110857760|NCT01318044|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110857761|NCT01318044|Anesthetics, General|anesthetics, general|mesh-ancestor
110857762|NCT01318044|Anesthetics|anesthetics|mesh-ancestor
110857763|NCT01318044|Anticonvulsants|anticonvulsants|mesh-ancestor
110857764|NCT01318044|GABA Modulators|gaba modulators|mesh-ancestor
110857765|NCT01318044|GABA Agents|gaba agents|mesh-ancestor
110857766|NCT01318044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110857767|NCT01318044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110857768|NCT01353846|Triptorelin Pamoate|triptorelin pamoate|mesh-list
110857769|NCT01353846|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110857770|NCT01353846|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110857771|NCT01353846|Estradiol|estradiol|mesh-list
110857772|NCT01353846|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110857773|NCT01353846|Progesterone|progesterone|mesh-list
110857774|NCT01353846|Estrogens|estrogens|mesh-ancestor
110857775|NCT01353846|Hormones|hormones|mesh-ancestor
110136020|NCT02001584|GABA Agents|gaba agents|mesh-ancestor
110857776|NCT01353846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110857777|NCT01353846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110857778|NCT01353846|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110857779|NCT01353846|Contraceptive Agents|contraceptive agents|mesh-ancestor
110857780|NCT01353846|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110857781|NCT01353846|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110857782|NCT01353846|Progestins|progestins|mesh-ancestor
110857783|NCT01353846|Luteolytic Agents|luteolytic agents|mesh-ancestor
110857784|NCT01353846|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110857785|NCT01353846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110857786|NCT01349010|Probucol|probucol|mesh-list
110857787|NCT01349010|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110857788|NCT01349010|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110857789|NCT01349010|Antimetabolites|antimetabolites|mesh-ancestor
110857790|NCT01349010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110857791|NCT01349010|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110857792|NCT01349010|Antioxidants|antioxidants|mesh-ancestor
110857793|NCT01349010|Protective Agents|protective agents|mesh-ancestor
110857794|NCT01349010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110857795|NCT05232370|Losartan|losartan|mesh-list
110857796|NCT05232370|Enalapril|enalapril|mesh-list
110857797|NCT05232370|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
110857798|NCT05232370|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
110857799|NCT05232370|Enzyme Inhibitors|enzyme inhibitors|mesh-list
110857800|NCT05232370|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110857801|NCT05232370|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110857802|NCT05232370|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110857803|NCT05232370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110857804|NCT05232370|Protease Inhibitors|protease inhibitors|mesh-ancestor
110857805|NCT01349088|Niacinamide|niacinamide|mesh-list
110857806|NCT01349088|Capecitabine|capecitabine|mesh-list
110857807|NCT01349088|Motesanib diphosphate|motesanib diphosphate|mesh-list
110857808|NCT01349088|Imetelstat|imetelstat|mesh-list
110857809|NCT01349088|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110857810|NCT01349088|Antimetabolites|antimetabolites|mesh-ancestor
110857811|NCT01349088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110857812|NCT01349088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110857813|NCT01349088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110857814|NCT01349088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110857815|NCT01349088|Vitamin B Complex|vitamin b complex|mesh-ancestor
110857816|NCT01349088|Vitamins|vitamins|mesh-ancestor
110857817|NCT01349088|Micronutrients|micronutrients|mesh-ancestor
110857818|NCT01349088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110857819|NCT04490434|Celecoxib|celecoxib|mesh-list
110857820|NCT04490434|Naproxen|naproxen|mesh-list
110857821|NCT04490434|Meloxicam|meloxicam|mesh-list
110857822|NCT04490434|Fexuprazan|fexuprazan|mesh-list
110833719|NCT03815305|Petrolatum|petrolatum|mesh-list
110857823|NCT04490434|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110857824|NCT04490434|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110857825|NCT04490434|Analgesics|analgesics|mesh-ancestor
110857826|NCT04490434|Sensory System Agents|sensory system agents|mesh-ancestor
110857827|NCT04490434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110338552|NCT00522132|Anthelmintics|anthelmintics|mesh-ancestor
110857828|NCT04490434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110857829|NCT04490434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110857830|NCT04490434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110857831|NCT04490434|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110857832|NCT04490434|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110857833|NCT04490434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110857834|NCT04490434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110857835|NCT04490434|Gout Suppressants|gout suppressants|mesh-ancestor
110857836|NCT04490434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110857837|NCT01353924|Aluminum sulfate|aluminum sulfate|mesh-list
110857838|NCT01353924|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110857840|NCT01353924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110857841|NCT03143166|Telmisartan|telmisartan|mesh-list
110857843|NCT03143166|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110857844|NCT03143166|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110857845|NCT03143166|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110857846|NCT03143166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110857847|NCT03143166|Antithrombins|antithrombins|mesh-ancestor
110857848|NCT03143166|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110857849|NCT03143166|Protease Inhibitors|protease inhibitors|mesh-ancestor
110857850|NCT03143166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110857851|NCT03143166|Anticoagulants|anticoagulants|mesh-ancestor
110857852|NCT02466568|Nivolumab|nivolumab|mesh-list
110857853|NCT02466568|Vaccines|vaccines|mesh-list
110857854|NCT02466568|Immunologic Factors|immunologic factors|mesh-ancestor
110857855|NCT02466568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110857856|NCT02466568|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110857857|NCT02466568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110857858|NCT02466568|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110857859|NCT02466568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110857860|NCT02879994|Pembrolizumab|pembrolizumab|mesh-list
110857861|NCT02879994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110857862|NCT02879994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110857863|NCT02879994|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110857864|NCT02879994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110857865|NCT02466022|Fentanyl|fentanyl|mesh-list
110857866|NCT02466022|Midazolam|midazolam|mesh-list
110857867|NCT02466022|Dexmedetomidine|dexmedetomidine|mesh-list
110857868|NCT02466022|Bupivacaine|bupivacaine|mesh-list
110857869|NCT02466022|Anesthetics, Local|anesthetics, local|mesh-ancestor
110857870|NCT02466022|Anesthetics|anesthetics|mesh-ancestor
110857871|NCT02466022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110857872|NCT02466022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110857873|NCT02466022|Sensory System Agents|sensory system agents|mesh-ancestor
110857874|NCT02466022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110857875|NCT02466022|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110857876|NCT02466022|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110857877|NCT02466022|Analgesics|analgesics|mesh-ancestor
110857878|NCT02466022|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110857879|NCT02466022|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110857880|NCT02466022|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110857881|NCT02466022|Adrenergic Agents|adrenergic agents|mesh-ancestor
110857882|NCT02466022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110857883|NCT02466022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110857884|NCT02466022|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110857885|NCT02466022|Narcotics|narcotics|mesh-ancestor
110857886|NCT02466022|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110857887|NCT02466022|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110857888|NCT02466022|Anesthetics, General|anesthetics, general|mesh-ancestor
110857889|NCT02466022|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110857890|NCT02466022|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110857891|NCT02466022|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110857892|NCT02466022|GABA Modulators|gaba modulators|mesh-ancestor
110857893|NCT02466022|GABA Agents|gaba agents|mesh-ancestor
110857894|NCT03937596|Cycloserine|cycloserine|mesh-list
110857895|NCT03937596|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110857896|NCT03937596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110857897|NCT03937596|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110857898|NCT03937596|Antitubercular Agents|antitubercular agents|mesh-ancestor
110857899|NCT03937596|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110857900|NCT03937596|Antimetabolites|antimetabolites|mesh-ancestor
110857901|NCT03937596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110857902|NCT03578172|Menotropins|menotropins|mesh-list
110857903|NCT03578172|Hormones|hormones|mesh-list
110857904|NCT03578172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110857905|NCT03578172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110857906|NCT03578172|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110857907|NCT03578172|Fertility Agents|fertility agents|mesh-ancestor
110857908|NCT03578172|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110857909|NCT03928158|Valsartan|valsartan|mesh-list
110857910|NCT03928158|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
110857911|NCT03928158|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110857912|NCT03928158|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110857913|NCT03928158|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110857914|NCT03928158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110857916|NCT05174884|Desogestrel|desogestrel|mesh-list
110857917|NCT05174884|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110857918|NCT05174884|Contraceptive Agents|contraceptive agents|mesh-ancestor
110857919|NCT05174884|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110857920|NCT05174884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110857921|NCT05174884|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110857922|NCT05174884|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110857923|NCT05174884|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110857924|NCT05174884|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110857925|NCT05174884|Progestins|progestins|mesh-ancestor
110857926|NCT05174884|Hormones|hormones|mesh-ancestor
110857927|NCT05174884|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110857928|NCT01354158|Droxidopa|droxidopa|mesh-list
110857929|NCT01354158|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110857930|NCT01354158|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110857931|NCT02466490|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110857932|NCT02466490|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110857933|NCT02466490|Diuretics|diuretics|mesh-ancestor
110857934|NCT02466490|Natriuretic Agents|natriuretic agents|mesh-ancestor
110857935|NCT02466490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110857936|NCT02466490|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110857937|NCT02466490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110136142|NCT02002195|Immunologic Factors|immunologic factors|mesh-ancestor
110857938|NCT02466490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110857939|NCT04547842|Dexamethasone|dexamethasone|mesh-list
110857940|NCT04547842|Mirtazapine|mirtazapine|mesh-list
110857941|NCT04547842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110857942|NCT04547842|Antiemetics|antiemetics|mesh-ancestor
110857943|NCT04547842|Autonomic Agents|autonomic agents|mesh-ancestor
110857944|NCT04547842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110857945|NCT04547842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110857946|NCT04547842|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110857947|NCT04547842|Glucocorticoids|glucocorticoids|mesh-ancestor
110857948|NCT04547842|Hormones|hormones|mesh-ancestor
110857949|NCT04547842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110857950|NCT04547842|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110857951|NCT04547842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110857952|NCT04547842|Antidepressive Agents|antidepressive agents|mesh-ancestor
110857953|NCT04547842|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110857954|NCT04547842|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110857955|NCT04547842|Histamine Antagonists|histamine antagonists|mesh-ancestor
110857956|NCT04547842|Histamine Agents|histamine agents|mesh-ancestor
110857957|NCT04547842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110833735|NCT01560091|Silodosin|silodosin|mesh-list
110857958|NCT04547842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110857959|NCT04547842|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110857960|NCT04547842|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110857961|NCT04547842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110136195|NCT02002377|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110857962|NCT04547842|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
110857963|NCT04547842|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110857964|NCT04547842|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110857965|NCT04547842|Adrenergic Agents|adrenergic agents|mesh-ancestor
110857966|NCT04547842|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110857967|NCT04547842|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110857968|NCT04547842|Serotonin Agents|serotonin agents|mesh-ancestor
110857969|NCT04547842|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110857970|NCT03142932|Carbon Monoxide|carbon monoxide|mesh-list
110857971|NCT03142932|Antimetabolites|antimetabolites|mesh-ancestor
110857972|NCT03142932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110857973|NCT03142932|Gasotransmitters|gasotransmitters|mesh-ancestor
110857974|NCT03142932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110857975|NCT03142932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110857976|NCT00702052|Everolimus|everolimus|mesh-list
110857977|NCT00702052|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110857978|NCT00702052|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110857979|NCT00702052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110857980|NCT00702052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110857981|NCT00702052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110857982|NCT00702052|Immunologic Factors|immunologic factors|mesh-ancestor
110857983|NCT00702052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110857984|NCT00702052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110857985|NCT01354470|Modafinil|modafinil|mesh-list
110857986|NCT01354470|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110857987|NCT01354470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110857988|NCT01354470|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
110857989|NCT01354470|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110857990|NCT01354470|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110857991|NCT01354470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110857992|NCT01349556|Tretinoin|tretinoin|mesh-list
110857993|NCT01349556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110857994|NCT01349556|Keratolytic Agents|keratolytic agents|mesh-ancestor
110857995|NCT01349556|Dermatologic Agents|dermatologic agents|mesh-ancestor
110857996|NCT01354704|Enoxaparin|enoxaparin|mesh-list
110857997|NCT01354704|Anticoagulants|anticoagulants|mesh-ancestor
110857998|NCT01354704|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110857999|NCT01354704|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110858000|NCT01354704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110858001|NCT01346670|Lovastatin|lovastatin|mesh-list
110858002|NCT01346670|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110858003|NCT01346670|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110858004|NCT01346670|Antimetabolites|antimetabolites|mesh-ancestor
110858005|NCT01346670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110858006|NCT01346670|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110136427|NCT02004197|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110858007|NCT01346670|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110858008|NCT01346670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110858010|NCT03136068|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110858011|NCT03136068|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110858012|NCT03136068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110858013|NCT03136068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110858014|NCT03136068|Protective Agents|protective agents|mesh-ancestor
110858015|NCT03136068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110858016|NCT01350024|Lidocaine|lidocaine|mesh-list
110858017|NCT01350024|Epinephrine|epinephrine|mesh-list
110858018|NCT01350024|Racepinephrine|racepinephrine|mesh-list
110858019|NCT01350024|Epinephryl borate|epinephryl borate|mesh-list
110858020|NCT01350024|Anesthetics, Local|anesthetics, local|mesh-ancestor
110858021|NCT01350024|Anesthetics|anesthetics|mesh-ancestor
110858022|NCT01350024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110858023|NCT01350024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110858024|NCT01350024|Sensory System Agents|sensory system agents|mesh-ancestor
110833743|NCT01560091|Urological Agents|urological agents|mesh-ancestor
110858025|NCT01350024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110858026|NCT01350024|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110858027|NCT01350024|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110858028|NCT01350024|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110858029|NCT01350024|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110858030|NCT01350024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110858031|NCT01350024|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110858032|NCT01350024|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110858033|NCT01350024|Adrenergic Agents|adrenergic agents|mesh-ancestor
110858034|NCT01350024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110136628|NCT02005718|Micronutrients|micronutrients|mesh-ancestor
110858035|NCT01350024|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110858036|NCT01350024|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110858037|NCT01350024|Autonomic Agents|autonomic agents|mesh-ancestor
110858038|NCT01350024|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110858039|NCT01350024|Respiratory System Agents|respiratory system agents|mesh-ancestor
110858041|NCT01350024|Sympathomimetics|sympathomimetics|mesh-ancestor
110858042|NCT01350024|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110858043|NCT01318590|Triamcinolone|triamcinolone|mesh-list
110858044|NCT01318590|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110858045|NCT01318590|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110858046|NCT01318590|Bupivacaine|bupivacaine|mesh-list
110858047|NCT01318590|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110858048|NCT01318590|Anesthetics, Local|anesthetics, local|mesh-ancestor
110858050|NCT01318590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110858051|NCT01318590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110858052|NCT01318590|Sensory System Agents|sensory system agents|mesh-ancestor
110858053|NCT01318590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110858054|NCT01318590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110858055|NCT01318590|Glucocorticoids|glucocorticoids|mesh-ancestor
110858056|NCT01318590|Hormones|hormones|mesh-ancestor
110136759|NCT05970679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110338620|NCT05148689|Phenylephrine|phenylephrine|mesh-list
110858057|NCT01318590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110858058|NCT01318590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110858059|NCT01318590|Immunologic Factors|immunologic factors|mesh-ancestor
110858060|NCT01318590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110858061|NCT01318590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110858062|NCT01346826|Infliximab|infliximab|mesh-list
110858063|NCT01346826|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110858064|NCT01346826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110858065|NCT01346826|Dermatologic Agents|dermatologic agents|mesh-ancestor
110858066|NCT01346826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110858067|NCT01346826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110858068|NCT01354860|Lobeline|lobeline|mesh-list
110858069|NCT01354860|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110858070|NCT01354860|Autonomic Agents|autonomic agents|mesh-ancestor
110136829|NCT05969847|Capecitabine|capecitabine|mesh-list
110858071|NCT01354860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110858072|NCT01354860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110858073|NCT01354860|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110858074|NCT01354860|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110858075|NCT01354860|Cholinergic Agents|cholinergic agents|mesh-ancestor
110858076|NCT01354860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110858077|NCT01354860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110858078|NCT01354860|Respiratory System Agents|respiratory system agents|mesh-ancestor
110858079|NCT02556606|Midazolam|midazolam|mesh-list
110858080|NCT02556606|Ketamine|ketamine|mesh-list
110858081|NCT02556606|Analgesics|analgesics|mesh-ancestor
110858082|NCT02556606|Sensory System Agents|sensory system agents|mesh-ancestor
110858083|NCT02556606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110858084|NCT02556606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110858085|NCT02556606|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110858086|NCT02556606|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110858087|NCT02556606|Anesthetics, General|anesthetics, general|mesh-ancestor
110858088|NCT02556606|Anesthetics|anesthetics|mesh-ancestor
110858089|NCT02556606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110858090|NCT02556606|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110858091|NCT02556606|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110858092|NCT02556606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110858093|NCT02556606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110858094|NCT02556606|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110858095|NCT02556606|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110858096|NCT02556606|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110858097|NCT02556606|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110858098|NCT02556606|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110858099|NCT02556606|GABA Modulators|gaba modulators|mesh-ancestor
110858100|NCT02556606|GABA Agents|gaba agents|mesh-ancestor
110858101|NCT01355562|Interleukin-2|interleukin-2|mesh-list
110858102|NCT01355562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110858103|NCT01355562|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110858104|NCT01355562|Analgesics|analgesics|mesh-ancestor
110858105|NCT01355562|Sensory System Agents|sensory system agents|mesh-ancestor
110858106|NCT01355562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110858107|NCT01355562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110858108|NCT01350570|Loperamide|loperamide|mesh-list
110858109|NCT01350570|Antidiarrheals|antidiarrheals|mesh-list
110858110|NCT01350570|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110858111|NCT01355718|Repaglinide|repaglinide|mesh-list
110858112|NCT01355718|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110858113|NCT01355718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110858114|NCT03377790|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110858115|NCT03377790|Cantharidin|cantharidin|mesh-list
110858116|NCT03377790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110858117|NCT03377790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110858118|NCT01347294|Bleomycin|bleomycin|mesh-list
110858119|NCT01347294|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110858120|NCT01347294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110858121|NCT02422368|Methylprednisolone|methylprednisolone|mesh-list
110858122|NCT02422368|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110858123|NCT02422368|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110858124|NCT02422368|Prednisolone|prednisolone|mesh-list
110858125|NCT02422368|Prednisolone acetate|prednisolone acetate|mesh-list
110858126|NCT02422368|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110858127|NCT02422368|Prednisolone phosphate|prednisolone phosphate|mesh-list
110858128|NCT02422368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110858129|NCT02422368|Antiemetics|antiemetics|mesh-ancestor
110858130|NCT02422368|Autonomic Agents|autonomic agents|mesh-ancestor
110858131|NCT02422368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110858132|NCT02422368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110858133|NCT02422368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110858134|NCT02422368|Glucocorticoids|glucocorticoids|mesh-ancestor
110858135|NCT02422368|Hormones|hormones|mesh-ancestor
110575696|NCT00654238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110858136|NCT02422368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110858137|NCT02422368|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110858138|NCT02422368|Protective Agents|protective agents|mesh-ancestor
110858139|NCT02422368|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110858140|NCT02422368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110858141|NCT01355952|Thioctic Acid|thioctic acid|mesh-list
110858142|NCT01355952|Antioxidants|antioxidants|mesh-ancestor
110858143|NCT01355952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110858144|NCT01355952|Protective Agents|protective agents|mesh-ancestor
110858145|NCT01355952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110858146|NCT01355952|Vitamin B Complex|vitamin b complex|mesh-ancestor
110858147|NCT01355952|Vitamins|vitamins|mesh-ancestor
110858148|NCT01355952|Micronutrients|micronutrients|mesh-ancestor
110858149|NCT05720572|Antazoline|antazoline|mesh-list
110858150|NCT05720572|Propafenone|propafenone|mesh-list
110858151|NCT05720572|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110858152|NCT05720572|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110858153|NCT05720572|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110858154|NCT05720572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110858155|NCT05720572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110858156|NCT05720572|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110858157|NCT05720572|Histamine Antagonists|histamine antagonists|mesh-ancestor
110858158|NCT05720572|Histamine Agents|histamine agents|mesh-ancestor
110858159|NCT05720572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110858160|NCT05720572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110858161|NCT05720572|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110858162|NCT05111002|Doxycycline|doxycycline|mesh-list
110858163|NCT05111002|Lefamulin|lefamulin|mesh-list
110858164|NCT05111002|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110858165|NCT05111002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110858166|NCT05111002|Antimalarials|antimalarials|mesh-ancestor
110858167|NCT05111002|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110858168|NCT05111002|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110858169|NCT01347684|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-list
110858170|NCT01347684|Antidepressive Agents|antidepressive agents|mesh-ancestor
110858171|NCT01347684|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110858172|NCT05716750|Vitamin D|vitamin d|mesh-list
110858173|NCT05716750|Vitamins|vitamins|mesh-ancestor
110858174|NCT05716750|Micronutrients|micronutrients|mesh-ancestor
110137446|NCT05687253|Bromides|bromides|mesh-list
110858175|NCT05716750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110858176|NCT05716750|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110858177|NCT01350882|Rituximab|rituximab|mesh-list
110858178|NCT01350882|Citric Acid|citric acid|mesh-list
110858179|NCT01350882|Sodium Citrate|sodium citrate|mesh-list
110858180|NCT01350882|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110858181|NCT01350882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110858182|NCT01350882|Immunologic Factors|immunologic factors|mesh-ancestor
110858183|NCT01350882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110858184|NCT01350882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110858185|NCT01350882|Anticoagulants|anticoagulants|mesh-ancestor
110137490|NCT05651594|Vitamin B Complex|vitamin b complex|mesh-ancestor
110137491|NCT05651594|Vitamins|vitamins|mesh-ancestor
110137492|NCT05651594|Micronutrients|micronutrients|mesh-ancestor
110137493|NCT05651594|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110137494|NCT05651594|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110137495|NCT05651594|Adrenergic Agents|adrenergic agents|mesh-ancestor
110137496|NCT05651594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110137497|NCT05651594|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110858186|NCT01350882|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110858187|NCT01350882|Chelating Agents|chelating agents|mesh-ancestor
110858188|NCT01350882|Sequestering Agents|sequestering agents|mesh-ancestor
110858189|NCT01350882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110858190|NCT01844856|Ertapenem|ertapenem|mesh-list
110858191|NCT01844856|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110858192|NCT01844856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110858193|NCT00618098|Thrombin|thrombin|mesh-list
110858194|NCT00618098|Hemostatics|hemostatics|mesh-ancestor
110858195|NCT00618098|Coagulants|coagulants|mesh-ancestor
110858196|NCT02464228|Tipifarnib|tipifarnib|mesh-list
110858197|NCT02464228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110858198|NCT01351038|Capecitabine|capecitabine|mesh-list
110858199|NCT01351038|Oxaliplatin|oxaliplatin|mesh-list
110858200|NCT01351038|Panitumumab|panitumumab|mesh-list
110858201|NCT01351038|Epirubicin|epirubicin|mesh-list
110858202|NCT01351038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110858203|NCT01351038|Antimetabolites|antimetabolites|mesh-ancestor
110137633|NCT05474560|Febuxostat|febuxostat|mesh-list
110858204|NCT01351038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110858205|NCT01351038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110858206|NCT01351038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110858207|NCT01351038|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110858208|NCT01351038|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110858209|NCT01351038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110858210|NCT01351038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110858212|NCT02464462|Cholecalciferol|cholecalciferol|mesh-list
110858213|NCT02464462|Calcium|calcium|mesh-list
110858214|NCT02464462|Vitamins|vitamins|mesh-ancestor
110858215|NCT02464462|Micronutrients|micronutrients|mesh-ancestor
110858216|NCT02464462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110858217|NCT02464462|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110858218|NCT02464462|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110858219|NCT04270864|Nivolumab|nivolumab|mesh-list
110858220|NCT04270864|Ipilimumab|ipilimumab|mesh-list
110858221|NCT04270864|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110858222|NCT04270864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110858223|NCT04270864|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110858224|NCT04270864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110858225|NCT01318668|Vaccines|vaccines|mesh-list
110858226|NCT01318668|Immunologic Factors|immunologic factors|mesh-ancestor
110858227|NCT01318668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110858228|NCT01351272|Methylphenidate|methylphenidate|mesh-list
110858229|NCT01351272|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110858230|NCT01351272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110858231|NCT01351272|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110137692|NCT05422066|Hormones|hormones|mesh-ancestor
110858232|NCT01351272|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110858233|NCT01351272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110858234|NCT01351272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110858236|NCT01351272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110858237|NCT01351428|Nifedipine|nifedipine|mesh-list
110858238|NCT01351428|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110858239|NCT01351428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110858240|NCT01351428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110858241|NCT01351428|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110858242|NCT01351428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110137808|NCT05268614|Cisplatin|cisplatin|mesh-list
110858243|NCT01351428|Vasodilator Agents|vasodilator agents|mesh-ancestor
110858244|NCT01351428|Tocolytic Agents|tocolytic agents|mesh-ancestor
110858245|NCT01351428|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110858246|NCT05006326|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
110858247|NCT05006326|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110858248|NCT05006326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110858249|NCT00701662|Immunoglobulins|immunoglobulins|mesh-list
110858250|NCT00701662|Immunologic Factors|immunologic factors|mesh-ancestor
110137902|NCT05077683|Rivaroxaban|rivaroxaban|mesh-list
110137903|NCT05077683|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110137904|NCT05077683|Antithrombins|antithrombins|mesh-ancestor
110137905|NCT05077683|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110137906|NCT05077683|Protease Inhibitors|protease inhibitors|mesh-ancestor
110137907|NCT05077683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110137908|NCT05077683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110137909|NCT05077683|Anticoagulants|anticoagulants|mesh-ancestor
110137910|NCT05076942|Cisplatin|cisplatin|mesh-list
110137911|NCT05076942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110137912|NCT05061368|Sildenafil Citrate|sildenafil citrate|mesh-list
110137913|NCT05061368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110137914|NCT05061368|Vasodilator Agents|vasodilator agents|mesh-ancestor
110137915|NCT05061368|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110137916|NCT05061368|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110137917|NCT05061368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110137918|NCT05061368|Urological Agents|urological agents|mesh-ancestor
110137919|NCT05022147|Dopamine|dopamine|mesh-list
110137920|NCT05022147|Dopamine Agonists|dopamine agonists|mesh-list
110137921|NCT05022147|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110137922|NCT05022147|Sympathomimetics|sympathomimetics|mesh-ancestor
110137923|NCT05022147|Autonomic Agents|autonomic agents|mesh-ancestor
110137924|NCT05022147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110137926|NCT05022147|Dopamine Agents|dopamine agents|mesh-ancestor
110858251|NCT00701662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110858252|NCT02464306|Fidaxomicin|fidaxomicin|mesh-list
110858253|NCT02464306|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110858254|NCT02464306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110858255|NCT01351818|Hormones|hormones|mesh-list
110858256|NCT01351818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110858257|NCT01351818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110858258|NCT02463994|Atezolizumab|atezolizumab|mesh-list
110858259|NCT02463994|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110858260|NCT02463994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110858261|NCT02463994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110858262|NCT02463994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110858263|NCT04235686|Amphetamine|amphetamine|mesh-list
110858264|NCT04235686|Dextroamphetamine|dextroamphetamine|mesh-list
110138091|NCT04870034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110138092|NCT04870034|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110138093|NCT04870034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110858265|NCT04235686|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110833764|NCT03351231|Nivolumab|nivolumab|mesh-list
110858266|NCT04235686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110858268|NCT04235686|Autonomic Agents|autonomic agents|mesh-ancestor
110858269|NCT04235686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110858271|NCT04235686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110858272|NCT04235686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110858273|NCT04235686|Adrenergic Agents|adrenergic agents|mesh-ancestor
110858274|NCT04235686|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110858275|NCT04235686|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110858276|NCT04235686|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110858277|NCT04235686|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110858279|NCT02079948|Vitamin B Complex|vitamin b complex|mesh-list
110858280|NCT02079948|Methotrexate|methotrexate|mesh-list
110858281|NCT02079948|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110858282|NCT02079948|Abortifacient Agents|abortifacient agents|mesh-ancestor
110858283|NCT02079948|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110858284|NCT02079948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110858285|NCT02079948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110575840|NCT02551276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110858286|NCT02079948|Antimetabolites|antimetabolites|mesh-ancestor
110858287|NCT02079948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110858288|NCT02079948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110858289|NCT02079948|Dermatologic Agents|dermatologic agents|mesh-ancestor
110858290|NCT02079948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110858291|NCT02079948|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110858292|NCT02079948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110858293|NCT02079948|Immunologic Factors|immunologic factors|mesh-ancestor
110858294|NCT02079948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110858295|NCT02079948|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110858296|NCT02079948|Hematinics|hematinics|mesh-ancestor
110858297|NCT02079948|Vitamins|vitamins|mesh-ancestor
110858298|NCT02079948|Micronutrients|micronutrients|mesh-ancestor
110858299|NCT01357902|Lamotrigine|lamotrigine|mesh-list
110858300|NCT01357902|Anticonvulsants|anticonvulsants|mesh-ancestor
110858301|NCT01357902|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110858302|NCT01357902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110858303|NCT01357902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110858304|NCT01357902|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110858305|NCT01357902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110858306|NCT01357902|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110858307|NCT01357902|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110858308|NCT01357902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110858309|NCT01357902|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110858310|NCT01357902|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110858311|NCT04634409|Bamlanivimab|bamlanivimab|mesh-list
110858312|NCT04634409|Sotrovimab|sotrovimab|mesh-list
110858313|NCT04634409|Antiviral Agents|antiviral agents|mesh-ancestor
110858314|NCT04634409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110858315|NCT01352130|Ondansetron|ondansetron|mesh-list
110858317|NCT01352130|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-list
110858318|NCT01352130|Antiemetics|antiemetics|mesh-ancestor
110858319|NCT01352130|Autonomic Agents|autonomic agents|mesh-ancestor
110138725|NCT03994172|Vitamin D|vitamin d|mesh-list
110858320|NCT01352130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110858321|NCT01352130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110858322|NCT01352130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110858323|NCT01352130|Antipruritics|antipruritics|mesh-ancestor
110858324|NCT01352130|Dermatologic Agents|dermatologic agents|mesh-ancestor
110858325|NCT01352130|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110858326|NCT01352130|Serotonin Agents|serotonin agents|mesh-ancestor
110858327|NCT01352130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110858328|NCT01352130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110858329|NCT05605834|Hydrogen Peroxide|hydrogen peroxide|mesh-list
110858330|NCT05605834|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110858331|NCT05605834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110138810|NCT03948867|Hydroxyurea|hydroxyurea|mesh-list
110858334|NCT00005780|Doxorubicin|doxorubicin|mesh-list
110858335|NCT00005780|Etoposide|etoposide|mesh-list
110858336|NCT00005780|Vincristine|vincristine|mesh-list
110858337|NCT00005780|Sargramostim|sargramostim|mesh-list
110858338|NCT00005780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110858339|NCT00005780|Immunologic Factors|immunologic factors|mesh-ancestor
110858340|NCT00005780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110858341|NCT00005780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110858342|NCT00005780|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110858343|NCT00005780|Alkylating Agents|alkylating agents|mesh-ancestor
110858344|NCT00005780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110858345|NCT00005780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110858346|NCT00005780|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110858347|NCT00005780|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110138890|NCT03859024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110138891|NCT03859024|Sensory System Agents|sensory system agents|mesh-ancestor
110138892|NCT03859024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110138893|NCT03859024|Analgesics|analgesics|mesh-ancestor
110138894|NCT03859024|Antipyretics|antipyretics|mesh-ancestor
110138895|NCT03859024|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110858348|NCT00005780|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110858349|NCT00005780|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110858350|NCT00005780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110858351|NCT00005780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110858352|NCT00005780|Glucocorticoids|glucocorticoids|mesh-ancestor
110858353|NCT00005780|Hormones|hormones|mesh-ancestor
110858354|NCT00005780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110858355|NCT00005780|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110858356|NCT00005780|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110858357|NCT00005780|Tubulin Modulators|tubulin modulators|mesh-ancestor
110858358|NCT00005780|Antimitotic Agents|antimitotic agents|mesh-ancestor
110858359|NCT00005780|Mitosis Modulators|mitosis modulators|mesh-ancestor
110858360|NCT01356732|Sufentanil|sufentanil|mesh-list
110858361|NCT01356732|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110858362|NCT01356732|Narcotics|narcotics|mesh-ancestor
110858363|NCT01356732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110858364|NCT01356732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110858365|NCT01356732|Analgesics|analgesics|mesh-ancestor
110858366|NCT01356732|Sensory System Agents|sensory system agents|mesh-ancestor
110858367|NCT01356732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110858368|NCT01356732|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110858369|NCT01356732|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110858370|NCT01356732|Anesthetics, General|anesthetics, general|mesh-ancestor
110858371|NCT01356732|Anesthetics|anesthetics|mesh-ancestor
110858372|NCT02463682|Insulin|insulin|mesh-list
110858373|NCT02463682|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110858374|NCT02463682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110858375|NCT01978938|Levofloxacin|levofloxacin|mesh-list
110858376|NCT01978938|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110858377|NCT01978938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110858378|NCT01978938|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110858379|NCT01978938|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110858380|NCT01978938|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110858381|NCT01978938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110858382|NCT01978938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110858383|NCT01978938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110858384|NCT01978938|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110858385|NCT01978938|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110858386|NCT02465320|Lidocaine|lidocaine|mesh-list
110858387|NCT02465320|Anesthetics, Local|anesthetics, local|mesh-ancestor
110858388|NCT02465320|Anesthetics|anesthetics|mesh-ancestor
110858389|NCT02465320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110858390|NCT02465320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110858391|NCT02465320|Sensory System Agents|sensory system agents|mesh-ancestor
110858392|NCT02465320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110858393|NCT02465320|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110858394|NCT02465320|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110858395|NCT02465320|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110858396|NCT02465320|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110139087|NCT03377023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110858397|NCT02465320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110858399|NCT02465008|Anesthetics, Local|anesthetics, local|mesh-ancestor
110858401|NCT02465008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110858402|NCT02465008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110858403|NCT02465008|Sensory System Agents|sensory system agents|mesh-ancestor
110858404|NCT02465008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110858405|NCT03228186|Docetaxel|docetaxel|mesh-list
110858406|NCT03228186|Pevonedistat|pevonedistat|mesh-list
110858407|NCT03228186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110858408|NCT03228186|Tubulin Modulators|tubulin modulators|mesh-ancestor
110858409|NCT03228186|Antimitotic Agents|antimitotic agents|mesh-ancestor
110858410|NCT03228186|Mitosis Modulators|mitosis modulators|mesh-ancestor
110858411|NCT03228186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110858412|NCT03228186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110858414|NCT04105114|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110858415|NCT04105114|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110858416|NCT04105114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110858417|NCT04105114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110858418|NCT04105114|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110858419|NCT04105114|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110858420|NCT04105114|Serotonin Agents|serotonin agents|mesh-ancestor
110858421|NCT04105114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110858422|NCT04105114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110858423|NCT05573230|Cyclosporine|cyclosporine|mesh-list
110858424|NCT05573230|Midazolam|midazolam|mesh-list
110858425|NCT05573230|Cyclosporins|cyclosporins|mesh-list
110858426|NCT05573230|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110858427|NCT05573230|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110858428|NCT05573230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110858429|NCT05573230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110858430|NCT05573230|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110858431|NCT05573230|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110858432|NCT05573230|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110858433|NCT05573230|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110858434|NCT05573230|Anesthetics, General|anesthetics, general|mesh-ancestor
110858435|NCT05573230|Anesthetics|anesthetics|mesh-ancestor
110858436|NCT05573230|GABA Modulators|gaba modulators|mesh-ancestor
110575991|NCT00647296|Dopamine Agents|dopamine agents|mesh-ancestor
110858438|NCT05573230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110858439|NCT05573230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110858440|NCT05573230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110139198|NCT02960659|Metformin|metformin|mesh-list
110858441|NCT05573230|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110858442|NCT05573230|Immunologic Factors|immunologic factors|mesh-ancestor
110858443|NCT05573230|Antifungal Agents|antifungal agents|mesh-ancestor
110858444|NCT05573230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110858445|NCT05573230|Dermatologic Agents|dermatologic agents|mesh-ancestor
110858446|NCT05573230|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110858447|NCT05573230|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110858448|NCT05550142|Vaccines|vaccines|mesh-list
110858449|NCT05550142|Immunologic Factors|immunologic factors|mesh-ancestor
110858450|NCT05550142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110858451|NCT00116142|Ascorbic Acid|ascorbic acid|mesh-list
110858452|NCT00116142|Docetaxel|docetaxel|mesh-list
110858453|NCT00116142|Methyltestosterone|methyltestosterone|mesh-list
110858454|NCT00116142|Androgens|androgens|mesh-list
110858455|NCT00116142|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
110858456|NCT00116142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110858457|NCT00116142|Tubulin Modulators|tubulin modulators|mesh-ancestor
110858458|NCT00116142|Antimitotic Agents|antimitotic agents|mesh-ancestor
110858459|NCT00116142|Mitosis Modulators|mitosis modulators|mesh-ancestor
110139248|NCT02913196|Docetaxel|docetaxel|mesh-list
110858460|NCT00116142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110858461|NCT00116142|Hormones|hormones|mesh-ancestor
110858462|NCT00116142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110858463|NCT00116142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110858464|NCT00116142|Antioxidants|antioxidants|mesh-ancestor
110858465|NCT00116142|Protective Agents|protective agents|mesh-ancestor
110858466|NCT00116142|Vitamins|vitamins|mesh-ancestor
110858467|NCT00116142|Micronutrients|micronutrients|mesh-ancestor
110858468|NCT00116142|Estrogens|estrogens|mesh-ancestor
110858469|NCT00116142|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110858470|NCT00116142|Anabolic Agents|anabolic agents|mesh-ancestor
110858471|NCT05547256|Vaccines|vaccines|mesh-list
110858472|NCT05547256|Immunologic Factors|immunologic factors|mesh-ancestor
110858473|NCT05547256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110858474|NCT01757782|Sildenafil Citrate|sildenafil citrate|mesh-list
110858475|NCT01757782|Vasodilator Agents|vasodilator agents|mesh-ancestor
110858476|NCT01757782|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110858477|NCT01757782|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110858478|NCT01757782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110858479|NCT01757782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110858480|NCT01757782|Urological Agents|urological agents|mesh-ancestor
110858481|NCT02023905|Everolimus|everolimus|mesh-list
110858482|NCT02023905|Temozolomide|temozolomide|mesh-list
110858483|NCT02023905|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110858484|NCT02023905|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110858485|NCT02023905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110858486|NCT02023905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110858487|NCT02023905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110858488|NCT02023905|Immunologic Factors|immunologic factors|mesh-ancestor
110858489|NCT02023905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110858490|NCT02023905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110858491|NCT02023905|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110858492|NCT02023905|Alkylating Agents|alkylating agents|mesh-ancestor
110858493|NCT01330563|Ketoconazole|ketoconazole|mesh-list
110858494|NCT01330563|Antifungal Agents|antifungal agents|mesh-ancestor
110858495|NCT01330563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110858496|NCT01330563|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110858497|NCT01330563|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110139438|NCT02253316|Ixazomib|ixazomib|mesh-list
110858499|NCT01330563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110858500|NCT01330563|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110858501|NCT01330563|Hormone Antagonists|hormone antagonists|mesh-ancestor
110858502|NCT01330563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110858503|NCT01330563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110858504|NCT01330563|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110858505|NCT01991379|Imatinib Mesylate|imatinib mesylate|mesh-list
110858506|NCT01991379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110858507|NCT01991379|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110858508|NCT01991379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110858509|NCT01991379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110858510|NCT02875080|Brexpiprazole|brexpiprazole|mesh-list
110858511|NCT02875080|Serotonin Agents|serotonin agents|mesh-ancestor
110858512|NCT02875080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110858513|NCT02875080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110858514|NCT02875080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110858515|NCT02875080|Dopamine Agonists|dopamine agonists|mesh-ancestor
110858516|NCT02875080|Dopamine Agents|dopamine agents|mesh-ancestor
110858517|NCT04897503|Riboflavin|riboflavin|mesh-list
110858518|NCT04897503|Vitamin B Complex|vitamin b complex|mesh-ancestor
110858519|NCT04897503|Vitamins|vitamins|mesh-ancestor
110858520|NCT04897503|Micronutrients|micronutrients|mesh-ancestor
110858521|NCT04897503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110858522|NCT04897503|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110858523|NCT04897503|Dermatologic Agents|dermatologic agents|mesh-ancestor
110858524|NCT01333917|Curcumin|curcumin|mesh-list
110858525|NCT01333917|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110858526|NCT01333917|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110858527|NCT01333917|Analgesics|analgesics|mesh-ancestor
110858528|NCT01333917|Sensory System Agents|sensory system agents|mesh-ancestor
110858529|NCT01333917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110858530|NCT01333917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110858531|NCT01333917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110858532|NCT01333917|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110858533|NCT01333917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110858534|NCT01333917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110858535|NCT01333917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110858536|NCT03129360|Levetiracetam|levetiracetam|mesh-list
110858537|NCT03129360|Anticonvulsants|anticonvulsants|mesh-ancestor
110858538|NCT03129360|Nootropic Agents|nootropic agents|mesh-ancestor
110858539|NCT01315275|Ranibizumab|ranibizumab|mesh-list
110858540|NCT01315275|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110139492|NCT01886872|Rituximab|rituximab|mesh-list
110858541|NCT01315275|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110858542|NCT01315275|Growth Substances|growth substances|mesh-ancestor
110858543|NCT01315275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110858544|NCT01315275|Growth Inhibitors|growth inhibitors|mesh-ancestor
110858545|NCT01315275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110858546|NCT01319448|Artesunate|artesunate|mesh-list
110858547|NCT01319448|Pyrimethamine|pyrimethamine|mesh-list
110858548|NCT01319448|Sulfadoxine|sulfadoxine|mesh-list
110139520|NCT01856192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110858549|NCT01319448|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
110858551|NCT01319448|Mefloquine|mefloquine|mesh-list
110858552|NCT01319448|Proguanil|proguanil|mesh-list
110858553|NCT01319448|Antimalarials|antimalarials|mesh-ancestor
110858554|NCT01319448|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110858555|NCT01319448|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110858556|NCT01319448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110858557|NCT01319448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110858558|NCT01319448|Antiviral Agents|antiviral agents|mesh-ancestor
110858559|NCT01319448|Schistosomicides|schistosomicides|mesh-ancestor
110858560|NCT01319448|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110858561|NCT01319448|Anthelmintics|anthelmintics|mesh-ancestor
110858562|NCT01319448|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110858563|NCT01319448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110858564|NCT01319448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110858565|NCT01319448|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110858566|NCT01319448|Antimetabolites|antimetabolites|mesh-ancestor
110858567|NCT01334073|Everolimus|everolimus|mesh-list
110858568|NCT01334073|Axitinib|axitinib|mesh-list
110858569|NCT01334073|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110858570|NCT01334073|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110858571|NCT01334073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110858572|NCT01334073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110858573|NCT01334073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110858574|NCT01334073|Immunologic Factors|immunologic factors|mesh-ancestor
110858575|NCT01334073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110858576|NCT01334073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110858577|NCT01928199|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110858578|NCT01928199|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110858579|NCT01928199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110858580|NCT01928199|Incretins|incretins|mesh-ancestor
110858581|NCT01928199|Hormones|hormones|mesh-ancestor
110139782|NCT02007408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110858582|NCT01928199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110858583|NCT01928199|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110858585|NCT01928199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110858586|NCT01928199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110858587|NCT01845441|Fentanyl|fentanyl|mesh-list
110858588|NCT01845441|Midazolam|midazolam|mesh-list
110858589|NCT01845441|Dexmedetomidine|dexmedetomidine|mesh-list
110858590|NCT01845441|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110858591|NCT01845441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110858592|NCT01845441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110858593|NCT01845441|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110858594|NCT01845441|Analgesics|analgesics|mesh-ancestor
110858595|NCT01845441|Sensory System Agents|sensory system agents|mesh-ancestor
110858596|NCT01845441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110858597|NCT01845441|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110858598|NCT01845441|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110858599|NCT01845441|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110858600|NCT01845441|Adrenergic Agents|adrenergic agents|mesh-ancestor
110858601|NCT01845441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110858602|NCT01845441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110858603|NCT01845441|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110858604|NCT01845441|Narcotics|narcotics|mesh-ancestor
110858605|NCT01845441|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110858606|NCT01845441|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110858607|NCT01845441|Anesthetics, General|anesthetics, general|mesh-ancestor
110858608|NCT01845441|Anesthetics|anesthetics|mesh-ancestor
110858609|NCT01845441|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110858610|NCT01845441|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110858611|NCT01845441|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110858612|NCT01845441|GABA Modulators|gaba modulators|mesh-ancestor
110858613|NCT01845441|GABA Agents|gaba agents|mesh-ancestor
110858615|NCT03296488|Nalbuphine|nalbuphine|mesh-list
110858616|NCT03296488|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110858617|NCT03296488|Narcotics|narcotics|mesh-ancestor
110139992|NCT02008747|Anesthetics|anesthetics|mesh-ancestor
110858618|NCT03296488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110858619|NCT03296488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110858620|NCT03296488|Analgesics|analgesics|mesh-ancestor
110858621|NCT03296488|Sensory System Agents|sensory system agents|mesh-ancestor
110858622|NCT03296488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110858623|NCT03296488|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110858624|NCT03296488|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110858625|NCT03296488|Anesthetics, General|anesthetics, general|mesh-ancestor
110858626|NCT03296488|Anesthetics|anesthetics|mesh-ancestor
110858627|NCT01365936|Menotropins|menotropins|mesh-list
110858628|NCT01365936|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110858629|NCT01365936|Fertility Agents|fertility agents|mesh-ancestor
110858630|NCT01365936|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110858631|NCT01365936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110858632|NCT01334151|Insulin|insulin|mesh-list
110858633|NCT01334151|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110858634|NCT01334151|Insulin Lispro|insulin lispro|mesh-list
110858635|NCT01334151|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110858636|NCT01334151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110858637|NCT03296410|Vaccines|vaccines|mesh-list
110858638|NCT03296410|Immunologic Factors|immunologic factors|mesh-ancestor
110858639|NCT03296410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110858640|NCT05189184|Paclitaxel|paclitaxel|mesh-list
110858641|NCT05189184|Apatinib|apatinib|mesh-list
110858642|NCT05189184|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110858643|NCT05189184|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110858644|NCT05189184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110858645|NCT05189184|Tubulin Modulators|tubulin modulators|mesh-ancestor
110858646|NCT05189184|Antimitotic Agents|antimitotic agents|mesh-ancestor
110858647|NCT05189184|Mitosis Modulators|mitosis modulators|mesh-ancestor
110858648|NCT05189184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110858649|NCT05189184|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110858650|NCT05189184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110858651|NCT01362036|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
110858652|NCT01362036|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110858653|NCT01362036|Vasodilator Agents|vasodilator agents|mesh-ancestor
110858654|NCT01358916|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110858655|NCT01358916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110858656|NCT03735290|Pembrolizumab|pembrolizumab|mesh-list
110858657|NCT03735290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110858658|NCT03735290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110858659|NCT03735290|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110140172|NCT05777369|Hormones|hormones|mesh-ancestor
110858660|NCT03735290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110858662|NCT03619538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110576217|NCT00445003|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110858663|NCT03619538|Analgesics|analgesics|mesh-ancestor
110858664|NCT03619538|Sensory System Agents|sensory system agents|mesh-ancestor
110858665|NCT03619538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110858666|NCT03619538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110858667|NCT03296098|Ulipristal acetate|ulipristal acetate|mesh-list
110858668|NCT03296098|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110858669|NCT03296098|Contraceptive Agents|contraceptive agents|mesh-ancestor
110858670|NCT03296098|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110858671|NCT03296098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110140315|NCT05085873|Midazolam|midazolam|mesh-list
110858672|NCT03296098|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110858673|NCT01366326|Bromides|bromides|mesh-list
110858674|NCT01366326|Methylnaltrexone|methylnaltrexone|mesh-list
110858675|NCT01366326|Anticonvulsants|anticonvulsants|mesh-ancestor
110858676|NCT01366326|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110858677|NCT01366326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110858678|NCT01366326|Sensory System Agents|sensory system agents|mesh-ancestor
110858679|NCT01366326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110858681|NCT01822275|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110858682|NCT01822275|Alkylating Agents|alkylating agents|mesh-ancestor
110140362|NCT04782830|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
110858683|NCT01822275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110858684|NCT01822275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110858685|NCT01331421|Exemestane|exemestane|mesh-list
110858686|NCT01331421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110858687|NCT01331421|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110858688|NCT01331421|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110858689|NCT01331421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110858690|NCT01331421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110858691|NCT01331421|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110858692|NCT01331421|Hormone Antagonists|hormone antagonists|mesh-ancestor
110858693|NCT01331421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110858694|NCT01331421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110858695|NCT01656434|Ferrous fumarate|ferrous fumarate|mesh-list
110858696|NCT01656434|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110858697|NCT01656434|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110858698|NCT01656434|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110858699|NCT01656434|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110858701|NCT01656434|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110858702|NCT01656434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110858703|NCT01656434|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110858704|NCT01656434|Estrogens|estrogens|mesh-ancestor
110858705|NCT01656434|Hormones|hormones|mesh-ancestor
110140490|NCT04112641|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110858706|NCT01656434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110858707|NCT01656434|Trace Elements|trace elements|mesh-ancestor
110858708|NCT01656434|Micronutrients|micronutrients|mesh-ancestor
110858709|NCT01319214|Propranolol|propranolol|mesh-list
110858710|NCT01319214|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110858711|NCT01319214|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110858712|NCT01319214|Adrenergic Agents|adrenergic agents|mesh-ancestor
110858713|NCT01319214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110858714|NCT01319214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110858715|NCT01319214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110858716|NCT01319214|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110858717|NCT01319214|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110858718|NCT01319214|Vasodilator Agents|vasodilator agents|mesh-ancestor
110858719|NCT01359228|Rifaximin|rifaximin|mesh-list
110858720|NCT01359228|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110858721|NCT01359228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110858722|NCT01359228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110858723|NCT02461030|Listerine|listerine|mesh-list
110858724|NCT02461030|Sodium Fluoride|sodium fluoride|mesh-list
110858725|NCT02461030|Cariostatic Agents|cariostatic agents|mesh-ancestor
110858726|NCT02461030|Protective Agents|protective agents|mesh-ancestor
110858727|NCT02461030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110858728|NCT02461030|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110858729|NCT02461030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110858730|NCT05168618|Atezolizumab|atezolizumab|mesh-list
110858731|NCT05168618|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110858732|NCT05168618|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110858733|NCT05168618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110858734|NCT05168618|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110858735|NCT05168618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110858736|NCT05168618|Immunologic Factors|immunologic factors|mesh-ancestor
110858737|NCT05168618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110858738|NCT01599494|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
110858739|NCT01599494|Progesterone|progesterone|mesh-list
110858740|NCT01599494|Ganirelix|ganirelix|mesh-list
110858741|NCT01599494|Progestins|progestins|mesh-ancestor
110858742|NCT01599494|Hormones|hormones|mesh-ancestor
110858743|NCT01599494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110858744|NCT01599494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110858745|NCT01599494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110858747|NCT03295786|Dopamine|dopamine|mesh-list
110858748|NCT03295786|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110858749|NCT03295786|Sympathomimetics|sympathomimetics|mesh-ancestor
110858750|NCT03295786|Autonomic Agents|autonomic agents|mesh-ancestor
110858751|NCT03295786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110858752|NCT03295786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110858753|NCT03295786|Dopamine Agents|dopamine agents|mesh-ancestor
110858754|NCT03295786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110858755|NCT03295786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110858756|NCT03295786|Protective Agents|protective agents|mesh-ancestor
110858757|NCT03194932|Cytarabine|cytarabine|mesh-list
110858758|NCT03194932|Hydrocortisone|hydrocortisone|mesh-list
110858759|NCT03194932|Methotrexate|methotrexate|mesh-list
110858760|NCT03194932|Azacitidine|azacitidine|mesh-list
110858761|NCT03194932|Venetoclax|venetoclax|mesh-list
110858762|NCT03194932|Idarubicin|idarubicin|mesh-list
110858763|NCT03194932|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110858764|NCT03194932|Abortifacient Agents|abortifacient agents|mesh-ancestor
110858765|NCT03194932|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110858766|NCT03194932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110858767|NCT03194932|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110858768|NCT03194932|Antimetabolites|antimetabolites|mesh-ancestor
110858769|NCT03194932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110858770|NCT03194932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110858771|NCT03194932|Dermatologic Agents|dermatologic agents|mesh-ancestor
110858772|NCT03194932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110858773|NCT03194932|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110858774|NCT03194932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110858775|NCT03194932|Immunologic Factors|immunologic factors|mesh-ancestor
110858776|NCT03194932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110858777|NCT03194932|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110858778|NCT03194932|Antiviral Agents|antiviral agents|mesh-ancestor
110858779|NCT03194932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110858780|NCT03194932|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110858781|NCT03194932|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110858782|NCT03194932|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110858783|NCT03194932|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110858784|NCT03037580|Treprostinil|treprostinil|mesh-list
110858785|NCT03037580|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110858786|NCT05154734|Belimumab|belimumab|mesh-list
110858787|NCT05154734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110858789|NCT05154734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110858790|NCT02978404|Nivolumab|nivolumab|mesh-list
110858791|NCT02978404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110858792|NCT02978404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110858793|NCT02978404|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110858794|NCT02978404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110858795|NCT04441918|Antibodies|antibodies|mesh-list
110858796|NCT04441918|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110858797|NCT04441918|Immunologic Factors|immunologic factors|mesh-ancestor
110858798|NCT04441918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110858799|NCT01331655|Tetrahydrofolates|tetrahydrofolates|mesh-list
110858800|NCT01331655|Drospirenone|drospirenone|mesh-list
110858801|NCT01331655|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110858802|NCT01331655|Hormone Antagonists|hormone antagonists|mesh-ancestor
110858803|NCT01331655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110858804|NCT01331655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110858805|NCT01331655|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110858806|NCT01331655|Diuretics|diuretics|mesh-ancestor
110858807|NCT01331655|Natriuretic Agents|natriuretic agents|mesh-ancestor
110858808|NCT01331655|Vitamin B Complex|vitamin b complex|mesh-ancestor
110858809|NCT01331655|Vitamins|vitamins|mesh-ancestor
110858810|NCT01331655|Micronutrients|micronutrients|mesh-ancestor
110858811|NCT03289390|Acetaminophen|acetaminophen|mesh-list
110858812|NCT03289390|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110858813|NCT03289390|Analgesics|analgesics|mesh-ancestor
110858814|NCT03289390|Sensory System Agents|sensory system agents|mesh-ancestor
110858815|NCT03289390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110858816|NCT03289390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110858817|NCT03289390|Antipyretics|antipyretics|mesh-ancestor
110858818|NCT00897104|Sumatriptan|sumatriptan|mesh-list
110858819|NCT00897104|Rizatriptan|rizatriptan|mesh-list
110858820|NCT00897104|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110858821|NCT00897104|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110858822|NCT00897104|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110858823|NCT00897104|Serotonin Agents|serotonin agents|mesh-ancestor
110858824|NCT00897104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110858825|NCT00897104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110858826|NCT00897104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110858827|NCT00792506|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
110858828|NCT00792506|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
110858829|NCT00792506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110858830|NCT00792506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110858832|NCT03295162|Antioxidants|antioxidants|mesh-ancestor
110858833|NCT03295162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110338788|NCT02947932|Resveratrol|resveratrol|mesh-list
110858834|NCT03295162|Protective Agents|protective agents|mesh-ancestor
110858835|NCT03295162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110858836|NCT03295162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110858837|NCT05237492|Tramadol|tramadol|mesh-list
110858838|NCT05237492|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110858839|NCT05237492|Narcotics|narcotics|mesh-ancestor
110858840|NCT05237492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110858841|NCT05237492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110858842|NCT05237492|Analgesics|analgesics|mesh-ancestor
110858843|NCT05237492|Sensory System Agents|sensory system agents|mesh-ancestor
110858844|NCT05237492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110858845|NCT03295084|Capecitabine|capecitabine|mesh-list
110858846|NCT03295084|Irinotecan|irinotecan|mesh-list
110858847|NCT03295084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110858848|NCT03295084|Antimetabolites|antimetabolites|mesh-ancestor
110858849|NCT03295084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110858850|NCT03295084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110858851|NCT03295084|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110858852|NCT03295084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110858853|NCT03295084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110858854|NCT04710134|Reslizumab|reslizumab|mesh-list
110858855|NCT04710134|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110858856|NCT04710134|Respiratory System Agents|respiratory system agents|mesh-ancestor
110858857|NCT01339689|Ganaxolone|ganaxolone|mesh-list
110858858|NCT01339689|Neurosteroids|neurosteroids|mesh-ancestor
110858859|NCT01339689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110858860|NCT01339689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110141108|NCT02010957|Etomidate|etomidate|mesh-list
110858861|NCT01339689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110858863|NCT01339689|GABA Agents|gaba agents|mesh-ancestor
110858864|NCT00702806|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
110858865|NCT00702806|Ganirelix|ganirelix|mesh-list
110858866|NCT00702806|Hormone Antagonists|hormone antagonists|mesh-ancestor
110858867|NCT00702806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110858868|NCT00702806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110858869|NCT00702806|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110858870|NCT01336803|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
110858871|NCT01336803|Hematinics|hematinics|mesh-ancestor
110858872|NCT01336803|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
110858873|NCT01336803|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110858875|NCT03635931|Mitosis Modulators|mitosis modulators|mesh-ancestor
110858876|NCT03635931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110858877|NCT01331967|Pioglitazone|pioglitazone|mesh-list
110858878|NCT01331967|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110858879|NCT01331967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110858880|NCT00696878|Progesterone|progesterone|mesh-list
110858881|NCT00696878|Progestins|progestins|mesh-ancestor
110858882|NCT00696878|Hormones|hormones|mesh-ancestor
110858883|NCT00696878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110858884|NCT00696878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110858885|NCT00731757|Adalimumab|adalimumab|mesh-list
110858886|NCT00731757|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110858887|NCT00731757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110858888|NCT00731757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110858889|NCT03108274|Fexofenadine|fexofenadine|mesh-list
110858890|NCT03108274|Mycophenolic Acid|mycophenolic acid|mesh-list
110858891|NCT03108274|Midazolam|midazolam|mesh-list
110858892|NCT03108274|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110576442|NCT00821392|Febuxostat|febuxostat|mesh-list
110858894|NCT03108274|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110858895|NCT03108274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110858896|NCT03108274|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110338803|NCT02947932|Tocolytic Agents|tocolytic agents|mesh-ancestor
110858897|NCT03108274|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110858898|NCT03108274|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110858899|NCT03108274|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110858900|NCT03108274|Anesthetics, General|anesthetics, general|mesh-ancestor
110858902|NCT03108274|GABA Modulators|gaba modulators|mesh-ancestor
110858903|NCT03108274|GABA Agents|gaba agents|mesh-ancestor
110858904|NCT03108274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110858905|NCT03108274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110858906|NCT03108274|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110858907|NCT03108274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110858908|NCT03108274|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110858909|NCT03108274|Antitubercular Agents|antitubercular agents|mesh-ancestor
110858910|NCT03108274|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110858911|NCT03108274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110858913|NCT03108274|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110858914|NCT03108274|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110858915|NCT03108274|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110858916|NCT03108274|Histamine Antagonists|histamine antagonists|mesh-ancestor
110858917|NCT03108274|Histamine Agents|histamine agents|mesh-ancestor
110858918|NCT02278588|Rasagiline|rasagiline|mesh-list
110858919|NCT02278588|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
110858920|NCT02278588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110858921|NCT02278588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110858922|NCT02278588|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110858923|NCT02278588|Protective Agents|protective agents|mesh-ancestor
110858924|NCT02278588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110858925|NCT03288610|Vasopressins|vasopressins|mesh-list
110858926|NCT03288610|Hemostatics|hemostatics|mesh-ancestor
110858927|NCT03288610|Coagulants|coagulants|mesh-ancestor
110858928|NCT03288610|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110858929|NCT03288610|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
110858930|NCT03288610|Natriuretic Agents|natriuretic agents|mesh-ancestor
110858931|NCT03288610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110858932|NCT00696800|Progesterone|progesterone|mesh-list
110858933|NCT00696800|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
110858934|NCT00696800|Ganirelix|ganirelix|mesh-list
110858936|NCT00696800|Hormones|hormones|mesh-ancestor
110858937|NCT00696800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110858938|NCT00696800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110858939|NCT00696800|Hormone Antagonists|hormone antagonists|mesh-ancestor
110858940|NCT03294772|Hand Sanitizers|hand sanitizers|mesh-list
110858941|NCT03294772|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110858942|NCT03294772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110858943|NCT03294772|Disinfectants|disinfectants|mesh-ancestor
110858944|NCT03288532|Durvalumab|durvalumab|mesh-list
110858945|NCT03288532|Tremelimumab|tremelimumab|mesh-list
110858946|NCT03288532|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110858947|NCT03288532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110858948|NCT00598208|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
110858950|NCT00598208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110858951|NCT00598208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110858953|NCT00480662|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110858954|NCT00480662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110858955|NCT00398606|Alendronate|alendronate|mesh-list
110858956|NCT00398606|Calcium Carbonate|calcium carbonate|mesh-list
110858958|NCT00398606|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110858959|NCT00398606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110858960|NCT00398606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110858961|NCT00398606|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110858962|NCT00398606|Antacids|antacids|mesh-ancestor
110858963|NCT00398606|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110858964|NCT00395408|Beclomethasone|beclomethasone|mesh-list
110858965|NCT00395408|Montelukast|montelukast|mesh-list
110858966|NCT00395408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110858967|NCT00395408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110858968|NCT00395408|Respiratory System Agents|respiratory system agents|mesh-ancestor
110858969|NCT00395408|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110142206|NCT02018055|Antipyretics|antipyretics|mesh-ancestor
110858970|NCT00395408|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110858971|NCT00395408|Hormone Antagonists|hormone antagonists|mesh-ancestor
110858972|NCT00395408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110858973|NCT00395408|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110858974|NCT00395408|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110858975|NCT00395408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110858976|NCT00395408|Glucocorticoids|glucocorticoids|mesh-ancestor
110858977|NCT00395408|Hormones|hormones|mesh-ancestor
110858978|NCT02462044|Iodine|iodine|mesh-list
110858979|NCT02462044|Cadexomer iodine|cadexomer iodine|mesh-list
110858980|NCT02462044|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110858981|NCT02462044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110858982|NCT02462044|Trace Elements|trace elements|mesh-ancestor
110858983|NCT02462044|Micronutrients|micronutrients|mesh-ancestor
110858984|NCT02462044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110858985|NCT00289874|Montelukast|montelukast|mesh-list
110858986|NCT00289874|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110858987|NCT00289874|Respiratory System Agents|respiratory system agents|mesh-ancestor
110858988|NCT00289874|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110858989|NCT00289874|Hormone Antagonists|hormone antagonists|mesh-ancestor
110142400|NCT02019160|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110858990|NCT00289874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110858991|NCT00289874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110858992|NCT00289874|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110858993|NCT00289874|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110858994|NCT00289874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110858995|NCT00245570|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110858996|NCT00245570|Montelukast|montelukast|mesh-list
110858997|NCT00245570|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110858998|NCT00245570|Autonomic Agents|autonomic agents|mesh-ancestor
110858999|NCT00245570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110859000|NCT00245570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110859001|NCT00245570|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110859002|NCT00245570|Respiratory System Agents|respiratory system agents|mesh-ancestor
110859003|NCT00245570|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110859004|NCT00245570|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110859005|NCT00245570|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110859006|NCT00245570|Adrenergic Agents|adrenergic agents|mesh-ancestor
110859007|NCT00245570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110859008|NCT00245570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110859009|NCT00245570|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110859010|NCT00245570|Hormone Antagonists|hormone antagonists|mesh-ancestor
110859011|NCT00245570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110859012|NCT00245570|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110859013|NCT00245570|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110859014|NCT02461888|Dexamethasone|dexamethasone|mesh-list
110859015|NCT02461888|Cyclophosphamide|cyclophosphamide|mesh-list
110859016|NCT02461888|Ixazomib|ixazomib|mesh-list
110859017|NCT02461888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110142683|NCT02021097|Levonorgestrel|levonorgestrel|mesh-list
110859018|NCT02461888|Immunologic Factors|immunologic factors|mesh-ancestor
110859019|NCT02461888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110859020|NCT02461888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110859021|NCT02461888|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110859022|NCT02461888|Alkylating Agents|alkylating agents|mesh-ancestor
110859023|NCT02461888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110859024|NCT02461888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110859025|NCT02461888|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110859026|NCT02461888|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110859027|NCT02461888|Antiemetics|antiemetics|mesh-ancestor
110859028|NCT02461888|Autonomic Agents|autonomic agents|mesh-ancestor
110859029|NCT02461888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110859030|NCT02461888|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110859031|NCT02461888|Glucocorticoids|glucocorticoids|mesh-ancestor
110859032|NCT02461888|Hormones|hormones|mesh-ancestor
110859033|NCT02461888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110859034|NCT02461888|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110859035|NCT02461888|Protease Inhibitors|protease inhibitors|mesh-ancestor
110859036|NCT02461888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110859037|NCT00229970|Montelukast|montelukast|mesh-list
110859038|NCT00229970|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110859039|NCT00229970|Respiratory System Agents|respiratory system agents|mesh-ancestor
110859040|NCT00229970|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110859041|NCT00229970|Hormone Antagonists|hormone antagonists|mesh-ancestor
110859042|NCT00229970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110859043|NCT00229970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110859044|NCT00229970|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110859045|NCT00229970|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110859046|NCT00229970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110859047|NCT00111722|Rizatriptan|rizatriptan|mesh-list
110859048|NCT00111722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110859049|NCT00111722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110859050|NCT00111722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110859051|NCT00111722|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110859052|NCT00111722|Serotonin Agents|serotonin agents|mesh-ancestor
110859053|NCT04626596|Etonogestrel|etonogestrel|mesh-list
110859054|NCT04626596|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110859055|NCT04626596|Contraceptive Agents|contraceptive agents|mesh-ancestor
110859056|NCT04626596|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110859057|NCT04626596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110859058|NCT04626596|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110859059|NCT05235100|Apatinib|apatinib|mesh-list
110859060|NCT05235100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110859061|NCT05235100|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110859062|NCT05235100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110859063|NCT05235100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110859064|NCT03294382|Botulinum Toxins|botulinum toxins|mesh-list
110859065|NCT03294382|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110859066|NCT03294382|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110859067|NCT03294382|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110859068|NCT03294382|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110859069|NCT03294382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110859070|NCT03294382|Cholinergic Agents|cholinergic agents|mesh-ancestor
110859071|NCT03294382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110859072|NCT03294382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110859073|NCT03294382|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110859074|NCT03294382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110859075|NCT00092066|Cholecalciferol|cholecalciferol|mesh-list
110859076|NCT00092066|Vitamin D|vitamin d|mesh-list
110859077|NCT00092066|Alendronate|alendronate|mesh-list
110859078|NCT00092066|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110859079|NCT00092066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110859080|NCT00092066|Vitamins|vitamins|mesh-ancestor
110859081|NCT00092066|Micronutrients|micronutrients|mesh-ancestor
110859082|NCT00092066|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110859083|NCT01334619|Ropivacaine|ropivacaine|mesh-list
110859084|NCT01334619|Anesthetics, Local|anesthetics, local|mesh-ancestor
110859085|NCT01334619|Anesthetics|anesthetics|mesh-ancestor
110338840|NCT00507143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110859086|NCT01334619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110859087|NCT01334619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110859088|NCT01334619|Sensory System Agents|sensory system agents|mesh-ancestor
110859089|NCT01334619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110859091|NCT03287128|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110859092|NCT03287128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110859093|NCT03287128|Immunotoxins|immunotoxins|mesh-ancestor
110859094|NCT03287128|Immunoconjugates|immunoconjugates|mesh-ancestor
110859095|NCT03287128|Immunologic Factors|immunologic factors|mesh-ancestor
110859096|NCT03287128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110859097|NCT00457275|Ezetimibe|ezetimibe|mesh-list
110859098|NCT00457275|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110859099|NCT00457275|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110859100|NCT00457275|Antimetabolites|antimetabolites|mesh-ancestor
110859101|NCT00457275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110859102|NCT00457275|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110859103|NCT03294070|Amlodipine|amlodipine|mesh-list
110859104|NCT03294070|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110859105|NCT03294070|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110859106|NCT03294070|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110859107|NCT03294070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110859108|NCT03294070|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110859109|NCT03294070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110859110|NCT03294070|Vasodilator Agents|vasodilator agents|mesh-ancestor
110859111|NCT04479566|Lithium Carbonate|lithium carbonate|mesh-list
110142956|NCT02022722|Triamcinolone|triamcinolone|mesh-list
110859112|NCT04479566|Calcium Carbonate|calcium carbonate|mesh-list
110859113|NCT04479566|Calcium|calcium|mesh-list
110576662|NCT04112550|Oxycodone|oxycodone|mesh-list
110859114|NCT04479566|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110859115|NCT04479566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110859116|NCT04479566|Antidepressive Agents|antidepressive agents|mesh-ancestor
110859117|NCT04479566|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110859118|NCT04479566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110859119|NCT04479566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110859120|NCT04479566|Antimanic Agents|antimanic agents|mesh-ancestor
110859121|NCT04479566|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110859122|NCT04479566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110859124|NCT04479566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110859125|NCT06030258|Carboplatin|carboplatin|mesh-list
110859126|NCT06030258|Etoposide|etoposide|mesh-list
110859127|NCT06030258|Tislelizumab|tislelizumab|mesh-list
110859128|NCT06030258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110859129|NCT06030258|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110859130|NCT06030258|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110859131|NCT06030258|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110859132|NCT06030258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110859133|NCT06030258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110143234|NCT02024308|Cytarabine|cytarabine|mesh-list
110859134|NCT06030258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110859136|NCT06030219|Vancomycin|vancomycin|mesh-list
110859137|NCT06030219|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110859138|NCT06030219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110859139|NCT06030219|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110859140|NCT06030219|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110859141|NCT06030219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110859142|NCT06030219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110859143|NCT06030219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110859144|NCT06030193|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110859145|NCT06030193|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110859146|NCT06030089|Azacitidine|azacitidine|mesh-list
110859147|NCT06030089|Venetoclax|venetoclax|mesh-list
110859148|NCT06030089|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110859149|NCT06030089|Antimetabolites|antimetabolites|mesh-ancestor
110859150|NCT06030089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110859151|NCT06030089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110859152|NCT06030089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110859153|NCT06030037|Pembrolizumab|pembrolizumab|mesh-list
110833848|NCT03806101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110859156|NCT06030037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110859157|NCT06030037|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110859158|NCT06030037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110859159|NCT06030037|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110859160|NCT06030037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110859161|NCT06029933|Vaccines|vaccines|mesh-list
110859162|NCT06029933|Immunologic Factors|immunologic factors|mesh-ancestor
110859163|NCT06029933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110859164|NCT06029907|Varenicline|varenicline|mesh-list
110859165|NCT06029907|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110859167|NCT06029907|Cholinergic Agents|cholinergic agents|mesh-ancestor
110859168|NCT06029907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110859169|NCT06029907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110859170|NCT06029907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110859171|NCT06029894|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
110859172|NCT06029894|Nootropic Agents|nootropic agents|mesh-ancestor
110859173|NCT06029803|Epinephrine|epinephrine|mesh-list
110859174|NCT06029803|Racepinephrine|racepinephrine|mesh-list
110859175|NCT06029803|Epinephryl borate|epinephryl borate|mesh-list
110859176|NCT06029803|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110143714|NCT02027220|Dexamethasone|dexamethasone|mesh-list
110859177|NCT06029803|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110859178|NCT06029803|Adrenergic Agents|adrenergic agents|mesh-ancestor
110859179|NCT06029803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110143785|NCT02027454|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110859180|NCT06029803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110859181|NCT06029803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110143880|NCT02028078|Insulin|insulin|mesh-list
110859182|NCT06029803|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110859183|NCT06029803|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110859184|NCT06029803|Autonomic Agents|autonomic agents|mesh-ancestor
110859185|NCT06029803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110859186|NCT06029803|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110859187|NCT06029803|Respiratory System Agents|respiratory system agents|mesh-ancestor
110576735|NCT00813488|Anesthetics|anesthetics|mesh-ancestor
110859188|NCT06029803|Mydriatics|mydriatics|mesh-ancestor
110859189|NCT06029803|Sympathomimetics|sympathomimetics|mesh-ancestor
110859190|NCT06029803|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110859191|NCT06029673|Cabergoline|cabergoline|mesh-list
110859192|NCT06029673|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110859193|NCT06029673|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110859194|NCT06029673|Dopamine Agonists|dopamine agonists|mesh-ancestor
110859195|NCT06029673|Dopamine Agents|dopamine agents|mesh-ancestor
110859196|NCT06029673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110859197|NCT06029673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110859198|NCT06029673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110859199|NCT06029569|Sirolimus|sirolimus|mesh-list
110859200|NCT06029569|Paclitaxel|paclitaxel|mesh-list
110859201|NCT06029569|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110859202|NCT06029569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110859203|NCT06029569|Tubulin Modulators|tubulin modulators|mesh-ancestor
110859204|NCT06029569|Antimitotic Agents|antimitotic agents|mesh-ancestor
110859205|NCT06029569|Mitosis Modulators|mitosis modulators|mesh-ancestor
110859206|NCT06029569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110859207|NCT06029569|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110859208|NCT06029569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110859209|NCT06029569|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110859210|NCT06029569|Antifungal Agents|antifungal agents|mesh-ancestor
110859211|NCT06029569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110859212|NCT06029569|Immunologic Factors|immunologic factors|mesh-ancestor
110859213|NCT06029569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110859214|NCT06029530|Atropine|atropine|mesh-list
110859215|NCT06029530|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110859216|NCT06029530|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110859217|NCT06029530|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110859218|NCT06029530|Autonomic Agents|autonomic agents|mesh-ancestor
110859219|NCT06029530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110859220|NCT06029530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110859221|NCT06029530|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110859222|NCT06029530|Respiratory System Agents|respiratory system agents|mesh-ancestor
110859224|NCT06029530|Parasympatholytics|parasympatholytics|mesh-ancestor
110859225|NCT06029530|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110859226|NCT06029530|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110859227|NCT06029530|Cholinergic Agents|cholinergic agents|mesh-ancestor
110859228|NCT06029530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110859229|NCT06029530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110859230|NCT06029309|Zanubrutinib|zanubrutinib|mesh-list
110859231|NCT06029309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110144340|NCT02036255|Taurolidine|taurolidine|mesh-list
110859233|NCT06029309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110859234|NCT06029309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110859236|NCT06029296|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110859237|NCT06029296|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110859238|NCT06029296|Analgesics|analgesics|mesh-ancestor
110859239|NCT06029296|Sensory System Agents|sensory system agents|mesh-ancestor
110859240|NCT06029296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110859241|NCT06029296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110859242|NCT06029296|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110859243|NCT06029296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110859244|NCT06029296|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110859245|NCT06029296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110859246|NCT06029296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110859247|NCT06029270|Cisplatin|cisplatin|mesh-list
110859248|NCT06029270|Carboplatin|carboplatin|mesh-list
110859249|NCT06029270|Gemcitabine|gemcitabine|mesh-list
110859250|NCT06029270|Nivolumab|nivolumab|mesh-list
110859251|NCT06029270|Relatlimab|relatlimab|mesh-list
110859252|NCT06029270|Immunoglobulins|immunoglobulins|mesh-list
110859253|NCT06029270|Immunoglobulin G|immunoglobulin g|mesh-list
110859254|NCT06029270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110859255|NCT06029270|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110859256|NCT06029270|Antimetabolites|antimetabolites|mesh-ancestor
110859257|NCT06029270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110859258|NCT06029270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110859259|NCT06029270|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110144409|NCT02040285|Metoclopramide|metoclopramide|mesh-list
110859260|NCT06029270|Immunologic Factors|immunologic factors|mesh-ancestor
110859261|NCT06029270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110859262|NCT06029127|Docetaxel|docetaxel|mesh-list
110859263|NCT06029127|Tislelizumab|tislelizumab|mesh-list
110859264|NCT06029127|Ramucirumab|ramucirumab|mesh-list
110144458|NCT02040441|Diuretics|diuretics|mesh-ancestor
110859265|NCT06029127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110859266|NCT06029127|Tubulin Modulators|tubulin modulators|mesh-ancestor
110859267|NCT06029127|Antimitotic Agents|antimitotic agents|mesh-ancestor
110859268|NCT06029127|Mitosis Modulators|mitosis modulators|mesh-ancestor
110859269|NCT06029127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110859270|NCT06029127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110859272|NCT06029049|Succinylcholine|succinylcholine|mesh-list
110859273|NCT06029049|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110859274|NCT06029049|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110859275|NCT06029049|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110859276|NCT06029049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110859277|NCT06029049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110859278|NCT06029049|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
110859280|NCT06029023|Curcumin|curcumin|mesh-list
110859281|NCT06029023|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110859282|NCT06029023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110859284|NCT06029023|Sensory System Agents|sensory system agents|mesh-ancestor
110859285|NCT06029023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110859286|NCT06029023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110859287|NCT06029023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110859288|NCT06029023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110859290|NCT06029023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110859291|NCT06029023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110859292|NCT06029023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110859293|NCT06028932|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
110859295|NCT06028932|Immunologic Factors|immunologic factors|mesh-ancestor
110859296|NCT06028932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110859297|NCT06028828|Fludarabine|fludarabine|mesh-list
110859298|NCT06028828|Melphalan|melphalan|mesh-list
110859299|NCT06028828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110859300|NCT06028828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110859301|NCT06028828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110859302|NCT06028828|Immunologic Factors|immunologic factors|mesh-ancestor
110859303|NCT06028828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110859304|NCT06028828|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110859305|NCT06028828|Alkylating Agents|alkylating agents|mesh-ancestor
110859306|NCT06028828|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110859307|NCT06028737|Leucovorin|leucovorin|mesh-list
110859308|NCT06028737|Docetaxel|docetaxel|mesh-list
110859309|NCT06028737|Fluorouracil|fluorouracil|mesh-list
110859310|NCT06028737|Oxaliplatin|oxaliplatin|mesh-list
110859311|NCT06028737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110859312|NCT06028737|Tubulin Modulators|tubulin modulators|mesh-ancestor
110859313|NCT06028737|Antimitotic Agents|antimitotic agents|mesh-ancestor
110859314|NCT06028737|Mitosis Modulators|mitosis modulators|mesh-ancestor
110859315|NCT06028737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110859316|NCT06028737|Antimetabolites|antimetabolites|mesh-ancestor
110859317|NCT06028737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110859318|NCT06028737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110859319|NCT06028737|Immunologic Factors|immunologic factors|mesh-ancestor
110859320|NCT06028737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110859321|NCT06028737|Antidotes|antidotes|mesh-ancestor
110859322|NCT06028737|Protective Agents|protective agents|mesh-ancestor
110859323|NCT06028737|Vitamin B Complex|vitamin b complex|mesh-ancestor
110859324|NCT06028737|Vitamins|vitamins|mesh-ancestor
110859325|NCT06028737|Micronutrients|micronutrients|mesh-ancestor
110859326|NCT06028633|Paclitaxel|paclitaxel|mesh-list
110859327|NCT06028633|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110859328|NCT06028633|Pembrolizumab|pembrolizumab|mesh-list
110859329|NCT06028633|Lenvatinib|lenvatinib|mesh-list
110859330|NCT06028633|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110859331|NCT06028633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110859332|NCT06028633|Tubulin Modulators|tubulin modulators|mesh-ancestor
110859333|NCT06028633|Antimitotic Agents|antimitotic agents|mesh-ancestor
110859334|NCT06028633|Mitosis Modulators|mitosis modulators|mesh-ancestor
110144917|NCT02044146|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110859335|NCT06028633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110859336|NCT06028633|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110859337|NCT06028633|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110576886|NCT02608112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110859338|NCT06028633|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110859339|NCT06028633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110859340|NCT06028438|Certolizumab Pegol|certolizumab pegol|mesh-list
110859341|NCT06028438|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110859342|NCT06028438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110859343|NCT06028438|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110859344|NCT06028438|Immunologic Factors|immunologic factors|mesh-ancestor
110145058|NCT02045056|Gemfibrozil|gemfibrozil|mesh-list
110859345|NCT06028438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110859346|NCT06028438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110859347|NCT06028321|Pindolol|pindolol|mesh-list
110859348|NCT06028321|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110859349|NCT06028321|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110145126|NCT02045810|Anesthetics|anesthetics|mesh-ancestor
110859350|NCT06028321|Adrenergic Agents|adrenergic agents|mesh-ancestor
110859351|NCT06028321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110859352|NCT06028321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110859353|NCT06028321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110859354|NCT06028321|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110859355|NCT06028321|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110859356|NCT06028321|Serotonin Agents|serotonin agents|mesh-ancestor
110859357|NCT06028321|Vasodilator Agents|vasodilator agents|mesh-ancestor
110859358|NCT06028256|Norepinephrine|norepinephrine|mesh-list
110859359|NCT06028256|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110859360|NCT06028256|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110859361|NCT06028256|Adrenergic Agents|adrenergic agents|mesh-ancestor
110859362|NCT06028256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110859363|NCT06028256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110859364|NCT06028256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110859365|NCT06028256|Sympathomimetics|sympathomimetics|mesh-ancestor
110859366|NCT06028256|Autonomic Agents|autonomic agents|mesh-ancestor
110859367|NCT06028256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110859368|NCT06028256|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110859369|NCT06026319|Cyclophosphamide|cyclophosphamide|mesh-list
110859370|NCT06026319|Fludarabine|fludarabine|mesh-list
110859371|NCT06026319|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110859372|NCT06026319|Immunologic Factors|immunologic factors|mesh-ancestor
110859373|NCT06026319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110859374|NCT06026319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110859375|NCT06026319|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110859376|NCT06026319|Alkylating Agents|alkylating agents|mesh-ancestor
110145549|NCT00005853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110859377|NCT06026319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110859378|NCT06026319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110859379|NCT06026319|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110859380|NCT06026254|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
110859381|NCT06026254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110145615|NCT00005883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110859382|NCT06026254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110859383|NCT06026254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110859384|NCT06018116|Avelumab|avelumab|mesh-list
110859385|NCT06018116|Bicalutamide|bicalutamide|mesh-list
110859386|NCT06018116|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110859387|NCT06018116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110859388|NCT06018116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110859389|NCT06018116|Immunologic Factors|immunologic factors|mesh-ancestor
110859390|NCT06018116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110859391|NCT06018116|Androgen Antagonists|androgen antagonists|mesh-ancestor
110859392|NCT06018116|Hormone Antagonists|hormone antagonists|mesh-ancestor
110859393|NCT06018116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110859394|NCT06014658|Antibodies|antibodies|mesh-list
110859395|NCT06014658|Immunoconjugates|immunoconjugates|mesh-list
110859396|NCT06014658|Immunologic Factors|immunologic factors|mesh-ancestor
110859397|NCT06014658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110859398|NCT06013839|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
110859399|NCT06013839|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110859400|NCT06013839|Vasodilator Agents|vasodilator agents|mesh-ancestor
110859401|NCT06012331|Mitogens|mitogens|mesh-list
110859402|NCT06012331|Mitosis Modulators|mitosis modulators|mesh-ancestor
110859403|NCT06012331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110859404|NCT05999084|Antibodies|antibodies|mesh-list
110859405|NCT05999084|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110859406|NCT05999084|Immunologic Factors|immunologic factors|mesh-ancestor
110859407|NCT05999084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110859408|NCT05990738|Topotecan|topotecan|mesh-list
110859409|NCT05990738|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110859410|NCT05990738|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110859411|NCT05990738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110859412|NCT05990738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110576962|NCT00700193|Vaccines|vaccines|mesh-list
110859413|NCT05990738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110859414|NCT05987956|Afatinib|afatinib|mesh-list
110859415|NCT05987956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110859416|NCT05987956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110859417|NCT05987956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110859418|NCT05987956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110859419|NCT05970354|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
110859420|NCT05970354|Anesthetics, Local|anesthetics, local|mesh-ancestor
110859421|NCT05970354|Anesthetics|anesthetics|mesh-ancestor
110859422|NCT05970354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110859423|NCT05970354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110859424|NCT05970354|Sensory System Agents|sensory system agents|mesh-ancestor
110859425|NCT05970354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110859426|NCT05970354|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
110859427|NCT05964335|Nalbuphine|nalbuphine|mesh-list
110859428|NCT05964335|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110859429|NCT05964335|Narcotics|narcotics|mesh-ancestor
110859430|NCT05964335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110859431|NCT05964335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110859432|NCT05964335|Analgesics|analgesics|mesh-ancestor
110859433|NCT05964335|Sensory System Agents|sensory system agents|mesh-ancestor
110859434|NCT05964335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110859435|NCT05959720|Cytarabine|cytarabine|mesh-list
110859436|NCT05959720|Prednisone|prednisone|mesh-list
110859437|NCT05959720|Cyclophosphamide|cyclophosphamide|mesh-list
110859438|NCT05959720|Doxorubicin|doxorubicin|mesh-list
110859439|NCT05959720|Methotrexate|methotrexate|mesh-list
110859440|NCT05959720|Daunorubicin|daunorubicin|mesh-list
110859441|NCT05959720|Asparaginase|asparaginase|mesh-list
110859442|NCT05959720|Mercaptopurine|mercaptopurine|mesh-list
110859443|NCT05959720|Pegaspargase|pegaspargase|mesh-list
110859444|NCT05959720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110859445|NCT05959720|Immunologic Factors|immunologic factors|mesh-ancestor
110859446|NCT05959720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110859447|NCT05959720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110859448|NCT05959720|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110859449|NCT05959720|Alkylating Agents|alkylating agents|mesh-ancestor
110859450|NCT05959720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110859451|NCT05959720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110859452|NCT05959720|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110859453|NCT05959720|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110859454|NCT05959720|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110859455|NCT05959720|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110859456|NCT05959720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110859457|NCT05959720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110859458|NCT05959720|Glucocorticoids|glucocorticoids|mesh-ancestor
110859459|NCT05959720|Hormones|hormones|mesh-ancestor
110859460|NCT05959720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110859461|NCT05959720|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110859462|NCT05959720|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110859463|NCT05959720|Abortifacient Agents|abortifacient agents|mesh-ancestor
110859464|NCT05959720|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110859465|NCT05959720|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110859466|NCT05959720|Antimetabolites|antimetabolites|mesh-ancestor
110859467|NCT05959720|Dermatologic Agents|dermatologic agents|mesh-ancestor
110859468|NCT05959720|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110859469|NCT05959720|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110859470|NCT05959720|Antiviral Agents|antiviral agents|mesh-ancestor
110859471|NCT05959720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110859472|NCT05929768|Paclitaxel|paclitaxel|mesh-list
110859473|NCT05929768|Docetaxel|docetaxel|mesh-list
110859474|NCT05929768|Cyclophosphamide|cyclophosphamide|mesh-list
110859475|NCT05929768|Carboplatin|carboplatin|mesh-list
110859476|NCT05929768|Doxorubicin|doxorubicin|mesh-list
110859477|NCT05929768|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110859478|NCT05929768|Pembrolizumab|pembrolizumab|mesh-list
110859479|NCT05929768|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110859481|NCT05929768|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110859482|NCT05929768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110146277|NCT05679336|Rituximab|rituximab|mesh-list
110859484|NCT05929768|Antimitotic Agents|antimitotic agents|mesh-ancestor
110859485|NCT05929768|Mitosis Modulators|mitosis modulators|mesh-ancestor
110577039|NCT05572476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110859486|NCT05929768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110859487|NCT05929768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110859489|NCT05929768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110859490|NCT05929768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110859491|NCT05929768|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110833883|NCT05281081|Morphine|morphine|mesh-list
110859492|NCT05929768|Alkylating Agents|alkylating agents|mesh-ancestor
110859493|NCT05929768|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110859494|NCT05929768|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110859495|NCT05929768|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110859496|NCT05929768|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110859497|NCT05929768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110859498|NCT05929768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110859499|NCT05929768|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110859500|NCT05926180|Digoxin|digoxin|mesh-list
110859501|NCT05926180|Midazolam|midazolam|mesh-list
110859502|NCT05926180|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110859503|NCT05926180|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110859504|NCT05926180|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110859505|NCT05926180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110859506|NCT05926180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110859507|NCT05926180|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110859508|NCT05926180|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110859509|NCT05926180|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110859510|NCT05926180|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110859511|NCT05926180|Anesthetics, General|anesthetics, general|mesh-ancestor
110859513|NCT05926180|GABA Modulators|gaba modulators|mesh-ancestor
110859514|NCT05926180|GABA Agents|gaba agents|mesh-ancestor
110859515|NCT05926180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110859516|NCT05926180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110859517|NCT05926180|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110859518|NCT05926180|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110859519|NCT05926180|Antimetabolites|antimetabolites|mesh-ancestor
110859520|NCT05926180|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110859521|NCT05926180|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110859522|NCT05926180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110859523|NCT05926180|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110859524|NCT05926180|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110859525|NCT05926180|Protective Agents|protective agents|mesh-ancestor
110859526|NCT05925140|Ritonavir|ritonavir|mesh-list
110859527|NCT05925140|Lopinavir|lopinavir|mesh-list
110859528|NCT05925140|Remdesivir|remdesivir|mesh-list
110859529|NCT05925140|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110859530|NCT05925140|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110859531|NCT05925140|Protease Inhibitors|protease inhibitors|mesh-ancestor
110859532|NCT05925140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110859533|NCT05925140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110859534|NCT05925140|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110859535|NCT05925140|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110859536|NCT05925140|Antiviral Agents|antiviral agents|mesh-ancestor
110859537|NCT05925140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110859538|NCT05925140|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110859539|NCT05925140|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110859540|NCT05925140|Antimetabolites|antimetabolites|mesh-ancestor
110859541|NCT05918861|Dalcetrapib|dalcetrapib|mesh-list
110859542|NCT05918861|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110859543|NCT05918861|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110859544|NCT05918861|Antimetabolites|antimetabolites|mesh-ancestor
110859545|NCT05918861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110859546|NCT05918861|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110859547|NCT05917067|Parathyroid Hormone|parathyroid hormone|mesh-list
110859548|NCT05917067|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110859549|NCT05917067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110859550|NCT05913232|Timolol|timolol|mesh-list
110859551|NCT05913232|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110859552|NCT05913232|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110859553|NCT05913232|Adrenergic Agents|adrenergic agents|mesh-ancestor
110859554|NCT05913232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110859555|NCT05913232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110859556|NCT05913232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110859557|NCT05913232|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110859558|NCT05913232|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110859559|NCT05912244|Nivolumab|nivolumab|mesh-list
110859560|NCT05912244|Relatlimab|relatlimab|mesh-list
110859561|NCT05912244|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110859562|NCT05912244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110577111|NCT00626392|Antipyretics|antipyretics|mesh-ancestor
110859563|NCT05912244|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110859564|NCT05912244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110859565|NCT05895955|Vaccines|vaccines|mesh-list
110859566|NCT05895955|Immunologic Factors|immunologic factors|mesh-ancestor
110859567|NCT05895955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110859568|NCT05875272|Hemostatics|hemostatics|mesh-list
110859569|NCT05875272|Coagulants|coagulants|mesh-ancestor
110859570|NCT05870761|Niraparib|niraparib|mesh-list
110859571|NCT05870761|Dostarlimab|dostarlimab|mesh-list
110859572|NCT05870761|Immunoglobulins|immunoglobulins|mesh-list
110859573|NCT05870761|Immunoglobulin G|immunoglobulin g|mesh-list
110859574|NCT05870761|Immunologic Factors|immunologic factors|mesh-ancestor
110859575|NCT05870761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110859576|NCT05870761|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110859577|NCT05870761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110859578|NCT05870761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110859579|NCT05870761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110859580|NCT05861999|Risdiplam|risdiplam|mesh-list
110859581|NCT05861999|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110859582|NCT05861999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110859583|NCT05861999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110859584|NCT05861986|Risdiplam|risdiplam|mesh-list
110859585|NCT05861986|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110859586|NCT05861986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110859587|NCT05861986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110859588|NCT05859074|Pembrolizumab|pembrolizumab|mesh-list
110859589|NCT05859074|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110859590|NCT05859074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110859591|NCT05859074|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110859592|NCT05859074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110859593|NCT05849610|Lenalidomide|lenalidomide|mesh-list
110859594|NCT05849610|Bortezomib|bortezomib|mesh-list
110859595|NCT05849610|Daratumumab|daratumumab|mesh-list
110859596|NCT05849610|Immunologic Factors|immunologic factors|mesh-ancestor
110859597|NCT05849610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110859598|NCT05849610|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110859599|NCT05849610|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110859600|NCT05849610|Growth Substances|growth substances|mesh-ancestor
110859601|NCT05849610|Growth Inhibitors|growth inhibitors|mesh-ancestor
110859602|NCT05849610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110859603|NCT05821686|Aldesleukin|aldesleukin|mesh-list
110859604|NCT05821686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110859605|NCT05821686|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110859606|NCT05821686|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110859607|NCT05821686|Antiviral Agents|antiviral agents|mesh-ancestor
110859608|NCT05821686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110859609|NCT05821517|Methoxyflurane|methoxyflurane|mesh-list
110859610|NCT05821517|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110859611|NCT05821517|Anesthetics, General|anesthetics, general|mesh-ancestor
110859612|NCT05821517|Anesthetics|anesthetics|mesh-ancestor
110859613|NCT05821517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110859614|NCT05821517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110859615|NCT05803811|Riboflavin|riboflavin|mesh-list
110859616|NCT05803811|Vitamin B Complex|vitamin b complex|mesh-ancestor
110859617|NCT05803811|Vitamins|vitamins|mesh-ancestor
110859618|NCT05803811|Micronutrients|micronutrients|mesh-ancestor
110859619|NCT05803811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110859620|NCT05803811|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110859622|NCT05797246|Bevacizumab|bevacizumab|mesh-list
110859623|NCT05797246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110859624|NCT05797246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110859625|NCT05797246|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110859626|NCT05797246|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110859627|NCT05797246|Growth Substances|growth substances|mesh-ancestor
110859628|NCT05797246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110859629|NCT05797246|Growth Inhibitors|growth inhibitors|mesh-ancestor
110859630|NCT05797233|Cyclophosphamide|cyclophosphamide|mesh-list
110859631|NCT05797233|Fludarabine|fludarabine|mesh-list
110859632|NCT05797233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110859633|NCT05797233|Immunologic Factors|immunologic factors|mesh-ancestor
110859634|NCT05797233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110859635|NCT05797233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110859636|NCT05797233|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110859637|NCT05797233|Alkylating Agents|alkylating agents|mesh-ancestor
110859638|NCT05797233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110859639|NCT05797233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110859640|NCT05797233|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110859642|NCT05782127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110859643|NCT05768711|Venetoclax|venetoclax|mesh-list
110859644|NCT05768711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110859645|NCT05764057|Dapagliflozin|dapagliflozin|mesh-list
110859646|NCT05764057|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110859647|NCT05764057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110859648|NCT05764057|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110859649|NCT05764057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110859650|NCT05758597|Midazolam|midazolam|mesh-list
110859651|NCT05758597|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110859652|NCT05758597|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110859653|NCT05758597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110859654|NCT05758597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110859655|NCT05758597|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110859656|NCT05758597|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110859657|NCT05758597|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110859658|NCT05758597|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110859659|NCT05758597|Anesthetics, General|anesthetics, general|mesh-ancestor
110859660|NCT05758597|Anesthetics|anesthetics|mesh-ancestor
110859661|NCT05758597|GABA Modulators|gaba modulators|mesh-ancestor
110859662|NCT05758597|GABA Agents|gaba agents|mesh-ancestor
110859663|NCT05758597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110859664|NCT05758597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110859665|NCT05745038|Zaleplon|zaleplon|mesh-list
110859666|NCT05745038|Anticonvulsants|anticonvulsants|mesh-ancestor
110859667|NCT05745038|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110859668|NCT05745038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110859669|NCT05745038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110859670|NCT05745038|GABA Modulators|gaba modulators|mesh-ancestor
110859671|NCT05745038|GABA Agents|gaba agents|mesh-ancestor
110859672|NCT05745038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110859673|NCT05745038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110859674|NCT05743244|Abrocitinib|abrocitinib|mesh-list
110859675|NCT05743244|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110859676|NCT05743244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110859677|NCT05743244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110859678|NCT05743036|Cetuximab|cetuximab|mesh-list
110859679|NCT05743036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110859680|NCT05743036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110859681|NCT05701995|Deucravacitinib|deucravacitinib|mesh-list
110859682|NCT05701995|Dermatologic Agents|dermatologic agents|mesh-ancestor
110859683|NCT05701995|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110859684|NCT05701995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110859685|NCT05701995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110859686|NCT05692180|Benralizumab|benralizumab|mesh-list
110859687|NCT05692180|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110859688|NCT05692180|Respiratory System Agents|respiratory system agents|mesh-ancestor
110859689|NCT05652673|Nivolumab|nivolumab|mesh-list
110859690|NCT05652673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110859691|NCT05652673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110859692|NCT05652673|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110859693|NCT05652673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110859694|NCT05641194|Caffeine|caffeine|mesh-list
110859695|NCT05641194|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110859696|NCT05641194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110859697|NCT05641194|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110859698|NCT05641194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110859699|NCT05641194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110833901|NCT03812965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110859700|NCT05641194|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110859701|NCT05641194|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110859702|NCT05641194|Purinergic Agents|purinergic agents|mesh-ancestor
110859703|NCT05641194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110859705|NCT05638932|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
110859706|NCT05638932|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110859707|NCT05638932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110859708|NCT05638932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110859709|NCT05631236|Methamphetamine|methamphetamine|mesh-list
110859710|NCT05631236|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110859711|NCT05631236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110859712|NCT05631236|Sympathomimetics|sympathomimetics|mesh-ancestor
110859713|NCT05631236|Autonomic Agents|autonomic agents|mesh-ancestor
110859714|NCT05631236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110859715|NCT05631236|Dopamine Agents|dopamine agents|mesh-ancestor
110859716|NCT05631236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110859717|NCT05631236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110859718|NCT05631236|Adrenergic Agents|adrenergic agents|mesh-ancestor
110859719|NCT05631236|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110859720|NCT05631236|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110859721|NCT05631236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110859722|NCT05631236|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110859723|NCT05600127|Avelumab|avelumab|mesh-list
110859724|NCT05600127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110859725|NCT05600127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110859726|NCT05590377|Daratumumab|daratumumab|mesh-list
110859727|NCT05590377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110859728|NCT05590325|Dolutegravir|dolutegravir|mesh-list
110859729|NCT05590325|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110859730|NCT05590325|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110859731|NCT05590325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110859732|NCT05590325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110859733|NCT05590325|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110859734|NCT05590325|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110859741|NCT05568160|Arginine Vasopressin|arginine vasopressin|mesh-list
110859742|NCT05568160|Norepinephrine|norepinephrine|mesh-list
110859743|NCT05568160|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110859744|NCT05568160|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110859745|NCT05568160|Adrenergic Agents|adrenergic agents|mesh-ancestor
110859746|NCT05568160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110859747|NCT05568160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110859748|NCT05568160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110859749|NCT05568160|Sympathomimetics|sympathomimetics|mesh-ancestor
110859750|NCT05568160|Autonomic Agents|autonomic agents|mesh-ancestor
110859751|NCT05568160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110859752|NCT05568160|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110859753|NCT05568160|Hemostatics|hemostatics|mesh-ancestor
110859754|NCT05568160|Coagulants|coagulants|mesh-ancestor
110859755|NCT05568160|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
110859756|NCT05568160|Natriuretic Agents|natriuretic agents|mesh-ancestor
110859757|NCT05561738|Niacinamide|niacinamide|mesh-list
110859759|NCT05561738|Nicotinic Acids|nicotinic acids|mesh-list
110859760|NCT05561738|Vitamin B Complex|vitamin b complex|mesh-ancestor
110859761|NCT05561738|Vitamins|vitamins|mesh-ancestor
110859762|NCT05561738|Micronutrients|micronutrients|mesh-ancestor
110859763|NCT05561738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110859764|NCT05561738|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110859765|NCT05561738|Antimetabolites|antimetabolites|mesh-ancestor
110859766|NCT05561738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110859767|NCT05561738|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110859768|NCT05561738|Vasodilator Agents|vasodilator agents|mesh-ancestor
110859769|NCT05555862|Artesunate|artesunate|mesh-list
110859770|NCT05555862|Artenimol|artenimol|mesh-list
110859771|NCT05555862|Artemisinins|artemisinins|mesh-list
110859772|NCT05555862|Artemisinin|artemisinin|mesh-list
110859773|NCT05555862|Antimalarials|antimalarials|mesh-ancestor
110859774|NCT05555862|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110859775|NCT05555862|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110859776|NCT05555862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110859777|NCT05555862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110859778|NCT05555862|Antiviral Agents|antiviral agents|mesh-ancestor
110859779|NCT05555862|Schistosomicides|schistosomicides|mesh-ancestor
110833907|NCT01303237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110859781|NCT05555862|Anthelmintics|anthelmintics|mesh-ancestor
110859782|NCT05555615|Pimavanserin|pimavanserin|mesh-list
110859783|NCT05555615|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110859784|NCT05555615|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110859785|NCT05555615|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110859786|NCT05555615|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110859787|NCT05555615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110859788|NCT05555615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110859789|NCT05555615|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110859790|NCT05555615|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110859791|NCT05555615|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110859792|NCT05555615|Serotonin Agents|serotonin agents|mesh-ancestor
110859793|NCT05555615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110859794|NCT05555615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110859796|NCT05552287|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110859797|NCT05552287|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110859798|NCT05552287|Dermatologic Agents|dermatologic agents|mesh-ancestor
110859799|NCT05552287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110859800|NCT05552287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110859801|NCT05543629|Paclitaxel|paclitaxel|mesh-list
110859802|NCT05543629|Docetaxel|docetaxel|mesh-list
110859803|NCT05543629|Carboplatin|carboplatin|mesh-list
110859804|NCT05543629|Nivolumab|nivolumab|mesh-list
110859805|NCT05543629|Taxane|taxane|mesh-list
110859806|NCT05543629|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110859807|NCT05543629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110859808|NCT05543629|Tubulin Modulators|tubulin modulators|mesh-ancestor
110859809|NCT05543629|Antimitotic Agents|antimitotic agents|mesh-ancestor
110859810|NCT05543629|Mitosis Modulators|mitosis modulators|mesh-ancestor
110859811|NCT05543629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110859812|NCT05543629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110859813|NCT05543629|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110859814|NCT05542407|Atezolizumab|atezolizumab|mesh-list
110859815|NCT05542407|TIC10 compound|tic10 compound|mesh-list
110859816|NCT05542407|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110859817|NCT05542407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110859818|NCT05542407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110859819|NCT05542407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110859820|NCT05523895|Pimavanserin|pimavanserin|mesh-list
110859821|NCT05523895|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110859822|NCT05523895|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110859823|NCT05523895|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110859824|NCT05523895|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110859825|NCT05523895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110859826|NCT05523895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110859827|NCT05523895|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110859828|NCT05523895|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110859829|NCT05523895|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110859830|NCT05523895|Serotonin Agents|serotonin agents|mesh-ancestor
110859831|NCT05523895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110859832|NCT05523895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110859833|NCT05517642|Vaccines|vaccines|mesh-list
110859834|NCT05517642|Immunologic Factors|immunologic factors|mesh-ancestor
110859835|NCT05517642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110859836|NCT05514054|Tamoxifen|tamoxifen|mesh-list
110859837|NCT05514054|Letrozole|letrozole|mesh-list
110859838|NCT05514054|Anastrozole|anastrozole|mesh-list
110859839|NCT05514054|Exemestane|exemestane|mesh-list
110859840|NCT05514054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110859841|NCT05514054|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110859842|NCT05514054|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110859843|NCT05514054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110859844|NCT05514054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110859845|NCT05514054|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110859846|NCT05514054|Hormone Antagonists|hormone antagonists|mesh-ancestor
110859847|NCT05514054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110859848|NCT05514054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110859849|NCT05514054|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110859850|NCT05514054|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110859851|NCT05514054|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110859852|NCT05514054|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110859853|NCT05513586|Immunoglobulins|immunoglobulins|mesh-list
110859854|NCT05513586|Immunologic Factors|immunologic factors|mesh-ancestor
110859855|NCT05513586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110859856|NCT05469737|Azacitidine|azacitidine|mesh-list
110859857|NCT05469737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110859858|NCT05469737|Antimetabolites|antimetabolites|mesh-ancestor
110859859|NCT05469737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110859860|NCT05469737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110859861|NCT05469737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110859862|NCT05442515|Cyclophosphamide|cyclophosphamide|mesh-list
110859863|NCT05442515|Fludarabine|fludarabine|mesh-list
110859864|NCT05442515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110859865|NCT05442515|Immunologic Factors|immunologic factors|mesh-ancestor
110859866|NCT05442515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110859867|NCT05442515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110577409|NCT00824200|Tamsulosin|tamsulosin|mesh-list
110859868|NCT05442515|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110859869|NCT05442515|Alkylating Agents|alkylating agents|mesh-ancestor
110859870|NCT05442515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110859871|NCT05442515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110859872|NCT05442515|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110859873|NCT05439616|Cariprazine|cariprazine|mesh-list
110859874|NCT05439616|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110859875|NCT05439616|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110859876|NCT05439616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110859877|NCT05439616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110859878|NCT05439616|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110859879|NCT05438498|Cilgavimab and tixagevimab drug combination|cilgavimab and tixagevimab drug combination|mesh-list
110859880|NCT05438498|Antiviral Agents|antiviral agents|mesh-ancestor
110859881|NCT05438498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110859882|NCT05437575|Fentanyl|fentanyl|mesh-list
110859883|NCT05437575|Ketamine|ketamine|mesh-list
110859884|NCT05437575|Analgesics|analgesics|mesh-ancestor
110859885|NCT05437575|Sensory System Agents|sensory system agents|mesh-ancestor
110859886|NCT05437575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110859887|NCT05437575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110859888|NCT05437575|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110859889|NCT05437575|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110859890|NCT05437575|Anesthetics, General|anesthetics, general|mesh-ancestor
110859891|NCT05437575|Anesthetics|anesthetics|mesh-ancestor
110859892|NCT05437575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110859893|NCT05437575|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110859894|NCT05437575|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110859895|NCT05437575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110859896|NCT05437575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110859897|NCT05437575|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110859898|NCT05437575|Narcotics|narcotics|mesh-ancestor
110859899|NCT05437575|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110859900|NCT05436964|Dexmedetomidine|dexmedetomidine|mesh-list
110859901|NCT05436964|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110859902|NCT05436964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110859903|NCT05436964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110859904|NCT05436964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110859905|NCT05436964|Analgesics|analgesics|mesh-ancestor
110859906|NCT05436964|Sensory System Agents|sensory system agents|mesh-ancestor
110147374|NCT00005869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110859913|NCT05436964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110859915|NCT05429762|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110859916|NCT05429762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110833922|NCT03919565|Tenofovir|tenofovir|mesh-list
110859917|NCT05429762|Tubulin Modulators|tubulin modulators|mesh-ancestor
110859918|NCT05429762|Antimitotic Agents|antimitotic agents|mesh-ancestor
110859919|NCT05429762|Mitosis Modulators|mitosis modulators|mesh-ancestor
110859920|NCT05429762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110859929|NCT05413018|Azacitidine|azacitidine|mesh-list
110859930|NCT05413018|Cc-486|cc-486|mesh-list
110859931|NCT05413018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110859932|NCT05413018|Antimetabolites|antimetabolites|mesh-ancestor
110859933|NCT05413018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110859934|NCT05413018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110859935|NCT05413018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110859936|NCT05412706|Niraparib|niraparib|mesh-list
110859937|NCT05412706|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110859938|NCT05412706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110859939|NCT05412706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110859940|NCT05412706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110859941|NCT05407675|Nivolumab|nivolumab|mesh-list
110859942|NCT05407675|Ipilimumab|ipilimumab|mesh-list
110859943|NCT05407675|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110859944|NCT05407675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110859945|NCT05407675|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110859946|NCT05407675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110859947|NCT05350202|Empagliflozin|empagliflozin|mesh-list
110859948|NCT05350202|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110859949|NCT05350202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110859951|NCT05350202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110859952|NCT05348577|Docetaxel|docetaxel|mesh-list
110859953|NCT05348577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110859954|NCT05348577|Tubulin Modulators|tubulin modulators|mesh-ancestor
110859955|NCT05348577|Antimitotic Agents|antimitotic agents|mesh-ancestor
110859956|NCT05348577|Mitosis Modulators|mitosis modulators|mesh-ancestor
110859957|NCT05348577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110859958|NCT05338671|Anesthetics|anesthetics|mesh-list
110859959|NCT05338671|Anesthetics, Local|anesthetics, local|mesh-list
110859960|NCT05338671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110859961|NCT05338671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110859962|NCT05338671|Sensory System Agents|sensory system agents|mesh-ancestor
110859963|NCT05338671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110859964|NCT05338398|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110859965|NCT05338398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
110859966|NCT05338398|Benzydamine|benzydamine|mesh-list
110859967|NCT05338398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110859968|NCT05326347|Brexpiprazole|brexpiprazole|mesh-list
110859969|NCT05326347|Serotonin Agents|serotonin agents|mesh-ancestor
110859970|NCT05326347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110859971|NCT05326347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110859972|NCT05326347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110859973|NCT05326347|Dopamine Agonists|dopamine agonists|mesh-ancestor
110859974|NCT05326347|Dopamine Agents|dopamine agents|mesh-ancestor
110859975|NCT05306548|Triamcinolone|triamcinolone|mesh-list
110859976|NCT05306548|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110859977|NCT05306548|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110859978|NCT05306548|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110859979|NCT05306548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110859980|NCT05306548|Glucocorticoids|glucocorticoids|mesh-ancestor
110859981|NCT05306548|Hormones|hormones|mesh-ancestor
110859982|NCT05306548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110859983|NCT05306548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110859984|NCT05306548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110859985|NCT05306548|Immunologic Factors|immunologic factors|mesh-ancestor
110859986|NCT05306548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110859987|NCT05306548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110859988|NCT05283720|Prednisone|prednisone|mesh-list
110859989|NCT05283720|Cyclophosphamide|cyclophosphamide|mesh-list
110859990|NCT05283720|Rituximab|rituximab|mesh-list
110859991|NCT05283720|Doxorubicin|doxorubicin|mesh-list
110859992|NCT05283720|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110859993|NCT05283720|Lenalidomide|lenalidomide|mesh-list
110859994|NCT05283720|Venetoclax|venetoclax|mesh-list
110859995|NCT05283720|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
110859996|NCT05283720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110859997|NCT05283720|Immunologic Factors|immunologic factors|mesh-ancestor
110859998|NCT05283720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110859999|NCT05283720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110860000|NCT05283720|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110860001|NCT05283720|Alkylating Agents|alkylating agents|mesh-ancestor
110860002|NCT05283720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110860003|NCT05283720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110860004|NCT05283720|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110860005|NCT05283720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110860006|NCT05283720|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110147461|NCT00386503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110860007|NCT05283720|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110860008|NCT05283720|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110860009|NCT05283720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110860010|NCT05283720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110860011|NCT05283720|Glucocorticoids|glucocorticoids|mesh-ancestor
110860012|NCT05283720|Hormones|hormones|mesh-ancestor
110860013|NCT05283720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110860014|NCT05283720|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110577557|NCT05526924|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110860015|NCT05283720|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110860016|NCT05283720|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110860017|NCT05283720|Growth Substances|growth substances|mesh-ancestor
110860018|NCT05283720|Growth Inhibitors|growth inhibitors|mesh-ancestor
110860019|NCT05283720|Immunoconjugates|immunoconjugates|mesh-ancestor
110860020|NCT05283109|Vaccines|vaccines|mesh-list
110860021|NCT05283109|Poly ICLC|poly iclc|mesh-list
110860022|NCT05283109|Immunologic Factors|immunologic factors|mesh-ancestor
110860023|NCT05283109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110860024|NCT05283109|Interferon Inducers|interferon inducers|mesh-ancestor
110860025|NCT05237687|Sirolimus|sirolimus|mesh-list
110860026|NCT05237687|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110860027|NCT05237687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110860028|NCT05237687|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110860029|NCT05237687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110860030|NCT05237687|Antifungal Agents|antifungal agents|mesh-ancestor
110860031|NCT05237687|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110860032|NCT05237687|Immunologic Factors|immunologic factors|mesh-ancestor
110860033|NCT05237687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110860034|NCT05236673|Empagliflozin|empagliflozin|mesh-list
110860035|NCT05236673|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110860036|NCT05236673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110860037|NCT05236673|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110860038|NCT05236673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110860039|NCT05205109|Pembrolizumab|pembrolizumab|mesh-list
110860040|NCT05205109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110860041|NCT05205109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110860042|NCT05205109|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110860043|NCT05205109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110860044|NCT05200143|Nivolumab|nivolumab|mesh-list
110860045|NCT05200143|Ipilimumab|ipilimumab|mesh-list
110860046|NCT05200143|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110860047|NCT05200143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110860048|NCT05200143|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110339030|NCT00526305|Cytarabine|cytarabine|mesh-list
110860049|NCT05200143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110860050|NCT05151640|Nintedanib|nintedanib|mesh-list
110860051|NCT05151640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110860052|NCT05151640|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110860053|NCT05151640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110860054|NCT05151640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110860055|NCT05142696|Carboplatin|carboplatin|mesh-list
110860056|NCT05142696|Etoposide|etoposide|mesh-list
110860057|NCT05142696|Tislelizumab|tislelizumab|mesh-list
110833935|NCT03380091|Metformin|metformin|mesh-list
110860058|NCT05142696|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
110860059|NCT05142696|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
110860060|NCT05142696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110860061|NCT05142696|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110860062|NCT05142696|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110860063|NCT05142696|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110860064|NCT05142696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110860065|NCT05142696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110860066|NCT05142696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110860067|NCT05142696|Chelating Agents|chelating agents|mesh-ancestor
110860068|NCT05142696|Sequestering Agents|sequestering agents|mesh-ancestor
110860069|NCT05142696|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110860070|NCT05142254|Hydroxyurea|hydroxyurea|mesh-list
110860071|NCT05142254|Tadalafil|tadalafil|mesh-list
110860072|NCT05142254|Vasodilator Agents|vasodilator agents|mesh-ancestor
110860073|NCT05142254|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110860074|NCT05142254|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110860075|NCT05142254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110860076|NCT05142254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110860077|NCT05142254|Urological Agents|urological agents|mesh-ancestor
110860078|NCT05142254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110860079|NCT05142254|Antisickling Agents|antisickling agents|mesh-ancestor
110860080|NCT05142254|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110860081|NCT05125978|Dipyrone|dipyrone|mesh-list
110860082|NCT05125978|Tramadol|tramadol|mesh-list
110860083|NCT05125978|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110860084|NCT05125978|Narcotics|narcotics|mesh-ancestor
110860085|NCT05125978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110860086|NCT05125978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110860087|NCT05125978|Analgesics|analgesics|mesh-ancestor
110860088|NCT05125978|Sensory System Agents|sensory system agents|mesh-ancestor
110860089|NCT05125978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110860090|NCT05125978|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110860091|NCT05125978|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110860092|NCT05125978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110860093|NCT05125978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110860094|NCT05125978|Antipyretics|antipyretics|mesh-ancestor
110860095|NCT05120349|Osimertinib|osimertinib|mesh-list
110860096|NCT05120349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110860097|NCT05120349|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110860098|NCT05120349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110860099|NCT05120349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110860100|NCT05101109|Antibodies, Bispecific|antibodies, bispecific|mesh-list
110860101|NCT05101109|Immunologic Factors|immunologic factors|mesh-ancestor
110860102|NCT05101109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110860103|NCT05098574|Drospirenone|drospirenone|mesh-list
110860104|NCT05098574|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110860105|NCT05098574|Estradiol|estradiol|mesh-list
110860106|NCT05098574|Estrogens|estrogens|mesh-ancestor
110860107|NCT05098574|Hormones|hormones|mesh-ancestor
110860108|NCT05098574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110860109|NCT05098574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110860110|NCT05098574|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110860111|NCT05098574|Contraceptive Agents|contraceptive agents|mesh-ancestor
110860112|NCT05098574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110860113|NCT05098574|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110860114|NCT05098574|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110860115|NCT05098574|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110860116|NCT05098574|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110860117|NCT05098574|Hormone Antagonists|hormone antagonists|mesh-ancestor
110860118|NCT05098574|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110860119|NCT05098574|Diuretics|diuretics|mesh-ancestor
110860120|NCT05098574|Natriuretic Agents|natriuretic agents|mesh-ancestor
110860122|NCT05082662|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110860123|NCT05082662|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110860124|NCT05082662|Analgesics|analgesics|mesh-ancestor
110860125|NCT05082662|Sensory System Agents|sensory system agents|mesh-ancestor
110860126|NCT05082662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110860127|NCT05082662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110860128|NCT05082662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110860129|NCT05082662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110860130|NCT05082662|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110860131|NCT05082662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110147813|NCT00006013|Semaxinib|semaxinib|mesh-list
110860132|NCT05082662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110860133|NCT05065216|Kallikreins|kallikreins|mesh-list
110860134|NCT05065216|Coagulants|coagulants|mesh-ancestor
110860135|NCT05065216|Fertility Agents, Male|fertility agents, male|mesh-ancestor
110860136|NCT05065216|Fertility Agents|fertility agents|mesh-ancestor
110860137|NCT05065216|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110860153|NCT05008484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110860154|NCT05008484|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110860155|NCT04970108|Empagliflozin|empagliflozin|mesh-list
110860156|NCT04970108|Telmisartan|telmisartan|mesh-list
110860157|NCT04970108|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110860158|NCT04970108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110860159|NCT04970108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110860160|NCT04970108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110860161|NCT04970108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110860162|NCT04970108|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110860163|NCT04970108|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110860164|NCT04968015|Cytarabine|cytarabine|mesh-list
110860165|NCT04968015|Venetoclax|venetoclax|mesh-list
110860166|NCT04968015|Idarubicin|idarubicin|mesh-list
110148236|NCT05247970|Midazolam|midazolam|mesh-list
110860167|NCT04968015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110860168|NCT04968015|Antimetabolites|antimetabolites|mesh-ancestor
110860169|NCT04968015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110860170|NCT04968015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110860171|NCT04968015|Antiviral Agents|antiviral agents|mesh-ancestor
110860172|NCT04968015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110860173|NCT04968015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110860174|NCT04968015|Immunologic Factors|immunologic factors|mesh-ancestor
110860175|NCT04968015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110860176|NCT04968015|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110860177|NCT04968015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110860178|NCT04968015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110860179|NCT04968015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110860180|NCT04955366|Abatacept|abatacept|mesh-list
110860181|NCT04955366|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110860182|NCT04955366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110860183|NCT04955366|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110860184|NCT04955366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110860185|NCT04955366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110860186|NCT04955366|Immunologic Factors|immunologic factors|mesh-ancestor
110860187|NCT04955366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110860188|NCT04955366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110860189|NCT04939597|Memantine|memantine|mesh-list
110860191|NCT04939597|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110860192|NCT04939597|Dopamine Agents|dopamine agents|mesh-ancestor
110860193|NCT04939597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110860194|NCT04939597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110860195|NCT04939597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110860196|NCT04939597|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110860197|NCT04939597|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110860223|NCT04881240|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110860224|NCT04881240|Immunologic Factors|immunologic factors|mesh-ancestor
110860225|NCT04881240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110860226|NCT04881240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110860227|NCT04881240|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110860228|NCT04881240|Alkylating Agents|alkylating agents|mesh-ancestor
110860229|NCT04881240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110860230|NCT04881240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110860231|NCT04881240|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110860233|NCT04864743|Coagulants|coagulants|mesh-ancestor
110860234|NCT04847453|Dexamethasone|dexamethasone|mesh-list
110860235|NCT04847453|Dexamethasone acetate|dexamethasone acetate|mesh-list
110860236|NCT04847453|Venetoclax|venetoclax|mesh-list
110860238|NCT04847453|Ichthammol|ichthammol|mesh-list
110860239|NCT04847453|BB 1101|bb 1101|mesh-list
110860240|NCT04847453|Glycine|glycine|mesh-list
110860241|NCT04847453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110860242|NCT04847453|Antiemetics|antiemetics|mesh-ancestor
110860243|NCT04847453|Autonomic Agents|autonomic agents|mesh-ancestor
110860244|NCT04847453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110860245|NCT04847453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110860246|NCT04847453|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110860247|NCT04847453|Glucocorticoids|glucocorticoids|mesh-ancestor
110860248|NCT04847453|Hormones|hormones|mesh-ancestor
110860249|NCT04847453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110860250|NCT04847453|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110860251|NCT04847453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110860252|NCT04847453|Protease Inhibitors|protease inhibitors|mesh-ancestor
110860253|NCT04847453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110860254|NCT04847453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110860255|NCT04847453|Dermatologic Agents|dermatologic agents|mesh-ancestor
110860256|NCT04847453|Glycine Agents|glycine agents|mesh-ancestor
110860257|NCT04847453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110860258|NCT04818216|Niacinamide|niacinamide|mesh-list
110860259|NCT04818216|Niacin|niacin|mesh-list
110860261|NCT04818216|Vitamin B Complex|vitamin b complex|mesh-ancestor
110860262|NCT04818216|Vitamins|vitamins|mesh-ancestor
110860263|NCT04818216|Micronutrients|micronutrients|mesh-ancestor
110860264|NCT04818216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110860265|NCT04818216|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110860266|NCT04818216|Antimetabolites|antimetabolites|mesh-ancestor
110860267|NCT04818216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110860268|NCT04818216|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110860269|NCT04818216|Vasodilator Agents|vasodilator agents|mesh-ancestor
110860271|NCT04785820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110860272|NCT04785820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110860273|NCT04785820|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110860274|NCT04785820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110860275|NCT04783935|Cladribine|cladribine|mesh-list
110860276|NCT04783935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110860277|NCT04783935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110860278|NCT04783935|Immunologic Factors|immunologic factors|mesh-ancestor
110860279|NCT04783935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110860280|NCT04767061|Propranolol|propranolol|mesh-list
110860282|NCT04767061|Atenolol|atenolol|mesh-list
110860283|NCT04767061|Sotalol|sotalol|mesh-list
110860284|NCT04767061|Nadolol|nadolol|mesh-list
110860285|NCT04767061|Acebutolol|acebutolol|mesh-list
110860286|NCT04767061|Carvedilol|carvedilol|mesh-list
110860287|NCT04767061|Nebivolol|nebivolol|mesh-list
110860288|NCT04767061|Bisoprolol|bisoprolol|mesh-list
110860289|NCT04767061|Labetalol|labetalol|mesh-list
110860290|NCT04767061|Pindolol|pindolol|mesh-list
110860291|NCT04767061|Betaxolol|betaxolol|mesh-list
110860292|NCT04767061|Penbutolol|penbutolol|mesh-list
110860293|NCT04767061|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
110860294|NCT04767061|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110860295|NCT04767061|Adrenergic Agents|adrenergic agents|mesh-ancestor
110860296|NCT04767061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110860297|NCT04767061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110860298|NCT04767061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110860299|NCT04767061|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110860300|NCT04767061|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110308310|NCT00271466|Anesthetics|anesthetics|mesh-ancestor
110860301|NCT04767061|Vasodilator Agents|vasodilator agents|mesh-ancestor
110860302|NCT04767061|Sympatholytics|sympatholytics|mesh-ancestor
110860303|NCT04767061|Autonomic Agents|autonomic agents|mesh-ancestor
110860304|NCT04767061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110860305|NCT04767061|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110860307|NCT04767061|Protective Agents|protective agents|mesh-ancestor
110860308|NCT04767061|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110860309|NCT04767061|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110860310|NCT04767061|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110860311|NCT04767061|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110860312|NCT04767061|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110860313|NCT04767061|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
110860314|NCT04767061|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110860316|NCT04767061|Sympathomimetics|sympathomimetics|mesh-ancestor
110860317|NCT04767061|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110860318|NCT04767061|Serotonin Agents|serotonin agents|mesh-ancestor
110860319|NCT04753294|Diazepam|diazepam|mesh-list
110860320|NCT04753294|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110860321|NCT04753294|Anticonvulsants|anticonvulsants|mesh-ancestor
110860322|NCT04753294|Antiemetics|antiemetics|mesh-ancestor
110860323|NCT04753294|Autonomic Agents|autonomic agents|mesh-ancestor
110860324|NCT04753294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110860325|NCT04753294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110860326|NCT04753294|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110860327|NCT04753294|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110860328|NCT04753294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110860329|NCT04753294|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110860330|NCT04753294|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110860331|NCT04753294|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110860332|NCT04753294|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110860333|NCT04753294|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110860334|NCT04753294|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110860336|NCT04753294|Anesthetics|anesthetics|mesh-ancestor
110860337|NCT04753294|GABA Modulators|gaba modulators|mesh-ancestor
110860338|NCT04753294|GABA Agents|gaba agents|mesh-ancestor
110860339|NCT04753294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110308715|NCT00273338|Calcitriol|calcitriol|mesh-list
110860340|NCT04753294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110860341|NCT04750967|Lidocaine|lidocaine|mesh-list
110860342|NCT04750967|Amitriptyline|amitriptyline|mesh-list
110860343|NCT04750967|Anesthetics, Local|anesthetics, local|mesh-ancestor
110860344|NCT04750967|Anesthetics|anesthetics|mesh-ancestor
110860345|NCT04750967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110860346|NCT04750967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110860347|NCT04750967|Sensory System Agents|sensory system agents|mesh-ancestor
110860348|NCT04750967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110860349|NCT04750967|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110860350|NCT04750967|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110860351|NCT04750967|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110860352|NCT04750967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110860353|NCT04750967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110860354|NCT04750967|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110308998|NCT00274391|Amiloride|amiloride|mesh-list
110860355|NCT04750967|Antidepressive Agents|antidepressive agents|mesh-ancestor
110860356|NCT04750967|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110860357|NCT04750967|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110860358|NCT04750967|Analgesics|analgesics|mesh-ancestor
110860359|NCT04750967|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110860360|NCT04750967|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110860361|NCT04750967|Adrenergic Agents|adrenergic agents|mesh-ancestor
110860362|NCT04750967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110860363|NCT04746235|Decitabine|decitabine|mesh-list
110860364|NCT04746235|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
110860365|NCT04746235|Venetoclax|venetoclax|mesh-list
110860366|NCT04746235|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110860367|NCT04746235|Antimetabolites|antimetabolites|mesh-ancestor
110309206|NCT00315081|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110860368|NCT04746235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110860369|NCT04746235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110860370|NCT04746235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110860371|NCT04742075|Durvalumab|durvalumab|mesh-list
110860372|NCT04742075|Olaparib|olaparib|mesh-list
110309281|NCT00278252|Etoposide|etoposide|mesh-list
110860373|NCT04742075|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110860374|NCT04742075|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110860375|NCT04742075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110860376|NCT04742075|Immunologic Factors|immunologic factors|mesh-ancestor
110860377|NCT04742075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110860378|NCT04742075|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110860379|NCT04742075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110860380|NCT04742075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110860381|NCT04729517|Azelastine|azelastine|mesh-list
110860382|NCT04729517|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110860383|NCT04729517|Autonomic Agents|autonomic agents|mesh-ancestor
110860384|NCT04729517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110860385|NCT04729517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110860386|NCT04729517|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110860387|NCT04729517|Respiratory System Agents|respiratory system agents|mesh-ancestor
110860388|NCT04729517|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
110860389|NCT04729517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110860390|NCT04729517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110860391|NCT04729517|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110860392|NCT04729517|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110860393|NCT04729517|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110860394|NCT04729517|Histamine Antagonists|histamine antagonists|mesh-ancestor
110860396|NCT04729517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110860398|NCT04726332|Fulvestrant|fulvestrant|mesh-list
110860399|NCT04726332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110860400|NCT04726332|Glucocorticoids|glucocorticoids|mesh-ancestor
110860402|NCT04726332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110860403|NCT04726332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110860404|NCT04726332|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110860405|NCT04726332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110309630|NCT00310089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110860406|NCT04726332|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110860407|NCT04726332|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110860408|NCT04726332|Hormone Antagonists|hormone antagonists|mesh-ancestor
110860409|NCT04720963|Dexmedetomidine|dexmedetomidine|mesh-list
110860410|NCT04720963|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110309705|NCT00416819|Antimetabolites|antimetabolites|mesh-ancestor
110860411|NCT04720963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110860412|NCT04720963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110860413|NCT04720963|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110860415|NCT04720963|Sensory System Agents|sensory system agents|mesh-ancestor
110860416|NCT04720963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110860417|NCT04720963|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110860418|NCT04720963|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110860419|NCT04720963|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110860420|NCT04720963|Adrenergic Agents|adrenergic agents|mesh-ancestor
110860421|NCT04720963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110860422|NCT04720963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110860423|NCT04700527|Butyric Acid|butyric acid|mesh-list
110860424|NCT04700527|Histamine Antagonists|histamine antagonists|mesh-ancestor
110860425|NCT04700527|Histamine Agents|histamine agents|mesh-ancestor
110860426|NCT04700527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110860427|NCT04700527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110860428|NCT04700527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110860430|NCT04685135|Adagrasib|adagrasib|mesh-list
110860431|NCT04685135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110860432|NCT04685135|Tubulin Modulators|tubulin modulators|mesh-ancestor
110860433|NCT04685135|Antimitotic Agents|antimitotic agents|mesh-ancestor
110860434|NCT04685135|Mitosis Modulators|mitosis modulators|mesh-ancestor
110860435|NCT04685135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110860436|NCT04666701|Ketorolac|ketorolac|mesh-list
110860437|NCT04666701|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
110860438|NCT04666701|Scopolamine|scopolamine|mesh-list
110860439|NCT04666701|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
110860440|NCT04666701|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110860441|NCT04666701|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110860442|NCT04666701|Analgesics|analgesics|mesh-ancestor
110860444|NCT04666701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110860445|NCT04666701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110860446|NCT04666701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110860447|NCT04666701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110860448|NCT04666701|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110860449|NCT04666701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110860450|NCT04666701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110860451|NCT04666701|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110860452|NCT04666701|Antiemetics|antiemetics|mesh-ancestor
110860453|NCT04666701|Autonomic Agents|autonomic agents|mesh-ancestor
110860454|NCT04666701|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110860455|NCT04666701|Mydriatics|mydriatics|mesh-ancestor
110860456|NCT04666701|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110860457|NCT04666701|Cholinergic Agents|cholinergic agents|mesh-ancestor
110860458|NCT04666701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110860459|NCT04666701|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110860460|NCT04666701|Parasympatholytics|parasympatholytics|mesh-ancestor
110860461|NCT04662710|Leucovorin|leucovorin|mesh-list
110860462|NCT04662710|Pembrolizumab|pembrolizumab|mesh-list
110860463|NCT04662710|Capecitabine|capecitabine|mesh-list
110860464|NCT04662710|Oxaliplatin|oxaliplatin|mesh-list
110860465|NCT04662710|Lenvatinib|lenvatinib|mesh-list
110860466|NCT04662710|Levoleucovorin|levoleucovorin|mesh-list
110860467|NCT04662710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110860468|NCT04662710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110860469|NCT04662710|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110860470|NCT04662710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110860471|NCT04662710|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110860472|NCT04662710|Antimetabolites|antimetabolites|mesh-ancestor
110860473|NCT04662710|Antidotes|antidotes|mesh-ancestor
110860474|NCT04662710|Protective Agents|protective agents|mesh-ancestor
110860475|NCT04662710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110860476|NCT04662710|Vitamin B Complex|vitamin b complex|mesh-ancestor
110860477|NCT04662710|Vitamins|vitamins|mesh-ancestor
110860478|NCT04662710|Micronutrients|micronutrients|mesh-ancestor
110860479|NCT04662710|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110860480|NCT04662710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110860481|NCT04643405|Paclitaxel|paclitaxel|mesh-list
110860482|NCT04643405|Gemcitabine|gemcitabine|mesh-list
110860483|NCT04643405|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110860484|NCT04643405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110860485|NCT04643405|Tubulin Modulators|tubulin modulators|mesh-ancestor
110860486|NCT04643405|Antimitotic Agents|antimitotic agents|mesh-ancestor
110860487|NCT04643405|Mitosis Modulators|mitosis modulators|mesh-ancestor
110860488|NCT04643405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110310238|NCT00318201|Vasodilator Agents|vasodilator agents|mesh-ancestor
110860489|NCT04643405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110860490|NCT04643405|Antimetabolites|antimetabolites|mesh-ancestor
110860491|NCT04641975|Mirabegron|mirabegron|mesh-list
110860492|NCT04641975|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
110860493|NCT04641975|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110860494|NCT04641975|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110860495|NCT04641975|Adrenergic Agents|adrenergic agents|mesh-ancestor
110860496|NCT04641975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110310366|NCT00312000|Capecitabine|capecitabine|mesh-list
110860497|NCT04641975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110860498|NCT04641975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110860499|NCT04641975|Urological Agents|urological agents|mesh-ancestor
110310446|NCT00312156|Insulin|insulin|mesh-list
110860501|NCT04638660|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110860502|NCT04638660|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110860503|NCT04638660|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110860504|NCT04638660|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110860505|NCT04638660|Adrenergic Agents|adrenergic agents|mesh-ancestor
110310507|NCT00318981|Methylphenidate|methylphenidate|mesh-list
110860506|NCT04638660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110860507|NCT04638660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110860508|NCT04638660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110860509|NCT04638660|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110860510|NCT04623775|Paclitaxel|paclitaxel|mesh-list
110860511|NCT04623775|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110860512|NCT04623775|Carboplatin|carboplatin|mesh-list
110860513|NCT04623775|Nivolumab|nivolumab|mesh-list
110860514|NCT04623775|Pemetrexed|pemetrexed|mesh-list
110860515|NCT04623775|Relatlimab|relatlimab|mesh-list
110860516|NCT04623775|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110860517|NCT04623775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110860518|NCT04623775|Tubulin Modulators|tubulin modulators|mesh-ancestor
110860519|NCT04623775|Antimitotic Agents|antimitotic agents|mesh-ancestor
110860520|NCT04623775|Mitosis Modulators|mitosis modulators|mesh-ancestor
110860521|NCT04623775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110860522|NCT04623775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110860523|NCT04623775|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110860524|NCT04623775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110860525|NCT04623775|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110860526|NCT04623775|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110860527|NCT04613492|Durvalumab|durvalumab|mesh-list
110860528|NCT04613492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110860529|NCT04613492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110860530|NCT04593329|Dipyrone|dipyrone|mesh-list
110860531|NCT04593329|Tramadol|tramadol|mesh-list
110860532|NCT04593329|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110860533|NCT04593329|Narcotics|narcotics|mesh-ancestor
110860534|NCT04593329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110860535|NCT04593329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110860536|NCT04593329|Analgesics|analgesics|mesh-ancestor
110860537|NCT04593329|Sensory System Agents|sensory system agents|mesh-ancestor
110860538|NCT04593329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110860539|NCT04593329|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110860540|NCT04593329|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110860541|NCT04593329|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110860542|NCT04593329|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110860543|NCT04593329|Antipyretics|antipyretics|mesh-ancestor
110860544|NCT04585958|Trastuzumab|trastuzumab|mesh-list
110860545|NCT04585958|Olaparib|olaparib|mesh-list
110860546|NCT04585958|Camptothecin|camptothecin|mesh-list
110860547|NCT04585958|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
110860548|NCT04585958|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
110860549|NCT04585958|Immunoconjugates|immunoconjugates|mesh-list
110860550|NCT04585958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110860551|NCT04585958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110860552|NCT04585958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110860553|NCT04585958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110860554|NCT04585958|Immunologic Factors|immunologic factors|mesh-ancestor
110860555|NCT04585958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110860556|NCT04585958|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110860557|NCT04585958|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110860558|NCT04585958|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110860563|NCT04448392|Valacyclovir|valacyclovir|mesh-list
110860564|NCT04448392|Antiviral Agents|antiviral agents|mesh-ancestor
110860565|NCT04448392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110860566|NCT04388904|Tenofovir|tenofovir|mesh-list
110860567|NCT04388904|Emtricitabine|emtricitabine|mesh-list
110860568|NCT04388904|Darunavir|darunavir|mesh-list
110860569|NCT04388904|Cobicistat|cobicistat|mesh-list
110860570|NCT04388904|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
110860571|NCT04388904|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
110860572|NCT04388904|Antiviral Agents|antiviral agents|mesh-ancestor
110860573|NCT04388904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110860574|NCT04388904|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110860575|NCT04388904|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110860576|NCT04388904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110860577|NCT04388904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110860578|NCT04388904|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110860579|NCT04388904|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110860580|NCT04388904|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110860581|NCT04388904|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110860582|NCT04388904|Protease Inhibitors|protease inhibitors|mesh-ancestor
110860583|NCT04388904|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110860584|NCT04388904|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110860586|NCT04375384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110860587|NCT04375384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110860588|NCT04373941|Lenograstim|lenograstim|mesh-list
110860589|NCT04373941|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110860590|NCT04373941|Immunologic Factors|immunologic factors|mesh-ancestor
110860591|NCT04373941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110860592|NCT04332068|Ivermectin|ivermectin|mesh-list
110860593|NCT04332068|Permethrin|permethrin|mesh-list
110310582|NCT00319332|Tositumomab I-131|tositumomab i-131|mesh-list
110860594|NCT04332068|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110860595|NCT04332068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110860596|NCT04332068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110860597|NCT04332068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110860598|NCT04281706|Propofol|propofol|mesh-list
110860599|NCT04281706|Etomidate|etomidate|mesh-list
110860600|NCT04281706|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110860601|NCT04281706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110860602|NCT04281706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110860603|NCT04281706|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110860604|NCT04281706|Anesthetics, General|anesthetics, general|mesh-ancestor
110860605|NCT04281706|Anesthetics|anesthetics|mesh-ancestor
110860606|NCT04246437|Carbidopa|carbidopa|mesh-list
110860607|NCT04246437|Entacapone|entacapone|mesh-list
110860608|NCT04246437|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110860609|NCT04246437|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110860610|NCT04246437|Dopamine Agents|dopamine agents|mesh-ancestor
110860611|NCT04246437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110860612|NCT04246437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110860613|NCT04246437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110860614|NCT04246437|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
110860615|NCT04246437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110860616|NCT04246437|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
110860617|NCT04161885|Azacitidine|azacitidine|mesh-list
110860618|NCT04161885|Venetoclax|venetoclax|mesh-list
110860619|NCT04161885|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110860620|NCT04161885|Antimetabolites|antimetabolites|mesh-ancestor
110860621|NCT04161885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110860622|NCT04161885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110860623|NCT04161885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110860624|NCT04111458|Trametinib|trametinib|mesh-list
110860625|NCT04111458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110310837|NCT00286403|Fenoldopam|fenoldopam|mesh-list
110860627|NCT04111458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110860628|NCT04111458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110860629|NCT04100018|Prednisone|prednisone|mesh-list
110860631|NCT04100018|Nivolumab|nivolumab|mesh-list
110860632|NCT04100018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110860633|NCT04100018|Tubulin Modulators|tubulin modulators|mesh-ancestor
110860634|NCT04100018|Antimitotic Agents|antimitotic agents|mesh-ancestor
110860635|NCT04100018|Mitosis Modulators|mitosis modulators|mesh-ancestor
110310980|NCT00313521|Thiotepa|thiotepa|mesh-list
110860636|NCT04100018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110860637|NCT04100018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110860640|NCT04100018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110860641|NCT04100018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110860642|NCT04100018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110860643|NCT04100018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110860644|NCT04100018|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110860645|NCT04098744|Artesunate|artesunate|mesh-list
110860646|NCT04098744|Artemisinins|artemisinins|mesh-list
110860647|NCT04098744|Artemisinin|artemisinin|mesh-list
110860648|NCT04098744|Antimalarials|antimalarials|mesh-ancestor
110860649|NCT04098744|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110860650|NCT04098744|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110860651|NCT04098744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110311106|NCT00287651|Insulin|insulin|mesh-list
110860652|NCT04098744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110860653|NCT04098744|Antiviral Agents|antiviral agents|mesh-ancestor
110860654|NCT04098744|Schistosomicides|schistosomicides|mesh-ancestor
110860655|NCT04098744|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110860656|NCT04098744|Anthelmintics|anthelmintics|mesh-ancestor
110860657|NCT04082754|Antibodies|antibodies|mesh-list
110860658|NCT04082754|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110860659|NCT04082754|Immunologic Factors|immunologic factors|mesh-ancestor
110860660|NCT04082754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110860662|NCT04049539|Daunorubicin|daunorubicin|mesh-list
110860663|NCT04049539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110860664|NCT04049539|Antimetabolites|antimetabolites|mesh-ancestor
110860665|NCT04049539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110860666|NCT04049539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110860667|NCT04049539|Antiviral Agents|antiviral agents|mesh-ancestor
110860668|NCT04049539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110860669|NCT04049539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110860670|NCT04049539|Immunologic Factors|immunologic factors|mesh-ancestor
110860671|NCT04049539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110860673|NCT04049539|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110860674|NCT04049539|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110860676|NCT03997370|Carboplatin|carboplatin|mesh-list
110860677|NCT03997370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110860678|NCT03976323|Cisplatin|cisplatin|mesh-list
110860679|NCT03976323|Carboplatin|carboplatin|mesh-list
110860680|NCT03976323|Pembrolizumab|pembrolizumab|mesh-list
110860681|NCT03976323|Pemetrexed|pemetrexed|mesh-list
110860682|NCT03976323|Olaparib|olaparib|mesh-list
110860683|NCT03976323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110860684|NCT03976323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110860685|NCT03976323|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110860686|NCT03976323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110860687|NCT03976323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110860688|NCT03976323|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110311581|NCT00289445|Alkylating Agents|alkylating agents|mesh-ancestor
110860689|NCT03976323|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110860690|NCT03976323|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110860691|NCT03974152|Nicotine|nicotine|mesh-list
110860692|NCT03974152|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110860693|NCT03974152|Autonomic Agents|autonomic agents|mesh-ancestor
110860694|NCT03974152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110860695|NCT03974152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110860696|NCT03974152|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110860697|NCT03974152|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110860698|NCT03974152|Cholinergic Agents|cholinergic agents|mesh-ancestor
110860699|NCT03974152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110860700|NCT03974152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110860701|NCT03940586|Letermovir|letermovir|mesh-list
110860702|NCT03940586|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110860703|NCT03940586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110860704|NCT03940586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110860705|NCT03940586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110860706|NCT03940586|Antiviral Agents|antiviral agents|mesh-ancestor
110860707|NCT03940586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110860708|NCT03933215|Cladribine|cladribine|mesh-list
110860709|NCT03933215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110860710|NCT03933215|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110860711|NCT03933215|Immunologic Factors|immunologic factors|mesh-ancestor
110860712|NCT03933215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110860714|NCT03905694|Renal Agents|renal agents|mesh-ancestor
110860715|NCT03826628|Sirolimus|sirolimus|mesh-list
110860716|NCT03826628|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110860717|NCT03826628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110860718|NCT03826628|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110860719|NCT03826628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110860720|NCT03826628|Antifungal Agents|antifungal agents|mesh-ancestor
110860721|NCT03826628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110860722|NCT03826628|Immunologic Factors|immunologic factors|mesh-ancestor
110860723|NCT03826628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110860725|NCT03772028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110860726|NCT03740165|Paclitaxel|paclitaxel|mesh-list
110860727|NCT03740165|Docetaxel|docetaxel|mesh-list
110860728|NCT03740165|Bevacizumab|bevacizumab|mesh-list
110860729|NCT03740165|Carboplatin|carboplatin|mesh-list
110860730|NCT03740165|Pembrolizumab|pembrolizumab|mesh-list
110860731|NCT03740165|Olaparib|olaparib|mesh-list
110860732|NCT03740165|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110860733|NCT03740165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110860734|NCT03740165|Tubulin Modulators|tubulin modulators|mesh-ancestor
110860735|NCT03740165|Antimitotic Agents|antimitotic agents|mesh-ancestor
110860736|NCT03740165|Mitosis Modulators|mitosis modulators|mesh-ancestor
110860737|NCT03740165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110860738|NCT03740165|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110860739|NCT03740165|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110860740|NCT03740165|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110860741|NCT03740165|Growth Substances|growth substances|mesh-ancestor
110860742|NCT03740165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110860743|NCT03740165|Growth Inhibitors|growth inhibitors|mesh-ancestor
110860744|NCT03740165|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110860745|NCT03740165|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110860746|NCT03740165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110860747|NCT03737240|Insulin|insulin|mesh-list
110860748|NCT03737240|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110860749|NCT03737240|Insulin Aspart|insulin aspart|mesh-list
110860750|NCT03737240|Liraglutide|liraglutide|mesh-list
110311922|NCT00291707|Cetuximab|cetuximab|mesh-list
110860752|NCT03737240|Xultophy|xultophy|mesh-list
110860753|NCT03737240|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110860754|NCT03737240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110860755|NCT03737240|Incretins|incretins|mesh-ancestor
110860756|NCT03737240|Hormones|hormones|mesh-ancestor
110860757|NCT03737240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110860758|NCT03719768|Avelumab|avelumab|mesh-list
110860759|NCT03719768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110860760|NCT03719768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110860761|NCT03681184|Lumasiran|lumasiran|mesh-list
110860762|NCT03681184|Renal Agents|renal agents|mesh-ancestor
110860763|NCT03634488|Hydroxyurea|hydroxyurea|mesh-list
110860764|NCT03634488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110860765|NCT03634488|Antisickling Agents|antisickling agents|mesh-ancestor
110860766|NCT03634488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110860767|NCT03634488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110860768|NCT03634488|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110860769|NCT03632044|Ropivacaine|ropivacaine|mesh-list
110860770|NCT03632044|Anesthetics, Local|anesthetics, local|mesh-ancestor
110860771|NCT03632044|Anesthetics|anesthetics|mesh-ancestor
110860772|NCT03632044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110860773|NCT03632044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110860774|NCT03632044|Sensory System Agents|sensory system agents|mesh-ancestor
110860775|NCT03632044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110860776|NCT03582722|Orlistat|orlistat|mesh-list
110860777|NCT03582722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110860778|NCT03582722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110860779|NCT03582722|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110860780|NCT03582722|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110860782|NCT03564340|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110860784|NCT03553875|Memantine|memantine|mesh-list
110860785|NCT03553875|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110860786|NCT03553875|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110860787|NCT03553875|Dopamine Agents|dopamine agents|mesh-ancestor
110860788|NCT03553875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110860789|NCT03553875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110860790|NCT03553875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110860791|NCT03553875|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110860792|NCT03553875|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110860793|NCT03532178|Rocuronium|rocuronium|mesh-list
110860794|NCT03532178|Succinylcholine|succinylcholine|mesh-list
110860795|NCT03532178|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110860796|NCT03532178|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110860797|NCT03532178|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110860798|NCT03532178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110860799|NCT03532178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110860800|NCT03532178|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
110860801|NCT03519997|Pembrolizumab|pembrolizumab|mesh-list
110312250|NCT00293150|Eplerenone|eplerenone|mesh-list
110860802|NCT03519997|Bavituximab|bavituximab|mesh-list
110860803|NCT03519997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110860804|NCT03519997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110860805|NCT03519997|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110860806|NCT03519997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110860807|NCT03511976|Methylphenidate|methylphenidate|mesh-list
110860808|NCT03511976|Amphetamine|amphetamine|mesh-list
110860809|NCT03511976|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110860810|NCT03511976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110860811|NCT03511976|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110860812|NCT03511976|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110860813|NCT03511976|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110860814|NCT03511976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110860815|NCT03511976|Dopamine Agents|dopamine agents|mesh-ancestor
110860816|NCT03511976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110860817|NCT03511976|Sympathomimetics|sympathomimetics|mesh-ancestor
110860818|NCT03511976|Autonomic Agents|autonomic agents|mesh-ancestor
110860819|NCT03511976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110860820|NCT03511976|Adrenergic Agents|adrenergic agents|mesh-ancestor
110860821|NCT03511976|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110860822|NCT03452111|ST 1435|st 1435|mesh-list
110860823|NCT03452111|Testosterone|testosterone|mesh-list
110860824|NCT03452111|Androgens|androgens|mesh-ancestor
110860825|NCT03452111|Hormones|hormones|mesh-ancestor
110860826|NCT03452111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110860827|NCT03452111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110860828|NCT03452111|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110860829|NCT03452111|Contraceptive Agents|contraceptive agents|mesh-ancestor
110860830|NCT03452111|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110860831|NCT03452111|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110860832|NCT03449901|Gemcitabine|gemcitabine|mesh-list
110860833|NCT03449901|Docetaxel|docetaxel|mesh-list
110860834|NCT03449901|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110860835|NCT03449901|Antimetabolites|antimetabolites|mesh-ancestor
110860836|NCT03449901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110860837|NCT03449901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110860838|NCT03449901|Tubulin Modulators|tubulin modulators|mesh-ancestor
110860839|NCT03449901|Antimitotic Agents|antimitotic agents|mesh-ancestor
110860840|NCT03449901|Mitosis Modulators|mitosis modulators|mesh-ancestor
110860841|NCT03441061|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
110860842|NCT03441061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110312440|NCT00325767|Albuterol|albuterol|mesh-list
110860843|NCT03441061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110860844|NCT03441061|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110860845|NCT03441061|Immunotoxins|immunotoxins|mesh-ancestor
110860846|NCT03441061|Immunoconjugates|immunoconjugates|mesh-ancestor
110860847|NCT03441061|Immunologic Factors|immunologic factors|mesh-ancestor
110860848|NCT03441061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110860849|NCT03417284|Melphalan|melphalan|mesh-list
110860850|NCT03417284|Lenograstim|lenograstim|mesh-list
110578376|NCT00763035|Purinergic Agonists|purinergic agonists|mesh-ancestor
110860851|NCT03417284|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110860852|NCT03417284|Immunologic Factors|immunologic factors|mesh-ancestor
110860853|NCT03417284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110860854|NCT03417284|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110860855|NCT03417284|Alkylating Agents|alkylating agents|mesh-ancestor
110860856|NCT03417284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110860857|NCT03417284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110312540|NCT00305487|Hormones|hormones|mesh-ancestor
110860858|NCT03417284|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110860859|NCT03417284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110860860|NCT03395184|PF-06700841|pf-06700841|mesh-list
110860861|NCT03395184|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110860863|NCT03395184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110860864|NCT03391869|Nivolumab|nivolumab|mesh-list
110860865|NCT03391869|Ipilimumab|ipilimumab|mesh-list
110860866|NCT03391869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110860867|NCT03391869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110860868|NCT03391869|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110860869|NCT03391869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110860870|NCT03363659|Copper|copper|mesh-list
110860871|NCT03363659|Temozolomide|temozolomide|mesh-list
110860872|NCT03363659|Disulfiram|disulfiram|mesh-list
110860873|NCT03363659|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110860874|NCT03363659|Alkylating Agents|alkylating agents|mesh-ancestor
110860875|NCT03363659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110860876|NCT03363659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110860877|NCT03363659|Trace Elements|trace elements|mesh-ancestor
110860878|NCT03363659|Micronutrients|micronutrients|mesh-ancestor
110860879|NCT03363659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110860880|NCT03363659|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110860881|NCT03363659|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
110860882|NCT03363659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110860883|NCT03295227|Pembrolizumab|pembrolizumab|mesh-list
110860884|NCT03295227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110860885|NCT03295227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110860886|NCT03295227|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110860887|NCT03295227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110860888|NCT03225664|Pembrolizumab|pembrolizumab|mesh-list
110860889|NCT03225664|Trametinib|trametinib|mesh-list
110860890|NCT03225664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110860891|NCT03225664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110860892|NCT03225664|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110860893|NCT03225664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110860894|NCT03225664|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110860895|NCT03225664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110860896|NCT03217747|Avelumab|avelumab|mesh-list
110860897|NCT03217747|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110860898|NCT03217747|Immunoglobulin G|immunoglobulin g|mesh-list
110860899|NCT03217747|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110860900|NCT03217747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110860901|NCT03217747|Immunologic Factors|immunologic factors|mesh-ancestor
110860902|NCT03217747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110860903|NCT03204812|Durvalumab|durvalumab|mesh-list
110860904|NCT03204812|Ipilimumab|ipilimumab|mesh-list
110860905|NCT03204812|Tremelimumab|tremelimumab|mesh-list
110860906|NCT03204812|Immunoglobulins|immunoglobulins|mesh-list
110860907|NCT03204812|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110860908|NCT03204812|Immunoglobulin G|immunoglobulin g|mesh-list
110860909|NCT03204812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110339187|NCT02945982|Antioxidants|antioxidants|mesh-ancestor
110860910|NCT03204812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110860911|NCT03204812|Immunologic Factors|immunologic factors|mesh-ancestor
110860912|NCT03204812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110860913|NCT03204812|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110860914|NCT03204812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110860915|NCT03201250|Dexamethasone|dexamethasone|mesh-list
110860916|NCT03201250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110860917|NCT03201250|Antiemetics|antiemetics|mesh-ancestor
110860918|NCT03201250|Autonomic Agents|autonomic agents|mesh-ancestor
110860919|NCT03201250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110860920|NCT03201250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110578450|NCT00842309|Cycloserine|cycloserine|mesh-list
110860921|NCT03201250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110860922|NCT03201250|Glucocorticoids|glucocorticoids|mesh-ancestor
110860923|NCT03201250|Hormones|hormones|mesh-ancestor
110860924|NCT03201250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110860925|NCT03201250|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110860926|NCT03201250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110860927|NCT03164616|Cisplatin|cisplatin|mesh-list
110860928|NCT03164616|Carboplatin|carboplatin|mesh-list
110860929|NCT03164616|Gemcitabine|gemcitabine|mesh-list
110860930|NCT03164616|Pemetrexed|pemetrexed|mesh-list
110860932|NCT03164616|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110860933|NCT03164616|Tremelimumab|tremelimumab|mesh-list
110860934|NCT03164616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110860935|NCT03164616|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110860936|NCT03164616|Antimetabolites|antimetabolites|mesh-ancestor
110860937|NCT03164616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110860938|NCT03164616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110860939|NCT03164616|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110860940|NCT03164616|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110860941|NCT03164616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110860942|NCT03149029|Pembrolizumab|pembrolizumab|mesh-list
110860943|NCT03149029|Trametinib|trametinib|mesh-list
110860944|NCT03149029|Dabrafenib|dabrafenib|mesh-list
110860945|NCT03149029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110860946|NCT03149029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110860947|NCT03149029|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110860948|NCT03149029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110860949|NCT03149029|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110860950|NCT03149029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110860952|NCT03132454|Dexamethasone acetate|dexamethasone acetate|mesh-list
110860953|NCT03132454|Sorafenib|sorafenib|mesh-list
110860954|NCT03132454|Decitabine|decitabine|mesh-list
110860955|NCT03132454|Palbociclib|palbociclib|mesh-list
110860956|NCT03132454|Ichthammol|ichthammol|mesh-list
110860957|NCT03132454|BB 1101|bb 1101|mesh-list
110860958|NCT03132454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110860959|NCT03132454|Antiemetics|antiemetics|mesh-ancestor
110860960|NCT03132454|Autonomic Agents|autonomic agents|mesh-ancestor
110860961|NCT03132454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110860962|NCT03132454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110860963|NCT03132454|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110860964|NCT03132454|Glucocorticoids|glucocorticoids|mesh-ancestor
110860965|NCT03132454|Hormones|hormones|mesh-ancestor
110860966|NCT03132454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110860967|NCT03132454|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110860968|NCT03132454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110860969|NCT03132454|Protease Inhibitors|protease inhibitors|mesh-ancestor
110860970|NCT03132454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110860971|NCT03132454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110860972|NCT03132454|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110860973|NCT03132454|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110860974|NCT03132454|Antimetabolites|antimetabolites|mesh-ancestor
110860975|NCT03132454|Dermatologic Agents|dermatologic agents|mesh-ancestor
110860976|NCT03006302|Cyclophosphamide|cyclophosphamide|mesh-list
110860977|NCT03006302|Pembrolizumab|pembrolizumab|mesh-list
110860978|NCT03006302|Immunologic Factors|immunologic factors|mesh-ancestor
110860979|NCT03006302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110860980|NCT03006302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110860981|NCT03006302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110860982|NCT03006302|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110860983|NCT03006302|Alkylating Agents|alkylating agents|mesh-ancestor
110860984|NCT03006302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110860985|NCT03006302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110860986|NCT03006302|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110860987|NCT03006302|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110860988|NCT03006302|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110860989|NCT03000387|Nicotine|nicotine|mesh-list
110860990|NCT03000387|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110860991|NCT03000387|Autonomic Agents|autonomic agents|mesh-ancestor
110860992|NCT03000387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110860993|NCT03000387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110860994|NCT03000387|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110860995|NCT03000387|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110578519|NCT00840827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110860996|NCT03000387|Cholinergic Agents|cholinergic agents|mesh-ancestor
110860997|NCT03000387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110860998|NCT03000387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110860999|NCT02960555|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110861000|NCT02960555|Immunologic Factors|immunologic factors|mesh-ancestor
110861001|NCT02960555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110312893|NCT00296972|Ribavirin|ribavirin|mesh-list
110861003|NCT02853305|Gemcitabine|gemcitabine|mesh-list
110861004|NCT02853305|Pembrolizumab|pembrolizumab|mesh-list
110861005|NCT02853305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110861006|NCT02853305|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110861007|NCT02853305|Antimetabolites|antimetabolites|mesh-ancestor
110861008|NCT02853305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110861009|NCT02853305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110861010|NCT02853305|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110861011|NCT02815995|Durvalumab|durvalumab|mesh-list
110861012|NCT02815995|Tremelimumab|tremelimumab|mesh-list
110861013|NCT02815995|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110861014|NCT02815995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110861015|NCT02735902|Aspirin|aspirin|mesh-list
110861016|NCT02735902|Vitamin K|vitamin k|mesh-list
110861017|NCT02735902|Anticoagulants|anticoagulants|mesh-list
110861018|NCT02735902|Vitamins|vitamins|mesh-ancestor
110861019|NCT02735902|Micronutrients|micronutrients|mesh-ancestor
110861020|NCT02735902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110861021|NCT02735902|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110861022|NCT02735902|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110861023|NCT02735902|Analgesics|analgesics|mesh-ancestor
110861024|NCT02735902|Sensory System Agents|sensory system agents|mesh-ancestor
110861025|NCT02735902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110861026|NCT02735902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110861028|NCT02735902|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110861029|NCT02735902|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110861030|NCT02735902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110861031|NCT02735902|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110861032|NCT02735902|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110861033|NCT02735902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110861034|NCT02735902|Antipyretics|antipyretics|mesh-ancestor
110861035|NCT02735902|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110861036|NCT02735902|Hemostatics|hemostatics|mesh-ancestor
110861037|NCT02735902|Coagulants|coagulants|mesh-ancestor
110861038|NCT02727803|Cyclophosphamide|cyclophosphamide|mesh-list
110861039|NCT02727803|Melphalan|melphalan|mesh-list
110861040|NCT02727803|Busulfan|busulfan|mesh-list
110861041|NCT02727803|Mechlorethamine|mechlorethamine|mesh-list
110861042|NCT02727803|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
110861043|NCT02727803|Rituximab|rituximab|mesh-list
110861044|NCT02727803|Fludarabine|fludarabine|mesh-list
110861045|NCT02727803|Fludarabine phosphate|fludarabine phosphate|mesh-list
110861046|NCT02727803|Clofarabine|clofarabine|mesh-list
110861047|NCT02727803|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110861048|NCT02727803|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110861049|NCT02727803|Antibodies|antibodies|mesh-list
110861050|NCT02727803|Immunoglobulins|immunoglobulins|mesh-list
110861051|NCT02727803|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110861052|NCT02727803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110861053|NCT02727803|Immunologic Factors|immunologic factors|mesh-ancestor
110861054|NCT02727803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110861055|NCT02727803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110861056|NCT02727803|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110861057|NCT02727803|Alkylating Agents|alkylating agents|mesh-ancestor
110861058|NCT02727803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110861059|NCT02727803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110861060|NCT02727803|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110861061|NCT02727803|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110861062|NCT02727803|Antimetabolites|antimetabolites|mesh-ancestor
110861063|NCT02689440|Venetoclax|venetoclax|mesh-list
110861064|NCT02689440|Dasatinib|dasatinib|mesh-list
110861065|NCT02689440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110861066|NCT02689440|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110861067|NCT02689440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110861068|NCT02689440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110861069|NCT02600949|Pembrolizumab|pembrolizumab|mesh-list
110861070|NCT02600949|Imiquimod|imiquimod|mesh-list
110861071|NCT02600949|Vaccines|vaccines|mesh-list
110861072|NCT02600949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110313003|NCT04231773|Autonomic Agents|autonomic agents|mesh-ancestor
110861073|NCT02600949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110861074|NCT02600949|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110861075|NCT02600949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110861076|NCT02600949|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110861077|NCT02600949|Immunologic Factors|immunologic factors|mesh-ancestor
110861078|NCT02600949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110861079|NCT02600949|Interferon Inducers|interferon inducers|mesh-ancestor
110861081|NCT02593175|Carboplatin|carboplatin|mesh-list
110861082|NCT02593175|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110861083|NCT02593175|Panitumumab|panitumumab|mesh-list
110339257|NCT00507962|Cisplatin|cisplatin|mesh-list
110861084|NCT02593175|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110861085|NCT02593175|Antibodies|antibodies|mesh-list
110861086|NCT02593175|Immunoglobulins|immunoglobulins|mesh-list
110861087|NCT02593175|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110861088|NCT02593175|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110861089|NCT02593175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110861090|NCT02593175|Tubulin Modulators|tubulin modulators|mesh-ancestor
110861091|NCT02593175|Antimitotic Agents|antimitotic agents|mesh-ancestor
110861092|NCT02593175|Mitosis Modulators|mitosis modulators|mesh-ancestor
110861093|NCT02593175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110861094|NCT02593175|Immunologic Factors|immunologic factors|mesh-ancestor
110861095|NCT02593175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110861096|NCT02524275|Docetaxel|docetaxel|mesh-list
110861097|NCT02524275|Capecitabine|capecitabine|mesh-list
110861098|NCT02524275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110861099|NCT02524275|Tubulin Modulators|tubulin modulators|mesh-ancestor
110861100|NCT02524275|Antimitotic Agents|antimitotic agents|mesh-ancestor
110861101|NCT02524275|Mitosis Modulators|mitosis modulators|mesh-ancestor
110861102|NCT02524275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110861103|NCT02524275|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110861104|NCT02524275|Antimetabolites|antimetabolites|mesh-ancestor
110861105|NCT02499120|Cetuximab|cetuximab|mesh-list
110861106|NCT02499120|Palbociclib|palbociclib|mesh-list
110861107|NCT02499120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110861108|NCT02499120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110861109|NCT02499120|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110861110|NCT02499120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110861111|NCT02499120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110861112|NCT02227992|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
110861113|NCT02227992|Hemostatics|hemostatics|mesh-ancestor
110861114|NCT02227992|Coagulants|coagulants|mesh-ancestor
110861115|NCT02101775|Gemcitabine|gemcitabine|mesh-list
110861116|NCT02101775|Adavosertib|adavosertib|mesh-list
110861117|NCT02101775|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110861118|NCT02101775|Antimetabolites|antimetabolites|mesh-ancestor
110861119|NCT02101775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110861120|NCT02101775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110861121|NCT02101775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110861122|NCT01955460|Aldesleukin|aldesleukin|mesh-list
110861123|NCT01955460|Cyclophosphamide|cyclophosphamide|mesh-list
110861124|NCT01955460|Fludarabine|fludarabine|mesh-list
110861125|NCT01955460|Fludarabine phosphate|fludarabine phosphate|mesh-list
110861126|NCT01955460|Interleukin-2|interleukin-2|mesh-list
110861127|NCT01955460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110861128|NCT01955460|Immunologic Factors|immunologic factors|mesh-ancestor
110861129|NCT01955460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110861130|NCT01955460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110861131|NCT01955460|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110861132|NCT01955460|Alkylating Agents|alkylating agents|mesh-ancestor
110861133|NCT01955460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110861134|NCT01955460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110861135|NCT01955460|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110861136|NCT01955460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110861137|NCT01955460|Antimetabolites|antimetabolites|mesh-ancestor
110861138|NCT01955460|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110861139|NCT01955460|Analgesics|analgesics|mesh-ancestor
110861140|NCT01955460|Sensory System Agents|sensory system agents|mesh-ancestor
110861141|NCT01955460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110861142|NCT01955460|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110861143|NCT01955460|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110861144|NCT01955460|Antiviral Agents|antiviral agents|mesh-ancestor
110861145|NCT01955460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110861147|NCT01931033|Oxytocics|oxytocics|mesh-ancestor
110861148|NCT01931033|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110861149|NCT01931033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110861150|NCT01919619|Lenalidomide|lenalidomide|mesh-list
110861151|NCT01919619|Ipilimumab|ipilimumab|mesh-list
110861152|NCT01919619|Immunologic Factors|immunologic factors|mesh-ancestor
110861153|NCT01919619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110861154|NCT01919619|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110861155|NCT01919619|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110861156|NCT01919619|Growth Substances|growth substances|mesh-ancestor
110313103|NCT00298454|Furosemide|furosemide|mesh-list
110861157|NCT01919619|Growth Inhibitors|growth inhibitors|mesh-ancestor
110861158|NCT01919619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110861159|NCT01919619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110861160|NCT01919619|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110861161|NCT01919619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110861163|NCT01906853|BCG Vaccine|bcg vaccine|mesh-list
110861164|NCT01906853|Immunologic Factors|immunologic factors|mesh-ancestor
110861165|NCT01906853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110861166|NCT01906853|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110861167|NCT01871766|Dactinomycin|dactinomycin|mesh-list
110861168|NCT01871766|Cyclophosphamide|cyclophosphamide|mesh-list
110861169|NCT01871766|Ifosfamide|ifosfamide|mesh-list
110861170|NCT01871766|Bevacizumab|bevacizumab|mesh-list
110861171|NCT01871766|Doxorubicin|doxorubicin|mesh-list
110861172|NCT01871766|Irinotecan|irinotecan|mesh-list
110861173|NCT01871766|Etoposide|etoposide|mesh-list
110861174|NCT01871766|Etoposide phosphate|etoposide phosphate|mesh-list
110861175|NCT01871766|Vincristine|vincristine|mesh-list
110861176|NCT01871766|Sorafenib|sorafenib|mesh-list
110861177|NCT01871766|Dexrazoxane|dexrazoxane|mesh-list
110861178|NCT01871766|Razoxane|razoxane|mesh-list
110861179|NCT01871766|Mitogens|mitogens|mesh-list
110861180|NCT01871766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110861181|NCT01871766|Immunologic Factors|immunologic factors|mesh-ancestor
110861182|NCT01871766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110313136|NCT05457894|Vaccines|vaccines|mesh-list
110861183|NCT01871766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110861184|NCT01871766|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110861185|NCT01871766|Alkylating Agents|alkylating agents|mesh-ancestor
110861186|NCT01871766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110861187|NCT01871766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110861188|NCT01871766|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110861189|NCT01871766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110861190|NCT01871766|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110861191|NCT01871766|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110861192|NCT01871766|Growth Substances|growth substances|mesh-ancestor
110861193|NCT01871766|Growth Inhibitors|growth inhibitors|mesh-ancestor
110861194|NCT01871766|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110861195|NCT01871766|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110861196|NCT01871766|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110861197|NCT01871766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110861198|NCT01871766|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110861199|NCT01871766|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110861200|NCT01871766|Tubulin Modulators|tubulin modulators|mesh-ancestor
110861201|NCT01871766|Antimitotic Agents|antimitotic agents|mesh-ancestor
110861202|NCT01871766|Mitosis Modulators|mitosis modulators|mesh-ancestor
110861203|NCT01871766|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110861204|NCT01871766|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110861205|NCT01871766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110861206|NCT01871766|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110861207|NCT01871766|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110861208|NCT01871766|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110861209|NCT01871766|Protective Agents|protective agents|mesh-ancestor
110861210|NCT01628029|Melatonin|melatonin|mesh-list
110861211|NCT01628029|Methylphenidate|methylphenidate|mesh-list
110861212|NCT01628029|Antioxidants|antioxidants|mesh-ancestor
110861213|NCT01628029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110861214|NCT01628029|Protective Agents|protective agents|mesh-ancestor
110861215|NCT01628029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110861216|NCT01628029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110861217|NCT01628029|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110834044|NCT01130909|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110861218|NCT01628029|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110861219|NCT01628029|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110861220|NCT01628029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110861221|NCT01628029|Dopamine Agents|dopamine agents|mesh-ancestor
110861222|NCT01628029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110861223|NCT01346787|Dexamethasone|dexamethasone|mesh-list
110861224|NCT01346787|Cyclophosphamide|cyclophosphamide|mesh-list
110861225|NCT01346787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110861226|NCT01346787|Immunologic Factors|immunologic factors|mesh-ancestor
110313389|NCT00301223|Analgesics|analgesics|mesh-ancestor
110861227|NCT01346787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110861228|NCT01346787|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110861229|NCT01346787|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110861230|NCT01346787|Alkylating Agents|alkylating agents|mesh-ancestor
110861231|NCT01346787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110861232|NCT01346787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110861233|NCT01346787|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110861234|NCT01346787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110861236|NCT01346787|Autonomic Agents|autonomic agents|mesh-ancestor
110861237|NCT01346787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110861238|NCT01346787|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110861239|NCT01346787|Glucocorticoids|glucocorticoids|mesh-ancestor
110861240|NCT01346787|Hormones|hormones|mesh-ancestor
110861241|NCT01346787|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110861242|NCT01346787|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110861244|NCT01064466|Etoposide phosphate|etoposide phosphate|mesh-list
110861245|NCT01064466|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110861246|NCT01064466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110861247|NCT01064466|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110861248|NCT01064466|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110861249|NCT01064466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110861250|NCT01064466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110861251|NCT01033565|Melatonin|melatonin|mesh-list
110861252|NCT01033565|Antioxidants|antioxidants|mesh-ancestor
110861253|NCT01033565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110861254|NCT01033565|Protective Agents|protective agents|mesh-ancestor
110861255|NCT01033565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110861256|NCT01033565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110861257|NCT00981656|Fluorouracil|fluorouracil|mesh-list
110861258|NCT00981656|Mitomycins|mitomycins|mesh-list
110861259|NCT00981656|Mitomycin|mitomycin|mesh-list
110861260|NCT00981656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110861261|NCT00981656|Antimetabolites|antimetabolites|mesh-ancestor
110861262|NCT00981656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110861263|NCT00981656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110861264|NCT00981656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110861265|NCT00981656|Immunologic Factors|immunologic factors|mesh-ancestor
110861266|NCT00981656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110861267|NCT00981656|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110861268|NCT00981656|Alkylating Agents|alkylating agents|mesh-ancestor
110861269|NCT00981656|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110861270|NCT00981656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110861271|NCT00742157|Hormones|hormones|mesh-list
110861272|NCT00742157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110861273|NCT00742157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110861274|NCT00539591|Interferons|interferons|mesh-list
110861275|NCT00539591|Interferon-alpha|interferon-alpha|mesh-list
110861276|NCT00539591|Interferon alpha-2|interferon alpha-2|mesh-list
110861277|NCT00539591|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110861278|NCT00539591|Temozolomide|temozolomide|mesh-list
110861279|NCT00539591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110861280|NCT00539591|Antiviral Agents|antiviral agents|mesh-ancestor
110861281|NCT00539591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110861282|NCT00539591|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110313833|NCT00332319|Casopitant|casopitant|mesh-list
110861283|NCT00539591|Alkylating Agents|alkylating agents|mesh-ancestor
110861284|NCT00539591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110861285|NCT00539591|Immunologic Factors|immunologic factors|mesh-ancestor
110861286|NCT00539591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110861287|NCT03293992|Latanoprost|latanoprost|mesh-list
110861288|NCT03293992|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110861289|NCT03293992|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110861290|NCT01332201|Tacrolimus|tacrolimus|mesh-list
110861291|NCT01332201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110861292|NCT01332201|Immunologic Factors|immunologic factors|mesh-ancestor
110861293|NCT01332201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110861294|NCT01332201|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110861295|NCT01332201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110861296|NCT01332201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110861297|NCT01332279|Everolimus|everolimus|mesh-list
110313962|NCT00304655|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110861298|NCT01332279|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110861299|NCT01332279|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110861300|NCT01332279|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110861301|NCT01332279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110314029|NCT00304811|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110861302|NCT01332279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110861303|NCT01332279|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110861304|NCT01332279|Immunologic Factors|immunologic factors|mesh-ancestor
110861305|NCT01332279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110861306|NCT01332279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110861307|NCT03298906|Ticlopidine|ticlopidine|mesh-list
110861308|NCT03298906|Esketamine|esketamine|mesh-list
110861309|NCT03298906|Antidepressive Agents|antidepressive agents|mesh-ancestor
110861310|NCT03298906|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110861311|NCT03298906|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110861312|NCT03298906|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110861313|NCT03298906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110861314|NCT03298906|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110861315|NCT03298906|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110861316|NCT03298906|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110861317|NCT03298906|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110314113|NCT00329394|Ketamine|ketamine|mesh-list
110861318|NCT03298906|Purinergic Agents|purinergic agents|mesh-ancestor
110861319|NCT03298906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110314160|NCT00329511|Sympatholytics|sympatholytics|mesh-ancestor
110861320|NCT03298906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110861321|NCT03298906|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110861322|NCT03298906|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110861323|NCT03298906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110861324|NCT03697629|Daratumumab|daratumumab|mesh-list
110861325|NCT03697629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110861326|NCT00398541|Losartan|losartan|mesh-list
110861327|NCT00398541|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110861328|NCT00398541|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110861329|NCT00398541|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110861330|NCT00398541|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110861331|NCT00398541|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110861332|NCT00398541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110861333|NCT00398541|Diuretics|diuretics|mesh-ancestor
110861334|NCT00398541|Natriuretic Agents|natriuretic agents|mesh-ancestor
110861335|NCT00398541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110861336|NCT00398541|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110861337|NCT00398541|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110861338|NCT03286582|Clobetasol|clobetasol|mesh-list
110861339|NCT03286582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110861340|NCT03286582|Glucocorticoids|glucocorticoids|mesh-ancestor
110861341|NCT03286582|Hormones|hormones|mesh-ancestor
110861342|NCT03286582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110861343|NCT03286582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110861344|NCT05202002|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
110861345|NCT05202002|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
110861346|NCT05202002|beta-Endorphin|beta-endorphin|mesh-list
110861347|NCT05202002|Hormones|hormones|mesh-ancestor
110861348|NCT05202002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110861349|NCT05202002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110861350|NCT05202002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110861351|NCT05202002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110861353|NCT02460640|Ropivacaine|ropivacaine|mesh-list
110861354|NCT02460640|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110861355|NCT02460640|Narcotics|narcotics|mesh-ancestor
110861356|NCT02460640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110861357|NCT02460640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110861358|NCT02460640|Analgesics|analgesics|mesh-ancestor
110861359|NCT02460640|Sensory System Agents|sensory system agents|mesh-ancestor
110861360|NCT02460640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110861361|NCT02460640|Anesthetics, Local|anesthetics, local|mesh-ancestor
110861362|NCT02460640|Anesthetics|anesthetics|mesh-ancestor
110861363|NCT03298516|Azacitidine|azacitidine|mesh-list
110861364|NCT03298516|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110861365|NCT03298516|Antimetabolites|antimetabolites|mesh-ancestor
110861366|NCT03298516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110861367|NCT03298516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110861368|NCT03298516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110861369|NCT03843008|Melatonin|melatonin|mesh-list
110861370|NCT03843008|Antioxidants|antioxidants|mesh-ancestor
110861371|NCT03843008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110861372|NCT03843008|Protective Agents|protective agents|mesh-ancestor
110861373|NCT03843008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110314776|NCT00334698|Sympathomimetics|sympathomimetics|mesh-ancestor
110861374|NCT03843008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110861375|NCT03285802|Everolimus|everolimus|mesh-list
110861376|NCT03285802|Letrozole|letrozole|mesh-list
110861377|NCT03285802|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110861378|NCT03285802|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110861379|NCT03285802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110861380|NCT03285802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110861381|NCT03285802|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110861382|NCT03285802|Immunologic Factors|immunologic factors|mesh-ancestor
110861383|NCT03285802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110861384|NCT03285802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110861385|NCT03285802|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110861386|NCT03285802|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110861387|NCT03285802|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110861388|NCT03285802|Hormone Antagonists|hormone antagonists|mesh-ancestor
110861389|NCT03285802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110861390|NCT05130086|Islatravir|islatravir|mesh-list
110861391|NCT05130086|Antiviral Agents|antiviral agents|mesh-ancestor
110861392|NCT05130086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110861393|NCT05130086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110861394|NCT05130086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110861395|NCT05130086|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110314986|NCT00336336|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110861396|NCT05130086|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110861397|NCT05130086|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110861398|NCT02461186|Piperaquine|piperaquine|mesh-list
110861399|NCT02461186|Artenimol|artenimol|mesh-list
110861400|NCT02461186|Antimalarials|antimalarials|mesh-ancestor
110861401|NCT02461186|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110861402|NCT02461186|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110861403|NCT02461186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110861404|NCT04921670|Infliximab|infliximab|mesh-list
110315092|NCT00336765|XL647|xl647|mesh-list
110861405|NCT04921670|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110861406|NCT04921670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110861407|NCT04921670|Dermatologic Agents|dermatologic agents|mesh-ancestor
110339304|NCT02953379|Mometasone Furoate|mometasone furoate|mesh-list
110861408|NCT04921670|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110861409|NCT04921670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110861410|NCT03512210|Sofosbuvir|sofosbuvir|mesh-list
110861411|NCT03512210|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
110861412|NCT03512210|Velpatasvir|velpatasvir|mesh-list
110861413|NCT03512210|Antiviral Agents|antiviral agents|mesh-ancestor
110861414|NCT03512210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110861415|NCT00383721|Mometasone Furoate|mometasone furoate|mesh-list
110861417|NCT00383721|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110861418|NCT00383721|Autonomic Agents|autonomic agents|mesh-ancestor
110861419|NCT00383721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110861420|NCT00383721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110861421|NCT00383721|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110861422|NCT00383721|Respiratory System Agents|respiratory system agents|mesh-ancestor
110861423|NCT00383721|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110861424|NCT00383721|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110861425|NCT00383721|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110861426|NCT00383721|Adrenergic Agents|adrenergic agents|mesh-ancestor
110861427|NCT00383721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110861428|NCT00383721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110861429|NCT00383721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110861430|NCT00383721|Dermatologic Agents|dermatologic agents|mesh-ancestor
110861431|NCT00383721|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110315320|NCT00307658|Immunoglobulins|immunoglobulins|mesh-list
110861434|NCT03292822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110861435|NCT03292822|Tubulin Modulators|tubulin modulators|mesh-ancestor
110861436|NCT03292822|Antimitotic Agents|antimitotic agents|mesh-ancestor
110861437|NCT03292822|Mitosis Modulators|mitosis modulators|mesh-ancestor
110861438|NCT03292822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110861439|NCT03297502|Pimecrolimus|pimecrolimus|mesh-list
110861441|NCT03297502|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110861442|NCT03297502|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110861443|NCT03297502|Analgesics|analgesics|mesh-ancestor
110861444|NCT03297502|Sensory System Agents|sensory system agents|mesh-ancestor
110861445|NCT03297502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110861446|NCT03297502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110861447|NCT03297502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110861448|NCT03297502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110861449|NCT03297502|Dermatologic Agents|dermatologic agents|mesh-ancestor
110861450|NCT03297502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110861451|NCT03297502|Immunologic Factors|immunologic factors|mesh-ancestor
110315595|NCT00309686|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110861452|NCT03297502|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110861453|NCT03297502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110861454|NCT03297502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110861455|NCT03292744|Cholecalciferol|cholecalciferol|mesh-list
110861456|NCT03292744|Alfacalcidol|alfacalcidol|mesh-list
110861457|NCT03292744|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
110861458|NCT03292744|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110861459|NCT03292744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110861460|NCT03292744|Vitamins|vitamins|mesh-ancestor
110861461|NCT03292744|Micronutrients|micronutrients|mesh-ancestor
110861462|NCT03292744|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110861463|NCT03035942|Dexamethasone|dexamethasone|mesh-list
110861464|NCT03035942|Ondansetron|ondansetron|mesh-list
110315743|NCT00338910|Hormones|hormones|mesh-ancestor
110861465|NCT03035942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110861466|NCT03035942|Antiemetics|antiemetics|mesh-ancestor
110861467|NCT03035942|Autonomic Agents|autonomic agents|mesh-ancestor
110861468|NCT03035942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110861469|NCT03035942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110861470|NCT03035942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110861471|NCT03035942|Glucocorticoids|glucocorticoids|mesh-ancestor
110861472|NCT03035942|Hormones|hormones|mesh-ancestor
110861473|NCT03035942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110861474|NCT03035942|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110861475|NCT03035942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110861476|NCT03035942|Antipruritics|antipruritics|mesh-ancestor
110861477|NCT03035942|Dermatologic Agents|dermatologic agents|mesh-ancestor
110861478|NCT03035942|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110861479|NCT03035942|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110861480|NCT03035942|Serotonin Agents|serotonin agents|mesh-ancestor
110861481|NCT03035942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110861482|NCT03035942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110861483|NCT02820519|Loxapine|loxapine|mesh-list
110861484|NCT02820519|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110861485|NCT02820519|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110315943|NCT00339417|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110834066|NCT03796507|Temozolomide|temozolomide|mesh-list
110861487|NCT02820519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110861488|NCT02820519|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110861489|NCT02820519|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110316012|NCT00342849|Succimer|succimer|mesh-list
110861490|NCT02820519|Dopamine Agents|dopamine agents|mesh-ancestor
110861491|NCT02820519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110861492|NCT02820519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110861493|NCT02616146|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110861494|NCT02616146|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110861495|NCT02616146|Levonorgestrel|levonorgestrel|mesh-list
110861496|NCT02616146|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110861498|NCT02616146|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
110861499|NCT02616146|Estradiol|estradiol|mesh-list
110861500|NCT02616146|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110861501|NCT02616146|Estrogens|estrogens|mesh-ancestor
110861502|NCT02616146|Hormones|hormones|mesh-ancestor
110316153|NCT00343239|Antimetabolites|antimetabolites|mesh-ancestor
110861503|NCT02616146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110861504|NCT02616146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110861505|NCT02616146|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110316229|NCT00313274|Clevudine|clevudine|mesh-list
110861506|NCT02616146|Contraceptive Agents|contraceptive agents|mesh-ancestor
110861507|NCT02616146|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110861508|NCT02616146|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110861509|NCT02616146|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110861510|NCT02616146|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110861511|NCT02616146|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110861512|NCT02616146|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110861513|NCT01332747|Atorvastatin|atorvastatin|mesh-list
110861514|NCT01332747|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110861515|NCT01332747|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110861516|NCT01332747|Antimetabolites|antimetabolites|mesh-ancestor
110861517|NCT01332747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110861518|NCT01332747|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110861519|NCT01332747|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110861520|NCT01332747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110861521|NCT03442413|Nicotine|nicotine|mesh-list
110316508|NCT00344409|Hematinics|hematinics|mesh-ancestor
110861522|NCT03442413|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110861523|NCT03442413|Autonomic Agents|autonomic agents|mesh-ancestor
110861524|NCT03442413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110861525|NCT03442413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110861526|NCT03442413|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110861527|NCT03442413|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110861528|NCT03442413|Cholinergic Agents|cholinergic agents|mesh-ancestor
110861529|NCT03442413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110861530|NCT03442413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110861531|NCT01337427|Interferons|interferons|mesh-list
110861532|NCT01337427|Interferon-beta|interferon-beta|mesh-list
110861533|NCT01337427|Interferon beta-1a|interferon beta-1a|mesh-list
110861534|NCT01337427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110861535|NCT01337427|Antiviral Agents|antiviral agents|mesh-ancestor
110316647|NCT00315536|Narcotics|narcotics|mesh-ancestor
110861536|NCT01337427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110861537|NCT01337427|Immunologic Factors|immunologic factors|mesh-ancestor
110861538|NCT01337427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110861539|NCT01337427|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110861541|NCT02459938|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
110861542|NCT02459938|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110861543|NCT02459938|Hormones|hormones|mesh-ancestor
110861544|NCT02459938|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110861545|NCT02459938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110861546|NCT02459938|Incretins|incretins|mesh-ancestor
110861548|NCT03284164|Antiviral Agents|antiviral agents|mesh-ancestor
110861549|NCT03284164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110861550|NCT03284164|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110861551|NCT03284164|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110316784|NCT00316160|Dopamine Agents|dopamine agents|mesh-ancestor
110861552|NCT03284164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110861553|NCT03284164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110861554|NCT03284164|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110861555|NCT03284164|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110861556|NCT01337583|Dapivirine|dapivirine|mesh-list
110861557|NCT01337583|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110861558|NCT01337583|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110861559|NCT01337583|Antiviral Agents|antiviral agents|mesh-ancestor
110861560|NCT01337583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110861561|NCT03107962|Pembrolizumab|pembrolizumab|mesh-list
110861562|NCT03107962|Antibodies|antibodies|mesh-list
110861563|NCT03107962|Antibodies, Blocking|antibodies, blocking|mesh-list
110861564|NCT03107962|Immunologic Factors|immunologic factors|mesh-ancestor
110861565|NCT03107962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110861566|NCT03107962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110861567|NCT03107962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110861568|NCT03107962|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110861569|NCT03107962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110861570|NCT04891172|Immunoglobulins|immunoglobulins|mesh-list
110861571|NCT04891172|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110861572|NCT04891172|Antibodies|antibodies|mesh-list
110861573|NCT04891172|gamma-Globulins|gamma-globulins|mesh-list
110861574|NCT04891172|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110861575|NCT04891172|Immunologic Factors|immunologic factors|mesh-ancestor
110861576|NCT04891172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110861577|NCT03135249|Alemtuzumab|alemtuzumab|mesh-list
110861578|NCT03135249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110861579|NCT03135249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110861580|NCT01335321|Triamcinolone|triamcinolone|mesh-list
110861581|NCT01335321|Hyaluronic Acid|hyaluronic acid|mesh-list
110861583|NCT01335321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110861584|NCT01335321|Glucocorticoids|glucocorticoids|mesh-ancestor
110861585|NCT01335321|Hormones|hormones|mesh-ancestor
110861586|NCT01335321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110861587|NCT01335321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110861588|NCT01335321|Immunologic Factors|immunologic factors|mesh-ancestor
110861589|NCT01335321|Viscosupplements|viscosupplements|mesh-ancestor
110861590|NCT01335321|Protective Agents|protective agents|mesh-ancestor
110861591|NCT01335321|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110861592|NCT01333137|Carboplatin|carboplatin|mesh-list
110861594|NCT01333137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110861595|NCT01333137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110861596|NCT01333137|Antimetabolites|antimetabolites|mesh-ancestor
110317271|NCT00345735|Anesthetics, General|anesthetics, general|mesh-ancestor
110861597|NCT01333137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110861598|NCT03282838|Celecoxib|celecoxib|mesh-list
110861599|NCT03282838|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110861600|NCT03282838|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110861601|NCT03282838|Analgesics|analgesics|mesh-ancestor
110861602|NCT03282838|Sensory System Agents|sensory system agents|mesh-ancestor
110861603|NCT03282838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110861604|NCT03282838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110861605|NCT03282838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110861606|NCT03282838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110861607|NCT03282838|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110861608|NCT03282838|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110861609|NCT03282838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110861610|NCT03282838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110861612|NCT04431466|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110861613|NCT04431466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110861614|NCT03291418|Naproxen|naproxen|mesh-list
110861615|NCT03291418|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110317483|NCT00319787|Gefitinib|gefitinib|mesh-list
110861616|NCT03291418|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110861617|NCT03291418|Analgesics|analgesics|mesh-ancestor
110861618|NCT03291418|Sensory System Agents|sensory system agents|mesh-ancestor
110861619|NCT03291418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110861620|NCT03291418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110861621|NCT03291418|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110861622|NCT03291418|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110861623|NCT03291418|Gout Suppressants|gout suppressants|mesh-ancestor
110861624|NCT03291418|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110861625|NCT03291418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110861626|NCT03291418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110861627|NCT02885181|Methotrexate|methotrexate|mesh-list
110861628|NCT02885181|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110861629|NCT02885181|Abortifacient Agents|abortifacient agents|mesh-ancestor
110861630|NCT02885181|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110861631|NCT02885181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110861632|NCT02885181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110861633|NCT02885181|Antimetabolites|antimetabolites|mesh-ancestor
110861634|NCT02885181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110861635|NCT02885181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110861636|NCT02885181|Dermatologic Agents|dermatologic agents|mesh-ancestor
110861637|NCT02885181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110861638|NCT02885181|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110861639|NCT02885181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110861640|NCT02885181|Immunologic Factors|immunologic factors|mesh-ancestor
110861641|NCT02885181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110861642|NCT02885181|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110861643|NCT02459782|Anesthetics|anesthetics|mesh-list
110861644|NCT02459782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110861645|NCT02459782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110861646|NCT02884089|Metformin|metformin|mesh-list
110861647|NCT02884089|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110861648|NCT02884089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110861649|NCT01315431|Capecitabine|capecitabine|mesh-list
110317751|NCT00321581|Cediranib|cediranib|mesh-list
110861650|NCT01315431|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110861651|NCT01315431|Antimetabolites|antimetabolites|mesh-ancestor
110861652|NCT01315431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110861653|NCT01315431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110861655|NCT00092625|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110861656|NCT00092625|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110861657|NCT00092625|Antimetabolites|antimetabolites|mesh-ancestor
110317881|NCT00331188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110861658|NCT00092625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110861659|NCT00092625|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110861660|NCT01333449|Decitabine|decitabine|mesh-list
110861661|NCT01333449|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110861662|NCT01333449|Antimetabolites|antimetabolites|mesh-ancestor
110861663|NCT01333449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110861664|NCT01333449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110861665|NCT01333449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110861666|NCT01341717|Metformin|metformin|mesh-list
110861667|NCT01341717|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110861668|NCT01341717|Glimepiride|glimepiride|mesh-list
110861669|NCT01341717|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110861670|NCT01341717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110861671|NCT01341717|Incretins|incretins|mesh-ancestor
110861672|NCT01341717|Hormones|hormones|mesh-ancestor
110339339|NCT00526695|Anesthetics|anesthetics|mesh-ancestor
110861673|NCT01341717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110861674|NCT01341717|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110861675|NCT01341717|Protease Inhibitors|protease inhibitors|mesh-ancestor
110861676|NCT01341717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110861677|NCT01341717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110861678|NCT01341717|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110861679|NCT01341717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110861680|NCT01341717|Immunologic Factors|immunologic factors|mesh-ancestor
110861681|NCT03157089|Pembrolizumab|pembrolizumab|mesh-list
110861682|NCT03157089|Afatinib|afatinib|mesh-list
110861683|NCT03157089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110861685|NCT03157089|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110861686|NCT03157089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110861687|NCT03157089|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110861688|NCT03157089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110861689|NCT01338129|Ascorbic Acid|ascorbic acid|mesh-list
110861690|NCT01338129|Vitamins|vitamins|mesh-ancestor
110861691|NCT01338129|Micronutrients|micronutrients|mesh-ancestor
110861692|NCT01338129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110861693|NCT01338129|Antioxidants|antioxidants|mesh-ancestor
110861694|NCT01338129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110861695|NCT01338129|Protective Agents|protective agents|mesh-ancestor
110861696|NCT05181969|Dextrans|dextrans|mesh-list
110318144|NCT00324467|Prednisone|prednisone|mesh-list
110861697|NCT05181969|Anticoagulants|anticoagulants|mesh-ancestor
110861698|NCT05181969|Plasma Substitutes|plasma substitutes|mesh-ancestor
110861699|NCT05181969|Blood Substitutes|blood substitutes|mesh-ancestor
110861700|NCT00092157|Simvastatin|simvastatin|mesh-list
110861701|NCT00092157|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110861702|NCT00092157|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110861703|NCT00092157|Antimetabolites|antimetabolites|mesh-ancestor
110861704|NCT00092157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110861705|NCT00092157|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110861706|NCT00092157|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110861707|NCT00092157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110861708|NCT00089895|Eptifibatide|eptifibatide|mesh-list
110861709|NCT00089895|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110861710|NCT05166291|Anesthetics|anesthetics|mesh-list
110861711|NCT05166291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110861712|NCT05166291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110861713|NCT01338441|Erythromycin|erythromycin|mesh-list
110861714|NCT01338441|Erythromycin Estolate|erythromycin estolate|mesh-list
110861715|NCT01338441|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
110861716|NCT01338441|Erythromycin stearate|erythromycin stearate|mesh-list
110861717|NCT01338441|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110861718|NCT01338441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110861719|NCT01338441|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110861720|NCT01338441|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110861721|NCT01338441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110861722|NCT01338441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110861723|NCT01341951|Lenograstim|lenograstim|mesh-list
110861724|NCT01341951|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110861725|NCT01341951|Immunologic Factors|immunologic factors|mesh-ancestor
110861726|NCT01341951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110861727|NCT01342185|Glycyrrhizic Acid|glycyrrhizic acid|mesh-list
110861728|NCT01342185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110861729|NCT02714218|Nivolumab|nivolumab|mesh-list
110861730|NCT02714218|Ipilimumab|ipilimumab|mesh-list
110861731|NCT02714218|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110861732|NCT02714218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110861733|NCT02714218|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110861734|NCT02714218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110861735|NCT05185869|Paclitaxel|paclitaxel|mesh-list
110861736|NCT05185869|Gemcitabine|gemcitabine|mesh-list
110318349|NCT00325325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110861737|NCT05185869|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110861738|NCT05185869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110861739|NCT05185869|Tubulin Modulators|tubulin modulators|mesh-ancestor
110861740|NCT05185869|Antimitotic Agents|antimitotic agents|mesh-ancestor
110861741|NCT05185869|Mitosis Modulators|mitosis modulators|mesh-ancestor
110318397|NCT00354198|Pentoxifylline|pentoxifylline|mesh-list
110861742|NCT05185869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110861743|NCT05185869|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110861744|NCT05185869|Antimetabolites|antimetabolites|mesh-ancestor
110861745|NCT01338675|Busulfan|busulfan|mesh-list
110861746|NCT01338675|Alkylating Agents|alkylating agents|mesh-ancestor
110861747|NCT01338675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110861748|NCT01338675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110861749|NCT01338675|Immunologic Factors|immunologic factors|mesh-ancestor
110861750|NCT01338675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110861751|NCT01338675|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110861752|NCT01338675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110861753|NCT01338675|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110861754|NCT01338753|Bevacizumab|bevacizumab|mesh-list
110861755|NCT01338753|Docetaxel|docetaxel|mesh-list
110861756|NCT01338753|Doxorubicin|doxorubicin|mesh-list
110579274|NCT00761514|Adalimumab|adalimumab|mesh-list
110861757|NCT01338753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110861759|NCT01338753|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110861760|NCT01338753|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110861761|NCT01338753|Growth Substances|growth substances|mesh-ancestor
110861762|NCT01338753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110861763|NCT01338753|Growth Inhibitors|growth inhibitors|mesh-ancestor
110861764|NCT01338753|Tubulin Modulators|tubulin modulators|mesh-ancestor
110861765|NCT01338753|Antimitotic Agents|antimitotic agents|mesh-ancestor
110861766|NCT01338753|Mitosis Modulators|mitosis modulators|mesh-ancestor
110861767|NCT01338753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110861768|NCT01338753|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110861769|NCT01338753|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110861770|NCT01338753|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110861771|NCT01338753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110861772|NCT02457286|Metformin|metformin|mesh-list
110861773|NCT02457286|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110861774|NCT02457286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110861775|NCT01338909|Clopidogrel|clopidogrel|mesh-list
110861776|NCT01338909|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
110861777|NCT01338909|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110861778|NCT01338909|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110861779|NCT01338909|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110861780|NCT01338909|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110318579|NCT00419549|Analgesics|analgesics|mesh-ancestor
110861781|NCT01338909|Purinergic Agents|purinergic agents|mesh-ancestor
110861782|NCT01338909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110861783|NCT01338909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110861784|NCT01338909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110861785|NCT03282136|Incretins|incretins|mesh-list
110861786|NCT03282136|Hormones|hormones|mesh-ancestor
110318647|NCT04708353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110861787|NCT03282136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110861788|NCT03282136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110861790|NCT03156621|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
110861791|NCT03156621|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110861792|NCT03156621|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110318739|NCT00427089|Vitamins|vitamins|mesh-ancestor
110861794|NCT03156621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110861795|NCT03156621|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110861796|NCT03156621|Protease Inhibitors|protease inhibitors|mesh-ancestor
110861797|NCT03156621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110861798|NCT03156621|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110861799|NCT03264586|Lidocaine|lidocaine|mesh-list
110861800|NCT03264586|Prilocaine|prilocaine|mesh-list
110861801|NCT03264586|Mepivacaine|mepivacaine|mesh-list
110339356|NCT00508859|Sertraline|sertraline|mesh-list
110861802|NCT03264586|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
110861803|NCT03264586|Anesthetics, Local|anesthetics, local|mesh-ancestor
110861804|NCT03264586|Anesthetics|anesthetics|mesh-ancestor
110318860|NCT02957448|Rifampin|rifampin|mesh-list
110861805|NCT03264586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110861806|NCT03264586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110861807|NCT03264586|Sensory System Agents|sensory system agents|mesh-ancestor
110861808|NCT03264586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110861809|NCT03264586|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110861810|NCT03264586|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110861811|NCT03264586|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110861812|NCT03264586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110861813|NCT03264586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110861814|NCT03264586|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
110861815|NCT01342731|Tigecycline|tigecycline|mesh-list
110861816|NCT01342731|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110861817|NCT01342731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110861818|NCT01342731|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110861819|NCT01342731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110861820|NCT01342731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110861821|NCT01339065|Ketamine|ketamine|mesh-list
110861822|NCT01339065|Analgesics|analgesics|mesh-ancestor
110861823|NCT01339065|Sensory System Agents|sensory system agents|mesh-ancestor
110861824|NCT01339065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110861825|NCT01339065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110861826|NCT01339065|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110861827|NCT01339065|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110861828|NCT01339065|Anesthetics, General|anesthetics, general|mesh-ancestor
110861829|NCT01339065|Anesthetics|anesthetics|mesh-ancestor
110861830|NCT01339065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110861831|NCT01339065|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110861832|NCT01339065|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110861833|NCT01339065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110861834|NCT01339065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110861836|NCT02460016|Antiviral Agents|antiviral agents|mesh-ancestor
110861837|NCT02460016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110861838|NCT05187507|Theobromine|theobromine|mesh-list
110861839|NCT05187507|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110861840|NCT05187507|Autonomic Agents|autonomic agents|mesh-ancestor
110861841|NCT05187507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110861842|NCT05187507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110861843|NCT05187507|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110861844|NCT05187507|Respiratory System Agents|respiratory system agents|mesh-ancestor
110861845|NCT05187507|Vasodilator Agents|vasodilator agents|mesh-ancestor
110861847|NCT01339143|Vildagliptin|vildagliptin|mesh-list
110861848|NCT01339143|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110319200|NCT04716569|Ivermectin|ivermectin|mesh-list
110861849|NCT01339143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110861850|NCT01339143|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110861852|NCT01339143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110861853|NCT01339143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110861854|NCT03264430|Ketamine|ketamine|mesh-list
110861855|NCT03264430|Bupivacaine|bupivacaine|mesh-list
110861856|NCT03264430|Anesthetics, Local|anesthetics, local|mesh-ancestor
110861857|NCT03264430|Anesthetics|anesthetics|mesh-ancestor
110861858|NCT03264430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110861859|NCT03264430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110861860|NCT03264430|Sensory System Agents|sensory system agents|mesh-ancestor
110861861|NCT03264430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110861862|NCT03264430|Analgesics|analgesics|mesh-ancestor
110861863|NCT03264430|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110861864|NCT03264430|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110861865|NCT03264430|Anesthetics, General|anesthetics, general|mesh-ancestor
110319320|NCT04704297|Acetaminophen|acetaminophen|mesh-list
110861866|NCT03264430|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110861867|NCT03264430|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110861868|NCT03264430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110861869|NCT03264430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110861871|NCT05250843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110861872|NCT05250843|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110861873|NCT05250843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110861874|NCT05250843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110861875|NCT03264274|Aflibercept|aflibercept|mesh-list
110319386|NCT00328718|Fluticasone|fluticasone|mesh-list
110861876|NCT03264274|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110861877|NCT03264274|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110861878|NCT03264274|Growth Substances|growth substances|mesh-ancestor
110861879|NCT03264274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110861880|NCT03264274|Growth Inhibitors|growth inhibitors|mesh-ancestor
110861881|NCT03264274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110861882|NCT02457208|Rifampin|rifampin|mesh-list
110861883|NCT02457208|Isoniazid|isoniazid|mesh-list
110861884|NCT02457208|Pyrazinamide|pyrazinamide|mesh-list
110861885|NCT02457208|Ethambutol|ethambutol|mesh-list
110319447|NCT00328874|Vitamins|vitamins|mesh-ancestor
110861886|NCT02457208|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110861887|NCT02457208|Antitubercular Agents|antitubercular agents|mesh-ancestor
110861888|NCT02457208|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110861889|NCT02457208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110861890|NCT02457208|Leprostatic Agents|leprostatic agents|mesh-ancestor
110861891|NCT02457208|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110861892|NCT02457208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110861893|NCT02457208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110861894|NCT02457208|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110861895|NCT02457208|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110861896|NCT02457208|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110861897|NCT02457208|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110861898|NCT02457208|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110861899|NCT02457208|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110861900|NCT02457208|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
110861901|NCT02457208|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110861902|NCT02457208|Antimetabolites|antimetabolites|mesh-ancestor
110861903|NCT02457208|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110861904|NCT02457130|Clopidogrel|clopidogrel|mesh-list
110861906|NCT02457130|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110861907|NCT02457130|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110861908|NCT02457130|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110861909|NCT02457130|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110861910|NCT02457130|Purinergic Agents|purinergic agents|mesh-ancestor
110861911|NCT02457130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110861912|NCT02457130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110861913|NCT02457130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110861914|NCT01340235|Erythromycin|erythromycin|mesh-list
110861915|NCT01340235|Erythromycin Estolate|erythromycin estolate|mesh-list
110861916|NCT01340235|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
110861917|NCT01340235|Erythromycin stearate|erythromycin stearate|mesh-list
110861918|NCT01340235|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110861919|NCT01340235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110861920|NCT01340235|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110861921|NCT01340235|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110861922|NCT01340235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110861923|NCT01340235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110861924|NCT03263962|Canrenone|canrenone|mesh-list
110861925|NCT03263962|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110861926|NCT03263962|Hormone Antagonists|hormone antagonists|mesh-ancestor
110861927|NCT03263962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110861928|NCT03263962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110861929|NCT03263962|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110861930|NCT03263962|Diuretics|diuretics|mesh-ancestor
110861931|NCT03263962|Natriuretic Agents|natriuretic agents|mesh-ancestor
110861932|NCT05186649|Warfarin|warfarin|mesh-list
110861933|NCT05186649|Anticoagulants|anticoagulants|mesh-ancestor
110861934|NCT05184465|Anesthetics|anesthetics|mesh-list
110861935|NCT05184465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110861936|NCT05184465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110861937|NCT03152019|Tacrolimus|tacrolimus|mesh-list
110861938|NCT03152019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110861939|NCT03152019|Immunologic Factors|immunologic factors|mesh-ancestor
110861940|NCT03152019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110861941|NCT03152019|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110861942|NCT03152019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110861943|NCT03152019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110861944|NCT04813107|Tislelizumab|tislelizumab|mesh-list
110861945|NCT04813107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110861946|NCT04813107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110861947|NCT02714062|Topiramate|topiramate|mesh-list
110861948|NCT02714062|Phentermine|phentermine|mesh-list
110861949|NCT02714062|Anticonvulsants|anticonvulsants|mesh-ancestor
110861950|NCT02714062|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110861951|NCT02714062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110861952|NCT02714062|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110861953|NCT02714062|Appetite Depressants|appetite depressants|mesh-ancestor
110861954|NCT02714062|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110861955|NCT02714062|Sympathomimetics|sympathomimetics|mesh-ancestor
110861956|NCT02714062|Autonomic Agents|autonomic agents|mesh-ancestor
110861957|NCT02714062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110861958|NCT02714062|Adrenergic Agents|adrenergic agents|mesh-ancestor
110861959|NCT02714062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110861960|NCT02714062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110861961|NCT03280342|Topiramate|topiramate|mesh-list
110861962|NCT03280342|Anticonvulsants|anticonvulsants|mesh-ancestor
110861963|NCT03280342|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110861964|NCT03280342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110861965|NCT04965519|Trastuzumab|trastuzumab|mesh-list
110861966|NCT04965519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110861967|NCT04965519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110861968|NCT03279796|Betamethasone|betamethasone|mesh-list
110861969|NCT03279796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110861970|NCT03279796|Glucocorticoids|glucocorticoids|mesh-ancestor
110861971|NCT03279796|Hormones|hormones|mesh-ancestor
110861972|NCT03279796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110861973|NCT03279796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110861974|NCT03279796|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110861975|NCT03279796|Respiratory System Agents|respiratory system agents|mesh-ancestor
110861976|NCT02713828|Glembatumumab vedotin|glembatumumab vedotin|mesh-list
110861977|NCT02713828|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110861978|NCT02713828|Immunoconjugates|immunoconjugates|mesh-ancestor
110861979|NCT02713828|Immunologic Factors|immunologic factors|mesh-ancestor
110861980|NCT02713828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110861981|NCT02713828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110861982|NCT02713828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110861983|NCT05183997|Verapamil|verapamil|mesh-list
110861984|NCT05183997|Thrombin|thrombin|mesh-list
110861985|NCT05183997|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110861986|NCT05183997|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110861987|NCT05183997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110861988|NCT05183997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110861989|NCT05183997|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110861990|NCT05183997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110861991|NCT05183997|Vasodilator Agents|vasodilator agents|mesh-ancestor
110861992|NCT05183997|Hemostatics|hemostatics|mesh-ancestor
110861993|NCT05183997|Coagulants|coagulants|mesh-ancestor
110861994|NCT05119101|Magnesium Sulfate|magnesium sulfate|mesh-list
110861995|NCT05119101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110861996|NCT05119101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110861997|NCT05119101|Analgesics|analgesics|mesh-ancestor
110861998|NCT05119101|Sensory System Agents|sensory system agents|mesh-ancestor
110861999|NCT05119101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110320517|NCT00438087|Prednisolone acetate|prednisolone acetate|mesh-list
110862000|NCT05119101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110862001|NCT05119101|Anesthetics|anesthetics|mesh-ancestor
110862002|NCT05119101|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110862003|NCT05119101|Anticonvulsants|anticonvulsants|mesh-ancestor
110862004|NCT05119101|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110320587|NCT04701606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110862005|NCT05119101|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110862006|NCT05119101|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110862007|NCT05119101|Tocolytic Agents|tocolytic agents|mesh-ancestor
110862008|NCT05119101|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110862009|NCT01340547|Isophosphamide mustard|isophosphamide mustard|mesh-list
110862010|NCT01340547|Ifosfamide|ifosfamide|mesh-list
110862011|NCT01340547|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110862012|NCT01340547|Alkylating Agents|alkylating agents|mesh-ancestor
110862013|NCT01340547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110862014|NCT01340547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110862015|NCT05183841|Fenoterol|fenoterol|mesh-list
110862016|NCT05183841|Ipratropium|ipratropium|mesh-list
110320724|NCT00437229|Dexamethasone|dexamethasone|mesh-list
110862017|NCT05183841|Bronchodilator Agents|bronchodilator agents|mesh-list
110862018|NCT05183841|Autonomic Agents|autonomic agents|mesh-ancestor
110862019|NCT05183841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110862020|NCT05183841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110862021|NCT05183841|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110862022|NCT05183841|Respiratory System Agents|respiratory system agents|mesh-ancestor
110320867|NCT00437697|Anticoagulants|anticoagulants|mesh-ancestor
110862024|NCT05183841|Cholinergic Agents|cholinergic agents|mesh-ancestor
110862025|NCT05183841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110862026|NCT05183841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110862027|NCT05183841|Sympathomimetics|sympathomimetics|mesh-ancestor
110834107|NCT01134341|Vitamin B 12|vitamin b 12|mesh-list
110862028|NCT05183841|Tocolytic Agents|tocolytic agents|mesh-ancestor
110862029|NCT05183841|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110862030|NCT05183841|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110862031|NCT05183841|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110862032|NCT05183841|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110321005|NCT00336518|Ribavirin|ribavirin|mesh-list
110862034|NCT03277222|Insulin|insulin|mesh-list
110862035|NCT03277222|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110862036|NCT03277222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110862037|NCT04931667|Lorecivivint|lorecivivint|mesh-list
110862038|NCT04931667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110862039|NCT03262948|Paclitaxel|paclitaxel|mesh-list
110862040|NCT03262948|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110862041|NCT03262948|Carboplatin|carboplatin|mesh-list
110862042|NCT03262948|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110862043|NCT03262948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110862044|NCT03262948|Tubulin Modulators|tubulin modulators|mesh-ancestor
110862045|NCT03262948|Antimitotic Agents|antimitotic agents|mesh-ancestor
110862046|NCT03262948|Mitosis Modulators|mitosis modulators|mesh-ancestor
110862047|NCT03262948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110862048|NCT02876328|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
110862049|NCT02876328|Antiviral Agents|antiviral agents|mesh-ancestor
110862050|NCT02876328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110862051|NCT03276598|Losartan|losartan|mesh-list
110579565|NCT00914420|Trapidil|trapidil|mesh-list
110862052|NCT03276598|Amlodipine|amlodipine|mesh-list
110862054|NCT03276598|Bisoprolol|bisoprolol|mesh-list
110862055|NCT03276598|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110862056|NCT03276598|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110862057|NCT03276598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110862058|NCT03276598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110862059|NCT03276598|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110862060|NCT03276598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110862061|NCT03276598|Vasodilator Agents|vasodilator agents|mesh-ancestor
110862062|NCT03276598|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110862063|NCT03276598|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110862064|NCT03276598|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110862066|NCT03276598|Natriuretic Agents|natriuretic agents|mesh-ancestor
110862067|NCT03276598|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110862068|NCT03276598|Sympatholytics|sympatholytics|mesh-ancestor
110862069|NCT03276598|Autonomic Agents|autonomic agents|mesh-ancestor
110862070|NCT03276598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110862071|NCT03276598|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110862072|NCT03276598|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110862073|NCT03276598|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110862074|NCT03276598|Adrenergic Agents|adrenergic agents|mesh-ancestor
110862075|NCT03276598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110862076|NCT03262792|Andrographolide|andrographolide|mesh-list
110862077|NCT03262792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110862078|NCT03262792|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110862079|NCT03262792|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110862080|NCT03262792|Analgesics|analgesics|mesh-ancestor
110862081|NCT03262792|Sensory System Agents|sensory system agents|mesh-ancestor
110862082|NCT03262792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110862083|NCT03262792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110862084|NCT03262792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110862085|NCT03262792|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110862086|NCT03262792|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110862087|NCT03262792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110862088|NCT03262792|Antiviral Agents|antiviral agents|mesh-ancestor
110862089|NCT03262792|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110862090|NCT01359462|Tolvaptan|tolvaptan|mesh-list
110321393|NCT00445575|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110862091|NCT01359462|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
110862092|NCT01359462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110862093|NCT01359462|Natriuretic Agents|natriuretic agents|mesh-ancestor
110321459|NCT00446004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110862094|NCT01359462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110862096|NCT02875392|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110862097|NCT02875392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110862098|NCT02875392|Anticoagulants|anticoagulants|mesh-ancestor
110862099|NCT02875392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110862100|NCT01359618|Moxifloxacin|moxifloxacin|mesh-list
110862101|NCT01359618|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
110862102|NCT01359618|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110862103|NCT01359618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110862104|NCT01359618|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110862105|NCT01359618|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110862106|NCT01359618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110862107|NCT01359618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110862108|NCT01359618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110862109|NCT01359618|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110862110|NCT01359618|Contraceptive Agents|contraceptive agents|mesh-ancestor
110862111|NCT01359618|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110862112|NCT01359618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110862113|NCT01359618|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110862114|NCT01359618|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110862115|NCT01359618|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110862116|NCT03267628|Morphine|morphine|mesh-list
110862117|NCT03267628|Anesthetics|anesthetics|mesh-list
110862118|NCT03267628|Anesthetics, Local|anesthetics, local|mesh-list
110862119|NCT03267628|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110862120|NCT03267628|Narcotics|narcotics|mesh-ancestor
110862121|NCT03267628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110862122|NCT03267628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110862124|NCT03267628|Sensory System Agents|sensory system agents|mesh-ancestor
110579639|NCT00758160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110862125|NCT03267628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110862126|NCT01359696|Gemcitabine|gemcitabine|mesh-list
110862127|NCT01359696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110862128|NCT01359696|Antimetabolites|antimetabolites|mesh-ancestor
110862129|NCT01359696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110862130|NCT01359696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110862131|NCT03268018|Calcium|calcium|mesh-list
110862132|NCT03268018|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110862133|NCT03268018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110321874|NCT00343850|Mesalamine|mesalamine|mesh-list
110862134|NCT01362426|Paliperidone Palmitate|paliperidone palmitate|mesh-list
110862135|NCT01362426|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110862136|NCT01362426|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110862137|NCT01362426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110862138|NCT01362426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110862139|NCT01362426|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110862140|NCT01362426|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110862141|NCT01362426|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110862142|NCT01362426|Serotonin Agents|serotonin agents|mesh-ancestor
110862143|NCT01362426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110862144|NCT01362426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110862145|NCT01362426|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110862146|NCT01362426|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110862149|NCT01367028|Trastuzumab|trastuzumab|mesh-list
110862150|NCT01367028|Docetaxel|docetaxel|mesh-list
110862151|NCT01367028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110862152|NCT01367028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110322080|NCT00344942|Immunologic Factors|immunologic factors|mesh-ancestor
110862153|NCT01367028|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110862154|NCT01367028|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110862155|NCT01367028|Growth Substances|growth substances|mesh-ancestor
110862156|NCT01367028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110862157|NCT01367028|Growth Inhibitors|growth inhibitors|mesh-ancestor
110862158|NCT01367028|Tubulin Modulators|tubulin modulators|mesh-ancestor
110862159|NCT01367028|Antimitotic Agents|antimitotic agents|mesh-ancestor
110862160|NCT01367028|Mitosis Modulators|mitosis modulators|mesh-ancestor
110862161|NCT01367028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110862162|NCT03965962|Vaccines|vaccines|mesh-list
110862163|NCT03965962|Immunoglobulins|immunoglobulins|mesh-list
110862164|NCT03965962|Antibodies|antibodies|mesh-list
110862165|NCT03965962|gamma-Globulins|gamma-globulins|mesh-list
110862166|NCT03965962|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110862167|NCT03965962|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110862168|NCT03965962|Immunologic Factors|immunologic factors|mesh-ancestor
110862169|NCT03965962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110862170|NCT03273088|Etanercept|etanercept|mesh-list
110862171|NCT03273088|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110862172|NCT03273088|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110862173|NCT03273088|Analgesics|analgesics|mesh-ancestor
110862174|NCT03273088|Sensory System Agents|sensory system agents|mesh-ancestor
110862175|NCT03273088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110862176|NCT03273088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110862177|NCT03273088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110862178|NCT03273088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110862179|NCT03273088|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110862180|NCT03273088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110862181|NCT03273088|Immunologic Factors|immunologic factors|mesh-ancestor
110862183|NCT04235634|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110862184|NCT04235634|Vasodilator Agents|vasodilator agents|mesh-ancestor
110862185|NCT04235634|Urological Agents|urological agents|mesh-ancestor
110862186|NCT03262090|Dexmedetomidine|dexmedetomidine|mesh-list
110862187|NCT03262090|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110322641|NCT00348335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110862188|NCT03262090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110862189|NCT03262090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110862190|NCT03262090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110862191|NCT03262090|Analgesics|analgesics|mesh-ancestor
110862192|NCT03262090|Sensory System Agents|sensory system agents|mesh-ancestor
110862193|NCT03262090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110862194|NCT03262090|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110862195|NCT03262090|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110862196|NCT03262090|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110862197|NCT03262090|Adrenergic Agents|adrenergic agents|mesh-ancestor
110862198|NCT03262090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110862199|NCT03262090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110862200|NCT03151551|Adalimumab|adalimumab|mesh-list
110862202|NCT03151551|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110862203|NCT03151551|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110862204|NCT03151551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110862205|NCT03151551|Dermatologic Agents|dermatologic agents|mesh-ancestor
110862206|NCT03267316|Paclitaxel|paclitaxel|mesh-list
110862207|NCT03267316|Gemcitabine|gemcitabine|mesh-list
110322844|NCT00456339|Glucocorticoids|glucocorticoids|mesh-ancestor
110862208|NCT03267316|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110862209|NCT03267316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110862210|NCT03267316|Tubulin Modulators|tubulin modulators|mesh-ancestor
110862211|NCT03267316|Antimitotic Agents|antimitotic agents|mesh-ancestor
110862212|NCT03267316|Mitosis Modulators|mitosis modulators|mesh-ancestor
110862213|NCT03267316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110862214|NCT03267316|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110862215|NCT03267316|Antimetabolites|antimetabolites|mesh-ancestor
110862216|NCT01359930|Naltrexone|naltrexone|mesh-list
110862217|NCT01359930|Bupropion|bupropion|mesh-list
110862218|NCT01359930|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110862220|NCT01359930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110862221|NCT01359930|Sensory System Agents|sensory system agents|mesh-ancestor
110862222|NCT01359930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110862223|NCT01359930|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110862224|NCT01359930|Antidepressive Agents|antidepressive agents|mesh-ancestor
110862225|NCT01359930|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110862226|NCT01359930|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110862227|NCT01359930|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110862228|NCT01359930|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110862229|NCT01359930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110862230|NCT01359930|Dopamine Agents|dopamine agents|mesh-ancestor
110862231|NCT01359930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110323198|NCT00352430|Nitric Oxide|nitric oxide|mesh-list
110862232|NCT01359930|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110862233|NCT01359930|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110862234|NCT01359930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110862235|NCT05075512|Fulvestrant|fulvestrant|mesh-list
110862236|NCT05075512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110862237|NCT05075512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110862238|NCT05075512|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110862239|NCT05075512|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110862240|NCT05075512|Hormone Antagonists|hormone antagonists|mesh-ancestor
110862241|NCT05075512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110862242|NCT05075512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110862243|NCT01316757|Paclitaxel|paclitaxel|mesh-list
110862244|NCT01316757|Carboplatin|carboplatin|mesh-list
110862245|NCT01316757|Cetuximab|cetuximab|mesh-list
110862246|NCT01316757|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110862247|NCT01316757|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110862248|NCT01316757|Antibodies|antibodies|mesh-list
110862249|NCT01316757|Immunoglobulins|immunoglobulins|mesh-list
110862250|NCT01316757|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110862251|NCT01316757|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110862252|NCT01316757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110862253|NCT01316757|Tubulin Modulators|tubulin modulators|mesh-ancestor
110862254|NCT01316757|Antimitotic Agents|antimitotic agents|mesh-ancestor
110323471|NCT00354185|Belinostat|belinostat|mesh-list
110862256|NCT01316757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110862257|NCT01316757|Immunologic Factors|immunologic factors|mesh-ancestor
110862258|NCT01316757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110862259|NCT01316757|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110862260|NCT01316757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110862261|NCT05074966|Cetuximab|cetuximab|mesh-list
110862262|NCT05074966|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110323612|NCT00426101|Cyclosporine|cyclosporine|mesh-list
110339472|NCT00528060|Protease Inhibitors|protease inhibitors|mesh-ancestor
110862263|NCT05074966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110862264|NCT03266926|Bupivacaine|bupivacaine|mesh-list
110862265|NCT03266926|Estrogens|estrogens|mesh-list
110862266|NCT03266926|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
110862267|NCT03266926|Anesthetics, Local|anesthetics, local|mesh-ancestor
110862268|NCT03266926|Anesthetics|anesthetics|mesh-ancestor
110862269|NCT03266926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110862270|NCT03266926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110862271|NCT03266926|Sensory System Agents|sensory system agents|mesh-ancestor
110862272|NCT03266926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110862273|NCT03266926|Hormones|hormones|mesh-ancestor
110862274|NCT03266926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110862275|NCT01343745|Formoterol Fumarate|formoterol fumarate|mesh-list
110862276|NCT01343745|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110862277|NCT01343745|Autonomic Agents|autonomic agents|mesh-ancestor
110862278|NCT01343745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110862279|NCT01343745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110862280|NCT01343745|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110862281|NCT01343745|Respiratory System Agents|respiratory system agents|mesh-ancestor
110862282|NCT01343745|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110862283|NCT01343745|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110862284|NCT01343745|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110862285|NCT01343745|Adrenergic Agents|adrenergic agents|mesh-ancestor
110862286|NCT01343745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110862287|NCT01343745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110862288|NCT01367418|Sufentanil|sufentanil|mesh-list
110862289|NCT01367418|Morphine|morphine|mesh-list
110862290|NCT01367418|Bupivacaine|bupivacaine|mesh-list
110862292|NCT01367418|Anesthetics, Local|anesthetics, local|mesh-ancestor
110862293|NCT01367418|Anesthetics|anesthetics|mesh-ancestor
110862294|NCT01367418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110862295|NCT01367418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110862296|NCT01367418|Sensory System Agents|sensory system agents|mesh-ancestor
110862297|NCT01367418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110862298|NCT01367418|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110862299|NCT01367418|Narcotics|narcotics|mesh-ancestor
110862300|NCT01367418|Analgesics|analgesics|mesh-ancestor
110862301|NCT01367418|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110862302|NCT01367418|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110862303|NCT01367418|Anesthetics, General|anesthetics, general|mesh-ancestor
110862304|NCT01360086|Leucovorin|leucovorin|mesh-list
110862305|NCT01360086|Fluorouracil|fluorouracil|mesh-list
110862306|NCT01360086|Cetuximab|cetuximab|mesh-list
110862307|NCT01360086|Calcium|calcium|mesh-list
110862308|NCT01360086|Levoleucovorin|levoleucovorin|mesh-list
110862309|NCT01360086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110862310|NCT01360086|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110862311|NCT01360086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110862312|NCT01360086|Antimetabolites|antimetabolites|mesh-ancestor
110862313|NCT01360086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110323877|NCT00459771|Candesartan|candesartan|mesh-list
110862314|NCT01360086|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110862315|NCT01360086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110862316|NCT01360086|Immunologic Factors|immunologic factors|mesh-ancestor
110862317|NCT01360086|Antidotes|antidotes|mesh-ancestor
110862318|NCT01360086|Protective Agents|protective agents|mesh-ancestor
110862319|NCT01360086|Vitamin B Complex|vitamin b complex|mesh-ancestor
110862320|NCT01360086|Vitamins|vitamins|mesh-ancestor
110862321|NCT01360086|Micronutrients|micronutrients|mesh-ancestor
110862322|NCT01360086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110862323|NCT02458924|Niacin|niacin|mesh-list
110862324|NCT02458924|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110862325|NCT02458924|Antimetabolites|antimetabolites|mesh-ancestor
110862326|NCT02458924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110862327|NCT02458924|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110862328|NCT02458924|Vasodilator Agents|vasodilator agents|mesh-ancestor
110862329|NCT02458924|Vitamin B Complex|vitamin b complex|mesh-ancestor
110862330|NCT02458924|Vitamins|vitamins|mesh-ancestor
110862331|NCT02458924|Micronutrients|micronutrients|mesh-ancestor
110862332|NCT02458924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110862333|NCT01367496|Naltrexone|naltrexone|mesh-list
110862334|NCT01367496|Methylnaltrexone|methylnaltrexone|mesh-list
110862335|NCT01367496|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110862336|NCT01367496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110862337|NCT01367496|Sensory System Agents|sensory system agents|mesh-ancestor
110862338|NCT01367496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110862339|NCT01367496|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110862340|NCT02459158|Arbekacin|arbekacin|mesh-list
110862341|NCT02459158|Dibekacin|dibekacin|mesh-list
110862342|NCT02459158|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110862343|NCT02459158|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110862344|NCT02459158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110862345|NCT01367574|Methylnaltrexone|methylnaltrexone|mesh-list
110862346|NCT01367574|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110862347|NCT01367574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110862348|NCT01367574|Sensory System Agents|sensory system agents|mesh-ancestor
110579874|NCT00751023|Modafinil|modafinil|mesh-list
110862349|NCT01367574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110862350|NCT04693689|Vaccines|vaccines|mesh-list
110862351|NCT04693689|Immunologic Factors|immunologic factors|mesh-ancestor
110862352|NCT04693689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110834159|NCT03795571|Hormones|hormones|mesh-ancestor
110862353|NCT03126786|Triamcinolone|triamcinolone|mesh-list
110862354|NCT03126786|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110862355|NCT03126786|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110862356|NCT03126786|Aflibercept|aflibercept|mesh-list
110862357|NCT03126786|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110324072|NCT00428129|Plasminogen|plasminogen|mesh-list
110862358|NCT03126786|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110862359|NCT03126786|Glucocorticoids|glucocorticoids|mesh-ancestor
110862360|NCT03126786|Hormones|hormones|mesh-ancestor
110862361|NCT03126786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110862362|NCT03126786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110862363|NCT03126786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110862364|NCT03126786|Immunologic Factors|immunologic factors|mesh-ancestor
110862365|NCT03126786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110862366|NCT03126786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110862367|NCT03126786|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110862368|NCT03126786|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110862369|NCT03126786|Growth Substances|growth substances|mesh-ancestor
110862370|NCT03126786|Growth Inhibitors|growth inhibitors|mesh-ancestor
110862371|NCT03126786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110862373|NCT01367652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110862374|NCT01367652|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110862375|NCT01367652|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110862376|NCT01367652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110862377|NCT01367652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110862378|NCT01367652|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110862379|NCT01367652|Hormone Antagonists|hormone antagonists|mesh-ancestor
110862380|NCT01367652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110862381|NCT01367652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110862382|NCT02456584|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
110862383|NCT02456584|Medroxyprogesterone|medroxyprogesterone|mesh-list
110862384|NCT02456584|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110862385|NCT02456584|Contraceptive Agents|contraceptive agents|mesh-ancestor
110339506|NCT00509639|Metronidazole|metronidazole|mesh-list
110862386|NCT02456584|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110862387|NCT02456584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110324188|NCT00469404|Narcotics|narcotics|mesh-ancestor
110862388|NCT02456584|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110862389|NCT02456584|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110862390|NCT02456584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110862391|NCT02456584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110862392|NCT02456584|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110862393|NCT02456584|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110862394|NCT02456584|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110862395|NCT03146403|Vaccines|vaccines|mesh-list
110862396|NCT03146403|Immunologic Factors|immunologic factors|mesh-ancestor
110862397|NCT03146403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110862398|NCT01360476|Vitamin D|vitamin d|mesh-list
110862399|NCT01360476|Cholecalciferol|cholecalciferol|mesh-list
110862400|NCT01360476|Vitamins|vitamins|mesh-ancestor
110862401|NCT01360476|Micronutrients|micronutrients|mesh-ancestor
110862402|NCT01360476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110862403|NCT01360476|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110862404|NCT01360476|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110862405|NCT01317069|Fluorouracil|fluorouracil|mesh-list
110862406|NCT01317069|Antimetabolites|antimetabolites|mesh-ancestor
110862407|NCT01317069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110862408|NCT01317069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110862409|NCT01317069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110862410|NCT01317069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110862411|NCT01317069|Immunologic Factors|immunologic factors|mesh-ancestor
110862412|NCT01317069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110862413|NCT01317225|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
110862414|NCT01317225|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
110862415|NCT01317225|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110862416|NCT01317225|Hormone Antagonists|hormone antagonists|mesh-ancestor
110862417|NCT01317225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110862418|NCT01317225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110862419|NCT01317225|Progestins|progestins|mesh-ancestor
110862421|NCT01363206|Ipilimumab|ipilimumab|mesh-list
110862422|NCT01363206|Molgramostim|molgramostim|mesh-list
110862423|NCT01363206|Sargramostim|sargramostim|mesh-list
110862424|NCT01363206|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110862425|NCT01363206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110862426|NCT01363206|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110324515|NCT00431054|Docetaxel|docetaxel|mesh-list
110862427|NCT01363206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110862428|NCT01363206|Immunologic Factors|immunologic factors|mesh-ancestor
110862429|NCT01363206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110862430|NCT01344213|Celecoxib|celecoxib|mesh-list
110862431|NCT01344213|Pregabalin|pregabalin|mesh-list
110862432|NCT01344213|Analgesics|analgesics|mesh-ancestor
110862433|NCT01344213|Sensory System Agents|sensory system agents|mesh-ancestor
110862434|NCT01344213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110862435|NCT01344213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110324650|NCT04703465|Tenofovir|tenofovir|mesh-list
110862436|NCT01344213|Anticonvulsants|anticonvulsants|mesh-ancestor
110862437|NCT01344213|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110862438|NCT01344213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110862439|NCT01344213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110862440|NCT01344213|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110862441|NCT01344213|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110862442|NCT01344213|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110862443|NCT01344213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110862444|NCT01344213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110862445|NCT01344213|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110862446|NCT01344213|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110862447|NCT01344213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110862448|NCT01344213|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110862449|NCT01344213|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110862450|NCT01344213|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110862451|NCT01344213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110862452|NCT04416048|Rivaroxaban|rivaroxaban|mesh-list
110862453|NCT04416048|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110862454|NCT04416048|Antithrombins|antithrombins|mesh-ancestor
110862455|NCT04416048|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110862456|NCT04416048|Protease Inhibitors|protease inhibitors|mesh-ancestor
110862457|NCT04416048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110862458|NCT04416048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110862459|NCT04416048|Anticoagulants|anticoagulants|mesh-ancestor
110862460|NCT01363284|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110862461|NCT01363284|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110862462|NCT01363284|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110862463|NCT01363284|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110862464|NCT01363284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110862465|NCT01363284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110862466|NCT01363284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110862467|NCT01363284|Analgesics|analgesics|mesh-ancestor
110862468|NCT01363284|Sensory System Agents|sensory system agents|mesh-ancestor
110862469|NCT01363284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110862470|NCT01363284|Antidepressive Agents|antidepressive agents|mesh-ancestor
110862471|NCT01363284|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110862472|NCT01363284|Dopamine Agents|dopamine agents|mesh-ancestor
110862473|NCT03265834|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110862474|NCT03265834|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
110862475|NCT03265834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110862476|NCT03265834|Antitubercular Agents|antitubercular agents|mesh-ancestor
110862477|NCT01344291|Curcumin|curcumin|mesh-list
110862478|NCT01344291|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110862479|NCT01344291|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110324843|NCT00432575|Surinabant|surinabant|mesh-list
110862481|NCT01344291|Sensory System Agents|sensory system agents|mesh-ancestor
110862482|NCT01344291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110862483|NCT01344291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110862484|NCT01344291|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110862485|NCT01344291|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110862486|NCT01344291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110862487|NCT01344291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110862488|NCT01344291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110862489|NCT01367964|Hormones|hormones|mesh-list
110862490|NCT01367964|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
110339541|NCT02953106|Azelastine|azelastine|mesh-list
110862491|NCT01367964|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
110862492|NCT01367964|beta-Endorphin|beta-endorphin|mesh-list
110862493|NCT01367964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110862494|NCT01367964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110862495|NCT01367964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110862496|NCT01367964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110862497|NCT04326933|Imatinib Mesylate|imatinib mesylate|mesh-list
110862498|NCT04326933|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
110862499|NCT04326933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110862500|NCT04326933|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110862501|NCT04326933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110325115|NCT00464256|Rimonabant|rimonabant|mesh-list
110862502|NCT04326933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110862503|NCT04733560|Bupivacaine|bupivacaine|mesh-list
110862504|NCT04733560|Anesthetics, Local|anesthetics, local|mesh-ancestor
110862505|NCT04733560|Anesthetics|anesthetics|mesh-ancestor
110862506|NCT04733560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110862507|NCT04733560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110862508|NCT04733560|Sensory System Agents|sensory system agents|mesh-ancestor
110325177|NCT00464451|Dexmedetomidine|dexmedetomidine|mesh-list
110862509|NCT04733560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110862510|NCT01347957|Nitric Oxide|nitric oxide|mesh-list
110862511|NCT01347957|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110862512|NCT01347957|Autonomic Agents|autonomic agents|mesh-ancestor
110862513|NCT01347957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110862514|NCT01347957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110862515|NCT01347957|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110862516|NCT01347957|Respiratory System Agents|respiratory system agents|mesh-ancestor
110862517|NCT01347957|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110862518|NCT01347957|Antioxidants|antioxidants|mesh-ancestor
110862519|NCT01347957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110862520|NCT01347957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110325306|NCT01050062|Telmisartan|telmisartan|mesh-list
110862521|NCT01347957|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
110862522|NCT01347957|Vasodilator Agents|vasodilator agents|mesh-ancestor
110862523|NCT01347957|Gasotransmitters|gasotransmitters|mesh-ancestor
110862524|NCT01347957|Protective Agents|protective agents|mesh-ancestor
110862525|NCT04735965|Meperidine|meperidine|mesh-list
110862526|NCT04735965|Dexmedetomidine|dexmedetomidine|mesh-list
110862527|NCT04735965|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110862528|NCT04735965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110862529|NCT04735965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110862530|NCT04735965|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110862531|NCT04735965|Analgesics|analgesics|mesh-ancestor
110325377|NCT00472875|Glyburide|glyburide|mesh-list
110862532|NCT04735965|Sensory System Agents|sensory system agents|mesh-ancestor
110862533|NCT04735965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110862534|NCT04735965|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110862535|NCT04735965|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110862537|NCT04735965|Adrenergic Agents|adrenergic agents|mesh-ancestor
110862538|NCT04735965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110862539|NCT04735965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110862540|NCT04735965|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110862541|NCT04735965|Narcotics|narcotics|mesh-ancestor
110862542|NCT04735965|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110862543|NCT02456428|Insulin|insulin|mesh-list
110862544|NCT02456428|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110862545|NCT02456428|Metformin|metformin|mesh-list
110834178|NCT04211272|Riociguat|riociguat|mesh-list
110862547|NCT02456428|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110862548|NCT02456428|Liraglutide|liraglutide|mesh-list
110862549|NCT02456428|Exenatide|exenatide|mesh-list
110862550|NCT02456428|Glimepiride|glimepiride|mesh-list
110862551|NCT02456428|Rosiglitazone|rosiglitazone|mesh-list
110862552|NCT02456428|Vildagliptin|vildagliptin|mesh-list
110862553|NCT02456428|Saxagliptin|saxagliptin|mesh-list
110862554|NCT02456428|Acarbose|acarbose|mesh-list
110862555|NCT02456428|Hypoglycemic Agents|hypoglycemic agents|mesh-list
110862556|NCT02456428|Repaglinide|repaglinide|mesh-list
110862557|NCT02456428|Gliclazide|gliclazide|mesh-list
110862558|NCT02456428|Glipizide|glipizide|mesh-list
110862559|NCT02456428|Biguanides|biguanides|mesh-list
110862560|NCT02456428|Tolbutamide|tolbutamide|mesh-list
110862562|NCT02456428|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
110862563|NCT02456428|Nateglinide|nateglinide|mesh-list
110862564|NCT02456428|Miglitol|miglitol|mesh-list
110862565|NCT02456428|Troglitazone|troglitazone|mesh-list
110862566|NCT02456428|Meglitinide|meglitinide|mesh-list
110862567|NCT02456428|Acetohexamide|acetohexamide|mesh-list
110862568|NCT02456428|Phenformin|phenformin|mesh-list
110862569|NCT02456428|Chlorpropamide|chlorpropamide|mesh-list
110862570|NCT02456428|Buformin|buformin|mesh-list
110862571|NCT02456428|Glibornuride|glibornuride|mesh-list
110862572|NCT02456428|Tolazamide|tolazamide|mesh-list
110862573|NCT02456428|Carbutamide|carbutamide|mesh-list
110862574|NCT02456428|Gliquidone|gliquidone|mesh-list
110325579|NCT00481533|Oxytocin|oxytocin|mesh-list
110862575|NCT02456428|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
110862576|NCT02456428|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
110862578|NCT02456428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110862580|NCT02456428|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110862581|NCT02456428|Protease Inhibitors|protease inhibitors|mesh-ancestor
110862582|NCT02456428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110862583|NCT02456428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110862584|NCT02456428|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110862585|NCT02456428|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110862586|NCT02456428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110862587|NCT02456428|Immunologic Factors|immunologic factors|mesh-ancestor
110862588|NCT03259516|Cytarabine|cytarabine|mesh-list
110862589|NCT03259516|Cyclophosphamide|cyclophosphamide|mesh-list
110862590|NCT03259516|Melphalan|melphalan|mesh-list
110862591|NCT03259516|Nivolumab|nivolumab|mesh-list
110862592|NCT03259516|Fludarabine|fludarabine|mesh-list
110862593|NCT03259516|Azacitidine|azacitidine|mesh-list
110862594|NCT03259516|Tretinoin|tretinoin|mesh-list
110862595|NCT03259516|Sildenafil Citrate|sildenafil citrate|mesh-list
110862596|NCT03259516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110862597|NCT03259516|Immunologic Factors|immunologic factors|mesh-ancestor
110862598|NCT03259516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110862599|NCT03259516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110862600|NCT03259516|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110862601|NCT03259516|Alkylating Agents|alkylating agents|mesh-ancestor
110862602|NCT03259516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110862603|NCT03259516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110862604|NCT03259516|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110862605|NCT03259516|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110862606|NCT03259516|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110862607|NCT03259516|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110862608|NCT03259516|Antimetabolites|antimetabolites|mesh-ancestor
110862609|NCT03259516|Antiviral Agents|antiviral agents|mesh-ancestor
110862610|NCT03259516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110862611|NCT03259516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110862612|NCT03259516|Vasodilator Agents|vasodilator agents|mesh-ancestor
110862613|NCT03259516|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110862614|NCT03259516|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110862615|NCT03259516|Urological Agents|urological agents|mesh-ancestor
110862616|NCT03259516|Keratolytic Agents|keratolytic agents|mesh-ancestor
110862617|NCT03259516|Dermatologic Agents|dermatologic agents|mesh-ancestor
110862619|NCT01344681|Micafungin|micafungin|mesh-list
110862620|NCT01344681|Antifungal Agents|antifungal agents|mesh-ancestor
110862621|NCT01344681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110862622|NCT01344681|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110862623|NCT01344681|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110862624|NCT01344681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110862625|NCT01344681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110862626|NCT01344681|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110862628|NCT01344681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110862629|NCT01344681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110862630|NCT01344681|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110862631|NCT01348269|Zoledronic Acid|zoledronic acid|mesh-list
110862632|NCT01348269|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110325886|NCT00474435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110862633|NCT01348269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110862634|NCT03259672|Sevoflurane|sevoflurane|mesh-list
110862635|NCT03259672|Desflurane|desflurane|mesh-list
110862636|NCT03259672|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110862637|NCT03259672|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110862638|NCT03259672|Anesthetics, General|anesthetics, general|mesh-ancestor
110862639|NCT03259672|Anesthetics|anesthetics|mesh-ancestor
110862640|NCT03259672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110862641|NCT03259672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110862642|NCT03537742|Alirocumab|alirocumab|mesh-list
110862643|NCT03537742|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
110862644|NCT03537742|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110862645|NCT03537742|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110862646|NCT03537742|Antimetabolites|antimetabolites|mesh-ancestor
110862647|NCT03537742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110862648|NCT03537742|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110862649|NCT03537742|Protease Inhibitors|protease inhibitors|mesh-ancestor
110862650|NCT03537742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110862651|NCT03537742|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110862652|NCT03259282|gamma-Globulins|gamma-globulins|mesh-list
110580158|NCT02596776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110862653|NCT03259282|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110862654|NCT03259282|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110862655|NCT03259282|Immunologic Factors|immunologic factors|mesh-ancestor
110862656|NCT03259282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110862657|NCT03265288|Fenretinide|fenretinide|mesh-list
110862658|NCT03265288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110862659|NCT03265288|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110862660|NCT03265288|Protective Agents|protective agents|mesh-ancestor
110862661|NCT03265288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110862662|NCT03261310|Acetaminophen|acetaminophen|mesh-list
110862663|NCT03261310|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110862664|NCT03261310|Analgesics|analgesics|mesh-ancestor
110862665|NCT03261310|Sensory System Agents|sensory system agents|mesh-ancestor
110326080|NCT00438776|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110862666|NCT03261310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110862667|NCT03261310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110862668|NCT03261310|Antipyretics|antipyretics|mesh-ancestor
110862669|NCT02456350|Cyclophosphamide|cyclophosphamide|mesh-list
110862670|NCT02456350|Fludarabine|fludarabine|mesh-list
110862671|NCT02456350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110862672|NCT02456350|Immunologic Factors|immunologic factors|mesh-ancestor
110862673|NCT02456350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110862674|NCT02456350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110862675|NCT02456350|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110862676|NCT02456350|Alkylating Agents|alkylating agents|mesh-ancestor
110862677|NCT02456350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110862678|NCT02456350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110862679|NCT02456350|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110862680|NCT01319370|Minoxidil|minoxidil|mesh-list
110862681|NCT01319370|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110862682|NCT01319370|Vasodilator Agents|vasodilator agents|mesh-ancestor
110862683|NCT01363752|Mycophenolic Acid|mycophenolic acid|mesh-list
110862684|NCT01363752|Sirolimus|sirolimus|mesh-list
110862685|NCT01363752|Tacrolimus|tacrolimus|mesh-list
110862686|NCT01363752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110862687|NCT01363752|Immunologic Factors|immunologic factors|mesh-ancestor
110862688|NCT01363752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110862689|NCT01363752|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110862690|NCT01363752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110862691|NCT01363752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110862692|NCT01363752|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110862693|NCT01363752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110862694|NCT01363752|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110862695|NCT01363752|Antitubercular Agents|antitubercular agents|mesh-ancestor
110862696|NCT01363752|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110862697|NCT01363752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110862698|NCT01363752|Antifungal Agents|antifungal agents|mesh-ancestor
110862699|NCT01368198|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110862700|NCT01368198|Lubricant Eye Drops|lubricant eye drops|mesh-list
110862701|NCT01368198|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110862702|NCT01360710|Irbesartan|irbesartan|mesh-list
110862703|NCT01360710|Moxonidine|moxonidine|mesh-list
110862704|NCT01360710|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110326408|NCT00438321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110862705|NCT01360710|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110862706|NCT01360710|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110862707|NCT01360710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110862708|NCT01360788|Albuterol|albuterol|mesh-list
110862709|NCT01360788|Ipratropium|ipratropium|mesh-list
110862710|NCT01360788|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110862711|NCT01360788|Autonomic Agents|autonomic agents|mesh-ancestor
110862712|NCT01360788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110862713|NCT01360788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110862714|NCT01360788|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110862715|NCT01360788|Respiratory System Agents|respiratory system agents|mesh-ancestor
110862716|NCT01360788|Tocolytic Agents|tocolytic agents|mesh-ancestor
110862717|NCT01360788|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110862718|NCT01360788|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110862719|NCT01360788|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110862720|NCT01360788|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110862721|NCT01360788|Adrenergic Agents|adrenergic agents|mesh-ancestor
110862722|NCT01360788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110339624|NCT03459833|Immunologic Factors|immunologic factors|mesh-ancestor
110862723|NCT01360788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110862724|NCT01360788|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110862725|NCT01360788|Cholinergic Agents|cholinergic agents|mesh-ancestor
110862726|NCT01361022|Brotizolam|brotizolam|mesh-list
110862727|NCT01361022|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110862728|NCT01361022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110862729|NCT01361022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110862730|NCT01364220|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110862731|NCT01364220|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110862732|NCT01364220|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110862733|NCT01364220|Antimetabolites|antimetabolites|mesh-ancestor
110862734|NCT01364220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110862735|NCT01364220|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110326472|NCT00440648|Sevelamer|sevelamer|mesh-list
110862736|NCT01364220|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110862737|NCT01364220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110862738|NCT02713204|Aflibercept|aflibercept|mesh-list
110862739|NCT02713204|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110326515|NCT00440843|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110862740|NCT02713204|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110862741|NCT02713204|Growth Substances|growth substances|mesh-ancestor
110862742|NCT02713204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110862743|NCT02713204|Growth Inhibitors|growth inhibitors|mesh-ancestor
110862744|NCT02713204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110862745|NCT03695172|Ropivacaine|ropivacaine|mesh-list
110862746|NCT03695172|Anesthetics, Local|anesthetics, local|mesh-ancestor
110862747|NCT03695172|Anesthetics|anesthetics|mesh-ancestor
110862748|NCT03695172|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110862749|NCT03695172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110326645|NCT02957162|Antimetabolites|antimetabolites|mesh-ancestor
110862750|NCT03695172|Sensory System Agents|sensory system agents|mesh-ancestor
110862751|NCT03695172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110862752|NCT01364376|Leucovorin|leucovorin|mesh-list
110862753|NCT01364376|Oxaliplatin|oxaliplatin|mesh-list
110862754|NCT01364376|Calcium|calcium|mesh-list
110862755|NCT01364376|Levoleucovorin|levoleucovorin|mesh-list
110326715|NCT00442052|Aspirin|aspirin|mesh-list
110862756|NCT01364376|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110862757|NCT01364376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110834193|NCT04211272|Enzyme Activators|enzyme activators|mesh-ancestor
110862758|NCT01364376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110862759|NCT01364376|Antidotes|antidotes|mesh-ancestor
110862760|NCT01364376|Protective Agents|protective agents|mesh-ancestor
110862761|NCT01364376|Vitamin B Complex|vitamin b complex|mesh-ancestor
110862762|NCT01364376|Vitamins|vitamins|mesh-ancestor
110862763|NCT01364376|Micronutrients|micronutrients|mesh-ancestor
110862764|NCT01348503|Lenalidomide|lenalidomide|mesh-list
110862765|NCT01348503|Sorafenib|sorafenib|mesh-list
110862766|NCT01348503|Immunologic Factors|immunologic factors|mesh-ancestor
110862767|NCT01348503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110862768|NCT01348503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110326851|NCT00478101|Anesthetics|anesthetics|mesh-ancestor
110862769|NCT01348503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110862770|NCT01348503|Growth Substances|growth substances|mesh-ancestor
110339637|NCT00511121|Antiviral Agents|antiviral agents|mesh-ancestor
110862771|NCT01348503|Growth Inhibitors|growth inhibitors|mesh-ancestor
110862772|NCT01348503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110862773|NCT01348503|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110862774|NCT01348503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110862775|NCT01348503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110862776|NCT01369290|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110862777|NCT01369290|Bupropion|bupropion|mesh-list
110862778|NCT01369290|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
110862779|NCT01369290|Escitalopram|escitalopram|mesh-list
110862780|NCT01369290|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110862781|NCT01369290|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110862782|NCT01369290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110862783|NCT01369290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110862784|NCT01369290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110862785|NCT01369290|Serotonin Agents|serotonin agents|mesh-ancestor
110862786|NCT01369290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110862787|NCT01369290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110862788|NCT01369290|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110862789|NCT01369290|Antidepressive Agents|antidepressive agents|mesh-ancestor
110862790|NCT01369290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110862791|NCT01369290|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110862792|NCT01369290|Dopamine Agents|dopamine agents|mesh-ancestor
110862793|NCT01369290|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110862794|NCT01369290|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110862795|NCT01369290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110862796|NCT01369290|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110862798|NCT01369290|Sensory System Agents|sensory system agents|mesh-ancestor
110862799|NCT03533452|Ropivacaine|ropivacaine|mesh-list
110862800|NCT03533452|Anesthetics, Local|anesthetics, local|mesh-ancestor
110862801|NCT03533452|Anesthetics|anesthetics|mesh-ancestor
110862802|NCT03533452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110862803|NCT03533452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110862804|NCT03533452|Sensory System Agents|sensory system agents|mesh-ancestor
110862805|NCT03533452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110862806|NCT04359147|Hydrocortisone|hydrocortisone|mesh-list
110862807|NCT04359147|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
110862808|NCT04359147|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
110862809|NCT04359147|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
110862810|NCT04359147|Yohimbine|yohimbine|mesh-list
110862811|NCT04359147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110862812|NCT04359147|Mydriatics|mydriatics|mesh-ancestor
110862813|NCT04359147|Autonomic Agents|autonomic agents|mesh-ancestor
110862814|NCT04359147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110862815|NCT04359147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110327246|NCT04700592|Anesthetics|anesthetics|mesh-ancestor
110862816|NCT04359147|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
110862817|NCT04359147|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110862819|NCT04359147|Adrenergic Agents|adrenergic agents|mesh-ancestor
110862820|NCT04359147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110862821|NCT04359147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110862822|NCT04359147|Urological Agents|urological agents|mesh-ancestor
110862823|NCT01369368|Azacitidine|azacitidine|mesh-list
110862824|NCT01369368|Valproic Acid|valproic acid|mesh-list
110834200|NCT05402189|Sensory System Agents|sensory system agents|mesh-ancestor
110862825|NCT01369368|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110862826|NCT01369368|Antimetabolites|antimetabolites|mesh-ancestor
110862827|NCT01369368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110862828|NCT01369368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110862829|NCT01369368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110327387|NCT00442221|Sensory System Agents|sensory system agents|mesh-ancestor
110327388|NCT00442221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110327389|NCT00442221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110862830|NCT01369368|Anticonvulsants|anticonvulsants|mesh-ancestor
110862832|NCT01369368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110862833|NCT01369368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110862834|NCT01369368|Antimanic Agents|antimanic agents|mesh-ancestor
110862835|NCT01369368|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110862836|NCT01369368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110862837|NCT01369368|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110862838|NCT04074759|Pembrolizumab|pembrolizumab|mesh-list
110327451|NCT00454883|Serotonin Agents|serotonin agents|mesh-ancestor
110862839|NCT04074759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110862840|NCT04074759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110862841|NCT04074759|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110862842|NCT04074759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110862844|NCT01369602|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1h-imidazol-1-yl)propanamido)nicotinic acid|mesh-list
110862845|NCT01369602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110862846|NCT01369602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110862847|NCT01369602|Vitamin B Complex|vitamin b complex|mesh-ancestor
110862848|NCT01369602|Vitamins|vitamins|mesh-ancestor
110862849|NCT01369602|Micronutrients|micronutrients|mesh-ancestor
110862850|NCT01369602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110862851|NCT03252496|Ephedrine|ephedrine|mesh-list
110862852|NCT03252496|Fentanyl|fentanyl|mesh-list
110862853|NCT03252496|Bupivacaine|bupivacaine|mesh-list
110862854|NCT03252496|Oxytocin|oxytocin|mesh-list
110862855|NCT03252496|Anesthetics, Local|anesthetics, local|mesh-ancestor
110862856|NCT03252496|Anesthetics|anesthetics|mesh-ancestor
110862857|NCT03252496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110862858|NCT03252496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110862859|NCT03252496|Sensory System Agents|sensory system agents|mesh-ancestor
110862860|NCT03252496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110862861|NCT03252496|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110862862|NCT03252496|Narcotics|narcotics|mesh-ancestor
110862863|NCT03252496|Analgesics|analgesics|mesh-ancestor
110862864|NCT03252496|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110862865|NCT03252496|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110862866|NCT03252496|Anesthetics, General|anesthetics, general|mesh-ancestor
110862867|NCT03252496|Oxytocics|oxytocics|mesh-ancestor
110862868|NCT03252496|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110862869|NCT03252496|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110862870|NCT03252496|Sympathomimetics|sympathomimetics|mesh-ancestor
110862871|NCT03252496|Autonomic Agents|autonomic agents|mesh-ancestor
110862872|NCT03252496|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110862873|NCT03252496|Adrenergic Agents|adrenergic agents|mesh-ancestor
110862874|NCT03252496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110862875|NCT03252496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110862876|NCT03252418|Ascorbic Acid|ascorbic acid|mesh-list
110862877|NCT03252418|Antioxidants|antioxidants|mesh-ancestor
110862878|NCT03252418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110862879|NCT03252418|Protective Agents|protective agents|mesh-ancestor
110862880|NCT03252418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110862881|NCT03252418|Vitamins|vitamins|mesh-ancestor
110862883|NCT01364688|Alfacalcidol|alfacalcidol|mesh-list
110862884|NCT01364688|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
110862885|NCT01364688|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110862886|NCT01364688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110862887|NCT01364688|Vitamins|vitamins|mesh-ancestor
110862888|NCT01364688|Micronutrients|micronutrients|mesh-ancestor
110862889|NCT01370148|Conivaptan|conivaptan|mesh-list
110862890|NCT01370148|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
110862891|NCT01370148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110862892|NCT01370148|Natriuretic Agents|natriuretic agents|mesh-ancestor
110862893|NCT01370148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110862894|NCT04684953|Hormones|hormones|mesh-list
110862895|NCT04684953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110862896|NCT04684953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110862897|NCT01349127|Calcium, Dietary|calcium, dietary|mesh-list
110862898|NCT01349127|Vitamin D|vitamin d|mesh-list
110862899|NCT01349127|Ergocalciferols|ergocalciferols|mesh-list
110862900|NCT01349127|Cholecalciferol|cholecalciferol|mesh-list
110862901|NCT01349127|Vitamins|vitamins|mesh-list
110862902|NCT01349127|Calcium|calcium|mesh-list
110862903|NCT01349127|Micronutrients|micronutrients|mesh-ancestor
110862904|NCT01349127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110862905|NCT01349127|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110862906|NCT01349127|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110862907|NCT03486964|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
110862908|NCT03486964|Protease Inhibitors|protease inhibitors|mesh-ancestor
110862909|NCT03486964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110862910|NCT03486964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110862911|NCT03486964|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110862912|NCT03486964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110862913|NCT01349205|Sodium Benzoate|sodium benzoate|mesh-list
110862914|NCT01349205|Caffeine, sodium benzoate drug combination|caffeine, sodium benzoate drug combination|mesh-list
110862915|NCT01349205|Caffeine|caffeine|mesh-list
110862916|NCT01349205|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110862917|NCT01349205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110862918|NCT01349205|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110862919|NCT01349205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110862920|NCT01349205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110862921|NCT01349205|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110862922|NCT01349205|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110327681|NCT00480597|Gemcitabine|gemcitabine|mesh-list
110862923|NCT01349205|Purinergic Agents|purinergic agents|mesh-ancestor
110862924|NCT01349205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110862925|NCT01349205|Antifungal Agents|antifungal agents|mesh-ancestor
110862926|NCT01349205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110862927|NCT01349205|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
110862928|NCT01349205|Protective Agents|protective agents|mesh-ancestor
110862929|NCT01349205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110862930|NCT01349205|Analgesics|analgesics|mesh-ancestor
110862931|NCT01349205|Sensory System Agents|sensory system agents|mesh-ancestor
110862932|NCT01349205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110862933|NCT01370304|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
110862934|NCT01370304|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110862935|NCT01370304|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110862936|NCT01370304|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110862937|NCT01370304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110862938|NCT01370304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110862939|NCT01370304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110862940|NCT01370304|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110862941|NCT01370304|Antidepressive Agents|antidepressive agents|mesh-ancestor
110862942|NCT01370304|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110862944|NCT03982485|Apatinib|apatinib|mesh-list
110862945|NCT03982485|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110862946|NCT03982485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110862947|NCT03982485|Tubulin Modulators|tubulin modulators|mesh-ancestor
110862948|NCT03982485|Antimitotic Agents|antimitotic agents|mesh-ancestor
110862949|NCT03982485|Mitosis Modulators|mitosis modulators|mesh-ancestor
110339688|NCT02953184|Cyclophosphamide|cyclophosphamide|mesh-list
110862950|NCT03982485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110862951|NCT03982485|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110862952|NCT03982485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110862953|NCT03966339|Hormones|hormones|mesh-list
110862954|NCT03966339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110862955|NCT03966339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110862956|NCT03251872|Olaparib|olaparib|mesh-list
110862957|NCT03251872|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110862958|NCT03251872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110862959|NCT03251872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110862960|NCT03251872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110862961|NCT03160521|Risperidone|risperidone|mesh-list
110862962|NCT03160521|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110862963|NCT03160521|Serotonin Agents|serotonin agents|mesh-ancestor
110862964|NCT03160521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110862965|NCT03160521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110862966|NCT03160521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110862967|NCT03160521|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110862968|NCT03160521|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110862969|NCT03160521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110862970|NCT03160521|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110862971|NCT03160521|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110862972|NCT03160521|Dopamine Agents|dopamine agents|mesh-ancestor
110862973|NCT01365000|Naloxegol|naloxegol|mesh-list
110862974|NCT01365000|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110862975|NCT01365000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110862976|NCT01365000|Sensory System Agents|sensory system agents|mesh-ancestor
110862977|NCT01365000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110862978|NCT03147040|Carboplatin|carboplatin|mesh-list
110862979|NCT03147040|Atezolizumab|atezolizumab|mesh-list
110862980|NCT03147040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110862981|NCT03147040|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110862982|NCT03147040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110862983|NCT03147040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110862984|NCT03251170|Fentanyl|fentanyl|mesh-list
110862985|NCT03251170|Midazolam|midazolam|mesh-list
110862986|NCT03251170|Ketamine|ketamine|mesh-list
110862987|NCT03251170|Analgesics|analgesics|mesh-ancestor
110327827|NCT00457145|Ranibizumab|ranibizumab|mesh-list
110862988|NCT03251170|Sensory System Agents|sensory system agents|mesh-ancestor
110862989|NCT03251170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110862990|NCT03251170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110862991|NCT03251170|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110862992|NCT03251170|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110862993|NCT03251170|Anesthetics, General|anesthetics, general|mesh-ancestor
110862995|NCT03251170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110862996|NCT03251170|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110862997|NCT03251170|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110862998|NCT03251170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110862999|NCT03251170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110863000|NCT03251170|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110863001|NCT03251170|Narcotics|narcotics|mesh-ancestor
110863002|NCT03251170|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110863003|NCT03251170|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110863005|NCT03251170|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110863006|NCT03251170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110863007|NCT03251170|GABA Modulators|gaba modulators|mesh-ancestor
110863008|NCT03251170|GABA Agents|gaba agents|mesh-ancestor
110863009|NCT03539601|Hydrocortisone|hydrocortisone|mesh-list
110863010|NCT03539601|Pimecrolimus|pimecrolimus|mesh-list
110863011|NCT03539601|Hydrocortisone-17-butyrate|hydrocortisone-17-butyrate|mesh-list
110863012|NCT03539601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110863013|NCT03539601|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110328007|NCT00458900|Moxifloxacin|moxifloxacin|mesh-list
110863014|NCT03539601|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110863015|NCT03539601|Analgesics|analgesics|mesh-ancestor
110863016|NCT03539601|Sensory System Agents|sensory system agents|mesh-ancestor
110863017|NCT03539601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110863018|NCT03539601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110863019|NCT03539601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110863020|NCT03539601|Dermatologic Agents|dermatologic agents|mesh-ancestor
110863021|NCT03539601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110863022|NCT03539601|Immunologic Factors|immunologic factors|mesh-ancestor
110863023|NCT03539601|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110863024|NCT03539601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110863025|NCT03539601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110863026|NCT02455180|Ascorbic Acid|ascorbic acid|mesh-list
110863027|NCT02455180|Vitamins|vitamins|mesh-ancestor
110863028|NCT02455180|Micronutrients|micronutrients|mesh-ancestor
110096409|NCT01719835|Hormones|hormones|mesh-ancestor
110863029|NCT02455180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110863030|NCT02455180|Antioxidants|antioxidants|mesh-ancestor
110863031|NCT02455180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110863032|NCT02455180|Protective Agents|protective agents|mesh-ancestor
110863033|NCT03514719|Avelumab|avelumab|mesh-list
110863034|NCT03514719|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110863035|NCT03514719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110863036|NCT03514719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110863037|NCT03514719|Immunologic Factors|immunologic factors|mesh-ancestor
110863038|NCT03514719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110863039|NCT01349439|Propranolol|propranolol|mesh-list
110863040|NCT01349439|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110863041|NCT01349439|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110863042|NCT01349439|Adrenergic Agents|adrenergic agents|mesh-ancestor
110863043|NCT01349439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110328120|NCT00459836|Gemcitabine|gemcitabine|mesh-list
110863044|NCT01349439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110863045|NCT01349439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110863046|NCT01349439|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110863047|NCT01349439|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110863048|NCT01349439|Vasodilator Agents|vasodilator agents|mesh-ancestor
110863049|NCT03245554|Propranolol|propranolol|mesh-list
110863050|NCT03245554|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110863051|NCT03245554|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110863052|NCT03245554|Adrenergic Agents|adrenergic agents|mesh-ancestor
110863053|NCT03245554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110863054|NCT03245554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110863055|NCT03245554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110863056|NCT03245554|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110863057|NCT03245554|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110863058|NCT03245554|Vasodilator Agents|vasodilator agents|mesh-ancestor
110863059|NCT01346007|Vaccines|vaccines|mesh-list
110863060|NCT01346007|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110863061|NCT01346007|Immunologic Factors|immunologic factors|mesh-ancestor
110863062|NCT01346007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110863063|NCT01349751|Levobupivacaine|levobupivacaine|mesh-list
110863064|NCT01349751|Anesthetics, Local|anesthetics, local|mesh-ancestor
110863065|NCT01349751|Anesthetics|anesthetics|mesh-ancestor
110863066|NCT01349751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110863067|NCT01349751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110863068|NCT01349751|Sensory System Agents|sensory system agents|mesh-ancestor
110863069|NCT01349751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110863070|NCT03004131|Fluticasone|fluticasone|mesh-list
110863072|NCT03004131|Loratadine|loratadine|mesh-list
110863073|NCT03004131|Azelastine|azelastine|mesh-list
110863074|NCT03004131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110863075|NCT03004131|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110863076|NCT03004131|Autonomic Agents|autonomic agents|mesh-ancestor
110863077|NCT03004131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110863078|NCT03004131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110863079|NCT03004131|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110863080|NCT03004131|Respiratory System Agents|respiratory system agents|mesh-ancestor
110863081|NCT03004131|Dermatologic Agents|dermatologic agents|mesh-ancestor
110863082|NCT03004131|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110863084|NCT03004131|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110863085|NCT03004131|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110863086|NCT03004131|Histamine Antagonists|histamine antagonists|mesh-ancestor
110863087|NCT03004131|Histamine Agents|histamine agents|mesh-ancestor
110863088|NCT03004131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110328368|NCT00591604|Micronutrients|micronutrients|mesh-ancestor
110863089|NCT03004131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110863090|NCT03004131|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
110863091|NCT03004131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110863092|NCT01350063|Troclosene|troclosene|mesh-list
110863093|NCT01350063|Antifungal Agents|antifungal agents|mesh-ancestor
110863094|NCT01350063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110863095|NCT01350063|Antiviral Agents|antiviral agents|mesh-ancestor
110863096|NCT01350063|Disinfectants|disinfectants|mesh-ancestor
110863097|NCT03421041|Dexamethasone|dexamethasone|mesh-list
110863098|NCT03421041|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110863099|NCT03421041|Antiemetics|antiemetics|mesh-ancestor
110863100|NCT03421041|Autonomic Agents|autonomic agents|mesh-ancestor
110863101|NCT03421041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110863102|NCT03421041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110863104|NCT03421041|Glucocorticoids|glucocorticoids|mesh-ancestor
110863105|NCT03421041|Hormones|hormones|mesh-ancestor
110863106|NCT03421041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110863107|NCT03421041|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110863108|NCT03421041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110863109|NCT03244774|Paclitaxel|paclitaxel|mesh-list
110863110|NCT03244774|Fluorouracil|fluorouracil|mesh-list
110863112|NCT03244774|Apatinib|apatinib|mesh-list
110863113|NCT03244774|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110863114|NCT03244774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110863115|NCT03244774|Tubulin Modulators|tubulin modulators|mesh-ancestor
110863116|NCT03244774|Antimitotic Agents|antimitotic agents|mesh-ancestor
110863117|NCT03244774|Mitosis Modulators|mitosis modulators|mesh-ancestor
110328622|NCT00105443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110863118|NCT03244774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110863120|NCT03244774|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110863121|NCT03244774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110863122|NCT03244774|Immunologic Factors|immunologic factors|mesh-ancestor
110863123|NCT03244774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110863124|NCT03244774|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110863125|NCT03244774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110863126|NCT02903823|Baclofen|baclofen|mesh-list
110863127|NCT02903823|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110863128|NCT02903823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110863129|NCT02903823|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110863130|NCT02903823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110863131|NCT02903823|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
110863132|NCT02903823|GABA Agonists|gaba agonists|mesh-ancestor
110863133|NCT02903823|GABA Agents|gaba agents|mesh-ancestor
110863134|NCT02903823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110863135|NCT02903823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110863136|NCT03244930|Plerixafor|plerixafor|mesh-list
110863137|NCT03244930|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110863138|NCT03244930|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110328899|NCT00491127|Hormones|hormones|mesh-ancestor
110863139|NCT03244930|Antiviral Agents|antiviral agents|mesh-ancestor
110863140|NCT03244930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110863141|NCT02855697|Olaparib|olaparib|mesh-list
110863142|NCT02855697|Cediranib|cediranib|mesh-list
110863143|NCT02855697|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110863145|NCT02855697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110863146|NCT02855697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110863147|NCT02855697|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110863148|NCT03894501|Methadone|methadone|mesh-list
110863149|NCT03894501|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110863150|NCT03894501|Narcotics|narcotics|mesh-ancestor
110863151|NCT03894501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110863152|NCT03894501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110863153|NCT03894501|Analgesics|analgesics|mesh-ancestor
110863154|NCT03894501|Sensory System Agents|sensory system agents|mesh-ancestor
110863155|NCT03894501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110863156|NCT03894501|Antitussive Agents|antitussive agents|mesh-ancestor
110863157|NCT03894501|Respiratory System Agents|respiratory system agents|mesh-ancestor
110863158|NCT01346865|Cilostazol|cilostazol|mesh-list
110863159|NCT01346865|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110863160|NCT01346865|Autonomic Agents|autonomic agents|mesh-ancestor
110863161|NCT01346865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110863162|NCT01346865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110329228|NCT00592306|Thymoglobulin|thymoglobulin|mesh-list
110863164|NCT01346865|Respiratory System Agents|respiratory system agents|mesh-ancestor
110863165|NCT01346865|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110863166|NCT01346865|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110863167|NCT01346865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110863168|NCT01346865|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110863169|NCT01346865|Vasodilator Agents|vasodilator agents|mesh-ancestor
110863170|NCT01346865|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110863171|NCT01346865|Protective Agents|protective agents|mesh-ancestor
110863172|NCT01346865|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110863173|NCT01346865|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110863174|NCT01346865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110863175|NCT03244462|Methotrexate|methotrexate|mesh-list
110863176|NCT03244462|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110863177|NCT03244462|Abortifacient Agents|abortifacient agents|mesh-ancestor
110863178|NCT03244462|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110863179|NCT03244462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110863180|NCT03244462|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110329365|NCT04327726|Analgesics|analgesics|mesh-ancestor
110863181|NCT03244462|Antimetabolites|antimetabolites|mesh-ancestor
110863182|NCT03244462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110863183|NCT03244462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110863184|NCT03244462|Dermatologic Agents|dermatologic agents|mesh-ancestor
110863185|NCT03244462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110863186|NCT03244462|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110863187|NCT03244462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110863188|NCT03244462|Immunologic Factors|immunologic factors|mesh-ancestor
110863189|NCT03244462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110863190|NCT03244462|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110863191|NCT03244540|Acetaminophen|acetaminophen|mesh-list
110863192|NCT03244540|Dipyrone|dipyrone|mesh-list
110863193|NCT03244540|Ketoprofen|ketoprofen|mesh-list
110863194|NCT03244540|Bupivacaine|bupivacaine|mesh-list
110863195|NCT03244540|Ropivacaine|ropivacaine|mesh-list
110863196|NCT03244540|Anesthetics, Local|anesthetics, local|mesh-ancestor
110863197|NCT03244540|Anesthetics|anesthetics|mesh-ancestor
110329433|NCT00492414|Paroxetine|paroxetine|mesh-list
110863198|NCT03244540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110029834|NCT03074539|Riociguat|riociguat|mesh-list
110863199|NCT03244540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110329489|NCT00622843|Vaccines|vaccines|mesh-list
110863200|NCT03244540|Sensory System Agents|sensory system agents|mesh-ancestor
110863201|NCT03244540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110863202|NCT03244540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110863203|NCT03244540|Analgesics|analgesics|mesh-ancestor
110863204|NCT03244540|Antipyretics|antipyretics|mesh-ancestor
110863205|NCT03244540|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110863206|NCT03244540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110863207|NCT03244540|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110863208|NCT03244540|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110863209|NCT03244540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110863210|NCT03244540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110863211|NCT03249298|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
110863212|NCT03249298|Plasma Substitutes|plasma substitutes|mesh-ancestor
110863213|NCT03249298|Blood Substitutes|blood substitutes|mesh-ancestor
110863215|NCT02454868|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110863216|NCT02454868|Narcotics|narcotics|mesh-ancestor
110863217|NCT02454868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110863218|NCT02454868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110863219|NCT02454868|Analgesics|analgesics|mesh-ancestor
110863220|NCT02454868|Sensory System Agents|sensory system agents|mesh-ancestor
110863221|NCT02454868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110863222|NCT03753087|Empagliflozin|empagliflozin|mesh-list
110863223|NCT03753087|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110863224|NCT03753087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110863225|NCT03753087|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110863226|NCT03753087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110863227|NCT02454712|Naltrexone|naltrexone|mesh-list
110863228|NCT02454712|Oxycodone|oxycodone|mesh-list
110863229|NCT02454712|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110863230|NCT02454712|Narcotics|narcotics|mesh-ancestor
110863231|NCT02454712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110863232|NCT02454712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110863233|NCT02454712|Analgesics|analgesics|mesh-ancestor
110863234|NCT02454712|Sensory System Agents|sensory system agents|mesh-ancestor
110863235|NCT02454712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110863236|NCT02454712|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110863238|NCT00832455|Montelukast|montelukast|mesh-list
110863239|NCT00832455|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110863240|NCT00832455|Respiratory System Agents|respiratory system agents|mesh-ancestor
110863241|NCT00832455|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110863242|NCT00832455|Hormone Antagonists|hormone antagonists|mesh-ancestor
110863243|NCT00832455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110863244|NCT00832455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110863245|NCT00832455|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110863246|NCT00832455|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110863247|NCT00832455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110863248|NCT00687531|Mometasone Furoate|mometasone furoate|mesh-list
110863249|NCT00687531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110863250|NCT00687531|Dermatologic Agents|dermatologic agents|mesh-ancestor
110863251|NCT00687531|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110863252|NCT01350921|Ticagrelor|ticagrelor|mesh-list
110863253|NCT01350921|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110863254|NCT01350921|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110863255|NCT01350921|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110329875|NCT01365481|Amlodipine|amlodipine|mesh-list
110863256|NCT01350921|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110863257|NCT01350921|Purinergic Agents|purinergic agents|mesh-ancestor
110863258|NCT01350921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110863259|NCT01350921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110863260|NCT01350921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110863261|NCT00423579|Simvastatin|simvastatin|mesh-list
110329953|NCT00493233|Olanzapine|olanzapine|mesh-list
110863263|NCT00423579|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
110863264|NCT00423579|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110863265|NCT00423579|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110863266|NCT00423579|Antimetabolites|antimetabolites|mesh-ancestor
110330020|NCT01243827|Bisoprolol|bisoprolol|mesh-list
110863267|NCT00423579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110863268|NCT00423579|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110863269|NCT00423579|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110863270|NCT00423579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110863271|NCT03243604|Hormones|hormones|mesh-list
110863272|NCT03243604|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110863273|NCT03243604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110863274|NCT02454556|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
110863275|NCT02454556|Hormones|hormones|mesh-ancestor
110863276|NCT02454556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110863277|NCT02454556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110863278|NCT01352559|Milnacipran|milnacipran|mesh-list
110863279|NCT01352559|Mirtazapine|mirtazapine|mesh-list
110863280|NCT01352559|Sertraline|sertraline|mesh-list
110863281|NCT01352559|Fluoxetine|fluoxetine|mesh-list
110863282|NCT01352559|Paroxetine|paroxetine|mesh-list
110863283|NCT01352559|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
110863284|NCT01352559|Nortriptyline|nortriptyline|mesh-list
110863285|NCT01352559|Antidepressive Agents|antidepressive agents|mesh-ancestor
110863286|NCT01352559|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110863287|NCT01352559|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110863288|NCT01352559|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110863289|NCT01352559|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110863290|NCT01352559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110863291|NCT01352559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110863292|NCT01352559|Serotonin Agents|serotonin agents|mesh-ancestor
110863293|NCT01352559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110330280|NCT00501111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110863294|NCT01352559|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110863295|NCT01352559|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110863296|NCT01352559|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110863297|NCT01352559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110863298|NCT01352559|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110863299|NCT01352559|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110863300|NCT01352559|Histamine Antagonists|histamine antagonists|mesh-ancestor
110863301|NCT01352559|Histamine Agents|histamine agents|mesh-ancestor
110863303|NCT01352559|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110863304|NCT01352559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110863305|NCT01352559|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
110863306|NCT01352559|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110863307|NCT01352559|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110863308|NCT01352559|Adrenergic Agents|adrenergic agents|mesh-ancestor
110863309|NCT01352559|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110863310|NCT01352559|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110863311|NCT01352559|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110863312|NCT01352559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110863313|NCT01352559|Analgesics|analgesics|mesh-ancestor
110863314|NCT01352559|Sensory System Agents|sensory system agents|mesh-ancestor
110863315|NCT01352559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110863316|NCT01352559|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110863317|NCT01352559|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110863318|NCT03247972|Evolocumab|evolocumab|mesh-list
110863319|NCT03247972|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
110863320|NCT03247972|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110863321|NCT03247972|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110863322|NCT03247972|Antimetabolites|antimetabolites|mesh-ancestor
110863323|NCT03247972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110863324|NCT03247972|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110863325|NCT03247972|Protease Inhibitors|protease inhibitors|mesh-ancestor
110863326|NCT03247972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110863327|NCT03247972|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110863328|NCT01350609|Candesartan|candesartan|mesh-list
110863329|NCT01350609|Candesartan cilexetil|candesartan cilexetil|mesh-list
110863330|NCT01350609|Nifedipine|nifedipine|mesh-list
110863331|NCT01350609|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110863332|NCT01350609|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110863333|NCT01350609|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110863334|NCT01350609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110863335|NCT01350609|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110863336|NCT01350609|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110863337|NCT01350609|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110863338|NCT01350609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110863339|NCT01350609|Vasodilator Agents|vasodilator agents|mesh-ancestor
110863340|NCT01350609|Tocolytic Agents|tocolytic agents|mesh-ancestor
110863341|NCT01350609|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110863342|NCT03269409|Coal Tar|coal tar|mesh-list
110863343|NCT03269409|Keratolytic Agents|keratolytic agents|mesh-ancestor
110863344|NCT03269409|Dermatologic Agents|dermatologic agents|mesh-ancestor
110863346|NCT03778372|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110863347|NCT03778372|Narcotics|narcotics|mesh-ancestor
110863348|NCT03778372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110863349|NCT03778372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110863350|NCT03778372|Analgesics|analgesics|mesh-ancestor
110863351|NCT03778372|Sensory System Agents|sensory system agents|mesh-ancestor
110863352|NCT03778372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110863353|NCT03778372|Antitussive Agents|antitussive agents|mesh-ancestor
110330748|NCT00601588|Sertraline|sertraline|mesh-list
110863354|NCT03778372|Respiratory System Agents|respiratory system agents|mesh-ancestor
110863355|NCT03246880|Tadalafil|tadalafil|mesh-list
110863356|NCT03246880|Tamsulosin|tamsulosin|mesh-list
110863357|NCT03246880|Vasodilator Agents|vasodilator agents|mesh-ancestor
110863358|NCT03246880|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110863359|NCT03246880|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110863360|NCT03246880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110863361|NCT03246880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110863362|NCT03246880|Urological Agents|urological agents|mesh-ancestor
110863363|NCT03246880|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110863364|NCT03246880|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110863365|NCT03246880|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110863367|NCT03246880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110863368|NCT03246880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110863369|NCT03257722|Pembrolizumab|pembrolizumab|mesh-list
110863370|NCT03257722|Idelalisib|idelalisib|mesh-list
110834249|NCT03921671|Paclitaxel|paclitaxel|mesh-list
110863371|NCT03257722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110863372|NCT03257722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110863373|NCT03257722|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110863374|NCT03257722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110863375|NCT03257722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110863376|NCT03268005|Insulin|insulin|mesh-list
110863377|NCT03268005|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110863378|NCT03268005|Metformin|metformin|mesh-list
110863379|NCT03268005|Insulin Aspart|insulin aspart|mesh-list
110863380|NCT03268005|Insulin, Long-Acting|insulin, long-acting|mesh-list
110863381|NCT03268005|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
110863382|NCT03268005|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110863383|NCT03268005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110863384|NCT03239314|Dexamethasone|dexamethasone|mesh-list
110863385|NCT03239314|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110863386|NCT03239314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110863387|NCT03239314|Antiemetics|antiemetics|mesh-ancestor
110863388|NCT03239314|Autonomic Agents|autonomic agents|mesh-ancestor
110863389|NCT03239314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110331116|NCT01324141|Tempol|tempol|mesh-list
110339771|NCT00510263|Valacyclovir|valacyclovir|mesh-list
110863390|NCT03239314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110863391|NCT03239314|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110863392|NCT03239314|Glucocorticoids|glucocorticoids|mesh-ancestor
110863394|NCT03239314|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110863395|NCT03239314|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110863396|NCT03239314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110863397|NCT03241888|Megestrol|megestrol|mesh-list
110863398|NCT03241888|Megestrol Acetate|megestrol acetate|mesh-list
110863399|NCT03241888|Levonorgestrel|levonorgestrel|mesh-list
110863400|NCT03241888|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110863401|NCT03241888|Contraceptive Agents|contraceptive agents|mesh-ancestor
110863402|NCT03241888|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110863403|NCT03241888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110863404|NCT03241888|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110863405|NCT03241888|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110863406|NCT03241888|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110863407|NCT03241888|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110863408|NCT03241888|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110863409|NCT03241888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110863410|NCT03241888|Appetite Stimulants|appetite stimulants|mesh-ancestor
110863411|NCT03241888|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110863412|NCT02454088|Calcium, Dietary|calcium, dietary|mesh-list
110863413|NCT02454088|Triamcinolone|triamcinolone|mesh-list
110863414|NCT02454088|Calcium|calcium|mesh-list
110863415|NCT02454088|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110863416|NCT02454088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110863417|NCT02454088|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110863418|NCT02454088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110863419|NCT02454088|Glucocorticoids|glucocorticoids|mesh-ancestor
110863420|NCT02454088|Hormones|hormones|mesh-ancestor
110331353|NCT01246752|Cytarabine|cytarabine|mesh-list
110863421|NCT02454088|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110863422|NCT02456116|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
110863423|NCT02456116|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110863424|NCT02456116|Analgesics|analgesics|mesh-ancestor
110863425|NCT02456116|Sensory System Agents|sensory system agents|mesh-ancestor
110863426|NCT02456116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110863427|NCT02456116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110863428|NCT02456116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110863429|NCT02456116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110863430|NCT03239236|Anesthetics|anesthetics|mesh-list
110863431|NCT03239236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110863432|NCT03239236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110863433|NCT03257800|Ketamine|ketamine|mesh-list
110863434|NCT03257800|Nitrous Oxide|nitrous oxide|mesh-list
110863435|NCT03257800|Sevoflurane|sevoflurane|mesh-list
110863436|NCT03257800|Analgesics|analgesics|mesh-ancestor
110863437|NCT03257800|Sensory System Agents|sensory system agents|mesh-ancestor
110863438|NCT03257800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110863439|NCT03257800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110863440|NCT03257800|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110863441|NCT03257800|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110863442|NCT03257800|Anesthetics, General|anesthetics, general|mesh-ancestor
110863443|NCT03257800|Anesthetics|anesthetics|mesh-ancestor
110863444|NCT03257800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110863445|NCT03257800|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110863446|NCT03257800|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110863447|NCT03257800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110863448|NCT03257800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110863449|NCT03257800|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110863450|NCT03257800|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110863451|NCT03257800|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110863452|NCT01353339|Levofloxacin|levofloxacin|mesh-list
110863453|NCT01353339|Ofloxacin|ofloxacin|mesh-list
110331554|NCT00477815|Alkylating Agents|alkylating agents|mesh-ancestor
110863454|NCT01353339|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110863455|NCT01353339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110863456|NCT01353339|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110863457|NCT01353339|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110863458|NCT01353339|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110331619|NCT01247493|Cytarabine|cytarabine|mesh-list
110863459|NCT01353339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110863460|NCT01353339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110863461|NCT01353339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110863462|NCT01353339|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110863463|NCT01353339|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110863464|NCT03239080|Denosumab|denosumab|mesh-list
110863465|NCT03239080|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110331683|NCT00478907|Ketamine|ketamine|mesh-list
110863466|NCT03239080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110863467|NCT03149055|Isavuconazole|isavuconazole|mesh-list
110863468|NCT03149055|Antifungal Agents|antifungal agents|mesh-ancestor
110863469|NCT03149055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110863470|NCT01352091|Goserelin|goserelin|mesh-list
110863471|NCT01352091|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110863472|NCT01352091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110863473|NCT02954523|Dasatinib|dasatinib|mesh-list
110863474|NCT02954523|Osimertinib|osimertinib|mesh-list
110331753|NCT02483247|Tubulin Modulators|tubulin modulators|mesh-ancestor
110863475|NCT02954523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110863476|NCT02954523|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110863477|NCT02954523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110863478|NCT02954523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110863479|NCT04486612|Anesthetics|anesthetics|mesh-list
110863480|NCT04486612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110863481|NCT04486612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110863482|NCT01353729|Moxifloxacin|moxifloxacin|mesh-list
110863484|NCT01353729|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
110863485|NCT01353729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110863486|NCT01353729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110863487|NCT01353729|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110863488|NCT01353729|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110863489|NCT01353729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110863490|NCT01353729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110863491|NCT01353729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110863492|NCT01353729|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110863493|NCT01353729|Contraceptive Agents|contraceptive agents|mesh-ancestor
110863494|NCT01353729|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110863495|NCT01353729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110863496|NCT01353729|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110863497|NCT01353729|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110863498|NCT01353729|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110863499|NCT01353729|Antiviral Agents|antiviral agents|mesh-ancestor
110863500|NCT01357317|Calcium, Dietary|calcium, dietary|mesh-list
110863501|NCT01357317|Calcium|calcium|mesh-list
110863502|NCT01357317|Calcium acetate|calcium acetate|mesh-list
110863503|NCT01357317|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110863504|NCT01357317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110863505|NCT01357317|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110863506|NCT01357317|Chelating Agents|chelating agents|mesh-ancestor
110863507|NCT01357317|Sequestering Agents|sequestering agents|mesh-ancestor
110331951|NCT00473486|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110863508|NCT01357317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110863509|NCT03238612|Clarithromycin|clarithromycin|mesh-list
110863510|NCT03238612|Oseltamivir|oseltamivir|mesh-list
110863511|NCT03238612|Antiviral Agents|antiviral agents|mesh-list
110863512|NCT03238612|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110863513|NCT03238612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110863514|NCT03238612|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110863515|NCT03238612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110863516|NCT03238612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110863517|NCT03238612|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110863518|NCT03238612|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110863519|NCT03137121|Olanzapine|olanzapine|mesh-list
110863520|NCT03137121|Antiemetics|antiemetics|mesh-ancestor
110863521|NCT03137121|Autonomic Agents|autonomic agents|mesh-ancestor
110863522|NCT03137121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110863523|NCT03137121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110863524|NCT03137121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110863525|NCT03137121|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110863526|NCT03137121|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110332079|NCT02891005|Paclitaxel|paclitaxel|mesh-list
110332080|NCT02891005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110863527|NCT03137121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110863528|NCT03137121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110863529|NCT03137121|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110863530|NCT03137121|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110863531|NCT03137121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110863532|NCT03137121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110863533|NCT03137121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110863534|NCT03137121|Serotonin Agents|serotonin agents|mesh-ancestor
110863535|NCT02453776|Infliximab|infliximab|mesh-list
110332212|NCT00482066|Abatacept|abatacept|mesh-list
110863536|NCT02453776|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110863537|NCT02453776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110863538|NCT02453776|Dermatologic Agents|dermatologic agents|mesh-ancestor
110863539|NCT02453776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110863540|NCT02453776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110863541|NCT03256864|Everolimus|everolimus|mesh-list
110863542|NCT03256864|Tacrolimus|tacrolimus|mesh-list
110863543|NCT03256864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110863544|NCT03256864|Immunologic Factors|immunologic factors|mesh-ancestor
110863545|NCT03256864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110863546|NCT03256864|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110863547|NCT03256864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110332350|NCT01240538|Cyclophosphamide|cyclophosphamide|mesh-list
110863548|NCT03256864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110863549|NCT03256864|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110863550|NCT03256864|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110863551|NCT03256864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110863552|NCT01317849|Vitamins|vitamins|mesh-list
110863553|NCT01317849|Folic Acid|folic acid|mesh-list
110863554|NCT01317849|Vitamin B 12|vitamin b 12|mesh-list
110863555|NCT01317849|Pyridoxine|pyridoxine|mesh-list
110863556|NCT01317849|Pyridoxal|pyridoxal|mesh-list
110863557|NCT01317849|Vitamin B 6|vitamin b 6|mesh-list
110863558|NCT01317849|Vitamin B Complex|vitamin b complex|mesh-list
110863559|NCT01317849|Micronutrients|micronutrients|mesh-ancestor
110863560|NCT01317849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110863561|NCT01317849|Hematinics|hematinics|mesh-ancestor
110863563|NCT01317927|Warfarin|warfarin|mesh-list
110863564|NCT01317927|Anticoagulants|anticoagulants|mesh-ancestor
110863565|NCT01317927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110863566|NCT01317927|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110863567|NCT01317927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110332555|NCT04325191|Protective Agents|protective agents|mesh-ancestor
110863568|NCT01317927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110863570|NCT02901483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110863571|NCT02874651|Apatinib|apatinib|mesh-list
110863572|NCT02874651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110863573|NCT02874651|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110863574|NCT02874651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110863575|NCT02874651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110863576|NCT02453932|Donepezil|donepezil|mesh-list
110863577|NCT02453932|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110863578|NCT02453932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110863579|NCT02453932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110863580|NCT02453932|Cholinergic Agents|cholinergic agents|mesh-ancestor
110863581|NCT02453932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110863582|NCT02453932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110863583|NCT02453932|Nootropic Agents|nootropic agents|mesh-ancestor
110863584|NCT00700570|Bevacizumab|bevacizumab|mesh-list
110863585|NCT00700570|Capecitabine|capecitabine|mesh-list
110863586|NCT00700570|Oxaliplatin|oxaliplatin|mesh-list
110863587|NCT00700570|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110863588|NCT00700570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110863589|NCT00700570|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110863590|NCT00700570|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110863591|NCT00700570|Growth Substances|growth substances|mesh-ancestor
110863592|NCT00700570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110863593|NCT00700570|Growth Inhibitors|growth inhibitors|mesh-ancestor
110863594|NCT00700570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110863595|NCT00700570|Antimetabolites|antimetabolites|mesh-ancestor
110863596|NCT00700570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110863597|NCT02453698|Methylphenidate|methylphenidate|mesh-list
110332970|NCT00483860|Topotecan|topotecan|mesh-list
110863598|NCT02453698|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110863599|NCT02453698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110863600|NCT02453698|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110863601|NCT02453698|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110863602|NCT02453698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110863603|NCT02453698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110863604|NCT02453698|Dopamine Agents|dopamine agents|mesh-ancestor
110863605|NCT02453698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110333178|NCT00484575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110863606|NCT01354275|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
110863607|NCT01354275|Hormones|hormones|mesh-ancestor
110863608|NCT01354275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110863609|NCT01354275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110863610|NCT01318161|Morphine|morphine|mesh-list
110863611|NCT01318161|Ropivacaine|ropivacaine|mesh-list
110863612|NCT01318161|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110863613|NCT01318161|Narcotics|narcotics|mesh-ancestor
110863614|NCT01318161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110863615|NCT01318161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110863616|NCT01318161|Analgesics|analgesics|mesh-ancestor
110863617|NCT01318161|Sensory System Agents|sensory system agents|mesh-ancestor
110333328|NCT00485004|Sirolimus|sirolimus|mesh-list
110863618|NCT01318161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110863619|NCT01318161|Anesthetics, Local|anesthetics, local|mesh-ancestor
110863620|NCT01318161|Anesthetics|anesthetics|mesh-ancestor
110863621|NCT03255226|Tolvaptan|tolvaptan|mesh-list
110863622|NCT03255226|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
110863623|NCT03255226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110863624|NCT03255226|Natriuretic Agents|natriuretic agents|mesh-ancestor
110863625|NCT03255226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110863626|NCT02455726|Pregabalin|pregabalin|mesh-list
110863627|NCT02455726|Oxycodone|oxycodone|mesh-list
110863628|NCT02455726|Magnesium Oxide|magnesium oxide|mesh-list
110863629|NCT02455726|Analgesics|analgesics|mesh-ancestor
110863630|NCT02455726|Sensory System Agents|sensory system agents|mesh-ancestor
110863631|NCT02455726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110863632|NCT02455726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110863633|NCT02455726|Anticonvulsants|anticonvulsants|mesh-ancestor
110863634|NCT02455726|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110863635|NCT02455726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110863636|NCT02455726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110863637|NCT02455726|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110863638|NCT02455726|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110863639|NCT02455726|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110863640|NCT02455726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110863641|NCT02455726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110863642|NCT02455726|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110863643|NCT02455726|Narcotics|narcotics|mesh-ancestor
110863644|NCT02455726|Antacids|antacids|mesh-ancestor
110333500|NCT01241487|Vasodilator Agents|vasodilator agents|mesh-ancestor
110863645|NCT02455726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110863646|NCT04488172|Vitamins|vitamins|mesh-list
110863647|NCT04488172|Micronutrients|micronutrients|mesh-ancestor
110863648|NCT04488172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110863649|NCT03239860|Antibodies|antibodies|mesh-list
110863650|NCT03239860|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110863651|NCT03239860|Immunologic Factors|immunologic factors|mesh-ancestor
110863652|NCT03239860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110863653|NCT04486690|Ketamine|ketamine|mesh-list
110863654|NCT04486690|Propofol|propofol|mesh-list
110863655|NCT04486690|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110863656|NCT04486690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110333637|NCT00489983|Gemcitabine|gemcitabine|mesh-list
110863657|NCT04486690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110863658|NCT04486690|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110863659|NCT04486690|Anesthetics, General|anesthetics, general|mesh-ancestor
110863660|NCT04486690|Anesthetics|anesthetics|mesh-ancestor
110863661|NCT04486690|Analgesics|analgesics|mesh-ancestor
110863662|NCT04486690|Sensory System Agents|sensory system agents|mesh-ancestor
110863663|NCT04486690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110863664|NCT04486690|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110863665|NCT04486690|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110863666|NCT04486690|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110863667|NCT04486690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110863668|NCT04486690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110863669|NCT03255148|Oxytocin|oxytocin|mesh-list
110863670|NCT03255148|Oxytocics|oxytocics|mesh-ancestor
110863671|NCT03255148|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110863672|NCT03255148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110863674|NCT03236818|Sildenafil Citrate|sildenafil citrate|mesh-list
110863675|NCT03236818|Tadalafil|tadalafil|mesh-list
110863676|NCT03236818|Macitentan|macitentan|mesh-list
110863677|NCT03236818|Vasodilator Agents|vasodilator agents|mesh-ancestor
110333847|NCT04511715|Bevacizumab|bevacizumab|mesh-list
110863678|NCT03236818|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110863679|NCT03236818|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110863680|NCT03236818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110863681|NCT03236818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110863682|NCT03236818|Urological Agents|urological agents|mesh-ancestor
110863683|NCT03236818|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110863684|NCT03236818|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
110863685|NCT03236818|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
110863686|NCT03236818|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
110863687|NCT03236974|Fulvestrant|fulvestrant|mesh-list
110863688|NCT03236974|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110863689|NCT03236974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110863690|NCT03236974|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110863691|NCT03236974|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110863692|NCT03236974|Hormone Antagonists|hormone antagonists|mesh-ancestor
110863693|NCT03236974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110863694|NCT03236974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110863695|NCT03748043|Lactoferrin|lactoferrin|mesh-list
110863696|NCT03748043|Teferrol|teferrol|mesh-list
110863697|NCT03748043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110863698|NCT03748043|Hematinics|hematinics|mesh-ancestor
110863699|NCT03750773|Gabapentin|gabapentin|mesh-list
110863700|NCT03750773|Analgesics|analgesics|mesh-ancestor
110863701|NCT03750773|Sensory System Agents|sensory system agents|mesh-ancestor
110863702|NCT03750773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110863703|NCT03750773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110863704|NCT03750773|Anticonvulsants|anticonvulsants|mesh-ancestor
110863705|NCT03750773|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110863706|NCT03750773|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110863707|NCT03750773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110863708|NCT03750773|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110863709|NCT03750773|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110863710|NCT03750773|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110863711|NCT03750773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110863712|NCT03750773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110863713|NCT03750773|Antimanic Agents|antimanic agents|mesh-ancestor
110863715|NCT02874924|Temsirolimus|temsirolimus|mesh-list
110863716|NCT02874924|MTOR Inhibitors|mtor inhibitors|mesh-list
110863717|NCT02874924|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110863718|NCT02874924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110863719|NCT02874924|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110863721|NCT02874924|Antifungal Agents|antifungal agents|mesh-ancestor
110863722|NCT02874924|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110863723|NCT02874924|Immunologic Factors|immunologic factors|mesh-ancestor
110863724|NCT02874924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110863725|NCT02874924|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110863726|NCT02874924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110863727|NCT02874924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110863728|NCT04425863|Aspirin|aspirin|mesh-list
110863729|NCT04425863|Ivermectin|ivermectin|mesh-list
110863731|NCT04425863|Dexamethasone acetate|dexamethasone acetate|mesh-list
110863732|NCT04425863|Enoxaparin|enoxaparin|mesh-list
110863733|NCT04425863|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110863734|NCT04425863|BB 1101|bb 1101|mesh-list
110863735|NCT04425863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110863737|NCT04425863|Autonomic Agents|autonomic agents|mesh-ancestor
110863738|NCT04425863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110863739|NCT04425863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110863740|NCT04425863|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110334376|NCT01242215|Glimepiride|glimepiride|mesh-list
110863742|NCT04425863|Hormones|hormones|mesh-ancestor
110863743|NCT04425863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110863744|NCT04425863|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110863745|NCT04425863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110863746|NCT04425863|Protease Inhibitors|protease inhibitors|mesh-ancestor
110863747|NCT04425863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110863748|NCT04425863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110334522|NCT01299805|Vortioxetine|vortioxetine|mesh-list
110863749|NCT04425863|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110863750|NCT04425863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110863752|NCT04425863|Sensory System Agents|sensory system agents|mesh-ancestor
110863753|NCT04425863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110863754|NCT04425863|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110334585|NCT00495326|Efavirenz|efavirenz|mesh-list
110863755|NCT04425863|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110863756|NCT04425863|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110863757|NCT04425863|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110863758|NCT04425863|Antipyretics|antipyretics|mesh-ancestor
110863759|NCT04425863|Anticoagulants|anticoagulants|mesh-ancestor
110863760|NCT04425863|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110863761|NCT04425863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110863762|NCT01370772|Cyclophosphamide|cyclophosphamide|mesh-list
110863763|NCT01370772|Rituximab|rituximab|mesh-list
110863764|NCT01370772|Fludarabine|fludarabine|mesh-list
110863765|NCT01370772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110863766|NCT01370772|Immunologic Factors|immunologic factors|mesh-ancestor
110863767|NCT01370772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110863768|NCT01370772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110863769|NCT01370772|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110863770|NCT01370772|Alkylating Agents|alkylating agents|mesh-ancestor
110863771|NCT01370772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110863772|NCT01370772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110863773|NCT01370772|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110863774|NCT01370772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110863775|NCT01842282|Amlexanox|amlexanox|mesh-list
110863776|NCT01842282|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110863777|NCT03234244|Cholecalciferol|cholecalciferol|mesh-list
110863778|NCT03234244|Vitamin D|vitamin d|mesh-list
110863779|NCT03234244|Bazedoxifene|bazedoxifene|mesh-list
110863780|NCT03234244|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110863781|NCT03234244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110863782|NCT03234244|Vitamins|vitamins|mesh-ancestor
110863783|NCT03234244|Micronutrients|micronutrients|mesh-ancestor
110863784|NCT03234244|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110863785|NCT03234244|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110863786|NCT03234244|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110863787|NCT03234244|Hormone Antagonists|hormone antagonists|mesh-ancestor
110863788|NCT03234244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110863789|NCT03234400|Dapivirine|dapivirine|mesh-list
110863790|NCT03234400|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110334790|NCT04511832|Analgesics|analgesics|mesh-ancestor
110863791|NCT03234400|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110863792|NCT03234400|Antiviral Agents|antiviral agents|mesh-ancestor
110863793|NCT03234400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110863794|NCT03254368|ZGN-1061|zgn-1061|mesh-list
110863795|NCT03254368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110863796|NCT03254368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110863797|NCT03254368|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110863799|NCT03236740|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110863800|NCT03236740|Estradiol|estradiol|mesh-list
110863801|NCT03236740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110863802|NCT03236740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110863803|NCT03236740|Estrogens|estrogens|mesh-ancestor
110863804|NCT03236740|Hormones|hormones|mesh-ancestor
110334911|NCT00493727|Antidotes|antidotes|mesh-ancestor
110863805|NCT03236740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110863806|NCT03236740|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110863807|NCT03236740|Contraceptive Agents|contraceptive agents|mesh-ancestor
110863808|NCT03236740|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110863809|NCT03236740|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110863810|NCT03236740|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110863811|NCT03236740|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110863812|NCT02453464|Leucovorin|leucovorin|mesh-list
110863813|NCT02453464|Irinotecan|irinotecan|mesh-list
110863814|NCT02453464|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110863815|NCT02453464|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110863816|NCT02453464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110863817|NCT02453464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110863818|NCT02453464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110863819|NCT02453464|Antidotes|antidotes|mesh-ancestor
110863820|NCT02453464|Protective Agents|protective agents|mesh-ancestor
110863821|NCT02453464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110863822|NCT02453464|Vitamin B Complex|vitamin b complex|mesh-ancestor
110863823|NCT02453464|Vitamins|vitamins|mesh-ancestor
110863824|NCT02453464|Micronutrients|micronutrients|mesh-ancestor
110863825|NCT03233932|Leuprolide|leuprolide|mesh-list
110863826|NCT03233932|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110863827|NCT03233932|Fertility Agents|fertility agents|mesh-ancestor
110863828|NCT03233932|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110863829|NCT03233932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110863830|NCT03233932|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110863831|NCT03233932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110863832|NCT03236584|Tenofovir|tenofovir|mesh-list
110863833|NCT03236584|Lamivudine|lamivudine|mesh-list
110863834|NCT03236584|Adefovir|adefovir|mesh-list
110863835|NCT03236584|Antiviral Agents|antiviral agents|mesh-ancestor
110863836|NCT03236584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110863837|NCT03236584|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110863838|NCT03236584|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110863839|NCT03236584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110863840|NCT03236584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110863841|NCT03236584|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110863842|NCT03236584|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110863843|NCT03233776|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
110863844|NCT03233776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110863845|NCT04614168|Hypoglycemic Agents|hypoglycemic agents|mesh-list
110863847|NCT04614168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110863848|NCT04614168|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
110863849|NCT04614168|Protective Agents|protective agents|mesh-ancestor
110863850|NCT01365312|Ethanol|ethanol|mesh-list
110863886|NCT01372644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110863887|NCT01372644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110863888|NCT03253198|Bupivacaine|bupivacaine|mesh-list
110863889|NCT03253198|Anesthetics, Local|anesthetics, local|mesh-ancestor
110863890|NCT03253198|Anesthetics|anesthetics|mesh-ancestor
110863891|NCT03253198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110863892|NCT03253198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110863893|NCT03253198|Sensory System Agents|sensory system agents|mesh-ancestor
110863894|NCT03253198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110863895|NCT04285086|Anagrelide|anagrelide|mesh-list
110335731|NCT00499811|Vorinostat|vorinostat|mesh-list
110863896|NCT04285086|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110863897|NCT04285086|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110863898|NCT04285086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110863899|NCT04285086|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110863900|NCT04485988|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
110863901|NCT04485988|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110863902|NCT04485988|Adrenergic Agents|adrenergic agents|mesh-ancestor
110863903|NCT04485988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110863904|NCT04485988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110863905|NCT04485988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110863906|NCT04234464|Budesonide|budesonide|mesh-list
110863907|NCT04234464|Albuterol|albuterol|mesh-list
110097310|NCT01735006|Vaccines|vaccines|mesh-list
110863908|NCT04234464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110863909|NCT04234464|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110863910|NCT04234464|Autonomic Agents|autonomic agents|mesh-ancestor
110863911|NCT04234464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110863912|NCT04234464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110863913|NCT04234464|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110863914|NCT04234464|Respiratory System Agents|respiratory system agents|mesh-ancestor
110863915|NCT04234464|Glucocorticoids|glucocorticoids|mesh-ancestor
110863916|NCT04234464|Hormones|hormones|mesh-ancestor
110863917|NCT04234464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110863918|NCT04234464|Tocolytic Agents|tocolytic agents|mesh-ancestor
110863919|NCT04234464|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110863920|NCT04234464|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110863921|NCT04234464|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110863922|NCT04234464|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110863923|NCT04234464|Adrenergic Agents|adrenergic agents|mesh-ancestor
110863924|NCT04234464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110863925|NCT04234464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110863926|NCT03233152|Nivolumab|nivolumab|mesh-list
110863927|NCT03233152|Ipilimumab|ipilimumab|mesh-list
110863928|NCT03233152|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110863929|NCT03233152|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110335863|NCT00507585|Vitamins|vitamins|mesh-ancestor
110863931|NCT03233152|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110863932|NCT03233152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110863933|NCT03229096|Apatinib|apatinib|mesh-list
110863934|NCT03229096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110863935|NCT03229096|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110863936|NCT03229096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110863937|NCT03229096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110863938|NCT03123588|Anagrelide|anagrelide|mesh-list
110863939|NCT03123588|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110863940|NCT03123588|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110863941|NCT03123588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110863942|NCT03123588|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110863943|NCT02452918|Oritavancin|oritavancin|mesh-list
110863944|NCT02452918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110863945|NCT02452918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110863946|NCT02821026|Mycophenolic Acid|mycophenolic acid|mesh-list
110863947|NCT02821026|Sirolimus|sirolimus|mesh-list
110863948|NCT02821026|Etanercept|etanercept|mesh-list
110863949|NCT02821026|Tacrolimus|tacrolimus|mesh-list
110863950|NCT02821026|Thymoglobulin|thymoglobulin|mesh-list
110863951|NCT02821026|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110863952|NCT02821026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110863953|NCT02821026|Immunologic Factors|immunologic factors|mesh-ancestor
110863954|NCT02821026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110863955|NCT02821026|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110863956|NCT02821026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110863957|NCT02821026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110863958|NCT02821026|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110863959|NCT02821026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110863960|NCT02821026|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110863961|NCT02821026|Antitubercular Agents|antitubercular agents|mesh-ancestor
110863962|NCT02821026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110863963|NCT02821026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110863964|NCT02821026|Antifungal Agents|antifungal agents|mesh-ancestor
110863965|NCT02821026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110863966|NCT02821026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110863967|NCT02821026|Analgesics|analgesics|mesh-ancestor
110863968|NCT02821026|Sensory System Agents|sensory system agents|mesh-ancestor
110863969|NCT02821026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110863970|NCT02821026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110863971|NCT02821026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110863972|NCT02821026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110863973|NCT03228628|Nitrous Oxide|nitrous oxide|mesh-list
110863974|NCT03228628|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110863975|NCT03228628|Anesthetics, General|anesthetics, general|mesh-ancestor
110863976|NCT03228628|Anesthetics|anesthetics|mesh-ancestor
110863977|NCT03228628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110863978|NCT03228628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110863979|NCT03228628|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110863980|NCT03228628|Analgesics|analgesics|mesh-ancestor
110863981|NCT03228628|Sensory System Agents|sensory system agents|mesh-ancestor
110863982|NCT03228628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110863984|NCT03232450|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110863985|NCT03232450|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110863986|NCT03232450|Analgesics|analgesics|mesh-ancestor
110863987|NCT03232450|Sensory System Agents|sensory system agents|mesh-ancestor
110863988|NCT03232450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110863989|NCT03232450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110863990|NCT03232450|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110863991|NCT03232450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110863992|NCT03232450|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110863993|NCT03232450|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110863994|NCT03232450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110863995|NCT03232450|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110863996|NCT03232450|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110863997|NCT03232450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110863998|NCT03232450|Antipyretics|antipyretics|mesh-ancestor
110863999|NCT04411667|gamma-Globulins|gamma-globulins|mesh-list
110864000|NCT04411667|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110864001|NCT04411667|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110864002|NCT04411667|Immunologic Factors|immunologic factors|mesh-ancestor
110864003|NCT04411667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110864004|NCT04358549|Favipiravir|favipiravir|mesh-list
110864005|NCT04358549|Antiviral Agents|antiviral agents|mesh-ancestor
110864006|NCT04358549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110864008|NCT01562483|Hallucinogens|hallucinogens|mesh-ancestor
110864009|NCT01562483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110864010|NCT01562483|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110864011|NCT01562483|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110864012|NCT01562483|Analgesics|analgesics|mesh-ancestor
110864013|NCT01562483|Sensory System Agents|sensory system agents|mesh-ancestor
110864014|NCT01562483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110864015|NCT01562483|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
110864016|NCT01562483|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110864017|NCT01562483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110864018|NCT01562483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110864019|NCT01562483|Hormones|hormones|mesh-ancestor
110864020|NCT01562483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110864021|NCT00700180|Bevacizumab|bevacizumab|mesh-list
110864022|NCT00700180|Carboplatin|carboplatin|mesh-list
110864023|NCT00700180|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110864024|NCT00700180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110864025|NCT00700180|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110864026|NCT00700180|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110864027|NCT00700180|Growth Substances|growth substances|mesh-ancestor
110864028|NCT00700180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110864029|NCT00700180|Growth Inhibitors|growth inhibitors|mesh-ancestor
110864030|NCT03222544|Methylene Blue|methylene blue|mesh-list
110864031|NCT03222544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110864032|NCT03222544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110864033|NCT03228862|Ergocalciferols|ergocalciferols|mesh-list
110864034|NCT03228862|Vitamin D|vitamin d|mesh-list
110864035|NCT03228862|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110864036|NCT03228862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110864037|NCT03228862|Vitamins|vitamins|mesh-ancestor
110864038|NCT03228862|Micronutrients|micronutrients|mesh-ancestor
110864039|NCT03228862|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110864040|NCT03228238|Vitamins|vitamins|mesh-list
110864041|NCT03228238|Ascorbic Acid|ascorbic acid|mesh-list
110864042|NCT03228238|Vitamin E|vitamin e|mesh-list
110864043|NCT03228238|Tocopherols|tocopherols|mesh-list
110864044|NCT03228238|Calcium Channel Blockers|calcium channel blockers|mesh-list
110864045|NCT03228238|Atorvastatin|atorvastatin|mesh-list
110864046|NCT03228238|Micronutrients|micronutrients|mesh-ancestor
110864047|NCT03228238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110864048|NCT03228238|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110864049|NCT03228238|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110864050|NCT03228238|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110864051|NCT03228238|Antimetabolites|antimetabolites|mesh-ancestor
110864052|NCT03228238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110864053|NCT03228238|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110864054|NCT03228238|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110864055|NCT03228238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110864056|NCT03228238|Antioxidants|antioxidants|mesh-ancestor
110864057|NCT03228238|Protective Agents|protective agents|mesh-ancestor
110864058|NCT03228238|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110864059|NCT03232216|Vitamin D|vitamin d|mesh-list
110864060|NCT03232216|Cholecalciferol|cholecalciferol|mesh-list
110864061|NCT03232216|Vitamins|vitamins|mesh-ancestor
110864062|NCT03232216|Micronutrients|micronutrients|mesh-ancestor
110642303|NCT03412643|Cyclophosphamide|cyclophosphamide|mesh-list
110864063|NCT03232216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110864064|NCT03232216|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110864065|NCT03232216|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110864066|NCT03231982|Amlodipine|amlodipine|mesh-list
110864067|NCT03231982|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110864068|NCT03231982|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110864069|NCT03231982|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110864070|NCT03231982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110864071|NCT03231982|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110864072|NCT03231982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110864073|NCT03231982|Vasodilator Agents|vasodilator agents|mesh-ancestor
110864074|NCT03222310|Itraconazole|itraconazole|mesh-list
110864075|NCT03222310|Ipatasertib|ipatasertib|mesh-list
110864076|NCT03222310|Antifungal Agents|antifungal agents|mesh-ancestor
110864077|NCT03222310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110864078|NCT03222310|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110864079|NCT03222310|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110864080|NCT03222310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110864081|NCT03222310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110864082|NCT03222310|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110864083|NCT03222310|Hormone Antagonists|hormone antagonists|mesh-ancestor
110864084|NCT03222310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110864085|NCT03222310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110864086|NCT03222310|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110864087|NCT03222310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110864088|NCT03222310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110864089|NCT04485520|Chlorhexidine|chlorhexidine|mesh-list
110864090|NCT04485520|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110864091|NCT04485520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110864092|NCT04485520|Disinfectants|disinfectants|mesh-ancestor
110864093|NCT03231436|Bupivacaine|bupivacaine|mesh-list
110864094|NCT03231436|Anesthetics, Local|anesthetics, local|mesh-ancestor
110864095|NCT03231436|Anesthetics|anesthetics|mesh-ancestor
110864096|NCT03231436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110864097|NCT03231436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110864098|NCT03231436|Sensory System Agents|sensory system agents|mesh-ancestor
110864099|NCT03231436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110864100|NCT02452450|Acetaminophen|acetaminophen|mesh-list
110864102|NCT02452450|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110864103|NCT02452450|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110864104|NCT02452450|Analgesics|analgesics|mesh-ancestor
110864105|NCT02452450|Sensory System Agents|sensory system agents|mesh-ancestor
110864106|NCT02452450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110864107|NCT02452450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110864108|NCT02452450|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110864109|NCT02452450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110864110|NCT02452450|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110864111|NCT02452450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110864112|NCT02452450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110864113|NCT02452450|Antipyretics|antipyretics|mesh-ancestor
110864114|NCT01204684|Poly ICLC|poly iclc|mesh-list
110864115|NCT01204684|Interferon Inducers|interferon inducers|mesh-ancestor
110864116|NCT01204684|Immunologic Factors|immunologic factors|mesh-ancestor
110864117|NCT01204684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110864118|NCT00594334|Risedronic Acid|risedronic acid|mesh-list
110864119|NCT00594334|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110366113|NCT04813653|Immunologic Factors|immunologic factors|mesh-ancestor
110864120|NCT00594334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110864121|NCT00594334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110864122|NCT00594334|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110864123|NCT00594334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110336063|NCT00501254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110864124|NCT00594334|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110864125|NCT00238420|Paclitaxel|paclitaxel|mesh-list
110864126|NCT00238420|Trastuzumab|trastuzumab|mesh-list
110864127|NCT00238420|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110864128|NCT00238420|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
110864129|NCT00238420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110864130|NCT00238420|Antibodies|antibodies|mesh-list
110864131|NCT00238420|Immunoglobulins|immunoglobulins|mesh-list
110864132|NCT00238420|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110864133|NCT00238420|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110864134|NCT00238420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110864135|NCT00238420|Tubulin Modulators|tubulin modulators|mesh-ancestor
110864136|NCT00238420|Antimitotic Agents|antimitotic agents|mesh-ancestor
110864137|NCT00238420|Mitosis Modulators|mitosis modulators|mesh-ancestor
110864138|NCT00238420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110864139|NCT00238420|Immunologic Factors|immunologic factors|mesh-ancestor
110864140|NCT00238420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110864141|NCT03221998|Acetaminophen|acetaminophen|mesh-list
110864142|NCT03221998|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110864143|NCT03221998|Analgesics|analgesics|mesh-ancestor
110864144|NCT03221998|Sensory System Agents|sensory system agents|mesh-ancestor
110864145|NCT03221998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110864146|NCT03221998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110864147|NCT03221998|Antipyretics|antipyretics|mesh-ancestor
110864148|NCT04492475|Interferons|interferons|mesh-list
110864149|NCT04492475|Interferon-beta|interferon-beta|mesh-list
110864150|NCT04492475|Interferon beta-1a|interferon beta-1a|mesh-list
110864151|NCT04492475|Remdesivir|remdesivir|mesh-list
110864152|NCT04492475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110864153|NCT04492475|Antiviral Agents|antiviral agents|mesh-ancestor
110864154|NCT04492475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110581656|NCT00723021|Hormone Antagonists|hormone antagonists|mesh-ancestor
110864155|NCT04492475|Immunologic Factors|immunologic factors|mesh-ancestor
110864156|NCT04492475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110864157|NCT04492475|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110864158|NCT04492475|Antimetabolites|antimetabolites|mesh-ancestor
110864159|NCT04492475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110864160|NCT04936763|Hyaluronic Acid|hyaluronic acid|mesh-list
110864161|NCT04936763|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110864162|NCT04936763|Immunologic Factors|immunologic factors|mesh-ancestor
110864163|NCT04936763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110864164|NCT04936763|Viscosupplements|viscosupplements|mesh-ancestor
110864165|NCT04936763|Protective Agents|protective agents|mesh-ancestor
110864166|NCT03752333|Pembrolizumab|pembrolizumab|mesh-list
110864167|NCT03752333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110864168|NCT03752333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110864169|NCT03752333|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110864170|NCT03752333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110864171|NCT03750383|Cyclosporine|cyclosporine|mesh-list
110864172|NCT03750383|Prednisone|prednisone|mesh-list
110864173|NCT03750383|Cyclosporins|cyclosporins|mesh-list
110864174|NCT03750383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110864175|NCT03750383|Glucocorticoids|glucocorticoids|mesh-ancestor
110864176|NCT03750383|Hormones|hormones|mesh-ancestor
110864177|NCT03750383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110864178|NCT03750383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110864179|NCT03750383|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110864180|NCT03750383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110864181|NCT03750383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110864182|NCT03750383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110864183|NCT03750383|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110864184|NCT03750383|Immunologic Factors|immunologic factors|mesh-ancestor
110864185|NCT03750383|Antifungal Agents|antifungal agents|mesh-ancestor
110864186|NCT03750383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110864187|NCT03750383|Dermatologic Agents|dermatologic agents|mesh-ancestor
110864188|NCT03750383|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110864189|NCT03750383|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110864190|NCT03226210|Insulin|insulin|mesh-list
110864191|NCT03226210|Insulin Aspart|insulin aspart|mesh-list
110864192|NCT03226210|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110864193|NCT03226210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110864194|NCT03229954|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
110864195|NCT03229954|Hematinics|hematinics|mesh-ancestor
110864196|NCT03220126|Mirikizumab|mirikizumab|mesh-list
110864197|NCT03220126|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110864198|NCT03220126|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110864199|NCT03220126|Analgesics|analgesics|mesh-ancestor
110864200|NCT03220126|Sensory System Agents|sensory system agents|mesh-ancestor
110864201|NCT03220126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110864202|NCT03220126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110864203|NCT03220126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110864204|NCT03220126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110864205|NCT03220126|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110864206|NCT03220126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110864207|NCT02452684|Eszopiclone|eszopiclone|mesh-list
110864208|NCT02452684|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110864209|NCT02452684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110864210|NCT02452684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110864211|NCT03119428|Nivolumab|nivolumab|mesh-list
110864212|NCT03119428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110864213|NCT03119428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110864214|NCT03119428|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110864215|NCT03119428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110864216|NCT04345367|Abrocitinib|abrocitinib|mesh-list
110864217|NCT04345367|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110864218|NCT04345367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110864219|NCT04345367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110864220|NCT02452606|Levodopa|levodopa|mesh-list
110864221|NCT02452606|Carbidopa|carbidopa|mesh-list
110864222|NCT02452606|Entacapone|entacapone|mesh-list
110864223|NCT02452606|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110864224|NCT02452606|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110864225|NCT02452606|Dopamine Agents|dopamine agents|mesh-ancestor
110864226|NCT02452606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110864227|NCT02452606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110581731|NCT00788372|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110864228|NCT02452606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110864229|NCT02452606|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
110864230|NCT02452606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110864231|NCT02452606|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
110864232|NCT03225352|Aspirin|aspirin|mesh-list
110864233|NCT03225352|Ibuprofen|ibuprofen|mesh-list
110864234|NCT03225352|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110864235|NCT03225352|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110864236|NCT03225352|Analgesics|analgesics|mesh-ancestor
110864237|NCT03225352|Sensory System Agents|sensory system agents|mesh-ancestor
110864238|NCT03225352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110864239|NCT03225352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110864240|NCT03225352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110864241|NCT03225352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110864242|NCT03225352|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110864243|NCT03225352|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110864244|NCT03225352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110864245|NCT03225352|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110864246|NCT03225352|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110864248|NCT03225352|Antipyretics|antipyretics|mesh-ancestor
110864249|NCT03208270|Antithrombins|antithrombins|mesh-list
110864250|NCT03208270|Antithrombin III|antithrombin iii|mesh-list
110864251|NCT03208270|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110864252|NCT03208270|Protease Inhibitors|protease inhibitors|mesh-ancestor
110864253|NCT03208270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110864254|NCT03208270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110864255|NCT03208270|Anticoagulants|anticoagulants|mesh-ancestor
110864256|NCT03208426|Amoxicillin|amoxicillin|mesh-list
110864257|NCT03208426|Metronidazole|metronidazole|mesh-list
110864258|NCT03208426|Clarithromycin|clarithromycin|mesh-list
110864259|NCT03208426|Tetracycline|tetracycline|mesh-list
110864260|NCT03208426|Esomeprazole|esomeprazole|mesh-list
110864261|NCT03208426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110864262|NCT03208426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110864263|NCT03208426|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110864264|NCT03208426|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110864265|NCT03208426|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110864266|NCT03208426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110864267|NCT03208426|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110864268|NCT03208426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110864269|NCT03208426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110864270|NCT03208426|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110864271|NCT03208426|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110864272|NCT03208426|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110864273|NCT03216070|Dasatinib|dasatinib|mesh-list
110864274|NCT03216070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110864275|NCT03216070|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110864276|NCT03216070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110864277|NCT03216070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110864278|NCT03215602|Pyrantel|pyrantel|mesh-list
110864279|NCT03215602|Pyrantel Pamoate|pyrantel pamoate|mesh-list
110864280|NCT03215602|Antinematodal Agents|antinematodal agents|mesh-ancestor
110864281|NCT03215602|Anthelmintics|anthelmintics|mesh-ancestor
110864282|NCT03215602|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110864283|NCT03215602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110864284|NCT03215602|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
110864285|NCT03215602|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110864286|NCT03215602|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110864287|NCT03215602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110864288|NCT03215602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110864289|NCT02450968|Dexamethasone|dexamethasone|mesh-list
110864290|NCT02450968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110864291|NCT02450968|Antiemetics|antiemetics|mesh-ancestor
110864292|NCT02450968|Autonomic Agents|autonomic agents|mesh-ancestor
110864293|NCT02450968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110864294|NCT02450968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110864295|NCT02450968|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110864296|NCT02450968|Glucocorticoids|glucocorticoids|mesh-ancestor
110864297|NCT02450968|Hormones|hormones|mesh-ancestor
110864298|NCT02450968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110864299|NCT02450968|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110864300|NCT02450968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110864301|NCT03749915|Tetracaine|tetracaine|mesh-list
110864302|NCT03749915|Anesthetics, Local|anesthetics, local|mesh-ancestor
110864303|NCT03749915|Anesthetics|anesthetics|mesh-ancestor
110864304|NCT03749915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110864305|NCT03749915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110864306|NCT03749915|Sensory System Agents|sensory system agents|mesh-ancestor
110864307|NCT03749915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110864309|NCT03119116|Apixaban|apixaban|mesh-list
110864310|NCT03119116|Dabigatran|dabigatran|mesh-list
110864311|NCT03119116|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110864312|NCT03119116|Antithrombins|antithrombins|mesh-ancestor
110864313|NCT03119116|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110864314|NCT03119116|Protease Inhibitors|protease inhibitors|mesh-ancestor
110864315|NCT03119116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110864316|NCT03119116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110864317|NCT03119116|Anticoagulants|anticoagulants|mesh-ancestor
110864318|NCT04329923|Hydroxychloroquine|hydroxychloroquine|mesh-list
110834346|NCT01560481|Metformin|metformin|mesh-list
110864319|NCT04329923|Antimalarials|antimalarials|mesh-ancestor
110864320|NCT04329923|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110864321|NCT04329923|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110864322|NCT04329923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110864323|NCT04329923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110864324|NCT04329923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110864325|NCT04329923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110864326|NCT04403399|Varenicline|varenicline|mesh-list
110864327|NCT04403399|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110864328|NCT04403399|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110864329|NCT04403399|Cholinergic Agents|cholinergic agents|mesh-ancestor
110864330|NCT04403399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110864331|NCT04403399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110864332|NCT04403399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110864333|NCT03224572|Ascorbic Acid|ascorbic acid|mesh-list
110864334|NCT03224572|Vitamins|vitamins|mesh-ancestor
110864335|NCT03224572|Micronutrients|micronutrients|mesh-ancestor
110864336|NCT03224572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110864337|NCT03224572|Antioxidants|antioxidants|mesh-ancestor
110864338|NCT03224572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110864339|NCT03224572|Protective Agents|protective agents|mesh-ancestor
110864340|NCT02452216|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
110864341|NCT02452216|Hematinics|hematinics|mesh-ancestor
110864342|NCT02452216|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
110864343|NCT02452216|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110864344|NCT03207334|Cytarabine|cytarabine|mesh-list
110864345|NCT03207334|Midostaurin|midostaurin|mesh-list
110366185|NCT04642430|Anticoagulants|anticoagulants|mesh-ancestor
110864346|NCT03207334|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110864347|NCT03207334|Antimetabolites|antimetabolites|mesh-ancestor
110336126|NCT02274545|Vaccines|vaccines|mesh-list
110864348|NCT03207334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110864349|NCT03207334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110864350|NCT03207334|Antiviral Agents|antiviral agents|mesh-ancestor
110864351|NCT03207334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110864352|NCT03207334|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110864353|NCT03207334|Immunologic Factors|immunologic factors|mesh-ancestor
110864354|NCT03207334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110864355|NCT03207334|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110864356|NCT03207334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110864357|NCT03212950|Insulin|insulin|mesh-list
110864358|NCT03212950|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110864359|NCT03212950|Insulin Aspart|insulin aspart|mesh-list
110864360|NCT03212950|Insulin, Long-Acting|insulin, long-acting|mesh-list
110336168|NCT00501410|Antidotes|antidotes|mesh-ancestor
110864361|NCT03212950|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
110864362|NCT03212950|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110864363|NCT03212950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110864364|NCT03207100|Antihypertensive Agents|antihypertensive agents|mesh-list
110864365|NCT01561937|Warfarin|warfarin|mesh-list
110864366|NCT01561937|Anticoagulants|anticoagulants|mesh-ancestor
110864367|NCT03210766|Nabilone|nabilone|mesh-list
110864368|NCT03210766|Antiemetics|antiemetics|mesh-ancestor
110864369|NCT03210766|Autonomic Agents|autonomic agents|mesh-ancestor
110864370|NCT03210766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110864371|NCT03210766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110864372|NCT03210766|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110864373|NCT03210766|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110864374|NCT03210766|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110864375|NCT03210766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110864376|NCT03210766|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110864377|NCT03747341|Fentanyl|fentanyl|mesh-list
110864378|NCT03747341|Oxycodone|oxycodone|mesh-list
110864380|NCT03747341|Ondansetron|ondansetron|mesh-list
110864381|NCT03747341|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110864382|NCT03747341|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110864383|NCT03747341|Narcotics|narcotics|mesh-ancestor
110864384|NCT03747341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110864385|NCT03747341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110864386|NCT03747341|Analgesics|analgesics|mesh-ancestor
110864387|NCT03747341|Sensory System Agents|sensory system agents|mesh-ancestor
110336431|NCT01249001|Aprepitant|aprepitant|mesh-list
110864388|NCT03747341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110864390|NCT03747341|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110864392|NCT03747341|Anesthetics|anesthetics|mesh-ancestor
110864393|NCT03747341|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110864394|NCT03747341|Antiemetics|antiemetics|mesh-ancestor
110864395|NCT03747341|Autonomic Agents|autonomic agents|mesh-ancestor
110864396|NCT03747341|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110864397|NCT03747341|Antipruritics|antipruritics|mesh-ancestor
110864398|NCT03747341|Dermatologic Agents|dermatologic agents|mesh-ancestor
110864399|NCT03747341|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110864400|NCT03747341|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110864401|NCT03747341|Serotonin Agents|serotonin agents|mesh-ancestor
110864402|NCT03747341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110864403|NCT03747341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110864404|NCT04401293|Heparin|heparin|mesh-list
110864405|NCT04401293|Enoxaparin|enoxaparin|mesh-list
110864406|NCT04401293|Calcium heparin|calcium heparin|mesh-list
110864407|NCT04401293|Dalteparin|dalteparin|mesh-list
110864408|NCT04401293|Enoxaparin sodium|enoxaparin sodium|mesh-list
110864409|NCT04401293|Anticoagulants|anticoagulants|mesh-ancestor
110864410|NCT04401293|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110336641|NCT00510393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110864411|NCT04401293|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110864412|NCT04401293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110864414|NCT03209908|Antiviral Agents|antiviral agents|mesh-ancestor
110864415|NCT03209908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110864416|NCT03209908|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110864417|NCT03209908|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110864418|NCT03209908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110336710|NCT01247090|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
110864419|NCT03209908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110864420|NCT03209908|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110864421|NCT03209908|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110864422|NCT04484740|Gepotidacin|gepotidacin|mesh-list
110864423|NCT04484740|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110864424|NCT04484740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110864425|NCT04484740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110864426|NCT04484740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110864427|NCT04319159|Aminolevulinic Acid|aminolevulinic acid|mesh-list
110864428|NCT04319159|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110864429|NCT04319159|Dermatologic Agents|dermatologic agents|mesh-ancestor
110864430|NCT03224338|Dolutegravir|dolutegravir|mesh-list
110864431|NCT03224338|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110864432|NCT03224338|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110336846|NCT00513552|Clarithromycin|clarithromycin|mesh-list
110864433|NCT03224338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110864434|NCT03224338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110864436|NCT03224338|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110864437|NCT03224338|Antiviral Agents|antiviral agents|mesh-ancestor
110336984|NCT00513981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110864438|NCT03224338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110864439|NCT04318535|Griseofulvin|griseofulvin|mesh-list
110864440|NCT04318535|Antifungal Agents|antifungal agents|mesh-ancestor
110864441|NCT04318535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110864442|NCT02451826|Ulipristal acetate|ulipristal acetate|mesh-list
110864443|NCT02451826|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110864444|NCT02451826|Contraceptive Agents|contraceptive agents|mesh-ancestor
110864445|NCT02451826|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110864446|NCT02451826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110864447|NCT02451826|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110864448|NCT03224416|Ethanol|ethanol|mesh-list
110864449|NCT03224416|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110864450|NCT03224416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110864451|NCT03224416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110864452|NCT03224416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110337130|NCT00514410|Folic Acid|folic acid|mesh-list
110864453|NCT01562561|Repaglinide|repaglinide|mesh-list
110864454|NCT01562561|Isophane Insulin, Human|isophane insulin, human|mesh-list
110864455|NCT01562561|Insulin, Isophane|insulin, isophane|mesh-list
110864456|NCT01562561|Isophane insulin, beef|isophane insulin, beef|mesh-list
110864457|NCT01562561|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110864458|NCT01562561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110864459|NCT03206944|Aspirin|aspirin|mesh-list
110864460|NCT03206944|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110864461|NCT03206944|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110864463|NCT03206944|Sensory System Agents|sensory system agents|mesh-ancestor
110864464|NCT03206944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110864465|NCT03206944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110864466|NCT03206944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110864468|NCT03206944|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110337267|NCT01240889|Fluticasone|fluticasone|mesh-list
110864469|NCT03206944|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110864470|NCT03206944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110864471|NCT03206944|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110864472|NCT03206944|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110864473|NCT03206944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110864474|NCT03206944|Antipyretics|antipyretics|mesh-ancestor
110864475|NCT04454567|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
110864476|NCT04454567|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110864477|NCT04454567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110864478|NCT04454567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110864479|NCT04454567|Antiviral Agents|antiviral agents|mesh-ancestor
110864480|NCT04454567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110864481|NCT03206554|Ropivacaine|ropivacaine|mesh-list
110864482|NCT03206554|Anesthetics, Local|anesthetics, local|mesh-ancestor
110864483|NCT03206554|Anesthetics|anesthetics|mesh-ancestor
110864484|NCT03206554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110864485|NCT03206554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110864486|NCT03206554|Sensory System Agents|sensory system agents|mesh-ancestor
110864487|NCT03206554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110864489|NCT03209206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110864490|NCT03209206|Tubulin Modulators|tubulin modulators|mesh-ancestor
110864491|NCT03209206|Antimitotic Agents|antimitotic agents|mesh-ancestor
110864492|NCT03209206|Mitosis Modulators|mitosis modulators|mesh-ancestor
110337531|NCT01246011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110864493|NCT03209206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110864494|NCT03223402|Lamivudine|lamivudine|mesh-list
110864495|NCT03223402|Nevirapine|nevirapine|mesh-list
110864496|NCT03223402|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110864497|NCT03223402|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110864498|NCT03223402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110864499|NCT03223402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110864500|NCT03223402|Antiviral Agents|antiviral agents|mesh-ancestor
110864502|NCT03223402|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110864503|NCT03223402|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110864504|NCT03223402|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110864505|NCT03223402|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110864506|NCT03208972|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
110337674|NCT04510337|Rocuronium|rocuronium|mesh-list
110864507|NCT03208972|Menotropins|menotropins|mesh-list
110864508|NCT03208972|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110864509|NCT03208972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110864510|NCT03208972|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110864511|NCT03208972|Fertility Agents|fertility agents|mesh-ancestor
110864512|NCT03206866|Antibodies|antibodies|mesh-list
110864513|NCT03206866|Immunologic Factors|immunologic factors|mesh-ancestor
110864514|NCT03206866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110864515|NCT02451748|Hydroxychloroquine|hydroxychloroquine|mesh-list
110864516|NCT02451748|Sulfasalazine|sulfasalazine|mesh-list
110864517|NCT02451748|Prednisone|prednisone|mesh-list
110864518|NCT02451748|Triamcinolone|triamcinolone|mesh-list
110864519|NCT02451748|Naproxen|naproxen|mesh-list
110864520|NCT02451748|Certolizumab Pegol|certolizumab pegol|mesh-list
110864522|NCT02451748|Leflunomide|leflunomide|mesh-list
110864523|NCT02451748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110864524|NCT02451748|Glucocorticoids|glucocorticoids|mesh-ancestor
110864525|NCT02451748|Hormones|hormones|mesh-ancestor
110337893|NCT00505505|Insulin|insulin|mesh-list
110864526|NCT02451748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110864527|NCT02451748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110864528|NCT02451748|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110864529|NCT02451748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110864530|NCT02451748|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110864531|NCT02451748|Abortifacient Agents|abortifacient agents|mesh-ancestor
110864532|NCT02451748|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110864533|NCT02451748|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110366210|NCT04557189|Serotonin Agents|serotonin agents|mesh-ancestor
110864535|NCT02451748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110864536|NCT02451748|Dermatologic Agents|dermatologic agents|mesh-ancestor
110864538|NCT02451748|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110864539|NCT02451748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110864540|NCT02451748|Immunologic Factors|immunologic factors|mesh-ancestor
110864541|NCT02451748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110864542|NCT02451748|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110864543|NCT02451748|Antimalarials|antimalarials|mesh-ancestor
110864544|NCT02451748|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110864545|NCT02451748|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110864546|NCT02451748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110864547|NCT02451748|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110864548|NCT02451748|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110864549|NCT02451748|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110864550|NCT02451748|Analgesics|analgesics|mesh-ancestor
110864551|NCT02451748|Sensory System Agents|sensory system agents|mesh-ancestor
110864552|NCT02451748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110864553|NCT02451748|Gout Suppressants|gout suppressants|mesh-ancestor
110864554|NCT02451748|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110864555|NCT02451748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110864556|NCT03208894|Furosemide|furosemide|mesh-list
110864557|NCT03208894|Diuretics|diuretics|mesh-ancestor
110864558|NCT03208894|Natriuretic Agents|natriuretic agents|mesh-ancestor
110864559|NCT03208894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110864560|NCT03208894|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110864561|NCT03208894|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110864562|NCT03208894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110864563|NCT02450656|Docetaxel|docetaxel|mesh-list
110864564|NCT02450656|Afatinib|afatinib|mesh-list
110864565|NCT02450656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110864566|NCT02450656|Tubulin Modulators|tubulin modulators|mesh-ancestor
110864567|NCT02450656|Antimitotic Agents|antimitotic agents|mesh-ancestor
110864568|NCT02450656|Mitosis Modulators|mitosis modulators|mesh-ancestor
110864569|NCT02450656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110864570|NCT02450656|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110864571|NCT02450656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110864572|NCT03206320|Lidocaine|lidocaine|mesh-list
110864573|NCT03206320|Anesthetics, Local|anesthetics, local|mesh-ancestor
110864574|NCT03206320|Anesthetics|anesthetics|mesh-ancestor
110864575|NCT03206320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110864576|NCT03206320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110864577|NCT03206320|Sensory System Agents|sensory system agents|mesh-ancestor
110864578|NCT03206320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110864579|NCT03206320|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110864580|NCT03206320|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110864581|NCT03206320|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110864582|NCT03206320|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110864583|NCT03206320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110864584|NCT04448561|Morphine|morphine|mesh-list
110864585|NCT04448561|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110864586|NCT04448561|Narcotics|narcotics|mesh-ancestor
110366230|NCT04442919|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110864587|NCT04448561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110864588|NCT04448561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110864589|NCT04448561|Analgesics|analgesics|mesh-ancestor
110864590|NCT04448561|Sensory System Agents|sensory system agents|mesh-ancestor
110864591|NCT04448561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110864592|NCT03206008|Magnesium Sulfate|magnesium sulfate|mesh-list
110864593|NCT03206008|Analgesics|analgesics|mesh-ancestor
110864594|NCT03206008|Sensory System Agents|sensory system agents|mesh-ancestor
110864595|NCT03206008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110864596|NCT03206008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110864597|NCT03206008|Anesthetics|anesthetics|mesh-ancestor
110864598|NCT03206008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110834370|NCT03368859|Leucovorin|leucovorin|mesh-list
110864599|NCT03206008|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110864600|NCT03206008|Anticonvulsants|anticonvulsants|mesh-ancestor
110864601|NCT03206008|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110864602|NCT03206008|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110864603|NCT03206008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110864604|NCT03206008|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110864605|NCT03206008|Tocolytic Agents|tocolytic agents|mesh-ancestor
110864606|NCT03206008|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110864607|NCT04978259|Remdesivir|remdesivir|mesh-list
110864608|NCT04978259|Antimetabolites|antimetabolites|mesh-ancestor
110864609|NCT04978259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110864610|NCT04978259|Antiviral Agents|antiviral agents|mesh-ancestor
110864611|NCT04978259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110864612|NCT03208582|Risedronic Acid|risedronic acid|mesh-list
110864613|NCT03208582|Diphosphonates|diphosphonates|mesh-list
110864614|NCT03208582|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110864615|NCT03208582|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110864616|NCT03208582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110864617|NCT03208582|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110864618|NCT03208582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110864619|NCT03208582|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110864620|NCT03200938|Zinc|zinc|mesh-list
110864621|NCT03200938|Zinc Oxide|zinc oxide|mesh-list
110864622|NCT03200938|Trace Elements|trace elements|mesh-ancestor
110864623|NCT03200938|Micronutrients|micronutrients|mesh-ancestor
110864624|NCT03200938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110864625|NCT03200938|Dermatologic Agents|dermatologic agents|mesh-ancestor
110864626|NCT03200938|Sunscreening Agents|sunscreening agents|mesh-ancestor
110864627|NCT03200938|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110864628|NCT03200938|Protective Agents|protective agents|mesh-ancestor
110864630|NCT04297241|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
110864631|NCT04297241|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
110864632|NCT04297241|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110864633|NCT04297241|Diuretics|diuretics|mesh-ancestor
110864634|NCT04297241|Natriuretic Agents|natriuretic agents|mesh-ancestor
110864635|NCT04297241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110864636|NCT04297241|Vasodilator Agents|vasodilator agents|mesh-ancestor
110338210|NCT02954939|Prednisone|prednisone|mesh-list
110864637|NCT04297241|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
110864638|NCT04297241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110864639|NCT04292171|Gabapentin|gabapentin|mesh-list
110864640|NCT04292171|Analgesics|analgesics|mesh-ancestor
110864641|NCT04292171|Sensory System Agents|sensory system agents|mesh-ancestor
110864642|NCT04292171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110864643|NCT04292171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110864644|NCT04292171|Anticonvulsants|anticonvulsants|mesh-ancestor
110864645|NCT04292171|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110864646|NCT04292171|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110864647|NCT04292171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110864648|NCT04292171|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110366253|NCT04415060|Anesthetics|anesthetics|mesh-ancestor
110864649|NCT04292171|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110864650|NCT04292171|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110864652|NCT04292171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110864653|NCT04292171|Antimanic Agents|antimanic agents|mesh-ancestor
110864654|NCT03200782|Empagliflozin|empagliflozin|mesh-list
110864655|NCT03200782|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
110338416|NCT00523185|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110864656|NCT03200782|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110864657|NCT03200782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110864658|NCT03200782|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110864659|NCT03200782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110864660|NCT03200782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110864662|NCT02449954|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
110864663|NCT02449954|Morphine|morphine|mesh-list
110864664|NCT02449954|Tramadol|tramadol|mesh-list
110864665|NCT02449954|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110864666|NCT02449954|Narcotics|narcotics|mesh-ancestor
110864667|NCT02449954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110864668|NCT02449954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110864669|NCT02449954|Analgesics|analgesics|mesh-ancestor
110864670|NCT02449954|Sensory System Agents|sensory system agents|mesh-ancestor
110864671|NCT02449954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110864672|NCT02449954|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110864673|NCT02449954|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110864674|NCT02449954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110864675|NCT02449954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110864676|NCT02449954|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110864677|NCT02449954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110864678|NCT02449954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110864679|NCT04393493|Chlorthalidone|chlorthalidone|mesh-list
110864680|NCT04393493|Furosemide|furosemide|mesh-list
110864681|NCT04393493|Spironolactone|spironolactone|mesh-list
110864682|NCT04393493|Diuretics|diuretics|mesh-ancestor
110864683|NCT04393493|Natriuretic Agents|natriuretic agents|mesh-ancestor
110582187|NCT00590135|Atorvastatin|atorvastatin|mesh-list
110864684|NCT04393493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110864685|NCT04393493|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110864686|NCT04393493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110864687|NCT04393493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110864688|NCT04393493|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110864689|NCT04393493|Hormone Antagonists|hormone antagonists|mesh-ancestor
110864690|NCT04393493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110864691|NCT04393493|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110864692|NCT04393493|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110864693|NCT04393493|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110864694|NCT02448082|Ichthammol|ichthammol|mesh-list
110864695|NCT02448082|Dermatologic Agents|dermatologic agents|mesh-ancestor
110864696|NCT03205228|Flupenthixol|flupenthixol|mesh-list
110864697|NCT03205228|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
110864698|NCT03205228|Omeprazole|omeprazole|mesh-list
110864699|NCT03205228|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110864700|NCT03205228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110864701|NCT03205228|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110864702|NCT03205228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110864703|NCT03205228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110864704|NCT03205228|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110864705|NCT03205228|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110864706|NCT03205228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110864707|NCT03205228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110864708|NCT03205228|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110864709|NCT03205228|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110864710|NCT03205228|Dopamine Agents|dopamine agents|mesh-ancestor
110864711|NCT03205228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110864712|NCT03195946|Midazolam|midazolam|mesh-list
110864713|NCT03195946|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110338734|NCT05141240|Palbociclib|palbociclib|mesh-list
110864714|NCT03195946|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110864715|NCT03195946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110338796|NCT02947932|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110864716|NCT03195946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110864717|NCT03195946|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110864718|NCT03195946|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110864719|NCT03195946|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110864720|NCT03195946|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110864721|NCT03195946|Anesthetics, General|anesthetics, general|mesh-ancestor
110864722|NCT03195946|Anesthetics|anesthetics|mesh-ancestor
110864723|NCT03195946|GABA Modulators|gaba modulators|mesh-ancestor
110864724|NCT03195946|GABA Agents|gaba agents|mesh-ancestor
110864725|NCT03195946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110864726|NCT03195946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110864727|NCT03204760|Dexamethasone|dexamethasone|mesh-list
110864728|NCT03204760|Prednisolone|prednisolone|mesh-list
110864729|NCT03204760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110864730|NCT03204760|Antiemetics|antiemetics|mesh-ancestor
110864731|NCT03204760|Autonomic Agents|autonomic agents|mesh-ancestor
110834385|NCT03368859|Immunologic Factors|immunologic factors|mesh-ancestor
110864732|NCT03204760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110864733|NCT03204760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110864734|NCT03204760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110864735|NCT03204760|Glucocorticoids|glucocorticoids|mesh-ancestor
110864737|NCT03204760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110864738|NCT03204760|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110864739|NCT03204760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110864740|NCT03200392|Chromium|chromium|mesh-list
110864741|NCT03200392|Trace Elements|trace elements|mesh-ancestor
110864742|NCT03200392|Micronutrients|micronutrients|mesh-ancestor
110864743|NCT03200392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110864744|NCT03200080|Amphetamine|amphetamine|mesh-list
110864745|NCT03200080|Dextroamphetamine|dextroamphetamine|mesh-list
110864746|NCT03200080|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110864747|NCT03200080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110864748|NCT03200080|Sympathomimetics|sympathomimetics|mesh-ancestor
110864749|NCT03200080|Autonomic Agents|autonomic agents|mesh-ancestor
110864750|NCT03200080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110864751|NCT03200080|Dopamine Agents|dopamine agents|mesh-ancestor
110864752|NCT03200080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110864753|NCT03200080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110864754|NCT03200080|Adrenergic Agents|adrenergic agents|mesh-ancestor
110864755|NCT03200080|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110864756|NCT03200080|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110864757|NCT03200080|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110864758|NCT03200080|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110864759|NCT03200236|Nicotine|nicotine|mesh-list
110366278|NCT04129086|Ketamine|ketamine|mesh-list
110864760|NCT03200236|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110339220|NCT00507845|Felodipine|felodipine|mesh-list
110864761|NCT03200236|Autonomic Agents|autonomic agents|mesh-ancestor
110864762|NCT03200236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110864763|NCT03200236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110864764|NCT03200236|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110864765|NCT03200236|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110864766|NCT03200236|Cholinergic Agents|cholinergic agents|mesh-ancestor
110864767|NCT03200236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110864768|NCT03200236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110864769|NCT03200002|Mycophenolic Acid|mycophenolic acid|mesh-list
110864770|NCT03200002|Cyclophosphamide|cyclophosphamide|mesh-list
110864771|NCT03200002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110864772|NCT03200002|Immunologic Factors|immunologic factors|mesh-ancestor
110864773|NCT03200002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110864774|NCT03200002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110864775|NCT03200002|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110864776|NCT03200002|Alkylating Agents|alkylating agents|mesh-ancestor
110864777|NCT03200002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110864778|NCT03200002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110864779|NCT03200002|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110864780|NCT03200002|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110864781|NCT03200002|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110864782|NCT03200002|Antitubercular Agents|antitubercular agents|mesh-ancestor
110864783|NCT03200002|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110864784|NCT03200002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110864785|NCT03200002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110864787|NCT02447380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110864788|NCT02447380|Tubulin Modulators|tubulin modulators|mesh-ancestor
110864789|NCT02447380|Antimitotic Agents|antimitotic agents|mesh-ancestor
110864790|NCT02447380|Mitosis Modulators|mitosis modulators|mesh-ancestor
110864791|NCT02447380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110864792|NCT02447224|Metronidazole|metronidazole|mesh-list
110864793|NCT02447224|Ertapenem|ertapenem|mesh-list
110864794|NCT02447224|Cefdinir|cefdinir|mesh-list
110864795|NCT02447224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110864796|NCT02447224|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110864797|NCT02447224|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110864798|NCT02447224|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110864799|NCT03199690|Rifampin|rifampin|mesh-list
110864800|NCT03199690|Dolutegravir|dolutegravir|mesh-list
110864801|NCT03199690|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110834389|NCT03368859|Antidotes|antidotes|mesh-ancestor
110864802|NCT03199690|Antitubercular Agents|antitubercular agents|mesh-ancestor
110339616|NCT03459911|Losartan|losartan|mesh-list
110864803|NCT03199690|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110864804|NCT03199690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110864805|NCT03199690|Leprostatic Agents|leprostatic agents|mesh-ancestor
110864806|NCT03199690|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110864807|NCT03199690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110864808|NCT03199690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110864809|NCT03199690|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110864810|NCT03199690|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110864811|NCT03199690|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110864812|NCT03199690|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110339753|NCT01356966|Folic Acid|folic acid|mesh-list
110864813|NCT03199690|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110864814|NCT03199690|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110864815|NCT03199690|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110864816|NCT03199690|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110864817|NCT03199690|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110864818|NCT03199690|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110864819|NCT03199690|Antiviral Agents|antiviral agents|mesh-ancestor
110864820|NCT03204058|Metformin|metformin|mesh-list
110864821|NCT03204058|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110864822|NCT03204058|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110864823|NCT03204058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110864824|NCT03204058|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110864825|NCT03204058|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110864826|NCT03204058|Antimetabolites|antimetabolites|mesh-ancestor
110864827|NCT03204058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110864828|NCT03204058|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110864829|NCT03204058|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110339894|NCT02944227|Ranibizumab|ranibizumab|mesh-list
110864830|NCT03204058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110864831|NCT03203746|Lycopene|lycopene|mesh-list
110864832|NCT03203746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110864833|NCT03203746|Antioxidants|antioxidants|mesh-ancestor
110864834|NCT03203746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110864835|NCT03203746|Protective Agents|protective agents|mesh-ancestor
110864836|NCT03203746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110864837|NCT03203746|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110864838|NCT03203746|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110864839|NCT03203746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110864840|NCT03203668|Choline|choline|mesh-list
110864841|NCT03203668|Lipotropic Agents|lipotropic agents|mesh-ancestor
110864842|NCT03203668|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110864843|NCT03203668|Antimetabolites|antimetabolites|mesh-ancestor
110864844|NCT03203668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110864845|NCT03203668|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110864846|NCT03203668|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110864847|NCT03203668|Nootropic Agents|nootropic agents|mesh-ancestor
110864848|NCT03199534|Botulinum Toxins|botulinum toxins|mesh-list
110864849|NCT03199534|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110340107|NCT00531336|Bevacizumab|bevacizumab|mesh-list
110864850|NCT03199534|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110864851|NCT03199534|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110864852|NCT03199534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110864853|NCT03199534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110864854|NCT03199534|Cholinergic Agents|cholinergic agents|mesh-ancestor
110340181|NCT00531687|Paclitaxel|paclitaxel|mesh-list
110864855|NCT03199534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110864856|NCT03199534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110864857|NCT03199534|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110864858|NCT03199534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110864860|NCT03203356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110864861|NCT03203356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110864862|NCT04280705|Remdesivir|remdesivir|mesh-list
110864863|NCT04280705|Antimetabolites|antimetabolites|mesh-ancestor
110864864|NCT04280705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110864865|NCT04280705|Antiviral Agents|antiviral agents|mesh-ancestor
110864866|NCT04280705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110864867|NCT03203590|Carboplatin|carboplatin|mesh-list
110864868|NCT03203590|Vinorelbine|vinorelbine|mesh-list
110864869|NCT03203590|Gefitinib|gefitinib|mesh-list
110366314|NCT03798639|Ipilimumab|ipilimumab|mesh-list
110864870|NCT03203590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110340241|NCT00531024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110864871|NCT03203590|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110864872|NCT03203590|Tubulin Modulators|tubulin modulators|mesh-ancestor
110864873|NCT03203590|Antimitotic Agents|antimitotic agents|mesh-ancestor
110864874|NCT03203590|Mitosis Modulators|mitosis modulators|mesh-ancestor
110864875|NCT03203590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110864876|NCT03203590|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110864877|NCT03203590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110864878|NCT02077166|Rituximab|rituximab|mesh-list
110864879|NCT02077166|Lenalidomide|lenalidomide|mesh-list
110864880|NCT02077166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110864881|NCT02077166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110864882|NCT02077166|Immunologic Factors|immunologic factors|mesh-ancestor
110864883|NCT02077166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110864884|NCT02077166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110864885|NCT02077166|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110864886|NCT02077166|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110864887|NCT02077166|Growth Substances|growth substances|mesh-ancestor
110864888|NCT02077166|Growth Inhibitors|growth inhibitors|mesh-ancestor
110864889|NCT02450188|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
110864891|NCT02450188|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110864892|NCT02450188|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110864893|NCT02450188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110864894|NCT02450188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110864895|NCT02450188|Urological Agents|urological agents|mesh-ancestor
110864896|NCT03198676|Poly I-C|poly i-c|mesh-list
110864897|NCT03198676|Antiviral Agents|antiviral agents|mesh-ancestor
110864898|NCT03198676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110864899|NCT03198676|Interferon Inducers|interferon inducers|mesh-ancestor
110864900|NCT03198676|Immunologic Factors|immunologic factors|mesh-ancestor
110864901|NCT03198676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110864903|NCT04484506|Cyclophosphamide|cyclophosphamide|mesh-list
110864904|NCT04484506|Etoposide|etoposide|mesh-list
110864906|NCT04484506|Pegaspargase|pegaspargase|mesh-list
110864907|NCT04484506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110864908|NCT04484506|Immunologic Factors|immunologic factors|mesh-ancestor
110864909|NCT04484506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110864910|NCT04484506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110864911|NCT04484506|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110864912|NCT04484506|Alkylating Agents|alkylating agents|mesh-ancestor
110864913|NCT04484506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110340795|NCT02940912|Autonomic Agents|autonomic agents|mesh-ancestor
110864914|NCT04484506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110864915|NCT04484506|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110864916|NCT04484506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110864919|NCT04484506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110864920|NCT04484506|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110864921|NCT04484506|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110864922|NCT04484506|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110864923|NCT04484506|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110864924|NCT04484506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110864925|NCT04484506|Tubulin Modulators|tubulin modulators|mesh-ancestor
110864926|NCT04484506|Antimitotic Agents|antimitotic agents|mesh-ancestor
110864927|NCT04484506|Mitosis Modulators|mitosis modulators|mesh-ancestor
110864929|NCT04332653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110864930|NCT04332653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110864931|NCT04332653|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110341012|NCT00519116|Sirolimus|sirolimus|mesh-list
110864932|NCT04332653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110864933|NCT02449564|Sirolimus|sirolimus|mesh-list
110864934|NCT02449564|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110864935|NCT02449564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110864936|NCT02449564|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110864937|NCT02449564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110864938|NCT02449564|Antifungal Agents|antifungal agents|mesh-ancestor
110864939|NCT02449564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110864940|NCT02449564|Immunologic Factors|immunologic factors|mesh-ancestor
110864941|NCT02449564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110864942|NCT02449720|Ropivacaine|ropivacaine|mesh-list
110864943|NCT02449720|Anesthetics, Local|anesthetics, local|mesh-ancestor
110864944|NCT02449720|Anesthetics|anesthetics|mesh-ancestor
110864945|NCT02449720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110864946|NCT02449720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110864947|NCT02449720|Sensory System Agents|sensory system agents|mesh-ancestor
110864948|NCT02449720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110864949|NCT03194620|Proanthocyanidin|proanthocyanidin|mesh-list
110864950|NCT03194620|Epicatechin gallate|epicatechin gallate|mesh-list
110864951|NCT03194620|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
110864952|NCT03194620|Procyanidin|procyanidin|mesh-list
110864953|NCT03194620|Theaflavin|theaflavin|mesh-list
110864954|NCT03194620|Antioxidants|antioxidants|mesh-ancestor
110864955|NCT03194620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110864956|NCT03194620|Protective Agents|protective agents|mesh-ancestor
110864957|NCT03194620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110864958|NCT03194620|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110864959|NCT03194620|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110864960|NCT03194620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110864961|NCT03194620|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110864962|NCT03194620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110864963|NCT03194620|Protease Inhibitors|protease inhibitors|mesh-ancestor
110864964|NCT03194620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110864965|NCT03194620|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
110864966|NCT03194620|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110864967|NCT03194620|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110864969|NCT03194620|Sequestering Agents|sequestering agents|mesh-ancestor
110864970|NCT02445976|Seviteronel|seviteronel|mesh-list
110864971|NCT02445976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110864972|NCT02445976|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110864973|NCT02445976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110864974|NCT02445976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110864975|NCT03198442|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110864976|NCT03198442|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110864977|NCT03198442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110864978|NCT03198208|Fentanyl|fentanyl|mesh-list
110864979|NCT03198208|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110864980|NCT03198208|Narcotics|narcotics|mesh-ancestor
110864981|NCT03198208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110864982|NCT03198208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110864983|NCT03198208|Analgesics|analgesics|mesh-ancestor
110864984|NCT03198208|Sensory System Agents|sensory system agents|mesh-ancestor
110864985|NCT03198208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110864986|NCT03198208|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110864987|NCT03198208|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110864988|NCT03198208|Anesthetics, General|anesthetics, general|mesh-ancestor
110864989|NCT03198208|Anesthetics|anesthetics|mesh-ancestor
110864990|NCT01044056|Contraceptive Agents|contraceptive agents|mesh-list
110864991|NCT01044056|Levonorgestrel|levonorgestrel|mesh-list
110864992|NCT01044056|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110864993|NCT01044056|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
110864994|NCT01044056|NuvaRing|nuvaring|mesh-list
110864995|NCT01044056|Contraceptives, Oral|contraceptives, oral|mesh-list
110864996|NCT01044056|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110864997|NCT01044056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110864998|NCT01044056|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110864999|NCT01044056|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110865000|NCT01044056|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110865001|NCT01044056|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110865002|NCT01044056|Estrogens|estrogens|mesh-ancestor
110865003|NCT01044056|Hormones|hormones|mesh-ancestor
110865004|NCT01044056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110865005|NCT01044056|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110865006|NCT01005056|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110865007|NCT01005056|Desogestrel|desogestrel|mesh-list
110865008|NCT01005056|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110865009|NCT01005056|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110865010|NCT01005056|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110865011|NCT01005056|Contraceptive Agents|contraceptive agents|mesh-ancestor
110865012|NCT01005056|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110865013|NCT01005056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110865015|NCT01005056|Estrogens|estrogens|mesh-ancestor
110865016|NCT01005056|Hormones|hormones|mesh-ancestor
110865017|NCT01005056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110865018|NCT01005056|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110865019|NCT01005056|Progestins|progestins|mesh-ancestor
110865020|NCT04796714|Aspirin|aspirin|mesh-list
110865021|NCT04796714|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110865022|NCT04796714|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110865024|NCT04796714|Sensory System Agents|sensory system agents|mesh-ancestor
110865025|NCT04796714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110865026|NCT04796714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110865027|NCT04796714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110865028|NCT04796714|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110865029|NCT04796714|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110865030|NCT04796714|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110865031|NCT04796714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110865032|NCT04796714|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110865033|NCT04796714|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110865034|NCT04796714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110865035|NCT04796714|Antipyretics|antipyretics|mesh-ancestor
110865036|NCT02445898|Methylprednisolone|methylprednisolone|mesh-list
110865037|NCT02445898|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110865038|NCT02445898|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110865039|NCT02445898|Prednisolone|prednisolone|mesh-list
110865040|NCT02445898|Prednisolone acetate|prednisolone acetate|mesh-list
110865041|NCT02445898|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110865042|NCT02445898|Prednisolone phosphate|prednisolone phosphate|mesh-list
110865043|NCT02445898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110865044|NCT02445898|Antiemetics|antiemetics|mesh-ancestor
110865045|NCT02445898|Autonomic Agents|autonomic agents|mesh-ancestor
110865046|NCT02445898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110865047|NCT02445898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110865048|NCT02445898|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110865049|NCT02445898|Glucocorticoids|glucocorticoids|mesh-ancestor
110865050|NCT02445898|Hormones|hormones|mesh-ancestor
110865051|NCT02445898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110865052|NCT02445898|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110865053|NCT02445898|Protective Agents|protective agents|mesh-ancestor
110341651|NCT00523913|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110865054|NCT02445898|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110865055|NCT02445898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110865056|NCT02445820|Plasma-lyte 148|plasma-lyte 148|mesh-list
110865057|NCT02445820|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110865058|NCT02445820|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110865059|NCT03198130|Cemiplimab|cemiplimab|mesh-list
110865060|NCT03198130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110865061|NCT03198130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110865062|NCT04238780|Fentanyl|fentanyl|mesh-list
110865063|NCT04238780|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110865064|NCT04238780|Narcotics|narcotics|mesh-ancestor
110341708|NCT00524966|Hemostatics|hemostatics|mesh-list
110865065|NCT04238780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110865066|NCT04238780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110865067|NCT04238780|Analgesics|analgesics|mesh-ancestor
110865068|NCT04238780|Sensory System Agents|sensory system agents|mesh-ancestor
110865069|NCT04238780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110865070|NCT04238780|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110865071|NCT04238780|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110865072|NCT04238780|Anesthetics, General|anesthetics, general|mesh-ancestor
110865073|NCT04238780|Anesthetics|anesthetics|mesh-ancestor
110865074|NCT00944216|Emollients|emollients|mesh-list
110865075|NCT00944216|Dermatologic Agents|dermatologic agents|mesh-ancestor
110865076|NCT04238663|Bevacizumab|bevacizumab|mesh-list
110865077|NCT04238663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110865078|NCT04238663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110865079|NCT04238663|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110865080|NCT04238663|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110865081|NCT04238663|Growth Substances|growth substances|mesh-ancestor
110865082|NCT04238663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110865083|NCT04238663|Growth Inhibitors|growth inhibitors|mesh-ancestor
110865084|NCT00878462|Asenapine|asenapine|mesh-list
110865085|NCT00878462|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110865086|NCT00878462|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110865087|NCT00878462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110865088|NCT00878462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110865089|NCT00878462|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110865090|NCT03197818|Budesonide|budesonide|mesh-list
110865091|NCT03197818|Formoterol Fumarate|formoterol fumarate|mesh-list
110865092|NCT03197818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110865093|NCT03197818|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110865094|NCT03197818|Autonomic Agents|autonomic agents|mesh-ancestor
110865095|NCT03197818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110865096|NCT03197818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110865097|NCT03197818|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110865098|NCT03197818|Respiratory System Agents|respiratory system agents|mesh-ancestor
110865099|NCT03197818|Glucocorticoids|glucocorticoids|mesh-ancestor
110865100|NCT03197818|Hormones|hormones|mesh-ancestor
110865101|NCT03197818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110865102|NCT03197818|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110865103|NCT03197818|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110865104|NCT03197818|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110865105|NCT03197818|Adrenergic Agents|adrenergic agents|mesh-ancestor
110865106|NCT03197818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110865107|NCT03197818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110865108|NCT03442088|Apremilast|apremilast|mesh-list
110865109|NCT03442088|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110865110|NCT03442088|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110865111|NCT03442088|Analgesics|analgesics|mesh-ancestor
110865112|NCT03442088|Sensory System Agents|sensory system agents|mesh-ancestor
110865113|NCT03442088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110865114|NCT03442088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110865115|NCT03442088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110865116|NCT03442088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110342113|NCT02928510|Idelalisib|idelalisib|mesh-list
110366369|NCT03313544|Nivolumab|nivolumab|mesh-list
110865117|NCT03442088|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
110865118|NCT03442088|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110865119|NCT03442088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110865120|NCT03442088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110865121|NCT01562405|Dexamethasone|dexamethasone|mesh-list
110865122|NCT01562405|Lenalidomide|lenalidomide|mesh-list
110865123|NCT01562405|Pomalidomide|pomalidomide|mesh-list
110865124|NCT01562405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110865125|NCT01562405|Antiemetics|antiemetics|mesh-ancestor
110865126|NCT01562405|Autonomic Agents|autonomic agents|mesh-ancestor
110865127|NCT01562405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110342178|NCT00526409|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110342179|NCT00526409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110342180|NCT00526409|Tubulin Modulators|tubulin modulators|mesh-ancestor
110342181|NCT00526409|Antimitotic Agents|antimitotic agents|mesh-ancestor
110342182|NCT00526409|Mitosis Modulators|mitosis modulators|mesh-ancestor
110342183|NCT00526409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110342184|NCT00526409|Glucocorticoids|glucocorticoids|mesh-ancestor
110865129|NCT01562405|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110865130|NCT01562405|Glucocorticoids|glucocorticoids|mesh-ancestor
110865131|NCT01562405|Hormones|hormones|mesh-ancestor
110582636|NCT05684913|Hemostatics|hemostatics|mesh-list
110865132|NCT01562405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110342242|NCT02945163|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110865133|NCT01562405|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110865134|NCT01562405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110865135|NCT01562405|Immunologic Factors|immunologic factors|mesh-ancestor
110865136|NCT01562405|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110865137|NCT01562405|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110865138|NCT01562405|Growth Substances|growth substances|mesh-ancestor
110865139|NCT01562405|Growth Inhibitors|growth inhibitors|mesh-ancestor
110865140|NCT03119194|Opicapone|opicapone|mesh-list
110865141|NCT03119194|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
110865142|NCT03119194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110865143|NCT03119194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110865144|NCT03119194|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110865145|NCT03119194|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110865146|NCT03107338|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
110865147|NCT03107338|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110865148|NCT03107338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110865149|NCT03107338|Analgesics|analgesics|mesh-ancestor
110865150|NCT03107338|Sensory System Agents|sensory system agents|mesh-ancestor
110865151|NCT03107338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110865152|NCT03107338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110865153|NCT03107338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110865154|NCT03107338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110865155|NCT05581940|Bupivacaine|bupivacaine|mesh-list
110865156|NCT05581940|Anesthetics|anesthetics|mesh-list
110865157|NCT05581940|Anesthetics, Local|anesthetics, local|mesh-ancestor
110865158|NCT05581940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110865159|NCT05581940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110865160|NCT05581940|Sensory System Agents|sensory system agents|mesh-ancestor
110342582|NCT02926053|Alkylating Agents|alkylating agents|mesh-ancestor
110865161|NCT05581940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110865162|NCT02445508|Cholecystokinin|cholecystokinin|mesh-list
110865164|NCT02445508|Chelating Agents|chelating agents|mesh-ancestor
110342664|NCT04231968|Ziresovir|ziresovir|mesh-list
110865165|NCT02445508|Sequestering Agents|sequestering agents|mesh-ancestor
110865166|NCT02445508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110865167|NCT02445508|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
110865168|NCT02445508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110865169|NCT03197584|Leucovorin|leucovorin|mesh-list
110865170|NCT03197584|Cyclophosphamide|cyclophosphamide|mesh-list
110865171|NCT03197584|Bevacizumab|bevacizumab|mesh-list
110865172|NCT03197584|Fluorouracil|fluorouracil|mesh-list
110865173|NCT03197584|Capecitabine|capecitabine|mesh-list
110865174|NCT03197584|Oxaliplatin|oxaliplatin|mesh-list
110865175|NCT03197584|Fulvestrant|fulvestrant|mesh-list
110865176|NCT03197584|Avelumab|avelumab|mesh-list
110865177|NCT03197584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110865178|NCT03197584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110865179|NCT03197584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110865180|NCT03197584|Immunologic Factors|immunologic factors|mesh-ancestor
110865181|NCT03197584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110865182|NCT03197584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110342870|NCT00531362|Antipyretics|antipyretics|mesh-ancestor
110865183|NCT03197584|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110865185|NCT03197584|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110865186|NCT03197584|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110865187|NCT03197584|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110342934|NCT02944175|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110865188|NCT03197584|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110865189|NCT03197584|Growth Substances|growth substances|mesh-ancestor
110865190|NCT03197584|Growth Inhibitors|growth inhibitors|mesh-ancestor
110865191|NCT03197584|Antimetabolites|antimetabolites|mesh-ancestor
110865192|NCT03197584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110865193|NCT03197584|Antidotes|antidotes|mesh-ancestor
110865194|NCT03197584|Protective Agents|protective agents|mesh-ancestor
110865195|NCT03197584|Vitamin B Complex|vitamin b complex|mesh-ancestor
110865196|NCT03197584|Vitamins|vitamins|mesh-ancestor
110865197|NCT03197584|Micronutrients|micronutrients|mesh-ancestor
110865198|NCT03197584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110865199|NCT03197584|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110865200|NCT03197584|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110865201|NCT03197584|Hormone Antagonists|hormone antagonists|mesh-ancestor
110865202|NCT03197584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110865203|NCT03722576|Calcium|calcium|mesh-list
110865204|NCT03722576|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110343005|NCT02943356|Urological Agents|urological agents|mesh-ancestor
110865205|NCT03722576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110865206|NCT03416348|Ethanol|ethanol|mesh-list
110865207|NCT03416348|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110582708|NCT00775190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110865208|NCT03416348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110865209|NCT03416348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110865210|NCT03416348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110865212|NCT03236012|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110865213|NCT03236012|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110343135|NCT02941913|Serotonin Agents|serotonin agents|mesh-ancestor
110865214|NCT03236012|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110865215|NCT03236012|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110865216|NCT03236012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110865217|NCT03236012|Cholinergic Agents|cholinergic agents|mesh-ancestor
110865218|NCT03236012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110865219|NCT03236012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110865220|NCT03236012|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110865221|NCT03236012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110865222|NCT02449486|Ropivacaine|ropivacaine|mesh-list
110865223|NCT02449486|Anesthetics, Local|anesthetics, local|mesh-ancestor
110865224|NCT02449486|Anesthetics|anesthetics|mesh-ancestor
110865225|NCT02449486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110865226|NCT02449486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110865227|NCT02449486|Sensory System Agents|sensory system agents|mesh-ancestor
110366391|NCT03251859|Ticagrelor|ticagrelor|mesh-list
110865228|NCT02449486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110865229|NCT03202186|Progesterone|progesterone|mesh-list
110865230|NCT03202186|Progestins|progestins|mesh-ancestor
110865231|NCT03202186|Hormones|hormones|mesh-ancestor
110865232|NCT03202186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110865233|NCT03202186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110865234|NCT03625076|Lidocaine|lidocaine|mesh-list
110865235|NCT03625076|Propofol|propofol|mesh-list
110865236|NCT03625076|Etomidate|etomidate|mesh-list
110865237|NCT03625076|Anesthetics, Local|anesthetics, local|mesh-ancestor
110865238|NCT03625076|Anesthetics|anesthetics|mesh-ancestor
110865239|NCT03625076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110865240|NCT03625076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110865241|NCT03625076|Sensory System Agents|sensory system agents|mesh-ancestor
110865242|NCT03625076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110865243|NCT03625076|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110343403|NCT06026163|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110865244|NCT03625076|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110865245|NCT03625076|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110865246|NCT03625076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110865247|NCT03625076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110865248|NCT03625076|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110865249|NCT03625076|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110865250|NCT03625076|Anesthetics, General|anesthetics, general|mesh-ancestor
110865251|NCT02445352|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110865252|NCT02445352|Ezetimibe|ezetimibe|mesh-list
110865253|NCT02445352|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110865254|NCT02445352|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110865255|NCT02445352|Antimetabolites|antimetabolites|mesh-ancestor
110865256|NCT02445352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110865257|NCT02445352|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110865258|NCT02445352|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110865260|NCT03693989|Fluprednisolone|fluprednisolone|mesh-list
110865261|NCT03693989|Difluprednate|difluprednate|mesh-list
110865262|NCT03693989|Glucocorticoids|glucocorticoids|mesh-ancestor
110865263|NCT03693989|Hormones|hormones|mesh-ancestor
110865264|NCT03693989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110865265|NCT03693989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110865266|NCT03693989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110865267|NCT04944212|Vitamin D|vitamin d|mesh-list
110865268|NCT04944212|Vitamins|vitamins|mesh-ancestor
110865269|NCT04944212|Micronutrients|micronutrients|mesh-ancestor
110865270|NCT04944212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110343752|NCT06022939|Immunologic Factors|immunologic factors|mesh-ancestor
110865271|NCT04944212|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110865272|NCT03197740|Donepezil|donepezil|mesh-list
110865273|NCT03197740|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110865274|NCT03197740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110865275|NCT03197740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110865276|NCT03197740|Cholinergic Agents|cholinergic agents|mesh-ancestor
110865277|NCT03197740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110865278|NCT03197740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110865279|NCT03197740|Nootropic Agents|nootropic agents|mesh-ancestor
110865280|NCT03201796|Levofloxacin|levofloxacin|mesh-list
110865281|NCT03201796|Prulifloxacin|prulifloxacin|mesh-list
110582783|NCT00724932|Atropine|atropine|mesh-list
110865282|NCT03201796|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110865283|NCT03201796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110343887|NCT06015880|Lenalidomide|lenalidomide|mesh-list
110366400|NCT02918409|Tobramycin|tobramycin|mesh-list
110865284|NCT03201796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110865285|NCT03201796|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110865286|NCT03201796|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110865287|NCT03201796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110343956|NCT06008405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110865288|NCT03201796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110865289|NCT03201796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110865290|NCT03201796|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110865291|NCT03201796|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110865292|NCT02727998|Midazolam|midazolam|mesh-list
110865293|NCT02727998|Ketamine|ketamine|mesh-list
110865294|NCT02727998|Analgesics|analgesics|mesh-ancestor
110865296|NCT02727998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110865297|NCT02727998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110865298|NCT02727998|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110865299|NCT02727998|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110865300|NCT02727998|Anesthetics, General|anesthetics, general|mesh-ancestor
110865301|NCT02727998|Anesthetics|anesthetics|mesh-ancestor
110865302|NCT02727998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110865303|NCT02727998|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110865304|NCT02727998|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110865305|NCT02727998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110865306|NCT02727998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110865307|NCT02727998|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110865308|NCT02727998|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110865309|NCT02727998|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110865310|NCT02727998|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110865311|NCT02727998|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110865312|NCT02727998|GABA Modulators|gaba modulators|mesh-ancestor
110865313|NCT02727998|GABA Agents|gaba agents|mesh-ancestor
110865314|NCT02636270|Mecasermin|mecasermin|mesh-list
110865315|NCT02636270|Growth Substances|growth substances|mesh-ancestor
110865316|NCT02636270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110865318|NCT02108990|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110865319|NCT02108990|Analgesics|analgesics|mesh-ancestor
110865320|NCT02108990|Sensory System Agents|sensory system agents|mesh-ancestor
110865321|NCT02108990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110834434|NCT03129646|Miltefosine|miltefosine|mesh-list
110865322|NCT02108990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110865323|NCT02108990|Antipyretics|antipyretics|mesh-ancestor
110865324|NCT03194074|Propofol|propofol|mesh-list
110865325|NCT03194074|Desflurane|desflurane|mesh-list
110865326|NCT03194074|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110865327|NCT03194074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110865328|NCT03194074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110865329|NCT03194074|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110865330|NCT03194074|Anesthetics, General|anesthetics, general|mesh-ancestor
110865331|NCT03194074|Anesthetics|anesthetics|mesh-ancestor
110865332|NCT03194074|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110865333|NCT03201952|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
110865334|NCT03201952|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
110865335|NCT03201952|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110865336|NCT04179461|Vitamin D|vitamin d|mesh-list
110865337|NCT04179461|Cholecalciferol|cholecalciferol|mesh-list
110865338|NCT04179461|Fluticasone|fluticasone|mesh-list
110865339|NCT04179461|Xhance|xhance|mesh-list
110865340|NCT04179461|Mometasone Furoate|mometasone furoate|mesh-list
110865341|NCT04179461|Cetirizine|cetirizine|mesh-list
110865342|NCT04179461|Loratadine|loratadine|mesh-list
110865343|NCT04179461|Azithromycin|azithromycin|mesh-list
110865344|NCT04179461|Budesonide|budesonide|mesh-list
110865345|NCT04179461|Beclomethasone|beclomethasone|mesh-list
110865346|NCT04179461|Emollients|emollients|mesh-list
110865347|NCT04179461|Formoterol Fumarate|formoterol fumarate|mesh-list
110865348|NCT04179461|Tiotropium Bromide|tiotropium bromide|mesh-list
110865349|NCT04179461|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110865350|NCT04179461|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
110865351|NCT04179461|Histamine Antagonists|histamine antagonists|mesh-list
110865352|NCT04179461|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
110865353|NCT04179461|Vitamins|vitamins|mesh-ancestor
110865354|NCT04179461|Micronutrients|micronutrients|mesh-ancestor
110865355|NCT04179461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110865356|NCT04179461|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110865357|NCT04179461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110865358|NCT04179461|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110865359|NCT04179461|Autonomic Agents|autonomic agents|mesh-ancestor
110865360|NCT04179461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110865361|NCT04179461|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110865362|NCT04179461|Respiratory System Agents|respiratory system agents|mesh-ancestor
110865363|NCT04179461|Dermatologic Agents|dermatologic agents|mesh-ancestor
110865364|NCT04179461|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110865365|NCT04179461|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110865366|NCT04179461|Glucocorticoids|glucocorticoids|mesh-ancestor
110865367|NCT04179461|Hormones|hormones|mesh-ancestor
110865368|NCT04179461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110865369|NCT04179461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110865370|NCT04179461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110865371|NCT04179461|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110865372|NCT04179461|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110865373|NCT04179461|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110865374|NCT04179461|Adrenergic Agents|adrenergic agents|mesh-ancestor
110865375|NCT04179461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110865376|NCT04179461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110865377|NCT04179461|Parasympatholytics|parasympatholytics|mesh-ancestor
110865378|NCT04179461|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110865379|NCT04179461|Cholinergic Agents|cholinergic agents|mesh-ancestor
110344400|NCT05838560|Antioxidants|antioxidants|mesh-ancestor
110865380|NCT04179461|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110865381|NCT04179461|Histamine Agents|histamine agents|mesh-ancestor
110865382|NCT04179461|Antipruritics|antipruritics|mesh-ancestor
110865383|NCT04179461|Sympathomimetics|sympathomimetics|mesh-ancestor
110865384|NCT04844528|Niacinamide|niacinamide|mesh-list
110865386|NCT04844528|Nicotinic Acids|nicotinic acids|mesh-list
110865387|NCT04844528|Vitamin B Complex|vitamin b complex|mesh-ancestor
110865388|NCT04844528|Vitamins|vitamins|mesh-ancestor
110865389|NCT04844528|Micronutrients|micronutrients|mesh-ancestor
110865390|NCT04844528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110865391|NCT04844528|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110865392|NCT04844528|Antimetabolites|antimetabolites|mesh-ancestor
110344467|NCT05811403|Antioxidants|antioxidants|mesh-ancestor
110865393|NCT04844528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110865395|NCT04844528|Vasodilator Agents|vasodilator agents|mesh-ancestor
110865396|NCT03196882|Iron|iron|mesh-list
110865397|NCT03196882|Trace Elements|trace elements|mesh-ancestor
110865398|NCT03196882|Micronutrients|micronutrients|mesh-ancestor
110865399|NCT03196882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110865400|NCT04172831|Cyclobenzaprine|cyclobenzaprine|mesh-list
110865401|NCT04172831|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110865402|NCT04172831|Antidepressive Agents|antidepressive agents|mesh-ancestor
110865403|NCT04172831|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110865404|NCT04172831|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110865405|NCT04172831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110865406|NCT04172831|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110865407|NCT04172831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110865408|NCT04172831|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110865409|NCT04172831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110865410|NCT01562717|Ibuprofen|ibuprofen|mesh-list
110865411|NCT01562717|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110865412|NCT01562717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110865413|NCT01562717|Analgesics|analgesics|mesh-ancestor
110865414|NCT01562717|Sensory System Agents|sensory system agents|mesh-ancestor
110865415|NCT01562717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110344587|NCT05756166|Interferons|interferons|mesh-list
110865416|NCT01562717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110865417|NCT01562717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110865418|NCT01562717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110865419|NCT01562717|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110865420|NCT01562717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110865421|NCT01562717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110865422|NCT03196648|Fluorides|fluorides|mesh-list
110865423|NCT03196648|Antioxidants|antioxidants|mesh-list
110865424|NCT03196648|Cariostatic Agents|cariostatic agents|mesh-ancestor
110865425|NCT03196648|Protective Agents|protective agents|mesh-ancestor
110865426|NCT03196648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110344724|NCT05660967|Lenalidomide|lenalidomide|mesh-list
110865427|NCT03196648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110865428|NCT03625310|Listerine|listerine|mesh-list
110865429|NCT03625310|Fluorides|fluorides|mesh-list
110865430|NCT03625310|Sodium Fluoride|sodium fluoride|mesh-list
110865431|NCT03625310|Cariostatic Agents|cariostatic agents|mesh-ancestor
110865432|NCT03625310|Protective Agents|protective agents|mesh-ancestor
110865433|NCT03625310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110865434|NCT03625310|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110865435|NCT03625310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110344790|NCT05625087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110344791|NCT05625087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110344792|NCT05595083|Dexmedetomidine|dexmedetomidine|mesh-list
110344793|NCT05595083|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110344794|NCT05595083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110344795|NCT05595083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110344796|NCT05595083|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110344797|NCT05595083|Analgesics|analgesics|mesh-ancestor
110865436|NCT05058404|Prednisone|prednisone|mesh-list
110582957|NCT03002389|Xhance|xhance|mesh-list
110865438|NCT05058404|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110865439|NCT05058404|Cyclophosphamide|cyclophosphamide|mesh-list
110865440|NCT05058404|Vincristine|vincristine|mesh-list
110865441|NCT05058404|Doxorubicin|doxorubicin|mesh-list
110865442|NCT05058404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110865443|NCT05058404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110865444|NCT05058404|Immunologic Factors|immunologic factors|mesh-ancestor
110865445|NCT05058404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110865446|NCT05058404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110865447|NCT05058404|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110865448|NCT05058404|Alkylating Agents|alkylating agents|mesh-ancestor
110865449|NCT05058404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110865450|NCT05058404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110865451|NCT05058404|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110865452|NCT05058404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110865454|NCT05058404|Hormones|hormones|mesh-ancestor
110865455|NCT05058404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110865456|NCT05058404|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110865457|NCT05058404|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110865458|NCT05058404|Tubulin Modulators|tubulin modulators|mesh-ancestor
110865459|NCT05058404|Antimitotic Agents|antimitotic agents|mesh-ancestor
110865460|NCT05058404|Mitosis Modulators|mitosis modulators|mesh-ancestor
110865461|NCT05058404|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110865462|NCT05058404|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110865463|NCT05058404|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110865464|NCT05058404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110865465|NCT03118336|Empagliflozin|empagliflozin|mesh-list
110865466|NCT03118336|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110865467|NCT03118336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110865468|NCT03118336|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110865469|NCT03118336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110865470|NCT02444572|Enoxaparin|enoxaparin|mesh-list
110344994|NCT05415215|Tubulin Modulators|tubulin modulators|mesh-ancestor
110344995|NCT05415215|Antimitotic Agents|antimitotic agents|mesh-ancestor
110344996|NCT05415215|Mitosis Modulators|mitosis modulators|mesh-ancestor
110344997|NCT05415215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110344998|NCT05415215|Immunotoxins|immunotoxins|mesh-ancestor
110344999|NCT05415215|Immunoconjugates|immunoconjugates|mesh-ancestor
110345000|NCT05415215|Immunologic Factors|immunologic factors|mesh-ancestor
110345001|NCT05415215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110345002|NCT05411718|Aspirin|aspirin|mesh-list
110865471|NCT02444572|Anticoagulants|anticoagulants|mesh-ancestor
110865472|NCT02444572|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110865473|NCT02444572|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110865474|NCT02444572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110865475|NCT04165031|Docetaxel|docetaxel|mesh-list
110865476|NCT04165031|Cetuximab|cetuximab|mesh-list
110865477|NCT04165031|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110865478|NCT04165031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110865479|NCT04165031|Tubulin Modulators|tubulin modulators|mesh-ancestor
110865480|NCT04165031|Antimitotic Agents|antimitotic agents|mesh-ancestor
110865481|NCT04165031|Mitosis Modulators|mitosis modulators|mesh-ancestor
110865482|NCT04165031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110865483|NCT04165031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110865484|NCT04165031|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110865485|NCT04165031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110865486|NCT05480150|Dexetimide|dexetimide|mesh-list
110865487|NCT05480150|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110865488|NCT05480150|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
110865489|NCT05480150|Citalopram|citalopram|mesh-list
110865490|NCT05480150|Escitalopram|escitalopram|mesh-list
110865491|NCT05480150|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110865492|NCT05480150|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110865493|NCT05480150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110865494|NCT05480150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110865495|NCT05480150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110865496|NCT05480150|Serotonin Agents|serotonin agents|mesh-ancestor
110865497|NCT05480150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110865498|NCT05480150|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110865499|NCT05480150|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110865500|NCT05480150|Parasympatholytics|parasympatholytics|mesh-ancestor
110865501|NCT05480150|Autonomic Agents|autonomic agents|mesh-ancestor
110865502|NCT05480150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110865503|NCT05480150|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110865504|NCT05480150|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110865505|NCT05480150|Cholinergic Agents|cholinergic agents|mesh-ancestor
110865506|NCT05480150|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110865507|NCT05480150|Antidepressive Agents|antidepressive agents|mesh-ancestor
110865508|NCT05480150|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110366453|NCT01941641|Capecitabine|capecitabine|mesh-list
110865509|NCT05480150|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110865510|NCT05480150|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110865511|NCT05480150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110834474|NCT03461302|Keratolytic Agents|keratolytic agents|mesh-ancestor
110865512|NCT05480150|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
110865513|NCT05480150|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110865514|NCT05480150|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110865515|NCT05480150|Adrenergic Agents|adrenergic agents|mesh-ancestor
110865516|NCT05480150|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110865517|NCT05480150|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110865518|NCT05480150|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110865519|NCT05480150|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110865520|NCT05480150|Dopamine Agents|dopamine agents|mesh-ancestor
110865521|NCT05464628|Atorvastatin|atorvastatin|mesh-list
110865522|NCT05464628|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110865523|NCT05464628|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110865524|NCT05464628|Antimetabolites|antimetabolites|mesh-ancestor
110865525|NCT05464628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110865526|NCT05464628|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110865527|NCT05464628|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110865528|NCT05464628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110865529|NCT03193918|Paclitaxel|paclitaxel|mesh-list
110865530|NCT03193918|Ramucirumab|ramucirumab|mesh-list
110865531|NCT03193918|Crenolanib|crenolanib|mesh-list
110865532|NCT03193918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110865533|NCT03193918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110865534|NCT03193918|Tubulin Modulators|tubulin modulators|mesh-ancestor
110865535|NCT03193918|Antimitotic Agents|antimitotic agents|mesh-ancestor
110865536|NCT03193918|Mitosis Modulators|mitosis modulators|mesh-ancestor
110865537|NCT03193918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110865538|NCT03117790|Dexmedetomidine|dexmedetomidine|mesh-list
110865539|NCT03117790|Morphine|morphine|mesh-list
110865540|NCT03117790|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110865541|NCT03117790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110865542|NCT03117790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110865543|NCT03117790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110865544|NCT03117790|Analgesics|analgesics|mesh-ancestor
110865545|NCT03117790|Sensory System Agents|sensory system agents|mesh-ancestor
110865546|NCT03117790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110865547|NCT03117790|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110865548|NCT03117790|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110865549|NCT03117790|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110865550|NCT03117790|Adrenergic Agents|adrenergic agents|mesh-ancestor
110865551|NCT03117790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110865552|NCT03117790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110865553|NCT03117790|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110865554|NCT03117790|Narcotics|narcotics|mesh-ancestor
110865555|NCT03193372|Azelaic acid|azelaic acid|mesh-list
110865556|NCT03193372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110865557|NCT03193372|Dermatologic Agents|dermatologic agents|mesh-ancestor
110865558|NCT03034772|Timolol|timolol|mesh-list
110865559|NCT03034772|Dorzolamide|dorzolamide|mesh-list
110865560|NCT03034772|Lubricant Eye Drops|lubricant eye drops|mesh-list
110865561|NCT03034772|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110865562|NCT03034772|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110865563|NCT03034772|Adrenergic Agents|adrenergic agents|mesh-ancestor
110865564|NCT03034772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110865565|NCT03034772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110865566|NCT03034772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110865567|NCT03034772|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110865568|NCT03034772|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110865569|NCT03034772|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110865570|NCT03034772|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110865571|NCT03034772|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110865572|NCT03034772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110865573|NCT03193606|Fluorides|fluorides|mesh-list
110865574|NCT03193606|Cariostatic Agents|cariostatic agents|mesh-ancestor
110865575|NCT03193606|Protective Agents|protective agents|mesh-ancestor
110865576|NCT03193606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110865577|NCT02448784|Donepezil|donepezil|mesh-list
110865578|NCT02448784|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110865580|NCT02448784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110865581|NCT02448784|Cholinergic Agents|cholinergic agents|mesh-ancestor
110865582|NCT02448784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110865583|NCT02448784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110865584|NCT02448784|Nootropic Agents|nootropic agents|mesh-ancestor
110583086|NCT02587845|Tranexamic Acid|tranexamic acid|mesh-list
110865585|NCT04050488|Zinc Sulfate|zinc sulfate|mesh-list
110865586|NCT04050488|Astringents|astringents|mesh-ancestor
110865587|NCT04050488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110865588|NCT04050488|Dermatologic Agents|dermatologic agents|mesh-ancestor
110865590|NCT02449252|Cyclophosphamide|cyclophosphamide|mesh-list
110865591|NCT02449252|Doxorubicin|doxorubicin|mesh-list
110865592|NCT02449252|Vincristine|vincristine|mesh-list
110865593|NCT02449252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110865594|NCT02449252|Immunologic Factors|immunologic factors|mesh-ancestor
110865595|NCT02449252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110865596|NCT02449252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110865597|NCT02449252|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110865598|NCT02449252|Alkylating Agents|alkylating agents|mesh-ancestor
110865599|NCT02449252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110865600|NCT02449252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110865601|NCT02449252|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110865602|NCT02449252|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110345106|NCT05364424|Obinutuzumab|obinutuzumab|mesh-list
110865603|NCT02449252|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110865604|NCT02449252|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110865605|NCT02449252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110865606|NCT02449252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110865608|NCT02449252|Hormones|hormones|mesh-ancestor
110865609|NCT02449252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110865610|NCT02449252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110865611|NCT02449252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110865612|NCT02449252|Tubulin Modulators|tubulin modulators|mesh-ancestor
110865613|NCT02449252|Antimitotic Agents|antimitotic agents|mesh-ancestor
110865614|NCT02449252|Mitosis Modulators|mitosis modulators|mesh-ancestor
110865615|NCT04779554|Mitomycins|mitomycins|mesh-list
110865616|NCT04779554|Mitomycin|mitomycin|mesh-list
110865617|NCT04779554|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110865618|NCT04779554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110865619|NCT04779554|Alkylating Agents|alkylating agents|mesh-ancestor
110865620|NCT04779554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110865621|NCT04779554|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110865622|NCT04779554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110865623|NCT02444260|Lidocaine|lidocaine|mesh-list
110865624|NCT02444260|Midazolam|midazolam|mesh-list
110865625|NCT02444260|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110865627|NCT02444260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110865628|NCT02444260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110865629|NCT02444260|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110865630|NCT02444260|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110865631|NCT02444260|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110865632|NCT02444260|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110865633|NCT02444260|Anesthetics, General|anesthetics, general|mesh-ancestor
110865634|NCT02444260|Anesthetics|anesthetics|mesh-ancestor
110865635|NCT02444260|GABA Modulators|gaba modulators|mesh-ancestor
110865636|NCT02444260|GABA Agents|gaba agents|mesh-ancestor
110865637|NCT02444260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110865638|NCT02444260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110865639|NCT02444260|Anesthetics, Local|anesthetics, local|mesh-ancestor
110865640|NCT02444260|Sensory System Agents|sensory system agents|mesh-ancestor
110865641|NCT02444260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110865642|NCT02444260|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110865643|NCT02444260|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110865644|NCT02444260|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110865645|NCT02444260|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110865646|NCT03195634|Carvedilol|carvedilol|mesh-list
110865647|NCT03195634|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110865648|NCT03195634|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110865649|NCT03195634|Adrenergic Agents|adrenergic agents|mesh-ancestor
110865650|NCT03195634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110865651|NCT03195634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110865652|NCT03195634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110865653|NCT03195634|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110865655|NCT03195634|Protective Agents|protective agents|mesh-ancestor
110865656|NCT03195634|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110865657|NCT03195634|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110865658|NCT03195634|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110865659|NCT03195634|Vasodilator Agents|vasodilator agents|mesh-ancestor
110865660|NCT03195634|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110865661|NCT03195634|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110865663|NCT02448550|Calcium heparin|calcium heparin|mesh-list
110865664|NCT02448550|Bivalirudin|bivalirudin|mesh-list
110865665|NCT02448550|Anticoagulants|anticoagulants|mesh-ancestor
110865666|NCT02448550|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110865667|NCT02448550|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110865668|NCT02448550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110345208|NCT05302921|Nivolumab|nivolumab|mesh-list
110865670|NCT02448550|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110865671|NCT02448550|Protease Inhibitors|protease inhibitors|mesh-ancestor
110865672|NCT02448550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110865673|NCT03701750|Heparin|heparin|mesh-list
110865674|NCT03701750|Enoxaparin|enoxaparin|mesh-list
110865675|NCT03701750|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
110865676|NCT03701750|Tinzaparin|tinzaparin|mesh-list
110865677|NCT03701750|Dalteparin|dalteparin|mesh-list
110865678|NCT03701750|Enoxaparin sodium|enoxaparin sodium|mesh-list
110865679|NCT03701750|Anticoagulants|anticoagulants|mesh-ancestor
110865680|NCT03701750|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110865681|NCT03701750|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110865682|NCT03701750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110865683|NCT03704246|Antibodies|antibodies|mesh-list
110865684|NCT03704246|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110865685|NCT03704246|Immunologic Factors|immunologic factors|mesh-ancestor
110865686|NCT03704246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110865687|NCT05239910|Tenalisib|tenalisib|mesh-list
110865688|NCT05239910|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
110865689|NCT05239910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110865690|NCT05239910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110865691|NCT03701672|Analgesics, Opioid|analgesics, opioid|mesh-list
110865692|NCT03701672|Analgesics|analgesics|mesh-list
110865693|NCT03701672|Narcotics|narcotics|mesh-ancestor
110865694|NCT03701672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110865695|NCT03701672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110865696|NCT03701672|Sensory System Agents|sensory system agents|mesh-ancestor
110865697|NCT03701672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110865698|NCT03624530|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
110865699|NCT03624530|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110366494|NCT01653223|Simvastatin|simvastatin|mesh-list
110865700|NCT03624530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110865701|NCT03624530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110865702|NCT03746327|Tedizolid phosphate|tedizolid phosphate|mesh-list
110865703|NCT03746327|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110865704|NCT03746327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110865705|NCT03746249|Lenvatinib|lenvatinib|mesh-list
110865706|NCT03746249|Antibodies|antibodies|mesh-list
110865707|NCT03746249|Immunoglobulins|immunoglobulins|mesh-list
110865708|NCT03746249|Immunologic Factors|immunologic factors|mesh-ancestor
110865709|NCT03746249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110865710|NCT03746249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110865711|NCT03746249|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110865712|NCT03746249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110865713|NCT03746249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110865714|NCT03698474|Ascorbic Acid|ascorbic acid|mesh-list
110865716|NCT03698474|Magnesium citrate|magnesium citrate|mesh-list
110865717|NCT03698474|Picosulfate sodium|picosulfate sodium|mesh-list
110865718|NCT03698474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110865719|NCT03698474|Analgesics|analgesics|mesh-ancestor
110865720|NCT03698474|Sensory System Agents|sensory system agents|mesh-ancestor
110865721|NCT03698474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110865722|NCT03698474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110865723|NCT03698474|Anesthetics|anesthetics|mesh-ancestor
110865724|NCT03698474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110865725|NCT03698474|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110865726|NCT03698474|Anticonvulsants|anticonvulsants|mesh-ancestor
110865727|NCT03698474|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110865728|NCT03698474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110865729|NCT03698474|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110865730|NCT03698474|Tocolytic Agents|tocolytic agents|mesh-ancestor
110865731|NCT03698474|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110865732|NCT03698474|Antioxidants|antioxidants|mesh-ancestor
110865733|NCT03698474|Protective Agents|protective agents|mesh-ancestor
110865734|NCT03698474|Vitamins|vitamins|mesh-ancestor
110865735|NCT03698474|Micronutrients|micronutrients|mesh-ancestor
110865736|NCT03698474|Cathartics|cathartics|mesh-ancestor
110865737|NCT03698474|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110865738|NCT04709276|Carboplatin|carboplatin|mesh-list
110865739|NCT04709276|Nivolumab|nivolumab|mesh-list
110865740|NCT04709276|Ipilimumab|ipilimumab|mesh-list
110865741|NCT04709276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110865742|NCT04709276|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110865743|NCT04709276|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110865744|NCT04709276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110865745|NCT01194622|Fluticasone|fluticasone|mesh-list
110865746|NCT01194622|Xhance|xhance|mesh-list
110865747|NCT01194622|Azelastine|azelastine|mesh-list
110865748|NCT01194622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110865749|NCT01194622|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110865750|NCT01194622|Autonomic Agents|autonomic agents|mesh-ancestor
110865751|NCT01194622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110865752|NCT01194622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110865753|NCT01194622|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110865754|NCT01194622|Respiratory System Agents|respiratory system agents|mesh-ancestor
110865755|NCT01194622|Dermatologic Agents|dermatologic agents|mesh-ancestor
110865756|NCT01194622|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110865757|NCT01194622|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
110865758|NCT01194622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110865759|NCT01194622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110865760|NCT01194622|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110865761|NCT01194622|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110366512|NCT01356290|Cytarabine|cytarabine|mesh-list
110865762|NCT01194622|Histamine Antagonists|histamine antagonists|mesh-ancestor
110865763|NCT01194622|Histamine Agents|histamine agents|mesh-ancestor
110865764|NCT01194622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110865765|NCT02448316|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110865766|NCT02448316|Methylprednisolone|methylprednisolone|mesh-list
110865767|NCT02448316|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110865768|NCT02448316|Prednisolone|prednisolone|mesh-list
110865769|NCT02448316|Prednisolone acetate|prednisolone acetate|mesh-list
110865770|NCT02448316|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110865771|NCT02448316|Prednisolone phosphate|prednisolone phosphate|mesh-list
110865772|NCT02448316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110865773|NCT02448316|Antiemetics|antiemetics|mesh-ancestor
110865774|NCT02448316|Autonomic Agents|autonomic agents|mesh-ancestor
110865775|NCT02448316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110865776|NCT02448316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110865777|NCT02448316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110865778|NCT02448316|Glucocorticoids|glucocorticoids|mesh-ancestor
110865779|NCT02448316|Hormones|hormones|mesh-ancestor
110865780|NCT02448316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110865781|NCT02448316|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110865782|NCT02448316|Protective Agents|protective agents|mesh-ancestor
110865783|NCT02448316|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110865784|NCT02448316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110865785|NCT04564898|Trifluridine|trifluridine|mesh-list
110865786|NCT04564898|Bevacizumab|bevacizumab|mesh-list
110865787|NCT04564898|Capecitabine|capecitabine|mesh-list
110865788|NCT04564898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110865789|NCT04564898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110865790|NCT04564898|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110865791|NCT04564898|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110865792|NCT04564898|Growth Substances|growth substances|mesh-ancestor
110865793|NCT04564898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110865794|NCT04564898|Growth Inhibitors|growth inhibitors|mesh-ancestor
110865795|NCT04564898|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110865796|NCT04564898|Antimetabolites|antimetabolites|mesh-ancestor
110865797|NCT04564898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110865798|NCT04564898|Antiviral Agents|antiviral agents|mesh-ancestor
110865799|NCT04564898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110345286|NCT05223478|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110345287|NCT05223478|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110345288|NCT05223478|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110345289|NCT05223478|Adrenergic Agents|adrenergic agents|mesh-ancestor
110345290|NCT05223478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110345291|NCT05223478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110345292|NCT05223478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110345293|NCT05223478|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110345304|NCT05208242|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110345305|NCT05206084|Sirolimus|sirolimus|mesh-list
110865800|NCT02443714|Insulin|insulin|mesh-list
110865801|NCT02443714|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110865802|NCT02443714|Insulin Lispro|insulin lispro|mesh-list
110865803|NCT02443714|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110865804|NCT02443714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110865805|NCT03703310|Veratrum Alkaloids|veratrum alkaloids|mesh-list
110865806|NCT03703310|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110865807|NCT03703154|Tacrolimus|tacrolimus|mesh-list
110865808|NCT03703154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110865809|NCT03703154|Immunologic Factors|immunologic factors|mesh-ancestor
110865810|NCT03703154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110865811|NCT03703154|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110865812|NCT03703154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110583318|NCT04081077|Moxifloxacin|moxifloxacin|mesh-list
110865813|NCT03703154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110865814|NCT02434276|Hemagglutinins|hemagglutinins|mesh-list
110865815|NCT02434276|Immunologic Factors|immunologic factors|mesh-ancestor
110366521|NCT01356290|Immunologic Factors|immunologic factors|mesh-ancestor
110865816|NCT02434276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110865817|NCT02434276|Agglutinins|agglutinins|mesh-ancestor
110865818|NCT02434276|Coagulants|coagulants|mesh-ancestor
110865819|NCT03190642|Methylprednisolone|methylprednisolone|mesh-list
110865820|NCT03190642|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110865821|NCT03190642|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110865822|NCT03190642|Prednisolone|prednisolone|mesh-list
110865823|NCT03190642|Prednisolone acetate|prednisolone acetate|mesh-list
110865824|NCT03190642|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110865825|NCT03190642|Prednisolone phosphate|prednisolone phosphate|mesh-list
110865826|NCT03190642|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110865827|NCT03190642|Antiemetics|antiemetics|mesh-ancestor
110345319|NCT05205499|Sirolimus|sirolimus|mesh-list
110865828|NCT03190642|Autonomic Agents|autonomic agents|mesh-ancestor
110865829|NCT03190642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110865830|NCT03190642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110865831|NCT03190642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110865832|NCT03190642|Glucocorticoids|glucocorticoids|mesh-ancestor
110865833|NCT03190642|Hormones|hormones|mesh-ancestor
110834520|NCT03810391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110865834|NCT03190642|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110865835|NCT03190642|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110865836|NCT03190642|Protective Agents|protective agents|mesh-ancestor
110865837|NCT03190642|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110865838|NCT03190642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110865839|NCT03702530|Albendazole|albendazole|mesh-list
110865840|NCT03702530|Anthelmintics|anthelmintics|mesh-ancestor
110865841|NCT03702530|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110865842|NCT03702530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110865843|NCT03702530|Anticestodal Agents|anticestodal agents|mesh-ancestor
110865844|NCT03702530|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110865845|NCT03702530|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110865846|NCT03702530|Tubulin Modulators|tubulin modulators|mesh-ancestor
110865847|NCT03702530|Antimitotic Agents|antimitotic agents|mesh-ancestor
110865848|NCT03702530|Mitosis Modulators|mitosis modulators|mesh-ancestor
110865849|NCT03702530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110865850|NCT03702530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110865851|NCT02443246|Vitamin D|vitamin d|mesh-list
110865852|NCT02443246|Cholecalciferol|cholecalciferol|mesh-list
110865853|NCT02443246|Vitamins|vitamins|mesh-ancestor
110865854|NCT02443246|Micronutrients|micronutrients|mesh-ancestor
110865855|NCT02443246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110865856|NCT02443246|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110865857|NCT02443246|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110865858|NCT03031496|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110865859|NCT03031496|Amiloride|amiloride|mesh-list
110865860|NCT03031496|Amiloride, hydrochlorothiazide drug combination|amiloride, hydrochlorothiazide drug combination|mesh-list
110865861|NCT03031496|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110865862|NCT03031496|Diuretics|diuretics|mesh-ancestor
110865863|NCT03031496|Natriuretic Agents|natriuretic agents|mesh-ancestor
110865864|NCT03031496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110865865|NCT03031496|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110865866|NCT03031496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110865867|NCT03031496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110865868|NCT03031496|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
110865869|NCT03031496|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110865870|NCT03031496|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
110865871|NCT03031496|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110865873|NCT03187912|Vitamin B Complex|vitamin b complex|mesh-ancestor
110865874|NCT03187912|Vitamins|vitamins|mesh-ancestor
110865875|NCT03187912|Micronutrients|micronutrients|mesh-ancestor
110865876|NCT03187912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110865877|NCT03187912|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110865878|NCT03187912|Dermatologic Agents|dermatologic agents|mesh-ancestor
110865879|NCT02443012|Nepafenac|nepafenac|mesh-list
110865880|NCT02443012|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110865881|NCT02443012|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110865882|NCT02443012|Analgesics|analgesics|mesh-ancestor
110865883|NCT02443012|Sensory System Agents|sensory system agents|mesh-ancestor
110865884|NCT02443012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110865885|NCT02443012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110865886|NCT02443012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110865887|NCT02443012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110583392|NCT04101578|Hormones|hormones|mesh-ancestor
110865888|NCT03701126|Bupivacaine|bupivacaine|mesh-list
110865889|NCT03701126|Anesthetics, Local|anesthetics, local|mesh-ancestor
110865890|NCT03701126|Anesthetics|anesthetics|mesh-ancestor
110345402|NCT05144854|Oxaliplatin|oxaliplatin|mesh-list
110865891|NCT03701126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110865892|NCT03701126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110865893|NCT03701126|Sensory System Agents|sensory system agents|mesh-ancestor
110865894|NCT03701126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110865895|NCT03702140|Teriparatide|teriparatide|mesh-list
110865896|NCT03702140|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110865897|NCT03702140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110865898|NCT03702140|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110865899|NCT03700814|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
110865900|NCT03700814|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110865902|NCT03700814|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110865903|NCT03700814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110865904|NCT03700814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110865905|NCT02433808|Neostigmine|neostigmine|mesh-list
110865906|NCT02433808|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110865907|NCT02433808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110865908|NCT02433808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110865909|NCT02433808|Cholinergic Agents|cholinergic agents|mesh-ancestor
110865910|NCT02433808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110865911|NCT02433808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110865912|NCT02433808|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110345454|NCT05117398|Dalbavancin|dalbavancin|mesh-list
110865913|NCT02433808|Autonomic Agents|autonomic agents|mesh-ancestor
110865914|NCT02433808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110865915|NCT03701984|Lidocaine|lidocaine|mesh-list
110865916|NCT03701984|Tramadol|tramadol|mesh-list
110865917|NCT03701984|Anesthetics, Local|anesthetics, local|mesh-ancestor
110865918|NCT03701984|Anesthetics|anesthetics|mesh-ancestor
110865919|NCT03701984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110865920|NCT03701984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110865921|NCT03701984|Sensory System Agents|sensory system agents|mesh-ancestor
110865922|NCT03701984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110865923|NCT03701984|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110865924|NCT03701984|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110865925|NCT03701984|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110865926|NCT03701984|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110865927|NCT03701984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110865929|NCT03701984|Narcotics|narcotics|mesh-ancestor
110865930|NCT03701984|Analgesics|analgesics|mesh-ancestor
110865931|NCT04651400|Antithrombins|antithrombins|mesh-list
110865932|NCT04651400|Antithrombin III|antithrombin iii|mesh-list
110865933|NCT04651400|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110865934|NCT04651400|Protease Inhibitors|protease inhibitors|mesh-ancestor
110865935|NCT04651400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110865936|NCT04651400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110865937|NCT04651400|Anticoagulants|anticoagulants|mesh-ancestor
110865938|NCT02439190|Aspirin|aspirin|mesh-list
110865939|NCT02439190|Clopidogrel|clopidogrel|mesh-list
110865940|NCT02439190|BMS-986120|bms-986120|mesh-list
110865941|NCT02439190|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110865942|NCT02439190|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110865943|NCT02439190|Analgesics|analgesics|mesh-ancestor
110865944|NCT02439190|Sensory System Agents|sensory system agents|mesh-ancestor
110865945|NCT02439190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110865946|NCT02439190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110865947|NCT02439190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110865948|NCT02439190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110865949|NCT02439190|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110865950|NCT02439190|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110865951|NCT02439190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110865952|NCT02439190|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110865953|NCT02439190|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110865954|NCT02439190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110865955|NCT02439190|Antipyretics|antipyretics|mesh-ancestor
110865956|NCT02439190|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110865957|NCT02439190|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110865958|NCT02439190|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110865959|NCT02439190|Purinergic Agents|purinergic agents|mesh-ancestor
110865960|NCT02439190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110865961|NCT02442466|BQ 788|bq 788|mesh-list
110865962|NCT02442466|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110865963|NCT02442466|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
110865964|NCT02442466|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
110865965|NCT02442466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110865967|NCT02439034|Ketoprofen|ketoprofen|mesh-list
110865968|NCT02439034|Codeine|codeine|mesh-list
110865969|NCT02439034|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110865971|NCT02439034|Sensory System Agents|sensory system agents|mesh-ancestor
110865972|NCT02439034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110865973|NCT02439034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110865974|NCT02439034|Antipyretics|antipyretics|mesh-ancestor
110865975|NCT02439034|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110865976|NCT02439034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110865977|NCT02439034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110865978|NCT02439034|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110865979|NCT02439034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110865980|NCT02439034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110865981|NCT02439034|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110345673|NCT05007873|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
110865983|NCT02439034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110865984|NCT02439034|Antitussive Agents|antitussive agents|mesh-ancestor
110865985|NCT02439034|Respiratory System Agents|respiratory system agents|mesh-ancestor
110865986|NCT04483492|Caffeine|caffeine|mesh-list
110865987|NCT04483492|Caffeine citrate|caffeine citrate|mesh-list
110865988|NCT04483492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110865989|NCT04483492|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110865990|NCT04483492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110865991|NCT04483492|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110865992|NCT04483492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110865993|NCT04483492|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110865994|NCT04483492|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110865995|NCT04483492|Purinergic Agents|purinergic agents|mesh-ancestor
110865996|NCT04483492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110865997|NCT03186742|Eplerenone|eplerenone|mesh-list
110865998|NCT03186742|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110865999|NCT03186742|Hormone Antagonists|hormone antagonists|mesh-ancestor
110866000|NCT03186742|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110866001|NCT03186742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110866002|NCT03186742|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110866003|NCT03186742|Diuretics|diuretics|mesh-ancestor
110866004|NCT03186742|Natriuretic Agents|natriuretic agents|mesh-ancestor
110866005|NCT03186742|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110866006|NCT03186664|Nabiximols|nabiximols|mesh-list
110866007|NCT03186664|Analgesics|analgesics|mesh-ancestor
110866008|NCT03186664|Sensory System Agents|sensory system agents|mesh-ancestor
110866009|NCT03186664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110866010|NCT03186664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110866011|NCT02441842|Atenolol|atenolol|mesh-list
110866012|NCT02441842|Lisinopril|lisinopril|mesh-list
110866013|NCT02441842|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110866014|NCT02441842|Protease Inhibitors|protease inhibitors|mesh-ancestor
110866015|NCT02441842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110866016|NCT02441842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110866017|NCT02441842|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110866018|NCT02441842|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110866019|NCT02441842|Protective Agents|protective agents|mesh-ancestor
110866020|NCT02441842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110866021|NCT02441842|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110866022|NCT02441842|Sympatholytics|sympatholytics|mesh-ancestor
110866023|NCT02441842|Autonomic Agents|autonomic agents|mesh-ancestor
110866024|NCT02441842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110866025|NCT02441842|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110866026|NCT02441842|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110866027|NCT02441842|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110866028|NCT02441842|Adrenergic Agents|adrenergic agents|mesh-ancestor
110866029|NCT02441842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110866030|NCT02438566|Tranexamic Acid|tranexamic acid|mesh-list
110866031|NCT02438566|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110866032|NCT02438566|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110866033|NCT02438566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110866034|NCT02438566|Hemostatics|hemostatics|mesh-ancestor
110866035|NCT02438566|Coagulants|coagulants|mesh-ancestor
110866037|NCT02433652|Immunologic Factors|immunologic factors|mesh-ancestor
110866038|NCT02433652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110866039|NCT03186586|Ulipristal acetate|ulipristal acetate|mesh-list
110866040|NCT03186586|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110866041|NCT03186586|Contraceptive Agents|contraceptive agents|mesh-ancestor
110866042|NCT03186586|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110866043|NCT03186586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110866044|NCT03186586|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110866045|NCT02433418|Diclofenac|diclofenac|mesh-list
110866046|NCT02433418|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110866047|NCT02433418|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110866048|NCT02433418|Analgesics|analgesics|mesh-ancestor
110866049|NCT02433418|Sensory System Agents|sensory system agents|mesh-ancestor
110866050|NCT02433418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110866051|NCT02433418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110866052|NCT02433418|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110866053|NCT02433418|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110866054|NCT02433418|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110866055|NCT02433418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110866056|NCT02433418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110866057|NCT02433730|Testosterone|testosterone|mesh-list
110866058|NCT02433730|Androgens|androgens|mesh-ancestor
110866059|NCT02433730|Hormones|hormones|mesh-ancestor
110866060|NCT02433730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110866061|NCT02433730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110866062|NCT02438098|Rivaroxaban|rivaroxaban|mesh-list
110866063|NCT02438098|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110866064|NCT02438098|Antithrombins|antithrombins|mesh-ancestor
110866065|NCT02438098|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110866066|NCT02438098|Protease Inhibitors|protease inhibitors|mesh-ancestor
110866067|NCT02438098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110866068|NCT02438098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110866069|NCT02438098|Anticoagulants|anticoagulants|mesh-ancestor
110866070|NCT02441530|Vitamin D|vitamin d|mesh-list
110866071|NCT02441530|Vitamins|vitamins|mesh-list
110866072|NCT02441530|Vitamin E|vitamin e|mesh-list
110866073|NCT02441530|Ibuprofen|ibuprofen|mesh-list
110866074|NCT02441530|Micronutrients|micronutrients|mesh-ancestor
110866075|NCT02441530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110345888|NCT04891809|Growth Inhibitors|growth inhibitors|mesh-ancestor
110345889|NCT04889066|Durvalumab|durvalumab|mesh-list
110345890|NCT04889066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110345891|NCT04889066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110345916|NCT04886531|Trastuzumab|trastuzumab|mesh-list
110345917|NCT04886531|Letrozole|letrozole|mesh-list
110345918|NCT04886531|Anastrozole|anastrozole|mesh-list
110345919|NCT04886531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110345920|NCT04886531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110345921|NCT04886531|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110345922|NCT04886531|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110345923|NCT04886531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110345924|NCT04886531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110345925|NCT04886531|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110345926|NCT04886531|Hormone Antagonists|hormone antagonists|mesh-ancestor
110345927|NCT04886531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110345928|NCT04886531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110345929|NCT04886531|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110345930|NCT04883528|Valsartan|valsartan|mesh-list
110345931|NCT04883528|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
110345932|NCT04883528|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110345936|NCT04879329|Pembrolizumab|pembrolizumab|mesh-list
110866076|NCT02441530|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110866077|NCT02441530|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110866078|NCT02441530|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110866079|NCT02441530|Analgesics|analgesics|mesh-ancestor
110866080|NCT02441530|Sensory System Agents|sensory system agents|mesh-ancestor
110866081|NCT02441530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110866082|NCT02441530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110866083|NCT02441530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110866084|NCT02441530|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110866085|NCT02441530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110866086|NCT02441530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110866088|NCT02441530|Protective Agents|protective agents|mesh-ancestor
110866089|NCT02433184|Hydroxychloroquine|hydroxychloroquine|mesh-list
110866090|NCT02433184|Sulfasalazine|sulfasalazine|mesh-list
110866091|NCT02433184|Etanercept|etanercept|mesh-list
110866092|NCT02433184|Methotrexate|methotrexate|mesh-list
110866093|NCT02433184|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110866094|NCT02433184|Abortifacient Agents|abortifacient agents|mesh-ancestor
110866095|NCT02433184|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110866096|NCT02433184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110346031|NCT04824638|Vaccines|vaccines|mesh-list
110866098|NCT02433184|Antimetabolites|antimetabolites|mesh-ancestor
110866099|NCT02433184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110866100|NCT02433184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110866101|NCT02433184|Dermatologic Agents|dermatologic agents|mesh-ancestor
110866102|NCT02433184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110866103|NCT02433184|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110866104|NCT02433184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110866105|NCT02433184|Immunologic Factors|immunologic factors|mesh-ancestor
110866106|NCT02433184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110866107|NCT02433184|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110866108|NCT02433184|Antimalarials|antimalarials|mesh-ancestor
110866109|NCT02433184|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110866110|NCT02433184|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110866111|NCT02433184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110866112|NCT02433184|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110866113|NCT02433184|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110866114|NCT02433184|Analgesics|analgesics|mesh-ancestor
110866115|NCT02433184|Sensory System Agents|sensory system agents|mesh-ancestor
110866116|NCT02433184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110866117|NCT02433184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110866118|NCT02433184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110866119|NCT02438020|Metformin|metformin|mesh-list
110866120|NCT02438020|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110866121|NCT02438020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110866122|NCT02440750|Dienogest|dienogest|mesh-list
110866123|NCT02440750|Ulipristal acetate|ulipristal acetate|mesh-list
110866124|NCT02440750|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110866125|NCT02440750|Contraceptive Agents|contraceptive agents|mesh-ancestor
110866126|NCT02440750|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110866127|NCT02440750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110866128|NCT02440750|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110866129|NCT02440750|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110866130|NCT02440750|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110866131|NCT02440750|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110866132|NCT02440750|Hormone Antagonists|hormone antagonists|mesh-ancestor
110866133|NCT02440750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110866134|NCT02440750|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110866135|NCT02440750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110866136|NCT03186352|Anti-Infective Agents|anti-infective agents|mesh-list
110866137|NCT03186352|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110866138|NCT02432872|Cytarabine|cytarabine|mesh-list
110866139|NCT02432872|Daunorubicin|daunorubicin|mesh-list
110866140|NCT02432872|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110866141|NCT02432872|Antimetabolites|antimetabolites|mesh-ancestor
110866142|NCT02432872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110866143|NCT02432872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110866144|NCT02432872|Antiviral Agents|antiviral agents|mesh-ancestor
110866145|NCT02432872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110866146|NCT02432872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110866147|NCT02432872|Immunologic Factors|immunologic factors|mesh-ancestor
110866148|NCT02432872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110866149|NCT02432872|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110366602|NCT00545246|Antimitotic Agents|antimitotic agents|mesh-ancestor
110866150|NCT02432872|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110866151|NCT02432872|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110866152|NCT02432872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110866153|NCT02436928|Vaccines|vaccines|mesh-list
110866154|NCT02436928|Immunologic Factors|immunologic factors|mesh-ancestor
110866155|NCT02436928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110866156|NCT02436538|Hormones|hormones|mesh-list
110866157|NCT02436538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110866158|NCT02436538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110866159|NCT02436694|Dexamethasone|dexamethasone|mesh-list
110866160|NCT02436694|Dexamethasone acetate|dexamethasone acetate|mesh-list
110866161|NCT02436694|Ropivacaine|ropivacaine|mesh-list
110866162|NCT02436694|Anesthetics, Local|anesthetics, local|mesh-list
110866163|NCT02436694|Anesthetics|anesthetics|mesh-list
110346115|NCT04780659|Vaccines|vaccines|mesh-list
110346116|NCT04780659|Immunologic Factors|immunologic factors|mesh-ancestor
110346117|NCT04780659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110346118|NCT04768023|Vitamin D|vitamin d|mesh-list
110346119|NCT04768023|Vitamins|vitamins|mesh-ancestor
110346120|NCT04768023|Micronutrients|micronutrients|mesh-ancestor
110346121|NCT04768023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110346122|NCT04768023|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110346123|NCT04763343|Ketamine|ketamine|mesh-list
110346124|NCT04763343|Analgesics|analgesics|mesh-ancestor
110346125|NCT04763343|Sensory System Agents|sensory system agents|mesh-ancestor
110346126|NCT04763343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110346127|NCT04763343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110346128|NCT04763343|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110346129|NCT04763343|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110346130|NCT04763343|Anesthetics, General|anesthetics, general|mesh-ancestor
110346131|NCT04763343|Anesthetics|anesthetics|mesh-ancestor
110346132|NCT04763343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110346133|NCT04763343|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110346134|NCT04763343|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110346135|NCT04763343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110866165|NCT02436694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110866166|NCT02436694|Antiemetics|antiemetics|mesh-ancestor
110866167|NCT02436694|Autonomic Agents|autonomic agents|mesh-ancestor
110866168|NCT02436694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110866169|NCT02436694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110866170|NCT02436694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110866171|NCT02436694|Glucocorticoids|glucocorticoids|mesh-ancestor
110866172|NCT02436694|Hormones|hormones|mesh-ancestor
110866173|NCT02436694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110866174|NCT02436694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110866175|NCT02436694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110866176|NCT02436694|Protease Inhibitors|protease inhibitors|mesh-ancestor
110866177|NCT02436694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110866178|NCT02436694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110866179|NCT02436694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110866180|NCT02436694|Sensory System Agents|sensory system agents|mesh-ancestor
110866181|NCT03186040|Lacosamide|lacosamide|mesh-list
110866182|NCT03186040|Anticonvulsants|anticonvulsants|mesh-ancestor
110366616|NCT03456401|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110866183|NCT03186040|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110866184|NCT03186040|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110866185|NCT03186040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110866186|NCT03186040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110866187|NCT02659020|Gemcitabine|gemcitabine|mesh-list
110866188|NCT02659020|Docetaxel|docetaxel|mesh-list
110866189|NCT02659020|Olaratumab|olaratumab|mesh-list
110866190|NCT02659020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110866191|NCT02659020|Antimetabolites|antimetabolites|mesh-ancestor
110866192|NCT02659020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110866193|NCT02659020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110866194|NCT02659020|Tubulin Modulators|tubulin modulators|mesh-ancestor
110866195|NCT02659020|Antimitotic Agents|antimitotic agents|mesh-ancestor
110866196|NCT02659020|Mitosis Modulators|mitosis modulators|mesh-ancestor
110866197|NCT03482011|Mirikizumab|mirikizumab|mesh-list
110866198|NCT03482011|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110866199|NCT03482011|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110866200|NCT03482011|Analgesics|analgesics|mesh-ancestor
110866201|NCT03482011|Sensory System Agents|sensory system agents|mesh-ancestor
110866202|NCT03482011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110866203|NCT03482011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110866204|NCT03482011|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110866205|NCT03482011|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110866206|NCT03482011|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110866207|NCT03482011|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110866208|NCT02436226|Citric Acid|citric acid|mesh-list
110866209|NCT02436226|Sodium Citrate|sodium citrate|mesh-list
110866210|NCT02436226|Clomiphene|clomiphene|mesh-list
110866211|NCT02436226|Enclomiphene|enclomiphene|mesh-list
110866212|NCT02436226|Zuclomiphene|zuclomiphene|mesh-list
110866213|NCT02436226|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
110866214|NCT02436226|Anticoagulants|anticoagulants|mesh-ancestor
110866215|NCT02436226|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110866216|NCT02436226|Chelating Agents|chelating agents|mesh-ancestor
110866217|NCT02436226|Sequestering Agents|sequestering agents|mesh-ancestor
110866218|NCT02436226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110866219|NCT02436226|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110866220|NCT02436226|Hormone Antagonists|hormone antagonists|mesh-ancestor
110866221|NCT02436226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110866222|NCT02436226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110866223|NCT02436226|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110866224|NCT02436226|Fertility Agents|fertility agents|mesh-ancestor
110866225|NCT02436226|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110866226|NCT02436226|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110866227|NCT02436226|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110866228|NCT01374126|Azithromycin|azithromycin|mesh-list
110866229|NCT01374126|Artesunate|artesunate|mesh-list
110866230|NCT01374126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110866231|NCT01374126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110866232|NCT01374126|Antimalarials|antimalarials|mesh-ancestor
110866233|NCT01374126|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110866234|NCT01374126|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110866235|NCT01374126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110866236|NCT01374126|Antiviral Agents|antiviral agents|mesh-ancestor
110866237|NCT01374126|Schistosomicides|schistosomicides|mesh-ancestor
110866238|NCT01374126|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110866239|NCT01374126|Anthelmintics|anthelmintics|mesh-ancestor
110866240|NCT02584920|Rituximab|rituximab|mesh-list
110866241|NCT02584920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110866242|NCT02584920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110866243|NCT02584920|Immunologic Factors|immunologic factors|mesh-ancestor
110866244|NCT02584920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110866245|NCT02584920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110866246|NCT02431936|Prazosin|prazosin|mesh-list
110866247|NCT02431936|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110866248|NCT02431936|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110866249|NCT02431936|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110866250|NCT02431936|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110866251|NCT02431936|Adrenergic Agents|adrenergic agents|mesh-ancestor
110866252|NCT02431936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110346193|NCT04753879|Paclitaxel|paclitaxel|mesh-list
110346194|NCT04753879|Gemcitabine|gemcitabine|mesh-list
110346195|NCT04753879|Pembrolizumab|pembrolizumab|mesh-list
110346196|NCT04753879|Capecitabine|capecitabine|mesh-list
110866253|NCT02431936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110866254|NCT02431936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110866255|NCT02440828|Tobramycin|tobramycin|mesh-list
110866256|NCT02440828|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110866257|NCT02440828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110866258|NCT01311037|Aromatase Inhibitors|aromatase inhibitors|mesh-list
110866259|NCT01311037|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110866260|NCT01311037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110866261|NCT01311037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110866262|NCT01311037|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110866263|NCT01311037|Hormone Antagonists|hormone antagonists|mesh-ancestor
110866264|NCT01311037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110866265|NCT01311037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110866267|NCT03789318|Fentanyl|fentanyl|mesh-list
110866268|NCT03789318|Oxycodone|oxycodone|mesh-list
110866269|NCT03789318|Hydromorphone|hydromorphone|mesh-list
110866270|NCT03789318|Bupivacaine|bupivacaine|mesh-list
110866271|NCT03789318|Anesthetics, Local|anesthetics, local|mesh-ancestor
110866272|NCT03789318|Anesthetics|anesthetics|mesh-ancestor
110866273|NCT03789318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110866274|NCT03789318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110866275|NCT03789318|Sensory System Agents|sensory system agents|mesh-ancestor
110866276|NCT03789318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110866277|NCT03789318|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110866278|NCT03789318|Narcotics|narcotics|mesh-ancestor
110866279|NCT03789318|Analgesics|analgesics|mesh-ancestor
110866280|NCT03789318|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110866281|NCT03789318|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110866282|NCT03789318|Anesthetics, General|anesthetics, general|mesh-ancestor
110866283|NCT03789318|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110866284|NCT03789318|Antipyretics|antipyretics|mesh-ancestor
110866285|NCT02435368|Mycophenolic Acid|mycophenolic acid|mesh-list
110866286|NCT02435368|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110866287|NCT02435368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110866288|NCT02435368|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110866289|NCT02435368|Antitubercular Agents|antitubercular agents|mesh-ancestor
110866290|NCT02435368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110346277|NCT04675827|Immunotoxins|immunotoxins|mesh-ancestor
110866292|NCT02435368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110866293|NCT02435368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110866295|NCT05160090|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110866296|NCT05160090|Antidepressive Agents|antidepressive agents|mesh-ancestor
110866297|NCT05160090|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110866298|NCT05160090|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110866299|NCT05160090|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110866300|NCT05160090|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110866301|NCT05160090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110866302|NCT05160090|Dopamine Agents|dopamine agents|mesh-ancestor
110866303|NCT05160090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110866304|NCT05160090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110866305|NCT05160090|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110866306|NCT05160090|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110866307|NCT05160090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110866308|NCT04516616|Paclitaxel|paclitaxel|mesh-list
110366656|NCT00545675|Valproic Acid|valproic acid|mesh-list
110866309|NCT04516616|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110866310|NCT04516616|Cisplatin|cisplatin|mesh-list
110866311|NCT04516616|Antibodies|antibodies|mesh-list
110866312|NCT04516616|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110866313|NCT04516616|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110866314|NCT04516616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110866315|NCT04516616|Tubulin Modulators|tubulin modulators|mesh-ancestor
110866316|NCT04516616|Antimitotic Agents|antimitotic agents|mesh-ancestor
110866317|NCT04516616|Mitosis Modulators|mitosis modulators|mesh-ancestor
110866318|NCT04516616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110866319|NCT04516616|Immunologic Factors|immunologic factors|mesh-ancestor
110866320|NCT04516616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110866321|NCT00511134|Eszopiclone|eszopiclone|mesh-list
110866322|NCT00511134|Bupropion|bupropion|mesh-list
110866323|NCT00511134|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110866324|NCT00511134|Antidepressive Agents|antidepressive agents|mesh-ancestor
110346339|NCT04622319|Immunologic Factors|immunologic factors|mesh-ancestor
110346340|NCT04622319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110346341|NCT04617002|TIC10 compound|tic10 compound|mesh-list
110346342|NCT04617002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110346371|NCT04597437|Zanamivir|zanamivir|mesh-list
110346372|NCT04597437|Antiviral Agents|antiviral agents|mesh-ancestor
110346373|NCT04597437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110346374|NCT04597437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110346375|NCT04597437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110346376|NCT04590937|Metformin|metformin|mesh-list
110346377|NCT04590937|Digoxin|digoxin|mesh-list
110346378|NCT04590937|Furosemide|furosemide|mesh-list
110346379|NCT04590937|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110346380|NCT04590937|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110866325|NCT00511134|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110866326|NCT00511134|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110866327|NCT00511134|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110866328|NCT00511134|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110866329|NCT00511134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110866330|NCT00511134|Dopamine Agents|dopamine agents|mesh-ancestor
110866331|NCT00511134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110866332|NCT00511134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110866333|NCT00511134|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110866334|NCT00511134|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110866335|NCT00511134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110866336|NCT00511134|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110866337|NCT00511134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110866339|NCT05103228|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
110866340|NCT05103228|Hormones|hormones|mesh-ancestor
110866341|NCT05103228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110866342|NCT05103228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110866343|NCT05103228|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110866344|NCT05103228|Fertility Agents|fertility agents|mesh-ancestor
110866345|NCT05103228|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110866346|NCT01372384|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110866347|NCT01372384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110866348|NCT01372384|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110866349|NCT01372384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110866350|NCT01372384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110866351|NCT03190798|Canagliflozin|canagliflozin|mesh-list
110866352|NCT03190798|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110866353|NCT03190798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110866354|NCT03190798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110866355|NCT03190798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110866356|NCT03696290|Aztreonam|aztreonam|mesh-list
110866357|NCT03696290|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110866358|NCT03696290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110866359|NCT03696212|Pembrolizumab|pembrolizumab|mesh-list
110866360|NCT03696212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110866361|NCT03696212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110866362|NCT03696212|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110866363|NCT03696212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110866364|NCT03692546|Bupivacaine|bupivacaine|mesh-list
110866365|NCT03692546|Anesthetics, Local|anesthetics, local|mesh-ancestor
110866366|NCT03692546|Anesthetics|anesthetics|mesh-ancestor
110866367|NCT03692546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110866368|NCT03692546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110866369|NCT03692546|Sensory System Agents|sensory system agents|mesh-ancestor
110866370|NCT03692546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110866371|NCT03480763|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110866372|NCT03480763|Immunologic Factors|immunologic factors|mesh-ancestor
110866373|NCT03480763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110866374|NCT02434822|Vaccines|vaccines|mesh-list
110866375|NCT02434822|Immunologic Factors|immunologic factors|mesh-ancestor
110866376|NCT02434822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110866377|NCT01371474|Paroxetine|paroxetine|mesh-list
110866378|NCT01371474|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110866379|NCT01371474|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110866380|NCT01371474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110866381|NCT01371474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110866382|NCT01371474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110866383|NCT01371474|Serotonin Agents|serotonin agents|mesh-ancestor
110866384|NCT01371474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110866385|NCT01371474|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110866386|NCT01371474|Antidepressive Agents|antidepressive agents|mesh-ancestor
110866387|NCT01371474|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110866388|NCT01371474|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110866389|NCT01371474|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110866390|NCT01371474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110866391|NCT03185104|Fluorides|fluorides|mesh-list
110866392|NCT03185104|Cariostatic Agents|cariostatic agents|mesh-ancestor
110866393|NCT03185104|Protective Agents|protective agents|mesh-ancestor
110866394|NCT03185104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110866395|NCT01319994|Metformin|metformin|mesh-list
110866396|NCT01319994|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110866397|NCT01319994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110866399|NCT02430298|Antioxidants|antioxidants|mesh-ancestor
110866400|NCT02430298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110866401|NCT02430298|Protective Agents|protective agents|mesh-ancestor
110866402|NCT02430298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110866403|NCT02430298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110866404|NCT03626376|Valacyclovir|valacyclovir|mesh-list
110866405|NCT03626376|Acyclovir|acyclovir|mesh-list
110866406|NCT03626376|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110866407|NCT03626376|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110583917|NCT04102592|Permethrin|permethrin|mesh-list
110866408|NCT03626376|Antiviral Agents|antiviral agents|mesh-ancestor
110866409|NCT03626376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110866410|NCT03695822|Mirabegron|mirabegron|mesh-list
110866411|NCT03695822|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
110866412|NCT03695822|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110866413|NCT03695822|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110866414|NCT03695822|Adrenergic Agents|adrenergic agents|mesh-ancestor
110866415|NCT03695822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110866416|NCT03695822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110866417|NCT03695822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110866418|NCT03695822|Urological Agents|urological agents|mesh-ancestor
110866419|NCT03718507|Atropine|atropine|mesh-list
110866420|NCT03718507|Fentanyl|fentanyl|mesh-list
110866421|NCT03718507|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110866422|NCT03718507|Narcotics|narcotics|mesh-ancestor
110866423|NCT03718507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110866424|NCT03718507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110866425|NCT03718507|Analgesics|analgesics|mesh-ancestor
110866426|NCT03718507|Sensory System Agents|sensory system agents|mesh-ancestor
110866427|NCT03718507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110866428|NCT03718507|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110866429|NCT03718507|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110866430|NCT03718507|Anesthetics, General|anesthetics, general|mesh-ancestor
110866431|NCT03718507|Anesthetics|anesthetics|mesh-ancestor
110866432|NCT03718507|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110866433|NCT03718507|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110866434|NCT03718507|Autonomic Agents|autonomic agents|mesh-ancestor
110866435|NCT03718507|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110866436|NCT03718507|Respiratory System Agents|respiratory system agents|mesh-ancestor
110866437|NCT03718507|Mydriatics|mydriatics|mesh-ancestor
110866438|NCT03718507|Parasympatholytics|parasympatholytics|mesh-ancestor
110866439|NCT03718507|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110866440|NCT03718507|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110866441|NCT03718507|Cholinergic Agents|cholinergic agents|mesh-ancestor
110866442|NCT03718507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110866443|NCT03718507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110866444|NCT01374282|Penicillamine|penicillamine|mesh-list
110866445|NCT01374282|Antidotes|antidotes|mesh-ancestor
110866446|NCT01374282|Protective Agents|protective agents|mesh-ancestor
110866447|NCT01374282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110866448|NCT01374282|Chelating Agents|chelating agents|mesh-ancestor
110866449|NCT01374282|Sequestering Agents|sequestering agents|mesh-ancestor
110866450|NCT01374282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110866451|NCT01374282|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110866452|NCT03691922|Epinephrine|epinephrine|mesh-list
110866453|NCT03691922|Racepinephrine|racepinephrine|mesh-list
110866454|NCT03691922|Bupivacaine|bupivacaine|mesh-list
110866455|NCT03691922|Epinephryl borate|epinephryl borate|mesh-list
110866456|NCT03691922|Anesthetics, Local|anesthetics, local|mesh-ancestor
110866457|NCT03691922|Anesthetics|anesthetics|mesh-ancestor
110866458|NCT03691922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110866459|NCT03691922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110866460|NCT03691922|Sensory System Agents|sensory system agents|mesh-ancestor
110866461|NCT03691922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110346580|NCT04478838|Autonomic Agents|autonomic agents|mesh-ancestor
110866462|NCT03691922|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110866463|NCT03691922|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110866464|NCT03691922|Adrenergic Agents|adrenergic agents|mesh-ancestor
110866465|NCT03691922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110866466|NCT03691922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110866467|NCT03691922|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110866468|NCT03691922|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110866469|NCT03691922|Autonomic Agents|autonomic agents|mesh-ancestor
110866470|NCT03691922|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110866471|NCT03691922|Respiratory System Agents|respiratory system agents|mesh-ancestor
110866473|NCT03691922|Sympathomimetics|sympathomimetics|mesh-ancestor
110866474|NCT03691922|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110866475|NCT03453151|Anesthetics|anesthetics|mesh-list
110866476|NCT03453151|Anesthetics, Local|anesthetics, local|mesh-list
110866477|NCT03453151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110866478|NCT03453151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110866479|NCT03453151|Sensory System Agents|sensory system agents|mesh-ancestor
110866480|NCT03453151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110866481|NCT03433248|Empagliflozin|empagliflozin|mesh-list
110866482|NCT03433248|Gliclazide|gliclazide|mesh-list
110866483|NCT03433248|Linagliptin|linagliptin|mesh-list
110866484|NCT03433248|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110866485|NCT03433248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110866486|NCT03433248|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110866487|NCT03433248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110866488|NCT03433248|Incretins|incretins|mesh-ancestor
110866489|NCT03433248|Hormones|hormones|mesh-ancestor
110346615|NCT04478292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110866490|NCT03433248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110866491|NCT03433248|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110866492|NCT03433248|Protease Inhibitors|protease inhibitors|mesh-ancestor
110866493|NCT03433248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110866494|NCT03691688|Aspirin|aspirin|mesh-list
110866495|NCT03691688|Clopidogrel|clopidogrel|mesh-list
110866496|NCT03691688|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110866497|NCT03691688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110866498|NCT03691688|Analgesics|analgesics|mesh-ancestor
110866499|NCT03691688|Sensory System Agents|sensory system agents|mesh-ancestor
110866500|NCT03691688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110866501|NCT03691688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110866502|NCT03691688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110866503|NCT03691688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110866504|NCT03691688|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110866505|NCT03691688|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110866506|NCT03691688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110866507|NCT03691688|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110866508|NCT03691688|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110866509|NCT03691688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110866510|NCT03691688|Antipyretics|antipyretics|mesh-ancestor
110866511|NCT03691688|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110866512|NCT03691688|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110866513|NCT03691688|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110866514|NCT03691688|Purinergic Agents|purinergic agents|mesh-ancestor
110866515|NCT03691688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110866516|NCT02887248|Paclitaxel|paclitaxel|mesh-list
110866517|NCT02887248|Gemcitabine|gemcitabine|mesh-list
110866518|NCT02887248|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110866519|NCT02887248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110866520|NCT02887248|Tubulin Modulators|tubulin modulators|mesh-ancestor
110866521|NCT02887248|Antimitotic Agents|antimitotic agents|mesh-ancestor
110866522|NCT02887248|Mitosis Modulators|mitosis modulators|mesh-ancestor
110866523|NCT02887248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110866524|NCT02887248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110866525|NCT02887248|Antimetabolites|antimetabolites|mesh-ancestor
110866526|NCT02425462|Dienogest|dienogest|mesh-list
110866527|NCT02425462|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110866528|NCT02425462|Contraceptive Agents|contraceptive agents|mesh-ancestor
110866529|NCT02425462|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110866530|NCT02425462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110366705|NCT00546065|Esomeprazole|esomeprazole|mesh-list
110866531|NCT02425462|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110866532|NCT02425462|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110866533|NCT02425462|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110866534|NCT02425462|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110866535|NCT02425462|Hormone Antagonists|hormone antagonists|mesh-ancestor
110866536|NCT02425462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110866537|NCT02425462|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110866538|NCT02425462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110866539|NCT03452527|Aflibercept|aflibercept|mesh-list
110866540|NCT03452527|Immunoconjugates|immunoconjugates|mesh-list
110346795|NCT04307576|Dexamethasone|dexamethasone|mesh-list
110866541|NCT03452527|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110866542|NCT03452527|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110866543|NCT03452527|Growth Substances|growth substances|mesh-ancestor
110866544|NCT03452527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110866545|NCT03452527|Growth Inhibitors|growth inhibitors|mesh-ancestor
110866546|NCT03452527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110866547|NCT03452527|Immunologic Factors|immunologic factors|mesh-ancestor
110866548|NCT04878510|Dexmedetomidine|dexmedetomidine|mesh-list
110866549|NCT04878510|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110866550|NCT04878510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110866551|NCT04878510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110866552|NCT04878510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110866553|NCT04878510|Analgesics|analgesics|mesh-ancestor
110866554|NCT04878510|Sensory System Agents|sensory system agents|mesh-ancestor
110866555|NCT04878510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110866556|NCT04878510|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110866557|NCT04878510|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110866558|NCT04878510|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110866559|NCT04878510|Adrenergic Agents|adrenergic agents|mesh-ancestor
110866560|NCT04878510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110866561|NCT04878510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110866562|NCT03028142|Tiotropium Bromide|tiotropium bromide|mesh-list
110866563|NCT03028142|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110866564|NCT03028142|Autonomic Agents|autonomic agents|mesh-ancestor
110866565|NCT03028142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110866566|NCT03028142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110866567|NCT03028142|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110866568|NCT03028142|Respiratory System Agents|respiratory system agents|mesh-ancestor
110866569|NCT03028142|Parasympatholytics|parasympatholytics|mesh-ancestor
110866570|NCT03028142|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110866571|NCT03028142|Cholinergic Agents|cholinergic agents|mesh-ancestor
110866572|NCT03028142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110866573|NCT03028142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110866574|NCT02800824|Budesonide|budesonide|mesh-list
110866575|NCT02800824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110866576|NCT02800824|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110866577|NCT02800824|Autonomic Agents|autonomic agents|mesh-ancestor
110866578|NCT02800824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110866579|NCT02800824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110866580|NCT02800824|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110866581|NCT02800824|Respiratory System Agents|respiratory system agents|mesh-ancestor
110866582|NCT02800824|Glucocorticoids|glucocorticoids|mesh-ancestor
110866583|NCT02800824|Hormones|hormones|mesh-ancestor
110866584|NCT02800824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110866585|NCT03715777|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
110866586|NCT03715777|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110866587|NCT03715777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110866588|NCT03715777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110866589|NCT03715777|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110866590|NCT03715777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110866591|NCT03715777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110866592|NCT03715777|Cholinergic Agents|cholinergic agents|mesh-ancestor
110866593|NCT03715777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110866594|NCT03715699|Prednisone|prednisone|mesh-list
110866595|NCT03715699|Leflunomide|leflunomide|mesh-list
110866596|NCT03715699|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110866597|NCT03715699|Glucocorticoids|glucocorticoids|mesh-ancestor
110866598|NCT03715699|Hormones|hormones|mesh-ancestor
110866599|NCT03715699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110866600|NCT03715699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110866601|NCT03715699|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110834595|NCT01304797|Doxorubicin|doxorubicin|mesh-list
110866602|NCT03715699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110866604|NCT03715699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110866605|NCT03715699|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110866606|NCT03715699|Immunologic Factors|immunologic factors|mesh-ancestor
110866607|NCT04776408|Nitric Oxide|nitric oxide|mesh-list
110866608|NCT04776408|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110866609|NCT04776408|Autonomic Agents|autonomic agents|mesh-ancestor
110866610|NCT04776408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110866611|NCT04776408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110866612|NCT04776408|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110866613|NCT04776408|Respiratory System Agents|respiratory system agents|mesh-ancestor
110866614|NCT04776408|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110866615|NCT04776408|Antioxidants|antioxidants|mesh-ancestor
110866616|NCT04776408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110866617|NCT04776408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110866618|NCT04776408|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
110866619|NCT04776408|Vasodilator Agents|vasodilator agents|mesh-ancestor
110866620|NCT04776408|Gasotransmitters|gasotransmitters|mesh-ancestor
110866621|NCT04776408|Protective Agents|protective agents|mesh-ancestor
110866622|NCT02429596|Lamotrigine|lamotrigine|mesh-list
110866623|NCT02429596|Carbamazepine|carbamazepine|mesh-list
110866624|NCT02429596|Anticonvulsants|anticonvulsants|mesh-ancestor
110866625|NCT02429596|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110866626|NCT02429596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110866627|NCT02429596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110866628|NCT02429596|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110866629|NCT02429596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110584134|NCT04113005|Coagulants|coagulants|mesh-ancestor
110866630|NCT02429596|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110866631|NCT02429596|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110866632|NCT02429596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110347087|NCT04198662|Mydriatics|mydriatics|mesh-ancestor
110866634|NCT02429596|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110866635|NCT02429596|Antimanic Agents|antimanic agents|mesh-ancestor
110866636|NCT02429596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110866637|NCT02429596|Analgesics|analgesics|mesh-ancestor
110866638|NCT02429596|Sensory System Agents|sensory system agents|mesh-ancestor
110866639|NCT02429596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110866640|NCT02429596|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110866641|NCT02429596|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110866642|NCT03418675|Brexpiprazole|brexpiprazole|mesh-list
110866643|NCT03418675|Serotonin Agents|serotonin agents|mesh-ancestor
110866644|NCT03418675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110866645|NCT03418675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110866646|NCT03418675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110866647|NCT03418675|Dopamine Agonists|dopamine agonists|mesh-ancestor
110866648|NCT03418675|Dopamine Agents|dopamine agents|mesh-ancestor
110866650|NCT02653092|Anticoagulants|anticoagulants|mesh-list
110866651|NCT02653092|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
110866652|NCT02653092|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110866653|NCT02653092|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110866654|NCT02653092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110866655|NCT02653092|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
110866656|NCT02653092|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
110866657|NCT02653092|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110866658|NCT03691454|Docetaxel|docetaxel|mesh-list
110866659|NCT03691454|Oxaliplatin|oxaliplatin|mesh-list
110866660|NCT03691454|Trastuzumab|trastuzumab|mesh-list
110866661|NCT03691454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110866662|NCT03691454|Tubulin Modulators|tubulin modulators|mesh-ancestor
110866663|NCT03691454|Antimitotic Agents|antimitotic agents|mesh-ancestor
110866664|NCT03691454|Mitosis Modulators|mitosis modulators|mesh-ancestor
110866665|NCT03691454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110866666|NCT03691454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110866667|NCT03718273|Digoxin|digoxin|mesh-list
110866668|NCT03718273|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110866669|NCT03718273|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110866670|NCT03718273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110866671|NCT03718273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110866672|NCT03718273|Protective Agents|protective agents|mesh-ancestor
110866673|NCT03718273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110866674|NCT02421640|Cisplatin|cisplatin|mesh-list
110866675|NCT02421640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110866676|NCT03715387|Bacitracin|bacitracin|mesh-list
110866677|NCT03715387|Polymyxin B|polymyxin b|mesh-list
110866678|NCT03715387|Tacrolimus|tacrolimus|mesh-list
110866679|NCT03715387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110866680|NCT03715387|Immunologic Factors|immunologic factors|mesh-ancestor
110866681|NCT03715387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110866682|NCT03715387|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110866683|NCT03715387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110866684|NCT03715387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110866685|NCT03715387|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110866686|NCT03715387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110866687|NCT03715387|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110866688|NCT03715309|Lenalidomide|lenalidomide|mesh-list
110866689|NCT03715309|Immunologic Factors|immunologic factors|mesh-ancestor
110866690|NCT03715309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110866691|NCT03715309|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110866692|NCT03715309|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110866693|NCT03715309|Growth Substances|growth substances|mesh-ancestor
110866694|NCT03715309|Growth Inhibitors|growth inhibitors|mesh-ancestor
110866695|NCT03715309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110866696|NCT03179254|Metformin|metformin|mesh-list
110866697|NCT03179254|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110866698|NCT03179254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110866699|NCT04147715|Dolutegravir|dolutegravir|mesh-list
110866700|NCT04147715|Midazolam|midazolam|mesh-list
110866701|NCT04147715|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110866702|NCT04147715|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110866703|NCT04147715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110866704|NCT04147715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110866705|NCT04147715|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110866706|NCT04147715|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110866707|NCT04147715|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110866708|NCT04147715|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110866709|NCT04147715|Anesthetics, General|anesthetics, general|mesh-ancestor
110866710|NCT04147715|Anesthetics|anesthetics|mesh-ancestor
110866711|NCT04147715|GABA Modulators|gaba modulators|mesh-ancestor
110866712|NCT04147715|GABA Agents|gaba agents|mesh-ancestor
110866713|NCT04147715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110866714|NCT04147715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110866715|NCT04147715|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110866716|NCT04147715|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110866717|NCT04147715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110866718|NCT04147715|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110866719|NCT04147715|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110866720|NCT04147715|Antiviral Agents|antiviral agents|mesh-ancestor
110866721|NCT04147715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110866722|NCT02420938|Rituximab|rituximab|mesh-list
110866723|NCT02420938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110866724|NCT02420938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110866725|NCT02420938|Immunologic Factors|immunologic factors|mesh-ancestor
110866726|NCT02420938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110866727|NCT02420938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110866728|NCT02429440|Molgramostim|molgramostim|mesh-list
110866729|NCT02429440|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
110866730|NCT02429440|Sargramostim|sargramostim|mesh-list
110866731|NCT02429440|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110866732|NCT02429440|Immunologic Factors|immunologic factors|mesh-ancestor
110347216|NCT04102020|Venetoclax|venetoclax|mesh-list
110866733|NCT02429440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110866734|NCT02429440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110866736|NCT02429518|Antifungal Agents|antifungal agents|mesh-ancestor
110866737|NCT02429518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110866738|NCT02429518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110866739|NCT02429518|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110866740|NCT02429518|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110866741|NCT00708526|Anesthetics|anesthetics|mesh-list
110866742|NCT00708526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110866743|NCT00708526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110866744|NCT03712735|Fentanyl|fentanyl|mesh-list
110866745|NCT03712735|Bupivacaine|bupivacaine|mesh-list
110866746|NCT03712735|Anesthetics, Local|anesthetics, local|mesh-ancestor
110866747|NCT03712735|Anesthetics|anesthetics|mesh-ancestor
110866748|NCT03712735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110866749|NCT03712735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110866750|NCT03712735|Sensory System Agents|sensory system agents|mesh-ancestor
110866751|NCT03712735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110866752|NCT03712735|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110866753|NCT03712735|Narcotics|narcotics|mesh-ancestor
110866754|NCT03712735|Analgesics|analgesics|mesh-ancestor
110866755|NCT03712735|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110866756|NCT03712735|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110866757|NCT03712735|Anesthetics, General|anesthetics, general|mesh-ancestor
110866758|NCT03182218|Heparin|heparin|mesh-list
110866759|NCT03182218|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
110866760|NCT03182218|Tinzaparin|tinzaparin|mesh-list
110866761|NCT03182218|Dalteparin|dalteparin|mesh-list
110866762|NCT03182218|Anticoagulants|anticoagulants|mesh-list
110866763|NCT03182218|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110866764|NCT03182218|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110866765|NCT03182218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110866766|NCT02452554|Maytansine|maytansine|mesh-list
110866767|NCT02452554|Lorvotuzumab mertansine|lorvotuzumab mertansine|mesh-list
110866768|NCT02452554|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
110866769|NCT02452554|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110866770|NCT02452554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110866771|NCT02452554|Tubulin Modulators|tubulin modulators|mesh-ancestor
110866772|NCT02452554|Antimitotic Agents|antimitotic agents|mesh-ancestor
110866773|NCT02452554|Mitosis Modulators|mitosis modulators|mesh-ancestor
110866774|NCT02452554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110866775|NCT02452554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110866777|NCT02452554|Immunoconjugates|immunoconjugates|mesh-ancestor
110866778|NCT02452554|Immunologic Factors|immunologic factors|mesh-ancestor
110866779|NCT02452554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110866780|NCT03182296|Exenatide|exenatide|mesh-list
110866781|NCT03182296|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110866782|NCT03182296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110866783|NCT03182296|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110866784|NCT03182296|Incretins|incretins|mesh-ancestor
110866786|NCT03182296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110866787|NCT03182374|Hylan|hylan|mesh-list
110866788|NCT03182374|Viscosupplements|viscosupplements|mesh-ancestor
110866789|NCT03182374|Protective Agents|protective agents|mesh-ancestor
110866790|NCT03182374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110866791|NCT01319682|Lidocaine|lidocaine|mesh-list
110866792|NCT01319682|Anesthetics, Local|anesthetics, local|mesh-ancestor
110866793|NCT01319682|Anesthetics|anesthetics|mesh-ancestor
110866794|NCT01319682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110866795|NCT01319682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110866796|NCT01319682|Sensory System Agents|sensory system agents|mesh-ancestor
110866797|NCT01319682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110866798|NCT01319682|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110866799|NCT01319682|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110866800|NCT01319682|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110347426|NCT03917381|Mitosis Modulators|mitosis modulators|mesh-ancestor
110347427|NCT03917381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110347428|NCT03917381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110347429|NCT03917381|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110150062|NCT00007891|Antibodies|antibodies|mesh-list
110347431|NCT03909334|Ramucirumab|ramucirumab|mesh-list
110347436|NCT03895099|Desogestrel|desogestrel|mesh-list
110866801|NCT01319682|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110866802|NCT01319682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110866803|NCT04009577|Lemborexant|lemborexant|mesh-list
110866804|NCT04009577|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
110866805|NCT04009577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110866806|NCT04009577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110866807|NCT04009577|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110866808|NCT04009577|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110866809|NCT04009577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110347476|NCT03822962|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110866810|NCT04009577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110866811|NCT02176668|Esomeprazole|esomeprazole|mesh-list
110866812|NCT02176668|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110866813|NCT02176668|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110866814|NCT02176668|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110866815|NCT02176668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110866816|NCT02176668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110866817|NCT03712423|Docetaxel|docetaxel|mesh-list
110866818|NCT03712423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110866819|NCT03712423|Tubulin Modulators|tubulin modulators|mesh-ancestor
110866820|NCT03712423|Antimitotic Agents|antimitotic agents|mesh-ancestor
110866821|NCT03712423|Mitosis Modulators|mitosis modulators|mesh-ancestor
110866822|NCT03712423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110866823|NCT04620252|Calcium, Dietary|calcium, dietary|mesh-list
110866824|NCT04620252|Calcium Carbonate|calcium carbonate|mesh-list
110866825|NCT04620252|Citric Acid|citric acid|mesh-list
110866826|NCT04620252|Sodium Citrate|sodium citrate|mesh-list
110866827|NCT04620252|Calcium|calcium|mesh-list
110866828|NCT04620252|Fluorides|fluorides|mesh-list
110866829|NCT04620252|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110866830|NCT04620252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110866831|NCT04620252|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110866832|NCT04620252|Anticoagulants|anticoagulants|mesh-ancestor
110866833|NCT04620252|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110866834|NCT04620252|Chelating Agents|chelating agents|mesh-ancestor
110347605|NCT03745950|Olaparib|olaparib|mesh-list
110866835|NCT04620252|Sequestering Agents|sequestering agents|mesh-ancestor
110866836|NCT04620252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110866837|NCT04620252|Cariostatic Agents|cariostatic agents|mesh-ancestor
110866838|NCT04620252|Protective Agents|protective agents|mesh-ancestor
110866839|NCT04620252|Antacids|antacids|mesh-ancestor
110866840|NCT04620252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110866841|NCT03694886|Caffeine|caffeine|mesh-list
110866842|NCT03694886|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110866843|NCT03694886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110866845|NCT03694886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110866846|NCT03694886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110866847|NCT03694886|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110866848|NCT03694886|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110866849|NCT03694886|Purinergic Agents|purinergic agents|mesh-ancestor
110866850|NCT03694886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110866851|NCT05602675|Repaglinide|repaglinide|mesh-list
110866852|NCT05602675|Methotrexate|methotrexate|mesh-list
110866854|NCT05602675|Dextromethorphan|dextromethorphan|mesh-list
110866856|NCT05602675|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110866857|NCT05602675|Abortifacient Agents|abortifacient agents|mesh-ancestor
110866858|NCT05602675|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110584379|NCT04219449|Protein C|protein c|mesh-list
110866859|NCT05602675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110866860|NCT05602675|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110866862|NCT05602675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110866863|NCT05602675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110866864|NCT05602675|Dermatologic Agents|dermatologic agents|mesh-ancestor
110866865|NCT05602675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110866866|NCT05602675|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110866867|NCT05602675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110866869|NCT05602675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110347982|NCT03383458|Nivolumab|nivolumab|mesh-list
110866870|NCT05602675|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110866871|NCT05602675|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110866872|NCT05602675|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110866873|NCT05602675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110348061|NCT03294460|Ethanol|ethanol|mesh-list
110866874|NCT05602675|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110866875|NCT05602675|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110866876|NCT05602675|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110866877|NCT05602675|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110866878|NCT05602675|Anesthetics, General|anesthetics, general|mesh-ancestor
110866879|NCT05602675|Anesthetics|anesthetics|mesh-ancestor
110866880|NCT05602675|GABA Modulators|gaba modulators|mesh-ancestor
110866881|NCT05602675|GABA Agents|gaba agents|mesh-ancestor
110866882|NCT05602675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110866883|NCT05602675|Anticoagulants|anticoagulants|mesh-ancestor
110866884|NCT05602675|Antitussive Agents|antitussive agents|mesh-ancestor
110348116|NCT03267680|Analgesics|analgesics|mesh-ancestor
110866885|NCT05602675|Respiratory System Agents|respiratory system agents|mesh-ancestor
110866886|NCT05602675|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110866887|NCT05602675|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110866888|NCT05602675|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110866890|NCT03714685|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110866891|NCT02705716|Fluorides|fluorides|mesh-list
110866892|NCT02705716|Tin Fluorides|tin fluorides|mesh-list
110866893|NCT02705716|Fluorophosphate|fluorophosphate|mesh-list
110866894|NCT02705716|Cariostatic Agents|cariostatic agents|mesh-ancestor
110866895|NCT02705716|Protective Agents|protective agents|mesh-ancestor
110866896|NCT02705716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110866897|NCT02429050|Morphine|morphine|mesh-list
110866898|NCT02429050|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110348321|NCT02967289|Irinotecan|irinotecan|mesh-list
110866900|NCT02429050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110866901|NCT02429050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110866902|NCT02429050|Analgesics|analgesics|mesh-ancestor
110866903|NCT02429050|Sensory System Agents|sensory system agents|mesh-ancestor
110866904|NCT02429050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110866905|NCT02417142|Exenatide|exenatide|mesh-list
110866906|NCT02417142|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110866907|NCT02417142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110866908|NCT02417142|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110866909|NCT02417142|Incretins|incretins|mesh-ancestor
110866910|NCT02417142|Hormones|hormones|mesh-ancestor
110866911|NCT02417142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110866912|NCT01374750|Cyclosporine|cyclosporine|mesh-list
110866913|NCT01374750|Sirolimus|sirolimus|mesh-list
110866914|NCT01374750|Tacrolimus|tacrolimus|mesh-list
110866915|NCT01374750|Cyclosporins|cyclosporins|mesh-list
110866916|NCT01374750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110866917|NCT01374750|Immunologic Factors|immunologic factors|mesh-ancestor
110866918|NCT01374750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110348672|NCT02386735|Glucocorticoids|glucocorticoids|mesh-ancestor
110866919|NCT01374750|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110866920|NCT01374750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110866921|NCT01374750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110866922|NCT01374750|Antifungal Agents|antifungal agents|mesh-ancestor
110866923|NCT01374750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110866924|NCT01374750|Dermatologic Agents|dermatologic agents|mesh-ancestor
110866925|NCT01374750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110866926|NCT01374750|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110866927|NCT01374750|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110348742|NCT02204683|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110348743|NCT02204683|Growth Substances|growth substances|mesh-ancestor
110348744|NCT02204683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110348745|NCT02204683|Growth Inhibitors|growth inhibitors|mesh-ancestor
110348746|NCT02204683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110348748|NCT02152995|Cadexomer iodine|cadexomer iodine|mesh-list
110348749|NCT02152995|Trametinib|trametinib|mesh-list
110348750|NCT02152995|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110348751|NCT02152995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110348752|NCT02152995|Trace Elements|trace elements|mesh-ancestor
110866928|NCT01374750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110866929|NCT03182140|Levonorgestrel|levonorgestrel|mesh-list
110866930|NCT03182140|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110866931|NCT03182140|Contraceptive Agents|contraceptive agents|mesh-ancestor
110866932|NCT03182140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110866933|NCT03182140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110866934|NCT03182140|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110584440|NCT02604797|Sufentanil|sufentanil|mesh-list
110866935|NCT03182140|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110866936|NCT03182140|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110866937|NCT01374828|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
110866938|NCT01374828|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110866939|NCT01374828|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110866940|NCT01374828|Analgesics|analgesics|mesh-ancestor
110866941|NCT01374828|Sensory System Agents|sensory system agents|mesh-ancestor
110866942|NCT01374828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110866943|NCT01374828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110866944|NCT01374828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110866945|NCT01374828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110866946|NCT01374828|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110866947|NCT01374828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110866948|NCT01374828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110866949|NCT03634332|Pembrolizumab|pembrolizumab|mesh-list
110348950|NCT01705158|Carboplatin|carboplatin|mesh-list
110866950|NCT03634332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110866951|NCT03634332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110866952|NCT03634332|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110866953|NCT03634332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110866955|NCT03744767|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110866956|NCT03744767|Hormone Antagonists|hormone antagonists|mesh-ancestor
110866957|NCT03744767|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110866958|NCT03744767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110866959|NCT03744767|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110866960|NCT03744767|Diuretics|diuretics|mesh-ancestor
110866961|NCT03744767|Natriuretic Agents|natriuretic agents|mesh-ancestor
110866962|NCT02428972|Propofol|propofol|mesh-list
110866963|NCT02428972|Sevoflurane|sevoflurane|mesh-list
110866964|NCT02428972|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110866965|NCT02428972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110866966|NCT02428972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110866967|NCT02428972|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110866970|NCT02428972|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110866971|NCT02428972|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110866972|NCT03699332|Labetuzumab|labetuzumab|mesh-list
110866973|NCT03699332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110866974|NCT03699332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110866975|NCT03389893|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110866976|NCT03389893|Immunologic Factors|immunologic factors|mesh-ancestor
110866977|NCT03389893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110866978|NCT03178708|Amantadine|amantadine|mesh-list
110866979|NCT03178708|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110866980|NCT03178708|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110866981|NCT03178708|Antiviral Agents|antiviral agents|mesh-ancestor
110866982|NCT03178708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110866983|NCT03178708|Dopamine Agents|dopamine agents|mesh-ancestor
110866984|NCT03178708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110349377|NCT00588770|Antimetabolites|antimetabolites|mesh-ancestor
110866985|NCT03178708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110866986|NCT03178708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110866987|NCT03178708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110866988|NCT03178708|Analgesics|analgesics|mesh-ancestor
110866989|NCT03178708|Sensory System Agents|sensory system agents|mesh-ancestor
110866990|NCT03178708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110866991|NCT00787176|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110866992|NCT00787176|Oxytocin|oxytocin|mesh-list
110866993|NCT00787176|Oxytocics|oxytocics|mesh-ancestor
110866994|NCT00787176|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110866995|NCT00787176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110866996|NCT03744689|Bupivacaine|bupivacaine|mesh-list
110866997|NCT03744689|Anesthetics, Local|anesthetics, local|mesh-ancestor
110866998|NCT03744689|Anesthetics|anesthetics|mesh-ancestor
110866999|NCT03744689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110867000|NCT03744689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110867001|NCT03744689|Sensory System Agents|sensory system agents|mesh-ancestor
110867002|NCT03744689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110867003|NCT02424214|Ionophores|ionophores|mesh-list
110867004|NCT02424214|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110867005|NCT02424214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110867006|NCT03712111|Norepinephrine|norepinephrine|mesh-list
110867007|NCT03712111|Bupivacaine|bupivacaine|mesh-list
110867008|NCT03712111|Anesthetics, Local|anesthetics, local|mesh-ancestor
110867009|NCT03712111|Anesthetics|anesthetics|mesh-ancestor
110867010|NCT03712111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110867011|NCT03712111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110867012|NCT03712111|Sensory System Agents|sensory system agents|mesh-ancestor
110349532|NCT02915250|Insulin Lispro|insulin lispro|mesh-list
110867013|NCT03712111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110366794|NCT00547352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110867014|NCT03712111|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110867015|NCT03712111|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110867016|NCT03712111|Adrenergic Agents|adrenergic agents|mesh-ancestor
110867017|NCT03712111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110349568|NCT05034536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110867018|NCT03712111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110867019|NCT03712111|Sympathomimetics|sympathomimetics|mesh-ancestor
110867020|NCT03712111|Autonomic Agents|autonomic agents|mesh-ancestor
110867021|NCT03712111|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110867022|NCT02925494|Norethindrone|norethindrone|mesh-list
110867023|NCT02925494|Norethindrone Acetate|norethindrone acetate|mesh-list
110867024|NCT02925494|Estradiol|estradiol|mesh-list
110867025|NCT02925494|Estrogens|estrogens|mesh-ancestor
110867026|NCT02925494|Hormones|hormones|mesh-ancestor
110834671|NCT01649947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110867027|NCT02925494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110867028|NCT02925494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110867029|NCT02925494|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110867030|NCT02925494|Contraceptive Agents|contraceptive agents|mesh-ancestor
110867031|NCT02925494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110867032|NCT02925494|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110867033|NCT02925494|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110867034|NCT02925494|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110867035|NCT02925494|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110867037|NCT03717415|Rebastinib|rebastinib|mesh-list
110867038|NCT03717415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110867039|NCT03717415|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110867040|NCT03717415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110867041|NCT03717415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110867042|NCT03689894|Rituximab|rituximab|mesh-list
110867043|NCT03689894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110867044|NCT03689894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110867045|NCT03689894|Immunologic Factors|immunologic factors|mesh-ancestor
110867046|NCT03689894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110867047|NCT03689894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110867048|NCT04126343|Moxifloxacin|moxifloxacin|mesh-list
110867049|NCT04126343|Padsevonil|padsevonil|mesh-list
110349842|NCT04324060|Danazol|danazol|mesh-list
110867050|NCT04126343|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110867051|NCT04126343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110867052|NCT04126343|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110867053|NCT04126343|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110867054|NCT04126343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110867055|NCT04126343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110867056|NCT04126343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110867057|NCT04126343|Anticonvulsants|anticonvulsants|mesh-ancestor
110867058|NCT04207710|Ethyl Chloride|ethyl chloride|mesh-list
110867060|NCT04207710|Anesthetics|anesthetics|mesh-ancestor
110867061|NCT04207710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110867062|NCT04207710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110867063|NCT04207710|Sensory System Agents|sensory system agents|mesh-ancestor
110867064|NCT04207710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110867065|NCT03119610|Oxytocin|oxytocin|mesh-list
110350025|NCT01289821|Leucovorin|leucovorin|mesh-list
110867066|NCT03119610|Oxytocics|oxytocics|mesh-ancestor
110867067|NCT03119610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110867068|NCT03119610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110867069|NCT01373736|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
110867070|NCT01373736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110867071|NCT01373736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110867072|NCT01373736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110867073|NCT01373736|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110867075|NCT03401749|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110867076|NCT03401749|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110867077|NCT03401749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110867078|NCT03401749|Disinfectants|disinfectants|mesh-ancestor
110867079|NCT03401749|Dermatologic Agents|dermatologic agents|mesh-ancestor
110867080|NCT03689114|Topiramate|topiramate|mesh-list
110867081|NCT03689114|Lamotrigine|lamotrigine|mesh-list
110867082|NCT03689114|Zonisamide|zonisamide|mesh-list
110867083|NCT03689114|Carbamazepine|carbamazepine|mesh-list
110867084|NCT03689114|Oxcarbazepine|oxcarbazepine|mesh-list
110867085|NCT03689114|Gabapentin|gabapentin|mesh-list
110867086|NCT03689114|Levetiracetam|levetiracetam|mesh-list
110867088|NCT03689114|Valproic Acid|valproic acid|mesh-list
110867089|NCT03689114|Analgesics|analgesics|mesh-ancestor
110867090|NCT03689114|Sensory System Agents|sensory system agents|mesh-ancestor
110867091|NCT03689114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110867092|NCT03689114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110867093|NCT03689114|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110867094|NCT03689114|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110867095|NCT03689114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110867096|NCT03689114|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110867097|NCT03689114|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110867099|NCT03689114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110867100|NCT03689114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110867101|NCT03689114|Antimanic Agents|antimanic agents|mesh-ancestor
110867102|NCT03689114|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110867103|NCT03689114|Nootropic Agents|nootropic agents|mesh-ancestor
110867104|NCT03689114|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110867105|NCT03689114|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110867106|NCT03689114|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110867107|NCT03689114|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110867108|NCT03689114|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110867109|NCT03689114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110867110|NCT03689114|GABA Agents|gaba agents|mesh-ancestor
110867111|NCT03689114|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110350242|NCT02935322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110867113|NCT03689114|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110867114|NCT03689114|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110867115|NCT02952001|Triamcinolone|triamcinolone|mesh-list
110867116|NCT02952001|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110867117|NCT02952001|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110867118|NCT02952001|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110867119|NCT02952001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110867120|NCT02952001|Glucocorticoids|glucocorticoids|mesh-ancestor
110867121|NCT02952001|Hormones|hormones|mesh-ancestor
110867122|NCT02952001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110867123|NCT02952001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110867124|NCT02952001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110867125|NCT02952001|Immunologic Factors|immunologic factors|mesh-ancestor
110867126|NCT02952001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110350386|NCT04689971|Vitamins|vitamins|mesh-list
110867127|NCT02952001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110867128|NCT04050176|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
110867129|NCT04050176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110867130|NCT04050176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110867131|NCT01311739|Vitamin B 12|vitamin b 12|mesh-list
110867132|NCT01311739|Hydroxocobalamin|hydroxocobalamin|mesh-list
110867133|NCT01311739|Vitamin B Complex|vitamin b complex|mesh-ancestor
110867134|NCT01311739|Vitamins|vitamins|mesh-ancestor
110867135|NCT01311739|Micronutrients|micronutrients|mesh-ancestor
110867136|NCT01311739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110867137|NCT01311739|Hematinics|hematinics|mesh-ancestor
110867138|NCT05507359|Benzocaine|benzocaine|mesh-list
110867139|NCT05507359|Anesthetics, Local|anesthetics, local|mesh-ancestor
110867140|NCT05507359|Anesthetics|anesthetics|mesh-ancestor
110867141|NCT05507359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110867142|NCT05507359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110867143|NCT05507359|Sensory System Agents|sensory system agents|mesh-ancestor
110867144|NCT05507359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110867145|NCT04123067|Pioglitazone|pioglitazone|mesh-list
110867146|NCT04123067|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110867147|NCT04123067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110867148|NCT03703050|Nivolumab|nivolumab|mesh-list
110867149|NCT03703050|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110867150|NCT03703050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110867151|NCT03703050|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110867152|NCT03703050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110867153|NCT03688958|Iodine|iodine|mesh-list
110867154|NCT03688958|Cadexomer iodine|cadexomer iodine|mesh-list
110867156|NCT03688958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110867157|NCT03688958|Trace Elements|trace elements|mesh-ancestor
110867158|NCT03688958|Micronutrients|micronutrients|mesh-ancestor
110867159|NCT03688958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110867160|NCT04117607|Rezafungin|rezafungin|mesh-list
110867161|NCT04117607|Antifungal Agents|antifungal agents|mesh-ancestor
110867162|NCT04117607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110867163|NCT03688568|Imatinib Mesylate|imatinib mesylate|mesh-list
110867164|NCT03688568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110867165|NCT03688568|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110867166|NCT03688568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110867167|NCT03688568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110867168|NCT05192304|Maleic acid|maleic acid|mesh-list
110867169|NCT05192304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110867170|NCT05192304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110867171|NCT03693872|Dopamine|dopamine|mesh-list
110867172|NCT03693872|Apomorphine|apomorphine|mesh-list
110867173|NCT03693872|Dopamine Agonists|dopamine agonists|mesh-list
110867174|NCT03693872|Emetics|emetics|mesh-ancestor
110867175|NCT03693872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110867176|NCT03693872|Autonomic Agents|autonomic agents|mesh-ancestor
110867177|NCT03693872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110867178|NCT03693872|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110867179|NCT03693872|Dopamine Agents|dopamine agents|mesh-ancestor
110867180|NCT03693872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110350722|NCT02933775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110867181|NCT03693872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110867182|NCT03693872|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110867183|NCT03693872|Sympathomimetics|sympathomimetics|mesh-ancestor
110867184|NCT03693872|Protective Agents|protective agents|mesh-ancestor
110867186|NCT03693638|Bupivacaine|bupivacaine|mesh-list
110867187|NCT03693638|Anesthetics, Local|anesthetics, local|mesh-ancestor
110867188|NCT03693638|Anesthetics|anesthetics|mesh-ancestor
110867189|NCT03693638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110867190|NCT03693638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110867191|NCT03693638|Sensory System Agents|sensory system agents|mesh-ancestor
110867192|NCT03693638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110867193|NCT03693638|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110867194|NCT03693638|Narcotics|narcotics|mesh-ancestor
110867195|NCT03693638|Analgesics|analgesics|mesh-ancestor
110867196|NCT03693638|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110867197|NCT03693638|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110867198|NCT03693638|Anesthetics, General|anesthetics, general|mesh-ancestor
110867199|NCT04112303|Sofosbuvir|sofosbuvir|mesh-list
110867200|NCT04112303|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
110867201|NCT04112303|Antiviral Agents|antiviral agents|mesh-ancestor
110867202|NCT04112303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110867203|NCT01319838|Isotretinoin|isotretinoin|mesh-list
110867204|NCT01319838|Dermatologic Agents|dermatologic agents|mesh-ancestor
110867205|NCT05191914|Fulvestrant|fulvestrant|mesh-list
110867207|NCT05191914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110867208|NCT05191914|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110867209|NCT05191914|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110867210|NCT05191914|Hormone Antagonists|hormone antagonists|mesh-ancestor
110350974|NCT02921165|Sensory System Agents|sensory system agents|mesh-ancestor
110867211|NCT05191914|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110867212|NCT05191914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110867213|NCT04060394|Prednisone|prednisone|mesh-list
110867214|NCT04060394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110867215|NCT04060394|Glucocorticoids|glucocorticoids|mesh-ancestor
110867216|NCT04060394|Hormones|hormones|mesh-ancestor
110351043|NCT02932566|Pirfenidone|pirfenidone|mesh-list
110867217|NCT04060394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110867218|NCT04060394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110867219|NCT04060394|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110867220|NCT04060394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110867221|NCT04099277|Pembrolizumab|pembrolizumab|mesh-list
110867222|NCT04099277|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110867223|NCT04099277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110867224|NCT04099277|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110867225|NCT04099277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110867226|NCT03743987|Pemetrexed|pemetrexed|mesh-list
110867227|NCT03743987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110867228|NCT03743987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110867229|NCT03743987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110867230|NCT03743987|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110867231|NCT03743987|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110867232|NCT03693326|Spartalizumab|spartalizumab|mesh-list
110867233|NCT03693326|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110867234|NCT03693326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110867235|NCT03693326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110867236|NCT03693326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110867238|NCT03988907|Risdiplam|risdiplam|mesh-list
110867239|NCT03988907|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110867240|NCT03988907|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110351326|NCT04736901|Enoxaparin|enoxaparin|mesh-list
110867241|NCT03988907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110867242|NCT03988907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110867243|NCT03988907|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110867244|NCT03988907|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110867245|NCT03988907|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110867246|NCT03988907|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110867247|NCT03988907|Anesthetics, General|anesthetics, general|mesh-ancestor
110867248|NCT03988907|Anesthetics|anesthetics|mesh-ancestor
110867249|NCT03988907|GABA Modulators|gaba modulators|mesh-ancestor
110867250|NCT03988907|GABA Agents|gaba agents|mesh-ancestor
110867251|NCT03988907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110867252|NCT03988907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110867253|NCT03988907|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110867254|NCT03988907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110867255|NCT03693248|Paclitaxel|paclitaxel|mesh-list
110867256|NCT03693248|Carboplatin|carboplatin|mesh-list
110867257|NCT03693248|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110867258|NCT03693248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110867259|NCT03693248|Tubulin Modulators|tubulin modulators|mesh-ancestor
110351393|NCT02918747|Dexamethasone|dexamethasone|mesh-list
110867260|NCT03693248|Antimitotic Agents|antimitotic agents|mesh-ancestor
110867261|NCT03693248|Mitosis Modulators|mitosis modulators|mesh-ancestor
110867262|NCT03693248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110867263|NCT03987191|Insulin|insulin|mesh-list
110867264|NCT03987191|Insulin Aspart|insulin aspart|mesh-list
110867265|NCT03987191|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
110867266|NCT03987191|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110351451|NCT05356104|Exenatide|exenatide|mesh-list
110867267|NCT03987191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110867269|NCT01373970|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110867270|NCT01373970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110867271|NCT01373970|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110867272|NCT01373970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110351510|NCT00532662|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110867273|NCT01373970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110867275|NCT04050098|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110867276|NCT04050098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110867277|NCT03745625|Propofol|propofol|mesh-list
110867278|NCT03745625|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110867279|NCT03745625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110867280|NCT03745625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110867281|NCT03745625|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110867282|NCT03745625|Anesthetics, General|anesthetics, general|mesh-ancestor
110867283|NCT03745625|Anesthetics|anesthetics|mesh-ancestor
110867284|NCT03698630|Dexamethasone|dexamethasone|mesh-list
110867285|NCT03698630|Prednisolone|prednisolone|mesh-list
110867286|NCT03698630|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110867287|NCT03698630|Methylprednisolone|methylprednisolone|mesh-list
110867288|NCT03698630|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110867289|NCT03698630|Prednisolone acetate|prednisolone acetate|mesh-list
110867290|NCT03698630|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110867291|NCT03698630|Prednisolone phosphate|prednisolone phosphate|mesh-list
110867292|NCT03698630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110867293|NCT03698630|Antiemetics|antiemetics|mesh-ancestor
110867294|NCT03698630|Autonomic Agents|autonomic agents|mesh-ancestor
110867295|NCT03698630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110867296|NCT03698630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110867297|NCT03698630|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110867298|NCT03698630|Glucocorticoids|glucocorticoids|mesh-ancestor
110867299|NCT03698630|Hormones|hormones|mesh-ancestor
110867300|NCT03698630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110867301|NCT03698630|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110867302|NCT03698630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110867303|NCT03698630|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110867304|NCT03698630|Protective Agents|protective agents|mesh-ancestor
110867305|NCT01375452|Letrozole|letrozole|mesh-list
110867306|NCT01375452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110867307|NCT01375452|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110867308|NCT01375452|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110867309|NCT01375452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110867310|NCT01375452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110867311|NCT01375452|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110867312|NCT01375452|Hormone Antagonists|hormone antagonists|mesh-ancestor
110867313|NCT01375452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110867314|NCT01375452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110867316|NCT03046836|Oxytocics|oxytocics|mesh-ancestor
110867317|NCT03046836|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110867318|NCT03046836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110867319|NCT03400033|Epoetin Alfa|epoetin alfa|mesh-list
110867320|NCT03400033|Hematinics|hematinics|mesh-ancestor
110867321|NCT05123820|Midazolam|midazolam|mesh-list
110867322|NCT05123820|Omeprazole|omeprazole|mesh-list
110867323|NCT05123820|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110867324|NCT05123820|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110867325|NCT05123820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110867326|NCT05123820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110867327|NCT05123820|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110867328|NCT05123820|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110867329|NCT05123820|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110867330|NCT05123820|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110867331|NCT05123820|Anesthetics, General|anesthetics, general|mesh-ancestor
110867332|NCT05123820|Anesthetics|anesthetics|mesh-ancestor
110867333|NCT05123820|GABA Modulators|gaba modulators|mesh-ancestor
110867334|NCT05123820|GABA Agents|gaba agents|mesh-ancestor
110867335|NCT05123820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110867336|NCT05123820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110867337|NCT05123820|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110867338|NCT05123820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110867339|NCT05123820|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110867340|NCT05123820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110867341|NCT03118518|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
110867342|NCT02876835|Darbepoetin alfa|darbepoetin alfa|mesh-list
110867343|NCT02876835|Hematinics|hematinics|mesh-ancestor
110867344|NCT03503318|Risperidone|risperidone|mesh-list
110867345|NCT03503318|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110867346|NCT03503318|Serotonin Agents|serotonin agents|mesh-ancestor
110867347|NCT03503318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110351885|NCT04686890|Acetaminophen|acetaminophen|mesh-list
110867348|NCT03503318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110867349|NCT03503318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110867350|NCT03503318|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110867351|NCT03503318|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110351955|NCT04687163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110867352|NCT03503318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110867353|NCT03503318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110867354|NCT03503318|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110867355|NCT03503318|Dopamine Agents|dopamine agents|mesh-ancestor
110867356|NCT01375920|Metyrapone|metyrapone|mesh-list
110867357|NCT01375920|Antimetabolites|antimetabolites|mesh-ancestor
110867358|NCT01375920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110867359|NCT01375920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110867360|NCT03683108|Resveratrol|resveratrol|mesh-list
110867361|NCT03683108|Antioxidants|antioxidants|mesh-ancestor
110867362|NCT03683108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110867363|NCT03683108|Protective Agents|protective agents|mesh-ancestor
110867364|NCT03683108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110867365|NCT03683108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110867366|NCT03683108|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110867367|NCT05137860|Bortezomib|bortezomib|mesh-list
110867368|NCT05137860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110867369|NCT03682952|Alprostadil|alprostadil|mesh-list
110867370|NCT03682952|Beraprost|beraprost|mesh-list
110867371|NCT03682952|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110867372|NCT03682952|Vasodilator Agents|vasodilator agents|mesh-ancestor
110867373|NCT03682952|Urological Agents|urological agents|mesh-ancestor
110867374|NCT03682718|Misoprostol|misoprostol|mesh-list
110867375|NCT03682718|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110867376|NCT03682718|Abortifacient Agents|abortifacient agents|mesh-ancestor
110867377|NCT03682718|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110867378|NCT03682718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110867379|NCT03682718|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110867380|NCT03682718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110867381|NCT03682718|Oxytocics|oxytocics|mesh-ancestor
110867382|NCT03682640|Insulin|insulin|mesh-list
110867383|NCT03682640|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110867384|NCT03682640|Insulin Lispro|insulin lispro|mesh-list
110867385|NCT03682640|Azithromycin|azithromycin|mesh-list
110867386|NCT03682640|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110584892|NCT04110587|Analgesics|analgesics|mesh-list
110867387|NCT03682640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110867388|NCT03682640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110867389|NCT03682640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110867390|NCT01376076|Moxifloxacin|moxifloxacin|mesh-list
110867391|NCT01376076|Risperidone|risperidone|mesh-list
110867392|NCT01376076|Cariprazine|cariprazine|mesh-list
110867393|NCT01376076|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
110867394|NCT01376076|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110867395|NCT01376076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110867396|NCT01376076|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110867397|NCT01376076|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110867398|NCT01376076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110867399|NCT01376076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110352222|NCT00533247|Analgesics|analgesics|mesh-ancestor
110867400|NCT01376076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110867401|NCT01376076|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110867402|NCT01376076|Contraceptive Agents|contraceptive agents|mesh-ancestor
110867403|NCT01376076|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110867404|NCT01376076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110867405|NCT01376076|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110867406|NCT01376076|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110352353|NCT05469035|Heparin|heparin|mesh-list
110867407|NCT01376076|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110867408|NCT01376076|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110867409|NCT01376076|Serotonin Agents|serotonin agents|mesh-ancestor
110867410|NCT01376076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110867411|NCT01376076|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110867412|NCT01376076|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110867413|NCT01376076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110867414|NCT01376076|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110867415|NCT01376076|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110867416|NCT01376076|Dopamine Agents|dopamine agents|mesh-ancestor
110867417|NCT03395353|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110867418|NCT03395353|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110867419|NCT03395353|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110867420|NCT03395353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110352496|NCT05468645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110867421|NCT03395353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110867422|NCT03395353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110867423|NCT03395353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110867424|NCT03395353|Analgesics|analgesics|mesh-ancestor
110867425|NCT03395353|Sensory System Agents|sensory system agents|mesh-ancestor
110867426|NCT03395353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110867427|NCT03395353|Antidepressive Agents|antidepressive agents|mesh-ancestor
110867428|NCT03395353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110867429|NCT03395353|Dopamine Agents|dopamine agents|mesh-ancestor
110867431|NCT01376154|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110867432|NCT01376154|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110867433|NCT01376154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110867434|NCT01376154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110867435|NCT01376154|Antiviral Agents|antiviral agents|mesh-ancestor
110867436|NCT01376154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110867437|NCT01376154|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110867438|NCT01376154|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110867439|NCT01562951|Adalimumab|adalimumab|mesh-list
110867440|NCT01562951|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110867441|NCT01562951|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110867442|NCT01562951|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110867443|NCT01375842|Atezolizumab|atezolizumab|mesh-list
110867444|NCT01375842|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110352695|NCT05467826|Ribavirin|ribavirin|mesh-list
110867445|NCT01375842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110867446|NCT01375842|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110867447|NCT01375842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110867448|NCT03682367|Gabapentin|gabapentin|mesh-list
110867449|NCT03682367|Analgesics|analgesics|mesh-ancestor
110867450|NCT03682367|Sensory System Agents|sensory system agents|mesh-ancestor
110867451|NCT03682367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110867452|NCT03682367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110867453|NCT03682367|Anticonvulsants|anticonvulsants|mesh-ancestor
110867454|NCT03682367|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110867455|NCT03682367|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110867456|NCT03682367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110867457|NCT03682367|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110867458|NCT03682367|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110867459|NCT03682367|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110867460|NCT03682367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110867461|NCT03682367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110867462|NCT03682367|Antimanic Agents|antimanic agents|mesh-ancestor
110867463|NCT05170464|Caffeine|caffeine|mesh-list
110867464|NCT05170464|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110867465|NCT05170464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110867466|NCT05170464|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110867467|NCT05170464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110867468|NCT05170464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110867469|NCT05170464|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110867470|NCT05170464|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110867471|NCT05170464|Purinergic Agents|purinergic agents|mesh-ancestor
110867472|NCT05170464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110867473|NCT03677492|Cytochalasin D|cytochalasin d|mesh-list
110867474|NCT03677492|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110867475|NCT03677492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110867476|NCT03677492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110867477|NCT03394885|Paclitaxel|paclitaxel|mesh-list
110867478|NCT03394885|Bevacizumab|bevacizumab|mesh-list
110867479|NCT03394885|Carboplatin|carboplatin|mesh-list
110867480|NCT03394885|Atezolizumab|atezolizumab|mesh-list
110867481|NCT03394885|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110867482|NCT03394885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110867483|NCT03394885|Tubulin Modulators|tubulin modulators|mesh-ancestor
110867484|NCT03394885|Antimitotic Agents|antimitotic agents|mesh-ancestor
110867485|NCT03394885|Mitosis Modulators|mitosis modulators|mesh-ancestor
110867486|NCT03394885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110352953|NCT00537251|Insulin Glargine|insulin glargine|mesh-list
110867487|NCT03394885|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110867488|NCT03394885|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110867489|NCT03394885|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110867490|NCT03394885|Growth Substances|growth substances|mesh-ancestor
110867491|NCT03394885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110867492|NCT03394885|Growth Inhibitors|growth inhibitors|mesh-ancestor
110867493|NCT03394885|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110867494|NCT01361373|Levodopa|levodopa|mesh-list
110867495|NCT01361373|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110867496|NCT01361373|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110867497|NCT01361373|Dopamine Agents|dopamine agents|mesh-ancestor
110867498|NCT01361373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110867499|NCT01361373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110867500|NCT01361373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110867501|NCT03677336|Progesterone|progesterone|mesh-list
110867502|NCT03677336|Dydrogesterone|dydrogesterone|mesh-list
110867503|NCT03677336|Progestins|progestins|mesh-ancestor
110867504|NCT03677336|Hormones|hormones|mesh-ancestor
110867505|NCT03677336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110867506|NCT03677336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110867508|NCT02877927|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110867509|NCT02877927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110867510|NCT02877927|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110867511|NCT02877927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110867512|NCT02877927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110867513|NCT02706886|Lumasiran|lumasiran|mesh-list
110867514|NCT02706886|Renal Agents|renal agents|mesh-ancestor
110867515|NCT02809131|Levofloxacin|levofloxacin|mesh-list
110867516|NCT02809131|Clindamycin|clindamycin|mesh-list
110867517|NCT02809131|Clindamycin palmitate|clindamycin palmitate|mesh-list
110867518|NCT02809131|Clindamycin phosphate|clindamycin phosphate|mesh-list
110867519|NCT02809131|Cephalexin|cephalexin|mesh-list
110867520|NCT02809131|Polymyxins|polymyxins|mesh-list
110353142|NCT04943757|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110353143|NCT04943757|Alkylating Agents|alkylating agents|mesh-ancestor
110353144|NCT04943757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110353145|NCT04943757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110867521|NCT02809131|Bacitracin|bacitracin|mesh-list
110867522|NCT02809131|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110867523|NCT02809131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110867524|NCT02809131|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110867525|NCT02809131|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110867526|NCT02809131|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110867527|NCT02809131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110867528|NCT02809131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110867529|NCT02809131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110867530|NCT02809131|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110867531|NCT02809131|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110867532|NCT02809131|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110867533|NCT02809131|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110867534|NCT05032950|Ritonavir|ritonavir|mesh-list
110867535|NCT05032950|Nirmatrelvir|nirmatrelvir|mesh-list
110867536|NCT05032950|Midazolam|midazolam|mesh-list
110867537|NCT05032950|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110867538|NCT05032950|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110585038|NCT03116997|Glycopyrrolate|glycopyrrolate|mesh-list
110867539|NCT05032950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110867540|NCT05032950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110867541|NCT05032950|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110867542|NCT05032950|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110867543|NCT05032950|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110867544|NCT05032950|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110867545|NCT05032950|Anesthetics, General|anesthetics, general|mesh-ancestor
110867547|NCT05032950|GABA Modulators|gaba modulators|mesh-ancestor
110867548|NCT05032950|GABA Agents|gaba agents|mesh-ancestor
110867549|NCT05032950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110867550|NCT05032950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110867551|NCT05032950|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110867552|NCT05032950|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110867553|NCT05032950|Protease Inhibitors|protease inhibitors|mesh-ancestor
110867554|NCT05032950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110867555|NCT05032950|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110867556|NCT05032950|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110867557|NCT05032950|Antiviral Agents|antiviral agents|mesh-ancestor
110867558|NCT05032950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110867559|NCT05032950|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110867560|NCT05032950|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110867561|NCT01442649|Leucovorin|leucovorin|mesh-list
110867562|NCT01442649|Folic Acid|folic acid|mesh-list
110867563|NCT01442649|Bevacizumab|bevacizumab|mesh-list
110867564|NCT01442649|Cetuximab|cetuximab|mesh-list
110353627|NCT01252186|Hormones|hormones|mesh-ancestor
110867565|NCT01442649|Oxaliplatin|oxaliplatin|mesh-list
110867567|NCT01442649|Fluorouracil|fluorouracil|mesh-list
110867568|NCT01442649|Levoleucovorin|levoleucovorin|mesh-list
110867569|NCT01442649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110867570|NCT01442649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110867571|NCT01442649|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110867572|NCT01442649|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110867573|NCT01442649|Growth Substances|growth substances|mesh-ancestor
110867574|NCT01442649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110834728|NCT01568294|Pomalidomide|pomalidomide|mesh-list
110867575|NCT01442649|Growth Inhibitors|growth inhibitors|mesh-ancestor
110867576|NCT01442649|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110867577|NCT01442649|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110867578|NCT01442649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110867579|NCT01442649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110867581|NCT01442649|Protective Agents|protective agents|mesh-ancestor
110867582|NCT01442649|Vitamin B Complex|vitamin b complex|mesh-ancestor
110867583|NCT01442649|Vitamins|vitamins|mesh-ancestor
110867584|NCT01442649|Micronutrients|micronutrients|mesh-ancestor
110867585|NCT01442649|Hematinics|hematinics|mesh-ancestor
110867586|NCT01442649|Antimetabolites|antimetabolites|mesh-ancestor
110867587|NCT01442649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110867588|NCT01442649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110353842|NCT05264142|Omeprazole|omeprazole|mesh-list
110867589|NCT01442649|Immunologic Factors|immunologic factors|mesh-ancestor
110867590|NCT04995120|Paclitaxel|paclitaxel|mesh-list
110867591|NCT04995120|Cisplatin|cisplatin|mesh-list
110867592|NCT04995120|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110867593|NCT04995120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110867594|NCT04995120|Tubulin Modulators|tubulin modulators|mesh-ancestor
110867595|NCT04995120|Antimitotic Agents|antimitotic agents|mesh-ancestor
110867596|NCT04995120|Mitosis Modulators|mitosis modulators|mesh-ancestor
110867597|NCT04995120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110867598|NCT01376232|Gemfibrozil|gemfibrozil|mesh-list
110867599|NCT01376232|Glycine|glycine|mesh-list
110867600|NCT01376232|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110867601|NCT01376232|Antimetabolites|antimetabolites|mesh-ancestor
110867602|NCT01376232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110867603|NCT01376232|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110867604|NCT01376232|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
110867605|NCT01376232|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110867606|NCT01376232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110867607|NCT01376232|Glycine Agents|glycine agents|mesh-ancestor
110867608|NCT01376232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110867609|NCT01376232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110867610|NCT01354665|Interferons|interferons|mesh-list
110867611|NCT01354665|Interferon-beta|interferon-beta|mesh-list
110867612|NCT01354665|Interferon beta-1b|interferon beta-1b|mesh-list
110867613|NCT01354665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110867614|NCT01354665|Antiviral Agents|antiviral agents|mesh-ancestor
110867615|NCT01354665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110867616|NCT01354665|Immunologic Factors|immunologic factors|mesh-ancestor
110867617|NCT01354665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110867618|NCT01354665|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110867620|NCT01354743|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110867621|NCT01354743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110867622|NCT01354743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110867623|NCT01354743|Cholinergic Agents|cholinergic agents|mesh-ancestor
110867624|NCT01354743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110867625|NCT01354743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110867626|NCT05008575|Fludarabine|fludarabine|mesh-list
110867627|NCT05008575|Cyclophosphamide|cyclophosphamide|mesh-list
110867628|NCT05008575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110867629|NCT05008575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110867630|NCT05008575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110867631|NCT05008575|Immunologic Factors|immunologic factors|mesh-ancestor
110867632|NCT05008575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110867633|NCT05008575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110867634|NCT05008575|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110867635|NCT05008575|Alkylating Agents|alkylating agents|mesh-ancestor
110867636|NCT05008575|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110867637|NCT01319487|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110867638|NCT01319487|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110867640|NCT03111108|Antiviral Agents|antiviral agents|mesh-ancestor
110867641|NCT03111108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110867642|NCT00702520|Triptorelin Pamoate|triptorelin pamoate|mesh-list
110867643|NCT00702520|Hormones|hormones|mesh-list
110354226|NCT00545961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110867645|NCT00702520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110354290|NCT01263925|Vasodilator Agents|vasodilator agents|mesh-ancestor
110867646|NCT00702520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110867647|NCT00702520|Luteolytic Agents|luteolytic agents|mesh-ancestor
110867648|NCT00702520|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110867649|NCT00702520|Contraceptive Agents|contraceptive agents|mesh-ancestor
110867650|NCT00702520|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110867651|NCT00702520|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110867652|NCT00702520|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110867653|NCT00702520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110867654|NCT05198856|Thalidomide|thalidomide|mesh-list
110867655|NCT05198856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110867656|NCT05198856|Immunologic Factors|immunologic factors|mesh-ancestor
110867657|NCT05198856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110867658|NCT05198856|Leprostatic Agents|leprostatic agents|mesh-ancestor
110867659|NCT05198856|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110867660|NCT05198856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110867661|NCT05198856|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110867662|NCT05198856|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110867663|NCT05198856|Growth Substances|growth substances|mesh-ancestor
110867664|NCT05198856|Growth Inhibitors|growth inhibitors|mesh-ancestor
110867665|NCT05198856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110366964|NCT00549107|Simendan|simendan|mesh-list
110867666|NCT02876601|Defibrotide|defibrotide|mesh-list
110867667|NCT02876601|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110867668|NCT02876601|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110867669|NCT02876601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110867670|NCT02876601|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110867672|NCT04059536|Heparin|heparin|mesh-list
110867673|NCT04059536|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110867674|NCT04059536|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110867675|NCT04059536|Analgesics|analgesics|mesh-ancestor
110867676|NCT04059536|Sensory System Agents|sensory system agents|mesh-ancestor
110867677|NCT04059536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110867678|NCT04059536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110867679|NCT04059536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110867680|NCT04059536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110867681|NCT04059536|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110867682|NCT04059536|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110867683|NCT04059536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110867684|NCT04059536|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110867685|NCT04059536|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110867686|NCT04059536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110867687|NCT04059536|Antipyretics|antipyretics|mesh-ancestor
110867688|NCT04059536|Anticoagulants|anticoagulants|mesh-ancestor
110867689|NCT03178396|Melatonin|melatonin|mesh-list
110867690|NCT03178396|Antioxidants|antioxidants|mesh-ancestor
110867691|NCT03178396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110867692|NCT03178396|Protective Agents|protective agents|mesh-ancestor
110867693|NCT03178396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110867694|NCT03178396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110867695|NCT03677258|Hyaluronic Acid|hyaluronic acid|mesh-list
110867696|NCT03677258|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110867697|NCT03677258|Immunologic Factors|immunologic factors|mesh-ancestor
110867698|NCT03677258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110867699|NCT03677258|Viscosupplements|viscosupplements|mesh-ancestor
110867700|NCT03677258|Protective Agents|protective agents|mesh-ancestor
110867702|NCT01361763|Antithrombins|antithrombins|mesh-ancestor
110867703|NCT01361763|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110867704|NCT01361763|Protease Inhibitors|protease inhibitors|mesh-ancestor
110867705|NCT01361763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110867706|NCT01361763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110867707|NCT01361763|Anticoagulants|anticoagulants|mesh-ancestor
110867708|NCT02420782|Itraconazole|itraconazole|mesh-list
110867710|NCT02420782|Pilocarpine|pilocarpine|mesh-list
110867711|NCT02420782|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110867712|NCT02420782|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110867713|NCT02420782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110867714|NCT02420782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110867715|NCT02420782|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110867716|NCT02420782|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110867717|NCT02420782|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110867718|NCT02420782|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110867719|NCT02420782|Anesthetics, General|anesthetics, general|mesh-ancestor
110867720|NCT02420782|Anesthetics|anesthetics|mesh-ancestor
110867721|NCT02420782|GABA Modulators|gaba modulators|mesh-ancestor
110867722|NCT02420782|GABA Agents|gaba agents|mesh-ancestor
110867723|NCT02420782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110867724|NCT02420782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110867725|NCT02420782|Antifungal Agents|antifungal agents|mesh-ancestor
110867726|NCT02420782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110867727|NCT02420782|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110867728|NCT02420782|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110867729|NCT02420782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110867730|NCT02420782|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110867731|NCT02420782|Hormone Antagonists|hormone antagonists|mesh-ancestor
110867732|NCT02420782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110867733|NCT02420782|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110867734|NCT02420782|Miotics|miotics|mesh-ancestor
110867735|NCT02420782|Autonomic Agents|autonomic agents|mesh-ancestor
110867736|NCT02420782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110867737|NCT02420782|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
110354871|NCT04682132|Antibodies|antibodies|mesh-list
110867738|NCT02420782|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110867739|NCT02420782|Cholinergic Agents|cholinergic agents|mesh-ancestor
110867740|NCT04054193|Dexamethasone|dexamethasone|mesh-list
110867741|NCT04054193|Fosaprepitant|fosaprepitant|mesh-list
110867742|NCT04054193|Aprepitant|aprepitant|mesh-list
110867743|NCT04054193|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-list
110867744|NCT04054193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110867745|NCT04054193|Antiemetics|antiemetics|mesh-ancestor
110867746|NCT04054193|Autonomic Agents|autonomic agents|mesh-ancestor
110867747|NCT04054193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110867748|NCT04054193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110867749|NCT04054193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110867750|NCT04054193|Glucocorticoids|glucocorticoids|mesh-ancestor
110867751|NCT04054193|Hormones|hormones|mesh-ancestor
110867752|NCT04054193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110867753|NCT04054193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110867754|NCT04054193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110867755|NCT04054193|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110867756|NCT04054193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110867757|NCT04054193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110867758|NCT04054193|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110867759|NCT04054193|Serotonin Agents|serotonin agents|mesh-ancestor
110867760|NCT03394027|TIC10 compound|tic10 compound|mesh-list
110867761|NCT03394027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110867762|NCT03682172|Glucagon|glucagon|mesh-list
110867763|NCT03682172|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
110867764|NCT03682172|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110585267|NCT04072263|Antimitotic Agents|antimitotic agents|mesh-ancestor
110176341|NCT00080275|Niacin|niacin|mesh-list
110867765|NCT03682172|Hormones|hormones|mesh-ancestor
110867766|NCT03682172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110867767|NCT03682172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110867768|NCT03682172|Incretins|incretins|mesh-ancestor
110867769|NCT03184480|Fluticasone|fluticasone|mesh-list
110867770|NCT03184480|Xhance|xhance|mesh-list
110867771|NCT03184480|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110867772|NCT03184480|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110867774|NCT03184480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110867775|NCT03184480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110867776|NCT03184480|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110867777|NCT03184480|Respiratory System Agents|respiratory system agents|mesh-ancestor
110867778|NCT03184480|Dermatologic Agents|dermatologic agents|mesh-ancestor
110867779|NCT03184480|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110867780|NCT03136107|Sunscreening Agents|sunscreening agents|mesh-list
110867781|NCT03136107|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110867782|NCT03136107|Protective Agents|protective agents|mesh-ancestor
110867783|NCT03136107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110366995|NCT00549146|Hormones|hormones|mesh-ancestor
110867784|NCT03136107|Dermatologic Agents|dermatologic agents|mesh-ancestor
110867785|NCT03686774|Memantine|memantine|mesh-list
110867786|NCT03686774|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110867787|NCT03686774|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110867788|NCT03686774|Dopamine Agents|dopamine agents|mesh-ancestor
110867789|NCT03686774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110867790|NCT03686774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110867791|NCT03686774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110867792|NCT03686774|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110867793|NCT03686774|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110867795|NCT02420392|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110867796|NCT02420392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110867797|NCT02420392|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110867798|NCT02420392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110867799|NCT01562795|Fluorometholone|fluorometholone|mesh-list
110867800|NCT01562795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
110867801|NCT01562795|Lubricant Eye Drops|lubricant eye drops|mesh-list
110867802|NCT01562795|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110867803|NCT01562795|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110867804|NCT01562795|Glucocorticoids|glucocorticoids|mesh-ancestor
110867805|NCT01562795|Hormones|hormones|mesh-ancestor
110355453|NCT03455764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110867806|NCT01562795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110867807|NCT01562795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110867808|NCT01562795|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110867809|NCT02424136|Nitric Oxide|nitric oxide|mesh-list
110867810|NCT02424136|Immunoglobulins|immunoglobulins|mesh-list
110867811|NCT02424136|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110867812|NCT02424136|Antibodies|antibodies|mesh-list
110867813|NCT02424136|Immunologic Factors|immunologic factors|mesh-ancestor
110867814|NCT02424136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110867815|NCT02424136|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110867816|NCT02424136|Autonomic Agents|autonomic agents|mesh-ancestor
110867817|NCT02424136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110867818|NCT02424136|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110867819|NCT02424136|Respiratory System Agents|respiratory system agents|mesh-ancestor
110355605|NCT00550992|Glucocorticoids|glucocorticoids|mesh-ancestor
110867820|NCT02424136|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110867822|NCT02424136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110867823|NCT02424136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110867824|NCT02424136|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
110867825|NCT02424136|Vasodilator Agents|vasodilator agents|mesh-ancestor
110867826|NCT02424136|Gasotransmitters|gasotransmitters|mesh-ancestor
110867827|NCT02424136|Protective Agents|protective agents|mesh-ancestor
110867828|NCT03770676|Selenium|selenium|mesh-list
110867829|NCT03770676|Antioxidants|antioxidants|mesh-ancestor
110867830|NCT03770676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110867831|NCT03770676|Protective Agents|protective agents|mesh-ancestor
110867832|NCT03770676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110867833|NCT03770676|Trace Elements|trace elements|mesh-ancestor
110867834|NCT03770676|Micronutrients|micronutrients|mesh-ancestor
110867835|NCT01361841|Bimatoprost|bimatoprost|mesh-list
110867836|NCT01361841|Travoprost|travoprost|mesh-list
110867837|NCT01361841|Latanoprost|latanoprost|mesh-list
110867838|NCT01361841|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110867839|NCT01361841|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110867840|NCT01361841|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110867841|NCT02583789|Treprostinil|treprostinil|mesh-list
110867842|NCT02583789|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110867844|NCT01355367|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110867845|NCT01355367|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110355804|NCT01099449|Tocolytic Agents|tocolytic agents|mesh-ancestor
110867846|NCT01355367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110867847|NCT01355367|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110867848|NCT01355367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110867849|NCT01355367|Vasodilator Agents|vasodilator agents|mesh-ancestor
110867850|NCT01355367|Tocolytic Agents|tocolytic agents|mesh-ancestor
110867851|NCT01355367|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110867852|NCT05759520|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110867853|NCT05759520|Immunologic Factors|immunologic factors|mesh-ancestor
110867854|NCT05759520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110867855|NCT02427880|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110867856|NCT02427880|Furosemide|furosemide|mesh-list
110867857|NCT02427880|Acetazolamide|acetazolamide|mesh-list
110867858|NCT02427880|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110867859|NCT02427880|Diuretics|diuretics|mesh-ancestor
110867860|NCT02427880|Natriuretic Agents|natriuretic agents|mesh-ancestor
110867861|NCT02427880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110867862|NCT02427880|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110867863|NCT02427880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110867864|NCT02427880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110867865|NCT02427880|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110867867|NCT02427880|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110867869|NCT01355445|Irinotecan|irinotecan|mesh-list
110867870|NCT01355445|Vincristine|vincristine|mesh-list
110867871|NCT01355445|Temozolomide|temozolomide|mesh-list
110867872|NCT01355445|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110867873|NCT01355445|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110867874|NCT01355445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110355995|NCT05288907|Anesthetics|anesthetics|mesh-ancestor
110867875|NCT01355445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110867876|NCT01355445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110867877|NCT01355445|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110867878|NCT01355445|Tubulin Modulators|tubulin modulators|mesh-ancestor
110867879|NCT01355445|Antimitotic Agents|antimitotic agents|mesh-ancestor
110867880|NCT01355445|Mitosis Modulators|mitosis modulators|mesh-ancestor
110867881|NCT01355445|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110867882|NCT01355445|Alkylating Agents|alkylating agents|mesh-ancestor
110867883|NCT02420080|Brincidofovir|brincidofovir|mesh-list
110867884|NCT02420080|Antiviral Agents|antiviral agents|mesh-ancestor
110867885|NCT02420080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110867886|NCT04483258|Sevoflurane|sevoflurane|mesh-list
110867887|NCT04483258|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110867888|NCT04483258|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110867889|NCT04483258|Anesthetics, General|anesthetics, general|mesh-ancestor
110867890|NCT04483258|Anesthetics|anesthetics|mesh-ancestor
110867891|NCT04483258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110867892|NCT04483258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110867893|NCT01355757|Anesthetics|anesthetics|mesh-list
110867894|NCT01355757|Anesthetics, Local|anesthetics, local|mesh-list
110867895|NCT01355757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110867896|NCT01355757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110867897|NCT01355757|Sensory System Agents|sensory system agents|mesh-ancestor
110867898|NCT01355757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110867899|NCT02507505|Anesthetics|anesthetics|mesh-list
110867900|NCT02507505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110867901|NCT02507505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110867902|NCT03181360|Tenecteplase|tenecteplase|mesh-list
110867903|NCT03181360|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110867904|NCT03181360|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110867905|NCT03181360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110867906|NCT04275531|Anesthetics|anesthetics|mesh-list
110867907|NCT04275531|Propofol|propofol|mesh-list
110867908|NCT04275531|Sevoflurane|sevoflurane|mesh-list
110867909|NCT04275531|Isoflurane|isoflurane|mesh-list
110867910|NCT04275531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110867911|NCT04275531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110867912|NCT04275531|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110867913|NCT04275531|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110867914|NCT04275531|Anesthetics, General|anesthetics, general|mesh-ancestor
110867915|NCT04275531|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110867917|NCT03689712|Manganese|manganese|mesh-list
110867918|NCT03689712|Avasopasem manganese|avasopasem manganese|mesh-list
110867919|NCT03689712|Trace Elements|trace elements|mesh-ancestor
110867920|NCT03689712|Micronutrients|micronutrients|mesh-ancestor
110867921|NCT03689712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110867922|NCT03689712|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110867923|NCT03689712|Antioxidants|antioxidants|mesh-ancestor
110834755|NCT03453190|Glucocorticoids|glucocorticoids|mesh-ancestor
110867924|NCT03689712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110867925|NCT03689712|Protective Agents|protective agents|mesh-ancestor
110867927|NCT01361997|Chlorhexidine|chlorhexidine|mesh-list
110867928|NCT01361997|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110867929|NCT01361997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110867930|NCT01361997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110867931|NCT01361997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110867932|NCT01361997|Disinfectants|disinfectants|mesh-ancestor
110867933|NCT04750824|Afatinib|afatinib|mesh-list
110867934|NCT04750824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110867935|NCT04750824|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110867936|NCT04750824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110867937|NCT04750824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110867938|NCT03180970|Lugol's solution|lugol's solution|mesh-list
110867939|NCT03180970|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110867940|NCT03180970|Hemostatics|hemostatics|mesh-ancestor
110867941|NCT03180970|Coagulants|coagulants|mesh-ancestor
110867942|NCT03631446|Picosulfate sodium|picosulfate sodium|mesh-list
110867943|NCT03631446|Magnesium Oxide|magnesium oxide|mesh-list
110867944|NCT03631446|Citric Acid|citric acid|mesh-list
110867945|NCT03631446|Sodium Citrate|sodium citrate|mesh-list
110867946|NCT03631446|Cathartics|cathartics|mesh-ancestor
110867947|NCT03631446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110867948|NCT03631446|Anticoagulants|anticoagulants|mesh-ancestor
110867949|NCT03631446|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110867950|NCT03631446|Chelating Agents|chelating agents|mesh-ancestor
110867951|NCT03631446|Sequestering Agents|sequestering agents|mesh-ancestor
110867952|NCT03631446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110867953|NCT03631446|Antacids|antacids|mesh-ancestor
110867954|NCT01362153|Golimumab|golimumab|mesh-list
110867955|NCT01362153|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110867956|NCT01362153|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110867957|NCT01362153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110867958|NCT01362153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110867959|NCT01362153|Immunologic Factors|immunologic factors|mesh-ancestor
110867960|NCT01362153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110867961|NCT03184324|Esomeprazole|esomeprazole|mesh-list
110867962|NCT03184324|Fexuprazan|fexuprazan|mesh-list
110867963|NCT03184324|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110867964|NCT03184324|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110867965|NCT03184324|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110867966|NCT03184324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110356367|NCT00554528|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110867967|NCT03184324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110867968|NCT02427334|Dienogest|dienogest|mesh-list
110867969|NCT02427334|Fluoxetine|fluoxetine|mesh-list
110867970|NCT02427334|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110867971|NCT02427334|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110867972|NCT02427334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110867973|NCT02427334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110867974|NCT02427334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110867975|NCT02427334|Serotonin Agents|serotonin agents|mesh-ancestor
110867976|NCT02427334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110867977|NCT02427334|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110867978|NCT02427334|Antidepressive Agents|antidepressive agents|mesh-ancestor
110356500|NCT02224235|Antipyretics|antipyretics|mesh-ancestor
110867979|NCT02427334|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110867980|NCT02427334|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110867981|NCT02427334|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110867982|NCT02427334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110867983|NCT02427334|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110867984|NCT02427334|Contraceptive Agents|contraceptive agents|mesh-ancestor
110867986|NCT02427334|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110867987|NCT02427334|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110867988|NCT02427334|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110867989|NCT02427334|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110834760|NCT01231139|Analgesics|analgesics|mesh-ancestor
110867990|NCT02427334|Hormone Antagonists|hormone antagonists|mesh-ancestor
110867991|NCT02427334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110867992|NCT02427334|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110867993|NCT02427334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110867995|NCT03620253|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110867996|NCT03620253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110867997|NCT03620253|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
110867998|NCT03620253|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110867999|NCT03620253|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110356694|NCT01230814|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110868000|NCT03620253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110868001|NCT01355991|Tiotropium Bromide|tiotropium bromide|mesh-list
110868002|NCT01355991|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110868003|NCT01355991|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110868004|NCT01355991|Autonomic Agents|autonomic agents|mesh-ancestor
110868005|NCT01355991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110868006|NCT01355991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110868007|NCT01355991|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110356783|NCT04721457|Eusol|eusol|mesh-list
110868008|NCT01355991|Respiratory System Agents|respiratory system agents|mesh-ancestor
110868009|NCT01355991|Parasympatholytics|parasympatholytics|mesh-ancestor
110868010|NCT01355991|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110868011|NCT01355991|Cholinergic Agents|cholinergic agents|mesh-ancestor
110868012|NCT01355991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110868013|NCT01355991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110868014|NCT01355991|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110868015|NCT01355991|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110868016|NCT01355991|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110868017|NCT01355991|Adrenergic Agents|adrenergic agents|mesh-ancestor
110868019|NCT01358253|Dexamethasone|dexamethasone|mesh-list
110868020|NCT01358253|Prednisone|prednisone|mesh-list
110868021|NCT01358253|Cyclophosphamide|cyclophosphamide|mesh-list
110868022|NCT01358253|Rituximab|rituximab|mesh-list
110868023|NCT01358253|Doxorubicin|doxorubicin|mesh-list
110868024|NCT01358253|Methotrexate|methotrexate|mesh-list
110868025|NCT01358253|Vincristine|vincristine|mesh-list
110868026|NCT01358253|Asparaginase|asparaginase|mesh-list
110868027|NCT01358253|Mercaptopurine|mercaptopurine|mesh-list
110868028|NCT01358253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110868029|NCT01358253|Immunologic Factors|immunologic factors|mesh-ancestor
110868030|NCT01358253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110868031|NCT01358253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110868032|NCT01358253|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110868033|NCT01358253|Alkylating Agents|alkylating agents|mesh-ancestor
110868034|NCT01358253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110868035|NCT01358253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110868036|NCT01358253|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110367041|NCT00549536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110868037|NCT01358253|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110868038|NCT01358253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110868039|NCT01358253|Antiemetics|antiemetics|mesh-ancestor
110868040|NCT01358253|Autonomic Agents|autonomic agents|mesh-ancestor
110868041|NCT01358253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110868042|NCT01358253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110868043|NCT01358253|Glucocorticoids|glucocorticoids|mesh-ancestor
110868044|NCT01358253|Hormones|hormones|mesh-ancestor
110868045|NCT01358253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110868046|NCT01358253|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110868047|NCT01358253|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110868048|NCT01358253|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110868049|NCT01358253|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110868050|NCT01358253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110356838|NCT04665362|Apatinib|apatinib|mesh-list
110868051|NCT01358253|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110868052|NCT01358253|Abortifacient Agents|abortifacient agents|mesh-ancestor
110868053|NCT01358253|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110868054|NCT01358253|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110356861|NCT00557102|Leucovorin|leucovorin|mesh-list
110868055|NCT01358253|Antimetabolites|antimetabolites|mesh-ancestor
110868056|NCT01358253|Dermatologic Agents|dermatologic agents|mesh-ancestor
110868057|NCT01358253|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110868058|NCT01358253|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110868059|NCT01358253|Antiviral Agents|antiviral agents|mesh-ancestor
110868060|NCT01358253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110868061|NCT01358253|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110868062|NCT01358253|Tubulin Modulators|tubulin modulators|mesh-ancestor
110868063|NCT01358253|Antimitotic Agents|antimitotic agents|mesh-ancestor
110868064|NCT01358253|Mitosis Modulators|mitosis modulators|mesh-ancestor
110868065|NCT03180346|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
110868066|NCT03180346|Laxatives|laxatives|mesh-ancestor
110868067|NCT03180346|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110868068|NCT01356225|Ketorolac|ketorolac|mesh-list
110868069|NCT01356225|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
110868070|NCT01356225|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110868071|NCT01356225|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110868072|NCT01356225|Analgesics|analgesics|mesh-ancestor
110868073|NCT01356225|Sensory System Agents|sensory system agents|mesh-ancestor
110868074|NCT01356225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110868075|NCT01356225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110868076|NCT01356225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110868077|NCT01356225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110868078|NCT01356225|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110868079|NCT01356225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110868080|NCT01356225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110868081|NCT02427412|Tranexamic Acid|tranexamic acid|mesh-list
110868082|NCT02427412|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110868083|NCT02427412|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110868084|NCT02427412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110868085|NCT02427412|Hemostatics|hemostatics|mesh-ancestor
110868086|NCT02427412|Coagulants|coagulants|mesh-ancestor
110868087|NCT01356303|Docetaxel|docetaxel|mesh-list
110868088|NCT01356303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110868089|NCT01356303|Tubulin Modulators|tubulin modulators|mesh-ancestor
110868090|NCT01356303|Antimitotic Agents|antimitotic agents|mesh-ancestor
110868091|NCT01356303|Mitosis Modulators|mitosis modulators|mesh-ancestor
110868092|NCT01356303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110868093|NCT02220309|Pramipexole|pramipexole|mesh-list
110868094|NCT02220309|Antioxidants|antioxidants|mesh-ancestor
110868095|NCT02220309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110868096|NCT02220309|Protective Agents|protective agents|mesh-ancestor
110868097|NCT02220309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110868098|NCT02220309|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110868099|NCT02220309|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110868100|NCT02220309|Dopamine Agonists|dopamine agonists|mesh-ancestor
110868101|NCT02220309|Dopamine Agents|dopamine agents|mesh-ancestor
110868102|NCT02220309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110868103|NCT02419534|Diltiazem|diltiazem|mesh-list
110868104|NCT02419534|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110357116|NCT01208038|Anabolic Agents|anabolic agents|mesh-ancestor
110868105|NCT02419534|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110868106|NCT02419534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110868107|NCT02419534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110868108|NCT02419534|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110868109|NCT02419534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110868110|NCT02419534|Vasodilator Agents|vasodilator agents|mesh-ancestor
110868111|NCT03527316|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
110868112|NCT03527316|Hallucinogens|hallucinogens|mesh-ancestor
110868113|NCT03527316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110868114|NCT03527316|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110868115|NCT03527316|Serotonin Agents|serotonin agents|mesh-ancestor
110868116|NCT03527316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110868117|NCT03527316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110868118|NCT03527316|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110868119|NCT03527316|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110834774|NCT01137695|Amylin Receptor Agonists|amylin receptor agonists|mesh-ancestor
110868120|NCT03527316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110868121|NCT03527316|Adrenergic Agents|adrenergic agents|mesh-ancestor
110868122|NCT01358409|Nebivolol|nebivolol|mesh-list
110868123|NCT01358409|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110868124|NCT01358409|Vasodilator Agents|vasodilator agents|mesh-ancestor
110868125|NCT01358409|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
110868126|NCT01358409|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110868127|NCT01358409|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110868128|NCT01358409|Adrenergic Agents|adrenergic agents|mesh-ancestor
110868129|NCT01358409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110868130|NCT01358409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110868131|NCT01358409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110868132|NCT02423590|Carboplatin|carboplatin|mesh-list
110868133|NCT02423590|Gemcitabine|gemcitabine|mesh-list
110868134|NCT02423590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110868135|NCT02423590|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110868136|NCT02423590|Antimetabolites|antimetabolites|mesh-ancestor
110868137|NCT02423590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110868138|NCT01362309|Cycloserine|cycloserine|mesh-list
110868139|NCT01362309|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110868140|NCT01362309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110868141|NCT01362309|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110868142|NCT01362309|Antitubercular Agents|antitubercular agents|mesh-ancestor
110868143|NCT01362309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110868144|NCT01362309|Antimetabolites|antimetabolites|mesh-ancestor
110868145|NCT01362309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110868146|NCT03710863|Vorolanib|vorolanib|mesh-list
110868147|NCT03710863|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110868148|NCT03710863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110868149|NCT03710863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110868150|NCT03178084|Lamivudine|lamivudine|mesh-list
110868151|NCT03178084|Zidovudine|zidovudine|mesh-list
110868152|NCT03178084|Efavirenz|efavirenz|mesh-list
110868153|NCT03178084|Maraviroc|maraviroc|mesh-list
110868154|NCT03178084|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110868155|NCT03178084|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110868156|NCT03178084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110868157|NCT03178084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110868158|NCT03178084|Antiviral Agents|antiviral agents|mesh-ancestor
110868159|NCT03178084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110868160|NCT03178084|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110868161|NCT03178084|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110357384|NCT00541125|Vitamins|vitamins|mesh-ancestor
110868162|NCT03178084|Antimetabolites|antimetabolites|mesh-ancestor
110868163|NCT03178084|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110868164|NCT03178084|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110868165|NCT03178084|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110868166|NCT03178084|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110868167|NCT03178084|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110868168|NCT03178084|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110868169|NCT03178084|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110868170|NCT03178084|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110868171|NCT03178084|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
110868173|NCT01356381|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110868174|NCT01356381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110868175|NCT01356381|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110868176|NCT01356381|Protease Inhibitors|protease inhibitors|mesh-ancestor
110868177|NCT01356381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110868178|NCT01356381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110868179|NCT03117166|Lidocaine|lidocaine|mesh-list
110868180|NCT03117166|Anesthetics, Local|anesthetics, local|mesh-ancestor
110868181|NCT03117166|Anesthetics|anesthetics|mesh-ancestor
110868182|NCT03117166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110367093|NCT00550160|Antiviral Agents|antiviral agents|mesh-ancestor
110868183|NCT03117166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110868184|NCT03117166|Sensory System Agents|sensory system agents|mesh-ancestor
110868185|NCT03117166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110357491|NCT00541554|Dopamine Agents|dopamine agents|mesh-ancestor
110868186|NCT03117166|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110834781|NCT02528825|Narcotics|narcotics|mesh-ancestor
110868187|NCT03117166|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110868188|NCT03117166|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110868189|NCT03117166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110868190|NCT03117166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110868191|NCT03302286|Mannitol|mannitol|mesh-list
110357548|NCT02546583|Chlorothiazide|chlorothiazide|mesh-list
110868192|NCT03302286|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110868193|NCT03302286|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110868194|NCT03302286|Diuretics|diuretics|mesh-ancestor
110357619|NCT04653623|Hemostatics|hemostatics|mesh-ancestor
110868195|NCT03302286|Natriuretic Agents|natriuretic agents|mesh-ancestor
110868196|NCT03302286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110868197|NCT01356615|Heparin|heparin|mesh-list
110868198|NCT01356615|Calcium heparin|calcium heparin|mesh-list
110868199|NCT01356615|Enoxaparin|enoxaparin|mesh-list
110868200|NCT01356615|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
110868201|NCT01356615|Tinzaparin|tinzaparin|mesh-list
110868202|NCT01356615|Dalteparin|dalteparin|mesh-list
110868203|NCT01356615|Enoxaparin sodium|enoxaparin sodium|mesh-list
110868204|NCT01356615|Anticoagulants|anticoagulants|mesh-ancestor
110868205|NCT01356615|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110868206|NCT01356615|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110868207|NCT01356615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110868208|NCT03180190|Hydroxychloroquine|hydroxychloroquine|mesh-list
110868209|NCT03180190|Antimalarials|antimalarials|mesh-ancestor
110868210|NCT03180190|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110868211|NCT03180190|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110868212|NCT03180190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110585723|NCT04071639|Dopamine Agents|dopamine agents|mesh-ancestor
110868213|NCT03180190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110868214|NCT03180190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110868215|NCT03180190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110868216|NCT04583592|Gabexate|gabexate|mesh-list
110868217|NCT04583592|Camostat|camostat|mesh-list
110868218|NCT04583592|Protease Inhibitors|protease inhibitors|mesh-ancestor
110868219|NCT04583592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110868220|NCT04583592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110868221|NCT04583592|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
110868222|NCT04583592|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110868224|NCT02418988|Chlorotrianisene|chlorotrianisene|mesh-list
110868225|NCT02418988|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
110868226|NCT02418988|Estrogens|estrogens|mesh-ancestor
110868227|NCT02418988|Hormones|hormones|mesh-ancestor
110868228|NCT02418988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110868229|NCT02418988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110868231|NCT02418988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110868232|NCT01356927|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
110868233|NCT01356927|Etonogestrel|etonogestrel|mesh-list
110868234|NCT01356927|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110868235|NCT01356927|Contraceptive Agents|contraceptive agents|mesh-ancestor
110868236|NCT01356927|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110868237|NCT01356927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110868238|NCT01356927|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110868239|NCT01356927|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110868240|NCT01356927|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110868241|NCT01356927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110868242|NCT03439670|Prednisone|prednisone|mesh-list
110868243|NCT03439670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110868244|NCT03439670|Glucocorticoids|glucocorticoids|mesh-ancestor
110868245|NCT03439670|Hormones|hormones|mesh-ancestor
110868246|NCT03439670|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110868247|NCT03439670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110868248|NCT03439670|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110868249|NCT03439670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110868250|NCT02930343|Folic Acid|folic acid|mesh-list
110834787|NCT01233245|Interferons|interferons|mesh-list
110868252|NCT02930343|Sulfasalazine|sulfasalazine|mesh-list
110868253|NCT02930343|Prednisolone|prednisolone|mesh-list
110358013|NCT01239745|Exemestane|exemestane|mesh-list
110868254|NCT02930343|Methotrexate|methotrexate|mesh-list
110868255|NCT02930343|Leflunomide|leflunomide|mesh-list
110868256|NCT02930343|Glucocorticoids|glucocorticoids|mesh-list
110868257|NCT02930343|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110868258|NCT02930343|Abortifacient Agents|abortifacient agents|mesh-ancestor
110868259|NCT02930343|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110868260|NCT02930343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110358093|NCT01229449|Ibuprofen|ibuprofen|mesh-list
110868261|NCT02930343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110868262|NCT02930343|Antimetabolites|antimetabolites|mesh-ancestor
110868263|NCT02930343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110868264|NCT02930343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110868265|NCT02930343|Dermatologic Agents|dermatologic agents|mesh-ancestor
110868266|NCT02930343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110868267|NCT02930343|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110868268|NCT02930343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110868269|NCT02930343|Immunologic Factors|immunologic factors|mesh-ancestor
110868270|NCT02930343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110358149|NCT06021977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110358150|NCT06021951|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
110358151|NCT06021951|Ezetimibe|ezetimibe|mesh-list
110358152|NCT06021951|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110358153|NCT06021951|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110358154|NCT06021951|Antimetabolites|antimetabolites|mesh-ancestor
110358155|NCT06021951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110868271|NCT02930343|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110868272|NCT02930343|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110868273|NCT02930343|Hormones|hormones|mesh-ancestor
110868274|NCT02930343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110868275|NCT02930343|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110868276|NCT02930343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110868277|NCT02930343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110868278|NCT02930343|Antimalarials|antimalarials|mesh-ancestor
110868279|NCT02930343|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110868280|NCT02930343|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110868281|NCT02930343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110868282|NCT02930343|Hematinics|hematinics|mesh-ancestor
110868283|NCT02930343|Vitamin B Complex|vitamin b complex|mesh-ancestor
110868284|NCT02930343|Vitamins|vitamins|mesh-ancestor
110868285|NCT02930343|Micronutrients|micronutrients|mesh-ancestor
110868286|NCT02930343|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110868287|NCT02930343|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110868288|NCT02930343|Analgesics|analgesics|mesh-ancestor
110868289|NCT02930343|Sensory System Agents|sensory system agents|mesh-ancestor
110868291|NCT03686618|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110868292|NCT03686618|Hormones|hormones|mesh-ancestor
110868293|NCT03686618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110868294|NCT03686618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110868295|NCT02426866|Efavirenz|efavirenz|mesh-list
110868296|NCT02426866|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110868297|NCT02426866|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110868298|NCT02426866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110868299|NCT02426866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110868300|NCT02426866|Antiviral Agents|antiviral agents|mesh-ancestor
110868301|NCT02426866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110868302|NCT02426866|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110868303|NCT02426866|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110868304|NCT02426866|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110868305|NCT02426866|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110868306|NCT02426866|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110868307|NCT02426866|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110868309|NCT02423824|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110868310|NCT02423824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110868311|NCT02423824|Incretins|incretins|mesh-ancestor
110868313|NCT02423824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110868314|NCT01012167|Galantamine|galantamine|mesh-list
110868315|NCT01012167|Oxytocin|oxytocin|mesh-list
110868316|NCT01012167|Oxytocics|oxytocics|mesh-ancestor
110868317|NCT01012167|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110868318|NCT01012167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110868319|NCT01012167|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110358639|NCT05591755|Ketotifen|ketotifen|mesh-list
110868320|NCT01012167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110868321|NCT01012167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110868322|NCT01012167|Cholinergic Agents|cholinergic agents|mesh-ancestor
110868323|NCT01012167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110868324|NCT01012167|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110868325|NCT01012167|Autonomic Agents|autonomic agents|mesh-ancestor
110868326|NCT01012167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110868327|NCT01012167|Nootropic Agents|nootropic agents|mesh-ancestor
110868328|NCT02423278|Oxaliplatin|oxaliplatin|mesh-list
110868329|NCT02423278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110868330|NCT05189067|Paclitaxel|paclitaxel|mesh-list
110868331|NCT05189067|Docetaxel|docetaxel|mesh-list
110868332|NCT05189067|Trastuzumab|trastuzumab|mesh-list
110868333|NCT05189067|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110868334|NCT05189067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110868335|NCT05189067|Tubulin Modulators|tubulin modulators|mesh-ancestor
110868336|NCT05189067|Antimitotic Agents|antimitotic agents|mesh-ancestor
110868337|NCT05189067|Mitosis Modulators|mitosis modulators|mesh-ancestor
110868338|NCT05189067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110868339|NCT05189067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110868340|NCT03133767|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110868341|NCT02422966|Acetaminophen|acetaminophen|mesh-list
110868342|NCT02422966|Ibuprofen|ibuprofen|mesh-list
110868343|NCT02422966|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110868344|NCT02422966|Analgesics|analgesics|mesh-ancestor
110868345|NCT02422966|Sensory System Agents|sensory system agents|mesh-ancestor
110868346|NCT02422966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110868347|NCT02422966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110868348|NCT02422966|Antipyretics|antipyretics|mesh-ancestor
110868349|NCT02422966|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110868350|NCT02422966|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110868351|NCT02422966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110868352|NCT02422966|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110868353|NCT02422966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110868354|NCT02422966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110868355|NCT02422888|Ticagrelor|ticagrelor|mesh-list
110868356|NCT02422888|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
110868357|NCT02422888|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110868358|NCT02422888|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110868359|NCT02422888|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110868360|NCT02422888|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110868361|NCT02422888|Purinergic Agents|purinergic agents|mesh-ancestor
110868362|NCT02422888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110868363|NCT02422888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110868364|NCT02422888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110868366|NCT03633552|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110868367|NCT03633552|Alkylating Agents|alkylating agents|mesh-ancestor
110868368|NCT03633552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110868369|NCT03633552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110868371|NCT05760456|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110868372|NCT05760456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110868373|NCT02418130|Inositol|inositol|mesh-list
110868374|NCT02418130|Thiamine|thiamine|mesh-list
110868375|NCT02418130|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
110868376|NCT02418130|Vitamin B Complex|vitamin b complex|mesh-ancestor
110868377|NCT02418130|Vitamins|vitamins|mesh-ancestor
110868378|NCT02418130|Micronutrients|micronutrients|mesh-ancestor
110868379|NCT02418130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110868380|NCT02418130|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
110868381|NCT02418130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110868382|NCT03391765|Tilavonemab|tilavonemab|mesh-list
110868383|NCT03391765|Nootropic Agents|nootropic agents|mesh-ancestor
110868384|NCT02802228|Ifetroban|ifetroban|mesh-list
110868385|NCT02802228|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110868386|NCT02801448|Sulforaphane|sulforaphane|mesh-list
110868387|NCT02801448|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110868388|NCT02801448|Protective Agents|protective agents|mesh-ancestor
110868389|NCT02801448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110868390|NCT02801448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110868391|NCT03179332|Insulin Lispro|insulin lispro|mesh-list
110868392|NCT03179332|Insulin Aspart|insulin aspart|mesh-list
110868393|NCT03179332|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110868394|NCT03179332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110868395|NCT03674177|Vaccines|vaccines|mesh-list
110868396|NCT03674177|Immunologic Factors|immunologic factors|mesh-ancestor
110868397|NCT03674177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110358870|NCT05120895|Antimetabolites|antimetabolites|mesh-ancestor
110358871|NCT05120895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110358872|NCT05120895|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110358873|NCT05120895|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110358874|NCT05120895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110358881|NCT05092360|Paclitaxel|paclitaxel|mesh-list
110868399|NCT02675790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110868400|NCT02675790|Antisickling Agents|antisickling agents|mesh-ancestor
110868401|NCT02675790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110868402|NCT02675790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110868403|NCT02675790|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110868404|NCT02417896|Spironolactone|spironolactone|mesh-list
110868405|NCT02417896|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110868406|NCT02417896|Hormone Antagonists|hormone antagonists|mesh-ancestor
110868407|NCT02417896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110868408|NCT02417896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110868409|NCT02417896|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110868410|NCT02417896|Diuretics|diuretics|mesh-ancestor
110868411|NCT02417896|Natriuretic Agents|natriuretic agents|mesh-ancestor
110868412|NCT03183544|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
110868413|NCT03183544|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110868414|NCT03183544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110868415|NCT04380090|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
110868416|NCT04380090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110868417|NCT04380090|Antidiarrheals|antidiarrheals|mesh-ancestor
110868418|NCT03116776|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110868419|NCT03116776|Hyaluronic Acid|hyaluronic acid|mesh-list
110868420|NCT03116776|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110868421|NCT03116776|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110868422|NCT03116776|Immunologic Factors|immunologic factors|mesh-ancestor
110868423|NCT03116776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110868424|NCT03116776|Viscosupplements|viscosupplements|mesh-ancestor
110868425|NCT03116776|Protective Agents|protective agents|mesh-ancestor
110868426|NCT02505204|Clonidine|clonidine|mesh-list
110359155|NCT04245085|Paclitaxel|paclitaxel|mesh-list
110359156|NCT04245085|Bevacizumab|bevacizumab|mesh-list
110359157|NCT04245085|Carboplatin|carboplatin|mesh-list
110359158|NCT04245085|Pemetrexed|pemetrexed|mesh-list
110359159|NCT04245085|Atezolizumab|atezolizumab|mesh-list
110359160|NCT04245085|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110359161|NCT04245085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110359162|NCT04245085|Tubulin Modulators|tubulin modulators|mesh-ancestor
110359163|NCT04245085|Antimitotic Agents|antimitotic agents|mesh-ancestor
110868428|NCT02505204|Sensory System Agents|sensory system agents|mesh-ancestor
110868429|NCT02505204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110868430|NCT02505204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110868431|NCT02505204|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110868432|NCT02505204|Sympatholytics|sympatholytics|mesh-ancestor
110868433|NCT02505204|Autonomic Agents|autonomic agents|mesh-ancestor
110359214|NCT04192019|Glucagon|glucagon|mesh-list
110868434|NCT02505204|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110868435|NCT02505204|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110585945|NCT00719472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110868436|NCT02505204|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110868437|NCT02505204|Adrenergic Agents|adrenergic agents|mesh-ancestor
110868438|NCT02505204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110868439|NCT02505204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110868441|NCT04351698|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110868442|NCT04351698|Respiratory System Agents|respiratory system agents|mesh-ancestor
110868443|NCT04351698|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110868444|NCT04351698|Hormone Antagonists|hormone antagonists|mesh-ancestor
110868445|NCT04351698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110868446|NCT04351698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110868447|NCT04351698|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110359347|NCT03808025|Analgesics, Opioid|analgesics, opioid|mesh-list
110868448|NCT04351698|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110868449|NCT04351698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110868450|NCT01359423|Cilostazol|cilostazol|mesh-list
110868451|NCT01359423|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110868452|NCT01359423|Autonomic Agents|autonomic agents|mesh-ancestor
110868453|NCT01359423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110868454|NCT01359423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110868455|NCT01359423|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110868456|NCT01359423|Respiratory System Agents|respiratory system agents|mesh-ancestor
110868457|NCT01359423|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110868458|NCT01359423|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110359416|NCT03674671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110868459|NCT01359423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110868460|NCT01359423|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110868461|NCT01359423|Vasodilator Agents|vasodilator agents|mesh-ancestor
110868462|NCT01359423|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110868463|NCT01359423|Protective Agents|protective agents|mesh-ancestor
110868464|NCT01359423|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110868466|NCT01359423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110868467|NCT01363089|Ketorolac|ketorolac|mesh-list
110868468|NCT01363089|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
110868469|NCT01363089|Phenylephrine|phenylephrine|mesh-list
110868471|NCT01363089|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110868472|NCT01363089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110868473|NCT01363089|Analgesics|analgesics|mesh-ancestor
110868474|NCT01363089|Sensory System Agents|sensory system agents|mesh-ancestor
110868475|NCT01363089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110868476|NCT01363089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110868477|NCT01363089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110868478|NCT01363089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110868479|NCT01363089|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110868480|NCT01363089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110868481|NCT01363089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110868482|NCT01363089|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110868483|NCT01363089|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110868484|NCT01363089|Adrenergic Agents|adrenergic agents|mesh-ancestor
110868485|NCT01363089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110868486|NCT01363089|Sympathomimetics|sympathomimetics|mesh-ancestor
110868487|NCT01363089|Autonomic Agents|autonomic agents|mesh-ancestor
110868488|NCT01363089|Nasal Decongestants|nasal decongestants|mesh-ancestor
110868489|NCT01363089|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110868490|NCT01363089|Respiratory System Agents|respiratory system agents|mesh-ancestor
110868491|NCT01363089|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110868492|NCT01363089|Mydriatics|mydriatics|mesh-ancestor
110868493|NCT01363089|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110868494|NCT01363089|Protective Agents|protective agents|mesh-ancestor
110868495|NCT01365741|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
110868496|NCT01365741|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110868497|NCT03361748|Idecabtagene vicleucel|idecabtagene vicleucel|mesh-list
110868498|NCT03361748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110868499|NCT03361748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110868500|NCT03681548|Doxorubicin|doxorubicin|mesh-list
110868501|NCT03681548|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110868502|NCT03681548|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110868503|NCT03681548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110868504|NCT03681548|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110868505|NCT03681548|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110868506|NCT03681548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110868507|NCT03681548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110868508|NCT02417506|Ibuprofen|ibuprofen|mesh-list
110868509|NCT02417506|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110868510|NCT02417506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110586020|NCT02578251|Acetaminophen|acetaminophen|mesh-list
110868511|NCT02417506|Analgesics|analgesics|mesh-ancestor
110868512|NCT02417506|Sensory System Agents|sensory system agents|mesh-ancestor
110868513|NCT02417506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110868514|NCT02417506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110868515|NCT02417506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110868516|NCT02417506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110868517|NCT02417506|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110868518|NCT02417506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110868519|NCT02417506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110868520|NCT05188911|Prednisone|prednisone|mesh-list
110868521|NCT05188911|Androgens|androgens|mesh-list
110868522|NCT05188911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110868523|NCT05188911|Glucocorticoids|glucocorticoids|mesh-ancestor
110868524|NCT05188911|Hormones|hormones|mesh-ancestor
110868525|NCT05188911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110868526|NCT05188911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110868527|NCT05188911|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110868528|NCT05188911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110868529|NCT03676946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110868530|NCT03676946|Antibodies|antibodies|mesh-list
110868531|NCT03676946|Immunoglobulins|immunoglobulins|mesh-list
110868532|NCT03676946|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110868533|NCT03676946|Immunologic Factors|immunologic factors|mesh-ancestor
110868534|NCT03676946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110868535|NCT03676946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110868536|NCT01363167|Vitamin D|vitamin d|mesh-list
110868537|NCT01363167|Cholecalciferol|cholecalciferol|mesh-list
110868538|NCT01363167|Vitamins|vitamins|mesh-ancestor
110868539|NCT01363167|Micronutrients|micronutrients|mesh-ancestor
110868540|NCT01363167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110868541|NCT01363167|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110868542|NCT01363167|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110868543|NCT01359579|Varespladib methyl|varespladib methyl|mesh-list
110868544|NCT01359579|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
110868546|NCT01359579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110868547|NCT02422654|Eliglustat|eliglustat|mesh-list
110868548|NCT02422654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110868549|NCT02422654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110868550|NCT05188833|Paroxetine|paroxetine|mesh-list
110868551|NCT05188833|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110868552|NCT05188833|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110868553|NCT05188833|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110868554|NCT05188833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110868555|NCT05188833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110868556|NCT05188833|Serotonin Agents|serotonin agents|mesh-ancestor
110868557|NCT05188833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110868558|NCT05188833|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110360143|NCT04646759|Capecitabine|capecitabine|mesh-list
110868559|NCT05188833|Antidepressive Agents|antidepressive agents|mesh-ancestor
110868560|NCT05188833|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110868561|NCT05188833|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110868562|NCT05188833|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110868563|NCT05188833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110868564|NCT02426164|Methylprednisolone|methylprednisolone|mesh-list
110868565|NCT02426164|Epinephrine|epinephrine|mesh-list
110868567|NCT02426164|Bupivacaine|bupivacaine|mesh-list
110868568|NCT02426164|Anesthetics, Local|anesthetics, local|mesh-ancestor
110868569|NCT02426164|Anesthetics|anesthetics|mesh-ancestor
110868570|NCT02426164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110868571|NCT02426164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110868572|NCT02426164|Sensory System Agents|sensory system agents|mesh-ancestor
110868573|NCT02426164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110868574|NCT02426164|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110868575|NCT02426164|Narcotics|narcotics|mesh-ancestor
110868576|NCT02426164|Analgesics|analgesics|mesh-ancestor
110868577|NCT02426164|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110868578|NCT02426164|Antiemetics|antiemetics|mesh-ancestor
110868579|NCT02426164|Autonomic Agents|autonomic agents|mesh-ancestor
110868580|NCT02426164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110868581|NCT02426164|Glucocorticoids|glucocorticoids|mesh-ancestor
110868582|NCT02426164|Hormones|hormones|mesh-ancestor
110868583|NCT02426164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110868584|NCT02426164|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110868585|NCT02426164|Protective Agents|protective agents|mesh-ancestor
110868586|NCT02426164|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110868588|NCT02426164|Adrenergic Agents|adrenergic agents|mesh-ancestor
110868589|NCT02426164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110868590|NCT02426164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110868591|NCT02426164|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110868592|NCT02426164|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110868593|NCT02426164|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110868594|NCT02426164|Respiratory System Agents|respiratory system agents|mesh-ancestor
110868595|NCT02426164|Mydriatics|mydriatics|mesh-ancestor
110868596|NCT02426164|Sympathomimetics|sympathomimetics|mesh-ancestor
110868597|NCT02426164|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110868598|NCT03745157|Insulin|insulin|mesh-list
110868599|NCT03745157|Insulin Aspart|insulin aspart|mesh-list
110868600|NCT03745157|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110868601|NCT03745157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110868602|NCT02426008|Mitogens|mitogens|mesh-list
110868603|NCT02426008|Mitosis Modulators|mitosis modulators|mesh-ancestor
110868604|NCT02426008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110868605|NCT04050371|Tenofovir|tenofovir|mesh-list
110868606|NCT04050371|Emtricitabine|emtricitabine|mesh-list
110868607|NCT04050371|Antiviral Agents|antiviral agents|mesh-ancestor
110360527|NCT02897856|GABA Agents|gaba agents|mesh-ancestor
110868608|NCT04050371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110868609|NCT04050371|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110868610|NCT04050371|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110868611|NCT04050371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110868612|NCT04050371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110868613|NCT04050371|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110360597|NCT01235728|Vitamins|vitamins|mesh-ancestor
110868614|NCT04050371|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110868615|NCT04447287|Buprenorphine|buprenorphine|mesh-list
110868616|NCT04447287|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
110868617|NCT04447287|ASP8062|asp8062|mesh-list
110868618|NCT04447287|Naloxone|naloxone|mesh-list
110868619|NCT04447287|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110868620|NCT04447287|Narcotics|narcotics|mesh-ancestor
110868621|NCT04447287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110868622|NCT04447287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110868623|NCT04447287|Analgesics|analgesics|mesh-ancestor
110868624|NCT04447287|Sensory System Agents|sensory system agents|mesh-ancestor
110868625|NCT04447287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110868626|NCT04447287|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110868627|NCT04447287|GABA Modulators|gaba modulators|mesh-ancestor
110868628|NCT04447287|GABA Agents|gaba agents|mesh-ancestor
110360669|NCT04638686|Lamivudine|lamivudine|mesh-list
110868629|NCT04447287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110868630|NCT04447287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110868631|NCT01879319|Evolocumab|evolocumab|mesh-list
110868632|NCT01879319|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110868633|NCT01879319|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
110868634|NCT01879319|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110868635|NCT01879319|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110868636|NCT01879319|Antimetabolites|antimetabolites|mesh-ancestor
110868637|NCT01879319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110868638|NCT01879319|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110868639|NCT01879319|Protease Inhibitors|protease inhibitors|mesh-ancestor
110868640|NCT01879319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110868641|NCT01879319|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110868642|NCT01879319|Immunologic Factors|immunologic factors|mesh-ancestor
110868643|NCT01879319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110868644|NCT04165122|Valacyclovir|valacyclovir|mesh-list
110868645|NCT04165122|Antiviral Agents|antiviral agents|mesh-ancestor
110868646|NCT04165122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110868647|NCT02422030|Atorvastatin|atorvastatin|mesh-list
110868648|NCT02422030|Fenofibric acid|fenofibric acid|mesh-list
110868649|NCT02422030|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110868650|NCT02422030|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110868651|NCT02422030|Antimetabolites|antimetabolites|mesh-ancestor
110868652|NCT02422030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110868653|NCT02422030|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110868654|NCT02422030|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110360854|NCT04637360|Micronutrients|micronutrients|mesh-ancestor
110868655|NCT02422030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110868656|NCT02425930|Oxaliplatin|oxaliplatin|mesh-list
110868657|NCT02425930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110868658|NCT01365897|Modafinil|modafinil|mesh-list
110868659|NCT01365897|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110868660|NCT01365897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110586205|NCT00918528|Mitomycins|mitomycins|mesh-list
110868661|NCT01365897|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
110868662|NCT01365897|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110361002|NCT02903901|Melatonin|melatonin|mesh-list
110868664|NCT01365897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110868665|NCT02422108|Denosumab|denosumab|mesh-list
110868666|NCT02422108|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110868667|NCT02422108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110868669|NCT01359657|Dexamethasone acetate|dexamethasone acetate|mesh-list
110868670|NCT01359657|Lenalidomide|lenalidomide|mesh-list
110868671|NCT01359657|Bortezomib|bortezomib|mesh-list
110868672|NCT01359657|BB 1101|bb 1101|mesh-list
110868673|NCT01359657|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110868674|NCT01359657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110868675|NCT01359657|Antiemetics|antiemetics|mesh-ancestor
110868676|NCT01359657|Autonomic Agents|autonomic agents|mesh-ancestor
110868677|NCT01359657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110868678|NCT01359657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110868679|NCT01359657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110868680|NCT01359657|Glucocorticoids|glucocorticoids|mesh-ancestor
110868681|NCT01359657|Hormones|hormones|mesh-ancestor
110361220|NCT00446420|Fentanyl|fentanyl|mesh-list
110868682|NCT01359657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110868683|NCT01359657|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110868684|NCT01359657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110868685|NCT01359657|Protease Inhibitors|protease inhibitors|mesh-ancestor
110868686|NCT01359657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110868687|NCT01359657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110868688|NCT01359657|Immunologic Factors|immunologic factors|mesh-ancestor
110868689|NCT01359657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110868690|NCT01359657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110868691|NCT01359657|Growth Substances|growth substances|mesh-ancestor
110868692|NCT01359657|Growth Inhibitors|growth inhibitors|mesh-ancestor
110868693|NCT02417116|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110868694|NCT02417116|Hyaluronic Acid|hyaluronic acid|mesh-list
110868695|NCT02417116|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110868696|NCT02417116|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110868697|NCT02417116|Immunologic Factors|immunologic factors|mesh-ancestor
110868698|NCT02417116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110868699|NCT02417116|Viscosupplements|viscosupplements|mesh-ancestor
110868700|NCT02417116|Protective Agents|protective agents|mesh-ancestor
110868701|NCT03183310|Chlorpromazine|chlorpromazine|mesh-list
110868702|NCT03183310|Antiemetics|antiemetics|mesh-ancestor
110868703|NCT03183310|Autonomic Agents|autonomic agents|mesh-ancestor
110868705|NCT03183310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110868706|NCT03183310|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110868707|NCT03183310|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110868708|NCT03183310|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110868709|NCT03183310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110868710|NCT03183310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110868711|NCT03183310|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110868712|NCT03183310|Dopamine Agents|dopamine agents|mesh-ancestor
110868713|NCT03183310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110868714|NCT03183310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110868715|NCT03177850|Acetazolamide|acetazolamide|mesh-list
110868716|NCT03177850|Anticonvulsants|anticonvulsants|mesh-ancestor
110868717|NCT03177850|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110868718|NCT03177850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110868719|NCT03177850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110868720|NCT03177850|Diuretics|diuretics|mesh-ancestor
110868721|NCT03177850|Natriuretic Agents|natriuretic agents|mesh-ancestor
110868722|NCT03177850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110868723|NCT03102918|Cannabidiol|cannabidiol|mesh-list
110868724|NCT03102918|Anticonvulsants|anticonvulsants|mesh-ancestor
110868725|NCT03102762|Botulinum Toxins|botulinum toxins|mesh-list
110868726|NCT03102762|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110868727|NCT03102762|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110361489|NCT00447863|Levonorgestrel|levonorgestrel|mesh-list
110868728|NCT03102762|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110868729|NCT03102762|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110868730|NCT03102762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110868731|NCT03102762|Cholinergic Agents|cholinergic agents|mesh-ancestor
110868732|NCT03102762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110868733|NCT03102762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110868734|NCT03102762|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110868735|NCT03102762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110868736|NCT03684824|Triptorelin Pamoate|triptorelin pamoate|mesh-list
110868737|NCT03684824|Luteolytic Agents|luteolytic agents|mesh-ancestor
110868738|NCT03684824|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110868739|NCT03684824|Contraceptive Agents|contraceptive agents|mesh-ancestor
110868740|NCT03684824|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110868741|NCT03684824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110834876|NCT05320588|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110868742|NCT03684824|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110868743|NCT03684824|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110868744|NCT03684824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110868745|NCT03177538|Menotropins|menotropins|mesh-list
110868746|NCT03177538|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
110868747|NCT03177538|Hormones|hormones|mesh-ancestor
110868748|NCT03177538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110361744|NCT00449501|Budesonide|budesonide|mesh-list
110868749|NCT03177538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110868750|NCT03177538|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110868751|NCT03177538|Fertility Agents|fertility agents|mesh-ancestor
110868752|NCT03177538|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110868753|NCT01363323|Moxifloxacin|moxifloxacin|mesh-list
110868754|NCT01363323|Naltrexone|naltrexone|mesh-list
110868755|NCT01363323|Methylnaltrexone|methylnaltrexone|mesh-list
110361826|NCT03276143|Enoxaparin|enoxaparin|mesh-list
110868756|NCT01363323|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110868757|NCT01363323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110868758|NCT01363323|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110868759|NCT01363323|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110868760|NCT01363323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110868761|NCT01363323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110868762|NCT01363323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110868763|NCT01363323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110868764|NCT01363323|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110868765|NCT01363323|Sensory System Agents|sensory system agents|mesh-ancestor
110361954|NCT02900430|Clotrimazole|clotrimazole|mesh-list
110868766|NCT01363323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110868767|NCT01363323|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110868768|NCT03183076|Anticonvulsants|anticonvulsants|mesh-list
110868769|NCT03106948|Ascorbic Acid|ascorbic acid|mesh-list
110868770|NCT03106948|Penicillamine|penicillamine|mesh-list
110868771|NCT03106948|Antioxidants|antioxidants|mesh-ancestor
110868772|NCT03106948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110868773|NCT03106948|Protective Agents|protective agents|mesh-ancestor
110868774|NCT03106948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110868775|NCT03106948|Vitamins|vitamins|mesh-ancestor
110868776|NCT03106948|Micronutrients|micronutrients|mesh-ancestor
110868777|NCT03106948|Antidotes|antidotes|mesh-ancestor
110868778|NCT03106948|Chelating Agents|chelating agents|mesh-ancestor
110868779|NCT03106948|Sequestering Agents|sequestering agents|mesh-ancestor
110868781|NCT01366365|Methylnaltrexone|methylnaltrexone|mesh-list
110868782|NCT01366365|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110868783|NCT01366365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110868784|NCT01366365|Sensory System Agents|sensory system agents|mesh-ancestor
110868785|NCT01366365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110868786|NCT01881048|Celecoxib|celecoxib|mesh-list
110868787|NCT01881048|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110868788|NCT01881048|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110868789|NCT01881048|Analgesics|analgesics|mesh-ancestor
110868790|NCT01881048|Sensory System Agents|sensory system agents|mesh-ancestor
110868791|NCT01881048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110868792|NCT01881048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110868793|NCT01881048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110367229|NCT04641780|Dopamine Agents|dopamine agents|mesh-ancestor
110868794|NCT01881048|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110868795|NCT01881048|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110868796|NCT01881048|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110868797|NCT01881048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110868798|NCT01881048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110868799|NCT01363557|Gefitinib|gefitinib|mesh-list
110868800|NCT01363557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110868801|NCT01363557|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110868802|NCT01363557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110868803|NCT01363557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110868804|NCT01346475|Valacyclovir|valacyclovir|mesh-list
110868805|NCT01346475|Antiviral Agents|antiviral agents|mesh-ancestor
110868806|NCT01346475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110868807|NCT01338636|Ambrisentan|ambrisentan|mesh-list
110868808|NCT01338636|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110868810|NCT02416258|Betamethasone Valerate|betamethasone valerate|mesh-list
110868811|NCT02416258|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
110868812|NCT02416258|Betamethasone benzoate|betamethasone benzoate|mesh-list
110868813|NCT02416258|Calcipotriene|calcipotriene|mesh-list
110868814|NCT02416258|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
110868816|NCT02416258|Glucocorticoids|glucocorticoids|mesh-ancestor
110868817|NCT02416258|Hormones|hormones|mesh-ancestor
110868818|NCT02416258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110868819|NCT02416258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110868820|NCT02416258|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110868821|NCT02416258|Respiratory System Agents|respiratory system agents|mesh-ancestor
110868822|NCT02416258|Dermatologic Agents|dermatologic agents|mesh-ancestor
110868823|NCT02410720|Picosulfate sodium|picosulfate sodium|mesh-list
110868824|NCT02410720|Cathartics|cathartics|mesh-ancestor
110362337|NCT02927405|Antimanic Agents|antimanic agents|mesh-ancestor
110868825|NCT02410720|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110868826|NCT02416570|Clarithromycin|clarithromycin|mesh-list
110868827|NCT02416570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110868828|NCT02416570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110868829|NCT02416570|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110868830|NCT02416570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110868831|NCT02416570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110868832|NCT02416570|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110362406|NCT04798287|Infliximab|infliximab|mesh-list
110868833|NCT02416570|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110868834|NCT05328336|Paclitaxel|paclitaxel|mesh-list
110868835|NCT05328336|Tislelizumab|tislelizumab|mesh-list
110868836|NCT05328336|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110868837|NCT05328336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110868838|NCT05328336|Tubulin Modulators|tubulin modulators|mesh-ancestor
110868839|NCT05328336|Antimitotic Agents|antimitotic agents|mesh-ancestor
110868840|NCT05328336|Mitosis Modulators|mitosis modulators|mesh-ancestor
110362471|NCT02205528|Metformin|metformin|mesh-list
110868841|NCT05328336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110868842|NCT05328336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110868843|NCT02873754|Bupropion|bupropion|mesh-list
110868844|NCT02873754|Nicotine|nicotine|mesh-list
110868845|NCT02873754|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110868846|NCT02873754|Autonomic Agents|autonomic agents|mesh-ancestor
110868847|NCT02873754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110868848|NCT02873754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110868849|NCT02873754|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110868850|NCT02873754|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110868851|NCT02873754|Cholinergic Agents|cholinergic agents|mesh-ancestor
110868852|NCT02873754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110868853|NCT02873754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110868854|NCT02873754|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110868855|NCT02873754|Antidepressive Agents|antidepressive agents|mesh-ancestor
110868856|NCT02873754|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110868857|NCT02873754|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110868858|NCT02873754|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110868859|NCT02873754|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110868860|NCT02873754|Dopamine Agents|dopamine agents|mesh-ancestor
110868861|NCT02873754|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110868862|NCT02873754|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110868863|NCT02873754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110868864|NCT03669614|Gallium citrate|gallium citrate|mesh-list
110868865|NCT03669614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110868866|NCT03669614|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110868867|NCT05200260|Niraparib|niraparib|mesh-list
110868868|NCT05200260|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
110868869|NCT05200260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110868870|NCT05200260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110868871|NCT05200260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110868872|NCT02416804|Buprenorphine|buprenorphine|mesh-list
110868873|NCT02416804|Tramadol|tramadol|mesh-list
110868874|NCT02416804|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110868875|NCT02416804|Narcotics|narcotics|mesh-ancestor
110868876|NCT02416804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110868877|NCT02416804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110868878|NCT02416804|Analgesics|analgesics|mesh-ancestor
110868879|NCT02416804|Sensory System Agents|sensory system agents|mesh-ancestor
110868880|NCT02416804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110868881|NCT02416804|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110868882|NCT04792320|Charcoal|charcoal|mesh-list
110868883|NCT04792320|Antidotes|antidotes|mesh-ancestor
110868884|NCT04792320|Protective Agents|protective agents|mesh-ancestor
110868885|NCT04792320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110868886|NCT03176758|Anesthetics|anesthetics|mesh-list
110868887|NCT03176758|Anesthetics, General|anesthetics, general|mesh-list
110868888|NCT03176758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110868889|NCT03176758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110868890|NCT03177070|Methylene Blue|methylene blue|mesh-list
110868891|NCT03177070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110868892|NCT03177070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110868894|NCT03680612|Enmetazobactam|enmetazobactam|mesh-list
110868895|NCT03680612|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110868896|NCT03680612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110868897|NCT03680612|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110868898|NCT03680612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110868899|NCT03680612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110868900|NCT02410096|Methacholine Chloride|methacholine chloride|mesh-list
110868901|NCT02410096|Miotics|miotics|mesh-ancestor
110868902|NCT02410096|Autonomic Agents|autonomic agents|mesh-ancestor
110868903|NCT02410096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110868904|NCT02410096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110868905|NCT02410096|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110868906|NCT02410096|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
110868907|NCT02410096|Respiratory System Agents|respiratory system agents|mesh-ancestor
110868908|NCT02410096|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
110868909|NCT02410096|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110868910|NCT02410096|Cholinergic Agents|cholinergic agents|mesh-ancestor
110868911|NCT02410096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110868912|NCT02410096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110868914|NCT04046939|Antioxidants|antioxidants|mesh-ancestor
110868915|NCT04046939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110868916|NCT04046939|Protective Agents|protective agents|mesh-ancestor
110868917|NCT04046939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110868918|NCT04046939|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110868919|NCT04046939|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110868920|NCT04046939|Dopamine Agonists|dopamine agonists|mesh-ancestor
110868921|NCT04046939|Dopamine Agents|dopamine agents|mesh-ancestor
110868922|NCT04046939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110868923|NCT05188131|Diclofenac|diclofenac|mesh-list
110868924|NCT05188131|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110868925|NCT05188131|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110868926|NCT05188131|Analgesics|analgesics|mesh-ancestor
110868927|NCT05188131|Sensory System Agents|sensory system agents|mesh-ancestor
110363108|NCT02912234|Apixaban|apixaban|mesh-list
110868928|NCT05188131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110868929|NCT05188131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110868930|NCT05188131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110868931|NCT05188131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110868932|NCT05188131|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110868934|NCT05188131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110868935|NCT01360437|Ticagrelor|ticagrelor|mesh-list
110868936|NCT01360437|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
110868937|NCT01360437|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110868938|NCT01360437|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110868939|NCT01360437|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110868941|NCT01360437|Purinergic Agents|purinergic agents|mesh-ancestor
110868942|NCT01360437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110363269|NCT01217437|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110834898|NCT01231685|Raltegravir Potassium|raltegravir potassium|mesh-list
110868943|NCT01360437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110868944|NCT01360437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110868946|NCT02409862|Oxytocics|oxytocics|mesh-ancestor
110868947|NCT02409862|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110868948|NCT02409862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110868949|NCT01360671|Sildenafil Citrate|sildenafil citrate|mesh-list
110868950|NCT01360671|Vasodilator Agents|vasodilator agents|mesh-ancestor
110868951|NCT01360671|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110868952|NCT01360671|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110868953|NCT01360671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110868954|NCT01360671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110868955|NCT01360671|Urological Agents|urological agents|mesh-ancestor
110868956|NCT02955797|Vaccines|vaccines|mesh-list
110868957|NCT02955797|Immunologic Factors|immunologic factors|mesh-ancestor
110868958|NCT02955797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110868959|NCT03680378|Cefepime|cefepime|mesh-list
110868960|NCT03680378|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110586469|NCT00719121|Analgesics|analgesics|mesh-ancestor
110868961|NCT03680378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110868962|NCT01319331|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
110868963|NCT01319331|Protein C Inhibitor|protein c inhibitor|mesh-list
110868964|NCT01319331|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
110868965|NCT01319331|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110868966|NCT01319331|Protease Inhibitors|protease inhibitors|mesh-ancestor
110868967|NCT01319331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110868968|NCT01319331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110868970|NCT03010176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110363616|NCT00555087|Testosterone|testosterone|mesh-list
110868971|NCT03010176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110868972|NCT03010176|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110868973|NCT03010176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110868974|NCT03176524|Glucagon|glucagon|mesh-list
110868975|NCT03176524|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
110868976|NCT03176524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110868977|NCT03176524|Hormones|hormones|mesh-ancestor
110363689|NCT04932083|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110868978|NCT03176524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110868979|NCT03176524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110868981|NCT03676088|Mitogens|mitogens|mesh-list
110868982|NCT03676088|Mitosis Modulators|mitosis modulators|mesh-ancestor
110868983|NCT03676088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110868984|NCT02414464|Calcium, Dietary|calcium, dietary|mesh-list
110868985|NCT02414464|Hydrogen Peroxide|hydrogen peroxide|mesh-list
110868986|NCT02414464|Calcium|calcium|mesh-list
110868987|NCT02414464|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110868988|NCT02414464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110868989|NCT02414464|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110868990|NCT02414464|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110868991|NCT02414464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110868992|NCT03226418|Cytarabine|cytarabine|mesh-list
110868993|NCT03226418|Azacitidine|azacitidine|mesh-list
110868994|NCT03226418|Decitabine|decitabine|mesh-list
110868995|NCT03226418|Daunorubicin|daunorubicin|mesh-list
110868996|NCT03226418|Venetoclax|venetoclax|mesh-list
110868997|NCT03226418|Idarubicin|idarubicin|mesh-list
110868998|NCT03226418|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110868999|NCT03226418|Antimetabolites|antimetabolites|mesh-ancestor
110869000|NCT03226418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110869001|NCT03226418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110869002|NCT03226418|Antiviral Agents|antiviral agents|mesh-ancestor
110869003|NCT03226418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110869004|NCT03226418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110869005|NCT03226418|Immunologic Factors|immunologic factors|mesh-ancestor
110869006|NCT03226418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110869007|NCT03226418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110869008|NCT03226418|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110869009|NCT03226418|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110869010|NCT03226418|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110869011|NCT04039503|Tirzepatide|tirzepatide|mesh-list
110869013|NCT04039503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110869014|NCT04039503|Incretins|incretins|mesh-ancestor
110869015|NCT04039503|Hormones|hormones|mesh-ancestor
110869016|NCT04039503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110869017|NCT05418114|Magnesium Sulfate|magnesium sulfate|mesh-list
110869018|NCT05418114|Analgesics|analgesics|mesh-ancestor
110869019|NCT05418114|Sensory System Agents|sensory system agents|mesh-ancestor
110869020|NCT05418114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110869021|NCT05418114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110869022|NCT05418114|Anesthetics|anesthetics|mesh-ancestor
110869023|NCT05418114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110869024|NCT05418114|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110869025|NCT05418114|Anticonvulsants|anticonvulsants|mesh-ancestor
110869026|NCT05418114|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110869027|NCT05418114|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110869028|NCT05418114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110869029|NCT05418114|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110869030|NCT05418114|Tocolytic Agents|tocolytic agents|mesh-ancestor
110869031|NCT05418114|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110869032|NCT05528952|Bevacizumab|bevacizumab|mesh-list
110869033|NCT05528952|Atezolizumab|atezolizumab|mesh-list
110869034|NCT05528952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110869035|NCT05528952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110869036|NCT05528952|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110869037|NCT05528952|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110869038|NCT05528952|Growth Substances|growth substances|mesh-ancestor
110869039|NCT05528952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110869040|NCT05528952|Growth Inhibitors|growth inhibitors|mesh-ancestor
110869041|NCT05528952|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110869042|NCT05528952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110363922|NCT04322123|Antimalarials|antimalarials|mesh-ancestor
110869044|NCT05189769|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110869045|NCT05189769|Contraceptive Agents|contraceptive agents|mesh-ancestor
110869046|NCT05189769|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110869047|NCT05189769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110869048|NCT05189769|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110869049|NCT05189769|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110869050|NCT05189769|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110869051|NCT03672812|Liraglutide|liraglutide|mesh-list
110869052|NCT03672812|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110869053|NCT03672812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110869054|NCT03672812|Incretins|incretins|mesh-ancestor
110869055|NCT03672812|Hormones|hormones|mesh-ancestor
110869056|NCT03672812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110869057|NCT05417880|Hypoglycemic Agents|hypoglycemic agents|mesh-list
110869058|NCT05417880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110869059|NCT05029726|Clonidine|clonidine|mesh-list
110869060|NCT05029726|Epinephrine|epinephrine|mesh-list
110869061|NCT05029726|Bupivacaine|bupivacaine|mesh-list
110869062|NCT05029726|Anesthetics, Local|anesthetics, local|mesh-ancestor
110869063|NCT05029726|Anesthetics|anesthetics|mesh-ancestor
110869064|NCT05029726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110869065|NCT05029726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110869066|NCT05029726|Sensory System Agents|sensory system agents|mesh-ancestor
110869067|NCT05029726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110869068|NCT05029726|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110869069|NCT05029726|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110869070|NCT05029726|Adrenergic Agents|adrenergic agents|mesh-ancestor
110368805|NCT04616352|Cefuroxime axetil|cefuroxime axetil|mesh-list
110869071|NCT05029726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110869072|NCT05029726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110869073|NCT05029726|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110869074|NCT05029726|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110869075|NCT05029726|Autonomic Agents|autonomic agents|mesh-ancestor
110869076|NCT05029726|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110869077|NCT05029726|Respiratory System Agents|respiratory system agents|mesh-ancestor
110869078|NCT05029726|Mydriatics|mydriatics|mesh-ancestor
110869079|NCT05029726|Sympathomimetics|sympathomimetics|mesh-ancestor
110869080|NCT05029726|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110869081|NCT05029726|Analgesics|analgesics|mesh-ancestor
110869082|NCT05029726|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110869083|NCT05029726|Sympatholytics|sympatholytics|mesh-ancestor
110869084|NCT05029726|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110364118|NCT00533585|Paclitaxel|paclitaxel|mesh-list
110869085|NCT05186883|Parathyroid Hormone|parathyroid hormone|mesh-list
110869086|NCT05186883|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110869087|NCT05186883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110869088|NCT05007652|Plerixafor|plerixafor|mesh-list
110869089|NCT05007652|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110869090|NCT05007652|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110869091|NCT05007652|Antiviral Agents|antiviral agents|mesh-ancestor
110869092|NCT05007652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110869093|NCT03632772|Solifenacin Succinate|solifenacin succinate|mesh-list
110869094|NCT03632772|Mirabegron|mirabegron|mesh-list
110869095|NCT03632772|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110869096|NCT03632772|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110869097|NCT03632772|Cholinergic Agents|cholinergic agents|mesh-ancestor
110869098|NCT03632772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110869099|NCT03632772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110869100|NCT03632772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110869101|NCT03632772|Urological Agents|urological agents|mesh-ancestor
110869102|NCT03632772|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
110869103|NCT03632772|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110869104|NCT03632772|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110869105|NCT03632772|Adrenergic Agents|adrenergic agents|mesh-ancestor
110869106|NCT01360749|Lidocaine|lidocaine|mesh-list
110869107|NCT01360749|Anesthetics, Local|anesthetics, local|mesh-ancestor
110869108|NCT01360749|Anesthetics|anesthetics|mesh-ancestor
110869109|NCT01360749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110869110|NCT01360749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110869111|NCT01360749|Sensory System Agents|sensory system agents|mesh-ancestor
110869112|NCT01360749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110869113|NCT01360749|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110869114|NCT01360749|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110869115|NCT01360749|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110869116|NCT01360749|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110869117|NCT01360749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110869118|NCT01367223|Amino-acid, glucose, and electrolyte solution|amino-acid, glucose, and electrolyte solution|mesh-list
110869119|NCT01367223|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
110869120|NCT01367223|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110869121|NCT03675854|Cefazolin|cefazolin|mesh-list
110869122|NCT03675854|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110869123|NCT03675854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110869124|NCT01360827|Cisplatin|cisplatin|mesh-list
110869125|NCT01360827|Fluorouracil|fluorouracil|mesh-list
110869126|NCT01360827|Cetuximab|cetuximab|mesh-list
110869127|NCT01360827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110869128|NCT01360827|Antimetabolites|antimetabolites|mesh-ancestor
110869129|NCT01360827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110869130|NCT01360827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110869131|NCT01360827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110869132|NCT01360827|Immunologic Factors|immunologic factors|mesh-ancestor
110869133|NCT01360827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110869134|NCT01360827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110869136|NCT03171610|Sufentanil|sufentanil|mesh-list
110869137|NCT03171610|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110869138|NCT03171610|Narcotics|narcotics|mesh-ancestor
110869139|NCT03171610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110869140|NCT03171610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110869141|NCT03171610|Analgesics|analgesics|mesh-ancestor
110869142|NCT03171610|Sensory System Agents|sensory system agents|mesh-ancestor
110869143|NCT03171610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110869144|NCT03171610|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110869145|NCT03171610|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110869146|NCT03171610|Anesthetics, General|anesthetics, general|mesh-ancestor
110869147|NCT03171610|Anesthetics|anesthetics|mesh-ancestor
110869149|NCT01364181|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110869150|NCT01364181|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110869151|NCT01364181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110869152|NCT01364181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110869153|NCT03679442|Acetylcysteine|acetylcysteine|mesh-list
110869154|NCT03679442|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110869155|NCT03679442|Antidotes|antidotes|mesh-list
110869156|NCT03679442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110869157|NCT03679442|Antiviral Agents|antiviral agents|mesh-ancestor
110869158|NCT03679442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110869159|NCT03679442|Expectorants|expectorants|mesh-ancestor
110869160|NCT03679442|Respiratory System Agents|respiratory system agents|mesh-ancestor
110869161|NCT03679442|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110869162|NCT03679442|Antioxidants|antioxidants|mesh-ancestor
110869163|NCT03679442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110869164|NCT03679442|Protective Agents|protective agents|mesh-ancestor
110869165|NCT01367535|Naltrexone|naltrexone|mesh-list
110869166|NCT01367535|Methylnaltrexone|methylnaltrexone|mesh-list
110869167|NCT01367535|Paroxetine|paroxetine|mesh-list
110869168|NCT01367535|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110869169|NCT01367535|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110869170|NCT01367535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110869171|NCT01367535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110869172|NCT01367535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110869173|NCT01367535|Serotonin Agents|serotonin agents|mesh-ancestor
110869174|NCT01367535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110869175|NCT01367535|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110869176|NCT01367535|Antidepressive Agents|antidepressive agents|mesh-ancestor
110869177|NCT01367535|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110869178|NCT01367535|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110869179|NCT01367535|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110869180|NCT01367535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110869181|NCT01367535|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110869182|NCT01367535|Sensory System Agents|sensory system agents|mesh-ancestor
110869183|NCT01367535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110586697|NCT02573025|Interferon alpha-2|interferon alpha-2|mesh-list
110869184|NCT01367535|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110869186|NCT02414776|Antimalarials|antimalarials|mesh-ancestor
110869187|NCT02414776|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110869188|NCT02414776|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110869189|NCT02414776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110869190|NCT02414776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110869191|NCT02414776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110869192|NCT02414776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110869193|NCT05187663|Chlorhexidine|chlorhexidine|mesh-list
110869194|NCT05187663|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110869195|NCT05187663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110869196|NCT05187663|Disinfectants|disinfectants|mesh-ancestor
110869198|NCT04482712|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110869199|NCT04482712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110869200|NCT04482712|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110869201|NCT04482712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110869202|NCT04482712|Antifungal Agents|antifungal agents|mesh-ancestor
110869203|NCT04482712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110869204|NCT04482712|Immunologic Factors|immunologic factors|mesh-ancestor
110869205|NCT04482712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110869206|NCT02409004|Rifampin|rifampin|mesh-list
110869207|NCT02409004|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110869208|NCT02409004|Antitubercular Agents|antitubercular agents|mesh-ancestor
110869209|NCT02409004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110869210|NCT02409004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110869211|NCT02409004|Leprostatic Agents|leprostatic agents|mesh-ancestor
110869212|NCT02409004|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110869213|NCT02409004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110367325|NCT05186675|Mydriatics|mydriatics|mesh-ancestor
110869214|NCT02409004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110869215|NCT02409004|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110869216|NCT02409004|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110869217|NCT02409004|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110869218|NCT02409004|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110869219|NCT02409004|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110365119|NCT00540137|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110869220|NCT02409004|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110869221|NCT03131895|Dexlansoprazole|dexlansoprazole|mesh-list
110869222|NCT03131895|Lansoprazole|lansoprazole|mesh-list
110869223|NCT03131895|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110869224|NCT03131895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110869225|NCT03131895|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110869226|NCT03131895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110869227|NCT03131895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110869228|NCT04039919|Padsevonil|padsevonil|mesh-list
110869229|NCT04039919|Anticonvulsants|anticonvulsants|mesh-ancestor
110869230|NCT01367613|Methylnaltrexone|methylnaltrexone|mesh-list
110869231|NCT01367613|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110365330|NCT00541853|Cilnidipine|cilnidipine|mesh-list
110869232|NCT01367613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110869233|NCT01367613|Sensory System Agents|sensory system agents|mesh-ancestor
110869234|NCT01367613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110869235|NCT02405104|Chlorzoxazone|chlorzoxazone|mesh-list
110869236|NCT02405104|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110869237|NCT02405104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110869238|NCT02405104|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110869239|NCT02405104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110869240|NCT01364415|Pasireotide|pasireotide|mesh-list
110869241|NCT01364415|Hormones|hormones|mesh-ancestor
110365470|NCT03456752|Antiemetics|antiemetics|mesh-ancestor
110869242|NCT01364415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110869243|NCT01364415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110869244|NCT03176446|Anesthetics|anesthetics|mesh-list
110869245|NCT03176446|Anesthetics, Local|anesthetics, local|mesh-list
110869246|NCT03176446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110869247|NCT03176446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110869248|NCT03176446|Sensory System Agents|sensory system agents|mesh-ancestor
110365609|NCT00544037|Interferons|interferons|mesh-list
110869249|NCT03176446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110869250|NCT03176212|Milk fat globule|milk fat globule|mesh-list
110869251|NCT03176212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110869252|NCT04035473|Paclitaxel|paclitaxel|mesh-list
110869253|NCT04035473|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110869254|NCT04035473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110869255|NCT04035473|Tubulin Modulators|tubulin modulators|mesh-ancestor
110365686|NCT00544349|Leucovorin|leucovorin|mesh-list
110869256|NCT04035473|Antimitotic Agents|antimitotic agents|mesh-ancestor
110869257|NCT04035473|Mitosis Modulators|mitosis modulators|mesh-ancestor
110365751|NCT05824468|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110869258|NCT04035473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110869259|NCT02408926|Vaccines|vaccines|mesh-list
110869260|NCT02408926|Immunologic Factors|immunologic factors|mesh-ancestor
110869261|NCT02408926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110869262|NCT00704158|Glembatumumab vedotin|glembatumumab vedotin|mesh-list
110869263|NCT00704158|Immunoconjugates|immunoconjugates|mesh-ancestor
110365826|NCT05822674|Metformin|metformin|mesh-list
110869264|NCT00704158|Immunologic Factors|immunologic factors|mesh-ancestor
110869265|NCT00704158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110869266|NCT00704158|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110869267|NCT00704158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110869269|NCT03738527|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110869270|NCT03738527|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110365890|NCT05751629|Growth Inhibitors|growth inhibitors|mesh-ancestor
110869271|NCT03738527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110869272|NCT03738527|Hemostatics|hemostatics|mesh-ancestor
110869273|NCT03738527|Coagulants|coagulants|mesh-ancestor
110869274|NCT02915978|Fentanyl|fentanyl|mesh-list
110869275|NCT02915978|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110869276|NCT02915978|Narcotics|narcotics|mesh-ancestor
110869277|NCT02915978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110869278|NCT02915978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110869279|NCT02915978|Analgesics|analgesics|mesh-ancestor
110869280|NCT02915978|Sensory System Agents|sensory system agents|mesh-ancestor
110869281|NCT02915978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110869282|NCT02915978|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110869283|NCT02915978|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110869284|NCT02915978|Anesthetics, General|anesthetics, general|mesh-ancestor
110869285|NCT02915978|Anesthetics|anesthetics|mesh-ancestor
110869286|NCT02412904|Menotropins|menotropins|mesh-list
110869287|NCT02412904|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110869288|NCT02412904|Fertility Agents|fertility agents|mesh-ancestor
110869289|NCT02412904|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110869290|NCT02412904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110869291|NCT02408302|Midazolam|midazolam|mesh-list
110869292|NCT02408302|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110869293|NCT02408302|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110869294|NCT02408302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110869295|NCT02408302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110869296|NCT02408302|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110869297|NCT02408302|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110869298|NCT02408302|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110869299|NCT02408302|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110869300|NCT02408302|Anesthetics, General|anesthetics, general|mesh-ancestor
110869301|NCT02408302|Anesthetics|anesthetics|mesh-ancestor
110869302|NCT02408302|GABA Modulators|gaba modulators|mesh-ancestor
110869303|NCT02408302|GABA Agents|gaba agents|mesh-ancestor
110869304|NCT02408302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110869305|NCT02408302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110869306|NCT02408146|Celecoxib|celecoxib|mesh-list
110869307|NCT02408146|Parecoxib|parecoxib|mesh-list
110869308|NCT02408146|Fentanyl|fentanyl|mesh-list
110869309|NCT02408146|Ondansetron|ondansetron|mesh-list
110869310|NCT02408146|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110869311|NCT02408146|Narcotics|narcotics|mesh-ancestor
110869312|NCT02408146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110869313|NCT02408146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110869315|NCT02408146|Sensory System Agents|sensory system agents|mesh-ancestor
110869316|NCT02408146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110869317|NCT02408146|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110869318|NCT02408146|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110869319|NCT02408146|Anesthetics, General|anesthetics, general|mesh-ancestor
110869320|NCT02408146|Anesthetics|anesthetics|mesh-ancestor
110869321|NCT02408146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110869322|NCT02408146|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110869323|NCT02408146|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110869324|NCT02408146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110869325|NCT02408146|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110869326|NCT02408146|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110869327|NCT02408146|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110869328|NCT02408146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110869329|NCT02408146|Antiemetics|antiemetics|mesh-ancestor
110869330|NCT02408146|Autonomic Agents|autonomic agents|mesh-ancestor
110869331|NCT02408146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110869332|NCT02408146|Antipruritics|antipruritics|mesh-ancestor
110586853|NCT02596256|Docetaxel|docetaxel|mesh-list
110869333|NCT02408146|Dermatologic Agents|dermatologic agents|mesh-ancestor
110869334|NCT02408146|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110869335|NCT02408146|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110869336|NCT02408146|Serotonin Agents|serotonin agents|mesh-ancestor
110869337|NCT02408146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110869338|NCT03175666|Leucovorin|leucovorin|mesh-list
110869339|NCT03175666|Paclitaxel|paclitaxel|mesh-list
110869340|NCT03175666|Cyclophosphamide|cyclophosphamide|mesh-list
110366416|NCT02774005|Idebenone|idebenone|mesh-list
110869342|NCT03175666|Fluorouracil|fluorouracil|mesh-list
110869343|NCT03175666|Capecitabine|capecitabine|mesh-list
110869344|NCT03175666|Avelumab|avelumab|mesh-list
110869345|NCT03175666|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110869346|NCT03175666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110869347|NCT03175666|Tubulin Modulators|tubulin modulators|mesh-ancestor
110869348|NCT03175666|Antimitotic Agents|antimitotic agents|mesh-ancestor
110869349|NCT03175666|Mitosis Modulators|mitosis modulators|mesh-ancestor
110869350|NCT03175666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110869351|NCT03175666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110869352|NCT03175666|Immunologic Factors|immunologic factors|mesh-ancestor
110869353|NCT03175666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110869354|NCT03175666|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110869355|NCT03175666|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110869356|NCT03175666|Alkylating Agents|alkylating agents|mesh-ancestor
110869357|NCT03175666|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110869358|NCT03175666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110869359|NCT03175666|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110869360|NCT03175666|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110869361|NCT03175666|Growth Substances|growth substances|mesh-ancestor
110869362|NCT03175666|Growth Inhibitors|growth inhibitors|mesh-ancestor
110869363|NCT03175666|Antimetabolites|antimetabolites|mesh-ancestor
110869364|NCT03175666|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110869365|NCT03175666|Antidotes|antidotes|mesh-ancestor
110869366|NCT03175666|Protective Agents|protective agents|mesh-ancestor
110869367|NCT03175666|Vitamin B Complex|vitamin b complex|mesh-ancestor
110869368|NCT03175666|Vitamins|vitamins|mesh-ancestor
110869369|NCT03175666|Micronutrients|micronutrients|mesh-ancestor
110869370|NCT03101358|Paclitaxel|paclitaxel|mesh-list
110869371|NCT03101358|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110869372|NCT03101358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110869373|NCT03101358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110869374|NCT03101358|Tubulin Modulators|tubulin modulators|mesh-ancestor
110869375|NCT03101358|Antimitotic Agents|antimitotic agents|mesh-ancestor
110869376|NCT03101358|Mitosis Modulators|mitosis modulators|mesh-ancestor
110869377|NCT03101358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110869378|NCT03171220|Cyclophosphamide|cyclophosphamide|mesh-list
110869379|NCT03171220|Fludarabine|fludarabine|mesh-list
110869380|NCT03171220|Interleukin-2|interleukin-2|mesh-list
110869381|NCT03171220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110869382|NCT03171220|Immunologic Factors|immunologic factors|mesh-ancestor
110869383|NCT03171220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110869384|NCT03171220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110869385|NCT03171220|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110869386|NCT03171220|Alkylating Agents|alkylating agents|mesh-ancestor
110869387|NCT03171220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110869388|NCT03171220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110869389|NCT03171220|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110869390|NCT03171220|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110869391|NCT03171220|Analgesics|analgesics|mesh-ancestor
110869392|NCT03171220|Sensory System Agents|sensory system agents|mesh-ancestor
110869393|NCT03171220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110869394|NCT04853004|Antibodies|antibodies|mesh-list
110869395|NCT04853004|Immunologic Factors|immunologic factors|mesh-ancestor
110869396|NCT04853004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110869397|NCT03116542|Alovudine|alovudine|mesh-list
110869398|NCT03116542|Antiviral Agents|antiviral agents|mesh-ancestor
110869399|NCT03116542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110869400|NCT03170596|Tazarotene|tazarotene|mesh-list
110869401|NCT03170596|Dermatologic Agents|dermatologic agents|mesh-ancestor
110869402|NCT03170596|Keratolytic Agents|keratolytic agents|mesh-ancestor
110869403|NCT03173326|Anesthetics|anesthetics|mesh-list
110869404|NCT03173326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110869406|NCT03172858|Oxytocin|oxytocin|mesh-list
110869407|NCT03172858|Oxytocics|oxytocics|mesh-ancestor
110869408|NCT03172858|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110869409|NCT03172858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110869410|NCT02403856|Methylprednisolone|methylprednisolone|mesh-list
110869411|NCT02403856|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110586927|NCT00721305|Lovastatin|lovastatin|mesh-list
110869412|NCT02403856|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110869413|NCT02403856|Prednisolone|prednisolone|mesh-list
110869414|NCT02403856|Prednisolone acetate|prednisolone acetate|mesh-list
110869415|NCT02403856|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110869416|NCT02403856|Prednisolone phosphate|prednisolone phosphate|mesh-list
110869417|NCT02403856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110869418|NCT02403856|Antiemetics|antiemetics|mesh-ancestor
110869419|NCT02403856|Autonomic Agents|autonomic agents|mesh-ancestor
110869420|NCT02403856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110869421|NCT02403856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110869422|NCT02403856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110869423|NCT02403856|Glucocorticoids|glucocorticoids|mesh-ancestor
110869424|NCT02403856|Hormones|hormones|mesh-ancestor
110869425|NCT02403856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110869426|NCT02403856|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110869427|NCT02403856|Protective Agents|protective agents|mesh-ancestor
110869428|NCT02403856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110869429|NCT02403856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110869430|NCT03170284|Bevacizumab|bevacizumab|mesh-list
110869431|NCT03170284|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110869432|NCT03170284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110367002|NCT00549341|Cholinergic Agents|cholinergic agents|mesh-ancestor
110869434|NCT03170284|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110869435|NCT03170284|Growth Substances|growth substances|mesh-ancestor
110869436|NCT03170284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110869438|NCT02407912|Cisplatin|cisplatin|mesh-list
110869439|NCT02407912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110869441|NCT03170050|Anesthetics, Local|anesthetics, local|mesh-ancestor
110869442|NCT03170050|Anesthetics|anesthetics|mesh-ancestor
110869443|NCT03170050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110869444|NCT03170050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110869445|NCT03170050|Sensory System Agents|sensory system agents|mesh-ancestor
110869446|NCT03170050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110869447|NCT03170050|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110869448|NCT03170050|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110869449|NCT03170050|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110869450|NCT03170050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110869451|NCT03170050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110869452|NCT02407834|Sodium Hypochlorite|sodium hypochlorite|mesh-list
110869454|NCT02407834|Disinfectants|disinfectants|mesh-ancestor
110869455|NCT02407834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110869456|NCT03169738|Leucovorin|leucovorin|mesh-list
110869457|NCT03169738|Cyclophosphamide|cyclophosphamide|mesh-list
110869458|NCT03169738|Bevacizumab|bevacizumab|mesh-list
110869459|NCT03169738|Fluorouracil|fluorouracil|mesh-list
110869460|NCT03169738|Capecitabine|capecitabine|mesh-list
110869461|NCT03169738|Oxaliplatin|oxaliplatin|mesh-list
110869462|NCT03169738|Nivolumab|nivolumab|mesh-list
110869463|NCT03169738|Fulvestrant|fulvestrant|mesh-list
110869464|NCT03169738|Avelumab|avelumab|mesh-list
110869465|NCT03169738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110869466|NCT03169738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110869467|NCT03169738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110367430|NCT04628676|Sympathomimetics|sympathomimetics|mesh-ancestor
110869469|NCT03169738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110869470|NCT03169738|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110869471|NCT03169738|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110869472|NCT03169738|Alkylating Agents|alkylating agents|mesh-ancestor
110869473|NCT03169738|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110869474|NCT03169738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110869475|NCT03169738|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110869476|NCT03169738|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110869477|NCT03169738|Growth Substances|growth substances|mesh-ancestor
110869478|NCT03169738|Growth Inhibitors|growth inhibitors|mesh-ancestor
110869479|NCT03169738|Antimetabolites|antimetabolites|mesh-ancestor
110869480|NCT03169738|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110869481|NCT03169738|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110869482|NCT03169738|Antidotes|antidotes|mesh-ancestor
110869483|NCT03169738|Protective Agents|protective agents|mesh-ancestor
110869484|NCT03169738|Vitamin B Complex|vitamin b complex|mesh-ancestor
110869486|NCT03169738|Micronutrients|micronutrients|mesh-ancestor
110869487|NCT03169738|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110869488|NCT03169738|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110869489|NCT03169738|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110367581|NCT04800302|Morphine|morphine|mesh-list
110869490|NCT03169738|Hormone Antagonists|hormone antagonists|mesh-ancestor
110869491|NCT03169738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110869492|NCT02407600|Aprepitant|aprepitant|mesh-list
110869494|NCT02407600|Antiemetics|antiemetics|mesh-ancestor
110869495|NCT02407600|Autonomic Agents|autonomic agents|mesh-ancestor
110869496|NCT02407600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110869497|NCT02407600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110869498|NCT02407600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110869499|NCT02407600|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110869500|NCT02407600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110869501|NCT02407600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110869502|NCT02403544|Capecitabine|capecitabine|mesh-list
110869503|NCT02403544|Oxaliplatin|oxaliplatin|mesh-list
110367703|NCT04654962|Anesthetics|anesthetics|mesh-list
110869505|NCT02403544|Antimetabolites|antimetabolites|mesh-ancestor
110869506|NCT02403544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110869507|NCT02403544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110869508|NCT02411344|Pertuzumab|pertuzumab|mesh-list
110869509|NCT02411344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110869510|NCT02411344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110869511|NCT03657095|Beraprost|beraprost|mesh-list
110869512|NCT03657095|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110869513|NCT03657095|Vasodilator Agents|vasodilator agents|mesh-ancestor
110869514|NCT02407366|Carboplatin|carboplatin|mesh-list
110869515|NCT02407366|Pemetrexed|pemetrexed|mesh-list
110869516|NCT02407366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110869517|NCT02407366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110869518|NCT02407366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110869519|NCT02407366|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110869520|NCT02407366|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110869521|NCT03738137|Lidocaine|lidocaine|mesh-list
110869522|NCT03738137|Midazolam|midazolam|mesh-list
110869523|NCT03738137|Sufentanil|sufentanil|mesh-list
110869524|NCT03738137|Anesthetics, Local|anesthetics, local|mesh-ancestor
110869525|NCT03738137|Anesthetics|anesthetics|mesh-ancestor
110869526|NCT03738137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110869527|NCT03738137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110869528|NCT03738137|Sensory System Agents|sensory system agents|mesh-ancestor
110869529|NCT03738137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110869530|NCT03738137|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110869531|NCT03738137|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110869532|NCT03738137|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110869533|NCT03738137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110869534|NCT03738137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110869535|NCT03738137|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110869536|NCT03738137|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110869537|NCT03738137|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110869538|NCT03738137|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110869539|NCT03738137|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110869540|NCT03738137|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110367812|NCT04654026|Antipyretics|antipyretics|mesh-ancestor
110869541|NCT03738137|Anesthetics, General|anesthetics, general|mesh-ancestor
110869542|NCT03738137|GABA Modulators|gaba modulators|mesh-ancestor
110869543|NCT03738137|GABA Agents|gaba agents|mesh-ancestor
110869544|NCT03738137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110869545|NCT03738137|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110869546|NCT03738137|Narcotics|narcotics|mesh-ancestor
110869547|NCT03738137|Analgesics|analgesics|mesh-ancestor
110869548|NCT02407210|Olmesartan|olmesartan|mesh-list
110869549|NCT02407210|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
110869550|NCT02407210|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
110869551|NCT02407210|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110869552|NCT02407210|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110869553|NCT02407210|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110367938|NCT00562068|Prednisolone|prednisolone|mesh-list
110869554|NCT02407210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110869555|NCT03737201|Chlorhexidine|chlorhexidine|mesh-list
110869556|NCT03737201|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110869557|NCT03737201|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110869558|NCT03737201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110869559|NCT03737201|Disinfectants|disinfectants|mesh-ancestor
110368008|NCT02902640|Expectorants|expectorants|mesh-ancestor
110869560|NCT03737201|Dermatologic Agents|dermatologic agents|mesh-ancestor
110869561|NCT03175042|Chrysarobin|chrysarobin|mesh-list
110869562|NCT03175042|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110869563|NCT03175042|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110869564|NCT03175042|Analgesics|analgesics|mesh-ancestor
110869565|NCT03175042|Sensory System Agents|sensory system agents|mesh-ancestor
110368073|NCT04623021|Immunologic Factors|immunologic factors|mesh-ancestor
110869566|NCT03175042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110869567|NCT03175042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110869568|NCT03175042|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110869569|NCT03175042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110869570|NCT03738059|Dexmedetomidine|dexmedetomidine|mesh-list
110869571|NCT03738059|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110869572|NCT03738059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110869573|NCT03738059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110869574|NCT03738059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110869575|NCT03738059|Analgesics|analgesics|mesh-ancestor
110869576|NCT03738059|Sensory System Agents|sensory system agents|mesh-ancestor
110869577|NCT03738059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110869578|NCT03738059|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110869579|NCT03738059|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110869580|NCT03738059|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110869581|NCT03738059|Adrenergic Agents|adrenergic agents|mesh-ancestor
110869582|NCT03738059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110869583|NCT03738059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110869584|NCT05233462|Bupivacaine|bupivacaine|mesh-list
110368147|NCT04621461|Zinc Sulfate|zinc sulfate|mesh-list
110869585|NCT05233462|Anesthetics, Local|anesthetics, local|mesh-ancestor
110869586|NCT05233462|Anesthetics|anesthetics|mesh-ancestor
110869587|NCT05233462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110869588|NCT05233462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110869589|NCT05233462|Sensory System Agents|sensory system agents|mesh-ancestor
110869590|NCT05233462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110869591|NCT02700412|Cannabidiol|cannabidiol|mesh-list
110869592|NCT02700412|Anticonvulsants|anticonvulsants|mesh-ancestor
110869593|NCT02351544|Botulinum Toxins|botulinum toxins|mesh-list
110869594|NCT02351544|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110869595|NCT02351544|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110869596|NCT02351544|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110869597|NCT02351544|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110869598|NCT02351544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110869599|NCT02351544|Cholinergic Agents|cholinergic agents|mesh-ancestor
110869600|NCT02351544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110869601|NCT02351544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110869602|NCT02351544|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110368259|NCT04621227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110869603|NCT02351544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110869605|NCT02288832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110869606|NCT02288832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110869607|NCT03116308|Opicapone|opicapone|mesh-list
110869608|NCT03116308|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
110869609|NCT03116308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110869610|NCT03116308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110869611|NCT03116308|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110869612|NCT03116308|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110869613|NCT03665441|Leucovorin|leucovorin|mesh-list
110869614|NCT03665441|Paclitaxel|paclitaxel|mesh-list
110869615|NCT03665441|Gemcitabine|gemcitabine|mesh-list
110869616|NCT03665441|Irinotecan|irinotecan|mesh-list
110869617|NCT03665441|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110869618|NCT03665441|Asparaginase|asparaginase|mesh-list
110869619|NCT03665441|Eryaspase|eryaspase|mesh-list
110869620|NCT03665441|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110869621|NCT03665441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110869622|NCT03665441|Tubulin Modulators|tubulin modulators|mesh-ancestor
110869623|NCT03665441|Antimitotic Agents|antimitotic agents|mesh-ancestor
110869624|NCT03665441|Mitosis Modulators|mitosis modulators|mesh-ancestor
110869625|NCT03665441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110869626|NCT03665441|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110869627|NCT03665441|Antimetabolites|antimetabolites|mesh-ancestor
110869628|NCT03665441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110869629|NCT03665441|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110834959|NCT03792295|Acetaminophen|acetaminophen|mesh-list
110869631|NCT03665441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110869632|NCT03665441|Antidotes|antidotes|mesh-ancestor
110869633|NCT03665441|Protective Agents|protective agents|mesh-ancestor
110869634|NCT03665441|Vitamin B Complex|vitamin b complex|mesh-ancestor
110869635|NCT03665441|Vitamins|vitamins|mesh-ancestor
110869636|NCT03665441|Micronutrients|micronutrients|mesh-ancestor
110869637|NCT03169660|Aflibercept|aflibercept|mesh-list
110869638|NCT03169660|Mitogens|mitogens|mesh-list
110869639|NCT03169660|Endothelial Growth Factors|endothelial growth factors|mesh-list
110869640|NCT03169660|Mitosis Modulators|mitosis modulators|mesh-ancestor
110368453|NCT01189435|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110367436|NCT04628676|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110869641|NCT03169660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110869642|NCT03169660|Growth Substances|growth substances|mesh-ancestor
110869643|NCT03169660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110869644|NCT03169660|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110869645|NCT03169660|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110869646|NCT03169660|Growth Inhibitors|growth inhibitors|mesh-ancestor
110869647|NCT03169660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110869648|NCT02401828|Dolutegravir|dolutegravir|mesh-list
110869649|NCT02401828|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110869650|NCT02401828|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110869651|NCT02401828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110869652|NCT02401828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110869653|NCT02401828|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110869654|NCT02401828|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110869655|NCT02401828|Antiviral Agents|antiviral agents|mesh-ancestor
110869656|NCT02401828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110869657|NCT02401594|Enoxaparin|enoxaparin|mesh-list
110869658|NCT02401594|Rivaroxaban|rivaroxaban|mesh-list
110869659|NCT02401594|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110869660|NCT02401594|Antithrombins|antithrombins|mesh-ancestor
110869661|NCT02401594|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110869662|NCT02401594|Protease Inhibitors|protease inhibitors|mesh-ancestor
110869663|NCT02401594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110869664|NCT02401594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110869665|NCT02401594|Anticoagulants|anticoagulants|mesh-ancestor
110869666|NCT02401594|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110869667|NCT02401594|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110869668|NCT02406508|Sorafenib|sorafenib|mesh-list
110869669|NCT02406508|Melphalan|melphalan|mesh-list
110869670|NCT02406508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110869671|NCT02406508|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110869672|NCT02406508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110869673|NCT02406508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110869674|NCT02406508|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110869675|NCT02406508|Alkylating Agents|alkylating agents|mesh-ancestor
110869676|NCT02406508|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110869677|NCT02406508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110869678|NCT02406508|Immunologic Factors|immunologic factors|mesh-ancestor
110869679|NCT02406508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110869680|NCT03662789|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
110869681|NCT03662789|Hematinics|hematinics|mesh-ancestor
110869682|NCT04481932|Trastuzumab|trastuzumab|mesh-list
110869683|NCT04481932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110869684|NCT04481932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110869685|NCT03169582|Sildenafil Citrate|sildenafil citrate|mesh-list
110869686|NCT03169582|Vasodilator Agents|vasodilator agents|mesh-ancestor
110869687|NCT03169582|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110869688|NCT03169582|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110869689|NCT03169582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110869690|NCT03169582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110869691|NCT03169582|Urological Agents|urological agents|mesh-ancestor
110869692|NCT03655691|Botulinum Toxins|botulinum toxins|mesh-list
110869693|NCT03655691|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110869694|NCT03655691|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110869695|NCT03655691|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110869696|NCT03655691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110064496|NCT01527864|Paclitaxel|paclitaxel|mesh-list
110869697|NCT03655691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110869698|NCT03655691|Cholinergic Agents|cholinergic agents|mesh-ancestor
110869699|NCT03655691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110869700|NCT03655691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110869701|NCT03655691|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110869702|NCT03655691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110869703|NCT03169504|Fluticasone|fluticasone|mesh-list
110869705|NCT03169504|Bromides|bromides|mesh-list
110064635|NCT01528644|Iron|iron|mesh-list
110869707|NCT03169504|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110869708|NCT03169504|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110869709|NCT03169504|Autonomic Agents|autonomic agents|mesh-ancestor
110869710|NCT03169504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110869711|NCT03169504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110869712|NCT03169504|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110869713|NCT03169504|Respiratory System Agents|respiratory system agents|mesh-ancestor
110869714|NCT03169504|Dermatologic Agents|dermatologic agents|mesh-ancestor
110869715|NCT03169504|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110869716|NCT03169504|Parasympatholytics|parasympatholytics|mesh-ancestor
110869717|NCT03169504|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110869718|NCT03169504|Cholinergic Agents|cholinergic agents|mesh-ancestor
110869719|NCT03169504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110869720|NCT03169504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110869721|NCT03169504|Anticonvulsants|anticonvulsants|mesh-ancestor
110869722|NCT03169426|Carvedilol|carvedilol|mesh-list
110869723|NCT03169426|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
110869724|NCT03169426|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110869726|NCT03169426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110869727|NCT03169426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110869728|NCT03169426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110869729|NCT03169426|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110869730|NCT03169426|Antioxidants|antioxidants|mesh-ancestor
110869731|NCT03169426|Protective Agents|protective agents|mesh-ancestor
110869732|NCT03169426|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110869733|NCT03169426|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110869734|NCT03169426|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110869735|NCT03169426|Vasodilator Agents|vasodilator agents|mesh-ancestor
110869736|NCT03169426|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110869737|NCT03169426|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110869738|NCT03580928|Venetoclax|venetoclax|mesh-list
110869739|NCT03580928|Obinutuzumab|obinutuzumab|mesh-list
110869740|NCT03580928|Acalabrutinib|acalabrutinib|mesh-list
110869741|NCT03580928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110869742|NCT03580928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110869743|NCT03169348|Sofosbuvir|sofosbuvir|mesh-list
110869744|NCT03169348|Ledipasvir|ledipasvir|mesh-list
110869745|NCT03169348|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
110869746|NCT03169348|Antiviral Agents|antiviral agents|mesh-ancestor
110869747|NCT03169348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110869748|NCT03631355|Tranexamic Acid|tranexamic acid|mesh-list
110869749|NCT03631355|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110869750|NCT03631355|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110869751|NCT03631355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110869752|NCT03631355|Hemostatics|hemostatics|mesh-ancestor
110869754|NCT03571568|Rituximab|rituximab|mesh-list
110869755|NCT03571568|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110869756|NCT03571568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110869757|NCT03571568|Immunologic Factors|immunologic factors|mesh-ancestor
110064962|NCT01530152|Lidocaine|lidocaine|mesh-list
110869758|NCT03571568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110869759|NCT03571568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110869760|NCT03169192|Zoledronic Acid|zoledronic acid|mesh-list
110869761|NCT03169192|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110869762|NCT03169192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110869763|NCT03679052|Clonidine|clonidine|mesh-list
110869765|NCT03679052|Analgesics|analgesics|mesh-ancestor
110869766|NCT03679052|Sensory System Agents|sensory system agents|mesh-ancestor
110869767|NCT03679052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110869768|NCT03679052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110869769|NCT03679052|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110869770|NCT03679052|Sympatholytics|sympatholytics|mesh-ancestor
110869771|NCT03679052|Autonomic Agents|autonomic agents|mesh-ancestor
110869772|NCT03679052|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110869773|NCT03679052|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110869774|NCT03679052|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110869775|NCT03679052|Adrenergic Agents|adrenergic agents|mesh-ancestor
110869776|NCT03679052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110869777|NCT03679052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110869778|NCT03679052|Antidepressive Agents|antidepressive agents|mesh-ancestor
110869779|NCT03679052|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110869780|NCT03679052|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110869781|NCT03679052|Histamine Antagonists|histamine antagonists|mesh-ancestor
110869782|NCT03679052|Histamine Agents|histamine agents|mesh-ancestor
110869783|NCT03679052|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110869784|NCT03679052|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110869785|NCT03679052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110869786|NCT03679052|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
110065375|NCT01532726|Anticonvulsants|anticonvulsants|mesh-ancestor
110869787|NCT03679052|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110869788|NCT03679052|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110869789|NCT03679052|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110869790|NCT03679052|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110869791|NCT03679052|Serotonin Agents|serotonin agents|mesh-ancestor
110869792|NCT03679052|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110869793|NCT03540914|Acetazolamide|acetazolamide|mesh-list
110869794|NCT03540914|Anticonvulsants|anticonvulsants|mesh-ancestor
110869795|NCT03540914|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110869796|NCT03540914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110869797|NCT03540914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110869798|NCT03540914|Diuretics|diuretics|mesh-ancestor
110869799|NCT03540914|Natriuretic Agents|natriuretic agents|mesh-ancestor
110869800|NCT03540914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110869801|NCT03629249|Indoleacetic Acids|indoleacetic acids|mesh-list
110869802|NCT03629249|Plant Growth Regulators|plant growth regulators|mesh-ancestor
110869803|NCT03629249|Growth Substances|growth substances|mesh-ancestor
110869804|NCT03629249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110869805|NCT03671174|Aspirin|aspirin|mesh-list
110869806|NCT03671174|Hydroxychloroquine|hydroxychloroquine|mesh-list
110869807|NCT03671174|Prednisone|prednisone|mesh-list
110869808|NCT03671174|Heparin|heparin|mesh-list
110869809|NCT03671174|Enoxaparin|enoxaparin|mesh-list
110869810|NCT03671174|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
110869811|NCT03671174|Tinzaparin|tinzaparin|mesh-list
110869812|NCT03671174|Dalteparin|dalteparin|mesh-list
110869813|NCT03671174|Nadroparin|nadroparin|mesh-list
110869814|NCT03671174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110065608|NCT01533740|Leucovorin|leucovorin|mesh-list
110869815|NCT03671174|Glucocorticoids|glucocorticoids|mesh-ancestor
110869817|NCT03671174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110869818|NCT03671174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110869819|NCT03671174|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110869820|NCT03671174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110869821|NCT03671174|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110869822|NCT03671174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110869823|NCT03671174|Analgesics|analgesics|mesh-ancestor
110869824|NCT03671174|Sensory System Agents|sensory system agents|mesh-ancestor
110869825|NCT03671174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110065726|NCT01534546|Oxaliplatin|oxaliplatin|mesh-list
110869826|NCT03671174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110869827|NCT03671174|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110869828|NCT03671174|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110869829|NCT03671174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110869830|NCT03671174|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110869831|NCT03671174|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110869832|NCT03671174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110869833|NCT03671174|Antipyretics|antipyretics|mesh-ancestor
110869834|NCT03671174|Anticoagulants|anticoagulants|mesh-ancestor
110869835|NCT03671174|Antimalarials|antimalarials|mesh-ancestor
110869836|NCT03671174|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110869837|NCT03671174|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110869838|NCT03671174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110869839|NCT03172234|Amantadine|amantadine|mesh-list
110869840|NCT03172234|Gabapentin|gabapentin|mesh-list
110869841|NCT03172234|Analgesics|analgesics|mesh-ancestor
110869842|NCT03172234|Sensory System Agents|sensory system agents|mesh-ancestor
110869843|NCT03172234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110869844|NCT03172234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110869845|NCT03172234|Anticonvulsants|anticonvulsants|mesh-ancestor
110869846|NCT03172234|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110869847|NCT03172234|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110869848|NCT03172234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110869849|NCT03172234|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110869850|NCT03172234|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110869851|NCT03172234|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110869852|NCT03172234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110869853|NCT03172234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110869854|NCT03172234|Antimanic Agents|antimanic agents|mesh-ancestor
110869855|NCT03172234|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110869856|NCT03172234|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110869857|NCT03172234|Antiviral Agents|antiviral agents|mesh-ancestor
110869858|NCT03172234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110869859|NCT03172234|Dopamine Agents|dopamine agents|mesh-ancestor
110869860|NCT03172234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110869861|NCT03709849|Citric Acid|citric acid|mesh-list
110869862|NCT03709849|Sodium Citrate|sodium citrate|mesh-list
110869863|NCT03709849|Clomiphene|clomiphene|mesh-list
110869864|NCT03709849|Enclomiphene|enclomiphene|mesh-list
110869865|NCT03709849|Zuclomiphene|zuclomiphene|mesh-list
110869866|NCT03709849|Anticoagulants|anticoagulants|mesh-ancestor
110869867|NCT03709849|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110869868|NCT03709849|Chelating Agents|chelating agents|mesh-ancestor
110869869|NCT03709849|Sequestering Agents|sequestering agents|mesh-ancestor
110869870|NCT03709849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110869871|NCT03709849|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110869872|NCT03709849|Hormone Antagonists|hormone antagonists|mesh-ancestor
110869873|NCT03709849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110869874|NCT03709849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110869875|NCT03709849|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110869876|NCT03709849|Fertility Agents|fertility agents|mesh-ancestor
110869877|NCT03709849|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110869878|NCT03709849|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110869879|NCT03709849|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110869880|NCT05343325|Paclitaxel|paclitaxel|mesh-list
110869881|NCT05343325|Cisplatin|cisplatin|mesh-list
110869882|NCT05343325|Tislelizumab|tislelizumab|mesh-list
110869883|NCT05343325|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110869884|NCT05343325|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110869885|NCT05343325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110869886|NCT05343325|Tubulin Modulators|tubulin modulators|mesh-ancestor
110869887|NCT05343325|Antimitotic Agents|antimitotic agents|mesh-ancestor
110869888|NCT05343325|Mitosis Modulators|mitosis modulators|mesh-ancestor
110869889|NCT05343325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110869890|NCT05343325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110869891|NCT03349333|Folic Acid|folic acid|mesh-list
110869892|NCT03349333|Vitamin B 12|vitamin b 12|mesh-list
110869893|NCT03349333|Hydroxocobalamin|hydroxocobalamin|mesh-list
110869894|NCT03349333|Vitamins|vitamins|mesh-ancestor
110869895|NCT03349333|Micronutrients|micronutrients|mesh-ancestor
110869896|NCT03349333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110869897|NCT03349333|Hematinics|hematinics|mesh-ancestor
110065892|NCT01535547|Isavuconazole|isavuconazole|mesh-list
110869898|NCT03349333|Vitamin B Complex|vitamin b complex|mesh-ancestor
110869899|NCT03365791|Spartalizumab|spartalizumab|mesh-list
110869900|NCT03365791|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110869901|NCT03365791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110869902|NCT03365791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110869903|NCT03365791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110869904|NCT03365011|Nitrous Oxide|nitrous oxide|mesh-list
110869905|NCT03365011|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110869906|NCT03365011|Anesthetics, General|anesthetics, general|mesh-ancestor
110869907|NCT03365011|Anesthetics|anesthetics|mesh-ancestor
110869908|NCT03365011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110869909|NCT03365011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110869910|NCT03365011|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110869911|NCT03365011|Analgesics|analgesics|mesh-ancestor
110869912|NCT03365011|Sensory System Agents|sensory system agents|mesh-ancestor
110869913|NCT03365011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110869914|NCT03627767|Abrocitinib|abrocitinib|mesh-list
110869915|NCT03627767|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110869916|NCT03627767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110869917|NCT03627767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110869918|NCT03732365|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110869919|NCT03732365|Cefazolin|cefazolin|mesh-list
110869920|NCT03732365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110869921|NCT03732287|Anesthetics|anesthetics|mesh-list
110869922|NCT03732287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110869923|NCT03732287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110869924|NCT02142738|Paclitaxel|paclitaxel|mesh-list
110869925|NCT02142738|Carboplatin|carboplatin|mesh-list
110869926|NCT02142738|Gemcitabine|gemcitabine|mesh-list
110869927|NCT02142738|Pembrolizumab|pembrolizumab|mesh-list
110869928|NCT02142738|Pemetrexed|pemetrexed|mesh-list
110869929|NCT02142738|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110066015|NCT01536158|Antipyretics|antipyretics|mesh-ancestor
110869930|NCT02142738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110869931|NCT02142738|Tubulin Modulators|tubulin modulators|mesh-ancestor
110869932|NCT02142738|Antimitotic Agents|antimitotic agents|mesh-ancestor
110869933|NCT02142738|Mitosis Modulators|mitosis modulators|mesh-ancestor
110869934|NCT02142738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110869935|NCT02142738|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110869936|NCT02142738|Antimetabolites|antimetabolites|mesh-ancestor
110869937|NCT02142738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110869938|NCT02142738|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110869939|NCT02142738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110367510|NCT01213966|Artefenomel|artefenomel|mesh-list
110869940|NCT02142738|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110869941|NCT02142738|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110869942|NCT03617861|Secretin|secretin|mesh-list
110869943|NCT03617861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110869944|NCT03617861|Hormones|hormones|mesh-ancestor
110869945|NCT03617861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110869946|NCT03617861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110869947|NCT03614975|Vaccines|vaccines|mesh-list
110869948|NCT03614975|Immunologic Factors|immunologic factors|mesh-ancestor
110066069|NCT01536431|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110869949|NCT03614975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110869950|NCT03613649|Moxifloxacin|moxifloxacin|mesh-list
110869951|NCT03613649|Zoliflodacin|zoliflodacin|mesh-list
110869952|NCT03613649|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110869953|NCT03613649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110869954|NCT03613649|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110869955|NCT03613649|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110869956|NCT03613649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110869957|NCT03613649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110869958|NCT03613649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110869959|NCT03096288|Evolocumab|evolocumab|mesh-list
110869960|NCT03096288|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
110869961|NCT03096288|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110869962|NCT03096288|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110869963|NCT03096288|Antimetabolites|antimetabolites|mesh-ancestor
110066197|NCT01537250|Ofloxacin|ofloxacin|mesh-list
110869964|NCT03096288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110869965|NCT03096288|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110869966|NCT03096288|Protease Inhibitors|protease inhibitors|mesh-ancestor
110869967|NCT03096288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110869968|NCT03096288|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110869969|NCT03731897|Lidocaine|lidocaine|mesh-list
110869970|NCT03731897|Anesthetics, Local|anesthetics, local|mesh-ancestor
110869971|NCT03731897|Anesthetics|anesthetics|mesh-ancestor
110869972|NCT03731897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110869973|NCT03731897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110869974|NCT03731897|Sensory System Agents|sensory system agents|mesh-ancestor
110869975|NCT03731897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110869976|NCT03731897|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110869977|NCT03731897|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110869978|NCT03731897|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110869979|NCT03731897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110869980|NCT03731897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110869981|NCT02072148|Cisplatin|cisplatin|mesh-list
110869982|NCT02072148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110869983|NCT04456608|Aspirin|aspirin|mesh-list
110869984|NCT04456608|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110869985|NCT04456608|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110869986|NCT04456608|Analgesics|analgesics|mesh-ancestor
110869987|NCT04456608|Sensory System Agents|sensory system agents|mesh-ancestor
110869988|NCT04456608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110066390|NCT01538459|Anesthetics|anesthetics|mesh-ancestor
110869989|NCT04456608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110869990|NCT04456608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110869991|NCT04456608|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110869992|NCT04456608|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110869993|NCT04456608|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110066454|NCT01538693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110869994|NCT04456608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110869995|NCT04456608|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110869996|NCT04456608|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110869997|NCT04456608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110869998|NCT04456608|Antipyretics|antipyretics|mesh-ancestor
110869999|NCT04450212|Vitamin K|vitamin k|mesh-list
110870000|NCT04450212|Vitamins|vitamins|mesh-ancestor
110870001|NCT04450212|Micronutrients|micronutrients|mesh-ancestor
110870002|NCT04450212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110870003|NCT04450212|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110870004|NCT04450212|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110870005|NCT04450212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110870006|NCT04450212|Hemostatics|hemostatics|mesh-ancestor
110870007|NCT04450212|Coagulants|coagulants|mesh-ancestor
110870009|NCT05074290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110870010|NCT03095508|Menthol|menthol|mesh-list
110870011|NCT03095508|Antipruritics|antipruritics|mesh-ancestor
110870012|NCT03095508|Dermatologic Agents|dermatologic agents|mesh-ancestor
110870013|NCT03632538|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
110870014|NCT03632538|Protein C Inhibitor|protein c inhibitor|mesh-list
110870015|NCT03632538|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
110870016|NCT03632538|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110870017|NCT03632538|Protease Inhibitors|protease inhibitors|mesh-ancestor
110870018|NCT03632538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110870019|NCT03632538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110870020|NCT03731741|Pentoxifylline|pentoxifylline|mesh-list
110870021|NCT03731741|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110587528|NCT04956627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110870022|NCT03731741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110870023|NCT03731741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110870024|NCT03731741|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110870025|NCT03731741|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110870026|NCT03731741|Protective Agents|protective agents|mesh-ancestor
110870027|NCT03731741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110870028|NCT03731741|Vasodilator Agents|vasodilator agents|mesh-ancestor
110870029|NCT03731741|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110870030|NCT03731741|Antioxidants|antioxidants|mesh-ancestor
110870031|NCT03736187|Metronidazole|metronidazole|mesh-list
110870032|NCT03736187|Cephalexin|cephalexin|mesh-list
110870033|NCT03736187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110870034|NCT03736187|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110870035|NCT03736187|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110066727|NCT01540032|Salicylates|salicylates|mesh-list
110870036|NCT03736187|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110870038|NCT03731429|Anesthetics, Local|anesthetics, local|mesh-ancestor
110870039|NCT03731429|Anesthetics|anesthetics|mesh-ancestor
110870040|NCT03731429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110870041|NCT03731429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110870042|NCT03731429|Sensory System Agents|sensory system agents|mesh-ancestor
110870043|NCT03731429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110870044|NCT03731429|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110870045|NCT03731429|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110870046|NCT03731429|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110870047|NCT03731429|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110870048|NCT03731429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110870049|NCT03602339|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
110870050|NCT03602339|Chelating Agents|chelating agents|mesh-ancestor
110870051|NCT03602339|Sequestering Agents|sequestering agents|mesh-ancestor
110870052|NCT03602339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110870053|NCT03653429|Tranexamic Acid|tranexamic acid|mesh-list
110870054|NCT03653429|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110870055|NCT03653429|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110870056|NCT03653429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110870057|NCT03653429|Hemostatics|hemostatics|mesh-ancestor
110870058|NCT03653429|Coagulants|coagulants|mesh-ancestor
110870059|NCT03731117|Furosemide|furosemide|mesh-list
110870060|NCT03731117|Diuretics|diuretics|mesh-ancestor
110870061|NCT03731117|Natriuretic Agents|natriuretic agents|mesh-ancestor
110870062|NCT03731117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110870063|NCT03731117|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110870064|NCT03731117|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110066927|NCT01541137|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110870065|NCT03731117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110870067|NCT03735251|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
110870068|NCT03735251|Diuretics|diuretics|mesh-list
110870069|NCT03735251|Natriuretic Agents|natriuretic agents|mesh-ancestor
110870070|NCT03735251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110870071|NCT03735251|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110870072|NCT03735251|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110870073|NCT03735251|Sympatholytics|sympatholytics|mesh-ancestor
110870074|NCT03735251|Autonomic Agents|autonomic agents|mesh-ancestor
110870075|NCT03735251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110870076|NCT03735251|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110870078|NCT03735251|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110870079|NCT03735251|Adrenergic Agents|adrenergic agents|mesh-ancestor
110870080|NCT03735251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110835026|NCT03448744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110870081|NCT03735251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110870082|NCT03098550|Nivolumab|nivolumab|mesh-list
110870083|NCT03098550|Daratumumab|daratumumab|mesh-list
110870084|NCT03098550|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110870085|NCT03098550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110870086|NCT03098550|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110870087|NCT03098550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110870088|NCT03095118|Daratumumab|daratumumab|mesh-list
110870089|NCT03095118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110870090|NCT04224480|Pembrolizumab|pembrolizumab|mesh-list
110870091|NCT04224480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110870092|NCT04224480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110870093|NCT04224480|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110870094|NCT04224480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110870095|NCT05386758|Molnupiravir|molnupiravir|mesh-list
110870096|NCT05386758|Antiviral Agents|antiviral agents|mesh-ancestor
110870097|NCT05386758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110870098|NCT03169114|Amikacin|amikacin|mesh-list
110870099|NCT03169114|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110870100|NCT03169114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110870101|NCT03115762|Bevacizumab|bevacizumab|mesh-list
110870102|NCT03115762|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110870103|NCT03115762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110870104|NCT03115762|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110870105|NCT03115762|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110870106|NCT03115762|Growth Substances|growth substances|mesh-ancestor
110870107|NCT03115762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110870108|NCT03115762|Growth Inhibitors|growth inhibitors|mesh-ancestor
110870109|NCT03168958|Methadone|methadone|mesh-list
110870110|NCT03168958|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110870111|NCT03168958|Narcotics|narcotics|mesh-ancestor
110367555|NCT00561756|Vaccines|vaccines|mesh-list
110870112|NCT03168958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110067102|NCT01542099|Remifentanil|remifentanil|mesh-list
110870113|NCT03168958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110870114|NCT03168958|Analgesics|analgesics|mesh-ancestor
110870115|NCT03168958|Sensory System Agents|sensory system agents|mesh-ancestor
110870116|NCT03168958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110870117|NCT03168958|Antitussive Agents|antitussive agents|mesh-ancestor
110870118|NCT03168958|Respiratory System Agents|respiratory system agents|mesh-ancestor
110870119|NCT03632460|Dexmedetomidine|dexmedetomidine|mesh-list
110870120|NCT03632460|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110870121|NCT03632460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110870122|NCT03632460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110870123|NCT03632460|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110870124|NCT03632460|Analgesics|analgesics|mesh-ancestor
110870125|NCT03632460|Sensory System Agents|sensory system agents|mesh-ancestor
110870126|NCT03632460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110870127|NCT03632460|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110870128|NCT03632460|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110870129|NCT03632460|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110870130|NCT03632460|Adrenergic Agents|adrenergic agents|mesh-ancestor
110870131|NCT03632460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110870132|NCT03632460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110870133|NCT05418660|Pembrolizumab|pembrolizumab|mesh-list
110870135|NCT05418660|Atezolizumab|atezolizumab|mesh-list
110870136|NCT05418660|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110870137|NCT05418660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110870138|NCT05418660|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110870139|NCT05418660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110870140|NCT03364309|Ixekizumab|ixekizumab|mesh-list
110870141|NCT03364309|Dermatologic Agents|dermatologic agents|mesh-ancestor
110870142|NCT03168178|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110870143|NCT03168178|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
110870144|NCT03168178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110870145|NCT03168178|Antitubercular Agents|antitubercular agents|mesh-ancestor
110870147|NCT05166096|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110870148|NCT05166096|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110870149|NCT05166096|Analgesics|analgesics|mesh-ancestor
110870150|NCT05166096|Sensory System Agents|sensory system agents|mesh-ancestor
110870151|NCT05166096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110870152|NCT05166096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110870153|NCT05166096|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110870154|NCT05166096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110870155|NCT05166096|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110870156|NCT05166096|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110870157|NCT05166096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110870158|NCT05166096|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110870159|NCT05166096|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110870160|NCT05166096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110870161|NCT05166096|Antipyretics|antipyretics|mesh-ancestor
110870162|NCT03168412|Vaccines|vaccines|mesh-list
110870163|NCT03168412|Immunologic Factors|immunologic factors|mesh-ancestor
110870164|NCT03168412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110870165|NCT05110638|Luliconazole|luliconazole|mesh-list
110870166|NCT05110638|Antifungal Agents|antifungal agents|mesh-ancestor
110870167|NCT05110638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110870168|NCT03700788|Chlorhexidine|chlorhexidine|mesh-list
110870169|NCT03700788|Calcium|calcium|mesh-list
110587680|NCT02569905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110870170|NCT03700788|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110870171|NCT03700788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110870172|NCT03700788|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110870173|NCT03700788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110870174|NCT03700788|Disinfectants|disinfectants|mesh-ancestor
110870175|NCT03334903|Gabapentin|gabapentin|mesh-list
110870176|NCT03334903|Analgesics|analgesics|mesh-ancestor
110870177|NCT03334903|Sensory System Agents|sensory system agents|mesh-ancestor
110870178|NCT03334903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110870179|NCT03334903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110870180|NCT03334903|Anticonvulsants|anticonvulsants|mesh-ancestor
110870181|NCT03334903|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110870182|NCT03334903|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110870183|NCT03334903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110870184|NCT03334903|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110870185|NCT03334903|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110870186|NCT03334903|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110870187|NCT03334903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110870188|NCT03334903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110870189|NCT03334903|Antimanic Agents|antimanic agents|mesh-ancestor
110870190|NCT03168100|Dexamethasone|dexamethasone|mesh-list
110870191|NCT03168100|Lenalidomide|lenalidomide|mesh-list
110870192|NCT03168100|Bortezomib|bortezomib|mesh-list
110870193|NCT03168100|Elotuzumab|elotuzumab|mesh-list
110870194|NCT03168100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110870195|NCT03168100|Antiemetics|antiemetics|mesh-ancestor
110870196|NCT03168100|Autonomic Agents|autonomic agents|mesh-ancestor
110870197|NCT03168100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110870198|NCT03168100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110870199|NCT03168100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110870200|NCT03168100|Glucocorticoids|glucocorticoids|mesh-ancestor
110870201|NCT03168100|Hormones|hormones|mesh-ancestor
110870202|NCT03168100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110870203|NCT03168100|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110870204|NCT03168100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110870205|NCT03168100|Immunologic Factors|immunologic factors|mesh-ancestor
110870206|NCT03168100|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110870207|NCT03168100|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110870208|NCT03168100|Growth Substances|growth substances|mesh-ancestor
110870209|NCT03168100|Growth Inhibitors|growth inhibitors|mesh-ancestor
110870210|NCT03709381|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
110870211|NCT03709381|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
110870212|NCT03709381|Cosyntropin|cosyntropin|mesh-list
110870213|NCT03709381|beta-Endorphin|beta-endorphin|mesh-list
110870214|NCT03709381|Hormones|hormones|mesh-ancestor
110870215|NCT03709381|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110870216|NCT03709381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110870217|NCT03709381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110870218|NCT03709381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110870219|NCT01353664|Romidepsin|romidepsin|mesh-list
110870220|NCT01353664|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110870221|NCT01353664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110870222|NCT01353664|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110870223|NCT01353664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110067359|NCT01543932|Ticagrelor|ticagrelor|mesh-list
110870224|NCT01353664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110870225|NCT02395744|Paclitaxel|paclitaxel|mesh-list
110870226|NCT02395744|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110870227|NCT02395744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110870228|NCT02395744|Tubulin Modulators|tubulin modulators|mesh-ancestor
110870229|NCT02395744|Antimitotic Agents|antimitotic agents|mesh-ancestor
110870230|NCT02395744|Mitosis Modulators|mitosis modulators|mesh-ancestor
110870231|NCT02395744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110870232|NCT02400268|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110870233|NCT02400268|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
110870234|NCT02400268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110870235|NCT02400268|Antitubercular Agents|antitubercular agents|mesh-ancestor
110870236|NCT03168568|Valsartan|valsartan|mesh-list
110870237|NCT03168568|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
110870238|NCT03168568|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110870239|NCT03168568|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110870240|NCT03168568|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110870241|NCT03168568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110870242|NCT02400112|Vancomycin|vancomycin|mesh-list
110870243|NCT02400112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110870244|NCT02400112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110870245|NCT02694328|Olanzapine|olanzapine|mesh-list
110870246|NCT02694328|Antiemetics|antiemetics|mesh-ancestor
110870247|NCT02694328|Autonomic Agents|autonomic agents|mesh-ancestor
110870248|NCT02694328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110870249|NCT02694328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110870250|NCT02694328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110870251|NCT02694328|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110870252|NCT02694328|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110870253|NCT02694328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110870254|NCT02694328|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110870255|NCT02694328|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110870256|NCT02694328|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110870257|NCT02694328|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110870258|NCT02694328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110870259|NCT02694328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110870260|NCT02694328|Serotonin Agents|serotonin agents|mesh-ancestor
110870261|NCT02395510|Vortioxetine|vortioxetine|mesh-list
110870262|NCT02395510|Antidepressive Agents|antidepressive agents|mesh-ancestor
110870263|NCT02395510|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110870264|NCT02395510|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110870265|NCT02395510|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110870266|NCT02395510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110870267|NCT02395510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110870268|NCT02395510|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110870269|NCT02395510|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110870270|NCT02395510|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110870271|NCT02395510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110870272|NCT02395510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110870273|NCT02395510|Serotonin Agents|serotonin agents|mesh-ancestor
110870274|NCT02395510|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110870275|NCT02395510|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110367603|NCT04710719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110870276|NCT02395510|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110870277|NCT02395510|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110870278|NCT02399800|Triamcinolone|triamcinolone|mesh-list
110870279|NCT02399800|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110870280|NCT02399800|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110870281|NCT02399800|Bupivacaine|bupivacaine|mesh-list
110870282|NCT02399800|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110870283|NCT02399800|Anesthetics, Local|anesthetics, local|mesh-ancestor
110870284|NCT02399800|Anesthetics|anesthetics|mesh-ancestor
110870285|NCT02399800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110870286|NCT02399800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110870287|NCT02399800|Sensory System Agents|sensory system agents|mesh-ancestor
110870288|NCT02399800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110870289|NCT02399800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110870290|NCT02399800|Glucocorticoids|glucocorticoids|mesh-ancestor
110870291|NCT02399800|Hormones|hormones|mesh-ancestor
110870292|NCT02399800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110870293|NCT02399800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110870294|NCT02399800|Immunologic Factors|immunologic factors|mesh-ancestor
110870295|NCT02399800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110870296|NCT02399800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110870297|NCT02399566|Pemetrexed|pemetrexed|mesh-list
110870298|NCT02399566|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110870299|NCT02399566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110870300|NCT02399566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110870301|NCT02399566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110870302|NCT02399566|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110870303|NCT02399566|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110870304|NCT02399566|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110870305|NCT03167164|Leucovorin|leucovorin|mesh-list
110870306|NCT03167164|Paclitaxel|paclitaxel|mesh-list
110067720|NCT01546090|Alprazolam|alprazolam|mesh-list
110870307|NCT03167164|Cyclophosphamide|cyclophosphamide|mesh-list
110870308|NCT03167164|Bevacizumab|bevacizumab|mesh-list
110870309|NCT03167164|Fluorouracil|fluorouracil|mesh-list
110870310|NCT03167164|Capecitabine|capecitabine|mesh-list
110870311|NCT03167164|Avelumab|avelumab|mesh-list
110870312|NCT03167164|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110870313|NCT03167164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110870314|NCT03167164|Tubulin Modulators|tubulin modulators|mesh-ancestor
110870315|NCT03167164|Antimitotic Agents|antimitotic agents|mesh-ancestor
110870316|NCT03167164|Mitosis Modulators|mitosis modulators|mesh-ancestor
110870317|NCT03167164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110870318|NCT03167164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110067855|NCT01547221|Clotrimazole|clotrimazole|mesh-list
110870319|NCT03167164|Immunologic Factors|immunologic factors|mesh-ancestor
110870320|NCT03167164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110870321|NCT03167164|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110870322|NCT03167164|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110870323|NCT03167164|Alkylating Agents|alkylating agents|mesh-ancestor
110870324|NCT03167164|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110870325|NCT03167164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110870326|NCT03167164|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110870327|NCT03167164|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110870328|NCT03167164|Growth Substances|growth substances|mesh-ancestor
110870329|NCT03167164|Growth Inhibitors|growth inhibitors|mesh-ancestor
110870330|NCT03167164|Antimetabolites|antimetabolites|mesh-ancestor
110870331|NCT03167164|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110870333|NCT03167164|Protective Agents|protective agents|mesh-ancestor
110870334|NCT03167164|Vitamin B Complex|vitamin b complex|mesh-ancestor
110870335|NCT03167164|Vitamins|vitamins|mesh-ancestor
110870336|NCT03167164|Micronutrients|micronutrients|mesh-ancestor
110870337|NCT03334747|Lumefantrine|lumefantrine|mesh-list
110870338|NCT03334747|Artemether|artemether|mesh-list
110870339|NCT03334747|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
110870340|NCT03334747|Antimalarials|antimalarials|mesh-ancestor
110870341|NCT03334747|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110870342|NCT03334747|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110870343|NCT03334747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110870344|NCT02394652|Metformin|metformin|mesh-list
110870345|NCT02394652|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
110870346|NCT02394652|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110870347|NCT02394652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110870348|NCT02394652|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110870349|NCT02394652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110870350|NCT02394496|Fulvestrant|fulvestrant|mesh-list
110870351|NCT02394496|Lapatinib|lapatinib|mesh-list
110870352|NCT02394496|Aromatase Inhibitors|aromatase inhibitors|mesh-list
110870353|NCT02394496|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110870354|NCT02394496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110870355|NCT02394496|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110870356|NCT02394496|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110870357|NCT02394496|Hormone Antagonists|hormone antagonists|mesh-ancestor
110870358|NCT02394496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110870359|NCT02394496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110870360|NCT02394496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110870361|NCT02394496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110870362|NCT02394496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110870363|NCT02394496|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110870364|NCT02394418|Dexmedetomidine|dexmedetomidine|mesh-list
110870365|NCT02394418|Propofol|propofol|mesh-list
110870366|NCT02394418|Sevoflurane|sevoflurane|mesh-list
110870367|NCT02394418|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110870368|NCT02394418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110870369|NCT02394418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111119179|NCT05272384|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
111119180|NCT05272384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111119181|NCT05272384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111119182|NCT05272384|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111119183|NCT05272384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111119184|NCT05272384|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111119185|NCT05272384|Antimetabolites|antimetabolites|mesh-ancestor
111119186|NCT05272384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111119187|NCT05251233|Pantoprazole|pantoprazole|mesh-list
111119188|NCT05251233|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111119189|NCT05251233|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111119190|NCT05251233|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111119191|NCT05251233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111119192|NCT05251233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111119193|NCT05229965|Acetaminophen|acetaminophen|mesh-list
111119194|NCT05229965|Codeine|codeine|mesh-list
111119195|NCT05229965|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111119196|NCT05229965|Analgesics|analgesics|mesh-ancestor
111119197|NCT05229965|Sensory System Agents|sensory system agents|mesh-ancestor
111119198|NCT05229965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111119199|NCT05229965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111119200|NCT05229965|Antipyretics|antipyretics|mesh-ancestor
111119201|NCT05229965|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111119202|NCT05229965|Narcotics|narcotics|mesh-ancestor
111119203|NCT05229965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111119204|NCT05229965|Antitussive Agents|antitussive agents|mesh-ancestor
111119205|NCT05229965|Respiratory System Agents|respiratory system agents|mesh-ancestor
111119206|NCT05227391|Letrozole|letrozole|mesh-list
111119207|NCT05227391|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
111119208|NCT05227391|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
111119209|NCT05227391|Estradiol|estradiol|mesh-list
111119210|NCT05227391|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
111119211|NCT05227391|Estrogens|estrogens|mesh-ancestor
111119212|NCT05227391|Hormones|hormones|mesh-ancestor
111119213|NCT05227391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110836309|NCT01310647|Estradiol|estradiol|mesh-list
111119214|NCT05227391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111119215|NCT05227391|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111119216|NCT05227391|Contraceptive Agents|contraceptive agents|mesh-ancestor
111119217|NCT05227391|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111119218|NCT05227391|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111119219|NCT05227391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111119220|NCT05227391|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111119221|NCT05227391|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111119222|NCT05227391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111119223|NCT05227391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111119224|NCT05227391|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111119225|NCT05227391|Hormone Antagonists|hormone antagonists|mesh-ancestor
111119227|NCT05224141|Pembrolizumab|pembrolizumab|mesh-list
111119228|NCT05224141|Etoposide|etoposide|mesh-list
111119229|NCT05224141|Atezolizumab|atezolizumab|mesh-list
111119230|NCT05224141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111119231|NCT05224141|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111119232|NCT05224141|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111119233|NCT05224141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111119234|NCT05224141|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111119235|NCT05224141|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111119236|NCT05224141|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111119237|NCT05224141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111119238|NCT05207709|Paclitaxel|paclitaxel|mesh-list
111119239|NCT05207709|Letrozole|letrozole|mesh-list
111119240|NCT05207709|Fulvestrant|fulvestrant|mesh-list
111119241|NCT05207709|Tislelizumab|tislelizumab|mesh-list
111119242|NCT05207709|Palbociclib|palbociclib|mesh-list
111119243|NCT05207709|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111119244|NCT05207709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111119245|NCT05207709|Tubulin Modulators|tubulin modulators|mesh-ancestor
111119246|NCT05207709|Antimitotic Agents|antimitotic agents|mesh-ancestor
111119247|NCT05207709|Mitosis Modulators|mitosis modulators|mesh-ancestor
110367667|NCT04655508|Glucocorticoids|glucocorticoids|mesh-ancestor
111119248|NCT05207709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111119249|NCT05207709|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111119250|NCT05207709|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111119251|NCT05207709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111119252|NCT05207709|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111119253|NCT05207709|Hormone Antagonists|hormone antagonists|mesh-ancestor
111119254|NCT05207709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111119255|NCT05207709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111119256|NCT05207709|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111119257|NCT05207709|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
111119258|NCT05207709|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111119259|NCT05207709|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111119260|NCT05203276|Endostar protein|endostar protein|mesh-list
111119261|NCT05203276|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111119262|NCT05203276|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111119263|NCT05203276|Growth Substances|growth substances|mesh-ancestor
111119264|NCT05203276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111119265|NCT05203276|Growth Inhibitors|growth inhibitors|mesh-ancestor
111119266|NCT05203276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111119267|NCT05201066|Azacitidine|azacitidine|mesh-list
111119268|NCT05201066|Decitabine|decitabine|mesh-list
111119269|NCT05201066|Venetoclax|venetoclax|mesh-list
111119270|NCT05201066|Spartalizumab|spartalizumab|mesh-list
111119271|NCT05201066|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111119272|NCT05201066|Antimetabolites|antimetabolites|mesh-ancestor
111119273|NCT05201066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111119274|NCT05201066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111119275|NCT05201066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111119276|NCT05201066|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111119277|NCT05201066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111119278|NCT05175105|Mitapivat|mitapivat|mesh-list
111119279|NCT05175105|Enzyme Activators|enzyme activators|mesh-ancestor
111119280|NCT05175105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111119281|NCT05167487|Cisplatin|cisplatin|mesh-list
111119282|NCT05167487|Carboplatin|carboplatin|mesh-list
111119283|NCT05167487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111119284|NCT05163808|BPN14770|bpn14770|mesh-list
111119285|NCT05163808|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
111119286|NCT05163808|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111119287|NCT05163808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111119288|NCT05163808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111119289|NCT05159778|Pembrolizumab|pembrolizumab|mesh-list
110835148|NCT03447184|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111119290|NCT05159778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111119291|NCT05159778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111119292|NCT05159778|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111119293|NCT05159778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111119294|NCT05159050|Paclitaxel|paclitaxel|mesh-list
111119295|NCT05159050|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111119296|NCT05159050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111119297|NCT05159050|Tubulin Modulators|tubulin modulators|mesh-ancestor
111119298|NCT05159050|Antimitotic Agents|antimitotic agents|mesh-ancestor
111119299|NCT05159050|Mitosis Modulators|mitosis modulators|mesh-ancestor
111119300|NCT05159050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111119301|NCT05152888|Evolocumab|evolocumab|mesh-list
111119302|NCT05152888|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
111119303|NCT05152888|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111119304|NCT05152888|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111119305|NCT05152888|Antimetabolites|antimetabolites|mesh-ancestor
111119306|NCT05152888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111119307|NCT05152888|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111119308|NCT05152888|Protease Inhibitors|protease inhibitors|mesh-ancestor
111119309|NCT05152888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111119310|NCT05152888|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111119311|NCT05151484|Alendronate|alendronate|mesh-list
111119312|NCT05151484|Teriparatide|teriparatide|mesh-list
111119313|NCT05151484|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111119314|NCT05151484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111119315|NCT05151484|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111119316|NCT05144256|Mitapivat|mitapivat|mesh-list
111119317|NCT05144256|Enzyme Activators|enzyme activators|mesh-ancestor
111119318|NCT05144256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111119319|NCT05131828|Metformin|metformin|mesh-list
111119320|NCT05131828|Clemastine|clemastine|mesh-list
111119321|NCT05131828|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111119322|NCT05131828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111119323|NCT05131828|Antipruritics|antipruritics|mesh-ancestor
111119324|NCT05131828|Dermatologic Agents|dermatologic agents|mesh-ancestor
111119325|NCT05131828|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111119326|NCT05131828|Histamine Antagonists|histamine antagonists|mesh-ancestor
111119327|NCT05131828|Histamine Agents|histamine agents|mesh-ancestor
111119328|NCT05131828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111119329|NCT05131828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111119330|NCT05131828|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111119331|NCT05122546|Nivolumab|nivolumab|mesh-list
111119332|NCT05122546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111119333|NCT05122546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111119334|NCT05122546|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111119335|NCT05122546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111119336|NCT05113537|177Lu-PSMA-617|177lu-psma-617|mesh-list
111119337|NCT05113537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111119338|NCT05113537|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111119339|NCT05110300|Triptorelin Pamoate|triptorelin pamoate|mesh-list
111119340|NCT05110300|Luteolytic Agents|luteolytic agents|mesh-ancestor
111119341|NCT05110300|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111119342|NCT05110300|Contraceptive Agents|contraceptive agents|mesh-ancestor
111119343|NCT05110300|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111119344|NCT05110300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111119345|NCT05110300|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111119346|NCT05110300|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111119347|NCT05110300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111119348|NCT05104554|Folic Acid|folic acid|mesh-list
111119349|NCT05104554|Micronutrients|micronutrients|mesh-list
111119350|NCT05104554|Trace Elements|trace elements|mesh-list
111119351|NCT05104554|Hematinics|hematinics|mesh-ancestor
111119352|NCT05104554|Vitamin B Complex|vitamin b complex|mesh-ancestor
111119353|NCT05104554|Vitamins|vitamins|mesh-ancestor
111119354|NCT05104554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111119355|NCT05101551|Gemcitabine|gemcitabine|mesh-list
111119356|NCT05101551|Topotecan|topotecan|mesh-list
111119357|NCT05101551|Talazoparib|talazoparib|mesh-list
110835158|NCT01135667|Clopidogrel|clopidogrel|mesh-list
111119358|NCT05101551|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111119359|NCT05101551|Antimetabolites|antimetabolites|mesh-ancestor
111119360|NCT05101551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111119361|NCT05101551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111119362|NCT05101551|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111119363|NCT05101551|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111119364|NCT05101551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111119365|NCT05101551|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111119367|NCT05088252|Desflurane|desflurane|mesh-list
111119368|NCT05088252|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111119369|NCT05088252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111119370|NCT05088252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111119371|NCT05088252|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111119372|NCT05088252|Anesthetics, General|anesthetics, general|mesh-ancestor
111119373|NCT05088252|Anesthetics|anesthetics|mesh-ancestor
111119374|NCT05088252|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111119375|NCT05073575|Hyaluronic Acid|hyaluronic acid|mesh-list
111119376|NCT05073575|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111119377|NCT05073575|Immunologic Factors|immunologic factors|mesh-ancestor
111119378|NCT05073575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111119379|NCT05073575|Viscosupplements|viscosupplements|mesh-ancestor
111119380|NCT05073575|Protective Agents|protective agents|mesh-ancestor
111119381|NCT05073003|Vaccines|vaccines|mesh-list
111119382|NCT05073003|Immunologic Factors|immunologic factors|mesh-ancestor
111119383|NCT05073003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111119384|NCT05069298|Silybin|silybin|mesh-list
111119385|NCT05069298|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111119386|NCT05069298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111119387|NCT05069298|Protective Agents|protective agents|mesh-ancestor
111119388|NCT05069298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111119389|NCT05047640|Vaccines|vaccines|mesh-list
111119390|NCT05047640|Immunologic Factors|immunologic factors|mesh-ancestor
111119391|NCT05047640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111119392|NCT05046314|Vincristine|vincristine|mesh-list
111119393|NCT05046314|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111119394|NCT05046314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111119395|NCT05046314|Tubulin Modulators|tubulin modulators|mesh-ancestor
111119396|NCT05046314|Antimitotic Agents|antimitotic agents|mesh-ancestor
111119397|NCT05046314|Mitosis Modulators|mitosis modulators|mesh-ancestor
111119398|NCT05046314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111119399|NCT05043714|Nivolumab|nivolumab|mesh-list
111119400|NCT05043714|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111119401|NCT05043714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111119402|NCT05043714|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111119403|NCT05043714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111119404|NCT05039073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111119405|NCT05039073|Nivolumab|nivolumab|mesh-list
111119406|NCT05039073|Brentuximab Vedotin|brentuximab vedotin|mesh-list
111119407|NCT05039073|Antibodies|antibodies|mesh-list
111119408|NCT05039073|Immunoglobulins|immunoglobulins|mesh-list
111119409|NCT05039073|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111119410|NCT05039073|Immunoconjugates|immunoconjugates|mesh-list
111119411|NCT05039073|Immunologic Factors|immunologic factors|mesh-ancestor
111119412|NCT05039073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111119413|NCT05039073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111119414|NCT05039073|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111119415|NCT05039073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111119416|NCT05039073|Immunotoxins|immunotoxins|mesh-ancestor
111119417|NCT05029999|Doxorubicin|doxorubicin|mesh-list
111119418|NCT05029999|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111119419|NCT05029999|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111119420|NCT05029999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111119421|NCT05029999|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111119422|NCT05029999|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111119423|NCT05029999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111119424|NCT05029999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111119425|NCT05023967|Metformin|metformin|mesh-list
111119426|NCT05023967|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111119427|NCT05023967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111119428|NCT05022004|Brinzolamide|brinzolamide|mesh-list
111119429|NCT05022004|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
111119430|NCT05022004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111119431|NCT05022004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111119432|NCT05012254|Paclitaxel|paclitaxel|mesh-list
111119433|NCT05012254|Cisplatin|cisplatin|mesh-list
111119434|NCT05012254|Carboplatin|carboplatin|mesh-list
111119435|NCT05012254|Nivolumab|nivolumab|mesh-list
111119436|NCT05012254|Pemetrexed|pemetrexed|mesh-list
111119437|NCT05012254|Ipilimumab|ipilimumab|mesh-list
111119438|NCT05012254|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111119439|NCT05012254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111119440|NCT05012254|Tubulin Modulators|tubulin modulators|mesh-ancestor
111119441|NCT05012254|Antimitotic Agents|antimitotic agents|mesh-ancestor
111119442|NCT05012254|Mitosis Modulators|mitosis modulators|mesh-ancestor
111119443|NCT05012254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111119444|NCT05012254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111119445|NCT05012254|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111119446|NCT05012254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111119447|NCT05012254|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111119448|NCT05012254|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111119450|NCT04995978|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111119451|NCT04995978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111119452|NCT04987294|Rasburicase|rasburicase|mesh-list
111119453|NCT04987294|Gout Suppressants|gout suppressants|mesh-ancestor
111119454|NCT04987294|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111119455|NCT04987242|Rasburicase|rasburicase|mesh-list
111119456|NCT04987242|Gout Suppressants|gout suppressants|mesh-ancestor
111119457|NCT04987242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111119458|NCT04976192|Omalizumab|omalizumab|mesh-list
111119459|NCT04976192|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111119460|NCT04976192|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111119461|NCT04976192|Respiratory System Agents|respiratory system agents|mesh-ancestor
111119462|NCT04958486|Trastuzumab|trastuzumab|mesh-list
111119463|NCT04958486|Azacitidine|azacitidine|mesh-list
111119464|NCT04958486|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111119465|NCT04958486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111119466|NCT04958486|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111119467|NCT04958486|Antimetabolites|antimetabolites|mesh-ancestor
111119468|NCT04958486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111119469|NCT04958486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111119470|NCT04942210|Vaccines|vaccines|mesh-list
111119471|NCT04942210|Immunologic Factors|immunologic factors|mesh-ancestor
111119472|NCT04942210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111119473|NCT04940767|Minocycline|minocycline|mesh-list
111119474|NCT04940767|Isotretinoin|isotretinoin|mesh-list
111119475|NCT04940767|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111119476|NCT04940767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111119477|NCT04940767|Dermatologic Agents|dermatologic agents|mesh-ancestor
111119478|NCT04929223|Bevacizumab|bevacizumab|mesh-list
111119479|NCT04929223|Cetuximab|cetuximab|mesh-list
111119480|NCT04929223|Atezolizumab|atezolizumab|mesh-list
111119481|NCT04929223|Inavolisib|inavolisib|mesh-list
111119482|NCT04929223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111119483|NCT04929223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111119484|NCT04929223|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111119485|NCT04929223|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111119486|NCT04929223|Growth Substances|growth substances|mesh-ancestor
111119487|NCT04929223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111119488|NCT04929223|Growth Inhibitors|growth inhibitors|mesh-ancestor
111119489|NCT04929223|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111119490|NCT04929223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111119491|NCT04929223|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
111119492|NCT04929223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111119493|NCT04925986|Pembrolizumab|pembrolizumab|mesh-list
111119494|NCT04925986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111119495|NCT04925986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111119496|NCT04925986|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111119497|NCT04925986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111119498|NCT04913805|Niacinamide|niacinamide|mesh-list
111119499|NCT04913805|Niacin|niacin|mesh-list
111119500|NCT04913805|Nicotinic Acids|nicotinic acids|mesh-list
111119501|NCT04913805|Vitamin B Complex|vitamin b complex|mesh-ancestor
111119502|NCT04913805|Vitamins|vitamins|mesh-ancestor
111119503|NCT04913805|Micronutrients|micronutrients|mesh-ancestor
111119504|NCT04913805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111119505|NCT04913805|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111119506|NCT04913805|Antimetabolites|antimetabolites|mesh-ancestor
111119507|NCT04913805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111119508|NCT04913805|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111119509|NCT04913805|Vasodilator Agents|vasodilator agents|mesh-ancestor
111119510|NCT04907968|Carboplatin|carboplatin|mesh-list
111119511|NCT04907968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111119512|NCT04900220|Methylprednisolone|methylprednisolone|mesh-list
111119513|NCT04900220|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111119514|NCT04900220|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111119515|NCT04900220|Prednisolone|prednisolone|mesh-list
111119516|NCT04900220|Prednisolone acetate|prednisolone acetate|mesh-list
111119517|NCT04900220|Betamethasone|betamethasone|mesh-list
111119518|NCT04900220|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111119519|NCT04900220|Prednisolone phosphate|prednisolone phosphate|mesh-list
111119520|NCT04900220|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111119521|NCT04900220|Antiemetics|antiemetics|mesh-ancestor
111119522|NCT04900220|Autonomic Agents|autonomic agents|mesh-ancestor
111119523|NCT04900220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111119524|NCT04900220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111119525|NCT04900220|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111119526|NCT04900220|Glucocorticoids|glucocorticoids|mesh-ancestor
111119528|NCT04900220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111119529|NCT04900220|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111119530|NCT04900220|Protective Agents|protective agents|mesh-ancestor
111119531|NCT04900220|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111119532|NCT04900220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111119533|NCT04900220|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111119534|NCT04900220|Respiratory System Agents|respiratory system agents|mesh-ancestor
111119535|NCT04896320|Tucatinib|tucatinib|mesh-list
111119536|NCT04896320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111119537|NCT04896320|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111119538|NCT04896320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111119539|NCT04896320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111119540|NCT04887259|Interleukin-2|interleukin-2|mesh-list
111119541|NCT04887259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111119542|NCT04887259|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111119543|NCT04887259|Analgesics|analgesics|mesh-ancestor
111119544|NCT04887259|Sensory System Agents|sensory system agents|mesh-ancestor
111119545|NCT04887259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111119546|NCT04887259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111119547|NCT04877613|Cyclophosphamide|cyclophosphamide|mesh-list
111119548|NCT04877613|Fludarabine|fludarabine|mesh-list
111119549|NCT04877613|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111119550|NCT04877613|Immunologic Factors|immunologic factors|mesh-ancestor
111119551|NCT04877613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111119552|NCT04877613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111119553|NCT04877613|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111119554|NCT04877613|Alkylating Agents|alkylating agents|mesh-ancestor
111119555|NCT04877613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111119556|NCT04877613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111119557|NCT04877613|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111119558|NCT04875195|Pembrolizumab|pembrolizumab|mesh-list
111119559|NCT04875195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111119560|NCT04875195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111119561|NCT04875195|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111119562|NCT04875195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111119563|NCT04871607|Cytarabine|cytarabine|mesh-list
111119564|NCT04871607|Etoposide|etoposide|mesh-list
111119565|NCT04871607|Podophyllotoxin|podophyllotoxin|mesh-list
111119566|NCT04871607|Etoposide phosphate|etoposide phosphate|mesh-list
111119567|NCT04871607|Carmustine|carmustine|mesh-list
111119568|NCT04871607|Basiliximab|basiliximab|mesh-list
111119569|NCT04871607|Lenograstim|lenograstim|mesh-list
111119570|NCT04871607|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111119571|NCT04871607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111119572|NCT04871607|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111119573|NCT04871607|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111119574|NCT04871607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111119575|NCT04871607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111119576|NCT04871607|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111119577|NCT04871607|Antimetabolites|antimetabolites|mesh-ancestor
111119578|NCT04871607|Antiviral Agents|antiviral agents|mesh-ancestor
111119579|NCT04871607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111119580|NCT04871607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111119581|NCT04871607|Immunologic Factors|immunologic factors|mesh-ancestor
111119582|NCT04871607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111119583|NCT04871607|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111119584|NCT04871607|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111119585|NCT04871607|Alkylating Agents|alkylating agents|mesh-ancestor
111119586|NCT04871607|Keratolytic Agents|keratolytic agents|mesh-ancestor
111119587|NCT04871607|Dermatologic Agents|dermatologic agents|mesh-ancestor
111119588|NCT04871607|Tubulin Modulators|tubulin modulators|mesh-ancestor
111119589|NCT04871607|Antimitotic Agents|antimitotic agents|mesh-ancestor
111119590|NCT04871607|Mitosis Modulators|mitosis modulators|mesh-ancestor
111119591|NCT04865042|Gabapentin|gabapentin|mesh-list
111119592|NCT04865042|Analgesics|analgesics|mesh-ancestor
111119593|NCT04865042|Sensory System Agents|sensory system agents|mesh-ancestor
110836677|NCT04453306|Topiramate|topiramate|mesh-list
111119594|NCT04865042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111119595|NCT04865042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111119597|NCT04865042|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111119598|NCT04865042|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111119599|NCT04865042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111119600|NCT04865042|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111119601|NCT04865042|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111119602|NCT04865042|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111119603|NCT04865042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111119604|NCT04865042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111119605|NCT04865042|Antimanic Agents|antimanic agents|mesh-ancestor
111119606|NCT04833790|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111119607|NCT04833790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111119608|NCT04830592|Pembrolizumab|pembrolizumab|mesh-list
111119609|NCT04830592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111119610|NCT04830592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111119611|NCT04830592|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111119612|NCT04830592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111119613|NCT04824131|Tenofovir|tenofovir|mesh-list
111119614|NCT04824131|Emtricitabine|emtricitabine|mesh-list
111119615|NCT04824131|Cabotegravir|cabotegravir|mesh-list
111119616|NCT04824131|Antiviral Agents|antiviral agents|mesh-ancestor
111119617|NCT04824131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111119618|NCT04824131|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111119619|NCT04824131|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111119620|NCT04824131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111119621|NCT04824131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111119622|NCT04824131|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111119623|NCT04824131|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111119624|NCT04824131|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111119625|NCT04824131|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111119626|NCT04776447|Carboplatin|carboplatin|mesh-list
111119627|NCT04776447|Atezolizumab|atezolizumab|mesh-list
111119628|NCT04776447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111119629|NCT04776447|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111119630|NCT04776447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111119631|NCT04776447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111119632|NCT04768504|Tofacitinib|tofacitinib|mesh-list
111119633|NCT04768504|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
111119634|NCT04768504|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111119635|NCT04768504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111119636|NCT04768504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111119637|NCT04748172|Antibodies|antibodies|mesh-list
111119638|NCT04748172|Immunologic Factors|immunologic factors|mesh-ancestor
111119639|NCT04748172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111119640|NCT04736823|Paclitaxel|paclitaxel|mesh-list
111119641|NCT04736823|Docetaxel|docetaxel|mesh-list
111119642|NCT04736823|Carboplatin|carboplatin|mesh-list
111119643|NCT04736823|Pemetrexed|pemetrexed|mesh-list
111119644|NCT04736823|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111119645|NCT04736823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111119646|NCT04736823|Tubulin Modulators|tubulin modulators|mesh-ancestor
111119647|NCT04736823|Antimitotic Agents|antimitotic agents|mesh-ancestor
111119648|NCT04736823|Mitosis Modulators|mitosis modulators|mesh-ancestor
111119649|NCT04736823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111119650|NCT04736823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111119651|NCT04736823|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111119652|NCT04736823|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111119653|NCT04729621|Denosumab|denosumab|mesh-list
111119654|NCT04729621|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111119655|NCT04729621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111119656|NCT04725383|Amitriptyline|amitriptyline|mesh-list
111119657|NCT04725383|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
111119658|NCT04725383|Antidepressive Agents|antidepressive agents|mesh-ancestor
111119659|NCT04725383|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111119660|NCT04725383|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111119661|NCT04725383|Analgesics|analgesics|mesh-ancestor
111119662|NCT04725383|Sensory System Agents|sensory system agents|mesh-ancestor
110367781|NCT02905760|Natriuretic Agents|natriuretic agents|mesh-ancestor
111119663|NCT04725383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111119664|NCT04725383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111119665|NCT04725383|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111119666|NCT04725383|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110836759|NCT04716634|Tislelizumab|tislelizumab|mesh-list
111119667|NCT04725383|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111119668|NCT04725383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111119669|NCT04725383|Adrenergic Agents|adrenergic agents|mesh-ancestor
111119670|NCT04725383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111119672|NCT04664023|Immunologic Factors|immunologic factors|mesh-ancestor
111119673|NCT04664023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111119674|NCT04633889|Deferoxamine|deferoxamine|mesh-list
111119675|NCT04633889|Siderophores|siderophores|mesh-ancestor
111119676|NCT04633889|Iron Chelating Agents|iron chelating agents|mesh-ancestor
111119677|NCT04633889|Chelating Agents|chelating agents|mesh-ancestor
111119678|NCT04633889|Sequestering Agents|sequestering agents|mesh-ancestor
111119679|NCT04633889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111119680|NCT04630886|Lidocaine|lidocaine|mesh-list
111119681|NCT04630886|Epinephrine|epinephrine|mesh-list
111119682|NCT04630886|Tranexamic Acid|tranexamic acid|mesh-list
111119683|NCT04630886|Anesthetics, Local|anesthetics, local|mesh-ancestor
111119684|NCT04630886|Anesthetics|anesthetics|mesh-ancestor
111119685|NCT04630886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111119686|NCT04630886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111119687|NCT04630886|Sensory System Agents|sensory system agents|mesh-ancestor
111119688|NCT04630886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111119689|NCT04630886|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111119690|NCT04630886|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111119691|NCT04630886|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111119692|NCT04630886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111119693|NCT04630886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111119694|NCT04630886|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111119695|NCT04630886|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111119696|NCT04630886|Hemostatics|hemostatics|mesh-ancestor
111119697|NCT04630886|Coagulants|coagulants|mesh-ancestor
111119698|NCT04630886|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111119699|NCT04630886|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111119700|NCT04630886|Adrenergic Agents|adrenergic agents|mesh-ancestor
111119701|NCT04630886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111119702|NCT04630886|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111119703|NCT04630886|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111119704|NCT04630886|Autonomic Agents|autonomic agents|mesh-ancestor
111119705|NCT04630886|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111119706|NCT04630886|Respiratory System Agents|respiratory system agents|mesh-ancestor
111119707|NCT04630886|Mydriatics|mydriatics|mesh-ancestor
111119708|NCT04630886|Sympathomimetics|sympathomimetics|mesh-ancestor
111119709|NCT04630886|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111119710|NCT04619316|Trametinib|trametinib|mesh-list
111119711|NCT04619316|Dabrafenib|dabrafenib|mesh-list
111119712|NCT04619316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111119713|NCT04619316|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111119714|NCT04619316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111119715|NCT04619316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111119716|NCT04610528|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
111119717|NCT04610528|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111119718|NCT04610528|Immunologic Factors|immunologic factors|mesh-ancestor
111119719|NCT04610528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111119720|NCT04610528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111119721|NCT04610528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111119722|NCT04609111|Aspirin|aspirin|mesh-list
111119723|NCT04609111|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111119724|NCT04609111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111119725|NCT04609111|Analgesics|analgesics|mesh-ancestor
111119726|NCT04609111|Sensory System Agents|sensory system agents|mesh-ancestor
111119727|NCT04609111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111119728|NCT04609111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111119729|NCT04609111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111119730|NCT04609111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111119731|NCT04609111|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111119732|NCT04609111|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111119733|NCT04609111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111119734|NCT04609111|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111119735|NCT04609111|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111119736|NCT04609111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111119737|NCT04609111|Antipyretics|antipyretics|mesh-ancestor
111119738|NCT04599062|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
111119739|NCT04599062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111119740|NCT04599062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111119741|NCT04590196|Curcumin|curcumin|mesh-list
111119742|NCT04590196|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111119743|NCT04590196|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111119744|NCT04590196|Analgesics|analgesics|mesh-ancestor
111119745|NCT04590196|Sensory System Agents|sensory system agents|mesh-ancestor
111119746|NCT04590196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111119747|NCT04590196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111119748|NCT04590196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111119749|NCT04590196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111119750|NCT04590196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110835217|NCT04659161|Xanomeline|xanomeline|mesh-list
111119751|NCT04590196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111119752|NCT04590196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111119753|NCT04589208|Ketamine|ketamine|mesh-list
111119754|NCT04589208|Analgesics|analgesics|mesh-ancestor
111119755|NCT04589208|Sensory System Agents|sensory system agents|mesh-ancestor
111119756|NCT04589208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111119757|NCT04589208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111119758|NCT04589208|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111119759|NCT04589208|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111119760|NCT04589208|Anesthetics, General|anesthetics, general|mesh-ancestor
111119761|NCT04589208|Anesthetics|anesthetics|mesh-ancestor
111119762|NCT04589208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111119763|NCT04589208|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111119764|NCT04589208|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111119765|NCT04589208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111119766|NCT04589208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111119767|NCT04585815|Axitinib|axitinib|mesh-list
111119768|NCT04585815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111119769|NCT04585815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111119770|NCT04585815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111119771|NCT04585815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111119772|NCT04566328|Dexamethasone|dexamethasone|mesh-list
111119773|NCT04566328|Dexamethasone acetate|dexamethasone acetate|mesh-list
111119774|NCT04566328|Lenalidomide|lenalidomide|mesh-list
111119775|NCT04566328|Bortezomib|bortezomib|mesh-list
111119776|NCT04566328|Daratumumab|daratumumab|mesh-list
111119777|NCT04566328|Ichthammol|ichthammol|mesh-list
111119778|NCT04566328|BB 1101|bb 1101|mesh-list
111119779|NCT04566328|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111119780|NCT04566328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111119781|NCT04566328|Antiemetics|antiemetics|mesh-ancestor
111119782|NCT04566328|Autonomic Agents|autonomic agents|mesh-ancestor
111119783|NCT04566328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111119784|NCT04566328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111119785|NCT04566328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111119786|NCT04566328|Glucocorticoids|glucocorticoids|mesh-ancestor
111119787|NCT04566328|Hormones|hormones|mesh-ancestor
111119788|NCT04566328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111119789|NCT04566328|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111119790|NCT04566328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111119791|NCT04566328|Protease Inhibitors|protease inhibitors|mesh-ancestor
111119792|NCT04566328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111119793|NCT04566328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111119794|NCT04566328|Immunologic Factors|immunologic factors|mesh-ancestor
111119795|NCT04566328|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111119796|NCT04566328|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111119797|NCT04566328|Growth Substances|growth substances|mesh-ancestor
111119798|NCT04566328|Growth Inhibitors|growth inhibitors|mesh-ancestor
111119799|NCT04566328|Dermatologic Agents|dermatologic agents|mesh-ancestor
111119800|NCT04559139|Cisplatin|cisplatin|mesh-list
111119801|NCT04559139|Gemcitabine|gemcitabine|mesh-list
111119802|NCT04559139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111119803|NCT04559139|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111119804|NCT04559139|Antimetabolites|antimetabolites|mesh-ancestor
111119805|NCT04559139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111119806|NCT04557449|Letrozole|letrozole|mesh-list
111119807|NCT04557449|Fulvestrant|fulvestrant|mesh-list
111119808|NCT04557449|Midazolam|midazolam|mesh-list
111119809|NCT04557449|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111119810|NCT04557449|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111119811|NCT04557449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111119812|NCT04557449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111119813|NCT04557449|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111119814|NCT04557449|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111119815|NCT04557449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111119816|NCT04557449|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111119817|NCT04557449|Anesthetics, General|anesthetics, general|mesh-ancestor
111119819|NCT04557449|GABA Modulators|gaba modulators|mesh-ancestor
111119820|NCT04557449|GABA Agents|gaba agents|mesh-ancestor
111119821|NCT04557449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111119822|NCT04557449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111119823|NCT04557449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111119824|NCT04557449|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111119825|NCT04557449|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111119826|NCT04557449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111119827|NCT04557449|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111119828|NCT04557449|Hormone Antagonists|hormone antagonists|mesh-ancestor
111119829|NCT04557449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111119830|NCT04557449|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111119831|NCT04557449|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
111119832|NCT04556773|Paclitaxel|paclitaxel|mesh-list
111119833|NCT04556773|Capecitabine|capecitabine|mesh-list
111119834|NCT04556773|Trastuzumab|trastuzumab|mesh-list
111119835|NCT04556773|Durvalumab|durvalumab|mesh-list
110367842|NCT04653792|Pregabalin|pregabalin|mesh-list
111119836|NCT04556773|Fulvestrant|fulvestrant|mesh-list
111119837|NCT04556773|Anastrozole|anastrozole|mesh-list
111119838|NCT04556773|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
111119839|NCT04556773|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111119840|NCT04556773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111119841|NCT04556773|Tubulin Modulators|tubulin modulators|mesh-ancestor
111119842|NCT04556773|Antimitotic Agents|antimitotic agents|mesh-ancestor
111119843|NCT04556773|Mitosis Modulators|mitosis modulators|mesh-ancestor
111119844|NCT04556773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111119845|NCT04556773|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111119846|NCT04556773|Antimetabolites|antimetabolites|mesh-ancestor
111119847|NCT04556773|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111119848|NCT04556773|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111119849|NCT04556773|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
111119850|NCT04556773|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111119851|NCT04556773|Hormone Antagonists|hormone antagonists|mesh-ancestor
111119852|NCT04556773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111119853|NCT04556773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111119854|NCT04556773|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111119855|NCT04556773|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111119856|NCT04556773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111119857|NCT04556773|Immunoconjugates|immunoconjugates|mesh-ancestor
111119858|NCT04556773|Immunologic Factors|immunologic factors|mesh-ancestor
111119859|NCT04551222|Probenecid|probenecid|mesh-list
111119860|NCT04551222|Uricosuric Agents|uricosuric agents|mesh-ancestor
111119861|NCT04551222|Gout Suppressants|gout suppressants|mesh-ancestor
111119862|NCT04551222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111119863|NCT04542148|Insulin|insulin|mesh-list
111119864|NCT04542148|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111119865|NCT04542148|Insulin Aspart|insulin aspart|mesh-list
111119866|NCT04542148|Insulin Lispro|insulin lispro|mesh-list
111119867|NCT04542148|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111119868|NCT04542148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111119869|NCT04527991|Paclitaxel|paclitaxel|mesh-list
111119870|NCT04527991|Docetaxel|docetaxel|mesh-list
111119871|NCT04527991|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
111119872|NCT04527991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111119873|NCT04527991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111119874|NCT04527991|Tubulin Modulators|tubulin modulators|mesh-ancestor
111119875|NCT04527991|Antimitotic Agents|antimitotic agents|mesh-ancestor
111119876|NCT04527991|Mitosis Modulators|mitosis modulators|mesh-ancestor
111119877|NCT04527991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111119878|NCT04527991|Immunoconjugates|immunoconjugates|mesh-ancestor
111119879|NCT04527991|Immunologic Factors|immunologic factors|mesh-ancestor
111119880|NCT04527991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111119881|NCT04527549|Hydroxychloroquine|hydroxychloroquine|mesh-list
111119882|NCT04527549|Trametinib|trametinib|mesh-list
111119883|NCT04527549|Dabrafenib|dabrafenib|mesh-list
111119884|NCT04527549|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
111119885|NCT04527549|Antimalarials|antimalarials|mesh-ancestor
111119886|NCT04527549|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111119887|NCT04527549|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111119888|NCT04527549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111119889|NCT04527549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111119890|NCT04527549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111119891|NCT04527549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111119892|NCT04527549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111119893|NCT04527549|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111119894|NCT04527549|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
111119896|NCT04527549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111119897|NCT04527549|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111119898|NCT04527549|Antioxidants|antioxidants|mesh-ancestor
111119899|NCT04512430|Bevacizumab|bevacizumab|mesh-list
111119900|NCT04512430|Atezolizumab|atezolizumab|mesh-list
111119901|NCT04512430|Carboplatin|carboplatin|mesh-list
111119902|NCT04512430|Pemetrexed|pemetrexed|mesh-list
111119903|NCT04512430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111119904|NCT04512430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111119905|NCT04512430|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111119906|NCT04512430|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111119907|NCT04512430|Growth Substances|growth substances|mesh-ancestor
111119908|NCT04512430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111119909|NCT04512430|Growth Inhibitors|growth inhibitors|mesh-ancestor
111119910|NCT04512430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111119911|NCT04512430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111119912|NCT04512430|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111119913|NCT04512430|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111119914|NCT04512430|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111119915|NCT04502433|Poractant alfa|poractant alfa|mesh-list
111119916|NCT04502433|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
111119917|NCT04502433|Respiratory System Agents|respiratory system agents|mesh-ancestor
111119918|NCT04484818|Leuprolide|leuprolide|mesh-list
111119919|NCT04484818|Goserelin|goserelin|mesh-list
111119920|NCT04484818|Triptorelin Pamoate|triptorelin pamoate|mesh-list
111119921|NCT04484818|Tryptophan|tryptophan|mesh-list
111119922|NCT04484818|Androgen Antagonists|androgen antagonists|mesh-list
111119923|NCT04484818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111119924|NCT04484818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111119925|NCT04484818|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111119926|NCT04484818|Fertility Agents|fertility agents|mesh-ancestor
111119927|NCT04484818|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111119928|NCT04484818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111119929|NCT04484818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111119930|NCT04484818|Luteolytic Agents|luteolytic agents|mesh-ancestor
111119931|NCT04484818|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111119932|NCT04484818|Contraceptive Agents|contraceptive agents|mesh-ancestor
111119933|NCT04484818|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111119934|NCT04484818|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111119935|NCT04484818|Antidepressive Agents|antidepressive agents|mesh-ancestor
111119936|NCT04484818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111119937|NCT04484818|Hormone Antagonists|hormone antagonists|mesh-ancestor
111119938|NCT04484012|Acalabrutinib|acalabrutinib|mesh-list
111119939|NCT04484012|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
111119940|NCT04484012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111119941|NCT04484012|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111119942|NCT04484012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111119943|NCT04484012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111119944|NCT04477200|Mycophenolic Acid|mycophenolic acid|mesh-list
111119945|NCT04477200|Temozolomide|temozolomide|mesh-list
111119946|NCT04477200|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111119947|NCT04477200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111119948|NCT04477200|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111119949|NCT04477200|Antitubercular Agents|antitubercular agents|mesh-ancestor
111119950|NCT04477200|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111119951|NCT04477200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111119952|NCT04477200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111119953|NCT04477200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111119954|NCT04477200|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111119955|NCT04477200|Alkylating Agents|alkylating agents|mesh-ancestor
111119956|NCT04455802|Morphine|morphine|mesh-list
111119957|NCT04455802|Buprenorphine|buprenorphine|mesh-list
111119958|NCT04455802|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111119959|NCT04455802|Narcotics|narcotics|mesh-ancestor
111119960|NCT04455802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111119961|NCT04455802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111119962|NCT04455802|Analgesics|analgesics|mesh-ancestor
111119963|NCT04455802|Sensory System Agents|sensory system agents|mesh-ancestor
111119964|NCT04455802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111119965|NCT04455802|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111119966|NCT04443088|Pembrolizumab|pembrolizumab|mesh-list
110835236|NCT03129256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111119968|NCT04443088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110837058|NCT03011450|Fenofibrate|fenofibrate|mesh-list
111119969|NCT04443088|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111119970|NCT04443088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111119971|NCT04438382|Prednisone|prednisone|mesh-list
111119972|NCT04438382|Infliximab|infliximab|mesh-list
111119973|NCT04438382|Cortisone|cortisone|mesh-list
111119974|NCT04438382|Immunoglobulins|immunoglobulins|mesh-list
111119975|NCT04438382|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111119976|NCT04438382|Antibodies|antibodies|mesh-list
111119977|NCT04438382|gamma-Globulins|gamma-globulins|mesh-list
111119978|NCT04438382|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
111119979|NCT04438382|Immunoglobulin G|immunoglobulin g|mesh-list
111119980|NCT04438382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111119981|NCT04438382|Glucocorticoids|glucocorticoids|mesh-ancestor
111119982|NCT04438382|Hormones|hormones|mesh-ancestor
111119983|NCT04438382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111119984|NCT04438382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111119985|NCT04438382|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111119986|NCT04438382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111119987|NCT04438382|Immunologic Factors|immunologic factors|mesh-ancestor
111119988|NCT04438382|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111119989|NCT04438382|Dermatologic Agents|dermatologic agents|mesh-ancestor
111119990|NCT04438382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111119991|NCT04438382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111119992|NCT04434040|Atezolizumab|atezolizumab|mesh-list
111119993|NCT04434040|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
111119994|NCT04434040|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111119995|NCT04434040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111119996|NCT04434040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111119997|NCT04434040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111119998|NCT04434040|Immunoconjugates|immunoconjugates|mesh-ancestor
111119999|NCT04434040|Immunologic Factors|immunologic factors|mesh-ancestor
111120000|NCT04434040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111120001|NCT04426890|Omalizumab|omalizumab|mesh-list
111120002|NCT04426890|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111120003|NCT04426890|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111120004|NCT04426890|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111120005|NCT04426890|Respiratory System Agents|respiratory system agents|mesh-ancestor
111120006|NCT04426890|Immunologic Factors|immunologic factors|mesh-ancestor
111120007|NCT04426890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111120008|NCT04411914|Clavulanic Acids|clavulanic acids|mesh-list
111120009|NCT04411914|Clavulanic Acid|clavulanic acid|mesh-list
111120010|NCT04411914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111120011|NCT04411914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111120012|NCT04411914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111120013|NCT04411914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111120014|NCT04411914|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
111120015|NCT04411836|Primaquine|primaquine|mesh-list
111120016|NCT04411836|Tafenoquine|tafenoquine|mesh-list
111120017|NCT04411836|Antimalarials|antimalarials|mesh-ancestor
111120018|NCT04411836|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111120019|NCT04411836|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111120020|NCT04411836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111120021|NCT04395365|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
111120022|NCT04395365|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111120023|NCT04395365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111120024|NCT04395365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111120025|NCT04395365|Antimalarials|antimalarials|mesh-ancestor
111120026|NCT04395365|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111120027|NCT04395365|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111120028|NCT04389671|Pulmonary Surfactants|pulmonary surfactants|mesh-list
111120029|NCT04389671|Respiratory System Agents|respiratory system agents|mesh-ancestor
111120030|NCT04386057|Hydroxychloroquine|hydroxychloroquine|mesh-list
111120031|NCT04386057|Antimalarials|antimalarials|mesh-ancestor
111120032|NCT04386057|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111120033|NCT04386057|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111120034|NCT04386057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111120035|NCT04386057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111120036|NCT04386057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111120037|NCT04386057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111120038|NCT04380545|Interferons|interferons|mesh-list
111120039|NCT04380545|Interferon-alpha|interferon-alpha|mesh-list
111120040|NCT04380545|Interferon alpha-2|interferon alpha-2|mesh-list
111120041|NCT04380545|Fluorouracil|fluorouracil|mesh-list
111120042|NCT04380545|Nivolumab|nivolumab|mesh-list
111120043|NCT04380545|Antimetabolites|antimetabolites|mesh-ancestor
111120044|NCT04380545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111120045|NCT04380545|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111120046|NCT04380545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111120047|NCT04380545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111120048|NCT04380545|Immunologic Factors|immunologic factors|mesh-ancestor
111120049|NCT04380545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111120050|NCT04380545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111120051|NCT04380545|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111120052|NCT04380545|Antiviral Agents|antiviral agents|mesh-ancestor
111120053|NCT04380545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111120054|NCT04364048|Cisplatin|cisplatin|mesh-list
111120055|NCT04364048|Carboplatin|carboplatin|mesh-list
111120056|NCT04364048|Etoposide|etoposide|mesh-list
111120057|NCT04364048|Pemetrexed|pemetrexed|mesh-list
111120058|NCT04364048|Durvalumab|durvalumab|mesh-list
111120059|NCT04364048|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111120060|NCT04364048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111120061|NCT04364048|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111120062|NCT04364048|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111120063|NCT04364048|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111120064|NCT04364048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111120065|NCT04364048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111120066|NCT04364048|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111120067|NCT04364048|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111120068|NCT04364048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111120069|NCT04364048|Immunologic Factors|immunologic factors|mesh-ancestor
111120070|NCT04364048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111120071|NCT04328727|Cyclosporine|cyclosporine|mesh-list
111120072|NCT04328727|Cyclosporins|cyclosporins|mesh-list
111120073|NCT04328727|Antilymphocyte Serum|antilymphocyte serum|mesh-list
111120074|NCT04328727|Thymoglobulin|thymoglobulin|mesh-list
111120075|NCT04328727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111120076|NCT04328727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111120077|NCT04328727|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111120078|NCT04328727|Immunologic Factors|immunologic factors|mesh-ancestor
111120079|NCT04328727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111120080|NCT04328727|Antifungal Agents|antifungal agents|mesh-ancestor
111120081|NCT04328727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111120082|NCT04328727|Dermatologic Agents|dermatologic agents|mesh-ancestor
111120083|NCT04328727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111120084|NCT04328727|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111120085|NCT04316117|Deoxyglucose|deoxyglucose|mesh-list
111120086|NCT04316117|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
111120087|NCT04316117|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111120088|NCT04316117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111120089|NCT04316117|Antimetabolites|antimetabolites|mesh-ancestor
111120090|NCT04316117|Antiviral Agents|antiviral agents|mesh-ancestor
111120091|NCT04316117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111120092|NCT04313634|Dasatinib|dasatinib|mesh-list
111120093|NCT04313634|Quercetin|quercetin|mesh-list
111120094|NCT04313634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111120095|NCT04313634|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111120096|NCT04313634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111120097|NCT04313634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111120098|NCT04313634|Antioxidants|antioxidants|mesh-ancestor
111120099|NCT04313634|Protective Agents|protective agents|mesh-ancestor
111120100|NCT04313634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111120101|NCT04311580|Mitomycins|mitomycins|mesh-list
111120102|NCT04311580|Mitomycin|mitomycin|mesh-list
111120103|NCT04311580|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110835255|NCT05364099|Triamcinolone|triamcinolone|mesh-list
111120104|NCT04311580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111120105|NCT04311580|Alkylating Agents|alkylating agents|mesh-ancestor
111120106|NCT04311580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111120107|NCT04311580|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111120108|NCT04311580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111120109|NCT04301492|Vortioxetine|vortioxetine|mesh-list
111120110|NCT04301492|Antidepressive Agents|antidepressive agents|mesh-ancestor
111120111|NCT04301492|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111120112|NCT04301492|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111120113|NCT04301492|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111120114|NCT04301492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111120115|NCT04301492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111120116|NCT04301492|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111120117|NCT04301492|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110837214|NCT01136759|Tenofovir|tenofovir|mesh-list
111120118|NCT04301492|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111120119|NCT04301492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111120120|NCT04301492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111120122|NCT04301492|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111120123|NCT04301492|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111120124|NCT04301492|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111120125|NCT04301492|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111120126|NCT04290039|Atropine|atropine|mesh-list
111120127|NCT04290039|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111120128|NCT04290039|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111120129|NCT04290039|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111120130|NCT04290039|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111120131|NCT04290039|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111120132|NCT04290039|Autonomic Agents|autonomic agents|mesh-ancestor
111120133|NCT04290039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111120134|NCT04290039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111120135|NCT04290039|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111120136|NCT04290039|Respiratory System Agents|respiratory system agents|mesh-ancestor
111120137|NCT04290039|Mydriatics|mydriatics|mesh-ancestor
111120138|NCT04290039|Parasympatholytics|parasympatholytics|mesh-ancestor
111120139|NCT04290039|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111120140|NCT04290039|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111120141|NCT04290039|Cholinergic Agents|cholinergic agents|mesh-ancestor
111120142|NCT04290039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111120143|NCT04290039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111120144|NCT04266249|Paclitaxel|paclitaxel|mesh-list
111120145|NCT04266249|Maytansine|maytansine|mesh-list
111120146|NCT04266249|Docetaxel|docetaxel|mesh-list
111120147|NCT04266249|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
111120148|NCT04266249|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111120149|NCT04266249|Trastuzumab|trastuzumab|mesh-list
111120150|NCT04266249|Pertuzumab|pertuzumab|mesh-list
111120151|NCT04266249|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
111120152|NCT04266249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111120153|NCT04266249|Antibodies|antibodies|mesh-list
111120154|NCT04266249|Immunoglobulins|immunoglobulins|mesh-list
111120155|NCT04266249|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111120156|NCT04266249|Immunoconjugates|immunoconjugates|mesh-list
111120157|NCT04266249|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111120158|NCT04266249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111120159|NCT04266249|Tubulin Modulators|tubulin modulators|mesh-ancestor
111120160|NCT04266249|Antimitotic Agents|antimitotic agents|mesh-ancestor
111120161|NCT04266249|Mitosis Modulators|mitosis modulators|mesh-ancestor
111120162|NCT04266249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111120163|NCT04266249|Immunologic Factors|immunologic factors|mesh-ancestor
111120164|NCT04266249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111120165|NCT04266249|Immunotoxins|immunotoxins|mesh-ancestor
111120166|NCT04260126|Pembrolizumab|pembrolizumab|mesh-list
111120167|NCT04260126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111120168|NCT04260126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110835258|NCT05364099|Anesthetics|anesthetics|mesh-ancestor
111120169|NCT04260126|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111120170|NCT04260126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111120171|NCT04248452|Calcium, Dietary|calcium, dietary|mesh-list
111120172|NCT04248452|Leucovorin|leucovorin|mesh-list
111120173|NCT04248452|Folic Acid|folic acid|mesh-list
111120174|NCT04248452|Fluorouracil|fluorouracil|mesh-list
111120175|NCT04248452|Capecitabine|capecitabine|mesh-list
111120176|NCT04248452|Oxaliplatin|oxaliplatin|mesh-list
111120177|NCT04248452|Calcium|calcium|mesh-list
111120178|NCT04248452|Levoleucovorin|levoleucovorin|mesh-list
111120179|NCT04248452|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111120180|NCT04248452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111120181|NCT04248452|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111120182|NCT04248452|Antimetabolites|antimetabolites|mesh-ancestor
111120183|NCT04248452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111120184|NCT04248452|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111120185|NCT04248452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111120186|NCT04248452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111120187|NCT04248452|Immunologic Factors|immunologic factors|mesh-ancestor
111120188|NCT04248452|Antidotes|antidotes|mesh-ancestor
111120189|NCT04248452|Protective Agents|protective agents|mesh-ancestor
111120190|NCT04248452|Vitamin B Complex|vitamin b complex|mesh-ancestor
111120191|NCT04248452|Vitamins|vitamins|mesh-ancestor
111120192|NCT04248452|Micronutrients|micronutrients|mesh-ancestor
111120193|NCT04248452|Hematinics|hematinics|mesh-ancestor
111120194|NCT04240054|Dexamethasone|dexamethasone|mesh-list
111120195|NCT04240054|Cyclophosphamide|cyclophosphamide|mesh-list
111120196|NCT04240054|Bortezomib|bortezomib|mesh-list
111120197|NCT04240054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111120198|NCT04240054|Immunologic Factors|immunologic factors|mesh-ancestor
111120200|NCT04240054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111120201|NCT04240054|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111120202|NCT04240054|Alkylating Agents|alkylating agents|mesh-ancestor
111120203|NCT04240054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111120204|NCT04240054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111120205|NCT04240054|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111120206|NCT04240054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111120207|NCT04240054|Antiemetics|antiemetics|mesh-ancestor
111120208|NCT04240054|Autonomic Agents|autonomic agents|mesh-ancestor
111120209|NCT04240054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111120210|NCT04240054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111120211|NCT04240054|Glucocorticoids|glucocorticoids|mesh-ancestor
111120212|NCT04240054|Hormones|hormones|mesh-ancestor
111120213|NCT04240054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111120214|NCT04240054|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111120215|NCT04233866|Calcium, Dietary|calcium, dietary|mesh-list
111120216|NCT04233866|Leucovorin|leucovorin|mesh-list
111120217|NCT04233866|Folic Acid|folic acid|mesh-list
111120218|NCT04233866|Paclitaxel|paclitaxel|mesh-list
111120219|NCT04233866|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111120220|NCT04233866|Gemcitabine|gemcitabine|mesh-list
111120221|NCT04233866|Fluorouracil|fluorouracil|mesh-list
111120222|NCT04233866|Irinotecan|irinotecan|mesh-list
111120223|NCT04233866|Calcium|calcium|mesh-list
111120224|NCT04233866|Levoleucovorin|levoleucovorin|mesh-list
111120225|NCT04233866|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111120226|NCT04233866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111120227|NCT04233866|Tubulin Modulators|tubulin modulators|mesh-ancestor
111120228|NCT04233866|Antimitotic Agents|antimitotic agents|mesh-ancestor
111120229|NCT04233866|Mitosis Modulators|mitosis modulators|mesh-ancestor
111120230|NCT04233866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111120231|NCT04233866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111120232|NCT04233866|Antimetabolites|antimetabolites|mesh-ancestor
111120233|NCT04233866|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111120234|NCT04233866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111120235|NCT04233866|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111120236|NCT04233866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111120237|NCT04233866|Immunologic Factors|immunologic factors|mesh-ancestor
111120238|NCT04233866|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111120239|NCT04233866|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111120240|NCT04233866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111120242|NCT04233866|Protective Agents|protective agents|mesh-ancestor
111120243|NCT04233866|Vitamin B Complex|vitamin b complex|mesh-ancestor
111120244|NCT04233866|Vitamins|vitamins|mesh-ancestor
111120245|NCT04233866|Micronutrients|micronutrients|mesh-ancestor
111120246|NCT04233866|Hematinics|hematinics|mesh-ancestor
111120247|NCT04233112|Melatonin|melatonin|mesh-list
111120248|NCT04233112|Antioxidants|antioxidants|mesh-ancestor
110924792|NCT03098680|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111120249|NCT04233112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111120250|NCT04233112|Protective Agents|protective agents|mesh-ancestor
111120251|NCT04233112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111120252|NCT04233112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111120253|NCT04221438|Alovudine|alovudine|mesh-list
111120254|NCT04221438|Antiviral Agents|antiviral agents|mesh-ancestor
111120255|NCT04221438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111120256|NCT04217954|Bevacizumab|bevacizumab|mesh-list
111120257|NCT04217954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111120258|NCT04217954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111120259|NCT04217954|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111120260|NCT04217954|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111120261|NCT04217954|Growth Substances|growth substances|mesh-ancestor
111120262|NCT04217954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111120263|NCT04217954|Growth Inhibitors|growth inhibitors|mesh-ancestor
111120264|NCT04210427|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
111120265|NCT04210427|Laxatives|laxatives|mesh-ancestor
111120266|NCT04210427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111120267|NCT04194034|Flucytosine|flucytosine|mesh-list
111120268|NCT04194034|Antifungal Agents|antifungal agents|mesh-ancestor
111120269|NCT04194034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111120270|NCT04194034|Antimetabolites|antimetabolites|mesh-ancestor
111120271|NCT04194034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111120272|NCT04191187|Fludarabine|fludarabine|mesh-list
111120273|NCT04191187|Melphalan|melphalan|mesh-list
110837349|NCT01137383|Antimetabolites|antimetabolites|mesh-ancestor
111120274|NCT04191187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111120275|NCT04191187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111120276|NCT04191187|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111120277|NCT04191187|Immunologic Factors|immunologic factors|mesh-ancestor
111120278|NCT04191187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111120279|NCT04191187|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111120280|NCT04191187|Alkylating Agents|alkylating agents|mesh-ancestor
111120281|NCT04191187|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111120283|NCT04191135|Gemcitabine|gemcitabine|mesh-list
111120284|NCT04191135|Pembrolizumab|pembrolizumab|mesh-list
111120285|NCT04191135|Olaparib|olaparib|mesh-list
111120286|NCT04191135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111120287|NCT04191135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111120288|NCT04191135|Antimetabolites|antimetabolites|mesh-ancestor
111120289|NCT04191135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111120290|NCT04191135|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111120291|NCT04191135|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111120292|NCT04191135|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111120293|NCT04191135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111120294|NCT04356170|Docetaxel|docetaxel|mesh-list
111120295|NCT04356170|Fluorouracil|fluorouracil|mesh-list
111120296|NCT04356170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111120297|NCT04356170|Tubulin Modulators|tubulin modulators|mesh-ancestor
111120298|NCT04356170|Antimitotic Agents|antimitotic agents|mesh-ancestor
111120299|NCT04356170|Mitosis Modulators|mitosis modulators|mesh-ancestor
111120300|NCT04356170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111120301|NCT04356170|Antimetabolites|antimetabolites|mesh-ancestor
111120302|NCT04356170|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111120303|NCT04356170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110367962|NCT00562068|Glucocorticoids|glucocorticoids|mesh-ancestor
111120304|NCT04356170|Immunologic Factors|immunologic factors|mesh-ancestor
111120305|NCT04356170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111120306|NCT04188418|Fentanyl|fentanyl|mesh-list
111120307|NCT04188418|Morphine|morphine|mesh-list
111120308|NCT04188418|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111120309|NCT04188418|Narcotics|narcotics|mesh-ancestor
111120310|NCT04188418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111120311|NCT04188418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111120312|NCT04188418|Analgesics|analgesics|mesh-ancestor
111120313|NCT04188418|Sensory System Agents|sensory system agents|mesh-ancestor
111120314|NCT04188418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111120315|NCT04188418|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111120316|NCT04188418|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111120317|NCT04188418|Anesthetics, General|anesthetics, general|mesh-ancestor
111120318|NCT04188418|Anesthetics|anesthetics|mesh-ancestor
111120319|NCT04166318|Fluorouracil|fluorouracil|mesh-list
111120320|NCT04166318|Capecitabine|capecitabine|mesh-list
111120321|NCT04166318|Mitomycins|mitomycins|mesh-list
111120322|NCT04166318|Mitomycin|mitomycin|mesh-list
111120323|NCT04166318|Antimetabolites|antimetabolites|mesh-ancestor
111120324|NCT04166318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111120325|NCT04166318|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111120326|NCT04166318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111120327|NCT04166318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111120328|NCT04166318|Immunologic Factors|immunologic factors|mesh-ancestor
111120329|NCT04166318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111120330|NCT04166318|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111120331|NCT04166318|Alkylating Agents|alkylating agents|mesh-ancestor
111120332|NCT04166318|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111120333|NCT04166318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111120334|NCT04150614|Dexamethasone|dexamethasone|mesh-list
111120335|NCT04150614|Ondansetron|ondansetron|mesh-list
111120336|NCT04150614|Granisetron|granisetron|mesh-list
111120337|NCT04150614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111120338|NCT04150614|Antiemetics|antiemetics|mesh-ancestor
111120339|NCT04150614|Autonomic Agents|autonomic agents|mesh-ancestor
111120340|NCT04150614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111120341|NCT04150614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111120342|NCT04150614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111120343|NCT04150614|Glucocorticoids|glucocorticoids|mesh-ancestor
111120344|NCT04150614|Hormones|hormones|mesh-ancestor
111120345|NCT04150614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111120346|NCT04150614|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111120347|NCT04150614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111120348|NCT04150614|Antipruritics|antipruritics|mesh-ancestor
111120349|NCT04150614|Dermatologic Agents|dermatologic agents|mesh-ancestor
111120350|NCT04150614|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111120351|NCT04150614|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111120352|NCT04150614|Serotonin Agents|serotonin agents|mesh-ancestor
111120353|NCT04150614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111120354|NCT04150614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111120355|NCT04145297|Hydroxychloroquine|hydroxychloroquine|mesh-list
111120356|NCT04145297|Antimalarials|antimalarials|mesh-ancestor
111120357|NCT04145297|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111120358|NCT04145297|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111120359|NCT04145297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111120360|NCT04145297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111120361|NCT04145297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111120362|NCT04145297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111120363|NCT04126096|Lactams|lactams|mesh-list
111120364|NCT04126096|beta-Lactams|beta-lactams|mesh-list
111120365|NCT04126096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111120366|NCT04126096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111120367|NCT04125836|Octreotide|octreotide|mesh-list
111120368|NCT04125836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111120369|NCT04125836|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111120370|NCT04125836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110383392|NCT06045013|Hormones|hormones|mesh-ancestor
111120371|NCT04121455|Bevacizumab|bevacizumab|mesh-list
111120372|NCT04121455|Pembrolizumab|pembrolizumab|mesh-list
111120373|NCT04121455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111120374|NCT04121455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111120375|NCT04121455|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111120377|NCT04121455|Growth Substances|growth substances|mesh-ancestor
111120378|NCT04121455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111120379|NCT04121455|Growth Inhibitors|growth inhibitors|mesh-ancestor
111120380|NCT04121455|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111120381|NCT04121455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111120382|NCT04117672|Antisecretory factor|antisecretory factor|mesh-list
111120383|NCT04117672|Antidiarrheals|antidiarrheals|mesh-ancestor
111120384|NCT04117672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111120385|NCT04115631|Cytarabine|cytarabine|mesh-list
111120386|NCT04115631|Rituximab|rituximab|mesh-list
111120387|NCT04115631|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111120388|NCT04115631|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
111120389|NCT04115631|Acalabrutinib|acalabrutinib|mesh-list
111120390|NCT04115631|Antibodies|antibodies|mesh-list
111120391|NCT04115631|Immunoglobulins|immunoglobulins|mesh-list
111120392|NCT04115631|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111120393|NCT04115631|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
111120394|NCT04115631|Immunologic Factors|immunologic factors|mesh-ancestor
111120395|NCT04115631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111120396|NCT04115631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111120397|NCT04115631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111120398|NCT04115631|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111120399|NCT04115631|Antimetabolites|antimetabolites|mesh-ancestor
111120400|NCT04115631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111120401|NCT04115631|Antiviral Agents|antiviral agents|mesh-ancestor
111120402|NCT04115631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111120403|NCT04115631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111120404|NCT04115631|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111120405|NCT04115631|Alkylating Agents|alkylating agents|mesh-ancestor
111120406|NCT04115631|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111120407|NCT04115631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111120408|NCT04109482|Cyclophosphamide|cyclophosphamide|mesh-list
111120409|NCT04109482|Fludarabine|fludarabine|mesh-list
111120410|NCT04109482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111120411|NCT04109482|Immunologic Factors|immunologic factors|mesh-ancestor
111120412|NCT04109482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111120413|NCT04109482|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111120414|NCT04109482|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111120415|NCT04109482|Alkylating Agents|alkylating agents|mesh-ancestor
111120416|NCT04109482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111120417|NCT04109482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111120418|NCT04109482|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111120419|NCT04094584|Naltrexone|naltrexone|mesh-list
111120420|NCT04094584|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111120421|NCT04094584|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111120422|NCT04094584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111120423|NCT04094584|Sensory System Agents|sensory system agents|mesh-ancestor
111120424|NCT04094584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111120425|NCT04086264|Azacitidine|azacitidine|mesh-list
111120426|NCT04086264|Decitabine|decitabine|mesh-list
110837501|NCT02824575|Paclitaxel|paclitaxel|mesh-list
111120427|NCT04086264|Venetoclax|venetoclax|mesh-list
111120428|NCT04086264|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111120429|NCT04086264|Antimetabolites|antimetabolites|mesh-ancestor
111120430|NCT04086264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111120431|NCT04086264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111120432|NCT04086264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111120433|NCT04075292|Rituximab|rituximab|mesh-list
111120434|NCT04075292|Acalabrutinib|acalabrutinib|mesh-list
111120435|NCT04075292|Chlorambucil|chlorambucil|mesh-list
111120436|NCT04075292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111120437|NCT04075292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111120438|NCT04075292|Immunologic Factors|immunologic factors|mesh-ancestor
111120439|NCT04075292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111120440|NCT04075292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111120441|NCT04075292|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111120442|NCT04075292|Alkylating Agents|alkylating agents|mesh-ancestor
111120443|NCT04075292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111120444|NCT04047472|Aflibercept|aflibercept|mesh-list
111120445|NCT04047472|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111120446|NCT04047472|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111120447|NCT04047472|Growth Substances|growth substances|mesh-ancestor
111120448|NCT04047472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111120449|NCT04047472|Growth Inhibitors|growth inhibitors|mesh-ancestor
111120450|NCT04047472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111120451|NCT04047355|Propranolol|propranolol|mesh-list
111120452|NCT04047355|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111120453|NCT04047355|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111120454|NCT04047355|Adrenergic Agents|adrenergic agents|mesh-ancestor
111120455|NCT04047355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111120456|NCT04047355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111120457|NCT04047355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111120458|NCT04047355|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111120459|NCT04047355|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111120460|NCT04047355|Vasodilator Agents|vasodilator agents|mesh-ancestor
111120462|NCT04045431|Viscosupplements|viscosupplements|mesh-ancestor
111120463|NCT04045431|Protective Agents|protective agents|mesh-ancestor
111120464|NCT04045431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111120465|NCT04020341|Nitrofurantoin|nitrofurantoin|mesh-list
111120466|NCT04020341|Gepotidacin|gepotidacin|mesh-list
111120467|NCT04020341|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111120468|NCT04020341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111120469|NCT04020341|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111120470|NCT04020341|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111120471|NCT04020341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111120472|NCT04020341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111120473|NCT04020341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111120474|NCT04011280|Varenicline|varenicline|mesh-list
111120475|NCT04011280|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111120476|NCT04011280|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111120477|NCT04011280|Cholinergic Agents|cholinergic agents|mesh-ancestor
111120478|NCT04011280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110924793|NCT03098680|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111120479|NCT04011280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111120480|NCT04011280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111120481|NCT04002934|Bazedoxifene|bazedoxifene|mesh-list
111120482|NCT04002934|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111120483|NCT04002934|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111120484|NCT04002934|Hormone Antagonists|hormone antagonists|mesh-ancestor
111120485|NCT04002934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111120486|NCT04002934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111120487|NCT04002934|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111120488|NCT04001829|Paclitaxel|paclitaxel|mesh-list
111120489|NCT04001829|Docetaxel|docetaxel|mesh-list
111120490|NCT04001829|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111120491|NCT04001829|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111120492|NCT04001829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111120493|NCT04001829|Tubulin Modulators|tubulin modulators|mesh-ancestor
111120494|NCT04001829|Antimitotic Agents|antimitotic agents|mesh-ancestor
111120495|NCT04001829|Mitosis Modulators|mitosis modulators|mesh-ancestor
111120496|NCT04001829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111120497|NCT03987711|Warfarin|warfarin|mesh-list
111120498|NCT03987711|Apixaban|apixaban|mesh-list
111120499|NCT03987711|Anticoagulants|anticoagulants|mesh-ancestor
111120500|NCT03987711|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111120501|NCT03987711|Antithrombins|antithrombins|mesh-ancestor
111120502|NCT03987711|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111120503|NCT03987711|Protease Inhibitors|protease inhibitors|mesh-ancestor
111120504|NCT03987711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111120505|NCT03987711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111120507|NCT03937635|Dexamethasone acetate|dexamethasone acetate|mesh-list
111120508|NCT03937635|Lenalidomide|lenalidomide|mesh-list
111120509|NCT03937635|Daratumumab|daratumumab|mesh-list
111120510|NCT03937635|Ichthammol|ichthammol|mesh-list
111120511|NCT03937635|BB 1101|bb 1101|mesh-list
111120512|NCT03937635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111120513|NCT03937635|Antiemetics|antiemetics|mesh-ancestor
111120514|NCT03937635|Autonomic Agents|autonomic agents|mesh-ancestor
111120515|NCT03937635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111120516|NCT03937635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111120517|NCT03937635|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111120518|NCT03937635|Glucocorticoids|glucocorticoids|mesh-ancestor
111120519|NCT03937635|Hormones|hormones|mesh-ancestor
111120520|NCT03937635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111120521|NCT03937635|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111120522|NCT03937635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111120523|NCT03937635|Immunologic Factors|immunologic factors|mesh-ancestor
111120524|NCT03937635|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111120525|NCT03937635|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111120526|NCT03937635|Growth Substances|growth substances|mesh-ancestor
111120527|NCT03937635|Growth Inhibitors|growth inhibitors|mesh-ancestor
111120528|NCT03937635|Protease Inhibitors|protease inhibitors|mesh-ancestor
111120529|NCT03937635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111120530|NCT03937635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111120531|NCT03937635|Dermatologic Agents|dermatologic agents|mesh-ancestor
111120532|NCT03892044|Nivolumab|nivolumab|mesh-list
111120533|NCT03892044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111120534|NCT03892044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111120535|NCT03892044|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111120536|NCT03892044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111120537|NCT03891953|Spartalizumab|spartalizumab|mesh-list
111120538|NCT03891953|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111120539|NCT03891953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111120540|NCT03891953|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111120541|NCT03891953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111120542|NCT03879629|Carvedilol|carvedilol|mesh-list
111120543|NCT03879629|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111120544|NCT03879629|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111120545|NCT03879629|Adrenergic Agents|adrenergic agents|mesh-ancestor
111120546|NCT03879629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111120547|NCT03879629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111120548|NCT03879629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111120549|NCT03879629|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111120550|NCT03879629|Antioxidants|antioxidants|mesh-ancestor
111120551|NCT03879629|Protective Agents|protective agents|mesh-ancestor
111120552|NCT03879629|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111120553|NCT03879629|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111120554|NCT03879629|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111120555|NCT03879629|Vasodilator Agents|vasodilator agents|mesh-ancestor
111120556|NCT03879629|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111120557|NCT03879629|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111120558|NCT03873389|Ocrelizumab|ocrelizumab|mesh-list
111120559|NCT03873389|Immunologic Factors|immunologic factors|mesh-ancestor
111120560|NCT03873389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111120561|NCT03867851|Heparin|heparin|mesh-list
111120562|NCT03867851|Anticoagulants|anticoagulants|mesh-ancestor
111120563|NCT03867851|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111120564|NCT03867851|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111120565|NCT03867851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111120566|NCT03850691|Aldesleukin|aldesleukin|mesh-list
111120567|NCT03850691|Nivolumab|nivolumab|mesh-list
111120568|NCT03850691|Ipilimumab|ipilimumab|mesh-list
111120569|NCT03850691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111120570|NCT03850691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111120571|NCT03850691|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110835314|NCT03791827|Prednisolone|prednisolone|mesh-list
111120572|NCT03850691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111120573|NCT03850691|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111120574|NCT03850691|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111120575|NCT03850691|Antiviral Agents|antiviral agents|mesh-ancestor
111120576|NCT03850691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111120577|NCT03822793|Tranexamic Acid|tranexamic acid|mesh-list
111120578|NCT03822793|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111120579|NCT03822793|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111120580|NCT03822793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111120581|NCT03822793|Hemostatics|hemostatics|mesh-ancestor
111120582|NCT03822793|Coagulants|coagulants|mesh-ancestor
111120583|NCT03809780|Dexamethasone|dexamethasone|mesh-list
111120584|NCT03809780|Lenalidomide|lenalidomide|mesh-list
111120585|NCT03809780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111120586|NCT03809780|Antiemetics|antiemetics|mesh-ancestor
111120587|NCT03809780|Autonomic Agents|autonomic agents|mesh-ancestor
111120588|NCT03809780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111120589|NCT03809780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111120590|NCT03809780|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111120591|NCT03809780|Glucocorticoids|glucocorticoids|mesh-ancestor
111120592|NCT03809780|Hormones|hormones|mesh-ancestor
111120593|NCT03809780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111120594|NCT03809780|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111120595|NCT03809780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111120596|NCT03809780|Immunologic Factors|immunologic factors|mesh-ancestor
111120597|NCT03809780|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111120598|NCT03809780|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111120599|NCT03809780|Growth Substances|growth substances|mesh-ancestor
111120600|NCT03809780|Growth Inhibitors|growth inhibitors|mesh-ancestor
111120601|NCT03808818|Nicotine|nicotine|mesh-list
111120602|NCT03808818|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111120603|NCT03808818|Autonomic Agents|autonomic agents|mesh-ancestor
111120604|NCT03808818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111120605|NCT03808818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111120606|NCT03808818|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111120607|NCT03808818|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111120608|NCT03808818|Cholinergic Agents|cholinergic agents|mesh-ancestor
111120609|NCT03808818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111120610|NCT03808818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111120611|NCT03802604|Atezolizumab|atezolizumab|mesh-list
111120612|NCT03802604|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
111120613|NCT03802604|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111120614|NCT03802604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111120615|NCT03802604|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111120616|NCT03802604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111120617|NCT03785873|Leucovorin|leucovorin|mesh-list
111120618|NCT03785873|Fluorouracil|fluorouracil|mesh-list
111120619|NCT03785873|Nivolumab|nivolumab|mesh-list
111120620|NCT03785873|Irinotecan|irinotecan|mesh-list
111120621|NCT03785873|Antimetabolites|antimetabolites|mesh-ancestor
111120622|NCT03785873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111120623|NCT03785873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111120624|NCT03785873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111120625|NCT03785873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111120626|NCT03785873|Immunologic Factors|immunologic factors|mesh-ancestor
111120627|NCT03785873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111120628|NCT03785873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111120629|NCT03785873|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111120630|NCT03785873|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111120631|NCT03785873|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111120632|NCT03785873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111120633|NCT03785873|Antidotes|antidotes|mesh-ancestor
111120634|NCT03785873|Protective Agents|protective agents|mesh-ancestor
111120635|NCT03785873|Vitamin B Complex|vitamin b complex|mesh-ancestor
111120636|NCT03785873|Vitamins|vitamins|mesh-ancestor
111120637|NCT03785873|Micronutrients|micronutrients|mesh-ancestor
111120638|NCT03784677|SOR-C13|sor-c13|mesh-list
111120639|NCT03784677|Calcium|calcium|mesh-list
111120640|NCT03784677|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111120641|NCT03784677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111120642|NCT03784677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111120643|NCT03784677|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111120644|NCT03784677|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111120645|NCT03784677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111120646|NCT03782064|Nivolumab|nivolumab|mesh-list
111120647|NCT03782064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111120648|NCT03782064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111120649|NCT03782064|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111120650|NCT03782064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111120651|NCT03764488|Technetium Tc 99m Mertiatide|technetium tc 99m mertiatide|mesh-list
111120652|NCT03764488|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111120653|NCT03764488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111120654|NCT03764293|Sorafenib|sorafenib|mesh-list
111120655|NCT03764293|Apatinib|apatinib|mesh-list
111120656|NCT03764293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111120657|NCT03764293|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111120658|NCT03764293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111120659|NCT03764293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111120660|NCT03763643|Rituximab|rituximab|mesh-list
111120661|NCT03763643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111120662|NCT03763643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111120663|NCT03763643|Immunologic Factors|immunologic factors|mesh-ancestor
111120664|NCT03763643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111120665|NCT03763643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111120666|NCT03747042|Letrozole|letrozole|mesh-list
111120667|NCT03747042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111120668|NCT03747042|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111120669|NCT03747042|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111120670|NCT03747042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111120671|NCT03747042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111120672|NCT03747042|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111120673|NCT03747042|Hormone Antagonists|hormone antagonists|mesh-ancestor
111120674|NCT03747042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111120675|NCT03747042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111120676|NCT03739112|Vaccines|vaccines|mesh-list
111120677|NCT03739112|Immunologic Factors|immunologic factors|mesh-ancestor
111120678|NCT03739112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111120679|NCT03734237|Vaccines|vaccines|mesh-list
111120680|NCT03734237|Immunologic Factors|immunologic factors|mesh-ancestor
111120681|NCT03734237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111120682|NCT03724071|Flucytosine|flucytosine|mesh-list
111120683|NCT03724071|Antifungal Agents|antifungal agents|mesh-ancestor
111120684|NCT03724071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111120685|NCT03724071|Antimetabolites|antimetabolites|mesh-ancestor
111120686|NCT03724071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111120687|NCT03709446|Leflunomide|leflunomide|mesh-list
111120688|NCT03709446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111120689|NCT03709446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111120690|NCT03709446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111120691|NCT03709446|Immunologic Factors|immunologic factors|mesh-ancestor
111120692|NCT03709446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111120693|NCT03678350|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
111120694|NCT03678350|Trioxsalen|trioxsalen|mesh-list
111120695|NCT03678350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111120696|NCT03678350|Dermatologic Agents|dermatologic agents|mesh-ancestor
111120697|NCT03678350|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111120698|NCT03671525|Nimodipine|nimodipine|mesh-list
111120699|NCT03671525|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111120700|NCT03671525|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111120701|NCT03671525|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111120702|NCT03671525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111120703|NCT03671525|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111120704|NCT03671525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111120705|NCT03671525|Vasodilator Agents|vasodilator agents|mesh-ancestor
111120706|NCT03648437|Acetaminophen|acetaminophen|mesh-list
111120707|NCT03648437|Ibuprofen|ibuprofen|mesh-list
111120708|NCT03648437|Indomethacin|indomethacin|mesh-list
111120709|NCT03648437|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111120710|NCT03648437|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111120711|NCT03648437|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111120712|NCT03648437|Analgesics|analgesics|mesh-ancestor
111120713|NCT03648437|Sensory System Agents|sensory system agents|mesh-ancestor
111120714|NCT03648437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111120715|NCT03648437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111120716|NCT03648437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111120717|NCT03648437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111120718|NCT03648437|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111120719|NCT03648437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111120720|NCT03648437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111120721|NCT03648437|Antipyretics|antipyretics|mesh-ancestor
111120722|NCT03648437|Gout Suppressants|gout suppressants|mesh-ancestor
111120723|NCT03648437|Tocolytic Agents|tocolytic agents|mesh-ancestor
111120724|NCT03648437|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111120725|NCT03646058|Buprenorphine|buprenorphine|mesh-list
111120726|NCT03646058|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111120727|NCT03646058|Narcotics|narcotics|mesh-ancestor
111120728|NCT03646058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111120729|NCT03646058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111120730|NCT03646058|Analgesics|analgesics|mesh-ancestor
111120731|NCT03646058|Sensory System Agents|sensory system agents|mesh-ancestor
111120732|NCT03646058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111120733|NCT03646058|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111120734|NCT03641209|Acetaminophen|acetaminophen|mesh-list
111120735|NCT03641209|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111120736|NCT03641209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111120737|NCT03641209|Analgesics|analgesics|mesh-ancestor
111120738|NCT03641209|Sensory System Agents|sensory system agents|mesh-ancestor
111120739|NCT03641209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111120740|NCT03641209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111120741|NCT03641209|Antipyretics|antipyretics|mesh-ancestor
111120742|NCT03622593|Aflibercept|aflibercept|mesh-list
111120743|NCT03622593|Faricimab|faricimab|mesh-list
111120744|NCT03622593|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111120745|NCT03622593|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111120746|NCT03622593|Growth Substances|growth substances|mesh-ancestor
111120747|NCT03622593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111120748|NCT03622593|Growth Inhibitors|growth inhibitors|mesh-ancestor
111120749|NCT03622593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111120750|NCT03602066|Chlorine dioxide|chlorine dioxide|mesh-list
111120751|NCT03602066|Dental Disinfectants|dental disinfectants|mesh-ancestor
111120752|NCT03602066|Disinfectants|disinfectants|mesh-ancestor
111120753|NCT03602066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111120754|NCT03597581|Bevacizumab|bevacizumab|mesh-list
111120755|NCT03597581|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111120756|NCT03597581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111120757|NCT03597581|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111120758|NCT03597581|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111120759|NCT03597581|Growth Substances|growth substances|mesh-ancestor
111120760|NCT03597581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111120761|NCT03597581|Growth Inhibitors|growth inhibitors|mesh-ancestor
111120762|NCT03593655|Tenofovir|tenofovir|mesh-list
111120763|NCT03593655|Emtricitabine|emtricitabine|mesh-list
111120764|NCT03593655|Dapivirine|dapivirine|mesh-list
111120765|NCT03593655|Antiviral Agents|antiviral agents|mesh-ancestor
111120766|NCT03593655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110368205|NCT00562419|Irinotecan|irinotecan|mesh-list
111120767|NCT03593655|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111120768|NCT03593655|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111120769|NCT03593655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111120770|NCT03593655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111120771|NCT03593655|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111120772|NCT03593655|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111120773|NCT03586661|Niraparib|niraparib|mesh-list
111120774|NCT03586661|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111120775|NCT03586661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111120776|NCT03586661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111120777|NCT03586661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111120778|NCT03572530|Azacitidine|azacitidine|mesh-list
111120779|NCT03572530|Decitabine|decitabine|mesh-list
111120780|NCT03572530|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111120781|NCT03572530|Antimetabolites|antimetabolites|mesh-ancestor
111120782|NCT03572530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111120783|NCT03572530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111120784|NCT03572530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111120785|NCT03570619|Nivolumab|nivolumab|mesh-list
111120786|NCT03570619|Ipilimumab|ipilimumab|mesh-list
111120787|NCT03570619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111120788|NCT03570619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111120789|NCT03570619|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111120790|NCT03570619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111120791|NCT03558087|Gemcitabine|gemcitabine|mesh-list
111120792|NCT03558087|Nivolumab|nivolumab|mesh-list
111120793|NCT03558087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111120794|NCT03558087|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111120795|NCT03558087|Antimetabolites|antimetabolites|mesh-ancestor
111120796|NCT03558087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111120797|NCT03558087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111120798|NCT03558087|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111120799|NCT03542695|Alendronate|alendronate|mesh-list
111120801|NCT03542695|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111120802|NCT03542695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110368222|NCT02900729|Losartan|losartan|mesh-list
111120803|NCT03542695|Trace Elements|trace elements|mesh-ancestor
111120804|NCT03542695|Micronutrients|micronutrients|mesh-ancestor
111120805|NCT03541902|Sunitinib|sunitinib|mesh-list
111120806|NCT03541902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111120807|NCT03541902|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111120808|NCT03541902|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111120809|NCT03541902|Growth Substances|growth substances|mesh-ancestor
111120810|NCT03541902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111120811|NCT03541902|Growth Inhibitors|growth inhibitors|mesh-ancestor
111120812|NCT03541902|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111120813|NCT03541902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111120814|NCT03541902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111120815|NCT03534180|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111120816|NCT03534180|Venetoclax|venetoclax|mesh-list
111120817|NCT03534180|Romidepsin|romidepsin|mesh-list
111120818|NCT03534180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111120819|NCT03534180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111120820|NCT03534180|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111120821|NCT03534180|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111120822|NCT03534180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111120823|NCT03534180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111120824|NCT03516279|Pembrolizumab|pembrolizumab|mesh-list
111120825|NCT03516279|Imatinib Mesylate|imatinib mesylate|mesh-list
111120826|NCT03516279|Dasatinib|dasatinib|mesh-list
111120827|NCT03516279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111120828|NCT03516279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111120829|NCT03516279|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111120830|NCT03516279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111120831|NCT03516279|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111120832|NCT03516279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111120833|NCT03512405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111120834|NCT03512405|Pembrolizumab|pembrolizumab|mesh-list
111120835|NCT03512405|Blinatumomab|blinatumomab|mesh-list
111120836|NCT03512405|Antibodies|antibodies|mesh-list
111120837|NCT03512405|Immunoglobulins|immunoglobulins|mesh-list
111120838|NCT03512405|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111120839|NCT03512405|Muromonab-CD3|muromonab-cd3|mesh-list
111120840|NCT03512405|Antibodies, Bispecific|antibodies, bispecific|mesh-list
111120841|NCT03512405|Immunologic Factors|immunologic factors|mesh-ancestor
111120842|NCT03512405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111120843|NCT03512405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111120844|NCT03512405|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111120845|NCT03512405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111120846|NCT03512405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111120847|NCT03493425|Cisplatin|cisplatin|mesh-list
111120848|NCT03493425|Carboplatin|carboplatin|mesh-list
111120849|NCT03493425|Docetaxel|docetaxel|mesh-list
111120850|NCT03493425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111120851|NCT03493425|Tubulin Modulators|tubulin modulators|mesh-ancestor
111120852|NCT03493425|Antimitotic Agents|antimitotic agents|mesh-ancestor
111120853|NCT03493425|Mitosis Modulators|mitosis modulators|mesh-ancestor
111120854|NCT03493425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111120855|NCT03458416|Cannabidiol|cannabidiol|mesh-list
111120856|NCT03458416|Anticonvulsants|anticonvulsants|mesh-ancestor
111120857|NCT03441113|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
111120858|NCT03441113|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111120859|NCT03441113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111120860|NCT03441113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111120861|NCT03430219|Calcium|calcium|mesh-list
111120862|NCT03430219|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111120863|NCT03430219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111120864|NCT03419234|Ascorbic Acid|ascorbic acid|mesh-list
111120865|NCT03419234|Prednisone|prednisone|mesh-list
111120866|NCT03419234|Cortisone|cortisone|mesh-list
111120867|NCT03419234|Methyltestosterone|methyltestosterone|mesh-list
111120868|NCT03419234|Abiraterone Acetate|abiraterone acetate|mesh-list
111120869|NCT03419234|Hormones|hormones|mesh-list
111120870|NCT03419234|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
111120871|NCT03419234|Androgens|androgens|mesh-list
111120872|NCT03419234|Androgen Antagonists|androgen antagonists|mesh-list
111120873|NCT03419234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111120874|NCT03419234|Glucocorticoids|glucocorticoids|mesh-ancestor
111120875|NCT03419234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111120876|NCT03419234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111120877|NCT03419234|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111120878|NCT03419234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111120879|NCT03419234|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111120881|NCT03419234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111120882|NCT03419234|Hormone Antagonists|hormone antagonists|mesh-ancestor
111120883|NCT03419234|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111120884|NCT03419234|Antioxidants|antioxidants|mesh-ancestor
111120885|NCT03419234|Protective Agents|protective agents|mesh-ancestor
111120887|NCT03419234|Micronutrients|micronutrients|mesh-ancestor
111120888|NCT03419234|Estrogens|estrogens|mesh-ancestor
111120889|NCT03419234|Anabolic Agents|anabolic agents|mesh-ancestor
111120890|NCT03384914|Vaccines|vaccines|mesh-list
111120891|NCT03384914|Immunologic Factors|immunologic factors|mesh-list
111120892|NCT03384914|Immunomodulating Agents|immunomodulating agents|mesh-list
111120893|NCT03384914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111120894|NCT03267433|Rituximab|rituximab|mesh-list
111120895|NCT03267433|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111120896|NCT03267433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111120897|NCT03267433|Immunologic Factors|immunologic factors|mesh-ancestor
111120898|NCT03267433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111120899|NCT03267433|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111120900|NCT03238300|Acetylcysteine|acetylcysteine|mesh-list
111120901|NCT03238300|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111120902|NCT03238300|Antiviral Agents|antiviral agents|mesh-ancestor
111120903|NCT03238300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111120904|NCT03238300|Expectorants|expectorants|mesh-ancestor
111120905|NCT03238300|Respiratory System Agents|respiratory system agents|mesh-ancestor
111120906|NCT03238300|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111120907|NCT03238300|Antioxidants|antioxidants|mesh-ancestor
111120908|NCT03238300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111120909|NCT03238300|Protective Agents|protective agents|mesh-ancestor
111120910|NCT03238300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111120911|NCT03238300|Antidotes|antidotes|mesh-ancestor
111120912|NCT03215511|Selitrectinib|selitrectinib|mesh-list
111120913|NCT03215511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111120914|NCT03215511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111120915|NCT03214003|Cisplatin|cisplatin|mesh-list
111120916|NCT03214003|Etoposide|etoposide|mesh-list
111120917|NCT03214003|Etoposide phosphate|etoposide phosphate|mesh-list
111120918|NCT03214003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111120919|NCT03214003|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111120920|NCT03214003|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111120921|NCT03214003|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111120922|NCT03214003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111120923|NCT03214003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111120924|NCT03181100|Paclitaxel|paclitaxel|mesh-list
111120925|NCT03181100|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111120926|NCT03181100|Bevacizumab|bevacizumab|mesh-list
111120927|NCT03181100|Atezolizumab|atezolizumab|mesh-list
111120928|NCT03181100|Vemurafenib|vemurafenib|mesh-list
111120929|NCT03181100|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111120930|NCT03181100|Endothelial Growth Factors|endothelial growth factors|mesh-list
111120931|NCT03181100|Antibodies|antibodies|mesh-list
111120932|NCT03181100|Immunoglobulins|immunoglobulins|mesh-list
111120933|NCT03181100|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111120934|NCT03181100|Immunoglobulin G|immunoglobulin g|mesh-list
111120935|NCT03181100|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111120936|NCT03181100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111120937|NCT03181100|Tubulin Modulators|tubulin modulators|mesh-ancestor
111120938|NCT03181100|Antimitotic Agents|antimitotic agents|mesh-ancestor
111120939|NCT03181100|Mitosis Modulators|mitosis modulators|mesh-ancestor
111120940|NCT03181100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111120941|NCT03181100|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111120942|NCT03181100|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111120943|NCT03181100|Growth Substances|growth substances|mesh-ancestor
111120944|NCT03181100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111120945|NCT03181100|Growth Inhibitors|growth inhibitors|mesh-ancestor
111120946|NCT03181100|Immunologic Factors|immunologic factors|mesh-ancestor
111120947|NCT03181100|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111120948|NCT03181100|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111120949|NCT03181100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111120950|NCT03139370|Cyclophosphamide|cyclophosphamide|mesh-list
111120951|NCT03139370|Fludarabine|fludarabine|mesh-list
111120952|NCT03139370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111120953|NCT03139370|Immunologic Factors|immunologic factors|mesh-ancestor
111120954|NCT03139370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111120955|NCT03139370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111120956|NCT03139370|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111120957|NCT03139370|Alkylating Agents|alkylating agents|mesh-ancestor
111120958|NCT03139370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111120959|NCT03139370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111120960|NCT03139370|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111120962|NCT03133221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111120963|NCT03133221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111120964|NCT03133221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111120965|NCT03113500|Prednisone|prednisone|mesh-list
111120966|NCT03113500|Cortisone|cortisone|mesh-list
111120967|NCT03113500|Cyclophosphamide|cyclophosphamide|mesh-list
111120968|NCT03113500|Doxorubicin|doxorubicin|mesh-list
111120969|NCT03113500|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111120970|NCT03113500|Etoposide|etoposide|mesh-list
111120971|NCT03113500|Etoposide phosphate|etoposide phosphate|mesh-list
111120972|NCT03113500|Daunorubicin|daunorubicin|mesh-list
111120973|NCT03113500|Brentuximab Vedotin|brentuximab vedotin|mesh-list
111120974|NCT03113500|Podophyllotoxin|podophyllotoxin|mesh-list
111120975|NCT03113500|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111120976|NCT03113500|Antibodies|antibodies|mesh-list
111120977|NCT03113500|Immunoglobulins|immunoglobulins|mesh-list
111120978|NCT03113500|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111120979|NCT03113500|Immunoconjugates|immunoconjugates|mesh-list
111120980|NCT03113500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111120981|NCT03113500|Immunologic Factors|immunologic factors|mesh-ancestor
110368412|NCT01190449|Ofatumumab|ofatumumab|mesh-list
111120982|NCT03113500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111120983|NCT03113500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111120984|NCT03113500|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111120985|NCT03113500|Alkylating Agents|alkylating agents|mesh-ancestor
111120986|NCT03113500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111120987|NCT03113500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111120988|NCT03113500|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111120989|NCT03113500|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111120990|NCT03113500|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111120991|NCT03113500|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111120992|NCT03113500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111120993|NCT03113500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111120994|NCT03113500|Glucocorticoids|glucocorticoids|mesh-ancestor
111120995|NCT03113500|Hormones|hormones|mesh-ancestor
111120996|NCT03113500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111120997|NCT03113500|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111120998|NCT03113500|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111120999|NCT03113500|Immunotoxins|immunotoxins|mesh-ancestor
111121000|NCT03113500|Keratolytic Agents|keratolytic agents|mesh-ancestor
111121001|NCT03113500|Dermatologic Agents|dermatologic agents|mesh-ancestor
111121002|NCT03113500|Tubulin Modulators|tubulin modulators|mesh-ancestor
111121003|NCT03113500|Antimitotic Agents|antimitotic agents|mesh-ancestor
111121004|NCT03113500|Mitosis Modulators|mitosis modulators|mesh-ancestor
111121005|NCT03108131|Atezolizumab|atezolizumab|mesh-list
111121006|NCT03108131|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111121007|NCT03108131|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111121008|NCT03108131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111121009|NCT03108131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110924794|NCT03098680|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111121010|NCT03108131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111121011|NCT03108131|Immunologic Factors|immunologic factors|mesh-ancestor
111121012|NCT03108131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111121013|NCT03089203|Cyclophosphamide|cyclophosphamide|mesh-list
111121014|NCT03089203|Fludarabine|fludarabine|mesh-list
111121015|NCT03089203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111121016|NCT03089203|Immunologic Factors|immunologic factors|mesh-ancestor
111121017|NCT03089203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111121018|NCT03089203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111121019|NCT03089203|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111121020|NCT03089203|Alkylating Agents|alkylating agents|mesh-ancestor
111121021|NCT03089203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111121022|NCT03089203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111121023|NCT03089203|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111121024|NCT03087071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111121025|NCT03087071|Panitumumab|panitumumab|mesh-list
111121027|NCT03087071|Antibodies|antibodies|mesh-list
111121028|NCT03087071|Immunoglobulins|immunoglobulins|mesh-list
111121029|NCT03087071|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111121030|NCT03087071|Immunologic Factors|immunologic factors|mesh-ancestor
111121031|NCT03087071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111121032|NCT03087071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111121033|NCT03087071|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111121035|NCT03087071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111121036|NCT03049540|Tadalafil|tadalafil|mesh-list
111121037|NCT03049540|Vasodilator Agents|vasodilator agents|mesh-ancestor
111121038|NCT03049540|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111121039|NCT03049540|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111121040|NCT03049540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111121041|NCT03049540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111121042|NCT03049540|Urological Agents|urological agents|mesh-ancestor
111121043|NCT03040596|Fluticasone|fluticasone|mesh-list
111121044|NCT03040596|Xhance|xhance|mesh-list
111121045|NCT03040596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111121046|NCT03040596|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111121047|NCT03040596|Autonomic Agents|autonomic agents|mesh-ancestor
111121048|NCT03040596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111121049|NCT03040596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111121050|NCT03040596|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111121051|NCT03040596|Respiratory System Agents|respiratory system agents|mesh-ancestor
111121052|NCT03040596|Dermatologic Agents|dermatologic agents|mesh-ancestor
111121053|NCT03040596|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111121054|NCT03012880|Dexamethasone|dexamethasone|mesh-list
111121055|NCT03012880|Dexamethasone acetate|dexamethasone acetate|mesh-list
111121056|NCT03012880|Lenalidomide|lenalidomide|mesh-list
111121057|NCT03012880|Daratumumab|daratumumab|mesh-list
111121058|NCT03012880|Ixazomib|ixazomib|mesh-list
111121059|NCT03012880|Ichthammol|ichthammol|mesh-list
111121060|NCT03012880|BB 1101|bb 1101|mesh-list
111121061|NCT03012880|Glycine|glycine|mesh-list
111121062|NCT03012880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111121063|NCT03012880|Antiemetics|antiemetics|mesh-ancestor
111121064|NCT03012880|Autonomic Agents|autonomic agents|mesh-ancestor
111121065|NCT03012880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111121066|NCT03012880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111121067|NCT03012880|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111121068|NCT03012880|Glucocorticoids|glucocorticoids|mesh-ancestor
111121069|NCT03012880|Hormones|hormones|mesh-ancestor
111121070|NCT03012880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111121071|NCT03012880|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111121072|NCT03012880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111121073|NCT03012880|Immunologic Factors|immunologic factors|mesh-ancestor
111121074|NCT03012880|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111121075|NCT03012880|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111121076|NCT03012880|Growth Substances|growth substances|mesh-ancestor
111121077|NCT03012880|Growth Inhibitors|growth inhibitors|mesh-ancestor
111121078|NCT03012880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111121079|NCT03012880|Protease Inhibitors|protease inhibitors|mesh-ancestor
111121080|NCT03012880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111121081|NCT03012880|Dermatologic Agents|dermatologic agents|mesh-ancestor
111121082|NCT03012880|Glycine Agents|glycine agents|mesh-ancestor
111121083|NCT03012880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111121084|NCT02999087|Cetuximab|cetuximab|mesh-list
111121085|NCT02999087|Avelumab|avelumab|mesh-list
111121086|NCT02999087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111121087|NCT02999087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111121088|NCT02983461|Sildenafil Citrate|sildenafil citrate|mesh-list
111121089|NCT02983461|Vasodilator Agents|vasodilator agents|mesh-ancestor
111121090|NCT02983461|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111121091|NCT02983461|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111121092|NCT02983461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111121093|NCT02983461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111121094|NCT02983461|Urological Agents|urological agents|mesh-ancestor
111121095|NCT02936102|Spartalizumab|spartalizumab|mesh-list
111121096|NCT02936102|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111121097|NCT02936102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111121098|NCT02936102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111121099|NCT02936102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111121100|NCT02924727|Valsartan|valsartan|mesh-list
111121101|NCT02924727|Ramipril|ramipril|mesh-list
111121102|NCT02924727|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
111121103|NCT02924727|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111121104|NCT02924727|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111121105|NCT02924727|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111121106|NCT02924727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111121107|NCT02924727|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
111121108|NCT02924727|Protease Inhibitors|protease inhibitors|mesh-ancestor
111121109|NCT02924727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111121111|NCT02905110|Etoposide|etoposide|mesh-list
111121112|NCT02905110|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111121113|NCT02905110|Abortifacient Agents|abortifacient agents|mesh-ancestor
111121114|NCT02905110|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111121115|NCT02905110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111121116|NCT02905110|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111121117|NCT02905110|Antimetabolites|antimetabolites|mesh-ancestor
111121118|NCT02905110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111121119|NCT02905110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111121120|NCT02905110|Dermatologic Agents|dermatologic agents|mesh-ancestor
111121121|NCT02905110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111121122|NCT02905110|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111121123|NCT02905110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111121124|NCT02905110|Immunologic Factors|immunologic factors|mesh-ancestor
111121125|NCT02905110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111121126|NCT02905110|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111121127|NCT02905110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111121128|NCT02905110|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111121129|NCT02905110|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111121130|NCT02798523|Methylprednisolone|methylprednisolone|mesh-list
111121131|NCT02798523|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111121132|NCT02798523|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111121133|NCT02798523|Prednisolone|prednisolone|mesh-list
111121134|NCT02798523|Prednisolone acetate|prednisolone acetate|mesh-list
111121135|NCT02798523|Methylprednisolone aceponate|methylprednisolone aceponate|mesh-list
111121136|NCT02798523|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111121137|NCT02798523|Prednisolone phosphate|prednisolone phosphate|mesh-list
111121138|NCT02798523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111121139|NCT02798523|Antiemetics|antiemetics|mesh-ancestor
111121140|NCT02798523|Autonomic Agents|autonomic agents|mesh-ancestor
111121141|NCT02798523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111121142|NCT02798523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111121143|NCT02798523|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111121144|NCT02798523|Glucocorticoids|glucocorticoids|mesh-ancestor
111121145|NCT02798523|Hormones|hormones|mesh-ancestor
111121146|NCT02798523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111121147|NCT02798523|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111121148|NCT02798523|Protective Agents|protective agents|mesh-ancestor
110835416|NCT03342963|Aripiprazole|aripiprazole|mesh-list
111121149|NCT02798523|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111121150|NCT02798523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111121152|NCT02797977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111121153|NCT02797977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111121154|NCT02797977|Antimetabolites|antimetabolites|mesh-ancestor
111121155|NCT02797977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111121156|NCT02772588|Leuprolide|leuprolide|mesh-list
111121157|NCT02772588|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111121158|NCT02772588|Fertility Agents|fertility agents|mesh-ancestor
111121159|NCT02772588|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111121160|NCT02772588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111121161|NCT02772588|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111121162|NCT02772588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111121163|NCT02766582|Paclitaxel|paclitaxel|mesh-list
111121164|NCT02766582|Carboplatin|carboplatin|mesh-list
111121165|NCT02766582|Pembrolizumab|pembrolizumab|mesh-list
111121166|NCT02766582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111121167|NCT02766582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111121168|NCT02766582|Tubulin Modulators|tubulin modulators|mesh-ancestor
111121169|NCT02766582|Antimitotic Agents|antimitotic agents|mesh-ancestor
111121170|NCT02766582|Mitosis Modulators|mitosis modulators|mesh-ancestor
111121171|NCT02766582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111121172|NCT02766582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111121173|NCT02766582|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111121174|NCT02720692|Meloxicam|meloxicam|mesh-list
111121175|NCT02720692|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111121176|NCT02720692|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111121177|NCT02720692|Analgesics|analgesics|mesh-ancestor
111121178|NCT02720692|Sensory System Agents|sensory system agents|mesh-ancestor
111121179|NCT02720692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111121180|NCT02720692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111121181|NCT02720692|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111121182|NCT02720692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111121183|NCT02720692|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111121184|NCT02720692|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111121185|NCT02720692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110924795|NCT03098680|Adrenergic Agents|adrenergic agents|mesh-ancestor
111121186|NCT02720692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111121187|NCT02712151|Ropivacaine|ropivacaine|mesh-list
111121188|NCT02712151|Anesthetics, Local|anesthetics, local|mesh-ancestor
111121189|NCT02712151|Anesthetics|anesthetics|mesh-ancestor
111121190|NCT02712151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111121191|NCT02712151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111121192|NCT02712151|Sensory System Agents|sensory system agents|mesh-ancestor
111121193|NCT02712151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111121194|NCT02707484|Thalidomide|thalidomide|mesh-list
111121195|NCT02707484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111121196|NCT02707484|Immunologic Factors|immunologic factors|mesh-ancestor
111121197|NCT02707484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111121198|NCT02707484|Leprostatic Agents|leprostatic agents|mesh-ancestor
111121199|NCT02707484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111121200|NCT02707484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111121201|NCT02707484|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111121202|NCT02707484|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111121203|NCT02707484|Growth Substances|growth substances|mesh-ancestor
111121204|NCT02707484|Growth Inhibitors|growth inhibitors|mesh-ancestor
111121205|NCT02707484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111121206|NCT02651662|Cemiplimab|cemiplimab|mesh-list
111121207|NCT02651662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111121208|NCT02651662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111121209|NCT02646683|Vedolizumab|vedolizumab|mesh-list
111121210|NCT02646683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111121211|NCT02628626|Clonidine|clonidine|mesh-list
111121212|NCT02628626|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
111121213|NCT02628626|Analgesics|analgesics|mesh-ancestor
111121214|NCT02628626|Sensory System Agents|sensory system agents|mesh-ancestor
111121215|NCT02628626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111121216|NCT02628626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111121217|NCT02628626|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111121218|NCT02628626|Sympatholytics|sympatholytics|mesh-ancestor
111121219|NCT02628626|Autonomic Agents|autonomic agents|mesh-ancestor
111121220|NCT02628626|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111121221|NCT02628626|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111121222|NCT02628626|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111121223|NCT02628626|Adrenergic Agents|adrenergic agents|mesh-ancestor
111121224|NCT02628626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111121225|NCT02628626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111121226|NCT02628626|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111121227|NCT02628626|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111121228|NCT02628626|Antimetabolites|antimetabolites|mesh-ancestor
111121229|NCT02628626|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111121230|NCT02616965|Brentuximab Vedotin|brentuximab vedotin|mesh-list
111121231|NCT02616965|Romidepsin|romidepsin|mesh-list
111121232|NCT02616965|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111121233|NCT02616965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111121234|NCT02616965|Immunotoxins|immunotoxins|mesh-ancestor
111121235|NCT02616965|Immunoconjugates|immunoconjugates|mesh-ancestor
111121236|NCT02616965|Immunologic Factors|immunologic factors|mesh-ancestor
111121237|NCT02616965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111121238|NCT02616965|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111121239|NCT02616965|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111121240|NCT02616965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111121241|NCT02616965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111121242|NCT02595424|Carboplatin|carboplatin|mesh-list
111121243|NCT02595424|Capecitabine|capecitabine|mesh-list
111121244|NCT02595424|Etoposide|etoposide|mesh-list
111121245|NCT02595424|Temozolomide|temozolomide|mesh-list
111121246|NCT02595424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111121247|NCT02595424|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110064066|NCT01526005|Nicotine|nicotine|mesh-list
111121248|NCT02595424|Antimetabolites|antimetabolites|mesh-ancestor
111121249|NCT02595424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111121250|NCT02595424|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111121251|NCT02595424|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111121252|NCT02595424|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110838333|NCT03434782|Fluorides|fluorides|mesh-list
111121253|NCT02595424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111121254|NCT02595424|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111121255|NCT02595424|Alkylating Agents|alkylating agents|mesh-ancestor
111121256|NCT02554812|Avelumab|avelumab|mesh-list
111121257|NCT02554812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111121258|NCT02554812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111121259|NCT02544815|Digoxin|digoxin|mesh-list
111121260|NCT02544815|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111121261|NCT02544815|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111121262|NCT02544815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111121263|NCT02544815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110835449|NCT03791515|Calcitonin|calcitonin|mesh-list
111121264|NCT02544815|Protective Agents|protective agents|mesh-ancestor
111121265|NCT02544815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111121266|NCT02527707|Ritonavir|ritonavir|mesh-list
111121267|NCT02527707|Lonafarnib|lonafarnib|mesh-list
111121268|NCT02527707|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111121269|NCT02527707|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111121270|NCT02527707|Protease Inhibitors|protease inhibitors|mesh-ancestor
111121271|NCT02527707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111121272|NCT02527707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111121273|NCT02527707|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111121274|NCT02527707|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111121275|NCT02527707|Antiviral Agents|antiviral agents|mesh-ancestor
111121276|NCT02527707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111121277|NCT02527707|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111121278|NCT02527707|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111121279|NCT02453191|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
111121280|NCT02453191|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111121281|NCT02453191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111121282|NCT02367924|Trabectedin|trabectedin|mesh-list
111121283|NCT02367924|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111121284|NCT02367924|Alkylating Agents|alkylating agents|mesh-ancestor
111121285|NCT02367924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111121286|NCT02367924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111121287|NCT02352090|Dienogest|dienogest|mesh-list
111121288|NCT02352090|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
111121289|NCT02352090|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
111121290|NCT02352090|Ethinyl Estradiol|ethinyl estradiol|mesh-list
111121291|NCT02352090|Estradiol|estradiol|mesh-list
111121292|NCT02352090|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
111121293|NCT02352090|Nandrolone|nandrolone|mesh-list
111121294|NCT02352090|Estrogens|estrogens|mesh-ancestor
111121295|NCT02352090|Hormones|hormones|mesh-ancestor
111121296|NCT02352090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111121297|NCT02352090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111121298|NCT02352090|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111121299|NCT02352090|Contraceptive Agents|contraceptive agents|mesh-ancestor
111121300|NCT02352090|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111121301|NCT02352090|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111121302|NCT02352090|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111121303|NCT02352090|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111121304|NCT02352090|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
111121305|NCT02352090|Hormone Antagonists|hormone antagonists|mesh-ancestor
111121306|NCT02352090|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111121307|NCT02352090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111121308|NCT02352090|Androgens|androgens|mesh-ancestor
111121309|NCT02352090|Anabolic Agents|anabolic agents|mesh-ancestor
111121310|NCT02135107|Rabeprazole|rabeprazole|mesh-list
111121311|NCT02135107|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111121312|NCT02135107|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111121313|NCT02135107|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111121314|NCT02135107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111121315|NCT02135107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111121316|NCT01982448|Paclitaxel|paclitaxel|mesh-list
111121317|NCT01982448|Cisplatin|cisplatin|mesh-list
111121318|NCT01982448|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111121319|NCT01982448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111121320|NCT01982448|Tubulin Modulators|tubulin modulators|mesh-ancestor
111121321|NCT01982448|Antimitotic Agents|antimitotic agents|mesh-ancestor
111121322|NCT01982448|Mitosis Modulators|mitosis modulators|mesh-ancestor
110870370|NCT02394418|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111121323|NCT01982448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111121324|NCT01938261|Acetaminophen|acetaminophen|mesh-list
111121325|NCT01938261|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111121326|NCT01938261|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111121327|NCT01938261|Analgesics|analgesics|mesh-ancestor
111121328|NCT01938261|Sensory System Agents|sensory system agents|mesh-ancestor
111121329|NCT01938261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111121330|NCT01938261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111121331|NCT01938261|Antipyretics|antipyretics|mesh-ancestor
111121332|NCT01809041|Remifentanil|remifentanil|mesh-list
111121333|NCT01809041|Propofol|propofol|mesh-list
111121334|NCT01809041|Sevoflurane|sevoflurane|mesh-list
111121335|NCT01809041|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111121336|NCT01809041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111121337|NCT01809041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111121338|NCT01809041|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111121339|NCT01809041|Anesthetics, General|anesthetics, general|mesh-ancestor
111121340|NCT01809041|Anesthetics|anesthetics|mesh-ancestor
111121341|NCT01809041|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111121342|NCT01809041|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111121343|NCT01809041|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111121344|NCT01809041|Narcotics|narcotics|mesh-ancestor
111121345|NCT01809041|Analgesics|analgesics|mesh-ancestor
111121346|NCT01809041|Sensory System Agents|sensory system agents|mesh-ancestor
111121347|NCT01809041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111121348|NCT01689727|Technetium Tc 99m-ethylenedicysteine|technetium tc 99m-ethylenedicysteine|mesh-list
111121349|NCT01689727|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111121350|NCT01689727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111121351|NCT01689714|Technetium Tc 99m-ethylenedicysteine|technetium tc 99m-ethylenedicysteine|mesh-list
111121352|NCT01689714|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111121353|NCT01689714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111121354|NCT01689662|Technetium Tc 99m-ethylenedicysteine|technetium tc 99m-ethylenedicysteine|mesh-list
111121355|NCT01689662|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111121356|NCT01689662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111121357|NCT01689636|Technetium Tc 99m-ethylenedicysteine|technetium tc 99m-ethylenedicysteine|mesh-list
111121358|NCT01689636|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111121359|NCT01689636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111121360|NCT01686256|Technetium Tc 99m-ethylenedicysteine|technetium tc 99m-ethylenedicysteine|mesh-list
111121361|NCT01686256|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110924796|NCT03098680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111121362|NCT01686256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111121363|NCT01684098|Technetium Tc 99m-ethylenedicysteine|technetium tc 99m-ethylenedicysteine|mesh-list
111121364|NCT01684098|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111121365|NCT01684098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111121366|NCT01659151|Aldesleukin|aldesleukin|mesh-list
111121367|NCT01659151|Cyclophosphamide|cyclophosphamide|mesh-list
111121368|NCT01659151|Fludarabine|fludarabine|mesh-list
111121369|NCT01659151|Interleukin-2|interleukin-2|mesh-list
111121370|NCT01659151|Vemurafenib|vemurafenib|mesh-list
111121371|NCT01659151|Enzyme Inhibitors|enzyme inhibitors|mesh-list
111121372|NCT01659151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111121373|NCT01659151|Immunologic Factors|immunologic factors|mesh-ancestor
111121374|NCT01659151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111121375|NCT01659151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111121376|NCT01659151|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111121377|NCT01659151|Alkylating Agents|alkylating agents|mesh-ancestor
111121378|NCT01659151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111121379|NCT01659151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111121380|NCT01659151|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111121381|NCT01659151|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111121382|NCT01659151|Analgesics|analgesics|mesh-ancestor
111121383|NCT01659151|Sensory System Agents|sensory system agents|mesh-ancestor
111121384|NCT01659151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111121385|NCT01659151|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111121386|NCT01659151|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111121387|NCT01659151|Antiviral Agents|antiviral agents|mesh-ancestor
111121388|NCT01659151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111121389|NCT01659151|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111121390|NCT01593254|Imatinib Mesylate|imatinib mesylate|mesh-list
111121391|NCT01593254|Dasatinib|dasatinib|mesh-list
111121392|NCT01593254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111121393|NCT01593254|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111121394|NCT01593254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111121395|NCT01593254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111121396|NCT01537601|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111121397|NCT01537601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111121398|NCT01525394|Moxifloxacin|moxifloxacin|mesh-list
111121399|NCT01525394|Lenvatinib|lenvatinib|mesh-list
111121400|NCT01525394|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111121401|NCT01525394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111121402|NCT01525394|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111121403|NCT01525394|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111121404|NCT01525394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111121405|NCT01525394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111121406|NCT01525394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111121407|NCT01525394|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111121408|NCT01454934|Gemcitabine|gemcitabine|mesh-list
111121409|NCT01454934|Docetaxel|docetaxel|mesh-list
111121410|NCT01454934|Pemetrexed|pemetrexed|mesh-list
111121411|NCT01454934|Vinorelbine|vinorelbine|mesh-list
111121412|NCT01454934|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111121413|NCT01454934|Antimetabolites|antimetabolites|mesh-ancestor
111121414|NCT01454934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111121415|NCT01454934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111121416|NCT01454934|Tubulin Modulators|tubulin modulators|mesh-ancestor
111121417|NCT01454934|Antimitotic Agents|antimitotic agents|mesh-ancestor
111121418|NCT01454934|Mitosis Modulators|mitosis modulators|mesh-ancestor
111121419|NCT01454934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111121420|NCT01454934|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111121421|NCT01454934|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111121422|NCT01454934|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111121423|NCT01442246|Leuprolide|leuprolide|mesh-list
111121424|NCT01442246|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111121425|NCT01442246|Fertility Agents|fertility agents|mesh-ancestor
111121426|NCT01442246|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111121427|NCT01442246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111121428|NCT01442246|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111121429|NCT01442246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111121430|NCT01439282|Capecitabine|capecitabine|mesh-list
111121431|NCT01439282|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111121432|NCT01439282|Antimetabolites|antimetabolites|mesh-ancestor
111121433|NCT01439282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111121434|NCT01439282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111121435|NCT01352520|Brentuximab Vedotin|brentuximab vedotin|mesh-list
111121436|NCT01352520|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111121437|NCT01352520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111121438|NCT01352520|Immunotoxins|immunotoxins|mesh-ancestor
111121439|NCT01352520|Immunoconjugates|immunoconjugates|mesh-ancestor
111121440|NCT01352520|Immunologic Factors|immunologic factors|mesh-ancestor
111121441|NCT01352520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111121442|NCT01326312|Leuprolide|leuprolide|mesh-list
111121443|NCT01326312|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111121444|NCT01326312|Fertility Agents|fertility agents|mesh-ancestor
111121445|NCT01326312|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111121446|NCT01326312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111121447|NCT01326312|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111121448|NCT01326312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111121449|NCT01321554|Lenvatinib|lenvatinib|mesh-list
111121450|NCT01321554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111121451|NCT01321554|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111121452|NCT01321554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111121453|NCT01321554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111121454|NCT01308437|Insulin|insulin|mesh-list
111121455|NCT01308437|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111121456|NCT01308437|Isophane Insulin, Human|isophane insulin, human|mesh-list
111121457|NCT01308437|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111121458|NCT01308437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111121459|NCT01268293|Lenvatinib|lenvatinib|mesh-list
110064137|NCT01526174|Golimumab|golimumab|mesh-list
111121460|NCT01268293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111121461|NCT01268293|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111121462|NCT01268293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111121463|NCT01268293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111121464|NCT01267175|Insulin|insulin|mesh-list
111121465|NCT01267175|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111121466|NCT01267175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111121467|NCT01231841|Cyclosporine|cyclosporine|mesh-list
111121468|NCT01231841|Cyclosporins|cyclosporins|mesh-list
111121469|NCT01231841|Thymoglobulin|thymoglobulin|mesh-list
111121470|NCT01231841|Antilymphocyte Serum|antilymphocyte serum|mesh-list
111121471|NCT01231841|Immunoglobulins|immunoglobulins|mesh-list
111121472|NCT01231841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111121473|NCT01231841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111121474|NCT01231841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111121475|NCT01231841|Immunologic Factors|immunologic factors|mesh-ancestor
111121476|NCT01231841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111121477|NCT01231841|Antifungal Agents|antifungal agents|mesh-ancestor
111121478|NCT01231841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111121479|NCT01231841|Dermatologic Agents|dermatologic agents|mesh-ancestor
111121480|NCT01231841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111121481|NCT01231841|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111121482|NCT01133756|Carboplatin|carboplatin|mesh-list
111121483|NCT01133756|Gemcitabine|gemcitabine|mesh-list
111121484|NCT01133756|Lenvatinib|lenvatinib|mesh-list
111121485|NCT01133756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111121486|NCT01133756|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111121487|NCT01133756|Antimetabolites|antimetabolites|mesh-ancestor
110870371|NCT02394418|Analgesics|analgesics|mesh-ancestor
111121488|NCT01133756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111121489|NCT01133756|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111121490|NCT01133756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111121491|NCT01126736|Pemetrexed|pemetrexed|mesh-list
111121492|NCT01126736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111121493|NCT01126736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111121494|NCT01126736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111121495|NCT01126736|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111121496|NCT01126736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111121497|NCT01111461|Lenvatinib|lenvatinib|mesh-list
111121498|NCT01111461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111121499|NCT01111461|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111121500|NCT01111461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111121501|NCT01111461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111121502|NCT01104155|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111121503|NCT01104155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111121504|NCT01104155|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111121505|NCT01104155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111121506|NCT01104155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111121507|NCT01067287|Pidilizumab|pidilizumab|mesh-list
111121508|NCT01067287|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111121509|NCT01067287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111121510|NCT01005745|Aldesleukin|aldesleukin|mesh-list
111121511|NCT01005745|Interleukin-2|interleukin-2|mesh-list
111121512|NCT01005745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111121513|NCT01005745|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111121514|NCT01005745|Analgesics|analgesics|mesh-ancestor
111121515|NCT01005745|Sensory System Agents|sensory system agents|mesh-ancestor
111121516|NCT01005745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111121517|NCT01005745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111121518|NCT01005745|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111121519|NCT01005745|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111121520|NCT01005745|Antiviral Agents|antiviral agents|mesh-ancestor
111121521|NCT01005745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111121522|NCT00978458|Temozolomide|temozolomide|mesh-list
111121523|NCT00978458|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111121524|NCT00978458|Alkylating Agents|alkylating agents|mesh-ancestor
111121525|NCT00978458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111121526|NCT00978458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111121527|NCT00832429|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
111121528|NCT00832429|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111121529|NCT00832429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111121530|NCT00796263|Dolutegravir|dolutegravir|mesh-list
111121531|NCT00796263|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111121532|NCT00796263|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111121533|NCT00796263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111121534|NCT00796263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111121535|NCT00796263|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111121536|NCT00796263|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111121537|NCT00796263|Antiviral Agents|antiviral agents|mesh-ancestor
111121538|NCT00796263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111121539|NCT00715442|Sunitinib|sunitinib|mesh-list
111121540|NCT00715442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111121541|NCT00715442|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111121542|NCT00715442|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111121543|NCT00715442|Growth Substances|growth substances|mesh-ancestor
111121544|NCT00715442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111121545|NCT00715442|Growth Inhibitors|growth inhibitors|mesh-ancestor
111121546|NCT00715442|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111121547|NCT00715442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111121548|NCT00715442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111121549|NCT00697684|Clofarabine|clofarabine|mesh-list
111121550|NCT00697684|Antilymphocyte Serum|antilymphocyte serum|mesh-list
111121551|NCT00697684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111121552|NCT00697684|Antimetabolites|antimetabolites|mesh-ancestor
110835541|NCT01136213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111121553|NCT00697684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111121554|NCT00697684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111121555|NCT00697684|Immunologic Factors|immunologic factors|mesh-ancestor
110838628|NCT01146977|Antimetabolites|antimetabolites|mesh-ancestor
111121556|NCT00697684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111121557|NCT00697684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111121558|NCT00675922|Silver Nitrate|silver nitrate|mesh-list
111121559|NCT00675922|Mafenide|mafenide|mesh-list
111121560|NCT00675922|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111121561|NCT00675922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111121562|NCT00675922|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111121563|NCT00675922|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
111121564|NCT00675922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111121565|NCT00675922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111121566|NCT00466531|Cyclophosphamide|cyclophosphamide|mesh-list
111121567|NCT00466531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111121568|NCT00466531|Immunologic Factors|immunologic factors|mesh-ancestor
111121569|NCT00466531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111121570|NCT00466531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111121571|NCT00466531|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111121572|NCT00466531|Alkylating Agents|alkylating agents|mesh-ancestor
111121573|NCT00466531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111121574|NCT00466531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111121575|NCT00466531|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111121576|NCT00244933|Gemcitabine|gemcitabine|mesh-list
111121577|NCT00244933|Genistein|genistein|mesh-list
111121578|NCT00244933|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111121579|NCT00244933|Antimetabolites|antimetabolites|mesh-ancestor
111121580|NCT00244933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111121581|NCT00244933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111121582|NCT00244933|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
111121583|NCT00244933|Protective Agents|protective agents|mesh-ancestor
111121584|NCT00244933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111121585|NCT00244933|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111121586|NCT00244933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111121587|NCT00244933|Phytoestrogens|phytoestrogens|mesh-ancestor
111121588|NCT00244933|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
111121589|NCT00244933|Estrogens|estrogens|mesh-ancestor
111121590|NCT00244933|Hormones|hormones|mesh-ancestor
111121591|NCT00244933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111121592|NCT00121719|Lenvatinib|lenvatinib|mesh-list
111121593|NCT00121719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111121594|NCT00121719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111121595|NCT00121719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111121596|NCT00121719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111121597|NCT00053209|Gemcitabine|gemcitabine|mesh-list
111121598|NCT00053209|Pemetrexed|pemetrexed|mesh-list
111121599|NCT00053209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111121600|NCT00053209|Antimetabolites|antimetabolites|mesh-ancestor
111121601|NCT00053209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111121602|NCT00053209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111121603|NCT00053209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111121604|NCT00053209|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111121605|NCT00053209|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111121606|NCT00039429|Atrasentan|atrasentan|mesh-list
111121607|NCT00039429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111121608|NCT00039429|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
110682912|NCT00605345|Darbepoetin alfa|darbepoetin alfa|mesh-list
111121609|NCT00039429|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
111121610|NCT00039429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111121611|NCT00014508|Cyclosporine|cyclosporine|mesh-list
111121612|NCT00014508|Cyclophosphamide|cyclophosphamide|mesh-list
111121613|NCT00014508|Melphalan|melphalan|mesh-list
111121614|NCT00014508|Fludarabine|fludarabine|mesh-list
111121615|NCT00014508|Fludarabine phosphate|fludarabine phosphate|mesh-list
111121616|NCT00014508|Cyclosporins|cyclosporins|mesh-list
111121617|NCT00014508|Sargramostim|sargramostim|mesh-list
111121618|NCT00014508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111121619|NCT00014508|Immunologic Factors|immunologic factors|mesh-ancestor
111121620|NCT00014508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111121621|NCT00014508|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111121622|NCT00014508|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111121623|NCT00014508|Alkylating Agents|alkylating agents|mesh-ancestor
111121624|NCT00014508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111121625|NCT00014508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111121626|NCT00014508|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111121627|NCT00014508|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111121628|NCT00014508|Antimetabolites|antimetabolites|mesh-ancestor
111121629|NCT00014508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111121630|NCT00014508|Antifungal Agents|antifungal agents|mesh-ancestor
111121631|NCT00014508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111121632|NCT00014508|Dermatologic Agents|dermatologic agents|mesh-ancestor
111121633|NCT00014508|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111121634|NCT00006390|Cyclophosphamide|cyclophosphamide|mesh-list
111121635|NCT00006390|Alemtuzumab|alemtuzumab|mesh-list
111121636|NCT00006390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111121637|NCT00006390|Immunologic Factors|immunologic factors|mesh-ancestor
111121638|NCT00006390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111121639|NCT00006390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111121640|NCT00006390|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111121641|NCT00006390|Alkylating Agents|alkylating agents|mesh-ancestor
111121642|NCT00006390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111121643|NCT00006390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111121644|NCT00006390|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111121645|NCT00006390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111121646|NCT00005962|Cytarabine|cytarabine|mesh-list
111121647|NCT00005962|Cyclophosphamide|cyclophosphamide|mesh-list
111121648|NCT00005962|Daunorubicin|daunorubicin|mesh-list
111121649|NCT00005962|Topotecan|topotecan|mesh-list
111121650|NCT00005962|Gemtuzumab|gemtuzumab|mesh-list
111121651|NCT00005962|Sargramostim|sargramostim|mesh-list
111121652|NCT00005962|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111121653|NCT00005962|Immunologic Factors|immunologic factors|mesh-ancestor
111121654|NCT00005962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111121655|NCT00005962|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111121656|NCT00005962|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111121657|NCT00005962|Alkylating Agents|alkylating agents|mesh-ancestor
111121658|NCT00005962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111121659|NCT00005962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111121660|NCT00005962|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111121661|NCT00005962|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111121662|NCT00005962|Antimetabolites|antimetabolites|mesh-ancestor
111121663|NCT00005962|Antiviral Agents|antiviral agents|mesh-ancestor
111121664|NCT00005962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111121665|NCT00005962|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111121666|NCT00005962|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111121667|NCT00005962|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111121668|NCT00005962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111121669|NCT00005962|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111121670|NCT00005962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111121671|NCT00005962|Immunotoxins|immunotoxins|mesh-ancestor
111121672|NCT00005962|Immunoconjugates|immunoconjugates|mesh-ancestor
111121673|NCT00005847|Interferons|interferons|mesh-list
111121674|NCT00005847|Interferon-alpha|interferon-alpha|mesh-list
111121675|NCT00005847|Paclitaxel|paclitaxel|mesh-list
111121676|NCT00005847|Vinorelbine|vinorelbine|mesh-list
111121677|NCT00005847|Mitoxantrone|mitoxantrone|mesh-list
111121678|NCT00005847|Estramustine|estramustine|mesh-list
111121679|NCT00005847|Isotretinoin|isotretinoin|mesh-list
111121680|NCT00005847|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111121681|NCT00005847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111121682|NCT00005847|Tubulin Modulators|tubulin modulators|mesh-ancestor
111121683|NCT00005847|Antimitotic Agents|antimitotic agents|mesh-ancestor
111121684|NCT00005847|Mitosis Modulators|mitosis modulators|mesh-ancestor
111121685|NCT00005847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111121686|NCT00005847|Antiviral Agents|antiviral agents|mesh-ancestor
111121687|NCT00005847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111121688|NCT00005847|Immunologic Factors|immunologic factors|mesh-ancestor
110064205|NCT01526499|Tubulin Modulators|tubulin modulators|mesh-ancestor
111121689|NCT00005847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111121690|NCT00005847|Analgesics|analgesics|mesh-ancestor
111121691|NCT00005847|Sensory System Agents|sensory system agents|mesh-ancestor
111121692|NCT00005847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111121693|NCT00005847|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111121694|NCT00005847|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111121695|NCT00005847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111121696|NCT00005847|Dermatologic Agents|dermatologic agents|mesh-ancestor
111121697|NCT00005847|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111121698|NCT00005847|Alkylating Agents|alkylating agents|mesh-ancestor
111121699|NCT00005847|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111121700|NCT00005644|Paclitaxel|paclitaxel|mesh-list
111121701|NCT00005644|Gemcitabine|gemcitabine|mesh-list
111121702|NCT00005644|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111121703|NCT00005644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111121704|NCT00005644|Tubulin Modulators|tubulin modulators|mesh-ancestor
111121705|NCT00005644|Antimitotic Agents|antimitotic agents|mesh-ancestor
111121706|NCT00005644|Mitosis Modulators|mitosis modulators|mesh-ancestor
111121707|NCT00005644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111121708|NCT00005644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111121709|NCT00005644|Antimetabolites|antimetabolites|mesh-ancestor
111121710|NCT00003871|Vaccines|vaccines|mesh-list
111121711|NCT00003871|Immunologic Factors|immunologic factors|mesh-ancestor
111121712|NCT00003871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111121713|NCT00003809|Cetuximab|cetuximab|mesh-list
111121714|NCT00003809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111121715|NCT00003809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111121716|NCT00003808|Theophylline|theophylline|mesh-list
111121717|NCT00003808|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111121718|NCT00003808|Autonomic Agents|autonomic agents|mesh-ancestor
111121719|NCT00003808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111121720|NCT00003808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111121721|NCT00003808|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111121722|NCT00003808|Respiratory System Agents|respiratory system agents|mesh-ancestor
111121723|NCT00003808|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111121724|NCT00003808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111121725|NCT00003808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111121726|NCT00003808|Vasodilator Agents|vasodilator agents|mesh-ancestor
111121727|NCT00003808|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
111121728|NCT00003808|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111121729|NCT00003808|Purinergic Agents|purinergic agents|mesh-ancestor
111121730|NCT00003808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111121731|NCT00003592|Paclitaxel|paclitaxel|mesh-list
111121732|NCT00003592|Methotrexate|methotrexate|mesh-list
111121733|NCT00003592|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111121734|NCT00003592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111121735|NCT00003592|Tubulin Modulators|tubulin modulators|mesh-ancestor
111121736|NCT00003592|Antimitotic Agents|antimitotic agents|mesh-ancestor
111121737|NCT00003592|Mitosis Modulators|mitosis modulators|mesh-ancestor
111121738|NCT00003592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111121739|NCT00003592|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111121740|NCT00003592|Abortifacient Agents|abortifacient agents|mesh-ancestor
111121741|NCT00003592|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111121742|NCT00003592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111121743|NCT00003592|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111121744|NCT00003592|Antimetabolites|antimetabolites|mesh-ancestor
111121745|NCT00003592|Dermatologic Agents|dermatologic agents|mesh-ancestor
111121746|NCT00003592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111121747|NCT00003592|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111121748|NCT00003592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111121749|NCT00003592|Immunologic Factors|immunologic factors|mesh-ancestor
111121750|NCT00003592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111121751|NCT00003592|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111121752|NCT00003518|Paclitaxel|paclitaxel|mesh-list
111121753|NCT00003518|Gemcitabine|gemcitabine|mesh-list
111121754|NCT00003518|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111121755|NCT00003518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111121756|NCT00003518|Tubulin Modulators|tubulin modulators|mesh-ancestor
111121757|NCT00003518|Antimitotic Agents|antimitotic agents|mesh-ancestor
111121758|NCT00003518|Mitosis Modulators|mitosis modulators|mesh-ancestor
111121759|NCT00003518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111121760|NCT00003518|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111121761|NCT00003518|Antimetabolites|antimetabolites|mesh-ancestor
111121762|NCT00003444|Interferons|interferons|mesh-list
111121763|NCT00003444|Interferon-alpha|interferon-alpha|mesh-list
111121764|NCT00003444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111121765|NCT00003444|Antiviral Agents|antiviral agents|mesh-ancestor
111121766|NCT00003444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111121767|NCT00003444|Immunologic Factors|immunologic factors|mesh-ancestor
111121768|NCT00003444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111121769|NCT00003388|Cytarabine|cytarabine|mesh-list
111121770|NCT00003388|Prednisone|prednisone|mesh-list
111121771|NCT00003388|Cyclophosphamide|cyclophosphamide|mesh-list
111121772|NCT00003388|Doxorubicin|doxorubicin|mesh-list
111121773|NCT00003388|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111121774|NCT00003388|Methotrexate|methotrexate|mesh-list
111121775|NCT00003388|Vincristine|vincristine|mesh-list
111121776|NCT00003388|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111121777|NCT00003388|Immunologic Factors|immunologic factors|mesh-ancestor
111121778|NCT00003388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111121779|NCT00003388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111121780|NCT00003388|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111121781|NCT00003388|Alkylating Agents|alkylating agents|mesh-ancestor
111121782|NCT00003388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111121783|NCT00003388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111121784|NCT00003388|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111121785|NCT00003388|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111121786|NCT00003388|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111121787|NCT00003388|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111121788|NCT00003388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111121789|NCT00003388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111121791|NCT00003388|Hormones|hormones|mesh-ancestor
111121792|NCT00003388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111121793|NCT00003388|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111121794|NCT00003388|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111121795|NCT00003388|Abortifacient Agents|abortifacient agents|mesh-ancestor
111121796|NCT00003388|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111121797|NCT00003388|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111121798|NCT00003388|Antimetabolites|antimetabolites|mesh-ancestor
111121799|NCT00003388|Dermatologic Agents|dermatologic agents|mesh-ancestor
111121800|NCT00003388|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111121801|NCT00003388|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111121802|NCT00003388|Antiviral Agents|antiviral agents|mesh-ancestor
111121803|NCT00003388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111121804|NCT00003388|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111121805|NCT00003388|Tubulin Modulators|tubulin modulators|mesh-ancestor
111121806|NCT00003388|Antimitotic Agents|antimitotic agents|mesh-ancestor
111121807|NCT00003388|Mitosis Modulators|mitosis modulators|mesh-ancestor
111121808|NCT00003376|Paclitaxel|paclitaxel|mesh-list
111121809|NCT00003376|Vinblastine|vinblastine|mesh-list
111121810|NCT00003376|Carboplatin|carboplatin|mesh-list
111121811|NCT00003376|Doxorubicin|doxorubicin|mesh-list
111121812|NCT00003376|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111121813|NCT00003376|Methotrexate|methotrexate|mesh-list
111121814|NCT00003376|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111121815|NCT00003376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111121816|NCT00003376|Tubulin Modulators|tubulin modulators|mesh-ancestor
111121817|NCT00003376|Antimitotic Agents|antimitotic agents|mesh-ancestor
111121818|NCT00003376|Mitosis Modulators|mitosis modulators|mesh-ancestor
110835575|NCT01141127|Hemostatics|hemostatics|mesh-ancestor
110064220|NCT01526525|Anesthetics|anesthetics|mesh-ancestor
111121819|NCT00003376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111121820|NCT00003376|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111121821|NCT00003376|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111121822|NCT00003376|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111121823|NCT00003376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111121824|NCT00003376|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111121825|NCT00003376|Abortifacient Agents|abortifacient agents|mesh-ancestor
111121826|NCT00003376|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111121827|NCT00003376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111121828|NCT00003376|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111121829|NCT00003376|Antimetabolites|antimetabolites|mesh-ancestor
111121830|NCT00003376|Dermatologic Agents|dermatologic agents|mesh-ancestor
111121831|NCT00003376|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111121832|NCT00003376|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111121833|NCT00003376|Immunologic Factors|immunologic factors|mesh-ancestor
111121834|NCT00003376|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111121835|NCT00003376|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111121836|NCT00003353|Melphalan|melphalan|mesh-list
111121837|NCT00003353|Immunologic Factors|immunologic factors|mesh-ancestor
111121838|NCT00003353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111121839|NCT00003353|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111121840|NCT00003353|Alkylating Agents|alkylating agents|mesh-ancestor
111121841|NCT00003353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111121842|NCT00003353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111121843|NCT00003353|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111121844|NCT00003353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111121845|NCT00003309|Cyclophosphamide|cyclophosphamide|mesh-list
111121846|NCT00003309|Etoposide|etoposide|mesh-list
111121847|NCT00003309|Vincristine|vincristine|mesh-list
111121848|NCT00003309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111121849|NCT00003309|Immunologic Factors|immunologic factors|mesh-ancestor
111121850|NCT00003309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111121851|NCT00003309|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111121852|NCT00003309|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111121853|NCT00003309|Alkylating Agents|alkylating agents|mesh-ancestor
111121854|NCT00003309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111121855|NCT00003309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111121856|NCT00003309|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111121857|NCT00003309|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111121858|NCT00003309|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111121859|NCT00003309|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111121860|NCT00003309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111121861|NCT00003309|Tubulin Modulators|tubulin modulators|mesh-ancestor
111121862|NCT00003309|Antimitotic Agents|antimitotic agents|mesh-ancestor
111121863|NCT00003309|Mitosis Modulators|mitosis modulators|mesh-ancestor
111121864|NCT00003237|Paclitaxel|paclitaxel|mesh-list
111121865|NCT00003237|Cisplatin|cisplatin|mesh-list
111121866|NCT00003237|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111121867|NCT00003237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111121868|NCT00003237|Tubulin Modulators|tubulin modulators|mesh-ancestor
111121869|NCT00003237|Antimitotic Agents|antimitotic agents|mesh-ancestor
111121870|NCT00003237|Mitosis Modulators|mitosis modulators|mesh-ancestor
111121871|NCT00003237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111121872|NCT00003129|Valrubicin|valrubicin|mesh-list
111121873|NCT00003129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111121874|NCT00003129|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111121875|NCT00003129|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111121876|NCT00003129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111121877|NCT00003129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111121878|NCT00003027|Interferons|interferons|mesh-list
111121879|NCT00003027|Interferon-alpha|interferon-alpha|mesh-list
111121880|NCT00003027|Aldesleukin|aldesleukin|mesh-list
111121881|NCT00003027|Dacarbazine|dacarbazine|mesh-list
111121882|NCT00003027|Vinblastine|vinblastine|mesh-list
111121883|NCT00003027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111121884|NCT00003027|Antiviral Agents|antiviral agents|mesh-ancestor
111121885|NCT00003027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111121886|NCT00003027|Immunologic Factors|immunologic factors|mesh-ancestor
111121887|NCT00003027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111121888|NCT00003027|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111121889|NCT00003027|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111121890|NCT00003027|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111121891|NCT00003027|Alkylating Agents|alkylating agents|mesh-ancestor
111121892|NCT00003027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111121893|NCT00003027|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111121894|NCT00003027|Tubulin Modulators|tubulin modulators|mesh-ancestor
111121895|NCT00003027|Antimitotic Agents|antimitotic agents|mesh-ancestor
111121896|NCT00003027|Mitosis Modulators|mitosis modulators|mesh-ancestor
111121897|NCT00002914|Piritrexim|piritrexim|mesh-list
111121898|NCT00002914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111121899|NCT00002914|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111121900|NCT00002914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111121901|NCT00002914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111121902|NCT00002872|Doxycycline|doxycycline|mesh-list
111121903|NCT00002872|Bleomycin|bleomycin|mesh-list
111121904|NCT00002872|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111121905|NCT00002872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111121906|NCT00002872|Antimalarials|antimalarials|mesh-ancestor
111121907|NCT00002872|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111121908|NCT00002872|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111121909|NCT00002872|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111121910|NCT00002872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111121911|NCT00002868|Interferons|interferons|mesh-list
111121912|NCT00002868|Cytarabine|cytarabine|mesh-list
111121913|NCT00002868|Interferon-alpha|interferon-alpha|mesh-list
111121914|NCT00002868|Etoposide|etoposide|mesh-list
111121915|NCT00002868|Idarubicin|idarubicin|mesh-list
111121916|NCT00002868|Busulfan|busulfan|mesh-list
111121917|NCT00002868|Hydroxyurea|hydroxyurea|mesh-list
111121918|NCT00002868|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111121919|NCT00002868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111121920|NCT00002868|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111121921|NCT00002868|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111121922|NCT00002868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111121923|NCT00002868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111121924|NCT00002868|Antiviral Agents|antiviral agents|mesh-ancestor
111121925|NCT00002868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111121926|NCT00002868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111121927|NCT00002868|Antimetabolites|antimetabolites|mesh-ancestor
111121928|NCT00002868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111121929|NCT00002868|Immunologic Factors|immunologic factors|mesh-ancestor
111121930|NCT00002868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111121931|NCT00002868|Alkylating Agents|alkylating agents|mesh-ancestor
111121932|NCT00002868|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111121933|NCT00002868|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111121934|NCT00002868|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111121935|NCT00002868|Antisickling Agents|antisickling agents|mesh-ancestor
111121936|NCT00002868|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111121938|NCT00002650|Hematinics|hematinics|mesh-ancestor
111121939|NCT00002650|Vitamin B Complex|vitamin b complex|mesh-ancestor
111121940|NCT00002650|Vitamins|vitamins|mesh-ancestor
111121941|NCT00002650|Micronutrients|micronutrients|mesh-ancestor
111121942|NCT00002650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111121943|NCT03078725|Metformin|metformin|mesh-list
111121944|NCT03078725|Glyburide|glyburide|mesh-list
111121945|NCT03078725|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111121946|NCT03078725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111121947|NCT02341963|Ketamine|ketamine|mesh-list
111121948|NCT02341963|Analgesics|analgesics|mesh-ancestor
111121949|NCT02341963|Sensory System Agents|sensory system agents|mesh-ancestor
111121950|NCT02341963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111121951|NCT02341963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111121952|NCT02341963|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111121953|NCT02341963|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111121954|NCT02341963|Anesthetics, General|anesthetics, general|mesh-ancestor
111121955|NCT02341963|Anesthetics|anesthetics|mesh-ancestor
111121956|NCT02341963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111121957|NCT02341963|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111121958|NCT02341963|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111121959|NCT02341963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111121960|NCT02341963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111121961|NCT05014685|Amoxicillin|amoxicillin|mesh-list
111121962|NCT05014685|Metronidazole|metronidazole|mesh-list
111121963|NCT05014685|Potassium Citrate|potassium citrate|mesh-list
111121964|NCT05014685|Rabeprazole|rabeprazole|mesh-list
111121966|NCT05014685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111121967|NCT05014685|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111121968|NCT05014685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111121969|NCT05014685|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111121970|NCT05014685|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111121971|NCT05014685|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111121972|NCT05014685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111121973|NCT05014685|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111121974|NCT05014685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111121975|NCT05014685|Antacids|antacids|mesh-ancestor
111121976|NCT05014685|Diuretics|diuretics|mesh-ancestor
111121977|NCT05014685|Natriuretic Agents|natriuretic agents|mesh-ancestor
111121978|NCT05014685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111121979|NCT05014685|Expectorants|expectorants|mesh-ancestor
111121980|NCT05014685|Respiratory System Agents|respiratory system agents|mesh-ancestor
111121981|NCT03111901|Pembrolizumab|pembrolizumab|mesh-list
111121982|NCT03111901|Interleukin-2|interleukin-2|mesh-list
111121983|NCT03111901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111121984|NCT03111901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111121985|NCT03111901|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111121986|NCT03111901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111121987|NCT03111901|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111121988|NCT03111901|Analgesics|analgesics|mesh-ancestor
111121989|NCT03111901|Sensory System Agents|sensory system agents|mesh-ancestor
111121990|NCT03111901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111121991|NCT03111901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111121992|NCT05014607|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
111121993|NCT05014607|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111121994|NCT05014607|Immunologic Factors|immunologic factors|mesh-ancestor
111121995|NCT05014607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111121996|NCT02341729|Ticagrelor|ticagrelor|mesh-list
111121997|NCT02341729|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111121998|NCT02341729|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111121999|NCT02341729|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111122000|NCT02341729|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111122001|NCT02341729|Purinergic Agents|purinergic agents|mesh-ancestor
111122002|NCT02341729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111122003|NCT02341729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111122004|NCT02341729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111122005|NCT05014373|Favipiravir|favipiravir|mesh-list
111122006|NCT05014373|Antiviral Agents|antiviral agents|mesh-ancestor
111122007|NCT05014373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111122008|NCT04762459|Pemetrexed|pemetrexed|mesh-list
111122009|NCT04762459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111122010|NCT04762459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111122011|NCT04762459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111122012|NCT04762459|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111122013|NCT04762459|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111122015|NCT03078569|Androgens|androgens|mesh-ancestor
111122016|NCT03078569|Hormones|hormones|mesh-ancestor
111122017|NCT03078569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111122018|NCT03078569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111122019|NCT02345863|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
111122020|NCT02345863|Obinutuzumab|obinutuzumab|mesh-list
111122021|NCT02345863|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111122022|NCT02345863|Alkylating Agents|alkylating agents|mesh-ancestor
111122023|NCT02345863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111122024|NCT02345863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111122025|NCT02345863|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111122027|NCT03078257|Tirofiban|tirofiban|mesh-list
111122028|NCT03078257|Fibrinolysin|fibrinolysin|mesh-list
111122029|NCT03078257|Clopidogrel|clopidogrel|mesh-list
111122030|NCT03078257|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111122031|NCT03078257|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111122032|NCT03078257|Analgesics|analgesics|mesh-ancestor
111122033|NCT03078257|Sensory System Agents|sensory system agents|mesh-ancestor
111122034|NCT03078257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111122035|NCT03078257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111122036|NCT03078257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111122037|NCT03078257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111122038|NCT03078257|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111122039|NCT03078257|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111122040|NCT03078257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111122041|NCT03078257|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111122042|NCT03078257|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111122043|NCT03078257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111122044|NCT03078257|Antipyretics|antipyretics|mesh-ancestor
111122045|NCT03078257|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111122046|NCT03078257|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111122047|NCT03078257|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111122048|NCT03078257|Purinergic Agents|purinergic agents|mesh-ancestor
111122049|NCT03078257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111122050|NCT02341573|Leukotriene Antagonists|leukotriene antagonists|mesh-list
111122051|NCT02341573|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111122052|NCT02341573|Respiratory System Agents|respiratory system agents|mesh-ancestor
111122053|NCT02341573|Hormone Antagonists|hormone antagonists|mesh-ancestor
111122054|NCT02341573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111122055|NCT02341573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111122056|NCT05005715|Dexmedetomidine|dexmedetomidine|mesh-list
111122057|NCT05005715|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111122058|NCT05005715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111122059|NCT05005715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111122060|NCT05005715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111122061|NCT05005715|Analgesics|analgesics|mesh-ancestor
111122062|NCT05005715|Sensory System Agents|sensory system agents|mesh-ancestor
111122063|NCT05005715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111122064|NCT05005715|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111122065|NCT05005715|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111122066|NCT05005715|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111122067|NCT05005715|Adrenergic Agents|adrenergic agents|mesh-ancestor
110064331|NCT01527019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111122068|NCT05005715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111122069|NCT05005715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111122070|NCT02345707|Cabotegravir|cabotegravir|mesh-list
111122071|NCT02345707|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111122072|NCT02345707|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111122073|NCT02345707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111122074|NCT02345707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111122075|NCT02345707|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111122076|NCT02345707|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111122077|NCT02345707|Antiviral Agents|antiviral agents|mesh-ancestor
111122078|NCT02345707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111122079|NCT05005637|Antitubercular Agents|antitubercular agents|mesh-list
111122080|NCT05005637|Prednisone|prednisone|mesh-list
111122081|NCT05005637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111122082|NCT05005637|Glucocorticoids|glucocorticoids|mesh-ancestor
111122083|NCT05005637|Hormones|hormones|mesh-ancestor
111122084|NCT05005637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111122085|NCT05005637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111122086|NCT05005637|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111122087|NCT05005637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111122088|NCT05005637|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111122089|NCT05005637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111122090|NCT02336659|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111122091|NCT02336659|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111122092|NCT02336659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111122095|NCT02336659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111122096|NCT02336659|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111122097|NCT02336659|Protease Inhibitors|protease inhibitors|mesh-ancestor
111122098|NCT02336659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111122099|NCT02336659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111122100|NCT03081923|Durvalumab|durvalumab|mesh-list
111122101|NCT03081923|Tremelimumab|tremelimumab|mesh-list
111122102|NCT03081923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111122103|NCT03081923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111122104|NCT02341105|Amiodarone|amiodarone|mesh-list
111122105|NCT02341105|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
111122106|NCT02341105|Vasodilator Agents|vasodilator agents|mesh-ancestor
111122107|NCT02341105|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
111122108|NCT02341105|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110064363|NCT01527097|Atorvastatin|atorvastatin|mesh-list
111122109|NCT02341105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111122110|NCT02341105|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111122111|NCT02341105|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111122112|NCT02341105|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111122113|NCT02341105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111122114|NCT02341105|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111122115|NCT02341105|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111122116|NCT02341105|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111122117|NCT03078101|Empagliflozin|empagliflozin|mesh-list
111122118|NCT03078101|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111122119|NCT03078101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111122120|NCT03078101|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111122121|NCT03078101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111122122|NCT02345239|Pantoprazole|pantoprazole|mesh-list
111122123|NCT02345239|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111122124|NCT02345239|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111122125|NCT02345239|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111122126|NCT02345239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111122127|NCT02345239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111122128|NCT04688203|Magnesium Sulfate|magnesium sulfate|mesh-list
111122129|NCT04688203|Labetalol|labetalol|mesh-list
111122130|NCT04688203|Analgesics|analgesics|mesh-ancestor
111122131|NCT04688203|Sensory System Agents|sensory system agents|mesh-ancestor
111122132|NCT04688203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111122133|NCT04688203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111122134|NCT04688203|Anesthetics|anesthetics|mesh-ancestor
111122135|NCT04688203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111122136|NCT04688203|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111122137|NCT04688203|Anticonvulsants|anticonvulsants|mesh-ancestor
111122138|NCT04688203|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111122139|NCT04688203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111122140|NCT04688203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111122141|NCT04688203|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111122142|NCT04688203|Tocolytic Agents|tocolytic agents|mesh-ancestor
111122143|NCT04688203|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111122144|NCT04688203|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111122145|NCT04688203|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111122146|NCT04688203|Adrenergic Agents|adrenergic agents|mesh-ancestor
111122147|NCT04688203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111122148|NCT04688203|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111122149|NCT04688203|Sympathomimetics|sympathomimetics|mesh-ancestor
111122150|NCT04688203|Autonomic Agents|autonomic agents|mesh-ancestor
111122151|NCT04688203|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111122152|NCT04688203|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111122153|NCT05254561|Immunomodulating Agents|immunomodulating agents|mesh-list
111122154|NCT05254561|Immunologic Factors|immunologic factors|mesh-ancestor
111122155|NCT05254561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111122158|NCT04509973|Antiemetics|antiemetics|mesh-ancestor
111122159|NCT04509973|Autonomic Agents|autonomic agents|mesh-ancestor
111122160|NCT04509973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110064393|NCT01527318|Clofibric Acid|clofibric acid|mesh-list
111122161|NCT04509973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111122162|NCT04509973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111122163|NCT04509973|Glucocorticoids|glucocorticoids|mesh-ancestor
111122164|NCT04509973|Hormones|hormones|mesh-ancestor
111122165|NCT04509973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111122166|NCT04509973|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111122167|NCT04509973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111122168|NCT02336347|Quinidine|quinidine|mesh-list
111122169|NCT02336347|Dextromethorphan|dextromethorphan|mesh-list
111122170|NCT02336347|Antitussive Agents|antitussive agents|mesh-ancestor
111122171|NCT02336347|Respiratory System Agents|respiratory system agents|mesh-ancestor
111122172|NCT02336347|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111122173|NCT02336347|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111122174|NCT02336347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111122175|NCT02336347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111122176|NCT02336347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111122177|NCT02336347|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111122178|NCT02336347|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111122179|NCT02336347|Adrenergic Agents|adrenergic agents|mesh-ancestor
111122180|NCT02336347|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111122181|NCT02336347|Antimalarials|antimalarials|mesh-ancestor
111122182|NCT02336347|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111122183|NCT02336347|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111122184|NCT02336347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111122185|NCT02336347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111122186|NCT02336347|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111122187|NCT02336347|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111122188|NCT02336347|Cholinergic Agents|cholinergic agents|mesh-ancestor
111122189|NCT02336347|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111122190|NCT02336347|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111122191|NCT02336347|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111122192|NCT02336347|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111122193|NCT02336347|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111122194|NCT02341027|Contraceptive Agents|contraceptive agents|mesh-list
111122195|NCT02341027|Levonorgestrel|levonorgestrel|mesh-list
111122196|NCT02341027|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111122197|NCT02341027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111122198|NCT02341027|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111122199|NCT02341027|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111122200|NCT02341027|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111122201|NCT02341027|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111122202|NCT02039479|Lithium Carbonate|lithium carbonate|mesh-list
111122203|NCT02039479|Antidepressive Agents|antidepressive agents|mesh-ancestor
111122204|NCT02039479|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111122205|NCT02039479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111122206|NCT02039479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111122207|NCT02039479|Antimanic Agents|antimanic agents|mesh-ancestor
111122208|NCT02039479|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111122209|NCT02039479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111122210|NCT02039479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111122211|NCT02340481|Simethicone|simethicone|mesh-list
111122212|NCT02340481|Loperamide|loperamide|mesh-list
111122213|NCT02340481|Antidiarrheals|antidiarrheals|mesh-list
111122214|NCT02340481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111122215|NCT02340481|Antifoaming Agents|antifoaming agents|mesh-ancestor
110064406|NCT01527422|Immunologic Factors|immunologic factors|mesh-ancestor
111122216|NCT02340481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111122217|NCT02340481|Emollients|emollients|mesh-ancestor
111122218|NCT02340481|Dermatologic Agents|dermatologic agents|mesh-ancestor
111122219|NCT03077633|Progesterone|progesterone|mesh-list
111122220|NCT03077633|Progestins|progestins|mesh-ancestor
111122221|NCT03077633|Hormones|hormones|mesh-ancestor
111122222|NCT03077633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111122223|NCT03077633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111122224|NCT05253781|Aspirin|aspirin|mesh-list
111122225|NCT05253781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111122226|NCT05253781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111122227|NCT05253781|Analgesics|analgesics|mesh-ancestor
111122228|NCT05253781|Sensory System Agents|sensory system agents|mesh-ancestor
111122229|NCT05253781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110839345|NCT01249937|Hormones|hormones|mesh-ancestor
111122230|NCT05253781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111122231|NCT05253781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111122232|NCT05253781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111122233|NCT05253781|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111122234|NCT05253781|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111122235|NCT05253781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111122236|NCT05253781|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111122237|NCT05253781|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111122238|NCT05253781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111122239|NCT05253781|Antipyretics|antipyretics|mesh-ancestor
111122240|NCT02340325|Kynurenic Acid|kynurenic acid|mesh-list
111122241|NCT02340325|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111122242|NCT02340325|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111122243|NCT02340325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111122244|NCT02340325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111122245|NCT02340325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111122246|NCT02340247|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
111122247|NCT02340247|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
111122248|NCT02340247|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
111122249|NCT02340247|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111122250|NCT02340247|Cathartics|cathartics|mesh-ancestor
111122251|NCT02340013|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
111122252|NCT02340013|Medroxyprogesterone|medroxyprogesterone|mesh-list
111122253|NCT02340013|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111122254|NCT02340013|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111122255|NCT02340013|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111122256|NCT02340013|Contraceptive Agents|contraceptive agents|mesh-ancestor
111122257|NCT02340013|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111122258|NCT02340013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111122259|NCT02340013|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111122260|NCT02340013|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111122261|NCT02340013|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
111122262|NCT02340013|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111122263|NCT02340013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111122264|NCT05178823|Chlorhexidine|chlorhexidine|mesh-list
111122265|NCT05178823|Chlorine dioxide|chlorine dioxide|mesh-list
111122266|NCT05178823|Fluorides|fluorides|mesh-list
111122267|NCT05178823|Sodium Fluoride|sodium fluoride|mesh-list
111122268|NCT05178823|Cariostatic Agents|cariostatic agents|mesh-ancestor
111122269|NCT05178823|Protective Agents|protective agents|mesh-ancestor
111122270|NCT05178823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111122271|NCT05178823|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111122272|NCT05178823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111122273|NCT05178823|Disinfectants|disinfectants|mesh-ancestor
111122274|NCT05178823|Dental Disinfectants|dental disinfectants|mesh-ancestor
111122275|NCT03105583|Vitamins|vitamins|mesh-list
111122276|NCT03105583|Micronutrients|micronutrients|mesh-ancestor
111122277|NCT03105583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111122278|NCT03105115|Fentanyl|fentanyl|mesh-list
111122279|NCT03105115|Bupivacaine|bupivacaine|mesh-list
111122280|NCT03105115|Anesthetics, Local|anesthetics, local|mesh-ancestor
111122281|NCT03105115|Anesthetics|anesthetics|mesh-ancestor
111122282|NCT03105115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111122283|NCT03105115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111122284|NCT03105115|Sensory System Agents|sensory system agents|mesh-ancestor
111122285|NCT03105115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111122286|NCT03105115|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111122287|NCT03105115|Narcotics|narcotics|mesh-ancestor
111122288|NCT03105115|Analgesics|analgesics|mesh-ancestor
111122289|NCT03105115|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111122290|NCT03105115|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111122291|NCT03105115|Anesthetics, General|anesthetics, general|mesh-ancestor
111122292|NCT03105349|Ribavirin|ribavirin|mesh-list
111122293|NCT03105349|Sofosbuvir|sofosbuvir|mesh-list
111122294|NCT03105349|Grazoprevir|grazoprevir|mesh-list
111122295|NCT03105349|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
111122296|NCT03105349|Antimetabolites|antimetabolites|mesh-ancestor
111122297|NCT03105349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111122298|NCT03105349|Antiviral Agents|antiviral agents|mesh-ancestor
111122299|NCT03105349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111122300|NCT03077555|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
111122301|NCT03077555|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
111122302|NCT03077555|Ethinyl Estradiol|ethinyl estradiol|mesh-list
111122303|NCT03077555|Estradiol|estradiol|mesh-list
111122304|NCT03077555|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
111122305|NCT03077555|Estrogens|estrogens|mesh-ancestor
111122306|NCT03077555|Hormones|hormones|mesh-ancestor
111122307|NCT03077555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111122308|NCT03077555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111122309|NCT03077555|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111122310|NCT03077555|Contraceptive Agents|contraceptive agents|mesh-ancestor
111122311|NCT03077555|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111122312|NCT03077555|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111122313|NCT03077555|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111122314|NCT03077555|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111122315|NCT02335255|Naftifine|naftifine|mesh-list
111122316|NCT02335255|Antifungal Agents|antifungal agents|mesh-ancestor
111122317|NCT02335255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111122318|NCT05012033|Prednisolone|prednisolone|mesh-list
111122319|NCT05012033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111122320|NCT05012033|Glucocorticoids|glucocorticoids|mesh-ancestor
111122321|NCT05012033|Hormones|hormones|mesh-ancestor
111122322|NCT05012033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111122323|NCT05012033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111122324|NCT05012033|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111122325|NCT05012033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111122326|NCT02344303|Moxifloxacin|moxifloxacin|mesh-list
111122327|NCT02344303|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111122328|NCT02344303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111122329|NCT02344303|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111122330|NCT02344303|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111122331|NCT02344303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111122332|NCT02344303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111122333|NCT02344303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111122334|NCT02334475|Methylprednisolone|methylprednisolone|mesh-list
111122335|NCT02334475|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111122336|NCT02334475|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111122337|NCT02334475|Prednisolone|prednisolone|mesh-list
111122338|NCT02334475|Prednisolone acetate|prednisolone acetate|mesh-list
111122339|NCT02334475|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111122340|NCT02334475|Prednisolone phosphate|prednisolone phosphate|mesh-list
111122341|NCT02334475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111122342|NCT02334475|Antiemetics|antiemetics|mesh-ancestor
111122343|NCT02334475|Autonomic Agents|autonomic agents|mesh-ancestor
111122344|NCT02334475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111122345|NCT02334475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111122346|NCT02334475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111122347|NCT02334475|Glucocorticoids|glucocorticoids|mesh-ancestor
111122349|NCT02334475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111122350|NCT02334475|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111122351|NCT02334475|Protective Agents|protective agents|mesh-ancestor
111122352|NCT02334475|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111122353|NCT02334475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111122354|NCT02334631|Simethicone|simethicone|mesh-list
111122355|NCT02334631|Antifoaming Agents|antifoaming agents|mesh-ancestor
111122356|NCT02334631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111122357|NCT02334631|Emollients|emollients|mesh-ancestor
111122358|NCT02334631|Dermatologic Agents|dermatologic agents|mesh-ancestor
111122359|NCT02338687|Calcium|calcium|mesh-list
111122360|NCT02338687|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111122361|NCT02338687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111122362|NCT02338531|Nirogacestat|nirogacestat|mesh-list
111122363|NCT02338531|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
111122364|NCT02338531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111122365|NCT02338531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111122366|NCT02332135|Vitamin D|vitamin d|mesh-list
111122367|NCT02332135|Vitamins|vitamins|mesh-ancestor
111122368|NCT02332135|Micronutrients|micronutrients|mesh-ancestor
111122369|NCT02332135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111122370|NCT02332135|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111122371|NCT02334163|Metronidazole|metronidazole|mesh-list
111122372|NCT02334163|Nitazoxanide|nitazoxanide|mesh-list
111122373|NCT02334163|Lactulose|lactulose|mesh-list
111122374|NCT02334163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111122375|NCT02334163|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111122376|NCT02334163|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111122377|NCT02334163|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111122378|NCT02334163|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111122379|NCT02332057|Diclofenac|diclofenac|mesh-list
111122380|NCT02332057|Lidocaine|lidocaine|mesh-list
111122381|NCT02332057|Anesthetics, Local|anesthetics, local|mesh-ancestor
111122382|NCT02332057|Anesthetics|anesthetics|mesh-ancestor
111122383|NCT02332057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111122384|NCT02332057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111122385|NCT02332057|Sensory System Agents|sensory system agents|mesh-ancestor
111122386|NCT02332057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111122387|NCT02332057|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111122388|NCT02332057|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111122389|NCT02332057|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111122390|NCT02332057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111122391|NCT02332057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111122392|NCT02332057|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111122393|NCT02332057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111122394|NCT02332057|Analgesics|analgesics|mesh-ancestor
111122395|NCT02332057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111122396|NCT02332057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111122397|NCT02332057|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111122398|NCT02332057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111122399|NCT02331745|Lenograstim|lenograstim|mesh-list
111122400|NCT02331745|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111122401|NCT02331745|Immunologic Factors|immunologic factors|mesh-ancestor
111122402|NCT02331745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111122403|NCT02638259|GP2015|gp2015|mesh-list
111122404|NCT02638259|Dermatologic Agents|dermatologic agents|mesh-ancestor
111122405|NCT02333929|Rivaroxaban|rivaroxaban|mesh-list
111122406|NCT02333929|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111122407|NCT02333929|Antithrombins|antithrombins|mesh-ancestor
111122408|NCT02333929|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111122409|NCT02333929|Protease Inhibitors|protease inhibitors|mesh-ancestor
111122410|NCT02333929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111122411|NCT02333929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111122412|NCT02333929|Anticoagulants|anticoagulants|mesh-ancestor
111122413|NCT02333851|Insulin, pork; isophane insulin, pork drug combination 30:70|insulin, pork; isophane insulin, pork drug combination 30:70|mesh-list
111122414|NCT02333851|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111122415|NCT02333851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111122416|NCT02334007|Dalteparin|dalteparin|mesh-list
111122417|NCT02334007|Tinzaparin|tinzaparin|mesh-list
111122418|NCT02334007|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
111122419|NCT02334007|Anticoagulants|anticoagulants|mesh-ancestor
111122420|NCT02334007|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111122421|NCT02334007|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111122422|NCT02334007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111122423|NCT02637323|Triamcinolone|triamcinolone|mesh-list
111122424|NCT02637323|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
111122425|NCT02637323|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
111122426|NCT02637323|FX006|fx006|mesh-list
111122427|NCT02637323|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
111122428|NCT02637323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111122429|NCT02637323|Glucocorticoids|glucocorticoids|mesh-ancestor
111122430|NCT02637323|Hormones|hormones|mesh-ancestor
111122431|NCT02637323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111122432|NCT02637323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111122433|NCT02637323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111122434|NCT02637323|Immunologic Factors|immunologic factors|mesh-ancestor
111122435|NCT02637323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111122436|NCT02637323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111122437|NCT02331823|Moxifloxacin|moxifloxacin|mesh-list
111122438|NCT02331823|Isoniazid|isoniazid|mesh-list
111122439|NCT02331823|Pyrazinamide|pyrazinamide|mesh-list
111122440|NCT02331823|Ethambutol|ethambutol|mesh-list
111122441|NCT02331823|Rifabutin|rifabutin|mesh-list
111122442|NCT02331823|Streptomycin|streptomycin|mesh-list
111122443|NCT02331823|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111122444|NCT02331823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111122445|NCT02331823|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111122446|NCT02331823|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111122447|NCT02331823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111122448|NCT02331823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111122449|NCT02331823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111122450|NCT02331823|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111122451|NCT02331823|Antitubercular Agents|antitubercular agents|mesh-ancestor
111122452|NCT02331823|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
111122453|NCT02331823|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111122454|NCT02331823|Antimetabolites|antimetabolites|mesh-ancestor
111122455|NCT02331823|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110839538|NCT04843462|Esketamine|esketamine|mesh-list
111122456|NCT02331823|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111122457|NCT02890459|Denatonium|denatonium|mesh-list
111122458|NCT02890459|Aversive Agents|aversive agents|mesh-ancestor
111122459|NCT02890459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111122460|NCT02890459|Abuse-Deterrent Formulations|abuse-deterrent formulations|mesh-ancestor
111122461|NCT02890459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111122462|NCT02890459|Sensory System Agents|sensory system agents|mesh-ancestor
111122463|NCT02890459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111122464|NCT03077009|Hyaluronic Acid|hyaluronic acid|mesh-list
111122465|NCT03077009|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111122466|NCT03077009|Immunologic Factors|immunologic factors|mesh-ancestor
111122467|NCT03077009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111122468|NCT03077009|Viscosupplements|viscosupplements|mesh-ancestor
111122469|NCT03077009|Protective Agents|protective agents|mesh-ancestor
111122470|NCT04477525|Bupivacaine|bupivacaine|mesh-list
111122471|NCT04477525|Anesthetics, Local|anesthetics, local|mesh-ancestor
111122472|NCT04477525|Anesthetics|anesthetics|mesh-ancestor
111122473|NCT04477525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111122474|NCT04477525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111122475|NCT04477525|Sensory System Agents|sensory system agents|mesh-ancestor
111122476|NCT04477525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111122477|NCT03079973|Calcipotriene|calcipotriene|mesh-list
111122478|NCT03079973|Dermatologic Agents|dermatologic agents|mesh-ancestor
111122479|NCT03861871|Fenfluramine|fenfluramine|mesh-list
111122480|NCT03861871|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111122481|NCT03861871|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111122482|NCT03861871|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111122483|NCT03861871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111122484|NCT03861871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111122485|NCT03861871|Serotonin Agents|serotonin agents|mesh-ancestor
111122486|NCT03861871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111122488|NCT05004545|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111122489|NCT05004545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111122490|NCT05004545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111122491|NCT05004545|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111122492|NCT05004545|Anesthetics, General|anesthetics, general|mesh-ancestor
111122493|NCT05004545|Anesthetics|anesthetics|mesh-ancestor
111122494|NCT03079895|Nicotine|nicotine|mesh-list
111122495|NCT03079895|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111122496|NCT03079895|Autonomic Agents|autonomic agents|mesh-ancestor
111122497|NCT03079895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111122498|NCT03079895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111122499|NCT03079895|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111122500|NCT03079895|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111122501|NCT03079895|Cholinergic Agents|cholinergic agents|mesh-ancestor
111122502|NCT03079895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111122503|NCT03079895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111122504|NCT04463615|Leflunomide|leflunomide|mesh-list
111122505|NCT04463615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111122506|NCT04463615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111122507|NCT04463615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111122508|NCT04463615|Immunologic Factors|immunologic factors|mesh-ancestor
111122509|NCT04463615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111122510|NCT05003765|Magnesium Sulfate|magnesium sulfate|mesh-list
111122511|NCT05003765|Buprenorphine|buprenorphine|mesh-list
111122512|NCT05003765|Bupivacaine|bupivacaine|mesh-list
111122513|NCT05003765|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111122514|NCT05003765|Anesthetics, Local|anesthetics, local|mesh-ancestor
111122515|NCT05003765|Anesthetics|anesthetics|mesh-ancestor
111122516|NCT05003765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111122517|NCT05003765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111122518|NCT05003765|Sensory System Agents|sensory system agents|mesh-ancestor
111122519|NCT05003765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111122520|NCT05003765|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111122521|NCT05003765|Narcotics|narcotics|mesh-ancestor
111122522|NCT05003765|Analgesics|analgesics|mesh-ancestor
111122523|NCT05003765|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111122524|NCT05003765|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111122525|NCT05003765|Anticonvulsants|anticonvulsants|mesh-ancestor
111122526|NCT05003765|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111122527|NCT05003765|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111122528|NCT05003765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111122529|NCT05003765|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111122530|NCT05003765|Tocolytic Agents|tocolytic agents|mesh-ancestor
111122531|NCT05003765|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111122532|NCT02337283|BI 425809|bi 425809|mesh-list
111122533|NCT02337283|Nootropic Agents|nootropic agents|mesh-ancestor
111122534|NCT02333305|Coenzyme Q10|coenzyme q10|mesh-list
111122535|NCT02333305|Vitamins|vitamins|mesh-ancestor
111122536|NCT02333305|Micronutrients|micronutrients|mesh-ancestor
111122537|NCT02333305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111122538|NCT02326987|Pregabalin|pregabalin|mesh-list
111122539|NCT02326987|Analgesics|analgesics|mesh-ancestor
111122540|NCT02326987|Sensory System Agents|sensory system agents|mesh-ancestor
111122541|NCT02326987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111122542|NCT02326987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111122543|NCT02326987|Anticonvulsants|anticonvulsants|mesh-ancestor
111122544|NCT02326987|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111122545|NCT02326987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111122546|NCT02326987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110064515|NCT01527890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111122547|NCT02326987|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111122548|NCT02326987|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111122549|NCT02326987|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111122550|NCT02326987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111122551|NCT02326987|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111122553|NCT02331511|Clopidogrel|clopidogrel|mesh-list
111122554|NCT02331511|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111122555|NCT02331511|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111122556|NCT02331511|Analgesics|analgesics|mesh-ancestor
111122557|NCT02331511|Sensory System Agents|sensory system agents|mesh-ancestor
111122558|NCT02331511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111122559|NCT02331511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111122560|NCT02331511|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111122561|NCT02331511|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111122562|NCT02331511|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111122563|NCT02331511|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111122564|NCT02331511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111122565|NCT02331511|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111122566|NCT02331511|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111122567|NCT02331511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111122568|NCT02331511|Antipyretics|antipyretics|mesh-ancestor
111122569|NCT02331511|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111122570|NCT02331511|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111122571|NCT02331511|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111122572|NCT02331511|Purinergic Agents|purinergic agents|mesh-ancestor
111122573|NCT02331511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111122574|NCT02326441|KX2-361|kx2-361|mesh-list
111122575|NCT02326441|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111122576|NCT02326441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111122577|NCT02326441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111122578|NCT02326441|Tubulin Modulators|tubulin modulators|mesh-ancestor
111122579|NCT02326441|Antimitotic Agents|antimitotic agents|mesh-ancestor
111122580|NCT02326441|Mitosis Modulators|mitosis modulators|mesh-ancestor
111122581|NCT02326441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111122582|NCT02039791|Paclitaxel|paclitaxel|mesh-list
111122583|NCT02039791|Carboplatin|carboplatin|mesh-list
111122584|NCT02039791|Nimotuzumab|nimotuzumab|mesh-list
111122585|NCT02039791|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111122586|NCT02039791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111122587|NCT02039791|Tubulin Modulators|tubulin modulators|mesh-ancestor
111122588|NCT02039791|Antimitotic Agents|antimitotic agents|mesh-ancestor
111122589|NCT02039791|Mitosis Modulators|mitosis modulators|mesh-ancestor
111122590|NCT02039791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111122591|NCT02039791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111122592|NCT03573817|Formoterol Fumarate|formoterol fumarate|mesh-list
111122593|NCT03573817|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111122594|NCT03573817|Autonomic Agents|autonomic agents|mesh-ancestor
111122595|NCT03573817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111122596|NCT03573817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111122597|NCT03573817|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111122598|NCT03573817|Respiratory System Agents|respiratory system agents|mesh-ancestor
111122599|NCT03573817|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111122600|NCT03573817|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111122601|NCT03573817|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111122602|NCT03573817|Adrenergic Agents|adrenergic agents|mesh-ancestor
111122603|NCT03573817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110064525|NCT01527903|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111122604|NCT03573817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111122605|NCT03111511|JNJ-56136379|jnj-56136379|mesh-list
111122606|NCT03111511|Drospirenone|drospirenone|mesh-list
110839683|NCT04547985|Naltrexone|naltrexone|mesh-list
111122607|NCT03111511|Midazolam|midazolam|mesh-list
111122608|NCT03111511|Ethinyl Estradiol|ethinyl estradiol|mesh-list
111122609|NCT03111511|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
111122610|NCT03111511|Betadex|betadex|mesh-list
111122611|NCT03111511|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111122612|NCT03111511|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111122613|NCT03111511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111122614|NCT03111511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111122615|NCT03111511|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111122616|NCT03111511|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111122617|NCT03111511|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111122618|NCT03111511|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111122619|NCT03111511|Anesthetics, General|anesthetics, general|mesh-ancestor
111122620|NCT03111511|Anesthetics|anesthetics|mesh-ancestor
111122621|NCT03111511|GABA Modulators|gaba modulators|mesh-ancestor
111122622|NCT03111511|GABA Agents|gaba agents|mesh-ancestor
111122623|NCT03111511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111122624|NCT03111511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111122625|NCT03111511|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111122626|NCT03111511|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111122627|NCT03111511|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111122628|NCT03111511|Contraceptive Agents|contraceptive agents|mesh-ancestor
111122629|NCT03111511|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111122630|NCT03111511|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111122631|NCT03111511|Estrogens|estrogens|mesh-ancestor
111122632|NCT03111511|Hormones|hormones|mesh-ancestor
111122633|NCT03111511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111122634|NCT03111511|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
111122635|NCT03111511|Hormone Antagonists|hormone antagonists|mesh-ancestor
111122636|NCT03111511|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
111122637|NCT03111511|Diuretics|diuretics|mesh-ancestor
111122638|NCT03111511|Natriuretic Agents|natriuretic agents|mesh-ancestor
111122639|NCT03111511|Antiviral Agents|antiviral agents|mesh-ancestor
111122640|NCT03111511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111122641|NCT03111511|Sequestering Agents|sequestering agents|mesh-ancestor
111122642|NCT03144115|Oxytocin|oxytocin|mesh-list
111122643|NCT03144115|Oxytocics|oxytocics|mesh-ancestor
111122644|NCT03144115|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111122645|NCT03144115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111122646|NCT02326285|Docetaxel|docetaxel|mesh-list
111122647|NCT02326285|Gefitinib|gefitinib|mesh-list
111122648|NCT02326285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111122649|NCT02326285|Tubulin Modulators|tubulin modulators|mesh-ancestor
111122650|NCT02326285|Antimitotic Agents|antimitotic agents|mesh-ancestor
111122651|NCT02326285|Mitosis Modulators|mitosis modulators|mesh-ancestor
111122652|NCT02326285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111122653|NCT02326285|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111122654|NCT02326285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111122655|NCT02332603|Methylprednisolone|methylprednisolone|mesh-list
111122656|NCT02332603|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111122657|NCT02332603|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111122658|NCT02332603|Prednisolone|prednisolone|mesh-list
111122659|NCT02332603|Prednisolone acetate|prednisolone acetate|mesh-list
111122660|NCT02332603|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111122661|NCT02332603|Prednisolone phosphate|prednisolone phosphate|mesh-list
111122662|NCT02332603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111122663|NCT02332603|Antiemetics|antiemetics|mesh-ancestor
111122664|NCT02332603|Autonomic Agents|autonomic agents|mesh-ancestor
111122665|NCT02332603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111122666|NCT02332603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111122667|NCT02332603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111122668|NCT02332603|Glucocorticoids|glucocorticoids|mesh-ancestor
111122669|NCT02332603|Hormones|hormones|mesh-ancestor
111122670|NCT02332603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111122671|NCT02332603|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111122672|NCT02332603|Protective Agents|protective agents|mesh-ancestor
111122673|NCT02332603|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111122674|NCT02332603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111122675|NCT02332447|Naloxone|naloxone|mesh-list
111122676|NCT02332447|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111122677|NCT02332447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111122678|NCT02332447|Sensory System Agents|sensory system agents|mesh-ancestor
111122679|NCT02332447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111122680|NCT05077813|Vitamin D|vitamin d|mesh-list
111122681|NCT05077813|Ergocalciferols|ergocalciferols|mesh-list
111122682|NCT05077813|Cholecalciferol|cholecalciferol|mesh-list
111122683|NCT05077813|Vitamins|vitamins|mesh-list
111122684|NCT05077813|Minocycline|minocycline|mesh-list
111122685|NCT05077813|Tretinoin|tretinoin|mesh-list
111122686|NCT05077813|Alitretinoin|alitretinoin|mesh-list
111122687|NCT05077813|Isotretinoin|isotretinoin|mesh-list
111122688|NCT05077813|Micronutrients|micronutrients|mesh-ancestor
111122689|NCT05077813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110835680|NCT01136525|Valacyclovir|valacyclovir|mesh-list
111122690|NCT05077813|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111122691|NCT05077813|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111122692|NCT05077813|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111122693|NCT05077813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111122694|NCT05077813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111122695|NCT05077813|Keratolytic Agents|keratolytic agents|mesh-ancestor
111122696|NCT05077813|Dermatologic Agents|dermatologic agents|mesh-ancestor
111122697|NCT02326051|Enoxaparin|enoxaparin|mesh-list
111122698|NCT02326051|Enoxaparin sodium|enoxaparin sodium|mesh-list
111122699|NCT02326051|Anticoagulants|anticoagulants|mesh-ancestor
111122700|NCT02326051|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111122701|NCT02326051|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111122702|NCT02326051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111122703|NCT05076955|Vancomycin|vancomycin|mesh-list
111122704|NCT05076955|Tobramycin|tobramycin|mesh-list
111122705|NCT05076955|Itraconazole|itraconazole|mesh-list
111122706|NCT05076955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111122707|NCT05076955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111122708|NCT05076955|Antifungal Agents|antifungal agents|mesh-ancestor
111122709|NCT05076955|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111122710|NCT05076955|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111122711|NCT05076955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111122712|NCT05076955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111122713|NCT05076955|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111122714|NCT05076955|Hormone Antagonists|hormone antagonists|mesh-ancestor
111122715|NCT05076955|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111122716|NCT05076955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111122717|NCT05076955|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111122718|NCT05077111|Anesthetics|anesthetics|mesh-list
111122719|NCT05077111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111122720|NCT05077111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111122721|NCT05075863|Letrozole|letrozole|mesh-list
111122722|NCT05075863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111122723|NCT05075863|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111122724|NCT05075863|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111122725|NCT05075863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111122726|NCT05075863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111122727|NCT05075863|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111122728|NCT05075863|Hormone Antagonists|hormone antagonists|mesh-ancestor
111122729|NCT05075863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111122730|NCT05075863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111122731|NCT02330419|Naltrexone|naltrexone|mesh-list
111122732|NCT02330419|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111122733|NCT02330419|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111122734|NCT02330419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111122735|NCT02330419|Sensory System Agents|sensory system agents|mesh-ancestor
111122736|NCT02330419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111122737|NCT05068141|Paclitaxel|paclitaxel|mesh-list
111122738|NCT05068141|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111122739|NCT05068141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111122740|NCT05068141|Tubulin Modulators|tubulin modulators|mesh-ancestor
111122741|NCT05068141|Antimitotic Agents|antimitotic agents|mesh-ancestor
111122742|NCT05068141|Mitosis Modulators|mitosis modulators|mesh-ancestor
111122743|NCT05068141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111122744|NCT03142165|Diphenhydramine|diphenhydramine|mesh-list
111122745|NCT03142165|Promethazine|promethazine|mesh-list
111122746|NCT03142165|Famotidine|famotidine|mesh-list
111122747|NCT03142165|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111122748|NCT03142165|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111122749|NCT03142165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111122750|NCT03142165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111122751|NCT03142165|Anesthetics, Local|anesthetics, local|mesh-ancestor
111122752|NCT03142165|Anesthetics|anesthetics|mesh-ancestor
111122753|NCT03142165|Sensory System Agents|sensory system agents|mesh-ancestor
111122754|NCT03142165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111122755|NCT03142165|Antiemetics|antiemetics|mesh-ancestor
111122756|NCT03142165|Autonomic Agents|autonomic agents|mesh-ancestor
111122757|NCT03142165|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111122758|NCT03142165|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111122759|NCT03142165|Histamine Antagonists|histamine antagonists|mesh-ancestor
111122760|NCT03142165|Histamine Agents|histamine agents|mesh-ancestor
111122761|NCT03142165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111122762|NCT03142165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111122763|NCT03142165|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111122764|NCT03142165|Antipruritics|antipruritics|mesh-ancestor
111122765|NCT03142165|Dermatologic Agents|dermatologic agents|mesh-ancestor
111122766|NCT03142165|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111122767|NCT03142165|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
111122768|NCT02330029|Pinaverium|pinaverium|mesh-list
111122769|NCT02330029|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111122770|NCT02330029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111122771|NCT02330029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111122772|NCT02330029|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111122773|NCT02330029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111122774|NCT02330029|Parasympatholytics|parasympatholytics|mesh-ancestor
111122775|NCT02330029|Autonomic Agents|autonomic agents|mesh-ancestor
111122776|NCT02330029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111122777|NCT04988971|Corticosterone|corticosterone|mesh-list
111122778|NCT04988971|Fluoromethyl 2,2-difluoro-1-(trifluoromethyl)vinyl ether|fluoromethyl 2,2-difluoro-1-(trifluoromethyl)vinyl ether|mesh-list
111122779|NCT04988971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111122780|NCT04988971|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111122781|NCT04988971|Anesthetics, General|anesthetics, general|mesh-ancestor
111122782|NCT04988971|Anesthetics|anesthetics|mesh-ancestor
111122783|NCT04988971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111122784|NCT04988971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111122785|NCT02329795|Temozolomide|temozolomide|mesh-list
111122786|NCT02329795|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111122787|NCT02329795|Alkylating Agents|alkylating agents|mesh-ancestor
111122788|NCT02329795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111122789|NCT02329795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111122790|NCT02329561|Tramadol|tramadol|mesh-list
111122791|NCT02329561|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111122792|NCT02329561|Narcotics|narcotics|mesh-ancestor
111122793|NCT02329561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111122794|NCT02329561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111122795|NCT02329561|Analgesics|analgesics|mesh-ancestor
111122796|NCT02329561|Sensory System Agents|sensory system agents|mesh-ancestor
111122797|NCT02329561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111122798|NCT03143491|Paclitaxel|paclitaxel|mesh-list
111122799|NCT03143491|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111122800|NCT03143491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111122801|NCT03143491|Tubulin Modulators|tubulin modulators|mesh-ancestor
111122802|NCT03143491|Antimitotic Agents|antimitotic agents|mesh-ancestor
111122803|NCT03143491|Mitosis Modulators|mitosis modulators|mesh-ancestor
111122804|NCT03143491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111122805|NCT05002673|Anesthetics|anesthetics|mesh-list
111122806|NCT05002673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111122807|NCT05002673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111122808|NCT03076151|Tacrolimus|tacrolimus|mesh-list
111122809|NCT03076151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111122810|NCT03076151|Immunologic Factors|immunologic factors|mesh-ancestor
111122811|NCT03076151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111122812|NCT03076151|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111122813|NCT03076151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111122814|NCT03076151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111122815|NCT05002517|Methylprednisolone|methylprednisolone|mesh-list
111122816|NCT05002517|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111122817|NCT05002517|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111122818|NCT05002517|Prednisolone|prednisolone|mesh-list
111122819|NCT05002517|Prednisolone acetate|prednisolone acetate|mesh-list
111122820|NCT05002517|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111122821|NCT05002517|Prednisolone phosphate|prednisolone phosphate|mesh-list
111122822|NCT05002517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111122823|NCT05002517|Antiemetics|antiemetics|mesh-ancestor
111122824|NCT05002517|Autonomic Agents|autonomic agents|mesh-ancestor
111122825|NCT05002517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111122826|NCT05002517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111122827|NCT05002517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111122828|NCT05002517|Glucocorticoids|glucocorticoids|mesh-ancestor
111122829|NCT05002517|Hormones|hormones|mesh-ancestor
111122830|NCT05002517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111122831|NCT05002517|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111122832|NCT05002517|Protective Agents|protective agents|mesh-ancestor
111122833|NCT05002517|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111122834|NCT05002517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111122836|NCT05002361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111122837|NCT05002361|Antiemetics|antiemetics|mesh-ancestor
111122838|NCT05002361|Autonomic Agents|autonomic agents|mesh-ancestor
111122839|NCT05002361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111122840|NCT05002361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111122841|NCT05002361|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111122842|NCT05002361|Glucocorticoids|glucocorticoids|mesh-ancestor
111122843|NCT05002361|Hormones|hormones|mesh-ancestor
111122844|NCT05002361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111122845|NCT05002361|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111122846|NCT05002361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111122847|NCT02329405|Rifampin|rifampin|mesh-list
111122848|NCT02329405|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111122849|NCT02329405|Antitubercular Agents|antitubercular agents|mesh-ancestor
111122850|NCT02329405|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111122851|NCT02329405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111122852|NCT02329405|Leprostatic Agents|leprostatic agents|mesh-ancestor
111122853|NCT02329405|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111122854|NCT02329405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111122855|NCT02329405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111122856|NCT02329405|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111122857|NCT02329405|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111122858|NCT02329405|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
111122859|NCT02329405|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
111122860|NCT02329405|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
111122861|NCT02329405|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111122862|NCT02329171|Imiquimod|imiquimod|mesh-list
111122863|NCT02329171|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111122864|NCT02329171|Immunologic Factors|immunologic factors|mesh-ancestor
111122865|NCT02329171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111122866|NCT02329171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111122867|NCT02329171|Interferon Inducers|interferon inducers|mesh-ancestor
111122868|NCT04498741|Midazolam|midazolam|mesh-list
111122869|NCT04498741|Dabigatran|dabigatran|mesh-list
111122870|NCT04498741|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111122871|NCT04498741|Tacrolimus|tacrolimus|mesh-list
111122872|NCT04498741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111122873|NCT04498741|Immunologic Factors|immunologic factors|mesh-ancestor
111122874|NCT04498741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111122875|NCT04498741|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111122876|NCT04498741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111122877|NCT04498741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111122878|NCT04498741|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111122879|NCT04498741|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111122880|NCT04498741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111122881|NCT04498741|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111122882|NCT04498741|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111122883|NCT04498741|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111122884|NCT04498741|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111122885|NCT04498741|Anesthetics, General|anesthetics, general|mesh-ancestor
111122886|NCT04498741|Anesthetics|anesthetics|mesh-ancestor
110835705|NCT03098030|Irinotecan|irinotecan|mesh-list
111122888|NCT04498741|GABA Agents|gaba agents|mesh-ancestor
110064603|NCT01528501|Panobinostat|panobinostat|mesh-list
111122889|NCT04498741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111122890|NCT04498741|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111122891|NCT04498741|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111122892|NCT04498741|Antimetabolites|antimetabolites|mesh-ancestor
111122893|NCT04498741|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111122894|NCT04498741|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111122895|NCT04498741|Antithrombins|antithrombins|mesh-ancestor
111122896|NCT04498741|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111122897|NCT04498741|Protease Inhibitors|protease inhibitors|mesh-ancestor
111122898|NCT04498741|Anticoagulants|anticoagulants|mesh-ancestor
111122899|NCT03551743|Edoxaban|edoxaban|mesh-list
111122900|NCT03551743|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111122901|NCT03551743|Antithrombins|antithrombins|mesh-ancestor
111122902|NCT03551743|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111122903|NCT03551743|Protease Inhibitors|protease inhibitors|mesh-ancestor
111122904|NCT03551743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111122905|NCT03551743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111122906|NCT03551743|Anticoagulants|anticoagulants|mesh-ancestor
111122907|NCT04654429|Ondansetron|ondansetron|mesh-list
111122908|NCT04654429|Antiemetics|antiemetics|mesh-ancestor
111122909|NCT04654429|Autonomic Agents|autonomic agents|mesh-ancestor
111122910|NCT04654429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111122911|NCT04654429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111122912|NCT04654429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111122913|NCT04654429|Antipruritics|antipruritics|mesh-ancestor
111122914|NCT04654429|Dermatologic Agents|dermatologic agents|mesh-ancestor
111122915|NCT04654429|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111122916|NCT04654429|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111122917|NCT04654429|Serotonin Agents|serotonin agents|mesh-ancestor
111122918|NCT04654429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111122919|NCT04654429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111122920|NCT03111121|Glycopyrrolate|glycopyrrolate|mesh-list
111122921|NCT03111121|Neostigmine|neostigmine|mesh-list
111122922|NCT03111121|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111122923|NCT03111121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111122924|NCT03111121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111122925|NCT03111121|Cholinergic Agents|cholinergic agents|mesh-ancestor
111122926|NCT03111121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111122927|NCT03111121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111122928|NCT03111121|Parasympathomimetics|parasympathomimetics|mesh-ancestor
111122929|NCT03111121|Autonomic Agents|autonomic agents|mesh-ancestor
111122930|NCT03111121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111122931|NCT03111121|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111122932|NCT03111121|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111122933|NCT03111121|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111122934|NCT02328469|Doxycycline|doxycycline|mesh-list
111122935|NCT02328469|Ceftriaxone|ceftriaxone|mesh-list
111122936|NCT02328469|Acyclovir|acyclovir|mesh-list
111122937|NCT02328469|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111122938|NCT02328469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111122939|NCT02328469|Antimalarials|antimalarials|mesh-ancestor
111122940|NCT02328469|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111122941|NCT02328469|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111122942|NCT02328469|Antiviral Agents|antiviral agents|mesh-ancestor
111122943|NCT04998071|Bupivacaine|bupivacaine|mesh-list
111122944|NCT04998071|Anesthetics, Local|anesthetics, local|mesh-ancestor
111122945|NCT04998071|Anesthetics|anesthetics|mesh-ancestor
111122946|NCT04998071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111122947|NCT04998071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111122948|NCT04998071|Sensory System Agents|sensory system agents|mesh-ancestor
111122949|NCT04998071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111122950|NCT03734263|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
111122951|NCT03734263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111122952|NCT03073343|Betaine|betaine|mesh-list
111122953|NCT03073343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111122954|NCT03073343|Lipotropic Agents|lipotropic agents|mesh-ancestor
111122955|NCT03073343|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111122956|NCT03073343|Antimetabolites|antimetabolites|mesh-ancestor
111122957|NCT03073343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111122958|NCT03073343|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111122959|NCT03073265|Apixaban|apixaban|mesh-list
111122960|NCT03073265|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111122961|NCT03073265|Antithrombins|antithrombins|mesh-ancestor
111122962|NCT03073265|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111122963|NCT03073265|Protease Inhibitors|protease inhibitors|mesh-ancestor
111122964|NCT03073265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111122965|NCT03073265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111122966|NCT03073265|Anticoagulants|anticoagulants|mesh-ancestor
111122967|NCT04997837|Capecitabine|capecitabine|mesh-list
111122968|NCT04997837|Tegafur|tegafur|mesh-list
111122969|NCT04997837|Oxaliplatin|oxaliplatin|mesh-list
111122970|NCT04997837|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
111122971|NCT04997837|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111122972|NCT04997837|Antimetabolites|antimetabolites|mesh-ancestor
111122973|NCT04997837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111122974|NCT04997837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111122975|NCT04997837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111122976|NCT04202263|Minocycline|minocycline|mesh-list
111122977|NCT04202263|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111122978|NCT04202263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111122979|NCT04996979|Ropivacaine|ropivacaine|mesh-list
111122980|NCT04996979|Anesthetics, Local|anesthetics, local|mesh-ancestor
111122981|NCT04996979|Anesthetics|anesthetics|mesh-ancestor
111122982|NCT04996979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111122983|NCT04996979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111122984|NCT04996979|Sensory System Agents|sensory system agents|mesh-ancestor
111122985|NCT04996979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111122986|NCT03145285|Abiraterone Acetate|abiraterone acetate|mesh-list
111122987|NCT03145285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111122988|NCT03145285|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111122990|NCT03145285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111122991|NCT03145285|Hormone Antagonists|hormone antagonists|mesh-ancestor
111122992|NCT03145285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111122993|NCT03145285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111122994|NCT03145285|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111122995|NCT04997291|Dexrazoxane|dexrazoxane|mesh-list
111122996|NCT04997291|Razoxane|razoxane|mesh-list
111122997|NCT04997291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111122998|NCT04997291|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111122999|NCT04997291|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110064651|NCT01528800|Vitamin K|vitamin k|mesh-list
111123000|NCT04997291|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111123001|NCT04997291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111123002|NCT04997291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111123003|NCT04997291|Protective Agents|protective agents|mesh-ancestor
111123004|NCT04997291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111123005|NCT04997291|Antimitotic Agents|antimitotic agents|mesh-ancestor
111123006|NCT04997291|Mitosis Modulators|mitosis modulators|mesh-ancestor
111123007|NCT02328079|Acyclovir|acyclovir|mesh-list
111123008|NCT02328079|Antiviral Agents|antiviral agents|mesh-list
111123009|NCT02328079|Prednisolone|prednisolone|mesh-list
111123010|NCT02328079|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111123011|NCT02328079|Methylprednisolone|methylprednisolone|mesh-list
111123012|NCT02328079|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111123013|NCT02328079|Prednisolone acetate|prednisolone acetate|mesh-list
111123014|NCT02328079|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111123015|NCT02328079|Prednisolone phosphate|prednisolone phosphate|mesh-list
111123016|NCT02328079|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111123017|NCT02328079|Glucocorticoids|glucocorticoids|mesh-ancestor
111123018|NCT02328079|Hormones|hormones|mesh-ancestor
111123019|NCT02328079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111123020|NCT02328079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111123021|NCT02328079|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111123022|NCT02328079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111123023|NCT02328079|Antiemetics|antiemetics|mesh-ancestor
111123024|NCT02328079|Autonomic Agents|autonomic agents|mesh-ancestor
111123025|NCT02328079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111123026|NCT02328079|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111123027|NCT02328079|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111123028|NCT02328079|Protective Agents|protective agents|mesh-ancestor
111123029|NCT02328079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111123030|NCT04992533|Oxymetazoline|oxymetazoline|mesh-list
111123031|NCT04992533|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111123032|NCT04992533|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111123033|NCT04992533|Adrenergic Agents|adrenergic agents|mesh-ancestor
111123034|NCT04992533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111123035|NCT04992533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111123036|NCT04992533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111123037|NCT04992533|Sympathomimetics|sympathomimetics|mesh-ancestor
111123038|NCT04992533|Autonomic Agents|autonomic agents|mesh-ancestor
111123039|NCT04992533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111123040|NCT04992533|Nasal Decongestants|nasal decongestants|mesh-ancestor
111123041|NCT04992533|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111123042|NCT04992533|Respiratory System Agents|respiratory system agents|mesh-ancestor
111123043|NCT02578069|Sirolimus|sirolimus|mesh-list
111123044|NCT02578069|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111123045|NCT02578069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111123046|NCT02578069|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111123047|NCT02578069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111123048|NCT02578069|Antifungal Agents|antifungal agents|mesh-ancestor
111123049|NCT02578069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111123050|NCT02578069|Immunologic Factors|immunologic factors|mesh-ancestor
111123051|NCT02578069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111123052|NCT03074825|Chiauranib|chiauranib|mesh-list
111123053|NCT03074825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111123054|NCT03074825|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111123055|NCT03074825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111123056|NCT03074825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111123057|NCT03072485|Metformin|metformin|mesh-list
111123058|NCT03072485|Sirolimus|sirolimus|mesh-list
111123059|NCT03072485|Diclofenac|diclofenac|mesh-list
111123060|NCT03072485|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111123061|NCT03072485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111123062|NCT03072485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111123063|NCT03072485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111123064|NCT03072485|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111123065|NCT03072485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111123067|NCT03072485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111123068|NCT03072485|Immunologic Factors|immunologic factors|mesh-ancestor
111123069|NCT03072485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111123070|NCT03072485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111123071|NCT03072485|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111123072|NCT03072485|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111123073|NCT03072485|Analgesics|analgesics|mesh-ancestor
111123074|NCT03072485|Sensory System Agents|sensory system agents|mesh-ancestor
111123075|NCT03072485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111123076|NCT03072485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111123077|NCT03072485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111123078|NCT03072485|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111123079|NCT05080543|Terlipressin|terlipressin|mesh-list
111123080|NCT05080543|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111123081|NCT05080543|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111123082|NCT03074591|Ferric Compounds|ferric compounds|mesh-list
111123083|NCT03074591|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111123084|NCT03074591|Hematinics|hematinics|mesh-ancestor
111123085|NCT04996433|Antidepressive Agents|antidepressive agents|mesh-list
111123086|NCT04996433|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111123087|NCT03111433|Ubiquinone|ubiquinone|mesh-list
111123088|NCT03111433|Coenzyme Q10|coenzyme q10|mesh-list
111123089|NCT03111433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111123090|NCT03111433|Micronutrients|micronutrients|mesh-ancestor
111123091|NCT03111433|Vitamins|vitamins|mesh-ancestor
111123092|NCT03143023|Fluorides|fluorides|mesh-list
111123093|NCT03143023|Cariostatic Agents|cariostatic agents|mesh-ancestor
111123094|NCT03143023|Protective Agents|protective agents|mesh-ancestor
111123095|NCT03143023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111123096|NCT03074435|Ivermectin|ivermectin|mesh-list
111123097|NCT03074435|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111123098|NCT03074435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111123100|NCT03142789|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111123101|NCT03142789|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111123102|NCT03142789|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111123103|NCT03142789|Antimetabolites|antimetabolites|mesh-ancestor
111123104|NCT03142789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111123105|NCT03142789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111123106|NCT03142789|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111123107|NCT03072329|Bupivacaine|bupivacaine|mesh-list
111123108|NCT03072329|Anesthetics, Local|anesthetics, local|mesh-ancestor
111123109|NCT03072329|Anesthetics|anesthetics|mesh-ancestor
111123110|NCT03072329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111123111|NCT03072329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111123112|NCT03072329|Sensory System Agents|sensory system agents|mesh-ancestor
111123113|NCT03072329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111123114|NCT02327689|Emtricitabine|emtricitabine|mesh-list
111123115|NCT02327689|Adefovir|adefovir|mesh-list
111123116|NCT02327689|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
111123117|NCT02327689|Antiviral Agents|antiviral agents|mesh-ancestor
111123118|NCT02327689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111123119|NCT02327689|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111123120|NCT02327689|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111123121|NCT02327689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111123122|NCT02327689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111123123|NCT02327689|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111123124|NCT02327689|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111123125|NCT02327923|Ketorolac|ketorolac|mesh-list
111123126|NCT02327923|Lidocaine|lidocaine|mesh-list
111123127|NCT02327923|Atropine|atropine|mesh-list
111123128|NCT02327923|Ephedrine|ephedrine|mesh-list
111123129|NCT02327923|Fentanyl|fentanyl|mesh-list
111123130|NCT02327923|Glycopyrrolate|glycopyrrolate|mesh-list
111123131|NCT02327923|Morphine|morphine|mesh-list
111123132|NCT02327923|Tramadol|tramadol|mesh-list
111123133|NCT02327923|Ondansetron|ondansetron|mesh-list
111123134|NCT02327923|Bupivacaine|bupivacaine|mesh-list
111123135|NCT02327923|Propofol|propofol|mesh-list
111123136|NCT02327923|Neostigmine|neostigmine|mesh-list
110064673|NCT01528865|Lamivudine|lamivudine|mesh-list
111123137|NCT02327923|Vecuronium Bromide|vecuronium bromide|mesh-list
111123138|NCT02327923|Esmolol|esmolol|mesh-list
111123139|NCT02327923|Anesthetics, Local|anesthetics, local|mesh-ancestor
111123140|NCT02327923|Anesthetics|anesthetics|mesh-ancestor
111123141|NCT02327923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111123142|NCT02327923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111123143|NCT02327923|Sensory System Agents|sensory system agents|mesh-ancestor
111123144|NCT02327923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111123145|NCT02327923|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111123146|NCT02327923|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111123147|NCT02327923|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111123148|NCT02327923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111123149|NCT02327923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111123150|NCT02327923|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111123151|NCT02327923|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111123152|NCT02327923|Anesthetics, General|anesthetics, general|mesh-ancestor
111123153|NCT02327923|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111123154|NCT02327923|Narcotics|narcotics|mesh-ancestor
111123155|NCT02327923|Analgesics|analgesics|mesh-ancestor
111123156|NCT02327923|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111123157|NCT02327923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111123158|NCT02327923|Antiemetics|antiemetics|mesh-ancestor
111123159|NCT02327923|Autonomic Agents|autonomic agents|mesh-ancestor
111123160|NCT02327923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111123161|NCT02327923|Antipruritics|antipruritics|mesh-ancestor
111123162|NCT02327923|Dermatologic Agents|dermatologic agents|mesh-ancestor
111123163|NCT02327923|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111123164|NCT02327923|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111123165|NCT02327923|Serotonin Agents|serotonin agents|mesh-ancestor
111123166|NCT02327923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111123167|NCT02327923|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111123168|NCT02327923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111123169|NCT02327923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111123170|NCT02327923|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111123171|NCT02327923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111123172|NCT02327923|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111123173|NCT02327923|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111123174|NCT02327923|Respiratory System Agents|respiratory system agents|mesh-ancestor
111123175|NCT02327923|Mydriatics|mydriatics|mesh-ancestor
111123176|NCT02327923|Parasympatholytics|parasympatholytics|mesh-ancestor
111123177|NCT02327923|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111123178|NCT02327923|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111123179|NCT02327923|Cholinergic Agents|cholinergic agents|mesh-ancestor
111123180|NCT02327923|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111123181|NCT02327923|Parasympathomimetics|parasympathomimetics|mesh-ancestor
111123182|NCT02327923|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
111123183|NCT02327923|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111123184|NCT02327923|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111123185|NCT02327923|Adrenergic Agents|adrenergic agents|mesh-ancestor
111123186|NCT02327923|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111123187|NCT02327923|Sympathomimetics|sympathomimetics|mesh-ancestor
111123188|NCT02327923|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111123189|NCT02327923|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
111123190|NCT02327923|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
111123191|NCT02327923|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111123192|NCT02327923|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
111123193|NCT04991207|Bosentan|bosentan|mesh-list
111123194|NCT04991207|Zamicastat|zamicastat|mesh-list
111123195|NCT04991207|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111123196|NCT04991207|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
111123197|NCT04991207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111123198|NCT04991207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111123199|NCT03072173|Xylometazoline|xylometazoline|mesh-list
111123200|NCT03072173|Nasal Decongestants|nasal decongestants|mesh-ancestor
111123201|NCT03072173|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111123202|NCT03072173|Respiratory System Agents|respiratory system agents|mesh-ancestor
111123203|NCT03074123|Cosyntropin|cosyntropin|mesh-list
111123204|NCT03074123|Hormones|hormones|mesh-ancestor
111123205|NCT03074123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111123206|NCT03074123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111123207|NCT02327299|Fesoterodine|fesoterodine|mesh-list
111123208|NCT02327299|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111123209|NCT02327299|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111123210|NCT02327299|Cholinergic Agents|cholinergic agents|mesh-ancestor
111123211|NCT02327299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111123212|NCT02327299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111123213|NCT02327299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111123214|NCT02327299|Urological Agents|urological agents|mesh-ancestor
111123215|NCT03494569|Fludarabine|fludarabine|mesh-list
111123216|NCT03494569|Melphalan|melphalan|mesh-list
111123217|NCT03494569|Mechlorethamine|mechlorethamine|mesh-list
111123218|NCT03494569|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
111123219|NCT03494569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111123220|NCT03494569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111123221|NCT03494569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111123222|NCT03494569|Immunologic Factors|immunologic factors|mesh-ancestor
111123223|NCT03494569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111123224|NCT03494569|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111123225|NCT03494569|Alkylating Agents|alkylating agents|mesh-ancestor
111123226|NCT03494569|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111123227|NCT03071549|Salicylic Acid|salicylic acid|mesh-list
111123228|NCT03071549|Salicylates|salicylates|mesh-list
111123229|NCT03071549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111123230|NCT03071549|Antifungal Agents|antifungal agents|mesh-ancestor
111123231|NCT03071549|Keratolytic Agents|keratolytic agents|mesh-ancestor
111123232|NCT03071549|Dermatologic Agents|dermatologic agents|mesh-ancestor
111123233|NCT03071549|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111123234|NCT03071549|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111123235|NCT03071549|Analgesics|analgesics|mesh-ancestor
111123236|NCT03071549|Sensory System Agents|sensory system agents|mesh-ancestor
111123237|NCT03071549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111123238|NCT03071549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111123239|NCT03071549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111123240|NCT03071549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111123241|NCT03071549|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111123242|NCT03071549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111123243|NCT03071549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111123244|NCT03144817|Dialysis Solutions|dialysis solutions|mesh-list
111123245|NCT03144817|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111123246|NCT04994951|Triamcinolone|triamcinolone|mesh-list
111123247|NCT04994951|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
111123248|NCT04994951|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
111123249|NCT04994951|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
111123250|NCT04994951|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111123251|NCT04994951|Glucocorticoids|glucocorticoids|mesh-ancestor
111123252|NCT04994951|Hormones|hormones|mesh-ancestor
111123253|NCT04994951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111123254|NCT04994951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110064710|NCT01529138|Axitinib|axitinib|mesh-list
111123255|NCT04994951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111123256|NCT04994951|Immunologic Factors|immunologic factors|mesh-ancestor
111123257|NCT04994951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111123258|NCT04994951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111123259|NCT03073889|Ropivacaine|ropivacaine|mesh-list
111123260|NCT03073889|Anesthetics, Local|anesthetics, local|mesh-ancestor
111123261|NCT03073889|Anesthetics|anesthetics|mesh-ancestor
111123262|NCT03073889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111123263|NCT03073889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111123264|NCT03073889|Sensory System Agents|sensory system agents|mesh-ancestor
111123265|NCT03073889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111123266|NCT03071705|Metformin|metformin|mesh-list
111123267|NCT03071705|Gefitinib|gefitinib|mesh-list
111123268|NCT03071705|Afatinib|afatinib|mesh-list
111123269|NCT03071705|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111123270|NCT03071705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111123271|NCT03071705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111123272|NCT03071705|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111123273|NCT03071705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111123274|NCT03071705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111123275|NCT03351439|Celecoxib|celecoxib|mesh-list
111123276|NCT03351439|Naproxen|naproxen|mesh-list
111123277|NCT03351439|Gabapentin|gabapentin|mesh-list
111123278|NCT03351439|Zopiclone|zopiclone|mesh-list
111123279|NCT03351439|Analgesics|analgesics|mesh-ancestor
111123280|NCT03351439|Sensory System Agents|sensory system agents|mesh-ancestor
111123281|NCT03351439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111123282|NCT03351439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111123283|NCT03351439|Anticonvulsants|anticonvulsants|mesh-ancestor
111123284|NCT03351439|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111123285|NCT03351439|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111123286|NCT03351439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111123287|NCT03351439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111123288|NCT03351439|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111123289|NCT03351439|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111123290|NCT03351439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110840363|NCT03256695|Albuterol|albuterol|mesh-list
111123291|NCT03351439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111123292|NCT03351439|Antimanic Agents|antimanic agents|mesh-ancestor
111123293|NCT03351439|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111123294|NCT03351439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111123295|NCT03351439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111123296|NCT03351439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111123297|NCT03351439|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111123298|NCT03351439|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111123299|NCT03351439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110064722|NCT01529164|Leucovorin|leucovorin|mesh-list
111123300|NCT03351439|Gout Suppressants|gout suppressants|mesh-ancestor
111123301|NCT03351439|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111123303|NCT03139747|Lenvatinib|lenvatinib|mesh-list
111123304|NCT03139747|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111123305|NCT03139747|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111123306|NCT03139747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111123307|NCT03139747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111123308|NCT03139747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111123309|NCT03139747|Immunologic Factors|immunologic factors|mesh-ancestor
111123310|NCT03139747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111123311|NCT03139747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111123312|NCT02037919|Etonogestrel|etonogestrel|mesh-list
111123313|NCT02037919|Desogestrel|desogestrel|mesh-list
111123314|NCT02037919|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111123315|NCT02037919|Contraceptive Agents|contraceptive agents|mesh-ancestor
111123316|NCT02037919|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111123317|NCT02037919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111123318|NCT02037919|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111123319|NCT02037919|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111123320|NCT02037919|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111123321|NCT02037919|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111123322|NCT02037919|Progestins|progestins|mesh-ancestor
111123323|NCT02037919|Hormones|hormones|mesh-ancestor
111123324|NCT02037919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111123325|NCT03139591|Dexamethasone|dexamethasone|mesh-list
111123326|NCT03139591|Lidocaine|lidocaine|mesh-list
111123327|NCT03139591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111123328|NCT03139591|Antiemetics|antiemetics|mesh-ancestor
111123329|NCT03139591|Autonomic Agents|autonomic agents|mesh-ancestor
111123330|NCT03139591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111123331|NCT03139591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111123332|NCT03139591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111123333|NCT03139591|Glucocorticoids|glucocorticoids|mesh-ancestor
111123334|NCT03139591|Hormones|hormones|mesh-ancestor
111123335|NCT03139591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111123336|NCT03139591|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111123337|NCT03139591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111123338|NCT03139591|Anesthetics, Local|anesthetics, local|mesh-ancestor
111123339|NCT03139591|Anesthetics|anesthetics|mesh-ancestor
111123340|NCT03139591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111123341|NCT03139591|Sensory System Agents|sensory system agents|mesh-ancestor
111123342|NCT03139591|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111123343|NCT03139591|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111123344|NCT03139591|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111123345|NCT03139591|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111123346|NCT03139591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111123347|NCT04412291|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111123348|NCT04412291|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
111123349|NCT04412291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111123350|NCT04412291|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111123351|NCT03139513|Vemurafenib|vemurafenib|mesh-list
111123352|NCT03139513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111123353|NCT03139513|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111123354|NCT03139513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111123355|NCT03139513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111123356|NCT04986995|Opicapone|opicapone|mesh-list
111123357|NCT04986995|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
111123358|NCT04986995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111123359|NCT04986995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111123360|NCT04986995|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111123361|NCT04986995|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111123362|NCT03971929|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
111123363|NCT03971929|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111123364|NCT03971929|Diuretics|diuretics|mesh-ancestor
111123365|NCT03971929|Natriuretic Agents|natriuretic agents|mesh-ancestor
110835756|NCT02522650|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
111123366|NCT03971929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111123367|NCT03971929|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
111123368|NCT03971929|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111123369|NCT03971929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111123370|NCT03070925|Anti-Infective Agents|anti-infective agents|mesh-list
111123371|NCT03070925|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111123373|NCT04986371|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111123374|NCT04986371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111123375|NCT04986371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111123376|NCT04986371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111123377|NCT03070847|Tranexamic Acid|tranexamic acid|mesh-list
111123378|NCT03070847|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111123379|NCT03070847|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111123380|NCT03070847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111123381|NCT03070847|Hemostatics|hemostatics|mesh-ancestor
111123382|NCT03070847|Coagulants|coagulants|mesh-ancestor
111123383|NCT03069911|Botulinum Toxins|botulinum toxins|mesh-list
111123384|NCT03069911|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111123385|NCT03069911|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110064756|NCT01529177|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111123386|NCT03069911|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111123387|NCT03069911|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111123388|NCT03069911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111123389|NCT03069911|Cholinergic Agents|cholinergic agents|mesh-ancestor
111123390|NCT03069911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111123391|NCT03069911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111123392|NCT03069911|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111123393|NCT03069911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111123394|NCT04989257|Clopidogrel|clopidogrel|mesh-list
111123395|NCT04989257|Ticagrelor|ticagrelor|mesh-list
111123396|NCT04989257|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111123397|NCT04989257|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111123398|NCT04989257|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111123399|NCT04989257|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111123400|NCT04989257|Purinergic Agents|purinergic agents|mesh-ancestor
111123401|NCT04989257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111123402|NCT04989257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111123403|NCT04989257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111123404|NCT04892069|Insulin|insulin|mesh-list
111123405|NCT04892069|Insulin Aspart|insulin aspart|mesh-list
111123406|NCT04892069|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111123407|NCT04892069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111123408|NCT03140449|Calcitriol|calcitriol|mesh-list
111123409|NCT03140449|Sirolimus|sirolimus|mesh-list
111123410|NCT03140449|Temsirolimus|temsirolimus|mesh-list
111123411|NCT03140449|MTOR Inhibitors|mtor inhibitors|mesh-list
111123412|NCT03140449|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111123413|NCT03140449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111123414|NCT03140449|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111123415|NCT03140449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111123416|NCT03140449|Antifungal Agents|antifungal agents|mesh-ancestor
111123417|NCT03140449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111123418|NCT03140449|Immunologic Factors|immunologic factors|mesh-ancestor
111123419|NCT03140449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111123420|NCT03140449|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111123421|NCT03140449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111123422|NCT03140449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111123423|NCT03140449|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111123424|NCT03140449|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
111123425|NCT03140449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111123426|NCT03140449|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111123427|NCT03140449|Vitamins|vitamins|mesh-ancestor
111123428|NCT03140449|Micronutrients|micronutrients|mesh-ancestor
111123429|NCT03140449|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111123430|NCT02659813|Copper|copper|mesh-list
111123431|NCT02659813|Nickel|nickel|mesh-list
111123432|NCT02659813|Trace Elements|trace elements|mesh-ancestor
111123433|NCT02659813|Micronutrients|micronutrients|mesh-ancestor
111123434|NCT02659813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111123435|NCT04985435|Adalimumab|adalimumab|mesh-list
111123436|NCT04985435|Etanercept|etanercept|mesh-list
111123437|NCT04985435|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111123438|NCT04985435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110840532|NCT03755479|Insulin|insulin|mesh-list
111123439|NCT04985435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111123440|NCT04985435|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111123441|NCT04985435|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111123442|NCT04985435|Analgesics|analgesics|mesh-ancestor
111123443|NCT04985435|Sensory System Agents|sensory system agents|mesh-ancestor
111123444|NCT04985435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111123445|NCT04985435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110064778|NCT01529229|Prednisolone|prednisolone|mesh-list
111123446|NCT04985435|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111123447|NCT04985435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111123448|NCT04985435|Immunologic Factors|immunologic factors|mesh-ancestor
111123449|NCT03070613|Lectins|lectins|mesh-list
111123450|NCT03070613|Agglutinins|agglutinins|mesh-ancestor
111123451|NCT03070613|Immunologic Factors|immunologic factors|mesh-ancestor
111123452|NCT03070613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111123453|NCT03070613|Coagulants|coagulants|mesh-ancestor
111123454|NCT03441139|Analgesics|analgesics|mesh-list
111123455|NCT03441139|Sensory System Agents|sensory system agents|mesh-ancestor
111123456|NCT03441139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111123457|NCT03441139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111123458|NCT04988789|Paclitaxel|paclitaxel|mesh-list
111123459|NCT04988789|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111123460|NCT04988789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111123461|NCT04988789|Tubulin Modulators|tubulin modulators|mesh-ancestor
111123462|NCT04988789|Antimitotic Agents|antimitotic agents|mesh-ancestor
111123463|NCT04988789|Mitosis Modulators|mitosis modulators|mesh-ancestor
111123464|NCT04988789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111123465|NCT04985669|Prucalopride|prucalopride|mesh-list
111123466|NCT04985669|Laxatives|laxatives|mesh-ancestor
111123467|NCT04985669|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111123468|NCT04985669|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
111123469|NCT04985669|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111123470|NCT04985669|Serotonin Agents|serotonin agents|mesh-ancestor
111123471|NCT04985669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111123472|NCT04985669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111123473|NCT04985669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111123474|NCT04753957|Progesterone|progesterone|mesh-list
111123475|NCT04753957|Progestins|progestins|mesh-ancestor
111123476|NCT04753957|Hormones|hormones|mesh-ancestor
111123477|NCT04753957|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111123478|NCT04753957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111123479|NCT03070379|Lidocaine|lidocaine|mesh-list
111123480|NCT03070379|Anesthetics, Local|anesthetics, local|mesh-ancestor
111123481|NCT03070379|Anesthetics|anesthetics|mesh-ancestor
111123482|NCT03070379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111123483|NCT03070379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111123484|NCT03070379|Sensory System Agents|sensory system agents|mesh-ancestor
111123485|NCT03070379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111123486|NCT03070379|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111123487|NCT03070379|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111123488|NCT03070379|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111123489|NCT03070379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111123490|NCT03070379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111123491|NCT03227263|Bevacizumab|bevacizumab|mesh-list
111123492|NCT03227263|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111123493|NCT03227263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111123494|NCT03227263|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111123495|NCT03227263|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111123496|NCT03227263|Growth Substances|growth substances|mesh-ancestor
111123497|NCT03227263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111123498|NCT03227263|Growth Inhibitors|growth inhibitors|mesh-ancestor
111123499|NCT04985201|Irinotecan|irinotecan|mesh-list
111123500|NCT04985201|Simvastatin|simvastatin|mesh-list
111123501|NCT04985201|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111123502|NCT04985201|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111123503|NCT04985201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111123504|NCT04985201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111123505|NCT04985201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111123506|NCT04985201|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111123507|NCT04985201|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111123508|NCT04985201|Antimetabolites|antimetabolites|mesh-ancestor
111123509|NCT04985201|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111123510|NCT04985201|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111123511|NCT02031601|Carboplatin|carboplatin|mesh-list
111123512|NCT02031601|Docetaxel|docetaxel|mesh-list
111123513|NCT02031601|Pemetrexed|pemetrexed|mesh-list
111123514|NCT02031601|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111123515|NCT02031601|Gefitinib|gefitinib|mesh-list
111123516|NCT02031601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111123517|NCT02031601|Tubulin Modulators|tubulin modulators|mesh-ancestor
111123518|NCT02031601|Antimitotic Agents|antimitotic agents|mesh-ancestor
111123519|NCT02031601|Mitosis Modulators|mitosis modulators|mesh-ancestor
111123520|NCT02031601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111123521|NCT02031601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111123522|NCT02031601|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111123523|NCT02031601|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111123524|NCT02031601|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111123525|NCT04984577|Edaravone|edaravone|mesh-list
111123526|NCT04984577|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111123527|NCT04984577|Antioxidants|antioxidants|mesh-ancestor
111123528|NCT04984577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111123529|NCT04984577|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111123530|NCT04984577|Protective Agents|protective agents|mesh-ancestor
111123531|NCT04984577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111123532|NCT05088343|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111123533|NCT05088343|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111123534|NCT05088343|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111123535|NCT05088343|Antimetabolites|antimetabolites|mesh-ancestor
111123536|NCT05088343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111123537|NCT05088343|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111123538|NCT05088343|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111123539|NCT05088343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111123540|NCT03068429|Sertraline|sertraline|mesh-list
111123541|NCT03068429|Antidepressive Agents|antidepressive agents|mesh-ancestor
111123542|NCT03068429|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111123543|NCT03068429|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111123544|NCT03068429|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111123545|NCT03068429|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111123546|NCT03068429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111123547|NCT03068429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111123548|NCT03068429|Serotonin Agents|serotonin agents|mesh-ancestor
111123549|NCT03068429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111123550|NCT03068351|Daratumumab|daratumumab|mesh-list
111123551|NCT03068351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111123552|NCT03140293|Lidocaine|lidocaine|mesh-list
111123553|NCT03140293|Ethyl Chloride|ethyl chloride|mesh-list
111123554|NCT03140293|Anesthetics, Local|anesthetics, local|mesh-ancestor
111123555|NCT03140293|Anesthetics|anesthetics|mesh-ancestor
111123556|NCT03140293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111123557|NCT03140293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111123558|NCT03140293|Sensory System Agents|sensory system agents|mesh-ancestor
111123559|NCT03140293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110064798|NCT01529229|Histamine Agents|histamine agents|mesh-ancestor
111123560|NCT03140293|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111123561|NCT03140293|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111123562|NCT03140293|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111123563|NCT03140293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111123564|NCT03140293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111123565|NCT04982861|Cefixime|cefixime|mesh-list
111123566|NCT04982861|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111123567|NCT04982861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111123568|NCT04572217|Topiramate|topiramate|mesh-list
111123569|NCT04572217|Phentermine|phentermine|mesh-list
111123570|NCT04572217|Anticonvulsants|anticonvulsants|mesh-ancestor
111123571|NCT04572217|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111123572|NCT04572217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111123573|NCT04572217|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111123574|NCT04572217|Appetite Depressants|appetite depressants|mesh-ancestor
111123575|NCT04572217|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111123576|NCT04572217|Sympathomimetics|sympathomimetics|mesh-ancestor
111123577|NCT04572217|Autonomic Agents|autonomic agents|mesh-ancestor
111123578|NCT04572217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111123579|NCT04572217|Adrenergic Agents|adrenergic agents|mesh-ancestor
111123580|NCT04572217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111123581|NCT04572217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111123582|NCT05635955|Propofol|propofol|mesh-list
111123583|NCT05635955|Esketamine|esketamine|mesh-list
111123584|NCT05635955|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111123585|NCT05635955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111123586|NCT05635955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111123587|NCT05635955|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111123588|NCT05635955|Anesthetics, General|anesthetics, general|mesh-ancestor
111123589|NCT05635955|Anesthetics|anesthetics|mesh-ancestor
111123590|NCT05635955|Antidepressive Agents|antidepressive agents|mesh-ancestor
111123591|NCT05635955|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111123592|NCT03137017|Acetaminophen|acetaminophen|mesh-list
111123593|NCT03137017|Hydrocodone|hydrocodone|mesh-list
111123594|NCT03137017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111123595|NCT03137017|Analgesics|analgesics|mesh-ancestor
111123596|NCT03137017|Sensory System Agents|sensory system agents|mesh-ancestor
111123597|NCT03137017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111123598|NCT03137017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111123599|NCT03137017|Antipyretics|antipyretics|mesh-ancestor
111123600|NCT03137017|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111123601|NCT03137017|Narcotics|narcotics|mesh-ancestor
111123602|NCT03137017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111123603|NCT03137017|Antitussive Agents|antitussive agents|mesh-ancestor
111123604|NCT03137017|Respiratory System Agents|respiratory system agents|mesh-ancestor
111123605|NCT03019003|Durvalumab|durvalumab|mesh-list
111123606|NCT03019003|Decitabine|decitabine|mesh-list
111123607|NCT03019003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111123608|NCT03019003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111123609|NCT03019003|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111123610|NCT03019003|Antimetabolites|antimetabolites|mesh-ancestor
111123611|NCT03019003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111123612|NCT03019003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111123613|NCT03013933|Cyclosporine|cyclosporine|mesh-list
111123614|NCT03013933|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111123615|NCT03013933|Brentuximab Vedotin|brentuximab vedotin|mesh-list
111123616|NCT03013933|Verapamil|verapamil|mesh-list
111123617|NCT03013933|Antibodies|antibodies|mesh-list
111123618|NCT03013933|Immunoglobulins|immunoglobulins|mesh-list
111123619|NCT03013933|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111123620|NCT03013933|Cyclosporins|cyclosporins|mesh-list
111123621|NCT03013933|Immunoconjugates|immunoconjugates|mesh-list
111123622|NCT03013933|Immunologic Factors|immunologic factors|mesh-ancestor
111123623|NCT03013933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111123624|NCT03013933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111123625|NCT03013933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111123626|NCT03013933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111123627|NCT03013933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111123628|NCT03013933|Antifungal Agents|antifungal agents|mesh-ancestor
111123629|NCT03013933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111123630|NCT03013933|Dermatologic Agents|dermatologic agents|mesh-ancestor
111123631|NCT03013933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111123632|NCT03013933|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111123633|NCT03013933|Immunotoxins|immunotoxins|mesh-ancestor
111123634|NCT03013933|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111123635|NCT03013933|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111123636|NCT03013933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111123637|NCT03013933|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111123638|NCT03013933|Vasodilator Agents|vasodilator agents|mesh-ancestor
111123639|NCT05635253|Hydrogen Peroxide|hydrogen peroxide|mesh-list
111123640|NCT05635253|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111123641|NCT05635253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111123642|NCT04262479|Vitamin D|vitamin d|mesh-list
111123643|NCT04262479|Vitamins|vitamins|mesh-ancestor
111123644|NCT04262479|Micronutrients|micronutrients|mesh-ancestor
111123645|NCT04262479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111123646|NCT04262479|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111123647|NCT04133311|Latanoprost|latanoprost|mesh-list
111123648|NCT04133311|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
111123649|NCT04133311|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111123650|NCT03217825|Losartan|losartan|mesh-list
111123651|NCT03217825|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111123652|NCT03217825|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111123653|NCT03217825|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111123654|NCT03217825|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111123655|NCT03217825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111123656|NCT04035187|Itraconazole|itraconazole|mesh-list
111123657|NCT04035187|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
111123658|NCT04035187|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111123659|NCT04035187|Antifungal Agents|antifungal agents|mesh-ancestor
111123660|NCT04035187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111123661|NCT04035187|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111123662|NCT04035187|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111123663|NCT04035187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111123664|NCT04035187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111123665|NCT04035187|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111123666|NCT04035187|Hormone Antagonists|hormone antagonists|mesh-ancestor
111123667|NCT04035187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111123668|NCT04035187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111123669|NCT04035187|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111123670|NCT00157963|Losartan|losartan|mesh-list
111123671|NCT00157963|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
111123672|NCT00157963|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111123673|NCT00157963|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111123674|NCT00157963|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111123675|NCT00157963|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111123676|NCT00157963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111123677|NCT00157963|Diuretics|diuretics|mesh-ancestor
111123678|NCT00157963|Natriuretic Agents|natriuretic agents|mesh-ancestor
111123679|NCT00157963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111123680|NCT00157963|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
111123681|NCT00157963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111123682|NCT05087797|Nicorandil|nicorandil|mesh-list
111123683|NCT05087797|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111123684|NCT05087797|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111123685|NCT05087797|Vasodilator Agents|vasodilator agents|mesh-ancestor
111123686|NCT05087797|Vitamin B Complex|vitamin b complex|mesh-ancestor
111123687|NCT05087797|Vitamins|vitamins|mesh-ancestor
111123688|NCT05087797|Micronutrients|micronutrients|mesh-ancestor
111123689|NCT05087797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111123690|NCT03906877|Hyaluronic Acid|hyaluronic acid|mesh-list
111123691|NCT03906877|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111123692|NCT03906877|Immunologic Factors|immunologic factors|mesh-ancestor
111123693|NCT03906877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111123694|NCT03906877|Viscosupplements|viscosupplements|mesh-ancestor
111123695|NCT03906877|Protective Agents|protective agents|mesh-ancestor
111123696|NCT03867799|Nivolumab|nivolumab|mesh-list
111123697|NCT03867799|Relatlimab|relatlimab|mesh-list
111123698|NCT03867799|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111123699|NCT03867799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111123700|NCT03867799|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111123701|NCT03867799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111123702|NCT04873297|Metoclopramide|metoclopramide|mesh-list
111123703|NCT04873297|Antiemetics|antiemetics|mesh-ancestor
111123704|NCT04873297|Autonomic Agents|autonomic agents|mesh-ancestor
111123705|NCT04873297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111123706|NCT04873297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111123707|NCT04873297|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111123708|NCT04873297|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111123709|NCT04873297|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111123710|NCT04873297|Dopamine Agents|dopamine agents|mesh-ancestor
111123711|NCT04873297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111123712|NCT04873297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111123713|NCT05634473|Methacholine Chloride|methacholine chloride|mesh-list
111123714|NCT05634473|Miotics|miotics|mesh-ancestor
111123715|NCT05634473|Autonomic Agents|autonomic agents|mesh-ancestor
111123716|NCT05634473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111123717|NCT05634473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111123718|NCT05634473|Parasympathomimetics|parasympathomimetics|mesh-ancestor
111123719|NCT05634473|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
111123720|NCT05634473|Respiratory System Agents|respiratory system agents|mesh-ancestor
111123721|NCT05634473|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
111123722|NCT05634473|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111123723|NCT05634473|Cholinergic Agents|cholinergic agents|mesh-ancestor
111123724|NCT05634473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111123725|NCT05634473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111123726|NCT03138499|Nivolumab|nivolumab|mesh-list
111123727|NCT03138499|Brentuximab Vedotin|brentuximab vedotin|mesh-list
111123728|NCT03138499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111123729|NCT03138499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111123730|NCT03138499|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111123731|NCT03138499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111123732|NCT03138499|Immunotoxins|immunotoxins|mesh-ancestor
111123733|NCT03138499|Immunoconjugates|immunoconjugates|mesh-ancestor
111123734|NCT03138499|Immunologic Factors|immunologic factors|mesh-ancestor
111123735|NCT03138499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111123736|NCT04858711|Lidocaine|lidocaine|mesh-list
111123737|NCT04858711|Fentanyl|fentanyl|mesh-list
111123738|NCT04858711|Dexmedetomidine|dexmedetomidine|mesh-list
111123739|NCT04858711|Ketamine|ketamine|mesh-list
111123740|NCT04858711|Anesthetics, Local|anesthetics, local|mesh-ancestor
111123741|NCT04858711|Anesthetics|anesthetics|mesh-ancestor
111123742|NCT04858711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111123743|NCT04858711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111123744|NCT04858711|Sensory System Agents|sensory system agents|mesh-ancestor
111123745|NCT04858711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111123746|NCT04858711|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111123747|NCT04858711|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111123748|NCT04858711|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111123749|NCT04858711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111123750|NCT04858711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111123751|NCT04858711|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111123752|NCT04858711|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111123753|NCT04858711|Analgesics|analgesics|mesh-ancestor
111123754|NCT04858711|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111123755|NCT04858711|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111123756|NCT04858711|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111123757|NCT04858711|Adrenergic Agents|adrenergic agents|mesh-ancestor
111123758|NCT04858711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111123759|NCT04858711|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111123760|NCT04858711|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111123761|NCT04858711|Anesthetics, General|anesthetics, general|mesh-ancestor
111123762|NCT04858711|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111123763|NCT04858711|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111123764|NCT04858711|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111123765|NCT04858711|Narcotics|narcotics|mesh-ancestor
111123766|NCT04858711|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111123767|NCT03068975|Alvimopan|alvimopan|mesh-list
111123768|NCT03068975|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111123769|NCT02034331|Acetylcholine|acetylcholine|mesh-list
111123770|NCT02034331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111123771|NCT02034331|Vasodilator Agents|vasodilator agents|mesh-ancestor
111123772|NCT02034331|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111123773|NCT02034331|Cholinergic Agents|cholinergic agents|mesh-ancestor
111123774|NCT02034331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111123775|NCT02034331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111123776|NCT03067883|Ritonavir|ritonavir|mesh-list
111123777|NCT03067883|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111123778|NCT03067883|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111123779|NCT03067883|Protease Inhibitors|protease inhibitors|mesh-ancestor
111123780|NCT03067883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111123781|NCT03067883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111123782|NCT03067883|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111123783|NCT03067883|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111123784|NCT03067883|Antiviral Agents|antiviral agents|mesh-ancestor
111123785|NCT03067883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111123786|NCT03067883|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111123787|NCT03067883|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111123788|NCT03285763|Atezolizumab|atezolizumab|mesh-list
111123789|NCT03285763|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111123790|NCT03285763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111123791|NCT03285763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111123792|NCT03285763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111123793|NCT05393011|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
111123794|NCT05393011|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111123795|NCT05393011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111123796|NCT03085771|Deferoxamine|deferoxamine|mesh-list
111123797|NCT03085771|Siderophores|siderophores|mesh-ancestor
111123798|NCT03085771|Iron Chelating Agents|iron chelating agents|mesh-ancestor
111123799|NCT03085771|Chelating Agents|chelating agents|mesh-ancestor
111123800|NCT03085771|Sequestering Agents|sequestering agents|mesh-ancestor
111123801|NCT03085771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111123802|NCT05619965|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
111123803|NCT05619965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111123804|NCT05619965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111123805|NCT04659629|Pembrolizumab|pembrolizumab|mesh-list
111123806|NCT04659629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111123807|NCT04659629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111123808|NCT04659629|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111123809|NCT04659629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111123810|NCT02998567|Pembrolizumab|pembrolizumab|mesh-list
111123811|NCT02998567|Guadecitabine|guadecitabine|mesh-list
111123812|NCT02998567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111123813|NCT02998567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111123814|NCT02998567|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111123815|NCT02998567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111123816|NCT02985619|Triamcinolone|triamcinolone|mesh-list
111123817|NCT02985619|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
111123818|NCT02985619|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
111123819|NCT02985619|Bevacizumab|bevacizumab|mesh-list
111123820|NCT02985619|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
111123821|NCT02985619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111123822|NCT02985619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111123823|NCT02985619|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111123824|NCT02985619|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111123825|NCT02985619|Growth Substances|growth substances|mesh-ancestor
111123826|NCT02985619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111123827|NCT02985619|Growth Inhibitors|growth inhibitors|mesh-ancestor
111123828|NCT02985619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111123829|NCT02985619|Glucocorticoids|glucocorticoids|mesh-ancestor
111123830|NCT02985619|Hormones|hormones|mesh-ancestor
111123831|NCT02985619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111123832|NCT02985619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111123833|NCT02985619|Immunologic Factors|immunologic factors|mesh-ancestor
111123834|NCT02985619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111123835|NCT02985619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111123836|NCT03110653|Remifentanil|remifentanil|mesh-list
111123837|NCT03110653|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111123838|NCT03110653|Narcotics|narcotics|mesh-ancestor
111123839|NCT03110653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110835808|NCT02891850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111123840|NCT03110653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111123841|NCT03110653|Analgesics|analgesics|mesh-ancestor
111123842|NCT03110653|Sensory System Agents|sensory system agents|mesh-ancestor
111123843|NCT03110653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111123844|NCT05392387|Antiviral Agents|antiviral agents|mesh-list
111123845|NCT05392387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111123846|NCT04450199|Vitamin D|vitamin d|mesh-list
111123847|NCT04450199|Ergocalciferols|ergocalciferols|mesh-list
111123848|NCT04450199|Cholecalciferol|cholecalciferol|mesh-list
111123849|NCT04450199|Vitamins|vitamins|mesh-list
111123850|NCT04450199|Micronutrients|micronutrients|mesh-ancestor
111123851|NCT04450199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111123852|NCT04450199|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111123853|NCT04450199|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111123854|NCT01884259|Docetaxel|docetaxel|mesh-list
111123855|NCT01884259|Fluorouracil|fluorouracil|mesh-list
111123856|NCT01884259|Cetuximab|cetuximab|mesh-list
111123857|NCT01884259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111123858|NCT01884259|Tubulin Modulators|tubulin modulators|mesh-ancestor
111123859|NCT01884259|Antimitotic Agents|antimitotic agents|mesh-ancestor
111123860|NCT01884259|Mitosis Modulators|mitosis modulators|mesh-ancestor
111123861|NCT01884259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111123862|NCT01884259|Antimetabolites|antimetabolites|mesh-ancestor
111123863|NCT01884259|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111123864|NCT01884259|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111123865|NCT01884259|Immunologic Factors|immunologic factors|mesh-ancestor
111123866|NCT01884259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111123867|NCT01884259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111123868|NCT04930549|Dapagliflozin|dapagliflozin|mesh-list
111123869|NCT04930549|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111123870|NCT04930549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111123871|NCT04930549|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111123872|NCT04930549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111123873|NCT04508621|Cyclobenzaprine|cyclobenzaprine|mesh-list
111123874|NCT04508621|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
111123875|NCT04508621|Antidepressive Agents|antidepressive agents|mesh-ancestor
111123876|NCT04508621|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111123877|NCT04508621|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
111123878|NCT04508621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111123879|NCT04508621|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111123880|NCT04508621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111123881|NCT04508621|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111123882|NCT04508621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111123883|NCT03067727|Dinoprostone|dinoprostone|mesh-list
111123884|NCT03067727|Oxytocics|oxytocics|mesh-ancestor
111123885|NCT03067727|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111123886|NCT03067727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111123887|NCT01794793|Cabergoline|cabergoline|mesh-list
111123889|NCT01794793|Somatostatin|somatostatin|mesh-list
111123890|NCT01794793|Hormones|hormones|mesh-ancestor
111123891|NCT01794793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111123892|NCT01794793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111123893|NCT01794793|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111123894|NCT01794793|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111123895|NCT01794793|Dopamine Agonists|dopamine agonists|mesh-ancestor
111123896|NCT01794793|Dopamine Agents|dopamine agents|mesh-ancestor
111123897|NCT01794793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111123898|NCT01794793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111123899|NCT03067103|Ketamine|ketamine|mesh-list
111123900|NCT03067103|Tramadol|tramadol|mesh-list
111123901|NCT03067103|Analgesics|analgesics|mesh-ancestor
111123902|NCT03067103|Sensory System Agents|sensory system agents|mesh-ancestor
111123903|NCT03067103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111123904|NCT03067103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111123905|NCT03067103|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111123906|NCT03067103|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111123907|NCT03067103|Anesthetics, General|anesthetics, general|mesh-ancestor
111123908|NCT03067103|Anesthetics|anesthetics|mesh-ancestor
111123909|NCT03067103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111123910|NCT03067103|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111123911|NCT03067103|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111123912|NCT03067103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111123913|NCT03067103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111123914|NCT03067103|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111123915|NCT03067103|Narcotics|narcotics|mesh-ancestor
111123916|NCT05492123|Cisplatin|cisplatin|mesh-list
111123917|NCT05492123|Nivolumab|nivolumab|mesh-list
111123918|NCT05492123|Ipilimumab|ipilimumab|mesh-list
111123919|NCT05492123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111123920|NCT05492123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111123921|NCT05492123|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111123922|NCT05492123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111123923|NCT01398319|Ethanol|ethanol|mesh-list
111123924|NCT01398319|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111123925|NCT01398319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111123926|NCT01398319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111123927|NCT01398319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111123928|NCT01305889|Sertraline|sertraline|mesh-list
111123929|NCT01305889|Antidepressive Agents|antidepressive agents|mesh-ancestor
111123930|NCT01305889|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111123931|NCT01305889|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111123932|NCT01305889|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111123933|NCT01305889|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111123934|NCT01305889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111123935|NCT01305889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111123936|NCT01305889|Serotonin Agents|serotonin agents|mesh-ancestor
111123937|NCT01305889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111123938|NCT05392075|Vaccines|vaccines|mesh-list
111123939|NCT05392075|Immunologic Factors|immunologic factors|mesh-ancestor
111123940|NCT05392075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111123941|NCT00223171|Androgens|androgens|mesh-list
111123942|NCT00223171|Hormones|hormones|mesh-ancestor
111123943|NCT00223171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111123944|NCT00223171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111123945|NCT03138031|Ethanol|ethanol|mesh-list
111123946|NCT03138031|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111123947|NCT03138031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111123948|NCT03138031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111123949|NCT03138031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111123950|NCT02735057|Paclitaxel|paclitaxel|mesh-list
111123951|NCT02735057|Carboplatin|carboplatin|mesh-list
111123952|NCT02735057|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111123953|NCT02735057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111123954|NCT02735057|Tubulin Modulators|tubulin modulators|mesh-ancestor
111123955|NCT02735057|Antimitotic Agents|antimitotic agents|mesh-ancestor
111123956|NCT02735057|Mitosis Modulators|mitosis modulators|mesh-ancestor
111123957|NCT02735057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111123958|NCT05431283|Tofacitinib|tofacitinib|mesh-list
111123959|NCT05431283|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
111123960|NCT05431283|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111123961|NCT05431283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111123962|NCT05431283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111123963|NCT03208985|Ulipristal acetate|ulipristal acetate|mesh-list
111123964|NCT03208985|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111123965|NCT03208985|Contraceptive Agents|contraceptive agents|mesh-ancestor
111123966|NCT03208985|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111123967|NCT03208985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111123968|NCT03208985|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111123969|NCT03644953|Hydroxyurea|hydroxyurea|mesh-list
111123970|NCT03644953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111123971|NCT03644953|Antisickling Agents|antisickling agents|mesh-ancestor
111123972|NCT03644953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111123973|NCT03644953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111123974|NCT03644953|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111123976|NCT03630835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111123977|NCT03630835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111123978|NCT04764097|Dapagliflozin|dapagliflozin|mesh-list
111123979|NCT04764097|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111123980|NCT04764097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111123981|NCT04764097|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111123982|NCT04764097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111123984|NCT02902757|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
111123985|NCT02902757|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111123986|NCT02902757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111123987|NCT02902757|Antimetabolites|antimetabolites|mesh-ancestor
111123988|NCT02902757|Antiviral Agents|antiviral agents|mesh-ancestor
111123989|NCT02902757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111123990|NCT05391451|Anesthetics|anesthetics|mesh-list
111123991|NCT05391451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111123992|NCT05391451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111123993|NCT03110341|Epoetin Alfa|epoetin alfa|mesh-list
111123994|NCT03110341|Hematinics|hematinics|mesh-ancestor
111123995|NCT04648189|Cetuximab|cetuximab|mesh-list
111123996|NCT04648189|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111123997|NCT04648189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111123998|NCT04537897|Midazolam|midazolam|mesh-list
110064953|NCT01530048|Insulin Aspart|insulin aspart|mesh-list
111123999|NCT04537897|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111124000|NCT04537897|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111124001|NCT04537897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111124002|NCT04537897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111124003|NCT04537897|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111124004|NCT04537897|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111124005|NCT04537897|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111124006|NCT04537897|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111124007|NCT04537897|Anesthetics, General|anesthetics, general|mesh-ancestor
111124008|NCT04537897|Anesthetics|anesthetics|mesh-ancestor
111124009|NCT04537897|GABA Modulators|gaba modulators|mesh-ancestor
111124010|NCT04537897|GABA Agents|gaba agents|mesh-ancestor
111124011|NCT04537897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111124012|NCT04537897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111124013|NCT04405063|Paclitaxel|paclitaxel|mesh-list
111124014|NCT04405063|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111124015|NCT04405063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111124016|NCT04405063|Tubulin Modulators|tubulin modulators|mesh-ancestor
111124017|NCT04405063|Antimitotic Agents|antimitotic agents|mesh-ancestor
111124018|NCT04405063|Mitosis Modulators|mitosis modulators|mesh-ancestor
111124019|NCT04405063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111124020|NCT05090449|Losartan|losartan|mesh-list
111124021|NCT05090449|Chlorthalidone|chlorthalidone|mesh-list
111124022|NCT05090449|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111124023|NCT05090449|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111124024|NCT05090449|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111124025|NCT05090449|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111124026|NCT05090449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111124027|NCT05090449|Diuretics|diuretics|mesh-ancestor
111124028|NCT05090449|Natriuretic Agents|natriuretic agents|mesh-ancestor
111124029|NCT05090449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111124030|NCT05090449|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
111124031|NCT05090449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111124032|NCT05090137|Diuretics|diuretics|mesh-list
111124033|NCT05090137|Natriuretic Agents|natriuretic agents|mesh-ancestor
111124034|NCT05090137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110841104|NCT01383044|Carvedilol|carvedilol|mesh-list
111124035|NCT03067415|Latanoprost|latanoprost|mesh-list
111124036|NCT03067415|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
111124037|NCT03067415|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111124038|NCT05089981|Acetylcysteine|acetylcysteine|mesh-list
111124039|NCT05089981|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111124040|NCT05089981|Antiviral Agents|antiviral agents|mesh-ancestor
111124041|NCT05089981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111124042|NCT05089981|Expectorants|expectorants|mesh-ancestor
110064974|NCT01530217|Ibuprofen|ibuprofen|mesh-list
111124043|NCT05089981|Respiratory System Agents|respiratory system agents|mesh-ancestor
111124044|NCT05089981|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111124045|NCT05089981|Antioxidants|antioxidants|mesh-ancestor
111124046|NCT05089981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111124047|NCT05089981|Protective Agents|protective agents|mesh-ancestor
110835829|NCT03785041|Tramadol|tramadol|mesh-list
111124048|NCT05089981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111124050|NCT04206059|Dexmedetomidine|dexmedetomidine|mesh-list
111124051|NCT04206059|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111124052|NCT04206059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111124053|NCT04206059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111124054|NCT04206059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111124055|NCT04206059|Analgesics|analgesics|mesh-ancestor
111124056|NCT04206059|Sensory System Agents|sensory system agents|mesh-ancestor
111124057|NCT04206059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111124058|NCT04206059|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111124059|NCT04206059|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111124060|NCT04206059|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111124061|NCT04206059|Adrenergic Agents|adrenergic agents|mesh-ancestor
111124062|NCT04206059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111124063|NCT04206059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111124064|NCT05431049|Anesthetics|anesthetics|mesh-list
111124065|NCT05431049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111124066|NCT05431049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111124068|NCT04132817|Nivolumab|nivolumab|mesh-list
111124069|NCT04132817|Ipilimumab|ipilimumab|mesh-list
111124070|NCT04132817|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111124071|NCT04132817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111124072|NCT04132817|Tubulin Modulators|tubulin modulators|mesh-ancestor
111124073|NCT04132817|Antimitotic Agents|antimitotic agents|mesh-ancestor
111124074|NCT04132817|Mitosis Modulators|mitosis modulators|mesh-ancestor
111124075|NCT04132817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111124076|NCT04132817|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111124077|NCT04132817|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111124078|NCT03066635|Botulinum Toxins|botulinum toxins|mesh-list
111124079|NCT03066635|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111124080|NCT03066635|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111124081|NCT03066635|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111124082|NCT03066635|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111124083|NCT03066635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111124084|NCT03066635|Cholinergic Agents|cholinergic agents|mesh-ancestor
111124085|NCT03066635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110064984|NCT01530217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111124086|NCT03066635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111124087|NCT03066635|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111124088|NCT03066635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111124089|NCT03136237|Cyclosporine|cyclosporine|mesh-list
111124090|NCT03136237|Digoxin|digoxin|mesh-list
111124091|NCT03136237|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111124092|NCT03136237|Cyclosporins|cyclosporins|mesh-list
111124093|NCT03136237|Berotralstat|berotralstat|mesh-list
111124094|NCT03136237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111124095|NCT03136237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111124096|NCT03136237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111124097|NCT03136237|Immunologic Factors|immunologic factors|mesh-ancestor
111124098|NCT03136237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111124099|NCT03136237|Antifungal Agents|antifungal agents|mesh-ancestor
111124100|NCT03136237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111124101|NCT03136237|Dermatologic Agents|dermatologic agents|mesh-ancestor
111124102|NCT03136237|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111124103|NCT03136237|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111124104|NCT03136237|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111124105|NCT03136237|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111124106|NCT03136237|Antimetabolites|antimetabolites|mesh-ancestor
111124107|NCT03136237|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111124108|NCT03136237|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111124109|NCT03136237|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111124110|NCT03136237|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111124111|NCT03136237|Protective Agents|protective agents|mesh-ancestor
111124112|NCT03136237|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111124113|NCT03136237|Protease Inhibitors|protease inhibitors|mesh-ancestor
111124114|NCT04001309|Anti-Infective Agents|anti-infective agents|mesh-list
111124115|NCT04001309|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111124116|NCT04021381|Magnesium citrate|magnesium citrate|mesh-list
111124118|NCT04021381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111124119|NCT03066791|Curcumin|curcumin|mesh-list
111124120|NCT03066791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111124121|NCT03066791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111124122|NCT03066791|Analgesics|analgesics|mesh-ancestor
111124123|NCT03066791|Sensory System Agents|sensory system agents|mesh-ancestor
111124124|NCT03066791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111124125|NCT03066791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111124126|NCT03066791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111124127|NCT03066791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111124128|NCT03066791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111124129|NCT03066791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111124130|NCT03066791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111124131|NCT05729555|Diphenhydramine|diphenhydramine|mesh-list
111124132|NCT05729555|Promethazine|promethazine|mesh-list
111124133|NCT05729555|Ibuprofen|ibuprofen|mesh-list
111124134|NCT05729555|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111124135|NCT05729555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111124136|NCT05729555|Analgesics|analgesics|mesh-ancestor
111124137|NCT05729555|Sensory System Agents|sensory system agents|mesh-ancestor
111124138|NCT05729555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111124139|NCT05729555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111124140|NCT05729555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111124141|NCT05729555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111124142|NCT05729555|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111124143|NCT05729555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111124144|NCT05729555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111124145|NCT05729555|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111124146|NCT05729555|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111124147|NCT05729555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111124148|NCT05729555|Anesthetics, Local|anesthetics, local|mesh-ancestor
111124149|NCT05729555|Anesthetics|anesthetics|mesh-ancestor
111124150|NCT05729555|Antiemetics|antiemetics|mesh-ancestor
111124151|NCT05729555|Autonomic Agents|autonomic agents|mesh-ancestor
111124152|NCT05729555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111124153|NCT05729555|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111124154|NCT05729555|Histamine Antagonists|histamine antagonists|mesh-ancestor
111124155|NCT05729555|Histamine Agents|histamine agents|mesh-ancestor
111124156|NCT05729555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111124157|NCT05729555|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111124158|NCT05729555|Antipruritics|antipruritics|mesh-ancestor
111124159|NCT05729555|Dermatologic Agents|dermatologic agents|mesh-ancestor
111124160|NCT01603459|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
111124161|NCT01603459|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111124162|NCT01603459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111124163|NCT01603459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111124164|NCT01603459|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111124165|NCT01603459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111124166|NCT01603459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111124167|NCT01603459|Cholinergic Agents|cholinergic agents|mesh-ancestor
111124168|NCT01603459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111124169|NCT02926027|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
111124170|NCT02926027|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111124171|NCT02926027|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111124172|NCT03136003|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
111124173|NCT03136003|Hemostatics|hemostatics|mesh-ancestor
111124174|NCT03136003|Coagulants|coagulants|mesh-ancestor
111124175|NCT03136003|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
111124176|NCT03136003|Natriuretic Agents|natriuretic agents|mesh-ancestor
111124177|NCT03136003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111124178|NCT05410847|Paclitaxel|paclitaxel|mesh-list
111124179|NCT05410847|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111124180|NCT05410847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111124181|NCT05410847|Tubulin Modulators|tubulin modulators|mesh-ancestor
111124182|NCT05410847|Antimitotic Agents|antimitotic agents|mesh-ancestor
111124183|NCT05410847|Mitosis Modulators|mitosis modulators|mesh-ancestor
111124184|NCT05410847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111124185|NCT04750291|Botulinum Toxins|botulinum toxins|mesh-list
111124186|NCT04750291|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111124187|NCT04750291|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111124188|NCT04750291|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111124189|NCT04750291|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111124190|NCT04750291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111124191|NCT04750291|Cholinergic Agents|cholinergic agents|mesh-ancestor
111124192|NCT04750291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111124193|NCT04750291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111124194|NCT04750291|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111124195|NCT04750291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111124196|NCT03726749|Prednisone|prednisone|mesh-list
111124197|NCT03726749|Glucocorticoids|glucocorticoids|mesh-list
111124198|NCT03726749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111124199|NCT03726749|Hormones|hormones|mesh-ancestor
111124200|NCT03726749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111124201|NCT03726749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111124202|NCT03726749|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111124203|NCT03726749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111124204|NCT03821077|Immunomodulating Agents|immunomodulating agents|mesh-list
111124205|NCT03821077|Immunologic Factors|immunologic factors|mesh-ancestor
111124206|NCT03821077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111124207|NCT03136705|Niacinamide|niacinamide|mesh-list
111124209|NCT03136705|Nicotinic Acids|nicotinic acids|mesh-list
111124210|NCT03136705|Vitamin B Complex|vitamin b complex|mesh-ancestor
111124211|NCT03136705|Vitamins|vitamins|mesh-ancestor
111124212|NCT03136705|Micronutrients|micronutrients|mesh-ancestor
111124213|NCT03136705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111124214|NCT03136705|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111124215|NCT03136705|Antimetabolites|antimetabolites|mesh-ancestor
111124216|NCT03136705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111124217|NCT03136705|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111124218|NCT03136705|Vasodilator Agents|vasodilator agents|mesh-ancestor
111124219|NCT03066557|Apatinib|apatinib|mesh-list
111124220|NCT03066557|Chlorotrianisene|chlorotrianisene|mesh-list
111124221|NCT03066557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111124222|NCT03066557|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111124223|NCT03066557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110835867|NCT03790345|Micronutrients|micronutrients|mesh-ancestor
111124224|NCT03066557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111124225|NCT03066557|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
111124226|NCT03066557|Estrogens|estrogens|mesh-ancestor
111124227|NCT03066557|Hormones|hormones|mesh-ancestor
111124228|NCT03066557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111124229|NCT03066557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111124230|NCT03066557|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111124231|NCT05737303|Paclitaxel|paclitaxel|mesh-list
111124232|NCT05737303|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111124233|NCT05737303|Carboplatin|carboplatin|mesh-list
111124234|NCT05737303|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111124235|NCT05737303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111124236|NCT05737303|Tubulin Modulators|tubulin modulators|mesh-ancestor
111124237|NCT05737303|Antimitotic Agents|antimitotic agents|mesh-ancestor
111124238|NCT05737303|Mitosis Modulators|mitosis modulators|mesh-ancestor
111124239|NCT05737303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111124240|NCT03066089|Fenugreek seed meal|fenugreek seed meal|mesh-list
111124241|NCT03066089|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111124242|NCT03066089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111124243|NCT05188313|Paclitaxel|paclitaxel|mesh-list
111124244|NCT05188313|Carboplatin|carboplatin|mesh-list
111124245|NCT05188313|Trastuzumab|trastuzumab|mesh-list
111124246|NCT05188313|Pertuzumab|pertuzumab|mesh-list
111124247|NCT05188313|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111124248|NCT05188313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111124249|NCT05188313|Tubulin Modulators|tubulin modulators|mesh-ancestor
111124250|NCT05188313|Antimitotic Agents|antimitotic agents|mesh-ancestor
111124251|NCT05188313|Mitosis Modulators|mitosis modulators|mesh-ancestor
111124252|NCT05188313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111124253|NCT05188313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111124254|NCT02514655|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111124255|NCT02514655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111124256|NCT03066011|Voriconazole|voriconazole|mesh-list
111124257|NCT03066011|Posaconazole|posaconazole|mesh-list
111124258|NCT03066011|Isavuconazole|isavuconazole|mesh-list
111124259|NCT03066011|Antifungal Agents|antifungal agents|mesh-ancestor
111124260|NCT03066011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111124261|NCT03066011|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111124262|NCT03066011|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111124263|NCT03066011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111124264|NCT03066011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111124265|NCT03066011|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111124266|NCT03066011|Hormone Antagonists|hormone antagonists|mesh-ancestor
111124267|NCT03066011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111124268|NCT03066011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111124269|NCT03066011|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111124270|NCT03066011|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
111124271|NCT03066011|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111124272|NCT03066011|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111124273|NCT03135769|Avelumab|avelumab|mesh-list
111124274|NCT03135769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111124275|NCT03135769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111124276|NCT03123211|Veliparib|veliparib|mesh-list
111124277|NCT03123211|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111124278|NCT03123211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111124279|NCT03123211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111124280|NCT03123211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111124281|NCT05520749|Luspatercept|luspatercept|mesh-list
111124282|NCT05520749|Hematinics|hematinics|mesh-ancestor
111124283|NCT03073525|Atezolizumab|atezolizumab|mesh-list
111124284|NCT03073525|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111124285|NCT03073525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111124286|NCT03073525|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111124287|NCT03073525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111124288|NCT02563015|Vitamin D|vitamin d|mesh-list
111124289|NCT02563015|Cholecalciferol|cholecalciferol|mesh-list
111124290|NCT02563015|Vitamins|vitamins|mesh-ancestor
111124291|NCT02563015|Micronutrients|micronutrients|mesh-ancestor
111124292|NCT02563015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111124293|NCT02563015|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111124294|NCT02563015|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111124295|NCT02382445|Anesthetics|anesthetics|mesh-list
111124296|NCT02382445|Propofol|propofol|mesh-list
111124297|NCT02382445|Sevoflurane|sevoflurane|mesh-list
111124298|NCT02382445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111124299|NCT02382445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111124300|NCT02382445|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111124301|NCT02382445|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111124302|NCT02382445|Anesthetics, General|anesthetics, general|mesh-ancestor
111124303|NCT02382445|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111124304|NCT02382445|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111124305|NCT05736757|Plasminogen|plasminogen|mesh-list
111124306|NCT05736757|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
111124307|NCT05736757|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111124308|NCT05736757|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111124309|NCT05736757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111124310|NCT05727475|Fluorides|fluorides|mesh-list
111124311|NCT05727475|Cariostatic Agents|cariostatic agents|mesh-ancestor
111124312|NCT05727475|Protective Agents|protective agents|mesh-ancestor
111124313|NCT05727475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111124314|NCT05091775|Mesalamine|mesalamine|mesh-list
111124315|NCT05091775|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111124316|NCT05091775|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111124317|NCT05091775|Analgesics|analgesics|mesh-ancestor
111124318|NCT05091775|Sensory System Agents|sensory system agents|mesh-ancestor
111124319|NCT05091775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111124320|NCT05091775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111124321|NCT05091775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111124322|NCT05091775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111124323|NCT04821869|Albuterol|albuterol|mesh-list
111124324|NCT04821869|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111124325|NCT04821869|Autonomic Agents|autonomic agents|mesh-ancestor
111124326|NCT04821869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111124327|NCT04821869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111124328|NCT04821869|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111124329|NCT04821869|Respiratory System Agents|respiratory system agents|mesh-ancestor
111124330|NCT04821869|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111124331|NCT04821869|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111124332|NCT04821869|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111124333|NCT04821869|Adrenergic Agents|adrenergic agents|mesh-ancestor
110841402|NCT05764304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111124334|NCT04821869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111124335|NCT04821869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111124336|NCT04821869|Tocolytic Agents|tocolytic agents|mesh-ancestor
110065053|NCT01530542|Oxycodone|oxycodone|mesh-list
111124337|NCT04821869|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111124338|NCT05091463|Glycoprotein, Klebsiella pneumoniae|glycoprotein, klebsiella pneumoniae|mesh-list
111124339|NCT05091463|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111124340|NCT05091463|Immunologic Factors|immunologic factors|mesh-ancestor
111124341|NCT05091463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111124342|NCT02631551|Mometasone Furoate|mometasone furoate|mesh-list
111124343|NCT02631551|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
111124344|NCT02631551|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111124345|NCT02631551|Dermatologic Agents|dermatologic agents|mesh-ancestor
111124346|NCT02631551|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111124347|NCT02631551|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111124348|NCT02631551|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111124349|NCT02631551|Analgesics|analgesics|mesh-ancestor
111124350|NCT02631551|Sensory System Agents|sensory system agents|mesh-ancestor
111124351|NCT02631551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111124352|NCT02631551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111124353|NCT02631551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111124354|NCT02631551|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
111124355|NCT02631551|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111124356|NCT02631551|Histamine Antagonists|histamine antagonists|mesh-ancestor
111124357|NCT02631551|Histamine Agents|histamine agents|mesh-ancestor
111124358|NCT02631551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111124359|NCT02631551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111124360|NCT05091151|Dexmedetomidine|dexmedetomidine|mesh-list
111124361|NCT05091151|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111124362|NCT05091151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111124363|NCT05091151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111124364|NCT05091151|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111124365|NCT05091151|Analgesics|analgesics|mesh-ancestor
111124366|NCT05091151|Sensory System Agents|sensory system agents|mesh-ancestor
111124367|NCT05091151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111124368|NCT05091151|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111124369|NCT05091151|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111124370|NCT05091151|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111124371|NCT05091151|Adrenergic Agents|adrenergic agents|mesh-ancestor
111124372|NCT05091151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111124373|NCT05091151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111124374|NCT05466539|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111124375|NCT05466539|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111124376|NCT05466539|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111124377|NCT05466539|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111124378|NCT05466539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111124379|NCT05466539|Cholinergic Agents|cholinergic agents|mesh-ancestor
111124380|NCT05466539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111124381|NCT05466539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111124382|NCT05466539|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111124383|NCT05466539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111124384|NCT04447469|Mavrilimumab|mavrilimumab|mesh-list
111124385|NCT04447469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111124386|NCT04447235|Ivermectin|ivermectin|mesh-list
111124387|NCT04447235|Losartan|losartan|mesh-list
111124388|NCT04447235|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111124389|NCT04447235|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111124390|NCT04447235|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111124391|NCT04447235|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111124392|NCT04447235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111124393|NCT04447235|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111124394|NCT04447235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111124395|NCT01680991|Obinutuzumab|obinutuzumab|mesh-list
111124396|NCT01680991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111124397|NCT01680991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111124398|NCT01700569|Leucovorin|leucovorin|mesh-list
111124399|NCT01700569|Folic Acid|folic acid|mesh-list
111124400|NCT01700569|Temozolomide|temozolomide|mesh-list
111124401|NCT01700569|Levoleucovorin|levoleucovorin|mesh-list
110553542|NCT00512707|Hormones|hormones|mesh-ancestor
111124402|NCT01700569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111124403|NCT01700569|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111124404|NCT01700569|Alkylating Agents|alkylating agents|mesh-ancestor
111124405|NCT01700569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111124406|NCT01700569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111124408|NCT01700569|Protective Agents|protective agents|mesh-ancestor
111124409|NCT01700569|Vitamin B Complex|vitamin b complex|mesh-ancestor
111124410|NCT01700569|Vitamins|vitamins|mesh-ancestor
111124411|NCT01700569|Micronutrients|micronutrients|mesh-ancestor
111124412|NCT01700569|Hematinics|hematinics|mesh-ancestor
111124413|NCT05090761|Magnesium Sulfate|magnesium sulfate|mesh-list
111124414|NCT05090761|Buprenorphine|buprenorphine|mesh-list
111124415|NCT05090761|Bupivacaine|bupivacaine|mesh-list
111124416|NCT05090761|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111124417|NCT05090761|Anesthetics, Local|anesthetics, local|mesh-ancestor
111124418|NCT05090761|Anesthetics|anesthetics|mesh-ancestor
111124419|NCT05090761|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111124420|NCT05090761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111124421|NCT05090761|Sensory System Agents|sensory system agents|mesh-ancestor
111124422|NCT05090761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111124423|NCT05090761|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111124424|NCT05090761|Narcotics|narcotics|mesh-ancestor
111124425|NCT05090761|Analgesics|analgesics|mesh-ancestor
111124426|NCT05090761|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111124427|NCT05090761|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111124428|NCT05090761|Anticonvulsants|anticonvulsants|mesh-ancestor
111124429|NCT05090761|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111124430|NCT05090761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111124431|NCT05090761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111124432|NCT05090761|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111124433|NCT05090761|Tocolytic Agents|tocolytic agents|mesh-ancestor
111124434|NCT05090761|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111124435|NCT03065309|Remifentanil|remifentanil|mesh-list
111124436|NCT03065309|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111124437|NCT03065309|Narcotics|narcotics|mesh-ancestor
111124438|NCT03065309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111124439|NCT03065309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111124440|NCT03065309|Analgesics|analgesics|mesh-ancestor
111124441|NCT03065309|Sensory System Agents|sensory system agents|mesh-ancestor
111124442|NCT03065309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111124443|NCT02819479|Bevacizumab|bevacizumab|mesh-list
111124444|NCT02819479|Mannitol|mannitol|mesh-list
111124445|NCT02819479|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111124446|NCT02819479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111124447|NCT02819479|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111124448|NCT02819479|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111124449|NCT02819479|Growth Substances|growth substances|mesh-ancestor
111124450|NCT02819479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111124451|NCT02819479|Growth Inhibitors|growth inhibitors|mesh-ancestor
111124452|NCT02819479|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
111124453|NCT02819479|Diuretics|diuretics|mesh-ancestor
111124454|NCT02819479|Natriuretic Agents|natriuretic agents|mesh-ancestor
111124455|NCT05376943|Antiviral Agents|antiviral agents|mesh-list
111124456|NCT05376943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111124457|NCT04074785|Bevacizumab|bevacizumab|mesh-list
111124458|NCT04074785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111124459|NCT04074785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111124460|NCT04074785|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111124461|NCT04074785|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111124462|NCT04074785|Growth Substances|growth substances|mesh-ancestor
111124463|NCT04074785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111124464|NCT04074785|Growth Inhibitors|growth inhibitors|mesh-ancestor
111124465|NCT04533841|Propranolol|propranolol|mesh-list
111124466|NCT04533841|Misoprostol|misoprostol|mesh-list
111124467|NCT04533841|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111124468|NCT04533841|Abortifacient Agents|abortifacient agents|mesh-ancestor
111124469|NCT04533841|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111124470|NCT04533841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111124471|NCT04533841|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111124472|NCT04533841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111124473|NCT04533841|Oxytocics|oxytocics|mesh-ancestor
111124474|NCT04533841|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111124475|NCT04533841|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111124476|NCT04533841|Adrenergic Agents|adrenergic agents|mesh-ancestor
111124477|NCT04533841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111124478|NCT04533841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111124479|NCT04533841|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111124480|NCT04533841|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111124481|NCT04533841|Vasodilator Agents|vasodilator agents|mesh-ancestor
111124482|NCT04536805|Metformin|metformin|mesh-list
111124483|NCT04536805|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111124484|NCT04536805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111124485|NCT05376865|Vitamin D|vitamin d|mesh-list
111124486|NCT05376865|Vitamins|vitamins|mesh-ancestor
111124487|NCT05376865|Micronutrients|micronutrients|mesh-ancestor
111124488|NCT05376865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111124489|NCT05376865|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111124490|NCT04064411|Abaloparatide|abaloparatide|mesh-list
111124491|NCT04064411|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
111124492|NCT04064411|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111124493|NCT04064411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111124494|NCT04064411|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111124495|NCT04012931|Rilpivirine|rilpivirine|mesh-list
111124496|NCT04012931|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111124497|NCT04012931|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111124498|NCT04012931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111124499|NCT04012931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111124500|NCT04012931|Antiviral Agents|antiviral agents|mesh-ancestor
111124501|NCT04012931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111124502|NCT04012931|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111124503|NCT04012931|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111124504|NCT03063359|Fentanyl|fentanyl|mesh-list
111124505|NCT03063359|Morphine|morphine|mesh-list
111124506|NCT03063359|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111124507|NCT03063359|Narcotics|narcotics|mesh-ancestor
111124508|NCT03063359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111124509|NCT03063359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111124510|NCT03063359|Analgesics|analgesics|mesh-ancestor
111124511|NCT03063359|Sensory System Agents|sensory system agents|mesh-ancestor
111124512|NCT03063359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111124513|NCT03063359|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111124514|NCT03063359|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111124515|NCT03063359|Anesthetics, General|anesthetics, general|mesh-ancestor
111124516|NCT03063359|Anesthetics|anesthetics|mesh-ancestor
111124517|NCT02660359|Hemagglutinins|hemagglutinins|mesh-list
111124518|NCT02660359|Botulinum Toxins|botulinum toxins|mesh-list
111124519|NCT02660359|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111124520|NCT02660359|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111124521|NCT02660359|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111124522|NCT02660359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111124523|NCT02660359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111124524|NCT02660359|Cholinergic Agents|cholinergic agents|mesh-ancestor
111124525|NCT02660359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111124526|NCT02660359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111124527|NCT02660359|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110065157|NCT01531140|Bisacodyl|bisacodyl|mesh-list
111124528|NCT02660359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111124529|NCT02660359|Agglutinins|agglutinins|mesh-ancestor
111124530|NCT02660359|Immunologic Factors|immunologic factors|mesh-ancestor
111124531|NCT02660359|Coagulants|coagulants|mesh-ancestor
111124532|NCT05067985|Anesthetics|anesthetics|mesh-list
111124533|NCT05067985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111124534|NCT05067985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111124535|NCT04262869|Paclitaxel|paclitaxel|mesh-list
111124536|NCT04262869|Carboplatin|carboplatin|mesh-list
111124537|NCT04262869|Pemetrexed|pemetrexed|mesh-list
111124538|NCT04262869|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111124539|NCT04262869|Durvalumab|durvalumab|mesh-list
111124540|NCT04262869|Immunoglobulins|immunoglobulins|mesh-list
111124541|NCT04262869|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111124542|NCT04262869|Immunoglobulin G|immunoglobulin g|mesh-list
111124543|NCT04262869|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111124545|NCT04262869|Tubulin Modulators|tubulin modulators|mesh-ancestor
111124546|NCT04262869|Antimitotic Agents|antimitotic agents|mesh-ancestor
111124547|NCT04262869|Mitosis Modulators|mitosis modulators|mesh-ancestor
111124548|NCT04262869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111124549|NCT04262869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111124550|NCT04262869|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111124551|NCT04262869|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111124552|NCT04262869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111124553|NCT04262869|Immunologic Factors|immunologic factors|mesh-ancestor
111124554|NCT04262869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111124555|NCT05092165|Methylene Blue|methylene blue|mesh-list
111124556|NCT05092165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111124557|NCT05092165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111124558|NCT03062813|Entecavir|entecavir|mesh-list
111124559|NCT03062813|Tacrolimus|tacrolimus|mesh-list
111124560|NCT03062813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111124561|NCT03062813|Immunologic Factors|immunologic factors|mesh-ancestor
111124562|NCT03062813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111124563|NCT03062813|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111124564|NCT03062813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111124565|NCT03062813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111124566|NCT03062813|Antiviral Agents|antiviral agents|mesh-ancestor
111124567|NCT03062813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111124568|NCT04582981|Raltitrexed|raltitrexed|mesh-list
111124569|NCT04582981|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111124570|NCT04582981|Antimetabolites|antimetabolites|mesh-ancestor
111124571|NCT04582981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111124572|NCT04582981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111124573|NCT04582981|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111124574|NCT04582981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111124575|NCT04469179|Immunoglobulins|immunoglobulins|mesh-list
111124576|NCT04469179|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111124577|NCT04469179|Immunologic Factors|immunologic factors|mesh-ancestor
111124578|NCT04469179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111124579|NCT04531579|Valproic Acid|valproic acid|mesh-list
111124580|NCT04531579|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111124581|NCT04531579|Anticonvulsants|anticonvulsants|mesh-ancestor
111124582|NCT04531579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111124583|NCT04531579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111124584|NCT04531579|GABA Agents|gaba agents|mesh-ancestor
111124585|NCT04531579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111124586|NCT04531579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111124587|NCT04531579|Antimanic Agents|antimanic agents|mesh-ancestor
111124588|NCT04531579|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111124589|NCT04531579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111124590|NCT04531579|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111124591|NCT03839459|Denosumab|denosumab|mesh-list
111124592|NCT03839459|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111124593|NCT03839459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111124594|NCT05097781|Antibodies|antibodies|mesh-list
111124595|NCT05097781|Antibodies, Blocking|antibodies, blocking|mesh-list
111124596|NCT05097781|Immunologic Factors|immunologic factors|mesh-ancestor
111124597|NCT05097781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111124598|NCT01117441|Cytarabine|cytarabine|mesh-list
111124599|NCT01117441|Dexamethasone|dexamethasone|mesh-list
111124600|NCT01117441|Prednisone|prednisone|mesh-list
111124601|NCT01117441|Cyclophosphamide|cyclophosphamide|mesh-list
111124602|NCT01117441|Ifosfamide|ifosfamide|mesh-list
111124603|NCT01117441|Doxorubicin|doxorubicin|mesh-list
111124604|NCT01117441|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111124605|NCT01117441|Methotrexate|methotrexate|mesh-list
111124606|NCT01117441|Fludarabine|fludarabine|mesh-list
111124607|NCT01117441|Etoposide|etoposide|mesh-list
111124608|NCT01117441|Vincristine|vincristine|mesh-list
111124609|NCT01117441|Daunorubicin|daunorubicin|mesh-list
111124610|NCT01117441|Asparaginase|asparaginase|mesh-list
111124611|NCT01117441|Mercaptopurine|mercaptopurine|mesh-list
111124612|NCT01117441|Thioguanine|thioguanine|mesh-list
111124614|NCT01117441|Vindesine|vindesine|mesh-list
111124615|NCT01117441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111124616|NCT01117441|Immunologic Factors|immunologic factors|mesh-ancestor
111124617|NCT01117441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111124618|NCT01117441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111124619|NCT01117441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111124620|NCT01117441|Alkylating Agents|alkylating agents|mesh-ancestor
111124621|NCT01117441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111124622|NCT01117441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111124623|NCT01117441|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111124624|NCT01117441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111124625|NCT01117441|Antiemetics|antiemetics|mesh-ancestor
111124626|NCT01117441|Autonomic Agents|autonomic agents|mesh-ancestor
111124627|NCT01117441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111124628|NCT01117441|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111124629|NCT01117441|Glucocorticoids|glucocorticoids|mesh-ancestor
111124630|NCT01117441|Hormones|hormones|mesh-ancestor
111124631|NCT01117441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111124632|NCT01117441|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110841705|NCT03243630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111124633|NCT01117441|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111124634|NCT01117441|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111124635|NCT01117441|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111124636|NCT01117441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111124637|NCT01117441|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111124638|NCT01117441|Abortifacient Agents|abortifacient agents|mesh-ancestor
111124639|NCT01117441|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111124640|NCT01117441|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111124641|NCT01117441|Antimetabolites|antimetabolites|mesh-ancestor
111124642|NCT01117441|Dermatologic Agents|dermatologic agents|mesh-ancestor
111124643|NCT01117441|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111124644|NCT01117441|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111124645|NCT01117441|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111124646|NCT01117441|Antiviral Agents|antiviral agents|mesh-ancestor
111124647|NCT01117441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111124648|NCT01117441|Tubulin Modulators|tubulin modulators|mesh-ancestor
111124649|NCT01117441|Antimitotic Agents|antimitotic agents|mesh-ancestor
111124650|NCT01117441|Mitosis Modulators|mitosis modulators|mesh-ancestor
111124651|NCT01101451|Cisplatin|cisplatin|mesh-list
111124652|NCT01101451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111124653|NCT03656627|Nivolumab|nivolumab|mesh-list
111124654|NCT03656627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111124655|NCT03656627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111124656|NCT03656627|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111124657|NCT03656627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111124658|NCT04759703|Pramipexole|pramipexole|mesh-list
111124659|NCT04759703|Antioxidants|antioxidants|mesh-ancestor
111124660|NCT04759703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111124661|NCT04759703|Protective Agents|protective agents|mesh-ancestor
111124662|NCT04759703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111124663|NCT04759703|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111124664|NCT04759703|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111124665|NCT04759703|Dopamine Agonists|dopamine agonists|mesh-ancestor
111124666|NCT04759703|Dopamine Agents|dopamine agents|mesh-ancestor
111124667|NCT04759703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111124668|NCT05026801|Azithromycin|azithromycin|mesh-list
111124669|NCT05026801|Hydroxychloroquine|hydroxychloroquine|mesh-list
111124670|NCT05026801|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111124671|NCT05026801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111124672|NCT05026801|Antimalarials|antimalarials|mesh-ancestor
111124673|NCT05026801|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111124674|NCT05026801|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111124675|NCT05026801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111124676|NCT05026801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111124677|NCT05026801|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111124678|NCT03511625|Methylprednisolone|methylprednisolone|mesh-list
111124679|NCT03511625|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111124680|NCT03511625|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111124681|NCT03511625|Prednisolone|prednisolone|mesh-list
111124682|NCT03511625|Prednisolone acetate|prednisolone acetate|mesh-list
111124683|NCT03511625|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111124684|NCT03511625|Prednisolone phosphate|prednisolone phosphate|mesh-list
111124685|NCT03511625|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
111124686|NCT03511625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111124687|NCT03511625|Antiemetics|antiemetics|mesh-ancestor
111124688|NCT03511625|Autonomic Agents|autonomic agents|mesh-ancestor
111124689|NCT03511625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111124690|NCT03511625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111124691|NCT03511625|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111124692|NCT03511625|Glucocorticoids|glucocorticoids|mesh-ancestor
111124693|NCT03511625|Hormones|hormones|mesh-ancestor
111124694|NCT03511625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111124695|NCT03511625|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111124696|NCT03511625|Protective Agents|protective agents|mesh-ancestor
111124697|NCT03511625|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111124698|NCT03511625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111124699|NCT03493061|Oxaliplatin|oxaliplatin|mesh-list
111124700|NCT03493061|Irinotecan|irinotecan|mesh-list
111124701|NCT03493061|Floxuridine|floxuridine|mesh-list
111124702|NCT03493061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111124703|NCT03493061|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111124704|NCT03493061|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111124705|NCT03493061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111124706|NCT03493061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111124707|NCT03493061|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111124708|NCT03493061|Antimetabolites|antimetabolites|mesh-ancestor
111124709|NCT04523935|Topiramate|topiramate|mesh-list
111124710|NCT04523935|Lamotrigine|lamotrigine|mesh-list
111124711|NCT04523935|Diazepam|diazepam|mesh-list
111124712|NCT04523935|Gabapentin|gabapentin|mesh-list
111124713|NCT04523935|Amitriptyline|amitriptyline|mesh-list
111124714|NCT04523935|Anticonvulsants|anticonvulsants|mesh-list
111124715|NCT04523935|Clonazepam|clonazepam|mesh-list
111124716|NCT04523935|Trihexyphenidyl|trihexyphenidyl|mesh-list
111124717|NCT04523935|Baclofen|baclofen|mesh-list
111124718|NCT04523935|Tetrabenazine|tetrabenazine|mesh-list
111124719|NCT04523935|Analgesics|analgesics|mesh-ancestor
111124720|NCT04523935|Sensory System Agents|sensory system agents|mesh-ancestor
111124721|NCT04523935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111124722|NCT04523935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111124723|NCT04523935|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111124724|NCT04523935|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111124725|NCT04523935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111124726|NCT04523935|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111124727|NCT04523935|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111124728|NCT04523935|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111124729|NCT04523935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111124730|NCT04523935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111124731|NCT04523935|Antimanic Agents|antimanic agents|mesh-ancestor
111124732|NCT04523935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111124733|NCT04523935|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111124734|NCT04523935|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111124735|NCT04523935|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111124736|NCT04523935|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111124737|NCT04523935|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111124738|NCT04523935|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
111124739|NCT04523935|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111124740|NCT04523935|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
111124741|NCT04523935|GABA Agonists|gaba agonists|mesh-ancestor
111124742|NCT04523935|GABA Agents|gaba agents|mesh-ancestor
111124743|NCT04523935|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
111124744|NCT04523935|Antidepressive Agents|antidepressive agents|mesh-ancestor
111124745|NCT04523935|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111124746|NCT04523935|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111124747|NCT04523935|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111124748|NCT04523935|Adrenergic Agents|adrenergic agents|mesh-ancestor
111124749|NCT04523935|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111124750|NCT04523935|Antiemetics|antiemetics|mesh-ancestor
111124751|NCT04523935|Autonomic Agents|autonomic agents|mesh-ancestor
111124752|NCT04523935|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111124753|NCT04523935|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111124754|NCT04523935|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111124755|NCT04523935|Anesthetics, General|anesthetics, general|mesh-ancestor
111124756|NCT04523935|Anesthetics|anesthetics|mesh-ancestor
111124757|NCT04523935|GABA Modulators|gaba modulators|mesh-ancestor
111124758|NCT04523935|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111124759|NCT04523935|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111124760|NCT04523935|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111124761|NCT04523935|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111124762|NCT04523935|Cholinergic Agents|cholinergic agents|mesh-ancestor
111124763|NCT02630693|Tamoxifen|tamoxifen|mesh-list
111124764|NCT02630693|Fulvestrant|fulvestrant|mesh-list
111124765|NCT02630693|Palbociclib|palbociclib|mesh-list
111124766|NCT02630693|Aromatase Inhibitors|aromatase inhibitors|mesh-list
111124767|NCT02630693|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111124768|NCT02630693|Hormone Antagonists|hormone antagonists|mesh-ancestor
111124769|NCT02630693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111124770|NCT02630693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111124771|NCT02630693|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111124772|NCT02630693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111124773|NCT02630693|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111124774|NCT02630693|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111124775|NCT02630693|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111124776|NCT02630693|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
111124777|NCT02630693|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111124778|NCT02630693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111124779|NCT02630693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111124780|NCT02630693|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111124781|NCT01938430|Sofosbuvir|sofosbuvir|mesh-list
111124782|NCT01938430|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
111124783|NCT01938430|Ledipasvir|ledipasvir|mesh-list
111124784|NCT01938430|Antiviral Agents|antiviral agents|mesh-ancestor
111124785|NCT01938430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111124786|NCT04625530|Tranexamic Acid|tranexamic acid|mesh-list
111124787|NCT04625530|Ferric Compounds|ferric compounds|mesh-list
111124788|NCT04625530|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111124789|NCT04625530|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111124790|NCT04625530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111124791|NCT04625530|Hemostatics|hemostatics|mesh-ancestor
111124792|NCT04625530|Coagulants|coagulants|mesh-ancestor
111124793|NCT04625530|Hematinics|hematinics|mesh-ancestor
111124794|NCT01916824|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
111124795|NCT01916824|Mirtazapine|mirtazapine|mesh-list
111124796|NCT01916824|Citalopram|citalopram|mesh-list
111124797|NCT01916824|Bupropion|bupropion|mesh-list
111124798|NCT01916824|Fluoxetine|fluoxetine|mesh-list
111124799|NCT01916824|Paroxetine|paroxetine|mesh-list
111124800|NCT01916824|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
111124801|NCT01916824|Sertraline|sertraline|mesh-list
111124802|NCT01916824|Antidepressive Agents|antidepressive agents|mesh-list
110065269|NCT01531764|Vinorelbine|vinorelbine|mesh-list
111124803|NCT01916824|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
111124804|NCT01916824|Escitalopram|escitalopram|mesh-list
111124805|NCT01916824|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111124806|NCT01916824|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111124807|NCT01916824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111124808|NCT01916824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111124809|NCT01916824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111124810|NCT01916824|Serotonin Agents|serotonin agents|mesh-ancestor
111124811|NCT01916824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111124812|NCT01916824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111124813|NCT01916824|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111124814|NCT01916824|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111124815|NCT01916824|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111124817|NCT01916824|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111124818|NCT01916824|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111124819|NCT01916824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111124820|NCT01916824|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111124821|NCT01916824|Analgesics|analgesics|mesh-ancestor
111124822|NCT01916824|Sensory System Agents|sensory system agents|mesh-ancestor
111124823|NCT01916824|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111124824|NCT01916824|Histamine Antagonists|histamine antagonists|mesh-ancestor
111124825|NCT01916824|Histamine Agents|histamine agents|mesh-ancestor
111124826|NCT01916824|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111124827|NCT01916824|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111124828|NCT01916824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111124829|NCT01916824|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
111124830|NCT01916824|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111124831|NCT01916824|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111124832|NCT01916824|Adrenergic Agents|adrenergic agents|mesh-ancestor
111124833|NCT01916824|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111124834|NCT01916824|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111124835|NCT01916824|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111124836|NCT01915732|Clindamycin|clindamycin|mesh-list
111124837|NCT01915732|Clindamycin palmitate|clindamycin palmitate|mesh-list
111124838|NCT01915732|Clindamycin phosphate|clindamycin phosphate|mesh-list
111124839|NCT01915732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111124840|NCT01915732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111124841|NCT01915732|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111124842|NCT01915732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111124843|NCT01915732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111124844|NCT01936870|Fesoterodine|fesoterodine|mesh-list
111124845|NCT01936870|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111124846|NCT01936870|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111124847|NCT01936870|Cholinergic Agents|cholinergic agents|mesh-ancestor
111124848|NCT01936870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111124849|NCT01936870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111124850|NCT01936870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111124851|NCT01936870|Urological Agents|urological agents|mesh-ancestor
111124852|NCT01618708|Hylan|hylan|mesh-list
111124853|NCT01618708|Viscosupplements|viscosupplements|mesh-ancestor
111124854|NCT01618708|Protective Agents|protective agents|mesh-ancestor
111124855|NCT01618708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111124856|NCT02229149|Paclitaxel|paclitaxel|mesh-list
111124857|NCT02229149|Vinorelbine|vinorelbine|mesh-list
111124858|NCT02229149|Docetaxel|docetaxel|mesh-list
111124859|NCT02229149|Capecitabine|capecitabine|mesh-list
111124860|NCT02229149|Trastuzumab|trastuzumab|mesh-list
111124861|NCT02229149|Pertuzumab|pertuzumab|mesh-list
111124862|NCT02229149|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111124863|NCT02229149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111124864|NCT02229149|Tubulin Modulators|tubulin modulators|mesh-ancestor
111124865|NCT02229149|Antimitotic Agents|antimitotic agents|mesh-ancestor
111124866|NCT02229149|Mitosis Modulators|mitosis modulators|mesh-ancestor
111124867|NCT02229149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111124868|NCT02229149|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111124869|NCT02229149|Antimetabolites|antimetabolites|mesh-ancestor
111124870|NCT02229149|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111124871|NCT04440371|Betamethasone|betamethasone|mesh-list
111124872|NCT04440371|Calcipotriene|calcipotriene|mesh-list
111124873|NCT04440371|Tacrolimus|tacrolimus|mesh-list
111124874|NCT04440371|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111124875|NCT04440371|Immunologic Factors|immunologic factors|mesh-ancestor
111124876|NCT04440371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111124877|NCT04440371|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111124878|NCT04440371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111124879|NCT04440371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111124880|NCT04440371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111124881|NCT04440371|Glucocorticoids|glucocorticoids|mesh-ancestor
111124882|NCT04440371|Hormones|hormones|mesh-ancestor
111124883|NCT04440371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111124884|NCT04440371|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111124885|NCT04440371|Respiratory System Agents|respiratory system agents|mesh-ancestor
111124886|NCT04440371|Dermatologic Agents|dermatologic agents|mesh-ancestor
111124887|NCT00694655|Vaccines|vaccines|mesh-list
111124888|NCT00694655|Immunologic Factors|immunologic factors|mesh-ancestor
111124889|NCT00694655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111124890|NCT04982939|Oxaliplatin|oxaliplatin|mesh-list
111124891|NCT04982939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111124892|NCT04982549|Paclitaxel|paclitaxel|mesh-list
111124893|NCT04982549|Carboplatin|carboplatin|mesh-list
111124894|NCT04982549|Pemetrexed|pemetrexed|mesh-list
111124895|NCT04982549|Durvalumab|durvalumab|mesh-list
111124896|NCT04982549|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111124897|NCT04982549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111124898|NCT04982549|Tubulin Modulators|tubulin modulators|mesh-ancestor
111124899|NCT04982549|Antimitotic Agents|antimitotic agents|mesh-ancestor
111124900|NCT04982549|Mitosis Modulators|mitosis modulators|mesh-ancestor
111124901|NCT04982549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111124902|NCT04982549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111124903|NCT04982549|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111124904|NCT04982549|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111124905|NCT04982549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111124906|NCT02592317|Pioglitazone|pioglitazone|mesh-list
111124907|NCT02592317|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111124908|NCT02592317|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111124909|NCT02592317|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111124910|NCT02592317|Antimetabolites|antimetabolites|mesh-ancestor
111124911|NCT02592317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111124912|NCT02592317|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111124913|NCT02592317|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111124914|NCT02592317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111124915|NCT02592317|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111124916|NCT02592317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111124917|NCT03062423|Sofosbuvir|sofosbuvir|mesh-list
111124918|NCT03062423|Antiviral Agents|antiviral agents|mesh-ancestor
111124919|NCT03062423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111124920|NCT00790933|Vedolizumab|vedolizumab|mesh-list
111124921|NCT00790933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111124922|NCT04981457|Misoprostol|misoprostol|mesh-list
111124923|NCT04981457|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111124924|NCT04981457|Abortifacient Agents|abortifacient agents|mesh-ancestor
111124925|NCT04981457|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111124926|NCT04981457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111124927|NCT04981457|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111124928|NCT04981457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111124929|NCT04981457|Oxytocics|oxytocics|mesh-ancestor
111124930|NCT01676701|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111124931|NCT01676701|Immunologic Factors|immunologic factors|mesh-ancestor
111124932|NCT01676701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111124933|NCT04981379|Hydroxychloroquine|hydroxychloroquine|mesh-list
111124934|NCT04981379|Favipiravir|favipiravir|mesh-list
111124935|NCT04981379|Antimalarials|antimalarials|mesh-ancestor
111124936|NCT04981379|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111124937|NCT04981379|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111124938|NCT04981379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111124939|NCT04981379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111124940|NCT04981379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110835988|NCT01307215|Ropivacaine|ropivacaine|mesh-list
111124941|NCT04981379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111124942|NCT04981379|Antiviral Agents|antiviral agents|mesh-ancestor
111124943|NCT04389775|Glucagon|glucagon|mesh-list
111124944|NCT04389775|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
111124945|NCT04389775|Incretins|incretins|mesh-ancestor
111124947|NCT04389775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111124948|NCT04389775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111124949|NCT04389775|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111124950|NCT03062501|Hydroxyurea|hydroxyurea|mesh-list
111124951|NCT03062501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111124952|NCT03062501|Antisickling Agents|antisickling agents|mesh-ancestor
111124953|NCT03062501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111124954|NCT03062501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111124955|NCT03062501|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111124956|NCT02102789|Leucovorin|leucovorin|mesh-list
111124957|NCT02102789|Dexamethasone|dexamethasone|mesh-list
111124958|NCT02102789|Fluorouracil|fluorouracil|mesh-list
111124959|NCT02102789|Oxaliplatin|oxaliplatin|mesh-list
111124960|NCT02102789|Floxuridine|floxuridine|mesh-list
111124961|NCT02102789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111124962|NCT02102789|Antiemetics|antiemetics|mesh-ancestor
111124963|NCT02102789|Autonomic Agents|autonomic agents|mesh-ancestor
111124964|NCT02102789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110065323|NCT01532011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111124965|NCT02102789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111124966|NCT02102789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111124967|NCT02102789|Glucocorticoids|glucocorticoids|mesh-ancestor
111124968|NCT02102789|Hormones|hormones|mesh-ancestor
111124969|NCT02102789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111124970|NCT02102789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111124971|NCT02102789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111124972|NCT02102789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111124973|NCT02102789|Antimetabolites|antimetabolites|mesh-ancestor
111124974|NCT02102789|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111124975|NCT02102789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111124976|NCT02102789|Immunologic Factors|immunologic factors|mesh-ancestor
111124977|NCT02102789|Antidotes|antidotes|mesh-ancestor
111124978|NCT02102789|Protective Agents|protective agents|mesh-ancestor
111124979|NCT02102789|Vitamin B Complex|vitamin b complex|mesh-ancestor
111124980|NCT02102789|Vitamins|vitamins|mesh-ancestor
111124981|NCT02102789|Micronutrients|micronutrients|mesh-ancestor
111124982|NCT02926651|Tranexamic Acid|tranexamic acid|mesh-list
111124983|NCT02926651|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111124984|NCT02926651|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111124985|NCT02926651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111124986|NCT02926651|Hemostatics|hemostatics|mesh-ancestor
111124987|NCT02926651|Coagulants|coagulants|mesh-ancestor
111124988|NCT04305145|Prednisone|prednisone|mesh-list
111124989|NCT04305145|Methylprednisolone|methylprednisolone|mesh-list
111124990|NCT04305145|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111124991|NCT04305145|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111124992|NCT04305145|Prednisolone|prednisolone|mesh-list
111124993|NCT04305145|Prednisolone acetate|prednisolone acetate|mesh-list
111124994|NCT04305145|Infliximab|infliximab|mesh-list
111124995|NCT04305145|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111124996|NCT04305145|Prednisolone phosphate|prednisolone phosphate|mesh-list
111124997|NCT04305145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111124998|NCT04305145|Glucocorticoids|glucocorticoids|mesh-ancestor
111124999|NCT04305145|Hormones|hormones|mesh-ancestor
111125000|NCT04305145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111125001|NCT04305145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111125002|NCT04305145|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111125003|NCT04305145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111125004|NCT04305145|Antiemetics|antiemetics|mesh-ancestor
111125005|NCT04305145|Autonomic Agents|autonomic agents|mesh-ancestor
111125006|NCT04305145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111125007|NCT04305145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111125008|NCT04305145|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111125009|NCT04305145|Protective Agents|protective agents|mesh-ancestor
111125010|NCT04305145|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111125011|NCT04305145|Dermatologic Agents|dermatologic agents|mesh-ancestor
111125012|NCT04305145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111125013|NCT01670279|Brexpiprazole|brexpiprazole|mesh-list
111125014|NCT01670279|Serotonin Agents|serotonin agents|mesh-ancestor
111125015|NCT01670279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111125016|NCT01670279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111125017|NCT01670279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111125018|NCT01670279|Dopamine Agonists|dopamine agonists|mesh-ancestor
111125019|NCT01670279|Dopamine Agents|dopamine agents|mesh-ancestor
111125020|NCT04188145|Bevacizumab|bevacizumab|mesh-list
111125021|NCT04188145|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111125022|NCT04188145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111125023|NCT04188145|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111125024|NCT04188145|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111125025|NCT04188145|Growth Substances|growth substances|mesh-ancestor
111125026|NCT04188145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111125027|NCT04188145|Growth Inhibitors|growth inhibitors|mesh-ancestor
111125028|NCT03063983|Cyclophosphamide|cyclophosphamide|mesh-list
111125029|NCT03063983|Methotrexate|methotrexate|mesh-list
111125030|NCT03063983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111125031|NCT03063983|Immunologic Factors|immunologic factors|mesh-ancestor
111125032|NCT03063983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111125033|NCT03063983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111125034|NCT03063983|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111125035|NCT03063983|Alkylating Agents|alkylating agents|mesh-ancestor
111125036|NCT03063983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111125037|NCT03063983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111125038|NCT03063983|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111125039|NCT03063983|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111125040|NCT03063983|Abortifacient Agents|abortifacient agents|mesh-ancestor
111125041|NCT03063983|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111125042|NCT03063983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111125043|NCT03063983|Antimetabolites|antimetabolites|mesh-ancestor
111125044|NCT03063983|Dermatologic Agents|dermatologic agents|mesh-ancestor
111125045|NCT03063983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111125046|NCT03063983|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111125047|NCT03063983|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111125049|NCT03945721|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111125050|NCT03945721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111125051|NCT03945721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111125052|NCT03945721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111125053|NCT01876355|Clonidine|clonidine|mesh-list
111125054|NCT01876355|Analgesics|analgesics|mesh-ancestor
111125055|NCT01876355|Sensory System Agents|sensory system agents|mesh-ancestor
111125056|NCT01876355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111125057|NCT01876355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111125058|NCT01876355|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111125059|NCT01876355|Sympatholytics|sympatholytics|mesh-ancestor
111125060|NCT01876355|Autonomic Agents|autonomic agents|mesh-ancestor
111125061|NCT01876355|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111125062|NCT01876355|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111125063|NCT01876355|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111125064|NCT01876355|Adrenergic Agents|adrenergic agents|mesh-ancestor
111125065|NCT01876355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111125066|NCT01876355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111125068|NCT02747407|Immunologic Factors|immunologic factors|mesh-ancestor
111125069|NCT02747407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111125070|NCT01870193|Acetylcysteine|acetylcysteine|mesh-list
111125071|NCT01870193|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111125072|NCT01870193|Glycine|glycine|mesh-list
111125073|NCT01870193|Antiviral Agents|antiviral agents|mesh-ancestor
111125074|NCT01870193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111125075|NCT01870193|Expectorants|expectorants|mesh-ancestor
111125076|NCT01870193|Respiratory System Agents|respiratory system agents|mesh-ancestor
110065380|NCT01532804|Bevacizumab|bevacizumab|mesh-list
111125077|NCT01870193|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111125078|NCT01870193|Antioxidants|antioxidants|mesh-ancestor
111125079|NCT01870193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111125080|NCT01870193|Protective Agents|protective agents|mesh-ancestor
111125081|NCT01870193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111125082|NCT01870193|Antidotes|antidotes|mesh-ancestor
111125083|NCT01870193|Glycine Agents|glycine agents|mesh-ancestor
111125084|NCT01870193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111125085|NCT03063905|Buprenorphine|buprenorphine|mesh-list
111125086|NCT03063905|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111125087|NCT03063905|Narcotics|narcotics|mesh-ancestor
111125088|NCT03063905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111125089|NCT03063905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111125090|NCT03063905|Analgesics|analgesics|mesh-ancestor
111125091|NCT03063905|Sensory System Agents|sensory system agents|mesh-ancestor
111125092|NCT03063905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111125093|NCT03063905|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111125094|NCT04432415|Fluorides|fluorides|mesh-list
111125095|NCT04432415|Fluorides, Topical|fluorides, topical|mesh-list
110842161|NCT04691856|Antipyretics|antipyretics|mesh-ancestor
111125096|NCT04432415|Cariostatic Agents|cariostatic agents|mesh-ancestor
111125097|NCT04432415|Protective Agents|protective agents|mesh-ancestor
111125098|NCT04432415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111125100|NCT01402271|Carboplatin|carboplatin|mesh-list
111125101|NCT01402271|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111125102|NCT01402271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111125103|NCT01402271|Tubulin Modulators|tubulin modulators|mesh-ancestor
111125104|NCT01402271|Antimitotic Agents|antimitotic agents|mesh-ancestor
111125105|NCT01402271|Mitosis Modulators|mitosis modulators|mesh-ancestor
111125106|NCT01402271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111125107|NCT03063671|Dexmedetomidine|dexmedetomidine|mesh-list
111125108|NCT03063671|Ketamine|ketamine|mesh-list
111125109|NCT03063671|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111125110|NCT03063671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111125111|NCT03063671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111125112|NCT03063671|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111125113|NCT03063671|Analgesics|analgesics|mesh-ancestor
111125114|NCT03063671|Sensory System Agents|sensory system agents|mesh-ancestor
111125115|NCT03063671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110836036|NCT02989402|Rivastigmine|rivastigmine|mesh-list
111125116|NCT03063671|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111125117|NCT03063671|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111125118|NCT03063671|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111125119|NCT03063671|Adrenergic Agents|adrenergic agents|mesh-ancestor
111125120|NCT03063671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111125121|NCT03063671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111125122|NCT03063671|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111125123|NCT03063671|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111125124|NCT03063671|Anesthetics, General|anesthetics, general|mesh-ancestor
111125126|NCT03063671|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111125127|NCT03063671|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111125128|NCT03063827|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111125129|NCT03063827|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111125130|NCT03063827|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111125131|NCT03063827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111125132|NCT03063827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111125133|NCT03063827|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111125134|NCT03063827|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111125135|NCT03063827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111125136|NCT03063827|Cholinergic Agents|cholinergic agents|mesh-ancestor
111125137|NCT03063827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111125138|NCT01669421|Protease Inhibitors|protease inhibitors|mesh-list
111125139|NCT01669421|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
111125140|NCT01669421|Protein C Inhibitor|protein c inhibitor|mesh-list
111125141|NCT01669421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111125142|NCT01669421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111125143|NCT01669421|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
111125144|NCT01669421|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111125145|NCT04973969|Triptorelin Pamoate|triptorelin pamoate|mesh-list
111125146|NCT04973969|Luteolytic Agents|luteolytic agents|mesh-ancestor
111125147|NCT04973969|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111125148|NCT04973969|Contraceptive Agents|contraceptive agents|mesh-ancestor
111125149|NCT04973969|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111125150|NCT04973969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111125151|NCT04973969|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111125152|NCT04973969|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111125153|NCT04973969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111125154|NCT02958709|Rifampin|rifampin|mesh-list
111125155|NCT02958709|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111125156|NCT02958709|Antitubercular Agents|antitubercular agents|mesh-ancestor
111125157|NCT02958709|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111125158|NCT02958709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111125159|NCT02958709|Leprostatic Agents|leprostatic agents|mesh-ancestor
111125160|NCT02958709|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111125161|NCT02958709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111125162|NCT02958709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111125163|NCT02958709|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111125164|NCT02958709|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111125165|NCT02958709|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
111125166|NCT02958709|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110842230|NCT03263767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111125167|NCT02958709|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
111125168|NCT02958709|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111125169|NCT04979663|Gemcitabine|gemcitabine|mesh-list
111125170|NCT04979663|Oxaliplatin|oxaliplatin|mesh-list
111125171|NCT04979663|Tislelizumab|tislelizumab|mesh-list
111125172|NCT04979663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111125174|NCT04979663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111125175|NCT04979663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111125176|NCT04979663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111125177|NCT04979585|Paclitaxel|paclitaxel|mesh-list
111125178|NCT04979585|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111125179|NCT04979585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111125180|NCT04979585|Tubulin Modulators|tubulin modulators|mesh-ancestor
111125181|NCT04979585|Antimitotic Agents|antimitotic agents|mesh-ancestor
111125182|NCT04979585|Mitosis Modulators|mitosis modulators|mesh-ancestor
111125183|NCT04979585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111125184|NCT05103397|Prednisolone|prednisolone|mesh-list
111125185|NCT05103397|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111125186|NCT05103397|Methylprednisolone|methylprednisolone|mesh-list
111125187|NCT05103397|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111125188|NCT05103397|Prednisolone acetate|prednisolone acetate|mesh-list
111125189|NCT05103397|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111125190|NCT05103397|Prednisolone phosphate|prednisolone phosphate|mesh-list
111125191|NCT05103397|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111125192|NCT05103397|Glucocorticoids|glucocorticoids|mesh-ancestor
111125193|NCT05103397|Hormones|hormones|mesh-ancestor
111125194|NCT05103397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111125195|NCT05103397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111125196|NCT05103397|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111125197|NCT05103397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111125198|NCT05103397|Antiemetics|antiemetics|mesh-ancestor
111125199|NCT05103397|Autonomic Agents|autonomic agents|mesh-ancestor
111125200|NCT05103397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111125201|NCT05103397|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111125202|NCT05103397|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111125203|NCT05103397|Protective Agents|protective agents|mesh-ancestor
111125204|NCT05101447|Mycophenolic Acid|mycophenolic acid|mesh-list
111125205|NCT05101447|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111125206|NCT05101447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111125207|NCT05101447|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111125208|NCT05101447|Antitubercular Agents|antitubercular agents|mesh-ancestor
111125209|NCT05101447|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111125210|NCT05101447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111125211|NCT05101447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111125212|NCT05101447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111125213|NCT05101291|Bupivacaine|bupivacaine|mesh-list
111125214|NCT05101291|Anesthetics, Local|anesthetics, local|mesh-ancestor
111125215|NCT05101291|Anesthetics|anesthetics|mesh-ancestor
111125216|NCT05101291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111125217|NCT05101291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111125218|NCT05101291|Sensory System Agents|sensory system agents|mesh-ancestor
111125219|NCT05101291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111125220|NCT04342169|Hydroxychloroquine|hydroxychloroquine|mesh-list
111125221|NCT04342169|Antimalarials|antimalarials|mesh-ancestor
111125222|NCT04342169|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111125223|NCT04342169|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111125224|NCT04342169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111125225|NCT04342169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111125226|NCT04342169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111125227|NCT04342169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111125228|NCT04979273|Epinephrine|epinephrine|mesh-list
111125229|NCT04979273|Racepinephrine|racepinephrine|mesh-list
111125230|NCT04979273|Epinephryl borate|epinephryl borate|mesh-list
111125231|NCT04979273|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111125232|NCT04979273|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111125233|NCT04979273|Adrenergic Agents|adrenergic agents|mesh-ancestor
111125234|NCT04979273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111125235|NCT04979273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111125236|NCT04979273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111125237|NCT04979273|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111125238|NCT04979273|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111125239|NCT04979273|Autonomic Agents|autonomic agents|mesh-ancestor
111125240|NCT04979273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111125241|NCT04979273|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111125242|NCT04979273|Respiratory System Agents|respiratory system agents|mesh-ancestor
111125243|NCT04979273|Mydriatics|mydriatics|mesh-ancestor
111125244|NCT04979273|Sympathomimetics|sympathomimetics|mesh-ancestor
111125245|NCT04979273|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111125246|NCT05103007|Chlorotrianisene|chlorotrianisene|mesh-list
111125247|NCT05103007|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
111125248|NCT05103007|Estrogens|estrogens|mesh-ancestor
111125249|NCT05103007|Hormones|hormones|mesh-ancestor
111125250|NCT05103007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111125251|NCT05103007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111125252|NCT05103007|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111125253|NCT05103007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111125254|NCT05092555|Fibrin fragment D|fibrin fragment d|mesh-list
111125255|NCT05092555|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111125256|NCT05092555|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111125257|NCT05092555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111125258|NCT05092555|Hemostatics|hemostatics|mesh-ancestor
111125259|NCT05092555|Coagulants|coagulants|mesh-ancestor
111125260|NCT05036473|Levodopa|levodopa|mesh-list
111125261|NCT05036473|Carbidopa|carbidopa|mesh-list
111125262|NCT05036473|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
111125263|NCT05036473|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111125264|NCT05036473|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111125265|NCT05036473|Dopamine Agents|dopamine agents|mesh-ancestor
111125266|NCT05036473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111125267|NCT05036473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111125268|NCT05036473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111125269|NCT05036473|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
111125270|NCT05036473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111125271|NCT05036473|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111125272|NCT05036473|Immunologic Factors|immunologic factors|mesh-ancestor
111125273|NCT05036473|Dopamine Agonists|dopamine agonists|mesh-ancestor
111125274|NCT04985851|Durvalumab|durvalumab|mesh-list
111125275|NCT04985851|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111125276|NCT04985851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111125277|NCT04985851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111125278|NCT04985851|Immunologic Factors|immunologic factors|mesh-ancestor
111125279|NCT04985851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111125280|NCT05099575|Oxytocin|oxytocin|mesh-list
111125281|NCT05099575|Oxytocics|oxytocics|mesh-ancestor
111125282|NCT05099575|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111125283|NCT05099575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111125284|NCT03063515|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
111125285|NCT03063515|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111125286|NCT03063515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111125287|NCT03063515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111125288|NCT03063515|Cholinergic Agents|cholinergic agents|mesh-ancestor
111125289|NCT03063515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111125290|NCT03063515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111125292|NCT04973579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111125293|NCT04973579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111125294|NCT04834063|Selenium|selenium|mesh-list
111125295|NCT04834063|Antioxidants|antioxidants|mesh-ancestor
111125296|NCT04834063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111125297|NCT04834063|Protective Agents|protective agents|mesh-ancestor
111125298|NCT04834063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111125299|NCT04834063|Trace Elements|trace elements|mesh-ancestor
111125300|NCT04834063|Micronutrients|micronutrients|mesh-ancestor
111125301|NCT04794205|Caryophyllene|caryophyllene|mesh-list
111125302|NCT04794205|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111125303|NCT04794205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111125304|NCT04794205|Analgesics|analgesics|mesh-ancestor
111125305|NCT04794205|Sensory System Agents|sensory system agents|mesh-ancestor
111125306|NCT04794205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111125307|NCT04794205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111125308|NCT04794205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111125309|NCT04794205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111125310|NCT04973033|Tofacitinib|tofacitinib|mesh-list
111125311|NCT04973033|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
111125312|NCT04973033|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111125313|NCT04973033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111125314|NCT04973033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111125315|NCT03061565|Epoetin Alfa|epoetin alfa|mesh-list
111125316|NCT03061565|Hematinics|hematinics|mesh-ancestor
111125317|NCT02660281|Cyclophosphamide|cyclophosphamide|mesh-list
111125319|NCT02660281|Busulfan|busulfan|mesh-list
111125320|NCT02660281|Thiotepa|thiotepa|mesh-list
111125321|NCT02660281|Fludarabine|fludarabine|mesh-list
111125322|NCT02660281|Mesna|mesna|mesh-list
111125323|NCT02660281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111125324|NCT02660281|Immunologic Factors|immunologic factors|mesh-ancestor
111125325|NCT02660281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111125326|NCT02660281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111125327|NCT02660281|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111125328|NCT02660281|Alkylating Agents|alkylating agents|mesh-ancestor
111125329|NCT02660281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111125330|NCT02660281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111125331|NCT02660281|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111125332|NCT02660281|Protective Agents|protective agents|mesh-ancestor
111125333|NCT02438995|Cetuximab|cetuximab|mesh-list
111125334|NCT02438995|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111125335|NCT02438995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111125336|NCT05107921|Bromfenac|bromfenac|mesh-list
111125337|NCT05107921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111125338|NCT05107921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111125339|NCT05107921|Analgesics|analgesics|mesh-ancestor
111125340|NCT05107921|Sensory System Agents|sensory system agents|mesh-ancestor
111125341|NCT05107921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111125342|NCT05107921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111125343|NCT05107921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111125344|NCT05107921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111125345|NCT01669811|Esomeprazole|esomeprazole|mesh-list
111125346|NCT01669811|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111125347|NCT01669811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111125348|NCT01669811|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111125349|NCT01669811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111125350|NCT01669811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111125351|NCT04978181|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
111125352|NCT04978181|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110836112|NCT03130426|Insulin|insulin|mesh-list
111125353|NCT04978181|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110065559|NCT01533506|Stiripentol|stiripentol|mesh-list
111125354|NCT04978181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111125356|NCT04437017|Fluprednisolone|fluprednisolone|mesh-list
111125357|NCT04437017|Olanzapine|olanzapine|mesh-list
111125358|NCT04437017|Serotonin|serotonin|mesh-list
111125359|NCT04437017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111125360|NCT04437017|Antiemetics|antiemetics|mesh-ancestor
111125361|NCT04437017|Autonomic Agents|autonomic agents|mesh-ancestor
111125362|NCT04437017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111125363|NCT04437017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111125364|NCT04437017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111125365|NCT04437017|Glucocorticoids|glucocorticoids|mesh-ancestor
111125366|NCT04437017|Hormones|hormones|mesh-ancestor
111125367|NCT04437017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111125368|NCT04437017|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111125369|NCT04437017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111125370|NCT04437017|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111125371|NCT04437017|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111125372|NCT04437017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111125373|NCT04437017|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111125374|NCT04437017|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110065700|NCT01534442|Atropine|atropine|mesh-list
111125375|NCT04437017|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111125376|NCT04437017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111125377|NCT04437017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111125378|NCT04437017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111125379|NCT04437017|Serotonin Agents|serotonin agents|mesh-ancestor
111125380|NCT04437017|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111125381|NCT03061253|Nicotine|nicotine|mesh-list
111125382|NCT03061253|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111125383|NCT03061253|Autonomic Agents|autonomic agents|mesh-ancestor
111125384|NCT03061253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111125385|NCT03061253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111125386|NCT03061253|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111125387|NCT03061253|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111125388|NCT03061253|Cholinergic Agents|cholinergic agents|mesh-ancestor
110842453|NCT03905759|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111125389|NCT03061253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111125390|NCT03061253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111125391|NCT05107063|Pravastatin|pravastatin|mesh-list
110065850|NCT01535183|Irinotecan|irinotecan|mesh-list
111125392|NCT05107063|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111125393|NCT05107063|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111125394|NCT05107063|Antimetabolites|antimetabolites|mesh-ancestor
111125395|NCT05107063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111125396|NCT05107063|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111125397|NCT05107063|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111125398|NCT05107063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111125399|NCT04977401|Glycerol|glycerol|mesh-list
111125400|NCT04977401|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
111125401|NCT04977401|Protective Agents|protective agents|mesh-ancestor
111125402|NCT04977401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111125403|NCT05106751|Hyaluronic Acid|hyaluronic acid|mesh-list
110836116|NCT03130426|Lixisenatide|lixisenatide|mesh-list
111125404|NCT05106751|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111125406|NCT05106751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111125407|NCT05106751|Viscosupplements|viscosupplements|mesh-ancestor
111125408|NCT05106751|Protective Agents|protective agents|mesh-ancestor
111125409|NCT04977557|Thiamine|thiamine|mesh-list
111125410|NCT04977557|Vitamin B Complex|vitamin b complex|mesh-ancestor
111125411|NCT04977557|Vitamins|vitamins|mesh-ancestor
111125412|NCT04977557|Micronutrients|micronutrients|mesh-ancestor
111125413|NCT04977557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111125414|NCT04316143|Zamicastat|zamicastat|mesh-list
111125415|NCT04316143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111125416|NCT04316143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111125417|NCT05104801|Tislelizumab|tislelizumab|mesh-list
111125418|NCT05104801|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111125419|NCT05104801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111125420|NCT04530877|Infliximab|infliximab|mesh-list
111125421|NCT04530877|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111125422|NCT04530877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111125423|NCT04530877|Dermatologic Agents|dermatologic agents|mesh-ancestor
111125424|NCT04530877|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111125425|NCT04530877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111125426|NCT04971239|Methotrexate|methotrexate|mesh-list
111125427|NCT04971239|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110066042|NCT01536249|Antioxidants|antioxidants|mesh-ancestor
111125428|NCT04971239|Abortifacient Agents|abortifacient agents|mesh-ancestor
111125429|NCT04971239|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111125430|NCT04971239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111125431|NCT04971239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111125432|NCT04971239|Antimetabolites|antimetabolites|mesh-ancestor
111125433|NCT04971239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111125434|NCT04971239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111125435|NCT04971239|Dermatologic Agents|dermatologic agents|mesh-ancestor
111125436|NCT04971239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111125437|NCT04971239|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111125438|NCT04971239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111125439|NCT04971239|Immunologic Factors|immunologic factors|mesh-ancestor
111125440|NCT04971239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111125441|NCT04971239|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111125442|NCT04903093|Famotidine|famotidine|mesh-list
111125443|NCT04903093|Abrocitinib|abrocitinib|mesh-list
111125444|NCT04903093|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111125445|NCT04903093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111125446|NCT04903093|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
111125447|NCT04903093|Histamine Antagonists|histamine antagonists|mesh-ancestor
111125448|NCT04903093|Histamine Agents|histamine agents|mesh-ancestor
111125449|NCT04903093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111125450|NCT04903093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111125451|NCT04903093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111125452|NCT04903093|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111125453|NCT04903093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111125454|NCT04529785|Ethanol|ethanol|mesh-list
111125455|NCT04529785|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111125456|NCT04529785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111125457|NCT04529785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111125458|NCT04529785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111125460|NCT04271293|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111125461|NCT04271293|Antithrombins|antithrombins|mesh-ancestor
111125462|NCT04271293|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110066310|NCT01538108|Paclitaxel|paclitaxel|mesh-list
111125463|NCT04271293|Protease Inhibitors|protease inhibitors|mesh-ancestor
111125464|NCT04271293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111125465|NCT04271293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111125466|NCT04271293|Anticoagulants|anticoagulants|mesh-ancestor
111125467|NCT03059849|Adalimumab|adalimumab|mesh-list
111125468|NCT03059849|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111125469|NCT03059849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111125470|NCT03059849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111125471|NCT04970693|Aflutinib|aflutinib|mesh-list
111125472|NCT04970693|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111125473|NCT04970693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111125474|NCT04970693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111125475|NCT04970069|Analgesics|analgesics|mesh-list
111125476|NCT04970069|Sensory System Agents|sensory system agents|mesh-ancestor
111125477|NCT04970069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111125478|NCT04970069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111125479|NCT04970303|Methylphenidate|methylphenidate|mesh-list
111125480|NCT04970303|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111125481|NCT04970303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111125482|NCT04970303|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111125483|NCT04970303|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111125484|NCT04970303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110066366|NCT01538446|Clopidogrel|clopidogrel|mesh-list
111125485|NCT04970303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111125486|NCT04970303|Dopamine Agents|dopamine agents|mesh-ancestor
111125487|NCT04970303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111125488|NCT04432259|Dexamethasone|dexamethasone|mesh-list
111125489|NCT04432259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111125490|NCT04432259|Antiemetics|antiemetics|mesh-ancestor
111125491|NCT04432259|Autonomic Agents|autonomic agents|mesh-ancestor
111125492|NCT04432259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111125493|NCT04432259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111125494|NCT04432259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111125495|NCT04432259|Glucocorticoids|glucocorticoids|mesh-ancestor
111125496|NCT04432259|Hormones|hormones|mesh-ancestor
110066415|NCT01538563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111125497|NCT04432259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111125498|NCT04432259|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111125499|NCT04432259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111125500|NCT04964219|Ketamine|ketamine|mesh-list
111125501|NCT04964219|Esketamine|esketamine|mesh-list
111125502|NCT04964219|Analgesics|analgesics|mesh-ancestor
111125503|NCT04964219|Sensory System Agents|sensory system agents|mesh-ancestor
111125504|NCT04964219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111125505|NCT04964219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111125506|NCT04964219|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111125507|NCT04964219|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111125508|NCT04964219|Anesthetics, General|anesthetics, general|mesh-ancestor
111125509|NCT04964219|Anesthetics|anesthetics|mesh-ancestor
111125510|NCT04964219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111125511|NCT04964219|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111125512|NCT04964219|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111125513|NCT04964219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111125514|NCT04964219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110066526|NCT01538953|Eusol|eusol|mesh-list
111125515|NCT04964219|Antidepressive Agents|antidepressive agents|mesh-ancestor
111125516|NCT04964219|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111125517|NCT04975373|Hyaluronic Acid|hyaluronic acid|mesh-list
111125518|NCT04975373|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110836161|NCT01307527|Riboflavin|riboflavin|mesh-list
111125519|NCT04975373|Immunologic Factors|immunologic factors|mesh-ancestor
111125520|NCT04975373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111125521|NCT04975373|Viscosupplements|viscosupplements|mesh-ancestor
111125522|NCT04975373|Protective Agents|protective agents|mesh-ancestor
111125523|NCT04974827|Carboplatin|carboplatin|mesh-list
111125524|NCT04974827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111125525|NCT04963595|Vinorelbine|vinorelbine|mesh-list
111125526|NCT04963595|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111125527|NCT04963595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111125528|NCT04963595|Tubulin Modulators|tubulin modulators|mesh-ancestor
111125529|NCT04963595|Antimitotic Agents|antimitotic agents|mesh-ancestor
111125530|NCT04963595|Mitosis Modulators|mitosis modulators|mesh-ancestor
111125531|NCT04963595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111125532|NCT04968509|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
111125533|NCT04968509|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-list
111125534|NCT04968509|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111125535|NCT04968509|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111125536|NCT04968509|Antimetabolites|antimetabolites|mesh-ancestor
111125537|NCT04968509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111125538|NCT04968509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111125539|NCT04968509|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111125540|NCT04968509|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110066608|NCT01539408|Misoprostol|misoprostol|mesh-list
111125541|NCT04968509|Protease Inhibitors|protease inhibitors|mesh-ancestor
111125543|NCT04962425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111125544|NCT04962425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111125545|NCT03060707|Bromides|bromides|mesh-list
111125546|NCT03060707|Rocuronium|rocuronium|mesh-list
111125547|NCT03060707|Anticonvulsants|anticonvulsants|mesh-ancestor
111125548|NCT03060707|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
111125549|NCT03060707|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
111125550|NCT03060707|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111125551|NCT03060707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111125552|NCT03060707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111125553|NCT04967417|Paclitaxel|paclitaxel|mesh-list
111125554|NCT04967417|Carboplatin|carboplatin|mesh-list
111125555|NCT04967417|Pembrolizumab|pembrolizumab|mesh-list
111125556|NCT04967417|Pemetrexed|pemetrexed|mesh-list
111125557|NCT04967417|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111125558|NCT04967417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111125559|NCT04967417|Tubulin Modulators|tubulin modulators|mesh-ancestor
111125560|NCT04967417|Antimitotic Agents|antimitotic agents|mesh-ancestor
111125561|NCT04967417|Mitosis Modulators|mitosis modulators|mesh-ancestor
111125562|NCT04967417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111125563|NCT04967417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111125564|NCT04967417|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111125565|NCT04967417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111125566|NCT04967417|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111125567|NCT04967417|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111125568|NCT03060005|Dextrans|dextrans|mesh-list
111125569|NCT03060005|Anticoagulants|anticoagulants|mesh-ancestor
111125570|NCT03060005|Plasma Substitutes|plasma substitutes|mesh-ancestor
111125571|NCT03060005|Blood Substitutes|blood substitutes|mesh-ancestor
111125572|NCT04210141|Antivenins|antivenins|mesh-list
111125573|NCT04210141|Immunologic Factors|immunologic factors|mesh-ancestor
111125574|NCT04210141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111125575|NCT04418531|Antibodies|antibodies|mesh-list
111125576|NCT04418531|Immunoglobulins|immunoglobulins|mesh-list
110066790|NCT01540500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111125577|NCT04418531|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111125578|NCT04418531|Immunologic Factors|immunologic factors|mesh-ancestor
111125579|NCT04418531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111125580|NCT02615119|Isoproterenol|isoproterenol|mesh-list
111125581|NCT02615119|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111125582|NCT02615119|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111125583|NCT02615119|Adrenergic Agents|adrenergic agents|mesh-ancestor
111125584|NCT02615119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111125585|NCT02615119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111125586|NCT02615119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111125587|NCT02615119|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110066854|NCT01540812|Daunorubicin|daunorubicin|mesh-list
111125588|NCT02615119|Autonomic Agents|autonomic agents|mesh-ancestor
111125589|NCT02615119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111125590|NCT02615119|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111125591|NCT02615119|Respiratory System Agents|respiratory system agents|mesh-ancestor
111125592|NCT02615119|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111125593|NCT02615119|Sympathomimetics|sympathomimetics|mesh-ancestor
111125594|NCT02615119|Protective Agents|protective agents|mesh-ancestor
111125595|NCT02555293|Rifaximin|rifaximin|mesh-list
111125596|NCT02555293|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111125597|NCT02555293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111125598|NCT02555293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111125599|NCT05104255|Anesthetics|anesthetics|mesh-list
111125600|NCT05104255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111125601|NCT05104255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111125602|NCT03293017|Diazepam|diazepam|mesh-list
111125603|NCT03293017|Baclofen|baclofen|mesh-list
111125604|NCT03293017|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
111125605|NCT03293017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111125606|NCT03293017|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111125607|NCT03293017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111125608|NCT03293017|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
111125609|NCT03293017|GABA Agonists|gaba agonists|mesh-ancestor
111125610|NCT03293017|GABA Agents|gaba agents|mesh-ancestor
111125611|NCT03293017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111125612|NCT03293017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111125613|NCT03293017|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111125614|NCT03293017|Anticonvulsants|anticonvulsants|mesh-ancestor
111125615|NCT03293017|Antiemetics|antiemetics|mesh-ancestor
111125616|NCT03293017|Autonomic Agents|autonomic agents|mesh-ancestor
111125617|NCT03293017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111125618|NCT03293017|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111125619|NCT03293017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111125621|NCT03293017|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111125622|NCT03293017|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111125623|NCT03293017|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111125624|NCT03293017|Anesthetics, General|anesthetics, general|mesh-ancestor
111125625|NCT03293017|Anesthetics|anesthetics|mesh-ancestor
111125626|NCT03293017|GABA Modulators|gaba modulators|mesh-ancestor
111125628|NCT03198559|Disulfiram|disulfiram|mesh-list
111125629|NCT03198559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111125630|NCT03198559|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111125631|NCT03198559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111125632|NCT03198559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111125633|NCT03198559|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110067035|NCT01541631|Praziquantel|praziquantel|mesh-list
111125634|NCT03198559|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
111125635|NCT02625623|Paclitaxel|paclitaxel|mesh-list
111125636|NCT02625623|Irinotecan|irinotecan|mesh-list
111125637|NCT02625623|Avelumab|avelumab|mesh-list
111125638|NCT02625623|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111125639|NCT02625623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111125640|NCT02625623|Tubulin Modulators|tubulin modulators|mesh-ancestor
111125641|NCT02625623|Antimitotic Agents|antimitotic agents|mesh-ancestor
111125642|NCT02625623|Mitosis Modulators|mitosis modulators|mesh-ancestor
111125643|NCT02625623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111125644|NCT02625623|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111125645|NCT02625623|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111125646|NCT02625623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111125647|NCT02625623|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111125648|NCT02749513|Itraconazole|itraconazole|mesh-list
111125649|NCT02749513|Antifungal Agents|antifungal agents|mesh-ancestor
111125650|NCT02749513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110067100|NCT01542060|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111125651|NCT02749513|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111125652|NCT02749513|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111125653|NCT02749513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111125654|NCT02749513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111125655|NCT02749513|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111125656|NCT02749513|Hormone Antagonists|hormone antagonists|mesh-ancestor
111125657|NCT02749513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111125658|NCT02749513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111125659|NCT02749513|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111125660|NCT05110339|Dexmedetomidine|dexmedetomidine|mesh-list
111125661|NCT05110339|Ropivacaine|ropivacaine|mesh-list
111125662|NCT05110339|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111125663|NCT05110339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111125664|NCT05110339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111125665|NCT05110339|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111125666|NCT05110339|Analgesics|analgesics|mesh-ancestor
111125667|NCT05110339|Sensory System Agents|sensory system agents|mesh-ancestor
111125668|NCT05110339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111125669|NCT05110339|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111125670|NCT05110339|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111125671|NCT05110339|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111125672|NCT05110339|Adrenergic Agents|adrenergic agents|mesh-ancestor
111125673|NCT05110339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111125674|NCT05110339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111125675|NCT05110339|Anesthetics, Local|anesthetics, local|mesh-ancestor
111125676|NCT05110339|Anesthetics|anesthetics|mesh-ancestor
111125677|NCT04965545|Copper|copper|mesh-list
111125678|NCT04965545|Trace Elements|trace elements|mesh-ancestor
111125679|NCT04965545|Micronutrients|micronutrients|mesh-ancestor
111125680|NCT04965545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111125681|NCT04425629|Casirivimab and imdevimab drug combination|casirivimab and imdevimab drug combination|mesh-list
111125682|NCT04425629|Antiviral Agents|antiviral agents|mesh-ancestor
111125683|NCT04425629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111125684|NCT05105347|Prednisone|prednisone|mesh-list
111125685|NCT05105347|Adalimumab|adalimumab|mesh-list
111125686|NCT05105347|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110836225|NCT05438992|Bupivacaine|bupivacaine|mesh-list
111125687|NCT05105347|Glucocorticoids|glucocorticoids|mesh-ancestor
111125688|NCT05105347|Hormones|hormones|mesh-ancestor
110067374|NCT01543945|BB 1101|bb 1101|mesh-list
111125689|NCT05105347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111125690|NCT05105347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111125691|NCT05105347|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111125692|NCT05105347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111125693|NCT05105347|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111125694|NCT05105347|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111125695|NCT05110651|Hydroxychloroquine|hydroxychloroquine|mesh-list
110067427|NCT01544192|Vitamins|vitamins|mesh-ancestor
111125696|NCT05110651|Antimalarials|antimalarials|mesh-ancestor
111125697|NCT05110651|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111125698|NCT05110651|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111125699|NCT05110651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111125700|NCT05110651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111125701|NCT05110651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111125702|NCT05110651|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111125703|NCT03060785|Tenofovir|tenofovir|mesh-list
111125704|NCT03060785|Emtricitabine|emtricitabine|mesh-list
111125705|NCT03060785|Antiviral Agents|antiviral agents|mesh-ancestor
111125706|NCT03060785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111125707|NCT03060785|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111125708|NCT03060785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111125709|NCT03060785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111125710|NCT03060785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111125711|NCT03060785|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111125712|NCT03060785|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111125713|NCT04952207|Sofosbuvir|sofosbuvir|mesh-list
111125714|NCT04952207|Antiviral Agents|antiviral agents|mesh-list
111125715|NCT04952207|Grazoprevir|grazoprevir|mesh-list
111125716|NCT04952207|Ledipasvir|ledipasvir|mesh-list
111125717|NCT04952207|Velpatasvir|velpatasvir|mesh-list
111125718|NCT04952207|Asunaprevir|asunaprevir|mesh-list
111125719|NCT04952207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111125720|NCT04952207|Protease Inhibitors|protease inhibitors|mesh-ancestor
111125721|NCT04952207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111125722|NCT04952207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111125723|NCT04632589|Losartan|losartan|mesh-list
111125724|NCT04632589|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111125725|NCT04632589|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111125726|NCT04632589|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111125727|NCT04632589|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111125728|NCT04632589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111125729|NCT05108545|Amphotericin B|amphotericin b|mesh-list
111125730|NCT05108545|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
111125731|NCT05108545|Amebicides|amebicides|mesh-ancestor
111125732|NCT05108545|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111125733|NCT05108545|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111125734|NCT05108545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111125735|NCT05108545|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111125736|NCT05108545|Antifungal Agents|antifungal agents|mesh-ancestor
111125737|NCT05102695|Fibrin fragment D|fibrin fragment d|mesh-list
111125738|NCT05102695|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111125739|NCT05102695|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111125740|NCT05102695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111125741|NCT05102695|Hemostatics|hemostatics|mesh-ancestor
111125742|NCT05102695|Coagulants|coagulants|mesh-ancestor
111125743|NCT04952129|Selenium|selenium|mesh-list
111125744|NCT04952129|Selenomethylselenocysteine|selenomethylselenocysteine|mesh-list
111125745|NCT04952129|Antioxidants|antioxidants|mesh-ancestor
111125746|NCT04952129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111125747|NCT04952129|Protective Agents|protective agents|mesh-ancestor
111125748|NCT04952129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111125749|NCT04952129|Trace Elements|trace elements|mesh-ancestor
111125750|NCT04952129|Micronutrients|micronutrients|mesh-ancestor
111125751|NCT04952129|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
111125752|NCT04952129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111125753|NCT05007769|Atezolizumab|atezolizumab|mesh-list
111125754|NCT05007769|Ramucirumab|ramucirumab|mesh-list
111125755|NCT05007769|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111125756|NCT05007769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111125757|NCT05007769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111125758|NCT05007769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111125759|NCT04952051|Folic Acid|folic acid|mesh-list
111125760|NCT04952051|Vitamin B Complex|vitamin b complex|mesh-list
111125761|NCT04952051|Amlodipine|amlodipine|mesh-list
111125762|NCT04952051|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
111125763|NCT04952051|Enalapril|enalapril|mesh-list
111125764|NCT04952051|Enalaprilat|enalaprilat|mesh-list
111125765|NCT04952051|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111125766|NCT04952051|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111125767|NCT04952051|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110067834|NCT01547143|Hormones|hormones|mesh-ancestor
111125768|NCT04952051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111125769|NCT04952051|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111125770|NCT04952051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111125771|NCT04952051|Vasodilator Agents|vasodilator agents|mesh-ancestor
111125772|NCT04952051|Hematinics|hematinics|mesh-ancestor
111125773|NCT04952051|Vitamins|vitamins|mesh-ancestor
111125774|NCT04952051|Micronutrients|micronutrients|mesh-ancestor
111125775|NCT04952051|Diuretics|diuretics|mesh-ancestor
111125776|NCT04952051|Natriuretic Agents|natriuretic agents|mesh-ancestor
111125777|NCT04952051|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
111125778|NCT04952051|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
111125779|NCT04952051|Protease Inhibitors|protease inhibitors|mesh-ancestor
111125780|NCT04952051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111125781|NCT04960943|Trastuzumab|trastuzumab|mesh-list
111125782|NCT04960943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111125783|NCT04960943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111125784|NCT04431713|Exenatide|exenatide|mesh-list
111125785|NCT04431713|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111125786|NCT04431713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111125787|NCT04431713|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111125788|NCT04431713|Incretins|incretins|mesh-ancestor
111125789|NCT04431713|Hormones|hormones|mesh-ancestor
111125790|NCT04431713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111125791|NCT05104333|Vaccines|vaccines|mesh-list
111125792|NCT05104333|Immunologic Factors|immunologic factors|mesh-ancestor
111125793|NCT05104333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111125794|NCT03059615|Doxorubicin|doxorubicin|mesh-list
111125795|NCT03059615|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111125796|NCT03059615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111125797|NCT03059615|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111125798|NCT03059615|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111125799|NCT03059615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111125800|NCT03059615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111125801|NCT04951505|Cefepime|cefepime|mesh-list
111125802|NCT04951505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111125803|NCT04951505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111125804|NCT04951349|Petrolatum|petrolatum|mesh-list
111125805|NCT04951349|Emollients|emollients|mesh-ancestor
111125806|NCT04951349|Dermatologic Agents|dermatologic agents|mesh-ancestor
111125807|NCT02658019|Pembrolizumab|pembrolizumab|mesh-list
111125808|NCT02658019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111125809|NCT02658019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111125810|NCT02658019|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110870372|NCT02394418|Sensory System Agents|sensory system agents|mesh-ancestor
111125811|NCT02658019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111125813|NCT03059303|Odalasvir|odalasvir|mesh-list
111125814|NCT03059303|Omeprazole|omeprazole|mesh-list
111125815|NCT03059303|Lansoprazole|lansoprazole|mesh-list
111125816|NCT03059303|Dexlansoprazole|dexlansoprazole|mesh-list
111125817|NCT03059303|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111125818|NCT03059303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111125819|NCT03059303|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111125820|NCT03059303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111125821|NCT03059303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111125822|NCT03059303|Antiviral Agents|antiviral agents|mesh-ancestor
111125823|NCT03059303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111125824|NCT03059303|Protease Inhibitors|protease inhibitors|mesh-ancestor
111125825|NCT03059537|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
111125826|NCT03059537|Cathartics|cathartics|mesh-ancestor
111125827|NCT03059537|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111125828|NCT04428775|Cromolyn Sodium|cromolyn sodium|mesh-list
111125829|NCT04428775|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
111125830|NCT04428775|Immunologic Factors|immunologic factors|mesh-ancestor
111125831|NCT04428775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111125832|NCT04428775|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111125833|NCT04428775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111125834|NCT04428775|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111125835|NCT04428775|Respiratory System Agents|respiratory system agents|mesh-ancestor
111125836|NCT04950569|Simendan|simendan|mesh-list
111125837|NCT04950569|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110068204|NCT01549418|Aspirin|aspirin|mesh-list
111125838|NCT04950569|Vasodilator Agents|vasodilator agents|mesh-ancestor
111125839|NCT04950569|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
111125840|NCT04950569|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111125841|NCT04950569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111125842|NCT04950569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111125843|NCT04950569|Protective Agents|protective agents|mesh-ancestor
111125844|NCT04950569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111125845|NCT04944641|Anticonvulsants|anticonvulsants|mesh-list
111125846|NCT04436419|Thioctic Acid|thioctic acid|mesh-list
111125847|NCT04436419|Antioxidants|antioxidants|mesh-ancestor
111125848|NCT04436419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111125849|NCT04436419|Protective Agents|protective agents|mesh-ancestor
111125850|NCT04436419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111125851|NCT04436419|Vitamin B Complex|vitamin b complex|mesh-ancestor
111125852|NCT04436419|Vitamins|vitamins|mesh-ancestor
111125853|NCT04436419|Micronutrients|micronutrients|mesh-ancestor
111125854|NCT04944173|Durvalumab|durvalumab|mesh-list
111125855|NCT04944173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111125856|NCT04944173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111125857|NCT04950647|Nitrofurazone|nitrofurazone|mesh-list
111125858|NCT04950647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111125859|NCT01675765|Cyclophosphamide|cyclophosphamide|mesh-list
111125860|NCT01675765|Cisplatin|cisplatin|mesh-list
111125861|NCT01675765|Pemetrexed|pemetrexed|mesh-list
111125862|NCT01675765|Immunologic Factors|immunologic factors|mesh-list
111125863|NCT01675765|Immunomodulating Agents|immunomodulating agents|mesh-list
111125864|NCT01675765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111125865|NCT01675765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111125866|NCT01675765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111125867|NCT01675765|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111125868|NCT01675765|Alkylating Agents|alkylating agents|mesh-ancestor
111125869|NCT01675765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111125870|NCT01675765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111125871|NCT01675765|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111125872|NCT01675765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110836263|NCT03339297|Defibrotide|defibrotide|mesh-list
111125873|NCT01675765|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111125874|NCT01675765|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111125875|NCT04943237|Sulfasalazine|sulfasalazine|mesh-list
111125876|NCT04943237|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
111125877|NCT04943237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111125878|NCT04943237|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111125879|NCT04943237|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111125880|NCT04943237|Analgesics|analgesics|mesh-ancestor
111125881|NCT04943237|Sensory System Agents|sensory system agents|mesh-ancestor
111125882|NCT04943237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111125883|NCT04943237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111125884|NCT04943237|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111125885|NCT04943237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111125886|NCT04285255|Lidocaine|lidocaine|mesh-list
111125887|NCT04285255|Fentanyl|fentanyl|mesh-list
111125888|NCT04285255|Dexmedetomidine|dexmedetomidine|mesh-list
111125889|NCT04285255|Ketamine|ketamine|mesh-list
111125890|NCT04285255|Anesthetics, Local|anesthetics, local|mesh-ancestor
111125891|NCT04285255|Anesthetics|anesthetics|mesh-ancestor
111125892|NCT04285255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111125893|NCT04285255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111125894|NCT04285255|Sensory System Agents|sensory system agents|mesh-ancestor
111125895|NCT04285255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111125896|NCT04285255|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111125897|NCT04285255|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111125898|NCT04285255|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111125899|NCT04285255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111125900|NCT04285255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111125901|NCT04285255|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111125902|NCT04285255|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111125903|NCT04285255|Analgesics|analgesics|mesh-ancestor
111125904|NCT04285255|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111125905|NCT04285255|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111125906|NCT04285255|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111125907|NCT04285255|Adrenergic Agents|adrenergic agents|mesh-ancestor
111125908|NCT04285255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111125909|NCT04285255|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111125910|NCT04285255|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111125911|NCT04285255|Anesthetics, General|anesthetics, general|mesh-ancestor
110068599|NCT01551810|Vaccines|vaccines|mesh-list
111125912|NCT04285255|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111125913|NCT04285255|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111125914|NCT04285255|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111125915|NCT04285255|Narcotics|narcotics|mesh-ancestor
111125916|NCT04285255|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111125917|NCT04121299|Amlodipine|amlodipine|mesh-list
111125918|NCT04121299|Carvedilol|carvedilol|mesh-list
111125919|NCT04121299|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111125920|NCT04121299|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111125921|NCT04121299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110842977|NCT01152203|Bevacizumab|bevacizumab|mesh-list
111125922|NCT04121299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111125923|NCT04121299|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111125924|NCT04121299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111125925|NCT04121299|Vasodilator Agents|vasodilator agents|mesh-ancestor
111125926|NCT04121299|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111125927|NCT04121299|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111125928|NCT04121299|Adrenergic Agents|adrenergic agents|mesh-ancestor
111125929|NCT04121299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111125930|NCT04121299|Antioxidants|antioxidants|mesh-ancestor
111125931|NCT04121299|Protective Agents|protective agents|mesh-ancestor
111125932|NCT04121299|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111125933|NCT04121299|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111125935|NCT04942769|Antioxidants|antioxidants|mesh-ancestor
111125936|NCT04942769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111125937|NCT04942769|Protective Agents|protective agents|mesh-ancestor
111125938|NCT04942769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111125939|NCT04942769|Trace Elements|trace elements|mesh-ancestor
111125940|NCT04942769|Micronutrients|micronutrients|mesh-ancestor
111125941|NCT04942301|Endostar protein|endostar protein|mesh-list
111125942|NCT04942301|Endostatins|endostatins|mesh-list
111125943|NCT04942301|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111125944|NCT04942301|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111125945|NCT04942301|Growth Substances|growth substances|mesh-ancestor
111125946|NCT04942301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111125947|NCT04942301|Growth Inhibitors|growth inhibitors|mesh-ancestor
111125948|NCT04942301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111125949|NCT03057899|Fenugreek seed meal|fenugreek seed meal|mesh-list
111125950|NCT03057899|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111125951|NCT03057899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111125952|NCT04434001|Thrombin|thrombin|mesh-list
111125953|NCT04434001|Hemostatics|hemostatics|mesh-ancestor
111125954|NCT04434001|Coagulants|coagulants|mesh-ancestor
111125955|NCT03540901|Acetazolamide|acetazolamide|mesh-list
111125956|NCT03540901|Anticonvulsants|anticonvulsants|mesh-ancestor
111125957|NCT03540901|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
111125958|NCT03540901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111125959|NCT03540901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111125960|NCT03540901|Diuretics|diuretics|mesh-ancestor
111125961|NCT03540901|Natriuretic Agents|natriuretic agents|mesh-ancestor
111125962|NCT03540901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111125963|NCT03517735|Remifentanil|remifentanil|mesh-list
111125964|NCT03517735|Propofol|propofol|mesh-list
111125965|NCT03517735|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111125966|NCT03517735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111125967|NCT03517735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111125968|NCT03517735|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111125969|NCT03517735|Anesthetics, General|anesthetics, general|mesh-ancestor
111125970|NCT03517735|Anesthetics|anesthetics|mesh-ancestor
111125971|NCT03517735|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111125972|NCT03517735|Narcotics|narcotics|mesh-ancestor
111125973|NCT03517735|Analgesics|analgesics|mesh-ancestor
111125974|NCT03517735|Sensory System Agents|sensory system agents|mesh-ancestor
111125975|NCT03517735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111125976|NCT04941131|Chlorhexidine|chlorhexidine|mesh-list
110068721|NCT01552850|Oxycodone|oxycodone|mesh-list
111125977|NCT04941131|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
111125978|NCT04941131|Povidone-Iodine|povidone-iodine|mesh-list
111125979|NCT04941131|Povidone|povidone|mesh-list
111125980|NCT04941131|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111125981|NCT04941131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111125982|NCT04941131|Disinfectants|disinfectants|mesh-ancestor
111125983|NCT04941131|Dermatologic Agents|dermatologic agents|mesh-ancestor
111125984|NCT04941131|Plasma Substitutes|plasma substitutes|mesh-ancestor
111125985|NCT04941131|Blood Substitutes|blood substitutes|mesh-ancestor
111125986|NCT03400501|Insulin|insulin|mesh-list
111125987|NCT03400501|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111125988|NCT03400501|Insulin Glargine|insulin glargine|mesh-list
111125989|NCT03400501|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111125990|NCT03400501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111125992|NCT04426591|Vitamin B Complex|vitamin b complex|mesh-ancestor
111125993|NCT04426591|Vitamins|vitamins|mesh-ancestor
111125994|NCT04426591|Micronutrients|micronutrients|mesh-ancestor
111125995|NCT04426591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111125996|NCT04940273|Remifentanil|remifentanil|mesh-list
111125997|NCT04940273|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111125998|NCT04940273|Narcotics|narcotics|mesh-ancestor
110843052|NCT01257893|Antipyretics|antipyretics|mesh-ancestor
111125999|NCT04940273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111126000|NCT04940273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111126001|NCT04940273|Analgesics|analgesics|mesh-ancestor
111126002|NCT04940273|Sensory System Agents|sensory system agents|mesh-ancestor
111126003|NCT04940273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111126005|NCT04948385|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111126006|NCT04948385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111126007|NCT04948385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111126008|NCT04948385|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110836315|NCT01310647|Androgens|androgens|mesh-ancestor
111126009|NCT04948385|Anesthetics, General|anesthetics, general|mesh-ancestor
111126010|NCT04948385|Anesthetics|anesthetics|mesh-ancestor
111126011|NCT03057821|Hydrogen Peroxide|hydrogen peroxide|mesh-list
111126012|NCT03057821|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111126013|NCT03057821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111126014|NCT04948151|Sildenafil Citrate|sildenafil citrate|mesh-list
111126015|NCT04948151|Vasodilator Agents|vasodilator agents|mesh-ancestor
111126016|NCT04948151|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111126017|NCT04948151|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111126018|NCT04948151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111126019|NCT04948151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111126020|NCT04948151|Urological Agents|urological agents|mesh-ancestor
111126021|NCT02633293|Treprostinil|treprostinil|mesh-list
111126022|NCT02633293|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111126023|NCT04938713|Ketamine|ketamine|mesh-list
111126024|NCT04938713|Esketamine|esketamine|mesh-list
111126025|NCT04938713|Analgesics|analgesics|mesh-ancestor
111126026|NCT04938713|Sensory System Agents|sensory system agents|mesh-ancestor
111126027|NCT04938713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111126028|NCT04938713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111126029|NCT04938713|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111126030|NCT04938713|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110068742|NCT01552980|Oxaliplatin|oxaliplatin|mesh-list
111126031|NCT04938713|Anesthetics, General|anesthetics, general|mesh-ancestor
111126032|NCT04938713|Anesthetics|anesthetics|mesh-ancestor
111126033|NCT04938713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111126034|NCT04938713|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111126035|NCT04938713|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111126036|NCT04938713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111126037|NCT04938713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111126038|NCT04938713|Antidepressive Agents|antidepressive agents|mesh-ancestor
111126039|NCT04938713|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111126040|NCT04938011|Progesterone|progesterone|mesh-list
111126041|NCT04938011|Progestins|progestins|mesh-ancestor
111126042|NCT04938011|Hormones|hormones|mesh-ancestor
111126043|NCT04938011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111126044|NCT04938011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111126045|NCT03057509|Octreotide|octreotide|mesh-list
111126046|NCT03057509|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111126047|NCT03057509|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111126048|NCT03057509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111126049|NCT03572413|Bromides|bromides|mesh-list
111126050|NCT03572413|Rocuronium|rocuronium|mesh-list
111126051|NCT03572413|Anticonvulsants|anticonvulsants|mesh-ancestor
111126052|NCT03572413|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
111126053|NCT03572413|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
111126054|NCT03572413|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111126055|NCT03572413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111126056|NCT03572413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111126057|NCT04956419|Fluconazole|fluconazole|mesh-list
111126058|NCT04956419|Antifungal Agents|antifungal agents|mesh-ancestor
111126059|NCT04956419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111126060|NCT04956419|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111126061|NCT04956419|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111126062|NCT04956419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111126063|NCT04956419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111126064|NCT04956419|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111126065|NCT04956419|Hormone Antagonists|hormone antagonists|mesh-ancestor
111126066|NCT04956419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111126067|NCT04956419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111126068|NCT04956419|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111126069|NCT04956419|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111126070|NCT04946669|Abatacept|abatacept|mesh-list
111126071|NCT04946669|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111126072|NCT04946669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110068816|NCT01553903|Tamoxifen|tamoxifen|mesh-list
111126073|NCT04946669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111126074|NCT04946669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111126075|NCT04946669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111126076|NCT04946669|Immunologic Factors|immunologic factors|mesh-ancestor
111126077|NCT04946669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111126078|NCT04946669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111126079|NCT03219775|Nivolumab|nivolumab|mesh-list
111126080|NCT03219775|Ipilimumab|ipilimumab|mesh-list
111126081|NCT03219775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111126082|NCT03219775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111126083|NCT03219775|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111126084|NCT03219775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111126085|NCT03100045|Artesunate|artesunate|mesh-list
111126086|NCT03100045|Artemisinins|artemisinins|mesh-list
111126087|NCT03100045|Artemisinin|artemisinin|mesh-list
111126088|NCT03100045|Antimalarials|antimalarials|mesh-ancestor
111126089|NCT03100045|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111126090|NCT03100045|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111126091|NCT03100045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111126092|NCT03100045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111126093|NCT03100045|Antiviral Agents|antiviral agents|mesh-ancestor
111126094|NCT03100045|Schistosomicides|schistosomicides|mesh-ancestor
111126095|NCT03100045|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
111126096|NCT03100045|Anthelmintics|anthelmintics|mesh-ancestor
111126097|NCT04946123|Selenium|selenium|mesh-list
111126098|NCT04946123|Antioxidants|antioxidants|mesh-ancestor
111126099|NCT04946123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111126100|NCT04946123|Protective Agents|protective agents|mesh-ancestor
111126101|NCT04946123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111126102|NCT04946123|Trace Elements|trace elements|mesh-ancestor
111126103|NCT04946123|Micronutrients|micronutrients|mesh-ancestor
111126104|NCT04945577|Vitamin D|vitamin d|mesh-list
111126105|NCT04945577|Vitamins|vitamins|mesh-ancestor
110069001|NCT01555190|Inositol|inositol|mesh-list
111126106|NCT04945577|Micronutrients|micronutrients|mesh-ancestor
111126107|NCT04945577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111126108|NCT04945577|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111126109|NCT02623829|Botulinum Toxins|botulinum toxins|mesh-list
111126110|NCT02623829|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111126111|NCT02623829|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111126112|NCT02623829|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111126113|NCT02623829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110069059|NCT01555788|Pancrelipase|pancrelipase|mesh-list
111126114|NCT02623829|Cholinergic Agents|cholinergic agents|mesh-ancestor
111126115|NCT02623829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111126116|NCT02623829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111126117|NCT02623829|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111126118|NCT02623829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111126120|NCT02655679|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111126121|NCT02655679|Anesthetics, General|anesthetics, general|mesh-ancestor
111126122|NCT02655679|Anesthetics|anesthetics|mesh-ancestor
111126123|NCT02655679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111126124|NCT02655679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111126125|NCT04936295|Fulvestrant|fulvestrant|mesh-list
111126126|NCT04936295|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111126127|NCT04936295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111126128|NCT04936295|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
111126129|NCT04936295|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111126130|NCT04936295|Hormone Antagonists|hormone antagonists|mesh-ancestor
111126131|NCT04936295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111126132|NCT04936295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111126133|NCT05114239|Timolol|timolol|mesh-list
111126134|NCT05114239|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111126135|NCT05114239|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111126136|NCT05114239|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111126137|NCT05114239|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111126138|NCT05114239|Adrenergic Agents|adrenergic agents|mesh-ancestor
111126139|NCT05114239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111126140|NCT05114239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111126141|NCT05114239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111126142|NCT05114239|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111126143|NCT05114239|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111126144|NCT04418999|Loteprednol Etabonate|loteprednol etabonate|mesh-list
111126145|NCT04418999|Dexamethasone|dexamethasone|mesh-list
111126146|NCT04418999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111126147|NCT04418999|Antiemetics|antiemetics|mesh-ancestor
111126148|NCT04418999|Autonomic Agents|autonomic agents|mesh-ancestor
111126149|NCT04418999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111126150|NCT04418999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111126151|NCT04418999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111126152|NCT04418999|Glucocorticoids|glucocorticoids|mesh-ancestor
110069258|NCT05846867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111126154|NCT04418999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111126155|NCT04418999|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111126156|NCT04418999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111126157|NCT04418999|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111126158|NCT05113459|Disitamab vedotin|disitamab vedotin|mesh-list
111126159|NCT05113459|Immunoconjugates|immunoconjugates|mesh-ancestor
111126160|NCT05113459|Immunologic Factors|immunologic factors|mesh-ancestor
111126161|NCT05113459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111126162|NCT04933019|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111126163|NCT04933019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111126164|NCT04935515|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111126165|NCT04935515|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
111126166|NCT04935515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
111126167|NCT04935515|Anticoagulants|anticoagulants|mesh-list
111126168|NCT04935515|Coagulants|coagulants|mesh-list
111126169|NCT04935515|Histamine Antagonists|histamine antagonists|mesh-list
111126170|NCT04935515|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
111126171|NCT04935515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111126172|NCT04935515|Antitubercular Agents|antitubercular agents|mesh-ancestor
111126173|NCT04935515|Histamine Agents|histamine agents|mesh-ancestor
111126174|NCT04935515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111126175|NCT04935515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111126176|NCT04935515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111126177|NCT04376281|Norepinephrine|norepinephrine|mesh-list
111126178|NCT04376281|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111126179|NCT04376281|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111126180|NCT04376281|Adrenergic Agents|adrenergic agents|mesh-ancestor
111126181|NCT04376281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110069447|NCT05839470|Antidotes|antidotes|mesh-ancestor
111126182|NCT04376281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111126183|NCT04376281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111126184|NCT04376281|Sympathomimetics|sympathomimetics|mesh-ancestor
111126185|NCT04376281|Autonomic Agents|autonomic agents|mesh-ancestor
111126186|NCT04376281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111126187|NCT04376281|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111126188|NCT04332445|Hyaluronic Acid|hyaluronic acid|mesh-list
111126189|NCT04332445|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111126190|NCT04332445|Immunologic Factors|immunologic factors|mesh-ancestor
111126191|NCT04332445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111126192|NCT04332445|Viscosupplements|viscosupplements|mesh-ancestor
111126193|NCT04332445|Protective Agents|protective agents|mesh-ancestor
111126194|NCT03890887|Itraconazole|itraconazole|mesh-list
111126195|NCT03890887|Antifungal Agents|antifungal agents|mesh-ancestor
111126196|NCT03890887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111126197|NCT03890887|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111126198|NCT03890887|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111126199|NCT03890887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110069603|NCT05552443|Hydromorphone|hydromorphone|mesh-list
111126200|NCT03890887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111126201|NCT03890887|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111126202|NCT03890887|Hormone Antagonists|hormone antagonists|mesh-ancestor
111126203|NCT03890887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111126204|NCT03890887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111126205|NCT03890887|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111126206|NCT04516993|Aspirin|aspirin|mesh-list
111126207|NCT04516993|Plasminogen|plasminogen|mesh-list
111126208|NCT04516993|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
111126209|NCT04516993|Tenecteplase|tenecteplase|mesh-list
111126210|NCT04516993|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111126211|NCT04516993|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111126212|NCT04516993|Analgesics|analgesics|mesh-ancestor
111126213|NCT04516993|Sensory System Agents|sensory system agents|mesh-ancestor
110836441|NCT01309789|Glucocorticoids|glucocorticoids|mesh-ancestor
111126214|NCT04516993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111126215|NCT04516993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111126216|NCT04516993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111126217|NCT04516993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111126218|NCT04516993|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111126219|NCT04516993|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111126220|NCT04516993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111126221|NCT04516993|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111126222|NCT04516993|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111126223|NCT04516993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110843278|NCT03889379|Albuterol|albuterol|mesh-list
111126225|NCT05015335|Adalimumab|adalimumab|mesh-list
111126226|NCT05015335|Methotrexate|methotrexate|mesh-list
111126227|NCT05015335|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111126228|NCT05015335|Abortifacient Agents|abortifacient agents|mesh-ancestor
111126229|NCT05015335|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111126230|NCT05015335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111126231|NCT05015335|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111126232|NCT05015335|Antimetabolites|antimetabolites|mesh-ancestor
111126233|NCT05015335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111126234|NCT05015335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111126235|NCT05015335|Dermatologic Agents|dermatologic agents|mesh-ancestor
111126236|NCT05015335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111126237|NCT05015335|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111126238|NCT05015335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111126239|NCT05015335|Immunologic Factors|immunologic factors|mesh-ancestor
111126240|NCT05015335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111126241|NCT05015335|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111126242|NCT05015335|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111126243|NCT05015335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111126244|NCT03056261|Anesthetics|anesthetics|mesh-list
111126245|NCT03056261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111126246|NCT03056261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111126247|NCT03533257|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
111126248|NCT03533257|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
111126249|NCT03533257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111126250|NCT03533257|Antiviral Agents|antiviral agents|mesh-ancestor
111126251|NCT03533257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111126252|NCT03533257|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
111126253|NCT03533257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111126254|NCT04574479|Morphine|morphine|mesh-list
111126255|NCT04574479|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111126256|NCT04574479|Narcotics|narcotics|mesh-ancestor
111126257|NCT04574479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110070027|NCT04297332|Nicotine|nicotine|mesh-list
111126258|NCT04574479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111126259|NCT04574479|Analgesics|analgesics|mesh-ancestor
111126260|NCT04574479|Sensory System Agents|sensory system agents|mesh-ancestor
111126261|NCT04574479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111126262|NCT04931225|Landiolol|landiolol|mesh-list
111126263|NCT04931225|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111126264|NCT04931225|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111126265|NCT04931225|Adrenergic Agents|adrenergic agents|mesh-ancestor
111126266|NCT04931225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111126267|NCT04931225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111126268|NCT04931225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111126269|NCT04931225|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111126270|NCT02195947|Hormones|hormones|mesh-list
111126271|NCT02195947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111126272|NCT02195947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111126273|NCT01698307|Adalimumab|adalimumab|mesh-list
111126274|NCT01698307|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111126275|NCT01698307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111126276|NCT01698307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111126277|NCT04954339|Bevacizumab|bevacizumab|mesh-list
111126278|NCT04954339|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111126279|NCT04954339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111126280|NCT04954339|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111126281|NCT04954339|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111126282|NCT04954339|Growth Substances|growth substances|mesh-ancestor
111126283|NCT04954339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111126284|NCT04954339|Growth Inhibitors|growth inhibitors|mesh-ancestor
111126285|NCT01966263|Epinephrine|epinephrine|mesh-list
111126286|NCT01966263|Racepinephrine|racepinephrine|mesh-list
111126287|NCT01966263|Ropivacaine|ropivacaine|mesh-list
111126288|NCT01966263|Epinephryl borate|epinephryl borate|mesh-list
111126289|NCT01966263|Anesthetics, Local|anesthetics, local|mesh-ancestor
111126290|NCT01966263|Anesthetics|anesthetics|mesh-ancestor
111126291|NCT01966263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111126292|NCT01966263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111126293|NCT01966263|Sensory System Agents|sensory system agents|mesh-ancestor
111126294|NCT01966263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111126295|NCT01966263|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111126296|NCT01966263|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111126297|NCT01966263|Adrenergic Agents|adrenergic agents|mesh-ancestor
111126298|NCT01966263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111126299|NCT01966263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111126300|NCT01966263|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111126301|NCT01966263|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111126302|NCT01966263|Autonomic Agents|autonomic agents|mesh-ancestor
111126303|NCT01966263|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111126304|NCT01966263|Respiratory System Agents|respiratory system agents|mesh-ancestor
110070332|NCT03648905|Dopamine|dopamine|mesh-list
111126305|NCT01966263|Mydriatics|mydriatics|mesh-ancestor
111126306|NCT01966263|Sympathomimetics|sympathomimetics|mesh-ancestor
111126307|NCT01966263|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111126308|NCT04400201|Propofol|propofol|mesh-list
111126309|NCT04400201|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111126310|NCT04400201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111126311|NCT04400201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111126312|NCT04400201|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111126313|NCT04400201|Anesthetics, General|anesthetics, general|mesh-ancestor
111126314|NCT04400201|Anesthetics|anesthetics|mesh-ancestor
111126315|NCT04423107|Acetaminophen|acetaminophen|mesh-list
111126316|NCT04423107|Ibuprofen|ibuprofen|mesh-list
111126317|NCT04423107|Oxycodone|oxycodone|mesh-list
111126318|NCT04423107|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111126319|NCT04423107|Analgesics|analgesics|mesh-ancestor
111126320|NCT04423107|Sensory System Agents|sensory system agents|mesh-ancestor
111126321|NCT04423107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111126322|NCT04423107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111126323|NCT04423107|Antipyretics|antipyretics|mesh-ancestor
111126324|NCT04423107|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111126325|NCT04423107|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111126326|NCT04423107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111126327|NCT04423107|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111126328|NCT04423107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111126329|NCT04423107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111126330|NCT04423107|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111126331|NCT04423107|Narcotics|narcotics|mesh-ancestor
111126332|NCT04423107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111126333|NCT01675531|Oxycodone|oxycodone|mesh-list
111126334|NCT01675531|Naloxone|naloxone|mesh-list
111126335|NCT01675531|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111126336|NCT01675531|Narcotics|narcotics|mesh-ancestor
111126337|NCT01675531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111126338|NCT01675531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111126339|NCT01675531|Analgesics|analgesics|mesh-ancestor
111126340|NCT01675531|Sensory System Agents|sensory system agents|mesh-ancestor
111126341|NCT01675531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111126342|NCT01675531|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111126343|NCT05406999|Prednisolone|prednisolone|mesh-list
111126344|NCT05406999|Abiraterone Acetate|abiraterone acetate|mesh-list
111126345|NCT05406999|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
111126346|NCT05406999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111126347|NCT05406999|Glucocorticoids|glucocorticoids|mesh-ancestor
111126348|NCT05406999|Hormones|hormones|mesh-ancestor
111126349|NCT05406999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111126350|NCT05406999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111126351|NCT05406999|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111126352|NCT05406999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111126353|NCT05406999|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111126354|NCT05406999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111126355|NCT05406999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111126356|NCT05406999|Hormone Antagonists|hormone antagonists|mesh-ancestor
111126357|NCT05406999|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111126358|NCT04930211|Dexamethasone|dexamethasone|mesh-list
111126359|NCT04930211|Lidocaine|lidocaine|mesh-list
111126360|NCT04930211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111126361|NCT04930211|Antiemetics|antiemetics|mesh-ancestor
111126362|NCT04930211|Autonomic Agents|autonomic agents|mesh-ancestor
111126363|NCT04930211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111126364|NCT04930211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111126365|NCT04930211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111126366|NCT04930211|Glucocorticoids|glucocorticoids|mesh-ancestor
111126367|NCT04930211|Hormones|hormones|mesh-ancestor
111126368|NCT04930211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111126369|NCT04930211|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111126370|NCT04930211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111126371|NCT04930211|Anesthetics, Local|anesthetics, local|mesh-ancestor
111126372|NCT04930211|Anesthetics|anesthetics|mesh-ancestor
111126373|NCT04930211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111126374|NCT04930211|Sensory System Agents|sensory system agents|mesh-ancestor
111126375|NCT04930211|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111126376|NCT04930211|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111126377|NCT04930211|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111126378|NCT04930211|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111126379|NCT04930211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111126380|NCT04912271|Dexamethasone|dexamethasone|mesh-list
111126381|NCT04912271|Aprepitant|aprepitant|mesh-list
111126382|NCT04912271|Fosaprepitant|fosaprepitant|mesh-list
111126383|NCT04912271|Palonosetron|palonosetron|mesh-list
111126384|NCT04912271|Granisetron|granisetron|mesh-list
111126385|NCT04912271|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111126386|NCT04912271|Antiemetics|antiemetics|mesh-ancestor
111126387|NCT04912271|Autonomic Agents|autonomic agents|mesh-ancestor
111126388|NCT04912271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110070861|NCT01889810|Vitamin D|vitamin d|mesh-list
111126389|NCT04912271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111126390|NCT04912271|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111126391|NCT04912271|Glucocorticoids|glucocorticoids|mesh-ancestor
111126392|NCT04912271|Hormones|hormones|mesh-ancestor
111126393|NCT04912271|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111126394|NCT04912271|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111126395|NCT04912271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111126396|NCT04912271|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
111126397|NCT04912271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110070932|NCT00843882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111126398|NCT04912271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111126399|NCT04912271|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111126400|NCT04912271|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111126401|NCT04912271|Serotonin Agents|serotonin agents|mesh-ancestor
111126402|NCT02807779|Dexamethasone|dexamethasone|mesh-list
111126403|NCT02807779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111126404|NCT02807779|Antiemetics|antiemetics|mesh-ancestor
111126405|NCT02807779|Autonomic Agents|autonomic agents|mesh-ancestor
111126406|NCT02807779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111126407|NCT02807779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111126408|NCT02807779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111126410|NCT02807779|Hormones|hormones|mesh-ancestor
111126411|NCT02807779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111126412|NCT02807779|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111126413|NCT02807779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111126414|NCT04912193|Antithrombins|antithrombins|mesh-list
111126415|NCT04912193|Antithrombin III|antithrombin iii|mesh-list
111126416|NCT04912193|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111126417|NCT04912193|Protease Inhibitors|protease inhibitors|mesh-ancestor
111126418|NCT04912193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111126419|NCT04912193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111126420|NCT04912193|Anticoagulants|anticoagulants|mesh-ancestor
111126421|NCT02680561|Fluticasone|fluticasone|mesh-list
111126423|NCT02680561|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110071069|NCT01557140|Antioxidants|antioxidants|mesh-ancestor
111126424|NCT02680561|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
111126425|NCT02680561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111126426|NCT02680561|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111126427|NCT02680561|Autonomic Agents|autonomic agents|mesh-ancestor
111126428|NCT02680561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111126429|NCT02680561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111126430|NCT02680561|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111126431|NCT02680561|Respiratory System Agents|respiratory system agents|mesh-ancestor
111126432|NCT02680561|Dermatologic Agents|dermatologic agents|mesh-ancestor
111126433|NCT02680561|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110071122|NCT01557335|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111126434|NCT02680561|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111126435|NCT02680561|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111126436|NCT02680561|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111126437|NCT02680561|Adrenergic Agents|adrenergic agents|mesh-ancestor
111126438|NCT02680561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111126439|NCT02680561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111126440|NCT02680561|Glucocorticoids|glucocorticoids|mesh-ancestor
111126441|NCT02680561|Hormones|hormones|mesh-ancestor
111126442|NCT02680561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111126443|NCT02680561|Sympathomimetics|sympathomimetics|mesh-ancestor
111126444|NCT05025163|Fluorides|fluorides|mesh-list
111126445|NCT05025163|Fluorides, Topical|fluorides, topical|mesh-list
111126446|NCT05025163|Cariostatic Agents|cariostatic agents|mesh-ancestor
111126447|NCT05025163|Protective Agents|protective agents|mesh-ancestor
111126448|NCT05025163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111126449|NCT02592031|Goserelin|goserelin|mesh-list
111126450|NCT02592031|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111126451|NCT02592031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111126452|NCT04784299|Lidocaine|lidocaine|mesh-list
111126453|NCT04784299|Anesthetics, Local|anesthetics, local|mesh-ancestor
111126454|NCT04784299|Anesthetics|anesthetics|mesh-ancestor
111126455|NCT04784299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111126456|NCT04784299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111126457|NCT04784299|Sensory System Agents|sensory system agents|mesh-ancestor
111126458|NCT04784299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111126459|NCT04784299|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111126460|NCT04784299|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111126461|NCT04784299|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111126462|NCT04784299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111126463|NCT04784299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111126465|NCT02333149|Antioxidants|antioxidants|mesh-ancestor
111126466|NCT02333149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111126467|NCT02333149|Protective Agents|protective agents|mesh-ancestor
111126468|NCT02333149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111126469|NCT02333149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111126470|NCT05117983|Antidepressive Agents|antidepressive agents|mesh-list
111126471|NCT05117983|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111126472|NCT03807817|Ethanol|ethanol|mesh-list
111126473|NCT03807817|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111126474|NCT03807817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111126475|NCT03807817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111126476|NCT03807817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111126477|NCT05122117|Methylene Blue|methylene blue|mesh-list
111126478|NCT05122117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111126479|NCT05122117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111126480|NCT05116345|Dexamethasone|dexamethasone|mesh-list
111126481|NCT05116345|Dexamethasone acetate|dexamethasone acetate|mesh-list
111126482|NCT05116345|BB 1101|bb 1101|mesh-list
111126483|NCT05116345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111126484|NCT05116345|Antiemetics|antiemetics|mesh-ancestor
111126485|NCT05116345|Autonomic Agents|autonomic agents|mesh-ancestor
111126486|NCT05116345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110071387|NCT01559142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111126487|NCT05116345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111126488|NCT05116345|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111126489|NCT05116345|Glucocorticoids|glucocorticoids|mesh-ancestor
111126490|NCT05116345|Hormones|hormones|mesh-ancestor
111126491|NCT05116345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111126492|NCT05116345|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111126493|NCT05116345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111126494|NCT05116345|Protease Inhibitors|protease inhibitors|mesh-ancestor
111126495|NCT05116345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111126496|NCT05116345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111126497|NCT05076097|Rituximab|rituximab|mesh-list
111126498|NCT05076097|Lenalidomide|lenalidomide|mesh-list
111126499|NCT05076097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111126500|NCT05076097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111126501|NCT05076097|Immunologic Factors|immunologic factors|mesh-ancestor
111126502|NCT05076097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111126503|NCT05076097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111126504|NCT05076097|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111126505|NCT05076097|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111126506|NCT05076097|Growth Substances|growth substances|mesh-ancestor
111126507|NCT05076097|Growth Inhibitors|growth inhibitors|mesh-ancestor
111126508|NCT04513639|Dexamethasone|dexamethasone|mesh-list
111126509|NCT04513639|Dexamethasone acetate|dexamethasone acetate|mesh-list
111126510|NCT04513639|Daratumumab|daratumumab|mesh-list
111126511|NCT04513639|BB 1101|bb 1101|mesh-list
111126512|NCT04513639|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111126513|NCT04513639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111126514|NCT04513639|Antiemetics|antiemetics|mesh-ancestor
111126515|NCT04513639|Autonomic Agents|autonomic agents|mesh-ancestor
111126516|NCT04513639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111126517|NCT04513639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111126518|NCT04513639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111126519|NCT04513639|Glucocorticoids|glucocorticoids|mesh-ancestor
111126520|NCT04513639|Hormones|hormones|mesh-ancestor
111126521|NCT04513639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111126522|NCT04513639|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111126523|NCT04513639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111126524|NCT04513639|Protease Inhibitors|protease inhibitors|mesh-ancestor
111126525|NCT04513639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111126526|NCT04513639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111126527|NCT04513639|Immunologic Factors|immunologic factors|mesh-ancestor
111126529|NCT05229913|Antidepressive Agents|antidepressive agents|mesh-ancestor
111126530|NCT05229913|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111126531|NCT05108155|Tacrine|tacrine|mesh-list
111126532|NCT05108155|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111126533|NCT05108155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111126534|NCT05108155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111126535|NCT05108155|Cholinergic Agents|cholinergic agents|mesh-ancestor
111126536|NCT05108155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111126537|NCT05108155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111126538|NCT05108155|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110071547|NCT05569590|Propolis|propolis|mesh-list
111126539|NCT05108155|Autonomic Agents|autonomic agents|mesh-ancestor
111126540|NCT05108155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111126541|NCT05108155|Nootropic Agents|nootropic agents|mesh-ancestor
111126542|NCT04375735|Pulmonary Surfactants|pulmonary surfactants|mesh-list
111126543|NCT04375735|Respiratory System Agents|respiratory system agents|mesh-ancestor
111126544|NCT01362439|Paliperidone Palmitate|paliperidone palmitate|mesh-list
111126545|NCT01362439|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111126546|NCT01362439|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111126547|NCT01362439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111126548|NCT01362439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111126549|NCT01362439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111126550|NCT01362439|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111126551|NCT01362439|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111126552|NCT01362439|Serotonin Agents|serotonin agents|mesh-ancestor
111126553|NCT01362439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111126554|NCT01362439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110071611|NCT05491304|Dexamethasone|dexamethasone|mesh-list
111126555|NCT01362439|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111126556|NCT01362439|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111126557|NCT01362439|Dopamine Agents|dopamine agents|mesh-ancestor
111126558|NCT05228743|Paclitaxel|paclitaxel|mesh-list
111126559|NCT05228743|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111126560|NCT05228743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111126561|NCT05228743|Tubulin Modulators|tubulin modulators|mesh-ancestor
111126562|NCT05228743|Antimitotic Agents|antimitotic agents|mesh-ancestor
111126563|NCT05228743|Mitosis Modulators|mitosis modulators|mesh-ancestor
111126564|NCT05228743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111126565|NCT04990921|Pembrolizumab|pembrolizumab|mesh-list
111126566|NCT04990921|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111126567|NCT04990921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111126568|NCT04990921|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111126569|NCT04990921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111126570|NCT04507477|Rituximab|rituximab|mesh-list
111126571|NCT04507477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111126572|NCT04507477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111126573|NCT04507477|Immunologic Factors|immunologic factors|mesh-ancestor
111126574|NCT04507477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111126575|NCT04507477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111126576|NCT01675141|Lenalidomide|lenalidomide|mesh-list
111126577|NCT01675141|Immunologic Factors|immunologic factors|mesh-ancestor
111126578|NCT01675141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111126579|NCT01675141|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111126580|NCT01675141|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111126581|NCT01675141|Growth Substances|growth substances|mesh-ancestor
110836622|NCT02897648|Lactams|lactams|mesh-list
111126582|NCT01675141|Growth Inhibitors|growth inhibitors|mesh-ancestor
111126583|NCT01675141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111126584|NCT05102149|Vildagliptin|vildagliptin|mesh-list
111126585|NCT05102149|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111126586|NCT05102149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111126587|NCT05102149|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111126588|NCT05102149|Protease Inhibitors|protease inhibitors|mesh-ancestor
111126589|NCT05102149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111126590|NCT05102149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111126591|NCT04412395|Lactoferrin|lactoferrin|mesh-list
111126592|NCT04412395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111126593|NCT04987099|Choline|choline|mesh-list
110071823|NCT03813121|Midazolam|midazolam|mesh-list
111126594|NCT04987099|Lipotropic Agents|lipotropic agents|mesh-ancestor
111126595|NCT04987099|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111126596|NCT04987099|Antimetabolites|antimetabolites|mesh-ancestor
111126597|NCT04987099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111126598|NCT04987099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111126599|NCT04987099|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111126600|NCT04987099|Nootropic Agents|nootropic agents|mesh-ancestor
111126601|NCT03906721|Oxycodone|oxycodone|mesh-list
111126602|NCT03906721|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111126603|NCT03906721|Narcotics|narcotics|mesh-ancestor
111126604|NCT03906721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111126605|NCT03906721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111126606|NCT03906721|Analgesics|analgesics|mesh-ancestor
111126607|NCT03906721|Sensory System Agents|sensory system agents|mesh-ancestor
111126608|NCT03906721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111126609|NCT04663711|Anesthetics|anesthetics|mesh-list
111126610|NCT04663711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111126611|NCT04663711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111126612|NCT04529863|Abatacept|abatacept|mesh-list
111126613|NCT04529863|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111126614|NCT04529863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111126615|NCT04529863|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111126616|NCT04529863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111126617|NCT04529863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111126618|NCT04529863|Immunologic Factors|immunologic factors|mesh-ancestor
111126619|NCT04529863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111126620|NCT04529863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111126621|NCT04582591|Cannabidiol|cannabidiol|mesh-list
111126622|NCT04582591|Anticonvulsants|anticonvulsants|mesh-ancestor
111126623|NCT04497883|Maribavir|maribavir|mesh-list
111126624|NCT04497883|Antiviral Agents|antiviral agents|mesh-ancestor
111126625|NCT04497883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111126626|NCT03688633|Candesartan|candesartan|mesh-list
111126627|NCT03688633|Candesartan cilexetil|candesartan cilexetil|mesh-list
111126628|NCT03688633|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111126629|NCT03688633|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111126630|NCT03688633|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111126631|NCT03688633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111126632|NCT03963895|Thrombin|thrombin|mesh-list
111126633|NCT03963895|Hemostatics|hemostatics|mesh-ancestor
111126634|NCT03963895|Coagulants|coagulants|mesh-ancestor
111126635|NCT03662815|Molgramostim|molgramostim|mesh-list
111126636|NCT03662815|Sargramostim|sargramostim|mesh-list
111126637|NCT03662815|Immunologic Factors|immunologic factors|mesh-ancestor
111126638|NCT03662815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111126639|NCT03662815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111126640|NCT03490903|Fentanyl|fentanyl|mesh-list
111126641|NCT03490903|Midazolam|midazolam|mesh-list
111126642|NCT03490903|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111126643|NCT03490903|Narcotics|narcotics|mesh-ancestor
111126644|NCT03490903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111126645|NCT03490903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111126646|NCT03490903|Analgesics|analgesics|mesh-ancestor
111126647|NCT03490903|Sensory System Agents|sensory system agents|mesh-ancestor
111126648|NCT03490903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111126649|NCT03490903|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111126650|NCT03490903|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111126651|NCT03490903|Anesthetics, General|anesthetics, general|mesh-ancestor
111126652|NCT03490903|Anesthetics|anesthetics|mesh-ancestor
111126653|NCT03490903|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111126654|NCT03490903|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111126655|NCT03490903|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111126656|NCT03490903|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111126657|NCT03490903|GABA Modulators|gaba modulators|mesh-ancestor
111126658|NCT03490903|GABA Agents|gaba agents|mesh-ancestor
111126659|NCT03490903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111126660|NCT03490903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111126661|NCT04169191|Sildenafil Citrate|sildenafil citrate|mesh-list
111126662|NCT04169191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111126663|NCT04169191|Vasodilator Agents|vasodilator agents|mesh-ancestor
111126664|NCT04169191|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111126665|NCT04169191|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111126666|NCT04169191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111126667|NCT04169191|Urological Agents|urological agents|mesh-ancestor
111126668|NCT03954613|Memantine|memantine|mesh-list
111126669|NCT03954613|Donepezil|donepezil|mesh-list
111126670|NCT03954613|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111126671|NCT03954613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111126672|NCT03954613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111126673|NCT03954613|Cholinergic Agents|cholinergic agents|mesh-ancestor
111126674|NCT03954613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111126675|NCT03954613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111126677|NCT03954613|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111126678|NCT03954613|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111126679|NCT03954613|Dopamine Agents|dopamine agents|mesh-ancestor
111126680|NCT03954613|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111126681|NCT03954613|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111126682|NCT03367819|Cemiplimab|cemiplimab|mesh-list
111126683|NCT03367819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111126684|NCT03367819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111126685|NCT04875871|Copper|copper|mesh-list
111126686|NCT04875871|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
111126687|NCT04875871|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111126688|NCT04875871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111126689|NCT04875871|Trace Elements|trace elements|mesh-ancestor
111126690|NCT04875871|Micronutrients|micronutrients|mesh-ancestor
111126691|NCT04875871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111126692|NCT04781725|Cisplatin|cisplatin|mesh-list
111126693|NCT04781725|Vinblastine|vinblastine|mesh-list
111126694|NCT04781725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111126695|NCT04781725|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111126696|NCT04781725|Tubulin Modulators|tubulin modulators|mesh-ancestor
111126697|NCT04781725|Antimitotic Agents|antimitotic agents|mesh-ancestor
111126698|NCT04781725|Mitosis Modulators|mitosis modulators|mesh-ancestor
111126699|NCT04781725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111126700|NCT03580525|Nicotine|nicotine|mesh-list
111126701|NCT03580525|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111126702|NCT03580525|Autonomic Agents|autonomic agents|mesh-ancestor
111126703|NCT03580525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111126704|NCT03580525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111126705|NCT03580525|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111126706|NCT03580525|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111126707|NCT03580525|Cholinergic Agents|cholinergic agents|mesh-ancestor
111126708|NCT03580525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111126709|NCT03580525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111126710|NCT03554707|Bevacizumab|bevacizumab|mesh-list
111126711|NCT03554707|Irinotecan|irinotecan|mesh-list
111126712|NCT03554707|Temozolomide|temozolomide|mesh-list
111126713|NCT03554707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111126714|NCT03554707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111126715|NCT03554707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111126716|NCT03554707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111126717|NCT03554707|Growth Substances|growth substances|mesh-ancestor
111126718|NCT03554707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110072377|NCT01571206|Infliximab|infliximab|mesh-list
111126719|NCT03554707|Growth Inhibitors|growth inhibitors|mesh-ancestor
111126720|NCT03554707|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111126721|NCT03554707|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111126722|NCT03554707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111126723|NCT03554707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111126724|NCT03554707|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111126725|NCT03554707|Alkylating Agents|alkylating agents|mesh-ancestor
111126726|NCT04264663|Furazolidone|furazolidone|mesh-list
111126727|NCT04264663|Tinidazole|tinidazole|mesh-list
111126728|NCT04264663|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111126729|NCT04264663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110072434|NCT01571583|Ribavirin|ribavirin|mesh-list
111126730|NCT04264663|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111126731|NCT04264663|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
111126732|NCT04264663|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111126733|NCT04264663|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111126734|NCT04264663|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
111126735|NCT04264663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111126736|NCT04264663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111126737|NCT04264663|Alkylating Agents|alkylating agents|mesh-ancestor
111126738|NCT04264663|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111126739|NCT05403307|Vaccines|vaccines|mesh-list
111126740|NCT05403307|Immunologic Factors|immunologic factors|mesh-ancestor
111126741|NCT05403307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111126742|NCT04563559|Prednisolone|prednisolone|mesh-list
111126743|NCT04563559|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111126744|NCT04563559|Methylprednisolone|methylprednisolone|mesh-list
111126745|NCT04563559|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111126746|NCT04563559|Prednisolone acetate|prednisolone acetate|mesh-list
111126747|NCT04563559|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111126748|NCT04563559|Prednisolone phosphate|prednisolone phosphate|mesh-list
111126749|NCT04563559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111126750|NCT04563559|Glucocorticoids|glucocorticoids|mesh-ancestor
111126751|NCT04563559|Hormones|hormones|mesh-ancestor
111126752|NCT04563559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111126753|NCT04563559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111126754|NCT04563559|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111126755|NCT04563559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111126756|NCT04563559|Antiemetics|antiemetics|mesh-ancestor
111126757|NCT04563559|Autonomic Agents|autonomic agents|mesh-ancestor
111126758|NCT04563559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111126759|NCT04563559|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111126760|NCT04563559|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111126761|NCT04563559|Protective Agents|protective agents|mesh-ancestor
111126762|NCT02124187|Nicotine|nicotine|mesh-list
111126763|NCT02124187|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111126764|NCT02124187|Autonomic Agents|autonomic agents|mesh-ancestor
111126765|NCT02124187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111126766|NCT02124187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111126767|NCT02124187|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111126768|NCT02124187|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111126769|NCT02124187|Cholinergic Agents|cholinergic agents|mesh-ancestor
111126770|NCT02124187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111126771|NCT02124187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111126772|NCT02002819|Levetiracetam|levetiracetam|mesh-list
111126773|NCT02002819|Anticonvulsants|anticonvulsants|mesh-ancestor
111126774|NCT02002819|Nootropic Agents|nootropic agents|mesh-ancestor
111126775|NCT01597193|Fulvestrant|fulvestrant|mesh-list
111126776|NCT01597193|Anastrozole|anastrozole|mesh-list
110072614|NCT01572285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111126778|NCT01597193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111126779|NCT01597193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111126780|NCT01597193|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
111126781|NCT01597193|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111126782|NCT01597193|Hormone Antagonists|hormone antagonists|mesh-ancestor
111126783|NCT01597193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111126784|NCT01597193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111126785|NCT01597193|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111126786|NCT01597193|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111126787|NCT01597193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111126788|NCT01597193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111126789|NCT04930133|Afatinib|afatinib|mesh-list
111126790|NCT04930133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111126791|NCT04930133|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111126792|NCT04930133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111126793|NCT04930133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111126794|NCT03057041|Fentanyl|fentanyl|mesh-list
111126795|NCT03057041|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111126796|NCT03057041|Narcotics|narcotics|mesh-ancestor
111126797|NCT03057041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111126798|NCT03057041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111126799|NCT03057041|Analgesics|analgesics|mesh-ancestor
111126800|NCT03057041|Sensory System Agents|sensory system agents|mesh-ancestor
111126801|NCT03057041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111126802|NCT03057041|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111126803|NCT03057041|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111126804|NCT03057041|Anesthetics, General|anesthetics, general|mesh-ancestor
111126805|NCT03057041|Anesthetics|anesthetics|mesh-ancestor
111126806|NCT05123287|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
111126807|NCT05123287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111126808|NCT05123287|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111126809|NCT05123287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111126810|NCT04911413|Tranexamic Acid|tranexamic acid|mesh-list
111126811|NCT04911413|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111126812|NCT04911413|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111126813|NCT04911413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111126814|NCT04911413|Hemostatics|hemostatics|mesh-ancestor
111126815|NCT04911413|Coagulants|coagulants|mesh-ancestor
111126816|NCT02622113|Canagliflozin|canagliflozin|mesh-list
111126817|NCT02622113|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111126818|NCT02622113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111126819|NCT02622113|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111126820|NCT02622113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111126821|NCT04430777|Tranexamic Acid|tranexamic acid|mesh-list
111126822|NCT04430777|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111126823|NCT04430777|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111126824|NCT04430777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111126825|NCT04430777|Hemostatics|hemostatics|mesh-ancestor
111126827|NCT04910477|Atropine|atropine|mesh-list
111126828|NCT04910477|Dexmedetomidine|dexmedetomidine|mesh-list
111126829|NCT04910477|Neostigmine|neostigmine|mesh-list
111126830|NCT04910477|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111126831|NCT04910477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111126832|NCT04910477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111126833|NCT04910477|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111126834|NCT04910477|Analgesics|analgesics|mesh-ancestor
111126835|NCT04910477|Sensory System Agents|sensory system agents|mesh-ancestor
111126836|NCT04910477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111126837|NCT04910477|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111126838|NCT04910477|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111126839|NCT04910477|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111126840|NCT04910477|Adrenergic Agents|adrenergic agents|mesh-ancestor
111126841|NCT04910477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111126842|NCT04910477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111126843|NCT04910477|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111126844|NCT04910477|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111126845|NCT04910477|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111126846|NCT04910477|Autonomic Agents|autonomic agents|mesh-ancestor
111126847|NCT04910477|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111126848|NCT04910477|Respiratory System Agents|respiratory system agents|mesh-ancestor
111126849|NCT04910477|Mydriatics|mydriatics|mesh-ancestor
111126850|NCT04910477|Parasympatholytics|parasympatholytics|mesh-ancestor
111126851|NCT04910477|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111126852|NCT04910477|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111126853|NCT04910477|Cholinergic Agents|cholinergic agents|mesh-ancestor
110073071|NCT01575795|Ticagrelor|ticagrelor|mesh-list
111126854|NCT04910477|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111126855|NCT04910477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111126856|NCT04910477|Parasympathomimetics|parasympathomimetics|mesh-ancestor
111126857|NCT03843151|Itraconazole|itraconazole|mesh-list
111126858|NCT03843151|Antifungal Agents|antifungal agents|mesh-ancestor
111126859|NCT03843151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111126860|NCT03843151|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111126861|NCT03843151|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111126862|NCT03843151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111126863|NCT03843151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111126864|NCT03843151|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111126865|NCT03843151|Hormone Antagonists|hormone antagonists|mesh-ancestor
111126866|NCT03843151|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111126867|NCT03843151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111126868|NCT03843151|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111126869|NCT04929509|Listerine|listerine|mesh-list
111126870|NCT04929509|Fluorides|fluorides|mesh-list
111126871|NCT04929509|Sodium Fluoride|sodium fluoride|mesh-list
111126872|NCT04929509|Fluorides, Topical|fluorides, topical|mesh-list
111126873|NCT04929509|Cariostatic Agents|cariostatic agents|mesh-ancestor
111126874|NCT04929509|Protective Agents|protective agents|mesh-ancestor
111126875|NCT04929509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111126876|NCT04929509|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111126877|NCT04929509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111126878|NCT03054467|Amlodipine|amlodipine|mesh-list
111126879|NCT03054467|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111126880|NCT03054467|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111126881|NCT03054467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111126882|NCT03054467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111126883|NCT03054467|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111126884|NCT03054467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111126885|NCT03054467|Vasodilator Agents|vasodilator agents|mesh-ancestor
111126886|NCT04910165|Ropivacaine|ropivacaine|mesh-list
111126887|NCT04910165|Anesthetics, Local|anesthetics, local|mesh-ancestor
111126888|NCT04910165|Anesthetics|anesthetics|mesh-ancestor
111126889|NCT04910165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111126890|NCT04910165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111126891|NCT04910165|Sensory System Agents|sensory system agents|mesh-ancestor
111126892|NCT04910165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111126893|NCT02730325|Immunoglobulins|immunoglobulins|mesh-list
111126894|NCT02730325|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111126895|NCT02730325|Antibodies|antibodies|mesh-list
111126896|NCT02730325|Immunologic Factors|immunologic factors|mesh-ancestor
111126897|NCT02730325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111126898|NCT04928495|Acetylcysteine|acetylcysteine|mesh-list
111126899|NCT04928495|Bromhexine|bromhexine|mesh-list
111126900|NCT04928495|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111126901|NCT04928495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111126902|NCT04928495|Antioxidants|antioxidants|mesh-ancestor
111126903|NCT04928495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111126904|NCT04928495|Protective Agents|protective agents|mesh-ancestor
111126905|NCT04928495|Antiviral Agents|antiviral agents|mesh-ancestor
111126906|NCT04928495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111126907|NCT04928495|Expectorants|expectorants|mesh-ancestor
111126908|NCT04928495|Respiratory System Agents|respiratory system agents|mesh-ancestor
111126909|NCT04928495|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111126910|NCT04928495|Antidotes|antidotes|mesh-ancestor
111126911|NCT01573429|Bisphenol A|bisphenol a|mesh-list
111126912|NCT01573429|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
111126913|NCT01573429|Estrogens|estrogens|mesh-ancestor
111126914|NCT01573429|Hormones|hormones|mesh-ancestor
111126915|NCT01573429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111126916|NCT01573429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111126917|NCT01573429|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111126918|NCT01573429|Antioxidants|antioxidants|mesh-ancestor
111126919|NCT01573429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111126920|NCT01573429|Protective Agents|protective agents|mesh-ancestor
111126921|NCT04909931|Vitamin D|vitamin d|mesh-list
111126922|NCT04909931|Ergocalciferols|ergocalciferols|mesh-list
111126923|NCT04909931|Vitamins|vitamins|mesh-ancestor
111126924|NCT04909931|Micronutrients|micronutrients|mesh-ancestor
111126925|NCT04909931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111126926|NCT04909931|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111126927|NCT04909931|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111126928|NCT04918589|Tranexamic Acid|tranexamic acid|mesh-list
111126929|NCT04918589|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111126930|NCT04918589|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111126931|NCT04918589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111126932|NCT04918589|Hemostatics|hemostatics|mesh-ancestor
111126933|NCT04918589|Coagulants|coagulants|mesh-ancestor
111126934|NCT04101643|Evolocumab|evolocumab|mesh-list
111126935|NCT04101643|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
111126936|NCT04101643|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111126937|NCT04101643|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111126938|NCT04101643|Antimetabolites|antimetabolites|mesh-ancestor
111126939|NCT04101643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111126940|NCT04101643|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111126941|NCT04101643|Protease Inhibitors|protease inhibitors|mesh-ancestor
111126942|NCT04101643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111126943|NCT04101643|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111126944|NCT02620787|Tedizolid|tedizolid|mesh-list
111126945|NCT02620787|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111126946|NCT02620787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111126947|NCT04909619|Anesthetics|anesthetics|mesh-list
111126948|NCT04909619|Anesthetics, Local|anesthetics, local|mesh-list
111126949|NCT04909619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111126950|NCT04909619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111126951|NCT04909619|Sensory System Agents|sensory system agents|mesh-ancestor
111126952|NCT04909619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111126953|NCT03520231|Vitamin D|vitamin d|mesh-list
111126954|NCT03520231|Denosumab|denosumab|mesh-list
111126955|NCT03520231|Carboplatin|carboplatin|mesh-list
111126956|NCT03520231|Gemcitabine|gemcitabine|mesh-list
111126957|NCT03520231|Calcium|calcium|mesh-list
111126958|NCT03520231|Vitamins|vitamins|mesh-ancestor
111126959|NCT03520231|Micronutrients|micronutrients|mesh-ancestor
111126960|NCT03520231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111126961|NCT03520231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110073496|NCT01578447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111126962|NCT03520231|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111126963|NCT03520231|Antimetabolites|antimetabolites|mesh-ancestor
111126964|NCT03520231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111126965|NCT03520231|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111126966|NCT03520231|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111126967|NCT04927481|Mitoxantrone|mitoxantrone|mesh-list
111126968|NCT04927481|Analgesics|analgesics|mesh-ancestor
111126969|NCT04927481|Sensory System Agents|sensory system agents|mesh-ancestor
111126970|NCT04927481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111126971|NCT04927481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111126972|NCT04927481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111126973|NCT04927481|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111126974|NCT04927481|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111126975|NCT04927481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111126976|NCT04927481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111126978|NCT03056495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111126979|NCT03056495|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111126980|NCT03056495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111126981|NCT03056495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111126982|NCT03171805|Propranolol|propranolol|mesh-list
111126983|NCT03171805|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110073621|NCT01579110|Levamisole|levamisole|mesh-list
111126984|NCT03171805|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111126985|NCT03171805|Adrenergic Agents|adrenergic agents|mesh-ancestor
111126986|NCT03171805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111126987|NCT03171805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111126988|NCT03171805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111126989|NCT03171805|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111126990|NCT03171805|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111126991|NCT03171805|Vasodilator Agents|vasodilator agents|mesh-ancestor
111126992|NCT04918433|Anesthetics|anesthetics|mesh-list
111126993|NCT04918433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111126994|NCT04918433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111126995|NCT04926467|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
111126996|NCT04926467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111126997|NCT03053219|Abivertinib|abivertinib|mesh-list
111126998|NCT03053219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111126999|NCT03053219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111127000|NCT03053219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111127001|NCT03055793|Budesonide|budesonide|mesh-list
111127002|NCT03055793|Formoterol Fumarate|formoterol fumarate|mesh-list
111127003|NCT03055793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111127004|NCT03055793|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111127005|NCT03055793|Autonomic Agents|autonomic agents|mesh-ancestor
111127006|NCT03055793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111127007|NCT03055793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111127008|NCT03055793|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111127009|NCT03055793|Respiratory System Agents|respiratory system agents|mesh-ancestor
111127010|NCT03055793|Glucocorticoids|glucocorticoids|mesh-ancestor
111127011|NCT03055793|Hormones|hormones|mesh-ancestor
111127012|NCT03055793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111127013|NCT03055793|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111127014|NCT03055793|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111127015|NCT03055793|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111127016|NCT03055793|Adrenergic Agents|adrenergic agents|mesh-ancestor
111127017|NCT03055793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111127018|NCT03055793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111127019|NCT04926155|Metformin|metformin|mesh-list
111127020|NCT04926155|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111127021|NCT04926155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111127022|NCT04909775|Gemcitabine|gemcitabine|mesh-list
111127023|NCT04909775|Tislelizumab|tislelizumab|mesh-list
111127024|NCT04909775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111127025|NCT04909775|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111127026|NCT04909775|Antimetabolites|antimetabolites|mesh-ancestor
111127027|NCT04909775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111127028|NCT04909775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111127029|NCT04925141|Dasatinib|dasatinib|mesh-list
111127030|NCT04925141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111127031|NCT04925141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111127032|NCT04925141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111127033|NCT04925141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111127034|NCT02651155|Lubiprostone|lubiprostone|mesh-list
111127035|NCT02651155|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
111127036|NCT02651155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110073949|NCT01588873|NuvaRing|nuvaring|mesh-list
111127037|NCT02651155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111127038|NCT04925063|Metformin|metformin|mesh-list
111127039|NCT04925063|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111127040|NCT04925063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111127041|NCT04909151|Methamphetamine|methamphetamine|mesh-list
111127042|NCT04909151|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111127043|NCT04909151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111127044|NCT04909151|Sympathomimetics|sympathomimetics|mesh-ancestor
111127045|NCT04909151|Autonomic Agents|autonomic agents|mesh-ancestor
111127046|NCT04909151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110074013|NCT01590199|Everolimus|everolimus|mesh-list
111127047|NCT04909151|Dopamine Agents|dopamine agents|mesh-ancestor
111127048|NCT04909151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111127049|NCT04909151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110844109|NCT02527109|Nifedipine|nifedipine|mesh-list
111127051|NCT04909151|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111127052|NCT04909151|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111127053|NCT04909151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111127054|NCT04909151|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111127055|NCT05132413|Bevacizumab|bevacizumab|mesh-list
111127056|NCT05132413|Cisplatin|cisplatin|mesh-list
111127057|NCT05132413|Carboplatin|carboplatin|mesh-list
111127058|NCT05132413|Pemetrexed|pemetrexed|mesh-list
111127059|NCT05132413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111127060|NCT05132413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110074075|NCT01590732|Carboplatin|carboplatin|mesh-list
111127061|NCT05132413|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111127062|NCT05132413|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111127063|NCT05132413|Growth Substances|growth substances|mesh-ancestor
111127064|NCT05132413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111127065|NCT05132413|Growth Inhibitors|growth inhibitors|mesh-ancestor
111127066|NCT05132413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111127067|NCT05132413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111127068|NCT05132413|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111127069|NCT05132413|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111127070|NCT04435717|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111127071|NCT04075981|Botulinum Toxins|botulinum toxins|mesh-list
110074134|NCT01591031|Rocuronium|rocuronium|mesh-list
111127072|NCT04075981|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111127073|NCT04075981|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111127074|NCT04075981|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
111127075|NCT04075981|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111127076|NCT04075981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111127077|NCT04075981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111127078|NCT04075981|Cholinergic Agents|cholinergic agents|mesh-ancestor
111127079|NCT04075981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111127080|NCT04075981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111127081|NCT04075981|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111127082|NCT04075981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111127083|NCT04917497|Simendan|simendan|mesh-list
111127084|NCT04917497|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111127085|NCT04917497|Vasodilator Agents|vasodilator agents|mesh-ancestor
111127086|NCT04917497|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
111127087|NCT04917497|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111127088|NCT04917497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111127089|NCT04917497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110836707|NCT03468010|Paclitaxel|paclitaxel|mesh-list
111127090|NCT04917497|Protective Agents|protective agents|mesh-ancestor
111127091|NCT04917497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111127092|NCT03933007|Fexofenadine|fexofenadine|mesh-list
111127093|NCT03933007|Colchicine|colchicine|mesh-list
111127094|NCT03933007|Midazolam|midazolam|mesh-list
111127095|NCT03933007|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111127096|NCT03933007|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111127097|NCT03933007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111127098|NCT03933007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111127099|NCT03933007|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111127100|NCT03933007|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111127101|NCT03933007|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111127102|NCT03933007|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111127103|NCT03933007|Anesthetics, General|anesthetics, general|mesh-ancestor
111127104|NCT03933007|Anesthetics|anesthetics|mesh-ancestor
111127105|NCT03933007|GABA Modulators|gaba modulators|mesh-ancestor
111127106|NCT03933007|GABA Agents|gaba agents|mesh-ancestor
111127107|NCT03933007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111127108|NCT03933007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111127109|NCT03933007|Gout Suppressants|gout suppressants|mesh-ancestor
111127110|NCT03933007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110074321|NCT01592162|Anesthetics|anesthetics|mesh-ancestor
111127111|NCT03933007|Tubulin Modulators|tubulin modulators|mesh-ancestor
111127112|NCT03933007|Antimitotic Agents|antimitotic agents|mesh-ancestor
111127113|NCT03933007|Mitosis Modulators|mitosis modulators|mesh-ancestor
111127114|NCT03933007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111127115|NCT03933007|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111127116|NCT03933007|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
111127117|NCT03933007|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111127118|NCT03933007|Histamine Antagonists|histamine antagonists|mesh-ancestor
111127119|NCT03933007|Histamine Agents|histamine agents|mesh-ancestor
111127120|NCT04907747|Amoxicillin|amoxicillin|mesh-list
111127121|NCT04907747|Furazolidone|furazolidone|mesh-list
111127122|NCT04907747|Esomeprazole|esomeprazole|mesh-list
111127123|NCT04907747|Bismuth|bismuth|mesh-list
110844189|NCT03380728|Ibogaine|ibogaine|mesh-list
111127124|NCT04907747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111127125|NCT04907747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111127126|NCT04907747|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111127127|NCT04907747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111127128|NCT04907747|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111127129|NCT04907747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111127130|NCT04907747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111127131|NCT04907747|Antacids|antacids|mesh-ancestor
111127132|NCT04907747|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111127133|NCT04907747|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111127134|NCT04907747|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
111127135|NCT04907747|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111127136|NCT04907747|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111127137|NCT04907747|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
111127138|NCT03052673|Fentanyl|fentanyl|mesh-list
111127139|NCT03052673|Ketamine|ketamine|mesh-list
111127140|NCT03052673|Analgesics|analgesics|mesh-ancestor
111127141|NCT03052673|Sensory System Agents|sensory system agents|mesh-ancestor
111127142|NCT03052673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111127143|NCT03052673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111127144|NCT03052673|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111127145|NCT03052673|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111127146|NCT03052673|Anesthetics, General|anesthetics, general|mesh-ancestor
111127147|NCT03052673|Anesthetics|anesthetics|mesh-ancestor
111127148|NCT03052673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111127149|NCT03052673|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111127150|NCT03052673|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111127151|NCT03052673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110074516|NCT01593306|Paclitaxel|paclitaxel|mesh-list
111127152|NCT03052673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111127153|NCT03052673|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111127154|NCT03052673|Narcotics|narcotics|mesh-ancestor
111127155|NCT03052673|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111127156|NCT04907123|Diuretics|diuretics|mesh-list
111127157|NCT04907123|Natriuretic Agents|natriuretic agents|mesh-ancestor
111127158|NCT04907123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111127159|NCT05030857|Midazolam|midazolam|mesh-list
111127160|NCT05030857|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110074575|NCT01593501|Vitamins|vitamins|mesh-ancestor
111127161|NCT05030857|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111127162|NCT05030857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111127163|NCT05030857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111127164|NCT05030857|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111127165|NCT05030857|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111127166|NCT05030857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111127167|NCT05030857|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111127168|NCT05030857|Anesthetics, General|anesthetics, general|mesh-ancestor
111127169|NCT05030857|Anesthetics|anesthetics|mesh-ancestor
111127170|NCT05030857|GABA Modulators|gaba modulators|mesh-ancestor
111127171|NCT05030857|GABA Agents|gaba agents|mesh-ancestor
111127172|NCT05030857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111127173|NCT05030857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111127174|NCT03319459|Trastuzumab|trastuzumab|mesh-list
111127175|NCT03319459|Cetuximab|cetuximab|mesh-list
111127176|NCT03319459|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111127177|NCT03319459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111127178|NCT04916951|Amoxicillin|amoxicillin|mesh-list
111127179|NCT04916951|Cephalexin|cephalexin|mesh-list
111127180|NCT04916951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111127181|NCT04916951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111127182|NCT04430933|Paclitaxel|paclitaxel|mesh-list
111127183|NCT04430933|Docetaxel|docetaxel|mesh-list
111127184|NCT04430933|Carboplatin|carboplatin|mesh-list
111127185|NCT04430933|Pemetrexed|pemetrexed|mesh-list
111127186|NCT04430933|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111127187|NCT04430933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111127188|NCT04430933|Tubulin Modulators|tubulin modulators|mesh-ancestor
111127189|NCT04430933|Antimitotic Agents|antimitotic agents|mesh-ancestor
111127190|NCT04430933|Mitosis Modulators|mitosis modulators|mesh-ancestor
111127191|NCT04430933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111127192|NCT04430933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111127193|NCT04430933|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111127194|NCT04430933|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111127195|NCT04906655|Glycopyrrolate|glycopyrrolate|mesh-list
111127196|NCT04906655|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111127197|NCT04906655|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111127198|NCT04906655|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111127199|NCT04906655|Cholinergic Agents|cholinergic agents|mesh-ancestor
111127200|NCT04906655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111127201|NCT04906655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111127202|NCT04906655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111127203|NCT03055091|Sorbitol|sorbitol|mesh-list
111127204|NCT03055091|Cathartics|cathartics|mesh-ancestor
111127205|NCT03055091|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111127206|NCT02648581|Ustekinumab|ustekinumab|mesh-list
111127207|NCT02648581|Dermatologic Agents|dermatologic agents|mesh-ancestor
111127208|NCT02609815|Metformin|metformin|mesh-list
111127209|NCT02609815|Glimepiride|glimepiride|mesh-list
111127210|NCT02609815|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111127211|NCT02609815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111127212|NCT02609815|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111127213|NCT02609815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111127214|NCT02609815|Immunologic Factors|immunologic factors|mesh-ancestor
111127215|NCT05132023|Metformin|metformin|mesh-list
111127216|NCT05132023|Empagliflozin|empagliflozin|mesh-list
111127217|NCT05132023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111127218|NCT05132023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111127219|NCT05132023|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111127220|NCT05132023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111127221|NCT05131711|Immunomodulating Agents|immunomodulating agents|mesh-list
111127222|NCT05131711|Immunologic Factors|immunologic factors|mesh-ancestor
111127223|NCT05131711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111127224|NCT02619617|Pasireotide|pasireotide|mesh-list
111127225|NCT02619617|Hormones|hormones|mesh-ancestor
111127226|NCT02619617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111127227|NCT02619617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111127228|NCT04012957|Darbepoetin alfa|darbepoetin alfa|mesh-list
111127229|NCT04012957|Hematinics|hematinics|mesh-ancestor
111127230|NCT04906031|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
111127231|NCT04906031|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111127232|NCT04906031|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111127233|NCT04906031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111127234|NCT04906031|Schistosomicides|schistosomicides|mesh-ancestor
111127235|NCT04906031|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
111127236|NCT04906031|Anthelmintics|anthelmintics|mesh-ancestor
111127237|NCT05125627|Progesterone|progesterone|mesh-list
111127238|NCT05125627|Progestins|progestins|mesh-ancestor
111127239|NCT05125627|Hormones|hormones|mesh-ancestor
111127240|NCT05125627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111127241|NCT05125627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111127242|NCT05125549|Clopidogrel|clopidogrel|mesh-list
111127243|NCT05125549|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111127244|NCT05125549|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111127245|NCT05125549|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111127246|NCT05125549|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111127247|NCT05125549|Purinergic Agents|purinergic agents|mesh-ancestor
111127248|NCT05125549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111127249|NCT05125549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111127250|NCT05125549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111127251|NCT04903847|Tenofovir|tenofovir|mesh-list
111127252|NCT04903847|Lamivudine|lamivudine|mesh-list
111127253|NCT04903847|Dolutegravir|dolutegravir|mesh-list
111127254|NCT04903847|Antiviral Agents|antiviral agents|mesh-ancestor
111127255|NCT04903847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111127256|NCT04903847|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111127257|NCT04903847|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111127258|NCT04903847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111127259|NCT04903847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111127260|NCT04903847|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111127261|NCT04903847|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111127262|NCT04903847|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111127263|NCT04903847|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111127264|NCT04905953|Neostigmine|neostigmine|mesh-list
111127265|NCT04905953|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111127266|NCT04905953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111127267|NCT04905953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111127268|NCT04905953|Cholinergic Agents|cholinergic agents|mesh-ancestor
111127269|NCT04905953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111127270|NCT04905953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111127271|NCT04905953|Parasympathomimetics|parasympathomimetics|mesh-ancestor
111127272|NCT04905953|Autonomic Agents|autonomic agents|mesh-ancestor
111127273|NCT04905953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111127274|NCT04916093|Metformin|metformin|mesh-list
111127275|NCT04916093|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111127276|NCT04916093|Vildagliptin|vildagliptin|mesh-list
110844321|NCT01160705|Docetaxel|docetaxel|mesh-list
111127277|NCT04916093|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111127278|NCT04916093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111127279|NCT04916093|Incretins|incretins|mesh-ancestor
111127280|NCT04916093|Hormones|hormones|mesh-ancestor
111127281|NCT04916093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110836736|NCT03780205|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111127282|NCT04916093|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111127283|NCT04916093|Protease Inhibitors|protease inhibitors|mesh-ancestor
111127284|NCT04916093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111127285|NCT04916093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111127286|NCT05130619|Ethanol|ethanol|mesh-list
111127287|NCT05130619|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111127288|NCT05130619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111127289|NCT05130619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111127290|NCT05130619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111127291|NCT03512119|Ivacaftor|ivacaftor|mesh-list
111127292|NCT03512119|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
111127293|NCT03512119|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111127294|NCT03512119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110074932|NCT01595685|Entecavir|entecavir|mesh-list
111127295|NCT02642809|Pembrolizumab|pembrolizumab|mesh-list
111127296|NCT02642809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111127297|NCT02642809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111127298|NCT02642809|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111127299|NCT02642809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111127300|NCT03052361|Ondansetron|ondansetron|mesh-list
111127301|NCT03052361|Antiemetics|antiemetics|mesh-ancestor
111127302|NCT03052361|Autonomic Agents|autonomic agents|mesh-ancestor
111127303|NCT03052361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111127304|NCT03052361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111127305|NCT03052361|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111127306|NCT03052361|Antipruritics|antipruritics|mesh-ancestor
111127307|NCT03052361|Dermatologic Agents|dermatologic agents|mesh-ancestor
111127308|NCT03052361|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111127309|NCT03052361|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111127310|NCT03052361|Serotonin Agents|serotonin agents|mesh-ancestor
111127311|NCT03052361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111127312|NCT03052361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111127313|NCT02370589|Vaccines|vaccines|mesh-list
111127314|NCT02370589|Immunologic Factors|immunologic factors|mesh-ancestor
111127315|NCT02370589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111127316|NCT04966507|Listerine|listerine|mesh-list
111127317|NCT04966507|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
111127318|NCT04966507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111127319|NCT04949113|Nivolumab|nivolumab|mesh-list
111127320|NCT04949113|Ipilimumab|ipilimumab|mesh-list
111127321|NCT04949113|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111127322|NCT04949113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111127323|NCT04949113|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111127324|NCT04949113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111127325|NCT05057845|Lenvatinib|lenvatinib|mesh-list
111127326|NCT05057845|Tislelizumab|tislelizumab|mesh-list
111127327|NCT05057845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111127328|NCT05057845|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111127329|NCT05057845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111127330|NCT05057845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111127331|NCT05057845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111127332|NCT05109949|Dapagliflozin|dapagliflozin|mesh-list
111127333|NCT05109949|Empagliflozin|empagliflozin|mesh-list
111127334|NCT05109949|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111127335|NCT05109949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111127336|NCT05109949|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111127337|NCT05109949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111127338|NCT04901663|Amoxicillin|amoxicillin|mesh-list
111127339|NCT04901663|Clarithromycin|clarithromycin|mesh-list
111127340|NCT04901663|Omeprazole|omeprazole|mesh-list
111127341|NCT04901663|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111127342|NCT04901663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111127343|NCT04901663|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111127344|NCT04901663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111127345|NCT04901663|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111127346|NCT04901663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111127347|NCT04901663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111127348|NCT04901663|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111127349|NCT04901663|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110075159|NCT01596556|Nicotine|nicotine|mesh-list
111127350|NCT04901663|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111127351|NCT05134519|Trastuzumab|trastuzumab|mesh-list
111127352|NCT05134519|Antibodies|antibodies|mesh-list
111127353|NCT05134519|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111127354|NCT05134519|Immunologic Factors|immunologic factors|mesh-ancestor
111127355|NCT05134519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111127356|NCT05134519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111127357|NCT05134519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111127358|NCT04394663|Omeprazole|omeprazole|mesh-list
111127359|NCT04394663|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111127360|NCT04394663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111127361|NCT04394663|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111127362|NCT04394663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111127363|NCT04394663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111127364|NCT05133193|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111127365|NCT05133193|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
111127366|NCT05133193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111127367|NCT05133193|Antitubercular Agents|antitubercular agents|mesh-ancestor
111127368|NCT04901117|Amoxicillin|amoxicillin|mesh-list
111127369|NCT04901117|Metronidazole|metronidazole|mesh-list
111127370|NCT04901117|Clarithromycin|clarithromycin|mesh-list
111127371|NCT04901117|Tetracycline|tetracycline|mesh-list
111127372|NCT04901117|Potassium Citrate|potassium citrate|mesh-list
111127373|NCT04901117|Bismuth|bismuth|mesh-list
111127374|NCT04901117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111127375|NCT04901117|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111127376|NCT04901117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111127377|NCT04901117|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111127378|NCT04901117|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111127379|NCT04901117|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111127380|NCT04901117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111127381|NCT04901117|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111127382|NCT04901117|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111127383|NCT04901117|Antacids|antacids|mesh-ancestor
111127384|NCT04901117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111127385|NCT04901117|Diuretics|diuretics|mesh-ancestor
111127386|NCT04901117|Natriuretic Agents|natriuretic agents|mesh-ancestor
110075235|NCT01596764|Loperamide|loperamide|mesh-list
111127387|NCT04901117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111127388|NCT04901117|Expectorants|expectorants|mesh-ancestor
111127389|NCT04901117|Respiratory System Agents|respiratory system agents|mesh-ancestor
111127390|NCT05121571|Sorafenib|sorafenib|mesh-list
111127391|NCT05121571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111127392|NCT05121571|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111127393|NCT05121571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111127394|NCT05121571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111127395|NCT03051269|Calcium, Dietary|calcium, dietary|mesh-list
111127396|NCT03051269|Calcium|calcium|mesh-list
111127397|NCT03051269|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111127398|NCT03051269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111127399|NCT03051269|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111127400|NCT04576663|Phenylephrine|phenylephrine|mesh-list
111127401|NCT04576663|Oxymetazoline|oxymetazoline|mesh-list
111127402|NCT04576663|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111127403|NCT04576663|Mydriatics|mydriatics|mesh-ancestor
111127404|NCT04576663|Autonomic Agents|autonomic agents|mesh-ancestor
111127405|NCT04576663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111127406|NCT04576663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111127407|NCT04576663|Sympathomimetics|sympathomimetics|mesh-ancestor
111127408|NCT04576663|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111127409|NCT04576663|Nasal Decongestants|nasal decongestants|mesh-ancestor
111127410|NCT04576663|Respiratory System Agents|respiratory system agents|mesh-ancestor
111127411|NCT04576663|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111127412|NCT04576663|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111127413|NCT04576663|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111127414|NCT04576663|Adrenergic Agents|adrenergic agents|mesh-ancestor
111127415|NCT04576663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111127416|NCT04576663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111127417|NCT04576663|Protective Agents|protective agents|mesh-ancestor
111127418|NCT05281549|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
111127419|NCT05281549|Tenecteplase|tenecteplase|mesh-list
111127420|NCT05281549|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111127421|NCT05281549|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111127422|NCT05281549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111127423|NCT04400695|Paclitaxel|paclitaxel|mesh-list
111127424|NCT04400695|Vinorelbine|vinorelbine|mesh-list
111127425|NCT04400695|Docetaxel|docetaxel|mesh-list
111127426|NCT04400695|Capecitabine|capecitabine|mesh-list
111127427|NCT04400695|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111127428|NCT04400695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111127429|NCT04400695|Tubulin Modulators|tubulin modulators|mesh-ancestor
111127430|NCT04400695|Antimitotic Agents|antimitotic agents|mesh-ancestor
111127431|NCT04400695|Mitosis Modulators|mitosis modulators|mesh-ancestor
111127432|NCT04400695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111127433|NCT04400695|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111127434|NCT04400695|Antimetabolites|antimetabolites|mesh-ancestor
111127435|NCT05191225|Rituximab|rituximab|mesh-list
111127436|NCT05191225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111127437|NCT05191225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111127438|NCT05191225|Immunologic Factors|immunologic factors|mesh-ancestor
111127439|NCT05191225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111127440|NCT05191225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111127441|NCT03909217|Dexetimide|dexetimide|mesh-list
111127442|NCT03909217|Citalopram|citalopram|mesh-list
111127443|NCT03909217|Escitalopram|escitalopram|mesh-list
111127444|NCT03909217|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111127445|NCT03909217|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111127446|NCT03909217|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111127447|NCT03909217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111127448|NCT03909217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111127449|NCT03909217|Serotonin Agents|serotonin agents|mesh-ancestor
111127450|NCT03909217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111127451|NCT03909217|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110075508|NCT01597895|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111127452|NCT03909217|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111127453|NCT03909217|Parasympatholytics|parasympatholytics|mesh-ancestor
111127454|NCT03909217|Autonomic Agents|autonomic agents|mesh-ancestor
111127455|NCT03909217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111127456|NCT03909217|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111127457|NCT03909217|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111127458|NCT03909217|Cholinergic Agents|cholinergic agents|mesh-ancestor
111127459|NCT03909217|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111127460|NCT03909217|Antidepressive Agents|antidepressive agents|mesh-ancestor
111127461|NCT03909217|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111127462|NCT02650921|Lidocaine|lidocaine|mesh-list
111127463|NCT02650921|Anesthetics, Local|anesthetics, local|mesh-ancestor
111127464|NCT02650921|Anesthetics|anesthetics|mesh-ancestor
111127465|NCT02650921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111127466|NCT02650921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111127467|NCT02650921|Sensory System Agents|sensory system agents|mesh-ancestor
111127468|NCT02650921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111127469|NCT02650921|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110075643|NCT01598584|Gemcitabine|gemcitabine|mesh-list
111127470|NCT02650921|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111127471|NCT02650921|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111127472|NCT02650921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111127473|NCT02650921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111127474|NCT04913987|Cimetidine|cimetidine|mesh-list
111127475|NCT04913987|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111127476|NCT04913987|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111127477|NCT04913987|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
111127478|NCT04913987|Histamine Antagonists|histamine antagonists|mesh-ancestor
111127479|NCT04913987|Histamine Agents|histamine agents|mesh-ancestor
111127480|NCT04913987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111127481|NCT04913987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111127482|NCT04913987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111127483|NCT04913987|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111127484|NCT04913987|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111127485|NCT04913987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111127486|NCT01596335|Immunoglobulins|immunoglobulins|mesh-list
111127487|NCT01596335|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111127488|NCT01596335|Antibodies|antibodies|mesh-list
111127489|NCT01596335|Immunologic Factors|immunologic factors|mesh-ancestor
111127490|NCT01596335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111127491|NCT04891679|Misoprostol|misoprostol|mesh-list
111127492|NCT04891679|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111127493|NCT04891679|Abortifacient Agents|abortifacient agents|mesh-ancestor
111127494|NCT04891679|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111127495|NCT04891679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111127496|NCT04891679|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111127497|NCT04891679|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111127498|NCT04891679|Oxytocics|oxytocics|mesh-ancestor
111127499|NCT04913831|Cerebrolysin|cerebrolysin|mesh-list
111127500|NCT04913831|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111127501|NCT04913831|Protective Agents|protective agents|mesh-ancestor
111127502|NCT04913831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111127503|NCT04913831|Nootropic Agents|nootropic agents|mesh-ancestor
111127505|NCT04900415|Vitamins|vitamins|mesh-ancestor
111127506|NCT04900415|Micronutrients|micronutrients|mesh-ancestor
111127507|NCT04900415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111127508|NCT04900571|Nitrofurantoin|nitrofurantoin|mesh-list
111127509|NCT04900571|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111127510|NCT04900571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111127511|NCT04900571|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111127512|NCT04891211|Vitamin D|vitamin d|mesh-list
111127513|NCT04891211|Vitamins|vitamins|mesh-ancestor
111127514|NCT04891211|Micronutrients|micronutrients|mesh-ancestor
111127515|NCT04891211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111127516|NCT04891211|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111127517|NCT03050957|Menthol|menthol|mesh-list
111127518|NCT03050957|Antipruritics|antipruritics|mesh-ancestor
111127519|NCT03050957|Dermatologic Agents|dermatologic agents|mesh-ancestor
111127520|NCT04885049|Racecadotril|racecadotril|mesh-list
111127521|NCT04885049|Antidiarrheals|antidiarrheals|mesh-ancestor
111127522|NCT04885049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111127523|NCT04885049|Protease Inhibitors|protease inhibitors|mesh-ancestor
111127524|NCT04885049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111127525|NCT04885049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111127526|NCT04890353|Dimethyl Fumarate|dimethyl fumarate|mesh-list
111127527|NCT04890353|Dermatologic Agents|dermatologic agents|mesh-ancestor
111127528|NCT04890353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111127529|NCT04890353|Immunologic Factors|immunologic factors|mesh-ancestor
111127530|NCT04890353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111127531|NCT04430621|Hormones|hormones|mesh-list
111127532|NCT04430621|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
111127533|NCT04430621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111127534|NCT04430621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111127535|NCT04884503|Clonazepam|clonazepam|mesh-list
111127536|NCT04884503|Anticonvulsants|anticonvulsants|mesh-ancestor
111127537|NCT04884503|GABA Modulators|gaba modulators|mesh-ancestor
111127538|NCT04884503|GABA Agents|gaba agents|mesh-ancestor
111127539|NCT04884503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111127540|NCT04884503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111127541|NCT04884503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111127542|NCT04889651|Abiraterone Acetate|abiraterone acetate|mesh-list
111127543|NCT04889651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111127544|NCT04889651|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111127545|NCT04889651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111127546|NCT04889651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111127547|NCT04889651|Hormone Antagonists|hormone antagonists|mesh-ancestor
111127548|NCT04889651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111127549|NCT04889651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111127550|NCT04889651|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111127551|NCT04898699|Tenofovir|tenofovir|mesh-list
111127552|NCT04898699|Emtricitabine|emtricitabine|mesh-list
111127553|NCT04898699|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
111127554|NCT04898699|Antiviral Agents|antiviral agents|mesh-ancestor
111127555|NCT04898699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111127556|NCT04898699|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111127557|NCT04898699|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111127558|NCT04898699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111127559|NCT04898699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111127560|NCT04898699|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111127561|NCT04898699|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111127562|NCT04888715|Pirfenidone|pirfenidone|mesh-list
111127563|NCT04888715|Nintedanib|nintedanib|mesh-list
111127564|NCT04888715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111127565|NCT04888715|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111127566|NCT04888715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111127567|NCT04888715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111127568|NCT04888715|Analgesics|analgesics|mesh-ancestor
111127569|NCT04888715|Sensory System Agents|sensory system agents|mesh-ancestor
111127570|NCT04888715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111127571|NCT04888715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111127572|NCT04888715|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111127573|NCT04888715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111127574|NCT04888715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111127575|NCT04888715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111127576|NCT04888403|Paclitaxel|paclitaxel|mesh-list
111127578|NCT04888403|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111127579|NCT04888403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111127580|NCT04888403|Tubulin Modulators|tubulin modulators|mesh-ancestor
111127581|NCT04888403|Antimitotic Agents|antimitotic agents|mesh-ancestor
110075931|NCT05473195|Isoniazid|isoniazid|mesh-list
111127582|NCT04888403|Mitosis Modulators|mitosis modulators|mesh-ancestor
111127583|NCT04888403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111127584|NCT03050177|Gefitinib|gefitinib|mesh-list
111127585|NCT03050177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111127586|NCT03050177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111127587|NCT03050177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111127588|NCT03050177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111127589|NCT03051581|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
111127590|NCT03051581|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111127591|NCT03051581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111127592|NCT03050411|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111127593|NCT03050411|Apatinib|apatinib|mesh-list
111127594|NCT03050411|Gefitinib|gefitinib|mesh-list
111127595|NCT03050411|Osimertinib|osimertinib|mesh-list
111127596|NCT03050411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110075994|NCT05189483|Tubulin Modulators|tubulin modulators|mesh-ancestor
111127597|NCT03050411|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111127598|NCT03050411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111127599|NCT03050411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111127600|NCT04887311|Tempol|tempol|mesh-list
111127601|NCT04887311|Antioxidants|antioxidants|mesh-ancestor
111127602|NCT04887311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111127603|NCT04887311|Protective Agents|protective agents|mesh-ancestor
111127604|NCT04887311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111127605|NCT04887311|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111127606|NCT04887311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111127607|NCT04887311|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111127608|NCT04887311|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111127609|NCT03051503|Fentanyl|fentanyl|mesh-list
111127610|NCT03051503|Morphine|morphine|mesh-list
111127611|NCT03051503|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111127612|NCT03051503|Narcotics|narcotics|mesh-ancestor
111127613|NCT03051503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111127614|NCT03051503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111127615|NCT03051503|Analgesics|analgesics|mesh-ancestor
111127616|NCT03051503|Sensory System Agents|sensory system agents|mesh-ancestor
111127617|NCT03051503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111127618|NCT03051503|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111127619|NCT03051503|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111127620|NCT03051503|Anesthetics, General|anesthetics, general|mesh-ancestor
111127621|NCT03051503|Anesthetics|anesthetics|mesh-ancestor
111127622|NCT04896125|Bimatoprost|bimatoprost|mesh-list
111127623|NCT04896125|Latanoprost|latanoprost|mesh-list
111127624|NCT04896125|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
111127625|NCT04896125|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111127626|NCT04896125|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111127627|NCT04895657|Tazobactam|tazobactam|mesh-list
111127628|NCT04895657|Piperacillin|piperacillin|mesh-list
111127629|NCT04895657|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
111127630|NCT04895657|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111127631|NCT04895657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111127632|NCT04895657|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
111127633|NCT04895657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111127634|NCT04895657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111127635|NCT04895423|Cyclosporine|cyclosporine|mesh-list
111127636|NCT04895423|Mycophenolic Acid|mycophenolic acid|mesh-list
111127637|NCT04895423|Methotrexate|methotrexate|mesh-list
111127638|NCT04895423|Cyclosporins|cyclosporins|mesh-list
111127639|NCT04895423|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111127640|NCT04895423|Abortifacient Agents|abortifacient agents|mesh-ancestor
111127641|NCT04895423|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110162001|NCT00007202|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111127642|NCT04895423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111127643|NCT04895423|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111127644|NCT04895423|Antimetabolites|antimetabolites|mesh-ancestor
111127645|NCT04895423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111127646|NCT04895423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111127647|NCT04895423|Dermatologic Agents|dermatologic agents|mesh-ancestor
111127648|NCT04895423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111127649|NCT04895423|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111127650|NCT04895423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111127651|NCT04895423|Immunologic Factors|immunologic factors|mesh-ancestor
110076178|NCT04265755|Erenumab|erenumab|mesh-list
111127652|NCT04895423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111127653|NCT04895423|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111127654|NCT04895423|Antifungal Agents|antifungal agents|mesh-ancestor
111127655|NCT04895423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111127656|NCT04895423|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111127657|NCT04895423|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111127658|NCT04895423|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111127659|NCT04895423|Antitubercular Agents|antitubercular agents|mesh-ancestor
111127660|NCT04895423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111127661|NCT04882163|Dexamethasone|dexamethasone|mesh-list
111127662|NCT04882163|Rituximab|rituximab|mesh-list
111127663|NCT04882163|Gemcitabine|gemcitabine|mesh-list
111127664|NCT04882163|Lenalidomide|lenalidomide|mesh-list
111127665|NCT04882163|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
111127666|NCT04882163|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
111127667|NCT04882163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111127668|NCT04882163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111127669|NCT04882163|Immunologic Factors|immunologic factors|mesh-ancestor
111127670|NCT04882163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110076235|NCT03547999|Nivolumab|nivolumab|mesh-list
111127671|NCT04882163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111127672|NCT04882163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111127673|NCT04882163|Antiemetics|antiemetics|mesh-ancestor
111127674|NCT04882163|Autonomic Agents|autonomic agents|mesh-ancestor
111127675|NCT04882163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111127676|NCT04882163|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111127677|NCT04882163|Glucocorticoids|glucocorticoids|mesh-ancestor
111127678|NCT04882163|Hormones|hormones|mesh-ancestor
111127679|NCT04882163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111127680|NCT04882163|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111127681|NCT04882163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110076295|NCT03294954|Fludarabine|fludarabine|mesh-list
111127682|NCT04882163|Antimetabolites|antimetabolites|mesh-ancestor
111127683|NCT04882163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111127684|NCT04882163|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111127685|NCT04882163|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111127686|NCT04882163|Growth Substances|growth substances|mesh-ancestor
111127687|NCT04882163|Growth Inhibitors|growth inhibitors|mesh-ancestor
111127688|NCT04882163|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111127689|NCT04882163|Alkylating Agents|alkylating agents|mesh-ancestor
111127690|NCT04882163|Immunoconjugates|immunoconjugates|mesh-ancestor
111127691|NCT04885751|Rebamipide|rebamipide|mesh-list
111127692|NCT04885751|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111127693|NCT04885751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111127694|NCT04885751|Antioxidants|antioxidants|mesh-ancestor
111127695|NCT04885751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111127696|NCT04885751|Protective Agents|protective agents|mesh-ancestor
111127697|NCT04885751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111127698|NCT04885751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111127699|NCT03049163|Proxymetacaine|proxymetacaine|mesh-list
111127700|NCT03049163|Propoxycaine|propoxycaine|mesh-list
111127701|NCT03049163|Anesthetics|anesthetics|mesh-ancestor
111127702|NCT03049163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111127703|NCT03049163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111127704|NCT03049163|Anesthetics, Local|anesthetics, local|mesh-ancestor
110076413|NCT05702190|Analgesics|analgesics|mesh-ancestor
111127705|NCT03049163|Sensory System Agents|sensory system agents|mesh-ancestor
111127706|NCT03049163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111127708|NCT04881851|Thioctic Acid|thioctic acid|mesh-list
111127709|NCT04881851|Inositol|inositol|mesh-list
111127710|NCT04881851|Hematinics|hematinics|mesh-ancestor
111127711|NCT04881851|Vitamin B Complex|vitamin b complex|mesh-ancestor
111127712|NCT04881851|Vitamins|vitamins|mesh-ancestor
111127713|NCT04881851|Micronutrients|micronutrients|mesh-ancestor
111127714|NCT04881851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111127715|NCT04881851|Antioxidants|antioxidants|mesh-ancestor
111127716|NCT04881851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111127717|NCT04881851|Protective Agents|protective agents|mesh-ancestor
111127718|NCT04871633|Azithromycin|azithromycin|mesh-list
111127719|NCT04871633|Remdesivir|remdesivir|mesh-list
111127720|NCT04871633|Dexamethasone|dexamethasone|mesh-list
111127721|NCT04871633|Prednisolone|prednisolone|mesh-list
111127722|NCT04871633|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111127723|NCT04871633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111127724|NCT04871633|Antiemetics|antiemetics|mesh-ancestor
111127725|NCT04871633|Autonomic Agents|autonomic agents|mesh-ancestor
111127726|NCT04871633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110844779|NCT04445506|Hormones|hormones|mesh-ancestor
110076483|NCT05271799|Gepotidacin|gepotidacin|mesh-list
111127727|NCT04871633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111127728|NCT04871633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111127729|NCT04871633|Glucocorticoids|glucocorticoids|mesh-ancestor
111127731|NCT04871633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111127732|NCT04871633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111127733|NCT04871633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111127734|NCT04871633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111127735|NCT04871633|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111127736|NCT04871633|Protective Agents|protective agents|mesh-ancestor
111127737|NCT04871633|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111127738|NCT04871633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111127739|NCT04871633|Antimetabolites|antimetabolites|mesh-ancestor
111127740|NCT04871633|Antiviral Agents|antiviral agents|mesh-ancestor
111127741|NCT04880993|Dapagliflozin|dapagliflozin|mesh-list
111127742|NCT04880993|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110183520|NCT00030420|Celecoxib|celecoxib|mesh-list
111127743|NCT04880993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111127744|NCT04880993|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111127745|NCT04880993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111127746|NCT03046979|Apatinib|apatinib|mesh-list
111127747|NCT03046979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111127748|NCT03046979|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111127749|NCT03046979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111127750|NCT03046979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111127751|NCT04676399|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
111127752|NCT04676399|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111127753|NCT04676399|Diuretics|diuretics|mesh-ancestor
111127754|NCT04676399|Natriuretic Agents|natriuretic agents|mesh-ancestor
111127755|NCT04676399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111127756|NCT04676399|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
111127757|NCT04676399|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111127758|NCT04676399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111127759|NCT03047057|Lidocaine|lidocaine|mesh-list
111127760|NCT03047057|Anesthetics, Local|anesthetics, local|mesh-ancestor
111127761|NCT03047057|Anesthetics|anesthetics|mesh-ancestor
111127762|NCT03047057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111127763|NCT03047057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111127764|NCT03047057|Sensory System Agents|sensory system agents|mesh-ancestor
111127765|NCT03047057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111127766|NCT03047057|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110076681|NCT03481634|Aflibercept|aflibercept|mesh-list
111127767|NCT03047057|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111127768|NCT03047057|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111127769|NCT03047057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111127770|NCT03047057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111127771|NCT04550195|Famotidine|famotidine|mesh-list
111127772|NCT04550195|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111127773|NCT04550195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111127774|NCT04550195|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
111127775|NCT04550195|Histamine Antagonists|histamine antagonists|mesh-ancestor
111127776|NCT04550195|Histamine Agents|histamine agents|mesh-ancestor
111127777|NCT04550195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111127778|NCT04550195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111127779|NCT04550195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111127780|NCT04525391|Durvalumab|durvalumab|mesh-list
111127781|NCT04525391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111127782|NCT04525391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111127783|NCT04879511|Metformin|metformin|mesh-list
111127784|NCT04879511|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111127785|NCT04879511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111127786|NCT04361825|Durvalumab|durvalumab|mesh-list
111127787|NCT04361825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111127788|NCT04361825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111127789|NCT03046901|Vancomycin|vancomycin|mesh-list
111127790|NCT03046901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111127791|NCT03046901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111127792|NCT03871049|Dexamethasone|dexamethasone|mesh-list
111127793|NCT03871049|Bupivacaine|bupivacaine|mesh-list
110076744|NCT03106454|Micronutrients|micronutrients|mesh-ancestor
111127794|NCT03871049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111127795|NCT03871049|Antiemetics|antiemetics|mesh-ancestor
111127796|NCT03871049|Autonomic Agents|autonomic agents|mesh-ancestor
111127797|NCT03871049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111127798|NCT03871049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111127799|NCT03871049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111127800|NCT03871049|Glucocorticoids|glucocorticoids|mesh-ancestor
111127801|NCT03871049|Hormones|hormones|mesh-ancestor
111127802|NCT03871049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111127803|NCT03871049|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111127804|NCT03871049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111127805|NCT03871049|Anesthetics, Local|anesthetics, local|mesh-ancestor
111127806|NCT03871049|Anesthetics|anesthetics|mesh-ancestor
111127807|NCT03871049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111127808|NCT03871049|Sensory System Agents|sensory system agents|mesh-ancestor
111127810|NCT04870541|Ondansetron|ondansetron|mesh-list
111127811|NCT04870541|Antiemetics|antiemetics|mesh-ancestor
111127812|NCT04870541|Autonomic Agents|autonomic agents|mesh-ancestor
111127813|NCT04870541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111127814|NCT04870541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111127815|NCT04870541|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111127816|NCT04870541|Antipruritics|antipruritics|mesh-ancestor
111127817|NCT04870541|Dermatologic Agents|dermatologic agents|mesh-ancestor
111127818|NCT04870541|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111127819|NCT04870541|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111127820|NCT04870541|Serotonin Agents|serotonin agents|mesh-ancestor
111127821|NCT04870541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111127822|NCT04870541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111127823|NCT04870541|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111127824|NCT04870541|Analgesics|analgesics|mesh-ancestor
111127825|NCT04870541|Sensory System Agents|sensory system agents|mesh-ancestor
111127826|NCT04870073|Mannitol|mannitol|mesh-list
111127827|NCT04870073|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
111127828|NCT04870073|Diuretics|diuretics|mesh-ancestor
111127829|NCT04870073|Natriuretic Agents|natriuretic agents|mesh-ancestor
111127830|NCT04870073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111127831|NCT02616029|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
111127832|NCT02616029|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111127833|NCT02616029|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111127834|NCT02616029|Antiviral Agents|antiviral agents|mesh-ancestor
111127835|NCT02616029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111127836|NCT04878497|Warfarin|warfarin|mesh-list
111127837|NCT04878497|Rivaroxaban|rivaroxaban|mesh-list
111127838|NCT04878497|Dabigatran|dabigatran|mesh-list
111127839|NCT04878497|Apixaban|apixaban|mesh-list
111127840|NCT04878497|Edoxaban|edoxaban|mesh-list
111127841|NCT04878497|Anticoagulants|anticoagulants|mesh-ancestor
111127842|NCT04878497|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111127843|NCT04878497|Antithrombins|antithrombins|mesh-ancestor
111127844|NCT04878497|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111127845|NCT04878497|Protease Inhibitors|protease inhibitors|mesh-ancestor
111127846|NCT04878497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111127847|NCT04878497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111127848|NCT03257033|Paclitaxel|paclitaxel|mesh-list
111127849|NCT03257033|Gemcitabine|gemcitabine|mesh-list
111127850|NCT03257033|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111127851|NCT03257033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111127852|NCT03257033|Tubulin Modulators|tubulin modulators|mesh-ancestor
111127853|NCT03257033|Antimitotic Agents|antimitotic agents|mesh-ancestor
111127854|NCT03257033|Mitosis Modulators|mitosis modulators|mesh-ancestor
111127855|NCT03257033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111127856|NCT03257033|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111127857|NCT03257033|Antimetabolites|antimetabolites|mesh-ancestor
111127858|NCT03250169|Alemtuzumab|alemtuzumab|mesh-list
111127859|NCT03250169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111127860|NCT03250169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111127861|NCT02614859|Metformin|metformin|mesh-list
111127862|NCT02614859|Bicalutamide|bicalutamide|mesh-list
111127863|NCT02614859|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111127864|NCT02614859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111127865|NCT02614859|Androgen Antagonists|androgen antagonists|mesh-ancestor
111127866|NCT02614859|Hormone Antagonists|hormone antagonists|mesh-ancestor
111127867|NCT02614859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111127868|NCT02614859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111127869|NCT04876859|Anesthetics|anesthetics|mesh-list
111127870|NCT04876859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111127871|NCT04876859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111127872|NCT04876313|Paclitaxel|paclitaxel|mesh-list
111127873|NCT04876313|Nivolumab|nivolumab|mesh-list
111127874|NCT04876313|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111127875|NCT04876313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111127876|NCT04876313|Tubulin Modulators|tubulin modulators|mesh-ancestor
111127877|NCT04876313|Antimitotic Agents|antimitotic agents|mesh-ancestor
111127878|NCT04876313|Mitosis Modulators|mitosis modulators|mesh-ancestor
110844929|NCT04280328|Daratumumab|daratumumab|mesh-list
111127879|NCT04876313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111127880|NCT04876313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111127881|NCT04876313|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111127882|NCT03049085|Aspirin|aspirin|mesh-list
111127883|NCT03049085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111127884|NCT03049085|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111127885|NCT03049085|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111127886|NCT03049085|Analgesics|analgesics|mesh-ancestor
111127887|NCT03049085|Sensory System Agents|sensory system agents|mesh-ancestor
111127888|NCT03049085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111127889|NCT03049085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111127890|NCT03049085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111127891|NCT03049085|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111127892|NCT03049085|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111127893|NCT03049085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111127894|NCT03049085|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111127895|NCT03049085|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111127896|NCT03049085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111127897|NCT03049085|Antipyretics|antipyretics|mesh-ancestor
111127898|NCT04875611|Nivolumab|nivolumab|mesh-list
111127899|NCT04875611|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111127900|NCT04875611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111127901|NCT04875611|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111127902|NCT04875611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111127903|NCT04386317|Terazosin|terazosin|mesh-list
111127904|NCT04386317|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111127905|NCT04386317|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111127906|NCT04386317|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111127907|NCT04386317|Adrenergic Agents|adrenergic agents|mesh-ancestor
111127908|NCT04386317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111127909|NCT04386317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111127910|NCT04386317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111127911|NCT04386317|Urological Agents|urological agents|mesh-ancestor
111127912|NCT05256953|Anesthetics|anesthetics|mesh-list
111127913|NCT05256953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111127914|NCT05256953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111127915|NCT04874675|Acetaminophen|acetaminophen|mesh-list
111127916|NCT04874675|Ibuprofen|ibuprofen|mesh-list
111127917|NCT04874675|Diclofenac|diclofenac|mesh-list
111127918|NCT04874675|Codeine|codeine|mesh-list
111127919|NCT04874675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111127920|NCT04874675|Analgesics|analgesics|mesh-ancestor
111127921|NCT04874675|Sensory System Agents|sensory system agents|mesh-ancestor
111127922|NCT04874675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111127923|NCT04874675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111127924|NCT04874675|Antipyretics|antipyretics|mesh-ancestor
111127925|NCT04874675|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111127926|NCT04874675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111127927|NCT04874675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111127928|NCT04874675|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111127929|NCT04874675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111127930|NCT04874675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111127931|NCT04874675|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111127932|NCT04874675|Narcotics|narcotics|mesh-ancestor
111127933|NCT04874675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111127934|NCT04874675|Antitussive Agents|antitussive agents|mesh-ancestor
111127935|NCT04874675|Respiratory System Agents|respiratory system agents|mesh-ancestor
111127936|NCT04868513|Chlorhexidine|chlorhexidine|mesh-list
111127937|NCT04868513|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
111127938|NCT04868513|Fluorides|fluorides|mesh-list
111127939|NCT04868513|Cariostatic Agents|cariostatic agents|mesh-ancestor
111127940|NCT04868513|Protective Agents|protective agents|mesh-ancestor
111127941|NCT04868513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111127942|NCT04868513|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111127943|NCT04868513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111127944|NCT04868513|Disinfectants|disinfectants|mesh-ancestor
111127945|NCT04868513|Dermatologic Agents|dermatologic agents|mesh-ancestor
111127946|NCT03047837|Aspirin|aspirin|mesh-list
111127947|NCT03047837|Metformin|metformin|mesh-list
111127948|NCT03047837|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111127949|NCT03047837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111127950|NCT03047837|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111127951|NCT03047837|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111127952|NCT03047837|Analgesics|analgesics|mesh-ancestor
111127953|NCT03047837|Sensory System Agents|sensory system agents|mesh-ancestor
111127954|NCT03047837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111127955|NCT03047837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111127956|NCT03047837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111127957|NCT03047837|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111127958|NCT03047837|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111127959|NCT03047837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111127960|NCT03047837|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111127961|NCT03047837|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111127962|NCT03047837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111127963|NCT03047837|Antipyretics|antipyretics|mesh-ancestor
111127964|NCT05256173|Melatonin|melatonin|mesh-list
111127965|NCT05256173|Antioxidants|antioxidants|mesh-ancestor
111127966|NCT05256173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111127967|NCT05256173|Protective Agents|protective agents|mesh-ancestor
111127968|NCT05256173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111127969|NCT05256173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111127970|NCT02648347|Darbepoetin alfa|darbepoetin alfa|mesh-list
111127971|NCT02648347|Hematinics|hematinics|mesh-ancestor
111127972|NCT02614703|Acetic Acid|acetic acid|mesh-list
111127973|NCT02614703|Retinol acetate|retinol acetate|mesh-list
111127974|NCT02614703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111127975|NCT02614703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111127976|NCT02614703|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111127977|NCT02614703|Immunologic Factors|immunologic factors|mesh-ancestor
111127978|NCT02614703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111127979|NCT02614703|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
111127980|NCT02614703|Protective Agents|protective agents|mesh-ancestor
111127981|NCT02614703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111127982|NCT01669343|Letrozole|letrozole|mesh-list
111127983|NCT01669343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111127984|NCT01669343|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111127985|NCT01669343|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111127986|NCT01669343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111127987|NCT01669343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111127988|NCT01669343|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111127989|NCT01669343|Hormone Antagonists|hormone antagonists|mesh-ancestor
111127990|NCT01669343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111127991|NCT01669343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111127992|NCT04383743|Cisplatin|cisplatin|mesh-list
111127993|NCT04383743|Doxorubicin|doxorubicin|mesh-list
111127994|NCT04383743|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111127995|NCT04383743|Pembrolizumab|pembrolizumab|mesh-list
111127996|NCT04383743|Methotrexate|methotrexate|mesh-list
111127997|NCT04383743|Daunorubicin|daunorubicin|mesh-list
111127998|NCT04383743|Vinblastine|vinblastine|mesh-list
111127999|NCT04383743|Lenograstim|lenograstim|mesh-list
111128000|NCT04383743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111128001|NCT04383743|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111128002|NCT04383743|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111128003|NCT04383743|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111128004|NCT04383743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111128005|NCT04383743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111128006|NCT04383743|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111128007|NCT04383743|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111128008|NCT04383743|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111128009|NCT04383743|Abortifacient Agents|abortifacient agents|mesh-ancestor
111128010|NCT04383743|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111128011|NCT04383743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111128012|NCT04383743|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111128013|NCT04383743|Antimetabolites|antimetabolites|mesh-ancestor
111128014|NCT04383743|Dermatologic Agents|dermatologic agents|mesh-ancestor
111128015|NCT04383743|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110077059|NCT02702492|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111128016|NCT04383743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111128017|NCT04383743|Immunologic Factors|immunologic factors|mesh-ancestor
111128018|NCT04383743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111128019|NCT04383743|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111128020|NCT04383743|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111128021|NCT04383743|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111128022|NCT04383743|Tubulin Modulators|tubulin modulators|mesh-ancestor
111128023|NCT04383743|Antimitotic Agents|antimitotic agents|mesh-ancestor
111128024|NCT04383743|Mitosis Modulators|mitosis modulators|mesh-ancestor
111128025|NCT03126643|Nivolumab|nivolumab|mesh-list
111128026|NCT03126643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111128027|NCT03126643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110077119|NCT02466243|Lenabasum|lenabasum|mesh-list
111128028|NCT03126643|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111128029|NCT03126643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111128030|NCT04617067|Paclitaxel|paclitaxel|mesh-list
111128031|NCT04617067|Gemcitabine|gemcitabine|mesh-list
111128032|NCT04617067|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111128033|NCT04617067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111128034|NCT04617067|Tubulin Modulators|tubulin modulators|mesh-ancestor
111128035|NCT04617067|Antimitotic Agents|antimitotic agents|mesh-ancestor
111128036|NCT04617067|Mitosis Modulators|mitosis modulators|mesh-ancestor
111128037|NCT04617067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111128038|NCT04617067|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111128039|NCT04617067|Antimetabolites|antimetabolites|mesh-ancestor
111128040|NCT01594931|Artesunate|artesunate|mesh-list
111128041|NCT01594931|Pyronaridine|pyronaridine|mesh-list
111128042|NCT01594931|Antimalarials|antimalarials|mesh-ancestor
110836890|NCT04534582|Denosumab|denosumab|mesh-list
111128043|NCT01594931|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111128044|NCT01594931|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111128045|NCT01594931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111128046|NCT01594931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111128047|NCT01594931|Antiviral Agents|antiviral agents|mesh-ancestor
111128048|NCT01594931|Schistosomicides|schistosomicides|mesh-ancestor
111128049|NCT01594931|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
111128050|NCT01594931|Anthelmintics|anthelmintics|mesh-ancestor
111128051|NCT03045185|Metronidazole|metronidazole|mesh-list
111128052|NCT03045185|Ciprofloxacin|ciprofloxacin|mesh-list
111128053|NCT03045185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111128054|NCT03045185|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111128055|NCT03045185|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111128056|NCT03045185|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110077257|NCT01600430|Vitamin D|vitamin d|mesh-list
111128057|NCT03045185|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111128058|NCT03045185|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111128059|NCT03045185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111128060|NCT03045185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111128061|NCT03045185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111128062|NCT03045185|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111128063|NCT03045185|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111128064|NCT04969237|Vitamin D|vitamin d|mesh-list
111128065|NCT04969237|Vitamins|vitamins|mesh-ancestor
111128066|NCT04969237|Micronutrients|micronutrients|mesh-ancestor
111128067|NCT04969237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111128068|NCT04969237|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111128069|NCT04341467|Olanzapine|olanzapine|mesh-list
111128070|NCT04341467|Amisulpride|amisulpride|mesh-list
111128071|NCT04341467|Antiemetics|antiemetics|mesh-ancestor
111128072|NCT04341467|Autonomic Agents|autonomic agents|mesh-ancestor
111128073|NCT04341467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111128074|NCT04341467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111128075|NCT04341467|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111128076|NCT04341467|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111128077|NCT04341467|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111128078|NCT04341467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111128079|NCT04341467|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111128080|NCT04341467|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111128081|NCT04341467|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111128082|NCT04341467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111128083|NCT04341467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111128084|NCT04341467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111128085|NCT04341467|Serotonin Agents|serotonin agents|mesh-ancestor
111128086|NCT04341467|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111128087|NCT04341467|Dopamine Agents|dopamine agents|mesh-ancestor
111128088|NCT04341467|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111128089|NCT04341467|Antidepressive Agents|antidepressive agents|mesh-ancestor
111128090|NCT04872881|Fentanyl|fentanyl|mesh-list
111128091|NCT04872881|Propofol|propofol|mesh-list
111128092|NCT04872881|Rocuronium|rocuronium|mesh-list
111128093|NCT04872881|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111128094|NCT04872881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111128095|NCT04872881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111128096|NCT04872881|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111128097|NCT04872881|Anesthetics, General|anesthetics, general|mesh-ancestor
111128098|NCT04872881|Anesthetics|anesthetics|mesh-ancestor
111128099|NCT04872881|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111128100|NCT04872881|Narcotics|narcotics|mesh-ancestor
111128101|NCT04872881|Analgesics|analgesics|mesh-ancestor
111128102|NCT04872881|Sensory System Agents|sensory system agents|mesh-ancestor
110845157|NCT03745261|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111128103|NCT04872881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111128104|NCT04872881|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111128105|NCT04872881|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
111128106|NCT04872881|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
111128107|NCT04872881|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111128108|NCT03044873|Deucravacitinib|deucravacitinib|mesh-list
111128109|NCT03044873|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111128110|NCT03044873|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111128111|NCT03044873|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111128113|NCT03044873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111128114|NCT03044873|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111128115|NCT03044873|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111128116|NCT03044873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111128117|NCT03044873|Dermatologic Agents|dermatologic agents|mesh-ancestor
111128118|NCT03044873|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111128119|NCT03044795|Veliparib|veliparib|mesh-list
111128120|NCT03044795|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111128121|NCT03044795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111128122|NCT03044795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111128123|NCT03044795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111128124|NCT04341155|Dexamethasone|dexamethasone|mesh-list
111128125|NCT04341155|Dexamethasone acetate|dexamethasone acetate|mesh-list
111128126|NCT04341155|BB 1101|bb 1101|mesh-list
111128127|NCT04341155|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111128128|NCT04341155|Antiemetics|antiemetics|mesh-ancestor
111128129|NCT04341155|Autonomic Agents|autonomic agents|mesh-ancestor
111128130|NCT04341155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111128131|NCT04341155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111128132|NCT04341155|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111128133|NCT04341155|Glucocorticoids|glucocorticoids|mesh-ancestor
111128134|NCT04341155|Hormones|hormones|mesh-ancestor
111128135|NCT04341155|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111128136|NCT04341155|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111128137|NCT04341155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111128138|NCT04341155|Protease Inhibitors|protease inhibitors|mesh-ancestor
111128139|NCT04341155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111128140|NCT04341155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111128141|NCT04865705|Paclitaxel|paclitaxel|mesh-list
111128142|NCT04865705|Cisplatin|cisplatin|mesh-list
111128143|NCT04865705|Carboplatin|carboplatin|mesh-list
111128144|NCT04865705|Tislelizumab|tislelizumab|mesh-list
111128145|NCT04865705|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111128146|NCT04865705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111128147|NCT04865705|Tubulin Modulators|tubulin modulators|mesh-ancestor
111128148|NCT04865705|Antimitotic Agents|antimitotic agents|mesh-ancestor
111128149|NCT04865705|Mitosis Modulators|mitosis modulators|mesh-ancestor
111128150|NCT04865705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111128151|NCT04865705|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111128152|NCT04858997|Palbociclib|palbociclib|mesh-list
111128153|NCT04858997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111128154|NCT04858997|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111128155|NCT04858997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111128156|NCT04858997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111128157|NCT05135143|Antioxidants|antioxidants|mesh-list
111128158|NCT05135143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111128159|NCT05135143|Protective Agents|protective agents|mesh-ancestor
111128160|NCT05135143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111128161|NCT04865653|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
111128162|NCT04865653|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111128163|NCT04865653|Hallucinogens|hallucinogens|mesh-ancestor
111128164|NCT04865653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111128165|NCT04865653|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111128166|NCT04865653|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111128167|NCT04865653|Serotonin Agents|serotonin agents|mesh-ancestor
111128168|NCT04865653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111128169|NCT04865653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111128170|NCT04865653|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111128171|NCT05305183|Alendronate|alendronate|mesh-list
111128172|NCT05305183|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111128173|NCT05305183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111128174|NCT01668797|Brexpiprazole|brexpiprazole|mesh-list
111128175|NCT01668797|Serotonin Agents|serotonin agents|mesh-ancestor
111128176|NCT01668797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111128177|NCT01668797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110845230|NCT05666765|Isotretinoin|isotretinoin|mesh-list
111128178|NCT01668797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111128179|NCT01668797|Dopamine Agonists|dopamine agonists|mesh-ancestor
111128180|NCT01668797|Dopamine Agents|dopamine agents|mesh-ancestor
111128181|NCT05304559|Ketamine|ketamine|mesh-list
111128182|NCT05304559|Esketamine|esketamine|mesh-list
111128183|NCT05304559|Analgesics|analgesics|mesh-ancestor
111128184|NCT05304559|Sensory System Agents|sensory system agents|mesh-ancestor
111128185|NCT05304559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111128186|NCT05304559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111128187|NCT05304559|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111128188|NCT05304559|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111128189|NCT05304559|Anesthetics, General|anesthetics, general|mesh-ancestor
111128190|NCT05304559|Anesthetics|anesthetics|mesh-ancestor
111128191|NCT05304559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111128192|NCT05304559|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111128193|NCT05304559|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111128194|NCT05304559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111128195|NCT05304559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111128196|NCT05304559|Antidepressive Agents|antidepressive agents|mesh-ancestor
111128197|NCT05304559|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111128198|NCT02613221|Panitumumab|panitumumab|mesh-list
111128199|NCT02613221|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111128200|NCT02613221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111128201|NCT05304169|Leuprolide|leuprolide|mesh-list
111128202|NCT05304169|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111128203|NCT05304169|Fertility Agents|fertility agents|mesh-ancestor
111128204|NCT05304169|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111128205|NCT05304169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111128206|NCT05304169|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111128207|NCT05304169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111128208|NCT04858841|Levetiracetam|levetiracetam|mesh-list
111128209|NCT04858841|Anticonvulsants|anticonvulsants|mesh-ancestor
111128210|NCT04858841|Nootropic Agents|nootropic agents|mesh-ancestor
111128211|NCT04858529|Carboplatin|carboplatin|mesh-list
111128212|NCT04858529|Docetaxel|docetaxel|mesh-list
111128213|NCT04858529|Trastuzumab|trastuzumab|mesh-list
111128214|NCT04858529|Pertuzumab|pertuzumab|mesh-list
111128215|NCT04858529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111128216|NCT04858529|Tubulin Modulators|tubulin modulators|mesh-ancestor
111128217|NCT04858529|Antimitotic Agents|antimitotic agents|mesh-ancestor
111128218|NCT04858529|Mitosis Modulators|mitosis modulators|mesh-ancestor
111128219|NCT04858529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111128220|NCT04858529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111128221|NCT04682743|Acetaminophen|acetaminophen|mesh-list
111128222|NCT04682743|Ondansetron|ondansetron|mesh-list
111128223|NCT04682743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111128224|NCT04682743|Analgesics|analgesics|mesh-ancestor
111128225|NCT04682743|Sensory System Agents|sensory system agents|mesh-ancestor
111128226|NCT04682743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111128227|NCT04682743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111128228|NCT04682743|Antipyretics|antipyretics|mesh-ancestor
111128229|NCT04682743|Antiemetics|antiemetics|mesh-ancestor
111128230|NCT04682743|Autonomic Agents|autonomic agents|mesh-ancestor
111128231|NCT04682743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111128232|NCT04682743|Antipruritics|antipruritics|mesh-ancestor
111128233|NCT04682743|Dermatologic Agents|dermatologic agents|mesh-ancestor
111128234|NCT04682743|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111128235|NCT04682743|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111128236|NCT04682743|Serotonin Agents|serotonin agents|mesh-ancestor
111128237|NCT04682743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110077968|NCT01613820|Autonomic Agents|autonomic agents|mesh-ancestor
111128238|NCT04682743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111128239|NCT03472573|Dexamethasone|dexamethasone|mesh-list
111128240|NCT03472573|Palbociclib|palbociclib|mesh-list
111128241|NCT03472573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111128242|NCT03472573|Antiemetics|antiemetics|mesh-ancestor
111128243|NCT03472573|Autonomic Agents|autonomic agents|mesh-ancestor
111128244|NCT03472573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111128245|NCT03472573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111128246|NCT03472573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111128247|NCT03472573|Glucocorticoids|glucocorticoids|mesh-ancestor
111128248|NCT03472573|Hormones|hormones|mesh-ancestor
111128249|NCT03472573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111128250|NCT03472573|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110078040|NCT01614132|Cisplatin|cisplatin|mesh-list
111128251|NCT03472573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111128252|NCT03472573|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111128253|NCT03472573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111128254|NCT03472573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111128256|NCT04636333|Immunologic Factors|immunologic factors|mesh-ancestor
111128257|NCT04636333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111128258|NCT03103009|Pasireotide|pasireotide|mesh-list
111128259|NCT03103009|Hormones|hormones|mesh-ancestor
111128260|NCT03103009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111128261|NCT03103009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111128262|NCT03694249|Ifetroban|ifetroban|mesh-list
111128263|NCT03694249|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111128264|NCT03020875|Acetaminophen|acetaminophen|mesh-list
111128265|NCT03020875|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111128266|NCT03020875|Analgesics|analgesics|mesh-ancestor
111128267|NCT03020875|Sensory System Agents|sensory system agents|mesh-ancestor
111128268|NCT03020875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111128269|NCT03020875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111128270|NCT03020875|Antipyretics|antipyretics|mesh-ancestor
111128271|NCT02996305|Gaboxadol|gaboxadol|mesh-list
111128272|NCT02996305|Analgesics|analgesics|mesh-ancestor
111128273|NCT02996305|Sensory System Agents|sensory system agents|mesh-ancestor
111128274|NCT02996305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111128275|NCT02996305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111128276|NCT02996305|Anticonvulsants|anticonvulsants|mesh-ancestor
111128277|NCT02996305|GABA Agonists|gaba agonists|mesh-ancestor
111128278|NCT02996305|GABA Agents|gaba agents|mesh-ancestor
110078161|NCT01614964|Antimalarials|antimalarials|mesh-ancestor
111128279|NCT02996305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111128280|NCT02996305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111128281|NCT04866485|Pembrolizumab|pembrolizumab|mesh-list
111128282|NCT04866485|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111128283|NCT04866485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111128284|NCT04866485|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111128285|NCT04866485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111128286|NCT02888041|Dinoprostone|dinoprostone|mesh-list
111128287|NCT02888041|Oxytocics|oxytocics|mesh-ancestor
111128288|NCT02888041|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111128289|NCT02888041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111128290|NCT02838745|Pemetrexed|pemetrexed|mesh-list
111128291|NCT02838745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111128292|NCT02838745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111128293|NCT02838745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111128294|NCT02838745|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111128295|NCT02838745|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111128296|NCT00136435|Leucovorin|leucovorin|mesh-list
111128297|NCT00136435|Cytarabine|cytarabine|mesh-list
111128298|NCT00136435|Dexamethasone|dexamethasone|mesh-list
111128299|NCT00136435|Prednisone|prednisone|mesh-list
111128300|NCT00136435|Hydrocortisone|hydrocortisone|mesh-list
111128301|NCT00136435|Doxorubicin|doxorubicin|mesh-list
111128302|NCT00136435|Methotrexate|methotrexate|mesh-list
111128303|NCT00136435|Vincristine|vincristine|mesh-list
111128304|NCT00136435|Asparaginase|asparaginase|mesh-list
111128305|NCT00136435|Mercaptopurine|mercaptopurine|mesh-list
111128306|NCT00136435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111128307|NCT00136435|Antiemetics|antiemetics|mesh-ancestor
111128308|NCT00136435|Autonomic Agents|autonomic agents|mesh-ancestor
110078351|NCT01616069|Autonomic Agents|autonomic agents|mesh-ancestor
111128309|NCT00136435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111128310|NCT00136435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111128311|NCT00136435|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111128312|NCT00136435|Glucocorticoids|glucocorticoids|mesh-ancestor
111128313|NCT00136435|Hormones|hormones|mesh-ancestor
111128314|NCT00136435|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111128315|NCT00136435|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111128316|NCT00136435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111128317|NCT00136435|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111128318|NCT00136435|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111128319|NCT00136435|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111128320|NCT00136435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111128321|NCT00136435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111128322|NCT00136435|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111128323|NCT00136435|Abortifacient Agents|abortifacient agents|mesh-ancestor
110078495|NCT01616992|Anesthetics|anesthetics|mesh-ancestor
111128324|NCT00136435|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111128325|NCT00136435|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111128326|NCT00136435|Antimetabolites|antimetabolites|mesh-ancestor
111128327|NCT00136435|Dermatologic Agents|dermatologic agents|mesh-ancestor
110845382|NCT03867929|Vitamins|vitamins|mesh-ancestor
111128328|NCT00136435|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111128329|NCT00136435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111128330|NCT00136435|Immunologic Factors|immunologic factors|mesh-ancestor
111128331|NCT00136435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111128332|NCT00136435|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111128333|NCT00136435|Antiviral Agents|antiviral agents|mesh-ancestor
111128334|NCT00136435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111128335|NCT00136435|Antidotes|antidotes|mesh-ancestor
111128336|NCT00136435|Protective Agents|protective agents|mesh-ancestor
111128337|NCT00136435|Vitamin B Complex|vitamin b complex|mesh-ancestor
111128338|NCT00136435|Vitamins|vitamins|mesh-ancestor
111128339|NCT00136435|Micronutrients|micronutrients|mesh-ancestor
111128340|NCT00136435|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111128341|NCT00136435|Tubulin Modulators|tubulin modulators|mesh-ancestor
111128342|NCT00136435|Antimitotic Agents|antimitotic agents|mesh-ancestor
111128343|NCT00136435|Mitosis Modulators|mitosis modulators|mesh-ancestor
111128344|NCT04864379|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
111128345|NCT04864379|Molgramostim|molgramostim|mesh-list
111128346|NCT04864379|Sargramostim|sargramostim|mesh-list
111128347|NCT04864379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111128348|NCT04864379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111128349|NCT04864379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111128350|NCT04864379|Immunologic Factors|immunologic factors|mesh-ancestor
111128351|NCT04864379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111128352|NCT03044561|Sildenafil Citrate|sildenafil citrate|mesh-list
111128353|NCT03044561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111128354|NCT03044561|Vasodilator Agents|vasodilator agents|mesh-ancestor
111128355|NCT03044561|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111128356|NCT03044561|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111128357|NCT03044561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111128358|NCT03044561|Urological Agents|urological agents|mesh-ancestor
111128359|NCT02455141|Cyclophosphamide|cyclophosphamide|mesh-list
111128360|NCT02455141|Carboplatin|carboplatin|mesh-list
111128361|NCT02455141|Epirubicin|epirubicin|mesh-list
111128363|NCT02455141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111128364|NCT02455141|Immunologic Factors|immunologic factors|mesh-ancestor
111128365|NCT02455141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111128366|NCT02455141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111128367|NCT02455141|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111128368|NCT02455141|Alkylating Agents|alkylating agents|mesh-ancestor
111128369|NCT02455141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111128370|NCT02455141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111128371|NCT02455141|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111128372|NCT02455141|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111128373|NCT02455141|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111128374|NCT02455141|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111128375|NCT02455141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111128376|NCT03044639|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
111128377|NCT03044639|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
111128378|NCT03044639|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111128379|NCT02439385|Curcumin|curcumin|mesh-list
111128380|NCT02439385|Bevacizumab|bevacizumab|mesh-list
111128381|NCT02439385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111128382|NCT02439385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111128383|NCT02439385|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111128384|NCT02439385|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111128385|NCT02439385|Growth Substances|growth substances|mesh-ancestor
111128386|NCT02439385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111128387|NCT02439385|Growth Inhibitors|growth inhibitors|mesh-ancestor
111128388|NCT02439385|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111128389|NCT02439385|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111128390|NCT02439385|Analgesics|analgesics|mesh-ancestor
111128391|NCT02439385|Sensory System Agents|sensory system agents|mesh-ancestor
111128392|NCT02439385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111128393|NCT02439385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111128394|NCT02439385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111128395|NCT02439385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111128396|NCT02439385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111128397|NCT03104959|Acetylcysteine|acetylcysteine|mesh-list
111128398|NCT03104959|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111128399|NCT03104959|Antiviral Agents|antiviral agents|mesh-ancestor
111128400|NCT03104959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111128401|NCT03104959|Expectorants|expectorants|mesh-ancestor
111128402|NCT03104959|Respiratory System Agents|respiratory system agents|mesh-ancestor
111128403|NCT03104959|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111128404|NCT03104959|Antioxidants|antioxidants|mesh-ancestor
111128405|NCT03104959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111128406|NCT03104959|Protective Agents|protective agents|mesh-ancestor
111128407|NCT03104959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111128408|NCT03104959|Antidotes|antidotes|mesh-ancestor
111128409|NCT03044171|Listerine|listerine|mesh-list
111128410|NCT03044171|Hydrogen Peroxide|hydrogen peroxide|mesh-list
111128411|NCT03044171|Fluorides|fluorides|mesh-list
111128412|NCT03044171|Sodium Fluoride|sodium fluoride|mesh-list
111128413|NCT03044171|Cariostatic Agents|cariostatic agents|mesh-ancestor
111128414|NCT03044171|Protective Agents|protective agents|mesh-ancestor
111128415|NCT03044171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111128416|NCT03044171|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111128417|NCT03044171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111128418|NCT04856969|Dapagliflozin|dapagliflozin|mesh-list
111128419|NCT04856969|Olmesartan|olmesartan|mesh-list
111128420|NCT04856969|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111128421|NCT04856969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111128422|NCT04856969|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111128423|NCT04856969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111128424|NCT04856969|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111128425|NCT04856969|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111128426|NCT04856969|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111128427|NCT03981211|Sofosbuvir|sofosbuvir|mesh-list
111128428|NCT03981211|Antiviral Agents|antiviral agents|mesh-ancestor
111128429|NCT03981211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111128430|NCT04856111|Pirfenidone|pirfenidone|mesh-list
111128431|NCT04856111|Nintedanib|nintedanib|mesh-list
111128432|NCT04856111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111128433|NCT04856111|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111128434|NCT04856111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111128435|NCT04856111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111128436|NCT04856111|Analgesics|analgesics|mesh-ancestor
111128437|NCT04856111|Sensory System Agents|sensory system agents|mesh-ancestor
111128438|NCT04856111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111128439|NCT04856111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111128440|NCT04856111|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111128441|NCT04856111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111128442|NCT04856111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111128443|NCT04856111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111128444|NCT02053051|Insulin Aspart|insulin aspart|mesh-list
111128445|NCT02053051|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111128446|NCT02053051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111128447|NCT01371981|Cytarabine|cytarabine|mesh-list
111128448|NCT01371981|Etoposide|etoposide|mesh-list
111128449|NCT01371981|Podophyllotoxin|podophyllotoxin|mesh-list
111128450|NCT01371981|Daunorubicin|daunorubicin|mesh-list
111128451|NCT01371981|Mitoxantrone|mitoxantrone|mesh-list
111128452|NCT01371981|Etoposide phosphate|etoposide phosphate|mesh-list
111128453|NCT01371981|Bortezomib|bortezomib|mesh-list
111128454|NCT01371981|Sorafenib|sorafenib|mesh-list
111128455|NCT01371981|Asparaginase|asparaginase|mesh-list
111128456|NCT01371981|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111128457|NCT01371981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111128458|NCT01371981|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110078751|NCT01618513|Octreotide|octreotide|mesh-list
111128459|NCT01371981|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111128460|NCT01371981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111128461|NCT01371981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111128462|NCT01371981|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111128463|NCT01371981|Antimetabolites|antimetabolites|mesh-ancestor
111128464|NCT01371981|Antiviral Agents|antiviral agents|mesh-ancestor
111128465|NCT01371981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111128466|NCT01371981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111128467|NCT01371981|Immunologic Factors|immunologic factors|mesh-ancestor
111128468|NCT01371981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111128469|NCT01371981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111128470|NCT01371981|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111128471|NCT01371981|Analgesics|analgesics|mesh-ancestor
111128472|NCT01371981|Sensory System Agents|sensory system agents|mesh-ancestor
111128473|NCT01371981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111128474|NCT01371981|Keratolytic Agents|keratolytic agents|mesh-ancestor
111128475|NCT01371981|Dermatologic Agents|dermatologic agents|mesh-ancestor
111128476|NCT01371981|Tubulin Modulators|tubulin modulators|mesh-ancestor
111128477|NCT01371981|Antimitotic Agents|antimitotic agents|mesh-ancestor
111128478|NCT01371981|Mitosis Modulators|mitosis modulators|mesh-ancestor
111128479|NCT02845453|Quetiapine Fumarate|quetiapine fumarate|mesh-list
111128480|NCT02845453|Antidepressive Agents|antidepressive agents|mesh-ancestor
111128481|NCT02845453|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111128482|NCT02845453|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111128483|NCT02845453|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111128484|NCT02845453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111128485|NCT02845453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111128486|NCT01799629|Glycerol|glycerol|mesh-list
111128487|NCT01799629|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
111128488|NCT01799629|Protective Agents|protective agents|mesh-ancestor
111128489|NCT01799629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111128490|NCT01597375|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
111128491|NCT01597375|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111128492|NCT03044093|Misoprostol|misoprostol|mesh-list
111128493|NCT03044093|Mifepristone|mifepristone|mesh-list
111128494|NCT03044093|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111128495|NCT03044093|Abortifacient Agents|abortifacient agents|mesh-ancestor
111128496|NCT03044093|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111128497|NCT03044093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111128498|NCT03044093|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111128499|NCT03044093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111128500|NCT03044093|Oxytocics|oxytocics|mesh-ancestor
111128501|NCT03044093|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
111128502|NCT03044093|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111128503|NCT03044093|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111128504|NCT03044093|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111128505|NCT03044093|Contraceptive Agents|contraceptive agents|mesh-ancestor
111128506|NCT03044093|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
111128507|NCT03044093|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
111128508|NCT03044093|Hormone Antagonists|hormone antagonists|mesh-ancestor
111128509|NCT03044093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111128510|NCT03044093|Luteolytic Agents|luteolytic agents|mesh-ancestor
111128511|NCT03044093|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111128512|NCT03044093|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
111128513|NCT01553071|Fenretinide|fenretinide|mesh-list
111128514|NCT01553071|Safingol|safingol|mesh-list
111128515|NCT01553071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111128516|NCT01553071|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
111128517|NCT01553071|Protective Agents|protective agents|mesh-ancestor
111128518|NCT01553071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111128519|NCT01553071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111128520|NCT01553071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111128521|NCT01506973|Hydroxychloroquine|hydroxychloroquine|mesh-list
111128522|NCT01506973|Gemcitabine|gemcitabine|mesh-list
111128523|NCT01506973|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111128524|NCT01506973|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111128525|NCT01506973|Antimetabolites|antimetabolites|mesh-ancestor
111128526|NCT01506973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111128527|NCT01506973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111128528|NCT01506973|Antimalarials|antimalarials|mesh-ancestor
111128529|NCT01506973|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111128530|NCT01506973|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111128531|NCT01506973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111128532|NCT01506973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111128533|NCT01506973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111128534|NCT03041207|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111128535|NCT03041207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111128536|NCT03101995|Gemcitabine|gemcitabine|mesh-list
111128537|NCT03101995|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111128538|NCT03101995|Antimetabolites|antimetabolites|mesh-ancestor
111128539|NCT03101995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111128540|NCT03101995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111128541|NCT04848467|Vaccines|vaccines|mesh-list
111128542|NCT04848467|Immunologic Factors|immunologic factors|mesh-ancestor
111128543|NCT04848467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111128544|NCT03104335|Apatinib|apatinib|mesh-list
111128545|NCT03104335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111128546|NCT03104335|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111128547|NCT03104335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111128548|NCT03104335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111128549|NCT04863365|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111128550|NCT04863365|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111128551|NCT00484471|Valproic Acid|valproic acid|mesh-list
111128552|NCT00484471|Aripiprazole|aripiprazole|mesh-list
111128553|NCT00484471|Antidepressive Agents|antidepressive agents|mesh-ancestor
111128554|NCT00484471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111128555|NCT00484471|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111128556|NCT00484471|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111128557|NCT00484471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111128558|NCT00484471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111128559|NCT00484471|Dopamine Agonists|dopamine agonists|mesh-ancestor
111128560|NCT00484471|Dopamine Agents|dopamine agents|mesh-ancestor
111128561|NCT00484471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111128562|NCT00484471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111128563|NCT00484471|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111128564|NCT00484471|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111128565|NCT00484471|Serotonin Agents|serotonin agents|mesh-ancestor
110836980|NCT05073744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111128566|NCT00484471|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111128567|NCT00484471|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111128568|NCT00484471|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111128569|NCT00484471|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111128570|NCT00484471|Anticonvulsants|anticonvulsants|mesh-ancestor
111128571|NCT00484471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111128572|NCT00484471|GABA Agents|gaba agents|mesh-ancestor
111128573|NCT00484471|Antimanic Agents|antimanic agents|mesh-ancestor
111128574|NCT05430841|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
111128575|NCT05430841|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111128576|NCT05430841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111128577|NCT01746849|Cyclophosphamide|cyclophosphamide|mesh-list
111128578|NCT01746849|Thiotepa|thiotepa|mesh-list
111128579|NCT01746849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111128580|NCT01746849|Immunologic Factors|immunologic factors|mesh-ancestor
111128581|NCT01746849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111128582|NCT01746849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111128583|NCT01746849|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111128584|NCT01746849|Alkylating Agents|alkylating agents|mesh-ancestor
111128585|NCT01746849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111128586|NCT01746849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111128587|NCT01746849|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111128588|NCT04847921|Dalbavancin|dalbavancin|mesh-list
111128589|NCT04847921|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111128590|NCT04847921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111128591|NCT04847687|Methylprednisolone|methylprednisolone|mesh-list
111128592|NCT04847687|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111128593|NCT04847687|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111128594|NCT04847687|Prednisolone|prednisolone|mesh-list
111128595|NCT04847687|Prednisolone acetate|prednisolone acetate|mesh-list
111128596|NCT04847687|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111128597|NCT04847687|Prednisolone phosphate|prednisolone phosphate|mesh-list
111128598|NCT04847687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111128599|NCT04847687|Antiemetics|antiemetics|mesh-ancestor
111128600|NCT04847687|Autonomic Agents|autonomic agents|mesh-ancestor
111128601|NCT04847687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111128602|NCT04847687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111128603|NCT04847687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111128604|NCT04847687|Glucocorticoids|glucocorticoids|mesh-ancestor
111128605|NCT04847687|Hormones|hormones|mesh-ancestor
111128606|NCT04847687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111128607|NCT04847687|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111128608|NCT04847687|Protective Agents|protective agents|mesh-ancestor
111128609|NCT04847687|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111128610|NCT04847687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111128611|NCT01729455|Belimumab|belimumab|mesh-list
111128612|NCT01729455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111128613|NCT01729455|Immunologic Factors|immunologic factors|mesh-ancestor
111128614|NCT01729455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111128615|NCT03103867|Insulin|insulin|mesh-list
111128616|NCT03103867|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111128617|NCT03103867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111128618|NCT04847375|Pulmonary Surfactants|pulmonary surfactants|mesh-list
111128619|NCT04847375|Respiratory System Agents|respiratory system agents|mesh-ancestor
111128620|NCT04737343|Azathioprine|azathioprine|mesh-list
111128621|NCT04737343|Leflunomide|leflunomide|mesh-list
111128622|NCT04737343|Antimetabolites|antimetabolites|mesh-ancestor
111128623|NCT04737343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111128624|NCT04737343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111128625|NCT04737343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111128626|NCT04737343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111128627|NCT04737343|Immunologic Factors|immunologic factors|mesh-ancestor
111128628|NCT04737343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111128629|NCT04737343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111128630|NCT04737343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111128631|NCT05579769|Cyclosporine|cyclosporine|mesh-list
111128632|NCT05579769|Cyclophosphamide|cyclophosphamide|mesh-list
111128633|NCT05579769|Busulfan|busulfan|mesh-list
111128634|NCT05579769|Thiotepa|thiotepa|mesh-list
111128635|NCT05579769|Methotrexate|methotrexate|mesh-list
110845679|NCT03209973|Tislelizumab|tislelizumab|mesh-list
111128636|NCT05579769|Fludarabine|fludarabine|mesh-list
111128637|NCT05579769|Cyclosporins|cyclosporins|mesh-list
111128638|NCT05579769|Thymoglobulin|thymoglobulin|mesh-list
111128639|NCT05579769|Antilymphocyte Serum|antilymphocyte serum|mesh-list
111128640|NCT05579769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111128641|NCT05579769|Immunologic Factors|immunologic factors|mesh-ancestor
111128642|NCT05579769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111128643|NCT05579769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111128644|NCT05579769|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111128645|NCT05579769|Alkylating Agents|alkylating agents|mesh-ancestor
111128646|NCT05579769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111128647|NCT05579769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111128648|NCT05579769|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111128649|NCT05579769|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111128650|NCT05579769|Abortifacient Agents|abortifacient agents|mesh-ancestor
111128651|NCT05579769|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111128652|NCT05579769|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111128653|NCT05579769|Antimetabolites|antimetabolites|mesh-ancestor
111128654|NCT05579769|Dermatologic Agents|dermatologic agents|mesh-ancestor
111128655|NCT05579769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111128656|NCT05579769|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111128657|NCT05579769|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111128658|NCT05579769|Antifungal Agents|antifungal agents|mesh-ancestor
111128659|NCT05579769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111128660|NCT05579769|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111128661|NCT02609399|Oseltamivir|oseltamivir|mesh-list
111128662|NCT02609399|Peramivir|peramivir|mesh-list
111128663|NCT02609399|Antiviral Agents|antiviral agents|mesh-ancestor
111128664|NCT02609399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111128665|NCT02609399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111128666|NCT02609399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111128667|NCT05430217|Buspirone|buspirone|mesh-list
111128668|NCT05430217|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111128669|NCT05430217|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111128670|NCT05430217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111128671|NCT05430217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111128672|NCT05430217|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111128673|NCT05430217|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111128674|NCT05430217|Serotonin Agents|serotonin agents|mesh-ancestor
111128675|NCT05430217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111128676|NCT05430217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111128677|NCT03103555|Cyclophosphamide|cyclophosphamide|mesh-list
111128678|NCT03103555|Bortezomib|bortezomib|mesh-list
111128679|NCT03103555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111128680|NCT03103555|Immunologic Factors|immunologic factors|mesh-ancestor
111128681|NCT03103555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111128682|NCT03103555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111128683|NCT03103555|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111128684|NCT03103555|Alkylating Agents|alkylating agents|mesh-ancestor
111128685|NCT03103555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110079220|NCT01621217|Antimetabolites|antimetabolites|mesh-ancestor
111128686|NCT03103555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111128687|NCT03103555|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111128688|NCT02720185|Dasatinib|dasatinib|mesh-list
111128689|NCT02720185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111128690|NCT02720185|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111128691|NCT02720185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111128692|NCT02720185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111128693|NCT04846673|Thioctic Acid|thioctic acid|mesh-list
111128694|NCT04846673|Pregabalin|pregabalin|mesh-list
111128695|NCT04846673|Analgesics|analgesics|mesh-ancestor
111128696|NCT04846673|Sensory System Agents|sensory system agents|mesh-ancestor
111128697|NCT04846673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111128698|NCT04846673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111128699|NCT04846673|Anticonvulsants|anticonvulsants|mesh-ancestor
111128700|NCT04846673|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111128701|NCT04846673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111128702|NCT04846673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111128703|NCT04846673|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111128704|NCT04846673|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111128705|NCT04846673|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111128706|NCT04846673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111128707|NCT04846673|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111128708|NCT04846673|Antioxidants|antioxidants|mesh-ancestor
111128709|NCT04846673|Protective Agents|protective agents|mesh-ancestor
111128710|NCT04846673|Vitamin B Complex|vitamin b complex|mesh-ancestor
111128711|NCT04846673|Vitamins|vitamins|mesh-ancestor
111128712|NCT04846673|Micronutrients|micronutrients|mesh-ancestor
111128713|NCT04498273|Aspirin|aspirin|mesh-list
111128714|NCT04498273|Apixaban|apixaban|mesh-list
111128715|NCT04498273|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111128716|NCT04498273|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111128717|NCT04498273|Analgesics|analgesics|mesh-ancestor
111128718|NCT04498273|Sensory System Agents|sensory system agents|mesh-ancestor
111128719|NCT04498273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111128720|NCT04498273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111128721|NCT04498273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111128722|NCT04498273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111128723|NCT04498273|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111128724|NCT04498273|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111128725|NCT04498273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111128726|NCT04498273|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111128727|NCT04498273|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111128728|NCT04498273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111128729|NCT04498273|Antipyretics|antipyretics|mesh-ancestor
111128730|NCT04498273|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111128731|NCT04498273|Antithrombins|antithrombins|mesh-ancestor
111128732|NCT04498273|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111128733|NCT04498273|Protease Inhibitors|protease inhibitors|mesh-ancestor
111128734|NCT04498273|Anticoagulants|anticoagulants|mesh-ancestor
111128735|NCT04853615|Empagliflozin|empagliflozin|mesh-list
111128736|NCT04853615|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
111128737|NCT04853615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111128738|NCT04853615|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111128739|NCT04853615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111128740|NCT05573607|Chromium|chromium|mesh-list
111128741|NCT05573607|Trace Elements|trace elements|mesh-ancestor
111128742|NCT05573607|Micronutrients|micronutrients|mesh-ancestor
111128743|NCT05573607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111128744|NCT04435483|Acalabrutinib|acalabrutinib|mesh-list
111128745|NCT04435483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110079365|NCT01621971|Milrinone|milrinone|mesh-list
111128746|NCT04862117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
111128747|NCT04862117|Cholinergic Agents|cholinergic agents|mesh-list
111128748|NCT04862117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111128749|NCT04862117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111128750|NCT04862117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111128751|NCT03040817|Esomeprazole|esomeprazole|mesh-list
111128752|NCT03040817|Mosapride|mosapride|mesh-list
111128753|NCT03040817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111128754|NCT03040817|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111128755|NCT03040817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111128756|NCT03040817|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111128757|NCT03040817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111128758|NCT03040817|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111128759|NCT03040817|Serotonin Agents|serotonin agents|mesh-ancestor
111128760|NCT03040817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111128761|NCT03040817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111128762|NCT04853069|Estradiol|estradiol|mesh-list
111128763|NCT04853069|Estrogens|estrogens|mesh-ancestor
111128764|NCT04853069|Hormones|hormones|mesh-ancestor
111128765|NCT04853069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111128766|NCT04853069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111128767|NCT05244811|Contraceptive Agents|contraceptive agents|mesh-list
111128768|NCT05244811|Contraceptives, Oral|contraceptives, oral|mesh-list
111128769|NCT05244811|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
111128770|NCT05244811|Progestins|progestins|mesh-list
111128771|NCT05244811|Estradiol|estradiol|mesh-list
111128772|NCT05244811|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111128773|NCT05244811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111128774|NCT05244811|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111128776|NCT05244811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111128777|NCT05244811|Estrogens|estrogens|mesh-ancestor
111128778|NCT05395065|Listerine|listerine|mesh-list
111128779|NCT05395065|Fluorides|fluorides|mesh-list
111128780|NCT05395065|Sodium Fluoride|sodium fluoride|mesh-list
110079481|NCT01622790|Lamivudine|lamivudine|mesh-list
111128781|NCT05395065|Fluorides, Topical|fluorides, topical|mesh-list
111128782|NCT05395065|Cariostatic Agents|cariostatic agents|mesh-ancestor
110845830|NCT01284725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111128783|NCT05395065|Protective Agents|protective agents|mesh-ancestor
111128784|NCT05395065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111128785|NCT05395065|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111128786|NCT05395065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111128787|NCT02710669|Propafenone|propafenone|mesh-list
111128788|NCT02710669|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110079547|NCT01623336|Interferon-alpha|interferon-alpha|mesh-list
111128789|NCT02710669|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111128790|NCT02710669|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111128791|NCT02710669|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111128792|NCT02710669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111128793|NCT05392959|Dapagliflozin|dapagliflozin|mesh-list
111128794|NCT05392959|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111128795|NCT05392959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111128796|NCT05392959|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111128797|NCT05392959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111128798|NCT04851977|Vaccines|vaccines|mesh-list
111128799|NCT04851977|Immunologic Factors|immunologic factors|mesh-ancestor
111128800|NCT04851977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111128801|NCT05370495|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111128802|NCT05370495|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111128803|NCT05370417|Fluorides|fluorides|mesh-list
111128804|NCT05370417|Cariostatic Agents|cariostatic agents|mesh-ancestor
111128805|NCT05370417|Protective Agents|protective agents|mesh-ancestor
111128806|NCT05370417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111128807|NCT05369793|Thioctic Acid|thioctic acid|mesh-list
111128808|NCT05369793|Antioxidants|antioxidants|mesh-ancestor
111128809|NCT05369793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111128810|NCT05369793|Protective Agents|protective agents|mesh-ancestor
111128811|NCT05369793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111128812|NCT05369793|Vitamin B Complex|vitamin b complex|mesh-ancestor
111128813|NCT05369793|Vitamins|vitamins|mesh-ancestor
111128814|NCT05369793|Micronutrients|micronutrients|mesh-ancestor
111128815|NCT04844333|Anesthetics|anesthetics|mesh-list
111128816|NCT04844333|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111128817|NCT04844333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111128818|NCT04423185|Atezolizumab|atezolizumab|mesh-list
111128819|NCT04423185|Imatinib Mesylate|imatinib mesylate|mesh-list
111128820|NCT04423185|Palbociclib|palbociclib|mesh-list
111128821|NCT04423185|Niraparib|niraparib|mesh-list
111128822|NCT04423185|Vemurafenib|vemurafenib|mesh-list
111128823|NCT04423185|Crizotinib|crizotinib|mesh-list
111128824|NCT04423185|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111128825|NCT04423185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111128826|NCT04423185|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111128827|NCT04423185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111128828|NCT04423185|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111128829|NCT04423185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111128830|NCT04423185|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111128831|NCT04850885|Dexamethasone|dexamethasone|mesh-list
111128832|NCT04850885|Lidocaine|lidocaine|mesh-list
111128833|NCT04850885|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111128834|NCT04850885|Antiemetics|antiemetics|mesh-ancestor
111128835|NCT04850885|Autonomic Agents|autonomic agents|mesh-ancestor
111128836|NCT04850885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111128837|NCT04850885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111128838|NCT04850885|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111128839|NCT04850885|Glucocorticoids|glucocorticoids|mesh-ancestor
111128840|NCT04850885|Hormones|hormones|mesh-ancestor
111128841|NCT04850885|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111128842|NCT04850885|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111128843|NCT04850885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111128844|NCT04850885|Anesthetics, Local|anesthetics, local|mesh-ancestor
111128845|NCT04850885|Anesthetics|anesthetics|mesh-ancestor
111128846|NCT04850885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111128847|NCT04850885|Sensory System Agents|sensory system agents|mesh-ancestor
111128848|NCT04850885|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111128849|NCT04850885|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111128850|NCT04850885|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111128851|NCT04850885|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111128852|NCT04850885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111128853|NCT04850417|Aspirin|aspirin|mesh-list
111128854|NCT04850417|Clopidogrel|clopidogrel|mesh-list
111128855|NCT04850417|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
111128856|NCT04850417|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111128857|NCT04850417|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111128858|NCT04850417|Analgesics|analgesics|mesh-ancestor
111128859|NCT04850417|Sensory System Agents|sensory system agents|mesh-ancestor
111128860|NCT04850417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110845904|NCT04060758|Latanoprost|latanoprost|mesh-list
111128862|NCT04850417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111128863|NCT04850417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111128864|NCT04850417|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111128865|NCT04850417|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111128866|NCT04850417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111128867|NCT04850417|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110079846|NCT01625494|Vasodilator Agents|vasodilator agents|mesh-ancestor
111128868|NCT04850417|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111128869|NCT04850417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111128870|NCT04850417|Antipyretics|antipyretics|mesh-ancestor
111128871|NCT04850417|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111128872|NCT04850417|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111128873|NCT04850417|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111128874|NCT04850417|Purinergic Agents|purinergic agents|mesh-ancestor
111128875|NCT04850417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111128876|NCT04850417|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111128877|NCT04850417|Adrenergic Agents|adrenergic agents|mesh-ancestor
111128878|NCT04843943|Bevacizumab|bevacizumab|mesh-list
111128879|NCT04843943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111128880|NCT04843943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111128881|NCT04843943|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111128882|NCT04843943|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111128883|NCT04843943|Growth Substances|growth substances|mesh-ancestor
111128884|NCT04843943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111128885|NCT04843943|Growth Inhibitors|growth inhibitors|mesh-ancestor
111128886|NCT04850261|Nafarelin|nafarelin|mesh-list
111128887|NCT04850261|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110837022|NCT03463564|Insulin|insulin|mesh-list
111128888|NCT04850261|Fertility Agents|fertility agents|mesh-ancestor
111128889|NCT04850261|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111128890|NCT04850261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111128891|NCT04843553|Niacinamide|niacinamide|mesh-list
111128892|NCT04843553|Niacin|niacin|mesh-list
111128893|NCT04843553|Nicotinic Acids|nicotinic acids|mesh-list
111128894|NCT04843553|Vitamins|vitamins|mesh-ancestor
111128895|NCT04843553|Micronutrients|micronutrients|mesh-ancestor
111128896|NCT04843553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111128897|NCT04843553|Vitamin B Complex|vitamin b complex|mesh-ancestor
111128898|NCT04843553|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111128899|NCT04843553|Antimetabolites|antimetabolites|mesh-ancestor
111128900|NCT04843553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111128901|NCT04843553|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111128902|NCT04843553|Vasodilator Agents|vasodilator agents|mesh-ancestor
111128903|NCT02684461|Paclitaxel|paclitaxel|mesh-list
111128904|NCT02684461|Pembrolizumab|pembrolizumab|mesh-list
111128905|NCT02684461|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111128906|NCT02684461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111128907|NCT02684461|Tubulin Modulators|tubulin modulators|mesh-ancestor
111128908|NCT02684461|Antimitotic Agents|antimitotic agents|mesh-ancestor
111128909|NCT02684461|Mitosis Modulators|mitosis modulators|mesh-ancestor
110079903|NCT01625806|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111128910|NCT02684461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111128911|NCT02684461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111128912|NCT02684461|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111128913|NCT03040193|Lidocaine|lidocaine|mesh-list
111128914|NCT03040193|Anesthetics, Local|anesthetics, local|mesh-ancestor
111128915|NCT03040193|Anesthetics|anesthetics|mesh-ancestor
111128916|NCT03040193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111128917|NCT03040193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111128918|NCT03040193|Sensory System Agents|sensory system agents|mesh-ancestor
111128919|NCT03040193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111128920|NCT03040193|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111128921|NCT03040193|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111128922|NCT03040193|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111128923|NCT03040193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111128924|NCT03040193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111128925|NCT03039101|Montelukast|montelukast|mesh-list
111128926|NCT03039101|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111128927|NCT03039101|Respiratory System Agents|respiratory system agents|mesh-ancestor
111128928|NCT03039101|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
111128929|NCT03039101|Hormone Antagonists|hormone antagonists|mesh-ancestor
111128930|NCT03039101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111128931|NCT03039101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111128932|NCT03039101|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
111128933|NCT03039101|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111128934|NCT03039101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111128935|NCT03103399|Levodopa|levodopa|mesh-list
111128936|NCT03103399|Carbidopa|carbidopa|mesh-list
111128937|NCT03103399|Entacapone|entacapone|mesh-list
111128938|NCT03103399|Benserazide|benserazide|mesh-list
111128939|NCT03103399|Dopa Decarboxylase|dopa decarboxylase|mesh-list
111128940|NCT03103399|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-list
111128941|NCT03103399|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111128942|NCT03103399|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111128943|NCT03103399|Dopamine Agents|dopamine agents|mesh-ancestor
111128944|NCT03103399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111128945|NCT03103399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111128946|NCT03103399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111128947|NCT03103399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111128948|NCT03103399|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
111128949|NCT03043157|Rocuronium|rocuronium|mesh-list
111128950|NCT03043157|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
111128951|NCT03043157|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
111128952|NCT03043157|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111128953|NCT03043157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111128954|NCT03043157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111128955|NCT05339113|FAPI-46|fapi-46|mesh-list
111128956|NCT05339113|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111128957|NCT05339113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111128958|NCT05332795|Metformin|metformin|mesh-list
111128959|NCT05332795|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111128960|NCT05332795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111128961|NCT03042923|Mannitol|mannitol|mesh-list
111128962|NCT03042923|Lactulose|lactulose|mesh-list
111128963|NCT03042923|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
111128964|NCT03042923|Diuretics|diuretics|mesh-ancestor
111128965|NCT03042923|Natriuretic Agents|natriuretic agents|mesh-ancestor
111128966|NCT03042923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110079970|NCT01626534|Clopidogrel|clopidogrel|mesh-list
111128967|NCT03042923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111128968|NCT04429295|Vaccines|vaccines|mesh-list
111128969|NCT04429295|Immunologic Factors|immunologic factors|mesh-ancestor
111128970|NCT04429295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111128971|NCT05258851|Colistin|colistin|mesh-list
111128972|NCT05258851|Ceftazidime|ceftazidime|mesh-list
111128973|NCT05258851|Avibactam|avibactam|mesh-list
111128974|NCT05258851|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
111128975|NCT05258851|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111128976|NCT05258851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111128977|NCT05258851|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
111128978|NCT05258851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110080034|NCT01627132|Dasatinib|dasatinib|mesh-list
111128979|NCT05258851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111128980|NCT03043001|Memantine|memantine|mesh-list
111128981|NCT03043001|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111128982|NCT03043001|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111128983|NCT03043001|Dopamine Agents|dopamine agents|mesh-ancestor
111128984|NCT03043001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111128985|NCT03043001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111128986|NCT03043001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111128987|NCT03043001|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111128988|NCT03043001|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111128989|NCT04843007|Pemetrexed|pemetrexed|mesh-list
111128990|NCT04843007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110080097|NCT01627236|Glucocorticoids|glucocorticoids|mesh-ancestor
111128991|NCT04843007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111128992|NCT04843007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111128993|NCT04843007|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111128994|NCT04843007|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111128995|NCT04840745|Leuprolide|leuprolide|mesh-list
111128996|NCT04840745|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111128997|NCT04840745|Fertility Agents|fertility agents|mesh-ancestor
111128998|NCT04840745|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111128999|NCT04840745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111129000|NCT04840745|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111129001|NCT04840745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111129002|NCT05072899|Hyaluronic Acid|hyaluronic acid|mesh-list
111129003|NCT05072899|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111129004|NCT05072899|Immunologic Factors|immunologic factors|mesh-ancestor
111129005|NCT05072899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111129006|NCT05072899|Viscosupplements|viscosupplements|mesh-ancestor
111129007|NCT05072899|Protective Agents|protective agents|mesh-ancestor
111129009|NCT04839653|Gentamicins|gentamicins|mesh-list
111129010|NCT04839653|Ceftriaxone|ceftriaxone|mesh-list
111129011|NCT04839653|Polymyxins|polymyxins|mesh-list
111129012|NCT04839653|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111129013|NCT04839653|Cefotaxime|cefotaxime|mesh-list
111129014|NCT04839653|Cefoxitin|cefoxitin|mesh-list
111129015|NCT04839653|Polymyxin B|polymyxin b|mesh-list
111129016|NCT04839653|Amphotericin B|amphotericin b|mesh-list
111129017|NCT04839653|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
111129018|NCT04839653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111129019|NCT04839653|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111129020|NCT04839653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111129021|NCT04839653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111129022|NCT04839653|Amebicides|amebicides|mesh-ancestor
111129023|NCT04839653|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111129024|NCT04839653|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111129025|NCT04839653|Antifungal Agents|antifungal agents|mesh-ancestor
111129026|NCT04842383|Peppermint oil|peppermint oil|mesh-list
111129027|NCT04842383|Antiemetics|antiemetics|mesh-ancestor
111129028|NCT04842383|Autonomic Agents|autonomic agents|mesh-ancestor
111129029|NCT04842383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111129030|NCT04842383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111129031|NCT04842383|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111129032|NCT04842383|Parasympatholytics|parasympatholytics|mesh-ancestor
111129033|NCT04884139|Tenofovir|tenofovir|mesh-list
111129034|NCT04884139|Lamivudine|lamivudine|mesh-list
111129035|NCT04884139|Emtricitabine|emtricitabine|mesh-list
111129036|NCT04884139|Dolutegravir|dolutegravir|mesh-list
111129037|NCT04884139|Antiviral Agents|antiviral agents|mesh-ancestor
111129038|NCT04884139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111129039|NCT04884139|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111129040|NCT04884139|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111129041|NCT04884139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111129042|NCT04884139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111129043|NCT04884139|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111129044|NCT04884139|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111129045|NCT04884139|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111129046|NCT04884139|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111129047|NCT04860167|Diclofenac|diclofenac|mesh-list
111129048|NCT04860167|Lidocaine|lidocaine|mesh-list
111129049|NCT04860167|Propofol|propofol|mesh-list
111129050|NCT04860167|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111129051|NCT04860167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111129052|NCT04860167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111129053|NCT04860167|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111129054|NCT04860167|Anesthetics, General|anesthetics, general|mesh-ancestor
111129055|NCT04860167|Anesthetics|anesthetics|mesh-ancestor
111129056|NCT04860167|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111129057|NCT04860167|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111129058|NCT04860167|Analgesics|analgesics|mesh-ancestor
110080410|NCT01629368|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111129059|NCT04860167|Sensory System Agents|sensory system agents|mesh-ancestor
111129060|NCT04860167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111129061|NCT04860167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111129062|NCT04860167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111129063|NCT04860167|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111129064|NCT04860167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111129065|NCT04860167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111129066|NCT04860167|Anesthetics, Local|anesthetics, local|mesh-ancestor
111129067|NCT04860167|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111129068|NCT04860167|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111129069|NCT04860167|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111129070|NCT04860167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111129071|NCT02514031|Beta-lapachone|beta-lapachone|mesh-list
111129072|NCT02514031|Paclitaxel|paclitaxel|mesh-list
111129073|NCT02514031|Gemcitabine|gemcitabine|mesh-list
111129074|NCT02514031|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111129075|NCT02514031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111129076|NCT02514031|Tubulin Modulators|tubulin modulators|mesh-ancestor
111129077|NCT02514031|Antimitotic Agents|antimitotic agents|mesh-ancestor
111129078|NCT02514031|Mitosis Modulators|mitosis modulators|mesh-ancestor
111129079|NCT02514031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111129080|NCT02514031|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111129081|NCT02514031|Antimetabolites|antimetabolites|mesh-ancestor
111129082|NCT02514031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111129083|NCT02514031|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111129084|NCT02514031|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111129085|NCT02514031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111129086|NCT02514031|Antiviral Agents|antiviral agents|mesh-ancestor
111129087|NCT04622917|Methylprednisolone|methylprednisolone|mesh-list
111129088|NCT04622917|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111129089|NCT04622917|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111129090|NCT04622917|Prednisolone|prednisolone|mesh-list
111129091|NCT04622917|Prednisolone acetate|prednisolone acetate|mesh-list
111129092|NCT04622917|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111129093|NCT04622917|Prednisolone phosphate|prednisolone phosphate|mesh-list
111129094|NCT04622917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111129095|NCT04622917|Antiemetics|antiemetics|mesh-ancestor
111129096|NCT04622917|Autonomic Agents|autonomic agents|mesh-ancestor
111129097|NCT04622917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111129098|NCT04622917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111129099|NCT04622917|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111129100|NCT04622917|Glucocorticoids|glucocorticoids|mesh-ancestor
111129101|NCT04622917|Hormones|hormones|mesh-ancestor
111129102|NCT04622917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111129103|NCT04622917|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111129104|NCT04622917|Protective Agents|protective agents|mesh-ancestor
111129105|NCT04622917|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111129106|NCT04622917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111129107|NCT03038477|Durvalumab|durvalumab|mesh-list
111129108|NCT03038477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111129109|NCT03038477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111129110|NCT03038243|Vaccines|vaccines|mesh-list
111129111|NCT03038243|Immunologic Factors|immunologic factors|mesh-ancestor
111129112|NCT03038243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111129113|NCT03038321|Levofloxacin|levofloxacin|mesh-list
111129114|NCT03038321|Lornoxicam|lornoxicam|mesh-list
111129115|NCT03038321|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111129116|NCT03038321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111129117|NCT03038321|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111129118|NCT03038321|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111129119|NCT03038321|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111129120|NCT03038321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111129121|NCT03038321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111129122|NCT03038321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111129123|NCT03038321|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111129124|NCT03038321|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111129125|NCT03038321|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111129126|NCT03038321|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111129127|NCT03038321|Analgesics|analgesics|mesh-ancestor
111129128|NCT03038321|Sensory System Agents|sensory system agents|mesh-ancestor
111129129|NCT03038321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111129130|NCT03038321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111129131|NCT03038321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111129132|NCT03038321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111129133|NCT02531373|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
111129134|NCT02531373|Immunologic Factors|immunologic factors|mesh-ancestor
111129135|NCT02531373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111129137|NCT03042377|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111129138|NCT03042377|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
111129139|NCT03042377|Calcium|calcium|mesh-list
111129140|NCT03042377|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111129141|NCT03042377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110080717|NCT01631383|Dopamine Agents|dopamine agents|mesh-ancestor
111129142|NCT03042377|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111129143|NCT03042377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111129144|NCT03042377|Antitubercular Agents|antitubercular agents|mesh-ancestor
111129145|NCT04859777|Pembrolizumab|pembrolizumab|mesh-list
111129146|NCT04859777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111129147|NCT04859777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111129148|NCT04859777|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111129149|NCT04859777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111129150|NCT05562609|Tranexamic Acid|tranexamic acid|mesh-list
111129151|NCT05562609|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111129152|NCT05562609|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111129153|NCT05562609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111129154|NCT05562609|Hemostatics|hemostatics|mesh-ancestor
111129155|NCT05562609|Coagulants|coagulants|mesh-ancestor
111129156|NCT05071339|Ganirelix|ganirelix|mesh-list
111129157|NCT05071339|Hormone Antagonists|hormone antagonists|mesh-ancestor
111129158|NCT05071339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111129159|NCT05071339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111129160|NCT02606279|Valsartan|valsartan|mesh-list
111129161|NCT02606279|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111129162|NCT02606279|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111129163|NCT02606279|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111129164|NCT02606279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111129166|NCT04859621|Ergocalciferols|ergocalciferols|mesh-list
111129167|NCT04859621|Cholecalciferol|cholecalciferol|mesh-list
111129168|NCT04859621|Vitamins|vitamins|mesh-list
111129169|NCT04859621|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111129170|NCT04859621|Micronutrients|micronutrients|mesh-ancestor
110080830|NCT01631838|Tocovid|tocovid|mesh-list
111129171|NCT04859621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111129172|NCT04859621|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111129173|NCT04859621|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111129174|NCT04859621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111129175|NCT03039491|Vaccines|vaccines|mesh-list
111129176|NCT03039491|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
111129177|NCT03039491|Immunologic Factors|immunologic factors|mesh-ancestor
111129178|NCT03039491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111129179|NCT03037775|Nicotine|nicotine|mesh-list
111129180|NCT03037775|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111129181|NCT03037775|Autonomic Agents|autonomic agents|mesh-ancestor
111129182|NCT03037775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111129183|NCT03037775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110837106|NCT04188860|Paclitaxel|paclitaxel|mesh-list
111129184|NCT03037775|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111129185|NCT03037775|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111129186|NCT03037775|Cholinergic Agents|cholinergic agents|mesh-ancestor
111129187|NCT03037775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111129188|NCT03037775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111129189|NCT03039257|Vitamin A|vitamin a|mesh-list
111129190|NCT03039257|Vitamins|vitamins|mesh-ancestor
111129191|NCT03039257|Micronutrients|micronutrients|mesh-ancestor
111129192|NCT03039257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111129193|NCT03038009|Pantoprazole|pantoprazole|mesh-list
111129194|NCT03038009|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111129195|NCT03038009|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111129196|NCT03038009|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111129197|NCT03038009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111129198|NCT03038009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111129199|NCT03466801|Prednisone|prednisone|mesh-list
111129200|NCT03466801|Glucocorticoids|glucocorticoids|mesh-list
111129201|NCT03466801|Immunosuppressive Agents|immunosuppressive agents|mesh-list
111129202|NCT03466801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111129203|NCT03466801|Hormones|hormones|mesh-ancestor
111129204|NCT03466801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111129205|NCT03466801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110081018|NCT01633749|Vaccines|vaccines|mesh-list
111129206|NCT03466801|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111129207|NCT03466801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111129208|NCT03466801|Immunologic Factors|immunologic factors|mesh-ancestor
111129209|NCT05069779|Diazepam|diazepam|mesh-list
111129210|NCT05069779|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111129211|NCT05069779|Anticonvulsants|anticonvulsants|mesh-ancestor
111129212|NCT05069779|Antiemetics|antiemetics|mesh-ancestor
111129213|NCT05069779|Autonomic Agents|autonomic agents|mesh-ancestor
111129214|NCT05069779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111129215|NCT05069779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111129216|NCT05069779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111129217|NCT05069779|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111129218|NCT05069779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111129219|NCT05069779|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110081096|NCT01634295|Vitamins|vitamins|mesh-ancestor
111129220|NCT05069779|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111129221|NCT05069779|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111129222|NCT05069779|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111129223|NCT05069779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111129224|NCT05069779|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111129225|NCT05069779|Anesthetics, General|anesthetics, general|mesh-ancestor
111129226|NCT05069779|Anesthetics|anesthetics|mesh-ancestor
111129227|NCT05069779|GABA Modulators|gaba modulators|mesh-ancestor
111129228|NCT05069779|GABA Agents|gaba agents|mesh-ancestor
111129229|NCT05069779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111129230|NCT05069779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111129231|NCT03251911|Ivacaftor|ivacaftor|mesh-list
111129232|NCT03251911|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
111129233|NCT03251911|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111129234|NCT03251911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111129235|NCT02643355|Clonidine|clonidine|mesh-list
111129236|NCT02643355|Olanzapine|olanzapine|mesh-list
111129237|NCT02643355|Antiemetics|antiemetics|mesh-ancestor
111129238|NCT02643355|Autonomic Agents|autonomic agents|mesh-ancestor
111129239|NCT02643355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111129240|NCT02643355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111129241|NCT02643355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111129242|NCT02643355|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111129243|NCT02643355|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111129244|NCT02643355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111129245|NCT02643355|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111129246|NCT02643355|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110081212|NCT01634789|Bazedoxifene|bazedoxifene|mesh-list
111129247|NCT02643355|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111129248|NCT02643355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111129249|NCT02643355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111129250|NCT02643355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111129251|NCT02643355|Serotonin Agents|serotonin agents|mesh-ancestor
111129253|NCT02643355|Sensory System Agents|sensory system agents|mesh-ancestor
111129254|NCT02643355|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111129255|NCT02643355|Sympatholytics|sympatholytics|mesh-ancestor
111129256|NCT02643355|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111129257|NCT02643355|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111129258|NCT02643355|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111129259|NCT02643355|Adrenergic Agents|adrenergic agents|mesh-ancestor
111129260|NCT03036605|Dexamethasone|dexamethasone|mesh-list
111129261|NCT03036605|Dexamethasone acetate|dexamethasone acetate|mesh-list
111129262|NCT03036605|Bupivacaine|bupivacaine|mesh-list
111129263|NCT03036605|BB 1101|bb 1101|mesh-list
111129264|NCT03036605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111129265|NCT03036605|Antiemetics|antiemetics|mesh-ancestor
111129266|NCT03036605|Autonomic Agents|autonomic agents|mesh-ancestor
111129267|NCT03036605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111129268|NCT03036605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111129269|NCT03036605|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111129270|NCT03036605|Glucocorticoids|glucocorticoids|mesh-ancestor
111129271|NCT03036605|Hormones|hormones|mesh-ancestor
111129272|NCT03036605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111129273|NCT03036605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111129274|NCT03036605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111129275|NCT03036605|Protease Inhibitors|protease inhibitors|mesh-ancestor
111129276|NCT03036605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111129277|NCT03036605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111129278|NCT03036605|Anesthetics, Local|anesthetics, local|mesh-ancestor
111129279|NCT03036605|Anesthetics|anesthetics|mesh-ancestor
111129280|NCT03036605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111129281|NCT03036605|Sensory System Agents|sensory system agents|mesh-ancestor
111129282|NCT03098875|Remifentanil|remifentanil|mesh-list
111129283|NCT03098875|Propofol|propofol|mesh-list
111129284|NCT03098875|Sevoflurane|sevoflurane|mesh-list
111129285|NCT03098875|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111129286|NCT03098875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111129287|NCT03098875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111129288|NCT03098875|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111129289|NCT03098875|Anesthetics, General|anesthetics, general|mesh-ancestor
111129290|NCT03098875|Anesthetics|anesthetics|mesh-ancestor
111129291|NCT03098875|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111129292|NCT03098875|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111129293|NCT03098875|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111129294|NCT03098875|Narcotics|narcotics|mesh-ancestor
111129295|NCT03098875|Analgesics|analgesics|mesh-ancestor
111129296|NCT03098875|Sensory System Agents|sensory system agents|mesh-ancestor
111129297|NCT03098875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111129298|NCT03099031|Tinzaparin|tinzaparin|mesh-list
111129299|NCT03099031|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
111129300|NCT03099031|Dalteparin|dalteparin|mesh-list
111129301|NCT03099031|Anticoagulants|anticoagulants|mesh-ancestor
111129302|NCT03099031|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111129303|NCT03099031|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111129304|NCT03099031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111129305|NCT03101137|Dexamethasone|dexamethasone|mesh-list
111129306|NCT03101137|Bupivacaine|bupivacaine|mesh-list
111129307|NCT03101137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111129308|NCT03101137|Antiemetics|antiemetics|mesh-ancestor
111129309|NCT03101137|Autonomic Agents|autonomic agents|mesh-ancestor
111129310|NCT03101137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111129311|NCT03101137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111129312|NCT03101137|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111129313|NCT03101137|Glucocorticoids|glucocorticoids|mesh-ancestor
111129314|NCT03101137|Hormones|hormones|mesh-ancestor
111129315|NCT03101137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111129316|NCT03101137|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111129317|NCT03101137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111129318|NCT03101137|Anesthetics, Local|anesthetics, local|mesh-ancestor
111129319|NCT03101137|Anesthetics|anesthetics|mesh-ancestor
111129320|NCT03101137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111129321|NCT03101137|Sensory System Agents|sensory system agents|mesh-ancestor
111129322|NCT04833257|Tislelizumab|tislelizumab|mesh-list
111129323|NCT04833257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111129324|NCT04833257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111129325|NCT03098953|Loteprednol Etabonate|loteprednol etabonate|mesh-list
111129326|NCT03098953|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111129327|NCT04833101|Vaccines|vaccines|mesh-list
111129328|NCT04833101|Immunologic Factors|immunologic factors|mesh-ancestor
111129329|NCT04833101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111129330|NCT00794599|Cetirizine|cetirizine|mesh-list
111129331|NCT00794599|Desloratadine|desloratadine|mesh-list
111129332|NCT00794599|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111129333|NCT00794599|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
111129334|NCT00794599|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111129335|NCT00794599|Histamine Antagonists|histamine antagonists|mesh-ancestor
111129336|NCT00794599|Histamine Agents|histamine agents|mesh-ancestor
111129337|NCT00794599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111129338|NCT00794599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111129339|NCT00794599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111129340|NCT00794599|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111129341|NCT00794599|Cholinergic Agents|cholinergic agents|mesh-ancestor
111129342|NCT00783133|Fexofenadine|fexofenadine|mesh-list
111129343|NCT00783133|Desloratadine|desloratadine|mesh-list
111129344|NCT00783133|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111129345|NCT00783133|Cholinergic Agents|cholinergic agents|mesh-ancestor
111129346|NCT00783133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111129347|NCT00783133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111129348|NCT00783133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111129349|NCT00783133|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
111129350|NCT00783133|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111129351|NCT00783133|Histamine Antagonists|histamine antagonists|mesh-ancestor
111129352|NCT00783133|Histamine Agents|histamine agents|mesh-ancestor
111129353|NCT00783133|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111129354|NCT03098407|Buprenorphine|buprenorphine|mesh-list
111129355|NCT03098407|Methadone|methadone|mesh-list
111129356|NCT03098407|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111129357|NCT03098407|Narcotics|narcotics|mesh-ancestor
111129358|NCT03098407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111129359|NCT03098407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111129360|NCT03098407|Analgesics|analgesics|mesh-ancestor
111129361|NCT03098407|Sensory System Agents|sensory system agents|mesh-ancestor
111129362|NCT03098407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111129363|NCT03098407|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111129364|NCT03098407|Antitussive Agents|antitussive agents|mesh-ancestor
111129365|NCT03098407|Respiratory System Agents|respiratory system agents|mesh-ancestor
111129366|NCT04836143|Mitogens|mitogens|mesh-list
111129367|NCT04836143|Endothelial Growth Factors|endothelial growth factors|mesh-list
111129368|NCT04836143|Mitosis Modulators|mitosis modulators|mesh-ancestor
111129369|NCT04836143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111129370|NCT04836143|Growth Substances|growth substances|mesh-ancestor
111129371|NCT04836143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111129372|NCT05068453|Antibodies|antibodies|mesh-list
111129373|NCT05068453|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111129374|NCT05068453|Immunologic Factors|immunologic factors|mesh-ancestor
111129375|NCT05068453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111129376|NCT00751075|Mometasone Furoate|mometasone furoate|mesh-list
111129377|NCT00751075|Amoxicillin|amoxicillin|mesh-list
111129378|NCT00751075|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111129379|NCT00751075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111129380|NCT00751075|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111129381|NCT00751075|Dermatologic Agents|dermatologic agents|mesh-ancestor
111129382|NCT00751075|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111129383|NCT00731185|Mometasone Furoate|mometasone furoate|mesh-list
111129384|NCT00731185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110837139|NCT04375228|Rituximab|rituximab|mesh-list
111129386|NCT00731185|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111129387|NCT04836299|Ivermectin|ivermectin|mesh-list
111129388|NCT04836299|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111129389|NCT04836299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111129390|NCT00651391|Simvastatin|simvastatin|mesh-list
111129391|NCT00651391|Ezetimibe|ezetimibe|mesh-list
111129392|NCT00651391|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111129393|NCT00651391|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111129394|NCT00651391|Antimetabolites|antimetabolites|mesh-ancestor
111129395|NCT00651391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111129396|NCT00651391|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111129397|NCT00651391|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111129398|NCT00651391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111129399|NCT00650689|Atorvastatin|atorvastatin|mesh-list
111129400|NCT00650689|Ezetimibe|ezetimibe|mesh-list
111129401|NCT00650689|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111129402|NCT00650689|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111129403|NCT00650689|Antimetabolites|antimetabolites|mesh-ancestor
111129404|NCT00650689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111129405|NCT00650689|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111129406|NCT00650689|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111129407|NCT00650689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111129408|NCT05067517|Nintedanib|nintedanib|mesh-list
111129409|NCT05067517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111129410|NCT05067517|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111129411|NCT05067517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111129412|NCT05067517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111129413|NCT03100513|Lactulose|lactulose|mesh-list
111129414|NCT03100513|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111129415|NCT00552097|Simvastatin|simvastatin|mesh-list
111129416|NCT00552097|Ezetimibe|ezetimibe|mesh-list
111129417|NCT00552097|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111129418|NCT00552097|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111129419|NCT00552097|Antimetabolites|antimetabolites|mesh-ancestor
111129420|NCT00552097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111129421|NCT00552097|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111129422|NCT00552097|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111129423|NCT00552097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111129424|NCT00396175|Finasteride|finasteride|mesh-list
111129425|NCT00396175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111129426|NCT00396175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111129427|NCT00396175|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
111129428|NCT00396175|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111129429|NCT00396175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111129430|NCT00396175|Hormone Antagonists|hormone antagonists|mesh-ancestor
111129431|NCT00396175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111129432|NCT00396175|Urological Agents|urological agents|mesh-ancestor
111129433|NCT02603393|Fluticasone|fluticasone|mesh-list
111129434|NCT02603393|Tiotropium Bromide|tiotropium bromide|mesh-list
111129435|NCT02603393|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
111129436|NCT02603393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111129437|NCT02603393|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111129438|NCT02603393|Autonomic Agents|autonomic agents|mesh-ancestor
111129439|NCT02603393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111129440|NCT02603393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111129441|NCT02603393|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111129442|NCT02603393|Respiratory System Agents|respiratory system agents|mesh-ancestor
111129443|NCT02603393|Dermatologic Agents|dermatologic agents|mesh-ancestor
111129444|NCT02603393|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111129445|NCT02603393|Parasympatholytics|parasympatholytics|mesh-ancestor
111129446|NCT02603393|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111129447|NCT02603393|Cholinergic Agents|cholinergic agents|mesh-ancestor
111129448|NCT02603393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111129449|NCT02603393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111129450|NCT02603393|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111129451|NCT02603393|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111129452|NCT02603393|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111129453|NCT02603393|Adrenergic Agents|adrenergic agents|mesh-ancestor
111129454|NCT04832945|Ivermectin|ivermectin|mesh-list
111129455|NCT04832945|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111129456|NCT04832945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111129457|NCT02642653|Lovastatin|lovastatin|mesh-list
111129458|NCT02642653|L 647318|l 647318|mesh-list
111129459|NCT02642653|Dihydromevinolin|dihydromevinolin|mesh-list
111129460|NCT02642653|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111129461|NCT02642653|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111129462|NCT02642653|Antimetabolites|antimetabolites|mesh-ancestor
111129463|NCT02642653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111129464|NCT02642653|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111129465|NCT02642653|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111129466|NCT02642653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111129467|NCT01659567|Interferons|interferons|mesh-list
111129468|NCT01659567|Ribavirin|ribavirin|mesh-list
111129469|NCT01659567|Interferon-alpha|interferon-alpha|mesh-list
111129470|NCT01659567|Interferon alpha-2|interferon alpha-2|mesh-list
111129471|NCT01659567|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
111129472|NCT01659567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111129473|NCT01659567|Antiviral Agents|antiviral agents|mesh-ancestor
111129474|NCT01659567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111129475|NCT01659567|Antimetabolites|antimetabolites|mesh-ancestor
111129476|NCT01659567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111129477|NCT01659567|Immunologic Factors|immunologic factors|mesh-ancestor
111129478|NCT01659567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111129479|NCT03100435|Carbon Fiber|carbon fiber|mesh-list
111129480|NCT03100435|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111129481|NCT03100435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111129482|NCT03036995|Apremilast|apremilast|mesh-list
111129483|NCT03036995|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111129484|NCT03036995|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111129485|NCT03036995|Analgesics|analgesics|mesh-ancestor
111129486|NCT03036995|Sensory System Agents|sensory system agents|mesh-ancestor
111129487|NCT03036995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111129488|NCT03036995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111129489|NCT03036995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111129490|NCT03036995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111129491|NCT03036995|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
111129492|NCT03036995|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111129493|NCT03036995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111129494|NCT03036995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111129495|NCT05066035|Neostigmine|neostigmine|mesh-list
111129496|NCT05066035|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111129497|NCT05066035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111129498|NCT05066035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111129499|NCT05066035|Cholinergic Agents|cholinergic agents|mesh-ancestor
111129500|NCT05066035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111129501|NCT05066035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111129502|NCT05066035|Parasympathomimetics|parasympathomimetics|mesh-ancestor
111129503|NCT05066035|Autonomic Agents|autonomic agents|mesh-ancestor
111129504|NCT05066035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111129505|NCT04822415|Carticaine|carticaine|mesh-list
111129506|NCT04822415|Mepivacaine|mepivacaine|mesh-list
111129507|NCT04822415|Anesthetics, Local|anesthetics, local|mesh-ancestor
111129508|NCT04822415|Anesthetics|anesthetics|mesh-ancestor
111129509|NCT04822415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111129510|NCT04822415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111129511|NCT04822415|Sensory System Agents|sensory system agents|mesh-ancestor
111129512|NCT04822415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111129513|NCT05065177|Vaccines|vaccines|mesh-list
111129514|NCT05065177|Immunologic Factors|immunologic factors|mesh-ancestor
111129515|NCT05065177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111129516|NCT04821947|Bupivacaine|bupivacaine|mesh-list
111129517|NCT04821947|Anesthetics, Local|anesthetics, local|mesh-list
111129518|NCT04821947|Anesthetics|anesthetics|mesh-list
111129519|NCT04821947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111129520|NCT04821947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111129521|NCT04821947|Sensory System Agents|sensory system agents|mesh-ancestor
111129522|NCT04821947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111129523|NCT03037073|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
111129524|NCT03037073|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111129525|NCT03037073|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111129526|NCT03037073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111129527|NCT03037073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111129528|NCT03037073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111129529|NCT03037073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111129530|NCT03037073|Analgesics|analgesics|mesh-ancestor
111129531|NCT03037073|Sensory System Agents|sensory system agents|mesh-ancestor
111129532|NCT03037073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111129533|NCT03037073|Antidepressive Agents|antidepressive agents|mesh-ancestor
111129534|NCT03037073|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111129535|NCT03037073|Dopamine Agents|dopamine agents|mesh-ancestor
111129536|NCT04470973|Amikacin|amikacin|mesh-list
111129537|NCT04470973|Cefuroxime|cefuroxime|mesh-list
111129538|NCT04470973|Cefuroxime axetil|cefuroxime axetil|mesh-list
111129539|NCT04470973|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110846590|NCT03117049|Paclitaxel|paclitaxel|mesh-list
111129540|NCT04470973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111129541|NCT05046457|Beta-Cryptoxanthin|beta-cryptoxanthin|mesh-list
111129542|NCT05046457|Provitamins|provitamins|mesh-ancestor
111129543|NCT05046457|Vitamins|vitamins|mesh-ancestor
111129544|NCT05046457|Micronutrients|micronutrients|mesh-ancestor
111129545|NCT05046457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111129546|NCT05063071|Tenofovir|tenofovir|mesh-list
111129547|NCT05063071|Antiviral Agents|antiviral agents|mesh-ancestor
111129548|NCT05063071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111129549|NCT05063071|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111129550|NCT05063071|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111129551|NCT05063071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111129552|NCT05063071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111129553|NCT05063071|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111129554|NCT05063071|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111129555|NCT05062681|Dexamethasone|dexamethasone|mesh-list
111129556|NCT05062681|Methylprednisolone|methylprednisolone|mesh-list
111129557|NCT05062681|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111129558|NCT05062681|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111129559|NCT05062681|Prednisolone|prednisolone|mesh-list
111129560|NCT05062681|Prednisolone acetate|prednisolone acetate|mesh-list
111129561|NCT05062681|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111129562|NCT05062681|Prednisolone phosphate|prednisolone phosphate|mesh-list
111129563|NCT05062681|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111129564|NCT05062681|Antiemetics|antiemetics|mesh-ancestor
111129565|NCT05062681|Autonomic Agents|autonomic agents|mesh-ancestor
111129566|NCT05062681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111129567|NCT05062681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111129568|NCT05062681|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111129569|NCT05062681|Glucocorticoids|glucocorticoids|mesh-ancestor
111129570|NCT05062681|Hormones|hormones|mesh-ancestor
111129571|NCT05062681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111129572|NCT05062681|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111129573|NCT05062681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111129574|NCT05062681|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111129575|NCT05062681|Protective Agents|protective agents|mesh-ancestor
111129576|NCT05056519|Vaccines|vaccines|mesh-list
111129577|NCT05056519|Immunologic Factors|immunologic factors|mesh-ancestor
111129578|NCT05056519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111129579|NCT05045443|Curcumin|curcumin|mesh-list
111129580|NCT05045443|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111129581|NCT05045443|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111129582|NCT05045443|Analgesics|analgesics|mesh-ancestor
111129583|NCT05045443|Sensory System Agents|sensory system agents|mesh-ancestor
111129584|NCT05045443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111129585|NCT05045443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111129586|NCT05045443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111129587|NCT05045443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111129588|NCT05045443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111129589|NCT05045443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110837157|NCT03548584|Brexpiprazole|brexpiprazole|mesh-list
111129590|NCT05045443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111129591|NCT05045053|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111129592|NCT05045053|Lifitegrast|lifitegrast|mesh-list
111129593|NCT05045053|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111129594|NCT05055895|Cholinergic Antagonists|cholinergic antagonists|mesh-list
111129595|NCT05055895|Cholinergic Agents|cholinergic agents|mesh-ancestor
111129596|NCT05055895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111129597|NCT05055895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111129598|NCT05055895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111129599|NCT05060809|Vitamin K|vitamin k|mesh-list
111129600|NCT05060809|Vitamin K 1|vitamin k 1|mesh-list
111129601|NCT05060809|Vitamins|vitamins|mesh-ancestor
111129602|NCT05060809|Micronutrients|micronutrients|mesh-ancestor
111129603|NCT05060809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111129604|NCT05060809|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111129605|NCT05060809|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111129606|NCT05060809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111129607|NCT05060809|Hemostatics|hemostatics|mesh-ancestor
111129608|NCT05060809|Coagulants|coagulants|mesh-ancestor
111129609|NCT05060419|Meropenem|meropenem|mesh-list
111129610|NCT05060419|Tazobactam|tazobactam|mesh-list
111129611|NCT05060419|Piperacillin|piperacillin|mesh-list
111129612|NCT05060419|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
111129613|NCT05060419|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111129614|NCT05060419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111129615|NCT05060419|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
111129616|NCT05060419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111129617|NCT05060419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111129618|NCT03097003|Apremilast|apremilast|mesh-list
111129619|NCT03097003|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111129620|NCT03097003|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111129621|NCT03097003|Analgesics|analgesics|mesh-ancestor
111129622|NCT03097003|Sensory System Agents|sensory system agents|mesh-ancestor
111129623|NCT03097003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111129624|NCT03097003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111129625|NCT03097003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111129626|NCT03097003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111129627|NCT03097003|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
111129628|NCT03097003|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111129629|NCT03097003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111129630|NCT03097003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111129631|NCT02605967|Spartalizumab|spartalizumab|mesh-list
111129632|NCT02605967|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111129633|NCT02605967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111129634|NCT02605967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111129635|NCT02605967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111129636|NCT03036059|Ivermectin|ivermectin|mesh-list
111129637|NCT03036059|Albendazole|albendazole|mesh-list
111129638|NCT03036059|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111129639|NCT03036059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111129640|NCT03036059|Anthelmintics|anthelmintics|mesh-ancestor
111129641|NCT03036059|Anticestodal Agents|anticestodal agents|mesh-ancestor
111129642|NCT03036059|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
111129643|NCT03036059|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110081460|NCT01636245|Vaccines|vaccines|mesh-list
111129644|NCT03036059|Tubulin Modulators|tubulin modulators|mesh-ancestor
111129645|NCT03036059|Antimitotic Agents|antimitotic agents|mesh-ancestor
111129646|NCT03036059|Mitosis Modulators|mitosis modulators|mesh-ancestor
111129647|NCT03036059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111129648|NCT03036059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111129649|NCT04834427|Ketamine|ketamine|mesh-list
111129650|NCT04834427|Esketamine|esketamine|mesh-list
111129651|NCT04834427|Analgesics|analgesics|mesh-ancestor
111129652|NCT04834427|Sensory System Agents|sensory system agents|mesh-ancestor
111129653|NCT04834427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111129654|NCT04834427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111129655|NCT04834427|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111129656|NCT04834427|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111129657|NCT04834427|Anesthetics, General|anesthetics, general|mesh-ancestor
111129658|NCT04834427|Anesthetics|anesthetics|mesh-ancestor
111129659|NCT04834427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110837166|NCT01381640|Analgesics|analgesics|mesh-ancestor
111129660|NCT04834427|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111129661|NCT04834427|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111129662|NCT04834427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111129663|NCT04834427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111129664|NCT04834427|Antidepressive Agents|antidepressive agents|mesh-ancestor
111129665|NCT04834427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111129666|NCT05035849|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111129668|NCT05035849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111129669|NCT05035849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111129670|NCT05035849|Incretins|incretins|mesh-ancestor
111129671|NCT05035849|Hormones|hormones|mesh-ancestor
111129672|NCT05035849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111129673|NCT05035849|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111129674|NCT05035849|Protease Inhibitors|protease inhibitors|mesh-ancestor
111129675|NCT05035849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111129676|NCT05035849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111129677|NCT05035849|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
111129678|NCT04428437|Lenvatinib|lenvatinib|mesh-list
111129679|NCT04428437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111129680|NCT04428437|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111129681|NCT04428437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111129682|NCT04428437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111129683|NCT05035381|Leucovorin|leucovorin|mesh-list
111129684|NCT05035381|Bevacizumab|bevacizumab|mesh-list
111129685|NCT05035381|Pembrolizumab|pembrolizumab|mesh-list
111129686|NCT05035381|Fluorouracil|fluorouracil|mesh-list
111129687|NCT05035381|Irinotecan|irinotecan|mesh-list
111129688|NCT05035381|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
111129689|NCT05035381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111129690|NCT05035381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111129691|NCT05035381|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111129692|NCT05035381|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111129693|NCT05035381|Growth Substances|growth substances|mesh-ancestor
111129694|NCT05035381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111129695|NCT05035381|Growth Inhibitors|growth inhibitors|mesh-ancestor
111129696|NCT05035381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111129697|NCT05035381|Antimetabolites|antimetabolites|mesh-ancestor
111129698|NCT05035381|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111129699|NCT05035381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111129700|NCT05035381|Immunologic Factors|immunologic factors|mesh-ancestor
111129701|NCT05035381|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111129702|NCT05035381|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111129703|NCT05035381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111129704|NCT05035381|Antidotes|antidotes|mesh-ancestor
111129705|NCT05035381|Protective Agents|protective agents|mesh-ancestor
111129706|NCT05035381|Vitamin B Complex|vitamin b complex|mesh-ancestor
111129707|NCT05035381|Vitamins|vitamins|mesh-ancestor
111129708|NCT05035381|Micronutrients|micronutrients|mesh-ancestor
111129709|NCT04821323|Indomethacin|indomethacin|mesh-list
111129710|NCT04821323|Mannitol|mannitol|mesh-list
111129711|NCT04821323|Lactulose|lactulose|mesh-list
111129712|NCT04821323|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
111129713|NCT04821323|Diuretics|diuretics|mesh-ancestor
111129714|NCT04821323|Natriuretic Agents|natriuretic agents|mesh-ancestor
111129715|NCT04821323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111129716|NCT04821323|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111129717|NCT04821323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111129718|NCT04821323|Analgesics|analgesics|mesh-ancestor
111129719|NCT04821323|Sensory System Agents|sensory system agents|mesh-ancestor
111129720|NCT04821323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111129721|NCT04821323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111129722|NCT04821323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111129723|NCT04821323|Gout Suppressants|gout suppressants|mesh-ancestor
111129724|NCT04821323|Tocolytic Agents|tocolytic agents|mesh-ancestor
111129725|NCT04821323|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111129726|NCT04821323|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111129727|NCT04821323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111129728|NCT04821323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111129729|NCT04821323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111129730|NCT05035069|Propofol|propofol|mesh-list
111129731|NCT05035069|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111129732|NCT05035069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111129733|NCT05035069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111129734|NCT05035069|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111129735|NCT05035069|Anesthetics, General|anesthetics, general|mesh-ancestor
111129736|NCT05035069|Anesthetics|anesthetics|mesh-ancestor
111129737|NCT05035147|Paclitaxel|paclitaxel|mesh-list
111129738|NCT05035147|Gemcitabine|gemcitabine|mesh-list
111129739|NCT05035147|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111129740|NCT05035147|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111129741|NCT05035147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111129742|NCT05035147|Tubulin Modulators|tubulin modulators|mesh-ancestor
111129743|NCT05035147|Antimitotic Agents|antimitotic agents|mesh-ancestor
111129744|NCT05035147|Mitosis Modulators|mitosis modulators|mesh-ancestor
111129745|NCT05035147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111129746|NCT05035147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111129747|NCT05035147|Antimetabolites|antimetabolites|mesh-ancestor
111129748|NCT04834115|Ivermectin|ivermectin|mesh-list
111129749|NCT04834115|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111129750|NCT04834115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111129751|NCT01505465|Melatonin|melatonin|mesh-list
111129752|NCT01505465|Antioxidants|antioxidants|mesh-ancestor
111129753|NCT01505465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111129754|NCT01505465|Protective Agents|protective agents|mesh-ancestor
111129755|NCT01505465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111129756|NCT01505465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111129757|NCT04831229|Menthol|menthol|mesh-list
111129758|NCT04831229|Antipruritics|antipruritics|mesh-ancestor
111129759|NCT04831229|Dermatologic Agents|dermatologic agents|mesh-ancestor
111129760|NCT04816253|Methylprednisolone|methylprednisolone|mesh-list
111129761|NCT04816253|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111129762|NCT04816253|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111129763|NCT04816253|Prednisolone|prednisolone|mesh-list
111129764|NCT04816253|Prednisolone acetate|prednisolone acetate|mesh-list
111129765|NCT04816253|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111129766|NCT04816253|Prednisolone phosphate|prednisolone phosphate|mesh-list
111129767|NCT04816253|Hyaluronic Acid|hyaluronic acid|mesh-list
111129768|NCT04816253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111129769|NCT04816253|Antiemetics|antiemetics|mesh-ancestor
111129770|NCT04816253|Autonomic Agents|autonomic agents|mesh-ancestor
111129771|NCT04816253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111129772|NCT04816253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111129773|NCT04816253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111129775|NCT04816253|Hormones|hormones|mesh-ancestor
111129776|NCT04816253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111129777|NCT04816253|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111129778|NCT04816253|Protective Agents|protective agents|mesh-ancestor
111129779|NCT04816253|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111129780|NCT04816253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111129781|NCT04816253|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111129782|NCT04816253|Immunologic Factors|immunologic factors|mesh-ancestor
111129783|NCT04816253|Viscosupplements|viscosupplements|mesh-ancestor
111129784|NCT04816097|Dexamethasone|dexamethasone|mesh-list
111129785|NCT04816097|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
111129786|NCT04816097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111129787|NCT04816097|Antiemetics|antiemetics|mesh-ancestor
111129788|NCT04816097|Autonomic Agents|autonomic agents|mesh-ancestor
111129789|NCT04816097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111129790|NCT04816097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111129791|NCT04816097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111129792|NCT04816097|Glucocorticoids|glucocorticoids|mesh-ancestor
111129793|NCT04816097|Hormones|hormones|mesh-ancestor
111129794|NCT04816097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111129795|NCT04816097|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111129796|NCT04816097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111129797|NCT02600351|Sofosbuvir|sofosbuvir|mesh-list
111129798|NCT02600351|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
111129799|NCT02600351|Ledipasvir|ledipasvir|mesh-list
111129800|NCT02600351|Antiviral Agents|antiviral agents|mesh-ancestor
111129801|NCT02600351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111129802|NCT04829435|Rasburicase|rasburicase|mesh-list
111129803|NCT04829435|Gout Suppressants|gout suppressants|mesh-ancestor
111129804|NCT04829435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111129805|NCT05042635|Ixekizumab|ixekizumab|mesh-list
111129806|NCT05042635|Dermatologic Agents|dermatologic agents|mesh-ancestor
111129807|NCT04815395|Oxytocin|oxytocin|mesh-list
111129808|NCT04815395|Oxytocics|oxytocics|mesh-ancestor
111129809|NCT04815395|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111129810|NCT04815395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111129811|NCT03096301|Salicylic Acid|salicylic acid|mesh-list
111129812|NCT03096301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111129813|NCT03096301|Antifungal Agents|antifungal agents|mesh-ancestor
111129814|NCT03096301|Keratolytic Agents|keratolytic agents|mesh-ancestor
111129815|NCT03096301|Dermatologic Agents|dermatologic agents|mesh-ancestor
111129816|NCT05034055|Atezolizumab|atezolizumab|mesh-list
111129817|NCT05034055|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111129818|NCT05034055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111129819|NCT05034055|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111129820|NCT05034055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111129821|NCT05042245|Silymarin|silymarin|mesh-list
111129822|NCT05042245|N-Methylaspartate|n-methylaspartate|mesh-list
111129823|NCT05042245|Antioxidants|antioxidants|mesh-ancestor
111129824|NCT05042245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111129825|NCT05042245|Protective Agents|protective agents|mesh-ancestor
111129826|NCT05042245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111129827|NCT05042245|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
111129828|NCT05042245|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111129829|NCT05042245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111129830|NCT03095209|Paclitaxel|paclitaxel|mesh-list
111129831|NCT03095209|Carboplatin|carboplatin|mesh-list
111129832|NCT03095209|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111129833|NCT03095209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111129834|NCT03095209|Tubulin Modulators|tubulin modulators|mesh-ancestor
111129835|NCT03095209|Antimitotic Agents|antimitotic agents|mesh-ancestor
111129836|NCT03095209|Mitosis Modulators|mitosis modulators|mesh-ancestor
111129837|NCT03095209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111129838|NCT05034133|Cisplatin|cisplatin|mesh-list
111129839|NCT05034133|Etoposide|etoposide|mesh-list
111129840|NCT05034133|Durvalumab|durvalumab|mesh-list
111129841|NCT05034133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111129842|NCT05034133|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111129843|NCT05034133|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111129844|NCT05034133|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111129845|NCT05034133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111129846|NCT05034133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111129847|NCT05034133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111129848|NCT03096457|Paromomycin|paromomycin|mesh-list
111129849|NCT03096457|Pentamidine|pentamidine|mesh-list
111129850|NCT03096457|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111129851|NCT03096457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111129852|NCT03096457|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111129853|NCT03096457|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111129854|NCT03096457|Antifungal Agents|antifungal agents|mesh-ancestor
111129855|NCT03096457|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
111129857|NCT03096223|Dermatologic Agents|dermatologic agents|mesh-ancestor
111129858|NCT04814303|Morphine|morphine|mesh-list
111129859|NCT04814303|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111129860|NCT04814303|Narcotics|narcotics|mesh-ancestor
111129861|NCT04814303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111129862|NCT04814303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111129863|NCT04814303|Analgesics|analgesics|mesh-ancestor
111129864|NCT04814303|Sensory System Agents|sensory system agents|mesh-ancestor
111129865|NCT04814303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111129866|NCT05053009|Ibuprofen|ibuprofen|mesh-list
111129867|NCT05053009|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111129868|NCT05053009|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111129869|NCT05053009|Analgesics|analgesics|mesh-ancestor
111129870|NCT05053009|Sensory System Agents|sensory system agents|mesh-ancestor
111129871|NCT05053009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110081660|NCT01636999|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111129872|NCT05053009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111129873|NCT05053009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111129874|NCT05053009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111129875|NCT05053009|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111129876|NCT05053009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110870373|NCT02394418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110081723|NCT01637259|Tenofovir|tenofovir|mesh-list
111129877|NCT05053009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111129878|NCT04813913|Bevacizumab|bevacizumab|mesh-list
110081796|NCT01637558|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111129879|NCT04813913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111129880|NCT04813913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111129881|NCT04813913|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111129882|NCT04813913|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111129883|NCT04813913|Growth Substances|growth substances|mesh-ancestor
111129884|NCT04813913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111129885|NCT04813913|Growth Inhibitors|growth inhibitors|mesh-ancestor
111129887|NCT03094663|Dexamethasone|dexamethasone|mesh-list
111129888|NCT03094663|Dexamethasone acetate|dexamethasone acetate|mesh-list
111129889|NCT03094663|Methylprednisolone|methylprednisolone|mesh-list
111129890|NCT03094663|Epinephrine|epinephrine|mesh-list
111129891|NCT03094663|Bupivacaine|bupivacaine|mesh-list
111129892|NCT03094663|BB 1101|bb 1101|mesh-list
111129893|NCT03094663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111129894|NCT03094663|Antiemetics|antiemetics|mesh-ancestor
111129895|NCT03094663|Autonomic Agents|autonomic agents|mesh-ancestor
111129896|NCT03094663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111129897|NCT03094663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111129898|NCT03094663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111129899|NCT03094663|Glucocorticoids|glucocorticoids|mesh-ancestor
111129900|NCT03094663|Hormones|hormones|mesh-ancestor
111129901|NCT03094663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111129902|NCT03094663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111129903|NCT03094663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110082460|NCT01648777|Anesthetics|anesthetics|mesh-ancestor
111129904|NCT03094663|Protease Inhibitors|protease inhibitors|mesh-ancestor
111129905|NCT03094663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111129906|NCT03094663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111129907|NCT03094663|Anesthetics, Local|anesthetics, local|mesh-ancestor
111129908|NCT03094663|Anesthetics|anesthetics|mesh-ancestor
111129909|NCT03094663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111129910|NCT03094663|Sensory System Agents|sensory system agents|mesh-ancestor
110082686|NCT01651325|Dextromethorphan|dextromethorphan|mesh-list
111129911|NCT03094663|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111129912|NCT03094663|Protective Agents|protective agents|mesh-ancestor
110082831|NCT01651988|Anesthetics|anesthetics|mesh-ancestor
111129913|NCT03094663|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110082925|NCT01652339|Amlodipine|amlodipine|mesh-list
111129914|NCT03094663|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111129915|NCT03094663|Adrenergic Agents|adrenergic agents|mesh-ancestor
111129916|NCT03094663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111129917|NCT03094663|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110083056|NCT01652794|Carboplatin|carboplatin|mesh-list
111129918|NCT03094663|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111129919|NCT03094663|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111129920|NCT03094663|Respiratory System Agents|respiratory system agents|mesh-ancestor
111129921|NCT03094663|Mydriatics|mydriatics|mesh-ancestor
111129922|NCT03094663|Sympathomimetics|sympathomimetics|mesh-ancestor
110083284|NCT01654211|Ritonavir|ritonavir|mesh-list
111129923|NCT03094663|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111129924|NCT03094663|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111129925|NCT03094663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110083431|NCT01655108|Minoxidil|minoxidil|mesh-list
111129926|NCT04814381|Magnesium Sulfate|magnesium sulfate|mesh-list
111129927|NCT04814381|Ketamine|ketamine|mesh-list
111129928|NCT04814381|Analgesics|analgesics|mesh-ancestor
111129929|NCT04814381|Sensory System Agents|sensory system agents|mesh-ancestor
111129930|NCT04814381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111129931|NCT04814381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111129932|NCT04814381|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111129933|NCT04814381|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110837188|NCT04283890|Nivolumab|nivolumab|mesh-list
111129934|NCT04814381|Anesthetics, General|anesthetics, general|mesh-ancestor
111129935|NCT04814381|Anesthetics|anesthetics|mesh-ancestor
111129936|NCT04814381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111129937|NCT04814381|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110083726|NCT01656122|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111129938|NCT04814381|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111129939|NCT04814381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111129940|NCT04814381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111129941|NCT04814381|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111129942|NCT04814381|Anticonvulsants|anticonvulsants|mesh-ancestor
111129943|NCT04814381|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111129944|NCT04814381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111129945|NCT04814381|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111129946|NCT04814381|Tocolytic Agents|tocolytic agents|mesh-ancestor
111129947|NCT04814381|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111129948|NCT04819217|Charcoal|charcoal|mesh-list
111129949|NCT04819217|Antidotes|antidotes|mesh-ancestor
111129950|NCT04819217|Protective Agents|protective agents|mesh-ancestor
110084094|NCT01658033|Growth Substances|growth substances|mesh-ancestor
110084165|NCT01658449|Hyaluronic Acid|hyaluronic acid|mesh-list
111129951|NCT04819217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111129952|NCT05052619|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111129953|NCT05052619|Cefmetazole|cefmetazole|mesh-list
111129954|NCT05052619|Sulperazone|sulperazone|mesh-list
110084317|NCT01659346|Antioxidants|antioxidants|mesh-ancestor
111129955|NCT05052619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111129956|NCT05052619|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111129957|NCT05052775|Chlorhexidine|chlorhexidine|mesh-list
111129958|NCT05052775|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110084474|NCT01660295|Certoparin|certoparin|mesh-list
111129959|NCT05052775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111129960|NCT05052775|Disinfectants|disinfectants|mesh-ancestor
111129961|NCT04813523|Cisplatin|cisplatin|mesh-list
111129962|NCT04813523|Pembrolizumab|pembrolizumab|mesh-list
111129963|NCT04813523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111129964|NCT04813523|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111129965|NCT04813523|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111129966|NCT04813523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111129967|NCT05032261|Norepinephrine|norepinephrine|mesh-list
111129968|NCT05032261|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111129969|NCT05032261|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111129970|NCT05032261|Adrenergic Agents|adrenergic agents|mesh-ancestor
111129971|NCT05032261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111129972|NCT05032261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111129973|NCT05032261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111129974|NCT05032261|Sympathomimetics|sympathomimetics|mesh-ancestor
111129975|NCT05032261|Autonomic Agents|autonomic agents|mesh-ancestor
111129976|NCT05032261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111129977|NCT05032261|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111129978|NCT05619341|Psyllium|psyllium|mesh-list
111129979|NCT05619341|Cathartics|cathartics|mesh-ancestor
111129980|NCT05619341|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111129981|NCT04814069|Tislelizumab|tislelizumab|mesh-list
111129982|NCT04814069|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111129983|NCT04814069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111129984|NCT05051137|Hydroxychloroquine|hydroxychloroquine|mesh-list
111129985|NCT05051137|Sulfasalazine|sulfasalazine|mesh-list
111129986|NCT05051137|Infliximab|infliximab|mesh-list
111129987|NCT05051137|Antimalarials|antimalarials|mesh-ancestor
111129988|NCT05051137|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111129989|NCT05051137|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111129990|NCT05051137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111129991|NCT05051137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111129992|NCT05051137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111129993|NCT05051137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111129994|NCT05051137|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111129995|NCT05051137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111129996|NCT05051137|Dermatologic Agents|dermatologic agents|mesh-ancestor
111129997|NCT05051137|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111129998|NCT05051137|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111129999|NCT05051137|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111130000|NCT05051137|Analgesics|analgesics|mesh-ancestor
110084870|NCT01662804|Interleukin-2|interleukin-2|mesh-list
111130001|NCT05051137|Sensory System Agents|sensory system agents|mesh-ancestor
111130002|NCT05051137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110085023|NCT01664260|Protective Agents|protective agents|mesh-ancestor
111130003|NCT05051137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111130005|NCT05038969|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111130006|NCT05038969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111130007|NCT05038969|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111130008|NCT05038969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111130009|NCT05038969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111130010|NCT05038657|Atezolizumab|atezolizumab|mesh-list
111130011|NCT05038657|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111130012|NCT05038657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111130013|NCT05038657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111130014|NCT05038657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111130015|NCT05038111|Dexmedetomidine|dexmedetomidine|mesh-list
111130016|NCT05038111|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111130017|NCT05038111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110085097|NCT01664871|Cariostatic Agents|cariostatic agents|mesh-ancestor
111130018|NCT05038111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111130019|NCT05038111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110085178|NCT01665248|Fluorides|fluorides|mesh-list
111130020|NCT05038111|Analgesics|analgesics|mesh-ancestor
111130021|NCT05038111|Sensory System Agents|sensory system agents|mesh-ancestor
111130022|NCT05038111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111130023|NCT05038111|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111130024|NCT05038111|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111130025|NCT05038111|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111130026|NCT05038111|Adrenergic Agents|adrenergic agents|mesh-ancestor
111130027|NCT05038111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111130028|NCT05038111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110085428|NCT01666691|CKD732|ckd732|mesh-list
111130029|NCT05030077|Carboplatin|carboplatin|mesh-list
111130030|NCT05030077|Gemcitabine|gemcitabine|mesh-list
111130031|NCT05030077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111130032|NCT05030077|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111130033|NCT05030077|Antimetabolites|antimetabolites|mesh-ancestor
111130034|NCT05030077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111130035|NCT05029531|Immunomodulating Agents|immunomodulating agents|mesh-list
110085609|NCT01668121|Hormones|hormones|mesh-ancestor
111130036|NCT05029531|Immunologic Factors|immunologic factors|mesh-ancestor
110085681|NCT01668680|Analgesics|analgesics|mesh-ancestor
111130037|NCT05029531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111130039|NCT05029453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111130040|NCT05029453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111130041|NCT05029453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111130042|NCT05029453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111130043|NCT02640157|Sofosbuvir|sofosbuvir|mesh-list
111130044|NCT02640157|Antiviral Agents|antiviral agents|mesh-ancestor
111130045|NCT02640157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111130046|NCT05037253|Vitamin D|vitamin d|mesh-list
111130047|NCT05037253|Vitamins|vitamins|mesh-ancestor
111130048|NCT05037253|Micronutrients|micronutrients|mesh-ancestor
110086050|NCT01678053|Botulinum Toxins|botulinum toxins|mesh-list
111130049|NCT05037253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111130050|NCT05037253|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111130051|NCT05029297|Capsaicin|capsaicin|mesh-list
111130052|NCT05029297|Antipruritics|antipruritics|mesh-ancestor
110086129|NCT01679093|Dopamine Agents|dopamine agents|mesh-ancestor
111130053|NCT05029297|Dermatologic Agents|dermatologic agents|mesh-ancestor
111130054|NCT05029297|Sensory System Agents|sensory system agents|mesh-ancestor
111130055|NCT05029297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111130056|NCT05029297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111130057|NCT05028907|Tocopherols|tocopherols|mesh-list
111130058|NCT05028907|Vitamin E|vitamin e|mesh-list
111130059|NCT05028907|alpha-Tocopherol|alpha-tocopherol|mesh-list
111130060|NCT05028907|Chloramphenicol|chloramphenicol|mesh-list
111130061|NCT05028907|Dexamethasone|dexamethasone|mesh-list
111130062|NCT05028907|Dexamethasone acetate|dexamethasone acetate|mesh-list
111130063|NCT05028907|Tetrahydrozoline|tetrahydrozoline|mesh-list
111130064|NCT05028907|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
111130065|NCT05028907|Hyaluronic Acid|hyaluronic acid|mesh-list
111130066|NCT05028907|BB 1101|bb 1101|mesh-list
111130067|NCT05028907|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111130068|NCT05028907|Antiemetics|antiemetics|mesh-ancestor
111130069|NCT05028907|Autonomic Agents|autonomic agents|mesh-ancestor
111130070|NCT05028907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111130071|NCT05028907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111130072|NCT05028907|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111130073|NCT05028907|Glucocorticoids|glucocorticoids|mesh-ancestor
111130074|NCT05028907|Hormones|hormones|mesh-ancestor
110837210|NCT05068037|Autonomic Agents|autonomic agents|mesh-ancestor
110086411|NCT05076838|Anticonvulsants|anticonvulsants|mesh-ancestor
110924797|NCT03098680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111130075|NCT05028907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111130076|NCT05028907|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111130077|NCT05028907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111130078|NCT05028907|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111130079|NCT05028907|Immunologic Factors|immunologic factors|mesh-ancestor
111130081|NCT05028907|Protective Agents|protective agents|mesh-ancestor
111130082|NCT05028907|Antioxidants|antioxidants|mesh-ancestor
111130083|NCT05028907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111130084|NCT05028907|Vitamins|vitamins|mesh-ancestor
111130085|NCT05028907|Micronutrients|micronutrients|mesh-ancestor
111130086|NCT05028907|Protease Inhibitors|protease inhibitors|mesh-ancestor
110086831|NCT03119038|Mydriatics|mydriatics|mesh-ancestor
111130087|NCT05028907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111130088|NCT05028907|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110086911|NCT02812862|Olodaterol|olodaterol|mesh-list
111130089|NCT05028907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111130090|NCT05028907|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111130091|NCT05028907|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
111130092|NCT05028907|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111130093|NCT05028907|Sympathomimetics|sympathomimetics|mesh-ancestor
111130094|NCT05028907|Nasal Decongestants|nasal decongestants|mesh-ancestor
111130095|NCT05028907|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111130096|NCT05028907|Respiratory System Agents|respiratory system agents|mesh-ancestor
111130097|NCT05028049|Sufentanil|sufentanil|mesh-list
111130098|NCT05028049|Remifentanil|remifentanil|mesh-list
111130100|NCT05028049|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111130101|NCT05028049|Narcotics|narcotics|mesh-ancestor
110087123|NCT05797558|Hormones|hormones|mesh-ancestor
111130102|NCT05028049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111130103|NCT05028049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111130104|NCT05028049|Analgesics|analgesics|mesh-ancestor
111130105|NCT05028049|Sensory System Agents|sensory system agents|mesh-ancestor
111130106|NCT05028049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111130107|NCT05028049|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111130108|NCT05028049|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111130109|NCT05028049|Anesthetics, General|anesthetics, general|mesh-ancestor
111130110|NCT05028049|Anesthetics|anesthetics|mesh-ancestor
111130111|NCT05023915|Dexamethasone|dexamethasone|mesh-list
111130112|NCT05023915|Glycyrrhizic Acid|glycyrrhizic acid|mesh-list
111130113|NCT05023915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111130114|NCT05023915|Antiemetics|antiemetics|mesh-ancestor
111130115|NCT05023915|Autonomic Agents|autonomic agents|mesh-ancestor
111130116|NCT05023915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111130117|NCT05023915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111130118|NCT05023915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111130119|NCT05023915|Glucocorticoids|glucocorticoids|mesh-ancestor
111130120|NCT05023915|Hormones|hormones|mesh-ancestor
111130121|NCT05023915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110087729|NCT01687751|GABA Modulators|gaba modulators|mesh-ancestor
111130122|NCT05023915|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111130123|NCT05023915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111130124|NCT05027581|Hyaluronic Acid|hyaluronic acid|mesh-list
111130125|NCT05027581|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111130126|NCT05027581|Immunologic Factors|immunologic factors|mesh-ancestor
111130127|NCT05027581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111130128|NCT05027581|Viscosupplements|viscosupplements|mesh-ancestor
111130129|NCT05027581|Protective Agents|protective agents|mesh-ancestor
111130130|NCT05027191|Sevoflurane|sevoflurane|mesh-list
111130131|NCT05027191|Desflurane|desflurane|mesh-list
110924798|NCT03098680|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111130132|NCT05027191|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111130133|NCT05027191|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110088010|NCT01690962|Vitamins|vitamins|mesh-list
111130134|NCT05027191|Anesthetics, General|anesthetics, general|mesh-ancestor
111130135|NCT05027191|Anesthetics|anesthetics|mesh-ancestor
111130136|NCT05027191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111130137|NCT05027191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111130138|NCT03094507|Dolutegravir|dolutegravir|mesh-list
111130139|NCT03094507|Darunavir|darunavir|mesh-list
111130140|NCT03094507|Cobicistat|cobicistat|mesh-list
110924800|NCT03098680|Sympathomimetics|sympathomimetics|mesh-ancestor
111130141|NCT03094507|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
111130142|NCT03094507|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111130143|NCT03094507|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111130144|NCT03094507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110837219|NCT01136759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111130145|NCT03094507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111130146|NCT03094507|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111130147|NCT03094507|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110088517|NCT05290857|Hemostatics|hemostatics|mesh-list
111130148|NCT03094507|Antiviral Agents|antiviral agents|mesh-ancestor
110088594|NCT05291793|Analgesics|analgesics|mesh-ancestor
111130149|NCT03094507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111130150|NCT03094507|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110088664|NCT05294640|Sensory System Agents|sensory system agents|mesh-ancestor
111130151|NCT03094507|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111130152|NCT03094507|Protease Inhibitors|protease inhibitors|mesh-ancestor
111130153|NCT03094507|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111130154|NCT03094507|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111130155|NCT02528253|Tramadol|tramadol|mesh-list
111130156|NCT02528253|Tanezumab|tanezumab|mesh-list
111130157|NCT02528253|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111130158|NCT02528253|Narcotics|narcotics|mesh-ancestor
111130159|NCT02528253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111130160|NCT02528253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111130161|NCT02528253|Analgesics|analgesics|mesh-ancestor
111130162|NCT02528253|Sensory System Agents|sensory system agents|mesh-ancestor
111130163|NCT02528253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111130164|NCT03093103|Empagliflozin|empagliflozin|mesh-list
111130165|NCT03093103|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110089116|NCT05030025|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111130166|NCT03093103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111130167|NCT03093103|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111130168|NCT03093103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110089193|NCT04871425|Fentanyl|fentanyl|mesh-list
111130169|NCT03093805|Calcipotriene|calcipotriene|mesh-list
111130170|NCT03093805|Dermatologic Agents|dermatologic agents|mesh-ancestor
110089268|NCT04659941|BCG Vaccine|bcg vaccine|mesh-list
111130171|NCT03093883|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
111130172|NCT03093883|Hematinics|hematinics|mesh-ancestor
111130173|NCT05023759|Cannabidiol|cannabidiol|mesh-list
111130174|NCT05023759|Anticonvulsants|anticonvulsants|mesh-ancestor
111130175|NCT01672957|Mycophenolic Acid|mycophenolic acid|mesh-list
110089483|NCT04159818|Doxorubicin|doxorubicin|mesh-list
111130176|NCT01672957|Immunosuppressive Agents|immunosuppressive agents|mesh-list
110089574|NCT04012177|Niacin|niacin|mesh-list
111130177|NCT01672957|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111130178|NCT01672957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110089660|NCT03922451|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111130179|NCT01672957|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111130180|NCT01672957|Antitubercular Agents|antitubercular agents|mesh-ancestor
110089733|NCT05801380|Memantine|memantine|mesh-list
111130181|NCT01672957|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111130182|NCT01672957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110089824|NCT05800756|Letrozole|letrozole|mesh-list
111130183|NCT01672957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111130184|NCT01672957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111130185|NCT01672957|Immunologic Factors|immunologic factors|mesh-ancestor
111130186|NCT01672957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111130187|NCT05047393|Vitamin D|vitamin d|mesh-list
111130188|NCT05047393|Vitamins|vitamins|mesh-ancestor
111130189|NCT05047393|Micronutrients|micronutrients|mesh-ancestor
111130190|NCT05047393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110090288|NCT04549792|Ustekinumab|ustekinumab|mesh-list
111130191|NCT05047393|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111130192|NCT05017987|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
110090352|NCT04112498|Nivolumab|nivolumab|mesh-list
111130193|NCT05017987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111130194|NCT05017987|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111130195|NCT05017987|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111130196|NCT05017987|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111130197|NCT05021887|Fluticasone|fluticasone|mesh-list
111130198|NCT05021887|Xhance|xhance|mesh-list
111130199|NCT05021887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111130200|NCT05021887|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111130201|NCT05021887|Autonomic Agents|autonomic agents|mesh-ancestor
111130202|NCT05021887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111130203|NCT05021887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111130204|NCT05021887|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111130205|NCT05021887|Respiratory System Agents|respiratory system agents|mesh-ancestor
111130206|NCT05021887|Dermatologic Agents|dermatologic agents|mesh-ancestor
111130207|NCT05021887|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111130208|NCT05021731|Rifampin|rifampin|mesh-list
111130209|NCT05021731|Rifapentine|rifapentine|mesh-list
111130210|NCT05021731|Isoniazid|isoniazid|mesh-list
111130211|NCT05021731|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111130212|NCT05021731|Antitubercular Agents|antitubercular agents|mesh-ancestor
111130214|NCT05021731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111130215|NCT05021731|Leprostatic Agents|leprostatic agents|mesh-ancestor
111130216|NCT05021731|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111130217|NCT05021731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110090544|NCT03227705|Progesterone|progesterone|mesh-list
111130218|NCT05021731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111130219|NCT05021731|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111130220|NCT05021731|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111130221|NCT05021731|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
111130222|NCT05021731|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
111130223|NCT05021731|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
111130224|NCT05021731|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111130225|NCT05021731|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
111130226|NCT05021731|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111130227|NCT05021731|Antimetabolites|antimetabolites|mesh-ancestor
111130228|NCT05021731|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111130229|NCT05009953|Leucovorin|leucovorin|mesh-list
111130230|NCT05009953|Fluorouracil|fluorouracil|mesh-list
111130231|NCT05009953|Irinotecan|irinotecan|mesh-list
111130232|NCT05009953|Antimetabolites|antimetabolites|mesh-ancestor
111130233|NCT05009953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111130234|NCT05009953|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111130235|NCT05009953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111130236|NCT05009953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111130237|NCT05009953|Immunologic Factors|immunologic factors|mesh-ancestor
110090776|NCT03836144|Expectorants|expectorants|mesh-ancestor
111130238|NCT05009953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111130239|NCT05009953|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111130240|NCT05009953|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110090930|NCT03660241|Abrocitinib|abrocitinib|mesh-list
111130241|NCT05009953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111130242|NCT05009953|Antidotes|antidotes|mesh-ancestor
111130243|NCT05009953|Protective Agents|protective agents|mesh-ancestor
111130244|NCT05009953|Vitamin B Complex|vitamin b complex|mesh-ancestor
111130245|NCT05009953|Vitamins|vitamins|mesh-ancestor
110091003|NCT03533712|Vitamins|vitamins|mesh-ancestor
111130246|NCT05009953|Micronutrients|micronutrients|mesh-ancestor
111130247|NCT03079453|Dexamethasone|dexamethasone|mesh-list
111130248|NCT03079453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111130249|NCT03079453|Antiemetics|antiemetics|mesh-ancestor
111130250|NCT03079453|Autonomic Agents|autonomic agents|mesh-ancestor
110091372|NCT01398839|Vitamins|vitamins|mesh-ancestor
110091451|NCT03012815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111130251|NCT03079453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111130252|NCT03079453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111130253|NCT03079453|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111130254|NCT03079453|Glucocorticoids|glucocorticoids|mesh-ancestor
111130255|NCT03079453|Hormones|hormones|mesh-ancestor
110924801|NCT03098680|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111130256|NCT03079453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111130257|NCT03079453|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111130258|NCT03079453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111130259|NCT05009017|Bevacizumab|bevacizumab|mesh-list
110091765|NCT02323100|Glycerol|glycerol|mesh-list
111130260|NCT05009017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111130261|NCT05009017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111130262|NCT05009017|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111130263|NCT05009017|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111130264|NCT05009017|Growth Substances|growth substances|mesh-ancestor
111130265|NCT05009017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111130266|NCT05009017|Growth Inhibitors|growth inhibitors|mesh-ancestor
111130267|NCT05008939|Sevoflurane|sevoflurane|mesh-list
110924802|NCT03098680|Nasal Decongestants|nasal decongestants|mesh-ancestor
111130268|NCT05008939|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110092118|NCT00579527|Methylprednisolone|methylprednisolone|mesh-list
110092196|NCT01694134|Antiemetics|antiemetics|mesh-ancestor
111130269|NCT05008939|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111130270|NCT05008939|Anesthetics, General|anesthetics, general|mesh-ancestor
111130271|NCT05008939|Anesthetics|anesthetics|mesh-ancestor
111130272|NCT05008939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111130273|NCT05008939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111130274|NCT05008861|Pembrolizumab|pembrolizumab|mesh-list
111130275|NCT05008861|Nivolumab|nivolumab|mesh-list
111130276|NCT05008861|Durvalumab|durvalumab|mesh-list
111130277|NCT05008861|Tislelizumab|tislelizumab|mesh-list
111130278|NCT05008861|Antibodies|antibodies|mesh-list
110837236|NCT01141439|Hormones|hormones|mesh-ancestor
110092425|NCT01696409|Vitamin D|vitamin d|mesh-list
111130279|NCT05008861|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111130280|NCT05008861|Immunologic Factors|immunologic factors|mesh-ancestor
110092494|NCT01696656|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111130281|NCT05008861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111130282|NCT05008861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111130283|NCT05008861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111130284|NCT05008861|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111130285|NCT05008861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111130286|NCT05360277|Capecitabine|capecitabine|mesh-list
111130287|NCT05360277|Tislelizumab|tislelizumab|mesh-list
111130288|NCT05360277|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111130289|NCT05360277|Antimetabolites|antimetabolites|mesh-ancestor
111130290|NCT05360277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111130291|NCT05360277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111130292|NCT05360277|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111130293|NCT05016973|Disitamab vedotin|disitamab vedotin|mesh-list
110092935|NCT01699594|Mannitol|mannitol|mesh-list
111130294|NCT05016973|Immunoconjugates|immunoconjugates|mesh-ancestor
111130295|NCT05016973|Immunologic Factors|immunologic factors|mesh-ancestor
111130296|NCT05016973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111130298|NCT03091699|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111130299|NCT03091699|Autonomic Agents|autonomic agents|mesh-ancestor
111130300|NCT03091699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111130301|NCT03091699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111130302|NCT03091699|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111130303|NCT03091699|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110093153|NCT01700803|Cadexomer iodine|cadexomer iodine|mesh-list
111130304|NCT03091699|Cholinergic Agents|cholinergic agents|mesh-ancestor
111130305|NCT03091699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110185999|NCT00275015|Antimetabolites|antimetabolites|mesh-ancestor
110924803|NCT03098680|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111130306|NCT03091699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111130307|NCT05344209|Sargramostim|sargramostim|mesh-list
111130308|NCT05344209|Immunologic Factors|immunologic factors|mesh-ancestor
111130309|NCT05344209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111130310|NCT03091543|Benserazide, levodopa drug combination|benserazide, levodopa drug combination|mesh-list
110093530|NCT01703234|Ramipril|ramipril|mesh-list
111130311|NCT03091543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110924804|NCT03098680|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111130312|NCT03091543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111130313|NCT03091543|Dopamine Agents|dopamine agents|mesh-ancestor
111130314|NCT03091543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111130315|NCT03091543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111130316|NCT04253457|Triamcinolone|triamcinolone|mesh-list
111130317|NCT04253457|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111130318|NCT04253457|Glucocorticoids|glucocorticoids|mesh-ancestor
111130319|NCT04253457|Hormones|hormones|mesh-ancestor
111130320|NCT04253457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111130321|NCT04253457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111130322|NCT05380947|Rabeprazole|rabeprazole|mesh-list
111130323|NCT05380947|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110924805|NCT03098680|Protective Agents|protective agents|mesh-ancestor
111130324|NCT05380947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111130325|NCT05380947|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111130326|NCT05380947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111130327|NCT05380947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111130328|NCT02525133|Bupivacaine|bupivacaine|mesh-list
111130329|NCT02525133|Anesthetics, Local|anesthetics, local|mesh-ancestor
111130330|NCT02525133|Anesthetics|anesthetics|mesh-ancestor
110094202|NCT01707407|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111130331|NCT02525133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111130332|NCT02525133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111130333|NCT02525133|Sensory System Agents|sensory system agents|mesh-ancestor
111130334|NCT02525133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111130335|NCT05602311|Anesthetics|anesthetics|mesh-list
111130336|NCT05602311|Anesthetics, General|anesthetics, general|mesh-list
111130337|NCT05602311|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110094416|NCT01708876|Primaquine|primaquine|mesh-list
111130338|NCT05602311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111130339|NCT05016349|Tamoxifen|tamoxifen|mesh-list
111130340|NCT05016349|Tocopherols|tocopherols|mesh-list
111130341|NCT05016349|Tretinoin|tretinoin|mesh-list
111130342|NCT05016349|Alitretinoin|alitretinoin|mesh-list
111130343|NCT05016349|Cannabidiol|cannabidiol|mesh-list
111130344|NCT05016349|Isotretinoin|isotretinoin|mesh-list
111130345|NCT05016349|Mifepristone|mifepristone|mesh-list
110094570|NCT01710072|Aspirin|aspirin|mesh-list
111130346|NCT05016349|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111130347|NCT05016349|Hormone Antagonists|hormone antagonists|mesh-ancestor
110837241|NCT05549531|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110924806|NCT03098680|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110094782|NCT01711112|Docetaxel|docetaxel|mesh-list
111130348|NCT05016349|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110094860|NCT01711489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111130349|NCT05016349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111130350|NCT05016349|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111130351|NCT05016349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110442513|NCT00912379|Chrysarobin|chrysarobin|mesh-list
110924807|NCT03098680|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110442651|NCT00688207|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111130352|NCT05016349|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111130353|NCT05016349|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111130354|NCT05016349|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111130355|NCT05016349|Anticonvulsants|anticonvulsants|mesh-ancestor
111130356|NCT05016349|Keratolytic Agents|keratolytic agents|mesh-ancestor
111130357|NCT05016349|Dermatologic Agents|dermatologic agents|mesh-ancestor
111130358|NCT05016349|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
111130359|NCT05016349|Abortifacient Agents|abortifacient agents|mesh-ancestor
111130360|NCT05016349|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110442795|NCT00683995|Analgesics|analgesics|mesh-ancestor
110442871|NCT02806492|Phenylephrine|phenylephrine|mesh-list
110442945|NCT00874237|Moxifloxacin|moxifloxacin|mesh-list
111130361|NCT05016349|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111130362|NCT05016349|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111130363|NCT05016349|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111130364|NCT05016349|Contraceptive Agents|contraceptive agents|mesh-ancestor
111130365|NCT05016349|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
111130366|NCT05016349|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
111130367|NCT05016349|Luteolytic Agents|luteolytic agents|mesh-ancestor
110443459|NCT02620423|Antimetabolites|antimetabolites|mesh-ancestor
111130368|NCT05016349|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111130369|NCT05016349|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
111130370|NCT05016349|Antioxidants|antioxidants|mesh-ancestor
111130371|NCT05016349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110443676|NCT00872599|Fenofibrate|fenofibrate|mesh-list
111130372|NCT05016349|Protective Agents|protective agents|mesh-ancestor
111130373|NCT05016349|Vitamins|vitamins|mesh-ancestor
111130374|NCT05016349|Micronutrients|micronutrients|mesh-ancestor
111130375|NCT05380635|Hypericin|hypericin|mesh-list
111130376|NCT05380635|Antidepressive Agents|antidepressive agents|mesh-ancestor
111130377|NCT05380635|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111130378|NCT05380635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111130379|NCT05380635|Antiviral Agents|antiviral agents|mesh-ancestor
111130380|NCT05380635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111130381|NCT05380635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111130382|NCT05380635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111130383|NCT05380635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111130384|NCT05380635|Immunologic Factors|immunologic factors|mesh-ancestor
111130385|NCT05380635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111130386|NCT05538819|Glimepiride|glimepiride|mesh-list
111130387|NCT05538819|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111130388|NCT05538819|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111130389|NCT05538819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110443940|NCT02788240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110444007|NCT02788552|Vitamins|vitamins|mesh-list
111130390|NCT05538819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111130391|NCT05538819|Immunologic Factors|immunologic factors|mesh-ancestor
111130392|NCT03079219|Dexamethasone|dexamethasone|mesh-list
111130393|NCT03079219|Dexamethasone acetate|dexamethasone acetate|mesh-list
110358129|NCT06022237|Vitamin D|vitamin d|mesh-list
111130394|NCT03079219|Ondansetron|ondansetron|mesh-list
111130395|NCT03079219|Olanzapine|olanzapine|mesh-list
111130396|NCT03079219|Aprepitant|aprepitant|mesh-list
111130397|NCT03079219|Fosaprepitant|fosaprepitant|mesh-list
111130398|NCT03079219|BB 1101|bb 1101|mesh-list
110444435|NCT02957032|Cytarabine|cytarabine|mesh-list
111130399|NCT03079219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111130400|NCT03079219|Antiemetics|antiemetics|mesh-ancestor
111130401|NCT03079219|Autonomic Agents|autonomic agents|mesh-ancestor
111130402|NCT03079219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111130403|NCT03079219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111130404|NCT03079219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111130405|NCT03079219|Glucocorticoids|glucocorticoids|mesh-ancestor
111130406|NCT03079219|Hormones|hormones|mesh-ancestor
111130407|NCT03079219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110064114|NCT01526161|Xhance|xhance|mesh-list
111130408|NCT03079219|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111130409|NCT03079219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111130410|NCT03079219|Protease Inhibitors|protease inhibitors|mesh-ancestor
111130411|NCT03079219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110444994|NCT00869557|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110445066|NCT01198574|Protective Agents|protective agents|mesh-ancestor
111130412|NCT03079219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111130413|NCT03079219|Antipruritics|antipruritics|mesh-ancestor
111130414|NCT03079219|Dermatologic Agents|dermatologic agents|mesh-ancestor
111130415|NCT03079219|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111130416|NCT03079219|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111130417|NCT03079219|Serotonin Agents|serotonin agents|mesh-ancestor
111130418|NCT03079219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111130419|NCT03079219|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111130420|NCT03079219|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111130421|NCT03079219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111130422|NCT03079219|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111130423|NCT03079219|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111130424|NCT03079219|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111130425|NCT03079219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111130426|NCT03079219|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
111130427|NCT03078829|Leuprolide|leuprolide|mesh-list
111130428|NCT03078829|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111130429|NCT03078829|Fertility Agents|fertility agents|mesh-ancestor
111130430|NCT03078829|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111130431|NCT03078829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111130432|NCT03078829|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110095952|NCT01717690|Chlorhexidine|chlorhexidine|mesh-list
111130433|NCT03078829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111130434|NCT05008237|Docetaxel|docetaxel|mesh-list
111130435|NCT05008237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111130436|NCT05008237|Tubulin Modulators|tubulin modulators|mesh-ancestor
111130437|NCT05008237|Antimitotic Agents|antimitotic agents|mesh-ancestor
111130438|NCT05008237|Mitosis Modulators|mitosis modulators|mesh-ancestor
111130439|NCT05008237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111130440|NCT05014711|Fentanyl|fentanyl|mesh-list
111130441|NCT05014711|Remifentanil|remifentanil|mesh-list
111130442|NCT05014711|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111130443|NCT05014711|Narcotics|narcotics|mesh-ancestor
111130444|NCT05014711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111130445|NCT05014711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111130446|NCT05014711|Analgesics|analgesics|mesh-ancestor
111130447|NCT05014711|Sensory System Agents|sensory system agents|mesh-ancestor
111130448|NCT05014711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111130449|NCT05014711|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111130450|NCT05014711|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110373810|NCT00571142|Temazepam|temazepam|mesh-list
111130451|NCT05014711|Anesthetics, General|anesthetics, general|mesh-ancestor
111130452|NCT05014711|Anesthetics|anesthetics|mesh-ancestor
111130453|NCT05018923|Metronidazole|metronidazole|mesh-list
111130454|NCT05018923|Doxycycline|doxycycline|mesh-list
111130455|NCT05018923|Tetracycline|tetracycline|mesh-list
110847487|NCT01181765|Infliximab|infliximab|mesh-list
111130456|NCT05018923|Potassium Citrate|potassium citrate|mesh-list
111130457|NCT05018923|Rabeprazole|rabeprazole|mesh-list
111130458|NCT05018923|Bismuth|bismuth|mesh-list
111130459|NCT05018923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111130460|NCT05018923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110572092|NCT04134065|Vitamin D|vitamin d|mesh-list
111130461|NCT05018923|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111130462|NCT05018923|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111130463|NCT05018923|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111130464|NCT05018923|Antimalarials|antimalarials|mesh-ancestor
111130465|NCT05018923|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111130466|NCT05018923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111130467|NCT05018923|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111130468|NCT05018923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111130469|NCT05018923|Antacids|antacids|mesh-ancestor
111130470|NCT05018923|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111130471|NCT05018923|Diuretics|diuretics|mesh-ancestor
110572380|NCT00798460|Antiviral Agents|antiviral agents|mesh-ancestor
111130472|NCT05018923|Natriuretic Agents|natriuretic agents|mesh-ancestor
111130473|NCT05018923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111130474|NCT05018923|Expectorants|expectorants|mesh-ancestor
111130475|NCT05018923|Respiratory System Agents|respiratory system agents|mesh-ancestor
111130476|NCT03086473|Caffeine|caffeine|mesh-list
111130477|NCT03086473|Caffeine citrate|caffeine citrate|mesh-list
111130478|NCT03086473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111130479|NCT03086473|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111130480|NCT03086473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111130481|NCT03086473|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111130482|NCT03086473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111130483|NCT03086473|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
111130484|NCT03086473|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111130485|NCT03086473|Purinergic Agents|purinergic agents|mesh-ancestor
111130486|NCT03086473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111130487|NCT03086005|Metformin|metformin|mesh-list
111130488|NCT03086005|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111130489|NCT03086005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111130490|NCT03079141|Eplerenone|eplerenone|mesh-list
111130491|NCT03079141|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
111130492|NCT03079141|Hormone Antagonists|hormone antagonists|mesh-ancestor
111130493|NCT03079141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111130494|NCT03079141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111130495|NCT03079141|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
111130496|NCT03079141|Diuretics|diuretics|mesh-ancestor
111130497|NCT03079141|Natriuretic Agents|natriuretic agents|mesh-ancestor
110573190|NCT00703898|Nevirapine|nevirapine|mesh-list
111130498|NCT03079141|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111130499|NCT03085849|Durvalumab|durvalumab|mesh-list
111130500|NCT03085849|Tremelimumab|tremelimumab|mesh-list
111130501|NCT03085849|Guadecitabine|guadecitabine|mesh-list
110573325|NCT00805194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111130502|NCT03085849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111130503|NCT03085849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111130504|NCT05001529|Antibodies|antibodies|mesh-list
111130505|NCT05001529|Immunologic Factors|immunologic factors|mesh-ancestor
111130506|NCT05001529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111130507|NCT05001061|Misoprostol|misoprostol|mesh-list
111130508|NCT05001061|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111130509|NCT05001061|Abortifacient Agents|abortifacient agents|mesh-ancestor
110573695|NCT00704600|Nelfinavir|nelfinavir|mesh-list
111130510|NCT05001061|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111130511|NCT05001061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110837288|NCT01235273|Hormones|hormones|mesh-list
111130513|NCT05001061|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111130514|NCT05001061|Oxytocics|oxytocics|mesh-ancestor
111130515|NCT05531955|Pirfenidone|pirfenidone|mesh-list
111130516|NCT05531955|Analgesics|analgesics|mesh-ancestor
111130517|NCT05531955|Sensory System Agents|sensory system agents|mesh-ancestor
111130518|NCT05531955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111130519|NCT05531955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110573992|NCT00838916|Incretins|incretins|mesh-ancestor
110924808|NCT03098680|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110574144|NCT03537924|Diuretics|diuretics|mesh-ancestor
111130520|NCT05531955|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110574294|NCT02607072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110574376|NCT03770455|Avelumab|avelumab|mesh-list
110574439|NCT01026415|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
111130521|NCT05531955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111130522|NCT05531955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111130523|NCT05531955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111130524|NCT05531955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111130525|NCT05339529|Glycine|glycine|mesh-list
111130526|NCT05339529|Thymalfasin|thymalfasin|mesh-list
110574664|NCT01023919|Sirolimus|sirolimus|mesh-list
111130527|NCT05339529|Glycine Agents|glycine agents|mesh-ancestor
111130528|NCT05339529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111130529|NCT05339529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111130530|NCT05339529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111130531|NCT05339529|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111130532|NCT05339529|Immunologic Factors|immunologic factors|mesh-ancestor
111130533|NCT05006911|Bromfenac|bromfenac|mesh-list
111130534|NCT05006911|Brimonidine Tartrate|brimonidine tartrate|mesh-list
111130535|NCT05006911|Phenylephrine|phenylephrine|mesh-list
111130536|NCT05006911|Oxymetazoline|oxymetazoline|mesh-list
111130537|NCT05006911|Hyaluronic Acid|hyaluronic acid|mesh-list
111130538|NCT05006911|Pilocarpine|pilocarpine|mesh-list
111130539|NCT05006911|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110575410|NCT01024543|Giapreza|giapreza|mesh-list
111130540|NCT05006911|Immunologic Factors|immunologic factors|mesh-ancestor
111130541|NCT05006911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111130542|NCT05006911|Viscosupplements|viscosupplements|mesh-ancestor
111130543|NCT05006911|Protective Agents|protective agents|mesh-ancestor
111130544|NCT05006911|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110575540|NCT00446641|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111130545|NCT05006911|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111130546|NCT05006911|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111130547|NCT05006911|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111130548|NCT05006911|Adrenergic Agents|adrenergic agents|mesh-ancestor
110575768|NCT00446251|Rituximab|rituximab|mesh-list
111130549|NCT05006911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110575832|NCT00808366|Dermatologic Agents|dermatologic agents|mesh-ancestor
111130550|NCT05006911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111130551|NCT05006911|Sympathomimetics|sympathomimetics|mesh-ancestor
111130552|NCT05006911|Autonomic Agents|autonomic agents|mesh-ancestor
110576061|NCT02551042|Factor VIII|factor viii|mesh-list
111130553|NCT05006911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111130554|NCT05006911|Nasal Decongestants|nasal decongestants|mesh-ancestor
111130555|NCT05006911|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111130556|NCT05006911|Respiratory System Agents|respiratory system agents|mesh-ancestor
111130557|NCT05006911|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111130558|NCT05006911|Mydriatics|mydriatics|mesh-ancestor
111130559|NCT05006911|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111130560|NCT05006911|Miotics|miotics|mesh-ancestor
110576346|NCT00828464|Clobetasol|clobetasol|mesh-list
111130561|NCT05006911|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
111130562|NCT05006911|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110576502|NCT00818584|Micafungin|micafungin|mesh-list
111130563|NCT05006911|Cholinergic Agents|cholinergic agents|mesh-ancestor
110576639|NCT00821782|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110576713|NCT04109742|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110576788|NCT00915408|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111130564|NCT05006911|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110576869|NCT00631696|Anticonvulsants|anticonvulsants|mesh-ancestor
111130565|NCT05006911|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111130566|NCT05006911|Analgesics|analgesics|mesh-ancestor
111130567|NCT05006911|Sensory System Agents|sensory system agents|mesh-ancestor
111130568|NCT05006911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111130569|NCT05006911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111130570|NCT05339295|Levofloxacin|levofloxacin|mesh-list
111130571|NCT05339295|Ofloxacin|ofloxacin|mesh-list
111130572|NCT05339295|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110577235|NCT02548780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111130573|NCT05339295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111130574|NCT05339295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111130575|NCT05339295|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111130576|NCT05339295|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111130577|NCT05339295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111130578|NCT05339295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111130579|NCT05339295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111130580|NCT05339295|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111130581|NCT05339295|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111130582|NCT02637037|Metformin|metformin|mesh-list
111130583|NCT02637037|Dapagliflozin|dapagliflozin|mesh-list
111130584|NCT02637037|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111130585|NCT02637037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111130586|NCT02637037|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111130587|NCT02637037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111130588|NCT05307081|Lubricant Eye Drops|lubricant eye drops|mesh-list
111130589|NCT05307081|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
111130590|NCT05307081|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111130591|NCT05306535|Salicylic Acid|salicylic acid|mesh-list
111130592|NCT05306535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111130593|NCT05306535|Antifungal Agents|antifungal agents|mesh-ancestor
111130594|NCT05306535|Keratolytic Agents|keratolytic agents|mesh-ancestor
111130595|NCT05306535|Dermatologic Agents|dermatologic agents|mesh-ancestor
111130596|NCT02637895|Vortioxetine|vortioxetine|mesh-list
111130597|NCT02637895|Antidepressive Agents|antidepressive agents|mesh-ancestor
110578487|NCT00703313|Levofloxacin|levofloxacin|mesh-list
111130598|NCT02637895|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111130599|NCT02637895|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111130600|NCT02637895|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110578634|NCT02611973|Analgesics|analgesics|mesh-ancestor
111130601|NCT02637895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111130602|NCT02637895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110578780|NCT00835679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110578857|NCT00913367|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111130603|NCT02637895|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111130604|NCT02637895|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111130605|NCT02637895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111130606|NCT02637895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111130607|NCT02637895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111130608|NCT02637895|Serotonin Agents|serotonin agents|mesh-ancestor
111130609|NCT02637895|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110579149|NCT04097847|Clodronic Acid|clodronic acid|mesh-list
111130610|NCT02637895|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111130611|NCT02637895|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111130612|NCT02637895|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111130613|NCT05013697|Paclitaxel|paclitaxel|mesh-list
110579305|NCT00705419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110579379|NCT02599701|Anticonvulsants|anticonvulsants|mesh-ancestor
110579470|NCT05742854|Oxytocin|oxytocin|mesh-list
110579527|NCT00815633|Alefacept|alefacept|mesh-list
110579681|NCT02607410|Insulin|insulin|mesh-list
110579833|NCT00751101|Nicotine|nicotine|mesh-list
111130614|NCT05013697|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111130615|NCT05013697|Cisplatin|cisplatin|mesh-list
111130616|NCT05013697|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111130617|NCT05013697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111130618|NCT05013697|Tubulin Modulators|tubulin modulators|mesh-ancestor
111130619|NCT05013697|Antimitotic Agents|antimitotic agents|mesh-ancestor
111130620|NCT05013697|Mitosis Modulators|mitosis modulators|mesh-ancestor
111130621|NCT05013697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110580206|NCT02598102|Diclofenac|diclofenac|mesh-list
111130622|NCT05509647|Heparin|heparin|mesh-list
111130623|NCT05509647|Calcium heparin|calcium heparin|mesh-list
111130624|NCT05509647|Anticoagulants|anticoagulants|mesh-ancestor
111130625|NCT05509647|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110580370|NCT00732303|Pemetrexed|pemetrexed|mesh-list
110580423|NCT00730275|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111130626|NCT05509647|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110580500|NCT00728481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111130627|NCT05509647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111130628|NCT05305911|Dapagliflozin|dapagliflozin|mesh-list
111130629|NCT05305911|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110837317|NCT02620150|Escitalopram|escitalopram|mesh-list
111130630|NCT05305911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111130631|NCT05305911|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111130632|NCT05305911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111130633|NCT05349435|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
111130634|NCT05349435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111130635|NCT05007223|Doxycycline|doxycycline|mesh-list
111130636|NCT05007223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110580575|NCT00585351|Histamine Agents|histamine agents|mesh-ancestor
111130637|NCT05007223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111130638|NCT05007223|Antimalarials|antimalarials|mesh-ancestor
111130639|NCT05007223|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111130640|NCT05007223|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111130641|NCT05000281|Ibuprofen|ibuprofen|mesh-list
110580860|NCT02595606|Hyaluronic Acid|hyaluronic acid|mesh-list
110580934|NCT00591149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110581012|NCT04111328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111130642|NCT05000281|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111130643|NCT05000281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111130644|NCT05000281|Analgesics|analgesics|mesh-ancestor
111130645|NCT05000281|Sensory System Agents|sensory system agents|mesh-ancestor
111130646|NCT05000281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111130647|NCT05000281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111130648|NCT05000281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111130649|NCT05000281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111130650|NCT05000281|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111130651|NCT05000281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110581534|NCT02603822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111130652|NCT05000281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111130653|NCT03081949|Selenium|selenium|mesh-list
111130654|NCT03081949|Selenious Acid|selenious acid|mesh-list
111130655|NCT03081949|Sodium Selenite|sodium selenite|mesh-list
111130656|NCT03081949|Antioxidants|antioxidants|mesh-ancestor
110581620|NCT00791258|Amlodipine|amlodipine|mesh-list
110581673|NCT04309409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111130657|NCT03081949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111130658|NCT03081949|Protective Agents|protective agents|mesh-ancestor
111130659|NCT03081949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111130660|NCT03081949|Trace Elements|trace elements|mesh-ancestor
111130661|NCT03081949|Micronutrients|micronutrients|mesh-ancestor
111130662|NCT05347173|Dexmedetomidine|dexmedetomidine|mesh-list
111130663|NCT05347173|Nalbuphine|nalbuphine|mesh-list
111130664|NCT05347173|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111130665|NCT05347173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110581968|NCT02606981|Micronutrients|micronutrients|mesh-ancestor
111130666|NCT05347173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111130667|NCT05347173|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111130668|NCT05347173|Analgesics|analgesics|mesh-ancestor
111130669|NCT05347173|Sensory System Agents|sensory system agents|mesh-ancestor
111130670|NCT05347173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111130671|NCT05347173|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111130672|NCT05347173|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111130673|NCT05347173|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111130674|NCT05347173|Adrenergic Agents|adrenergic agents|mesh-ancestor
111130675|NCT05347173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111130676|NCT05347173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111130677|NCT05347173|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111130678|NCT05347173|Narcotics|narcotics|mesh-ancestor
111130679|NCT05006287|Warfarin|warfarin|mesh-list
111130680|NCT05006287|Rivaroxaban|rivaroxaban|mesh-list
111130681|NCT05006287|Dabigatran|dabigatran|mesh-list
111130682|NCT05006287|Apixaban|apixaban|mesh-list
111130683|NCT05006287|Anticoagulants|anticoagulants|mesh-list
111130684|NCT05006287|Edoxaban|edoxaban|mesh-list
111130685|NCT05006287|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111130686|NCT05006287|Antithrombins|antithrombins|mesh-ancestor
111130687|NCT05006287|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111130688|NCT05006287|Protease Inhibitors|protease inhibitors|mesh-ancestor
111130689|NCT05006287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110582861|NCT00724854|Antiviral Agents|antiviral agents|mesh-ancestor
111130690|NCT05006287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111130691|NCT05013151|Castor Oil|castor oil|mesh-list
111130692|NCT05013151|Cathartics|cathartics|mesh-ancestor
111130693|NCT05013151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111130694|NCT05006209|Calcium|calcium|mesh-list
110583081|NCT04082559|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111130695|NCT05006209|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111130696|NCT05006209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111130697|NCT05335629|Dapagliflozin|dapagliflozin|mesh-list
111130698|NCT05335629|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110583234|NCT00799487|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111130699|NCT05335629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111130700|NCT05335629|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110837334|NCT05488613|Midostaurin|midostaurin|mesh-list
111130701|NCT05335629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111130702|NCT03076099|Dexmedetomidine|dexmedetomidine|mesh-list
111130703|NCT03076099|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111130704|NCT03076099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110583545|NCT04079517|Tamoxifen|tamoxifen|mesh-list
111130705|NCT03076099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111130706|NCT03076099|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111130707|NCT03076099|Analgesics|analgesics|mesh-ancestor
111130708|NCT03076099|Sensory System Agents|sensory system agents|mesh-ancestor
111130709|NCT03076099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111130710|NCT03076099|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111130711|NCT03076099|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111130712|NCT03076099|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111130713|NCT03076099|Adrenergic Agents|adrenergic agents|mesh-ancestor
111130714|NCT03076099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111130715|NCT03076099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111130716|NCT05554965|Propofol|propofol|mesh-list
111130717|NCT05554965|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110583904|NCT05637515|Adalimumab|adalimumab|mesh-list
110583976|NCT00771914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111130718|NCT05554965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111130719|NCT05554965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111130720|NCT05554965|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111130721|NCT05554965|Anesthetics, General|anesthetics, general|mesh-ancestor
111130722|NCT05554965|Anesthetics|anesthetics|mesh-ancestor
111130723|NCT05554419|Cytarabine|cytarabine|mesh-list
111130724|NCT05554419|Azacitidine|azacitidine|mesh-list
111130725|NCT05554419|Daunorubicin|daunorubicin|mesh-list
111130726|NCT05554419|Venetoclax|venetoclax|mesh-list
111130727|NCT05554419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111130728|NCT05554419|Antimetabolites|antimetabolites|mesh-ancestor
111130729|NCT05554419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111130730|NCT05554419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111130731|NCT05554419|Antiviral Agents|antiviral agents|mesh-ancestor
111130732|NCT05554419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111130733|NCT05554419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111130734|NCT05554419|Immunologic Factors|immunologic factors|mesh-ancestor
110584187|NCT02605811|Temozolomide|temozolomide|mesh-list
111130735|NCT05554419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111130736|NCT05554419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111130737|NCT05554419|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111130738|NCT05554419|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111130739|NCT05554419|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111130740|NCT05331573|Apomorphine|apomorphine|mesh-list
111130741|NCT05331573|Emetics|emetics|mesh-ancestor
110584488|NCT03904563|Growth Substances|growth substances|mesh-ancestor
111130742|NCT05331573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111130743|NCT05331573|Autonomic Agents|autonomic agents|mesh-ancestor
111130744|NCT05331573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111130745|NCT05331573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111130746|NCT05331573|Dopamine Agonists|dopamine agonists|mesh-ancestor
111130747|NCT05331573|Dopamine Agents|dopamine agents|mesh-ancestor
110584790|NCT03475953|Avelumab|avelumab|mesh-list
110584855|NCT04108013|Tubulin Modulators|tubulin modulators|mesh-ancestor
111130748|NCT05331573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111130749|NCT05331573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111130750|NCT05260359|Ethanol|ethanol|mesh-list
111130751|NCT05260359|Sunscreening Agents|sunscreening agents|mesh-list
111130752|NCT05260359|Petrolatum|petrolatum|mesh-list
111130753|NCT05260359|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111130754|NCT05260359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111130755|NCT05260359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111130756|NCT05260359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111130757|NCT05260359|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111130758|NCT05260359|Protective Agents|protective agents|mesh-ancestor
110585001|NCT02419287|Crizotinib|crizotinib|mesh-list
111130759|NCT05260359|Dermatologic Agents|dermatologic agents|mesh-ancestor
111130760|NCT05260359|Emollients|emollients|mesh-ancestor
111130761|NCT05329155|Heparin|heparin|mesh-list
110585095|NCT01816971|Hormones|hormones|mesh-ancestor
111130762|NCT05329155|Calcium heparin|calcium heparin|mesh-list
111130763|NCT05329155|Anticoagulants|anticoagulants|mesh-ancestor
111130764|NCT05329155|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110585146|NCT00723606|Serotonin Agents|serotonin agents|mesh-ancestor
111130765|NCT05329155|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111130766|NCT05329155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111130767|NCT05294835|Ketamine|ketamine|mesh-list
111130768|NCT05294835|Analgesics|analgesics|mesh-ancestor
111130769|NCT05294835|Sensory System Agents|sensory system agents|mesh-ancestor
110585289|NCT03996655|Neostigmine|neostigmine|mesh-list
111130770|NCT05294835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111130771|NCT05294835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111130772|NCT05294835|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110585446|NCT00916760|Antacids|antacids|mesh-ancestor
111130773|NCT05294835|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110585512|NCT04086108|GABA Agents|gaba agents|mesh-ancestor
111130774|NCT05294835|Anesthetics, General|anesthetics, general|mesh-ancestor
111130775|NCT05294835|Anesthetics|anesthetics|mesh-ancestor
111130776|NCT05294835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111130777|NCT05294835|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111130778|NCT05294835|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111130779|NCT05294835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110585814|NCT00719862|Azelastine|azelastine|mesh-list
111130780|NCT05294835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111130781|NCT02522325|Cocaine|cocaine|mesh-list
111130782|NCT02522325|Phendimetrazine|phendimetrazine|mesh-list
111130783|NCT02522325|Anesthetics, Local|anesthetics, local|mesh-ancestor
111130784|NCT02522325|Anesthetics|anesthetics|mesh-ancestor
111130785|NCT02522325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111130786|NCT02522325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111130787|NCT02522325|Sensory System Agents|sensory system agents|mesh-ancestor
110586032|NCT05285358|Paclitaxel|paclitaxel|mesh-list
111130788|NCT02522325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110586107|NCT02574975|Glucocorticoids|glucocorticoids|mesh-ancestor
111130789|NCT02522325|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111130790|NCT02522325|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111130791|NCT02522325|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111130792|NCT02522325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111130793|NCT02522325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111130794|NCT02522325|Dopamine Agents|dopamine agents|mesh-ancestor
111130795|NCT02522325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111130796|NCT02522325|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111130797|NCT01659021|Ofatumumab|ofatumumab|mesh-list
111130798|NCT01659021|Idelalisib|idelalisib|mesh-list
111130799|NCT01659021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111130800|NCT01659021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110586395|NCT00715455|Heparin|heparin|mesh-list
110586472|NCT00719121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111130801|NCT01659021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111130802|NCT05012137|Ropivacaine|ropivacaine|mesh-list
111130803|NCT05012137|Anesthetics, Local|anesthetics, local|mesh-ancestor
111130804|NCT05012137|Anesthetics|anesthetics|mesh-ancestor
111130805|NCT05012137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111130806|NCT05012137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111130807|NCT05012137|Sensory System Agents|sensory system agents|mesh-ancestor
111130808|NCT05012137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111130809|NCT04925167|Heparin|heparin|mesh-list
111130810|NCT04925167|Calcium heparin|calcium heparin|mesh-list
111130811|NCT04925167|Argatroban|argatroban|mesh-list
111130812|NCT04925167|Anticoagulants|anticoagulants|mesh-ancestor
111130813|NCT04925167|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111130814|NCT04925167|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111130815|NCT04925167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111130816|NCT04925167|Antithrombins|antithrombins|mesh-ancestor
111130817|NCT04925167|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111130818|NCT04925167|Protease Inhibitors|protease inhibitors|mesh-ancestor
111130819|NCT04925167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111130820|NCT04925167|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111130821|NCT05011669|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
111130822|NCT05011669|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111130823|NCT05011669|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111130824|NCT05011669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111130825|NCT05011669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111130826|NCT05011669|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111130827|NCT05011669|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
111130828|NCT05011669|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111130829|NCT05011669|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111130830|NCT05011669|Adrenergic Agents|adrenergic agents|mesh-ancestor
111130831|NCT05011669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110870374|NCT02394418|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111130832|NCT05011669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111130833|NCT05011669|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111130835|NCT05011669|Serotonin Agents|serotonin agents|mesh-ancestor
110847887|NCT03732703|Venetoclax|venetoclax|mesh-list
111130836|NCT05011669|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111130837|NCT05011669|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111130838|NCT05011669|Dopamine Agents|dopamine agents|mesh-ancestor
111130839|NCT02524665|Salicylic Acid|salicylic acid|mesh-list
111130840|NCT02524665|Salicylates|salicylates|mesh-list
111130841|NCT02524665|Benzoyl Peroxide|benzoyl peroxide|mesh-list
111130842|NCT02524665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111130843|NCT02524665|Antifungal Agents|antifungal agents|mesh-ancestor
111130844|NCT02524665|Keratolytic Agents|keratolytic agents|mesh-ancestor
111130845|NCT02524665|Dermatologic Agents|dermatologic agents|mesh-ancestor
111130846|NCT02524665|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111130847|NCT02524665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111130848|NCT02524665|Analgesics|analgesics|mesh-ancestor
111130849|NCT02524665|Sensory System Agents|sensory system agents|mesh-ancestor
111130850|NCT02524665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111130851|NCT02524665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111130852|NCT02524665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111130853|NCT02524665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111130854|NCT02524665|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111130855|NCT02524665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111130856|NCT02524665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111130857|NCT04998253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
111130858|NCT04998253|Propofol|propofol|mesh-list
111130859|NCT04998253|Sevoflurane|sevoflurane|mesh-list
111130860|NCT04998253|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111130861|NCT04998253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111130862|NCT04998253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111130863|NCT04998253|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111130864|NCT04998253|Anesthetics, General|anesthetics, general|mesh-ancestor
111130865|NCT04998253|Anesthetics|anesthetics|mesh-ancestor
111130866|NCT04998253|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111130867|NCT04998253|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111130868|NCT02638129|Naltrexone|naltrexone|mesh-list
111130869|NCT02638129|Bupropion|bupropion|mesh-list
111130870|NCT02638129|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111130871|NCT02638129|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111130872|NCT02638129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111130873|NCT02638129|Sensory System Agents|sensory system agents|mesh-ancestor
111130874|NCT02638129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111130875|NCT02638129|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111130876|NCT02638129|Antidepressive Agents|antidepressive agents|mesh-ancestor
111130877|NCT02638129|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111130878|NCT02638129|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111130879|NCT02638129|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111130880|NCT02638129|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110586654|NCT04082598|Clavulanic Acids|clavulanic acids|mesh-list
111130881|NCT02638129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111130882|NCT02638129|Dopamine Agents|dopamine agents|mesh-ancestor
111130883|NCT02638129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111130884|NCT02638129|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111130885|NCT02638129|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111130886|NCT02638129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111130887|NCT03079687|Olaparib|olaparib|mesh-list
111130888|NCT03079687|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111130889|NCT03079687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111130890|NCT03079687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111130891|NCT03079687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111130892|NCT04997707|Propofol|propofol|mesh-list
111130893|NCT04997707|Sevoflurane|sevoflurane|mesh-list
111130894|NCT04997707|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111130895|NCT04997707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111130896|NCT04997707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111130897|NCT04997707|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111130898|NCT04997707|Anesthetics, General|anesthetics, general|mesh-ancestor
111130899|NCT04997707|Anesthetics|anesthetics|mesh-ancestor
111130900|NCT04997707|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111130901|NCT04997707|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111130902|NCT05010499|Bupivacaine|bupivacaine|mesh-list
111130903|NCT05010499|Levobupivacaine|levobupivacaine|mesh-list
111130904|NCT05010499|Anesthetics, Local|anesthetics, local|mesh-ancestor
111130905|NCT05010499|Anesthetics|anesthetics|mesh-ancestor
111130906|NCT05010499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111130907|NCT05010499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111130908|NCT05010499|Sensory System Agents|sensory system agents|mesh-ancestor
111130909|NCT05010499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111130910|NCT03075241|Zolpidem|zolpidem|mesh-list
111130912|NCT03075241|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111130913|NCT03075241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111130914|NCT03075241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111130915|NCT03075241|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
111130916|NCT03075241|GABA Agonists|gaba agonists|mesh-ancestor
111130917|NCT03075241|GABA Agents|gaba agents|mesh-ancestor
111130918|NCT03075241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111130919|NCT03075241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111130920|NCT04994119|Warfarin|warfarin|mesh-list
111130921|NCT04994119|Zamicastat|zamicastat|mesh-list
111130922|NCT04994119|Anticoagulants|anticoagulants|mesh-ancestor
111130923|NCT04994119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111130924|NCT04994119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111130925|NCT01658943|Fluorouracil|fluorouracil|mesh-list
111130926|NCT01658943|Oxaliplatin|oxaliplatin|mesh-list
111130927|NCT01658943|Antimetabolites|antimetabolites|mesh-ancestor
111130928|NCT01658943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111130929|NCT01658943|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111130930|NCT01658943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111130931|NCT01658943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111130932|NCT01658943|Immunologic Factors|immunologic factors|mesh-ancestor
111130933|NCT01658943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111130934|NCT02600819|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
111130935|NCT02600819|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111130936|NCT02600819|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111130937|NCT02600819|Antiviral Agents|antiviral agents|mesh-ancestor
111130938|NCT02600819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111130939|NCT04433533|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111130940|NCT04433533|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111130941|NCT04433533|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111130942|NCT04433533|Antimetabolites|antimetabolites|mesh-ancestor
111130943|NCT04433533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111130944|NCT04433533|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111130945|NCT04433533|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111130946|NCT04433533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111130947|NCT04996459|Tislelizumab|tislelizumab|mesh-list
111130948|NCT04996459|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111130949|NCT04996459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111130950|NCT03074773|Dexamethasone|dexamethasone|mesh-list
111130951|NCT03074773|Bupivacaine|bupivacaine|mesh-list
111130952|NCT03074773|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111130953|NCT03074773|Antiemetics|antiemetics|mesh-ancestor
111130954|NCT03074773|Autonomic Agents|autonomic agents|mesh-ancestor
111130955|NCT03074773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111130956|NCT03074773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111130957|NCT03074773|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111130958|NCT03074773|Glucocorticoids|glucocorticoids|mesh-ancestor
111130959|NCT03074773|Hormones|hormones|mesh-ancestor
111130960|NCT03074773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111130961|NCT03074773|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111130962|NCT03074773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111130963|NCT03074773|Anesthetics, Local|anesthetics, local|mesh-ancestor
111130964|NCT03074773|Anesthetics|anesthetics|mesh-ancestor
111130965|NCT03074773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111130966|NCT03074773|Sensory System Agents|sensory system agents|mesh-ancestor
111130967|NCT03077581|Anesthetics|anesthetics|mesh-list
111130968|NCT03077581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111130969|NCT03077581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111130970|NCT03077503|Fentanyl|fentanyl|mesh-list
111130971|NCT03077503|Dexmedetomidine|dexmedetomidine|mesh-list
111130972|NCT03077503|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111130973|NCT03077503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111130974|NCT03077503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111130975|NCT03077503|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111130976|NCT03077503|Analgesics|analgesics|mesh-ancestor
111130977|NCT03077503|Sensory System Agents|sensory system agents|mesh-ancestor
111130978|NCT03077503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111130979|NCT03077503|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111130980|NCT03077503|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111130981|NCT03077503|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111130982|NCT03077503|Adrenergic Agents|adrenergic agents|mesh-ancestor
111130983|NCT03077503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111130984|NCT03077503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111130985|NCT03077503|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111130986|NCT03077503|Narcotics|narcotics|mesh-ancestor
111130987|NCT03077503|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111130988|NCT03077503|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111130989|NCT03077503|Anesthetics, General|anesthetics, general|mesh-ancestor
111130990|NCT03077503|Anesthetics|anesthetics|mesh-ancestor
111130991|NCT05518695|Antibodies, Blocking|antibodies, blocking|mesh-list
111130992|NCT05518695|Immunologic Factors|immunologic factors|mesh-ancestor
111130993|NCT05518695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111130994|NCT04136067|Insulin Glargine|insulin glargine|mesh-list
111130995|NCT04136067|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111130996|NCT04136067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111130997|NCT03073057|Budesonide|budesonide|mesh-list
111130998|NCT03073057|Formoterol Fumarate|formoterol fumarate|mesh-list
111130999|NCT03073057|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
111131000|NCT03073057|Charcoal|charcoal|mesh-list
111131001|NCT03073057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111131002|NCT03073057|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111131003|NCT03073057|Autonomic Agents|autonomic agents|mesh-ancestor
111131004|NCT03073057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111131005|NCT03073057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111131006|NCT03073057|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111131007|NCT03073057|Respiratory System Agents|respiratory system agents|mesh-ancestor
111131008|NCT03073057|Glucocorticoids|glucocorticoids|mesh-ancestor
111131009|NCT03073057|Hormones|hormones|mesh-ancestor
111131010|NCT03073057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111131011|NCT03073057|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111131012|NCT03073057|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111131013|NCT03073057|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111131014|NCT03073057|Adrenergic Agents|adrenergic agents|mesh-ancestor
111131015|NCT03073057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111131016|NCT03073057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111131017|NCT03073057|Antidotes|antidotes|mesh-ancestor
111131018|NCT03073057|Protective Agents|protective agents|mesh-ancestor
111131019|NCT03073369|Ergocalciferols|ergocalciferols|mesh-list
111131020|NCT03073369|Vitamin D|vitamin d|mesh-list
111131021|NCT03073369|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111131022|NCT03073369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111131023|NCT03073369|Vitamins|vitamins|mesh-ancestor
111131024|NCT03073369|Micronutrients|micronutrients|mesh-ancestor
111131025|NCT03073369|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111131027|NCT04433611|Anesthetics, Local|anesthetics, local|mesh-ancestor
111131028|NCT04433611|Anesthetics|anesthetics|mesh-ancestor
111131029|NCT04433611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111131030|NCT04433611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111131031|NCT04433611|Sensory System Agents|sensory system agents|mesh-ancestor
111131032|NCT04433611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111131033|NCT04433611|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111131034|NCT04433611|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111131035|NCT04433611|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111131036|NCT04433611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111131037|NCT04433611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111131038|NCT04992481|Fluorides|fluorides|mesh-list
111131039|NCT04992481|Fluorides, Topical|fluorides, topical|mesh-list
111131040|NCT04992481|Cariostatic Agents|cariostatic agents|mesh-ancestor
111131041|NCT04992481|Protective Agents|protective agents|mesh-ancestor
111131042|NCT04992481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111131043|NCT02597933|Nintedanib|nintedanib|mesh-list
111131044|NCT02597933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111131045|NCT02597933|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111131046|NCT02597933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111131047|NCT02597933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111131048|NCT04911127|Cannabidiol|cannabidiol|mesh-list
111131049|NCT04911127|Anticonvulsants|anticonvulsants|mesh-ancestor
111131050|NCT04995133|Colistin|colistin|mesh-list
111131051|NCT04995133|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111131052|NCT04995133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111131053|NCT04360889|Tocopherols|tocopherols|mesh-list
111131054|NCT04360889|Vitamin E|vitamin e|mesh-list
111131055|NCT04360889|Tocotrienols|tocotrienols|mesh-list
111131056|NCT04360889|alpha-Tocopherol|alpha-tocopherol|mesh-list
111131057|NCT04360889|Antioxidants|antioxidants|mesh-ancestor
111131058|NCT04360889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111131059|NCT04360889|Protective Agents|protective agents|mesh-ancestor
111131060|NCT04360889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111131061|NCT04360889|Vitamins|vitamins|mesh-ancestor
110586730|NCT04082286|Antibodies|antibodies|mesh-list
111131062|NCT04360889|Micronutrients|micronutrients|mesh-ancestor
111131063|NCT03072589|Regadenoson|regadenoson|mesh-list
111131064|NCT03072589|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
111131065|NCT03072589|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
111131066|NCT03072589|Purinergic Agonists|purinergic agonists|mesh-ancestor
111131067|NCT03072589|Purinergic Agents|purinergic agents|mesh-ancestor
111131068|NCT03072589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111131069|NCT03072589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111131070|NCT03072589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111131071|NCT04994743|Cortisone|cortisone|mesh-list
111131072|NCT04994743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111131073|NCT04994353|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111131074|NCT04807829|Nabilone|nabilone|mesh-list
111131075|NCT04807829|Antiemetics|antiemetics|mesh-ancestor
111131076|NCT04807829|Autonomic Agents|autonomic agents|mesh-ancestor
111131077|NCT04807829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111131078|NCT04807829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111131079|NCT04807829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111131080|NCT04807829|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111131081|NCT04807829|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111131082|NCT04807829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111131083|NCT04807829|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111131084|NCT03072511|Nicotine|nicotine|mesh-list
111131085|NCT03072511|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111131086|NCT03072511|Autonomic Agents|autonomic agents|mesh-ancestor
111131087|NCT03072511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111131088|NCT03072511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111131089|NCT03072511|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111131090|NCT03072511|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111131091|NCT03072511|Cholinergic Agents|cholinergic agents|mesh-ancestor
111131092|NCT03072511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111131093|NCT03072511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111131094|NCT03072121|Aspirin|aspirin|mesh-list
111131095|NCT03072121|Metoprolol|metoprolol|mesh-list
111131096|NCT03072121|Isosorbide|isosorbide|mesh-list
111131097|NCT03072121|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
111131098|NCT03072121|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
111131099|NCT03072121|Trimetazidine|trimetazidine|mesh-list
111131100|NCT03072121|Clopidogrel|clopidogrel|mesh-list
111131101|NCT03072121|Atorvastatin|atorvastatin|mesh-list
111131102|NCT03072121|Calcium|calcium|mesh-list
111131103|NCT03072121|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111131104|NCT03072121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111131105|NCT03072121|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111131106|NCT03072121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111131107|NCT03072121|Analgesics|analgesics|mesh-ancestor
111131108|NCT03072121|Sensory System Agents|sensory system agents|mesh-ancestor
111131109|NCT03072121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111131110|NCT03072121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111131111|NCT03072121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111131112|NCT03072121|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111131113|NCT03072121|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111131114|NCT03072121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111131115|NCT03072121|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111131116|NCT03072121|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111131117|NCT03072121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111131118|NCT03072121|Antipyretics|antipyretics|mesh-ancestor
111131119|NCT03072121|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111131120|NCT03072121|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111131121|NCT03072121|Antimetabolites|antimetabolites|mesh-ancestor
111131122|NCT03072121|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111131123|NCT03072121|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110586734|NCT00720447|Cytarabine|cytarabine|mesh-list
111131124|NCT03072121|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111131125|NCT03072121|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111131126|NCT03072121|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111131127|NCT03072121|Purinergic Agents|purinergic agents|mesh-ancestor
111131128|NCT03072121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111131129|NCT03072121|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111131130|NCT03072121|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111131131|NCT03072121|Sympatholytics|sympatholytics|mesh-ancestor
111131132|NCT03072121|Autonomic Agents|autonomic agents|mesh-ancestor
111131133|NCT03072121|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
111131134|NCT03072121|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111131135|NCT03072121|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111131137|NCT03072121|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
111131138|NCT03072121|Diuretics|diuretics|mesh-ancestor
111131139|NCT03072121|Natriuretic Agents|natriuretic agents|mesh-ancestor
111131140|NCT03072121|Vasodilator Agents|vasodilator agents|mesh-ancestor
111131141|NCT03072121|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
111131142|NCT02597855|Aflibercept|aflibercept|mesh-list
111131143|NCT02597855|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111131144|NCT02597855|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111131145|NCT02597855|Growth Substances|growth substances|mesh-ancestor
111131146|NCT02597855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111131147|NCT02597855|Growth Inhibitors|growth inhibitors|mesh-ancestor
111131148|NCT02597855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111131149|NCT04987567|Antioxidants|antioxidants|mesh-list
111131150|NCT04987567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111131151|NCT04987567|Protective Agents|protective agents|mesh-ancestor
111131152|NCT04987567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111131153|NCT03072199|Rituximab|rituximab|mesh-list
111131154|NCT03072199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111131155|NCT03072199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111131156|NCT03072199|Immunologic Factors|immunologic factors|mesh-ancestor
111131157|NCT03072199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111131158|NCT03072199|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111131159|NCT04806737|Teriflunomide|teriflunomide|mesh-list
111131160|NCT04806737|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111131161|NCT04806737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111131162|NCT04806737|Analgesics|analgesics|mesh-ancestor
111131163|NCT04806737|Sensory System Agents|sensory system agents|mesh-ancestor
111131164|NCT04806737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111131165|NCT04806737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111131166|NCT04806737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111131167|NCT04806737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111131168|NCT04806737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111131169|NCT04806737|Immunologic Factors|immunologic factors|mesh-ancestor
111131170|NCT04991155|Zamicastat|zamicastat|mesh-list
111131171|NCT04991155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111131172|NCT04991155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111131173|NCT04462315|Cobalt|cobalt|mesh-list
111131174|NCT04462315|Chromium|chromium|mesh-list
111131175|NCT04462315|Everolimus|everolimus|mesh-list
111131176|NCT04462315|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111131177|NCT04462315|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111131178|NCT04462315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111131179|NCT04462315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111131180|NCT04462315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111131181|NCT04462315|Immunologic Factors|immunologic factors|mesh-ancestor
111131182|NCT04462315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111131183|NCT04462315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111131184|NCT04462315|Trace Elements|trace elements|mesh-ancestor
111131185|NCT04462315|Micronutrients|micronutrients|mesh-ancestor
111131186|NCT04806425|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
111131187|NCT04806425|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
111131188|NCT04806425|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
111131189|NCT04806425|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111131190|NCT03071731|Bromides|bromides|mesh-list
111131191|NCT03071731|Ipratropium|ipratropium|mesh-list
111131192|NCT03071731|Bronchodilator Agents|bronchodilator agents|mesh-list
111131193|NCT03071731|Anticonvulsants|anticonvulsants|mesh-ancestor
111131194|NCT03071731|Autonomic Agents|autonomic agents|mesh-ancestor
111131195|NCT03071731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111131196|NCT03071731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111131197|NCT03071731|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111131198|NCT03071731|Respiratory System Agents|respiratory system agents|mesh-ancestor
111131199|NCT03071731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111131200|NCT03071731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111131201|NCT03071731|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111131202|NCT03071731|Cholinergic Agents|cholinergic agents|mesh-ancestor
111131203|NCT04809935|Ethanol|ethanol|mesh-list
111131204|NCT04809935|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111131205|NCT04809935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111131206|NCT04809935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111131207|NCT04809935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111131208|NCT04255927|Triclosan|triclosan|mesh-list
111131209|NCT04255927|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111131210|NCT04255927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110848244|NCT03729973|Ketamine|ketamine|mesh-list
111131211|NCT04255927|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
111131212|NCT04255927|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111131213|NCT04255927|Antimetabolites|antimetabolites|mesh-ancestor
111131214|NCT04255927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111131215|NCT04255927|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111131216|NCT03069781|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
111131217|NCT03069781|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
111131218|NCT03069781|Estradiol|estradiol|mesh-list
111131219|NCT03069781|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
111131220|NCT03069781|Estrogens|estrogens|mesh-ancestor
111131221|NCT03069781|Hormones|hormones|mesh-ancestor
111131222|NCT03069781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111131223|NCT03069781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111131224|NCT03069781|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111131225|NCT03069781|Contraceptive Agents|contraceptive agents|mesh-ancestor
111131226|NCT03069781|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111131227|NCT03069781|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111131228|NCT03071575|Vaccines|vaccines|mesh-list
111131229|NCT03071575|Immunologic Factors|immunologic factors|mesh-ancestor
111131230|NCT03071575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111131231|NCT04798391|Dexamethasone|dexamethasone|mesh-list
111131232|NCT04798391|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111131233|NCT04798391|Antiemetics|antiemetics|mesh-ancestor
111131234|NCT04798391|Autonomic Agents|autonomic agents|mesh-ancestor
111131235|NCT04798391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111131236|NCT04798391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111131237|NCT04798391|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111131238|NCT04798391|Glucocorticoids|glucocorticoids|mesh-ancestor
111131239|NCT04798391|Hormones|hormones|mesh-ancestor
111131240|NCT04798391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111131241|NCT04798391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111131242|NCT04798391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111131243|NCT03071497|Protoporphyrin IX|protoporphyrin ix|mesh-list
111131244|NCT03071497|Zinc protoporphyrin|zinc protoporphyrin|mesh-list
111131245|NCT03071497|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111131246|NCT03071497|Dermatologic Agents|dermatologic agents|mesh-ancestor
111131247|NCT03071497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111131248|NCT03071497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111131249|NCT05616455|Nitroglycerin|nitroglycerin|mesh-list
111131250|NCT05616455|Vasodilator Agents|vasodilator agents|mesh-ancestor
111131251|NCT04986319|Vitamin D|vitamin d|mesh-list
111131252|NCT04986319|Vitamins|vitamins|mesh-ancestor
111131253|NCT04986319|Micronutrients|micronutrients|mesh-ancestor
111131254|NCT04986319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111131255|NCT04986319|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111131256|NCT02593097|Metformin|metformin|mesh-list
111131257|NCT02593097|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111131258|NCT02593097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111131259|NCT04805801|Antibodies, Bispecific|antibodies, bispecific|mesh-list
111131260|NCT04805801|Immunologic Factors|immunologic factors|mesh-ancestor
111131261|NCT04805801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111131262|NCT01657461|Plasminogen|plasminogen|mesh-list
111131263|NCT01657461|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
111131264|NCT01657461|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111131265|NCT01657461|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111131266|NCT01657461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111131268|NCT05001919|Mitosis Modulators|mitosis modulators|mesh-ancestor
111131269|NCT05001919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111131270|NCT05001763|Prucalopride|prucalopride|mesh-list
111131271|NCT05001763|Laxatives|laxatives|mesh-ancestor
111131272|NCT05001763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111131273|NCT05001763|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
111131274|NCT05001763|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111131275|NCT05001763|Serotonin Agents|serotonin agents|mesh-ancestor
111131276|NCT05001763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111131277|NCT05001763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111131278|NCT05001763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111131279|NCT04989985|Oxaliplatin|oxaliplatin|mesh-list
111131280|NCT04989985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111131281|NCT02592551|Durvalumab|durvalumab|mesh-list
111131282|NCT02592551|Tremelimumab|tremelimumab|mesh-list
111131283|NCT02592551|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111131284|NCT02592551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111131285|NCT04989127|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111131286|NCT04989127|Penicillins|penicillins|mesh-list
111131287|NCT04989127|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
111131288|NCT04989127|Analgesics|analgesics|mesh-list
111131289|NCT04989127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111131290|NCT04989127|Antitubercular Agents|antitubercular agents|mesh-ancestor
111131291|NCT04989127|Sensory System Agents|sensory system agents|mesh-ancestor
111131292|NCT04989127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111131293|NCT04989127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111131294|NCT04982809|Dexamethasone|dexamethasone|mesh-list
111131295|NCT04982809|Prednisolone|prednisolone|mesh-list
111131296|NCT04982809|Betamethasone|betamethasone|mesh-list
111131297|NCT04982809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111131298|NCT04982809|Antiemetics|antiemetics|mesh-ancestor
111131299|NCT04982809|Autonomic Agents|autonomic agents|mesh-ancestor
111131300|NCT04982809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111131301|NCT04982809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111131302|NCT04982809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111131303|NCT04982809|Glucocorticoids|glucocorticoids|mesh-ancestor
111131304|NCT04982809|Hormones|hormones|mesh-ancestor
111131305|NCT04982809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111131306|NCT04982809|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111131307|NCT04982809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111131308|NCT04982809|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111131309|NCT04982809|Respiratory System Agents|respiratory system agents|mesh-ancestor
111131310|NCT03068533|Calcium Carbonate|calcium carbonate|mesh-list
111131311|NCT03068533|Calcium|calcium|mesh-list
111131312|NCT03068533|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111131313|NCT03068533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111131314|NCT03068533|Antacids|antacids|mesh-ancestor
111131315|NCT03068533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111131316|NCT03068533|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111131317|NCT05281341|Hormones|hormones|mesh-list
111131318|NCT05281341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111131319|NCT05281341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111131320|NCT04808687|Paclitaxel|paclitaxel|mesh-list
111131321|NCT04808687|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111131322|NCT04808687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111131323|NCT04808687|Tubulin Modulators|tubulin modulators|mesh-ancestor
111131324|NCT04808687|Antimitotic Agents|antimitotic agents|mesh-ancestor
111131325|NCT04808687|Mitosis Modulators|mitosis modulators|mesh-ancestor
111131326|NCT04808687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111131327|NCT05279703|Epinephrine|epinephrine|mesh-list
111131328|NCT05279703|Racepinephrine|racepinephrine|mesh-list
111131329|NCT05279703|Epinephryl borate|epinephryl borate|mesh-list
111131330|NCT05279703|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111131331|NCT05279703|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111131332|NCT05279703|Adrenergic Agents|adrenergic agents|mesh-ancestor
111131333|NCT05279703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111131334|NCT05279703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111131335|NCT05279703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111131336|NCT05279703|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111131337|NCT05279703|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111131338|NCT05279703|Autonomic Agents|autonomic agents|mesh-ancestor
111131339|NCT05279703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111131340|NCT05279703|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111131341|NCT05279703|Respiratory System Agents|respiratory system agents|mesh-ancestor
111131342|NCT05279703|Mydriatics|mydriatics|mesh-ancestor
111131343|NCT05279703|Sympathomimetics|sympathomimetics|mesh-ancestor
111131344|NCT05279703|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111131345|NCT05392933|Lidocaine|lidocaine|mesh-list
111131346|NCT05392933|Anesthetics, Local|anesthetics, local|mesh-ancestor
111131347|NCT05392933|Anesthetics|anesthetics|mesh-ancestor
111131348|NCT05392933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111131349|NCT05392933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111131350|NCT05392933|Sensory System Agents|sensory system agents|mesh-ancestor
111131351|NCT05392933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111131352|NCT05392933|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111131353|NCT05392933|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111131354|NCT05392933|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111131355|NCT05392933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111131356|NCT05392933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111131357|NCT04796675|Cyclophosphamide|cyclophosphamide|mesh-list
111131358|NCT04796675|Fludarabine|fludarabine|mesh-list
111131359|NCT04796675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111131360|NCT04796675|Immunologic Factors|immunologic factors|mesh-ancestor
111131361|NCT04796675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111131362|NCT04796675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111131363|NCT04796675|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111131364|NCT04796675|Alkylating Agents|alkylating agents|mesh-ancestor
111131365|NCT04796675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111131366|NCT04796675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111131367|NCT04796675|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111131368|NCT05275725|Sildenafil Citrate|sildenafil citrate|mesh-list
111131369|NCT05275725|Vasodilator Agents|vasodilator agents|mesh-ancestor
111131370|NCT05275725|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111131371|NCT05275725|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111131372|NCT05275725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111131373|NCT05275725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111131374|NCT05275725|Urological Agents|urological agents|mesh-ancestor
111131375|NCT05315817|Dialysis Solutions|dialysis solutions|mesh-list
111131376|NCT05315817|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111131377|NCT04785755|Etilefrine|etilefrine|mesh-list
111131378|NCT04785755|Furosemide|furosemide|mesh-list
111131379|NCT04785755|Spironolactone|spironolactone|mesh-list
111131380|NCT04785755|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111131381|NCT04785755|Diuretics|diuretics|mesh-list
111131382|NCT04785755|Natriuretic Agents|natriuretic agents|mesh-ancestor
111131383|NCT04785755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110586915|NCT00740792|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111131384|NCT04785755|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
111131385|NCT04785755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111131386|NCT04785755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111131387|NCT04785755|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
111131388|NCT04785755|Hormone Antagonists|hormone antagonists|mesh-ancestor
111131389|NCT04785755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111131390|NCT04785755|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
111131391|NCT04785755|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111131392|NCT04785755|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111131393|NCT04785755|Adrenergic Agents|adrenergic agents|mesh-ancestor
111131394|NCT04785755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111131395|NCT04785755|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111131396|NCT04785755|Sympathomimetics|sympathomimetics|mesh-ancestor
111131397|NCT04785755|Autonomic Agents|autonomic agents|mesh-ancestor
111131398|NCT04785755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111131399|NCT04785755|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111131400|NCT04785755|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
111131402|NCT04785755|Protective Agents|protective agents|mesh-ancestor
111131403|NCT04785911|Antiemetics|antiemetics|mesh-list
111131404|NCT04785911|Histamine|histamine|mesh-list
111131405|NCT04785911|Histamine Agonists|histamine agonists|mesh-ancestor
111131406|NCT04785911|Histamine Agents|histamine agents|mesh-ancestor
111131407|NCT04785911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111131408|NCT04785911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111131409|NCT04785911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111131410|NCT04785911|Autonomic Agents|autonomic agents|mesh-ancestor
111131411|NCT04785911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111131412|NCT04785911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111131413|NCT04243941|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
111131414|NCT04243941|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111131415|NCT04243941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111131416|NCT05314101|Bevacizumab|bevacizumab|mesh-list
111131417|NCT05314101|Tislelizumab|tislelizumab|mesh-list
111131418|NCT05314101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111131419|NCT05314101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111131420|NCT05314101|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111131421|NCT05314101|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111131422|NCT05314101|Growth Substances|growth substances|mesh-ancestor
111131423|NCT05314101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111131424|NCT05314101|Growth Inhibitors|growth inhibitors|mesh-ancestor
111131425|NCT02595749|Oxytocin|oxytocin|mesh-list
111131426|NCT02595749|Oxytocics|oxytocics|mesh-ancestor
111131427|NCT02595749|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111131428|NCT02595749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111131429|NCT04426721|Hyaluronic Acid|hyaluronic acid|mesh-list
111131430|NCT04426721|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111131431|NCT04426721|Immunologic Factors|immunologic factors|mesh-ancestor
111131432|NCT04426721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111131433|NCT04426721|Viscosupplements|viscosupplements|mesh-ancestor
111131434|NCT04426721|Protective Agents|protective agents|mesh-ancestor
111131435|NCT05221359|Insulin Aspart|insulin aspart|mesh-list
111131436|NCT05221359|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111131437|NCT05221359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111131438|NCT04794413|Pimavanserin|pimavanserin|mesh-list
111131439|NCT04794413|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111131440|NCT04794413|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111131441|NCT04794413|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111131442|NCT04794413|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111131443|NCT04794413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111131444|NCT04794413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111131445|NCT04794413|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111131446|NCT04794413|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111131447|NCT04794413|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111131448|NCT04794413|Serotonin Agents|serotonin agents|mesh-ancestor
111131449|NCT04794413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111131450|NCT04794413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111131451|NCT05214573|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
111131452|NCT05214573|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
111131454|NCT05214573|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
111131455|NCT05214573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111131456|NCT05214573|Hormones|hormones|mesh-ancestor
111131457|NCT05214573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111131458|NCT05214573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111131459|NCT05214573|Incretins|incretins|mesh-ancestor
111131460|NCT05214573|Protease Inhibitors|protease inhibitors|mesh-ancestor
111131461|NCT05214573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111131462|NCT05214573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111131463|NCT05214573|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111131464|NCT04988191|Bevacizumab|bevacizumab|mesh-list
111131465|NCT04988191|Irinotecan|irinotecan|mesh-list
111131466|NCT04988191|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111131467|NCT04988191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111131468|NCT04988191|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110837467|NCT01235819|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111131469|NCT04988191|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111131470|NCT04988191|Growth Substances|growth substances|mesh-ancestor
111131471|NCT04988191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111131472|NCT04988191|Growth Inhibitors|growth inhibitors|mesh-ancestor
111131473|NCT04988191|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111131474|NCT04988191|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111131475|NCT04988191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111131476|NCT04988191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111131477|NCT03069001|Ribavirin|ribavirin|mesh-list
111131478|NCT03069001|Sofosbuvir|sofosbuvir|mesh-list
111131479|NCT03069001|Simeprevir|simeprevir|mesh-list
111131480|NCT03069001|Antimetabolites|antimetabolites|mesh-ancestor
111131481|NCT03069001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111131482|NCT03069001|Antiviral Agents|antiviral agents|mesh-ancestor
111131483|NCT03069001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111131484|NCT03069001|Protease Inhibitors|protease inhibitors|mesh-ancestor
111131485|NCT03069001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111131486|NCT03070405|Tenofovir|tenofovir|mesh-list
111131487|NCT03070405|Aminosalicylic Acid|aminosalicylic acid|mesh-list
111131488|NCT03070405|Antiviral Agents|antiviral agents|mesh-ancestor
111131489|NCT03070405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111131490|NCT03070405|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111131491|NCT03070405|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111131492|NCT03070405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111131493|NCT03070405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111131494|NCT03070405|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111131495|NCT03070405|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111131496|NCT03070405|Antitubercular Agents|antitubercular agents|mesh-ancestor
111131497|NCT03070405|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111131498|NCT03068065|Metformin|metformin|mesh-list
111131499|NCT03068065|Liraglutide|liraglutide|mesh-list
111131500|NCT03068065|Gliclazide|gliclazide|mesh-list
111131501|NCT03068065|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111131502|NCT03068065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111131503|NCT03068065|Incretins|incretins|mesh-ancestor
111131504|NCT03068065|Hormones|hormones|mesh-ancestor
111131505|NCT03068065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111131506|NCT05161611|Zinc Sulfate|zinc sulfate|mesh-list
111131507|NCT05161611|Astringents|astringents|mesh-ancestor
111131508|NCT05161611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111131509|NCT05161611|Dermatologic Agents|dermatologic agents|mesh-ancestor
111131510|NCT03660475|Naltrexone|naltrexone|mesh-list
110848549|NCT03729505|Lidocaine|lidocaine|mesh-list
111131511|NCT03660475|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111131512|NCT03660475|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111131513|NCT03660475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111131514|NCT03660475|Sensory System Agents|sensory system agents|mesh-ancestor
111131515|NCT03660475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111131516|NCT05211609|Methyldopa|methyldopa|mesh-list
111131517|NCT05211609|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111131518|NCT05211609|Sympatholytics|sympatholytics|mesh-ancestor
111131519|NCT05211609|Autonomic Agents|autonomic agents|mesh-ancestor
111131520|NCT05211609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111131521|NCT05211609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111131522|NCT05211609|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111131523|NCT05211609|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111131524|NCT05211609|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111131525|NCT05211609|Adrenergic Agents|adrenergic agents|mesh-ancestor
111131526|NCT05211609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111131527|NCT05211609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111131528|NCT05615987|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111131529|NCT05615987|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111131530|NCT05615987|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111131531|NCT05615987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111131532|NCT05615987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111131533|NCT05615987|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111131534|NCT05615987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111131535|NCT05615987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111131536|NCT05615987|Cholinergic Agents|cholinergic agents|mesh-ancestor
111131537|NCT05615987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111131538|NCT02594735|Abatacept|abatacept|mesh-list
111131539|NCT02594735|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111131540|NCT02594735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111131541|NCT02594735|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111131542|NCT02594735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111131543|NCT02594735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111131544|NCT02594735|Immunologic Factors|immunologic factors|mesh-ancestor
111131545|NCT02594735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111131546|NCT02594735|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111131547|NCT04793243|Vitamin D|vitamin d|mesh-list
111131548|NCT04793243|Cholecalciferol|cholecalciferol|mesh-list
111131549|NCT04793243|Vitamins|vitamins|mesh-ancestor
111131550|NCT04793243|Micronutrients|micronutrients|mesh-ancestor
111131551|NCT04793243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111131552|NCT04793243|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111131553|NCT04793243|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111131554|NCT04793399|Atezolizumab|atezolizumab|mesh-list
110586971|NCT04083066|Rituximab|rituximab|mesh-list
111131555|NCT04793399|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111131556|NCT04793399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111131557|NCT04793399|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111131558|NCT04793399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111131559|NCT05157711|Bismuth subgallate|bismuth subgallate|mesh-list
111131560|NCT05157711|Phenylephrine|phenylephrine|mesh-list
111131561|NCT05157711|Oxymetazoline|oxymetazoline|mesh-list
111131562|NCT05157711|Zinc Oxide|zinc oxide|mesh-list
111131563|NCT05157711|Bismuth|bismuth|mesh-list
111131564|NCT05157711|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111131565|NCT05157711|Mydriatics|mydriatics|mesh-ancestor
111131566|NCT05157711|Autonomic Agents|autonomic agents|mesh-ancestor
111131567|NCT05157711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111131568|NCT05157711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111131569|NCT05157711|Sympathomimetics|sympathomimetics|mesh-ancestor
111131570|NCT05157711|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111131571|NCT05157711|Nasal Decongestants|nasal decongestants|mesh-ancestor
111131572|NCT05157711|Respiratory System Agents|respiratory system agents|mesh-ancestor
111131573|NCT05157711|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111131574|NCT05157711|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111131575|NCT05157711|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111131576|NCT05157711|Adrenergic Agents|adrenergic agents|mesh-ancestor
111131577|NCT05157711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111131578|NCT05157711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111131579|NCT05157711|Protective Agents|protective agents|mesh-ancestor
111131580|NCT05157711|Antacids|antacids|mesh-ancestor
111131581|NCT05157711|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111131582|NCT05157711|Dermatologic Agents|dermatologic agents|mesh-ancestor
111131583|NCT05157711|Sunscreening Agents|sunscreening agents|mesh-ancestor
111131584|NCT05157711|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110848618|NCT02729896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111131585|NCT05157711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111131586|NCT05157711|Hemostatics|hemostatics|mesh-ancestor
111131587|NCT05157711|Coagulants|coagulants|mesh-ancestor
111131588|NCT05105997|Dexamethasone|dexamethasone|mesh-list
111131589|NCT05105997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111131590|NCT05105997|Antiemetics|antiemetics|mesh-ancestor
111131591|NCT05105997|Autonomic Agents|autonomic agents|mesh-ancestor
111131592|NCT05105997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111131593|NCT05105997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111131594|NCT05105997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111131595|NCT05105997|Glucocorticoids|glucocorticoids|mesh-ancestor
111131596|NCT05105997|Hormones|hormones|mesh-ancestor
111131597|NCT05105997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111131598|NCT05105997|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111131599|NCT05105997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111131600|NCT03424525|Trimethoprim|trimethoprim|mesh-list
111131601|NCT03424525|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111131602|NCT03424525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111131603|NCT03424525|Antimalarials|antimalarials|mesh-ancestor
111131604|NCT03424525|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111131605|NCT03424525|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111131606|NCT03424525|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111131607|NCT03424525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111131608|NCT03424525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111131609|NCT03424525|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111131610|NCT03424525|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
111131611|NCT03424525|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111131612|NCT04801511|Ascorbic Acid|ascorbic acid|mesh-list
111131613|NCT04801511|Vitamins|vitamins|mesh-ancestor
111131614|NCT04801511|Micronutrients|micronutrients|mesh-ancestor
111131615|NCT04801511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111131616|NCT04801511|Antioxidants|antioxidants|mesh-ancestor
111131617|NCT04801511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111131618|NCT04801511|Protective Agents|protective agents|mesh-ancestor
111131619|NCT05471687|Adenosine|adenosine|mesh-list
111131620|NCT05471687|Analgesics|analgesics|mesh-ancestor
111131621|NCT05471687|Sensory System Agents|sensory system agents|mesh-ancestor
111131622|NCT05471687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111131623|NCT05471687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111131624|NCT05471687|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111131625|NCT05471687|Vasodilator Agents|vasodilator agents|mesh-ancestor
111131626|NCT05471687|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
111131627|NCT05471687|Purinergic Agonists|purinergic agonists|mesh-ancestor
111131628|NCT05471687|Purinergic Agents|purinergic agents|mesh-ancestor
111131629|NCT05471687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111131630|NCT05471687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111131631|NCT05370729|Acetylcysteine|acetylcysteine|mesh-list
111131632|NCT05370729|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111131633|NCT05370729|Antiviral Agents|antiviral agents|mesh-ancestor
111131634|NCT05370729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111131635|NCT05370729|Expectorants|expectorants|mesh-ancestor
111131636|NCT05370729|Respiratory System Agents|respiratory system agents|mesh-ancestor
111131637|NCT05370729|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111131638|NCT05370729|Antioxidants|antioxidants|mesh-ancestor
111131639|NCT05370729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111131640|NCT05370729|Protective Agents|protective agents|mesh-ancestor
111131641|NCT05370729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111131642|NCT05370729|Antidotes|antidotes|mesh-ancestor
111131643|NCT05471531|Vaccines|vaccines|mesh-list
111131644|NCT05471531|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
111131645|NCT05471531|Immunologic Factors|immunologic factors|mesh-ancestor
111131646|NCT05471531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111131647|NCT05204667|Acetaminophen|acetaminophen|mesh-list
111131648|NCT05204667|Aspirin|aspirin|mesh-list
111131649|NCT05204667|Methocarbamol|methocarbamol|mesh-list
111131650|NCT05204667|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111131651|NCT05204667|Analgesics|analgesics|mesh-ancestor
111131652|NCT05204667|Sensory System Agents|sensory system agents|mesh-ancestor
111131653|NCT05204667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111131654|NCT05204667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111131655|NCT05204667|Antipyretics|antipyretics|mesh-ancestor
111131656|NCT05204667|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111131657|NCT05204667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111131658|NCT05204667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111131659|NCT05204667|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111131660|NCT05204667|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111131661|NCT05204667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111131662|NCT05204667|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111131663|NCT05204667|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111131664|NCT05204667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111131665|NCT05204667|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
111131666|NCT05204667|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111131667|NCT04801199|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111131668|NCT04801199|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111131669|NCT04801199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111131670|NCT04801199|Incretins|incretins|mesh-ancestor
111131671|NCT04801199|Hormones|hormones|mesh-ancestor
111131672|NCT04801199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111131673|NCT04801199|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111131674|NCT04801199|Protease Inhibitors|protease inhibitors|mesh-ancestor
111131675|NCT04801199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111131676|NCT04801199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111131677|NCT05445791|Metformin|metformin|mesh-list
111131678|NCT05445791|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111131679|NCT05445791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111131680|NCT04799873|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
111131681|NCT04799873|Protein C Inhibitor|protein c inhibitor|mesh-list
111131682|NCT04799873|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
111131683|NCT04799873|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111131684|NCT04799873|Protease Inhibitors|protease inhibitors|mesh-ancestor
111131685|NCT04799873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111131686|NCT04799873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111131687|NCT04799639|Paclitaxel|paclitaxel|mesh-list
111131688|NCT04799639|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111131689|NCT04799639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111131690|NCT04799639|Tubulin Modulators|tubulin modulators|mesh-ancestor
111131691|NCT04799639|Antimitotic Agents|antimitotic agents|mesh-ancestor
111131692|NCT04799639|Mitosis Modulators|mitosis modulators|mesh-ancestor
111131693|NCT04799639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111131694|NCT04798703|Paclitaxel|paclitaxel|mesh-list
111131695|NCT04798703|Hyaluronic Acid|hyaluronic acid|mesh-list
111131696|NCT04798703|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111131697|NCT04798703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111131698|NCT04798703|Tubulin Modulators|tubulin modulators|mesh-ancestor
111131699|NCT04798703|Antimitotic Agents|antimitotic agents|mesh-ancestor
111131700|NCT04798703|Mitosis Modulators|mitosis modulators|mesh-ancestor
111131701|NCT04798703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111131702|NCT04798703|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111131703|NCT04798703|Immunologic Factors|immunologic factors|mesh-ancestor
111131704|NCT04798703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111131705|NCT04798703|Viscosupplements|viscosupplements|mesh-ancestor
111131706|NCT04798703|Protective Agents|protective agents|mesh-ancestor
111131707|NCT04798313|Denosumab|denosumab|mesh-list
111131708|NCT04798313|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111131709|NCT04798313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111131710|NCT01655823|Tetrodotoxin|tetrodotoxin|mesh-list
111131711|NCT01655823|Anesthetics, Local|anesthetics, local|mesh-ancestor
111131712|NCT01655823|Anesthetics|anesthetics|mesh-ancestor
111131713|NCT01655823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111131714|NCT01655823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111131715|NCT01655823|Sensory System Agents|sensory system agents|mesh-ancestor
111131716|NCT01655823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111131717|NCT01655823|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111131718|NCT01655823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111131719|NCT01655823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111131720|NCT05197257|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
111131721|NCT05197257|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110837514|NCT03631316|Valganciclovir|valganciclovir|mesh-list
111131722|NCT05197257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111131723|NCT05092581|Casirivimab and imdevimab drug combination|casirivimab and imdevimab drug combination|mesh-list
111131724|NCT05092581|Antiviral Agents|antiviral agents|mesh-ancestor
111131725|NCT05092581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111131726|NCT04848857|Colchicine|colchicine|mesh-list
111131727|NCT04848857|Gout Suppressants|gout suppressants|mesh-ancestor
111131728|NCT04848857|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111131729|NCT04848857|Tubulin Modulators|tubulin modulators|mesh-ancestor
111131730|NCT04848857|Antimitotic Agents|antimitotic agents|mesh-ancestor
111131731|NCT04848857|Mitosis Modulators|mitosis modulators|mesh-ancestor
111131732|NCT04848857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111131733|NCT04848857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111131734|NCT04338659|Antibodies|antibodies|mesh-list
111131735|NCT04338659|Antibodies, Bispecific|antibodies, bispecific|mesh-list
111131737|NCT04338659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111131738|NCT05189535|Paclitaxel|paclitaxel|mesh-list
111131739|NCT05189535|Pentoxifylline|pentoxifylline|mesh-list
111131740|NCT05189535|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111131741|NCT05189535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111131742|NCT05189535|Tubulin Modulators|tubulin modulators|mesh-ancestor
111131743|NCT05189535|Antimitotic Agents|antimitotic agents|mesh-ancestor
111131744|NCT05189535|Mitosis Modulators|mitosis modulators|mesh-ancestor
111131745|NCT05189535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111131746|NCT05189535|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111131747|NCT05189535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111131748|NCT05189535|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111131749|NCT05189535|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111131750|NCT05189535|Protective Agents|protective agents|mesh-ancestor
111131751|NCT05189535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111131752|NCT05189535|Vasodilator Agents|vasodilator agents|mesh-ancestor
111131753|NCT05189535|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111131754|NCT05189535|Antioxidants|antioxidants|mesh-ancestor
111131755|NCT05089461|Mitoxantrone|mitoxantrone|mesh-list
111131756|NCT05089461|Analgesics|analgesics|mesh-ancestor
111131757|NCT05089461|Sensory System Agents|sensory system agents|mesh-ancestor
111131758|NCT05089461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111131759|NCT05089461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111131760|NCT05089461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111131761|NCT05089461|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111131762|NCT05089461|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111131763|NCT05089461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111131764|NCT05089461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111131765|NCT05730439|Lobeline|lobeline|mesh-list
111131766|NCT05730439|Nicotine|nicotine|mesh-list
111131767|NCT05730439|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111131768|NCT05730439|Autonomic Agents|autonomic agents|mesh-ancestor
111131769|NCT05730439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111131770|NCT05730439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111131771|NCT05730439|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111131772|NCT05730439|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111131773|NCT05730439|Cholinergic Agents|cholinergic agents|mesh-ancestor
111131774|NCT05730439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111131775|NCT05730439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111131776|NCT05730439|Respiratory System Agents|respiratory system agents|mesh-ancestor
111131777|NCT04805515|Nicotine|nicotine|mesh-list
111131778|NCT04805515|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111131779|NCT04805515|Autonomic Agents|autonomic agents|mesh-ancestor
111131780|NCT04805515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111131781|NCT04805515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111131782|NCT04805515|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111131783|NCT04805515|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111131784|NCT04805515|Cholinergic Agents|cholinergic agents|mesh-ancestor
111131785|NCT04805515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111131786|NCT04805515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111131787|NCT05170919|Olanzapine|olanzapine|mesh-list
111131788|NCT05170919|Mirtazapine|mirtazapine|mesh-list
111131789|NCT05170919|Antiemetics|antiemetics|mesh-ancestor
111131790|NCT05170919|Autonomic Agents|autonomic agents|mesh-ancestor
111131791|NCT05170919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111131792|NCT05170919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111131793|NCT05170919|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111131794|NCT05170919|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111131795|NCT05170919|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111131796|NCT05170919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111131797|NCT05170919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111131798|NCT05170919|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111131799|NCT05170919|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111131800|NCT05170919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111131801|NCT05170919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111131802|NCT05170919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111131803|NCT05170919|Serotonin Agents|serotonin agents|mesh-ancestor
111131804|NCT05170919|Antidepressive Agents|antidepressive agents|mesh-ancestor
111131805|NCT05170919|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111131806|NCT05170919|Histamine Antagonists|histamine antagonists|mesh-ancestor
111131807|NCT05170919|Histamine Agents|histamine agents|mesh-ancestor
111131808|NCT05170919|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111131809|NCT05170919|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
111131810|NCT05170919|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111131811|NCT05170919|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111131813|NCT05170919|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111131814|NCT05170919|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111131815|NCT05170919|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111131816|NCT05613491|Insulin|insulin|mesh-list
111131817|NCT05613491|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111131818|NCT05613491|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111131819|NCT05613491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111131820|NCT04788407|Nitazoxanide|nitazoxanide|mesh-list
111131821|NCT04788407|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111131822|NCT04788407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111131823|NCT03066427|Sunitinib|sunitinib|mesh-list
111131824|NCT03066427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111131825|NCT03066427|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111131826|NCT03066427|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111131827|NCT03066427|Growth Substances|growth substances|mesh-ancestor
111131828|NCT03066427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111131829|NCT03066427|Growth Inhibitors|growth inhibitors|mesh-ancestor
111131830|NCT03066427|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111131831|NCT03066427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111131832|NCT03066427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111131833|NCT05177133|Capecitabine|capecitabine|mesh-list
111131834|NCT05177133|Oxaliplatin|oxaliplatin|mesh-list
111131835|NCT05177133|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111131836|NCT05177133|Antimetabolites|antimetabolites|mesh-ancestor
111131837|NCT05177133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111131838|NCT05177133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111131839|NCT02866643|Contraceptive Agents|contraceptive agents|mesh-list
111131840|NCT02866643|Etonogestrel|etonogestrel|mesh-list
111131841|NCT02866643|Desogestrel|desogestrel|mesh-list
111131842|NCT02866643|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111131843|NCT02866643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111131844|NCT02866643|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111131845|NCT02866643|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111131846|NCT02866643|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111131847|NCT02866643|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111131848|NCT02866643|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111131849|NCT02866643|Progestins|progestins|mesh-ancestor
111131850|NCT02866643|Hormones|hormones|mesh-ancestor
111131851|NCT02866643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111131852|NCT05176821|Amoxicillin|amoxicillin|mesh-list
111131853|NCT05176821|Furazolidone|furazolidone|mesh-list
111131854|NCT05176821|Potassium Citrate|potassium citrate|mesh-list
111131855|NCT05176821|Esomeprazole|esomeprazole|mesh-list
111131856|NCT05176821|Bismuth|bismuth|mesh-list
111131857|NCT05176821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111131858|NCT05176821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111131859|NCT05176821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111131860|NCT05176821|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111131861|NCT05176821|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111131862|NCT05176821|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111131863|NCT05176821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111131864|NCT05176821|Antacids|antacids|mesh-ancestor
111131865|NCT05176821|Diuretics|diuretics|mesh-ancestor
111131866|NCT05176821|Natriuretic Agents|natriuretic agents|mesh-ancestor
111131867|NCT05176821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111131868|NCT05176821|Expectorants|expectorants|mesh-ancestor
111131869|NCT05176821|Respiratory System Agents|respiratory system agents|mesh-ancestor
111131870|NCT05176821|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111131871|NCT05176821|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111131872|NCT05176821|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
111131873|NCT05176821|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111131874|NCT05176821|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111131875|NCT05176821|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
111131876|NCT05555641|Nafamostat|nafamostat|mesh-list
111131877|NCT05555641|Heparin|heparin|mesh-list
111131878|NCT05555641|Calcium heparin|calcium heparin|mesh-list
111131879|NCT05555641|Anticoagulants|anticoagulants|mesh-ancestor
111131880|NCT05555641|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111131881|NCT05555641|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111131882|NCT05555641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111131883|NCT05555641|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111131884|NCT05555641|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111131885|NCT05555641|Analgesics|analgesics|mesh-ancestor
111131886|NCT05555641|Sensory System Agents|sensory system agents|mesh-ancestor
111131887|NCT05555641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111131888|NCT05555641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111131889|NCT05555641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111131890|NCT05555641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111131891|NCT05555641|Protease Inhibitors|protease inhibitors|mesh-ancestor
111131892|NCT05555641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111131893|NCT05555641|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
111131894|NCT05555641|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111131895|NCT05555641|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
111131896|NCT05555641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111131897|NCT05555641|Immunologic Factors|immunologic factors|mesh-ancestor
111131898|NCT01672801|Nimodipine|nimodipine|mesh-list
111131899|NCT01672801|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111131900|NCT01672801|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111131901|NCT01672801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111131902|NCT01672801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111131903|NCT01672801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111131904|NCT01672801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111131905|NCT01672801|Vasodilator Agents|vasodilator agents|mesh-ancestor
111131906|NCT05613335|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
111131907|NCT05613335|Hemostatics|hemostatics|mesh-ancestor
111131908|NCT05613335|Coagulants|coagulants|mesh-ancestor
111131909|NCT05078463|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
111131910|NCT05078463|Terephthalic acid|terephthalic acid|mesh-list
111131911|NCT05078463|Anesthetics, Local|anesthetics, local|mesh-ancestor
111131912|NCT05078463|Anesthetics|anesthetics|mesh-ancestor
111131913|NCT05078463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111131914|NCT05078463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111131915|NCT05078463|Sensory System Agents|sensory system agents|mesh-ancestor
111131917|NCT05078463|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
111131918|NCT05078463|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111131919|NCT05078463|Antioxidants|antioxidants|mesh-ancestor
111131920|NCT05078463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111131921|NCT05078463|Protective Agents|protective agents|mesh-ancestor
111131922|NCT05170113|Caffeine|caffeine|mesh-list
111131923|NCT05170113|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111131924|NCT05170113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111131925|NCT05170113|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111131926|NCT05170113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111131927|NCT05170113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111131928|NCT05170113|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
111131929|NCT05170113|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111131930|NCT05170113|Purinergic Agents|purinergic agents|mesh-ancestor
111131931|NCT05170113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111131932|NCT05611463|Docetaxel|docetaxel|mesh-list
111131933|NCT05611463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111131934|NCT05611463|Tubulin Modulators|tubulin modulators|mesh-ancestor
111131935|NCT05611463|Antimitotic Agents|antimitotic agents|mesh-ancestor
111131936|NCT05611463|Mitosis Modulators|mitosis modulators|mesh-ancestor
111131937|NCT05611463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111131938|NCT05611385|Amphetamine|amphetamine|mesh-list
111131939|NCT05611385|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111131940|NCT05611385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111131941|NCT05611385|Sympathomimetics|sympathomimetics|mesh-ancestor
111131942|NCT05611385|Autonomic Agents|autonomic agents|mesh-ancestor
111131943|NCT05611385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111131944|NCT05611385|Dopamine Agents|dopamine agents|mesh-ancestor
111131945|NCT05611385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111131946|NCT05611385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111131947|NCT05611385|Adrenergic Agents|adrenergic agents|mesh-ancestor
111131948|NCT05611385|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111131949|NCT05611385|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111131950|NCT05611385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111131951|NCT05611385|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111131952|NCT05475041|Liver Extracts|liver extracts|mesh-list
111131953|NCT05475041|Hematinics|hematinics|mesh-ancestor
111131954|NCT05611307|Hormones|hormones|mesh-list
111131955|NCT05611307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111131956|NCT05611307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111131957|NCT02631577|Lenalidomide|lenalidomide|mesh-list
111131958|NCT02631577|Atezolizumab|atezolizumab|mesh-list
111131959|NCT02631577|Obinutuzumab|obinutuzumab|mesh-list
111131960|NCT02631577|Immunologic Factors|immunologic factors|mesh-ancestor
111131961|NCT02631577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111131962|NCT02631577|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111131963|NCT02631577|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111131964|NCT02631577|Growth Substances|growth substances|mesh-ancestor
111131965|NCT02631577|Growth Inhibitors|growth inhibitors|mesh-ancestor
111131966|NCT02631577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111131967|NCT02631577|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111131968|NCT02631577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111131969|NCT02631577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111131970|NCT01667081|Grazoprevir|grazoprevir|mesh-list
111131971|NCT01667081|Antiviral Agents|antiviral agents|mesh-ancestor
111131972|NCT01667081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111131973|NCT03067753|Methylprednisolone|methylprednisolone|mesh-list
111131974|NCT03067753|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111131975|NCT03067753|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111131976|NCT03067753|Prednisolone|prednisolone|mesh-list
111131977|NCT03067753|Prednisolone acetate|prednisolone acetate|mesh-list
111131978|NCT03067753|Hormones|hormones|mesh-list
111131979|NCT03067753|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111131980|NCT03067753|Prednisolone phosphate|prednisolone phosphate|mesh-list
111131981|NCT03067753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111131982|NCT03067753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111131983|NCT03067753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111131984|NCT03067753|Antiemetics|antiemetics|mesh-ancestor
111131985|NCT03067753|Autonomic Agents|autonomic agents|mesh-ancestor
111131986|NCT03067753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111131987|NCT03067753|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111131988|NCT03067753|Glucocorticoids|glucocorticoids|mesh-ancestor
111131989|NCT03067753|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111131990|NCT03067753|Protective Agents|protective agents|mesh-ancestor
111131991|NCT03067753|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111131992|NCT03067753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111131994|NCT04331639|Cholecalciferol|cholecalciferol|mesh-list
111131995|NCT04331639|Vitamins|vitamins|mesh-ancestor
111131996|NCT04331639|Micronutrients|micronutrients|mesh-ancestor
111131997|NCT04331639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111131998|NCT04331639|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111131999|NCT04331639|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111132000|NCT03067597|Dinoprostone|dinoprostone|mesh-list
111132001|NCT03067597|Oxytocics|oxytocics|mesh-ancestor
111132002|NCT03067597|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111132003|NCT03067597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111132004|NCT02518971|Tamsulosin|tamsulosin|mesh-list
111132005|NCT02518971|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111132006|NCT02518971|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111132007|NCT02518971|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111132008|NCT02518971|Adrenergic Agents|adrenergic agents|mesh-ancestor
111132009|NCT02518971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111132010|NCT02518971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111132011|NCT02518971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111132012|NCT02518971|Urological Agents|urological agents|mesh-ancestor
111132013|NCT04733963|Bevacizumab|bevacizumab|mesh-list
111132014|NCT04733963|Capecitabine|capecitabine|mesh-list
111132015|NCT04733963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111132016|NCT04733963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111132017|NCT04733963|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111132018|NCT04733963|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111132019|NCT04733963|Growth Substances|growth substances|mesh-ancestor
111132020|NCT04733963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111132021|NCT04733963|Growth Inhibitors|growth inhibitors|mesh-ancestor
111132022|NCT04733963|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111132023|NCT04733963|Antimetabolites|antimetabolites|mesh-ancestor
111132024|NCT04733963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111132025|NCT03066115|Ascorbic Acid|ascorbic acid|mesh-list
111132026|NCT03066115|Ketorolac|ketorolac|mesh-list
111132027|NCT03066115|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111132028|NCT03066115|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111132029|NCT03066115|Analgesics|analgesics|mesh-ancestor
111132030|NCT03066115|Sensory System Agents|sensory system agents|mesh-ancestor
111132031|NCT03066115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111132032|NCT03066115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111132033|NCT03066115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111132034|NCT03066115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111132035|NCT03066115|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111132036|NCT03066115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111132037|NCT03066115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111132038|NCT03066115|Antioxidants|antioxidants|mesh-ancestor
111132039|NCT03066115|Protective Agents|protective agents|mesh-ancestor
111132040|NCT03066115|Vitamins|vitamins|mesh-ancestor
111132041|NCT03066115|Micronutrients|micronutrients|mesh-ancestor
111132042|NCT04212039|Bupivacaine|bupivacaine|mesh-list
111132043|NCT04212039|Anesthetics, Local|anesthetics, local|mesh-ancestor
111132044|NCT04212039|Anesthetics|anesthetics|mesh-ancestor
110837566|NCT01142453|Antiviral Agents|antiviral agents|mesh-ancestor
111132045|NCT04212039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111132046|NCT04212039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111132047|NCT04212039|Sensory System Agents|sensory system agents|mesh-ancestor
111132048|NCT04212039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111132049|NCT05048589|Vaccines|vaccines|mesh-list
111132050|NCT05048589|Immunologic Factors|immunologic factors|mesh-ancestor
111132051|NCT05048589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111132052|NCT05728333|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
111132053|NCT05728333|Tirofiban|tirofiban|mesh-list
111132054|NCT05728333|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111132055|NCT05728333|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111132056|NCT05728333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111132057|NCT05728333|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111132058|NCT04447651|Immunomodulating Agents|immunomodulating agents|mesh-list
111132059|NCT04447651|Immunologic Factors|immunologic factors|mesh-ancestor
111132060|NCT04447651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111132061|NCT01364727|Amrubicin|amrubicin|mesh-list
111132062|NCT01364727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111132063|NCT04990869|Niacinamide|niacinamide|mesh-list
111132064|NCT04990869|Niacin|niacin|mesh-list
111132065|NCT04990869|Nicotinic Acids|nicotinic acids|mesh-list
111132066|NCT04990869|Vitamin B Complex|vitamin b complex|mesh-ancestor
111132067|NCT04990869|Vitamins|vitamins|mesh-ancestor
111132068|NCT04990869|Micronutrients|micronutrients|mesh-ancestor
111132069|NCT04990869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111132070|NCT04990869|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111132071|NCT04990869|Antimetabolites|antimetabolites|mesh-ancestor
111132072|NCT04990869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111132073|NCT04990869|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111132074|NCT04990869|Vasodilator Agents|vasodilator agents|mesh-ancestor
111132075|NCT04401553|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111132076|NCT04401553|Vancomycin|vancomycin|mesh-list
111132077|NCT04401553|Cephalosporins|cephalosporins|mesh-list
111132078|NCT04401553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111132079|NCT01364649|Vortioxetine|vortioxetine|mesh-list
111132080|NCT01364649|Escitalopram|escitalopram|mesh-list
111132081|NCT01364649|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111132082|NCT01364649|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111132083|NCT01364649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111132084|NCT01364649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111132085|NCT01364649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111132086|NCT01364649|Serotonin Agents|serotonin agents|mesh-ancestor
111132087|NCT01364649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111132088|NCT01364649|Antidepressive Agents|antidepressive agents|mesh-ancestor
111132089|NCT01364649|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111132090|NCT01364649|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111132091|NCT01364649|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111132092|NCT01364649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111132093|NCT01364649|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111132094|NCT01364649|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111132095|NCT01364649|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111132096|NCT01364649|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111132097|NCT03065569|Bupivacaine|bupivacaine|mesh-list
111132098|NCT03065569|Anesthetics, Local|anesthetics, local|mesh-ancestor
111132099|NCT03065569|Anesthetics|anesthetics|mesh-ancestor
111132100|NCT03065569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111132101|NCT03065569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111132102|NCT03065569|Sensory System Agents|sensory system agents|mesh-ancestor
111132103|NCT03065569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111132104|NCT05723419|Anesthetics|anesthetics|mesh-list
111132105|NCT05723419|Anesthetics, Local|anesthetics, local|mesh-list
111132106|NCT05723419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111132107|NCT05723419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110587221|NCT04067505|Protease Inhibitors|protease inhibitors|mesh-ancestor
111132108|NCT05723419|Sensory System Agents|sensory system agents|mesh-ancestor
111132109|NCT05723419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111132110|NCT02588261|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111132112|NCT02588261|Naquotinib|naquotinib|mesh-list
111132113|NCT02588261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111132114|NCT02588261|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111132115|NCT02588261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111132116|NCT02588261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111132117|NCT04989699|Aflibercept|aflibercept|mesh-list
111132118|NCT04989699|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111132119|NCT04989699|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111132120|NCT04989699|Growth Substances|growth substances|mesh-ancestor
111132121|NCT04989699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111132122|NCT04989699|Growth Inhibitors|growth inhibitors|mesh-ancestor
111132123|NCT04989699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111132124|NCT05279131|Tirbanibulin|tirbanibulin|mesh-list
111132125|NCT05279131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111132126|NCT05279131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111132127|NCT04426487|Progesterone|progesterone|mesh-list
111132128|NCT04426487|Progestins|progestins|mesh-ancestor
111132130|NCT04426487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111132131|NCT04426487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111132132|NCT04988217|Interferons|interferons|mesh-list
111132133|NCT04988217|Interferon-alpha|interferon-alpha|mesh-list
111132134|NCT04988217|Interferon alpha-2|interferon alpha-2|mesh-list
111132135|NCT04988217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111132136|NCT04988217|Antiviral Agents|antiviral agents|mesh-ancestor
111132137|NCT04988217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111132138|NCT04988217|Immunologic Factors|immunologic factors|mesh-ancestor
111132139|NCT04988217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111132140|NCT01672723|Naltrexone|naltrexone|mesh-list
111132141|NCT01672723|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111132142|NCT01672723|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111132143|NCT01672723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111132144|NCT01672723|Sensory System Agents|sensory system agents|mesh-ancestor
111132145|NCT01672723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111132146|NCT04443673|Glycine|glycine|mesh-list
111132147|NCT04443673|Glycine Agents|glycine agents|mesh-ancestor
111132148|NCT04443673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111132149|NCT04443673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111132150|NCT04443673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111132151|NCT05036577|Dexamethasone|dexamethasone|mesh-list
111132152|NCT05036577|Rituximab|rituximab|mesh-list
111132153|NCT05036577|Methotrexate|methotrexate|mesh-list
111132154|NCT05036577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111132155|NCT05036577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111132156|NCT05036577|Immunologic Factors|immunologic factors|mesh-ancestor
111132157|NCT05036577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111132158|NCT05036577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111132159|NCT05036577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111132160|NCT05036577|Antiemetics|antiemetics|mesh-ancestor
111132161|NCT05036577|Autonomic Agents|autonomic agents|mesh-ancestor
111132162|NCT05036577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111132163|NCT05036577|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111132164|NCT05036577|Glucocorticoids|glucocorticoids|mesh-ancestor
111132165|NCT05036577|Hormones|hormones|mesh-ancestor
111132166|NCT05036577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111132167|NCT05036577|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111132168|NCT05036577|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111132169|NCT05036577|Abortifacient Agents|abortifacient agents|mesh-ancestor
111132170|NCT05036577|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111132171|NCT05036577|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111132172|NCT05036577|Antimetabolites|antimetabolites|mesh-ancestor
111132173|NCT05036577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111132174|NCT05036577|Dermatologic Agents|dermatologic agents|mesh-ancestor
111132175|NCT05036577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111132176|NCT05036577|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111132177|NCT05036577|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111132178|NCT05036577|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111132179|NCT04982367|Sirolimus|sirolimus|mesh-list
111132180|NCT04982367|Paclitaxel|paclitaxel|mesh-list
111132181|NCT04982367|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111132182|NCT04982367|Temsirolimus|temsirolimus|mesh-list
111132183|NCT04982367|MTOR Inhibitors|mtor inhibitors|mesh-list
111132184|NCT04982367|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111132185|NCT04982367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111132186|NCT04982367|Tubulin Modulators|tubulin modulators|mesh-ancestor
111132187|NCT04982367|Antimitotic Agents|antimitotic agents|mesh-ancestor
111132188|NCT04982367|Mitosis Modulators|mitosis modulators|mesh-ancestor
111132189|NCT04982367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111132190|NCT04982367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111132191|NCT04982367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111132192|NCT04982367|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111132193|NCT04982367|Antifungal Agents|antifungal agents|mesh-ancestor
111132194|NCT04982367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111132195|NCT04982367|Immunologic Factors|immunologic factors|mesh-ancestor
111132196|NCT04982367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111132197|NCT04982367|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111132198|NCT04982367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111132199|NCT05034627|Asparaginase|asparaginase|mesh-list
111132200|NCT05034627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111132201|NCT05031975|Irinotecan|irinotecan|mesh-list
111132202|NCT05031975|Temozolomide|temozolomide|mesh-list
111132203|NCT05031975|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111132204|NCT05031975|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111132205|NCT05031975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110587265|NCT00794573|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111132206|NCT05031975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111132207|NCT05031975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111132208|NCT05031975|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111132209|NCT05031975|Alkylating Agents|alkylating agents|mesh-ancestor
111132210|NCT02632747|Empagliflozin|empagliflozin|mesh-list
111132211|NCT02632747|Ramipril|ramipril|mesh-list
111132212|NCT02632747|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111132213|NCT02632747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111132214|NCT02632747|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111132215|NCT02632747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111132216|NCT02632747|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
111132217|NCT02632747|Protease Inhibitors|protease inhibitors|mesh-ancestor
111132218|NCT02632747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111132219|NCT02632747|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111132220|NCT04216797|Diazepam|diazepam|mesh-list
111132221|NCT04216797|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111132222|NCT04216797|Anticonvulsants|anticonvulsants|mesh-ancestor
111132223|NCT04216797|Antiemetics|antiemetics|mesh-ancestor
111132224|NCT04216797|Autonomic Agents|autonomic agents|mesh-ancestor
111132225|NCT04216797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111132226|NCT04216797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111132227|NCT04216797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111132228|NCT04216797|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111132229|NCT04216797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111132230|NCT04216797|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
111132231|NCT04216797|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111132232|NCT04216797|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111132233|NCT04216797|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111132234|NCT04216797|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111132235|NCT04216797|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111132236|NCT04216797|Anesthetics, General|anesthetics, general|mesh-ancestor
111132237|NCT04216797|Anesthetics|anesthetics|mesh-ancestor
111132238|NCT04216797|GABA Modulators|gaba modulators|mesh-ancestor
111132239|NCT04216797|GABA Agents|gaba agents|mesh-ancestor
111132240|NCT04216797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111132241|NCT04216797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111132242|NCT05029401|Ibogaine|ibogaine|mesh-list
111132243|NCT05029401|Hallucinogens|hallucinogens|mesh-ancestor
111132244|NCT05029401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111132245|NCT05029401|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111132246|NCT05029401|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111132247|NCT05029401|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111132248|NCT05029401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111132249|NCT05029401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110837594|NCT04678479|Ganaxolone|ganaxolone|mesh-list
111132251|NCT05025813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111132252|NCT05025813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111132253|NCT05025813|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111132254|NCT05025813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111132255|NCT04033237|Nicotine|nicotine|mesh-list
110849292|NCT01791478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111132256|NCT04033237|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111132257|NCT04033237|Autonomic Agents|autonomic agents|mesh-ancestor
111132258|NCT04033237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111132259|NCT04033237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111132260|NCT04033237|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111132261|NCT04033237|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111132262|NCT04033237|Cholinergic Agents|cholinergic agents|mesh-ancestor
111132263|NCT04033237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111132264|NCT04033237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111132265|NCT04421547|Letrozole|letrozole|mesh-list
111132266|NCT04421547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111132267|NCT04421547|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111132268|NCT04421547|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111132269|NCT04421547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111132270|NCT04421547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111132271|NCT04421547|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111132272|NCT04421547|Hormone Antagonists|hormone antagonists|mesh-ancestor
111132273|NCT04421547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111132274|NCT04421547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111132275|NCT03066817|Ergocalciferols|ergocalciferols|mesh-list
111132276|NCT03066817|Vitamin D|vitamin d|mesh-list
111132277|NCT03066817|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111132278|NCT03066817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111132279|NCT03066817|Vitamins|vitamins|mesh-ancestor
111132280|NCT03066817|Micronutrients|micronutrients|mesh-ancestor
111132281|NCT03066817|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111132282|NCT05060913|Lidocaine|lidocaine|mesh-list
111132283|NCT05060913|Prilocaine|prilocaine|mesh-list
111132284|NCT05060913|Benzocaine|benzocaine|mesh-list
111132285|NCT05060913|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
111132286|NCT05060913|Anesthetics, Local|anesthetics, local|mesh-ancestor
111132287|NCT05060913|Anesthetics|anesthetics|mesh-ancestor
111132288|NCT05060913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111132289|NCT05060913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111132290|NCT05060913|Sensory System Agents|sensory system agents|mesh-ancestor
111132291|NCT05060913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111132292|NCT05060913|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111132293|NCT05060913|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111132294|NCT05060913|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111132295|NCT05060913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111132296|NCT05060913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111132297|NCT05060913|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
111132298|NCT05165251|Amlodipine|amlodipine|mesh-list
111132299|NCT05165251|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
111132300|NCT05165251|Atorvastatin|atorvastatin|mesh-list
111132301|NCT05165251|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111132302|NCT05165251|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111132303|NCT05165251|Antimetabolites|antimetabolites|mesh-ancestor
111132304|NCT05165251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111132305|NCT05165251|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111132306|NCT05165251|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111132307|NCT05165251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111132308|NCT05165251|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111132309|NCT05165251|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111132310|NCT05165251|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111132311|NCT05165251|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111132312|NCT05165251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111132313|NCT05165251|Vasodilator Agents|vasodilator agents|mesh-ancestor
111132314|NCT04209075|Metformin|metformin|mesh-list
111132315|NCT04209075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111132316|NCT04209075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111132317|NCT05023473|Morphine|morphine|mesh-list
111132318|NCT05023473|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111132319|NCT05023473|Narcotics|narcotics|mesh-ancestor
111132320|NCT05023473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111132321|NCT05023473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111132322|NCT05023473|Analgesics|analgesics|mesh-ancestor
111132323|NCT05023473|Sensory System Agents|sensory system agents|mesh-ancestor
111132324|NCT05023473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111132325|NCT03066661|Entrectinib|entrectinib|mesh-list
111132326|NCT03066661|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111132327|NCT03066661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111132328|NCT03066661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111132329|NCT03775629|Tramadol|tramadol|mesh-list
111132330|NCT03775629|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111132331|NCT03775629|Narcotics|narcotics|mesh-ancestor
111132332|NCT03775629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111132333|NCT03775629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111132334|NCT03775629|Analgesics|analgesics|mesh-ancestor
111132335|NCT03775629|Sensory System Agents|sensory system agents|mesh-ancestor
111132336|NCT03775629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111132337|NCT01671319|Cyclophosphamide|cyclophosphamide|mesh-list
111132338|NCT01671319|Docetaxel|docetaxel|mesh-list
111132339|NCT01671319|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111132340|NCT01671319|Immunologic Factors|immunologic factors|mesh-ancestor
111132341|NCT01671319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111132342|NCT01671319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111132343|NCT01671319|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111132344|NCT01671319|Alkylating Agents|alkylating agents|mesh-ancestor
111132345|NCT01671319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111132346|NCT01671319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111132347|NCT01671319|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111132348|NCT01671319|Tubulin Modulators|tubulin modulators|mesh-ancestor
111132349|NCT01671319|Antimitotic Agents|antimitotic agents|mesh-ancestor
111132350|NCT01671319|Mitosis Modulators|mitosis modulators|mesh-ancestor
111132351|NCT05016609|Sofosbuvir|sofosbuvir|mesh-list
111132352|NCT05016609|Velpatasvir|velpatasvir|mesh-list
111132353|NCT05016609|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
111132354|NCT05016609|Antibodies|antibodies|mesh-list
111132355|NCT05016609|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
111132356|NCT05016609|Immunologic Factors|immunologic factors|mesh-ancestor
111132357|NCT05016609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111132358|NCT05016609|Antiviral Agents|antiviral agents|mesh-ancestor
111132359|NCT05016609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111132360|NCT03763305|Fentanyl|fentanyl|mesh-list
111132361|NCT03763305|Remifentanil|remifentanil|mesh-list
111132362|NCT03763305|Propofol|propofol|mesh-list
111132363|NCT03763305|Sevoflurane|sevoflurane|mesh-list
111132364|NCT03763305|Desflurane|desflurane|mesh-list
111132365|NCT03763305|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111132366|NCT03763305|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111132367|NCT03763305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111132368|NCT03763305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111132369|NCT03763305|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111132370|NCT03763305|Anesthetics, General|anesthetics, general|mesh-ancestor
111132371|NCT03763305|Anesthetics|anesthetics|mesh-ancestor
111132372|NCT03763305|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111132373|NCT03763305|Narcotics|narcotics|mesh-ancestor
111132374|NCT03763305|Analgesics|analgesics|mesh-ancestor
110837604|NCT02251821|Cyclophosphamide|cyclophosphamide|mesh-list
111132375|NCT03763305|Sensory System Agents|sensory system agents|mesh-ancestor
111132376|NCT03763305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111132377|NCT03763305|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111132378|NCT03763305|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111132379|NCT03763305|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111132381|NCT05054361|Lactulose|lactulose|mesh-list
111132382|NCT05054361|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
111132383|NCT05054361|Diuretics|diuretics|mesh-ancestor
111132384|NCT05054361|Natriuretic Agents|natriuretic agents|mesh-ancestor
111132385|NCT05054361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111132386|NCT05054361|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111132387|NCT04906213|Empagliflozin|empagliflozin|mesh-list
111132388|NCT04906213|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111132389|NCT04906213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111132390|NCT04906213|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111132391|NCT04906213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111132392|NCT01670539|Triamcinolone|triamcinolone|mesh-list
111132393|NCT01670539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111132394|NCT01670539|Glucocorticoids|glucocorticoids|mesh-ancestor
111132395|NCT01670539|Hormones|hormones|mesh-ancestor
111132396|NCT01670539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111132397|NCT01670539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111132398|NCT02252887|Gemcitabine|gemcitabine|mesh-list
111132399|NCT02252887|Trastuzumab|trastuzumab|mesh-list
111132400|NCT02252887|Pertuzumab|pertuzumab|mesh-list
111132401|NCT02252887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111132402|NCT02252887|Antimetabolites|antimetabolites|mesh-ancestor
111132403|NCT02252887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111132404|NCT02252887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111132405|NCT02252887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111132406|NCT04431895|Tofacitinib|tofacitinib|mesh-list
111132407|NCT04431895|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
111132408|NCT04431895|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111132409|NCT04431895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111132410|NCT04431895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111132411|NCT03064633|Dexamethasone|dexamethasone|mesh-list
111132412|NCT03064633|Dexamethasone acetate|dexamethasone acetate|mesh-list
111132413|NCT03064633|Dexmedetomidine|dexmedetomidine|mesh-list
111132414|NCT03064633|Bupivacaine|bupivacaine|mesh-list
111132415|NCT03064633|BB 1101|bb 1101|mesh-list
111132416|NCT03064633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111132417|NCT03064633|Antiemetics|antiemetics|mesh-ancestor
111132418|NCT03064633|Autonomic Agents|autonomic agents|mesh-ancestor
111132419|NCT03064633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111132420|NCT03064633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111132421|NCT03064633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111132422|NCT03064633|Glucocorticoids|glucocorticoids|mesh-ancestor
111132423|NCT03064633|Hormones|hormones|mesh-ancestor
111132424|NCT03064633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111132425|NCT03064633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111132426|NCT03064633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111132427|NCT03064633|Protease Inhibitors|protease inhibitors|mesh-ancestor
111132428|NCT03064633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111132429|NCT03064633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111132430|NCT03064633|Anesthetics, Local|anesthetics, local|mesh-ancestor
111132431|NCT03064633|Anesthetics|anesthetics|mesh-ancestor
111132432|NCT03064633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111132433|NCT03064633|Sensory System Agents|sensory system agents|mesh-ancestor
111132434|NCT03064633|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111132435|NCT03064633|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111132436|NCT03064633|Analgesics|analgesics|mesh-ancestor
111132437|NCT03064633|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111132438|NCT03064633|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111132439|NCT03064633|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111132440|NCT03064633|Adrenergic Agents|adrenergic agents|mesh-ancestor
111132441|NCT03064633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111132442|NCT04950465|Fluorides|fluorides|mesh-list
111132443|NCT04950465|Cariostatic Agents|cariostatic agents|mesh-ancestor
111132444|NCT04950465|Protective Agents|protective agents|mesh-ancestor
111132445|NCT04950465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111132446|NCT02589665|Mirikizumab|mirikizumab|mesh-list
111132447|NCT02589665|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111132448|NCT02589665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111132449|NCT02589665|Analgesics|analgesics|mesh-ancestor
111132450|NCT02589665|Sensory System Agents|sensory system agents|mesh-ancestor
111132451|NCT02589665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111132452|NCT02589665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111132453|NCT02589665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111132454|NCT02589665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111132455|NCT02589665|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111132456|NCT02589665|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111132457|NCT01697527|Aldesleukin|aldesleukin|mesh-list
111132458|NCT01697527|Cyclophosphamide|cyclophosphamide|mesh-list
111132459|NCT01697527|Fludarabine|fludarabine|mesh-list
111132460|NCT01697527|Fludarabine phosphate|fludarabine phosphate|mesh-list
111132461|NCT01697527|Interleukin-2|interleukin-2|mesh-list
111132462|NCT01697527|Vaccines|vaccines|mesh-list
111132463|NCT01697527|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
111132464|NCT01697527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111132465|NCT01697527|Immunologic Factors|immunologic factors|mesh-ancestor
111132466|NCT01697527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111132467|NCT01697527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111132468|NCT01697527|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111132469|NCT01697527|Alkylating Agents|alkylating agents|mesh-ancestor
111132470|NCT01697527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111132471|NCT01697527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111132472|NCT01697527|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111132473|NCT01697527|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111132474|NCT01697527|Antimetabolites|antimetabolites|mesh-ancestor
111132475|NCT01697527|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111132476|NCT01697527|Analgesics|analgesics|mesh-ancestor
111132477|NCT01697527|Sensory System Agents|sensory system agents|mesh-ancestor
111132478|NCT01697527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111132479|NCT01697527|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111132480|NCT01697527|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111132481|NCT01697527|Antiviral Agents|antiviral agents|mesh-ancestor
111132482|NCT01697527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111132483|NCT01697527|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111132484|NCT04426409|Ofloxacin|ofloxacin|mesh-list
111132485|NCT04426409|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111132486|NCT04426409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111132487|NCT04426409|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111132488|NCT04426409|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110676987|NCT03233724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111132489|NCT04426409|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111132490|NCT04426409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111132491|NCT04426409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110587417|NCT00435409|Capecitabine|capecitabine|mesh-list
111132492|NCT04426409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111132493|NCT04426409|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111132494|NCT04426409|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111132495|NCT04426097|Iodine|iodine|mesh-list
111132496|NCT04426097|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111132497|NCT04426097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111132498|NCT04426097|Trace Elements|trace elements|mesh-ancestor
111132499|NCT04426097|Micronutrients|micronutrients|mesh-ancestor
111132500|NCT04426097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111132501|NCT05556083|Sildenafil Citrate|sildenafil citrate|mesh-list
111132502|NCT05556083|Vasodilator Agents|vasodilator agents|mesh-ancestor
111132503|NCT05556083|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111132504|NCT05556083|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111132505|NCT05556083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111132506|NCT05556083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111132507|NCT05556083|Urological Agents|urological agents|mesh-ancestor
111132508|NCT05556005|Trimetazidine|trimetazidine|mesh-list
111132509|NCT05556005|Vasodilator Agents|vasodilator agents|mesh-ancestor
111132510|NCT04373603|Tranexamic Acid|tranexamic acid|mesh-list
111132511|NCT04373603|Hyaluronic Acid|hyaluronic acid|mesh-list
111132512|NCT04373603|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111132513|NCT04373603|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111132514|NCT04373603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111132515|NCT04373603|Hemostatics|hemostatics|mesh-ancestor
111132516|NCT04373603|Coagulants|coagulants|mesh-ancestor
111132517|NCT04373603|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111132518|NCT04373603|Immunologic Factors|immunologic factors|mesh-ancestor
111132519|NCT04373603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111132520|NCT04373603|Viscosupplements|viscosupplements|mesh-ancestor
111132521|NCT04373603|Protective Agents|protective agents|mesh-ancestor
111132522|NCT02519595|Ketamine|ketamine|mesh-list
111132523|NCT02519595|Analgesics|analgesics|mesh-ancestor
111132524|NCT02519595|Sensory System Agents|sensory system agents|mesh-ancestor
111132525|NCT02519595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111132526|NCT02519595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111132527|NCT02519595|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111132528|NCT02519595|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111132529|NCT02519595|Anesthetics, General|anesthetics, general|mesh-ancestor
111132530|NCT02519595|Anesthetics|anesthetics|mesh-ancestor
111132531|NCT02519595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111132532|NCT02519595|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111132533|NCT02519595|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111132534|NCT02519595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111132535|NCT02519595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111132536|NCT04278755|Drospirenone|drospirenone|mesh-list
111132537|NCT04278755|Ethinyl Estradiol|ethinyl estradiol|mesh-list
111132538|NCT04278755|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
111132539|NCT04278755|Estradiol|estradiol|mesh-list
111132540|NCT04278755|Estrogens|estrogens|mesh-ancestor
111132541|NCT04278755|Hormones|hormones|mesh-ancestor
111132542|NCT04278755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111132543|NCT04278755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111132544|NCT04278755|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111132545|NCT04278755|Contraceptive Agents|contraceptive agents|mesh-ancestor
111132546|NCT04278755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111132547|NCT04278755|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111132548|NCT04278755|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111132549|NCT04278755|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111132550|NCT04278755|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
111132551|NCT04278755|Hormone Antagonists|hormone antagonists|mesh-ancestor
111132552|NCT04278755|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
111132553|NCT04278755|Diuretics|diuretics|mesh-ancestor
111132554|NCT04278755|Natriuretic Agents|natriuretic agents|mesh-ancestor
111132555|NCT04277975|Analgesics, Opioid|analgesics, opioid|mesh-list
111132556|NCT04277975|Narcotics|narcotics|mesh-ancestor
111132557|NCT04277975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111132558|NCT04277975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111132559|NCT04277975|Analgesics|analgesics|mesh-ancestor
111132560|NCT04277975|Sensory System Agents|sensory system agents|mesh-ancestor
110849588|NCT03346096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111132561|NCT04277975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111132562|NCT04062695|Tofacitinib|tofacitinib|mesh-list
111132563|NCT04062695|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
111132564|NCT04062695|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111132565|NCT04062695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111132566|NCT04062695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111132567|NCT04330079|Dapagliflozin|dapagliflozin|mesh-list
111132568|NCT04330079|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111132569|NCT04330079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111132570|NCT04330079|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111132571|NCT04330079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111132573|NCT00660673|Carbidopa|carbidopa|mesh-list
111132574|NCT00660673|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
111132575|NCT00660673|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111132576|NCT00660673|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111132577|NCT00660673|Dopamine Agents|dopamine agents|mesh-ancestor
111132578|NCT00660673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111132579|NCT00660673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111132580|NCT00660673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111132581|NCT00660673|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
111132582|NCT00660673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111132583|NCT00660673|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111132584|NCT00660673|Immunologic Factors|immunologic factors|mesh-ancestor
111132585|NCT00660673|Dopamine Agonists|dopamine agonists|mesh-ancestor
111132586|NCT03644381|Immunomodulating Agents|immunomodulating agents|mesh-list
111132587|NCT03644381|Immunologic Factors|immunologic factors|mesh-ancestor
111132588|NCT03644381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111132589|NCT05612711|Dronabinol|dronabinol|mesh-list
111132590|NCT05612711|Hallucinogens|hallucinogens|mesh-ancestor
111132591|NCT05612711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111132592|NCT05612711|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111132593|NCT05612711|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111132594|NCT05612711|Analgesics|analgesics|mesh-ancestor
111132595|NCT05612711|Sensory System Agents|sensory system agents|mesh-ancestor
111132596|NCT05612711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111132597|NCT05612711|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
111132598|NCT05612711|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
111132599|NCT05612711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111132600|NCT05612711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111132601|NCT05612711|Hormones|hormones|mesh-ancestor
111132602|NCT05612711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111132603|NCT04807309|Danazol|danazol|mesh-list
111132604|NCT04807309|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111132605|NCT04807309|Hormone Antagonists|hormone antagonists|mesh-ancestor
111132606|NCT04807309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111132607|NCT04807309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111132608|NCT04744649|Fluorouracil|fluorouracil|mesh-list
111132609|NCT04744649|Antimetabolites|antimetabolites|mesh-ancestor
111132610|NCT04744649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111132611|NCT04744649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111132612|NCT04744649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111132613|NCT04744649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111132614|NCT04744649|Immunologic Factors|immunologic factors|mesh-ancestor
111132615|NCT04744649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111132616|NCT04426955|Paclitaxel|paclitaxel|mesh-list
111132617|NCT04426955|Cisplatin|cisplatin|mesh-list
111132618|NCT04426955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111132619|NCT04426955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111132620|NCT04426955|Tubulin Modulators|tubulin modulators|mesh-ancestor
111132621|NCT04426955|Antimitotic Agents|antimitotic agents|mesh-ancestor
111132622|NCT04426955|Mitosis Modulators|mitosis modulators|mesh-ancestor
111132623|NCT04426955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111132624|NCT02630563|Cyclosporine|cyclosporine|mesh-list
111132625|NCT02630563|Mycophenolic Acid|mycophenolic acid|mesh-list
111132626|NCT02630563|Cyclosporins|cyclosporins|mesh-list
111132627|NCT02630563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111132628|NCT02630563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111132629|NCT02630563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111132630|NCT02630563|Immunologic Factors|immunologic factors|mesh-ancestor
111132631|NCT02630563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111132632|NCT02630563|Antifungal Agents|antifungal agents|mesh-ancestor
111132633|NCT02630563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111132634|NCT02630563|Dermatologic Agents|dermatologic agents|mesh-ancestor
111132635|NCT02630563|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111132636|NCT02630563|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111132637|NCT02630563|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111132638|NCT02630563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111132639|NCT02630563|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111132640|NCT02630563|Antitubercular Agents|antitubercular agents|mesh-ancestor
111132641|NCT02630563|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111132642|NCT05700695|Lactulose|lactulose|mesh-list
111132643|NCT05700695|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111132644|NCT05555147|Ropivacaine|ropivacaine|mesh-list
111132645|NCT05555147|Anesthetics, Local|anesthetics, local|mesh-ancestor
111132646|NCT05555147|Anesthetics|anesthetics|mesh-ancestor
111132647|NCT05555147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111132648|NCT05555147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111132649|NCT05555147|Sensory System Agents|sensory system agents|mesh-ancestor
111132650|NCT05555147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111132651|NCT02587247|Antibodies|antibodies|mesh-list
111132652|NCT02587247|Immunologic Factors|immunologic factors|mesh-ancestor
111132653|NCT02587247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111132654|NCT02555111|Rivaroxaban|rivaroxaban|mesh-list
111132655|NCT02555111|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111132656|NCT02555111|Antithrombins|antithrombins|mesh-ancestor
111132657|NCT02555111|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111132658|NCT02555111|Protease Inhibitors|protease inhibitors|mesh-ancestor
111132659|NCT02555111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111132660|NCT02555111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111132661|NCT02555111|Anticoagulants|anticoagulants|mesh-ancestor
111132662|NCT02521415|Acetaminophen|acetaminophen|mesh-list
111132663|NCT02521415|Ibuprofen|ibuprofen|mesh-list
111132664|NCT02521415|Fentanyl|fentanyl|mesh-list
111132665|NCT02521415|Ketamine|ketamine|mesh-list
111132666|NCT02521415|Analgesics|analgesics|mesh-list
111132667|NCT02521415|Sensory System Agents|sensory system agents|mesh-ancestor
111132668|NCT02521415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111132669|NCT02521415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111132670|NCT02521415|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111132671|NCT02521415|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111132672|NCT02521415|Anesthetics, General|anesthetics, general|mesh-ancestor
111132673|NCT02521415|Anesthetics|anesthetics|mesh-ancestor
111132674|NCT02521415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111132675|NCT02521415|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111132676|NCT02521415|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111132677|NCT02521415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111132678|NCT02521415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111132679|NCT02521415|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111132680|NCT02521415|Narcotics|narcotics|mesh-ancestor
111132681|NCT02521415|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111132682|NCT02521415|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111132683|NCT02521415|Antipyretics|antipyretics|mesh-ancestor
111132684|NCT02521415|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111132685|NCT02521415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111132686|NCT02521415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111132687|NCT02521415|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111132688|NCT02521415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111132689|NCT02078141|Deoxyglucose|deoxyglucose|mesh-list
111132690|NCT02078141|Antimetabolites|antimetabolites|mesh-ancestor
111132691|NCT02078141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111132692|NCT02078141|Antiviral Agents|antiviral agents|mesh-ancestor
111132693|NCT02078141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111132694|NCT02588339|Sirolimus|sirolimus|mesh-list
111132695|NCT02588339|Panobinostat|panobinostat|mesh-list
111132696|NCT02588339|Tacrolimus|tacrolimus|mesh-list
111132697|NCT02588339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111132698|NCT02588339|Immunologic Factors|immunologic factors|mesh-ancestor
111132699|NCT02588339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111132700|NCT02588339|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111132701|NCT02588339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111132702|NCT02588339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111132703|NCT02588339|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111132704|NCT02588339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111132705|NCT02588339|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111132706|NCT02588339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111132707|NCT02588339|Antifungal Agents|antifungal agents|mesh-ancestor
111132708|NCT02588339|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111132710|NCT01752491|Temozolomide|temozolomide|mesh-list
110849737|NCT01078454|Dexamethasone|dexamethasone|mesh-list
111132711|NCT01752491|Vitamins|vitamins|mesh-ancestor
111132712|NCT01752491|Micronutrients|micronutrients|mesh-ancestor
111132713|NCT01752491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111132714|NCT01752491|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111132715|NCT01752491|Alkylating Agents|alkylating agents|mesh-ancestor
111132716|NCT01752491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111132717|NCT01752491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111132718|NCT01752491|Antioxidants|antioxidants|mesh-ancestor
111132719|NCT01752491|Protective Agents|protective agents|mesh-ancestor
111132720|NCT05554055|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
111132721|NCT05554055|Dalteparin|dalteparin|mesh-list
111132722|NCT05554055|Anticoagulants|anticoagulants|mesh-ancestor
111132723|NCT05554055|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111132724|NCT05554055|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111132725|NCT05554055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111132726|NCT05700617|Dobutamine|dobutamine|mesh-list
111132727|NCT05700617|Milrinone|milrinone|mesh-list
111132728|NCT05700617|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111132729|NCT05700617|Sympathomimetics|sympathomimetics|mesh-ancestor
111132730|NCT05700617|Autonomic Agents|autonomic agents|mesh-ancestor
111132731|NCT05700617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111132732|NCT05700617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110837671|NCT03319953|Antipsychotic Agents|antipsychotic agents|mesh-list
111132733|NCT05700617|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
111132734|NCT05700617|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111132735|NCT05700617|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111132736|NCT05700617|Adrenergic Agents|adrenergic agents|mesh-ancestor
111132737|NCT05700617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110587477|NCT04070001|Ibuprofen|ibuprofen|mesh-list
111132738|NCT05700617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111132739|NCT05700617|Protective Agents|protective agents|mesh-ancestor
111132740|NCT05700617|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111132741|NCT05700617|Vasodilator Agents|vasodilator agents|mesh-ancestor
111132742|NCT05700617|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
111132743|NCT05700617|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111132744|NCT05700617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111132745|NCT05553743|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111132746|NCT05553743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111132747|NCT05553665|Lidocaine|lidocaine|mesh-list
111132748|NCT05553665|Fentanyl|fentanyl|mesh-list
111132749|NCT05553665|Midazolam|midazolam|mesh-list
111132750|NCT05553665|Complement System Proteins|complement system proteins|mesh-list
111132751|NCT05553665|Complement C4|complement c4|mesh-list
111132752|NCT05553665|Anesthetics, Local|anesthetics, local|mesh-ancestor
111132753|NCT05553665|Anesthetics|anesthetics|mesh-ancestor
111132754|NCT05553665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111132755|NCT05553665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111132756|NCT05553665|Sensory System Agents|sensory system agents|mesh-ancestor
111132757|NCT05553665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111132758|NCT05553665|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111132759|NCT05553665|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111132760|NCT05553665|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111132761|NCT05553665|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111132762|NCT05553665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111132763|NCT05553665|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111132764|NCT05553665|Narcotics|narcotics|mesh-ancestor
111132765|NCT05553665|Analgesics|analgesics|mesh-ancestor
111132766|NCT05553665|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111132767|NCT05553665|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111132768|NCT05553665|Anesthetics, General|anesthetics, general|mesh-ancestor
111132769|NCT05553665|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111132770|NCT05553665|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111132771|NCT05553665|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111132772|NCT05553665|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111132773|NCT05553665|GABA Modulators|gaba modulators|mesh-ancestor
111132774|NCT05553665|GABA Agents|gaba agents|mesh-ancestor
111132775|NCT05553665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111132776|NCT05553665|Immunologic Factors|immunologic factors|mesh-ancestor
111132777|NCT02629159|Adalimumab|adalimumab|mesh-list
111132778|NCT02629159|Upadacitinib|upadacitinib|mesh-list
111132779|NCT02629159|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111132780|NCT02629159|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111132781|NCT02629159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111132782|NCT02629159|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
111132783|NCT02629159|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111132784|NCT02629159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111132785|NCT02629159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111132786|NCT02628769|Solithromycin|solithromycin|mesh-list
111132787|NCT02628769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111132788|NCT02628769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111132789|NCT05552807|Paclitaxel|paclitaxel|mesh-list
111132790|NCT05552807|Docetaxel|docetaxel|mesh-list
111132791|NCT05552807|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111132792|NCT05552807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111132793|NCT05552807|Tubulin Modulators|tubulin modulators|mesh-ancestor
111132794|NCT05552807|Antimitotic Agents|antimitotic agents|mesh-ancestor
111132795|NCT05552807|Mitosis Modulators|mitosis modulators|mesh-ancestor
111132796|NCT05552807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111132797|NCT05552729|Vitamin D|vitamin d|mesh-list
111132798|NCT05552729|Ergocalciferols|ergocalciferols|mesh-list
111132799|NCT05552729|Cholecalciferol|cholecalciferol|mesh-list
111132800|NCT05552729|Vitamins|vitamins|mesh-list
111132801|NCT05552729|Micronutrients|micronutrients|mesh-ancestor
111132802|NCT05552729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111132803|NCT05552729|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111132804|NCT05552729|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111132805|NCT05699993|Itraconazole|itraconazole|mesh-list
111132806|NCT05699993|Dextromethorphan|dextromethorphan|mesh-list
111132807|NCT05699993|Antifungal Agents|antifungal agents|mesh-ancestor
111132808|NCT05699993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111132809|NCT05699993|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111132810|NCT05699993|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111132811|NCT05699993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111132812|NCT05699993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111132813|NCT05699993|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111132814|NCT05699993|Hormone Antagonists|hormone antagonists|mesh-ancestor
111132815|NCT05699993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111132816|NCT05699993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111132817|NCT05699993|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111132818|NCT05699993|Antitussive Agents|antitussive agents|mesh-ancestor
111132819|NCT05699993|Respiratory System Agents|respiratory system agents|mesh-ancestor
111132820|NCT05699993|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111132821|NCT05699993|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111132822|NCT05699993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111132823|NCT05552651|Paclitaxel|paclitaxel|mesh-list
111132824|NCT05552651|Carboplatin|carboplatin|mesh-list
111132825|NCT05552651|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111132826|NCT05552651|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111132827|NCT05552651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111132828|NCT05552651|Tubulin Modulators|tubulin modulators|mesh-ancestor
111132829|NCT05552651|Antimitotic Agents|antimitotic agents|mesh-ancestor
111132830|NCT05552651|Mitosis Modulators|mitosis modulators|mesh-ancestor
111132831|NCT05552651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111132832|NCT04981327|Apixaban|apixaban|mesh-list
111132833|NCT04981327|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111132834|NCT04981327|Antithrombins|antithrombins|mesh-ancestor
111132835|NCT04981327|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111132836|NCT04981327|Protease Inhibitors|protease inhibitors|mesh-ancestor
111132837|NCT04981327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111132838|NCT04981327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111132839|NCT04981327|Anticoagulants|anticoagulants|mesh-ancestor
111132840|NCT05547659|Acetaminophen|acetaminophen|mesh-list
111132841|NCT05547659|Celecoxib|celecoxib|mesh-list
111132842|NCT05547659|Pregabalin|pregabalin|mesh-list
110587511|NCT02570841|Capsaicin|capsaicin|mesh-list
111132843|NCT05547659|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111132844|NCT05547659|Analgesics|analgesics|mesh-ancestor
111132845|NCT05547659|Sensory System Agents|sensory system agents|mesh-ancestor
111132846|NCT05547659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111132847|NCT05547659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111132848|NCT05547659|Antipyretics|antipyretics|mesh-ancestor
111132849|NCT05547659|Anticonvulsants|anticonvulsants|mesh-ancestor
111132850|NCT05547659|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111132851|NCT05547659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111132852|NCT05547659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111132853|NCT05547659|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111132854|NCT05547659|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111132855|NCT05547659|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111132856|NCT05547659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111132857|NCT05547659|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111132858|NCT05547659|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111132859|NCT05547659|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111132860|NCT05547659|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111132861|NCT05547659|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111132862|NCT05547659|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111132863|NCT05547659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111132864|NCT05541419|Budesonide|budesonide|mesh-list
111132865|NCT05541419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111132866|NCT05541419|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111132867|NCT05541419|Autonomic Agents|autonomic agents|mesh-ancestor
111132868|NCT05541419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111132869|NCT05541419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111132870|NCT05541419|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111132871|NCT05541419|Respiratory System Agents|respiratory system agents|mesh-ancestor
111132872|NCT05541419|Glucocorticoids|glucocorticoids|mesh-ancestor
111132873|NCT05541419|Hormones|hormones|mesh-ancestor
111132874|NCT05541419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111132875|NCT05546879|Bevacizumab|bevacizumab|mesh-list
111132876|NCT05546879|Atezolizumab|atezolizumab|mesh-list
110587535|NCT04956627|Anticonvulsants|anticonvulsants|mesh-ancestor
111132877|NCT05546879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111132878|NCT05546879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111132879|NCT05546879|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111132880|NCT05546879|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111132881|NCT05546879|Growth Substances|growth substances|mesh-ancestor
111132882|NCT05546879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111132883|NCT05546879|Growth Inhibitors|growth inhibitors|mesh-ancestor
111132884|NCT05546879|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111132885|NCT05546879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111132886|NCT05541185|Naproxen|naproxen|mesh-list
111132887|NCT05541185|Lidocaine|lidocaine|mesh-list
111132888|NCT05541185|Anesthetics, Local|anesthetics, local|mesh-ancestor
111132889|NCT05541185|Anesthetics|anesthetics|mesh-ancestor
111132890|NCT05541185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111132891|NCT05541185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111132892|NCT05541185|Sensory System Agents|sensory system agents|mesh-ancestor
111132893|NCT05541185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111132894|NCT05541185|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111132895|NCT05541185|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111132896|NCT05541185|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111132897|NCT05541185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111132898|NCT05541185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111132899|NCT05541185|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111132900|NCT05541185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111132901|NCT05541185|Analgesics|analgesics|mesh-ancestor
111132902|NCT05541185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111132903|NCT05541185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111132904|NCT05541185|Gout Suppressants|gout suppressants|mesh-ancestor
111132905|NCT05541185|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111132906|NCT05541185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111132907|NCT02518113|Dexamethasone|dexamethasone|mesh-list
111132908|NCT02518113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111132909|NCT02518113|Antiemetics|antiemetics|mesh-ancestor
111132910|NCT02518113|Autonomic Agents|autonomic agents|mesh-ancestor
111132911|NCT02518113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111132912|NCT02518113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111132913|NCT02518113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111132914|NCT02518113|Glucocorticoids|glucocorticoids|mesh-ancestor
111132916|NCT02518113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111132917|NCT02518113|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111132918|NCT02518113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111132919|NCT05541107|Amphotericin B|amphotericin b|mesh-list
111132920|NCT05541107|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
111132921|NCT05541107|Amebicides|amebicides|mesh-ancestor
111132922|NCT05541107|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111132923|NCT05541107|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111132924|NCT05541107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111132925|NCT05541107|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111132926|NCT05541107|Antifungal Agents|antifungal agents|mesh-ancestor
111132927|NCT03062839|Melatonin|melatonin|mesh-list
111132928|NCT03062839|Antioxidants|antioxidants|mesh-ancestor
111132929|NCT03062839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111132930|NCT03062839|Protective Agents|protective agents|mesh-ancestor
111132931|NCT03062839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111132932|NCT03062839|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111132933|NCT05540951|Bevacizumab|bevacizumab|mesh-list
111132934|NCT05540951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111132935|NCT05540951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111132936|NCT05540951|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111132937|NCT05540951|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110849968|NCT03599089|Analgesics|analgesics|mesh-ancestor
111132938|NCT05540951|Growth Substances|growth substances|mesh-ancestor
111132939|NCT05540951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111132940|NCT05540951|Growth Inhibitors|growth inhibitors|mesh-ancestor
111132942|NCT04981093|Dexamethasone acetate|dexamethasone acetate|mesh-list
111132943|NCT04981093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111132944|NCT04981093|Antiemetics|antiemetics|mesh-ancestor
111132945|NCT04981093|Autonomic Agents|autonomic agents|mesh-ancestor
111132946|NCT04981093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111132947|NCT04981093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111132948|NCT04981093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111132949|NCT04981093|Glucocorticoids|glucocorticoids|mesh-ancestor
111132950|NCT04981093|Hormones|hormones|mesh-ancestor
111132951|NCT04981093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111132952|NCT04981093|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111132953|NCT04981093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111132954|NCT05551247|Endostatins|endostatins|mesh-list
111132955|NCT05551247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111132956|NCT05551247|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111132957|NCT05551247|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111132958|NCT05551247|Growth Substances|growth substances|mesh-ancestor
111132959|NCT05551247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111132960|NCT05551247|Growth Inhibitors|growth inhibitors|mesh-ancestor
111132961|NCT05540483|Disitamab vedotin|disitamab vedotin|mesh-list
111132962|NCT05540483|Immunoconjugates|immunoconjugates|mesh-ancestor
111132963|NCT05540483|Immunologic Factors|immunologic factors|mesh-ancestor
111132964|NCT05540483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111132965|NCT02629861|Calcitonin|calcitonin|mesh-list
111132966|NCT02629861|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
111132967|NCT02629861|Katacalcin|katacalcin|mesh-list
111132968|NCT02629861|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111132969|NCT02629861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111132970|NCT02629861|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111132971|NCT02629861|Vasodilator Agents|vasodilator agents|mesh-ancestor
111132972|NCT02513823|Vitamin D|vitamin d|mesh-list
111132973|NCT02513823|Cholecalciferol|cholecalciferol|mesh-list
111132974|NCT02513823|Vitamins|vitamins|mesh-ancestor
111132975|NCT02513823|Micronutrients|micronutrients|mesh-ancestor
111132976|NCT02513823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111132977|NCT02513823|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111132978|NCT02513823|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111132979|NCT05545475|Heparin|heparin|mesh-list
111132980|NCT05545475|Enoxaparin|enoxaparin|mesh-list
111132981|NCT05545475|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
111132982|NCT05545475|Tinzaparin|tinzaparin|mesh-list
111132983|NCT05545475|Dalteparin|dalteparin|mesh-list
111132984|NCT05545475|Nadroparin|nadroparin|mesh-list
111132985|NCT05545475|Warfarin|warfarin|mesh-list
111132986|NCT05545475|Anticoagulants|anticoagulants|mesh-ancestor
111132987|NCT05545475|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111132988|NCT05545475|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111132989|NCT05545475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111132990|NCT05545397|Propofol|propofol|mesh-list
111132991|NCT05545397|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111132992|NCT05545397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111132993|NCT05545397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111132994|NCT05545397|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111132995|NCT05545397|Anesthetics, General|anesthetics, general|mesh-ancestor
111132996|NCT05545397|Anesthetics|anesthetics|mesh-ancestor
111132997|NCT04952727|Vaccines|vaccines|mesh-list
111132998|NCT04952727|Immunologic Factors|immunologic factors|mesh-ancestor
111132999|NCT04952727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111133000|NCT04433143|Minocycline|minocycline|mesh-list
111133001|NCT04433143|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111133002|NCT04433143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111133003|NCT01665911|Listerine|listerine|mesh-list
111133004|NCT01665911|Fluorides|fluorides|mesh-list
111133005|NCT01665911|Sodium Fluoride|sodium fluoride|mesh-list
111133006|NCT01665911|Cariostatic Agents|cariostatic agents|mesh-ancestor
111133007|NCT01665911|Protective Agents|protective agents|mesh-ancestor
111133008|NCT01665911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111133009|NCT01665911|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111133010|NCT01665911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111133011|NCT03063073|Dexmedetomidine|dexmedetomidine|mesh-list
111133012|NCT03063073|Bupivacaine|bupivacaine|mesh-list
110850041|NCT01202435|Pregabalin|pregabalin|mesh-list
111133013|NCT03063073|Anesthetics, Local|anesthetics, local|mesh-ancestor
111133014|NCT03063073|Anesthetics|anesthetics|mesh-ancestor
111133015|NCT03063073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111133016|NCT03063073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111133017|NCT03063073|Sensory System Agents|sensory system agents|mesh-ancestor
110837786|NCT03110510|Levoleucovorin|levoleucovorin|mesh-list
111133018|NCT03063073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111133019|NCT03063073|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111133020|NCT03063073|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111133021|NCT03063073|Analgesics|analgesics|mesh-ancestor
111133022|NCT03063073|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111133023|NCT03063073|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111133024|NCT03063073|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111133025|NCT03063073|Adrenergic Agents|adrenergic agents|mesh-ancestor
111133026|NCT03063073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111133027|NCT03063073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111133028|NCT04620733|Seladelpar|seladelpar|mesh-list
111133029|NCT04620733|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111133030|NCT04620733|Antimetabolites|antimetabolites|mesh-ancestor
111133031|NCT04620733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111133032|NCT04620733|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111133033|NCT02476617|Ritonavir|ritonavir|mesh-list
111133034|NCT02476617|Ribavirin|ribavirin|mesh-list
111133035|NCT02476617|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111133036|NCT02476617|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111133037|NCT02476617|Protease Inhibitors|protease inhibitors|mesh-ancestor
111133038|NCT02476617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111133039|NCT02476617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111133040|NCT02476617|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111133041|NCT02476617|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111133042|NCT02476617|Antiviral Agents|antiviral agents|mesh-ancestor
111133043|NCT02476617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111133044|NCT02476617|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111133045|NCT02476617|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111133046|NCT02476617|Antimetabolites|antimetabolites|mesh-ancestor
111133047|NCT04428307|Artemisinins|artemisinins|mesh-list
111133048|NCT04428307|Artemisinin|artemisinin|mesh-list
111133049|NCT04428307|Antimalarials|antimalarials|mesh-ancestor
111133050|NCT04428307|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111133051|NCT04428307|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111133052|NCT04428307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111133053|NCT05535725|Vancomycin|vancomycin|mesh-list
111133054|NCT05535725|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111133055|NCT05535725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111133056|NCT05535569|Paclitaxel|paclitaxel|mesh-list
111133057|NCT05535569|Nivolumab|nivolumab|mesh-list
111133058|NCT05535569|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111133059|NCT05535569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111133060|NCT05535569|Tubulin Modulators|tubulin modulators|mesh-ancestor
111133061|NCT05535569|Antimitotic Agents|antimitotic agents|mesh-ancestor
111133062|NCT05535569|Mitosis Modulators|mitosis modulators|mesh-ancestor
111133063|NCT05535569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111133064|NCT05535569|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111133065|NCT05535569|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111133066|NCT03822871|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
111133067|NCT03822871|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111133068|NCT03822871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111133069|NCT03064165|Epinephrine|epinephrine|mesh-list
111133070|NCT03064165|Bupivacaine|bupivacaine|mesh-list
111133071|NCT03064165|Anesthetics, Local|anesthetics, local|mesh-ancestor
111133072|NCT03064165|Anesthetics|anesthetics|mesh-ancestor
111133073|NCT03064165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111133074|NCT03064165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111133075|NCT03064165|Sensory System Agents|sensory system agents|mesh-ancestor
111133076|NCT03064165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111133077|NCT03064165|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111133078|NCT03064165|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111133079|NCT03064165|Adrenergic Agents|adrenergic agents|mesh-ancestor
111133080|NCT03064165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111133081|NCT03064165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111133082|NCT03064165|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110837806|NCT03319719|Lidocaine|lidocaine|mesh-list
111133083|NCT03064165|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111133084|NCT03064165|Autonomic Agents|autonomic agents|mesh-ancestor
111133085|NCT03064165|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111133086|NCT03064165|Respiratory System Agents|respiratory system agents|mesh-ancestor
111133087|NCT03064165|Mydriatics|mydriatics|mesh-ancestor
111133088|NCT03064165|Sympathomimetics|sympathomimetics|mesh-ancestor
111133089|NCT03064165|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111133090|NCT05535413|Capecitabine|capecitabine|mesh-list
111133091|NCT05535413|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111133092|NCT05535413|Antimetabolites|antimetabolites|mesh-ancestor
111133093|NCT05535413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111133094|NCT05535413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111133095|NCT03813199|Methotrexate|methotrexate|mesh-list
111133096|NCT03813199|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111133097|NCT03813199|Abortifacient Agents|abortifacient agents|mesh-ancestor
111133098|NCT03813199|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111133099|NCT03813199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111133100|NCT03813199|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111133101|NCT03813199|Antimetabolites|antimetabolites|mesh-ancestor
111133102|NCT03813199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111133103|NCT03813199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111133104|NCT03813199|Dermatologic Agents|dermatologic agents|mesh-ancestor
111133105|NCT03813199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111133106|NCT03813199|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111133107|NCT03813199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111133108|NCT03813199|Immunologic Factors|immunologic factors|mesh-ancestor
111133109|NCT03813199|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111133110|NCT03813199|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111133111|NCT05699135|Avelumab|avelumab|mesh-list
111133112|NCT05699135|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111133113|NCT05699135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111133114|NCT03791593|Evolocumab|evolocumab|mesh-list
111133115|NCT03791593|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
111133116|NCT03791593|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111133117|NCT03791593|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111133118|NCT03791593|Antimetabolites|antimetabolites|mesh-ancestor
111133119|NCT03791593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111133120|NCT03791593|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111133121|NCT03791593|Protease Inhibitors|protease inhibitors|mesh-ancestor
111133122|NCT03791593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111133123|NCT03791593|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111133124|NCT03064243|Apatinib|apatinib|mesh-list
111133125|NCT03064243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111133126|NCT03064243|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111133127|NCT03064243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111133128|NCT03064243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111133129|NCT03765619|Aspirin|aspirin|mesh-list
111133130|NCT03765619|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111133131|NCT03765619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111133132|NCT03765619|Analgesics|analgesics|mesh-ancestor
111133133|NCT03765619|Sensory System Agents|sensory system agents|mesh-ancestor
111133134|NCT03765619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111133135|NCT03765619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111133136|NCT03765619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111133137|NCT03765619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111133138|NCT03765619|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111133139|NCT03765619|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111133140|NCT03765619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111133141|NCT03765619|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111133142|NCT03765619|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111133143|NCT03765619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111133144|NCT03765619|Antipyretics|antipyretics|mesh-ancestor
111133145|NCT05543603|Chlorhexidine|chlorhexidine|mesh-list
111133146|NCT05543603|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
111133147|NCT05543603|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111133148|NCT05543603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111133149|NCT05543603|Disinfectants|disinfectants|mesh-ancestor
111133150|NCT05543603|Dermatologic Agents|dermatologic agents|mesh-ancestor
111133151|NCT04979923|Lidocaine|lidocaine|mesh-list
111133152|NCT04979923|Anesthetics, Local|anesthetics, local|mesh-ancestor
111133153|NCT04979923|Anesthetics|anesthetics|mesh-ancestor
111133154|NCT04979923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111133155|NCT04979923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111133156|NCT04979923|Sensory System Agents|sensory system agents|mesh-ancestor
111133157|NCT04979923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111133158|NCT04979923|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111133159|NCT04979923|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111133160|NCT04979923|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111133161|NCT04979923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110587768|NCT00727077|Interferon alpha-2|interferon alpha-2|mesh-list
111133162|NCT04979923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111133163|NCT03706885|Efavirenz|efavirenz|mesh-list
111133164|NCT03706885|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111133165|NCT03706885|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111133166|NCT03706885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111133167|NCT03706885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111133168|NCT03706885|Antiviral Agents|antiviral agents|mesh-ancestor
111133169|NCT03706885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111133170|NCT03706885|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111133171|NCT03706885|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111133172|NCT03706885|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111133173|NCT03706885|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111133174|NCT03706885|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111133175|NCT03706885|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111133176|NCT01665599|Testosterone|testosterone|mesh-list
111133177|NCT01665599|Androgens|androgens|mesh-ancestor
111133178|NCT01665599|Hormones|hormones|mesh-ancestor
111133179|NCT01665599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111133180|NCT01665599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111133181|NCT04979221|Cyproheptadine|cyproheptadine|mesh-list
111133182|NCT04979221|Antipruritics|antipruritics|mesh-ancestor
111133183|NCT04979221|Dermatologic Agents|dermatologic agents|mesh-ancestor
111133184|NCT04979221|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111133185|NCT04979221|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111133186|NCT04979221|Histamine Antagonists|histamine antagonists|mesh-ancestor
111133187|NCT04979221|Histamine Agents|histamine agents|mesh-ancestor
111133188|NCT04979221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111133189|NCT04979221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111133190|NCT04979221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111133191|NCT04979221|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111133192|NCT04979221|Serotonin Agents|serotonin agents|mesh-ancestor
111133193|NCT04979221|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111133194|NCT05697809|Dexamethasone|dexamethasone|mesh-list
111133195|NCT05697809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111133196|NCT05697809|Antiemetics|antiemetics|mesh-ancestor
111133197|NCT05697809|Autonomic Agents|autonomic agents|mesh-ancestor
111133198|NCT05697809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111133199|NCT05697809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111133200|NCT05697809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111133201|NCT05697809|Glucocorticoids|glucocorticoids|mesh-ancestor
111133202|NCT05697809|Hormones|hormones|mesh-ancestor
111133203|NCT05697809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111133204|NCT05697809|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111133205|NCT05697809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111133206|NCT03980483|Methotrexate|methotrexate|mesh-list
111133207|NCT03980483|Tofacitinib|tofacitinib|mesh-list
111133208|NCT03980483|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111133209|NCT03980483|Abortifacient Agents|abortifacient agents|mesh-ancestor
111133210|NCT03980483|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111133211|NCT03980483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111133212|NCT03980483|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111133213|NCT03980483|Antimetabolites|antimetabolites|mesh-ancestor
111133214|NCT03980483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111133215|NCT03980483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111133216|NCT03980483|Dermatologic Agents|dermatologic agents|mesh-ancestor
111133217|NCT03980483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111133218|NCT03980483|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111133219|NCT03980483|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111133220|NCT03980483|Immunologic Factors|immunologic factors|mesh-ancestor
111133221|NCT03980483|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111133222|NCT03980483|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111133223|NCT03980483|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
111133224|NCT03980483|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111133225|NCT03063775|Fibrin Foam|fibrin foam|mesh-list
111133226|NCT03063775|Hemostatics|hemostatics|mesh-ancestor
111133227|NCT03063775|Coagulants|coagulants|mesh-ancestor
111133228|NCT03063541|Aspirin|aspirin|mesh-list
111133229|NCT03063541|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111133230|NCT03063541|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111133231|NCT03063541|Analgesics|analgesics|mesh-ancestor
111133232|NCT03063541|Sensory System Agents|sensory system agents|mesh-ancestor
111133233|NCT03063541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111133234|NCT03063541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111133235|NCT03063541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111133236|NCT03063541|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111133237|NCT03063541|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111133238|NCT03063541|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111133239|NCT03063541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111133240|NCT03063541|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111133241|NCT03063541|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111133242|NCT03063541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111133243|NCT03063541|Antipyretics|antipyretics|mesh-ancestor
111133244|NCT04978597|Opicapone|opicapone|mesh-list
111133245|NCT04978597|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
111133246|NCT04978597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111133247|NCT04978597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111133248|NCT04978597|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111133249|NCT04978597|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111133250|NCT03490513|Anastrozole|anastrozole|mesh-list
111133251|NCT03490513|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111133252|NCT03490513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111133253|NCT03490513|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111133254|NCT03490513|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111133255|NCT03490513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111133256|NCT03490513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111133257|NCT03490513|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111133258|NCT03490513|Hormone Antagonists|hormone antagonists|mesh-ancestor
111133259|NCT03490513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111133260|NCT03490513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111133261|NCT03439345|Fenofibrate|fenofibrate|mesh-list
111133262|NCT03439345|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111133263|NCT03439345|Antimetabolites|antimetabolites|mesh-ancestor
111133264|NCT03439345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111133265|NCT03439345|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111133266|NCT04977661|Vitamin E|vitamin e|mesh-list
111133267|NCT04977661|Tocopherols|tocopherols|mesh-list
111133268|NCT04977661|alpha-Tocopherol|alpha-tocopherol|mesh-list
111133269|NCT04977661|Pentoxifylline|pentoxifylline|mesh-list
111133270|NCT04977661|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
111133271|NCT04977661|Vitamins|vitamins|mesh-ancestor
111133272|NCT04977661|Micronutrients|micronutrients|mesh-ancestor
111133273|NCT04977661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111133274|NCT04977661|Antioxidants|antioxidants|mesh-ancestor
111133275|NCT04977661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111133276|NCT04977661|Protective Agents|protective agents|mesh-ancestor
111133277|NCT04977661|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111133278|NCT04977661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111133279|NCT04977661|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111133280|NCT04977661|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111133281|NCT04977661|Vasodilator Agents|vasodilator agents|mesh-ancestor
111133282|NCT04977661|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111133283|NCT04977661|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
111133284|NCT04977661|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111133285|NCT04977427|Prednisolone|prednisolone|mesh-list
111133286|NCT04977427|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111133287|NCT04977427|Methylprednisolone|methylprednisolone|mesh-list
111133288|NCT04977427|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111133289|NCT04977427|Prednisolone acetate|prednisolone acetate|mesh-list
111133290|NCT04977427|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111133291|NCT04977427|Prednisolone phosphate|prednisolone phosphate|mesh-list
111133292|NCT04977427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111133293|NCT04977427|Glucocorticoids|glucocorticoids|mesh-ancestor
111133294|NCT04977427|Hormones|hormones|mesh-ancestor
111133295|NCT04977427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111133296|NCT04977427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111133297|NCT04977427|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111133298|NCT04977427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111133299|NCT04977427|Antiemetics|antiemetics|mesh-ancestor
111133300|NCT04977427|Autonomic Agents|autonomic agents|mesh-ancestor
111133301|NCT04977427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111133302|NCT04977427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111133303|NCT04977427|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111133304|NCT04977427|Protective Agents|protective agents|mesh-ancestor
111133305|NCT04261855|Avelumab|avelumab|mesh-list
111133306|NCT04261855|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
111133307|NCT04261855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111133308|NCT04261855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111133309|NCT04261855|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111133310|NCT04261855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111133311|NCT04224415|Irinotecan|irinotecan|mesh-list
111133312|NCT04224415|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111133313|NCT04224415|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111133314|NCT04224415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111133315|NCT04224415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111133316|NCT04224415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111133317|NCT03239899|Pembrolizumab|pembrolizumab|mesh-list
111133318|NCT03239899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111133319|NCT03239899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111133320|NCT03239899|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111133321|NCT03239899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111133322|NCT03061981|Metformin|metformin|mesh-list
111133323|NCT03061981|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111133324|NCT03061981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111133325|NCT02510001|Crizotinib|crizotinib|mesh-list
111133326|NCT02510001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111133327|NCT02510001|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111133328|NCT02510001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111133329|NCT02510001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111133330|NCT02452047|Imipenem|imipenem|mesh-list
111133331|NCT02452047|Relebactam|relebactam|mesh-list
111133332|NCT02452047|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
111133333|NCT02452047|Cilastatin|cilastatin|mesh-list
111133334|NCT02452047|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111133335|NCT02452047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111133336|NCT02452047|Protease Inhibitors|protease inhibitors|mesh-ancestor
111133337|NCT02452047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110587910|NCT02582736|Dopamine Agents|dopamine agents|mesh-ancestor
111133338|NCT02452047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111133339|NCT02452047|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
111133340|NCT04925505|Anesthetics|anesthetics|mesh-list
111133341|NCT04925505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111133342|NCT04925505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111133343|NCT02475369|Pancrelipase|pancrelipase|mesh-list
111133344|NCT02475369|Pancreatin|pancreatin|mesh-list
111133345|NCT02475369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111133346|NCT02474589|Tecovirimat|tecovirimat|mesh-list
111133347|NCT02474589|Antiviral Agents|antiviral agents|mesh-ancestor
111133348|NCT02474589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111133349|NCT03862157|Azacitidine|azacitidine|mesh-list
111133350|NCT03862157|Venetoclax|venetoclax|mesh-list
111133351|NCT03862157|Enzyme Inhibitors|enzyme inhibitors|mesh-list
111133352|NCT03862157|Pevonedistat|pevonedistat|mesh-list
111133353|NCT03862157|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111133354|NCT03862157|Antimetabolites|antimetabolites|mesh-ancestor
111133355|NCT03862157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111133356|NCT03862157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111133357|NCT02474355|Osimertinib|osimertinib|mesh-list
111133358|NCT02474355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111133359|NCT02474355|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111133360|NCT02474355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111133361|NCT02474355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111133362|NCT02474199|Acetaminophen|acetaminophen|mesh-list
111133363|NCT02474199|Diphenhydramine|diphenhydramine|mesh-list
111133364|NCT02474199|Promethazine|promethazine|mesh-list
111133365|NCT02474199|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111133366|NCT02474199|Analgesics|analgesics|mesh-ancestor
111133367|NCT02474199|Sensory System Agents|sensory system agents|mesh-ancestor
111133368|NCT02474199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111133369|NCT02474199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111133370|NCT02474199|Antipyretics|antipyretics|mesh-ancestor
111133371|NCT02474199|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111133372|NCT02474199|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111133373|NCT02474199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111133374|NCT02474199|Anesthetics, Local|anesthetics, local|mesh-ancestor
111133375|NCT02474199|Anesthetics|anesthetics|mesh-ancestor
111133376|NCT02474199|Antiemetics|antiemetics|mesh-ancestor
111133377|NCT02474199|Autonomic Agents|autonomic agents|mesh-ancestor
111133378|NCT02474199|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111133379|NCT02474199|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111133380|NCT02474199|Histamine Antagonists|histamine antagonists|mesh-ancestor
111133381|NCT02474199|Histamine Agents|histamine agents|mesh-ancestor
111133382|NCT02474199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111133383|NCT02474199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111133384|NCT02474199|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111133385|NCT02474199|Antipruritics|antipruritics|mesh-ancestor
111133386|NCT02474199|Dermatologic Agents|dermatologic agents|mesh-ancestor
111133388|NCT02450487|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111133389|NCT02450487|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111133390|NCT02450487|Analgesics|analgesics|mesh-ancestor
111133391|NCT02450487|Sensory System Agents|sensory system agents|mesh-ancestor
111133392|NCT02450487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111133393|NCT02450487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111133394|NCT02450487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111133395|NCT02450487|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111133396|NCT02450487|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111133397|NCT02450487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111133398|NCT02450487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111133399|NCT02506881|Darbepoetin alfa|darbepoetin alfa|mesh-list
111133400|NCT02506881|Hematinics|hematinics|mesh-ancestor
111133401|NCT02506257|Biguanides|biguanides|mesh-list
111133402|NCT02506257|Polihexanide|polihexanide|mesh-list
111133403|NCT02506257|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111133404|NCT02506257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111133405|NCT02506257|Disinfectants|disinfectants|mesh-ancestor
111133406|NCT02506257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111133407|NCT02505945|Omeprazole|omeprazole|mesh-list
111133408|NCT02505945|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111133409|NCT02505945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111133410|NCT02505945|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111133411|NCT02505945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111133412|NCT02505945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111133413|NCT04213885|Riboflavin|riboflavin|mesh-list
111133414|NCT04213885|Vitamin B Complex|vitamin b complex|mesh-ancestor
111133415|NCT04213885|Vitamins|vitamins|mesh-ancestor
111133416|NCT04213885|Micronutrients|micronutrients|mesh-ancestor
111133417|NCT04213885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111133418|NCT04213885|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111133419|NCT04213885|Dermatologic Agents|dermatologic agents|mesh-ancestor
111133420|NCT02448771|Bazedoxifene|bazedoxifene|mesh-list
111133421|NCT02448771|Palbociclib|palbociclib|mesh-list
111133422|NCT02448771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111133423|NCT02448771|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111133424|NCT02448771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111133425|NCT02448771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111133426|NCT02448771|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111133427|NCT02448771|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111133428|NCT02448771|Hormone Antagonists|hormone antagonists|mesh-ancestor
111133429|NCT02448771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111133430|NCT02448771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111133431|NCT02448771|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111133432|NCT02504541|Methyltestosterone|methyltestosterone|mesh-list
111133433|NCT02504541|Testosterone|testosterone|mesh-list
111133434|NCT02504541|Testosterone undecanoate|testosterone undecanoate|mesh-list
111133435|NCT02504541|Testosterone enanthate|testosterone enanthate|mesh-list
111133436|NCT02504541|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
111133437|NCT02504541|Androgens|androgens|mesh-ancestor
111133438|NCT02504541|Hormones|hormones|mesh-ancestor
111133439|NCT02504541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111133440|NCT02504541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111133441|NCT02504541|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111133442|NCT02504541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111133443|NCT02504541|Anabolic Agents|anabolic agents|mesh-ancestor
111133444|NCT04924257|Esketamine|esketamine|mesh-list
111133445|NCT04924257|Antidepressive Agents|antidepressive agents|mesh-ancestor
111133446|NCT04924257|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111133447|NCT04924179|Tislelizumab|tislelizumab|mesh-list
111133448|NCT04924179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111133449|NCT04924179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111133450|NCT04975945|Ceftriaxone|ceftriaxone|mesh-list
111133451|NCT04975945|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111133452|NCT04975945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111133453|NCT03063307|Fluorides|fluorides|mesh-list
111133454|NCT03063307|Cariostatic Agents|cariostatic agents|mesh-ancestor
111133455|NCT03063307|Protective Agents|protective agents|mesh-ancestor
111133456|NCT03063307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111133457|NCT04874935|Lansoprazole|lansoprazole|mesh-list
111133458|NCT04874935|Dexlansoprazole|dexlansoprazole|mesh-list
111133459|NCT04874935|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111133460|NCT04874935|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111133461|NCT04874935|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111133462|NCT04874935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111133463|NCT04874935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111133464|NCT02961361|Dexmedetomidine|dexmedetomidine|mesh-list
111133465|NCT02961361|Ropivacaine|ropivacaine|mesh-list
111133466|NCT02961361|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110850487|NCT02504164|Midazolam|midazolam|mesh-list
111133467|NCT02961361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111133468|NCT02961361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111133469|NCT02961361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111133470|NCT02961361|Analgesics|analgesics|mesh-ancestor
111133471|NCT02961361|Sensory System Agents|sensory system agents|mesh-ancestor
111133472|NCT02961361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111133473|NCT02961361|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111133474|NCT02961361|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111133475|NCT02961361|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111133476|NCT02961361|Adrenergic Agents|adrenergic agents|mesh-ancestor
111133477|NCT02961361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111133478|NCT02961361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111133479|NCT02961361|Anesthetics, Local|anesthetics, local|mesh-ancestor
111133480|NCT02961361|Anesthetics|anesthetics|mesh-ancestor
111133481|NCT04974853|Complement System Proteins|complement system proteins|mesh-list
111133482|NCT04974853|Immunologic Factors|immunologic factors|mesh-ancestor
111133483|NCT04974853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111133484|NCT02725177|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
111133485|NCT02725177|Hormones|hormones|mesh-ancestor
111133486|NCT02725177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111133487|NCT02725177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111133488|NCT02426281|Paclitaxel|paclitaxel|mesh-list
111133489|NCT02426281|Gemcitabine|gemcitabine|mesh-list
111133490|NCT02426281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111133491|NCT02426281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111133492|NCT02426281|Tubulin Modulators|tubulin modulators|mesh-ancestor
111133493|NCT02426281|Antimitotic Agents|antimitotic agents|mesh-ancestor
111133494|NCT02426281|Mitosis Modulators|mitosis modulators|mesh-ancestor
111133495|NCT02426281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111133496|NCT02426281|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111133497|NCT02426281|Antimetabolites|antimetabolites|mesh-ancestor
111133498|NCT02448537|Gemcitabine|gemcitabine|mesh-list
111133499|NCT02448537|Doxorubicin|doxorubicin|mesh-list
111133500|NCT02448537|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111133501|NCT02448537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111133502|NCT02448537|Antimetabolites|antimetabolites|mesh-ancestor
111133503|NCT02448537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111133504|NCT02448537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111133505|NCT02448537|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111133506|NCT02448537|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111133507|NCT02448537|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111133508|NCT02448537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111133509|NCT04838743|Xultophy|xultophy|mesh-list
111133510|NCT04838743|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111133511|NCT04838743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111133512|NCT04838743|Incretins|incretins|mesh-ancestor
111133513|NCT04838743|Hormones|hormones|mesh-ancestor
111133514|NCT04838743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111133515|NCT03060265|Acetaminophen|acetaminophen|mesh-list
111133516|NCT03060265|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111133517|NCT03060265|Analgesics|analgesics|mesh-ancestor
111133518|NCT03060265|Sensory System Agents|sensory system agents|mesh-ancestor
111133519|NCT03060265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111133520|NCT03060265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111133521|NCT03060265|Antipyretics|antipyretics|mesh-ancestor
111133522|NCT02504151|Cannabidiol|cannabidiol|mesh-list
111133523|NCT02504151|Anticonvulsants|anticonvulsants|mesh-ancestor
111133524|NCT02448381|Hypericin|hypericin|mesh-list
111133525|NCT02448381|Antidepressive Agents|antidepressive agents|mesh-ancestor
111133526|NCT02448381|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111133527|NCT02448381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111133528|NCT02448381|Antiviral Agents|antiviral agents|mesh-ancestor
111133529|NCT02448381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111133530|NCT02448381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111133531|NCT02448381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111133532|NCT02448381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111133533|NCT02448381|Immunologic Factors|immunologic factors|mesh-ancestor
111133534|NCT02448381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111133535|NCT02448225|Deoxyglucose|deoxyglucose|mesh-list
111133536|NCT02448225|Fluorides|fluorides|mesh-list
111133537|NCT02448225|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
111133538|NCT02448225|Cariostatic Agents|cariostatic agents|mesh-ancestor
111133539|NCT02448225|Protective Agents|protective agents|mesh-ancestor
111133540|NCT02448225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111133541|NCT02448225|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111133542|NCT02448225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111133543|NCT02448225|Antimetabolites|antimetabolites|mesh-ancestor
111133544|NCT02448225|Antiviral Agents|antiviral agents|mesh-ancestor
111133545|NCT02448225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111133546|NCT02447991|Rizatriptan|rizatriptan|mesh-list
111133547|NCT02447991|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111133548|NCT02447991|Serotonin Agents|serotonin agents|mesh-ancestor
111133549|NCT02447991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111133550|NCT02447991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111133551|NCT02447991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111133552|NCT02586155|Atorvastatin|atorvastatin|mesh-list
111133553|NCT02586155|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111133554|NCT02586155|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111133555|NCT02586155|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111133556|NCT02586155|Antimetabolites|antimetabolites|mesh-ancestor
111133557|NCT02586155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111133558|NCT02586155|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111133559|NCT02586155|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111133560|NCT02586155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111133561|NCT05536661|Lubricant Eye Drops|lubricant eye drops|mesh-list
111133562|NCT05536661|Hyaluronic Acid|hyaluronic acid|mesh-list
111133563|NCT05536661|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111133564|NCT05536661|Immunologic Factors|immunologic factors|mesh-ancestor
111133565|NCT05536661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111133566|NCT05536661|Viscosupplements|viscosupplements|mesh-ancestor
111133567|NCT05536661|Protective Agents|protective agents|mesh-ancestor
111133568|NCT05536661|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
111133569|NCT05536661|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111133570|NCT05536271|Bisoprolol|bisoprolol|mesh-list
111133571|NCT05536271|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111133572|NCT05536271|Sympatholytics|sympatholytics|mesh-ancestor
111133573|NCT05536271|Autonomic Agents|autonomic agents|mesh-ancestor
111133574|NCT05536271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111133575|NCT05536271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111133576|NCT05536271|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
111133577|NCT05536271|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111133578|NCT05536271|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111133579|NCT05536271|Adrenergic Agents|adrenergic agents|mesh-ancestor
111133580|NCT05536271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111133581|NCT05536271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111133582|NCT05536193|Metformin|metformin|mesh-list
111133583|NCT05536193|Salicylic Acid|salicylic acid|mesh-list
111133584|NCT05536193|Salicylates|salicylates|mesh-list
111133585|NCT05536193|Mitogens|mitogens|mesh-list
111133586|NCT05536193|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111133587|NCT05536193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111133588|NCT05536193|Mitosis Modulators|mitosis modulators|mesh-ancestor
111133589|NCT05536193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111133590|NCT05536193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111133591|NCT05536193|Antifungal Agents|antifungal agents|mesh-ancestor
111133592|NCT05536193|Keratolytic Agents|keratolytic agents|mesh-ancestor
111133593|NCT05536193|Dermatologic Agents|dermatologic agents|mesh-ancestor
111133594|NCT05536193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111133595|NCT05536193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111133596|NCT05536193|Analgesics|analgesics|mesh-ancestor
111133597|NCT05536193|Sensory System Agents|sensory system agents|mesh-ancestor
111133598|NCT05536193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111133599|NCT05536193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111133600|NCT05536193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111133601|NCT05536193|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111133602|NCT05536193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111133603|NCT04425707|Hydroxychloroquine|hydroxychloroquine|mesh-list
111133604|NCT04425707|Ivermectin|ivermectin|mesh-list
111133605|NCT04425707|Antimalarials|antimalarials|mesh-ancestor
111133606|NCT04425707|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111133607|NCT04425707|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111133608|NCT04425707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111133609|NCT04425707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111133610|NCT04425707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111133611|NCT04425707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111133612|NCT05697185|Evolocumab|evolocumab|mesh-list
111133613|NCT05697185|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
111133614|NCT05697185|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111133615|NCT05697185|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111133616|NCT05697185|Antimetabolites|antimetabolites|mesh-ancestor
111133617|NCT05697185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111133618|NCT05697185|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111133619|NCT05697185|Protease Inhibitors|protease inhibitors|mesh-ancestor
111133620|NCT05697185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111133621|NCT05697185|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111133622|NCT02581163|Ritonavir|ritonavir|mesh-list
111133623|NCT02581163|Ribavirin|ribavirin|mesh-list
111133624|NCT02581163|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111133625|NCT02581163|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111133626|NCT02581163|Protease Inhibitors|protease inhibitors|mesh-ancestor
111133627|NCT02581163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111133628|NCT02581163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111133629|NCT02581163|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111133630|NCT02581163|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111133631|NCT02581163|Antiviral Agents|antiviral agents|mesh-ancestor
111133632|NCT02581163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111133633|NCT02581163|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111133634|NCT02581163|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111133635|NCT02581163|Antimetabolites|antimetabolites|mesh-ancestor
111133636|NCT05591417|Dexamethasone|dexamethasone|mesh-list
111133637|NCT05591417|Dexamethasone acetate|dexamethasone acetate|mesh-list
111133638|NCT05591417|Dexmedetomidine|dexmedetomidine|mesh-list
111133639|NCT05591417|Morphine|morphine|mesh-list
111133640|NCT05591417|BB 1101|bb 1101|mesh-list
111133641|NCT05591417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111133642|NCT05591417|Antiemetics|antiemetics|mesh-ancestor
111133643|NCT05591417|Autonomic Agents|autonomic agents|mesh-ancestor
111133644|NCT05591417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111133645|NCT05591417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111133646|NCT05591417|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111133647|NCT05591417|Glucocorticoids|glucocorticoids|mesh-ancestor
111133648|NCT05591417|Hormones|hormones|mesh-ancestor
110870375|NCT02394418|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111133649|NCT05591417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111133650|NCT05591417|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111133651|NCT05591417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111133652|NCT05591417|Protease Inhibitors|protease inhibitors|mesh-ancestor
111133653|NCT05591417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111133654|NCT05591417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111133655|NCT05591417|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111133656|NCT05591417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111133657|NCT05591417|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111133658|NCT05591417|Analgesics|analgesics|mesh-ancestor
111133659|NCT05591417|Sensory System Agents|sensory system agents|mesh-ancestor
111133660|NCT05591417|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111133661|NCT05591417|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111133662|NCT05591417|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111133663|NCT05591417|Adrenergic Agents|adrenergic agents|mesh-ancestor
111133664|NCT05591417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111133665|NCT05591417|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111133666|NCT05591417|Narcotics|narcotics|mesh-ancestor
111133667|NCT01938547|Clevidipine|clevidipine|mesh-list
111133668|NCT01938547|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111133669|NCT01938547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111133670|NCT01938547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111133671|NCT01938547|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111133672|NCT01938547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111133673|NCT05695625|Anesthetics|anesthetics|mesh-list
111133674|NCT05695625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111133675|NCT05695625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111133676|NCT05586737|Rituximab|rituximab|mesh-list
111133677|NCT05586737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111133678|NCT05586737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111133679|NCT05586737|Immunologic Factors|immunologic factors|mesh-ancestor
111133680|NCT05586737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111133681|NCT05586737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111133682|NCT05678933|Prednisone|prednisone|mesh-list
111133683|NCT05678933|Cyclophosphamide|cyclophosphamide|mesh-list
111133684|NCT05678933|Vincristine|vincristine|mesh-list
111133685|NCT05678933|Azacitidine|azacitidine|mesh-list
111133686|NCT05678933|Epirubicin|epirubicin|mesh-list
111133687|NCT05678933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111133688|NCT05678933|Immunologic Factors|immunologic factors|mesh-ancestor
111133689|NCT05678933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111133690|NCT05678933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111133691|NCT05678933|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111133692|NCT05678933|Alkylating Agents|alkylating agents|mesh-ancestor
111133693|NCT05678933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111133694|NCT05678933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111133695|NCT05678933|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110588141|NCT00737139|Mydriatics|mydriatics|mesh-ancestor
111133696|NCT05678933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111133697|NCT05678933|Glucocorticoids|glucocorticoids|mesh-ancestor
111133698|NCT05678933|Hormones|hormones|mesh-ancestor
111133699|NCT05678933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111133700|NCT05678933|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111133701|NCT05678933|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111133702|NCT05678933|Tubulin Modulators|tubulin modulators|mesh-ancestor
111133703|NCT05678933|Antimitotic Agents|antimitotic agents|mesh-ancestor
111133704|NCT05678933|Mitosis Modulators|mitosis modulators|mesh-ancestor
111133705|NCT05678933|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111133706|NCT05678933|Antimetabolites|antimetabolites|mesh-ancestor
111133707|NCT05678933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111133708|NCT05678933|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111133709|NCT05678933|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111133710|NCT05678933|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111133711|NCT05678621|Amoxicillin|amoxicillin|mesh-list
111133712|NCT05678621|Ciprofloxacin|ciprofloxacin|mesh-list
111133713|NCT05678621|Clavulanic Acids|clavulanic acids|mesh-list
111133714|NCT05678621|Clavulanic Acid|clavulanic acid|mesh-list
111133715|NCT05678621|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
111133716|NCT05678621|Trimethoprim|trimethoprim|mesh-list
111133717|NCT05678621|Sulfamethoxazole|sulfamethoxazole|mesh-list
111133718|NCT05678621|Immunoglobulins|immunoglobulins|mesh-list
111133719|NCT05678621|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111133720|NCT05678621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111133721|NCT05678621|Immunologic Factors|immunologic factors|mesh-ancestor
111133722|NCT05678621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111133723|NCT05678621|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111133724|NCT05678621|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111133725|NCT05678621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111133726|NCT05678621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111133727|NCT05678621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111133728|NCT05678621|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111133729|NCT05678621|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111133730|NCT05678621|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111133731|NCT05678621|Antimalarials|antimalarials|mesh-ancestor
111133732|NCT05678621|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111133733|NCT05678621|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111133734|NCT05678621|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111133735|NCT05678621|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111133736|NCT05678621|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
111133737|NCT05678621|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
111133738|NCT05697029|Tetrandrine|tetrandrine|mesh-list
111133739|NCT05697029|Antimalarials|antimalarials|mesh-ancestor
111133740|NCT05697029|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111133741|NCT05697029|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111133742|NCT05697029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111133743|NCT05697029|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111133744|NCT05697029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111133745|NCT05697029|Antiviral Agents|antiviral agents|mesh-ancestor
111133746|NCT05697029|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111133747|NCT05697029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111133748|NCT05697029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111133749|NCT05697029|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111133750|NCT05697029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111133751|NCT05697029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111133752|NCT05697029|Immunologic Factors|immunologic factors|mesh-ancestor
111133753|NCT02627677|Ponatinib|ponatinib|mesh-list
111133754|NCT02627677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111133755|NCT02627677|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111133756|NCT02627677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111133757|NCT02627677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111133758|NCT04964479|Pembrolizumab|pembrolizumab|mesh-list
111133759|NCT04964479|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111133760|NCT04964479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111133761|NCT04964479|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111133762|NCT04964479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111133763|NCT02501811|Plasma-lyte 148|plasma-lyte 148|mesh-list
111133764|NCT02501811|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
111133765|NCT02501811|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111133766|NCT02585999|Contraceptive Agents|contraceptive agents|mesh-list
111133767|NCT02585999|Ortho Evra|ortho evra|mesh-list
111133768|NCT02585999|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111133769|NCT02585999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111133770|NCT02585999|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110837946|NCT03775993|Hormones|hormones|mesh-list
111133771|NCT05696951|Tranylcypromine|tranylcypromine|mesh-list
111133772|NCT05696951|Antidepressive Agents|antidepressive agents|mesh-ancestor
111133773|NCT05696951|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111133774|NCT05696951|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
111133775|NCT05696951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111133776|NCT05696951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111133777|NCT05696951|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111133778|NCT05696951|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111133779|NCT05696951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111133780|NCT05696951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111133782|NCT05674253|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
111133783|NCT05674253|Dexmedetomidine|dexmedetomidine|mesh-list
111133784|NCT05674253|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111133785|NCT05674253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111133786|NCT05674253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111133787|NCT05674253|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111133788|NCT05674253|Analgesics|analgesics|mesh-ancestor
111133789|NCT05674253|Sensory System Agents|sensory system agents|mesh-ancestor
111133790|NCT05674253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111133791|NCT05674253|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111133792|NCT05674253|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111133793|NCT05674253|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111133794|NCT05674253|Adrenergic Agents|adrenergic agents|mesh-ancestor
111133795|NCT05674253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111133796|NCT05674253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111133797|NCT05674253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111133798|NCT02500641|Naproxen|naproxen|mesh-list
111133799|NCT02500641|Colchicine|colchicine|mesh-list
111133800|NCT02500641|Allopurinol|allopurinol|mesh-list
111133801|NCT02500641|Febuxostat|febuxostat|mesh-list
111133802|NCT02500641|Omeprazole|omeprazole|mesh-list
111133803|NCT02500641|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111133804|NCT02500641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111133805|NCT02500641|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111133806|NCT02500641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111133807|NCT02500641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111133808|NCT02500641|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111133809|NCT02500641|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111133810|NCT02500641|Analgesics|analgesics|mesh-ancestor
111133811|NCT02500641|Sensory System Agents|sensory system agents|mesh-ancestor
111133812|NCT02500641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111133813|NCT02500641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111133814|NCT02500641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111133815|NCT02500641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111133816|NCT02500641|Gout Suppressants|gout suppressants|mesh-ancestor
111133817|NCT02500641|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111133818|NCT02500641|Tubulin Modulators|tubulin modulators|mesh-ancestor
111133819|NCT02500641|Antimitotic Agents|antimitotic agents|mesh-ancestor
111133820|NCT02500641|Mitosis Modulators|mitosis modulators|mesh-ancestor
111133821|NCT02500641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111133822|NCT02500641|Antimetabolites|antimetabolites|mesh-ancestor
111133823|NCT02500641|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111133824|NCT02500641|Antioxidants|antioxidants|mesh-ancestor
111133825|NCT02500641|Protective Agents|protective agents|mesh-ancestor
111133826|NCT04973293|Bevacizumab|bevacizumab|mesh-list
111133827|NCT04973293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111133828|NCT04973293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111133829|NCT04973293|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111133830|NCT04973293|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111133831|NCT04973293|Growth Substances|growth substances|mesh-ancestor
111133832|NCT04973293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111133833|NCT04973293|Growth Inhibitors|growth inhibitors|mesh-ancestor
111133834|NCT04962451|Ticagrelor|ticagrelor|mesh-list
111133835|NCT04962451|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111133836|NCT04962451|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111133837|NCT04962451|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111133838|NCT04962451|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111133839|NCT04962451|Purinergic Agents|purinergic agents|mesh-ancestor
111133840|NCT04962451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111133841|NCT04962451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111133842|NCT04962451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111133843|NCT04953871|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
111133844|NCT04953871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111133845|NCT03059719|Exenatide|exenatide|mesh-list
111133846|NCT03059719|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111133847|NCT03059719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111133848|NCT03059719|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
111133849|NCT03059719|Incretins|incretins|mesh-ancestor
111133850|NCT03059719|Hormones|hormones|mesh-ancestor
111133851|NCT03059719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111133852|NCT03060031|Oxytocin|oxytocin|mesh-list
111133853|NCT03060031|Oxytocics|oxytocics|mesh-ancestor
111133854|NCT03060031|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111133855|NCT03060031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111133856|NCT02499783|Adalimumab|adalimumab|mesh-list
111133857|NCT02499783|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111133858|NCT02499783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111133859|NCT02499783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111133860|NCT04972045|Curcumin|curcumin|mesh-list
111133861|NCT04972045|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111133862|NCT04972045|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111133863|NCT04972045|Analgesics|analgesics|mesh-ancestor
111133864|NCT04972045|Sensory System Agents|sensory system agents|mesh-ancestor
111133865|NCT04972045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111133866|NCT04972045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111133867|NCT04972045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111133868|NCT04972045|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111133869|NCT04972045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111133870|NCT04972045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111133871|NCT04972045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111133872|NCT03059017|Albuterol|albuterol|mesh-list
111133873|NCT03059017|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111133874|NCT03059017|Autonomic Agents|autonomic agents|mesh-ancestor
111133875|NCT03059017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111133876|NCT03059017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111133877|NCT03059017|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111133878|NCT03059017|Respiratory System Agents|respiratory system agents|mesh-ancestor
111133879|NCT03059017|Tocolytic Agents|tocolytic agents|mesh-ancestor
111133880|NCT03059017|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111133881|NCT03059017|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111133882|NCT03059017|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111133883|NCT03059017|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111133884|NCT03059017|Adrenergic Agents|adrenergic agents|mesh-ancestor
111133885|NCT03059017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110870376|NCT02394418|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110588417|NCT02568735|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111133886|NCT03059017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111133887|NCT04425655|Fludarabine|fludarabine|mesh-list
111133888|NCT04425655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111133889|NCT04970719|Remdesivir|remdesivir|mesh-list
111133890|NCT04970719|Dexamethasone|dexamethasone|mesh-list
111133891|NCT04970719|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
111133892|NCT04970719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111133893|NCT04970719|Antiemetics|antiemetics|mesh-ancestor
111133894|NCT04970719|Autonomic Agents|autonomic agents|mesh-ancestor
111133895|NCT04970719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111133896|NCT04970719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111133897|NCT04970719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111133898|NCT04970719|Glucocorticoids|glucocorticoids|mesh-ancestor
111133899|NCT04970719|Hormones|hormones|mesh-ancestor
111133900|NCT04970719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111133901|NCT04970719|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111133902|NCT04970719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111133903|NCT04970719|Antimetabolites|antimetabolites|mesh-ancestor
111133904|NCT04970719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111133905|NCT04970719|Antiviral Agents|antiviral agents|mesh-ancestor
111133906|NCT04970719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111133907|NCT04970719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111133908|NCT04970719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111133909|NCT02466399|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111133910|NCT02466399|Latanoprost|latanoprost|mesh-list
111133911|NCT02466399|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111133912|NCT03059251|Obinutuzumab|obinutuzumab|mesh-list
111133913|NCT03059251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111133914|NCT03059251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111133915|NCT04970251|Aflibercept|aflibercept|mesh-list
111133916|NCT04970251|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111133917|NCT04970251|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111133918|NCT04970251|Growth Substances|growth substances|mesh-ancestor
111133919|NCT04970251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111133920|NCT04970251|Growth Inhibitors|growth inhibitors|mesh-ancestor
111133921|NCT04970251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111133922|NCT04970329|Dextrans|dextrans|mesh-list
111133923|NCT04970329|Anticoagulants|anticoagulants|mesh-ancestor
111133924|NCT04970329|Plasma Substitutes|plasma substitutes|mesh-ancestor
111133925|NCT04970329|Blood Substitutes|blood substitutes|mesh-ancestor
111133926|NCT04960657|Glyburide|glyburide|mesh-list
111133927|NCT04960657|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
111133928|NCT04960657|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111133929|NCT04960657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111133930|NCT04960657|Growth Substances|growth substances|mesh-ancestor
111133931|NCT04960657|Vasodilator Agents|vasodilator agents|mesh-ancestor
111133932|NCT04960657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111133933|NCT04960657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111133934|NCT02464059|Vitamin D|vitamin d|mesh-list
111133935|NCT02464059|Cholecalciferol|cholecalciferol|mesh-list
111133936|NCT02464059|Vitamins|vitamins|mesh-ancestor
111133937|NCT02464059|Micronutrients|micronutrients|mesh-ancestor
111133938|NCT02464059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111133939|NCT02464059|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111133940|NCT02464059|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111133941|NCT02463357|Metformin|metformin|mesh-list
111133942|NCT02463357|Nifedipine|nifedipine|mesh-list
111133943|NCT02463357|Methazolamide|methazolamide|mesh-list
111133944|NCT02463357|Quercetin|quercetin|mesh-list
111133945|NCT02463357|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111133946|NCT02463357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111133947|NCT02463357|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111133948|NCT02463357|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111133949|NCT02463357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111133950|NCT02463357|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111133951|NCT02463357|Vasodilator Agents|vasodilator agents|mesh-ancestor
111133952|NCT02463357|Tocolytic Agents|tocolytic agents|mesh-ancestor
111133954|NCT02463357|Antioxidants|antioxidants|mesh-ancestor
111133955|NCT02463357|Protective Agents|protective agents|mesh-ancestor
111133956|NCT02463357|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
111133957|NCT02463357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111133958|NCT02463357|Diuretics|diuretics|mesh-ancestor
111133959|NCT02463357|Natriuretic Agents|natriuretic agents|mesh-ancestor
111133960|NCT04959721|Triamcinolone|triamcinolone|mesh-list
111133961|NCT04959721|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
111133962|NCT04959721|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
111133963|NCT04959721|Bupivacaine|bupivacaine|mesh-list
111133964|NCT04959721|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
111133965|NCT04959721|Anesthetics, Local|anesthetics, local|mesh-ancestor
111133966|NCT04959721|Anesthetics|anesthetics|mesh-ancestor
111133967|NCT04959721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111133968|NCT04959721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111133969|NCT04959721|Sensory System Agents|sensory system agents|mesh-ancestor
111133970|NCT04959721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111133971|NCT04959721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111133972|NCT04959721|Glucocorticoids|glucocorticoids|mesh-ancestor
111133973|NCT04959721|Hormones|hormones|mesh-ancestor
110588494|NCT02567955|Vaccines|vaccines|mesh-list
111133974|NCT04959721|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111133975|NCT04959721|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111133976|NCT04959721|Immunologic Factors|immunologic factors|mesh-ancestor
111133977|NCT04959721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111133978|NCT04959721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111133979|NCT04968613|Benserazide, levodopa drug combination|benserazide, levodopa drug combination|mesh-list
111133980|NCT04968613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111133981|NCT04968613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111133982|NCT04968613|Dopamine Agents|dopamine agents|mesh-ancestor
111133983|NCT04968613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111133984|NCT04968613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111133985|NCT04676555|Ofatumumab|ofatumumab|mesh-list
111133986|NCT04676555|Ocrelizumab|ocrelizumab|mesh-list
111133987|NCT04676555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111133988|NCT04676555|Immunologic Factors|immunologic factors|mesh-ancestor
111133989|NCT04676555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111133990|NCT04314167|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-list
111133991|NCT04314167|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111133992|NCT04314167|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111133993|NCT04314167|Antimetabolites|antimetabolites|mesh-ancestor
111133994|NCT04314167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111133995|NCT04314167|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111133996|NCT04314167|Protease Inhibitors|protease inhibitors|mesh-ancestor
111133997|NCT04314167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111133998|NCT04314167|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111133999|NCT05575427|Levofloxacin|levofloxacin|mesh-list
111134000|NCT05575427|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
111134001|NCT05575427|Minocycline|minocycline|mesh-list
111134002|NCT05575427|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111134003|NCT05575427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111134004|NCT05575427|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111134005|NCT05575427|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111134006|NCT05575427|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111134007|NCT05575427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111134008|NCT05575427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111134009|NCT05575427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111134010|NCT05575427|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111134011|NCT05575427|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111134012|NCT05575427|Antimalarials|antimalarials|mesh-ancestor
111134013|NCT05575427|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111134014|NCT05575427|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111134016|NCT04959253|Hallucinogens|hallucinogens|mesh-ancestor
111134017|NCT04959253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111134018|NCT04959253|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111134019|NCT02499159|Bupivacaine|bupivacaine|mesh-list
111134020|NCT02499159|Anesthetics, Local|anesthetics, local|mesh-ancestor
111134021|NCT02499159|Anesthetics|anesthetics|mesh-ancestor
111134022|NCT02499159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111134023|NCT02499159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111134024|NCT02499159|Sensory System Agents|sensory system agents|mesh-ancestor
111134025|NCT02499159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111134026|NCT01664039|Bimatoprost|bimatoprost|mesh-list
111134027|NCT01664039|Travoprost|travoprost|mesh-list
111134028|NCT01664039|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111134029|NCT01664039|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111134030|NCT01664039|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111134031|NCT05645705|Listerine|listerine|mesh-list
111134032|NCT05645705|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
111134033|NCT05645705|Sodium Fluoride|sodium fluoride|mesh-list
111134034|NCT05645705|Cariostatic Agents|cariostatic agents|mesh-ancestor
111134035|NCT05645705|Protective Agents|protective agents|mesh-ancestor
111134036|NCT05645705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111134037|NCT05645705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111134038|NCT02445339|Naltrexone|naltrexone|mesh-list
111134039|NCT02445339|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
111134040|NCT02445339|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111134041|NCT02445339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111134042|NCT02445339|Sensory System Agents|sensory system agents|mesh-ancestor
111134043|NCT02445339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111134044|NCT04959409|Tetracaine|tetracaine|mesh-list
111134045|NCT04959409|Anesthetics, Local|anesthetics, local|mesh-ancestor
111134046|NCT04959409|Anesthetics|anesthetics|mesh-ancestor
111134047|NCT04959409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111134048|NCT04959409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111134049|NCT04959409|Sensory System Agents|sensory system agents|mesh-ancestor
111134050|NCT04959409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111134051|NCT03058939|Tamoxifen|tamoxifen|mesh-list
111134052|NCT03058939|Paclitaxel|paclitaxel|mesh-list
111134053|NCT03058939|Carboplatin|carboplatin|mesh-list
111134054|NCT03058939|Trastuzumab|trastuzumab|mesh-list
111134055|NCT03058939|Letrozole|letrozole|mesh-list
111134056|NCT03058939|Pertuzumab|pertuzumab|mesh-list
111134057|NCT03058939|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111134058|NCT03058939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111134059|NCT03058939|Tubulin Modulators|tubulin modulators|mesh-ancestor
111134060|NCT03058939|Antimitotic Agents|antimitotic agents|mesh-ancestor
111134061|NCT03058939|Mitosis Modulators|mitosis modulators|mesh-ancestor
111134062|NCT03058939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111134063|NCT03058939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111134064|NCT03058939|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111134065|NCT03058939|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111134066|NCT03058939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111134067|NCT03058939|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111134068|NCT03058939|Hormone Antagonists|hormone antagonists|mesh-ancestor
111134069|NCT03058939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110851088|NCT03336346|Antiviral Agents|antiviral agents|mesh-ancestor
111134070|NCT03058939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111134071|NCT03058939|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111134072|NCT03058939|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111134073|NCT03058939|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111134074|NCT03058939|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111134075|NCT03058471|Methotrexate|methotrexate|mesh-list
111134076|NCT03058471|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111134077|NCT03058471|Abortifacient Agents|abortifacient agents|mesh-ancestor
111134078|NCT03058471|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111134079|NCT03058471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111134080|NCT03058471|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111134081|NCT03058471|Antimetabolites|antimetabolites|mesh-ancestor
111134082|NCT03058471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111134083|NCT03058471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111134084|NCT03058471|Dermatologic Agents|dermatologic agents|mesh-ancestor
111134085|NCT03058471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111134086|NCT03058471|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111134087|NCT03058471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111134088|NCT03058471|Immunologic Factors|immunologic factors|mesh-ancestor
111134089|NCT03058471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111134090|NCT03058471|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111134091|NCT02579603|Pirfenidone|pirfenidone|mesh-list
111134092|NCT02579603|Nintedanib|nintedanib|mesh-list
111134093|NCT02579603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111134094|NCT02579603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111134095|NCT02579603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111134096|NCT02579603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111134097|NCT02579603|Analgesics|analgesics|mesh-ancestor
111134098|NCT02579603|Sensory System Agents|sensory system agents|mesh-ancestor
111134099|NCT02579603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111134100|NCT02579603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111134101|NCT02579603|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111134102|NCT02579603|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111134103|NCT02579603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111134104|NCT02579603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111134105|NCT03060889|Tranexamic Acid|tranexamic acid|mesh-list
110588572|NCT00740103|Semapimod|semapimod|mesh-list
111134106|NCT03060889|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111134107|NCT03060889|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111134108|NCT03060889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111134109|NCT03060889|Hemostatics|hemostatics|mesh-ancestor
111134110|NCT03060889|Coagulants|coagulants|mesh-ancestor
111134111|NCT05546957|Aspirin|aspirin|mesh-list
111134112|NCT05546957|Rivaroxaban|rivaroxaban|mesh-list
111134113|NCT05546957|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111134114|NCT05546957|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111134115|NCT05546957|Analgesics|analgesics|mesh-ancestor
111134116|NCT05546957|Sensory System Agents|sensory system agents|mesh-ancestor
111134117|NCT05546957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111134118|NCT05546957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111134119|NCT05546957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111134120|NCT05546957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111134121|NCT05546957|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111134122|NCT05546957|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111134123|NCT05546957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111134124|NCT05546957|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111134125|NCT05546957|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111134126|NCT05546957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111134127|NCT05546957|Antipyretics|antipyretics|mesh-ancestor
111134128|NCT05546957|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111134129|NCT05546957|Antithrombins|antithrombins|mesh-ancestor
111134130|NCT05546957|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111134131|NCT05546957|Protease Inhibitors|protease inhibitors|mesh-ancestor
111134132|NCT05546957|Anticoagulants|anticoagulants|mesh-ancestor
111134133|NCT04950205|Sevoflurane|sevoflurane|mesh-list
111134134|NCT04950205|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111134135|NCT04950205|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111134136|NCT04950205|Anesthetics, General|anesthetics, general|mesh-ancestor
111134137|NCT04950205|Anesthetics|anesthetics|mesh-ancestor
111134138|NCT04950205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111134139|NCT04950205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111134140|NCT02625259|Lansoprazole|lansoprazole|mesh-list
111134141|NCT02625259|Dexlansoprazole|dexlansoprazole|mesh-list
111134142|NCT02625259|Serabelisib|serabelisib|mesh-list
111134143|NCT02625259|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111134144|NCT02625259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111134145|NCT02625259|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110851162|NCT01206881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111134146|NCT02625259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111134147|NCT02625259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111134148|NCT02577107|Ranibizumab|ranibizumab|mesh-list
111134149|NCT02577107|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111134150|NCT02577107|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111134151|NCT02577107|Growth Substances|growth substances|mesh-ancestor
111134152|NCT02577107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111134153|NCT02577107|Growth Inhibitors|growth inhibitors|mesh-ancestor
111134154|NCT02577107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111134155|NCT04958473|Axitinib|axitinib|mesh-list
111134156|NCT04958473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111134157|NCT04958473|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111134158|NCT04958473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111134159|NCT04958473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111134160|NCT04957927|Fluticasone|fluticasone|mesh-list
111134161|NCT04957927|Xhance|xhance|mesh-list
111134162|NCT04957927|Montelukast|montelukast|mesh-list
111134163|NCT04957927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111134164|NCT04957927|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111134165|NCT04957927|Autonomic Agents|autonomic agents|mesh-ancestor
111134166|NCT04957927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111134167|NCT04957927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111134168|NCT04957927|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111134169|NCT04957927|Respiratory System Agents|respiratory system agents|mesh-ancestor
111134170|NCT04957927|Dermatologic Agents|dermatologic agents|mesh-ancestor
111134171|NCT04957927|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111134172|NCT04957927|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
111134173|NCT04957927|Hormone Antagonists|hormone antagonists|mesh-ancestor
111134174|NCT04957927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111134175|NCT04957927|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
111134176|NCT04957927|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111134177|NCT04957927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111134178|NCT04688801|Antineoplastic Agents|antineoplastic agents|mesh-list
111134179|NCT04950049|Dexamethasone|dexamethasone|mesh-list
111134180|NCT04950049|Dexamethasone acetate|dexamethasone acetate|mesh-list
111134181|NCT04950049|BB 1101|bb 1101|mesh-list
111134182|NCT04950049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111134183|NCT04950049|Antiemetics|antiemetics|mesh-ancestor
111134184|NCT04950049|Autonomic Agents|autonomic agents|mesh-ancestor
111134185|NCT04950049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111134186|NCT04950049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111134187|NCT04950049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111134188|NCT04950049|Glucocorticoids|glucocorticoids|mesh-ancestor
111134189|NCT04950049|Hormones|hormones|mesh-ancestor
110588623|NCT05711667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111134190|NCT04950049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111134191|NCT04950049|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111134192|NCT04950049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111134193|NCT04950049|Protease Inhibitors|protease inhibitors|mesh-ancestor
111134194|NCT04950049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111134195|NCT04950049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111134196|NCT05587673|Methylprednisolone|methylprednisolone|mesh-list
111134197|NCT05587673|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111134198|NCT05587673|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111134199|NCT05587673|Prednisolone|prednisolone|mesh-list
111134200|NCT05587673|Prednisolone acetate|prednisolone acetate|mesh-list
111134201|NCT05587673|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111134202|NCT05587673|Prednisolone phosphate|prednisolone phosphate|mesh-list
110838028|NCT01321021|Autonomic Agents|autonomic agents|mesh-ancestor
111134203|NCT05587673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111134204|NCT05587673|Antiemetics|antiemetics|mesh-ancestor
111134205|NCT05587673|Autonomic Agents|autonomic agents|mesh-ancestor
111134206|NCT05587673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111134207|NCT05587673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111134208|NCT05587673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111134209|NCT05587673|Glucocorticoids|glucocorticoids|mesh-ancestor
111134210|NCT05587673|Hormones|hormones|mesh-ancestor
111134211|NCT05587673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111134212|NCT05587673|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111134213|NCT05587673|Protective Agents|protective agents|mesh-ancestor
111134214|NCT05587673|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111134215|NCT05587673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111134216|NCT02444793|Mogamulizumab|mogamulizumab|mesh-list
111134217|NCT02444793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111134218|NCT04966429|Maraviroc|maraviroc|mesh-list
111134219|NCT04966429|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
111134220|NCT04966429|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
111134221|NCT04966429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111134222|NCT04966429|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111134223|NCT04966429|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111134224|NCT04966429|Antiviral Agents|antiviral agents|mesh-ancestor
111134225|NCT04966429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111134226|NCT04966429|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
111134227|NCT04949347|Glycerol|glycerol|mesh-list
111134228|NCT04949347|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
111134229|NCT04949347|Protective Agents|protective agents|mesh-ancestor
111134230|NCT04949347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111134231|NCT04948957|Nitroglycerin|nitroglycerin|mesh-list
111134232|NCT04948957|Esmolol|esmolol|mesh-list
111134233|NCT04948957|Vasodilator Agents|vasodilator agents|mesh-ancestor
111134234|NCT04948957|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
111134235|NCT04948957|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111134236|NCT04948957|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111134237|NCT04948957|Adrenergic Agents|adrenergic agents|mesh-ancestor
111134238|NCT04948957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111134239|NCT04948957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111134240|NCT04948957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111134241|NCT04948801|Sofosbuvir|sofosbuvir|mesh-list
111134242|NCT04948801|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
111134243|NCT04948801|Velpatasvir|velpatasvir|mesh-list
111134244|NCT04948801|Antiviral Agents|antiviral agents|mesh-ancestor
111134245|NCT04948801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111134246|NCT04948567|Magnesium Sulfate|magnesium sulfate|mesh-list
111134247|NCT04948567|Analgesics|analgesics|mesh-ancestor
111134248|NCT04948567|Sensory System Agents|sensory system agents|mesh-ancestor
111134249|NCT04948567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111134250|NCT04948567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111134251|NCT04948567|Anesthetics|anesthetics|mesh-ancestor
111134252|NCT04948567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111134253|NCT04948567|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111134254|NCT04948567|Anticonvulsants|anticonvulsants|mesh-ancestor
111134255|NCT04948567|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111134256|NCT04948567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111134257|NCT04948567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111134258|NCT04948567|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111134259|NCT04948567|Tocolytic Agents|tocolytic agents|mesh-ancestor
111134260|NCT04948567|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111134261|NCT04419181|Carboplatin|carboplatin|mesh-list
111134262|NCT04419181|Docetaxel|docetaxel|mesh-list
111134263|NCT04419181|Trastuzumab|trastuzumab|mesh-list
111134264|NCT04419181|Pertuzumab|pertuzumab|mesh-list
111134265|NCT04419181|Maytansine|maytansine|mesh-list
111134266|NCT04419181|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
111134267|NCT04419181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111134268|NCT04419181|Tubulin Modulators|tubulin modulators|mesh-ancestor
110588679|NCT00785213|Analgesics|analgesics|mesh-ancestor
111134269|NCT04419181|Antimitotic Agents|antimitotic agents|mesh-ancestor
111134270|NCT04419181|Mitosis Modulators|mitosis modulators|mesh-ancestor
111134271|NCT04419181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111134272|NCT04419181|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111134273|NCT04419181|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111134274|NCT04419181|Immunotoxins|immunotoxins|mesh-ancestor
111134275|NCT04419181|Immunoconjugates|immunoconjugates|mesh-ancestor
111134276|NCT04419181|Immunologic Factors|immunologic factors|mesh-ancestor
111134277|NCT04419181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111134278|NCT04430179|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111134279|NCT04430179|Immunologic Factors|immunologic factors|mesh-ancestor
111134280|NCT04430179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111134282|NCT04946929|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
111134283|NCT04946929|Tinzaparin|tinzaparin|mesh-list
111134284|NCT04946929|Dalteparin|dalteparin|mesh-list
111134285|NCT04946929|Ticagrelor|ticagrelor|mesh-list
111134286|NCT04946929|Anticoagulants|anticoagulants|mesh-ancestor
111134287|NCT04946929|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111134288|NCT04946929|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111134289|NCT04946929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111134290|NCT04946929|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111134291|NCT04946929|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111134292|NCT04946929|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111134293|NCT04946929|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111134294|NCT04946929|Purinergic Agents|purinergic agents|mesh-ancestor
111134295|NCT04946929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111134296|NCT04946929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111134297|NCT03058237|Arbaclofen placarbil|arbaclofen placarbil|mesh-list
111134298|NCT03058237|Baclofen|baclofen|mesh-list
111134299|NCT03058237|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
111134300|NCT03058237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111134301|NCT03058237|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111134302|NCT03058237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111134303|NCT03058237|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
111134304|NCT03058237|GABA Agonists|gaba agonists|mesh-ancestor
111134305|NCT03058237|GABA Agents|gaba agents|mesh-ancestor
111134306|NCT03058237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111134307|NCT03058237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111134308|NCT04947241|Gemcitabine|gemcitabine|mesh-list
111134309|NCT04947241|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
111134310|NCT04947241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111134311|NCT04947241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111134312|NCT04947241|Antimetabolites|antimetabolites|mesh-ancestor
111134313|NCT04947241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111134314|NCT04947241|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111134316|NCT04933279|Cadexomer iodine|cadexomer iodine|mesh-list
111134317|NCT04933279|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111134318|NCT04933279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111134319|NCT04933279|Trace Elements|trace elements|mesh-ancestor
111134320|NCT04933279|Micronutrients|micronutrients|mesh-ancestor
110838058|NCT03779347|Praziquantel|praziquantel|mesh-list
111134321|NCT04933279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111134322|NCT02577029|Interferons|interferons|mesh-list
111134323|NCT02577029|Tenofovir|tenofovir|mesh-list
111134324|NCT02577029|Interferon-alpha|interferon-alpha|mesh-list
111134325|NCT02577029|Interferon alpha-2|interferon alpha-2|mesh-list
111134326|NCT02577029|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
111134327|NCT02577029|Entecavir|entecavir|mesh-list
111134328|NCT02577029|Histamine Antagonists|histamine antagonists|mesh-list
111134329|NCT02577029|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
111134330|NCT02577029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111134331|NCT02577029|Antiviral Agents|antiviral agents|mesh-ancestor
111134332|NCT02577029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111134333|NCT02577029|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111134334|NCT02577029|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111134335|NCT02577029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111134336|NCT02577029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111134337|NCT02577029|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111134338|NCT02577029|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111134339|NCT02577029|Immunologic Factors|immunologic factors|mesh-ancestor
111134340|NCT02577029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111134341|NCT02577029|Histamine Agents|histamine agents|mesh-ancestor
111134342|NCT02577029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111134343|NCT04946383|Dasatinib|dasatinib|mesh-list
111134344|NCT04946383|Quercetin|quercetin|mesh-list
111134345|NCT04946383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111134346|NCT04946383|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111134347|NCT04946383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111134348|NCT04946383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111134349|NCT04946383|Antioxidants|antioxidants|mesh-ancestor
111134350|NCT04946383|Protective Agents|protective agents|mesh-ancestor
111134351|NCT04946383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111134352|NCT04943653|Paclitaxel|paclitaxel|mesh-list
111134353|NCT04943653|Capecitabine|capecitabine|mesh-list
111134354|NCT04943653|Oxaliplatin|oxaliplatin|mesh-list
111134355|NCT04943653|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111134356|NCT04943653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111134357|NCT04943653|Tubulin Modulators|tubulin modulators|mesh-ancestor
111134358|NCT04943653|Antimitotic Agents|antimitotic agents|mesh-ancestor
111134359|NCT04943653|Mitosis Modulators|mitosis modulators|mesh-ancestor
111134360|NCT04943653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111134361|NCT04943653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111134362|NCT04943653|Antimetabolites|antimetabolites|mesh-ancestor
111134363|NCT04943029|Paclitaxel|paclitaxel|mesh-list
111134364|NCT04943029|Carboplatin|carboplatin|mesh-list
111134365|NCT04943029|Pemetrexed|pemetrexed|mesh-list
110588767|NCT02595242|Prednisone|prednisone|mesh-list
111134366|NCT04943029|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111134367|NCT04943029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111134368|NCT04943029|Tubulin Modulators|tubulin modulators|mesh-ancestor
111134369|NCT04943029|Antimitotic Agents|antimitotic agents|mesh-ancestor
111134370|NCT04943029|Mitosis Modulators|mitosis modulators|mesh-ancestor
111134371|NCT04943029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111134372|NCT04943029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111134373|NCT04943029|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111134374|NCT04943029|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111134375|NCT03660059|Antirheumatic Agents|antirheumatic agents|mesh-list
111134376|NCT03660059|Peficitinib|peficitinib|mesh-list
111134377|NCT03660059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111134378|NCT03660059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111134379|NCT03660059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111134380|NCT03660059|Immunologic Factors|immunologic factors|mesh-ancestor
111134381|NCT03660059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111134382|NCT04946227|Paclitaxel|paclitaxel|mesh-list
111134384|NCT04946227|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111134385|NCT04946227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111134386|NCT04946227|Tubulin Modulators|tubulin modulators|mesh-ancestor
111134387|NCT04946227|Antimitotic Agents|antimitotic agents|mesh-ancestor
111134388|NCT04946227|Mitosis Modulators|mitosis modulators|mesh-ancestor
111134389|NCT04946227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111134390|NCT04946227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111134391|NCT04946227|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111134392|NCT04932187|Capecitabine|capecitabine|mesh-list
111134393|NCT04932187|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111134394|NCT04932187|Antimetabolites|antimetabolites|mesh-ancestor
111134395|NCT04932187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111134396|NCT04932187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111134397|NCT04945681|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
111134398|NCT04945681|Immunologic Factors|immunologic factors|mesh-ancestor
111134399|NCT04945681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111134400|NCT03597347|Molgramostim|molgramostim|mesh-list
111134401|NCT03597347|Sargramostim|sargramostim|mesh-list
111134402|NCT03597347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111134403|NCT03597347|Immunologic Factors|immunologic factors|mesh-ancestor
111134404|NCT03597347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111134405|NCT04930627|Empagliflozin|empagliflozin|mesh-list
111134406|NCT04930627|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111134407|NCT04930627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111134408|NCT04930627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111134409|NCT04930627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111134410|NCT03057769|Indomethacin|indomethacin|mesh-list
111134411|NCT03057769|Epinephrine|epinephrine|mesh-list
111134412|NCT03057769|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111134413|NCT03057769|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111134414|NCT03057769|Adrenergic Agents|adrenergic agents|mesh-ancestor
111134415|NCT03057769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111134416|NCT03057769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111134417|NCT03057769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111134418|NCT03057769|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111134419|NCT03057769|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111134420|NCT03057769|Autonomic Agents|autonomic agents|mesh-ancestor
111134421|NCT03057769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111134422|NCT03057769|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111134423|NCT03057769|Respiratory System Agents|respiratory system agents|mesh-ancestor
111134424|NCT03057769|Mydriatics|mydriatics|mesh-ancestor
111134425|NCT03057769|Sympathomimetics|sympathomimetics|mesh-ancestor
111134426|NCT03057769|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111134427|NCT03057769|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111134428|NCT03057769|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111134429|NCT03057769|Analgesics|analgesics|mesh-ancestor
111134430|NCT03057769|Sensory System Agents|sensory system agents|mesh-ancestor
111134431|NCT03057769|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111134432|NCT03057769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111134433|NCT03057769|Gout Suppressants|gout suppressants|mesh-ancestor
111134434|NCT03057769|Tocolytic Agents|tocolytic agents|mesh-ancestor
111134435|NCT03057769|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111134436|NCT03057769|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111134437|NCT03057769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111134438|NCT04633577|Lidocaine|lidocaine|mesh-list
111134439|NCT04633577|Anesthetics, Local|anesthetics, local|mesh-ancestor
111134440|NCT04633577|Anesthetics|anesthetics|mesh-ancestor
111134441|NCT04633577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111134442|NCT04633577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111134443|NCT04633577|Sensory System Agents|sensory system agents|mesh-ancestor
111134444|NCT04633577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110838092|NCT03779035|Gemcitabine|gemcitabine|mesh-list
111134445|NCT04633577|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111134446|NCT04633577|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111134447|NCT04633577|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111134448|NCT04633577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110588868|NCT00711243|Oxaliplatin|oxaliplatin|mesh-list
111134449|NCT04633577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111134450|NCT04941625|Cystatins|cystatins|mesh-list
111134451|NCT04941625|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
111134452|NCT04941625|Protease Inhibitors|protease inhibitors|mesh-ancestor
111134453|NCT04941625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111134454|NCT04941625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111134455|NCT04922047|Tislelizumab|tislelizumab|mesh-list
111134456|NCT04922047|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111134457|NCT04922047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111134458|NCT04921657|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111134459|NCT04921657|Simvastatin|simvastatin|mesh-list
111134460|NCT04921657|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111134461|NCT04921657|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111134462|NCT04921657|Antimetabolites|antimetabolites|mesh-ancestor
111134463|NCT04921657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111134464|NCT04921657|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111134465|NCT04921657|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111134466|NCT04921657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111134467|NCT04930471|Metformin|metformin|mesh-list
111134468|NCT04930471|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111134469|NCT04930471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111134470|NCT04940689|Lidocaine|lidocaine|mesh-list
111134471|NCT04940689|Dexmedetomidine|dexmedetomidine|mesh-list
111134472|NCT04940689|Remifentanil|remifentanil|mesh-list
111134473|NCT04940689|Anesthetics, Local|anesthetics, local|mesh-ancestor
111134474|NCT04940689|Anesthetics|anesthetics|mesh-ancestor
111134475|NCT04940689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111134476|NCT04940689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111134477|NCT04940689|Sensory System Agents|sensory system agents|mesh-ancestor
111134478|NCT04940689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111134479|NCT04940689|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111134480|NCT04940689|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111134481|NCT04940689|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111134482|NCT04940689|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111134483|NCT04940689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111134484|NCT04940689|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111134485|NCT04940689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111134486|NCT04940689|Analgesics|analgesics|mesh-ancestor
111134487|NCT04940689|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111134488|NCT04940689|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111134489|NCT04940689|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111134490|NCT04940689|Adrenergic Agents|adrenergic agents|mesh-ancestor
111134491|NCT04940689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111134492|NCT04940689|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111134493|NCT04940689|Narcotics|narcotics|mesh-ancestor
111134494|NCT05530811|Dexamethasone|dexamethasone|mesh-list
111134495|NCT05530811|Bupivacaine|bupivacaine|mesh-list
111134496|NCT05530811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111134497|NCT05530811|Antiemetics|antiemetics|mesh-ancestor
111134498|NCT05530811|Autonomic Agents|autonomic agents|mesh-ancestor
111134499|NCT05530811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111134500|NCT05530811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111134501|NCT05530811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111134502|NCT05530811|Glucocorticoids|glucocorticoids|mesh-ancestor
111134503|NCT05530811|Hormones|hormones|mesh-ancestor
111134504|NCT05530811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111134505|NCT05530811|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111134506|NCT05530811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111134507|NCT05530811|Anesthetics, Local|anesthetics, local|mesh-ancestor
111134508|NCT05530811|Anesthetics|anesthetics|mesh-ancestor
111134509|NCT05530811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111134510|NCT05530811|Sensory System Agents|sensory system agents|mesh-ancestor
111134511|NCT04940845|Denosumab|denosumab|mesh-list
111134512|NCT04940845|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111134513|NCT04940845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111134514|NCT04921111|Aluminum phosphate|aluminum phosphate|mesh-list
111134515|NCT04921111|Vaccines|vaccines|mesh-list
111134516|NCT04921111|Immunologic Factors|immunologic factors|mesh-ancestor
111134517|NCT04921111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111134518|NCT04921111|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111134519|NCT04921111|Antacids|antacids|mesh-ancestor
111134520|NCT04921111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111134521|NCT04921111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110851541|NCT05865288|Oxytocin|oxytocin|mesh-list
111134523|NCT03387917|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111134524|NCT03387917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111134525|NCT03057145|Olaparib|olaparib|mesh-list
111134526|NCT03057145|Prexasertib|prexasertib|mesh-list
111134527|NCT03057145|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111134528|NCT03057145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111134529|NCT03057145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111134530|NCT03057145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111134531|NCT03057145|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111134532|NCT04940143|Botulinum Toxins|botulinum toxins|mesh-list
111134533|NCT04940143|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111134534|NCT04940143|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111134535|NCT04940143|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111134536|NCT04940143|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111134537|NCT04940143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111134538|NCT04940143|Cholinergic Agents|cholinergic agents|mesh-ancestor
111134539|NCT04940143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111134540|NCT04940143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111134541|NCT04940143|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111134542|NCT04940143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111134543|NCT04939675|Lamotrigine|lamotrigine|mesh-list
111134544|NCT04939675|Zonisamide|zonisamide|mesh-list
111134545|NCT04939675|Levetiracetam|levetiracetam|mesh-list
111134546|NCT04939675|Anticonvulsants|anticonvulsants|mesh-ancestor
111134547|NCT04939675|Nootropic Agents|nootropic agents|mesh-ancestor
111134548|NCT04939675|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111134549|NCT04939675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111134550|NCT04939675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111134551|NCT04939675|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111134552|NCT04939675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111134553|NCT04939675|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111134554|NCT04939675|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111134555|NCT04939675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111134556|NCT04939675|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111134557|NCT04939675|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111134558|NCT04938583|Paclitaxel|paclitaxel|mesh-list
111134559|NCT04938583|Bevacizumab|bevacizumab|mesh-list
111134560|NCT04938583|Carboplatin|carboplatin|mesh-list
111134561|NCT04938583|Oregovomab|oregovomab|mesh-list
111134562|NCT04938583|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111134563|NCT04938583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111134564|NCT04938583|Tubulin Modulators|tubulin modulators|mesh-ancestor
111134565|NCT04938583|Antimitotic Agents|antimitotic agents|mesh-ancestor
111134566|NCT04938583|Mitosis Modulators|mitosis modulators|mesh-ancestor
111134567|NCT04938583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111134568|NCT04938583|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111134569|NCT04938583|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111134570|NCT04938583|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111134571|NCT04938583|Growth Substances|growth substances|mesh-ancestor
111134572|NCT04938583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111134573|NCT04938583|Growth Inhibitors|growth inhibitors|mesh-ancestor
111134574|NCT03055663|Midazolam|midazolam|mesh-list
111134575|NCT03055663|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
111134576|NCT03055663|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111134577|NCT03055663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111134578|NCT03055663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111134579|NCT03055663|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111134580|NCT03055663|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111134581|NCT03055663|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111134582|NCT03055663|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111134583|NCT03055663|Anesthetics, General|anesthetics, general|mesh-ancestor
111134584|NCT03055663|Anesthetics|anesthetics|mesh-ancestor
111134585|NCT03055663|GABA Modulators|gaba modulators|mesh-ancestor
111134586|NCT03055663|GABA Agents|gaba agents|mesh-ancestor
111134587|NCT03055663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111134588|NCT03055663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111134589|NCT03057691|Antidepressive Agents|antidepressive agents|mesh-list
111134590|NCT03057691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111134591|NCT04928365|Antibodies|antibodies|mesh-list
111134592|NCT04928365|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111134593|NCT04928365|Immunologic Factors|immunologic factors|mesh-ancestor
111134594|NCT04928365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111134595|NCT04938037|Methylprednisolone|methylprednisolone|mesh-list
111134596|NCT04938037|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111134597|NCT04938037|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110588984|NCT02582190|Colchicine|colchicine|mesh-list
111134598|NCT04938037|Prednisolone|prednisolone|mesh-list
111134599|NCT04938037|Prednisolone acetate|prednisolone acetate|mesh-list
111134600|NCT04938037|Bupivacaine|bupivacaine|mesh-list
111134601|NCT04938037|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111134602|NCT04938037|Prednisolone phosphate|prednisolone phosphate|mesh-list
111134603|NCT04938037|Anesthetics, Local|anesthetics, local|mesh-ancestor
111134604|NCT04938037|Anesthetics|anesthetics|mesh-ancestor
111134605|NCT04938037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111134606|NCT04938037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111134607|NCT04938037|Sensory System Agents|sensory system agents|mesh-ancestor
111134608|NCT04938037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111134609|NCT04938037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111134610|NCT04938037|Antiemetics|antiemetics|mesh-ancestor
111134611|NCT04938037|Autonomic Agents|autonomic agents|mesh-ancestor
111134612|NCT04938037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111134613|NCT04938037|Glucocorticoids|glucocorticoids|mesh-ancestor
111134614|NCT04938037|Hormones|hormones|mesh-ancestor
111134615|NCT04938037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111134616|NCT04938037|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111134617|NCT04938037|Protective Agents|protective agents|mesh-ancestor
111134618|NCT04938037|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111134619|NCT04938037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111134620|NCT04937569|Ivermectin|ivermectin|mesh-list
111134621|NCT04937569|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111134622|NCT04937569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111134623|NCT04937101|Chlorpheniramine|chlorpheniramine|mesh-list
111134624|NCT04937101|Codeine|codeine|mesh-list
111134625|NCT04937101|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111134626|NCT04937101|Narcotics|narcotics|mesh-ancestor
111134627|NCT04937101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111134628|NCT04937101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111134629|NCT04937101|Analgesics|analgesics|mesh-ancestor
111134630|NCT04937101|Sensory System Agents|sensory system agents|mesh-ancestor
111134631|NCT04937101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111134632|NCT04937101|Antitussive Agents|antitussive agents|mesh-ancestor
111134633|NCT04937101|Respiratory System Agents|respiratory system agents|mesh-ancestor
111134634|NCT04937101|Antipruritics|antipruritics|mesh-ancestor
111134635|NCT04937101|Dermatologic Agents|dermatologic agents|mesh-ancestor
111134636|NCT04937101|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111134637|NCT04937101|Histamine Antagonists|histamine antagonists|mesh-ancestor
111134638|NCT04937101|Histamine Agents|histamine agents|mesh-ancestor
111134639|NCT04937101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111134640|NCT04937101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111134641|NCT04937101|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111134642|NCT04937023|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
111134643|NCT04937023|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
111134644|NCT04937023|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111134645|NCT04936711|Bupivacaine|bupivacaine|mesh-list
111134646|NCT04936711|Anesthetics, Local|anesthetics, local|mesh-ancestor
111134647|NCT04936711|Anesthetics|anesthetics|mesh-ancestor
111134648|NCT04936711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111134649|NCT04936711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111134650|NCT04936711|Sensory System Agents|sensory system agents|mesh-ancestor
111134651|NCT04936711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111134652|NCT04431349|Clopidogrel|clopidogrel|mesh-list
111134653|NCT04431349|Ticagrelor|ticagrelor|mesh-list
111134654|NCT04431349|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111134655|NCT04431349|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111134656|NCT04431349|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111134657|NCT04431349|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111134658|NCT04431349|Purinergic Agents|purinergic agents|mesh-ancestor
111134659|NCT04431349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111134660|NCT04431349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111134661|NCT04431349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111134662|NCT03055741|Donepezil|donepezil|mesh-list
111134663|NCT03055741|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111134664|NCT03055741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111134665|NCT03055741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111134666|NCT03055741|Cholinergic Agents|cholinergic agents|mesh-ancestor
111134667|NCT03055741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111134668|NCT03055741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111134669|NCT03055741|Nootropic Agents|nootropic agents|mesh-ancestor
111134670|NCT04927039|Iloprost|iloprost|mesh-list
111134671|NCT04927039|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111134672|NCT04927039|Vasodilator Agents|vasodilator agents|mesh-ancestor
111134674|NCT04917679|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111134675|NCT02443155|Liraglutide|liraglutide|mesh-list
111134676|NCT02443155|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111134677|NCT02443155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111134678|NCT02443155|Incretins|incretins|mesh-ancestor
111134679|NCT02443155|Hormones|hormones|mesh-ancestor
111134680|NCT02443155|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111134681|NCT04935541|Dexmedetomidine|dexmedetomidine|mesh-list
111134682|NCT04935541|Remifentanil|remifentanil|mesh-list
111134683|NCT04935541|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111134684|NCT04935541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111134685|NCT04935541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111134686|NCT04935541|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111134687|NCT04935541|Analgesics|analgesics|mesh-ancestor
111134688|NCT04935541|Sensory System Agents|sensory system agents|mesh-ancestor
111134689|NCT04935541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111134690|NCT04935541|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111134691|NCT04935541|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111134692|NCT04935541|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111134693|NCT04935541|Adrenergic Agents|adrenergic agents|mesh-ancestor
111134694|NCT04935541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111134695|NCT04935541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111134696|NCT04935541|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111134697|NCT04935541|Narcotics|narcotics|mesh-ancestor
111134698|NCT04935073|Cetrorelix|cetrorelix|mesh-list
111134699|NCT04935073|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
111134700|NCT04935073|Hormones|hormones|mesh-ancestor
111134701|NCT04935073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111134702|NCT04935073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111134703|NCT04935073|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111134704|NCT04935073|Fertility Agents|fertility agents|mesh-ancestor
111134705|NCT04935073|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111134706|NCT04935073|Hormone Antagonists|hormone antagonists|mesh-ancestor
111134707|NCT04917757|Dexamethasone|dexamethasone|mesh-list
111134708|NCT04917757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111134709|NCT04917757|Antiemetics|antiemetics|mesh-ancestor
111134710|NCT04917757|Autonomic Agents|autonomic agents|mesh-ancestor
111134711|NCT04917757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111134712|NCT04917757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111134713|NCT04917757|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111134714|NCT04917757|Glucocorticoids|glucocorticoids|mesh-ancestor
111134715|NCT04917757|Hormones|hormones|mesh-ancestor
111134716|NCT04917757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111134717|NCT04917757|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111134718|NCT04917757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111134719|NCT04916899|Rifampin|rifampin|mesh-list
111134720|NCT04916899|Isoniazid|isoniazid|mesh-list
111134721|NCT04916899|Pyrazinamide|pyrazinamide|mesh-list
111134722|NCT04916899|Ethambutol|ethambutol|mesh-list
111134723|NCT04916899|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111134724|NCT04916899|Antitubercular Agents|antitubercular agents|mesh-ancestor
111134725|NCT04916899|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111134726|NCT04916899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111134727|NCT04916899|Leprostatic Agents|leprostatic agents|mesh-ancestor
111134728|NCT04916899|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111134729|NCT04916899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111134730|NCT04916899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111134731|NCT04916899|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
111134732|NCT04916899|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111134733|NCT04916899|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
111134734|NCT04916899|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
111134735|NCT04916899|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
111134736|NCT04916899|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
111134737|NCT04916899|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
111134738|NCT04916899|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111134739|NCT04916899|Antimetabolites|antimetabolites|mesh-ancestor
111134740|NCT04916899|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111134741|NCT04916821|Propolis|propolis|mesh-list
111134742|NCT04916821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111134743|NCT04916665|Teduglutide|teduglutide|mesh-list
111134744|NCT04916665|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111134745|NCT04916665|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111134746|NCT04916665|Protective Agents|protective agents|mesh-ancestor
110851765|NCT05856500|Curcumin|curcumin|mesh-list
111134747|NCT04916665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111134748|NCT04916353|Triamcinolone|triamcinolone|mesh-list
111134749|NCT04916353|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
111134750|NCT04916353|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
111134751|NCT04916353|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
111134752|NCT04916353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111134753|NCT04916353|Glucocorticoids|glucocorticoids|mesh-ancestor
111134755|NCT04916353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111134756|NCT04916353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111134757|NCT04916353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111134758|NCT04916353|Immunologic Factors|immunologic factors|mesh-ancestor
111134759|NCT04916353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111134760|NCT04916353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111134761|NCT03056599|Interferons|interferons|mesh-list
111134762|NCT03056599|Interferon-alpha|interferon-alpha|mesh-list
111134763|NCT03056599|Interferon alpha-2|interferon alpha-2|mesh-list
111134764|NCT03056599|Aldesleukin|aldesleukin|mesh-list
111134765|NCT03056599|Interferon-gamma|interferon-gamma|mesh-list
111134766|NCT03056599|Gemcitabine|gemcitabine|mesh-list
111134767|NCT03056599|Docetaxel|docetaxel|mesh-list
111134768|NCT03056599|Doxorubicin|doxorubicin|mesh-list
111134769|NCT03056599|Pembrolizumab|pembrolizumab|mesh-list
111134770|NCT03056599|Nivolumab|nivolumab|mesh-list
111134771|NCT03056599|Bortezomib|bortezomib|mesh-list
111134772|NCT03056599|Ipilimumab|ipilimumab|mesh-list
111134773|NCT03056599|Atezolizumab|atezolizumab|mesh-list
111134774|NCT03056599|Durvalumab|durvalumab|mesh-list
111134775|NCT03056599|Avelumab|avelumab|mesh-list
111134776|NCT03056599|Trabectedin|trabectedin|mesh-list
111134777|NCT03056599|Olaratumab|olaratumab|mesh-list
111134778|NCT03056599|Entrectinib|entrectinib|mesh-list
111134779|NCT03056599|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111134780|NCT03056599|Antimetabolites|antimetabolites|mesh-ancestor
111134781|NCT03056599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111134782|NCT03056599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111134783|NCT03056599|Tubulin Modulators|tubulin modulators|mesh-ancestor
111134784|NCT03056599|Antimitotic Agents|antimitotic agents|mesh-ancestor
111134785|NCT03056599|Mitosis Modulators|mitosis modulators|mesh-ancestor
111134786|NCT03056599|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111134787|NCT03056599|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111134788|NCT03056599|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111134789|NCT03056599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111134790|NCT03056599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111134791|NCT03056599|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111134792|NCT03056599|Antiviral Agents|antiviral agents|mesh-ancestor
111134793|NCT03056599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111134794|NCT03056599|Immunologic Factors|immunologic factors|mesh-ancestor
111134795|NCT03056599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111134796|NCT03056599|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111134797|NCT03056599|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111134798|NCT03056599|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111134799|NCT03056599|Alkylating Agents|alkylating agents|mesh-ancestor
111134800|NCT03056599|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111134801|NCT04915885|Contraceptive Agents|contraceptive agents|mesh-list
111134802|NCT04915885|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111134803|NCT04915885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111134804|NCT04915963|Vitamin D|vitamin d|mesh-list
111134805|NCT04915963|Vitamins|vitamins|mesh-ancestor
111134806|NCT04915963|Micronutrients|micronutrients|mesh-ancestor
111134807|NCT04915963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111134808|NCT04915963|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111134809|NCT04915807|Paclitaxel|paclitaxel|mesh-list
111134810|NCT04915807|Irinotecan|irinotecan|mesh-list
111134811|NCT04915807|Ramucirumab|ramucirumab|mesh-list
111134812|NCT04915807|Taxane|taxane|mesh-list
111134813|NCT04915807|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111134814|NCT04915807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111134815|NCT04915807|Tubulin Modulators|tubulin modulators|mesh-ancestor
111134816|NCT04915807|Antimitotic Agents|antimitotic agents|mesh-ancestor
111134817|NCT04915807|Mitosis Modulators|mitosis modulators|mesh-ancestor
111134818|NCT04915807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111134819|NCT04915807|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111134820|NCT04915807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111134821|NCT04915807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111134822|NCT01360021|Budesonide|budesonide|mesh-list
111134823|NCT01360021|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
111134824|NCT01360021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111134825|NCT01360021|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111134826|NCT01360021|Autonomic Agents|autonomic agents|mesh-ancestor
111134827|NCT01360021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111134828|NCT01360021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111134829|NCT01360021|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111134830|NCT01360021|Respiratory System Agents|respiratory system agents|mesh-ancestor
111134831|NCT01360021|Glucocorticoids|glucocorticoids|mesh-ancestor
111134832|NCT01360021|Hormones|hormones|mesh-ancestor
111134833|NCT01360021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111134834|NCT04912297|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
111134835|NCT04912297|Immunologic Factors|immunologic factors|mesh-ancestor
111134836|NCT04912297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111134837|NCT02497287|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
111134838|NCT02497287|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
111134839|NCT02497287|Sertraline|sertraline|mesh-list
111134840|NCT02497287|Antidepressive Agents|antidepressive agents|mesh-list
111134841|NCT02497287|Esketamine|esketamine|mesh-list
111134842|NCT02497287|Escitalopram|escitalopram|mesh-list
111134843|NCT02497287|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111134844|NCT02497287|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111134845|NCT02497287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111134846|NCT02497287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111134847|NCT02497287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111134848|NCT02497287|Serotonin Agents|serotonin agents|mesh-ancestor
111134849|NCT02497287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111134850|NCT02497287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110589124|NCT02581566|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111134851|NCT02497287|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111134852|NCT02497287|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111134853|NCT02497287|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111134854|NCT02497287|Analgesics|analgesics|mesh-ancestor
111134855|NCT02497287|Sensory System Agents|sensory system agents|mesh-ancestor
111134856|NCT02497287|Dopamine Agents|dopamine agents|mesh-ancestor
111134857|NCT04912141|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
111134858|NCT04912141|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
111134859|NCT04912141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111134860|NCT04912141|Immunologic Factors|immunologic factors|mesh-ancestor
111134861|NCT04912141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111134862|NCT02458287|Bococizumab|bococizumab|mesh-list
111134863|NCT02458287|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111134864|NCT02458287|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111134865|NCT02458287|Antimetabolites|antimetabolites|mesh-ancestor
111134866|NCT02458287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111134867|NCT02458287|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111134868|NCT03056053|Zolpidem|zolpidem|mesh-list
110838180|NCT04326478|Azithromycin|azithromycin|mesh-list
111134869|NCT03056053|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111134870|NCT03056053|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111134871|NCT03056053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111134872|NCT03056053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111134873|NCT03056053|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
111134874|NCT03056053|GABA Agonists|gaba agonists|mesh-ancestor
111134875|NCT03056053|GABA Agents|gaba agents|mesh-ancestor
111134876|NCT03056053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111134877|NCT03056053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111134878|NCT02496039|Quinidine|quinidine|mesh-list
111134879|NCT02496039|Dextromethorphan|dextromethorphan|mesh-list
111134880|NCT02496039|Antitussive Agents|antitussive agents|mesh-ancestor
111134881|NCT02496039|Respiratory System Agents|respiratory system agents|mesh-ancestor
111134882|NCT02496039|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111134883|NCT02496039|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111134884|NCT02496039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111134885|NCT02496039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111134886|NCT02496039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111134887|NCT02496039|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111134888|NCT02496039|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111134889|NCT02496039|Adrenergic Agents|adrenergic agents|mesh-ancestor
111134890|NCT02496039|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111134891|NCT02496039|Antimalarials|antimalarials|mesh-ancestor
111134892|NCT02496039|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111134893|NCT02496039|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111134894|NCT02496039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111134895|NCT02496039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111134896|NCT02496039|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111134897|NCT02496039|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111134898|NCT02496039|Cholinergic Agents|cholinergic agents|mesh-ancestor
111134899|NCT02496039|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111134900|NCT02496039|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111134901|NCT02496039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111134902|NCT02496039|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111134903|NCT02496039|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111134904|NCT04922359|Lidocaine|lidocaine|mesh-list
111134905|NCT04922359|Anesthetics, Local|anesthetics, local|mesh-ancestor
111134906|NCT04922359|Anesthetics|anesthetics|mesh-ancestor
111134907|NCT04922359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111134908|NCT04922359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111134909|NCT04922359|Sensory System Agents|sensory system agents|mesh-ancestor
111134910|NCT04922359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111134911|NCT04922359|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111134912|NCT04922359|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111134913|NCT04922359|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111134914|NCT04922359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111134915|NCT04922359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111134916|NCT02495883|Ethanol|ethanol|mesh-list
111134917|NCT02495883|Propranolol|propranolol|mesh-list
111134918|NCT02495883|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111134919|NCT02495883|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111134920|NCT02495883|Adrenergic Agents|adrenergic agents|mesh-ancestor
111134921|NCT02495883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111134922|NCT02495883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111134923|NCT02495883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111134924|NCT02495883|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111134925|NCT02495883|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111134926|NCT02495883|Vasodilator Agents|vasodilator agents|mesh-ancestor
111134927|NCT02495883|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111134928|NCT02495883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111134929|NCT02495883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111134930|NCT04910347|Nivolumab|nivolumab|mesh-list
111134931|NCT04910347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111134932|NCT04910347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111134933|NCT04910347|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111134934|NCT04910347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111134935|NCT02439957|Valganciclovir|valganciclovir|mesh-list
111134936|NCT02439957|Brincidofovir|brincidofovir|mesh-list
111134937|NCT02439957|Antiviral Agents|antiviral agents|mesh-ancestor
111134938|NCT02439957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111134939|NCT02457195|Granisetron|granisetron|mesh-list
111134940|NCT02457195|Antiemetics|antiemetics|mesh-ancestor
111134941|NCT02457195|Autonomic Agents|autonomic agents|mesh-ancestor
111134942|NCT02457195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111134943|NCT02457195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111134944|NCT02457195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111134945|NCT02457195|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111134946|NCT02457195|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111134947|NCT02457195|Serotonin Agents|serotonin agents|mesh-ancestor
111134948|NCT02457195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111134949|NCT02457195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111134950|NCT04913779|Immunomodulating Agents|immunomodulating agents|mesh-list
111134951|NCT04913779|Immunologic Factors|immunologic factors|mesh-ancestor
111134952|NCT04913779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111134953|NCT03054259|Methylprednisolone|methylprednisolone|mesh-list
111134954|NCT03054259|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111134955|NCT03054259|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111134956|NCT03054259|Prednisolone|prednisolone|mesh-list
111134957|NCT03054259|Prednisolone acetate|prednisolone acetate|mesh-list
111134958|NCT03054259|Rituximab|rituximab|mesh-list
111134959|NCT03054259|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111134960|NCT03054259|Prednisolone phosphate|prednisolone phosphate|mesh-list
110589152|NCT04062357|Anesthetics|anesthetics|mesh-ancestor
111134961|NCT03054259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111134962|NCT03054259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111134963|NCT03054259|Immunologic Factors|immunologic factors|mesh-ancestor
111134964|NCT03054259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111134965|NCT03054259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111134966|NCT03054259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111134967|NCT03054259|Antiemetics|antiemetics|mesh-ancestor
111134968|NCT03054259|Autonomic Agents|autonomic agents|mesh-ancestor
111134969|NCT03054259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111134970|NCT03054259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111134971|NCT03054259|Glucocorticoids|glucocorticoids|mesh-ancestor
111134973|NCT03054259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111134974|NCT03054259|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111134975|NCT03054259|Protective Agents|protective agents|mesh-ancestor
111134976|NCT03054259|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111134977|NCT01653327|Ketamine|ketamine|mesh-list
111134978|NCT01653327|Analgesics|analgesics|mesh-ancestor
111134979|NCT01653327|Sensory System Agents|sensory system agents|mesh-ancestor
111134980|NCT01653327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111134981|NCT01653327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111134982|NCT01653327|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111134983|NCT01653327|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111134984|NCT01653327|Anesthetics, General|anesthetics, general|mesh-ancestor
111134985|NCT01653327|Anesthetics|anesthetics|mesh-ancestor
111134986|NCT01653327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111134987|NCT01653327|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111134988|NCT01653327|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111134989|NCT01653327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111134990|NCT01653327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111134991|NCT03053869|Diazepam|diazepam|mesh-list
111134992|NCT03053869|Lorazepam|lorazepam|mesh-list
111134993|NCT03053869|Alprazolam|alprazolam|mesh-list
111134994|NCT03053869|Anticonvulsants|anticonvulsants|mesh-ancestor
111134995|NCT03053869|Antiemetics|antiemetics|mesh-ancestor
111134996|NCT03053869|Autonomic Agents|autonomic agents|mesh-ancestor
111134997|NCT03053869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111134998|NCT03053869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111134999|NCT03053869|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111135000|NCT03053869|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111135001|NCT03053869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111135002|NCT03053869|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111135003|NCT03053869|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111135004|NCT03053869|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111135005|NCT03053869|GABA Modulators|gaba modulators|mesh-ancestor
111135006|NCT03053869|GABA Agents|gaba agents|mesh-ancestor
111135007|NCT03053869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111135008|NCT03053869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111135009|NCT03053869|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111135010|NCT03053869|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
111135011|NCT03053869|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111135012|NCT03053869|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111135013|NCT03053869|Anesthetics, General|anesthetics, general|mesh-ancestor
111135014|NCT03053869|Anesthetics|anesthetics|mesh-ancestor
111135015|NCT03053947|Ketamine|ketamine|mesh-list
111135016|NCT03053947|Analgesics|analgesics|mesh-ancestor
111135017|NCT03053947|Sensory System Agents|sensory system agents|mesh-ancestor
111135018|NCT03053947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111135019|NCT03053947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111135020|NCT03053947|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111135021|NCT03053947|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111135022|NCT03053947|Anesthetics, General|anesthetics, general|mesh-ancestor
111135023|NCT03053947|Anesthetics|anesthetics|mesh-ancestor
111135024|NCT03053947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111135025|NCT03053947|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111135026|NCT03053947|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111135027|NCT03053947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111135028|NCT03053947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111135029|NCT04893733|Folic Acid|folic acid|mesh-list
111135030|NCT04893733|Vitamin B Complex|vitamin b complex|mesh-list
111135031|NCT04893733|Vitamins|vitamins|mesh-ancestor
111135032|NCT04893733|Micronutrients|micronutrients|mesh-ancestor
111135033|NCT04893733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111135034|NCT04893733|Hematinics|hematinics|mesh-ancestor
111135035|NCT02493855|Ritonavir|ritonavir|mesh-list
111135036|NCT02493855|Ribavirin|ribavirin|mesh-list
111135037|NCT02493855|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111135038|NCT02493855|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111135039|NCT02493855|Protease Inhibitors|protease inhibitors|mesh-ancestor
111135040|NCT02493855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111135041|NCT02493855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111135042|NCT02493855|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111135043|NCT02493855|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111135044|NCT02493855|Antiviral Agents|antiviral agents|mesh-ancestor
111135045|NCT02493855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111135046|NCT02493855|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111135047|NCT02493855|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111135048|NCT02493855|Antimetabolites|antimetabolites|mesh-ancestor
111135049|NCT04892563|Morphine|morphine|mesh-list
111135050|NCT04892563|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111135051|NCT04892563|Narcotics|narcotics|mesh-ancestor
111135052|NCT04892563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111135053|NCT04892563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111135054|NCT04892563|Analgesics|analgesics|mesh-ancestor
111135055|NCT04892563|Sensory System Agents|sensory system agents|mesh-ancestor
111135056|NCT04892563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111135057|NCT04909255|Solifenacin Succinate|solifenacin succinate|mesh-list
111135058|NCT04909255|Mirabegron|mirabegron|mesh-list
111135059|NCT04909255|Tolterodine Tartrate|tolterodine tartrate|mesh-list
111135060|NCT04909255|Oxybutynin|oxybutynin|mesh-list
111135061|NCT04909255|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111135062|NCT04909255|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111135063|NCT04909255|Cholinergic Agents|cholinergic agents|mesh-ancestor
111135064|NCT04909255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111135065|NCT04909255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111135066|NCT04909255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111135067|NCT04909255|Urological Agents|urological agents|mesh-ancestor
111135068|NCT04909255|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
111135069|NCT04909255|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111135070|NCT04909255|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111135071|NCT04909255|Adrenergic Agents|adrenergic agents|mesh-ancestor
111135072|NCT04909255|Parasympatholytics|parasympatholytics|mesh-ancestor
111135073|NCT04909255|Autonomic Agents|autonomic agents|mesh-ancestor
111135074|NCT04909255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111135075|NCT04891861|Rivaroxaban|rivaroxaban|mesh-list
111135076|NCT04891861|Apixaban|apixaban|mesh-list
111135077|NCT04891861|Edoxaban|edoxaban|mesh-list
111135078|NCT04891861|Dabigatran|dabigatran|mesh-list
111135079|NCT04891861|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111135080|NCT04891861|Antithrombins|antithrombins|mesh-ancestor
111135081|NCT04891861|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111135082|NCT04891861|Protease Inhibitors|protease inhibitors|mesh-ancestor
111135083|NCT04891861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111135084|NCT04891861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111135085|NCT04891861|Anticoagulants|anticoagulants|mesh-ancestor
111135086|NCT03053167|Irinotecan|irinotecan|mesh-list
111135087|NCT03053167|Raltitrexed|raltitrexed|mesh-list
111135088|NCT03053167|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111135089|NCT03053167|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111135090|NCT03053167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111135091|NCT03053167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111135092|NCT03053167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111135093|NCT03053167|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111135094|NCT03053167|Antimetabolites|antimetabolites|mesh-ancestor
111135095|NCT03053167|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111135096|NCT04901923|Itraconazole|itraconazole|mesh-list
111135097|NCT04901923|Acalabrutinib|acalabrutinib|mesh-list
111135098|NCT04901923|Antifungal Agents|antifungal agents|mesh-ancestor
111135099|NCT04901923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111135100|NCT04901923|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111135101|NCT04901923|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111135102|NCT04901923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111135103|NCT04901923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111135104|NCT04901923|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111135105|NCT04901923|Hormone Antagonists|hormone antagonists|mesh-ancestor
111135106|NCT04901923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111135107|NCT04901923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111135108|NCT04901923|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111135109|NCT04901923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111135110|NCT03050905|Ritonavir|ritonavir|mesh-list
111135111|NCT03050905|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111135112|NCT03050905|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111135113|NCT03050905|Protease Inhibitors|protease inhibitors|mesh-ancestor
111135114|NCT03050905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111135115|NCT03050905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111135116|NCT03050905|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111135117|NCT03050905|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111135118|NCT03050905|Antiviral Agents|antiviral agents|mesh-ancestor
111135119|NCT03050905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111135120|NCT03050905|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111135121|NCT03050905|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111135122|NCT03050827|Oxybutynin|oxybutynin|mesh-list
111135123|NCT03050827|Parasympatholytics|parasympatholytics|mesh-ancestor
111135124|NCT03050827|Autonomic Agents|autonomic agents|mesh-ancestor
111135125|NCT03050827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111135126|NCT03050827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111135127|NCT03050827|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111135128|NCT03050827|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110838297|NCT01146041|Rivastigmine|rivastigmine|mesh-list
111135129|NCT03050827|Cholinergic Agents|cholinergic agents|mesh-ancestor
111135130|NCT03050827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111135131|NCT03050827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111135132|NCT03050827|Urological Agents|urological agents|mesh-ancestor
111135133|NCT02438787|Golimumab|golimumab|mesh-list
111135134|NCT02438787|Ustekinumab|ustekinumab|mesh-list
111135135|NCT02438787|Dermatologic Agents|dermatologic agents|mesh-ancestor
111135136|NCT02438787|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111135137|NCT02438787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111135138|NCT02438787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111135139|NCT02438787|Immunologic Factors|immunologic factors|mesh-ancestor
111135140|NCT02438787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111135141|NCT04901065|Lidocaine|lidocaine|mesh-list
111135142|NCT04901065|Anesthetics, Local|anesthetics, local|mesh-ancestor
111135143|NCT04901065|Anesthetics|anesthetics|mesh-ancestor
111135144|NCT04901065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111135145|NCT04901065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111135146|NCT04901065|Sensory System Agents|sensory system agents|mesh-ancestor
111135147|NCT04901065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111135148|NCT04901065|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111135149|NCT04901065|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111135150|NCT04901065|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111135151|NCT04901065|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111135152|NCT04901065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111135153|NCT02493777|Methylphenidate|methylphenidate|mesh-list
111135154|NCT02493777|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111135155|NCT02493777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111135156|NCT02493777|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111135157|NCT02493777|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111135158|NCT02493777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111135159|NCT02493777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111135160|NCT02493777|Dopamine Agents|dopamine agents|mesh-ancestor
111135161|NCT02493777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111135162|NCT04907149|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111135163|NCT04906915|Ketamine|ketamine|mesh-list
111135164|NCT04906915|Analgesics|analgesics|mesh-ancestor
111135165|NCT04906915|Sensory System Agents|sensory system agents|mesh-ancestor
111135166|NCT04906915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111135167|NCT04906915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111135168|NCT04906915|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110589245|NCT04137354|Antioxidants|antioxidants|mesh-ancestor
111135169|NCT04906915|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111135170|NCT04906915|Anesthetics, General|anesthetics, general|mesh-ancestor
111135171|NCT04906915|Anesthetics|anesthetics|mesh-ancestor
111135172|NCT04906915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111135173|NCT04906915|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111135174|NCT04906915|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111135175|NCT04906915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111135176|NCT04906915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111135177|NCT04890379|Dimethyl Fumarate|dimethyl fumarate|mesh-list
111135178|NCT04890379|Dermatologic Agents|dermatologic agents|mesh-ancestor
111135179|NCT04890379|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111135180|NCT04890379|Immunologic Factors|immunologic factors|mesh-ancestor
111135181|NCT04890379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111135182|NCT04900129|Acetylcysteine|acetylcysteine|mesh-list
111135183|NCT04900129|Diclofenac|diclofenac|mesh-list
111135184|NCT04900129|Salicylates|salicylates|mesh-list
111135185|NCT04900129|Methyl salicylate|methyl salicylate|mesh-list
111135186|NCT04900129|Menthol|menthol|mesh-list
111135187|NCT04900129|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111135188|NCT04900129|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111135189|NCT04900129|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111135190|NCT04900129|Analgesics|analgesics|mesh-ancestor
111135191|NCT04900129|Sensory System Agents|sensory system agents|mesh-ancestor
111135192|NCT04900129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111135193|NCT04900129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111135194|NCT04900129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111135195|NCT04900129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111135196|NCT04900129|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111135197|NCT04900129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111135198|NCT04900129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111135199|NCT04900129|Antipruritics|antipruritics|mesh-ancestor
111135200|NCT04900129|Dermatologic Agents|dermatologic agents|mesh-ancestor
111135201|NCT04900129|Antiviral Agents|antiviral agents|mesh-ancestor
111135202|NCT04900129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111135203|NCT04900129|Expectorants|expectorants|mesh-ancestor
111135204|NCT04900129|Respiratory System Agents|respiratory system agents|mesh-ancestor
111135205|NCT04900129|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111135206|NCT04900129|Antioxidants|antioxidants|mesh-ancestor
111135207|NCT04900129|Protective Agents|protective agents|mesh-ancestor
111135208|NCT04900129|Antidotes|antidotes|mesh-ancestor
111135209|NCT02616601|Fluorouracil|fluorouracil|mesh-list
111135210|NCT02616601|Antimetabolites|antimetabolites|mesh-ancestor
111135211|NCT02616601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111135212|NCT02616601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111135213|NCT02616601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111135214|NCT02616601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111135215|NCT02616601|Immunologic Factors|immunologic factors|mesh-ancestor
111135216|NCT02616601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111135217|NCT02492997|Glycerol|glycerol|mesh-list
111135218|NCT02492997|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
111135219|NCT02492997|Protective Agents|protective agents|mesh-ancestor
111135220|NCT02492997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111135221|NCT04393207|Dexamethasone|dexamethasone|mesh-list
111135222|NCT04393207|Dexamethasone acetate|dexamethasone acetate|mesh-list
111135223|NCT04393207|Methylprednisolone|methylprednisolone|mesh-list
110589261|NCT03498378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111135224|NCT04393207|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111135225|NCT04393207|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111135226|NCT04393207|Prednisolone|prednisolone|mesh-list
111135227|NCT04393207|Prednisolone acetate|prednisolone acetate|mesh-list
111135228|NCT04393207|Bupivacaine|bupivacaine|mesh-list
111135229|NCT04393207|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111135230|NCT04393207|Prednisolone phosphate|prednisolone phosphate|mesh-list
111135231|NCT04393207|BB 1101|bb 1101|mesh-list
111135232|NCT04393207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111135233|NCT04393207|Antiemetics|antiemetics|mesh-ancestor
111135234|NCT04393207|Autonomic Agents|autonomic agents|mesh-ancestor
111135235|NCT04393207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111135236|NCT04393207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111135237|NCT04393207|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111135238|NCT04393207|Glucocorticoids|glucocorticoids|mesh-ancestor
111135239|NCT04393207|Hormones|hormones|mesh-ancestor
111135240|NCT04393207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111135241|NCT04393207|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111135242|NCT04393207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111135243|NCT04393207|Protease Inhibitors|protease inhibitors|mesh-ancestor
111135244|NCT04393207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111135245|NCT04393207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111135246|NCT04393207|Anesthetics, Local|anesthetics, local|mesh-ancestor
111135247|NCT04393207|Anesthetics|anesthetics|mesh-ancestor
111135248|NCT04393207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111135249|NCT04393207|Sensory System Agents|sensory system agents|mesh-ancestor
111135250|NCT04393207|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111135251|NCT04393207|Protective Agents|protective agents|mesh-ancestor
111135252|NCT02492841|Calcium, Dietary|calcium, dietary|mesh-list
111135253|NCT02492841|Calcium|calcium|mesh-list
111135254|NCT02492841|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111135255|NCT02492841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111135256|NCT02492841|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111135257|NCT04814875|Carboplatin|carboplatin|mesh-list
111135259|NCT04814875|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111135260|NCT04814875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111135261|NCT04814875|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111135262|NCT04814875|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111135263|NCT04814875|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111135264|NCT04814875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111135265|NCT04814875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111135266|NCT04812535|Pembrolizumab|pembrolizumab|mesh-list
111135267|NCT04812535|Vilobelimab|vilobelimab|mesh-list
111135268|NCT04812535|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111135269|NCT04812535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111135270|NCT04812535|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111135271|NCT04812535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111135272|NCT04812535|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
111135273|NCT04812535|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111135275|NCT04812535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111135276|NCT02492763|Metformin|metformin|mesh-list
111135277|NCT02492763|Liraglutide|liraglutide|mesh-list
111135278|NCT02492763|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111135279|NCT02492763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111135280|NCT02492763|Incretins|incretins|mesh-ancestor
111135281|NCT02492763|Hormones|hormones|mesh-ancestor
111135282|NCT02492763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111135283|NCT04899817|Granisetron|granisetron|mesh-list
111135284|NCT04899817|Antiemetics|antiemetics|mesh-ancestor
111135285|NCT04899817|Autonomic Agents|autonomic agents|mesh-ancestor
111135286|NCT04899817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111135287|NCT04899817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111135288|NCT04899817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111135289|NCT04899817|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111135290|NCT04899817|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111135291|NCT04899817|Serotonin Agents|serotonin agents|mesh-ancestor
111135292|NCT04899817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111135293|NCT04899817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111135294|NCT04905667|Trastuzumab|trastuzumab|mesh-list
111135295|NCT04905667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111135296|NCT04905667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111135297|NCT04397107|Aldesleukin|aldesleukin|mesh-list
111135298|NCT04397107|Interleukin-2|interleukin-2|mesh-list
111135299|NCT04397107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111135300|NCT04397107|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111135301|NCT04397107|Analgesics|analgesics|mesh-ancestor
111135302|NCT04397107|Sensory System Agents|sensory system agents|mesh-ancestor
111135303|NCT04397107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111135304|NCT04397107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111135305|NCT04397107|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111135306|NCT04397107|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111135307|NCT04397107|Antiviral Agents|antiviral agents|mesh-ancestor
111135308|NCT04397107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111135309|NCT02453841|Phenylephrine|phenylephrine|mesh-list
111135310|NCT02453841|Oxymetazoline|oxymetazoline|mesh-list
111135311|NCT02453841|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111135312|NCT02453841|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111135313|NCT02453841|Adrenergic Agents|adrenergic agents|mesh-ancestor
111135314|NCT02453841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111135315|NCT02453841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111135316|NCT02453841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111135317|NCT02453841|Sympathomimetics|sympathomimetics|mesh-ancestor
111135318|NCT02453841|Autonomic Agents|autonomic agents|mesh-ancestor
111135319|NCT02453841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111135320|NCT02453841|Nasal Decongestants|nasal decongestants|mesh-ancestor
111135321|NCT02453841|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111135322|NCT02453841|Respiratory System Agents|respiratory system agents|mesh-ancestor
111135323|NCT02453841|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111135325|NCT02453841|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111135326|NCT02453841|Protective Agents|protective agents|mesh-ancestor
111135327|NCT03081689|Paclitaxel|paclitaxel|mesh-list
111135328|NCT03081689|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111135329|NCT03081689|Carboplatin|carboplatin|mesh-list
111135330|NCT03081689|Nivolumab|nivolumab|mesh-list
111135331|NCT03081689|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111135332|NCT03081689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111135333|NCT03081689|Tubulin Modulators|tubulin modulators|mesh-ancestor
111135334|NCT03081689|Antimitotic Agents|antimitotic agents|mesh-ancestor
111135335|NCT03081689|Mitosis Modulators|mitosis modulators|mesh-ancestor
111135336|NCT03081689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111135337|NCT03081689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111135338|NCT03081689|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111135339|NCT04888663|Paclitaxel|paclitaxel|mesh-list
111135340|NCT04888663|Trastuzumab|trastuzumab|mesh-list
111135341|NCT04888663|Ramucirumab|ramucirumab|mesh-list
111135342|NCT04888663|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111135343|NCT04888663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111135344|NCT04888663|Tubulin Modulators|tubulin modulators|mesh-ancestor
111135345|NCT04888663|Antimitotic Agents|antimitotic agents|mesh-ancestor
111135346|NCT04888663|Mitosis Modulators|mitosis modulators|mesh-ancestor
111135347|NCT04888663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111135348|NCT04888663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111135349|NCT04899427|Tislelizumab|tislelizumab|mesh-list
111135350|NCT04899427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111135351|NCT04899427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111135352|NCT02453685|Insulin|insulin|mesh-list
111135353|NCT02453685|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111135354|NCT02453685|Insulin Glargine|insulin glargine|mesh-list
111135355|NCT02453685|Insulin Aspart|insulin aspart|mesh-list
111135356|NCT02453685|Insulin, Long-Acting|insulin, long-acting|mesh-list
111135357|NCT02453685|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
111135358|NCT02453685|Biphasic Insulins|biphasic insulins|mesh-list
111135359|NCT02453685|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
111135360|NCT02453685|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111135361|NCT02453685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111135362|NCT03051841|Dexamethasone|dexamethasone|mesh-list
111135363|NCT03051841|Bortezomib|bortezomib|mesh-list
111135364|NCT03051841|CKD-581|ckd-581|mesh-list
111135365|NCT03051841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111135366|NCT03051841|Antiemetics|antiemetics|mesh-ancestor
111135367|NCT03051841|Autonomic Agents|autonomic agents|mesh-ancestor
111135368|NCT03051841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111135369|NCT03051841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111135370|NCT03051841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111135371|NCT03051841|Glucocorticoids|glucocorticoids|mesh-ancestor
111135372|NCT03051841|Hormones|hormones|mesh-ancestor
111135373|NCT03051841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111135374|NCT03051841|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111135375|NCT03051841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111135376|NCT03051841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111135377|NCT03051841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111135378|NCT03051841|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111135379|NCT04905043|Acalabrutinib|acalabrutinib|mesh-list
111135380|NCT04905043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111135381|NCT02436759|Phenylephrine|phenylephrine|mesh-list
111135382|NCT02436759|Oxymetazoline|oxymetazoline|mesh-list
111135383|NCT02436759|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111135384|NCT02436759|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111135385|NCT02436759|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111135386|NCT02436759|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111135387|NCT02436759|Adrenergic Agents|adrenergic agents|mesh-ancestor
110838348|NCT03434704|Miconazole|miconazole|mesh-list
111135388|NCT02436759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111135389|NCT02436759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111135390|NCT02436759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111135391|NCT02436759|Sympathomimetics|sympathomimetics|mesh-ancestor
111135392|NCT02436759|Autonomic Agents|autonomic agents|mesh-ancestor
111135393|NCT02436759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111135394|NCT02436759|Nasal Decongestants|nasal decongestants|mesh-ancestor
111135395|NCT02436759|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111135396|NCT02436759|Respiratory System Agents|respiratory system agents|mesh-ancestor
111135397|NCT02436759|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111135398|NCT02436759|Mydriatics|mydriatics|mesh-ancestor
111135399|NCT02436759|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111135400|NCT02436759|Protective Agents|protective agents|mesh-ancestor
111135402|NCT04888819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111135403|NCT04904185|Cyclophosphamide|cyclophosphamide|mesh-list
111135404|NCT04904185|Pembrolizumab|pembrolizumab|mesh-list
111135405|NCT04904185|Fludarabine|fludarabine|mesh-list
111135406|NCT04904185|Fludarabine phosphate|fludarabine phosphate|mesh-list
111135407|NCT04904185|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111135408|NCT04904185|Immunologic Factors|immunologic factors|mesh-ancestor
111135409|NCT04904185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111135410|NCT04904185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111135411|NCT04904185|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111135412|NCT04904185|Alkylating Agents|alkylating agents|mesh-ancestor
111135413|NCT04904185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111135414|NCT04904185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111135415|NCT04904185|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111135416|NCT04904185|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111135417|NCT04904185|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111135418|NCT04904185|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111135419|NCT04904185|Antimetabolites|antimetabolites|mesh-ancestor
111135420|NCT04887961|Trabectedin|trabectedin|mesh-list
111135421|NCT04887961|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111135422|NCT04887961|Alkylating Agents|alkylating agents|mesh-ancestor
111135423|NCT04887961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110852460|NCT02329080|Cytarabine|cytarabine|mesh-list
111135424|NCT04887961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111135425|NCT04887649|Morphine|morphine|mesh-list
111135426|NCT04887649|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111135427|NCT04887649|Narcotics|narcotics|mesh-ancestor
111135428|NCT04887649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111135429|NCT04887649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111135430|NCT04887649|Analgesics|analgesics|mesh-ancestor
111135431|NCT04887649|Sensory System Agents|sensory system agents|mesh-ancestor
111135432|NCT04887649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111135433|NCT03050437|Pemetrexed|pemetrexed|mesh-list
111135434|NCT03050437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111135435|NCT03050437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111135436|NCT03050437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111135437|NCT03050437|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111135438|NCT03050437|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111135439|NCT02436135|Idelalisib|idelalisib|mesh-list
111135440|NCT02436135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111135441|NCT02436135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111135442|NCT02436135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111135443|NCT02435277|Metformin|metformin|mesh-list
111135444|NCT02435277|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111135445|NCT02435277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111135446|NCT02420223|Propranolol|propranolol|mesh-list
111135447|NCT02420223|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111135448|NCT02420223|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111135449|NCT02420223|Adrenergic Agents|adrenergic agents|mesh-ancestor
111135450|NCT02420223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111135451|NCT02420223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111135452|NCT02420223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111135453|NCT02420223|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111135454|NCT02420223|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111135455|NCT02420223|Vasodilator Agents|vasodilator agents|mesh-ancestor
111135456|NCT02433483|Cytarabine|cytarabine|mesh-list
111135457|NCT02433483|Hydrocortisone|hydrocortisone|mesh-list
111135458|NCT02433483|Methotrexate|methotrexate|mesh-list
111135459|NCT02433483|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111135460|NCT02433483|Abortifacient Agents|abortifacient agents|mesh-ancestor
111135461|NCT02433483|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111135462|NCT02433483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111135463|NCT02433483|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111135464|NCT02433483|Antimetabolites|antimetabolites|mesh-ancestor
111135465|NCT02433483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111135466|NCT02433483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111135467|NCT02433483|Dermatologic Agents|dermatologic agents|mesh-ancestor
111135468|NCT02433483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111135469|NCT02433483|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111135470|NCT02433483|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111135471|NCT02433483|Immunologic Factors|immunologic factors|mesh-ancestor
111135472|NCT02433483|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111135473|NCT02433483|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111135474|NCT02433483|Antiviral Agents|antiviral agents|mesh-ancestor
111135475|NCT02433483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111135476|NCT02433483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111135477|NCT02419755|Cytarabine|cytarabine|mesh-list
111135478|NCT02419755|Dexamethasone|dexamethasone|mesh-list
111135479|NCT02419755|Hydrocortisone|hydrocortisone|mesh-list
111135480|NCT02419755|Doxorubicin|doxorubicin|mesh-list
111135481|NCT02419755|Methotrexate|methotrexate|mesh-list
111135482|NCT02419755|Bortezomib|bortezomib|mesh-list
111135483|NCT02419755|Asparaginase|asparaginase|mesh-list
111135484|NCT02419755|Mitoxantrone|mitoxantrone|mesh-list
111135485|NCT02419755|Mercaptopurine|mercaptopurine|mesh-list
111135486|NCT02419755|Vorinostat|vorinostat|mesh-list
111135487|NCT02419755|Pegaspargase|pegaspargase|mesh-list
111135488|NCT02419755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111135489|NCT02419755|Antiemetics|antiemetics|mesh-ancestor
111135490|NCT02419755|Autonomic Agents|autonomic agents|mesh-ancestor
111135491|NCT02419755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111135492|NCT02419755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111135493|NCT02419755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111135494|NCT02419755|Glucocorticoids|glucocorticoids|mesh-ancestor
111135495|NCT02419755|Hormones|hormones|mesh-ancestor
111135496|NCT02419755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111135497|NCT02419755|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111135498|NCT02419755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111135499|NCT02419755|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110852517|NCT00071071|Zanolimumab|zanolimumab|mesh-list
111135500|NCT02419755|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111135501|NCT02419755|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111135502|NCT02419755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111135503|NCT02419755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111135504|NCT02419755|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111135505|NCT02419755|Abortifacient Agents|abortifacient agents|mesh-ancestor
111135506|NCT02419755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111135507|NCT02419755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111135508|NCT02419755|Antimetabolites|antimetabolites|mesh-ancestor
111135509|NCT02419755|Dermatologic Agents|dermatologic agents|mesh-ancestor
111135510|NCT02419755|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111135511|NCT02419755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111135512|NCT02419755|Immunologic Factors|immunologic factors|mesh-ancestor
111135513|NCT02419755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111135514|NCT02419755|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111135515|NCT02419755|Antiviral Agents|antiviral agents|mesh-ancestor
111135516|NCT02419755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111135518|NCT02419755|Sensory System Agents|sensory system agents|mesh-ancestor
111135519|NCT02419755|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111135520|NCT04913025|Pembrolizumab|pembrolizumab|mesh-list
111135521|NCT04913025|Nivolumab|nivolumab|mesh-list
111135522|NCT04913025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111135523|NCT04913025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111135524|NCT04913025|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111135525|NCT04913025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111135526|NCT04898101|Acalabrutinib|acalabrutinib|mesh-list
111135527|NCT04898101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111135528|NCT02432703|JNJ-42165279|jnj-42165279|mesh-list
111135529|NCT02432703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111135530|NCT02432703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111135531|NCT04887493|Alprostadil|alprostadil|mesh-list
111135532|NCT04887493|Misoprostol|misoprostol|mesh-list
111135533|NCT04887493|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111135534|NCT04887493|Abortifacient Agents|abortifacient agents|mesh-ancestor
111135535|NCT04887493|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111135536|NCT04887493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111135537|NCT04887493|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111135538|NCT04887493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111135539|NCT04887493|Oxytocics|oxytocics|mesh-ancestor
111135540|NCT04887493|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111135541|NCT04887493|Vasodilator Agents|vasodilator agents|mesh-ancestor
111135542|NCT04887493|Urological Agents|urological agents|mesh-ancestor
111135543|NCT02486757|Estradiol|estradiol|mesh-list
111135544|NCT02486757|Progesterone|progesterone|mesh-list
111135545|NCT02486757|Estrogens|estrogens|mesh-ancestor
111135546|NCT02486757|Hormones|hormones|mesh-ancestor
111135547|NCT02486757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111135548|NCT02486757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111135549|NCT02486757|Progestins|progestins|mesh-ancestor
111135550|NCT04883203|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111135551|NCT04883203|Plasma-lyte 148|plasma-lyte 148|mesh-list
111135552|NCT04883203|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
111135553|NCT03051529|Anesthetics|anesthetics|mesh-list
111135554|NCT03051529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111135555|NCT03051529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111135556|NCT04886869|Caffeine|caffeine|mesh-list
111135557|NCT04886869|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111135558|NCT04886869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111135559|NCT04886869|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111135560|NCT04886869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111135561|NCT04886869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111135562|NCT04886869|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
111135563|NCT04886869|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111135564|NCT04886869|Purinergic Agents|purinergic agents|mesh-ancestor
111135565|NCT04886869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111135566|NCT04897477|Azacitidine|azacitidine|mesh-list
111135567|NCT04897477|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
111135568|NCT04897477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111135569|NCT04897477|Antimetabolites|antimetabolites|mesh-ancestor
111135570|NCT04897477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111135571|NCT04897477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111135572|NCT04897477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111135573|NCT04897477|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111135574|NCT04897477|Alkylating Agents|alkylating agents|mesh-ancestor
110852598|NCT03332524|Antipruritics|antipruritics|mesh-ancestor
111135575|NCT02576639|Umibecestat|umibecestat|mesh-list
111135576|NCT02576639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111135577|NCT02576639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111135578|NCT02418585|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
111135579|NCT02418585|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
111135580|NCT02418585|Sertraline|sertraline|mesh-list
111135581|NCT02418585|Antidepressive Agents|antidepressive agents|mesh-list
111135582|NCT02418585|Esketamine|esketamine|mesh-list
111135583|NCT02418585|Escitalopram|escitalopram|mesh-list
111135584|NCT02418585|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110870377|NCT02394418|Adrenergic Agents|adrenergic agents|mesh-ancestor
111135585|NCT02418585|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111135586|NCT02418585|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111135587|NCT02418585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111135588|NCT02418585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111135589|NCT02418585|Serotonin Agents|serotonin agents|mesh-ancestor
111135590|NCT02418585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111135591|NCT02418585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111135592|NCT02418585|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111135593|NCT02418585|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111135594|NCT02418585|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111135595|NCT02418585|Analgesics|analgesics|mesh-ancestor
111135596|NCT02418585|Sensory System Agents|sensory system agents|mesh-ancestor
111135597|NCT02418585|Dopamine Agents|dopamine agents|mesh-ancestor
111135598|NCT05529875|Propofol|propofol|mesh-list
111135599|NCT05529875|Sevoflurane|sevoflurane|mesh-list
111135600|NCT05529875|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111135601|NCT05529875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111135602|NCT05529875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111135603|NCT05529875|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111135604|NCT05529875|Anesthetics, General|anesthetics, general|mesh-ancestor
111135605|NCT05529875|Anesthetics|anesthetics|mesh-ancestor
111135606|NCT05529875|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111135607|NCT05529875|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111135608|NCT03051451|Metformin|metformin|mesh-list
111135609|NCT03051451|Fluoxetine|fluoxetine|mesh-list
111135610|NCT03051451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111135611|NCT03051451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111135612|NCT03051451|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111135613|NCT03051451|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111135614|NCT03051451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111135615|NCT03051451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111135616|NCT03051451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111135617|NCT03051451|Serotonin Agents|serotonin agents|mesh-ancestor
111135618|NCT03051451|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111135619|NCT03051451|Antidepressive Agents|antidepressive agents|mesh-ancestor
111135620|NCT03051451|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111135621|NCT03051451|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111135622|NCT03051451|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111135623|NCT03051451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111135624|NCT02417961|Benralizumab|benralizumab|mesh-list
111135625|NCT02417961|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111135626|NCT02417961|Respiratory System Agents|respiratory system agents|mesh-ancestor
111135627|NCT02869217|Cyclophosphamide|cyclophosphamide|mesh-list
111135628|NCT02869217|Fludarabine|fludarabine|mesh-list
111135629|NCT02869217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111135630|NCT02869217|Immunologic Factors|immunologic factors|mesh-ancestor
111135631|NCT02869217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111135632|NCT02869217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111135633|NCT02869217|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111135634|NCT02869217|Alkylating Agents|alkylating agents|mesh-ancestor
111135635|NCT02869217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111135636|NCT02869217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111135637|NCT02869217|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111135638|NCT04883125|Pioglitazone|pioglitazone|mesh-list
111135639|NCT04883125|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111135640|NCT04883125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111135641|NCT05474183|Dexmedetomidine|dexmedetomidine|mesh-list
111135642|NCT05474183|Ketamine|ketamine|mesh-list
111135643|NCT05474183|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111135644|NCT05474183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111135645|NCT05474183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111135646|NCT05474183|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111135647|NCT05474183|Analgesics|analgesics|mesh-ancestor
111135648|NCT05474183|Sensory System Agents|sensory system agents|mesh-ancestor
111135649|NCT05474183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110838386|NCT02891226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111135650|NCT05474183|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111135651|NCT05474183|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111135652|NCT05474183|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111135653|NCT05474183|Adrenergic Agents|adrenergic agents|mesh-ancestor
111135654|NCT05474183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111135655|NCT05474183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111135656|NCT05474183|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111135657|NCT05474183|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111135658|NCT05474183|Anesthetics, General|anesthetics, general|mesh-ancestor
111135659|NCT05474183|Anesthetics|anesthetics|mesh-ancestor
111135660|NCT05474183|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111135661|NCT05474183|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111135663|NCT04885777|Anesthetics, Local|anesthetics, local|mesh-ancestor
111135664|NCT04885777|Anesthetics|anesthetics|mesh-ancestor
111135665|NCT04885777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110589416|NCT02664558|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111135666|NCT04885777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111135667|NCT04885777|Sensory System Agents|sensory system agents|mesh-ancestor
111135668|NCT04885777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111135669|NCT04885777|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111135670|NCT04885777|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111135671|NCT04885777|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111135672|NCT04885777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111135673|NCT04885777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111135674|NCT04885855|Sofosbuvir|sofosbuvir|mesh-list
111135675|NCT04885855|Antiviral Agents|antiviral agents|mesh-ancestor
111135676|NCT04885855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111135677|NCT02632721|Decitabine|decitabine|mesh-list
111135678|NCT02632721|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111135679|NCT02632721|Antimetabolites|antimetabolites|mesh-ancestor
111135680|NCT02632721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111135681|NCT02632721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111135682|NCT02632721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111135683|NCT05529095|Apomorphine|apomorphine|mesh-list
111135684|NCT05529095|Emetics|emetics|mesh-ancestor
111135685|NCT05529095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111135686|NCT05529095|Autonomic Agents|autonomic agents|mesh-ancestor
111135687|NCT05529095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111135688|NCT05529095|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111135689|NCT05529095|Dopamine Agonists|dopamine agonists|mesh-ancestor
111135690|NCT05529095|Dopamine Agents|dopamine agents|mesh-ancestor
111135691|NCT05529095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111135692|NCT05529095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111135693|NCT01596127|Rituximab|rituximab|mesh-list
111135694|NCT01596127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111135695|NCT01596127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111135696|NCT01596127|Immunologic Factors|immunologic factors|mesh-ancestor
111135697|NCT01596127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111135698|NCT01596127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111135699|NCT03051373|Paclitaxel|paclitaxel|mesh-list
111135700|NCT03051373|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111135701|NCT03051373|Gemcitabine|gemcitabine|mesh-list
111135702|NCT03051373|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111135703|NCT03051373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111135704|NCT03051373|Tubulin Modulators|tubulin modulators|mesh-ancestor
111135705|NCT03051373|Antimitotic Agents|antimitotic agents|mesh-ancestor
111135706|NCT03051373|Mitosis Modulators|mitosis modulators|mesh-ancestor
111135707|NCT03051373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111135708|NCT03051373|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111135709|NCT03051373|Antimetabolites|antimetabolites|mesh-ancestor
111135710|NCT04895059|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111135711|NCT04895059|Ezetimibe|ezetimibe|mesh-list
111135712|NCT04895059|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111135713|NCT04895059|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111135714|NCT04895059|Antimetabolites|antimetabolites|mesh-ancestor
111135715|NCT04895059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111135716|NCT04895059|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111135717|NCT04895059|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111135718|NCT04895059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111135719|NCT05467475|Esomeprazole|esomeprazole|mesh-list
111135720|NCT05467475|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111135721|NCT05467475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111135722|NCT05467475|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111135723|NCT05467475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111135724|NCT05467475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111135725|NCT05534165|Tecovirimat|tecovirimat|mesh-list
111135726|NCT05534165|Antiviral Agents|antiviral agents|mesh-ancestor
111135727|NCT05534165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111135728|NCT01595581|Methyltestosterone|methyltestosterone|mesh-list
111135729|NCT01595581|Testosterone|testosterone|mesh-list
111135730|NCT01595581|Testosterone undecanoate|testosterone undecanoate|mesh-list
111135731|NCT01595581|Testosterone enanthate|testosterone enanthate|mesh-list
111135732|NCT01595581|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
111135733|NCT01595581|Androgens|androgens|mesh-ancestor
111135734|NCT01595581|Hormones|hormones|mesh-ancestor
111135735|NCT01595581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111135736|NCT01595581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111135737|NCT01595581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111135738|NCT01595581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111135739|NCT01595581|Anabolic Agents|anabolic agents|mesh-ancestor
111135740|NCT04885153|Fenofibrate|fenofibrate|mesh-list
111135741|NCT04885153|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111135742|NCT04885153|Antimetabolites|antimetabolites|mesh-ancestor
111135743|NCT04885153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111135744|NCT04885153|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111135745|NCT03048643|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111135746|NCT03048643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111135747|NCT04884997|Temozolomide|temozolomide|mesh-list
111135748|NCT04884997|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111135749|NCT04884997|Alkylating Agents|alkylating agents|mesh-ancestor
111135750|NCT04884997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111135751|NCT04884997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111135752|NCT04885075|Midazolam|midazolam|mesh-list
111135753|NCT04885075|Diazepam|diazepam|mesh-list
111135754|NCT04885075|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111135755|NCT04885075|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111135756|NCT04885075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111135757|NCT04885075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111135758|NCT04885075|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111135759|NCT04885075|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111135760|NCT04885075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111135761|NCT04885075|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111135762|NCT04885075|Anesthetics, General|anesthetics, general|mesh-ancestor
111135763|NCT04885075|Anesthetics|anesthetics|mesh-ancestor
111135764|NCT04885075|GABA Modulators|gaba modulators|mesh-ancestor
111135765|NCT04885075|GABA Agents|gaba agents|mesh-ancestor
111135766|NCT04885075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111135767|NCT04885075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111135768|NCT04885075|Anticonvulsants|anticonvulsants|mesh-ancestor
111135769|NCT04885075|Antiemetics|antiemetics|mesh-ancestor
111135770|NCT04885075|Autonomic Agents|autonomic agents|mesh-ancestor
111135771|NCT04885075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111135772|NCT04885075|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111135773|NCT04885075|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
111135774|NCT04885075|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111135775|NCT01610687|Nabiximols|nabiximols|mesh-list
111135776|NCT01610687|Analgesics|analgesics|mesh-ancestor
111135777|NCT01610687|Sensory System Agents|sensory system agents|mesh-ancestor
111135778|NCT01610687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111135779|NCT01610687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111135780|NCT04884919|Chitosan|chitosan|mesh-list
111135781|NCT04884919|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111135783|NCT04884919|Antimetabolites|antimetabolites|mesh-ancestor
111135784|NCT04884919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111135785|NCT04884919|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111135786|NCT04884919|Chelating Agents|chelating agents|mesh-ancestor
111135787|NCT04884919|Sequestering Agents|sequestering agents|mesh-ancestor
111135788|NCT04884919|Hemostatics|hemostatics|mesh-ancestor
111135789|NCT04884919|Coagulants|coagulants|mesh-ancestor
111135790|NCT04878835|Ranibizumab|ranibizumab|mesh-list
111135791|NCT04878835|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111135792|NCT04878835|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111135793|NCT04878835|Growth Substances|growth substances|mesh-ancestor
110264431|NCT02935231|Nicotine|nicotine|mesh-list
111135794|NCT04878835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111135795|NCT04878835|Growth Inhibitors|growth inhibitors|mesh-ancestor
111135796|NCT04878835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111135797|NCT04872283|Aspirin|aspirin|mesh-list
111135798|NCT04872283|Acetaminophen|acetaminophen|mesh-list
111135799|NCT04872283|Ketorolac|ketorolac|mesh-list
111135800|NCT04872283|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
111135801|NCT04872283|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
111135803|NCT04872283|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111135804|NCT04872283|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111135805|NCT04872283|Analgesics|analgesics|mesh-ancestor
111135806|NCT04872283|Sensory System Agents|sensory system agents|mesh-ancestor
111135807|NCT04872283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111135808|NCT04872283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111135809|NCT04872283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111135810|NCT04872283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111135811|NCT04872283|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111135812|NCT04872283|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111135813|NCT04872283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111135814|NCT04872283|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111135815|NCT04872283|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111135816|NCT04872283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111135817|NCT04872283|Antipyretics|antipyretics|mesh-ancestor
111135818|NCT04872283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111135819|NCT04872283|Narcotics|narcotics|mesh-ancestor
111135820|NCT04872283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111135821|NCT05182385|Venetoclax|venetoclax|mesh-list
111135822|NCT05182385|Blinatumomab|blinatumomab|mesh-list
111135823|NCT05182385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111135824|NCT05533619|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
111135825|NCT05533619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111135826|NCT05533619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111135827|NCT04389073|Cyclophosphamide|cyclophosphamide|mesh-list
111135828|NCT04389073|Bevacizumab|bevacizumab|mesh-list
111135829|NCT04389073|Capecitabine|capecitabine|mesh-list
111135830|NCT04389073|Vinorelbine|vinorelbine|mesh-list
111135831|NCT04389073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111135832|NCT04389073|Immunologic Factors|immunologic factors|mesh-ancestor
111135833|NCT04389073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111135834|NCT04389073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111135835|NCT04389073|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111135836|NCT04389073|Alkylating Agents|alkylating agents|mesh-ancestor
110589460|NCT00730028|Sulfamethoxazole|sulfamethoxazole|mesh-list
111135837|NCT04389073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111135838|NCT04389073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111135839|NCT04389073|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111135840|NCT04389073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111135841|NCT04389073|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111135842|NCT04389073|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111135843|NCT04389073|Growth Substances|growth substances|mesh-ancestor
111135844|NCT04389073|Growth Inhibitors|growth inhibitors|mesh-ancestor
111135845|NCT04389073|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111135846|NCT04389073|Antimetabolites|antimetabolites|mesh-ancestor
111135847|NCT04389073|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111135848|NCT04389073|Tubulin Modulators|tubulin modulators|mesh-ancestor
111135849|NCT04389073|Antimitotic Agents|antimitotic agents|mesh-ancestor
111135850|NCT04389073|Mitosis Modulators|mitosis modulators|mesh-ancestor
111135851|NCT04371445|Dexamethasone|dexamethasone|mesh-list
111135852|NCT04371445|Prednisolone|prednisolone|mesh-list
111135853|NCT04371445|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111135854|NCT04371445|Methylprednisolone|methylprednisolone|mesh-list
111135855|NCT04371445|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111135856|NCT04371445|Prednisolone acetate|prednisolone acetate|mesh-list
111135857|NCT04371445|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111135858|NCT04371445|Prednisolone phosphate|prednisolone phosphate|mesh-list
111135859|NCT04371445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111135860|NCT04371445|Antiemetics|antiemetics|mesh-ancestor
111135861|NCT04371445|Autonomic Agents|autonomic agents|mesh-ancestor
111135862|NCT04371445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111135863|NCT04371445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111135864|NCT04371445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111135865|NCT04371445|Glucocorticoids|glucocorticoids|mesh-ancestor
111135866|NCT04371445|Hormones|hormones|mesh-ancestor
111135867|NCT04371445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111135868|NCT04371445|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111135869|NCT04371445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111135870|NCT04371445|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111135871|NCT04371445|Protective Agents|protective agents|mesh-ancestor
111135872|NCT03049267|Apremilast|apremilast|mesh-list
111135873|NCT03049267|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111135874|NCT03049267|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111135875|NCT03049267|Analgesics|analgesics|mesh-ancestor
111135876|NCT03049267|Sensory System Agents|sensory system agents|mesh-ancestor
111135877|NCT03049267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111135878|NCT03049267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111135879|NCT03049267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111135880|NCT03049267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111135881|NCT03049267|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
111135882|NCT03049267|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111135883|NCT03049267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111135884|NCT03049267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111135885|NCT05524259|Folic Acid|folic acid|mesh-list
111135886|NCT05524259|Vitamin B Complex|vitamin b complex|mesh-list
111135887|NCT05524259|Inositol|inositol|mesh-list
111135888|NCT05524259|Hematinics|hematinics|mesh-ancestor
111135889|NCT05524259|Vitamins|vitamins|mesh-ancestor
111135890|NCT05524259|Micronutrients|micronutrients|mesh-ancestor
111135891|NCT05524259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111135893|NCT04112095|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
111135894|NCT04112095|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
111135895|NCT04112095|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111135896|NCT04112095|Contraceptive Agents|contraceptive agents|mesh-ancestor
111135897|NCT04112095|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111135898|NCT04112095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111135899|NCT04112095|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111135900|NCT04112095|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
111135901|NCT05257993|Paclitaxel|paclitaxel|mesh-list
111135902|NCT05257993|Gemcitabine|gemcitabine|mesh-list
111135903|NCT05257993|Folfirinox|folfirinox|mesh-list
111135904|NCT05257993|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111135905|NCT05257993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111135906|NCT05257993|Tubulin Modulators|tubulin modulators|mesh-ancestor
111135907|NCT05257993|Antimitotic Agents|antimitotic agents|mesh-ancestor
111135908|NCT05257993|Mitosis Modulators|mitosis modulators|mesh-ancestor
111135909|NCT05257993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111135910|NCT05257993|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111135911|NCT05257993|Antimetabolites|antimetabolites|mesh-ancestor
111135912|NCT05533073|Etoricoxib|etoricoxib|mesh-list
111135913|NCT05533073|Tramadol|tramadol|mesh-list
111135914|NCT05533073|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111135915|NCT05533073|Narcotics|narcotics|mesh-ancestor
111135916|NCT05533073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111135917|NCT05533073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111135918|NCT05533073|Analgesics|analgesics|mesh-ancestor
111135919|NCT05533073|Sensory System Agents|sensory system agents|mesh-ancestor
111135920|NCT05533073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111135921|NCT05533073|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111135922|NCT05533073|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111135923|NCT05533073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111135924|NCT05533073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111135925|NCT05533073|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111135926|NCT05533073|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111135927|NCT05533073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111135928|NCT05533073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111135929|NCT04050553|Tirzepatide|tirzepatide|mesh-list
111135930|NCT04050553|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111135931|NCT04050553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111135932|NCT04050553|Incretins|incretins|mesh-ancestor
111135933|NCT04050553|Hormones|hormones|mesh-ancestor
111135934|NCT04050553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111135935|NCT03946891|Furosemide|furosemide|mesh-list
111135936|NCT03946891|Diuretics|diuretics|mesh-ancestor
111135937|NCT03946891|Natriuretic Agents|natriuretic agents|mesh-ancestor
111135938|NCT03946891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111135939|NCT03946891|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
111135940|NCT03946891|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111135941|NCT03946891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111135942|NCT03849625|Aspirin|aspirin|mesh-list
111135943|NCT03849625|Acetaminophen|acetaminophen|mesh-list
111135944|NCT03849625|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111135945|NCT03849625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111135946|NCT03849625|Analgesics|analgesics|mesh-ancestor
111135947|NCT03849625|Sensory System Agents|sensory system agents|mesh-ancestor
111135948|NCT03849625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111135949|NCT03849625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111135950|NCT03849625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111135951|NCT03849625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111135952|NCT03849625|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111135953|NCT03849625|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111135954|NCT03849625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111135955|NCT03849625|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111135956|NCT03849625|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111135957|NCT03849625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111135958|NCT03849625|Antipyretics|antipyretics|mesh-ancestor
111135959|NCT03046693|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
111135960|NCT03046693|Nootropic Agents|nootropic agents|mesh-ancestor
111135961|NCT03049345|Methylene Blue|methylene blue|mesh-list
111135962|NCT03049345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111135963|NCT03049345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111135964|NCT05526911|Tenofovir|tenofovir|mesh-list
111135965|NCT05526911|Lamivudine|lamivudine|mesh-list
111135966|NCT05526911|Dolutegravir|dolutegravir|mesh-list
111135967|NCT05526911|Digoxin|digoxin|mesh-list
111135968|NCT05526911|Midazolam|midazolam|mesh-list
111135969|NCT05526911|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111135970|NCT05526911|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111135971|NCT05526911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111135972|NCT05526911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111135973|NCT05526911|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111135974|NCT05526911|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111135975|NCT05526911|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111135976|NCT05526911|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111135977|NCT05526911|Anesthetics, General|anesthetics, general|mesh-ancestor
111135978|NCT05526911|Anesthetics|anesthetics|mesh-ancestor
111135979|NCT05526911|GABA Modulators|gaba modulators|mesh-ancestor
111135980|NCT05526911|GABA Agents|gaba agents|mesh-ancestor
111135981|NCT05526911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111135982|NCT05526911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111135983|NCT05526911|Antiviral Agents|antiviral agents|mesh-ancestor
111135984|NCT05526911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111135985|NCT05526911|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111135986|NCT05526911|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111135987|NCT05526911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111135988|NCT05526911|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111135989|NCT05526911|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111135990|NCT05526911|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111135991|NCT05526911|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111135992|NCT05526911|Protective Agents|protective agents|mesh-ancestor
111135993|NCT05526911|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111135994|NCT05526911|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111135995|NCT04870489|Isotretinoin|isotretinoin|mesh-list
111135996|NCT04870489|Dermatologic Agents|dermatologic agents|mesh-ancestor
111135997|NCT02574845|Metformin|metformin|mesh-list
111135998|NCT02574845|Furosemide|furosemide|mesh-list
111135999|NCT02574845|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111136000|NCT02574845|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111136001|NCT02574845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111136002|NCT02574845|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111136003|NCT02574845|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110589535|NCT00736190|Tenofovir|tenofovir|mesh-list
111136004|NCT02574845|Antimetabolites|antimetabolites|mesh-ancestor
111136005|NCT02574845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111136006|NCT02574845|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111136007|NCT02574845|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111136008|NCT02574845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111136009|NCT02574845|Diuretics|diuretics|mesh-ancestor
111136010|NCT02574845|Natriuretic Agents|natriuretic agents|mesh-ancestor
111136011|NCT02574845|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
111136012|NCT02574845|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111136013|NCT05334485|Bromides|bromides|mesh-list
111136014|NCT05334485|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
111136015|NCT05334485|Anticonvulsants|anticonvulsants|mesh-ancestor
111136016|NCT05334485|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111136017|NCT05334485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111136018|NCT05334485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111136019|NCT05334485|Cholinergic Agents|cholinergic agents|mesh-ancestor
111136020|NCT05334485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111136021|NCT05334485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111136022|NCT05231941|Lidocaine|lidocaine|mesh-list
111136023|NCT05231941|Ropivacaine|ropivacaine|mesh-list
111136024|NCT05231941|Anesthetics, Local|anesthetics, local|mesh-ancestor
111136025|NCT05231941|Anesthetics|anesthetics|mesh-ancestor
110838459|NCT04763928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111136026|NCT05231941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111136027|NCT05231941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111136028|NCT05231941|Sensory System Agents|sensory system agents|mesh-ancestor
111136029|NCT05231941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111136030|NCT05231941|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111136031|NCT05231941|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111136032|NCT05231941|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111136033|NCT05231941|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111136034|NCT05231941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111136036|NCT05216575|Respiratory System Agents|respiratory system agents|mesh-ancestor
111136037|NCT04877509|Vitamin D|vitamin d|mesh-list
111136038|NCT04877509|Vitamin A|vitamin a|mesh-list
111136039|NCT04877509|Selenium|selenium|mesh-list
111136040|NCT04877509|Copper|copper|mesh-list
111136041|NCT04877509|Vitamins|vitamins|mesh-ancestor
111136042|NCT04877509|Micronutrients|micronutrients|mesh-ancestor
111136043|NCT04877509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111136044|NCT04877509|Antioxidants|antioxidants|mesh-ancestor
111136045|NCT04877509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111136046|NCT04877509|Protective Agents|protective agents|mesh-ancestor
111136047|NCT04877509|Trace Elements|trace elements|mesh-ancestor
111136048|NCT04877509|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111136049|NCT03044743|Cyclophosphamide|cyclophosphamide|mesh-list
111136050|NCT03044743|Fludarabine|fludarabine|mesh-list
111136051|NCT03044743|Interleukin-2|interleukin-2|mesh-list
111136052|NCT03044743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111136053|NCT03044743|Immunologic Factors|immunologic factors|mesh-ancestor
111136054|NCT03044743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111136055|NCT03044743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111136056|NCT03044743|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111136057|NCT03044743|Alkylating Agents|alkylating agents|mesh-ancestor
111136058|NCT03044743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111136059|NCT03044743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111136060|NCT03044743|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111136061|NCT03044743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111136062|NCT03044743|Analgesics|analgesics|mesh-ancestor
111136063|NCT03044743|Sensory System Agents|sensory system agents|mesh-ancestor
110589554|NCT00729326|Exenatide|exenatide|mesh-list
111136064|NCT03044743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111136065|NCT03044665|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
111136066|NCT03044665|Ezetimibe|ezetimibe|mesh-list
111136067|NCT03044665|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111136068|NCT03044665|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111136069|NCT03044665|Antimetabolites|antimetabolites|mesh-ancestor
111136070|NCT03044665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111136071|NCT03044665|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111136072|NCT03044665|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111136073|NCT03044665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111136074|NCT05525351|Dexmedetomidine|dexmedetomidine|mesh-list
111136075|NCT05525351|Alfentanil|alfentanil|mesh-list
111136076|NCT05525351|Propofol|propofol|mesh-list
111136077|NCT05525351|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111136078|NCT05525351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111136079|NCT05525351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111136080|NCT05525351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111136081|NCT05525351|Analgesics|analgesics|mesh-ancestor
111136082|NCT05525351|Sensory System Agents|sensory system agents|mesh-ancestor
111136083|NCT05525351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111136084|NCT05525351|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111136085|NCT05525351|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111136086|NCT05525351|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111136087|NCT05525351|Adrenergic Agents|adrenergic agents|mesh-ancestor
111136088|NCT05525351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111136089|NCT05525351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111136090|NCT05525351|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111136091|NCT05525351|Anesthetics, General|anesthetics, general|mesh-ancestor
111136092|NCT05525351|Anesthetics|anesthetics|mesh-ancestor
111136093|NCT05525351|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111136094|NCT05525351|Narcotics|narcotics|mesh-ancestor
111136095|NCT04869475|Arsenic Trioxide|arsenic trioxide|mesh-list
111136096|NCT04869475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111136097|NCT05521763|Vaccines|vaccines|mesh-list
111136098|NCT05521763|Immunologic Factors|immunologic factors|mesh-ancestor
111136099|NCT05521763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111136100|NCT05100017|Methocarbamol|methocarbamol|mesh-list
111136101|NCT05100017|Oxybutynin|oxybutynin|mesh-list
111136102|NCT05100017|Parasympatholytics|parasympatholytics|mesh-ancestor
111136103|NCT05100017|Autonomic Agents|autonomic agents|mesh-ancestor
111136104|NCT05100017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111136105|NCT05100017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111136106|NCT05100017|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111136107|NCT05100017|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111136108|NCT05100017|Cholinergic Agents|cholinergic agents|mesh-ancestor
111136109|NCT05100017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111136110|NCT05100017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111136111|NCT05100017|Urological Agents|urological agents|mesh-ancestor
111136112|NCT05100017|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
111136113|NCT05100017|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111136114|NCT04865185|Ethanol|ethanol|mesh-list
111136115|NCT04865185|Lidocaine|lidocaine|mesh-list
111136116|NCT04865185|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111136117|NCT04865185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111136118|NCT04865185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111136119|NCT04865185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111136120|NCT04865185|Anesthetics, Local|anesthetics, local|mesh-ancestor
111136121|NCT04865185|Anesthetics|anesthetics|mesh-ancestor
111136122|NCT04865185|Sensory System Agents|sensory system agents|mesh-ancestor
111136123|NCT04865185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111136124|NCT04865185|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111136125|NCT04865185|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111136126|NCT04865185|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111136127|NCT04865185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111136128|NCT04865185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111136129|NCT04876807|Acalabrutinib|acalabrutinib|mesh-list
111136130|NCT04876807|Omeprazole|omeprazole|mesh-list
111136131|NCT04876807|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111136132|NCT04876807|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111136133|NCT04876807|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111136134|NCT04876807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111136135|NCT04876807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111136136|NCT04876807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111136137|NCT05518409|Donepezil|donepezil|mesh-list
111136138|NCT05518409|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111136139|NCT05518409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111136140|NCT05518409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111136141|NCT05518409|Cholinergic Agents|cholinergic agents|mesh-ancestor
111136142|NCT05518409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111136143|NCT05518409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111136144|NCT05518409|Nootropic Agents|nootropic agents|mesh-ancestor
111136145|NCT04876573|Cyproheptadine|cyproheptadine|mesh-list
111136146|NCT04876573|Antipruritics|antipruritics|mesh-ancestor
111136147|NCT04876573|Dermatologic Agents|dermatologic agents|mesh-ancestor
111136148|NCT04876573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111136149|NCT04876573|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111136150|NCT04876573|Histamine Antagonists|histamine antagonists|mesh-ancestor
111136151|NCT04876573|Histamine Agents|histamine agents|mesh-ancestor
111136152|NCT04876573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111136153|NCT04876573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111136154|NCT04876573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111136155|NCT04876573|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111136156|NCT04876573|Serotonin Agents|serotonin agents|mesh-ancestor
111136157|NCT04876573|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111136159|NCT04864717|Isotretinoin|isotretinoin|mesh-list
111136160|NCT04864717|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111136161|NCT04864717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111136162|NCT04864717|Antimalarials|antimalarials|mesh-ancestor
111136163|NCT04864717|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111136164|NCT04864717|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111136165|NCT04864717|Dermatologic Agents|dermatologic agents|mesh-ancestor
111136166|NCT04876261|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
111136167|NCT04876261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111136168|NCT04876261|Antioxidants|antioxidants|mesh-ancestor
111136169|NCT04876261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111136170|NCT04876261|Protective Agents|protective agents|mesh-ancestor
111136171|NCT04876261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111136172|NCT04876261|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111136173|NCT02613871|Sofosbuvir|sofosbuvir|mesh-list
111136174|NCT02613871|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
111136175|NCT02613871|Ledipasvir|ledipasvir|mesh-list
110589588|NCT03980925|Carboplatin|carboplatin|mesh-list
111136176|NCT02613871|Antiviral Agents|antiviral agents|mesh-ancestor
111136177|NCT02613871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111136178|NCT04869709|Betamethasone|betamethasone|mesh-list
111136179|NCT04869709|Betamethasone Valerate|betamethasone valerate|mesh-list
110853199|NCT04710732|Enoxaparin|enoxaparin|mesh-list
111136180|NCT04869709|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
111136182|NCT04869709|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
111136183|NCT04869709|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111136184|NCT04869709|Glucocorticoids|glucocorticoids|mesh-ancestor
111136185|NCT04869709|Hormones|hormones|mesh-ancestor
111136186|NCT04869709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111136187|NCT04869709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111136188|NCT04869709|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111136189|NCT04869709|Respiratory System Agents|respiratory system agents|mesh-ancestor
111136190|NCT02612077|Bevacizumab|bevacizumab|mesh-list
111136191|NCT02612077|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111136192|NCT02612077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111136193|NCT02612077|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111136194|NCT02612077|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111136195|NCT02612077|Growth Substances|growth substances|mesh-ancestor
111136196|NCT02612077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111136197|NCT02612077|Growth Inhibitors|growth inhibitors|mesh-ancestor
111136198|NCT04622735|Acetaminophen|acetaminophen|mesh-list
111136199|NCT04622735|Nefopam|nefopam|mesh-list
111136200|NCT04622735|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111136201|NCT04622735|Analgesics|analgesics|mesh-ancestor
111136202|NCT04622735|Sensory System Agents|sensory system agents|mesh-ancestor
111136203|NCT04622735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111136204|NCT04622735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111136205|NCT04622735|Antipyretics|antipyretics|mesh-ancestor
111136206|NCT05531591|Aripiprazole|aripiprazole|mesh-list
111136207|NCT05531591|Lithium Carbonate|lithium carbonate|mesh-list
111136208|NCT05531591|Bupropion|bupropion|mesh-list
111136209|NCT05531591|Nortriptyline|nortriptyline|mesh-list
111136210|NCT05531591|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111136211|NCT05531591|Antidepressive Agents|antidepressive agents|mesh-ancestor
111136212|NCT05531591|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111136213|NCT05531591|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111136214|NCT05531591|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111136215|NCT05531591|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110838497|NCT05363592|Protease Inhibitors|protease inhibitors|mesh-ancestor
111136216|NCT05531591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111136218|NCT05531591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111136219|NCT05531591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111136220|NCT05531591|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111136221|NCT05531591|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111136222|NCT05531591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111136223|NCT05531591|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111136224|NCT05531591|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111136225|NCT05531591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111136226|NCT05531591|Dopamine Agonists|dopamine agonists|mesh-ancestor
111136227|NCT05531591|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111136228|NCT05531591|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111136229|NCT05531591|Serotonin Agents|serotonin agents|mesh-ancestor
111136230|NCT05531591|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111136231|NCT05531591|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111136232|NCT05531591|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111136233|NCT05531591|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111136234|NCT05531591|Antimanic Agents|antimanic agents|mesh-ancestor
111136235|NCT05531591|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
111136236|NCT05531591|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111136237|NCT05531591|Adrenergic Agents|adrenergic agents|mesh-ancestor
111136238|NCT05048615|Itraconazole|itraconazole|mesh-list
111136239|NCT05048615|Azacitidine|azacitidine|mesh-list
111136240|NCT05048615|Venetoclax|venetoclax|mesh-list
111136241|NCT05048615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111136242|NCT05048615|Antimetabolites|antimetabolites|mesh-ancestor
111136243|NCT05048615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111136244|NCT05048615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111136245|NCT05048615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111136246|NCT05048615|Antifungal Agents|antifungal agents|mesh-ancestor
111136247|NCT05048615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111136248|NCT05048615|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111136249|NCT05048615|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111136250|NCT05048615|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111136251|NCT05048615|Hormone Antagonists|hormone antagonists|mesh-ancestor
111136252|NCT05048615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111136253|NCT05048615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111136254|NCT05048615|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111136255|NCT05531435|Anesthetics|anesthetics|mesh-list
111136256|NCT05531435|Anesthetics, Local|anesthetics, local|mesh-list
111136257|NCT05531435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111136258|NCT05531435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111136259|NCT05531435|Sensory System Agents|sensory system agents|mesh-ancestor
111136260|NCT05531435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111136261|NCT05517239|Gemcitabine|gemcitabine|mesh-list
111136262|NCT05517239|Oxaliplatin|oxaliplatin|mesh-list
111136263|NCT05517239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111136264|NCT05517239|Antimetabolites|antimetabolites|mesh-ancestor
111136265|NCT05517239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111136266|NCT05517239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111136267|NCT05519813|Metformin|metformin|mesh-list
111136268|NCT05519813|Pioglitazone|pioglitazone|mesh-list
111136269|NCT05519813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111136270|NCT05519813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111136271|NCT02613403|Ribavirin|ribavirin|mesh-list
111136272|NCT02613403|Uprifosbuvir|uprifosbuvir|mesh-list
111136273|NCT02613403|Antimetabolites|antimetabolites|mesh-ancestor
111136274|NCT02613403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111136275|NCT02613403|Antiviral Agents|antiviral agents|mesh-ancestor
111136276|NCT02613403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111136277|NCT05002127|Paclitaxel|paclitaxel|mesh-list
111136278|NCT05002127|Trastuzumab|trastuzumab|mesh-list
111136279|NCT05002127|Ramucirumab|ramucirumab|mesh-list
111136280|NCT05002127|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111136281|NCT05002127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111136282|NCT05002127|Tubulin Modulators|tubulin modulators|mesh-ancestor
111136283|NCT05002127|Antimitotic Agents|antimitotic agents|mesh-ancestor
111136284|NCT05002127|Mitosis Modulators|mitosis modulators|mesh-ancestor
111136285|NCT05002127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111136286|NCT05002127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111136287|NCT04429867|Hydroxychloroquine|hydroxychloroquine|mesh-list
111136288|NCT04429867|Antimalarials|antimalarials|mesh-ancestor
111136289|NCT04429867|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111136290|NCT04429867|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111136291|NCT04429867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111136292|NCT04429867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111136293|NCT04429867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111136294|NCT04429867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111136295|NCT03044041|Tranexamic Acid|tranexamic acid|mesh-list
111136296|NCT03044041|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111136297|NCT03044041|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111136298|NCT03044041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111136299|NCT03044041|Hemostatics|hemostatics|mesh-ancestor
111136300|NCT03044041|Coagulants|coagulants|mesh-ancestor
111136301|NCT03048097|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
111136302|NCT03048097|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111136303|NCT03048097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111136304|NCT05516303|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
111136305|NCT05516303|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
111136306|NCT05516303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111136307|NCT05516303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111136308|NCT05516303|Immunologic Factors|immunologic factors|mesh-ancestor
111136309|NCT05516303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111136310|NCT04863079|Pembrolizumab|pembrolizumab|mesh-list
111136311|NCT04863079|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111136312|NCT04863079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111136313|NCT04863079|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111136314|NCT04863079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111136315|NCT05512325|Bevacizumab|bevacizumab|mesh-list
111136316|NCT05512325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111136317|NCT05512325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111136318|NCT05512325|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111136319|NCT05512325|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111136320|NCT05512325|Growth Substances|growth substances|mesh-ancestor
111136321|NCT05512325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111136322|NCT05512325|Growth Inhibitors|growth inhibitors|mesh-ancestor
111136323|NCT04868227|Vitamin D|vitamin d|mesh-list
111136324|NCT04868227|Cholecalciferol|cholecalciferol|mesh-list
111136325|NCT04868227|Vitamins|vitamins|mesh-ancestor
111136326|NCT04868227|Micronutrients|micronutrients|mesh-ancestor
111136327|NCT04868227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111136328|NCT04868227|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111136329|NCT04868227|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111136330|NCT04863001|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
111136332|NCT04873531|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111136333|NCT04873531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111136334|NCT04873531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111136335|NCT04873531|Cholinergic Agents|cholinergic agents|mesh-ancestor
111136336|NCT04873531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111136337|NCT04873531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111136338|NCT04873531|Parasympathomimetics|parasympathomimetics|mesh-ancestor
111136339|NCT04873531|Autonomic Agents|autonomic agents|mesh-ancestor
111136340|NCT04873531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111136341|NCT04862845|Pregabalin|pregabalin|mesh-list
111136342|NCT04862845|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
111136343|NCT04862845|Analgesics|analgesics|mesh-ancestor
111136344|NCT04862845|Sensory System Agents|sensory system agents|mesh-ancestor
111136345|NCT04862845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111136346|NCT04862845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111136347|NCT04862845|Anticonvulsants|anticonvulsants|mesh-ancestor
111136348|NCT04862845|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111136349|NCT04862845|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111136350|NCT04862845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111136351|NCT04862845|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111136352|NCT04862845|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111136353|NCT04862845|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111136354|NCT04862845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111136355|NCT04862845|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111136356|NCT04862845|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111136357|NCT04862845|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111136358|NCT04862845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111136359|NCT04862845|Antidepressive Agents|antidepressive agents|mesh-ancestor
111136360|NCT04862845|Dopamine Agents|dopamine agents|mesh-ancestor
111136361|NCT04862377|Budesonide|budesonide|mesh-list
111136362|NCT04862377|Poractant alfa|poractant alfa|mesh-list
111136363|NCT04862377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111136364|NCT04862377|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111136365|NCT04862377|Autonomic Agents|autonomic agents|mesh-ancestor
111136366|NCT04862377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111136367|NCT04862377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111136368|NCT04862377|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111136369|NCT04862377|Respiratory System Agents|respiratory system agents|mesh-ancestor
111136370|NCT04862377|Glucocorticoids|glucocorticoids|mesh-ancestor
111136371|NCT04862377|Hormones|hormones|mesh-ancestor
111136372|NCT04862377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111136373|NCT04862377|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
111136374|NCT04867993|Amikacin|amikacin|mesh-list
111136375|NCT04867993|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111136376|NCT04867993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111136377|NCT04872985|Paclitaxel|paclitaxel|mesh-list
111136378|NCT04872985|Docetaxel|docetaxel|mesh-list
111136379|NCT04872985|Cyclophosphamide|cyclophosphamide|mesh-list
111136380|NCT04872985|Doxorubicin|doxorubicin|mesh-list
111136381|NCT04872985|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111136382|NCT04872985|Epirubicin|epirubicin|mesh-list
111136383|NCT04872985|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111136384|NCT04872985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111136385|NCT04872985|Tubulin Modulators|tubulin modulators|mesh-ancestor
111136386|NCT04872985|Antimitotic Agents|antimitotic agents|mesh-ancestor
111136387|NCT04872985|Mitosis Modulators|mitosis modulators|mesh-ancestor
111136388|NCT04872985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111136389|NCT04872985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111136390|NCT04872985|Immunologic Factors|immunologic factors|mesh-ancestor
111136391|NCT04872985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111136392|NCT04872985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111136393|NCT04872985|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111136394|NCT04872985|Alkylating Agents|alkylating agents|mesh-ancestor
111136395|NCT04872985|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111136396|NCT04872985|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111136397|NCT04872985|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111136398|NCT04872985|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111136399|NCT04872985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111136400|NCT04872907|Fluorides|fluorides|mesh-list
111136401|NCT04872907|Fluorides, Topical|fluorides, topical|mesh-list
110853453|NCT03324490|Fentanyl|fentanyl|mesh-list
111136402|NCT04872907|Cariostatic Agents|cariostatic agents|mesh-ancestor
111136403|NCT04872907|Protective Agents|protective agents|mesh-ancestor
111136404|NCT04872907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111136405|NCT02566031|Glycopyrrolate|glycopyrrolate|mesh-list
111136406|NCT02566031|Tiotropium Bromide|tiotropium bromide|mesh-list
111136407|NCT02566031|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111136408|NCT02566031|Autonomic Agents|autonomic agents|mesh-ancestor
111136409|NCT02566031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111136410|NCT02566031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111136411|NCT02566031|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111136412|NCT02566031|Respiratory System Agents|respiratory system agents|mesh-ancestor
111136413|NCT02566031|Parasympatholytics|parasympatholytics|mesh-ancestor
111136414|NCT02566031|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111136415|NCT02566031|Cholinergic Agents|cholinergic agents|mesh-ancestor
111136416|NCT02566031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111136417|NCT02566031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111136418|NCT02566031|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110838516|NCT03433534|Nivolumab|nivolumab|mesh-list
111136419|NCT02566031|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111136420|NCT05507411|Immunomodulating Agents|immunomodulating agents|mesh-list
111136421|NCT05507411|Immunologic Factors|immunologic factors|mesh-ancestor
111136422|NCT05507411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111136423|NCT05512013|Ibuprofen|ibuprofen|mesh-list
111136424|NCT05512013|Celecoxib|celecoxib|mesh-list
111136425|NCT05512013|Flurbiprofen|flurbiprofen|mesh-list
111136426|NCT05512013|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111136427|NCT05512013|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111136428|NCT05512013|Analgesics|analgesics|mesh-ancestor
111136429|NCT05512013|Sensory System Agents|sensory system agents|mesh-ancestor
111136430|NCT05512013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111136431|NCT05512013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111136432|NCT05512013|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111136433|NCT05512013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111136434|NCT05512013|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111136435|NCT05512013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111136436|NCT05512013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111136437|NCT05512013|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111136438|NCT04894643|Paclitaxel|paclitaxel|mesh-list
111136439|NCT04894643|Gemcitabine|gemcitabine|mesh-list
111136440|NCT04894643|Capecitabine|capecitabine|mesh-list
111136441|NCT04894643|Pancrelipase|pancrelipase|mesh-list
111136442|NCT04894643|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111136443|NCT04894643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111136444|NCT04894643|Tubulin Modulators|tubulin modulators|mesh-ancestor
111136445|NCT04894643|Antimitotic Agents|antimitotic agents|mesh-ancestor
111136446|NCT04894643|Mitosis Modulators|mitosis modulators|mesh-ancestor
111136447|NCT04894643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111136448|NCT04894643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111136449|NCT04894643|Antimetabolites|antimetabolites|mesh-ancestor
111136450|NCT04894643|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111136451|NCT05506865|Tiotropium Bromide|tiotropium bromide|mesh-list
111136452|NCT05506865|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111136453|NCT05506865|Autonomic Agents|autonomic agents|mesh-ancestor
111136454|NCT05506865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111136455|NCT05506865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111136456|NCT05506865|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111136457|NCT05506865|Respiratory System Agents|respiratory system agents|mesh-ancestor
111136458|NCT05506865|Parasympatholytics|parasympatholytics|mesh-ancestor
111136459|NCT05506865|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111136460|NCT05506865|Cholinergic Agents|cholinergic agents|mesh-ancestor
111136461|NCT05506865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111136462|NCT05506865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111136463|NCT03048019|Tirofiban|tirofiban|mesh-list
111136464|NCT03048019|Cangrelor|cangrelor|mesh-list
111136465|NCT03048019|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111136466|NCT03048019|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111136467|NCT03048019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111136468|NCT03048019|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111136469|NCT03048019|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111136470|NCT03048019|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111136471|NCT03048019|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111136472|NCT03048019|Purinergic Agents|purinergic agents|mesh-ancestor
111136473|NCT03048019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111136474|NCT03048019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111136475|NCT05506319|Vasopressins|vasopressins|mesh-list
111136477|NCT05506319|Norepinephrine|norepinephrine|mesh-list
111136478|NCT05506319|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111136479|NCT05506319|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111136480|NCT05506319|Adrenergic Agents|adrenergic agents|mesh-ancestor
111136481|NCT05506319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111136482|NCT05506319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111136483|NCT05506319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111136484|NCT05506319|Sympathomimetics|sympathomimetics|mesh-ancestor
111136485|NCT05506319|Autonomic Agents|autonomic agents|mesh-ancestor
111136486|NCT05506319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111136487|NCT05506319|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111136488|NCT05506319|Hemostatics|hemostatics|mesh-ancestor
111136489|NCT05506319|Coagulants|coagulants|mesh-ancestor
111136490|NCT05506319|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
111136491|NCT05506319|Natriuretic Agents|natriuretic agents|mesh-ancestor
111136492|NCT05505539|Fluorouracil|fluorouracil|mesh-list
111136493|NCT05505539|Antimetabolites|antimetabolites|mesh-ancestor
111136494|NCT05505539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111136495|NCT05505539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111136496|NCT05505539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111136497|NCT05505539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111136498|NCT05505539|Immunologic Factors|immunologic factors|mesh-ancestor
111136499|NCT05505539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111136500|NCT05505461|Antibodies|antibodies|mesh-list
111136501|NCT05505461|Immunologic Factors|immunologic factors|mesh-ancestor
111136502|NCT05505461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111136503|NCT05514275|Capecitabine|capecitabine|mesh-list
111136504|NCT05514275|Endostatins|endostatins|mesh-list
111136505|NCT05514275|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111136506|NCT05514275|Antimetabolites|antimetabolites|mesh-ancestor
111136507|NCT05514275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111136508|NCT05514275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111136509|NCT05514275|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111136510|NCT05514275|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111136511|NCT05514275|Growth Substances|growth substances|mesh-ancestor
111136512|NCT05514275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111136513|NCT05514275|Growth Inhibitors|growth inhibitors|mesh-ancestor
111136514|NCT05514041|Varenicline|varenicline|mesh-list
111136515|NCT05514041|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111136516|NCT05514041|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111136517|NCT05514041|Cholinergic Agents|cholinergic agents|mesh-ancestor
111136518|NCT05514041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111136519|NCT05514041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111136520|NCT05514041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111136521|NCT04667663|Dexamethasone|dexamethasone|mesh-list
111136522|NCT04667663|Cyclophosphamide|cyclophosphamide|mesh-list
111136523|NCT04667663|Daratumumab|daratumumab|mesh-list
111136524|NCT04667663|Pomalidomide|pomalidomide|mesh-list
111136525|NCT04667663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111136526|NCT04667663|Immunologic Factors|immunologic factors|mesh-ancestor
111136527|NCT04667663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111136528|NCT04667663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111136529|NCT04667663|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111136530|NCT04667663|Alkylating Agents|alkylating agents|mesh-ancestor
111136531|NCT04667663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111136532|NCT04667663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111136533|NCT04667663|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111136534|NCT04667663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111136535|NCT04667663|Antiemetics|antiemetics|mesh-ancestor
111136536|NCT04667663|Autonomic Agents|autonomic agents|mesh-ancestor
111136537|NCT04667663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111136538|NCT04667663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111136539|NCT04667663|Glucocorticoids|glucocorticoids|mesh-ancestor
111136540|NCT04667663|Hormones|hormones|mesh-ancestor
111136541|NCT04667663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111136542|NCT04667663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111136543|NCT04667663|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111136544|NCT04667663|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111136545|NCT04667663|Growth Substances|growth substances|mesh-ancestor
111136546|NCT04667663|Growth Inhibitors|growth inhibitors|mesh-ancestor
111136548|NCT02570711|Gemcitabine|gemcitabine|mesh-list
111136549|NCT02570711|Acalabrutinib|acalabrutinib|mesh-list
111136550|NCT02570711|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110853573|NCT04494100|Epinephrine|epinephrine|mesh-list
111136551|NCT02570711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111136552|NCT02570711|Tubulin Modulators|tubulin modulators|mesh-ancestor
111136553|NCT02570711|Antimitotic Agents|antimitotic agents|mesh-ancestor
111136554|NCT02570711|Mitosis Modulators|mitosis modulators|mesh-ancestor
111136555|NCT02570711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111136556|NCT02570711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111136557|NCT02570711|Antimetabolites|antimetabolites|mesh-ancestor
111136558|NCT05513729|Pioglitazone|pioglitazone|mesh-list
111136559|NCT05513729|Canagliflozin|canagliflozin|mesh-list
111136560|NCT05513729|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111136561|NCT05513729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111136562|NCT05513729|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111136563|NCT05513729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111136564|NCT05504603|Rituximab|rituximab|mesh-list
111136565|NCT05504603|Zanubrutinib|zanubrutinib|mesh-list
111136566|NCT05504603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111136567|NCT05504603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111136568|NCT05504603|Immunologic Factors|immunologic factors|mesh-ancestor
111136569|NCT05504603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111136570|NCT05504603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111136571|NCT05504603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111136572|NCT05504603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111136573|NCT05504603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111136574|NCT05504213|Fulvestrant|fulvestrant|mesh-list
111136575|NCT05504213|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111136576|NCT05504213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111136577|NCT05504213|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
111136578|NCT05504213|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111136579|NCT05504213|Hormone Antagonists|hormone antagonists|mesh-ancestor
111136580|NCT05504213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111136581|NCT05504213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111136582|NCT05510219|Obinutuzumab|obinutuzumab|mesh-list
111136583|NCT05510219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111136584|NCT05510219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111136585|NCT02564471|Doxycycline|doxycycline|mesh-list
111136586|NCT02564471|Chloroquine|chloroquine|mesh-list
111136587|NCT02564471|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
111136588|NCT02564471|Atovaquone|atovaquone|mesh-list
111136589|NCT02564471|Proguanil|proguanil|mesh-list
111136590|NCT02564471|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111136591|NCT02564471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111136592|NCT02564471|Antimalarials|antimalarials|mesh-ancestor
111136593|NCT02564471|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111136594|NCT02564471|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111136595|NCT02564471|Amebicides|amebicides|mesh-ancestor
111136596|NCT02564471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111136597|NCT02564471|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111136598|NCT02564471|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111136599|NCT02564471|Analgesics|analgesics|mesh-ancestor
111136600|NCT02564471|Sensory System Agents|sensory system agents|mesh-ancestor
111136601|NCT02564471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111136602|NCT02564471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111136603|NCT02564471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111136604|NCT02564471|Filaricides|filaricides|mesh-ancestor
111136605|NCT02564471|Antinematodal Agents|antinematodal agents|mesh-ancestor
111136606|NCT02564471|Anthelmintics|anthelmintics|mesh-ancestor
111136607|NCT02564471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111136608|NCT02564471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111136609|NCT02564471|Antimetabolites|antimetabolites|mesh-ancestor
111136610|NCT05503667|Bevacizumab|bevacizumab|mesh-list
111136611|NCT05503667|Aflutinib|aflutinib|mesh-list
110589750|NCT00727532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111136612|NCT05503667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111136613|NCT05503667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111136614|NCT05503667|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111136615|NCT05503667|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111136616|NCT05503667|Growth Substances|growth substances|mesh-ancestor
111136617|NCT05503667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111136618|NCT05503667|Growth Inhibitors|growth inhibitors|mesh-ancestor
111136619|NCT05503667|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111136620|NCT05503667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111136621|NCT05503667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111136622|NCT02563067|Indoleacetic Acids|indoleacetic acids|mesh-list
111136623|NCT02563067|Plant Growth Regulators|plant growth regulators|mesh-ancestor
111136624|NCT02563067|Growth Substances|growth substances|mesh-ancestor
111136625|NCT02563067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110853648|NCT03323710|Growth Inhibitors|growth inhibitors|mesh-ancestor
111136626|NCT02568683|Vincristine|vincristine|mesh-list
111136627|NCT02568683|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111136628|NCT02568683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111136629|NCT02568683|Tubulin Modulators|tubulin modulators|mesh-ancestor
111136630|NCT02568683|Antimitotic Agents|antimitotic agents|mesh-ancestor
111136631|NCT02568683|Mitosis Modulators|mitosis modulators|mesh-ancestor
111136632|NCT02568683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111136633|NCT05502731|Adalimumab|adalimumab|mesh-list
111136634|NCT05502731|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111136635|NCT05502731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111136636|NCT05502731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111136637|NCT05503043|Lidocaine|lidocaine|mesh-list
111136638|NCT05503043|Anesthetics, Local|anesthetics, local|mesh-ancestor
111136639|NCT05503043|Anesthetics|anesthetics|mesh-ancestor
111136640|NCT05503043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111136641|NCT05503043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111136642|NCT05503043|Sensory System Agents|sensory system agents|mesh-ancestor
111136643|NCT05503043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111136644|NCT05503043|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111136645|NCT05503043|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111136646|NCT05503043|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111136647|NCT05503043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111136648|NCT05503043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111136649|NCT02563925|Durvalumab|durvalumab|mesh-list
111136650|NCT02563925|Tremelimumab|tremelimumab|mesh-list
111136651|NCT02563925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111136652|NCT02563925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111136653|NCT01663727|Paclitaxel|paclitaxel|mesh-list
111136654|NCT01663727|Bevacizumab|bevacizumab|mesh-list
111136655|NCT01663727|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111136656|NCT01663727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111136657|NCT01663727|Tubulin Modulators|tubulin modulators|mesh-ancestor
111136658|NCT01663727|Antimitotic Agents|antimitotic agents|mesh-ancestor
111136659|NCT01663727|Mitosis Modulators|mitosis modulators|mesh-ancestor
111136660|NCT01663727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111136661|NCT01663727|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111136662|NCT01663727|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111136663|NCT01663727|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111136664|NCT01663727|Growth Substances|growth substances|mesh-ancestor
111136665|NCT01663727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111136666|NCT01663727|Growth Inhibitors|growth inhibitors|mesh-ancestor
111136667|NCT03042325|Alogliptin|alogliptin|mesh-list
110589762|NCT00720902|Hormones|hormones|mesh-list
111136668|NCT03042325|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111136669|NCT03042325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111136670|NCT03042325|Incretins|incretins|mesh-ancestor
111136671|NCT03042325|Hormones|hormones|mesh-ancestor
111136672|NCT03042325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111136673|NCT03042325|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111136674|NCT03042325|Protease Inhibitors|protease inhibitors|mesh-ancestor
111136675|NCT03042325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111136676|NCT03042325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111136677|NCT01594333|Methotrexate|methotrexate|mesh-list
111136678|NCT01594333|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111136679|NCT01594333|Abortifacient Agents|abortifacient agents|mesh-ancestor
111136680|NCT01594333|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111136681|NCT01594333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111136682|NCT01594333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111136683|NCT01594333|Antimetabolites|antimetabolites|mesh-ancestor
111136684|NCT01594333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111136685|NCT01594333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111136686|NCT01594333|Dermatologic Agents|dermatologic agents|mesh-ancestor
111136687|NCT01594333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111136688|NCT01594333|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111136689|NCT01594333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111136690|NCT01594333|Immunologic Factors|immunologic factors|mesh-ancestor
111136691|NCT01594333|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111136692|NCT01594333|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111136693|NCT04858633|Hydroxychloroquine|hydroxychloroquine|mesh-list
111136694|NCT04858633|Antimalarials|antimalarials|mesh-ancestor
111136695|NCT04858633|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111136696|NCT04858633|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111136697|NCT04858633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111136698|NCT04858633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111136699|NCT04858633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111136701|NCT03043495|Dexamethasone|dexamethasone|mesh-list
111136702|NCT03043495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111136703|NCT03043495|Antiemetics|antiemetics|mesh-ancestor
111136704|NCT03043495|Autonomic Agents|autonomic agents|mesh-ancestor
111136705|NCT03043495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111136706|NCT03043495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111136707|NCT03043495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111136708|NCT03043495|Glucocorticoids|glucocorticoids|mesh-ancestor
111136709|NCT03043495|Hormones|hormones|mesh-ancestor
111136710|NCT03043495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111136711|NCT03043495|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111136712|NCT03043495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111136713|NCT03043027|Bupivacaine|bupivacaine|mesh-list
111136714|NCT03043027|Anesthetics, Local|anesthetics, local|mesh-ancestor
111136715|NCT03043027|Anesthetics|anesthetics|mesh-ancestor
111136716|NCT03043027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111136717|NCT03043027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111136718|NCT03043027|Sensory System Agents|sensory system agents|mesh-ancestor
111136719|NCT03043027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111136720|NCT04861207|Cladribine|cladribine|mesh-list
111136721|NCT04861207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111136722|NCT04861207|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111136723|NCT04861207|Immunologic Factors|immunologic factors|mesh-ancestor
111136724|NCT04861207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111136725|NCT04858087|Lumefantrine|lumefantrine|mesh-list
111136726|NCT04858087|Artemether|artemether|mesh-list
111136727|NCT04858087|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
111136728|NCT04858087|Antimalarials|antimalarials|mesh-ancestor
111136729|NCT04858087|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111136730|NCT04858087|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111136731|NCT04858087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111136732|NCT03041935|Acetaminophen|acetaminophen|mesh-list
111136733|NCT03041935|Dexamethasone|dexamethasone|mesh-list
111136734|NCT03041935|Ketorolac|ketorolac|mesh-list
111136735|NCT03041935|Morphine|morphine|mesh-list
111136736|NCT03041935|Remifentanil|remifentanil|mesh-list
111136737|NCT03041935|Ondansetron|ondansetron|mesh-list
111136738|NCT03041935|Propofol|propofol|mesh-list
111136739|NCT03041935|Ropivacaine|ropivacaine|mesh-list
111136740|NCT03041935|Sevoflurane|sevoflurane|mesh-list
111136741|NCT03041935|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111136742|NCT03041935|Antiemetics|antiemetics|mesh-ancestor
111136743|NCT03041935|Autonomic Agents|autonomic agents|mesh-ancestor
111136744|NCT03041935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111136745|NCT03041935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111136746|NCT03041935|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111136747|NCT03041935|Glucocorticoids|glucocorticoids|mesh-ancestor
111136748|NCT03041935|Hormones|hormones|mesh-ancestor
111136749|NCT03041935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111136750|NCT03041935|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111136751|NCT03041935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111136752|NCT03041935|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111136753|NCT03041935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111136754|NCT03041935|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111136755|NCT03041935|Anesthetics, General|anesthetics, general|mesh-ancestor
111136756|NCT03041935|Anesthetics|anesthetics|mesh-ancestor
111136757|NCT03041935|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111136758|NCT03041935|Narcotics|narcotics|mesh-ancestor
111136759|NCT03041935|Analgesics|analgesics|mesh-ancestor
111136760|NCT03041935|Sensory System Agents|sensory system agents|mesh-ancestor
111136761|NCT03041935|Anesthetics, Local|anesthetics, local|mesh-ancestor
111136762|NCT03041935|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111136763|NCT03041935|Antipyretics|antipyretics|mesh-ancestor
111136764|NCT03041935|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111136765|NCT03041935|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111136766|NCT03041935|Antipruritics|antipruritics|mesh-ancestor
111136767|NCT03041935|Dermatologic Agents|dermatologic agents|mesh-ancestor
111136768|NCT03041935|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111136769|NCT03041935|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111136770|NCT03041935|Serotonin Agents|serotonin agents|mesh-ancestor
111136771|NCT03041935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111136772|NCT03041935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111136773|NCT03041935|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111136774|NCT03041935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111136775|NCT03041935|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111136776|NCT03041935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111136777|NCT03042013|Naquotinib|naquotinib|mesh-list
111136778|NCT03042013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111136779|NCT03042013|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111136780|NCT03042013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111136781|NCT03042013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111136782|NCT03042871|Ranibizumab|ranibizumab|mesh-list
111136783|NCT03042871|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111136784|NCT03042871|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111136785|NCT03042871|Growth Substances|growth substances|mesh-ancestor
111136786|NCT03042871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111136787|NCT03042871|Growth Inhibitors|growth inhibitors|mesh-ancestor
111136788|NCT03042871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111136789|NCT03042637|Tacrolimus|tacrolimus|mesh-list
111136790|NCT03042637|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111136791|NCT03042637|Immunologic Factors|immunologic factors|mesh-ancestor
111136792|NCT03042637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111136793|NCT03042637|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111136794|NCT03042637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111136795|NCT03042637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111136796|NCT03045133|Morphine|morphine|mesh-list
111136797|NCT03045133|Methadone|methadone|mesh-list
111136798|NCT03045133|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111136799|NCT03045133|Narcotics|narcotics|mesh-ancestor
111136800|NCT03045133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111136801|NCT03045133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111136802|NCT03045133|Analgesics|analgesics|mesh-ancestor
111136803|NCT03045133|Sensory System Agents|sensory system agents|mesh-ancestor
111136804|NCT03045133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111136805|NCT03045133|Antitussive Agents|antitussive agents|mesh-ancestor
111136806|NCT03045133|Respiratory System Agents|respiratory system agents|mesh-ancestor
111136807|NCT02609659|Ritonavir|ritonavir|mesh-list
111136808|NCT02609659|Ribavirin|ribavirin|mesh-list
111136809|NCT02609659|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111136810|NCT02609659|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111136811|NCT02609659|Protease Inhibitors|protease inhibitors|mesh-ancestor
111136812|NCT02609659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110838576|NCT02944656|Gabapentin|gabapentin|mesh-list
111136813|NCT02609659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111136814|NCT02609659|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111136815|NCT02609659|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111136816|NCT02609659|Antiviral Agents|antiviral agents|mesh-ancestor
111136817|NCT02609659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111136818|NCT02609659|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111136819|NCT02609659|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111136820|NCT02609659|Antimetabolites|antimetabolites|mesh-ancestor
111136822|NCT04429711|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111136823|NCT04429711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111136824|NCT04429633|Candesartan|candesartan|mesh-list
111136825|NCT04429633|Candesartan cilexetil|candesartan cilexetil|mesh-list
111136826|NCT04429633|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111136827|NCT04429633|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111136828|NCT04429633|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111136829|NCT04429633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111136830|NCT03042091|Metronidazole|metronidazole|mesh-list
111136831|NCT03042091|Ethanol|ethanol|mesh-list
111136832|NCT03042091|Neomycin|neomycin|mesh-list
111136833|NCT03042091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111136834|NCT03042091|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111136835|NCT03042091|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111136836|NCT03042091|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111136837|NCT03042091|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111136838|NCT03042091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111136839|NCT03042091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111136840|NCT03042091|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111136841|NCT03042091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111136842|NCT03042091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111136843|NCT04859569|Denosumab|denosumab|mesh-list
111136844|NCT04859569|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110589818|NCT00694551|Poly I-C|poly i-c|mesh-list
111136845|NCT04859569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111136846|NCT04856371|Letrozole|letrozole|mesh-list
111136847|NCT04856371|Fulvestrant|fulvestrant|mesh-list
111136848|NCT04856371|Palbociclib|palbociclib|mesh-list
111136849|NCT04856371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111136850|NCT04856371|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111136851|NCT04856371|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111136852|NCT04856371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111136853|NCT04856371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111136854|NCT04856371|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111136855|NCT04856371|Hormone Antagonists|hormone antagonists|mesh-ancestor
111136856|NCT04856371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111136857|NCT04856371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111136858|NCT04856371|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111136859|NCT04856371|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
111136860|NCT04856371|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111136861|NCT03041779|Acetaminophen|acetaminophen|mesh-list
111136862|NCT03041779|Diclofenac|diclofenac|mesh-list
111136863|NCT03041779|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111136864|NCT03041779|Analgesics|analgesics|mesh-ancestor
111136865|NCT03041779|Sensory System Agents|sensory system agents|mesh-ancestor
111136866|NCT03041779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111136867|NCT03041779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111136868|NCT03041779|Antipyretics|antipyretics|mesh-ancestor
111136869|NCT03041779|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111136870|NCT03041779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111136871|NCT03041779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111136872|NCT03041779|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111136873|NCT03041779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111136874|NCT03041779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111136875|NCT02612779|Dexamethasone|dexamethasone|mesh-list
111136876|NCT02612779|Nivolumab|nivolumab|mesh-list
111136877|NCT02612779|Pomalidomide|pomalidomide|mesh-list
111136878|NCT02612779|Elotuzumab|elotuzumab|mesh-list
111136879|NCT02612779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111136880|NCT02612779|Antiemetics|antiemetics|mesh-ancestor
111136881|NCT02612779|Autonomic Agents|autonomic agents|mesh-ancestor
111136882|NCT02612779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111136883|NCT02612779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111136884|NCT02612779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111136885|NCT02612779|Glucocorticoids|glucocorticoids|mesh-ancestor
111136886|NCT02612779|Hormones|hormones|mesh-ancestor
111136887|NCT02612779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111136888|NCT02612779|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111136889|NCT02612779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111136890|NCT02612779|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111136891|NCT02612779|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111136892|NCT02612779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111136893|NCT02612779|Immunologic Factors|immunologic factors|mesh-ancestor
111136894|NCT02612779|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111136895|NCT02612779|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111136896|NCT02612779|Growth Substances|growth substances|mesh-ancestor
111136897|NCT02612779|Growth Inhibitors|growth inhibitors|mesh-ancestor
111136898|NCT04866355|Ibuprofen|ibuprofen|mesh-list
111136899|NCT04866355|Scopolamine|scopolamine|mesh-list
111136900|NCT04866355|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111136901|NCT04866355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111136902|NCT04866355|Analgesics|analgesics|mesh-ancestor
111136903|NCT04866355|Sensory System Agents|sensory system agents|mesh-ancestor
111136904|NCT04866355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111136905|NCT04866355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111136906|NCT04866355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111136907|NCT04866355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111136908|NCT04866355|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111136909|NCT04866355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111136910|NCT04866355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111136911|NCT04866355|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111136912|NCT04866355|Antiemetics|antiemetics|mesh-ancestor
111136913|NCT04866355|Autonomic Agents|autonomic agents|mesh-ancestor
111136914|NCT04866355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111136915|NCT04866355|Mydriatics|mydriatics|mesh-ancestor
111136916|NCT04866355|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111136917|NCT04866355|Cholinergic Agents|cholinergic agents|mesh-ancestor
111136918|NCT04866355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111136919|NCT04866355|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111136920|NCT02607865|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111136921|NCT02607865|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111136922|NCT02607865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111136923|NCT02607865|Incretins|incretins|mesh-ancestor
110853952|NCT03791801|Neostigmine|neostigmine|mesh-list
111136924|NCT02607865|Hormones|hormones|mesh-ancestor
111136925|NCT02607865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111136926|NCT02607865|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111136927|NCT02607865|Protease Inhibitors|protease inhibitors|mesh-ancestor
111136928|NCT02607865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111136929|NCT02607865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111136931|NCT04856137|Rituximab|rituximab|mesh-list
111136932|NCT04856137|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111136933|NCT04856137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111136934|NCT04856137|Tubulin Modulators|tubulin modulators|mesh-ancestor
111136935|NCT04856137|Antimitotic Agents|antimitotic agents|mesh-ancestor
111136936|NCT04856137|Mitosis Modulators|mitosis modulators|mesh-ancestor
111136937|NCT04856137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111136938|NCT04856137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111136939|NCT04856137|Immunologic Factors|immunologic factors|mesh-ancestor
111136940|NCT04856137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111136941|NCT04856137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111136942|NCT04855279|Listerine|listerine|mesh-list
111136943|NCT04855279|Fluorides|fluorides|mesh-list
111136944|NCT04855279|Sodium Fluoride|sodium fluoride|mesh-list
111136945|NCT04855279|Glycerol|glycerol|mesh-list
111136946|NCT04855279|Cariostatic Agents|cariostatic agents|mesh-ancestor
111136947|NCT04855279|Protective Agents|protective agents|mesh-ancestor
111136948|NCT04855279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110838590|NCT02944656|Antimanic Agents|antimanic agents|mesh-ancestor
111136949|NCT04855279|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111136950|NCT04855279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111136951|NCT04855279|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
111136953|NCT04848259|Dexamethasone acetate|dexamethasone acetate|mesh-list
111136954|NCT04848259|BB 1101|bb 1101|mesh-list
111136955|NCT04848259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111136956|NCT04848259|Antiemetics|antiemetics|mesh-ancestor
111136957|NCT04848259|Autonomic Agents|autonomic agents|mesh-ancestor
111136958|NCT04848259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111136959|NCT04848259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111136960|NCT04848259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111136961|NCT04848259|Glucocorticoids|glucocorticoids|mesh-ancestor
111136962|NCT04848259|Hormones|hormones|mesh-ancestor
111136963|NCT04848259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111136964|NCT04848259|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111136965|NCT04848259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111136966|NCT04848259|Protease Inhibitors|protease inhibitors|mesh-ancestor
111136967|NCT04848259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111136968|NCT04848259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111136969|NCT03039049|Triptorelin Pamoate|triptorelin pamoate|mesh-list
111136970|NCT03039049|Luteolytic Agents|luteolytic agents|mesh-ancestor
111136971|NCT03039049|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111136972|NCT03039049|Contraceptive Agents|contraceptive agents|mesh-ancestor
111136973|NCT03039049|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111136974|NCT03039049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111136975|NCT03039049|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111136976|NCT03039049|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111136977|NCT03039049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111136978|NCT04848181|Cyproterone Acetate|cyproterone acetate|mesh-list
111136979|NCT04848181|Finasteride|finasteride|mesh-list
111136980|NCT04848181|Cyproterone|cyproterone|mesh-list
111136981|NCT04848181|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
111136982|NCT04848181|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111136983|NCT04848181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111136984|NCT04848181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111136985|NCT04848181|Hormone Antagonists|hormone antagonists|mesh-ancestor
111136986|NCT04848181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111136987|NCT04848181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111136988|NCT04848181|Urological Agents|urological agents|mesh-ancestor
111136989|NCT04848181|Androgen Antagonists|androgen antagonists|mesh-ancestor
111136990|NCT04848181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111136991|NCT04848181|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
111136992|NCT04848181|Contraceptive Agents|contraceptive agents|mesh-ancestor
111136993|NCT04848181|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111136994|NCT04847791|Lactoferrin|lactoferrin|mesh-list
111136995|NCT04847791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111136996|NCT04375813|Sirolimus|sirolimus|mesh-list
111136997|NCT04375813|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111136998|NCT04375813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111136999|NCT04375813|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111137000|NCT04375813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111137001|NCT04375813|Antifungal Agents|antifungal agents|mesh-ancestor
111137002|NCT04375813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111137003|NCT04375813|Immunologic Factors|immunologic factors|mesh-ancestor
111137004|NCT04375813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111137005|NCT04847245|Pregabalin|pregabalin|mesh-list
111137006|NCT04847245|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
111137007|NCT04847245|Esketamine|esketamine|mesh-list
111137008|NCT04847245|Analgesics|analgesics|mesh-ancestor
111137009|NCT04847245|Sensory System Agents|sensory system agents|mesh-ancestor
111137010|NCT04847245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111137011|NCT04847245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111137012|NCT04847245|Anticonvulsants|anticonvulsants|mesh-ancestor
111137013|NCT04847245|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111137014|NCT04847245|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110589869|NCT00720356|Growth Substances|growth substances|mesh-ancestor
111137015|NCT04847245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111137016|NCT04847245|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111137017|NCT04847245|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111137018|NCT04847245|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111137019|NCT04847245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111137020|NCT04847245|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111137021|NCT04847245|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111137022|NCT04847245|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111137023|NCT04847245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111137024|NCT04847245|Antidepressive Agents|antidepressive agents|mesh-ancestor
111137025|NCT04847245|Dopamine Agents|dopamine agents|mesh-ancestor
111137026|NCT04839913|Antibodies|antibodies|mesh-list
111137027|NCT04839913|Immunologic Factors|immunologic factors|mesh-ancestor
111137028|NCT04839913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111137029|NCT04846621|Calcium Channel Blockers|calcium channel blockers|mesh-list
111137030|NCT04846621|Calcium|calcium|mesh-list
111137031|NCT04846621|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111137032|NCT04846621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111137033|NCT04846621|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111137034|NCT04846621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111137035|NCT04854577|Anesthetics|anesthetics|mesh-list
111137036|NCT04854577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111137037|NCT04854577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111137038|NCT04839445|Anesthetics|anesthetics|mesh-list
111137039|NCT04839445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111137040|NCT04839445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111137041|NCT04845607|Amiodarone|amiodarone|mesh-list
111137042|NCT04845607|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111137043|NCT04845607|Vasodilator Agents|vasodilator agents|mesh-ancestor
111137044|NCT04845607|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
111137045|NCT04845607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111137046|NCT04845607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111137047|NCT04845607|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111137048|NCT04845607|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111137049|NCT04845607|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111137050|NCT04845607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111137051|NCT04845607|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111137052|NCT04845607|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111137053|NCT04845607|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111137054|NCT04853797|Calcium|calcium|mesh-list
111137055|NCT04853797|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111137056|NCT04853797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111137057|NCT03040531|Vitamin D|vitamin d|mesh-list
111137058|NCT03040531|Cholecalciferol|cholecalciferol|mesh-list
111137059|NCT03040531|Alendronate|alendronate|mesh-list
111137060|NCT03040531|Genistein|genistein|mesh-list
111137061|NCT03040531|Calcium|calcium|mesh-list
111137062|NCT03040531|Vitamins|vitamins|mesh-ancestor
111137063|NCT03040531|Micronutrients|micronutrients|mesh-ancestor
111137064|NCT03040531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111137065|NCT03040531|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111137066|NCT03040531|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111137067|NCT03040531|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
111137068|NCT03040531|Protective Agents|protective agents|mesh-ancestor
111137069|NCT03040531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110589882|NCT00745953|Natriuretic Agents|natriuretic agents|mesh-ancestor
111137070|NCT03040531|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111137071|NCT03040531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111137072|NCT03040531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111137073|NCT03040531|Phytoestrogens|phytoestrogens|mesh-ancestor
111137074|NCT03040531|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
111137075|NCT03040531|Estrogens|estrogens|mesh-ancestor
111137077|NCT03040531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111137078|NCT04838665|Phenylephrine|phenylephrine|mesh-list
111137079|NCT04838665|Oxymetazoline|oxymetazoline|mesh-list
111137080|NCT04838665|Tropicamide|tropicamide|mesh-list
111137081|NCT04838665|Cyclopentolate|cyclopentolate|mesh-list
111137082|NCT04838665|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111137083|NCT04838665|Mydriatics|mydriatics|mesh-ancestor
111137084|NCT04838665|Autonomic Agents|autonomic agents|mesh-ancestor
111137085|NCT04838665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111137086|NCT04838665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111137087|NCT04838665|Sympathomimetics|sympathomimetics|mesh-ancestor
111137088|NCT04838665|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111137089|NCT04838665|Nasal Decongestants|nasal decongestants|mesh-ancestor
111137090|NCT04838665|Respiratory System Agents|respiratory system agents|mesh-ancestor
111137091|NCT04838665|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
111137092|NCT04838665|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111137093|NCT04838665|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111137094|NCT04838665|Adrenergic Agents|adrenergic agents|mesh-ancestor
111137095|NCT04838665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111137096|NCT04838665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111137097|NCT04838665|Protective Agents|protective agents|mesh-ancestor
111137098|NCT04838665|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111137099|NCT04838665|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111137100|NCT04838665|Cholinergic Agents|cholinergic agents|mesh-ancestor
111137101|NCT04838665|Parasympatholytics|parasympatholytics|mesh-ancestor
111137102|NCT04845061|Nebivolol|nebivolol|mesh-list
111137103|NCT04845061|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111137104|NCT04845061|Vasodilator Agents|vasodilator agents|mesh-ancestor
111137105|NCT04845061|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
111137106|NCT04845061|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111137107|NCT04845061|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111137108|NCT04845061|Adrenergic Agents|adrenergic agents|mesh-ancestor
111137109|NCT04845061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111137110|NCT04845061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111137111|NCT04845061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111137112|NCT03040765|Zoledronic Acid|zoledronic acid|mesh-list
111137113|NCT03040765|Denosumab|denosumab|mesh-list
111137114|NCT03040765|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111137115|NCT03040765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111137116|NCT01668667|Gabapentin|gabapentin|mesh-list
111137117|NCT01668667|Analgesics|analgesics|mesh-ancestor
111137118|NCT01668667|Sensory System Agents|sensory system agents|mesh-ancestor
111137119|NCT01668667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111137120|NCT01668667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111137121|NCT01668667|Anticonvulsants|anticonvulsants|mesh-ancestor
111137122|NCT01668667|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111137123|NCT01668667|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111137124|NCT01668667|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111137125|NCT01668667|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111137126|NCT01668667|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111137127|NCT01668667|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111137128|NCT01668667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111137129|NCT01668667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111137130|NCT01668667|Antimanic Agents|antimanic agents|mesh-ancestor
111137131|NCT03040219|Folic Acid|folic acid|mesh-list
111137132|NCT03040219|Hematinics|hematinics|mesh-ancestor
111137133|NCT03040219|Vitamin B Complex|vitamin b complex|mesh-ancestor
111137134|NCT03040219|Vitamins|vitamins|mesh-ancestor
111137135|NCT03040219|Micronutrients|micronutrients|mesh-ancestor
111137136|NCT03040219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111137137|NCT03038503|Terlipressin|terlipressin|mesh-list
111137138|NCT03038503|Methylene Blue|methylene blue|mesh-list
111137139|NCT03038503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111137140|NCT03038503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111137141|NCT03038503|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111137142|NCT03038503|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111137143|NCT02608879|Chlorhexidine|chlorhexidine|mesh-list
111137144|NCT02608879|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111137145|NCT02608879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111137146|NCT02608879|Disinfectants|disinfectants|mesh-ancestor
111137147|NCT04852315|Caffeine|caffeine|mesh-list
111137148|NCT04852315|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110838610|NCT04800627|Pembrolizumab|pembrolizumab|mesh-list
111137149|NCT04852315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111137150|NCT04852315|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111137151|NCT04852315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111137152|NCT04852315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111137153|NCT04852315|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
111137154|NCT04852315|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111137155|NCT04852315|Purinergic Agents|purinergic agents|mesh-ancestor
111137156|NCT04852315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111137157|NCT03038425|Ropivacaine|ropivacaine|mesh-list
111137158|NCT03038425|Anesthetics, Local|anesthetics, local|mesh-ancestor
111137159|NCT03038425|Anesthetics|anesthetics|mesh-ancestor
111137160|NCT03038425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111137161|NCT03038425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111137162|NCT03038425|Sensory System Agents|sensory system agents|mesh-ancestor
111137163|NCT03038425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111137164|NCT04851769|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
111137165|NCT04851769|Alirocumab|alirocumab|mesh-list
111137166|NCT04851769|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-list
111137167|NCT04851769|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111137168|NCT04851769|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111137169|NCT04851769|Antimetabolites|antimetabolites|mesh-ancestor
111137170|NCT04851769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111137171|NCT04851769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111137172|NCT04851769|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111137173|NCT04851769|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111137174|NCT04851769|Protease Inhibitors|protease inhibitors|mesh-ancestor
111137175|NCT04843267|Tislelizumab|tislelizumab|mesh-list
111137176|NCT04843267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111137177|NCT04843267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111137178|NCT04852081|Tamoxifen|tamoxifen|mesh-list
111137179|NCT04852081|Letrozole|letrozole|mesh-list
111137180|NCT04852081|Fulvestrant|fulvestrant|mesh-list
111137181|NCT04852081|Palbociclib|palbociclib|mesh-list
111137182|NCT04852081|Anastrozole|anastrozole|mesh-list
111137183|NCT04852081|Exemestane|exemestane|mesh-list
111137184|NCT04852081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111137185|NCT04852081|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111137186|NCT04852081|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111137187|NCT04852081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111137188|NCT04852081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111137189|NCT04852081|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111137190|NCT04852081|Hormone Antagonists|hormone antagonists|mesh-ancestor
111137191|NCT04852081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111137192|NCT04852081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111137193|NCT04852081|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111137194|NCT04852081|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111137195|NCT04852081|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111137196|NCT04852081|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111137197|NCT04852081|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
111137198|NCT04852081|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111137199|NCT04851457|Tirofiban|tirofiban|mesh-list
111137200|NCT04851457|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111137201|NCT04851457|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111137202|NCT04851457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111137203|NCT04851457|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111137204|NCT02608099|Apixaban|apixaban|mesh-list
111137205|NCT02608099|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111137206|NCT02608099|Antithrombins|antithrombins|mesh-ancestor
111137207|NCT02608099|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111137208|NCT02608099|Protease Inhibitors|protease inhibitors|mesh-ancestor
111137209|NCT02608099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111137210|NCT02608099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111137211|NCT02608099|Anticoagulants|anticoagulants|mesh-ancestor
111137212|NCT04850755|Nivolumab|nivolumab|mesh-list
111137213|NCT04850755|Ipilimumab|ipilimumab|mesh-list
111137214|NCT04850755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111137215|NCT04850755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111137216|NCT04850755|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111137217|NCT04850755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111137218|NCT04842487|Prednisone|prednisone|mesh-list
111137219|NCT04842487|Cyclophosphamide|cyclophosphamide|mesh-list
111137220|NCT04842487|Rituximab|rituximab|mesh-list
111137221|NCT04842487|Vincristine|vincristine|mesh-list
111137222|NCT04842487|Lenalidomide|lenalidomide|mesh-list
111137223|NCT04842487|Doxorubicin|doxorubicin|mesh-list
111137224|NCT04842487|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
111137225|NCT04842487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111137226|NCT04842487|Immunologic Factors|immunologic factors|mesh-ancestor
111137227|NCT04842487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111137228|NCT04842487|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111137229|NCT04842487|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111137230|NCT04842487|Alkylating Agents|alkylating agents|mesh-ancestor
111137231|NCT04842487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111137232|NCT04842487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111137233|NCT04842487|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111137234|NCT04842487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111137235|NCT04842487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111137236|NCT04842487|Glucocorticoids|glucocorticoids|mesh-ancestor
111137237|NCT04842487|Hormones|hormones|mesh-ancestor
111137238|NCT04842487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111137239|NCT04842487|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111137240|NCT04842487|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111137241|NCT04842487|Tubulin Modulators|tubulin modulators|mesh-ancestor
111137242|NCT04842487|Antimitotic Agents|antimitotic agents|mesh-ancestor
111137243|NCT04842487|Mitosis Modulators|mitosis modulators|mesh-ancestor
111137244|NCT04842487|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111137245|NCT04842487|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111137246|NCT04842487|Growth Substances|growth substances|mesh-ancestor
111137247|NCT04842487|Growth Inhibitors|growth inhibitors|mesh-ancestor
111137248|NCT04842487|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111137249|NCT04842487|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111137250|NCT04842487|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111137251|NCT04842487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111137252|NCT04842331|Nitric Oxide|nitric oxide|mesh-list
111137253|NCT04842331|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111137254|NCT04842331|Autonomic Agents|autonomic agents|mesh-ancestor
111137255|NCT04842331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111137256|NCT04842331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111137257|NCT04842331|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111137258|NCT04842331|Respiratory System Agents|respiratory system agents|mesh-ancestor
111137259|NCT04842331|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111137260|NCT04842331|Antioxidants|antioxidants|mesh-ancestor
111137261|NCT04842331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111137262|NCT04842331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111137263|NCT04842331|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
111137264|NCT04842331|Vasodilator Agents|vasodilator agents|mesh-ancestor
111137265|NCT04842331|Gasotransmitters|gasotransmitters|mesh-ancestor
111137266|NCT04842331|Protective Agents|protective agents|mesh-ancestor
111137267|NCT04837885|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
111137268|NCT04837885|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111137269|NCT04837885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111137270|NCT04833205|Nimotuzumab|nimotuzumab|mesh-list
111137271|NCT04833205|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111137272|NCT04833205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111137273|NCT04312243|Nitric Oxide|nitric oxide|mesh-list
111137274|NCT04312243|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111137275|NCT04312243|Autonomic Agents|autonomic agents|mesh-ancestor
111137276|NCT04312243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111137277|NCT04312243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111137278|NCT04312243|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111137279|NCT04312243|Respiratory System Agents|respiratory system agents|mesh-ancestor
111137280|NCT04312243|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111137281|NCT04312243|Antioxidants|antioxidants|mesh-ancestor
111137282|NCT04312243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111137283|NCT04312243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111137284|NCT04312243|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
111137285|NCT04312243|Vasodilator Agents|vasodilator agents|mesh-ancestor
111137286|NCT04312243|Gasotransmitters|gasotransmitters|mesh-ancestor
111137287|NCT04312243|Protective Agents|protective agents|mesh-ancestor
111137288|NCT04841551|Deoxycholic Acid|deoxycholic acid|mesh-list
111137289|NCT04841551|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
111137290|NCT04841551|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111137291|NCT04837651|Antibodies|antibodies|mesh-list
111137292|NCT04837651|Immunologic Factors|immunologic factors|mesh-ancestor
111137293|NCT04837651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111137294|NCT03039205|Clopidogrel|clopidogrel|mesh-list
111137295|NCT03039205|Ticagrelor|ticagrelor|mesh-list
111137296|NCT03039205|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111137297|NCT03039205|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111137298|NCT03039205|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111137299|NCT03039205|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111137300|NCT03039205|Purinergic Agents|purinergic agents|mesh-ancestor
111137301|NCT03039205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111137302|NCT03039205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111137303|NCT03039205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111137304|NCT04837261|Propranolol|propranolol|mesh-list
111137305|NCT04837261|Amiodarone|amiodarone|mesh-list
111137306|NCT04837261|Flecainide|flecainide|mesh-list
111137307|NCT04837261|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111137308|NCT04837261|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111137309|NCT04837261|Adrenergic Agents|adrenergic agents|mesh-ancestor
111137310|NCT04837261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111137311|NCT04837261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111137312|NCT04837261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111137313|NCT04837261|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111137314|NCT04837261|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111137315|NCT04837261|Vasodilator Agents|vasodilator agents|mesh-ancestor
111137316|NCT04837261|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
111137317|NCT04837261|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111137318|NCT04837261|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111137319|NCT04837261|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111137320|NCT04837261|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111137321|NCT04837261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111137322|NCT04837261|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
111137323|NCT04837261|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111137324|NCT04837261|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111137325|NCT04837261|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111137326|NCT04832035|Psychotropic Drugs|psychotropic drugs|mesh-list
111137327|NCT04824937|Talazoparib|talazoparib|mesh-list
111137328|NCT04824937|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111137329|NCT04824937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111137330|NCT04824937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111137331|NCT04824937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111137332|NCT03036085|Epinephrine|epinephrine|mesh-list
111137333|NCT03036085|Bupivacaine|bupivacaine|mesh-list
111137334|NCT03036085|Anesthetics, Local|anesthetics, local|mesh-ancestor
111137335|NCT03036085|Anesthetics|anesthetics|mesh-ancestor
110838630|NCT01146977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111137336|NCT03036085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111137337|NCT03036085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111137338|NCT03036085|Sensory System Agents|sensory system agents|mesh-ancestor
111137339|NCT03036085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111137340|NCT03036085|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111137341|NCT03036085|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111137342|NCT03036085|Adrenergic Agents|adrenergic agents|mesh-ancestor
111137343|NCT03036085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111137344|NCT03036085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111137345|NCT03036085|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111137346|NCT03036085|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111137347|NCT03036085|Autonomic Agents|autonomic agents|mesh-ancestor
111137348|NCT03036085|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111137349|NCT03036085|Respiratory System Agents|respiratory system agents|mesh-ancestor
111137350|NCT03036085|Mydriatics|mydriatics|mesh-ancestor
111137351|NCT03036085|Sympathomimetics|sympathomimetics|mesh-ancestor
111137352|NCT03036085|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111137353|NCT04831255|Triamcinolone|triamcinolone|mesh-list
111137354|NCT04831255|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
111137355|NCT04831255|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
111137356|NCT04831255|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
111137357|NCT04831255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111137358|NCT04831255|Glucocorticoids|glucocorticoids|mesh-ancestor
111137359|NCT04831255|Hormones|hormones|mesh-ancestor
111137360|NCT04831255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111137361|NCT04831255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111137362|NCT04831255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111137363|NCT04831255|Immunologic Factors|immunologic factors|mesh-ancestor
111137364|NCT04831255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111137365|NCT04831255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111137366|NCT02431533|Calcium|calcium|mesh-list
111137367|NCT02431533|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111137368|NCT02431533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111137369|NCT02413593|Sofosbuvir|sofosbuvir|mesh-list
111137370|NCT02413593|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
111137371|NCT02413593|Ledipasvir|ledipasvir|mesh-list
111137372|NCT02413593|Antiviral Agents|antiviral agents|mesh-ancestor
111137373|NCT02413593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111137374|NCT01652703|Evolocumab|evolocumab|mesh-list
111137375|NCT01652703|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
111137376|NCT01652703|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111137377|NCT01652703|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111137378|NCT01652703|Antimetabolites|antimetabolites|mesh-ancestor
111137379|NCT01652703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111137380|NCT01652703|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111137381|NCT01652703|Protease Inhibitors|protease inhibitors|mesh-ancestor
111137382|NCT01652703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111137383|NCT01652703|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111137384|NCT01652469|Docetaxel|docetaxel|mesh-list
111137385|NCT01652469|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111137386|NCT01652469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111137387|NCT01652469|Tubulin Modulators|tubulin modulators|mesh-ancestor
111137388|NCT01652469|Antimitotic Agents|antimitotic agents|mesh-ancestor
111137389|NCT01652469|Mitosis Modulators|mitosis modulators|mesh-ancestor
111137390|NCT01652469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111137391|NCT01652469|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111137392|NCT01652469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111137393|NCT02429427|Celecoxib|celecoxib|mesh-list
111137394|NCT02429427|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111137395|NCT02429427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111137396|NCT02429427|Analgesics|analgesics|mesh-ancestor
111137397|NCT02429427|Sensory System Agents|sensory system agents|mesh-ancestor
111137398|NCT02429427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111137399|NCT02429427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111137400|NCT02429427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111137401|NCT02429427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111137402|NCT02429427|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111137403|NCT02429427|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111137404|NCT02429427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111137405|NCT02429427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111137406|NCT02412657|Dexamethasone|dexamethasone|mesh-list
111137407|NCT02412657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111137408|NCT02412657|Antiemetics|antiemetics|mesh-ancestor
111137409|NCT02412657|Autonomic Agents|autonomic agents|mesh-ancestor
111137410|NCT02412657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111137411|NCT02412657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111137412|NCT02412657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111137413|NCT02412657|Glucocorticoids|glucocorticoids|mesh-ancestor
111137414|NCT02412657|Hormones|hormones|mesh-ancestor
111137415|NCT02412657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111137416|NCT02412657|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111137417|NCT02412657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111137418|NCT02412111|Ivacaftor|ivacaftor|mesh-list
111137419|NCT02412111|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
111137420|NCT02412111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111137421|NCT02412111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111137422|NCT02426541|Dapagliflozin|dapagliflozin|mesh-list
111137423|NCT02426541|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111137424|NCT02426541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111137425|NCT02426541|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111137426|NCT02426541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111137427|NCT02484651|Rocuronium|rocuronium|mesh-list
111137428|NCT02484651|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
111137429|NCT02484651|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
111137430|NCT02484651|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111137431|NCT02484651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111137432|NCT02484651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111137433|NCT02410551|Fludarabine|fludarabine|mesh-list
111137434|NCT02410551|Fludarabine phosphate|fludarabine phosphate|mesh-list
111137435|NCT02410551|Busulfan|busulfan|mesh-list
111137436|NCT02410551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111137437|NCT02410551|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111137438|NCT02410551|Antimetabolites|antimetabolites|mesh-ancestor
111137439|NCT02410551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111137440|NCT02410551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111137441|NCT02410551|Immunologic Factors|immunologic factors|mesh-ancestor
111137442|NCT02410551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111137443|NCT02410551|Alkylating Agents|alkylating agents|mesh-ancestor
111137444|NCT02410551|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111137445|NCT02410551|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111137446|NCT02424591|Ketamine|ketamine|mesh-list
111137447|NCT02424591|Analgesics|analgesics|mesh-ancestor
111137448|NCT02424591|Sensory System Agents|sensory system agents|mesh-ancestor
111137449|NCT02424591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111137450|NCT02424591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111137451|NCT02424591|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
111137452|NCT02424591|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111137453|NCT02424591|Anesthetics, General|anesthetics, general|mesh-ancestor
111137454|NCT02424591|Anesthetics|anesthetics|mesh-ancestor
111137455|NCT02424591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111137456|NCT02424591|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111137457|NCT02424591|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111137458|NCT02424591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111137459|NCT02424591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111137460|NCT02408523|Lacosamide|lacosamide|mesh-list
111137461|NCT02408523|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111137462|NCT02408523|Anticonvulsants|anticonvulsants|mesh-ancestor
111137463|NCT02408523|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
111137464|NCT02408523|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
111137465|NCT02408523|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111137466|NCT02408523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111137468|NCT04822909|Apremilast|apremilast|mesh-list
111137469|NCT04822909|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111137470|NCT04822909|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111137471|NCT04822909|Analgesics|analgesics|mesh-ancestor
111137472|NCT04822909|Sensory System Agents|sensory system agents|mesh-ancestor
111137473|NCT04822909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111137474|NCT04822909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111137475|NCT04822909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111137476|NCT04822909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111137477|NCT04822909|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
111137478|NCT04822909|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111137479|NCT04822909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111137480|NCT04822909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111137481|NCT04822909|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111137482|NCT04822909|Immunologic Factors|immunologic factors|mesh-ancestor
111137483|NCT04822909|Leprostatic Agents|leprostatic agents|mesh-ancestor
111137484|NCT04822909|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111137485|NCT04822909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111137486|NCT04822909|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111137487|NCT04822909|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111137488|NCT04822909|Growth Substances|growth substances|mesh-ancestor
111137489|NCT04822909|Growth Inhibitors|growth inhibitors|mesh-ancestor
111137490|NCT04822909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111137491|NCT04831099|Testosterone|testosterone|mesh-list
111137492|NCT04831099|Androgens|androgens|mesh-ancestor
111137493|NCT04831099|Hormones|hormones|mesh-ancestor
111137494|NCT04831099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111137495|NCT04831099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111137496|NCT04830241|Antidepressive Agents|antidepressive agents|mesh-list
111137497|NCT04830241|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111137498|NCT02603419|Avelumab|avelumab|mesh-list
111137499|NCT02603419|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111137500|NCT02603419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111137501|NCT02603419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111137502|NCT02603419|Immunologic Factors|immunologic factors|mesh-ancestor
111137503|NCT02603419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111137504|NCT04367935|Pentoxifylline|pentoxifylline|mesh-list
111137505|NCT04367935|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111137506|NCT04367935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111137507|NCT04367935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111137508|NCT04367935|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111137509|NCT04367935|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111137510|NCT04367935|Protective Agents|protective agents|mesh-ancestor
111137511|NCT04367935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111137512|NCT04367935|Vasodilator Agents|vasodilator agents|mesh-ancestor
111137513|NCT04367935|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111137514|NCT04367935|Antioxidants|antioxidants|mesh-ancestor
111137515|NCT04829773|Midazolam|midazolam|mesh-list
111137516|NCT04829773|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111137517|NCT04829773|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111137518|NCT04829773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111137519|NCT04829773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111137520|NCT04829773|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111137521|NCT04829773|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111137522|NCT04829773|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111137523|NCT04829773|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111137524|NCT04829773|Anesthetics, General|anesthetics, general|mesh-ancestor
111137525|NCT04829773|Anesthetics|anesthetics|mesh-ancestor
111137526|NCT04829773|GABA Modulators|gaba modulators|mesh-ancestor
111137527|NCT04829773|GABA Agents|gaba agents|mesh-ancestor
111137528|NCT04829773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111137529|NCT04829773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111137530|NCT04829695|Artesunate|artesunate|mesh-list
111137531|NCT04829695|Lumefantrine|lumefantrine|mesh-list
111137532|NCT04829695|Artemether|artemether|mesh-list
111137533|NCT04829695|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
111137534|NCT04829695|Amodiaquine|amodiaquine|mesh-list
111137535|NCT04829695|Antimalarials|antimalarials|mesh-ancestor
111137536|NCT04829695|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111137537|NCT04829695|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111137538|NCT04829695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111137539|NCT04829695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111137540|NCT04829695|Antiviral Agents|antiviral agents|mesh-ancestor
111137541|NCT04829695|Schistosomicides|schistosomicides|mesh-ancestor
111137542|NCT04829695|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
111137543|NCT04829695|Anthelmintics|anthelmintics|mesh-ancestor
111137544|NCT04835233|Methyldopa|methyldopa|mesh-list
111137545|NCT04835233|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111137546|NCT04835233|Sympatholytics|sympatholytics|mesh-ancestor
111137547|NCT04835233|Autonomic Agents|autonomic agents|mesh-ancestor
111137548|NCT04835233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111137549|NCT04835233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111137550|NCT04835233|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111137551|NCT04835233|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111137552|NCT04835233|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111137553|NCT04835233|Adrenergic Agents|adrenergic agents|mesh-ancestor
111137554|NCT04835233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111137555|NCT04835233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111137556|NCT03035695|Hemostatics|hemostatics|mesh-list
111137557|NCT03035695|Coagulants|coagulants|mesh-ancestor
111137558|NCT04821583|Hydrocortisone|hydrocortisone|mesh-list
111137559|NCT04821583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111137560|NCT01667731|Sofosbuvir|sofosbuvir|mesh-list
111137561|NCT01667731|Antiviral Agents|antiviral agents|mesh-ancestor
111137562|NCT01667731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111137563|NCT04828525|Dexamethasone|dexamethasone|mesh-list
111137564|NCT04828525|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111137565|NCT04828525|Antiemetics|antiemetics|mesh-ancestor
111137566|NCT04828525|Autonomic Agents|autonomic agents|mesh-ancestor
111137567|NCT04828525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111137568|NCT04828525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111137569|NCT04828525|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111137570|NCT04828525|Glucocorticoids|glucocorticoids|mesh-ancestor
111137571|NCT04828525|Hormones|hormones|mesh-ancestor
111137572|NCT04828525|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111137573|NCT04828525|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111137574|NCT04828525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111137575|NCT04821193|Chlorhexidine|chlorhexidine|mesh-list
111137576|NCT04821193|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
111137577|NCT04821193|Disinfectants|disinfectants|mesh-list
111137578|NCT04821193|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111137579|NCT04821193|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111137580|NCT04821193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111137581|NCT04821193|Dermatologic Agents|dermatologic agents|mesh-ancestor
111137582|NCT04820803|Cetylpyridinium|cetylpyridinium|mesh-list
111137583|NCT04820803|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111137584|NCT04820803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111137585|NCT04827667|Dimercaprol|dimercaprol|mesh-list
111137586|NCT04827667|Chelating Agents|chelating agents|mesh-ancestor
111137587|NCT04827667|Sequestering Agents|sequestering agents|mesh-ancestor
111137588|NCT04827667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111137589|NCT04360135|Acetaminophen|acetaminophen|mesh-list
111137590|NCT04360135|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111137591|NCT04360135|Analgesics|analgesics|mesh-ancestor
111137592|NCT04360135|Sensory System Agents|sensory system agents|mesh-ancestor
111137593|NCT04360135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111137594|NCT04360135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111137595|NCT04360135|Antipyretics|antipyretics|mesh-ancestor
111137596|NCT02605837|Budesonide|budesonide|mesh-list
111137597|NCT02605837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111137598|NCT02605837|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111137599|NCT02605837|Autonomic Agents|autonomic agents|mesh-ancestor
111137600|NCT02605837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111137601|NCT02605837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111137602|NCT02605837|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111137603|NCT02605837|Respiratory System Agents|respiratory system agents|mesh-ancestor
111137604|NCT02605837|Glucocorticoids|glucocorticoids|mesh-ancestor
111137605|NCT02605837|Hormones|hormones|mesh-ancestor
111137606|NCT02605837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111137607|NCT04820101|Dexmedetomidine|dexmedetomidine|mesh-list
111137608|NCT04820101|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111137609|NCT04820101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111137610|NCT04820101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111137611|NCT04820101|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111137612|NCT04820101|Analgesics|analgesics|mesh-ancestor
111137613|NCT04820101|Sensory System Agents|sensory system agents|mesh-ancestor
111137614|NCT04820101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111137615|NCT04820101|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111137616|NCT04820101|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111137617|NCT04820101|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111137618|NCT04820101|Adrenergic Agents|adrenergic agents|mesh-ancestor
111137619|NCT04820101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111137620|NCT04820101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111137621|NCT04819867|Propolis|propolis|mesh-list
111137622|NCT04819867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111137623|NCT02423343|Nivolumab|nivolumab|mesh-list
111137624|NCT02423343|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111137625|NCT02423343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111137626|NCT02423343|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111137627|NCT02423343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111137628|NCT04909515|Isotretinoin|isotretinoin|mesh-list
111137629|NCT04909515|Dermatologic Agents|dermatologic agents|mesh-ancestor
111137630|NCT05617729|Povidone-Iodine|povidone-iodine|mesh-list
111137631|NCT05617729|Povidone|povidone|mesh-list
111137632|NCT05617729|Plasma Substitutes|plasma substitutes|mesh-ancestor
111137633|NCT05617729|Blood Substitutes|blood substitutes|mesh-ancestor
111137634|NCT05617729|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111137635|NCT05617729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111137636|NCT04818931|Cefazolin|cefazolin|mesh-list
111137637|NCT04818931|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111137638|NCT04818931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111137639|NCT02406261|Midazolam|midazolam|mesh-list
111137640|NCT02406261|Donepezil|donepezil|mesh-list
111137641|NCT02406261|Simvastatin|simvastatin|mesh-list
111137642|NCT02406261|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111137643|NCT02406261|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111137644|NCT02406261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111137645|NCT02406261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111137646|NCT02406261|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111137647|NCT02406261|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111137648|NCT02406261|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111137649|NCT02406261|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111137650|NCT02406261|Anesthetics, General|anesthetics, general|mesh-ancestor
111137651|NCT02406261|Anesthetics|anesthetics|mesh-ancestor
111137652|NCT02406261|GABA Modulators|gaba modulators|mesh-ancestor
111137653|NCT02406261|GABA Agents|gaba agents|mesh-ancestor
111137654|NCT02406261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111137655|NCT02406261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111137656|NCT02406261|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111137657|NCT02406261|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111137658|NCT02406261|Antimetabolites|antimetabolites|mesh-ancestor
111137659|NCT02406261|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111137660|NCT02406261|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111137661|NCT02406261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111137662|NCT02406261|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111137663|NCT02406261|Cholinergic Agents|cholinergic agents|mesh-ancestor
111137664|NCT02406261|Nootropic Agents|nootropic agents|mesh-ancestor
111137665|NCT02485353|Cytarabine|cytarabine|mesh-list
111137666|NCT02485353|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111137667|NCT02485353|Antimetabolites|antimetabolites|mesh-ancestor
111137668|NCT02485353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111137669|NCT02485353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111137670|NCT02485353|Antiviral Agents|antiviral agents|mesh-ancestor
111137671|NCT02485353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111137672|NCT02485353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111137673|NCT02485353|Immunologic Factors|immunologic factors|mesh-ancestor
111137674|NCT02485353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111137675|NCT02603107|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
111137676|NCT02603107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111137677|NCT02603107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111137678|NCT02603107|Antiviral Agents|antiviral agents|mesh-ancestor
111137679|NCT02603107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111137680|NCT02603107|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111137681|NCT02603107|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111137682|NCT02603107|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111137683|NCT02603107|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111137684|NCT02603107|Protease Inhibitors|protease inhibitors|mesh-ancestor
111137685|NCT02601625|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111137686|NCT02601625|Immunologic Factors|immunologic factors|mesh-ancestor
111137687|NCT02601625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111137688|NCT04826497|Nicorandil|nicorandil|mesh-list
111137689|NCT04826497|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111137690|NCT04826497|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111137691|NCT04826497|Vasodilator Agents|vasodilator agents|mesh-ancestor
111137692|NCT04826497|Vitamin B Complex|vitamin b complex|mesh-ancestor
111137693|NCT04826497|Vitamins|vitamins|mesh-ancestor
111137694|NCT04826497|Micronutrients|micronutrients|mesh-ancestor
111137695|NCT04826497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111137696|NCT04819243|Atezolizumab|atezolizumab|mesh-list
111137697|NCT04819243|Talazoparib|talazoparib|mesh-list
111137698|NCT04819243|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111137699|NCT04819243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111137700|NCT04819243|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111137701|NCT04819243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111137702|NCT04819243|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111137703|NCT04819243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111137704|NCT02604589|Hydromorphone|hydromorphone|mesh-list
111137705|NCT02604589|Bupivacaine|bupivacaine|mesh-list
111137706|NCT02604589|Anesthetics, Local|anesthetics, local|mesh-ancestor
111137707|NCT02604589|Anesthetics|anesthetics|mesh-ancestor
111137708|NCT02604589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111137709|NCT02604589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111137710|NCT02604589|Sensory System Agents|sensory system agents|mesh-ancestor
111137711|NCT02604589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111137712|NCT02604589|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111137713|NCT02604589|Narcotics|narcotics|mesh-ancestor
111137714|NCT02604589|Analgesics|analgesics|mesh-ancestor
111137715|NCT04818151|Warfarin|warfarin|mesh-list
111137716|NCT04818151|Apixaban|apixaban|mesh-list
111137717|NCT04818151|Anticoagulants|anticoagulants|mesh-ancestor
111137718|NCT04818151|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111137719|NCT04818151|Antithrombins|antithrombins|mesh-ancestor
111137720|NCT04818151|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111137721|NCT04818151|Protease Inhibitors|protease inhibitors|mesh-ancestor
111137722|NCT04818151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111137723|NCT04818151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111137724|NCT04817527|Edaravone|edaravone|mesh-list
111137725|NCT04817527|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111137726|NCT04817527|Antioxidants|antioxidants|mesh-ancestor
110838693|NCT01883297|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111137727|NCT04817527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111137728|NCT04817527|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111137729|NCT04817527|Protective Agents|protective agents|mesh-ancestor
111137730|NCT04817527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111137731|NCT04357795|Cyclosporine|cyclosporine|mesh-list
111137732|NCT04357795|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111137733|NCT04357795|Cyclosporins|cyclosporins|mesh-list
111137734|NCT04357795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111137735|NCT04357795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111137736|NCT04357795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111137737|NCT04357795|Immunologic Factors|immunologic factors|mesh-ancestor
111137738|NCT04357795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111137739|NCT04357795|Antifungal Agents|antifungal agents|mesh-ancestor
111137740|NCT04357795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111137741|NCT04357795|Dermatologic Agents|dermatologic agents|mesh-ancestor
111137742|NCT04357795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111137743|NCT04357795|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111137744|NCT04357795|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111137745|NCT02604199|Tenofovir|tenofovir|mesh-list
111137746|NCT02604199|Entecavir|entecavir|mesh-list
111137747|NCT02604199|Histamine Antagonists|histamine antagonists|mesh-list
111137748|NCT02604199|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
111137749|NCT02604199|Antiviral Agents|antiviral agents|mesh-ancestor
110854777|NCT01567475|Everolimus|everolimus|mesh-list
111137750|NCT02604199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111137751|NCT02604199|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111137752|NCT02604199|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111137753|NCT02604199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111137754|NCT02604199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111137755|NCT02604199|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111137756|NCT02604199|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111137757|NCT02604199|Histamine Agents|histamine agents|mesh-ancestor
111137758|NCT02604199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111137759|NCT02604199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111137760|NCT04807543|Castor Oil|castor oil|mesh-list
111137761|NCT04807543|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
111137762|NCT04807543|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
111137763|NCT04807543|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111137764|NCT04807543|Hormone Antagonists|hormone antagonists|mesh-ancestor
111137765|NCT04807543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111137766|NCT04807543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111137767|NCT04807543|Progestins|progestins|mesh-ancestor
111137768|NCT04807543|Hormones|hormones|mesh-ancestor
111137769|NCT04807543|Cathartics|cathartics|mesh-ancestor
111137770|NCT04807543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111137771|NCT04797949|Aspirin|aspirin|mesh-list
111137772|NCT04797949|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111137773|NCT04797949|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111137774|NCT04797949|Analgesics|analgesics|mesh-ancestor
111137775|NCT04797949|Sensory System Agents|sensory system agents|mesh-ancestor
111137776|NCT04797949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111137777|NCT04797949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111137778|NCT04797949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111137779|NCT04797949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111137780|NCT04797949|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111137781|NCT04797949|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111137782|NCT04797949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111137783|NCT04797949|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111137784|NCT04797949|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111137785|NCT04797949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111137786|NCT04797949|Antipyretics|antipyretics|mesh-ancestor
111137787|NCT04797793|Adapalene|adapalene|mesh-list
111137788|NCT04797793|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111137789|NCT04797793|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111137790|NCT04797793|Analgesics|analgesics|mesh-ancestor
111137791|NCT04797793|Sensory System Agents|sensory system agents|mesh-ancestor
111137792|NCT04797793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110838703|NCT01883297|Analgesics|analgesics|mesh-ancestor
111137793|NCT04797793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111137794|NCT04797793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111137795|NCT04797793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111137796|NCT04797793|Dermatologic Agents|dermatologic agents|mesh-ancestor
111137797|NCT04796857|Lenalidomide|lenalidomide|mesh-list
111137798|NCT04796857|Tislelizumab|tislelizumab|mesh-list
111137800|NCT04796857|Immunologic Factors|immunologic factors|mesh-ancestor
111137801|NCT04796857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111137802|NCT04796857|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111137803|NCT04796857|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111137804|NCT04796857|Growth Substances|growth substances|mesh-ancestor
111137805|NCT04796857|Growth Inhibitors|growth inhibitors|mesh-ancestor
111137806|NCT04796857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111137807|NCT04796857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111137808|NCT04796623|Fulvestrant|fulvestrant|mesh-list
111137809|NCT04796623|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111137810|NCT04796623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111137811|NCT04796623|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
111137812|NCT04796623|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111137813|NCT04796623|Hormone Antagonists|hormone antagonists|mesh-ancestor
111137814|NCT04796623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111137815|NCT04796623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111137816|NCT04815265|Dexmedetomidine|dexmedetomidine|mesh-list
111137817|NCT04815265|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111137818|NCT04815265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111137819|NCT04815265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111137820|NCT04815265|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111137821|NCT04815265|Analgesics|analgesics|mesh-ancestor
111137822|NCT04815265|Sensory System Agents|sensory system agents|mesh-ancestor
111137823|NCT04815265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111137824|NCT04815265|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111137825|NCT04815265|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111137826|NCT04815265|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111137827|NCT04815265|Adrenergic Agents|adrenergic agents|mesh-ancestor
111137828|NCT04815265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110854849|NCT02489266|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111137829|NCT04815265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111137830|NCT04815187|Montelukast|montelukast|mesh-list
111137831|NCT04815187|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111137832|NCT04815187|Respiratory System Agents|respiratory system agents|mesh-ancestor
111137833|NCT04815187|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
111137834|NCT04815187|Hormone Antagonists|hormone antagonists|mesh-ancestor
111137835|NCT04815187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111137836|NCT04815187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111137837|NCT04815187|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
111137838|NCT04815187|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
111137839|NCT04815187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111137840|NCT04814719|Pentosan Sulfuric Polyester|pentosan sulfuric polyester|mesh-list
111137841|NCT04814719|Anticoagulants|anticoagulants|mesh-ancestor
111137842|NCT04805827|Gabapentin|gabapentin|mesh-list
111137843|NCT04805827|Analgesics|analgesics|mesh-ancestor
111137844|NCT04805827|Sensory System Agents|sensory system agents|mesh-ancestor
111137845|NCT04805827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111137846|NCT04805827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111137847|NCT04805827|Anticonvulsants|anticonvulsants|mesh-ancestor
111137848|NCT04805827|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111137849|NCT04805827|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111137850|NCT04805827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111137851|NCT04805827|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111137852|NCT04805827|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111137853|NCT04805827|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111137854|NCT04805827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111137855|NCT04805827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111137856|NCT04805827|Antimanic Agents|antimanic agents|mesh-ancestor
111137857|NCT02596711|Nicotine|nicotine|mesh-list
111137858|NCT02596711|Carbon Monoxide|carbon monoxide|mesh-list
111137859|NCT02596711|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111137860|NCT02596711|Autonomic Agents|autonomic agents|mesh-ancestor
111137861|NCT02596711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111137862|NCT02596711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111137863|NCT02596711|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111137864|NCT02596711|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111137865|NCT02596711|Cholinergic Agents|cholinergic agents|mesh-ancestor
111137866|NCT02596711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111137867|NCT02596711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111137868|NCT02596711|Antimetabolites|antimetabolites|mesh-ancestor
111137869|NCT02596711|Gasotransmitters|gasotransmitters|mesh-ancestor
111137870|NCT04805281|Lithium Carbonate|lithium carbonate|mesh-list
111137871|NCT04805281|Antidepressive Agents|antidepressive agents|mesh-ancestor
111137872|NCT04805281|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111137873|NCT04805281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111137874|NCT04805281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111137875|NCT04805281|Antimanic Agents|antimanic agents|mesh-ancestor
111137876|NCT04805281|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111137877|NCT04805281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110590132|NCT00688545|Celecoxib|celecoxib|mesh-list
111137878|NCT04805281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111137879|NCT04814485|Paclitaxel|paclitaxel|mesh-list
111137880|NCT04814485|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111137881|NCT04814485|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111137882|NCT04814485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111137883|NCT04814485|Tubulin Modulators|tubulin modulators|mesh-ancestor
111137884|NCT04814485|Antimitotic Agents|antimitotic agents|mesh-ancestor
111137885|NCT04814485|Mitosis Modulators|mitosis modulators|mesh-ancestor
111137886|NCT04814485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111137887|NCT04804423|Listerine|listerine|mesh-list
111137888|NCT04804423|Fluorides|fluorides|mesh-list
111137889|NCT04804423|Sodium Fluoride|sodium fluoride|mesh-list
111137890|NCT04804423|Fluorides, Topical|fluorides, topical|mesh-list
111137891|NCT04804423|Sodium fluoride topical preparation|sodium fluoride topical preparation|mesh-list
111137892|NCT04804423|Cariostatic Agents|cariostatic agents|mesh-ancestor
111137893|NCT04804423|Protective Agents|protective agents|mesh-ancestor
111137894|NCT04804423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111137895|NCT04804423|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111137896|NCT04804423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111137897|NCT04794049|Lactulose|lactulose|mesh-list
111137898|NCT04794049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111137899|NCT04794127|Pioglitazone|pioglitazone|mesh-list
111137900|NCT04794127|Trabectedin|trabectedin|mesh-list
111137901|NCT04794127|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110854926|NCT03719053|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111137902|NCT04794127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111137903|NCT04794127|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111137904|NCT04794127|Alkylating Agents|alkylating agents|mesh-ancestor
111137905|NCT04794127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111137906|NCT04794127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111137907|NCT04804267|Linaclotide|linaclotide|mesh-list
111137908|NCT04804267|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
111137909|NCT04804267|Enzyme Activators|enzyme activators|mesh-ancestor
111137910|NCT04804267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111137911|NCT04804267|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111137912|NCT04813471|Folic Acid|folic acid|mesh-list
111137913|NCT04813471|Nicorandil|nicorandil|mesh-list
111137914|NCT04813471|Vitamin B Complex|vitamin b complex|mesh-list
111137915|NCT04813471|Atorvastatin|atorvastatin|mesh-list
111137916|NCT04813471|Vitamins|vitamins|mesh-ancestor
111137917|NCT04813471|Micronutrients|micronutrients|mesh-ancestor
111137918|NCT04813471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111137919|NCT04813471|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111137920|NCT04813471|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111137921|NCT04813471|Antimetabolites|antimetabolites|mesh-ancestor
111137922|NCT04813471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111137923|NCT04813471|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110838710|NCT04546581|Remdesivir|remdesivir|mesh-list
111137924|NCT04813471|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111137925|NCT04813471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111137926|NCT04813471|Hematinics|hematinics|mesh-ancestor
111137927|NCT04813471|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111137928|NCT04813471|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111137929|NCT04813471|Vasodilator Agents|vasodilator agents|mesh-ancestor
111137930|NCT04803175|Valsartan|valsartan|mesh-list
111137931|NCT04803175|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
111137932|NCT04803175|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111137933|NCT04803175|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111137934|NCT04803175|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111137935|NCT04803175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111137936|NCT04792723|Aspirin|aspirin|mesh-list
111137937|NCT04792723|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111137938|NCT04792723|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111137939|NCT04792723|Analgesics|analgesics|mesh-ancestor
111137940|NCT04792723|Sensory System Agents|sensory system agents|mesh-ancestor
111137941|NCT04792723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111137942|NCT04792723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111137943|NCT04792723|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111137944|NCT04792723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111137945|NCT04792723|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111137946|NCT04792723|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111137947|NCT04792723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111137948|NCT04792723|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111137949|NCT04792723|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111137950|NCT04792723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111137951|NCT04792723|Antipyretics|antipyretics|mesh-ancestor
111137952|NCT04792333|Firibastat|firibastat|mesh-list
111137953|NCT04792333|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111137954|NCT04802785|Aspirin|aspirin|mesh-list
111137955|NCT04802785|Domperidone|domperidone|mesh-list
111137956|NCT04802785|Melatonin|melatonin|mesh-list
111137957|NCT04802785|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
111137958|NCT04802785|Simethicone|simethicone|mesh-list
111137959|NCT04802785|Magnesium Hydroxide|magnesium hydroxide|mesh-list
111137960|NCT04802785|Citric Acid|citric acid|mesh-list
111137961|NCT04802785|Sodium Citrate|sodium citrate|mesh-list
111137962|NCT04802785|Anticoagulants|anticoagulants|mesh-ancestor
111137963|NCT04802785|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
111137964|NCT04802785|Chelating Agents|chelating agents|mesh-ancestor
111137965|NCT04802785|Sequestering Agents|sequestering agents|mesh-ancestor
111137966|NCT04802785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111137967|NCT04802785|Antioxidants|antioxidants|mesh-ancestor
111137968|NCT04802785|Protective Agents|protective agents|mesh-ancestor
111137969|NCT04802785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111137970|NCT04802785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111137971|NCT04802785|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111137972|NCT04802785|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111137973|NCT04802785|Analgesics|analgesics|mesh-ancestor
111137974|NCT04802785|Sensory System Agents|sensory system agents|mesh-ancestor
111137975|NCT04802785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111137976|NCT04802785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111137977|NCT04802785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110854999|NCT03786887|Nalbuphine|nalbuphine|mesh-list
111137978|NCT04802785|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111137979|NCT04802785|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111137980|NCT04802785|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111137981|NCT04802785|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111137982|NCT04802785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111137983|NCT04802785|Antipyretics|antipyretics|mesh-ancestor
111137984|NCT04802785|Antiemetics|antiemetics|mesh-ancestor
111137985|NCT04802785|Autonomic Agents|autonomic agents|mesh-ancestor
111137986|NCT04802785|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111137987|NCT04802785|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111137988|NCT04802785|Dopamine Agents|dopamine agents|mesh-ancestor
111137989|NCT04802785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111137990|NCT04802785|Antifoaming Agents|antifoaming agents|mesh-ancestor
111137991|NCT04802785|Emollients|emollients|mesh-ancestor
111137992|NCT04802785|Dermatologic Agents|dermatologic agents|mesh-ancestor
111137993|NCT04802785|Nootropic Agents|nootropic agents|mesh-ancestor
111137994|NCT04802785|Antacids|antacids|mesh-ancestor
111137995|NCT02598193|Pirfenidone|pirfenidone|mesh-list
111137996|NCT02598193|Nintedanib|nintedanib|mesh-list
111137997|NCT02598193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111137998|NCT02598193|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111137999|NCT02598193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111138000|NCT02598193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111138001|NCT02598193|Analgesics|analgesics|mesh-ancestor
111138002|NCT02598193|Sensory System Agents|sensory system agents|mesh-ancestor
111138003|NCT02598193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111138004|NCT02598193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111138005|NCT02598193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111138006|NCT02598193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111138007|NCT02598193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111138008|NCT02598193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111138009|NCT04802083|Eculizumab|eculizumab|mesh-list
111138010|NCT04802083|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
111138011|NCT04802083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111138012|NCT04802083|Immunologic Factors|immunologic factors|mesh-ancestor
111138013|NCT04802083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111138014|NCT04801303|Calcitriol|calcitriol|mesh-list
111138015|NCT04801303|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111138016|NCT04801303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111138017|NCT04801303|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
111138018|NCT04801303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111138019|NCT04801303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111138020|NCT04801303|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111138021|NCT04801303|Vitamins|vitamins|mesh-ancestor
111138022|NCT04801303|Micronutrients|micronutrients|mesh-ancestor
111138023|NCT04801303|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111138024|NCT04790383|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
111138025|NCT04790383|Vasodilator Agents|vasodilator agents|mesh-ancestor
111138026|NCT04790383|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
111138027|NCT04790383|Protective Agents|protective agents|mesh-ancestor
111138028|NCT04790383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111138029|NCT02388165|Vaccines|vaccines|mesh-list
111138030|NCT02388165|Immunologic Factors|immunologic factors|mesh-ancestor
111138031|NCT02388165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111138032|NCT04811911|Methotrexate|methotrexate|mesh-list
111138033|NCT04811911|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111138034|NCT04811911|Abortifacient Agents|abortifacient agents|mesh-ancestor
111138035|NCT04811911|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111138036|NCT04811911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111138037|NCT04811911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111138038|NCT04811911|Antimetabolites|antimetabolites|mesh-ancestor
111138039|NCT04811911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111138040|NCT04811911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111138041|NCT04811911|Dermatologic Agents|dermatologic agents|mesh-ancestor
111138042|NCT04811911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111138043|NCT04811911|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111138044|NCT04811911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111138045|NCT04811911|Immunologic Factors|immunologic factors|mesh-ancestor
111138046|NCT04811911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111138047|NCT04811911|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111138048|NCT04788979|Melatonin|melatonin|mesh-list
111138049|NCT04788979|Antioxidants|antioxidants|mesh-ancestor
111138050|NCT04788979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111138051|NCT04788979|Protective Agents|protective agents|mesh-ancestor
111138052|NCT04788979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111138053|NCT04788979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111138054|NCT04811209|Analgesics|analgesics|mesh-list
111138055|NCT04811209|Anesthetics|anesthetics|mesh-list
111138056|NCT04811209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111138057|NCT04811209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111138058|NCT04811209|Sensory System Agents|sensory system agents|mesh-ancestor
111138059|NCT04811209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111138060|NCT04788355|Hydroxychloroquine|hydroxychloroquine|mesh-list
111138061|NCT04788355|Apixaban|apixaban|mesh-list
111138062|NCT04788355|Antimalarials|antimalarials|mesh-ancestor
111138063|NCT04788355|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111138064|NCT04788355|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111138065|NCT04788355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111138066|NCT04788355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111138067|NCT04788355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111138068|NCT04788355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111138069|NCT04788355|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111138070|NCT04788355|Antithrombins|antithrombins|mesh-ancestor
111138071|NCT04788355|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111138072|NCT04788355|Protease Inhibitors|protease inhibitors|mesh-ancestor
111138073|NCT04788355|Anticoagulants|anticoagulants|mesh-ancestor
111138074|NCT04799743|Resveratrol|resveratrol|mesh-list
111138075|NCT04799743|Antioxidants|antioxidants|mesh-ancestor
111138076|NCT04799743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111138077|NCT04799743|Protective Agents|protective agents|mesh-ancestor
111138078|NCT04799743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111138079|NCT04799743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111138080|NCT04799743|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111138081|NCT04788121|Tranexamic Acid|tranexamic acid|mesh-list
111138082|NCT04788121|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111138083|NCT04788121|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111138084|NCT04788121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111138085|NCT04788121|Hemostatics|hemostatics|mesh-ancestor
111138086|NCT04788121|Coagulants|coagulants|mesh-ancestor
111138087|NCT04810819|Methylprednisolone|methylprednisolone|mesh-list
111138088|NCT04810819|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111138089|NCT04810819|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111138090|NCT04810819|Prednisolone|prednisolone|mesh-list
111138091|NCT04810819|Prednisolone acetate|prednisolone acetate|mesh-list
111138092|NCT04810819|Dyphylline|dyphylline|mesh-list
111138093|NCT04810819|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111138094|NCT04810819|Prednisolone phosphate|prednisolone phosphate|mesh-list
111138095|NCT04810819|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111138096|NCT04810819|Antiemetics|antiemetics|mesh-ancestor
111138097|NCT04810819|Autonomic Agents|autonomic agents|mesh-ancestor
111138098|NCT04810819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111138099|NCT04810819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111138100|NCT04810819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111138101|NCT04810819|Glucocorticoids|glucocorticoids|mesh-ancestor
111138102|NCT04810819|Hormones|hormones|mesh-ancestor
111138103|NCT04810819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111138104|NCT04810819|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111138105|NCT04810819|Protective Agents|protective agents|mesh-ancestor
111138106|NCT04810819|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111138107|NCT04810819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111138108|NCT04810819|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111138109|NCT04810819|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111138110|NCT04810819|Respiratory System Agents|respiratory system agents|mesh-ancestor
111138111|NCT04810819|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111138112|NCT04810819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111138113|NCT04810819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111138114|NCT04810819|Vasodilator Agents|vasodilator agents|mesh-ancestor
111138115|NCT04810507|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111138116|NCT04810507|Anagliptin|anagliptin|mesh-list
111138117|NCT04810507|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111138118|NCT04810507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111138119|NCT04810507|Incretins|incretins|mesh-ancestor
111138120|NCT04810507|Hormones|hormones|mesh-ancestor
111138121|NCT04810507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111138122|NCT04810507|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
111138123|NCT04810507|Protease Inhibitors|protease inhibitors|mesh-ancestor
111138124|NCT04810507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111138125|NCT04810507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111138126|NCT04810585|Aflibercept|aflibercept|mesh-list
111138127|NCT04810585|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111138128|NCT04810585|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111138129|NCT04810585|Growth Substances|growth substances|mesh-ancestor
111138130|NCT04810585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111138131|NCT04810585|Growth Inhibitors|growth inhibitors|mesh-ancestor
111138132|NCT04810585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111138133|NCT04798729|Salicylic Acid|salicylic acid|mesh-list
111138134|NCT04798729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111138135|NCT04798729|Antifungal Agents|antifungal agents|mesh-ancestor
111138136|NCT04798729|Keratolytic Agents|keratolytic agents|mesh-ancestor
111138137|NCT04798729|Dermatologic Agents|dermatologic agents|mesh-ancestor
111138138|NCT04809649|Itraconazole|itraconazole|mesh-list
111138139|NCT04809649|Antifungal Agents|antifungal agents|mesh-ancestor
111138140|NCT04809649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111138141|NCT04809649|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111138142|NCT04809649|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111138143|NCT04809649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111138144|NCT04809649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111138145|NCT04809649|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111138146|NCT04809649|Hormone Antagonists|hormone antagonists|mesh-ancestor
111138147|NCT04809649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111138148|NCT04809649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111138149|NCT04809649|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111138150|NCT04786795|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
111138151|NCT04786795|Pancreatin|pancreatin|mesh-list
111138152|NCT04786795|Pancrelipase|pancrelipase|mesh-list
111138153|NCT04786795|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
111138154|NCT04786795|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111138155|NCT02596945|Epoetin Alfa|epoetin alfa|mesh-list
111138156|NCT02596945|Hematinics|hematinics|mesh-ancestor
111138157|NCT04786327|Edetic Acid|edetic acid|mesh-list
111138158|NCT04786327|Mitogens|mitogens|mesh-list
111138159|NCT04786327|Pentetic Acid|pentetic acid|mesh-list
111138160|NCT04786327|Mitosis Modulators|mitosis modulators|mesh-ancestor
111138161|NCT04786327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111138162|NCT04786327|Anticoagulants|anticoagulants|mesh-ancestor
111138163|NCT04786327|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
111138164|NCT04786327|Chelating Agents|chelating agents|mesh-ancestor
111138165|NCT04786327|Sequestering Agents|sequestering agents|mesh-ancestor
111138166|NCT04786327|Antidotes|antidotes|mesh-ancestor
111138167|NCT04786327|Protective Agents|protective agents|mesh-ancestor
111138168|NCT04786327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111138169|NCT04786327|Iron Chelating Agents|iron chelating agents|mesh-ancestor
111138170|NCT04153435|Calcium|calcium|mesh-list
111138171|NCT04153435|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111138172|NCT04153435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111138173|NCT01667419|Vemurafenib|vemurafenib|mesh-list
111138174|NCT01667419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111138175|NCT01667419|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111138176|NCT01667419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111138177|NCT01667419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111138178|NCT04808791|Trifluridine|trifluridine|mesh-list
111138179|NCT04808791|Oxaliplatin|oxaliplatin|mesh-list
111138180|NCT04808791|Irinotecan|irinotecan|mesh-list
111138181|NCT04808791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111138182|NCT04808791|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111138183|NCT04808791|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111138184|NCT04808791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111138185|NCT04808791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111138186|NCT04808791|Antimetabolites|antimetabolites|mesh-ancestor
111138187|NCT04808791|Antiviral Agents|antiviral agents|mesh-ancestor
111138188|NCT04808791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111138189|NCT04785547|Blinatumomab|blinatumomab|mesh-list
111138190|NCT04785547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111138191|NCT03843853|Bevacizumab|bevacizumab|mesh-list
111138192|NCT03843853|Pemetrexed|pemetrexed|mesh-list
111138193|NCT03843853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111138194|NCT03843853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111138195|NCT03843853|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111138196|NCT03843853|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111138197|NCT03843853|Growth Substances|growth substances|mesh-ancestor
111138198|NCT03843853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111138199|NCT03843853|Growth Inhibitors|growth inhibitors|mesh-ancestor
111138200|NCT03843853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111138201|NCT03843853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111138202|NCT03843853|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111138203|NCT03843853|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111138204|NCT04784767|Saponin QA-21V1|saponin qa-21v1|mesh-list
111138205|NCT04784767|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111138206|NCT04784767|Immunologic Factors|immunologic factors|mesh-ancestor
111138207|NCT04784767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111138208|NCT05054179|Ropivacaine|ropivacaine|mesh-list
111138209|NCT05054179|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111138210|NCT05054179|Anesthetics, Local|anesthetics, local|mesh-ancestor
111138211|NCT05054179|Anesthetics|anesthetics|mesh-ancestor
111138212|NCT05054179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111138213|NCT05054179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111138214|NCT05054179|Sensory System Agents|sensory system agents|mesh-ancestor
111138215|NCT05054179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111138216|NCT05611879|Paclitaxel|paclitaxel|mesh-list
111138217|NCT05611879|Carboplatin|carboplatin|mesh-list
111138218|NCT05611879|Pemetrexed|pemetrexed|mesh-list
111138219|NCT05611879|Tislelizumab|tislelizumab|mesh-list
111138220|NCT05611879|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111138221|NCT05611879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111138222|NCT05611879|Tubulin Modulators|tubulin modulators|mesh-ancestor
111138223|NCT05611879|Antimitotic Agents|antimitotic agents|mesh-ancestor
111138224|NCT05611879|Mitosis Modulators|mitosis modulators|mesh-ancestor
111138225|NCT05611879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111138226|NCT05611879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111138227|NCT05611879|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111138228|NCT05611879|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111138229|NCT05611879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111138230|NCT04789057|Atorvastatin|atorvastatin|mesh-list
111138231|NCT04789057|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111138232|NCT04789057|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111138233|NCT04789057|Antimetabolites|antimetabolites|mesh-ancestor
111138234|NCT04789057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111138235|NCT04789057|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111138236|NCT04789057|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111138237|NCT04789057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111138238|NCT05613361|Colistin|colistin|mesh-list
111138239|NCT05613361|Curcumin|curcumin|mesh-list
111138240|NCT05613361|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111138241|NCT05613361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111138242|NCT05613361|Analgesics|analgesics|mesh-ancestor
111138243|NCT05613361|Sensory System Agents|sensory system agents|mesh-ancestor
111138244|NCT05613361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111138245|NCT05613361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111138246|NCT05613361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111138247|NCT05613361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111138248|NCT05613361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111138249|NCT05613361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111138250|NCT05613361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111138251|NCT05613361|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111138252|NCT05613361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111138253|NCT05611645|Bevacizumab|bevacizumab|mesh-list
111138254|NCT05611645|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111138255|NCT05611645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111138256|NCT05611645|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111138257|NCT05611645|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111138258|NCT05611645|Growth Substances|growth substances|mesh-ancestor
110838757|NCT03164655|Antidotes|antidotes|mesh-ancestor
111138259|NCT05611645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111138260|NCT05611645|Growth Inhibitors|growth inhibitors|mesh-ancestor
111138261|NCT03267121|Apatinib|apatinib|mesh-list
111138262|NCT03267121|Tegafur|tegafur|mesh-list
111138263|NCT03267121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111138264|NCT03267121|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111138265|NCT03267121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111138266|NCT03267121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111138267|NCT03267121|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111138268|NCT03267121|Antimetabolites|antimetabolites|mesh-ancestor
111138269|NCT02835079|Tamoxifen|tamoxifen|mesh-list
111138270|NCT02835079|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111138271|NCT02835079|Hormone Antagonists|hormone antagonists|mesh-ancestor
111138272|NCT02835079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111138273|NCT02835079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111138274|NCT02835079|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111138275|NCT02835079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111138276|NCT02835079|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111138277|NCT02835079|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111138278|NCT02835079|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111138279|NCT01667107|Posaconazole|posaconazole|mesh-list
111138280|NCT01667107|Antifungal Agents|antifungal agents|mesh-ancestor
111138281|NCT01667107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111138282|NCT01667107|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
111138283|NCT01667107|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111138284|NCT01667107|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111138285|NCT01667107|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
111138286|NCT01667107|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111138287|NCT01667107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111138288|NCT01667107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111138289|NCT01667107|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111138290|NCT01667107|Hormone Antagonists|hormone antagonists|mesh-ancestor
111138291|NCT01667107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111138292|NCT01667107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111138293|NCT05240131|Atezolizumab|atezolizumab|mesh-list
111138294|NCT05240131|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111138295|NCT05240131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111138296|NCT05240131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111138297|NCT05240131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111138298|NCT05188339|Heparin|heparin|mesh-list
111138299|NCT05188339|Citric Acid|citric acid|mesh-list
111138300|NCT05188339|Sodium Citrate|sodium citrate|mesh-list
111138301|NCT05188339|Anticoagulants|anticoagulants|mesh-ancestor
111138302|NCT05188339|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
111138303|NCT05188339|Chelating Agents|chelating agents|mesh-ancestor
111138304|NCT05188339|Sequestering Agents|sequestering agents|mesh-ancestor
111138305|NCT05188339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111138306|NCT05188339|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111138307|NCT05188339|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111138308|NCT05614765|Ezetimibe|ezetimibe|mesh-list
111138309|NCT05614765|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111138310|NCT05614765|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111138311|NCT05614765|Antimetabolites|antimetabolites|mesh-ancestor
111138312|NCT05614765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111138313|NCT05614765|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111138314|NCT02590003|Paclitaxel|paclitaxel|mesh-list
111138315|NCT02590003|Carboplatin|carboplatin|mesh-list
111138316|NCT02590003|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111138317|NCT02590003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111138318|NCT02590003|Tubulin Modulators|tubulin modulators|mesh-ancestor
111138319|NCT02590003|Antimitotic Agents|antimitotic agents|mesh-ancestor
111138320|NCT02590003|Mitosis Modulators|mitosis modulators|mesh-ancestor
111138321|NCT02590003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111138322|NCT04134325|Pembrolizumab|pembrolizumab|mesh-list
111138323|NCT04134325|Nivolumab|nivolumab|mesh-list
111138324|NCT04134325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111138325|NCT04134325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111138327|NCT04134325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111138328|NCT05474053|Ticagrelor|ticagrelor|mesh-list
111138329|NCT05474053|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111138330|NCT05474053|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111138331|NCT05474053|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111138332|NCT05474053|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111138333|NCT05474053|Purinergic Agents|purinergic agents|mesh-ancestor
111138334|NCT05474053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111138335|NCT05474053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111138336|NCT05474053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111138337|NCT05473819|Anesthetics|anesthetics|mesh-list
111138338|NCT05473819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111138339|NCT05473819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111138340|NCT04330729|Aspirin|aspirin|mesh-list
111138341|NCT04330729|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111138342|NCT04330729|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111138343|NCT04330729|Analgesics|analgesics|mesh-ancestor
111138344|NCT04330729|Sensory System Agents|sensory system agents|mesh-ancestor
111138345|NCT04330729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111138346|NCT04330729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111138347|NCT04330729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111138348|NCT04330729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111138349|NCT04330729|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111138350|NCT04330729|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111138351|NCT04330729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111138352|NCT04330729|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111138353|NCT04330729|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111138354|NCT04330729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111138355|NCT04330729|Antipyretics|antipyretics|mesh-ancestor
111138356|NCT03882307|Sofosbuvir|sofosbuvir|mesh-list
111138357|NCT03882307|Antiviral Agents|antiviral agents|mesh-ancestor
111138358|NCT03882307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111138359|NCT04762771|Colchicine|colchicine|mesh-list
111138360|NCT04762771|Gout Suppressants|gout suppressants|mesh-ancestor
111138361|NCT04762771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111138362|NCT04762771|Tubulin Modulators|tubulin modulators|mesh-ancestor
111138363|NCT04762771|Antimitotic Agents|antimitotic agents|mesh-ancestor
111138364|NCT04762771|Mitosis Modulators|mitosis modulators|mesh-ancestor
111138365|NCT04762771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111138366|NCT04762771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111138367|NCT04754737|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111138368|NCT04754737|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
111138369|NCT04754737|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111138370|NCT04754737|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111138371|NCT04754737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111138372|NCT04754737|Antitubercular Agents|antitubercular agents|mesh-ancestor
111138373|NCT04754737|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111138374|NCT04754737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111138375|NCT04754737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111138376|NCT04754737|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111138377|NCT04754737|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111138378|NCT04754737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111138379|NCT04754737|Cholinergic Agents|cholinergic agents|mesh-ancestor
111138380|NCT04754737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111138381|NCT04481035|Acetylcysteine|acetylcysteine|mesh-list
111138382|NCT04481035|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111138383|NCT04481035|Antiviral Agents|antiviral agents|mesh-ancestor
111138384|NCT04481035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111138385|NCT04481035|Expectorants|expectorants|mesh-ancestor
110838771|NCT02561273|Podophyllotoxin|podophyllotoxin|mesh-list
111138386|NCT04481035|Respiratory System Agents|respiratory system agents|mesh-ancestor
111138387|NCT04481035|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111138388|NCT04481035|Antioxidants|antioxidants|mesh-ancestor
111138389|NCT04481035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111138390|NCT04481035|Protective Agents|protective agents|mesh-ancestor
111138391|NCT04481035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111138392|NCT04481035|Antidotes|antidotes|mesh-ancestor
111138393|NCT02404311|MF59 oil emulsion|mf59 oil emulsion|mesh-list
111138394|NCT02404311|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111138395|NCT02404311|Immunologic Factors|immunologic factors|mesh-ancestor
111138396|NCT02404311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111138397|NCT03032107|Pembrolizumab|pembrolizumab|mesh-list
111138398|NCT03032107|Trastuzumab|trastuzumab|mesh-list
111138399|NCT03032107|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
111138400|NCT03032107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111138401|NCT03032107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111138402|NCT03032107|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111138403|NCT03032107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111138404|NCT03032107|Tubulin Modulators|tubulin modulators|mesh-ancestor
111138405|NCT03032107|Antimitotic Agents|antimitotic agents|mesh-ancestor
111138406|NCT03032107|Mitosis Modulators|mitosis modulators|mesh-ancestor
111138407|NCT03032107|Immunotoxins|immunotoxins|mesh-ancestor
111138408|NCT03032107|Immunoconjugates|immunoconjugates|mesh-ancestor
111138409|NCT03032107|Immunologic Factors|immunologic factors|mesh-ancestor
111138410|NCT03032107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111138411|NCT05388175|Pulmonary Surfactants|pulmonary surfactants|mesh-list
111138412|NCT05388175|Respiratory System Agents|respiratory system agents|mesh-ancestor
111138413|NCT05700955|Pembrolizumab|pembrolizumab|mesh-list
111138414|NCT05700955|Temozolomide|temozolomide|mesh-list
111138415|NCT05700955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111138416|NCT05700955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111138417|NCT05700955|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111138418|NCT05700955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111138419|NCT05700955|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111138420|NCT05700955|Alkylating Agents|alkylating agents|mesh-ancestor
111138421|NCT01650519|Ibuprofen|ibuprofen|mesh-list
111138422|NCT01650519|Ketorolac|ketorolac|mesh-list
111138423|NCT01650519|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110590310|NCT00687609|Adrenergic Agents|adrenergic agents|mesh-ancestor
111138424|NCT01650519|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111138425|NCT01650519|Analgesics|analgesics|mesh-ancestor
111138426|NCT01650519|Sensory System Agents|sensory system agents|mesh-ancestor
111138427|NCT01650519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111138428|NCT01650519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111138429|NCT01650519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111138430|NCT01650519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111138431|NCT01650519|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111138432|NCT01650519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111138433|NCT01650519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111138434|NCT02197039|Esomeprazole|esomeprazole|mesh-list
111138435|NCT02197039|Pantoprazole|pantoprazole|mesh-list
111138436|NCT02197039|Hemostatics|hemostatics|mesh-list
111138437|NCT02197039|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111138438|NCT02197039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111138439|NCT02197039|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
111138440|NCT02197039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111138441|NCT02197039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111138442|NCT02197039|Coagulants|coagulants|mesh-ancestor
111138443|NCT05557903|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
111138444|NCT05557903|Alemtuzumab|alemtuzumab|mesh-list
111138445|NCT05557903|Antibodies|antibodies|mesh-list
111138446|NCT05557903|Immunoglobulins|immunoglobulins|mesh-list
111138447|NCT05557903|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111138448|NCT05557903|Immunologic Factors|immunologic factors|mesh-ancestor
111138449|NCT05557903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111138450|NCT05557903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111138451|NCT02386839|Mecasermin|mecasermin|mesh-list
111138452|NCT02386839|Growth Substances|growth substances|mesh-ancestor
111138453|NCT02386839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111138454|NCT05347459|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
111138456|NCT05347459|Empagliflozin|empagliflozin|mesh-list
111138457|NCT05347459|Linagliptin|linagliptin|mesh-list
111138458|NCT05347459|Canagliflozin|canagliflozin|mesh-list
111138459|NCT05347459|Vildagliptin|vildagliptin|mesh-list
111138460|NCT05347459|Saxagliptin|saxagliptin|mesh-list
111138461|NCT05347459|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111138462|NCT05347459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111138463|NCT05347459|Incretins|incretins|mesh-ancestor
111138464|NCT05347459|Hormones|hormones|mesh-ancestor
111138465|NCT05347459|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111138466|NCT05347459|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110590327|NCT04085120|Lidocaine|lidocaine|mesh-list
111138467|NCT05347459|Protease Inhibitors|protease inhibitors|mesh-ancestor
111138468|NCT05347459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111138469|NCT05347459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111138470|NCT05347459|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
111138471|NCT05346445|Fluoxetine|fluoxetine|mesh-list
111138472|NCT05346445|Citalopram|citalopram|mesh-list
111138473|NCT05346445|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111138474|NCT05346445|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111138475|NCT05346445|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111138476|NCT05346445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111138477|NCT05346445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111138478|NCT05346445|Serotonin Agents|serotonin agents|mesh-ancestor
111138479|NCT05346445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111138480|NCT05346445|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111138481|NCT05346445|Antidepressive Agents|antidepressive agents|mesh-ancestor
111138482|NCT05346445|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111138483|NCT05346445|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111138484|NCT05346445|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111138485|NCT05346445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111138486|NCT01649271|Trastuzumab|trastuzumab|mesh-list
111138487|NCT01649271|Afatinib|afatinib|mesh-list
111138488|NCT01649271|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111138489|NCT01649271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111138490|NCT01649271|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111138491|NCT01649271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111138492|NCT01649271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111138493|NCT02385669|Ipilimumab|ipilimumab|mesh-list
111138494|NCT02385669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111138495|NCT02385669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111138496|NCT02385669|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111138497|NCT02385669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111138498|NCT02402907|Chlorhexidine|chlorhexidine|mesh-list
111138499|NCT02402907|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
111138500|NCT02402907|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111138501|NCT02402907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111138502|NCT02402907|Disinfectants|disinfectants|mesh-ancestor
111138503|NCT02402907|Dermatologic Agents|dermatologic agents|mesh-ancestor
111138505|NCT02400333|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111138506|NCT02400333|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111138507|NCT02400333|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111138508|NCT02400333|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111138509|NCT02400333|Purinergic Agents|purinergic agents|mesh-ancestor
111138510|NCT02400333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111138511|NCT02400333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111138512|NCT02400333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111138513|NCT02399475|Hormones|hormones|mesh-list
111138514|NCT02399475|Thyrotropin-Releasing Hormone|thyrotropin-releasing hormone|mesh-list
111138515|NCT02399475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111138516|NCT02399475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111138517|NCT02399163|Fluorides|fluorides|mesh-list
111138518|NCT02399163|Cariostatic Agents|cariostatic agents|mesh-ancestor
111138519|NCT02399163|Protective Agents|protective agents|mesh-ancestor
111138520|NCT02399163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111138521|NCT02397837|Pramipexole|pramipexole|mesh-list
111138522|NCT02397837|Antioxidants|antioxidants|mesh-ancestor
111138523|NCT02397837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111138524|NCT02397837|Protective Agents|protective agents|mesh-ancestor
111138525|NCT02397837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111138526|NCT02397837|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111138527|NCT02397837|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111138528|NCT02397837|Dopamine Agonists|dopamine agonists|mesh-ancestor
111138529|NCT02397837|Dopamine Agents|dopamine agents|mesh-ancestor
111138530|NCT02397837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111138531|NCT05549167|Sirolimus|sirolimus|mesh-list
111138532|NCT05549167|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111138533|NCT05549167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111138534|NCT05549167|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111138535|NCT05549167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111138536|NCT05549167|Antifungal Agents|antifungal agents|mesh-ancestor
111138537|NCT05549167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111138538|NCT05549167|Immunologic Factors|immunologic factors|mesh-ancestor
111138539|NCT05549167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111138540|NCT05700721|Niraparib|niraparib|mesh-list
111138541|NCT05700721|Dostarlimab|dostarlimab|mesh-list
111138542|NCT05700721|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111138543|NCT05700721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111138544|NCT05700721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111138545|NCT05700721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111138546|NCT04134559|Pembrolizumab|pembrolizumab|mesh-list
111138547|NCT04134559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111138548|NCT04134559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111138549|NCT04134559|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111138550|NCT04134559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111138551|NCT05542147|Fenofibrate|fenofibrate|mesh-list
111138552|NCT05542147|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111138553|NCT05542147|Antimetabolites|antimetabolites|mesh-ancestor
111138554|NCT05542147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111138555|NCT05542147|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111138556|NCT05548465|Sufentanil|sufentanil|mesh-list
111138557|NCT05548465|Remifentanil|remifentanil|mesh-list
111138558|NCT05548465|Dsuvia|dsuvia|mesh-list
111138559|NCT05548465|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111138560|NCT05548465|Narcotics|narcotics|mesh-ancestor
111138561|NCT05548465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111138562|NCT05548465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111138563|NCT05548465|Analgesics|analgesics|mesh-ancestor
111138564|NCT05548465|Sensory System Agents|sensory system agents|mesh-ancestor
111138565|NCT05548465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111138566|NCT05548465|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111138567|NCT05548465|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111138568|NCT05548465|Anesthetics, General|anesthetics, general|mesh-ancestor
111138569|NCT05548465|Anesthetics|anesthetics|mesh-ancestor
111138570|NCT05548075|Psilocybin|psilocybin|mesh-list
111138571|NCT05548075|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
111138572|NCT05548075|Hallucinogens|hallucinogens|mesh-ancestor
111138573|NCT05548075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111138574|NCT05548075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111138575|NCT05548075|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111138576|NCT05548075|Serotonin Agents|serotonin agents|mesh-ancestor
111138577|NCT05548075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110590381|NCT00684645|Sunitinib|sunitinib|mesh-list
111138578|NCT05548075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111138579|NCT05548075|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111138581|NCT05554003|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111138582|NCT05554003|Alkylating Agents|alkylating agents|mesh-ancestor
111138583|NCT05554003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111138584|NCT05554003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111138585|NCT05541757|Heparin|heparin|mesh-list
111138586|NCT05541757|Anticoagulants|anticoagulants|mesh-ancestor
111138587|NCT05541757|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111138588|NCT05541757|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111138589|NCT05541757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111138590|NCT05700565|Immunosuppressive Agents|immunosuppressive agents|mesh-list
111138591|NCT05700565|Immunomodulating Agents|immunomodulating agents|mesh-list
111138592|NCT05700565|Immunologic Factors|immunologic factors|mesh-ancestor
111138593|NCT05700565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111138594|NCT05541445|Pembrolizumab|pembrolizumab|mesh-list
111138595|NCT05541445|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111138596|NCT05541445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111138597|NCT05541445|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111138598|NCT05541445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111138599|NCT05540977|Donepezil|donepezil|mesh-list
111138600|NCT05540977|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
111138601|NCT05540977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111138602|NCT05540977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111138603|NCT05540977|Cholinergic Agents|cholinergic agents|mesh-ancestor
111138604|NCT05540977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111138605|NCT05540977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111138606|NCT05540977|Nootropic Agents|nootropic agents|mesh-ancestor
111138607|NCT05547685|Methylene Blue|methylene blue|mesh-list
111138608|NCT05547685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111138609|NCT05547685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111138610|NCT05540587|Warfarin|warfarin|mesh-list
111138611|NCT05540587|Edoxaban|edoxaban|mesh-list
111138612|NCT05540587|Anticoagulants|anticoagulants|mesh-ancestor
111138613|NCT05540587|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111138614|NCT05540587|Antithrombins|antithrombins|mesh-ancestor
111138615|NCT05540587|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111138616|NCT05540587|Protease Inhibitors|protease inhibitors|mesh-ancestor
111138617|NCT05540587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111138618|NCT05540587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111138619|NCT05540431|Charcoal|charcoal|mesh-list
111138620|NCT05540431|Antidotes|antidotes|mesh-ancestor
111138621|NCT05540431|Protective Agents|protective agents|mesh-ancestor
111138622|NCT05540431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111138623|NCT05553067|Antibodies|antibodies|mesh-list
111138624|NCT05553067|Immunologic Factors|immunologic factors|mesh-ancestor
111138625|NCT05553067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111138626|NCT05540275|Bevacizumab|bevacizumab|mesh-list
111138627|NCT05540275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111138628|NCT05540275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111138629|NCT05540275|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111138630|NCT05540275|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111138631|NCT05540275|Growth Substances|growth substances|mesh-ancestor
111138632|NCT05540275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111138633|NCT05540275|Growth Inhibitors|growth inhibitors|mesh-ancestor
111138634|NCT04426123|Botulinum Toxins|botulinum toxins|mesh-list
111138635|NCT04426123|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111138636|NCT04426123|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111138637|NCT04426123|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111138638|NCT04426123|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111138639|NCT04426123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111138640|NCT04426123|Cholinergic Agents|cholinergic agents|mesh-ancestor
111138641|NCT04426123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111138642|NCT04426123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111138643|NCT04426123|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111138644|NCT04426123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111138645|NCT01666951|Tacrolimus|tacrolimus|mesh-list
111138647|NCT01666951|Immunologic Factors|immunologic factors|mesh-ancestor
111138648|NCT01666951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111138649|NCT01666951|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111138650|NCT01666951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111138651|NCT01666951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111138652|NCT02586805|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111138653|NCT02586805|Immunologic Factors|immunologic factors|mesh-ancestor
111138654|NCT02586805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111138655|NCT05550415|Simvastatin|simvastatin|mesh-list
111138656|NCT05550415|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111138657|NCT05550415|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111138658|NCT05550415|Antimetabolites|antimetabolites|mesh-ancestor
111138659|NCT05550415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111138660|NCT05550415|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111138661|NCT05550415|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111138662|NCT05550415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111138663|NCT02586727|Aflibercept|aflibercept|mesh-list
111138664|NCT02586727|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111138665|NCT02586727|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111138666|NCT02586727|Growth Substances|growth substances|mesh-ancestor
111138667|NCT02586727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111138668|NCT02586727|Growth Inhibitors|growth inhibitors|mesh-ancestor
111138669|NCT02586727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111138670|NCT05550025|Apatinib|apatinib|mesh-list
111138671|NCT05550025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111138672|NCT05550025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111138673|NCT05550025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111138674|NCT05550025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111138675|NCT05700253|Hyaluronic Acid|hyaluronic acid|mesh-list
111138676|NCT05700253|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111138677|NCT05700253|Immunologic Factors|immunologic factors|mesh-ancestor
111138678|NCT05700253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111138679|NCT05700253|Viscosupplements|viscosupplements|mesh-ancestor
111138680|NCT05700253|Protective Agents|protective agents|mesh-ancestor
111138681|NCT05544253|Mitomycins|mitomycins|mesh-list
111138682|NCT05544253|Mitomycin|mitomycin|mesh-list
111138683|NCT05544253|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111138684|NCT05544253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111138685|NCT05544253|Alkylating Agents|alkylating agents|mesh-ancestor
111138686|NCT05544253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111138687|NCT05544253|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111138688|NCT05544253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111138689|NCT05535517|Emollients|emollients|mesh-list
111138690|NCT05535517|Dermatologic Agents|dermatologic agents|mesh-ancestor
111138691|NCT05543941|Povidone-Iodine|povidone-iodine|mesh-list
111138692|NCT05543941|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111138693|NCT05543941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111138694|NCT02580877|Insulin|insulin|mesh-list
111138695|NCT02580877|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
111138696|NCT02580877|Insulin, Isophane|insulin, isophane|mesh-list
111138697|NCT02580877|Methamphetamine|methamphetamine|mesh-list
111138698|NCT02580877|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111138699|NCT02580877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111138700|NCT02580877|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111138701|NCT02580877|Sympathomimetics|sympathomimetics|mesh-ancestor
111138702|NCT02580877|Autonomic Agents|autonomic agents|mesh-ancestor
111138703|NCT02580877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111138704|NCT02580877|Dopamine Agents|dopamine agents|mesh-ancestor
111138705|NCT02580877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111138706|NCT02580877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111138707|NCT02580877|Adrenergic Agents|adrenergic agents|mesh-ancestor
111138708|NCT02580877|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111138709|NCT02580877|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111138710|NCT02580877|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111138711|NCT02580877|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111138712|NCT01905631|Diphenhydramine|diphenhydramine|mesh-list
110568661|NCT00822120|Prednisone|prednisone|mesh-list
111138714|NCT01905631|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111138715|NCT01905631|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111138716|NCT01905631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111138717|NCT01905631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111138718|NCT01905631|Anesthetics, Local|anesthetics, local|mesh-ancestor
111138719|NCT01905631|Anesthetics|anesthetics|mesh-ancestor
111138720|NCT01905631|Sensory System Agents|sensory system agents|mesh-ancestor
111138721|NCT01905631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111138722|NCT01905631|Antiemetics|antiemetics|mesh-ancestor
111138723|NCT01905631|Autonomic Agents|autonomic agents|mesh-ancestor
111138724|NCT01905631|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111138725|NCT01905631|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111138726|NCT01905631|Histamine Antagonists|histamine antagonists|mesh-ancestor
111138727|NCT01905631|Histamine Agents|histamine agents|mesh-ancestor
111138728|NCT01905631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111138729|NCT01905631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111138730|NCT01905631|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111138731|NCT01905631|Antipruritics|antipruritics|mesh-ancestor
111138732|NCT01905631|Dermatologic Agents|dermatologic agents|mesh-ancestor
111138733|NCT05679037|Thioctic Acid|thioctic acid|mesh-list
111138734|NCT05679037|Antioxidants|antioxidants|mesh-ancestor
111138735|NCT05679037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111138736|NCT05679037|Protective Agents|protective agents|mesh-ancestor
111138737|NCT05679037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111138738|NCT05679037|Vitamin B Complex|vitamin b complex|mesh-ancestor
111138739|NCT05679037|Vitamins|vitamins|mesh-ancestor
111138740|NCT05679037|Micronutrients|micronutrients|mesh-ancestor
111138741|NCT05197621|Vaccines|vaccines|mesh-list
111138742|NCT05197621|Immunologic Factors|immunologic factors|mesh-ancestor
111138743|NCT05197621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111138744|NCT02582983|Enfuvirtide|enfuvirtide|mesh-list
111138745|NCT02582983|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
111138746|NCT02582983|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
111138747|NCT02582983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111138748|NCT02582983|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111138749|NCT02582983|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111138750|NCT02582983|Antiviral Agents|antiviral agents|mesh-ancestor
111138751|NCT02582983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111138752|NCT02582749|Bicalutamide|bicalutamide|mesh-list
111138753|NCT02582749|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
111138754|NCT02582749|Androgen Antagonists|androgen antagonists|mesh-ancestor
111138755|NCT02582749|Hormone Antagonists|hormone antagonists|mesh-ancestor
111138756|NCT02582749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111138757|NCT02582749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111138758|NCT02582749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111138759|NCT05695495|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
111138760|NCT05695495|Hallucinogens|hallucinogens|mesh-ancestor
111138761|NCT05695495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111138762|NCT05695495|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111138763|NCT05695495|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111138764|NCT05695495|Serotonin Agents|serotonin agents|mesh-ancestor
111138765|NCT05695495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111138766|NCT05695495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111138767|NCT05695495|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111138768|NCT05461261|Prednisolone|prednisolone|mesh-list
111138769|NCT05461261|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111138770|NCT05461261|Methylprednisolone|methylprednisolone|mesh-list
111138771|NCT05461261|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111138772|NCT05461261|Prednisolone acetate|prednisolone acetate|mesh-list
111138773|NCT05461261|Docetaxel|docetaxel|mesh-list
111138774|NCT05461261|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111138775|NCT05461261|Prednisolone phosphate|prednisolone phosphate|mesh-list
111138776|NCT05461261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111138777|NCT05461261|Tubulin Modulators|tubulin modulators|mesh-ancestor
111138778|NCT05461261|Antimitotic Agents|antimitotic agents|mesh-ancestor
111138779|NCT05461261|Mitosis Modulators|mitosis modulators|mesh-ancestor
110838834|NCT03427216|Anticonvulsants|anticonvulsants|mesh-ancestor
111138780|NCT05461261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111138781|NCT05461261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111138782|NCT05461261|Glucocorticoids|glucocorticoids|mesh-ancestor
111138783|NCT05461261|Hormones|hormones|mesh-ancestor
111138784|NCT05461261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111138785|NCT05461261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111138786|NCT05461261|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111138787|NCT05461261|Antiemetics|antiemetics|mesh-ancestor
111138788|NCT05461261|Autonomic Agents|autonomic agents|mesh-ancestor
111138789|NCT05461261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111138790|NCT05461261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111138791|NCT05461261|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111138792|NCT05461261|Protective Agents|protective agents|mesh-ancestor
111138793|NCT05678413|Paclitaxel|paclitaxel|mesh-list
111138794|NCT05678413|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111138795|NCT05678413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111138796|NCT05678413|Tubulin Modulators|tubulin modulators|mesh-ancestor
111138797|NCT05678413|Antimitotic Agents|antimitotic agents|mesh-ancestor
111138798|NCT05678413|Mitosis Modulators|mitosis modulators|mesh-ancestor
111138799|NCT05678413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111138800|NCT05123365|Acetylcysteine|acetylcysteine|mesh-list
111138801|NCT05123365|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111138802|NCT05123365|Antiviral Agents|antiviral agents|mesh-ancestor
111138803|NCT05123365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111138804|NCT05123365|Expectorants|expectorants|mesh-ancestor
111138805|NCT05123365|Respiratory System Agents|respiratory system agents|mesh-ancestor
111138807|NCT05123365|Antioxidants|antioxidants|mesh-ancestor
111138808|NCT05123365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111138809|NCT05123365|Protective Agents|protective agents|mesh-ancestor
111138810|NCT05123365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111138811|NCT05123365|Antidotes|antidotes|mesh-ancestor
111138812|NCT05678335|Hydroxychloroquine|hydroxychloroquine|mesh-list
111138813|NCT05678335|Tacrolimus|tacrolimus|mesh-list
111138814|NCT05678335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111138815|NCT05678335|Immunologic Factors|immunologic factors|mesh-ancestor
111138816|NCT05678335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111138817|NCT05678335|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111138818|NCT05678335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111138819|NCT05678335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111138820|NCT05678335|Antimalarials|antimalarials|mesh-ancestor
111138821|NCT05678335|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111138822|NCT05678335|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111138823|NCT05678335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111138824|NCT05678335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111138825|NCT02582671|Ritonavir|ritonavir|mesh-list
111138826|NCT02582671|Ribavirin|ribavirin|mesh-list
111138827|NCT02582671|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111138828|NCT02582671|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111138829|NCT02582671|Protease Inhibitors|protease inhibitors|mesh-ancestor
111138830|NCT02582671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111138831|NCT02582671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111138832|NCT02582671|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111138833|NCT02582671|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111138834|NCT02582671|Antiviral Agents|antiviral agents|mesh-ancestor
111138835|NCT02582671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111138836|NCT02582671|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111138837|NCT02582671|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111138838|NCT02582671|Antimetabolites|antimetabolites|mesh-ancestor
111138839|NCT05696977|Cyclosporine|cyclosporine|mesh-list
111138840|NCT05696977|Cyclosporins|cyclosporins|mesh-list
111138841|NCT05696977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111138842|NCT05696977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111138843|NCT05696977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111138844|NCT05696977|Immunologic Factors|immunologic factors|mesh-ancestor
111138845|NCT05696977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111138846|NCT05696977|Antifungal Agents|antifungal agents|mesh-ancestor
111138847|NCT05696977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111138848|NCT05696977|Dermatologic Agents|dermatologic agents|mesh-ancestor
111138849|NCT05696977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111138850|NCT05696977|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111138851|NCT02585713|Dalteparin|dalteparin|mesh-list
111138852|NCT02585713|Tinzaparin|tinzaparin|mesh-list
111138853|NCT02585713|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
111138854|NCT02585713|Apixaban|apixaban|mesh-list
111138855|NCT02585713|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111138856|NCT02585713|Antithrombins|antithrombins|mesh-ancestor
111138857|NCT02585713|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111138858|NCT02585713|Protease Inhibitors|protease inhibitors|mesh-ancestor
111138859|NCT02585713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111138860|NCT02585713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111138861|NCT02585713|Anticoagulants|anticoagulants|mesh-ancestor
111138862|NCT02585713|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111138863|NCT02585713|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111138864|NCT05078671|Cobicistat|cobicistat|mesh-list
111138865|NCT05078671|Olaparib|olaparib|mesh-list
111138866|NCT05078671|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111138867|NCT05078671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111138868|NCT05078671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111138869|NCT05078671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111138870|NCT05078671|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111138871|NCT05078671|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111138872|NCT05078671|Antiviral Agents|antiviral agents|mesh-ancestor
111138873|NCT05078671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111138874|NCT05078671|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111138875|NCT05078671|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111138876|NCT02579863|Dexamethasone|dexamethasone|mesh-list
111138877|NCT02579863|Pembrolizumab|pembrolizumab|mesh-list
111138878|NCT02579863|Lenalidomide|lenalidomide|mesh-list
111138879|NCT02579863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111138880|NCT02579863|Antiemetics|antiemetics|mesh-ancestor
111138881|NCT02579863|Autonomic Agents|autonomic agents|mesh-ancestor
111138882|NCT02579863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111138883|NCT02579863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111138884|NCT02579863|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111138885|NCT02579863|Glucocorticoids|glucocorticoids|mesh-ancestor
111138886|NCT02579863|Hormones|hormones|mesh-ancestor
111138887|NCT02579863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111138888|NCT02579863|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111138889|NCT02579863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111138890|NCT02579863|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111138891|NCT02579863|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111138892|NCT02579863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111138893|NCT02579863|Immunologic Factors|immunologic factors|mesh-ancestor
111138894|NCT02579863|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111138895|NCT02579863|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111138896|NCT02579863|Growth Substances|growth substances|mesh-ancestor
111138897|NCT02579863|Growth Inhibitors|growth inhibitors|mesh-ancestor
111138898|NCT05677945|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111138899|NCT05677945|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
111138900|NCT05677945|Simvastatin|simvastatin|mesh-list
111138901|NCT05677945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111138902|NCT05677945|Antitubercular Agents|antitubercular agents|mesh-ancestor
111138903|NCT05677945|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111138904|NCT05677945|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111138905|NCT05677945|Antimetabolites|antimetabolites|mesh-ancestor
111138906|NCT05677945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111138907|NCT05677945|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111138908|NCT05677945|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111138909|NCT05677945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111138910|NCT02582515|Cycloserine|cycloserine|mesh-list
111138911|NCT02582515|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111138912|NCT02582515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111138913|NCT02582515|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111138914|NCT02582515|Antitubercular Agents|antitubercular agents|mesh-ancestor
111138915|NCT02582515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111138916|NCT02582515|Antimetabolites|antimetabolites|mesh-ancestor
111138917|NCT02582515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111138918|NCT02579629|Ropivacaine|ropivacaine|mesh-list
111138919|NCT02579629|Anesthetics, Local|anesthetics, local|mesh-ancestor
111138920|NCT02579629|Anesthetics|anesthetics|mesh-ancestor
111138921|NCT02579629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111138922|NCT02579629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111138923|NCT02579629|Sensory System Agents|sensory system agents|mesh-ancestor
111138924|NCT02579629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111138925|NCT05677555|Colchicine|colchicine|mesh-list
111138926|NCT05677555|Gout Suppressants|gout suppressants|mesh-ancestor
111138927|NCT05677555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111138928|NCT05677555|Tubulin Modulators|tubulin modulators|mesh-ancestor
111138929|NCT05677555|Antimitotic Agents|antimitotic agents|mesh-ancestor
111138930|NCT05677555|Mitosis Modulators|mitosis modulators|mesh-ancestor
111138931|NCT05677555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111138932|NCT05677555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111138933|NCT02343939|Cytarabine|cytarabine|mesh-list
111138934|NCT02343939|Azacitidine|azacitidine|mesh-list
111138935|NCT02343939|Decitabine|decitabine|mesh-list
111138936|NCT02343939|Daunorubicin|daunorubicin|mesh-list
111138937|NCT02343939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111138938|NCT02343939|Antimetabolites|antimetabolites|mesh-ancestor
111138939|NCT02343939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111138940|NCT02343939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111138941|NCT02343939|Antiviral Agents|antiviral agents|mesh-ancestor
111138942|NCT02343939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111138943|NCT02343939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111138944|NCT02343939|Immunologic Factors|immunologic factors|mesh-ancestor
111138945|NCT02343939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111138946|NCT02343939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111138947|NCT02343939|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111138948|NCT02343939|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111138949|NCT02343939|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111138950|NCT02343549|Bevacizumab|bevacizumab|mesh-list
111138951|NCT02343549|Temozolomide|temozolomide|mesh-list
111138952|NCT02343549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111138953|NCT02343549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110838878|NCT03767569|Micronutrients|micronutrients|mesh-ancestor
111138954|NCT02343549|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111138955|NCT02343549|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111138956|NCT02343549|Growth Substances|growth substances|mesh-ancestor
111138957|NCT02343549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111138958|NCT02343549|Growth Inhibitors|growth inhibitors|mesh-ancestor
111138959|NCT02343549|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111138960|NCT02343549|Alkylating Agents|alkylating agents|mesh-ancestor
111138961|NCT02343549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111138962|NCT02343159|Dimethyl Fumarate|dimethyl fumarate|mesh-list
111138963|NCT02343159|Dermatologic Agents|dermatologic agents|mesh-ancestor
111138964|NCT02343159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111138965|NCT02343159|Immunologic Factors|immunologic factors|mesh-ancestor
111138966|NCT02343159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111138967|NCT02395653|Fentanyl|fentanyl|mesh-list
111138968|NCT02395653|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111138969|NCT02395653|Narcotics|narcotics|mesh-ancestor
111138970|NCT02395653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111138971|NCT02395653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111138972|NCT02395653|Analgesics|analgesics|mesh-ancestor
111138973|NCT02395653|Sensory System Agents|sensory system agents|mesh-ancestor
111138974|NCT02395653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111138975|NCT02395653|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111138976|NCT02395653|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111138977|NCT02395653|Anesthetics, General|anesthetics, general|mesh-ancestor
111138978|NCT02395653|Anesthetics|anesthetics|mesh-ancestor
111138979|NCT01664923|Bicalutamide|bicalutamide|mesh-list
111138980|NCT01664923|Androgen Antagonists|androgen antagonists|mesh-ancestor
111138981|NCT01664923|Hormone Antagonists|hormone antagonists|mesh-ancestor
111138982|NCT01664923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111138983|NCT01664923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111138984|NCT01664923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111138985|NCT04778527|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
111138986|NCT04778527|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111138987|NCT04778527|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111138988|NCT04778527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111138989|NCT04778527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111138990|NCT04778527|Antiviral Agents|antiviral agents|mesh-ancestor
111138991|NCT04778527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111138992|NCT04778527|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111138993|NCT04778527|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111138994|NCT04403347|Losartan|losartan|mesh-list
111138995|NCT04403347|Antihypertensive Agents|antihypertensive agents|mesh-list
111138996|NCT04403347|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111138997|NCT04403347|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111138998|NCT04403347|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111138999|NCT04403347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111139000|NCT01664533|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
111139001|NCT01664533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111139002|NCT01664533|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111139003|NCT01664533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111139004|NCT01664533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111139005|NCT05673655|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111139006|NCT05673655|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111139007|NCT05673655|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111139008|NCT05673655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111139009|NCT05673655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111139010|NCT05673655|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111139011|NCT05673655|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111139012|NCT05673655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111139013|NCT05673655|Cholinergic Agents|cholinergic agents|mesh-ancestor
111139014|NCT05673655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111139015|NCT05692297|Denosumab|denosumab|mesh-list
111139016|NCT05692297|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111139017|NCT05692297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111139018|NCT05696509|Anesthetics|anesthetics|mesh-list
111139019|NCT05696509|Propofol|propofol|mesh-list
111139020|NCT05696509|Sevoflurane|sevoflurane|mesh-list
111139021|NCT05696509|Isoflurane|isoflurane|mesh-list
111139022|NCT05696509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111139023|NCT05696509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111139024|NCT05696509|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111139025|NCT05696509|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111139026|NCT05696509|Anesthetics, General|anesthetics, general|mesh-ancestor
111139027|NCT05696509|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110856052|NCT02478034|Fludrocortisone|fludrocortisone|mesh-list
111139028|NCT05696509|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111139029|NCT02584855|Ixekizumab|ixekizumab|mesh-list
111139030|NCT02584855|Dermatologic Agents|dermatologic agents|mesh-ancestor
111139031|NCT02581891|Aflibercept|aflibercept|mesh-list
111139032|NCT02581891|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111139033|NCT02581891|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111139034|NCT02581891|Growth Substances|growth substances|mesh-ancestor
111139035|NCT02581891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111139036|NCT02581891|Growth Inhibitors|growth inhibitors|mesh-ancestor
111139037|NCT02581891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111139038|NCT04523857|Hydroxychloroquine|hydroxychloroquine|mesh-list
111139039|NCT04523857|Antimalarials|antimalarials|mesh-ancestor
111139040|NCT04523857|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111139041|NCT04523857|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111139042|NCT04523857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111139043|NCT04523857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111139044|NCT04523857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111139045|NCT04523857|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111139046|NCT02581345|Adalimumab|adalimumab|mesh-list
111139047|NCT02581345|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
111139048|NCT02581345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111139049|NCT02581345|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111139050|NCT05579509|Fentanyl|fentanyl|mesh-list
111139051|NCT05579509|Midazolam|midazolam|mesh-list
111139052|NCT05579509|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111139053|NCT05579509|Narcotics|narcotics|mesh-ancestor
111139054|NCT05579509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111139055|NCT05579509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111139056|NCT05579509|Analgesics|analgesics|mesh-ancestor
111139057|NCT05579509|Sensory System Agents|sensory system agents|mesh-ancestor
111139058|NCT05579509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111139059|NCT05579509|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111139060|NCT05579509|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111139061|NCT05579509|Anesthetics, General|anesthetics, general|mesh-ancestor
111139062|NCT05579509|Anesthetics|anesthetics|mesh-ancestor
111139063|NCT05579509|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111139064|NCT05579509|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111139065|NCT05579509|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111139066|NCT05579509|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111139067|NCT05579509|GABA Modulators|gaba modulators|mesh-ancestor
111139068|NCT05579509|GABA Agents|gaba agents|mesh-ancestor
111139069|NCT05579509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111139070|NCT05579509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111139071|NCT05696431|Fluorides|fluorides|mesh-list
111139072|NCT05696431|Cariostatic Agents|cariostatic agents|mesh-ancestor
111139073|NCT05696431|Protective Agents|protective agents|mesh-ancestor
111139074|NCT05696431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111139075|NCT05575219|Clonidine|clonidine|mesh-list
111139076|NCT05575219|Analgesics|analgesics|mesh-ancestor
111139077|NCT05575219|Sensory System Agents|sensory system agents|mesh-ancestor
111139078|NCT05575219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111139079|NCT05575219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111139080|NCT05575219|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111139081|NCT05575219|Sympatholytics|sympatholytics|mesh-ancestor
111139082|NCT05575219|Autonomic Agents|autonomic agents|mesh-ancestor
111139083|NCT05575219|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111139084|NCT05575219|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111139085|NCT05575219|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111139086|NCT05575219|Adrenergic Agents|adrenergic agents|mesh-ancestor
111139087|NCT05575219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111139088|NCT05575219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111139089|NCT05568745|Misoprostol|misoprostol|mesh-list
111139090|NCT05568745|Oxytocin|oxytocin|mesh-list
111139091|NCT05568745|Oxytocics|oxytocics|mesh-ancestor
111139092|NCT05568745|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111139093|NCT05568745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111139094|NCT05568745|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111139095|NCT05568745|Abortifacient Agents|abortifacient agents|mesh-ancestor
111139096|NCT05568745|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
111139097|NCT05568745|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111139098|NCT04314895|Paclitaxel|paclitaxel|mesh-list
111139099|NCT04314895|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111139100|NCT04314895|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111139101|NCT04314895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111139102|NCT04314895|Tubulin Modulators|tubulin modulators|mesh-ancestor
111139103|NCT04314895|Antimitotic Agents|antimitotic agents|mesh-ancestor
111139104|NCT04314895|Mitosis Modulators|mitosis modulators|mesh-ancestor
111139105|NCT04314895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111139107|NCT02581189|Ribavirin|ribavirin|mesh-list
111139108|NCT02581189|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
111139109|NCT02581189|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
111139110|NCT02581189|Protease Inhibitors|protease inhibitors|mesh-ancestor
111139111|NCT02581189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111139112|NCT02581189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111139113|NCT02581189|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111139114|NCT02581189|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111139115|NCT02581189|Antiviral Agents|antiviral agents|mesh-ancestor
111139116|NCT02581189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111139117|NCT02581189|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111139118|NCT02581189|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111139119|NCT02581189|Antimetabolites|antimetabolites|mesh-ancestor
111139120|NCT05569681|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
111139121|NCT05569681|Bemiparin|bemiparin|mesh-list
111139122|NCT05569681|Anticoagulants|anticoagulants|mesh-ancestor
111139123|NCT05569681|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111139124|NCT05569681|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111139125|NCT05569681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111139126|NCT02576977|Dexamethasone|dexamethasone|mesh-list
111139127|NCT02576977|Pembrolizumab|pembrolizumab|mesh-list
111139128|NCT02576977|Pomalidomide|pomalidomide|mesh-list
111139129|NCT02576977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111139130|NCT02576977|Antiemetics|antiemetics|mesh-ancestor
111139131|NCT02576977|Autonomic Agents|autonomic agents|mesh-ancestor
111139132|NCT02576977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111139133|NCT02576977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111139134|NCT02576977|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111139135|NCT02576977|Glucocorticoids|glucocorticoids|mesh-ancestor
111139136|NCT02576977|Hormones|hormones|mesh-ancestor
111139137|NCT02576977|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111139138|NCT02576977|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111139139|NCT02576977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111139140|NCT02576977|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111139141|NCT02576977|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111139142|NCT02576977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111139143|NCT02576977|Immunologic Factors|immunologic factors|mesh-ancestor
111139144|NCT02576977|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111139145|NCT02576977|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111139146|NCT02576977|Growth Substances|growth substances|mesh-ancestor
111139147|NCT02576977|Growth Inhibitors|growth inhibitors|mesh-ancestor
111139148|NCT05867251|Carboplatin|carboplatin|mesh-list
111139149|NCT05867251|Letrozole|letrozole|mesh-list
111139150|NCT05867251|Fulvestrant|fulvestrant|mesh-list
111139151|NCT05867251|Palbociclib|palbociclib|mesh-list
111139152|NCT05867251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111139153|NCT05867251|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111139154|NCT05867251|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111139155|NCT05867251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111139156|NCT05867251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110838913|NCT00458003|Ephedrine|ephedrine|mesh-list
111139157|NCT05867251|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111139158|NCT05867251|Hormone Antagonists|hormone antagonists|mesh-ancestor
111139159|NCT05867251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111139160|NCT05867251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111139161|NCT05867251|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111139162|NCT05867251|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
111139163|NCT05867251|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111139164|NCT05867212|Cabotegravir|cabotegravir|mesh-list
111139165|NCT05867212|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
111139166|NCT05867212|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
111139167|NCT05867212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111139168|NCT05867212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111139169|NCT05867212|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111139170|NCT05867212|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111139171|NCT05867212|Antiviral Agents|antiviral agents|mesh-ancestor
111139172|NCT05867212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111139173|NCT05867030|Rituximab|rituximab|mesh-list
111139174|NCT05867030|Lenalidomide|lenalidomide|mesh-list
111139175|NCT05867030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111139176|NCT05867030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111139177|NCT05867030|Immunologic Factors|immunologic factors|mesh-ancestor
111139178|NCT05867030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111139179|NCT05867030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111139180|NCT05867030|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111139181|NCT05867030|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111139182|NCT05867030|Growth Substances|growth substances|mesh-ancestor
111139183|NCT05867030|Growth Inhibitors|growth inhibitors|mesh-ancestor
111139184|NCT05866848|Caffeine|caffeine|mesh-list
111139185|NCT05866848|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111139186|NCT05866848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111139187|NCT05866848|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111139188|NCT05866848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111139189|NCT05866848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111139190|NCT05866848|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
111139191|NCT05866848|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111139192|NCT05866848|Purinergic Agents|purinergic agents|mesh-ancestor
111139193|NCT05866848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111139194|NCT05866614|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111139195|NCT05866614|Immunologic Factors|immunologic factors|mesh-ancestor
111139196|NCT05866614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111139197|NCT05866588|Coal Tar|coal tar|mesh-list
111139198|NCT05866588|Keratolytic Agents|keratolytic agents|mesh-ancestor
111139199|NCT05866588|Dermatologic Agents|dermatologic agents|mesh-ancestor
111139200|NCT05866575|Vortioxetine|vortioxetine|mesh-list
111139201|NCT05866575|Escitalopram|escitalopram|mesh-list
111139202|NCT05866575|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111139203|NCT05866575|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111139204|NCT05866575|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111139205|NCT05866575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111139206|NCT05866575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111139207|NCT05866575|Serotonin Agents|serotonin agents|mesh-ancestor
111139208|NCT05866575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111139209|NCT05866575|Antidepressive Agents|antidepressive agents|mesh-ancestor
111139210|NCT05866575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111139211|NCT05866575|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111139212|NCT05866575|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111139213|NCT05866575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111139214|NCT05866575|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111139215|NCT05866575|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111139216|NCT05866575|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111139217|NCT05866575|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111139218|NCT05866172|Zoledronic Acid|zoledronic acid|mesh-list
111139219|NCT05866172|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111139220|NCT05866172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111139221|NCT05866068|Clomiphene|clomiphene|mesh-list
111139222|NCT05866068|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111139223|NCT05866068|Hormone Antagonists|hormone antagonists|mesh-ancestor
110590628|NCT00684177|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111139224|NCT05866068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111139225|NCT05866068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111139226|NCT05866068|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111139227|NCT05866068|Fertility Agents|fertility agents|mesh-ancestor
111139228|NCT05866068|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111139229|NCT05866068|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111139230|NCT05866068|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111139231|NCT05865990|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
111139232|NCT05865990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111139233|NCT05865990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111139234|NCT05865925|Irinotecan|irinotecan|mesh-list
111139235|NCT05865925|Floxuridine|floxuridine|mesh-list
111139236|NCT05865925|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111139237|NCT05865925|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111139238|NCT05865925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111139239|NCT05865925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111139240|NCT05865925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111139241|NCT05865925|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111139242|NCT05865925|Antimetabolites|antimetabolites|mesh-ancestor
111139243|NCT05865548|Aspirin|aspirin|mesh-list
111139244|NCT05865548|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111139245|NCT05865548|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111139246|NCT05865548|Analgesics|analgesics|mesh-ancestor
111139247|NCT05865548|Sensory System Agents|sensory system agents|mesh-ancestor
111139248|NCT05865548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111139249|NCT05865548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111139250|NCT05865548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111139251|NCT05865548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111139252|NCT05865548|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110856269|NCT03770039|PF-06700841|pf-06700841|mesh-list
111139254|NCT05865548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111139255|NCT05865548|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111139256|NCT05865548|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111139257|NCT05865548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111139258|NCT05865548|Antipyretics|antipyretics|mesh-ancestor
111139259|NCT05861440|Antitubercular Agents|antitubercular agents|mesh-list
111139260|NCT05861440|Prednisolone|prednisolone|mesh-list
111139261|NCT05861440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111139262|NCT05861440|Glucocorticoids|glucocorticoids|mesh-ancestor
111139263|NCT05861440|Hormones|hormones|mesh-ancestor
111139264|NCT05861440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111139265|NCT05861440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111139266|NCT05861440|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111139267|NCT05861440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111139268|NCT05861440|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111139269|NCT05861440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111139270|NCT05827068|Vaccines|vaccines|mesh-list
111139271|NCT05827068|Immunologic Factors|immunologic factors|mesh-ancestor
111139272|NCT05827068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111139273|NCT05815680|Metformin|metformin|mesh-list
111139274|NCT05815680|Digoxin|digoxin|mesh-list
111139275|NCT05815680|Warfarin|warfarin|mesh-list
111139276|NCT05815680|Atorvastatin|atorvastatin|mesh-list
111139277|NCT05815680|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111139278|NCT05815680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111139279|NCT05815680|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111139280|NCT05815680|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111139281|NCT05815680|Antimetabolites|antimetabolites|mesh-ancestor
111139282|NCT05815680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111139283|NCT05815680|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111139284|NCT05815680|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111139285|NCT05815680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111139286|NCT05815680|Anticoagulants|anticoagulants|mesh-ancestor
111139287|NCT05815680|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111139288|NCT05815680|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111139289|NCT05815680|Protective Agents|protective agents|mesh-ancestor
111139290|NCT05801419|Nicotine|nicotine|mesh-list
111139291|NCT05801419|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
111139292|NCT05801419|Autonomic Agents|autonomic agents|mesh-ancestor
111139293|NCT05801419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111139294|NCT05801419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111139295|NCT05801419|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111139296|NCT05801419|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111139297|NCT05801419|Cholinergic Agents|cholinergic agents|mesh-ancestor
111139298|NCT05801419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111139299|NCT05801419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111139300|NCT05786417|Calcium Channel Blockers|calcium channel blockers|mesh-list
111139301|NCT05786417|Calcium|calcium|mesh-list
111139302|NCT05786417|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
111139303|NCT05786417|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111139304|NCT05786417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111139305|NCT05786417|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111139306|NCT05786417|Adrenergic Agents|adrenergic agents|mesh-ancestor
111139307|NCT05786417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111139308|NCT05786417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111139309|NCT05786417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111139310|NCT05781217|Goserelin|goserelin|mesh-list
111139311|NCT05781217|Triptorelin Pamoate|triptorelin pamoate|mesh-list
111139312|NCT05781217|Leuprolide|leuprolide|mesh-list
111139313|NCT05781217|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111139314|NCT05781217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111139315|NCT05781217|Luteolytic Agents|luteolytic agents|mesh-ancestor
111139316|NCT05781217|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
111139317|NCT05781217|Contraceptive Agents|contraceptive agents|mesh-ancestor
111139318|NCT05781217|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111139319|NCT05781217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111139320|NCT05781217|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
111139321|NCT05781217|Fertility Agents, Female|fertility agents, female|mesh-ancestor
111139322|NCT05781217|Fertility Agents|fertility agents|mesh-ancestor
111139323|NCT05776823|Naloxone|naloxone|mesh-list
111139324|NCT05776823|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
111139325|NCT05776823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110856340|NCT03762785|Dexmedetomidine|dexmedetomidine|mesh-list
111139326|NCT05776823|Sensory System Agents|sensory system agents|mesh-ancestor
111139327|NCT05776823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111139329|NCT05866029|Teriparatide|teriparatide|mesh-list
111139330|NCT05866029|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111139331|NCT05866029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111139332|NCT05866029|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111139333|NCT05769530|Dexmedetomidine|dexmedetomidine|mesh-list
111139334|NCT05769530|Nalbuphine|nalbuphine|mesh-list
111139335|NCT05769530|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111139336|NCT05769530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111139337|NCT05769530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111139338|NCT05769530|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111139339|NCT05769530|Analgesics|analgesics|mesh-ancestor
111139340|NCT05769530|Sensory System Agents|sensory system agents|mesh-ancestor
111139341|NCT05769530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111139342|NCT05769530|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
111139343|NCT05769530|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111139344|NCT05769530|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111139345|NCT05769530|Adrenergic Agents|adrenergic agents|mesh-ancestor
111139346|NCT05769530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111139347|NCT05769530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111139348|NCT05769530|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111139349|NCT05769530|Narcotics|narcotics|mesh-ancestor
111139350|NCT05740618|Mannitol|mannitol|mesh-list
111139351|NCT05740618|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
111139352|NCT05740618|Diuretics|diuretics|mesh-ancestor
111139353|NCT05740618|Natriuretic Agents|natriuretic agents|mesh-ancestor
111139354|NCT05740618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111139355|NCT05705505|Letrozole|letrozole|mesh-list
111139356|NCT05705505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111139357|NCT05705505|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111139358|NCT05705505|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111139359|NCT05705505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111139360|NCT05705505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111139361|NCT05705505|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111139362|NCT05705505|Hormone Antagonists|hormone antagonists|mesh-ancestor
111139363|NCT05705505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111139364|NCT05705505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111139365|NCT05677295|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
111139366|NCT05677295|Imipramine|imipramine|mesh-list
111139367|NCT05677295|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111139368|NCT05677295|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111139369|NCT05677295|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111139370|NCT05677295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111139371|NCT05677295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111139372|NCT05677295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111139373|NCT05677295|Analgesics|analgesics|mesh-ancestor
111139374|NCT05677295|Sensory System Agents|sensory system agents|mesh-ancestor
111139375|NCT05677295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111139376|NCT05677295|Antidepressive Agents|antidepressive agents|mesh-ancestor
111139377|NCT05677295|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111139378|NCT05677295|Dopamine Agents|dopamine agents|mesh-ancestor
111139379|NCT05677295|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
111139380|NCT05677295|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
111139381|NCT05677295|Adrenergic Agents|adrenergic agents|mesh-ancestor
111139382|NCT05664750|Immunoglobulins|immunoglobulins|mesh-list
111139383|NCT05664750|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111139384|NCT05664750|Antibodies|antibodies|mesh-list
111139385|NCT05664750|Immunologic Factors|immunologic factors|mesh-ancestor
111139386|NCT05664750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111139387|NCT05580523|Aspirin|aspirin|mesh-list
111139388|NCT05580523|Metformin|metformin|mesh-list
111139389|NCT05580523|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111139390|NCT05580523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111139391|NCT05580523|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111139392|NCT05580523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111139393|NCT05580523|Analgesics|analgesics|mesh-ancestor
111139394|NCT05580523|Sensory System Agents|sensory system agents|mesh-ancestor
111139395|NCT05580523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111139396|NCT05580523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111139397|NCT05580523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111139398|NCT05580523|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111139399|NCT05580523|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110856416|NCT03760445|Cytarabine|cytarabine|mesh-list
111139400|NCT05580523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111139401|NCT05580523|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111139402|NCT05580523|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111139403|NCT05580523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111139404|NCT05580523|Antipyretics|antipyretics|mesh-ancestor
111139405|NCT05476991|Aspirin|aspirin|mesh-list
111139406|NCT05476991|Colchicine|colchicine|mesh-list
111139407|NCT05476991|Ticagrelor|ticagrelor|mesh-list
111139408|NCT05476991|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111139409|NCT05476991|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111139410|NCT05476991|Analgesics|analgesics|mesh-ancestor
111139411|NCT05476991|Sensory System Agents|sensory system agents|mesh-ancestor
111139412|NCT05476991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110838958|NCT01567657|Midazolam|midazolam|mesh-list
111139413|NCT05476991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111139414|NCT05476991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111139415|NCT05476991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111139416|NCT05476991|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111139417|NCT05476991|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111139418|NCT05476991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111139419|NCT05476991|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111139420|NCT05476991|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111139421|NCT05476991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111139422|NCT05476991|Antipyretics|antipyretics|mesh-ancestor
111139423|NCT05476991|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111139424|NCT05476991|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111139425|NCT05476991|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111139426|NCT05476991|Purinergic Agents|purinergic agents|mesh-ancestor
111139427|NCT05476991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111139428|NCT05476991|Gout Suppressants|gout suppressants|mesh-ancestor
111139429|NCT05476991|Tubulin Modulators|tubulin modulators|mesh-ancestor
111139430|NCT05476991|Antimitotic Agents|antimitotic agents|mesh-ancestor
111139431|NCT05476991|Mitosis Modulators|mitosis modulators|mesh-ancestor
111139432|NCT05476991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111139433|NCT05465226|Analgesics, Opioid|analgesics, opioid|mesh-list
111139434|NCT05465226|Narcotics|narcotics|mesh-ancestor
111139435|NCT05465226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111139436|NCT05465226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111139437|NCT05465226|Analgesics|analgesics|mesh-ancestor
111139438|NCT05465226|Sensory System Agents|sensory system agents|mesh-ancestor
111139439|NCT05465226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111139440|NCT05463393|Xanthohumol|xanthohumol|mesh-list
111139441|NCT05463393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111139442|NCT05463393|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111139443|NCT05463393|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111139444|NCT05463393|Growth Substances|growth substances|mesh-ancestor
111139445|NCT05463393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111139446|NCT05463393|Growth Inhibitors|growth inhibitors|mesh-ancestor
111139447|NCT05419050|Denosumab|denosumab|mesh-list
111139448|NCT05419050|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111139449|NCT05419050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111139450|NCT05382806|Flumazenil|flumazenil|mesh-list
111139451|NCT05382806|Antidotes|antidotes|mesh-ancestor
111139452|NCT05382806|Protective Agents|protective agents|mesh-ancestor
111139453|NCT05382806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111139454|NCT05382806|GABA Modulators|gaba modulators|mesh-ancestor
111139455|NCT05382806|GABA Agents|gaba agents|mesh-ancestor
111139456|NCT05382806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111139457|NCT05382806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111139458|NCT05379972|Pembrolizumab|pembrolizumab|mesh-list
111139459|NCT05379972|Olaparib|olaparib|mesh-list
111139460|NCT05379972|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111139461|NCT05379972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111139462|NCT05379972|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111139463|NCT05379972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111139464|NCT05379972|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111139465|NCT05379972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111139466|NCT05312008|Oxytocin|oxytocin|mesh-list
111139467|NCT05312008|Oxytocics|oxytocics|mesh-ancestor
111139468|NCT05312008|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111139469|NCT05312008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111139470|NCT05265546|Psilocybin|psilocybin|mesh-list
111139471|NCT05265546|Hallucinogens|hallucinogens|mesh-ancestor
111139472|NCT05265546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111139473|NCT05265546|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111139474|NCT05238883|Tislelizumab|tislelizumab|mesh-list
111139475|NCT05238883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111139476|NCT05238883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111139478|NCT05163496|Hallucinogens|hallucinogens|mesh-ancestor
111139479|NCT05163496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111139480|NCT05163496|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111139481|NCT05162443|Adagrasib|adagrasib|mesh-list
111139482|NCT05162443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111139483|NCT05107960|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
111139484|NCT05107960|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
111139485|NCT05107960|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
111139486|NCT05107960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111139487|NCT04952402|Vaccines|vaccines|mesh-list
111139488|NCT04952402|Immunologic Factors|immunologic factors|mesh-ancestor
111139489|NCT04952402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111139490|NCT04941144|Vaccines|vaccines|mesh-list
111139491|NCT04941144|Immunologic Factors|immunologic factors|mesh-ancestor
111139492|NCT04941144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111139493|NCT04842045|Midazolam|midazolam|mesh-list
111139494|NCT04842045|Psilocybin|psilocybin|mesh-list
111139495|NCT04842045|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111139496|NCT04842045|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111139497|NCT04842045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111139498|NCT04842045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111139499|NCT04842045|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111139500|NCT04842045|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111139501|NCT04842045|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111139502|NCT04842045|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111139503|NCT04842045|Anesthetics, General|anesthetics, general|mesh-ancestor
111139504|NCT04842045|Anesthetics|anesthetics|mesh-ancestor
111139505|NCT04842045|GABA Modulators|gaba modulators|mesh-ancestor
111139506|NCT04842045|GABA Agents|gaba agents|mesh-ancestor
111139507|NCT04842045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111139508|NCT04842045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111139509|NCT04842045|Hallucinogens|hallucinogens|mesh-ancestor
111139510|NCT04754945|Dexamethasone|dexamethasone|mesh-list
111139511|NCT04754945|Dexamethasone acetate|dexamethasone acetate|mesh-list
111139512|NCT04754945|Cyclophosphamide|cyclophosphamide|mesh-list
111139513|NCT04754945|Bortezomib|bortezomib|mesh-list
111139514|NCT04754945|Ichthammol|ichthammol|mesh-list
111139515|NCT04754945|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111139516|NCT04754945|BB 1101|bb 1101|mesh-list
111139517|NCT04754945|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111139518|NCT04754945|Immunologic Factors|immunologic factors|mesh-ancestor
111139519|NCT04754945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111139520|NCT04754945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111139521|NCT04754945|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111139522|NCT04754945|Alkylating Agents|alkylating agents|mesh-ancestor
111139523|NCT04754945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111139524|NCT04754945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111139525|NCT04754945|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111139526|NCT04754945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111139527|NCT04754945|Antiemetics|antiemetics|mesh-ancestor
111139528|NCT04754945|Autonomic Agents|autonomic agents|mesh-ancestor
111139529|NCT04754945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111139530|NCT04754945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111139531|NCT04754945|Glucocorticoids|glucocorticoids|mesh-ancestor
111139532|NCT04754945|Hormones|hormones|mesh-ancestor
111139533|NCT04754945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111139534|NCT04754945|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111139535|NCT04754945|Protease Inhibitors|protease inhibitors|mesh-ancestor
111139536|NCT04754945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111139537|NCT04754945|Dermatologic Agents|dermatologic agents|mesh-ancestor
111139538|NCT04640779|Salicylates|salicylates|mesh-list
111139539|NCT04640779|Choline|choline|mesh-list
111139540|NCT04640779|Lipotropic Agents|lipotropic agents|mesh-ancestor
111139541|NCT04640779|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111139542|NCT04640779|Antimetabolites|antimetabolites|mesh-ancestor
111139543|NCT04640779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111139544|NCT04640779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111139545|NCT04640779|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111139546|NCT04640779|Nootropic Agents|nootropic agents|mesh-ancestor
111139547|NCT04640779|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111139548|NCT04640779|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111139549|NCT04640779|Analgesics|analgesics|mesh-ancestor
111139550|NCT04640779|Sensory System Agents|sensory system agents|mesh-ancestor
111139551|NCT04640779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111139552|NCT04640779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111139554|NCT04640779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111139555|NCT04640779|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111139556|NCT04640779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111139557|NCT04582669|Triamcinolone|triamcinolone|mesh-list
111139558|NCT04582669|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
111139559|NCT04582669|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
111139560|NCT04582669|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
111139561|NCT04582669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111139562|NCT04582669|Glucocorticoids|glucocorticoids|mesh-ancestor
111139564|NCT04582669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111139565|NCT04582669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111139566|NCT04582669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111139567|NCT04582669|Immunologic Factors|immunologic factors|mesh-ancestor
111139568|NCT04582669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111139569|NCT04582669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111139570|NCT04580498|Paclitaxel|paclitaxel|mesh-list
111139571|NCT04580498|Carboplatin|carboplatin|mesh-list
111139572|NCT04580498|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111139573|NCT04580498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111139574|NCT04580498|Tubulin Modulators|tubulin modulators|mesh-ancestor
111139575|NCT04580498|Antimitotic Agents|antimitotic agents|mesh-ancestor
111139576|NCT04580498|Mitosis Modulators|mitosis modulators|mesh-ancestor
111139577|NCT04580498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111139578|NCT04483414|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
111139579|NCT04483414|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111139580|NCT04483414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111139581|NCT04428385|Artemisinins|artemisinins|mesh-list
111139582|NCT04428385|Artemisinin|artemisinin|mesh-list
111139583|NCT04428385|Antimalarials|antimalarials|mesh-ancestor
111139584|NCT04428385|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111139585|NCT04428385|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111139586|NCT04428385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111139587|NCT04074161|Liraglutide|liraglutide|mesh-list
111139588|NCT04074161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111139589|NCT04074161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111139590|NCT04074161|Incretins|incretins|mesh-ancestor
111139591|NCT04074161|Hormones|hormones|mesh-ancestor
111139592|NCT04074161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111139593|NCT04046575|Paclitaxel|paclitaxel|mesh-list
111139594|NCT04046575|Carboplatin|carboplatin|mesh-list
111139595|NCT04046575|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111139596|NCT04046575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111139597|NCT04046575|Tubulin Modulators|tubulin modulators|mesh-ancestor
111139598|NCT04046575|Antimitotic Agents|antimitotic agents|mesh-ancestor
111139599|NCT04046575|Mitosis Modulators|mitosis modulators|mesh-ancestor
111139600|NCT04046575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111139601|NCT03997903|Imatinib Mesylate|imatinib mesylate|mesh-list
111139602|NCT03997903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111139603|NCT03997903|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111139604|NCT03997903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111139605|NCT03997903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111139606|NCT03982212|Glatiramer Acetate|glatiramer acetate|mesh-list
111139607|NCT03982212|(T,G)-A-L|(t,g)-a-l|mesh-list
111139608|NCT03982212|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111139609|NCT03982212|Immunologic Factors|immunologic factors|mesh-ancestor
111139610|NCT03982212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111139611|NCT03982212|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111139612|NCT03982212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111139613|NCT03913559|Acetaminophen|acetaminophen|mesh-list
111139614|NCT03913559|Diphenhydramine|diphenhydramine|mesh-list
111139615|NCT03913559|Promethazine|promethazine|mesh-list
111139616|NCT03913559|Cytarabine|cytarabine|mesh-list
111139617|NCT03913559|Methylprednisolone|methylprednisolone|mesh-list
111139618|NCT03913559|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111139619|NCT03913559|Hydrocortisone|hydrocortisone|mesh-list
111139620|NCT03913559|Methotrexate|methotrexate|mesh-list
111139621|NCT03913559|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
111139622|NCT03913559|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
111139623|NCT03913559|Abortifacient Agents|abortifacient agents|mesh-ancestor
111139624|NCT03913559|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111139625|NCT03913559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111139626|NCT03913559|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111139627|NCT03913559|Antimetabolites|antimetabolites|mesh-ancestor
110856640|NCT05199818|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111139628|NCT03913559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111139629|NCT03913559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111139630|NCT03913559|Dermatologic Agents|dermatologic agents|mesh-ancestor
111139631|NCT03913559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111139632|NCT03913559|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111139633|NCT03913559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111139634|NCT03913559|Immunologic Factors|immunologic factors|mesh-ancestor
111139635|NCT03913559|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111139636|NCT03913559|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111139638|NCT03913559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111139639|NCT03913559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111139640|NCT03913559|Analgesics|analgesics|mesh-ancestor
111139641|NCT03913559|Sensory System Agents|sensory system agents|mesh-ancestor
111139642|NCT03913559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111139643|NCT03913559|Antipyretics|antipyretics|mesh-ancestor
111139644|NCT03913559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111139645|NCT03913559|Antiemetics|antiemetics|mesh-ancestor
111139646|NCT03913559|Autonomic Agents|autonomic agents|mesh-ancestor
111139647|NCT03913559|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111139648|NCT03913559|Glucocorticoids|glucocorticoids|mesh-ancestor
111139649|NCT03913559|Hormones|hormones|mesh-ancestor
111139650|NCT03913559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111139651|NCT03913559|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111139652|NCT03913559|Protective Agents|protective agents|mesh-ancestor
111139653|NCT03913559|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111139654|NCT03913559|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
111139655|NCT03913559|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111139656|NCT03913559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111139657|NCT03913559|Anesthetics, Local|anesthetics, local|mesh-ancestor
111139658|NCT03913559|Anesthetics|anesthetics|mesh-ancestor
111139659|NCT03913559|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
111139660|NCT03913559|Histamine Antagonists|histamine antagonists|mesh-ancestor
111139661|NCT03913559|Histamine Agents|histamine agents|mesh-ancestor
111139662|NCT03913559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111139663|NCT03913559|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111139664|NCT03913559|Antipruritics|antipruritics|mesh-ancestor
111139665|NCT03913559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111139666|NCT03913559|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111139667|NCT03913559|Immunotoxins|immunotoxins|mesh-ancestor
111139668|NCT03913559|Immunoconjugates|immunoconjugates|mesh-ancestor
111139669|NCT03843528|Azacitidine|azacitidine|mesh-list
111139670|NCT03843528|Vorinostat|vorinostat|mesh-list
111139671|NCT03843528|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111139672|NCT03843528|Antimetabolites|antimetabolites|mesh-ancestor
111139673|NCT03843528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111139674|NCT03843528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111139675|NCT03843528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111139676|NCT03843528|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
111139677|NCT03779789|Vortioxetine|vortioxetine|mesh-list
111139678|NCT03779789|Fluvoxamine|fluvoxamine|mesh-list
111139679|NCT03779789|Citalopram|citalopram|mesh-list
111139680|NCT03779789|Fluoxetine|fluoxetine|mesh-list
111139681|NCT03779789|Paroxetine|paroxetine|mesh-list
111139682|NCT03779789|Sertraline|sertraline|mesh-list
111139683|NCT03779789|Escitalopram|escitalopram|mesh-list
111139684|NCT03779789|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111139685|NCT03779789|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111139686|NCT03779789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111139687|NCT03779789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111139688|NCT03779789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111139689|NCT03779789|Serotonin Agents|serotonin agents|mesh-ancestor
111139690|NCT03779789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111139691|NCT03779789|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111139692|NCT03779789|Antidepressive Agents|antidepressive agents|mesh-ancestor
111139693|NCT03779789|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111139694|NCT03779789|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111139695|NCT03779789|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111139696|NCT03779789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111139697|NCT03779789|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111139698|NCT03779789|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111139699|NCT03779789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111139700|NCT03779789|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111139701|NCT03779789|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111139702|NCT03779789|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
111139703|NCT03779789|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111139704|NCT03779789|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
111139705|NCT03779789|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
111139706|NCT03733210|Panitumumab|panitumumab|mesh-list
111139707|NCT03733210|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111139708|NCT03733210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111139710|NCT03733132|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111139711|NCT03733132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111139712|NCT03667820|Osimertinib|osimertinib|mesh-list
111139713|NCT03667820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111139714|NCT03667820|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111139715|NCT03667820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111139716|NCT03667820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111139717|NCT03654053|Simvastatin|simvastatin|mesh-list
111139718|NCT03654053|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
111139719|NCT03654053|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
111139720|NCT03654053|Antimetabolites|antimetabolites|mesh-ancestor
111139721|NCT03654053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111139722|NCT03654053|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
111139723|NCT03654053|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
111139724|NCT03654053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111139725|NCT03627468|Bromides|bromides|mesh-list
111139726|NCT03627468|Anticonvulsants|anticonvulsants|mesh-ancestor
111139727|NCT03614949|Atezolizumab|atezolizumab|mesh-list
111139728|NCT03614949|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111139729|NCT03614949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111139730|NCT03614949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111139731|NCT03614949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111139732|NCT03613116|Vitamin D|vitamin d|mesh-list
111139733|NCT03613116|Cholecalciferol|cholecalciferol|mesh-list
111139734|NCT03613116|Vitamins|vitamins|mesh-ancestor
111139735|NCT03613116|Micronutrients|micronutrients|mesh-ancestor
111139736|NCT03613116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111139737|NCT03613116|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111139738|NCT03613116|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111139739|NCT03588039|Paclitaxel|paclitaxel|mesh-list
111139740|NCT03588039|Pembrolizumab|pembrolizumab|mesh-list
111139741|NCT03588039|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111139742|NCT03588039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111139743|NCT03588039|Tubulin Modulators|tubulin modulators|mesh-ancestor
111139744|NCT03588039|Antimitotic Agents|antimitotic agents|mesh-ancestor
111139745|NCT03588039|Mitosis Modulators|mitosis modulators|mesh-ancestor
110590770|NCT00718640|Autonomic Agents|autonomic agents|mesh-ancestor
111139746|NCT03588039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111139747|NCT03588039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111139748|NCT03588039|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111139749|NCT03553004|Niraparib|niraparib|mesh-list
111139750|NCT03553004|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111139751|NCT03553004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111139752|NCT03553004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111139753|NCT03553004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111139754|NCT03516617|Obinutuzumab|obinutuzumab|mesh-list
111139755|NCT03516617|Acalabrutinib|acalabrutinib|mesh-list
111139756|NCT03516617|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
111139757|NCT03516617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111139758|NCT03516617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111139759|NCT03516617|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111139760|NCT03516617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111139761|NCT03516617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111139762|NCT03488667|Pembrolizumab|pembrolizumab|mesh-list
111139763|NCT03488667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111139764|NCT03488667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111139765|NCT03488667|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111139766|NCT03488667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111139767|NCT03406247|Nivolumab|nivolumab|mesh-list
111139768|NCT03406247|Ipilimumab|ipilimumab|mesh-list
111139769|NCT03406247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111139770|NCT03406247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111139771|NCT03406247|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111139772|NCT03406247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111139773|NCT03399175|Immunosuppressive Agents|immunosuppressive agents|mesh-list
111139774|NCT03399175|Immunologic Factors|immunologic factors|mesh-ancestor
110856795|NCT02470780|Rifaximin|rifaximin|mesh-list
111139775|NCT03399175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111139776|NCT03317535|Anesthetics|anesthetics|mesh-list
111139777|NCT03317535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111139778|NCT03317535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111139779|NCT03313206|Pembrolizumab|pembrolizumab|mesh-list
111139780|NCT03313206|Lenvatinib|lenvatinib|mesh-list
111139781|NCT03313206|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111139782|NCT03313206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110839007|NCT02061293|Promethazine|promethazine|mesh-list
111139784|NCT03313206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111139785|NCT03313206|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111139786|NCT03313206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111139787|NCT03250377|Brivaracetam|brivaracetam|mesh-list
111139788|NCT03250377|Anticonvulsants|anticonvulsants|mesh-ancestor
111139789|NCT03066648|Azacitidine|azacitidine|mesh-list
111139790|NCT03066648|Decitabine|decitabine|mesh-list
111139791|NCT03066648|Spartalizumab|spartalizumab|mesh-list
111139792|NCT03066648|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111139793|NCT03066648|Antimetabolites|antimetabolites|mesh-ancestor
111139794|NCT03066648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111139795|NCT03066648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111139796|NCT03066648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111139797|NCT03066648|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111139798|NCT03066648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111139799|NCT03052816|Hydromorphone|hydromorphone|mesh-list
111139800|NCT03052816|Analgesics|analgesics|mesh-ancestor
111139801|NCT03052816|Sensory System Agents|sensory system agents|mesh-ancestor
110590781|NCT00753051|Clozapine|clozapine|mesh-list
111139802|NCT03052816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111139803|NCT03052816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111139804|NCT03052816|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
111139805|NCT03052816|Narcotics|narcotics|mesh-ancestor
111139806|NCT03052816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111139807|NCT03005145|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111139808|NCT03005145|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
111139809|NCT03005145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111139810|NCT03005145|Antitubercular Agents|antitubercular agents|mesh-ancestor
111139811|NCT02955940|Capecitabine|capecitabine|mesh-list
111139812|NCT02955940|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111139813|NCT02955940|Antimetabolites|antimetabolites|mesh-ancestor
111139814|NCT02955940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111139815|NCT02955940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111139816|NCT02883062|Paclitaxel|paclitaxel|mesh-list
111139817|NCT02883062|Carboplatin|carboplatin|mesh-list
111139818|NCT02883062|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
111139819|NCT02883062|Atezolizumab|atezolizumab|mesh-list
111139820|NCT02883062|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111139821|NCT02883062|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111139822|NCT02883062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111139823|NCT02883062|Tubulin Modulators|tubulin modulators|mesh-ancestor
111139824|NCT02883062|Antimitotic Agents|antimitotic agents|mesh-ancestor
111139825|NCT02883062|Mitosis Modulators|mitosis modulators|mesh-ancestor
111139826|NCT02883062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111139827|NCT02883062|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111139828|NCT02883062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111139829|NCT02883062|Immunologic Factors|immunologic factors|mesh-ancestor
111139830|NCT02883062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111139831|NCT02721732|Pembrolizumab|pembrolizumab|mesh-list
111139832|NCT02721732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111139833|NCT02721732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111139834|NCT02721732|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110839042|NCT03415906|Valsartan|valsartan|mesh-list
111139835|NCT02721732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111139836|NCT02684058|Carboplatin|carboplatin|mesh-list
111139837|NCT02684058|Vincristine|vincristine|mesh-list
111139838|NCT02684058|Trametinib|trametinib|mesh-list
111139839|NCT02684058|Dabrafenib|dabrafenib|mesh-list
111139840|NCT02684058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111139841|NCT02684058|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111139842|NCT02684058|Tubulin Modulators|tubulin modulators|mesh-ancestor
111139843|NCT02684058|Antimitotic Agents|antimitotic agents|mesh-ancestor
111139844|NCT02684058|Mitosis Modulators|mitosis modulators|mesh-ancestor
111139845|NCT02684058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111139846|NCT02684058|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111139847|NCT02684058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111139848|NCT02393625|Nivolumab|nivolumab|mesh-list
110856865|NCT02470702|Oritavancin|oritavancin|mesh-list
111139849|NCT02393625|Ceritinib|ceritinib|mesh-list
111139850|NCT02393625|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111139851|NCT02393625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111139852|NCT02393625|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111139853|NCT02393625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111139854|NCT02393625|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111139855|NCT02393625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111139856|NCT02294032|Immunosuppressive Agents|immunosuppressive agents|mesh-list
111139857|NCT02294032|Immunologic Factors|immunologic factors|mesh-ancestor
111139858|NCT02294032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111139860|NCT02168829|Rivaroxaban|rivaroxaban|mesh-list
111139861|NCT02168829|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111139862|NCT02168829|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111139863|NCT02168829|Analgesics|analgesics|mesh-ancestor
111139864|NCT02168829|Sensory System Agents|sensory system agents|mesh-ancestor
111139865|NCT02168829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111139866|NCT02168829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111139867|NCT02168829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111139868|NCT02168829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111139869|NCT02168829|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111139870|NCT02168829|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111139871|NCT02168829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111139872|NCT02168829|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111139873|NCT02168829|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111139874|NCT02168829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111139875|NCT02168829|Antipyretics|antipyretics|mesh-ancestor
111139876|NCT02168829|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111139877|NCT02168829|Antithrombins|antithrombins|mesh-ancestor
111139878|NCT02168829|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111139879|NCT02168829|Protease Inhibitors|protease inhibitors|mesh-ancestor
111139880|NCT02168829|Anticoagulants|anticoagulants|mesh-ancestor
111139881|NCT01433289|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
111139882|NCT01433289|Antioxidants|antioxidants|mesh-ancestor
111139883|NCT01433289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111139884|NCT01433289|Protective Agents|protective agents|mesh-ancestor
111139885|NCT01433289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111139886|NCT01433289|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
111139887|NCT01433289|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
111139888|NCT01433289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111139889|NCT01433289|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111139891|NCT00995475|Xhance|xhance|mesh-list
111139892|NCT00995475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111139893|NCT00995475|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111139894|NCT00995475|Autonomic Agents|autonomic agents|mesh-ancestor
111139895|NCT00995475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111139896|NCT00995475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111139897|NCT00995475|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111139898|NCT00995475|Respiratory System Agents|respiratory system agents|mesh-ancestor
111139899|NCT00995475|Dermatologic Agents|dermatologic agents|mesh-ancestor
111139900|NCT00995475|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
111139901|NCT00945529|Nitric Oxide|nitric oxide|mesh-list
111139902|NCT00945529|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111139903|NCT00945529|Autonomic Agents|autonomic agents|mesh-ancestor
111139904|NCT00945529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111139905|NCT00945529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111139906|NCT00945529|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111139907|NCT00945529|Respiratory System Agents|respiratory system agents|mesh-ancestor
111139908|NCT00945529|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111139909|NCT00945529|Antioxidants|antioxidants|mesh-ancestor
111139910|NCT00945529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111139911|NCT00945529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111139912|NCT00945529|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
111139913|NCT00945529|Vasodilator Agents|vasodilator agents|mesh-ancestor
111139914|NCT00945529|Gasotransmitters|gasotransmitters|mesh-ancestor
111139915|NCT00945529|Protective Agents|protective agents|mesh-ancestor
111139916|NCT00921115|Fulvestrant|fulvestrant|mesh-list
111139917|NCT00921115|Anastrozole|anastrozole|mesh-list
111139918|NCT00921115|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111139919|NCT00921115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111139920|NCT00921115|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
111139921|NCT00921115|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111139922|NCT00921115|Hormone Antagonists|hormone antagonists|mesh-ancestor
111139923|NCT00921115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111139924|NCT00921115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111139925|NCT00921115|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111139926|NCT00921115|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111139927|NCT00921115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111139928|NCT00921115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111139929|NCT00130351|Formoterol Fumarate|formoterol fumarate|mesh-list
111139930|NCT00130351|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111139931|NCT00130351|Autonomic Agents|autonomic agents|mesh-ancestor
111139932|NCT00130351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111139933|NCT00130351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111139934|NCT00130351|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111139935|NCT00130351|Respiratory System Agents|respiratory system agents|mesh-ancestor
110839091|NCT03916679|Fludarabine|fludarabine|mesh-list
111139936|NCT00130351|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111139937|NCT00130351|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111139938|NCT00130351|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111139939|NCT00130351|Adrenergic Agents|adrenergic agents|mesh-ancestor
111139940|NCT00130351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111139941|NCT00130351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111139942|NCT04028401|Benzoyl Peroxide|benzoyl peroxide|mesh-list
111139943|NCT04028401|Dermatologic Agents|dermatologic agents|mesh-ancestor
111139944|NCT04425187|Bevacizumab|bevacizumab|mesh-list
111139946|NCT04425187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111139947|NCT04425187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111139948|NCT04425187|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111139949|NCT04425187|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111139950|NCT04425187|Growth Substances|growth substances|mesh-ancestor
111139951|NCT04425187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111139952|NCT04425187|Growth Inhibitors|growth inhibitors|mesh-ancestor
111139953|NCT04425187|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111139954|NCT04425187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111139955|NCT04425187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111139956|NCT05519839|Vaccines|vaccines|mesh-list
111139957|NCT05519839|Immunologic Factors|immunologic factors|mesh-ancestor
111139958|NCT05519839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111139959|NCT05529667|Paclitaxel|paclitaxel|mesh-list
111139960|NCT05529667|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111139961|NCT05529667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111139962|NCT05529667|Tubulin Modulators|tubulin modulators|mesh-ancestor
111139963|NCT05529667|Antimitotic Agents|antimitotic agents|mesh-ancestor
111139964|NCT05529667|Mitosis Modulators|mitosis modulators|mesh-ancestor
111139965|NCT05529667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111139966|NCT03571633|Paclitaxel|paclitaxel|mesh-list
111139967|NCT03571633|Trastuzumab|trastuzumab|mesh-list
111139968|NCT03571633|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111139969|NCT03571633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111139970|NCT03571633|Tubulin Modulators|tubulin modulators|mesh-ancestor
111139971|NCT03571633|Antimitotic Agents|antimitotic agents|mesh-ancestor
111139972|NCT03571633|Mitosis Modulators|mitosis modulators|mesh-ancestor
111139973|NCT03571633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111139974|NCT03571633|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111139975|NCT03519685|Contraceptive Agents|contraceptive agents|mesh-list
111139976|NCT03519685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111139977|NCT03519685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111139978|NCT05533255|Z 350|z 350|mesh-list
111139979|NCT05533255|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
111139980|NCT05533255|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111139981|NCT05533255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111139982|NCT05533255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111139983|NCT05533255|Hormone Antagonists|hormone antagonists|mesh-ancestor
111139984|NCT05533255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111139985|NCT05533255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111139986|NCT05529355|Tegafur|tegafur|mesh-list
111139987|NCT05529355|Endostar protein|endostar protein|mesh-list
111139988|NCT05529355|Endostatins|endostatins|mesh-list
111139989|NCT05529355|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111139990|NCT05529355|Antimetabolites|antimetabolites|mesh-ancestor
111139991|NCT05529355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111139992|NCT05529355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111139993|NCT05529355|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111139994|NCT05529355|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111139995|NCT05529355|Growth Substances|growth substances|mesh-ancestor
111139996|NCT05529355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111139997|NCT05529355|Growth Inhibitors|growth inhibitors|mesh-ancestor
111139998|NCT05528887|Cyclophosphamide|cyclophosphamide|mesh-list
111139999|NCT05528887|Fludarabine|fludarabine|mesh-list
111140000|NCT05528887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111140001|NCT05528887|Immunologic Factors|immunologic factors|mesh-ancestor
111140002|NCT05528887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111140003|NCT05528887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111140004|NCT05528887|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111140005|NCT05528887|Alkylating Agents|alkylating agents|mesh-ancestor
111140006|NCT05528887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111140007|NCT05528887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111140008|NCT05528887|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111140009|NCT05501821|Pembrolizumab|pembrolizumab|mesh-list
111140010|NCT05501821|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111140011|NCT05501821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111140012|NCT05501821|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111140013|NCT05501821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111140014|NCT05528653|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
111140015|NCT05528653|Antiviral Agents|antiviral agents|mesh-ancestor
111140016|NCT05528653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111140017|NCT05528653|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
111140018|NCT05528653|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111140019|NCT05528653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111140020|NCT05528653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111140021|NCT05528653|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111140022|NCT05528653|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
111140023|NCT03009019|Celecoxib|celecoxib|mesh-list
111140024|NCT03009019|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111140025|NCT03009019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111140026|NCT03009019|Analgesics|analgesics|mesh-ancestor
111140027|NCT03009019|Sensory System Agents|sensory system agents|mesh-ancestor
111140028|NCT03009019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111140029|NCT03009019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111140030|NCT03009019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111140031|NCT03009019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111140032|NCT03009019|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
111140033|NCT03009019|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111140034|NCT03009019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111140035|NCT03009019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111140036|NCT02575807|Pembrolizumab|pembrolizumab|mesh-list
111140037|NCT02575807|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111140038|NCT02575807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111140039|NCT02575807|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111140040|NCT02575807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111140041|NCT02813785|Docetaxel|docetaxel|mesh-list
111140042|NCT02813785|Atezolizumab|atezolizumab|mesh-list
111140043|NCT02813785|Antibodies|antibodies|mesh-list
111140044|NCT02813785|Immunologic Factors|immunologic factors|mesh-ancestor
111140045|NCT02813785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111140046|NCT02813785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111140047|NCT02813785|Tubulin Modulators|tubulin modulators|mesh-ancestor
111140048|NCT02813785|Antimitotic Agents|antimitotic agents|mesh-ancestor
111140049|NCT02813785|Mitosis Modulators|mitosis modulators|mesh-ancestor
111140050|NCT02813785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111140051|NCT02813785|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111140052|NCT02813785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111140053|NCT04302181|Ropivacaine|ropivacaine|mesh-list
111140054|NCT04302181|Anesthetics, Local|anesthetics, local|mesh-ancestor
111140055|NCT04302181|Anesthetics|anesthetics|mesh-ancestor
111140056|NCT04302181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110590884|NCT00790205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111140057|NCT04302181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111140058|NCT04302181|Sensory System Agents|sensory system agents|mesh-ancestor
111140059|NCT04302181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111140060|NCT02644369|Pembrolizumab|pembrolizumab|mesh-list
111140061|NCT02644369|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111140062|NCT02644369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111140063|NCT02644369|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111140064|NCT02644369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111140065|NCT05527795|Oxymetazoline|oxymetazoline|mesh-list
111140066|NCT05527795|Immunomodulating Agents|immunomodulating agents|mesh-list
111140067|NCT05527795|Immunologic Factors|immunologic factors|mesh-ancestor
111140068|NCT05527795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110857089|NCT04641312|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111140069|NCT05527795|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
111140070|NCT05527795|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111140071|NCT05527795|Adrenergic Agents|adrenergic agents|mesh-ancestor
111140072|NCT05527795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111140073|NCT05527795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111140074|NCT05527795|Sympathomimetics|sympathomimetics|mesh-ancestor
111140075|NCT05527795|Autonomic Agents|autonomic agents|mesh-ancestor
111140076|NCT05527795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111140077|NCT05527795|Nasal Decongestants|nasal decongestants|mesh-ancestor
111140078|NCT05527795|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111140079|NCT05527795|Respiratory System Agents|respiratory system agents|mesh-ancestor
111140080|NCT05532241|Chlorhexidine|chlorhexidine|mesh-list
111140081|NCT05532241|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111140082|NCT05532241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111140083|NCT05532241|Disinfectants|disinfectants|mesh-ancestor
111140084|NCT05532085|Analgesics|analgesics|mesh-list
111140085|NCT05532085|Anesthetics|anesthetics|mesh-list
111140086|NCT05532085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111140087|NCT05532085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111140088|NCT05532085|Sensory System Agents|sensory system agents|mesh-ancestor
111140089|NCT05532085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111140090|NCT02303119|Rituximab|rituximab|mesh-list
111140091|NCT02303119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111140092|NCT02303119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111140093|NCT02303119|Immunologic Factors|immunologic factors|mesh-ancestor
111140094|NCT02303119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111140095|NCT02303119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111140097|NCT02575339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111140098|NCT02575339|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111140099|NCT02575339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111140100|NCT02575339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111140101|NCT01640587|Artesunate|artesunate|mesh-list
111140102|NCT01640587|Piperaquine|piperaquine|mesh-list
111140103|NCT01640587|Artenimol|artenimol|mesh-list
111140104|NCT01640587|Mefloquine|mefloquine|mesh-list
111140105|NCT01640587|Antimalarials|antimalarials|mesh-ancestor
111140106|NCT01640587|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111140107|NCT01640587|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111140108|NCT01640587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111140109|NCT01640587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111140110|NCT01640587|Antiviral Agents|antiviral agents|mesh-ancestor
111140111|NCT01640587|Schistosomicides|schistosomicides|mesh-ancestor
111140112|NCT01640587|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
111140113|NCT01640587|Anthelmintics|anthelmintics|mesh-ancestor
111140114|NCT01610713|Nabiximols|nabiximols|mesh-list
111140115|NCT01610713|Analgesics|analgesics|mesh-ancestor
111140116|NCT01610713|Sensory System Agents|sensory system agents|mesh-ancestor
111140117|NCT01610713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111140118|NCT01610713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111140119|NCT01606189|Nabiximols|nabiximols|mesh-list
111140120|NCT01606189|Analgesics|analgesics|mesh-ancestor
111140121|NCT01606189|Sensory System Agents|sensory system agents|mesh-ancestor
111140122|NCT01606189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110590901|NCT00715208|Prednisone|prednisone|mesh-list
111140123|NCT01606189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111140124|NCT01663987|Bromides|bromides|mesh-list
111140125|NCT01663987|Tiotropium Bromide|tiotropium bromide|mesh-list
111140126|NCT01663987|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111140127|NCT01663987|Autonomic Agents|autonomic agents|mesh-ancestor
111140128|NCT01663987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111140129|NCT01663987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111140130|NCT01663987|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111140131|NCT01663987|Respiratory System Agents|respiratory system agents|mesh-ancestor
111140132|NCT01663987|Parasympatholytics|parasympatholytics|mesh-ancestor
111140133|NCT01663987|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111140134|NCT01663987|Cholinergic Agents|cholinergic agents|mesh-ancestor
111140135|NCT01663987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111140136|NCT01663987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111140137|NCT01663987|Anticonvulsants|anticonvulsants|mesh-ancestor
111140138|NCT05305651|Sotrovimab|sotrovimab|mesh-list
111140139|NCT05305651|Antiviral Agents|antiviral agents|mesh-ancestor
111140140|NCT05305651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111140141|NCT05526469|Bupivacaine|bupivacaine|mesh-list
111140142|NCT05526469|Anesthetics, Local|anesthetics, local|mesh-ancestor
111140143|NCT05526469|Anesthetics|anesthetics|mesh-ancestor
111140144|NCT05526469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111140145|NCT05526469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111140146|NCT05526469|Sensory System Agents|sensory system agents|mesh-ancestor
111140147|NCT05526469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111140149|NCT02380287|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111140150|NCT02380287|Immunologic Factors|immunologic factors|mesh-ancestor
111140151|NCT02380287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111140152|NCT02342223|Hyaluronic Acid|hyaluronic acid|mesh-list
111140153|NCT02342223|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111140154|NCT02342223|Immunologic Factors|immunologic factors|mesh-ancestor
111140155|NCT02342223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111140156|NCT02342223|Viscosupplements|viscosupplements|mesh-ancestor
111140157|NCT02342223|Protective Agents|protective agents|mesh-ancestor
111140158|NCT02393547|Varenicline|varenicline|mesh-list
111140159|NCT02393547|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
111140160|NCT02393547|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111140161|NCT02393547|Cholinergic Agents|cholinergic agents|mesh-ancestor
111140162|NCT02393547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111140163|NCT02393547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111140164|NCT02393547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111140165|NCT02574637|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111140166|NCT02574637|Immunologic Factors|immunologic factors|mesh-ancestor
111140167|NCT02574637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111140168|NCT05531383|Memantine|memantine|mesh-list
111140169|NCT05531383|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
111140170|NCT05531383|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
111140171|NCT05531383|Dopamine Agents|dopamine agents|mesh-ancestor
111140172|NCT05531383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111140173|NCT05531383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111140174|NCT05531383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111140175|NCT05531383|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
111140176|NCT05531383|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
111140177|NCT02392611|Fulvestrant|fulvestrant|mesh-list
111140178|NCT02392611|Exemestane|exemestane|mesh-list
111140179|NCT02392611|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111140180|NCT02392611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111140181|NCT02392611|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
111140182|NCT02392611|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111140183|NCT02392611|Hormone Antagonists|hormone antagonists|mesh-ancestor
111140184|NCT02392611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110590922|NCT00715208|Hormones|hormones|mesh-ancestor
111140185|NCT02392611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111140186|NCT02392611|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111140187|NCT02392611|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111140188|NCT02392611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111140189|NCT02392611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111140190|NCT02378961|Sofosbuvir|sofosbuvir|mesh-list
111140191|NCT02378961|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
111140192|NCT02378961|Velpatasvir|velpatasvir|mesh-list
111140193|NCT02378961|Antiviral Agents|antiviral agents|mesh-ancestor
111140194|NCT02378961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111140195|NCT05140525|Macitentan|macitentan|mesh-list
111140196|NCT05140525|Riociguat|riociguat|mesh-list
111140197|NCT05140525|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
111140198|NCT05140525|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
111140199|NCT05140525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111140200|NCT05140525|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
111140201|NCT05140525|Enzyme Activators|enzyme activators|mesh-ancestor
111140202|NCT05518513|Bupivacaine|bupivacaine|mesh-list
111140203|NCT05518513|Anesthetics, Local|anesthetics, local|mesh-ancestor
111140204|NCT05518513|Anesthetics|anesthetics|mesh-ancestor
111140205|NCT05518513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111140206|NCT05518513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111140207|NCT05518513|Sensory System Agents|sensory system agents|mesh-ancestor
111140208|NCT05518513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111140209|NCT05518279|Tranexamic Acid|tranexamic acid|mesh-list
111140210|NCT05518279|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111140211|NCT05518279|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111140212|NCT05518279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111140213|NCT05518279|Hemostatics|hemostatics|mesh-ancestor
111140215|NCT05523661|Dasatinib|dasatinib|mesh-list
111140216|NCT05523661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111140217|NCT05523661|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111140218|NCT05523661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111140219|NCT05523661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111140220|NCT05523037|Sevoflurane|sevoflurane|mesh-list
111140221|NCT05523037|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111140222|NCT05523037|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
111140223|NCT05523037|Anesthetics, General|anesthetics, general|mesh-ancestor
111140224|NCT05523037|Anesthetics|anesthetics|mesh-ancestor
111140225|NCT05523037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111140226|NCT05523037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111140227|NCT04625647|Sotorasib|sotorasib|mesh-list
111140228|NCT04625647|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111140229|NCT04625647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111140230|NCT04625647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111140231|NCT04625647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111140232|NCT05122741|Aspirin|aspirin|mesh-list
111140233|NCT05122741|Clopidogrel|clopidogrel|mesh-list
111140234|NCT05122741|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111140235|NCT05122741|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111140236|NCT05122741|Analgesics|analgesics|mesh-ancestor
111140237|NCT05122741|Sensory System Agents|sensory system agents|mesh-ancestor
111140238|NCT05122741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111140239|NCT05122741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111140240|NCT05122741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111140241|NCT05122741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111140242|NCT05122741|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111140243|NCT05122741|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111140244|NCT05122741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111140245|NCT05122741|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111140246|NCT05122741|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111140247|NCT05122741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111140248|NCT05122741|Antipyretics|antipyretics|mesh-ancestor
111140249|NCT05122741|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
111140250|NCT05122741|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
111140251|NCT05122741|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
111140252|NCT05122741|Purinergic Agents|purinergic agents|mesh-ancestor
111140253|NCT05122741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111140254|NCT05525767|Bevacizumab|bevacizumab|mesh-list
111140255|NCT05525767|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111140256|NCT05525767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111140257|NCT05525767|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111140258|NCT05525767|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111140259|NCT05525767|Growth Substances|growth substances|mesh-ancestor
111140260|NCT05525767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111140261|NCT05525767|Growth Inhibitors|growth inhibitors|mesh-ancestor
111140262|NCT05025085|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
111140263|NCT05025085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111140264|NCT05025085|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111140265|NCT05025085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111140266|NCT05522491|Olaparib|olaparib|mesh-list
111140267|NCT05522491|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
111140268|NCT05522491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111140269|NCT05522491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111140270|NCT05522491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111140271|NCT02340975|Durvalumab|durvalumab|mesh-list
111140272|NCT02340975|Tremelimumab|tremelimumab|mesh-list
111140273|NCT02340975|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111140274|NCT02340975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111140275|NCT02340975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111140276|NCT02340975|Immunologic Factors|immunologic factors|mesh-ancestor
111140277|NCT02340975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111140278|NCT02392377|Leucovorin|leucovorin|mesh-list
111140279|NCT02392377|Paclitaxel|paclitaxel|mesh-list
111140280|NCT02392377|Carboplatin|carboplatin|mesh-list
111140281|NCT02392377|Fluorouracil|fluorouracil|mesh-list
111140282|NCT02392377|Oxaliplatin|oxaliplatin|mesh-list
111140283|NCT02392377|Calcium|calcium|mesh-list
111140284|NCT02392377|Levoleucovorin|levoleucovorin|mesh-list
111140285|NCT02392377|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111140286|NCT02392377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111140287|NCT02392377|Tubulin Modulators|tubulin modulators|mesh-ancestor
111140288|NCT02392377|Antimitotic Agents|antimitotic agents|mesh-ancestor
111140289|NCT02392377|Mitosis Modulators|mitosis modulators|mesh-ancestor
111140290|NCT02392377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111140291|NCT02392377|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111140292|NCT02392377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111140293|NCT02392377|Antimetabolites|antimetabolites|mesh-ancestor
110676988|NCT03233724|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111140294|NCT02392377|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111140295|NCT02392377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111140296|NCT02392377|Immunologic Factors|immunologic factors|mesh-ancestor
111140297|NCT02392377|Antidotes|antidotes|mesh-ancestor
111140298|NCT02392377|Protective Agents|protective agents|mesh-ancestor
111140299|NCT02392377|Vitamin B Complex|vitamin b complex|mesh-ancestor
111140300|NCT02392377|Vitamins|vitamins|mesh-ancestor
111140301|NCT02392377|Micronutrients|micronutrients|mesh-ancestor
111140302|NCT02340819|Teduglutide|teduglutide|mesh-list
111140303|NCT02340819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111140304|NCT02340819|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111140305|NCT02340819|Protective Agents|protective agents|mesh-ancestor
111140306|NCT02340819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111140307|NCT04903899|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
111140308|NCT04903899|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111140309|NCT04903899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111140310|NCT04903509|Acetaminophen|acetaminophen|mesh-list
111140311|NCT04903509|Liraglutide|liraglutide|mesh-list
111140312|NCT04903509|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111140313|NCT04903509|Analgesics|analgesics|mesh-ancestor
111140314|NCT04903509|Sensory System Agents|sensory system agents|mesh-ancestor
111140315|NCT04903509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111140316|NCT04903509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111140317|NCT04903509|Antipyretics|antipyretics|mesh-ancestor
111140318|NCT04903509|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111140319|NCT04903509|Incretins|incretins|mesh-ancestor
111140320|NCT04903509|Hormones|hormones|mesh-ancestor
111140321|NCT04903509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111140322|NCT05517499|Dexamethasone|dexamethasone|mesh-list
111140323|NCT05517499|Dexamethasone acetate|dexamethasone acetate|mesh-list
111140324|NCT05517499|BB 1101|bb 1101|mesh-list
111140325|NCT05517499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111140326|NCT05517499|Antiemetics|antiemetics|mesh-ancestor
111140327|NCT05517499|Autonomic Agents|autonomic agents|mesh-ancestor
111140328|NCT05517499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111140329|NCT05517499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111140330|NCT05517499|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111140331|NCT05517499|Glucocorticoids|glucocorticoids|mesh-ancestor
111140332|NCT05517499|Hormones|hormones|mesh-ancestor
111140333|NCT05517499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111140334|NCT05517499|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111140335|NCT05517499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111140336|NCT05517499|Protease Inhibitors|protease inhibitors|mesh-ancestor
111140337|NCT05517499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111140338|NCT05517499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111140339|NCT05512351|Bevacizumab|bevacizumab|mesh-list
111140340|NCT05512351|Tislelizumab|tislelizumab|mesh-list
110839209|NCT01322191|Sensory System Agents|sensory system agents|mesh-ancestor
111140341|NCT05512351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111140342|NCT05512351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111140343|NCT05512351|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111140344|NCT05512351|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111140345|NCT05512351|Growth Substances|growth substances|mesh-ancestor
111140346|NCT05512351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111140347|NCT05512351|Growth Inhibitors|growth inhibitors|mesh-ancestor
111140348|NCT02569957|Acetylcysteine|acetylcysteine|mesh-list
111140349|NCT02569957|Topotecan|topotecan|mesh-list
111140350|NCT02569957|N-monoacetylcystine|n-monoacetylcystine|mesh-list
111140351|NCT02569957|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111140352|NCT02569957|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111140353|NCT02569957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111140354|NCT02569957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111140355|NCT02569957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111140356|NCT02569957|Antiviral Agents|antiviral agents|mesh-ancestor
111140357|NCT02569957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111140358|NCT02569957|Expectorants|expectorants|mesh-ancestor
111140359|NCT02569957|Respiratory System Agents|respiratory system agents|mesh-ancestor
111140360|NCT02569957|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111140361|NCT02569957|Antioxidants|antioxidants|mesh-ancestor
111140362|NCT02569957|Protective Agents|protective agents|mesh-ancestor
111140363|NCT02569957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111140364|NCT02569957|Antidotes|antidotes|mesh-ancestor
111140365|NCT01649427|Tacrolimus|tacrolimus|mesh-list
111140366|NCT01649427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111140367|NCT01649427|Immunologic Factors|immunologic factors|mesh-ancestor
110857398|NCT05162274|Lazertinib|lazertinib|mesh-list
111140368|NCT01649427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111140369|NCT01649427|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111140370|NCT01649427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111140371|NCT01649427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111140372|NCT05521633|Metformin|metformin|mesh-list
111140373|NCT05521633|Pioglitazone|pioglitazone|mesh-list
111140374|NCT05521633|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111140375|NCT05521633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111140376|NCT02336607|Metoprolol|metoprolol|mesh-list
111140377|NCT02336607|Felodipine|felodipine|mesh-list
111140378|NCT02336607|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
111140379|NCT02336607|Lisinopril|lisinopril|mesh-list
111140380|NCT02336607|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111140381|NCT02336607|Diuretics|diuretics|mesh-ancestor
111140382|NCT02336607|Natriuretic Agents|natriuretic agents|mesh-ancestor
111140383|NCT02336607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111140384|NCT02336607|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
111140385|NCT02336607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111140386|NCT02336607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111140387|NCT02336607|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111140388|NCT02336607|Sympatholytics|sympatholytics|mesh-ancestor
111140389|NCT02336607|Autonomic Agents|autonomic agents|mesh-ancestor
111140390|NCT02336607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111140391|NCT02336607|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
111140392|NCT02336607|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111140393|NCT02336607|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111140394|NCT02336607|Adrenergic Agents|adrenergic agents|mesh-ancestor
111140395|NCT02336607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111140396|NCT02336607|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
111140397|NCT02336607|Protease Inhibitors|protease inhibitors|mesh-ancestor
111140398|NCT02336607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111140399|NCT02336607|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
111140400|NCT02336607|Protective Agents|protective agents|mesh-ancestor
111140401|NCT02336607|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111140402|NCT02336607|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111140403|NCT02336607|Vasodilator Agents|vasodilator agents|mesh-ancestor
111140404|NCT02569801|Fulvestrant|fulvestrant|mesh-list
111140405|NCT02569801|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111140406|NCT02569801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111140407|NCT02569801|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
111140408|NCT02569801|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111140409|NCT02569801|Hormone Antagonists|hormone antagonists|mesh-ancestor
110870378|NCT02394418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111140410|NCT02569801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111140411|NCT02569801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111140413|NCT02573311|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111140414|NCT02573311|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111140415|NCT02573311|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111140416|NCT02573311|Adrenergic Agents|adrenergic agents|mesh-ancestor
111140417|NCT02573311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111140418|NCT02573311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111140419|NCT02573311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111140420|NCT02573311|Urological Agents|urological agents|mesh-ancestor
111140421|NCT05520853|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
111140422|NCT05520853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111140423|NCT05520853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111140424|NCT05520853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111140425|NCT05516251|Topiramate|topiramate|mesh-list
111140426|NCT05516251|Anticonvulsants|anticonvulsants|mesh-ancestor
111140427|NCT05516251|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
111140428|NCT05516251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111140429|NCT05086393|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
111140430|NCT05086393|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
111140431|NCT05086393|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111140432|NCT05086393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111140433|NCT05086393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111140434|NCT05086393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111140435|NCT05086393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111140436|NCT05086393|Analgesics|analgesics|mesh-ancestor
111140437|NCT05086393|Sensory System Agents|sensory system agents|mesh-ancestor
111140438|NCT05086393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111140439|NCT05086393|Antidepressive Agents|antidepressive agents|mesh-ancestor
111140440|NCT05086393|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111140441|NCT05086393|Dopamine Agents|dopamine agents|mesh-ancestor
111140442|NCT02571049|Sumatriptan|sumatriptan|mesh-list
111140443|NCT02571049|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111140444|NCT02571049|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111140445|NCT02571049|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111140446|NCT02571049|Serotonin Agents|serotonin agents|mesh-ancestor
111140447|NCT02571049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111140448|NCT02571049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111140449|NCT02571049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111140450|NCT04295941|Trazodone|trazodone|mesh-list
111140451|NCT04295941|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
111140452|NCT04295941|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111140453|NCT04295941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111140454|NCT04295941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111140455|NCT04295941|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111140456|NCT04295941|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111140457|NCT04295941|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111140458|NCT04295941|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111140459|NCT04295941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111140460|NCT04295941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111140461|NCT04295941|Serotonin Agents|serotonin agents|mesh-ancestor
111140462|NCT04295941|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111140463|NCT04295941|Antidepressive Agents|antidepressive agents|mesh-ancestor
111140464|NCT02573155|Tiotropium Bromide|tiotropium bromide|mesh-list
111140465|NCT02573155|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111140466|NCT02573155|Autonomic Agents|autonomic agents|mesh-ancestor
111140467|NCT02573155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111140468|NCT02573155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111140469|NCT02573155|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111140470|NCT02573155|Respiratory System Agents|respiratory system agents|mesh-ancestor
111140471|NCT02573155|Parasympatholytics|parasympatholytics|mesh-ancestor
111140472|NCT02573155|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111140473|NCT02573155|Cholinergic Agents|cholinergic agents|mesh-ancestor
111140474|NCT02573155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111140475|NCT02573155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111140476|NCT05515471|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111140477|NCT05515471|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
111140479|NCT05515315|Tislelizumab|tislelizumab|mesh-list
111140480|NCT05515315|Nedaplatin|nedaplatin|mesh-list
111140481|NCT05515315|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111140482|NCT05515315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111140483|NCT05515315|Tubulin Modulators|tubulin modulators|mesh-ancestor
111140484|NCT05515315|Antimitotic Agents|antimitotic agents|mesh-ancestor
111140485|NCT05515315|Mitosis Modulators|mitosis modulators|mesh-ancestor
111140486|NCT05515315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111140487|NCT05515315|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111140488|NCT05519371|Propofol|propofol|mesh-list
111140489|NCT05519371|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
111140490|NCT05519371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111140491|NCT05519371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111140492|NCT05519371|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
111140493|NCT05519371|Anesthetics, General|anesthetics, general|mesh-ancestor
111140494|NCT05519371|Anesthetics|anesthetics|mesh-ancestor
111140495|NCT04847947|Vitamin D|vitamin d|mesh-list
111140496|NCT04847947|Cholecalciferol|cholecalciferol|mesh-list
111140497|NCT04847947|Vitamins|vitamins|mesh-ancestor
111140498|NCT04847947|Micronutrients|micronutrients|mesh-ancestor
111140499|NCT04847947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111140500|NCT04847947|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111140501|NCT04847947|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111140502|NCT05514925|Bevacizumab|bevacizumab|mesh-list
111140503|NCT05514925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111140504|NCT05514925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111140505|NCT05514925|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111140506|NCT05514925|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111140507|NCT05514925|Growth Substances|growth substances|mesh-ancestor
111140508|NCT05514925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111140509|NCT05514925|Growth Inhibitors|growth inhibitors|mesh-ancestor
111140510|NCT05514847|Aspirin|aspirin|mesh-list
111140511|NCT05514847|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111140512|NCT05514847|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111140513|NCT05514847|Analgesics|analgesics|mesh-ancestor
111140514|NCT05514847|Sensory System Agents|sensory system agents|mesh-ancestor
111140515|NCT05514847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111140516|NCT05514847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110857544|NCT03299296|Enoxaparin|enoxaparin|mesh-list
111140517|NCT05514847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111140518|NCT05514847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111140519|NCT05514847|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111140520|NCT05514847|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111140521|NCT05514847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111140522|NCT05514847|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111140523|NCT05514847|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111140524|NCT05514847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111140525|NCT05514847|Antipyretics|antipyretics|mesh-ancestor
111140526|NCT05510323|Prednisolone|prednisolone|mesh-list
111140527|NCT05510323|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
111140528|NCT05510323|Methylprednisolone|methylprednisolone|mesh-list
111140529|NCT05510323|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
111140530|NCT05510323|Prednisolone acetate|prednisolone acetate|mesh-list
111140531|NCT05510323|Cyclophosphamide|cyclophosphamide|mesh-list
111140532|NCT05510323|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
111140533|NCT05510323|Prednisolone phosphate|prednisolone phosphate|mesh-list
111140534|NCT05510323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111140535|NCT05510323|Immunologic Factors|immunologic factors|mesh-ancestor
111140536|NCT05510323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111140537|NCT05510323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111140538|NCT05510323|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111140539|NCT05510323|Alkylating Agents|alkylating agents|mesh-ancestor
111140540|NCT05510323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111140541|NCT05510323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111140542|NCT05510323|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111140543|NCT05510323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111140544|NCT05510323|Glucocorticoids|glucocorticoids|mesh-ancestor
111140545|NCT05510323|Hormones|hormones|mesh-ancestor
111140546|NCT05510323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111140547|NCT05510323|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111140548|NCT05510323|Antiemetics|antiemetics|mesh-ancestor
111140549|NCT05510323|Autonomic Agents|autonomic agents|mesh-ancestor
111140550|NCT05510323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111140551|NCT05510323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111140552|NCT05510323|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
111140553|NCT05510323|Protective Agents|protective agents|mesh-ancestor
111140554|NCT04843579|Clarithromycin|clarithromycin|mesh-list
111140555|NCT04843579|Dexamethasone|dexamethasone|mesh-list
111140556|NCT04843579|Pomalidomide|pomalidomide|mesh-list
111140557|NCT04843579|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111140558|NCT04843579|Antiemetics|antiemetics|mesh-ancestor
111140559|NCT04843579|Autonomic Agents|autonomic agents|mesh-ancestor
111140560|NCT04843579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111140561|NCT04843579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111140562|NCT04843579|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111140563|NCT04843579|Glucocorticoids|glucocorticoids|mesh-ancestor
111140564|NCT04843579|Hormones|hormones|mesh-ancestor
111140565|NCT04843579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111140566|NCT04843579|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111140567|NCT04843579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111140568|NCT04843579|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111140569|NCT04843579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111140570|NCT04843579|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111140571|NCT04843579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111140572|NCT04843579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111140573|NCT04843579|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
111140574|NCT04843579|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111140575|NCT04843579|Immunologic Factors|immunologic factors|mesh-ancestor
111140576|NCT04843579|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111140577|NCT04843579|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111140578|NCT04843579|Growth Substances|growth substances|mesh-ancestor
111140579|NCT04843579|Growth Inhibitors|growth inhibitors|mesh-ancestor
111140580|NCT05507671|BCG Vaccine|bcg vaccine|mesh-list
111140581|NCT05507671|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111140582|NCT05507671|Immunologic Factors|immunologic factors|mesh-ancestor
111140583|NCT05507671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111140584|NCT02568397|Dabigatran|dabigatran|mesh-list
111140585|NCT02568397|Antithrombins|antithrombins|mesh-ancestor
111140586|NCT02568397|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111140587|NCT02568397|Protease Inhibitors|protease inhibitors|mesh-ancestor
111140588|NCT02568397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111140589|NCT02568397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111140590|NCT02568397|Anticoagulants|anticoagulants|mesh-ancestor
111140591|NCT04812379|Aripiprazole|aripiprazole|mesh-list
111140592|NCT04812379|Antidepressive Agents|antidepressive agents|mesh-ancestor
111140594|NCT04812379|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
111140595|NCT04812379|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
111140596|NCT04812379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111140597|NCT04812379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111140598|NCT04812379|Dopamine Agonists|dopamine agonists|mesh-ancestor
111140599|NCT04812379|Dopamine Agents|dopamine agents|mesh-ancestor
111140600|NCT04812379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110068020|NCT01548209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111140601|NCT04812379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111140602|NCT04812379|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111140603|NCT04812379|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111140605|NCT04812379|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
111140606|NCT04812379|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
111140607|NCT04812379|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
111140608|NCT04812379|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
111140609|NCT04757857|Rivaroxaban|rivaroxaban|mesh-list
111140610|NCT04757857|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111140611|NCT04757857|Antithrombins|antithrombins|mesh-ancestor
111140612|NCT04757857|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111140613|NCT04757857|Protease Inhibitors|protease inhibitors|mesh-ancestor
111140614|NCT04757857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111140615|NCT04757857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111140616|NCT04757857|Anticoagulants|anticoagulants|mesh-ancestor
111140617|NCT04755283|Rivaroxaban|rivaroxaban|mesh-list
111140618|NCT04755283|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
111140619|NCT04755283|Antithrombins|antithrombins|mesh-ancestor
111140620|NCT04755283|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
111140621|NCT04755283|Protease Inhibitors|protease inhibitors|mesh-ancestor
111140622|NCT04755283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111140623|NCT04755283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111140624|NCT04755283|Anticoagulants|anticoagulants|mesh-ancestor
111140625|NCT05506969|Vaccines|vaccines|mesh-list
111140626|NCT05506969|1018 oligonucleotide|1018 oligonucleotide|mesh-list
111140627|NCT05506969|Immunologic Factors|immunologic factors|mesh-ancestor
111140628|NCT05506969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111140629|NCT05506969|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111140630|NCT04291885|Avelumab|avelumab|mesh-list
111140631|NCT04291885|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111140632|NCT04291885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111140633|NCT05513131|Azacitidine|azacitidine|mesh-list
111140634|NCT05513131|Venetoclax|venetoclax|mesh-list
111140635|NCT05513131|Homoharringtonine|homoharringtonine|mesh-list
111140636|NCT05513131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111140637|NCT05513131|Antimetabolites|antimetabolites|mesh-ancestor
111140638|NCT05513131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111140639|NCT05513131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111140640|NCT05513131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111140641|NCT05513131|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111140642|NCT05513131|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
111140643|NCT05506501|Anesthetics|anesthetics|mesh-list
111140644|NCT05506501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111140645|NCT05506501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111140646|NCT05502913|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111140647|NCT05502913|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
111140648|NCT05502913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111140649|NCT05502913|Antitubercular Agents|antitubercular agents|mesh-ancestor
111140650|NCT05509153|Acetylcysteine|acetylcysteine|mesh-list
111140651|NCT05509153|Antiviral Agents|antiviral agents|mesh-ancestor
111140652|NCT05509153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111140653|NCT05509153|Expectorants|expectorants|mesh-ancestor
111140654|NCT05509153|Respiratory System Agents|respiratory system agents|mesh-ancestor
111140655|NCT05509153|Free Radical Scavengers|free radical scavengers|mesh-ancestor
111140656|NCT05509153|Antioxidants|antioxidants|mesh-ancestor
111140657|NCT05509153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111140658|NCT05509153|Protective Agents|protective agents|mesh-ancestor
111140659|NCT05509153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111140660|NCT04735393|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
111140661|NCT04735393|Ophthalmic Solutions|ophthalmic solutions|mesh-list
111140662|NCT04584853|Tamoxifen|tamoxifen|mesh-list
111140663|NCT04584853|Letrozole|letrozole|mesh-list
111140664|NCT04584853|Anastrozole|anastrozole|mesh-list
111140665|NCT04584853|Exemestane|exemestane|mesh-list
111140666|NCT04584853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111140667|NCT04584853|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
111140668|NCT04584853|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
111140669|NCT04584853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110839261|NCT03638076|Ritonavir|ritonavir|mesh-list
111140670|NCT04584853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111140671|NCT04584853|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
111140672|NCT04584853|Hormone Antagonists|hormone antagonists|mesh-ancestor
111140673|NCT04584853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111140674|NCT04584853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111140675|NCT04584853|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111140676|NCT04584853|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
111140677|NCT04584853|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
111140678|NCT04584853|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111140679|NCT05505877|Tislelizumab|tislelizumab|mesh-list
111140680|NCT05505877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111140681|NCT05505877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111140682|NCT04712851|Pembrolizumab|pembrolizumab|mesh-list
111140683|NCT04712851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111140684|NCT04712851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111140685|NCT04712851|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111140686|NCT04712851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111140687|NCT02336451|Ceritinib|ceritinib|mesh-list
111140688|NCT02336451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111140689|NCT02336451|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111140690|NCT02336451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111140691|NCT02336451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111140692|NCT01648101|Ezogabine|ezogabine|mesh-list
111140693|NCT01648101|Anticonvulsants|anticonvulsants|mesh-ancestor
111140694|NCT01648101|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111140695|NCT01648101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111140696|NCT02336373|Hydroxyurea|hydroxyurea|mesh-list
111140697|NCT02336373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111140698|NCT02336373|Antisickling Agents|antisickling agents|mesh-ancestor
111140699|NCT02336373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111140700|NCT02336373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111140701|NCT02336373|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111140702|NCT02372799|Fluoxetine|fluoxetine|mesh-list
111140703|NCT02372799|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
111140704|NCT02372799|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110591045|NCT04101929|Irinotecan|irinotecan|mesh-list
111140705|NCT02372799|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111140706|NCT02372799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111140707|NCT02372799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111140708|NCT02372799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111140709|NCT02372799|Serotonin Agents|serotonin agents|mesh-ancestor
111140710|NCT02372799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111140711|NCT02372799|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111140712|NCT02372799|Antidepressive Agents|antidepressive agents|mesh-ancestor
111140713|NCT02372799|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111140714|NCT02372799|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111140715|NCT02372799|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111140716|NCT02372799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111140717|NCT02372799|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
111140718|NCT02372799|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
111140719|NCT02566993|Cyclophosphamide|cyclophosphamide|mesh-list
111140720|NCT02566993|Doxorubicin|doxorubicin|mesh-list
111140721|NCT02566993|Vincristine|vincristine|mesh-list
111140722|NCT02566993|Topotecan|topotecan|mesh-list
111140723|NCT02566993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111140724|NCT02566993|Immunologic Factors|immunologic factors|mesh-ancestor
111140725|NCT02566993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111140726|NCT02566993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111140727|NCT02566993|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111140728|NCT02566993|Alkylating Agents|alkylating agents|mesh-ancestor
111140729|NCT02566993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111140730|NCT02566993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111140731|NCT02566993|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111140732|NCT02566993|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110839267|NCT03638076|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
111140733|NCT02566993|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111140734|NCT02566993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111140735|NCT02566993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111140736|NCT02566993|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111140737|NCT02566993|Tubulin Modulators|tubulin modulators|mesh-ancestor
111140738|NCT02566993|Antimitotic Agents|antimitotic agents|mesh-ancestor
111140739|NCT02566993|Mitosis Modulators|mitosis modulators|mesh-ancestor
111140740|NCT02566993|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
111140741|NCT02311881|Acetaminophen|acetaminophen|mesh-list
111140742|NCT02311881|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111140743|NCT02311881|Analgesics|analgesics|mesh-ancestor
111140744|NCT02311881|Sensory System Agents|sensory system agents|mesh-ancestor
111140745|NCT02311881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111140746|NCT02311881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111140747|NCT02311881|Antipyretics|antipyretics|mesh-ancestor
111140748|NCT02565511|Umibecestat|umibecestat|mesh-list
111140749|NCT02565511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111140750|NCT02565511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111140751|NCT04549051|Anesthetics|anesthetics|mesh-list
111140752|NCT04549051|Anesthetics, Local|anesthetics, local|mesh-list
111140753|NCT04549051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111140754|NCT04549051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111140755|NCT04549051|Sensory System Agents|sensory system agents|mesh-ancestor
111140756|NCT04549051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111140757|NCT05505253|Alfacalcidol|alfacalcidol|mesh-list
111140758|NCT05505253|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
111140759|NCT05505253|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
111140760|NCT05505253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111140761|NCT05505253|Vitamins|vitamins|mesh-ancestor
111140762|NCT05505253|Micronutrients|micronutrients|mesh-ancestor
111140763|NCT04697719|Aspirin|aspirin|mesh-list
111140764|NCT04697719|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
111140765|NCT04697719|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
111140766|NCT04697719|Analgesics|analgesics|mesh-ancestor
111140767|NCT04697719|Sensory System Agents|sensory system agents|mesh-ancestor
111140768|NCT04697719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111140769|NCT04697719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111140770|NCT04697719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111140771|NCT04697719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111140772|NCT04697719|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
111140773|NCT04697719|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111140774|NCT04697719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111140775|NCT04697719|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
111140776|NCT04697719|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
111140777|NCT04697719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111140778|NCT04697719|Antipyretics|antipyretics|mesh-ancestor
111140779|NCT05504863|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
111140780|NCT05504863|Ferric Compounds|ferric compounds|mesh-list
111140781|NCT05504863|Hematinics|hematinics|mesh-ancestor
111140782|NCT05507983|Tranexamic Acid|tranexamic acid|mesh-list
111140783|NCT05507983|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111140784|NCT05507983|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111140785|NCT05507983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111140786|NCT05507983|Hemostatics|hemostatics|mesh-ancestor
111140787|NCT05507983|Coagulants|coagulants|mesh-ancestor
111140788|NCT02335983|Dexamethasone|dexamethasone|mesh-list
111140789|NCT02335983|Lenalidomide|lenalidomide|mesh-list
111140790|NCT02335983|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111140791|NCT02335983|Antiemetics|antiemetics|mesh-ancestor
111140792|NCT02335983|Autonomic Agents|autonomic agents|mesh-ancestor
111140793|NCT02335983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111140794|NCT02335983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111140795|NCT02335983|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111140796|NCT02335983|Glucocorticoids|glucocorticoids|mesh-ancestor
111140797|NCT02335983|Hormones|hormones|mesh-ancestor
111140798|NCT02335983|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111140799|NCT02335983|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110839273|NCT01329731|Olaflur|olaflur|mesh-list
111140800|NCT02335983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111140801|NCT02335983|Immunologic Factors|immunologic factors|mesh-ancestor
111140802|NCT02335983|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111140803|NCT02335983|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111140804|NCT02335983|Growth Substances|growth substances|mesh-ancestor
111140805|NCT02335983|Growth Inhibitors|growth inhibitors|mesh-ancestor
111140806|NCT04578691|Titanium dioxide|titanium dioxide|mesh-list
111140807|NCT04578691|Sunscreening Agents|sunscreening agents|mesh-ancestor
111140808|NCT04578691|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
111140809|NCT04578691|Protective Agents|protective agents|mesh-ancestor
111140810|NCT04578691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111140811|NCT04578691|Dermatologic Agents|dermatologic agents|mesh-ancestor
110857839|NCT01353924|Immunologic Factors|immunologic factors|mesh-ancestor
111140812|NCT04578691|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
111140813|NCT02334423|Botulinum Toxins|botulinum toxins|mesh-list
111140814|NCT02334423|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111140815|NCT02334423|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111140816|NCT02334423|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111140817|NCT02334423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111140818|NCT02334423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111140819|NCT02334423|Cholinergic Agents|cholinergic agents|mesh-ancestor
111140820|NCT02334423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110591077|NCT00757185|Hormones|hormones|mesh-ancestor
111140821|NCT02334423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111140822|NCT02334423|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111140823|NCT02334423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111140825|NCT02310789|Pilocarpine|pilocarpine|mesh-list
111140826|NCT02310789|Adrenergic Agents|adrenergic agents|mesh-list
111140827|NCT02310789|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
111140828|NCT02310789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111140829|NCT02310789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111140830|NCT02310789|Miotics|miotics|mesh-ancestor
111140831|NCT02310789|Autonomic Agents|autonomic agents|mesh-ancestor
111140832|NCT02310789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111140833|NCT02310789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111140834|NCT02310789|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
111140835|NCT02310789|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
111140836|NCT02310789|Cholinergic Agents|cholinergic agents|mesh-ancestor
111140837|NCT02310789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111140838|NCT02372253|Verapamil|verapamil|mesh-list
111140839|NCT02372253|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111140840|NCT02372253|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
111140841|NCT02372253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111140842|NCT02372253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111140843|NCT02372253|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111140844|NCT02372253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111140845|NCT02372253|Vasodilator Agents|vasodilator agents|mesh-ancestor
111140846|NCT02371629|Glycopyrrolate|glycopyrrolate|mesh-list
111140847|NCT02371629|Bromides|bromides|mesh-list
111140848|NCT02371629|Albuterol|albuterol|mesh-list
111140849|NCT02371629|Anticonvulsants|anticonvulsants|mesh-ancestor
111140850|NCT02371629|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
111140851|NCT02371629|Autonomic Agents|autonomic agents|mesh-ancestor
111140852|NCT02371629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111140853|NCT02371629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111140854|NCT02371629|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
111140855|NCT02371629|Respiratory System Agents|respiratory system agents|mesh-ancestor
111140856|NCT02371629|Tocolytic Agents|tocolytic agents|mesh-ancestor
111140857|NCT02371629|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111140858|NCT02371629|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
111140859|NCT02371629|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
111140860|NCT02371629|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
111140861|NCT02371629|Adrenergic Agents|adrenergic agents|mesh-ancestor
111140862|NCT02371629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111140863|NCT02371629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111140864|NCT02371629|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
111140865|NCT02371629|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111140866|NCT02371629|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111140867|NCT02371629|Cholinergic Agents|cholinergic agents|mesh-ancestor
111140868|NCT02559817|Linaclotide|linaclotide|mesh-list
111140869|NCT02559817|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
111140870|NCT02559817|Enzyme Activators|enzyme activators|mesh-ancestor
111140871|NCT02559817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111140872|NCT02559817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111140873|NCT04577443|Adenosine|adenosine|mesh-list
111140874|NCT04577443|Analgesics|analgesics|mesh-ancestor
111140875|NCT04577443|Sensory System Agents|sensory system agents|mesh-ancestor
111140876|NCT04577443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111140877|NCT04577443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111140878|NCT04577443|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111140879|NCT04577443|Vasodilator Agents|vasodilator agents|mesh-ancestor
111140880|NCT04577443|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
111140881|NCT04577443|Purinergic Agonists|purinergic agonists|mesh-ancestor
111140882|NCT04577443|Purinergic Agents|purinergic agents|mesh-ancestor
111140883|NCT04577443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111140884|NCT04577443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111140885|NCT04411537|Capecitabine|capecitabine|mesh-list
111140886|NCT04411537|Irinotecan|irinotecan|mesh-list
111140887|NCT04411537|Antibodies|antibodies|mesh-list
110857915|NCT05174884|Etonogestrel|etonogestrel|mesh-list
111140888|NCT04411537|Immunologic Factors|immunologic factors|mesh-ancestor
111140889|NCT04411537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111140890|NCT04411537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
111140891|NCT04411537|Antimetabolites|antimetabolites|mesh-ancestor
111140892|NCT04411537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111140893|NCT04411537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111140894|NCT04411537|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110839289|NCT03311841|Rifampin|rifampin|mesh-list
111140895|NCT04411537|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111140896|NCT04411537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111140897|NCT04630171|Anesthetics|anesthetics|mesh-list
111140898|NCT04630171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111140899|NCT04630171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111140900|NCT05503147|Nabiximols|nabiximols|mesh-list
111140901|NCT05503147|Analgesics|analgesics|mesh-ancestor
111140902|NCT05503147|Sensory System Agents|sensory system agents|mesh-ancestor
111140903|NCT05503147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111140904|NCT05503147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111140905|NCT04619095|Psyllium|psyllium|mesh-list
111140906|NCT04619095|Cathartics|cathartics|mesh-ancestor
111140907|NCT04619095|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111140908|NCT05502991|Bevacizumab|bevacizumab|mesh-list
111140909|NCT05502991|Tislelizumab|tislelizumab|mesh-list
111140910|NCT05502991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111140911|NCT05502991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111140912|NCT05502991|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111140913|NCT05502991|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111140914|NCT05502991|Growth Substances|growth substances|mesh-ancestor
111140915|NCT05502991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111140916|NCT05502991|Growth Inhibitors|growth inhibitors|mesh-ancestor
111140917|NCT02563561|Apaziquone|apaziquone|mesh-list
111140918|NCT02563561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111140919|NCT05499481|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
111140920|NCT05499481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111140921|NCT05497765|Silybin|silybin|mesh-list
111140922|NCT05497765|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111140923|NCT05497765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111140924|NCT05497765|Protective Agents|protective agents|mesh-ancestor
111140925|NCT05497765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111140926|NCT04424875|Melatonin|melatonin|mesh-list
111140927|NCT04424875|Antioxidants|antioxidants|mesh-ancestor
111140928|NCT04424875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111140929|NCT04424875|Protective Agents|protective agents|mesh-ancestor
111140930|NCT04424875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111140931|NCT04424875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111140932|NCT04277845|Dexamethasone|dexamethasone|mesh-list
111140933|NCT04277845|Dexamethasone acetate|dexamethasone acetate|mesh-list
111140934|NCT04277845|Lenalidomide|lenalidomide|mesh-list
111140935|NCT04277845|Bortezomib|bortezomib|mesh-list
111140936|NCT04277845|BB 1101|bb 1101|mesh-list
111140937|NCT04277845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111140938|NCT04277845|Antiemetics|antiemetics|mesh-ancestor
111140939|NCT04277845|Autonomic Agents|autonomic agents|mesh-ancestor
111140940|NCT04277845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111140941|NCT04277845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111140942|NCT04277845|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111140943|NCT04277845|Glucocorticoids|glucocorticoids|mesh-ancestor
111140944|NCT04277845|Hormones|hormones|mesh-ancestor
111140945|NCT04277845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111140946|NCT04277845|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
111140947|NCT04277845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111140948|NCT04277845|Protease Inhibitors|protease inhibitors|mesh-ancestor
111140949|NCT04277845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111140950|NCT04277845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111140951|NCT04277845|Immunologic Factors|immunologic factors|mesh-ancestor
111140952|NCT04277845|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111140953|NCT04277845|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111140954|NCT04277845|Growth Substances|growth substances|mesh-ancestor
111140955|NCT04277845|Growth Inhibitors|growth inhibitors|mesh-ancestor
111140956|NCT02559505|Vaccines|vaccines|mesh-list
111140957|NCT02559505|Immunologic Factors|immunologic factors|mesh-ancestor
111140958|NCT02559505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111140959|NCT05497063|Pyrimethamine|pyrimethamine|mesh-list
111140960|NCT05497063|Sulfadoxine|sulfadoxine|mesh-list
111140961|NCT05497063|Antimalarials|antimalarials|mesh-ancestor
111140962|NCT05497063|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111140963|NCT05497063|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111140964|NCT05497063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111140965|NCT05497063|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
111140966|NCT05497063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111140967|NCT05497063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111140968|NCT05497063|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
111140969|NCT05560945|Listerine|listerine|mesh-list
111140970|NCT05560945|Fluorides|fluorides|mesh-list
111140971|NCT05560945|Sodium Fluoride|sodium fluoride|mesh-list
111140972|NCT05560945|Cariostatic Agents|cariostatic agents|mesh-ancestor
111140973|NCT05560945|Protective Agents|protective agents|mesh-ancestor
111140974|NCT05560945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111140975|NCT05560945|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111140976|NCT05560945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111140977|NCT04424563|Aminocaproic Acid|aminocaproic acid|mesh-list
111140978|NCT04424563|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
111140979|NCT04424563|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
111140980|NCT04424563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111140981|NCT04424563|Hemostatics|hemostatics|mesh-ancestor
111140982|NCT04424563|Coagulants|coagulants|mesh-ancestor
111140983|NCT05495893|Mycophenolic Acid|mycophenolic acid|mesh-list
111140984|NCT05495893|Cyclophosphamide|cyclophosphamide|mesh-list
111140985|NCT05495893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111140986|NCT05495893|Immunologic Factors|immunologic factors|mesh-ancestor
111140987|NCT05495893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111140988|NCT05495893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111140989|NCT05495893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
111140990|NCT05495893|Alkylating Agents|alkylating agents|mesh-ancestor
111140991|NCT05495893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111140992|NCT05495893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111140993|NCT05495893|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
111140994|NCT05495893|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111140995|NCT05495893|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
111140996|NCT05495893|Antitubercular Agents|antitubercular agents|mesh-ancestor
111140997|NCT05495893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111140998|NCT05495893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111140999|NCT05495893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111141000|NCT03542461|Nivolumab|nivolumab|mesh-list
111141001|NCT03542461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111141002|NCT03542461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111141003|NCT03542461|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111141004|NCT03542461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111141005|NCT02556307|Ribavirin|ribavirin|mesh-list
111141006|NCT02556307|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
111141007|NCT02556307|Antimetabolites|antimetabolites|mesh-ancestor
111141008|NCT02556307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111141009|NCT02556307|Antiviral Agents|antiviral agents|mesh-ancestor
111141010|NCT02556307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111141011|NCT04352101|Bupropion|bupropion|mesh-list
111141012|NCT04352101|Escitalopram|escitalopram|mesh-list
111141013|NCT04352101|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
111141014|NCT04352101|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111141015|NCT04352101|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111141016|NCT04352101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111141017|NCT04352101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111141018|NCT04352101|Serotonin Agents|serotonin agents|mesh-ancestor
111141019|NCT04352101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111141020|NCT04352101|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
111141021|NCT04352101|Antidepressive Agents|antidepressive agents|mesh-ancestor
111141022|NCT04352101|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111141023|NCT04352101|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
111141025|NCT04352101|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
111141026|NCT04352101|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
111141027|NCT04352101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111141028|NCT04424485|Parathyroid Hormone|parathyroid hormone|mesh-list
111141029|NCT04424485|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
111141030|NCT04424485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111141031|NCT05494645|Bupivacaine|bupivacaine|mesh-list
111141032|NCT05494645|Anesthetics, Local|anesthetics, local|mesh-ancestor
111141033|NCT05494645|Anesthetics|anesthetics|mesh-ancestor
111141034|NCT05494645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111141035|NCT05494645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111141036|NCT05494645|Sensory System Agents|sensory system agents|mesh-ancestor
111141037|NCT05494645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110676989|NCT03233724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111141038|NCT05494567|Tadalafil|tadalafil|mesh-list
111141039|NCT05494567|Tamsulosin|tamsulosin|mesh-list
111141040|NCT05494567|Solifenacin Succinate|solifenacin succinate|mesh-list
111141041|NCT05494567|Vasodilator Agents|vasodilator agents|mesh-ancestor
111141042|NCT05494567|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
111141043|NCT05494567|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
111141044|NCT05494567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111141045|NCT05494567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111141046|NCT05494567|Urological Agents|urological agents|mesh-ancestor
111141047|NCT05494567|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
111141048|NCT05494567|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
111141049|NCT05494567|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111141050|NCT05494567|Adrenergic Agents|adrenergic agents|mesh-ancestor
111141051|NCT05494567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111141052|NCT05494567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111141053|NCT05494567|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
111141054|NCT05494567|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
111141055|NCT05494567|Cholinergic Agents|cholinergic agents|mesh-ancestor
111141056|NCT00609115|Methylamphotericin B|methylamphotericin b|mesh-list
111141057|NCT00609115|Antifungal Agents|antifungal agents|mesh-ancestor
111141058|NCT00609115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111141059|NCT05494411|Mitomycins|mitomycins|mesh-list
111141060|NCT05494411|Mitomycin|mitomycin|mesh-list
111141061|NCT05494411|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
111141062|NCT05494411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111141063|NCT05494411|Alkylating Agents|alkylating agents|mesh-ancestor
111141064|NCT05494411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111141065|NCT05494411|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111141066|NCT05494411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111141067|NCT04085887|Panitumumab|panitumumab|mesh-list
111141068|NCT04085887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111141069|NCT04085887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111141070|NCT04080895|Lumefantrine|lumefantrine|mesh-list
111141071|NCT04080895|Artemether|artemether|mesh-list
111141072|NCT04080895|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
111141073|NCT04080895|Amodiaquine|amodiaquine|mesh-list
111141074|NCT04080895|Antimalarials|antimalarials|mesh-ancestor
111141075|NCT04080895|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
111141076|NCT04080895|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
111141077|NCT04080895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111141078|NCT04251169|Paclitaxel|paclitaxel|mesh-list
111141079|NCT04251169|Pembrolizumab|pembrolizumab|mesh-list
111141080|NCT04251169|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111141081|NCT04251169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111141082|NCT04251169|Tubulin Modulators|tubulin modulators|mesh-ancestor
111141083|NCT04251169|Antimitotic Agents|antimitotic agents|mesh-ancestor
111141084|NCT04251169|Mitosis Modulators|mitosis modulators|mesh-ancestor
111141085|NCT04251169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111141086|NCT04251169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111141087|NCT04251169|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
111141088|NCT04279561|Edetic Acid|edetic acid|mesh-list
110591159|NCT05266040|Valacyclovir|valacyclovir|mesh-list
111141089|NCT04279561|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
111141090|NCT04279561|Chelating Agents|chelating agents|mesh-ancestor
111141091|NCT04279561|Sequestering Agents|sequestering agents|mesh-ancestor
111141092|NCT04279561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111141093|NCT04279561|Anticoagulants|anticoagulants|mesh-ancestor
111141094|NCT04279561|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
111141095|NCT04279561|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111141096|NCT01662895|Deferoxamine|deferoxamine|mesh-list
111141097|NCT01662895|Siderophores|siderophores|mesh-ancestor
111141098|NCT01662895|Iron Chelating Agents|iron chelating agents|mesh-ancestor
111141099|NCT01662895|Chelating Agents|chelating agents|mesh-ancestor
111141100|NCT01662895|Sequestering Agents|sequestering agents|mesh-ancestor
111141101|NCT01662895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111141102|NCT05498857|Ephedrine|ephedrine|mesh-list
111141103|NCT05498857|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
111141104|NCT05498857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111141105|NCT05498857|Sympathomimetics|sympathomimetics|mesh-ancestor
111141106|NCT05498857|Autonomic Agents|autonomic agents|mesh-ancestor
111141107|NCT05498857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111141108|NCT05498857|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
111141109|NCT05498857|Adrenergic Agents|adrenergic agents|mesh-ancestor
111141110|NCT05498857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111141111|NCT05498857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111141112|NCT05498467|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
111141113|NCT05498467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111141114|NCT04139395|Citric Acid|citric acid|mesh-list
111141115|NCT04139395|Sodium Citrate|sodium citrate|mesh-list
111141116|NCT04139395|Gallium citrate|gallium citrate|mesh-list
111141117|NCT04139395|Anticoagulants|anticoagulants|mesh-ancestor
111141118|NCT04139395|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
111141119|NCT04139395|Chelating Agents|chelating agents|mesh-ancestor
111141120|NCT04139395|Sequestering Agents|sequestering agents|mesh-ancestor
111141121|NCT04139395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111141122|NCT04139395|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
111141123|NCT02555215|Dimethyl Fumarate|dimethyl fumarate|mesh-list
111141124|NCT02555215|Dermatologic Agents|dermatologic agents|mesh-ancestor
111141125|NCT02555215|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111141126|NCT02555215|Immunologic Factors|immunologic factors|mesh-ancestor
111141127|NCT02555215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111141128|NCT02555683|Indoleacetic Acids|indoleacetic acids|mesh-list
111141129|NCT02555683|Plant Growth Regulators|plant growth regulators|mesh-ancestor
111141130|NCT02555683|Growth Substances|growth substances|mesh-ancestor
111141131|NCT02555683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111141132|NCT02554981|Cyclosporine|cyclosporine|mesh-list
111141133|NCT02554981|Cyclosporins|cyclosporins|mesh-list
111141134|NCT02554981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111141135|NCT02554981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111141136|NCT02554981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111141137|NCT02554981|Immunologic Factors|immunologic factors|mesh-ancestor
111141138|NCT02554981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111141139|NCT02554981|Antifungal Agents|antifungal agents|mesh-ancestor
111141140|NCT02554981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111141141|NCT02554981|Dermatologic Agents|dermatologic agents|mesh-ancestor
111141142|NCT02554981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111141143|NCT02554981|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111141144|NCT02556775|Immunoglobulins|immunoglobulins|mesh-list
111141145|NCT02556775|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
111141146|NCT02556775|Antibodies|antibodies|mesh-list
111141147|NCT02556775|gamma-Globulins|gamma-globulins|mesh-list
111141148|NCT02556775|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
111141149|NCT02556775|Immunologic Factors|immunologic factors|mesh-ancestor
111141150|NCT02556775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111141151|NCT04080739|Ropivacaine|ropivacaine|mesh-list
111141152|NCT04080739|Anesthetics, Local|anesthetics, local|mesh-ancestor
111141153|NCT04080739|Anesthetics|anesthetics|mesh-ancestor
111141154|NCT04080739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111141155|NCT04080739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111141156|NCT04080739|Sensory System Agents|sensory system agents|mesh-ancestor
111141157|NCT04080739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111141158|NCT05485207|Botulinum Toxins|botulinum toxins|mesh-list
111141159|NCT05485207|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
111141160|NCT05485207|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
111141161|NCT05485207|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
111141162|NCT05485207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111141163|NCT05485207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111141164|NCT05485207|Cholinergic Agents|cholinergic agents|mesh-ancestor
111141165|NCT05485207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111141166|NCT05485207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111141167|NCT05485207|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
111141168|NCT05485207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111141169|NCT03879109|Folfirinox|folfirinox|mesh-list
111141170|NCT03879109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111141171|NCT05488327|Lenalidomide|lenalidomide|mesh-list
111141172|NCT05488327|Immunologic Factors|immunologic factors|mesh-ancestor
111141173|NCT05488327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111141174|NCT05488327|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111141175|NCT05488327|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111141176|NCT05488327|Growth Substances|growth substances|mesh-ancestor
111141177|NCT05488327|Growth Inhibitors|growth inhibitors|mesh-ancestor
111141178|NCT05488327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111141179|NCT05488171|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
111141180|NCT05488171|Hallucinogens|hallucinogens|mesh-ancestor
111141181|NCT05488171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111141182|NCT05488171|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
111141183|NCT05488171|Serotonin Agents|serotonin agents|mesh-ancestor
111141184|NCT05488171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111141185|NCT05488171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111141186|NCT05488171|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110591205|NCT00682929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111141187|NCT05488171|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
111141188|NCT05488171|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
111141189|NCT05488171|Adrenergic Agents|adrenergic agents|mesh-ancestor
111141191|NCT05485051|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
111141192|NCT05485051|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
111141193|NCT05485051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111141194|NCT05485051|Disinfectants|disinfectants|mesh-ancestor
111141195|NCT05485051|Dermatologic Agents|dermatologic agents|mesh-ancestor
111141196|NCT05484817|Hormones|hormones|mesh-list
111141197|NCT05484817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111141198|NCT05484817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111141199|NCT05484583|Carboplatin|carboplatin|mesh-list
111141200|NCT05484583|Etoposide|etoposide|mesh-list
111141201|NCT05484583|Durvalumab|durvalumab|mesh-list
111141202|NCT05484583|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
111141203|NCT05484583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111141204|NCT05484583|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111141205|NCT05484583|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
111141206|NCT05484583|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
111141207|NCT05484583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111141208|NCT05484583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111141209|NCT05484583|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
111141210|NCT05484583|Immunologic Factors|immunologic factors|mesh-ancestor
111141211|NCT05484583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111141213|NCT05479747|Sensory System Agents|sensory system agents|mesh-ancestor
111141214|NCT05479747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111141215|NCT05479747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111141216|NCT05487469|Thymalfasin|thymalfasin|mesh-list
111141217|NCT05487469|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
111141218|NCT05487469|Immunologic Factors|immunologic factors|mesh-ancestor
111141219|NCT05487469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111141220|NCT05479357|Oxytocin|oxytocin|mesh-list
111141221|NCT05479357|Carbetocin|carbetocin|mesh-list
111141222|NCT05479357|Oxytocics|oxytocics|mesh-ancestor
111141223|NCT05479357|Reproductive Control Agents|reproductive control agents|mesh-ancestor
111141224|NCT05479357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111141225|NCT05487391|Paclitaxel|paclitaxel|mesh-list
111141226|NCT05487391|Vinorelbine|vinorelbine|mesh-list
111141227|NCT05487391|Carboplatin|carboplatin|mesh-list
111141228|NCT05487391|Pemetrexed|pemetrexed|mesh-list
111141229|NCT05487391|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
111141230|NCT05487391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111141231|NCT05487391|Tubulin Modulators|tubulin modulators|mesh-ancestor
111141232|NCT05487391|Antimitotic Agents|antimitotic agents|mesh-ancestor
111141233|NCT05487391|Mitosis Modulators|mitosis modulators|mesh-ancestor
111141234|NCT05487391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111141235|NCT05487391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111141236|NCT05487391|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110591232|NCT00758199|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111141237|NCT05487391|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
111141238|NCT05484193|Progesterone|progesterone|mesh-list
111141239|NCT05484193|Progestins|progestins|mesh-ancestor
111141240|NCT05484193|Hormones|hormones|mesh-ancestor
111141241|NCT05484193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111141242|NCT05484193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111141243|NCT03796195|Bupivacaine|bupivacaine|mesh-list
111141244|NCT03796195|Anesthetics, Local|anesthetics, local|mesh-ancestor
111141245|NCT03796195|Anesthetics|anesthetics|mesh-ancestor
111141246|NCT03796195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111141247|NCT03796195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111141248|NCT03796195|Sensory System Agents|sensory system agents|mesh-ancestor
111141249|NCT03796195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111141250|NCT05479123|Timolol|timolol|mesh-list
111141251|NCT05479123|Propranolol|propranolol|mesh-list
111141252|NCT05479123|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
111141253|NCT05479123|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
111141254|NCT05479123|Adrenergic Agents|adrenergic agents|mesh-ancestor
111141255|NCT05479123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111141256|NCT05479123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111141257|NCT05479123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111141258|NCT05479123|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
111141259|NCT05479123|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
111141260|NCT05479123|Vasodilator Agents|vasodilator agents|mesh-ancestor
111141261|NCT04268407|Amoxicillin|amoxicillin|mesh-list
111141262|NCT04268407|Clavulanic Acid|clavulanic acid|mesh-list
111141263|NCT04268407|Clavulanic Acids|clavulanic acids|mesh-list
111141264|NCT04268407|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
111141265|NCT04268407|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
111141266|NCT04268407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
111141267|NCT04268407|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
111141268|NCT04268407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111141269|NCT04268407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111141270|NCT05487001|Dexamethasone|dexamethasone|mesh-list
111141271|NCT05487001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
111141272|NCT05487001|Antiemetics|antiemetics|mesh-ancestor
111141273|NCT05487001|Autonomic Agents|autonomic agents|mesh-ancestor
111141274|NCT05487001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
111141275|NCT05487001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111141276|NCT05487001|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
111141277|NCT05487001|Glucocorticoids|glucocorticoids|mesh-ancestor
111141278|NCT05487001|Hormones|hormones|mesh-ancestor
111141279|NCT05487001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
111141280|NCT05487001|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110591258|NCT00680745|Pioglitazone|pioglitazone|mesh-list
111141281|NCT05487001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111141282|NCT05483647|Anesthetics|anesthetics|mesh-list
111141283|NCT05483647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
111141284|NCT05483647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111141285|NCT05475379|Vaccines|vaccines|mesh-list
111141286|NCT05475379|Immunologic Factors|immunologic factors|mesh-ancestor
111141287|NCT05475379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111141288|NCT05475223|Carbon Monoxide|carbon monoxide|mesh-list
111141289|NCT05475223|Antimetabolites|antimetabolites|mesh-ancestor
111141290|NCT05475223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111141291|NCT05475223|Gasotransmitters|gasotransmitters|mesh-ancestor
111141292|NCT05475223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
111141293|NCT05475223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111141294|NCT04542733|Everolimus|everolimus|mesh-list
111141295|NCT04542733|Tacrolimus|tacrolimus|mesh-list
111141296|NCT04542733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
111141297|NCT04542733|Immunologic Factors|immunologic factors|mesh-ancestor
111141298|NCT04542733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111141299|NCT04542733|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
111141300|NCT04542733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111141301|NCT04542733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111141302|NCT04542733|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
111141303|NCT04542733|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
111141304|NCT04542733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111141305|NCT04424017|Antibodies|antibodies|mesh-list
111141306|NCT04424017|Immunologic Factors|immunologic factors|mesh-ancestor
111141307|NCT04424017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111141308|NCT05477797|Lenalidomide|lenalidomide|mesh-list
111141309|NCT05477797|Ixazomib|ixazomib|mesh-list
111141310|NCT05477797|Immunologic Factors|immunologic factors|mesh-ancestor
111141311|NCT05477797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
111141312|NCT05477797|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
111141313|NCT05477797|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
111141314|NCT05477797|Growth Substances|growth substances|mesh-ancestor
111141315|NCT05477797|Growth Inhibitors|growth inhibitors|mesh-ancestor
111141316|NCT05477797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
111141317|NCT05477797|Protease Inhibitors|protease inhibitors|mesh-ancestor
111141318|NCT05477797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
111141319|NCT05477797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
111141320|NCT05472337|Colchicine|colchicine|mesh-list
111141321|NCT05472337|Gout Suppressants|gout suppressants|mesh-ancestor
111141322|NCT05472337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
111141323|NCT05472337|Tubulin Modulators|tubulin modulators|mesh-ancestor
111141324|NCT05472337|Antimitotic Agents|antimitotic agents|mesh-ancestor
111141325|NCT05472337|Mitosis Modulators|mitosis modulators|mesh-ancestor
111141326|NCT05472337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110839422|NCT03764527|Artesunate|artesunate|mesh-list
110504624|NCT04115774|Diphosphonates|diphosphonates|mesh-list
110504625|NCT04115774|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110504626|NCT04115774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110504627|NCT04083170|Vidarabine|vidarabine|mesh-list
110504628|NCT04083170|Cyclophosphamide|cyclophosphamide|mesh-list
110504629|NCT04083170|Thiotepa|thiotepa|mesh-list
110504630|NCT04083170|Fludarabine|fludarabine|mesh-list
110504631|NCT04083170|Fludarabine phosphate|fludarabine phosphate|mesh-list
110504632|NCT04083170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110504633|NCT04083170|Immunologic Factors|immunologic factors|mesh-ancestor
110504634|NCT04083170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110504635|NCT04083170|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110504636|NCT04083170|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110504637|NCT04083170|Alkylating Agents|alkylating agents|mesh-ancestor
110504638|NCT04083170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110504639|NCT04083170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110504640|NCT04083170|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110504641|NCT04083170|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110504642|NCT04083170|Antimetabolites|antimetabolites|mesh-ancestor
110504643|NCT04083170|Antiviral Agents|antiviral agents|mesh-ancestor
110504644|NCT04083170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110504645|NCT04025359|Dronabinol|dronabinol|mesh-list
110504646|NCT04025359|Hallucinogens|hallucinogens|mesh-ancestor
110504647|NCT04025359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110504648|NCT04025359|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110504649|NCT04025359|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110504650|NCT04025359|Analgesics|analgesics|mesh-ancestor
110504651|NCT04025359|Sensory System Agents|sensory system agents|mesh-ancestor
110311915|NCT00303888|Docetaxel|docetaxel|mesh-list
110504652|NCT04025359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110504653|NCT04025359|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
110504654|NCT04025359|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110453185|NCT01006356|Sensory System Agents|sensory system agents|mesh-ancestor
110453186|NCT01006356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110453188|NCT01089725|Analgesics|analgesics|mesh-ancestor
110453189|NCT01089725|Sensory System Agents|sensory system agents|mesh-ancestor
110453190|NCT01089725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110453191|NCT01089725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110453192|NCT00619216|Mycophenolic Acid|mycophenolic acid|mesh-list
110453193|NCT00619216|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110453194|NCT00619216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110453195|NCT00619216|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110453196|NCT00619216|Antitubercular Agents|antitubercular agents|mesh-ancestor
110453197|NCT00619216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110453198|NCT00619216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110504655|NCT04025359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110504656|NCT04025359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110504657|NCT04025359|Hormones|hormones|mesh-ancestor
110504658|NCT04025359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110504659|NCT04005716|Cisplatin|cisplatin|mesh-list
110504660|NCT04005716|Carboplatin|carboplatin|mesh-list
110504661|NCT04005716|Etoposide|etoposide|mesh-list
110504662|NCT04005716|Etoposide phosphate|etoposide phosphate|mesh-list
110504663|NCT04005716|Tislelizumab|tislelizumab|mesh-list
110504664|NCT04005716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110504665|NCT04005716|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110504666|NCT04005716|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110504667|NCT04005716|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110504668|NCT04005716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110504669|NCT04005716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110504670|NCT04005716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110504671|NCT03972280|Antibodies|antibodies|mesh-list
110152011|NCT00000171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110504672|NCT03972280|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110504673|NCT03972280|Lenograstim|lenograstim|mesh-list
110504674|NCT03972280|Immunologic Factors|immunologic factors|mesh-ancestor
110169146|NCT00000899|Lamivudine|lamivudine|mesh-list
110453199|NCT00619216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110453200|NCT00619216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110453201|NCT00619372|Muromonab-CD3|muromonab-cd3|mesh-list
110453202|NCT00619372|Immunologic Factors|immunologic factors|mesh-ancestor
110453203|NCT00619372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110453204|NCT00619372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110453205|NCT00618202|Balsalazide|balsalazide|mesh-list
110453206|NCT00618202|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110453207|NCT00618202|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110453208|NCT00618202|Analgesics|analgesics|mesh-ancestor
110453209|NCT00618202|Sensory System Agents|sensory system agents|mesh-ancestor
110453210|NCT00618202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110453211|NCT00618202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110453212|NCT00618202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110453213|NCT00618202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110453214|NCT00618202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110453215|NCT00626015|Temozolomide|temozolomide|mesh-list
110453217|NCT00626015|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110453218|NCT00626015|Alkylating Agents|alkylating agents|mesh-ancestor
110453219|NCT00626015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110453220|NCT00626015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110453221|NCT00626015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110453222|NCT00626015|Immunologic Factors|immunologic factors|mesh-ancestor
110453223|NCT00626015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110453225|NCT00618280|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110453226|NCT00618280|Autonomic Agents|autonomic agents|mesh-ancestor
110453227|NCT00618280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110298412|NCT05893771|Hormones|hormones|mesh-ancestor
110453228|NCT00618280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110453229|NCT00618280|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110453230|NCT00618280|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110504675|NCT03972280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110504676|NCT03972280|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110504677|NCT03961568|Cenobamate|cenobamate|mesh-list
110504678|NCT03961568|Anticonvulsants|anticonvulsants|mesh-ancestor
110504679|NCT03941886|Aspirin|aspirin|mesh-list
110504680|NCT03941886|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110504681|NCT03941886|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110504682|NCT03941886|Analgesics|analgesics|mesh-ancestor
110504683|NCT03941886|Sensory System Agents|sensory system agents|mesh-ancestor
110504684|NCT03941886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110504685|NCT03941886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110504686|NCT03941886|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110504687|NCT03941886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110504688|NCT03941886|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110504689|NCT03941886|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110504690|NCT03941886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110504691|NCT03941886|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110504692|NCT03941886|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110504693|NCT03941886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110504694|NCT03941886|Antipyretics|antipyretics|mesh-ancestor
110504695|NCT03921008|Paclitaxel|paclitaxel|mesh-list
110504696|NCT03921008|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110453231|NCT00618280|Cholinergic Agents|cholinergic agents|mesh-ancestor
110453232|NCT00618280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110453233|NCT00618280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110453235|NCT01101191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110453236|NCT01101191|Narcotics|narcotics|mesh-ancestor
110453237|NCT01101191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110453238|NCT01101191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110453239|NCT01101191|Analgesics|analgesics|mesh-ancestor
110453240|NCT01101191|Sensory System Agents|sensory system agents|mesh-ancestor
110453241|NCT01101191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110453242|NCT00622258|Everolimus|everolimus|mesh-list
110453243|NCT00622258|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110453244|NCT00622258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110453245|NCT00622258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110453246|NCT00622258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110453247|NCT00622258|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110453248|NCT00622258|Immunologic Factors|immunologic factors|mesh-ancestor
110453249|NCT00622258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110453250|NCT00622258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110453251|NCT01812616|Nabiximols|nabiximols|mesh-list
110453252|NCT01812616|Analgesics|analgesics|mesh-ancestor
110453253|NCT01812616|Sensory System Agents|sensory system agents|mesh-ancestor
110453254|NCT01812616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110453255|NCT01812616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110453256|NCT00618358|Thrombin|thrombin|mesh-list
110453257|NCT00618358|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
110453258|NCT00618358|Hemostatics|hemostatics|mesh-ancestor
110453259|NCT00618358|Coagulants|coagulants|mesh-ancestor
110453260|NCT01178762|Azithromycin|azithromycin|mesh-list
110453261|NCT01178762|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110453262|NCT01178762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110453263|NCT03563560|Cytarabine|cytarabine|mesh-list
110453264|NCT03563560|Mitoxantrone|mitoxantrone|mesh-list
110504697|NCT03921008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110504698|NCT03921008|Tubulin Modulators|tubulin modulators|mesh-ancestor
110504699|NCT03921008|Antimitotic Agents|antimitotic agents|mesh-ancestor
110504700|NCT03921008|Mitosis Modulators|mitosis modulators|mesh-ancestor
110504701|NCT03921008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110504702|NCT03845296|Rucaparib|rucaparib|mesh-list
110504703|NCT03845296|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110504704|NCT03845296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110504705|NCT03845296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110453265|NCT03563560|Alvocidib|alvocidib|mesh-list
110453266|NCT03563560|Daunorubicin|daunorubicin|mesh-list
110453267|NCT03563560|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110453268|NCT03563560|Antimetabolites|antimetabolites|mesh-ancestor
110453269|NCT03563560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110453270|NCT03563560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110453271|NCT03563560|Antiviral Agents|antiviral agents|mesh-ancestor
110453272|NCT03563560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110453273|NCT03563560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110453274|NCT03563560|Immunologic Factors|immunologic factors|mesh-ancestor
110453275|NCT03563560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110453276|NCT03563560|Analgesics|analgesics|mesh-ancestor
110453277|NCT03563560|Sensory System Agents|sensory system agents|mesh-ancestor
110453278|NCT03563560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110453279|NCT03563560|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110453280|NCT03563560|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110100354|NCT01754831|Fluorides|fluorides|mesh-list
110453281|NCT03563560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110591337|NCT00679341|Docetaxel|docetaxel|mesh-list
110453282|NCT03563560|Growth Inhibitors|growth inhibitors|mesh-ancestor
110453283|NCT03563560|Growth Substances|growth substances|mesh-ancestor
110453284|NCT03563560|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110453285|NCT03563560|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110453286|NCT01178138|Prazosin|prazosin|mesh-list
110453287|NCT01178138|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110453288|NCT01178138|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110453289|NCT01178138|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110453290|NCT01178138|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110453291|NCT01178138|Adrenergic Agents|adrenergic agents|mesh-ancestor
110453292|NCT01178138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110453293|NCT01178138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110453294|NCT01178138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110453295|NCT01190228|Vaccines|vaccines|mesh-list
110453296|NCT01190228|Immunologic Factors|immunologic factors|mesh-ancestor
110453297|NCT01190228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110453298|NCT01009086|Ustekinumab|ustekinumab|mesh-list
110453299|NCT01009086|Dermatologic Agents|dermatologic agents|mesh-ancestor
110453300|NCT01190150|Tranexamic Acid|tranexamic acid|mesh-list
110453301|NCT01190150|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110453302|NCT01190150|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110453303|NCT01190150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110453304|NCT01190150|Hemostatics|hemostatics|mesh-ancestor
110453305|NCT01190150|Coagulants|coagulants|mesh-ancestor
110453306|NCT04315688|Insulin|insulin|mesh-list
110453307|NCT04315688|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110453308|NCT04315688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110453309|NCT05210062|Succinylcholine|succinylcholine|mesh-list
110453310|NCT05210062|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
110453311|NCT05210062|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110453312|NCT05210062|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110453313|NCT05210062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110453314|NCT05210062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110453315|NCT01001520|Tolcapone|tolcapone|mesh-list
110453316|NCT01001520|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110453317|NCT01001520|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110453318|NCT01001520|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
110453319|NCT01001520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110504706|NCT03845296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110504707|NCT03813108|Lumefantrine|lumefantrine|mesh-list
110504709|NCT03813108|Mefloquine|mefloquine|mesh-list
110504710|NCT03813108|Atovaquone|atovaquone|mesh-list
110504711|NCT03813108|Proguanil|proguanil|mesh-list
110504712|NCT03813108|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
110504713|NCT03813108|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
110504714|NCT03813108|Antimalarials|antimalarials|mesh-ancestor
110504715|NCT03813108|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110504716|NCT03813108|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110504717|NCT03813108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110504718|NCT03813108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110504719|NCT03813108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110504720|NCT03813108|Antimetabolites|antimetabolites|mesh-ancestor
110504721|NCT03675737|Pembrolizumab|pembrolizumab|mesh-list
110504722|NCT03675737|Fluorouracil|fluorouracil|mesh-list
110453320|NCT01001520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110453321|NCT00619840|Methylphenidate|methylphenidate|mesh-list
110453322|NCT00619840|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110453323|NCT00619840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110453324|NCT00619840|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110453325|NCT00619840|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110453326|NCT00619840|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110453327|NCT00619840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110453328|NCT00619840|Dopamine Agents|dopamine agents|mesh-ancestor
110453329|NCT00619840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110453330|NCT01189604|Propofol|propofol|mesh-list
110453331|NCT01189604|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110453332|NCT01189604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110453333|NCT01189604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110453334|NCT01189604|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110453335|NCT01189604|Anesthetics, General|anesthetics, general|mesh-ancestor
110453336|NCT01189604|Anesthetics|anesthetics|mesh-ancestor
110453337|NCT02697058|Calcium, Dietary|calcium, dietary|mesh-list
110453338|NCT02697058|Leucovorin|leucovorin|mesh-list
110453339|NCT02697058|Fluorouracil|fluorouracil|mesh-list
110453340|NCT02697058|Calcium|calcium|mesh-list
110453341|NCT02697058|Levoleucovorin|levoleucovorin|mesh-list
110453342|NCT02697058|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110453343|NCT02697058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110453344|NCT02697058|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110453345|NCT02697058|Antimetabolites|antimetabolites|mesh-ancestor
110453346|NCT02697058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110453348|NCT02697058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110453349|NCT02697058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110453350|NCT02697058|Immunologic Factors|immunologic factors|mesh-ancestor
110453351|NCT02697058|Antidotes|antidotes|mesh-ancestor
110453352|NCT02697058|Protective Agents|protective agents|mesh-ancestor
110453353|NCT02697058|Vitamin B Complex|vitamin b complex|mesh-ancestor
110453354|NCT02697058|Vitamins|vitamins|mesh-ancestor
110453355|NCT02697058|Micronutrients|micronutrients|mesh-ancestor
110453356|NCT00622414|Aflibercept|aflibercept|mesh-list
110453357|NCT00622414|Endothelial Growth Factors|endothelial growth factors|mesh-list
110453358|NCT00622414|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110453359|NCT00622414|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110453360|NCT00622414|Growth Substances|growth substances|mesh-ancestor
110453361|NCT00622414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110453362|NCT00622414|Growth Inhibitors|growth inhibitors|mesh-ancestor
110453363|NCT00622414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110453364|NCT01008696|Rabeprazole|rabeprazole|mesh-list
110504723|NCT03675737|Capecitabine|capecitabine|mesh-list
110504724|NCT03675737|Oxaliplatin|oxaliplatin|mesh-list
110504725|NCT03675737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110504726|NCT03675737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110504727|NCT03675737|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110169368|NCT00396721|Immunologic Factors|immunologic factors|mesh-ancestor
110453365|NCT01008696|Lansoprazole|lansoprazole|mesh-list
110453366|NCT01008696|Dexlansoprazole|dexlansoprazole|mesh-list
110453367|NCT01008696|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110453368|NCT01008696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110453369|NCT01008696|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110591391|NCT00921765|Anesthetics|anesthetics|mesh-ancestor
110453370|NCT01008696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110453371|NCT01008696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110453372|NCT01955980|Budesonide|budesonide|mesh-list
110453373|NCT01955980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110453374|NCT01955980|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110453375|NCT01955980|Autonomic Agents|autonomic agents|mesh-ancestor
110453376|NCT01955980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110453377|NCT01955980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110453378|NCT01955980|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110453379|NCT01955980|Respiratory System Agents|respiratory system agents|mesh-ancestor
110453380|NCT01955980|Glucocorticoids|glucocorticoids|mesh-ancestor
110453382|NCT01955980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110453383|NCT02870478|Atropine|atropine|mesh-list
110453384|NCT02870478|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110453385|NCT02870478|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110453386|NCT02870478|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110453387|NCT02870478|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110453388|NCT02870478|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110453389|NCT02870478|Autonomic Agents|autonomic agents|mesh-ancestor
110453390|NCT02870478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110453391|NCT02870478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110453392|NCT02870478|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110453393|NCT02870478|Respiratory System Agents|respiratory system agents|mesh-ancestor
110453394|NCT02870478|Mydriatics|mydriatics|mesh-ancestor
110453395|NCT02870478|Parasympatholytics|parasympatholytics|mesh-ancestor
110453396|NCT02870478|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110453397|NCT02870478|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110453398|NCT02870478|Cholinergic Agents|cholinergic agents|mesh-ancestor
110453399|NCT02870478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110453400|NCT02870478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110453401|NCT04296162|Capecitabine|capecitabine|mesh-list
110453402|NCT04296162|Trastuzumab|trastuzumab|mesh-list
110453403|NCT04296162|Vinorelbine|vinorelbine|mesh-list
110453404|NCT04296162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110453405|NCT04296162|Antimetabolites|antimetabolites|mesh-ancestor
110453406|NCT04296162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110298552|NCT05434546|Pregnanolone|pregnanolone|mesh-list
110453407|NCT04296162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110453408|NCT04296162|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110453409|NCT04296162|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110453410|NCT04296162|Tubulin Modulators|tubulin modulators|mesh-ancestor
110453411|NCT04296162|Antimitotic Agents|antimitotic agents|mesh-ancestor
110453412|NCT04296162|Mitosis Modulators|mitosis modulators|mesh-ancestor
110453413|NCT00619996|Docetaxel|docetaxel|mesh-list
110453414|NCT00619996|Sorafenib|sorafenib|mesh-list
110453415|NCT00619996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110453416|NCT00619996|Tubulin Modulators|tubulin modulators|mesh-ancestor
110453417|NCT00619996|Antimitotic Agents|antimitotic agents|mesh-ancestor
110453418|NCT00619996|Mitosis Modulators|mitosis modulators|mesh-ancestor
110453419|NCT00619996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110453420|NCT00619996|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110453421|NCT00619996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110453422|NCT02870790|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110453423|NCT02870790|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110453424|NCT02870790|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110453425|NCT02870790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110504728|NCT03675737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110504729|NCT03675737|Antimetabolites|antimetabolites|mesh-ancestor
110504730|NCT03675737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110504731|NCT03675737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110504732|NCT03675737|Immunologic Factors|immunologic factors|mesh-ancestor
110453426|NCT02870790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110453427|NCT02870790|Antiviral Agents|antiviral agents|mesh-ancestor
110453428|NCT02870790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110453429|NCT02870790|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110453430|NCT02870790|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110453431|NCT00622570|Pentobarbital|pentobarbital|mesh-list
110453432|NCT00622570|Thiopental|thiopental|mesh-list
110453433|NCT00622570|Anticonvulsants|anticonvulsants|mesh-ancestor
110453434|NCT00622570|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110453435|NCT00622570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110453436|NCT00622570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110453437|NCT00622570|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110453438|NCT00622570|Anesthetics, General|anesthetics, general|mesh-ancestor
110453439|NCT00622570|Anesthetics|anesthetics|mesh-ancestor
110453440|NCT00622570|GABA Modulators|gaba modulators|mesh-ancestor
110453441|NCT00622570|GABA Agents|gaba agents|mesh-ancestor
110453442|NCT00622570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110453443|NCT00622570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110453444|NCT00622570|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110453445|NCT00890266|Riboflavin|riboflavin|mesh-list
110453446|NCT00890266|Vitamin B Complex|vitamin b complex|mesh-ancestor
110453447|NCT00890266|Vitamins|vitamins|mesh-ancestor
110453448|NCT00890266|Micronutrients|micronutrients|mesh-ancestor
110453449|NCT00890266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110453450|NCT00890266|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110453451|NCT00890266|Dermatologic Agents|dermatologic agents|mesh-ancestor
110453452|NCT01176968|Eplerenone|eplerenone|mesh-list
110453453|NCT01176968|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110453454|NCT01176968|Hormone Antagonists|hormone antagonists|mesh-ancestor
110453455|NCT01176968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110453456|NCT01176968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110453457|NCT01176968|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110453459|NCT01176968|Natriuretic Agents|natriuretic agents|mesh-ancestor
110453460|NCT01176968|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110453461|NCT02697370|Factor VIII|factor viii|mesh-list
110453462|NCT02697370|Coagulants|coagulants|mesh-ancestor
110453463|NCT02691442|Epinephrine|epinephrine|mesh-list
110453464|NCT02691442|Ropivacaine|ropivacaine|mesh-list
110453465|NCT02691442|Levobupivacaine|levobupivacaine|mesh-list
110453466|NCT02691442|Anesthetics, Local|anesthetics, local|mesh-ancestor
110453467|NCT02691442|Anesthetics|anesthetics|mesh-ancestor
110453468|NCT02691442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110591427|NCT00755313|Docetaxel|docetaxel|mesh-list
110453469|NCT02691442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110453470|NCT02691442|Sensory System Agents|sensory system agents|mesh-ancestor
110453471|NCT02691442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110453472|NCT02691442|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110453473|NCT02691442|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110453474|NCT02691442|Adrenergic Agents|adrenergic agents|mesh-ancestor
110453475|NCT02691442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110453476|NCT02691442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110453477|NCT02691442|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110453478|NCT02691442|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110453479|NCT02691442|Autonomic Agents|autonomic agents|mesh-ancestor
110453480|NCT02691442|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110453481|NCT02691442|Respiratory System Agents|respiratory system agents|mesh-ancestor
110453482|NCT02691442|Mydriatics|mydriatics|mesh-ancestor
110453483|NCT02691442|Sympathomimetics|sympathomimetics|mesh-ancestor
110453484|NCT02691442|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110453485|NCT00622648|Enoxaparin|enoxaparin|mesh-list
110453486|NCT00622648|Anticoagulants|anticoagulants|mesh-ancestor
110453487|NCT00622648|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110453488|NCT00622648|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110453489|NCT00622648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110453490|NCT02687854|Vitamin K|vitamin k|mesh-list
110453491|NCT02687854|Apixaban|apixaban|mesh-list
110453492|NCT02687854|Vitamins|vitamins|mesh-ancestor
110453493|NCT02687854|Micronutrients|micronutrients|mesh-ancestor
110504733|NCT03675737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110504735|NCT03621748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110504736|NCT03621748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110504737|NCT03586453|Osimertinib|osimertinib|mesh-list
110504738|NCT03586453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110504739|NCT03586453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110504740|NCT03586453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110504741|NCT03586453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110504742|NCT03440450|Gemcitabine|gemcitabine|mesh-list
110504743|NCT03440450|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110504744|NCT03440450|Antimetabolites|antimetabolites|mesh-ancestor
110169498|NCT05083975|Sensory System Agents|sensory system agents|mesh-ancestor
110453494|NCT02687854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110453495|NCT02687854|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110453496|NCT02687854|Antithrombins|antithrombins|mesh-ancestor
110453497|NCT02687854|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110453498|NCT02687854|Protease Inhibitors|protease inhibitors|mesh-ancestor
110453499|NCT02687854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110453500|NCT02687854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110453501|NCT02687854|Anticoagulants|anticoagulants|mesh-ancestor
110453502|NCT02687854|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110453503|NCT02687854|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110453504|NCT02687854|Hemostatics|hemostatics|mesh-ancestor
110453505|NCT02687854|Coagulants|coagulants|mesh-ancestor
110453506|NCT01005966|Listerine|listerine|mesh-list
110453507|NCT01005966|Fluorides|fluorides|mesh-list
110453508|NCT01005966|Sodium Fluoride|sodium fluoride|mesh-list
110453509|NCT01005966|Fluorophosphate|fluorophosphate|mesh-list
110453510|NCT01005966|Cariostatic Agents|cariostatic agents|mesh-ancestor
110453511|NCT01005966|Protective Agents|protective agents|mesh-ancestor
110453512|NCT01005966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110453513|NCT01005966|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110453514|NCT01005966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110453515|NCT00628680|Heparin|heparin|mesh-list
110453516|NCT00628680|Anticoagulants|anticoagulants|mesh-ancestor
110453517|NCT00628680|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110453518|NCT00628680|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110453519|NCT00628680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110453520|NCT00603304|Saw palmetto extract|saw palmetto extract|mesh-list
110453521|NCT00603304|Urological Agents|urological agents|mesh-ancestor
110453522|NCT01176032|Losartan|losartan|mesh-list
110453523|NCT01176032|Amlodipine|amlodipine|mesh-list
110453524|NCT01176032|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110453525|NCT01176032|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110453526|NCT01176032|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110453527|NCT01176032|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110453528|NCT01176032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110298661|NCT04923776|Etoposide|etoposide|mesh-list
110453529|NCT01176032|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110453530|NCT01176032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110453532|NCT01176032|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110453533|NCT01176032|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110453534|NCT01176032|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110453535|NCT01176032|Diuretics|diuretics|mesh-ancestor
110453536|NCT01176032|Natriuretic Agents|natriuretic agents|mesh-ancestor
110453537|NCT01176032|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110453538|NCT01008618|Fentanyl|fentanyl|mesh-list
110453539|NCT01008618|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110453540|NCT01008618|Narcotics|narcotics|mesh-ancestor
110453541|NCT01008618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110453542|NCT01008618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110453543|NCT01008618|Analgesics|analgesics|mesh-ancestor
110453544|NCT01008618|Sensory System Agents|sensory system agents|mesh-ancestor
110504745|NCT03440450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110504746|NCT03440450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110504748|NCT03417154|Nivolumab|nivolumab|mesh-list
110504749|NCT03417154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110504750|NCT03417154|Immunologic Factors|immunologic factors|mesh-ancestor
110504751|NCT03417154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110504752|NCT03417154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110504753|NCT03417154|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110504754|NCT03417154|Alkylating Agents|alkylating agents|mesh-ancestor
110169564|NCT04896541|Antiviral Agents|antiviral agents|mesh-ancestor
110453545|NCT01008618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110453546|NCT01008618|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110453547|NCT01008618|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110453548|NCT01008618|Anesthetics, General|anesthetics, general|mesh-ancestor
110453549|NCT01008618|Anesthetics|anesthetics|mesh-ancestor
110453550|NCT01001208|Etanercept|etanercept|mesh-list
110453551|NCT01001208|Methotrexate|methotrexate|mesh-list
110453552|NCT01001208|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110453553|NCT01001208|Abortifacient Agents|abortifacient agents|mesh-ancestor
110453554|NCT01001208|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110453555|NCT01001208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110453556|NCT01001208|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110453557|NCT01001208|Antimetabolites|antimetabolites|mesh-ancestor
110453558|NCT01001208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110453559|NCT01001208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110453560|NCT01001208|Dermatologic Agents|dermatologic agents|mesh-ancestor
110453561|NCT01001208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110453562|NCT01001208|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110453563|NCT01001208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110453564|NCT01001208|Immunologic Factors|immunologic factors|mesh-ancestor
110453565|NCT01001208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110453566|NCT01001208|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110453567|NCT01001208|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110453568|NCT01001208|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110453569|NCT01001208|Analgesics|analgesics|mesh-ancestor
110453570|NCT01001208|Sensory System Agents|sensory system agents|mesh-ancestor
110453571|NCT01001208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110453572|NCT01001208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110453573|NCT01001208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110453574|NCT01000974|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110453575|NCT01000974|Immunologic Factors|immunologic factors|mesh-ancestor
110453576|NCT01000974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110453577|NCT01193842|Prednisone|prednisone|mesh-list
110453578|NCT01193842|Cortisone|cortisone|mesh-list
110453579|NCT01193842|Cyclophosphamide|cyclophosphamide|mesh-list
110453580|NCT01193842|Rituximab|rituximab|mesh-list
110453581|NCT01193842|Doxorubicin|doxorubicin|mesh-list
110453582|NCT01193842|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110100655|NCT01756417|Metformin|metformin|mesh-list
110453583|NCT01193842|Etoposide|etoposide|mesh-list
110453584|NCT01193842|Vincristine|vincristine|mesh-list
110453585|NCT01193842|Etoposide phosphate|etoposide phosphate|mesh-list
110453587|NCT01193842|Podophyllotoxin|podophyllotoxin|mesh-list
110453588|NCT01193842|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110453589|NCT01193842|Antibodies|antibodies|mesh-list
110453590|NCT01193842|Immunoglobulins|immunoglobulins|mesh-list
110453591|NCT01193842|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110453592|NCT01193842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110453593|NCT01193842|Immunologic Factors|immunologic factors|mesh-ancestor
110453594|NCT01193842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110453595|NCT01193842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110453596|NCT01193842|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110453597|NCT01193842|Alkylating Agents|alkylating agents|mesh-ancestor
110453598|NCT01193842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110453599|NCT01193842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110504755|NCT03417154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110504756|NCT03417154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110504757|NCT03417154|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110504758|NCT03417154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110504759|NCT03417154|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110504760|NCT03396315|Zoledronic Acid|zoledronic acid|mesh-list
110504761|NCT03396315|Alendronate|alendronate|mesh-list
110504762|NCT03396315|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110504763|NCT03396315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110504764|NCT03332017|Obinutuzumab|obinutuzumab|mesh-list
110504765|NCT03332017|Zanubrutinib|zanubrutinib|mesh-list
110504766|NCT03332017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110504767|NCT03332017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110453600|NCT01193842|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110453601|NCT01193842|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110453602|NCT01193842|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110453603|NCT01193842|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110453604|NCT01193842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110453605|NCT01193842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110453606|NCT01193842|Glucocorticoids|glucocorticoids|mesh-ancestor
110453608|NCT01193842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110453609|NCT01193842|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110453610|NCT01193842|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110453611|NCT01193842|Tubulin Modulators|tubulin modulators|mesh-ancestor
110453612|NCT01193842|Antimitotic Agents|antimitotic agents|mesh-ancestor
110453613|NCT01193842|Mitosis Modulators|mitosis modulators|mesh-ancestor
110453614|NCT01193842|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110453615|NCT01193842|Keratolytic Agents|keratolytic agents|mesh-ancestor
110453616|NCT01193842|Dermatologic Agents|dermatologic agents|mesh-ancestor
110453617|NCT01004406|Atorvastatin|atorvastatin|mesh-list
110453618|NCT01004406|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
110453619|NCT01004406|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110453620|NCT01004406|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110453621|NCT01004406|Antimetabolites|antimetabolites|mesh-ancestor
110453622|NCT01004406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110453623|NCT01004406|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110453624|NCT01004406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110453626|NCT01093612|Trastuzumab|trastuzumab|mesh-list
110453627|NCT01093612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110453628|NCT01093612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110453629|NCT01093612|Trace Elements|trace elements|mesh-ancestor
110453630|NCT01093612|Micronutrients|micronutrients|mesh-ancestor
110453631|NCT01093612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110453632|NCT01182350|Bevacizumab|bevacizumab|mesh-list
110453633|NCT01182350|Temozolomide|temozolomide|mesh-list
110453634|NCT01182350|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110453635|NCT01182350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110453636|NCT01182350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110453637|NCT01182350|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110453638|NCT01182350|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110453639|NCT01182350|Growth Substances|growth substances|mesh-ancestor
110453640|NCT01182350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110453641|NCT01182350|Growth Inhibitors|growth inhibitors|mesh-ancestor
110453642|NCT01182350|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110453643|NCT01182350|Alkylating Agents|alkylating agents|mesh-ancestor
110453644|NCT01182350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110453645|NCT01182350|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110453646|NCT01182350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110453647|NCT00603538|Paclitaxel|paclitaxel|mesh-list
110453648|NCT00603538|Carboplatin|carboplatin|mesh-list
110504768|NCT03332017|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110504769|NCT03332017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110504770|NCT03332017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110504771|NCT03221036|Vedolizumab|vedolizumab|mesh-list
110504772|NCT03221036|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110504773|NCT03032783|Mycophenolic Acid|mycophenolic acid|mesh-list
110504774|NCT03032783|Cyclophosphamide|cyclophosphamide|mesh-list
110504775|NCT03032783|Tacrolimus|tacrolimus|mesh-list
110504776|NCT03032783|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110504777|NCT03032783|Immunologic Factors|immunologic factors|mesh-ancestor
110453649|NCT00603538|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110453650|NCT00603538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110453651|NCT00603538|Tubulin Modulators|tubulin modulators|mesh-ancestor
110453652|NCT00603538|Antimitotic Agents|antimitotic agents|mesh-ancestor
110453653|NCT00603538|Mitosis Modulators|mitosis modulators|mesh-ancestor
110453654|NCT00603538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110453655|NCT04185766|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110453656|NCT02537860|Fentanyl|fentanyl|mesh-list
110453657|NCT02537860|Bupivacaine|bupivacaine|mesh-list
110453658|NCT02537860|Anesthetics, Local|anesthetics, local|mesh-ancestor
110453659|NCT02537860|Anesthetics|anesthetics|mesh-ancestor
110453660|NCT02537860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110453661|NCT02537860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110453662|NCT02537860|Sensory System Agents|sensory system agents|mesh-ancestor
110453663|NCT02537860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110453664|NCT02537860|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110453665|NCT02537860|Narcotics|narcotics|mesh-ancestor
110453666|NCT02537860|Analgesics|analgesics|mesh-ancestor
110453667|NCT02537860|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110453668|NCT02537860|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110453669|NCT02537860|Anesthetics, General|anesthetics, general|mesh-ancestor
110453670|NCT03844750|Pembrolizumab|pembrolizumab|mesh-list
110453671|NCT03844750|Vactosertib|vactosertib|mesh-list
110453672|NCT03844750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110453673|NCT03844750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110453674|NCT03844750|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110453675|NCT03844750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110453677|NCT03844750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110453678|NCT04521946|Mycophenolic Acid|mycophenolic acid|mesh-list
110453679|NCT04521946|Fludarabine|fludarabine|mesh-list
110591476|NCT04082858|GABA Agents|gaba agents|mesh-ancestor
110453680|NCT04521946|Fludarabine phosphate|fludarabine phosphate|mesh-list
110453682|NCT04521946|Etoposide phosphate|etoposide phosphate|mesh-list
110453683|NCT04521946|Melphalan|melphalan|mesh-list
110453684|NCT04521946|Mechlorethamine|mechlorethamine|mesh-list
110453685|NCT04521946|Thiotepa|thiotepa|mesh-list
110453686|NCT04521946|Podophyllotoxin|podophyllotoxin|mesh-list
110453687|NCT04521946|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
110453688|NCT04521946|Tacrolimus|tacrolimus|mesh-list
110453689|NCT04521946|Thymoglobulin|thymoglobulin|mesh-list
110453690|NCT04521946|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110453691|NCT04521946|Immunoglobulins|immunoglobulins|mesh-list
110453692|NCT04521946|Antibodies|antibodies|mesh-list
110453693|NCT04521946|gamma-Globulins|gamma-globulins|mesh-list
110453694|NCT04521946|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110453695|NCT04521946|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110453696|NCT04521946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110453697|NCT04521946|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110453698|NCT04521946|Antimetabolites|antimetabolites|mesh-ancestor
110453699|NCT04521946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110453700|NCT04521946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110453701|NCT04521946|Immunologic Factors|immunologic factors|mesh-ancestor
110453702|NCT04521946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110453703|NCT04521946|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110453704|NCT04521946|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110453705|NCT04521946|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110453706|NCT04521946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110453707|NCT04521946|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110453708|NCT04521946|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110504778|NCT03032783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110504779|NCT03032783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110504780|NCT03032783|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110504781|NCT03032783|Alkylating Agents|alkylating agents|mesh-ancestor
110504782|NCT03032783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110504783|NCT03032783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110504784|NCT03032783|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110504785|NCT03032783|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110504786|NCT03032783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110504787|NCT03032783|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110504788|NCT03032783|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110453709|NCT04521946|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110453710|NCT04521946|Antitubercular Agents|antitubercular agents|mesh-ancestor
110453711|NCT04521946|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110453712|NCT04521946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110453713|NCT04521946|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110453714|NCT04521946|Alkylating Agents|alkylating agents|mesh-ancestor
110453715|NCT04521946|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110453716|NCT04521946|Keratolytic Agents|keratolytic agents|mesh-ancestor
110453717|NCT04521946|Dermatologic Agents|dermatologic agents|mesh-ancestor
110453718|NCT04521946|Tubulin Modulators|tubulin modulators|mesh-ancestor
110453719|NCT04521946|Antimitotic Agents|antimitotic agents|mesh-ancestor
110453720|NCT04521946|Mitosis Modulators|mitosis modulators|mesh-ancestor
110453721|NCT01162304|Oxycodone|oxycodone|mesh-list
110453722|NCT01162304|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110453723|NCT01162304|Narcotics|narcotics|mesh-ancestor
110453724|NCT01162304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110453725|NCT01162304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110453726|NCT01162304|Analgesics|analgesics|mesh-ancestor
110453727|NCT01162304|Sensory System Agents|sensory system agents|mesh-ancestor
110453728|NCT01162304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110453729|NCT04515394|Cetuximab|cetuximab|mesh-list
110453730|NCT04515394|Tepotinib|tepotinib|mesh-list
110453731|NCT04515394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110453732|NCT04515394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110453733|NCT04206176|Ticagrelor|ticagrelor|mesh-list
110453734|NCT04206176|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110453735|NCT04206176|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110453736|NCT04206176|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110453737|NCT04206176|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110453738|NCT04206176|Purinergic Agents|purinergic agents|mesh-ancestor
110453739|NCT04206176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110453740|NCT04206176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110453741|NCT04206176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110453742|NCT01175018|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
110453743|NCT01175018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110453744|NCT00638326|Clopidogrel|clopidogrel|mesh-list
110453745|NCT00638326|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110453746|NCT00638326|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110453747|NCT00638326|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110453748|NCT00638326|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110453749|NCT00638326|Purinergic Agents|purinergic agents|mesh-ancestor
110453750|NCT00638326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110560320|NCT02684123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110453751|NCT00638326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110453752|NCT00638326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110453753|NCT04314674|Mannitol|mannitol|mesh-list
110453754|NCT04314674|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110453755|NCT04314674|Diuretics|diuretics|mesh-ancestor
110453756|NCT04314674|Natriuretic Agents|natriuretic agents|mesh-ancestor
110453757|NCT04314674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110453758|NCT00639262|Temozolomide|temozolomide|mesh-list
110453759|NCT00639262|Sorafenib|sorafenib|mesh-list
110504789|NCT03032783|Antitubercular Agents|antitubercular agents|mesh-ancestor
110504790|NCT03032783|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110504791|NCT03032783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110504792|NCT02778685|Pembrolizumab|pembrolizumab|mesh-list
110504793|NCT02778685|Letrozole|letrozole|mesh-list
110504794|NCT02778685|Fulvestrant|fulvestrant|mesh-list
110504795|NCT02778685|Palbociclib|palbociclib|mesh-list
110504796|NCT02778685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110504797|NCT02778685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110504798|NCT02778685|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110504799|NCT02778685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110504800|NCT02778685|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110504801|NCT02778685|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110504802|NCT02778685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110504803|NCT02778685|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110504804|NCT02778685|Hormone Antagonists|hormone antagonists|mesh-ancestor
110504805|NCT02778685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110504806|NCT02778685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110504807|NCT02778685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110504808|NCT02778685|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110504809|NCT02778685|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110504811|NCT02740985|Durvalumab|durvalumab|mesh-list
110504812|NCT02740985|Abiraterone Acetate|abiraterone acetate|mesh-list
110504813|NCT02740985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110504814|NCT02740985|Tubulin Modulators|tubulin modulators|mesh-ancestor
110504815|NCT02740985|Antimitotic Agents|antimitotic agents|mesh-ancestor
110591506|NCT00919022|Cyproterone|cyproterone|mesh-list
110504816|NCT02740985|Mitosis Modulators|mitosis modulators|mesh-ancestor
110504817|NCT02740985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110504818|NCT02740985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110504819|NCT02740985|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110504820|NCT02740985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110504821|NCT02740985|Hormone Antagonists|hormone antagonists|mesh-ancestor
110504822|NCT02740985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110169828|NCT02970916|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110453760|NCT00639262|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110453761|NCT00639262|Alkylating Agents|alkylating agents|mesh-ancestor
110453762|NCT00639262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110453763|NCT00639262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110504823|NCT02740985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110504824|NCT02740985|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110504825|NCT02728531|Cytarabine|cytarabine|mesh-list
110504826|NCT02728531|Rituximab|rituximab|mesh-list
110504827|NCT02728531|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110504828|NCT02728531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110504829|NCT02728531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110504830|NCT02728531|Immunologic Factors|immunologic factors|mesh-ancestor
110453764|NCT00639262|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110453765|NCT00639262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110453766|NCT02885558|Efonidipine|efonidipine|mesh-list
110453767|NCT02885558|Nifedipine|nifedipine|mesh-list
110453768|NCT02885558|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110453769|NCT02885558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110453770|NCT02885558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110453771|NCT02885558|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110453772|NCT02885558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110453773|NCT02885558|Vasodilator Agents|vasodilator agents|mesh-ancestor
110453774|NCT02885558|Tocolytic Agents|tocolytic agents|mesh-ancestor
110453775|NCT02885558|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110453776|NCT02885558|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110453777|NCT02885558|Diuretics|diuretics|mesh-ancestor
110453778|NCT02885558|Natriuretic Agents|natriuretic agents|mesh-ancestor
110453779|NCT01008150|Paclitaxel|paclitaxel|mesh-list
110453780|NCT01008150|Cyclophosphamide|cyclophosphamide|mesh-list
110453781|NCT01008150|Doxorubicin|doxorubicin|mesh-list
110453782|NCT01008150|Trastuzumab|trastuzumab|mesh-list
110453783|NCT01008150|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110453784|NCT01008150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110453785|NCT01008150|Tubulin Modulators|tubulin modulators|mesh-ancestor
110453786|NCT01008150|Antimitotic Agents|antimitotic agents|mesh-ancestor
110453787|NCT01008150|Mitosis Modulators|mitosis modulators|mesh-ancestor
110453788|NCT01008150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110453789|NCT01008150|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110453790|NCT01008150|Immunologic Factors|immunologic factors|mesh-ancestor
110453791|NCT01008150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110453792|NCT01008150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110453793|NCT01008150|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110453794|NCT01008150|Alkylating Agents|alkylating agents|mesh-ancestor
110453795|NCT01008150|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110453796|NCT01008150|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110453797|NCT01008150|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110453798|NCT01008150|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110453799|NCT01008150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110591512|NCT00919022|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110453800|NCT01008150|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110453801|NCT04186936|Simethicone|simethicone|mesh-list
110453803|NCT04186936|Antidiarrheals|antidiarrheals|mesh-list
110453804|NCT04186936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110453805|NCT04186936|Antifoaming Agents|antifoaming agents|mesh-ancestor
110453806|NCT04186936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110453807|NCT04186936|Emollients|emollients|mesh-ancestor
110453808|NCT04186936|Dermatologic Agents|dermatologic agents|mesh-ancestor
110453809|NCT02689180|Furosemide|furosemide|mesh-list
110453810|NCT02689180|Diuretics|diuretics|mesh-ancestor
110453811|NCT02689180|Natriuretic Agents|natriuretic agents|mesh-ancestor
110453812|NCT02689180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110453813|NCT02689180|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110453814|NCT02689180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110453815|NCT02689180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110453816|NCT02689336|Temozolomide|temozolomide|mesh-list
110453817|NCT02689336|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110453818|NCT02689336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110453819|NCT02689336|Alkylating Agents|alkylating agents|mesh-ancestor
110453820|NCT02689336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110453821|NCT02689336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110453822|NCT02689336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110504831|NCT02728531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110504832|NCT02728531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110504833|NCT02728531|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110504834|NCT02728531|Antimetabolites|antimetabolites|mesh-ancestor
110504835|NCT02728531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110504836|NCT02728531|Antiviral Agents|antiviral agents|mesh-ancestor
110504837|NCT02728531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110453823|NCT02689336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110453824|NCT03650764|Pembrolizumab|pembrolizumab|mesh-list
110453825|NCT03650764|Ramucirumab|ramucirumab|mesh-list
110453826|NCT03650764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110453827|NCT03650764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110453828|NCT03650764|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110453829|NCT03650764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110453830|NCT02685592|Aminolevulinic Acid|aminolevulinic acid|mesh-list
110453831|NCT02685592|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110453832|NCT02685592|Dermatologic Agents|dermatologic agents|mesh-ancestor
110453834|NCT01007448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110453835|NCT02686684|Dimethyl Fumarate|dimethyl fumarate|mesh-list
110453836|NCT02686684|Dermatologic Agents|dermatologic agents|mesh-ancestor
110453837|NCT02686684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110453838|NCT02686684|Immunologic Factors|immunologic factors|mesh-ancestor
110453839|NCT02686684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110453840|NCT04294056|Propofol|propofol|mesh-list
110453841|NCT04294056|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110453842|NCT04294056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110453843|NCT04294056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110453844|NCT04294056|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110453845|NCT04294056|Anesthetics, General|anesthetics, general|mesh-ancestor
110453846|NCT04294056|Anesthetics|anesthetics|mesh-ancestor
110453847|NCT04186702|Ranibizumab|ranibizumab|mesh-list
110453848|NCT04186702|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110453849|NCT04186702|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110453850|NCT04186702|Growth Substances|growth substances|mesh-ancestor
110453851|NCT04186702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110453852|NCT04186702|Growth Inhibitors|growth inhibitors|mesh-ancestor
110453853|NCT04186702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110453854|NCT04187014|Tranexamic Acid|tranexamic acid|mesh-list
110453855|NCT04187014|Aminocaproic Acid|aminocaproic acid|mesh-list
110453856|NCT04187014|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110453857|NCT04187014|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110453858|NCT04187014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110453859|NCT04187014|Hemostatics|hemostatics|mesh-ancestor
110453860|NCT04187014|Coagulants|coagulants|mesh-ancestor
110453861|NCT02686840|Misoprostol|misoprostol|mesh-list
110453862|NCT02686840|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110453863|NCT02686840|Abortifacient Agents|abortifacient agents|mesh-ancestor
110453864|NCT02686840|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110453865|NCT02686840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110453866|NCT02686840|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110453867|NCT02686840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110453868|NCT02686840|Oxytocics|oxytocics|mesh-ancestor
110453869|NCT00638482|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110453870|NCT00638482|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110453871|NCT00638482|Diuretics|diuretics|mesh-ancestor
110453872|NCT00638482|Natriuretic Agents|natriuretic agents|mesh-ancestor
110453873|NCT00638482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110453874|NCT00638482|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110453875|NCT00638482|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110453876|NCT00638482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110453877|NCT00638560|Vitamins|vitamins|mesh-list
110453878|NCT00638560|Vitamin E|vitamin e|mesh-list
110453879|NCT00638560|Antioxidants|antioxidants|mesh-list
110453880|NCT00638560|Micronutrients|micronutrients|mesh-ancestor
110453881|NCT00638560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110453882|NCT00638560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110453883|NCT00638560|Protective Agents|protective agents|mesh-ancestor
110453884|NCT00638638|Abciximab|abciximab|mesh-list
110504838|NCT02728531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110504839|NCT02728531|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110504840|NCT02728531|Alkylating Agents|alkylating agents|mesh-ancestor
110504841|NCT02723331|Paclitaxel|paclitaxel|mesh-list
110504842|NCT02723331|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110504843|NCT02723331|Gemcitabine|gemcitabine|mesh-list
110504844|NCT02723331|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110504845|NCT02723331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110504846|NCT02723331|Tubulin Modulators|tubulin modulators|mesh-ancestor
110453885|NCT00638638|Anticoagulants|anticoagulants|mesh-ancestor
110453886|NCT00638638|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110100946|NCT01757795|Otaplimastat|otaplimastat|mesh-list
110453887|NCT02684812|Tranexamic Acid|tranexamic acid|mesh-list
110453888|NCT02684812|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110453889|NCT02684812|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110453890|NCT02684812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110453891|NCT02684812|Hemostatics|hemostatics|mesh-ancestor
110453892|NCT02684812|Coagulants|coagulants|mesh-ancestor
110453893|NCT04203160|Cisplatin|cisplatin|mesh-list
110453894|NCT04203160|Gemcitabine|gemcitabine|mesh-list
110453895|NCT04203160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110453896|NCT04203160|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110453897|NCT04203160|Antimetabolites|antimetabolites|mesh-ancestor
110453898|NCT04203160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110453899|NCT01004250|Bevacizumab|bevacizumab|mesh-list
110453900|NCT01004250|Pemetrexed|pemetrexed|mesh-list
110453901|NCT01004250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110453902|NCT01004250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110453903|NCT01004250|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110453904|NCT01004250|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110453905|NCT01004250|Growth Substances|growth substances|mesh-ancestor
110453906|NCT01004250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110453907|NCT01004250|Growth Inhibitors|growth inhibitors|mesh-ancestor
110453908|NCT01004250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110453909|NCT01004250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110453910|NCT01004250|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110453911|NCT01004250|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110453912|NCT02688634|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110453913|NCT02688634|Amoxicillin|amoxicillin|mesh-list
110453914|NCT02688634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110453915|NCT00639496|Acetylcysteine|acetylcysteine|mesh-list
110453916|NCT00639496|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110453917|NCT00639496|Antiviral Agents|antiviral agents|mesh-ancestor
110453918|NCT00639496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110453919|NCT00639496|Expectorants|expectorants|mesh-ancestor
110453920|NCT00639496|Respiratory System Agents|respiratory system agents|mesh-ancestor
110453921|NCT00639496|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110453922|NCT00639496|Antioxidants|antioxidants|mesh-ancestor
110453923|NCT00639496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110453924|NCT00639496|Protective Agents|protective agents|mesh-ancestor
110453925|NCT00639496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110453926|NCT00639496|Antidotes|antidotes|mesh-ancestor
110453928|NCT02688400|Diacerein|diacerein|mesh-list
110453929|NCT02688400|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110453930|NCT02688400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110453931|NCT02688400|Analgesics|analgesics|mesh-ancestor
110453932|NCT02688400|Sensory System Agents|sensory system agents|mesh-ancestor
110453933|NCT02688400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110453934|NCT02688400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110453935|NCT02688400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110453936|NCT02688400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110453937|NCT02688400|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110453938|NCT02688400|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110453939|NCT02688400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110453940|NCT02688400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110453941|NCT00639574|Nefopam|nefopam|mesh-list
110453942|NCT00639574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110504847|NCT02723331|Antimitotic Agents|antimitotic agents|mesh-ancestor
110504848|NCT02723331|Mitosis Modulators|mitosis modulators|mesh-ancestor
110504849|NCT02723331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110504850|NCT02723331|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110504851|NCT02723331|Antimetabolites|antimetabolites|mesh-ancestor
110504853|NCT02593526|Dialysis Solutions|dialysis solutions|mesh-list
110453943|NCT00639574|Analgesics|analgesics|mesh-ancestor
110453944|NCT00639574|Sensory System Agents|sensory system agents|mesh-ancestor
110453945|NCT00639574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110453946|NCT00639574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110453947|NCT02685046|Imatinib Mesylate|imatinib mesylate|mesh-list
110453948|NCT02685046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110453949|NCT02685046|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110453950|NCT02685046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110453951|NCT02685046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110453952|NCT01004172|Bevacizumab|bevacizumab|mesh-list
110453953|NCT01004172|Trastuzumab|trastuzumab|mesh-list
110453954|NCT01004172|Carboplatin|carboplatin|mesh-list
110453955|NCT01004172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110453956|NCT01004172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110453957|NCT01004172|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110453958|NCT01004172|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110453959|NCT01004172|Growth Substances|growth substances|mesh-ancestor
110453960|NCT01004172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110453961|NCT01004172|Growth Inhibitors|growth inhibitors|mesh-ancestor
110453962|NCT02688322|Sulbactam|sulbactam|mesh-list
110453963|NCT02688322|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110453964|NCT02688322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110453965|NCT02688322|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110453966|NCT02688322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110453967|NCT02688322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110453968|NCT02685748|Aspirin|aspirin|mesh-list
110453969|NCT02685748|Pantoprazole|pantoprazole|mesh-list
110453970|NCT02685748|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110453971|NCT02685748|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110453972|NCT02685748|Analgesics|analgesics|mesh-ancestor
110453973|NCT02685748|Sensory System Agents|sensory system agents|mesh-ancestor
110453974|NCT02685748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110453975|NCT02685748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110453976|NCT02685748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110453977|NCT02685748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110453978|NCT02685748|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110453979|NCT02685748|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110453980|NCT02685748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110453981|NCT02685748|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110453982|NCT02685748|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110453983|NCT02685748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110453984|NCT02685748|Antipyretics|antipyretics|mesh-ancestor
110453985|NCT02685748|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110453986|NCT02685748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110453987|NCT02685748|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110453988|NCT02685670|Cyclophosphamide|cyclophosphamide|mesh-list
110453997|NCT02685670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110453998|NCT02685670|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110454000|NCT02687932|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
110454001|NCT02687932|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110454002|NCT02687932|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110454003|NCT02687932|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110454004|NCT02687932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110454005|NCT00641602|Esomeprazole|esomeprazole|mesh-list
110454006|NCT00641602|Lansoprazole|lansoprazole|mesh-list
110454007|NCT00641602|Dexlansoprazole|dexlansoprazole|mesh-list
110454008|NCT00641602|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110454009|NCT00641602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110454010|NCT00641602|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110454011|NCT00641602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110504854|NCT02593526|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110504856|NCT02593526|Natriuretic Agents|natriuretic agents|mesh-ancestor
110504857|NCT02593526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110504858|NCT02593526|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110504859|NCT02593526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110504860|NCT02593526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110504861|NCT02484677|Docetaxel|docetaxel|mesh-list
110504862|NCT02484677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110454012|NCT00641602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110454013|NCT05663944|Sirolimus|sirolimus|mesh-list
110454014|NCT05663944|Liver Extracts|liver extracts|mesh-list
110454015|NCT05663944|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110454016|NCT05663944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110454017|NCT05663944|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110454018|NCT05663944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110454019|NCT05663944|Antifungal Agents|antifungal agents|mesh-ancestor
110454020|NCT05663944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110454021|NCT05663944|Immunologic Factors|immunologic factors|mesh-ancestor
110454022|NCT05663944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110454023|NCT05663944|Hematinics|hematinics|mesh-ancestor
110454024|NCT02682862|Bromides|bromides|mesh-list
110454025|NCT02682862|Tiotropium Bromide|tiotropium bromide|mesh-list
110454026|NCT02682862|Olodaterol|olodaterol|mesh-list
110454027|NCT02682862|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110454028|NCT02682862|Autonomic Agents|autonomic agents|mesh-ancestor
110454029|NCT02682862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110454030|NCT02682862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110454031|NCT02682862|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110454032|NCT02682862|Respiratory System Agents|respiratory system agents|mesh-ancestor
110454033|NCT02682862|Parasympatholytics|parasympatholytics|mesh-ancestor
110454034|NCT02682862|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110454035|NCT02682862|Cholinergic Agents|cholinergic agents|mesh-ancestor
110454036|NCT02682862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110454037|NCT02682862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110454038|NCT02682862|Anticonvulsants|anticonvulsants|mesh-ancestor
110454048|NCT00640198|Memantine|memantine|mesh-list
110454049|NCT00640198|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110454050|NCT00640198|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110454051|NCT00640198|Dopamine Agents|dopamine agents|mesh-ancestor
110454052|NCT00640198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110454053|NCT00640198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110454054|NCT00640198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110454055|NCT00640198|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110454056|NCT00640198|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110454057|NCT04293822|Cetirizine|cetirizine|mesh-list
110454058|NCT04293822|Minoxidil|minoxidil|mesh-list
110454059|NCT04293822|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110454060|NCT04293822|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110454061|NCT04293822|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110454062|NCT04293822|Histamine Antagonists|histamine antagonists|mesh-ancestor
110454063|NCT04293822|Histamine Agents|histamine agents|mesh-ancestor
110454064|NCT04293822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110454065|NCT04293822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110454066|NCT04293822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110454067|NCT04293822|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110454068|NCT04293822|Vasodilator Agents|vasodilator agents|mesh-ancestor
110454069|NCT02680600|Cefepime|cefepime|mesh-list
110454070|NCT02680600|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110454071|NCT02680600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110454072|NCT02680678|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110454073|NCT04182724|Paclitaxel|paclitaxel|mesh-list
110454074|NCT04182724|Apatinib|apatinib|mesh-list
110454075|NCT04182724|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110454076|NCT04182724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110454077|NCT04182724|Tubulin Modulators|tubulin modulators|mesh-ancestor
110504863|NCT02484677|Tubulin Modulators|tubulin modulators|mesh-ancestor
110504864|NCT02484677|Antimitotic Agents|antimitotic agents|mesh-ancestor
110504865|NCT02484677|Mitosis Modulators|mitosis modulators|mesh-ancestor
110504866|NCT02484677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110504868|NCT02476097|Omeprazole|omeprazole|mesh-list
110591569|NCT02559141|Dobutamine|dobutamine|mesh-list
110504869|NCT02476097|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110504870|NCT02476097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110170204|NCT00038623|Rituximab|rituximab|mesh-list
110454078|NCT04182724|Antimitotic Agents|antimitotic agents|mesh-ancestor
110454079|NCT04182724|Mitosis Modulators|mitosis modulators|mesh-ancestor
110454080|NCT04182724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110454081|NCT04182724|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110454082|NCT04182724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110454083|NCT04184518|Durvalumab|durvalumab|mesh-list
110454084|NCT04184518|Cediranib|cediranib|mesh-list
110454085|NCT04184518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110454086|NCT04184518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110454087|NCT04184518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110454088|NCT04184518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110454089|NCT04184518|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110454090|NCT01174238|Paclitaxel|paclitaxel|mesh-list
110454091|NCT01174238|Carboplatin|carboplatin|mesh-list
110454092|NCT01174238|Axitinib|axitinib|mesh-list
110454093|NCT01174238|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110454094|NCT01174238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110454095|NCT01174238|Tubulin Modulators|tubulin modulators|mesh-ancestor
110454096|NCT01174238|Antimitotic Agents|antimitotic agents|mesh-ancestor
110454097|NCT01174238|Mitosis Modulators|mitosis modulators|mesh-ancestor
110454098|NCT01174238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110454099|NCT01174238|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110454100|NCT01174238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110454101|NCT02928406|Atezolizumab|atezolizumab|mesh-list
110454102|NCT02928406|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110454103|NCT02928406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110454104|NCT02928406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110454105|NCT02928406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110454106|NCT04315454|Levobupivacaine|levobupivacaine|mesh-list
110454107|NCT04315454|Anesthetics, Local|anesthetics, local|mesh-ancestor
110454108|NCT04315454|Anesthetics|anesthetics|mesh-ancestor
110454109|NCT04315454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110454110|NCT04315454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110454111|NCT04315454|Sensory System Agents|sensory system agents|mesh-ancestor
110454112|NCT04315454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110454113|NCT01161446|Antibodies|antibodies|mesh-list
110454114|NCT01161446|Immunoglobulins|immunoglobulins|mesh-list
110454115|NCT01161446|Immunologic Factors|immunologic factors|mesh-ancestor
110454116|NCT01161446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110454117|NCT00641680|Fluticasone|fluticasone|mesh-list
110454118|NCT00641680|Xhance|xhance|mesh-list
110454119|NCT00641680|Budesonide|budesonide|mesh-list
110454120|NCT00641680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110454121|NCT00641680|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110454122|NCT00641680|Autonomic Agents|autonomic agents|mesh-ancestor
110454123|NCT00641680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110454124|NCT00641680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110454125|NCT00641680|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110454126|NCT00641680|Respiratory System Agents|respiratory system agents|mesh-ancestor
110454127|NCT00641680|Dermatologic Agents|dermatologic agents|mesh-ancestor
110454128|NCT00641680|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110454130|NCT00641680|Hormones|hormones|mesh-ancestor
110454131|NCT00641680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110454132|NCT01174004|Pimavanserin|pimavanserin|mesh-list
110454133|NCT01174004|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110454134|NCT01174004|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110454135|NCT01174004|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110454136|NCT01174004|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110454137|NCT01174004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110504871|NCT02476097|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110504872|NCT02476097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110504873|NCT02476097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110504875|NCT03946358|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110504876|NCT03946358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110504877|NCT03946358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110504878|NCT03946358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110504879|NCT02115282|Exemestane|exemestane|mesh-list
110504880|NCT02115282|Goserelin|goserelin|mesh-list
110454138|NCT01174004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110454139|NCT01174004|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110454140|NCT01174004|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110454141|NCT01174004|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110454142|NCT01174004|Serotonin Agents|serotonin agents|mesh-ancestor
110454143|NCT01174004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110454144|NCT01174004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110454145|NCT01173692|Minocycline|minocycline|mesh-list
110454146|NCT01173692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110454147|NCT01173692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110454148|NCT00641758|Pycnogenols|pycnogenols|mesh-list
110454149|NCT00641758|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110454150|NCT00641758|Immunologic Factors|immunologic factors|mesh-ancestor
110454151|NCT00641758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110454152|NCT00641758|Antioxidants|antioxidants|mesh-ancestor
110454153|NCT00641758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110454154|NCT00641758|Protective Agents|protective agents|mesh-ancestor
110454155|NCT00641758|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110454156|NCT00640276|Pitavastatin|pitavastatin|mesh-list
110454157|NCT00640276|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110454158|NCT00640276|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110454159|NCT00640276|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110454160|NCT00640276|Antimetabolites|antimetabolites|mesh-ancestor
110591626|NCT03205137|Vasodilator Agents|vasodilator agents|mesh-ancestor
110454161|NCT00640276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110454162|NCT00640276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110454163|NCT00640276|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110454164|NCT02680132|Esomeprazole|esomeprazole|mesh-list
110454165|NCT02680132|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110454166|NCT02680132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110454167|NCT02680132|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110454168|NCT02680132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110454169|NCT02680132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110454170|NCT02683564|Infliximab|infliximab|mesh-list
110454171|NCT02683564|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110454172|NCT02683564|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110454173|NCT02683564|Dermatologic Agents|dermatologic agents|mesh-ancestor
110454174|NCT02683564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110454175|NCT02683564|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110454176|NCT01101035|Allopurinol|allopurinol|mesh-list
110454177|NCT01101035|Febuxostat|febuxostat|mesh-list
110454178|NCT01101035|Antimetabolites|antimetabolites|mesh-ancestor
110454179|NCT01101035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110454180|NCT01101035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110454181|NCT01101035|Gout Suppressants|gout suppressants|mesh-ancestor
110454182|NCT01101035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110454183|NCT01101035|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110454184|NCT01101035|Antioxidants|antioxidants|mesh-ancestor
110454185|NCT01101035|Protective Agents|protective agents|mesh-ancestor
110454186|NCT01101035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110454187|NCT01160822|Naproxen|naproxen|mesh-list
110454188|NCT01160822|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110454189|NCT01160822|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110454190|NCT01160822|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110454192|NCT01160822|Sensory System Agents|sensory system agents|mesh-ancestor
110504882|NCT02115282|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
110504883|NCT02115282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110504884|NCT02115282|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110504885|NCT02115282|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110504886|NCT02115282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110504887|NCT02115282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110504888|NCT02115282|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110504889|NCT02115282|Hormone Antagonists|hormone antagonists|mesh-ancestor
110504890|NCT02115282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110504891|NCT02115282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110454193|NCT01160822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110454194|NCT01160822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110454195|NCT01160822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110454196|NCT01160822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110454197|NCT01160822|Gout Suppressants|gout suppressants|mesh-ancestor
110454198|NCT01160822|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110454199|NCT01160822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110454200|NCT01160822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110454201|NCT01160822|Immunologic Factors|immunologic factors|mesh-ancestor
110454202|NCT01006980|Dacarbazine|dacarbazine|mesh-list
110454203|NCT01006980|Vemurafenib|vemurafenib|mesh-list
110560321|NCT02684123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110454204|NCT01006980|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110454205|NCT01006980|Alkylating Agents|alkylating agents|mesh-ancestor
110454206|NCT01006980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110454207|NCT01006980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110454208|NCT01006980|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110454209|NCT01006980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110454210|NCT04296240|Capecitabine|capecitabine|mesh-list
110454211|NCT04296240|Oxaliplatin|oxaliplatin|mesh-list
110454212|NCT04296240|Antiemetics|antiemetics|mesh-list
110454213|NCT04296240|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110454214|NCT04296240|Antimetabolites|antimetabolites|mesh-ancestor
110454215|NCT04296240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110454216|NCT04296240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110454217|NCT04296240|Autonomic Agents|autonomic agents|mesh-ancestor
110454218|NCT04296240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110454219|NCT04296240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110454220|NCT04296240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110454221|NCT04205058|Caffeine|caffeine|mesh-list
110454222|NCT04205058|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110454223|NCT04205058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110454224|NCT04205058|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110454225|NCT04205058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110454226|NCT04205058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110454227|NCT04205058|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110454228|NCT04205058|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110454229|NCT04205058|Purinergic Agents|purinergic agents|mesh-ancestor
110454230|NCT04205058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110454231|NCT04183738|Ritonavir|ritonavir|mesh-list
110454232|NCT04183738|Darunavir|darunavir|mesh-list
110454233|NCT04183738|Dolutegravir|dolutegravir|mesh-list
110454234|NCT04183738|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110454235|NCT04183738|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110454236|NCT04183738|Protease Inhibitors|protease inhibitors|mesh-ancestor
110454237|NCT04183738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110454238|NCT04183738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110454239|NCT04183738|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110454240|NCT04183738|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110454241|NCT04183738|Antiviral Agents|antiviral agents|mesh-ancestor
110504892|NCT02115282|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110504893|NCT02106507|Everolimus|everolimus|mesh-list
110504894|NCT02106507|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110504895|NCT02106507|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110504896|NCT02106507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110504897|NCT02106507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110504898|NCT02106507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110504899|NCT02106507|Immunologic Factors|immunologic factors|mesh-ancestor
110454242|NCT04183738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110454243|NCT04183738|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110454244|NCT04183738|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110454245|NCT04183738|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110454246|NCT04183738|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110454247|NCT02682082|Bupivacaine|bupivacaine|mesh-list
110454248|NCT02682082|Anesthetics, Local|anesthetics, local|mesh-ancestor
110454249|NCT02682082|Anesthetics|anesthetics|mesh-ancestor
110454250|NCT02682082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110454251|NCT02682082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110454252|NCT02682082|Sensory System Agents|sensory system agents|mesh-ancestor
110454253|NCT02682082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110454254|NCT00640432|Celecoxib|celecoxib|mesh-list
110454255|NCT00640432|Diclofenac|diclofenac|mesh-list
110454256|NCT00640432|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110454257|NCT00640432|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110454258|NCT00640432|Analgesics|analgesics|mesh-ancestor
110454259|NCT00640432|Sensory System Agents|sensory system agents|mesh-ancestor
110454260|NCT00640432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110454261|NCT00640432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110454262|NCT00640432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110454263|NCT00640432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110454264|NCT00640432|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110454265|NCT00640432|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110454266|NCT00640432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110454267|NCT00640432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110454268|NCT02679664|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110454269|NCT02679664|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110454270|NCT02679664|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110454271|NCT02679664|Antimetabolites|antimetabolites|mesh-ancestor
110454272|NCT02679664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110454273|NCT02679664|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110454274|NCT02679664|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110454275|NCT02679664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110454277|NCT00641212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110454278|NCT00641212|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110454279|NCT00641212|Autonomic Agents|autonomic agents|mesh-ancestor
110454280|NCT00641212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110454281|NCT00641212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110454282|NCT00641212|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110454283|NCT00641212|Respiratory System Agents|respiratory system agents|mesh-ancestor
110454284|NCT00641212|Glucocorticoids|glucocorticoids|mesh-ancestor
110454285|NCT00641212|Hormones|hormones|mesh-ancestor
110454286|NCT00641212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110454287|NCT04183192|Reslizumab|reslizumab|mesh-list
110454288|NCT04183192|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110454289|NCT04183192|Respiratory System Agents|respiratory system agents|mesh-ancestor
110454290|NCT02681848|Nicotine|nicotine|mesh-list
110454291|NCT02681848|Varenicline|varenicline|mesh-list
110454292|NCT02681848|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110454293|NCT02681848|Autonomic Agents|autonomic agents|mesh-ancestor
110454294|NCT02681848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110454295|NCT02681848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110454296|NCT02681848|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110454297|NCT02681848|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110454298|NCT02681848|Cholinergic Agents|cholinergic agents|mesh-ancestor
110454299|NCT02681848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110454300|NCT02681848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110504900|NCT02106507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110504901|NCT02106507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110504903|NCT02051218|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110504904|NCT02051218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110504905|NCT01940094|Prednisone|prednisone|mesh-list
110504906|NCT01940094|Glucocorticoids|glucocorticoids|mesh-list
110504907|NCT01940094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110504908|NCT01940094|Hormones|hormones|mesh-ancestor
110170466|NCT00040144|Dexelvucitabine|dexelvucitabine|mesh-list
110454301|NCT00997386|Melphalan|melphalan|mesh-list
110454302|NCT00997386|Busulfan|busulfan|mesh-list
110454303|NCT00997386|Alemtuzumab|alemtuzumab|mesh-list
110454304|NCT00997386|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110454305|NCT00997386|Alkylating Agents|alkylating agents|mesh-ancestor
110454306|NCT00997386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110454307|NCT00997386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110454308|NCT00997386|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110454309|NCT00997386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110454310|NCT00997386|Immunologic Factors|immunologic factors|mesh-ancestor
110454311|NCT00997386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110454312|NCT00997386|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110454314|NCT02679820|Trace Elements|trace elements|mesh-ancestor
110454315|NCT02679820|Micronutrients|micronutrients|mesh-ancestor
110454316|NCT02679820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110454317|NCT00641914|Budesonide|budesonide|mesh-list
110454318|NCT00641914|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110454319|NCT00641914|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110454320|NCT00641914|Autonomic Agents|autonomic agents|mesh-ancestor
110454321|NCT00641914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110454322|NCT00641914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110454323|NCT00641914|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110454324|NCT00641914|Respiratory System Agents|respiratory system agents|mesh-ancestor
110454325|NCT00641914|Glucocorticoids|glucocorticoids|mesh-ancestor
110454326|NCT00641914|Hormones|hormones|mesh-ancestor
110454327|NCT00641914|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110454329|NCT00640588|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
110454330|NCT00640588|Telbivudine|telbivudine|mesh-list
110454331|NCT00640588|Antiviral Agents|antiviral agents|mesh-ancestor
110454332|NCT00640588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110454333|NCT00640588|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110454334|NCT00640588|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110454335|NCT00640588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110454336|NCT00640588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110454338|NCT05663398|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110454339|NCT05663398|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110454340|NCT05663398|Analgesics|analgesics|mesh-ancestor
110454341|NCT05663398|Sensory System Agents|sensory system agents|mesh-ancestor
110454342|NCT05663398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110454343|NCT05663398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110454344|NCT05663398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110454345|NCT05663398|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110454346|NCT05663398|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110454347|NCT05663398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110454348|NCT05663398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110454349|NCT00640744|Atorvastatin|atorvastatin|mesh-list
110454350|NCT00640744|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110454351|NCT00640744|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110454352|NCT00640744|Antimetabolites|antimetabolites|mesh-ancestor
110454353|NCT00640744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110454354|NCT00640744|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110454355|NCT00640744|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110454356|NCT00640744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110454357|NCT02678104|Chlorhexidine|chlorhexidine|mesh-list
110454358|NCT02678104|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110504909|NCT01940094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110504910|NCT01940094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110504911|NCT01940094|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110504912|NCT01940094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110504914|NCT01905046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110504915|NCT01905046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110504916|NCT01786265|Prednisone|prednisone|mesh-list
110504917|NCT01786265|Cortisone|cortisone|mesh-list
110504918|NCT01786265|Leuprolide|leuprolide|mesh-list
110504919|NCT01786265|Goserelin|goserelin|mesh-list
110504920|NCT01786265|Flutamide|flutamide|mesh-list
110170533|NCT00040690|Cytarabine|cytarabine|mesh-list
110454359|NCT02678104|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110454360|NCT02678104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110454361|NCT02678104|Disinfectants|disinfectants|mesh-ancestor
110454362|NCT02678104|Dermatologic Agents|dermatologic agents|mesh-ancestor
110454363|NCT02681536|Triptorelin Pamoate|triptorelin pamoate|mesh-list
110454364|NCT02681536|Contraceptive Agents|contraceptive agents|mesh-list
110454365|NCT02681536|Contraceptives, Oral|contraceptives, oral|mesh-list
110454366|NCT02681536|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
110454367|NCT02681536|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110454368|NCT02681536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110454369|NCT02681536|Luteolytic Agents|luteolytic agents|mesh-ancestor
110454370|NCT02681536|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110454371|NCT02681536|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110454372|NCT02681536|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110454373|NCT02681536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110454374|NCT04183114|Vaccines|vaccines|mesh-list
110454375|NCT04183114|Immunologic Factors|immunologic factors|mesh-ancestor
110454376|NCT04183114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110454377|NCT00996996|Iodine|iodine|mesh-list
110454378|NCT00996996|Tositumomab I-131|tositumomab i-131|mesh-list
110454379|NCT00996996|Antibodies|antibodies|mesh-list
110454380|NCT00996996|Immunoglobulins|immunoglobulins|mesh-list
110454381|NCT00996996|Immunologic Factors|immunologic factors|mesh-ancestor
110454382|NCT00996996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110454383|NCT00996996|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110454384|NCT00996996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110454385|NCT00996996|Trace Elements|trace elements|mesh-ancestor
110454386|NCT00996996|Micronutrients|micronutrients|mesh-ancestor
110454387|NCT00996996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110454388|NCT04182568|Paclitaxel|paclitaxel|mesh-list
110454389|NCT04182568|Docetaxel|docetaxel|mesh-list
110454390|NCT04182568|Cyclophosphamide|cyclophosphamide|mesh-list
110454391|NCT04182568|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110454392|NCT04182568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110454393|NCT04182568|Tubulin Modulators|tubulin modulators|mesh-ancestor
110454394|NCT04182568|Antimitotic Agents|antimitotic agents|mesh-ancestor
110454395|NCT04182568|Mitosis Modulators|mitosis modulators|mesh-ancestor
110454396|NCT04182568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110454397|NCT04182568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110454398|NCT04182568|Immunologic Factors|immunologic factors|mesh-ancestor
110454399|NCT04182568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110454400|NCT04182568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110454401|NCT04182568|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110454402|NCT04182568|Alkylating Agents|alkylating agents|mesh-ancestor
110454403|NCT04182568|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110454404|NCT00641446|Budesonide|budesonide|mesh-list
110454405|NCT00641446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110454406|NCT00641446|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110454407|NCT00641446|Autonomic Agents|autonomic agents|mesh-ancestor
110454408|NCT00641446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110454409|NCT00641446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110454410|NCT00641446|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110454411|NCT00641446|Respiratory System Agents|respiratory system agents|mesh-ancestor
110504921|NCT01786265|Abiraterone Acetate|abiraterone acetate|mesh-list
110504922|NCT01786265|Bicalutamide|bicalutamide|mesh-list
110504923|NCT01786265|Nilutamide|nilutamide|mesh-list
110504924|NCT01786265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110504925|NCT01786265|Glucocorticoids|glucocorticoids|mesh-ancestor
110504926|NCT01786265|Hormones|hormones|mesh-ancestor
110504927|NCT01786265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110504928|NCT01786265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110504929|NCT01786265|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110504930|NCT01786265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110504931|NCT01786265|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110504932|NCT01786265|Fertility Agents|fertility agents|mesh-ancestor
110504933|NCT01786265|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110504934|NCT01786265|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110504935|NCT01786265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110504936|NCT01786265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110504937|NCT01786265|Hormone Antagonists|hormone antagonists|mesh-ancestor
110504938|NCT01786265|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110504939|NCT01786265|Androgen Antagonists|androgen antagonists|mesh-ancestor
110504940|NCT01596621|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110504941|NCT01596621|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110504942|NCT01596621|Alkylating Agents|alkylating agents|mesh-ancestor
110504943|NCT01596621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110504944|NCT01596621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110504946|NCT01264315|Immunologic Factors|immunologic factors|mesh-ancestor
110504947|NCT01264315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110454412|NCT00641446|Glucocorticoids|glucocorticoids|mesh-ancestor
110454413|NCT00641446|Hormones|hormones|mesh-ancestor
110454414|NCT00641446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110454415|NCT05663164|Thiamine|thiamine|mesh-list
110454416|NCT05663164|Vitamins|vitamins|mesh-ancestor
110454417|NCT05663164|Micronutrients|micronutrients|mesh-ancestor
110454418|NCT05663164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110454419|NCT05663164|Vitamin B Complex|vitamin b complex|mesh-ancestor
110454420|NCT02537470|Remogliflozin etabonate|remogliflozin etabonate|mesh-list
110454421|NCT02537470|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110454422|NCT02537470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110454423|NCT02537470|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110454424|NCT02537470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110454425|NCT02678728|Dexmedetomidine|dexmedetomidine|mesh-list
110454426|NCT02678728|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110454427|NCT02678728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110454428|NCT02678728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110454429|NCT02678728|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110454430|NCT02678728|Analgesics|analgesics|mesh-ancestor
110454431|NCT02678728|Sensory System Agents|sensory system agents|mesh-ancestor
110454432|NCT02678728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110504948|NCT01264315|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110504949|NCT01264315|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110504950|NCT01264315|Growth Substances|growth substances|mesh-ancestor
110504951|NCT01264315|Growth Inhibitors|growth inhibitors|mesh-ancestor
110504952|NCT01264315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110504953|NCT01108627|Formoterol Fumarate|formoterol fumarate|mesh-list
110504954|NCT01108627|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110504955|NCT01108627|Autonomic Agents|autonomic agents|mesh-ancestor
110504956|NCT01108627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110504957|NCT01108627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110170646|NCT00017355|Immunologic Factors|immunologic factors|mesh-ancestor
110454433|NCT02678728|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110454434|NCT02678728|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110454435|NCT02678728|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110454436|NCT02678728|Adrenergic Agents|adrenergic agents|mesh-ancestor
110454437|NCT02678728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110454438|NCT02678728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110454439|NCT04180072|Bevacizumab|bevacizumab|mesh-list
110454440|NCT04180072|Atezolizumab|atezolizumab|mesh-list
110454441|NCT04180072|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110454442|NCT04180072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110454443|NCT04180072|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110454444|NCT04180072|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110454445|NCT04180072|Growth Substances|growth substances|mesh-ancestor
110454446|NCT04180072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110454447|NCT04180072|Growth Inhibitors|growth inhibitors|mesh-ancestor
110454448|NCT04180072|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110454449|NCT04180072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110454450|NCT02678650|Anesthetics|anesthetics|mesh-list
110454451|NCT02678650|Propofol|propofol|mesh-list
110454452|NCT02678650|Isoflurane|isoflurane|mesh-list
110454453|NCT02678650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110454454|NCT02678650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110454455|NCT02678650|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110454456|NCT02678650|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110454457|NCT02678650|Anesthetics, General|anesthetics, general|mesh-ancestor
110454458|NCT02678650|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110454459|NCT04180150|Entecavir|entecavir|mesh-list
110454461|NCT04180150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110454462|NCT02678338|Magrolimab|magrolimab|mesh-list
110454463|NCT02678338|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110454464|NCT02678338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110454465|NCT00642226|Triamcinolone|triamcinolone|mesh-list
110454466|NCT00642226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110454467|NCT00642226|Glucocorticoids|glucocorticoids|mesh-ancestor
110454468|NCT00642226|Hormones|hormones|mesh-ancestor
110454469|NCT00642226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110454470|NCT00642226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110454471|NCT02675530|Ketamine|ketamine|mesh-list
110454472|NCT02675530|Analgesics|analgesics|mesh-ancestor
110454473|NCT02675530|Sensory System Agents|sensory system agents|mesh-ancestor
110454474|NCT02675530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110454475|NCT02675530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110454476|NCT02675530|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110454477|NCT02675530|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110454478|NCT02675530|Anesthetics, General|anesthetics, general|mesh-ancestor
110454479|NCT02675530|Anesthetics|anesthetics|mesh-ancestor
110454480|NCT02675530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110454481|NCT02675530|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110454482|NCT02675530|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110454483|NCT02675530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110454484|NCT02675530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110454485|NCT02675374|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
110504958|NCT01108627|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110504959|NCT01108627|Respiratory System Agents|respiratory system agents|mesh-ancestor
110504960|NCT01108627|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110504961|NCT01108627|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110504962|NCT01108627|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110504963|NCT01108627|Adrenergic Agents|adrenergic agents|mesh-ancestor
110504964|NCT01108627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110170712|NCT00017472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110454486|NCT02675374|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110454487|NCT02675374|Histamine Antagonists|histamine antagonists|mesh-ancestor
110454488|NCT02675374|Histamine Agents|histamine agents|mesh-ancestor
110454489|NCT02675374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110454490|NCT02675374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110454491|NCT02675374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110454492|NCT02678260|Spartalizumab|spartalizumab|mesh-list
110454493|NCT02678260|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110454494|NCT02678260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110454495|NCT02678260|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110454496|NCT02678260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110454497|NCT04179604|Simendan|simendan|mesh-list
110454498|NCT04179604|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110454499|NCT04179604|Vasodilator Agents|vasodilator agents|mesh-ancestor
110454500|NCT04179604|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110454501|NCT04179604|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110454502|NCT04179604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110454503|NCT04179604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110454504|NCT04179604|Protective Agents|protective agents|mesh-ancestor
110454505|NCT04179604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110454506|NCT02675140|Vitamins|vitamins|mesh-list
110454507|NCT02675140|Vitamin A|vitamin a|mesh-list
110454508|NCT02675140|Albendazole|albendazole|mesh-list
110454509|NCT02675140|Retinol palmitate|retinol palmitate|mesh-list
110454510|NCT02675140|Micronutrients|micronutrients|mesh-ancestor
110591797|NCT00673179|Gemcitabine|gemcitabine|mesh-list
110454511|NCT02675140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110454512|NCT02675140|Antioxidants|antioxidants|mesh-ancestor
110454513|NCT02675140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110454514|NCT02675140|Protective Agents|protective agents|mesh-ancestor
110454515|NCT02675140|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110454516|NCT02675140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110454517|NCT02675140|Anthelmintics|anthelmintics|mesh-ancestor
110454518|NCT02675140|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110454519|NCT02675140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110454520|NCT02675140|Anticestodal Agents|anticestodal agents|mesh-ancestor
110454521|NCT02675140|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110454522|NCT02675140|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110454523|NCT02675140|Tubulin Modulators|tubulin modulators|mesh-ancestor
110454524|NCT02675140|Antimitotic Agents|antimitotic agents|mesh-ancestor
110454525|NCT02675140|Mitosis Modulators|mitosis modulators|mesh-ancestor
110454526|NCT02674906|Heparin|heparin|mesh-list
110454527|NCT02674906|Calcium heparin|calcium heparin|mesh-list
110454528|NCT02674906|Anticoagulants|anticoagulants|mesh-list
110454529|NCT02674906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110454530|NCT02674906|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110454531|NCT02674906|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110454532|NCT01160744|Carboplatin|carboplatin|mesh-list
110454533|NCT01160744|Gemcitabine|gemcitabine|mesh-list
110454534|NCT01160744|Pemetrexed|pemetrexed|mesh-list
110454535|NCT01160744|Ramucirumab|ramucirumab|mesh-list
110454536|NCT01160744|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110454537|NCT01160744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110454538|NCT01160744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110454539|NCT01160744|Antimetabolites|antimetabolites|mesh-ancestor
110454540|NCT01160744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110454541|NCT01160744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110454542|NCT01160744|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110454543|NCT01160744|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110454544|NCT01160744|Immunologic Factors|immunologic factors|mesh-ancestor
110454545|NCT01160744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110504965|NCT01108627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110504966|NCT00890149|Ondansetron|ondansetron|mesh-list
110504967|NCT00890149|Antiemetics|antiemetics|mesh-ancestor
110504968|NCT00890149|Autonomic Agents|autonomic agents|mesh-ancestor
110504969|NCT00890149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110504970|NCT00890149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110504971|NCT00890149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110504972|NCT00890149|Antipruritics|antipruritics|mesh-ancestor
110504973|NCT00890149|Dermatologic Agents|dermatologic agents|mesh-ancestor
110504974|NCT00890149|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110504975|NCT00890149|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110170790|NCT00042328|Antiviral Agents|antiviral agents|mesh-ancestor
110454546|NCT02677246|Denosumab|denosumab|mesh-list
110454547|NCT02677246|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110454548|NCT02677246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110454549|NCT01160354|Plerixafor|plerixafor|mesh-list
110454550|NCT01160354|Clofarabine|clofarabine|mesh-list
110454551|NCT01160354|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110454552|NCT01160354|Antimetabolites|antimetabolites|mesh-ancestor
110454553|NCT01160354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110454554|NCT01160354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110454555|NCT01160354|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110454556|NCT01160354|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110454557|NCT01160354|Antiviral Agents|antiviral agents|mesh-ancestor
110454558|NCT01160354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110454559|NCT04178512|Dexamethasone|dexamethasone|mesh-list
110454560|NCT04178512|Dexamethasone acetate|dexamethasone acetate|mesh-list
110454561|NCT04178512|Fentanyl|fentanyl|mesh-list
110454562|NCT04178512|BB 1101|bb 1101|mesh-list
110454563|NCT04178512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110454564|NCT04178512|Antiemetics|antiemetics|mesh-ancestor
110454565|NCT04178512|Autonomic Agents|autonomic agents|mesh-ancestor
110454566|NCT04178512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110454567|NCT04178512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110454568|NCT04178512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110454569|NCT04178512|Glucocorticoids|glucocorticoids|mesh-ancestor
110454571|NCT04178512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110454572|NCT04178512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110454573|NCT04178512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110454574|NCT04178512|Protease Inhibitors|protease inhibitors|mesh-ancestor
110454575|NCT04178512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110454576|NCT04178512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110454577|NCT04178512|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110454578|NCT04178512|Narcotics|narcotics|mesh-ancestor
110454579|NCT04178512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110454580|NCT04178512|Analgesics|analgesics|mesh-ancestor
110454581|NCT04178512|Sensory System Agents|sensory system agents|mesh-ancestor
110454582|NCT04178512|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110454583|NCT04178512|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110454584|NCT04178512|Anesthetics, General|anesthetics, general|mesh-ancestor
110454585|NCT04178512|Anesthetics|anesthetics|mesh-ancestor
110454586|NCT01160198|Ascorbic Acid|ascorbic acid|mesh-list
110454587|NCT01160198|Chelating Agents|chelating agents|mesh-list
110454588|NCT01160198|Glycine|glycine|mesh-list
110454589|NCT01160198|Sequestering Agents|sequestering agents|mesh-ancestor
110454590|NCT01160198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110454591|NCT01160198|Glycine Agents|glycine agents|mesh-ancestor
110454592|NCT01160198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110454593|NCT01160198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110454594|NCT01160198|Antioxidants|antioxidants|mesh-ancestor
110454595|NCT01160198|Protective Agents|protective agents|mesh-ancestor
110454596|NCT01160198|Vitamins|vitamins|mesh-ancestor
110454597|NCT01160198|Micronutrients|micronutrients|mesh-ancestor
110454598|NCT02676934|Anesthetics|anesthetics|mesh-list
110454599|NCT02676934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110504978|NCT00890149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110504979|NCT00566098|Melphalan|melphalan|mesh-list
110504980|NCT00566098|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110504981|NCT00566098|Alkylating Agents|alkylating agents|mesh-ancestor
110504982|NCT00566098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110504983|NCT00566098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110504984|NCT00566098|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110454600|NCT02676934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110454601|NCT05351086|Dihydroergotamine|dihydroergotamine|mesh-list
110454602|NCT05351086|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110454603|NCT05351086|Dopamine Agonists|dopamine agonists|mesh-ancestor
110454604|NCT05351086|Dopamine Agents|dopamine agents|mesh-ancestor
110454605|NCT05351086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110454606|NCT05351086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110454607|NCT05351086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110454608|NCT05351086|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110454609|NCT05351086|Analgesics|analgesics|mesh-ancestor
110454610|NCT05351086|Sensory System Agents|sensory system agents|mesh-ancestor
110454611|NCT05351086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110454612|NCT02885168|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
110454613|NCT02885168|Phenylephrine|phenylephrine|mesh-list
110454614|NCT02885168|Protein C|protein c|mesh-list
110454615|NCT02885168|Oxymetazoline|oxymetazoline|mesh-list
110454616|NCT02885168|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110454617|NCT02885168|Mydriatics|mydriatics|mesh-ancestor
110454618|NCT02885168|Autonomic Agents|autonomic agents|mesh-ancestor
110454619|NCT02885168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110454620|NCT02885168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110454621|NCT02885168|Sympathomimetics|sympathomimetics|mesh-ancestor
110454622|NCT02885168|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110454623|NCT02885168|Nasal Decongestants|nasal decongestants|mesh-ancestor
110454624|NCT02885168|Respiratory System Agents|respiratory system agents|mesh-ancestor
110454625|NCT02885168|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110454626|NCT02885168|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110454627|NCT02885168|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110454628|NCT02885168|Adrenergic Agents|adrenergic agents|mesh-ancestor
110454629|NCT02885168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110454630|NCT02885168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110454631|NCT02885168|Protective Agents|protective agents|mesh-ancestor
110454632|NCT02885168|Anticoagulants|anticoagulants|mesh-ancestor
110454633|NCT02885168|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110454634|NCT02885168|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110454635|NCT02885168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110454636|NCT01159574|Clarithromycin|clarithromycin|mesh-list
110454637|NCT01159574|Dexamethasone|dexamethasone|mesh-list
110454638|NCT01159574|Pomalidomide|pomalidomide|mesh-list
110454639|NCT01159574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110454640|NCT01159574|Antiemetics|antiemetics|mesh-ancestor
110454641|NCT01159574|Autonomic Agents|autonomic agents|mesh-ancestor
110454642|NCT01159574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110454643|NCT01159574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110454644|NCT01159574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110454645|NCT01159574|Glucocorticoids|glucocorticoids|mesh-ancestor
110454646|NCT01159574|Hormones|hormones|mesh-ancestor
110454647|NCT01159574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110454648|NCT01159574|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110454649|NCT01159574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110454650|NCT01159574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110454651|NCT01159574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110454652|NCT01159574|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110454653|NCT01159574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110454654|NCT01159574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110454655|NCT01159574|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110377318|NCT00475670|Paclitaxel|paclitaxel|mesh-list
110454656|NCT01159574|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110504985|NCT00566098|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110504986|NCT00566098|Immunologic Factors|immunologic factors|mesh-ancestor
110504987|NCT00566098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110504988|NCT00248287|Carboplatin|carboplatin|mesh-list
110504989|NCT00248287|Irinotecan|irinotecan|mesh-list
110504990|NCT00248287|Cetuximab|cetuximab|mesh-list
110504991|NCT00248287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110504992|NCT00248287|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110454658|NCT01159574|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110454659|NCT01159574|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110454660|NCT01159574|Growth Substances|growth substances|mesh-ancestor
110454661|NCT01159574|Growth Inhibitors|growth inhibitors|mesh-ancestor
110454662|NCT01158950|Tolcapone|tolcapone|mesh-list
110299797|NCT00239954|Serotonin Agents|serotonin agents|mesh-ancestor
110454663|NCT01158950|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110454664|NCT01158950|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110454665|NCT01158950|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
110454666|NCT01158950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110454667|NCT01158950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110454668|NCT00910234|Epoetin Alfa|epoetin alfa|mesh-list
110454669|NCT00910234|Hematinics|hematinics|mesh-ancestor
110454670|NCT05652322|Furosemide|furosemide|mesh-list
110454671|NCT05652322|Diuretics|diuretics|mesh-ancestor
110454672|NCT05652322|Natriuretic Agents|natriuretic agents|mesh-ancestor
110454673|NCT05652322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110454674|NCT05652322|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110454675|NCT05652322|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110454676|NCT05652322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110454677|NCT01172288|Acetylcysteine|acetylcysteine|mesh-list
110454678|NCT01172288|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110454679|NCT01172288|Antiviral Agents|antiviral agents|mesh-ancestor
110454680|NCT01172288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110454681|NCT01172288|Expectorants|expectorants|mesh-ancestor
110454682|NCT01172288|Respiratory System Agents|respiratory system agents|mesh-ancestor
110454683|NCT01172288|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110454684|NCT01172288|Antioxidants|antioxidants|mesh-ancestor
110454685|NCT01172288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110454686|NCT01172288|Protective Agents|protective agents|mesh-ancestor
110454687|NCT01172288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110454688|NCT01172288|Antidotes|antidotes|mesh-ancestor
110454689|NCT02676622|Aldesleukin|aldesleukin|mesh-list
110454690|NCT02676622|Cyclophosphamide|cyclophosphamide|mesh-list
110454691|NCT02676622|Thymoglobulin|thymoglobulin|mesh-list
110454692|NCT02676622|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110454693|NCT02676622|Immunologic Factors|immunologic factors|mesh-ancestor
110454694|NCT02676622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110454695|NCT02676622|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110454696|NCT02676622|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110454697|NCT02676622|Alkylating Agents|alkylating agents|mesh-ancestor
110454698|NCT02676622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110454699|NCT02676622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110454700|NCT02676622|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110454701|NCT02676622|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110454702|NCT02676622|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110454703|NCT02676622|Antiviral Agents|antiviral agents|mesh-ancestor
110454704|NCT02676622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110454705|NCT00644020|Fluorouracil|fluorouracil|mesh-list
110454706|NCT00644020|Mitomycins|mitomycins|mesh-list
110454707|NCT00644020|Mitomycin|mitomycin|mesh-list
110454708|NCT00644020|Antimetabolites|antimetabolites|mesh-ancestor
110454709|NCT00644020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110454710|NCT00644020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110454711|NCT00644020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110454712|NCT00644020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110454713|NCT00644020|Immunologic Factors|immunologic factors|mesh-ancestor
110454714|NCT00644020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110454715|NCT00644020|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110454716|NCT00644020|Alkylating Agents|alkylating agents|mesh-ancestor
110454717|NCT00644020|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110504993|NCT00248287|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110504994|NCT00248287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110504995|NCT00248287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110504996|NCT00248287|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110504997|NCT04249284|Deucravacitinib|deucravacitinib|mesh-list
110504998|NCT04249284|Dermatologic Agents|dermatologic agents|mesh-ancestor
110504999|NCT04249284|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110505000|NCT04249284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110505001|NCT04249284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110505002|NCT04474938|Dexamethasone|dexamethasone|mesh-list
110505003|NCT04474938|Bortezomib|bortezomib|mesh-list
110505004|NCT04474938|Daratumumab|daratumumab|mesh-list
110505005|NCT04474938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110505006|NCT04474938|Antiemetics|antiemetics|mesh-ancestor
110505007|NCT04474938|Autonomic Agents|autonomic agents|mesh-ancestor
110505008|NCT04474938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110505009|NCT04474938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110505010|NCT04474938|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110505011|NCT04474938|Glucocorticoids|glucocorticoids|mesh-ancestor
110505012|NCT04474938|Hormones|hormones|mesh-ancestor
110505013|NCT04474938|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110505014|NCT04474938|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110505015|NCT04474938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110505016|NCT00837213|Doxycycline|doxycycline|mesh-list
110505017|NCT00837213|Clindamycin|clindamycin|mesh-list
110299867|NCT00240149|Insulin|insulin|mesh-list
110454718|NCT00644020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110454719|NCT04178980|Simvastatin|simvastatin|mesh-list
110454720|NCT04178980|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110454721|NCT04178980|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110454722|NCT04178980|Antimetabolites|antimetabolites|mesh-ancestor
110454723|NCT04178980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110454724|NCT04178980|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110454725|NCT04178980|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110454726|NCT04178980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110454727|NCT02674048|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
110454728|NCT02674048|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110454729|NCT02674048|Dermatologic Agents|dermatologic agents|mesh-ancestor
110454730|NCT02672566|Enoxaparin|enoxaparin|mesh-list
110454731|NCT02672566|Anticoagulants|anticoagulants|mesh-ancestor
110454732|NCT02672566|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110454733|NCT02672566|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110454734|NCT02672566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110454735|NCT02672488|Metformin|metformin|mesh-list
110454736|NCT02672488|Sorafenib|sorafenib|mesh-list
110454737|NCT02672488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110454738|NCT02672488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110454739|NCT02672488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110454740|NCT02672488|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110454741|NCT02672488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110454742|NCT02672488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110505018|NCT00837213|Clindamycin palmitate|clindamycin palmitate|mesh-list
110505019|NCT00837213|Clindamycin phosphate|clindamycin phosphate|mesh-list
110505020|NCT00837213|Benzoyl Peroxide|benzoyl peroxide|mesh-list
110505021|NCT00837213|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110505022|NCT00837213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110505023|NCT00837213|Antimalarials|antimalarials|mesh-ancestor
110505024|NCT00837213|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110505025|NCT00837213|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110505026|NCT00837213|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110505027|NCT00837213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110505028|NCT00837213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110505029|NCT00837213|Dermatologic Agents|dermatologic agents|mesh-ancestor
110505030|NCT02833038|Magnesium Sulfate|magnesium sulfate|mesh-list
110505031|NCT02833038|Analgesics|analgesics|mesh-ancestor
110505032|NCT02833038|Sensory System Agents|sensory system agents|mesh-ancestor
110505033|NCT02833038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110505034|NCT02833038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110505035|NCT02833038|Anesthetics|anesthetics|mesh-ancestor
110505036|NCT02833038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110505037|NCT02833038|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110505038|NCT02833038|Anticonvulsants|anticonvulsants|mesh-ancestor
110171044|NCT00043381|Decitabine|decitabine|mesh-list
110454743|NCT02537392|Folic Acid|folic acid|mesh-list
110454744|NCT02537392|Vitamin B Complex|vitamin b complex|mesh-list
110454745|NCT02537392|Vitamins|vitamins|mesh-ancestor
110454746|NCT02537392|Micronutrients|micronutrients|mesh-ancestor
110591860|NCT00920270|Colistin|colistin|mesh-list
110454747|NCT02537392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110454748|NCT02537392|Hematinics|hematinics|mesh-ancestor
110454749|NCT02673814|Durvalumab|durvalumab|mesh-list
110454750|NCT02673814|Bavituximab|bavituximab|mesh-list
110454751|NCT02673814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110454752|NCT02673814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110454753|NCT00644176|Azithromycin|azithromycin|mesh-list
110454754|NCT00644176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110454755|NCT00644176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110454756|NCT04178200|Lidocaine|lidocaine|mesh-list
110454757|NCT04178200|Bupivacaine|bupivacaine|mesh-list
110454758|NCT04178200|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110454759|NCT04178200|Anesthetics, Local|anesthetics, local|mesh-ancestor
110454760|NCT04178200|Anesthetics|anesthetics|mesh-ancestor
110454761|NCT04178200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110454762|NCT04178200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110454763|NCT04178200|Sensory System Agents|sensory system agents|mesh-ancestor
110454764|NCT04178200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110454765|NCT04178200|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110454766|NCT04178200|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110454767|NCT04178200|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110454768|NCT04178200|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110454769|NCT04178200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110454770|NCT02537158|Sorafenib|sorafenib|mesh-list
110454771|NCT02537158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110454772|NCT02537158|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110454773|NCT02537158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110299919|NCT00240305|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110454774|NCT02537158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110454775|NCT02676154|Fesoterodine|fesoterodine|mesh-list
110505039|NCT02833038|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110505040|NCT02833038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110505041|NCT02833038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110505042|NCT02833038|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110505043|NCT02833038|Tocolytic Agents|tocolytic agents|mesh-ancestor
110505044|NCT02833038|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110505045|NCT00703755|Metformin|metformin|mesh-list
110505046|NCT00703755|Fenofibrate|fenofibrate|mesh-list
110505047|NCT00703755|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110152386|NCT00000504|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110505048|NCT00703755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110505050|NCT00703755|Antimetabolites|antimetabolites|mesh-ancestor
110171082|NCT00043576|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110454776|NCT02676154|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110454777|NCT02676154|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110454778|NCT02676154|Cholinergic Agents|cholinergic agents|mesh-ancestor
110454779|NCT02676154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110454780|NCT02676154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110454781|NCT02676154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110454782|NCT02676154|Urological Agents|urological agents|mesh-ancestor
110454783|NCT02676310|Bimatoprost|bimatoprost|mesh-list
110454784|NCT02676310|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110454785|NCT04177186|Botulinum Toxins|botulinum toxins|mesh-list
110454786|NCT04177186|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110591872|NCT02584010|Silicon|silicon|mesh-list
110454787|NCT04177186|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110454788|NCT04177186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110454789|NCT04177186|Cholinergic Agents|cholinergic agents|mesh-ancestor
110454790|NCT04177186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110454791|NCT04177186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110454793|NCT04180384|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110454794|NCT04180384|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110454795|NCT04180384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110454796|NCT04180384|Tubulin Modulators|tubulin modulators|mesh-ancestor
110454797|NCT04180384|Antimitotic Agents|antimitotic agents|mesh-ancestor
110454798|NCT04180384|Mitosis Modulators|mitosis modulators|mesh-ancestor
110454799|NCT04180384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110454800|NCT00643240|Antibodies|antibodies|mesh-list
110454801|NCT00643240|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110454802|NCT00643240|Immunologic Factors|immunologic factors|mesh-ancestor
110454803|NCT00643240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110454804|NCT02671708|Cyclophosphamide|cyclophosphamide|mesh-list
110454805|NCT02671708|Busulfan|busulfan|mesh-list
110454806|NCT02671708|Idarubicin|idarubicin|mesh-list
110454807|NCT02671708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110454808|NCT02671708|Immunologic Factors|immunologic factors|mesh-ancestor
110454809|NCT02671708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110454810|NCT02671708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110454811|NCT02671708|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110454812|NCT02671708|Alkylating Agents|alkylating agents|mesh-ancestor
110454813|NCT02671708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110454814|NCT02671708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110454815|NCT02671708|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110454816|NCT02671708|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110454817|NCT02671708|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110454818|NCT02671708|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110454819|NCT02671708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110454820|NCT04176328|Teicoplanin|teicoplanin|mesh-list
110454821|NCT04176328|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110454822|NCT04176328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110454823|NCT04177342|Fentanyl|fentanyl|mesh-list
110454824|NCT04177342|Oxycodone|oxycodone|mesh-list
110454825|NCT04177342|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110505051|NCT00703755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110505052|NCT00703755|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110505053|NCT02838342|Interferons|interferons|mesh-list
110505054|NCT02838342|Interferon-alpha|interferon-alpha|mesh-list
110505055|NCT02838342|Cyclophosphamide|cyclophosphamide|mesh-list
110505056|NCT02838342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110505057|NCT02838342|Immunologic Factors|immunologic factors|mesh-ancestor
110505058|NCT02838342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110505059|NCT02838342|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110505060|NCT02838342|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110505061|NCT02838342|Alkylating Agents|alkylating agents|mesh-ancestor
110505062|NCT02838342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110171144|NCT00043888|Fosamprenavir|fosamprenavir|mesh-list
110454826|NCT04177342|Narcotics|narcotics|mesh-ancestor
110454827|NCT04177342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110454828|NCT04177342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110454829|NCT04177342|Analgesics|analgesics|mesh-ancestor
110454830|NCT04177342|Sensory System Agents|sensory system agents|mesh-ancestor
110454831|NCT04177342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110454832|NCT04177342|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110454833|NCT04177342|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110454834|NCT04177342|Anesthetics, General|anesthetics, general|mesh-ancestor
110454835|NCT04177342|Anesthetics|anesthetics|mesh-ancestor
110454836|NCT04175158|Bevacizumab|bevacizumab|mesh-list
110454837|NCT04175158|Endothelial Growth Factors|endothelial growth factors|mesh-list
110454838|NCT04175158|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110454839|NCT04175158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110454840|NCT04175158|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110454841|NCT04175158|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110454842|NCT04175158|Growth Substances|growth substances|mesh-ancestor
110454843|NCT04175158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110454844|NCT04175158|Growth Inhibitors|growth inhibitors|mesh-ancestor
110454846|NCT02671318|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110454847|NCT02671318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110454848|NCT02671318|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110454849|NCT02671318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110454850|NCT02671318|Antifungal Agents|antifungal agents|mesh-ancestor
110454851|NCT02671318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110454852|NCT02671318|Immunologic Factors|immunologic factors|mesh-ancestor
110454853|NCT02671318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110454854|NCT00644722|Pyrithione zinc|pyrithione zinc|mesh-list
110454855|NCT00644722|Keratolytic Agents|keratolytic agents|mesh-ancestor
110454856|NCT00644722|Dermatologic Agents|dermatologic agents|mesh-ancestor
110454857|NCT02668588|Octreotide|octreotide|mesh-list
110454858|NCT02668588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110454859|NCT02668588|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110454860|NCT02668588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110454861|NCT02671084|Sevoflurane|sevoflurane|mesh-list
110454862|NCT02671084|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110454863|NCT02671084|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110454864|NCT02671084|Anesthetics, General|anesthetics, general|mesh-ancestor
110454865|NCT02671084|Anesthetics|anesthetics|mesh-ancestor
110454866|NCT02671084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110454867|NCT02671084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110454868|NCT00644800|Ziprasidone|ziprasidone|mesh-list
110454869|NCT00644800|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110454870|NCT00644800|Serotonin Agents|serotonin agents|mesh-ancestor
110454871|NCT00644800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110454872|NCT00644800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110454873|NCT00644800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110454874|NCT00644800|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110454875|NCT00644800|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110505063|NCT02838342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110505064|NCT02838342|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110505065|NCT02838342|Antiviral Agents|antiviral agents|mesh-ancestor
110505066|NCT02838342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110505067|NCT05333640|Sirolimus|sirolimus|mesh-list
110505068|NCT05333640|Paclitaxel|paclitaxel|mesh-list
110505069|NCT05333640|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110505070|NCT05333640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110505071|NCT05333640|Tubulin Modulators|tubulin modulators|mesh-ancestor
110505072|NCT05333640|Antimitotic Agents|antimitotic agents|mesh-ancestor
110505073|NCT05333640|Mitosis Modulators|mitosis modulators|mesh-ancestor
110505074|NCT05333640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110505075|NCT05333640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110505076|NCT05333640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110505077|NCT05333640|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110505078|NCT05333640|Antifungal Agents|antifungal agents|mesh-ancestor
110505079|NCT05333640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110505080|NCT05333640|Immunologic Factors|immunologic factors|mesh-ancestor
110505081|NCT05333640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110505082|NCT02838264|Itraconazole|itraconazole|mesh-list
110505083|NCT02838264|Antifungal Agents|antifungal agents|mesh-ancestor
110505084|NCT02838264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110505085|NCT02838264|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110505086|NCT02838264|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110505087|NCT02838264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110454876|NCT00644800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110454877|NCT00644800|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110454878|NCT00644800|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110454879|NCT00644800|Dopamine Agents|dopamine agents|mesh-ancestor
110454880|NCT02670616|Prednisolone|prednisolone|mesh-list
110454881|NCT02670616|Cyclophosphamide|cyclophosphamide|mesh-list
110454882|NCT02670616|Rituximab|rituximab|mesh-list
110454884|NCT02670616|Vincristine|vincristine|mesh-list
110454885|NCT02670616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110454886|NCT02670616|Immunologic Factors|immunologic factors|mesh-ancestor
110454887|NCT02670616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110454888|NCT02670616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110454889|NCT02670616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110454890|NCT02670616|Alkylating Agents|alkylating agents|mesh-ancestor
110454891|NCT02670616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110454892|NCT02670616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110454893|NCT02670616|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110454894|NCT02670616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110454895|NCT02670616|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110454896|NCT02670616|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110454897|NCT02670616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110454898|NCT02670616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110454899|NCT02670616|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110454900|NCT02670616|Tubulin Modulators|tubulin modulators|mesh-ancestor
110454901|NCT02670616|Antimitotic Agents|antimitotic agents|mesh-ancestor
110454902|NCT02670616|Mitosis Modulators|mitosis modulators|mesh-ancestor
110505088|NCT02838264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110505089|NCT02838264|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110505090|NCT02838264|Hormone Antagonists|hormone antagonists|mesh-ancestor
110505091|NCT02838264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110505092|NCT02838264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110505093|NCT02838264|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110505095|NCT00633438|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110505096|NCT00633438|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110505097|NCT00633438|Analgesics|analgesics|mesh-ancestor
110505098|NCT00633438|Sensory System Agents|sensory system agents|mesh-ancestor
110505099|NCT00633438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110505100|NCT00633438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110505101|NCT00633438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110505102|NCT00633438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110454903|NCT02670616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110454904|NCT02670616|Glucocorticoids|glucocorticoids|mesh-ancestor
110454905|NCT02670616|Hormones|hormones|mesh-ancestor
110454906|NCT02670616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110454907|NCT02670616|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110454908|NCT00645502|Risperidone|risperidone|mesh-list
110454909|NCT00645502|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110454910|NCT00645502|Serotonin Agents|serotonin agents|mesh-ancestor
110454911|NCT00645502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110454912|NCT00645502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110454913|NCT00645502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110454914|NCT00645502|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110454915|NCT00645502|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110454916|NCT00645502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110300047|NCT00250536|Nandrolone|nandrolone|mesh-list
110454917|NCT00645502|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110454918|NCT00645502|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110454919|NCT00645502|Dopamine Agents|dopamine agents|mesh-ancestor
110454920|NCT00644956|Sildenafil Citrate|sildenafil citrate|mesh-list
110454921|NCT00644956|Tadalafil|tadalafil|mesh-list
110454922|NCT00644956|Vasodilator Agents|vasodilator agents|mesh-ancestor
110454923|NCT00644956|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110454924|NCT00644956|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110454925|NCT00644956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110454926|NCT00644956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110454927|NCT00644956|Urological Agents|urological agents|mesh-ancestor
110454928|NCT04175002|Progesterone|progesterone|mesh-list
110454929|NCT04175002|Progestins|progestins|mesh-ancestor
110454930|NCT04175002|Hormones|hormones|mesh-ancestor
110454931|NCT04175002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110454932|NCT04175002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110454933|NCT02670772|Tenofovir|tenofovir|mesh-list
110454934|NCT02670772|Stavudine|stavudine|mesh-list
110454935|NCT02670772|Antiviral Agents|antiviral agents|mesh-ancestor
110454936|NCT02670772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110454937|NCT02670772|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110454938|NCT02670772|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110454939|NCT02670772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110454940|NCT02670772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110454941|NCT02670772|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110454942|NCT02670772|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110454943|NCT02670772|Antimetabolites|antimetabolites|mesh-ancestor
110454944|NCT02667730|Acetaminophen|acetaminophen|mesh-list
110454945|NCT02667730|Celecoxib|celecoxib|mesh-list
110454946|NCT02667730|Naproxen|naproxen|mesh-list
110505103|NCT00633438|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110505104|NCT00633438|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110505105|NCT00633438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110505106|NCT00633438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110505107|NCT02833116|Dexamethasone|dexamethasone|mesh-list
110505108|NCT02833116|Betamethasone|betamethasone|mesh-list
110505109|NCT02833116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110505110|NCT02833116|Antiemetics|antiemetics|mesh-ancestor
110505111|NCT02833116|Autonomic Agents|autonomic agents|mesh-ancestor
110505112|NCT02833116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110505113|NCT02833116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110505114|NCT02833116|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110505115|NCT02833116|Glucocorticoids|glucocorticoids|mesh-ancestor
110505116|NCT02833116|Hormones|hormones|mesh-ancestor
110454947|NCT02667730|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110454948|NCT02667730|Analgesics|analgesics|mesh-ancestor
110454949|NCT02667730|Sensory System Agents|sensory system agents|mesh-ancestor
110454950|NCT02667730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110454951|NCT02667730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110454952|NCT02667730|Antipyretics|antipyretics|mesh-ancestor
110454953|NCT02667730|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110454954|NCT02667730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110454955|NCT02667730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110454956|NCT02667730|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110454957|NCT02667730|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110454959|NCT02667730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110454960|NCT02667730|Gout Suppressants|gout suppressants|mesh-ancestor
110454961|NCT04294992|Ondansetron|ondansetron|mesh-list
110454962|NCT04294992|Antiemetics|antiemetics|mesh-ancestor
110454963|NCT04294992|Autonomic Agents|autonomic agents|mesh-ancestor
110454964|NCT04294992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110454965|NCT04294992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110454966|NCT04294992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110454967|NCT04294992|Antipruritics|antipruritics|mesh-ancestor
110454968|NCT04294992|Dermatologic Agents|dermatologic agents|mesh-ancestor
110454969|NCT04294992|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110454970|NCT04294992|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110454971|NCT04294992|Serotonin Agents|serotonin agents|mesh-ancestor
110454972|NCT04294992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110454973|NCT04294992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110454974|NCT00628914|Dexetimide|dexetimide|mesh-list
110454975|NCT00628914|Eszopiclone|eszopiclone|mesh-list
110454976|NCT00628914|Citalopram|citalopram|mesh-list
110454977|NCT00628914|Escitalopram|escitalopram|mesh-list
110454978|NCT00628914|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110454979|NCT00628914|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110454980|NCT00628914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110454981|NCT00628914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110454982|NCT00628914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110454983|NCT00628914|Serotonin Agents|serotonin agents|mesh-ancestor
110454984|NCT00628914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110454985|NCT00628914|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110454986|NCT00628914|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110454987|NCT00628914|Parasympatholytics|parasympatholytics|mesh-ancestor
110454988|NCT00628914|Autonomic Agents|autonomic agents|mesh-ancestor
110454989|NCT00628914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110454990|NCT00628914|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110454991|NCT00628914|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110454992|NCT00628914|Cholinergic Agents|cholinergic agents|mesh-ancestor
110454993|NCT00628914|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110454994|NCT00628914|Antidepressive Agents|antidepressive agents|mesh-ancestor
110505117|NCT02833116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110505118|NCT02833116|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110505119|NCT02833116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110152489|NCT00000531|Amiodarone|amiodarone|mesh-list
110505120|NCT02833116|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110505121|NCT02833116|Respiratory System Agents|respiratory system agents|mesh-ancestor
110454995|NCT00628914|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110454996|NCT00628914|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110454997|NCT00628914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110454998|NCT02870634|Copper|copper|mesh-list
110454999|NCT02870634|Trace Elements|trace elements|mesh-ancestor
110455000|NCT02870634|Micronutrients|micronutrients|mesh-ancestor
110455001|NCT02870634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110455002|NCT00645580|Fluvoxamine|fluvoxamine|mesh-list
110455003|NCT00645580|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110455004|NCT00645580|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110455005|NCT00645580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110455006|NCT00645580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110455007|NCT00645580|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110455008|NCT00645580|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110455009|NCT00645580|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110455010|NCT00645580|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110455011|NCT00645580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110455012|NCT00645580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110455013|NCT00645580|Serotonin Agents|serotonin agents|mesh-ancestor
110455014|NCT00645580|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110455015|NCT00645580|Antidepressive Agents|antidepressive agents|mesh-ancestor
110455016|NCT00645580|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110455017|NCT00645580|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110455018|NCT00645580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110455019|NCT00645580|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110455020|NCT02670304|Aspirin|aspirin|mesh-list
110455021|NCT02670304|Letrozole|letrozole|mesh-list
110455022|NCT02670304|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110455023|NCT02670304|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110455024|NCT02670304|Analgesics|analgesics|mesh-ancestor
110455025|NCT02670304|Sensory System Agents|sensory system agents|mesh-ancestor
110455026|NCT02670304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110455027|NCT02670304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110455028|NCT02670304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110455029|NCT02670304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110455030|NCT02670304|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110455031|NCT02670304|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110455032|NCT02670304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110455033|NCT02670304|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110455034|NCT02670304|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110455035|NCT02670304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110455036|NCT02670304|Antipyretics|antipyretics|mesh-ancestor
110455037|NCT02670304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110455038|NCT02670304|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110455039|NCT02670304|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110455040|NCT02670304|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110455041|NCT02670304|Hormone Antagonists|hormone antagonists|mesh-ancestor
110455042|NCT02670304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110455043|NCT00998946|Vitamins|vitamins|mesh-list
110455044|NCT00998946|Folic Acid|folic acid|mesh-list
110455045|NCT00998946|Vitamin B 12|vitamin b 12|mesh-list
110455046|NCT00998946|Vitamin B Complex|vitamin b complex|mesh-list
110455047|NCT00998946|10-deazaaminopterin|10-deazaaminopterin|mesh-list
110455048|NCT00998946|Micronutrients|micronutrients|mesh-ancestor
110455049|NCT00998946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110455050|NCT00998946|Hematinics|hematinics|mesh-ancestor
110455051|NCT00998946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110455052|NCT00998946|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110455053|NCT00998946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110455054|NCT00998946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110455055|NCT01158404|LY900009|ly900009|mesh-list
110505122|NCT00703989|Thioctic Acid|thioctic acid|mesh-list
110505123|NCT00703989|Benphothiamine|benphothiamine|mesh-list
110505124|NCT00703989|Antioxidants|antioxidants|mesh-ancestor
110505125|NCT00703989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110505126|NCT00703989|Protective Agents|protective agents|mesh-ancestor
110505127|NCT00703989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110505128|NCT00703989|Vitamin B Complex|vitamin b complex|mesh-ancestor
110505129|NCT00703989|Vitamins|vitamins|mesh-ancestor
110505130|NCT00703989|Micronutrients|micronutrients|mesh-ancestor
110505131|NCT00703989|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110505132|NCT00703989|Immunologic Factors|immunologic factors|mesh-ancestor
110505133|NCT00703989|Chelating Agents|chelating agents|mesh-ancestor
110505134|NCT00703989|Sequestering Agents|sequestering agents|mesh-ancestor
110505135|NCT05335460|Capecitabine|capecitabine|mesh-list
110505136|NCT05335460|Oxaliplatin|oxaliplatin|mesh-list
110505137|NCT05335460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110505138|NCT05335460|Antimetabolites|antimetabolites|mesh-ancestor
110171442|NCT00045370|Interferon-alpha|interferon-alpha|mesh-list
110455056|NCT01158404|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
110455057|NCT01158404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110455058|NCT01158404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110455059|NCT02670070|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110455060|NCT02670070|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110455061|NCT02670070|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110455062|NCT02670070|Antimetabolites|antimetabolites|mesh-ancestor
110455063|NCT02670070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110455064|NCT02670070|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110455065|NCT02670070|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110455066|NCT02670070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110455067|NCT00645034|Sildenafil Citrate|sildenafil citrate|mesh-list
110455068|NCT00645034|Vasodilator Agents|vasodilator agents|mesh-ancestor
110455069|NCT00645034|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110455070|NCT00645034|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110455071|NCT00645034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110455072|NCT00645034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110455073|NCT00645034|Urological Agents|urological agents|mesh-ancestor
110455075|NCT04173832|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110455076|NCT04173832|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110455077|NCT04173832|Antiviral Agents|antiviral agents|mesh-ancestor
110455078|NCT04173832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110455079|NCT04173832|Dopamine Agents|dopamine agents|mesh-ancestor
110455080|NCT04173832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110455081|NCT04173832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110455082|NCT04173832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110455083|NCT04173832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110455084|NCT04173832|Analgesics|analgesics|mesh-ancestor
110455085|NCT04173832|Sensory System Agents|sensory system agents|mesh-ancestor
110455086|NCT04173832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110455087|NCT00645658|Testosterone|testosterone|mesh-list
110455088|NCT00645658|Androgens|androgens|mesh-ancestor
110455089|NCT00645658|Hormones|hormones|mesh-ancestor
110102154|NCT01763710|Antimitotic Agents|antimitotic agents|mesh-ancestor
110455090|NCT00645658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110455091|NCT00645658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110455092|NCT02666170|Thioctic Acid|thioctic acid|mesh-list
110455093|NCT02666170|Antioxidants|antioxidants|mesh-ancestor
110455094|NCT02666170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110455095|NCT02666170|Protective Agents|protective agents|mesh-ancestor
110505139|NCT05335460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110505140|NCT05335460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110505141|NCT02836002|Pyrimethamine|pyrimethamine|mesh-list
110505142|NCT02836002|Piperaquine|piperaquine|mesh-list
110505143|NCT02836002|Sulfadoxine|sulfadoxine|mesh-list
110505144|NCT02836002|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
110505145|NCT02836002|Atovaquone|atovaquone|mesh-list
110505146|NCT02836002|Proguanil|proguanil|mesh-list
110455096|NCT02666170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110455097|NCT02666170|Vitamin B Complex|vitamin b complex|mesh-ancestor
110455098|NCT02666170|Vitamins|vitamins|mesh-ancestor
110455099|NCT02666170|Micronutrients|micronutrients|mesh-ancestor
110455100|NCT02667262|Analgesics, Opioid|analgesics, opioid|mesh-list
110455101|NCT02667262|Narcotics|narcotics|mesh-ancestor
110455102|NCT02667262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110455103|NCT02667262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110455104|NCT02667262|Analgesics|analgesics|mesh-ancestor
110455105|NCT02667262|Sensory System Agents|sensory system agents|mesh-ancestor
110455106|NCT02667262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110455107|NCT00646126|Artesunate|artesunate|mesh-list
110455108|NCT00646126|Pyrimethamine|pyrimethamine|mesh-list
110455109|NCT00646126|Sulfadoxine|sulfadoxine|mesh-list
110455110|NCT00646126|Antimalarials|antimalarials|mesh-ancestor
110455111|NCT00646126|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110455112|NCT00646126|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110455113|NCT00646126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110455114|NCT00646126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110455115|NCT00646126|Antiviral Agents|antiviral agents|mesh-ancestor
110455116|NCT00646126|Schistosomicides|schistosomicides|mesh-ancestor
110455117|NCT00646126|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110455118|NCT00646126|Anthelmintics|anthelmintics|mesh-ancestor
110300252|NCT00250692|Analgesics|analgesics|mesh-ancestor
110455119|NCT00646126|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110455120|NCT00646126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110455121|NCT00646126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110455122|NCT00646126|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110455123|NCT02537080|Nimodipine|nimodipine|mesh-list
110455124|NCT02537080|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110455125|NCT02537080|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110455126|NCT02537080|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110455127|NCT02537080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110455128|NCT02537080|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110455129|NCT02537080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110455130|NCT02537080|Vasodilator Agents|vasodilator agents|mesh-ancestor
110455131|NCT02667496|Sargramostim|sargramostim|mesh-list
110455132|NCT02667496|Immunologic Factors|immunologic factors|mesh-ancestor
110455133|NCT02667496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110455134|NCT00645112|Azithromycin|azithromycin|mesh-list
110455135|NCT00645112|Cefdinir|cefdinir|mesh-list
110455136|NCT00645112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110455137|NCT00645112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110455138|NCT02666092|Antibodies|antibodies|mesh-list
110455139|NCT02666092|Immunologic Factors|immunologic factors|mesh-ancestor
110455140|NCT02666092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110455141|NCT00645814|Adalimumab|adalimumab|mesh-list
110455142|NCT00645814|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110455143|NCT00645814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110455144|NCT00645814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110455145|NCT04174378|Triptorelin Pamoate|triptorelin pamoate|mesh-list
110455146|NCT04174378|Luteolytic Agents|luteolytic agents|mesh-ancestor
110455147|NCT04174378|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110455148|NCT04174378|Contraceptive Agents|contraceptive agents|mesh-ancestor
110455149|NCT04174378|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110455150|NCT04174378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110455151|NCT04174378|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110455152|NCT04174378|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110455153|NCT04174378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110455154|NCT00645892|Adalimumab|adalimumab|mesh-list
110455155|NCT00645892|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110455156|NCT00645892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110505147|NCT02836002|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
110505148|NCT02836002|Antimalarials|antimalarials|mesh-ancestor
110505149|NCT02836002|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110505150|NCT02836002|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110505151|NCT02836002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110505152|NCT02836002|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110505153|NCT02836002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110505154|NCT02836002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110505155|NCT02836002|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110505156|NCT02836002|Antimetabolites|antimetabolites|mesh-ancestor
110505157|NCT02297516|Botulinum Toxins|botulinum toxins|mesh-list
110505158|NCT02297516|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110505159|NCT02297516|Hyaluronic Acid|hyaluronic acid|mesh-list
110455157|NCT00645892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110455158|NCT00645190|Galantamine|galantamine|mesh-list
110455159|NCT00645190|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110455160|NCT00645190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110455161|NCT00645190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110455162|NCT00645190|Cholinergic Agents|cholinergic agents|mesh-ancestor
110455163|NCT00645190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110455164|NCT00645190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110455165|NCT00645190|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110455166|NCT00645190|Autonomic Agents|autonomic agents|mesh-ancestor
110102231|NCT01763424|Calcitriol|calcitriol|mesh-list
110455167|NCT00645190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110455168|NCT00645190|Nootropic Agents|nootropic agents|mesh-ancestor
110455170|NCT00910390|Plant Growth Regulators|plant growth regulators|mesh-ancestor
110455171|NCT00910390|Growth Substances|growth substances|mesh-ancestor
110455172|NCT00910390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110455173|NCT02665936|Dexamethasone|dexamethasone|mesh-list
110455174|NCT02665936|Dexamethasone acetate|dexamethasone acetate|mesh-list
110455175|NCT02665936|Levobupivacaine|levobupivacaine|mesh-list
110455176|NCT02665936|BB 1101|bb 1101|mesh-list
110455177|NCT02665936|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110455178|NCT02665936|Antiemetics|antiemetics|mesh-ancestor
110455179|NCT02665936|Autonomic Agents|autonomic agents|mesh-ancestor
110455180|NCT02665936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110455181|NCT02665936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110455182|NCT02665936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110455184|NCT02665936|Hormones|hormones|mesh-ancestor
110455185|NCT02665936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110591977|NCT00764907|Antidotes|antidotes|mesh-ancestor
110455186|NCT02665936|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110300315|NCT01689298|Oxytocics|oxytocics|mesh-ancestor
110455187|NCT02665936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110455188|NCT02665936|Protease Inhibitors|protease inhibitors|mesh-ancestor
110455189|NCT02665936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110455190|NCT02665936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110455191|NCT02665936|Anesthetics, Local|anesthetics, local|mesh-ancestor
110455192|NCT02665936|Anesthetics|anesthetics|mesh-ancestor
110455193|NCT02665936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110455194|NCT02665936|Sensory System Agents|sensory system agents|mesh-ancestor
110455195|NCT02665780|Cetylpyridinium|cetylpyridinium|mesh-list
110455196|NCT02665780|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110455197|NCT02665780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110455198|NCT04292886|Tamoxifen|tamoxifen|mesh-list
110455199|NCT04292886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110455200|NCT04292886|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110455201|NCT04292886|Hormone Antagonists|hormone antagonists|mesh-ancestor
110455202|NCT04292886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110455203|NCT04292886|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110455204|NCT04292886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110455205|NCT04292886|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110505160|NCT02297516|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110505161|NCT02297516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110505162|NCT02297516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110505163|NCT02297516|Cholinergic Agents|cholinergic agents|mesh-ancestor
110505164|NCT02297516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110505165|NCT02297516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110505166|NCT02297516|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110505167|NCT02297516|Immunologic Factors|immunologic factors|mesh-ancestor
110505168|NCT02297516|Viscosupplements|viscosupplements|mesh-ancestor
110505169|NCT02297516|Protective Agents|protective agents|mesh-ancestor
110505170|NCT02842580|Leucovorin|leucovorin|mesh-list
110505171|NCT02842580|Bevacizumab|bevacizumab|mesh-list
110505172|NCT02842580|Capecitabine|capecitabine|mesh-list
110505173|NCT02842580|Oxaliplatin|oxaliplatin|mesh-list
110505174|NCT02842580|Irinotecan|irinotecan|mesh-list
110505175|NCT02842580|Levoleucovorin|levoleucovorin|mesh-list
110171631|NCT00045955|Hormone Antagonists|hormone antagonists|mesh-ancestor
110455206|NCT04292886|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110455207|NCT04292886|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110455208|NCT04292418|Mycophenolic Acid|mycophenolic acid|mesh-list
110455209|NCT04292418|Tacrolimus|tacrolimus|mesh-list
110455210|NCT04292418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110455211|NCT04292418|Immunologic Factors|immunologic factors|mesh-ancestor
110455212|NCT04292418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110455213|NCT04292418|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110455214|NCT04292418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110455215|NCT04292418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110455216|NCT04292418|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110455217|NCT04292418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110455218|NCT04292418|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110455219|NCT04292418|Antitubercular Agents|antitubercular agents|mesh-ancestor
110455220|NCT04292418|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110455221|NCT04292418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110455222|NCT02666716|Fluconazole|fluconazole|mesh-list
110455223|NCT02666716|Antifungal Agents|antifungal agents|mesh-ancestor
110455224|NCT02666716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110455225|NCT02666716|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110455226|NCT02666716|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110455227|NCT02666716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110455228|NCT02666716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110455229|NCT02666716|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110455230|NCT02666716|Hormone Antagonists|hormone antagonists|mesh-ancestor
110455231|NCT02666716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110591987|NCT02583698|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110455232|NCT02666716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110455233|NCT02666716|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110455234|NCT02666716|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110455235|NCT04064476|Paliperidone Palmitate|paliperidone palmitate|mesh-list
110455236|NCT04064476|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110455237|NCT04064476|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110455238|NCT04064476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110102344|NCT01765010|Vitamin D|vitamin d|mesh-list
110455239|NCT04064476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110455240|NCT04064476|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110455241|NCT04064476|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110455242|NCT04064476|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110455243|NCT04064476|Serotonin Agents|serotonin agents|mesh-ancestor
110455244|NCT04064476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110455245|NCT04064476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110505176|NCT02842580|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110505177|NCT02842580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110505178|NCT02842580|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110505179|NCT02842580|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110505180|NCT02842580|Growth Substances|growth substances|mesh-ancestor
110505181|NCT02842580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110505182|NCT02842580|Growth Inhibitors|growth inhibitors|mesh-ancestor
110505183|NCT02842580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110505184|NCT02842580|Antimetabolites|antimetabolites|mesh-ancestor
110505185|NCT02842580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110505186|NCT02842580|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110505187|NCT02842580|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110505188|NCT02842580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110505189|NCT02842580|Antidotes|antidotes|mesh-ancestor
110505190|NCT02842580|Protective Agents|protective agents|mesh-ancestor
110455246|NCT04064476|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110455247|NCT04064476|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110455248|NCT04064476|Dopamine Agents|dopamine agents|mesh-ancestor
110455249|NCT02669368|Magnesium Sulfate|magnesium sulfate|mesh-list
110455250|NCT02669368|Rocuronium|rocuronium|mesh-list
110455251|NCT02669368|Analgesics|analgesics|mesh-ancestor
110455252|NCT02669368|Sensory System Agents|sensory system agents|mesh-ancestor
110455253|NCT02669368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110455254|NCT02669368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110455256|NCT02669368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110455257|NCT02669368|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110455258|NCT02669368|Anticonvulsants|anticonvulsants|mesh-ancestor
110455259|NCT02669368|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110455260|NCT02669368|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110455261|NCT02669368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110455262|NCT02669368|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110455263|NCT02669368|Tocolytic Agents|tocolytic agents|mesh-ancestor
110455264|NCT02669368|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110455265|NCT02669368|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110455266|NCT02669368|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110455267|NCT02669368|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110455268|NCT00645268|Sildenafil Citrate|sildenafil citrate|mesh-list
110455269|NCT00645268|Vasodilator Agents|vasodilator agents|mesh-ancestor
110455270|NCT00645268|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110455271|NCT00645268|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110455272|NCT00645268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110455273|NCT00645268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110455274|NCT00645268|Urological Agents|urological agents|mesh-ancestor
110455275|NCT02666014|Neostigmine|neostigmine|mesh-list
110455276|NCT02666014|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110455277|NCT02666014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110455278|NCT02666014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110455279|NCT02666014|Cholinergic Agents|cholinergic agents|mesh-ancestor
110455280|NCT02666014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110455281|NCT02666014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110455282|NCT02666014|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110455283|NCT02666014|Autonomic Agents|autonomic agents|mesh-ancestor
110455284|NCT02666014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110455285|NCT02665702|Cisplatin|cisplatin|mesh-list
110455286|NCT02665702|Vinorelbine|vinorelbine|mesh-list
110455287|NCT02665702|Endostar protein|endostar protein|mesh-list
110455288|NCT02665702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110455289|NCT02665702|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110505191|NCT02842580|Vitamin B Complex|vitamin b complex|mesh-ancestor
110152528|NCT00000555|Progesterone|progesterone|mesh-list
110505192|NCT02842580|Vitamins|vitamins|mesh-ancestor
110505193|NCT02842580|Micronutrients|micronutrients|mesh-ancestor
110505194|NCT00836277|Irinotecan|irinotecan|mesh-list
110505195|NCT00836277|Panitumumab|panitumumab|mesh-list
110505196|NCT00836277|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110505197|NCT00836277|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110505198|NCT00836277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110505199|NCT00836277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110505200|NCT00836277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110505201|NCT00836277|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110505202|NCT00831025|Immunomodulating Agents|immunomodulating agents|mesh-list
110505203|NCT00831025|Immunologic Factors|immunologic factors|mesh-ancestor
110505204|NCT00831025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110505205|NCT00835731|Vitamin B 12|vitamin b 12|mesh-list
110505206|NCT00835731|Hydroxocobalamin|hydroxocobalamin|mesh-list
110505207|NCT00835731|Misoprostol|misoprostol|mesh-list
110505209|NCT00835731|Micronutrients|micronutrients|mesh-ancestor
110505210|NCT00835731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110505211|NCT00835731|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110505212|NCT00835731|Abortifacient Agents|abortifacient agents|mesh-ancestor
110505213|NCT00835731|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110505214|NCT00835731|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110505215|NCT00835731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110505216|NCT00835731|Oxytocics|oxytocics|mesh-ancestor
110505217|NCT00835731|Vitamin B Complex|vitamin b complex|mesh-ancestor
110505218|NCT00835731|Hematinics|hematinics|mesh-ancestor
110505219|NCT03721406|Ropivacaine|ropivacaine|mesh-list
110505220|NCT03721406|Anesthetics, Local|anesthetics, local|mesh-ancestor
110505221|NCT03721406|Anesthetics|anesthetics|mesh-ancestor
110505222|NCT03721406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110505223|NCT03721406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110505224|NCT03721406|Sensory System Agents|sensory system agents|mesh-ancestor
110505225|NCT03721406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110455290|NCT02665702|Tubulin Modulators|tubulin modulators|mesh-ancestor
110455291|NCT02665702|Antimitotic Agents|antimitotic agents|mesh-ancestor
110455292|NCT02665702|Mitosis Modulators|mitosis modulators|mesh-ancestor
110455293|NCT02665702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110455294|NCT02665702|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110455295|NCT02665702|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110455296|NCT02665702|Growth Substances|growth substances|mesh-ancestor
110455297|NCT02665702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110505227|NCT00751166|Desloratadine|desloratadine|mesh-list
110592015|NCT00762255|Bevacizumab|bevacizumab|mesh-list
110505228|NCT00751166|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110505229|NCT00751166|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110505230|NCT00751166|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110505231|NCT00751166|Histamine Antagonists|histamine antagonists|mesh-ancestor
110505232|NCT00751166|Histamine Agents|histamine agents|mesh-ancestor
110505233|NCT00751166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110505234|NCT00751166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110505235|NCT00751166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110505236|NCT00751166|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110505237|NCT00751166|Cholinergic Agents|cholinergic agents|mesh-ancestor
110505238|NCT00837343|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110505239|NCT00837343|Antidepressive Agents|antidepressive agents|mesh-ancestor
110505240|NCT00837343|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110505241|NCT00837343|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110505242|NCT00837343|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110505243|NCT00837343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110505244|NCT00837343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110505245|NCT00732368|Mometasone Furoate|mometasone furoate|mesh-list
110505246|NCT00732368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110505247|NCT00732368|Dermatologic Agents|dermatologic agents|mesh-ancestor
110505248|NCT00732368|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110505249|NCT00704145|Paclitaxel|paclitaxel|mesh-list
110505250|NCT00704145|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110505251|NCT00704145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110505252|NCT00704145|Tubulin Modulators|tubulin modulators|mesh-ancestor
110505253|NCT00704145|Antimitotic Agents|antimitotic agents|mesh-ancestor
110505254|NCT00704145|Mitosis Modulators|mitosis modulators|mesh-ancestor
110505255|NCT00704145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110505256|NCT03508232|Doxycycline|doxycycline|mesh-list
110505271|NCT00704301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110505272|NCT00704301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110505273|NCT00704301|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110505274|NCT00704301|Protective Agents|protective agents|mesh-ancestor
110505275|NCT00831103|Valacyclovir|valacyclovir|mesh-list
110505276|NCT00831103|Antiviral Agents|antiviral agents|mesh-ancestor
110505277|NCT00831103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110505278|NCT00704444|Ezetimibe|ezetimibe|mesh-list
110505279|NCT00704444|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110505280|NCT00704444|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110505281|NCT00704444|Antimetabolites|antimetabolites|mesh-ancestor
110505282|NCT00704444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110505283|NCT00704444|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110505284|NCT00704691|Lenalidomide|lenalidomide|mesh-list
110505285|NCT00704691|Immunologic Factors|immunologic factors|mesh-ancestor
110505286|NCT00704691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110505287|NCT00704691|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110505288|NCT00704691|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110505289|NCT00704691|Growth Substances|growth substances|mesh-ancestor
110505290|NCT00704691|Growth Inhibitors|growth inhibitors|mesh-ancestor
110505291|NCT00704691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110505292|NCT00704925|Amifampridine|amifampridine|mesh-list
110505293|NCT00704925|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110505294|NCT00704925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110505295|NCT00704925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110505296|NCT00704925|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
110505297|NCT00704925|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110505298|NCT00704925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110455298|NCT02665702|Growth Inhibitors|growth inhibitors|mesh-ancestor
110455299|NCT00646750|Rituximab|rituximab|mesh-list
110455300|NCT00646750|Melphalan|melphalan|mesh-list
110455301|NCT00646750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110455302|NCT00646750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110455303|NCT00646750|Immunologic Factors|immunologic factors|mesh-ancestor
110455304|NCT00646750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110455305|NCT00646750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110455306|NCT00646750|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110455307|NCT00646750|Alkylating Agents|alkylating agents|mesh-ancestor
110455308|NCT00646750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110455309|NCT00646750|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110455310|NCT00646750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110455311|NCT00646516|Budesonide|budesonide|mesh-list
110455312|NCT00646516|Formoterol Fumarate|formoterol fumarate|mesh-list
110455313|NCT00646516|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
110455314|NCT00646516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110455315|NCT00646516|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110455316|NCT00646516|Autonomic Agents|autonomic agents|mesh-ancestor
110505299|NCT00574249|Adalimumab|adalimumab|mesh-list
110505300|NCT00574249|Betamethasone|betamethasone|mesh-list
110505301|NCT00574249|Calcipotriene|calcipotriene|mesh-list
110505302|NCT00574249|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110505303|NCT00574249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110505304|NCT00574249|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110505305|NCT00574249|Glucocorticoids|glucocorticoids|mesh-ancestor
110505306|NCT00574249|Hormones|hormones|mesh-ancestor
110505307|NCT00574249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110505308|NCT00574249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110505309|NCT00574249|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110505310|NCT00574249|Respiratory System Agents|respiratory system agents|mesh-ancestor
110505311|NCT00574249|Dermatologic Agents|dermatologic agents|mesh-ancestor
110505312|NCT00891228|ST 1435|st 1435|mesh-list
110505313|NCT00891228|Testosterone|testosterone|mesh-list
110505314|NCT00891228|Androgens|androgens|mesh-ancestor
110505315|NCT00891228|Hormones|hormones|mesh-ancestor
110505316|NCT00891228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110505317|NCT00891228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110505318|NCT00891228|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110505319|NCT00891228|Contraceptive Agents|contraceptive agents|mesh-ancestor
110505320|NCT00891228|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110505321|NCT00891228|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110505322|NCT00896168|Infliximab|infliximab|mesh-list
110505323|NCT00896168|Methotrexate|methotrexate|mesh-list
110505324|NCT00896168|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110455317|NCT00646516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110455318|NCT00646516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110455319|NCT00646516|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110455320|NCT00646516|Respiratory System Agents|respiratory system agents|mesh-ancestor
110455321|NCT00646516|Glucocorticoids|glucocorticoids|mesh-ancestor
110455322|NCT00646516|Hormones|hormones|mesh-ancestor
110455323|NCT00646516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110455324|NCT00646516|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110455325|NCT00646516|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110455327|NCT00646516|Adrenergic Agents|adrenergic agents|mesh-ancestor
110455328|NCT00646516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110455329|NCT00646516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110455330|NCT02665624|Calcium, Dietary|calcium, dietary|mesh-list
110455331|NCT02665624|Sennosides|sennosides|mesh-list
110455332|NCT02665624|Senna Extract|senna extract|mesh-list
110455333|NCT02665624|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110455334|NCT02665624|Calcium|calcium|mesh-list
110455335|NCT02665624|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110455336|NCT02665624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110455337|NCT02665624|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110455338|NCT02665624|Laxatives|laxatives|mesh-ancestor
110455339|NCT02665624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110455340|NCT02665624|Cathartics|cathartics|mesh-ancestor
110455341|NCT00646594|Fluticasone|fluticasone|mesh-list
110455342|NCT00646594|Budesonide|budesonide|mesh-list
110505325|NCT00896168|Abortifacient Agents|abortifacient agents|mesh-ancestor
110505326|NCT00896168|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110505327|NCT00896168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110505328|NCT00896168|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110505329|NCT00896168|Antimetabolites|antimetabolites|mesh-ancestor
110505330|NCT00896168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110505331|NCT00896168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110505332|NCT00896168|Dermatologic Agents|dermatologic agents|mesh-ancestor
110505333|NCT00896168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110505334|NCT00896168|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110505335|NCT00896168|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110505336|NCT00896168|Immunologic Factors|immunologic factors|mesh-ancestor
110505337|NCT00896168|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110505338|NCT00896168|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110505339|NCT00896168|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110505340|NCT00896168|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110505341|NCT00896168|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110505342|NCT00833703|Clopidogrel|clopidogrel|mesh-list
110505343|NCT00833703|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110505344|NCT00833703|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110505345|NCT00833703|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110505346|NCT00833703|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110505347|NCT00833703|Purinergic Agents|purinergic agents|mesh-ancestor
110505348|NCT00833703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110505349|NCT00833703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110505350|NCT00833703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110505351|NCT00833547|Eszopiclone|eszopiclone|mesh-list
110505352|NCT00833547|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110505353|NCT00833547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110505354|NCT00833547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110505355|NCT00833469|Escitalopram|escitalopram|mesh-list
110505356|NCT00833469|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110171920|NCT00047281|Alkylating Agents|alkylating agents|mesh-ancestor
110455343|NCT00646594|Formoterol Fumarate|formoterol fumarate|mesh-list
110455344|NCT00646594|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110455345|NCT00646594|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
110455346|NCT00646594|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
110455347|NCT00646594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110505357|NCT00833469|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110505358|NCT00833469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110505359|NCT00833469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110505360|NCT00833469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110505361|NCT00833469|Serotonin Agents|serotonin agents|mesh-ancestor
110505362|NCT00833469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110505363|NCT02831478|Sunscreening Agents|sunscreening agents|mesh-list
110505364|NCT02831478|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110505365|NCT02831478|Protective Agents|protective agents|mesh-ancestor
110505366|NCT02831478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110505367|NCT02831478|Dermatologic Agents|dermatologic agents|mesh-ancestor
110505368|NCT00837655|Calcium Carbonate|calcium carbonate|mesh-list
110505369|NCT00837655|Calcium|calcium|mesh-list
110505370|NCT00837655|Sevelamer|sevelamer|mesh-list
110505371|NCT00837655|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110505372|NCT00837655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110505373|NCT00837655|Antacids|antacids|mesh-ancestor
110505374|NCT00837655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110505375|NCT00837655|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110505376|NCT00837655|Chelating Agents|chelating agents|mesh-ancestor
110505377|NCT00837655|Sequestering Agents|sequestering agents|mesh-ancestor
110505378|NCT00843661|Ezetimibe|ezetimibe|mesh-list
110505379|NCT00843661|Pravastatin|pravastatin|mesh-list
110505380|NCT00843661|Fenofibrate|fenofibrate|mesh-list
110505381|NCT00843661|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110505382|NCT00843661|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110505383|NCT00843661|Antimetabolites|antimetabolites|mesh-ancestor
110505384|NCT00843661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110505385|NCT00843661|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110311928|NCT00291707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110505386|NCT00843661|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110505387|NCT00843661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110505389|NCT00832377|Dorzolamide|dorzolamide|mesh-list
110505390|NCT00832377|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110505391|NCT00832377|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110455348|NCT00646594|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110455349|NCT00646594|Autonomic Agents|autonomic agents|mesh-ancestor
110455350|NCT00646594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110455351|NCT00646594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110505392|NCT00832377|Adrenergic Agents|adrenergic agents|mesh-ancestor
110505393|NCT00832377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110505394|NCT00832377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110505395|NCT00832377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110455352|NCT00646594|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110455353|NCT00646594|Respiratory System Agents|respiratory system agents|mesh-ancestor
110455354|NCT00646594|Dermatologic Agents|dermatologic agents|mesh-ancestor
110455355|NCT00646594|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110455356|NCT00646594|Glucocorticoids|glucocorticoids|mesh-ancestor
110455357|NCT00646594|Hormones|hormones|mesh-ancestor
110455358|NCT00646594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110455359|NCT00646594|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110455360|NCT00646594|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110455361|NCT00646594|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110455362|NCT00646594|Adrenergic Agents|adrenergic agents|mesh-ancestor
110455363|NCT00646594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110455364|NCT00646594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110455365|NCT00646594|Sympathomimetics|sympathomimetics|mesh-ancestor
110455366|NCT00646984|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
110455367|NCT00646984|Antiviral Agents|antiviral agents|mesh-ancestor
110455368|NCT00646984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110455369|NCT04773184|Capsaicin|capsaicin|mesh-list
110455370|NCT04773184|Antipruritics|antipruritics|mesh-ancestor
110455371|NCT04773184|Dermatologic Agents|dermatologic agents|mesh-ancestor
110455372|NCT04773184|Sensory System Agents|sensory system agents|mesh-ancestor
110455373|NCT04773184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110455374|NCT04773184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110455375|NCT00647140|Levodopa|levodopa|mesh-list
110455376|NCT00647140|Dopamine Agents|dopamine agents|mesh-ancestor
110455377|NCT00647140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110455378|NCT00647140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110455379|NCT00647140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110455380|NCT00647140|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110455381|NCT00647140|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110455382|NCT00647218|Paclitaxel|paclitaxel|mesh-list
110455383|NCT00647218|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110455384|NCT00647218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110455385|NCT00647218|Tubulin Modulators|tubulin modulators|mesh-ancestor
110455386|NCT00647218|Antimitotic Agents|antimitotic agents|mesh-ancestor
110455387|NCT00647218|Mitosis Modulators|mitosis modulators|mesh-ancestor
110455388|NCT00647218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110455390|NCT00994890|Analgesics|analgesics|mesh-ancestor
110455391|NCT00994890|Sensory System Agents|sensory system agents|mesh-ancestor
110300532|NCT00264654|Paroxetine|paroxetine|mesh-list
110455392|NCT00994890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110455393|NCT00994890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110455394|NCT02663830|Sildenafil Citrate|sildenafil citrate|mesh-list
110455395|NCT02663830|Clomiphene|clomiphene|mesh-list
110455396|NCT02663830|Enclomiphene|enclomiphene|mesh-list
110455397|NCT02663830|Zuclomiphene|zuclomiphene|mesh-list
110455398|NCT02663830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110455399|NCT02663830|Vasodilator Agents|vasodilator agents|mesh-ancestor
110455400|NCT02663830|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110455401|NCT02663830|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110455402|NCT02663830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110455403|NCT02663830|Urological Agents|urological agents|mesh-ancestor
110455404|NCT02663830|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110455405|NCT02663830|Hormone Antagonists|hormone antagonists|mesh-ancestor
110455406|NCT02663830|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110455407|NCT02663830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110455408|NCT02663830|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110455409|NCT02663830|Fertility Agents|fertility agents|mesh-ancestor
110455410|NCT02663830|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110455411|NCT02663830|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110455412|NCT02663830|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110455413|NCT00648544|Pravastatin|pravastatin|mesh-list
110455414|NCT00648544|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110455415|NCT00648544|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110455416|NCT00648544|Antimetabolites|antimetabolites|mesh-ancestor
110455417|NCT00648544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110505396|NCT00832377|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110505397|NCT00832377|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110505398|NCT00832377|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110505399|NCT00832377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110505400|NCT00843895|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110505401|NCT00843895|Immunologic Factors|immunologic factors|mesh-ancestor
110505402|NCT00843895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110455418|NCT00648544|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110455419|NCT00648544|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110455420|NCT00648544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110455422|NCT00648622|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110455423|NCT00648622|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110455424|NCT00648622|Adrenergic Agents|adrenergic agents|mesh-ancestor
110455425|NCT00648622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110455426|NCT00648622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110455427|NCT00648622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110455428|NCT00648622|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110455429|NCT00648622|Antioxidants|antioxidants|mesh-ancestor
110592091|NCT00766155|Capecitabine|capecitabine|mesh-list
110455430|NCT00648622|Protective Agents|protective agents|mesh-ancestor
110455431|NCT00648622|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110455432|NCT00648622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110455433|NCT00648622|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110455434|NCT00648622|Vasodilator Agents|vasodilator agents|mesh-ancestor
110455435|NCT00648622|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110455436|NCT00648622|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110455437|NCT00994422|Ivermectin|ivermectin|mesh-list
110455438|NCT00994422|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110455439|NCT00994422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110455440|NCT00648778|Loxapine|loxapine|mesh-list
110455441|NCT00648778|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110455442|NCT00648778|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110455443|NCT00648778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110455444|NCT00648778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110455445|NCT00648778|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110455446|NCT00648778|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110455447|NCT00648778|Dopamine Agents|dopamine agents|mesh-ancestor
110455448|NCT00648778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110455449|NCT00648778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110455450|NCT00645424|Atorvastatin|atorvastatin|mesh-list
110455451|NCT00645424|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110455452|NCT00645424|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110455453|NCT00645424|Antimetabolites|antimetabolites|mesh-ancestor
110455454|NCT00645424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110455455|NCT00645424|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110455456|NCT00645424|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110455457|NCT00645424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110455458|NCT04172740|Calcium|calcium|mesh-list
110455459|NCT04172740|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110102539|NCT01766154|Tirofiban|tirofiban|mesh-list
110455460|NCT04172740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110455461|NCT02663596|Vancomycin|vancomycin|mesh-list
110455462|NCT02663596|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110455463|NCT02663596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110455464|NCT00647530|Fluorouracil|fluorouracil|mesh-list
110455465|NCT00647530|Capecitabine|capecitabine|mesh-list
110455466|NCT00647530|Oxaliplatin|oxaliplatin|mesh-list
110455467|NCT00647530|Panitumumab|panitumumab|mesh-list
110455468|NCT00647530|Antimetabolites|antimetabolites|mesh-ancestor
110455469|NCT00647530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110455470|NCT00647530|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110455471|NCT00647530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110455472|NCT00647530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110378133|NCT00479388|Niacin|niacin|mesh-list
110455473|NCT00647530|Immunologic Factors|immunologic factors|mesh-ancestor
110455474|NCT00647530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110455475|NCT00647530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110455476|NCT00647608|Propranolol|propranolol|mesh-list
110505403|NCT00705315|Bevacizumab|bevacizumab|mesh-list
110505404|NCT00705315|Docetaxel|docetaxel|mesh-list
110505405|NCT00705315|Epirubicin|epirubicin|mesh-list
110505406|NCT00705315|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110505407|NCT00705315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110505408|NCT00705315|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110505409|NCT00705315|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110505410|NCT00705315|Growth Substances|growth substances|mesh-ancestor
110455477|NCT00647608|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110455478|NCT00647608|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110455479|NCT00647608|Adrenergic Agents|adrenergic agents|mesh-ancestor
110455480|NCT00647608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110455481|NCT00647608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110455482|NCT00647608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110455483|NCT00647608|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110455484|NCT00647608|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110455485|NCT00647608|Vasodilator Agents|vasodilator agents|mesh-ancestor
110455486|NCT02663440|Temozolomide|temozolomide|mesh-list
110455487|NCT02663440|Molgramostim|molgramostim|mesh-list
110455488|NCT02663440|Sargramostim|sargramostim|mesh-list
110455489|NCT02663440|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110455490|NCT02663440|Alkylating Agents|alkylating agents|mesh-ancestor
110455491|NCT02663440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110455492|NCT02663440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110455493|NCT02663440|Immunologic Factors|immunologic factors|mesh-ancestor
110455494|NCT02663440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110455496|NCT04171180|Formoterol Fumarate|formoterol fumarate|mesh-list
110455497|NCT04171180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110455498|NCT04171180|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110455499|NCT04171180|Autonomic Agents|autonomic agents|mesh-ancestor
110455500|NCT04171180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110455501|NCT04171180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110455502|NCT04171180|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110455503|NCT04171180|Respiratory System Agents|respiratory system agents|mesh-ancestor
110455504|NCT04171180|Glucocorticoids|glucocorticoids|mesh-ancestor
110455505|NCT04171180|Hormones|hormones|mesh-ancestor
110455506|NCT04171180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110455507|NCT04171180|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110455508|NCT04171180|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110455509|NCT04171180|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110455510|NCT04171180|Adrenergic Agents|adrenergic agents|mesh-ancestor
110455511|NCT04171180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110455512|NCT04171180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110455513|NCT02660008|Glucagon|glucagon|mesh-list
110455514|NCT02660008|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
110455515|NCT02660008|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110455516|NCT02660008|Hormones|hormones|mesh-ancestor
110455517|NCT02660008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110455518|NCT02660008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110455519|NCT02660008|Incretins|incretins|mesh-ancestor
110455520|NCT00649168|Bromocriptine|bromocriptine|mesh-list
110455521|NCT00649168|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110455522|NCT00649168|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110455523|NCT00649168|Hormone Antagonists|hormone antagonists|mesh-ancestor
110455524|NCT00649168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110455525|NCT00649168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110455526|NCT00649168|Dopamine Agonists|dopamine agonists|mesh-ancestor
110455527|NCT00649168|Dopamine Agents|dopamine agents|mesh-ancestor
110455528|NCT00649168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110455529|NCT00649168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110455530|NCT02663206|Botulinum Toxins|botulinum toxins|mesh-list
110455531|NCT02663206|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110455532|NCT02663206|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110455533|NCT02663206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110455534|NCT02663206|Cholinergic Agents|cholinergic agents|mesh-ancestor
110455535|NCT02663206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110505411|NCT00705315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110505412|NCT00705315|Growth Inhibitors|growth inhibitors|mesh-ancestor
110505413|NCT00705315|Tubulin Modulators|tubulin modulators|mesh-ancestor
110505414|NCT00705315|Antimitotic Agents|antimitotic agents|mesh-ancestor
110505415|NCT00705315|Mitosis Modulators|mitosis modulators|mesh-ancestor
110505416|NCT00705315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110505417|NCT00705315|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110505418|NCT00705315|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110505419|NCT00705315|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110505420|NCT00705315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110505421|NCT00892008|Pregabalin|pregabalin|mesh-list
110152749|NCT00390208|Growth Substances|growth substances|mesh-ancestor
110505422|NCT00892008|Analgesics|analgesics|mesh-ancestor
110455536|NCT02663206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110455537|NCT02663284|Ropivacaine|ropivacaine|mesh-list
110455538|NCT02663284|Anesthetics, Local|anesthetics, local|mesh-ancestor
110455539|NCT02663284|Anesthetics|anesthetics|mesh-ancestor
110455540|NCT02663284|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110455541|NCT02663284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110455542|NCT02663284|Sensory System Agents|sensory system agents|mesh-ancestor
110455543|NCT02663284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110455544|NCT00647686|Fentanyl|fentanyl|mesh-list
110455545|NCT00647686|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110455546|NCT00647686|Narcotics|narcotics|mesh-ancestor
110455547|NCT00647686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110455548|NCT00647686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110455549|NCT00647686|Analgesics|analgesics|mesh-ancestor
110455550|NCT00647686|Sensory System Agents|sensory system agents|mesh-ancestor
110455551|NCT00647686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110455552|NCT00647686|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110455553|NCT00647686|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110455554|NCT00647686|Anesthetics, General|anesthetics, general|mesh-ancestor
110455555|NCT00647686|Anesthetics|anesthetics|mesh-ancestor
110455556|NCT02663050|Diclofenac|diclofenac|mesh-list
110455557|NCT02663050|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110455558|NCT02663050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110455559|NCT02663050|Analgesics|analgesics|mesh-ancestor
110455560|NCT02663050|Sensory System Agents|sensory system agents|mesh-ancestor
110455561|NCT02663050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110455562|NCT02663050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110455563|NCT02663050|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110455564|NCT02663050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110455565|NCT02663050|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110455566|NCT02663050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110455567|NCT02663050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110455568|NCT00648856|Sertraline|sertraline|mesh-list
110455569|NCT00648856|Antidepressive Agents|antidepressive agents|mesh-ancestor
110455570|NCT00648856|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110455571|NCT00648856|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110455572|NCT00648856|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110455573|NCT00648856|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110300702|NCT00242606|Nootropic Agents|nootropic agents|mesh-ancestor
110455574|NCT00648856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110455576|NCT00648856|Serotonin Agents|serotonin agents|mesh-ancestor
110455577|NCT00648856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110455578|NCT01171976|Ranibizumab|ranibizumab|mesh-list
110455579|NCT01171976|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110455580|NCT01171976|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110455581|NCT01171976|Growth Substances|growth substances|mesh-ancestor
110455582|NCT01171976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110455583|NCT01171976|Growth Inhibitors|growth inhibitors|mesh-ancestor
110455584|NCT01171976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110505423|NCT00892008|Sensory System Agents|sensory system agents|mesh-ancestor
110505424|NCT00892008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110505425|NCT00892008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110505426|NCT00892008|Anticonvulsants|anticonvulsants|mesh-ancestor
110505427|NCT00892008|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110505428|NCT00892008|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110505429|NCT00892008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110505430|NCT00892008|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110505431|NCT00892008|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110505432|NCT00892008|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110505433|NCT00892008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110455585|NCT00996216|Antiviral Agents|antiviral agents|mesh-list
110455586|NCT00996216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110455587|NCT00647842|Fentanyl|fentanyl|mesh-list
110455588|NCT00647842|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110455589|NCT00647842|Narcotics|narcotics|mesh-ancestor
110455590|NCT00647842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110455591|NCT00647842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110455592|NCT00647842|Analgesics|analgesics|mesh-ancestor
110455593|NCT00647842|Sensory System Agents|sensory system agents|mesh-ancestor
110455594|NCT00647842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110455595|NCT00647842|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110455596|NCT00647842|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110455597|NCT00647842|Anesthetics, General|anesthetics, general|mesh-ancestor
110455598|NCT00647842|Anesthetics|anesthetics|mesh-ancestor
110455599|NCT02662972|Botulinum Toxins|botulinum toxins|mesh-list
110455600|NCT02662972|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110455601|NCT02662972|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110455602|NCT02662972|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110455603|NCT02662972|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110455604|NCT02662972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110455605|NCT02662972|Cholinergic Agents|cholinergic agents|mesh-ancestor
110455606|NCT02662972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110455607|NCT02662972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110455608|NCT02662972|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110455609|NCT02662972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110455611|NCT02662894|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110455612|NCT02662894|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110455613|NCT02662894|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110455614|NCT02662894|Antimetabolites|antimetabolites|mesh-ancestor
110455615|NCT02662894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110455616|NCT02662894|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110455617|NCT02662894|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110455618|NCT02662894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110455619|NCT02662894|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110592160|NCT00766545|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110455620|NCT02662894|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110455621|NCT02662894|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110455622|NCT04291794|Propofol|propofol|mesh-list
110455623|NCT04291794|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110455624|NCT04291794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110455625|NCT04291794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110455626|NCT04291794|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110455627|NCT04291794|Anesthetics, General|anesthetics, general|mesh-ancestor
110455628|NCT04291794|Anesthetics|anesthetics|mesh-ancestor
110455629|NCT02662660|Acetaminophen|acetaminophen|mesh-list
110455630|NCT02662660|Dipyrone|dipyrone|mesh-list
110455631|NCT02662660|Bupivacaine|bupivacaine|mesh-list
110455632|NCT02662660|Levobupivacaine|levobupivacaine|mesh-list
110455633|NCT02662660|Anesthetics, Local|anesthetics, local|mesh-ancestor
110455634|NCT02662660|Anesthetics|anesthetics|mesh-ancestor
110455635|NCT02662660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110455636|NCT02662660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110505434|NCT00892008|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110505435|NCT00623233|Bevacizumab|bevacizumab|mesh-list
110505436|NCT00623233|Gemcitabine|gemcitabine|mesh-list
110505437|NCT00623233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110505438|NCT00623233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110505439|NCT00623233|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110455637|NCT02662660|Sensory System Agents|sensory system agents|mesh-ancestor
110455638|NCT02662660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110455639|NCT02662660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110455640|NCT02662660|Analgesics|analgesics|mesh-ancestor
110455641|NCT02662660|Antipyretics|antipyretics|mesh-ancestor
110455642|NCT02662660|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110455643|NCT02662660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110455644|NCT02662660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110455645|NCT02868606|Insulin|insulin|mesh-list
110455646|NCT02868606|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110455647|NCT02868606|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110455648|NCT02868606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110455649|NCT00647920|Adalimumab|adalimumab|mesh-list
110455650|NCT00647920|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110455651|NCT00647920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110455652|NCT00647920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110455653|NCT00830869|Ixazomib|ixazomib|mesh-list
110455654|NCT00830869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110455655|NCT00830869|Protease Inhibitors|protease inhibitors|mesh-ancestor
110455656|NCT00830869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110455657|NCT00830869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110455658|NCT02662504|Cisplatin|cisplatin|mesh-list
110455659|NCT02662504|Pemetrexed|pemetrexed|mesh-list
110455660|NCT02662504|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
110455661|NCT02662504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110455662|NCT02662504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110455663|NCT02662504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110455664|NCT02662504|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110455665|NCT02662504|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110455666|NCT02662504|Dermatologic Agents|dermatologic agents|mesh-ancestor
110455667|NCT02662504|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110455668|NCT00648934|Topiramate|topiramate|mesh-list
110455669|NCT00648934|Anticonvulsants|anticonvulsants|mesh-ancestor
110455670|NCT00648934|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110455671|NCT00648934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110455672|NCT02659228|Anesthetics|anesthetics|mesh-list
110455673|NCT02659228|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
110455674|NCT02659228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110455675|NCT02659228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110455676|NCT02659228|Anesthetics, General|anesthetics, general|mesh-ancestor
110455677|NCT00844519|Maraviroc|maraviroc|mesh-list
110455678|NCT00844519|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110455679|NCT00844519|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110455680|NCT00844519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110455681|NCT00844519|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110455682|NCT00844519|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110455683|NCT00844519|Antiviral Agents|antiviral agents|mesh-ancestor
110455684|NCT00844519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110455685|NCT00844519|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
110455687|NCT00702793|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110455688|NCT00702793|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110455689|NCT00702793|Cholinergic Agents|cholinergic agents|mesh-ancestor
110455690|NCT00702793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110455691|NCT00702793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110455692|NCT00702793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110455693|NCT02662426|Oseltamivir|oseltamivir|mesh-list
110455694|NCT02662426|Antiviral Agents|antiviral agents|mesh-ancestor
110455695|NCT02662426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110455696|NCT02662426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110455697|NCT02662426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110455698|NCT00994110|Pasireotide|pasireotide|mesh-list
110455699|NCT00994110|Hormones|hormones|mesh-ancestor
110455700|NCT00994110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110300831|NCT00243464|Dermatologic Agents|dermatologic agents|mesh-ancestor
110505440|NCT00623233|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110505441|NCT00623233|Growth Substances|growth substances|mesh-ancestor
110505442|NCT00623233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110505443|NCT00623233|Growth Inhibitors|growth inhibitors|mesh-ancestor
110505444|NCT00623233|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110505445|NCT00623233|Antimetabolites|antimetabolites|mesh-ancestor
110505446|NCT00623233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110505447|NCT00837889|Diuretics|diuretics|mesh-list
110505448|NCT00837889|Natriuretic Agents|natriuretic agents|mesh-ancestor
110505449|NCT00837889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110505450|NCT02841488|Fentanyl|fentanyl|mesh-list
110505451|NCT02841488|Ropivacaine|ropivacaine|mesh-list
110505452|NCT02841488|Anesthetics, Local|anesthetics, local|mesh-ancestor
110505453|NCT02841488|Anesthetics|anesthetics|mesh-ancestor
110505454|NCT02841488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110455701|NCT00994110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110455702|NCT02662348|Aldesleukin|aldesleukin|mesh-list
110455703|NCT02662348|Interleukin-2|interleukin-2|mesh-list
110455704|NCT02662348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110455705|NCT02662348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110455706|NCT02662348|Analgesics|analgesics|mesh-ancestor
110455707|NCT02662348|Sensory System Agents|sensory system agents|mesh-ancestor
110455708|NCT02662348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110455709|NCT02662348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110455710|NCT02662348|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110455711|NCT02662348|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110455712|NCT02662348|Antiviral Agents|antiviral agents|mesh-ancestor
110455713|NCT02662348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110455714|NCT02868372|Povidone-Iodine|povidone-iodine|mesh-list
110455715|NCT02868372|Povidone|povidone|mesh-list
110455716|NCT02868372|Plasma Substitutes|plasma substitutes|mesh-ancestor
110455717|NCT02868372|Blood Substitutes|blood substitutes|mesh-ancestor
110455718|NCT02868372|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110455719|NCT02868372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110455720|NCT00629148|Capecitabine|capecitabine|mesh-list
110455721|NCT00629148|Vinorelbine|vinorelbine|mesh-list
110455722|NCT00629148|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110455723|NCT00629148|Antimetabolites|antimetabolites|mesh-ancestor
110455724|NCT00629148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110455725|NCT00629148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110455726|NCT00629148|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110455727|NCT00629148|Tubulin Modulators|tubulin modulators|mesh-ancestor
110455728|NCT00629148|Antimitotic Agents|antimitotic agents|mesh-ancestor
110455729|NCT00629148|Mitosis Modulators|mitosis modulators|mesh-ancestor
110455730|NCT01157234|Metoprolol|metoprolol|mesh-list
110455731|NCT01157234|Nebivolol|nebivolol|mesh-list
110455732|NCT01157234|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110455733|NCT01157234|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110455734|NCT01157234|Sympatholytics|sympatholytics|mesh-ancestor
110455735|NCT01157234|Autonomic Agents|autonomic agents|mesh-ancestor
110455736|NCT01157234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110455737|NCT01157234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110455738|NCT01157234|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110455739|NCT01157234|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110455740|NCT01157234|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110455741|NCT01157234|Adrenergic Agents|adrenergic agents|mesh-ancestor
110455742|NCT01157234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110455743|NCT01157234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110455744|NCT01157234|Vasodilator Agents|vasodilator agents|mesh-ancestor
110455745|NCT01157234|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
110455746|NCT01157234|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110505455|NCT02841488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110505456|NCT02841488|Sensory System Agents|sensory system agents|mesh-ancestor
110311929|NCT00324519|Misoprostol|misoprostol|mesh-list
110505457|NCT02841488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110505459|NCT02841488|Narcotics|narcotics|mesh-ancestor
110505460|NCT02841488|Analgesics|analgesics|mesh-ancestor
110505461|NCT02841488|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110505462|NCT02841488|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110505463|NCT02841488|Anesthetics, General|anesthetics, general|mesh-ancestor
110505464|NCT02832726|Vitamin B 12|vitamin b 12|mesh-list
110505465|NCT02832726|Hydroxocobalamin|hydroxocobalamin|mesh-list
110505466|NCT02832726|Vitamins|vitamins|mesh-ancestor
110505467|NCT02832726|Micronutrients|micronutrients|mesh-ancestor
110505468|NCT02832726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110505469|NCT02832726|Vitamin B Complex|vitamin b complex|mesh-ancestor
110505470|NCT02832726|Hematinics|hematinics|mesh-ancestor
110505471|NCT00202904|Ezetimibe|ezetimibe|mesh-list
110505472|NCT00202904|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110505473|NCT00202904|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110505474|NCT00202904|Antimetabolites|antimetabolites|mesh-ancestor
110505475|NCT00202904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110505476|NCT00202904|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110505477|NCT02690870|Tamoxifen|tamoxifen|mesh-list
110505478|NCT02690870|Clomiphene|clomiphene|mesh-list
110505479|NCT02690870|Enclomiphene|enclomiphene|mesh-list
110505480|NCT02690870|Zuclomiphene|zuclomiphene|mesh-list
110505481|NCT02690870|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110505482|NCT02690870|Hormone Antagonists|hormone antagonists|mesh-ancestor
110505483|NCT02690870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110505484|NCT02690870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110505485|NCT02690870|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110505486|NCT02690870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110455747|NCT01157234|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110455748|NCT04170790|Saxagliptin|saxagliptin|mesh-list
110455749|NCT04170790|Sildenafil Citrate|sildenafil citrate|mesh-list
110455750|NCT04170790|Vasodilator Agents|vasodilator agents|mesh-ancestor
110455751|NCT04170790|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110455752|NCT04170790|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110455753|NCT04170790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110455754|NCT04170790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110455755|NCT04170790|Urological Agents|urological agents|mesh-ancestor
110455756|NCT04170790|Incretins|incretins|mesh-ancestor
110455757|NCT04170790|Hormones|hormones|mesh-ancestor
110455758|NCT04170790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110455759|NCT04170790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110455760|NCT04170790|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110505487|NCT02690870|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110505488|NCT02690870|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110505489|NCT02690870|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110505490|NCT02690870|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110505491|NCT02690870|Fertility Agents|fertility agents|mesh-ancestor
110505492|NCT02690870|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110505493|NCT00844207|Azithromycin|azithromycin|mesh-list
110505494|NCT00844207|Chloroquine|chloroquine|mesh-list
110505495|NCT00844207|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
110505496|NCT00844207|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110505497|NCT00844207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110505498|NCT00844207|Amebicides|amebicides|mesh-ancestor
110505499|NCT00844207|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110505500|NCT00844207|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110505501|NCT00844207|Antimalarials|antimalarials|mesh-ancestor
110505502|NCT00844207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110505503|NCT00844207|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110505504|NCT00844207|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110505505|NCT00844207|Analgesics|analgesics|mesh-ancestor
110505506|NCT00844207|Sensory System Agents|sensory system agents|mesh-ancestor
110505507|NCT00844207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110505508|NCT00844207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110505509|NCT00844207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110505510|NCT00844207|Filaricides|filaricides|mesh-ancestor
110505511|NCT00844207|Antinematodal Agents|antinematodal agents|mesh-ancestor
110455761|NCT04170790|Protease Inhibitors|protease inhibitors|mesh-ancestor
110455762|NCT04170790|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110455763|NCT00995670|Sevoflurane|sevoflurane|mesh-list
110455764|NCT00995670|Simvastatin|simvastatin|mesh-list
110455765|NCT00995670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110455766|NCT00995670|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110455767|NCT00995670|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110455768|NCT00995670|Antimetabolites|antimetabolites|mesh-ancestor
110455769|NCT00995670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110455770|NCT00995670|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110455771|NCT00995670|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110455772|NCT00995670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110455773|NCT00995670|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110455774|NCT00995670|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110455775|NCT00995670|Anesthetics, General|anesthetics, general|mesh-ancestor
110455776|NCT00995670|Anesthetics|anesthetics|mesh-ancestor
110455777|NCT00995670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110455778|NCT02658838|Heparin|heparin|mesh-list
110455779|NCT02658838|Calcium heparin|calcium heparin|mesh-list
110455780|NCT02658838|Enoxaparin|enoxaparin|mesh-list
110455781|NCT02658838|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
110455782|NCT02658838|Tinzaparin|tinzaparin|mesh-list
110455783|NCT02658838|Dalteparin|dalteparin|mesh-list
110455784|NCT02658838|Enoxaparin sodium|enoxaparin sodium|mesh-list
110455785|NCT02658838|Ticagrelor|ticagrelor|mesh-list
110455786|NCT02658838|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
110455787|NCT02658838|Anticoagulants|anticoagulants|mesh-ancestor
110455788|NCT02658838|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110505512|NCT00844207|Anthelmintics|anthelmintics|mesh-ancestor
110505513|NCT02841722|Lenograstim|lenograstim|mesh-list
110505514|NCT02841722|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110505515|NCT02841722|Immunologic Factors|immunologic factors|mesh-ancestor
110505516|NCT02841722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110505517|NCT02548117|Finasteride|finasteride|mesh-list
110505518|NCT02548117|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
110505519|NCT02548117|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110505520|NCT02548117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110505521|NCT02548117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110505522|NCT02548117|Hormone Antagonists|hormone antagonists|mesh-ancestor
110505523|NCT02548117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110505524|NCT02548117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110505525|NCT02548117|Urological Agents|urological agents|mesh-ancestor
110505526|NCT02841800|Phenobarbital|phenobarbital|mesh-list
110505527|NCT02841800|Anticonvulsants|anticonvulsants|mesh-ancestor
110505528|NCT02841800|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110505529|NCT02841800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110505530|NCT02841800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110505531|NCT02841800|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110505532|NCT02841800|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110505533|NCT02841800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110505562|NCT00621751|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110505563|NCT00621751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110505564|NCT00621751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110505565|NCT00621751|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110505566|NCT00621751|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110505567|NCT02690792|Vitamin E|vitamin e|mesh-list
110505568|NCT02690792|Vitamins|vitamins|mesh-ancestor
110505569|NCT02690792|Micronutrients|micronutrients|mesh-ancestor
110505570|NCT02690792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110505571|NCT02690792|Antioxidants|antioxidants|mesh-ancestor
110152901|NCT00000696|Interferons|interferons|mesh-list
110505572|NCT02690792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110505573|NCT02690792|Protective Agents|protective agents|mesh-ancestor
110505574|NCT00831649|Natalizumab|natalizumab|mesh-list
110505575|NCT00831649|Immunologic Factors|immunologic factors|mesh-ancestor
110505576|NCT00831649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110505577|NCT02841332|Misonidazole|misonidazole|mesh-list
110505578|NCT02841332|Bevacizumab|bevacizumab|mesh-list
110505579|NCT02841332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110505580|NCT02841332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110505581|NCT02841332|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110505582|NCT02841332|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110505583|NCT02841332|Growth Substances|growth substances|mesh-ancestor
110505584|NCT02841332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110505585|NCT02841332|Growth Inhibitors|growth inhibitors|mesh-ancestor
110505586|NCT02841332|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110505587|NCT02841332|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110455789|NCT02658838|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110455790|NCT02658838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110455791|NCT02658838|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110455792|NCT02658838|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110455793|NCT02658838|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110455794|NCT02658838|Purinergic Agents|purinergic agents|mesh-ancestor
110592239|NCT00767559|PENTA|penta|mesh-list
110455795|NCT02658838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110455796|NCT02658838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110455797|NCT00648076|Valproic Acid|valproic acid|mesh-list
110455798|NCT00648076|Anticonvulsants|anticonvulsants|mesh-ancestor
110455799|NCT00648076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110455800|NCT00648076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110455801|NCT00648076|GABA Agents|gaba agents|mesh-ancestor
110455802|NCT00648076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110455803|NCT00648076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110455804|NCT00648076|Antimanic Agents|antimanic agents|mesh-ancestor
110455805|NCT00648076|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110455806|NCT00648076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110455807|NCT00648076|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110455808|NCT00649012|Pioglitazone|pioglitazone|mesh-list
110455809|NCT00649012|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110505588|NCT02841332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110505590|NCT00838357|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110505591|NCT00838357|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110505592|NCT00838357|Antiviral Agents|antiviral agents|mesh-ancestor
110505593|NCT00838357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110505594|NCT00156104|Haloperidol|haloperidol|mesh-list
110505595|NCT00156104|Haloperidol decanoate|haloperidol decanoate|mesh-list
110505596|NCT00156104|Asenapine|asenapine|mesh-list
110505597|NCT00156104|Antiemetics|antiemetics|mesh-ancestor
110505598|NCT00156104|Autonomic Agents|autonomic agents|mesh-ancestor
110505599|NCT00156104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110505600|NCT00156104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110505601|NCT00156104|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110505602|NCT00156104|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110505603|NCT00156104|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110505604|NCT00156104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110505605|NCT00156104|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110505606|NCT00156104|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110505607|NCT00156104|Dopamine Agents|dopamine agents|mesh-ancestor
110505608|NCT00156104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110505609|NCT00156104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110505610|NCT00156104|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110505611|NCT00254462|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
110505612|NCT00254462|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110505613|NCT00254462|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110505614|NCT00254462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110505615|NCT00254462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110505616|NCT00254462|Adrenergic Agents|adrenergic agents|mesh-ancestor
110505617|NCT00254462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110505618|NCT00254462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110505619|NCT00891930|Irinotecan|irinotecan|mesh-list
110505620|NCT00891930|Panitumumab|panitumumab|mesh-list
110505621|NCT00891930|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110505622|NCT00891930|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110455810|NCT00649012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110455811|NCT04685590|Dasatinib|dasatinib|mesh-list
110455812|NCT04685590|Quercetin|quercetin|mesh-list
110455813|NCT04685590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110455814|NCT04685590|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110455815|NCT04685590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110455816|NCT04685590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110455817|NCT04685590|Antioxidants|antioxidants|mesh-ancestor
110505623|NCT00891930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110505624|NCT00891930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110505625|NCT00891930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110505626|NCT00891930|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110505627|NCT02831088|Salicylates|salicylates|mesh-list
110505628|NCT02831088|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110505629|NCT02831088|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110505630|NCT02831088|Analgesics|analgesics|mesh-ancestor
110505631|NCT02831088|Sensory System Agents|sensory system agents|mesh-ancestor
110505632|NCT02831088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110505633|NCT02831088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110505634|NCT02831088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110505635|NCT02831088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110505636|NCT02831088|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110505637|NCT02831088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110505638|NCT02831088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110505639|NCT02841176|Golimumab|golimumab|mesh-list
110172688|NCT00053092|Rituximab|rituximab|mesh-list
110455818|NCT04685590|Protective Agents|protective agents|mesh-ancestor
110455819|NCT04685590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110455820|NCT04170088|Tranexamic Acid|tranexamic acid|mesh-list
110455821|NCT04170088|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110455822|NCT04170088|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110455823|NCT04170088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110455824|NCT04170088|Hemostatics|hemostatics|mesh-ancestor
110455825|NCT04170088|Coagulants|coagulants|mesh-ancestor
110455826|NCT00648154|Letrozole|letrozole|mesh-list
110455827|NCT00648154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110455828|NCT00648154|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110455829|NCT00648154|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110455830|NCT00648154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110455831|NCT00648154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110455832|NCT00648154|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110455833|NCT00648154|Hormone Antagonists|hormone antagonists|mesh-ancestor
110455834|NCT00648154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110455835|NCT00648154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110455836|NCT02664142|Anesthetics|anesthetics|mesh-list
110455837|NCT02664142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110300971|NCT00273975|Lamivudine|lamivudine|mesh-list
110455838|NCT02664142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110455839|NCT04169854|Lidocaine|lidocaine|mesh-list
110455840|NCT04169854|Anesthetics, Local|anesthetics, local|mesh-ancestor
110455841|NCT04169854|Anesthetics|anesthetics|mesh-ancestor
110455842|NCT04169854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110455843|NCT04169854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110455844|NCT04169854|Sensory System Agents|sensory system agents|mesh-ancestor
110455845|NCT04169854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110455846|NCT04169854|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110455847|NCT04169854|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110455848|NCT04169854|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110455849|NCT04169854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110455850|NCT04169854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110455852|NCT02661100|Poly ICLC|poly iclc|mesh-list
110455853|NCT02661100|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110455854|NCT02661100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110505640|NCT02841176|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110505641|NCT02841176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110505642|NCT02841176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110505643|NCT02841176|Immunologic Factors|immunologic factors|mesh-ancestor
110505644|NCT02841176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110505645|NCT01615874|Prednisone|prednisone|mesh-list
110505646|NCT01615874|Prednisolone|prednisolone|mesh-list
110505647|NCT01615874|Montelukast|montelukast|mesh-list
110505648|NCT01615874|Mometasone Furoate, Formoterol Fumarate Drug Combination|mometasone furoate, formoterol fumarate drug combination|mesh-list
110505649|NCT01615874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110505650|NCT01615874|Glucocorticoids|glucocorticoids|mesh-ancestor
110505651|NCT01615874|Hormones|hormones|mesh-ancestor
110505652|NCT01615874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110505653|NCT01615874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110505654|NCT01615874|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110505655|NCT01615874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110505656|NCT01615874|Autonomic Agents|autonomic agents|mesh-ancestor
110505657|NCT01615874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110505658|NCT01615874|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110505659|NCT01615874|Respiratory System Agents|respiratory system agents|mesh-ancestor
110505660|NCT01615874|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110505661|NCT01615874|Hormone Antagonists|hormone antagonists|mesh-ancestor
110505662|NCT01615874|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110505663|NCT01615874|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110505664|NCT01615874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110505665|NCT01615874|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110505666|NCT00891462|Bromides|bromides|mesh-list
110505667|NCT00891462|Anticonvulsants|anticonvulsants|mesh-ancestor
110505668|NCT04248348|Heparin|heparin|mesh-list
110505669|NCT04248348|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
110505670|NCT04248348|Tinzaparin|tinzaparin|mesh-list
110505671|NCT04248348|Dalteparin|dalteparin|mesh-list
110505672|NCT04248348|Anticoagulants|anticoagulants|mesh-ancestor
110024836|NCT00005646|Paclitaxel|paclitaxel|mesh-list
110455855|NCT02661100|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110455856|NCT02661100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110455857|NCT02661100|Interferon Inducers|interferon inducers|mesh-ancestor
110455858|NCT02661100|Immunologic Factors|immunologic factors|mesh-ancestor
110455859|NCT02661100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110455860|NCT00601354|Orlistat|orlistat|mesh-list
110505673|NCT04248348|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110505674|NCT04248348|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110505675|NCT04248348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110505676|NCT04245774|Bupivacaine|bupivacaine|mesh-list
110505677|NCT04245774|Levobupivacaine|levobupivacaine|mesh-list
110505678|NCT04245774|Anesthetics, Local|anesthetics, local|mesh-ancestor
110505679|NCT04245774|Anesthetics|anesthetics|mesh-ancestor
110505680|NCT04245774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110505681|NCT04245774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110505682|NCT04245774|Sensory System Agents|sensory system agents|mesh-ancestor
110505683|NCT04245774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110505684|NCT04247646|Melatonin|melatonin|mesh-list
110505685|NCT04247646|Antioxidants|antioxidants|mesh-ancestor
110505686|NCT04247646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110505687|NCT04247646|Protective Agents|protective agents|mesh-ancestor
110505688|NCT04247646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110505689|NCT04247646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110505690|NCT00900146|Metformin|metformin|mesh-list
110505691|NCT00900146|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110505692|NCT00900146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110505693|NCT00140972|Diclofenac|diclofenac|mesh-list
110505694|NCT00140972|Etoricoxib|etoricoxib|mesh-list
110172763|NCT00053599|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110455861|NCT00601354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110455862|NCT00601354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110455863|NCT00601354|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110455864|NCT00601354|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110455865|NCT02660866|Vorapaxar|vorapaxar|mesh-list
110455866|NCT02660866|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110455867|NCT00853099|Adalimumab|adalimumab|mesh-list
110455868|NCT00853099|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110455869|NCT00853099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110455870|NCT00853099|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110455871|NCT00648310|Tolterodine Tartrate|tolterodine tartrate|mesh-list
110455872|NCT00648310|Estrogens|estrogens|mesh-list
110455873|NCT00648310|Hormones|hormones|mesh-ancestor
110455874|NCT00648310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110455875|NCT00648310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110455876|NCT00648310|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110455877|NCT00648310|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110455878|NCT00648310|Cholinergic Agents|cholinergic agents|mesh-ancestor
110455879|NCT00648310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110455880|NCT00648310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110455881|NCT00648310|Urological Agents|urological agents|mesh-ancestor
110455882|NCT00702871|Ranitidine|ranitidine|mesh-list
110455883|NCT00702871|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
110455884|NCT00702871|Sucralfate|sucralfate|mesh-list
110455885|NCT00702871|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110455886|NCT00702871|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110455887|NCT00702871|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110455888|NCT00702871|Histamine Antagonists|histamine antagonists|mesh-ancestor
110455889|NCT00702871|Histamine Agents|histamine agents|mesh-ancestor
110455890|NCT00702871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110505695|NCT00140972|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110505696|NCT00140972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110505697|NCT00140972|Analgesics|analgesics|mesh-ancestor
110505698|NCT00140972|Sensory System Agents|sensory system agents|mesh-ancestor
110505699|NCT00140972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110505700|NCT00140972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110505701|NCT00140972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110505702|NCT00140972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110505703|NCT00140972|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110505704|NCT00140972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110505705|NCT00140972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110505706|NCT00140972|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110505707|NCT02830932|Vaccines|vaccines|mesh-list
110505708|NCT02830932|Immunologic Factors|immunologic factors|mesh-ancestor
110505709|NCT02830932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110505710|NCT00895310|Ketoconazole|ketoconazole|mesh-list
110505711|NCT00895310|Hydrocortisone|hydrocortisone|mesh-list
110505712|NCT00895310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110505713|NCT00895310|Antifungal Agents|antifungal agents|mesh-ancestor
110505714|NCT00895310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110505715|NCT00895310|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110505716|NCT00895310|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110505717|NCT00895310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110505718|NCT00895310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110505719|NCT00895310|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110505720|NCT00895310|Hormone Antagonists|hormone antagonists|mesh-ancestor
110505721|NCT00895310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110505722|NCT00895310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110455891|NCT00702871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110455892|NCT00702871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110455893|NCT00830167|Pregabalin|pregabalin|mesh-list
110455894|NCT00830167|Analgesics|analgesics|mesh-ancestor
110455895|NCT00830167|Sensory System Agents|sensory system agents|mesh-ancestor
110455896|NCT00830167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110455897|NCT00830167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110455898|NCT00830167|Anticonvulsants|anticonvulsants|mesh-ancestor
110455899|NCT00830167|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110455900|NCT00830167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110455901|NCT00830167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110455902|NCT00830167|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110455903|NCT00830167|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110455904|NCT00830167|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110455905|NCT00830167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110505723|NCT00895310|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110505724|NCT04245618|Cisplatin|cisplatin|mesh-list
110505725|NCT04245618|Gemcitabine|gemcitabine|mesh-list
110505726|NCT04245618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110505727|NCT04245618|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110505728|NCT04245618|Antimetabolites|antimetabolites|mesh-ancestor
110505729|NCT04245618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110505730|NCT00092768|Celecoxib|celecoxib|mesh-list
110505731|NCT00092768|Etoricoxib|etoricoxib|mesh-list
110505732|NCT00092768|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110505733|NCT00092768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110505734|NCT00092768|Analgesics|analgesics|mesh-ancestor
110505735|NCT00092768|Sensory System Agents|sensory system agents|mesh-ancestor
110505736|NCT00092768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110455906|NCT00830167|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110455908|NCT00992394|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110455909|NCT00992394|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110455910|NCT00992394|Analgesics|analgesics|mesh-ancestor
110455911|NCT00992394|Sensory System Agents|sensory system agents|mesh-ancestor
110455912|NCT00992394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110455913|NCT00992394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110455914|NCT00992394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110455915|NCT00992394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110455916|NCT00992394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110455917|NCT00992394|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110455918|NCT00992394|Immunologic Factors|immunologic factors|mesh-ancestor
110455919|NCT00829933|Warfarin|warfarin|mesh-list
110455920|NCT00829933|Edoxaban|edoxaban|mesh-list
110455921|NCT00829933|Anticoagulants|anticoagulants|mesh-ancestor
110455922|NCT00829933|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110455923|NCT00829933|Antithrombins|antithrombins|mesh-ancestor
110378587|NCT01129882|Aripiprazole|aripiprazole|mesh-list
110455924|NCT00829933|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110455925|NCT00829933|Protease Inhibitors|protease inhibitors|mesh-ancestor
110455926|NCT00829933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110455927|NCT00829933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110455928|NCT01170962|Ribavirin|ribavirin|mesh-list
110455929|NCT01170962|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110455930|NCT01170962|Antimetabolites|antimetabolites|mesh-ancestor
110455931|NCT01170962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110455932|NCT01170962|Antiviral Agents|antiviral agents|mesh-ancestor
110455933|NCT01170962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110455934|NCT00843193|Fluticasone|fluticasone|mesh-list
110455936|NCT00843193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110455937|NCT00843193|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110455938|NCT00843193|Autonomic Agents|autonomic agents|mesh-ancestor
110455939|NCT00843193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110455940|NCT00843193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110455941|NCT00843193|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110455942|NCT00843193|Respiratory System Agents|respiratory system agents|mesh-ancestor
110455943|NCT00843193|Dermatologic Agents|dermatologic agents|mesh-ancestor
110455944|NCT00843193|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110455945|NCT00853021|Aldesleukin|aldesleukin|mesh-list
110455946|NCT00853021|Bevacizumab|bevacizumab|mesh-list
110455947|NCT00853021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110455948|NCT00853021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110455949|NCT00853021|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110455950|NCT00853021|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110455951|NCT00853021|Growth Substances|growth substances|mesh-ancestor
110455952|NCT00853021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110455953|NCT00853021|Growth Inhibitors|growth inhibitors|mesh-ancestor
110455954|NCT00853021|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110505738|NCT00092768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110505739|NCT00092768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110505740|NCT00092768|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110505741|NCT00092768|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110505742|NCT00092768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110505743|NCT00092768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110505744|NCT02831712|Ferrous fumarate|ferrous fumarate|mesh-list
110505745|NCT02831712|Trace Elements|trace elements|mesh-ancestor
110505746|NCT02831712|Micronutrients|micronutrients|mesh-ancestor
110505747|NCT02831712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110505748|NCT02843984|Lactoferrin|lactoferrin|mesh-list
110505749|NCT02843984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110505750|NCT02840708|Sargramostim|sargramostim|mesh-list
110505752|NCT02840708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110505753|NCT00817076|Desloratadine|desloratadine|mesh-list
110505754|NCT00817076|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110505755|NCT00817076|Cholinergic Agents|cholinergic agents|mesh-ancestor
110505756|NCT00817076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110505757|NCT00817076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110505758|NCT00817076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110505759|NCT00817076|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110505760|NCT00817076|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110505761|NCT00817076|Histamine Antagonists|histamine antagonists|mesh-ancestor
110505762|NCT00817076|Histamine Agents|histamine agents|mesh-ancestor
110505763|NCT02844062|Cyclophosphamide|cyclophosphamide|mesh-list
110505764|NCT02844062|Fludarabine|fludarabine|mesh-list
110505765|NCT02844062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110505766|NCT02844062|Immunologic Factors|immunologic factors|mesh-ancestor
110505767|NCT02844062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110505768|NCT02844062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110505769|NCT02844062|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110505770|NCT02844062|Alkylating Agents|alkylating agents|mesh-ancestor
110505771|NCT02844062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110505774|NCT02830230|Azithromycin|azithromycin|mesh-list
110505778|NCT02840240|Gabapentin|gabapentin|mesh-list
110505779|NCT02840240|Analgesics|analgesics|mesh-ancestor
110505780|NCT02840240|Sensory System Agents|sensory system agents|mesh-ancestor
110505781|NCT02840240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110505782|NCT02840240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110505783|NCT02840240|Anticonvulsants|anticonvulsants|mesh-ancestor
110153126|NCT00000792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110153127|NCT00000792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110153128|NCT00000792|Immunologic Factors|immunologic factors|mesh-ancestor
110455955|NCT00853021|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110455956|NCT00853021|Antiviral Agents|antiviral agents|mesh-ancestor
110455957|NCT00853021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110455958|NCT00913237|Desipramine|desipramine|mesh-list
110455959|NCT00913237|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110455960|NCT00913237|Antidepressive Agents|antidepressive agents|mesh-ancestor
110455961|NCT00913237|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110455962|NCT00913237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110455963|NCT00913237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110455964|NCT00913237|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110455965|NCT00913237|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110455966|NCT00913237|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110455967|NCT00913237|Adrenergic Agents|adrenergic agents|mesh-ancestor
110455968|NCT00913237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110455969|NCT00913237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110455970|NCT05367284|Testosterone|testosterone|mesh-list
110455971|NCT05367284|Androgens|androgens|mesh-ancestor
110455972|NCT05367284|Hormones|hormones|mesh-ancestor
110455973|NCT05367284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110455974|NCT05367284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110455975|NCT00843115|Donepezil|donepezil|mesh-list
110455976|NCT00843115|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110455977|NCT00843115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110592303|NCT00767871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110455978|NCT00843115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110455979|NCT00843115|Cholinergic Agents|cholinergic agents|mesh-ancestor
110455980|NCT00843115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110455981|NCT00843115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110455982|NCT00843115|Nootropic Agents|nootropic agents|mesh-ancestor
110455983|NCT01156376|Listerine|listerine|mesh-list
110455984|NCT01156376|Fluorides|fluorides|mesh-list
110455985|NCT01156376|Cariostatic Agents|cariostatic agents|mesh-ancestor
110455986|NCT01156376|Protective Agents|protective agents|mesh-ancestor
110455987|NCT01156376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110455988|NCT01156376|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110455989|NCT01156376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110455990|NCT01156142|Doxepin|doxepin|mesh-list
110455991|NCT01156142|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110455992|NCT01156142|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110455993|NCT01156142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110455994|NCT01156142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110455995|NCT01156142|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110455996|NCT01156142|Antidepressive Agents|antidepressive agents|mesh-ancestor
110455997|NCT01156142|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110455998|NCT01156142|Histamine Antagonists|histamine antagonists|mesh-ancestor
110455999|NCT01156142|Histamine Agents|histamine agents|mesh-ancestor
110456001|NCT01156142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110456002|NCT00842257|Panitumumab|panitumumab|mesh-list
110456003|NCT00842257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110456004|NCT00842257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110456005|NCT00706069|Capecitabine|capecitabine|mesh-list
110456006|NCT00706069|Vinorelbine|vinorelbine|mesh-list
110456007|NCT00706069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110456008|NCT00706069|Antimetabolites|antimetabolites|mesh-ancestor
110456009|NCT00706069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110456010|NCT00706069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110456011|NCT00706069|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110153129|NCT00000792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110153131|NCT03937609|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110153132|NCT03937609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110153133|NCT03937609|Dermatologic Agents|dermatologic agents|mesh-ancestor
110153134|NCT03937609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110153135|NCT03937609|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110153136|NCT00390520|Vildagliptin|vildagliptin|mesh-list
110153143|NCT00000813|polysaccharide-K|polysaccharide-k|mesh-list
110505784|NCT02840240|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110505785|NCT02840240|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110505786|NCT02840240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110505787|NCT02840240|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110505788|NCT02840240|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110505789|NCT02840240|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110505790|NCT02840240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110505791|NCT02840240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110456012|NCT00706069|Tubulin Modulators|tubulin modulators|mesh-ancestor
110456013|NCT00706069|Antimitotic Agents|antimitotic agents|mesh-ancestor
110456014|NCT00706069|Mitosis Modulators|mitosis modulators|mesh-ancestor
110456015|NCT01155284|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110456016|NCT01155284|Lansoprazole|lansoprazole|mesh-list
110456017|NCT01155284|Dexlansoprazole|dexlansoprazole|mesh-list
110456018|NCT01155284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110456019|NCT01155284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110456020|NCT01155284|Incretins|incretins|mesh-ancestor
110456021|NCT01155284|Hormones|hormones|mesh-ancestor
110456022|NCT01155284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110456023|NCT01155284|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110456024|NCT01155284|Protease Inhibitors|protease inhibitors|mesh-ancestor
110456025|NCT01155284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110456026|NCT01155284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110456027|NCT01155284|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110456028|NCT01155284|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110456029|NCT01155284|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110456030|NCT00852397|Apixaban|apixaban|mesh-list
110456031|NCT00852397|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110456032|NCT00852397|Antithrombins|antithrombins|mesh-ancestor
110456033|NCT00852397|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110456034|NCT00852397|Protease Inhibitors|protease inhibitors|mesh-ancestor
110456035|NCT00852397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110456036|NCT00852397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110456037|NCT00852397|Anticoagulants|anticoagulants|mesh-ancestor
110456038|NCT00852241|Hyaluronic Acid|hyaluronic acid|mesh-list
110456039|NCT00852241|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110456040|NCT00852241|Immunologic Factors|immunologic factors|mesh-ancestor
110456041|NCT00852241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110456042|NCT00852241|Viscosupplements|viscosupplements|mesh-ancestor
110456043|NCT00852241|Protective Agents|protective agents|mesh-ancestor
110456044|NCT02612233|Pregabalin|pregabalin|mesh-list
110456045|NCT02612233|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110456046|NCT02612233|Analgesics|analgesics|mesh-ancestor
110456047|NCT02612233|Sensory System Agents|sensory system agents|mesh-ancestor
110456048|NCT02612233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110456049|NCT02612233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110456050|NCT02612233|Anticonvulsants|anticonvulsants|mesh-ancestor
110456051|NCT02612233|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110456052|NCT02612233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110505792|NCT02840240|Antimanic Agents|antimanic agents|mesh-ancestor
110505793|NCT00888654|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
110505794|NCT00888654|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110505795|NCT00888654|Protective Agents|protective agents|mesh-ancestor
110505796|NCT00888654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110505797|NCT00888654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110505798|NCT03238430|Morphine|morphine|mesh-list
110505799|NCT03238430|Ropivacaine|ropivacaine|mesh-list
110505800|NCT03238430|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110505801|NCT03238430|Narcotics|narcotics|mesh-ancestor
110505802|NCT03238430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110505803|NCT03238430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110505804|NCT03238430|Analgesics|analgesics|mesh-ancestor
110505805|NCT03238430|Sensory System Agents|sensory system agents|mesh-ancestor
110505806|NCT03238430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110505807|NCT03238430|Anesthetics, Local|anesthetics, local|mesh-ancestor
110456053|NCT02612233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110456054|NCT02612233|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110456055|NCT02612233|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110456056|NCT02612233|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110456057|NCT02612233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110456058|NCT02612233|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110456059|NCT02612233|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110456060|NCT02612233|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110456061|NCT02612233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110456062|NCT02612233|Antidepressive Agents|antidepressive agents|mesh-ancestor
110456064|NCT01169636|Carboplatin|carboplatin|mesh-list
110456065|NCT01169636|Etoposide|etoposide|mesh-list
110456066|NCT01169636|Ifosfamide|ifosfamide|mesh-list
110456067|NCT01169636|Panobinostat|panobinostat|mesh-list
110456068|NCT01169636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110456069|NCT01169636|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110456070|NCT01169636|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110456071|NCT01169636|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110456072|NCT01169636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110456073|NCT01169636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110456074|NCT01169636|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110456075|NCT01169636|Alkylating Agents|alkylating agents|mesh-ancestor
110456076|NCT01169636|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110456077|NCT00706225|Bazedoxifene|bazedoxifene|mesh-list
110456078|NCT00706225|Estrogens|estrogens|mesh-list
110456079|NCT00706225|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
110456080|NCT00706225|Hormones|hormones|mesh-ancestor
110456081|NCT00706225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110456082|NCT00706225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110456083|NCT00706225|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110456084|NCT00706225|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110456085|NCT00706225|Hormone Antagonists|hormone antagonists|mesh-ancestor
110456086|NCT00706225|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110456087|NCT04117009|Remifentanil|remifentanil|mesh-list
110456088|NCT04117009|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110456089|NCT04117009|Narcotics|narcotics|mesh-ancestor
110456090|NCT04117009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110456091|NCT04117009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110456092|NCT04117009|Analgesics|analgesics|mesh-ancestor
110456093|NCT04117009|Sensory System Agents|sensory system agents|mesh-ancestor
110456094|NCT04117009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110456095|NCT04117243|Misoprostol|misoprostol|mesh-list
110456096|NCT04117243|Tranexamic Acid|tranexamic acid|mesh-list
110456097|NCT04117243|Oxytocin|oxytocin|mesh-list
110505808|NCT03238430|Anesthetics|anesthetics|mesh-ancestor
110505809|NCT02829840|Azacitidine|azacitidine|mesh-list
110505810|NCT02829840|Ponatinib|ponatinib|mesh-list
110505811|NCT02829840|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110505812|NCT02829840|Antimetabolites|antimetabolites|mesh-ancestor
110505813|NCT02829840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110505814|NCT02829840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110505815|NCT02829840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110505816|NCT02829840|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110505818|NCT03223220|Ketamine|ketamine|mesh-list
110505819|NCT03223220|Analgesics|analgesics|mesh-ancestor
110505820|NCT03223220|Sensory System Agents|sensory system agents|mesh-ancestor
110456098|NCT04117243|Oxytocics|oxytocics|mesh-ancestor
110456099|NCT04117243|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110456100|NCT04117243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110456101|NCT04117243|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110456102|NCT04117243|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110456103|NCT04117243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110456104|NCT04117243|Hemostatics|hemostatics|mesh-ancestor
110456105|NCT04117243|Coagulants|coagulants|mesh-ancestor
110456106|NCT04117243|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110456107|NCT04117243|Abortifacient Agents|abortifacient agents|mesh-ancestor
110456108|NCT04117243|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110456109|NCT04117243|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110456110|NCT01169558|Bevacizumab|bevacizumab|mesh-list
110456111|NCT01169558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110456112|NCT01169558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110456113|NCT01169558|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110456114|NCT01169558|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110456115|NCT01169558|Growth Substances|growth substances|mesh-ancestor
110456116|NCT01169558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110456117|NCT01169558|Growth Inhibitors|growth inhibitors|mesh-ancestor
110456118|NCT00700687|Aspirin|aspirin|mesh-list
110456119|NCT00700687|Celecoxib|celecoxib|mesh-list
110456120|NCT00700687|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110456121|NCT00700687|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110456122|NCT00700687|Analgesics|analgesics|mesh-ancestor
110456123|NCT00700687|Sensory System Agents|sensory system agents|mesh-ancestor
110456124|NCT00700687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110456125|NCT00700687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110456126|NCT00700687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110456127|NCT00700687|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110456128|NCT00700687|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110456129|NCT00700687|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110592342|NCT02557581|Autonomic Agents|autonomic agents|mesh-ancestor
110456130|NCT00700687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110456131|NCT00700687|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110456132|NCT00700687|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110456133|NCT00700687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110456134|NCT00700687|Antipyretics|antipyretics|mesh-ancestor
110456135|NCT00700687|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110456136|NCT00840463|Ambrisentan|ambrisentan|mesh-list
110456137|NCT00840463|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110456138|NCT00700765|Insulin Detemir|insulin detemir|mesh-list
110456139|NCT00700765|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110456140|NCT00700765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110456141|NCT00839527|Metformin|metformin|mesh-list
110456142|NCT00839527|Pioglitazone|pioglitazone|mesh-list
110456143|NCT00839527|Glimepiride|glimepiride|mesh-list
110456144|NCT00839527|rGLP-1 protein|rglp-1 protein|mesh-list
110456145|NCT00839527|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
110456146|NCT00839527|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110456147|NCT00839527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110456148|NCT00839527|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110456149|NCT00839527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110456150|NCT00839527|Immunologic Factors|immunologic factors|mesh-ancestor
110456151|NCT00839527|Incretins|incretins|mesh-ancestor
110505821|NCT03223220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110505822|NCT03223220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110505823|NCT03223220|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110505824|NCT03223220|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110505825|NCT03223220|Anesthetics, General|anesthetics, general|mesh-ancestor
110505826|NCT03223220|Anesthetics|anesthetics|mesh-ancestor
110505827|NCT03223220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110456152|NCT00839527|Hormones|hormones|mesh-ancestor
110456153|NCT00839527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110456154|NCT00706927|Timolol|timolol|mesh-list
110456155|NCT00706927|Brimonidine Tartrate|brimonidine tartrate|mesh-list
110456156|NCT00706927|Latanoprost|latanoprost|mesh-list
110456157|NCT00706927|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110456158|NCT00706927|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110456159|NCT00706927|Adrenergic Agents|adrenergic agents|mesh-ancestor
110456160|NCT00706927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110456161|NCT00706927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110456162|NCT00706927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110456163|NCT00706927|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110456164|NCT00706927|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110456165|NCT00706927|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110456166|NCT00706927|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110456167|NCT00706927|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110456168|NCT00706927|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110456169|NCT00706927|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110456170|NCT00707083|Dexamethasone|dexamethasone|mesh-list
110456171|NCT00707083|Methotrexate|methotrexate|mesh-list
110456172|NCT00707083|Vincristine|vincristine|mesh-list
110456173|NCT00707083|Mercaptopurine|mercaptopurine|mesh-list
110456174|NCT00707083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110456175|NCT00707083|Antiemetics|antiemetics|mesh-ancestor
110456176|NCT00707083|Autonomic Agents|autonomic agents|mesh-ancestor
110456177|NCT00707083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110456178|NCT00707083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110456179|NCT00707083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110456180|NCT00707083|Glucocorticoids|glucocorticoids|mesh-ancestor
110456181|NCT00707083|Hormones|hormones|mesh-ancestor
110456182|NCT00707083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110456183|NCT00707083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110456184|NCT00707083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110456185|NCT00707083|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110456186|NCT00707083|Abortifacient Agents|abortifacient agents|mesh-ancestor
110456188|NCT00707083|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110456189|NCT00707083|Antimetabolites|antimetabolites|mesh-ancestor
110456190|NCT00707083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110456191|NCT00707083|Dermatologic Agents|dermatologic agents|mesh-ancestor
110456192|NCT00707083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110456193|NCT00707083|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110456194|NCT00707083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110456195|NCT00707083|Immunologic Factors|immunologic factors|mesh-ancestor
110456196|NCT00707083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110456197|NCT00707083|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110456198|NCT00707083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110456199|NCT00707083|Tubulin Modulators|tubulin modulators|mesh-ancestor
110456200|NCT00707083|Antimitotic Agents|antimitotic agents|mesh-ancestor
110456201|NCT00707083|Mitosis Modulators|mitosis modulators|mesh-ancestor
110456202|NCT05500261|Dexmedetomidine|dexmedetomidine|mesh-list
110456203|NCT05500261|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110456204|NCT05500261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110456205|NCT05500261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110456206|NCT05500261|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110456207|NCT05500261|Analgesics|analgesics|mesh-ancestor
110456208|NCT05500261|Sensory System Agents|sensory system agents|mesh-ancestor
110456209|NCT05500261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110456210|NCT05500261|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110456211|NCT05500261|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110456212|NCT05500261|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110505828|NCT03223220|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110505829|NCT03223220|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110505830|NCT03223220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110505831|NCT03223220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110505832|NCT03223220|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110505833|NCT03223220|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110505834|NCT03223220|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110505835|NCT03223220|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110505836|NCT03223220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110505838|NCT03223220|GABA Agents|gaba agents|mesh-ancestor
110505839|NCT02827890|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110505840|NCT02827890|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110505841|NCT02827890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110505842|NCT02827890|Incretins|incretins|mesh-ancestor
110505843|NCT02827890|Hormones|hormones|mesh-ancestor
110505844|NCT02827890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110505845|NCT02827890|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110505846|NCT02827890|Protease Inhibitors|protease inhibitors|mesh-ancestor
110505847|NCT02827890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110505848|NCT02827890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110505849|NCT04250792|Naltrexone|naltrexone|mesh-list
110456213|NCT05500261|Adrenergic Agents|adrenergic agents|mesh-ancestor
110456214|NCT05500261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110456215|NCT05500261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110456217|NCT04116931|Ticagrelor|ticagrelor|mesh-list
110456218|NCT04116931|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110456219|NCT04116931|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110456220|NCT04116931|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110456221|NCT04116931|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110456222|NCT04116931|Purinergic Agents|purinergic agents|mesh-ancestor
110456223|NCT04116931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110456224|NCT04116931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110456225|NCT04116931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110456226|NCT00600886|Octreotide|octreotide|mesh-list
110456227|NCT00600886|Pasireotide|pasireotide|mesh-list
110456228|NCT00600886|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110456229|NCT00600886|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110456230|NCT00600886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110456231|NCT00600886|Hormones|hormones|mesh-ancestor
110456232|NCT00600886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110456233|NCT00600886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110456234|NCT00649324|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110456235|NCT00649324|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110456236|NCT00649324|Diuretics|diuretics|mesh-ancestor
110456237|NCT00649324|Natriuretic Agents|natriuretic agents|mesh-ancestor
110456238|NCT00649324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110456239|NCT00649324|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110456240|NCT00649324|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110456241|NCT00649324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110456242|NCT00648388|Cilostazol|cilostazol|mesh-list
110505850|NCT04250792|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110505851|NCT04250792|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110505852|NCT04250792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110505853|NCT04250792|Sensory System Agents|sensory system agents|mesh-ancestor
110505854|NCT04250792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110505855|NCT02840162|Celecoxib|celecoxib|mesh-list
110505856|NCT02840162|Benzenesulfonamide|benzenesulfonamide|mesh-list
110505857|NCT02840162|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110505858|NCT02840162|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110505859|NCT02840162|Analgesics|analgesics|mesh-ancestor
110505860|NCT02840162|Sensory System Agents|sensory system agents|mesh-ancestor
110505861|NCT02840162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110505862|NCT02840162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110505863|NCT02840162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110505864|NCT02840162|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110505865|NCT02840162|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110505866|NCT02840162|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110505867|NCT02840162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110505868|NCT02840162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110505869|NCT02840162|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110505870|NCT02827656|Triptorelin Pamoate|triptorelin pamoate|mesh-list
110505871|NCT02827656|Luteolytic Agents|luteolytic agents|mesh-ancestor
110456243|NCT00648388|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110456244|NCT00648388|Autonomic Agents|autonomic agents|mesh-ancestor
110456245|NCT00648388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110456246|NCT00648388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110456247|NCT00648388|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110456248|NCT00648388|Respiratory System Agents|respiratory system agents|mesh-ancestor
110456249|NCT00648388|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110456250|NCT00648388|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110456251|NCT00648388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110456252|NCT00648388|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110456253|NCT00648388|Vasodilator Agents|vasodilator agents|mesh-ancestor
110456254|NCT00648388|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110456255|NCT00648388|Protective Agents|protective agents|mesh-ancestor
110456256|NCT00648388|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110456257|NCT00648388|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110456258|NCT00648388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110456259|NCT02658760|Dexmedetomidine|dexmedetomidine|mesh-list
110456260|NCT02658760|Bupivacaine|bupivacaine|mesh-list
110456261|NCT02658760|Anesthetics, Local|anesthetics, local|mesh-ancestor
110456262|NCT02658760|Anesthetics|anesthetics|mesh-ancestor
110456263|NCT02658760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110456264|NCT02658760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110456265|NCT02658760|Sensory System Agents|sensory system agents|mesh-ancestor
110456266|NCT02658760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110456267|NCT02658760|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110456268|NCT02658760|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110456269|NCT02658760|Analgesics|analgesics|mesh-ancestor
110456270|NCT02658760|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110456271|NCT02658760|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110456272|NCT02658760|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110505872|NCT02827656|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110505873|NCT02827656|Contraceptive Agents|contraceptive agents|mesh-ancestor
110505874|NCT02827656|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110505875|NCT02827656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110505876|NCT02827656|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110505877|NCT02827656|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110505878|NCT02827656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110505879|NCT02827578|Tamsulosin|tamsulosin|mesh-list
110505880|NCT02827578|Solifenacin Succinate|solifenacin succinate|mesh-list
110505881|NCT02827578|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110505882|NCT02827578|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110505883|NCT02827578|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110505884|NCT02827578|Adrenergic Agents|adrenergic agents|mesh-ancestor
110505885|NCT02827578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110311936|NCT00324519|Oxytocics|oxytocics|mesh-ancestor
110505886|NCT02827578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110505887|NCT02827578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110505888|NCT02827578|Urological Agents|urological agents|mesh-ancestor
110456273|NCT02658760|Adrenergic Agents|adrenergic agents|mesh-ancestor
110456274|NCT02658760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110456275|NCT02658760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110456276|NCT02536690|Midazolam|midazolam|mesh-list
110456277|NCT02536690|Remifentanil|remifentanil|mesh-list
110456278|NCT02536690|Propofol|propofol|mesh-list
110456279|NCT02536690|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110456280|NCT02536690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110456281|NCT02536690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110456282|NCT02536690|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110103345|NCT01770236|Acetaminophen|acetaminophen|mesh-list
110456283|NCT02536690|Anesthetics, General|anesthetics, general|mesh-ancestor
110456284|NCT02536690|Anesthetics|anesthetics|mesh-ancestor
110456285|NCT02536690|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110456286|NCT02536690|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110456287|NCT02536690|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110456288|NCT02536690|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110456289|NCT02536690|GABA Modulators|gaba modulators|mesh-ancestor
110456290|NCT02536690|GABA Agents|gaba agents|mesh-ancestor
110456291|NCT02536690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110456292|NCT02536690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110456293|NCT02536690|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110456294|NCT02536690|Narcotics|narcotics|mesh-ancestor
110456295|NCT02536690|Analgesics|analgesics|mesh-ancestor
110456296|NCT02536690|Sensory System Agents|sensory system agents|mesh-ancestor
110456297|NCT02536690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110456299|NCT00649090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110456300|NCT00649090|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110456301|NCT00649090|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110456302|NCT00649090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110456303|NCT00649090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110456304|NCT00649090|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110456305|NCT00649090|Hormone Antagonists|hormone antagonists|mesh-ancestor
110456306|NCT00649090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110456307|NCT00649090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110456308|NCT00838903|Metformin|metformin|mesh-list
110456309|NCT00838903|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110456310|NCT00838903|Glimepiride|glimepiride|mesh-list
110456311|NCT00838903|rGLP-1 protein|rglp-1 protein|mesh-list
110505889|NCT02827578|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110505890|NCT02827578|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110505891|NCT02827578|Cholinergic Agents|cholinergic agents|mesh-ancestor
110505892|NCT02829372|Antibodies|antibodies|mesh-list
110505893|NCT02829372|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110505894|NCT02829372|Antibodies, Bispecific|antibodies, bispecific|mesh-list
110505895|NCT02829372|Immunologic Factors|immunologic factors|mesh-ancestor
110505896|NCT02829372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110505897|NCT00899678|Certolizumab Pegol|certolizumab pegol|mesh-list
110505898|NCT00899678|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110505899|NCT00899678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110505900|NCT00899678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110505901|NCT00899678|Immunologic Factors|immunologic factors|mesh-ancestor
110456312|NCT00838903|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
110456313|NCT00838903|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110456314|NCT00838903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110456315|NCT00838903|Incretins|incretins|mesh-ancestor
110456316|NCT00838903|Hormones|hormones|mesh-ancestor
110456317|NCT00838903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110456318|NCT00838903|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110456319|NCT00838903|Protease Inhibitors|protease inhibitors|mesh-ancestor
110456320|NCT00838903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110456321|NCT00838903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110456322|NCT00838903|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110456323|NCT00838903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110456324|NCT00838903|Immunologic Factors|immunologic factors|mesh-ancestor
110456325|NCT00648466|Sumatriptan|sumatriptan|mesh-list
110456326|NCT00648466|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110456327|NCT00648466|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110456328|NCT00648466|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110456329|NCT00648466|Serotonin Agents|serotonin agents|mesh-ancestor
110456330|NCT00648466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110456331|NCT00648466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110456332|NCT00648466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110456333|NCT00649402|Amlodipine|amlodipine|mesh-list
110456334|NCT00649402|Benazepril|benazepril|mesh-list
110456335|NCT00649402|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110456336|NCT00649402|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110456337|NCT00649402|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110456338|NCT00649402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110456339|NCT00649402|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110456340|NCT00649402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110456341|NCT00649402|Vasodilator Agents|vasodilator agents|mesh-ancestor
110456342|NCT00649402|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110456343|NCT00649402|Protease Inhibitors|protease inhibitors|mesh-ancestor
110456344|NCT00649402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110456345|NCT04477486|Venetoclax|venetoclax|mesh-list
110456346|NCT04477486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110456347|NCT00649480|Balsalazide|balsalazide|mesh-list
110456348|NCT00649480|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110456349|NCT00649480|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110456350|NCT00649480|Analgesics|analgesics|mesh-ancestor
110456351|NCT00649480|Sensory System Agents|sensory system agents|mesh-ancestor
110456352|NCT00649480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110456353|NCT00649480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110456354|NCT00649480|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110456355|NCT00649480|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110456356|NCT00649480|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110456357|NCT02656342|Cycloserine|cycloserine|mesh-list
110456358|NCT02656342|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110456359|NCT02656342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110456360|NCT02656342|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110505902|NCT00899678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110505903|NCT00899678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110505904|NCT00887484|Clindamycin|clindamycin|mesh-list
110505905|NCT00887484|Clindamycin palmitate|clindamycin palmitate|mesh-list
110505906|NCT00887484|Clindamycin phosphate|clindamycin phosphate|mesh-list
110505907|NCT00887484|Adapalene|adapalene|mesh-list
110505908|NCT00887484|Benzoyl Peroxide|benzoyl peroxide|mesh-list
110505909|NCT00887484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110505910|NCT00887484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110505911|NCT00887484|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110505912|NCT00887484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110505913|NCT00887484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110505914|NCT00887484|Dermatologic Agents|dermatologic agents|mesh-ancestor
110505915|NCT00887484|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110505916|NCT00887484|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110505917|NCT00887484|Analgesics|analgesics|mesh-ancestor
110505918|NCT00887484|Sensory System Agents|sensory system agents|mesh-ancestor
110505919|NCT00887484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110505920|NCT00887484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110505921|NCT00887484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110505922|NCT00887484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110505923|NCT00794378|Cetirizine|cetirizine|mesh-list
110505924|NCT00794378|Desloratadine|desloratadine|mesh-list
110505925|NCT00794378|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110505926|NCT00794378|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110505927|NCT00794378|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110505928|NCT00794378|Histamine Antagonists|histamine antagonists|mesh-ancestor
110505929|NCT00794378|Histamine Agents|histamine agents|mesh-ancestor
110505930|NCT00794378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110505931|NCT00794378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110173502|NCT02969473|Antimitotic Agents|antimitotic agents|mesh-ancestor
110456361|NCT02656342|Antitubercular Agents|antitubercular agents|mesh-ancestor
110456362|NCT02656342|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110456363|NCT02656342|Antimetabolites|antimetabolites|mesh-ancestor
110456364|NCT02656342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110456365|NCT04169464|Sofosbuvir|sofosbuvir|mesh-list
110456366|NCT04169464|Antiviral Agents|antiviral agents|mesh-ancestor
110456367|NCT04169464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110456368|NCT00650416|Carvedilol|carvedilol|mesh-list
110456369|NCT00650416|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110456370|NCT00650416|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110456371|NCT00650416|Adrenergic Agents|adrenergic agents|mesh-ancestor
110456372|NCT00650416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110456373|NCT00650416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110505932|NCT00794378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110153277|NCT03357952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110505933|NCT00794378|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110505934|NCT00794378|Cholinergic Agents|cholinergic agents|mesh-ancestor
110505935|NCT00789152|Levocetirizine|levocetirizine|mesh-list
110505936|NCT00789152|Desloratadine|desloratadine|mesh-list
110505937|NCT00789152|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110505938|NCT00789152|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110505939|NCT00789152|Histamine Antagonists|histamine antagonists|mesh-ancestor
110505940|NCT00789152|Histamine Agents|histamine agents|mesh-ancestor
110505941|NCT00789152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110505942|NCT00789152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110505943|NCT00789152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110505944|NCT00789152|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110505945|NCT00789152|Cholinergic Agents|cholinergic agents|mesh-ancestor
110505946|NCT00783458|Fluticasone|fluticasone|mesh-list
110505947|NCT00783458|Mometasone Furoate|mometasone furoate|mesh-list
110505948|NCT00783458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110505949|NCT00783458|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110505950|NCT00783458|Autonomic Agents|autonomic agents|mesh-ancestor
110505951|NCT00783458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110505952|NCT00783458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110505953|NCT00783458|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110505954|NCT00783458|Respiratory System Agents|respiratory system agents|mesh-ancestor
110505955|NCT00783458|Dermatologic Agents|dermatologic agents|mesh-ancestor
110505956|NCT00783458|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110505957|NCT00620659|Modafinil|modafinil|mesh-list
110505958|NCT00620659|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110505959|NCT00620659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110505960|NCT00620659|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
110505961|NCT00620659|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110505962|NCT00620659|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110505963|NCT00620659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110505964|NCT02829060|Gentamicins|gentamicins|mesh-list
110505965|NCT02829060|Ampicillin|ampicillin|mesh-list
110505971|NCT02829060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110505972|NCT02829060|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110505973|NCT00838669|Paliperidone Palmitate|paliperidone palmitate|mesh-list
110505974|NCT00838669|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110505975|NCT00838669|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110505976|NCT00838669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110505977|NCT00838669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110505978|NCT00838669|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110505979|NCT00838669|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110505980|NCT00838669|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110505981|NCT00838669|Serotonin Agents|serotonin agents|mesh-ancestor
110505982|NCT00838669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110505983|NCT00838669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110505984|NCT00838669|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110505985|NCT00838669|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110505986|NCT00838669|Dopamine Agents|dopamine agents|mesh-ancestor
110505987|NCT00783146|Fexofenadine|fexofenadine|mesh-list
110505988|NCT00783146|Desloratadine|desloratadine|mesh-list
110505989|NCT00783146|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110505990|NCT00783146|Cholinergic Agents|cholinergic agents|mesh-ancestor
110456374|NCT00650416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110456375|NCT00650416|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110456376|NCT00650416|Antioxidants|antioxidants|mesh-ancestor
110456377|NCT00650416|Protective Agents|protective agents|mesh-ancestor
110456378|NCT00650416|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110456379|NCT00650416|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110456380|NCT00650416|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110456381|NCT00650416|Vasodilator Agents|vasodilator agents|mesh-ancestor
110456382|NCT00650416|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110456383|NCT00650416|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110456384|NCT00649948|Metformin|metformin|mesh-list
110456385|NCT00649948|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110456386|NCT00649948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110456387|NCT04167982|Isotretinoin|isotretinoin|mesh-list
110456388|NCT04167982|Aminolevulinic Acid|aminolevulinic acid|mesh-list
110456389|NCT04167982|Dermatologic Agents|dermatologic agents|mesh-ancestor
110456390|NCT04167982|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110456391|NCT00649558|Pioglitazone|pioglitazone|mesh-list
110456392|NCT00649558|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110456393|NCT00649558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110456394|NCT02658526|Anesthetics|anesthetics|mesh-list
110456395|NCT02658526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110456396|NCT02658526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110456397|NCT00650494|Valacyclovir|valacyclovir|mesh-list
110456398|NCT00650494|Antiviral Agents|antiviral agents|mesh-ancestor
110456399|NCT00650494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110456400|NCT02655874|Vaccines|vaccines|mesh-list
110456401|NCT02655874|Immunologic Factors|immunologic factors|mesh-ancestor
110456402|NCT02655874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110456403|NCT00828139|Aflibercept|aflibercept|mesh-list
110456404|NCT00828139|Topotecan|topotecan|mesh-list
110456405|NCT00828139|Endothelial Growth Factors|endothelial growth factors|mesh-list
110456406|NCT00828139|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110456407|NCT00828139|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110456408|NCT00828139|Growth Substances|growth substances|mesh-ancestor
110505991|NCT00783146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110505992|NCT00783146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110505993|NCT00783146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110505994|NCT00783146|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110505995|NCT00783146|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110505996|NCT00783146|Histamine Antagonists|histamine antagonists|mesh-ancestor
110505997|NCT00783146|Histamine Agents|histamine agents|mesh-ancestor
110505998|NCT00783146|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110505999|NCT00844675|Rabeprazole|rabeprazole|mesh-list
110506000|NCT00844675|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110506001|NCT00844675|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110506002|NCT00844675|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110506003|NCT00844675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110506004|NCT00844675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110506005|NCT02840006|Anesthetics|anesthetics|mesh-list
110506006|NCT02840006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110173627|NCT02968927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110456409|NCT00828139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110456410|NCT00828139|Growth Inhibitors|growth inhibitors|mesh-ancestor
110456411|NCT00828139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110456412|NCT00828139|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110456413|NCT00828139|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110456414|NCT00828139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110456415|NCT00828139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110456416|NCT02658214|Leucovorin|leucovorin|mesh-list
110456417|NCT02658214|Folic Acid|folic acid|mesh-list
110456418|NCT02658214|Paclitaxel|paclitaxel|mesh-list
110456419|NCT02658214|Etoposide|etoposide|mesh-list
110456420|NCT02658214|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110456421|NCT02658214|Carboplatin|carboplatin|mesh-list
110456422|NCT02658214|Gemcitabine|gemcitabine|mesh-list
110456423|NCT02658214|Fluorouracil|fluorouracil|mesh-list
110456424|NCT02658214|Oxaliplatin|oxaliplatin|mesh-list
110456425|NCT02658214|Durvalumab|durvalumab|mesh-list
110456426|NCT02658214|Tremelimumab|tremelimumab|mesh-list
110456427|NCT02658214|Levoleucovorin|levoleucovorin|mesh-list
110456428|NCT02658214|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110456429|NCT02658214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110456430|NCT02658214|Tubulin Modulators|tubulin modulators|mesh-ancestor
110103497|NCT01771458|Tamoxifen|tamoxifen|mesh-list
110456431|NCT02658214|Antimitotic Agents|antimitotic agents|mesh-ancestor
110456432|NCT02658214|Mitosis Modulators|mitosis modulators|mesh-ancestor
110456433|NCT02658214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110456434|NCT02658214|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110456435|NCT02658214|Antimetabolites|antimetabolites|mesh-ancestor
110301586|NCT00247052|Analgesics|analgesics|mesh-ancestor
110456436|NCT02658214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110456437|NCT02658214|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110456438|NCT02658214|Immunologic Factors|immunologic factors|mesh-ancestor
110456439|NCT02658214|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110456440|NCT02658214|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110456441|NCT02658214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110456442|NCT02658214|Antidotes|antidotes|mesh-ancestor
110456443|NCT02658214|Protective Agents|protective agents|mesh-ancestor
110456444|NCT02658214|Vitamin B Complex|vitamin b complex|mesh-ancestor
110456445|NCT02658214|Vitamins|vitamins|mesh-ancestor
110456446|NCT02658214|Micronutrients|micronutrients|mesh-ancestor
110456447|NCT02658214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110456448|NCT02658214|Hematinics|hematinics|mesh-ancestor
110456449|NCT04169230|Citalopram|citalopram|mesh-list
110506007|NCT02840006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110506009|NCT02826252|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110506010|NCT02826252|Vasodilator Agents|vasodilator agents|mesh-ancestor
110506011|NCT02839928|Ketamine|ketamine|mesh-list
110506012|NCT02839928|Analgesics|analgesics|mesh-list
110506013|NCT02839928|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
110506014|NCT02839928|Sensory System Agents|sensory system agents|mesh-ancestor
110506015|NCT02839928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110506016|NCT02839928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110506017|NCT02839928|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110506018|NCT02839928|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110506019|NCT02839928|Anesthetics, General|anesthetics, general|mesh-ancestor
110506020|NCT02839928|Anesthetics|anesthetics|mesh-ancestor
110506021|NCT02839928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110506022|NCT02839928|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110506023|NCT02839928|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110506024|NCT02839928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110456450|NCT04169230|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110456451|NCT04169230|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110456452|NCT04169230|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110456453|NCT04169230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110456454|NCT04169230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110456455|NCT04169230|Serotonin Agents|serotonin agents|mesh-ancestor
110456456|NCT04169230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110456457|NCT04169230|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110456458|NCT04169230|Antidepressive Agents|antidepressive agents|mesh-ancestor
110456459|NCT04169230|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110456461|NCT04201756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110456462|NCT04201756|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110456463|NCT04201756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110456464|NCT04201756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110456465|NCT02651350|Methylprednisolone|methylprednisolone|mesh-list
110456466|NCT02651350|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110456467|NCT02651350|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110456468|NCT02651350|Prednisolone|prednisolone|mesh-list
110456469|NCT02651350|Prednisolone acetate|prednisolone acetate|mesh-list
110456470|NCT02651350|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110456471|NCT02651350|Prednisolone phosphate|prednisolone phosphate|mesh-list
110456472|NCT02651350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110456473|NCT02651350|Antiemetics|antiemetics|mesh-ancestor
110456474|NCT02651350|Autonomic Agents|autonomic agents|mesh-ancestor
110456475|NCT02651350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110456476|NCT02651350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110456477|NCT02651350|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110456478|NCT02651350|Glucocorticoids|glucocorticoids|mesh-ancestor
110456479|NCT02651350|Hormones|hormones|mesh-ancestor
110456480|NCT02651350|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110456481|NCT02651350|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110456482|NCT02651350|Protective Agents|protective agents|mesh-ancestor
110456483|NCT02651350|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110456484|NCT02651350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110456485|NCT02658292|Naftifine|naftifine|mesh-list
110456486|NCT02658292|Antifungal Agents|antifungal agents|mesh-ancestor
110456487|NCT02658292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110456488|NCT02651038|Micafungin|micafungin|mesh-list
110456489|NCT02651038|Antifungal Agents|antifungal agents|mesh-ancestor
110506025|NCT02839928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110506026|NCT02839928|Anesthetics, Local|anesthetics, local|mesh-ancestor
110506027|NCT02839928|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
110506028|NCT05018520|Prednisone|prednisone|mesh-list
110506029|NCT05018520|Rituximab|rituximab|mesh-list
110506030|NCT05018520|Cyclophosphamide|cyclophosphamide|mesh-list
110506031|NCT05018520|Vincristine|vincristine|mesh-list
110506032|NCT05018520|Doxorubicin|doxorubicin|mesh-list
110506033|NCT05018520|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110506035|NCT05018520|Immunologic Factors|immunologic factors|mesh-ancestor
110506036|NCT05018520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110506037|NCT05018520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110506038|NCT05018520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110506039|NCT05018520|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110506040|NCT05018520|Alkylating Agents|alkylating agents|mesh-ancestor
110506041|NCT05018520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110506042|NCT05018520|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110506043|NCT05018520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110506044|NCT05018520|Glucocorticoids|glucocorticoids|mesh-ancestor
110506045|NCT05018520|Hormones|hormones|mesh-ancestor
110506046|NCT05018520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110506047|NCT05018520|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110506048|NCT05018520|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110506049|NCT05018520|Tubulin Modulators|tubulin modulators|mesh-ancestor
110506050|NCT05018520|Antimitotic Agents|antimitotic agents|mesh-ancestor
110506051|NCT05018520|Mitosis Modulators|mitosis modulators|mesh-ancestor
110506052|NCT05018520|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110456490|NCT02651038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110456491|NCT00650026|Adalimumab|adalimumab|mesh-list
110456492|NCT00650026|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110456493|NCT00650026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110456494|NCT00650026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110456495|NCT00838513|Eculizumab|eculizumab|mesh-list
110240963|NCT04701463|Calcium|calcium|mesh-list
110456496|NCT00838513|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
110456497|NCT00838513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110456498|NCT00838513|Immunologic Factors|immunologic factors|mesh-ancestor
110456499|NCT00838513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110456500|NCT00649636|Fluoxetine|fluoxetine|mesh-list
110456501|NCT00649636|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110456502|NCT00649636|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110456503|NCT00649636|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110456504|NCT00649636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110456505|NCT00649636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110456506|NCT00649636|Serotonin Agents|serotonin agents|mesh-ancestor
110456507|NCT00649636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110456508|NCT00649636|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110456509|NCT00649636|Antidepressive Agents|antidepressive agents|mesh-ancestor
110506053|NCT05018520|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110506054|NCT05018520|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110506055|NCT05018520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110506056|NCT04321746|Ketamine|ketamine|mesh-list
110506057|NCT04321746|Analgesics|analgesics|mesh-ancestor
110506058|NCT04321746|Sensory System Agents|sensory system agents|mesh-ancestor
110506059|NCT04321746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110506060|NCT04321746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110506061|NCT04321746|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110506062|NCT04321746|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110506063|NCT04321746|Anesthetics, General|anesthetics, general|mesh-ancestor
110506064|NCT04321746|Anesthetics|anesthetics|mesh-ancestor
110506065|NCT04321746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110506066|NCT04321746|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110506067|NCT04321746|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110506068|NCT04321746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110506069|NCT04321746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110506070|NCT02839694|Celecoxib|celecoxib|mesh-list
110506071|NCT02839694|Decitabine|decitabine|mesh-list
110506072|NCT02839694|Tetrahydrouridine|tetrahydrouridine|mesh-list
110506073|NCT02839694|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110506074|NCT02839694|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110506075|NCT02839694|Analgesics|analgesics|mesh-ancestor
110506076|NCT02839694|Sensory System Agents|sensory system agents|mesh-ancestor
110506077|NCT02839694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110506078|NCT02839694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110506079|NCT02839694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110506080|NCT02839694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110506081|NCT02839694|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110506082|NCT02839694|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110506084|NCT02839694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110506085|NCT02839694|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110456510|NCT00649636|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110456511|NCT00649636|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110456512|NCT00649636|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110456513|NCT00649636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110456515|NCT04030663|Papaverine|papaverine|mesh-list
110456516|NCT04030663|Vasodilator Agents|vasodilator agents|mesh-ancestor
110456517|NCT04030663|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110456518|NCT04030663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110456519|NCT04030663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110506086|NCT02839694|Antimetabolites|antimetabolites|mesh-ancestor
110506087|NCT02839694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110506088|NCT04243434|Prednisone|prednisone|mesh-list
110506089|NCT04243434|Cyclophosphamide|cyclophosphamide|mesh-list
110506090|NCT04243434|Doxorubicin|doxorubicin|mesh-list
110506091|NCT04243434|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110506092|NCT04243434|Vincristine|vincristine|mesh-list
110506093|NCT04243434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110506094|NCT04243434|Immunologic Factors|immunologic factors|mesh-ancestor
110506095|NCT04243434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110241039|NCT00106847|Infliximab|infliximab|mesh-list
110506096|NCT04243434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110506097|NCT04243434|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110506098|NCT04243434|Alkylating Agents|alkylating agents|mesh-ancestor
110506099|NCT04243434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110506100|NCT04243434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110506101|NCT04243434|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110506102|NCT04243434|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110506103|NCT04243434|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110506104|NCT04243434|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110506105|NCT04243434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110506106|NCT04243434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110506108|NCT04243434|Hormones|hormones|mesh-ancestor
110506109|NCT04243434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110506110|NCT04243434|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110506111|NCT04243434|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110506112|NCT04243434|Tubulin Modulators|tubulin modulators|mesh-ancestor
110506113|NCT04243434|Antimitotic Agents|antimitotic agents|mesh-ancestor
110506114|NCT04243434|Mitosis Modulators|mitosis modulators|mesh-ancestor
110506115|NCT00832039|Selenious Acid|selenious acid|mesh-list
110506116|NCT00832039|Sodium Selenite|sodium selenite|mesh-list
110506117|NCT00832039|Trace Elements|trace elements|mesh-ancestor
110506132|NCT02837978|Antimetabolites|antimetabolites|mesh-ancestor
110506133|NCT02837978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110506134|NCT02837978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110506135|NCT02837978|Dermatologic Agents|dermatologic agents|mesh-ancestor
110506136|NCT02837978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110506137|NCT02837978|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110506138|NCT02837978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110506139|NCT02837978|Immunologic Factors|immunologic factors|mesh-ancestor
110506140|NCT02837978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110506141|NCT02837978|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110506142|NCT02837978|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110506143|NCT00839059|Lenalidomide|lenalidomide|mesh-list
110506144|NCT00839059|Immunologic Factors|immunologic factors|mesh-ancestor
110506145|NCT00839059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110506146|NCT00839059|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110506147|NCT00839059|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110506148|NCT00839059|Growth Substances|growth substances|mesh-ancestor
110506149|NCT00839059|Growth Inhibitors|growth inhibitors|mesh-ancestor
110506150|NCT00839059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110506151|NCT02839538|Anesthetics|anesthetics|mesh-list
110506152|NCT02839538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110153506|NCT00000966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110506153|NCT02839538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110506155|NCT02826174|Anesthetics|anesthetics|mesh-list
110506156|NCT02826174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110506157|NCT02826174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110506158|NCT00621517|Bupropion|bupropion|mesh-list
110506159|NCT00621517|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110506160|NCT00621517|Antidepressive Agents|antidepressive agents|mesh-ancestor
110506161|NCT00621517|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110506162|NCT00621517|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110506163|NCT00621517|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110506164|NCT00621517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110456520|NCT04030663|Urological Agents|urological agents|mesh-ancestor
110456521|NCT00700921|Lovastatin|lovastatin|mesh-list
110456522|NCT00700921|L 647318|l 647318|mesh-list
110456523|NCT00700921|Dihydromevinolin|dihydromevinolin|mesh-list
110456524|NCT00700921|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110456525|NCT00700921|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110456526|NCT00700921|Antimetabolites|antimetabolites|mesh-ancestor
110592428|NCT02582372|Narcotics|narcotics|mesh-ancestor
110456527|NCT00700921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110506165|NCT00621517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110506166|NCT00621517|Dopamine Agents|dopamine agents|mesh-ancestor
110506167|NCT00621517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110506168|NCT00621517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110506169|NCT00621517|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110506170|NCT00621517|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110506171|NCT00621517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110506172|NCT02827266|Epoetin Alfa|epoetin alfa|mesh-list
110506173|NCT02827266|Hematinics|hematinics|mesh-ancestor
110506174|NCT00845221|Imatinib Mesylate|imatinib mesylate|mesh-list
110506175|NCT00845221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110506176|NCT00845221|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110506177|NCT00845221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110506178|NCT00845221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110506179|NCT02546401|Insulin Aspart|insulin aspart|mesh-list
110506180|NCT02546401|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110506181|NCT02546401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110506182|NCT02826876|Ropivacaine|ropivacaine|mesh-list
110506183|NCT02826876|Anesthetics, Local|anesthetics, local|mesh-ancestor
110506184|NCT02826876|Anesthetics|anesthetics|mesh-ancestor
110506185|NCT02826876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110506186|NCT02826876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110506187|NCT02826876|Sensory System Agents|sensory system agents|mesh-ancestor
110506188|NCT02826876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110506189|NCT04244448|Emtricitabine|emtricitabine|mesh-list
110506190|NCT04244448|Antiviral Agents|antiviral agents|mesh-ancestor
110506191|NCT04244448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110506192|NCT04244448|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110506193|NCT04244448|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110506194|NCT04244448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110506195|NCT04244448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110506209|NCT02547025|Antitubercular Agents|antitubercular agents|mesh-ancestor
110506210|NCT02547025|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110506211|NCT02547025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110506212|NCT02547025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110506213|NCT02547025|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110506214|NCT02547025|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110506215|NCT02547025|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110506216|NCT02547025|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110506217|NCT02547025|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110506218|NCT02547025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110506219|NCT02547025|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110506220|NCT02547025|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110506221|NCT02547025|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110506222|NCT02547025|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110506223|NCT02547025|Antacids|antacids|mesh-ancestor
110506224|NCT00839293|Fenofibric acid|fenofibric acid|mesh-list
110506225|NCT00839293|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110506226|NCT00839293|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110506227|NCT00839293|Antimetabolites|antimetabolites|mesh-ancestor
110506228|NCT00839293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110506229|NCT00839293|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110506231|NCT05660382|Clotrimazole|clotrimazole|mesh-list
110506232|NCT05660382|Mineral Oil|mineral oil|mesh-list
110506233|NCT05660382|Antifungal Agents|antifungal agents|mesh-ancestor
110456528|NCT00700921|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110456529|NCT00700921|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110456530|NCT00700921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110456531|NCT00850993|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
110456532|NCT00850993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110456533|NCT00850993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110456534|NCT02657512|Rivaroxaban|rivaroxaban|mesh-list
110456535|NCT02657512|Charcoal|charcoal|mesh-list
110456536|NCT02657512|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110456537|NCT02657512|Antithrombins|antithrombins|mesh-ancestor
110456538|NCT02657512|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110456539|NCT02657512|Protease Inhibitors|protease inhibitors|mesh-ancestor
110456540|NCT02657512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110456541|NCT02657512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110456542|NCT02657512|Anticoagulants|anticoagulants|mesh-ancestor
110456543|NCT02657512|Antidotes|antidotes|mesh-ancestor
110456544|NCT02657512|Protective Agents|protective agents|mesh-ancestor
110456545|NCT02657512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110456546|NCT00818779|Amlodipine|amlodipine|mesh-list
110456547|NCT00818779|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110456548|NCT00818779|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110456549|NCT00818779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110456550|NCT00818779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110456551|NCT00818779|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110456552|NCT00818779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110506234|NCT05660382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110506235|NCT05660382|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110506236|NCT05660382|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110506237|NCT05660382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110506238|NCT05660382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110506239|NCT05660382|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110506240|NCT05660382|Hormone Antagonists|hormone antagonists|mesh-ancestor
110506241|NCT05660382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110506242|NCT05660382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110506243|NCT05660382|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110506244|NCT05660382|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110506245|NCT05660382|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110506246|NCT05660382|Emollients|emollients|mesh-ancestor
110506247|NCT05660382|Dermatologic Agents|dermatologic agents|mesh-ancestor
110506248|NCT00839371|Midazolam|midazolam|mesh-list
110506249|NCT00839371|Propofol|propofol|mesh-list
110506250|NCT00839371|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110506251|NCT00839371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110506252|NCT00839371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110506253|NCT00839371|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110506254|NCT00839371|Anesthetics, General|anesthetics, general|mesh-ancestor
110456553|NCT00818779|Vasodilator Agents|vasodilator agents|mesh-ancestor
110456554|NCT00649714|Zonisamide|zonisamide|mesh-list
110456555|NCT00649714|Anticonvulsants|anticonvulsants|mesh-ancestor
110456556|NCT00649714|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110456557|NCT00649714|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110456558|NCT00649714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110456559|NCT00649714|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110456560|NCT00649714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110456561|NCT00600028|Thalidomide|thalidomide|mesh-list
110456562|NCT00600028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110456563|NCT00600028|Immunologic Factors|immunologic factors|mesh-ancestor
110456564|NCT00600028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110456565|NCT00600028|Leprostatic Agents|leprostatic agents|mesh-ancestor
110456566|NCT00600028|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110456567|NCT00600028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110456568|NCT00600028|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110456569|NCT00600028|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110456570|NCT00600028|Growth Substances|growth substances|mesh-ancestor
110456571|NCT00600028|Growth Inhibitors|growth inhibitors|mesh-ancestor
110456572|NCT00600028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110456573|NCT02650102|Olanzapine|olanzapine|mesh-list
110456574|NCT02650102|Risperidone|risperidone|mesh-list
110456575|NCT02650102|Aripiprazole|aripiprazole|mesh-list
110456576|NCT02650102|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110456577|NCT02650102|Ziprasidone|ziprasidone|mesh-list
110456578|NCT02650102|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110456579|NCT02650102|Serotonin Agents|serotonin agents|mesh-ancestor
110456580|NCT02650102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110456581|NCT02650102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110456582|NCT02650102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110456583|NCT02650102|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110506255|NCT00839371|Anesthetics|anesthetics|mesh-ancestor
110506256|NCT00839371|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110506257|NCT00839371|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110506258|NCT00839371|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110506259|NCT00839371|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110506260|NCT00839371|GABA Modulators|gaba modulators|mesh-ancestor
110506261|NCT00839371|GABA Agents|gaba agents|mesh-ancestor
110506262|NCT00839371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110506263|NCT00839371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110506264|NCT02826408|Rabeprazole|rabeprazole|mesh-list
110506265|NCT02826408|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110506266|NCT02826408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110506267|NCT02826408|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110506268|NCT02826408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110506269|NCT02826408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110506270|NCT00573937|Morphine|morphine|mesh-list
110506271|NCT00573937|Methadone|methadone|mesh-list
110506272|NCT00573937|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110506273|NCT00573937|Narcotics|narcotics|mesh-ancestor
110506274|NCT00573937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110506275|NCT00573937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110506276|NCT00573937|Analgesics|analgesics|mesh-ancestor
110506277|NCT00573937|Sensory System Agents|sensory system agents|mesh-ancestor
110506278|NCT00573937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110506279|NCT00573937|Antitussive Agents|antitussive agents|mesh-ancestor
110506280|NCT00573937|Respiratory System Agents|respiratory system agents|mesh-ancestor
110506281|NCT00845533|Piperaquine|piperaquine|mesh-list
110506282|NCT00845533|Artenimol|artenimol|mesh-list
110506283|NCT00845533|Antimalarials|antimalarials|mesh-ancestor
110506284|NCT00845533|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110506285|NCT00845533|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110506286|NCT00845533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110174040|NCT00062179|Paclitaxel|paclitaxel|mesh-list
110456584|NCT02650102|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110456585|NCT02650102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110456586|NCT02650102|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110456587|NCT02650102|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110456588|NCT02650102|Dopamine Agents|dopamine agents|mesh-ancestor
110456589|NCT02650102|Antiemetics|antiemetics|mesh-ancestor
110456590|NCT02650102|Autonomic Agents|autonomic agents|mesh-ancestor
110456591|NCT02650102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110456592|NCT02650102|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110456593|NCT02650102|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110456594|NCT02650102|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110456595|NCT02650102|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110456596|NCT02650102|Antidepressive Agents|antidepressive agents|mesh-ancestor
110506287|NCT00839449|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
110506288|NCT00839449|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110506289|NCT00839449|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110506290|NCT04958538|Methotrexate|methotrexate|mesh-list
110506291|NCT04958538|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110506292|NCT04958538|Abortifacient Agents|abortifacient agents|mesh-ancestor
110506293|NCT04958538|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110506294|NCT04958538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110506295|NCT04958538|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110506296|NCT04958538|Antimetabolites|antimetabolites|mesh-ancestor
110506297|NCT04958538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110592463|NCT00770445|Metformin|metformin|mesh-list
110506298|NCT04958538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110506299|NCT04958538|Dermatologic Agents|dermatologic agents|mesh-ancestor
110506300|NCT04958538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110506301|NCT04958538|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110506302|NCT04958538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110506303|NCT04958538|Immunologic Factors|immunologic factors|mesh-ancestor
110506304|NCT04958538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110506305|NCT04958538|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110506306|NCT02548195|Gemcitabine|gemcitabine|mesh-list
110506307|NCT02548195|Capecitabine|capecitabine|mesh-list
110506308|NCT02548195|Oxaliplatin|oxaliplatin|mesh-list
110506309|NCT02548195|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110506310|NCT02548195|Antimetabolites|antimetabolites|mesh-ancestor
110506311|NCT02548195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110506312|NCT02548195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110506313|NCT00573859|Methylphenidate|methylphenidate|mesh-list
110506314|NCT00573859|Amphetamine|amphetamine|mesh-list
110506315|NCT00573859|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
110506316|NCT00573859|Dextroamphetamine|dextroamphetamine|mesh-list
110506317|NCT00573859|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
110506318|NCT00573859|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110506319|NCT00573859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110174094|NCT04733625|Vitamin D|vitamin d|mesh-list
110456597|NCT02650102|Dopamine Agonists|dopamine agonists|mesh-ancestor
110456598|NCT02650102|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110456599|NCT02650102|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110456600|NCT02650102|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110456601|NCT02650102|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110506320|NCT00573859|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110506321|NCT00573859|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110506322|NCT00573859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110506323|NCT00573859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110506324|NCT00573859|Dopamine Agents|dopamine agents|mesh-ancestor
110506325|NCT00573859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110506326|NCT00573859|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110506328|NCT00573859|Sympathomimetics|sympathomimetics|mesh-ancestor
110506329|NCT00573859|Autonomic Agents|autonomic agents|mesh-ancestor
110506330|NCT00573859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110506331|NCT04043065|Anti-Infective Agents|anti-infective agents|mesh-list
110506332|NCT04043065|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110506333|NCT00839605|Dexmedetomidine|dexmedetomidine|mesh-list
110506334|NCT00839605|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110506335|NCT00839605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110506336|NCT00839605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110506337|NCT00839605|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110506339|NCT00839605|Sensory System Agents|sensory system agents|mesh-ancestor
110506340|NCT00839605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110506341|NCT00839605|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110506342|NCT00839605|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110506343|NCT00839605|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110506344|NCT00839605|Adrenergic Agents|adrenergic agents|mesh-ancestor
110506345|NCT00839605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110506346|NCT00839605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110506347|NCT00839683|Dapagliflozin|dapagliflozin|mesh-list
110506348|NCT00839683|Valsartan|valsartan|mesh-list
110506349|NCT00839683|Simvastatin|simvastatin|mesh-list
110506350|NCT00839683|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110456602|NCT00650182|Fentanyl|fentanyl|mesh-list
110456603|NCT00650182|Naltrexone|naltrexone|mesh-list
110456604|NCT00650182|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110456605|NCT00650182|Narcotics|narcotics|mesh-ancestor
110456606|NCT00650182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110456607|NCT00650182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110456608|NCT00650182|Analgesics|analgesics|mesh-ancestor
110456609|NCT00650182|Sensory System Agents|sensory system agents|mesh-ancestor
110456610|NCT00650182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110456611|NCT00650182|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110456612|NCT00650182|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110456613|NCT00650182|Anesthetics, General|anesthetics, general|mesh-ancestor
110456614|NCT00650182|Anesthetics|anesthetics|mesh-ancestor
110456615|NCT00650182|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110456616|NCT00650182|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110506351|NCT00839683|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110506352|NCT00839683|Antimetabolites|antimetabolites|mesh-ancestor
110506353|NCT00839683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110506354|NCT00839683|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110506355|NCT00839683|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110506356|NCT00839683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110506357|NCT00839683|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110506358|NCT00839683|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110506359|NCT00839683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110506360|NCT00839683|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110506361|NCT00839683|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110506362|NCT00839683|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110506363|NCT00839761|Iron|iron|mesh-list
110506364|NCT00839761|Trace Elements|trace elements|mesh-ancestor
110506365|NCT00839761|Micronutrients|micronutrients|mesh-ancestor
110506366|NCT00839761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110506367|NCT02825394|Ecarin|ecarin|mesh-list
110506368|NCT02825394|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110506369|NCT02825394|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110506370|NCT02825394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110506371|NCT00845611|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
110506372|NCT00845611|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110506373|NCT00845611|Immunologic Factors|immunologic factors|mesh-ancestor
110506374|NCT00845611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110506375|NCT00845689|Adenosine|adenosine|mesh-list
110506376|NCT00845689|Analgesics|analgesics|mesh-ancestor
110506378|NCT00845689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110506379|NCT00845689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110506380|NCT00845689|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110506381|NCT00845689|Vasodilator Agents|vasodilator agents|mesh-ancestor
110456617|NCT00910780|Olanzapine|olanzapine|mesh-list
110456618|NCT00910780|Aripiprazole|aripiprazole|mesh-list
110456619|NCT00910780|Antidepressive Agents|antidepressive agents|mesh-ancestor
110456620|NCT00910780|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110456621|NCT00910780|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110456622|NCT00910780|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110456623|NCT00910780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110456624|NCT00910780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110456625|NCT00910780|Dopamine Agonists|dopamine agonists|mesh-ancestor
110456626|NCT00910780|Dopamine Agents|dopamine agents|mesh-ancestor
110456627|NCT00910780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110456628|NCT00910780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110456629|NCT00910780|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110456630|NCT00910780|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110506382|NCT00845689|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
110506383|NCT00845689|Purinergic Agonists|purinergic agonists|mesh-ancestor
110506384|NCT00845689|Purinergic Agents|purinergic agents|mesh-ancestor
110506385|NCT00845689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110506386|NCT00845689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110506387|NCT05660694|Vitamin E|vitamin e|mesh-list
110506388|NCT05660694|Triamcinolone|triamcinolone|mesh-list
110506389|NCT05660694|Pentoxifylline|pentoxifylline|mesh-list
110506390|NCT05660694|Vitamins|vitamins|mesh-ancestor
110506391|NCT05660694|Micronutrients|micronutrients|mesh-ancestor
110506392|NCT05660694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110506393|NCT05660694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110506394|NCT05660694|Glucocorticoids|glucocorticoids|mesh-ancestor
110506395|NCT05660694|Hormones|hormones|mesh-ancestor
110506396|NCT05660694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110506397|NCT05660694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110506398|NCT05660694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110506399|NCT05660694|Antioxidants|antioxidants|mesh-ancestor
110456631|NCT00910780|Serotonin Agents|serotonin agents|mesh-ancestor
110456632|NCT00910780|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110456633|NCT00910780|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110456634|NCT00910780|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110456635|NCT00910780|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110456636|NCT00910780|Antiemetics|antiemetics|mesh-ancestor
110456637|NCT00910780|Autonomic Agents|autonomic agents|mesh-ancestor
110456638|NCT00910780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110456639|NCT00910780|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110456640|NCT00910780|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110456641|NCT00910780|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110456642|NCT00910780|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110456643|NCT02656810|Teriparatide|teriparatide|mesh-list
110301779|NCT00247910|Diuretics|diuretics|mesh-ancestor
110456644|NCT02656810|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110456645|NCT02656810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110456646|NCT02656810|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110456647|NCT02649478|Fluticasone|fluticasone|mesh-list
110456648|NCT02649478|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110456649|NCT02649478|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
110456650|NCT02649478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110456651|NCT02649478|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110456652|NCT02649478|Autonomic Agents|autonomic agents|mesh-ancestor
110456653|NCT02649478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110456654|NCT02649478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110456655|NCT02649478|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110456656|NCT02649478|Respiratory System Agents|respiratory system agents|mesh-ancestor
110456657|NCT02649478|Dermatologic Agents|dermatologic agents|mesh-ancestor
110103719|NCT01773096|Methylnaltrexone|methylnaltrexone|mesh-list
110456658|NCT02649478|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110456659|NCT02649478|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110456660|NCT02649478|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110456661|NCT02649478|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110456662|NCT02649478|Adrenergic Agents|adrenergic agents|mesh-ancestor
110456663|NCT02649478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110456664|NCT02649478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110456665|NCT02649478|Glucocorticoids|glucocorticoids|mesh-ancestor
110456666|NCT02649478|Hormones|hormones|mesh-ancestor
110311943|NCT00303927|Capecitabine|capecitabine|mesh-list
110506401|NCT05660694|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110506402|NCT05660694|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110506403|NCT05660694|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110506405|NCT05660694|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110506406|NCT05113368|Fulvestrant|fulvestrant|mesh-list
110506407|NCT05113368|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110506408|NCT05113368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110506409|NCT05113368|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110506410|NCT05113368|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110506411|NCT05113368|Hormone Antagonists|hormone antagonists|mesh-ancestor
110506412|NCT05113368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110506413|NCT05113368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110506414|NCT02824614|Erythritol|erythritol|mesh-list
110506415|NCT02824614|Vasodilator Agents|vasodilator agents|mesh-ancestor
110506416|NCT00840229|Triamcinolone|triamcinolone|mesh-list
110506417|NCT00840229|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110506418|NCT00840229|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110174276|NCT00064636|Bortezomib|bortezomib|mesh-list
110456667|NCT02649478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110456668|NCT02649478|Sympathomimetics|sympathomimetics|mesh-ancestor
110456669|NCT04167592|Benzydamine|benzydamine|mesh-list
110456670|NCT04167592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110456671|NCT04168294|Propofol|propofol|mesh-list
110456672|NCT04168294|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110456673|NCT04168294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110456674|NCT04168294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110456675|NCT04168294|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110456676|NCT04168294|Anesthetics, General|anesthetics, general|mesh-ancestor
110456677|NCT04168294|Anesthetics|anesthetics|mesh-ancestor
110456678|NCT04168138|Cytarabine|cytarabine|mesh-list
110456679|NCT04168138|Decitabine|decitabine|mesh-list
110456680|NCT04168138|Aclarubicin|aclarubicin|mesh-list
110456681|NCT04168138|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110456682|NCT04168138|Antimetabolites|antimetabolites|mesh-ancestor
110456683|NCT04168138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110456684|NCT04168138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110456685|NCT04168138|Antiviral Agents|antiviral agents|mesh-ancestor
110456686|NCT04168138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110456687|NCT04168138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110456688|NCT04168138|Immunologic Factors|immunologic factors|mesh-ancestor
110456689|NCT04168138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110456690|NCT04168138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110456691|NCT04168138|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110456692|NCT04168138|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110456693|NCT04168138|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110456694|NCT00649870|Valacyclovir|valacyclovir|mesh-list
110456695|NCT00649870|Antiviral Agents|antiviral agents|mesh-ancestor
110456696|NCT00649870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110456697|NCT04167280|Ipratropium|ipratropium|mesh-list
110456698|NCT04167280|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110456699|NCT04167280|Autonomic Agents|autonomic agents|mesh-ancestor
110456700|NCT04167280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110456701|NCT04167280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110456702|NCT04167280|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110506419|NCT00840229|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110506420|NCT00840229|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110506421|NCT00840229|Glucocorticoids|glucocorticoids|mesh-ancestor
110506423|NCT00840229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110506424|NCT00840229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110506425|NCT00840229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110506426|NCT00840229|Immunologic Factors|immunologic factors|mesh-ancestor
110506427|NCT00840229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110506428|NCT00840229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110506429|NCT00831441|Apixaban|apixaban|mesh-list
110506430|NCT00831441|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110506431|NCT00831441|Antithrombins|antithrombins|mesh-ancestor
110506432|NCT00831441|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110506433|NCT00831441|Protease Inhibitors|protease inhibitors|mesh-ancestor
110506434|NCT00831441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110506435|NCT00831441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110506436|NCT00831441|Anticoagulants|anticoagulants|mesh-ancestor
110506437|NCT00840385|Vidarabine|vidarabine|mesh-list
110506438|NCT00840385|Fludarabine|fludarabine|mesh-list
110506439|NCT00840385|Fludarabine phosphate|fludarabine phosphate|mesh-list
110506440|NCT00840385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110506441|NCT00840385|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110456703|NCT04167280|Respiratory System Agents|respiratory system agents|mesh-ancestor
110456704|NCT04167280|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110456705|NCT04167280|Cholinergic Agents|cholinergic agents|mesh-ancestor
110456706|NCT04167280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110456707|NCT04167280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110456708|NCT02648854|Metformin|metformin|mesh-list
110456709|NCT02648854|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110456710|NCT02648854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110456711|NCT02652598|Tolcapone|tolcapone|mesh-list
110456712|NCT02652598|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110456713|NCT02652598|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110456714|NCT02652598|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
110456715|NCT02652598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110456716|NCT02652598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110456717|NCT02648776|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
110456718|NCT02648776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110456719|NCT02648776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110456720|NCT02648464|Hydroxychloroquine|hydroxychloroquine|mesh-list
110456721|NCT02648464|Antimalarials|antimalarials|mesh-ancestor
110456722|NCT02648464|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110456723|NCT02648464|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110456724|NCT02648464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110456725|NCT02648464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110456726|NCT02648464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110456727|NCT02648464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110456728|NCT02645032|Vaccines|vaccines|mesh-list
110456729|NCT02645032|Immunologic Factors|immunologic factors|mesh-ancestor
110456730|NCT02645032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110103801|NCT01773616|Glucocorticoids|glucocorticoids|mesh-ancestor
110506442|NCT00840385|Antimetabolites|antimetabolites|mesh-ancestor
110506443|NCT00840385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110506444|NCT00840385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110506445|NCT00840385|Immunologic Factors|immunologic factors|mesh-ancestor
110506446|NCT00840385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110506447|NCT00840385|Antiviral Agents|antiviral agents|mesh-ancestor
110506448|NCT00840385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110506449|NCT02824458|Apatinib|apatinib|mesh-list
110506450|NCT02824458|Gefitinib|gefitinib|mesh-list
110506451|NCT02824458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110506452|NCT02824458|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110506453|NCT02824458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110506454|NCT02824458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110506455|NCT00840931|Lenalidomide|lenalidomide|mesh-list
110506456|NCT00840931|Immunologic Factors|immunologic factors|mesh-ancestor
110506457|NCT00840931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110506458|NCT00840931|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110506459|NCT00840931|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110506460|NCT00840931|Growth Substances|growth substances|mesh-ancestor
110506461|NCT00840931|Growth Inhibitors|growth inhibitors|mesh-ancestor
110506462|NCT00840931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110506463|NCT05659992|Cytarabine|cytarabine|mesh-list
110506464|NCT05659992|Azacitidine|azacitidine|mesh-list
110506465|NCT05659992|Venetoclax|venetoclax|mesh-list
110506466|NCT05659992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110506467|NCT05659992|Antimetabolites|antimetabolites|mesh-ancestor
110506468|NCT05659992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110506469|NCT05659992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110506470|NCT05659992|Antiviral Agents|antiviral agents|mesh-ancestor
110506471|NCT05659992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110506472|NCT05659992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110506473|NCT05659992|Immunologic Factors|immunologic factors|mesh-ancestor
110506474|NCT05659992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110506475|NCT05659992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110456731|NCT02644954|Metformin|metformin|mesh-list
110456732|NCT02644954|Calcipotriene|calcipotriene|mesh-list
110456733|NCT02644954|Coal Tar|coal tar|mesh-list
110456734|NCT02644954|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110456735|NCT02644954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110456736|NCT02644954|Dermatologic Agents|dermatologic agents|mesh-ancestor
110456737|NCT02644954|Keratolytic Agents|keratolytic agents|mesh-ancestor
110456738|NCT00650338|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110456739|NCT00650338|Latanoprost|latanoprost|mesh-list
110456740|NCT00650338|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110506476|NCT00834379|Pravastatin|pravastatin|mesh-list
110506477|NCT00834379|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110506478|NCT00834379|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110506479|NCT00834379|Antimetabolites|antimetabolites|mesh-ancestor
110506480|NCT00834379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110506481|NCT00834379|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110506482|NCT00834379|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110506483|NCT00834379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110506484|NCT00834457|Ritonavir|ritonavir|mesh-list
110506485|NCT00834457|Lopinavir|lopinavir|mesh-list
110506486|NCT00834457|Zidovudine|zidovudine|mesh-list
110506487|NCT00834457|Lamivudine|lamivudine|mesh-list
110506488|NCT00834457|Abacavir|abacavir|mesh-list
110506489|NCT00834457|Dideoxynucleosides|dideoxynucleosides|mesh-list
110456741|NCT02644720|Dexamethasone|dexamethasone|mesh-list
110456742|NCT02644720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110456743|NCT02644720|Antiemetics|antiemetics|mesh-ancestor
110456744|NCT02644720|Autonomic Agents|autonomic agents|mesh-ancestor
110456745|NCT02644720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110456746|NCT02644720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110456747|NCT02644720|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110456748|NCT02644720|Glucocorticoids|glucocorticoids|mesh-ancestor
110456750|NCT02644720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110456751|NCT02644720|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110456752|NCT02644720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110456753|NCT03542266|Azacitidine|azacitidine|mesh-list
110456754|NCT03542266|Cc-486|cc-486|mesh-list
110456755|NCT03542266|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110456756|NCT03542266|Antimetabolites|antimetabolites|mesh-ancestor
110456757|NCT03542266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110456758|NCT03542266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110456759|NCT03542266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110456760|NCT00652600|Propranolol|propranolol|mesh-list
110456761|NCT00652600|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110456762|NCT00652600|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110456763|NCT00652600|Adrenergic Agents|adrenergic agents|mesh-ancestor
110456764|NCT00652600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110456765|NCT00652600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110456766|NCT00652600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110456767|NCT00652600|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110301910|NCT00248456|Hormones|hormones|mesh-ancestor
110456768|NCT00652600|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110456769|NCT00652600|Vasodilator Agents|vasodilator agents|mesh-ancestor
110456770|NCT04166578|Lidocaine|lidocaine|mesh-list
110456771|NCT04166578|Anesthetics, Local|anesthetics, local|mesh-ancestor
110456772|NCT04166578|Anesthetics|anesthetics|mesh-ancestor
110456773|NCT04166578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110456774|NCT04166578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110456775|NCT04166578|Sensory System Agents|sensory system agents|mesh-ancestor
110456776|NCT04166578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110456777|NCT04166578|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110456778|NCT04166578|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110456779|NCT04166578|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110456780|NCT04166578|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110456781|NCT04166578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110456782|NCT04166734|Pembrolizumab|pembrolizumab|mesh-list
110456783|NCT04166734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110456784|NCT04166734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110456785|NCT04166734|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110456786|NCT04166734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110456787|NCT00651352|Nicotine|nicotine|mesh-list
110456788|NCT00651352|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110456789|NCT00651352|Autonomic Agents|autonomic agents|mesh-ancestor
110506490|NCT00834457|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110506491|NCT00834457|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110506492|NCT00834457|Protease Inhibitors|protease inhibitors|mesh-ancestor
110506493|NCT00834457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110506494|NCT00834457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110506495|NCT00834457|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110506496|NCT00834457|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110506497|NCT00834457|Antiviral Agents|antiviral agents|mesh-ancestor
110506498|NCT00834457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110174486|NCT00389987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110456790|NCT00651352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110456791|NCT00651352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110456792|NCT00651352|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110456793|NCT00651352|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110456794|NCT00651352|Cholinergic Agents|cholinergic agents|mesh-ancestor
110456795|NCT00651352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110456796|NCT00651352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110456797|NCT02641210|Albendazole|albendazole|mesh-list
110456798|NCT02641210|Anthelmintics|anthelmintics|mesh-ancestor
110456799|NCT02641210|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110456800|NCT02641210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110456801|NCT02641210|Anticestodal Agents|anticestodal agents|mesh-ancestor
110456802|NCT02641210|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110456803|NCT02641210|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110456804|NCT02641210|Tubulin Modulators|tubulin modulators|mesh-ancestor
110456805|NCT02641210|Antimitotic Agents|antimitotic agents|mesh-ancestor
110456806|NCT02641210|Mitosis Modulators|mitosis modulators|mesh-ancestor
110456807|NCT02641210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110456809|NCT02644408|Megestrol|megestrol|mesh-list
110456810|NCT02644408|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110456811|NCT02644408|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110456812|NCT02644408|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110456813|NCT02644408|Contraceptive Agents|contraceptive agents|mesh-ancestor
110456814|NCT02644408|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110456815|NCT02644408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110456816|NCT02644408|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110456817|NCT02644408|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110456818|NCT02644408|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110456819|NCT02644408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110456820|NCT02644486|Irbesartan|irbesartan|mesh-list
110456821|NCT02644486|Sevelamer|sevelamer|mesh-list
110456822|NCT02644486|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110456823|NCT02644486|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110456824|NCT02644486|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110456825|NCT02644486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110456826|NCT02644486|Chelating Agents|chelating agents|mesh-ancestor
110456827|NCT02644486|Sequestering Agents|sequestering agents|mesh-ancestor
110456828|NCT00827359|Everolimus|everolimus|mesh-list
110456829|NCT00827359|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110456830|NCT00827359|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110456831|NCT00827359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110456832|NCT00827359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110456833|NCT00827359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110456834|NCT00827359|Immunologic Factors|immunologic factors|mesh-ancestor
110456835|NCT00827359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110456836|NCT00827359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110456837|NCT02641288|Ropivacaine|ropivacaine|mesh-list
110456838|NCT02641288|Anesthetics, Local|anesthetics, local|mesh-ancestor
110456839|NCT02641288|Anesthetics|anesthetics|mesh-ancestor
110456840|NCT02641288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110456841|NCT02641288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110456842|NCT02641288|Sensory System Agents|sensory system agents|mesh-ancestor
110456843|NCT02641288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110456844|NCT04165174|Apatinib|apatinib|mesh-list
110456845|NCT04165174|Antibodies|antibodies|mesh-list
110506499|NCT00834457|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110506500|NCT00834457|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110506502|NCT00834457|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110506503|NCT00834457|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110506504|NCT03851965|Plasminogen|plasminogen|mesh-list
110506505|NCT03851965|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110506506|NCT03851965|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110506507|NCT03851965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110506508|NCT02611635|Warfarin|warfarin|mesh-list
110506509|NCT02611635|Rivaroxaban|rivaroxaban|mesh-list
110506510|NCT02611635|Dabigatran|dabigatran|mesh-list
110506511|NCT02611635|Apixaban|apixaban|mesh-list
110506512|NCT02611635|Edoxaban|edoxaban|mesh-list
110506513|NCT02611635|Anticoagulants|anticoagulants|mesh-ancestor
110506514|NCT02611635|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110506515|NCT02611635|Antithrombins|antithrombins|mesh-ancestor
110506516|NCT02611635|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110456846|NCT04165174|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110456847|NCT04165174|Immunologic Factors|immunologic factors|mesh-ancestor
110456848|NCT04165174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110456849|NCT04165174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110456850|NCT04165174|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110456851|NCT04165174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110456852|NCT04165174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110456853|NCT02613247|Hylan|hylan|mesh-list
110456854|NCT02613247|Viscosupplements|viscosupplements|mesh-ancestor
110456855|NCT02613247|Protective Agents|protective agents|mesh-ancestor
110456856|NCT02613247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110456857|NCT02641132|Mitomycins|mitomycins|mesh-list
110456858|NCT02641132|Mitomycin|mitomycin|mesh-list
110456859|NCT02641132|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110456860|NCT02641132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110456861|NCT02641132|Alkylating Agents|alkylating agents|mesh-ancestor
110456862|NCT02641132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110456863|NCT02641132|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110456864|NCT02641132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110456865|NCT00653614|Drospirenone|drospirenone|mesh-list
110456866|NCT00653614|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110456867|NCT00653614|Hormone Antagonists|hormone antagonists|mesh-ancestor
110456868|NCT00653614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110456869|NCT00653614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110456870|NCT00653614|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110456871|NCT00653614|Diuretics|diuretics|mesh-ancestor
110456872|NCT00653614|Natriuretic Agents|natriuretic agents|mesh-ancestor
110456873|NCT02644252|Tocotrienols|tocotrienols|mesh-list
110456874|NCT02644252|Vitamin E|vitamin e|mesh-list
110456875|NCT02644252|Tocopherols|tocopherols|mesh-list
110456876|NCT02644252|Carboplatin|carboplatin|mesh-list
110456877|NCT02644252|Vinorelbine|vinorelbine|mesh-list
110456878|NCT02644252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110456879|NCT02644252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110456880|NCT02644252|Tubulin Modulators|tubulin modulators|mesh-ancestor
110456881|NCT02644252|Antimitotic Agents|antimitotic agents|mesh-ancestor
110456882|NCT02644252|Mitosis Modulators|mitosis modulators|mesh-ancestor
110456883|NCT02644252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110456884|NCT02644252|Antioxidants|antioxidants|mesh-ancestor
110456885|NCT02644252|Protective Agents|protective agents|mesh-ancestor
110456886|NCT02644252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110456887|NCT02644252|Vitamins|vitamins|mesh-ancestor
110506517|NCT02611635|Protease Inhibitors|protease inhibitors|mesh-ancestor
110506518|NCT02611635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110506519|NCT02611635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110506521|NCT02824926|Antifungal Agents|antifungal agents|mesh-ancestor
110506522|NCT02824926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110506523|NCT02824926|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110506524|NCT02824926|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110506525|NCT02824926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110506526|NCT02824926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110506527|NCT02824926|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110506528|NCT02824926|Hormone Antagonists|hormone antagonists|mesh-ancestor
110506529|NCT02824926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110506530|NCT02824926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110506531|NCT02824926|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110506532|NCT00705471|Infliximab|infliximab|mesh-list
110506533|NCT00705471|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110506534|NCT00705471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110506535|NCT00705471|Dermatologic Agents|dermatologic agents|mesh-ancestor
110506536|NCT00705471|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110506537|NCT00705471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110506538|NCT00705549|Cisplatin|cisplatin|mesh-list
110456888|NCT02644252|Micronutrients|micronutrients|mesh-ancestor
110456889|NCT00818389|Riluzole|riluzole|mesh-list
110456890|NCT00818389|Lithium Carbonate|lithium carbonate|mesh-list
110456891|NCT00818389|Antidepressive Agents|antidepressive agents|mesh-ancestor
110456892|NCT00818389|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110456893|NCT00818389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110456894|NCT00818389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110456895|NCT00818389|Antimanic Agents|antimanic agents|mesh-ancestor
110456896|NCT00818389|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110456897|NCT00818389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110456898|NCT00818389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110456899|NCT00818389|Anticonvulsants|anticonvulsants|mesh-ancestor
110456900|NCT00818389|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110456901|NCT00818389|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110456902|NCT00818389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110456903|NCT00818389|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110456904|NCT00818389|Protective Agents|protective agents|mesh-ancestor
110456905|NCT02640976|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
110456907|NCT02640976|Menotropins|menotropins|mesh-list
110456908|NCT02640976|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110456909|NCT02640976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110456910|NCT02640976|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110456911|NCT02640976|Fertility Agents|fertility agents|mesh-ancestor
110456912|NCT02640976|Hormone Antagonists|hormone antagonists|mesh-ancestor
110456913|NCT02640976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110456914|NCT02644018|Pentanedioic acid imidazolyl ethanamide|pentanedioic acid imidazolyl ethanamide|mesh-list
110456915|NCT02644018|Antiviral Agents|antiviral agents|mesh-ancestor
110456916|NCT02644018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110506539|NCT00705549|Gemcitabine|gemcitabine|mesh-list
110506540|NCT00705549|Docetaxel|docetaxel|mesh-list
110506541|NCT00705549|Vinorelbine|vinorelbine|mesh-list
110506542|NCT00705549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110506543|NCT00705549|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110506544|NCT00705549|Antimetabolites|antimetabolites|mesh-ancestor
110506545|NCT00705549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110506546|NCT00705549|Tubulin Modulators|tubulin modulators|mesh-ancestor
110506547|NCT00705549|Antimitotic Agents|antimitotic agents|mesh-ancestor
110506548|NCT00705549|Mitosis Modulators|mitosis modulators|mesh-ancestor
110506549|NCT00705549|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110506550|NCT02824770|Tramadol|tramadol|mesh-list
110506551|NCT02824770|Bupivacaine|bupivacaine|mesh-list
110506552|NCT02824770|Anesthetics, Local|anesthetics, local|mesh-ancestor
110506553|NCT02824770|Anesthetics|anesthetics|mesh-ancestor
110506554|NCT02824770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110506555|NCT02824770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110592695|NCT02556411|Estrogens|estrogens|mesh-ancestor
110506556|NCT02824770|Sensory System Agents|sensory system agents|mesh-ancestor
110506557|NCT02824770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110506558|NCT02824770|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110506559|NCT02824770|Narcotics|narcotics|mesh-ancestor
110506560|NCT02824770|Analgesics|analgesics|mesh-ancestor
110506561|NCT02824536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110506562|NCT02824536|Antibodies|antibodies|mesh-list
110506563|NCT02824536|Immunoglobulins|immunoglobulins|mesh-list
110506564|NCT02824536|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110506565|NCT02824536|Immunologic Factors|immunologic factors|mesh-ancestor
110456917|NCT02647918|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
110456918|NCT02647918|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110456919|NCT02647918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110456920|NCT02647918|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110456921|NCT02647918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110456922|NCT03130036|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110456923|NCT03130036|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110456924|NCT03130036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110456925|NCT02640898|Docetaxel|docetaxel|mesh-list
110456926|NCT02640898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110456927|NCT02640898|Tubulin Modulators|tubulin modulators|mesh-ancestor
110456928|NCT02640898|Antimitotic Agents|antimitotic agents|mesh-ancestor
110456929|NCT02640898|Mitosis Modulators|mitosis modulators|mesh-ancestor
110456930|NCT02640898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110456931|NCT02535910|Vitamin D|vitamin d|mesh-list
110456932|NCT02535910|Cholecalciferol|cholecalciferol|mesh-list
110456933|NCT02535910|Calcifediol|calcifediol|mesh-list
110456934|NCT02535910|Vitamins|vitamins|mesh-ancestor
110456935|NCT02535910|Micronutrients|micronutrients|mesh-ancestor
110456936|NCT02535910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110456937|NCT02535910|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110506566|NCT02824536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110506567|NCT02824536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110506568|NCT00831129|Rosiglitazone|rosiglitazone|mesh-list
110506569|NCT00831129|Simvastatin|simvastatin|mesh-list
110506570|NCT00831129|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110506571|NCT00831129|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110506572|NCT00831129|Antimetabolites|antimetabolites|mesh-ancestor
110506573|NCT00831129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110506574|NCT00831129|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110506575|NCT00831129|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110506576|NCT00831129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110456938|NCT02535910|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110456939|NCT00849901|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110456940|NCT00849901|Fluoxetine|fluoxetine|mesh-list
110456941|NCT00849901|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110456942|NCT00849901|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110456943|NCT00849901|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110456944|NCT00849901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110456945|NCT00849901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110456946|NCT00849901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110456947|NCT00849901|Analgesics|analgesics|mesh-ancestor
110456948|NCT00849901|Sensory System Agents|sensory system agents|mesh-ancestor
110456949|NCT00849901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110456950|NCT00849901|Antidepressive Agents|antidepressive agents|mesh-ancestor
110456951|NCT00849901|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110456952|NCT00849901|Dopamine Agents|dopamine agents|mesh-ancestor
110456953|NCT00849901|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110456954|NCT00849901|Serotonin Agents|serotonin agents|mesh-ancestor
110456955|NCT00849901|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110456956|NCT00849901|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110456957|NCT00849901|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110456959|NCT02641054|Levodopa|levodopa|mesh-list
110456960|NCT02641054|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110456961|NCT02641054|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110456962|NCT02641054|Dopamine Agents|dopamine agents|mesh-ancestor
110456963|NCT02641054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110456964|NCT02641054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110456965|NCT02641054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110456966|NCT02643784|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110456967|NCT02643784|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110456968|NCT02643784|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110456969|NCT02643784|Antimetabolites|antimetabolites|mesh-ancestor
110456970|NCT02643784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110456971|NCT02643784|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110456972|NCT02643784|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110456973|NCT02643784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110456974|NCT04166890|Epinephrine|epinephrine|mesh-list
110456976|NCT04166890|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110456977|NCT04166890|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110456978|NCT04166890|Adrenergic Agents|adrenergic agents|mesh-ancestor
110456979|NCT04166890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110456980|NCT04166890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110456981|NCT04166890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110592749|NCT02580344|Ibuprofen|ibuprofen|mesh-list
110456982|NCT04166890|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110456983|NCT04166890|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110456984|NCT04166890|Autonomic Agents|autonomic agents|mesh-ancestor
110456985|NCT04166890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110456986|NCT04166890|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110456987|NCT04166890|Respiratory System Agents|respiratory system agents|mesh-ancestor
110456988|NCT04166890|Mydriatics|mydriatics|mesh-ancestor
110456989|NCT04166890|Sympathomimetics|sympathomimetics|mesh-ancestor
110506577|NCT00831129|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110506578|NCT00831129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110506579|NCT00637962|polysaccharide-K|polysaccharide-k|mesh-list
110506580|NCT00637962|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110506581|NCT00637962|Immunologic Factors|immunologic factors|mesh-ancestor
110506582|NCT00637962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110506583|NCT00637962|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110506584|NCT00637962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110506585|NCT00637962|Antiviral Agents|antiviral agents|mesh-ancestor
110506586|NCT00637962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110506587|NCT00637962|Interferon Inducers|interferon inducers|mesh-ancestor
110506588|NCT00637962|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110506589|NCT00637962|Protective Agents|protective agents|mesh-ancestor
110506590|NCT00913341|Alprazolam|alprazolam|mesh-list
110506591|NCT00913341|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110506592|NCT00913341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110506593|NCT00913341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110506594|NCT00913341|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110506595|NCT00913341|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110506596|NCT00913341|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110506597|NCT00913341|GABA Modulators|gaba modulators|mesh-ancestor
110506598|NCT00913341|GABA Agents|gaba agents|mesh-ancestor
110506599|NCT00913341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110506600|NCT00913341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110506601|NCT00620113|Vitamin D|vitamin d|mesh-list
110506602|NCT00620113|Cholecalciferol|cholecalciferol|mesh-list
110456990|NCT04166890|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110456991|NCT04166890|Anesthetics, Local|anesthetics, local|mesh-ancestor
110456992|NCT04166890|Anesthetics|anesthetics|mesh-ancestor
110456993|NCT04166890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110456994|NCT04166890|Sensory System Agents|sensory system agents|mesh-ancestor
110456995|NCT00652912|Clonazepam|clonazepam|mesh-list
110456996|NCT00652912|Anticonvulsants|anticonvulsants|mesh-ancestor
110456997|NCT00652912|GABA Modulators|gaba modulators|mesh-ancestor
110456998|NCT00652912|GABA Agents|gaba agents|mesh-ancestor
110456999|NCT00652912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110457000|NCT00652912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110457001|NCT00652912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110457002|NCT01168232|Epothilones|epothilones|mesh-list
110457003|NCT01168232|Epothilone B|epothilone b|mesh-list
110457004|NCT01168232|Tubulin Modulators|tubulin modulators|mesh-ancestor
110457005|NCT01168232|Antimitotic Agents|antimitotic agents|mesh-ancestor
110457006|NCT01168232|Mitosis Modulators|mitosis modulators|mesh-ancestor
110457007|NCT01168232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110457008|NCT01168232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110457009|NCT00817531|Dasatinib|dasatinib|mesh-list
110457010|NCT00817531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110457011|NCT00817531|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110457012|NCT00817531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110457013|NCT00817531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110457014|NCT00651586|Ciprofloxacin|ciprofloxacin|mesh-list
110506603|NCT00620113|Calcium Carbonate|calcium carbonate|mesh-list
110506604|NCT00620113|Calcium|calcium|mesh-list
110506605|NCT00620113|Vitamins|vitamins|mesh-ancestor
110506606|NCT00620113|Micronutrients|micronutrients|mesh-ancestor
110506607|NCT00620113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110506608|NCT00620113|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110506609|NCT00620113|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110506611|NCT00620113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110506612|NCT00620113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110506613|NCT00830115|Pantoprazole|pantoprazole|mesh-list
110506614|NCT00830115|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110506615|NCT00830115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110506616|NCT00830115|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110506617|NCT00830115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110506618|NCT00830115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110506619|NCT00633672|Esomeprazole|esomeprazole|mesh-list
110506620|NCT00633672|Ranitidine|ranitidine|mesh-list
110506621|NCT00633672|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
110506622|NCT00633672|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110506623|NCT00633672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110506624|NCT00633672|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110506625|NCT00633672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110506626|NCT00633672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110506627|NCT00633672|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110506628|NCT00633672|Histamine Antagonists|histamine antagonists|mesh-ancestor
110457015|NCT00651586|Gatifloxacin|gatifloxacin|mesh-list
110457016|NCT00651586|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110457017|NCT00651586|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110457018|NCT00651586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110457019|NCT00651586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110457020|NCT00651586|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110457021|NCT00651586|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110457022|NCT00651586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110457023|NCT00651586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110457024|NCT00651586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110457025|NCT00651586|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110457026|NCT00651586|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110457027|NCT02640508|Lenvatinib|lenvatinib|mesh-list
110457028|NCT02640508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110457029|NCT02640508|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110457030|NCT02640508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110457031|NCT02640508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110457032|NCT05312606|Chlorhexidine|chlorhexidine|mesh-list
110457033|NCT05312606|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110457034|NCT05312606|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110457035|NCT05312606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110457036|NCT05312606|Disinfectants|disinfectants|mesh-ancestor
110457037|NCT05312606|Dermatologic Agents|dermatologic agents|mesh-ancestor
110457038|NCT05259566|Menthol|menthol|mesh-list
110457039|NCT05259566|Antipruritics|antipruritics|mesh-ancestor
110506630|NCT00633672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110506631|NCT00633672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110506632|NCT02547103|Chlorhexidine|chlorhexidine|mesh-list
110506633|NCT02547103|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110506634|NCT02547103|Mupirocin|mupirocin|mesh-list
110506635|NCT02547103|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110506636|NCT02547103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110506637|NCT02547103|Disinfectants|disinfectants|mesh-ancestor
110506638|NCT02547103|Dermatologic Agents|dermatologic agents|mesh-ancestor
110506639|NCT02547103|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110592772|NCT00776217|Histamine Agents|histamine agents|mesh-ancestor
110506640|NCT02547103|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110506641|NCT02547103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110506642|NCT02547103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110506643|NCT02822586|Brentuximab Vedotin|brentuximab vedotin|mesh-list
110506644|NCT02822586|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110506645|NCT02822586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110506646|NCT02822586|Immunotoxins|immunotoxins|mesh-ancestor
110506647|NCT02822586|Immunoconjugates|immunoconjugates|mesh-ancestor
110506648|NCT02822586|Immunologic Factors|immunologic factors|mesh-ancestor
110506649|NCT02822586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110506650|NCT00848809|Vancomycin|vancomycin|mesh-list
110506651|NCT00848809|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110506652|NCT00848809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110506653|NCT00834847|Pravastatin|pravastatin|mesh-list
110457040|NCT05259566|Dermatologic Agents|dermatologic agents|mesh-ancestor
110457041|NCT02643550|Cetuximab|cetuximab|mesh-list
110457042|NCT02643550|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110457043|NCT02643550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110457044|NCT00817063|Alitretinoin|alitretinoin|mesh-list
110457045|NCT00817063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110457046|NCT00817063|Dermatologic Agents|dermatologic agents|mesh-ancestor
110457047|NCT04313270|Evolocumab|evolocumab|mesh-list
110457048|NCT04313270|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
110457049|NCT04313270|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110457050|NCT04313270|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110457051|NCT04313270|Antimetabolites|antimetabolites|mesh-ancestor
110457052|NCT04313270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110457053|NCT04313270|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110457054|NCT04313270|Protease Inhibitors|protease inhibitors|mesh-ancestor
110457055|NCT04313270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110457056|NCT04313270|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110457057|NCT02640118|Lixisenatide|lixisenatide|mesh-list
110457058|NCT02640118|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110457059|NCT02640118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110457060|NCT00826267|Trastuzumab|trastuzumab|mesh-list
110457061|NCT00826267|Lapatinib|lapatinib|mesh-list
110457062|NCT00826267|Afatinib|afatinib|mesh-list
110457063|NCT00826267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110457064|NCT00826267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110457065|NCT00826267|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110457066|NCT00826267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110457067|NCT00826267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110506654|NCT00834847|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110506655|NCT00834847|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110506656|NCT00834847|Antimetabolites|antimetabolites|mesh-ancestor
110506657|NCT00834847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110506658|NCT00834847|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110506659|NCT00834847|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110506660|NCT00834847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110506661|NCT00841477|Vaccines|vaccines|mesh-list
110506662|NCT00841477|Immunologic Factors|immunologic factors|mesh-ancestor
110506663|NCT00841477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110506664|NCT00834925|Diltiazem|diltiazem|mesh-list
110506665|NCT00834925|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110506666|NCT00834925|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110506667|NCT00834925|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110506668|NCT00834925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110506669|NCT00834925|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110506670|NCT00834925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110506671|NCT00834925|Vasodilator Agents|vasodilator agents|mesh-ancestor
110506672|NCT00841633|Norepinephrine|norepinephrine|mesh-list
110506673|NCT00841633|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110506674|NCT00841633|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110457068|NCT00653848|Docetaxel|docetaxel|mesh-list
110457069|NCT00653848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110457070|NCT00653848|Tubulin Modulators|tubulin modulators|mesh-ancestor
110457071|NCT00653848|Antimitotic Agents|antimitotic agents|mesh-ancestor
110457072|NCT00653848|Mitosis Modulators|mitosis modulators|mesh-ancestor
110457073|NCT00653848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110457074|NCT00707551|Ketoconazole|ketoconazole|mesh-list
110457075|NCT00707551|Verapamil|verapamil|mesh-list
110457076|NCT00707551|Antifungal Agents|antifungal agents|mesh-ancestor
110457077|NCT00707551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110457078|NCT00707551|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110457079|NCT00707551|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110457080|NCT00707551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110457081|NCT00707551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110457082|NCT00707551|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110457083|NCT00707551|Hormone Antagonists|hormone antagonists|mesh-ancestor
110457084|NCT00707551|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110457085|NCT00707551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110457086|NCT00707551|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110457087|NCT00707551|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110457088|NCT00707551|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110457089|NCT00707551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110457090|NCT00707551|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110457091|NCT00707551|Vasodilator Agents|vasodilator agents|mesh-ancestor
110457092|NCT00986154|Heparin|heparin|mesh-list
110457093|NCT00986154|Calcium heparin|calcium heparin|mesh-list
110457094|NCT00986154|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
110457095|NCT00986154|Tinzaparin|tinzaparin|mesh-list
110457096|NCT00986154|Dalteparin|dalteparin|mesh-list
110457097|NCT00986154|Warfarin|warfarin|mesh-list
110457098|NCT00986154|Edoxaban|edoxaban|mesh-list
110457099|NCT00986154|Anticoagulants|anticoagulants|mesh-ancestor
110506675|NCT00841633|Adrenergic Agents|adrenergic agents|mesh-ancestor
110506676|NCT00841633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110506677|NCT00841633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110506678|NCT00841633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110506679|NCT00841633|Sympathomimetics|sympathomimetics|mesh-ancestor
110506680|NCT00841633|Autonomic Agents|autonomic agents|mesh-ancestor
110506681|NCT00841633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110506682|NCT00841633|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110506683|NCT02823912|Capsaicin|capsaicin|mesh-list
110506684|NCT02823912|Magnesium Oxide|magnesium oxide|mesh-list
110506685|NCT02823912|Antipruritics|antipruritics|mesh-ancestor
110457100|NCT00986154|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110457101|NCT00986154|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110457102|NCT00986154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110457103|NCT00986154|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110457104|NCT00986154|Antithrombins|antithrombins|mesh-ancestor
110457105|NCT00986154|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110457106|NCT00986154|Protease Inhibitors|protease inhibitors|mesh-ancestor
110457107|NCT00986154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110457108|NCT00653926|Epinephrine|epinephrine|mesh-list
110457109|NCT00653926|Ropivacaine|ropivacaine|mesh-list
110457110|NCT00653926|Anesthetics, Local|anesthetics, local|mesh-ancestor
110457111|NCT00653926|Anesthetics|anesthetics|mesh-ancestor
110457112|NCT00653926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110457113|NCT00653926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110457114|NCT00653926|Sensory System Agents|sensory system agents|mesh-ancestor
110457115|NCT00653926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110457116|NCT00653926|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110457117|NCT00653926|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110457118|NCT00653926|Adrenergic Agents|adrenergic agents|mesh-ancestor
110457119|NCT00653926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110457120|NCT00653926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110457121|NCT00653926|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110457122|NCT00653926|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110457123|NCT00653926|Autonomic Agents|autonomic agents|mesh-ancestor
110457124|NCT00653926|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110457125|NCT00653926|Respiratory System Agents|respiratory system agents|mesh-ancestor
110457126|NCT00653926|Mydriatics|mydriatics|mesh-ancestor
110457127|NCT00653926|Sympathomimetics|sympathomimetics|mesh-ancestor
110457128|NCT00653926|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110457130|NCT02613091|Antipruritics|antipruritics|mesh-ancestor
110457131|NCT02613091|Dermatologic Agents|dermatologic agents|mesh-ancestor
110457132|NCT02613091|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110457133|NCT02613091|Histamine Antagonists|histamine antagonists|mesh-ancestor
110457134|NCT02613091|Histamine Agents|histamine agents|mesh-ancestor
110457135|NCT02613091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110457136|NCT02613091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110457137|NCT02613091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110457138|NCT02613091|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110457139|NCT02639806|Lidocaine|lidocaine|mesh-list
110457140|NCT02639806|Sevoflurane|sevoflurane|mesh-list
110457141|NCT02639806|Anesthetics, Local|anesthetics, local|mesh-ancestor
110457142|NCT02639806|Anesthetics|anesthetics|mesh-ancestor
110457143|NCT02639806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110457144|NCT02639806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110457145|NCT02639806|Sensory System Agents|sensory system agents|mesh-ancestor
110457146|NCT02639806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110457147|NCT02639806|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110457148|NCT02639806|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110457149|NCT02639806|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110457150|NCT02639806|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110457151|NCT02639806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110457152|NCT02639806|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110457153|NCT02639806|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110506686|NCT02823912|Dermatologic Agents|dermatologic agents|mesh-ancestor
110506687|NCT02823912|Sensory System Agents|sensory system agents|mesh-ancestor
110506688|NCT02823912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110506689|NCT02823912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110506690|NCT02823912|Antacids|antacids|mesh-ancestor
110506691|NCT02823912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110506692|NCT02823912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110506693|NCT00841945|Prednisone|prednisone|mesh-list
110506694|NCT00841945|Rituximab|rituximab|mesh-list
110506695|NCT00841945|Doxorubicin|doxorubicin|mesh-list
110506696|NCT00841945|Vincristine|vincristine|mesh-list
110506697|NCT00841945|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110506698|NCT00841945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110506699|NCT00841945|Immunologic Factors|immunologic factors|mesh-ancestor
110506700|NCT00841945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110506701|NCT00841945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110506702|NCT00841945|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110506703|NCT00841945|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110506704|NCT00841945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110506705|NCT00841945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110506706|NCT00841945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110506707|NCT00841945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110506708|NCT00841945|Glucocorticoids|glucocorticoids|mesh-ancestor
110506709|NCT00841945|Hormones|hormones|mesh-ancestor
110506710|NCT00841945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110506711|NCT00841945|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110506712|NCT00841945|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110457154|NCT02639806|Anesthetics, General|anesthetics, general|mesh-ancestor
110457155|NCT02646904|Beclomethasone|beclomethasone|mesh-list
110457156|NCT02646904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110457157|NCT02646904|Glucocorticoids|glucocorticoids|mesh-ancestor
110457158|NCT02646904|Hormones|hormones|mesh-ancestor
110457159|NCT02646904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110457160|NCT02646904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110457161|NCT02646904|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110457162|NCT02646904|Respiratory System Agents|respiratory system agents|mesh-ancestor
110457163|NCT00848965|Fluticasone|fluticasone|mesh-list
110457165|NCT00848965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110457166|NCT00848965|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110457167|NCT00848965|Autonomic Agents|autonomic agents|mesh-ancestor
110457168|NCT00848965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110457169|NCT00848965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110457170|NCT00848965|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110457171|NCT00848965|Respiratory System Agents|respiratory system agents|mesh-ancestor
110457172|NCT00848965|Dermatologic Agents|dermatologic agents|mesh-ancestor
110457173|NCT00848965|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110457174|NCT00654082|Sildenafil Citrate|sildenafil citrate|mesh-list
110506713|NCT00841945|Tubulin Modulators|tubulin modulators|mesh-ancestor
110506714|NCT00841945|Antimitotic Agents|antimitotic agents|mesh-ancestor
110506715|NCT00841945|Mitosis Modulators|mitosis modulators|mesh-ancestor
110506716|NCT02822196|Lidocaine|lidocaine|mesh-list
110506717|NCT02822196|Bupivacaine|bupivacaine|mesh-list
110506718|NCT02822196|Anesthetics, Local|anesthetics, local|mesh-ancestor
110506719|NCT02822196|Anesthetics|anesthetics|mesh-ancestor
110506720|NCT02822196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110506721|NCT02822196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110506722|NCT02822196|Sensory System Agents|sensory system agents|mesh-ancestor
110506723|NCT02822196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110506724|NCT02822196|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110506725|NCT02822196|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110506726|NCT02822196|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110506727|NCT02822196|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110506728|NCT02822196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110506729|NCT00706017|Insulin Detemir|insulin detemir|mesh-list
110506730|NCT00706017|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110506731|NCT00706017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110506732|NCT00829179|Omalizumab|omalizumab|mesh-list
110506733|NCT00829179|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110506734|NCT00829179|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110506735|NCT00829179|Respiratory System Agents|respiratory system agents|mesh-ancestor
110506736|NCT00849355|Rituximab|rituximab|mesh-list
110506737|NCT00849355|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110506738|NCT00849355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110506739|NCT00849355|Immunologic Factors|immunologic factors|mesh-ancestor
110506740|NCT00849355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110506741|NCT00849355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110506742|NCT00835393|Pantoprazole|pantoprazole|mesh-list
110506743|NCT00835393|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110457175|NCT00654082|Vasodilator Agents|vasodilator agents|mesh-ancestor
110457176|NCT00654082|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110457177|NCT00654082|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110457178|NCT00654082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110457179|NCT00654082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110457180|NCT00654082|Urological Agents|urological agents|mesh-ancestor
110457182|NCT00654160|Fluorouracil|fluorouracil|mesh-list
110457183|NCT00654160|Irinotecan|irinotecan|mesh-list
110457184|NCT00654160|Calcium|calcium|mesh-list
110457185|NCT00654160|Levoleucovorin|levoleucovorin|mesh-list
110457186|NCT00654160|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110457187|NCT00654160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110457188|NCT00654160|Antimetabolites|antimetabolites|mesh-ancestor
110457189|NCT00654160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110506744|NCT00835393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110506745|NCT00835393|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110506746|NCT00835393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110506747|NCT00835393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110506748|NCT00706173|Hydrocortisone|hydrocortisone|mesh-list
110506749|NCT00706173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110506750|NCT02822742|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110506751|NCT02822742|Latanoprost|latanoprost|mesh-list
110506752|NCT02822742|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110506753|NCT00835471|Docetaxel|docetaxel|mesh-list
110506754|NCT00835471|Pemetrexed|pemetrexed|mesh-list
110506755|NCT00835471|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110506756|NCT00835471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110506757|NCT00835471|Tubulin Modulators|tubulin modulators|mesh-ancestor
110506758|NCT00835471|Antimitotic Agents|antimitotic agents|mesh-ancestor
110506759|NCT00835471|Mitosis Modulators|mitosis modulators|mesh-ancestor
110506760|NCT00835471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110457190|NCT00654160|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110457191|NCT00654160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110457192|NCT00654160|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110457193|NCT00654160|Immunologic Factors|immunologic factors|mesh-ancestor
110457194|NCT00654160|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110457195|NCT00654160|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110457196|NCT00654160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110457197|NCT00654160|Antidotes|antidotes|mesh-ancestor
110457198|NCT00654160|Protective Agents|protective agents|mesh-ancestor
110457199|NCT00654160|Vitamin B Complex|vitamin b complex|mesh-ancestor
110457200|NCT00654160|Vitamins|vitamins|mesh-ancestor
110457201|NCT00654160|Micronutrients|micronutrients|mesh-ancestor
110457202|NCT02642380|Dexamethasone|dexamethasone|mesh-list
110457203|NCT02642380|Dexamethasone acetate|dexamethasone acetate|mesh-list
110457204|NCT02642380|BB 1101|bb 1101|mesh-list
110457205|NCT02642380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110457206|NCT02642380|Antiemetics|antiemetics|mesh-ancestor
110457207|NCT02642380|Autonomic Agents|autonomic agents|mesh-ancestor
110457208|NCT02642380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110457209|NCT02642380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110457210|NCT02642380|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110457211|NCT02642380|Glucocorticoids|glucocorticoids|mesh-ancestor
110457212|NCT02642380|Hormones|hormones|mesh-ancestor
110457213|NCT02642380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110457214|NCT02642380|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110457215|NCT02642380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110457216|NCT02642380|Protease Inhibitors|protease inhibitors|mesh-ancestor
110457217|NCT02642380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110457218|NCT02642380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110457219|NCT01154036|Atorvastatin|atorvastatin|mesh-list
110457220|NCT01154036|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110457221|NCT01154036|Ezetimibe|ezetimibe|mesh-list
110457222|NCT01154036|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110457223|NCT01154036|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110457224|NCT01154036|Antimetabolites|antimetabolites|mesh-ancestor
110457225|NCT01154036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110457226|NCT01154036|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110457227|NCT01154036|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110457228|NCT01154036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110457229|NCT00816595|Cyclophosphamide|cyclophosphamide|mesh-list
110457230|NCT00816595|Bevacizumab|bevacizumab|mesh-list
110457231|NCT00816595|Rituximab|rituximab|mesh-list
110457232|NCT00816595|Pentostatin|pentostatin|mesh-list
110457233|NCT00816595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110506761|NCT00835471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110506762|NCT00835471|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110506763|NCT00835471|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110506764|NCT00835471|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110506765|NCT00849511|Melatonin|melatonin|mesh-list
110506766|NCT00849511|Antioxidants|antioxidants|mesh-ancestor
110506767|NCT00849511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110506768|NCT00849511|Protective Agents|protective agents|mesh-ancestor
110506769|NCT00849511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110506770|NCT00849511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110506771|NCT02546791|Dasatinib|dasatinib|mesh-list
110506772|NCT02546791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110506773|NCT02546791|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110506774|NCT02546791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110506775|NCT02546791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110506776|NCT00966875|Ixekizumab|ixekizumab|mesh-list
110506777|NCT00966875|Dermatologic Agents|dermatologic agents|mesh-ancestor
110506778|NCT00849745|Alemtuzumab|alemtuzumab|mesh-list
110506779|NCT00849745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110506780|NCT00849745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110506781|NCT00835627|Sertraline|sertraline|mesh-list
110506782|NCT00835627|Antidepressive Agents|antidepressive agents|mesh-ancestor
110506783|NCT00835627|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110506784|NCT00835627|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110506785|NCT00835627|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110506786|NCT00835627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110506787|NCT00835627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110506788|NCT00835627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110506789|NCT00835627|Serotonin Agents|serotonin agents|mesh-ancestor
110506790|NCT00835627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110506791|NCT00842491|Cisplatin|cisplatin|mesh-list
110506792|NCT00842491|Capecitabine|capecitabine|mesh-list
110506793|NCT00842491|Endostar protein|endostar protein|mesh-list
110506794|NCT00842491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110506795|NCT00842491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110506796|NCT00842491|Antimetabolites|antimetabolites|mesh-ancestor
110506799|NCT00842491|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110506800|NCT00842491|Growth Substances|growth substances|mesh-ancestor
110506801|NCT00842491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110506802|NCT00842491|Growth Inhibitors|growth inhibitors|mesh-ancestor
110506804|NCT05659212|Magnesium Sulfate|magnesium sulfate|mesh-list
110506805|NCT05659212|Dexmedetomidine|dexmedetomidine|mesh-list
110506806|NCT05659212|Anesthetics, Local|anesthetics, local|mesh-ancestor
110506807|NCT05659212|Anesthetics|anesthetics|mesh-ancestor
110506808|NCT05659212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110506809|NCT05659212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110506810|NCT05659212|Sensory System Agents|sensory system agents|mesh-ancestor
110506811|NCT05659212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110506812|NCT05659212|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110506813|NCT05659212|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110506814|NCT05659212|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110506815|NCT05659212|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110506816|NCT05659212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110506817|NCT05659212|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110506818|NCT05659212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110457234|NCT00816595|Immunologic Factors|immunologic factors|mesh-ancestor
110457235|NCT00816595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110457236|NCT00816595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110457237|NCT00816595|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110457238|NCT00816595|Alkylating Agents|alkylating agents|mesh-ancestor
110457239|NCT00816595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110457240|NCT00816595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110457241|NCT00816595|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110457242|NCT00816595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110457243|NCT00816595|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110457244|NCT00816595|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110457245|NCT00816595|Growth Substances|growth substances|mesh-ancestor
110457246|NCT00816595|Growth Inhibitors|growth inhibitors|mesh-ancestor
110457247|NCT00816595|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
110457248|NCT00816595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110457249|NCT01166438|Solifenacin Succinate|solifenacin succinate|mesh-list
110457250|NCT01166438|Trospium chloride|trospium chloride|mesh-list
110457251|NCT01166438|Botulinum Toxins|botulinum toxins|mesh-list
110457252|NCT01166438|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110457253|NCT01166438|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110457254|NCT01166438|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110104319|NCT01778842|Clopidogrel|clopidogrel|mesh-list
110457255|NCT01166438|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110457256|NCT01166438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110457257|NCT01166438|Cholinergic Agents|cholinergic agents|mesh-ancestor
110457258|NCT01166438|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110457259|NCT01166438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110457260|NCT01166438|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110457261|NCT01166438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110457262|NCT01166438|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110457263|NCT01166438|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110457264|NCT01166438|Urological Agents|urological agents|mesh-ancestor
110457265|NCT01166438|Parasympatholytics|parasympatholytics|mesh-ancestor
110506819|NCT05659212|Analgesics|analgesics|mesh-ancestor
110506820|NCT05659212|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110506821|NCT05659212|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110506822|NCT05659212|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110506823|NCT05659212|Adrenergic Agents|adrenergic agents|mesh-ancestor
110506824|NCT05659212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110506825|NCT05659212|Anticonvulsants|anticonvulsants|mesh-ancestor
110506826|NCT05659212|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110506827|NCT05659212|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110506828|NCT05659212|Tocolytic Agents|tocolytic agents|mesh-ancestor
110506829|NCT05659212|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110506830|NCT00835939|Lidocaine|lidocaine|mesh-list
110506831|NCT00835939|Anesthetics, Local|anesthetics, local|mesh-ancestor
110506832|NCT00835939|Anesthetics|anesthetics|mesh-ancestor
110506833|NCT00835939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110506834|NCT00835939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110506835|NCT00835939|Sensory System Agents|sensory system agents|mesh-ancestor
110506836|NCT00835939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110506837|NCT00835939|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110506838|NCT00835939|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110175291|NCT00072865|Pemetrexed|pemetrexed|mesh-list
110457266|NCT01166438|Autonomic Agents|autonomic agents|mesh-ancestor
110457267|NCT00707707|Paclitaxel|paclitaxel|mesh-list
110457268|NCT00707707|Olaparib|olaparib|mesh-list
110457269|NCT00707707|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110457270|NCT00707707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110457271|NCT00707707|Tubulin Modulators|tubulin modulators|mesh-ancestor
110457272|NCT00707707|Antimitotic Agents|antimitotic agents|mesh-ancestor
110457273|NCT00707707|Mitosis Modulators|mitosis modulators|mesh-ancestor
110457274|NCT00707707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110457275|NCT00707707|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110457276|NCT00707707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110457277|NCT01153958|Metronidazole|metronidazole|mesh-list
110457278|NCT01153958|Chlorquinaldol|chlorquinaldol|mesh-list
110457279|NCT01153958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110457280|NCT01153958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110457281|NCT01153958|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110457282|NCT01153958|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110457283|NCT00707785|Vitamin A|vitamin a|mesh-list
110457284|NCT00707785|Vitamins|vitamins|mesh-ancestor
110457285|NCT00707785|Micronutrients|micronutrients|mesh-ancestor
110457286|NCT00707785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110457287|NCT00599638|Pregabalin|pregabalin|mesh-list
110457288|NCT00599638|Analgesics|analgesics|mesh-ancestor
110457289|NCT00599638|Sensory System Agents|sensory system agents|mesh-ancestor
110457290|NCT00599638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110457291|NCT00599638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110457292|NCT00599638|Anticonvulsants|anticonvulsants|mesh-ancestor
110457293|NCT00599638|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110457294|NCT00599638|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110457295|NCT00599638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110457296|NCT00599638|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110457297|NCT00599638|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110457298|NCT00599638|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110457299|NCT00599638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110506840|NCT00835939|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110506841|NCT00835939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110506842|NCT05659368|Tirzepatide|tirzepatide|mesh-list
110506843|NCT05659368|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110506844|NCT05659368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110506845|NCT05659368|Incretins|incretins|mesh-ancestor
110506846|NCT05659368|Hormones|hormones|mesh-ancestor
110506847|NCT05659368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110506848|NCT00818649|Bortezomib|bortezomib|mesh-list
110506849|NCT00818649|Vorinostat|vorinostat|mesh-list
110506850|NCT00818649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110506851|NCT00818649|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110506852|NCT00818649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110506853|NCT00818649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110506854|NCT02861105|Enoxaparin|enoxaparin|mesh-list
110506855|NCT02861105|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110506856|NCT02861105|Anticoagulants|anticoagulants|mesh-ancestor
110506857|NCT02861105|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110035995|NCT01408446|Menthol|menthol|mesh-list
110457300|NCT00599638|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110457301|NCT02642146|Calcium Channel Blockers|calcium channel blockers|mesh-list
110457302|NCT02642146|Vasodilator Agents|vasodilator agents|mesh-list
110457303|NCT02642146|Calcium|calcium|mesh-list
110457304|NCT02642146|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-list
110457305|NCT02642146|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110457306|NCT02642146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110457307|NCT02642146|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110457308|NCT02642146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110457309|NCT02642146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110457310|NCT00654394|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110457311|NCT00654394|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110457312|NCT00654394|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110457313|NCT00654394|Antimetabolites|antimetabolites|mesh-ancestor
110457314|NCT00654394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110457315|NCT00654394|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110457316|NCT00654394|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110457317|NCT00654394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110457318|NCT00653302|Metformin|metformin|mesh-list
110457319|NCT00653302|Insulin Glargine|insulin glargine|mesh-list
110457320|NCT00653302|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110457321|NCT00653302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110457322|NCT02638870|Amitriptyline|amitriptyline|mesh-list
110457323|NCT02638870|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110457324|NCT02638870|Antidepressive Agents|antidepressive agents|mesh-ancestor
110457325|NCT02638870|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110457326|NCT02638870|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110457327|NCT02638870|Analgesics|analgesics|mesh-ancestor
110457328|NCT02638870|Sensory System Agents|sensory system agents|mesh-ancestor
110457329|NCT02638870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110457330|NCT02638870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110104396|NCT01779401|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110457331|NCT02638870|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110457332|NCT02638870|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110457333|NCT02638870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110506858|NCT02861105|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110506859|NCT02861105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110506860|NCT02820558|Substance P|substance p|mesh-list
110506861|NCT02820558|Neurokinin A|neurokinin a|mesh-list
110506862|NCT02820558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110506863|NCT02820558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110506864|NCT02820558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110506865|NCT00961571|Capecitabine|capecitabine|mesh-list
110506867|NCT00961571|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110506868|NCT00961571|Antimetabolites|antimetabolites|mesh-ancestor
110506869|NCT00961571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110506870|NCT00961571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110506871|NCT00961571|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110506872|NCT00961571|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110506873|NCT00961571|Growth Substances|growth substances|mesh-ancestor
110175400|NCT00073840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110457334|NCT02638870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110457335|NCT02638870|Adrenergic Agents|adrenergic agents|mesh-ancestor
110457336|NCT02638870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110457338|NCT02641990|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110457339|NCT02641990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110457340|NCT02641990|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110457341|NCT02641990|Incretins|incretins|mesh-ancestor
110457342|NCT02641990|Hormones|hormones|mesh-ancestor
110457343|NCT02641990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110457344|NCT00653380|Doxycycline|doxycycline|mesh-list
110457345|NCT00653380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110457346|NCT00653380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110457347|NCT00653380|Antimalarials|antimalarials|mesh-ancestor
110457348|NCT00653380|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110457349|NCT00653380|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110457350|NCT02646592|Alfentanil|alfentanil|mesh-list
110457351|NCT02646592|Propofol|propofol|mesh-list
110457352|NCT02646592|Sevoflurane|sevoflurane|mesh-list
110457353|NCT02646592|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110457354|NCT02646592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110457355|NCT02646592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110457356|NCT02646592|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110457357|NCT02646592|Anesthetics, General|anesthetics, general|mesh-ancestor
110457358|NCT02646592|Anesthetics|anesthetics|mesh-ancestor
110457359|NCT02646592|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110457360|NCT02646592|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110457361|NCT02646592|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110457362|NCT02646592|Narcotics|narcotics|mesh-ancestor
110457363|NCT02646592|Analgesics|analgesics|mesh-ancestor
110457364|NCT02646592|Sensory System Agents|sensory system agents|mesh-ancestor
110457365|NCT02646592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110457366|NCT02646670|Ranibizumab|ranibizumab|mesh-list
110457367|NCT02646670|Aflibercept|aflibercept|mesh-list
110457368|NCT02646670|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110457369|NCT02646670|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110457370|NCT02646670|Growth Substances|growth substances|mesh-ancestor
110457371|NCT02646670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110457372|NCT02646670|Growth Inhibitors|growth inhibitors|mesh-ancestor
110457373|NCT02646670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110457374|NCT00651976|Letrozole|letrozole|mesh-list
110457375|NCT00651976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110457376|NCT00651976|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110506874|NCT00961571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110506875|NCT00961571|Growth Inhibitors|growth inhibitors|mesh-ancestor
110506876|NCT00961571|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110506877|NCT00961571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110506878|NCT02820948|Vitamins|vitamins|mesh-list
110506879|NCT02820948|Vitamin E|vitamin e|mesh-list
110506880|NCT02820948|Tocopherols|tocopherols|mesh-list
110506881|NCT02820948|Tocotrienols|tocotrienols|mesh-list
110506882|NCT02820948|alpha-Tocopherol|alpha-tocopherol|mesh-list
110506883|NCT02820948|Micronutrients|micronutrients|mesh-ancestor
110506884|NCT02820948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110506885|NCT02820948|Antioxidants|antioxidants|mesh-ancestor
110506886|NCT02820948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110506887|NCT02820948|Protective Agents|protective agents|mesh-ancestor
110506888|NCT02860949|Ketorolac|ketorolac|mesh-list
110506889|NCT02860949|Epinephrine|epinephrine|mesh-list
110506890|NCT02860949|Morphine|morphine|mesh-list
110506891|NCT02860949|Bupivacaine|bupivacaine|mesh-list
110506892|NCT02860949|Anesthetics, Local|anesthetics, local|mesh-ancestor
110506893|NCT02860949|Anesthetics|anesthetics|mesh-ancestor
110506894|NCT02860949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110506895|NCT02860949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110506896|NCT02860949|Sensory System Agents|sensory system agents|mesh-ancestor
110506897|NCT02860949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110457377|NCT00651976|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110457378|NCT00651976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110457379|NCT00651976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110457380|NCT00651976|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110457381|NCT00651976|Hormone Antagonists|hormone antagonists|mesh-ancestor
110457382|NCT00651976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110457383|NCT00651976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110457384|NCT01166282|Adalimumab|adalimumab|mesh-list
110457385|NCT01166282|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110457386|NCT01166282|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110457387|NCT01166282|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110457388|NCT01153724|Fluconazole|fluconazole|mesh-list
110457389|NCT01153724|Antifungal Agents|antifungal agents|mesh-ancestor
110457390|NCT01153724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110457391|NCT01153724|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110457392|NCT01153724|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110457393|NCT01153724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110457394|NCT01153724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110457395|NCT01153724|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110457396|NCT01153724|Hormone Antagonists|hormone antagonists|mesh-ancestor
110457397|NCT01153724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110457398|NCT01153724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110457399|NCT01153724|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110457400|NCT01153724|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110457401|NCT02884388|Anesthetics|anesthetics|mesh-list
110457402|NCT02884388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110457403|NCT02884388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110457404|NCT02885948|Naloxone|naloxone|mesh-list
110506898|NCT02860949|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110506899|NCT02860949|Narcotics|narcotics|mesh-ancestor
110506900|NCT02860949|Analgesics|analgesics|mesh-ancestor
110506901|NCT02860949|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110506902|NCT02860949|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110506903|NCT02860949|Adrenergic Agents|adrenergic agents|mesh-ancestor
110506904|NCT02860949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110506905|NCT02860949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110506906|NCT02860949|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110506907|NCT02860949|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110506908|NCT02860949|Autonomic Agents|autonomic agents|mesh-ancestor
110506909|NCT02860949|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110506910|NCT02860949|Respiratory System Agents|respiratory system agents|mesh-ancestor
110506911|NCT02860949|Mydriatics|mydriatics|mesh-ancestor
110506912|NCT02860949|Sympathomimetics|sympathomimetics|mesh-ancestor
110506913|NCT02860949|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110506914|NCT02860949|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110506915|NCT02860949|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110506916|NCT02860949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110506917|NCT02860949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110506918|NCT02860949|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110506919|NCT02860949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110506920|NCT03248063|Cefazolin|cefazolin|mesh-list
110506921|NCT03248063|Cloxacillin|cloxacillin|mesh-list
110506922|NCT03248063|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110506923|NCT03248063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110506924|NCT00964223|Clindamycin|clindamycin|mesh-list
110506925|NCT00964223|Clindamycin palmitate|clindamycin palmitate|mesh-list
110506926|NCT00964223|Clindamycin phosphate|clindamycin phosphate|mesh-list
110506927|NCT00964223|Adapalene|adapalene|mesh-list
110506928|NCT00964223|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
110506929|NCT00964223|Benzoyl Peroxide|benzoyl peroxide|mesh-list
110506930|NCT00964223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110506931|NCT00964223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110506932|NCT00964223|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110506933|NCT00964223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110506938|NCT00964223|Analgesics|analgesics|mesh-ancestor
110506939|NCT00964223|Sensory System Agents|sensory system agents|mesh-ancestor
110506940|NCT00964223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110506941|NCT00964223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110506942|NCT00964223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110506943|NCT00964223|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110506944|NCT00620815|Vaccines|vaccines|mesh-list
110506945|NCT00620815|MF59 oil emulsion|mf59 oil emulsion|mesh-list
110506946|NCT00620815|Immunologic Factors|immunologic factors|mesh-ancestor
110506947|NCT00620815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110506948|NCT00620815|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110506949|NCT04238988|Paclitaxel|paclitaxel|mesh-list
110506950|NCT04238988|Carboplatin|carboplatin|mesh-list
110506951|NCT04238988|Pembrolizumab|pembrolizumab|mesh-list
110506952|NCT04238988|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110506953|NCT04238988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110506954|NCT04238988|Tubulin Modulators|tubulin modulators|mesh-ancestor
110506955|NCT04238988|Antimitotic Agents|antimitotic agents|mesh-ancestor
110506956|NCT04238988|Mitosis Modulators|mitosis modulators|mesh-ancestor
110506957|NCT04238988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110506958|NCT04238988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110592919|NCT00667719|Amlodipine|amlodipine|mesh-list
110175549|NCT00074776|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110457405|NCT02885948|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110457406|NCT02885948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110457407|NCT02885948|Sensory System Agents|sensory system agents|mesh-ancestor
110457408|NCT02885948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110457410|NCT01152788|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110457411|NCT01152788|Alkylating Agents|alkylating agents|mesh-ancestor
110302572|NCT05140096|Fluconazole|fluconazole|mesh-list
110457412|NCT01152788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110457413|NCT01152788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110457414|NCT01165424|Mometasone Furoate|mometasone furoate|mesh-list
110457415|NCT01165424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110457416|NCT01165424|Dermatologic Agents|dermatologic agents|mesh-ancestor
110457417|NCT01165424|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110457419|NCT00598702|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110457420|NCT00598702|Analgesics|analgesics|mesh-ancestor
110457421|NCT00598702|Sensory System Agents|sensory system agents|mesh-ancestor
110457422|NCT00598702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110457423|NCT00598702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110457424|NCT00598702|Antipyretics|antipyretics|mesh-ancestor
110457425|NCT01148810|Siponimod|siponimod|mesh-list
110457426|NCT01148810|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
110457427|NCT01148810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110457428|NCT01148810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110457429|NCT01148810|Immunologic Factors|immunologic factors|mesh-ancestor
110457430|NCT01148810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110457431|NCT02884310|Remifentanil|remifentanil|mesh-list
110457432|NCT02884310|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110457433|NCT02884310|Narcotics|narcotics|mesh-ancestor
110457434|NCT02884310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110457435|NCT02884310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110457436|NCT02884310|Analgesics|analgesics|mesh-ancestor
110457437|NCT02884310|Sensory System Agents|sensory system agents|mesh-ancestor
110457438|NCT02884310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110506959|NCT04238988|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110506961|NCT04284215|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110506962|NCT04284215|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110506963|NCT04284215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110506964|NCT04284215|Tubulin Modulators|tubulin modulators|mesh-ancestor
110506965|NCT04284215|Antimitotic Agents|antimitotic agents|mesh-ancestor
110506966|NCT04284215|Mitosis Modulators|mitosis modulators|mesh-ancestor
110506967|NCT04284215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110506968|NCT02816970|Vildagliptin|vildagliptin|mesh-list
110506969|NCT02816970|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110506970|NCT02816970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110506971|NCT02816970|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110506972|NCT02816970|Protease Inhibitors|protease inhibitors|mesh-ancestor
110506973|NCT02816970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110506974|NCT02816970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110506975|NCT03372941|Dalbavancin|dalbavancin|mesh-list
110506976|NCT03372941|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110506977|NCT03372941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110506978|NCT04238832|Nicotine|nicotine|mesh-list
110506979|NCT04238832|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110506980|NCT04238832|Autonomic Agents|autonomic agents|mesh-ancestor
110506981|NCT04238832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110506982|NCT04238832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110506983|NCT04238832|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110506984|NCT04238832|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110506985|NCT04238832|Cholinergic Agents|cholinergic agents|mesh-ancestor
110506986|NCT04238832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110506987|NCT04238832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110506988|NCT04622904|Lidocaine|lidocaine|mesh-list
110506989|NCT04622904|Ketamine|ketamine|mesh-list
110506990|NCT04622904|Anesthetics, Local|anesthetics, local|mesh-ancestor
110506991|NCT04622904|Anesthetics|anesthetics|mesh-ancestor
110506992|NCT04622904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110507000|NCT04622904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110507001|NCT04622904|Analgesics|analgesics|mesh-ancestor
110507002|NCT04622904|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110507003|NCT04622904|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110507004|NCT04622904|Anesthetics, General|anesthetics, general|mesh-ancestor
110507005|NCT04622904|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110507006|NCT04622904|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110507007|NCT04622904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110507008|NCT00634062|Lamotrigine|lamotrigine|mesh-list
110507009|NCT00634062|Anticonvulsants|anticonvulsants|mesh-ancestor
110507010|NCT00634062|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110507011|NCT00634062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110507012|NCT00634062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110507013|NCT00634062|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110507014|NCT00634062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110507015|NCT00634062|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110507016|NCT00634062|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110507017|NCT00634062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110507018|NCT00634062|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110507019|NCT00634062|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110507021|NCT00634140|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110507022|NCT00634140|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110507023|NCT00634140|Antimetabolites|antimetabolites|mesh-ancestor
110507024|NCT00634140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110507025|NCT00634140|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110507026|NCT02819544|Ropivacaine|ropivacaine|mesh-list
110507027|NCT02819544|Anesthetics, Local|anesthetics, local|mesh-ancestor
110507028|NCT02819544|Anesthetics|anesthetics|mesh-ancestor
110507029|NCT02819544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110507030|NCT02819544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110507031|NCT02819544|Sensory System Agents|sensory system agents|mesh-ancestor
110507032|NCT02819544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110507033|NCT02819388|Contraceptive Agents|contraceptive agents|mesh-list
110507034|NCT02819388|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110507035|NCT02819388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110457439|NCT01164956|Methylphenidate|methylphenidate|mesh-list
110457440|NCT01164956|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110507037|NCT02818140|Anesthetics, Local|anesthetics, local|mesh-ancestor
110507038|NCT02818140|Anesthetics|anesthetics|mesh-ancestor
110507039|NCT02818140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110507040|NCT02818140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110507041|NCT02818140|Sensory System Agents|sensory system agents|mesh-ancestor
110507042|NCT02818140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110507043|NCT04238208|Lidocaine|lidocaine|mesh-list
110507044|NCT04238208|Capsaicin|capsaicin|mesh-list
110507045|NCT04238208|Anesthetics, Local|anesthetics, local|mesh-ancestor
110507046|NCT04238208|Anesthetics|anesthetics|mesh-ancestor
110507047|NCT04238208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110507048|NCT04238208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110507049|NCT04238208|Sensory System Agents|sensory system agents|mesh-ancestor
110507050|NCT04238208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110507051|NCT04238208|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110507052|NCT04238208|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110507053|NCT04238208|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110507054|NCT04238208|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110507055|NCT04238208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110507056|NCT04238208|Antipruritics|antipruritics|mesh-ancestor
110507057|NCT04238208|Dermatologic Agents|dermatologic agents|mesh-ancestor
110507058|NCT02816112|Ciprofloxacin|ciprofloxacin|mesh-list
110507059|NCT02816112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110507060|NCT02816112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110507061|NCT02816112|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110507062|NCT02816112|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110507063|NCT02816112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110507064|NCT02816112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110507065|NCT02816112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110507066|NCT02816112|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110507067|NCT02816112|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110507068|NCT02815722|Simvastatin|simvastatin|mesh-list
110507069|NCT02815722|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110457441|NCT01164956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110457442|NCT01164956|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110457443|NCT01164956|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110457444|NCT01164956|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110302621|NCT00280215|Losartan|losartan|mesh-list
110507070|NCT02815722|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110507071|NCT02815722|Antimetabolites|antimetabolites|mesh-ancestor
110507072|NCT02815722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110507073|NCT02815722|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110507074|NCT02815722|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110507075|NCT02815722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110507076|NCT02817750|Zolpidem|zolpidem|mesh-list
110507077|NCT02817750|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110507078|NCT02817750|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110507079|NCT02817750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110507080|NCT02817750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110507081|NCT02817750|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
110507082|NCT02817750|GABA Agonists|gaba agonists|mesh-ancestor
110507083|NCT02817750|GABA Agents|gaba agents|mesh-ancestor
110507084|NCT02817750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110507085|NCT02817750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110507086|NCT02815410|Levetiracetam|levetiracetam|mesh-list
110507087|NCT02815410|Anticonvulsants|anticonvulsants|mesh-ancestor
110507088|NCT02815410|Nootropic Agents|nootropic agents|mesh-ancestor
110507089|NCT02814630|Omalizumab|omalizumab|mesh-list
110507090|NCT02814630|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110507091|NCT02814630|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110507092|NCT02814630|Respiratory System Agents|respiratory system agents|mesh-ancestor
110507093|NCT00619957|Risedronic Acid|risedronic acid|mesh-list
110507094|NCT00619957|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110507095|NCT00619957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110507096|NCT00619957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110507097|NCT00619957|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110507098|NCT00619957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110507099|NCT00619957|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110507114|NCT04519476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110507115|NCT04519476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110507116|NCT04519476|Antiemetics|antiemetics|mesh-ancestor
110507117|NCT04519476|Autonomic Agents|autonomic agents|mesh-ancestor
110507118|NCT04519476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110507119|NCT04519476|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110507120|NCT04519476|Glucocorticoids|glucocorticoids|mesh-ancestor
110507121|NCT04519476|Hormones|hormones|mesh-ancestor
110507122|NCT04519476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110507123|NCT04519476|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110507124|NCT04519476|Protective Agents|protective agents|mesh-ancestor
110507125|NCT04519476|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110507126|NCT00961415|Bevacizumab|bevacizumab|mesh-list
110507127|NCT00961415|Pemetrexed|pemetrexed|mesh-list
110507128|NCT00961415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110507129|NCT00961415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110507130|NCT00961415|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110507131|NCT00961415|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110507132|NCT00961415|Growth Substances|growth substances|mesh-ancestor
110507133|NCT00961415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110507134|NCT00961415|Growth Inhibitors|growth inhibitors|mesh-ancestor
110507135|NCT00961415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110507136|NCT00961415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110507137|NCT00961415|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110507138|NCT00961415|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110507139|NCT00851227|Conivaptan|conivaptan|mesh-list
110507140|NCT00851227|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
110507141|NCT00851227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110507142|NCT00851227|Natriuretic Agents|natriuretic agents|mesh-ancestor
110507143|NCT00851227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110507144|NCT03365609|Bismuth|bismuth|mesh-list
110507146|NCT03365609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110507147|NCT03365609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110507148|NCT05636904|Minoxidil|minoxidil|mesh-list
110457445|NCT01164956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110457447|NCT01164956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110457448|NCT01151540|Rufinamide|rufinamide|mesh-list
110457449|NCT01151540|Anticonvulsants|anticonvulsants|mesh-ancestor
110457450|NCT01151540|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110507149|NCT05636904|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110507150|NCT05636904|Dinoprost|dinoprost|mesh-list
110507151|NCT05636904|Dinoprost tromethamine|dinoprost tromethamine|mesh-list
110507152|NCT05636904|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110507153|NCT05636904|Vasodilator Agents|vasodilator agents|mesh-ancestor
110507154|NCT05636904|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110507155|NCT05636904|Abortifacient Agents|abortifacient agents|mesh-ancestor
110507156|NCT05636904|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110507157|NCT05636904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110507158|NCT05636904|Oxytocics|oxytocics|mesh-ancestor
110507159|NCT00963599|Loratadine|loratadine|mesh-list
110507160|NCT00963599|Montelukast|montelukast|mesh-list
110507161|NCT00963599|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110507162|NCT00963599|Respiratory System Agents|respiratory system agents|mesh-ancestor
110507163|NCT00963599|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110507164|NCT00963599|Hormone Antagonists|hormone antagonists|mesh-ancestor
110507165|NCT00963599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110507166|NCT00963599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110507167|NCT00963599|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110507168|NCT00963599|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110507169|NCT00963599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110507170|NCT00963599|Antipruritics|antipruritics|mesh-ancestor
110507171|NCT00963599|Dermatologic Agents|dermatologic agents|mesh-ancestor
110507172|NCT00963599|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110507173|NCT00963599|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110507174|NCT00963599|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110507175|NCT00963599|Histamine Antagonists|histamine antagonists|mesh-ancestor
110507176|NCT00963599|Histamine Agents|histamine agents|mesh-ancestor
110507177|NCT00963599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110507178|NCT05636592|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
110592981|NCT00467779|Anesthetics|anesthetics|mesh-ancestor
110507179|NCT05636592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110507180|NCT05636592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110507181|NCT05636592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110507182|NCT00851461|Goserelin|goserelin|mesh-list
110507183|NCT00851461|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110507187|NCT04205136|Hormone Antagonists|hormone antagonists|mesh-ancestor
110507188|NCT04205136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110507189|NCT04205136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110507190|NCT04205136|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110507192|NCT04205136|Natriuretic Agents|natriuretic agents|mesh-ancestor
110507193|NCT02815332|Minocycline|minocycline|mesh-list
110507194|NCT02815332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110507195|NCT02815332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110507196|NCT02811354|Osimertinib|osimertinib|mesh-list
110507197|NCT02811354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110507198|NCT02811354|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110507199|NCT02811354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110507200|NCT02811354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110507201|NCT02810808|Ranibizumab|ranibizumab|mesh-list
110507202|NCT02810808|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110507203|NCT02810808|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110507204|NCT02810808|Growth Substances|growth substances|mesh-ancestor
110507205|NCT02810808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110507206|NCT02810808|Growth Inhibitors|growth inhibitors|mesh-ancestor
110507207|NCT02810808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110507208|NCT00619801|Levocetirizine|levocetirizine|mesh-list
110507209|NCT00619801|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110507210|NCT00619801|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110507211|NCT00619801|Histamine Antagonists|histamine antagonists|mesh-ancestor
110507212|NCT00619801|Histamine Agents|histamine agents|mesh-ancestor
110507213|NCT00619801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110507214|NCT00619801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110507215|NCT00619801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110507216|NCT02545777|Diclofenac|diclofenac|mesh-list
110311949|NCT00419484|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110507217|NCT02545777|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110507219|NCT02545777|Analgesics|analgesics|mesh-ancestor
110507220|NCT02545777|Sensory System Agents|sensory system agents|mesh-ancestor
110507221|NCT02545777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110175820|NCT00077194|Romidepsin|romidepsin|mesh-list
110457451|NCT01151540|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110457452|NCT01151540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110507222|NCT02545777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110507223|NCT02545777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110592990|NCT03704480|Durvalumab|durvalumab|mesh-list
110507224|NCT02545777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110507225|NCT02545777|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110507226|NCT02545777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110507227|NCT02545777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110507228|NCT02810886|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
110507229|NCT02810886|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110507230|NCT02810886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110507231|NCT00962741|Etanercept|etanercept|mesh-list
110507232|NCT00962741|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110507233|NCT00962741|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110507234|NCT00962741|Analgesics|analgesics|mesh-ancestor
110507235|NCT00962741|Sensory System Agents|sensory system agents|mesh-ancestor
110507236|NCT00962741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110507237|NCT00962741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110507238|NCT00962741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110507243|NCT00851929|Ambrisentan|ambrisentan|mesh-list
110507280|NCT00619645|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110507281|NCT00852163|Busulfan|busulfan|mesh-list
110507282|NCT00852163|Clofarabine|clofarabine|mesh-list
110507283|NCT00852163|Alkylating Agents|alkylating agents|mesh-ancestor
110507284|NCT00852163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110507285|NCT00852163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110507286|NCT00852163|Immunologic Factors|immunologic factors|mesh-ancestor
110507287|NCT00852163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110507288|NCT00852163|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110507349|NCT02812992|Tubulin Modulators|tubulin modulators|mesh-ancestor
110507350|NCT02812992|Antimitotic Agents|antimitotic agents|mesh-ancestor
110507351|NCT02812992|Mitosis Modulators|mitosis modulators|mesh-ancestor
110507352|NCT02812992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110507353|NCT02812992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110507354|NCT02812992|Antimetabolites|antimetabolites|mesh-ancestor
110507355|NCT00856063|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
110507356|NCT00856063|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110507357|NCT00856063|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110507358|NCT00856063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110507359|NCT00856063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110507360|NCT00856063|Adrenergic Agents|adrenergic agents|mesh-ancestor
110507361|NCT00856063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110507362|NCT00856063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110507363|NCT02812602|Lidocaine|lidocaine|mesh-list
110507365|NCT02812602|Anesthetics|anesthetics|mesh-ancestor
110507404|NCT00621985|Glucocorticoids|glucocorticoids|mesh-ancestor
110507406|NCT00621985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110507407|NCT00621985|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110507408|NCT00621985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110507409|NCT02812368|Clonidine|clonidine|mesh-list
110507410|NCT02812368|Analgesics|analgesics|mesh-ancestor
110507411|NCT02812368|Sensory System Agents|sensory system agents|mesh-ancestor
110507412|NCT02812368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110507467|NCT00861367|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110507468|NCT00861367|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110507469|NCT00861367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110507470|NCT00861367|Antipyretics|antipyretics|mesh-ancestor
110507471|NCT04285073|Paclitaxel|paclitaxel|mesh-list
110507472|NCT04285073|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110507473|NCT04285073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110593013|NCT02556723|Aflibercept|aflibercept|mesh-list
110507474|NCT04285073|Tubulin Modulators|tubulin modulators|mesh-ancestor
110507475|NCT04285073|Antimitotic Agents|antimitotic agents|mesh-ancestor
110507476|NCT04285073|Mitosis Modulators|mitosis modulators|mesh-ancestor
110507477|NCT04285073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110507478|NCT00861445|Lacosamide|lacosamide|mesh-list
110507479|NCT00861445|Anticonvulsants|anticonvulsants|mesh-ancestor
110507480|NCT00861445|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110507481|NCT00861445|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110507482|NCT00861445|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110507483|NCT00861445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110507484|NCT04284059|Vitamin D|vitamin d|mesh-list
110507485|NCT04284059|Vitamins|vitamins|mesh-list
110507486|NCT04284059|Micronutrients|micronutrients|mesh-ancestor
110507487|NCT04284059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110507488|NCT04284059|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110507489|NCT00852709|Cyclophosphamide|cyclophosphamide|mesh-list
110507518|NCT00861523|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110507519|NCT00861523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110507520|NCT00861523|Anesthetics, Local|anesthetics, local|mesh-ancestor
110507521|NCT00861523|Anesthetics|anesthetics|mesh-ancestor
110507522|NCT00861523|Sensory System Agents|sensory system agents|mesh-ancestor
110507523|NCT00861523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110507524|NCT00861523|Antiemetics|antiemetics|mesh-ancestor
110507525|NCT00861523|Autonomic Agents|autonomic agents|mesh-ancestor
110507526|NCT00861523|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110507527|NCT02811978|Dexamethasone|dexamethasone|mesh-list
110507529|NCT02811978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110507530|NCT02811978|Antiemetics|antiemetics|mesh-ancestor
110507531|NCT02811978|Autonomic Agents|autonomic agents|mesh-ancestor
110507532|NCT02811978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110507533|NCT02811978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110507579|NCT04111926|Sensory System Agents|sensory system agents|mesh-ancestor
110507580|NCT04111926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110507581|NCT04111926|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110507582|NCT04111926|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110507583|NCT04111926|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110507584|NCT04111926|Adrenergic Agents|adrenergic agents|mesh-ancestor
110507585|NCT04111926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110507586|NCT04111926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110507588|NCT04041349|Mitosis Modulators|mitosis modulators|mesh-ancestor
110507590|NCT00961181|Paclitaxel|paclitaxel|mesh-list
110507642|NCT00853177|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110507643|NCT00853177|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110507644|NCT00853177|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110507645|NCT00853177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110507646|NCT00924079|Nalbuphine|nalbuphine|mesh-list
110507647|NCT00924079|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110507648|NCT00924079|Narcotics|narcotics|mesh-ancestor
110507649|NCT00924079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110507650|NCT00924079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110507651|NCT00924079|Analgesics|analgesics|mesh-ancestor
110507652|NCT00924079|Sensory System Agents|sensory system agents|mesh-ancestor
110507653|NCT00924079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110507654|NCT00817479|Dexamethasone|dexamethasone|mesh-list
110507656|NCT00817479|Antiemetics|antiemetics|mesh-ancestor
110507704|NCT02807298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110507705|NCT04041427|Albendazole|albendazole|mesh-list
110507706|NCT04041427|Anthelmintics|anthelmintics|mesh-ancestor
110507707|NCT04041427|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110507708|NCT04041427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110507709|NCT04041427|Anticestodal Agents|anticestodal agents|mesh-ancestor
110507710|NCT04041427|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110507711|NCT04041427|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110507712|NCT04041427|Tubulin Modulators|tubulin modulators|mesh-ancestor
110507713|NCT04041427|Antimitotic Agents|antimitotic agents|mesh-ancestor
110507714|NCT04041427|Mitosis Modulators|mitosis modulators|mesh-ancestor
110507715|NCT04041427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110507716|NCT04041427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110507717|NCT00961961|Lithium Carbonate|lithium carbonate|mesh-list
110507719|NCT00961961|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110507720|NCT00961961|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110507721|NCT00961961|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110507722|NCT00961961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110507723|NCT00961961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110507724|NCT00961961|Serotonin Agents|serotonin agents|mesh-ancestor
110507759|NCT00817089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110507760|NCT00817089|Sensory System Agents|sensory system agents|mesh-ancestor
110507761|NCT00817089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110507763|NCT03296033|Enoxaparin sodium|enoxaparin sodium|mesh-list
110507764|NCT03296033|Anticoagulants|anticoagulants|mesh-ancestor
110507765|NCT03296033|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110507766|NCT03296033|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110507767|NCT03296033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110507768|NCT00857779|Immunomodulating Agents|immunomodulating agents|mesh-list
110507769|NCT00857779|Immunologic Factors|immunologic factors|mesh-ancestor
110507770|NCT00857779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110507771|NCT05758389|Paclitaxel|paclitaxel|mesh-list
110507772|NCT05758389|Tislelizumab|tislelizumab|mesh-list
110507773|NCT05758389|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110507774|NCT05758389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110507820|NCT00854035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110507821|NCT00854035|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110507822|NCT00854035|Protease Inhibitors|protease inhibitors|mesh-ancestor
110507823|NCT00854035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110507824|NCT00854035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110507825|NCT00957905|Calcium, Dietary|calcium, dietary|mesh-list
110507826|NCT00957905|Leucovorin|leucovorin|mesh-list
110507827|NCT00957905|Folic Acid|folic acid|mesh-list
110507828|NCT00957905|Fluorouracil|fluorouracil|mesh-list
110507829|NCT00957905|Oxaliplatin|oxaliplatin|mesh-list
110507830|NCT00957905|Alvocidib|alvocidib|mesh-list
110507831|NCT00957905|Calcium|calcium|mesh-list
110507832|NCT00957905|Levoleucovorin|levoleucovorin|mesh-list
110507833|NCT00957905|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110507834|NCT00957905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110507883|NCT02804490|Provitamins|provitamins|mesh-list
110507884|NCT02804490|Carotenoids|carotenoids|mesh-list
110507885|NCT02804490|Vitamins|vitamins|mesh-ancestor
110507886|NCT02804490|Micronutrients|micronutrients|mesh-ancestor
110507887|NCT02804490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110507888|NCT02804490|Antioxidants|antioxidants|mesh-ancestor
110507889|NCT02804490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110507890|NCT02804490|Protective Agents|protective agents|mesh-ancestor
110507891|NCT00960323|Colchicine|colchicine|mesh-list
110507892|NCT00960323|Atorvastatin|atorvastatin|mesh-list
110507893|NCT00960323|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110507894|NCT00960323|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110507895|NCT00960323|Antimetabolites|antimetabolites|mesh-ancestor
110507896|NCT00960323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110507897|NCT00960323|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110507898|NCT00960323|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110507899|NCT00960323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110507900|NCT00960323|Gout Suppressants|gout suppressants|mesh-ancestor
110507901|NCT00960323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110507902|NCT00960323|Tubulin Modulators|tubulin modulators|mesh-ancestor
110507903|NCT00960323|Antimitotic Agents|antimitotic agents|mesh-ancestor
110507904|NCT00960323|Mitosis Modulators|mitosis modulators|mesh-ancestor
110507905|NCT00960323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110507906|NCT00617929|Rituximab|rituximab|mesh-list
110507907|NCT00617929|Clofarabine|clofarabine|mesh-list
110507908|NCT00617929|Thymoglobulin|thymoglobulin|mesh-list
110507909|NCT00617929|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110507910|NCT00617929|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110507911|NCT00617929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110507912|NCT00617929|Immunologic Factors|immunologic factors|mesh-ancestor
110507930|NCT00815295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110507931|NCT00815295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110507932|NCT00815295|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110507934|NCT00815295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110507935|NCT00630383|Histamine|histamine|mesh-list
110507936|NCT00630383|Histamine Agonists|histamine agonists|mesh-ancestor
110507937|NCT00630383|Histamine Agents|histamine agents|mesh-ancestor
110507938|NCT00630383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110507939|NCT00630383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110507940|NCT00630383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110507941|NCT02806752|Triamcinolone|triamcinolone|mesh-list
110507942|NCT02806752|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110507943|NCT02806752|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110507944|NCT02806752|Ranibizumab|ranibizumab|mesh-list
110507945|NCT02806752|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110507946|NCT02806752|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110507947|NCT02806752|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110508011|NCT00858715|Analgesics|analgesics|mesh-ancestor
110508012|NCT00858715|Sensory System Agents|sensory system agents|mesh-ancestor
110508013|NCT00858715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110508014|NCT00858715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110508015|NCT00858715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110508016|NCT00858715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110508017|NCT00858715|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110508018|NCT00858715|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110508019|NCT00858715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110508020|NCT00858715|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110508021|NCT00858715|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110508022|NCT00858715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110508023|NCT00858715|Antipyretics|antipyretics|mesh-ancestor
110508024|NCT00858715|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110508025|NCT00858715|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110508026|NCT00858715|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110508027|NCT00858715|Purinergic Agents|purinergic agents|mesh-ancestor
110508028|NCT00858715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110508029|NCT02806284|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110508030|NCT02806284|Immunologic Factors|immunologic factors|mesh-ancestor
110508032|NCT00960869|Aspirin|aspirin|mesh-list
110508062|NCT02799888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110508063|NCT02799888|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110508064|NCT02799888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110508065|NCT02799888|Immunologic Factors|immunologic factors|mesh-ancestor
110508066|NCT02799888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110508067|NCT02799888|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110508068|NCT02799888|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110508069|NCT02799888|Antifungal Agents|antifungal agents|mesh-ancestor
110508070|NCT02799888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110508071|NCT02799888|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110508072|NCT02799888|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110508073|NCT02799888|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110508128|NCT05980000|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110508129|NCT05980000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110508130|NCT05979961|Cisplatin|cisplatin|mesh-list
110508131|NCT05979961|Gemcitabine|gemcitabine|mesh-list
110508132|NCT05979961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110508133|NCT05979961|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110508134|NCT05979961|Antimetabolites|antimetabolites|mesh-ancestor
110508135|NCT05979961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110508136|NCT05979909|Mitomycins|mitomycins|mesh-list
110508137|NCT05979909|Mitomycin|mitomycin|mesh-list
110508138|NCT05979909|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110508139|NCT05979909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110508140|NCT05979909|Alkylating Agents|alkylating agents|mesh-ancestor
110508141|NCT05979909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110508142|NCT05979909|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110508143|NCT05979909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110508144|NCT05979818|Propranolol|propranolol|mesh-list
110508145|NCT05979818|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110508146|NCT05979818|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110508147|NCT05979818|Adrenergic Agents|adrenergic agents|mesh-ancestor
110508148|NCT05979818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110508151|NCT05979818|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110508182|NCT05979324|Coal Tar|coal tar|mesh-list
110508183|NCT05979324|Keratolytic Agents|keratolytic agents|mesh-ancestor
110508184|NCT05979324|Dermatologic Agents|dermatologic agents|mesh-ancestor
110508185|NCT05979311|Tenofovir|tenofovir|mesh-list
110508186|NCT05979311|Lamivudine|lamivudine|mesh-list
110508187|NCT05979311|Emtricitabine|emtricitabine|mesh-list
110508188|NCT05979311|Dolutegravir|dolutegravir|mesh-list
110508189|NCT05979311|Antiviral Agents|antiviral agents|mesh-ancestor
110508190|NCT05979311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110508191|NCT05979311|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110508192|NCT05979311|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110508193|NCT05979311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110508194|NCT05979311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110508195|NCT05979311|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110508196|NCT05979311|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110508197|NCT05979311|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110508198|NCT05979311|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110508199|NCT05979298|Gemcitabine|gemcitabine|mesh-list
110508200|NCT05979298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110508236|NCT05978726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110508237|NCT05978713|Tirzepatide|tirzepatide|mesh-list
110508238|NCT05978713|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110508309|NCT05978401|Carboplatin|carboplatin|mesh-list
110508310|NCT05978401|Pemetrexed|pemetrexed|mesh-list
110508311|NCT05978401|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110508312|NCT05978401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110508313|NCT05978401|Tubulin Modulators|tubulin modulators|mesh-ancestor
110508314|NCT05978401|Antimitotic Agents|antimitotic agents|mesh-ancestor
110508315|NCT05978401|Mitosis Modulators|mitosis modulators|mesh-ancestor
110508316|NCT05978401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110508317|NCT05978401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110508318|NCT05978401|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110508319|NCT05978401|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110508320|NCT05978206|Nandrolone Decanoate|nandrolone decanoate|mesh-list
110508322|NCT05978206|Nandrolone phenpropionate|nandrolone phenpropionate|mesh-list
110508323|NCT05978206|Androgens|androgens|mesh-ancestor
110508324|NCT05978206|Hormones|hormones|mesh-ancestor
110508325|NCT05978206|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110508326|NCT05978206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110508327|NCT05978206|Anabolic Agents|anabolic agents|mesh-ancestor
110508328|NCT05978206|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110508363|NCT05977920|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110508364|NCT05977920|Purinergic Agents|purinergic agents|mesh-ancestor
110508365|NCT05977920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110508366|NCT05977907|Pembrolizumab|pembrolizumab|mesh-list
110508367|NCT05977907|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110508368|NCT05977907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110508369|NCT05977907|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110508370|NCT05977907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110508371|NCT05977868|Amoxicillin|amoxicillin|mesh-list
110508372|NCT05977868|Moxifloxacin|moxifloxacin|mesh-list
110508373|NCT05977868|Metronidazole|metronidazole|mesh-list
110508374|NCT05977868|Vancomycin|vancomycin|mesh-list
110508375|NCT05977868|Doxycycline|doxycycline|mesh-list
110508376|NCT05977868|Ciprofloxacin|ciprofloxacin|mesh-list
110508377|NCT05977868|Levofloxacin|levofloxacin|mesh-list
110508378|NCT05977868|Rifampin|rifampin|mesh-list
110508379|NCT05977868|Meropenem|meropenem|mesh-list
110508380|NCT05977868|Cefazolin|cefazolin|mesh-list
110508381|NCT05977868|Tazobactam|tazobactam|mesh-list
110508382|NCT05977868|Linezolid|linezolid|mesh-list
110508383|NCT05977868|Piperacillin|piperacillin|mesh-list
110508384|NCT05977868|Clavulanic Acid|clavulanic acid|mesh-list
110508385|NCT05977868|Daptomycin|daptomycin|mesh-list
110508386|NCT05977868|Penicillins|penicillins|mesh-list
110508387|NCT05977868|Ceftazidime|ceftazidime|mesh-list
110508388|NCT05977868|Ampicillin|ampicillin|mesh-list
110508389|NCT05977868|Cephalexin|cephalexin|mesh-list
110508390|NCT05977868|Cefepime|cefepime|mesh-list
110508391|NCT05977868|Ertapenem|ertapenem|mesh-list
110508397|NCT05977868|Avibactam|avibactam|mesh-list
110508419|NCT05977868|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110508420|NCT05977868|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110508421|NCT05977868|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110508422|NCT05977868|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110508423|NCT05977868|Antitubercular Agents|antitubercular agents|mesh-ancestor
110508424|NCT05977868|Leprostatic Agents|leprostatic agents|mesh-ancestor
110508425|NCT05977868|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110508426|NCT05977868|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110508427|NCT05977868|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110508482|NCT05964868|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110508483|NCT05964868|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110508484|NCT05964868|Adrenergic Agents|adrenergic agents|mesh-ancestor
110508485|NCT05964868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110508486|NCT05964868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110508487|NCT05964868|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110508488|NCT05964868|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110508489|NCT05964868|Autonomic Agents|autonomic agents|mesh-ancestor
110508490|NCT05964868|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110508491|NCT05964868|Respiratory System Agents|respiratory system agents|mesh-ancestor
110508492|NCT05964868|Mydriatics|mydriatics|mesh-ancestor
110508493|NCT05964868|Sympathomimetics|sympathomimetics|mesh-ancestor
110508494|NCT05964868|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110508495|NCT05948579|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
110508496|NCT05948579|Antidepressive Agents|antidepressive agents|mesh-ancestor
110508497|NCT05948579|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110508498|NCT05948579|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110508499|NCT05948579|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110508500|NCT05948579|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110508501|NCT05948579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110508502|NCT05948579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110508503|NCT05948579|Serotonin Agents|serotonin agents|mesh-ancestor
110508504|NCT05948579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110508505|NCT05948579|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110508530|NCT05929898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110508531|NCT05929898|Protective Agents|protective agents|mesh-ancestor
110508532|NCT05840718|Thiamine|thiamine|mesh-list
110508533|NCT05840718|Vitamin B Complex|vitamin b complex|mesh-ancestor
110508534|NCT05840718|Vitamins|vitamins|mesh-ancestor
110508535|NCT05840718|Micronutrients|micronutrients|mesh-ancestor
110508536|NCT05840718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110508537|NCT05838521|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
110508541|NCT05836740|Minocycline|minocycline|mesh-list
110508542|NCT05836740|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110508543|NCT05836740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110508547|NCT05829603|Harmine|harmine|mesh-list
110508548|NCT05829603|Hallucinogens|hallucinogens|mesh-ancestor
110508549|NCT05829603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110508550|NCT05829603|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110508551|NCT05829603|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
110508552|NCT05829603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110508553|NCT05829603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110508554|NCT05825430|Bupivacaine|bupivacaine|mesh-list
110508556|NCT05825430|Anesthetics, General|anesthetics, general|mesh-list
110508557|NCT05825430|Anesthetics, Local|anesthetics, local|mesh-ancestor
110508558|NCT05825430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110508559|NCT05825430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110508560|NCT05825430|Sensory System Agents|sensory system agents|mesh-ancestor
110508561|NCT05825430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110508562|NCT05782270|Warfarin|warfarin|mesh-list
110508563|NCT05782270|Anticoagulants|anticoagulants|mesh-ancestor
110508564|NCT05780710|Antihypertensive Agents|antihypertensive agents|mesh-list
110508565|NCT05753189|Brimonidine Tartrate|brimonidine tartrate|mesh-list
110508566|NCT05753189|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110508567|NCT05753189|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110508568|NCT05753189|Aceclidine|aceclidine|mesh-list
110508569|NCT05753189|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110508570|NCT05753189|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110508571|NCT05753189|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110508572|NCT05753189|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110508573|NCT05753189|Adrenergic Agents|adrenergic agents|mesh-ancestor
110457453|NCT01151540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110457454|NCT01163786|Bortezomib|bortezomib|mesh-list
110457455|NCT01163786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110508574|NCT05753189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110508575|NCT05753189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110508576|NCT05753189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110508577|NCT05753189|Miotics|miotics|mesh-ancestor
110508578|NCT05753189|Autonomic Agents|autonomic agents|mesh-ancestor
110508579|NCT05753189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110508580|NCT05753189|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110508581|NCT05750992|Fentanyl|fentanyl|mesh-list
110508582|NCT05750992|Meperidine|meperidine|mesh-list
110508583|NCT05750992|Bupivacaine|bupivacaine|mesh-list
110508584|NCT05750992|Anesthetics, Local|anesthetics, local|mesh-ancestor
110508585|NCT05750992|Anesthetics|anesthetics|mesh-ancestor
110508586|NCT05750992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110508587|NCT05750992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110508588|NCT05750992|Sensory System Agents|sensory system agents|mesh-ancestor
110508639|NCT05602519|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110508640|NCT05602519|Narcotics|narcotics|mesh-ancestor
110508641|NCT05602519|Analgesics|analgesics|mesh-ancestor
110508642|NCT05602519|Sensory System Agents|sensory system agents|mesh-ancestor
110508643|NCT05602519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110508644|NCT05602519|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110508645|NCT05602519|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110508646|NCT05602519|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110508647|NCT05602519|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110508648|NCT05557695|Acalabrutinib|acalabrutinib|mesh-list
110508649|NCT05557695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110508650|NCT05536856|Fluorouracil|fluorouracil|mesh-list
110508651|NCT05536856|Antimetabolites|antimetabolites|mesh-ancestor
110508652|NCT05536856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110508653|NCT05536856|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110508654|NCT05536856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110508655|NCT05536856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110508656|NCT05536856|Immunologic Factors|immunologic factors|mesh-ancestor
110176279|NCT00392886|Antimetabolites|antimetabolites|mesh-ancestor
110457456|NCT05367362|Minocycline|minocycline|mesh-list
110457457|NCT05367362|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110457458|NCT05367362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110457459|NCT00984282|Sorafenib|sorafenib|mesh-list
110457460|NCT00984282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110457461|NCT00984282|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110457462|NCT00984282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110457463|NCT00984282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110457464|NCT04187196|Propofol|propofol|mesh-list
110457465|NCT04187196|Methohexital|methohexital|mesh-list
110457466|NCT04187196|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110457467|NCT04187196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110457468|NCT04187196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110457469|NCT04187196|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110457470|NCT04187196|Anesthetics, General|anesthetics, general|mesh-ancestor
110457471|NCT04187196|Anesthetics|anesthetics|mesh-ancestor
110457472|NCT04292184|Sodium thiosulfate|sodium thiosulfate|mesh-list
110457473|NCT04292184|Antidotes|antidotes|mesh-ancestor
110457474|NCT04292184|Protective Agents|protective agents|mesh-ancestor
110457475|NCT04292184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110457476|NCT04292184|Antioxidants|antioxidants|mesh-ancestor
110457477|NCT04292184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110457478|NCT04292184|Antitubercular Agents|antitubercular agents|mesh-ancestor
110457479|NCT04292184|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110457480|NCT04292184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110457481|NCT04292184|Chelating Agents|chelating agents|mesh-ancestor
110457482|NCT04292184|Sequestering Agents|sequestering agents|mesh-ancestor
110457483|NCT01147640|Metronidazole|metronidazole|mesh-list
110457484|NCT01147640|Meropenem|meropenem|mesh-list
110457485|NCT01147640|Tazobactam|tazobactam|mesh-list
110457486|NCT01147640|Ceftolozane|ceftolozane|mesh-list
110457487|NCT01147640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110457488|NCT01147640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110457489|NCT01147640|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110457490|NCT01147640|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110457491|NCT01147640|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110457492|NCT01147640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110457493|NCT01147640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110457494|NCT02867982|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110508657|NCT05536856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110508658|NCT05493709|Leuprolide|leuprolide|mesh-list
110508659|NCT05493709|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110508660|NCT05493709|Fertility Agents|fertility agents|mesh-ancestor
110508661|NCT05493709|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110508662|NCT05493709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110508663|NCT05493709|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110508664|NCT05493709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110508665|NCT05487885|Ketamine|ketamine|mesh-list
110508666|NCT05487885|Analgesics|analgesics|mesh-ancestor
110508667|NCT05487885|Sensory System Agents|sensory system agents|mesh-ancestor
110508668|NCT05487885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110508669|NCT05487885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110508670|NCT05487885|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110508671|NCT05487885|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110508672|NCT05487885|Anesthetics, General|anesthetics, general|mesh-ancestor
110508673|NCT05487885|Anesthetics|anesthetics|mesh-ancestor
110508674|NCT05487885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110508714|NCT05406388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110508715|NCT05406388|Analgesics|analgesics|mesh-ancestor
110508716|NCT05406388|Sensory System Agents|sensory system agents|mesh-ancestor
110508717|NCT05406388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110508718|NCT05406388|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110508719|NCT05406388|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110508720|NCT05406388|Anesthetics, General|anesthetics, general|mesh-ancestor
110508721|NCT05406388|Anesthetics|anesthetics|mesh-ancestor
110508722|NCT05403502|Insulin|insulin|mesh-list
110508723|NCT05403502|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110508724|NCT05403502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110508725|NCT05399550|Balovaptan|balovaptan|mesh-list
110508726|NCT05399550|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
110508727|NCT05399550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110508728|NCT05399550|Natriuretic Agents|natriuretic agents|mesh-ancestor
110508729|NCT05399550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110508730|NCT05253131|Durvalumab|durvalumab|mesh-list
110508731|NCT05253131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110508732|NCT05253131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110508733|NCT05239468|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
110508734|NCT05239468|Bezafibrate|bezafibrate|mesh-list
110508735|NCT05239468|Cathartics|cathartics|mesh-ancestor
110508736|NCT05239468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110508737|NCT05239468|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110508738|NCT05239468|Antimetabolites|antimetabolites|mesh-ancestor
110508739|NCT05239468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110508740|NCT05239468|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110508741|NCT05230810|Fulvestrant|fulvestrant|mesh-list
110508742|NCT05230810|Tucatinib|tucatinib|mesh-list
110508746|NCT05230810|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110508759|NCT05204927|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110508760|NCT05204927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110508761|NCT05193591|Autoantibodies|autoantibodies|mesh-list
110508762|NCT05193591|Immunologic Factors|immunologic factors|mesh-ancestor
110508763|NCT05193591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110508764|NCT05183126|Paclitaxel|paclitaxel|mesh-list
110508765|NCT05183126|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110508766|NCT05183126|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110508767|NCT05183126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110508768|NCT05183126|Tubulin Modulators|tubulin modulators|mesh-ancestor
110508825|NCT04960709|Tremelimumab|tremelimumab|mesh-list
110508826|NCT04960709|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110508827|NCT04960709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110508828|NCT04960618|Gemcitabine|gemcitabine|mesh-list
110508829|NCT04960618|Pembrolizumab|pembrolizumab|mesh-list
110508830|NCT04960618|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110508831|NCT04960618|Antimetabolites|antimetabolites|mesh-ancestor
110508832|NCT04960618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110508833|NCT04960618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110508834|NCT04960618|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110508835|NCT04960618|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110508858|NCT04954664|Histamine Agents|histamine agents|mesh-ancestor
110508859|NCT04954664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110508860|NCT04954664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110508862|NCT04900792|Temozolomide|temozolomide|mesh-list
110508909|NCT04776148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110508910|NCT04750707|Hydroxyurea|hydroxyurea|mesh-list
110508911|NCT04750707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110508912|NCT04750707|Antisickling Agents|antisickling agents|mesh-ancestor
110508913|NCT04750707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110508914|NCT04750707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110508915|NCT04750707|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110508916|NCT04748809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
110508917|NCT04692831|Pertuzumab|pertuzumab|mesh-list
110508918|NCT04692831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110508919|NCT04692831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110508934|NCT04644029|Tenofovir|tenofovir|mesh-list
110508935|NCT04644029|Emtricitabine|emtricitabine|mesh-list
110508937|NCT04644029|Islatravir|islatravir|mesh-list
110508985|NCT04512235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110508986|NCT04512235|Immunologic Factors|immunologic factors|mesh-ancestor
110508987|NCT04512235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110508988|NCT04512235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110508989|NCT04512235|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110508990|NCT04512235|Alkylating Agents|alkylating agents|mesh-ancestor
110508991|NCT04512235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110508992|NCT04512235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110508993|NCT04512235|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110508994|NCT04512235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110508996|NCT04512235|Autonomic Agents|autonomic agents|mesh-ancestor
110508997|NCT04512235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110508998|NCT04512235|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110508999|NCT04512235|Glucocorticoids|glucocorticoids|mesh-ancestor
110509000|NCT04512235|Hormones|hormones|mesh-ancestor
110509001|NCT04512235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110509002|NCT04512235|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110509003|NCT04479306|Osimertinib|osimertinib|mesh-list
110509004|NCT04479306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110509005|NCT04479306|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110509006|NCT04479306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110509007|NCT04479306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110509034|NCT04410991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110509035|NCT04410991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110509036|NCT04410991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110509037|NCT04410991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110509038|NCT04410991|Immunologic Factors|immunologic factors|mesh-ancestor
110509039|NCT04410978|Teriflunomide|teriflunomide|mesh-list
110509040|NCT04410978|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110509041|NCT04410978|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110509042|NCT04410978|Analgesics|analgesics|mesh-ancestor
110509102|NCT04154189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110509103|NCT04154189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110509104|NCT04154189|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110509105|NCT04154189|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110509106|NCT04154189|Alkylating Agents|alkylating agents|mesh-ancestor
110509107|NCT04152161|BCG Vaccine|bcg vaccine|mesh-list
110509108|NCT04152161|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110509109|NCT04152161|Immunologic Factors|immunologic factors|mesh-ancestor
110509110|NCT04152161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110509111|NCT04116320|Poly ICLC|poly iclc|mesh-list
110509112|NCT04116320|Interferon Inducers|interferon inducers|mesh-ancestor
110509113|NCT04116320|Immunologic Factors|immunologic factors|mesh-ancestor
110509114|NCT04116320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110509115|NCT04094311|Tisagenlecleucel|tisagenlecleucel|mesh-list
110509116|NCT04094311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110509117|NCT04094311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110509118|NCT04008355|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110509119|NCT03964727|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
110509120|NCT03964727|Immunoconjugates|immunoconjugates|mesh-ancestor
110509121|NCT03964727|Immunologic Factors|immunologic factors|mesh-ancestor
110509122|NCT03964727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110509123|NCT03934905|Sulforaphane|sulforaphane|mesh-list
110509128|NCT03916263|Metformin|metformin|mesh-list
110509155|NCT03788694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110509156|NCT03788694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110509157|NCT03749109|Quinagolide|quinagolide|mesh-list
110509158|NCT03749109|Dopamine Agonists|dopamine agonists|mesh-ancestor
110509159|NCT03749109|Dopamine Agents|dopamine agents|mesh-ancestor
110509160|NCT03749109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110509161|NCT03749109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110509227|NCT03471182|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110509228|NCT03471182|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110509229|NCT03471182|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110509230|NCT03471182|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110509231|NCT03471182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110509232|NCT03471182|Dopamine Agents|dopamine agents|mesh-ancestor
110156596|NCT03151369|Morphine|morphine|mesh-list
110509233|NCT03471182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110509234|NCT03466294|Azacitidine|azacitidine|mesh-list
110509235|NCT03466294|Venetoclax|venetoclax|mesh-list
110509236|NCT03466294|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110509237|NCT03466294|Antimetabolites|antimetabolites|mesh-ancestor
110509238|NCT03466294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110509239|NCT03466294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110509240|NCT03466294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110509241|NCT03363867|Bevacizumab|bevacizumab|mesh-list
110509288|NCT03191084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110509290|NCT03005366|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110509291|NCT03005366|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110509292|NCT03005366|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110509293|NCT03005366|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110509294|NCT03005366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110509295|NCT02922764|Carboplatin|carboplatin|mesh-list
110509296|NCT02922764|Docetaxel|docetaxel|mesh-list
110509297|NCT02922764|Pembrolizumab|pembrolizumab|mesh-list
110509298|NCT02922764|Pemetrexed|pemetrexed|mesh-list
110509299|NCT02922764|Ipilimumab|ipilimumab|mesh-list
110509300|NCT02922764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110509301|NCT02922764|Tubulin Modulators|tubulin modulators|mesh-ancestor
110509302|NCT02922764|Antimitotic Agents|antimitotic agents|mesh-ancestor
110509303|NCT02922764|Mitosis Modulators|mitosis modulators|mesh-ancestor
110509304|NCT02922764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110509305|NCT02922764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110509306|NCT02922764|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110509307|NCT02922764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110509308|NCT02922764|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110509309|NCT02922764|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110509310|NCT02738866|Fulvestrant|fulvestrant|mesh-list
110509311|NCT02738866|Palbociclib|palbociclib|mesh-list
110509322|NCT02576912|Dronabinol|dronabinol|mesh-list
110509338|NCT02232152|Antimetabolites|antimetabolites|mesh-ancestor
110509339|NCT02232152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110509340|NCT02232152|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110509341|NCT02232152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110509342|NCT02232152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110509343|NCT02232152|Immunologic Factors|immunologic factors|mesh-ancestor
110509344|NCT02232152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110509345|NCT02232152|Antioxidants|antioxidants|mesh-ancestor
110509346|NCT02232152|Protective Agents|protective agents|mesh-ancestor
110509347|NCT02232152|Vitamin B Complex|vitamin b complex|mesh-ancestor
110509348|NCT02232152|Vitamins|vitamins|mesh-ancestor
110509349|NCT02232152|Micronutrients|micronutrients|mesh-ancestor
110509350|NCT02211755|Bortezomib|bortezomib|mesh-list
110509351|NCT02211755|Clofarabine|clofarabine|mesh-list
110509352|NCT02211755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110509400|NCT01950520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110509401|NCT01950520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110509402|NCT01950520|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110509403|NCT01950520|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110509404|NCT01950520|Purinergic Agents|purinergic agents|mesh-ancestor
110509405|NCT01950520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110509406|NCT01950520|Analgesics|analgesics|mesh-ancestor
110509407|NCT01950520|Anesthetics|anesthetics|mesh-ancestor
110509408|NCT01950520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110509409|NCT01950520|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110509410|NCT01950520|Anticonvulsants|anticonvulsants|mesh-ancestor
110509411|NCT01950520|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110509412|NCT01950520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110509414|NCT01950520|Tocolytic Agents|tocolytic agents|mesh-ancestor
110509463|NCT01758432|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110509464|NCT01758432|Protease Inhibitors|protease inhibitors|mesh-ancestor
110509465|NCT01758432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110509466|NCT01758432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110509467|NCT01758432|Anticoagulants|anticoagulants|mesh-ancestor
110509468|NCT01583218|Enoxaparin|enoxaparin|mesh-list
110509469|NCT01583218|Betrixaban|betrixaban|mesh-list
110509470|NCT01583218|Anticoagulants|anticoagulants|mesh-ancestor
110509471|NCT01583218|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110509472|NCT01583218|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110509475|NCT01583218|Antithrombins|antithrombins|mesh-ancestor
110509531|NCT02545231|Pitavastatin|pitavastatin|mesh-list
110509532|NCT02545231|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110509533|NCT02545231|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110509534|NCT02545231|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110509535|NCT02545231|Antimetabolites|antimetabolites|mesh-ancestor
110509536|NCT02545231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110509537|NCT02545231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110509538|NCT02545231|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110509539|NCT02803788|Dexamethasone|dexamethasone|mesh-list
110509540|NCT02803788|Ondansetron|ondansetron|mesh-list
110509541|NCT02803788|Ramosetron|ramosetron|mesh-list
110509542|NCT02803788|Antiemetics|antiemetics|mesh-list
110509543|NCT02803788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110509544|NCT02803788|Autonomic Agents|autonomic agents|mesh-ancestor
110509545|NCT02803788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110509546|NCT02803788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110509547|NCT02803788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110509588|NCT05757063|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110509589|NCT05757063|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110509590|NCT05757063|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110509591|NCT05757063|Adrenergic Agents|adrenergic agents|mesh-ancestor
110509592|NCT05757063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110509593|NCT05757063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110509594|NCT05757063|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110509595|NCT05757063|Anesthetics, General|anesthetics, general|mesh-ancestor
110509597|NCT02799498|Etanercept|etanercept|mesh-list
110509598|NCT02799498|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110509599|NCT02799498|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110509600|NCT02799498|Analgesics|analgesics|mesh-ancestor
110509601|NCT02799498|Sensory System Agents|sensory system agents|mesh-ancestor
110509602|NCT02799498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110509649|NCT02799030|Aminolevulinic Acid|aminolevulinic acid|mesh-list
110509650|NCT02799030|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110509651|NCT02799030|Dermatologic Agents|dermatologic agents|mesh-ancestor
110509652|NCT00812955|Simvastatin|simvastatin|mesh-list
110509653|NCT00812955|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110509654|NCT00812955|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110509655|NCT00812955|Antimetabolites|antimetabolites|mesh-ancestor
110509656|NCT00812955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110593176|NCT05118477|Caffeine|caffeine|mesh-list
110509657|NCT00812955|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110509658|NCT00812955|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110509660|NCT04235478|Triamcinolone|triamcinolone|mesh-list
110509661|NCT04235478|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110509662|NCT04235478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110509663|NCT04235478|Glucocorticoids|glucocorticoids|mesh-ancestor
110509710|NCT02799264|Cabotegravir|cabotegravir|mesh-list
110509711|NCT02799264|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110509712|NCT02799264|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110509713|NCT02799264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110509714|NCT02799264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110509715|NCT02799264|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110509716|NCT02799264|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110509717|NCT02799264|Antiviral Agents|antiviral agents|mesh-ancestor
110509718|NCT02799264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110509719|NCT00959699|Interferons|interferons|mesh-list
110509777|NCT05550636|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110509778|NCT05550636|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110509779|NCT05550636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110509780|NCT05550636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110509781|NCT05550636|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110509782|NCT05550636|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110509783|NCT05550636|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110509784|NCT05550636|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110509785|NCT05550636|Anesthetics, General|anesthetics, general|mesh-ancestor
110509786|NCT05550636|Anesthetics|anesthetics|mesh-ancestor
110509787|NCT05550636|GABA Modulators|gaba modulators|mesh-ancestor
110509788|NCT05550636|GABA Agents|gaba agents|mesh-ancestor
110509789|NCT05550636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110509790|NCT05550636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110509791|NCT02857829|Caffeine|caffeine|mesh-list
110509792|NCT02857829|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110509793|NCT02857829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110509794|NCT02857829|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110509832|NCT00865111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110509833|NCT00865111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110509835|NCT00865111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110509836|NCT00865111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110509837|NCT00865111|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110509838|NCT00865111|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110509839|NCT00865111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110509840|NCT02802696|Furosemide|furosemide|mesh-list
110509841|NCT02802696|Diuretics|diuretics|mesh-ancestor
110509842|NCT02802696|Natriuretic Agents|natriuretic agents|mesh-ancestor
110509843|NCT02802696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110509895|NCT00865501|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110509896|NCT00865501|Hormone Antagonists|hormone antagonists|mesh-ancestor
110509897|NCT00865501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110509898|NCT00865501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110509899|NCT00865501|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110509900|NCT00865501|Diuretics|diuretics|mesh-ancestor
110509901|NCT00865501|Natriuretic Agents|natriuretic agents|mesh-ancestor
110509902|NCT02797704|Aflibercept|aflibercept|mesh-list
110509903|NCT02797704|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110509904|NCT02797704|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110509905|NCT02797704|Growth Substances|growth substances|mesh-ancestor
110509906|NCT02797704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110509907|NCT02797704|Growth Inhibitors|growth inhibitors|mesh-ancestor
110509908|NCT02797704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110509909|NCT04281095|Botulinum Toxins|botulinum toxins|mesh-list
110509910|NCT04281095|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110509911|NCT04281095|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110509912|NCT04281095|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110509913|NCT04281095|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110509950|NCT02802072|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110509951|NCT02802072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110509952|NCT02802072|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110509953|NCT02802072|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110509954|NCT02802072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110509955|NCT02802072|Antipyretics|antipyretics|mesh-ancestor
110509956|NCT00865657|Alprazolam|alprazolam|mesh-list
110509957|NCT00865657|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110509958|NCT00865657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110509959|NCT00865657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110509960|NCT00865657|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110509961|NCT00865657|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110509962|NCT00865657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110509963|NCT00865657|GABA Modulators|gaba modulators|mesh-ancestor
110509964|NCT00865657|GABA Agents|gaba agents|mesh-ancestor
110509965|NCT00865657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110509966|NCT00865657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110509967|NCT00863395|Lidocaine|lidocaine|mesh-list
110510006|NCT04276025|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110510007|NCT04276025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110510008|NCT02797860|Rocuronium|rocuronium|mesh-list
110510009|NCT02797860|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110510010|NCT02797860|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110510011|NCT02797860|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110510012|NCT02797860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110510013|NCT02797860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110510014|NCT00860899|Clonidine|clonidine|mesh-list
110510015|NCT00860899|Levobupivacaine|levobupivacaine|mesh-list
110510016|NCT00860899|Analgesics|analgesics|mesh-ancestor
110510017|NCT00860899|Sensory System Agents|sensory system agents|mesh-ancestor
110510018|NCT00860899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110510019|NCT00860899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110510020|NCT00860899|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110510021|NCT00860899|Sympatholytics|sympatholytics|mesh-ancestor
110510022|NCT00860899|Autonomic Agents|autonomic agents|mesh-ancestor
110510023|NCT00860899|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110510024|NCT00860899|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110510025|NCT00860899|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110510026|NCT00860899|Adrenergic Agents|adrenergic agents|mesh-ancestor
110510027|NCT00860899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110510028|NCT00860899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110510029|NCT00860899|Anesthetics, Local|anesthetics, local|mesh-ancestor
110510030|NCT00860899|Anesthetics|anesthetics|mesh-ancestor
110510031|NCT00860899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110510032|NCT02797782|Antibodies|antibodies|mesh-list
110510033|NCT02797782|Immunologic Factors|immunologic factors|mesh-ancestor
110510034|NCT02797782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110510035|NCT00863629|Insulin|insulin|mesh-list
110510036|NCT00863629|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110510037|NCT00863629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110457495|NCT02867982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110457496|NCT01121900|Trazodone|trazodone|mesh-list
110457497|NCT01121900|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110457498|NCT01121900|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110457499|NCT01121900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110457500|NCT01121900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110457501|NCT01121900|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110457502|NCT01121900|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110457503|NCT01121900|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110457504|NCT01121900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110510038|NCT00860977|Valacyclovir|valacyclovir|mesh-list
110510039|NCT00860977|Antiviral Agents|antiviral agents|mesh-ancestor
110510040|NCT00860977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110510041|NCT00865891|Nifedipine|nifedipine|mesh-list
110510042|NCT00865891|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110510043|NCT00865891|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110510044|NCT00865891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110510045|NCT00865891|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110510046|NCT00865891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110510047|NCT00865891|Vasodilator Agents|vasodilator agents|mesh-ancestor
110510048|NCT00865891|Tocolytic Agents|tocolytic agents|mesh-ancestor
110510049|NCT00865891|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110510050|NCT02797236|Vaccines|vaccines|mesh-list
110510051|NCT02797236|Immunologic Factors|immunologic factors|mesh-ancestor
110510052|NCT02797236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110510053|NCT00863785|Acetylcysteine|acetylcysteine|mesh-list
110510054|NCT00863785|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110510055|NCT00863785|Antiviral Agents|antiviral agents|mesh-ancestor
110510056|NCT00863785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110157412|NCT03772964|Metformin|metformin|mesh-list
110510057|NCT00863785|Expectorants|expectorants|mesh-ancestor
110510058|NCT00863785|Respiratory System Agents|respiratory system agents|mesh-ancestor
110510059|NCT00863785|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110510060|NCT00863785|Antioxidants|antioxidants|mesh-ancestor
110510061|NCT00863785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110510062|NCT00863785|Protective Agents|protective agents|mesh-ancestor
110510064|NCT00863785|Antidotes|antidotes|mesh-ancestor
110510086|NCT02805426|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110510087|NCT02805426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110510089|NCT02805426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110510090|NCT02805426|Oxytocics|oxytocics|mesh-ancestor
110510091|NCT02801292|Ketamine|ketamine|mesh-list
110510092|NCT02801292|Analgesics|analgesics|mesh-ancestor
110510093|NCT02801292|Sensory System Agents|sensory system agents|mesh-ancestor
110510094|NCT02801292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110510095|NCT02801292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110510096|NCT02801292|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110510097|NCT02801292|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110510150|NCT00870337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110510151|NCT00870337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110510152|NCT00866437|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110510153|NCT00866437|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110510154|NCT00866437|Estropipate|estropipate|mesh-list
110510155|NCT00866437|Estradiol|estradiol|mesh-list
110510156|NCT00866437|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110510157|NCT00866437|Estrone|estrone|mesh-list
110510158|NCT00866437|Progesterone|progesterone|mesh-list
110510159|NCT00866437|Estrogens|estrogens|mesh-ancestor
110510160|NCT00866437|Hormones|hormones|mesh-ancestor
110510162|NCT00866437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110510215|NCT00864019|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110510216|NCT00864019|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110510217|NCT00864019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110510218|NCT00864019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110510219|NCT00864019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110510220|NCT00864019|Serotonin Agents|serotonin agents|mesh-ancestor
110510221|NCT00864019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110510222|NCT00812487|Insulin|insulin|mesh-list
110510223|NCT00812487|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110510278|NCT00870571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110510279|NCT00870571|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110510280|NCT00870571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110510281|NCT00870571|Vasodilator Agents|vasodilator agents|mesh-ancestor
110510285|NCT00616759|Propofol|propofol|mesh-list
110510346|NCT00870961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110510347|NCT00870961|Vitamins|vitamins|mesh-ancestor
110510350|NCT00811941|Nalmefene|nalmefene|mesh-list
110510419|NCT04234776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110510420|NCT04234776|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110510421|NCT04234776|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110510422|NCT04234776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110510423|NCT04234776|Serotonin Agents|serotonin agents|mesh-ancestor
110510424|NCT04234776|Antidepressive Agents|antidepressive agents|mesh-ancestor
110510425|NCT04234776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110510426|NCT04234776|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110510427|NCT04234776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110510428|NCT04234776|Dopamine Agonists|dopamine agonists|mesh-ancestor
110510429|NCT04234776|Dopamine Agents|dopamine agents|mesh-ancestor
110510430|NCT04234776|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110510431|NCT04234776|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110510432|NCT04234776|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110510480|NCT00811473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110510481|NCT00811473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110510482|NCT00871507|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110510483|NCT00871507|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110510484|NCT00871507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110510485|NCT00871507|Incretins|incretins|mesh-ancestor
110510486|NCT00871507|Hormones|hormones|mesh-ancestor
110510487|NCT00871507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110510488|NCT00871507|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110510489|NCT00871507|Protease Inhibitors|protease inhibitors|mesh-ancestor
110510490|NCT00871507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110510491|NCT00871507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110510541|NCT00872209|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110510544|NCT00872365|Trace Elements|trace elements|mesh-list
110510545|NCT00872365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110510546|NCT03637062|Progesterone|progesterone|mesh-list
110510547|NCT03637062|Progestins|progestins|mesh-ancestor
110510548|NCT03637062|Hormones|hormones|mesh-ancestor
110510549|NCT03637062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110510550|NCT03637062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110510551|NCT02793648|Vitamins|vitamins|mesh-list
110510552|NCT02793648|Ascorbic Acid|ascorbic acid|mesh-list
110510553|NCT02793648|Vitamin E|vitamin e|mesh-list
110510554|NCT02793648|Tocopherols|tocopherols|mesh-list
110510555|NCT02793648|alpha-Tocopherol|alpha-tocopherol|mesh-list
110510556|NCT02793648|Micronutrients|micronutrients|mesh-ancestor
110510557|NCT02793648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110510558|NCT02793648|Antioxidants|antioxidants|mesh-ancestor
110510559|NCT02793648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110510560|NCT02793648|Protective Agents|protective agents|mesh-ancestor
110510561|NCT02789358|Adenosine|adenosine|mesh-list
110510562|NCT02789358|Analgesics|analgesics|mesh-ancestor
110510563|NCT02789358|Sensory System Agents|sensory system agents|mesh-ancestor
110510564|NCT02789358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110510597|NCT00617305|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110510598|NCT00617305|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110510599|NCT00617305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110510600|NCT00617305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110510601|NCT00617305|Urological Agents|urological agents|mesh-ancestor
110510602|NCT00617305|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110510603|NCT02792712|Clopidogrel|clopidogrel|mesh-list
110510604|NCT02792712|Ticagrelor|ticagrelor|mesh-list
110510605|NCT02792712|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110510606|NCT02792712|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110510607|NCT02792712|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110510608|NCT02792712|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110510609|NCT02792712|Purinergic Agents|purinergic agents|mesh-ancestor
110510610|NCT02792712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110510660|NCT00876577|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
110510661|NCT00876577|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110510662|NCT00876577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110510663|NCT00876577|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110510664|NCT00876577|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110510665|NCT00876577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110510666|NCT00876577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110510667|NCT00876577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110510668|NCT00876577|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110510669|NCT00876577|Contraceptive Agents|contraceptive agents|mesh-ancestor
110510670|NCT00876577|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110510671|NCT00876577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110510672|NCT00876577|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110510673|NCT00876577|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110510674|NCT00876577|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110510675|NCT02787798|Valsartan|valsartan|mesh-list
110510676|NCT02787798|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
110510715|NCT05755659|Autonomic Agents|autonomic agents|mesh-ancestor
110510716|NCT05755659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110510717|NCT05755659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110510718|NCT05755659|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110510719|NCT05755659|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110510720|NCT05755659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110510721|NCT05755659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110510722|NCT00913887|Diclofenac|diclofenac|mesh-list
110510724|NCT00913887|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110510779|NCT00868153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110510780|NCT00868153|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110510781|NCT00868153|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110510782|NCT00868153|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110510783|NCT00876889|Riluzole|riluzole|mesh-list
110510784|NCT00876889|Anticonvulsants|anticonvulsants|mesh-ancestor
110510785|NCT00876889|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110510786|NCT00876889|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110510787|NCT00876889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110510788|NCT00876889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110510845|NCT00615901|Methotrexate|methotrexate|mesh-list
110510846|NCT00615901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110510847|NCT00615901|Immunologic Factors|immunologic factors|mesh-ancestor
110510848|NCT00615901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110510849|NCT00615901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110510850|NCT00615901|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110510851|NCT00615901|Alkylating Agents|alkylating agents|mesh-ancestor
110510852|NCT00615901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110510853|NCT00615901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110510867|NCT00616603|BB 1101|bb 1101|mesh-list
110510910|NCT02790450|Gout Suppressants|gout suppressants|mesh-ancestor
110510911|NCT02790450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110510912|NCT02790528|Atorvastatin|atorvastatin|mesh-list
110510913|NCT02790528|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110510914|NCT02790528|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110510915|NCT02790528|Antimetabolites|antimetabolites|mesh-ancestor
110510916|NCT02790528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110510919|NCT02790528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110510976|NCT02787018|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110510977|NCT02787018|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110510978|NCT02787018|Adrenergic Agents|adrenergic agents|mesh-ancestor
110510979|NCT02787018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110510980|NCT02787018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110510981|NCT02787018|Anesthetics, Local|anesthetics, local|mesh-ancestor
110510982|NCT02787018|Anesthetics|anesthetics|mesh-ancestor
110510984|NCT00873925|Vitamins|vitamins|mesh-ancestor
110510985|NCT00873925|Micronutrients|micronutrients|mesh-ancestor
110510986|NCT00873925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110510987|NCT00873925|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110510988|NCT03412266|Cytarabine|cytarabine|mesh-list
110511041|NCT00877591|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110511042|NCT00877591|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110511043|NCT04200222|Vanadium|vanadium|mesh-list
110511044|NCT04200222|Trace Elements|trace elements|mesh-ancestor
110511045|NCT04200222|Micronutrients|micronutrients|mesh-ancestor
110511046|NCT04200222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110511047|NCT00874003|Mirtazapine|mirtazapine|mesh-list
110511048|NCT00874003|Antidepressive Agents|antidepressive agents|mesh-ancestor
110511049|NCT00874003|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110511110|NCT05753865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110511111|NCT05753865|Tubulin Modulators|tubulin modulators|mesh-ancestor
110511112|NCT05753865|Antimitotic Agents|antimitotic agents|mesh-ancestor
110511113|NCT05753865|Mitosis Modulators|mitosis modulators|mesh-ancestor
110511114|NCT05753865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110511115|NCT00869869|Melatonin|melatonin|mesh-list
110511116|NCT00869869|Antioxidants|antioxidants|mesh-ancestor
110511117|NCT00869869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110511118|NCT00869869|Protective Agents|protective agents|mesh-ancestor
110511119|NCT00869869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110511120|NCT00869869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110511123|NCT00874315|Cyclosporine|cyclosporine|mesh-list
110511124|NCT00874315|Mycophenolic Acid|mycophenolic acid|mesh-list
110511125|NCT00874315|Fludarabine|fludarabine|mesh-list
110511126|NCT00874315|Fludarabine phosphate|fludarabine phosphate|mesh-list
110511173|NCT02786550|Botulinum Toxins|botulinum toxins|mesh-list
110511174|NCT02786550|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110511175|NCT02786550|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110511176|NCT02786550|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110511177|NCT02786550|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110511178|NCT02786550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110158543|NCT00006089|Immunologic Factors|immunologic factors|mesh-ancestor
110511179|NCT02786550|Cholinergic Agents|cholinergic agents|mesh-ancestor
110511180|NCT02786550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110511181|NCT02786550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110511182|NCT02786550|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110511185|NCT02784054|Melphalan|melphalan|mesh-list
110511236|NCT02066220|Tubulin Modulators|tubulin modulators|mesh-ancestor
110511237|NCT02066220|Antimitotic Agents|antimitotic agents|mesh-ancestor
110511238|NCT02066220|Mitosis Modulators|mitosis modulators|mesh-ancestor
110511239|NCT00573391|Thalidomide|thalidomide|mesh-list
110511240|NCT00573391|Dexamethasone|dexamethasone|mesh-list
110511241|NCT00573391|Dexamethasone acetate|dexamethasone acetate|mesh-list
110511242|NCT00573391|Melphalan|melphalan|mesh-list
110511243|NCT00573391|Bortezomib|bortezomib|mesh-list
110511244|NCT00573391|BB 1101|bb 1101|mesh-list
110511245|NCT00573391|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110511246|NCT00573391|Antiemetics|antiemetics|mesh-ancestor
110511247|NCT00573391|Autonomic Agents|autonomic agents|mesh-ancestor
110511248|NCT00573391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110511302|NCT04029831|Ketamine|ketamine|mesh-list
110511303|NCT04029831|Propofol|propofol|mesh-list
110511304|NCT04029831|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110511305|NCT04029831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110511306|NCT04029831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110511307|NCT04029831|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110511308|NCT04029831|Anesthetics, General|anesthetics, general|mesh-ancestor
110511309|NCT04029831|Anesthetics|anesthetics|mesh-ancestor
110511310|NCT04029831|Analgesics|analgesics|mesh-ancestor
110593261|NCT00667017|Immunotoxins|immunotoxins|mesh-list
110511311|NCT04029831|Sensory System Agents|sensory system agents|mesh-ancestor
110511312|NCT04029831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110511313|NCT04029831|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110511314|NCT04029831|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110511315|NCT04029831|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110511318|NCT00878449|Etoposide|etoposide|mesh-list
110511363|NCT02783586|Bupivacaine|bupivacaine|mesh-list
110511364|NCT02783586|Anesthetics, Local|anesthetics, local|mesh-ancestor
110511365|NCT02783586|Anesthetics|anesthetics|mesh-ancestor
110511366|NCT02783586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110511367|NCT02783586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110511370|NCT00590577|Paliperidone Palmitate|paliperidone palmitate|mesh-list
110511433|NCT02785068|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110511434|NCT02785068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110511435|NCT02785068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110511436|NCT02785068|Immunologic Factors|immunologic factors|mesh-ancestor
110511437|NCT02785068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110511439|NCT02785068|Protective Agents|protective agents|mesh-ancestor
110511440|NCT02785068|Vitamin B Complex|vitamin b complex|mesh-ancestor
110511441|NCT02785068|Vitamins|vitamins|mesh-ancestor
110511442|NCT02785068|Micronutrients|micronutrients|mesh-ancestor
110511443|NCT05752929|Insulin|insulin|mesh-list
110511502|NCT02786082|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110511503|NCT02786082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110511505|NCT05275686|Xhance|xhance|mesh-list
110511506|NCT05275686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110511507|NCT05275686|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110511509|NCT05275686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110511510|NCT05275686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110511511|NCT05275686|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110511512|NCT05275686|Respiratory System Agents|respiratory system agents|mesh-ancestor
110511513|NCT05275686|Dermatologic Agents|dermatologic agents|mesh-ancestor
110511514|NCT05275686|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110511515|NCT01503606|Clarithromycin|clarithromycin|mesh-list
110511516|NCT01503606|Cefazolin|cefazolin|mesh-list
110511517|NCT01503606|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110511518|NCT01503606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110511561|NCT00805545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110511562|NCT00805545|Antitubercular Agents|antitubercular agents|mesh-ancestor
110511563|NCT00590031|Irinotecan|irinotecan|mesh-list
110511564|NCT00590031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110511565|NCT00590031|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110511566|NCT00590031|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110511567|NCT00590031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110511568|NCT00590031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110511569|NCT02783196|Liraglutide|liraglutide|mesh-list
110511570|NCT02783196|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110511571|NCT02783196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110511572|NCT02783196|Incretins|incretins|mesh-ancestor
110511573|NCT02783196|Hormones|hormones|mesh-ancestor
110511574|NCT02783196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110511575|NCT05188170|Niclosamide|niclosamide|mesh-list
110511576|NCT05188170|Anticestodal Agents|anticestodal agents|mesh-ancestor
110511577|NCT05188170|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110511578|NCT05188170|Anthelmintics|anthelmintics|mesh-ancestor
110511579|NCT05188170|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110511580|NCT05188170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110511581|NCT05188170|Antinematodal Agents|antinematodal agents|mesh-ancestor
110511582|NCT02782338|Diclofenac|diclofenac|mesh-list
110511583|NCT02782338|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110511584|NCT02782338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110511585|NCT02782338|Analgesics|analgesics|mesh-ancestor
110511586|NCT02782338|Sensory System Agents|sensory system agents|mesh-ancestor
110511587|NCT02782338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110511588|NCT02782338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110511589|NCT02782338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110511607|NCT03577704|Paclitaxel|paclitaxel|mesh-list
110511608|NCT03577704|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110511609|NCT03577704|Cisplatin|cisplatin|mesh-list
110511610|NCT03577704|Carboplatin|carboplatin|mesh-list
110511611|NCT03577704|Gemcitabine|gemcitabine|mesh-list
110511612|NCT03577704|Oxaliplatin|oxaliplatin|mesh-list
110511613|NCT03577704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110511614|NCT03577704|Antibodies|antibodies|mesh-list
110511677|NCT02782182|Protective Agents|protective agents|mesh-ancestor
110511678|NCT02782182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110511679|NCT02782182|Vitamin B Complex|vitamin b complex|mesh-ancestor
110511680|NCT02782182|Vitamins|vitamins|mesh-ancestor
110511681|NCT02782182|Micronutrients|micronutrients|mesh-ancestor
110511682|NCT02780778|Docetaxel|docetaxel|mesh-list
110511683|NCT02780778|Apatinib|apatinib|mesh-list
110511684|NCT02780778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110511685|NCT02780778|Tubulin Modulators|tubulin modulators|mesh-ancestor
110511686|NCT02780778|Antimitotic Agents|antimitotic agents|mesh-ancestor
110511687|NCT02780778|Mitosis Modulators|mitosis modulators|mesh-ancestor
110511688|NCT02780778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110511689|NCT02780778|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110511690|NCT02780778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110511691|NCT00881101|Paclitaxel|paclitaxel|mesh-list
110511692|NCT00881101|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110511693|NCT00881101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110511694|NCT00881101|Tubulin Modulators|tubulin modulators|mesh-ancestor
110511695|NCT00881101|Antimitotic Agents|antimitotic agents|mesh-ancestor
110511696|NCT00881101|Mitosis Modulators|mitosis modulators|mesh-ancestor
110511697|NCT00881101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110511698|NCT00883909|Dutasteride|dutasteride|mesh-list
110511699|NCT00883909|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
110511700|NCT00883909|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110511701|NCT00883909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110511702|NCT00883909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110511703|NCT00883909|Hormone Antagonists|hormone antagonists|mesh-ancestor
110511706|NCT00634686|Vitamin D|vitamin d|mesh-list
110511727|NCT03955861|Sensory System Agents|sensory system agents|mesh-ancestor
110511728|NCT03955861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110511729|NCT03955861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110511730|NCT03955861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110511731|NCT03955861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110511732|NCT03955861|Immunologic Factors|immunologic factors|mesh-ancestor
110511733|NCT00881179|Clarithromycin|clarithromycin|mesh-list
110511734|NCT00881179|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110511794|NCT02937116|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110511795|NCT02937116|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110511796|NCT02937116|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110511798|NCT03927105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110511799|NCT03927105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110511800|NCT03927105|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110511801|NCT03927105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110511802|NCT00613327|Oxybutynin|oxybutynin|mesh-list
110511803|NCT00613327|Parasympatholytics|parasympatholytics|mesh-ancestor
110511804|NCT00613327|Autonomic Agents|autonomic agents|mesh-ancestor
110511859|NCT05339646|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110511860|NCT05339646|Protease Inhibitors|protease inhibitors|mesh-ancestor
110511861|NCT05339646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110511862|NCT05339646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110511864|NCT05339646|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110511865|NCT05339646|Antiviral Agents|antiviral agents|mesh-ancestor
110511866|NCT05339646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110511867|NCT05339646|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110511868|NCT05339646|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110511870|NCT00630695|Somatostatin|somatostatin|mesh-list
110593279|NCT00778245|Cefprozil|cefprozil|mesh-list
110511871|NCT00630695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110511872|NCT00630695|Hormones|hormones|mesh-ancestor
110511875|NCT02843438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
110511920|NCT05156892|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110511921|NCT05156892|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110511922|NCT05156892|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110511923|NCT05156892|Antifungal Agents|antifungal agents|mesh-ancestor
110511924|NCT05156892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110511925|NCT05156892|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110511926|NCT05156892|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110511931|NCT03894345|Prazosin|prazosin|mesh-list
110511986|NCT00914121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110511987|NCT00914121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110511988|NCT00953225|Vitamin D|vitamin d|mesh-list
110511989|NCT00953225|Cholecalciferol|cholecalciferol|mesh-list
110511990|NCT00953225|Vitamins|vitamins|mesh-ancestor
110511991|NCT00953225|Micronutrients|micronutrients|mesh-ancestor
110511992|NCT00953225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110511993|NCT00953225|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110511994|NCT00953225|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110511995|NCT03819231|Oxytocin|oxytocin|mesh-list
110511996|NCT03819231|Oxytocics|oxytocics|mesh-ancestor
110511997|NCT03819231|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110511998|NCT03819231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110511999|NCT00613015|Guanfacine|guanfacine|mesh-list
110512000|NCT00613015|Modafinil|modafinil|mesh-list
110512001|NCT00613015|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110512002|NCT00613015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110512045|NCT00879541|Coagulants|coagulants|mesh-ancestor
110512046|NCT00884299|Antioxidants|antioxidants|mesh-list
110512047|NCT00884299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110512048|NCT00884299|Protective Agents|protective agents|mesh-ancestor
110512049|NCT00884299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110512050|NCT02843126|Trastuzumab|trastuzumab|mesh-list
110512051|NCT02843126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110512052|NCT02843126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110512053|NCT04201652|Anesthetics|anesthetics|mesh-list
110512054|NCT04201652|Anesthetics, Local|anesthetics, local|mesh-list
110512055|NCT04201652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110512056|NCT04201652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110512057|NCT04201652|Sensory System Agents|sensory system agents|mesh-ancestor
110512058|NCT04201652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110512059|NCT05338476|Midazolam|midazolam|mesh-list
110512105|NCT04227990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110512106|NCT04227990|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110512107|NCT04227990|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110512108|NCT04227990|Alkylating Agents|alkylating agents|mesh-ancestor
110512109|NCT04227990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110512110|NCT04227990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110512111|NCT04227990|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110512112|NCT04227990|Tubulin Modulators|tubulin modulators|mesh-ancestor
110512113|NCT04227990|Antimitotic Agents|antimitotic agents|mesh-ancestor
110512114|NCT04227990|Mitosis Modulators|mitosis modulators|mesh-ancestor
110512115|NCT04227990|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110512116|NCT04227990|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110512117|NCT04227990|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110512118|NCT04227990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110512119|NCT02606409|Dexmedetomidine|dexmedetomidine|mesh-list
110512165|NCT02837198|FYX-051|fyx-051|mesh-list
110512166|NCT02837198|Uricosuric Agents|uricosuric agents|mesh-ancestor
110512167|NCT02837198|Gout Suppressants|gout suppressants|mesh-ancestor
110512168|NCT02837198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110512169|NCT02837198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110512170|NCT02837198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110512171|NCT00611533|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
110512172|NCT00611533|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110512173|NCT00611533|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110512174|NCT00611533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110312010|NCT00304317|Celecoxib|celecoxib|mesh-list
110512175|NCT00611533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110512176|NCT00611533|Adrenergic Agents|adrenergic agents|mesh-ancestor
110512225|NCT05333744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110512226|NCT05333744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110512227|NCT05333744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110512228|NCT05333744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110512229|NCT04250246|Nivolumab|nivolumab|mesh-list
110512230|NCT04250246|Ipilimumab|ipilimumab|mesh-list
110512232|NCT04250246|Azacitidine|azacitidine|mesh-list
110512234|NCT04250246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110512293|NCT02857361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110512294|NCT02857361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110512295|NCT02857361|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110512296|NCT02857361|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110512297|NCT02857361|Anesthetics, General|anesthetics, general|mesh-ancestor
110512298|NCT02857361|Anesthetics|anesthetics|mesh-ancestor
110512299|NCT02857361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110512300|NCT02857361|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110512301|NCT02857361|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110512302|NCT02857361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110512303|NCT02857361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110512304|NCT02778126|Prexasertib|prexasertib|mesh-list
110512305|NCT02778126|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110512306|NCT02778126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110512307|NCT02778126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110512309|NCT02232737|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110512310|NCT02232737|Autonomic Agents|autonomic agents|mesh-ancestor
110512311|NCT02232737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110512312|NCT02232737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110512313|NCT02232737|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110512347|NCT04204928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110512349|NCT02834546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110512350|NCT02834546|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110512351|NCT02834546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110512352|NCT02834546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110512353|NCT00948857|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
110512354|NCT00948857|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110512355|NCT00948857|Immunologic Factors|immunologic factors|mesh-ancestor
110512356|NCT00948857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110512357|NCT04227912|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
110512358|NCT04227912|Anesthetics|anesthetics|mesh-list
110512359|NCT04227912|Anesthetics, Local|anesthetics, local|mesh-list
110512408|NCT02777736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110512409|NCT02777736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110512410|NCT02836184|Niacin|niacin|mesh-list
110512411|NCT02836184|Nicotinic Acids|nicotinic acids|mesh-list
110512412|NCT02836184|Niacinamide|niacinamide|mesh-list
110512413|NCT02836184|Calcium Carbonate|calcium carbonate|mesh-list
110512414|NCT02836184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110512415|NCT02836184|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110512416|NCT02836184|Antimetabolites|antimetabolites|mesh-ancestor
110512418|NCT02836184|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110512475|NCT02836028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110512476|NCT02836028|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110512477|NCT02836028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110512478|NCT01778946|Nicotine|nicotine|mesh-list
110512479|NCT01778946|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110512480|NCT01778946|Autonomic Agents|autonomic agents|mesh-ancestor
110512481|NCT01778946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110512482|NCT01778946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110593298|NCT00666705|Maraviroc|maraviroc|mesh-list
110512483|NCT01778946|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110512484|NCT01778946|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110512485|NCT01778946|Cholinergic Agents|cholinergic agents|mesh-ancestor
110512486|NCT01778946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110512487|NCT01778946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110512488|NCT04227210|Vaccines|vaccines|mesh-list
110512538|NCT00948389|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110512539|NCT00948389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110512540|NCT00948389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110512541|NCT00948389|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110512542|NCT00948389|Alkylating Agents|alkylating agents|mesh-ancestor
110512543|NCT02775318|Bupivacaine|bupivacaine|mesh-list
110512544|NCT02775318|Anesthetics, Local|anesthetics, local|mesh-ancestor
110512545|NCT02775318|Anesthetics|anesthetics|mesh-ancestor
110312013|NCT00304317|Analgesics|analgesics|mesh-ancestor
110512546|NCT02775318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110512550|NCT00948155|Varenicline|varenicline|mesh-list
110512601|NCT04851834|Carboplatin|carboplatin|mesh-list
110512602|NCT04851834|Temozolomide|temozolomide|mesh-list
110512603|NCT04851834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110512604|NCT04851834|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110512605|NCT04851834|Alkylating Agents|alkylating agents|mesh-ancestor
110512606|NCT04851834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110512607|NCT02776722|Tagatose|tagatose|mesh-list
110512609|NCT02776722|Chelating Agents|chelating agents|mesh-ancestor
110512670|NCT02772354|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110512671|NCT02772354|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110512672|NCT02772354|Adrenergic Agents|adrenergic agents|mesh-ancestor
110512673|NCT02772354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110512674|NCT02772354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110512675|NCT02772354|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110512676|NCT02772354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110512678|NCT02772354|Vasodilator Agents|vasodilator agents|mesh-ancestor
110512736|NCT02833688|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110512737|NCT02833688|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110512738|NCT02833688|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110512739|NCT02833688|Adrenergic Agents|adrenergic agents|mesh-ancestor
110512740|NCT02833688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110512741|NCT02833688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110512742|NCT00947531|Cerebrolysin|cerebrolysin|mesh-list
110512743|NCT00947531|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110512744|NCT00947531|Protective Agents|protective agents|mesh-ancestor
110512745|NCT00947531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110512746|NCT00947531|Nootropic Agents|nootropic agents|mesh-ancestor
110512747|NCT00612313|Fluoxetine|fluoxetine|mesh-list
110512748|NCT00612313|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110512749|NCT00612313|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110512797|NCT02833376|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110512798|NCT02833376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110512799|NCT02833376|Disinfectants|disinfectants|mesh-ancestor
110512800|NCT02542813|Oxytocin|oxytocin|mesh-list
110512801|NCT02542813|Oxytocics|oxytocics|mesh-ancestor
110512802|NCT02542813|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110512803|NCT02542813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110512804|NCT02772120|Progesterone|progesterone|mesh-list
110512805|NCT02772120|Progestins|progestins|mesh-ancestor
110512866|NCT04246502|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110512867|NCT04246502|Antimetabolites|antimetabolites|mesh-ancestor
110512868|NCT04246502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110512869|NCT04246502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110512870|NCT04246502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110512871|NCT02767362|Atorvastatin|atorvastatin|mesh-list
110512872|NCT02767362|Ezetimibe|ezetimibe|mesh-list
110512873|NCT02767362|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110512874|NCT02767362|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110512875|NCT02767362|Antimetabolites|antimetabolites|mesh-ancestor
110512876|NCT02767362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110512890|NCT02541643|Elotuzumab|elotuzumab|mesh-list
110512927|NCT02771418|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110512928|NCT02771418|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110512929|NCT02771418|Anesthetics, General|anesthetics, general|mesh-ancestor
110512930|NCT02771418|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110512931|NCT02771418|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110512932|NCT00888901|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110512933|NCT00888901|Methylprednisolone|methylprednisolone|mesh-list
110512934|NCT00888901|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110512935|NCT00888901|Prednisolone|prednisolone|mesh-list
110512936|NCT00888901|Prednisolone acetate|prednisolone acetate|mesh-list
110512937|NCT00888901|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110512938|NCT00888901|Prednisolone phosphate|prednisolone phosphate|mesh-list
110512939|NCT00888901|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110512940|NCT00888901|Antiemetics|antiemetics|mesh-ancestor
110512941|NCT00888901|Autonomic Agents|autonomic agents|mesh-ancestor
110512942|NCT00888901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110512943|NCT00888901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110512944|NCT00888901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110512985|NCT00890084|Diuretics|diuretics|mesh-ancestor
110512986|NCT00890084|Natriuretic Agents|natriuretic agents|mesh-ancestor
110512987|NCT00890084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110512988|NCT00890084|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110512989|NCT00890084|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110512990|NCT00890084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110512991|NCT00890084|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110512992|NCT00890084|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110512993|NCT00884845|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110512994|NCT00884845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110512995|NCT00884845|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110512999|NCT02773602|Clonidine|clonidine|mesh-list
110513046|NCT02829008|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110513047|NCT02829008|Growth Substances|growth substances|mesh-ancestor
110513048|NCT02829008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110513049|NCT02829008|Growth Inhibitors|growth inhibitors|mesh-ancestor
110513050|NCT02829008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110513051|NCT02829008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110513052|NCT02829008|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110513053|NCT02829008|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110513054|NCT00889135|Droxidopa|droxidopa|mesh-list
110513055|NCT00889135|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110513056|NCT00889135|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110513057|NCT00889213|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
110513058|NCT00889213|Hemostatics|hemostatics|mesh-ancestor
110513059|NCT00889213|Coagulants|coagulants|mesh-ancestor
110513060|NCT00382200|Decitabine|decitabine|mesh-list
110513061|NCT00382200|Tretinoin|tretinoin|mesh-list
110513062|NCT00382200|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110513063|NCT00382200|Antimetabolites|antimetabolites|mesh-ancestor
110513064|NCT00382200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110513065|NCT00382200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110513066|NCT00382200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110513067|NCT00382200|Keratolytic Agents|keratolytic agents|mesh-ancestor
110513068|NCT00382200|Dermatologic Agents|dermatologic agents|mesh-ancestor
110513099|NCT02766192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110513100|NCT02766192|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110513101|NCT02766192|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110513102|NCT02766192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110513103|NCT02766192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110513104|NCT05278897|Hyaluronic Acid|hyaluronic acid|mesh-list
110513105|NCT05278897|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110513106|NCT05278897|Immunologic Factors|immunologic factors|mesh-ancestor
110513107|NCT05278897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110513108|NCT05278897|Viscosupplements|viscosupplements|mesh-ancestor
110513109|NCT05278897|Protective Agents|protective agents|mesh-ancestor
110513110|NCT00889525|Cabergoline|cabergoline|mesh-list
110513111|NCT00889525|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110513112|NCT00889525|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110513114|NCT00889525|Dopamine Agents|dopamine agents|mesh-ancestor
110513159|NCT00608569|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110513160|NCT00608569|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110513161|NCT00608569|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110513162|NCT00608569|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110513163|NCT00608569|Antimetabolites|antimetabolites|mesh-ancestor
110513165|NCT04699422|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110513166|NCT04699422|Narcotics|narcotics|mesh-ancestor
110513167|NCT04699422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110513168|NCT04699422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110513169|NCT04699422|Analgesics|analgesics|mesh-ancestor
110513170|NCT04699422|Sensory System Agents|sensory system agents|mesh-ancestor
110513171|NCT04699422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110513172|NCT02828384|Psyllium|psyllium|mesh-list
110513175|NCT00886717|Paclitaxel|paclitaxel|mesh-list
110513219|NCT04243850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110513220|NCT04243850|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110513221|NCT04243850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110513222|NCT04243850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110513223|NCT04243850|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110513224|NCT04243850|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110513225|NCT04243850|Purinergic Agents|purinergic agents|mesh-ancestor
110513226|NCT04243850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110513227|NCT04243850|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110513228|NCT04243850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110513229|NCT00892801|Everolimus|everolimus|mesh-list
110513230|NCT00892801|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110513231|NCT00892801|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110513232|NCT00892801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110513233|NCT00892801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110513234|NCT00892801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110513235|NCT00892801|Immunologic Factors|immunologic factors|mesh-ancestor
110513236|NCT00892801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110513237|NCT00892801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110513238|NCT04222842|Vorolanib|vorolanib|mesh-list
110513239|NCT04222842|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110513240|NCT04222842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110513241|NCT04222842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110513242|NCT00633542|Interferons|interferons|mesh-list
110513243|NCT00633542|Interferon-alpha|interferon-alpha|mesh-list
110513268|NCT00610675|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110513269|NCT00610675|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110513270|NCT00610675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110513271|NCT00610675|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
110513272|NCT00610675|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110513273|NCT00610675|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110513274|NCT00610675|Adrenergic Agents|adrenergic agents|mesh-ancestor
110513275|NCT00610675|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110513276|NCT00610675|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110513277|NCT00610675|Serotonin Agents|serotonin agents|mesh-ancestor
110513278|NCT00610675|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110513279|NCT02828228|Vitamin D|vitamin d|mesh-list
110513280|NCT02828228|Cholecalciferol|cholecalciferol|mesh-list
110513281|NCT02828228|Vitamins|vitamins|mesh-ancestor
110513329|NCT00887107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110513331|NCT00802737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110513332|NCT02769390|Clonidine|clonidine|mesh-list
110513333|NCT02769390|Diazepam|diazepam|mesh-list
110513334|NCT02769390|Analgesics|analgesics|mesh-ancestor
110513335|NCT02769390|Sensory System Agents|sensory system agents|mesh-ancestor
110513336|NCT02769390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110513337|NCT02769390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110513338|NCT02769390|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110513339|NCT02769390|Sympatholytics|sympatholytics|mesh-ancestor
110513340|NCT02769390|Autonomic Agents|autonomic agents|mesh-ancestor
110513341|NCT02769390|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110513342|NCT02769390|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110513343|NCT02769390|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110513344|NCT02769390|Adrenergic Agents|adrenergic agents|mesh-ancestor
110513345|NCT02769390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110513346|NCT02769390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110513347|NCT02769390|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110513348|NCT02769390|Anticonvulsants|anticonvulsants|mesh-ancestor
110513349|NCT02769390|Antiemetics|antiemetics|mesh-ancestor
110513350|NCT02769390|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110513351|NCT02769390|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110513352|NCT02769390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110513353|NCT02769390|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110513354|NCT02769390|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110513355|NCT02769390|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110513356|NCT02769390|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110513379|NCT00887263|Autonomic Agents|autonomic agents|mesh-ancestor
110513380|NCT00887263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110513381|NCT00887263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110513382|NCT00887263|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110513383|NCT00887263|Respiratory System Agents|respiratory system agents|mesh-ancestor
110513384|NCT00887263|Glucocorticoids|glucocorticoids|mesh-ancestor
110513385|NCT00887263|Hormones|hormones|mesh-ancestor
110513386|NCT00887263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110513387|NCT00415233|Hormones|hormones|mesh-list
110513388|NCT00415233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110513389|NCT00415233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110513390|NCT00914667|Warfarin|warfarin|mesh-list
110513391|NCT00914667|Fesoterodine|fesoterodine|mesh-list
110513392|NCT00914667|Anticoagulants|anticoagulants|mesh-ancestor
110513393|NCT00914667|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110513394|NCT00914667|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110513395|NCT00914667|Cholinergic Agents|cholinergic agents|mesh-ancestor
110513433|NCT00607789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110513434|NCT00607789|Analgesics|analgesics|mesh-ancestor
110513435|NCT00607789|Sensory System Agents|sensory system agents|mesh-ancestor
110513436|NCT00607789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110513437|NCT00607789|Antidepressive Agents|antidepressive agents|mesh-ancestor
110513438|NCT00607789|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110513439|NCT00607789|Dopamine Agents|dopamine agents|mesh-ancestor
110513440|NCT02761512|Lansoprazole|lansoprazole|mesh-list
110513441|NCT02761512|Dexlansoprazole|dexlansoprazole|mesh-list
110513442|NCT02761512|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110513443|NCT02761512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110513444|NCT02761512|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110513445|NCT02761512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110513446|NCT02761512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110513448|NCT00893269|Eszopiclone|eszopiclone|mesh-list
110513449|NCT00893269|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110513450|NCT00893269|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110513451|NCT00893269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110513454|NCT00893269|GABA Agonists|gaba agonists|mesh-ancestor
110513492|NCT02542111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110513493|NCT02542111|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110513494|NCT02542111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110513495|NCT02542111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110513496|NCT02542111|Antimetabolites|antimetabolites|mesh-ancestor
110513497|NCT02542111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110513498|NCT02768688|Dexmedetomidine|dexmedetomidine|mesh-list
110513499|NCT02768688|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110513500|NCT02768688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110513501|NCT02768688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110513502|NCT02768688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110513504|NCT02768688|Sensory System Agents|sensory system agents|mesh-ancestor
110513505|NCT02768688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110513506|NCT02768688|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110513507|NCT02768688|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110513508|NCT02768688|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110513509|NCT02768688|Adrenergic Agents|adrenergic agents|mesh-ancestor
110513510|NCT02768688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110513511|NCT02768688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110513512|NCT00891163|Lidocaine|lidocaine|mesh-list
110513513|NCT00891163|Tetracaine|tetracaine|mesh-list
110513543|NCT00951665|Tubulin Modulators|tubulin modulators|mesh-ancestor
110513544|NCT00951665|Antimitotic Agents|antimitotic agents|mesh-ancestor
110513545|NCT00951665|Mitosis Modulators|mitosis modulators|mesh-ancestor
110513546|NCT00951665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110513547|NCT00951665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110513548|NCT00951665|Immunotoxins|immunotoxins|mesh-ancestor
110513549|NCT00951665|Immunoconjugates|immunoconjugates|mesh-ancestor
110513550|NCT00951665|Immunologic Factors|immunologic factors|mesh-ancestor
110513551|NCT00951665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110513552|NCT02769078|Warfarin|warfarin|mesh-list
110513553|NCT02769078|Rivaroxaban|rivaroxaban|mesh-list
110513554|NCT02769078|Dabigatran|dabigatran|mesh-list
110513555|NCT02769078|Apixaban|apixaban|mesh-list
110513556|NCT02769078|Anticoagulants|anticoagulants|mesh-ancestor
110513557|NCT02769078|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110513558|NCT02769078|Antithrombins|antithrombins|mesh-ancestor
110513559|NCT02769078|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110513560|NCT02769078|Protease Inhibitors|protease inhibitors|mesh-ancestor
110513561|NCT02769078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110513562|NCT02769078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110513563|NCT04036201|Bupivacaine|bupivacaine|mesh-list
110513564|NCT04036201|Hyaluronic Acid|hyaluronic acid|mesh-list
110513565|NCT04036201|Anesthetics, Local|anesthetics, local|mesh-ancestor
110513566|NCT04036201|Anesthetics|anesthetics|mesh-ancestor
110513567|NCT04036201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110513568|NCT04036201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110513569|NCT04036201|Sensory System Agents|sensory system agents|mesh-ancestor
110513570|NCT04036201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110513571|NCT04036201|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110513572|NCT04036201|Immunologic Factors|immunologic factors|mesh-ancestor
110513573|NCT04036201|Viscosupplements|viscosupplements|mesh-ancestor
110513589|NCT02768610|Analgesics|analgesics|mesh-ancestor
110513590|NCT02768610|Sensory System Agents|sensory system agents|mesh-ancestor
110513591|NCT02768610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110513592|NCT02768610|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110513593|NCT02768610|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110513594|NCT02768610|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110513595|NCT02768610|Adrenergic Agents|adrenergic agents|mesh-ancestor
110513596|NCT02768610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110513597|NCT02768610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110513598|NCT02764710|Amoxicillin|amoxicillin|mesh-list
110513599|NCT02764710|Clavulanic Acid|clavulanic acid|mesh-list
110513654|NCT02768376|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110513655|NCT02768376|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110513656|NCT02768376|Anesthetics, General|anesthetics, general|mesh-ancestor
110513657|NCT02696460|Lidocaine|lidocaine|mesh-list
110513658|NCT02696460|Prilocaine|prilocaine|mesh-list
110513659|NCT02696460|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
110513660|NCT02696460|Anesthetics, Local|anesthetics, local|mesh-ancestor
110513661|NCT02696460|Anesthetics|anesthetics|mesh-ancestor
110513662|NCT02696460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110513663|NCT02696460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110513664|NCT02696460|Sensory System Agents|sensory system agents|mesh-ancestor
110513665|NCT02696460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110513666|NCT02696460|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110513667|NCT02696460|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110513668|NCT02696460|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110513712|NCT00799617|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
110513714|NCT00799617|Hormones|hormones|mesh-ancestor
110513715|NCT00799617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110513716|NCT00799617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110513717|NCT00799617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110513718|NCT00799617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110513719|NCT00799617|Anabolic Agents|anabolic agents|mesh-ancestor
110513720|NCT00607087|Insulin|insulin|mesh-list
110513721|NCT00607087|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110513723|NCT00607087|Insulin Lispro|insulin lispro|mesh-list
110513724|NCT00607087|Insulin glulisine|insulin glulisine|mesh-list
110513725|NCT00607087|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110513726|NCT00607087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110513727|NCT00610363|Rilonacept|rilonacept|mesh-list
110513728|NCT00610363|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110513730|NCT00887588|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
110513731|NCT00887588|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110513732|NCT00887588|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110513733|NCT00887588|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110513734|NCT00887588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110513735|NCT00799383|Vitamin D|vitamin d|mesh-list
110513736|NCT00799383|Calcium|calcium|mesh-list
110513764|NCT00891397|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110513765|NCT00891397|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110513766|NCT00891397|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110513767|NCT00891397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110513768|NCT00891397|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110513769|NCT02767596|Lixisenatide|lixisenatide|mesh-list
110513835|NCT04113915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110513836|NCT04113915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110513837|NCT04113915|Glucocorticoids|glucocorticoids|mesh-ancestor
110513838|NCT04113915|Hormones|hormones|mesh-ancestor
110513839|NCT04113915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110513840|NCT04113915|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110513841|NCT04113915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110513842|NCT04113915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110513843|NCT04113915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110513844|NCT04113915|Antifungal Agents|antifungal agents|mesh-ancestor
110513845|NCT04113915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110513898|NCT00798603|Pemetrexed|pemetrexed|mesh-list
110513899|NCT00798603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110513900|NCT00798603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110513901|NCT00798603|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110513902|NCT00798603|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110513903|NCT00798603|Growth Substances|growth substances|mesh-ancestor
110513904|NCT00798603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110513905|NCT00798603|Growth Inhibitors|growth inhibitors|mesh-ancestor
110513906|NCT00798603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110513907|NCT00798603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110513908|NCT00798603|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110513909|NCT00798603|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110513910|NCT04036981|Botulinum Toxins|botulinum toxins|mesh-list
110513911|NCT04036981|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110513912|NCT04036981|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110513957|NCT00945815|Epratuzumab|epratuzumab|mesh-list
110513958|NCT00945815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110513959|NCT00945815|Antimetabolites|antimetabolites|mesh-ancestor
110513960|NCT00945815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110513961|NCT00945815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110513962|NCT00945815|Antiviral Agents|antiviral agents|mesh-ancestor
110513963|NCT00945815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110513964|NCT00945815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110513965|NCT00945815|Immunologic Factors|immunologic factors|mesh-ancestor
110513966|NCT00945815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110513967|NCT00945815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110513968|NCT00606307|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
110513969|NCT00606307|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110513970|NCT00606307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110513971|NCT00606307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110513972|NCT00798369|Triamcinolone|triamcinolone|mesh-list
110513973|NCT00798369|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110513974|NCT00798369|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110513975|NCT00798369|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110514012|NCT00894283|Antithrombins|antithrombins|mesh-ancestor
110514013|NCT00894283|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110514014|NCT00894283|Protease Inhibitors|protease inhibitors|mesh-ancestor
110514015|NCT00894283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110514016|NCT00895609|Neostigmine|neostigmine|mesh-list
110514017|NCT00895609|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110514018|NCT00895609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110514019|NCT00895609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110514020|NCT00895609|Cholinergic Agents|cholinergic agents|mesh-ancestor
110514026|NCT00894439|Piperacillin|piperacillin|mesh-list
110514076|NCT02762838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110514077|NCT02762838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110514078|NCT02762838|Hematinics|hematinics|mesh-ancestor
110514079|NCT02762838|Vitamin B Complex|vitamin b complex|mesh-ancestor
110514080|NCT02762838|Vitamins|vitamins|mesh-ancestor
110514081|NCT02762838|Micronutrients|micronutrients|mesh-ancestor
110514082|NCT02753166|Dexamethasone|dexamethasone|mesh-list
110514083|NCT02753166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110514084|NCT02753166|Antiemetics|antiemetics|mesh-ancestor
110514085|NCT02753166|Autonomic Agents|autonomic agents|mesh-ancestor
110514086|NCT02753166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110514087|NCT02753166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110514088|NCT02753166|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110514089|NCT02753166|Glucocorticoids|glucocorticoids|mesh-ancestor
110514090|NCT02753166|Hormones|hormones|mesh-ancestor
110514092|NCT02753166|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110514139|NCT02757144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110514140|NCT02757144|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110514141|NCT02757144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110514142|NCT02757144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110514143|NCT04568616|Letrozole|letrozole|mesh-list
110514144|NCT04568616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110514145|NCT04568616|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110514146|NCT04568616|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110514147|NCT04568616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110514148|NCT04568616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110514149|NCT04568616|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110514150|NCT04568616|Hormone Antagonists|hormone antagonists|mesh-ancestor
110514151|NCT04568616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110514152|NCT04568616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110514153|NCT00950807|Tiotropium Bromide|tiotropium bromide|mesh-list
110514199|NCT01082393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110514200|NCT01082393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110514201|NCT01082393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110514202|NCT01082393|Dermatologic Agents|dermatologic agents|mesh-ancestor
110514203|NCT01082393|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110514204|NCT01082393|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110514205|NCT01082393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110514206|NCT01082393|Analgesics|analgesics|mesh-ancestor
110514207|NCT01082393|Sensory System Agents|sensory system agents|mesh-ancestor
110514266|NCT02752308|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110514267|NCT02752308|Parasympatholytics|parasympatholytics|mesh-ancestor
110514268|NCT02752308|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110514269|NCT02752308|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110514270|NCT02752308|Cholinergic Agents|cholinergic agents|mesh-ancestor
110514271|NCT02752308|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110514272|NCT02752308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110514273|NCT02752308|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110514274|NCT00894751|Dexmedetomidine|dexmedetomidine|mesh-list
110514275|NCT00894751|Propofol|propofol|mesh-list
110514276|NCT00894751|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110514277|NCT00894751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110514278|NCT00894751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110514279|NCT00894751|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110514280|NCT00894751|Analgesics|analgesics|mesh-ancestor
110514281|NCT00894751|Sensory System Agents|sensory system agents|mesh-ancestor
110514282|NCT00894751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110514283|NCT00894751|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110514284|NCT00894751|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110514285|NCT00894751|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110514286|NCT00894751|Adrenergic Agents|adrenergic agents|mesh-ancestor
110514287|NCT00894751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110514288|NCT00894751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110514289|NCT00894751|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110514290|NCT00894751|Anesthetics, General|anesthetics, general|mesh-ancestor
110514291|NCT00894751|Anesthetics|anesthetics|mesh-ancestor
110514292|NCT00896077|Lisofylline|lisofylline|mesh-list
110514293|NCT00896077|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110514294|NCT00896077|Immunologic Factors|immunologic factors|mesh-ancestor
110514295|NCT00896077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110514296|NCT00896077|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110514297|NCT00896077|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110514298|NCT00896077|Analgesics|analgesics|mesh-ancestor
110514299|NCT00896077|Sensory System Agents|sensory system agents|mesh-ancestor
110514300|NCT00896077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110514306|NCT00792909|Immunologic Factors|immunologic factors|mesh-ancestor
110514307|NCT00792909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110514308|NCT00896155|Tamoxifen|tamoxifen|mesh-list
110514309|NCT00896155|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110514310|NCT00896155|Hormone Antagonists|hormone antagonists|mesh-ancestor
110514311|NCT00896155|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110514312|NCT00896155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110514313|NCT00896155|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110514314|NCT00896155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110514315|NCT00896155|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110514316|NCT00896155|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110514317|NCT00896155|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110514318|NCT00896311|Nitroglycerin|nitroglycerin|mesh-list
110514319|NCT00896311|Vasodilator Agents|vasodilator agents|mesh-ancestor
110514320|NCT02751996|Tenofovir|tenofovir|mesh-list
110514321|NCT02751996|Antiviral Agents|antiviral agents|mesh-ancestor
110514322|NCT02751996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110514323|NCT02751996|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110514329|NCT00944645|Niacin|niacin|mesh-list
110514364|NCT00901069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110514365|NCT00901069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110514366|NCT00901069|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110514367|NCT00901069|Alkylating Agents|alkylating agents|mesh-ancestor
110514368|NCT00901069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110514369|NCT00901069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110514370|NCT00901069|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110514371|NCT00901069|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110514372|NCT00901069|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110514373|NCT00901069|Tubulin Modulators|tubulin modulators|mesh-ancestor
110514374|NCT00901069|Antimitotic Agents|antimitotic agents|mesh-ancestor
110514423|NCT02756598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110514424|NCT02756598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110514426|NCT02756598|Anesthetics, General|anesthetics, general|mesh-ancestor
110514427|NCT02756598|Anesthetics|anesthetics|mesh-ancestor
110514428|NCT02756598|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110514429|NCT02756598|Narcotics|narcotics|mesh-ancestor
110514430|NCT02756598|Analgesics|analgesics|mesh-ancestor
110514431|NCT02756598|Sensory System Agents|sensory system agents|mesh-ancestor
110514432|NCT02756598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110514489|NCT00631085|alpha-Tocopherol|alpha-tocopherol|mesh-list
110514490|NCT00631085|gamma-Tocopherol|gamma-tocopherol|mesh-list
110514491|NCT00631085|Antioxidants|antioxidants|mesh-ancestor
110514492|NCT00631085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110514493|NCT00631085|Protective Agents|protective agents|mesh-ancestor
110514494|NCT00631085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110514495|NCT00631085|Vitamins|vitamins|mesh-ancestor
110514496|NCT00631085|Micronutrients|micronutrients|mesh-ancestor
110514497|NCT04269863|Aspirin|aspirin|mesh-list
110514498|NCT04269863|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110514499|NCT04269863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110514500|NCT04269863|Analgesics|analgesics|mesh-ancestor
110514501|NCT04269863|Sensory System Agents|sensory system agents|mesh-ancestor
110514512|NCT04269863|Antipyretics|antipyretics|mesh-ancestor
110514551|NCT00895063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110514552|NCT00895063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110514554|NCT00895063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110514555|NCT00895063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110514556|NCT02751294|Tafenoquine|tafenoquine|mesh-list
110514557|NCT02751294|Antimalarials|antimalarials|mesh-ancestor
110514558|NCT02751294|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110514559|NCT02751294|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110514616|NCT02758782|Immunologic Factors|immunologic factors|mesh-ancestor
110514618|NCT04221672|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110514619|NCT04221672|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110514620|NCT00895297|Dasatinib|dasatinib|mesh-list
110514621|NCT00895297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110514622|NCT00895297|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110514623|NCT00895297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110514624|NCT00895297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110514625|NCT00943319|Fludarabine|fludarabine|mesh-list
110514626|NCT00943319|Busulfan|busulfan|mesh-list
110514627|NCT00943319|Alemtuzumab|alemtuzumab|mesh-list
110514628|NCT00943319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110514629|NCT00943319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110514630|NCT00943319|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110514631|NCT00943319|Immunologic Factors|immunologic factors|mesh-ancestor
110514632|NCT00943319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110514637|NCT02603991|Levetiracetam|levetiracetam|mesh-list
110514677|NCT02540785|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110514678|NCT02540785|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110514679|NCT04243278|Aspirin|aspirin|mesh-list
110514680|NCT04243278|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110514681|NCT04243278|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110514682|NCT04243278|Analgesics|analgesics|mesh-ancestor
110514683|NCT04243278|Sensory System Agents|sensory system agents|mesh-ancestor
110514684|NCT04243278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110514685|NCT04243278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110514686|NCT04243278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110514687|NCT04243278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110514688|NCT04243278|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110514689|NCT04243278|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110514690|NCT04243278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110514691|NCT04243278|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110514692|NCT04243278|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110514694|NCT04243278|Antipyretics|antipyretics|mesh-ancestor
110514732|NCT05429580|Hemostatics|hemostatics|mesh-ancestor
110514733|NCT05429580|Coagulants|coagulants|mesh-ancestor
110514734|NCT00790647|Bortezomib|bortezomib|mesh-list
110514735|NCT00790647|Melphalan|melphalan|mesh-list
110514736|NCT00790647|Immunologic Factors|immunologic factors|mesh-ancestor
110514737|NCT00790647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110514738|NCT00790647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110514739|NCT00790647|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110514740|NCT00790647|Alkylating Agents|alkylating agents|mesh-ancestor
110514741|NCT00790647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110514800|NCT00604253|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110514801|NCT00604253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110514802|NCT02754960|Thalidomide|thalidomide|mesh-list
110514803|NCT02754960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110514804|NCT02754960|Immunologic Factors|immunologic factors|mesh-ancestor
110514805|NCT02754960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110514806|NCT02754960|Leprostatic Agents|leprostatic agents|mesh-ancestor
110514807|NCT02754960|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110514808|NCT02754960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110514809|NCT02754960|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110514810|NCT02754960|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110514811|NCT02754960|Growth Substances|growth substances|mesh-ancestor
110514863|NCT04547166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110514864|NCT04547166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110514865|NCT04547166|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110514866|NCT04547166|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110514867|NCT04547166|Growth Substances|growth substances|mesh-ancestor
110514868|NCT04547166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110514869|NCT04547166|Growth Inhibitors|growth inhibitors|mesh-ancestor
110514870|NCT00602693|Sirolimus|sirolimus|mesh-list
110514871|NCT00602693|Cyclophosphamide|cyclophosphamide|mesh-list
110514872|NCT00602693|Fludarabine|fludarabine|mesh-list
110514873|NCT00602693|Fludarabine phosphate|fludarabine phosphate|mesh-list
110514874|NCT00602693|Allopurinol|allopurinol|mesh-list
110514875|NCT00602693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110514876|NCT00602693|Immunologic Factors|immunologic factors|mesh-ancestor
110514924|NCT00604409|Antimetabolites|antimetabolites|mesh-ancestor
110514925|NCT00604409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110514926|NCT00604409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110514927|NCT00905905|Simvastatin|simvastatin|mesh-list
110514929|NCT00905905|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
110514930|NCT00905905|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110514931|NCT00905905|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110514932|NCT00905905|Antimetabolites|antimetabolites|mesh-ancestor
110514933|NCT00905905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110514934|NCT00905905|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110514935|NCT00905905|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110514936|NCT00905905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110514937|NCT00902473|Topiramate|topiramate|mesh-list
110514938|NCT00902473|Anticonvulsants|anticonvulsants|mesh-ancestor
110514988|NCT02602509|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110514989|NCT02602509|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110514990|NCT02602509|Analgesics|analgesics|mesh-ancestor
110514991|NCT02602509|Sensory System Agents|sensory system agents|mesh-ancestor
110514992|NCT02602509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110514993|NCT02602509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110514994|NCT02602509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110514995|NCT02602509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110514996|NCT02602509|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110514997|NCT02602509|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110515052|NCT00906139|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110515053|NCT00906139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110515054|NCT00906139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110515055|NCT00906139|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110515056|NCT00906139|Anesthetics, General|anesthetics, general|mesh-ancestor
110515057|NCT00906139|Anesthetics|anesthetics|mesh-ancestor
110515059|NCT00906139|Narcotics|narcotics|mesh-ancestor
110515060|NCT00906139|Analgesics|analgesics|mesh-ancestor
110515061|NCT00906139|Sensory System Agents|sensory system agents|mesh-ancestor
110515062|NCT00906139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110515116|NCT02852681|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110515118|NCT02852681|Natriuretic Agents|natriuretic agents|mesh-ancestor
110515119|NCT02754180|Gemcitabine|gemcitabine|mesh-list
110515120|NCT02754180|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110515121|NCT02754180|Antimetabolites|antimetabolites|mesh-ancestor
110515122|NCT02754180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110515123|NCT02754180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110515124|NCT00602849|Sertraline|sertraline|mesh-list
110515125|NCT00602849|Antidepressive Agents|antidepressive agents|mesh-ancestor
110515126|NCT00602849|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110515129|NCT00602849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110515179|NCT04103697|Capecitabine|capecitabine|mesh-list
110515180|NCT04103697|Oxaliplatin|oxaliplatin|mesh-list
110515181|NCT04103697|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110515182|NCT04103697|Antimetabolites|antimetabolites|mesh-ancestor
110515183|NCT04103697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110515184|NCT04103697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110515185|NCT00898573|Lapatinib|lapatinib|mesh-list
110515186|NCT00898573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110515187|NCT00898573|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110515188|NCT00898573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110515189|NCT00898573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110515190|NCT04321668|Hylan|hylan|mesh-list
110515191|NCT04321668|Viscosupplements|viscosupplements|mesh-ancestor
110515192|NCT04321668|Protective Agents|protective agents|mesh-ancestor
110515193|NCT04321668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110515194|NCT02851745|Linagliptin|linagliptin|mesh-list
110515195|NCT02851745|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110515196|NCT02851745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110515197|NCT02851745|Incretins|incretins|mesh-ancestor
110515198|NCT02851745|Hormones|hormones|mesh-ancestor
110515199|NCT02851745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110515230|NCT02753712|Adrenergic Agents|adrenergic agents|mesh-ancestor
110515231|NCT02753712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110515232|NCT02753712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110515233|NCT04220892|Pembrolizumab|pembrolizumab|mesh-list
110515234|NCT04220892|Pemetrexed|pemetrexed|mesh-list
110515235|NCT04220892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110515236|NCT04220892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110515237|NCT04220892|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110515238|NCT04220892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110515239|NCT04220892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110515240|NCT04220892|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110515241|NCT04220892|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110515242|NCT02696148|Liraglutide|liraglutide|mesh-list
110593420|NCT00784797|Oxytocin|oxytocin|mesh-list
110515243|NCT02696148|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110515244|NCT02696148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110515245|NCT02696148|Incretins|incretins|mesh-ancestor
110515246|NCT02696148|Hormones|hormones|mesh-ancestor
110515247|NCT02696148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110515248|NCT00887198|Prednisone|prednisone|mesh-list
110515249|NCT00887198|Abiraterone Acetate|abiraterone acetate|mesh-list
110515250|NCT00887198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110515251|NCT00887198|Glucocorticoids|glucocorticoids|mesh-ancestor
110515252|NCT00887198|Hormones|hormones|mesh-ancestor
110515253|NCT00887198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110515254|NCT00887198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110515255|NCT00887198|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110515256|NCT00887198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110515257|NCT00887198|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110515258|NCT00887198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110515259|NCT00887198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110515260|NCT00887198|Hormone Antagonists|hormone antagonists|mesh-ancestor
110515271|NCT00782067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110515272|NCT00782067|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110515273|NCT00782067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110515274|NCT00782067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110515276|NCT05520723|Antidiarrheals|antidiarrheals|mesh-list
110515277|NCT05520723|Lenograstim|lenograstim|mesh-list
110515278|NCT05520723|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
110515279|NCT05520723|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110515280|NCT05520723|Immunologic Factors|immunologic factors|mesh-ancestor
110515281|NCT05520723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110515283|NCT05520723|Immunoconjugates|immunoconjugates|mesh-ancestor
110515335|NCT00605215|Immunologic Factors|immunologic factors|mesh-ancestor
110515336|NCT00605215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110515337|NCT02827682|Anesthetics|anesthetics|mesh-list
110515338|NCT02827682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110515339|NCT02827682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110515340|NCT02826200|Acenocoumarol|acenocoumarol|mesh-list
110515401|NCT02695212|Sensory System Agents|sensory system agents|mesh-ancestor
110515402|NCT02695212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110515403|NCT02695212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110515404|NCT02695212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110515405|NCT02695212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110515406|NCT02695212|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
110515470|NCT00781911|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110515471|NCT00781911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110515472|NCT00605917|Sertraline|sertraline|mesh-list
110515473|NCT00605917|Antidepressive Agents|antidepressive agents|mesh-ancestor
110515474|NCT00605917|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110515475|NCT00605917|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110515476|NCT00605917|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110515477|NCT00605917|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110515478|NCT00605917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110515479|NCT00605917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110515480|NCT00605917|Serotonin Agents|serotonin agents|mesh-ancestor
110515481|NCT00605917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110515482|NCT04919096|Aflibercept|aflibercept|mesh-list
110515483|NCT04919096|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110515484|NCT04919096|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110515491|NCT00781599|Varenicline|varenicline|mesh-list
110515526|NCT00899197|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110515527|NCT00899197|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110515528|NCT00899197|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110515529|NCT00603083|Ketorolac|ketorolac|mesh-list
110515530|NCT00603083|Ropivacaine|ropivacaine|mesh-list
110515531|NCT00603083|Anesthetics, Local|anesthetics, local|mesh-ancestor
110515532|NCT00603083|Anesthetics|anesthetics|mesh-ancestor
110515533|NCT00603083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110515539|NCT00603083|Analgesics|analgesics|mesh-ancestor
110515592|NCT04242914|Anesthetics, General|anesthetics, general|mesh-ancestor
110515593|NCT04242914|Anesthetics|anesthetics|mesh-ancestor
110515594|NCT04242914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110515595|NCT04242914|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110515596|NCT04242914|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110515597|NCT04242914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110515598|NCT04242914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110515599|NCT04242914|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110515600|NCT04242914|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110515601|NCT04242914|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110515602|NCT04242914|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110515603|NCT04242914|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110515604|NCT04242914|GABA Modulators|gaba modulators|mesh-ancestor
110515605|NCT04242914|GABA Agents|gaba agents|mesh-ancestor
110515606|NCT00780273|Cimetidine|cimetidine|mesh-list
110515607|NCT00780273|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110515608|NCT00780273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110515609|NCT00780273|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110515610|NCT00780273|Histamine Antagonists|histamine antagonists|mesh-ancestor
110515611|NCT00780273|Histamine Agents|histamine agents|mesh-ancestor
110515612|NCT00780273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110515613|NCT00780273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110515614|NCT00780273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110515643|NCT00899821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110515644|NCT00899821|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110515645|NCT00899821|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110515646|NCT00899821|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110515647|NCT00899821|Growth Substances|growth substances|mesh-ancestor
110515648|NCT00899821|Growth Inhibitors|growth inhibitors|mesh-ancestor
110515650|NCT00005112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110515651|NCT00005112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110515652|NCT04163406|Ferrous fumarate|ferrous fumarate|mesh-list
110515653|NCT04163406|Trace Elements|trace elements|mesh-ancestor
110515654|NCT04163406|Micronutrients|micronutrients|mesh-ancestor
110515655|NCT04163406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110515656|NCT04218552|Amlodipine|amlodipine|mesh-list
110515703|NCT00779259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110515704|NCT00779259|Vasodilator Agents|vasodilator agents|mesh-ancestor
110515705|NCT00779259|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110515706|NCT00779259|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110515707|NCT00779259|Purinergic Agents|purinergic agents|mesh-ancestor
110515708|NCT00779259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110515709|NCT00779259|Antimalarials|antimalarials|mesh-ancestor
110515710|NCT00779259|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110515711|NCT00779259|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110515712|NCT00779259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110515713|NCT00779259|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110515714|NCT00779259|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110515715|NCT00779259|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110515716|NCT00779259|Analgesics|analgesics|mesh-ancestor
110515717|NCT00779259|Sensory System Agents|sensory system agents|mesh-ancestor
110515718|NCT02746380|Adalimumab|adalimumab|mesh-list
110515719|NCT02746380|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110515721|NCT02746380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110515760|NCT00900445|Cortisone|cortisone|mesh-list
110515761|NCT00900445|Vincristine|vincristine|mesh-list
110515762|NCT00900445|Daunorubicin|daunorubicin|mesh-list
110515763|NCT00900445|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110515764|NCT00900445|Prednisolone phosphate|prednisolone phosphate|mesh-list
110515765|NCT00900445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110515766|NCT00900445|Glucocorticoids|glucocorticoids|mesh-ancestor
110515767|NCT00900445|Hormones|hormones|mesh-ancestor
110515768|NCT00900445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110515769|NCT00900445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110515770|NCT00900445|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110515771|NCT00900445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110515772|NCT00900445|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110515773|NCT00900445|Tubulin Modulators|tubulin modulators|mesh-ancestor
110515774|NCT00900445|Antimitotic Agents|antimitotic agents|mesh-ancestor
110515775|NCT00900445|Mitosis Modulators|mitosis modulators|mesh-ancestor
110515776|NCT00900445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110515777|NCT00900445|Antiemetics|antiemetics|mesh-ancestor
110515778|NCT00900445|Autonomic Agents|autonomic agents|mesh-ancestor
110515787|NCT03994419|Anesthetics|anesthetics|mesh-list
110515817|NCT04241276|Dermatologic Agents|dermatologic agents|mesh-ancestor
110515818|NCT00905047|Leucovorin|leucovorin|mesh-list
110515819|NCT00905047|Folic Acid|folic acid|mesh-list
110515820|NCT00905047|Tegafur|tegafur|mesh-list
110515821|NCT00905047|Levoleucovorin|levoleucovorin|mesh-list
110515822|NCT00905047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110515823|NCT00905047|Antimetabolites|antimetabolites|mesh-ancestor
110515824|NCT00905047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110515825|NCT00905047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110515826|NCT00905047|Antidotes|antidotes|mesh-ancestor
110515827|NCT00905047|Protective Agents|protective agents|mesh-ancestor
110515828|NCT00905047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110515829|NCT00905047|Vitamin B Complex|vitamin b complex|mesh-ancestor
110515830|NCT00905047|Vitamins|vitamins|mesh-ancestor
110515831|NCT00905047|Micronutrients|micronutrients|mesh-ancestor
110515832|NCT00905047|Hematinics|hematinics|mesh-ancestor
110515833|NCT04102449|Apremilast|apremilast|mesh-list
110515834|NCT04102449|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110515835|NCT04102449|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110515836|NCT04102449|Analgesics|analgesics|mesh-ancestor
110515837|NCT04102449|Sensory System Agents|sensory system agents|mesh-ancestor
110515838|NCT04102449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110515839|NCT04102449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110515840|NCT04102449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110515841|NCT04102449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110515842|NCT04102449|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
110515843|NCT04102449|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110515844|NCT04102449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110515845|NCT04102449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110515846|NCT02823236|Triamcinolone|triamcinolone|mesh-list
110515849|NCT02823236|Pirfenidone|pirfenidone|mesh-list
110515863|NCT02823236|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110515864|NCT02823236|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110515866|NCT02823236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110515868|NCT00633698|Nicotinic Acids|nicotinic acids|mesh-list
110515869|NCT00633698|Niacinamide|niacinamide|mesh-list
110515870|NCT00633698|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110515871|NCT00633698|Antimetabolites|antimetabolites|mesh-ancestor
110515872|NCT00633698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110515873|NCT00633698|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110515874|NCT00633698|Vasodilator Agents|vasodilator agents|mesh-ancestor
110515875|NCT00633698|Vitamin B Complex|vitamin b complex|mesh-ancestor
110515876|NCT00633698|Vitamins|vitamins|mesh-ancestor
110515877|NCT00633698|Micronutrients|micronutrients|mesh-ancestor
110515878|NCT00633698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110515879|NCT02825342|Citalopram|citalopram|mesh-list
110515880|NCT02825342|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
110515881|NCT02825342|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110515882|NCT02825342|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110515907|NCT02745912|Metformin|metformin|mesh-list
110515919|NCT02745912|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110515920|NCT02745912|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110515921|NCT02745912|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110593441|NCT00774969|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110515922|NCT02745912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110515923|NCT02745912|Dopamine Agents|dopamine agents|mesh-ancestor
110515924|NCT02745912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110515925|NCT02745912|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110515926|NCT02745912|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110515927|NCT02745912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110515928|NCT02825186|Dexamethasone|dexamethasone|mesh-list
110515929|NCT02825186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110515931|NCT02825186|Autonomic Agents|autonomic agents|mesh-ancestor
110515932|NCT02825186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110515933|NCT02825186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110515934|NCT02825186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110515935|NCT02825186|Glucocorticoids|glucocorticoids|mesh-ancestor
110515937|NCT02825186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110515938|NCT02825186|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110515939|NCT02825186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110515972|NCT02851433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110515973|NCT02851433|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110515974|NCT02851433|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110515975|NCT02851433|Anesthetics, General|anesthetics, general|mesh-ancestor
110515976|NCT02851433|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110515977|NCT02851433|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110515978|NCT05629806|Metformin|metformin|mesh-list
110515979|NCT05629806|Pioglitazone|pioglitazone|mesh-list
110515980|NCT05629806|Acarbose|acarbose|mesh-list
110515981|NCT05629806|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110515982|NCT05629806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110515983|NCT05629806|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
110515984|NCT05629806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110515985|NCT05629806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110515986|NCT02745756|Vaccines|vaccines|mesh-list
110515987|NCT02745756|Immunologic Factors|immunologic factors|mesh-ancestor
110515988|NCT02745756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110515989|NCT04242368|Fluticasone|fluticasone|mesh-list
110515990|NCT04242368|Xhance|xhance|mesh-list
110515991|NCT04242368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110515992|NCT04242368|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110515993|NCT04242368|Autonomic Agents|autonomic agents|mesh-ancestor
110515994|NCT04242368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110515995|NCT04242368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110515996|NCT04242368|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110516024|NCT00900913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110516025|NCT00900913|Sensory System Agents|sensory system agents|mesh-ancestor
110516026|NCT00900913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110516027|NCT04216836|Magnesium Oxide|magnesium oxide|mesh-list
110516028|NCT04216836|Antacids|antacids|mesh-ancestor
110516029|NCT04216836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110516030|NCT04216836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110516031|NCT00937157|Glatiramer Acetate|glatiramer acetate|mesh-list
110516032|NCT00937157|(T,G)-A-L|(t,g)-a-l|mesh-list
110163430|NCT00118690|Xhance|xhance|mesh-list
110516089|NCT05378867|Growth Inhibitors|growth inhibitors|mesh-ancestor
110516090|NCT02749656|Desoximetasone|desoximetasone|mesh-list
110516091|NCT02749656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110516092|NCT02749656|Glucocorticoids|glucocorticoids|mesh-ancestor
110516094|NCT02749656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110516095|NCT02749656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110516096|NCT00603317|Amoxicillin|amoxicillin|mesh-list
110516097|NCT00603317|Clavulanic Acids|clavulanic acids|mesh-list
110516098|NCT00603317|Clavulanic Acid|clavulanic acid|mesh-list
110516099|NCT00603317|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
110516100|NCT00603317|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110516101|NCT00603317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110516102|NCT00603317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110516103|NCT00603317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110593453|NCT00662025|Sunitinib|sunitinib|mesh-list
110516104|NCT00603317|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110516105|NCT02745522|Oxytocin|oxytocin|mesh-list
110516106|NCT02745522|Oxytocics|oxytocics|mesh-ancestor
110516107|NCT02745522|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110516146|NCT02821520|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110516147|NCT02821520|Dermatologic Agents|dermatologic agents|mesh-ancestor
110516148|NCT00604955|Paromomycin|paromomycin|mesh-list
110516149|NCT00604955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110516150|NCT00604955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110516151|NCT00604955|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110516152|NCT00604955|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110516153|NCT04266509|Rifampin|rifampin|mesh-list
110516154|NCT04266509|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110516155|NCT04266509|Antitubercular Agents|antitubercular agents|mesh-ancestor
110516156|NCT04266509|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110516157|NCT04266509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110516158|NCT04266509|Leprostatic Agents|leprostatic agents|mesh-ancestor
110516159|NCT04266509|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110516171|NCT02824874|Incretins|incretins|mesh-ancestor
110516207|NCT04267913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110516208|NCT04267913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110516209|NCT04267913|Tubulin Modulators|tubulin modulators|mesh-ancestor
110516210|NCT04267913|Antimitotic Agents|antimitotic agents|mesh-ancestor
110516211|NCT04267913|Mitosis Modulators|mitosis modulators|mesh-ancestor
110516213|NCT04216758|Gemcitabine|gemcitabine|mesh-list
110516214|NCT04216758|Tegafur|tegafur|mesh-list
110516215|NCT04216758|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110516216|NCT04216758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110516217|NCT04216758|Tubulin Modulators|tubulin modulators|mesh-ancestor
110516218|NCT04216758|Antimitotic Agents|antimitotic agents|mesh-ancestor
110516219|NCT04216758|Mitosis Modulators|mitosis modulators|mesh-ancestor
110516220|NCT04216758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110516221|NCT04216758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110516222|NCT04216758|Antimetabolites|antimetabolites|mesh-ancestor
110516223|NCT00606437|Fludarabine|fludarabine|mesh-list
110516224|NCT00606437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110516225|NCT02538211|Vaccines|vaccines|mesh-list
110516226|NCT02538211|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110516227|NCT02538211|Immunologic Factors|immunologic factors|mesh-ancestor
110516228|NCT02538211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110516229|NCT02821676|Anesthetics|anesthetics|mesh-list
110516230|NCT02821676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110516231|NCT02821676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110516232|NCT02745054|Anticoagulants|anticoagulants|mesh-list
110516233|NCT00908089|Sulfasalazine|sulfasalazine|mesh-list
110516234|NCT00908089|Hydroxychloroquine|hydroxychloroquine|mesh-list
110516235|NCT00908089|Prednisolone|prednisolone|mesh-list
110516236|NCT00908089|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110516254|NCT00908089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110516255|NCT00908089|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110516256|NCT00908089|Protective Agents|protective agents|mesh-ancestor
110516257|NCT00908089|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110516258|NCT00908089|Dermatologic Agents|dermatologic agents|mesh-ancestor
110516259|NCT00908089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110516260|NCT00908089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110516261|NCT00908089|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110516262|NCT00908089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110516264|NCT00908089|Sensory System Agents|sensory system agents|mesh-ancestor
110516265|NCT00908089|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110516266|NCT00908089|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110516267|NCT00908089|Antimalarials|antimalarials|mesh-ancestor
110516268|NCT00908089|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110516269|NCT00908089|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110516270|NCT00908089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110516271|NCT00908089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110516272|NCT04758416|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110516273|NCT04758416|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110516310|NCT00606515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110516311|NCT00908323|Vaccines|vaccines|mesh-list
110516312|NCT00908323|Immunologic Factors|immunologic factors|mesh-ancestor
110516313|NCT00908323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110516314|NCT02749032|Metformin|metformin|mesh-list
110516315|NCT02749032|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110516316|NCT02749032|Vildagliptin|vildagliptin|mesh-list
110516317|NCT02749032|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110516318|NCT02749032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110516319|NCT02749032|Incretins|incretins|mesh-ancestor
110516320|NCT02749032|Hormones|hormones|mesh-ancestor
110516321|NCT02749032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110516322|NCT02749032|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110516323|NCT02749032|Protease Inhibitors|protease inhibitors|mesh-ancestor
110516324|NCT02749032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110516325|NCT02749032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110516369|NCT00605111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110516370|NCT04240496|Clozapine|clozapine|mesh-list
110516371|NCT04240496|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110516372|NCT04240496|Serotonin Agents|serotonin agents|mesh-ancestor
110516373|NCT04240496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110516374|NCT04240496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110312061|NCT00324831|Glucocorticoids|glucocorticoids|mesh-ancestor
110516375|NCT04240496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110516376|NCT04240496|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110516377|NCT04240496|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110516378|NCT04240496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110516379|NCT04240496|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110516380|NCT04240496|GABA Antagonists|gaba antagonists|mesh-ancestor
110516382|NCT00909337|Bosentan|bosentan|mesh-list
110516383|NCT00909337|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110516384|NCT00909337|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
110516385|NCT00909337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110516427|NCT00931645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110516429|NCT00931645|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110516430|NCT00931645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110516431|NCT00931645|Antiemetics|antiemetics|mesh-ancestor
110516432|NCT00931645|Autonomic Agents|autonomic agents|mesh-ancestor
110516433|NCT00931645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110516434|NCT00931645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110516435|NCT00931645|Glucocorticoids|glucocorticoids|mesh-ancestor
110516436|NCT00931645|Hormones|hormones|mesh-ancestor
110516437|NCT00931645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110516438|NCT00931645|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110516439|NCT00931645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110516440|NCT00931645|Antimetabolites|antimetabolites|mesh-ancestor
110516441|NCT00931645|Antiviral Agents|antiviral agents|mesh-ancestor
110516442|NCT00931645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110516489|NCT05658692|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110516490|NCT05658692|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110516491|NCT05658692|GABA Modulators|gaba modulators|mesh-ancestor
110163886|NCT00122512|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110516492|NCT05658692|GABA Agents|gaba agents|mesh-ancestor
110516493|NCT05658692|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110516494|NCT05658692|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110516496|NCT05658692|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110516497|NCT05658692|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110516498|NCT05658692|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110516499|NCT05658692|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110516500|NCT05658692|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110516501|NCT05658692|Respiratory System Agents|respiratory system agents|mesh-ancestor
110516502|NCT05658692|Mydriatics|mydriatics|mesh-ancestor
110516503|NCT05658692|Sympathomimetics|sympathomimetics|mesh-ancestor
110516504|NCT05658692|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110516505|NCT05658692|Anticonvulsants|anticonvulsants|mesh-ancestor
110516506|NCT05658692|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110516507|NCT05658692|Vasodilator Agents|vasodilator agents|mesh-ancestor
110516508|NCT05658692|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110516544|NCT00927511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110516545|NCT00927511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110516547|NCT03211338|Mitogens|mitogens|mesh-list
110516548|NCT03211338|Progestins|progestins|mesh-ancestor
110516549|NCT03211338|Hormones|hormones|mesh-ancestor
110516550|NCT03211338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110516551|NCT03211338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110516552|NCT03211338|Mitosis Modulators|mitosis modulators|mesh-ancestor
110516553|NCT03211338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110516554|NCT00936611|Panobinostat|panobinostat|mesh-list
110516555|NCT00936611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110516556|NCT00936611|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110516557|NCT00936611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110516558|NCT00936611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110516559|NCT02744196|Methotrexate|methotrexate|mesh-list
110516560|NCT02744196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110516561|NCT02744196|Immunologic Factors|immunologic factors|mesh-ancestor
110516562|NCT02744196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110516563|NCT02744196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110516597|NCT02748330|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110516598|NCT02748330|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110516600|NCT02748330|Sensory System Agents|sensory system agents|mesh-ancestor
110516601|NCT02748330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110516602|NCT02748330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110516603|NCT02748330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110516604|NCT02748330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110516605|NCT02748330|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110516606|NCT02748330|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110516607|NCT02748330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110516608|NCT02748330|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110516609|NCT02748330|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110516610|NCT02748330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110516611|NCT02748330|Antipyretics|antipyretics|mesh-ancestor
110516612|NCT02748330|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110516613|NCT02748330|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110516614|NCT02748330|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110516615|NCT02748330|Purinergic Agents|purinergic agents|mesh-ancestor
110516616|NCT02748330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110516617|NCT05379569|Cyclophosphamide|cyclophosphamide|mesh-list
110516618|NCT05379569|Fludarabine|fludarabine|mesh-list
110516648|NCT00936221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110516649|NCT00776919|Clindamycin|clindamycin|mesh-list
110516650|NCT00776919|Clindamycin palmitate|clindamycin palmitate|mesh-list
110516651|NCT00776919|Clindamycin phosphate|clindamycin phosphate|mesh-list
110516652|NCT00776919|Benzoyl Peroxide|benzoyl peroxide|mesh-list
110516653|NCT00776919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110516654|NCT00776919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110516655|NCT00776919|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110516656|NCT00776919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110516658|NCT00776919|Dermatologic Agents|dermatologic agents|mesh-ancestor
110516715|NCT05382923|Antioxidants|antioxidants|mesh-ancestor
110516716|NCT05382923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110516717|NCT05382923|Protective Agents|protective agents|mesh-ancestor
110516718|NCT05382923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110516719|NCT05382923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110516720|NCT02743572|Iron|iron|mesh-list
110516721|NCT02743572|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
110516722|NCT02743572|Trace Elements|trace elements|mesh-ancestor
110516723|NCT02743572|Micronutrients|micronutrients|mesh-ancestor
110516724|NCT02743572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110516725|NCT02743572|Hematinics|hematinics|mesh-ancestor
110516726|NCT00775593|Sirolimus|sirolimus|mesh-list
110516727|NCT00775593|Temsirolimus|temsirolimus|mesh-list
110516777|NCT02743260|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110516778|NCT02743260|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110516779|NCT02743260|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110516781|NCT02743260|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110516782|NCT02819648|Prednisolone|prednisolone|mesh-list
110516783|NCT02819648|Glucocorticoids|glucocorticoids|mesh-list
110516784|NCT02819648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110516785|NCT02819648|Hormones|hormones|mesh-ancestor
110516786|NCT02819648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110516787|NCT02819648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110164180|NCT00128323|Nystatin|nystatin|mesh-list
110516841|NCT02743104|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110516842|NCT02743104|Anesthetics, General|anesthetics, general|mesh-ancestor
110516844|NCT02743104|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110516845|NCT02743104|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110516846|NCT02743104|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110516847|NCT02743104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110516848|NCT02743104|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110516849|NCT02743104|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110516850|NCT02743104|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110516851|NCT02743104|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110516852|NCT02743104|GABA Modulators|gaba modulators|mesh-ancestor
110516853|NCT02743104|GABA Agents|gaba agents|mesh-ancestor
110516854|NCT02743104|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110516855|NCT02743104|Autonomic Agents|autonomic agents|mesh-ancestor
110516856|NCT02743104|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110516857|NCT02743104|Respiratory System Agents|respiratory system agents|mesh-ancestor
110516858|NCT02743104|Mydriatics|mydriatics|mesh-ancestor
110516859|NCT02743104|Parasympatholytics|parasympatholytics|mesh-ancestor
110516860|NCT02743104|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110516861|NCT02743104|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110516862|NCT02743104|Cholinergic Agents|cholinergic agents|mesh-ancestor
110516863|NCT00775203|Trazodone|trazodone|mesh-list
110516864|NCT00775203|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110516865|NCT00775203|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110516866|NCT00775203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110164253|NCT00018850|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110516867|NCT00775203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110516868|NCT00775203|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110516869|NCT00775203|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110516870|NCT00775203|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110516871|NCT00775203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110516872|NCT00775203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110516883|NCT02747316|Iron|iron|mesh-list
110516884|NCT02747316|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110516885|NCT02747316|Trace Elements|trace elements|mesh-ancestor
110516886|NCT02747316|Micronutrients|micronutrients|mesh-ancestor
110516887|NCT02747316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110516888|NCT05648708|Bupivacaine|bupivacaine|mesh-list
110516889|NCT05648708|Prilocaine|prilocaine|mesh-list
110516890|NCT05648708|Anesthetics, Local|anesthetics, local|mesh-ancestor
110516891|NCT05648708|Anesthetics|anesthetics|mesh-ancestor
110516892|NCT05648708|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110516893|NCT05648708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110516894|NCT05648708|Sensory System Agents|sensory system agents|mesh-ancestor
110516895|NCT05648708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110516948|NCT02741232|Anesthetics, Local|anesthetics, local|mesh-ancestor
110516949|NCT02741232|Anesthetics|anesthetics|mesh-ancestor
110516950|NCT02741232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110516951|NCT02741232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110516952|NCT02741232|Sensory System Agents|sensory system agents|mesh-ancestor
110516953|NCT02741232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110516954|NCT02741232|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110516955|NCT02741232|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110516956|NCT02741232|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110516957|NCT02741232|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110516958|NCT02741232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110516959|NCT02741232|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110516960|NCT02741232|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110516961|NCT02741232|Adrenergic Agents|adrenergic agents|mesh-ancestor
110516962|NCT02741232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110516963|NCT02741232|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110516964|NCT02741232|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110516965|NCT02741232|Autonomic Agents|autonomic agents|mesh-ancestor
110516971|NCT04239014|Olaparib|olaparib|mesh-list
110517002|NCT04342026|Endocrine Disruptors|endocrine disruptors|mesh-list
110517003|NCT04342026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110517004|NCT02819180|Vaccines|vaccines|mesh-list
110517005|NCT02819180|Immunologic Factors|immunologic factors|mesh-ancestor
110517006|NCT02819180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110517007|NCT04661930|Fenofibrate|fenofibrate|mesh-list
110517008|NCT04661930|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110517009|NCT04661930|Antimetabolites|antimetabolites|mesh-ancestor
110517010|NCT04661930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110517011|NCT04661930|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110517012|NCT02815046|Botulinum Toxins|botulinum toxins|mesh-list
110517013|NCT02815046|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110517014|NCT02815046|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110517015|NCT02815046|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110517016|NCT02815046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110517017|NCT02815046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110517018|NCT02815046|Cholinergic Agents|cholinergic agents|mesh-ancestor
110517059|NCT00931957|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110517060|NCT00931957|Analgesics|analgesics|mesh-ancestor
110517061|NCT00931957|Sensory System Agents|sensory system agents|mesh-ancestor
110517062|NCT02731950|Magnesium Sulfate|magnesium sulfate|mesh-list
110517063|NCT02731950|Bupivacaine|bupivacaine|mesh-list
110593547|NCT00440947|Lamivudine|lamivudine|mesh-list
110517064|NCT02731950|Anesthetics, Local|anesthetics, local|mesh-ancestor
110517065|NCT02731950|Anesthetics|anesthetics|mesh-ancestor
110517066|NCT02731950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110517067|NCT02731950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110517068|NCT02731950|Sensory System Agents|sensory system agents|mesh-ancestor
110517069|NCT02731950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110517070|NCT02731950|Analgesics|analgesics|mesh-ancestor
110517071|NCT02731950|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110517072|NCT02731950|Anticonvulsants|anticonvulsants|mesh-ancestor
110517073|NCT02731950|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110517074|NCT02731950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110517077|NCT02731950|Tocolytic Agents|tocolytic agents|mesh-ancestor
110517118|NCT02741154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110517119|NCT02741154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110517120|NCT02741154|Luteolytic Agents|luteolytic agents|mesh-ancestor
110517121|NCT02741154|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110517122|NCT02741154|Contraceptive Agents|contraceptive agents|mesh-ancestor
110517123|NCT02741154|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110517124|NCT02741154|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110517125|NCT02741154|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110517126|NCT04287816|Antithrombin III|antithrombin iii|mesh-list
110517127|NCT04287816|Antithrombins|antithrombins|mesh-list
110517128|NCT04287816|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110517129|NCT04287816|Protease Inhibitors|protease inhibitors|mesh-ancestor
110517130|NCT04287816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110517131|NCT04287816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110517132|NCT04287816|Anticoagulants|anticoagulants|mesh-ancestor
110517176|NCT05303909|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110517177|NCT05303909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110517178|NCT05303909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110517180|NCT04306692|Clomiphene|clomiphene|mesh-list
110517181|NCT04306692|Enclomiphene|enclomiphene|mesh-list
110517182|NCT04306692|Zuclomiphene|zuclomiphene|mesh-list
110517183|NCT04306692|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110517184|NCT04306692|Hormone Antagonists|hormone antagonists|mesh-ancestor
110517185|NCT04306692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110517186|NCT04306692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110517187|NCT04306692|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110517188|NCT04306692|Fertility Agents|fertility agents|mesh-ancestor
110517189|NCT04306692|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110517190|NCT04306692|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110517191|NCT04306692|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110517234|NCT00928837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110517235|NCT00928837|Gout Suppressants|gout suppressants|mesh-ancestor
110517236|NCT00928837|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110517237|NCT00928837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110517238|NCT00928837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110517239|NCT02730936|Anti-Infective Agents|anti-infective agents|mesh-list
110517240|NCT02730936|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110164642|NCT00020761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110517243|NCT00925093|Teicoplanin|teicoplanin|mesh-list
110517244|NCT00925093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110517245|NCT00925093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110517246|NCT00925093|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110517297|NCT02814500|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110517299|NCT00939341|Budesonide|budesonide|mesh-list
110517300|NCT00939341|Formoterol Fumarate|formoterol fumarate|mesh-list
110517301|NCT00939341|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
110517302|NCT00939341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110517303|NCT00939341|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110517310|NCT00939341|Hormones|hormones|mesh-ancestor
110517364|NCT02739672|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110517365|NCT02739672|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110517366|NCT02739672|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110517367|NCT00932971|Tenofovir|tenofovir|mesh-list
110517368|NCT00932971|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110517369|NCT00932971|Interferon-alpha|interferon-alpha|mesh-list
110517370|NCT00932971|Interferon alpha-2|interferon alpha-2|mesh-list
110517371|NCT00932971|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
110517372|NCT00932971|Antiviral Agents|antiviral agents|mesh-ancestor
110517373|NCT00932971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110517374|NCT00932971|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110517375|NCT00932971|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110517376|NCT00932971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110517377|NCT00932971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110517378|NCT00932971|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110517379|NCT00932971|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110517380|NCT00932971|Immunologic Factors|immunologic factors|mesh-ancestor
110517381|NCT00932971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110517382|NCT00932971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110517383|NCT05382143|Atosiban|atosiban|mesh-list
110517384|NCT05382143|Hormone Antagonists|hormone antagonists|mesh-ancestor
110517385|NCT05382143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110517386|NCT05382143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110517387|NCT05382143|Tocolytic Agents|tocolytic agents|mesh-ancestor
110517397|NCT05788393|Lidocaine|lidocaine|mesh-list
110517412|NCT05788393|Analgesics|analgesics|mesh-ancestor
110517413|NCT05788393|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110517414|NCT05788393|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110517415|NCT05788393|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110517416|NCT05788393|Adrenergic Agents|adrenergic agents|mesh-ancestor
110517417|NCT05788393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110517418|NCT05788159|Lacosamide|lacosamide|mesh-list
110517419|NCT05788159|Anticonvulsants|anticonvulsants|mesh-ancestor
110517420|NCT05788159|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110517421|NCT05788159|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110517422|NCT05788159|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110517423|NCT05788159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110517424|NCT05788094|Chloroquine|chloroquine|mesh-list
110517477|NCT05787535|Immunologic Factors|immunologic factors|mesh-ancestor
110517478|NCT05787535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110517479|NCT05787535|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110517480|NCT05787535|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110517481|NCT05787535|Alkylating Agents|alkylating agents|mesh-ancestor
110517482|NCT05787535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110517483|NCT05787535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110517484|NCT05787535|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110517486|NCT05787509|Progestins|progestins|mesh-ancestor
110517487|NCT05787509|Hormones|hormones|mesh-ancestor
110517489|NCT05787509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110517541|NCT05785897|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
110517542|NCT05785897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110517543|NCT05785897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110517544|NCT05785897|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110517545|NCT05785897|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110517546|NCT05785897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110517547|NCT05785897|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110517548|NCT05785897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110517549|NCT05785897|Antifungal Agents|antifungal agents|mesh-ancestor
110517550|NCT05785897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110517551|NCT05785897|Immunologic Factors|immunologic factors|mesh-ancestor
110517552|NCT05785897|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110517553|NCT05785897|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110517554|NCT05785897|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110517555|NCT05785897|Purinergic Agents|purinergic agents|mesh-ancestor
110517556|NCT05785897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110312075|NCT00292253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110517559|NCT05784688|Pembrolizumab|pembrolizumab|mesh-list
110517560|NCT05784688|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110517561|NCT05784688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110517562|NCT05784688|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110517563|NCT05784688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110517564|NCT05776459|Prednisolone|prednisolone|mesh-list
110517587|NCT05739136|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110517588|NCT05739136|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110517589|NCT05739136|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110517590|NCT05739136|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110517591|NCT05739136|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110517592|NCT05739136|Androgen Antagonists|androgen antagonists|mesh-ancestor
110517593|NCT05739136|Hormone Antagonists|hormone antagonists|mesh-ancestor
110517594|NCT05737030|N-Methylaspartate|n-methylaspartate|mesh-list
110517595|NCT05737030|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
110517596|NCT05737030|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110517597|NCT05737030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110517598|NCT05737030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110517599|NCT05737030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110517600|NCT05716295|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
110517601|NCT05716295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110517602|NCT05716295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110517603|NCT05716295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110517642|NCT05654298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110517643|NCT05649293|Vitamin B 6|vitamin b 6|mesh-list
110517644|NCT05649293|Pyridoxal|pyridoxal|mesh-list
110517645|NCT05649293|Pyridoxine|pyridoxine|mesh-list
110517646|NCT05649293|Vitamins|vitamins|mesh-ancestor
110517647|NCT05649293|Micronutrients|micronutrients|mesh-ancestor
110517648|NCT05649293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110517649|NCT05649293|Vitamin B Complex|vitamin b complex|mesh-ancestor
110517650|NCT05639972|Aldesleukin|aldesleukin|mesh-list
110517651|NCT05639972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110517708|NCT05503875|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110517709|NCT05503875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110517710|NCT05503875|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110517711|NCT05487950|Rivaroxaban|rivaroxaban|mesh-list
110517712|NCT05487950|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110517713|NCT05487950|Antithrombins|antithrombins|mesh-ancestor
110517714|NCT05487950|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110517715|NCT05487950|Protease Inhibitors|protease inhibitors|mesh-ancestor
110517716|NCT05487950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110517717|NCT05487950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110517718|NCT05487950|Anticoagulants|anticoagulants|mesh-ancestor
110517723|NCT05452512|Vitamin D|vitamin d|mesh-list
110517724|NCT05452512|Vitamins|vitamins|mesh-list
110517725|NCT05452512|Micronutrients|micronutrients|mesh-ancestor
110517726|NCT05452512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110517727|NCT05452512|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110517728|NCT05432089|Oxytocin|oxytocin|mesh-list
110517729|NCT05432089|Oxytocics|oxytocics|mesh-ancestor
110517730|NCT05432089|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110517765|NCT05360264|Antimetabolites|antimetabolites|mesh-ancestor
110517766|NCT05360264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110517767|NCT05360264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110517768|NCT05360264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110517769|NCT05321524|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
110517770|NCT05321524|Cathartics|cathartics|mesh-ancestor
110517771|NCT05321524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110517772|NCT05280496|Metformin|metformin|mesh-list
110517773|NCT05280496|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110517774|NCT05280496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110517775|NCT05280457|Nivolumab|nivolumab|mesh-list
110517777|NCT05280457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110517831|NCT05136560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110517832|NCT05125016|Cemiplimab|cemiplimab|mesh-list
110517833|NCT05125016|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110517834|NCT05125016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110517835|NCT05084586|Epirubicin|epirubicin|mesh-list
110517836|NCT05084586|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110517837|NCT05084586|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110517838|NCT05084586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110517839|NCT05084586|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110517840|NCT05084586|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110517896|NCT04850911|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110517897|NCT04850911|Anesthetics, General|anesthetics, general|mesh-ancestor
110517898|NCT04850911|Anesthetics|anesthetics|mesh-ancestor
110517899|NCT04850911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110517900|NCT04850911|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110517901|NCT04850911|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110517902|NCT04850911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110517903|NCT04850911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110517904|NCT04836533|Antidepressive Agents|antidepressive agents|mesh-list
110517905|NCT04836533|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110517906|NCT04827056|Ethanol|ethanol|mesh-list
110517907|NCT04827056|Dexmedetomidine|dexmedetomidine|mesh-list
110517908|NCT04827056|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110517909|NCT04827056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110517910|NCT04827056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110517911|NCT04827056|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110517912|NCT04827056|Analgesics|analgesics|mesh-ancestor
110517913|NCT04827056|Sensory System Agents|sensory system agents|mesh-ancestor
110517914|NCT04827056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110517915|NCT04827056|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110517916|NCT04827056|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110517948|NCT04642352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110517949|NCT04642352|Glucocorticoids|glucocorticoids|mesh-ancestor
110517950|NCT04642352|Hormones|hormones|mesh-ancestor
110517951|NCT04642352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110517952|NCT04642352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110517953|NCT04642352|Immunologic Factors|immunologic factors|mesh-ancestor
110517954|NCT04637282|Gemfibrozil|gemfibrozil|mesh-list
110517955|NCT04637282|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110517956|NCT04637282|Antimetabolites|antimetabolites|mesh-ancestor
110517957|NCT04637282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110517958|NCT04637282|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110517959|NCT04637282|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
110517960|NCT04637282|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110517961|NCT04637282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110517962|NCT04598477|Prednisone|prednisone|mesh-list
110517963|NCT04598477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110517964|NCT04598477|Glucocorticoids|glucocorticoids|mesh-ancestor
110517965|NCT04598477|Hormones|hormones|mesh-ancestor
110517966|NCT04598477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110517967|NCT04598477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110517968|NCT04598477|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110517969|NCT04598477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110517970|NCT04594408|Epinephrine|epinephrine|mesh-list
110517971|NCT04594408|Racepinephrine|racepinephrine|mesh-list
110517972|NCT04594408|Tranexamic Acid|tranexamic acid|mesh-list
110517973|NCT04594408|Epinephryl borate|epinephryl borate|mesh-list
110517974|NCT04594408|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110517997|NCT04557215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110517998|NCT04557215|Expectorants|expectorants|mesh-ancestor
110517999|NCT04557215|Respiratory System Agents|respiratory system agents|mesh-ancestor
110518000|NCT04557215|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110518001|NCT04557215|Antioxidants|antioxidants|mesh-ancestor
110518002|NCT04557215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110518003|NCT04557215|Protective Agents|protective agents|mesh-ancestor
110518004|NCT04557215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110518005|NCT04557215|Antidotes|antidotes|mesh-ancestor
110518006|NCT04557215|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110518007|NCT04557215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110518008|NCT04423627|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110518009|NCT04423627|Clonidine|clonidine|mesh-list
110518058|NCT04339062|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110518059|NCT04339062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110518060|NCT04339062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110165471|NCT00023920|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110518062|NCT04339062|Immunologic Factors|immunologic factors|mesh-ancestor
110518063|NCT04339062|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110518064|NCT04339062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110518065|NCT04339062|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110518066|NCT04339062|Antifungal Agents|antifungal agents|mesh-ancestor
110518067|NCT04339062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110518068|NCT04303195|Metopimazine|metopimazine|mesh-list
110518069|NCT04303195|Antiemetics|antiemetics|mesh-ancestor
110593708|NCT02430194|Interferons|interferons|mesh-list
110518070|NCT04303195|Autonomic Agents|autonomic agents|mesh-ancestor
110518071|NCT04303195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110518072|NCT04303195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110518073|NCT04303195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110518074|NCT04292470|Amitriptyline|amitriptyline|mesh-list
110518075|NCT04292470|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110518076|NCT04292470|Antidepressive Agents|antidepressive agents|mesh-ancestor
110518077|NCT04292470|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110518078|NCT04292470|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110518079|NCT04292470|Analgesics|analgesics|mesh-ancestor
110518080|NCT04292470|Sensory System Agents|sensory system agents|mesh-ancestor
110518081|NCT04292470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110518082|NCT04292470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110518083|NCT04292470|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110518084|NCT04292470|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110518085|NCT04292470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110518086|NCT04292470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110518102|NCT04074967|Ipilimumab|ipilimumab|mesh-list
110518103|NCT04074967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110518104|NCT04074967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110518105|NCT04074967|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110518106|NCT04074967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110518107|NCT04073797|Colchicine|colchicine|mesh-list
110518108|NCT04073797|Gout Suppressants|gout suppressants|mesh-ancestor
110518109|NCT04073797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110518110|NCT04073797|Tubulin Modulators|tubulin modulators|mesh-ancestor
110518111|NCT04073797|Antimitotic Agents|antimitotic agents|mesh-ancestor
110518112|NCT04073797|Mitosis Modulators|mitosis modulators|mesh-ancestor
110518113|NCT04073797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110518114|NCT04073797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110518115|NCT04060017|Calcium, Dietary|calcium, dietary|mesh-list
110518116|NCT04060017|Leucovorin|leucovorin|mesh-list
110518117|NCT04060017|Calcium|calcium|mesh-list
110518118|NCT04060017|Levoleucovorin|levoleucovorin|mesh-list
110518122|NCT04060017|Antidotes|antidotes|mesh-ancestor
110518161|NCT03988933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110518162|NCT03988933|Leprostatic Agents|leprostatic agents|mesh-ancestor
110518163|NCT03988933|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110518164|NCT03988933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110518165|NCT03988933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110518166|NCT03988933|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110518167|NCT03988933|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110518168|NCT03988933|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110518169|NCT03988933|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110518170|NCT03988933|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110518171|NCT03988933|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110518172|NCT03958565|Zoledronic Acid|zoledronic acid|mesh-list
110518173|NCT03958565|Denosumab|denosumab|mesh-list
110518174|NCT03958565|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110518218|NCT03644667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110518219|NCT03644667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110518220|NCT03644667|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110518221|NCT03644667|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110518222|NCT03644667|Antitubercular Agents|antitubercular agents|mesh-ancestor
110518223|NCT03644667|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110518224|NCT03644667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110518226|NCT03644667|Autonomic Agents|autonomic agents|mesh-ancestor
110518227|NCT03644667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110518228|NCT03644667|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110518229|NCT03644667|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110518230|NCT03644667|Protective Agents|protective agents|mesh-ancestor
110518231|NCT03330106|Paclitaxel|paclitaxel|mesh-list
110518232|NCT03330106|Docetaxel|docetaxel|mesh-list
110518233|NCT03330106|Carboplatin|carboplatin|mesh-list
110518234|NCT03330106|Pevonedistat|pevonedistat|mesh-list
110518236|NCT03330106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110518280|NCT03070886|Fertility Agents|fertility agents|mesh-ancestor
110518281|NCT03070886|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110518282|NCT03070886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110518283|NCT03070886|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110518284|NCT03070886|Androgen Antagonists|androgen antagonists|mesh-ancestor
110518286|NCT03070886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110518287|NCT02987257|Cyclosporine|cyclosporine|mesh-list
110518288|NCT02987257|Etanercept|etanercept|mesh-list
110518289|NCT02987257|Cyclosporins|cyclosporins|mesh-list
110518290|NCT02987257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110518291|NCT02987257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110518292|NCT02987257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110518293|NCT02987257|Immunologic Factors|immunologic factors|mesh-ancestor
110518294|NCT02987257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110518295|NCT02987257|Antifungal Agents|antifungal agents|mesh-ancestor
110518296|NCT02987257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110518297|NCT02987257|Dermatologic Agents|dermatologic agents|mesh-ancestor
110518298|NCT02987257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110518299|NCT02987257|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110518337|NCT02772003|Growth Inhibitors|growth inhibitors|mesh-ancestor
110518338|NCT02772003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110518339|NCT02619682|Lenalidomide|lenalidomide|mesh-list
110518340|NCT02619682|Ixazomib|ixazomib|mesh-list
110518341|NCT02619682|Glycine|glycine|mesh-list
110518342|NCT02619682|Immunologic Factors|immunologic factors|mesh-ancestor
110518343|NCT02619682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110518344|NCT02619682|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110518345|NCT02619682|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110518346|NCT02619682|Growth Substances|growth substances|mesh-ancestor
110518347|NCT02619682|Growth Inhibitors|growth inhibitors|mesh-ancestor
110518348|NCT02619682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110518349|NCT02619682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110518350|NCT02619682|Protease Inhibitors|protease inhibitors|mesh-ancestor
110518351|NCT02619682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110518352|NCT02619682|Glycine Agents|glycine agents|mesh-ancestor
110518353|NCT02619682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110518398|NCT02340169|Desoximetasone|desoximetasone|mesh-list
110518399|NCT02340169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110518400|NCT02340169|Glucocorticoids|glucocorticoids|mesh-ancestor
110518401|NCT02340169|Hormones|hormones|mesh-ancestor
110518402|NCT02340169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110518403|NCT02340169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110518404|NCT02337829|Acalabrutinib|acalabrutinib|mesh-list
110518405|NCT02337829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110518406|NCT02257528|Nivolumab|nivolumab|mesh-list
110518407|NCT02257528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110518408|NCT02257528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110518409|NCT02257528|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110518410|NCT02257528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110518459|NCT01515137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110518460|NCT01515137|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110518461|NCT01393509|9H-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-N-(1-methylethyl)-|9h-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-n-(1-methylethyl)-|mesh-list
110518462|NCT01393509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110518463|NCT01375829|Sirolimus|sirolimus|mesh-list
110518464|NCT01375829|Temsirolimus|temsirolimus|mesh-list
110518465|NCT01375829|Epothilone B|epothilone b|mesh-list
110518466|NCT01375829|MTOR Inhibitors|mtor inhibitors|mesh-list
110518467|NCT01375829|Epothilones|epothilones|mesh-list
110518468|NCT01375829|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110518469|NCT01375829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110518470|NCT01375829|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110518471|NCT01375829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110518472|NCT01375829|Antifungal Agents|antifungal agents|mesh-ancestor
110518520|NCT02808104|Mazindol|mazindol|mesh-list
110518521|NCT02808104|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110518522|NCT02808104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110518523|NCT02808104|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110518524|NCT02808104|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110518525|NCT02808104|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110518526|NCT02808104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110518527|NCT02808104|Adrenergic Agents|adrenergic agents|mesh-ancestor
110518528|NCT02808104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110518529|NCT02808104|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110518530|NCT02808104|Dopamine Agents|dopamine agents|mesh-ancestor
110518531|NCT05165771|Tofacitinib|tofacitinib|mesh-list
110518532|NCT05165771|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
110518533|NCT05165771|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110518534|NCT05165771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110518535|NCT05165771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110518577|NCT02813486|Vaccines|vaccines|mesh-list
110518578|NCT02813486|Immunologic Factors|immunologic factors|mesh-ancestor
110518579|NCT02813486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110518580|NCT02739516|Letrozole|letrozole|mesh-list
110518581|NCT02739516|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
110518582|NCT02739516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110518583|NCT02739516|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110518584|NCT02739516|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110518585|NCT02739516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110518587|NCT02739516|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110518644|NCT04173962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110518645|NCT04173962|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110518646|NCT04173962|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110518647|NCT04173962|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110518648|NCT04173962|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110518649|NCT04173962|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110518650|NCT04173962|GABA Modulators|gaba modulators|mesh-ancestor
110518651|NCT04173962|GABA Agents|gaba agents|mesh-ancestor
110518652|NCT00772005|Modafinil|modafinil|mesh-list
110518653|NCT00772005|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110518654|NCT00772005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110518655|NCT00772005|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
110166085|NCT00026260|Semaxinib|semaxinib|mesh-list
110518705|NCT02812940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110518706|NCT02812940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110518707|NCT02812940|Immunologic Factors|immunologic factors|mesh-ancestor
110518708|NCT02812940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110518709|NCT02812940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110518710|NCT00933439|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110518711|NCT00933439|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110518712|NCT00933439|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110518713|NCT00933439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110518714|NCT00933439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110518715|NCT00933439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110518716|NCT00933439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110518717|NCT00933439|Analgesics|analgesics|mesh-ancestor
110518718|NCT00933439|Sensory System Agents|sensory system agents|mesh-ancestor
110518719|NCT00933439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110518720|NCT00933439|Antidepressive Agents|antidepressive agents|mesh-ancestor
110518721|NCT00933439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110518722|NCT00933439|Dopamine Agents|dopamine agents|mesh-ancestor
110518723|NCT00608075|Lithium Carbonate|lithium carbonate|mesh-list
110518724|NCT00608075|Antidepressive Agents|antidepressive agents|mesh-ancestor
110518725|NCT00608075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110518726|NCT00608075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110518754|NCT02729376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110518755|NCT00933517|Cyclophosphamide|cyclophosphamide|mesh-list
110518756|NCT00933517|Docetaxel|docetaxel|mesh-list
110518757|NCT00933517|Panitumumab|panitumumab|mesh-list
110518758|NCT00933517|Epirubicin|epirubicin|mesh-list
110518759|NCT00933517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110518760|NCT00933517|Immunologic Factors|immunologic factors|mesh-ancestor
110518761|NCT00933517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110518762|NCT00933517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110518763|NCT00933517|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110518764|NCT00933517|Alkylating Agents|alkylating agents|mesh-ancestor
110518765|NCT00933517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110518766|NCT00933517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110518767|NCT00933517|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110518768|NCT00933517|Tubulin Modulators|tubulin modulators|mesh-ancestor
110518769|NCT00933517|Antimitotic Agents|antimitotic agents|mesh-ancestor
110518770|NCT00933517|Mitosis Modulators|mitosis modulators|mesh-ancestor
110518771|NCT00933517|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110518772|NCT00933517|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110518773|NCT00933517|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110518774|NCT00933517|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110518775|NCT00933517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110518776|NCT00926341|Pioglitazone|pioglitazone|mesh-list
110518784|NCT00926419|Vaccines|vaccines|mesh-list
110518804|NCT02739204|Analgesics|analgesics|mesh-ancestor
110518805|NCT02739204|Sensory System Agents|sensory system agents|mesh-ancestor
110518806|NCT02739204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110518807|NCT02739204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110518808|NCT02739204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110518809|NCT02739204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110518810|NCT02739204|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110518811|NCT02739204|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110518812|NCT02739204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110518813|NCT02739204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110518814|NCT00927485|Curcumin|curcumin|mesh-list
110518815|NCT00927485|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110518816|NCT00927485|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110518817|NCT00927485|Analgesics|analgesics|mesh-ancestor
110518818|NCT00927485|Sensory System Agents|sensory system agents|mesh-ancestor
110518819|NCT00927485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110518820|NCT00927485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110518821|NCT00927485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110518822|NCT00927485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110518826|NCT00926653|Escitalopram|escitalopram|mesh-list
110518858|NCT04260269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110518859|NCT02738970|Trastuzumab|trastuzumab|mesh-list
110518860|NCT02738970|Pertuzumab|pertuzumab|mesh-list
110518861|NCT02738970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110518862|NCT02738970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110518863|NCT00926731|Cytarabine|cytarabine|mesh-list
110518864|NCT00926731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110518865|NCT00926731|Antimetabolites|antimetabolites|mesh-ancestor
110518866|NCT00926731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110518867|NCT00926731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110518868|NCT00926731|Antiviral Agents|antiviral agents|mesh-ancestor
110518869|NCT00926731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110518870|NCT00926731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110518871|NCT00926731|Immunologic Factors|immunologic factors|mesh-ancestor
110518872|NCT00926731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110518873|NCT00926809|Amoxicillin|amoxicillin|mesh-list
110518874|NCT00926809|Clarithromycin|clarithromycin|mesh-list
110518875|NCT00926809|Lansoprazole|lansoprazole|mesh-list
110518894|NCT04262765|Amlodipine|amlodipine|mesh-list
110593750|NCT02400242|Growth Substances|growth substances|mesh-ancestor
110518916|NCT03112434|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110518917|NCT03112434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110518918|NCT03112434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110518919|NCT03112434|Cholinergic Agents|cholinergic agents|mesh-ancestor
110518920|NCT03112434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110518921|NCT03112434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110518922|NCT03112434|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110518923|NCT03112434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110518924|NCT02738814|Propofol|propofol|mesh-list
110518925|NCT02738814|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110518926|NCT02738814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110518927|NCT02738814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110518934|NCT02729064|Insulin|insulin|mesh-list
110518975|NCT04260113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110518976|NCT02738658|Everolimus|everolimus|mesh-list
110518977|NCT02738658|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110518978|NCT02738658|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110518979|NCT02738658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110518980|NCT02738658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110518981|NCT02738658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110518982|NCT02738658|Immunologic Factors|immunologic factors|mesh-ancestor
110518983|NCT02738658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110518984|NCT02738658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110518985|NCT02733510|Methylprednisolone|methylprednisolone|mesh-list
110518986|NCT02733510|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110518988|NCT02733510|Prednisolone|prednisolone|mesh-list
110519038|NCT02812394|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110519040|NCT02812394|Dopamine Agonists|dopamine agonists|mesh-ancestor
110519041|NCT00930475|Carboplatin|carboplatin|mesh-list
110519042|NCT00930475|Everolimus|everolimus|mesh-list
110519043|NCT00930475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110519044|NCT00930475|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110519045|NCT00930475|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110519046|NCT00930475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110519047|NCT00930475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110519048|NCT00930475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110519049|NCT00930475|Immunologic Factors|immunologic factors|mesh-ancestor
110519050|NCT00930475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110519051|NCT05623592|Methotrexate|methotrexate|mesh-list
110519052|NCT05623592|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110519053|NCT05623592|Abortifacient Agents|abortifacient agents|mesh-ancestor
110519067|NCT02728518|Amikacin|amikacin|mesh-list
110519097|NCT00936793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110519098|NCT00936793|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110519099|NCT00936793|Respiratory System Agents|respiratory system agents|mesh-ancestor
110519100|NCT02805452|Solifenacin Succinate|solifenacin succinate|mesh-list
110519101|NCT02805452|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110519102|NCT02805452|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110519103|NCT02805452|Cholinergic Agents|cholinergic agents|mesh-ancestor
110519104|NCT02805452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110519105|NCT02805452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110519106|NCT02805452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110519107|NCT02805452|Urological Agents|urological agents|mesh-ancestor
110519108|NCT00937027|Aminopterin|aminopterin|mesh-list
110519109|NCT00937027|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110519158|NCT02738346|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110519160|NCT00932165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110519161|NCT00932165|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110519162|NCT00932165|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110519163|NCT00932165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110593761|NCT03087656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110519164|NCT00932165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110519165|NCT00932165|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110519166|NCT00932165|Hormone Antagonists|hormone antagonists|mesh-ancestor
110519167|NCT00932165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110519168|NCT00932165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110519170|NCT00937183|Immunologic Factors|immunologic factors|mesh-ancestor
110519171|NCT00937183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110519172|NCT00937261|Risperidone|risperidone|mesh-list
110519173|NCT00937261|Paliperidone Palmitate|paliperidone palmitate|mesh-list
110519174|NCT00937261|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110519175|NCT00937261|Serotonin Agents|serotonin agents|mesh-ancestor
110519188|NCT05906433|Triamcinolone|triamcinolone|mesh-list
110519215|NCT05906199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110519216|NCT05906199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110519217|NCT05906199|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110519218|NCT05906199|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110519219|NCT05906199|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110519220|NCT05906199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110519221|NCT05906199|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110519222|NCT05906199|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110519223|NCT05906199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110519225|NCT05905965|Empagliflozin|empagliflozin|mesh-list
110519226|NCT05905965|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110519228|NCT05905965|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110519279|NCT05905367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110519280|NCT05905367|Analgesics|analgesics|mesh-ancestor
110519281|NCT05905367|Sensory System Agents|sensory system agents|mesh-ancestor
110519282|NCT05905367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110519283|NCT05905367|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110519284|NCT05905367|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110519285|NCT05905367|Anesthetics, General|anesthetics, general|mesh-ancestor
110519286|NCT05905367|Anesthetics|anesthetics|mesh-ancestor
110519287|NCT05905367|Antitussive Agents|antitussive agents|mesh-ancestor
110519288|NCT05905367|Respiratory System Agents|respiratory system agents|mesh-ancestor
110519289|NCT05905315|Paclitaxel|paclitaxel|mesh-list
110519290|NCT05905315|Carboplatin|carboplatin|mesh-list
110519291|NCT05905315|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110519292|NCT05905315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110519293|NCT05905315|Tubulin Modulators|tubulin modulators|mesh-ancestor
110519294|NCT05905315|Antimitotic Agents|antimitotic agents|mesh-ancestor
110519295|NCT05905315|Mitosis Modulators|mitosis modulators|mesh-ancestor
110519297|NCT05905185|Vitamin E|vitamin e|mesh-list
110519340|NCT05881811|Gout Suppressants|gout suppressants|mesh-ancestor
110519341|NCT05881811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110519342|NCT05881811|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110519343|NCT05881811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110519344|NCT05881811|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110519345|NCT05881811|Histamine Antagonists|histamine antagonists|mesh-ancestor
110519346|NCT05881811|Histamine Agents|histamine agents|mesh-ancestor
110519347|NCT05881811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110519348|NCT05881811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110519349|NCT05881811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110519350|NCT05881811|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110519351|NCT05881811|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110519352|NCT05881811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110519402|NCT05825924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110519403|NCT05807048|Daratumumab|daratumumab|mesh-list
110519404|NCT05807048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110519405|NCT05789992|Remifentanil|remifentanil|mesh-list
110519406|NCT05789992|Propofol|propofol|mesh-list
110519407|NCT05789992|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110519408|NCT05789992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110519409|NCT05789992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110519410|NCT05789992|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110519411|NCT05789992|Anesthetics, General|anesthetics, general|mesh-ancestor
110519412|NCT05789992|Anesthetics|anesthetics|mesh-ancestor
110519467|NCT05681273|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110519468|NCT05681273|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110519469|NCT05681273|Antimetabolites|antimetabolites|mesh-ancestor
110519470|NCT05681273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110519471|NCT05681273|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110519472|NCT05681273|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110519473|NCT05681273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110519474|NCT05681273|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110519475|NCT05681273|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110519476|NCT05681273|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110519477|NCT05681273|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110519478|NCT05681273|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110519479|NCT05681273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110519480|NCT05656742|Vitamin D|vitamin d|mesh-list
110519481|NCT05656742|Vitamins|vitamins|mesh-ancestor
110519482|NCT05656742|Micronutrients|micronutrients|mesh-ancestor
110519483|NCT05656742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110519484|NCT05656742|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110519485|NCT05549505|Anastrozole|anastrozole|mesh-list
110519486|NCT05549505|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110519522|NCT05488847|Tramadol|tramadol|mesh-list
110519523|NCT05488847|Tizanidine|tizanidine|mesh-list
110519524|NCT05488847|Magnesium Oxide|magnesium oxide|mesh-list
110519525|NCT05488847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110519526|NCT05488847|Antiemetics|antiemetics|mesh-ancestor
110519527|NCT05488847|Autonomic Agents|autonomic agents|mesh-ancestor
110519528|NCT05488847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110519529|NCT05488847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110519530|NCT05488847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110519531|NCT05488847|Glucocorticoids|glucocorticoids|mesh-ancestor
110519589|NCT05418556|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
110519590|NCT05418556|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110519591|NCT05418556|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110519592|NCT05418556|Analgesics|analgesics|mesh-ancestor
110519593|NCT05418556|Sensory System Agents|sensory system agents|mesh-ancestor
110519594|NCT05418556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110519595|NCT05418556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110519596|NCT05418556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110519597|NCT05418556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110519598|NCT05418556|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110519599|NCT05418556|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110519603|NCT05418556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110519654|NCT05222984|Venetoclax|venetoclax|mesh-list
110519655|NCT05222984|Navitoclax|navitoclax|mesh-list
110519656|NCT05222984|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110519657|NCT05222984|Antimetabolites|antimetabolites|mesh-ancestor
110519658|NCT05222984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110519659|NCT05222984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110519660|NCT05222984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110519661|NCT05177848|Nicotine|nicotine|mesh-list
110519662|NCT05177848|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110519721|NCT04548999|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110519722|NCT04548999|Protective Agents|protective agents|mesh-ancestor
110519723|NCT04548999|Immunologic Factors|immunologic factors|mesh-ancestor
110519725|NCT04548999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110519726|NCT04548999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110519727|NCT04544436|Methylprednisolone|methylprednisolone|mesh-list
110519728|NCT04544436|Ocrelizumab|ocrelizumab|mesh-list
110519729|NCT04544436|Histamine Antagonists|histamine antagonists|mesh-list
110519730|NCT04544436|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
110519731|NCT04544436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110519738|NCT04544436|Hormones|hormones|mesh-ancestor
110519786|NCT04395079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110519787|NCT04391309|Remdesivir|remdesivir|mesh-list
110519788|NCT04391309|Antimetabolites|antimetabolites|mesh-ancestor
110519789|NCT04391309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110519790|NCT04391309|Antiviral Agents|antiviral agents|mesh-ancestor
110519791|NCT04391309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110519792|NCT04381897|Acetylcysteine|acetylcysteine|mesh-list
110519793|NCT04381897|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110519794|NCT04381897|Antiviral Agents|antiviral agents|mesh-ancestor
110519795|NCT04381897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110519796|NCT04381897|Expectorants|expectorants|mesh-ancestor
110519798|NCT04381897|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110519853|NCT04337827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110519855|NCT04337827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110519856|NCT04337827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110519857|NCT04263922|Valsartan|valsartan|mesh-list
110519858|NCT04263922|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110519859|NCT04263922|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110519860|NCT04263922|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110519861|NCT04263922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110519862|NCT04251117|Pembrolizumab|pembrolizumab|mesh-list
110519871|NCT04246047|Dexamethasone|dexamethasone|mesh-list
110519917|NCT04195139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110519918|NCT04195139|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110519919|NCT04195139|Alkylating Agents|alkylating agents|mesh-ancestor
110519920|NCT04174352|Tamoxifen|tamoxifen|mesh-list
110519921|NCT04174352|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110519922|NCT04174352|Hormone Antagonists|hormone antagonists|mesh-ancestor
110519923|NCT04174352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110519924|NCT04174352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110519925|NCT04174352|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110519926|NCT04174352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110519927|NCT04174352|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110519928|NCT04174352|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110167369|NCT00000560|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
110519929|NCT04174352|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110519930|NCT04150289|Panobinostat|panobinostat|mesh-list
110519931|NCT04150289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110519932|NCT04150289|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110519933|NCT04150289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110519934|NCT04150289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110519935|NCT04136756|Rituximab|rituximab|mesh-list
110519936|NCT04136756|Daratumumab|daratumumab|mesh-list
110519937|NCT04136756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110519938|NCT04136756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110519939|NCT04136756|Immunologic Factors|immunologic factors|mesh-ancestor
110519964|NCT04052880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110519965|NCT04052880|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110519966|NCT04052880|Glucocorticoids|glucocorticoids|mesh-ancestor
110519967|NCT04052880|Hormones|hormones|mesh-ancestor
110519968|NCT04052880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110519969|NCT04052880|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110519970|NCT04052880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110519971|NCT04052880|Immunologic Factors|immunologic factors|mesh-ancestor
110519972|NCT04052880|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110519973|NCT04052880|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110519990|NCT03969446|Pembrolizumab|pembrolizumab|mesh-list
110520029|NCT03853954|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110520030|NCT03853954|Anesthetics, General|anesthetics, general|mesh-ancestor
110520032|NCT03853954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110520033|NCT03853954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110520034|NCT03806985|Psilocybin|psilocybin|mesh-list
110520035|NCT03806985|Hallucinogens|hallucinogens|mesh-ancestor
110520036|NCT03806985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110520037|NCT03806985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110520038|NCT03806452|Hydroxyurea|hydroxyurea|mesh-list
110520039|NCT03806452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110520040|NCT03806452|Antisickling Agents|antisickling agents|mesh-ancestor
110520041|NCT03806452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110520042|NCT03806452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110520043|NCT03806452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110520059|NCT03634228|Cytarabine|cytarabine|mesh-list
110520101|NCT03532139|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110520102|NCT03532139|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110520103|NCT03532139|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110520104|NCT03532139|Antimetabolites|antimetabolites|mesh-ancestor
110520105|NCT03532139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110520106|NCT03532139|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110520169|NCT03324425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110520170|NCT03324425|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110520171|NCT03324425|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110520172|NCT03324425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110520174|NCT03317457|Durvalumab|durvalumab|mesh-list
110520175|NCT03317457|Tremelimumab|tremelimumab|mesh-list
110520176|NCT03317457|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110520177|NCT03317457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110520178|NCT03317457|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110520233|NCT03003546|Rituximab|rituximab|mesh-list
110520234|NCT03003546|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110520235|NCT03003546|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110520236|NCT03003546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110520237|NCT03003546|Tubulin Modulators|tubulin modulators|mesh-ancestor
110520238|NCT03003546|Antimitotic Agents|antimitotic agents|mesh-ancestor
110520239|NCT03003546|Mitosis Modulators|mitosis modulators|mesh-ancestor
110520240|NCT03003546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110520241|NCT03003546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110520242|NCT03003546|Immunologic Factors|immunologic factors|mesh-ancestor
110520243|NCT03003546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110520244|NCT03003546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110520245|NCT02996825|Gemcitabine|gemcitabine|mesh-list
110520246|NCT02996825|Maytansine|maytansine|mesh-list
110520247|NCT02996825|Mirvetuximab soravtansine|mirvetuximab soravtansine|mesh-list
110520248|NCT02996825|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110520249|NCT02996825|Antimetabolites|antimetabolites|mesh-ancestor
110520250|NCT02996825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110520290|NCT02675829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110520291|NCT02675829|Immunotoxins|immunotoxins|mesh-ancestor
110520292|NCT02675829|Immunoconjugates|immunoconjugates|mesh-ancestor
110520293|NCT02675829|Immunologic Factors|immunologic factors|mesh-ancestor
110520294|NCT02675829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110520295|NCT02554851|Mitogens|mitogens|mesh-list
110520296|NCT02554851|Mitosis Modulators|mitosis modulators|mesh-ancestor
110520297|NCT02554851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110520298|NCT02520141|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110520299|NCT02520141|Ramucirumab|ramucirumab|mesh-list
110520300|NCT02520141|Antibodies|antibodies|mesh-list
110520301|NCT02520141|Immunoglobulins|immunoglobulins|mesh-list
110520302|NCT02520141|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110520303|NCT02520141|Lexatumumab|lexatumumab|mesh-list
110520304|NCT02520141|Immunologic Factors|immunologic factors|mesh-ancestor
110520305|NCT02520141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110520306|NCT02520141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110520353|NCT02119468|Ixazomib|ixazomib|mesh-list
110520354|NCT02119468|Glycine|glycine|mesh-list
110520355|NCT02119468|Proteasome Inhibitors|proteasome inhibitors|mesh-list
110520356|NCT02119468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110520357|NCT02119468|Antiemetics|antiemetics|mesh-ancestor
110520358|NCT02119468|Autonomic Agents|autonomic agents|mesh-ancestor
110520359|NCT02119468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110520360|NCT02119468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110520361|NCT02119468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110520362|NCT02119468|Glucocorticoids|glucocorticoids|mesh-ancestor
110520363|NCT02119468|Hormones|hormones|mesh-ancestor
110167827|NCT00033280|Temozolomide|temozolomide|mesh-list
110520419|NCT01824836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110520420|NCT01824836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110520421|NCT01824836|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110520422|NCT01824836|Hormone Antagonists|hormone antagonists|mesh-ancestor
110520423|NCT01824836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110520424|NCT01824836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110520426|NCT01552434|Bevacizumab|bevacizumab|mesh-list
110520427|NCT01552434|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110520428|NCT01552434|Cetuximab|cetuximab|mesh-list
110520429|NCT01552434|Temsirolimus|temsirolimus|mesh-list
110520430|NCT01552434|MTOR Inhibitors|mtor inhibitors|mesh-list
110520431|NCT01552434|Valproic Acid|valproic acid|mesh-list
110520432|NCT01552434|Endothelial Growth Factors|endothelial growth factors|mesh-list
110520433|NCT01552434|Antibodies|antibodies|mesh-list
110520434|NCT01552434|Immunoglobulins|immunoglobulins|mesh-list
110520435|NCT01552434|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110520436|NCT01552434|Immunoglobulin G|immunoglobulin g|mesh-list
110520437|NCT01552434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110520438|NCT01552434|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110520475|NCT01164228|Gemcitabine|gemcitabine|mesh-list
110520476|NCT01164228|Sunitinib|sunitinib|mesh-list
110520477|NCT01164228|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110520478|NCT01164228|Antimetabolites|antimetabolites|mesh-ancestor
110520479|NCT01164228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110520480|NCT01164228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110520481|NCT01164228|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110520482|NCT01164228|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110520483|NCT01164228|Growth Substances|growth substances|mesh-ancestor
110520484|NCT01164228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110520485|NCT01164228|Growth Inhibitors|growth inhibitors|mesh-ancestor
110520486|NCT01164228|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110520488|NCT00950846|Cyclophosphamide|cyclophosphamide|mesh-list
110520489|NCT00950846|Busulfan|busulfan|mesh-list
110520490|NCT00950846|Fludarabine|fludarabine|mesh-list
110520491|NCT00950846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110520492|NCT00950846|Immunologic Factors|immunologic factors|mesh-ancestor
110520493|NCT00950846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110520494|NCT00950846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110520495|NCT00950846|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110520496|NCT00950846|Alkylating Agents|alkylating agents|mesh-ancestor
110520497|NCT00950846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110520498|NCT00950846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110520499|NCT00950846|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110520527|NCT00329043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110520528|NCT00329043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110520529|NCT00329043|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110520531|NCT00329043|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110520532|NCT00329043|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110520533|NCT00209586|Fospropofol|fospropofol|mesh-list
110520534|NCT00209586|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110520535|NCT00209586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110520536|NCT00209586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110520537|NCT00107289|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
110520538|NCT00107289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110520539|NCT00107289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110520591|NCT00054561|Immunologic Factors|immunologic factors|mesh-ancestor
110520592|NCT00054561|Antioxidants|antioxidants|mesh-ancestor
110520593|NCT00054561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110520594|NCT00054561|Protective Agents|protective agents|mesh-ancestor
110520595|NCT00054561|Dermatologic Agents|dermatologic agents|mesh-ancestor
110520596|NCT00049517|Cytarabine|cytarabine|mesh-list
110520597|NCT00049517|Cyclophosphamide|cyclophosphamide|mesh-list
110520598|NCT00049517|Busulfan|busulfan|mesh-list
110520599|NCT00049517|Daunorubicin|daunorubicin|mesh-list
110520600|NCT00049517|Gemtuzumab|gemtuzumab|mesh-list
110520601|NCT00049517|Sargramostim|sargramostim|mesh-list
110520602|NCT00049517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110520603|NCT00049517|Immunologic Factors|immunologic factors|mesh-ancestor
110520604|NCT00049517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110520605|NCT00049517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110520606|NCT00049517|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110520607|NCT00049517|Alkylating Agents|alkylating agents|mesh-ancestor
110520608|NCT00049517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110520610|NCT00049517|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110520611|NCT00049517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110520612|NCT00049517|Antimetabolites|antimetabolites|mesh-ancestor
110520613|NCT00049517|Antiviral Agents|antiviral agents|mesh-ancestor
110520614|NCT00049517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110520615|NCT00049517|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110520616|NCT00049517|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110520617|NCT00049517|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110520618|NCT00049517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110520619|NCT00049517|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110520620|NCT00049517|Immunotoxins|immunotoxins|mesh-ancestor
110520621|NCT00049517|Immunoconjugates|immunoconjugates|mesh-ancestor
110520639|NCT00041314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110520640|NCT00041314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110520642|NCT00028990|Bevacizumab|bevacizumab|mesh-list
110520643|NCT00028990|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110520644|NCT00028990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110520645|NCT00028990|Tubulin Modulators|tubulin modulators|mesh-ancestor
110520646|NCT00028990|Antimitotic Agents|antimitotic agents|mesh-ancestor
110520647|NCT00028990|Mitosis Modulators|mitosis modulators|mesh-ancestor
110520648|NCT00028990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110520649|NCT00028990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110520650|NCT00028990|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110520651|NCT00028990|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110520652|NCT00028990|Growth Substances|growth substances|mesh-ancestor
110520653|NCT00028990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110520654|NCT00028990|Growth Inhibitors|growth inhibitors|mesh-ancestor
110520655|NCT00027859|Ketoconazole|ketoconazole|mesh-list
110520656|NCT00027859|Hydrocortisone|hydrocortisone|mesh-list
110520657|NCT00027859|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
110520658|NCT00027859|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
110520659|NCT00027859|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
110520660|NCT00027859|Docetaxel|docetaxel|mesh-list
110520661|NCT00027859|Estramustine|estramustine|mesh-list
110520662|NCT00027859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110520663|NCT00027859|Tubulin Modulators|tubulin modulators|mesh-ancestor
110520664|NCT00027859|Antimitotic Agents|antimitotic agents|mesh-ancestor
110520665|NCT00027859|Mitosis Modulators|mitosis modulators|mesh-ancestor
110520666|NCT00027859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110520667|NCT00027859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110520668|NCT00027859|Antifungal Agents|antifungal agents|mesh-ancestor
110520669|NCT00027859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110520670|NCT00027859|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110520671|NCT00027859|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110520672|NCT00027859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110520673|NCT00027859|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110520674|NCT00027859|Hormone Antagonists|hormone antagonists|mesh-ancestor
110520678|NCT00027859|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110520679|NCT00027859|Alkylating Agents|alkylating agents|mesh-ancestor
110520680|NCT00027859|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110520681|NCT00026286|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
110520682|NCT00026286|Medroxyprogesterone|medroxyprogesterone|mesh-list
110520684|NCT00026286|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
110520685|NCT00026286|Hormones|hormones|mesh-ancestor
110520686|NCT00026286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110520687|NCT00026286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110520688|NCT00026286|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110520689|NCT00026286|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110520690|NCT00026286|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110520691|NCT00026286|Contraceptive Agents|contraceptive agents|mesh-ancestor
110520692|NCT00026286|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110520693|NCT00026286|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110520694|NCT00026286|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110520695|NCT00026286|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110520696|NCT00026286|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110520697|NCT00026286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110520698|NCT00014118|Paclitaxel|paclitaxel|mesh-list
110520699|NCT00014118|Carboplatin|carboplatin|mesh-list
110520700|NCT00014118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110520701|NCT00014118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110520702|NCT00014118|Tubulin Modulators|tubulin modulators|mesh-ancestor
110520703|NCT00014118|Antimitotic Agents|antimitotic agents|mesh-ancestor
110520704|NCT00014118|Mitosis Modulators|mitosis modulators|mesh-ancestor
110520705|NCT00014118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110520706|NCT00006004|Paclitaxel|paclitaxel|mesh-list
110520707|NCT00006004|Carboplatin|carboplatin|mesh-list
110520708|NCT00006004|Gemcitabine|gemcitabine|mesh-list
110520709|NCT00006004|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110520710|NCT00006004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110520711|NCT00006004|Tubulin Modulators|tubulin modulators|mesh-ancestor
110520720|NCT00004860|Levoleucovorin|levoleucovorin|mesh-list
110520721|NCT00004860|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110520722|NCT00004860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110520723|NCT00004860|Antidotes|antidotes|mesh-ancestor
110520724|NCT00004860|Protective Agents|protective agents|mesh-ancestor
110520725|NCT00004860|Vitamin B Complex|vitamin b complex|mesh-ancestor
110520726|NCT00004860|Vitamins|vitamins|mesh-ancestor
110520727|NCT00004860|Micronutrients|micronutrients|mesh-ancestor
110520732|NCT00003864|Carboplatin|carboplatin|mesh-list
110520786|NCT00003614|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110520787|NCT00003614|Alkylating Agents|alkylating agents|mesh-ancestor
110520788|NCT00003614|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110520789|NCT00003519|Cyclophosphamide|cyclophosphamide|mesh-list
110520790|NCT00003519|Docetaxel|docetaxel|mesh-list
110520791|NCT00003519|Doxorubicin|doxorubicin|mesh-list
110520792|NCT00003519|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110520793|NCT00003519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110520794|NCT00003519|Immunologic Factors|immunologic factors|mesh-ancestor
110520795|NCT00003519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110520796|NCT00003519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110520797|NCT00003519|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110520798|NCT00003519|Alkylating Agents|alkylating agents|mesh-ancestor
110520799|NCT00003519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110520800|NCT00003519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110520801|NCT00003519|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110520802|NCT00003519|Tubulin Modulators|tubulin modulators|mesh-ancestor
110520803|NCT00003519|Antimitotic Agents|antimitotic agents|mesh-ancestor
110520804|NCT00003519|Mitosis Modulators|mitosis modulators|mesh-ancestor
110520805|NCT00003519|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110520806|NCT00003519|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110520807|NCT00003519|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110520808|NCT00003519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110520809|NCT00003283|Prednisone|prednisone|mesh-list
110520810|NCT00003283|Octreotide|octreotide|mesh-list
110520811|NCT00003283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110520812|NCT00003283|Glucocorticoids|glucocorticoids|mesh-ancestor
110520813|NCT00003283|Hormones|hormones|mesh-ancestor
110520814|NCT00003283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110520819|NCT00003235|Paclitaxel|paclitaxel|mesh-list
110520833|NCT00003206|Mitosis Modulators|mitosis modulators|mesh-ancestor
110520834|NCT00003206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110520835|NCT00003010|Marimastat|marimastat|mesh-list
110520836|NCT00003010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110520837|NCT00003010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110520838|NCT00003008|Ritonavir|ritonavir|mesh-list
110520839|NCT00003008|Nelfinavir|nelfinavir|mesh-list
110520840|NCT00003008|Indinavir|indinavir|mesh-list
110520841|NCT00003008|Saquinavir|saquinavir|mesh-list
110520842|NCT00003008|Paclitaxel|paclitaxel|mesh-list
110520843|NCT00003008|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110520844|NCT00003008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110520845|NCT00003008|Tubulin Modulators|tubulin modulators|mesh-ancestor
110520846|NCT00003008|Antimitotic Agents|antimitotic agents|mesh-ancestor
110520847|NCT00003008|Mitosis Modulators|mitosis modulators|mesh-ancestor
110520848|NCT00003008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110520849|NCT00003008|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110520850|NCT00003008|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110520851|NCT00003008|Protease Inhibitors|protease inhibitors|mesh-ancestor
110520890|NCT00002632|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110520891|NCT00002632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110520892|NCT00002632|Tubulin Modulators|tubulin modulators|mesh-ancestor
110520893|NCT00002632|Antimitotic Agents|antimitotic agents|mesh-ancestor
110520894|NCT00002632|Mitosis Modulators|mitosis modulators|mesh-ancestor
110520895|NCT00002632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110520896|NCT00002520|Nicotine|nicotine|mesh-list
110520897|NCT00002520|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110520898|NCT00002520|Autonomic Agents|autonomic agents|mesh-ancestor
110520899|NCT00002520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110520900|NCT00002520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110520901|NCT00002520|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110520902|NCT00002520|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110520903|NCT00002520|Cholinergic Agents|cholinergic agents|mesh-ancestor
110520904|NCT00002520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110520905|NCT00002520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110168349|NCT00000689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110520926|NCT00937417|Docetaxel|docetaxel|mesh-list
110520947|NCT00930865|Dapagliflozin|dapagliflozin|mesh-list
110520948|NCT00930865|Bumetanide|bumetanide|mesh-list
110520949|NCT00930865|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110593850|NCT04072640|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110520950|NCT00930865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110520951|NCT00930865|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110520952|NCT00930865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110520953|NCT00930865|Diuretics|diuretics|mesh-ancestor
110520954|NCT00930865|Natriuretic Agents|natriuretic agents|mesh-ancestor
110520955|NCT00930865|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110520956|NCT00930865|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110521009|NCT02808728|Sensory System Agents|sensory system agents|mesh-ancestor
110521010|NCT02808728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110521011|NCT05331053|Atorvastatin|atorvastatin|mesh-list
110521012|NCT05331053|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110521013|NCT05331053|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110521077|NCT02732418|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110521078|NCT02732418|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110521079|NCT02732418|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110521080|NCT02732418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110521081|NCT02732418|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110521082|NCT02732418|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110521083|NCT02732418|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110521084|NCT02811692|Aflibercept|aflibercept|mesh-list
110521085|NCT02811692|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110521141|NCT02727504|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110521142|NCT02727504|Adrenergic Agents|adrenergic agents|mesh-ancestor
110521143|NCT02727504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110521144|NCT02727504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110521145|NCT02727504|Protective Agents|protective agents|mesh-ancestor
110521146|NCT02727348|Anesthetics|anesthetics|mesh-list
110521212|NCT04259333|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110521213|NCT04259333|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110521214|NCT04259333|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110521215|NCT04259333|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110521216|NCT04259333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110521217|NCT04259333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110521218|NCT04259333|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110521219|NCT04259333|Narcotics|narcotics|mesh-ancestor
110521220|NCT04259333|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110521221|NCT04259333|Antitussive Agents|antitussive agents|mesh-ancestor
110521222|NCT04259333|Respiratory System Agents|respiratory system agents|mesh-ancestor
110312143|NCT00325104|Calcium|calcium|mesh-list
110521279|NCT00931463|Lopinavir|lopinavir|mesh-list
110521280|NCT00931463|Raltegravir Potassium|raltegravir potassium|mesh-list
110521281|NCT00931463|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110521282|NCT00931463|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110521283|NCT00931463|Protease Inhibitors|protease inhibitors|mesh-ancestor
110521284|NCT00931463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110521285|NCT00931463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110521286|NCT00931463|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110521346|NCT00610493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110521347|NCT00610493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110521348|NCT00610493|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110521349|NCT00610493|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110521350|NCT00610493|Growth Substances|growth substances|mesh-ancestor
110521351|NCT00610493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110521352|NCT00610493|Growth Inhibitors|growth inhibitors|mesh-ancestor
110521353|NCT00610493|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110521354|NCT00610493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110521355|NCT00610493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110521356|NCT00610493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110521358|NCT00610493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110521359|NCT00610493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110521360|NCT00610493|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110521361|NCT00610493|Antifungal Agents|antifungal agents|mesh-ancestor
110521362|NCT02716272|Nivolumab|nivolumab|mesh-list
110521363|NCT02716272|Ipilimumab|ipilimumab|mesh-list
110521368|NCT02720406|Ketamine|ketamine|mesh-list
110593876|NCT02576288|Hormones|hormones|mesh-ancestor
110521403|NCT02802722|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110521405|NCT02802644|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110521406|NCT02802644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110521407|NCT02802644|Incretins|incretins|mesh-ancestor
110521475|NCT02725242|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110521476|NCT02725242|Adrenergic Agents|adrenergic agents|mesh-ancestor
110521477|NCT02725242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110521478|NCT02725242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110521479|NCT00564733|Paclitaxel|paclitaxel|mesh-list
110521480|NCT00564733|Docetaxel|docetaxel|mesh-list
110521481|NCT00564733|Carboplatin|carboplatin|mesh-list
110521482|NCT00564733|Gemcitabine|gemcitabine|mesh-list
110521483|NCT00564733|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110521541|NCT00938509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110521542|NCT02724618|Curcumin|curcumin|mesh-list
110521543|NCT02724618|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110521610|NCT00938821|Morphine|morphine|mesh-list
110521611|NCT00938821|Bupivacaine|bupivacaine|mesh-list
110521613|NCT00938821|Anesthetics|anesthetics|mesh-ancestor
110521689|NCT04014361|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110521690|NCT04014361|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110521759|NCT03259165|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
110521760|NCT03259165|Natriuretic Agents|natriuretic agents|mesh-ancestor
110521761|NCT03259165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110521762|NCT03259165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110521763|NCT03259165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110521764|NCT04013659|Hydrogen Peroxide|hydrogen peroxide|mesh-list
110521765|NCT04013659|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110521826|NCT00939835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110521827|NCT00939835|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110521828|NCT00939835|Antidepressive Agents|antidepressive agents|mesh-ancestor
110521829|NCT00939835|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110521830|NCT00939835|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110521831|NCT00939835|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110521832|NCT00939835|Parasympatholytics|parasympatholytics|mesh-ancestor
110521833|NCT00939835|Autonomic Agents|autonomic agents|mesh-ancestor
110521834|NCT00939835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110521892|NCT02794220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110521893|NCT02794220|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110521894|NCT02794220|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110521895|NCT02794220|Cholinergic Agents|cholinergic agents|mesh-ancestor
110521896|NCT02794220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110521897|NCT02794220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110521898|NCT00941083|Raltegravir Potassium|raltegravir potassium|mesh-list
110521899|NCT00941083|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110521900|NCT00941083|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110521901|NCT00941083|Antiviral Agents|antiviral agents|mesh-ancestor
110521902|NCT00941083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110521903|NCT00941083|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110521904|NCT00941083|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110521905|NCT00941083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110521907|NCT04405999|Bromhexine|bromhexine|mesh-list
110521953|NCT00771654|Sympathomimetics|sympathomimetics|mesh-ancestor
110521954|NCT00771654|Autonomic Agents|autonomic agents|mesh-ancestor
110521955|NCT00771654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110521956|NCT00771654|Adrenergic Agents|adrenergic agents|mesh-ancestor
110521957|NCT00771654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110521958|NCT00771654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110521960|NCT00941239|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110521961|NCT00941239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110521963|NCT04235426|Hydroxocobalamin|hydroxocobalamin|mesh-list
110521964|NCT04235426|Diclofenac|diclofenac|mesh-list
110521965|NCT04235426|Vitamins|vitamins|mesh-ancestor
110522018|NCT00925769|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110522019|NCT00925769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110522020|NCT00925769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110522021|NCT00925769|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110522022|NCT00925769|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110522024|NCT00925769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110522025|NCT00925769|Growth Inhibitors|growth inhibitors|mesh-ancestor
110522026|NCT00925769|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110522027|NCT00925769|Antimetabolites|antimetabolites|mesh-ancestor
110522028|NCT00925769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110522030|NCT00925769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110522081|NCT02798510|Antimetabolites|antimetabolites|mesh-ancestor
110522082|NCT02798510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110522083|NCT02798510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110522084|NCT00941473|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110522085|NCT00941473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110522086|NCT00941473|Glucocorticoids|glucocorticoids|mesh-ancestor
110522088|NCT00941473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110522089|NCT00941473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110522090|NCT00941473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110522091|NCT00941473|Immunologic Factors|immunologic factors|mesh-ancestor
110522092|NCT04258475|Raltegravir Potassium|raltegravir potassium|mesh-list
110522144|NCT02793050|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110522145|NCT02793050|Alkylating Agents|alkylating agents|mesh-ancestor
110522221|NCT04258163|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110522222|NCT04258163|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110522223|NCT04258163|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110522224|NCT04258163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110522225|NCT04258163|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110522226|NCT04258163|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110522227|NCT04258163|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110522228|NCT04258163|Hormone Antagonists|hormone antagonists|mesh-ancestor
110522229|NCT04258163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110522230|NCT04258163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110522231|NCT04258163|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110522286|NCT02792426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110522287|NCT02792426|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110522288|NCT02792426|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110522289|NCT02792426|Cholinergic Agents|cholinergic agents|mesh-ancestor
110522290|NCT02792426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110522291|NCT02792426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110522292|NCT00770211|Botulinum Toxins|botulinum toxins|mesh-list
110522293|NCT00770211|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110522294|NCT00770211|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110522295|NCT00770211|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
110522296|NCT00770211|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110522297|NCT00770211|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110522298|NCT00770211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110522347|NCT04256525|Analgesics|analgesics|mesh-ancestor
110522348|NCT04256525|Sensory System Agents|sensory system agents|mesh-ancestor
110522349|NCT04256525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110522350|NCT04256525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110522351|NCT04256525|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110522352|NCT04256525|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110522353|NCT04256525|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110522354|NCT04256525|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110522355|NCT04256525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110522365|NCT02791958|Ramipril|ramipril|mesh-list
110522412|NCT00943345|Sensory System Agents|sensory system agents|mesh-ancestor
110522413|NCT00943345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110522414|NCT00943345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110522415|NCT00943345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110522480|NCT02796794|Estrogens|estrogens|mesh-ancestor
110522481|NCT02796794|Hormones|hormones|mesh-ancestor
110522482|NCT02796794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110522483|NCT04097613|Povidone-Iodine|povidone-iodine|mesh-list
110522484|NCT04097613|Budesonide|budesonide|mesh-list
110522485|NCT04097613|Povidone|povidone|mesh-list
110522486|NCT04097613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110522487|NCT04097613|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110522488|NCT04097613|Autonomic Agents|autonomic agents|mesh-ancestor
110522489|NCT04097613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110522490|NCT04097613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110522491|NCT04097613|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110522542|NCT06005714|Dermatologic Agents|dermatologic agents|mesh-ancestor
110522543|NCT06005714|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110522544|NCT06005714|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110522545|NCT06005714|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110522546|NCT06005714|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110522547|NCT06005714|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110522548|NCT06005714|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110170009|NCT00016380|Dexamethasone|dexamethasone|mesh-list
110522561|NCT06005571|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110522562|NCT06005558|Methylene Blue|methylene blue|mesh-list
110522563|NCT06005558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110522564|NCT06005558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110522565|NCT06005363|Dexmedetomidine|dexmedetomidine|mesh-list
110522566|NCT06005363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110522567|NCT06005363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110522568|NCT06005363|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110522569|NCT06005363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110522570|NCT06005363|Analgesics|analgesics|mesh-ancestor
110522571|NCT06005363|Sensory System Agents|sensory system agents|mesh-ancestor
110522572|NCT06005363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110522573|NCT06005363|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110522574|NCT06005363|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110522575|NCT06005363|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110522593|NCT06005324|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110522594|NCT06005324|Immunologic Factors|immunologic factors|mesh-ancestor
110522595|NCT06005324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110522596|NCT06005324|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110522597|NCT06005324|Antisickling Agents|antisickling agents|mesh-ancestor
110522598|NCT06005324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110522599|NCT06005324|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110522600|NCT06005259|Spironolactone|spironolactone|mesh-list
110522601|NCT06005259|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110522606|NCT06005259|Diuretics|diuretics|mesh-ancestor
110522658|NCT06004947|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110522659|NCT06004947|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110522737|NCT06004401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110522738|NCT06004401|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110522739|NCT06004401|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110522740|NCT06004401|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110522741|NCT06004401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110522742|NCT06004401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110522806|NCT06003218|Remifentanil|remifentanil|mesh-list
110522807|NCT06003218|Oxycodone|oxycodone|mesh-list
110522808|NCT06003218|Esketamine|esketamine|mesh-list
110522809|NCT06003218|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110522810|NCT06003218|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110522811|NCT06003218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110522813|NCT06003218|Analgesics|analgesics|mesh-ancestor
110522876|NCT05949281|Antimitotic Agents|antimitotic agents|mesh-ancestor
110522877|NCT05949281|Mitosis Modulators|mitosis modulators|mesh-ancestor
110522878|NCT05949281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110522879|NCT05949281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110522881|NCT05949099|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
110522882|NCT05949099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110522883|NCT05949099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110522884|NCT05933603|Oxybutynin|oxybutynin|mesh-list
110522885|NCT05933603|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
110522886|NCT05933603|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110522887|NCT05933603|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110522890|NCT05933603|Adrenergic Agents|adrenergic agents|mesh-ancestor
110522937|NCT05869136|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110522938|NCT05869136|Immunologic Factors|immunologic factors|mesh-ancestor
110522939|NCT05869136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110522940|NCT05869136|Viscosupplements|viscosupplements|mesh-ancestor
110522941|NCT05869136|Protective Agents|protective agents|mesh-ancestor
110523009|NCT05766553|Autonomic Agents|autonomic agents|mesh-ancestor
110523010|NCT05766553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110523011|NCT05766553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110523012|NCT05766553|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110523013|NCT05766553|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110523014|NCT05766553|Cholinergic Agents|cholinergic agents|mesh-ancestor
110523015|NCT05766553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110523016|NCT05766553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110523017|NCT05765851|Trastuzumab|trastuzumab|mesh-list
110523018|NCT05765851|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
110523019|NCT05765851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110523020|NCT05765851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110523021|NCT05765851|Immunoconjugates|immunoconjugates|mesh-ancestor
110523022|NCT05765851|Immunologic Factors|immunologic factors|mesh-ancestor
110523023|NCT05765851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110523024|NCT05741632|Moxifloxacin|moxifloxacin|mesh-list
110523025|NCT05741632|Levofloxacin|levofloxacin|mesh-list
110523026|NCT05741632|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110523027|NCT05741632|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110523028|NCT05741632|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110523029|NCT05741632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110523030|NCT05741632|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110523031|NCT05741632|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110523032|NCT05741632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110523033|NCT05741632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110523034|NCT05741632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110523035|NCT05741632|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110523036|NCT05741632|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110523037|NCT05741632|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110523038|NCT05739981|Paclitaxel|paclitaxel|mesh-list
110523053|NCT05728645|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
110523054|NCT05728645|Plasma Substitutes|plasma substitutes|mesh-ancestor
110523055|NCT05728645|Blood Substitutes|blood substitutes|mesh-ancestor
110523057|NCT05690087|Anesthetics, Local|anesthetics, local|mesh-ancestor
110523058|NCT05690087|Anesthetics|anesthetics|mesh-ancestor
110523059|NCT05690087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110523060|NCT05690087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110523061|NCT05690087|Sensory System Agents|sensory system agents|mesh-ancestor
110523062|NCT05690087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110523063|NCT05690087|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110523064|NCT05690087|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110523065|NCT05690087|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110523066|NCT05690087|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110523067|NCT05690087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110523068|NCT05685342|Acetaminophen|acetaminophen|mesh-list
110523070|NCT05685342|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110523112|NCT05625503|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110523113|NCT05625503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110523114|NCT05625503|Vasodilator Agents|vasodilator agents|mesh-ancestor
110523115|NCT05625503|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110523184|NCT05366777|Acetaminophen|acetaminophen|mesh-list
110523185|NCT05366777|Ibuprofen|ibuprofen|mesh-list
110523186|NCT05366777|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110523187|NCT05366777|Analgesics|analgesics|mesh-ancestor
110523188|NCT05366777|Sensory System Agents|sensory system agents|mesh-ancestor
110523189|NCT05366777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110523190|NCT05366777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110523191|NCT05366777|Antipyretics|antipyretics|mesh-ancestor
110523192|NCT05366777|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110523193|NCT05366777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110523194|NCT05366777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110523195|NCT05366777|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110523196|NCT05366777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110523197|NCT05366777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110523198|NCT05353829|Methotrexate|methotrexate|mesh-list
110523199|NCT05353829|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110523200|NCT05353829|Abortifacient Agents|abortifacient agents|mesh-ancestor
110523214|NCT05345509|Donepezil|donepezil|mesh-list
110523239|NCT05287035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110523240|NCT05287035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110523241|NCT05287035|Glucocorticoids|glucocorticoids|mesh-ancestor
110523243|NCT05287035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110523244|NCT05287035|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110523245|NCT05287035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110523308|NCT05113940|GABA Modulators|gaba modulators|mesh-ancestor
110523309|NCT05113940|GABA Agents|gaba agents|mesh-ancestor
110523310|NCT05113940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110523311|NCT05113940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110523317|NCT05101096|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
110523318|NCT05101096|Immunoconjugates|immunoconjugates|mesh-ancestor
110523319|NCT05101096|Immunologic Factors|immunologic factors|mesh-ancestor
110523320|NCT05101096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110523321|NCT05096884|Metoprolol|metoprolol|mesh-list
110523322|NCT05096884|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110523323|NCT05096884|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110523324|NCT05096884|Sympatholytics|sympatholytics|mesh-ancestor
110523325|NCT05096884|Autonomic Agents|autonomic agents|mesh-ancestor
110523326|NCT05096884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110523327|NCT05096884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110523328|NCT05096884|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110523329|NCT05096884|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110523330|NCT05096884|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110523331|NCT05096884|Adrenergic Agents|adrenergic agents|mesh-ancestor
110523332|NCT05096884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110523334|NCT05082259|Pembrolizumab|pembrolizumab|mesh-list
110523369|NCT05042505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110523370|NCT05042505|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110523371|NCT05042505|Protease Inhibitors|protease inhibitors|mesh-ancestor
110523372|NCT05042505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110523373|NCT05042505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110523374|NCT05042505|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110523375|NCT04962672|Anesthetics|anesthetics|mesh-list
110170834|NCT00017628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110523376|NCT04962672|Propofol|propofol|mesh-list
110523377|NCT04962672|Sevoflurane|sevoflurane|mesh-list
110523378|NCT04962672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110523431|NCT04732286|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110523432|NCT04732286|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110523433|NCT04732286|Growth Substances|growth substances|mesh-ancestor
110523434|NCT04732286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110523435|NCT04732286|Growth Inhibitors|growth inhibitors|mesh-ancestor
110523436|NCT04732286|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110312169|NCT00418509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110523437|NCT04732286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110523451|NCT04676477|Osimertinib|osimertinib|mesh-list
110170907|NCT00042835|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110523452|NCT04676477|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
110523453|NCT04676477|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110523454|NCT04676477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110523455|NCT04676477|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110523456|NCT04676477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110523464|NCT04546009|Letrozole|letrozole|mesh-list
110523499|NCT04493853|Hormone Antagonists|hormone antagonists|mesh-ancestor
110523500|NCT04493853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110523501|NCT04493853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110523502|NCT04493853|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110523503|NCT04485104|Cannabidiol|cannabidiol|mesh-list
110523504|NCT04485104|Anticonvulsants|anticonvulsants|mesh-ancestor
110523505|NCT04483466|Methotrexate|methotrexate|mesh-list
110523506|NCT04483466|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110312172|NCT00292721|Celecoxib|celecoxib|mesh-list
110523507|NCT04483466|Abortifacient Agents|abortifacient agents|mesh-ancestor
110523541|NCT04349579|Rifamycins|rifamycins|mesh-list
110523564|NCT04194203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110523565|NCT04194203|Tubulin Modulators|tubulin modulators|mesh-ancestor
110523566|NCT04194203|Antimitotic Agents|antimitotic agents|mesh-ancestor
110523567|NCT04194203|Mitosis Modulators|mitosis modulators|mesh-ancestor
110523568|NCT04194203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110523569|NCT04194203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110523570|NCT04194203|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110523571|NCT04194203|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110523572|NCT04194203|Growth Substances|growth substances|mesh-ancestor
110523573|NCT04194203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110523574|NCT04194203|Growth Inhibitors|growth inhibitors|mesh-ancestor
110523575|NCT04194203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110523576|NCT04194203|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110523577|NCT04194203|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110523578|NCT04194203|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110523579|NCT04158713|Piperaquine|piperaquine|mesh-list
110523580|NCT04158713|Artenimol|artenimol|mesh-list
110523581|NCT04158713|Antimalarials|antimalarials|mesh-ancestor
110523636|NCT03994146|Remifentanil|remifentanil|mesh-list
110171131|NCT00001586|Rituximab|rituximab|mesh-list
110523675|NCT03962465|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110523676|NCT03962465|Antiviral Agents|antiviral agents|mesh-ancestor
110523677|NCT03962465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110523678|NCT03962465|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110523679|NCT03962465|Tubulin Modulators|tubulin modulators|mesh-ancestor
110523680|NCT03962465|Antimitotic Agents|antimitotic agents|mesh-ancestor
110523681|NCT03962465|Mitosis Modulators|mitosis modulators|mesh-ancestor
110523682|NCT03962465|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110523683|NCT03962465|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110523684|NCT03962465|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110523685|NCT03962465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110523686|NCT03962465|Immunotoxins|immunotoxins|mesh-ancestor
110523687|NCT03962465|Immunoconjugates|immunoconjugates|mesh-ancestor
110523688|NCT03952299|Mandelic Acids|mandelic acids|mesh-list
110523689|NCT03952299|Oxybutynin|oxybutynin|mesh-list
110523690|NCT03952299|Parasympatholytics|parasympatholytics|mesh-ancestor
110523691|NCT03952299|Autonomic Agents|autonomic agents|mesh-ancestor
110523692|NCT03952299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110523693|NCT03952299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110523694|NCT03952299|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110523695|NCT03952299|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110523729|NCT03728933|Dopamine Agonists|dopamine agonists|mesh-ancestor
110523730|NCT03728933|Dopamine Agents|dopamine agents|mesh-ancestor
110523731|NCT03728933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110523732|NCT03728933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110523733|NCT03728933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110523734|NCT03695250|Nivolumab|nivolumab|mesh-list
110523735|NCT03695250|Linrodostat|linrodostat|mesh-list
110523736|NCT03695250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110523737|NCT03695250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110523741|NCT03678753|Cenobamate|cenobamate|mesh-list
110523795|NCT03526354|Dopamine Agonists|dopamine agonists|mesh-ancestor
110523796|NCT03526354|Dopamine Agents|dopamine agents|mesh-ancestor
110523797|NCT03393884|Paclitaxel|paclitaxel|mesh-list
110523798|NCT03393884|Carboplatin|carboplatin|mesh-list
110523898|NCT03054831|Sensory System Agents|sensory system agents|mesh-ancestor
110523899|NCT03054831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110523900|NCT03049189|Everolimus|everolimus|mesh-list
110523901|NCT03049189|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110523902|NCT03049189|Edotreotide|edotreotide|mesh-list
110523903|NCT03049189|Edotreotide lutetium LU-177|edotreotide lutetium lu-177|mesh-list
110523904|NCT03049189|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110523905|NCT03049189|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110523906|NCT03049189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110523907|NCT03049189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110523908|NCT03049189|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110523909|NCT03049189|Immunologic Factors|immunologic factors|mesh-ancestor
110523910|NCT03049189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110523911|NCT03049189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110523962|NCT02827877|Micronutrients|micronutrients|mesh-ancestor
110523964|NCT02823665|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110523965|NCT02823665|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110523966|NCT02823665|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110523967|NCT02823665|Autonomic Agents|autonomic agents|mesh-ancestor
110524036|NCT02576574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110524037|NCT02576574|Tubulin Modulators|tubulin modulators|mesh-ancestor
110524038|NCT02576574|Antimitotic Agents|antimitotic agents|mesh-ancestor
110524039|NCT02576574|Mitosis Modulators|mitosis modulators|mesh-ancestor
110524040|NCT02576574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110524041|NCT02576574|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110524042|NCT02576574|Antimetabolites|antimetabolites|mesh-ancestor
110524043|NCT02576574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110524044|NCT02576574|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110524045|NCT02576574|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110524046|NCT02576574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110524047|NCT02576574|Immunologic Factors|immunologic factors|mesh-ancestor
110524048|NCT02576574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110524049|NCT02494973|Oxaliplatin|oxaliplatin|mesh-list
110524050|NCT02494973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110524051|NCT02317783|Deoxyglucose|deoxyglucose|mesh-list
110524052|NCT02317783|Flutemetamol|flutemetamol|mesh-list
110524053|NCT02317783|Antimetabolites|antimetabolites|mesh-ancestor
110524054|NCT02317783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110524055|NCT02317783|Antiviral Agents|antiviral agents|mesh-ancestor
110524056|NCT02317783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110524089|NCT01772472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110524090|NCT01470417|Gemcitabine|gemcitabine|mesh-list
110524091|NCT01470417|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110524092|NCT01470417|Paclitaxel|paclitaxel|mesh-list
110524093|NCT01470417|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110524094|NCT01470417|Antimetabolites|antimetabolites|mesh-ancestor
110524095|NCT01470417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110524096|NCT01470417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110524097|NCT01470417|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110524098|NCT01470417|Tubulin Modulators|tubulin modulators|mesh-ancestor
110524099|NCT01470417|Antimitotic Agents|antimitotic agents|mesh-ancestor
110524100|NCT01470417|Mitosis Modulators|mitosis modulators|mesh-ancestor
110524101|NCT01463072|Paclitaxel|paclitaxel|mesh-list
110524109|NCT01409772|Ethanol|ethanol|mesh-list
110524152|NCT00999336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110524153|NCT00999336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110524154|NCT00999336|Anticoagulants|anticoagulants|mesh-ancestor
110524155|NCT00992901|Atropine|atropine|mesh-list
110524156|NCT00992901|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
110524157|NCT00992901|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110524158|NCT00992901|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110524159|NCT00992901|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110524160|NCT00992901|Autonomic Agents|autonomic agents|mesh-ancestor
110524161|NCT00992901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110524162|NCT00992901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110524163|NCT00992901|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110524164|NCT00992901|Respiratory System Agents|respiratory system agents|mesh-ancestor
110524165|NCT00992901|Mydriatics|mydriatics|mesh-ancestor
110524166|NCT00992901|Parasympatholytics|parasympatholytics|mesh-ancestor
110524167|NCT00992901|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110524168|NCT00992901|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110524169|NCT00992901|Cholinergic Agents|cholinergic agents|mesh-ancestor
110524170|NCT00992901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110524172|NCT00992901|Incretins|incretins|mesh-ancestor
110524207|NCT00489710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110524208|NCT00489710|Immunologic Factors|immunologic factors|mesh-ancestor
110524209|NCT00489710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110524210|NCT00482677|Temozolomide|temozolomide|mesh-list
110524211|NCT00482677|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110524212|NCT00482677|Alkylating Agents|alkylating agents|mesh-ancestor
110524213|NCT00482677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110524214|NCT00482677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110524215|NCT00314756|Imiquimod|imiquimod|mesh-list
110524216|NCT00314756|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110524217|NCT00314756|Immunologic Factors|immunologic factors|mesh-ancestor
110524218|NCT00314756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110524219|NCT00314756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110524220|NCT00314756|Interferon Inducers|interferon inducers|mesh-ancestor
110524221|NCT00101101|Aldesleukin|aldesleukin|mesh-list
110524222|NCT00101101|Dexamethasone|dexamethasone|mesh-list
110524223|NCT00101101|Prednisone|prednisone|mesh-list
110524224|NCT00101101|Cyclophosphamide|cyclophosphamide|mesh-list
110524225|NCT00101101|Doxorubicin|doxorubicin|mesh-list
110524226|NCT00101101|Vincristine|vincristine|mesh-list
110524227|NCT00101101|Interleukin-2|interleukin-2|mesh-list
110524228|NCT00101101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110524229|NCT00101101|Immunologic Factors|immunologic factors|mesh-ancestor
110524230|NCT00101101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110524231|NCT00101101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110524232|NCT00101101|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110524233|NCT00101101|Alkylating Agents|alkylating agents|mesh-ancestor
110524234|NCT00101101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110524235|NCT00101101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110524236|NCT00101101|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110524237|NCT00101101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110524252|NCT00101101|Antimitotic Agents|antimitotic agents|mesh-ancestor
110524253|NCT00101101|Mitosis Modulators|mitosis modulators|mesh-ancestor
110524254|NCT00101101|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110524255|NCT00101101|Analgesics|analgesics|mesh-ancestor
110524256|NCT00101101|Sensory System Agents|sensory system agents|mesh-ancestor
110524257|NCT00101101|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110524258|NCT00101101|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110524259|NCT00101101|Antiviral Agents|antiviral agents|mesh-ancestor
110524260|NCT00101101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110524261|NCT00946621|Ramipril|ramipril|mesh-list
110524262|NCT00946621|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110524263|NCT00946621|Protease Inhibitors|protease inhibitors|mesh-ancestor
110524270|NCT04235894|Propofol|propofol|mesh-list
110524318|NCT02796950|Acipimox|acipimox|mesh-list
110524319|NCT02796950|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110524320|NCT02796950|Antimetabolites|antimetabolites|mesh-ancestor
110524321|NCT02796950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110524322|NCT02796950|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110524323|NCT00755079|Adrenergic Agents|adrenergic agents|mesh-list
110524324|NCT00755079|Adrenergic Agonists|adrenergic agonists|mesh-list
110524325|NCT00755079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110524327|NCT00755079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110524384|NCT04200092|Serotonin Agents|serotonin agents|mesh-ancestor
110524385|NCT04200092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110524386|NCT04200092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110524387|NCT00754065|Moxifloxacin|moxifloxacin|mesh-list
110524388|NCT00754065|Dienogest|dienogest|mesh-list
110524389|NCT00754065|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110524390|NCT00754065|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110524452|NCT04094805|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110524453|NCT04094805|Vitamins|vitamins|mesh-ancestor
110524454|NCT04094805|Micronutrients|micronutrients|mesh-ancestor
110524455|NCT04094805|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110524526|NCT02787356|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110524527|NCT02787356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110524529|NCT02787278|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110524530|NCT02787278|Protective Agents|protective agents|mesh-ancestor
110524531|NCT02787278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110524532|NCT03083678|Afatinib|afatinib|mesh-list
110524533|NCT03083678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110524534|NCT03083678|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110524535|NCT03083678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110524536|NCT03083678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110524537|NCT04232150|Midazolam|midazolam|mesh-list
110524588|NCT02784392|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110524589|NCT02784392|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110524590|NCT02784392|Dopamine Agents|dopamine agents|mesh-ancestor
110524591|NCT02784392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110524593|NCT00634556|Levodopa|levodopa|mesh-list
110524659|NCT02783144|Hormones|hormones|mesh-ancestor
110524660|NCT02783144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110524661|NCT02783144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110172099|NCT00048802|Valproic Acid|valproic acid|mesh-list
110524662|NCT02783144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110524663|NCT02783144|Protease Inhibitors|protease inhibitors|mesh-ancestor
110524664|NCT02783144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110524723|NCT02722746|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110524724|NCT02722746|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110524725|NCT02722746|Adrenergic Agents|adrenergic agents|mesh-ancestor
110524726|NCT02722746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110524727|NCT02722746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110524728|NCT02722746|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110524790|NCT05133518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110524791|NCT05133518|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110524864|NCT02600247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110524865|NCT02600247|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110524866|NCT02600247|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110524867|NCT02600247|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110524935|NCT00923273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110525008|NCT04256057|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110525009|NCT04256057|Tocolytic Agents|tocolytic agents|mesh-ancestor
110525010|NCT04256057|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110525011|NCT04189302|Pyrithione zinc|pyrithione zinc|mesh-list
110525012|NCT04189302|Keratolytic Agents|keratolytic agents|mesh-ancestor
110525013|NCT04189302|Dermatologic Agents|dermatologic agents|mesh-ancestor
110525014|NCT02714010|Gefitinib|gefitinib|mesh-list
110525076|NCT04908605|Histamine Agents|histamine agents|mesh-ancestor
110525077|NCT04908605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110525078|NCT04908605|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110525079|NCT04908605|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110525080|NCT04908605|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
110525083|NCT04908605|Adrenergic Agents|adrenergic agents|mesh-ancestor
110525145|NCT02780102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110525217|NCT00636870|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110525218|NCT00636870|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110525219|NCT00636870|Histamine Antagonists|histamine antagonists|mesh-ancestor
110525286|NCT02713074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110525287|NCT00637793|(S)-2-ethyl-8-methyl-1-thia-4,8-diazaspiro(4.5)decan-3-one|(s)-2-ethyl-8-methyl-1-thia-4,8-diazaspiro(4.5)decan-3-one|mesh-list
110525288|NCT00637793|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
110525356|NCT00745095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110525357|NCT00745095|Cholinergic Agents|cholinergic agents|mesh-ancestor
110525358|NCT00745095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110525359|NCT00745095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110525360|NCT00745095|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110525361|NCT00745095|Autonomic Agents|autonomic agents|mesh-ancestor
110525362|NCT00745095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110525363|NCT05181462|Carboplatin|carboplatin|mesh-list
110525364|NCT05181462|Gemcitabine|gemcitabine|mesh-list
110525365|NCT05181462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110525366|NCT05181462|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110525367|NCT05181462|Antimetabolites|antimetabolites|mesh-ancestor
110525368|NCT05181462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110525369|NCT00612612|Rituximab|rituximab|mesh-list
110525370|NCT00612612|Fludarabine|fludarabine|mesh-list
110525371|NCT00612612|Fludarabine phosphate|fludarabine phosphate|mesh-list
110525372|NCT00612612|Obatoclax|obatoclax|mesh-list
110525373|NCT00612612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110525374|NCT00612612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110525375|NCT00612612|Immunologic Factors|immunologic factors|mesh-ancestor
110525379|NCT00612612|Antimetabolites|antimetabolites|mesh-ancestor
110525410|NCT02598063|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110525411|NCT02707458|Probucol|probucol|mesh-list
110525412|NCT02707458|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110525483|NCT05301205|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110525484|NCT05301205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110525485|NCT05301205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110525486|NCT05301205|Antimanic Agents|antimanic agents|mesh-ancestor
110525487|NCT02707224|Candesartan|candesartan|mesh-list
110525501|NCT04229264|Clopidogrel|clopidogrel|mesh-list
110525553|NCT02711358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110525554|NCT02711358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110525555|NCT02711358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110525556|NCT02711358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110525626|NCT00952003|Mitosis Modulators|mitosis modulators|mesh-ancestor
110525627|NCT00952003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110525628|NCT00952003|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110525629|NCT00952003|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110525697|NCT00948649|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110525698|NCT00948649|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110525699|NCT00948649|Cholinergic Agents|cholinergic agents|mesh-ancestor
110525700|NCT00948649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110525703|NCT00952159|Tramadol|tramadol|mesh-list
110525770|NCT00562159|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110525771|NCT00562159|Tocolytic Agents|tocolytic agents|mesh-ancestor
110525772|NCT00562159|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110525773|NCT00562159|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110525774|NCT00562159|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110525838|NCT05109416|Sensory System Agents|sensory system agents|mesh-ancestor
110525839|NCT05109416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110525840|NCT04074564|Apatinib|apatinib|mesh-list
110525841|NCT04074564|Antibodies|antibodies|mesh-list
110525842|NCT04074564|Immunologic Factors|immunologic factors|mesh-ancestor
110525843|NCT04074564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110525844|NCT04074564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110525846|NCT04074564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110525909|NCT04255589|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110525910|NCT04255589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110525911|NCT04255589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110525912|NCT04255589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110525913|NCT00744471|Tanezumab|tanezumab|mesh-list
110525981|NCT04688814|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110525982|NCT04688814|Narcotics|narcotics|mesh-ancestor
110525983|NCT04688814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110525984|NCT04688814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110525985|NCT04688814|Analgesics|analgesics|mesh-ancestor
110525986|NCT04688814|Sensory System Agents|sensory system agents|mesh-ancestor
110526051|NCT04875728|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110526052|NCT04875728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110526053|NCT00611910|Sirolimus|sirolimus|mesh-list
110526054|NCT00611910|Paclitaxel|paclitaxel|mesh-list
110526055|NCT00611910|Temsirolimus|temsirolimus|mesh-list
110526122|NCT04570644|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110526123|NCT04570644|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110526124|NCT04570644|Respiratory System Agents|respiratory system agents|mesh-ancestor
110526125|NCT02775110|Natalizumab|natalizumab|mesh-list
110526126|NCT02775110|Immunologic Factors|immunologic factors|mesh-ancestor
110526127|NCT02775110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110526128|NCT02775266|Thioctic Acid|thioctic acid|mesh-list
110526129|NCT02775266|Antioxidants|antioxidants|mesh-ancestor
110526130|NCT02775266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110594032|NCT02598960|Nivolumab|nivolumab|mesh-list
110526131|NCT02775266|Protective Agents|protective agents|mesh-ancestor
110526132|NCT02775266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110526133|NCT02775266|Vitamin B Complex|vitamin b complex|mesh-ancestor
110526134|NCT02775266|Vitamins|vitamins|mesh-ancestor
110526135|NCT02775266|Micronutrients|micronutrients|mesh-ancestor
110526184|NCT02774564|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110526185|NCT02774564|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110526186|NCT02774564|Dopamine Agonists|dopamine agonists|mesh-ancestor
110526187|NCT02774564|Dopamine Agents|dopamine agents|mesh-ancestor
110526188|NCT02774564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110526189|NCT02774564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110526190|NCT00613470|Citalopram|citalopram|mesh-list
110526191|NCT00613470|Escitalopram|escitalopram|mesh-list
110526192|NCT00613470|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110526193|NCT00613470|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110526194|NCT00613470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110526195|NCT00613470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110526196|NCT00613470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110526244|NCT04181385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110526245|NCT04181385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110526246|NCT04181385|Serotonin Agents|serotonin agents|mesh-ancestor
110526247|NCT04181385|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110526248|NCT04181385|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110526249|NCT04181385|Hormone Antagonists|hormone antagonists|mesh-ancestor
110526250|NCT04181385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110526252|NCT04181385|Dopamine Agents|dopamine agents|mesh-ancestor
110526253|NCT00924443|Clofarabine|clofarabine|mesh-list
110526254|NCT00924443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110526255|NCT00924443|Antimetabolites|antimetabolites|mesh-ancestor
110526256|NCT00924443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110526257|NCT00924443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110526258|NCT02677155|Rituximab|rituximab|mesh-list
110526259|NCT02677155|Pembrolizumab|pembrolizumab|mesh-list
110526260|NCT02677155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110526261|NCT02677155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110526289|NCT04255121|Lidocaine|lidocaine|mesh-list
110526301|NCT04255121|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110526302|NCT04255121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110526303|NCT04255121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110526304|NCT04255121|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110526305|NCT04255121|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110526306|NCT04255121|Adrenergic Agents|adrenergic agents|mesh-ancestor
110526307|NCT04255121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110526308|NCT04255121|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110173763|NCT00060931|Metoprolol|metoprolol|mesh-list
110526372|NCT00642681|Insulin|insulin|mesh-list
110526373|NCT00642681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110526374|NCT00642681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110526441|NCT02776748|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110526442|NCT02776748|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110526443|NCT02676609|Insulin|insulin|mesh-list
110526444|NCT02676609|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110526445|NCT02676609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110526510|NCT05141682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110526511|NCT05141682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110526512|NCT05141682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110526514|NCT00643227|Clarithromycin|clarithromycin|mesh-list
110526515|NCT00643227|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110526516|NCT00643227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110526517|NCT00643227|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110526518|NCT00643227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110526519|NCT00643227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110526520|NCT00643227|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110526521|NCT00643227|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110526522|NCT00613392|Antioxidants|antioxidants|mesh-list
110526523|NCT00613392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110526524|NCT00613392|Protective Agents|protective agents|mesh-ancestor
110526525|NCT00613392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110526526|NCT02537457|Rivaroxaban|rivaroxaban|mesh-list
110526566|NCT04658654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110526567|NCT04658654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110526568|NCT02770508|Ritonavir|ritonavir|mesh-list
110526569|NCT02770508|Darunavir|darunavir|mesh-list
110526570|NCT02770508|Tenofovir|tenofovir|mesh-list
110526571|NCT02770508|Lamivudine|lamivudine|mesh-list
110526572|NCT02770508|Emtricitabine|emtricitabine|mesh-list
110526573|NCT02770508|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110526574|NCT02770508|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110526575|NCT02770508|Protease Inhibitors|protease inhibitors|mesh-ancestor
110526576|NCT02770508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110526577|NCT02770508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110526578|NCT02770508|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110526579|NCT02770508|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110526629|NCT04224116|Tranexamic Acid|tranexamic acid|mesh-list
110526630|NCT04224116|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110526631|NCT04224116|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110526632|NCT04224116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110526633|NCT04224116|Hemostatics|hemostatics|mesh-ancestor
110526634|NCT04224116|Coagulants|coagulants|mesh-ancestor
110526635|NCT02672709|Apixaban|apixaban|mesh-list
110526636|NCT02672709|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110526637|NCT02672709|Antithrombins|antithrombins|mesh-ancestor
110526695|NCT04224350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110526696|NCT04224350|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110526697|NCT04224350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110526698|NCT04224350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110526700|NCT02770716|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110526701|NCT02770716|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110526702|NCT02672241|Temozolomide|temozolomide|mesh-list
110526703|NCT02672241|Nimotuzumab|nimotuzumab|mesh-list
110526704|NCT02672241|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110526705|NCT02672241|Alkylating Agents|alkylating agents|mesh-ancestor
110526706|NCT02672241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110526707|NCT02672241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110526708|NCT02672241|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110526710|NCT04177875|Docetaxel|docetaxel|mesh-list
110526711|NCT04177875|Cisplatin|cisplatin|mesh-list
110526712|NCT04177875|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110526713|NCT04177875|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110526714|NCT04177875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110526750|NCT04178109|Anesthetics, Local|anesthetics, local|mesh-ancestor
110526751|NCT04178109|Anesthetics|anesthetics|mesh-ancestor
110526752|NCT04178109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110526753|NCT04178109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110526754|NCT04178109|Sensory System Agents|sensory system agents|mesh-ancestor
110526757|NCT04178109|Analgesics|analgesics|mesh-ancestor
110526819|NCT00915473|Autonomic Agents|autonomic agents|mesh-ancestor
110526820|NCT00915473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110526821|NCT00915473|Glucocorticoids|glucocorticoids|mesh-ancestor
110526822|NCT00915473|Hormones|hormones|mesh-ancestor
110526823|NCT00915473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110526824|NCT00915473|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110526825|NCT00915473|Protective Agents|protective agents|mesh-ancestor
110526826|NCT00915473|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110526827|NCT00915473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110526828|NCT04691726|Dipyrone|dipyrone|mesh-list
110526829|NCT04691726|Lidocaine|lidocaine|mesh-list
110526830|NCT04691726|Morphine|morphine|mesh-list
110526831|NCT04691726|Anesthetics, Local|anesthetics, local|mesh-ancestor
110526832|NCT04691726|Anesthetics|anesthetics|mesh-ancestor
110174281|NCT00065143|Clofarabine|clofarabine|mesh-list
110526833|NCT04691726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110526834|NCT04691726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110526835|NCT04691726|Sensory System Agents|sensory system agents|mesh-ancestor
110526836|NCT04691726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110526837|NCT04691726|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110526838|NCT04691726|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110526839|NCT04691726|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110526840|NCT04691726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110526841|NCT04691726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110526842|NCT04691726|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110526868|NCT04177173|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110526869|NCT04177173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110526870|NCT04177173|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110526871|NCT04177173|Antimetabolites|antimetabolites|mesh-ancestor
110526873|NCT04177173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110526939|NCT04253873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110526940|NCT04253873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110526941|NCT04253873|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110526942|NCT04253873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110526943|NCT05147727|Fluconazole|fluconazole|mesh-list
110526944|NCT05147727|Antifungal Agents|antifungal agents|mesh-ancestor
110526945|NCT05147727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110526946|NCT05147727|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110526947|NCT05147727|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110526948|NCT05147727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110526950|NCT05147727|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110527003|NCT02769572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110527004|NCT02769572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110527005|NCT02769572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110527006|NCT02769572|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110527007|NCT02769572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110527009|NCT02669589|Heparin|heparin|mesh-list
110527073|NCT04679012|Prednisone|prednisone|mesh-list
110527074|NCT04679012|Cyclophosphamide|cyclophosphamide|mesh-list
110527075|NCT04679012|Rituximab|rituximab|mesh-list
110527076|NCT04679012|Doxorubicin|doxorubicin|mesh-list
110527077|NCT04679012|Etoposide|etoposide|mesh-list
110527078|NCT04679012|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110527079|NCT04679012|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
110527080|NCT04679012|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110527081|NCT04679012|Immunologic Factors|immunologic factors|mesh-ancestor
110527096|NCT04679012|Hormones|hormones|mesh-ancestor
110527140|NCT02764736|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110527142|NCT00646737|Mycophenolic Acid|mycophenolic acid|mesh-list
110527143|NCT00646737|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110527144|NCT00646737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110527145|NCT00646737|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110527146|NCT00646737|Antitubercular Agents|antitubercular agents|mesh-ancestor
110527207|NCT02696330|Purinergic Agents|purinergic agents|mesh-ancestor
110527208|NCT02696330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110527209|NCT02696330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110527210|NCT02696330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110527211|NCT02696330|Anticoagulants|anticoagulants|mesh-ancestor
110527212|NCT02696330|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110527213|NCT02696330|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110527276|NCT00561925|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110527277|NCT00561925|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110527278|NCT00561925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110527279|NCT00561925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110527347|NCT00647829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110527348|NCT00647829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110527349|NCT00647829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110527350|NCT02517918|Zoledronic Acid|zoledronic acid|mesh-list
110527351|NCT02517918|Sirolimus|sirolimus|mesh-list
110527352|NCT02517918|Methotrexate|methotrexate|mesh-list
110527353|NCT02517918|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110527354|NCT02517918|Abortifacient Agents|abortifacient agents|mesh-ancestor
110527355|NCT02517918|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110527356|NCT02517918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110174810|NCT00070174|Cytarabine|cytarabine|mesh-list
110527357|NCT02517918|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110527358|NCT02517918|Antimetabolites|antimetabolites|mesh-ancestor
110527359|NCT02517918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110527360|NCT02517918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110527361|NCT02517918|Dermatologic Agents|dermatologic agents|mesh-ancestor
110527362|NCT02517918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110527363|NCT02517918|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110527364|NCT02517918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110527365|NCT02517918|Immunologic Factors|immunologic factors|mesh-ancestor
110527366|NCT02517918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110527367|NCT02517918|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110527368|NCT02517918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110527369|NCT02517918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110527370|NCT02517918|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110527371|NCT02517918|Antifungal Agents|antifungal agents|mesh-ancestor
110527372|NCT02517918|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110527374|NCT00647907|Antifungal Agents|antifungal agents|mesh-ancestor
110527375|NCT00647907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110527385|NCT04017546|Venetoclax|venetoclax|mesh-list
110527390|NCT04003818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110527391|NCT04003818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110527392|NCT00949663|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
110527393|NCT00949663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110527460|NCT00648219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110527461|NCT00648297|Nadolol|nadolol|mesh-list
110527462|NCT00648297|Bendroflumethiazide|bendroflumethiazide|mesh-list
110527463|NCT00648297|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110527464|NCT00648297|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110527465|NCT00648297|Adrenergic Agents|adrenergic agents|mesh-ancestor
110527466|NCT00648297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110527467|NCT00648297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110527468|NCT00648297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110527469|NCT00648297|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110527470|NCT00648297|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110527471|NCT00648297|Sympatholytics|sympatholytics|mesh-ancestor
110527472|NCT00648297|Autonomic Agents|autonomic agents|mesh-ancestor
110527473|NCT00648297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110527474|NCT00648297|Diuretics|diuretics|mesh-ancestor
110527475|NCT00648297|Natriuretic Agents|natriuretic agents|mesh-ancestor
110527476|NCT00648297|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110527477|NCT00648297|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110527478|NCT00648453|Clopidogrel|clopidogrel|mesh-list
110527479|NCT00648453|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110527480|NCT00648453|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110527481|NCT00648453|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110527482|NCT00648453|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110527483|NCT00648453|Purinergic Agents|purinergic agents|mesh-ancestor
110527487|NCT00549445|Azithromycin|azithromycin|mesh-list
110527507|NCT02758340|Abortifacient Agents|abortifacient agents|mesh-ancestor
110527508|NCT02758340|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110527509|NCT02758340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110527510|NCT02758340|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110527511|NCT02758340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110527512|NCT02758340|Oxytocics|oxytocics|mesh-ancestor
110527581|NCT02658825|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110527582|NCT02658825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110527583|NCT02658825|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110527584|NCT02658825|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110527585|NCT02658825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110527586|NCT02658825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110527587|NCT02658825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110527588|NCT02658825|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110527589|NCT02658825|Contraceptive Agents|contraceptive agents|mesh-ancestor
110527590|NCT02658825|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110527591|NCT02658825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110527592|NCT02658825|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110527593|NCT02658825|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110527594|NCT02658825|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110527640|NCT02692248|Gemcitabine|gemcitabine|mesh-list
110527641|NCT02692248|Oxaliplatin|oxaliplatin|mesh-list
110527642|NCT02692248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110527643|NCT02692248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110527644|NCT02692248|Immunologic Factors|immunologic factors|mesh-ancestor
110527645|NCT02692248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110527646|NCT02692248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110527647|NCT02692248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110527648|NCT02692248|Antiemetics|antiemetics|mesh-ancestor
110527649|NCT02692248|Autonomic Agents|autonomic agents|mesh-ancestor
110527650|NCT02692248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110527703|NCT02462538|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110527704|NCT02462538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110527705|NCT02462538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110527706|NCT02462538|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110527708|NCT02462538|Immunoconjugates|immunoconjugates|mesh-ancestor
110527709|NCT02462538|Immunologic Factors|immunologic factors|mesh-ancestor
110527710|NCT02462538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110527711|NCT02752646|Ketorolac|ketorolac|mesh-list
110527712|NCT02752646|Nepafenac|nepafenac|mesh-list
110527713|NCT02752646|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110527714|NCT02752646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110527767|NCT00649545|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110527768|NCT00649545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110527769|NCT00649545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110527770|NCT00635414|Esomeprazole|esomeprazole|mesh-list
110527771|NCT00635414|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110527772|NCT00635414|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110527773|NCT00635414|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110527774|NCT00635414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110527775|NCT00635414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110527776|NCT02658435|Tafenoquine|tafenoquine|mesh-list
110527832|NCT02657187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110527833|NCT02657187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110527834|NCT00649779|Albuterol|albuterol|mesh-list
110527835|NCT00649779|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110527836|NCT00649779|Autonomic Agents|autonomic agents|mesh-ancestor
110527837|NCT00649779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110527898|NCT02759042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110527899|NCT02755532|Bupivacaine|bupivacaine|mesh-list
110527900|NCT02755532|Anesthetics, Local|anesthetics, local|mesh-ancestor
110527901|NCT02755532|Anesthetics|anesthetics|mesh-ancestor
110527902|NCT02755532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110527903|NCT02755532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110527904|NCT02755532|Sensory System Agents|sensory system agents|mesh-ancestor
110527906|NCT02755376|Hyaluronic Acid|hyaluronic acid|mesh-list
110527964|NCT02755064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110527965|NCT02755064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110527966|NCT02705976|Warfarin|warfarin|mesh-list
110527967|NCT02705976|Anticoagulants|anticoagulants|mesh-ancestor
110527968|NCT02752412|Insulin|insulin|mesh-list
110527969|NCT02752412|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110527970|NCT02752412|Metformin|metformin|mesh-list
110527971|NCT02752412|Insulin Glargine|insulin glargine|mesh-list
110528032|NCT04220996|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110528033|NCT02702700|Verteporfin|verteporfin|mesh-list
110528034|NCT02702700|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110528035|NCT02702700|Dermatologic Agents|dermatologic agents|mesh-ancestor
110528036|NCT02702622|Provitamins|provitamins|mesh-list
110528037|NCT02702622|Beta Carotene|beta carotene|mesh-list
110528038|NCT02702622|Vitamins|vitamins|mesh-ancestor
110528101|NCT02702076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110528174|NCT02704962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110528175|NCT02704962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110528176|NCT02704962|Serotonin Agents|serotonin agents|mesh-ancestor
110528177|NCT00631943|Pregabalin|pregabalin|mesh-list
110528178|NCT00631943|Analgesics|analgesics|mesh-ancestor
110528179|NCT00631943|Sensory System Agents|sensory system agents|mesh-ancestor
110528180|NCT00631943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110528181|NCT00631943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110528182|NCT00631943|Anticonvulsants|anticonvulsants|mesh-ancestor
110528183|NCT00631943|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110528184|NCT00631943|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110528185|NCT00631943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110528186|NCT00631943|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110528187|NCT00631943|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110528188|NCT00631943|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110528189|NCT00631943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110528190|NCT00631943|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110528192|NCT05429684|Capecitabine|capecitabine|mesh-list
110528232|NCT02750696|Acetaminophen|acetaminophen|mesh-list
110528233|NCT02750696|Tramadol|tramadol|mesh-list
110528234|NCT02750696|Codeine|codeine|mesh-list
110528235|NCT02750696|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110528236|NCT02750696|Analgesics|analgesics|mesh-ancestor
110528237|NCT02750696|Sensory System Agents|sensory system agents|mesh-ancestor
110528238|NCT02750696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110528239|NCT02750696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110528240|NCT02750696|Antipyretics|antipyretics|mesh-ancestor
110528241|NCT02750696|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110528242|NCT02750696|Narcotics|narcotics|mesh-ancestor
110528243|NCT02750696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110528244|NCT02750696|Antitussive Agents|antitussive agents|mesh-ancestor
110528246|NCT02695550|Conteltinib|conteltinib|mesh-list
110528296|NCT02701608|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110528297|NCT02701608|Antitubercular Agents|antitubercular agents|mesh-ancestor
110528298|NCT02701608|Leprostatic Agents|leprostatic agents|mesh-ancestor
110528299|NCT02701608|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110528306|NCT00635960|Hormones|hormones|mesh-list
110528365|NCT02862210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110528366|NCT02862210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110528368|NCT02862210|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110528369|NCT02862210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110528370|NCT02862210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110528371|NCT05323422|Ketamine|ketamine|mesh-list
110594115|NCT00791739|Pregabalin|pregabalin|mesh-list
110528372|NCT05323422|Analgesics|analgesics|mesh-ancestor
110528385|NCT02700906|Lidocaine|lidocaine|mesh-list
110528432|NCT04772196|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110528433|NCT04772196|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110528434|NCT05428670|Rituximab|rituximab|mesh-list
110528435|NCT05428670|Lenalidomide|lenalidomide|mesh-list
110528436|NCT05428670|Zanubrutinib|zanubrutinib|mesh-list
110528437|NCT05428670|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110528438|NCT05428670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110528440|NCT05428670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110528441|NCT05428670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110528449|NCT00635726|Cisplatin|cisplatin|mesh-list
110528498|NCT04216706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110528499|NCT04216706|Autonomic Agents|autonomic agents|mesh-ancestor
110528500|NCT04216706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110528501|NCT00913835|Doxorubicin|doxorubicin|mesh-list
110528502|NCT00913835|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110528503|NCT00913835|Olaratumab|olaratumab|mesh-list
110528504|NCT00913835|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110528505|NCT00913835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110528506|NCT00913835|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110528507|NCT00913835|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110528508|NCT00913835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110528562|NCT05412056|Metformin|metformin|mesh-list
110528563|NCT05412056|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110528564|NCT05412056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110528565|NCT04453046|Pembrolizumab|pembrolizumab|mesh-list
110528566|NCT04453046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110528567|NCT04453046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110528568|NCT04453046|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110528569|NCT04453046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110528570|NCT04217096|Paclitaxel|paclitaxel|mesh-list
110528571|NCT04217096|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110528572|NCT04217096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110528573|NCT04217096|Tubulin Modulators|tubulin modulators|mesh-ancestor
110528625|NCT04032626|Immunologic Factors|immunologic factors|mesh-ancestor
110528626|NCT04032626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110528627|NCT04032626|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110528628|NCT04032626|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110528629|NCT04032626|Growth Substances|growth substances|mesh-ancestor
110528630|NCT04032626|Growth Inhibitors|growth inhibitors|mesh-ancestor
110528631|NCT04032626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110528632|NCT04214106|Thiamine|thiamine|mesh-list
110528633|NCT04214106|Vitamin B Complex|vitamin b complex|mesh-ancestor
110528634|NCT04214106|Vitamins|vitamins|mesh-ancestor
110528635|NCT04214106|Micronutrients|micronutrients|mesh-ancestor
110528636|NCT04214106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110528637|NCT02747732|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110528640|NCT02747732|Alkylating Agents|alkylating agents|mesh-ancestor
110528688|NCT03355157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110528689|NCT03355157|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110528690|NCT03355157|Antimetabolites|antimetabolites|mesh-ancestor
110528691|NCT03355157|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110528692|NCT03355157|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110528693|NCT03355157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110528694|NCT03355157|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110528695|NCT03355157|Hormone Antagonists|hormone antagonists|mesh-ancestor
110528696|NCT03355157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110528697|NCT03355157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110528698|NCT03355157|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110528699|NCT03355157|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110528700|NCT03355157|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110528701|NCT03355157|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110528702|NCT03355157|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110528703|NCT03355157|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110528704|NCT03355157|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110528707|NCT04215432|Propolis|propolis|mesh-list
110528742|NCT00616746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110528743|NCT00616746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110528744|NCT00616746|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110528745|NCT00616746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110528746|NCT00616746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110528747|NCT00632255|Imatinib Mesylate|imatinib mesylate|mesh-list
110528748|NCT00632255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110528749|NCT00632255|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110528750|NCT00632255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110528751|NCT00632255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110528752|NCT05271578|Nicotine|nicotine|mesh-list
110528753|NCT05271578|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110528754|NCT05271578|Autonomic Agents|autonomic agents|mesh-ancestor
110528755|NCT05271578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110528756|NCT05271578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110528757|NCT05271578|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110528758|NCT05271578|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110528759|NCT05271578|Cholinergic Agents|cholinergic agents|mesh-ancestor
110528760|NCT05271578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110528761|NCT05271578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110528762|NCT04203485|Paclitaxel|paclitaxel|mesh-list
110528763|NCT04203485|Carboplatin|carboplatin|mesh-list
110528764|NCT04203485|Pemetrexed|pemetrexed|mesh-list
110528765|NCT04203485|Apatinib|apatinib|mesh-list
110528766|NCT04203485|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110528782|NCT03851627|Hormones|hormones|mesh-ancestor
110528793|NCT03116126|Adrenergic Agents|adrenergic agents|mesh-ancestor
110528794|NCT03116126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110528861|NCT00910091|Appetite Stimulants|appetite stimulants|mesh-ancestor
110528862|NCT00910091|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110528863|NCT04216550|Apatinib|apatinib|mesh-list
110528864|NCT04216550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110528934|NCT03812588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110528935|NCT03812588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110528936|NCT03812588|Serotonin Agents|serotonin agents|mesh-ancestor
110528937|NCT03812588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110528938|NCT02387099|Everolimus|everolimus|mesh-list
110528939|NCT02387099|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110528940|NCT02387099|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110528941|NCT02387099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110528942|NCT02387099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110528943|NCT02387099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110528944|NCT02387099|Immunologic Factors|immunologic factors|mesh-ancestor
110528945|NCT02387099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110528946|NCT02387099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110528947|NCT02745860|Selexipag|selexipag|mesh-list
110528948|NCT02745860|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110528949|NCT04788641|Cyclosporine|cyclosporine|mesh-list
110528992|NCT02736500|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
110528993|NCT02736500|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110529065|NCT02744456|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110529066|NCT02744456|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110529067|NCT02744456|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110529068|NCT02744456|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110529069|NCT02744456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110529070|NCT02744456|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110529135|NCT02735798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110529136|NCT03760718|Chloroprocaine|chloroprocaine|mesh-list
110529137|NCT03760718|Procaine|procaine|mesh-list
110529138|NCT03760718|Anesthetics, Local|anesthetics, local|mesh-ancestor
110529139|NCT03760718|Anesthetics|anesthetics|mesh-ancestor
110529140|NCT03760718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110176606|NCT00081874|Everolimus|everolimus|mesh-list
110529141|NCT03760718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110529142|NCT03760718|Sensory System Agents|sensory system agents|mesh-ancestor
110529143|NCT03760718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110529144|NCT05590286|Amoxicillin|amoxicillin|mesh-list
110529145|NCT05590286|Esomeprazole|esomeprazole|mesh-list
110529146|NCT05590286|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110529147|NCT05590286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110529148|NCT05590286|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110529195|NCT02631941|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110529196|NCT02631941|Adrenergic Agents|adrenergic agents|mesh-ancestor
110529197|NCT02631941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110529198|NCT02631941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110529199|NCT02631941|Antidotes|antidotes|mesh-ancestor
110529200|NCT02631941|Protective Agents|protective agents|mesh-ancestor
110529201|NCT02690987|Exenatide|exenatide|mesh-list
110529202|NCT02690987|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110529203|NCT02690987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110529204|NCT02690987|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110529205|NCT02690987|Incretins|incretins|mesh-ancestor
110529206|NCT02690987|Hormones|hormones|mesh-ancestor
110529207|NCT02690987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110529208|NCT02740166|Propranolol|propranolol|mesh-list
110529209|NCT02740166|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110529257|NCT02731664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110529258|NCT02731664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110529259|NCT02731664|Incretins|incretins|mesh-ancestor
110529260|NCT02543255|Prednisone|prednisone|mesh-list
110529261|NCT02543255|Leuprolide|leuprolide|mesh-list
110529330|NCT02731040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110529331|NCT02734160|Durvalumab|durvalumab|mesh-list
110529332|NCT02734160|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110529333|NCT02734160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110529334|NCT02730572|Methylphenidate|methylphenidate|mesh-list
110529335|NCT02730572|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110529397|NCT02729870|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110529398|NCT05628662|Insulin|insulin|mesh-list
110529401|NCT02694848|Aspirin|aspirin|mesh-list
110529468|NCT02728700|Antitubercular Agents|antitubercular agents|mesh-ancestor
110529469|NCT02728700|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110529470|NCT02728700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110529472|NCT02728700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110529473|NCT02728700|Antifungal Agents|antifungal agents|mesh-ancestor
110529474|NCT02728700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110529475|NCT02728700|Immunologic Factors|immunologic factors|mesh-ancestor
110529537|NCT02733380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110529538|NCT02733380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110529539|NCT02733380|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110529540|NCT02733380|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110529541|NCT02733380|Growth Substances|growth substances|mesh-ancestor
110529542|NCT02733380|Growth Inhibitors|growth inhibitors|mesh-ancestor
110529543|NCT02733380|Analgesics|analgesics|mesh-ancestor
110529544|NCT02733380|Sensory System Agents|sensory system agents|mesh-ancestor
110529604|NCT02727296|Sevoflurane|sevoflurane|mesh-list
110529605|NCT02727296|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110529606|NCT02727296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110529678|NCT02726984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110529679|NCT02726984|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110529680|NCT02726984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110529681|NCT02726828|Ketamine|ketamine|mesh-list
110529682|NCT02726828|Morphine|morphine|mesh-list
110529683|NCT02726828|Analgesics|analgesics|mesh-ancestor
110529684|NCT02726828|Sensory System Agents|sensory system agents|mesh-ancestor
110529685|NCT02726828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110529686|NCT02726828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110529687|NCT02726828|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110529688|NCT02726828|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110529689|NCT02726828|Anesthetics, General|anesthetics, general|mesh-ancestor
110529690|NCT02726828|Anesthetics|anesthetics|mesh-ancestor
110529691|NCT02726828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110529696|NCT02726828|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110529741|NCT04167176|Anesthetics, Local|anesthetics, local|mesh-ancestor
110529742|NCT04167176|Anesthetics|anesthetics|mesh-ancestor
110529743|NCT04167176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110529744|NCT04167176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110529745|NCT04167176|Sensory System Agents|sensory system agents|mesh-ancestor
110529746|NCT04167176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110529747|NCT04167176|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110529748|NCT04167176|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110529749|NCT04167176|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110529750|NCT04167176|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110529751|NCT04167176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110529752|NCT02720120|Ocrelizumab|ocrelizumab|mesh-list
110529753|NCT02720120|Immunologic Factors|immunologic factors|mesh-ancestor
110529803|NCT02129348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110529804|NCT02129348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110529805|NCT02725736|Nifedipine|nifedipine|mesh-list
110529806|NCT02725736|Atosiban|atosiban|mesh-list
110529807|NCT02725736|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110529808|NCT02725736|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110529809|NCT02725736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110529810|NCT02725736|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110529811|NCT02725736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110529812|NCT02725736|Vasodilator Agents|vasodilator agents|mesh-ancestor
110529813|NCT02725736|Tocolytic Agents|tocolytic agents|mesh-ancestor
110529868|NCT02725502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110529869|NCT02725502|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110529870|NCT02725502|Protease Inhibitors|protease inhibitors|mesh-ancestor
110529871|NCT02725502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110529872|NCT02725502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110529873|NCT02718716|Rozanolixizumab|rozanolixizumab|mesh-list
110529874|NCT02718716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110529875|NCT02718716|Immunologic Factors|immunologic factors|mesh-ancestor
110529876|NCT02718716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110529877|NCT01959464|Progesterone|progesterone|mesh-list
110529878|NCT01959464|Progestins|progestins|mesh-ancestor
110529879|NCT01959464|Hormones|hormones|mesh-ancestor
110529881|NCT01959464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110529930|NCT02717780|Desflurane|desflurane|mesh-list
110529931|NCT02717780|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110529932|NCT02717780|Narcotics|narcotics|mesh-ancestor
110529933|NCT02717780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110529934|NCT02717780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110529935|NCT02717780|Analgesics|analgesics|mesh-ancestor
110529936|NCT02717780|Sensory System Agents|sensory system agents|mesh-ancestor
110529937|NCT02717780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110529938|NCT02717780|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110529939|NCT02717780|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110529940|NCT02717780|Anesthetics, General|anesthetics, general|mesh-ancestor
110529941|NCT02717780|Anesthetics|anesthetics|mesh-ancestor
110529942|NCT02717780|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110529943|NCT02717780|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110529944|NCT02724098|Dexmedetomidine|dexmedetomidine|mesh-list
110529945|NCT02724098|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110529946|NCT02724098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110529947|NCT02724098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110529948|NCT02724098|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110529949|NCT02724098|Analgesics|analgesics|mesh-ancestor
110529950|NCT02724098|Sensory System Agents|sensory system agents|mesh-ancestor
110529951|NCT02724098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110529952|NCT02724098|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110529953|NCT02724098|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110529954|NCT02724098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110529955|NCT02724098|Adrenergic Agents|adrenergic agents|mesh-ancestor
110529956|NCT02724098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110529957|NCT02724098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110529958|NCT02723942|Immunomodulating Agents|immunomodulating agents|mesh-list
110529959|NCT02723942|Immunologic Factors|immunologic factors|mesh-ancestor
110529960|NCT02723942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110529961|NCT04138316|Candesartan|candesartan|mesh-list
110529972|NCT04189484|Evolocumab|evolocumab|mesh-list
110529973|NCT04189484|Alirocumab|alirocumab|mesh-list
110529974|NCT04189484|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110529975|NCT04189484|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
110529976|NCT04189484|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110529977|NCT04189484|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110529978|NCT04189484|Antimetabolites|antimetabolites|mesh-ancestor
110529979|NCT04189484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110529980|NCT04189484|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110529981|NCT04189484|Protease Inhibitors|protease inhibitors|mesh-ancestor
110529982|NCT04189484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110529983|NCT04189484|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110529984|NCT04189484|Immunologic Factors|immunologic factors|mesh-ancestor
110529985|NCT04189484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110529986|NCT00636740|Zoledronic Acid|zoledronic acid|mesh-list
110529990|NCT02716766|Oxaliplatin|oxaliplatin|mesh-list
110530032|NCT04189094|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110530033|NCT04189094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110530034|NCT04189094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110530036|NCT02712944|Androgens|androgens|mesh-ancestor
110530037|NCT02712944|Hormones|hormones|mesh-ancestor
110530038|NCT02712944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110530099|NCT02651727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110530100|NCT02651727|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110530101|NCT02651727|Antimetabolites|antimetabolites|mesh-ancestor
110530170|NCT02650479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110530171|NCT02650479|Antiemetics|antiemetics|mesh-ancestor
110530172|NCT02650479|Autonomic Agents|autonomic agents|mesh-ancestor
110530173|NCT02650479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110530174|NCT02650479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110530175|NCT02650479|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110530176|NCT02650479|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110530177|NCT02650479|Serotonin Agents|serotonin agents|mesh-ancestor
110530178|NCT02650479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110530179|NCT02722772|Etanercept|etanercept|mesh-list
110530180|NCT02722772|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110530181|NCT02722772|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110530182|NCT02722772|Analgesics|analgesics|mesh-ancestor
110530183|NCT02722772|Sensory System Agents|sensory system agents|mesh-ancestor
110530184|NCT02722772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110530185|NCT02722772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110530186|NCT02722772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110530187|NCT02722772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110530188|NCT02722772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110530189|NCT02722772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110530190|NCT02722772|Immunologic Factors|immunologic factors|mesh-ancestor
110530191|NCT02650245|Lactulose|lactulose|mesh-list
110530192|NCT02650245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110177675|NCT00138736|Lectins|lectins|mesh-list
110530193|NCT00650793|Paliperidone Palmitate|paliperidone palmitate|mesh-list
110530195|NCT00650793|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110530196|NCT00650793|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110530197|NCT00650793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110530198|NCT00650793|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110530199|NCT00650793|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110530200|NCT00650793|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110530201|NCT00650793|Serotonin Agents|serotonin agents|mesh-ancestor
110530202|NCT00650793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110530203|NCT00650793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110180934|NCT00016991|Gefitinib|gefitinib|mesh-list
110457505|NCT01121900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110457506|NCT01121900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110457507|NCT01121900|Serotonin Agents|serotonin agents|mesh-ancestor
110594146|NCT00430573|Cycloserine|cycloserine|mesh-list
110530204|NCT00650793|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110530205|NCT00650793|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110530206|NCT00650793|Dopamine Agents|dopamine agents|mesh-ancestor
110530207|NCT00910767|Insulin|insulin|mesh-list
110530208|NCT00910767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110530209|NCT00910767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110530210|NCT02722694|Methotrexate|methotrexate|mesh-list
110530211|NCT02722694|Abatacept|abatacept|mesh-list
110530212|NCT02722694|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110530213|NCT02722694|Abortifacient Agents|abortifacient agents|mesh-ancestor
110530214|NCT02722694|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110530215|NCT02722694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110530216|NCT02722694|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110530217|NCT02722694|Antimetabolites|antimetabolites|mesh-ancestor
110530218|NCT02722694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110530219|NCT02722694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110530220|NCT02722694|Dermatologic Agents|dermatologic agents|mesh-ancestor
110530221|NCT02722694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110530222|NCT02722694|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110530223|NCT02722694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110530256|NCT02694146|Hylan|hylan|mesh-list
110530257|NCT02694146|Viscosupplements|viscosupplements|mesh-ancestor
110530258|NCT02694146|Protective Agents|protective agents|mesh-ancestor
110530259|NCT02694146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110530331|NCT02644395|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110530332|NCT02644395|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110530333|NCT02644395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110530334|NCT02644395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110530335|NCT02644395|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110530336|NCT02644395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110530337|NCT02644395|Vasodilator Agents|vasodilator agents|mesh-ancestor
110530399|NCT02714036|Respiratory System Agents|respiratory system agents|mesh-ancestor
110530400|NCT02714036|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110530401|NCT02714036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110530402|NCT02714036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110530403|NCT02714036|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110530404|NCT02714036|Vasodilator Agents|vasodilator agents|mesh-ancestor
110530405|NCT02710448|Metformin|metformin|mesh-list
110530406|NCT02710448|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110530407|NCT02710448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110530408|NCT04602026|Coal Tar|coal tar|mesh-list
110530409|NCT04602026|Keratolytic Agents|keratolytic agents|mesh-ancestor
110530410|NCT04602026|Dermatologic Agents|dermatologic agents|mesh-ancestor
110530411|NCT04166253|Vitamin D|vitamin d|mesh-list
110530412|NCT04166253|Alfacalcidol|alfacalcidol|mesh-list
110530413|NCT04166253|Vitamins|vitamins|mesh-ancestor
110530414|NCT04166253|Micronutrients|micronutrients|mesh-ancestor
110177884|NCT02825979|Flecainide|flecainide|mesh-list
110530457|NCT04165629|Purinergic Agents|purinergic agents|mesh-ancestor
110530458|NCT04165629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110530459|NCT02642523|Insulin|insulin|mesh-list
110530460|NCT02642523|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110530461|NCT02642523|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
110530462|NCT02642523|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110530463|NCT02642523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110530464|NCT02642523|Natriuretic Agents|natriuretic agents|mesh-ancestor
110530465|NCT02713802|Propofol|propofol|mesh-list
110530466|NCT02713802|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110530467|NCT02713802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110530468|NCT02713802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110530469|NCT02713802|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110530470|NCT02713802|Anesthetics, General|anesthetics, general|mesh-ancestor
110530471|NCT02713802|Anesthetics|anesthetics|mesh-ancestor
110530472|NCT02642601|Indomethacin|indomethacin|mesh-list
110530473|NCT02642601|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110530474|NCT02642601|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110530475|NCT02642601|Analgesics|analgesics|mesh-ancestor
110530476|NCT02642601|Sensory System Agents|sensory system agents|mesh-ancestor
110530477|NCT02642601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110530478|NCT02642601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110594159|NCT00783471|Docetaxel|docetaxel|mesh-list
110530479|NCT02642601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110530509|NCT02709824|Chlorhexidine|chlorhexidine|mesh-list
110530510|NCT02709824|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110530511|NCT02709824|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110530512|NCT02709824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110530513|NCT02709824|Disinfectants|disinfectants|mesh-ancestor
110530514|NCT02709824|Dermatologic Agents|dermatologic agents|mesh-ancestor
110530515|NCT02642367|Rocuronium|rocuronium|mesh-list
110530516|NCT02642367|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110530517|NCT02642367|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110530518|NCT02642367|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110530519|NCT02642367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110530520|NCT02642367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110530521|NCT00653445|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110530522|NCT00653445|Ezetimibe|ezetimibe|mesh-list
110530523|NCT00653445|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110530524|NCT00653445|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110530525|NCT00653445|Antimetabolites|antimetabolites|mesh-ancestor
110530526|NCT00653445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110530527|NCT00653445|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110530528|NCT00653445|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110530529|NCT00653445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110530530|NCT02641899|Acetaminophen|acetaminophen|mesh-list
110530531|NCT02641899|Exenatide|exenatide|mesh-list
110530532|NCT02641899|Digoxin|digoxin|mesh-list
110530533|NCT02641899|Lisinopril|lisinopril|mesh-list
110530534|NCT02641899|Warfarin|warfarin|mesh-list
110530535|NCT02641899|Atorvastatin|atorvastatin|mesh-list
110530536|NCT02641899|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110181033|NCT00017225|Melphalan|melphalan|mesh-list
110457508|NCT01121900|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110457509|NCT01121900|Antidepressive Agents|antidepressive agents|mesh-ancestor
110457510|NCT01121666|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
110457512|NCT01121666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110457513|NCT01121666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110457514|NCT00984126|Factor VIII|factor viii|mesh-list
110457515|NCT00984126|Coagulants|coagulants|mesh-ancestor
110457516|NCT02868996|Kallikreins|kallikreins|mesh-list
110457517|NCT02868996|Coagulants|coagulants|mesh-ancestor
110457518|NCT02868996|Fertility Agents, Male|fertility agents, male|mesh-ancestor
110457519|NCT02868996|Fertility Agents|fertility agents|mesh-ancestor
110457520|NCT02868996|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110457521|NCT02868996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110457522|NCT00629226|Cetuximab|cetuximab|mesh-list
110457523|NCT00629226|Bortezomib|bortezomib|mesh-list
110457524|NCT00629226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110457525|NCT00629226|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110457526|NCT00629304|Antithrombin III|antithrombin iii|mesh-list
110457527|NCT00629304|Antithrombins|antithrombins|mesh-list
110457528|NCT00629304|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110457529|NCT00629304|Protease Inhibitors|protease inhibitors|mesh-ancestor
110530537|NCT02641899|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110530538|NCT02641899|Antimetabolites|antimetabolites|mesh-ancestor
110530539|NCT02641899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110530540|NCT02641899|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110530541|NCT02641899|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110530542|NCT02641899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110530543|NCT02641899|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110530544|NCT02641899|Analgesics|analgesics|mesh-ancestor
110530545|NCT02641899|Sensory System Agents|sensory system agents|mesh-ancestor
110530546|NCT02641899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110530547|NCT02641899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110530548|NCT02641899|Antipyretics|antipyretics|mesh-ancestor
110530549|NCT02641899|Anticoagulants|anticoagulants|mesh-ancestor
110530550|NCT02641899|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110530551|NCT02641899|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110530552|NCT02641899|Protective Agents|protective agents|mesh-ancestor
110530553|NCT02641899|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110457530|NCT00629304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110457531|NCT00629304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110457532|NCT00629304|Anticoagulants|anticoagulants|mesh-ancestor
110457533|NCT05297929|Irbesartan|irbesartan|mesh-list
110457534|NCT05297929|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110457535|NCT05297929|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110457536|NCT05297929|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110457537|NCT05297929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110457538|NCT00826111|Eszopiclone|eszopiclone|mesh-list
110457539|NCT00826111|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110457540|NCT00826111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110457541|NCT00826111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110457542|NCT00982644|Insulin|insulin|mesh-list
110457543|NCT00982644|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110457544|NCT00982644|Insulin Glargine|insulin glargine|mesh-list
110457545|NCT00982644|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110457546|NCT00982644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110457547|NCT00815659|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110457548|NCT00815659|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110457549|NCT00815659|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110457550|NCT00815659|Antimetabolites|antimetabolites|mesh-ancestor
110457551|NCT00815659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110457552|NCT00815659|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110457553|NCT00815659|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110457554|NCT00815659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110457555|NCT02867904|Methylprednisolone|methylprednisolone|mesh-list
110457556|NCT02867904|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110457557|NCT02867904|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110457558|NCT02867904|Prednisolone|prednisolone|mesh-list
110457559|NCT02867904|Prednisolone acetate|prednisolone acetate|mesh-list
110457560|NCT02867904|Bupivacaine|bupivacaine|mesh-list
110457561|NCT02867904|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110457562|NCT02867904|Prednisolone phosphate|prednisolone phosphate|mesh-list
110457563|NCT02867904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110457564|NCT02867904|Antiemetics|antiemetics|mesh-ancestor
110457565|NCT02867904|Autonomic Agents|autonomic agents|mesh-ancestor
110457566|NCT02867904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110457567|NCT02867904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110457568|NCT02867904|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110457569|NCT02867904|Glucocorticoids|glucocorticoids|mesh-ancestor
110530554|NCT02641899|Protease Inhibitors|protease inhibitors|mesh-ancestor
110530555|NCT02641899|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110530556|NCT02641899|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110530557|NCT02641899|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110530558|NCT02641899|Incretins|incretins|mesh-ancestor
110530559|NCT02641899|Hormones|hormones|mesh-ancestor
110530560|NCT02641899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110530561|NCT02641821|Nifedipine|nifedipine|mesh-list
110530562|NCT02641821|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110457570|NCT02867904|Hormones|hormones|mesh-ancestor
110594179|NCT00787371|Immunologic Factors|immunologic factors|mesh-ancestor
110457571|NCT02867904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110380233|NCT04552613|Pemetrexed|pemetrexed|mesh-list
110457572|NCT02867904|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110457573|NCT02867904|Protective Agents|protective agents|mesh-ancestor
110457574|NCT02867904|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110457575|NCT02867904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110457576|NCT02867904|Anesthetics, Local|anesthetics, local|mesh-ancestor
110457577|NCT02867904|Anesthetics|anesthetics|mesh-ancestor
110457578|NCT02867904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110457579|NCT02867904|Sensory System Agents|sensory system agents|mesh-ancestor
110457580|NCT04290936|Tenofovir|tenofovir|mesh-list
110457581|NCT04290936|Antiviral Agents|antiviral agents|mesh-ancestor
110457582|NCT04290936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110457583|NCT04290936|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110457584|NCT04290936|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110457585|NCT04290936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110457586|NCT04290936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110457587|NCT04290936|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110457588|NCT04290936|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110457589|NCT00707941|Oseltamivir|oseltamivir|mesh-list
110457590|NCT00707941|Antiviral Agents|antiviral agents|mesh-ancestor
110457591|NCT00707941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110457592|NCT00707941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110457593|NCT00707941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110457594|NCT00824473|Azelastine|azelastine|mesh-list
110457595|NCT00824473|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110457596|NCT00824473|Autonomic Agents|autonomic agents|mesh-ancestor
110457597|NCT00824473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110457598|NCT00824473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110457599|NCT00824473|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110457600|NCT00824473|Respiratory System Agents|respiratory system agents|mesh-ancestor
110457601|NCT00824473|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
110457602|NCT00824473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110457603|NCT00824473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110457604|NCT00824473|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110457605|NCT00824473|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110457606|NCT00824473|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110457607|NCT00824473|Histamine Antagonists|histamine antagonists|mesh-ancestor
110457608|NCT00824473|Histamine Agents|histamine agents|mesh-ancestor
110457609|NCT00824473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110457610|NCT04291092|Immunomodulating Agents|immunomodulating agents|mesh-list
110457611|NCT04291092|Immunologic Factors|immunologic factors|mesh-ancestor
110457612|NCT04291092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110457613|NCT02867280|Sorafenib|sorafenib|mesh-list
110457614|NCT02867280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110457615|NCT02867280|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110457616|NCT02867280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110457617|NCT02867280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110457618|NCT04290390|Itraconazole|itraconazole|mesh-list
110457619|NCT04290390|Rifampin|rifampin|mesh-list
110457620|NCT04290390|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110457621|NCT04290390|Estradiol|estradiol|mesh-list
110457622|NCT04290390|Estrogens|estrogens|mesh-ancestor
110457623|NCT04290390|Hormones|hormones|mesh-ancestor
110457624|NCT04290390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110457625|NCT04290390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110457626|NCT04290390|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110530563|NCT02641821|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110530564|NCT02641821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110530565|NCT02641821|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110530566|NCT02641821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110530567|NCT02641821|Vasodilator Agents|vasodilator agents|mesh-ancestor
110530568|NCT02641821|Tocolytic Agents|tocolytic agents|mesh-ancestor
110530569|NCT02641821|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110530570|NCT01320345|Fenofibrate|fenofibrate|mesh-list
110530571|NCT01320345|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110530572|NCT01320345|Antimetabolites|antimetabolites|mesh-ancestor
110530573|NCT01320345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110530574|NCT01320345|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110530575|NCT04164615|Capecitabine|capecitabine|mesh-list
110457627|NCT04290390|Contraceptive Agents|contraceptive agents|mesh-ancestor
110104700|NCT01781377|Dopamine Agents|dopamine agents|mesh-ancestor
110457628|NCT04290390|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110457629|NCT04290390|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110457630|NCT04290390|Antifungal Agents|antifungal agents|mesh-ancestor
110457631|NCT04290390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110457632|NCT04290390|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110457633|NCT04290390|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110457634|NCT04290390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110457635|NCT04290390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110457636|NCT04290390|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110457637|NCT04290390|Hormone Antagonists|hormone antagonists|mesh-ancestor
110457638|NCT04290390|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110457639|NCT04290390|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110457640|NCT04290390|Antitubercular Agents|antitubercular agents|mesh-ancestor
110457641|NCT04290390|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110457642|NCT04290390|Leprostatic Agents|leprostatic agents|mesh-ancestor
110457643|NCT04290390|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110457644|NCT04290390|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110457645|NCT04290390|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110457646|NCT04290390|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110457647|NCT04290390|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110457648|NCT04290390|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110457649|NCT04290390|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110457650|NCT04290390|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110457651|NCT04290390|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110457653|NCT04290858|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110457654|NCT04290858|Autonomic Agents|autonomic agents|mesh-ancestor
110457655|NCT04290858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110457656|NCT04290858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110457657|NCT04290858|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110457658|NCT04290858|Respiratory System Agents|respiratory system agents|mesh-ancestor
110457659|NCT04290858|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110457661|NCT04290858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110457662|NCT04290858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110457663|NCT04290858|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
110457664|NCT04290858|Vasodilator Agents|vasodilator agents|mesh-ancestor
110457665|NCT04290858|Gasotransmitters|gasotransmitters|mesh-ancestor
110457666|NCT04290858|Protective Agents|protective agents|mesh-ancestor
110457667|NCT05326555|Imidacloprid|imidacloprid|mesh-list
110457668|NCT05326555|Cholinergic Agents|cholinergic agents|mesh-ancestor
110457669|NCT05326555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110457670|NCT05326555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110457671|NCT05326555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110457672|NCT02610829|Vitamin E|vitamin e|mesh-list
110530576|NCT04164615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110530577|NCT04164615|Antimetabolites|antimetabolites|mesh-ancestor
110530578|NCT04164615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110530579|NCT04164615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110530580|NCT04164459|Latanoprost|latanoprost|mesh-list
110530581|NCT04164459|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110530582|NCT04164459|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110530583|NCT04164693|Heparin|heparin|mesh-list
110530584|NCT04164693|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
110530585|NCT04164693|Tinzaparin|tinzaparin|mesh-list
110530586|NCT04164693|Dalteparin|dalteparin|mesh-list
110530587|NCT04164693|Warfarin|warfarin|mesh-list
110530588|NCT04164693|Anticoagulants|anticoagulants|mesh-ancestor
110594205|NCT04895280|Ketorolac|ketorolac|mesh-list
110530589|NCT04164693|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110530590|NCT04164693|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110530591|NCT04164693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110530592|NCT00655785|Gemcitabine|gemcitabine|mesh-list
110530593|NCT00655785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110530594|NCT00655785|Antimetabolites|antimetabolites|mesh-ancestor
110530595|NCT00655785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110530596|NCT00655785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110530597|NCT00885495|Ritonavir|ritonavir|mesh-list
110530598|NCT00885495|Darunavir|darunavir|mesh-list
110530599|NCT00885495|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110530600|NCT00885495|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110530601|NCT00885495|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110530602|NCT00885495|Protease Inhibitors|protease inhibitors|mesh-ancestor
110530603|NCT00885495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110530604|NCT00885495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110530605|NCT00885495|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110530606|NCT00885495|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110530607|NCT00885495|Antiviral Agents|antiviral agents|mesh-ancestor
110530608|NCT00885495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110530609|NCT00885495|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110530610|NCT00885495|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110530611|NCT00885495|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110530612|NCT00885495|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110457673|NCT02610829|Tocopherols|tocopherols|mesh-list
110457674|NCT02610829|Tocotrienols|tocotrienols|mesh-list
110457675|NCT02610829|alpha-Tocopherol|alpha-tocopherol|mesh-list
110530613|NCT00885495|Antimetabolites|antimetabolites|mesh-ancestor
110530614|NCT00885495|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110530615|NCT00885495|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110530616|NCT02637375|Paclitaxel|paclitaxel|mesh-list
110530617|NCT02637375|Cyclophosphamide|cyclophosphamide|mesh-list
110530618|NCT02637375|Doxorubicin|doxorubicin|mesh-list
110530619|NCT02637375|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110530620|NCT02637375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110530621|NCT02637375|Tubulin Modulators|tubulin modulators|mesh-ancestor
110530622|NCT02637375|Antimitotic Agents|antimitotic agents|mesh-ancestor
110530623|NCT02637375|Mitosis Modulators|mitosis modulators|mesh-ancestor
110534648|NCT04179006|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110457676|NCT02610829|gamma-Tocopherol|gamma-tocopherol|mesh-list
110457677|NCT02610829|Vitamins|vitamins|mesh-ancestor
110457678|NCT02610829|Micronutrients|micronutrients|mesh-ancestor
110457679|NCT02610829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110457680|NCT02610829|Antioxidants|antioxidants|mesh-ancestor
110457681|NCT02610829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110457682|NCT02610829|Protective Agents|protective agents|mesh-ancestor
110457683|NCT02865564|Gentamicins|gentamicins|mesh-list
110457684|NCT02865564|Ampicillin|ampicillin|mesh-list
110457685|NCT02865564|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110457686|NCT02865564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110457687|NCT02865564|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110457688|NCT02865564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110457689|NCT02865564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110457690|NCT00814879|Raltegravir Potassium|raltegravir potassium|mesh-list
110457691|NCT00814879|Atazanavir Sulfate|atazanavir sulfate|mesh-list
110457692|NCT00814879|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110457693|NCT00814879|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110457694|NCT00814879|Antiviral Agents|antiviral agents|mesh-ancestor
110457695|NCT00814879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110457696|NCT00814879|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110457697|NCT00814879|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110457698|NCT00814879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110457699|NCT00814879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110457700|NCT00814879|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110457701|NCT00814879|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110457702|NCT00814879|Protease Inhibitors|protease inhibitors|mesh-ancestor
110594216|NCT04895280|Hormones|hormones|mesh-ancestor
110457704|NCT00814801|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110457705|NCT00814801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110457706|NCT00814801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110457707|NCT00814801|Cholinergic Agents|cholinergic agents|mesh-ancestor
110457708|NCT00814801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110457709|NCT00814801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110457710|NCT00814801|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110457711|NCT00814801|Autonomic Agents|autonomic agents|mesh-ancestor
110457712|NCT00814801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110457713|NCT00814801|Nootropic Agents|nootropic agents|mesh-ancestor
110457714|NCT00653458|Ondansetron|ondansetron|mesh-list
110457715|NCT00653458|Antiemetics|antiemetics|mesh-ancestor
110457716|NCT00653458|Autonomic Agents|autonomic agents|mesh-ancestor
110457717|NCT00653458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110457718|NCT00653458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110457719|NCT00653458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110457720|NCT00653458|Antipruritics|antipruritics|mesh-ancestor
110457721|NCT00653458|Dermatologic Agents|dermatologic agents|mesh-ancestor
110457722|NCT00653458|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110457723|NCT00653458|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110457724|NCT00653458|Serotonin Agents|serotonin agents|mesh-ancestor
110457725|NCT00653458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110457726|NCT00653458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110457727|NCT00708565|Iloprost|iloprost|mesh-list
110457728|NCT00708565|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110457729|NCT00708565|Vasodilator Agents|vasodilator agents|mesh-ancestor
110530624|NCT02637375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110530625|NCT02637375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110530626|NCT02637375|Immunologic Factors|immunologic factors|mesh-ancestor
110530627|NCT02637375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110530628|NCT02637375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110530629|NCT02637375|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110530630|NCT02637375|Alkylating Agents|alkylating agents|mesh-ancestor
110530631|NCT02637375|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110530632|NCT02637375|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110530633|NCT02637375|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110530634|NCT02637375|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110457730|NCT00812461|Nalmefene|nalmefene|mesh-list
110457731|NCT00812461|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110457732|NCT00812461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110457733|NCT00812461|Sensory System Agents|sensory system agents|mesh-ancestor
110457734|NCT00812461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110457735|NCT00599326|Deferasirox|deferasirox|mesh-list
110457736|NCT00599326|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110457737|NCT00599326|Chelating Agents|chelating agents|mesh-ancestor
110457739|NCT00599326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110457740|NCT00978432|Everolimus|everolimus|mesh-list
110457741|NCT00978432|Panobinostat|panobinostat|mesh-list
110457742|NCT00978432|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110457743|NCT00978432|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110457744|NCT00978432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110457745|NCT00978432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110457746|NCT00978432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110457747|NCT00978432|Immunologic Factors|immunologic factors|mesh-ancestor
110457748|NCT00978432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110457749|NCT00978432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110457750|NCT00978432|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110457751|NCT04166812|Nitric Oxide|nitric oxide|mesh-list
110457752|NCT04166812|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110457753|NCT04166812|Autonomic Agents|autonomic agents|mesh-ancestor
110457754|NCT04166812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110457755|NCT04166812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110457756|NCT04166812|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110457757|NCT04166812|Respiratory System Agents|respiratory system agents|mesh-ancestor
110457758|NCT04166812|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110457759|NCT04166812|Antioxidants|antioxidants|mesh-ancestor
110457760|NCT04166812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110594224|NCT04895280|Analgesics|analgesics|mesh-ancestor
110457761|NCT04166812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110457762|NCT04166812|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
110457763|NCT04166812|Vasodilator Agents|vasodilator agents|mesh-ancestor
110457764|NCT04166812|Gasotransmitters|gasotransmitters|mesh-ancestor
110457765|NCT04166812|Protective Agents|protective agents|mesh-ancestor
110457766|NCT00708799|Azithromycin|azithromycin|mesh-list
110457767|NCT00708799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110457768|NCT00708799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110457769|NCT02610127|Factor VIII|factor viii|mesh-list
110457770|NCT02610127|Coagulants|coagulants|mesh-ancestor
110457771|NCT00814333|Thrombin|thrombin|mesh-list
110457772|NCT00814333|Polyvinyl alcohol formaldehyde foam|polyvinyl alcohol formaldehyde foam|mesh-list
110457773|NCT00814333|Hemostatics|hemostatics|mesh-ancestor
110457774|NCT00814333|Coagulants|coagulants|mesh-ancestor
110457775|NCT01147250|Lixisenatide|lixisenatide|mesh-list
110457776|NCT01147250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110457777|NCT01147250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110457778|NCT00813943|Temozolomide|temozolomide|mesh-list
110457779|NCT00813943|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110457780|NCT00813943|Alkylating Agents|alkylating agents|mesh-ancestor
110457781|NCT00813943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110457782|NCT00813943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110457783|NCT00821509|Disinfectants|disinfectants|mesh-list
110530635|NCT02637375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110530636|NCT04163523|Zanubrutinib|zanubrutinib|mesh-list
110530637|NCT04163523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110530638|NCT04163523|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110530639|NCT04163523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110530640|NCT04163523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110530642|NCT00885105|Immunologic Factors|immunologic factors|mesh-ancestor
110530643|NCT00885105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110530644|NCT02709668|Vitamin B Complex|vitamin b complex|mesh-list
110530645|NCT02709668|Vitamins|vitamins|mesh-ancestor
110530646|NCT02709668|Micronutrients|micronutrients|mesh-ancestor
110530647|NCT02709668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110457784|NCT00821509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110457785|NCT00913861|Fentanyl|fentanyl|mesh-list
110457786|NCT00913861|Propofol|propofol|mesh-list
110457787|NCT00913861|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110457788|NCT00913861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110457789|NCT00913861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110457790|NCT00913861|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110457791|NCT00913861|Anesthetics, General|anesthetics, general|mesh-ancestor
110457792|NCT00913861|Anesthetics|anesthetics|mesh-ancestor
110457793|NCT00913861|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110457794|NCT00913861|Narcotics|narcotics|mesh-ancestor
110457795|NCT00913861|Analgesics|analgesics|mesh-ancestor
110457796|NCT00913861|Sensory System Agents|sensory system agents|mesh-ancestor
110457797|NCT00913861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110457798|NCT00913861|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110457800|NCT00709189|Norgestimate|norgestimate|mesh-list
110457801|NCT00709189|Estradiol|estradiol|mesh-list
110457802|NCT00709189|Estrogens|estrogens|mesh-ancestor
110457803|NCT00709189|Hormones|hormones|mesh-ancestor
110457804|NCT00709189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110457805|NCT00709189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110457806|NCT00709189|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110457808|NCT00709189|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110457809|NCT00709189|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110457810|NCT00709189|Hematinics|hematinics|mesh-ancestor
110457811|NCT00709189|Vitamin B Complex|vitamin b complex|mesh-ancestor
110457812|NCT00709189|Vitamins|vitamins|mesh-ancestor
110457813|NCT00709189|Micronutrients|micronutrients|mesh-ancestor
110457814|NCT00709189|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110457815|NCT00709189|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110457816|NCT00709267|Folic Acid|folic acid|mesh-list
110457817|NCT00709267|Hematinics|hematinics|mesh-ancestor
110457818|NCT00709267|Vitamin B Complex|vitamin b complex|mesh-ancestor
110457819|NCT00709267|Vitamins|vitamins|mesh-ancestor
110457820|NCT00709267|Micronutrients|micronutrients|mesh-ancestor
110457821|NCT00709267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110457822|NCT00591565|Acamprosate|acamprosate|mesh-list
110457823|NCT00591565|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110457824|NCT00978120|Vaccines|vaccines|mesh-list
110457825|NCT00978120|Immunologic Factors|immunologic factors|mesh-ancestor
110457826|NCT00978120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110457827|NCT01133678|Paclitaxel|paclitaxel|mesh-list
110457828|NCT01133678|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110457829|NCT01133678|Cisplatin|cisplatin|mesh-list
110457830|NCT01133678|Cetuximab|cetuximab|mesh-list
110457831|NCT01133678|Everolimus|everolimus|mesh-list
110457832|NCT01133678|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110457833|NCT01133678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110457834|NCT01133678|Tubulin Modulators|tubulin modulators|mesh-ancestor
110457835|NCT01133678|Antimitotic Agents|antimitotic agents|mesh-ancestor
110457836|NCT01133678|Mitosis Modulators|mitosis modulators|mesh-ancestor
110457837|NCT01133678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110457838|NCT01133678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110457839|NCT01133678|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110530648|NCT04188782|Sevoflurane|sevoflurane|mesh-list
110530649|NCT04188782|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110530650|NCT04188782|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110530651|NCT04188782|Anesthetics, General|anesthetics, general|mesh-ancestor
110530652|NCT04188782|Anesthetics|anesthetics|mesh-ancestor
110530653|NCT04188782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110530654|NCT04188782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110530655|NCT02709590|Diclofenac|diclofenac|mesh-list
110530656|NCT02709590|Lidocaine|lidocaine|mesh-list
110530657|NCT02709590|Anesthetics, Local|anesthetics, local|mesh-ancestor
110530658|NCT02709590|Anesthetics|anesthetics|mesh-ancestor
110530659|NCT02709590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110530660|NCT02709590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110530661|NCT02709590|Sensory System Agents|sensory system agents|mesh-ancestor
110530662|NCT02709590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110181492|NCT00019500|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
110457840|NCT01133678|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110457841|NCT01133678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110457842|NCT01133678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110457843|NCT01133678|Immunologic Factors|immunologic factors|mesh-ancestor
110457844|NCT01133678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110457845|NCT00652132|Sodium thiosulfate|sodium thiosulfate|mesh-list
110457846|NCT00652132|Antidotes|antidotes|mesh-ancestor
110457847|NCT00652132|Protective Agents|protective agents|mesh-ancestor
110457848|NCT00652132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110457849|NCT00652132|Antioxidants|antioxidants|mesh-ancestor
110457850|NCT00652132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110457851|NCT00652132|Antitubercular Agents|antitubercular agents|mesh-ancestor
110457852|NCT00652132|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110457853|NCT00652132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110104926|NCT01783106|Autonomic Agents|autonomic agents|mesh-ancestor
110457854|NCT00652132|Chelating Agents|chelating agents|mesh-ancestor
110457855|NCT00652132|Sequestering Agents|sequestering agents|mesh-ancestor
110457856|NCT00655174|Fluvoxamine|fluvoxamine|mesh-list
110457857|NCT00655174|Sertraline|sertraline|mesh-list
110457858|NCT00655174|Antidepressive Agents|antidepressive agents|mesh-ancestor
110457859|NCT00655174|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110457860|NCT00655174|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110457861|NCT00655174|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110457862|NCT00655174|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110457863|NCT00655174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110457864|NCT00655174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110457865|NCT00655174|Serotonin Agents|serotonin agents|mesh-ancestor
110457866|NCT00655174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110457867|NCT00655174|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110457868|NCT00655174|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110457869|NCT00655174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110457870|NCT00655174|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110457871|NCT00655174|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110457872|NCT00655174|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110457873|NCT00655174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110457874|NCT00655174|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110457875|NCT00655018|Ascorbic Acid|ascorbic acid|mesh-list
110457876|NCT00655018|Tocopherols|tocopherols|mesh-list
110457877|NCT00655018|Vitamin E|vitamin e|mesh-list
110457878|NCT00655018|alpha-Tocopherol|alpha-tocopherol|mesh-list
110457879|NCT00655018|Vitamins|vitamins|mesh-ancestor
110457880|NCT00655018|Micronutrients|micronutrients|mesh-ancestor
110457881|NCT00655018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110457882|NCT00655018|Antioxidants|antioxidants|mesh-ancestor
110530663|NCT02709590|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110530664|NCT02709590|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110530665|NCT02709590|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110530666|NCT02709590|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110530667|NCT02709590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110530668|NCT02709590|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110530669|NCT02709590|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110530670|NCT02709590|Analgesics|analgesics|mesh-ancestor
110530671|NCT02709590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110530672|NCT02709590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110530673|NCT02709590|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110530674|NCT02709590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110530675|NCT02707874|Ropivacaine|ropivacaine|mesh-list
110530676|NCT02707874|Anesthetics, Local|anesthetics, local|mesh-ancestor
110530677|NCT02707874|Anesthetics|anesthetics|mesh-ancestor
110181552|NCT00019890|Sargramostim|sargramostim|mesh-list
110457883|NCT00655018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110457884|NCT00655018|Protective Agents|protective agents|mesh-ancestor
110457885|NCT02635750|Donepezil|donepezil|mesh-list
110457886|NCT02635750|BI 409306|bi 409306|mesh-list
110457887|NCT02635750|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110457888|NCT02635750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110457889|NCT02635750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110457890|NCT02635750|Cholinergic Agents|cholinergic agents|mesh-ancestor
110457891|NCT02635750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110457892|NCT02635750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110457893|NCT02635750|Nootropic Agents|nootropic agents|mesh-ancestor
110457894|NCT02635750|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110457895|NCT04164238|Paclitaxel|paclitaxel|mesh-list
110457896|NCT04164238|Carboplatin|carboplatin|mesh-list
110457897|NCT04164238|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110457898|NCT04164238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110457899|NCT04164238|Tubulin Modulators|tubulin modulators|mesh-ancestor
110457900|NCT04164238|Antimitotic Agents|antimitotic agents|mesh-ancestor
110457901|NCT04164238|Mitosis Modulators|mitosis modulators|mesh-ancestor
110457902|NCT04164238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110457903|NCT02645734|Bevacizumab|bevacizumab|mesh-list
110457904|NCT02645734|Aflibercept|aflibercept|mesh-list
110457905|NCT02645734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110457906|NCT02645734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110457907|NCT02645734|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110457908|NCT02645734|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110457909|NCT02645734|Growth Substances|growth substances|mesh-ancestor
110457910|NCT02645734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110457911|NCT02645734|Growth Inhibitors|growth inhibitors|mesh-ancestor
110457912|NCT01133522|Evolocumab|evolocumab|mesh-list
110457913|NCT01133522|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
110457914|NCT01133522|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110457915|NCT01133522|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110457916|NCT01133522|Antimetabolites|antimetabolites|mesh-ancestor
110457917|NCT01133522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110457918|NCT01133522|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110457919|NCT01133522|Protease Inhibitors|protease inhibitors|mesh-ancestor
110457920|NCT01133522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110457921|NCT01133522|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110457922|NCT02881892|Dialysis Solutions|dialysis solutions|mesh-list
110457923|NCT02881892|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110457924|NCT00655252|Everolimus|everolimus|mesh-list
110457925|NCT00655252|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110457926|NCT00655252|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110530678|NCT02707874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110530679|NCT02707874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110530680|NCT02707874|Sensory System Agents|sensory system agents|mesh-ancestor
110594243|NCT03994783|Glucocorticoids|glucocorticoids|mesh-ancestor
110530681|NCT02707874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110530682|NCT02709200|Dexmedetomidine|dexmedetomidine|mesh-list
110530683|NCT02709200|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110530684|NCT02709200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110457927|NCT00655252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110457928|NCT00655252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110457930|NCT00655252|Immunologic Factors|immunologic factors|mesh-ancestor
110457931|NCT00655252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110105003|NCT01783964|Cytarabine|cytarabine|mesh-list
110457932|NCT00655252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110457933|NCT00883090|Fibrinolysin|fibrinolysin|mesh-list
110457934|NCT00883090|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110457935|NCT00883090|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110457936|NCT00883090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110457937|NCT02645656|Curcumin|curcumin|mesh-list
110457938|NCT02645656|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110457939|NCT02645656|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110457940|NCT02645656|Analgesics|analgesics|mesh-ancestor
110457941|NCT02645656|Sensory System Agents|sensory system agents|mesh-ancestor
110457942|NCT02645656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110457943|NCT02645656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110457944|NCT02645656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110457945|NCT02645656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110457946|NCT02645656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110457947|NCT02645656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110457948|NCT02645656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110457949|NCT01132820|Cediranib|cediranib|mesh-list
110457950|NCT01132820|Maleic acid|maleic acid|mesh-list
110457951|NCT01132820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110457952|NCT01132820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110457953|NCT01132820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110457954|NCT01132820|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110457955|NCT00655330|Valsartan|valsartan|mesh-list
110457956|NCT00655330|Probucol|probucol|mesh-list
110457957|NCT00655330|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110457958|NCT00655330|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110457959|NCT00655330|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110457960|NCT00655330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110457961|NCT00655330|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110457962|NCT00655330|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110457963|NCT00655330|Antimetabolites|antimetabolites|mesh-ancestor
110457964|NCT00655330|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110457965|NCT00655330|Antioxidants|antioxidants|mesh-ancestor
110457966|NCT00655330|Protective Agents|protective agents|mesh-ancestor
110457967|NCT00655330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110457968|NCT00655408|Iron|iron|mesh-list
110457969|NCT00655408|Trace Elements|trace elements|mesh-ancestor
110457970|NCT00655408|Micronutrients|micronutrients|mesh-ancestor
110457971|NCT00655408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110457972|NCT04163536|Methylprednisolone|methylprednisolone|mesh-list
110457973|NCT04163536|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110457974|NCT04163536|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110457975|NCT04163536|Prednisolone|prednisolone|mesh-list
110457976|NCT04163536|Prednisolone acetate|prednisolone acetate|mesh-list
110457977|NCT04163536|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110457978|NCT04163536|Prednisolone phosphate|prednisolone phosphate|mesh-list
110457979|NCT04163536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110457980|NCT04163536|Antiemetics|antiemetics|mesh-ancestor
110457981|NCT04163536|Autonomic Agents|autonomic agents|mesh-ancestor
110457982|NCT04163536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110457983|NCT04163536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110457984|NCT04163536|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110457985|NCT04163536|Glucocorticoids|glucocorticoids|mesh-ancestor
110457986|NCT04163536|Hormones|hormones|mesh-ancestor
110530685|NCT02709200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110594247|NCT03994783|Protective Agents|protective agents|mesh-ancestor
110530686|NCT02709200|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110530687|NCT02709200|Analgesics|analgesics|mesh-ancestor
110530688|NCT02709200|Sensory System Agents|sensory system agents|mesh-ancestor
110530689|NCT02709200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110530690|NCT02709200|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110530691|NCT02709200|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110530692|NCT02709200|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110181684|NCT00020748|Irinotecan|irinotecan|mesh-list
110457987|NCT04163536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110457988|NCT04163536|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110457989|NCT04163536|Protective Agents|protective agents|mesh-ancestor
110457990|NCT04163536|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110457991|NCT04163536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110457992|NCT00652288|Insulin|insulin|mesh-list
110457993|NCT00652288|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110457994|NCT00652288|Insulin Glargine|insulin glargine|mesh-list
110457995|NCT00652288|Insulin Aspart|insulin aspart|mesh-list
110457996|NCT00652288|Insulin, Long-Acting|insulin, long-acting|mesh-list
110457997|NCT00652288|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
110457998|NCT00652288|Insulin Lispro|insulin lispro|mesh-list
110457999|NCT00652288|Insulin Detemir|insulin detemir|mesh-list
110458000|NCT00652288|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110458001|NCT00652288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110458002|NCT00911092|Fluorouracil|fluorouracil|mesh-list
110458003|NCT00911092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110458004|NCT00911092|Antimetabolites|antimetabolites|mesh-ancestor
110458005|NCT00911092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110458006|NCT00911092|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110105081|NCT01784315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110458007|NCT00911092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110458008|NCT00911092|Immunologic Factors|immunologic factors|mesh-ancestor
110458009|NCT00911092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110458010|NCT02635360|Pembrolizumab|pembrolizumab|mesh-list
110458011|NCT02635360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110458012|NCT02635360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110458013|NCT02635360|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110458014|NCT02635360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110458015|NCT02635282|Fentanyl|fentanyl|mesh-list
110458016|NCT02635282|Midazolam|midazolam|mesh-list
110458017|NCT02635282|Ketamine|ketamine|mesh-list
110458018|NCT02635282|Analgesics|analgesics|mesh-ancestor
110458019|NCT02635282|Sensory System Agents|sensory system agents|mesh-ancestor
110458020|NCT02635282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110458021|NCT02635282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110458022|NCT02635282|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110458023|NCT02635282|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110458024|NCT02635282|Anesthetics, General|anesthetics, general|mesh-ancestor
110458025|NCT02635282|Anesthetics|anesthetics|mesh-ancestor
110458026|NCT02635282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110458027|NCT02635282|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110458028|NCT02635282|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110458029|NCT02635282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110458030|NCT02635282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110458031|NCT02635282|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110458033|NCT02635282|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110458034|NCT02635282|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110458035|NCT02635282|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110458036|NCT02635282|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110458037|NCT02635282|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110458038|NCT02635282|GABA Modulators|gaba modulators|mesh-ancestor
110458039|NCT02635282|GABA Agents|gaba agents|mesh-ancestor
110458040|NCT00655798|Antioxidants|antioxidants|mesh-list
110458041|NCT00655798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110458042|NCT00655798|Protective Agents|protective agents|mesh-ancestor
110458043|NCT00655798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110530693|NCT02709200|Adrenergic Agents|adrenergic agents|mesh-ancestor
110530694|NCT02709200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110530695|NCT02709200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110530696|NCT00611936|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
110530697|NCT00611936|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110530698|NCT00611936|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110530699|NCT00611936|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110530700|NCT00611936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110530701|NCT00611936|Adrenergic Agents|adrenergic agents|mesh-ancestor
110530702|NCT00611936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110530703|NCT00611936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110530704|NCT02707328|Paclitaxel|paclitaxel|mesh-list
110530705|NCT02707328|Gemcitabine|gemcitabine|mesh-list
110530706|NCT02707328|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110530707|NCT02707328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110530708|NCT02707328|Tubulin Modulators|tubulin modulators|mesh-ancestor
110530709|NCT02707328|Antimitotic Agents|antimitotic agents|mesh-ancestor
110458044|NCT02637700|Immunoglobulins|immunoglobulins|mesh-list
110458045|NCT02637700|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110458046|NCT02637700|Antibodies|antibodies|mesh-list
110458047|NCT02637700|gamma-Globulins|gamma-globulins|mesh-list
110458048|NCT02637700|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110458049|NCT02637700|Immunologic Factors|immunologic factors|mesh-ancestor
110458050|NCT02637700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110458051|NCT02637466|Vortioxetine|vortioxetine|mesh-list
110458052|NCT02637466|Antidepressive Agents|antidepressive agents|mesh-ancestor
110458053|NCT02637466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110458054|NCT02637466|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110458055|NCT02637466|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110458056|NCT02637466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110458057|NCT02637466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110458058|NCT02637466|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110458059|NCT02637466|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110458060|NCT02637466|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110458061|NCT02637466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110458062|NCT02637466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110458063|NCT02637466|Serotonin Agents|serotonin agents|mesh-ancestor
110458064|NCT02637466|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110458065|NCT02637466|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110458066|NCT02637466|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110458067|NCT02637466|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110458068|NCT02634970|Ranibizumab|ranibizumab|mesh-list
110458069|NCT02634970|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110458070|NCT02634970|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110458071|NCT02634970|Growth Substances|growth substances|mesh-ancestor
110458072|NCT02634970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110458073|NCT02634970|Growth Inhibitors|growth inhibitors|mesh-ancestor
110458074|NCT02634970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110458075|NCT00885352|Metformin|metformin|mesh-list
110458076|NCT00885352|Pioglitazone|pioglitazone|mesh-list
110458077|NCT00885352|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110458078|NCT00885352|Glipizide|glipizide|mesh-list
110458079|NCT00885352|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110458080|NCT00885352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110458081|NCT00885352|Incretins|incretins|mesh-ancestor
110458082|NCT00885352|Hormones|hormones|mesh-ancestor
110530711|NCT02707328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110530712|NCT02707328|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110530713|NCT02707328|Antimetabolites|antimetabolites|mesh-ancestor
110530714|NCT00612638|Irinotecan|irinotecan|mesh-list
110530715|NCT00612638|Temozolomide|temozolomide|mesh-list
110530716|NCT00612638|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
110530717|NCT00612638|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110530718|NCT00612638|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110594269|NCT04072328|Midazolam|midazolam|mesh-list
110530719|NCT00612638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110458083|NCT00885352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110458084|NCT00885352|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110458085|NCT00885352|Protease Inhibitors|protease inhibitors|mesh-ancestor
110458086|NCT00885352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110458087|NCT00885352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110458088|NCT00656032|Cinacalcet|cinacalcet|mesh-list
110458089|NCT00656032|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110458090|NCT00656032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110458091|NCT00656032|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
110458092|NCT00656032|Hormone Antagonists|hormone antagonists|mesh-ancestor
110458093|NCT00656032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110458094|NCT00885118|Empagliflozin|empagliflozin|mesh-list
110458095|NCT00885118|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110458096|NCT00885118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110458097|NCT00885118|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110148319|NCT00388011|Analgesics|analgesics|mesh-ancestor
110458098|NCT00885118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110458100|NCT00656812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110458101|NCT00656812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110458102|NCT00656812|Immunologic Factors|immunologic factors|mesh-ancestor
110458103|NCT00656812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110458104|NCT00656812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110458106|NCT00656110|Methylprednisolone|methylprednisolone|mesh-list
110458107|NCT00656110|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110458108|NCT00656110|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110458109|NCT00656110|Prednisolone|prednisolone|mesh-list
110458110|NCT00656110|Prednisolone acetate|prednisolone acetate|mesh-list
110458111|NCT00656110|Lidocaine|lidocaine|mesh-list
110458112|NCT00656110|Bupivacaine|bupivacaine|mesh-list
110458113|NCT00656110|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110458114|NCT00656110|Prednisolone phosphate|prednisolone phosphate|mesh-list
110458115|NCT00656110|Anesthetics, Local|anesthetics, local|mesh-ancestor
110458116|NCT00656110|Anesthetics|anesthetics|mesh-ancestor
110458117|NCT00656110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110458118|NCT00656110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110458119|NCT00656110|Sensory System Agents|sensory system agents|mesh-ancestor
110458120|NCT00656110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110458121|NCT00656110|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110458122|NCT00656110|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110458123|NCT00656110|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110458124|NCT00656110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110458125|NCT00656110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110458126|NCT00656110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110458127|NCT00656110|Antiemetics|antiemetics|mesh-ancestor
110458128|NCT00656110|Autonomic Agents|autonomic agents|mesh-ancestor
110458129|NCT00656110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110458130|NCT00656110|Glucocorticoids|glucocorticoids|mesh-ancestor
110458131|NCT00656110|Hormones|hormones|mesh-ancestor
110458132|NCT00656110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110458133|NCT00656110|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110458134|NCT00656110|Protective Agents|protective agents|mesh-ancestor
110458135|NCT00656110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110458136|NCT00656110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110530720|NCT00612638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110530721|NCT00612638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110530722|NCT00612638|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110530723|NCT00612638|Alkylating Agents|alkylating agents|mesh-ancestor
110530724|NCT05151848|Adalimumab|adalimumab|mesh-list
110530725|NCT05151848|Tofacitinib|tofacitinib|mesh-list
110594276|NCT04072328|Anesthetics|anesthetics|mesh-ancestor
110530726|NCT05151848|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110530727|NCT05151848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110530728|NCT05151848|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110530729|NCT05151848|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
110530730|NCT05151848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110530731|NCT05151848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110530732|NCT05151848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110530733|NCT05134688|Magnesium Sulfate|magnesium sulfate|mesh-list
110530734|NCT05134688|Analgesics|analgesics|mesh-ancestor
110530735|NCT05134688|Sensory System Agents|sensory system agents|mesh-ancestor
110458137|NCT00656110|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110458138|NCT00656110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110458139|NCT00656188|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
110458140|NCT00656188|Vasodilator Agents|vasodilator agents|mesh-ancestor
110458141|NCT00656188|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110458142|NCT00656188|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110458143|NCT00656188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110458144|NCT00656188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110458145|NCT00656188|Urological Agents|urological agents|mesh-ancestor
110458146|NCT00880906|Fluticasone|fluticasone|mesh-list
110458147|NCT00880906|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
110458148|NCT00880906|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110458149|NCT00880906|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110458150|NCT00880906|Autonomic Agents|autonomic agents|mesh-ancestor
110458151|NCT00880906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110458152|NCT00880906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110458153|NCT00880906|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110458154|NCT00880906|Respiratory System Agents|respiratory system agents|mesh-ancestor
110458155|NCT00880906|Dermatologic Agents|dermatologic agents|mesh-ancestor
110458156|NCT00880906|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110458157|NCT00880906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110458158|NCT00880906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110458159|NCT04160026|Pyrimethamine|pyrimethamine|mesh-list
110458160|NCT04160026|Piperaquine|piperaquine|mesh-list
110458161|NCT04160026|Sulfadoxine|sulfadoxine|mesh-list
110458162|NCT04160026|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
110458163|NCT04160026|Antimalarials|antimalarials|mesh-ancestor
110303319|NCT00287742|Dopamine Agents|dopamine agents|mesh-ancestor
110458164|NCT04160026|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110458165|NCT04160026|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110458166|NCT04160026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110458167|NCT04160026|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110458168|NCT04160026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110458169|NCT04160026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110458170|NCT04160026|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110458171|NCT04159870|Rifaximin|rifaximin|mesh-list
110458172|NCT04159870|Norfloxacin|norfloxacin|mesh-list
110458173|NCT04159870|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110458174|NCT04159870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110458175|NCT04159870|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110458176|NCT04159870|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110458177|NCT04159870|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110458178|NCT04159870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110530736|NCT05134688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110530737|NCT05134688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110530738|NCT05134688|Anesthetics|anesthetics|mesh-ancestor
110530739|NCT05134688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110530740|NCT05134688|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110530741|NCT05134688|Anticonvulsants|anticonvulsants|mesh-ancestor
110530742|NCT05134688|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110530743|NCT05134688|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110530744|NCT05134688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110530745|NCT05134688|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110530746|NCT05134688|Tocolytic Agents|tocolytic agents|mesh-ancestor
110530747|NCT05134688|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110458179|NCT04159870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110458180|NCT04159870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110458181|NCT04159870|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110458182|NCT04159870|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110458184|NCT00657514|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110458185|NCT00657514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110458186|NCT00657514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110458187|NCT00656266|Mycophenolic Acid|mycophenolic acid|mesh-list
110458188|NCT00656266|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110458189|NCT00656266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110458190|NCT00656266|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110458191|NCT00656266|Antitubercular Agents|antitubercular agents|mesh-ancestor
110458192|NCT00656266|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110458193|NCT00656266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110458194|NCT00656266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110458195|NCT00656266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110458196|NCT00882310|Gemcitabine|gemcitabine|mesh-list
110458197|NCT00882310|Capecitabine|capecitabine|mesh-list
110458198|NCT00882310|Docetaxel|docetaxel|mesh-list
110458199|NCT00882310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110458200|NCT00882310|Antimetabolites|antimetabolites|mesh-ancestor
110458201|NCT00882310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110458202|NCT00882310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110458203|NCT00882310|Tubulin Modulators|tubulin modulators|mesh-ancestor
110458204|NCT00882310|Antimitotic Agents|antimitotic agents|mesh-ancestor
110458205|NCT00882310|Mitosis Modulators|mitosis modulators|mesh-ancestor
110458206|NCT00884650|Analgesics|analgesics|mesh-list
110458207|NCT00884650|Sensory System Agents|sensory system agents|mesh-ancestor
110458208|NCT00884650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110458209|NCT00884650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110458210|NCT02636842|Aripiprazole|aripiprazole|mesh-list
110458211|NCT02636842|Aripiprazole lauroxil|aripiprazole lauroxil|mesh-list
110458212|NCT02636842|Antidepressive Agents|antidepressive agents|mesh-ancestor
110458213|NCT02636842|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110458214|NCT02636842|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110458215|NCT02636842|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110458216|NCT02636842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110458217|NCT02636842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110458218|NCT02636842|Dopamine Agonists|dopamine agonists|mesh-ancestor
110458219|NCT02636842|Dopamine Agents|dopamine agents|mesh-ancestor
110458220|NCT02636842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110458221|NCT02636842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110458222|NCT02636842|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110458223|NCT02636842|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110458224|NCT02636842|Serotonin Agents|serotonin agents|mesh-ancestor
110458225|NCT02636842|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110458226|NCT02636842|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110530748|NCT02693288|Anesthetics|anesthetics|mesh-list
110530749|NCT02693288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110530750|NCT02693288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110530751|NCT02693210|Cyclophosphamide|cyclophosphamide|mesh-list
110530752|NCT02693210|Rituximab|rituximab|mesh-list
110530753|NCT02693210|Methotrexate|methotrexate|mesh-list
110530754|NCT02693210|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110530755|NCT02693210|Immunologic Factors|immunologic factors|mesh-ancestor
110530756|NCT02693210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110530757|NCT02693210|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110530758|NCT02693210|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110530759|NCT02693210|Alkylating Agents|alkylating agents|mesh-ancestor
110530760|NCT02693210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110530761|NCT02693210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110530762|NCT02693210|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110530763|NCT02693210|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110530764|NCT02693210|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110530765|NCT02693210|Abortifacient Agents|abortifacient agents|mesh-ancestor
110181989|NCT00022074|Anticonvulsants|anticonvulsants|mesh-ancestor
110458227|NCT02636842|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110458228|NCT02636842|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110458229|NCT04161976|Insulin Lispro|insulin lispro|mesh-list
110458230|NCT04161976|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110458231|NCT04161976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110458232|NCT00656422|Insulin|insulin|mesh-list
110458233|NCT00656422|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110458234|NCT00656422|Insulin Detemir|insulin detemir|mesh-list
110458235|NCT00656422|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110458236|NCT00656422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110458237|NCT02634034|Pitavastatin|pitavastatin|mesh-list
110458238|NCT02634034|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110458239|NCT02634034|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110458240|NCT02634034|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110458241|NCT02634034|Antimetabolites|antimetabolites|mesh-ancestor
110458242|NCT02634034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110458243|NCT02634034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110458244|NCT02634034|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110458245|NCT00657748|Triacetin|triacetin|mesh-list
110458246|NCT00657748|Lithium Carbonate|lithium carbonate|mesh-list
110458247|NCT00657748|Antidepressive Agents|antidepressive agents|mesh-ancestor
110458248|NCT00657748|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110458249|NCT00657748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110458250|NCT00657748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110458251|NCT00657748|Antimanic Agents|antimanic agents|mesh-ancestor
110458252|NCT00657748|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110458253|NCT00657748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110458254|NCT00657748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110458255|NCT00657748|Antifungal Agents|antifungal agents|mesh-ancestor
110458256|NCT00657748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110458257|NCT04161586|Prilocaine|prilocaine|mesh-list
110458258|NCT04161586|Anesthetics, Local|anesthetics, local|mesh-ancestor
110458259|NCT04161586|Anesthetics|anesthetics|mesh-ancestor
110458260|NCT04161586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110458261|NCT04161586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110458262|NCT04161586|Sensory System Agents|sensory system agents|mesh-ancestor
110458263|NCT04161586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110530766|NCT02693210|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110530767|NCT02693210|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110530768|NCT02693210|Antimetabolites|antimetabolites|mesh-ancestor
110530769|NCT02693210|Dermatologic Agents|dermatologic agents|mesh-ancestor
110530770|NCT02693210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110530771|NCT02693210|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110530772|NCT02693210|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110458264|NCT02636218|Ketamine|ketamine|mesh-list
110458265|NCT02636218|Analgesics|analgesics|mesh-ancestor
110458266|NCT02636218|Sensory System Agents|sensory system agents|mesh-ancestor
110458267|NCT02636218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110458268|NCT02636218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110458269|NCT02636218|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110458270|NCT02636218|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110594317|NCT02578550|Tenofovir|tenofovir|mesh-list
110458271|NCT02636218|Anesthetics, General|anesthetics, general|mesh-ancestor
110458272|NCT02636218|Anesthetics|anesthetics|mesh-ancestor
110458273|NCT02636218|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110458274|NCT02636218|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110458275|NCT02636218|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110458276|NCT02636218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110458277|NCT02636218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110458278|NCT04161508|Glycopyrrolate|glycopyrrolate|mesh-list
110458279|NCT04161508|Neostigmine|neostigmine|mesh-list
110458280|NCT04161508|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110458281|NCT04161508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110458282|NCT04161508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110458283|NCT04161508|Cholinergic Agents|cholinergic agents|mesh-ancestor
110458284|NCT04161508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110458285|NCT04161508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110458286|NCT04161508|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110458287|NCT04161508|Autonomic Agents|autonomic agents|mesh-ancestor
110458288|NCT04161508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110458289|NCT04161508|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110458290|NCT04161508|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110458291|NCT04161508|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110458292|NCT00598078|Sodium Oxybate|sodium oxybate|mesh-list
110458293|NCT00598078|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110458294|NCT00598078|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110458295|NCT00598078|Anesthetics, General|anesthetics, general|mesh-ancestor
110458296|NCT00598078|Anesthetics|anesthetics|mesh-ancestor
110458297|NCT00598078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110458298|NCT00598078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110458299|NCT00883558|Insulin|insulin|mesh-list
110458300|NCT00883558|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110458301|NCT00883558|Insulin Glargine|insulin glargine|mesh-list
110458302|NCT00883558|Insulin Lispro|insulin lispro|mesh-list
110458303|NCT00883558|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110458304|NCT00883558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110458305|NCT04162834|Papaverine|papaverine|mesh-list
110458306|NCT04162834|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110458307|NCT04162834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110458308|NCT04162834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110458309|NCT04162834|Vasodilator Agents|vasodilator agents|mesh-ancestor
110458310|NCT04162834|Urological Agents|urological agents|mesh-ancestor
110458312|NCT00657904|Androgen Antagonists|androgen antagonists|mesh-ancestor
110458313|NCT00657904|Hormone Antagonists|hormone antagonists|mesh-ancestor
110458314|NCT00657904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110458315|NCT00657904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110458316|NCT00657904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110458317|NCT02633878|Progesterone|progesterone|mesh-list
110458318|NCT02633878|Progestins|progestins|mesh-ancestor
110458319|NCT02633878|Hormones|hormones|mesh-ancestor
110458320|NCT02633878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110458321|NCT02633878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110458322|NCT00597766|Triamcinolone|triamcinolone|mesh-list
110458323|NCT00597766|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110458324|NCT00597766|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110458326|NCT00597766|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110530773|NCT05024006|Interferons|interferons|mesh-list
110530774|NCT05024006|Ritonavir|ritonavir|mesh-list
110530775|NCT05024006|Lopinavir|lopinavir|mesh-list
110530776|NCT05024006|Interferon-beta|interferon-beta|mesh-list
110530777|NCT05024006|Interferon beta-1a|interferon beta-1a|mesh-list
110530778|NCT05024006|Remdesivir|remdesivir|mesh-list
110458327|NCT00597766|Anesthetics, Local|anesthetics, local|mesh-ancestor
110458329|NCT00597766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110458330|NCT00597766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110458331|NCT00597766|Sensory System Agents|sensory system agents|mesh-ancestor
110458332|NCT00597766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110458333|NCT00597766|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110458334|NCT00597766|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110458335|NCT00597766|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110458336|NCT00597766|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110458337|NCT00597766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110458338|NCT00597766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110458339|NCT00597766|Glucocorticoids|glucocorticoids|mesh-ancestor
110458340|NCT00597766|Hormones|hormones|mesh-ancestor
110458341|NCT00597766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110458342|NCT00597766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110458343|NCT00597766|Immunologic Factors|immunologic factors|mesh-ancestor
110458344|NCT00597766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110458345|NCT04161274|Silver Nitrate|silver nitrate|mesh-list
110458346|NCT04161274|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110458347|NCT04161274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110458348|NCT00657982|Everolimus|everolimus|mesh-list
110458349|NCT00657982|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110458350|NCT00657982|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110458351|NCT00657982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110458352|NCT00657982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110458353|NCT00657982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110458354|NCT00657982|Immunologic Factors|immunologic factors|mesh-ancestor
110458355|NCT00657982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110458356|NCT00657982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110458357|NCT04159246|Sofosbuvir|sofosbuvir|mesh-list
110458358|NCT04159246|Antiviral Agents|antiviral agents|mesh-ancestor
110458359|NCT04159246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110458360|NCT00979992|Sunitinib|sunitinib|mesh-list
110458361|NCT00979992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110458362|NCT00979992|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110458363|NCT00979992|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110458364|NCT00979992|Growth Substances|growth substances|mesh-ancestor
110458365|NCT00979992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110458366|NCT00979992|Growth Inhibitors|growth inhibitors|mesh-ancestor
110458367|NCT00979992|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110458368|NCT00979992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110458369|NCT00979992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110458370|NCT01079741|Poly I-C|poly i-c|mesh-list
110458371|NCT01079741|Mineral Oil|mineral oil|mesh-list
110458372|NCT01079741|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
110458373|NCT01079741|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
110458374|NCT01079741|Freund's Adjuvant|freund's adjuvant|mesh-list
110458375|NCT01079741|Poly ICLC|poly iclc|mesh-list
110458376|NCT01079741|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110458377|NCT01079741|Immunologic Factors|immunologic factors|mesh-ancestor
110458378|NCT01079741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110458379|NCT01079741|Interferon Inducers|interferon inducers|mesh-ancestor
110458380|NCT01079741|Laxatives|laxatives|mesh-ancestor
110458381|NCT01079741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110458382|NCT01079741|Antiviral Agents|antiviral agents|mesh-ancestor
110458383|NCT01079741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110458384|NCT01079741|Emollients|emollients|mesh-ancestor
110458385|NCT01079741|Dermatologic Agents|dermatologic agents|mesh-ancestor
110458386|NCT02877641|Vitamin D|vitamin d|mesh-list
110458387|NCT02877641|Cholecalciferol|cholecalciferol|mesh-list
110458388|NCT02877641|Vitamins|vitamins|mesh-list
110458389|NCT02877641|Micronutrients|micronutrients|mesh-ancestor
110458390|NCT02877641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110458391|NCT02877641|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110458392|NCT02877641|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110458393|NCT01079663|Chlorhexidine|chlorhexidine|mesh-list
110458394|NCT01079663|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110530779|NCT05024006|Hydroxychloroquine|hydroxychloroquine|mesh-list
110530780|NCT05024006|Acalabrutinib|acalabrutinib|mesh-list
110530781|NCT05024006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110530782|NCT05024006|Antiviral Agents|antiviral agents|mesh-ancestor
110530783|NCT05024006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110594337|NCT00788463|Beclomethasone|beclomethasone|mesh-list
110530784|NCT05024006|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110530785|NCT05024006|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110530786|NCT05024006|Protease Inhibitors|protease inhibitors|mesh-ancestor
110182202|NCT02971878|Vitamins|vitamins|mesh-ancestor
110458395|NCT01079663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110458396|NCT01079663|Disinfectants|disinfectants|mesh-ancestor
110458397|NCT02867046|Dexamethasone|dexamethasone|mesh-list
110458398|NCT02867046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110458399|NCT02867046|Antiemetics|antiemetics|mesh-ancestor
110458400|NCT02867046|Autonomic Agents|autonomic agents|mesh-ancestor
110458401|NCT02867046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110458402|NCT02867046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110458403|NCT02867046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110458404|NCT02867046|Glucocorticoids|glucocorticoids|mesh-ancestor
110458405|NCT02867046|Hormones|hormones|mesh-ancestor
110458406|NCT02867046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110458407|NCT02867046|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110458408|NCT02867046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110458409|NCT02865174|Heparin|heparin|mesh-list
110458410|NCT02865174|Enoxaparin|enoxaparin|mesh-list
110458411|NCT02865174|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
110458412|NCT02865174|Tinzaparin|tinzaparin|mesh-list
110458413|NCT02865174|Dalteparin|dalteparin|mesh-list
110458414|NCT02865174|Tranylcypromine|tranylcypromine|mesh-list
110458415|NCT02865174|Tranexamic Acid|tranexamic acid|mesh-list
110458416|NCT02865174|Thrombin|thrombin|mesh-list
110458417|NCT02865174|Anticoagulants|anticoagulants|mesh-ancestor
110458418|NCT02865174|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110458419|NCT02865174|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110458420|NCT02865174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110458421|NCT02865174|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110458422|NCT02865174|Hemostatics|hemostatics|mesh-ancestor
110458423|NCT02865174|Coagulants|coagulants|mesh-ancestor
110458424|NCT02865174|Antidepressive Agents|antidepressive agents|mesh-ancestor
110458425|NCT02865174|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110458426|NCT02865174|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
110458427|NCT02865174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110458428|NCT02865174|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110458429|NCT02865174|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110458430|NCT02865174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110458431|NCT02865174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110458432|NCT00879814|Vaccines|vaccines|mesh-list
110458433|NCT00879814|Immunologic Factors|immunologic factors|mesh-ancestor
110458434|NCT00879814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110458435|NCT02633176|Docetaxel|docetaxel|mesh-list
110458436|NCT02633176|Capecitabine|capecitabine|mesh-list
110458437|NCT02633176|Cetuximab|cetuximab|mesh-list
110458438|NCT02633176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110458439|NCT02633176|Tubulin Modulators|tubulin modulators|mesh-ancestor
110458440|NCT02633176|Antimitotic Agents|antimitotic agents|mesh-ancestor
110458441|NCT02633176|Mitosis Modulators|mitosis modulators|mesh-ancestor
110458442|NCT02633176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110458443|NCT02633176|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110458444|NCT02633176|Antimetabolites|antimetabolites|mesh-ancestor
110458445|NCT02633176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110458447|NCT04156984|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110458448|NCT04156984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110458449|NCT04156984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110458450|NCT04156984|Immunologic Factors|immunologic factors|mesh-ancestor
110458451|NCT04156984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110458452|NCT04158778|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
110458453|NCT04158778|Hallucinogens|hallucinogens|mesh-ancestor
110458454|NCT04158778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110458455|NCT04158778|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110458456|NCT04158778|Serotonin Agents|serotonin agents|mesh-ancestor
110530788|NCT05024006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110530789|NCT05024006|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110530790|NCT05024006|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110530791|NCT05024006|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110530792|NCT05024006|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110530793|NCT05024006|Antimalarials|antimalarials|mesh-ancestor
110530794|NCT05024006|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110530795|NCT05024006|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110530796|NCT05024006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110530797|NCT05024006|Immunologic Factors|immunologic factors|mesh-ancestor
110530798|NCT05024006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110530799|NCT05024006|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110530800|NCT05024006|Antimetabolites|antimetabolites|mesh-ancestor
110530801|NCT02707250|Meperidine|meperidine|mesh-list
110530802|NCT02707250|Bupivacaine|bupivacaine|mesh-list
110530803|NCT02707250|Anesthetics, Local|anesthetics, local|mesh-ancestor
110530804|NCT02707250|Anesthetics|anesthetics|mesh-ancestor
110530805|NCT02707250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110530806|NCT02707250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110216834|NCT00266578|Xhance|xhance|mesh-list
110458457|NCT04158778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110458458|NCT04158778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110458459|NCT04158778|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110458460|NCT04158778|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110458461|NCT04158778|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110458462|NCT04158778|Adrenergic Agents|adrenergic agents|mesh-ancestor
110458463|NCT01132664|Capecitabine|capecitabine|mesh-list
110458464|NCT01132664|Trastuzumab|trastuzumab|mesh-list
110458465|NCT01132664|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110458466|NCT01132664|Antimetabolites|antimetabolites|mesh-ancestor
110458467|NCT01132664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110458468|NCT01132664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110458469|NCT01132664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110458470|NCT01078805|Teriparatide|teriparatide|mesh-list
110458471|NCT01078805|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110458472|NCT01078805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110458473|NCT01078805|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110458474|NCT00820027|Ibuprofen|ibuprofen|mesh-list
110458475|NCT00820027|Etoricoxib|etoricoxib|mesh-list
110458476|NCT00820027|Morphine|morphine|mesh-list
110458477|NCT00820027|Oxycodone|oxycodone|mesh-list
110458478|NCT00820027|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110458479|NCT00820027|Narcotics|narcotics|mesh-ancestor
110458480|NCT00820027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110458481|NCT00820027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110458482|NCT00820027|Analgesics|analgesics|mesh-ancestor
110458483|NCT00820027|Sensory System Agents|sensory system agents|mesh-ancestor
110458484|NCT00820027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110458485|NCT00820027|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110458486|NCT00820027|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110458487|NCT00820027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110458488|NCT00820027|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110458489|NCT00820027|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110458490|NCT00820027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110530807|NCT02707250|Sensory System Agents|sensory system agents|mesh-ancestor
110530808|NCT02707250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110530809|NCT02707250|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110530810|NCT02707250|Narcotics|narcotics|mesh-ancestor
110530811|NCT02707250|Analgesics|analgesics|mesh-ancestor
110530812|NCT02707250|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110530813|NCT03781544|Acetaminophen|acetaminophen|mesh-list
110530815|NCT03781544|Tramadol|tramadol|mesh-list
110530816|NCT03781544|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110530817|NCT03781544|Analgesics|analgesics|mesh-ancestor
110530818|NCT03781544|Sensory System Agents|sensory system agents|mesh-ancestor
110530819|NCT03781544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110530820|NCT03781544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110530821|NCT03781544|Antipyretics|antipyretics|mesh-ancestor
110594353|NCT00579254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110530822|NCT03781544|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110530823|NCT03781544|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110530824|NCT03781544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110458491|NCT00820027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110458492|NCT00820027|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110458493|NCT02876549|Chloroquine|chloroquine|mesh-list
110458494|NCT02876549|Primaquine|primaquine|mesh-list
110458495|NCT02876549|Amebicides|amebicides|mesh-ancestor
110458496|NCT02876549|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110458497|NCT02876549|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110458498|NCT02876549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110458499|NCT02876549|Antimalarials|antimalarials|mesh-ancestor
110458500|NCT02876549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110458502|NCT00913549|Antipruritics|antipruritics|mesh-ancestor
110458503|NCT00913549|Dermatologic Agents|dermatologic agents|mesh-ancestor
110458504|NCT00913549|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110458505|NCT00913549|Histamine Antagonists|histamine antagonists|mesh-ancestor
110458506|NCT00913549|Histamine Agents|histamine agents|mesh-ancestor
110458507|NCT00913549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110458508|NCT00913549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110458509|NCT00913549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110458510|NCT00913549|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110458511|NCT01076153|Clarithromycin|clarithromycin|mesh-list
110458512|NCT01076153|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110458513|NCT01076153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110458514|NCT01076153|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110458515|NCT01076153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110458516|NCT01076153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110458517|NCT01076153|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110458518|NCT01076153|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110458519|NCT01076075|Metformin|metformin|mesh-list
110458520|NCT01076075|Pioglitazone|pioglitazone|mesh-list
110458521|NCT01076075|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110458522|NCT01076075|Glimepiride|glimepiride|mesh-list
110458523|NCT01076075|Gliclazide|gliclazide|mesh-list
110458524|NCT01076075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110458525|NCT01076075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110458526|NCT01076075|Incretins|incretins|mesh-ancestor
110458527|NCT01076075|Hormones|hormones|mesh-ancestor
110458528|NCT01076075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110458529|NCT01076075|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110458530|NCT01076075|Protease Inhibitors|protease inhibitors|mesh-ancestor
110458531|NCT01076075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110458532|NCT01076075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110530825|NCT03781544|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110530826|NCT03781544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110530827|NCT03781544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110530828|NCT03781544|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110530830|NCT03781544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110530831|NCT02707094|Immunologic Factors|immunologic factors|mesh-list
110530832|NCT02707094|Immunomodulating Agents|immunomodulating agents|mesh-list
110530833|NCT02707094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110530834|NCT02707016|Sevoflurane|sevoflurane|mesh-list
110530835|NCT02707016|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110530836|NCT02707016|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110182379|NCT02971982|Hormones|hormones|mesh-ancestor
110458533|NCT01076075|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110458534|NCT01076075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110458535|NCT01076075|Immunologic Factors|immunologic factors|mesh-ancestor
110458536|NCT01075763|Interferons|interferons|mesh-list
110458537|NCT01075763|Interferon-beta|interferon-beta|mesh-list
110458538|NCT01075763|Interferon beta-1a|interferon beta-1a|mesh-list
110458539|NCT01075763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110458540|NCT01075763|Antiviral Agents|antiviral agents|mesh-ancestor
110458541|NCT01075763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110458542|NCT01075763|Immunologic Factors|immunologic factors|mesh-ancestor
110458543|NCT01075763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110303718|NCT01687582|Liraglutide|liraglutide|mesh-list
110458544|NCT01075763|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110458545|NCT00881530|Metformin|metformin|mesh-list
110458546|NCT00881530|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110458547|NCT00881530|Empagliflozin|empagliflozin|mesh-list
110458548|NCT00881530|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110458549|NCT00881530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110458550|NCT00881530|Incretins|incretins|mesh-ancestor
110458551|NCT00881530|Hormones|hormones|mesh-ancestor
110458552|NCT00881530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110458553|NCT00881530|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110458555|NCT00881530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110458556|NCT00881530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110458557|NCT00881530|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110458558|NCT02632474|Tenofovir|tenofovir|mesh-list
110458559|NCT02632474|Lamivudine|lamivudine|mesh-list
110458560|NCT02632474|Efavirenz|efavirenz|mesh-list
110458561|NCT02632474|Antiviral Agents|antiviral agents|mesh-ancestor
110458562|NCT02632474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110458563|NCT02632474|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110458564|NCT02632474|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110458565|NCT02632474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110458566|NCT02632474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110458567|NCT02632474|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110458568|NCT02632474|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110458569|NCT02632474|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110458570|NCT02632474|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110458571|NCT02632474|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110458572|NCT02632474|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110458573|NCT02632474|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110458574|NCT02632474|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110458575|NCT04156750|Metformin|metformin|mesh-list
110458576|NCT04156750|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110458577|NCT04156750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110458578|NCT02877173|Alprostadil|alprostadil|mesh-list
110458579|NCT02877173|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110458580|NCT02877173|Vasodilator Agents|vasodilator agents|mesh-ancestor
110458581|NCT02877173|Urological Agents|urological agents|mesh-ancestor
110530837|NCT02707016|Anesthetics, General|anesthetics, general|mesh-ancestor
110530838|NCT02707016|Anesthetics|anesthetics|mesh-ancestor
110530839|NCT02707016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110530840|NCT02707016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110530841|NCT04956146|Carboplatin|carboplatin|mesh-list
110530842|NCT04956146|Pemetrexed|pemetrexed|mesh-list
110530843|NCT04956146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110530844|NCT04956146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110182433|NCT00023946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110458582|NCT04305743|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110458583|NCT04305743|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110458584|NCT04305743|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110458585|NCT04305743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110458586|NCT04305743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110458587|NCT04305743|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110458588|NCT04305743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110458589|NCT04305743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110458590|NCT04305743|Cholinergic Agents|cholinergic agents|mesh-ancestor
110458591|NCT04305743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110458592|NCT00661180|Sorafenib|sorafenib|mesh-list
110458593|NCT00661180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110458594|NCT00661180|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110458595|NCT00661180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110458596|NCT00661180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110458597|NCT01078571|Adalimumab|adalimumab|mesh-list
110458598|NCT01078571|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110458599|NCT01078571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110458600|NCT01078571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110458601|NCT04160416|Capecitabine|capecitabine|mesh-list
110458602|NCT04160416|Oxaliplatin|oxaliplatin|mesh-list
110458603|NCT04160416|Irinotecan|irinotecan|mesh-list
110303762|NCT00287976|Irinotecan|irinotecan|mesh-list
110458604|NCT04160416|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110458605|NCT04160416|Antimetabolites|antimetabolites|mesh-ancestor
110458606|NCT04160416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110105688|NCT01788501|Abortifacient Agents|abortifacient agents|mesh-ancestor
110458607|NCT04160416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110458608|NCT04160416|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110458609|NCT04160416|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110458610|NCT04160416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110458612|NCT00661336|Buthionine Sulfoximine|buthionine sulfoximine|mesh-list
110458613|NCT00661336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110458614|NCT00661336|Alkylating Agents|alkylating agents|mesh-ancestor
110458615|NCT00661336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110458616|NCT00661336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110458617|NCT00661336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110458618|NCT00661336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110458619|NCT00661336|Immunologic Factors|immunologic factors|mesh-ancestor
110458620|NCT00661336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110458621|NCT00661336|Antimetabolites|antimetabolites|mesh-ancestor
110458622|NCT00661336|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110458623|NCT00661336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110458624|NCT00661336|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110458625|NCT00661336|Protective Agents|protective agents|mesh-ancestor
110458626|NCT04158700|Pembrolizumab|pembrolizumab|mesh-list
110458627|NCT04158700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110458628|NCT04158700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110458629|NCT04158700|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110458630|NCT04158700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110458631|NCT00657202|Ranibizumab|ranibizumab|mesh-list
110458632|NCT00657202|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110458633|NCT00657202|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110458634|NCT00657202|Growth Substances|growth substances|mesh-ancestor
110458635|NCT00657202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110458636|NCT00657202|Growth Inhibitors|growth inhibitors|mesh-ancestor
110458637|NCT00657202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110530845|NCT04956146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110530846|NCT04956146|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110530847|NCT04956146|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110530848|NCT00612794|Exenatide|exenatide|mesh-list
110530849|NCT00612794|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110530850|NCT00612794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110530851|NCT00612794|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110530852|NCT00612794|Incretins|incretins|mesh-ancestor
110530853|NCT00612794|Hormones|hormones|mesh-ancestor
110530854|NCT00612794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110530855|NCT03773276|Norepinephrine|norepinephrine|mesh-list
110530856|NCT03773276|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110530857|NCT03773276|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110182500|NCT00024492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110182501|NCT00024531|Atorvastatin|atorvastatin|mesh-list
110182502|NCT00024531|Calcium|calcium|mesh-list
110182503|NCT00024531|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110182504|NCT00024531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110182505|NCT00024531|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110182506|NCT00024531|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110182507|NCT00024531|Antimetabolites|antimetabolites|mesh-ancestor
110182508|NCT00024531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110182509|NCT00024531|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110182510|NCT00024531|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110182511|NCT00024531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110458638|NCT00626483|Basiliximab|basiliximab|mesh-list
110458639|NCT00626483|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110458640|NCT00626483|Immunologic Factors|immunologic factors|mesh-ancestor
110594380|NCT00661089|Cholinergic Agents|cholinergic agents|mesh-ancestor
110458641|NCT00626483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110458643|NCT00626717|Vitamin B Complex|vitamin b complex|mesh-ancestor
110458644|NCT00626717|Vitamins|vitamins|mesh-ancestor
110458645|NCT00626717|Micronutrients|micronutrients|mesh-ancestor
110458646|NCT00626717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110458647|NCT00626717|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110458648|NCT00626717|Dermatologic Agents|dermatologic agents|mesh-ancestor
110458649|NCT04156204|Tacrolimus|tacrolimus|mesh-list
110458650|NCT04156204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110458651|NCT04156204|Immunologic Factors|immunologic factors|mesh-ancestor
110458652|NCT04156204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110458653|NCT04156204|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110458654|NCT04156204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110458655|NCT04156204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110458656|NCT02631694|Propranolol|propranolol|mesh-list
110458657|NCT02631694|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110458658|NCT02631694|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110458659|NCT02631694|Adrenergic Agents|adrenergic agents|mesh-ancestor
110458660|NCT02631694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110530858|NCT03773276|Adrenergic Agents|adrenergic agents|mesh-ancestor
110530859|NCT03773276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110530860|NCT03773276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110530861|NCT03773276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110530862|NCT03773276|Sympathomimetics|sympathomimetics|mesh-ancestor
110530863|NCT03773276|Autonomic Agents|autonomic agents|mesh-ancestor
110530864|NCT03773276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110530865|NCT03773276|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110530866|NCT02706860|Atorvastatin|atorvastatin|mesh-list
110530868|NCT02706860|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110530869|NCT02706860|Antimetabolites|antimetabolites|mesh-ancestor
110530870|NCT02706860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110530871|NCT02706860|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110182577|NCT00025077|Cyclophosphamide|cyclophosphamide|mesh-list
110182578|NCT00025077|Thiotepa|thiotepa|mesh-list
110182579|NCT00025077|Carboplatin|carboplatin|mesh-list
110182580|NCT00025077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110182581|NCT00025077|Immunologic Factors|immunologic factors|mesh-ancestor
110182582|NCT00025077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110182583|NCT00025077|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110182584|NCT00025077|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110182585|NCT00025077|Alkylating Agents|alkylating agents|mesh-ancestor
110182586|NCT00025077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110182587|NCT00025077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110182588|NCT00025077|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110182589|NCT05051891|Prednisone|prednisone|mesh-list
110182590|NCT05051891|Cyclophosphamide|cyclophosphamide|mesh-list
110182591|NCT05051891|Vincristine|vincristine|mesh-list
110458661|NCT02631694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110458662|NCT02631694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110458663|NCT02631694|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110458664|NCT02631694|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110458665|NCT02631694|Vasodilator Agents|vasodilator agents|mesh-ancestor
110458666|NCT04305587|Clopidogrel|clopidogrel|mesh-list
110458667|NCT04305587|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110458668|NCT04305587|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110458669|NCT04305587|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110458670|NCT04305587|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110458671|NCT04305587|Purinergic Agents|purinergic agents|mesh-ancestor
110458672|NCT04305587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110458673|NCT04305587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110458674|NCT04305587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110458675|NCT00658840|Capecitabine|capecitabine|mesh-list
110458676|NCT00658840|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110458677|NCT00658840|Antimetabolites|antimetabolites|mesh-ancestor
110458678|NCT00658840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110530872|NCT02706860|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110530874|NCT02706470|Cyclosporine|cyclosporine|mesh-list
110530875|NCT02706470|Cyclosporins|cyclosporins|mesh-list
110530876|NCT02706470|Dydrogesterone|dydrogesterone|mesh-list
110458679|NCT00658840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110458680|NCT00658918|Ciclesonide|ciclesonide|mesh-list
110458681|NCT00658918|Glucocorticoids|glucocorticoids|mesh-ancestor
110458682|NCT00658918|Hormones|hormones|mesh-ancestor
110105760|NCT01788982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110458683|NCT00658918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110458684|NCT00658918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110458685|NCT00658918|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110458686|NCT02876081|Afatinib|afatinib|mesh-list
110458687|NCT02876081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110458688|NCT02876081|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110458689|NCT02876081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110458690|NCT02876081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110458691|NCT02631616|Somatostatin|somatostatin|mesh-list
110458692|NCT02631616|Hormones|hormones|mesh-ancestor
110458693|NCT02631616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110458694|NCT02631616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110458695|NCT00661648|Pancrelipase|pancrelipase|mesh-list
110458696|NCT00661648|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110458697|NCT00659074|Ondansetron|ondansetron|mesh-list
110458699|NCT00659074|Autonomic Agents|autonomic agents|mesh-ancestor
110458700|NCT00659074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110458701|NCT00659074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110458702|NCT00659074|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110458703|NCT00659074|Antipruritics|antipruritics|mesh-ancestor
110303896|NCT00417729|Acarbose|acarbose|mesh-list
110458704|NCT00659074|Dermatologic Agents|dermatologic agents|mesh-ancestor
110458705|NCT00659074|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110458706|NCT00659074|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110458707|NCT00659074|Serotonin Agents|serotonin agents|mesh-ancestor
110458708|NCT00659074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110458709|NCT00659074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110458710|NCT01077713|Bevacizumab|bevacizumab|mesh-list
110458711|NCT01077713|Gemcitabine|gemcitabine|mesh-list
110458712|NCT01077713|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110458713|NCT01077713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110458714|NCT01077713|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110458715|NCT01077713|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110458716|NCT01077713|Growth Substances|growth substances|mesh-ancestor
110458717|NCT01077713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110458718|NCT01077713|Growth Inhibitors|growth inhibitors|mesh-ancestor
110458719|NCT01077713|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110458720|NCT01077713|Antimetabolites|antimetabolites|mesh-ancestor
110458721|NCT01077713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110458722|NCT00813709|Interferon beta-1a|interferon beta-1a|mesh-list
110458723|NCT00813709|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110458724|NCT00813709|Immunologic Factors|immunologic factors|mesh-ancestor
110458725|NCT00813709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110458726|NCT00813709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110458727|NCT00813709|Antiviral Agents|antiviral agents|mesh-ancestor
110458728|NCT00813709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110458730|NCT01077323|Hypoglycemic Agents|hypoglycemic agents|mesh-list
110458731|NCT01077323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110458732|NCT01077323|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110458733|NCT01077323|Incretins|incretins|mesh-ancestor
110458734|NCT01077323|Hormones|hormones|mesh-ancestor
110458735|NCT01077323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110458736|NCT03870438|Lamivudine|lamivudine|mesh-list
110458737|NCT03870438|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110458738|NCT03870438|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110458740|NCT03870438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110458741|NCT03870438|Antiviral Agents|antiviral agents|mesh-ancestor
110458742|NCT03870438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110458743|NCT03870438|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110458744|NCT03870438|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110458745|NCT04287894|Pemetrexed|pemetrexed|mesh-list
110530877|NCT02706470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110530878|NCT02706470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110530879|NCT02706470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110530880|NCT02706470|Immunologic Factors|immunologic factors|mesh-ancestor
110530881|NCT02706470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110530882|NCT02706470|Antifungal Agents|antifungal agents|mesh-ancestor
110530883|NCT02706470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110530884|NCT02706470|Dermatologic Agents|dermatologic agents|mesh-ancestor
110458747|NCT04287894|Tremelimumab|tremelimumab|mesh-list
110458748|NCT04287894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110458749|NCT04287894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110458750|NCT04287894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110458751|NCT04287894|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110458752|NCT04287894|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110458753|NCT04287894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110458754|NCT04287426|Remifentanil|remifentanil|mesh-list
110458755|NCT04287426|Rocuronium|rocuronium|mesh-list
110458756|NCT04287426|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110458757|NCT04287426|Narcotics|narcotics|mesh-ancestor
110458758|NCT04287426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110458759|NCT04287426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110458760|NCT04287426|Analgesics|analgesics|mesh-ancestor
110458761|NCT04287426|Sensory System Agents|sensory system agents|mesh-ancestor
110458762|NCT04287426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110458763|NCT04287426|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110458764|NCT04287426|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110458765|NCT04287426|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110458766|NCT04047576|Sirolimus|sirolimus|mesh-list
110458767|NCT04047576|Prednisone|prednisone|mesh-list
110458768|NCT04047576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110458769|NCT04047576|Glucocorticoids|glucocorticoids|mesh-ancestor
110458770|NCT04047576|Hormones|hormones|mesh-ancestor
110458771|NCT04047576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110458772|NCT04047576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110458773|NCT04047576|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110458774|NCT04047576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110458775|NCT04047576|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110458776|NCT04047576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110458777|NCT04047576|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110458778|NCT04047576|Antifungal Agents|antifungal agents|mesh-ancestor
110458779|NCT04047576|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110458780|NCT04047576|Immunologic Factors|immunologic factors|mesh-ancestor
110458781|NCT00976950|Ritonavir|ritonavir|mesh-list
110458782|NCT00976950|Tipranavir|tipranavir|mesh-list
110458783|NCT00976950|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110458784|NCT00976950|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110458785|NCT00976950|Protease Inhibitors|protease inhibitors|mesh-ancestor
110458786|NCT00976950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110458787|NCT00976950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110458788|NCT00976950|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110458789|NCT00976950|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110458790|NCT00976950|Antiviral Agents|antiviral agents|mesh-ancestor
110458791|NCT00976950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110458792|NCT00976950|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110458793|NCT00976950|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110458794|NCT00629382|Polymyxins|polymyxins|mesh-list
110458795|NCT00629382|Polymyxin B|polymyxin b|mesh-list
110458796|NCT00629382|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110458797|NCT00629382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110458798|NCT02866032|Ciclopirox|ciclopirox|mesh-list
110458799|NCT02866032|Antifungal Agents|antifungal agents|mesh-ancestor
110458800|NCT02866032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110458801|NCT00976716|Celecoxib|celecoxib|mesh-list
110458802|NCT00976716|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110458803|NCT00976716|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110458804|NCT00976716|Analgesics|analgesics|mesh-ancestor
110458805|NCT00976716|Sensory System Agents|sensory system agents|mesh-ancestor
110530885|NCT02706470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110530886|NCT02706470|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110530887|NCT02706470|Progestins|progestins|mesh-ancestor
110530888|NCT02706470|Hormones|hormones|mesh-ancestor
110530889|NCT02706470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110530890|NCT03769766|Curcumin|curcumin|mesh-list
110530891|NCT03769766|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110530892|NCT03769766|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110458806|NCT00976716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110458807|NCT00976716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110458808|NCT00976716|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110458809|NCT00976716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110458810|NCT00976716|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110458811|NCT00976716|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110458812|NCT00976716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110458813|NCT00976716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110458814|NCT00973674|Estrogens|estrogens|mesh-list
110458815|NCT00973674|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
110458816|NCT00973674|Hormones|hormones|mesh-ancestor
110458817|NCT00973674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110458818|NCT00973674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110458819|NCT00819091|Linagliptin|linagliptin|mesh-list
110458820|NCT00819091|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110458821|NCT00819091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110458822|NCT00819091|Incretins|incretins|mesh-ancestor
110458823|NCT00819091|Hormones|hormones|mesh-ancestor
110458824|NCT00819091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110458825|NCT00819091|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110458826|NCT00819091|Protease Inhibitors|protease inhibitors|mesh-ancestor
110458827|NCT00819091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110458828|NCT00819091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110458829|NCT02864784|Calcium Carbonate|calcium carbonate|mesh-list
110458830|NCT02864784|Calcium|calcium|mesh-list
110458831|NCT02864784|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110458832|NCT02864784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110458833|NCT02864784|Antacids|antacids|mesh-ancestor
110458834|NCT02864784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110458835|NCT02864784|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110458836|NCT00819013|Vaccines|vaccines|mesh-list
110458837|NCT00819013|Immunologic Factors|immunologic factors|mesh-ancestor
110458838|NCT00819013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110458839|NCT04868461|Caseins|caseins|mesh-list
110458840|NCT04868461|Chelating Agents|chelating agents|mesh-ancestor
110458841|NCT04868461|Sequestering Agents|sequestering agents|mesh-ancestor
110458842|NCT04868461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110458843|NCT02865642|Escitalopram|escitalopram|mesh-list
110458844|NCT02865642|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
110458845|NCT02865642|Serotonin|serotonin|mesh-list
110458846|NCT02865642|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110458847|NCT02865642|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110458848|NCT02865642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110458849|NCT02865642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110458850|NCT02865642|Serotonin Agents|serotonin agents|mesh-ancestor
110458851|NCT02865642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110458852|NCT02865642|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110458853|NCT03762564|Paclitaxel|paclitaxel|mesh-list
110458854|NCT03762564|Ramucirumab|ramucirumab|mesh-list
110458855|NCT03762564|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110458856|NCT03762564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110458857|NCT03762564|Tubulin Modulators|tubulin modulators|mesh-ancestor
110458858|NCT03762564|Antimitotic Agents|antimitotic agents|mesh-ancestor
110458859|NCT03762564|Mitosis Modulators|mitosis modulators|mesh-ancestor
110458860|NCT03762564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110458861|NCT00629616|Fulvestrant|fulvestrant|mesh-list
110458862|NCT00629616|Anastrozole|anastrozole|mesh-list
110458863|NCT00629616|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110530893|NCT03769766|Analgesics|analgesics|mesh-ancestor
110530894|NCT03769766|Sensory System Agents|sensory system agents|mesh-ancestor
110530895|NCT03769766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110530896|NCT03769766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110530897|NCT03769766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110530898|NCT03769766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110530899|NCT03769766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110530900|NCT03769766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110182814|NCT00026130|Immunologic Factors|immunologic factors|mesh-ancestor
110458864|NCT00629616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110458865|NCT00629616|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110458866|NCT00629616|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110458867|NCT00629616|Hormone Antagonists|hormone antagonists|mesh-ancestor
110458868|NCT00629616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110458869|NCT00629616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110458870|NCT00629616|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110458871|NCT00629616|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110458872|NCT00629616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110458873|NCT00629616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110458874|NCT02864628|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
110458875|NCT02864628|Antiviral Agents|antiviral agents|mesh-ancestor
110458876|NCT02864628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110458878|NCT01120184|Maytansine|maytansine|mesh-list
110458879|NCT01120184|Docetaxel|docetaxel|mesh-list
110458880|NCT01120184|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
110458881|NCT01120184|Trastuzumab|trastuzumab|mesh-list
110458882|NCT01120184|Pertuzumab|pertuzumab|mesh-list
110458883|NCT01120184|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110458884|NCT01120184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110458885|NCT01120184|Tubulin Modulators|tubulin modulators|mesh-ancestor
110458886|NCT01120184|Antimitotic Agents|antimitotic agents|mesh-ancestor
110458887|NCT01120184|Mitosis Modulators|mitosis modulators|mesh-ancestor
110458888|NCT01120184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110458889|NCT01120184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110458890|NCT01120184|Immunotoxins|immunotoxins|mesh-ancestor
110458891|NCT01120184|Immunoconjugates|immunoconjugates|mesh-ancestor
110458892|NCT01120184|Immunologic Factors|immunologic factors|mesh-ancestor
110458893|NCT01120184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110458894|NCT01120028|Sirolimus|sirolimus|mesh-list
110458895|NCT01120028|Alemtuzumab|alemtuzumab|mesh-list
110458896|NCT01120028|Tacrolimus|tacrolimus|mesh-list
110458897|NCT01120028|Basiliximab|basiliximab|mesh-list
110458898|NCT01120028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110458899|NCT01120028|Immunologic Factors|immunologic factors|mesh-ancestor
110458900|NCT01120028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110458901|NCT01120028|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110458902|NCT01120028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110458903|NCT01120028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110458904|NCT01120028|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110458905|NCT01120028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110458906|NCT01120028|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110458907|NCT01120028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110458908|NCT01120028|Antifungal Agents|antifungal agents|mesh-ancestor
110458909|NCT01120028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110458911|NCT00878800|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110458912|NCT00878800|Belinostat|belinostat|mesh-list
110458913|NCT00878800|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110458914|NCT00878800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110594423|NCT00709982|Hematinics|hematinics|mesh-ancestor
110458915|NCT00878800|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110458916|NCT00878800|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110458917|NCT00878800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110458918|NCT00878800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110458919|NCT00878800|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110458920|NCT00662272|Vaccines|vaccines|mesh-list
110458921|NCT00662272|Immunologic Factors|immunologic factors|mesh-ancestor
110530901|NCT03769766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110530903|NCT03764540|Docetaxel|docetaxel|mesh-list
110530904|NCT03764540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110530905|NCT03764540|Tubulin Modulators|tubulin modulators|mesh-ancestor
110530906|NCT03764540|Antimitotic Agents|antimitotic agents|mesh-ancestor
110530907|NCT03764540|Mitosis Modulators|mitosis modulators|mesh-ancestor
110530908|NCT03764540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110530909|NCT03764540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110530910|NCT03764540|Glucocorticoids|glucocorticoids|mesh-ancestor
110530911|NCT03764540|Hormones|hormones|mesh-ancestor
110458922|NCT00662272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110458923|NCT04158856|Trastuzumab|trastuzumab|mesh-list
110458924|NCT04158856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110458925|NCT04158856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110458926|NCT01119950|Glycopyrrolate|glycopyrrolate|mesh-list
110458927|NCT01119950|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110458928|NCT01119950|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110458929|NCT01119950|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110458930|NCT01119950|Cholinergic Agents|cholinergic agents|mesh-ancestor
110458931|NCT01119950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110458932|NCT01119950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110458933|NCT01119950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110458934|NCT02882828|Tacrolimus|tacrolimus|mesh-list
110458935|NCT02882828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110458936|NCT02882828|Immunologic Factors|immunologic factors|mesh-ancestor
110458937|NCT02882828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110458938|NCT02882828|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110458939|NCT02882828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110458940|NCT02882828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110458941|NCT02882126|Treprostinil|treprostinil|mesh-list
110458942|NCT02882126|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110458943|NCT01145222|Midazolam|midazolam|mesh-list
110458944|NCT01145222|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110458945|NCT01145222|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110458946|NCT01145222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110458947|NCT01145222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110458948|NCT01145222|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110458949|NCT01145222|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110458950|NCT01145222|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110458951|NCT01145222|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110458952|NCT01145222|Anesthetics, General|anesthetics, general|mesh-ancestor
110458953|NCT01145222|Anesthetics|anesthetics|mesh-ancestor
110458954|NCT01145222|GABA Modulators|gaba modulators|mesh-ancestor
110458955|NCT01145222|GABA Agents|gaba agents|mesh-ancestor
110458956|NCT01145222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110458957|NCT01145222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110458958|NCT01145066|Borage oil|borage oil|mesh-list
110458959|NCT01145066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110458960|NCT01132118|Hydroxychloroquine|hydroxychloroquine|mesh-list
110458961|NCT01132118|Antimalarials|antimalarials|mesh-ancestor
110458962|NCT01132118|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110458963|NCT01132118|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110458964|NCT01132118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110458965|NCT01132118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110458966|NCT01132118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110458967|NCT01132118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110458968|NCT00637442|Galantamine|galantamine|mesh-list
110458969|NCT00637442|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110458970|NCT00637442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110458971|NCT00637442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110458972|NCT00637442|Cholinergic Agents|cholinergic agents|mesh-ancestor
110458973|NCT00637442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110458974|NCT00637442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110458975|NCT00637442|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110530912|NCT03764540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110530913|NCT03764540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110530914|NCT03764540|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110530915|NCT03763370|Immunoconjugates|immunoconjugates|mesh-list
110530916|NCT03763370|Immunologic Factors|immunologic factors|mesh-ancestor
110530917|NCT03763370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110530918|NCT02706236|Pancrelipase|pancrelipase|mesh-list
110530919|NCT02706236|Pancreatin|pancreatin|mesh-list
110530920|NCT02706236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110530921|NCT00613496|Irbesartan|irbesartan|mesh-list
110182961|NCT00027495|Curcumin|curcumin|mesh-list
110458976|NCT00637442|Autonomic Agents|autonomic agents|mesh-ancestor
110458977|NCT00637442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110458978|NCT00637442|Nootropic Agents|nootropic agents|mesh-ancestor
110458979|NCT00969618|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
110458980|NCT00969618|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110458981|NCT00969618|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110458982|NCT00969618|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110458983|NCT00969618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110458984|NCT00969618|Adrenergic Agents|adrenergic agents|mesh-ancestor
110458985|NCT00969618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110458986|NCT00969618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110458987|NCT02864472|Ranibizumab|ranibizumab|mesh-list
110458988|NCT02864472|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110458989|NCT02864472|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110458990|NCT02864472|Growth Substances|growth substances|mesh-ancestor
110458991|NCT02864472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110458992|NCT02864472|Growth Inhibitors|growth inhibitors|mesh-ancestor
110458993|NCT02864472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110458994|NCT00975000|Cinacalcet|cinacalcet|mesh-list
110458995|NCT00975000|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110458996|NCT00975000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110458997|NCT00975000|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
110458998|NCT00975000|Hormone Antagonists|hormone antagonists|mesh-ancestor
110458999|NCT00975000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110459000|NCT02863614|Ibuprofen|ibuprofen|mesh-list
110459001|NCT02863614|Lorazepam|lorazepam|mesh-list
110459002|NCT02863614|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110459003|NCT02863614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110459004|NCT02863614|Analgesics|analgesics|mesh-ancestor
110459005|NCT02863614|Sensory System Agents|sensory system agents|mesh-ancestor
110459006|NCT02863614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110459007|NCT02863614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110459008|NCT02863614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110459009|NCT02863614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110459010|NCT02863614|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110459011|NCT02863614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110459012|NCT02863614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110459013|NCT02863614|Anticonvulsants|anticonvulsants|mesh-ancestor
110459014|NCT02863614|Antiemetics|antiemetics|mesh-ancestor
110459015|NCT02863614|Autonomic Agents|autonomic agents|mesh-ancestor
110459016|NCT02863614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110459017|NCT02863614|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110459018|NCT02863614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110459019|NCT02863614|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110459020|NCT02863614|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110459021|NCT02863614|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110594442|NCT00710216|Lamivudine|lamivudine|mesh-list
110459022|NCT02863614|GABA Modulators|gaba modulators|mesh-ancestor
110459023|NCT02863614|GABA Agents|gaba agents|mesh-ancestor
110459024|NCT02863614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110459025|NCT00974922|Vitamin D|vitamin d|mesh-list
110459026|NCT00974922|Cholecalciferol|cholecalciferol|mesh-list
110459027|NCT00974922|Vitamins|vitamins|mesh-ancestor
110459028|NCT00974922|Micronutrients|micronutrients|mesh-ancestor
110459029|NCT00974922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110530922|NCT00613496|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110530923|NCT00613496|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110530924|NCT00613496|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110530925|NCT00613496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110530926|NCT00612950|Glucagon|glucagon|mesh-list
110530927|NCT00612950|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
110530928|NCT00612950|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
110530929|NCT00612950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110530930|NCT00612950|Hormones|hormones|mesh-ancestor
110459030|NCT00974922|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110459031|NCT00974922|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110459032|NCT00972504|Cetirizine|cetirizine|mesh-list
110459033|NCT00972504|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110459034|NCT00972504|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110459035|NCT00972504|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110459036|NCT00972504|Histamine Antagonists|histamine antagonists|mesh-ancestor
110459037|NCT00972504|Histamine Agents|histamine agents|mesh-ancestor
110459038|NCT00972504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110459039|NCT00972504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110459040|NCT00972504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110459041|NCT00969150|Milnacipran|milnacipran|mesh-list
110459042|NCT00969150|Levomilnacipran|levomilnacipran|mesh-list
110459043|NCT00969150|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110459044|NCT00969150|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110459045|NCT00969150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110459046|NCT00969150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110459047|NCT00969150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110459048|NCT00969150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110459049|NCT00969150|Antidepressive Agents|antidepressive agents|mesh-ancestor
110459050|NCT00969150|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110459051|NCT00969150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110459052|NCT00969150|Analgesics|analgesics|mesh-ancestor
110459053|NCT00969150|Sensory System Agents|sensory system agents|mesh-ancestor
110459054|NCT00969150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110459055|NCT03925194|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
110106136|NCT01798446|Axitinib|axitinib|mesh-list
110459056|NCT03925194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110459057|NCT00974220|Fentanyl|fentanyl|mesh-list
110459058|NCT00974220|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110459059|NCT00974220|Narcotics|narcotics|mesh-ancestor
110459060|NCT00974220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110459061|NCT00974220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110459062|NCT00974220|Analgesics|analgesics|mesh-ancestor
110459063|NCT00974220|Sensory System Agents|sensory system agents|mesh-ancestor
110459064|NCT00974220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110459065|NCT00974220|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110459066|NCT00974220|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110459067|NCT00974220|Anesthetics, General|anesthetics, general|mesh-ancestor
110459068|NCT00974220|Anesthetics|anesthetics|mesh-ancestor
110459069|NCT00971178|Dexmedetomidine|dexmedetomidine|mesh-list
110459070|NCT00971178|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110459071|NCT00971178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110459072|NCT00971178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110459073|NCT00971178|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110459074|NCT00971178|Analgesics|analgesics|mesh-ancestor
110459075|NCT00971178|Sensory System Agents|sensory system agents|mesh-ancestor
110459076|NCT00971178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110459077|NCT00971178|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110594455|NCT00710528|Idelalisib|idelalisib|mesh-list
110459078|NCT00971178|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110459079|NCT00971178|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110459080|NCT00971178|Adrenergic Agents|adrenergic agents|mesh-ancestor
110459081|NCT00971178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110459082|NCT00971178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110459083|NCT00970944|Amantadine|amantadine|mesh-list
110530931|NCT00612950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110530932|NCT00612950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110530933|NCT00612950|Incretins|incretins|mesh-ancestor
110530934|NCT00884793|Ritonavir|ritonavir|mesh-list
110530935|NCT00884793|Lopinavir|lopinavir|mesh-list
110530936|NCT00884793|Atazanavir Sulfate|atazanavir sulfate|mesh-list
110183092|NCT04022876|Pemetrexed|pemetrexed|mesh-list
110459084|NCT00970944|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110459085|NCT00970944|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110459086|NCT00970944|Antiviral Agents|antiviral agents|mesh-ancestor
110459087|NCT00970944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110459088|NCT00970944|Dopamine Agents|dopamine agents|mesh-ancestor
110459089|NCT00970944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110459090|NCT00970944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110459091|NCT00970944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110459092|NCT00970944|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110459093|NCT00970944|Analgesics|analgesics|mesh-ancestor
110459094|NCT00970944|Sensory System Agents|sensory system agents|mesh-ancestor
110459095|NCT00970944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110459096|NCT05780723|Mesalamine|mesalamine|mesh-list
110459097|NCT05780723|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110459098|NCT05780723|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110459099|NCT05780723|Analgesics|analgesics|mesh-ancestor
110459100|NCT05780723|Sensory System Agents|sensory system agents|mesh-ancestor
110459101|NCT05780723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110459102|NCT05780723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110459103|NCT05780723|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110459104|NCT05780723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110459105|NCT05780515|Immunoglobulins|immunoglobulins|mesh-list
110459106|NCT05780515|Immunoglobulin G|immunoglobulin g|mesh-list
110459107|NCT05780515|Immunologic Factors|immunologic factors|mesh-ancestor
110459108|NCT05780515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110459109|NCT05780489|Estradiol|estradiol|mesh-list
110459110|NCT05780489|Progesterone|progesterone|mesh-list
110459111|NCT05780489|Estrogens|estrogens|mesh-ancestor
110459112|NCT05780489|Hormones|hormones|mesh-ancestor
110459113|NCT05780489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110459114|NCT05780489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110459115|NCT05780489|Progestins|progestins|mesh-ancestor
110459116|NCT05780320|Amiodarone|amiodarone|mesh-list
110459117|NCT05780320|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110459118|NCT05780320|Vasodilator Agents|vasodilator agents|mesh-ancestor
110459119|NCT05780320|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
110459120|NCT05780320|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110459121|NCT05780320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110459122|NCT05780320|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110459123|NCT05780320|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110459124|NCT05780320|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110459125|NCT05780320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110459126|NCT05780320|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110459127|NCT05780320|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110459128|NCT05780320|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110459129|NCT05780294|Asparaginase|asparaginase|mesh-list
110459130|NCT05780294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110459131|NCT05780229|Analgesics|analgesics|mesh-list
110459132|NCT05780229|Sensory System Agents|sensory system agents|mesh-ancestor
110459133|NCT05780229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110150889|NCT00000646|Protective Agents|protective agents|mesh-ancestor
110459134|NCT05780229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110459135|NCT05780151|Insulin Glargine|insulin glargine|mesh-list
110459136|NCT05780151|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110459137|NCT05780151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110459138|NCT05780086|Icodextrin|icodextrin|mesh-list
110459139|NCT05780086|Dialysis Solutions|dialysis solutions|mesh-ancestor
110459140|NCT05780086|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110459141|NCT05779514|Mirabegron|mirabegron|mesh-list
110459142|NCT05779514|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
110459143|NCT05779514|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110459144|NCT05779514|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110459145|NCT05779514|Adrenergic Agents|adrenergic agents|mesh-ancestor
110530937|NCT00884793|Fosamprenavir|fosamprenavir|mesh-list
110530938|NCT00884793|Raltegravir Potassium|raltegravir potassium|mesh-list
110530939|NCT00884793|Efavirenz|efavirenz|mesh-list
110530940|NCT00884793|Etravirine|etravirine|mesh-list
110530941|NCT00884793|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110530942|NCT00884793|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110530943|NCT00884793|Protease Inhibitors|protease inhibitors|mesh-ancestor
110530944|NCT00884793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110183147|NCT00395655|GABA Agents|gaba agents|mesh-ancestor
110183148|NCT00395655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110459146|NCT05779514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110459147|NCT05779514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110459148|NCT05779514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110459150|NCT05779423|Nivolumab|nivolumab|mesh-list
110459151|NCT05779423|Ipilimumab|ipilimumab|mesh-list
110459152|NCT05779423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110459153|NCT05779423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110459154|NCT05779423|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110459155|NCT05779423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110459156|NCT05779410|Vitamin D|vitamin d|mesh-list
110459157|NCT05779410|Ergocalciferols|ergocalciferols|mesh-list
110459158|NCT05779410|Cholecalciferol|cholecalciferol|mesh-list
110459159|NCT05779410|Vitamins|vitamins|mesh-list
110459160|NCT05779410|Micronutrients|micronutrients|mesh-ancestor
110459161|NCT05779410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110459162|NCT05779410|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110459163|NCT05779410|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110459164|NCT05779254|Metronidazole|metronidazole|mesh-list
110459165|NCT05779254|Neomycin|neomycin|mesh-list
110459166|NCT05779254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110459167|NCT05779254|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110459168|NCT05779254|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110459169|NCT05779254|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110459170|NCT05779254|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110459171|NCT05779254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110459172|NCT05779254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110459173|NCT05779059|Ticagrelor|ticagrelor|mesh-list
110459174|NCT05779059|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
110459175|NCT05779059|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110459176|NCT05779059|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110459177|NCT05779059|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110459178|NCT05779059|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110459179|NCT05779059|Purinergic Agents|purinergic agents|mesh-ancestor
110459180|NCT05779059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110459181|NCT05779059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110459182|NCT05779059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110459183|NCT05778422|Anesthetics|anesthetics|mesh-list
110459184|NCT05778422|Anesthetics, Local|anesthetics, local|mesh-list
110459185|NCT05778422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110459186|NCT05778422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110459187|NCT05778422|Sensory System Agents|sensory system agents|mesh-ancestor
110459188|NCT05778422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110459189|NCT05774067|Terlipressin|terlipressin|mesh-list
110459190|NCT05774067|Vasopressins|vasopressins|mesh-list
110459191|NCT05774067|Norepinephrine|norepinephrine|mesh-list
110459192|NCT05774067|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110459193|NCT05774067|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110459194|NCT05774067|Adrenergic Agents|adrenergic agents|mesh-ancestor
110459195|NCT05774067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110459196|NCT05774067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110459197|NCT05774067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110459198|NCT05774067|Sympathomimetics|sympathomimetics|mesh-ancestor
110459199|NCT05774067|Autonomic Agents|autonomic agents|mesh-ancestor
110459200|NCT05774067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110459201|NCT05774067|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110459202|NCT05774067|Hemostatics|hemostatics|mesh-ancestor
110459203|NCT05774067|Coagulants|coagulants|mesh-ancestor
110530945|NCT00884793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110530946|NCT00884793|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110530947|NCT00884793|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110530949|NCT00884793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110530950|NCT00884793|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110530951|NCT00884793|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110530952|NCT00884793|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110530953|NCT00884793|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110530954|NCT00884793|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110530955|NCT00884793|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110530956|NCT00884793|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110530957|NCT00884793|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110530958|NCT00884793|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110530959|NCT00884793|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110530960|NCT00884793|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110530961|NCT02636829|Calcium|calcium|mesh-list
110530962|NCT02636829|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110530963|NCT02636829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110530964|NCT00884325|Levocetirizine|levocetirizine|mesh-list
110530965|NCT00884325|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110530966|NCT00884325|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110183224|NCT03959852|Anesthetics|anesthetics|mesh-ancestor
110459204|NCT05774067|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
110459205|NCT05774067|Natriuretic Agents|natriuretic agents|mesh-ancestor
110459206|NCT05774067|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110459207|NCT05769842|Propofol|propofol|mesh-list
110459208|NCT05769842|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110459209|NCT05769842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110459210|NCT05769842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110459211|NCT05769842|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110459212|NCT05769842|Anesthetics, General|anesthetics, general|mesh-ancestor
110459213|NCT05769842|Anesthetics|anesthetics|mesh-ancestor
110459214|NCT05739929|Colchicine|colchicine|mesh-list
110459215|NCT05739929|Gout Suppressants|gout suppressants|mesh-ancestor
110459216|NCT05739929|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110459217|NCT05739929|Tubulin Modulators|tubulin modulators|mesh-ancestor
110459218|NCT05739929|Antimitotic Agents|antimitotic agents|mesh-ancestor
110459219|NCT05739929|Mitosis Modulators|mitosis modulators|mesh-ancestor
110459220|NCT05739929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110459221|NCT05739929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110459222|NCT05734508|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
110459224|NCT05734508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110459225|NCT05712265|Fluvoxamine|fluvoxamine|mesh-list
110459226|NCT05712265|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110459227|NCT05712265|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110459228|NCT05712265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110459229|NCT05712265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110459230|NCT05712265|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110459231|NCT05712265|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110530967|NCT00884325|Histamine Antagonists|histamine antagonists|mesh-ancestor
110530968|NCT00884325|Histamine Agents|histamine agents|mesh-ancestor
110530969|NCT00884325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110530970|NCT00884325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110530971|NCT00884325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110530972|NCT00656409|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110530973|NCT00656409|Immunologic Factors|immunologic factors|mesh-ancestor
110530974|NCT00656409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110183270|NCT00028665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110183271|NCT00028665|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110183275|NCT03959540|Levodopa|levodopa|mesh-list
110459232|NCT05712265|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110459233|NCT05712265|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110459234|NCT05712265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110459235|NCT05712265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110459236|NCT05712265|Serotonin Agents|serotonin agents|mesh-ancestor
110459237|NCT05712265|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110459238|NCT05712265|Antidepressive Agents|antidepressive agents|mesh-ancestor
110459239|NCT05712265|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110459240|NCT05712265|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110459241|NCT05712265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110459242|NCT05712265|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110459243|NCT05659654|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
110459244|NCT05659654|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
110459245|NCT05659654|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110459246|NCT05637060|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110459247|NCT05637060|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110459248|NCT05637060|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110459250|NCT05637060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110459251|NCT05637060|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110459252|NCT05637060|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110459253|NCT05637060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110459254|NCT05616494|Docetaxel|docetaxel|mesh-list
110459255|NCT05616494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110459256|NCT05616494|Tubulin Modulators|tubulin modulators|mesh-ancestor
110459257|NCT05616494|Antimitotic Agents|antimitotic agents|mesh-ancestor
110459258|NCT05616494|Mitosis Modulators|mitosis modulators|mesh-ancestor
110459259|NCT05616494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110459260|NCT05614609|Lidocaine|lidocaine|mesh-list
110459261|NCT05614609|Anesthetics, Local|anesthetics, local|mesh-ancestor
110459262|NCT05614609|Anesthetics|anesthetics|mesh-ancestor
110459263|NCT05614609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110459264|NCT05614609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110459265|NCT05614609|Sensory System Agents|sensory system agents|mesh-ancestor
110459266|NCT05614609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110459267|NCT05614609|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110459268|NCT05614609|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110459269|NCT05614609|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110459270|NCT05614609|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110459271|NCT05614609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110459272|NCT05598957|Vitamin D|vitamin d|mesh-list
110459273|NCT05598957|Vitamins|vitamins|mesh-ancestor
110459274|NCT05598957|Micronutrients|micronutrients|mesh-ancestor
110459275|NCT05598957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110459276|NCT05598957|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110459277|NCT05567068|Mesalamine|mesalamine|mesh-list
110459278|NCT05567068|Atorvastatin|atorvastatin|mesh-list
110459279|NCT05567068|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110459280|NCT05567068|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110459281|NCT05567068|Antimetabolites|antimetabolites|mesh-ancestor
110530975|NCT05264558|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
110530977|NCT05264558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110530978|NCT04705844|Adalimumab|adalimumab|mesh-list
110530979|NCT04705844|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110530980|NCT04705844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110530981|NCT04705844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110530982|NCT00636896|Olanzapine|olanzapine|mesh-list
110530983|NCT00636896|Modafinil|modafinil|mesh-list
110530984|NCT00636896|Antiemetics|antiemetics|mesh-ancestor
110530985|NCT00636896|Autonomic Agents|autonomic agents|mesh-ancestor
110530986|NCT00636896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110530987|NCT00636896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110530988|NCT00636896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110530989|NCT00636896|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110459282|NCT05567068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110459283|NCT05567068|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110459284|NCT05567068|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110459285|NCT05567068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110459286|NCT05567068|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110459287|NCT05567068|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110459288|NCT05567068|Analgesics|analgesics|mesh-ancestor
110459289|NCT05567068|Sensory System Agents|sensory system agents|mesh-ancestor
110459290|NCT05567068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110459291|NCT05567068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110459292|NCT05567068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110459293|NCT05567068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110459295|NCT05565001|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110459296|NCT05565001|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110459298|NCT05565001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110459299|NCT05565001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110459300|NCT05565001|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110459301|NCT05565001|Respiratory System Agents|respiratory system agents|mesh-ancestor
110459302|NCT05565001|Parasympatholytics|parasympatholytics|mesh-ancestor
110459303|NCT05565001|Vasodilator Agents|vasodilator agents|mesh-ancestor
110459304|NCT05561062|Atorvastatin|atorvastatin|mesh-list
110459305|NCT05561062|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110459306|NCT05561062|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110459307|NCT05561062|Antimetabolites|antimetabolites|mesh-ancestor
110459308|NCT05561062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110459309|NCT05561062|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110459310|NCT05561062|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110459311|NCT05561062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110459312|NCT05550402|Bromides|bromides|mesh-list
110459313|NCT05550402|Albuterol|albuterol|mesh-list
110459314|NCT05550402|Ipratropium|ipratropium|mesh-list
110459315|NCT05550402|Anticonvulsants|anticonvulsants|mesh-ancestor
110459316|NCT05550402|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110459317|NCT05550402|Autonomic Agents|autonomic agents|mesh-ancestor
110459318|NCT05550402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110459319|NCT05550402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110459320|NCT05550402|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110459321|NCT05550402|Respiratory System Agents|respiratory system agents|mesh-ancestor
110459322|NCT05550402|Tocolytic Agents|tocolytic agents|mesh-ancestor
110459323|NCT05550402|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110459324|NCT05550402|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110459325|NCT05550402|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110459326|NCT05550402|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110459327|NCT05550402|Adrenergic Agents|adrenergic agents|mesh-ancestor
110459328|NCT05550402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110530990|NCT00636896|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110530991|NCT00636896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110530992|NCT00636896|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110530993|NCT00636896|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110530994|NCT00636896|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110530995|NCT00636896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110530996|NCT00636896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110530997|NCT00636896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110530998|NCT00636896|Serotonin Agents|serotonin agents|mesh-ancestor
110530999|NCT00636896|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110531000|NCT00636896|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
110183404|NCT00029523|Cytarabine|cytarabine|mesh-list
110459329|NCT05550402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110459330|NCT05550402|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110459331|NCT05550402|Cholinergic Agents|cholinergic agents|mesh-ancestor
110459332|NCT05444946|Itraconazole|itraconazole|mesh-list
110459333|NCT05444946|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
110459334|NCT05444946|Prednisone|prednisone|mesh-list
110459335|NCT05444946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110459336|NCT05444946|Glucocorticoids|glucocorticoids|mesh-ancestor
110459337|NCT05444946|Hormones|hormones|mesh-ancestor
110459338|NCT05444946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110459339|NCT05444946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110459340|NCT05444946|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110459341|NCT05444946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110459342|NCT05444946|Antifungal Agents|antifungal agents|mesh-ancestor
110459343|NCT05444946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110459344|NCT05444946|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110459345|NCT05444946|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110459346|NCT05444946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110459347|NCT05444946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110459348|NCT05444946|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110459349|NCT05444946|Hormone Antagonists|hormone antagonists|mesh-ancestor
110459350|NCT05444946|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110459351|NCT05409157|Bisacodyl|bisacodyl|mesh-list
110459352|NCT05409157|Cathartics|cathartics|mesh-ancestor
110459353|NCT05409157|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110459354|NCT05409157|Laxatives|laxatives|mesh-ancestor
110459355|NCT05407519|Tislelizumab|tislelizumab|mesh-list
110459356|NCT05407519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110459357|NCT05407519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110459358|NCT05380856|Neurotransmitter Agents|neurotransmitter agents|mesh-list
110459359|NCT05380856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110459360|NCT05380856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110459361|NCT05355311|Acetylcarnitine|acetylcarnitine|mesh-list
110459362|NCT05355311|Vitamin B Complex|vitamin b complex|mesh-ancestor
110459363|NCT05355311|Vitamins|vitamins|mesh-ancestor
110459364|NCT05355311|Micronutrients|micronutrients|mesh-ancestor
110459365|NCT05355311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110459366|NCT05355311|Nootropic Agents|nootropic agents|mesh-ancestor
110459367|NCT05311033|Tranexamic Acid|tranexamic acid|mesh-list
110459368|NCT05311033|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110459369|NCT05311033|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110459370|NCT05311033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110459372|NCT05311033|Coagulants|coagulants|mesh-ancestor
110459373|NCT05281562|Ascorbic Acid|ascorbic acid|mesh-list
110459374|NCT05281562|Vitamins|vitamins|mesh-ancestor
110459375|NCT05281562|Micronutrients|micronutrients|mesh-ancestor
110459376|NCT05281562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110459377|NCT05281562|Antioxidants|antioxidants|mesh-ancestor
110459378|NCT05281562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110531002|NCT00636896|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110531003|NCT04470674|Carboplatin|carboplatin|mesh-list
110531004|NCT04470674|Pemetrexed|pemetrexed|mesh-list
110531005|NCT04470674|Durvalumab|durvalumab|mesh-list
110531006|NCT04470674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110531007|NCT04470674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110531008|NCT04470674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110531009|NCT04470674|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110531010|NCT04470674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110531011|NCT04470674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110183459|NCT00395772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110459379|NCT05281562|Protective Agents|protective agents|mesh-ancestor
110459380|NCT05276596|Norepinephrine|norepinephrine|mesh-list
110459381|NCT05276596|Ephedrine|ephedrine|mesh-list
110459382|NCT05276596|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110459383|NCT05276596|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110459384|NCT05276596|Adrenergic Agents|adrenergic agents|mesh-ancestor
110459385|NCT05276596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110459386|NCT05276596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110459387|NCT05276596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110459388|NCT05276596|Sympathomimetics|sympathomimetics|mesh-ancestor
110459389|NCT05276596|Autonomic Agents|autonomic agents|mesh-ancestor
110459390|NCT05276596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110459391|NCT05276596|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110459392|NCT05276596|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110459393|NCT05241262|Acetylcysteine|acetylcysteine|mesh-list
110459394|NCT05241262|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110459395|NCT05241262|Antiviral Agents|antiviral agents|mesh-ancestor
110459396|NCT05241262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110459397|NCT05241262|Expectorants|expectorants|mesh-ancestor
110459398|NCT05241262|Respiratory System Agents|respiratory system agents|mesh-ancestor
110459399|NCT05241262|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110459400|NCT05241262|Antioxidants|antioxidants|mesh-ancestor
110459401|NCT05241262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110459402|NCT05241262|Protective Agents|protective agents|mesh-ancestor
110459403|NCT05241262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110459404|NCT05241262|Antidotes|antidotes|mesh-ancestor
110459405|NCT05178849|Anesthetics|anesthetics|mesh-list
110459406|NCT05178849|Anesthetics, Local|anesthetics, local|mesh-list
110459407|NCT05178849|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110459408|NCT05178849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110459409|NCT05178849|Sensory System Agents|sensory system agents|mesh-ancestor
110459410|NCT05178849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110459411|NCT05161936|Lumasiran|lumasiran|mesh-list
110459412|NCT05161936|Renal Agents|renal agents|mesh-ancestor
110459413|NCT05143424|Morphine|morphine|mesh-list
110459414|NCT05143424|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110459415|NCT05143424|Narcotics|narcotics|mesh-ancestor
110459416|NCT05143424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110459417|NCT05143424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110459418|NCT05143424|Analgesics|analgesics|mesh-ancestor
110459419|NCT05143424|Sensory System Agents|sensory system agents|mesh-ancestor
110459420|NCT05143424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110459421|NCT05126238|Lithium Carbonate|lithium carbonate|mesh-list
110459422|NCT05126238|Antidepressive Agents|antidepressive agents|mesh-ancestor
110459423|NCT05126238|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110459424|NCT05126238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110459425|NCT05126238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110459426|NCT05126238|Antimanic Agents|antimanic agents|mesh-ancestor
110459427|NCT05126238|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110304601|NCT00290082|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110459428|NCT05126238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110531012|NCT00883779|Carboplatin|carboplatin|mesh-list
110531013|NCT00883779|Gemcitabine|gemcitabine|mesh-list
110531014|NCT00883779|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110531015|NCT00883779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110531016|NCT00883779|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110531017|NCT00883779|Antimetabolites|antimetabolites|mesh-ancestor
110178484|NCT01806948|Ramosetron|ramosetron|mesh-list
110531018|NCT00883779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110531019|NCT00883779|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110531020|NCT00883779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110183524|NCT00030420|Antimitotic Agents|antimitotic agents|mesh-ancestor
110183526|NCT00030420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110459429|NCT05126238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110459431|NCT05108649|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110459432|NCT05108649|Autonomic Agents|autonomic agents|mesh-ancestor
110459433|NCT05108649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110459434|NCT05108649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110459435|NCT05108649|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110459436|NCT05108649|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110459437|NCT05108649|Cholinergic Agents|cholinergic agents|mesh-ancestor
110459438|NCT05108649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110459439|NCT05108649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110459440|NCT05023070|Cannabidiol|cannabidiol|mesh-list
110459441|NCT05023070|Anticonvulsants|anticonvulsants|mesh-ancestor
110459442|NCT05003713|Prednisone|prednisone|mesh-list
110459443|NCT05003713|Cortisone|cortisone|mesh-list
110459444|NCT05003713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110459445|NCT05003713|Glucocorticoids|glucocorticoids|mesh-ancestor
110459447|NCT05003713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110459448|NCT05003713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110459449|NCT05003713|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110459450|NCT05003713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110459451|NCT04990128|Triamcinolone|triamcinolone|mesh-list
110459452|NCT04990128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110459453|NCT04990128|Glucocorticoids|glucocorticoids|mesh-ancestor
110459454|NCT04990128|Hormones|hormones|mesh-ancestor
110459455|NCT04990128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110459456|NCT04990128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110459457|NCT04907370|Cisplatin|cisplatin|mesh-list
110459458|NCT04907370|Gemcitabine|gemcitabine|mesh-list
110459459|NCT04907370|Antibodies|antibodies|mesh-list
110459460|NCT04907370|Antibodies, Blocking|antibodies, blocking|mesh-list
110459461|NCT04907370|Immunologic Factors|immunologic factors|mesh-ancestor
110459462|NCT04907370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110459463|NCT04907370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110459464|NCT04907370|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110459465|NCT04907370|Antimetabolites|antimetabolites|mesh-ancestor
110459466|NCT04907370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110459467|NCT04903054|Mycophenolic Acid|mycophenolic acid|mesh-list
110459468|NCT04903054|Prednisone|prednisone|mesh-list
110459469|NCT04903054|Methylprednisolone|methylprednisolone|mesh-list
110459470|NCT04903054|Tacrolimus|tacrolimus|mesh-list
110459471|NCT04903054|Thymoglobulin|thymoglobulin|mesh-list
110459472|NCT04903054|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110459473|NCT04903054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110459474|NCT04903054|Glucocorticoids|glucocorticoids|mesh-ancestor
110459475|NCT04903054|Hormones|hormones|mesh-ancestor
110459476|NCT04903054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110459477|NCT04903054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110459478|NCT04903054|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110459479|NCT04903054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110459480|NCT04903054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110459481|NCT04903054|Immunologic Factors|immunologic factors|mesh-ancestor
110459482|NCT04903054|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110531021|NCT05263778|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
110531022|NCT05263778|Ezetimibe|ezetimibe|mesh-list
110531023|NCT05263778|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110531024|NCT05263778|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110531025|NCT05263778|Antimetabolites|antimetabolites|mesh-ancestor
110531026|NCT05263778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110531027|NCT05263778|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110531028|NCT05263778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110531029|NCT05263778|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110531030|NCT05263778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110183587|NCT00030654|Ketoconazole|ketoconazole|mesh-list
110459483|NCT04903054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110459484|NCT04903054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110459485|NCT04903054|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110459486|NCT04903054|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110459487|NCT04903054|Antitubercular Agents|antitubercular agents|mesh-ancestor
110459488|NCT04903054|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110459489|NCT04903054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110459490|NCT04903054|Antiemetics|antiemetics|mesh-ancestor
110459491|NCT04903054|Autonomic Agents|autonomic agents|mesh-ancestor
110459492|NCT04903054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110459493|NCT04903054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110459494|NCT04903054|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110459495|NCT04903054|Protective Agents|protective agents|mesh-ancestor
110459497|NCT04901702|Temozolomide|temozolomide|mesh-list
110459498|NCT04901702|Talazoparib|talazoparib|mesh-list
110459499|NCT04901702|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110459500|NCT04901702|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110459501|NCT04901702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110594518|NCT00662649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110459502|NCT04901702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110459503|NCT04901702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110459504|NCT04901702|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110459505|NCT04901702|Alkylating Agents|alkylating agents|mesh-ancestor
110459506|NCT04901702|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110459507|NCT04879225|Menthol|menthol|mesh-list
110459508|NCT04879225|Antipruritics|antipruritics|mesh-ancestor
110459509|NCT04879225|Dermatologic Agents|dermatologic agents|mesh-ancestor
110459510|NCT04834557|Digoxin|digoxin|mesh-list
110459511|NCT04834557|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
110459512|NCT04834557|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110459513|NCT04834557|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110459514|NCT04834557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110459515|NCT04834557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110459516|NCT04834557|Protective Agents|protective agents|mesh-ancestor
110459517|NCT04834557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110459518|NCT04834557|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
110459519|NCT04834557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110459520|NCT04825093|Vitamin D|vitamin d|mesh-list
110459521|NCT04825093|Vitamins|vitamins|mesh-ancestor
110459522|NCT04825093|Micronutrients|micronutrients|mesh-ancestor
110459523|NCT04825093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110459524|NCT04825093|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110459525|NCT04793152|Vancomycin|vancomycin|mesh-list
110459526|NCT04793152|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110459527|NCT04793152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110459528|NCT04770493|Lamotrigine|lamotrigine|mesh-list
110459529|NCT04770493|Anticonvulsants|anticonvulsants|mesh-ancestor
110459530|NCT04770493|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110459531|NCT04770493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110459532|NCT04770493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110459533|NCT04770493|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110459534|NCT04770493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110459535|NCT04770493|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110459536|NCT04770493|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110531032|NCT02693444|Anesthetics, Local|anesthetics, local|mesh-ancestor
110531033|NCT02693444|Anesthetics|anesthetics|mesh-ancestor
110531034|NCT02693444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110531035|NCT02693444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110531036|NCT02693444|Sensory System Agents|sensory system agents|mesh-ancestor
110531037|NCT02693444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110531038|NCT02693444|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110531039|NCT02693444|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110531040|NCT02693444|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110531041|NCT02693444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110531042|NCT02693444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110531043|NCT04162743|Trazodone|trazodone|mesh-list
110531044|NCT04162743|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110531045|NCT04162743|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110531046|NCT04162743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110531047|NCT04162743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110531048|NCT04162743|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110531049|NCT04162743|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110531050|NCT04162743|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110531051|NCT04162743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110531052|NCT04162743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110531053|NCT04162743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110531054|NCT04162743|Serotonin Agents|serotonin agents|mesh-ancestor
110531055|NCT04162743|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110531056|NCT04162743|Antidepressive Agents|antidepressive agents|mesh-ancestor
110531057|NCT03813992|Nitroglycerin|nitroglycerin|mesh-list
110531058|NCT03813992|Vasodilator Agents|vasodilator agents|mesh-ancestor
110531059|NCT04302896|Tenofovir|tenofovir|mesh-list
110531060|NCT04302896|Lamivudine|lamivudine|mesh-list
110531061|NCT04302896|Emtricitabine|emtricitabine|mesh-list
110531073|NCT04302896|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110531074|NCT00656643|Sirolimus|sirolimus|mesh-list
110531075|NCT00656643|Temsirolimus|temsirolimus|mesh-list
110531076|NCT00656643|MTOR Inhibitors|mtor inhibitors|mesh-list
110250898|NCT02955706|Vitamins|vitamins|mesh-ancestor
110531077|NCT00656643|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110531078|NCT00656643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110531079|NCT00656643|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110531080|NCT00656643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110531081|NCT00656643|Antifungal Agents|antifungal agents|mesh-ancestor
110531082|NCT00656643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110531083|NCT00656643|Immunologic Factors|immunologic factors|mesh-ancestor
110531084|NCT00656643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110531085|NCT00656643|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110531086|NCT00656643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110531087|NCT00656643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110531088|NCT02635971|Gemcitabine|gemcitabine|mesh-list
110531089|NCT02635971|Oxaliplatin|oxaliplatin|mesh-list
110531090|NCT02635971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110178555|NCT01806675|Glycine Agents|glycine agents|mesh-ancestor
110531091|NCT02635971|Antimetabolites|antimetabolites|mesh-ancestor
110531092|NCT02635971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110531093|NCT02635971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110183684|NCT00030888|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110459537|NCT04770493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110459538|NCT04770493|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110459539|NCT04770493|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110459540|NCT04741464|Tinzaparin|tinzaparin|mesh-list
110459541|NCT04741464|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
110459542|NCT04741464|Dalteparin|dalteparin|mesh-list
110459543|NCT04741464|Anticoagulants|anticoagulants|mesh-ancestor
110459544|NCT04741464|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110459545|NCT04741464|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110459546|NCT04741464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110459547|NCT04663555|Dexamethasone|dexamethasone|mesh-list
110459548|NCT04663555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110459549|NCT04663555|Antiemetics|antiemetics|mesh-ancestor
110459550|NCT04663555|Autonomic Agents|autonomic agents|mesh-ancestor
110459551|NCT04663555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110459552|NCT04663555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110459553|NCT04663555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110459554|NCT04663555|Glucocorticoids|glucocorticoids|mesh-ancestor
110459555|NCT04663555|Hormones|hormones|mesh-ancestor
110459556|NCT04663555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110459557|NCT04663555|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110459558|NCT04663555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110459559|NCT04565288|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
110459560|NCT04565288|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110459561|NCT04565288|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110459562|NCT04565288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110459563|NCT04565288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110459564|NCT04565288|Adrenergic Agents|adrenergic agents|mesh-ancestor
110459565|NCT04565288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110531094|NCT00657423|Cisplatin|cisplatin|mesh-list
110531095|NCT00657423|Docetaxel|docetaxel|mesh-list
110531096|NCT00657423|Endostar protein|endostar protein|mesh-list
110531097|NCT00657423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110531098|NCT00657423|Tubulin Modulators|tubulin modulators|mesh-ancestor
110531099|NCT00657423|Antimitotic Agents|antimitotic agents|mesh-ancestor
110531100|NCT00657423|Mitosis Modulators|mitosis modulators|mesh-ancestor
110531101|NCT00657423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110531102|NCT00657423|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110531103|NCT00657423|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110531104|NCT00657423|Growth Substances|growth substances|mesh-ancestor
110531105|NCT00657423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110531106|NCT00657423|Growth Inhibitors|growth inhibitors|mesh-ancestor
110531107|NCT00911235|Fluconazole|fluconazole|mesh-list
110531108|NCT00911235|Fesoterodine|fesoterodine|mesh-list
110531109|NCT00911235|Antifungal Agents|antifungal agents|mesh-ancestor
110531110|NCT00911235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110594531|NCT00129896|Docetaxel|docetaxel|mesh-list
110531111|NCT00911235|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110531112|NCT00911235|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110531113|NCT00911235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110531114|NCT00911235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110531115|NCT00911235|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110183735|NCT04711863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110459566|NCT04565288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110459567|NCT04496024|Ofloxacin|ofloxacin|mesh-list
110459568|NCT04496024|Levofloxacin|levofloxacin|mesh-list
110459569|NCT04496024|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110459570|NCT04496024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110459571|NCT04496024|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110459572|NCT04496024|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110459573|NCT04496024|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110459574|NCT04496024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110459575|NCT04496024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110459576|NCT04496024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110459577|NCT04496024|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110459578|NCT04496024|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110459579|NCT04425473|Esketamine|esketamine|mesh-list
110459580|NCT04425473|Antidepressive Agents|antidepressive agents|mesh-ancestor
110459581|NCT04425473|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110459582|NCT04387071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110459584|NCT04387071|Immunoglobulins|immunoglobulins|mesh-list
110459585|NCT04387071|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110459586|NCT04387071|Immunologic Factors|immunologic factors|mesh-ancestor
110459587|NCT04387071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110459588|NCT04387071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110459589|NCT04300920|Acetylcysteine|acetylcysteine|mesh-list
110459590|NCT04300920|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110459591|NCT04300920|Antiviral Agents|antiviral agents|mesh-ancestor
110459592|NCT04300920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110459593|NCT04300920|Expectorants|expectorants|mesh-ancestor
110459594|NCT04300920|Respiratory System Agents|respiratory system agents|mesh-ancestor
110459595|NCT04300920|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110459596|NCT04300920|Antioxidants|antioxidants|mesh-ancestor
110531116|NCT00911235|Hormone Antagonists|hormone antagonists|mesh-ancestor
110531117|NCT00911235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110531118|NCT00911235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110531119|NCT00911235|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110531120|NCT00911235|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110531121|NCT00911235|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110531122|NCT00911235|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110531123|NCT00911235|Cholinergic Agents|cholinergic agents|mesh-ancestor
110459597|NCT04300920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110459598|NCT04300920|Protective Agents|protective agents|mesh-ancestor
110459599|NCT04300920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110459600|NCT04300920|Antidotes|antidotes|mesh-ancestor
110459602|NCT04252768|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110459603|NCT04252768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110459604|NCT04252768|Tubulin Modulators|tubulin modulators|mesh-ancestor
110459605|NCT04252768|Antimitotic Agents|antimitotic agents|mesh-ancestor
110459606|NCT04252768|Mitosis Modulators|mitosis modulators|mesh-ancestor
110459607|NCT04252768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110459608|NCT04084171|Insulin|insulin|mesh-list
110459609|NCT04084171|Pancrelipase|pancrelipase|mesh-list
110459610|NCT04084171|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110459611|NCT04084171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110459612|NCT04084171|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110459613|NCT04047706|Nivolumab|nivolumab|mesh-list
110459614|NCT04047706|Temozolomide|temozolomide|mesh-list
110459615|NCT04047706|Linrodostat|linrodostat|mesh-list
110459616|NCT04047706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110459617|NCT04047706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110459618|NCT04047706|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110459619|NCT04047706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110459620|NCT04047706|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110459621|NCT04047706|Alkylating Agents|alkylating agents|mesh-ancestor
110459622|NCT04047706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110459623|NCT03967249|Octreotide|octreotide|mesh-list
110459624|NCT03967249|Lanreotide|lanreotide|mesh-list
110459625|NCT03967249|Somatostatin|somatostatin|mesh-list
110459626|NCT03967249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110459627|NCT03967249|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110459628|NCT03967249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110459629|NCT03967249|Hormones|hormones|mesh-ancestor
110459630|NCT03967249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110459631|NCT03967249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110459632|NCT03935139|Glycerol|glycerol|mesh-list
110459633|NCT03935139|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
110459634|NCT03935139|Protective Agents|protective agents|mesh-ancestor
110459635|NCT03935139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110459636|NCT03926403|Anesthetics|anesthetics|mesh-list
110459637|NCT03926403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110459638|NCT03926403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110459639|NCT03884101|Paclitaxel|paclitaxel|mesh-list
110459640|NCT03884101|Carboplatin|carboplatin|mesh-list
110459641|NCT03884101|Pembrolizumab|pembrolizumab|mesh-list
110459642|NCT03884101|Lenvatinib|lenvatinib|mesh-list
110459643|NCT03884101|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110459644|NCT03884101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110459645|NCT03884101|Tubulin Modulators|tubulin modulators|mesh-ancestor
110459646|NCT03884101|Antimitotic Agents|antimitotic agents|mesh-ancestor
110459647|NCT03884101|Mitosis Modulators|mitosis modulators|mesh-ancestor
110459648|NCT03884101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110459649|NCT03884101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110459650|NCT03884101|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110459651|NCT03884101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110459652|NCT03884101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110459653|NCT03871621|Metformin|metformin|mesh-list
110459654|NCT03871621|Dapagliflozin|dapagliflozin|mesh-list
110106732|NCT01804361|Antifungal Agents|antifungal agents|mesh-ancestor
110531124|NCT00911235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110531125|NCT00911235|Urological Agents|urological agents|mesh-ancestor
110531126|NCT00636974|Anesthetics|anesthetics|mesh-list
110531127|NCT00636974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110531128|NCT00636974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110531129|NCT02535351|Sunitinib|sunitinib|mesh-list
110531130|NCT02535351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110531131|NCT02535351|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110531132|NCT02535351|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110531133|NCT02535351|Growth Substances|growth substances|mesh-ancestor
110531134|NCT02535351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110183849|NCT00031395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110183852|NCT00031395|Analgesics|analgesics|mesh-ancestor
110459655|NCT03871621|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
110459656|NCT03871621|Meglitinide|meglitinide|mesh-list
110459657|NCT03871621|Hypoglycemic Agents|hypoglycemic agents|mesh-list
110459658|NCT03871621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110459659|NCT03871621|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110459660|NCT03871621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110459662|NCT03867188|Anesthetics, Local|anesthetics, local|mesh-ancestor
110459663|NCT03867188|Anesthetics|anesthetics|mesh-ancestor
110459664|NCT03867188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110459665|NCT03867188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110459666|NCT03867188|Sensory System Agents|sensory system agents|mesh-ancestor
110459667|NCT03867188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110459668|NCT03796884|Linaclotide|linaclotide|mesh-list
110459669|NCT03796884|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
110459670|NCT03796884|Enzyme Activators|enzyme activators|mesh-ancestor
110459671|NCT03796884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110594544|NCT02574338|Alprostadil|alprostadil|mesh-list
110459672|NCT03796884|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110459673|NCT03745040|Bupivacaine|bupivacaine|mesh-list
110459674|NCT03745040|Anesthetics, Local|anesthetics, local|mesh-ancestor
110459675|NCT03745040|Anesthetics|anesthetics|mesh-ancestor
110459676|NCT03745040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110459677|NCT03745040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110459678|NCT03745040|Sensory System Agents|sensory system agents|mesh-ancestor
110459679|NCT03745040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110459680|NCT03740737|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
110459681|NCT03740737|Hormones|hormones|mesh-ancestor
110459682|NCT03740737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110459683|NCT03740737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110459684|NCT03686345|Midostaurin|midostaurin|mesh-list
110459685|NCT03686345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110459686|NCT03686345|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110459687|NCT03686345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110459688|NCT03686345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110459689|NCT03671967|Meropenem|meropenem|mesh-list
110459690|NCT03671967|Tazobactam|tazobactam|mesh-list
110459691|NCT03671967|Piperacillin|piperacillin|mesh-list
110459692|NCT03671967|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
110459693|NCT03671967|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110459694|NCT03671967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110459695|NCT03671967|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110459696|NCT03671967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110459697|NCT03671967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110459698|NCT03657810|Acetaminophen|acetaminophen|mesh-list
110459699|NCT03657810|Promethazine|promethazine|mesh-list
110459700|NCT03657810|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
110459701|NCT03657810|Hydrocodone|hydrocodone|mesh-list
110459702|NCT03657810|Oxycodone|oxycodone|mesh-list
110459703|NCT03657810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110531135|NCT02535351|Growth Inhibitors|growth inhibitors|mesh-ancestor
110531136|NCT02535351|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110531137|NCT02535351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110531138|NCT02535351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110531140|NCT00613964|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
110531141|NCT00613964|Natriuretic Agents|natriuretic agents|mesh-ancestor
110183914|NCT00031707|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110183915|NCT00031707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110183918|NCT00031746|Caseins|caseins|mesh-list
110459704|NCT03657810|Analgesics|analgesics|mesh-ancestor
110459705|NCT03657810|Sensory System Agents|sensory system agents|mesh-ancestor
110459706|NCT03657810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110304858|NCT00271245|Protective Agents|protective agents|mesh-ancestor
110459707|NCT03657810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110459708|NCT03657810|Antipyretics|antipyretics|mesh-ancestor
110459709|NCT03657810|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110459710|NCT03657810|Narcotics|narcotics|mesh-ancestor
110459711|NCT03657810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110459712|NCT03657810|Antitussive Agents|antitussive agents|mesh-ancestor
110459713|NCT03657810|Respiratory System Agents|respiratory system agents|mesh-ancestor
110459714|NCT03657810|Antipruritics|antipruritics|mesh-ancestor
110459715|NCT03657810|Dermatologic Agents|dermatologic agents|mesh-ancestor
110459716|NCT03657810|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110459717|NCT03657810|Histamine Antagonists|histamine antagonists|mesh-ancestor
110459718|NCT03657810|Histamine Agents|histamine agents|mesh-ancestor
110459719|NCT03657810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110459720|NCT03657810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110459721|NCT03657810|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110459722|NCT03657810|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110459723|NCT03657810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110594552|NCT02574338|Oxytocics|oxytocics|mesh-ancestor
110459724|NCT03657810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110459726|NCT03640026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110459727|NCT03640026|Immunologic Factors|immunologic factors|mesh-ancestor
110459728|NCT03640026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110459729|NCT03640026|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110459730|NCT03640026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110106807|NCT01805115|Misoprostol|misoprostol|mesh-list
110459731|NCT03640026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110459732|NCT03638297|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-list
110459733|NCT03638297|Antibodies|antibodies|mesh-list
110459734|NCT03638297|Immunologic Factors|immunologic factors|mesh-ancestor
110459735|NCT03638297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110459736|NCT03638297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110459737|NCT03638297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110459738|NCT03638297|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110459739|NCT03638297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110459740|NCT03638297|Analgesics|analgesics|mesh-ancestor
110459741|NCT03638297|Sensory System Agents|sensory system agents|mesh-ancestor
110459742|NCT03638297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110459743|NCT03638297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110459744|NCT03638297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110459745|NCT03544736|Paclitaxel|paclitaxel|mesh-list
110459746|NCT03544736|Carboplatin|carboplatin|mesh-list
110459747|NCT03544736|Nivolumab|nivolumab|mesh-list
110459748|NCT03544736|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110459749|NCT03544736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110459750|NCT03544736|Tubulin Modulators|tubulin modulators|mesh-ancestor
110459751|NCT03544736|Antimitotic Agents|antimitotic agents|mesh-ancestor
110459752|NCT03544736|Mitosis Modulators|mitosis modulators|mesh-ancestor
110459753|NCT03544736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110459754|NCT03544736|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110459755|NCT03544736|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110459756|NCT03533010|Vitamin D|vitamin d|mesh-list
110459757|NCT03533010|Vitamins|vitamins|mesh-ancestor
110531142|NCT00613964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110531143|NCT00613964|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110531144|NCT00613964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110531145|NCT05342870|Dexmedetomidine|dexmedetomidine|mesh-list
110531146|NCT05342870|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110531147|NCT05342870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110531148|NCT05342870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110183990|NCT00031902|Prednisolone|prednisolone|mesh-list
110459758|NCT03533010|Micronutrients|micronutrients|mesh-ancestor
110459759|NCT03533010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110459760|NCT03533010|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110459761|NCT03409198|Cyclophosphamide|cyclophosphamide|mesh-list
110459762|NCT03409198|Doxorubicin|doxorubicin|mesh-list
110459763|NCT03409198|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110459764|NCT03409198|Nivolumab|nivolumab|mesh-list
110459765|NCT03409198|Ipilimumab|ipilimumab|mesh-list
110459766|NCT03409198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110459767|NCT03409198|Immunologic Factors|immunologic factors|mesh-ancestor
110459768|NCT03409198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110459769|NCT03409198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110459770|NCT03409198|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110459771|NCT03409198|Alkylating Agents|alkylating agents|mesh-ancestor
110459772|NCT03409198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110459773|NCT03409198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110459774|NCT03409198|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110459775|NCT03409198|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110459776|NCT03409198|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110459777|NCT03409198|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110459778|NCT03409198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110459779|NCT03409198|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110459780|NCT03409198|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110459781|NCT03382548|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110459782|NCT03382548|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
110459783|NCT03382548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110459784|NCT03382548|Antitubercular Agents|antitubercular agents|mesh-ancestor
110459785|NCT03321656|Tacrolimus|tacrolimus|mesh-list
110459786|NCT03321656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110459787|NCT03321656|Immunologic Factors|immunologic factors|mesh-ancestor
110459788|NCT03321656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110459789|NCT03321656|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110459790|NCT03321656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110459791|NCT03321656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110459792|NCT03236987|Azithromycin|azithromycin|mesh-list
110459793|NCT03236987|Clarithromycin|clarithromycin|mesh-list
110459794|NCT03236987|Rifampin|rifampin|mesh-list
110459795|NCT03236987|Ethambutol|ethambutol|mesh-list
110459796|NCT03236987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110459797|NCT03236987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110459798|NCT03236987|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110459799|NCT03236987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110459800|NCT03236987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110459801|NCT03236987|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110459802|NCT03236987|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110459803|NCT03236987|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110459804|NCT03236987|Antitubercular Agents|antitubercular agents|mesh-ancestor
110459805|NCT03236987|Leprostatic Agents|leprostatic agents|mesh-ancestor
110459806|NCT03236987|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110459807|NCT03236987|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110459808|NCT03236987|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110459809|NCT03236987|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110459810|NCT03236987|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110459811|NCT03236987|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110459812|NCT03236987|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110459813|NCT03094637|Pembrolizumab|pembrolizumab|mesh-list
110459814|NCT03094637|Azacitidine|azacitidine|mesh-list
110531149|NCT05342870|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110531150|NCT05342870|Analgesics|analgesics|mesh-ancestor
110531151|NCT05342870|Sensory System Agents|sensory system agents|mesh-ancestor
110531152|NCT05342870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110531153|NCT05342870|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110531154|NCT05342870|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110531155|NCT05342870|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110531156|NCT05342870|Adrenergic Agents|adrenergic agents|mesh-ancestor
110531157|NCT05342870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110531158|NCT05342870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110531159|NCT00657579|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110184048|NCT00032019|Cyclophosphamide|cyclophosphamide|mesh-list
110184049|NCT00032019|Rituximab|rituximab|mesh-list
110184050|NCT00032019|Doxorubicin|doxorubicin|mesh-list
110184051|NCT00032019|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110459815|NCT03094637|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110459816|NCT03094637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110459817|NCT03094637|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110459818|NCT03094637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110459819|NCT03094637|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110459833|NCT03055507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110459834|NCT03055507|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110459835|NCT03055507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110459836|NCT03055507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110459837|NCT03055507|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110459839|NCT03055507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110459840|NCT03038256|Capecitabine|capecitabine|mesh-list
110459841|NCT03038256|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110459842|NCT03038256|Antimetabolites|antimetabolites|mesh-ancestor
110459843|NCT03038256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110459844|NCT03038256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110459845|NCT02870738|Triamcinolone|triamcinolone|mesh-list
110459846|NCT02870738|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110459847|NCT02870738|Glucocorticoids|glucocorticoids|mesh-ancestor
110459848|NCT02870738|Hormones|hormones|mesh-ancestor
110459849|NCT02870738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110459850|NCT02870738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110459851|NCT02789982|Propranolol|propranolol|mesh-list
110459852|NCT02789982|Adrenergic Agents|adrenergic agents|mesh-list
110459853|NCT02789982|Adrenergic Antagonists|adrenergic antagonists|mesh-list
110459854|NCT02789982|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110459855|NCT02789982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110459856|NCT02789982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110459857|NCT02789982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110459858|NCT02789982|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110459859|NCT02789982|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110459860|NCT02789982|Vasodilator Agents|vasodilator agents|mesh-ancestor
110459861|NCT02667886|Axitinib|axitinib|mesh-list
110459862|NCT02667886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110459863|NCT02667886|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110459864|NCT02667886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110459865|NCT02667886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110459879|NCT02587195|Teriflunomide|teriflunomide|mesh-list
110459880|NCT02587195|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110459881|NCT02587195|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110459882|NCT02587195|Analgesics|analgesics|mesh-ancestor
110459883|NCT02587195|Sensory System Agents|sensory system agents|mesh-ancestor
110459884|NCT02587195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110531160|NCT00657579|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110531161|NCT05342792|Capecitabine|capecitabine|mesh-list
110531162|NCT05342792|Tislelizumab|tislelizumab|mesh-list
110531163|NCT05342792|Antibodies|antibodies|mesh-list
110531164|NCT05342792|Immunologic Factors|immunologic factors|mesh-ancestor
110531165|NCT05342792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110531166|NCT05342792|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110531167|NCT05342792|Antimetabolites|antimetabolites|mesh-ancestor
110184110|NCT00032136|Hormone Antagonists|hormone antagonists|mesh-ancestor
110184111|NCT00032136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110459885|NCT02587195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110459886|NCT02587195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110459887|NCT02587195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110459888|NCT02587195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110459889|NCT02587195|Immunologic Factors|immunologic factors|mesh-ancestor
110459890|NCT02582008|Bupropion|bupropion|mesh-list
110459891|NCT02582008|Nicotine|nicotine|mesh-list
110459892|NCT02582008|Varenicline|varenicline|mesh-list
110459893|NCT02582008|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110459894|NCT02582008|Autonomic Agents|autonomic agents|mesh-ancestor
110459895|NCT02582008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110459896|NCT02582008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110459897|NCT02582008|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110459898|NCT02582008|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110459899|NCT02582008|Cholinergic Agents|cholinergic agents|mesh-ancestor
110459900|NCT02582008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110459901|NCT02582008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110459902|NCT02582008|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110459903|NCT02582008|Antidepressive Agents|antidepressive agents|mesh-ancestor
110459904|NCT02582008|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110459905|NCT02582008|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110459906|NCT02582008|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110459907|NCT02582008|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110459908|NCT02582008|Dopamine Agents|dopamine agents|mesh-ancestor
110459909|NCT02582008|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110459910|NCT02582008|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110459911|NCT02582008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110459912|NCT02502799|Methylphenidate|methylphenidate|mesh-list
110459913|NCT02502799|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110459914|NCT02502799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110459915|NCT02502799|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110459916|NCT02502799|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110459917|NCT02502799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110459918|NCT02502799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110459919|NCT02502799|Dopamine Agents|dopamine agents|mesh-ancestor
110459920|NCT02502799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110459921|NCT01993836|Anesthetics|anesthetics|mesh-list
110459922|NCT01993836|Propofol|propofol|mesh-list
110459923|NCT01993836|Isoflurane|isoflurane|mesh-list
110459924|NCT01993836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110459925|NCT01993836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110459926|NCT01993836|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110459927|NCT01993836|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110459928|NCT01993836|Anesthetics, General|anesthetics, general|mesh-ancestor
110459929|NCT01993836|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110459930|NCT01818739|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110459931|NCT01717586|Pravastatin|pravastatin|mesh-list
110459932|NCT01717586|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110459933|NCT01717586|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110459934|NCT01717586|Antimetabolites|antimetabolites|mesh-ancestor
110459935|NCT01717586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110459936|NCT01717586|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110459937|NCT01717586|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110459938|NCT01717586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110459939|NCT01107717|Metformin|metformin|mesh-list
110531168|NCT05342792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110531169|NCT05342792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110531170|NCT05342792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110531172|NCT00657891|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110531173|NCT00657891|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110531174|NCT00657891|Respiratory System Agents|respiratory system agents|mesh-ancestor
110531175|NCT05162300|Botulinum Toxins|botulinum toxins|mesh-list
110531176|NCT05162300|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110531177|NCT05162300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110531178|NCT05162300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110531179|NCT05162300|Cholinergic Agents|cholinergic agents|mesh-ancestor
110531180|NCT05162300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110531181|NCT05162300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110531182|NCT04159077|Tamsulosin|tamsulosin|mesh-list
110531183|NCT04159077|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110531184|NCT04159077|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110531185|NCT04159077|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110531186|NCT04159077|Adrenergic Agents|adrenergic agents|mesh-ancestor
110531187|NCT04159077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110531188|NCT04159077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110531189|NCT04159077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110531190|NCT04159077|Urological Agents|urological agents|mesh-ancestor
110531191|NCT02690480|Fulvestrant|fulvestrant|mesh-list
110531192|NCT02690480|Palbociclib|palbociclib|mesh-list
110531193|NCT02690480|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110531194|NCT02690480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110531195|NCT02690480|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110531196|NCT02690480|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110184176|NCT03150797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110459940|NCT01107717|Pioglitazone|pioglitazone|mesh-list
110459941|NCT01107717|Exenatide|exenatide|mesh-list
110459942|NCT01107717|Glyburide|glyburide|mesh-list
110459943|NCT01107717|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110459944|NCT01107717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110459945|NCT01107717|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110459946|NCT01107717|Incretins|incretins|mesh-ancestor
110459947|NCT01107717|Hormones|hormones|mesh-ancestor
110459948|NCT01107717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110459949|NCT00782574|Olaparib|olaparib|mesh-list
110459950|NCT00782574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110459951|NCT00782574|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110459952|NCT00782574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110531197|NCT02690480|Hormone Antagonists|hormone antagonists|mesh-ancestor
110531198|NCT02690480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110531199|NCT02690480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110531200|NCT02690480|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110531201|NCT02690480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110531202|NCT02690480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110531204|NCT00880269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110531205|NCT00880269|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110531206|NCT00880269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110531207|NCT00880269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110531208|NCT00880191|Dexamethasone|dexamethasone|mesh-list
110531209|NCT00880191|Gabapentin|gabapentin|mesh-list
110531210|NCT00880191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110531211|NCT00880191|Antiemetics|antiemetics|mesh-ancestor
110531212|NCT00880191|Autonomic Agents|autonomic agents|mesh-ancestor
110531213|NCT00880191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110531214|NCT00880191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110531215|NCT00880191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110531216|NCT00880191|Glucocorticoids|glucocorticoids|mesh-ancestor
110531217|NCT00880191|Hormones|hormones|mesh-ancestor
110459953|NCT00782574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110459954|NCT00753545|Olaparib|olaparib|mesh-list
110459955|NCT00753545|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110459956|NCT00753545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110459957|NCT00753545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110459958|NCT00753545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110459959|NCT00635362|Levonorgestrel|levonorgestrel|mesh-list
110459960|NCT00635362|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110459961|NCT00635362|Contraceptive Agents|contraceptive agents|mesh-ancestor
110459962|NCT00635362|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110459963|NCT00635362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110459964|NCT00635362|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110459965|NCT00635362|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110459966|NCT00635362|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110459967|NCT00408447|Fludarabine|fludarabine|mesh-list
110459968|NCT00408447|Busulfan|busulfan|mesh-list
110459969|NCT00408447|Alemtuzumab|alemtuzumab|mesh-list
110459970|NCT00408447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110459971|NCT00408447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110459972|NCT00408447|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110459973|NCT00408447|Immunologic Factors|immunologic factors|mesh-ancestor
110459974|NCT00408447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110459975|NCT00408447|Alkylating Agents|alkylating agents|mesh-ancestor
110459976|NCT00408447|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110459977|NCT00408447|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110459978|NCT00408447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110459979|NCT00278915|Fulvestrant|fulvestrant|mesh-list
110459980|NCT00278915|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110459981|NCT00278915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110459982|NCT00278915|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110459983|NCT00278915|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110531218|NCT00880191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110531219|NCT00880191|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110531220|NCT00880191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110531222|NCT00880191|Sensory System Agents|sensory system agents|mesh-ancestor
110531223|NCT00880191|Anticonvulsants|anticonvulsants|mesh-ancestor
110531224|NCT00880191|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110531225|NCT00880191|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110531226|NCT00880191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110531227|NCT00880191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110531228|NCT00880191|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110531229|NCT00880191|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110531230|NCT00880191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110184256|NCT00033111|Dopamine Agonists|dopamine agonists|mesh-ancestor
110459984|NCT00278915|Hormone Antagonists|hormone antagonists|mesh-ancestor
110459985|NCT00278915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110459986|NCT00278915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110459987|NCT04285320|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110459988|NCT04285320|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
110459989|NCT04285320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110459990|NCT04285320|Antitubercular Agents|antitubercular agents|mesh-ancestor
110459991|NCT00970632|Tadalafil|tadalafil|mesh-list
110459992|NCT00970632|Tamsulosin|tamsulosin|mesh-list
110459993|NCT00970632|Vasodilator Agents|vasodilator agents|mesh-ancestor
110459994|NCT00970632|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110459995|NCT00970632|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110459996|NCT00970632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110459997|NCT00970632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110459998|NCT00970632|Urological Agents|urological agents|mesh-ancestor
110459999|NCT00970632|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110460000|NCT00970632|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110460001|NCT00970632|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110460002|NCT00970632|Adrenergic Agents|adrenergic agents|mesh-ancestor
110460003|NCT00970632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110460004|NCT00970632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110460006|NCT01144364|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110460007|NCT01144364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110460008|NCT01144364|Immunologic Factors|immunologic factors|mesh-ancestor
110460009|NCT01144364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110460010|NCT01144364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110460011|NCT00965094|Mycophenolic Acid|mycophenolic acid|mesh-list
110460012|NCT00965094|Everolimus|everolimus|mesh-list
110460013|NCT00965094|Tacrolimus|tacrolimus|mesh-list
110460014|NCT00965094|Basiliximab|basiliximab|mesh-list
110460015|NCT00965094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110460016|NCT00965094|Immunologic Factors|immunologic factors|mesh-ancestor
110460017|NCT00965094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110460018|NCT00965094|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110460019|NCT00965094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110460020|NCT00965094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110460021|NCT00965094|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110460022|NCT00965094|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110460023|NCT00965094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110460024|NCT00965094|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110460025|NCT00965094|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110460026|NCT00965094|Antitubercular Agents|antitubercular agents|mesh-ancestor
110460027|NCT00965094|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110460028|NCT00965094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110460029|NCT01131182|Metformin|metformin|mesh-list
110531231|NCT00880191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110531232|NCT00880191|Antimanic Agents|antimanic agents|mesh-ancestor
110531234|NCT00659451|Amlodipine|amlodipine|mesh-list
110531235|NCT00659451|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110178708|NCT02647892|Lidocaine|lidocaine|mesh-list
110531236|NCT00659451|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110531237|NCT00659451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110531238|NCT00659451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110531239|NCT00659451|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110531240|NCT00659451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110531241|NCT00659451|Vasodilator Agents|vasodilator agents|mesh-ancestor
110531242|NCT00659451|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110531243|NCT00659451|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110531244|NCT00659451|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110531246|NCT00911313|Letrozole|letrozole|mesh-list
110460030|NCT01131182|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110460031|NCT01131182|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110460032|NCT01131182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110460033|NCT01131182|Incretins|incretins|mesh-ancestor
110460034|NCT01131182|Hormones|hormones|mesh-ancestor
110460035|NCT01131182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110460036|NCT01131182|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110460037|NCT01131182|Protease Inhibitors|protease inhibitors|mesh-ancestor
110460038|NCT01131182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110460039|NCT01131182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110460040|NCT01131104|Sildenafil Citrate|sildenafil citrate|mesh-list
110460041|NCT01131104|Tadalafil|tadalafil|mesh-list
110460042|NCT01131104|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
110460043|NCT01131104|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
110460044|NCT01131104|Vasodilator Agents|vasodilator agents|mesh-ancestor
110460045|NCT01131104|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110460046|NCT01131104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110460047|NCT01131104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110460048|NCT01131104|Urological Agents|urological agents|mesh-ancestor
110460049|NCT04264884|Daratumumab|daratumumab|mesh-list
110460050|NCT04264884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110460051|NCT01118780|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110460052|NCT01118780|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110460053|NCT01118780|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110460054|NCT01118780|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110460055|NCT01118780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110460056|NCT01118780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110460057|NCT01118780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110460058|NCT01118780|Analgesics|analgesics|mesh-ancestor
110460059|NCT01118780|Sensory System Agents|sensory system agents|mesh-ancestor
110460060|NCT01118780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110460061|NCT01118780|Antidepressive Agents|antidepressive agents|mesh-ancestor
110460062|NCT01118780|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110460063|NCT01118780|Dopamine Agents|dopamine agents|mesh-ancestor
110460064|NCT00629928|Esomeprazole|esomeprazole|mesh-list
110460065|NCT00629928|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110460066|NCT00629928|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110460067|NCT00629928|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110460068|NCT00629928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110460069|NCT00629928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110460070|NCT00964782|Sildenafil Citrate|sildenafil citrate|mesh-list
110531248|NCT00911313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110531249|NCT00911313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110531250|NCT00911313|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110531251|NCT00911313|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110531252|NCT00911313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110184387|NCT00033891|Infliximab|infliximab|mesh-list
110460071|NCT00964782|Vasodilator Agents|vasodilator agents|mesh-ancestor
110460072|NCT00964782|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110460073|NCT00964782|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110460074|NCT00964782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110460075|NCT00964782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110460076|NCT00964782|Urological Agents|urological agents|mesh-ancestor
110460077|NCT02882984|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110460079|NCT02882984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110460080|NCT02882984|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110460081|NCT02882984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110460082|NCT02882984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110460083|NCT00966654|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
110460084|NCT00966654|Incretins|incretins|mesh-ancestor
110460085|NCT00966654|Hormones|hormones|mesh-ancestor
110460086|NCT00966654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110460087|NCT00966654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110460088|NCT00625196|Fluticasone|fluticasone|mesh-list
110460089|NCT00625196|Xhance|xhance|mesh-list
110460090|NCT00625196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110460091|NCT00625196|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110460092|NCT00625196|Autonomic Agents|autonomic agents|mesh-ancestor
110460093|NCT00625196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110460094|NCT00625196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110460095|NCT00625196|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110460096|NCT00625196|Respiratory System Agents|respiratory system agents|mesh-ancestor
110460097|NCT00625196|Dermatologic Agents|dermatologic agents|mesh-ancestor
110460098|NCT00625196|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110460099|NCT03262116|Insulin|insulin|mesh-list
110460100|NCT03262116|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110460101|NCT03262116|Insulin Lispro|insulin lispro|mesh-list
110460102|NCT03262116|Insulin Aspart|insulin aspart|mesh-list
110460104|NCT03262116|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110460105|NCT03262116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110460106|NCT03262116|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110460107|NCT01130168|Amlodipine|amlodipine|mesh-list
110460108|NCT01130168|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110460109|NCT01130168|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110460110|NCT01130168|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110460111|NCT01130168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110460112|NCT01130168|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110460113|NCT01130168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110460114|NCT01130168|Vasodilator Agents|vasodilator agents|mesh-ancestor
110460115|NCT04284852|Niraparib|niraparib|mesh-list
110460116|NCT04284852|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110460117|NCT04284852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110560322|NCT02684123|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
110460118|NCT04284852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110460119|NCT04284852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110460120|NCT04283292|Capsaicin|capsaicin|mesh-list
110460121|NCT04283292|Antipruritics|antipruritics|mesh-ancestor
110460122|NCT04283292|Dermatologic Agents|dermatologic agents|mesh-ancestor
110460123|NCT04283292|Sensory System Agents|sensory system agents|mesh-ancestor
110460124|NCT04283292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110460125|NCT04283292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110460126|NCT01144052|Interferons|interferons|mesh-list
110460127|NCT01144052|Interferon-beta|interferon-beta|mesh-list
110460128|NCT01144052|Natalizumab|natalizumab|mesh-list
110460129|NCT01144052|Interferon beta-1b|interferon beta-1b|mesh-list
110460130|NCT01144052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110460131|NCT01144052|Antiviral Agents|antiviral agents|mesh-ancestor
110460132|NCT01144052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110460133|NCT01144052|Immunologic Factors|immunologic factors|mesh-ancestor
110531253|NCT00911313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110531254|NCT00911313|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110531255|NCT00911313|Hormone Antagonists|hormone antagonists|mesh-ancestor
110531256|NCT00911313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110531257|NCT00659685|Ondansetron|ondansetron|mesh-list
110531258|NCT00659685|Antiemetics|antiemetics|mesh-ancestor
110531259|NCT00659685|Autonomic Agents|autonomic agents|mesh-ancestor
110531260|NCT00659685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110531261|NCT00659685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110531262|NCT00659685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110531263|NCT00659685|Antipruritics|antipruritics|mesh-ancestor
110531264|NCT00659685|Dermatologic Agents|dermatologic agents|mesh-ancestor
110531265|NCT00659685|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110531266|NCT00659685|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110531267|NCT00659685|Serotonin Agents|serotonin agents|mesh-ancestor
110531268|NCT00659685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110531269|NCT00659685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110531270|NCT00659841|Ciclesonide|ciclesonide|mesh-list
110531271|NCT00659841|Glucocorticoids|glucocorticoids|mesh-ancestor
110531272|NCT00659841|Hormones|hormones|mesh-ancestor
110531273|NCT00659841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110531274|NCT00659841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110531275|NCT00659841|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110460134|NCT01144052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110460135|NCT01144052|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110460136|NCT04283526|Decitabine|decitabine|mesh-list
110460137|NCT04283526|Spartalizumab|spartalizumab|mesh-list
110460138|NCT04283526|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110460139|NCT04283526|Antimetabolites|antimetabolites|mesh-ancestor
110460140|NCT04283526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110460141|NCT04283526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110460142|NCT04283526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110460143|NCT04283526|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110460144|NCT04283526|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110460145|NCT01118312|Mometasone Furoate|mometasone furoate|mesh-list
110460146|NCT01118312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110460147|NCT01118312|Dermatologic Agents|dermatologic agents|mesh-ancestor
110460148|NCT01118312|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110460150|NCT01117766|Analgesics|analgesics|mesh-ancestor
110460151|NCT01117766|Sensory System Agents|sensory system agents|mesh-ancestor
110460152|NCT01117766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110460153|NCT01117766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110460154|NCT01117766|Anticonvulsants|anticonvulsants|mesh-ancestor
110460155|NCT01117766|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110460156|NCT01117766|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110460157|NCT01117766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110460158|NCT01117766|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110460159|NCT01117766|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110460160|NCT01117766|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110531277|NCT00659919|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110531278|NCT00659919|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110531279|NCT00659919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110531280|NCT00659919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110531281|NCT00659919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110531282|NCT00659919|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110531283|NCT00659919|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110531284|NCT00659919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110531285|NCT00659919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110531286|NCT00659919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110531287|NCT00659919|Serotonin Agents|serotonin agents|mesh-ancestor
110531288|NCT00659919|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110531289|NCT00659919|Antidepressive Agents|antidepressive agents|mesh-ancestor
110531290|NCT00659997|Albendazole|albendazole|mesh-list
110531291|NCT00659997|Levamisole|levamisole|mesh-list
110531292|NCT00659997|Anthelmintics|anthelmintics|mesh-ancestor
110531293|NCT00659997|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110531294|NCT00659997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110531295|NCT00659997|Anticestodal Agents|anticestodal agents|mesh-ancestor
110531296|NCT00659997|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110531297|NCT00659997|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110531298|NCT00659997|Tubulin Modulators|tubulin modulators|mesh-ancestor
110531299|NCT00659997|Antimitotic Agents|antimitotic agents|mesh-ancestor
110531300|NCT00659997|Mitosis Modulators|mitosis modulators|mesh-ancestor
110460161|NCT01117766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110460162|NCT01117766|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110460163|NCT04312880|Tranexamic Acid|tranexamic acid|mesh-list
110460164|NCT04312880|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110460165|NCT04312880|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110460166|NCT04312880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110460167|NCT04312880|Hemostatics|hemostatics|mesh-ancestor
110460168|NCT04312880|Coagulants|coagulants|mesh-ancestor
110460169|NCT01117454|Flecainide|flecainide|mesh-list
110460170|NCT01117454|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
110460171|NCT01117454|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110460172|NCT01117454|Adrenergic Agents|adrenergic agents|mesh-ancestor
110460173|NCT01117454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110377340|NCT00474929|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110460174|NCT01117454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110460175|NCT01117454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110460176|NCT01117454|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110460177|NCT01117454|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110460178|NCT01117454|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110460179|NCT01117454|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110460181|NCT01129622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110460182|NCT01129622|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110460183|NCT01129622|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110460184|NCT01129622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110460185|NCT01129622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110531301|NCT00659997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110531303|NCT00659997|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110531304|NCT00659997|Immunologic Factors|immunologic factors|mesh-ancestor
110531305|NCT00659997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110531306|NCT00659997|Antinematodal Agents|antinematodal agents|mesh-ancestor
110531307|NCT00659997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110531308|NCT00660153|Tivozanib|tivozanib|mesh-list
110531309|NCT00660153|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110531310|NCT00660153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110531311|NCT00660153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110531312|NCT00660231|Gemcitabine|gemcitabine|mesh-list
110531313|NCT00660231|Bexarotene|bexarotene|mesh-list
110531314|NCT00660231|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110531315|NCT00660231|Antimetabolites|antimetabolites|mesh-ancestor
110531316|NCT00660231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110531317|NCT00660231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110531318|NCT00597519|Cyclophosphamide|cyclophosphamide|mesh-list
110531319|NCT00597519|Fludarabine|fludarabine|mesh-list
110531320|NCT00597519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110531321|NCT00597519|Immunologic Factors|immunologic factors|mesh-ancestor
110531322|NCT00597519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110531323|NCT00597519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110460186|NCT01129622|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110460187|NCT01129622|Hormone Antagonists|hormone antagonists|mesh-ancestor
110460188|NCT01129622|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110460189|NCT01129622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110460190|NCT01128842|Capecitabine|capecitabine|mesh-list
110460191|NCT01128842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110460193|NCT01128842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110460194|NCT01128842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110460195|NCT00625274|Esomeprazole|esomeprazole|mesh-list
110460196|NCT00625274|Pantoprazole|pantoprazole|mesh-list
110460197|NCT00625274|Lansoprazole|lansoprazole|mesh-list
110460198|NCT00625274|Dexlansoprazole|dexlansoprazole|mesh-list
110460199|NCT00625274|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110460200|NCT00625274|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110460201|NCT00625274|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110460202|NCT00625274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110460203|NCT00625274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110460204|NCT03624036|Cyclophosphamide|cyclophosphamide|mesh-list
110460205|NCT03624036|Fludarabine|fludarabine|mesh-list
110460206|NCT03624036|Brexucabtagene autoleucel|brexucabtagene autoleucel|mesh-list
110460207|NCT03624036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110460208|NCT03624036|Immunologic Factors|immunologic factors|mesh-ancestor
110460209|NCT03624036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110460210|NCT03624036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110460211|NCT03624036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110460212|NCT03624036|Alkylating Agents|alkylating agents|mesh-ancestor
110460213|NCT03624036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110460214|NCT03624036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110531324|NCT00597519|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110531325|NCT00597519|Alkylating Agents|alkylating agents|mesh-ancestor
110531326|NCT00597519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110531327|NCT00597519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110531328|NCT00597519|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110531330|NCT00660621|Temozolomide|temozolomide|mesh-list
110531331|NCT00660621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110531332|NCT00660621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110531333|NCT00660621|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110531334|NCT00660621|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110460215|NCT03624036|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110460216|NCT03624036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110460217|NCT00915525|Botulinum Toxins|botulinum toxins|mesh-list
110460218|NCT00915525|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110460219|NCT00915525|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110460220|NCT00915525|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110460221|NCT00915525|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110460222|NCT00915525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110460223|NCT00915525|Cholinergic Agents|cholinergic agents|mesh-ancestor
110460224|NCT00915525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110460225|NCT00915525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110460226|NCT00915525|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110460227|NCT00915525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110460228|NCT04669041|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110460229|NCT04669041|Ezetimibe|ezetimibe|mesh-list
110460230|NCT04669041|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110460231|NCT04669041|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110460232|NCT04669041|Antimetabolites|antimetabolites|mesh-ancestor
110460233|NCT04669041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110460234|NCT04669041|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110460235|NCT04669041|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110460236|NCT04669041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110460237|NCT05132595|Ketorolac|ketorolac|mesh-list
110460238|NCT05132595|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
110460239|NCT05132595|Esketamine|esketamine|mesh-list
110460240|NCT05132595|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110460241|NCT05132595|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110460242|NCT05132595|Analgesics|analgesics|mesh-ancestor
110460243|NCT05132595|Sensory System Agents|sensory system agents|mesh-ancestor
110460244|NCT05132595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110460245|NCT05132595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110460246|NCT05132595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110460247|NCT05132595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110460248|NCT05132595|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110460249|NCT05132595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110460250|NCT05132595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110460251|NCT05132595|Antidepressive Agents|antidepressive agents|mesh-ancestor
110460252|NCT05132595|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110460253|NCT01074047|Azacitidine|azacitidine|mesh-list
110460254|NCT01074047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110460255|NCT01074047|Antimetabolites|antimetabolites|mesh-ancestor
110460256|NCT01074047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110460257|NCT01074047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110460258|NCT01074047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110460259|NCT05226117|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
110460260|NCT05226117|Immunoconjugates|immunoconjugates|mesh-ancestor
110460261|NCT05226117|Immunologic Factors|immunologic factors|mesh-ancestor
110460262|NCT05226117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110460263|NCT01142726|Methotrexate|methotrexate|mesh-list
110460264|NCT01142726|Abatacept|abatacept|mesh-list
110460265|NCT01142726|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110531335|NCT00660621|Growth Substances|growth substances|mesh-ancestor
110531336|NCT00660621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110531337|NCT00660621|Growth Inhibitors|growth inhibitors|mesh-ancestor
110531338|NCT00660621|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110531339|NCT00660621|Alkylating Agents|alkylating agents|mesh-ancestor
110531340|NCT00660621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110531341|NCT02632305|Paclitaxel|paclitaxel|mesh-list
110531342|NCT02632305|Gemcitabine|gemcitabine|mesh-list
110531343|NCT02632305|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110531344|NCT02632305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110184665|NCT00034983|Antiemetics|antiemetics|mesh-ancestor
110460267|NCT01142726|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110460268|NCT01142726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110460269|NCT01142726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110460270|NCT01142726|Antimetabolites|antimetabolites|mesh-ancestor
110460271|NCT01142726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110460272|NCT01142726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110460273|NCT01142726|Dermatologic Agents|dermatologic agents|mesh-ancestor
110460274|NCT01142726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110460275|NCT01142726|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110460276|NCT01142726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110460277|NCT01142726|Immunologic Factors|immunologic factors|mesh-ancestor
110460278|NCT01142726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110460279|NCT01142726|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110460280|NCT01142726|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110460281|NCT01142726|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110460282|NCT04472637|Atorvastatin|atorvastatin|mesh-list
110460283|NCT04472637|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110460284|NCT04472637|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110460285|NCT04472637|Antimetabolites|antimetabolites|mesh-ancestor
110460286|NCT04472637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110460287|NCT04472637|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110460288|NCT04472637|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110460289|NCT04472637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110460290|NCT01142336|Simvastatin|simvastatin|mesh-list
110460291|NCT01142336|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110460292|NCT01142336|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110460293|NCT01142336|Antimetabolites|antimetabolites|mesh-ancestor
110460294|NCT01142336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110460295|NCT01142336|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110460296|NCT01142336|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110460297|NCT01142336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110460298|NCT00915681|Silybin|silybin|mesh-list
110460299|NCT00915681|Protective Agents|protective agents|mesh-ancestor
110460300|NCT00915681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110460301|NCT00915681|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110460302|NCT00915681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110460303|NCT01128296|Hydroxychloroquine|hydroxychloroquine|mesh-list
110460304|NCT01128296|Gemcitabine|gemcitabine|mesh-list
110460305|NCT01128296|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110460306|NCT01128296|Antimetabolites|antimetabolites|mesh-ancestor
110460307|NCT01128296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110460308|NCT01128296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110460309|NCT01128296|Antimalarials|antimalarials|mesh-ancestor
110460310|NCT01128296|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110460311|NCT01128296|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110460312|NCT01128296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110460313|NCT01128296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110460314|NCT01128296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110460315|NCT05082909|Probenecid|probenecid|mesh-list
110460316|NCT05082909|Uricosuric Agents|uricosuric agents|mesh-ancestor
110460317|NCT05082909|Gout Suppressants|gout suppressants|mesh-ancestor
110460318|NCT05082909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110594671|NCT00712556|Fluorides|fluorides|mesh-list
110531345|NCT02632305|Tubulin Modulators|tubulin modulators|mesh-ancestor
110531346|NCT02632305|Antimitotic Agents|antimitotic agents|mesh-ancestor
110531347|NCT02632305|Mitosis Modulators|mitosis modulators|mesh-ancestor
110531348|NCT02632305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110531349|NCT02632305|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110531351|NCT02631993|Furocoumarins|furocoumarins|mesh-list
110531352|NCT02631993|Dermatologic Agents|dermatologic agents|mesh-ancestor
110531353|NCT02631993|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110531354|NCT00660855|Parecoxib|parecoxib|mesh-list
110531355|NCT00660855|Valdecoxib|valdecoxib|mesh-list
110531356|NCT00660855|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110531357|NCT00660855|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110531358|NCT00660855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110531359|NCT00660855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110531360|NCT00660855|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110531361|NCT00660855|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110531362|NCT00660855|Analgesics|analgesics|mesh-ancestor
110531363|NCT00660855|Sensory System Agents|sensory system agents|mesh-ancestor
110531364|NCT00660855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110531365|NCT00660855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110531366|NCT00660855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110531367|NCT00660855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110531368|NCT00660933|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
110531369|NCT00660933|Hematinics|hematinics|mesh-ancestor
110531370|NCT02632071|Paclitaxel|paclitaxel|mesh-list
110531371|NCT02632071|Ricolinostat|ricolinostat|mesh-list
110531380|NCT00879333|Everolimus|everolimus|mesh-list
110531396|NCT02630823|Mitosis Modulators|mitosis modulators|mesh-ancestor
110531397|NCT02630823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110531398|NCT02630823|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110531399|NCT02630823|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110531400|NCT02630511|Mannitol|mannitol|mesh-list
110531401|NCT02630511|Methacholine Chloride|methacholine chloride|mesh-list
110531402|NCT02630511|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110531403|NCT02630511|Diuretics|diuretics|mesh-ancestor
110531404|NCT02630511|Natriuretic Agents|natriuretic agents|mesh-ancestor
110531405|NCT02630511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110531406|NCT02630511|Miotics|miotics|mesh-ancestor
110531407|NCT02630511|Autonomic Agents|autonomic agents|mesh-ancestor
110531408|NCT02630511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110531409|NCT02630511|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110531410|NCT02630511|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
110531411|NCT02630511|Respiratory System Agents|respiratory system agents|mesh-ancestor
110531412|NCT02630511|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
110531413|NCT02630511|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110531414|NCT02630511|Cholinergic Agents|cholinergic agents|mesh-ancestor
110531415|NCT02630511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110531416|NCT02630511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110531417|NCT00666159|Pimecrolimus|pimecrolimus|mesh-list
110531418|NCT00666159|Tacrolimus|tacrolimus|mesh-list
110531419|NCT00666159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110531420|NCT00666159|Immunologic Factors|immunologic factors|mesh-ancestor
110460319|NCT04253145|Atezolizumab|atezolizumab|mesh-list
110460320|NCT04253145|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110460321|NCT04253145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110460322|NCT04253145|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110107416|NCT01812135|Immunologic Factors|immunologic factors|mesh-ancestor
110460323|NCT04253145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110460324|NCT04240509|Tenofovir|tenofovir|mesh-list
110460325|NCT04240509|Emtricitabine|emtricitabine|mesh-list
110460326|NCT04240509|Antiviral Agents|antiviral agents|mesh-ancestor
110460327|NCT04240509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110460328|NCT04240509|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110460329|NCT04240509|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110460330|NCT04240509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110460331|NCT04240509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110460332|NCT04240509|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110460333|NCT04240509|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110460334|NCT04450329|Aflibercept|aflibercept|mesh-list
110460335|NCT04450329|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110460336|NCT04450329|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110460337|NCT04450329|Growth Substances|growth substances|mesh-ancestor
110383007|NCT06047379|Paclitaxel|paclitaxel|mesh-list
110460338|NCT04450329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110460339|NCT04450329|Growth Inhibitors|growth inhibitors|mesh-ancestor
110460340|NCT04450329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110460341|NCT01115738|Clopidogrel|clopidogrel|mesh-list
110531421|NCT00666159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110531422|NCT00666159|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110531423|NCT00666159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110531424|NCT00666159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110531425|NCT00666159|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110531426|NCT00666159|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110531427|NCT00666159|Analgesics|analgesics|mesh-ancestor
110531428|NCT00666159|Sensory System Agents|sensory system agents|mesh-ancestor
110531429|NCT00666159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110531430|NCT00666159|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110531431|NCT00666159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110460342|NCT01115738|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
110460343|NCT01115738|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110460344|NCT01115738|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110460345|NCT01115738|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110460346|NCT01115738|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110460347|NCT01115738|Purinergic Agents|purinergic agents|mesh-ancestor
110460348|NCT01115738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110305494|NCT00271518|Hormones|hormones|mesh-list
110460349|NCT01115738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110460350|NCT01115738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110460352|NCT00632073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110460353|NCT00632073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110460354|NCT01141478|Sorafenib|sorafenib|mesh-list
110460355|NCT01141478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110460356|NCT01141478|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110460357|NCT01141478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110460358|NCT01141478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110460359|NCT01114880|Adalimumab|adalimumab|mesh-list
110460360|NCT01114880|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110460361|NCT01114880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110460362|NCT01114880|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110460363|NCT00625352|Gemcitabine|gemcitabine|mesh-list
110460364|NCT00625352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110460365|NCT00625352|Antimetabolites|antimetabolites|mesh-ancestor
110460366|NCT00625352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110460367|NCT00625352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110460368|NCT04539873|Colchicine|colchicine|mesh-list
110460369|NCT04539873|Gout Suppressants|gout suppressants|mesh-ancestor
110460370|NCT04539873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110460371|NCT04539873|Tubulin Modulators|tubulin modulators|mesh-ancestor
110460372|NCT04539873|Antimitotic Agents|antimitotic agents|mesh-ancestor
110460373|NCT04539873|Mitosis Modulators|mitosis modulators|mesh-ancestor
110460374|NCT04539873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110460375|NCT04539873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110460376|NCT02861040|Vincristine|vincristine|mesh-list
110460377|NCT02861040|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110460378|NCT02861040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110460379|NCT02861040|Tubulin Modulators|tubulin modulators|mesh-ancestor
110460380|NCT02861040|Antimitotic Agents|antimitotic agents|mesh-ancestor
110460381|NCT02861040|Mitosis Modulators|mitosis modulators|mesh-ancestor
110460382|NCT02861040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110460383|NCT04646187|Adalimumab|adalimumab|mesh-list
110460384|NCT04646187|Infliximab|infliximab|mesh-list
110460385|NCT04646187|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110460386|NCT04646187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110460387|NCT04646187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110460388|NCT04646187|Dermatologic Agents|dermatologic agents|mesh-ancestor
110460389|NCT04646187|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110460390|NCT04282902|Pirfenidone|pirfenidone|mesh-list
110460391|NCT04282902|Analgesics|analgesics|mesh-ancestor
110460392|NCT04282902|Sensory System Agents|sensory system agents|mesh-ancestor
110531432|NCT00666159|Dermatologic Agents|dermatologic agents|mesh-ancestor
110531433|NCT00666393|Fentanyl|fentanyl|mesh-list
110531434|NCT00666393|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110531435|NCT00666393|Narcotics|narcotics|mesh-ancestor
110531436|NCT00666393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110531437|NCT00666393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110531438|NCT00666393|Analgesics|analgesics|mesh-ancestor
110531439|NCT00666393|Sensory System Agents|sensory system agents|mesh-ancestor
110531440|NCT00666393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110531441|NCT00666393|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110531442|NCT00666393|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110531443|NCT00666393|Anesthetics, General|anesthetics, general|mesh-ancestor
110531444|NCT00666393|Anesthetics|anesthetics|mesh-ancestor
110531445|NCT00666627|Alendronate|alendronate|mesh-list
110184875|NCT01805531|Rivaroxaban|rivaroxaban|mesh-list
110460393|NCT04282902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110460394|NCT04282902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110460395|NCT04282902|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110460396|NCT04282902|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110460397|NCT04282902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110460398|NCT04282902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110460399|NCT04282902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110460400|NCT02860962|Dextromethorphan|dextromethorphan|mesh-list
110460401|NCT02860962|Antitussive Agents|antitussive agents|mesh-ancestor
110460402|NCT02860962|Respiratory System Agents|respiratory system agents|mesh-ancestor
110460403|NCT02860962|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110460404|NCT02860962|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110460405|NCT02860962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110460406|NCT02860962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110460407|NCT02860962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110460408|NCT04432623|Benserazide|benserazide|mesh-list
110460409|NCT04432623|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110460410|NCT04432623|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110460411|NCT04432623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110460412|NCT04432623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110460413|NCT04432623|Dopamine Agents|dopamine agents|mesh-ancestor
110460414|NCT04432623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110305559|NCT04709315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110460415|NCT04432623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110460416|NCT00878722|Idarubicin|idarubicin|mesh-list
110460417|NCT00878722|Belinostat|belinostat|mesh-list
110460418|NCT00878722|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110460419|NCT00878722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110460420|NCT00878722|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110460421|NCT00878722|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110460422|NCT00878722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110460423|NCT00878722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110460424|NCT00878722|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110460425|NCT03432897|Olaparib|olaparib|mesh-list
110460426|NCT03432897|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110460427|NCT03432897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110460428|NCT03432897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110460429|NCT03432897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110460430|NCT00659386|Immunoglobulins|immunoglobulins|mesh-list
110460431|NCT00659386|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110460432|NCT00659386|Antibodies|antibodies|mesh-list
110460433|NCT00659386|gamma-Globulins|gamma-globulins|mesh-list
110460434|NCT00659386|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110460435|NCT00659386|Immunologic Factors|immunologic factors|mesh-ancestor
110460436|NCT00659386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110460437|NCT04160325|Azathioprine|azathioprine|mesh-list
110531446|NCT00666627|Risedronic Acid|risedronic acid|mesh-list
110531447|NCT00666627|Ibandronic Acid|ibandronic acid|mesh-list
110594688|NCT00793377|Tamoxifen|tamoxifen|mesh-list
110531448|NCT00666627|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110531449|NCT00666627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110531450|NCT00666627|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110531451|NCT00666627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110531452|NCT00666627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110531453|NCT00666627|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110531454|NCT00666783|Palonosetron|palonosetron|mesh-list
110531455|NCT00666783|Granisetron|granisetron|mesh-list
110531456|NCT00666783|Antiemetics|antiemetics|mesh-ancestor
110531457|NCT00666783|Autonomic Agents|autonomic agents|mesh-ancestor
110531458|NCT00666783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110531459|NCT00666783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110531460|NCT00666783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110531461|NCT00666783|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110531462|NCT00666783|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110531463|NCT00666783|Serotonin Agents|serotonin agents|mesh-ancestor
110531464|NCT00666783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110531465|NCT00666783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110531466|NCT00666939|Gabapentin|gabapentin|mesh-list
110531467|NCT00666939|Analgesics|analgesics|mesh-ancestor
110531468|NCT00666939|Sensory System Agents|sensory system agents|mesh-ancestor
110531469|NCT00666939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110531471|NCT00666939|Anticonvulsants|anticonvulsants|mesh-ancestor
110531495|NCT00667407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110531496|NCT00667407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110531497|NCT00667485|Sirolimus|sirolimus|mesh-list
110531498|NCT00667485|Bevacizumab|bevacizumab|mesh-list
110531499|NCT00667485|Temsirolimus|temsirolimus|mesh-list
110531500|NCT00667485|MTOR Inhibitors|mtor inhibitors|mesh-list
110531501|NCT00667485|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110531502|NCT00667485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110531503|NCT00667485|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110531504|NCT00667485|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110531505|NCT00667485|Growth Substances|growth substances|mesh-ancestor
110531506|NCT00667485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110531507|NCT00667485|Growth Inhibitors|growth inhibitors|mesh-ancestor
110531508|NCT00667485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110531509|NCT00667485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110531510|NCT00667485|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110531511|NCT00667485|Antifungal Agents|antifungal agents|mesh-ancestor
110531512|NCT00667485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110531513|NCT00667485|Immunologic Factors|immunologic factors|mesh-ancestor
110531514|NCT00667485|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110531515|NCT00667485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110460438|NCT04160325|Antimetabolites|antimetabolites|mesh-ancestor
110460439|NCT04160325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110460440|NCT04160325|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110460441|NCT04160325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110460442|NCT04160325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110460443|NCT04160325|Immunologic Factors|immunologic factors|mesh-ancestor
110460444|NCT04160325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110460445|NCT04160325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110460446|NCT04155814|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
110460447|NCT04155814|Hematinics|hematinics|mesh-ancestor
110460448|NCT04547439|Melatonin|melatonin|mesh-list
110460449|NCT04547439|Antioxidants|antioxidants|mesh-ancestor
110460450|NCT04547439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110460451|NCT04547439|Protective Agents|protective agents|mesh-ancestor
110460452|NCT04547439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110460453|NCT04547439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110460454|NCT04158076|Amlodipine|amlodipine|mesh-list
110460455|NCT04158076|Telmisartan|telmisartan|mesh-list
110460456|NCT04158076|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
110460457|NCT04158076|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110460458|NCT04158076|Ezetimibe|ezetimibe|mesh-list
110460459|NCT04158076|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110460460|NCT04158076|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110460461|NCT04158076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110460462|NCT04158076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110460463|NCT04158076|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110460464|NCT04158076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110460465|NCT04158076|Vasodilator Agents|vasodilator agents|mesh-ancestor
110460466|NCT04158076|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110460467|NCT04158076|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110460468|NCT04158076|Antimetabolites|antimetabolites|mesh-ancestor
110460469|NCT04158076|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110460470|NCT04158076|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110531516|NCT00667485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110531518|NCT00667641|Bortezomib|bortezomib|mesh-list
110531519|NCT00667641|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110531520|NCT00667641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110531521|NCT00667641|Tubulin Modulators|tubulin modulators|mesh-ancestor
110531522|NCT00667641|Antimitotic Agents|antimitotic agents|mesh-ancestor
110531523|NCT00667641|Mitosis Modulators|mitosis modulators|mesh-ancestor
110531524|NCT00667641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110531525|NCT00667797|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110531526|NCT00667797|Albuterol|albuterol|mesh-list
110531527|NCT00667797|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110531528|NCT00667797|Autonomic Agents|autonomic agents|mesh-ancestor
110531529|NCT00667797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110531530|NCT00667797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110531531|NCT00667797|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110531532|NCT00667797|Respiratory System Agents|respiratory system agents|mesh-ancestor
110531533|NCT00667797|Tocolytic Agents|tocolytic agents|mesh-ancestor
110179026|NCT01466517|Ibuprofen|ibuprofen|mesh-list
110531534|NCT00667797|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110531535|NCT00667797|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110531536|NCT00667797|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110531537|NCT00667797|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110531538|NCT00667797|Adrenergic Agents|adrenergic agents|mesh-ancestor
110531539|NCT00667797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110531540|NCT00667797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110531541|NCT03481556|Dexamethasone|dexamethasone|mesh-list
110531542|NCT03481556|Dexamethasone acetate|dexamethasone acetate|mesh-list
110531543|NCT03481556|Bortezomib|bortezomib|mesh-list
110460471|NCT04158076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110460472|NCT04158076|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110460473|NCT04158076|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110460474|NCT00961350|Aspirin|aspirin|mesh-list
110460475|NCT00961350|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110460476|NCT00961350|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110460477|NCT00961350|Analgesics|analgesics|mesh-ancestor
110460478|NCT00961350|Sensory System Agents|sensory system agents|mesh-ancestor
110460479|NCT00961350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110460480|NCT00961350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110460481|NCT00961350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110460482|NCT00961350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110460483|NCT00961350|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110460484|NCT00961350|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110560323|NCT02684123|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110460485|NCT00961350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110460487|NCT00961350|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110531544|NCT03481556|Melphalan|melphalan|mesh-list
110531545|NCT03481556|Daratumumab|daratumumab|mesh-list
110531546|NCT03481556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110531547|NCT03481556|Antiemetics|antiemetics|mesh-ancestor
110531548|NCT03481556|Autonomic Agents|autonomic agents|mesh-ancestor
110531549|NCT03481556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110531550|NCT03481556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110531551|NCT03481556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110531552|NCT03481556|Glucocorticoids|glucocorticoids|mesh-ancestor
110531553|NCT03481556|Hormones|hormones|mesh-ancestor
110531554|NCT03481556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110531555|NCT03481556|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110531556|NCT03481556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110531557|NCT03481556|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110460488|NCT00961350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110460490|NCT03537690|Paclitaxel|paclitaxel|mesh-list
110460491|NCT03537690|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110460492|NCT03537690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110460493|NCT03537690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110460494|NCT03537690|Tubulin Modulators|tubulin modulators|mesh-ancestor
110460495|NCT03537690|Antimitotic Agents|antimitotic agents|mesh-ancestor
110460496|NCT03537690|Mitosis Modulators|mitosis modulators|mesh-ancestor
110460497|NCT03537690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110460498|NCT04032184|Chlorhexidine|chlorhexidine|mesh-list
110460499|NCT04032184|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110460500|NCT04032184|Fluorides|fluorides|mesh-list
110460501|NCT04032184|Cariostatic Agents|cariostatic agents|mesh-ancestor
110460502|NCT04032184|Protective Agents|protective agents|mesh-ancestor
110460503|NCT04032184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110460504|NCT04032184|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110460505|NCT04032184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110460506|NCT04032184|Disinfectants|disinfectants|mesh-ancestor
110460507|NCT04032184|Dermatologic Agents|dermatologic agents|mesh-ancestor
110460508|NCT00662896|Ibuprofen|ibuprofen|mesh-list
110460509|NCT00662896|Naproxen|naproxen|mesh-list
110460510|NCT00662896|Naproxen-n-butyl nitrate|naproxen-n-butyl nitrate|mesh-list
110460511|NCT00662896|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110460512|NCT00662896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110460513|NCT00662896|Analgesics|analgesics|mesh-ancestor
110460514|NCT00662896|Sensory System Agents|sensory system agents|mesh-ancestor
110460515|NCT00662896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110460516|NCT00662896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110460517|NCT00662896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110460518|NCT00662896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110460519|NCT00662896|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110460520|NCT00662896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110460521|NCT00662896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110460522|NCT00662896|Gout Suppressants|gout suppressants|mesh-ancestor
110460523|NCT00662896|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
110460524|NCT00963924|Cycloserine|cycloserine|mesh-list
110460525|NCT00963924|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110460526|NCT00963924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110460527|NCT00963924|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110460528|NCT00963924|Antitubercular Agents|antitubercular agents|mesh-ancestor
110460529|NCT00963924|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110460530|NCT00963924|Antimetabolites|antimetabolites|mesh-ancestor
110460531|NCT00963924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110460532|NCT04155658|Fluorides|fluorides|mesh-list
110460533|NCT04155658|Cariostatic Agents|cariostatic agents|mesh-ancestor
110460534|NCT04155658|Protective Agents|protective agents|mesh-ancestor
110460535|NCT04155658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110460536|NCT02861976|Analgesics, Opioid|analgesics, opioid|mesh-list
110531558|NCT03481556|Alkylating Agents|alkylating agents|mesh-ancestor
110531559|NCT03481556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110531560|NCT03481556|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110531561|NCT03481556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110531562|NCT03481556|Immunologic Factors|immunologic factors|mesh-ancestor
110531563|NCT00668031|Aprotinin|aprotinin|mesh-list
110531564|NCT00668031|Hemostatics|hemostatics|mesh-ancestor
110531565|NCT00668031|Coagulants|coagulants|mesh-ancestor
110531566|NCT00668031|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
110531567|NCT00668031|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110531568|NCT00668031|Protease Inhibitors|protease inhibitors|mesh-ancestor
110531569|NCT00668031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110531570|NCT00668031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110531571|NCT00668109|Tadalafil|tadalafil|mesh-list
110531572|NCT00668109|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
110531573|NCT00668109|Vasodilator Agents|vasodilator agents|mesh-ancestor
110531574|NCT00668109|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110531575|NCT00668109|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110531576|NCT00668109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110185076|NCT01465685|Methylphenidate|methylphenidate|mesh-list
110460537|NCT02861976|Narcotics|narcotics|mesh-ancestor
110460538|NCT02861976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110460539|NCT02861976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110460540|NCT02861976|Analgesics|analgesics|mesh-ancestor
110460541|NCT02861976|Sensory System Agents|sensory system agents|mesh-ancestor
110460542|NCT02861976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110460543|NCT00666484|Prednisolone|prednisolone|mesh-list
110460544|NCT00666484|Cyclophosphamide|cyclophosphamide|mesh-list
110460545|NCT00666484|Doxorubicin|doxorubicin|mesh-list
110460546|NCT00666484|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110460547|NCT00666484|Etoposide|etoposide|mesh-list
110460549|NCT00666484|Procarbazine|procarbazine|mesh-list
110460550|NCT00666484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110460551|NCT00666484|Immunologic Factors|immunologic factors|mesh-ancestor
110460552|NCT00666484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110460553|NCT00666484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110460554|NCT00666484|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110460555|NCT00666484|Alkylating Agents|alkylating agents|mesh-ancestor
110460556|NCT00666484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110460557|NCT00666484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110460558|NCT00666484|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110460559|NCT00666484|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110460560|NCT00666484|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110460561|NCT00666484|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110460562|NCT00666484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110460563|NCT00666484|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110460564|NCT00666484|Tubulin Modulators|tubulin modulators|mesh-ancestor
110460565|NCT00666484|Antimitotic Agents|antimitotic agents|mesh-ancestor
110460566|NCT00666484|Mitosis Modulators|mitosis modulators|mesh-ancestor
110460567|NCT00666484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110460568|NCT00666484|Glucocorticoids|glucocorticoids|mesh-ancestor
110460569|NCT00666484|Hormones|hormones|mesh-ancestor
110460570|NCT00666484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110460571|NCT00666484|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110460572|NCT00663130|Tadalafil|tadalafil|mesh-list
110460573|NCT00663130|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
110460574|NCT00663130|Vasodilator Agents|vasodilator agents|mesh-ancestor
110531577|NCT00668109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110531578|NCT00668109|Urological Agents|urological agents|mesh-ancestor
110531579|NCT00668343|Simvastatin|simvastatin|mesh-list
110531580|NCT00668343|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110531581|NCT00668343|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110531582|NCT00668343|Antimetabolites|antimetabolites|mesh-ancestor
110531583|NCT00668343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110531584|NCT00668343|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110531585|NCT00668343|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110531586|NCT00668343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110531587|NCT04717700|Dexamethasone|dexamethasone|mesh-list
110531588|NCT04717700|Lenalidomide|lenalidomide|mesh-list
110531589|NCT04717700|Bortezomib|bortezomib|mesh-list
110531590|NCT04717700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110531591|NCT04717700|Antiemetics|antiemetics|mesh-ancestor
110531592|NCT04717700|Autonomic Agents|autonomic agents|mesh-ancestor
110531593|NCT04717700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110531594|NCT04717700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110531595|NCT04717700|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110531596|NCT04717700|Glucocorticoids|glucocorticoids|mesh-ancestor
110531597|NCT04717700|Hormones|hormones|mesh-ancestor
110531598|NCT04717700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110531599|NCT04717700|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110531600|NCT04717700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110531601|NCT04717700|Immunologic Factors|immunologic factors|mesh-ancestor
110531602|NCT04717700|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110531603|NCT04717700|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110531604|NCT04717700|Growth Substances|growth substances|mesh-ancestor
110531605|NCT04717700|Growth Inhibitors|growth inhibitors|mesh-ancestor
110531606|NCT02630277|Aflibercept|aflibercept|mesh-list
110531607|NCT02630277|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110460575|NCT00663130|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110460576|NCT00663130|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110460577|NCT00663130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110460578|NCT00663130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110460579|NCT00663130|Urological Agents|urological agents|mesh-ancestor
110460580|NCT00965562|Fluoxetine|fluoxetine|mesh-list
110460581|NCT00965562|Calcium|calcium|mesh-list
110460582|NCT00965562|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110460583|NCT00965562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110460584|NCT00965562|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110460585|NCT00965562|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110460586|NCT00965562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110531608|NCT02630277|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110531609|NCT02630277|Growth Substances|growth substances|mesh-ancestor
110531610|NCT02630277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110531611|NCT02630277|Growth Inhibitors|growth inhibitors|mesh-ancestor
110531612|NCT02630277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110531613|NCT00668499|Pemetrexed|pemetrexed|mesh-list
110531614|NCT00668499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110531615|NCT00668499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110531616|NCT00668499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110531617|NCT00668499|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110531618|NCT00668499|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110531619|NCT05201846|Insulin|insulin|mesh-list
110531620|NCT05201846|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110531621|NCT05201846|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110531622|NCT05201846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110531623|NCT00668967|Verapamil|verapamil|mesh-list
110531624|NCT00668967|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110531625|NCT00668967|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110531626|NCT00668967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110531627|NCT00668967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110531628|NCT00668967|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110531629|NCT00668967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110531630|NCT00668967|Vasodilator Agents|vasodilator agents|mesh-ancestor
110531631|NCT03583658|Ambroxol|ambroxol|mesh-list
110531632|NCT03583658|Expectorants|expectorants|mesh-ancestor
110531633|NCT03583658|Respiratory System Agents|respiratory system agents|mesh-ancestor
110531634|NCT03555968|Dronabinol|dronabinol|mesh-list
110531635|NCT03555968|Hallucinogens|hallucinogens|mesh-ancestor
110460587|NCT00965562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110460588|NCT00965562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110460589|NCT00965562|Serotonin Agents|serotonin agents|mesh-ancestor
110460590|NCT00965562|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110460591|NCT00965562|Antidepressive Agents|antidepressive agents|mesh-ancestor
110460592|NCT00965562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110460593|NCT00965562|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110460594|NCT00965562|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110460595|NCT00965562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110460596|NCT00659698|Pancrelipase|pancrelipase|mesh-list
110460597|NCT00659698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110460598|NCT00666796|Ethanol|ethanol|mesh-list
110460599|NCT00666796|Gabapentin|gabapentin|mesh-list
110460600|NCT00666796|Analgesics|analgesics|mesh-ancestor
110460601|NCT00666796|Sensory System Agents|sensory system agents|mesh-ancestor
110460602|NCT00666796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110460603|NCT00666796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110460604|NCT00666796|Anticonvulsants|anticonvulsants|mesh-ancestor
110460605|NCT00666796|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110531636|NCT03555968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110531637|NCT03555968|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110531638|NCT03555968|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110531639|NCT03555968|Analgesics|analgesics|mesh-ancestor
110531640|NCT03555968|Sensory System Agents|sensory system agents|mesh-ancestor
110531641|NCT03555968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110531642|NCT03555968|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
110531643|NCT03555968|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110531644|NCT03555968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110531645|NCT03555968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110531647|NCT03555968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110531648|NCT04593680|Tenofovir|tenofovir|mesh-list
110531649|NCT04593680|Emtricitabine|emtricitabine|mesh-list
110460606|NCT00666796|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110460607|NCT00666796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110460608|NCT00666796|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110460609|NCT00666796|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110460610|NCT00666796|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110460611|NCT00666796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110460612|NCT00666796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110460613|NCT00666796|Antimanic Agents|antimanic agents|mesh-ancestor
110460614|NCT00666796|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110460616|NCT00912093|Icatibant|icatibant|mesh-list
110460617|NCT00912093|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110460618|NCT00912093|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110460619|NCT00912093|Analgesics|analgesics|mesh-ancestor
110460620|NCT00912093|Sensory System Agents|sensory system agents|mesh-ancestor
110460621|NCT00912093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110460622|NCT00912093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110460623|NCT00912093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110460624|NCT00912093|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110460625|NCT00912093|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
110460626|NCT00912093|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
110460627|NCT00912093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110460628|NCT00912093|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
110460629|NCT00912093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110460630|NCT00912093|Immunologic Factors|immunologic factors|mesh-ancestor
110460631|NCT00659776|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
110460632|NCT00659776|Hematinics|hematinics|mesh-ancestor
110460633|NCT00659776|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
110460634|NCT00659776|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110460635|NCT03500484|Liraglutide|liraglutide|mesh-list
110460636|NCT03500484|Glucagon|glucagon|mesh-list
110460637|NCT03500484|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
110460638|NCT03500484|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110460639|NCT03500484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110460640|NCT03500484|Incretins|incretins|mesh-ancestor
110460641|NCT03500484|Hormones|hormones|mesh-ancestor
110460642|NCT03500484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110460643|NCT03500484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110460644|NCT03929601|Rituximab|rituximab|mesh-list
110460645|NCT03929601|Abatacept|abatacept|mesh-list
110460646|NCT03929601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110460647|NCT03929601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110460648|NCT03929601|Immunologic Factors|immunologic factors|mesh-ancestor
110460649|NCT03929601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110460650|NCT03929601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110460651|NCT03929601|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110531650|NCT04593680|Antiviral Agents|antiviral agents|mesh-ancestor
110531651|NCT04593680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110531652|NCT04593680|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110531653|NCT04593680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110531654|NCT04593680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110531655|NCT04593680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110531656|NCT04593680|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110531657|NCT04593680|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110531658|NCT00669435|Losartan|losartan|mesh-list
110531659|NCT00669435|Amlodipine|amlodipine|mesh-list
110531660|NCT00669435|Simvastatin|simvastatin|mesh-list
110531661|NCT00669435|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110531662|NCT00669435|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110531663|NCT00669435|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110531664|NCT00669435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110531665|NCT00669435|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110531666|NCT00669435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110531667|NCT00669435|Vasodilator Agents|vasodilator agents|mesh-ancestor
110531668|NCT00669435|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110531669|NCT00669435|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110531670|NCT00669435|Antimetabolites|antimetabolites|mesh-ancestor
110531671|NCT00669435|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110531672|NCT00669435|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110531673|NCT00669435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110531674|NCT00669435|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110531675|NCT00669435|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110531676|NCT00669435|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110531677|NCT00669591|Bavituximab|bavituximab|mesh-list
110531678|NCT00669591|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110531679|NCT00669591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110460652|NCT03929601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110460653|NCT03929601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110460654|NCT02631460|Carboplatin|carboplatin|mesh-list
110460655|NCT02631460|Pemetrexed|pemetrexed|mesh-list
110460656|NCT02631460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110460657|NCT02631460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110460658|NCT02631460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110460659|NCT02631460|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110460660|NCT02631460|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110460661|NCT04282824|Edetic Acid|edetic acid|mesh-list
110460662|NCT04282824|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
110460663|NCT04282824|Chelating Agents|chelating agents|mesh-ancestor
110460664|NCT04282824|Sequestering Agents|sequestering agents|mesh-ancestor
110531680|NCT00669747|Carboplatin|carboplatin|mesh-list
110531681|NCT00669747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110531682|NCT00596427|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
110531683|NCT00596427|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110531684|NCT00596427|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110531685|NCT00596427|Antimetabolites|antimetabolites|mesh-ancestor
110531686|NCT00596427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110531687|NCT00596427|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110460665|NCT04282824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110460666|NCT04282824|Anticoagulants|anticoagulants|mesh-ancestor
110460667|NCT04282824|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110460668|NCT04282824|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110460669|NCT00663286|Clindamycin|clindamycin|mesh-list
110460670|NCT00663286|Clindamycin palmitate|clindamycin palmitate|mesh-list
110460671|NCT00663286|Clindamycin phosphate|clindamycin phosphate|mesh-list
110460672|NCT00663286|Benzoyl Peroxide|benzoyl peroxide|mesh-list
110460673|NCT00663286|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110460674|NCT00663286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110460675|NCT00663286|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110460676|NCT00663286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110460677|NCT00663286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110460678|NCT00663286|Dermatologic Agents|dermatologic agents|mesh-ancestor
110460679|NCT03237702|Carotenoids|carotenoids|mesh-list
110460680|NCT03237702|Antioxidants|antioxidants|mesh-ancestor
110460681|NCT03237702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110460682|NCT03237702|Protective Agents|protective agents|mesh-ancestor
110460683|NCT03237702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110460684|NCT00667108|Gabapentin|gabapentin|mesh-list
110460685|NCT00667108|Analgesics|analgesics|mesh-ancestor
110460686|NCT00667108|Sensory System Agents|sensory system agents|mesh-ancestor
110460687|NCT00667108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110460688|NCT00667108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110460689|NCT00667108|Anticonvulsants|anticonvulsants|mesh-ancestor
110460690|NCT00667108|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110460691|NCT00667108|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110460692|NCT00667108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110460693|NCT00667108|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110460694|NCT00667108|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110460695|NCT00667108|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110460696|NCT00667108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110460697|NCT00667108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110460699|NCT00961116|Fenofibrate|fenofibrate|mesh-list
110460700|NCT00961116|Fenofibric acid|fenofibric acid|mesh-list
110460701|NCT00961116|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110460702|NCT00961116|Antimetabolites|antimetabolites|mesh-ancestor
110460703|NCT00961116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110460704|NCT00961116|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110460705|NCT00961116|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110460706|NCT04158388|Tryptophan|tryptophan|mesh-list
110460707|NCT04158388|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110460708|NCT04158388|Antidepressive Agents|antidepressive agents|mesh-ancestor
110460709|NCT04158388|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110460710|NCT04283136|Padsevonil|padsevonil|mesh-list
110460711|NCT04283136|Anticonvulsants|anticonvulsants|mesh-ancestor
110460712|NCT04283058|Ketamine|ketamine|mesh-list
110460713|NCT04283058|Anesthetics|anesthetics|mesh-list
110460714|NCT04283058|Analgesics|analgesics|mesh-ancestor
110460715|NCT04283058|Sensory System Agents|sensory system agents|mesh-ancestor
110460716|NCT04283058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110460717|NCT04283058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110460718|NCT04283058|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110460719|NCT04283058|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110460720|NCT04283058|Anesthetics, General|anesthetics, general|mesh-ancestor
110594784|NCT01650792|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110460721|NCT04283058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110460722|NCT04283058|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110460723|NCT04283058|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110460724|NCT04283058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110531688|NCT00670215|Ciprofloxacin|ciprofloxacin|mesh-list
110531689|NCT00670215|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110531690|NCT00670215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110531691|NCT00670215|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110531692|NCT00670215|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110531693|NCT00670215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110531694|NCT00670215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110531695|NCT00670215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110531696|NCT00670215|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110531697|NCT00670215|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110531698|NCT00670293|Raclopride|raclopride|mesh-list
110531699|NCT00670293|Methylphenidate|methylphenidate|mesh-list
110185394|NCT05432934|Dexamethasone|dexamethasone|mesh-list
110460725|NCT04283058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110460726|NCT00631995|Vaccines|vaccines|mesh-list
110460727|NCT00631995|Immunologic Factors|immunologic factors|mesh-ancestor
110460728|NCT00631995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110460729|NCT00663442|Methylphenidate|methylphenidate|mesh-list
110460730|NCT00663442|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110460731|NCT00663442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110460732|NCT00663442|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110460733|NCT00663442|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110460734|NCT00663442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110460735|NCT00663442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110460736|NCT00663442|Dopamine Agents|dopamine agents|mesh-ancestor
110460737|NCT00663442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110460738|NCT00912015|Tramadol|tramadol|mesh-list
110460739|NCT00912015|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110460740|NCT00912015|Narcotics|narcotics|mesh-ancestor
110460741|NCT00912015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110460742|NCT00912015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110460743|NCT00912015|Analgesics|analgesics|mesh-ancestor
110460744|NCT00912015|Sensory System Agents|sensory system agents|mesh-ancestor
110460745|NCT00912015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110460746|NCT00960804|Tanezumab|tanezumab|mesh-list
110460747|NCT00960804|Analgesics|analgesics|mesh-ancestor
110460748|NCT00960804|Sensory System Agents|sensory system agents|mesh-ancestor
110460749|NCT00960804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110460750|NCT00960804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110460751|NCT01126580|Metformin|metformin|mesh-list
110460752|NCT01126580|Dulaglutide|dulaglutide|mesh-list
110460753|NCT01126580|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110460754|NCT01126580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110460755|NCT00911157|Heparin|heparin|mesh-list
110460756|NCT00911157|Calcium heparin|calcium heparin|mesh-list
110460757|NCT00911157|PENTA|penta|mesh-list
110460758|NCT00911157|Fondaparinux|fondaparinux|mesh-list
110460759|NCT00911157|Anticoagulants|anticoagulants|mesh-ancestor
110460760|NCT00911157|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110460761|NCT00911157|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110460762|NCT00911157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110460763|NCT00911157|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110460764|NCT00911157|Antithrombins|antithrombins|mesh-ancestor
110460765|NCT00911157|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110460766|NCT00911157|Protease Inhibitors|protease inhibitors|mesh-ancestor
110460767|NCT00911157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110460768|NCT00960570|Efavirenz|efavirenz|mesh-list
110460769|NCT00960570|Fenofibric acid|fenofibric acid|mesh-list
110460770|NCT00960570|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110460771|NCT00960570|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110460772|NCT00960570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110460773|NCT00960570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110460774|NCT00960570|Antiviral Agents|antiviral agents|mesh-ancestor
110531700|NCT00670293|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110531701|NCT00670293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110531702|NCT00670293|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110531703|NCT00670293|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110531704|NCT00670293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110531705|NCT00670293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110531706|NCT00670293|Dopamine Agents|dopamine agents|mesh-ancestor
110531707|NCT00670293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110531708|NCT00670293|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110531709|NCT00670293|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110185452|NCT00846677|Ergocalciferols|ergocalciferols|mesh-list
110460775|NCT00960570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110460776|NCT00960570|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110460777|NCT00960570|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110460778|NCT00960570|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110460779|NCT00960570|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110460780|NCT00960570|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110460781|NCT00960570|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110460782|NCT00960570|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110460783|NCT00960570|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110460784|NCT00960570|Antimetabolites|antimetabolites|mesh-ancestor
110460785|NCT00960570|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110460786|NCT04204278|Hyaluronic Acid|hyaluronic acid|mesh-list
110460787|NCT04204278|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110460788|NCT04204278|Immunologic Factors|immunologic factors|mesh-ancestor
110460789|NCT04204278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110460790|NCT04204278|Viscosupplements|viscosupplements|mesh-ancestor
110460791|NCT04204278|Protective Agents|protective agents|mesh-ancestor
110460792|NCT00625430|Fludarabine|fludarabine|mesh-list
110460793|NCT00625430|Fludarabine phosphate|fludarabine phosphate|mesh-list
110460794|NCT00625430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110460795|NCT00625430|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110460796|NCT00625430|Antimetabolites|antimetabolites|mesh-ancestor
110460797|NCT00625430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110460798|NCT00625430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110460799|NCT00625430|Immunologic Factors|immunologic factors|mesh-ancestor
110460800|NCT00625430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110460802|NCT04282746|Analgesics|analgesics|mesh-ancestor
110460803|NCT04282746|Sensory System Agents|sensory system agents|mesh-ancestor
110460804|NCT04282746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110460805|NCT04282746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110460806|NCT04282746|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110460807|NCT04282746|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110460808|NCT04282746|Anesthetics, General|anesthetics, general|mesh-ancestor
110460809|NCT04282746|Anesthetics|anesthetics|mesh-ancestor
110460810|NCT04282746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110460811|NCT04282746|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110460812|NCT04282746|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110460813|NCT04282746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110460814|NCT04282746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110460815|NCT03773445|Golimumab|golimumab|mesh-list
110460816|NCT03773445|Antibodies|antibodies|mesh-list
110460817|NCT03773445|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110460818|NCT03773445|Immunologic Factors|immunologic factors|mesh-ancestor
110460819|NCT03773445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110460820|NCT03773445|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110460821|NCT03773445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110460822|NCT03773445|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110460823|NCT00630084|Interferons|interferons|mesh-list
110460824|NCT00630084|Ribavirin|ribavirin|mesh-list
110460825|NCT00630084|Interferon-alpha|interferon-alpha|mesh-list
110460826|NCT00630084|Interferon alpha-2|interferon alpha-2|mesh-list
110531710|NCT00670293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110531711|NCT00670293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110531712|NCT00670293|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110531713|NCT00670683|Insulin Detemir|insulin detemir|mesh-list
110531714|NCT00670683|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110531715|NCT00670683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110531716|NCT00670761|Misoprostol|misoprostol|mesh-list
110531717|NCT00670761|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110531718|NCT00670761|Abortifacient Agents|abortifacient agents|mesh-ancestor
110531719|NCT00670761|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110531720|NCT00670761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110531721|NCT00670761|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110531722|NCT00670761|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110531723|NCT00670761|Oxytocics|oxytocics|mesh-ancestor
110531724|NCT00680433|Ketamine|ketamine|mesh-list
110531725|NCT00680433|Analgesics|analgesics|mesh-ancestor
110531726|NCT00680433|Sensory System Agents|sensory system agents|mesh-ancestor
110185516|NCT00846248|Micronutrients|micronutrients|mesh-ancestor
110460827|NCT00630084|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110460828|NCT00630084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110460829|NCT00630084|Antiviral Agents|antiviral agents|mesh-ancestor
110460830|NCT00630084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110460831|NCT00630084|Antimetabolites|antimetabolites|mesh-ancestor
110460832|NCT00630084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110460833|NCT00630084|Immunologic Factors|immunologic factors|mesh-ancestor
110460834|NCT00630084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110460835|NCT01126424|Solifenacin Succinate|solifenacin succinate|mesh-list
110460836|NCT01126424|Oxybutynin|oxybutynin|mesh-list
110460837|NCT01126424|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110460838|NCT01126424|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110460839|NCT01126424|Cholinergic Agents|cholinergic agents|mesh-ancestor
110460840|NCT01126424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110460841|NCT01126424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110460842|NCT01126424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110460843|NCT01126424|Urological Agents|urological agents|mesh-ancestor
110460844|NCT01126424|Parasympatholytics|parasympatholytics|mesh-ancestor
110460845|NCT01126424|Autonomic Agents|autonomic agents|mesh-ancestor
110460846|NCT01126424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110460847|NCT04204902|Tepotinib|tepotinib|mesh-list
110460848|NCT04204902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110460849|NCT01126268|Retapamulin|retapamulin|mesh-list
110460850|NCT01126268|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110460851|NCT01126268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110460852|NCT04284150|Midazolam|midazolam|mesh-list
110460853|NCT04284150|Dexmedetomidine|dexmedetomidine|mesh-list
110460854|NCT04284150|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110460855|NCT04284150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110460856|NCT04284150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110460857|NCT04284150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110460858|NCT04284150|Analgesics|analgesics|mesh-ancestor
110460859|NCT04284150|Sensory System Agents|sensory system agents|mesh-ancestor
110460860|NCT04284150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110460861|NCT04284150|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110594817|NCT00582738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110460862|NCT04284150|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110460864|NCT04284150|Adrenergic Agents|adrenergic agents|mesh-ancestor
110460865|NCT04284150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110460866|NCT04284150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110460867|NCT04284150|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110460868|NCT04284150|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110531727|NCT00680433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110531728|NCT00680433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110531729|NCT00680433|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110531730|NCT00680433|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110531731|NCT00680433|Anesthetics, General|anesthetics, general|mesh-ancestor
110531732|NCT00680433|Anesthetics|anesthetics|mesh-ancestor
110531733|NCT00680433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110531734|NCT00680433|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110531735|NCT00680433|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110531736|NCT00680433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110531737|NCT00680433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110531738|NCT03322280|Chlorotrianisene|chlorotrianisene|mesh-list
110460869|NCT04284150|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110460870|NCT04284150|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110460871|NCT04284150|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110460872|NCT04284150|Anesthetics, General|anesthetics, general|mesh-ancestor
110460873|NCT04284150|Anesthetics|anesthetics|mesh-ancestor
110460874|NCT04284150|GABA Modulators|gaba modulators|mesh-ancestor
110460875|NCT04284150|GABA Agents|gaba agents|mesh-ancestor
110460876|NCT03311334|Pembrolizumab|pembrolizumab|mesh-list
110460877|NCT03311334|Nivolumab|nivolumab|mesh-list
110460878|NCT03311334|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110460879|NCT03311334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110460880|NCT03311334|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110460881|NCT03311334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110460882|NCT04313036|Defibrotide|defibrotide|mesh-list
110460883|NCT04313036|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110460884|NCT04313036|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110460885|NCT04313036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110460886|NCT04313036|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110460887|NCT00879658|Siponimod|siponimod|mesh-list
110460888|NCT00879658|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
110460889|NCT00879658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110460890|NCT00879658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110460891|NCT00879658|Immunologic Factors|immunologic factors|mesh-ancestor
110460892|NCT00879658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110460893|NCT00959946|Capecitabine|capecitabine|mesh-list
110460894|NCT00959946|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110460895|NCT00959946|Antimetabolites|antimetabolites|mesh-ancestor
110460896|NCT00959946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110460897|NCT00959946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110460898|NCT00667264|Ropivacaine|ropivacaine|mesh-list
110460899|NCT00667264|Anesthetics, Local|anesthetics, local|mesh-ancestor
110460900|NCT00667264|Anesthetics|anesthetics|mesh-ancestor
110460901|NCT00667264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110460902|NCT00667264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110460903|NCT00667264|Sensory System Agents|sensory system agents|mesh-ancestor
110460904|NCT00667264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110460905|NCT00660244|Anastrozole|anastrozole|mesh-list
110460906|NCT00660244|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110460907|NCT00660244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110460908|NCT00660244|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110460909|NCT00660244|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110460910|NCT00660244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110594838|NCT00789711|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110460911|NCT00660244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110460912|NCT00660244|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110460913|NCT00660244|Hormone Antagonists|hormone antagonists|mesh-ancestor
110460914|NCT00660244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110460915|NCT00660244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110460916|NCT04282200|Ketorolac|ketorolac|mesh-list
110531739|NCT03322280|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
110531740|NCT03322280|Estrogens|estrogens|mesh-ancestor
110531741|NCT03322280|Hormones|hormones|mesh-ancestor
110531742|NCT03322280|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110531743|NCT03322280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110531744|NCT03322280|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110531745|NCT03322280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110531746|NCT04150575|Paclitaxel|paclitaxel|mesh-list
110531747|NCT04150575|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110531748|NCT04150575|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110531749|NCT04150575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110531750|NCT04150575|Tubulin Modulators|tubulin modulators|mesh-ancestor
110460917|NCT04282200|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110460918|NCT04282200|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110460919|NCT04282200|Analgesics|analgesics|mesh-ancestor
110460920|NCT04282200|Sensory System Agents|sensory system agents|mesh-ancestor
110460921|NCT04282200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110460922|NCT04282200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110460923|NCT04282200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110460925|NCT04282200|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110460926|NCT04282200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110460927|NCT04282200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110460928|NCT00667498|Metformin|metformin|mesh-list
110460929|NCT00667498|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110460930|NCT00667498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110460931|NCT02860650|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
110460932|NCT02860650|Antiviral Agents|antiviral agents|mesh-ancestor
110460933|NCT02860650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110560324|NCT02684123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110460934|NCT00667966|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
110460935|NCT00667966|Vasodilator Agents|vasodilator agents|mesh-ancestor
110460936|NCT00667966|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110460937|NCT00667966|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110460938|NCT00667966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110460939|NCT00667966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110460940|NCT00667966|Urological Agents|urological agents|mesh-ancestor
110460941|NCT04283916|Botulinum Toxins|botulinum toxins|mesh-list
110460942|NCT04283916|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110460943|NCT04283916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110460944|NCT04283916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110460945|NCT04283916|Cholinergic Agents|cholinergic agents|mesh-ancestor
110460946|NCT04283916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110460947|NCT04283916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110460948|NCT00911937|Fesoterodine|fesoterodine|mesh-list
110460949|NCT00911937|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110460950|NCT00911937|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110460951|NCT00911937|Cholinergic Agents|cholinergic agents|mesh-ancestor
110460952|NCT00911937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110460953|NCT00911937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110460954|NCT00911937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110460955|NCT00911937|Urological Agents|urological agents|mesh-ancestor
110460956|NCT00663598|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
110460957|NCT00663598|Vasodilator Agents|vasodilator agents|mesh-ancestor
110460958|NCT00663598|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110460959|NCT00663598|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110460960|NCT00663598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110460961|NCT00663598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110460962|NCT00663598|Urological Agents|urological agents|mesh-ancestor
110460963|NCT02859480|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110460964|NCT02859480|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110531751|NCT04150575|Antimitotic Agents|antimitotic agents|mesh-ancestor
110531752|NCT04150575|Mitosis Modulators|mitosis modulators|mesh-ancestor
110531753|NCT04150575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110531754|NCT05345132|Magnesium Sulfate|magnesium sulfate|mesh-list
110531755|NCT05345132|Nifedipine|nifedipine|mesh-list
110531756|NCT05345132|Analgesics|analgesics|mesh-ancestor
110179233|NCT00009854|Ethanol|ethanol|mesh-list
110531757|NCT05345132|Sensory System Agents|sensory system agents|mesh-ancestor
110531758|NCT05345132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110531759|NCT05345132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110460965|NCT02859480|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110460966|NCT02859480|Antimetabolites|antimetabolites|mesh-ancestor
110460967|NCT02859480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110460968|NCT02859480|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110460969|NCT02859480|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110460970|NCT02859480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110460971|NCT01076543|Sirolimus|sirolimus|mesh-list
110460972|NCT01076543|Lenalidomide|lenalidomide|mesh-list
110460973|NCT01076543|Temsirolimus|temsirolimus|mesh-list
110460974|NCT01076543|MTOR Inhibitors|mtor inhibitors|mesh-list
110460975|NCT01076543|Immunologic Factors|immunologic factors|mesh-ancestor
110460976|NCT01076543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110460977|NCT01076543|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110460978|NCT01076543|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110460979|NCT01076543|Growth Substances|growth substances|mesh-ancestor
110460980|NCT01076543|Growth Inhibitors|growth inhibitors|mesh-ancestor
110460981|NCT01076543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110460982|NCT01076543|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110460983|NCT01076543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110460984|NCT01076543|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110460985|NCT01076543|Antifungal Agents|antifungal agents|mesh-ancestor
110460986|NCT01076543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110460987|NCT01076543|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110460988|NCT01076543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110460989|NCT01076543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110460990|NCT00668044|Ciprofloxacin|ciprofloxacin|mesh-list
110460991|NCT00668044|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110108098|NCT01816035|Maytansine|maytansine|mesh-list
110460992|NCT00668044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110460993|NCT00668044|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110460994|NCT00668044|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110460995|NCT00668044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110460996|NCT00668044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110460997|NCT00668044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110460998|NCT00668044|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110460999|NCT00668044|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110461000|NCT02860494|Everolimus|everolimus|mesh-list
110461001|NCT02860494|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110461002|NCT02860494|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110461003|NCT02860494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110461004|NCT02860494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110461005|NCT02860494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110461006|NCT02860494|Immunologic Factors|immunologic factors|mesh-ancestor
110461007|NCT02860494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110461008|NCT02860494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110461009|NCT00663832|Panobinostat|panobinostat|mesh-list
110461010|NCT00663832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110461011|NCT00663832|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110461012|NCT00663832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110461013|NCT00663832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110461014|NCT04281576|Capecitabine|capecitabine|mesh-list
110461015|NCT04281576|Oxaliplatin|oxaliplatin|mesh-list
110461016|NCT04281576|Trastuzumab|trastuzumab|mesh-list
110461017|NCT04281576|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110306186|NCT00261287|Ciclesonide|ciclesonide|mesh-list
110531760|NCT05345132|Anesthetics|anesthetics|mesh-ancestor
110531761|NCT05345132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110531762|NCT05345132|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110531763|NCT05345132|Anticonvulsants|anticonvulsants|mesh-ancestor
110531764|NCT05345132|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110531765|NCT05345132|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110531766|NCT05345132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110531767|NCT05345132|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110531768|NCT05345132|Tocolytic Agents|tocolytic agents|mesh-ancestor
110531769|NCT05345132|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110531770|NCT05345132|Vasodilator Agents|vasodilator agents|mesh-ancestor
110531771|NCT04349306|Rasburicase|rasburicase|mesh-list
110531772|NCT04349306|Gout Suppressants|gout suppressants|mesh-ancestor
110531773|NCT04349306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110531774|NCT00614588|Anesthetics|anesthetics|mesh-list
110461018|NCT04281576|Antimetabolites|antimetabolites|mesh-ancestor
110461019|NCT04281576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110461020|NCT04281576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110461021|NCT04281576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110461022|NCT00668122|Ciprofloxacin|ciprofloxacin|mesh-list
110461023|NCT00668122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110461024|NCT00668122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110461025|NCT00668122|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110461026|NCT00668122|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110461027|NCT00668122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110461028|NCT00668122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110461029|NCT00668122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110461030|NCT00668122|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110461031|NCT00668122|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110461032|NCT04304807|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110461033|NCT04304807|Melatonin|melatonin|mesh-list
110461034|NCT04304807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110461035|NCT04304807|Antioxidants|antioxidants|mesh-ancestor
110461036|NCT04304807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110461037|NCT04304807|Protective Agents|protective agents|mesh-ancestor
110461038|NCT04304807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110461039|NCT04304807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110461040|NCT04280874|Dinoprostone|dinoprostone|mesh-list
110461041|NCT04280874|Oxytocics|oxytocics|mesh-ancestor
110461042|NCT04280874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110461043|NCT04280874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110461044|NCT00663910|Aminolevulinic Acid|aminolevulinic acid|mesh-list
110461045|NCT00663910|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110461046|NCT00663910|Dermatologic Agents|dermatologic agents|mesh-ancestor
110461047|NCT04157998|Metoclopramide|metoclopramide|mesh-list
110461048|NCT04157998|Antiemetics|antiemetics|mesh-ancestor
110461049|NCT04157998|Autonomic Agents|autonomic agents|mesh-ancestor
110461050|NCT04157998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110461051|NCT04157998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110461052|NCT04157998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110461053|NCT04157998|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110461054|NCT04157998|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110461055|NCT04157998|Dopamine Agents|dopamine agents|mesh-ancestor
110461056|NCT04157998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110461057|NCT04157998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110461058|NCT01072877|Polidocanol|polidocanol|mesh-list
110461059|NCT01072877|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
110461060|NCT01072877|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110461061|NCT00630474|Xylometazoline|xylometazoline|mesh-list
110461062|NCT00630474|Nasal Decongestants|nasal decongestants|mesh-ancestor
110531775|NCT00614588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110531776|NCT00614588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110531777|NCT02699840|Vaccines|vaccines|mesh-list
110531778|NCT02699840|Immunologic Factors|immunologic factors|mesh-ancestor
110531779|NCT02699840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110531780|NCT00613808|Nitric Oxide|nitric oxide|mesh-list
110531781|NCT00613808|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110531782|NCT00613808|Autonomic Agents|autonomic agents|mesh-ancestor
110531783|NCT00613808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110531784|NCT00613808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110531785|NCT00613808|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110185814|NCT00275756|Timolol|timolol|mesh-list
110461063|NCT00630474|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110461064|NCT00630474|Respiratory System Agents|respiratory system agents|mesh-ancestor
110108171|NCT01816555|Vitamin D|vitamin d|mesh-list
110461065|NCT00957528|Methyltestosterone|methyltestosterone|mesh-list
110461066|NCT00957528|Testosterone|testosterone|mesh-list
110461067|NCT00957528|Testosterone undecanoate|testosterone undecanoate|mesh-list
110461068|NCT00957528|Testosterone enanthate|testosterone enanthate|mesh-list
110461069|NCT00957528|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
110461070|NCT00957528|Androgens|androgens|mesh-ancestor
110461071|NCT00957528|Hormones|hormones|mesh-ancestor
110461072|NCT00957528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110461073|NCT00957528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110461074|NCT00957528|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110461075|NCT00957528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110461076|NCT00957528|Anabolic Agents|anabolic agents|mesh-ancestor
110461077|NCT02857062|Emollients|emollients|mesh-list
110461078|NCT02857062|Dermatologic Agents|dermatologic agents|mesh-ancestor
110461079|NCT00958776|Peramivir|peramivir|mesh-list
110461080|NCT00958776|Antiviral Agents|antiviral agents|mesh-ancestor
110461081|NCT00958776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110461082|NCT00958776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110461083|NCT00958776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110461084|NCT02858856|Juzentaihoto|juzentaihoto|mesh-list
110461085|NCT02858856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110461086|NCT02858856|Mitogens|mitogens|mesh-ancestor
110461087|NCT02858856|Mitosis Modulators|mitosis modulators|mesh-ancestor
110461088|NCT02858856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110461089|NCT02858622|Fentanyl|fentanyl|mesh-list
110461090|NCT02858622|Meperidine|meperidine|mesh-list
110461091|NCT02858622|Bupivacaine|bupivacaine|mesh-list
110461092|NCT02858622|Anesthetics, Local|anesthetics, local|mesh-ancestor
110461093|NCT02858622|Anesthetics|anesthetics|mesh-ancestor
110461094|NCT02858622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110461095|NCT02858622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110461096|NCT02858622|Sensory System Agents|sensory system agents|mesh-ancestor
110461097|NCT02858622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110461098|NCT02858622|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110461099|NCT02858622|Narcotics|narcotics|mesh-ancestor
110461100|NCT02858622|Analgesics|analgesics|mesh-ancestor
110461101|NCT02858622|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110461102|NCT02858622|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110461103|NCT02858622|Anesthetics, General|anesthetics, general|mesh-ancestor
110461104|NCT02191566|Oxaliplatin|oxaliplatin|mesh-list
110461105|NCT02191566|Tegafur|tegafur|mesh-list
110461106|NCT02191566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110461107|NCT02191566|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110461108|NCT02191566|Antimetabolites|antimetabolites|mesh-ancestor
110461109|NCT02191566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110461110|NCT00596830|Paclitaxel|paclitaxel|mesh-list
110461111|NCT00596830|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110461112|NCT00596830|Carboplatin|carboplatin|mesh-list
110461113|NCT00596830|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110461114|NCT00596830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110461115|NCT00596830|Tubulin Modulators|tubulin modulators|mesh-ancestor
110531786|NCT00613808|Respiratory System Agents|respiratory system agents|mesh-ancestor
110531787|NCT00613808|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110531788|NCT00613808|Antioxidants|antioxidants|mesh-ancestor
110531789|NCT00613808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110531790|NCT00613808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110531791|NCT00613808|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
110531792|NCT00613808|Vasodilator Agents|vasodilator agents|mesh-ancestor
110531793|NCT00613808|Gasotransmitters|gasotransmitters|mesh-ancestor
110531794|NCT00613808|Protective Agents|protective agents|mesh-ancestor
110531795|NCT05344742|Paclitaxel|paclitaxel|mesh-list
110531796|NCT05344742|Capecitabine|capecitabine|mesh-list
110531797|NCT05344742|Mitoxantrone|mitoxantrone|mesh-list
110531798|NCT05344742|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110531799|NCT05344742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110531800|NCT05344742|Tubulin Modulators|tubulin modulators|mesh-ancestor
110461116|NCT00596830|Antimitotic Agents|antimitotic agents|mesh-ancestor
110461117|NCT00596830|Mitosis Modulators|mitosis modulators|mesh-ancestor
110461118|NCT00596830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110461119|NCT00957372|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
110461120|NCT00957372|Anticonvulsants|anticonvulsants|mesh-ancestor
110461121|NCT00957372|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110461122|NCT00957372|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110461123|NCT00957372|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110461124|NCT00957372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110461125|NCT04270968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
110461126|NCT05143164|Gentamicins|gentamicins|mesh-list
110461127|NCT05143164|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110461128|NCT05143164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110461129|NCT05143164|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110461130|NCT05143164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110461131|NCT05143164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110461132|NCT00664144|Rasburicase|rasburicase|mesh-list
110461133|NCT00664144|Gout Suppressants|gout suppressants|mesh-ancestor
110461134|NCT00664144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110461135|NCT02819856|Ebselen|ebselen|mesh-list
110461136|NCT02819856|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110461137|NCT02819856|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110461138|NCT02819856|Analgesics|analgesics|mesh-ancestor
110461139|NCT02819856|Sensory System Agents|sensory system agents|mesh-ancestor
110461140|NCT02819856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110461141|NCT02819856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110461143|NCT02819856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110461144|NCT02819856|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110461145|NCT02819856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110461146|NCT02819856|Antioxidants|antioxidants|mesh-ancestor
110461147|NCT02819856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110461148|NCT02819856|Protective Agents|protective agents|mesh-ancestor
110461149|NCT02819856|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110461150|NCT02819856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110461151|NCT02819856|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110461152|NCT02630290|Dexmedetomidine|dexmedetomidine|mesh-list
110461153|NCT02630290|Ropivacaine|ropivacaine|mesh-list
110461154|NCT02630290|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110461155|NCT02630290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110461156|NCT02630290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110461157|NCT02630290|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110461158|NCT02630290|Analgesics|analgesics|mesh-ancestor
110461159|NCT02630290|Sensory System Agents|sensory system agents|mesh-ancestor
110461160|NCT02630290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110461161|NCT02630290|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110531801|NCT05344742|Antimitotic Agents|antimitotic agents|mesh-ancestor
110531802|NCT05344742|Mitosis Modulators|mitosis modulators|mesh-ancestor
110531803|NCT05344742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110531804|NCT05344742|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110531805|NCT05344742|Antimetabolites|antimetabolites|mesh-ancestor
110531806|NCT05344742|Analgesics|analgesics|mesh-ancestor
110531807|NCT05344742|Sensory System Agents|sensory system agents|mesh-ancestor
110531808|NCT05344742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110531809|NCT05344742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110531810|NCT05344742|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110531811|NCT05344742|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110531812|NCT05344742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110531813|NCT02046434|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
110531814|NCT02046434|Glycerol|glycerol|mesh-list
110531815|NCT02046434|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
110185938|NCT03430596|Dopamine Agents|dopamine agents|mesh-ancestor
110461162|NCT02630290|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110461164|NCT02630290|Adrenergic Agents|adrenergic agents|mesh-ancestor
110461165|NCT02630290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110461166|NCT02630290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110461167|NCT02630290|Anesthetics, Local|anesthetics, local|mesh-ancestor
110461168|NCT02630290|Anesthetics|anesthetics|mesh-ancestor
110461169|NCT02856906|Salicylic Acid|salicylic acid|mesh-list
110461170|NCT02856906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110461171|NCT02856906|Antifungal Agents|antifungal agents|mesh-ancestor
110461172|NCT02856906|Keratolytic Agents|keratolytic agents|mesh-ancestor
110461173|NCT02856906|Dermatologic Agents|dermatologic agents|mesh-ancestor
110461174|NCT00668356|Didanosine|didanosine|mesh-list
110461175|NCT00668356|Antimetabolites|antimetabolites|mesh-ancestor
110461176|NCT00668356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110461177|NCT00668356|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110461178|NCT00668356|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110461179|NCT00668356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110461180|NCT00668356|Antiviral Agents|antiviral agents|mesh-ancestor
110461181|NCT00668356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110461182|NCT00668356|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110461183|NCT00668356|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110461184|NCT00664222|Furosemide|furosemide|mesh-list
110461185|NCT00664222|Spironolactone|spironolactone|mesh-list
110461186|NCT00664222|Diuretics|diuretics|mesh-ancestor
110461187|NCT00664222|Natriuretic Agents|natriuretic agents|mesh-ancestor
110461188|NCT00664222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110461189|NCT00664222|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110461190|NCT00664222|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110461191|NCT00664222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110461192|NCT00664222|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110461193|NCT00664222|Hormone Antagonists|hormone antagonists|mesh-ancestor
110461194|NCT00664222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110461195|NCT00664222|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110461196|NCT00952614|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
110461197|NCT00952614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110461198|NCT00952614|Glucocorticoids|glucocorticoids|mesh-ancestor
110461199|NCT00952614|Hormones|hormones|mesh-ancestor
110594918|NCT00793923|Hormones|hormones|mesh-ancestor
110461200|NCT00952614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110461201|NCT00952614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110461202|NCT00911859|Prednisone|prednisone|mesh-list
110461203|NCT00911859|Bortezomib|bortezomib|mesh-list
110461204|NCT00911859|Melphalan|melphalan|mesh-list
110461205|NCT00911859|Siltuximab|siltuximab|mesh-list
110531816|NCT02046434|Protective Agents|protective agents|mesh-ancestor
110531817|NCT02046434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110531818|NCT02046434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110531820|NCT03930446|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110531821|NCT03930446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110531822|NCT03930446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110531823|NCT03930446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110531824|NCT00614666|Nikkomycin|nikkomycin|mesh-list
110531825|NCT00614666|Antifungal Agents|antifungal agents|mesh-ancestor
110531826|NCT00614666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110531827|NCT00614666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110531828|NCT00614666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110531829|NCT03794336|Aspirin|aspirin|mesh-list
110461206|NCT00911859|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110461207|NCT00911859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110461208|NCT00911859|Glucocorticoids|glucocorticoids|mesh-ancestor
110461209|NCT00911859|Hormones|hormones|mesh-ancestor
110461210|NCT00911859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110461211|NCT00911859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110461212|NCT00911859|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110461213|NCT00911859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110461214|NCT00911859|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110461215|NCT00911859|Alkylating Agents|alkylating agents|mesh-ancestor
110461216|NCT00911859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110461217|NCT00911859|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110461218|NCT00911859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110461220|NCT02725593|Dapagliflozin|dapagliflozin|mesh-list
110461221|NCT02725593|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110461222|NCT02725593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110461223|NCT02725593|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110461224|NCT02725593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110461225|NCT00911625|Insulin|insulin|mesh-list
110461226|NCT00911625|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110461227|NCT00911625|Insulin Glargine|insulin glargine|mesh-list
110461228|NCT00911625|Insulin glulisine|insulin glulisine|mesh-list
110461229|NCT00911625|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110461230|NCT00911625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110461231|NCT00596752|Alprostadil|alprostadil|mesh-list
110461232|NCT00596752|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110461233|NCT00596752|Vasodilator Agents|vasodilator agents|mesh-ancestor
110461234|NCT00596752|Urological Agents|urological agents|mesh-ancestor
110461235|NCT04151277|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110461236|NCT04151277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110461237|NCT00958074|Vorinostat|vorinostat|mesh-list
110461238|NCT00958074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110461239|NCT00958074|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110461240|NCT00958074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110461241|NCT00958074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110461242|NCT00660868|Pentoxifylline|pentoxifylline|mesh-list
110461243|NCT00660868|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110461244|NCT00660868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110461245|NCT00660868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110461246|NCT00660868|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110461247|NCT00660868|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110461248|NCT00660868|Protective Agents|protective agents|mesh-ancestor
110461249|NCT00660868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110461250|NCT00660868|Vasodilator Agents|vasodilator agents|mesh-ancestor
110461251|NCT00660868|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110461252|NCT00660868|Antioxidants|antioxidants|mesh-ancestor
110461253|NCT00664690|Celecoxib|celecoxib|mesh-list
110531830|NCT03794336|Metformin|metformin|mesh-list
110531831|NCT03794336|Alogliptin|alogliptin|mesh-list
110179318|NCT01465152|Metformin|metformin|mesh-list
110531833|NCT03794336|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110531834|NCT03794336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110461254|NCT00664690|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110461255|NCT00664690|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110461256|NCT00664690|Analgesics|analgesics|mesh-ancestor
110461257|NCT00664690|Sensory System Agents|sensory system agents|mesh-ancestor
110461258|NCT00664690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110461259|NCT00664690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110461260|NCT00664690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110461261|NCT00664690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110461262|NCT00664690|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110461263|NCT00664690|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110461264|NCT00664690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110461265|NCT00664690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110461266|NCT00809965|Rivaroxaban|rivaroxaban|mesh-list
110461267|NCT00809965|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110461268|NCT00809965|Antithrombins|antithrombins|mesh-ancestor
110461269|NCT00809965|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110461270|NCT00809965|Protease Inhibitors|protease inhibitors|mesh-ancestor
110461271|NCT00809965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110461272|NCT00809965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110461273|NCT00809965|Anticoagulants|anticoagulants|mesh-ancestor
110461274|NCT04338165|Evolocumab|evolocumab|mesh-list
110461275|NCT04338165|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
110461276|NCT04338165|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110461277|NCT04338165|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110461278|NCT04338165|Antimetabolites|antimetabolites|mesh-ancestor
110461279|NCT04338165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110461280|NCT04338165|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110461281|NCT04338165|Protease Inhibitors|protease inhibitors|mesh-ancestor
110461282|NCT04338165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110461283|NCT04338165|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110461284|NCT00664846|Aspirin|aspirin|mesh-list
110461285|NCT00664846|Clopidogrel|clopidogrel|mesh-list
110461286|NCT00664846|Atorvastatin|atorvastatin|mesh-list
110461287|NCT00664846|Simvastatin|simvastatin|mesh-list
110461288|NCT00664846|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110461289|NCT00664846|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110461290|NCT00664846|Analgesics|analgesics|mesh-ancestor
110461291|NCT00664846|Sensory System Agents|sensory system agents|mesh-ancestor
110461292|NCT00664846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110461293|NCT00664846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110461294|NCT00664846|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110461295|NCT00664846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110461296|NCT00664846|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110461297|NCT00664846|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110461298|NCT00664846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110461299|NCT00664846|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110461300|NCT00664846|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110461301|NCT00664846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110461302|NCT00664846|Antipyretics|antipyretics|mesh-ancestor
110461303|NCT00664846|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110461304|NCT00664846|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110461305|NCT00664846|Antimetabolites|antimetabolites|mesh-ancestor
110461306|NCT00664846|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110461307|NCT00664846|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110461308|NCT00664846|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110461309|NCT00664846|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110461310|NCT00664846|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110461311|NCT00664846|Purinergic Agents|purinergic agents|mesh-ancestor
110461312|NCT00664846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110461313|NCT00913783|Clomipramine|clomipramine|mesh-list
110461314|NCT00913783|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110461315|NCT00913783|Antidepressive Agents|antidepressive agents|mesh-ancestor
110461316|NCT00913783|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110461317|NCT00913783|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110461318|NCT00913783|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110461319|NCT00913783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110531835|NCT03794336|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110531836|NCT03794336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110531838|NCT03794336|Sensory System Agents|sensory system agents|mesh-ancestor
110531839|NCT03794336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110531840|NCT03794336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110531841|NCT03794336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110531842|NCT03794336|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110531843|NCT03794336|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110531844|NCT03794336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110531845|NCT03794336|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110531846|NCT03794336|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110461320|NCT00913783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110461321|NCT00913783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110461322|NCT00913783|Serotonin Agents|serotonin agents|mesh-ancestor
110461323|NCT00913783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110461324|NCT00661102|Capecitabine|capecitabine|mesh-list
110461325|NCT00661102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110461326|NCT00661102|Antimetabolites|antimetabolites|mesh-ancestor
110461327|NCT00661102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110461328|NCT00661102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110461330|NCT00669370|Capecitabine|capecitabine|mesh-list
110461331|NCT00669370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110461332|NCT00669370|Tubulin Modulators|tubulin modulators|mesh-ancestor
110461333|NCT00669370|Antimitotic Agents|antimitotic agents|mesh-ancestor
110461334|NCT00669370|Mitosis Modulators|mitosis modulators|mesh-ancestor
110461335|NCT00669370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110461336|NCT00669370|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110461337|NCT00669370|Antimetabolites|antimetabolites|mesh-ancestor
110461338|NCT00665314|Plerixafor|plerixafor|mesh-list
110461339|NCT00665314|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110461340|NCT00665314|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110461341|NCT00665314|Antiviral Agents|antiviral agents|mesh-ancestor
110461342|NCT00665314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110461343|NCT04154722|Azithromycin|azithromycin|mesh-list
110461344|NCT04154722|Meropenem|meropenem|mesh-list
110461345|NCT04154722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110461346|NCT04154722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110461347|NCT02631928|Insulin|insulin|mesh-list
110461348|NCT02631928|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110461349|NCT02631928|Biphasic Insulins|biphasic insulins|mesh-list
110461350|NCT02631928|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110461351|NCT02631928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110461352|NCT00632385|Eletriptan|eletriptan|mesh-list
110461353|NCT00632385|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110461354|NCT00632385|Serotonin Agents|serotonin agents|mesh-ancestor
110461355|NCT00632385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110461356|NCT00632385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110461357|NCT00632385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110461358|NCT00910689|Propranolol|propranolol|mesh-list
110461359|NCT00910689|Nadolol|nadolol|mesh-list
110461360|NCT00910689|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110461361|NCT00910689|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110461362|NCT00910689|Adrenergic Agents|adrenergic agents|mesh-ancestor
110461363|NCT00910689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110108464|NCT01818869|Vasodilator Agents|vasodilator agents|mesh-ancestor
110461364|NCT00910689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110461365|NCT00910689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110461366|NCT00910689|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110461367|NCT00910689|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110461368|NCT00910689|Vasodilator Agents|vasodilator agents|mesh-ancestor
110461369|NCT00910689|Sympatholytics|sympatholytics|mesh-ancestor
110461370|NCT00910689|Autonomic Agents|autonomic agents|mesh-ancestor
110531847|NCT03794336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110531848|NCT03794336|Antipyretics|antipyretics|mesh-ancestor
110531849|NCT03794336|Incretins|incretins|mesh-ancestor
110531850|NCT03794336|Hormones|hormones|mesh-ancestor
110531851|NCT03794336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110531852|NCT03794336|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110531853|NCT03794336|Protease Inhibitors|protease inhibitors|mesh-ancestor
110531854|NCT03794336|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
110531855|NCT03774914|Alemtuzumab|alemtuzumab|mesh-list
110461371|NCT00910689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110461372|NCT04669717|Amoxicillin|amoxicillin|mesh-list
110461373|NCT04669717|Azithromycin|azithromycin|mesh-list
110461374|NCT04669717|Metronidazole|metronidazole|mesh-list
110461375|NCT04669717|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110461376|NCT04669717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110461377|NCT04669717|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110461378|NCT04669717|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110461379|NCT00809341|Prednisone|prednisone|mesh-list
110461380|NCT00809341|Cyclophosphamide|cyclophosphamide|mesh-list
110461381|NCT00809341|Ifosfamide|ifosfamide|mesh-list
110461382|NCT00809341|Rituximab|rituximab|mesh-list
110461383|NCT00809341|Carboplatin|carboplatin|mesh-list
110461384|NCT00809341|Doxorubicin|doxorubicin|mesh-list
110461385|NCT00809341|Etoposide|etoposide|mesh-list
110461386|NCT00809341|Vincristine|vincristine|mesh-list
110461387|NCT00809341|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110461388|NCT00809341|Immunologic Factors|immunologic factors|mesh-ancestor
110461389|NCT00809341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110461390|NCT00809341|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110461391|NCT00809341|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110461392|NCT00809341|Alkylating Agents|alkylating agents|mesh-ancestor
110461393|NCT00809341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110461394|NCT00809341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110461395|NCT00809341|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110461396|NCT00809341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110461397|NCT00809341|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110461398|NCT00809341|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110461399|NCT00809341|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110461400|NCT00809341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110461401|NCT00809341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110461402|NCT00809341|Glucocorticoids|glucocorticoids|mesh-ancestor
110461403|NCT00809341|Hormones|hormones|mesh-ancestor
110461404|NCT00809341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110461405|NCT00809341|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110461406|NCT00809341|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110461407|NCT00809341|Tubulin Modulators|tubulin modulators|mesh-ancestor
110461408|NCT00809341|Antimitotic Agents|antimitotic agents|mesh-ancestor
110461409|NCT00809341|Mitosis Modulators|mitosis modulators|mesh-ancestor
110461410|NCT02609581|Immunomodulating Agents|immunomodulating agents|mesh-list
110461411|NCT02609581|Immunologic Factors|immunologic factors|mesh-list
110461412|NCT02609581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110461413|NCT00811135|Bevacizumab|bevacizumab|mesh-list
110461414|NCT00811135|Trastuzumab|trastuzumab|mesh-list
110461415|NCT00811135|Capecitabine|capecitabine|mesh-list
110461416|NCT00811135|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110461417|NCT00811135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110461418|NCT00811135|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110461419|NCT00811135|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110461420|NCT00811135|Growth Substances|growth substances|mesh-ancestor
110461421|NCT00811135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110461422|NCT00811135|Growth Inhibitors|growth inhibitors|mesh-ancestor
110461423|NCT00811135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110461424|NCT00811135|Antimetabolites|antimetabolites|mesh-ancestor
110461425|NCT00811135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110461426|NCT00811057|Indomethacin|indomethacin|mesh-list
110461427|NCT00811057|Magnesium Sulfate|magnesium sulfate|mesh-list
110461428|NCT00811057|Nifedipine|nifedipine|mesh-list
110461429|NCT00811057|Analgesics|analgesics|mesh-ancestor
110461430|NCT00811057|Sensory System Agents|sensory system agents|mesh-ancestor
110531856|NCT03774914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110531858|NCT03687554|Venglustat|venglustat|mesh-list
110531859|NCT03687554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110531860|NCT03687554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110531861|NCT03681158|Valproic Acid|valproic acid|mesh-list
110531862|NCT03681158|Anticonvulsants|anticonvulsants|mesh-ancestor
110531863|NCT03681158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110531864|NCT03681158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110531865|NCT03681158|GABA Agents|gaba agents|mesh-ancestor
110461431|NCT00811057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110461432|NCT00811057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110461433|NCT00811057|Anesthetics|anesthetics|mesh-ancestor
110461434|NCT00811057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110461435|NCT00811057|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110461436|NCT00811057|Anticonvulsants|anticonvulsants|mesh-ancestor
110461437|NCT00811057|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110461438|NCT00811057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110461439|NCT00811057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110461440|NCT00811057|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110461441|NCT00811057|Tocolytic Agents|tocolytic agents|mesh-ancestor
110461442|NCT00811057|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110461444|NCT00811057|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110461445|NCT00811057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110461446|NCT00811057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110461447|NCT00811057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110461448|NCT00811057|Gout Suppressants|gout suppressants|mesh-ancestor
110461449|NCT00811057|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110461450|NCT00811057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110461451|NCT00879970|Vitamin D|vitamin d|mesh-list
110461452|NCT00879970|Pioglitazone|pioglitazone|mesh-list
110461453|NCT00879970|Rosiglitazone|rosiglitazone|mesh-list
110461454|NCT00879970|Vitamins|vitamins|mesh-ancestor
110461455|NCT00879970|Micronutrients|micronutrients|mesh-ancestor
110461456|NCT00879970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110461457|NCT00879970|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110461458|NCT00879970|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110461459|NCT00808639|Doxorubicin|doxorubicin|mesh-list
110461460|NCT00808639|Methotrexate|methotrexate|mesh-list
110461461|NCT00808639|Vinblastine|vinblastine|mesh-list
110461462|NCT00808639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110461463|NCT00808639|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110461464|NCT00808639|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110461465|NCT00808639|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110461466|NCT00808639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110461467|NCT00808639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110461468|NCT00808639|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110461469|NCT00808639|Abortifacient Agents|abortifacient agents|mesh-ancestor
110461470|NCT00808639|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110461471|NCT00808639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110461472|NCT00808639|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110461473|NCT00808639|Antimetabolites|antimetabolites|mesh-ancestor
110461474|NCT00808639|Dermatologic Agents|dermatologic agents|mesh-ancestor
110461475|NCT00808639|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110461476|NCT00808639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110461477|NCT00808639|Immunologic Factors|immunologic factors|mesh-ancestor
110461478|NCT00808639|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110461479|NCT00808639|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110461480|NCT00808639|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110461481|NCT00808639|Tubulin Modulators|tubulin modulators|mesh-ancestor
110461482|NCT00808639|Antimitotic Agents|antimitotic agents|mesh-ancestor
110461483|NCT00808639|Mitosis Modulators|mitosis modulators|mesh-ancestor
110461484|NCT00910299|Clopidogrel|clopidogrel|mesh-list
110461485|NCT00910299|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
110461486|NCT00910299|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110531866|NCT03681158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110531867|NCT03681158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110531868|NCT03681158|Antimanic Agents|antimanic agents|mesh-ancestor
110531869|NCT03681158|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110531870|NCT03681158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110531871|NCT03681158|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110531872|NCT05343806|Magnesium Sulfate|magnesium sulfate|mesh-list
110531873|NCT05343806|Nifedipine|nifedipine|mesh-list
110531874|NCT05343806|Analgesics|analgesics|mesh-ancestor
110531875|NCT05343806|Sensory System Agents|sensory system agents|mesh-ancestor
110531876|NCT05343806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110461487|NCT00910299|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110461488|NCT00910299|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110461489|NCT00910299|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110461490|NCT00910299|Purinergic Agents|purinergic agents|mesh-ancestor
110461491|NCT00910299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110461492|NCT00910299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110461493|NCT00910299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110461494|NCT03007329|Dapagliflozin|dapagliflozin|mesh-list
110461495|NCT03007329|Exenatide|exenatide|mesh-list
110461496|NCT03007329|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110461497|NCT03007329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110461498|NCT03007329|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110461499|NCT03007329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110461500|NCT03007329|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110461501|NCT03007329|Incretins|incretins|mesh-ancestor
110461502|NCT03007329|Hormones|hormones|mesh-ancestor
110306664|NCT00263393|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110461503|NCT03007329|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110461504|NCT04072341|Propolis|propolis|mesh-list
110461505|NCT04072341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110461506|NCT04030039|Interferons|interferons|mesh-list
110461507|NCT04030039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110461508|NCT04030039|Antiviral Agents|antiviral agents|mesh-ancestor
110461509|NCT04030039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110461510|NCT02628574|Gemcitabine|gemcitabine|mesh-list
110461511|NCT02628574|Pembrolizumab|pembrolizumab|mesh-list
110461512|NCT02628574|Nivolumab|nivolumab|mesh-list
110461513|NCT02628574|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110461514|NCT02628574|Antimetabolites|antimetabolites|mesh-ancestor
110461515|NCT02628574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110461516|NCT02628574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110461517|NCT02628574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110461518|NCT02628574|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110461519|NCT00596362|Bevacizumab|bevacizumab|mesh-list
110461520|NCT00596362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110461521|NCT00596362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110461522|NCT00596362|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110461523|NCT00596362|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110461524|NCT00596362|Growth Substances|growth substances|mesh-ancestor
110461525|NCT00596362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110461526|NCT00596362|Growth Inhibitors|growth inhibitors|mesh-ancestor
110461527|NCT00907803|Tecovirimat|tecovirimat|mesh-list
110461528|NCT00907803|Antiviral Agents|antiviral agents|mesh-ancestor
110461529|NCT00907803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110461530|NCT00669994|Ciprofloxacin|ciprofloxacin|mesh-list
110461531|NCT00669994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110461532|NCT00669994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110461533|NCT00669994|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110461534|NCT00669994|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110461535|NCT00669994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110461536|NCT00669994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110461537|NCT00669994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110531877|NCT05343806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110531878|NCT05343806|Anesthetics|anesthetics|mesh-ancestor
110531879|NCT05343806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110531880|NCT05343806|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110531881|NCT05343806|Anticonvulsants|anticonvulsants|mesh-ancestor
110531882|NCT05343806|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110531883|NCT05343806|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110531884|NCT05343806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110186385|NCT05765305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110461538|NCT00669994|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110461539|NCT00669994|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110461540|NCT02790723|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
110461541|NCT02790723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110461542|NCT00676156|Thioctic Acid|thioctic acid|mesh-list
110461543|NCT00676156|Antioxidants|antioxidants|mesh-ancestor
110461544|NCT00676156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110461545|NCT00676156|Protective Agents|protective agents|mesh-ancestor
110461546|NCT00676156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110461547|NCT00676156|Vitamin B Complex|vitamin b complex|mesh-ancestor
110461549|NCT00676156|Micronutrients|micronutrients|mesh-ancestor
110461550|NCT00670150|Arsenic Trioxide|arsenic trioxide|mesh-list
110461551|NCT00670150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110461552|NCT00914017|Atorvastatin|atorvastatin|mesh-list
110461553|NCT00914017|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110461554|NCT00914017|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110461555|NCT00914017|Antimetabolites|antimetabolites|mesh-ancestor
110461556|NCT00914017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110461557|NCT00914017|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110461558|NCT00914017|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110461559|NCT00914017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110461560|NCT00671320|Diclofenac|diclofenac|mesh-list
110461561|NCT00671320|Valdecoxib|valdecoxib|mesh-list
110461562|NCT00671320|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110461563|NCT00671320|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110461564|NCT00671320|Analgesics|analgesics|mesh-ancestor
110461565|NCT00671320|Sensory System Agents|sensory system agents|mesh-ancestor
110461566|NCT00671320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110461567|NCT00671320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110306728|NCT00300222|Capsaicin|capsaicin|mesh-list
110461569|NCT00671320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110461570|NCT00671320|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110461571|NCT00671320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110461572|NCT00671320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110461573|NCT00671320|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110461574|NCT00676468|Montelukast|montelukast|mesh-list
110461575|NCT00676468|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110461576|NCT00676468|Respiratory System Agents|respiratory system agents|mesh-ancestor
110461577|NCT00676468|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110461578|NCT00676468|Hormone Antagonists|hormone antagonists|mesh-ancestor
110461579|NCT00676468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110461580|NCT00676468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110461581|NCT00676468|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110461582|NCT00676468|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110461583|NCT00676468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110461584|NCT00591253|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
110461585|NCT00591253|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110461586|NCT00591253|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110461587|NCT00591253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110461588|NCT00676702|Vitamin K|vitamin k|mesh-list
110461589|NCT00676702|Pancrelipase|pancrelipase|mesh-list
110461591|NCT00676702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110461592|NCT00676702|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110461593|NCT00676702|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110531885|NCT05343806|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110531887|NCT05343806|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110531888|NCT05343806|Vasodilator Agents|vasodilator agents|mesh-ancestor
110531889|NCT05343728|Hemostatics|hemostatics|mesh-list
110531890|NCT05343728|Coagulants|coagulants|mesh-ancestor
110531891|NCT00436748|Darbepoetin alfa|darbepoetin alfa|mesh-list
110531892|NCT00436748|Hematinics|hematinics|mesh-ancestor
110531893|NCT02704598|Warfarin|warfarin|mesh-list
110531894|NCT02704598|Rivaroxaban|rivaroxaban|mesh-list
110531895|NCT02704598|Anticoagulants|anticoagulants|mesh-ancestor
110186452|NCT05706727|Sympathomimetics|sympathomimetics|mesh-ancestor
110461594|NCT00676702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110461595|NCT00676702|Hemostatics|hemostatics|mesh-ancestor
110461596|NCT00676702|Coagulants|coagulants|mesh-ancestor
110461597|NCT00676702|Vitamins|vitamins|mesh-ancestor
110461598|NCT00676702|Micronutrients|micronutrients|mesh-ancestor
110461599|NCT00676702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110461600|NCT05753371|Metformin|metformin|mesh-list
110461601|NCT05753371|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110461602|NCT05753371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110461603|NCT00671476|Doxorubicin|doxorubicin|mesh-list
110461604|NCT00671476|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110461605|NCT00671476|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110461606|NCT00671476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110461607|NCT00671476|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110461608|NCT00671476|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110461609|NCT00671476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110461610|NCT00671476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110461611|NCT00908583|Methylprednisolone|methylprednisolone|mesh-list
110461612|NCT00908583|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110461613|NCT00908583|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110461614|NCT00908583|Prednisolone|prednisolone|mesh-list
110461615|NCT00908583|Prednisolone acetate|prednisolone acetate|mesh-list
110461616|NCT00908583|Rituximab|rituximab|mesh-list
110461617|NCT00908583|Bortezomib|bortezomib|mesh-list
110461618|NCT00908583|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110461619|NCT00908583|Prednisolone phosphate|prednisolone phosphate|mesh-list
110461620|NCT00908583|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110461621|NCT00908583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110461622|NCT00908583|Immunologic Factors|immunologic factors|mesh-ancestor
110461623|NCT00908583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110461624|NCT00908583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110461625|NCT00908583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110461626|NCT00908583|Antiemetics|antiemetics|mesh-ancestor
110461627|NCT00908583|Autonomic Agents|autonomic agents|mesh-ancestor
110461628|NCT00908583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110461629|NCT00908583|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110461630|NCT00908583|Glucocorticoids|glucocorticoids|mesh-ancestor
110461631|NCT00908583|Hormones|hormones|mesh-ancestor
110461632|NCT00908583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110461633|NCT00908583|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110461634|NCT00908583|Protective Agents|protective agents|mesh-ancestor
110306790|NCT00264251|Rosiglitazone|rosiglitazone|mesh-list
110461637|NCT05519241|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110461638|NCT05519241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110461639|NCT05519241|Tubulin Modulators|tubulin modulators|mesh-ancestor
110461640|NCT05519241|Antimitotic Agents|antimitotic agents|mesh-ancestor
110461641|NCT05519241|Mitosis Modulators|mitosis modulators|mesh-ancestor
110461642|NCT05519241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110461643|NCT00671632|Triazolam|triazolam|mesh-list
110461644|NCT00671632|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110461645|NCT00671632|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110461646|NCT00671632|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110461647|NCT00671632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110461648|NCT00671632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110461649|NCT00671632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110531897|NCT02704598|Antithrombins|antithrombins|mesh-ancestor
110531898|NCT02704598|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110531899|NCT02704598|Protease Inhibitors|protease inhibitors|mesh-ancestor
110531900|NCT02704598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110531901|NCT02704598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110461650|NCT00671632|GABA Modulators|gaba modulators|mesh-ancestor
110461651|NCT00671632|GABA Agents|gaba agents|mesh-ancestor
110461652|NCT00671632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110461653|NCT00671632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110461654|NCT04153708|Antibodies|antibodies|mesh-list
110461655|NCT04153708|Immunoglobulins|immunoglobulins|mesh-list
110461656|NCT04153708|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
110461657|NCT04153708|Immunologic Factors|immunologic factors|mesh-ancestor
110461658|NCT04153708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110461659|NCT00676936|Methylprednisolone|methylprednisolone|mesh-list
110461660|NCT00676936|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110108759|NCT01820832|Calcitriol|calcitriol|mesh-list
110461661|NCT00676936|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110461662|NCT00676936|Prednisolone|prednisolone|mesh-list
110461663|NCT00676936|Prednisolone acetate|prednisolone acetate|mesh-list
110461664|NCT00676936|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110461665|NCT00676936|Prednisolone phosphate|prednisolone phosphate|mesh-list
110461666|NCT00676936|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110461667|NCT00676936|Antiemetics|antiemetics|mesh-ancestor
110461668|NCT00676936|Autonomic Agents|autonomic agents|mesh-ancestor
110461669|NCT00676936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110461670|NCT00676936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110461671|NCT00676936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110461672|NCT00676936|Glucocorticoids|glucocorticoids|mesh-ancestor
110461673|NCT00676936|Hormones|hormones|mesh-ancestor
110461674|NCT00676936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110461675|NCT00676936|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110461676|NCT00676936|Protective Agents|protective agents|mesh-ancestor
110461677|NCT00676936|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110461678|NCT00676936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110461679|NCT02629744|Etrolizumab|etrolizumab|mesh-list
110461680|NCT02629744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110461681|NCT02629744|Immunologic Factors|immunologic factors|mesh-ancestor
110461682|NCT02629744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110461683|NCT00677170|Pevonedistat|pevonedistat|mesh-list
110461684|NCT00677170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110306853|NCT00264446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110461685|NCT00677170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110461686|NCT00908349|Oxcarbazepine|oxcarbazepine|mesh-list
110461687|NCT00908349|Anticonvulsants|anticonvulsants|mesh-ancestor
110461688|NCT00908349|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110461689|NCT00908349|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110461690|NCT00908349|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110461691|NCT00908349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110461692|NCT00908349|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110461693|NCT00908349|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110461694|NCT01125566|Trastuzumab|trastuzumab|mesh-list
110461695|NCT01125566|Vinorelbine|vinorelbine|mesh-list
110461696|NCT01125566|Afatinib|afatinib|mesh-list
110461697|NCT01125566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110461698|NCT01125566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110461699|NCT01125566|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110461700|NCT01125566|Tubulin Modulators|tubulin modulators|mesh-ancestor
110461701|NCT01125566|Antimitotic Agents|antimitotic agents|mesh-ancestor
110461702|NCT01125566|Mitosis Modulators|mitosis modulators|mesh-ancestor
110461703|NCT01125566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110461704|NCT01125566|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110461705|NCT01125566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110461706|NCT04031872|Capecitabine|capecitabine|mesh-list
110461707|NCT04031872|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110461708|NCT04031872|Antimetabolites|antimetabolites|mesh-ancestor
110461709|NCT04031872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110461710|NCT04031872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110531902|NCT03342404|Luspatercept|luspatercept|mesh-list
110531903|NCT03342404|Hematinics|hematinics|mesh-ancestor
110531904|NCT03094052|Trastuzumab|trastuzumab|mesh-list
110531905|NCT03094052|Atropine|atropine|mesh-list
110531906|NCT03094052|Diphenoxylate|diphenoxylate|mesh-list
110531907|NCT03094052|Loperamide|loperamide|mesh-list
110531908|NCT03094052|Antidiarrheals|antidiarrheals|mesh-list
110531909|NCT03094052|Atropine sulfate-diphenoxylate hydrochloride drug combination|atropine sulfate-diphenoxylate hydrochloride drug combination|mesh-list
110531910|NCT03094052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110531911|NCT03094052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110531912|NCT03094052|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110531913|NCT03094052|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110531914|NCT03094052|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110531915|NCT03094052|Autonomic Agents|autonomic agents|mesh-ancestor
110461711|NCT00670696|Tetracaine|tetracaine|mesh-list
110461712|NCT00670696|Anesthetics, Local|anesthetics, local|mesh-ancestor
110461713|NCT00670696|Anesthetics|anesthetics|mesh-ancestor
110461714|NCT00670696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110461715|NCT00670696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110461716|NCT00670696|Sensory System Agents|sensory system agents|mesh-ancestor
110461717|NCT00670696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110461718|NCT00677248|Ezetimibe|ezetimibe|mesh-list
110461719|NCT00677248|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110461720|NCT00677248|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110461721|NCT00677248|Antimetabolites|antimetabolites|mesh-ancestor
110461722|NCT00677248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110461723|NCT00677248|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110461724|NCT00671710|Aminolevulinic Acid|aminolevulinic acid|mesh-list
110461725|NCT00671710|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110461726|NCT00671710|Dermatologic Agents|dermatologic agents|mesh-ancestor
110461727|NCT00671008|Insulin|insulin|mesh-list
110461728|NCT00671008|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110461729|NCT00671008|Insulin Aspart|insulin aspart|mesh-list
110461730|NCT00671008|Insulin Detemir|insulin detemir|mesh-list
110461731|NCT00671008|Biphasic Insulins|biphasic insulins|mesh-list
110461732|NCT00671008|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
110461733|NCT00671008|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110461734|NCT00671008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110461735|NCT00911716|Cyclophosphamide|cyclophosphamide|mesh-list
110461736|NCT00911716|Bevacizumab|bevacizumab|mesh-list
110461737|NCT00911716|Docetaxel|docetaxel|mesh-list
110461738|NCT00911716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110461739|NCT00911716|Immunologic Factors|immunologic factors|mesh-ancestor
110461740|NCT00911716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110461741|NCT00911716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110461742|NCT00911716|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110461743|NCT00911716|Alkylating Agents|alkylating agents|mesh-ancestor
110461744|NCT00911716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110461745|NCT00911716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110461746|NCT00911716|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110461747|NCT00911716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110461748|NCT00911716|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110461749|NCT00911716|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110461750|NCT00911716|Growth Substances|growth substances|mesh-ancestor
110461751|NCT00911716|Growth Inhibitors|growth inhibitors|mesh-ancestor
110461752|NCT00911716|Tubulin Modulators|tubulin modulators|mesh-ancestor
110461753|NCT00911716|Antimitotic Agents|antimitotic agents|mesh-ancestor
110461754|NCT00911716|Mitosis Modulators|mitosis modulators|mesh-ancestor
110461756|NCT00595582|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110461757|NCT00595582|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110461758|NCT00595582|Analgesics|analgesics|mesh-ancestor
110461759|NCT00595582|Sensory System Agents|sensory system agents|mesh-ancestor
110461760|NCT00595582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110531916|NCT03094052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110531917|NCT03094052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110531918|NCT03094052|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110531919|NCT03094052|Respiratory System Agents|respiratory system agents|mesh-ancestor
110531920|NCT03094052|Mydriatics|mydriatics|mesh-ancestor
110531921|NCT03094052|Parasympatholytics|parasympatholytics|mesh-ancestor
110531922|NCT03094052|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110531923|NCT03094052|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110531924|NCT03094052|Cholinergic Agents|cholinergic agents|mesh-ancestor
110531925|NCT03094052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110186648|NCT05192850|Metformin|metformin|mesh-list
110461761|NCT00595582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110461762|NCT00595582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110461763|NCT00595582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110461764|NCT00595582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110461765|NCT00595582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110461766|NCT00595582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110461767|NCT00680446|Immunoglobulins|immunoglobulins|mesh-list
110461768|NCT00680446|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110461769|NCT00680446|Antibodies|antibodies|mesh-list
110461770|NCT00680446|Immunoglobulin G|immunoglobulin g|mesh-list
110461771|NCT00680446|Immunologic Factors|immunologic factors|mesh-ancestor
110461772|NCT00680446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110461773|NCT00672022|Miglustat|miglustat|mesh-list
110461774|NCT00672022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110461775|NCT00672022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110461776|NCT00672022|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110461777|NCT00672022|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110461778|NCT00672022|Antiviral Agents|antiviral agents|mesh-ancestor
110461779|NCT00672022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110461780|NCT00672022|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
110461781|NCT00672022|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110461782|NCT00672022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110461783|NCT00680602|Sertraline|sertraline|mesh-list
110461784|NCT00680602|Fluoxetine|fluoxetine|mesh-list
110461785|NCT00680602|Paroxetine|paroxetine|mesh-list
110461786|NCT00680602|Citalopram|citalopram|mesh-list
110461787|NCT00680602|Antidepressive Agents|antidepressive agents|mesh-ancestor
110461788|NCT00680602|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110461789|NCT00680602|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110461790|NCT00680602|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110461791|NCT00680602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110461792|NCT00680602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110461793|NCT00680602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110461794|NCT00680602|Serotonin Agents|serotonin agents|mesh-ancestor
110461795|NCT00680602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110461796|NCT00680602|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110461797|NCT00680602|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110461798|NCT00680602|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110461799|NCT00680602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110461800|NCT00680680|Dutasteride|dutasteride|mesh-list
110461801|NCT00680680|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
110461802|NCT00680680|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110461803|NCT00680680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110461804|NCT00680680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110461805|NCT00680680|Hormone Antagonists|hormone antagonists|mesh-ancestor
110461806|NCT00680680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110461807|NCT00680680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110461809|NCT00808015|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110461810|NCT00808015|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110461811|NCT00808015|Cholinergic Agents|cholinergic agents|mesh-ancestor
110461812|NCT00808015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110461813|NCT00808015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110531926|NCT03094052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110531927|NCT03094052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110531928|NCT03094052|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110531929|NCT03094052|Narcotics|narcotics|mesh-ancestor
110531930|NCT03094052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110531931|NCT03094052|Analgesics|analgesics|mesh-ancestor
110531932|NCT03094052|Sensory System Agents|sensory system agents|mesh-ancestor
110531933|NCT05343338|Sivelestat|sivelestat|mesh-list
110531934|NCT05343338|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110531935|NCT05343338|Protease Inhibitors|protease inhibitors|mesh-ancestor
110531936|NCT05343338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110531937|NCT05343338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110461814|NCT00808015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110461815|NCT00680758|Paclitaxel|paclitaxel|mesh-list
110461816|NCT00680758|Everolimus|everolimus|mesh-list
110461817|NCT00680758|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110461818|NCT00680758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110461819|NCT00680758|Tubulin Modulators|tubulin modulators|mesh-ancestor
110461820|NCT00680758|Antimitotic Agents|antimitotic agents|mesh-ancestor
110461821|NCT00680758|Mitosis Modulators|mitosis modulators|mesh-ancestor
110461822|NCT00680758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110461823|NCT00680758|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110461824|NCT00680758|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110461825|NCT00680758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110461826|NCT00680758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110461827|NCT00680758|Immunologic Factors|immunologic factors|mesh-ancestor
110461828|NCT00680758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110461829|NCT00678106|Dalbavancin|dalbavancin|mesh-list
110461830|NCT00678106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110461831|NCT00678106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110461832|NCT00810199|Methotrexate|methotrexate|mesh-list
110461833|NCT00810199|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110461834|NCT00810199|Abortifacient Agents|abortifacient agents|mesh-ancestor
110461835|NCT00810199|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110461836|NCT00810199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110461837|NCT00810199|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110461838|NCT00810199|Antimetabolites|antimetabolites|mesh-ancestor
110461839|NCT00810199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110461840|NCT00810199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110461841|NCT00810199|Dermatologic Agents|dermatologic agents|mesh-ancestor
110461842|NCT00810199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110461843|NCT00810199|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110461844|NCT00810199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110461845|NCT00810199|Immunologic Factors|immunologic factors|mesh-ancestor
110461846|NCT00810199|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110461847|NCT00810199|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110461848|NCT00877006|Prednisone|prednisone|mesh-list
110461849|NCT00877006|Cyclophosphamide|cyclophosphamide|mesh-list
110461850|NCT00877006|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110461851|NCT00877006|Rituximab|rituximab|mesh-list
110461852|NCT00877006|Doxorubicin|doxorubicin|mesh-list
110461853|NCT00877006|Vincristine|vincristine|mesh-list
110461854|NCT00877006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110461855|NCT00877006|Immunologic Factors|immunologic factors|mesh-ancestor
110461856|NCT00877006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110461857|NCT00877006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110461858|NCT00877006|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110461859|NCT00877006|Alkylating Agents|alkylating agents|mesh-ancestor
110461860|NCT00877006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110461861|NCT00877006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110461862|NCT00877006|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110461863|NCT00877006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110461864|NCT00877006|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110531938|NCT02704052|Enoxaparin|enoxaparin|mesh-list
110531939|NCT02704052|Enoxaparin sodium|enoxaparin sodium|mesh-list
110531940|NCT02704052|Anticoagulants|anticoagulants|mesh-ancestor
110531941|NCT02704052|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110531942|NCT02704052|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110531943|NCT02704052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110531944|NCT02703896|Esomeprazole|esomeprazole|mesh-list
110531945|NCT02703896|Omeprazole|omeprazole|mesh-list
110531946|NCT02703896|Pantoprazole|pantoprazole|mesh-list
110531947|NCT02703896|Lansoprazole|lansoprazole|mesh-list
110531948|NCT02703896|Famotidine|famotidine|mesh-list
110461865|NCT00877006|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110595095|NCT00581100|Immunologic Factors|immunologic factors|mesh-ancestor
110461866|NCT00877006|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110461867|NCT00877006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110461868|NCT00877006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110461869|NCT00877006|Glucocorticoids|glucocorticoids|mesh-ancestor
110461870|NCT00877006|Hormones|hormones|mesh-ancestor
110461871|NCT00877006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110461872|NCT00877006|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110461873|NCT00877006|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110461874|NCT00877006|Tubulin Modulators|tubulin modulators|mesh-ancestor
110461875|NCT00877006|Antimitotic Agents|antimitotic agents|mesh-ancestor
110461876|NCT00877006|Mitosis Modulators|mitosis modulators|mesh-ancestor
110461877|NCT00678184|Atorvastatin|atorvastatin|mesh-list
110461878|NCT00678184|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110461879|NCT00678184|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110461880|NCT00678184|Antimetabolites|antimetabolites|mesh-ancestor
110461881|NCT00678184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110461882|NCT00678184|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110461883|NCT00678184|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110461884|NCT00678184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110461885|NCT00876928|Vitamin D|vitamin d|mesh-list
110461886|NCT00876928|Vitamins|vitamins|mesh-ancestor
110461887|NCT00876928|Micronutrients|micronutrients|mesh-ancestor
110461888|NCT00876928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110461889|NCT00876928|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110461890|NCT02627950|Metoclopramide|metoclopramide|mesh-list
110461891|NCT02627950|Ticagrelor|ticagrelor|mesh-list
110461892|NCT02627950|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110461893|NCT02627950|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110461894|NCT02627950|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110461895|NCT02627950|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110461896|NCT02627950|Purinergic Agents|purinergic agents|mesh-ancestor
110461897|NCT02627950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110461898|NCT02627950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110461899|NCT02627950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110461900|NCT02627950|Antiemetics|antiemetics|mesh-ancestor
110461901|NCT02627950|Autonomic Agents|autonomic agents|mesh-ancestor
110461902|NCT02627950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110461903|NCT02627950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110461904|NCT02627950|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110461905|NCT02627950|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110461906|NCT02627950|Dopamine Agents|dopamine agents|mesh-ancestor
110461907|NCT00807937|Lorazepam|lorazepam|mesh-list
110461908|NCT00807937|Anticonvulsants|anticonvulsants|mesh-ancestor
110461909|NCT00807937|Antiemetics|antiemetics|mesh-ancestor
110461910|NCT00807937|Autonomic Agents|autonomic agents|mesh-ancestor
110461911|NCT00807937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110461912|NCT00807937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110461913|NCT00807937|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110461914|NCT00807937|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110461915|NCT00807937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110461916|NCT00807937|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110461917|NCT00807937|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110461918|NCT00807937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110461919|NCT00807937|GABA Modulators|gaba modulators|mesh-ancestor
110461920|NCT00807937|GABA Agents|gaba agents|mesh-ancestor
110032410|NCT05268627|Hormones|hormones|mesh-ancestor
110531949|NCT02703896|Ranitidine|ranitidine|mesh-list
110531950|NCT02703896|Cimetidine|cimetidine|mesh-list
110531951|NCT02703896|Nizatidine|nizatidine|mesh-list
110531952|NCT02703896|Lafutidine|lafutidine|mesh-list
110531953|NCT02703896|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110531954|NCT02703896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110531955|NCT02703896|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110186846|NCT04765709|Pemetrexed|pemetrexed|mesh-list
110461921|NCT00807937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110461922|NCT00807937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110461923|NCT00681148|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110461924|NCT00681148|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110461925|NCT00681148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110461926|NCT00681148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110461927|NCT00681148|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110461928|NCT00681148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110461929|NCT00681148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110461930|NCT00681148|Cholinergic Agents|cholinergic agents|mesh-ancestor
110461931|NCT00681148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110461932|NCT04935229|Nivolumab|nivolumab|mesh-list
110461933|NCT04935229|Ipilimumab|ipilimumab|mesh-list
110461934|NCT04935229|Relatlimab|relatlimab|mesh-list
110461935|NCT04935229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110461936|NCT04935229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110461937|NCT04935229|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110461938|NCT04935229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110461939|NCT00681226|Ramipril|ramipril|mesh-list
110461940|NCT00681226|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110461941|NCT00681226|Protease Inhibitors|protease inhibitors|mesh-ancestor
110461942|NCT00681226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110461943|NCT00681226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110461944|NCT00681226|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110461945|NCT00678964|Carboplatin|carboplatin|mesh-list
110461946|NCT00678964|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110461947|NCT00678964|Vinorelbine|vinorelbine|mesh-list
110461948|NCT00678964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110461949|NCT00678964|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110461950|NCT00678964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110461951|NCT00678964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110461952|NCT00678964|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110461953|NCT00678964|Tubulin Modulators|tubulin modulators|mesh-ancestor
110461954|NCT00678964|Antimitotic Agents|antimitotic agents|mesh-ancestor
110461955|NCT00678964|Mitosis Modulators|mitosis modulators|mesh-ancestor
110461956|NCT02627248|Cyclophosphamide|cyclophosphamide|mesh-list
110461957|NCT02627248|Docetaxel|docetaxel|mesh-list
110461958|NCT02627248|Epirubicin|epirubicin|mesh-list
110461959|NCT02627248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110461960|NCT02627248|Immunologic Factors|immunologic factors|mesh-ancestor
110461961|NCT02627248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110461962|NCT02627248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110461963|NCT02627248|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110461964|NCT02627248|Alkylating Agents|alkylating agents|mesh-ancestor
110461965|NCT02627248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110461966|NCT02627248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110461967|NCT02627248|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110461968|NCT02627248|Tubulin Modulators|tubulin modulators|mesh-ancestor
110461969|NCT02627248|Antimitotic Agents|antimitotic agents|mesh-ancestor
110461970|NCT02627248|Mitosis Modulators|mitosis modulators|mesh-ancestor
110461971|NCT02627248|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110461972|NCT02627248|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110461973|NCT02627248|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110461974|NCT02627248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110461976|NCT03993535|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
110461977|NCT03993535|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110461978|NCT03993535|Serotonin Agents|serotonin agents|mesh-ancestor
110461979|NCT03993535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110461980|NCT03993535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110461981|NCT03993535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110531956|NCT02703896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110531957|NCT02703896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110531958|NCT02703896|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110531959|NCT02703896|Histamine Antagonists|histamine antagonists|mesh-ancestor
110531960|NCT02703896|Histamine Agents|histamine agents|mesh-ancestor
110531961|NCT02703896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110531962|NCT02703896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110531963|NCT02703896|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110531964|NCT02703896|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110531965|NCT02737436|Oxytocin|oxytocin|mesh-list
110531966|NCT02737436|Oxytocics|oxytocics|mesh-ancestor
110531967|NCT02737436|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110531968|NCT02737436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110461996|NCT00912262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110461997|NCT00912262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110461998|NCT00906945|Cytarabine|cytarabine|mesh-list
110461999|NCT00906945|Plerixafor|plerixafor|mesh-list
110462000|NCT00906945|Etoposide|etoposide|mesh-list
110462001|NCT00906945|Mitoxantrone|mitoxantrone|mesh-list
110462002|NCT00906945|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110462003|NCT00906945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110462004|NCT00906945|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110462005|NCT00906945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110462006|NCT00906945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110462007|NCT00906945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110462008|NCT00906945|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110462009|NCT00906945|Antimetabolites|antimetabolites|mesh-ancestor
110462010|NCT00906945|Antiviral Agents|antiviral agents|mesh-ancestor
110462011|NCT00906945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110462012|NCT00906945|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110462013|NCT00906945|Immunologic Factors|immunologic factors|mesh-ancestor
110462014|NCT00906945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110462015|NCT00906945|Analgesics|analgesics|mesh-ancestor
110462016|NCT00906945|Sensory System Agents|sensory system agents|mesh-ancestor
110462017|NCT00906945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110462018|NCT00906945|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110462019|NCT00906945|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110462020|NCT00807235|Pulmonary Surfactants|pulmonary surfactants|mesh-list
110462021|NCT00807235|Respiratory System Agents|respiratory system agents|mesh-ancestor
110462022|NCT02627560|Tranexamic Acid|tranexamic acid|mesh-list
110462023|NCT02627560|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110462024|NCT02627560|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110462025|NCT02627560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110462026|NCT02627560|Hemostatics|hemostatics|mesh-ancestor
110462027|NCT02627560|Coagulants|coagulants|mesh-ancestor
110462028|NCT00681460|Metformin|metformin|mesh-list
110462029|NCT00681460|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110462030|NCT00681460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110462031|NCT00876694|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110462032|NCT00876694|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110462033|NCT00876694|Autonomic Agents|autonomic agents|mesh-ancestor
110462034|NCT00876694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110462035|NCT00876694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110462036|NCT00876694|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110462037|NCT00876694|Respiratory System Agents|respiratory system agents|mesh-ancestor
110462038|NCT00876694|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110462039|NCT00876694|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110462040|NCT00876694|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110462041|NCT00876694|Adrenergic Agents|adrenergic agents|mesh-ancestor
110462042|NCT00876694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110595136|NCT02577432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110462043|NCT00876694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110531969|NCT00614978|Temozolomide|temozolomide|mesh-list
110531970|NCT00614978|Lapatinib|lapatinib|mesh-list
110531971|NCT00614978|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110531972|NCT00614978|Alkylating Agents|alkylating agents|mesh-ancestor
110531973|NCT00614978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110531974|NCT00614978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110531975|NCT00614978|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110462075|NCT00590317|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110462076|NCT00590317|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110462077|NCT00590317|Serotonin Agents|serotonin agents|mesh-ancestor
110462078|NCT00590317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110462079|NCT00590317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110462080|NCT00590317|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110462081|NCT00590317|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110462082|NCT00590317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110462083|NCT00590317|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110462084|NCT00590317|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110462085|NCT00590317|Dopamine Agents|dopamine agents|mesh-ancestor
110462086|NCT01139762|Tadalafil|tadalafil|mesh-list
110462087|NCT01139762|Finasteride|finasteride|mesh-list
110462088|NCT01139762|Vasodilator Agents|vasodilator agents|mesh-ancestor
110462089|NCT01139762|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110462090|NCT01139762|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110462091|NCT01139762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110462092|NCT01139762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110462093|NCT01139762|Urological Agents|urological agents|mesh-ancestor
110462094|NCT01139762|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
110462095|NCT01139762|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110462096|NCT01139762|Hormone Antagonists|hormone antagonists|mesh-ancestor
110462097|NCT01139762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110462098|NCT01139762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110462099|NCT00805285|Budesonide|budesonide|mesh-list
110462100|NCT00805285|Hydrocortisone|hydrocortisone|mesh-list
110462101|NCT00805285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110462102|NCT00805285|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110462103|NCT00805285|Autonomic Agents|autonomic agents|mesh-ancestor
110462104|NCT00805285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110462105|NCT00805285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110462106|NCT00805285|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110462107|NCT00805285|Respiratory System Agents|respiratory system agents|mesh-ancestor
110462108|NCT00805285|Glucocorticoids|glucocorticoids|mesh-ancestor
110462109|NCT00805285|Hormones|hormones|mesh-ancestor
110462110|NCT00805285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110462111|NCT02606773|Ascorbic Acid|ascorbic acid|mesh-list
110462112|NCT02606773|Antioxidants|antioxidants|mesh-ancestor
110109210|NCT01823848|Mineral Oil|mineral oil|mesh-list
110462113|NCT02606773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110462115|NCT02606773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110462116|NCT02606773|Vitamins|vitamins|mesh-ancestor
110462117|NCT02606773|Micronutrients|micronutrients|mesh-ancestor
110462118|NCT04310774|Tegafur|tegafur|mesh-list
110462119|NCT04310774|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110462120|NCT04310774|Antimetabolites|antimetabolites|mesh-ancestor
110462121|NCT04310774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110462122|NCT04310774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110462123|NCT01139450|Tacrolimus|tacrolimus|mesh-list
110462124|NCT01139450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110462125|NCT01139450|Immunologic Factors|immunologic factors|mesh-ancestor
110462126|NCT01139450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110462127|NCT01139450|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110462128|NCT01139450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110462129|NCT01139450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110462130|NCT00805207|Estradiol|estradiol|mesh-list
110462131|NCT00805207|Estrogens|estrogens|mesh-list
110462132|NCT00805207|Testosterone|testosterone|mesh-list
110462133|NCT00805207|Progesterone|progesterone|mesh-list
110462134|NCT00805207|Glucocorticoids|glucocorticoids|mesh-list
110531976|NCT00614978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110531977|NCT03188354|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110531978|NCT03188354|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110531979|NCT03188354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110531980|NCT02703740|Lidocaine|lidocaine|mesh-list
110531981|NCT02703740|Hyaluronic Acid|hyaluronic acid|mesh-list
110179457|NCT00011297|Gabapentin|gabapentin|mesh-list
110531982|NCT02703740|Anesthetics, Local|anesthetics, local|mesh-ancestor
110531983|NCT02703740|Anesthetics|anesthetics|mesh-ancestor
110187045|NCT04202835|Thymoglobulin|thymoglobulin|mesh-list
110462135|NCT00805207|Hormones|hormones|mesh-ancestor
110462136|NCT00805207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110462137|NCT00805207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110462138|NCT00805207|Androgens|androgens|mesh-ancestor
110462139|NCT00805207|Progestins|progestins|mesh-ancestor
110462140|NCT00805675|Tenofovir|tenofovir|mesh-list
110462141|NCT00805675|Telbivudine|telbivudine|mesh-list
110462142|NCT00805675|Antiviral Agents|antiviral agents|mesh-ancestor
110462143|NCT00805675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110462144|NCT00805675|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110462145|NCT00805675|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110462146|NCT00805675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110462147|NCT00805675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110462148|NCT00805675|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110462149|NCT00805675|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110462150|NCT03958201|Rocuronium|rocuronium|mesh-list
110462151|NCT03958201|Neostigmine|neostigmine|mesh-list
110462152|NCT03958201|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110462153|NCT03958201|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110462154|NCT03958201|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110462155|NCT03958201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110462156|NCT03958201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110462157|NCT03958201|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110462158|NCT03958201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110462159|NCT03958201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110462160|NCT03958201|Cholinergic Agents|cholinergic agents|mesh-ancestor
110462161|NCT03958201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110462162|NCT03958201|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110462163|NCT03958201|Autonomic Agents|autonomic agents|mesh-ancestor
110462164|NCT00589303|Metoprolol|metoprolol|mesh-list
110462165|NCT00589303|Amiodarone|amiodarone|mesh-list
110462166|NCT00589303|Verapamil|verapamil|mesh-list
110462167|NCT00589303|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110462168|NCT00589303|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110462169|NCT00589303|Sympatholytics|sympatholytics|mesh-ancestor
110462170|NCT00589303|Autonomic Agents|autonomic agents|mesh-ancestor
110462171|NCT00589303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110462172|NCT00589303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110462173|NCT00589303|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110462174|NCT00589303|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110462175|NCT00589303|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110462176|NCT00589303|Adrenergic Agents|adrenergic agents|mesh-ancestor
110462177|NCT00589303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110462178|NCT00589303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110462179|NCT00589303|Vasodilator Agents|vasodilator agents|mesh-ancestor
110462180|NCT00589303|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
110462181|NCT00589303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110462182|NCT00589303|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110462183|NCT00589303|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110462184|NCT00589303|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110462185|NCT00589303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110307181|NCT00266123|Sirolimus|sirolimus|mesh-list
110462186|NCT00589303|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110462187|NCT00589303|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110462188|NCT00589303|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110462189|NCT00589303|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110531984|NCT02703740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110531985|NCT02703740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110531986|NCT02703740|Sensory System Agents|sensory system agents|mesh-ancestor
110531987|NCT02703740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110531988|NCT02703740|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110531989|NCT02703740|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110531990|NCT02703740|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110531991|NCT02703740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110531992|NCT02703740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110531993|NCT02703740|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110531994|NCT02703740|Immunologic Factors|immunologic factors|mesh-ancestor
110531995|NCT02703740|Viscosupplements|viscosupplements|mesh-ancestor
110531996|NCT02703740|Protective Agents|protective agents|mesh-ancestor
110531998|NCT00615368|Hematinics|hematinics|mesh-ancestor
110462190|NCT00589303|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110462191|NCT02607943|Insulin|insulin|mesh-list
110462192|NCT02607943|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110462193|NCT02607943|Insulin Glargine|insulin glargine|mesh-list
110462194|NCT02607943|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110462195|NCT02607943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110462196|NCT02606617|Mosapride|mosapride|mesh-list
110462197|NCT02606617|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110462198|NCT02606617|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110462199|NCT02606617|Serotonin Agents|serotonin agents|mesh-ancestor
110462200|NCT02606617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110462201|NCT02606617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110462202|NCT02606617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110462203|NCT00914095|Methylphenidate|methylphenidate|mesh-list
110462204|NCT00914095|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110462205|NCT00914095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110462206|NCT00914095|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110462207|NCT00914095|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110462208|NCT00914095|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110462209|NCT00914095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110462210|NCT00914095|Dopamine Agents|dopamine agents|mesh-ancestor
110462211|NCT00914095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110462212|NCT03903835|Prednisone|prednisone|mesh-list
110462213|NCT03903835|Carboplatin|carboplatin|mesh-list
110462214|NCT03903835|Docetaxel|docetaxel|mesh-list
110462215|NCT03903835|Abiraterone Acetate|abiraterone acetate|mesh-list
110462216|NCT03903835|Niraparib|niraparib|mesh-list
110462217|NCT03903835|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
110462218|NCT03903835|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110462219|NCT03903835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110462220|NCT03903835|Tubulin Modulators|tubulin modulators|mesh-ancestor
110462221|NCT03903835|Antimitotic Agents|antimitotic agents|mesh-ancestor
110462222|NCT03903835|Mitosis Modulators|mitosis modulators|mesh-ancestor
110462223|NCT03903835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110462224|NCT03903835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110462225|NCT03903835|Glucocorticoids|glucocorticoids|mesh-ancestor
110462226|NCT03903835|Hormones|hormones|mesh-ancestor
110462227|NCT03903835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110462228|NCT03903835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110462229|NCT03903835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110462230|NCT03903835|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110462231|NCT03903835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110462232|NCT03903835|Hormone Antagonists|hormone antagonists|mesh-ancestor
110531999|NCT00615446|Gemcitabine|gemcitabine|mesh-list
110532001|NCT00615446|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110532002|NCT00615446|Antimetabolites|antimetabolites|mesh-ancestor
110532003|NCT00615446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110532004|NCT00615446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110532005|NCT00615446|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110532006|NCT00615446|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110532007|NCT00615446|Growth Substances|growth substances|mesh-ancestor
110532008|NCT00615446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110532009|NCT00615446|Growth Inhibitors|growth inhibitors|mesh-ancestor
110187175|NCT03878082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110462233|NCT03903835|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110462234|NCT03903835|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110462235|NCT05745337|Metoprolol|metoprolol|mesh-list
110462236|NCT05745337|Verapamil|verapamil|mesh-list
110462237|NCT05745337|Diltiazem|diltiazem|mesh-list
110462238|NCT05745337|Calcium Channel Blockers|calcium channel blockers|mesh-list
110462239|NCT05745337|Calcium|calcium|mesh-list
110462240|NCT05745337|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
110462241|NCT05745337|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110462242|NCT05745337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110462243|NCT05745337|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110462244|NCT05745337|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110462245|NCT05745337|Sympatholytics|sympatholytics|mesh-ancestor
110462246|NCT05745337|Autonomic Agents|autonomic agents|mesh-ancestor
110462247|NCT05745337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110462248|NCT05745337|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110462249|NCT05745337|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110462250|NCT05745337|Adrenergic Agents|adrenergic agents|mesh-ancestor
110462251|NCT05745337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110462252|NCT05745337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110462253|NCT05745337|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110462254|NCT05745337|Vasodilator Agents|vasodilator agents|mesh-ancestor
110462255|NCT00952380|Dalteparin|dalteparin|mesh-list
110462256|NCT00952380|Tinzaparin|tinzaparin|mesh-list
110462257|NCT00952380|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
110462258|NCT00952380|Anticoagulants|anticoagulants|mesh-ancestor
110462259|NCT00952380|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110462260|NCT00952380|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110109394|NCT01825083|Ketamine|ketamine|mesh-list
110462261|NCT00952380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110462262|NCT03859921|Dydrogesterone|dydrogesterone|mesh-list
110462263|NCT03859921|Progestins|progestins|mesh-ancestor
110462264|NCT03859921|Hormones|hormones|mesh-ancestor
110462265|NCT03859921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110462266|NCT03859921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110462267|NCT02856750|Gabapentin|gabapentin|mesh-list
110462268|NCT02856750|Analgesics|analgesics|mesh-ancestor
110462269|NCT02856750|Sensory System Agents|sensory system agents|mesh-ancestor
110462270|NCT02856750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110462271|NCT02856750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110462272|NCT02856750|Anticonvulsants|anticonvulsants|mesh-ancestor
110462273|NCT02856750|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110462274|NCT02856750|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110462275|NCT02856750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110462276|NCT02856750|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110462277|NCT02856750|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110462278|NCT02856750|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110462279|NCT02856750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110462280|NCT02856750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110462281|NCT02856750|Antimanic Agents|antimanic agents|mesh-ancestor
110462282|NCT05751967|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
110462283|NCT05751967|Fenofibrate|fenofibrate|mesh-list
110462284|NCT05751967|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110532010|NCT00615446|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110532011|NCT00615446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110532012|NCT02703272|Dexamethasone|dexamethasone|mesh-list
110532013|NCT02703272|Rituximab|rituximab|mesh-list
110532014|NCT02703272|Carboplatin|carboplatin|mesh-list
110532015|NCT02703272|Etoposide|etoposide|mesh-list
110532016|NCT02703272|Vincristine|vincristine|mesh-list
110532017|NCT02703272|Ifosfamide|ifosfamide|mesh-list
110532018|NCT02703272|Idarubicin|idarubicin|mesh-list
110532019|NCT02703272|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110187236|NCT03356873|Ergocalciferols|ergocalciferols|mesh-list
110462285|NCT05751967|Antimetabolites|antimetabolites|mesh-ancestor
110462286|NCT05751967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110462287|NCT05751967|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110462288|NCT05751967|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
110462289|NCT05751967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110462290|NCT02857920|Bevacizumab|bevacizumab|mesh-list
110462291|NCT02857920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110462292|NCT02857920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110462293|NCT02857920|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110462294|NCT02857920|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110462295|NCT02857920|Growth Substances|growth substances|mesh-ancestor
110462296|NCT02857920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110462297|NCT02857920|Growth Inhibitors|growth inhibitors|mesh-ancestor
110462298|NCT02607631|Pembrolizumab|pembrolizumab|mesh-list
110462299|NCT02607631|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110462300|NCT02607631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110462301|NCT02607631|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110462302|NCT02607631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110462303|NCT02857842|Prednisolone|prednisolone|mesh-list
110462304|NCT02857842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110462305|NCT02857842|Glucocorticoids|glucocorticoids|mesh-ancestor
110462306|NCT02857842|Hormones|hormones|mesh-ancestor
110462307|NCT02857842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110462308|NCT02857842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110462309|NCT02857842|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110462310|NCT02857842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110462311|NCT03635437|Alprazolam|alprazolam|mesh-list
110462312|NCT03635437|gamma-Aminobutyric Acid|gamma-aminobutyric acid|mesh-list
110462313|NCT03635437|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110462314|NCT03635437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110462315|NCT03635437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110462316|NCT03635437|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110462317|NCT03635437|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110462318|NCT03635437|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110462319|NCT03635437|GABA Modulators|gaba modulators|mesh-ancestor
110462320|NCT03635437|GABA Agents|gaba agents|mesh-ancestor
110462321|NCT03635437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110462322|NCT03635437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110462323|NCT00803179|Hormones|hormones|mesh-list
110595195|NCT00794859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110462324|NCT00803179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110462325|NCT00803179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110462326|NCT00804193|Ciclopirox|ciclopirox|mesh-list
110462327|NCT00804193|Antifungal Agents|antifungal agents|mesh-ancestor
110462328|NCT00804193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110462329|NCT05697211|Ferric maltol|ferric maltol|mesh-list
110462330|NCT05697211|Hematinics|hematinics|mesh-ancestor
110462331|NCT00957996|Peramivir|peramivir|mesh-list
110462332|NCT00957996|Antiviral Agents|antiviral agents|mesh-ancestor
110462333|NCT00957996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110462334|NCT00957996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110109467|NCT01825616|Vitamin D|vitamin d|mesh-list
110462335|NCT00957996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110462336|NCT02606539|Leucovorin|leucovorin|mesh-list
110462337|NCT02606539|Folic Acid|folic acid|mesh-list
110462338|NCT02606539|Methotrexate|methotrexate|mesh-list
110462339|NCT02606539|Levoleucovorin|levoleucovorin|mesh-list
110462340|NCT02606539|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110532020|NCT02703272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110532022|NCT02703272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110532023|NCT02703272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110532024|NCT02703272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110532025|NCT02703272|Antiemetics|antiemetics|mesh-ancestor
110532026|NCT02703272|Autonomic Agents|autonomic agents|mesh-ancestor
110532027|NCT02703272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110532028|NCT02703272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110532029|NCT02703272|Glucocorticoids|glucocorticoids|mesh-ancestor
110532030|NCT02703272|Hormones|hormones|mesh-ancestor
110187308|NCT03017131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110462341|NCT02606539|Abortifacient Agents|abortifacient agents|mesh-ancestor
110462342|NCT02606539|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110462343|NCT02606539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110462344|NCT02606539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110462345|NCT02606539|Antimetabolites|antimetabolites|mesh-ancestor
110462346|NCT02606539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110462347|NCT02606539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110462348|NCT02606539|Dermatologic Agents|dermatologic agents|mesh-ancestor
110462349|NCT02606539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110462350|NCT02606539|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110462351|NCT02606539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110462352|NCT02606539|Immunologic Factors|immunologic factors|mesh-ancestor
110462353|NCT02606539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110462354|NCT02606539|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110462356|NCT02606539|Protective Agents|protective agents|mesh-ancestor
110462357|NCT02606539|Vitamin B Complex|vitamin b complex|mesh-ancestor
110462358|NCT02606539|Vitamins|vitamins|mesh-ancestor
110462359|NCT02606539|Micronutrients|micronutrients|mesh-ancestor
110462360|NCT02606539|Hematinics|hematinics|mesh-ancestor
110462361|NCT00589693|Imipenem|imipenem|mesh-list
110462362|NCT00589693|Doripenem|doripenem|mesh-list
110462363|NCT00589693|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
110462364|NCT00589693|Cilastatin|cilastatin|mesh-list
110462365|NCT00589693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110462366|NCT00589693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110462367|NCT00589693|Protease Inhibitors|protease inhibitors|mesh-ancestor
110462368|NCT00589693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110462369|NCT00589693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110462371|NCT02606383|Antifungal Agents|antifungal agents|mesh-ancestor
110462372|NCT02606383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110462373|NCT02606383|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110462374|NCT02606383|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110462375|NCT02606383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110462376|NCT02606383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110462377|NCT02606383|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110462378|NCT02606383|Hormone Antagonists|hormone antagonists|mesh-ancestor
110462379|NCT02606383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110462380|NCT02606383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110462381|NCT02606383|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110462382|NCT05660473|Cytarabine|cytarabine|mesh-list
110462383|NCT05660473|Dexamethasone|dexamethasone|mesh-list
110462384|NCT05660473|Prednisone|prednisone|mesh-list
110462385|NCT05660473|Cyclophosphamide|cyclophosphamide|mesh-list
110462386|NCT05660473|Methotrexate|methotrexate|mesh-list
110462387|NCT05660473|Vincristine|vincristine|mesh-list
110462388|NCT05660473|Daunorubicin|daunorubicin|mesh-list
110462389|NCT05660473|Venetoclax|venetoclax|mesh-list
110462390|NCT05660473|Mercaptopurine|mercaptopurine|mesh-list
110462391|NCT05660473|Pegaspargase|pegaspargase|mesh-list
110462392|NCT05660473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110462393|NCT05660473|Immunologic Factors|immunologic factors|mesh-ancestor
110462394|NCT05660473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110462395|NCT05660473|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110462396|NCT05660473|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110532031|NCT02703272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110532032|NCT02703272|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110532033|NCT02703272|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110532034|NCT02703272|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110532035|NCT02703272|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110532036|NCT02703272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110532037|NCT02703272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110462397|NCT05660473|Alkylating Agents|alkylating agents|mesh-ancestor
110462398|NCT05660473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110462399|NCT05660473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110462400|NCT05660473|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110462401|NCT05660473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110462402|NCT05660473|Antiemetics|antiemetics|mesh-ancestor
110462403|NCT05660473|Autonomic Agents|autonomic agents|mesh-ancestor
110462404|NCT05660473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110462405|NCT05660473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110462406|NCT05660473|Glucocorticoids|glucocorticoids|mesh-ancestor
110462407|NCT05660473|Hormones|hormones|mesh-ancestor
110462408|NCT05660473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110462409|NCT05660473|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110462410|NCT05660473|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110462411|NCT05660473|Abortifacient Agents|abortifacient agents|mesh-ancestor
110462412|NCT05660473|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110462413|NCT05660473|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110462414|NCT05660473|Antimetabolites|antimetabolites|mesh-ancestor
110462415|NCT05660473|Dermatologic Agents|dermatologic agents|mesh-ancestor
110462416|NCT05660473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110462417|NCT05660473|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110462418|NCT05660473|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110462419|NCT05660473|Antiviral Agents|antiviral agents|mesh-ancestor
110462420|NCT05660473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110462421|NCT05660473|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110462422|NCT05660473|Tubulin Modulators|tubulin modulators|mesh-ancestor
110462423|NCT05660473|Antimitotic Agents|antimitotic agents|mesh-ancestor
110462424|NCT05660473|Mitosis Modulators|mitosis modulators|mesh-ancestor
110462425|NCT05660473|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110462426|NCT05660473|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110462427|NCT05660473|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110462428|NCT00803101|Protein C|protein c|mesh-list
110462429|NCT00803101|Protein S|protein s|mesh-list
110462430|NCT00803101|Anticoagulants|anticoagulants|mesh-ancestor
110462431|NCT00803101|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110462432|NCT00803101|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110462433|NCT00803101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110462434|NCT00801229|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
110462435|NCT00801229|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110462436|NCT00801229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110462437|NCT00801229|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110462438|NCT00801229|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110462439|NCT00801229|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110462440|NCT00801229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110462441|NCT00801229|Dopamine Agents|dopamine agents|mesh-ancestor
110462442|NCT00801229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110462443|NCT04269954|Heparin|heparin|mesh-list
110462444|NCT04269954|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
110462445|NCT04269954|Tinzaparin|tinzaparin|mesh-list
110462446|NCT04269954|Dalteparin|dalteparin|mesh-list
110462447|NCT04269954|Batroxobin|batroxobin|mesh-list
110462448|NCT04269954|Anticoagulants|anticoagulants|mesh-ancestor
110462449|NCT04269954|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110462450|NCT04269954|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110462451|NCT04269954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110462452|NCT04269954|Hemostatics|hemostatics|mesh-ancestor
110462453|NCT04269954|Coagulants|coagulants|mesh-ancestor
110462454|NCT00630630|Levetiracetam|levetiracetam|mesh-list
110532040|NCT02703272|Mitosis Modulators|mitosis modulators|mesh-ancestor
110532041|NCT02703272|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110532042|NCT02703272|Alkylating Agents|alkylating agents|mesh-ancestor
110532043|NCT02703272|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110532044|NCT02703194|Prednisone|prednisone|mesh-list
110532045|NCT02703194|Prednisolone|prednisolone|mesh-list
110532046|NCT02703194|Leflunomide|leflunomide|mesh-list
110532047|NCT02703194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110187445|NCT01604135|Riboflavin|riboflavin|mesh-list
110462455|NCT00630630|Anticonvulsants|anticonvulsants|mesh-ancestor
110462456|NCT00630630|Nootropic Agents|nootropic agents|mesh-ancestor
110462457|NCT01254864|Prednisone|prednisone|mesh-list
110462458|NCT01254864|Sunitinib|sunitinib|mesh-list
110462459|NCT01254864|Dasatinib|dasatinib|mesh-list
110462460|NCT01254864|Abiraterone Acetate|abiraterone acetate|mesh-list
110462461|NCT01254864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110462462|NCT01254864|Glucocorticoids|glucocorticoids|mesh-ancestor
110462463|NCT01254864|Hormones|hormones|mesh-ancestor
110462464|NCT01254864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110462465|NCT01254864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110462466|NCT01254864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110462467|NCT01254864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110462468|NCT01254864|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110462469|NCT01254864|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110462470|NCT01254864|Growth Substances|growth substances|mesh-ancestor
110462471|NCT01254864|Growth Inhibitors|growth inhibitors|mesh-ancestor
110462472|NCT01254864|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110462473|NCT01254864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110462474|NCT01254864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110462475|NCT01254864|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110462476|NCT01254864|Hormone Antagonists|hormone antagonists|mesh-ancestor
110462477|NCT01254864|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110462478|NCT02854722|Calcium, Dietary|calcium, dietary|mesh-list
110462479|NCT02854722|Vitamin D|vitamin d|mesh-list
110462480|NCT02854722|Ergocalciferols|ergocalciferols|mesh-list
110462481|NCT02854722|Cholecalciferol|cholecalciferol|mesh-list
110462482|NCT02854722|Vitamins|vitamins|mesh-list
110462483|NCT02854722|Calcium|calcium|mesh-list
110462484|NCT02854722|Deferasirox|deferasirox|mesh-list
110462485|NCT02854722|Micronutrients|micronutrients|mesh-ancestor
110462486|NCT02854722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110462487|NCT02854722|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110462488|NCT02854722|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110462489|NCT02854722|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110462490|NCT02854722|Chelating Agents|chelating agents|mesh-ancestor
110462491|NCT02854722|Sequestering Agents|sequestering agents|mesh-ancestor
110462492|NCT02854722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110462493|NCT00800683|Linagliptin|linagliptin|mesh-list
110462494|NCT00800683|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110462495|NCT00800683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110462497|NCT00800683|Hormones|hormones|mesh-ancestor
110462498|NCT00800683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110462499|NCT00800683|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110462500|NCT00800683|Protease Inhibitors|protease inhibitors|mesh-ancestor
110462501|NCT00800683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110462502|NCT00800683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110462503|NCT01113710|Rotigotine|rotigotine|mesh-list
110462504|NCT01113710|Dopamine Agonists|dopamine agonists|mesh-ancestor
110462505|NCT01113710|Dopamine Agents|dopamine agents|mesh-ancestor
110462506|NCT01113710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110462507|NCT01113710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110462508|NCT01113710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110462510|NCT01124162|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110462511|NCT01124162|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110462512|NCT01124162|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110462513|NCT01124162|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110532048|NCT02703194|Glucocorticoids|glucocorticoids|mesh-ancestor
110532049|NCT02703194|Hormones|hormones|mesh-ancestor
110532050|NCT02703194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110532051|NCT02703194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110532052|NCT02703194|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110532053|NCT02703194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110532054|NCT02703194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110532055|NCT02703194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110532056|NCT02703194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110532057|NCT02703194|Immunologic Factors|immunologic factors|mesh-ancestor
110532058|NCT02402660|Vitamin A|vitamin a|mesh-list
110532059|NCT02402660|Retinol acetate|retinol acetate|mesh-list
110532060|NCT02402660|Vitamins|vitamins|mesh-ancestor
110532061|NCT02402660|Micronutrients|micronutrients|mesh-ancestor
110462514|NCT01124162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110462515|NCT00923533|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110462516|NCT00923533|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110462517|NCT00923533|Diuretics|diuretics|mesh-ancestor
110462518|NCT00923533|Natriuretic Agents|natriuretic agents|mesh-ancestor
110462519|NCT00923533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110462520|NCT00923533|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110462521|NCT00923533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110462522|NCT00923533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110462523|NCT00906399|Interferons|interferons|mesh-list
110462524|NCT00906399|Interferon-beta|interferon-beta|mesh-list
110462525|NCT00906399|Interferon beta-1a|interferon beta-1a|mesh-list
110462526|NCT00906399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110462527|NCT00906399|Antiviral Agents|antiviral agents|mesh-ancestor
110462528|NCT00906399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110462529|NCT00906399|Immunologic Factors|immunologic factors|mesh-ancestor
110462530|NCT00906399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110462531|NCT00906399|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110462532|NCT00947856|Brentuximab Vedotin|brentuximab vedotin|mesh-list
110462533|NCT00947856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110462534|NCT00947856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110462535|NCT00947856|Immunotoxins|immunotoxins|mesh-ancestor
110462536|NCT00947856|Immunoconjugates|immunoconjugates|mesh-ancestor
110462537|NCT00947856|Immunologic Factors|immunologic factors|mesh-ancestor
110462538|NCT00947856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110462539|NCT00947544|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
110462540|NCT00947544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110462541|NCT00907335|Tretinoin|tretinoin|mesh-list
110462542|NCT00907335|Benzoyl Peroxide|benzoyl peroxide|mesh-list
110462543|NCT00907335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110462544|NCT00907335|Keratolytic Agents|keratolytic agents|mesh-ancestor
110462545|NCT00907335|Dermatologic Agents|dermatologic agents|mesh-ancestor
110462546|NCT00947154|Aripiprazole|aripiprazole|mesh-list
110462547|NCT00947154|Antidepressive Agents|antidepressive agents|mesh-ancestor
110462548|NCT00947154|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110462549|NCT00947154|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110462550|NCT00947154|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110462551|NCT00947154|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110462552|NCT00947154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110462553|NCT00947154|Dopamine Agonists|dopamine agonists|mesh-ancestor
110462554|NCT00947154|Dopamine Agents|dopamine agents|mesh-ancestor
110462555|NCT00947154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110462556|NCT00947154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110462557|NCT00947154|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110462558|NCT00947154|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110462559|NCT00947154|Serotonin Agents|serotonin agents|mesh-ancestor
110462560|NCT00947154|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110532062|NCT02402660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110532063|NCT02402660|Protective Agents|protective agents|mesh-ancestor
110532064|NCT02402660|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110532065|NCT02402660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110532066|NCT02402660|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110532067|NCT02402660|Immunologic Factors|immunologic factors|mesh-ancestor
110532068|NCT02702960|Mycophenolic Acid|mycophenolic acid|mesh-list
110532069|NCT02702960|Prednisone|prednisone|mesh-list
110462561|NCT00947154|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110109648|NCT01827280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110462562|NCT00947154|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110462563|NCT00947154|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110462564|NCT01862952|Anticonvulsants|anticonvulsants|mesh-list
110462565|NCT00952068|Tramadol|tramadol|mesh-list
110462566|NCT00952068|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110462567|NCT00952068|Narcotics|narcotics|mesh-ancestor
110462568|NCT00952068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110462569|NCT00952068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110462570|NCT00952068|Analgesics|analgesics|mesh-ancestor
110462571|NCT00952068|Sensory System Agents|sensory system agents|mesh-ancestor
110462572|NCT00952068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110462573|NCT00951912|Genistein|genistein|mesh-list
110462574|NCT00951912|Daidzein|daidzein|mesh-list
110462575|NCT00951912|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110462576|NCT00951912|Protective Agents|protective agents|mesh-ancestor
110462577|NCT00951912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110462578|NCT00951912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110462579|NCT00951912|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110462580|NCT00951912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110462581|NCT00951912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110462582|NCT00951912|Phytoestrogens|phytoestrogens|mesh-ancestor
110462583|NCT00951912|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
110462584|NCT00951912|Estrogens|estrogens|mesh-ancestor
110462585|NCT00951912|Hormones|hormones|mesh-ancestor
110462586|NCT00951912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110462587|NCT02882594|Anesthetics|anesthetics|mesh-list
110462588|NCT02882594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110462589|NCT02882594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110462590|NCT02856048|Triptorelin Pamoate|triptorelin pamoate|mesh-list
110462591|NCT02856048|Luteolytic Agents|luteolytic agents|mesh-ancestor
110462592|NCT02856048|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110462593|NCT02856048|Contraceptive Agents|contraceptive agents|mesh-ancestor
110595262|NCT00795015|Insulin|insulin|mesh-list
110462594|NCT02856048|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110462595|NCT02856048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110462596|NCT02856048|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110462597|NCT02856048|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110462598|NCT02856048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110462599|NCT01123070|Rituximab|rituximab|mesh-list
110462600|NCT01123070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110462601|NCT01123070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110462602|NCT01123070|Immunologic Factors|immunologic factors|mesh-ancestor
110462603|NCT01123070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110462604|NCT01123070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110462605|NCT02857686|Anesthetics|anesthetics|mesh-list
110462606|NCT02857686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110462607|NCT02857686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110462608|NCT03198741|Aspirin|aspirin|mesh-list
110462609|NCT03198741|Clopidogrel|clopidogrel|mesh-list
110462610|NCT03198741|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110462611|NCT03198741|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110462612|NCT03198741|Analgesics|analgesics|mesh-ancestor
110462613|NCT03198741|Sensory System Agents|sensory system agents|mesh-ancestor
110462614|NCT03198741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110462615|NCT03198741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110462616|NCT03198741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110462617|NCT03198741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110462618|NCT03198741|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110462619|NCT03198741|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110532070|NCT02702960|Cyclophosphamide|cyclophosphamide|mesh-list
110532071|NCT02702960|Fludarabine|fludarabine|mesh-list
110532072|NCT02702960|Tacrolimus|tacrolimus|mesh-list
110532073|NCT02702960|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110532074|NCT02702960|Mesna|mesna|mesh-list
110532075|NCT02702960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110532076|NCT02702960|Immunologic Factors|immunologic factors|mesh-ancestor
110532077|NCT02702960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110532078|NCT02702960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110532079|NCT02702960|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110532080|NCT02702960|Alkylating Agents|alkylating agents|mesh-ancestor
110532081|NCT02702960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110532082|NCT02702960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110532083|NCT02702960|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110532084|NCT02702960|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110532085|NCT02702960|Glucocorticoids|glucocorticoids|mesh-ancestor
110532086|NCT02702960|Hormones|hormones|mesh-ancestor
110532087|NCT02702960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110532088|NCT02702960|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110532089|NCT02702960|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110532090|NCT02702960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110532091|NCT02702960|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110532092|NCT02702960|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110532093|NCT02702960|Antitubercular Agents|antitubercular agents|mesh-ancestor
110532094|NCT02702960|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110532095|NCT02702960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110532096|NCT02702960|Protective Agents|protective agents|mesh-ancestor
110532097|NCT02699528|Methylphenidate|methylphenidate|mesh-list
110532098|NCT02699528|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110462620|NCT03198741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110462621|NCT03198741|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110462622|NCT03198741|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110462623|NCT03198741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110462624|NCT03198741|Antipyretics|antipyretics|mesh-ancestor
110462625|NCT03198741|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110462626|NCT03198741|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110462627|NCT03198741|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110462628|NCT03198741|Purinergic Agents|purinergic agents|mesh-ancestor
110462629|NCT03198741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110462630|NCT01122680|Bromides|bromides|mesh-list
110462631|NCT01122680|Tiotropium Bromide|tiotropium bromide|mesh-list
110462632|NCT01122680|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110462633|NCT01122680|Autonomic Agents|autonomic agents|mesh-ancestor
110462634|NCT01122680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110462635|NCT01122680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110109729|NCT01827722|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110532099|NCT02699528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110532100|NCT02699528|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110532101|NCT02699528|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110532102|NCT02699528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110532103|NCT02699528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110532104|NCT02699528|Dopamine Agents|dopamine agents|mesh-ancestor
110532105|NCT02699528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110532106|NCT04215770|Penicillins|penicillins|mesh-list
110532107|NCT04215770|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
110532108|NCT04215770|Penicillin G|penicillin g|mesh-list
110532109|NCT04215770|Penicillin G Benzathine|penicillin g benzathine|mesh-list
110532110|NCT04215770|Penicillin G Procaine|penicillin g procaine|mesh-list
110532111|NCT04215770|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110187677|NCT05750875|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110187678|NCT05750875|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110187679|NCT05750875|Histamine Antagonists|histamine antagonists|mesh-ancestor
110187680|NCT05750875|Histamine Agents|histamine agents|mesh-ancestor
110187681|NCT05715073|Caffeine|caffeine|mesh-list
110187682|NCT05715073|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110462636|NCT01122680|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110462637|NCT01122680|Respiratory System Agents|respiratory system agents|mesh-ancestor
110462638|NCT01122680|Parasympatholytics|parasympatholytics|mesh-ancestor
110462639|NCT01122680|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110462640|NCT01122680|Cholinergic Agents|cholinergic agents|mesh-ancestor
110462641|NCT01122680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110462642|NCT01122680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110462643|NCT01122680|Anticonvulsants|anticonvulsants|mesh-ancestor
110462644|NCT00946998|Sertraline|sertraline|mesh-list
110462645|NCT00946998|Antidepressive Agents|antidepressive agents|mesh-ancestor
110462646|NCT00946998|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110462647|NCT00946998|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110462648|NCT00946998|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110462649|NCT00946998|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110462650|NCT00946998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110462651|NCT00946998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110462652|NCT00946998|Serotonin Agents|serotonin agents|mesh-ancestor
110462653|NCT00946998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110462654|NCT01138826|Amlodipine|amlodipine|mesh-list
110462655|NCT01138826|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110462656|NCT01138826|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110462657|NCT01138826|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110462658|NCT01138826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110462659|NCT01138826|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110595296|NCT04042948|Acetaminophen|acetaminophen|mesh-list
110462660|NCT01138826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110462661|NCT01138826|Vasodilator Agents|vasodilator agents|mesh-ancestor
110462663|NCT00906087|Dorzolamide|dorzolamide|mesh-list
110462664|NCT00906087|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110462665|NCT00906087|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110462666|NCT00906087|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110462667|NCT00906087|Adrenergic Agents|adrenergic agents|mesh-ancestor
110462668|NCT00906087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110462669|NCT00906087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110532112|NCT04215770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110532113|NCT04215770|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110532114|NCT04215770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110532115|NCT04215770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110532116|NCT02702882|Fenugreek seed meal|fenugreek seed meal|mesh-list
110532117|NCT02702882|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110532118|NCT02702882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110532120|NCT02699138|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110532121|NCT02699138|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110532122|NCT02699138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110532123|NCT02699138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110532124|NCT02699138|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110532125|NCT02699138|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110187756|NCT05549206|Immunologic Factors|immunologic factors|mesh-ancestor
110187757|NCT05549206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110187758|NCT05533684|Gabapentin|gabapentin|mesh-list
110187759|NCT05533684|Analgesics|analgesics|mesh-ancestor
110187760|NCT05533684|Sensory System Agents|sensory system agents|mesh-ancestor
110187761|NCT05533684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110187762|NCT05533684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110187763|NCT05533684|Anticonvulsants|anticonvulsants|mesh-ancestor
110187764|NCT05533684|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110187765|NCT05533684|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110187766|NCT05533684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110187767|NCT05533684|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110187768|NCT05533684|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110187769|NCT05533684|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110187770|NCT05533684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110462670|NCT00906087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110462671|NCT00906087|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110462672|NCT00906087|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110462673|NCT00906087|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110462674|NCT00906087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110462675|NCT00906087|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110462676|NCT03525795|Ipilimumab|ipilimumab|mesh-list
110462677|NCT03525795|(R)-N-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)-1H-indole-3-carboxamide|(r)-n-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)-1h-indole-3-carboxamide|mesh-list
110462678|NCT03525795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110462679|NCT03525795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110462680|NCT03525795|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110532126|NCT02699138|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110532127|NCT02699138|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110532128|NCT02699138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110532129|NCT02699138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110532131|NCT02699138|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110532132|NCT02699138|Antidepressive Agents|antidepressive agents|mesh-ancestor
110462681|NCT03525795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110462682|NCT03525795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110462683|NCT03522831|Albuterol|albuterol|mesh-list
110462684|NCT03522831|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110462685|NCT03522831|Autonomic Agents|autonomic agents|mesh-ancestor
110462686|NCT03522831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110462687|NCT03522831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110462688|NCT03522831|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110462689|NCT03522831|Respiratory System Agents|respiratory system agents|mesh-ancestor
110462690|NCT03522831|Tocolytic Agents|tocolytic agents|mesh-ancestor
110462691|NCT03522831|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110462692|NCT03522831|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110462693|NCT03522831|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110462694|NCT03522831|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110462695|NCT03522831|Adrenergic Agents|adrenergic agents|mesh-ancestor
110462696|NCT03522831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110462697|NCT03522831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110462698|NCT03504501|Lamotrigine|lamotrigine|mesh-list
110462699|NCT03504501|Lovastatin|lovastatin|mesh-list
110462700|NCT03504501|L 647318|l 647318|mesh-list
110462701|NCT03504501|Dihydromevinolin|dihydromevinolin|mesh-list
110462702|NCT03504501|Anticonvulsants|anticonvulsants|mesh-ancestor
110462703|NCT03504501|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110462704|NCT03504501|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110462705|NCT03504501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110462706|NCT03504501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110462707|NCT03504501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110462708|NCT03504501|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110462709|NCT03504501|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110462710|NCT03504501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110462711|NCT03504501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110462712|NCT03504501|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110462713|NCT03504501|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110462714|NCT03504501|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110462715|NCT03504501|Antimetabolites|antimetabolites|mesh-ancestor
110462716|NCT03504501|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110462717|NCT03504501|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110462718|NCT03504501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110462719|NCT02420574|Albendazole|albendazole|mesh-list
110462720|NCT02420574|Anthelmintics|anthelmintics|mesh-ancestor
110462721|NCT02420574|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110462722|NCT02420574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110462723|NCT02420574|Anticestodal Agents|anticestodal agents|mesh-ancestor
110462724|NCT02420574|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110385400|NCT05363319|Cemiplimab|cemiplimab|mesh-list
110462725|NCT02420574|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110462726|NCT02420574|Tubulin Modulators|tubulin modulators|mesh-ancestor
110462727|NCT02420574|Antimitotic Agents|antimitotic agents|mesh-ancestor
110462728|NCT02420574|Mitosis Modulators|mitosis modulators|mesh-ancestor
110462729|NCT02420574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110462730|NCT02420574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110462731|NCT02855502|Prednisolone|prednisolone|mesh-list
110462732|NCT02855502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110462733|NCT02855502|Glucocorticoids|glucocorticoids|mesh-ancestor
110462735|NCT02855502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110462736|NCT02855502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110462737|NCT02855502|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110462738|NCT02855502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110462739|NCT02853864|Dexmedetomidine|dexmedetomidine|mesh-list
110532133|NCT00615134|Enfuvirtide|enfuvirtide|mesh-list
110179608|NCT00847314|Androgens|androgens|mesh-ancestor
110532134|NCT00615134|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110532135|NCT00615134|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110532136|NCT00615134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110532137|NCT00615134|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110532138|NCT00615134|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110462740|NCT02853864|Propofol|propofol|mesh-list
110462741|NCT02853864|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110462742|NCT02853864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110462743|NCT02853864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110462744|NCT02853864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110462745|NCT02853864|Analgesics|analgesics|mesh-ancestor
110462746|NCT02853864|Sensory System Agents|sensory system agents|mesh-ancestor
110462747|NCT02853864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110462748|NCT02853864|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110462749|NCT02853864|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110462750|NCT02853864|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110462751|NCT02853864|Adrenergic Agents|adrenergic agents|mesh-ancestor
110462752|NCT02853864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110462753|NCT02853864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110462754|NCT02853864|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110462755|NCT02853864|Anesthetics, General|anesthetics, general|mesh-ancestor
110462756|NCT02853864|Anesthetics|anesthetics|mesh-ancestor
110462757|NCT00907257|Tretinoin|tretinoin|mesh-list
110462758|NCT00907257|Benzoyl Peroxide|benzoyl peroxide|mesh-list
110462759|NCT00907257|Dermatologic Agents|dermatologic agents|mesh-ancestor
110462760|NCT00907257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110462761|NCT00907257|Keratolytic Agents|keratolytic agents|mesh-ancestor
110462762|NCT01138046|Paclitaxel|paclitaxel|mesh-list
110462763|NCT01138046|Lapatinib|lapatinib|mesh-list
110462764|NCT01138046|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110462765|NCT01138046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110462766|NCT01138046|Tubulin Modulators|tubulin modulators|mesh-ancestor
110462767|NCT01138046|Antimitotic Agents|antimitotic agents|mesh-ancestor
110462768|NCT01138046|Mitosis Modulators|mitosis modulators|mesh-ancestor
110462769|NCT01138046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110462770|NCT01138046|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110462771|NCT01138046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110462773|NCT00876460|Nintedanib|nintedanib|mesh-list
110462774|NCT00876460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110462775|NCT00876460|Tubulin Modulators|tubulin modulators|mesh-ancestor
110462776|NCT00876460|Antimitotic Agents|antimitotic agents|mesh-ancestor
110462777|NCT00876460|Mitosis Modulators|mitosis modulators|mesh-ancestor
110462778|NCT00876460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110462779|NCT00876460|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110462780|NCT00876460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110462781|NCT01137812|Metformin|metformin|mesh-list
110462782|NCT01137812|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110462783|NCT01137812|Canagliflozin|canagliflozin|mesh-list
110462784|NCT01137812|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110462785|NCT01137812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110462786|NCT01137812|Incretins|incretins|mesh-ancestor
110462787|NCT01137812|Hormones|hormones|mesh-ancestor
110462788|NCT01137812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110462789|NCT01137812|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110462790|NCT01137812|Protease Inhibitors|protease inhibitors|mesh-ancestor
110462791|NCT01137812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110462792|NCT01137812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110462793|NCT01137812|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110462794|NCT00679510|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110462795|NCT00679510|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110462796|NCT00679510|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110462797|NCT00679510|Antimetabolites|antimetabolites|mesh-ancestor
110462798|NCT00679510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110462799|NCT00679510|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110462800|NCT00679510|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110462801|NCT00679510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110532139|NCT00615134|Antiviral Agents|antiviral agents|mesh-ancestor
110532140|NCT00615134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110532141|NCT01831076|Tamoxifen|tamoxifen|mesh-list
110532142|NCT01831076|Exemestane|exemestane|mesh-list
110532143|NCT01831076|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110532144|NCT01831076|Hormone Antagonists|hormone antagonists|mesh-ancestor
110532145|NCT01831076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110532146|NCT01831076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110462802|NCT04146220|Prednisolone|prednisolone|mesh-list
110462803|NCT04146220|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110462804|NCT04146220|Glucocorticoids|glucocorticoids|mesh-ancestor
110462805|NCT04146220|Hormones|hormones|mesh-ancestor
110462806|NCT04146220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110462807|NCT04146220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110462808|NCT04146220|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110462809|NCT04146220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110462810|NCT00679666|Riboflavin|riboflavin|mesh-list
110462811|NCT00679666|Vitamins|vitamins|mesh-ancestor
110462812|NCT00679666|Micronutrients|micronutrients|mesh-ancestor
110462813|NCT00679666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110462814|NCT00679666|Vitamin B Complex|vitamin b complex|mesh-ancestor
110462815|NCT00679666|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110462816|NCT00679666|Dermatologic Agents|dermatologic agents|mesh-ancestor
110462817|NCT00679744|Pyrimethamine|pyrimethamine|mesh-list
110462818|NCT00679744|Antimalarials|antimalarials|mesh-ancestor
110462819|NCT00679744|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110462820|NCT00679744|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110462821|NCT00679744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110462822|NCT00679744|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110462823|NCT00679744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110462824|NCT00679744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110462825|NCT00681772|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
110462826|NCT00681772|Vasodilator Agents|vasodilator agents|mesh-ancestor
110462827|NCT00681772|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110462828|NCT00681772|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110462829|NCT00681772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110462830|NCT00681772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110462831|NCT00681772|Urological Agents|urological agents|mesh-ancestor
110462832|NCT00946920|Goserelin|goserelin|mesh-list
110462833|NCT00946920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110462834|NCT00946920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110462835|NCT00679900|SR 46349B|sr 46349b|mesh-list
110462836|NCT00679900|Lormetazepam|lormetazepam|mesh-list
110462837|NCT00679900|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110462838|NCT00679900|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110462839|NCT00679900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110462840|NCT00679900|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110462841|NCT00679900|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110462842|NCT00679900|Serotonin Agents|serotonin agents|mesh-ancestor
110462843|NCT00679900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110462844|NCT00679900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110462845|NCT00679900|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110462846|NCT00679900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110462847|NCT00945906|Fibrinolysin|fibrinolysin|mesh-list
110462848|NCT00945906|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110462849|NCT00945906|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110462850|NCT00945906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110462852|NCT00681928|Anastrozole|anastrozole|mesh-list
110462853|NCT00681928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110462854|NCT00681928|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110462855|NCT00681928|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110109962|NCT01829711|Immunotoxins|immunotoxins|mesh-ancestor
110462856|NCT00681928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110462857|NCT00681928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110462859|NCT00681928|Hormone Antagonists|hormone antagonists|mesh-ancestor
110462860|NCT00681928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110462861|NCT00681928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110532147|NCT01831076|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110532148|NCT01831076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110532149|NCT01831076|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110532150|NCT01831076|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110532151|NCT01831076|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110532152|NCT01831076|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110532153|NCT01831076|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110532154|NCT01831076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110462862|NCT00681928|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110462864|NCT00594646|Emtricitabine|emtricitabine|mesh-list
110462865|NCT00594646|Raltegravir Potassium|raltegravir potassium|mesh-list
110462866|NCT00594646|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110462867|NCT00594646|Antiviral Agents|antiviral agents|mesh-ancestor
110462868|NCT00594646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110462869|NCT00594646|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110462870|NCT00594646|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110462871|NCT00594646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110462872|NCT00594646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110462873|NCT00594646|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110462874|NCT00594646|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110462875|NCT00594646|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110462876|NCT00594646|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110462877|NCT00680134|Tavaborole|tavaborole|mesh-list
110462878|NCT00680134|Antifungal Agents|antifungal agents|mesh-ancestor
110462879|NCT00680134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110462880|NCT00680212|Beta Carotene|beta carotene|mesh-list
110462881|NCT00680212|Carotenoids|carotenoids|mesh-list
110462882|NCT00680212|Antioxidants|antioxidants|mesh-ancestor
110462883|NCT00680212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110462884|NCT00680212|Protective Agents|protective agents|mesh-ancestor
110462885|NCT00680212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110462886|NCT00680212|Provitamins|provitamins|mesh-ancestor
110462887|NCT00680212|Vitamins|vitamins|mesh-ancestor
110462888|NCT00680212|Micronutrients|micronutrients|mesh-ancestor
110462889|NCT00682006|Chlorhexidine|chlorhexidine|mesh-list
110462890|NCT00682006|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110462891|NCT00682006|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110462892|NCT00682006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110462893|NCT00682006|Disinfectants|disinfectants|mesh-ancestor
110462894|NCT00682006|Dermatologic Agents|dermatologic agents|mesh-ancestor
110462895|NCT02855346|Dapivirine|dapivirine|mesh-list
110462896|NCT02855346|Levonorgestrel|levonorgestrel|mesh-list
110462897|NCT02855346|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110462898|NCT02855346|Contraceptive Agents|contraceptive agents|mesh-ancestor
110462899|NCT02855346|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110462900|NCT02855346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110462901|NCT02855346|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110462902|NCT02855346|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110462903|NCT02855346|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110462904|NCT02855346|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110462905|NCT02855346|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110462906|NCT02855346|Antiviral Agents|antiviral agents|mesh-ancestor
110462907|NCT02855346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110462908|NCT01111604|Ramucirumab|ramucirumab|mesh-list
110462909|NCT01111604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110462910|NCT00950742|Trastuzumab|trastuzumab|mesh-list
110462911|NCT00950742|Afatinib|afatinib|mesh-list
110462912|NCT00950742|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110462913|NCT00950742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110462914|NCT00950742|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110462915|NCT00950742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110462916|NCT00950742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110462917|NCT04310228|Favipiravir|favipiravir|mesh-list
110462918|NCT04310228|Antiviral Agents|antiviral agents|mesh-ancestor
110462919|NCT04310228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110462920|NCT00955110|Oxymorphone|oxymorphone|mesh-list
110462921|NCT00955110|Oxycodone|oxycodone|mesh-list
110532155|NCT01831076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110532156|NCT02698982|Anesthetics|anesthetics|mesh-list
110532157|NCT02698982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110532158|NCT02698982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110532159|NCT00615524|Exemestane|exemestane|mesh-list
110532160|NCT00615524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110532161|NCT00615524|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110532162|NCT00615524|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110532163|NCT00615524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110532164|NCT00615524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110532165|NCT00615524|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110532166|NCT00615524|Hormone Antagonists|hormone antagonists|mesh-ancestor
110462922|NCT00955110|Hydromorphone|hydromorphone|mesh-list
110462923|NCT00955110|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110462924|NCT00955110|Narcotics|narcotics|mesh-ancestor
110462925|NCT00955110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110462926|NCT00955110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110462927|NCT00955110|Analgesics|analgesics|mesh-ancestor
110462928|NCT00955110|Sensory System Agents|sensory system agents|mesh-ancestor
110462929|NCT00955110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110462930|NCT00955110|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110462931|NCT05056142|Anesthetics|anesthetics|mesh-list
110462932|NCT05056142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110462933|NCT05056142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110462934|NCT00950664|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110462935|NCT00950664|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110462936|NCT00950664|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110462937|NCT00950664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110462938|NCT00950664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110462939|NCT00950664|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110462940|NCT00950664|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110462941|NCT00950664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110462942|NCT00950664|Cholinergic Agents|cholinergic agents|mesh-ancestor
110462943|NCT00950664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110462944|NCT01111526|Panobinostat|panobinostat|mesh-list
110462945|NCT01111526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110462946|NCT01111526|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110462947|NCT01111526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110462948|NCT01111526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110462949|NCT02881346|Betamethasone|betamethasone|mesh-list
110462950|NCT02881346|Betamethasone Valerate|betamethasone valerate|mesh-list
110462951|NCT02881346|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
110462952|NCT02881346|Betamethasone benzoate|betamethasone benzoate|mesh-list
110462953|NCT02881346|Calcipotriene|calcipotriene|mesh-list
110462954|NCT02881346|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
110462955|NCT02881346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110462956|NCT02881346|Glucocorticoids|glucocorticoids|mesh-ancestor
110595386|NCT00656799|Bromides|bromides|mesh-list
110462958|NCT02881346|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110462959|NCT02881346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110462960|NCT02881346|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110462961|NCT02881346|Respiratory System Agents|respiratory system agents|mesh-ancestor
110462962|NCT02881346|Dermatologic Agents|dermatologic agents|mesh-ancestor
110462963|NCT00630708|Losartan|losartan|mesh-list
110462964|NCT00630708|Benazepril|benazepril|mesh-list
110462965|NCT00630708|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110462966|NCT00630708|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110462967|NCT00630708|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110462968|NCT00630708|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110462969|NCT00630708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110462970|NCT00630708|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110532167|NCT00615524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110532168|NCT00615524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110532169|NCT00908141|Sargramostim|sargramostim|mesh-list
110532170|NCT00908141|Immunologic Factors|immunologic factors|mesh-ancestor
110532171|NCT00908141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110532172|NCT01246310|Inositol|inositol|mesh-list
110532173|NCT01246310|Vitamin B Complex|vitamin b complex|mesh-ancestor
110532174|NCT01246310|Vitamins|vitamins|mesh-ancestor
110532175|NCT01246310|Micronutrients|micronutrients|mesh-ancestor
110532176|NCT01246310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110532177|NCT00700076|Ketamine|ketamine|mesh-list
110532178|NCT00700076|Analgesics|analgesics|mesh-ancestor
110532179|NCT00700076|Sensory System Agents|sensory system agents|mesh-ancestor
110532180|NCT00700076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110532181|NCT00700076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110188136|NCT04512079|Protease Inhibitors|protease inhibitors|mesh-ancestor
110462971|NCT00630708|Protease Inhibitors|protease inhibitors|mesh-ancestor
110462972|NCT00630708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110462973|NCT01111292|Inositol|inositol|mesh-list
110307288|NCT00266357|Gaboxadol|gaboxadol|mesh-list
110462974|NCT01111292|Vitamin B Complex|vitamin b complex|mesh-ancestor
110462976|NCT01111292|Micronutrients|micronutrients|mesh-ancestor
110462977|NCT01111292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110462978|NCT02853630|Metformin|metformin|mesh-list
110462979|NCT02853630|Vildagliptin|vildagliptin|mesh-list
110462980|NCT02853630|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110462981|NCT02853630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110462982|NCT02853630|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110462983|NCT02853630|Protease Inhibitors|protease inhibitors|mesh-ancestor
110462984|NCT02853630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110462985|NCT02853630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110462986|NCT04309838|Treprostinil|treprostinil|mesh-list
110462987|NCT04309838|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110462988|NCT05367206|Paclitaxel|paclitaxel|mesh-list
110462989|NCT05367206|Carboplatin|carboplatin|mesh-list
110462990|NCT05367206|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110462991|NCT05367206|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110462992|NCT05367206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110462993|NCT05367206|Tubulin Modulators|tubulin modulators|mesh-ancestor
110462994|NCT05367206|Antimitotic Agents|antimitotic agents|mesh-ancestor
110462995|NCT05367206|Mitosis Modulators|mitosis modulators|mesh-ancestor
110462996|NCT05367206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110462997|NCT00637286|Zolmitriptan|zolmitriptan|mesh-list
110462998|NCT00637286|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110462999|NCT00637286|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110463000|NCT00637286|Serotonin Agents|serotonin agents|mesh-ancestor
110463001|NCT00637286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110463002|NCT00637286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110463003|NCT00637286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110463004|NCT00944658|Apremilast|apremilast|mesh-list
110110116|NCT01834820|Hormones|hormones|mesh-ancestor
110463005|NCT00944658|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110463006|NCT00944658|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110463007|NCT00944658|Analgesics|analgesics|mesh-ancestor
110463008|NCT00944658|Sensory System Agents|sensory system agents|mesh-ancestor
110463009|NCT00944658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110463010|NCT00944658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110463011|NCT00944658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110463012|NCT00944658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110463013|NCT00944658|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
110032729|NCT05271253|Bupivacaine|bupivacaine|mesh-list
110532183|NCT00700076|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110532184|NCT00700076|Anesthetics, General|anesthetics, general|mesh-ancestor
110532185|NCT00700076|Anesthetics|anesthetics|mesh-ancestor
110532186|NCT00700076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110532187|NCT00700076|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110188196|NCT04318691|Dimercaprol|dimercaprol|mesh-list
110463014|NCT00944658|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110463015|NCT00944658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110463016|NCT00944658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110463017|NCT01110200|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110463018|NCT01110200|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
110463019|NCT01110200|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110463020|NCT01110200|Autonomic Agents|autonomic agents|mesh-ancestor
110463021|NCT01110200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110463022|NCT01110200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110463023|NCT01110200|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110463024|NCT01110200|Respiratory System Agents|respiratory system agents|mesh-ancestor
110463025|NCT01110200|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110463027|NCT01110200|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110463028|NCT01110200|Adrenergic Agents|adrenergic agents|mesh-ancestor
110463029|NCT01110200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110463030|NCT01110200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110463031|NCT01110200|Glucocorticoids|glucocorticoids|mesh-ancestor
110463032|NCT01110200|Hormones|hormones|mesh-ancestor
110463033|NCT01110200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110463034|NCT01110200|Sympathomimetics|sympathomimetics|mesh-ancestor
110463035|NCT05182112|Gemcitabine|gemcitabine|mesh-list
110463036|NCT05182112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110463037|NCT05182112|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110463038|NCT05182112|Antimetabolites|antimetabolites|mesh-ancestor
110463039|NCT05182112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110463040|NCT01136954|Zonisamide|zonisamide|mesh-list
110463041|NCT01136954|Anticonvulsants|anticonvulsants|mesh-ancestor
110463042|NCT01136954|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110463043|NCT01136954|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110463044|NCT01136954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110463045|NCT01136954|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110463046|NCT01136954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110463047|NCT01108094|Itraconazole|itraconazole|mesh-list
110463048|NCT01108094|Antifungal Agents|antifungal agents|mesh-ancestor
110463049|NCT01108094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110463050|NCT01108094|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110463051|NCT01108094|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110463052|NCT01108094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110463053|NCT01108094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110463054|NCT01108094|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110463055|NCT01108094|Hormone Antagonists|hormone antagonists|mesh-ancestor
110463056|NCT01108094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110463057|NCT01108094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110463058|NCT01108094|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110463059|NCT00954174|Paclitaxel|paclitaxel|mesh-list
110463060|NCT00954174|Carboplatin|carboplatin|mesh-list
110463061|NCT00954174|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110463062|NCT00954174|Ifosfamide|ifosfamide|mesh-list
110463063|NCT00954174|Isophosphamide mustard|isophosphamide mustard|mesh-list
110463064|NCT00954174|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110463065|NCT00954174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110463066|NCT00954174|Tubulin Modulators|tubulin modulators|mesh-ancestor
110463067|NCT00954174|Antimitotic Agents|antimitotic agents|mesh-ancestor
110463068|NCT00954174|Mitosis Modulators|mitosis modulators|mesh-ancestor
110463069|NCT00954174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110463070|NCT00954174|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110463071|NCT00954174|Alkylating Agents|alkylating agents|mesh-ancestor
110463072|NCT04309058|Vitamin D|vitamin d|mesh-list
110532188|NCT00700076|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110532189|NCT00700076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110532190|NCT00700076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110532192|NCT02698514|Desflurane|desflurane|mesh-list
110532193|NCT02698514|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110188262|NCT03865940|Lidocaine|lidocaine|mesh-list
110463073|NCT04309058|Vitamins|vitamins|mesh-ancestor
110463074|NCT04309058|Micronutrients|micronutrients|mesh-ancestor
110463075|NCT04309058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110463076|NCT04309058|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110463077|NCT01136408|Warfarin|warfarin|mesh-list
110463078|NCT01136408|Dabigatran|dabigatran|mesh-list
110463079|NCT01136408|Anticoagulants|anticoagulants|mesh-ancestor
110463080|NCT01136408|Antithrombins|antithrombins|mesh-ancestor
110463081|NCT01136408|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110463082|NCT01136408|Protease Inhibitors|protease inhibitors|mesh-ancestor
110463083|NCT01136408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110463084|NCT01136408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110463085|NCT01136174|Nintedanib|nintedanib|mesh-list
110463086|NCT01136174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110463087|NCT01136174|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110463088|NCT01136174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110463089|NCT01136174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110463090|NCT01135394|Pioglitazone|pioglitazone|mesh-list
110463091|NCT01135394|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110463092|NCT01135394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110463093|NCT00949884|Losartan|losartan|mesh-list
110463094|NCT00949884|Olmesartan|olmesartan|mesh-list
110463095|NCT00949884|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
110463096|NCT00949884|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110463097|NCT00949884|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110463098|NCT00949884|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110463099|NCT00949884|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110463100|NCT00949884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110463101|NCT00949650|Pemetrexed|pemetrexed|mesh-list
110463102|NCT00949650|Afatinib|afatinib|mesh-list
110307303|NCT00295698|Diethylcarbamazine|diethylcarbamazine|mesh-list
110463103|NCT00949650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110463104|NCT00949650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110463105|NCT00949650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110463106|NCT00949650|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110463107|NCT00949650|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110463108|NCT00949650|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110463109|NCT03082755|Gabapentin|gabapentin|mesh-list
110463110|NCT03082755|Analgesics|analgesics|mesh-ancestor
110463111|NCT03082755|Sensory System Agents|sensory system agents|mesh-ancestor
110463112|NCT03082755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110463113|NCT03082755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110463114|NCT03082755|Anticonvulsants|anticonvulsants|mesh-ancestor
110463115|NCT03082755|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110463116|NCT03082755|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110463117|NCT03082755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110463118|NCT03082755|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110463119|NCT03082755|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110463120|NCT03082755|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110463121|NCT03082755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110463122|NCT03082755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110463123|NCT03082755|Antimanic Agents|antimanic agents|mesh-ancestor
110463124|NCT05332353|BCG Vaccine|bcg vaccine|mesh-list
110463125|NCT05332353|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110463126|NCT05332353|Immunologic Factors|immunologic factors|mesh-ancestor
110463127|NCT05332353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110463128|NCT00904215|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110463129|NCT00904215|Telmisartan|telmisartan|mesh-list
110463130|NCT00904215|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110463131|NCT00904215|Diuretics|diuretics|mesh-ancestor
110463132|NCT00904215|Natriuretic Agents|natriuretic agents|mesh-ancestor
110463133|NCT00904215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110532194|NCT02698514|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110532195|NCT02698514|Anesthetics, General|anesthetics, general|mesh-ancestor
110532196|NCT02698514|Anesthetics|anesthetics|mesh-ancestor
110532197|NCT02698514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110532198|NCT02698514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110532199|NCT02706158|Vitamin D|vitamin d|mesh-list
110532200|NCT02706158|Calcium|calcium|mesh-list
110532201|NCT02706158|Vitamins|vitamins|mesh-ancestor
110532202|NCT02706158|Micronutrients|micronutrients|mesh-ancestor
110532203|NCT02706158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110463134|NCT00904215|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110463135|NCT00904215|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110463136|NCT00904215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110463137|NCT00904215|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110463138|NCT00904215|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110463139|NCT05317689|Psilocybin|psilocybin|mesh-list
110463140|NCT05317689|Psilocin|psilocin|mesh-list
110463141|NCT05317689|Hallucinogens|hallucinogens|mesh-ancestor
110463142|NCT05317689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110463143|NCT05317689|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110463144|NCT05293665|Vaccines|vaccines|mesh-list
110463145|NCT05293665|Immunologic Factors|immunologic factors|mesh-ancestor
110463146|NCT05293665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110463147|NCT00905307|Aripiprazole|aripiprazole|mesh-list
110463148|NCT00905307|Antidepressive Agents|antidepressive agents|mesh-ancestor
110463149|NCT00905307|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110463150|NCT00905307|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110463151|NCT00905307|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110463152|NCT00905307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110463153|NCT00905307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110463154|NCT00905307|Dopamine Agonists|dopamine agonists|mesh-ancestor
110463155|NCT00905307|Dopamine Agents|dopamine agents|mesh-ancestor
110463156|NCT00905307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110463157|NCT00905307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110463158|NCT00905307|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110463159|NCT00905307|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110463160|NCT00905307|Serotonin Agents|serotonin agents|mesh-ancestor
110463161|NCT00905307|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110463162|NCT00905307|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110463163|NCT00905307|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110463164|NCT00905307|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110463165|NCT00904839|Bevacizumab|bevacizumab|mesh-list
110463166|NCT00904839|Nintedanib|nintedanib|mesh-list
110463167|NCT00904839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110463168|NCT00904839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110463169|NCT00904839|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110463170|NCT00904839|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110463171|NCT00904839|Growth Substances|growth substances|mesh-ancestor
110463172|NCT00904839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110463174|NCT00904839|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110463175|NCT00904839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110463176|NCT00904839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110463177|NCT04985955|Tofacitinib|tofacitinib|mesh-list
110463178|NCT04985955|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
110463179|NCT04985955|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110463180|NCT04985955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110463181|NCT04985955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110463182|NCT02821923|Erythritol|erythritol|mesh-list
110463183|NCT02821923|Vasodilator Agents|vasodilator agents|mesh-ancestor
110463184|NCT00903357|Ascorbic Acid|ascorbic acid|mesh-list
110463185|NCT00903357|Montelukast|montelukast|mesh-list
110463186|NCT00903357|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110463187|NCT00903357|Respiratory System Agents|respiratory system agents|mesh-ancestor
110463188|NCT00903357|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110463189|NCT00903357|Hormone Antagonists|hormone antagonists|mesh-ancestor
110478557|NCT01018862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110532204|NCT02706158|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110532205|NCT02706158|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110532207|NCT03739853|Adalimumab|adalimumab|mesh-list
110179699|NCT00847002|Laxatives|laxatives|mesh-ancestor
110532208|NCT03739853|Methotrexate|methotrexate|mesh-list
110532209|NCT03739853|Leflunomide|leflunomide|mesh-list
110532210|NCT03739853|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110532211|NCT03739853|Abortifacient Agents|abortifacient agents|mesh-ancestor
110532212|NCT03739853|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110532213|NCT03739853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110532214|NCT03739853|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110532215|NCT03739853|Antimetabolites|antimetabolites|mesh-ancestor
110532216|NCT03739853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110532217|NCT03739853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110532218|NCT03739853|Dermatologic Agents|dermatologic agents|mesh-ancestor
110463190|NCT00903357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110463191|NCT00903357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110595457|NCT00782717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110463192|NCT00903357|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110463193|NCT00903357|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110463194|NCT00903357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110463195|NCT00903357|Antioxidants|antioxidants|mesh-ancestor
110463196|NCT00903357|Protective Agents|protective agents|mesh-ancestor
110463197|NCT00903357|Vitamins|vitamins|mesh-ancestor
110463198|NCT00903357|Micronutrients|micronutrients|mesh-ancestor
110463199|NCT02754063|3,4,4a,10b-tetrahydro-4-propyl-2H,5H-(1)benzopyrano(4,3-b)-1,4-oxazin-9-ol|3,4,4a,10b-tetrahydro-4-propyl-2h,5h-(1)benzopyrano(4,3-b)-1,4-oxazin-9-ol|mesh-list
110463200|NCT02754063|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110463201|NCT02754063|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110463202|NCT02754063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110463203|NCT02754063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110463204|NCT02754063|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110463205|NCT02754063|Dopamine Agonists|dopamine agonists|mesh-ancestor
110463206|NCT02754063|Dopamine Agents|dopamine agents|mesh-ancestor
110463207|NCT02754063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110463208|NCT02754063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110463209|NCT04202289|Sulfadiazine|sulfadiazine|mesh-list
110463210|NCT04202289|Silver Sulfadiazine|silver sulfadiazine|mesh-list
110463211|NCT04202289|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110463212|NCT04202289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110463213|NCT04202289|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110463214|NCT04202289|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110463215|NCT04202289|Coccidiostats|coccidiostats|mesh-ancestor
110463216|NCT04202289|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110463217|NCT01730313|Pyridoxine|pyridoxine|mesh-list
110463218|NCT01730313|Vitamin B 6|vitamin b 6|mesh-list
110463219|NCT01730313|Phenytoin|phenytoin|mesh-list
110463220|NCT01730313|Valproic Acid|valproic acid|mesh-list
110463221|NCT01730313|Vitamins|vitamins|mesh-ancestor
110463222|NCT01730313|Micronutrients|micronutrients|mesh-ancestor
110463223|NCT01730313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110463224|NCT01730313|Vitamin B Complex|vitamin b complex|mesh-ancestor
110463225|NCT01730313|Anticonvulsants|anticonvulsants|mesh-ancestor
110463226|NCT01730313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110110325|NCT01840774|Anesthetics|anesthetics|mesh-ancestor
110463227|NCT01730313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110463229|NCT01730313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110463230|NCT01730313|Antimanic Agents|antimanic agents|mesh-ancestor
110463231|NCT01730313|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110463232|NCT01730313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110532219|NCT03739853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110532220|NCT03739853|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110532221|NCT03739853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110532222|NCT03739853|Immunologic Factors|immunologic factors|mesh-ancestor
110532223|NCT03739853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110532224|NCT03739853|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110532225|NCT03739853|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110532226|NCT03739853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110532227|NCT03739853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110532228|NCT03739853|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110532229|NCT03739853|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110532230|NCT03739853|Analgesics|analgesics|mesh-ancestor
110532231|NCT03739853|Sensory System Agents|sensory system agents|mesh-ancestor
110188461|NCT02899611|Valproic Acid|valproic acid|mesh-list
110463233|NCT01730313|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110463234|NCT01730313|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110463235|NCT01730313|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110463236|NCT01730313|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110463237|NCT01730313|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110463238|NCT01730313|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110463239|NCT02849379|Immunomodulating Agents|immunomodulating agents|mesh-list
110463240|NCT02849379|Immunologic Factors|immunologic factors|mesh-ancestor
110463241|NCT02849379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110463242|NCT01104662|Vancomycin|vancomycin|mesh-list
110463243|NCT01104662|Daptomycin|daptomycin|mesh-list
110463244|NCT01104662|Penicillins|penicillins|mesh-list
110463245|NCT01104662|Cloxacillin|cloxacillin|mesh-list
110463246|NCT01104662|Oxacillin|oxacillin|mesh-list
110463247|NCT01104662|Nafcillin|nafcillin|mesh-list
110463248|NCT01104662|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110463249|NCT01104662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110463250|NCT05062785|Insulin|insulin|mesh-list
110463251|NCT05062785|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110463252|NCT05062785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110463253|NCT01103960|Amlodipine|amlodipine|mesh-list
110463254|NCT01103960|Telmisartan|telmisartan|mesh-list
110463255|NCT01103960|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110463256|NCT01103960|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110463257|NCT01103960|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110463258|NCT01103960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110463259|NCT01103960|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110463260|NCT01103960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110463261|NCT01103960|Vasodilator Agents|vasodilator agents|mesh-ancestor
110463262|NCT01103960|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110463263|NCT01103960|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110463264|NCT04413279|Dexamethasone|dexamethasone|mesh-list
110463265|NCT04413279|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110463266|NCT04413279|Antiemetics|antiemetics|mesh-ancestor
110463267|NCT04413279|Autonomic Agents|autonomic agents|mesh-ancestor
110463268|NCT04413279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110463269|NCT04413279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110463270|NCT04413279|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110463271|NCT04413279|Glucocorticoids|glucocorticoids|mesh-ancestor
110463272|NCT04413279|Hormones|hormones|mesh-ancestor
110463273|NCT04413279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110463274|NCT04413279|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110463275|NCT04413279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110463276|NCT04975256|Adagrasib|adagrasib|mesh-list
110463277|NCT04975256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110463278|NCT02880800|Morphine|morphine|mesh-list
110463279|NCT02880800|Hydromorphone|hydromorphone|mesh-list
110463280|NCT02880800|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110532232|NCT03739853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110532233|NCT03739853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110532234|NCT00615602|Cyclophosphamide|cyclophosphamide|mesh-list
110532235|NCT00615602|Docetaxel|docetaxel|mesh-list
110532236|NCT00615602|Trastuzumab|trastuzumab|mesh-list
110532237|NCT00615602|Epirubicin|epirubicin|mesh-list
110532238|NCT00615602|Fluorouracil|fluorouracil|mesh-list
110532239|NCT00615602|Lenograstim|lenograstim|mesh-list
110532240|NCT00615602|Mitogens|mitogens|mesh-list
110532241|NCT00615602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110532242|NCT00615602|Immunologic Factors|immunologic factors|mesh-ancestor
110463281|NCT02880800|Narcotics|narcotics|mesh-ancestor
110463282|NCT02880800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110463283|NCT02880800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110463284|NCT02880800|Analgesics|analgesics|mesh-ancestor
110463285|NCT02880800|Sensory System Agents|sensory system agents|mesh-ancestor
110463286|NCT02880800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110463287|NCT01107392|Botulinum Toxins|botulinum toxins|mesh-list
110463288|NCT01107392|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110463289|NCT01107392|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110463290|NCT01107392|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110463291|NCT01107392|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110463292|NCT01107392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110463293|NCT01107392|Cholinergic Agents|cholinergic agents|mesh-ancestor
110463294|NCT01107392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110463295|NCT01107392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110463296|NCT01107392|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110463297|NCT01107392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110463298|NCT05037279|BCG Vaccine|bcg vaccine|mesh-list
110463299|NCT05037279|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110463300|NCT05037279|Immunologic Factors|immunologic factors|mesh-ancestor
110463301|NCT05037279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110463302|NCT01106846|Ketamine|ketamine|mesh-list
110463303|NCT01106846|Analgesics|analgesics|mesh-ancestor
110463304|NCT01106846|Sensory System Agents|sensory system agents|mesh-ancestor
110463305|NCT01106846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110463306|NCT01106846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110463307|NCT01106846|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110463308|NCT01106846|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110463309|NCT01106846|Anesthetics, General|anesthetics, general|mesh-ancestor
110463310|NCT01106846|Anesthetics|anesthetics|mesh-ancestor
110463311|NCT01106846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110463312|NCT01106846|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110463313|NCT01106846|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110463314|NCT01106846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110463315|NCT01106846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110463316|NCT05034783|Exenatide|exenatide|mesh-list
110463317|NCT05034783|Edetic Acid|edetic acid|mesh-list
110463318|NCT05034783|Chelating Agents|chelating agents|mesh-ancestor
110463319|NCT05034783|Sequestering Agents|sequestering agents|mesh-ancestor
110463320|NCT05034783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110463321|NCT05034783|Anticoagulants|anticoagulants|mesh-ancestor
110463322|NCT05034783|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110463323|NCT05034783|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110463324|NCT05034783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110463325|NCT05034783|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110463326|NCT05034783|Incretins|incretins|mesh-ancestor
110463327|NCT05034783|Hormones|hormones|mesh-ancestor
110463328|NCT05034783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110463329|NCT00902577|Misonidazole|misonidazole|mesh-list
110463330|NCT00902577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110463331|NCT00902577|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110463332|NCT00902577|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110463333|NCT00902577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110463334|NCT04202367|Bupivacaine|bupivacaine|mesh-list
110463335|NCT04202367|Anesthetics, Local|anesthetics, local|mesh-ancestor
110463336|NCT04202367|Anesthetics|anesthetics|mesh-ancestor
110478558|NCT01018862|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110532243|NCT00615602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110532245|NCT00615602|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110532246|NCT00615602|Alkylating Agents|alkylating agents|mesh-ancestor
110532247|NCT00615602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110463337|NCT04202367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110463338|NCT04202367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110463339|NCT04202367|Sensory System Agents|sensory system agents|mesh-ancestor
110463340|NCT04202367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110463341|NCT02846493|Dexamethasone|dexamethasone|mesh-list
110463342|NCT02846493|Bromocriptine|bromocriptine|mesh-list
110463343|NCT02846493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110463344|NCT02846493|Antiemetics|antiemetics|mesh-ancestor
110463345|NCT02846493|Autonomic Agents|autonomic agents|mesh-ancestor
110463346|NCT02846493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110463347|NCT02846493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110463348|NCT02846493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110463349|NCT02846493|Glucocorticoids|glucocorticoids|mesh-ancestor
110463350|NCT02846493|Hormones|hormones|mesh-ancestor
110463351|NCT02846493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110463352|NCT02846493|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110463353|NCT02846493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110463354|NCT02846493|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110463355|NCT02846493|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110463356|NCT02846493|Hormone Antagonists|hormone antagonists|mesh-ancestor
110463357|NCT02846493|Dopamine Agonists|dopamine agonists|mesh-ancestor
110463358|NCT02846493|Dopamine Agents|dopamine agents|mesh-ancestor
110463359|NCT02846493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110463360|NCT02846493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110463361|NCT01106690|Metformin|metformin|mesh-list
110463362|NCT01106690|Pioglitazone|pioglitazone|mesh-list
110463363|NCT01106690|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110463364|NCT01106690|Canagliflozin|canagliflozin|mesh-list
110463365|NCT01106690|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110463366|NCT01106690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110463367|NCT01106690|Incretins|incretins|mesh-ancestor
110463368|NCT01106690|Hormones|hormones|mesh-ancestor
110463369|NCT01106690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110463370|NCT01106690|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110463371|NCT01106690|Protease Inhibitors|protease inhibitors|mesh-ancestor
110463372|NCT01106690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110463373|NCT01106690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110307325|NCT00301587|Moxifloxacin|moxifloxacin|mesh-list
110463374|NCT01106690|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110463375|NCT04286529|Calcitriol|calcitriol|mesh-list
110463376|NCT04286529|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110463377|NCT04286529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110110471|NCT01841515|Natriuretic Agents|natriuretic agents|mesh-ancestor
110463378|NCT04286529|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
110463379|NCT04286529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110463380|NCT04286529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110463381|NCT04286529|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110463382|NCT04286529|Vitamins|vitamins|mesh-ancestor
110463383|NCT04286529|Micronutrients|micronutrients|mesh-ancestor
110463384|NCT04286529|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110463385|NCT01103180|Escitalopram|escitalopram|mesh-list
110463386|NCT01103180|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110463387|NCT01103180|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110463388|NCT01103180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110463389|NCT01103180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110463390|NCT01103180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110463391|NCT01103180|Serotonin Agents|serotonin agents|mesh-ancestor
110463392|NCT01103180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110463393|NCT00625898|Cyclophosphamide|cyclophosphamide|mesh-list
110463394|NCT00625898|Bevacizumab|bevacizumab|mesh-list
110463395|NCT00625898|Carboplatin|carboplatin|mesh-list
110463397|NCT00625898|Fluorouracil|fluorouracil|mesh-list
110463398|NCT00625898|Trastuzumab|trastuzumab|mesh-list
110463399|NCT00625898|Epirubicin|epirubicin|mesh-list
110532248|NCT00615602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110532249|NCT00615602|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110532250|NCT00615602|Tubulin Modulators|tubulin modulators|mesh-ancestor
110532251|NCT00615602|Antimitotic Agents|antimitotic agents|mesh-ancestor
110532252|NCT00615602|Mitosis Modulators|mitosis modulators|mesh-ancestor
110532253|NCT00615602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110532254|NCT00615602|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110595503|NCT00656019|Vitamin D|vitamin d|mesh-list
110532255|NCT00615602|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110532256|NCT00615602|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110532257|NCT00615602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110532258|NCT00615602|Antimetabolites|antimetabolites|mesh-ancestor
110188658|NCT00042471|Pramlintide|pramlintide|mesh-list
110463400|NCT00625898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110463401|NCT00625898|Immunologic Factors|immunologic factors|mesh-ancestor
110463402|NCT00625898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110463403|NCT00625898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110463404|NCT00625898|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110463405|NCT00625898|Alkylating Agents|alkylating agents|mesh-ancestor
110463406|NCT00625898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110463407|NCT00625898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110463408|NCT00625898|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110463409|NCT00625898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110463410|NCT00625898|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110463411|NCT00625898|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110463412|NCT00625898|Growth Substances|growth substances|mesh-ancestor
110463413|NCT00625898|Growth Inhibitors|growth inhibitors|mesh-ancestor
110463414|NCT00625898|Tubulin Modulators|tubulin modulators|mesh-ancestor
110463415|NCT00625898|Antimitotic Agents|antimitotic agents|mesh-ancestor
110463416|NCT00625898|Mitosis Modulators|mitosis modulators|mesh-ancestor
110463417|NCT00625898|Antimetabolites|antimetabolites|mesh-ancestor
110463418|NCT00625898|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110463419|NCT00625898|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110463420|NCT00625898|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110463421|NCT00625898|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110463422|NCT00625898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110463423|NCT02853552|Misoprostol|misoprostol|mesh-list
110463424|NCT02853552|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110463426|NCT02853552|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110463427|NCT02853552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110463428|NCT02853552|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110463429|NCT02853552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110463430|NCT02853552|Oxytocics|oxytocics|mesh-ancestor
110463431|NCT04268472|Darunavir|darunavir|mesh-list
110463432|NCT04268472|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110463433|NCT04268472|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110463434|NCT04268472|Protease Inhibitors|protease inhibitors|mesh-ancestor
110463435|NCT04268472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110463436|NCT04268472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110463437|NCT04268472|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110463438|NCT04268472|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110463439|NCT04268472|Antiviral Agents|antiviral agents|mesh-ancestor
110463440|NCT04268472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110463441|NCT02844621|Omeprazole|omeprazole|mesh-list
110463442|NCT02844621|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110463443|NCT02844621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110463444|NCT02844621|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110463445|NCT02844621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110463446|NCT02844621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110463447|NCT01106534|Aspirin|aspirin|mesh-list
110463448|NCT01106534|Everolimus|everolimus|mesh-list
110463449|NCT01106534|Clopidogrel|clopidogrel|mesh-list
110463450|NCT01106534|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
110463451|NCT01106534|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110463452|NCT01106534|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110532259|NCT00615602|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110532260|NCT00615602|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110532262|NCT02698748|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
110532263|NCT02698748|Amebicides|amebicides|mesh-ancestor
110532264|NCT02698748|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110532265|NCT02698748|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110532266|NCT02698748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110532267|NCT02698748|Antimalarials|antimalarials|mesh-ancestor
110532268|NCT02698748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110532269|NCT02698748|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110532270|NCT02698748|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110532271|NCT02698748|Analgesics|analgesics|mesh-ancestor
110532272|NCT02698748|Sensory System Agents|sensory system agents|mesh-ancestor
110532273|NCT02698748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110532274|NCT02698748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110532275|NCT02698748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110532276|NCT02698748|Filaricides|filaricides|mesh-ancestor
110532277|NCT02698748|Antinematodal Agents|antinematodal agents|mesh-ancestor
110532278|NCT02698748|Anthelmintics|anthelmintics|mesh-ancestor
110532279|NCT04750343|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110532280|NCT04214990|Aspirin|aspirin|mesh-list
110532281|NCT04214990|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110463453|NCT01106534|Analgesics|analgesics|mesh-ancestor
110463454|NCT01106534|Sensory System Agents|sensory system agents|mesh-ancestor
110463455|NCT01106534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110463456|NCT01106534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110463457|NCT01106534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110463458|NCT01106534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110463459|NCT01106534|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110463460|NCT01106534|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110463461|NCT01106534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110463462|NCT01106534|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110463463|NCT01106534|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110463464|NCT01106534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110463465|NCT01106534|Antipyretics|antipyretics|mesh-ancestor
110463466|NCT01106534|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110463467|NCT01106534|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110463468|NCT01106534|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110463469|NCT01106534|Immunologic Factors|immunologic factors|mesh-ancestor
110463470|NCT01106534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110463471|NCT01106534|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110463472|NCT01106534|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110463473|NCT01106534|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110463474|NCT01106534|Purinergic Agents|purinergic agents|mesh-ancestor
110463475|NCT01106534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110463476|NCT00941304|Oxycodone|oxycodone|mesh-list
110463477|NCT00941304|Buprenorphine|buprenorphine|mesh-list
110463478|NCT00941304|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110463479|NCT00941304|Narcotics|narcotics|mesh-ancestor
110463480|NCT00941304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110463481|NCT00941304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110463483|NCT00941304|Sensory System Agents|sensory system agents|mesh-ancestor
110032730|NCT05271253|Anesthetics, Local|anesthetics, local|mesh-ancestor
110532282|NCT04214990|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110532283|NCT04214990|Analgesics|analgesics|mesh-ancestor
110532284|NCT04214990|Sensory System Agents|sensory system agents|mesh-ancestor
110532285|NCT04214990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110532286|NCT04214990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110463484|NCT00941304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110463485|NCT00941304|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110463486|NCT02846025|Folic Acid|folic acid|mesh-list
110463487|NCT02846025|Vitamin B Complex|vitamin b complex|mesh-list
110463488|NCT02846025|Antioxidants|antioxidants|mesh-list
110463489|NCT02846025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110463490|NCT02846025|Protective Agents|protective agents|mesh-ancestor
110463491|NCT02846025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110463492|NCT02846025|Hematinics|hematinics|mesh-ancestor
110463493|NCT02846025|Vitamins|vitamins|mesh-ancestor
110463494|NCT02846025|Micronutrients|micronutrients|mesh-ancestor
110463495|NCT02880410|Temozolomide|temozolomide|mesh-list
110463496|NCT02880410|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110463497|NCT02880410|Alkylating Agents|alkylating agents|mesh-ancestor
110463498|NCT02880410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110463499|NCT02880410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110463500|NCT02879006|Omalizumab|omalizumab|mesh-list
110463501|NCT02879006|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110463502|NCT02879006|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110463503|NCT02879006|Respiratory System Agents|respiratory system agents|mesh-ancestor
110463504|NCT00941070|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110463505|NCT00941070|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110463506|NCT00941070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110463507|NCT02857218|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
110463508|NCT02857218|Hematinics|hematinics|mesh-ancestor
110463509|NCT02857218|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
110463510|NCT02857218|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110463511|NCT00602316|Chelating Agents|chelating agents|mesh-list
110463512|NCT00602316|Sequestering Agents|sequestering agents|mesh-ancestor
110463513|NCT00602316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110463514|NCT00602394|Lithium Carbonate|lithium carbonate|mesh-list
110463515|NCT00602394|Antidepressive Agents|antidepressive agents|mesh-ancestor
110463516|NCT00602394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110463517|NCT00602394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110463518|NCT00602394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110463519|NCT00602394|Antimanic Agents|antimanic agents|mesh-ancestor
110463520|NCT00602394|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110463521|NCT00602394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110463522|NCT00602394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110463523|NCT04956302|Dexamethasone|dexamethasone|mesh-list
110463524|NCT04956302|Dexamethasone acetate|dexamethasone acetate|mesh-list
110463525|NCT04956302|Bortezomib|bortezomib|mesh-list
110463526|NCT04956302|Daratumumab|daratumumab|mesh-list
110463527|NCT04956302|Panobinostat|panobinostat|mesh-list
110463528|NCT04956302|Ichthammol|ichthammol|mesh-list
110463529|NCT04956302|BB 1101|bb 1101|mesh-list
110463530|NCT04956302|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110463531|NCT04956302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110463532|NCT04956302|Antiemetics|antiemetics|mesh-ancestor
110463533|NCT04956302|Autonomic Agents|autonomic agents|mesh-ancestor
110463534|NCT04956302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110463535|NCT04956302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110463536|NCT04956302|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110463537|NCT04956302|Glucocorticoids|glucocorticoids|mesh-ancestor
110463538|NCT04956302|Hormones|hormones|mesh-ancestor
110463539|NCT04956302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110463540|NCT04956302|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110307380|NCT00266669|Nitroglycerin|nitroglycerin|mesh-list
110463541|NCT04956302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110463542|NCT04956302|Protease Inhibitors|protease inhibitors|mesh-ancestor
110463543|NCT04956302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110463544|NCT04956302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110463545|NCT04956302|Immunologic Factors|immunologic factors|mesh-ancestor
110463546|NCT04956302|Dermatologic Agents|dermatologic agents|mesh-ancestor
110463547|NCT04956302|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110463549|NCT02848443|Bevacizumab|bevacizumab|mesh-list
110463550|NCT02848443|Nivolumab|nivolumab|mesh-list
110532287|NCT04214990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110532289|NCT04214990|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110532290|NCT04214990|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110532291|NCT04214990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110532292|NCT04214990|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110532293|NCT04214990|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110532294|NCT04214990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110532295|NCT04214990|Antipyretics|antipyretics|mesh-ancestor
110532296|NCT00615212|Rosiglitazone|rosiglitazone|mesh-list
110532297|NCT00615212|Flurbiprofen|flurbiprofen|mesh-list
110532298|NCT00615212|Midazolam|midazolam|mesh-list
110532299|NCT00615212|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110532300|NCT00615212|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110463551|NCT02848443|Oxaliplatin|oxaliplatin|mesh-list
110463552|NCT02848443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110463553|NCT02848443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110463554|NCT02848443|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110463555|NCT02848443|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110463556|NCT02848443|Growth Substances|growth substances|mesh-ancestor
110463557|NCT02848443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110463558|NCT02848443|Growth Inhibitors|growth inhibitors|mesh-ancestor
110463559|NCT02848443|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110463560|NCT02848443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110463561|NCT02848443|Antimetabolites|antimetabolites|mesh-ancestor
110463562|NCT02848443|Antiviral Agents|antiviral agents|mesh-ancestor
110463563|NCT02848443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110463564|NCT00632697|Pentoxifylline|pentoxifylline|mesh-list
110463565|NCT00632697|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110463566|NCT00632697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110463567|NCT00632697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110463568|NCT00632697|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110463569|NCT00632697|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110463570|NCT00632697|Protective Agents|protective agents|mesh-ancestor
110463571|NCT00632697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110463572|NCT00632697|Vasodilator Agents|vasodilator agents|mesh-ancestor
110463573|NCT00632697|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110463574|NCT00632697|Antioxidants|antioxidants|mesh-ancestor
110463575|NCT02848209|Phenol|phenol|mesh-list
110463576|NCT02848209|Croton Oil|croton oil|mesh-list
110463577|NCT02848209|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110463578|NCT02848209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110463579|NCT02848209|Disinfectants|disinfectants|mesh-ancestor
110463580|NCT02848209|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
110463581|NCT02848209|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110463582|NCT02848209|Dermatologic Agents|dermatologic agents|mesh-ancestor
110463583|NCT05337969|Metformin|metformin|mesh-list
110463584|NCT05337969|Vildagliptin|vildagliptin|mesh-list
110463585|NCT05337969|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110463586|NCT05337969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110463587|NCT05337969|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110463588|NCT05337969|Protease Inhibitors|protease inhibitors|mesh-ancestor
110463589|NCT05337969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110463590|NCT05337969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110463591|NCT02844153|Metformin|metformin|mesh-list
110463592|NCT02844153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110463593|NCT02844153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110463594|NCT02844387|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110463595|NCT02844075|Pembrolizumab|pembrolizumab|mesh-list
110463596|NCT02844075|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110463597|NCT02844075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110463598|NCT02844075|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110463599|NCT02844075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110463600|NCT02844309|Thalidomide|thalidomide|mesh-list
110532301|NCT00615212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110532302|NCT00615212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110532303|NCT00615212|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110532304|NCT00615212|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110532305|NCT00615212|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110532306|NCT00615212|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110532307|NCT00615212|Anesthetics, General|anesthetics, general|mesh-ancestor
110532308|NCT00615212|Anesthetics|anesthetics|mesh-ancestor
110532309|NCT00615212|GABA Modulators|gaba modulators|mesh-ancestor
110463601|NCT02844309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110463602|NCT02844309|Immunologic Factors|immunologic factors|mesh-ancestor
110463603|NCT02844309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110463604|NCT02844309|Leprostatic Agents|leprostatic agents|mesh-ancestor
110463605|NCT02844309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110110697|NCT01843179|Antiviral Agents|antiviral agents|mesh-ancestor
110463606|NCT02844309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110463607|NCT02844309|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110463608|NCT02844309|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110595551|NCT00718796|Micronutrients|micronutrients|mesh-ancestor
110463609|NCT02844309|Growth Substances|growth substances|mesh-ancestor
110463610|NCT02844309|Growth Inhibitors|growth inhibitors|mesh-ancestor
110463611|NCT02844309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110463612|NCT02845713|Ivermectin|ivermectin|mesh-list
110463613|NCT02845713|Albendazole|albendazole|mesh-list
110463614|NCT02845713|Diethylcarbamazine|diethylcarbamazine|mesh-list
110463615|NCT02845713|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110463616|NCT02845713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110463617|NCT02845713|Anthelmintics|anthelmintics|mesh-ancestor
110463618|NCT02845713|Anticestodal Agents|anticestodal agents|mesh-ancestor
110463619|NCT02845713|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110463620|NCT02845713|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110463621|NCT02845713|Tubulin Modulators|tubulin modulators|mesh-ancestor
110463622|NCT02845713|Antimitotic Agents|antimitotic agents|mesh-ancestor
110386305|NCT04892446|Dexamethasone|dexamethasone|mesh-list
110463623|NCT02845713|Mitosis Modulators|mitosis modulators|mesh-ancestor
110463624|NCT02845713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110463625|NCT02845713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110463626|NCT02845713|Filaricides|filaricides|mesh-ancestor
110463627|NCT02845713|Antinematodal Agents|antinematodal agents|mesh-ancestor
110463628|NCT02845713|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
110463629|NCT02845713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110463630|NCT00902265|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
110463631|NCT00902265|Hemostatics|hemostatics|mesh-ancestor
110463632|NCT00902265|Coagulants|coagulants|mesh-ancestor
110463633|NCT00902265|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
110463634|NCT00902265|Natriuretic Agents|natriuretic agents|mesh-ancestor
110463635|NCT00902265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110463636|NCT02848287|Ropivacaine|ropivacaine|mesh-list
110463637|NCT02848287|Anesthetics, Local|anesthetics, local|mesh-ancestor
110463638|NCT02848287|Anesthetics|anesthetics|mesh-ancestor
110463639|NCT02848287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110463640|NCT02848287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110463641|NCT02848287|Sensory System Agents|sensory system agents|mesh-ancestor
110463642|NCT02848287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110463643|NCT05337657|Letrozole|letrozole|mesh-list
110463644|NCT05337657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110463645|NCT05337657|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110463646|NCT05337657|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110463647|NCT05337657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110463648|NCT05337657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110463649|NCT05337657|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110463650|NCT05337657|Hormone Antagonists|hormone antagonists|mesh-ancestor
110463651|NCT05337657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110463652|NCT05337657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110463653|NCT02690883|Exenatide|exenatide|mesh-list
110463654|NCT02690883|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110463655|NCT02690883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110463656|NCT02690883|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110463657|NCT02690883|Incretins|incretins|mesh-ancestor
110463658|NCT02690883|Hormones|hormones|mesh-ancestor
110532310|NCT00615212|GABA Agents|gaba agents|mesh-ancestor
110532311|NCT00615212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110532312|NCT00615212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110532313|NCT00615212|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110532314|NCT00615212|Analgesics|analgesics|mesh-ancestor
110532315|NCT00615212|Sensory System Agents|sensory system agents|mesh-ancestor
110532316|NCT00615212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110532317|NCT00615212|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110463659|NCT02690883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110463660|NCT04385589|Dapagliflozin|dapagliflozin|mesh-list
110463661|NCT04385589|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
110463662|NCT04385589|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110463663|NCT04385589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110463664|NCT04385589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110463665|NCT02847429|Crenolanib|crenolanib|mesh-list
110463666|NCT02847429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110463667|NCT04750005|Listerine|listerine|mesh-list
110463668|NCT04750005|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110463669|NCT04750005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110463672|NCT05336721|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110463673|NCT05336721|Antimetabolites|antimetabolites|mesh-ancestor
110463674|NCT05336721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110463675|NCT05336721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110463676|NCT05336721|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110463677|NCT05336721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110463678|NCT00653913|Ezetimibe|ezetimibe|mesh-list
110463679|NCT00653913|Pitavastatin|pitavastatin|mesh-list
110463680|NCT00653913|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110463681|NCT00653913|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110463682|NCT00653913|Antimetabolites|antimetabolites|mesh-ancestor
110463683|NCT00653913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110463684|NCT00653913|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110463685|NCT00653913|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110463686|NCT00653913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110463687|NCT00652431|Niacin|niacin|mesh-list
110463688|NCT00652431|Niacinamide|niacinamide|mesh-list
110463689|NCT00652431|Nicotinic Acids|nicotinic acids|mesh-list
110463690|NCT00652431|Simvastatin|simvastatin|mesh-list
110463691|NCT00652431|Ezetimibe|ezetimibe|mesh-list
110463692|NCT00652431|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
110463693|NCT00652431|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110463694|NCT00652431|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110463695|NCT00652431|Antimetabolites|antimetabolites|mesh-ancestor
110463696|NCT00652431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110463697|NCT00652431|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110463698|NCT00652431|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110463699|NCT00652431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110463700|NCT00652431|Vasodilator Agents|vasodilator agents|mesh-ancestor
110463701|NCT00652431|Vitamin B Complex|vitamin b complex|mesh-ancestor
110463702|NCT00652431|Vitamins|vitamins|mesh-ancestor
110463703|NCT00652431|Micronutrients|micronutrients|mesh-ancestor
110463704|NCT00652431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110463705|NCT00380523|Etoricoxib|etoricoxib|mesh-list
110463706|NCT00380523|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110463707|NCT00380523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110463708|NCT00380523|Analgesics|analgesics|mesh-ancestor
110463709|NCT00380523|Sensory System Agents|sensory system agents|mesh-ancestor
110463710|NCT00380523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110463711|NCT00380523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110463712|NCT00380523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110463713|NCT00380523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110463714|NCT00380523|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110463715|NCT00380523|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110463716|NCT00380523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110463717|NCT00380523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110463718|NCT00319995|Loratadine|loratadine|mesh-list
110532318|NCT00615212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110532319|NCT00615212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110532320|NCT00615212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110532321|NCT00615212|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110595576|NCT00655863|Pioglitazone|pioglitazone|mesh-list
110532322|NCT00615212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110532323|NCT02701478|Nitrous Oxide|nitrous oxide|mesh-list
110532324|NCT02701478|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110532325|NCT02701478|Anesthetics, General|anesthetics, general|mesh-ancestor
110532326|NCT02701478|Anesthetics|anesthetics|mesh-ancestor
110532327|NCT02701478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110532328|NCT02701478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110463719|NCT00319995|Montelukast|montelukast|mesh-list
110463720|NCT00319995|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110463721|NCT00319995|Respiratory System Agents|respiratory system agents|mesh-ancestor
110463722|NCT00319995|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110463723|NCT00319995|Hormone Antagonists|hormone antagonists|mesh-ancestor
110463724|NCT00319995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110463725|NCT00319995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110463726|NCT00319995|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110463727|NCT00319995|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110463728|NCT00319995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110463729|NCT00319995|Antipruritics|antipruritics|mesh-ancestor
110463730|NCT00319995|Dermatologic Agents|dermatologic agents|mesh-ancestor
110463731|NCT00319995|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110463732|NCT00319995|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110463733|NCT00319995|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110463734|NCT00319995|Histamine Antagonists|histamine antagonists|mesh-ancestor
110463735|NCT00319995|Histamine Agents|histamine agents|mesh-ancestor
110463736|NCT00319995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110463737|NCT03304821|Sargramostim|sargramostim|mesh-list
110463738|NCT03304821|Immunologic Factors|immunologic factors|mesh-ancestor
110463739|NCT03304821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110463740|NCT02842281|Levan|levan|mesh-list
110463741|NCT02842281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110463742|NCT03721341|Hormones|hormones|mesh-list
110463743|NCT03721341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110463744|NCT03721341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110463745|NCT02842437|Dexmedetomidine|dexmedetomidine|mesh-list
110463746|NCT02842437|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110463747|NCT02842437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110463748|NCT02842437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110463749|NCT02842437|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110463750|NCT02842437|Analgesics|analgesics|mesh-ancestor
110463751|NCT02842437|Sensory System Agents|sensory system agents|mesh-ancestor
110463752|NCT02842437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110463753|NCT02842437|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110463754|NCT02842437|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110463755|NCT02842437|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110463756|NCT02842437|Adrenergic Agents|adrenergic agents|mesh-ancestor
110463757|NCT02842437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110463758|NCT02842437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110463759|NCT00157911|Simvastatin|simvastatin|mesh-list
110463760|NCT00157911|Ezetimibe|ezetimibe|mesh-list
110463761|NCT00157911|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110463762|NCT00157911|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110463763|NCT00157911|Antimetabolites|antimetabolites|mesh-ancestor
110463764|NCT00157911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110463765|NCT00157911|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110463766|NCT00157911|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110463767|NCT00157911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110463768|NCT05336175|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
110463769|NCT05336175|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110463770|NCT05336175|Vasodilator Agents|vasodilator agents|mesh-ancestor
110532329|NCT02701478|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110532330|NCT02701478|Analgesics|analgesics|mesh-ancestor
110532331|NCT02701478|Sensory System Agents|sensory system agents|mesh-ancestor
110532332|NCT02701478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110532333|NCT03314363|Trace Elements|trace elements|mesh-list
110532334|NCT03314363|Micronutrients|micronutrients|mesh-list
110532335|NCT03314363|Citric Acid|citric acid|mesh-list
110532336|NCT03314363|Sodium Citrate|sodium citrate|mesh-list
110532337|NCT03314363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110189109|NCT00020189|Antipyretics|antipyretics|mesh-ancestor
110463771|NCT02842125|Pembrolizumab|pembrolizumab|mesh-list
110463772|NCT02842125|Nivolumab|nivolumab|mesh-list
110463773|NCT02842125|Capecitabine|capecitabine|mesh-list
110463774|NCT02842125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110463775|NCT02842125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110463776|NCT02842125|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110463777|NCT02842125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110463778|NCT02842125|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110463779|NCT02842125|Antimetabolites|antimetabolites|mesh-ancestor
110463780|NCT03708549|Metformin|metformin|mesh-list
110463781|NCT03708549|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110463782|NCT03708549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110463783|NCT00156117|Olanzapine|olanzapine|mesh-list
110463784|NCT00156117|Asenapine|asenapine|mesh-list
110463785|NCT00156117|Antiemetics|antiemetics|mesh-ancestor
110463786|NCT00156117|Autonomic Agents|autonomic agents|mesh-ancestor
110463787|NCT00156117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110463788|NCT00156117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110463789|NCT00156117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110463790|NCT00156117|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110463791|NCT00156117|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110463792|NCT00156117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110463793|NCT00156117|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110463794|NCT00156117|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110463795|NCT00156117|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110463796|NCT00156117|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110463797|NCT00156117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110463798|NCT00156117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110463799|NCT00156117|Serotonin Agents|serotonin agents|mesh-ancestor
110463800|NCT00140985|Losartan|losartan|mesh-list
110463801|NCT00140985|Amlodipine|amlodipine|mesh-list
110463802|NCT00140985|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110463803|NCT00140985|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110463804|NCT00140985|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110463805|NCT00140985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110463806|NCT00140985|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110463807|NCT00140985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110463808|NCT00140985|Vasodilator Agents|vasodilator agents|mesh-ancestor
110463809|NCT00140985|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110463810|NCT00140985|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110463811|NCT00140985|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110463813|NCT00140907|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110463814|NCT00140907|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110463815|NCT00140907|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110463816|NCT00140907|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110463817|NCT00140907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110463818|NCT00132717|Atorvastatin|atorvastatin|mesh-list
110463819|NCT00132717|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110463820|NCT00132717|Simvastatin|simvastatin|mesh-list
110463821|NCT00132717|Ezetimibe|ezetimibe|mesh-list
110463822|NCT00132717|Pravastatin|pravastatin|mesh-list
110463823|NCT00132717|Lovastatin|lovastatin|mesh-list
110463824|NCT00132717|L 647318|l 647318|mesh-list
110463825|NCT00132717|Dihydromevinolin|dihydromevinolin|mesh-list
110463826|NCT00132717|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110463827|NCT00132717|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110463828|NCT00132717|Antimetabolites|antimetabolites|mesh-ancestor
110032731|NCT05271253|Anesthetics|anesthetics|mesh-ancestor
110532338|NCT03314363|Anticoagulants|anticoagulants|mesh-ancestor
110532339|NCT03314363|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110532340|NCT03314363|Chelating Agents|chelating agents|mesh-ancestor
110532341|NCT03314363|Sequestering Agents|sequestering agents|mesh-ancestor
110189174|NCT00040053|Serotonin Agents|serotonin agents|mesh-ancestor
110463829|NCT00132717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110463830|NCT00132717|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110110929|NCT01844622|Domperidone|domperidone|mesh-list
110463831|NCT00132717|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110463833|NCT00127179|Finasteride|finasteride|mesh-list
110463834|NCT00127179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110463835|NCT00127179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110463836|NCT00127179|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
110463837|NCT00127179|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110463838|NCT00127179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110463839|NCT00127179|Hormone Antagonists|hormone antagonists|mesh-ancestor
110463840|NCT00127179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110463841|NCT00127179|Urological Agents|urological agents|mesh-ancestor
110463842|NCT00953706|Ivacaftor|ivacaftor|mesh-list
110463843|NCT00953706|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
110463844|NCT00953706|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110463845|NCT00953706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110463847|NCT02852382|Bupivacaine|bupivacaine|mesh-list
110463848|NCT02852382|Anesthetics, Local|anesthetics, local|mesh-ancestor
110463849|NCT02852382|Anesthetics|anesthetics|mesh-ancestor
110463850|NCT02852382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110463851|NCT02852382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110463852|NCT02852382|Sensory System Agents|sensory system agents|mesh-ancestor
110463853|NCT02852382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110463854|NCT02852382|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110463855|NCT02852382|Narcotics|narcotics|mesh-ancestor
110463856|NCT02852382|Analgesics|analgesics|mesh-ancestor
110463857|NCT00630942|Minocycline|minocycline|mesh-list
110463858|NCT00630942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110463859|NCT00630942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110463860|NCT00602550|Zidovudine|zidovudine|mesh-list
110463861|NCT00602550|Antimetabolites|antimetabolites|mesh-ancestor
110463862|NCT00602550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110463863|NCT00602550|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110463864|NCT00602550|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110463865|NCT00602550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110463866|NCT00602550|Antiviral Agents|antiviral agents|mesh-ancestor
110463867|NCT00602550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110463868|NCT00602550|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110463869|NCT00602550|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110463870|NCT00602706|Melphalan|melphalan|mesh-list
110463871|NCT00602706|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
110463872|NCT00602706|Sargramostim|sargramostim|mesh-list
110463873|NCT00602706|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110463874|NCT00602706|Alkylating Agents|alkylating agents|mesh-ancestor
110463875|NCT00602706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110463876|NCT00602706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110463877|NCT00602706|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110463878|NCT00602706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110463879|NCT00602706|Immunologic Factors|immunologic factors|mesh-ancestor
110463880|NCT00602706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110463881|NCT00602706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110463882|NCT00602706|Analgesics|analgesics|mesh-ancestor
110463883|NCT00602706|Sensory System Agents|sensory system agents|mesh-ancestor
110463884|NCT00602706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110463885|NCT00604344|Insulin|insulin|mesh-list
110463886|NCT00604344|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110463887|NCT00604344|Insulin Detemir|insulin detemir|mesh-list
110463888|NCT00604344|Isophane Insulin, Human|isophane insulin, human|mesh-list
110463889|NCT00604344|Insulin, Isophane|insulin, isophane|mesh-list
110463890|NCT00604344|Isophane insulin, beef|isophane insulin, beef|mesh-list
110463891|NCT00604344|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110463892|NCT00604344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110463893|NCT02851914|Antidepressive Agents|antidepressive agents|mesh-list
110463894|NCT02851914|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-list
110463895|NCT02851914|Serotonin|serotonin|mesh-list
110532342|NCT03314363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110532344|NCT00906347|Oxytocin|oxytocin|mesh-list
110532345|NCT00906347|Oxytocics|oxytocics|mesh-ancestor
110532346|NCT00906347|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110532347|NCT00906347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110532348|NCT00906347|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110532349|NCT00906347|Abortifacient Agents|abortifacient agents|mesh-ancestor
110532350|NCT00906347|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110532351|NCT00906347|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110532352|NCT02705768|Carbamazepine|carbamazepine|mesh-list
110532353|NCT02705768|Oxcarbazepine|oxcarbazepine|mesh-list
110532354|NCT02705768|Anticonvulsants|anticonvulsants|mesh-ancestor
110532355|NCT02705768|Antimanic Agents|antimanic agents|mesh-ancestor
110532356|NCT02705768|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110463896|NCT02851914|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
110463897|NCT02851914|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110463898|NCT02851914|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110463899|NCT02851914|Serotonin Agents|serotonin agents|mesh-ancestor
110463900|NCT02851914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110463901|NCT02851914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110463902|NCT02851914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110463903|NCT02851914|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110111003|NCT01845038|Timolol|timolol|mesh-list
110463904|NCT02851914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110463906|NCT00938964|Anesthetics, Local|anesthetics, local|mesh-ancestor
110463907|NCT00938964|Anesthetics|anesthetics|mesh-ancestor
110463908|NCT00938964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110463909|NCT00938964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110463910|NCT00938964|Sensory System Agents|sensory system agents|mesh-ancestor
110463911|NCT00938964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110463912|NCT00938964|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110463913|NCT00938964|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110463914|NCT00938964|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110463915|NCT00938964|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110463916|NCT00938964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110463917|NCT00938886|Naltrexone|naltrexone|mesh-list
110463918|NCT00938886|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110463919|NCT00938886|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110463920|NCT00938886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110463921|NCT00938886|Sensory System Agents|sensory system agents|mesh-ancestor
110463922|NCT00938886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110463923|NCT02852070|Dimercaprol|dimercaprol|mesh-list
110463924|NCT02852070|Chelating Agents|chelating agents|mesh-ancestor
110463925|NCT02852070|Sequestering Agents|sequestering agents|mesh-ancestor
110463926|NCT02852070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110463927|NCT00602862|Bevacizumab|bevacizumab|mesh-list
110463928|NCT00602862|Sorafenib|sorafenib|mesh-list
110463929|NCT00602862|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110463930|NCT00602862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110463931|NCT00602862|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110463932|NCT00602862|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110463933|NCT00602862|Growth Substances|growth substances|mesh-ancestor
110463934|NCT00602862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110463935|NCT00602862|Growth Inhibitors|growth inhibitors|mesh-ancestor
110463936|NCT00602862|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110463937|NCT00602862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110463938|NCT00602862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110463939|NCT00942708|Fluoxetine|fluoxetine|mesh-list
110463940|NCT00942708|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110532357|NCT02705768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110532358|NCT02705768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110532359|NCT02705768|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110532360|NCT02705768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110532361|NCT02705768|Analgesics|analgesics|mesh-ancestor
110532362|NCT02705768|Sensory System Agents|sensory system agents|mesh-ancestor
110532363|NCT02705768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110532364|NCT02705768|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110532365|NCT02705768|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110189305|NCT00020774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110463941|NCT00942708|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110463942|NCT00942708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110463943|NCT00942708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110463944|NCT00942708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110463945|NCT00942708|Serotonin Agents|serotonin agents|mesh-ancestor
110463946|NCT00942708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110463947|NCT00942708|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110463948|NCT00942708|Antidepressive Agents|antidepressive agents|mesh-ancestor
110463949|NCT00942708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110463950|NCT00942708|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110463951|NCT00942708|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110463952|NCT00942708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110463953|NCT00942084|Acyclovir|acyclovir|mesh-list
110463954|NCT00942084|Antiviral Agents|antiviral agents|mesh-ancestor
110463955|NCT00942084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110463956|NCT00941928|Cyclophosphamide|cyclophosphamide|mesh-list
110463957|NCT00941928|Fludarabine|fludarabine|mesh-list
110463958|NCT00941928|Fludarabine phosphate|fludarabine phosphate|mesh-list
110463959|NCT00941928|Interleukin-2|interleukin-2|mesh-list
110463960|NCT00941928|Epratuzumab|epratuzumab|mesh-list
110463961|NCT00941928|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110463962|NCT00941928|Immunologic Factors|immunologic factors|mesh-ancestor
110463963|NCT00941928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110463964|NCT00941928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110463965|NCT00941928|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110463966|NCT00941928|Alkylating Agents|alkylating agents|mesh-ancestor
110463967|NCT00941928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110463968|NCT00941928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110463969|NCT00941928|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110463970|NCT00941928|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110463971|NCT00941928|Antimetabolites|antimetabolites|mesh-ancestor
110463972|NCT00941928|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110463973|NCT00941928|Analgesics|analgesics|mesh-ancestor
110463974|NCT00941928|Sensory System Agents|sensory system agents|mesh-ancestor
110463975|NCT00941928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110111079|NCT01845194|Diuretics|diuretics|mesh-ancestor
110463976|NCT00941928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110463977|NCT02852694|Adalimumab|adalimumab|mesh-list
110463978|NCT02852694|Methotrexate|methotrexate|mesh-list
110463979|NCT02852694|Mercaptopurine|mercaptopurine|mesh-list
110463980|NCT02852694|Azathioprine|azathioprine|mesh-list
110463981|NCT02852694|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110463982|NCT02852694|Abortifacient Agents|abortifacient agents|mesh-ancestor
110463983|NCT02852694|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110463984|NCT02852694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110463985|NCT02852694|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110463986|NCT02852694|Antimetabolites|antimetabolites|mesh-ancestor
110463987|NCT02852694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110463988|NCT02852694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110463989|NCT02852694|Dermatologic Agents|dermatologic agents|mesh-ancestor
110463990|NCT02852694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110463991|NCT02852694|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110463992|NCT02852694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110463993|NCT02852694|Immunologic Factors|immunologic factors|mesh-ancestor
110532366|NCT02705768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110532367|NCT02705768|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110532368|NCT02705768|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110532369|NCT02705768|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110532371|NCT00616070|Glucocorticoids|glucocorticoids|mesh-ancestor
110043638|NCT01449123|Mannitol|mannitol|mesh-list
110463994|NCT02852694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110463995|NCT02852694|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110463996|NCT02852694|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110463997|NCT02852694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110463998|NCT00604578|Pioglitazone|pioglitazone|mesh-list
110463999|NCT00604578|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110464000|NCT00604578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110464001|NCT00937560|Paclitaxel|paclitaxel|mesh-list
110464002|NCT00937560|Bevacizumab|bevacizumab|mesh-list
110464003|NCT00937560|Carboplatin|carboplatin|mesh-list
110464004|NCT00937560|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110464005|NCT00937560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110464006|NCT00937560|Tubulin Modulators|tubulin modulators|mesh-ancestor
110464007|NCT00937560|Antimitotic Agents|antimitotic agents|mesh-ancestor
110464008|NCT00937560|Mitosis Modulators|mitosis modulators|mesh-ancestor
110464009|NCT00937560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110464010|NCT00937560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110464011|NCT00937560|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110464012|NCT00937560|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110464013|NCT00937560|Growth Substances|growth substances|mesh-ancestor
110464014|NCT00937560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110464015|NCT00937560|Growth Inhibitors|growth inhibitors|mesh-ancestor
110464016|NCT04268394|Metformin|metformin|mesh-list
110464017|NCT04268394|Itraconazole|itraconazole|mesh-list
110464018|NCT04268394|Rifampin|rifampin|mesh-list
110464019|NCT04268394|Sulfasalazine|sulfasalazine|mesh-list
110464020|NCT04268394|Methotrexate|methotrexate|mesh-list
110464021|NCT04268394|Digoxin|digoxin|mesh-list
110464022|NCT04268394|Midazolam|midazolam|mesh-list
110464023|NCT04268394|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110464024|NCT04268394|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110464025|NCT04268394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110464026|NCT04268394|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110464027|NCT04268394|Abortifacient Agents|abortifacient agents|mesh-ancestor
110464028|NCT04268394|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110464029|NCT04268394|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110464030|NCT04268394|Antimetabolites|antimetabolites|mesh-ancestor
110464031|NCT04268394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110464032|NCT04268394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110464033|NCT04268394|Dermatologic Agents|dermatologic agents|mesh-ancestor
110464034|NCT04268394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110464035|NCT04268394|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110464036|NCT04268394|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110464037|NCT04268394|Immunologic Factors|immunologic factors|mesh-ancestor
110464038|NCT04268394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110464039|NCT04268394|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110464040|NCT04268394|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110464041|NCT04268394|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110464042|NCT04268394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110464043|NCT04268394|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110464044|NCT04268394|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110464045|NCT04268394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110464046|NCT04268394|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110464047|NCT04268394|Anesthetics, General|anesthetics, general|mesh-ancestor
110464048|NCT04268394|Anesthetics|anesthetics|mesh-ancestor
110464049|NCT04268394|GABA Modulators|gaba modulators|mesh-ancestor
110464050|NCT04268394|GABA Agents|gaba agents|mesh-ancestor
110464051|NCT04268394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110464052|NCT04268394|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110464053|NCT04268394|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110464054|NCT04268394|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110464055|NCT04268394|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110532373|NCT00616070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110532374|NCT00616070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110532375|NCT03153527|Prednisone|prednisone|mesh-list
110532376|NCT03153527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110532377|NCT03153527|Glucocorticoids|glucocorticoids|mesh-ancestor
110532378|NCT03153527|Hormones|hormones|mesh-ancestor
110532379|NCT03153527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110532380|NCT03153527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110532381|NCT03153527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110464056|NCT04268394|Antifungal Agents|antifungal agents|mesh-ancestor
110464057|NCT04268394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110464058|NCT04268394|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110464059|NCT04268394|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110464060|NCT04268394|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110464061|NCT04268394|Hormone Antagonists|hormone antagonists|mesh-ancestor
110464062|NCT04268394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110464063|NCT04268394|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110464064|NCT04268394|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110464065|NCT04268394|Antitubercular Agents|antitubercular agents|mesh-ancestor
110464066|NCT04268394|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110464067|NCT04268394|Leprostatic Agents|leprostatic agents|mesh-ancestor
110464068|NCT04268394|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110464069|NCT04268394|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110464070|NCT04268394|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110464071|NCT04268394|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110464072|NCT04268394|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110464073|NCT04268394|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110464074|NCT04268394|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110464075|NCT04268394|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110464076|NCT04268394|Protective Agents|protective agents|mesh-ancestor
110464077|NCT04268394|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110464078|NCT04268394|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110464079|NCT04268394|Analgesics|analgesics|mesh-ancestor
110464080|NCT04268394|Sensory System Agents|sensory system agents|mesh-ancestor
110464081|NCT04268394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110464082|NCT04268394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110464083|NCT04268394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110464084|NCT02851212|Metformin|metformin|mesh-list
110464085|NCT02851212|Canagliflozin|canagliflozin|mesh-list
110464086|NCT02851212|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110464087|NCT02851212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110464088|NCT02851212|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110464089|NCT02851212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110464090|NCT00594568|N2-((2S)-2-(3,5-difluorophenyl)-2-hydroxyethanoyl)-N1-((7S)-5-methyl-6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-L-alaninamide|n2-((2s)-2-(3,5-difluorophenyl)-2-hydroxyethanoyl)-n1-((7s)-5-methyl-6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-l-alaninamide|mesh-list
110464091|NCT00594568|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
110464092|NCT00594568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110464093|NCT00594568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110464094|NCT04143802|Dulaglutide|dulaglutide|mesh-list
110464095|NCT04143802|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110464096|NCT04143802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110464097|NCT00682630|Artesunate|artesunate|mesh-list
110464098|NCT00682630|Pyronaridine|pyronaridine|mesh-list
110464099|NCT00682630|Pyronaridine tetraphosphate, artesunate drug combination|pyronaridine tetraphosphate, artesunate drug combination|mesh-list
110464100|NCT00682630|Antimalarials|antimalarials|mesh-ancestor
110464101|NCT00682630|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110464102|NCT00682630|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110464103|NCT00682630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110464104|NCT00682630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110464105|NCT00682630|Antiviral Agents|antiviral agents|mesh-ancestor
110464106|NCT00682630|Schistosomicides|schistosomicides|mesh-ancestor
110532382|NCT03153527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110532383|NCT02705534|Ribavirin|ribavirin|mesh-list
110532384|NCT02705534|Sofosbuvir|sofosbuvir|mesh-list
110532385|NCT02705534|Ledipasvir|ledipasvir|mesh-list
110532386|NCT02705534|Antimetabolites|antimetabolites|mesh-ancestor
110532387|NCT02705534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110532388|NCT02705534|Antiviral Agents|antiviral agents|mesh-ancestor
110532389|NCT02705534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110532390|NCT02701166|Bezafibrate|bezafibrate|mesh-list
110532391|NCT02701166|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110532392|NCT02701166|Antimetabolites|antimetabolites|mesh-ancestor
110189509|NCT00021671|Erythromycin|erythromycin|mesh-list
110464107|NCT00682630|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110464108|NCT00682630|Anthelmintics|anthelmintics|mesh-ancestor
110464109|NCT00875056|Vorinostat|vorinostat|mesh-list
110464110|NCT00875056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110464111|NCT00875056|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110464112|NCT00875056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110464113|NCT00875056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110464114|NCT00685594|Vitamin D|vitamin d|mesh-list
110464115|NCT00685594|Cholecalciferol|cholecalciferol|mesh-list
110464116|NCT00685594|Vitamins|vitamins|mesh-ancestor
110464117|NCT00685594|Micronutrients|micronutrients|mesh-ancestor
110464118|NCT00685594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110464119|NCT00685594|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110464120|NCT00685594|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110464121|NCT00685672|Epinephrine|epinephrine|mesh-list
110464122|NCT00685672|Racepinephrine|racepinephrine|mesh-list
110111236|NCT01846325|Vitamin E|vitamin e|mesh-list
110464123|NCT00685672|Epinephryl borate|epinephryl borate|mesh-list
110464124|NCT00685672|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110464125|NCT00685672|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110464126|NCT00685672|Adrenergic Agents|adrenergic agents|mesh-ancestor
110464127|NCT00685672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110464128|NCT00685672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110464129|NCT00685672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110464130|NCT00685672|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110464131|NCT00685672|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110464132|NCT00685672|Autonomic Agents|autonomic agents|mesh-ancestor
110464133|NCT00685672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110464134|NCT00685672|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110464135|NCT00685672|Respiratory System Agents|respiratory system agents|mesh-ancestor
110464136|NCT00685672|Mydriatics|mydriatics|mesh-ancestor
110464137|NCT00685672|Sympathomimetics|sympathomimetics|mesh-ancestor
110464138|NCT00685672|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110464139|NCT00683176|Choline|choline|mesh-list
110464140|NCT00683176|Fenofibrate|fenofibrate|mesh-list
110464141|NCT00683176|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110464142|NCT00683176|Antimetabolites|antimetabolites|mesh-ancestor
110464143|NCT00683176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110464144|NCT00683176|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110464145|NCT00683176|Lipotropic Agents|lipotropic agents|mesh-ancestor
110464146|NCT00683176|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110464147|NCT00683176|Nootropic Agents|nootropic agents|mesh-ancestor
110464148|NCT02626234|Digoxin|digoxin|mesh-list
110464149|NCT02626234|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110464150|NCT02626234|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110464151|NCT02626234|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110464152|NCT02626234|Antimetabolites|antimetabolites|mesh-ancestor
110464153|NCT02626234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110464154|NCT02626234|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110464155|NCT02626234|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110464156|NCT02626234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110464157|NCT02626234|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110464158|NCT02626234|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110464159|NCT02626234|Protective Agents|protective agents|mesh-ancestor
110464160|NCT02626234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110532393|NCT02701166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110532394|NCT02701166|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110532395|NCT03141203|Romidepsin|romidepsin|mesh-list
110532396|NCT03141203|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110532397|NCT03141203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110532398|NCT03141203|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110532399|NCT03141203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110532400|NCT03141203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110532401|NCT05320991|Ketamine|ketamine|mesh-list
110532402|NCT05320991|Analgesics|analgesics|mesh-ancestor
110532403|NCT05320991|Sensory System Agents|sensory system agents|mesh-ancestor
110532404|NCT05320991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110532405|NCT05320991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110532406|NCT05320991|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110532407|NCT05320991|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110532408|NCT05320991|Anesthetics, General|anesthetics, general|mesh-ancestor
110532409|NCT05320991|Anesthetics|anesthetics|mesh-ancestor
110532410|NCT05320991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110532411|NCT05320991|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110532412|NCT05320991|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110532413|NCT05320991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110532414|NCT05320991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110464161|NCT00685828|Imatinib Mesylate|imatinib mesylate|mesh-list
110464162|NCT00685828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110464163|NCT00685828|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110464164|NCT00685828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110464165|NCT00685828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110464166|NCT00685906|Ticagrelor|ticagrelor|mesh-list
110464167|NCT00685906|Levonorgestrel|levonorgestrel|mesh-list
110464168|NCT00685906|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110464169|NCT00685906|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
110464170|NCT00685906|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
110464171|NCT00685906|Estradiol|estradiol|mesh-list
110464172|NCT00685906|Estrogens|estrogens|mesh-ancestor
110464173|NCT00685906|Hormones|hormones|mesh-ancestor
110464174|NCT00685906|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110464175|NCT00685906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110464176|NCT00685906|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110464177|NCT00685906|Contraceptive Agents|contraceptive agents|mesh-ancestor
110464178|NCT00685906|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110464179|NCT00685906|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110464180|NCT00685906|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110464181|NCT00685906|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110464182|NCT00685906|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110464183|NCT00685906|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110464184|NCT00685906|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110464185|NCT00685906|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110464186|NCT00685906|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110464187|NCT00685906|Purinergic Agents|purinergic agents|mesh-ancestor
110532415|NCT04215614|Lidocaine|lidocaine|mesh-list
110532416|NCT04215614|Bupivacaine|bupivacaine|mesh-list
110532417|NCT04215614|Anesthetics, Local|anesthetics, local|mesh-ancestor
110532418|NCT04215614|Anesthetics|anesthetics|mesh-ancestor
110532419|NCT04215614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110532420|NCT04215614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110532421|NCT04215614|Sensory System Agents|sensory system agents|mesh-ancestor
110532422|NCT04215614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110532423|NCT04215614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110532424|NCT04215614|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110532425|NCT04215614|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110532426|NCT04215614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110464188|NCT00685906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110464189|NCT00685906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110464190|NCT00685906|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110464191|NCT00685906|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
110464192|NCT00685906|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
110464193|NCT00685906|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
110464194|NCT04139824|Naproxen|naproxen|mesh-list
110111308|NCT01847144|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110464195|NCT04139824|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
110464196|NCT04139824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
110464197|NCT04139824|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110464198|NCT04139824|Analgesics|analgesics|mesh-ancestor
110464199|NCT04139824|Sensory System Agents|sensory system agents|mesh-ancestor
110464200|NCT04139824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110464201|NCT04139824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110464202|NCT04139824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110464203|NCT04139824|Gout Suppressants|gout suppressants|mesh-ancestor
110464204|NCT04139824|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110464205|NCT04139824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110464206|NCT04139824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110464207|NCT00940602|Deferasirox|deferasirox|mesh-list
110464208|NCT00940602|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110464209|NCT00940602|Chelating Agents|chelating agents|mesh-ancestor
110464210|NCT00940602|Sequestering Agents|sequestering agents|mesh-ancestor
110464211|NCT00940602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110464212|NCT00686140|Celecoxib|celecoxib|mesh-list
110464213|NCT00686140|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110464214|NCT00686140|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110464215|NCT00686140|Analgesics|analgesics|mesh-ancestor
110464216|NCT00686140|Sensory System Agents|sensory system agents|mesh-ancestor
110464217|NCT00686140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110464218|NCT00686140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110464219|NCT00686140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110464220|NCT00686140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110464221|NCT00686140|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110464222|NCT00686140|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110464223|NCT00686140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110464224|NCT00686140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110464225|NCT00686218|Imatinib Mesylate|imatinib mesylate|mesh-list
110464226|NCT00686218|Panobinostat|panobinostat|mesh-list
110464227|NCT00686218|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
110464228|NCT00686218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110464229|NCT00686218|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110464230|NCT00686218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110464231|NCT00686218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110464232|NCT00683956|Propofol|propofol|mesh-list
110464233|NCT00683956|Anesthetics|anesthetics|mesh-ancestor
110464234|NCT00683956|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110464235|NCT00683956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110532427|NCT04215614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110532428|NCT00906035|Aspirin|aspirin|mesh-list
110532429|NCT00906035|Dipyridamole|dipyridamole|mesh-list
110532430|NCT00906035|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110532431|NCT00906035|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110532432|NCT00906035|Analgesics|analgesics|mesh-ancestor
110532433|NCT00906035|Sensory System Agents|sensory system agents|mesh-ancestor
110532434|NCT00906035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110189688|NCT00049569|Leucovorin|leucovorin|mesh-list
110189689|NCT00049569|Cytarabine|cytarabine|mesh-list
110189690|NCT00049569|Prednisone|prednisone|mesh-list
110189693|NCT00049569|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
110464236|NCT00683956|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110464237|NCT00683956|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110464238|NCT00683956|Anesthetics, General|anesthetics, general|mesh-ancestor
110464239|NCT02850744|Temozolomide|temozolomide|mesh-list
110464240|NCT02850744|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110464241|NCT02850744|Alkylating Agents|alkylating agents|mesh-ancestor
110464242|NCT02850744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110464243|NCT02850744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110464245|NCT04139668|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110464246|NCT04139668|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110464247|NCT04139668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110464248|NCT04139668|Sensory System Agents|sensory system agents|mesh-ancestor
110464249|NCT04139668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110464250|NCT04266756|Selexipag|selexipag|mesh-list
110464251|NCT04266756|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110464252|NCT00606060|Factor VIII|factor viii|mesh-list
110464253|NCT00606060|Coagulants|coagulants|mesh-ancestor
110464254|NCT00875524|Vaccines|vaccines|mesh-list
110464255|NCT00875524|Immunologic Factors|immunologic factors|mesh-ancestor
110464256|NCT00875524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110464257|NCT01094288|Docetaxel|docetaxel|mesh-list
110464258|NCT01094288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110464259|NCT01094288|Tubulin Modulators|tubulin modulators|mesh-ancestor
110464260|NCT01094288|Antimitotic Agents|antimitotic agents|mesh-ancestor
110464261|NCT01094288|Mitosis Modulators|mitosis modulators|mesh-ancestor
110464262|NCT01094288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110464263|NCT05380986|Apatinib|apatinib|mesh-list
110464264|NCT05380986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110595724|NCT00842452|Topotecan|topotecan|mesh-list
110464265|NCT05380986|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110464266|NCT05380986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110464267|NCT05380986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110464268|NCT00684112|Gabapentin|gabapentin|mesh-list
110111382|NCT01847677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110464269|NCT00684112|Analgesics|analgesics|mesh-ancestor
110464270|NCT00684112|Sensory System Agents|sensory system agents|mesh-ancestor
110464271|NCT00684112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110464272|NCT00684112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110464273|NCT00684112|Anticonvulsants|anticonvulsants|mesh-ancestor
110464274|NCT00684112|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110464275|NCT00684112|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110464276|NCT00684112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110464277|NCT00684112|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110464278|NCT00684112|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110464279|NCT00684112|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110464280|NCT00684112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110464281|NCT00684112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110464282|NCT00684112|Antimanic Agents|antimanic agents|mesh-ancestor
110464283|NCT00684190|Esomeprazole|esomeprazole|mesh-list
110464284|NCT00684190|Lesogaberan|lesogaberan|mesh-list
110464285|NCT00684190|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110464286|NCT00684190|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110464287|NCT00684190|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110464288|NCT00684190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110532435|NCT00906035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110532436|NCT00906035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110532437|NCT00906035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110532438|NCT00906035|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110532439|NCT00906035|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110532440|NCT00906035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110532441|NCT00906035|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110464289|NCT00684190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110464290|NCT00684190|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
110464291|NCT00684190|GABA Agonists|gaba agonists|mesh-ancestor
110464293|NCT00684190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110464294|NCT00684190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110464295|NCT00684268|Silybin|silybin|mesh-list
110464296|NCT00684268|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110464297|NCT00684268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110464298|NCT00684268|Protective Agents|protective agents|mesh-ancestor
110464299|NCT00684268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110464300|NCT00604656|Insulin Aspart|insulin aspart|mesh-list
110464301|NCT00604656|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110464302|NCT00604656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110464303|NCT00684346|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110464304|NCT00684346|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110464305|NCT00684346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110464306|NCT00874120|Phenylephrine|phenylephrine|mesh-list
110464307|NCT00874120|Oxymetazoline|oxymetazoline|mesh-list
110464308|NCT00874120|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110464309|NCT00874120|Mydriatics|mydriatics|mesh-ancestor
110464310|NCT00874120|Autonomic Agents|autonomic agents|mesh-ancestor
110464311|NCT00874120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110464312|NCT00874120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110464313|NCT00874120|Sympathomimetics|sympathomimetics|mesh-ancestor
110464314|NCT00874120|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110464315|NCT00874120|Nasal Decongestants|nasal decongestants|mesh-ancestor
110464316|NCT00874120|Respiratory System Agents|respiratory system agents|mesh-ancestor
110464317|NCT00874120|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110464318|NCT00874120|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110464319|NCT00874120|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110464320|NCT00874120|Adrenergic Agents|adrenergic agents|mesh-ancestor
110464321|NCT00874120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110464322|NCT00874120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110464323|NCT00874120|Protective Agents|protective agents|mesh-ancestor
110464324|NCT00939822|Simvastatin|simvastatin|mesh-list
110464325|NCT00939822|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110464326|NCT00939822|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110464327|NCT00939822|Antimetabolites|antimetabolites|mesh-ancestor
110464328|NCT00939822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110464329|NCT00939822|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110464330|NCT00939822|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110464331|NCT00939822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110464332|NCT00685126|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110464333|NCT00685126|Albuterol|albuterol|mesh-list
110464334|NCT00685126|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110464335|NCT00685126|Autonomic Agents|autonomic agents|mesh-ancestor
110464336|NCT00685126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110464337|NCT00685126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110464338|NCT00685126|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110464339|NCT00685126|Respiratory System Agents|respiratory system agents|mesh-ancestor
110464340|NCT00685126|Tocolytic Agents|tocolytic agents|mesh-ancestor
110464341|NCT00685126|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110464342|NCT00685126|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110464343|NCT00685126|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110464344|NCT00685126|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110464345|NCT00685126|Adrenergic Agents|adrenergic agents|mesh-ancestor
110464346|NCT00685126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110464347|NCT00685126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110532442|NCT00906035|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110532443|NCT00906035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110532444|NCT00906035|Antipyretics|antipyretics|mesh-ancestor
110532445|NCT00906035|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110532446|NCT00906035|Vasodilator Agents|vasodilator agents|mesh-ancestor
110532447|NCT02698280|Bevacizumab|bevacizumab|mesh-list
110532448|NCT02698280|Nimustine|nimustine|mesh-list
110532449|NCT02698280|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110532450|NCT02698280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110532451|NCT02698280|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110189793|NCT00049803|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110464348|NCT00687388|Celecoxib|celecoxib|mesh-list
110464349|NCT00687388|Doxazosin|doxazosin|mesh-list
110464350|NCT00687388|Prazosin|prazosin|mesh-list
110464351|NCT00687388|Tamsulosin|tamsulosin|mesh-list
110464352|NCT00687388|Alfuzosin|alfuzosin|mesh-list
110464353|NCT00687388|Terazosin|terazosin|mesh-list
110464354|NCT00687388|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
110464355|NCT00687388|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110464356|NCT00687388|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110464357|NCT00687388|Analgesics|analgesics|mesh-ancestor
110464358|NCT00687388|Sensory System Agents|sensory system agents|mesh-ancestor
110464359|NCT00687388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110464360|NCT00687388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110464361|NCT00687388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110464362|NCT00687388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110464363|NCT00687388|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110464364|NCT00687388|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110464365|NCT00687388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110464366|NCT00687388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110464367|NCT00687388|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110464368|NCT00687388|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110464369|NCT00687388|Adrenergic Agents|adrenergic agents|mesh-ancestor
110464370|NCT00687388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110464371|NCT00687388|Urological Agents|urological agents|mesh-ancestor
110464372|NCT00687388|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110464374|NCT00939510|Sargramostim|sargramostim|mesh-list
110464375|NCT00939510|Immunologic Factors|immunologic factors|mesh-ancestor
110464376|NCT00939510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110464377|NCT00939510|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110464378|NCT00939510|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110464379|NCT00939510|Growth Substances|growth substances|mesh-ancestor
110464380|NCT00939510|Growth Inhibitors|growth inhibitors|mesh-ancestor
110464381|NCT00939510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110464382|NCT00687466|Insulin|insulin|mesh-list
110464383|NCT00687466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110464384|NCT00687466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110464385|NCT04266288|Ketamine|ketamine|mesh-list
110464386|NCT04266288|Analgesics|analgesics|mesh-ancestor
110464387|NCT04266288|Sensory System Agents|sensory system agents|mesh-ancestor
110464388|NCT04266288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110464389|NCT04266288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110464390|NCT04266288|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110464391|NCT04266288|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110464392|NCT04266288|Anesthetics, General|anesthetics, general|mesh-ancestor
110464393|NCT04266288|Anesthetics|anesthetics|mesh-ancestor
110464394|NCT04266288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110464395|NCT04266288|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110464396|NCT04266288|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110464397|NCT04266288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110464398|NCT04266288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110464399|NCT00687622|Trametinib|trametinib|mesh-list
110464400|NCT00687622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110464401|NCT00687622|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110464402|NCT00687622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110595788|NCT00803439|Clobetasol|clobetasol|mesh-list
110464403|NCT00687622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110532452|NCT02698280|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110532453|NCT02698280|Growth Substances|growth substances|mesh-ancestor
110532454|NCT02698280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110532455|NCT02698280|Growth Inhibitors|growth inhibitors|mesh-ancestor
110532457|NCT03087773|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110464404|NCT00687700|Propranolol|propranolol|mesh-list
110464405|NCT00687700|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110464406|NCT00687700|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110464407|NCT00687700|Adrenergic Agents|adrenergic agents|mesh-ancestor
110464408|NCT00687700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110464409|NCT00687700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110464410|NCT00687700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110464411|NCT00687700|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110464412|NCT00687700|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110464413|NCT00687700|Vasodilator Agents|vasodilator agents|mesh-ancestor
110464414|NCT00935532|Insulin|insulin|mesh-list
110464415|NCT00935532|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110464416|NCT00935532|Insulin Glargine|insulin glargine|mesh-list
110464417|NCT00935532|Exenatide|exenatide|mesh-list
110464418|NCT00935532|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110464419|NCT00935532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110464420|NCT00935532|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110464422|NCT00935532|Hormones|hormones|mesh-ancestor
110464423|NCT00935532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110464424|NCT04138420|Bevacizumab|bevacizumab|mesh-list
110464425|NCT04138420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110464426|NCT04138420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110464427|NCT04138420|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110464428|NCT04138420|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110464429|NCT04138420|Growth Substances|growth substances|mesh-ancestor
110464430|NCT04138420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110464431|NCT04138420|Growth Inhibitors|growth inhibitors|mesh-ancestor
110464432|NCT05378646|Interferons|interferons|mesh-list
110464433|NCT05378646|Interferon-gamma|interferon-gamma|mesh-list
110464434|NCT05378646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110464435|NCT05378646|Antiviral Agents|antiviral agents|mesh-ancestor
110307527|NCT00301860|Melphalan|melphalan|mesh-list
110464436|NCT05378646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110464437|NCT01093586|Cyclosporine|cyclosporine|mesh-list
110464438|NCT01093586|Mycophenolic Acid|mycophenolic acid|mesh-list
110464439|NCT01093586|Methylprednisolone|methylprednisolone|mesh-list
110464440|NCT01093586|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110464441|NCT01093586|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110464442|NCT01093586|Prednisolone|prednisolone|mesh-list
110464443|NCT01093586|Prednisolone acetate|prednisolone acetate|mesh-list
110464444|NCT01093586|Cyclophosphamide|cyclophosphamide|mesh-list
110464446|NCT01093586|Cyclosporins|cyclosporins|mesh-list
110464447|NCT01093586|Thymoglobulin|thymoglobulin|mesh-list
110464448|NCT01093586|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110464449|NCT01093586|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110464450|NCT01093586|Prednisolone phosphate|prednisolone phosphate|mesh-list
110464451|NCT01093586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110464452|NCT01093586|Immunologic Factors|immunologic factors|mesh-ancestor
110464453|NCT01093586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110464454|NCT01093586|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110464455|NCT01093586|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110464456|NCT01093586|Alkylating Agents|alkylating agents|mesh-ancestor
110464457|NCT01093586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110464458|NCT01093586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110464459|NCT01093586|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110464460|NCT01093586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110464461|NCT01093586|Antifungal Agents|antifungal agents|mesh-ancestor
110464462|NCT01093586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110464463|NCT01093586|Dermatologic Agents|dermatologic agents|mesh-ancestor
110464464|NCT01093586|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110464465|NCT01093586|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110464466|NCT01093586|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110464467|NCT01093586|Antitubercular Agents|antitubercular agents|mesh-ancestor
110464468|NCT01093586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110032810|NCT05270434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110532458|NCT03087773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110532459|NCT03087773|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110532460|NCT03087773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110532461|NCT02705612|Nimotuzumab|nimotuzumab|mesh-list
110532462|NCT02705612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110532463|NCT02705612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110532464|NCT05333159|Dapagliflozin|dapagliflozin|mesh-list
110532465|NCT05333159|Empagliflozin|empagliflozin|mesh-list
110532466|NCT05333159|Canagliflozin|canagliflozin|mesh-list
110532467|NCT05333159|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
110532468|NCT05333159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110532469|NCT05333159|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110532470|NCT05333159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110532471|NCT02698124|Decitabine|decitabine|mesh-list
110532472|NCT02698124|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110532473|NCT02698124|Antimetabolites|antimetabolites|mesh-ancestor
110532474|NCT02698124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110532475|NCT02698124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110532476|NCT02698124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110532477|NCT00905489|Nevirapine|nevirapine|mesh-list
110532478|NCT00905489|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110532479|NCT00905489|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110532480|NCT00905489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110464469|NCT01093586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110464470|NCT01093586|Antiemetics|antiemetics|mesh-ancestor
110464471|NCT01093586|Autonomic Agents|autonomic agents|mesh-ancestor
110464472|NCT01093586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110464473|NCT01093586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110464474|NCT01093586|Glucocorticoids|glucocorticoids|mesh-ancestor
110464475|NCT01093586|Hormones|hormones|mesh-ancestor
110464476|NCT01093586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110464477|NCT01093586|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110464478|NCT01093586|Protective Agents|protective agents|mesh-ancestor
110464479|NCT01093586|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110464480|NCT04266132|Bupivacaine|bupivacaine|mesh-list
110464481|NCT04266132|Anesthetics, Local|anesthetics, local|mesh-ancestor
110464482|NCT04266132|Anesthetics|anesthetics|mesh-ancestor
110464483|NCT04266132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110464484|NCT04266132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110464485|NCT04266132|Sensory System Agents|sensory system agents|mesh-ancestor
110464486|NCT04266132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110464487|NCT02625454|Acetaminophen|acetaminophen|mesh-list
110464488|NCT02625454|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110464489|NCT02625454|Analgesics|analgesics|mesh-ancestor
110464490|NCT02625454|Sensory System Agents|sensory system agents|mesh-ancestor
110464491|NCT02625454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110464492|NCT02625454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110464493|NCT02625454|Antipyretics|antipyretics|mesh-ancestor
110464494|NCT00606450|Thalidomide|thalidomide|mesh-list
110464495|NCT00606450|Apremilast|apremilast|mesh-list
110464496|NCT00606450|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110532481|NCT00905489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110532482|NCT00905489|Antiviral Agents|antiviral agents|mesh-ancestor
110532483|NCT00905489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110532484|NCT00905489|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110532485|NCT00905489|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110532486|NCT00905489|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110532487|NCT00905489|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110532489|NCT02705378|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110532490|NCT02705378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110532491|NCT02705378|Sensory System Agents|sensory system agents|mesh-ancestor
110532492|NCT02705378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110532493|NCT03059147|Nivolumab|nivolumab|mesh-list
110532494|NCT03059147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110189966|NCT00023231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110189967|NCT00023231|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110189968|NCT00023231|Protective Agents|protective agents|mesh-ancestor
110189969|NCT00023231|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110189970|NCT00023231|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110189971|NCT00023231|Antimetabolites|antimetabolites|mesh-ancestor
110464497|NCT00606450|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110464499|NCT00606450|Sensory System Agents|sensory system agents|mesh-ancestor
110464500|NCT00606450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110464501|NCT00606450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110464502|NCT00606450|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110464503|NCT00606450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110370631|NCT04595877|Dipyrone|dipyrone|mesh-list
110464504|NCT00606450|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
110464505|NCT00606450|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110464506|NCT00606450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110464507|NCT00606450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110464508|NCT00606450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110464509|NCT00606450|Immunologic Factors|immunologic factors|mesh-ancestor
110464510|NCT00606450|Leprostatic Agents|leprostatic agents|mesh-ancestor
110464511|NCT00606450|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110464512|NCT00606450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110464513|NCT00606450|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110464514|NCT00606450|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110464515|NCT00606450|Growth Substances|growth substances|mesh-ancestor
110464516|NCT00606450|Growth Inhibitors|growth inhibitors|mesh-ancestor
110464517|NCT00606450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110464518|NCT04138888|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110464520|NCT04138888|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
110464521|NCT04138888|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110464522|NCT04138888|Diuretics|diuretics|mesh-ancestor
110464523|NCT04138888|Natriuretic Agents|natriuretic agents|mesh-ancestor
110464524|NCT04138888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110464525|NCT04138888|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110464526|NCT04138888|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110464527|NCT04138888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110464528|NCT04138888|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110464529|NCT04138888|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110464530|NCT01098110|Asenapine|asenapine|mesh-list
110464531|NCT01098110|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110464532|NCT01098110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110532495|NCT03059147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110532496|NCT03059147|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110532497|NCT03059147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110532499|NCT03356834|Antiviral Agents|antiviral agents|mesh-ancestor
110532500|NCT03356834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110532501|NCT03356834|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110532502|NCT03356834|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110532503|NCT03356834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110464533|NCT01098110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110464534|NCT01098110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110464535|NCT01098110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110464536|NCT00688402|Lesogaberan|lesogaberan|mesh-list
110464537|NCT00688402|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110595889|NCT00620854|Vasodilator Agents|vasodilator agents|mesh-ancestor
110464538|NCT00688402|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
110464539|NCT00688402|GABA Agonists|gaba agonists|mesh-ancestor
110464540|NCT00688402|GABA Agents|gaba agents|mesh-ancestor
110464541|NCT00688402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110464542|NCT00688402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110464543|NCT00688402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110464544|NCT04138264|Analgesics, Opioid|analgesics, opioid|mesh-list
110464545|NCT04138264|Narcotics|narcotics|mesh-ancestor
110464546|NCT04138264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110464547|NCT04138264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110464548|NCT04138264|Analgesics|analgesics|mesh-ancestor
110464549|NCT04138264|Sensory System Agents|sensory system agents|mesh-ancestor
110464550|NCT04138264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110464551|NCT00688480|Allopurinol|allopurinol|mesh-list
110464552|NCT00688480|Antimetabolites|antimetabolites|mesh-ancestor
110464553|NCT00688480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110464554|NCT00688480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110464555|NCT00688480|Gout Suppressants|gout suppressants|mesh-ancestor
110464556|NCT00688480|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110464557|NCT00688480|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110464558|NCT00688480|Antioxidants|antioxidants|mesh-ancestor
110464559|NCT00688480|Protective Agents|protective agents|mesh-ancestor
110464560|NCT00688480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110464561|NCT01092728|Dasatinib|dasatinib|mesh-list
110464562|NCT01092728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110464563|NCT01092728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110464564|NCT01092728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110464565|NCT01092728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110464566|NCT00688558|Simvastatin|simvastatin|mesh-list
110464567|NCT00688558|Dalcetrapib|dalcetrapib|mesh-list
110464568|NCT00688558|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110464569|NCT00688558|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110464570|NCT00688558|Antimetabolites|antimetabolites|mesh-ancestor
110111695|NCT01850095|Estradiol|estradiol|mesh-list
110464571|NCT00688558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110464572|NCT00688558|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110307545|NCT00301860|Antifungal Agents|antifungal agents|mesh-ancestor
110464573|NCT00688558|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110464574|NCT00688558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110464575|NCT02625376|Resveratrol|resveratrol|mesh-list
110464576|NCT02625376|Antioxidants|antioxidants|mesh-ancestor
110464577|NCT02625376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110464578|NCT02625376|Protective Agents|protective agents|mesh-ancestor
110464579|NCT02625376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110464580|NCT02625376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110464581|NCT02625376|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110464582|NCT04153084|Picosulfate sodium|picosulfate sodium|mesh-list
110464583|NCT04153084|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
110464584|NCT04153084|Cathartics|cathartics|mesh-ancestor
110464585|NCT04153084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110464588|NCT00688948|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110032814|NCT05270421|Natriuretic Agents|natriuretic agents|mesh-ancestor
110532504|NCT03356834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110532505|NCT03356834|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110532506|NCT03356834|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110179978|NCT00276978|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110595929|NCT04068506|Gabapentin|gabapentin|mesh-list
110532507|NCT02705066|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
110532508|NCT02705066|Nootropic Agents|nootropic agents|mesh-ancestor
110532509|NCT00615758|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110532510|NCT00615758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110464589|NCT00688948|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110464590|NCT00688948|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110464591|NCT00688948|Adrenergic Agents|adrenergic agents|mesh-ancestor
110464592|NCT00688948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110464593|NCT00688948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110464594|NCT00688948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110464595|NCT00688948|Urological Agents|urological agents|mesh-ancestor
110464596|NCT04152694|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
110464597|NCT04152694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110464598|NCT04152694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110464600|NCT00873730|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110464601|NCT00873730|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110464602|NCT00873730|Analgesics|analgesics|mesh-ancestor
110464603|NCT00873730|Sensory System Agents|sensory system agents|mesh-ancestor
110464604|NCT00873730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110464605|NCT00873730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110464606|NCT00873730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110464607|NCT00873730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110464608|NCT00873730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110464609|NCT00873730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110464610|NCT00873730|Immunologic Factors|immunologic factors|mesh-ancestor
110464611|NCT00689416|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110464612|NCT00689416|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110464613|NCT00689416|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110464614|NCT00689416|Antimetabolites|antimetabolites|mesh-ancestor
110464615|NCT00689416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110464616|NCT00689416|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110464617|NCT00689416|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110464618|NCT00689416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110464619|NCT00689494|Levonorgestrel|levonorgestrel|mesh-list
110464620|NCT00689494|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110464621|NCT00689494|Contraceptive Agents|contraceptive agents|mesh-ancestor
110464622|NCT00689494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110464623|NCT00689494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110464624|NCT00689494|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110464625|NCT00689494|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110464626|NCT00689494|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110464627|NCT00672568|Capsaicin|capsaicin|mesh-list
110464628|NCT00672568|Antipruritics|antipruritics|mesh-ancestor
110464629|NCT00672568|Dermatologic Agents|dermatologic agents|mesh-ancestor
110464630|NCT00672568|Sensory System Agents|sensory system agents|mesh-ancestor
110464631|NCT00672568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110464632|NCT00672568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110464633|NCT00604032|Tretinoin|tretinoin|mesh-list
110464634|NCT00604032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110464635|NCT00604032|Keratolytic Agents|keratolytic agents|mesh-ancestor
110464636|NCT00604032|Dermatologic Agents|dermatologic agents|mesh-ancestor
110464637|NCT00874432|Lisinopril|lisinopril|mesh-list
110307551|NCT00301899|Trastuzumab|trastuzumab|mesh-list
110464638|NCT00874432|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
110464639|NCT00874432|Enzyme Inhibitors|enzyme inhibitors|mesh-list
110464640|NCT00874432|Protease Inhibitors|protease inhibitors|mesh-ancestor
110464641|NCT00874432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110464642|NCT00874432|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110464643|NCT00874432|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110464644|NCT00874432|Protective Agents|protective agents|mesh-ancestor
110464645|NCT00874432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110464646|NCT00935220|Linagliptin|linagliptin|mesh-list
110532511|NCT00615758|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110532512|NCT00615758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110532513|NCT00615758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110532514|NCT02704988|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110532515|NCT02704754|Suvorexant|suvorexant|mesh-list
110532516|NCT02704754|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110532517|NCT02704754|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110532518|NCT02704754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110532519|NCT02704754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110532520|NCT02704754|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
110532521|NCT02704754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110532522|NCT02704754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110532523|NCT05182658|Empagliflozin|empagliflozin|mesh-list
110532524|NCT05182658|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110532525|NCT05182658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110532526|NCT05182658|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110532527|NCT05182658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110532528|NCT04214054|Calcium|calcium|mesh-list
110047792|NCT03126916|Etoposide|etoposide|mesh-list
110464647|NCT00935220|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110464648|NCT00935220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110464649|NCT00935220|Incretins|incretins|mesh-ancestor
110464650|NCT00935220|Hormones|hormones|mesh-ancestor
110464651|NCT00935220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110464652|NCT00935220|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110464653|NCT00935220|Protease Inhibitors|protease inhibitors|mesh-ancestor
110464654|NCT00935220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110464655|NCT00935220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110464656|NCT00691912|Paclitaxel|paclitaxel|mesh-list
110464657|NCT00691912|Doxorubicin|doxorubicin|mesh-list
110464658|NCT00691912|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110464659|NCT00691912|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110464660|NCT00691912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110464661|NCT00691912|Tubulin Modulators|tubulin modulators|mesh-ancestor
110464662|NCT00691912|Antimitotic Agents|antimitotic agents|mesh-ancestor
110464663|NCT00691912|Mitosis Modulators|mitosis modulators|mesh-ancestor
110595978|NCT00806871|Antiemetics|antiemetics|mesh-ancestor
110464664|NCT00691912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110464665|NCT00691912|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110464666|NCT00691912|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110464667|NCT00691912|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110464668|NCT00691912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110464669|NCT05382390|Cytarabine|cytarabine|mesh-list
110464670|NCT05382390|Decitabine|decitabine|mesh-list
110464671|NCT05382390|Aclarubicin|aclarubicin|mesh-list
110464672|NCT05382390|Lenograstim|lenograstim|mesh-list
110464673|NCT05382390|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110464674|NCT05382390|Antimetabolites|antimetabolites|mesh-ancestor
110464675|NCT05382390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110464676|NCT05382390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110464677|NCT05382390|Antiviral Agents|antiviral agents|mesh-ancestor
110464678|NCT05382390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110464679|NCT05382390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110464680|NCT05382390|Immunologic Factors|immunologic factors|mesh-ancestor
110464681|NCT05382390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110532529|NCT04214054|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110532530|NCT04214054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110532531|NCT02909036|Melphalan|melphalan|mesh-list
110532532|NCT02909036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110532533|NCT02909036|Alkylating Agents|alkylating agents|mesh-ancestor
110532534|NCT02909036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110532535|NCT02909036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110532536|NCT02909036|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110532537|NCT02909036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110532538|NCT02909036|Immunologic Factors|immunologic factors|mesh-ancestor
110532539|NCT02909036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110532540|NCT04213898|Paclitaxel|paclitaxel|mesh-list
110532541|NCT04213898|Epirubicin|epirubicin|mesh-list
110532542|NCT04213898|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110190198|NCT00023894|Alvocidib|alvocidib|mesh-list
110464682|NCT05382390|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110464683|NCT05382390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110464684|NCT05382390|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110464685|NCT05382390|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110464686|NCT05382390|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110464687|NCT00689806|Lovastatin|lovastatin|mesh-list
110464688|NCT00689806|L 647318|l 647318|mesh-list
110464689|NCT00689806|Dihydromevinolin|dihydromevinolin|mesh-list
110464690|NCT00689806|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110464691|NCT00689806|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110464692|NCT00689806|Antimetabolites|antimetabolites|mesh-ancestor
110464693|NCT00689806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110464694|NCT00689806|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110464695|NCT00689806|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110464696|NCT00689806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110464697|NCT00594958|Vaccines|vaccines|mesh-list
110464698|NCT00594958|Immunologic Factors|immunologic factors|mesh-ancestor
110464699|NCT00594958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110464700|NCT04204044|Folic Acid|folic acid|mesh-list
110464701|NCT04204044|Vitamin B Complex|vitamin b complex|mesh-list
110464702|NCT04204044|Inositol|inositol|mesh-list
110464703|NCT04204044|Metformin|metformin|mesh-list
110595979|NCT00806871|Autonomic Agents|autonomic agents|mesh-ancestor
110464704|NCT04204044|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110464705|NCT04204044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110464706|NCT04204044|Hematinics|hematinics|mesh-ancestor
110464707|NCT04204044|Vitamins|vitamins|mesh-ancestor
110464708|NCT04204044|Micronutrients|micronutrients|mesh-ancestor
110464709|NCT00594880|Interferons|interferons|mesh-list
110464710|NCT00594880|Interferon-alpha|interferon-alpha|mesh-list
110464711|NCT00594880|Interferon alpha-2|interferon alpha-2|mesh-list
110464712|NCT00594880|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110464713|NCT00594880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110464714|NCT00594880|Antiviral Agents|antiviral agents|mesh-ancestor
110464715|NCT00594880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110464716|NCT00594880|Immunologic Factors|immunologic factors|mesh-ancestor
110464717|NCT00594880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110464718|NCT00690118|Pioglitazone|pioglitazone|mesh-list
110111841|NCT01851005|Narcotics|narcotics|mesh-ancestor
110464719|NCT00690118|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110464720|NCT00690118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110464721|NCT00694252|Lapatinib|lapatinib|mesh-list
110464722|NCT00694252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110464723|NCT00694252|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110464724|NCT00694252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110464725|NCT00694252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110464726|NCT00871858|Fulvestrant|fulvestrant|mesh-list
110464727|NCT00871858|Anastrozole|anastrozole|mesh-list
110464728|NCT00871858|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110532543|NCT04213898|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110532545|NCT04213898|Tubulin Modulators|tubulin modulators|mesh-ancestor
110532546|NCT04213898|Antimitotic Agents|antimitotic agents|mesh-ancestor
110532547|NCT04213898|Mitosis Modulators|mitosis modulators|mesh-ancestor
110532548|NCT04213898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110532549|NCT04213898|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110532550|NCT04213898|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110532551|NCT04213898|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110532552|NCT04213898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110532554|NCT03170882|Pomalidomide|pomalidomide|mesh-list
110464729|NCT00871858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110464730|NCT00871858|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110464731|NCT00871858|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110464732|NCT00871858|Hormone Antagonists|hormone antagonists|mesh-ancestor
110464733|NCT00871858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110464734|NCT00871858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110464735|NCT00871858|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110464736|NCT00871858|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110464737|NCT00871858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110464738|NCT00871858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110464739|NCT00673270|Hydrocortisone|hydrocortisone|mesh-list
110596012|NCT00845104|Bevacizumab|bevacizumab|mesh-list
110464740|NCT00673270|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
110464741|NCT00673270|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
110464742|NCT00673270|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
110464743|NCT00673270|Fludrocortisone|fludrocortisone|mesh-list
110464744|NCT00673270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110464745|NCT00871780|Natalizumab|natalizumab|mesh-list
110464746|NCT00871780|Immunologic Factors|immunologic factors|mesh-ancestor
110464747|NCT00871780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110464748|NCT00694408|Methylprednisolone|methylprednisolone|mesh-list
110464749|NCT00694408|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110464750|NCT00694408|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110464751|NCT00694408|Prednisolone|prednisolone|mesh-list
110464752|NCT00694408|Prednisolone acetate|prednisolone acetate|mesh-list
110464753|NCT00694408|Hydrocortisone|hydrocortisone|mesh-list
110464754|NCT00694408|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
110464755|NCT00694408|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
110464756|NCT00694408|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
110464757|NCT00694408|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110464758|NCT00694408|Prednisolone phosphate|prednisolone phosphate|mesh-list
110464759|NCT00694408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110464760|NCT00694408|Antiemetics|antiemetics|mesh-ancestor
110464761|NCT00694408|Autonomic Agents|autonomic agents|mesh-ancestor
110464762|NCT00694408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110464763|NCT00694408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110464764|NCT00694408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110464765|NCT00694408|Glucocorticoids|glucocorticoids|mesh-ancestor
110464766|NCT00694408|Hormones|hormones|mesh-ancestor
110464767|NCT00694408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110464768|NCT00694408|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110464769|NCT00694408|Protective Agents|protective agents|mesh-ancestor
110464770|NCT00694408|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110464771|NCT00694408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110464772|NCT04136782|Paclitaxel|paclitaxel|mesh-list
110464773|NCT04136782|Docetaxel|docetaxel|mesh-list
110464774|NCT04136782|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110464775|NCT04136782|Carboplatin|carboplatin|mesh-list
110464776|NCT04136782|Epirubicin|epirubicin|mesh-list
110464777|NCT04136782|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110464778|NCT04136782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110464779|NCT04136782|Tubulin Modulators|tubulin modulators|mesh-ancestor
110464780|NCT04136782|Antimitotic Agents|antimitotic agents|mesh-ancestor
110464781|NCT04136782|Mitosis Modulators|mitosis modulators|mesh-ancestor
110532555|NCT03170882|Ixazomib|ixazomib|mesh-list
110532556|NCT03170882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110532557|NCT03170882|Antiemetics|antiemetics|mesh-ancestor
110532558|NCT03170882|Autonomic Agents|autonomic agents|mesh-ancestor
110532559|NCT03170882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110532560|NCT03170882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110532561|NCT03170882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110532562|NCT03170882|Glucocorticoids|glucocorticoids|mesh-ancestor
110532563|NCT03170882|Hormones|hormones|mesh-ancestor
110532564|NCT03170882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110532565|NCT03170882|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110532566|NCT03170882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110532567|NCT03170882|Immunologic Factors|immunologic factors|mesh-ancestor
110532568|NCT03170882|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110464782|NCT04136782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110464783|NCT04136782|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110464784|NCT04136782|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110464785|NCT04136782|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110464786|NCT04136782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110464787|NCT04137640|Cyclophosphamide|cyclophosphamide|mesh-list
110464788|NCT04137640|Docetaxel|docetaxel|mesh-list
110464789|NCT04137640|Letrozole|letrozole|mesh-list
110464790|NCT04137640|Epirubicin|epirubicin|mesh-list
110464791|NCT04137640|Palbociclib|palbociclib|mesh-list
110464792|NCT04137640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110464793|NCT04137640|Immunologic Factors|immunologic factors|mesh-ancestor
110464794|NCT04137640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110464795|NCT04137640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110464796|NCT04137640|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110464797|NCT04137640|Alkylating Agents|alkylating agents|mesh-ancestor
110464798|NCT04137640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110464799|NCT04137640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110464800|NCT04137640|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110464801|NCT04137640|Tubulin Modulators|tubulin modulators|mesh-ancestor
110464802|NCT04137640|Antimitotic Agents|antimitotic agents|mesh-ancestor
110464803|NCT04137640|Mitosis Modulators|mitosis modulators|mesh-ancestor
110464804|NCT04137640|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110464805|NCT04137640|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110464806|NCT04137640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110464807|NCT04137640|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110464808|NCT04137640|Hormone Antagonists|hormone antagonists|mesh-ancestor
110464809|NCT04137640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110464810|NCT04137640|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110464811|NCT04137640|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110464812|NCT04137640|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110464813|NCT04137640|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110464815|NCT02624830|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110464816|NCT02624830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110464817|NCT02629042|Prednisolone|prednisolone|mesh-list
110464818|NCT02629042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110464819|NCT02629042|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110464820|NCT02629042|Glucocorticoids|glucocorticoids|mesh-ancestor
110464821|NCT02629042|Hormones|hormones|mesh-ancestor
110464822|NCT02629042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110464823|NCT02629042|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110464824|NCT02629042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110464825|NCT00692614|Triamcinolone|triamcinolone|mesh-list
110464826|NCT00692614|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110464827|NCT00692614|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110464828|NCT00692614|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110464829|NCT00692614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110532569|NCT03170882|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110532570|NCT03170882|Growth Substances|growth substances|mesh-ancestor
110532571|NCT03170882|Growth Inhibitors|growth inhibitors|mesh-ancestor
110532572|NCT03170882|Protease Inhibitors|protease inhibitors|mesh-ancestor
110532573|NCT03170882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110532574|NCT03170882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110532575|NCT00616850|Lidocaine|lidocaine|mesh-list
110532576|NCT00616850|Anesthetics, Local|anesthetics, local|mesh-ancestor
110532577|NCT00616850|Anesthetics|anesthetics|mesh-ancestor
110532578|NCT00616850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110532579|NCT00616850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110180065|NCT00014144|Gefitinib|gefitinib|mesh-list
110464830|NCT00692614|Glucocorticoids|glucocorticoids|mesh-ancestor
110464831|NCT00692614|Hormones|hormones|mesh-ancestor
110596047|NCT00762762|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110464832|NCT00692614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110464833|NCT00692614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110464834|NCT00692614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110464835|NCT00692614|Immunologic Factors|immunologic factors|mesh-ancestor
110464836|NCT00692614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110464837|NCT00692614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110464838|NCT04136470|Nivolumab|nivolumab|mesh-list
110464839|NCT04136470|Ipilimumab|ipilimumab|mesh-list
110464840|NCT04136470|Atezolizumab|atezolizumab|mesh-list
110464841|NCT04136470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110464842|NCT04136470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110464843|NCT04136470|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110464844|NCT04136470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110464845|NCT00673426|Enoxaparin|enoxaparin|mesh-list
110464846|NCT00673426|Anticoagulants|anticoagulants|mesh-ancestor
110464847|NCT00673426|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110464848|NCT00673426|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110464849|NCT00673426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110464851|NCT00673504|Sunitinib|sunitinib|mesh-list
110464852|NCT00673504|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110464853|NCT00673504|Antimetabolites|antimetabolites|mesh-ancestor
110464854|NCT00673504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110464855|NCT00673504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110464856|NCT00673504|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110464857|NCT00673504|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110464858|NCT00673504|Growth Substances|growth substances|mesh-ancestor
110464859|NCT00673504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110464860|NCT00673504|Growth Inhibitors|growth inhibitors|mesh-ancestor
110464861|NCT00673504|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110464862|NCT00673504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110464863|NCT00673582|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110464864|NCT00673582|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110464865|NCT00673582|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110464866|NCT00673582|Antimetabolites|antimetabolites|mesh-ancestor
110464867|NCT00673582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110464868|NCT00673582|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110464869|NCT00673582|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110464870|NCT00673582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110464871|NCT00912574|Molgramostim|molgramostim|mesh-list
110464872|NCT00912574|Sargramostim|sargramostim|mesh-list
110464873|NCT00912574|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
110464875|NCT00912574|Immunologic Factors|immunologic factors|mesh-ancestor
110464876|NCT00912574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110464877|NCT00912574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110464878|NCT00912574|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110464879|NCT00695032|Ifosfamide|ifosfamide|mesh-list
110464880|NCT00695032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110464881|NCT00695032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110464882|NCT00695032|Alkylating Agents|alkylating agents|mesh-ancestor
110532580|NCT00616850|Sensory System Agents|sensory system agents|mesh-ancestor
110532581|NCT00616850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110532582|NCT00616850|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110532583|NCT00616850|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110596066|NCT00424489|Antiemetics|antiemetics|mesh-ancestor
110532584|NCT00616850|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110532585|NCT00616850|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110532586|NCT00616850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110532588|NCT00618644|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110532589|NCT00618644|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110532590|NCT00618644|Growth Substances|growth substances|mesh-ancestor
110532591|NCT00618644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110532592|NCT00618644|Growth Inhibitors|growth inhibitors|mesh-ancestor
110532593|NCT00618644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110532594|NCT05324774|Aflibercept|aflibercept|mesh-list
110532595|NCT05324774|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110532596|NCT05324774|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110464883|NCT00695032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110464884|NCT04137328|Liraglutide|liraglutide|mesh-list
110464885|NCT04137328|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110464886|NCT04137328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110464887|NCT04137328|Incretins|incretins|mesh-ancestor
110464888|NCT04137328|Hormones|hormones|mesh-ancestor
110464889|NCT04137328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110464890|NCT00693004|Donepezil|donepezil|mesh-list
110464891|NCT00693004|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110464892|NCT00693004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110464893|NCT00693004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110464894|NCT00693004|Cholinergic Agents|cholinergic agents|mesh-ancestor
110464895|NCT00693004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110464896|NCT00693004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110464897|NCT00693004|Nootropic Agents|nootropic agents|mesh-ancestor
110464898|NCT00695344|Mycophenolic Acid|mycophenolic acid|mesh-list
110464899|NCT00695344|Everolimus|everolimus|mesh-list
110464900|NCT00695344|Azathioprine|azathioprine|mesh-list
110464901|NCT00695344|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110464902|NCT00695344|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110464903|NCT00695344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110464904|NCT00695344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110464905|NCT00695344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110464906|NCT00695344|Immunologic Factors|immunologic factors|mesh-ancestor
110464907|NCT00695344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110464908|NCT00695344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110464909|NCT00695344|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110464910|NCT00695344|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110464911|NCT00695344|Antitubercular Agents|antitubercular agents|mesh-ancestor
110464912|NCT00695344|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110464913|NCT00695344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110464914|NCT00695344|Antimetabolites|antimetabolites|mesh-ancestor
110464915|NCT00695344|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110464916|NCT00695344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110464917|NCT02624362|Phenylethyl Alcohol|phenylethyl alcohol|mesh-list
110464918|NCT02624362|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110464919|NCT02624362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110464920|NCT02624362|Disinfectants|disinfectants|mesh-ancestor
110464921|NCT00607542|Baclofen|baclofen|mesh-list
110464922|NCT00607542|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110464923|NCT00607542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110532597|NCT05324774|Growth Substances|growth substances|mesh-ancestor
110532598|NCT05324774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110532599|NCT05324774|Growth Inhibitors|growth inhibitors|mesh-ancestor
110532600|NCT05324774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110532601|NCT05324618|Hydrocortisone|hydrocortisone|mesh-list
110532602|NCT05324618|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
110532603|NCT05324618|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
110532604|NCT05324618|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
110532605|NCT05324618|Tacrolimus|tacrolimus|mesh-list
110532606|NCT05324618|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110532607|NCT05324618|Immunologic Factors|immunologic factors|mesh-ancestor
110532608|NCT05324618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110532609|NCT05324618|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110532610|NCT05324618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110464924|NCT00607542|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110464925|NCT00607542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110464926|NCT00607542|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
110464927|NCT00607542|GABA Agonists|gaba agonists|mesh-ancestor
110464928|NCT00607542|GABA Agents|gaba agents|mesh-ancestor
110464929|NCT00607542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110464930|NCT00607542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110464931|NCT00936858|Everolimus|everolimus|mesh-list
110464932|NCT00936858|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110464933|NCT00936858|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110464934|NCT00936858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110464935|NCT00936858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110464936|NCT00936858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110464937|NCT00936858|Immunologic Factors|immunologic factors|mesh-ancestor
110464938|NCT00936858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110464939|NCT00936858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110464940|NCT02624440|Clarithromycin|clarithromycin|mesh-list
110464941|NCT02624440|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
110464942|NCT02624440|Trimethoprim|trimethoprim|mesh-list
110464943|NCT02624440|Sulfamethoxazole|sulfamethoxazole|mesh-list
110464944|NCT02624440|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110464945|NCT02624440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110464946|NCT02624440|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110464947|NCT02624440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110464948|NCT02624440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110464949|NCT02624440|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110464950|NCT02624440|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110464951|NCT02624440|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110464952|NCT02624440|Antimalarials|antimalarials|mesh-ancestor
110464953|NCT02624440|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110464954|NCT02624440|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110464955|NCT02624440|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110464956|NCT02624440|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110464957|NCT02624440|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
110464958|NCT04136080|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
110464960|NCT00693862|Carbidopa|carbidopa|mesh-list
110464961|NCT00693862|Entacapone|entacapone|mesh-list
110464962|NCT00693862|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110464963|NCT00693862|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110464964|NCT00693862|Dopamine Agents|dopamine agents|mesh-ancestor
110464965|NCT00693862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110464966|NCT00693862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110464967|NCT00693862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110464968|NCT00693862|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
110464969|NCT00693862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110464970|NCT00693862|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
110464971|NCT05377788|Lazertinib|lazertinib|mesh-list
110532611|NCT05324618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110532612|NCT05324618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110532613|NCT03654989|Treprostinil|treprostinil|mesh-list
110532614|NCT03654989|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110532615|NCT05300594|Vitamins|vitamins|mesh-list
110464972|NCT05377788|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110464973|NCT05377788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110464974|NCT05377788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110464975|NCT00674050|Fluticasone|fluticasone|mesh-list
110464976|NCT00674050|Albuterol|albuterol|mesh-list
110464977|NCT00674050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110464978|NCT00674050|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110464979|NCT00674050|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110464980|NCT00674050|Autonomic Agents|autonomic agents|mesh-ancestor
110464981|NCT00674050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110464982|NCT00674050|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110464983|NCT00674050|Respiratory System Agents|respiratory system agents|mesh-ancestor
110464984|NCT00674050|Dermatologic Agents|dermatologic agents|mesh-ancestor
110464985|NCT00674050|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110464986|NCT00674050|Tocolytic Agents|tocolytic agents|mesh-ancestor
110464987|NCT00674050|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110464988|NCT00674050|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110464989|NCT00674050|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110464990|NCT00674050|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110464991|NCT00674050|Adrenergic Agents|adrenergic agents|mesh-ancestor
110464992|NCT00674050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110464993|NCT00674050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110464994|NCT00872170|Sildenafil Citrate|sildenafil citrate|mesh-list
110464995|NCT00872170|Vasodilator Agents|vasodilator agents|mesh-ancestor
110464996|NCT00872170|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110464997|NCT00872170|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110464998|NCT00872170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110464999|NCT00872170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110465000|NCT00872170|Urological Agents|urological agents|mesh-ancestor
110465001|NCT00936702|Paclitaxel|paclitaxel|mesh-list
110465002|NCT00936702|Carboplatin|carboplatin|mesh-list
110465003|NCT00936702|Everolimus|everolimus|mesh-list
110465004|NCT00936702|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110465005|NCT00936702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110465006|NCT00936702|Tubulin Modulators|tubulin modulators|mesh-ancestor
110465007|NCT00936702|Antimitotic Agents|antimitotic agents|mesh-ancestor
110465008|NCT00936702|Mitosis Modulators|mitosis modulators|mesh-ancestor
110465009|NCT00936702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110465010|NCT00936702|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110465011|NCT00936702|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110465012|NCT00936702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110465013|NCT00936702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110465014|NCT00936702|Immunologic Factors|immunologic factors|mesh-ancestor
110465015|NCT00936702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110465016|NCT00694174|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110465017|NCT00607932|Indole-3-carbinol|indole-3-carbinol|mesh-list
110465018|NCT00607932|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110465019|NCT00607932|Protective Agents|protective agents|mesh-ancestor
110465020|NCT00607932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110112131|NCT01852994|Testosterone|testosterone|mesh-list
110465021|NCT00607932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110465023|NCT00674596|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110465024|NCT00674596|Protease Inhibitors|protease inhibitors|mesh-ancestor
110465025|NCT00674596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110465026|NCT00674596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110465027|NCT00674596|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110465028|NCT00674674|Topotecan|topotecan|mesh-list
110465029|NCT00674674|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110465030|NCT00674674|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110465031|NCT00674674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110465032|NCT00674674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110465033|NCT00674674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110465034|NCT02628886|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110465035|NCT02628886|Immunologic Factors|immunologic factors|mesh-ancestor
110532616|NCT05300594|Micronutrients|micronutrients|mesh-ancestor
110532617|NCT05300594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110532619|NCT00907517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110532620|NCT00907517|Antimetabolites|antimetabolites|mesh-ancestor
110532621|NCT00907517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110532622|NCT00907517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110532623|NCT00907517|Antiviral Agents|antiviral agents|mesh-ancestor
110532624|NCT00907517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110532625|NCT00907517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110532626|NCT00907517|Immunologic Factors|immunologic factors|mesh-ancestor
110532627|NCT00907517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110532628|NCT03043547|Leucovorin|leucovorin|mesh-list
110532629|NCT03043547|Antidotes|antidotes|mesh-ancestor
110532630|NCT03043547|Protective Agents|protective agents|mesh-ancestor
110532631|NCT03043547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110532632|NCT03043547|Vitamin B Complex|vitamin b complex|mesh-ancestor
110532633|NCT03043547|Vitamins|vitamins|mesh-ancestor
110532634|NCT03043547|Micronutrients|micronutrients|mesh-ancestor
110190634|NCT00025103|Melphalan|melphalan|mesh-list
110465036|NCT02628886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110465037|NCT04265508|Hemostatics|hemostatics|mesh-list
110465038|NCT04265508|Coagulants|coagulants|mesh-ancestor
110465039|NCT02623738|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110465040|NCT02623738|Latanoprost|latanoprost|mesh-list
110465041|NCT02623738|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110465042|NCT00607074|Albendazole|albendazole|mesh-list
110465044|NCT00607074|Secnidazole|secnidazole|mesh-list
110465045|NCT00607074|Metronidazole|metronidazole|mesh-list
110465046|NCT00607074|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110465047|NCT00607074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110465048|NCT00607074|Anticestodal Agents|anticestodal agents|mesh-ancestor
110465049|NCT00607074|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110465050|NCT00607074|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110465051|NCT00607074|Tubulin Modulators|tubulin modulators|mesh-ancestor
110465052|NCT00607074|Antimitotic Agents|antimitotic agents|mesh-ancestor
110465053|NCT00607074|Mitosis Modulators|mitosis modulators|mesh-ancestor
110465054|NCT00607074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110465055|NCT00607074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110465056|NCT00607074|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110465057|NCT02623582|Cyclophosphamide|cyclophosphamide|mesh-list
110465058|NCT02623582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110465059|NCT02623582|Immunologic Factors|immunologic factors|mesh-ancestor
110465060|NCT02623582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110465061|NCT02623582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110465062|NCT02623582|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110465063|NCT02623582|Alkylating Agents|alkylating agents|mesh-ancestor
110465064|NCT02623582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110465065|NCT02623582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110465066|NCT02623582|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110465067|NCT00696202|Levonorgestrel|levonorgestrel|mesh-list
110465068|NCT00696202|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110465069|NCT00696202|Contraceptive Agents|contraceptive agents|mesh-ancestor
110465070|NCT00696202|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110465071|NCT00696202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110465072|NCT00696202|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110033132|NCT04870333|Anthelmintics|anthelmintics|mesh-ancestor
110532635|NCT00905255|Lixisenatide|lixisenatide|mesh-list
110532636|NCT00905255|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110532637|NCT00905255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110532638|NCT00905021|Sunitinib|sunitinib|mesh-list
110532639|NCT00905021|Exemestane|exemestane|mesh-list
110532640|NCT00905021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110532641|NCT00905021|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110532642|NCT00905021|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110532643|NCT00905021|Growth Substances|growth substances|mesh-ancestor
110190690|NCT00053118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110465073|NCT00696202|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110465074|NCT00696202|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110465075|NCT00674752|Gabapentin|gabapentin|mesh-list
110465076|NCT00674752|Analgesics|analgesics|mesh-ancestor
110465077|NCT00674752|Sensory System Agents|sensory system agents|mesh-ancestor
110465078|NCT00674752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110465079|NCT00674752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110465080|NCT00674752|Anticonvulsants|anticonvulsants|mesh-ancestor
110465081|NCT00674752|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110465082|NCT00674752|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110465083|NCT00674752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110465084|NCT00674752|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110465085|NCT00674752|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110465086|NCT00674752|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110465087|NCT00674752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110465088|NCT00674752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110465089|NCT00674752|Antimanic Agents|antimanic agents|mesh-ancestor
110465091|NCT04265274|Disulfiram|disulfiram|mesh-list
110465092|NCT04265274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110465093|NCT04265274|Trace Elements|trace elements|mesh-ancestor
110465094|NCT04265274|Micronutrients|micronutrients|mesh-ancestor
110465095|NCT04265274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110465096|NCT04265274|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110465097|NCT04265274|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
110465098|NCT04265274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110465099|NCT00607152|Allopurinol|allopurinol|mesh-list
110465100|NCT00607152|Rasburicase|rasburicase|mesh-list
110465101|NCT00607152|Antimetabolites|antimetabolites|mesh-ancestor
110465102|NCT00607152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110465103|NCT00607152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110465104|NCT00607152|Gout Suppressants|gout suppressants|mesh-ancestor
110465105|NCT00607152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110465106|NCT00607152|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110465107|NCT00607152|Antioxidants|antioxidants|mesh-ancestor
110465108|NCT00607152|Protective Agents|protective agents|mesh-ancestor
110465109|NCT00607152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110465110|NCT00696748|Methyltestosterone|methyltestosterone|mesh-list
110465111|NCT00696748|Testosterone|testosterone|mesh-list
110465112|NCT00696748|Testosterone undecanoate|testosterone undecanoate|mesh-list
110465113|NCT00696748|Testosterone enanthate|testosterone enanthate|mesh-list
110465114|NCT00696748|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
110465115|NCT00696748|Androgens|androgens|mesh-ancestor
110465116|NCT00696748|Hormones|hormones|mesh-ancestor
110465117|NCT00696748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110465118|NCT00696748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110465119|NCT00696748|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110465120|NCT00696748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110465121|NCT00696748|Anabolic Agents|anabolic agents|mesh-ancestor
110465122|NCT02621554|Resveratrol|resveratrol|mesh-list
110465123|NCT02621554|Antioxidants|antioxidants|mesh-ancestor
110465124|NCT02621554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110465125|NCT02621554|Protective Agents|protective agents|mesh-ancestor
110465126|NCT02621554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110465127|NCT02621554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110465128|NCT02621554|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110465129|NCT02623036|Enalapril|enalapril|mesh-list
110465130|NCT02623036|Lisinopril|lisinopril|mesh-list
110532645|NCT00905021|Growth Inhibitors|growth inhibitors|mesh-ancestor
110532646|NCT00905021|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110532647|NCT00905021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110532648|NCT00905021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110532649|NCT00905021|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110532650|NCT00905021|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110532651|NCT00905021|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110532652|NCT00905021|Hormone Antagonists|hormone antagonists|mesh-ancestor
110532653|NCT00905021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110532654|NCT03537131|Dapagliflozin|dapagliflozin|mesh-list
110532655|NCT03537131|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110532656|NCT03537131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110532657|NCT03537131|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110190753|NCT00053196|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110465131|NCT02623036|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110465132|NCT02623036|Protease Inhibitors|protease inhibitors|mesh-ancestor
110465133|NCT02623036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110465134|NCT02623036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110465135|NCT02623036|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110465136|NCT02623036|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110465137|NCT02623036|Protective Agents|protective agents|mesh-ancestor
110465138|NCT02623036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110465139|NCT00696826|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110465140|NCT00696826|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110465141|NCT00696826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110465142|NCT00696826|Incretins|incretins|mesh-ancestor
110465143|NCT00696826|Hormones|hormones|mesh-ancestor
110465144|NCT00696826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110465145|NCT00696826|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110465146|NCT00696826|Protease Inhibitors|protease inhibitors|mesh-ancestor
110465147|NCT00696826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110465148|NCT00696826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110465149|NCT01092182|Prednisone|prednisone|mesh-list
110465150|NCT01092182|Cyclophosphamide|cyclophosphamide|mesh-list
110465151|NCT01092182|Rituximab|rituximab|mesh-list
110465152|NCT01092182|Doxorubicin|doxorubicin|mesh-list
110465153|NCT01092182|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110465154|NCT01092182|Etoposide|etoposide|mesh-list
110465155|NCT01092182|Etoposide phosphate|etoposide phosphate|mesh-list
110465156|NCT01092182|Vincristine|vincristine|mesh-list
110465157|NCT01092182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110465158|NCT01092182|Immunologic Factors|immunologic factors|mesh-ancestor
110465159|NCT01092182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110465160|NCT01092182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110465161|NCT01092182|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110465162|NCT01092182|Alkylating Agents|alkylating agents|mesh-ancestor
110465163|NCT01092182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110596165|NCT01410942|Dopamine Agents|dopamine agents|mesh-ancestor
110465164|NCT01092182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110465165|NCT01092182|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110465166|NCT01092182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110465167|NCT01092182|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110465168|NCT01092182|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110465169|NCT01092182|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110465170|NCT01092182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110465171|NCT01092182|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110465173|NCT01092182|Hormones|hormones|mesh-ancestor
110532658|NCT03537131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110532659|NCT02677805|Botulinum Toxins|botulinum toxins|mesh-list
110532660|NCT02677805|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110532661|NCT02677805|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110532662|NCT02677805|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110532663|NCT02677805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110532664|NCT02677805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110532665|NCT02677805|Cholinergic Agents|cholinergic agents|mesh-ancestor
110190817|NCT00053430|Growth Substances|growth substances|mesh-ancestor
110465174|NCT01092182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110465175|NCT01092182|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110465176|NCT01092182|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110465177|NCT01092182|Tubulin Modulators|tubulin modulators|mesh-ancestor
110465178|NCT01092182|Antimitotic Agents|antimitotic agents|mesh-ancestor
110465179|NCT01092182|Mitosis Modulators|mitosis modulators|mesh-ancestor
110465180|NCT04135378|Ascorbic Acid|ascorbic acid|mesh-list
110465181|NCT04135378|Vitamins|vitamins|mesh-ancestor
110465182|NCT04135378|Micronutrients|micronutrients|mesh-ancestor
110465183|NCT04135378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110465184|NCT04135378|Antioxidants|antioxidants|mesh-ancestor
110465185|NCT04135378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110465186|NCT04135378|Protective Agents|protective agents|mesh-ancestor
110465188|NCT02878772|Vinpocetine|vinpocetine|mesh-list
110465189|NCT02878772|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110465190|NCT02878772|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110465192|NCT02878772|Sensory System Agents|sensory system agents|mesh-ancestor
110465193|NCT02878772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110465194|NCT02878772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110465195|NCT02878772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110465196|NCT02878772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110465197|NCT02878772|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110465198|NCT02878772|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110465199|NCT02878772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110465200|NCT02878772|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110465201|NCT02878772|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110465202|NCT02878772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110465203|NCT02878772|Antipyretics|antipyretics|mesh-ancestor
110465204|NCT02878772|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110465205|NCT02878772|Vasodilator Agents|vasodilator agents|mesh-ancestor
110465206|NCT02878772|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110465207|NCT02878772|Protective Agents|protective agents|mesh-ancestor
110465208|NCT02878772|Nootropic Agents|nootropic agents|mesh-ancestor
110465209|NCT02623114|Methylphenidate|methylphenidate|mesh-list
110465210|NCT02623114|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
110465211|NCT02623114|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110465212|NCT02623114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110465213|NCT02623114|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110465214|NCT02623114|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110465215|NCT02623114|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110465216|NCT02623114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110465217|NCT02623114|Dopamine Agents|dopamine agents|mesh-ancestor
110465218|NCT02623114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110465219|NCT02623114|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110465220|NCT02623114|Adrenergic Agents|adrenergic agents|mesh-ancestor
110465221|NCT00932646|Olodaterol|olodaterol|mesh-list
110465222|NCT00932646|Formoterol Fumarate|formoterol fumarate|mesh-list
110465223|NCT00932646|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110465224|NCT00932646|Autonomic Agents|autonomic agents|mesh-ancestor
110465225|NCT00932646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110465226|NCT00932646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110465227|NCT00932646|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110465228|NCT00932646|Respiratory System Agents|respiratory system agents|mesh-ancestor
110465229|NCT00932646|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110532667|NCT02677805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110532668|NCT02677805|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110532669|NCT02677805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110532670|NCT04202861|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110532671|NCT04202861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110532672|NCT04202471|Chlorhexidine|chlorhexidine|mesh-list
110532673|NCT04202471|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110532674|NCT04202471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110532675|NCT04202471|Disinfectants|disinfectants|mesh-ancestor
110534649|NCT02672592|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
110465230|NCT00932646|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110465231|NCT00932646|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110465232|NCT00932646|Adrenergic Agents|adrenergic agents|mesh-ancestor
110465233|NCT00932646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110465234|NCT00932646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110465235|NCT00871234|Etravirine|etravirine|mesh-list
110465236|NCT00871234|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110465237|NCT00871234|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110465238|NCT00871234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110465239|NCT00871234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110465240|NCT00871234|Antiviral Agents|antiviral agents|mesh-ancestor
110465241|NCT00871234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110465242|NCT04267224|Ticagrelor|ticagrelor|mesh-list
110465243|NCT04267224|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110465244|NCT04267224|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110465245|NCT04267224|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110465246|NCT04267224|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110465247|NCT04267224|Purinergic Agents|purinergic agents|mesh-ancestor
110465248|NCT04267224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110465249|NCT04267224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110465250|NCT04267224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110465251|NCT00675220|Insulin Aspart|insulin aspart|mesh-list
110465252|NCT00675220|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110465253|NCT00675220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110465254|NCT04264260|Colchicine|colchicine|mesh-list
110465255|NCT04264260|Gout Suppressants|gout suppressants|mesh-ancestor
110465256|NCT04264260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110465257|NCT04264260|Tubulin Modulators|tubulin modulators|mesh-ancestor
110465258|NCT04264260|Antimitotic Agents|antimitotic agents|mesh-ancestor
110465259|NCT04264260|Mitosis Modulators|mitosis modulators|mesh-ancestor
110465260|NCT04264260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110465261|NCT04264260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110465262|NCT04267146|Nivolumab|nivolumab|mesh-list
110465263|NCT04267146|Temozolomide|temozolomide|mesh-list
110465264|NCT04267146|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110465265|NCT04267146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110465266|NCT04267146|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110465267|NCT04267146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110465268|NCT04267146|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110465269|NCT04267146|Alkylating Agents|alkylating agents|mesh-ancestor
110465270|NCT02621320|Vitamin D|vitamin d|mesh-list
110465271|NCT02621320|Vitamins|vitamins|mesh-ancestor
110465272|NCT02621320|Micronutrients|micronutrients|mesh-ancestor
110465273|NCT02621320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110465274|NCT02621320|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110465275|NCT01097330|Amiodarone|amiodarone|mesh-list
110465276|NCT01097330|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110465277|NCT01097330|Vasodilator Agents|vasodilator agents|mesh-ancestor
110465278|NCT01097330|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
110465279|NCT01097330|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110465280|NCT01097330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110465281|NCT01097330|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110532676|NCT02395601|(R)-N-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)-1H-indole-3-carboxamide|(r)-n-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)-1h-indole-3-carboxamide|mesh-list
110532677|NCT02395601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110532678|NCT02395601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110532679|NCT00632645|Olanzapine|olanzapine|mesh-list
110532680|NCT00632645|Tiapride Hydrochloride|tiapride hydrochloride|mesh-list
110532681|NCT00632645|Tetrabenazine|tetrabenazine|mesh-list
110532682|NCT00632645|Antiemetics|antiemetics|mesh-ancestor
110532683|NCT00632645|Autonomic Agents|autonomic agents|mesh-ancestor
110190952|NCT00054054|Fluorouracil|fluorouracil|mesh-list
110465282|NCT01097330|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110465283|NCT01097330|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110465284|NCT01097330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110465285|NCT01097330|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110465286|NCT01097330|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110465287|NCT01097330|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110465288|NCT00934440|Bevacizumab|bevacizumab|mesh-list
110465289|NCT00934440|Azacitidine|azacitidine|mesh-list
110465290|NCT00934440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110465291|NCT00934440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110465292|NCT00934440|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110465293|NCT00934440|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110465294|NCT00934440|Growth Substances|growth substances|mesh-ancestor
110465295|NCT00934440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110465296|NCT00934440|Growth Inhibitors|growth inhibitors|mesh-ancestor
110465297|NCT00934440|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110465298|NCT00934440|Antimetabolites|antimetabolites|mesh-ancestor
110465299|NCT00934440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110465300|NCT00934440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110465301|NCT02622802|Acetaminophen|acetaminophen|mesh-list
110465302|NCT02622802|Azithromycin|azithromycin|mesh-list
110465303|NCT02622802|Erythromycin|erythromycin|mesh-list
110465304|NCT02622802|Erythromycin Estolate|erythromycin estolate|mesh-list
110465305|NCT02622802|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
110465306|NCT02622802|Erythromycin stearate|erythromycin stearate|mesh-list
110465307|NCT02622802|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110465308|NCT02622802|Analgesics|analgesics|mesh-ancestor
110465309|NCT02622802|Sensory System Agents|sensory system agents|mesh-ancestor
110465310|NCT02622802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110465311|NCT02622802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110465312|NCT02622802|Antipyretics|antipyretics|mesh-ancestor
110465313|NCT02622802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110465314|NCT02622802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110465315|NCT02622802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110465316|NCT02622802|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110465317|NCT02622802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110112434|NCT01855256|Autonomic Agents|autonomic agents|mesh-ancestor
110465318|NCT02622802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110465319|NCT05158374|Aspirin|aspirin|mesh-list
110465320|NCT05158374|Metformin|metformin|mesh-list
110465321|NCT05158374|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110465322|NCT05158374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110465323|NCT05158374|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110465324|NCT05158374|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110465325|NCT05158374|Analgesics|analgesics|mesh-ancestor
110465326|NCT05158374|Sensory System Agents|sensory system agents|mesh-ancestor
110465327|NCT05158374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110465328|NCT05158374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110465329|NCT05158374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110465330|NCT05158374|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110465331|NCT05158374|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110465332|NCT05158374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110465333|NCT05158374|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110532684|NCT00632645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110532685|NCT00632645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110532686|NCT00632645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110532687|NCT00632645|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110532688|NCT00632645|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110532689|NCT00632645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110532690|NCT00632645|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110532691|NCT00632645|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110191021|NCT00054288|Irinotecan|irinotecan|mesh-list
110465334|NCT05158374|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110465335|NCT05158374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110465336|NCT05158374|Antipyretics|antipyretics|mesh-ancestor
110465337|NCT00934362|Pulmonary Surfactants|pulmonary surfactants|mesh-list
110465338|NCT00934362|Respiratory System Agents|respiratory system agents|mesh-ancestor
110465339|NCT00675688|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
110465340|NCT00675688|Bazedoxifene|bazedoxifene|mesh-list
110465341|NCT00675688|Estrogens|estrogens|mesh-list
110465342|NCT00675688|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
110465343|NCT00675688|Hormones|hormones|mesh-ancestor
110465344|NCT00675688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110465345|NCT00675688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110465346|NCT00675688|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110465347|NCT00675688|Hormone Antagonists|hormone antagonists|mesh-ancestor
110465348|NCT00675688|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110465349|NCT00675688|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110465350|NCT00675688|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110465351|NCT02622334|Latanoprost|latanoprost|mesh-list
110465352|NCT02622334|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110465353|NCT02622334|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110465354|NCT00696514|Vitamin D|vitamin d|mesh-list
110465355|NCT00696514|Ergocalciferols|ergocalciferols|mesh-list
110465356|NCT00696514|Cholecalciferol|cholecalciferol|mesh-list
110465357|NCT00696514|Vitamins|vitamins|mesh-list
110465358|NCT00696514|Folic Acid|folic acid|mesh-list
110465359|NCT00696514|Vitamin B 12|vitamin b 12|mesh-list
110465360|NCT00696514|Micronutrients|micronutrients|mesh-ancestor
110465361|NCT00696514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110465362|NCT00696514|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110465363|NCT00696514|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110465364|NCT00696514|Hematinics|hematinics|mesh-ancestor
110465365|NCT00696514|Vitamin B Complex|vitamin b complex|mesh-ancestor
110465366|NCT04263870|Capecitabine|capecitabine|mesh-list
110465367|NCT04263870|Oxaliplatin|oxaliplatin|mesh-list
110465368|NCT04263870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110465369|NCT04263870|Antimetabolites|antimetabolites|mesh-ancestor
110465370|NCT04263870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110465371|NCT04263870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110465372|NCT05317182|Salicylic Acid|salicylic acid|mesh-list
110465373|NCT05317182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110465374|NCT05317182|Antifungal Agents|antifungal agents|mesh-ancestor
110465375|NCT05317182|Keratolytic Agents|keratolytic agents|mesh-ancestor
110465376|NCT05317182|Dermatologic Agents|dermatologic agents|mesh-ancestor
110465377|NCT00871000|Pentetic Acid|pentetic acid|mesh-list
110465378|NCT00871000|Antidotes|antidotes|mesh-ancestor
110465379|NCT00871000|Protective Agents|protective agents|mesh-ancestor
110465380|NCT00871000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110465381|NCT00871000|Chelating Agents|chelating agents|mesh-ancestor
110465382|NCT00871000|Sequestering Agents|sequestering agents|mesh-ancestor
110465383|NCT00871000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110465384|NCT00871000|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110465385|NCT01096784|Mecasermin|mecasermin|mesh-list
110465386|NCT01096784|Growth Substances|growth substances|mesh-ancestor
110465387|NCT01096784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110465388|NCT00696592|Bevacizumab|bevacizumab|mesh-list
110465389|NCT00696592|Verteporfin|verteporfin|mesh-list
110465390|NCT00696592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110465391|NCT00696592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110465392|NCT00696592|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110532692|NCT00632645|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110532693|NCT00632645|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110532694|NCT00632645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110532695|NCT00632645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110532696|NCT00632645|Serotonin Agents|serotonin agents|mesh-ancestor
110532697|NCT00632645|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110532698|NCT00632645|Adrenergic Agents|adrenergic agents|mesh-ancestor
110532699|NCT00632645|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110532700|NCT00632645|Dopamine Agents|dopamine agents|mesh-ancestor
110532701|NCT02849873|Tazarotene|tazarotene|mesh-list
110532702|NCT02849873|Dermatologic Agents|dermatologic agents|mesh-ancestor
110191087|NCT00054483|Bortezomib|bortezomib|mesh-list
110465393|NCT00696592|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110112512|NCT01855581|Anesthetics|anesthetics|mesh-ancestor
110465394|NCT00696592|Growth Substances|growth substances|mesh-ancestor
110465395|NCT00696592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110465396|NCT00696592|Growth Inhibitors|growth inhibitors|mesh-ancestor
110465397|NCT00696592|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110465398|NCT00696592|Dermatologic Agents|dermatologic agents|mesh-ancestor
110465399|NCT02622022|Morphine|morphine|mesh-list
110465400|NCT02622022|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110465401|NCT02622022|Narcotics|narcotics|mesh-ancestor
110465402|NCT02622022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110465403|NCT02622022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110465404|NCT02622022|Analgesics|analgesics|mesh-ancestor
110465405|NCT02622022|Sensory System Agents|sensory system agents|mesh-ancestor
110465406|NCT02622022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110465407|NCT00934050|Inositol|inositol|mesh-list
110465408|NCT00934050|Vitamin B Complex|vitamin b complex|mesh-ancestor
110465409|NCT00934050|Vitamins|vitamins|mesh-ancestor
110465410|NCT00934050|Micronutrients|micronutrients|mesh-ancestor
110465411|NCT00934050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110465412|NCT02620618|Infliximab|infliximab|mesh-list
110465413|NCT02620618|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110465414|NCT02620618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110465415|NCT02620618|Dermatologic Agents|dermatologic agents|mesh-ancestor
110465416|NCT02620618|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110465417|NCT02620618|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110465419|NCT04135456|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110465420|NCT04135456|Diuretics|diuretics|mesh-ancestor
110465421|NCT04135456|Natriuretic Agents|natriuretic agents|mesh-ancestor
110465422|NCT04135456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110465423|NCT01091168|Alkylating Agents|alkylating agents|mesh-list
110465424|NCT01091168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110465425|NCT05321576|Analgesics, Opioid|analgesics, opioid|mesh-list
110465426|NCT05321576|Narcotics|narcotics|mesh-ancestor
110465427|NCT05321576|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110465428|NCT05321576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110465429|NCT05321576|Analgesics|analgesics|mesh-ancestor
110465430|NCT05321576|Sensory System Agents|sensory system agents|mesh-ancestor
110465431|NCT05321576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110465432|NCT00864916|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
110465433|NCT00864916|Pentoxifylline|pentoxifylline|mesh-list
110465434|NCT00864916|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110465435|NCT00864916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110465436|NCT00864916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110465437|NCT00864916|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110465438|NCT00864916|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110465439|NCT00864916|Protective Agents|protective agents|mesh-ancestor
110465440|NCT00864916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110465441|NCT00864916|Vasodilator Agents|vasodilator agents|mesh-ancestor
110465442|NCT00864916|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110465443|NCT00864916|Antioxidants|antioxidants|mesh-ancestor
110465444|NCT00864916|Antiviral Agents|antiviral agents|mesh-ancestor
110465445|NCT00864916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110532703|NCT02849873|Keratolytic Agents|keratolytic agents|mesh-ancestor
110532704|NCT02304809|Vemurafenib|vemurafenib|mesh-list
110532705|NCT02304809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110532706|NCT02304809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110532707|NCT02304809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110532708|NCT02304809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110532709|NCT02849483|Ramosetron|ramosetron|mesh-list
110532710|NCT02849483|Antiemetics|antiemetics|mesh-ancestor
110532711|NCT02849483|Autonomic Agents|autonomic agents|mesh-ancestor
110532712|NCT02849483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110532713|NCT02849483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110465446|NCT00864682|Lidocaine|lidocaine|mesh-list
110465447|NCT00864682|Propofol|propofol|mesh-list
110465448|NCT00864682|Anesthetics, Local|anesthetics, local|mesh-ancestor
110465449|NCT00864682|Anesthetics|anesthetics|mesh-ancestor
110465450|NCT00864682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110465451|NCT00864682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110465452|NCT00864682|Sensory System Agents|sensory system agents|mesh-ancestor
110465453|NCT00864682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110465454|NCT00864682|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110465455|NCT00864682|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110465456|NCT00864682|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110465457|NCT00864682|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110465458|NCT00864682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110465459|NCT00864682|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110465460|NCT00864682|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110465461|NCT00864682|Anesthetics, General|anesthetics, general|mesh-ancestor
110465462|NCT00931944|Pramipexole|pramipexole|mesh-list
110465463|NCT00931944|Antioxidants|antioxidants|mesh-ancestor
110465464|NCT00931944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110465465|NCT00931944|Protective Agents|protective agents|mesh-ancestor
110465466|NCT00931944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110465467|NCT00931944|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110465468|NCT00931944|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110465469|NCT00931944|Dopamine Agonists|dopamine agonists|mesh-ancestor
110465470|NCT00931944|Dopamine Agents|dopamine agents|mesh-ancestor
110465471|NCT00931944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110465473|NCT02614456|Interferon-gamma|interferon-gamma|mesh-list
110465474|NCT02614456|Nivolumab|nivolumab|mesh-list
110465475|NCT02614456|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110465476|NCT02614456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110465477|NCT02614456|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110465478|NCT02614456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110465479|NCT02614456|Antiviral Agents|antiviral agents|mesh-ancestor
110465480|NCT02614456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110465481|NCT04130230|Choline|choline|mesh-list
110465482|NCT04130230|Neostigmine|neostigmine|mesh-list
110465483|NCT04130230|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110465484|NCT04130230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110465485|NCT04130230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110465486|NCT04130230|Cholinergic Agents|cholinergic agents|mesh-ancestor
110465487|NCT04130230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110465488|NCT04130230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110465489|NCT04130230|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110465491|NCT04130230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110465492|NCT04130230|Lipotropic Agents|lipotropic agents|mesh-ancestor
110465493|NCT04130230|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110465494|NCT04130230|Antimetabolites|antimetabolites|mesh-ancestor
110465495|NCT04130230|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110465496|NCT04130230|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110465497|NCT04130230|Nootropic Agents|nootropic agents|mesh-ancestor
110465498|NCT05148702|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110465499|NCT05148702|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
110465500|NCT05148702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110465501|NCT05148702|Antitubercular Agents|antitubercular agents|mesh-ancestor
110532714|NCT02849483|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110532715|NCT02849483|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110532716|NCT02849483|Serotonin Agents|serotonin agents|mesh-ancestor
110532717|NCT02849483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110532718|NCT02849483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110532719|NCT02849327|Immunomodulating Agents|immunomodulating agents|mesh-list
110532720|NCT02849327|Immunologic Factors|immunologic factors|mesh-ancestor
110053876|NCT01489202|Cobalt|cobalt|mesh-list
110465502|NCT02616874|Romidepsin|romidepsin|mesh-list
110465503|NCT02616874|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110465504|NCT02616874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110465505|NCT02616874|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110465506|NCT02616874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110465507|NCT02616874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110465508|NCT04133428|Valsartan|valsartan|mesh-list
110465509|NCT04133428|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
110465510|NCT04133428|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110465511|NCT04133428|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110465512|NCT04133428|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110465513|NCT04133428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110465514|NCT00869050|Capecitabine|capecitabine|mesh-list
110465515|NCT00869050|Temozolomide|temozolomide|mesh-list
110465516|NCT00869050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110465517|NCT00869050|Antimetabolites|antimetabolites|mesh-ancestor
110465518|NCT00869050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110465519|NCT00869050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110465520|NCT00869050|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110465521|NCT00869050|Alkylating Agents|alkylating agents|mesh-ancestor
110465522|NCT04133506|Aspirin|aspirin|mesh-list
110465523|NCT04133506|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110465524|NCT04133506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110465525|NCT04133506|Analgesics|analgesics|mesh-ancestor
110465526|NCT04133506|Sensory System Agents|sensory system agents|mesh-ancestor
110465527|NCT04133506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110465528|NCT04133506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110465529|NCT04133506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110465530|NCT04133506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110465531|NCT04133506|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110465532|NCT04133506|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110465533|NCT04133506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110465534|NCT04133506|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110465535|NCT04133506|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110465536|NCT04133506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110465537|NCT04133506|Antipyretics|antipyretics|mesh-ancestor
110465538|NCT04872218|Abatacept|abatacept|mesh-list
110465539|NCT04872218|Immunologic Factors|immunologic factors|mesh-ancestor
110465540|NCT04872218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110465541|NCT04872218|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110596301|NCT02576340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110465542|NCT04872218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110465543|NCT04872218|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110465544|NCT04872218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110465545|NCT04872218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110465547|NCT00698464|Pasireotide|pasireotide|mesh-list
110465548|NCT00698464|Hormones|hormones|mesh-ancestor
110465549|NCT00698464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110465550|NCT00698464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110465551|NCT04933682|Rifampin|rifampin|mesh-list
110465552|NCT04933682|Fluconazole|fluconazole|mesh-list
110465553|NCT04933682|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110465554|NCT04933682|Antitubercular Agents|antitubercular agents|mesh-ancestor
110465555|NCT04933682|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110465556|NCT04933682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110465557|NCT04933682|Leprostatic Agents|leprostatic agents|mesh-ancestor
110465558|NCT04933682|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110465559|NCT04933682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110532721|NCT02849327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110532722|NCT00618696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110532723|NCT00618696|Antibodies|antibodies|mesh-list
110532724|NCT00618696|Immunoglobulins|immunoglobulins|mesh-list
110532725|NCT00618696|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110532726|NCT00618696|Immunologic Factors|immunologic factors|mesh-ancestor
110532727|NCT00618696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110532728|NCT00618696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110532729|NCT00618852|Furosemide|furosemide|mesh-list
110532730|NCT00618852|Diuretics|diuretics|mesh-ancestor
110532731|NCT00618852|Natriuretic Agents|natriuretic agents|mesh-ancestor
110532732|NCT00618852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110532733|NCT00618852|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110532734|NCT00618852|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110532735|NCT00618852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110465560|NCT04933682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110465561|NCT04933682|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110465562|NCT04933682|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110465564|NCT04933682|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110465565|NCT04933682|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110465566|NCT04933682|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110465567|NCT04933682|Antifungal Agents|antifungal agents|mesh-ancestor
110465568|NCT04933682|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110465569|NCT04933682|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110465570|NCT04933682|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110465571|NCT04933682|Hormone Antagonists|hormone antagonists|mesh-ancestor
110465572|NCT04933682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110465573|NCT04933682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110465574|NCT04933682|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110465575|NCT04933682|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110465576|NCT00927186|Zoledronic Acid|zoledronic acid|mesh-list
110465577|NCT00927186|Teriparatide|teriparatide|mesh-list
110465578|NCT00927186|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110465579|NCT00927186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110465580|NCT00927186|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110465581|NCT00593554|Fludarabine|fludarabine|mesh-list
110465582|NCT00593554|Thiotepa|thiotepa|mesh-list
110465583|NCT00593554|Thymoglobulin|thymoglobulin|mesh-list
110465584|NCT00593554|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110465585|NCT00593554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110465586|NCT00593554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110465587|NCT00593554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110465588|NCT00593554|Immunologic Factors|immunologic factors|mesh-ancestor
110465589|NCT00593554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110465590|NCT00593554|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110465591|NCT00593554|Alkylating Agents|alkylating agents|mesh-ancestor
110465592|NCT00593554|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110465593|NCT01101308|Oxycodone|oxycodone|mesh-list
110465594|NCT01101308|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110465595|NCT01101308|Narcotics|narcotics|mesh-ancestor
110465596|NCT01101308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110465597|NCT01101308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110465598|NCT01101308|Analgesics|analgesics|mesh-ancestor
110465599|NCT01101308|Sensory System Agents|sensory system agents|mesh-ancestor
110465600|NCT01101308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110465601|NCT00626054|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110465602|NCT00926796|Azithromycin|azithromycin|mesh-list
110532736|NCT02073474|Nabiximols|nabiximols|mesh-list
110532737|NCT02073474|Analgesics|analgesics|mesh-ancestor
110532738|NCT02073474|Sensory System Agents|sensory system agents|mesh-ancestor
110532739|NCT02073474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110532740|NCT02073474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110532741|NCT00637104|Chromium|chromium|mesh-list
110532742|NCT00637104|Trace Elements|trace elements|mesh-ancestor
110532743|NCT00637104|Micronutrients|micronutrients|mesh-ancestor
110532744|NCT00637104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110532745|NCT00617760|Vaccines|vaccines|mesh-list
110532746|NCT00617760|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110532747|NCT00617760|Immunologic Factors|immunologic factors|mesh-ancestor
110532748|NCT00617760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110532749|NCT00620490|Ropivacaine|ropivacaine|mesh-list
110465603|NCT00926796|Gentamicins|gentamicins|mesh-list
110465604|NCT00926796|Gemifloxacin|gemifloxacin|mesh-list
110465605|NCT00926796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110465606|NCT00926796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110465607|NCT00926796|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110465608|NCT00926796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110465609|NCT00926796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110465610|NCT00926796|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110465611|NCT00926796|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110465612|NCT00926796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110465613|NCT00696982|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110465615|NCT00696982|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110112768|NCT01856998|Propofol|propofol|mesh-list
110465616|NCT00696982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110465617|NCT00696982|Incretins|incretins|mesh-ancestor
110465619|NCT00696982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110465620|NCT00696982|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110465621|NCT00696982|Protease Inhibitors|protease inhibitors|mesh-ancestor
110465622|NCT00696982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110465623|NCT00696982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110465624|NCT01087736|Topiramate|topiramate|mesh-list
110465625|NCT01087736|Anticonvulsants|anticonvulsants|mesh-ancestor
110465626|NCT01087736|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110465627|NCT01087736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110465628|NCT04262388|Durvalumab|durvalumab|mesh-list
110465629|NCT04262388|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110465630|NCT04262388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110465631|NCT00608712|Esomeprazole|esomeprazole|mesh-list
110465632|NCT00608712|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110465633|NCT00608712|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110465634|NCT00608712|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110465635|NCT00608712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110465636|NCT00608712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110465637|NCT01079936|Lenalidomide|lenalidomide|mesh-list
110465638|NCT01079936|Melphalan|melphalan|mesh-list
110465639|NCT01079936|Immunologic Factors|immunologic factors|mesh-ancestor
110465640|NCT01079936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110465641|NCT01079936|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110465642|NCT01079936|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110465643|NCT01079936|Growth Substances|growth substances|mesh-ancestor
110465644|NCT01079936|Growth Inhibitors|growth inhibitors|mesh-ancestor
110465645|NCT01079936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110465646|NCT01079936|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110465647|NCT01079936|Alkylating Agents|alkylating agents|mesh-ancestor
110465648|NCT01079936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110465649|NCT01079936|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110465650|NCT01079936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110465651|NCT00931710|Losartan|losartan|mesh-list
110465652|NCT00931710|Amlodipine|amlodipine|mesh-list
110532750|NCT00620490|Anesthetics, Local|anesthetics, local|mesh-ancestor
110532752|NCT00620490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110532753|NCT00620490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110532754|NCT00620490|Sensory System Agents|sensory system agents|mesh-ancestor
110532755|NCT00620490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110532756|NCT04212078|Levofloxacin|levofloxacin|mesh-list
110532757|NCT04212078|Cefuroxime|cefuroxime|mesh-list
110532758|NCT04212078|Cefuroxime axetil|cefuroxime axetil|mesh-list
110532759|NCT04212078|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110191404|NCT00027833|Leucovorin|leucovorin|mesh-list
110465653|NCT00931710|Valsartan|valsartan|mesh-list
110465654|NCT00931710|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110465655|NCT00931710|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110465656|NCT00931710|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110465657|NCT00931710|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110465658|NCT00931710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110465659|NCT00931710|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110465660|NCT00931710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110465662|NCT00931710|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110465663|NCT00931710|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110465664|NCT00931710|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110465665|NCT00931710|Diuretics|diuretics|mesh-ancestor
110465666|NCT00931710|Natriuretic Agents|natriuretic agents|mesh-ancestor
110465667|NCT00931710|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110465668|NCT01100528|Interferons|interferons|mesh-list
110465669|NCT01100528|Interferon-alpha|interferon-alpha|mesh-list
110465670|NCT01100528|Interferon alpha-2|interferon alpha-2|mesh-list
110465671|NCT01100528|Dacarbazine|dacarbazine|mesh-list
110465672|NCT01100528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110465673|NCT01100528|Antiviral Agents|antiviral agents|mesh-ancestor
110465674|NCT01100528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110465675|NCT01100528|Immunologic Factors|immunologic factors|mesh-ancestor
110465676|NCT01100528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110465677|NCT01100528|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110465678|NCT01100528|Alkylating Agents|alkylating agents|mesh-ancestor
110465679|NCT01100528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110465680|NCT01079234|Insulin|insulin|mesh-list
110465681|NCT01079234|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110465682|NCT01079234|Insulin Glargine|insulin glargine|mesh-list
110465683|NCT01079234|Insulin Aspart|insulin aspart|mesh-list
110465684|NCT01079234|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110465685|NCT01079234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110465686|NCT00931632|Nitric Oxide|nitric oxide|mesh-list
110465687|NCT00931632|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110465688|NCT00931632|Autonomic Agents|autonomic agents|mesh-ancestor
110465689|NCT00931632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110465690|NCT00931632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110465691|NCT00931632|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110465692|NCT00931632|Respiratory System Agents|respiratory system agents|mesh-ancestor
110465693|NCT00931632|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110465694|NCT00931632|Antioxidants|antioxidants|mesh-ancestor
110465695|NCT00931632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110465696|NCT00931632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110465697|NCT00931632|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
110465698|NCT00931632|Vasodilator Agents|vasodilator agents|mesh-ancestor
110465699|NCT00931632|Gasotransmitters|gasotransmitters|mesh-ancestor
110465700|NCT00931632|Protective Agents|protective agents|mesh-ancestor
110465701|NCT00608790|Albuterol|albuterol|mesh-list
110465702|NCT00608790|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110465703|NCT00608790|Autonomic Agents|autonomic agents|mesh-ancestor
110465704|NCT00608790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110465705|NCT00608790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110465706|NCT00608790|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110465707|NCT00608790|Respiratory System Agents|respiratory system agents|mesh-ancestor
110532760|NCT04212078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110532761|NCT04212078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110532762|NCT04212078|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110532763|NCT04212078|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110532764|NCT04212078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110532765|NCT04212078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110532766|NCT04212078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110532767|NCT04212078|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110465708|NCT00608790|Tocolytic Agents|tocolytic agents|mesh-ancestor
110465709|NCT00608790|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110465710|NCT00608790|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110465711|NCT00608790|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110465712|NCT00608790|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110465713|NCT00608790|Adrenergic Agents|adrenergic agents|mesh-ancestor
110465714|NCT00608790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110465715|NCT00608790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110465717|NCT01078922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110465718|NCT00609570|Calcium|calcium|mesh-list
110465719|NCT00609570|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110465720|NCT00609570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110465722|NCT00863746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110465723|NCT00863746|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110465724|NCT00863746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110465725|NCT00863746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110465726|NCT04992156|Palbociclib|palbociclib|mesh-list
110465727|NCT04992156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110465728|NCT04992156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110465729|NCT04992156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110465730|NCT04992156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110465731|NCT00608946|Copper|copper|mesh-list
110465732|NCT00608946|Trace Elements|trace elements|mesh-ancestor
110465733|NCT00608946|Micronutrients|micronutrients|mesh-ancestor
110465734|NCT00608946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110465735|NCT02615938|Hydroxychloroquine|hydroxychloroquine|mesh-list
110465736|NCT02615938|Antimalarials|antimalarials|mesh-ancestor
110465737|NCT02615938|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110465738|NCT02615938|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110465739|NCT02615938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110465740|NCT02615938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110465741|NCT02615938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110465742|NCT02615938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110465743|NCT00926328|Triclosan|triclosan|mesh-list
110465744|NCT00926328|Fluorides|fluorides|mesh-list
110465745|NCT00926328|Cariostatic Agents|cariostatic agents|mesh-ancestor
110465746|NCT00926328|Protective Agents|protective agents|mesh-ancestor
110465747|NCT00926328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110465748|NCT00926328|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110465749|NCT00926328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110465750|NCT00926328|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
110465751|NCT00926328|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110465752|NCT00926328|Antimetabolites|antimetabolites|mesh-ancestor
110465753|NCT00926328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110465754|NCT00926328|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110465755|NCT04203732|Anesthetics|anesthetics|mesh-list
110465756|NCT04203732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110465757|NCT04203732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110465758|NCT00863512|Gemcitabine|gemcitabine|mesh-list
110465759|NCT00863512|Docetaxel|docetaxel|mesh-list
110465760|NCT00863512|Pemetrexed|pemetrexed|mesh-list
110465761|NCT00863512|Vinorelbine|vinorelbine|mesh-list
110465762|NCT00863512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110465763|NCT00863512|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110465764|NCT00863512|Antimetabolites|antimetabolites|mesh-ancestor
110465765|NCT00863512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110465766|NCT00863512|Tubulin Modulators|tubulin modulators|mesh-ancestor
110465767|NCT00863512|Antimitotic Agents|antimitotic agents|mesh-ancestor
110532768|NCT04212078|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110532770|NCT01898520|Analgesics|analgesics|mesh-ancestor
110532771|NCT01898520|Sensory System Agents|sensory system agents|mesh-ancestor
110532772|NCT01898520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110596419|NCT02575638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110532773|NCT01898520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110532775|NCT00903617|Nicotinic Acids|nicotinic acids|mesh-list
110532776|NCT00903617|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110532777|NCT00903617|Antimetabolites|antimetabolites|mesh-ancestor
110532778|NCT00903617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110532779|NCT00903617|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110532780|NCT00903617|Vasodilator Agents|vasodilator agents|mesh-ancestor
110532781|NCT00903617|Vitamin B Complex|vitamin b complex|mesh-ancestor
110532782|NCT00903617|Vitamins|vitamins|mesh-ancestor
110532783|NCT00903617|Micronutrients|micronutrients|mesh-ancestor
110532784|NCT00903617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110532785|NCT02848937|Citric Acid|citric acid|mesh-list
110532786|NCT02848937|Sodium Citrate|sodium citrate|mesh-list
110532787|NCT02848937|Anticoagulants|anticoagulants|mesh-ancestor
110532788|NCT02848937|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110532789|NCT02848937|Chelating Agents|chelating agents|mesh-ancestor
110532790|NCT02848937|Sequestering Agents|sequestering agents|mesh-ancestor
110532791|NCT02848937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110465768|NCT00863512|Mitosis Modulators|mitosis modulators|mesh-ancestor
110465769|NCT00863512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110465770|NCT00863512|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110465771|NCT00863512|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110465772|NCT00863512|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110465773|NCT02619994|Levofloxacin|levofloxacin|mesh-list
110465774|NCT02619994|Linezolid|linezolid|mesh-list
110465775|NCT02619994|Pyrazinamide|pyrazinamide|mesh-list
110465776|NCT02619994|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110465777|NCT02619994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110465778|NCT02619994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110465779|NCT02619994|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110465780|NCT02619994|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110465781|NCT02619994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110465782|NCT02619994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110465783|NCT02619994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110465784|NCT02619994|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110465785|NCT02619994|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110465786|NCT02619994|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110465787|NCT02619994|Antitubercular Agents|antitubercular agents|mesh-ancestor
110465789|NCT04263402|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110465790|NCT04263402|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110465791|NCT04263402|Prednisolone|prednisolone|mesh-list
110465792|NCT04263402|Prednisolone acetate|prednisolone acetate|mesh-list
110465794|NCT04263402|Prednisolone phosphate|prednisolone phosphate|mesh-list
110465795|NCT04263402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110465796|NCT04263402|Antiemetics|antiemetics|mesh-ancestor
110465797|NCT04263402|Autonomic Agents|autonomic agents|mesh-ancestor
110465798|NCT04263402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110465799|NCT04263402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110532792|NCT00343824|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
110532793|NCT00343824|Laxatives|laxatives|mesh-ancestor
110596433|NCT02574468|Dexamethasone|dexamethasone|mesh-list
110532794|NCT00343824|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110532795|NCT02849015|Immunomodulating Agents|immunomodulating agents|mesh-list
110532796|NCT02849015|Immunologic Factors|immunologic factors|mesh-ancestor
110532797|NCT02849015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110532798|NCT01428089|Progesterone|progesterone|mesh-list
110532799|NCT01428089|Progestins|progestins|mesh-ancestor
110532800|NCT01428089|Hormones|hormones|mesh-ancestor
110191610|NCT00028847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110465800|NCT04263402|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110465801|NCT04263402|Glucocorticoids|glucocorticoids|mesh-ancestor
110465802|NCT04263402|Hormones|hormones|mesh-ancestor
110465803|NCT04263402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110465804|NCT04263402|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110465805|NCT04263402|Protective Agents|protective agents|mesh-ancestor
110465806|NCT04263402|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110465807|NCT04263402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110465808|NCT00868192|Bevacizumab|bevacizumab|mesh-list
110465809|NCT00868192|Pemetrexed|pemetrexed|mesh-list
110465810|NCT00868192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110465811|NCT00868192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110465812|NCT00868192|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110465813|NCT00868192|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110465814|NCT00868192|Growth Substances|growth substances|mesh-ancestor
110465815|NCT00868192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110465816|NCT00868192|Growth Inhibitors|growth inhibitors|mesh-ancestor
110465817|NCT00868192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110465818|NCT00868192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110465819|NCT00868192|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110465820|NCT00868192|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110465821|NCT02615782|Tadalafil|tadalafil|mesh-list
110465822|NCT02615782|Tamsulosin|tamsulosin|mesh-list
110465823|NCT02615782|Vasodilator Agents|vasodilator agents|mesh-ancestor
110465824|NCT02615782|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110465825|NCT02615782|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110465826|NCT02615782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110465827|NCT02615782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110465828|NCT02615782|Urological Agents|urological agents|mesh-ancestor
110465829|NCT02615782|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110465830|NCT02615782|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110465831|NCT02615782|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110465832|NCT02615782|Adrenergic Agents|adrenergic agents|mesh-ancestor
110465833|NCT02615782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110465834|NCT02615782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110465835|NCT00930930|Paclitaxel|paclitaxel|mesh-list
110465836|NCT00930930|Everolimus|everolimus|mesh-list
110465837|NCT00930930|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110465838|NCT00930930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110465839|NCT00930930|Tubulin Modulators|tubulin modulators|mesh-ancestor
110465840|NCT00930930|Antimitotic Agents|antimitotic agents|mesh-ancestor
110465841|NCT00930930|Mitosis Modulators|mitosis modulators|mesh-ancestor
110465842|NCT00930930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110465843|NCT00930930|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110465844|NCT00930930|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110465845|NCT00930930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110465846|NCT00930930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110465847|NCT00930930|Immunologic Factors|immunologic factors|mesh-ancestor
110465848|NCT00930930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110465849|NCT00698776|Lenalidomide|lenalidomide|mesh-list
110465850|NCT00698776|KRN 7000|krn 7000|mesh-list
110465851|NCT00698776|Immunologic Factors|immunologic factors|mesh-ancestor
110465852|NCT00698776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110465853|NCT00698776|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110465854|NCT00698776|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110465855|NCT00698776|Growth Substances|growth substances|mesh-ancestor
110532801|NCT01428089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110532802|NCT01428089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110532804|NCT04212000|Antifungal Agents|antifungal agents|mesh-ancestor
110532805|NCT04212000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110532806|NCT04212000|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110532807|NCT04212000|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110532808|NCT04212000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110532809|NCT04212000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110532810|NCT04212000|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110532811|NCT04212000|Hormone Antagonists|hormone antagonists|mesh-ancestor
110465856|NCT00698776|Growth Inhibitors|growth inhibitors|mesh-ancestor
110465857|NCT00698776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110465858|NCT00698776|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110465860|NCT04122040|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110465861|NCT04122040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110465864|NCT04258956|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110465865|NCT04258956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110465866|NCT04258956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110465867|NCT04258956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110465868|NCT04258956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110465869|NCT00862654|Ketoconazole|ketoconazole|mesh-list
110465870|NCT00862654|Clobetasol|clobetasol|mesh-list
110465871|NCT00862654|Antifungal Agents|antifungal agents|mesh-ancestor
110465872|NCT00862654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110465873|NCT00862654|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110465874|NCT00862654|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110465875|NCT00862654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110465876|NCT00862654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110465877|NCT00862654|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110465878|NCT00862654|Hormone Antagonists|hormone antagonists|mesh-ancestor
110465879|NCT00862654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110465880|NCT00862654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110465881|NCT00862654|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110465882|NCT00862654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110465883|NCT00862654|Glucocorticoids|glucocorticoids|mesh-ancestor
110465884|NCT00862654|Hormones|hormones|mesh-ancestor
110465885|NCT00609180|Antioxidants|antioxidants|mesh-list
110465886|NCT00609180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110465887|NCT00609180|Protective Agents|protective agents|mesh-ancestor
110465888|NCT00609180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110465889|NCT00867490|Amlodipine|amlodipine|mesh-list
110465890|NCT00867490|Candesartan|candesartan|mesh-list
110465891|NCT00867490|Candesartan cilexetil|candesartan cilexetil|mesh-list
110465892|NCT00867490|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110465893|NCT00867490|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110465894|NCT00867490|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110465895|NCT00867490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110465896|NCT00867490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110465897|NCT00867490|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110465898|NCT00867490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110465899|NCT00867490|Vasodilator Agents|vasodilator agents|mesh-ancestor
110465900|NCT00867490|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110465901|NCT00867490|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110465902|NCT00867490|Diuretics|diuretics|mesh-ancestor
110465903|NCT00867490|Natriuretic Agents|natriuretic agents|mesh-ancestor
110465904|NCT00867490|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110465905|NCT00697060|Docetaxel|docetaxel|mesh-list
110465906|NCT00697060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110465907|NCT00697060|Tubulin Modulators|tubulin modulators|mesh-ancestor
110465908|NCT00697060|Antimitotic Agents|antimitotic agents|mesh-ancestor
110532812|NCT04212000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110532813|NCT04212000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110532814|NCT04212000|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110532816|NCT00619398|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110532817|NCT00619398|Immunologic Factors|immunologic factors|mesh-ancestor
110532818|NCT00619398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110532819|NCT00619398|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110191762|NCT00423696|Vitamins|vitamins|mesh-ancestor
110465909|NCT00697060|Mitosis Modulators|mitosis modulators|mesh-ancestor
110465910|NCT00697060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110465911|NCT00867334|Imatinib Mesylate|imatinib mesylate|mesh-list
110465912|NCT00867334|Panitumumab|panitumumab|mesh-list
110465913|NCT00867334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110465914|NCT00867334|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110465915|NCT00867334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110465916|NCT00867334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110465917|NCT00867334|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110465919|NCT00925704|Sevelamer|sevelamer|mesh-list
110465920|NCT00925704|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110465921|NCT00925704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110465922|NCT00925704|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
110465923|NCT00925704|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110465924|NCT00925704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110465925|NCT00925704|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110465926|NCT00925704|Vitamins|vitamins|mesh-ancestor
110465927|NCT00925704|Micronutrients|micronutrients|mesh-ancestor
110465928|NCT00925704|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110465930|NCT00925704|Sequestering Agents|sequestering agents|mesh-ancestor
110465931|NCT00697138|Amphetamine|amphetamine|mesh-list
110465932|NCT00697138|Dextroamphetamine|dextroamphetamine|mesh-list
110465933|NCT00697138|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
110465934|NCT00697138|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110465935|NCT00697138|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110465936|NCT00697138|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110465937|NCT00697138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110465938|NCT00697138|Adrenergic Agents|adrenergic agents|mesh-ancestor
110465939|NCT00697138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110465940|NCT00697138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110465941|NCT00697138|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110465942|NCT00697138|Sympathomimetics|sympathomimetics|mesh-ancestor
110465943|NCT00697138|Autonomic Agents|autonomic agents|mesh-ancestor
110465944|NCT00697138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110465945|NCT00697138|Dopamine Agents|dopamine agents|mesh-ancestor
110465946|NCT00697138|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110465947|NCT00609960|Midazolam|midazolam|mesh-list
110465948|NCT00609960|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110465949|NCT00609960|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110465950|NCT00609960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110465951|NCT00609960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110465952|NCT00609960|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110465953|NCT00609960|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110465954|NCT00609960|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110465955|NCT00609960|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110465956|NCT00609960|Anesthetics, General|anesthetics, general|mesh-ancestor
110465957|NCT00609960|Anesthetics|anesthetics|mesh-ancestor
110465958|NCT00609960|GABA Modulators|gaba modulators|mesh-ancestor
110465959|NCT00609960|GABA Agents|gaba agents|mesh-ancestor
110465960|NCT00609960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110465961|NCT00609960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110465962|NCT04879134|Apomorphine|apomorphine|mesh-list
110465963|NCT04879134|Emetics|emetics|mesh-ancestor
110465964|NCT04879134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110465965|NCT04879134|Autonomic Agents|autonomic agents|mesh-ancestor
110033133|NCT04870333|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110532821|NCT00619398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110532822|NCT00620646|Aspirin|aspirin|mesh-list
110532823|NCT00620646|Cilostazol|cilostazol|mesh-list
110532824|NCT00620646|Clopidogrel|clopidogrel|mesh-list
110532825|NCT00620646|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110532826|NCT00620646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110532827|NCT00620646|Analgesics|analgesics|mesh-ancestor
110532828|NCT00620646|Sensory System Agents|sensory system agents|mesh-ancestor
110532829|NCT00620646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110532830|NCT00620646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110532831|NCT00620646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110532832|NCT00620646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110465966|NCT04879134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110465967|NCT04879134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110465968|NCT04879134|Dopamine Agonists|dopamine agonists|mesh-ancestor
110465969|NCT04879134|Dopamine Agents|dopamine agents|mesh-ancestor
110465970|NCT04879134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110465971|NCT04879134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110465972|NCT04134130|Methyltestosterone|methyltestosterone|mesh-list
110465973|NCT04134130|Testosterone|testosterone|mesh-list
110465974|NCT04134130|Testosterone undecanoate|testosterone undecanoate|mesh-list
110465975|NCT04134130|Testosterone enanthate|testosterone enanthate|mesh-list
110465976|NCT04134130|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
110465977|NCT04134130|Androgens|androgens|mesh-ancestor
110465978|NCT04134130|Hormones|hormones|mesh-ancestor
110465979|NCT04134130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110465980|NCT04134130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110465981|NCT04134130|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110465982|NCT04134130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110465983|NCT04134130|Anabolic Agents|anabolic agents|mesh-ancestor
110465984|NCT04258644|Paclitaxel|paclitaxel|mesh-list
110465985|NCT04258644|Apatinib|apatinib|mesh-list
110465986|NCT04258644|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110465987|NCT04258644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110465988|NCT04258644|Tubulin Modulators|tubulin modulators|mesh-ancestor
110465989|NCT04258644|Antimitotic Agents|antimitotic agents|mesh-ancestor
110465990|NCT04258644|Mitosis Modulators|mitosis modulators|mesh-ancestor
110465991|NCT04258644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110465992|NCT04258644|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110465993|NCT04258644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110465994|NCT02619448|Paclitaxel|paclitaxel|mesh-list
110465995|NCT02619448|Carboplatin|carboplatin|mesh-list
110465996|NCT02619448|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110465997|NCT02619448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110465998|NCT02619448|Tubulin Modulators|tubulin modulators|mesh-ancestor
110465999|NCT02619448|Antimitotic Agents|antimitotic agents|mesh-ancestor
110466000|NCT02619448|Mitosis Modulators|mitosis modulators|mesh-ancestor
110466001|NCT02619448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110466003|NCT00610038|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110466004|NCT00610038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110466005|NCT02619526|Carvedilol|carvedilol|mesh-list
110466006|NCT02619526|Nebivolol|nebivolol|mesh-list
110466007|NCT02619526|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110466008|NCT02619526|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110466009|NCT02619526|Adrenergic Agents|adrenergic agents|mesh-ancestor
110466010|NCT02619526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110466011|NCT02619526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110466012|NCT02619526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110466013|NCT02619526|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110466014|NCT02619526|Antioxidants|antioxidants|mesh-ancestor
110466015|NCT02619526|Protective Agents|protective agents|mesh-ancestor
110466016|NCT02619526|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110532833|NCT00620646|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110532834|NCT00620646|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110532835|NCT00620646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110532836|NCT00620646|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110532837|NCT00620646|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110532838|NCT00620646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110532839|NCT00620646|Antipyretics|antipyretics|mesh-ancestor
110532840|NCT00620646|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110532841|NCT00620646|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110532842|NCT00620646|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110466017|NCT02619526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110466018|NCT02619526|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110466019|NCT02619526|Vasodilator Agents|vasodilator agents|mesh-ancestor
110466020|NCT02619526|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110466021|NCT02619526|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110466022|NCT02619526|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
110466023|NCT02619526|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110466024|NCT02619526|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110466025|NCT04119622|Capecitabine|capecitabine|mesh-list
110466026|NCT04119622|Oxaliplatin|oxaliplatin|mesh-list
110466027|NCT04119622|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110466028|NCT04119622|Antimetabolites|antimetabolites|mesh-ancestor
110466029|NCT04119622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110466030|NCT04119622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110466031|NCT00925548|Cyclophosphamide|cyclophosphamide|mesh-list
110466032|NCT00925548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110466033|NCT00925548|Immunologic Factors|immunologic factors|mesh-ancestor
110466034|NCT00925548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110466035|NCT00925548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110466036|NCT00925548|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110466037|NCT00925548|Alkylating Agents|alkylating agents|mesh-ancestor
110466038|NCT00925548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110466039|NCT00925548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110466040|NCT00925548|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110466041|NCT00866788|Omalizumab|omalizumab|mesh-list
110466042|NCT00866788|Diphenhydramine|diphenhydramine|mesh-list
110466043|NCT00866788|Promethazine|promethazine|mesh-list
110466044|NCT00866788|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
110466045|NCT00866788|Histamine Antagonists|histamine antagonists|mesh-list
110466046|NCT00866788|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110466047|NCT00866788|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110466048|NCT00866788|Respiratory System Agents|respiratory system agents|mesh-ancestor
110466049|NCT00866788|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110466050|NCT00866788|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110466051|NCT00866788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110466052|NCT00866788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110466053|NCT00866788|Anesthetics, Local|anesthetics, local|mesh-ancestor
110466054|NCT00866788|Anesthetics|anesthetics|mesh-ancestor
110466055|NCT00866788|Sensory System Agents|sensory system agents|mesh-ancestor
110466056|NCT00866788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110466057|NCT00866788|Antiemetics|antiemetics|mesh-ancestor
110466058|NCT00866788|Autonomic Agents|autonomic agents|mesh-ancestor
110466059|NCT00866788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110466060|NCT00866788|Histamine Agents|histamine agents|mesh-ancestor
110466061|NCT00866788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110466062|NCT00866788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110466063|NCT00866788|Antipruritics|antipruritics|mesh-ancestor
110466064|NCT00866788|Dermatologic Agents|dermatologic agents|mesh-ancestor
110466065|NCT04132570|Budesonide|budesonide|mesh-list
110466066|NCT04132570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110466067|NCT04132570|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110466068|NCT04132570|Autonomic Agents|autonomic agents|mesh-ancestor
110466069|NCT04132570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110532843|NCT00620646|Purinergic Agents|purinergic agents|mesh-ancestor
110532844|NCT00620646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110532845|NCT00620646|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110532847|NCT00620646|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110532848|NCT00620646|Respiratory System Agents|respiratory system agents|mesh-ancestor
110532849|NCT00620646|Vasodilator Agents|vasodilator agents|mesh-ancestor
110532850|NCT00620646|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110532851|NCT00620646|Protective Agents|protective agents|mesh-ancestor
110532852|NCT00620646|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110466070|NCT04132570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110466072|NCT04132570|Respiratory System Agents|respiratory system agents|mesh-ancestor
110466073|NCT04132570|Glucocorticoids|glucocorticoids|mesh-ancestor
110466074|NCT04132570|Hormones|hormones|mesh-ancestor
110466075|NCT04132570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110466076|NCT00699244|Anesthetics|anesthetics|mesh-list
110466077|NCT00699244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110466078|NCT00699244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110466079|NCT00699322|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110466080|NCT00699322|Glimepiride|glimepiride|mesh-list
110466081|NCT00699322|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110466082|NCT00699322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110466083|NCT00699322|Incretins|incretins|mesh-ancestor
110466084|NCT00699322|Hormones|hormones|mesh-ancestor
110466085|NCT00699322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110466086|NCT00699322|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110466087|NCT00699322|Protease Inhibitors|protease inhibitors|mesh-ancestor
110466088|NCT00699322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110466089|NCT00699322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110466090|NCT00699322|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110466091|NCT00699322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110466092|NCT00699322|Immunologic Factors|immunologic factors|mesh-ancestor
110466093|NCT00860470|Iron|iron|mesh-list
110466094|NCT00860470|Trace Elements|trace elements|mesh-list
110466095|NCT00860470|Folic Acid|folic acid|mesh-list
110466096|NCT00860470|Micronutrients|micronutrients|mesh-list
110466097|NCT00860470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110466098|NCT00860470|Hematinics|hematinics|mesh-ancestor
110466099|NCT00860470|Vitamin B Complex|vitamin b complex|mesh-ancestor
110466100|NCT00860470|Vitamins|vitamins|mesh-ancestor
110466101|NCT00923364|Cyclophosphamide|cyclophosphamide|mesh-list
110466102|NCT00923364|Fludarabine|fludarabine|mesh-list
110466103|NCT00923364|Fludarabine phosphate|fludarabine phosphate|mesh-list
110466104|NCT00923364|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110466105|NCT00923364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110466106|NCT00923364|Immunologic Factors|immunologic factors|mesh-ancestor
110466107|NCT00923364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110466108|NCT00923364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110466109|NCT00923364|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110466110|NCT00923364|Alkylating Agents|alkylating agents|mesh-ancestor
110466111|NCT00923364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110466112|NCT00923364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110466113|NCT00923364|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110466114|NCT00923364|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110466115|NCT00923364|Antimetabolites|antimetabolites|mesh-ancestor
110466116|NCT02613676|Bilirubin|bilirubin|mesh-list
110466117|NCT02613676|Antioxidants|antioxidants|mesh-ancestor
110466118|NCT02613676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110466119|NCT02613676|Protective Agents|protective agents|mesh-ancestor
110466120|NCT02613676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110466121|NCT00860158|Dasatinib|dasatinib|mesh-list
110466122|NCT00860158|Leuprolide|leuprolide|mesh-list
110466123|NCT00860158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110466124|NCT00860158|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110466125|NCT00860158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110466126|NCT00860158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110466127|NCT00860158|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110466128|NCT00860158|Fertility Agents|fertility agents|mesh-ancestor
110532853|NCT00620646|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110532854|NCT00810017|Trastuzumab|trastuzumab|mesh-list
110532855|NCT00810017|Etoposide|etoposide|mesh-list
110532856|NCT00810017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110532857|NCT00810017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110532858|NCT00810017|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110532859|NCT00810017|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110532860|NCT00810017|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110532861|NCT00810017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110532862|NCT00810017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110532863|NCT00620724|Nifedipine|nifedipine|mesh-list
110532864|NCT00620724|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110534650|NCT02672592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110466129|NCT00860158|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110466130|NCT00860158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110466131|NCT00860158|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110466132|NCT02878538|Deferiprone|deferiprone|mesh-list
110466133|NCT02878538|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110466134|NCT02878538|Chelating Agents|chelating agents|mesh-ancestor
110466135|NCT02878538|Sequestering Agents|sequestering agents|mesh-ancestor
110466137|NCT04134598|Tamoxifen|tamoxifen|mesh-list
110466138|NCT04134598|Letrozole|letrozole|mesh-list
110466139|NCT04134598|Anastrozole|anastrozole|mesh-list
110466140|NCT04134598|Exemestane|exemestane|mesh-list
110596712|NCT05695508|Antiemetics|antiemetics|mesh-ancestor
110466141|NCT04134598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110466142|NCT04134598|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110466143|NCT04134598|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110466144|NCT04134598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110466145|NCT04134598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110466146|NCT04134598|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110466147|NCT04134598|Hormone Antagonists|hormone antagonists|mesh-ancestor
110466148|NCT04134598|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110466149|NCT04134598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110466150|NCT04134598|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110466151|NCT04134598|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110466152|NCT04134598|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110466153|NCT04134598|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110466154|NCT04134052|Midazolam|midazolam|mesh-list
110466155|NCT04134052|Ketamine|ketamine|mesh-list
110466156|NCT04134052|Analgesics|analgesics|mesh-ancestor
110466157|NCT04134052|Sensory System Agents|sensory system agents|mesh-ancestor
110466158|NCT04134052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110466159|NCT04134052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110466160|NCT04134052|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110466161|NCT04134052|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110466162|NCT04134052|Anesthetics, General|anesthetics, general|mesh-ancestor
110466163|NCT04134052|Anesthetics|anesthetics|mesh-ancestor
110466164|NCT04134052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110466165|NCT04134052|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110466166|NCT04134052|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110466167|NCT04134052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110466168|NCT04134052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110466169|NCT04134052|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110466170|NCT04134052|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110466171|NCT04134052|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110466172|NCT04134052|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110466173|NCT04134052|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110466174|NCT04134052|GABA Modulators|gaba modulators|mesh-ancestor
110466175|NCT04134052|GABA Agents|gaba agents|mesh-ancestor
110466176|NCT02615080|Pemirolast|pemirolast|mesh-list
110466177|NCT02615080|Histamine Antagonists|histamine antagonists|mesh-ancestor
110466178|NCT02615080|Histamine Agents|histamine agents|mesh-ancestor
110532865|NCT00620724|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110532866|NCT00620724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110532867|NCT00620724|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110532868|NCT00620724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110532869|NCT00620724|Vasodilator Agents|vasodilator agents|mesh-ancestor
110466179|NCT02615080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110466180|NCT02615080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110466181|NCT02615080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110466183|NCT00859456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110466184|NCT00859456|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110466185|NCT00859456|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110466186|NCT00859456|Growth Substances|growth substances|mesh-ancestor
110466187|NCT00859456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110466188|NCT00859456|Growth Inhibitors|growth inhibitors|mesh-ancestor
110466189|NCT00859456|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110466190|NCT00859456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110466191|NCT00859456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110466192|NCT01075646|Ropivacaine|ropivacaine|mesh-list
110466193|NCT01075646|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110466194|NCT01075646|Anesthetics, Local|anesthetics, local|mesh-ancestor
110466195|NCT01075646|Anesthetics|anesthetics|mesh-ancestor
110466196|NCT01075646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110466197|NCT01075646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110466198|NCT01075646|Sensory System Agents|sensory system agents|mesh-ancestor
110466199|NCT01075646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110466200|NCT00799903|Darapladib|darapladib|mesh-list
110466201|NCT00799903|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
110466202|NCT00799903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110466203|NCT00799903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110466204|NCT01075256|Calcium, Dietary|calcium, dietary|mesh-list
110466205|NCT01075256|Calcium|calcium|mesh-list
110466206|NCT01075256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110466207|NCT01075256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110466208|NCT01075256|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110466209|NCT02876432|Diclofenac|diclofenac|mesh-list
110466210|NCT02876432|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110466211|NCT02876432|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110466212|NCT02876432|Analgesics|analgesics|mesh-ancestor
110466213|NCT02876432|Sensory System Agents|sensory system agents|mesh-ancestor
110466214|NCT02876432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110466215|NCT02876432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110466216|NCT02876432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110466217|NCT02876432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110466218|NCT02876432|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110466219|NCT02876432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110466220|NCT02876432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110466221|NCT02876276|Hyaluronic Acid|hyaluronic acid|mesh-list
110466222|NCT02876276|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110466223|NCT02876276|Immunologic Factors|immunologic factors|mesh-ancestor
110466224|NCT02876276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110466225|NCT02876276|Viscosupplements|viscosupplements|mesh-ancestor
110466226|NCT02876276|Protective Agents|protective agents|mesh-ancestor
110466227|NCT00923130|Bevacizumab|bevacizumab|mesh-list
110466228|NCT00923130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110466229|NCT00923130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110466230|NCT00923130|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110466231|NCT00923130|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110466232|NCT00923130|Growth Substances|growth substances|mesh-ancestor
110466233|NCT00923130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110466234|NCT00923130|Growth Inhibitors|growth inhibitors|mesh-ancestor
110466235|NCT04258098|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110466237|NCT04258098|Streptomycin|streptomycin|mesh-list
110466238|NCT04258098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110466239|NCT04258098|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110466240|NCT04258098|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110466241|NCT04258098|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110532870|NCT00620724|Tocolytic Agents|tocolytic agents|mesh-ancestor
110532871|NCT00620724|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110532873|NCT04209426|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110532874|NCT04209426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110532875|NCT04209426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110532876|NCT04209426|Cholinergic Agents|cholinergic agents|mesh-ancestor
110532877|NCT04209426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110532878|NCT04209426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110532879|NCT04209426|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110532880|NCT04209426|Autonomic Agents|autonomic agents|mesh-ancestor
110192133|NCT00058227|Antimetabolites|antimetabolites|mesh-ancestor
110466242|NCT04258098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110466243|NCT04258098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110466244|NCT02605915|Cyclophosphamide|cyclophosphamide|mesh-list
110466245|NCT02605915|Carboplatin|carboplatin|mesh-list
110466246|NCT02605915|Docetaxel|docetaxel|mesh-list
110466247|NCT02605915|Doxorubicin|doxorubicin|mesh-list
110466248|NCT02605915|Trastuzumab|trastuzumab|mesh-list
110466249|NCT02605915|Atezolizumab|atezolizumab|mesh-list
110466250|NCT02605915|Pertuzumab|pertuzumab|mesh-list
110466251|NCT02605915|Maytansine|maytansine|mesh-list
110466252|NCT02605915|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
110466253|NCT02605915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110466254|NCT02605915|Immunologic Factors|immunologic factors|mesh-ancestor
110466255|NCT02605915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110466256|NCT02605915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110466257|NCT02605915|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110466258|NCT02605915|Alkylating Agents|alkylating agents|mesh-ancestor
110466259|NCT02605915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110466260|NCT02605915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110466261|NCT02605915|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110466262|NCT02605915|Tubulin Modulators|tubulin modulators|mesh-ancestor
110466263|NCT02605915|Antimitotic Agents|antimitotic agents|mesh-ancestor
110466264|NCT02605915|Mitosis Modulators|mitosis modulators|mesh-ancestor
110466265|NCT02605915|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110466266|NCT02605915|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110466267|NCT02605915|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110466268|NCT02605915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110466269|NCT02605915|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110466270|NCT02605915|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110466271|NCT02605915|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110466272|NCT02605915|Immunotoxins|immunotoxins|mesh-ancestor
110466273|NCT02605915|Immunoconjugates|immunoconjugates|mesh-ancestor
110466274|NCT04028323|Octreotide|octreotide|mesh-list
110466275|NCT04028323|Terlipressin|terlipressin|mesh-list
110466276|NCT04028323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110466277|NCT04028323|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110466278|NCT04028323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110466279|NCT04028323|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110466280|NCT04028323|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110466281|NCT02607163|Dexmedetomidine|dexmedetomidine|mesh-list
110466282|NCT02607163|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110466283|NCT02607163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110466284|NCT02607163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110466285|NCT02607163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110466286|NCT02607163|Analgesics|analgesics|mesh-ancestor
110466287|NCT02607163|Sensory System Agents|sensory system agents|mesh-ancestor
110466288|NCT02607163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110596780|NCT05610800|Incretins|incretins|mesh-ancestor
110466289|NCT02607163|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110113427|NCT01860235|Benzocaine|benzocaine|mesh-list
110466290|NCT02607163|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110466291|NCT02607163|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110466292|NCT02607163|Adrenergic Agents|adrenergic agents|mesh-ancestor
110466293|NCT02607163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110532881|NCT04209426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110532883|NCT00620802|Clopidogrel|clopidogrel|mesh-list
110532884|NCT00620802|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110532885|NCT00620802|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110532886|NCT00620802|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110532887|NCT00620802|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110532888|NCT00620802|Purinergic Agents|purinergic agents|mesh-ancestor
110532889|NCT00620802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110532890|NCT00620802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110532891|NCT00620802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110532892|NCT02848157|Dexmedetomidine|dexmedetomidine|mesh-list
110532893|NCT02848157|Ropivacaine|ropivacaine|mesh-list
110532894|NCT02848157|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110532895|NCT02848157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110532896|NCT02848157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110532897|NCT02848157|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110532898|NCT02848157|Analgesics|analgesics|mesh-ancestor
110532899|NCT02848157|Sensory System Agents|sensory system agents|mesh-ancestor
110532900|NCT02848157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110532901|NCT02848157|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110532902|NCT02848157|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110532903|NCT02848157|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110532904|NCT02848157|Adrenergic Agents|adrenergic agents|mesh-ancestor
110532905|NCT02848157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110534651|NCT04178850|Folic Acid|folic acid|mesh-list
110466294|NCT02607163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110466295|NCT01075100|Carboplatin|carboplatin|mesh-list
110466296|NCT01075100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110466297|NCT02876354|Vitamin K|vitamin k|mesh-list
110466298|NCT02876354|Vitamin K 2|vitamin k 2|mesh-list
110466299|NCT02876354|Vitamins|vitamins|mesh-ancestor
110466300|NCT02876354|Micronutrients|micronutrients|mesh-ancestor
110466301|NCT02876354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110466302|NCT02876354|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110466303|NCT02876354|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110466304|NCT02876354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110466305|NCT02876354|Hemostatics|hemostatics|mesh-ancestor
110466306|NCT02876354|Coagulants|coagulants|mesh-ancestor
110466307|NCT00626678|Prednisone|prednisone|mesh-list
110466308|NCT00626678|Azathioprine|azathioprine|mesh-list
110466309|NCT00626678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110466310|NCT00626678|Glucocorticoids|glucocorticoids|mesh-ancestor
110466312|NCT00626678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110466313|NCT00626678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110466314|NCT00626678|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110466315|NCT00626678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110466316|NCT00626678|Antimetabolites|antimetabolites|mesh-ancestor
110532906|NCT02848157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110532907|NCT02848157|Anesthetics, Local|anesthetics, local|mesh-ancestor
110532908|NCT02848157|Anesthetics|anesthetics|mesh-ancestor
110532910|NCT04211844|Ledipasvir|ledipasvir|mesh-list
110532911|NCT04211844|Antiviral Agents|antiviral agents|mesh-ancestor
110532912|NCT04211844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110532913|NCT00619710|Meropenem|meropenem|mesh-list
110532914|NCT00619710|Imipenem|imipenem|mesh-list
110532915|NCT00619710|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
110532916|NCT00619710|Cilastatin|cilastatin|mesh-list
110532917|NCT00619710|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110532918|NCT00619710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110532919|NCT00619710|Protease Inhibitors|protease inhibitors|mesh-ancestor
110532920|NCT00619710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110532921|NCT00619710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110466317|NCT00626678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110466318|NCT00626678|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110466319|NCT00626678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110466320|NCT00626678|Immunologic Factors|immunologic factors|mesh-ancestor
110466321|NCT00626678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110466322|NCT00803023|Sodium Oxybate|sodium oxybate|mesh-list
110466323|NCT00803023|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110466324|NCT00803023|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110466325|NCT00803023|Anesthetics, General|anesthetics, general|mesh-ancestor
110466326|NCT00803023|Anesthetics|anesthetics|mesh-ancestor
110466327|NCT00803023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110466328|NCT00803023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110466329|NCT03076021|Dextromethorphan|dextromethorphan|mesh-list
110466330|NCT03076021|Isotretinoin|isotretinoin|mesh-list
110466331|NCT03076021|Antitussive Agents|antitussive agents|mesh-ancestor
110466332|NCT03076021|Respiratory System Agents|respiratory system agents|mesh-ancestor
110466333|NCT03076021|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110466334|NCT03076021|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110466335|NCT03076021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110466336|NCT03076021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110466337|NCT03076021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110466338|NCT03076021|Dermatologic Agents|dermatologic agents|mesh-ancestor
110466339|NCT00859222|Bevacizumab|bevacizumab|mesh-list
110466340|NCT00859222|Panobinostat|panobinostat|mesh-list
110466341|NCT00859222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110466342|NCT00859222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110466343|NCT00859222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110466344|NCT00859222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110466345|NCT00859222|Growth Substances|growth substances|mesh-ancestor
110466346|NCT00859222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110466347|NCT00859222|Growth Inhibitors|growth inhibitors|mesh-ancestor
110466348|NCT00859222|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110466349|NCT00859222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110596816|NCT05516654|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110466350|NCT00859222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110466351|NCT00858988|Rifaximin|rifaximin|mesh-list
110466352|NCT00858988|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110466353|NCT00858988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110466354|NCT00858988|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110466355|NCT00858832|Methylergonovine|methylergonovine|mesh-list
110466356|NCT00858832|Oxytocics|oxytocics|mesh-ancestor
110466357|NCT00858832|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110466358|NCT00858832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110466359|NCT01071512|Natalizumab|natalizumab|mesh-list
110466360|NCT01071512|Immunologic Factors|immunologic factors|mesh-ancestor
110033134|NCT04870333|Antinematodal Agents|antinematodal agents|mesh-ancestor
110532922|NCT03929627|Hydrocortisone|hydrocortisone|mesh-list
110532923|NCT03929627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110532925|NCT04019015|Hemostatics|hemostatics|mesh-ancestor
110532926|NCT04019015|Coagulants|coagulants|mesh-ancestor
110532927|NCT02846909|Progesterone|progesterone|mesh-list
110532928|NCT02846909|Progestins|progestins|mesh-ancestor
110532929|NCT02846909|Hormones|hormones|mesh-ancestor
110532930|NCT02846909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110532931|NCT02846909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110532932|NCT00632723|Gefitinib|gefitinib|mesh-list
110466361|NCT01071512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110466362|NCT00626834|Vigabatrin|vigabatrin|mesh-list
110466363|NCT00626834|Anticonvulsants|anticonvulsants|mesh-ancestor
110466364|NCT00626834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110466365|NCT00626834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110466366|NCT00626834|GABA Agents|gaba agents|mesh-ancestor
110466367|NCT00626834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110466368|NCT00626834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110466369|NCT04255992|Calcium, Dietary|calcium, dietary|mesh-list
110466370|NCT04255992|Vitamin D|vitamin d|mesh-list
110466371|NCT04255992|Calcium|calcium|mesh-list
110466372|NCT04255992|Vitamins|vitamins|mesh-ancestor
110466373|NCT04255992|Micronutrients|micronutrients|mesh-ancestor
110466374|NCT04255992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110466375|NCT04255992|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110466376|NCT04255992|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110466377|NCT02618824|Tryptophan|tryptophan|mesh-list
110466378|NCT02618824|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110466379|NCT02618824|Antidepressive Agents|antidepressive agents|mesh-ancestor
110466380|NCT02618824|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110466381|NCT00610350|Simendan|simendan|mesh-list
110466382|NCT00610350|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110466383|NCT00610350|Vasodilator Agents|vasodilator agents|mesh-ancestor
110466384|NCT00610350|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110389127|NCT02456194|Calcium|calcium|mesh-list
110466385|NCT00610350|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110466386|NCT00610350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110466387|NCT00610350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110466388|NCT00610350|Protective Agents|protective agents|mesh-ancestor
110466389|NCT00610350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110466390|NCT01071200|Hormones|hormones|mesh-list
110466391|NCT01071200|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
110466392|NCT01071200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110466393|NCT01071200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110466394|NCT04255836|Durvalumab|durvalumab|mesh-list
110466395|NCT04255836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110466396|NCT04255836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110466397|NCT00699478|Vitamin B 12|vitamin b 12|mesh-list
110466398|NCT00699478|Vitamin B Complex|vitamin b complex|mesh-ancestor
110466399|NCT00699478|Vitamins|vitamins|mesh-ancestor
110466400|NCT00699478|Micronutrients|micronutrients|mesh-ancestor
110466401|NCT00699478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110466402|NCT01070888|Budesonide|budesonide|mesh-list
110466403|NCT01070888|Formoterol Fumarate|formoterol fumarate|mesh-list
110466404|NCT01070888|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110466405|NCT01070888|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110466406|NCT01070888|Autonomic Agents|autonomic agents|mesh-ancestor
110466407|NCT01070888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110372514|NCT04598594|Nicotine|nicotine|mesh-list
110466408|NCT01070888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110466410|NCT01070888|Respiratory System Agents|respiratory system agents|mesh-ancestor
110466411|NCT01070888|Glucocorticoids|glucocorticoids|mesh-ancestor
110466412|NCT01070888|Hormones|hormones|mesh-ancestor
110466413|NCT01070888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110466414|NCT01070888|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110466415|NCT01070888|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110466416|NCT01070888|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110466417|NCT01070888|Adrenergic Agents|adrenergic agents|mesh-ancestor
110532933|NCT00632723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110532934|NCT00632723|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110532935|NCT00632723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110532936|NCT00632723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110532938|NCT02847143|Oxytocics|oxytocics|mesh-ancestor
110532939|NCT02847143|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110532940|NCT02847143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110466418|NCT01070888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110466419|NCT01070888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110466420|NCT00857896|Fesoterodine|fesoterodine|mesh-list
110466421|NCT00857896|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110466422|NCT00857896|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110466423|NCT00857896|Cholinergic Agents|cholinergic agents|mesh-ancestor
110466424|NCT00857896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110466425|NCT00857896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110466426|NCT00857896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110466427|NCT00857896|Urological Agents|urological agents|mesh-ancestor
110466428|NCT00857818|Risperidone|risperidone|mesh-list
110466429|NCT00857818|Aripiprazole|aripiprazole|mesh-list
110466430|NCT00857818|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110466431|NCT00857818|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110466432|NCT00857818|Serotonin Agents|serotonin agents|mesh-ancestor
110466433|NCT00857818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110466434|NCT00857818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110466435|NCT00857818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110466436|NCT00857818|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110466437|NCT00857818|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110466438|NCT00857818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110466439|NCT00857818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110466440|NCT00857818|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110466441|NCT00857818|Dopamine Agents|dopamine agents|mesh-ancestor
110466442|NCT00857818|Antidepressive Agents|antidepressive agents|mesh-ancestor
110466443|NCT00857818|Dopamine Agonists|dopamine agonists|mesh-ancestor
110466444|NCT00857818|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110466445|NCT00857818|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110596862|NCT05372887|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110466446|NCT00857818|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110466447|NCT00857818|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110466449|NCT02618668|Propofol|propofol|mesh-list
110466450|NCT02618668|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110466451|NCT02618668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110466452|NCT02618668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110466453|NCT02618668|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110466454|NCT02618668|Anesthetics, General|anesthetics, general|mesh-ancestor
110466455|NCT02618668|Anesthetics|anesthetics|mesh-ancestor
110466456|NCT02618668|Analgesics|analgesics|mesh-ancestor
110466457|NCT02618668|Sensory System Agents|sensory system agents|mesh-ancestor
110466458|NCT02618668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110466459|NCT02618668|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110466461|NCT02618668|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110466462|NCT02618668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110466463|NCT02618668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110466464|NCT01074944|Eliglustat|eliglustat|mesh-list
110466465|NCT01074944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110466466|NCT01074944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110466467|NCT00802945|Etirinotecan pegol|etirinotecan pegol|mesh-list
110466468|NCT00802945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110466469|NCT00802945|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110466470|NCT00802945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110466471|NCT00802945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110466472|NCT00802945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110466473|NCT01074554|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110466474|NCT01074554|Azithromycin|azithromycin|mesh-list
110466475|NCT01074554|Levofloxacin|levofloxacin|mesh-list
110466476|NCT01074554|Rifampin|rifampin|mesh-list
110466477|NCT01074554|Ethambutol|ethambutol|mesh-list
110532941|NCT02847455|Rabeprazole|rabeprazole|mesh-list
110532942|NCT02847455|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110532943|NCT02847455|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110532944|NCT02847455|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110532945|NCT02847455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110532946|NCT02847455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110532947|NCT03897335|Aminophylline|aminophylline|mesh-list
110532948|NCT03897335|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110532949|NCT03897335|Autonomic Agents|autonomic agents|mesh-ancestor
110532950|NCT03897335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110532951|NCT03897335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110532953|NCT03897335|Respiratory System Agents|respiratory system agents|mesh-ancestor
110532954|NCT03897335|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110532955|NCT03897335|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110532956|NCT03897335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110466478|NCT01074554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110466479|NCT01074554|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110466480|NCT01074554|Antitubercular Agents|antitubercular agents|mesh-ancestor
110466481|NCT01074554|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110466485|NCT01074554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110466487|NCT01074554|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110466488|NCT01074554|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110466489|NCT01074554|Leprostatic Agents|leprostatic agents|mesh-ancestor
110466490|NCT01074554|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110596881|NCT05359835|Edetic Acid|edetic acid|mesh-list
110466491|NCT01074554|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110466492|NCT01074554|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110466493|NCT01074554|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110466494|NCT01074554|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110466495|NCT01074554|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110466496|NCT01074554|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110466497|NCT00857584|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110466498|NCT00857584|Sertraline|sertraline|mesh-list
110466499|NCT00857584|Antidepressive Agents|antidepressive agents|mesh-ancestor
110466500|NCT00857584|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110466501|NCT00857584|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110466502|NCT00857584|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110466503|NCT00857584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110466504|NCT00857584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110466505|NCT00857584|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110466506|NCT00857584|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110466507|NCT00857584|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110466508|NCT00857584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110466509|NCT00857584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110466510|NCT00857584|Serotonin Agents|serotonin agents|mesh-ancestor
110466511|NCT00798967|Teduglutide|teduglutide|mesh-list
110466512|NCT00798967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110466513|NCT00798967|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110466514|NCT00798967|Protective Agents|protective agents|mesh-ancestor
110466515|NCT00798967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110466516|NCT04132102|Afatinib|afatinib|mesh-list
110466517|NCT04132102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110466518|NCT04132102|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110466519|NCT04132102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110466520|NCT04132102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110466521|NCT02618356|Raltitrexed|raltitrexed|mesh-list
110466522|NCT02618356|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110466523|NCT02618356|Antimetabolites|antimetabolites|mesh-ancestor
110532957|NCT03897335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110532958|NCT03897335|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110532959|NCT03897335|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110532960|NCT03897335|Purinergic Agents|purinergic agents|mesh-ancestor
110532961|NCT03897335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110532962|NCT03897335|Protective Agents|protective agents|mesh-ancestor
110532963|NCT01617096|Dapivirine|dapivirine|mesh-list
110532964|NCT01617096|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110532965|NCT01617096|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110532966|NCT01617096|Antiviral Agents|antiviral agents|mesh-ancestor
110532967|NCT01617096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110532968|NCT00619944|Ritonavir|ritonavir|mesh-list
110532969|NCT00619944|Lopinavir|lopinavir|mesh-list
110532970|NCT00619944|Lumefantrine|lumefantrine|mesh-list
110532971|NCT00619944|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
110466524|NCT02618356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110466525|NCT02618356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110466526|NCT02618356|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110466527|NCT02618356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110466528|NCT00697996|Rituximab|rituximab|mesh-list
110466529|NCT00697996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110466530|NCT00697996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110466531|NCT00697996|Immunologic Factors|immunologic factors|mesh-ancestor
110596898|NCT05355051|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110466532|NCT00697996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110466533|NCT00697996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110466534|NCT04118842|Rifampin|rifampin|mesh-list
110466535|NCT04118842|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110466536|NCT04118842|Antitubercular Agents|antitubercular agents|mesh-ancestor
110466537|NCT04118842|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110466538|NCT04118842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110466539|NCT04118842|Leprostatic Agents|leprostatic agents|mesh-ancestor
110466540|NCT04118842|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110466541|NCT04118842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110466542|NCT04118842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110466543|NCT04118842|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110466544|NCT04118842|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110466545|NCT04118842|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110466546|NCT04118842|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110466547|NCT04118842|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110466548|NCT04118842|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110466550|NCT00699634|Antiemetics|antiemetics|mesh-ancestor
110466551|NCT00699634|Autonomic Agents|autonomic agents|mesh-ancestor
110466552|NCT00699634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110466553|NCT00699634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110466554|NCT00699634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110466555|NCT00699634|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110466556|NCT00699634|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110466557|NCT00699634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110466558|NCT00699634|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110466559|NCT00798889|Sunitinib|sunitinib|mesh-list
110466560|NCT00798889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110466561|NCT00798889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110466562|NCT00798889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110466563|NCT00798889|Growth Substances|growth substances|mesh-ancestor
110466564|NCT00798889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110466565|NCT00798889|Growth Inhibitors|growth inhibitors|mesh-ancestor
110466566|NCT00798889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110466567|NCT00798889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110466568|NCT00798889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110466569|NCT04113889|Acetylcarnitine|acetylcarnitine|mesh-list
110532972|NCT00619944|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110532973|NCT00619944|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110532974|NCT00619944|Protease Inhibitors|protease inhibitors|mesh-ancestor
110532975|NCT00619944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110532976|NCT00619944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110534652|NCT04178850|Vitamin B Complex|vitamin b complex|mesh-list
110466570|NCT04113889|Metformin|metformin|mesh-list
110466571|NCT04113889|Pioglitazone|pioglitazone|mesh-list
110466572|NCT04113889|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110466573|NCT04113889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110466574|NCT04113889|Vitamin B Complex|vitamin b complex|mesh-ancestor
110466575|NCT04113889|Vitamins|vitamins|mesh-ancestor
110466576|NCT04113889|Micronutrients|micronutrients|mesh-ancestor
110466577|NCT04113889|Nootropic Agents|nootropic agents|mesh-ancestor
110466578|NCT00796861|Sunitinib|sunitinib|mesh-list
110466579|NCT00796861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110466580|NCT00796861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110466581|NCT00796861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110466582|NCT00796861|Growth Substances|growth substances|mesh-ancestor
110466583|NCT00796861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110466584|NCT00796861|Growth Inhibitors|growth inhibitors|mesh-ancestor
110466585|NCT00796861|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110466586|NCT00796861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110466587|NCT00796861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110466588|NCT00914563|Lithium Carbonate|lithium carbonate|mesh-list
110466589|NCT00914563|Antidepressive Agents|antidepressive agents|mesh-ancestor
110466590|NCT00914563|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110466591|NCT00914563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110466592|NCT00914563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110466593|NCT00914563|Antimanic Agents|antimanic agents|mesh-ancestor
110466594|NCT00914563|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110466595|NCT00914563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110466596|NCT00914563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110466597|NCT00914797|Terbutaline|terbutaline|mesh-list
110466598|NCT00914797|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110466599|NCT00914797|Autonomic Agents|autonomic agents|mesh-ancestor
110466600|NCT00914797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110466601|NCT00914797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110466602|NCT00914797|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110466603|NCT00914797|Respiratory System Agents|respiratory system agents|mesh-ancestor
110466604|NCT00914797|Sympathomimetics|sympathomimetics|mesh-ancestor
110466605|NCT00914797|Tocolytic Agents|tocolytic agents|mesh-ancestor
110466606|NCT00914797|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110466607|NCT00914797|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110466610|NCT00914797|Adrenergic Agents|adrenergic agents|mesh-ancestor
110466611|NCT00914797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110466612|NCT00914797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110466613|NCT00798655|Cisplatin|cisplatin|mesh-list
110466614|NCT00798655|Panitumumab|panitumumab|mesh-list
110466615|NCT00798655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110466616|NCT00798655|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110466617|NCT00914641|Apixaban|apixaban|mesh-list
110466618|NCT00914641|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110466619|NCT00914641|Antithrombins|antithrombins|mesh-ancestor
110466620|NCT00914641|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110466621|NCT00914641|Protease Inhibitors|protease inhibitors|mesh-ancestor
110466622|NCT00914641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110466623|NCT00914641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110466624|NCT00914641|Anticoagulants|anticoagulants|mesh-ancestor
110466625|NCT00796549|Afatinib|afatinib|mesh-list
110466626|NCT00796549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110466627|NCT00796549|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110466628|NCT00796549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110466629|NCT00796549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110466630|NCT00856492|Paclitaxel|paclitaxel|mesh-list
110466631|NCT00856492|Cyclophosphamide|cyclophosphamide|mesh-list
110466632|NCT00856492|Bevacizumab|bevacizumab|mesh-list
110466633|NCT00856492|Doxorubicin|doxorubicin|mesh-list
110466634|NCT00856492|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110532978|NCT00619944|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110532980|NCT00619944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110532981|NCT00619944|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110532982|NCT00619944|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110532983|NCT00619944|Antimalarials|antimalarials|mesh-ancestor
110532984|NCT00619944|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110466635|NCT00856492|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110466636|NCT00856492|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110466637|NCT00856492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110466638|NCT00856492|Tubulin Modulators|tubulin modulators|mesh-ancestor
110466639|NCT00856492|Antimitotic Agents|antimitotic agents|mesh-ancestor
110466640|NCT00856492|Mitosis Modulators|mitosis modulators|mesh-ancestor
110466641|NCT00856492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110466642|NCT00856492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110466643|NCT00856492|Immunologic Factors|immunologic factors|mesh-ancestor
110466644|NCT00856492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110466645|NCT00856492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110466646|NCT00856492|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110466647|NCT00856492|Alkylating Agents|alkylating agents|mesh-ancestor
110466648|NCT00856492|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110466649|NCT00856492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110466650|NCT00856492|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110466651|NCT00856492|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110466652|NCT00856492|Growth Substances|growth substances|mesh-ancestor
110466653|NCT00856492|Growth Inhibitors|growth inhibitors|mesh-ancestor
110466654|NCT00856492|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110466655|NCT00856492|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110466656|NCT00856492|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110466657|NCT00856492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110466658|NCT04111159|Propofol|propofol|mesh-list
110466659|NCT04111159|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110466660|NCT04111159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110466661|NCT04111159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110466662|NCT04111159|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110466663|NCT04111159|Anesthetics, General|anesthetics, general|mesh-ancestor
110466664|NCT04111159|Anesthetics|anesthetics|mesh-ancestor
110466665|NCT00697372|Sirolimus|sirolimus|mesh-list
110466666|NCT00697372|Everolimus|everolimus|mesh-list
110466667|NCT00697372|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110466668|NCT00697372|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110466669|NCT00697372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110466670|NCT00697372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110466671|NCT00697372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110466672|NCT00697372|Immunologic Factors|immunologic factors|mesh-ancestor
110466673|NCT00697372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110466674|NCT00697372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110466675|NCT00697372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110466676|NCT00697372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110466677|NCT00697372|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110466678|NCT00697372|Antifungal Agents|antifungal agents|mesh-ancestor
110466679|NCT04111003|Anesthetics|anesthetics|mesh-list
110466680|NCT04111003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110466682|NCT00856180|Cyclophosphamide|cyclophosphamide|mesh-list
110466683|NCT00856180|Bevacizumab|bevacizumab|mesh-list
110466684|NCT00856180|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110466685|NCT00856180|Immunologic Factors|immunologic factors|mesh-ancestor
110466686|NCT00856180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110466687|NCT00856180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110466688|NCT00856180|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110466689|NCT00856180|Alkylating Agents|alkylating agents|mesh-ancestor
110466690|NCT00856180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110466691|NCT00856180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110466692|NCT00856180|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110466693|NCT00856180|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110466694|NCT00856180|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110596952|NCT05068752|Sorafenib|sorafenib|mesh-list
110466695|NCT00856180|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110532985|NCT00619944|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110532986|NCT00621036|Methotrexate|methotrexate|mesh-list
110532987|NCT00621036|Thiotepa|thiotepa|mesh-list
110532988|NCT00621036|Immunoglobulins|immunoglobulins|mesh-list
110532989|NCT00621036|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110532990|NCT00621036|Antibodies|antibodies|mesh-list
110532991|NCT00621036|Sargramostim|sargramostim|mesh-list
110532992|NCT00621036|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
110192695|NCT00060684|Glucocorticoids|glucocorticoids|mesh-ancestor
110466696|NCT00856180|Growth Substances|growth substances|mesh-ancestor
110466697|NCT00856180|Growth Inhibitors|growth inhibitors|mesh-ancestor
110466698|NCT02605213|Vancomycin|vancomycin|mesh-list
110466699|NCT02605213|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110466700|NCT02605213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110466701|NCT00900627|Paclitaxel|paclitaxel|mesh-list
110466702|NCT00900627|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110466703|NCT00900627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110466704|NCT00900627|Tubulin Modulators|tubulin modulators|mesh-ancestor
110466705|NCT00900627|Antimitotic Agents|antimitotic agents|mesh-ancestor
110466706|NCT00900627|Mitosis Modulators|mitosis modulators|mesh-ancestor
110466707|NCT00900627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110466708|NCT00866320|Sorafenib|sorafenib|mesh-list
110466709|NCT00866320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110466710|NCT00866320|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110466711|NCT00866320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110466712|NCT00866320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110466713|NCT04115449|Dexmedetomidine|dexmedetomidine|mesh-list
110466714|NCT04115449|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110466715|NCT04115449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110466716|NCT04115449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110466717|NCT04115449|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110466718|NCT04115449|Analgesics|analgesics|mesh-ancestor
110466719|NCT04115449|Sensory System Agents|sensory system agents|mesh-ancestor
110466720|NCT04115449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110466721|NCT04115449|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110466722|NCT04115449|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110466723|NCT04115449|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110466724|NCT04115449|Adrenergic Agents|adrenergic agents|mesh-ancestor
110466725|NCT04115449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110466726|NCT04115449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110466727|NCT04133974|Methadone|methadone|mesh-list
110466728|NCT04133974|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110466729|NCT04133974|Narcotics|narcotics|mesh-ancestor
110466730|NCT04133974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110466731|NCT04133974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110466732|NCT04133974|Analgesics|analgesics|mesh-ancestor
110466733|NCT04133974|Sensory System Agents|sensory system agents|mesh-ancestor
110466734|NCT04133974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110466735|NCT04133974|Antitussive Agents|antitussive agents|mesh-ancestor
110466736|NCT04133974|Respiratory System Agents|respiratory system agents|mesh-ancestor
110466737|NCT03679611|Neostigmine|neostigmine|mesh-list
110466738|NCT03679611|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110466739|NCT03679611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110466740|NCT03679611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110466741|NCT03679611|Cholinergic Agents|cholinergic agents|mesh-ancestor
110466742|NCT03679611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110466743|NCT03679611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110466744|NCT03679611|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110466745|NCT03679611|Autonomic Agents|autonomic agents|mesh-ancestor
110466746|NCT03679611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110466747|NCT00914953|Oxytocin|oxytocin|mesh-list
110466748|NCT00914953|Oxytocics|oxytocics|mesh-ancestor
110466749|NCT00914953|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110466750|NCT00914953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110466751|NCT00869518|Trimethoprim|trimethoprim|mesh-list
110466752|NCT00869518|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
110466753|NCT00869518|Sulfamethoxazole|sulfamethoxazole|mesh-list
110466754|NCT00869518|Rifabutin|rifabutin|mesh-list
110466755|NCT00869518|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110532993|NCT00621036|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110532994|NCT00621036|Abortifacient Agents|abortifacient agents|mesh-ancestor
110532995|NCT00621036|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110532996|NCT00621036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110466756|NCT00869518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110466757|NCT00869518|Antimalarials|antimalarials|mesh-ancestor
110466758|NCT00869518|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110466759|NCT00869518|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110466760|NCT00869518|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110466761|NCT00869518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110466762|NCT00869518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110466763|NCT00869518|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110466764|NCT00869518|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
110466765|NCT00869518|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110466766|NCT00869518|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110466767|NCT00869518|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110466768|NCT00869518|Antitubercular Agents|antitubercular agents|mesh-ancestor
110466769|NCT00869440|Midazolam|midazolam|mesh-list
110466770|NCT00869440|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110466771|NCT00869440|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110466772|NCT00869440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110466773|NCT00869440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110466774|NCT00869440|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110466775|NCT00869440|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110466776|NCT00869440|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110466777|NCT00869440|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110466778|NCT00869440|Anesthetics, General|anesthetics, general|mesh-ancestor
110466779|NCT00869440|Anesthetics|anesthetics|mesh-ancestor
110466780|NCT00869440|GABA Modulators|gaba modulators|mesh-ancestor
110466781|NCT00869440|GABA Agents|gaba agents|mesh-ancestor
110466782|NCT00869440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110466783|NCT00869440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110466784|NCT00895947|Interferons|interferons|mesh-list
110466785|NCT00895947|Interferon-alpha|interferon-alpha|mesh-list
110466786|NCT00895947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110466787|NCT00895947|Antiviral Agents|antiviral agents|mesh-ancestor
110466788|NCT00895947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110466789|NCT00895947|Immunologic Factors|immunologic factors|mesh-ancestor
110466790|NCT00895947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110466791|NCT02604823|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110466792|NCT02604823|Antiviral Agents|antiviral agents|mesh-ancestor
110466793|NCT02604823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110466794|NCT02841579|Osimertinib|osimertinib|mesh-list
110466795|NCT02841579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110466796|NCT02841579|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110466797|NCT02841579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110466798|NCT02841579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110466799|NCT00588445|Gefitinib|gefitinib|mesh-list
110466800|NCT00588445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110466801|NCT00588445|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110466802|NCT00588445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110466803|NCT00588445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110466804|NCT00092781|Celecoxib|celecoxib|mesh-list
110466805|NCT00092781|Etoricoxib|etoricoxib|mesh-list
110466806|NCT00092781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110466807|NCT00092781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110466808|NCT00092781|Analgesics|analgesics|mesh-ancestor
110466809|NCT00092781|Sensory System Agents|sensory system agents|mesh-ancestor
110466810|NCT00092781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110466811|NCT00092781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110466812|NCT00092781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110466813|NCT00092781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110113939|NCT01863654|Montelukast|montelukast|mesh-list
110466814|NCT00092781|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110466815|NCT00092781|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110466816|NCT00092781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110466817|NCT00092781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110466818|NCT00092703|Diclofenac|diclofenac|mesh-list
110466819|NCT00092703|Etoricoxib|etoricoxib|mesh-list
110466820|NCT00092703|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110466821|NCT00092703|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110532997|NCT00621036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110532998|NCT00621036|Antimetabolites|antimetabolites|mesh-ancestor
110532999|NCT00621036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110533000|NCT00621036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110533001|NCT00621036|Dermatologic Agents|dermatologic agents|mesh-ancestor
110533002|NCT00621036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110533003|NCT00621036|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110533004|NCT00621036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110533005|NCT00621036|Immunologic Factors|immunologic factors|mesh-ancestor
110533006|NCT00621036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110533007|NCT00621036|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110533008|NCT00621036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110192871|NCT00033566|S 3304|s 3304|mesh-list
110466822|NCT00092703|Analgesics|analgesics|mesh-ancestor
110466823|NCT00092703|Sensory System Agents|sensory system agents|mesh-ancestor
110466824|NCT00092703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110466825|NCT00092703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110466826|NCT00092703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110466827|NCT00092703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110466828|NCT00092703|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110466830|NCT00092703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110466831|NCT00092703|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110466832|NCT00699946|Olanzapine|olanzapine|mesh-list
110466833|NCT00699946|Antiemetics|antiemetics|mesh-ancestor
110466834|NCT00699946|Autonomic Agents|autonomic agents|mesh-ancestor
110466835|NCT00699946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110466836|NCT00699946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110466837|NCT00699946|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110466838|NCT00699946|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110466839|NCT00699946|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110466840|NCT00699946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110466841|NCT00699946|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110466842|NCT00699946|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110466843|NCT00699946|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110466844|NCT00699946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110466845|NCT00699946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110466846|NCT00699946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110466847|NCT00699946|Serotonin Agents|serotonin agents|mesh-ancestor
110466848|NCT00796315|Doxylamine|doxylamine|mesh-list
110466849|NCT00796315|Doxylamine succinate|doxylamine succinate|mesh-list
110466850|NCT00796315|Antiemetics|antiemetics|mesh-ancestor
110466851|NCT00796315|Autonomic Agents|autonomic agents|mesh-ancestor
110466852|NCT00796315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110466853|NCT00796315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110466854|NCT00796315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110466855|NCT00796315|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110466856|NCT00796315|Histamine Antagonists|histamine antagonists|mesh-ancestor
110466857|NCT00796315|Histamine Agents|histamine agents|mesh-ancestor
110466858|NCT00796315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110466859|NCT00796315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110466860|NCT00855166|Metformin|metformin|mesh-list
110466861|NCT00855166|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110466862|NCT00855166|Dapagliflozin|dapagliflozin|mesh-list
110466863|NCT00855166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110466864|NCT00855166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110466865|NCT00855166|Incretins|incretins|mesh-ancestor
110466866|NCT00855166|Hormones|hormones|mesh-ancestor
110466867|NCT00855166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110466868|NCT00855166|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110466869|NCT00855166|Protease Inhibitors|protease inhibitors|mesh-ancestor
110466870|NCT00855166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110533009|NCT00621036|Alkylating Agents|alkylating agents|mesh-ancestor
110533010|NCT00621036|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110533011|NCT02846831|Insulin|insulin|mesh-list
110533012|NCT02846831|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110533013|NCT02846831|Hormones|hormones|mesh-list
110533014|NCT02846831|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110533015|NCT02846831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110533016|NCT02846831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110533017|NCT01497509|Epinephrine|epinephrine|mesh-list
110533018|NCT01497509|Racepinephrine|racepinephrine|mesh-list
110533019|NCT01497509|Fentanyl|fentanyl|mesh-list
110533020|NCT01497509|Bupivacaine|bupivacaine|mesh-list
110533021|NCT01497509|Epinephryl borate|epinephryl borate|mesh-list
110533022|NCT01497509|Anesthetics, Local|anesthetics, local|mesh-ancestor
110533023|NCT01497509|Anesthetics|anesthetics|mesh-ancestor
110533024|NCT01497509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110533025|NCT01497509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110597034|NCT04981899|Etoposide|etoposide|mesh-list
110466871|NCT00855166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110466872|NCT00855166|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110466873|NCT00854620|Sorafenib|sorafenib|mesh-list
110466874|NCT00854620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110466875|NCT00854620|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110466876|NCT00854620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110466877|NCT00854620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110466878|NCT00793585|Allopurinol|allopurinol|mesh-list
110466879|NCT00793585|Antimetabolites|antimetabolites|mesh-ancestor
110466880|NCT00793585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110466881|NCT00793585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110466882|NCT00793585|Gout Suppressants|gout suppressants|mesh-ancestor
110466883|NCT00793585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110466884|NCT00793585|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110466885|NCT00793585|Antioxidants|antioxidants|mesh-ancestor
110466886|NCT00793585|Protective Agents|protective agents|mesh-ancestor
110466887|NCT00793585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110466889|NCT02013141|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110466890|NCT02013141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110466891|NCT04107103|Nivolumab|nivolumab|mesh-list
110466892|NCT04107103|Pemetrexed|pemetrexed|mesh-list
110466893|NCT04107103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110466894|NCT04107103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110466895|NCT04107103|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110466896|NCT04107103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110466897|NCT04107103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110466898|NCT04107103|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110466899|NCT04107103|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110466900|NCT02617810|Midazolam|midazolam|mesh-list
110466901|NCT02617810|Warfarin|warfarin|mesh-list
110466902|NCT02617810|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110466903|NCT02617810|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110466904|NCT02617810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110466905|NCT02617810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110466906|NCT02617810|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110466907|NCT02617810|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110466908|NCT02617810|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110466909|NCT02617810|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110466910|NCT02617810|Anesthetics, General|anesthetics, general|mesh-ancestor
110466912|NCT02617810|GABA Modulators|gaba modulators|mesh-ancestor
110466913|NCT02617810|GABA Agents|gaba agents|mesh-ancestor
110466914|NCT02617810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110466915|NCT02617810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110533026|NCT01497509|Sensory System Agents|sensory system agents|mesh-ancestor
110533027|NCT01497509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110533028|NCT01497509|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110533030|NCT01497509|Analgesics|analgesics|mesh-ancestor
110533031|NCT01497509|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110533032|NCT01497509|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110533033|NCT01497509|Anesthetics, General|anesthetics, general|mesh-ancestor
110533034|NCT01497509|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110533035|NCT01497509|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110533036|NCT01497509|Adrenergic Agents|adrenergic agents|mesh-ancestor
110533037|NCT01497509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110533038|NCT01497509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110466916|NCT02617810|Anticoagulants|anticoagulants|mesh-ancestor
110466917|NCT00898443|Anesthetics|anesthetics|mesh-list
110466918|NCT00898443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110466919|NCT00898443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110466920|NCT02614612|Prednisone|prednisone|mesh-list
110466921|NCT02614612|Methylprednisolone|methylprednisolone|mesh-list
110466922|NCT02614612|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110466923|NCT02614612|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110466924|NCT02614612|Prednisolone|prednisolone|mesh-list
110466925|NCT02614612|Prednisolone acetate|prednisolone acetate|mesh-list
110466926|NCT02614612|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110466927|NCT02614612|Prednisolone phosphate|prednisolone phosphate|mesh-list
110466928|NCT02614612|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110466929|NCT02614612|Glucocorticoids|glucocorticoids|mesh-ancestor
110466930|NCT02614612|Hormones|hormones|mesh-ancestor
110466931|NCT02614612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110466932|NCT02614612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110466933|NCT02614612|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110466934|NCT02614612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110466935|NCT02614612|Antiemetics|antiemetics|mesh-ancestor
110466936|NCT02614612|Autonomic Agents|autonomic agents|mesh-ancestor
110466937|NCT02614612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110466938|NCT02614612|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110466939|NCT02614612|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110466940|NCT02614612|Protective Agents|protective agents|mesh-ancestor
110466941|NCT00900159|Eszopiclone|eszopiclone|mesh-list
110466942|NCT00900159|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110466943|NCT00900159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110466944|NCT00900159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110466945|NCT01689909|Zolpidem|zolpidem|mesh-list
110466946|NCT01689909|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110466947|NCT01689909|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110466948|NCT01689909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110466949|NCT01689909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110466950|NCT01689909|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
110466951|NCT01689909|GABA Agonists|gaba agonists|mesh-ancestor
110466952|NCT01689909|GABA Agents|gaba agents|mesh-ancestor
110466953|NCT01689909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110466954|NCT01689909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110466955|NCT00854308|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110466956|NCT00854308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110466957|NCT00854308|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110466958|NCT00854308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110466959|NCT00854308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110466960|NCT00592852|Fluoxetine|fluoxetine|mesh-list
110466961|NCT00592852|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110466962|NCT00592852|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110466963|NCT00592852|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110466964|NCT00592852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110466965|NCT00592852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110533039|NCT01497509|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110533040|NCT01497509|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110533041|NCT01497509|Autonomic Agents|autonomic agents|mesh-ancestor
110533042|NCT01497509|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110533043|NCT01497509|Respiratory System Agents|respiratory system agents|mesh-ancestor
110533045|NCT01497509|Sympathomimetics|sympathomimetics|mesh-ancestor
110533046|NCT01497509|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110533047|NCT02844881|Apatinib|apatinib|mesh-list
110533048|NCT02844881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110533049|NCT02844881|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110533050|NCT02844881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110534653|NCT04178850|Infliximab|infliximab|mesh-list
110466967|NCT00592852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110466968|NCT00592852|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110466969|NCT00592852|Antidepressive Agents|antidepressive agents|mesh-ancestor
110466970|NCT00592852|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110466971|NCT00592852|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110466972|NCT00592852|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110466973|NCT00592852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110466974|NCT00895245|Dexamethasone|dexamethasone|mesh-list
110466975|NCT00895245|Palonosetron|palonosetron|mesh-list
110466976|NCT00895245|Fosaprepitant|fosaprepitant|mesh-list
110466977|NCT00895245|Aprepitant|aprepitant|mesh-list
110466978|NCT00895245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110466979|NCT00895245|Antiemetics|antiemetics|mesh-ancestor
110466980|NCT00895245|Autonomic Agents|autonomic agents|mesh-ancestor
110466981|NCT00895245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110466982|NCT00895245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110466983|NCT00895245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110466984|NCT00895245|Glucocorticoids|glucocorticoids|mesh-ancestor
110466986|NCT00895245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110466987|NCT00895245|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110466988|NCT00895245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110466989|NCT00895245|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110466990|NCT00895245|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110466991|NCT00895245|Serotonin Agents|serotonin agents|mesh-ancestor
110466992|NCT00895245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110466993|NCT00895245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110466994|NCT00895245|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110466995|NCT03172377|Adalimumab|adalimumab|mesh-list
110466996|NCT03172377|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110466997|NCT03172377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110466998|NCT03172377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110466999|NCT02617654|Liraglutide|liraglutide|mesh-list
110467000|NCT02617654|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110467001|NCT02617654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110467002|NCT02617654|Incretins|incretins|mesh-ancestor
110467003|NCT02617654|Hormones|hormones|mesh-ancestor
110467004|NCT02617654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110467005|NCT00700024|Methyltestosterone|methyltestosterone|mesh-list
110467006|NCT00700024|Testosterone|testosterone|mesh-list
110467007|NCT00700024|Testosterone undecanoate|testosterone undecanoate|mesh-list
110467008|NCT00700024|Testosterone enanthate|testosterone enanthate|mesh-list
110467009|NCT00700024|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
110467010|NCT00700024|Androgens|androgens|mesh-ancestor
110467011|NCT00700024|Hormones|hormones|mesh-ancestor
110467012|NCT00700024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110467013|NCT00700024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110467014|NCT00700024|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110467015|NCT00700024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110467016|NCT00700024|Anabolic Agents|anabolic agents|mesh-ancestor
110467017|NCT00697450|Insulin Detemir|insulin detemir|mesh-list
110467018|NCT00697450|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110533051|NCT02844881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110533052|NCT02846519|Rifampin|rifampin|mesh-list
110533053|NCT02846519|Esketamine|esketamine|mesh-list
110533054|NCT02846519|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110533055|NCT02846519|Antitubercular Agents|antitubercular agents|mesh-ancestor
110533056|NCT02846519|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110533057|NCT02846519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110533058|NCT02846519|Leprostatic Agents|leprostatic agents|mesh-ancestor
110533059|NCT02846519|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110533060|NCT02846519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110533061|NCT02846519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110533062|NCT02846519|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110193076|NCT00034541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110467019|NCT00697450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110467020|NCT00796003|Decitabine|decitabine|mesh-list
110467021|NCT00796003|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110467022|NCT00796003|Antimetabolites|antimetabolites|mesh-ancestor
110467023|NCT00796003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110467024|NCT00796003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110467025|NCT00796003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110467026|NCT04110535|Midazolam|midazolam|mesh-list
110467027|NCT04110535|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110467028|NCT04110535|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110368854|NCT04934228|Sensory System Agents|sensory system agents|mesh-ancestor
110467029|NCT04110535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110467030|NCT04110535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110467031|NCT04110535|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110467032|NCT04110535|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110467033|NCT04110535|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110467034|NCT04110535|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110467035|NCT04110535|Anesthetics, General|anesthetics, general|mesh-ancestor
110467036|NCT04110535|Anesthetics|anesthetics|mesh-ancestor
110467037|NCT04110535|GABA Modulators|gaba modulators|mesh-ancestor
110467038|NCT04110535|GABA Agents|gaba agents|mesh-ancestor
110467039|NCT04110535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110467040|NCT04110535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110467042|NCT04025203|Ibuprofen arginine|ibuprofen arginine|mesh-list
110467043|NCT04025203|Gabapentin|gabapentin|mesh-list
110467044|NCT04025203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110467045|NCT04025203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110467046|NCT04025203|Analgesics|analgesics|mesh-ancestor
110467047|NCT04025203|Sensory System Agents|sensory system agents|mesh-ancestor
110467048|NCT04025203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110467049|NCT04025203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110467050|NCT04025203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110467051|NCT04025203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110467052|NCT04025203|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110389808|NCT00217737|Vitamins|vitamins|mesh-ancestor
110467053|NCT04025203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110467054|NCT04025203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110467055|NCT04025203|Anticonvulsants|anticonvulsants|mesh-ancestor
110467056|NCT04025203|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110467057|NCT04025203|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110467058|NCT04025203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110467059|NCT04025203|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110467060|NCT04025203|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110467061|NCT04025203|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110467062|NCT04025203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110467063|NCT04025203|Antimanic Agents|antimanic agents|mesh-ancestor
110467064|NCT02843607|Immunomodulating Agents|immunomodulating agents|mesh-list
110467065|NCT02843607|Immunologic Factors|immunologic factors|mesh-ancestor
110533063|NCT02846519|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110533064|NCT02846519|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110533065|NCT02846519|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110533066|NCT02846519|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110533067|NCT02846519|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110533068|NCT02846519|Antidepressive Agents|antidepressive agents|mesh-ancestor
110533069|NCT02846519|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110533071|NCT00618228|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110533073|NCT00618228|Analgesics|analgesics|mesh-ancestor
110533074|NCT00618228|Sensory System Agents|sensory system agents|mesh-ancestor
110533075|NCT00618228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110533076|NCT00618228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110533077|NCT00618228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110533078|NCT00618228|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110533079|NCT00618228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110533080|NCT03711305|Carboplatin|carboplatin|mesh-list
110467066|NCT02843607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110467067|NCT02843685|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
110467068|NCT02843685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110467070|NCT00915577|Interferon-beta|interferon-beta|mesh-list
110467071|NCT00915577|Interferon beta-1a|interferon beta-1a|mesh-list
110467072|NCT00915577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110467073|NCT00915577|Antiviral Agents|antiviral agents|mesh-ancestor
110467074|NCT00915577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110467075|NCT00915577|Immunologic Factors|immunologic factors|mesh-ancestor
110467076|NCT00915577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110467077|NCT00915577|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110467078|NCT00899847|Acetaminophen|acetaminophen|mesh-list
110467079|NCT00899847|Diphenhydramine|diphenhydramine|mesh-list
110467080|NCT00899847|Promethazine|promethazine|mesh-list
110467081|NCT00899847|Cyclosporine|cyclosporine|mesh-list
110467082|NCT00899847|Mycophenolic Acid|mycophenolic acid|mesh-list
110467083|NCT00899847|Hydrocortisone|hydrocortisone|mesh-list
110467084|NCT00899847|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110467085|NCT00899847|Cyclophosphamide|cyclophosphamide|mesh-list
110467086|NCT00899847|Melphalan|melphalan|mesh-list
110467087|NCT00899847|Mechlorethamine|mechlorethamine|mesh-list
110467088|NCT00899847|Cyclosporins|cyclosporins|mesh-list
110467089|NCT00899847|Thymoglobulin|thymoglobulin|mesh-list
110467090|NCT00899847|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110467091|NCT00899847|Lenograstim|lenograstim|mesh-list
110467092|NCT00899847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110467093|NCT00899847|Immunologic Factors|immunologic factors|mesh-ancestor
110467094|NCT00899847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110467095|NCT00899847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110467096|NCT00899847|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110467097|NCT00899847|Alkylating Agents|alkylating agents|mesh-ancestor
110467098|NCT00899847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110467099|NCT00899847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110467100|NCT00899847|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110467101|NCT00899847|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110467102|NCT00899847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110467103|NCT00899847|Antifungal Agents|antifungal agents|mesh-ancestor
110467104|NCT00899847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110467105|NCT00899847|Dermatologic Agents|dermatologic agents|mesh-ancestor
110467106|NCT00899847|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110467107|NCT00899847|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110467108|NCT00899847|Analgesics|analgesics|mesh-ancestor
110533082|NCT03711305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110533083|NCT03711305|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110533084|NCT03711305|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110533085|NCT03711305|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110533086|NCT03711305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110533087|NCT03711305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110533088|NCT00618384|Sorafenib|sorafenib|mesh-list
110533089|NCT00618384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110533090|NCT00618384|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110533091|NCT00618384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110533092|NCT00618384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110533093|NCT03608657|Apremilast|apremilast|mesh-list
110533094|NCT03608657|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110533095|NCT03608657|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110533096|NCT03608657|Analgesics|analgesics|mesh-ancestor
110533097|NCT03608657|Sensory System Agents|sensory system agents|mesh-ancestor
110533098|NCT03608657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110533099|NCT03608657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110180589|NCT00016016|Cytarabine|cytarabine|mesh-list
110533100|NCT03608657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110533101|NCT03608657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110533102|NCT03608657|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
110533103|NCT03608657|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110533104|NCT03608657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110193195|NCT00062127|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110467109|NCT00899847|Sensory System Agents|sensory system agents|mesh-ancestor
110467110|NCT00899847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110467111|NCT00899847|Antipyretics|antipyretics|mesh-ancestor
110467112|NCT00899847|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110467113|NCT00899847|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110467114|NCT00899847|Antitubercular Agents|antitubercular agents|mesh-ancestor
110467115|NCT00899847|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110467116|NCT00899847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110467117|NCT00899847|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110467118|NCT00899847|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110467119|NCT00899847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110467120|NCT00899847|Anesthetics, Local|anesthetics, local|mesh-ancestor
110467121|NCT00899847|Anesthetics|anesthetics|mesh-ancestor
110467122|NCT00899847|Antiemetics|antiemetics|mesh-ancestor
110467123|NCT00899847|Autonomic Agents|autonomic agents|mesh-ancestor
110467124|NCT00899847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110467125|NCT00899847|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110467126|NCT00899847|Histamine Antagonists|histamine antagonists|mesh-ancestor
110467127|NCT00899847|Histamine Agents|histamine agents|mesh-ancestor
110467128|NCT00899847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110467129|NCT00899847|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110389892|NCT06031454|Rifampin|rifampin|mesh-list
110467130|NCT00899847|Antipruritics|antipruritics|mesh-ancestor
110533105|NCT03608657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110533106|NCT05000658|Dexamethasone|dexamethasone|mesh-list
110533107|NCT05000658|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
110533108|NCT05000658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110533109|NCT05000658|Antiemetics|antiemetics|mesh-ancestor
110533110|NCT05000658|Autonomic Agents|autonomic agents|mesh-ancestor
110533111|NCT05000658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110533112|NCT05000658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110533113|NCT05000658|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110533114|NCT05000658|Glucocorticoids|glucocorticoids|mesh-ancestor
110533115|NCT05000658|Hormones|hormones|mesh-ancestor
110533116|NCT05000658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110533117|NCT05000658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110533118|NCT05000658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110533119|NCT02844803|Metformin|metformin|mesh-list
110533120|NCT02844803|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110533121|NCT02844803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110533122|NCT04211298|Dexmedetomidine|dexmedetomidine|mesh-list
110533123|NCT04211298|Propofol|propofol|mesh-list
110533124|NCT04211298|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110533125|NCT04211298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110533126|NCT04211298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110533127|NCT04211298|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110533128|NCT04211298|Analgesics|analgesics|mesh-ancestor
110533129|NCT04211298|Sensory System Agents|sensory system agents|mesh-ancestor
110533130|NCT04211298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110467131|NCT00899847|Glucocorticoids|glucocorticoids|mesh-ancestor
110467133|NCT00899847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110467134|NCT00899847|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110467135|NCT00899847|Protective Agents|protective agents|mesh-ancestor
110467136|NCT00899847|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110467137|NCT04106791|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
110467138|NCT00529113|Gemcitabine|gemcitabine|mesh-list
110467139|NCT00529113|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110467140|NCT00529113|Antimetabolites|antimetabolites|mesh-ancestor
110467141|NCT00529113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110467142|NCT00529113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110467143|NCT04106557|Gaboxadol|gaboxadol|mesh-list
110467144|NCT04106557|Analgesics|analgesics|mesh-ancestor
110467145|NCT04106557|Sensory System Agents|sensory system agents|mesh-ancestor
110467146|NCT04106557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110467147|NCT04106557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110467148|NCT04106557|Anticonvulsants|anticonvulsants|mesh-ancestor
110467149|NCT04106557|GABA Agonists|gaba agonists|mesh-ancestor
110467150|NCT04106557|GABA Agents|gaba agents|mesh-ancestor
110467151|NCT04106557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110467152|NCT04106557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110467153|NCT04117750|Cholecalciferol|cholecalciferol|mesh-list
110467154|NCT04117750|Vitamin D|vitamin d|mesh-list
110533131|NCT04211298|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110533132|NCT04211298|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110533133|NCT04211298|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110533134|NCT04211298|Adrenergic Agents|adrenergic agents|mesh-ancestor
110533135|NCT04211298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110533136|NCT04211298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110533137|NCT04211298|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110533138|NCT04211298|Anesthetics, General|anesthetics, general|mesh-ancestor
110533139|NCT04211298|Anesthetics|anesthetics|mesh-ancestor
110533140|NCT04212702|Everolimus|everolimus|mesh-list
110533141|NCT04212702|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110533142|NCT04212702|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110193347|NCT00062556|Niacin|niacin|mesh-list
110467155|NCT04117750|Calcium Carbonate|calcium carbonate|mesh-list
110467156|NCT04117750|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110467157|NCT04117750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110467158|NCT04117750|Vitamins|vitamins|mesh-ancestor
110467159|NCT04117750|Micronutrients|micronutrients|mesh-ancestor
110467160|NCT04117750|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110467161|NCT04117750|Antacids|antacids|mesh-ancestor
110467162|NCT04117750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110467163|NCT04117750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110467164|NCT04131322|Adalimumab|adalimumab|mesh-list
110467165|NCT04131322|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110467166|NCT04131322|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110467167|NCT04131322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110467168|NCT04131322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110467169|NCT02840175|Adalimumab|adalimumab|mesh-list
110467170|NCT02840175|Etanercept|etanercept|mesh-list
110467171|NCT02840175|Abatacept|abatacept|mesh-list
110467172|NCT02840175|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110467173|NCT02840175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110467174|NCT02840175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110467175|NCT02840175|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110467176|NCT02840175|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110467177|NCT02840175|Analgesics|analgesics|mesh-ancestor
110467178|NCT02840175|Sensory System Agents|sensory system agents|mesh-ancestor
110467179|NCT02840175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110467180|NCT02840175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110467181|NCT02840175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110467182|NCT02840175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110467183|NCT02840175|Immunologic Factors|immunologic factors|mesh-ancestor
110467184|NCT02840175|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110467185|NCT02840175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110467186|NCT02840175|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110467187|NCT02840175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110467188|NCT02603497|Peficitinib|peficitinib|mesh-list
110467189|NCT02603497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110467190|NCT02603497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110467191|NCT02603497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110467192|NCT02603497|Immunologic Factors|immunologic factors|mesh-ancestor
110467193|NCT02603497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110467194|NCT02840409|Bevacizumab|bevacizumab|mesh-list
110467195|NCT02840409|Vinblastine|vinblastine|mesh-list
110467196|NCT02840409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110467197|NCT02840409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110467198|NCT02840409|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110467199|NCT02840409|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110467200|NCT02840409|Growth Substances|growth substances|mesh-ancestor
110467201|NCT02840409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110467202|NCT02840409|Growth Inhibitors|growth inhibitors|mesh-ancestor
110467203|NCT02840409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110467204|NCT02840409|Tubulin Modulators|tubulin modulators|mesh-ancestor
110533143|NCT04212702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110533144|NCT04212702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110533145|NCT04212702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110533146|NCT04212702|Immunologic Factors|immunologic factors|mesh-ancestor
110533147|NCT04212702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110533148|NCT04212702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110533149|NCT02691780|Sorafenib|sorafenib|mesh-list
110533150|NCT02691780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110533151|NCT02691780|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110193357|NCT00062556|Vitamins|vitamins|mesh-ancestor
110467205|NCT02840409|Antimitotic Agents|antimitotic agents|mesh-ancestor
110467206|NCT02840409|Mitosis Modulators|mitosis modulators|mesh-ancestor
110467207|NCT02840409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110467208|NCT02839941|Mycophenolic Acid|mycophenolic acid|mesh-list
110467210|NCT02839941|Glucocorticoids|glucocorticoids|mesh-list
110467211|NCT02839941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110467212|NCT02839941|Immunologic Factors|immunologic factors|mesh-ancestor
110467213|NCT02839941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110467214|NCT02839941|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110467215|NCT02839941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110467216|NCT02839941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110467217|NCT02839941|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110467218|NCT02839941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110467219|NCT02839941|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110467220|NCT02839941|Antitubercular Agents|antitubercular agents|mesh-ancestor
110467221|NCT02839941|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110467222|NCT02839941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110467224|NCT02839941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110467225|NCT02842983|Esmolol|esmolol|mesh-list
110467226|NCT02842983|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110467227|NCT02842983|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110467228|NCT02842983|Adrenergic Agents|adrenergic agents|mesh-ancestor
110467229|NCT02842983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110467230|NCT02842983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110597146|NCT04684238|Anesthetics, General|anesthetics, general|mesh-ancestor
110467231|NCT02842983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110467232|NCT02842983|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110467233|NCT02839785|Ibuprofen|ibuprofen|mesh-list
110467234|NCT02839785|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110467235|NCT02839785|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110467236|NCT02839785|Analgesics|analgesics|mesh-ancestor
110467237|NCT02839785|Sensory System Agents|sensory system agents|mesh-ancestor
110467238|NCT02839785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110467239|NCT02839785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110467240|NCT02839785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110467241|NCT02839785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110467242|NCT02839785|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110467243|NCT02839785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110467244|NCT02839785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110467245|NCT02843061|Rituximab|rituximab|mesh-list
110467246|NCT02843061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110467247|NCT02843061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110467248|NCT02843061|Immunologic Factors|immunologic factors|mesh-ancestor
110467249|NCT02843061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110467250|NCT02843061|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110467251|NCT02839239|Vitamin D|vitamin d|mesh-list
110467252|NCT02839239|Ergocalciferols|ergocalciferols|mesh-list
110467253|NCT02839239|Cholecalciferol|cholecalciferol|mesh-list
110467254|NCT02839239|Vitamins|vitamins|mesh-list
110467255|NCT02839239|Micronutrients|micronutrients|mesh-ancestor
110467256|NCT02839239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110467257|NCT02839239|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110467258|NCT02839239|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110467259|NCT02837835|Ceftazidime|ceftazidime|mesh-list
110467260|NCT02837835|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110533152|NCT02691780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110533153|NCT02691780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110533154|NCT02845661|Dexmedetomidine|dexmedetomidine|mesh-list
110533155|NCT02845661|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110533156|NCT02845661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110533157|NCT02845661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110533158|NCT02845661|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110533160|NCT02845661|Sensory System Agents|sensory system agents|mesh-ancestor
110533161|NCT02845661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110533162|NCT02845661|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110533163|NCT02845661|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110533164|NCT02845661|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110533165|NCT02845661|Adrenergic Agents|adrenergic agents|mesh-ancestor
110533166|NCT02845661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110533167|NCT02845661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110533168|NCT02844335|Immunomodulating Agents|immunomodulating agents|mesh-list
110533169|NCT02844335|Immunologic Factors|immunologic factors|mesh-ancestor
110467261|NCT02837835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110467262|NCT02839161|Aluminum Hydroxide|aluminum hydroxide|mesh-list
110467263|NCT02839161|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110467264|NCT02839161|Immunologic Factors|immunologic factors|mesh-ancestor
110114390|NCT01867463|Immunologic Factors|immunologic factors|mesh-ancestor
110467265|NCT02839161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110467266|NCT02839161|Antacids|antacids|mesh-ancestor
110467267|NCT02839161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110597170|NCT04576078|Nefopam|nefopam|mesh-list
110467268|NCT02839161|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110467269|NCT04249713|Brodalumab|brodalumab|mesh-list
110467270|NCT04249713|Dermatologic Agents|dermatologic agents|mesh-ancestor
110467271|NCT00610506|Dexetimide|dexetimide|mesh-list
110467272|NCT00610506|Citalopram|citalopram|mesh-list
110467273|NCT00610506|Escitalopram|escitalopram|mesh-list
110467274|NCT00610506|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110467275|NCT00610506|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110467276|NCT00610506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110467277|NCT00610506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110390041|NCT06030934|Paclitaxel|paclitaxel|mesh-list
110467279|NCT00610506|Serotonin Agents|serotonin agents|mesh-ancestor
110467280|NCT00610506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110467281|NCT00610506|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110467282|NCT00610506|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110467283|NCT00610506|Parasympatholytics|parasympatholytics|mesh-ancestor
110467284|NCT00610506|Autonomic Agents|autonomic agents|mesh-ancestor
110467285|NCT00610506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110467286|NCT00610506|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110467287|NCT00610506|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110467288|NCT00610506|Cholinergic Agents|cholinergic agents|mesh-ancestor
110467289|NCT00610506|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110467290|NCT00610506|Antidepressive Agents|antidepressive agents|mesh-ancestor
110467291|NCT00610506|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110467292|NCT04260828|Aspirin|aspirin|mesh-list
110467293|NCT04260828|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110467294|NCT04260828|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110467295|NCT04260828|Analgesics|analgesics|mesh-ancestor
110467296|NCT04260828|Sensory System Agents|sensory system agents|mesh-ancestor
110368910|NCT04725812|Eculizumab|eculizumab|mesh-list
110533170|NCT02844335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110533171|NCT00880074|Alovudine|alovudine|mesh-list
110533172|NCT00880074|Antiviral Agents|antiviral agents|mesh-ancestor
110533173|NCT00880074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110533174|NCT04375787|Atorvastatin|atorvastatin|mesh-list
110533175|NCT04375787|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110533176|NCT04375787|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110533177|NCT04375787|Antimetabolites|antimetabolites|mesh-ancestor
110533178|NCT04375787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110533179|NCT04375787|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110533180|NCT04375787|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110533181|NCT04375787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110467297|NCT04260828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110467298|NCT04260828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110467299|NCT04260828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110467300|NCT04260828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110467301|NCT04260828|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110467302|NCT04260828|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110467303|NCT04260828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110467304|NCT04260828|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110467305|NCT04260828|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110467306|NCT04260828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110597187|NCT04561375|Fentanyl|fentanyl|mesh-list
110467307|NCT04260828|Antipyretics|antipyretics|mesh-ancestor
110467308|NCT00928746|Bromides|bromides|mesh-list
110467309|NCT00928746|Ipratropium|ipratropium|mesh-list
110467310|NCT00928746|Anticonvulsants|anticonvulsants|mesh-ancestor
110467311|NCT00928746|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110467312|NCT00928746|Autonomic Agents|autonomic agents|mesh-ancestor
110467313|NCT00928746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110467314|NCT00928746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110467315|NCT00928746|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110467316|NCT00928746|Respiratory System Agents|respiratory system agents|mesh-ancestor
110467317|NCT00928746|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110467318|NCT00928746|Cholinergic Agents|cholinergic agents|mesh-ancestor
110467319|NCT00928746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110467320|NCT00928746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110467321|NCT04468815|Esomeprazole|esomeprazole|mesh-list
110467322|NCT04468815|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110467323|NCT04468815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110467324|NCT04468815|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110467325|NCT04468815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110467326|NCT04468815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110467327|NCT00610584|Cetirizine|cetirizine|mesh-list
110467328|NCT00610584|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110467329|NCT00610584|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110467330|NCT00610584|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110467331|NCT00610584|Histamine Antagonists|histamine antagonists|mesh-ancestor
110467332|NCT00610584|Histamine Agents|histamine agents|mesh-ancestor
110467333|NCT00610584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110467334|NCT00610584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110467335|NCT00610584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110467336|NCT00894543|Escitalopram|escitalopram|mesh-list
110467337|NCT00894543|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110467338|NCT00894543|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110467339|NCT00894543|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110467340|NCT00894543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110467341|NCT00894543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110467342|NCT00894543|Serotonin Agents|serotonin agents|mesh-ancestor
110467343|NCT00894543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110467344|NCT00922272|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
110467345|NCT00922272|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110533182|NCT00825630|Esomeprazole|esomeprazole|mesh-list
110533183|NCT00825630|Pantoprazole|pantoprazole|mesh-list
110533184|NCT00825630|Lansoprazole|lansoprazole|mesh-list
110533185|NCT00825630|Dexlansoprazole|dexlansoprazole|mesh-list
110533186|NCT00825630|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110533187|NCT00825630|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110533188|NCT00825630|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110533189|NCT00825630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110533190|NCT00825630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110533191|NCT00620100|Docetaxel|docetaxel|mesh-list
110533192|NCT00620100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110533193|NCT00620100|Tubulin Modulators|tubulin modulators|mesh-ancestor
110533194|NCT00620100|Antimitotic Agents|antimitotic agents|mesh-ancestor
110533195|NCT00620100|Mitosis Modulators|mitosis modulators|mesh-ancestor
110533196|NCT00620100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110533197|NCT02845349|Vortioxetine|vortioxetine|mesh-list
110533198|NCT02845349|Antidepressive Agents|antidepressive agents|mesh-ancestor
110533199|NCT02845349|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110533200|NCT02845349|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110533201|NCT02845349|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110533202|NCT02845349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110533203|NCT02845349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110533204|NCT02845349|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110533205|NCT02845349|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110597205|NCT04536532|Entecavir|entecavir|mesh-list
110533206|NCT02845349|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110534654|NCT04178850|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110467346|NCT00922272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110467347|NCT00922272|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110467348|NCT00922272|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110467349|NCT00922272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110467351|NCT00922272|Dopamine Agents|dopamine agents|mesh-ancestor
110467352|NCT00922272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110467353|NCT00853372|Sunitinib|sunitinib|mesh-list
110467354|NCT00853372|Trebananib|trebananib|mesh-list
110467355|NCT00853372|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
110467356|NCT00853372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110467357|NCT00853372|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110467358|NCT00853372|Growth Substances|growth substances|mesh-ancestor
110467359|NCT00853372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110467360|NCT00853372|Growth Inhibitors|growth inhibitors|mesh-ancestor
110467361|NCT00853372|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110467362|NCT00853372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110467363|NCT00853372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110467364|NCT02836977|Tegafur|tegafur|mesh-list
110467365|NCT02836977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110467366|NCT02836977|Antimetabolites|antimetabolites|mesh-ancestor
110467367|NCT02836977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110467368|NCT02836977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110533207|NCT02845349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110533209|NCT02845349|Serotonin Agents|serotonin agents|mesh-ancestor
110533210|NCT02845349|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110533211|NCT02845349|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110533212|NCT02845349|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110533213|NCT02845349|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110533214|NCT03852251|Capecitabine|capecitabine|mesh-list
110533215|NCT03852251|Oxaliplatin|oxaliplatin|mesh-list
110533216|NCT03852251|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110533217|NCT03852251|Antimetabolites|antimetabolites|mesh-ancestor
110193585|NCT00063687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110193586|NCT00063687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110193587|NCT00036764|Epothilones|epothilones|mesh-list
110467369|NCT04988256|Cyclosporine|cyclosporine|mesh-list
110467370|NCT04988256|Prednisone|prednisone|mesh-list
110467371|NCT04988256|Methylprednisolone|methylprednisolone|mesh-list
110467372|NCT04988256|Cyclosporins|cyclosporins|mesh-list
110467373|NCT04988256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110467374|NCT04988256|Glucocorticoids|glucocorticoids|mesh-ancestor
110467375|NCT04988256|Hormones|hormones|mesh-ancestor
110467376|NCT04988256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110467377|NCT04988256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110467378|NCT04988256|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110467379|NCT04988256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110467380|NCT04988256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110467381|NCT04988256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110467382|NCT04988256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110467383|NCT04988256|Immunologic Factors|immunologic factors|mesh-ancestor
110467384|NCT04988256|Antifungal Agents|antifungal agents|mesh-ancestor
110467385|NCT04988256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110467386|NCT04988256|Dermatologic Agents|dermatologic agents|mesh-ancestor
110467387|NCT04988256|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110597215|NCT04508634|Metformin|metformin|mesh-list
110467388|NCT04988256|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110467389|NCT04988256|Antiemetics|antiemetics|mesh-ancestor
110467390|NCT04988256|Autonomic Agents|autonomic agents|mesh-ancestor
110467391|NCT04988256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110467392|NCT04988256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110467393|NCT04988256|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110467394|NCT04988256|Protective Agents|protective agents|mesh-ancestor
110467395|NCT00848536|Travoprost|travoprost|mesh-list
110467396|NCT00848536|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110467397|NCT00848536|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110467398|NCT00848536|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110467399|NCT00922116|Epoetin Alfa|epoetin alfa|mesh-list
110467400|NCT00922116|Hematinics|hematinics|mesh-ancestor
110467401|NCT04260516|Acetylcysteine|acetylcysteine|mesh-list
110467402|NCT04260516|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110467403|NCT04260516|Antiviral Agents|antiviral agents|mesh-ancestor
110467404|NCT04260516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110467405|NCT04260516|Expectorants|expectorants|mesh-ancestor
110467406|NCT04260516|Respiratory System Agents|respiratory system agents|mesh-ancestor
110467407|NCT04260516|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110467408|NCT04260516|Antioxidants|antioxidants|mesh-ancestor
110467409|NCT04260516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110467410|NCT04260516|Protective Agents|protective agents|mesh-ancestor
110467411|NCT04260516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110467412|NCT04260516|Antidotes|antidotes|mesh-ancestor
110467413|NCT00921024|Ceftazidime|ceftazidime|mesh-list
110467414|NCT00921024|Ceftolozane|ceftolozane|mesh-list
110467415|NCT00921024|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110533218|NCT03852251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110533219|NCT03852251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110533220|NCT00620178|Losartan|losartan|mesh-list
110533221|NCT00620178|Candesartan|candesartan|mesh-list
110533222|NCT00620178|Candesartan cilexetil|candesartan cilexetil|mesh-list
110533223|NCT00620178|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110533224|NCT00620178|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110533225|NCT00620178|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110533226|NCT00620178|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110533227|NCT00620178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110467416|NCT00921024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110467418|NCT00928668|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110467419|NCT00928668|Autonomic Agents|autonomic agents|mesh-ancestor
110467420|NCT00928668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110467421|NCT00928668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110467422|NCT00928668|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110467423|NCT00928668|Respiratory System Agents|respiratory system agents|mesh-ancestor
110467424|NCT00700960|Insulin Detemir|insulin detemir|mesh-list
110467425|NCT00700960|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110467426|NCT00700960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110467428|NCT00700492|Progestins|progestins|mesh-ancestor
110467429|NCT00700492|Hormones|hormones|mesh-ancestor
110597233|NCT04447092|Tubulin Modulators|tubulin modulators|mesh-ancestor
110467430|NCT00700492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110467431|NCT00700492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110467432|NCT00700648|Insulin Aspart|insulin aspart|mesh-list
110467433|NCT00700648|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110467434|NCT00700648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110467435|NCT00703300|Bortezomib|bortezomib|mesh-list
110467436|NCT00703300|Decitabine|decitabine|mesh-list
110467437|NCT00703300|Azacitidine|azacitidine|mesh-list
110467438|NCT00703300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110467439|NCT00703300|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110467440|NCT00703300|Antimetabolites|antimetabolites|mesh-ancestor
110467441|NCT00703300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110467442|NCT00703300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110467443|NCT00703378|Docetaxel|docetaxel|mesh-list
110467444|NCT00703378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110467445|NCT00703378|Tubulin Modulators|tubulin modulators|mesh-ancestor
110467446|NCT00703378|Antimitotic Agents|antimitotic agents|mesh-ancestor
110467447|NCT00703378|Mitosis Modulators|mitosis modulators|mesh-ancestor
110467448|NCT00703378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110467449|NCT00852202|Cariprazine|cariprazine|mesh-list
110467450|NCT00852202|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110467451|NCT00852202|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110467452|NCT00852202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110467453|NCT00852202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110467454|NCT00852202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110467455|NCT01074008|Ritonavir|ritonavir|mesh-list
110467456|NCT01074008|Ribavirin|ribavirin|mesh-list
110467457|NCT01074008|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110467458|NCT01074008|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110467459|NCT01074008|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110467460|NCT01074008|Protease Inhibitors|protease inhibitors|mesh-ancestor
110467461|NCT01074008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110467462|NCT01074008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110467463|NCT01074008|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110467464|NCT01074008|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110467465|NCT01074008|Antiviral Agents|antiviral agents|mesh-ancestor
110467466|NCT01074008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110467467|NCT01074008|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110467468|NCT01074008|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110467469|NCT01074008|Antimetabolites|antimetabolites|mesh-ancestor
110467470|NCT02613052|Propofol|propofol|mesh-list
110467471|NCT02613052|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110033135|NCT04835402|Pembrolizumab|pembrolizumab|mesh-list
110533228|NCT04349982|Fibrin fragment D|fibrin fragment d|mesh-list
110533229|NCT04349982|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110533230|NCT04349982|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110533231|NCT04349982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110533232|NCT04349982|Hemostatics|hemostatics|mesh-ancestor
110533233|NCT04349982|Coagulants|coagulants|mesh-ancestor
110533234|NCT04315350|Prednisolone|prednisolone|mesh-list
110533235|NCT04315350|Curcumin|curcumin|mesh-list
110533236|NCT04315350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110533237|NCT04315350|Glucocorticoids|glucocorticoids|mesh-ancestor
110533238|NCT04315350|Hormones|hormones|mesh-ancestor
110533239|NCT04315350|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110533240|NCT04315350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110533241|NCT04315350|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110467472|NCT02613052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110467473|NCT02613052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110467474|NCT02613052|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110467475|NCT02613052|Anesthetics, General|anesthetics, general|mesh-ancestor
110467476|NCT02613052|Anesthetics|anesthetics|mesh-ancestor
110467477|NCT01073930|Bisacodyl|bisacodyl|mesh-list
110467478|NCT01073930|Picosulfate sodium|picosulfate sodium|mesh-list
110467479|NCT01073930|Cathartics|cathartics|mesh-ancestor
110467480|NCT01073930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110467481|NCT01073930|Laxatives|laxatives|mesh-ancestor
110467482|NCT01073618|Voriconazole|voriconazole|mesh-list
110467483|NCT01073618|Antifungal Agents|antifungal agents|mesh-ancestor
110467484|NCT01073618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110467485|NCT01073618|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110467486|NCT01073618|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110467487|NCT01073618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110114623|NCT01869036|Morphine|morphine|mesh-list
110467488|NCT01073618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110467489|NCT01073618|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110467490|NCT01073618|Hormone Antagonists|hormone antagonists|mesh-ancestor
110467491|NCT01073618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110467492|NCT01073618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110467493|NCT01073618|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110467495|NCT00789373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110467496|NCT00789373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110467497|NCT00789373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110467498|NCT00789373|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110467499|NCT00789373|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110467500|NCT00851890|Interferons|interferons|mesh-list
110467501|NCT00851890|Ribavirin|ribavirin|mesh-list
110390256|NCT05931276|Antioxidants|antioxidants|mesh-ancestor
110467502|NCT00851890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110467503|NCT00851890|Antiviral Agents|antiviral agents|mesh-ancestor
110467504|NCT00851890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110467505|NCT00851890|Antimetabolites|antimetabolites|mesh-ancestor
110467506|NCT00851890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110467507|NCT00592072|Decanoic acid|decanoic acid|mesh-list
110467508|NCT00592072|Antifungal Agents|antifungal agents|mesh-ancestor
110467509|NCT00592072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110467510|NCT00626288|Mesalamine|mesalamine|mesh-list
110467511|NCT00626288|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110467512|NCT00626288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110467513|NCT00626288|Analgesics|analgesics|mesh-ancestor
110467514|NCT00626288|Sensory System Agents|sensory system agents|mesh-ancestor
110467515|NCT00626288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110467516|NCT00626288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110467517|NCT00626288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110467518|NCT00626288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110533242|NCT04315350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110533243|NCT04315350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110533244|NCT04315350|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110533245|NCT04315350|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110533246|NCT04315350|Analgesics|analgesics|mesh-ancestor
110533247|NCT04315350|Sensory System Agents|sensory system agents|mesh-ancestor
110533248|NCT04315350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110533249|NCT04315350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110533250|NCT04315350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110533252|NCT04288206|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110467519|NCT00792571|Epoprostenol|epoprostenol|mesh-list
110467520|NCT00792571|Beraprost|beraprost|mesh-list
110467521|NCT00792571|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110467522|NCT00792571|Vasodilator Agents|vasodilator agents|mesh-ancestor
110467523|NCT00792571|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110467524|NCT00794365|Varenicline|varenicline|mesh-list
110467525|NCT00794365|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110467526|NCT00794365|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110467527|NCT00794365|Cholinergic Agents|cholinergic agents|mesh-ancestor
110467528|NCT00794365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110467529|NCT00794365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110467530|NCT00794365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110467531|NCT01067144|Gabapentin|gabapentin|mesh-list
110467532|NCT01067144|Lorazepam|lorazepam|mesh-list
110467533|NCT01067144|Analgesics|analgesics|mesh-ancestor
110467534|NCT01067144|Sensory System Agents|sensory system agents|mesh-ancestor
110467535|NCT01067144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110467536|NCT01067144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110467537|NCT01067144|Anticonvulsants|anticonvulsants|mesh-ancestor
110467538|NCT01067144|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110467539|NCT01067144|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110467540|NCT01067144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110467541|NCT01067144|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110467542|NCT01067144|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110467543|NCT01067144|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110467544|NCT01067144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110467545|NCT01067144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110467546|NCT01067144|Antimanic Agents|antimanic agents|mesh-ancestor
110467547|NCT01067144|Antiemetics|antiemetics|mesh-ancestor
110467548|NCT01067144|Autonomic Agents|autonomic agents|mesh-ancestor
110467549|NCT01067144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110467550|NCT01067144|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110467551|NCT01067144|GABA Modulators|gaba modulators|mesh-ancestor
110467552|NCT01067144|GABA Agents|gaba agents|mesh-ancestor
110467553|NCT01078298|Varenicline|varenicline|mesh-list
110467554|NCT01078298|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110467555|NCT01078298|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110467556|NCT01078298|Cholinergic Agents|cholinergic agents|mesh-ancestor
110467557|NCT01078298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110467558|NCT01078298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110467559|NCT01078298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110467560|NCT00788593|Pancreatin|pancreatin|mesh-list
110467561|NCT00788593|Pancrelipase|pancrelipase|mesh-list
110467562|NCT00788593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110467563|NCT04106011|Gabapentin|gabapentin|mesh-list
110467564|NCT04106011|Analgesics|analgesics|mesh-ancestor
110467565|NCT04106011|Sensory System Agents|sensory system agents|mesh-ancestor
110467566|NCT04106011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110467567|NCT04106011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110467568|NCT04106011|Anticonvulsants|anticonvulsants|mesh-ancestor
110467569|NCT04106011|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110467570|NCT04106011|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110467571|NCT04106011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110467572|NCT04106011|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110033297|NCT04245644|Protease Inhibitors|protease inhibitors|mesh-ancestor
110533253|NCT04288206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110533254|NCT04958772|Lenograstim|lenograstim|mesh-list
110533255|NCT04958772|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110533256|NCT04958772|Immunologic Factors|immunologic factors|mesh-ancestor
110533257|NCT04958772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110533258|NCT02771249|Pyridoxine|pyridoxine|mesh-list
110533259|NCT02771249|Isoniazid|isoniazid|mesh-list
110533260|NCT02771249|Darunavir|darunavir|mesh-list
110533261|NCT02771249|Cobicistat|cobicistat|mesh-list
110533262|NCT02771249|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
110533263|NCT02771249|Antitubercular Agents|antitubercular agents|mesh-ancestor
110533264|NCT02771249|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110533265|NCT02771249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110061399|NCT05891262|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110061400|NCT05891262|Norethindrone|norethindrone|mesh-list
110467573|NCT04106011|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110467574|NCT04106011|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110467575|NCT04106011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110467576|NCT04106011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110467577|NCT04106011|Antimanic Agents|antimanic agents|mesh-ancestor
110467578|NCT02875886|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110467579|NCT02875886|Amiloride|amiloride|mesh-list
110467580|NCT02875886|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110467581|NCT02875886|Diuretics|diuretics|mesh-ancestor
110467582|NCT02875886|Natriuretic Agents|natriuretic agents|mesh-ancestor
110467583|NCT02875886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110467584|NCT02875886|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110467585|NCT02875886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110467586|NCT02875886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110467587|NCT02875886|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
110467588|NCT02875886|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110467589|NCT02875886|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
110467590|NCT02875886|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110467591|NCT00793819|Silodosin|silodosin|mesh-list
110467592|NCT00793819|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110467593|NCT00793819|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110467594|NCT00793819|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110467595|NCT00793819|Adrenergic Agents|adrenergic agents|mesh-ancestor
110467596|NCT00793819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110467597|NCT00793819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110467598|NCT00793819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110467599|NCT00793819|Urological Agents|urological agents|mesh-ancestor
110467600|NCT04109833|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110467601|NCT04109833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110467602|NCT02836665|Dermatologic Agents|dermatologic agents|mesh-list
110467603|NCT02836821|Rifampin|rifampin|mesh-list
110467604|NCT02836821|Apatinib|apatinib|mesh-list
110467605|NCT02836821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110467606|NCT02836821|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110467607|NCT02836821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110467608|NCT02836821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110467609|NCT02836821|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110467610|NCT02836821|Antitubercular Agents|antitubercular agents|mesh-ancestor
110467611|NCT02836821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110467612|NCT02836821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110467613|NCT02836821|Leprostatic Agents|leprostatic agents|mesh-ancestor
110467614|NCT02836821|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110467615|NCT02836821|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110467616|NCT02836821|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110467617|NCT02836821|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110467618|NCT02836821|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110533266|NCT02771249|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
110533267|NCT02771249|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110533269|NCT02771249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110533270|NCT02771249|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110533271|NCT02771249|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110533272|NCT02771249|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110533273|NCT02771249|Protease Inhibitors|protease inhibitors|mesh-ancestor
110533274|NCT02771249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110533275|NCT02771249|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110533276|NCT02771249|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110533277|NCT02771249|Antiviral Agents|antiviral agents|mesh-ancestor
110533278|NCT02771249|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110193791|NCT00037817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110467619|NCT02836821|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110467620|NCT02836821|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110467621|NCT02836743|Melatonin|melatonin|mesh-list
110467622|NCT02836743|Antioxidants|antioxidants|mesh-ancestor
110467623|NCT02836743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110467624|NCT02836743|Protective Agents|protective agents|mesh-ancestor
110467625|NCT02836743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110467626|NCT02836743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110467627|NCT04255368|Choline|choline|mesh-list
110467628|NCT04255368|Lipotropic Agents|lipotropic agents|mesh-ancestor
110467629|NCT04255368|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110467630|NCT04255368|Antimetabolites|antimetabolites|mesh-ancestor
110467631|NCT04255368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110467632|NCT04255368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110467633|NCT04255368|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110467634|NCT04255368|Nootropic Agents|nootropic agents|mesh-ancestor
110467635|NCT00610818|Mitogens|mitogens|mesh-list
110467636|NCT00610818|Mitosis Modulators|mitosis modulators|mesh-ancestor
110467637|NCT00610818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110467638|NCT00787891|Rabeprazole|rabeprazole|mesh-list
110467639|NCT00787891|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110467640|NCT00787891|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110467641|NCT00787891|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110467642|NCT00787891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110467643|NCT00787891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110467644|NCT00892437|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110467646|NCT00892437|Cobicistat|cobicistat|mesh-list
110467647|NCT00892437|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110467648|NCT00892437|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110467649|NCT00892437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110467650|NCT00892437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110467652|NCT00892437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110467653|NCT00892437|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110467654|NCT00892437|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110467655|NCT00892437|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110467656|NCT00892437|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110467657|NCT00892437|Protease Inhibitors|protease inhibitors|mesh-ancestor
110467658|NCT00892437|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110467659|NCT00892437|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110597343|NCT04216524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110467660|NCT02838537|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-list
110467661|NCT02838537|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110467662|NCT02838537|Serotonin Agents|serotonin agents|mesh-ancestor
110467663|NCT02838537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110467664|NCT02838537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110533279|NCT02771249|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110533280|NCT02771249|Vitamin B Complex|vitamin b complex|mesh-ancestor
110533281|NCT02771249|Vitamins|vitamins|mesh-ancestor
110533282|NCT02771249|Micronutrients|micronutrients|mesh-ancestor
110533283|NCT02771249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110533284|NCT04048278|Lidocaine|lidocaine|mesh-list
110533285|NCT04048278|Anesthetics, Local|anesthetics, local|mesh-ancestor
110533286|NCT04048278|Anesthetics|anesthetics|mesh-ancestor
110533287|NCT04048278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110533288|NCT04048278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110533289|NCT04048278|Sensory System Agents|sensory system agents|mesh-ancestor
110533290|NCT04048278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110061562|NCT05757843|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110061563|NCT05757843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110061564|NCT05733611|Bevacizumab|bevacizumab|mesh-list
110193816|NCT00065169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110193818|NCT00065169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110193819|NCT00065169|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110193820|NCT00065169|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110467665|NCT02838537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110467666|NCT02836509|Acetaminophen|acetaminophen|mesh-list
110467667|NCT02836509|Ibuprofen|ibuprofen|mesh-list
110467668|NCT02836509|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110467669|NCT02836509|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110467670|NCT02836509|Analgesics|analgesics|mesh-ancestor
110467671|NCT02836509|Sensory System Agents|sensory system agents|mesh-ancestor
110467672|NCT02836509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110467673|NCT02836509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110467674|NCT02836509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110467675|NCT02836509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110467676|NCT02836509|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110467677|NCT02836509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110467678|NCT02836509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110467679|NCT02836509|Antipyretics|antipyretics|mesh-ancestor
110467680|NCT05306379|Simvastatin|simvastatin|mesh-list
110467681|NCT05306379|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110467682|NCT05306379|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110467683|NCT05306379|Antimetabolites|antimetabolites|mesh-ancestor
110467684|NCT05306379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110467685|NCT05306379|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110467686|NCT05306379|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110467687|NCT05306379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110467688|NCT05304663|Lomustine|lomustine|mesh-list
110467689|NCT05304663|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110467690|NCT05304663|Alkylating Agents|alkylating agents|mesh-ancestor
110467691|NCT05304663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110467692|NCT05304663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110467693|NCT04109755|Pembrolizumab|pembrolizumab|mesh-list
110467694|NCT04109755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110467695|NCT04109755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110377779|NCT01083641|Hormones|hormones|mesh-ancestor
110467696|NCT04109755|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110467697|NCT04109755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110467698|NCT04248309|Progesterone|progesterone|mesh-list
110467699|NCT04248309|Progestins|progestins|mesh-ancestor
110467700|NCT04248309|Hormones|hormones|mesh-ancestor
110533291|NCT04048278|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110533292|NCT04048278|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110533293|NCT04048278|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110533294|NCT04048278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110533295|NCT04048278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110533296|NCT02697318|Timolol|timolol|mesh-list
110533297|NCT02697318|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110533298|NCT02697318|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110533299|NCT02697318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110533300|NCT02697318|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110467701|NCT04248309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110467702|NCT04248309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110467703|NCT00892281|Doxycycline|doxycycline|mesh-list
110467704|NCT00892281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110467705|NCT00892281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110467706|NCT00892281|Antimalarials|antimalarials|mesh-ancestor
110467707|NCT00892281|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110467708|NCT00892281|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110467709|NCT02836353|Rifaximin|rifaximin|mesh-list
110467710|NCT02836353|Somatostatin|somatostatin|mesh-list
110467711|NCT02836353|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110467712|NCT02836353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110467713|NCT02836353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110467714|NCT02836353|Hormones|hormones|mesh-ancestor
110467715|NCT02836353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110467716|NCT02836353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110467717|NCT02836431|Dexmedetomidine|dexmedetomidine|mesh-list
110467718|NCT02836431|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110467719|NCT02836431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110467720|NCT02836431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110467721|NCT02836431|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110467722|NCT02836431|Analgesics|analgesics|mesh-ancestor
110467723|NCT02836431|Sensory System Agents|sensory system agents|mesh-ancestor
110467724|NCT02836431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110467725|NCT02836431|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110467726|NCT02836431|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110467727|NCT02836431|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110467728|NCT02836431|Adrenergic Agents|adrenergic agents|mesh-ancestor
110467729|NCT02836431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110467730|NCT02836431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110467731|NCT05326425|Lazertinib|lazertinib|mesh-list
110467732|NCT05326425|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110467733|NCT05326425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110467734|NCT05326425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110467735|NCT00784693|Tanezumab|tanezumab|mesh-list
110467736|NCT00784693|Analgesics|analgesics|mesh-ancestor
110467737|NCT00784693|Sensory System Agents|sensory system agents|mesh-ancestor
110467738|NCT00784693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110467739|NCT00784693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110467740|NCT00915811|Fludarabine|fludarabine|mesh-list
110467741|NCT00915811|Busulfan|busulfan|mesh-list
110467742|NCT00915811|Thymoglobulin|thymoglobulin|mesh-list
110467743|NCT00915811|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110467744|NCT00915811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110467745|NCT00915811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110467746|NCT00915811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110467747|NCT00915811|Immunologic Factors|immunologic factors|mesh-ancestor
110467748|NCT00915811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110467749|NCT00915811|Alkylating Agents|alkylating agents|mesh-ancestor
110467750|NCT00915811|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110467751|NCT00915811|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110467752|NCT00892047|Aripiprazole|aripiprazole|mesh-list
110467753|NCT00892047|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
110533301|NCT02697318|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110533302|NCT02697318|Adrenergic Agents|adrenergic agents|mesh-ancestor
110533303|NCT02697318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110533304|NCT02697318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110533305|NCT02697318|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110533306|NCT02697318|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110533307|NCT05242133|Interferons|interferons|mesh-list
110533308|NCT05242133|Interferon-beta|interferon-beta|mesh-list
110533309|NCT05242133|Interferon beta-1a|interferon beta-1a|mesh-list
110533310|NCT05242133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110533311|NCT05242133|Antiviral Agents|antiviral agents|mesh-ancestor
110533312|NCT05242133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110533313|NCT05242133|Immunologic Factors|immunologic factors|mesh-ancestor
110533314|NCT05242133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110533315|NCT05242133|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110533316|NCT00621816|Nitroprusside|nitroprusside|mesh-list
110533317|NCT00621816|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110533318|NCT00621816|Vasodilator Agents|vasodilator agents|mesh-ancestor
110467754|NCT00892047|Antidepressive Agents|antidepressive agents|mesh-ancestor
110467755|NCT00892047|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110467756|NCT00892047|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110467757|NCT00892047|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110467758|NCT00892047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110467759|NCT00892047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110467760|NCT00892047|Dopamine Agonists|dopamine agonists|mesh-ancestor
110467761|NCT00892047|Dopamine Agents|dopamine agents|mesh-ancestor
110467762|NCT00892047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110467763|NCT00892047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110467764|NCT00892047|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110467765|NCT00892047|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110467766|NCT00892047|Serotonin Agents|serotonin agents|mesh-ancestor
110467767|NCT00892047|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110467768|NCT00892047|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110467769|NCT00892047|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110467770|NCT00892047|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110597397|NCT04168112|Methylprednisolone|methylprednisolone|mesh-list
110467771|NCT00892047|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110467772|NCT00892047|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110467773|NCT00892047|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110467774|NCT00892047|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110467775|NCT02835729|Cytarabine|cytarabine|mesh-list
110467776|NCT02835729|Idarubicin|idarubicin|mesh-list
110467777|NCT02835729|Tryptophan|tryptophan|mesh-list
110467778|NCT02835729|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110467779|NCT02835729|Antimetabolites|antimetabolites|mesh-ancestor
110467780|NCT02835729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110467781|NCT02835729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110467782|NCT02835729|Antiviral Agents|antiviral agents|mesh-ancestor
110467783|NCT02835729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110467784|NCT02835729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110467785|NCT02835729|Immunologic Factors|immunologic factors|mesh-ancestor
110467786|NCT02835729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110467787|NCT02835729|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110467788|NCT02835729|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110467789|NCT02835729|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110467790|NCT02835729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110467791|NCT02835729|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110467792|NCT02835729|Antidepressive Agents|antidepressive agents|mesh-ancestor
110533319|NCT00621816|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
110533320|NCT00621816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110533321|NCT05368974|Antiviral Agents|antiviral agents|mesh-list
110533322|NCT05368974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110533323|NCT04186026|Glucagon|glucagon|mesh-list
110533324|NCT04186026|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
110533325|NCT04186026|Incretins|incretins|mesh-ancestor
110533326|NCT04186026|Hormones|hormones|mesh-ancestor
110533327|NCT04186026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110533328|NCT04186026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110533329|NCT04186026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110533330|NCT00900731|Tiotropium Bromide|tiotropium bromide|mesh-list
110533331|NCT00900731|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110533332|NCT00900731|Autonomic Agents|autonomic agents|mesh-ancestor
110533333|NCT00900731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110533334|NCT00900731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110533335|NCT00900731|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110533336|NCT00900731|Respiratory System Agents|respiratory system agents|mesh-ancestor
110533337|NCT00900731|Parasympatholytics|parasympatholytics|mesh-ancestor
110533338|NCT00900731|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110193972|NCT05433428|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110467793|NCT02835729|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110467794|NCT02835651|Palmitic Acid|palmitic acid|mesh-list
110467795|NCT02835651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110467796|NCT02835651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110467797|NCT00787267|Dasatinib|dasatinib|mesh-list
110467798|NCT00787267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110467799|NCT00787267|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110467800|NCT00787267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110467801|NCT00787267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110467802|NCT02838615|Dexamethasone|dexamethasone|mesh-list
110467803|NCT02838615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110467804|NCT02838615|Antiemetics|antiemetics|mesh-ancestor
110467805|NCT02838615|Autonomic Agents|autonomic agents|mesh-ancestor
110467806|NCT02838615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110467807|NCT02838615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110467808|NCT02838615|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110467809|NCT02838615|Glucocorticoids|glucocorticoids|mesh-ancestor
110467810|NCT02838615|Hormones|hormones|mesh-ancestor
110467811|NCT02838615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110467812|NCT02838615|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110467813|NCT02838615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110467814|NCT02838225|Cyclophosphamide|cyclophosphamide|mesh-list
110467815|NCT02838225|Docetaxel|docetaxel|mesh-list
110467816|NCT02838225|Doxorubicin|doxorubicin|mesh-list
110467817|NCT02838225|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110467818|NCT02838225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110467819|NCT02838225|Immunologic Factors|immunologic factors|mesh-ancestor
110467820|NCT02838225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110467821|NCT02838225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110467822|NCT02838225|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110467823|NCT02838225|Alkylating Agents|alkylating agents|mesh-ancestor
110467824|NCT02838225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110467825|NCT02838225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110533339|NCT00900731|Cholinergic Agents|cholinergic agents|mesh-ancestor
110533340|NCT00900731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110533341|NCT00900731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110533342|NCT02687490|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110533343|NCT02687490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110533344|NCT05241821|Fibrinolytic Agents|fibrinolytic agents|mesh-list
110533345|NCT05241821|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110533346|NCT05241821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110533347|NCT00650819|Simvastatin|simvastatin|mesh-list
110533348|NCT00650819|Ezetimibe|ezetimibe|mesh-list
110533349|NCT00650819|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110533350|NCT00650819|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110533351|NCT00650819|Antimetabolites|antimetabolites|mesh-ancestor
110533352|NCT00650819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110533353|NCT00650819|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110533354|NCT00650819|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110533355|NCT00650819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110467826|NCT02838225|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110467827|NCT02838225|Tubulin Modulators|tubulin modulators|mesh-ancestor
110467828|NCT02838225|Antimitotic Agents|antimitotic agents|mesh-ancestor
110467829|NCT02838225|Mitosis Modulators|mitosis modulators|mesh-ancestor
110467830|NCT02838225|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110467831|NCT02838225|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110467832|NCT02838225|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110467833|NCT02838225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110467834|NCT00928434|Leuprolide|leuprolide|mesh-list
110467835|NCT00928434|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110467836|NCT00928434|Fertility Agents|fertility agents|mesh-ancestor
110467837|NCT00928434|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110467838|NCT00928434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110467839|NCT00928434|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110467840|NCT00928434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110467841|NCT04248621|Goserelin|goserelin|mesh-list
110467842|NCT04248621|Triptorelin Pamoate|triptorelin pamoate|mesh-list
110467843|NCT04248621|Leuprolide|leuprolide|mesh-list
110467844|NCT04248621|Flutamide|flutamide|mesh-list
110467845|NCT04248621|Bicalutamide|bicalutamide|mesh-list
110467846|NCT04248621|Androgens|androgens|mesh-list
110467847|NCT04248621|Androgen Antagonists|androgen antagonists|mesh-list
110467848|NCT04248621|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110467849|NCT04248621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110467850|NCT04248621|Hormones|hormones|mesh-ancestor
110467851|NCT04248621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110467852|NCT04248621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110467853|NCT04248621|Hormone Antagonists|hormone antagonists|mesh-ancestor
110467854|NCT04248621|Luteolytic Agents|luteolytic agents|mesh-ancestor
110467855|NCT04248621|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110467856|NCT04248621|Contraceptive Agents|contraceptive agents|mesh-ancestor
110467857|NCT04248621|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110467858|NCT04248621|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110467859|NCT04248621|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110467860|NCT04248621|Fertility Agents|fertility agents|mesh-ancestor
110114992|NCT01871129|Analgesics|analgesics|mesh-ancestor
110467862|NCT00784459|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110467863|NCT00784459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110467864|NCT00784459|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110467865|NCT00784459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110533356|NCT05662410|Aflibercept|aflibercept|mesh-list
110533357|NCT05662410|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110533358|NCT05662410|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110533359|NCT05662410|Growth Substances|growth substances|mesh-ancestor
110533360|NCT05662410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110533361|NCT05662410|Growth Inhibitors|growth inhibitors|mesh-ancestor
110533362|NCT05662410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110533363|NCT02689362|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110533364|NCT02689362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110533365|NCT02689362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110533366|NCT02689362|Incretins|incretins|mesh-ancestor
110533367|NCT02689362|Hormones|hormones|mesh-ancestor
110533368|NCT02689362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110533369|NCT02689362|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110533370|NCT02689362|Protease Inhibitors|protease inhibitors|mesh-ancestor
110467866|NCT00784459|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110467867|NCT00784459|Immunologic Factors|immunologic factors|mesh-ancestor
110467868|NCT00784459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110467869|NCT00784459|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110467870|NCT02835183|Insulin|insulin|mesh-list
110467871|NCT02835183|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110467872|NCT02835183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110467874|NCT02602483|Ibuprofen|ibuprofen|mesh-list
110467875|NCT02602483|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110467876|NCT02602483|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110467877|NCT02602483|Analgesics|analgesics|mesh-ancestor
110467878|NCT02602483|Sensory System Agents|sensory system agents|mesh-ancestor
110467879|NCT02602483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110467880|NCT02602483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110467881|NCT02602483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110467882|NCT02602483|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110467883|NCT02602483|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110467884|NCT02602483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110467885|NCT02602483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110467886|NCT02602483|Antioxidants|antioxidants|mesh-ancestor
110467887|NCT02602483|Protective Agents|protective agents|mesh-ancestor
110467888|NCT02602483|Vitamins|vitamins|mesh-ancestor
110467889|NCT02602483|Micronutrients|micronutrients|mesh-ancestor
110467890|NCT00784147|Ibalizumab|ibalizumab|mesh-list
110467891|NCT00784147|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110467892|NCT00784147|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110467893|NCT00784147|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110467894|NCT00784147|Antiviral Agents|antiviral agents|mesh-ancestor
110467895|NCT00784147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110467896|NCT00784147|Immunologic Factors|immunologic factors|mesh-ancestor
110467897|NCT00784147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110467898|NCT04260360|Docetaxel|docetaxel|mesh-list
110467899|NCT04260360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110467900|NCT04260360|Tubulin Modulators|tubulin modulators|mesh-ancestor
110467901|NCT04260360|Antimitotic Agents|antimitotic agents|mesh-ancestor
110467902|NCT04260360|Mitosis Modulators|mitosis modulators|mesh-ancestor
110467903|NCT04260360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110467904|NCT04254822|Carvedilol|carvedilol|mesh-list
110467905|NCT04254822|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110467906|NCT04254822|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110467907|NCT04254822|Adrenergic Agents|adrenergic agents|mesh-ancestor
110467908|NCT04254822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110467909|NCT04254822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110467910|NCT04254822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110467911|NCT04254822|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110467912|NCT04254822|Antioxidants|antioxidants|mesh-ancestor
110533372|NCT02689362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110533373|NCT02687256|Heparin|heparin|mesh-list
110533374|NCT02687256|Anticoagulants|anticoagulants|mesh-ancestor
110533375|NCT02687256|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110533376|NCT02687256|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110533377|NCT02687256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110533378|NCT00622206|Ritonavir|ritonavir|mesh-list
110533379|NCT00622206|Saquinavir|saquinavir|mesh-list
110533380|NCT00622206|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110194144|NCT00070200|Dermatologic Agents|dermatologic agents|mesh-ancestor
110194146|NCT00066339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110467913|NCT04254822|Protective Agents|protective agents|mesh-ancestor
110467914|NCT04254822|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110467915|NCT04254822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110467916|NCT04254822|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110467917|NCT04254822|Vasodilator Agents|vasodilator agents|mesh-ancestor
110467918|NCT04254822|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110467919|NCT04254822|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110467920|NCT00891813|Ergocalciferols|ergocalciferols|mesh-list
110368960|NCT00563394|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110467921|NCT00891813|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110467922|NCT00891813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110467923|NCT00891813|Vitamins|vitamins|mesh-ancestor
110151378|NCT00000943|Vaccines|vaccines|mesh-list
110467924|NCT00891813|Micronutrients|micronutrients|mesh-ancestor
110467925|NCT00891813|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110467926|NCT04255056|Cyclophosphamide|cyclophosphamide|mesh-list
110467927|NCT04255056|Epirubicin|epirubicin|mesh-list
110467928|NCT04255056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110467929|NCT04255056|Immunologic Factors|immunologic factors|mesh-ancestor
110467930|NCT04255056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110467931|NCT04255056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110467932|NCT04255056|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110467933|NCT04255056|Alkylating Agents|alkylating agents|mesh-ancestor
110467934|NCT04255056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110467935|NCT04255056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110467936|NCT04255056|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110467937|NCT04255056|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110467938|NCT04255056|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110467939|NCT04255056|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110467940|NCT04255056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110467941|NCT00783835|Methylphenidate|methylphenidate|mesh-list
110467942|NCT00783835|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110467943|NCT00783835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110467944|NCT00783835|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110467945|NCT00783835|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110467946|NCT00783835|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110467947|NCT00783835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110467948|NCT00783835|Dopamine Agents|dopamine agents|mesh-ancestor
110467949|NCT00783835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110467951|NCT04254744|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110467952|NCT04254744|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110467953|NCT04254744|Anesthetics, General|anesthetics, general|mesh-ancestor
110467954|NCT04254744|Anesthetics|anesthetics|mesh-ancestor
110467955|NCT04254744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110467956|NCT04254744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110467957|NCT02831361|Metformin|metformin|mesh-list
110467958|NCT02831361|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110467959|NCT02831361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110467960|NCT04103905|Antibodies|antibodies|mesh-list
110467961|NCT04103905|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110467962|NCT04103905|Immunologic Factors|immunologic factors|mesh-ancestor
110533381|NCT00622206|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110533382|NCT00622206|Protease Inhibitors|protease inhibitors|mesh-ancestor
110533383|NCT00622206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110533384|NCT00622206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110533385|NCT00622206|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110533386|NCT00622206|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110533387|NCT00622206|Antiviral Agents|antiviral agents|mesh-ancestor
110533388|NCT00622206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110533389|NCT00622206|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110533390|NCT00622206|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110533391|NCT03582293|Tranexamic Acid|tranexamic acid|mesh-list
110533392|NCT03582293|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110533393|NCT03582293|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110533394|NCT03582293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110533395|NCT03582293|Hemostatics|hemostatics|mesh-ancestor
110533396|NCT03582293|Coagulants|coagulants|mesh-ancestor
110533397|NCT03574337|Neostigmine|neostigmine|mesh-list
110533398|NCT03574337|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110533399|NCT03574337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110194209|NCT00066417|Alkylating Agents|alkylating agents|mesh-ancestor
110467963|NCT04103905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110467964|NCT02831205|Cobalt|cobalt|mesh-list
110467965|NCT02831205|Chromium|chromium|mesh-list
110467966|NCT02831205|Everolimus|everolimus|mesh-list
110467967|NCT02831205|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110467968|NCT02831205|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110467969|NCT02831205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110467970|NCT02831205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110467971|NCT02831205|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110467972|NCT02831205|Immunologic Factors|immunologic factors|mesh-ancestor
110467973|NCT02831205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110467974|NCT02831205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110467975|NCT02831205|Trace Elements|trace elements|mesh-ancestor
110467976|NCT02831205|Micronutrients|micronutrients|mesh-ancestor
110467977|NCT00783289|Benralizumab|benralizumab|mesh-list
110467978|NCT00783289|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110467979|NCT00783289|Respiratory System Agents|respiratory system agents|mesh-ancestor
110467980|NCT02828163|Triamcinolone|triamcinolone|mesh-list
110467981|NCT02828163|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110467982|NCT02828163|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110467983|NCT02828163|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110467984|NCT02828163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110467985|NCT02828163|Glucocorticoids|glucocorticoids|mesh-ancestor
110467986|NCT02828163|Hormones|hormones|mesh-ancestor
110467987|NCT02828163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110467988|NCT02828163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110467989|NCT02828163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110467990|NCT02828163|Immunologic Factors|immunologic factors|mesh-ancestor
110467991|NCT02828163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110467992|NCT02828163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110467993|NCT04107805|Midazolam|midazolam|mesh-list
110467994|NCT04107805|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110467995|NCT04107805|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110467996|NCT04107805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110467997|NCT04107805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110533400|NCT03574337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110533401|NCT03574337|Cholinergic Agents|cholinergic agents|mesh-ancestor
110533402|NCT03574337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110533403|NCT03574337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110533404|NCT03574337|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110533405|NCT03574337|Autonomic Agents|autonomic agents|mesh-ancestor
110533406|NCT03574337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110533407|NCT02689596|Oxytocin|oxytocin|mesh-list
110533408|NCT02689596|Oxytocics|oxytocics|mesh-ancestor
110533409|NCT02689596|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110533410|NCT02689596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110467998|NCT04107805|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110467999|NCT04107805|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110468000|NCT04107805|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110468001|NCT04107805|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110468002|NCT04107805|Anesthetics, General|anesthetics, general|mesh-ancestor
110468003|NCT04107805|Anesthetics|anesthetics|mesh-ancestor
110468004|NCT04107805|GABA Modulators|gaba modulators|mesh-ancestor
110468005|NCT04107805|GABA Agents|gaba agents|mesh-ancestor
110468006|NCT04107805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110468007|NCT04107805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110468008|NCT02833155|Exemestane|exemestane|mesh-list
110468009|NCT02833155|Entinostat|entinostat|mesh-list
110468010|NCT02833155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110115141|NCT01871792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110468011|NCT02833155|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110468012|NCT02833155|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110468013|NCT02833155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110468014|NCT02833155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110468015|NCT02833155|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110468016|NCT02833155|Hormone Antagonists|hormone antagonists|mesh-ancestor
110468017|NCT02833155|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110468018|NCT02833155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110468019|NCT02833155|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110468020|NCT04672460|Talazoparib|talazoparib|mesh-list
110468021|NCT04672460|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110468022|NCT04672460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110468023|NCT04672460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110468024|NCT04672460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110468025|NCT00847912|Fluorouracil|fluorouracil|mesh-list
110468026|NCT00847912|Antimetabolites|antimetabolites|mesh-ancestor
110468027|NCT00847912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110468028|NCT00847912|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110468029|NCT00847912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110468030|NCT00847912|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110468031|NCT00847912|Immunologic Factors|immunologic factors|mesh-ancestor
110468032|NCT00847912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110468033|NCT00850564|Hormones|hormones|mesh-list
110468034|NCT00850564|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
110468035|NCT00850564|Tesamorelin|tesamorelin|mesh-list
110468036|NCT00850564|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110468037|NCT00850564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110468038|NCT00850564|Growth Substances|growth substances|mesh-ancestor
110468039|NCT00837148|Sorafenib|sorafenib|mesh-list
110468040|NCT00837148|Dacarbazine|dacarbazine|mesh-list
110468041|NCT00837148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110468042|NCT00837148|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110468043|NCT00837148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110468044|NCT00837148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110468045|NCT00837148|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110468046|NCT00837148|Alkylating Agents|alkylating agents|mesh-ancestor
110468047|NCT00703690|Fenofibrate|fenofibrate|mesh-list
110468048|NCT00703690|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110533411|NCT04574856|Temozolomide|temozolomide|mesh-list
110533412|NCT04574856|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110533413|NCT04574856|Alkylating Agents|alkylating agents|mesh-ancestor
110533414|NCT04574856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110533415|NCT04574856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110533416|NCT00423995|Loratadine|loratadine|mesh-list
110533417|NCT00423995|Montelukast|montelukast|mesh-list
110533418|NCT00423995|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110533419|NCT00423995|Respiratory System Agents|respiratory system agents|mesh-ancestor
110533420|NCT00423995|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110533421|NCT00423995|Hormone Antagonists|hormone antagonists|mesh-ancestor
110533422|NCT00423995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110533423|NCT00423995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110533424|NCT00423995|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110533425|NCT00423995|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110533426|NCT00423995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110533427|NCT00423995|Antipruritics|antipruritics|mesh-ancestor
110533428|NCT00423995|Dermatologic Agents|dermatologic agents|mesh-ancestor
110468049|NCT00703690|Antimetabolites|antimetabolites|mesh-ancestor
110468050|NCT00703690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110468051|NCT00703690|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110468052|NCT05297968|Oseltamivir|oseltamivir|mesh-list
110468053|NCT05297968|Antiviral Agents|antiviral agents|mesh-ancestor
110468054|NCT05297968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110468055|NCT05297968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110468056|NCT05297968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110468057|NCT02613130|Fluorides|fluorides|mesh-list
110468058|NCT02613130|Tin Fluorides|tin fluorides|mesh-list
110468059|NCT02613130|Cariostatic Agents|cariostatic agents|mesh-ancestor
110468060|NCT02613130|Protective Agents|protective agents|mesh-ancestor
110468061|NCT02613130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110468062|NCT00849472|Paclitaxel|paclitaxel|mesh-list
110468063|NCT00849472|Cyclophosphamide|cyclophosphamide|mesh-list
110468064|NCT00849472|Doxorubicin|doxorubicin|mesh-list
110468065|NCT00849472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110468066|NCT00849472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110468067|NCT00849472|Tubulin Modulators|tubulin modulators|mesh-ancestor
110468068|NCT00849472|Antimitotic Agents|antimitotic agents|mesh-ancestor
110468069|NCT00849472|Mitosis Modulators|mitosis modulators|mesh-ancestor
110468070|NCT00849472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110468071|NCT00849472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110468072|NCT00849472|Immunologic Factors|immunologic factors|mesh-ancestor
110468073|NCT00849472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110468074|NCT00849472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110468075|NCT00849472|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110468076|NCT00849472|Alkylating Agents|alkylating agents|mesh-ancestor
110468077|NCT00849472|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110468078|NCT00849472|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110468079|NCT00849472|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110468080|NCT00849472|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110468081|NCT00849472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110468082|NCT00782509|Olodaterol|olodaterol|mesh-list
110468083|NCT00782509|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110115228|NCT01872013|ASP7991|asp7991|mesh-list
110468084|NCT00782509|Autonomic Agents|autonomic agents|mesh-ancestor
110468085|NCT00782509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110533429|NCT00423995|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110533430|NCT00423995|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110533431|NCT00423995|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110533432|NCT00423995|Histamine Antagonists|histamine antagonists|mesh-ancestor
110533433|NCT00423995|Histamine Agents|histamine agents|mesh-ancestor
110533434|NCT00423995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110533435|NCT00380627|Etoricoxib|etoricoxib|mesh-list
110533436|NCT00380627|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110533437|NCT00380627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110533438|NCT00380627|Analgesics|analgesics|mesh-ancestor
110533439|NCT00380627|Sensory System Agents|sensory system agents|mesh-ancestor
110533440|NCT00380627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110533441|NCT00380627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110533442|NCT00380627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110533443|NCT00380627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110533444|NCT00380627|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110533445|NCT00380627|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110533446|NCT00380627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110533447|NCT00380627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110533449|NCT00212771|Asenapine|asenapine|mesh-list
110533450|NCT00212771|Antiemetics|antiemetics|mesh-ancestor
110468086|NCT00782509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110468087|NCT00782509|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110468088|NCT00782509|Respiratory System Agents|respiratory system agents|mesh-ancestor
110468090|NCT00701428|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110468091|NCT00701428|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110468092|NCT00701428|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110468093|NCT00701428|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110468094|NCT00701428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110468095|NCT00848926|Brentuximab Vedotin|brentuximab vedotin|mesh-list
110468096|NCT00848926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110468098|NCT00848926|Immunotoxins|immunotoxins|mesh-ancestor
110468099|NCT00848926|Immunoconjugates|immunoconjugates|mesh-ancestor
110468100|NCT00848926|Immunologic Factors|immunologic factors|mesh-ancestor
110468101|NCT00848926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110468102|NCT00706888|Vitamin B 6|vitamin b 6|mesh-list
110468103|NCT00706888|Pyridoxal|pyridoxal|mesh-list
110468104|NCT00706888|Pyridoxine|pyridoxine|mesh-list
110468105|NCT00706888|Vitamins|vitamins|mesh-ancestor
110468106|NCT00706888|Micronutrients|micronutrients|mesh-ancestor
110468107|NCT00706888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110468108|NCT00706888|Vitamin B Complex|vitamin b complex|mesh-ancestor
110468109|NCT05019534|Cetuximab|cetuximab|mesh-list
110468110|NCT05019534|Vemurafenib|vemurafenib|mesh-list
110468111|NCT05019534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110468112|NCT05019534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110468113|NCT05019534|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110468114|NCT05019534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110468115|NCT05019534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110468116|NCT04254042|Perindopril|perindopril|mesh-list
110468117|NCT04254042|Zofenopril|zofenopril|mesh-list
110468118|NCT04254042|Captopril|captopril|mesh-list
110468119|NCT04254042|Calcium|calcium|mesh-list
110468120|NCT04254042|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110468121|NCT04254042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110533451|NCT00212771|Autonomic Agents|autonomic agents|mesh-ancestor
110533452|NCT00212771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110533453|NCT00212771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110533454|NCT00212771|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110533455|NCT00212771|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110533456|NCT00212771|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110533457|NCT00212771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110533458|NCT00212771|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110533459|NCT00212771|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110533460|NCT00212771|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110533461|NCT00212771|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110533462|NCT00212771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110468122|NCT04254042|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110468123|NCT04254042|Protease Inhibitors|protease inhibitors|mesh-ancestor
110468124|NCT04254042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110468125|NCT04254042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110468126|NCT04254042|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110468128|NCT00918138|Saxagliptin|saxagliptin|mesh-list
110468129|NCT00918138|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110468130|NCT00918138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110468131|NCT00918138|Incretins|incretins|mesh-ancestor
110468132|NCT00918138|Hormones|hormones|mesh-ancestor
110368972|NCT00563472|Desogestrel|desogestrel|mesh-list
110468133|NCT00918138|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110468134|NCT00918138|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110468135|NCT00918138|Protease Inhibitors|protease inhibitors|mesh-ancestor
110468136|NCT00918138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110468137|NCT00918138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110468138|NCT04253574|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110468139|NCT04253574|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110468140|NCT04253574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110468142|NCT00782275|Bevacizumab|bevacizumab|mesh-list
110468143|NCT00782275|Temsirolimus|temsirolimus|mesh-list
110468144|NCT00782275|MTOR Inhibitors|mtor inhibitors|mesh-list
110468145|NCT00782275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110468146|NCT00782275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110468147|NCT00782275|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110468148|NCT00782275|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110468149|NCT00782275|Growth Substances|growth substances|mesh-ancestor
110468150|NCT00782275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110468151|NCT00782275|Growth Inhibitors|growth inhibitors|mesh-ancestor
110468152|NCT00782275|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110468153|NCT00782275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110468154|NCT00782275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110468155|NCT00782275|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110468156|NCT00782275|Immunologic Factors|immunologic factors|mesh-ancestor
110468157|NCT00782275|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110468158|NCT00782275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110468159|NCT00782275|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110468160|NCT00782275|Antifungal Agents|antifungal agents|mesh-ancestor
110468162|NCT00791557|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110468163|NCT00791557|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110468164|NCT00791557|Dermatologic Agents|dermatologic agents|mesh-ancestor
110468165|NCT00791557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110468166|NCT00791557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110468167|NCT00920790|Mogamulizumab|mogamulizumab|mesh-list
110468168|NCT00920790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110468169|NCT05176314|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110468170|NCT05176314|Pirtobrutinib|pirtobrutinib|mesh-list
110533463|NCT00212771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110533464|NCT00212771|Serotonin Agents|serotonin agents|mesh-ancestor
110533465|NCT03842436|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110533466|NCT03842436|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110533467|NCT03842436|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110533468|NCT03842436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110180964|NCT00017108|Cyclophosphamide|cyclophosphamide|mesh-list
110533469|NCT03842436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110533470|NCT03842436|Antiviral Agents|antiviral agents|mesh-ancestor
110533471|NCT03842436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110533472|NCT03842436|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110194497|NCT00071136|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110468171|NCT05176314|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110468172|NCT05176314|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110468173|NCT05176314|Antimetabolites|antimetabolites|mesh-ancestor
110468174|NCT05176314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110468175|NCT05176314|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110468176|NCT05176314|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110468178|NCT05176314|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110468179|NCT00920556|Bortezomib|bortezomib|mesh-list
110468180|NCT00920556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110468181|NCT00781885|Beraprost|beraprost|mesh-list
110468182|NCT00781885|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110468183|NCT00781885|Vasodilator Agents|vasodilator agents|mesh-ancestor
110468184|NCT04901676|Leronlimab|leronlimab|mesh-list
110468185|NCT04901676|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110468186|NCT04901676|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110468187|NCT04901676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110468188|NCT04901676|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110468189|NCT04901676|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110468190|NCT04901676|Antiviral Agents|antiviral agents|mesh-ancestor
110468191|NCT04901676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110468192|NCT04831086|Tocolytic Agents|tocolytic agents|mesh-list
110468193|NCT04831086|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110468194|NCT04831086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110468196|NCT02603965|Trace Elements|trace elements|mesh-ancestor
110468197|NCT02603965|Micronutrients|micronutrients|mesh-ancestor
110468198|NCT02603965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110468199|NCT00918684|Escitalopram|escitalopram|mesh-list
110468200|NCT00918684|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110468201|NCT00918684|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110468202|NCT00918684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110468203|NCT00918684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110468204|NCT00918684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110468205|NCT00918684|Serotonin Agents|serotonin agents|mesh-ancestor
110468206|NCT00918684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110468208|NCT00919854|Darunavir|darunavir|mesh-list
110468209|NCT00919854|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110468210|NCT00919854|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110468211|NCT00919854|Protease Inhibitors|protease inhibitors|mesh-ancestor
110468212|NCT00919854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110468213|NCT00919854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110468214|NCT00919854|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110468215|NCT00919854|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110468216|NCT00919854|Antiviral Agents|antiviral agents|mesh-ancestor
110468217|NCT00919854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110468218|NCT00919854|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110468219|NCT00919854|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110468220|NCT04669782|Teriparatide|teriparatide|mesh-list
110468221|NCT04669782|Vitamin K|vitamin k|mesh-list
110533473|NCT03842436|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110533474|NCT03829722|Paclitaxel|paclitaxel|mesh-list
110533475|NCT03829722|Carboplatin|carboplatin|mesh-list
110533476|NCT03829722|Nivolumab|nivolumab|mesh-list
110533477|NCT03829722|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110533478|NCT03829722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110533479|NCT03829722|Tubulin Modulators|tubulin modulators|mesh-ancestor
110533480|NCT03829722|Antimitotic Agents|antimitotic agents|mesh-ancestor
110533481|NCT03829722|Mitosis Modulators|mitosis modulators|mesh-ancestor
110533482|NCT03829722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110533483|NCT03829722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110533484|NCT03829722|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110533485|NCT03822312|Tobramycin|tobramycin|mesh-list
110468222|NCT04669782|Vitamins|vitamins|mesh-ancestor
110468223|NCT04669782|Micronutrients|micronutrients|mesh-ancestor
110468224|NCT04669782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110468225|NCT04669782|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110468226|NCT04669782|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110468227|NCT04669782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110468228|NCT04669782|Hemostatics|hemostatics|mesh-ancestor
110468229|NCT04669782|Coagulants|coagulants|mesh-ancestor
110468230|NCT04669782|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110468231|NCT04669782|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110468232|NCT00891735|Ranibizumab|ranibizumab|mesh-list
110468233|NCT00891735|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110115380|NCT01872858|Antipyretics|antipyretics|mesh-ancestor
110468234|NCT00891735|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110468235|NCT00891735|Growth Substances|growth substances|mesh-ancestor
110468236|NCT00891735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110468237|NCT00891735|Growth Inhibitors|growth inhibitors|mesh-ancestor
110468238|NCT00891735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110468240|NCT04252248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110468241|NCT04252248|Antimetabolites|antimetabolites|mesh-ancestor
110468242|NCT04252248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110468243|NCT04252248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110468244|NCT04252248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110468245|NCT04247373|Ropivacaine|ropivacaine|mesh-list
110468246|NCT04247373|Anesthetics, Local|anesthetics, local|mesh-ancestor
110468247|NCT04247373|Anesthetics|anesthetics|mesh-ancestor
110391012|NCT04535362|Nicotine|nicotine|mesh-list
110468248|NCT04247373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110468249|NCT04247373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110468250|NCT04247373|Sensory System Agents|sensory system agents|mesh-ancestor
110468251|NCT04247373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110468252|NCT02832999|Liraglutide|liraglutide|mesh-list
110468253|NCT02832999|Vildagliptin|vildagliptin|mesh-list
110468254|NCT02832999|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110468255|NCT02832999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110468256|NCT02832999|Incretins|incretins|mesh-ancestor
110468257|NCT02832999|Hormones|hormones|mesh-ancestor
110468258|NCT02832999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110468259|NCT02832999|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110468260|NCT02832999|Protease Inhibitors|protease inhibitors|mesh-ancestor
110468261|NCT02832999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110468262|NCT02832999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110468263|NCT04245033|Piperaquine|piperaquine|mesh-list
110468264|NCT04245033|Artenimol|artenimol|mesh-list
110468265|NCT04245033|Antimalarials|antimalarials|mesh-ancestor
110468266|NCT04245033|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110468267|NCT04245033|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110468268|NCT04245033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110468269|NCT00915018|Paclitaxel|paclitaxel|mesh-list
110468270|NCT00915018|Trastuzumab|trastuzumab|mesh-list
110468271|NCT00915018|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110533486|NCT03822312|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110533487|NCT03822312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110533488|NCT02687178|Canrenone|canrenone|mesh-list
110533489|NCT02687178|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110533490|NCT02687178|Hormone Antagonists|hormone antagonists|mesh-ancestor
110533491|NCT02687178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110533492|NCT02687178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110533493|NCT02687178|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110533494|NCT02687178|Diuretics|diuretics|mesh-ancestor
110533495|NCT02687178|Natriuretic Agents|natriuretic agents|mesh-ancestor
110533496|NCT03711318|Buprenorphine|buprenorphine|mesh-list
110468272|NCT00915018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110468273|NCT00915018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110468274|NCT00915018|Tubulin Modulators|tubulin modulators|mesh-ancestor
110468275|NCT00915018|Antimitotic Agents|antimitotic agents|mesh-ancestor
110468276|NCT00915018|Mitosis Modulators|mitosis modulators|mesh-ancestor
110468277|NCT00915018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110468278|NCT00915018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110468279|NCT04246905|Sulforaphane|sulforaphane|mesh-list
110468280|NCT04246905|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110468281|NCT04246905|Protective Agents|protective agents|mesh-ancestor
110468282|NCT04246905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110468283|NCT04246905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110468284|NCT02830347|Amoxicillin|amoxicillin|mesh-list
110468285|NCT02830347|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110468286|NCT02830347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110468287|NCT00916578|Capecitabine|capecitabine|mesh-list
110468288|NCT00916578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110468289|NCT00916578|Antimetabolites|antimetabolites|mesh-ancestor
110468290|NCT00916578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110468291|NCT00916578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110468293|NCT04675866|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110468294|NCT04675866|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110468295|NCT04675866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110468296|NCT04675866|Tubulin Modulators|tubulin modulators|mesh-ancestor
110468297|NCT04675866|Antimitotic Agents|antimitotic agents|mesh-ancestor
110468298|NCT04675866|Mitosis Modulators|mitosis modulators|mesh-ancestor
110468299|NCT04675866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110468300|NCT02829879|Listerine|listerine|mesh-list
110468301|NCT02829879|Fluorides|fluorides|mesh-list
110468302|NCT02829879|Sodium Fluoride|sodium fluoride|mesh-list
110468303|NCT02829879|Fluorophosphate|fluorophosphate|mesh-list
110468304|NCT02829879|Cariostatic Agents|cariostatic agents|mesh-ancestor
110468305|NCT02829879|Protective Agents|protective agents|mesh-ancestor
110468306|NCT02829879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110468307|NCT02829879|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110468308|NCT02829879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110468309|NCT05246007|Dexmedetomidine|dexmedetomidine|mesh-list
110468310|NCT05246007|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110468311|NCT05246007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110468312|NCT05246007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110468313|NCT05246007|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110468314|NCT05246007|Analgesics|analgesics|mesh-ancestor
110468315|NCT05246007|Sensory System Agents|sensory system agents|mesh-ancestor
110468316|NCT05246007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110468317|NCT05246007|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110468318|NCT05246007|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110468319|NCT05246007|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110468320|NCT05246007|Adrenergic Agents|adrenergic agents|mesh-ancestor
110468321|NCT05246007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110468322|NCT05246007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110468324|NCT00914940|Fludarabine phosphate|fludarabine phosphate|mesh-list
110468325|NCT00914940|Thiotepa|thiotepa|mesh-list
110533497|NCT03711318|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
110533498|NCT03711318|Naloxone|naloxone|mesh-list
110533499|NCT03711318|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110533500|NCT03711318|Narcotics|narcotics|mesh-ancestor
110533501|NCT03711318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110533502|NCT03711318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110468326|NCT00914940|Tacrolimus|tacrolimus|mesh-list
110468327|NCT00914940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110468328|NCT00914940|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110468329|NCT00914940|Antimetabolites|antimetabolites|mesh-ancestor
110468330|NCT00914940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110468331|NCT00914940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110468332|NCT00914940|Immunologic Factors|immunologic factors|mesh-ancestor
110468333|NCT00914940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110468334|NCT00914940|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110468335|NCT00914940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110468336|NCT00914940|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110468337|NCT00914940|Alkylating Agents|alkylating agents|mesh-ancestor
110468338|NCT00914940|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110468339|NCT00835978|Axitinib|axitinib|mesh-list
110468340|NCT00835978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110468341|NCT00835978|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110368985|NCT04679597|Capecitabine|capecitabine|mesh-list
110468342|NCT00835978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110468343|NCT00835978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110468344|NCT01077518|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110468345|NCT01077518|Ofatumumab|ofatumumab|mesh-list
110468346|NCT01077518|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110468347|NCT01077518|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110468348|NCT01077518|Alkylating Agents|alkylating agents|mesh-ancestor
110468349|NCT01077518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110468350|NCT01077518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110468351|NCT01077518|Immunologic Factors|immunologic factors|mesh-ancestor
110468352|NCT01077518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110468353|NCT04203186|Lumefantrine|lumefantrine|mesh-list
110468354|NCT04203186|Artemether|artemether|mesh-list
110468355|NCT04203186|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
110468356|NCT04203186|Atovaquone|atovaquone|mesh-list
110468357|NCT04203186|Proguanil|proguanil|mesh-list
110468358|NCT04203186|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
110468359|NCT04203186|Antimalarials|antimalarials|mesh-ancestor
110468360|NCT04203186|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110468361|NCT04203186|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110468362|NCT04203186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110468363|NCT04203186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110468364|NCT04203186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110468365|NCT04203186|Antimetabolites|antimetabolites|mesh-ancestor
110468366|NCT00835120|Pioglitazone|pioglitazone|mesh-list
110468367|NCT00835120|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110468368|NCT00835120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110468369|NCT00914316|Ranolazine|ranolazine|mesh-list
110468370|NCT00914316|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110468371|NCT00914316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110468372|NCT00914316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110468373|NCT00701740|Isotretinoin|isotretinoin|mesh-list
110468374|NCT00701740|Terephthalylidene dicamphor sulfonic acid|terephthalylidene dicamphor sulfonic acid|mesh-list
110468375|NCT00701740|Dermatologic Agents|dermatologic agents|mesh-ancestor
110468376|NCT00701740|Sunscreening Agents|sunscreening agents|mesh-ancestor
110468377|NCT00701740|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110468378|NCT00701740|Protective Agents|protective agents|mesh-ancestor
110468379|NCT00701740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110468380|NCT04938882|Lidocaine|lidocaine|mesh-list
110468381|NCT04938882|Ropivacaine|ropivacaine|mesh-list
110468382|NCT04938882|Anesthetics, Local|anesthetics, local|mesh-ancestor
110468383|NCT04938882|Anesthetics|anesthetics|mesh-ancestor
110468384|NCT04938882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110468385|NCT04938882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110468386|NCT04938882|Sensory System Agents|sensory system agents|mesh-ancestor
110468387|NCT04938882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110533504|NCT03711318|Sensory System Agents|sensory system agents|mesh-ancestor
110533505|NCT03711318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110533506|NCT03711318|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110533519|NCT03704298|Cyclophosphamide|cyclophosphamide|mesh-list
110533520|NCT03704298|Fludarabine|fludarabine|mesh-list
110533521|NCT03704298|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
110533522|NCT03704298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110468388|NCT04938882|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110468389|NCT04938882|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110468390|NCT04938882|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110468391|NCT04938882|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110468392|NCT04938882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110468393|NCT00704080|Temozolomide|temozolomide|mesh-list
110468394|NCT00704080|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110468395|NCT00704080|Alkylating Agents|alkylating agents|mesh-ancestor
110468396|NCT00704080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110468397|NCT00704080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110468398|NCT05253066|Docetaxel|docetaxel|mesh-list
110468399|NCT05253066|Epirubicin|epirubicin|mesh-list
110468400|NCT05253066|Exemestane|exemestane|mesh-list
110468401|NCT05253066|Goserelin|goserelin|mesh-list
110468402|NCT05253066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110468403|NCT05253066|Tubulin Modulators|tubulin modulators|mesh-ancestor
110468404|NCT05253066|Antimitotic Agents|antimitotic agents|mesh-ancestor
110468405|NCT05253066|Mitosis Modulators|mitosis modulators|mesh-ancestor
110468406|NCT05253066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110468407|NCT05253066|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110468408|NCT05253066|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110468409|NCT05253066|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110468410|NCT05253066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110468411|NCT05253066|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110468412|NCT05253066|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110468413|NCT05253066|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110468414|NCT05253066|Hormone Antagonists|hormone antagonists|mesh-ancestor
110468415|NCT05253066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110468416|NCT05253066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110468417|NCT05253066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110468418|NCT04303598|Tenofovir|tenofovir|mesh-list
110468419|NCT04303598|Lamivudine|lamivudine|mesh-list
110468420|NCT04303598|Efavirenz|efavirenz|mesh-list
110468421|NCT04303598|Antiviral Agents|antiviral agents|mesh-ancestor
110468422|NCT04303598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110468423|NCT04303598|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110468424|NCT04303598|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110468425|NCT04303598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110468426|NCT04303598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110468427|NCT04303598|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110468428|NCT04303598|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110468429|NCT04303598|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110468430|NCT04303598|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110468431|NCT04303598|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110468432|NCT04303598|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110468433|NCT04303598|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110468434|NCT04303598|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110468435|NCT04636086|Cholecalciferol|cholecalciferol|mesh-list
110468436|NCT04636086|Vitamin D|vitamin d|mesh-list
110468437|NCT04636086|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110468438|NCT04636086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110468439|NCT04636086|Vitamins|vitamins|mesh-ancestor
110468440|NCT04636086|Micronutrients|micronutrients|mesh-ancestor
110468441|NCT04636086|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110468442|NCT00827242|Tadalafil|tadalafil|mesh-list
110468443|NCT00827242|Vasodilator Agents|vasodilator agents|mesh-ancestor
110468444|NCT00827242|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110468445|NCT00827242|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110468446|NCT00827242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110533523|NCT03704298|Immunologic Factors|immunologic factors|mesh-ancestor
110533524|NCT03704298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110533525|NCT03704298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110533526|NCT03704298|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110533527|NCT03704298|Alkylating Agents|alkylating agents|mesh-ancestor
110468447|NCT00827242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110468448|NCT00827242|Urological Agents|urological agents|mesh-ancestor
110468449|NCT01077362|Ustekinumab|ustekinumab|mesh-list
110468450|NCT01077362|Dermatologic Agents|dermatologic agents|mesh-ancestor
110468451|NCT00846586|Tiotropium Bromide|tiotropium bromide|mesh-list
110468452|NCT00846586|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110468453|NCT00846586|Autonomic Agents|autonomic agents|mesh-ancestor
110468454|NCT00846586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110468455|NCT00846586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110468456|NCT00846586|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110468457|NCT00846586|Respiratory System Agents|respiratory system agents|mesh-ancestor
110468458|NCT00846586|Parasympatholytics|parasympatholytics|mesh-ancestor
110468459|NCT00846586|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110468460|NCT00846586|Cholinergic Agents|cholinergic agents|mesh-ancestor
110468461|NCT00846586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110468462|NCT00846586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110468463|NCT00785785|Imatinib Mesylate|imatinib mesylate|mesh-list
110468464|NCT00785785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110468465|NCT00785785|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110468466|NCT00785785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110468467|NCT00785785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110468468|NCT00707278|Capecitabine|capecitabine|mesh-list
110468469|NCT00707278|Oxaliplatin|oxaliplatin|mesh-list
110468470|NCT00707278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110468471|NCT00707278|Antimetabolites|antimetabolites|mesh-ancestor
110368996|NCT04615910|Hormones|hormones|mesh-ancestor
110468472|NCT00707278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110468473|NCT00707278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110468474|NCT01077284|Allopurinol|allopurinol|mesh-list
110468476|NCT01077284|Antimetabolites|antimetabolites|mesh-ancestor
110468477|NCT01077284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110468478|NCT01077284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110468479|NCT01077284|Gout Suppressants|gout suppressants|mesh-ancestor
110468480|NCT01077284|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110468481|NCT01077284|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110468482|NCT01077284|Antioxidants|antioxidants|mesh-ancestor
110468483|NCT01077284|Protective Agents|protective agents|mesh-ancestor
110468484|NCT01077284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110468485|NCT00704314|Simvastatin|simvastatin|mesh-list
110468486|NCT00704314|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110468487|NCT00704314|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110468488|NCT00704314|Antimetabolites|antimetabolites|mesh-ancestor
110468489|NCT00704314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110468490|NCT00704314|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110468491|NCT00704314|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110468492|NCT00704314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110468494|NCT00704392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110468495|NCT00704392|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110468496|NCT00704392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110468497|NCT00704392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110468498|NCT04103125|Hyaluronic Acid|hyaluronic acid|mesh-list
110468499|NCT04103125|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110468500|NCT04103125|Immunologic Factors|immunologic factors|mesh-ancestor
110468501|NCT04103125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110468502|NCT04103125|Viscosupplements|viscosupplements|mesh-ancestor
110468503|NCT04103125|Protective Agents|protective agents|mesh-ancestor
110468504|NCT00826618|Ranibizumab|ranibizumab|mesh-list
110468505|NCT00826618|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110468506|NCT00826618|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110468507|NCT00826618|Growth Substances|growth substances|mesh-ancestor
110468508|NCT00826618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110468509|NCT00826618|Growth Inhibitors|growth inhibitors|mesh-ancestor
110468510|NCT00826618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110468511|NCT02876822|Vitamin D|vitamin d|mesh-list
110468512|NCT02876822|Cholecalciferol|cholecalciferol|mesh-list
110533528|NCT03704298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110533529|NCT03704298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110533530|NCT03704298|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110533531|NCT03704298|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110533532|NCT02687100|Beclomethasone|beclomethasone|mesh-list
110533533|NCT02687100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110533534|NCT02687100|Glucocorticoids|glucocorticoids|mesh-ancestor
110533535|NCT02687100|Hormones|hormones|mesh-ancestor
110533536|NCT02687100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110533537|NCT02687100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110468513|NCT02876822|Vitamins|vitamins|mesh-ancestor
110468514|NCT02876822|Micronutrients|micronutrients|mesh-ancestor
110468515|NCT02876822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110468516|NCT02876822|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110468517|NCT02876822|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110468518|NCT00826540|Bevacizumab|bevacizumab|mesh-list
110468519|NCT00826540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110468520|NCT00826540|Sorafenib|sorafenib|mesh-list
110468521|NCT00826540|Antibodies|antibodies|mesh-list
110468522|NCT00826540|Immunoglobulins|immunoglobulins|mesh-list
110468523|NCT00826540|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110468524|NCT00826540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110468525|NCT00826540|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110468526|NCT00826540|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110468527|NCT00826540|Growth Substances|growth substances|mesh-ancestor
110468528|NCT00826540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110468529|NCT00826540|Growth Inhibitors|growth inhibitors|mesh-ancestor
110468530|NCT00826540|Immunologic Factors|immunologic factors|mesh-ancestor
110468531|NCT00826540|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110468532|NCT00826540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110468533|NCT00826540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110468534|NCT04303130|Endostar protein|endostar protein|mesh-list
110468535|NCT04303130|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110468536|NCT04303130|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110468537|NCT04303130|Growth Substances|growth substances|mesh-ancestor
110468538|NCT04303130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110468539|NCT04303130|Growth Inhibitors|growth inhibitors|mesh-ancestor
110369010|NCT04612998|Atropine|atropine|mesh-list
110468540|NCT04303130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110468542|NCT00626600|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110468543|NCT00626600|Narcotics|narcotics|mesh-ancestor
110468544|NCT00626600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110468545|NCT00626600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110468546|NCT00626600|Analgesics|analgesics|mesh-ancestor
110468547|NCT00626600|Sensory System Agents|sensory system agents|mesh-ancestor
110391312|NCT04079218|Estradiol|estradiol|mesh-list
110468548|NCT00626600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110468549|NCT00707512|Natalizumab|natalizumab|mesh-list
110468550|NCT00707512|Immunologic Factors|immunologic factors|mesh-ancestor
110468551|NCT00707512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110468552|NCT00704548|Simvastatin|simvastatin|mesh-list
110468553|NCT00704548|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110468554|NCT00704548|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110468555|NCT00704548|Antimetabolites|antimetabolites|mesh-ancestor
110468556|NCT00704548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110468557|NCT00704548|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110468558|NCT00704548|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110468559|NCT00704548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110468560|NCT00592384|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
110468561|NCT00592384|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110468562|NCT00592384|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110468563|NCT00592384|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110468564|NCT00592384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110533538|NCT02687100|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110533539|NCT02687100|Respiratory System Agents|respiratory system agents|mesh-ancestor
110533540|NCT05662098|Hydroxyurea|hydroxyurea|mesh-list
110533541|NCT05662098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110533542|NCT05662098|Antisickling Agents|antisickling agents|mesh-ancestor
110533543|NCT05662098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110533544|NCT05662098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110468565|NCT00592384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110468566|NCT00592384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110468567|NCT00592384|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110468568|NCT00592384|Antidepressive Agents|antidepressive agents|mesh-ancestor
110468569|NCT00592384|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110468570|NCT00846040|Fallypride|fallypride|mesh-list
110468571|NCT00846040|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110468572|NCT00846040|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110468573|NCT00846040|Dopamine Agents|dopamine agents|mesh-ancestor
110468574|NCT00846040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110468575|NCT00846040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110468576|NCT00846040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110468577|NCT02611336|Tadalafil|tadalafil|mesh-list
110468578|NCT02611336|Vasodilator Agents|vasodilator agents|mesh-ancestor
110468579|NCT02611336|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110468580|NCT02611336|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110468581|NCT02611336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110468582|NCT02611336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110468583|NCT02611336|Urological Agents|urological agents|mesh-ancestor
110468584|NCT00704704|Thalidomide|thalidomide|mesh-list
110468585|NCT00704704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110468586|NCT00704704|Immunologic Factors|immunologic factors|mesh-ancestor
110468587|NCT00704704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110468588|NCT00704704|Leprostatic Agents|leprostatic agents|mesh-ancestor
110468589|NCT00704704|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110468590|NCT00704704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110468591|NCT00704704|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110468592|NCT00704704|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110468593|NCT00704704|Growth Substances|growth substances|mesh-ancestor
110468594|NCT00704704|Growth Inhibitors|growth inhibitors|mesh-ancestor
110468595|NCT00704704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110468596|NCT00707824|Nalbuphine|nalbuphine|mesh-list
110468597|NCT00707824|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110468598|NCT00707824|Narcotics|narcotics|mesh-ancestor
110468599|NCT00707824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110468600|NCT00707824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110468601|NCT00707824|Analgesics|analgesics|mesh-ancestor
110468602|NCT00707824|Sensory System Agents|sensory system agents|mesh-ancestor
110468603|NCT00707824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110468604|NCT00826228|Teriparatide|teriparatide|mesh-list
110468605|NCT00826228|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110468606|NCT00826228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110468607|NCT00826228|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110468608|NCT00791479|Dulaglutide|dulaglutide|mesh-list
110468609|NCT00791479|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110468610|NCT00791479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110468611|NCT00890097|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110468612|NCT00890097|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110468613|NCT02831751|Vaccines|vaccines|mesh-list
110468614|NCT02831751|Immunologic Factors|immunologic factors|mesh-ancestor
110468615|NCT02831751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110468616|NCT00913458|Etanercept|etanercept|mesh-list
110468617|NCT00913458|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110468618|NCT00913458|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110468619|NCT00913458|Analgesics|analgesics|mesh-ancestor
110468620|NCT00913458|Sensory System Agents|sensory system agents|mesh-ancestor
110468622|NCT00913458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110468623|NCT00913458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110468624|NCT00913458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110468625|NCT00913458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110468626|NCT00913458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110533545|NCT05662098|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110533548|NCT02153645|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110533549|NCT02153645|Antiviral Agents|antiviral agents|mesh-ancestor
110195007|NCT00072072|Celecoxib|celecoxib|mesh-list
110468627|NCT00913458|Immunologic Factors|immunologic factors|mesh-ancestor
110468628|NCT05208333|Albendazole|albendazole|mesh-list
110468629|NCT05208333|Anthelmintics|anthelmintics|mesh-ancestor
110468630|NCT05208333|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110468631|NCT05208333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110468632|NCT05208333|Anticestodal Agents|anticestodal agents|mesh-ancestor
110468633|NCT05208333|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110597823|NCT01718873|Vitamins|vitamins|mesh-ancestor
110468634|NCT05208333|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110468635|NCT05208333|Tubulin Modulators|tubulin modulators|mesh-ancestor
110468636|NCT05208333|Antimitotic Agents|antimitotic agents|mesh-ancestor
110468637|NCT05208333|Mitosis Modulators|mitosis modulators|mesh-ancestor
110468638|NCT05208333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110468639|NCT05208333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110468640|NCT04309773|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
110468641|NCT04309773|Bezafibrate|bezafibrate|mesh-list
110468642|NCT04309773|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
110468643|NCT04309773|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110468644|NCT04309773|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110468645|NCT04309773|Antimetabolites|antimetabolites|mesh-ancestor
110468646|NCT04309773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110468647|NCT04309773|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110468648|NCT02829333|Anesthetics|anesthetics|mesh-list
110468649|NCT02829333|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110468650|NCT02829333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110468651|NCT05251662|Bevacizumab|bevacizumab|mesh-list
110468652|NCT05251662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110468653|NCT05251662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110468654|NCT05251662|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110468655|NCT05251662|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110468656|NCT05251662|Growth Substances|growth substances|mesh-ancestor
110468657|NCT05251662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110468658|NCT05251662|Growth Inhibitors|growth inhibitors|mesh-ancestor
110468659|NCT02829177|Allopurinol|allopurinol|mesh-list
110468660|NCT02829177|Antimetabolites|antimetabolites|mesh-ancestor
110468661|NCT02829177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110468662|NCT02829177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110468663|NCT02829177|Gout Suppressants|gout suppressants|mesh-ancestor
110468664|NCT02829177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110468665|NCT02829177|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110468666|NCT02829177|Antioxidants|antioxidants|mesh-ancestor
110468667|NCT02829177|Protective Agents|protective agents|mesh-ancestor
110468668|NCT02829177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110468669|NCT05112081|Botulinum Toxins|botulinum toxins|mesh-list
110468670|NCT05112081|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110468671|NCT05112081|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110468672|NCT05112081|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110468673|NCT05112081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110468674|NCT05112081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110374770|NCT00564200|Hormones|hormones|mesh-ancestor
110468675|NCT05112081|Cholinergic Agents|cholinergic agents|mesh-ancestor
110468676|NCT05112081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110468677|NCT05112081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110468678|NCT05112081|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110468679|NCT05112081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110468681|NCT04244097|Neostigmine|neostigmine|mesh-list
110468682|NCT04244097|Anesthetics, Local|anesthetics, local|mesh-ancestor
110468684|NCT04244097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110468685|NCT04244097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110468686|NCT04244097|Sensory System Agents|sensory system agents|mesh-ancestor
110468687|NCT04244097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110468688|NCT04244097|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110468689|NCT04244097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110468690|NCT04244097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110468691|NCT04244097|Cholinergic Agents|cholinergic agents|mesh-ancestor
110468692|NCT04244097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110533550|NCT02153645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110533551|NCT02153645|Dopamine Agents|dopamine agents|mesh-ancestor
110533552|NCT02153645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110533553|NCT02153645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110533554|NCT02153645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110533555|NCT02153645|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110533556|NCT02153645|Analgesics|analgesics|mesh-ancestor
110533557|NCT02153645|Sensory System Agents|sensory system agents|mesh-ancestor
110533558|NCT02153645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110533559|NCT02688738|Doxycycline|doxycycline|mesh-list
110533560|NCT02688738|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110533561|NCT02688738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110533562|NCT02688738|Antimalarials|antimalarials|mesh-ancestor
110533563|NCT02688738|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110468693|NCT04244097|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110468694|NCT04244097|Autonomic Agents|autonomic agents|mesh-ancestor
110468695|NCT00785629|Calcium|calcium|mesh-list
110468696|NCT00785629|Sevelamer|sevelamer|mesh-list
110468697|NCT00785629|Calcium acetate|calcium acetate|mesh-list
110468698|NCT00785629|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110468699|NCT00785629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110468700|NCT00785629|Chelating Agents|chelating agents|mesh-ancestor
110468701|NCT00785629|Sequestering Agents|sequestering agents|mesh-ancestor
110468702|NCT00785629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110468703|NCT00915733|Aspirin|aspirin|mesh-list
110468704|NCT00915733|Cilostazol|cilostazol|mesh-list
110468705|NCT00915733|Clopidogrel|clopidogrel|mesh-list
110468706|NCT00915733|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110468707|NCT00915733|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110468708|NCT00915733|Analgesics|analgesics|mesh-ancestor
110468709|NCT00915733|Sensory System Agents|sensory system agents|mesh-ancestor
110468710|NCT00915733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110468711|NCT00915733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110468712|NCT00915733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110468713|NCT00915733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110468714|NCT00915733|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110468715|NCT00915733|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110468716|NCT00915733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110468717|NCT00915733|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110468718|NCT00915733|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110468719|NCT00915733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110468720|NCT00915733|Antipyretics|antipyretics|mesh-ancestor
110468721|NCT00915733|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110468722|NCT00915733|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110468723|NCT00915733|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110468724|NCT00915733|Purinergic Agents|purinergic agents|mesh-ancestor
110468725|NCT00915733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110468726|NCT00915733|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110468727|NCT00915733|Autonomic Agents|autonomic agents|mesh-ancestor
110468728|NCT00915733|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110468729|NCT00915733|Respiratory System Agents|respiratory system agents|mesh-ancestor
110468730|NCT00915733|Vasodilator Agents|vasodilator agents|mesh-ancestor
110468731|NCT00915733|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110468732|NCT00915733|Protective Agents|protective agents|mesh-ancestor
110468733|NCT00915733|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110468734|NCT00915733|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110468735|NCT00913770|Buprenorphine|buprenorphine|mesh-list
110468736|NCT00913770|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110468737|NCT00913770|Narcotics|narcotics|mesh-ancestor
110468738|NCT00913770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110468739|NCT00913770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110468740|NCT00913770|Analgesics|analgesics|mesh-ancestor
110533565|NCT00639366|Trastuzumab|trastuzumab|mesh-list
110195129|NCT00204646|Alkylating Agents|alkylating agents|mesh-ancestor
110468741|NCT00913770|Sensory System Agents|sensory system agents|mesh-ancestor
110468742|NCT00913770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110369037|NCT00563589|Cyclosporine|cyclosporine|mesh-list
110468743|NCT00913770|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110468744|NCT00912912|Sunitinib|sunitinib|mesh-list
110468745|NCT00912912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110468746|NCT00912912|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110468747|NCT00912912|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110468748|NCT00912912|Growth Substances|growth substances|mesh-ancestor
110468749|NCT00912912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110468750|NCT00912912|Growth Inhibitors|growth inhibitors|mesh-ancestor
110468751|NCT00912912|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110468752|NCT00912912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110468753|NCT00912912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110468754|NCT00913692|Glycine|glycine|mesh-list
110468755|NCT00913692|Glycine Agents|glycine agents|mesh-ancestor
110468756|NCT00913692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110115890|NCT05458375|Estradiol|estradiol|mesh-list
110468757|NCT00913692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110468758|NCT00913692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110468759|NCT00784927|Dexamethasone|dexamethasone|mesh-list
110468760|NCT00784927|Cyclophosphamide|cyclophosphamide|mesh-list
110468762|NCT00784927|Lenalidomide|lenalidomide|mesh-list
110468763|NCT00784927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110468764|NCT00784927|Immunologic Factors|immunologic factors|mesh-ancestor
110468765|NCT00784927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110468766|NCT00784927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110468767|NCT00784927|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110468768|NCT00784927|Alkylating Agents|alkylating agents|mesh-ancestor
110468769|NCT00784927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110468770|NCT00784927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110468772|NCT00784927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110468773|NCT00784927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110468774|NCT00784927|Antiemetics|antiemetics|mesh-ancestor
110468775|NCT00784927|Autonomic Agents|autonomic agents|mesh-ancestor
110468776|NCT00784927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110468777|NCT00784927|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110468778|NCT00784927|Glucocorticoids|glucocorticoids|mesh-ancestor
110468779|NCT00784927|Hormones|hormones|mesh-ancestor
110468780|NCT00784927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110468781|NCT00784927|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110468782|NCT00784927|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110468783|NCT00784927|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110468784|NCT00784927|Growth Substances|growth substances|mesh-ancestor
110468785|NCT00784927|Growth Inhibitors|growth inhibitors|mesh-ancestor
110468786|NCT00637884|Fexofenadine|fexofenadine|mesh-list
110468787|NCT00637884|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110468788|NCT00637884|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110468789|NCT00637884|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110468790|NCT00637884|Histamine Antagonists|histamine antagonists|mesh-ancestor
110468791|NCT00637884|Histamine Agents|histamine agents|mesh-ancestor
110468792|NCT00637884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110468793|NCT00637884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110468794|NCT00637884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110468795|NCT04203342|Ketoconazole|ketoconazole|mesh-list
110468796|NCT04203342|Antifungal Agents|antifungal agents|mesh-ancestor
110468797|NCT04203342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110468798|NCT04203342|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110468799|NCT04203342|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110468800|NCT04203342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110468801|NCT04203342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110468802|NCT04203342|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110468803|NCT04203342|Hormone Antagonists|hormone antagonists|mesh-ancestor
110468804|NCT04203342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110468805|NCT04203342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110468806|NCT04203342|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110468807|NCT04834206|Docetaxel|docetaxel|mesh-list
110468808|NCT04834206|Fluorouracil|fluorouracil|mesh-list
110468809|NCT04834206|Nedaplatin|nedaplatin|mesh-list
110533566|NCT00639366|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110533567|NCT00639366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110533568|NCT02686788|Tarenflurbil|tarenflurbil|mesh-list
110533569|NCT02686788|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
110533570|NCT02686788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110533571|NCT02686788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110533572|NCT02686710|Propofol|propofol|mesh-list
110533573|NCT02686710|Sevoflurane|sevoflurane|mesh-list
110468810|NCT04834206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110468812|NCT04834206|Antimitotic Agents|antimitotic agents|mesh-ancestor
110468813|NCT04834206|Mitosis Modulators|mitosis modulators|mesh-ancestor
110115963|NCT05323838|Immunologic Factors|immunologic factors|mesh-ancestor
110115964|NCT05323838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110115965|NCT05302999|Gabapentin|gabapentin|mesh-list
110115966|NCT05302999|Analgesics|analgesics|mesh-ancestor
110115967|NCT05302999|Sensory System Agents|sensory system agents|mesh-ancestor
110115968|NCT05302999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110115969|NCT05302999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110115970|NCT05302999|Anticonvulsants|anticonvulsants|mesh-ancestor
110115971|NCT05302999|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110115972|NCT05302999|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110115973|NCT05302999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110115974|NCT05302999|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110115975|NCT05302999|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110115976|NCT05302999|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110115977|NCT05302999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110115979|NCT05302999|Antimanic Agents|antimanic agents|mesh-ancestor
110468814|NCT04834206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110468815|NCT04834206|Antimetabolites|antimetabolites|mesh-ancestor
110468816|NCT04834206|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110468817|NCT04834206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110468818|NCT04834206|Immunologic Factors|immunologic factors|mesh-ancestor
110468819|NCT04834206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110468820|NCT00631722|Haloperidol|haloperidol|mesh-list
110468821|NCT00631722|Haloperidol decanoate|haloperidol decanoate|mesh-list
110468822|NCT00631722|Antiemetics|antiemetics|mesh-ancestor
110468823|NCT00631722|Autonomic Agents|autonomic agents|mesh-ancestor
110468824|NCT00631722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110468825|NCT00631722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110468826|NCT00631722|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110468827|NCT00631722|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110468828|NCT00631722|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110468829|NCT00631722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110468830|NCT00631722|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110468831|NCT00631722|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110468832|NCT00631722|Dopamine Agents|dopamine agents|mesh-ancestor
110468833|NCT00631722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110468834|NCT00631722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110468835|NCT00631722|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110468836|NCT00845728|Tiotropium Bromide|tiotropium bromide|mesh-list
110468837|NCT00845728|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110468838|NCT00845728|Autonomic Agents|autonomic agents|mesh-ancestor
110468839|NCT00845728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110468840|NCT00845728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110468841|NCT00845728|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110468842|NCT00845728|Respiratory System Agents|respiratory system agents|mesh-ancestor
110468843|NCT00845728|Parasympatholytics|parasympatholytics|mesh-ancestor
110468844|NCT00845728|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110468845|NCT00845728|Cholinergic Agents|cholinergic agents|mesh-ancestor
110468846|NCT00845728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110468847|NCT00845728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110468848|NCT00779467|Fentanyl|fentanyl|mesh-list
110468849|NCT00779467|Bupivacaine|bupivacaine|mesh-list
110468850|NCT00779467|Neostigmine|neostigmine|mesh-list
110468851|NCT00779467|Anesthetics, Local|anesthetics, local|mesh-ancestor
110468852|NCT00779467|Anesthetics|anesthetics|mesh-ancestor
110468853|NCT00779467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110533574|NCT02686710|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110533575|NCT02686710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110533576|NCT02686710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110533577|NCT02686710|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110533578|NCT02686710|Anesthetics, General|anesthetics, general|mesh-ancestor
110533579|NCT02686710|Anesthetics|anesthetics|mesh-ancestor
110533580|NCT02686710|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110533581|NCT02686710|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110533582|NCT01818167|Benzoyl Peroxide|benzoyl peroxide|mesh-list
110533583|NCT01818167|Dermatologic Agents|dermatologic agents|mesh-ancestor
110533584|NCT01773083|Heparin|heparin|mesh-list
110533585|NCT01773083|Calcium heparin|calcium heparin|mesh-list
110533586|NCT01773083|Anticoagulants|anticoagulants|mesh-ancestor
110533587|NCT01773083|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110533588|NCT01773083|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110533589|NCT01773083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110533590|NCT02354898|Sorafenib|sorafenib|mesh-list
110533591|NCT02354898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110533592|NCT02354898|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110533593|NCT02354898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110468854|NCT00779467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110468855|NCT00779467|Sensory System Agents|sensory system agents|mesh-ancestor
110468856|NCT00779467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110468857|NCT00779467|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110468858|NCT00779467|Narcotics|narcotics|mesh-ancestor
110468859|NCT00779467|Analgesics|analgesics|mesh-ancestor
110468860|NCT00779467|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110468861|NCT00779467|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110468862|NCT00779467|Anesthetics, General|anesthetics, general|mesh-ancestor
110468863|NCT00779467|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110468864|NCT00779467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110468865|NCT00779467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110468866|NCT00779467|Cholinergic Agents|cholinergic agents|mesh-ancestor
110468867|NCT00779467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110468868|NCT00779467|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110468869|NCT00779467|Autonomic Agents|autonomic agents|mesh-ancestor
110468870|NCT04559100|Carbon Monoxide|carbon monoxide|mesh-list
110468871|NCT04559100|Antimetabolites|antimetabolites|mesh-ancestor
110468872|NCT04559100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110468873|NCT04559100|Gasotransmitters|gasotransmitters|mesh-ancestor
110468874|NCT04559100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110468875|NCT04559100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110468877|NCT00778921|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110468878|NCT00778921|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110468879|NCT00778921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110468880|NCT00778921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110468881|NCT00778921|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110468882|NCT00778921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110468883|NCT00778921|Vasodilator Agents|vasodilator agents|mesh-ancestor
110468884|NCT04173312|Bupivacaine|bupivacaine|mesh-list
110468885|NCT04173312|Anesthetics, Local|anesthetics, local|mesh-ancestor
110468886|NCT04173312|Anesthetics|anesthetics|mesh-ancestor
110468887|NCT04173312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110468888|NCT04173312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110468889|NCT04173312|Sensory System Agents|sensory system agents|mesh-ancestor
110533594|NCT02354898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110533595|NCT00110435|Atorvastatin|atorvastatin|mesh-list
110533596|NCT00110435|Simvastatin|simvastatin|mesh-list
110533597|NCT00110435|Ezetimibe|ezetimibe|mesh-list
110533598|NCT00110435|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110533599|NCT00110435|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110533600|NCT00110435|Antimetabolites|antimetabolites|mesh-ancestor
110533601|NCT00110435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110468890|NCT04173312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110468891|NCT00587431|Docetaxel|docetaxel|mesh-list
110468892|NCT00587431|Leuprolide|leuprolide|mesh-list
110468893|NCT00587431|Testosterone|testosterone|mesh-list
110468894|NCT00587431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110468895|NCT00587431|Tubulin Modulators|tubulin modulators|mesh-ancestor
110468896|NCT00587431|Antimitotic Agents|antimitotic agents|mesh-ancestor
110468897|NCT00587431|Mitosis Modulators|mitosis modulators|mesh-ancestor
110468898|NCT00587431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110468899|NCT00587431|Androgens|androgens|mesh-ancestor
110468900|NCT00587431|Hormones|hormones|mesh-ancestor
110468901|NCT00587431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110468902|NCT00587431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110468903|NCT00587431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110468904|NCT00587431|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110468905|NCT00587431|Fertility Agents|fertility agents|mesh-ancestor
110468906|NCT00587431|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110468907|NCT00776659|Exemestane|exemestane|mesh-list
110468908|NCT00776659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110468909|NCT00776659|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110468910|NCT00776659|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110468911|NCT00776659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110468912|NCT00776659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110468913|NCT00776659|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110468914|NCT00776659|Hormone Antagonists|hormone antagonists|mesh-ancestor
110468915|NCT00776659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110468916|NCT00776659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110468917|NCT00632268|Leucovorin|leucovorin|mesh-list
110468918|NCT00632268|Everolimus|everolimus|mesh-list
110468919|NCT00632268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110468920|NCT00632268|Antidotes|antidotes|mesh-ancestor
110468921|NCT00632268|Protective Agents|protective agents|mesh-ancestor
110468922|NCT00632268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110468923|NCT00632268|Vitamin B Complex|vitamin b complex|mesh-ancestor
110468925|NCT00632268|Micronutrients|micronutrients|mesh-ancestor
110468926|NCT00632268|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110468927|NCT00632268|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110468928|NCT00632268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110468929|NCT00632268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110597991|NCT00845572|Serotonin Agents|serotonin agents|mesh-ancestor
110468930|NCT00632268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110468931|NCT00632268|Immunologic Factors|immunologic factors|mesh-ancestor
110468932|NCT04145076|Citalopram|citalopram|mesh-list
110468933|NCT04145076|Tianeptine|tianeptine|mesh-list
110468934|NCT04145076|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110468935|NCT04145076|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110468936|NCT04145076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110468937|NCT04145076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110468938|NCT04145076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110468939|NCT04145076|Serotonin Agents|serotonin agents|mesh-ancestor
110468940|NCT04145076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110468941|NCT04145076|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110468942|NCT04145076|Antidepressive Agents|antidepressive agents|mesh-ancestor
110468943|NCT04145076|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110468944|NCT04145076|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110468945|NCT00707902|Chlorhexidine|chlorhexidine|mesh-list
110468946|NCT00707902|Lidocaine|lidocaine|mesh-list
110468947|NCT00707902|Anesthetics, Local|anesthetics, local|mesh-ancestor
110468948|NCT00707902|Anesthetics|anesthetics|mesh-ancestor
110468949|NCT00707902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110533602|NCT00110435|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110533603|NCT00110435|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110533604|NCT00110435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110533605|NCT00093899|Simvastatin|simvastatin|mesh-list
110533606|NCT00093899|Ezetimibe|ezetimibe|mesh-list
110533607|NCT00093899|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110533608|NCT00093899|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110468950|NCT00707902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110468951|NCT00707902|Sensory System Agents|sensory system agents|mesh-ancestor
110468952|NCT00707902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110468953|NCT00707902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110468954|NCT00707902|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110468955|NCT00707902|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110468956|NCT00707902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110468957|NCT00707902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110468958|NCT00707902|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110468959|NCT00707902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110468960|NCT00707902|Disinfectants|disinfectants|mesh-ancestor
110116112|NCT05001828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110468961|NCT00704860|Antidepressive Agents|antidepressive agents|mesh-list
110468963|NCT05511337|Citric Acid|citric acid|mesh-list
110468964|NCT05511337|Sodium Citrate|sodium citrate|mesh-list
110468965|NCT05511337|Anticoagulants|anticoagulants|mesh-ancestor
110468966|NCT05511337|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110468967|NCT05511337|Chelating Agents|chelating agents|mesh-ancestor
110468968|NCT05511337|Sequestering Agents|sequestering agents|mesh-ancestor
110468969|NCT05511337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110468970|NCT00833794|Tramadol|tramadol|mesh-list
110468971|NCT00833794|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110468972|NCT00833794|Narcotics|narcotics|mesh-ancestor
110468973|NCT00833794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110468974|NCT00833794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110468975|NCT00833794|Analgesics|analgesics|mesh-ancestor
110468976|NCT00833794|Sensory System Agents|sensory system agents|mesh-ancestor
110468977|NCT00833794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110468978|NCT00778375|Cytarabine|cytarabine|mesh-list
110468979|NCT00778375|Decitabine|decitabine|mesh-list
110468980|NCT00778375|Clofarabine|clofarabine|mesh-list
110468981|NCT00778375|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110468982|NCT00778375|Antimetabolites|antimetabolites|mesh-ancestor
110468983|NCT00778375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110468984|NCT00778375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110468985|NCT00778375|Antiviral Agents|antiviral agents|mesh-ancestor
110468986|NCT00778375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110468987|NCT00778375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110468988|NCT00778375|Immunologic Factors|immunologic factors|mesh-ancestor
110468989|NCT00778375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110468990|NCT00778375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110468992|NCT04102267|Bupivacaine|bupivacaine|mesh-list
110468993|NCT04102267|Anesthetics, Local|anesthetics, local|mesh-ancestor
110468994|NCT04102267|Anesthetics|anesthetics|mesh-ancestor
110468995|NCT04102267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110468996|NCT04102267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110468997|NCT04102267|Sensory System Agents|sensory system agents|mesh-ancestor
110468998|NCT04102267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110468999|NCT04102267|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110469000|NCT04102267|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110469001|NCT04102267|Adrenergic Agents|adrenergic agents|mesh-ancestor
110469002|NCT04102267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110469003|NCT04102267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110469004|NCT04102267|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110469005|NCT04102267|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110469006|NCT04102267|Autonomic Agents|autonomic agents|mesh-ancestor
110469007|NCT04102267|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110469008|NCT04102267|Respiratory System Agents|respiratory system agents|mesh-ancestor
110469009|NCT04102267|Mydriatics|mydriatics|mesh-ancestor
110469010|NCT04102267|Sympathomimetics|sympathomimetics|mesh-ancestor
110469011|NCT04102267|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110469012|NCT00777829|Zolpidem|zolpidem|mesh-list
110533609|NCT00093899|Antimetabolites|antimetabolites|mesh-ancestor
110533610|NCT00093899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110533611|NCT00093899|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110533612|NCT00093899|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110533613|NCT00093899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110533614|NCT00092807|Ezetimibe|ezetimibe|mesh-list
110533615|NCT00092807|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110533616|NCT00092807|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110469013|NCT00777829|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110469014|NCT00777829|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110469015|NCT00777829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110469016|NCT00777829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110469017|NCT00777829|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
110469018|NCT00777829|GABA Agonists|gaba agonists|mesh-ancestor
110469019|NCT00777829|GABA Agents|gaba agents|mesh-ancestor
110469020|NCT00777829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110369085|NCT02187302|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110469021|NCT00777829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110469022|NCT00916045|Vidarabine|vidarabine|mesh-list
110469023|NCT00916045|Cyclosporine|cyclosporine|mesh-list
110469024|NCT00916045|Mycophenolic Acid|mycophenolic acid|mesh-list
110469025|NCT00916045|Cyclophosphamide|cyclophosphamide|mesh-list
110469026|NCT00916045|Melphalan|melphalan|mesh-list
110469027|NCT00916045|Busulfan|busulfan|mesh-list
110469028|NCT00916045|Thiotepa|thiotepa|mesh-list
110469029|NCT00916045|Fludarabine|fludarabine|mesh-list
110469030|NCT00916045|Fludarabine phosphate|fludarabine phosphate|mesh-list
110469031|NCT00916045|Cyclosporins|cyclosporins|mesh-list
110469032|NCT00916045|Thymoglobulin|thymoglobulin|mesh-list
110469033|NCT00916045|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110469034|NCT00916045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110469035|NCT00916045|Immunologic Factors|immunologic factors|mesh-ancestor
110469036|NCT00916045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110469037|NCT00916045|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110469038|NCT00916045|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110469039|NCT00916045|Alkylating Agents|alkylating agents|mesh-ancestor
110469040|NCT00916045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110469041|NCT00916045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110469042|NCT00916045|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110469043|NCT00916045|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110469044|NCT00916045|Antimetabolites|antimetabolites|mesh-ancestor
110469045|NCT00916045|Antiviral Agents|antiviral agents|mesh-ancestor
110469046|NCT00916045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110469047|NCT00916045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110469048|NCT00916045|Antifungal Agents|antifungal agents|mesh-ancestor
110469049|NCT00916045|Dermatologic Agents|dermatologic agents|mesh-ancestor
110469050|NCT00916045|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110469051|NCT00916045|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110469052|NCT00916045|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110469053|NCT00916045|Antitubercular Agents|antitubercular agents|mesh-ancestor
110469054|NCT00916045|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110469056|NCT00916123|Docetaxel|docetaxel|mesh-list
110469057|NCT00916123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110469058|NCT00916123|Tubulin Modulators|tubulin modulators|mesh-ancestor
110469059|NCT00916123|Antimitotic Agents|antimitotic agents|mesh-ancestor
110469060|NCT00916123|Mitosis Modulators|mitosis modulators|mesh-ancestor
110469061|NCT00916123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110469062|NCT00916123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110469063|NCT00916123|Glucocorticoids|glucocorticoids|mesh-ancestor
110469064|NCT00916123|Hormones|hormones|mesh-ancestor
110469065|NCT00916123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110469066|NCT00916123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110469067|NCT00916123|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110469068|NCT00916201|Cannabidiol|cannabidiol|mesh-list
110469069|NCT00916201|Anticonvulsants|anticonvulsants|mesh-ancestor
110469070|NCT00833638|Tadalafil|tadalafil|mesh-list
110469071|NCT00833638|Vasodilator Agents|vasodilator agents|mesh-ancestor
110469072|NCT00833638|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110533618|NCT00092807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110533619|NCT00092807|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110533620|NCT00092729|Naproxen|naproxen|mesh-list
110533621|NCT00092729|Etoricoxib|etoricoxib|mesh-list
110533622|NCT00092729|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110533623|NCT00092729|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110533624|NCT00092729|Analgesics|analgesics|mesh-ancestor
110469073|NCT00833638|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110469074|NCT00833638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110469075|NCT00833638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110469076|NCT00833638|Urological Agents|urological agents|mesh-ancestor
110469077|NCT01041404|Fluorouracil|fluorouracil|mesh-list
110469078|NCT01041404|Capecitabine|capecitabine|mesh-list
110469079|NCT01041404|Trastuzumab|trastuzumab|mesh-list
110469080|NCT01041404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110469081|NCT01041404|Antimetabolites|antimetabolites|mesh-ancestor
110469082|NCT01041404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110469083|NCT01041404|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110469084|NCT01041404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110469085|NCT01041404|Immunologic Factors|immunologic factors|mesh-ancestor
110469086|NCT01041404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110469087|NCT01041404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110469088|NCT00777049|Panobinostat|panobinostat|mesh-list
110469089|NCT00777049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110469090|NCT00777049|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110469091|NCT00777049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110469092|NCT00777049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110469093|NCT00774787|Imiquimod|imiquimod|mesh-list
110469094|NCT00774787|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110469095|NCT00774787|Immunologic Factors|immunologic factors|mesh-ancestor
110469096|NCT00774787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110469097|NCT00774787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110469098|NCT00774787|Interferon Inducers|interferon inducers|mesh-ancestor
110469099|NCT00888927|Mogamulizumab|mogamulizumab|mesh-list
110469100|NCT00888927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110469101|NCT01040780|Gefitinib|gefitinib|mesh-list
110469102|NCT01040780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110469103|NCT01040780|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110469104|NCT01040780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110469105|NCT01040780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110469106|NCT04303988|Bevacizumab|bevacizumab|mesh-list
110469107|NCT04303988|Carboplatin|carboplatin|mesh-list
110469108|NCT04303988|Temozolomide|temozolomide|mesh-list
110469109|NCT04303988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110469110|NCT04303988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110469111|NCT04303988|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110469112|NCT04303988|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110469113|NCT04303988|Growth Substances|growth substances|mesh-ancestor
110469114|NCT04303988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110469115|NCT04303988|Growth Inhibitors|growth inhibitors|mesh-ancestor
110469116|NCT04303988|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110469117|NCT04303988|Alkylating Agents|alkylating agents|mesh-ancestor
110469118|NCT04303988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110469119|NCT01059812|Insulin|insulin|mesh-list
110469120|NCT01059812|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110469121|NCT01059812|Insulin Aspart|insulin aspart|mesh-list
110469122|NCT01059812|Insulin, Long-Acting|insulin, long-acting|mesh-list
110469123|NCT01059812|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
110469124|NCT01059812|Biphasic Insulins|biphasic insulins|mesh-list
110469125|NCT01059812|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
110469126|NCT01059812|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110469127|NCT01059812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110469128|NCT00888615|Paclitaxel|paclitaxel|mesh-list
110469129|NCT00888615|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110469130|NCT00888615|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110469131|NCT00888615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110533625|NCT00092729|Sensory System Agents|sensory system agents|mesh-ancestor
110533626|NCT00092729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110533627|NCT00092729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110533628|NCT00092729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110533629|NCT00092729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110533630|NCT00092729|Gout Suppressants|gout suppressants|mesh-ancestor
110533631|NCT00092729|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110533632|NCT00092729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110533633|NCT00092729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110469133|NCT00888615|Antimitotic Agents|antimitotic agents|mesh-ancestor
110469134|NCT00888615|Mitosis Modulators|mitosis modulators|mesh-ancestor
110469135|NCT00888615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110469136|NCT00845650|Immunoglobulins|immunoglobulins|mesh-list
110469137|NCT00845650|gamma-Globulins|gamma-globulins|mesh-list
110469138|NCT00845650|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110469139|NCT00845650|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110469140|NCT00845650|Immunologic Factors|immunologic factors|mesh-ancestor
110469141|NCT00845650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110469143|NCT00888381|Immunologic Factors|immunologic factors|mesh-ancestor
110469144|NCT00888381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110469145|NCT00833560|Dexamethasone|dexamethasone|mesh-list
110469146|NCT00833560|Cyclophosphamide|cyclophosphamide|mesh-list
110469147|NCT00833560|Bortezomib|bortezomib|mesh-list
110469148|NCT00833560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110469149|NCT00833560|Immunologic Factors|immunologic factors|mesh-ancestor
110369139|NCT00563823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110469150|NCT00833560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110469151|NCT00833560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110469152|NCT00833560|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110469153|NCT00833560|Alkylating Agents|alkylating agents|mesh-ancestor
110469154|NCT00833560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110469155|NCT00833560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110469156|NCT00833560|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110469157|NCT00833560|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110469159|NCT00833560|Autonomic Agents|autonomic agents|mesh-ancestor
110469160|NCT00833560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110469161|NCT00833560|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110469162|NCT00833560|Glucocorticoids|glucocorticoids|mesh-ancestor
110469163|NCT00833560|Hormones|hormones|mesh-ancestor
110469164|NCT00833560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110469165|NCT00833560|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110469166|NCT04242927|Nicotinic Acids|nicotinic acids|mesh-list
110469167|NCT04242927|Niacin|niacin|mesh-list
110469168|NCT04242927|Niacinamide|niacinamide|mesh-list
110469169|NCT04242927|Vitamin B Complex|vitamin b complex|mesh-ancestor
110469170|NCT04242927|Vitamins|vitamins|mesh-ancestor
110469171|NCT04242927|Micronutrients|micronutrients|mesh-ancestor
110469172|NCT04242927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110469173|NCT04242927|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110469174|NCT04242927|Antimetabolites|antimetabolites|mesh-ancestor
110469175|NCT04242927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110469176|NCT04242927|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110469177|NCT04242927|Vasodilator Agents|vasodilator agents|mesh-ancestor
110469178|NCT00887679|Escitalopram|escitalopram|mesh-list
110469179|NCT00887679|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110469180|NCT00887679|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110469181|NCT00887679|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110469182|NCT00887679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110469183|NCT00887679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110469184|NCT00887679|Serotonin Agents|serotonin agents|mesh-ancestor
110469185|NCT00887679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110469186|NCT04241523|Lenvatinib|lenvatinib|mesh-list
110469187|NCT04241523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110469188|NCT04241523|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110533634|NCT00092729|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110533635|NCT02686476|Empagliflozin|empagliflozin|mesh-list
110533636|NCT02686476|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110533637|NCT02686476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110533638|NCT02686476|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110533639|NCT02686476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110533640|NCT04972175|Insulin Lispro|insulin lispro|mesh-list
110533641|NCT04972175|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110533642|NCT04972175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110469189|NCT04241523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110469190|NCT04241523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110469191|NCT00833482|Ritonavir|ritonavir|mesh-list
110469192|NCT00833482|Atazanavir Sulfate|atazanavir sulfate|mesh-list
110469193|NCT00833482|Voriconazole|voriconazole|mesh-list
110469194|NCT00833482|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110469195|NCT00833482|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110469196|NCT00833482|Protease Inhibitors|protease inhibitors|mesh-ancestor
110469197|NCT00833482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110469198|NCT00833482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110469199|NCT00833482|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110469200|NCT00833482|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110469201|NCT00833482|Antiviral Agents|antiviral agents|mesh-ancestor
110469202|NCT00833482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110469203|NCT00833482|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110469204|NCT00833482|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110469205|NCT00833482|Antifungal Agents|antifungal agents|mesh-ancestor
110469206|NCT00833482|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110469207|NCT00833482|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110469208|NCT00833482|Hormone Antagonists|hormone antagonists|mesh-ancestor
110469209|NCT00833482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110469210|NCT00833482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110469211|NCT00845182|Pioglitazone|pioglitazone|mesh-list
110469213|NCT00845182|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110469214|NCT00845182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110469215|NCT00845182|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110469216|NCT00845182|Incretins|incretins|mesh-ancestor
110469217|NCT00845182|Hormones|hormones|mesh-ancestor
110469218|NCT00845182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110469219|NCT00833248|Goserelin|goserelin|mesh-list
110469220|NCT00833248|Bicalutamide|bicalutamide|mesh-list
110369149|NCT04611711|Decitabine|decitabine|mesh-list
110469221|NCT00833248|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110469222|NCT00833248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110469223|NCT00833248|Androgen Antagonists|androgen antagonists|mesh-ancestor
110469224|NCT00833248|Hormone Antagonists|hormone antagonists|mesh-ancestor
110469225|NCT00833248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110469226|NCT00833248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110469227|NCT00702130|Pravastatin|pravastatin|mesh-list
110469228|NCT00702130|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110469229|NCT00702130|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110469230|NCT00702130|Antimetabolites|antimetabolites|mesh-ancestor
110469231|NCT00702130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110469232|NCT00702130|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110469233|NCT00702130|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110469234|NCT00702130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110469235|NCT00823264|Charcoal|charcoal|mesh-list
110469236|NCT00823264|Antidotes|antidotes|mesh-ancestor
110469237|NCT00823264|Protective Agents|protective agents|mesh-ancestor
110469238|NCT00823264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110469239|NCT04241211|Denosumab|denosumab|mesh-list
110469240|NCT04241211|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110469241|NCT04241211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110469242|NCT00702442|Droperidol|droperidol|mesh-list
110469243|NCT00702442|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110469244|NCT00702442|Antiemetics|antiemetics|mesh-ancestor
110533643|NCT00616382|Indomethacin|indomethacin|mesh-list
110533644|NCT00616382|Pentoxifylline|pentoxifylline|mesh-list
110533645|NCT00616382|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110533646|NCT00616382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110533647|NCT00616382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110533648|NCT00616382|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110533649|NCT00616382|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110533650|NCT00616382|Protective Agents|protective agents|mesh-ancestor
110533651|NCT00616382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110533652|NCT00616382|Vasodilator Agents|vasodilator agents|mesh-ancestor
110533653|NCT00616382|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110533655|NCT00616382|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110533656|NCT00616382|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110533657|NCT00616382|Analgesics|analgesics|mesh-ancestor
110195704|NCT00072969|Daclizumab|daclizumab|mesh-list
110469245|NCT00702442|Autonomic Agents|autonomic agents|mesh-ancestor
110469246|NCT00702442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110469247|NCT00702442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110469248|NCT00702442|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110469249|NCT00702442|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110469250|NCT00702442|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110469251|NCT00702442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110469252|NCT00702442|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110469253|NCT00702442|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110469254|NCT00702442|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110469255|NCT00702442|Dopamine Agents|dopamine agents|mesh-ancestor
110469256|NCT00702442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110469257|NCT00702442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110469258|NCT02612272|Ketorolac|ketorolac|mesh-list
110469259|NCT02612272|Betamethasone|betamethasone|mesh-list
110469260|NCT02612272|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110469261|NCT02612272|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110469262|NCT02612272|Analgesics|analgesics|mesh-ancestor
110469263|NCT02612272|Sensory System Agents|sensory system agents|mesh-ancestor
110116416|NCT04062656|Micronutrients|micronutrients|mesh-ancestor
110469264|NCT02612272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110469265|NCT02612272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110469266|NCT02612272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110469267|NCT02612272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110469268|NCT02612272|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110469269|NCT02612272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110469270|NCT02612272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110469271|NCT02612272|Glucocorticoids|glucocorticoids|mesh-ancestor
110469273|NCT02612272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110469274|NCT02612272|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110469275|NCT02612272|Respiratory System Agents|respiratory system agents|mesh-ancestor
110469276|NCT00832624|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110469277|NCT00832624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110469278|NCT00832624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110392062|NCT01644071|Dexetimide|dexetimide|mesh-list
110469280|NCT00832624|Hormones|hormones|mesh-ancestor
110469281|NCT00832624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110369151|NCT04611711|Antimetabolites|antimetabolites|mesh-ancestor
110469282|NCT00832624|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110469283|NCT00832624|Protease Inhibitors|protease inhibitors|mesh-ancestor
110469284|NCT00832624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110469285|NCT00832624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110469286|NCT00913120|Enoxaparin|enoxaparin|mesh-list
110469287|NCT00913120|Anticoagulants|anticoagulants|mesh-ancestor
110533658|NCT00616382|Sensory System Agents|sensory system agents|mesh-ancestor
110533659|NCT00616382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110533660|NCT00616382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110533661|NCT00616382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110533662|NCT00616382|Gout Suppressants|gout suppressants|mesh-ancestor
110533663|NCT00616382|Tocolytic Agents|tocolytic agents|mesh-ancestor
110533664|NCT00616382|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110533665|NCT00616382|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110533666|NCT01864746|Palbociclib|palbociclib|mesh-list
110533667|NCT01864746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110533668|NCT01864746|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110533669|NCT01864746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110533670|NCT01864746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110533671|NCT04967573|Rivaroxaban|rivaroxaban|mesh-list
110533672|NCT04967573|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110533673|NCT04967573|Antithrombins|antithrombins|mesh-ancestor
110533674|NCT04967573|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110533675|NCT04967573|Protease Inhibitors|protease inhibitors|mesh-ancestor
110469288|NCT00913120|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110469289|NCT00913120|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110469290|NCT00913120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110469291|NCT00822172|Cilostazol|cilostazol|mesh-list
110469292|NCT00822172|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110469293|NCT00822172|Autonomic Agents|autonomic agents|mesh-ancestor
110469294|NCT00822172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110469295|NCT00822172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110469296|NCT00822172|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110469297|NCT00822172|Respiratory System Agents|respiratory system agents|mesh-ancestor
110469298|NCT00822172|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110469299|NCT00822172|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110469300|NCT00822172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110469301|NCT00822172|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110469302|NCT00822172|Vasodilator Agents|vasodilator agents|mesh-ancestor
110469303|NCT00822172|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110469304|NCT00822172|Protective Agents|protective agents|mesh-ancestor
110469305|NCT00822172|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110469306|NCT00822172|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110469307|NCT00822172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110469308|NCT00832000|Mexiletine|mexiletine|mesh-list
110469309|NCT00832000|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110469310|NCT00832000|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110469311|NCT00832000|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110469312|NCT00832000|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110469313|NCT00832000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110469314|NCT04202952|Sofosbuvir|sofosbuvir|mesh-list
110469315|NCT04202952|Antiviral Agents|antiviral agents|mesh-ancestor
110469316|NCT04202952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110469317|NCT04054674|Salicylic Acid|salicylic acid|mesh-list
110469318|NCT04054674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110469319|NCT04054674|Antifungal Agents|antifungal agents|mesh-ancestor
110469320|NCT04054674|Keratolytic Agents|keratolytic agents|mesh-ancestor
110469321|NCT04054674|Dermatologic Agents|dermatologic agents|mesh-ancestor
110469322|NCT04166292|Lidocaine|lidocaine|mesh-list
110469323|NCT04166292|Anesthetics, Local|anesthetics, local|mesh-ancestor
110469324|NCT04166292|Anesthetics|anesthetics|mesh-ancestor
110469325|NCT04166292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110469326|NCT04166292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110533676|NCT04967573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110533677|NCT04967573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110533678|NCT04967573|Anticoagulants|anticoagulants|mesh-ancestor
110533679|NCT04212650|Losartan|losartan|mesh-list
110533680|NCT04212650|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110533681|NCT04212650|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110195823|NCT00068952|Temozolomide|temozolomide|mesh-list
110469327|NCT04166292|Sensory System Agents|sensory system agents|mesh-ancestor
110469328|NCT04166292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110469329|NCT04166292|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110469330|NCT04166292|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110469331|NCT04166292|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110469332|NCT04166292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110469333|NCT04166292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110469334|NCT04099771|Ketamine|ketamine|mesh-list
110469335|NCT04099771|Analgesics|analgesics|mesh-ancestor
110469336|NCT04099771|Sensory System Agents|sensory system agents|mesh-ancestor
110469338|NCT04099771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110469339|NCT04099771|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110469340|NCT04099771|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110469341|NCT04099771|Anesthetics, General|anesthetics, general|mesh-ancestor
110469342|NCT04099771|Anesthetics|anesthetics|mesh-ancestor
110469343|NCT04099771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110369163|NCT02092922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110469345|NCT04099771|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110469346|NCT04099771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110469347|NCT04099771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110469348|NCT00768469|Paclitaxel|paclitaxel|mesh-list
110469349|NCT00768469|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110469350|NCT00768469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110469351|NCT00768469|Tubulin Modulators|tubulin modulators|mesh-ancestor
110469352|NCT00768469|Antimitotic Agents|antimitotic agents|mesh-ancestor
110469353|NCT00768469|Mitosis Modulators|mitosis modulators|mesh-ancestor
110469354|NCT00768469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110469356|NCT02825121|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110469357|NCT02825121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110469358|NCT02825121|Trace Elements|trace elements|mesh-ancestor
110469359|NCT02825121|Micronutrients|micronutrients|mesh-ancestor
110469360|NCT02825121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110469361|NCT02825199|Caffeine|caffeine|mesh-list
110469362|NCT02825199|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110469363|NCT02825199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110469364|NCT02825199|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110469365|NCT02825199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110469366|NCT02825199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110469367|NCT02825199|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110469368|NCT02825199|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110469369|NCT02825199|Purinergic Agents|purinergic agents|mesh-ancestor
110469370|NCT02825199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110469371|NCT02824965|Pembrolizumab|pembrolizumab|mesh-list
110469372|NCT02824965|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110469373|NCT02824965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110469374|NCT02824965|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110469375|NCT02824965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110469376|NCT00886743|Oprelvekin|oprelvekin|mesh-list
110469377|NCT00886743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110469378|NCT02826759|Insulin|insulin|mesh-list
110469379|NCT02826759|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110469380|NCT02826759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110469381|NCT02823951|Dimethyl Fumarate|dimethyl fumarate|mesh-list
110469382|NCT02823951|Dermatologic Agents|dermatologic agents|mesh-ancestor
110469383|NCT02823951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110469384|NCT02823951|Immunologic Factors|immunologic factors|mesh-ancestor
110469385|NCT02823951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110469386|NCT02826837|Bevacizumab|bevacizumab|mesh-list
110469387|NCT02826837|Cetuximab|cetuximab|mesh-list
110033298|NCT04238845|Vitamin A|vitamin a|mesh-list
110533682|NCT04212650|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110533683|NCT04212650|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110533684|NCT04212650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110533686|NCT02574728|Celecoxib|celecoxib|mesh-list
110533687|NCT02574728|Cyclophosphamide|cyclophosphamide|mesh-list
110533688|NCT02574728|Etoposide|etoposide|mesh-list
110533689|NCT02574728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110533690|NCT02574728|Immunologic Factors|immunologic factors|mesh-ancestor
110533691|NCT02574728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110533692|NCT02574728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110181182|NCT00017576|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110533693|NCT02574728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110533694|NCT02574728|Alkylating Agents|alkylating agents|mesh-ancestor
110533695|NCT02574728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110533696|NCT02574728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110533697|NCT02574728|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110533698|NCT02574728|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110533699|NCT02574728|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110533700|NCT02574728|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110533701|NCT02574728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110469388|NCT02826837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110469389|NCT02826837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110469390|NCT02826837|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110469391|NCT02826837|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110469392|NCT02826837|Growth Substances|growth substances|mesh-ancestor
110469393|NCT02826837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110469394|NCT02826837|Growth Inhibitors|growth inhibitors|mesh-ancestor
110469395|NCT02822547|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110469396|NCT02822547|Antiviral Agents|antiviral agents|mesh-ancestor
110469397|NCT02822547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110469398|NCT02823483|Sunscreening Agents|sunscreening agents|mesh-list
110469399|NCT02823483|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110469400|NCT02823483|Protective Agents|protective agents|mesh-ancestor
110469401|NCT02823483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110469402|NCT02823483|Dermatologic Agents|dermatologic agents|mesh-ancestor
110469403|NCT04848597|Paclitaxel|paclitaxel|mesh-list
110469404|NCT04848597|Antibodies|antibodies|mesh-list
110469405|NCT04848597|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110469406|NCT04848597|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110469407|NCT04848597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110469408|NCT04848597|Tubulin Modulators|tubulin modulators|mesh-ancestor
110469409|NCT04848597|Antimitotic Agents|antimitotic agents|mesh-ancestor
110469410|NCT04848597|Mitosis Modulators|mitosis modulators|mesh-ancestor
110469411|NCT04848597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110469412|NCT04848597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110469413|NCT04848597|Immunologic Factors|immunologic factors|mesh-ancestor
110469414|NCT05037045|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
110469415|NCT05037045|Incretins|incretins|mesh-ancestor
110469417|NCT05037045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110469418|NCT05037045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110469419|NCT05660811|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
110533702|NCT02574728|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110533703|NCT02574728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110533704|NCT02574728|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110533705|NCT02574728|Antifungal Agents|antifungal agents|mesh-ancestor
110533706|NCT02574728|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110533707|NCT02574728|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110533708|NCT02574728|Analgesics|analgesics|mesh-ancestor
110533709|NCT02574728|Sensory System Agents|sensory system agents|mesh-ancestor
110533710|NCT02574728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110533711|NCT02574728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110533712|NCT02574728|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110195943|NCT00208897|Antidepressive Agents|antidepressive agents|mesh-ancestor
110469420|NCT02823405|Pembrolizumab|pembrolizumab|mesh-list
110469421|NCT02823405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110469422|NCT02823405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110598143|NCT00712374|Sulfadoxine|sulfadoxine|mesh-list
110469423|NCT02823405|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110469424|NCT02823405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110469425|NCT02823249|Erythritol|erythritol|mesh-list
110469426|NCT02823249|Tryptophan|tryptophan|mesh-list
110469427|NCT02823249|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110469428|NCT02823249|Antidepressive Agents|antidepressive agents|mesh-ancestor
110469429|NCT02823249|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110469430|NCT02823249|Vasodilator Agents|vasodilator agents|mesh-ancestor
110469432|NCT00768079|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110469433|NCT00768079|Respiratory System Agents|respiratory system agents|mesh-ancestor
110469434|NCT02603575|Caspofungin|caspofungin|mesh-list
110469435|NCT02603575|Sulfanilamide|sulfanilamide|mesh-list
110469436|NCT02603575|Sulfanilamides|sulfanilamides|mesh-list
110469437|NCT02603575|Methylprednisolone|methylprednisolone|mesh-list
110469438|NCT02603575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110469439|NCT02603575|Antiemetics|antiemetics|mesh-ancestor
110469440|NCT02603575|Autonomic Agents|autonomic agents|mesh-ancestor
110469441|NCT02603575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110469442|NCT02603575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110469443|NCT02603575|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110469444|NCT02603575|Glucocorticoids|glucocorticoids|mesh-ancestor
110469445|NCT02603575|Hormones|hormones|mesh-ancestor
110469446|NCT02603575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110469447|NCT02603575|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110469448|NCT02603575|Protective Agents|protective agents|mesh-ancestor
110469449|NCT02603575|Antifungal Agents|antifungal agents|mesh-ancestor
110469450|NCT02603575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110469451|NCT02603575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110469452|NCT02603575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110469453|NCT02603575|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110469454|NCT02601859|Lithium Carbonate|lithium carbonate|mesh-list
110469455|NCT02601859|Antidepressive Agents|antidepressive agents|mesh-ancestor
110469456|NCT02601859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110469457|NCT02601859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110469458|NCT02601859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110469459|NCT02601859|Antimanic Agents|antimanic agents|mesh-ancestor
110469460|NCT02601859|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110469461|NCT02601859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110469462|NCT02601859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110469463|NCT02822157|Paclitaxel|paclitaxel|mesh-list
110469464|NCT02822157|Carboplatin|carboplatin|mesh-list
110469465|NCT02822157|Gemcitabine|gemcitabine|mesh-list
110469466|NCT02822157|Doxorubicin|doxorubicin|mesh-list
110469467|NCT02822157|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110469468|NCT02822157|Topotecan|topotecan|mesh-list
110469469|NCT02822157|Olaparib|olaparib|mesh-list
110469470|NCT02822157|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110469471|NCT02822157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110469472|NCT02822157|Tubulin Modulators|tubulin modulators|mesh-ancestor
110533713|NCT02574728|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110533714|NCT00617474|Epoetin Alfa|epoetin alfa|mesh-list
110533715|NCT00617474|Hematinics|hematinics|mesh-ancestor
110533716|NCT00619034|Diclofenac|diclofenac|mesh-list
110533717|NCT00619034|Dorzolamide|dorzolamide|mesh-list
110533718|NCT00619034|Latanoprost|latanoprost|mesh-list
110533719|NCT00619034|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110533720|NCT00619034|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110533721|NCT00619034|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110533722|NCT00619034|Analgesics|analgesics|mesh-ancestor
110533723|NCT00619034|Sensory System Agents|sensory system agents|mesh-ancestor
110312304|NCT00293696|Hormone Antagonists|hormone antagonists|mesh-ancestor
110533724|NCT00619034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110533725|NCT00619034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110196010|NCT00209209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110469473|NCT02822157|Antimitotic Agents|antimitotic agents|mesh-ancestor
110469474|NCT02822157|Mitosis Modulators|mitosis modulators|mesh-ancestor
110469475|NCT02822157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110469476|NCT02822157|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110469477|NCT02822157|Antimetabolites|antimetabolites|mesh-ancestor
110469478|NCT02822157|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110469479|NCT02822157|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110469480|NCT02822157|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110469481|NCT02822157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110469482|NCT02822157|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110469483|NCT02822157|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110469484|NCT02822937|Triazolam|triazolam|mesh-list
110116643|NCT03147859|Vedolizumab|vedolizumab|mesh-list
110469485|NCT02822937|Methylphenidate|methylphenidate|mesh-list
110469486|NCT02822937|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110469487|NCT02822937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110469488|NCT02822937|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110469489|NCT02822937|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110469490|NCT02822937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110469491|NCT02822937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110469493|NCT02822937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110469494|NCT02822937|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110469495|NCT02822937|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110469496|NCT02822937|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110469497|NCT02822937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110469498|NCT02822937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110469499|NCT02822937|GABA Modulators|gaba modulators|mesh-ancestor
110469500|NCT02822937|GABA Agents|gaba agents|mesh-ancestor
110469501|NCT04200885|Dexamethasone|dexamethasone|mesh-list
110469502|NCT04200885|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
110469503|NCT04200885|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
110469504|NCT04200885|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110469505|NCT04200885|Antiemetics|antiemetics|mesh-ancestor
110469506|NCT04200885|Autonomic Agents|autonomic agents|mesh-ancestor
110469507|NCT04200885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110469508|NCT04200885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110469509|NCT04200885|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110469510|NCT04200885|Glucocorticoids|glucocorticoids|mesh-ancestor
110469511|NCT04200885|Hormones|hormones|mesh-ancestor
110469512|NCT04200885|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110469513|NCT04200885|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110469514|NCT04200885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110469515|NCT04200885|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110469516|NCT04200885|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110469517|NCT04200885|Analgesics|analgesics|mesh-ancestor
110469518|NCT04200885|Sensory System Agents|sensory system agents|mesh-ancestor
110533726|NCT00619034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110533727|NCT00619034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110533728|NCT00619034|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110533729|NCT00619034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110533730|NCT00619034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110533731|NCT00619034|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110533732|NCT00619034|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110533733|NCT00619034|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110533734|NCT01614912|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
110533735|NCT01614912|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110533736|NCT01614912|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110196067|NCT00399126|Tubulin Modulators|tubulin modulators|mesh-ancestor
110469519|NCT04200885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110469521|NCT05659251|Carboplatin|carboplatin|mesh-list
110469522|NCT05659251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110469523|NCT05659251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110469524|NCT05659251|Tubulin Modulators|tubulin modulators|mesh-ancestor
110469525|NCT05659251|Antimitotic Agents|antimitotic agents|mesh-ancestor
110469526|NCT05659251|Mitosis Modulators|mitosis modulators|mesh-ancestor
110369215|NCT00554918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110469527|NCT05659251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110469528|NCT00766831|Hydromorphone|hydromorphone|mesh-list
110469529|NCT00766831|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110469530|NCT00766831|Narcotics|narcotics|mesh-ancestor
110469531|NCT00766831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110469532|NCT00766831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110469533|NCT00766831|Analgesics|analgesics|mesh-ancestor
110469534|NCT00766831|Sensory System Agents|sensory system agents|mesh-ancestor
110469535|NCT00766831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110469536|NCT02821689|Pirfenidone|pirfenidone|mesh-list
110469537|NCT02821689|Analgesics|analgesics|mesh-ancestor
110469538|NCT02821689|Sensory System Agents|sensory system agents|mesh-ancestor
110469539|NCT02821689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110469540|NCT02821689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110469541|NCT02821689|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110469542|NCT02821689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110469543|NCT02821689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110469544|NCT02821689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110469545|NCT02821689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110469546|NCT02821533|Cisplatin|cisplatin|mesh-list
110469547|NCT02821533|Antineoplastic Agents|antineoplastic agents|mesh-list
110469548|NCT05659407|Rituximab|rituximab|mesh-list
110469549|NCT05659407|Belimumab|belimumab|mesh-list
110469550|NCT05659407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110469551|NCT05659407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110469552|NCT05659407|Immunologic Factors|immunologic factors|mesh-ancestor
110469553|NCT05659407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110469554|NCT05659407|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110469555|NCT05659407|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110469556|NCT00766675|Acetaminophen|acetaminophen|mesh-list
110469557|NCT00766675|Tramadol|tramadol|mesh-list
110469558|NCT00766675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110469559|NCT00766675|Analgesics|analgesics|mesh-ancestor
110469560|NCT00766675|Sensory System Agents|sensory system agents|mesh-ancestor
110116715|NCT02412566|SMOFlipid|smoflipid|mesh-list
110469561|NCT00766675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110469562|NCT00766675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110469563|NCT00766675|Antipyretics|antipyretics|mesh-ancestor
110469564|NCT00766675|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110469565|NCT00766675|Narcotics|narcotics|mesh-ancestor
110469566|NCT00766675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110469567|NCT02820441|Zopiclone|zopiclone|mesh-list
110469568|NCT02820441|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110469569|NCT02820441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110533737|NCT01614912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110533738|NCT01614912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110533739|NCT01614912|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110533740|NCT01614912|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
110533741|NCT01614912|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110533742|NCT01614912|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110533743|NCT01614912|Adrenergic Agents|adrenergic agents|mesh-ancestor
110533744|NCT01614912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110533745|NCT01614912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110598175|NCT02573220|Vitamins|vitamins|mesh-ancestor
110533746|NCT01614912|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110533747|NCT01614912|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110533748|NCT01614912|Serotonin Agents|serotonin agents|mesh-ancestor
110533749|NCT01614912|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110533750|NCT01614912|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110533751|NCT01614912|Dopamine Agents|dopamine agents|mesh-ancestor
110533752|NCT00638742|Latanoprost|latanoprost|mesh-list
110533753|NCT00638742|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110196137|NCT00041210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110469570|NCT02820441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110469571|NCT02821377|Furosemide|furosemide|mesh-list
110469572|NCT02821377|Diuretics|diuretics|mesh-ancestor
110469573|NCT02821377|Natriuretic Agents|natriuretic agents|mesh-ancestor
110469574|NCT02821377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110469575|NCT02821377|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110469576|NCT02821377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110469577|NCT02821377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110469578|NCT02820987|Meropenem|meropenem|mesh-list
110469579|NCT02820987|Tazobactam|tazobactam|mesh-list
110469581|NCT02820987|Cefepime|cefepime|mesh-list
110469582|NCT02820987|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
110469583|NCT02820987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110469584|NCT02820987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110469585|NCT02820987|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110469586|NCT02820987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110469587|NCT02820987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110469588|NCT04052490|Salicylic Acid|salicylic acid|mesh-list
110469589|NCT04052490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110469590|NCT04052490|Antifungal Agents|antifungal agents|mesh-ancestor
110469591|NCT04052490|Keratolytic Agents|keratolytic agents|mesh-ancestor
110469592|NCT04052490|Dermatologic Agents|dermatologic agents|mesh-ancestor
110469593|NCT00773383|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110469594|NCT00773383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110469595|NCT00773383|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110469596|NCT00773383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110469597|NCT00773383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110469598|NCT02818881|Methamphetamine|methamphetamine|mesh-list
110469599|NCT02818881|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110469600|NCT02818881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110469601|NCT02818881|Sympathomimetics|sympathomimetics|mesh-ancestor
110469602|NCT02818881|Autonomic Agents|autonomic agents|mesh-ancestor
110469603|NCT02818881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110469604|NCT02818881|Dopamine Agents|dopamine agents|mesh-ancestor
110469605|NCT02818881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110469606|NCT02818881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110469607|NCT02818881|Adrenergic Agents|adrenergic agents|mesh-ancestor
110533755|NCT03512418|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110533756|NCT03512418|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110533757|NCT03512418|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110533758|NCT03512418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110533759|NCT03512418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110533760|NCT03512418|Antiviral Agents|antiviral agents|mesh-ancestor
110533761|NCT03512418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110533762|NCT03512418|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110533763|NCT03512418|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110533764|NCT02686242|Anesthetics|anesthetics|mesh-list
110533765|NCT02686242|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110469608|NCT02818881|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110469609|NCT02818881|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110469610|NCT02818881|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110469611|NCT02818881|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110469612|NCT02818803|Propolis|propolis|mesh-list
110469613|NCT02818803|Miconazole|miconazole|mesh-list
110469614|NCT02818803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110469615|NCT02818803|Antifungal Agents|antifungal agents|mesh-ancestor
110469616|NCT02818803|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110469617|NCT02818803|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110469618|NCT02818803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110469619|NCT02818803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110469620|NCT02818803|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110469621|NCT02818803|Hormone Antagonists|hormone antagonists|mesh-ancestor
110469622|NCT02818803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110469623|NCT02818803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110469624|NCT02818803|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110469625|NCT02818803|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110469626|NCT02818725|Cisplatin|cisplatin|mesh-list
110469627|NCT02818725|Doxorubicin|doxorubicin|mesh-list
110469628|NCT02818725|Methotrexate|methotrexate|mesh-list
110469629|NCT02818725|Panitumumab|panitumumab|mesh-list
110469630|NCT02818725|Vinblastine|vinblastine|mesh-list
110469631|NCT02818725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110469632|NCT02818725|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110469633|NCT02818725|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110469634|NCT02818725|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110469635|NCT02818725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110469636|NCT02818725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110469637|NCT02818725|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110469638|NCT02818725|Abortifacient Agents|abortifacient agents|mesh-ancestor
110469639|NCT02818725|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110469640|NCT02818725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110469641|NCT02818725|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110469642|NCT02818725|Antimetabolites|antimetabolites|mesh-ancestor
110469643|NCT02818725|Dermatologic Agents|dermatologic agents|mesh-ancestor
110469644|NCT02818725|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110469645|NCT02818725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110469646|NCT02818725|Immunologic Factors|immunologic factors|mesh-ancestor
110469647|NCT02818725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110469648|NCT02818725|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110469649|NCT02818725|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110469650|NCT02818725|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110469651|NCT02818725|Tubulin Modulators|tubulin modulators|mesh-ancestor
110469652|NCT02818725|Antimitotic Agents|antimitotic agents|mesh-ancestor
110469653|NCT02818725|Mitosis Modulators|mitosis modulators|mesh-ancestor
110469655|NCT02820051|Midazolam|midazolam|mesh-list
110469656|NCT02820051|Nalbuphine|nalbuphine|mesh-list
110533766|NCT02686242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110533767|NCT05661786|Antiviral Agents|antiviral agents|mesh-list
110533768|NCT05661786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110533769|NCT00639522|Paclitaxel|paclitaxel|mesh-list
110533770|NCT00639522|Capecitabine|capecitabine|mesh-list
110533771|NCT00639522|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110533772|NCT00639522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110469657|NCT02820051|Propofol|propofol|mesh-list
110469658|NCT02820051|Anesthetics, Local|anesthetics, local|mesh-ancestor
110469659|NCT02820051|Anesthetics|anesthetics|mesh-ancestor
110469660|NCT02820051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110469661|NCT02820051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110469662|NCT02820051|Sensory System Agents|sensory system agents|mesh-ancestor
110469663|NCT02820051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110469664|NCT02820051|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110469665|NCT02820051|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110469666|NCT02820051|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110469667|NCT02820051|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110469668|NCT02820051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110469669|NCT02820051|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110469670|NCT02820051|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110469671|NCT02820051|Anesthetics, General|anesthetics, general|mesh-ancestor
110469672|NCT02820051|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110469673|NCT02820051|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110469674|NCT02820051|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110469675|NCT02820051|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110469676|NCT02820051|GABA Modulators|gaba modulators|mesh-ancestor
110469677|NCT02820051|GABA Agents|gaba agents|mesh-ancestor
110469678|NCT02820051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110469679|NCT02820051|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110469680|NCT02820051|Narcotics|narcotics|mesh-ancestor
110469681|NCT02820051|Analgesics|analgesics|mesh-ancestor
110469682|NCT02817243|Simvastatin|simvastatin|mesh-list
110469683|NCT02817243|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110469684|NCT02817243|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110469685|NCT02817243|Antimetabolites|antimetabolites|mesh-ancestor
110469686|NCT02817243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110469687|NCT02817243|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110469688|NCT02817243|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110469689|NCT02817243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110469690|NCT00766363|Rivastigmine|rivastigmine|mesh-list
110469691|NCT00766363|Donepezil|donepezil|mesh-list
110469692|NCT00766363|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110469693|NCT00766363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110469694|NCT00766363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110469695|NCT00766363|Cholinergic Agents|cholinergic agents|mesh-ancestor
110469696|NCT00766363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110469697|NCT00766363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110469698|NCT00766363|Nootropic Agents|nootropic agents|mesh-ancestor
110469699|NCT00766363|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110469700|NCT00766363|Protective Agents|protective agents|mesh-ancestor
110469701|NCT02636946|Bimatoprost|bimatoprost|mesh-list
110469702|NCT02636946|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110469703|NCT02819661|Morphine|morphine|mesh-list
110469704|NCT02819661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110469705|NCT02819661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110469706|NCT02819661|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110469707|NCT02819661|Narcotics|narcotics|mesh-ancestor
110469708|NCT02819661|Analgesics|analgesics|mesh-ancestor
110469709|NCT02819661|Sensory System Agents|sensory system agents|mesh-ancestor
110116901|NCT01873157|Bortezomib|bortezomib|mesh-list
110469710|NCT02819661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110469712|NCT00765817|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110469713|NCT00765817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110469714|NCT00765817|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110469715|NCT00765817|Incretins|incretins|mesh-ancestor
110469716|NCT00765817|Hormones|hormones|mesh-ancestor
110469717|NCT00765817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110469718|NCT02818491|Dexamethasone|dexamethasone|mesh-list
110469719|NCT02818491|Dexamethasone acetate|dexamethasone acetate|mesh-list
110533773|NCT00639522|Tubulin Modulators|tubulin modulators|mesh-ancestor
110533774|NCT00639522|Antimitotic Agents|antimitotic agents|mesh-ancestor
110533775|NCT00639522|Mitosis Modulators|mitosis modulators|mesh-ancestor
110533776|NCT00639522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110533777|NCT00639522|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110533778|NCT00639522|Antimetabolites|antimetabolites|mesh-ancestor
110533779|NCT00411138|Paclitaxel|paclitaxel|mesh-list
110533780|NCT00411138|Carboplatin|carboplatin|mesh-list
110533781|NCT00411138|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110533782|NCT00411138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110533783|NCT00411138|Tubulin Modulators|tubulin modulators|mesh-ancestor
110533784|NCT00411138|Antimitotic Agents|antimitotic agents|mesh-ancestor
110533785|NCT00411138|Mitosis Modulators|mitosis modulators|mesh-ancestor
110533786|NCT00411138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110533787|NCT02686086|Albuterol|albuterol|mesh-list
110533788|NCT02686086|Ipratropium|ipratropium|mesh-list
110533789|NCT02686086|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110533790|NCT02686086|Autonomic Agents|autonomic agents|mesh-ancestor
110533791|NCT02686086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110533792|NCT02686086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110533793|NCT02686086|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110533794|NCT02686086|Respiratory System Agents|respiratory system agents|mesh-ancestor
110533795|NCT02686086|Tocolytic Agents|tocolytic agents|mesh-ancestor
110533796|NCT02686086|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110469720|NCT02818491|Ropivacaine|ropivacaine|mesh-list
110469721|NCT02818491|BB 1101|bb 1101|mesh-list
110469722|NCT02818491|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110469723|NCT02818491|Antiemetics|antiemetics|mesh-ancestor
110469724|NCT02818491|Autonomic Agents|autonomic agents|mesh-ancestor
110469725|NCT02818491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110469726|NCT02818491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110469727|NCT02818491|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110469728|NCT02818491|Glucocorticoids|glucocorticoids|mesh-ancestor
110469729|NCT02818491|Hormones|hormones|mesh-ancestor
110469730|NCT02818491|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110469731|NCT02818491|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110469732|NCT02818491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110469733|NCT02818491|Protease Inhibitors|protease inhibitors|mesh-ancestor
110469734|NCT02818491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110469735|NCT02818491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110469736|NCT02818491|Anesthetics, Local|anesthetics, local|mesh-ancestor
110469737|NCT02818491|Anesthetics|anesthetics|mesh-ancestor
110469738|NCT02818491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110469739|NCT02818491|Sensory System Agents|sensory system agents|mesh-ancestor
110469740|NCT02816853|Moxifloxacin|moxifloxacin|mesh-list
110469741|NCT02816853|Domperidone|domperidone|mesh-list
110469742|NCT02816853|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110469743|NCT02816853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110469744|NCT02816853|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110469745|NCT02816853|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110469746|NCT02816853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110469747|NCT02816853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110533797|NCT02686086|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110533798|NCT02686086|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110533800|NCT02686086|Adrenergic Agents|adrenergic agents|mesh-ancestor
110533801|NCT02686086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110533802|NCT02686086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110533803|NCT02686086|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110533804|NCT02686086|Cholinergic Agents|cholinergic agents|mesh-ancestor
110533805|NCT03460158|Hyaluronic Acid|hyaluronic acid|mesh-list
110533806|NCT03460158|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110533807|NCT03460158|Immunologic Factors|immunologic factors|mesh-ancestor
110533808|NCT03460158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110533809|NCT03460158|Viscosupplements|viscosupplements|mesh-ancestor
110533810|NCT03460158|Protective Agents|protective agents|mesh-ancestor
110533811|NCT02697630|Pembrolizumab|pembrolizumab|mesh-list
110533812|NCT02697630|Entinostat|entinostat|mesh-list
110533813|NCT02697630|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110533814|NCT02697630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110533815|NCT02697630|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110533816|NCT02697630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110533817|NCT02697630|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110533818|NCT02697630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110533819|NCT02685852|Exenatide|exenatide|mesh-list
110533820|NCT02685852|Acarbose|acarbose|mesh-list
110533821|NCT02685852|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110533822|NCT02685852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110469748|NCT02816853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110598223|NCT00856804|Ribavirin|ribavirin|mesh-list
110469749|NCT02816853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110469750|NCT02816853|Antiemetics|antiemetics|mesh-ancestor
110469751|NCT02816853|Autonomic Agents|autonomic agents|mesh-ancestor
110469752|NCT02816853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110469753|NCT02816853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110469754|NCT02816853|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110469755|NCT02816853|Dopamine Agents|dopamine agents|mesh-ancestor
110469756|NCT02816853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110469757|NCT00772603|Oxcarbazepine|oxcarbazepine|mesh-list
110469758|NCT00772603|Anticonvulsants|anticonvulsants|mesh-ancestor
110469759|NCT00772603|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110469760|NCT00772603|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110469761|NCT00772603|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110469762|NCT00772603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110469763|NCT00772603|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110469764|NCT00772603|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110469766|NCT05658861|Chelating Agents|chelating agents|mesh-ancestor
110469767|NCT05658861|Sequestering Agents|sequestering agents|mesh-ancestor
110469768|NCT05658861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110469769|NCT00772447|Vancomycin|vancomycin|mesh-list
110469770|NCT00772447|Daptomycin|daptomycin|mesh-list
110469771|NCT00772447|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110533823|NCT02685852|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110533824|NCT02685852|Incretins|incretins|mesh-ancestor
110533825|NCT02685852|Hormones|hormones|mesh-ancestor
110533826|NCT02685852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110533827|NCT02685852|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
110533828|NCT02685852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110533829|NCT02685852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110533830|NCT02697162|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
110533831|NCT02697162|Octenidine|octenidine|mesh-list
110533832|NCT02697162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110533833|NCT02685930|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110533834|NCT02685930|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
110533835|NCT02685930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110469772|NCT00772447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110469773|NCT04238169|Bevacizumab|bevacizumab|mesh-list
110469774|NCT04238169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110469775|NCT04238169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110469776|NCT04238169|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110469777|NCT04238169|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110469778|NCT04238169|Growth Substances|growth substances|mesh-ancestor
110469779|NCT04238169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110469780|NCT04238169|Growth Inhibitors|growth inhibitors|mesh-ancestor
110469781|NCT00831844|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110469782|NCT00831844|Immunologic Factors|immunologic factors|mesh-ancestor
110469783|NCT00831844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110469784|NCT00764881|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
110469785|NCT00764881|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
110469786|NCT00764881|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110469787|NCT00764881|Contraceptive Agents|contraceptive agents|mesh-ancestor
110469788|NCT00764881|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110469789|NCT00764881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110598232|NCT00856804|Leprostatic Agents|leprostatic agents|mesh-ancestor
110469790|NCT00764881|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110469791|NCT00764881|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110469792|NCT00764881|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110469793|NCT00764881|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110469794|NCT00764881|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110469795|NCT00764881|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
110469796|NCT00764881|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
110469797|NCT00764881|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
110469798|NCT00702676|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110469799|NCT00702676|Antidepressive Agents|antidepressive agents|mesh-ancestor
110469800|NCT00702676|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110469801|NCT00702676|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110469802|NCT00702676|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110469803|NCT00702676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110469804|NCT00702676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110469806|NCT02817477|Morphine|morphine|mesh-list
110469807|NCT02817477|Analgesics|analgesics|mesh-ancestor
110469808|NCT02817477|Sensory System Agents|sensory system agents|mesh-ancestor
110469809|NCT02817477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110469810|NCT02817477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110469811|NCT02817477|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110469812|NCT02817477|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110469813|NCT02817477|Anesthetics, General|anesthetics, general|mesh-ancestor
110469814|NCT02817477|Anesthetics|anesthetics|mesh-ancestor
110469815|NCT02817477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110469816|NCT02817477|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110469817|NCT02817477|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110469818|NCT02817477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110533836|NCT02685930|Antitubercular Agents|antitubercular agents|mesh-ancestor
110533837|NCT00622674|Cetuximab|cetuximab|mesh-list
110533838|NCT00622674|Bortezomib|bortezomib|mesh-list
110181330|NCT00018200|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110533839|NCT00622674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110533840|NCT00622674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110533841|NCT02687724|Golimumab|golimumab|mesh-list
110533842|NCT02687724|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110533843|NCT02687724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110533844|NCT02687724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110533845|NCT02687724|Immunologic Factors|immunologic factors|mesh-ancestor
110533846|NCT02687724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110533847|NCT02685774|Metformin|metformin|mesh-list
110533848|NCT02685774|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110533849|NCT02685774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110533850|NCT00638976|Eptifibatide|eptifibatide|mesh-list
110533851|NCT00638976|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110533852|NCT00639756|Allopurinol|allopurinol|mesh-list
110533853|NCT00639756|Antimetabolites|antimetabolites|mesh-ancestor
110533854|NCT00639756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110533855|NCT00639756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110533856|NCT00639756|Gout Suppressants|gout suppressants|mesh-ancestor
110533857|NCT00639756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110533858|NCT00639756|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110533859|NCT00639756|Antioxidants|antioxidants|mesh-ancestor
110533860|NCT00639756|Protective Agents|protective agents|mesh-ancestor
110533861|NCT00639756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110469819|NCT02817477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110469820|NCT02817477|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110469821|NCT02817477|Narcotics|narcotics|mesh-ancestor
110469822|NCT02819115|Vaccines|vaccines|mesh-list
110469823|NCT02819115|Immunologic Factors|immunologic factors|mesh-ancestor
110469824|NCT02819115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110469825|NCT04099069|Anesthetics|anesthetics|mesh-list
110469826|NCT04099069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110469827|NCT04099069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110469828|NCT02816151|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110469829|NCT02816151|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110469830|NCT02816151|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110469831|NCT02816151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110469832|NCT02816151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110469833|NCT02816151|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110469834|NCT02816151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110469835|NCT02816151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110369275|NCT04611126|Nivolumab|nivolumab|mesh-list
110469836|NCT02816151|Cholinergic Agents|cholinergic agents|mesh-ancestor
110469837|NCT02816151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110469839|NCT04101019|Anesthetics, Local|anesthetics, local|mesh-ancestor
110469840|NCT04101019|Anesthetics|anesthetics|mesh-ancestor
110469841|NCT04101019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110533863|NCT00622752|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110533864|NCT00622752|Autonomic Agents|autonomic agents|mesh-ancestor
110533865|NCT00622752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110533866|NCT00622752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110533867|NCT00622752|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110533868|NCT00622752|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110533869|NCT00622752|Cholinergic Agents|cholinergic agents|mesh-ancestor
110533870|NCT00622752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110533871|NCT00622752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110533872|NCT03451578|alpha-MSH|alpha-msh|mesh-list
110533873|NCT03451578|Hormones|hormones|mesh-ancestor
110533874|NCT03451578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110533875|NCT03451578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110469842|NCT04101019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110469843|NCT04101019|Sensory System Agents|sensory system agents|mesh-ancestor
110469844|NCT04101019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110469845|NCT04101019|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110469846|NCT04101019|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110469847|NCT04101019|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110469848|NCT04101019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110469849|NCT04101019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110469850|NCT02817321|Morphine|morphine|mesh-list
110469851|NCT02817321|Ropivacaine|ropivacaine|mesh-list
110469852|NCT02817321|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110469853|NCT02817321|Narcotics|narcotics|mesh-ancestor
110469854|NCT02817321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110117035|NCT01874002|Sirolimus|sirolimus|mesh-list
110469855|NCT02817321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110469857|NCT02817321|Sensory System Agents|sensory system agents|mesh-ancestor
110469858|NCT02817321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110469859|NCT02817321|Anesthetics, Local|anesthetics, local|mesh-ancestor
110272581|NCT05090085|Z 350|z 350|mesh-list
110469860|NCT02817321|Anesthetics|anesthetics|mesh-ancestor
110469861|NCT00844480|Zoledronic Acid|zoledronic acid|mesh-list
110469862|NCT00844480|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110469863|NCT00844480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110469864|NCT00771901|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
110469865|NCT00771901|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
110469866|NCT00771901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110469867|NCT00771901|Antiviral Agents|antiviral agents|mesh-ancestor
110469868|NCT00771901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110469869|NCT00771901|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
110469870|NCT00771901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110469871|NCT00705562|Caseins|caseins|mesh-list
110469872|NCT00705562|Chelating Agents|chelating agents|mesh-ancestor
110469873|NCT00705562|Sequestering Agents|sequestering agents|mesh-ancestor
110469874|NCT00705562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110469875|NCT00843856|Mycophenolic Acid|mycophenolic acid|mesh-list
110469876|NCT00843856|Tacrolimus|tacrolimus|mesh-list
110469877|NCT00843856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110469878|NCT00843856|Immunologic Factors|immunologic factors|mesh-ancestor
110469879|NCT00843856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110469880|NCT00843856|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110469881|NCT00843856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110469882|NCT00843856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110469883|NCT00843856|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110469884|NCT00843856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110469885|NCT00843856|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110469886|NCT00843856|Antitubercular Agents|antitubercular agents|mesh-ancestor
110469887|NCT00843856|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110033299|NCT04238845|Vitamins|vitamins|mesh-ancestor
110533877|NCT02686008|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110533878|NCT02686008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110533879|NCT02686008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110533880|NCT02686008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110533881|NCT02685618|Iloprost|iloprost|mesh-list
110533882|NCT02685618|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110533883|NCT02685618|Vasodilator Agents|vasodilator agents|mesh-ancestor
110533884|NCT00602472|Linagliptin|linagliptin|mesh-list
110533885|NCT00602472|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110533886|NCT00602472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110533887|NCT00602472|Incretins|incretins|mesh-ancestor
110533888|NCT00602472|Hormones|hormones|mesh-ancestor
110533889|NCT00602472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110533890|NCT00602472|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110533891|NCT00602472|Protease Inhibitors|protease inhibitors|mesh-ancestor
110533892|NCT00602472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110533893|NCT00602472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110533894|NCT03384654|Cytarabine|cytarabine|mesh-list
110533895|NCT03384654|Prednisone|prednisone|mesh-list
110533896|NCT03384654|Cyclophosphamide|cyclophosphamide|mesh-list
110533897|NCT03384654|Doxorubicin|doxorubicin|mesh-list
110533898|NCT03384654|Methotrexate|methotrexate|mesh-list
110469888|NCT00843856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110469889|NCT04480125|Azacitidine|azacitidine|mesh-list
110469890|NCT04480125|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110469891|NCT04480125|Antimetabolites|antimetabolites|mesh-ancestor
110469892|NCT04480125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110469893|NCT04480125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110469894|NCT04480125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110469895|NCT00705640|Freund's Adjuvant|freund's adjuvant|mesh-list
110469896|NCT00705640|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110469897|NCT00705640|Immunologic Factors|immunologic factors|mesh-ancestor
110469898|NCT00705640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110469899|NCT00705796|Methyltestosterone|methyltestosterone|mesh-list
110469900|NCT00705796|Testosterone|testosterone|mesh-list
110469901|NCT00705796|Testosterone undecanoate|testosterone undecanoate|mesh-list
110469902|NCT00705796|Testosterone enanthate|testosterone enanthate|mesh-list
110469903|NCT00705796|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
110469904|NCT00705796|Androgens|androgens|mesh-ancestor
110469905|NCT00705796|Hormones|hormones|mesh-ancestor
110598281|NCT00712764|Adenosine|adenosine|mesh-list
110469906|NCT00705796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110469907|NCT00705796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110469908|NCT00705796|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110469909|NCT00705796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110469910|NCT00705796|Anabolic Agents|anabolic agents|mesh-ancestor
110469911|NCT00843778|Certolizumab Pegol|certolizumab pegol|mesh-list
110469912|NCT00843778|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110469913|NCT00843778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110469914|NCT00843778|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110469915|NCT00843778|Immunologic Factors|immunologic factors|mesh-ancestor
110469916|NCT00843778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110469917|NCT00843778|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110469918|NCT05631249|Sotorasib|sotorasib|mesh-list
110533900|NCT03384654|Asparaginase|asparaginase|mesh-list
110533901|NCT03384654|Mercaptopurine|mercaptopurine|mesh-list
110533902|NCT03384654|Daratumumab|daratumumab|mesh-list
110533903|NCT03384654|Pegaspargase|pegaspargase|mesh-list
110533904|NCT03384654|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110533905|NCT03384654|Immunologic Factors|immunologic factors|mesh-ancestor
110533906|NCT03384654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110533907|NCT03384654|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110533908|NCT03384654|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110469919|NCT05631249|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110469920|NCT05631249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110469921|NCT05631249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110469922|NCT05631249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110469923|NCT05629923|Cilgavimab and tixagevimab drug combination|cilgavimab and tixagevimab drug combination|mesh-list
110469924|NCT05629923|Antiviral Agents|antiviral agents|mesh-ancestor
110469925|NCT05629923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110469926|NCT00820222|Capecitabine|capecitabine|mesh-list
110469927|NCT00820222|Trastuzumab|trastuzumab|mesh-list
110469928|NCT00820222|Lapatinib|lapatinib|mesh-list
110117095|NCT01874561|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110469929|NCT00820222|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110469930|NCT00820222|Antimetabolites|antimetabolites|mesh-ancestor
110469931|NCT00820222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110469932|NCT00820222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110469933|NCT00820222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110469934|NCT00820222|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110469935|NCT00820222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110469937|NCT02815449|Trace Elements|trace elements|mesh-ancestor
110469938|NCT02815449|Micronutrients|micronutrients|mesh-ancestor
110469939|NCT02815449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110469940|NCT01039688|Antirheumatic Agents|antirheumatic agents|mesh-list
110469941|NCT01039688|Tofacitinib|tofacitinib|mesh-list
110469942|NCT01039688|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
110469943|NCT01039688|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110469944|NCT01039688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110469945|NCT01039688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110469946|NCT02237508|Budesonide|budesonide|mesh-list
110469947|NCT02237508|Formoterol Fumarate|formoterol fumarate|mesh-list
110469948|NCT02237508|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
110469950|NCT02237508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110469951|NCT02237508|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110469952|NCT02237508|Autonomic Agents|autonomic agents|mesh-ancestor
110469953|NCT02237508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110469954|NCT02237508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110469955|NCT02237508|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110469956|NCT02237508|Respiratory System Agents|respiratory system agents|mesh-ancestor
110469957|NCT02237508|Glucocorticoids|glucocorticoids|mesh-ancestor
110469958|NCT02237508|Hormones|hormones|mesh-ancestor
110469959|NCT02237508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110469960|NCT02237508|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110469961|NCT02237508|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110469962|NCT02237508|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110469963|NCT02237508|Adrenergic Agents|adrenergic agents|mesh-ancestor
110469964|NCT02237508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110469965|NCT02237508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110469966|NCT02237508|Antidotes|antidotes|mesh-ancestor
110469967|NCT02237508|Protective Agents|protective agents|mesh-ancestor
110469968|NCT02809755|Lidocaine|lidocaine|mesh-list
110469969|NCT02809755|Anesthetics, Local|anesthetics, local|mesh-ancestor
110469970|NCT02809755|Anesthetics|anesthetics|mesh-ancestor
110469971|NCT02809755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110469972|NCT02809755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110469973|NCT02809755|Sensory System Agents|sensory system agents|mesh-ancestor
110469974|NCT02809755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110533909|NCT03384654|Alkylating Agents|alkylating agents|mesh-ancestor
110533910|NCT03384654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110533911|NCT03384654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110533912|NCT03384654|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110533913|NCT03384654|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110533914|NCT03384654|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110533915|NCT03384654|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110533916|NCT03384654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110533917|NCT03384654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110533918|NCT03384654|Glucocorticoids|glucocorticoids|mesh-ancestor
110533919|NCT03384654|Hormones|hormones|mesh-ancestor
110533920|NCT03384654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110533921|NCT03384654|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110469975|NCT02809755|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110469976|NCT02809755|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110469977|NCT02809755|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110469978|NCT02809755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110469979|NCT02809755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110469980|NCT02812719|Salicylic Acid|salicylic acid|mesh-list
110469981|NCT02812719|Salicylates|salicylates|mesh-list
110469982|NCT02812719|Glycolic acid|glycolic acid|mesh-list
110469983|NCT02812719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110469984|NCT02812719|Antifungal Agents|antifungal agents|mesh-ancestor
110469985|NCT02812719|Keratolytic Agents|keratolytic agents|mesh-ancestor
110469986|NCT02812719|Dermatologic Agents|dermatologic agents|mesh-ancestor
110469987|NCT02812719|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110469988|NCT02812719|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110469989|NCT02812719|Analgesics|analgesics|mesh-ancestor
110469990|NCT02812719|Sensory System Agents|sensory system agents|mesh-ancestor
110469991|NCT02812719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110469992|NCT02812719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110469993|NCT02812719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110469994|NCT02812719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110469995|NCT02812719|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110469996|NCT02812719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110469997|NCT02812719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110469998|NCT02876978|Cyclophosphamide|cyclophosphamide|mesh-list
110469999|NCT02876978|Fludarabine|fludarabine|mesh-list
110470000|NCT02876978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110470001|NCT02876978|Immunologic Factors|immunologic factors|mesh-ancestor
110470002|NCT02876978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110470003|NCT02876978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110470004|NCT02876978|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110470005|NCT02876978|Alkylating Agents|alkylating agents|mesh-ancestor
110470006|NCT02876978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110470007|NCT02876978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110470008|NCT02876978|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110470010|NCT00909480|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110470011|NCT00909480|Insulin Glargine|insulin glargine|mesh-list
110470012|NCT00909480|Insulin Detemir|insulin detemir|mesh-list
110470013|NCT00909480|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110470014|NCT00909480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110470015|NCT05642715|Varenicline|varenicline|mesh-list
110470016|NCT05642715|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110470017|NCT05642715|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110470018|NCT05642715|Cholinergic Agents|cholinergic agents|mesh-ancestor
110470019|NCT05642715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110470020|NCT05642715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110470021|NCT05642715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110470022|NCT02874326|Octreotide|octreotide|mesh-list
110533922|NCT03384654|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110533923|NCT03384654|Abortifacient Agents|abortifacient agents|mesh-ancestor
110533924|NCT03384654|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110533925|NCT03384654|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110533926|NCT03384654|Antimetabolites|antimetabolites|mesh-ancestor
110533927|NCT03384654|Dermatologic Agents|dermatologic agents|mesh-ancestor
110533928|NCT03384654|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110533929|NCT03384654|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110533930|NCT03384654|Antiviral Agents|antiviral agents|mesh-ancestor
110533931|NCT03384654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110533932|NCT03384654|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110533933|NCT03384654|Tubulin Modulators|tubulin modulators|mesh-ancestor
110533934|NCT03384654|Antimitotic Agents|antimitotic agents|mesh-ancestor
110533935|NCT03384654|Mitosis Modulators|mitosis modulators|mesh-ancestor
110470023|NCT02874326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110470024|NCT02874326|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110470025|NCT02874326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110470026|NCT02812641|Bevacizumab|bevacizumab|mesh-list
110470027|NCT02812641|Cisplatin|cisplatin|mesh-list
110470028|NCT02812641|Fluorouracil|fluorouracil|mesh-list
110369306|NCT02014649|Laninamivir|laninamivir|mesh-list
110470029|NCT02812641|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110470030|NCT02812641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110470031|NCT02812641|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110470032|NCT02812641|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110470033|NCT02812641|Growth Substances|growth substances|mesh-ancestor
110470034|NCT02812641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110470035|NCT02812641|Growth Inhibitors|growth inhibitors|mesh-ancestor
110470036|NCT02812641|Antimetabolites|antimetabolites|mesh-ancestor
110470037|NCT02812641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110470038|NCT02812641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110470039|NCT02812641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110470040|NCT02812641|Immunologic Factors|immunologic factors|mesh-ancestor
110470041|NCT01058096|Cariprazine|cariprazine|mesh-list
110470042|NCT01058096|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110470043|NCT01058096|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110470044|NCT01058096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110470045|NCT01058096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110470046|NCT01058096|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110470047|NCT01057862|Naltrexone|naltrexone|mesh-list
110470048|NCT01057862|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110470049|NCT01057862|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110470050|NCT01057862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110470051|NCT01057862|Sensory System Agents|sensory system agents|mesh-ancestor
110470052|NCT01057862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110470053|NCT01038128|Memantine|memantine|mesh-list
110470054|NCT01038128|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110470055|NCT01038128|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110470056|NCT01038128|Dopamine Agents|dopamine agents|mesh-ancestor
110470057|NCT01038128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110470058|NCT01038128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110470059|NCT01038128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110470060|NCT01038128|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110470061|NCT01038128|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110470062|NCT04303520|Cyclophosphamide|cyclophosphamide|mesh-list
110470063|NCT04303520|Fludarabine|fludarabine|mesh-list
110470064|NCT04303520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110470065|NCT04303520|Immunologic Factors|immunologic factors|mesh-ancestor
110470066|NCT04303520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110470067|NCT04303520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110470068|NCT04303520|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110533937|NCT02685462|Caffeine|caffeine|mesh-list
110533938|NCT02685462|Atorvastatin|atorvastatin|mesh-list
110533939|NCT02685462|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110533940|NCT02685462|Simvastatin|simvastatin|mesh-list
110533941|NCT02685462|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110533942|NCT02685462|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110533943|NCT02685462|Antimetabolites|antimetabolites|mesh-ancestor
110533944|NCT02685462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110533945|NCT02685462|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110533946|NCT02685462|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110533947|NCT02685462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110533948|NCT02685462|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110533949|NCT02685462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110533950|NCT02685462|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110533951|NCT02685462|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110533952|NCT02685462|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110533953|NCT02685462|Purinergic Agents|purinergic agents|mesh-ancestor
110533954|NCT02685462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110533955|NCT02685462|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110533956|NCT02685462|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110196833|NCT00215176|Modafinil|modafinil|mesh-list
110470069|NCT04303520|Alkylating Agents|alkylating agents|mesh-ancestor
110470070|NCT04303520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110470071|NCT04303520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110470072|NCT04303520|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110470073|NCT02562378|Doxorubicin|doxorubicin|mesh-list
110470074|NCT02562378|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110470075|NCT02562378|Trastuzumab|trastuzumab|mesh-list
110470076|NCT02562378|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110470077|NCT02562378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110470078|NCT02562378|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110470079|NCT02562378|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110470080|NCT02562378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110470081|NCT02562378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110470082|NCT02562378|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110470083|NCT00842530|Vaccines|vaccines|mesh-list
110470084|NCT00842530|Immunologic Factors|immunologic factors|mesh-ancestor
110470085|NCT00842530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110470086|NCT05580510|Empagliflozin|empagliflozin|mesh-list
110470087|NCT05580510|Valsartan|valsartan|mesh-list
110598322|NCT00848770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110470088|NCT05580510|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
110470089|NCT05580510|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110470090|NCT05580510|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110470091|NCT05580510|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110470092|NCT05580510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110470093|NCT05580510|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110470094|NCT05580510|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110369322|NCT04610580|Nootropic Agents|nootropic agents|mesh-ancestor
110470095|NCT05580510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110470097|NCT02811627|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110470098|NCT02811627|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110533957|NCT02685462|Protective Agents|protective agents|mesh-ancestor
110533959|NCT02685306|Taxane|taxane|mesh-list
110533960|NCT02685306|Bavituximab|bavituximab|mesh-list
110533961|NCT02685306|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110533962|NCT02685306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110533963|NCT02685306|Tubulin Modulators|tubulin modulators|mesh-ancestor
110533964|NCT02685306|Antimitotic Agents|antimitotic agents|mesh-ancestor
110533965|NCT02685306|Mitosis Modulators|mitosis modulators|mesh-ancestor
110533966|NCT02685306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110533967|NCT02685306|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110533968|NCT02680938|Oxytocin|oxytocin|mesh-list
110533969|NCT02680938|Oxytocics|oxytocics|mesh-ancestor
110533970|NCT02680938|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110533971|NCT02680938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110533972|NCT05663892|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110533973|NCT05663892|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110533974|NCT05663892|Estradiol|estradiol|mesh-list
110533975|NCT05663892|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110533976|NCT05663892|Estrogens|estrogens|mesh-ancestor
110533977|NCT05663892|Hormones|hormones|mesh-ancestor
110533978|NCT05663892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110533979|NCT05663892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110533980|NCT05663892|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110533981|NCT05663892|Contraceptive Agents|contraceptive agents|mesh-ancestor
110533982|NCT05663892|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110533983|NCT05663892|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110533984|NCT02685228|Gemcitabine|gemcitabine|mesh-list
110533985|NCT02685228|Decitabine|decitabine|mesh-list
110533986|NCT02685228|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110533987|NCT02685228|Antimetabolites|antimetabolites|mesh-ancestor
110533988|NCT02685228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110533989|NCT02685228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110533990|NCT02685228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110533991|NCT00616460|Bivalirudin|bivalirudin|mesh-list
110533992|NCT00616460|Antithrombins|antithrombins|mesh-ancestor
110533993|NCT00616460|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110533994|NCT00616460|Protease Inhibitors|protease inhibitors|mesh-ancestor
110533995|NCT00616460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110470099|NCT02811627|Dopamine Agents|dopamine agents|mesh-ancestor
110533996|NCT00616460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110533997|NCT00616460|Anticoagulants|anticoagulants|mesh-ancestor
110533998|NCT00616538|Fluticasone|fluticasone|mesh-list
110533999|NCT00616538|Xhance|xhance|mesh-list
110534000|NCT00616538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110534001|NCT00616538|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110534002|NCT00616538|Autonomic Agents|autonomic agents|mesh-ancestor
110534003|NCT00616538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110534004|NCT00616538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110470100|NCT02811627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110470101|NCT02811627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110470102|NCT02811627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110470103|NCT02811627|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110470104|NCT02811627|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110470105|NCT00634413|Budesonide|budesonide|mesh-list
110470106|NCT00634413|Theophylline|theophylline|mesh-list
110470107|NCT00634413|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110470108|NCT00634413|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110470109|NCT00634413|Autonomic Agents|autonomic agents|mesh-ancestor
110470110|NCT00634413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110470111|NCT00634413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110470112|NCT00634413|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110470113|NCT00634413|Respiratory System Agents|respiratory system agents|mesh-ancestor
110470114|NCT00634413|Glucocorticoids|glucocorticoids|mesh-ancestor
110470115|NCT00634413|Hormones|hormones|mesh-ancestor
110470116|NCT00634413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110470117|NCT00634413|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110470118|NCT00634413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110470119|NCT00634413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110470120|NCT00634413|Vasodilator Agents|vasodilator agents|mesh-ancestor
110470121|NCT00634413|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110470122|NCT00634413|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110470123|NCT00634413|Purinergic Agents|purinergic agents|mesh-ancestor
110470124|NCT00634413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110470125|NCT02815059|Prednisone|prednisone|mesh-list
110470126|NCT02815059|Dasatinib|dasatinib|mesh-list
110470127|NCT02815059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110470128|NCT02815059|Glucocorticoids|glucocorticoids|mesh-ancestor
110470129|NCT02815059|Hormones|hormones|mesh-ancestor
110470130|NCT02815059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110470131|NCT02815059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110470132|NCT02815059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110470133|NCT02815059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110470134|NCT02815059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110470135|NCT02815059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110470136|NCT02815059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110470137|NCT00819910|Rosiglitazone|rosiglitazone|mesh-list
110470138|NCT00819910|Fenofibrate|fenofibrate|mesh-list
110470139|NCT00819910|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110470140|NCT00819910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110470141|NCT00819910|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110470142|NCT00819910|Antimetabolites|antimetabolites|mesh-ancestor
110470143|NCT00819910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110470144|NCT00819910|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110470145|NCT02808117|Micronutrients|micronutrients|mesh-list
110470146|NCT02808117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110470147|NCT04321395|Vigabatrin|vigabatrin|mesh-list
110470148|NCT04321395|Anticonvulsants|anticonvulsants|mesh-ancestor
110470149|NCT04321395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110470150|NCT04321395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110470151|NCT04321395|GABA Agents|gaba agents|mesh-ancestor
110470152|NCT04321395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110470153|NCT04321395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110470154|NCT02814669|Atezolizumab|atezolizumab|mesh-list
110470155|NCT02814669|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
110033300|NCT04238845|Micronutrients|micronutrients|mesh-ancestor
110534005|NCT00616538|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110534006|NCT00616538|Respiratory System Agents|respiratory system agents|mesh-ancestor
110534007|NCT00616538|Dermatologic Agents|dermatologic agents|mesh-ancestor
110534008|NCT00616538|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110534009|NCT02680548|Methylprednisolone|methylprednisolone|mesh-list
110534010|NCT02680548|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110534011|NCT02680548|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110470156|NCT02814669|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110470157|NCT02814669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110470158|NCT02814669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110470159|NCT02814669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110470161|NCT02808741|Antifungal Agents|antifungal agents|mesh-ancestor
110470162|NCT02808741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110470163|NCT02807727|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
110470164|NCT02807727|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
110470165|NCT02807727|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
110470166|NCT02807727|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110470168|NCT02807415|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
110470169|NCT02807415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110470170|NCT02807415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110470171|NCT02804841|Vitamin D|vitamin d|mesh-list
110470172|NCT02804841|Ergocalciferols|ergocalciferols|mesh-list
110470173|NCT02804841|Cholecalciferol|cholecalciferol|mesh-list
110470174|NCT02804841|Vitamins|vitamins|mesh-list
110470175|NCT02804841|Micronutrients|micronutrients|mesh-ancestor
110470176|NCT02804841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110470177|NCT02804841|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110470178|NCT02804841|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110470179|NCT00634491|Acetazolamide|acetazolamide|mesh-list
110470180|NCT00634491|Anticonvulsants|anticonvulsants|mesh-ancestor
110470181|NCT00634491|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110470182|NCT00634491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110470183|NCT00634491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110470184|NCT00634491|Diuretics|diuretics|mesh-ancestor
110470185|NCT00634491|Natriuretic Agents|natriuretic agents|mesh-ancestor
110470186|NCT00634491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110470187|NCT02807103|Cyclophosphamide|cyclophosphamide|mesh-list
110470188|NCT02807103|Rituximab|rituximab|mesh-list
110470189|NCT02807103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110470190|NCT02807103|Immunologic Factors|immunologic factors|mesh-ancestor
110470191|NCT02807103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110470192|NCT02807103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110470193|NCT02807103|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110470194|NCT02807103|Alkylating Agents|alkylating agents|mesh-ancestor
110470195|NCT02807103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110470196|NCT02807103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110470197|NCT02807103|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110470198|NCT02807103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110470199|NCT02806791|Lenograstim|lenograstim|mesh-list
110470200|NCT02806791|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110470201|NCT02806791|Immunologic Factors|immunologic factors|mesh-ancestor
110470202|NCT02806791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110470203|NCT00830128|Pregabalin|pregabalin|mesh-list
110470204|NCT00830128|Analgesics|analgesics|mesh-ancestor
110470205|NCT00830128|Sensory System Agents|sensory system agents|mesh-ancestor
110470206|NCT00830128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110470207|NCT00830128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110470208|NCT00830128|Anticonvulsants|anticonvulsants|mesh-ancestor
110470209|NCT00830128|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110470210|NCT00830128|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110470211|NCT00830128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110470212|NCT00830128|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110470213|NCT00830128|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110470214|NCT00830128|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110470215|NCT00830128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110470216|NCT00830128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110534012|NCT02680548|Prednisolone|prednisolone|mesh-list
110534013|NCT02680548|Prednisolone acetate|prednisolone acetate|mesh-list
110534014|NCT02680548|Bupivacaine|bupivacaine|mesh-list
110534015|NCT02680548|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110534016|NCT02680548|Prednisolone phosphate|prednisolone phosphate|mesh-list
110534017|NCT02680548|Anesthetics, Local|anesthetics, local|mesh-ancestor
110534018|NCT02680548|Anesthetics|anesthetics|mesh-ancestor
110312307|NCT00293735|Labetalol|labetalol|mesh-list
110534019|NCT02680548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110534020|NCT02680548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110470217|NCT05498103|Methazolamide|methazolamide|mesh-list
110470218|NCT05498103|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110470219|NCT05498103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110470220|NCT05498103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110470221|NCT05498103|Diuretics|diuretics|mesh-ancestor
110470222|NCT05498103|Natriuretic Agents|natriuretic agents|mesh-ancestor
110470223|NCT05498103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110470224|NCT00771667|Ustekinumab|ustekinumab|mesh-list
110470225|NCT00771667|Dermatologic Agents|dermatologic agents|mesh-ancestor
110470227|NCT03893175|Ibuprofen|ibuprofen|mesh-list
110470228|NCT03893175|Oxycodone|oxycodone|mesh-list
110470229|NCT03893175|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110470230|NCT03893175|Analgesics|analgesics|mesh-ancestor
110470231|NCT03893175|Sensory System Agents|sensory system agents|mesh-ancestor
110470232|NCT03893175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110470233|NCT03893175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110470235|NCT03893175|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110470236|NCT03893175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110470237|NCT03893175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110470238|NCT03893175|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110470239|NCT03893175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110470240|NCT03893175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110470241|NCT03893175|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110470242|NCT03893175|Narcotics|narcotics|mesh-ancestor
110470243|NCT03893175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110470244|NCT04236453|Tenofovir|tenofovir|mesh-list
110470245|NCT04236453|Emtricitabine|emtricitabine|mesh-list
110470246|NCT04236453|Darunavir|darunavir|mesh-list
110470247|NCT04236453|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110470248|NCT04236453|Cobicistat|cobicistat|mesh-list
110470249|NCT04236453|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
110470250|NCT04236453|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
110470251|NCT04236453|Antiviral Agents|antiviral agents|mesh-ancestor
110470252|NCT04236453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110470253|NCT04236453|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110470254|NCT04236453|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110470255|NCT04236453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110470256|NCT04236453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110470257|NCT04236453|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110470258|NCT04236453|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110470259|NCT04236453|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110470260|NCT04236453|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110470261|NCT04236453|Protease Inhibitors|protease inhibitors|mesh-ancestor
110470262|NCT04236453|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110470263|NCT04236453|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110470264|NCT05333250|Modafinil|modafinil|mesh-list
110470265|NCT05333250|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110470266|NCT05333250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110470267|NCT05333250|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
110470268|NCT05333250|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110470269|NCT05333250|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110470270|NCT05333250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110470271|NCT05461339|Ranibizumab|ranibizumab|mesh-list
110470272|NCT05461339|Antibodies|antibodies|mesh-list
110470273|NCT05461339|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110470274|NCT05461339|Immunologic Factors|immunologic factors|mesh-ancestor
110534021|NCT02680548|Sensory System Agents|sensory system agents|mesh-ancestor
110534022|NCT02680548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110534023|NCT02680548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110534024|NCT02680548|Antiemetics|antiemetics|mesh-ancestor
110534025|NCT02680548|Autonomic Agents|autonomic agents|mesh-ancestor
110534026|NCT02680548|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110534027|NCT02680548|Glucocorticoids|glucocorticoids|mesh-ancestor
110534028|NCT02680548|Hormones|hormones|mesh-ancestor
110534029|NCT02680548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110534030|NCT02680548|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110534031|NCT02680548|Protective Agents|protective agents|mesh-ancestor
110534032|NCT02680548|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110534033|NCT02680548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110470275|NCT05461339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110470276|NCT05461339|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110470277|NCT05461339|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110470278|NCT05461339|Growth Substances|growth substances|mesh-ancestor
110470279|NCT05461339|Growth Inhibitors|growth inhibitors|mesh-ancestor
110470280|NCT05461339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110470281|NCT03409848|Nivolumab|nivolumab|mesh-list
110470282|NCT03409848|Ipilimumab|ipilimumab|mesh-list
110470283|NCT03409848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110470284|NCT03409848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110470285|NCT03409848|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110470286|NCT03409848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110470287|NCT00763555|Calcitriol|calcitriol|mesh-list
110470288|NCT00763555|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110470289|NCT00763555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110470290|NCT00763555|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
110470291|NCT00763555|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110470292|NCT00763555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110470293|NCT00763555|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110470294|NCT00763555|Vitamins|vitamins|mesh-ancestor
110470295|NCT00763555|Micronutrients|micronutrients|mesh-ancestor
110470296|NCT00763555|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110470297|NCT02804373|Oxytocin|oxytocin|mesh-list
110470298|NCT02804373|Oxytocics|oxytocics|mesh-ancestor
110470299|NCT02804373|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110470300|NCT02804373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110470302|NCT00763321|Hydrocodone|hydrocodone|mesh-list
110470303|NCT00763321|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110470304|NCT00763321|Analgesics|analgesics|mesh-ancestor
110470305|NCT00763321|Sensory System Agents|sensory system agents|mesh-ancestor
110470306|NCT00763321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110470307|NCT00763321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110470308|NCT00763321|Antipyretics|antipyretics|mesh-ancestor
110470309|NCT00763321|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110470310|NCT00763321|Narcotics|narcotics|mesh-ancestor
110470311|NCT00763321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110470312|NCT00763321|Antitussive Agents|antitussive agents|mesh-ancestor
110470313|NCT00763321|Respiratory System Agents|respiratory system agents|mesh-ancestor
110470314|NCT02799927|Calcium|calcium|mesh-list
110470315|NCT02799927|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110470316|NCT02799927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110470317|NCT00770653|Metformin|metformin|mesh-list
110470318|NCT00770653|Pioglitazone|pioglitazone|mesh-list
110470319|NCT00770653|Glimepiride|glimepiride|mesh-list
110470320|NCT00770653|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110470321|NCT00770653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110470322|NCT00770653|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110470323|NCT00770653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110470324|NCT00770653|Immunologic Factors|immunologic factors|mesh-ancestor
110470325|NCT02799615|Infliximab|infliximab|mesh-list
110534035|NCT05663736|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110534036|NCT05663736|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110534037|NCT05663736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110534038|NCT05663736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110534039|NCT05663736|Immunologic Factors|immunologic factors|mesh-ancestor
110534040|NCT02685150|Omeprazole|omeprazole|mesh-list
110534041|NCT02685150|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
110534042|NCT02685150|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110534043|NCT02685150|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110534044|NCT02685150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110534045|NCT02685150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110534046|NCT02682186|Ropivacaine|ropivacaine|mesh-list
110534047|NCT02682186|Anesthetics, Local|anesthetics, local|mesh-ancestor
110534048|NCT02682186|Anesthetics|anesthetics|mesh-ancestor
110534049|NCT02682186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110534050|NCT02682186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110534051|NCT02682186|Sensory System Agents|sensory system agents|mesh-ancestor
110534052|NCT02682186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110534053|NCT00619268|Interferons|interferons|mesh-list
110534054|NCT00619268|Interferon-alpha|interferon-alpha|mesh-list
110534055|NCT00619268|Interferon alpha-2|interferon alpha-2|mesh-list
110534056|NCT00619268|Sirolimus|sirolimus|mesh-list
110534057|NCT00619268|Bevacizumab|bevacizumab|mesh-list
110534058|NCT00619268|Sunitinib|sunitinib|mesh-list
110534059|NCT00619268|Temsirolimus|temsirolimus|mesh-list
110534060|NCT00619268|MTOR Inhibitors|mtor inhibitors|mesh-list
110534061|NCT00619268|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110470326|NCT02799615|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110470327|NCT02799615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110470328|NCT02799615|Dermatologic Agents|dermatologic agents|mesh-ancestor
110470329|NCT02799615|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110470330|NCT02799615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110470331|NCT00819052|Nevirapine|nevirapine|mesh-list
110470332|NCT00819052|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110470333|NCT00819052|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110470334|NCT00819052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110470335|NCT00819052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110470336|NCT00819052|Antiviral Agents|antiviral agents|mesh-ancestor
110470337|NCT00819052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110470338|NCT00819052|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110470339|NCT00819052|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110470340|NCT00819052|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110470341|NCT00819052|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110470342|NCT00763009|Dipyridamole|dipyridamole|mesh-list
110470343|NCT00763009|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110470344|NCT00763009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110470345|NCT00763009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110470346|NCT00763009|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110470347|NCT00763009|Vasodilator Agents|vasodilator agents|mesh-ancestor
110534062|NCT00619268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110534063|NCT00619268|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110534064|NCT00619268|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110534065|NCT00619268|Growth Substances|growth substances|mesh-ancestor
110534066|NCT00619268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110534067|NCT00619268|Growth Inhibitors|growth inhibitors|mesh-ancestor
110534068|NCT00619268|Antiviral Agents|antiviral agents|mesh-ancestor
110534069|NCT00619268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110534070|NCT00619268|Immunologic Factors|immunologic factors|mesh-ancestor
110534071|NCT00619268|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110534072|NCT00619268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110534073|NCT00619268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110534074|NCT00619268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110534075|NCT00619268|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110470348|NCT02799459|Anesthetics|anesthetics|mesh-list
110470349|NCT02799459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110470350|NCT02799459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110470351|NCT05477589|Cyclophosphamide|cyclophosphamide|mesh-list
110470352|NCT05477589|Melphalan|melphalan|mesh-list
110470353|NCT05477589|Busulfan|busulfan|mesh-list
110470354|NCT05477589|Fludarabine|fludarabine|mesh-list
110470355|NCT05477589|Clofarabine|clofarabine|mesh-list
110470356|NCT05477589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110470357|NCT05477589|Immunologic Factors|immunologic factors|mesh-ancestor
110470358|NCT05477589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110470359|NCT05477589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110470360|NCT05477589|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110470361|NCT05477589|Alkylating Agents|alkylating agents|mesh-ancestor
110470362|NCT05477589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110470363|NCT05477589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110470364|NCT05477589|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110470365|NCT05477589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110470366|NCT05477589|Antimetabolites|antimetabolites|mesh-ancestor
110470368|NCT00841672|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110470369|NCT00841672|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110470370|NCT00841672|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110470371|NCT00841672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110470372|NCT00841672|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110117542|NCT01878227|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110470373|NCT00841672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110470374|NCT00841672|Vasodilator Agents|vasodilator agents|mesh-ancestor
110470375|NCT05549115|Amoxicillin|amoxicillin|mesh-list
110470376|NCT05549115|Clarithromycin|clarithromycin|mesh-list
110470377|NCT05549115|Levofloxacin|levofloxacin|mesh-list
110470378|NCT05549115|Ofloxacin|ofloxacin|mesh-list
110470379|NCT05549115|Furazolidone|furazolidone|mesh-list
110470380|NCT05549115|Bismuth|bismuth|mesh-list
110470381|NCT05549115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110470382|NCT05549115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110470383|NCT05549115|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110470384|NCT05549115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110470385|NCT05549115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110470386|NCT05549115|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110470387|NCT05549115|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110470388|NCT05549115|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110598431|NCT00852436|Pregabalin|pregabalin|mesh-list
110470389|NCT05549115|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110470390|NCT05549115|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110470391|NCT05549115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110470392|NCT05549115|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110470393|NCT05549115|Antacids|antacids|mesh-ancestor
110534076|NCT00619268|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110534077|NCT00619268|Antifungal Agents|antifungal agents|mesh-ancestor
110534078|NCT00619346|Pafuramidine|pafuramidine|mesh-list
110534079|NCT00619346|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
110534080|NCT00619346|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110534081|NCT00619346|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110534082|NCT00619346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110534084|NCT04182828|Anesthetics, Local|anesthetics, local|mesh-ancestor
110534085|NCT04182828|Anesthetics|anesthetics|mesh-ancestor
110534086|NCT04182828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110534087|NCT04182828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110534088|NCT04182828|Sensory System Agents|sensory system agents|mesh-ancestor
110534089|NCT04182828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110534090|NCT04182828|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110534655|NCT04178850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110470394|NCT05549115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110470395|NCT05549115|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110470396|NCT05549115|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
110470397|NCT05549115|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110470398|NCT05549115|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110470399|NCT05549115|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
110470400|NCT04236219|Rasburicase|rasburicase|mesh-list
110470401|NCT04236219|Gout Suppressants|gout suppressants|mesh-ancestor
110470402|NCT04236219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110470403|NCT00908232|Dexamethasone|dexamethasone|mesh-list
110470404|NCT00908232|Cyclophosphamide|cyclophosphamide|mesh-list
110470405|NCT00908232|Lenalidomide|lenalidomide|mesh-list
110470406|NCT00908232|Bortezomib|bortezomib|mesh-list
110470407|NCT00908232|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110470408|NCT00908232|Immunologic Factors|immunologic factors|mesh-ancestor
110470409|NCT00908232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110470410|NCT00908232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110470411|NCT00908232|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110470412|NCT00908232|Alkylating Agents|alkylating agents|mesh-ancestor
110470413|NCT00908232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110470414|NCT00908232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110470415|NCT00908232|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110470416|NCT00908232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110470417|NCT00908232|Antiemetics|antiemetics|mesh-ancestor
110470418|NCT00908232|Autonomic Agents|autonomic agents|mesh-ancestor
110470419|NCT00908232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110470420|NCT00908232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110470421|NCT00908232|Glucocorticoids|glucocorticoids|mesh-ancestor
110470422|NCT00908232|Hormones|hormones|mesh-ancestor
110470423|NCT00908232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110470424|NCT00908232|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110470425|NCT00908232|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110470426|NCT00908232|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110470427|NCT00908232|Growth Substances|growth substances|mesh-ancestor
110470428|NCT00908232|Growth Inhibitors|growth inhibitors|mesh-ancestor
110470429|NCT00770341|Vancomycin|vancomycin|mesh-list
110470430|NCT00770341|Daptomycin|daptomycin|mesh-list
110470431|NCT00770341|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110470432|NCT00770341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110470433|NCT05472753|Selenium|selenium|mesh-list
110470434|NCT05472753|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
110470435|NCT05472753|Curcumin|curcumin|mesh-list
110470436|NCT05472753|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110470437|NCT05472753|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110470438|NCT05472753|Analgesics|analgesics|mesh-ancestor
110470439|NCT05472753|Sensory System Agents|sensory system agents|mesh-ancestor
110470440|NCT05472753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110534091|NCT04182828|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110534093|NCT04182828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110534094|NCT04182828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110534095|NCT00619424|Pemetrexed|pemetrexed|mesh-list
110534096|NCT00619424|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110534097|NCT00619424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110534098|NCT00619424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110534099|NCT00619424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110534100|NCT00619424|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110534101|NCT00619424|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110534102|NCT00619424|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110534103|NCT00641004|Esomeprazole|esomeprazole|mesh-list
110534104|NCT00641004|Rebamipide|rebamipide|mesh-list
110534105|NCT00641004|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110197349|NCT00219271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110197350|NCT00219310|Famciclovir|famciclovir|mesh-list
110197351|NCT00219310|Antiviral Agents|antiviral agents|mesh-ancestor
110197352|NCT00219310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110197353|NCT00219310|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110197354|NCT00219310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110470441|NCT05472753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110470442|NCT05472753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110470443|NCT05472753|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110470444|NCT05472753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110470445|NCT05472753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110470446|NCT05472753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110117617|NCT01878695|Acetylcysteine|acetylcysteine|mesh-list
110470447|NCT05472753|Antioxidants|antioxidants|mesh-ancestor
110470448|NCT05472753|Protective Agents|protective agents|mesh-ancestor
110470449|NCT05472753|Trace Elements|trace elements|mesh-ancestor
110470450|NCT05472753|Micronutrients|micronutrients|mesh-ancestor
110470451|NCT05472753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110470452|NCT05472753|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110470453|NCT03396276|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
110470454|NCT03396276|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110470455|NCT03396276|Narcotics|narcotics|mesh-ancestor
110470456|NCT03396276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110470457|NCT03396276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110470458|NCT03396276|Analgesics|analgesics|mesh-ancestor
110470459|NCT03396276|Sensory System Agents|sensory system agents|mesh-ancestor
110470460|NCT03396276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110470461|NCT03396276|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110470462|NCT02799147|Fludarabine|fludarabine|mesh-list
110470463|NCT02799147|Fludarabine phosphate|fludarabine phosphate|mesh-list
110470464|NCT02799147|Busulfan|busulfan|mesh-list
110470465|NCT02799147|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110470466|NCT02799147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110470467|NCT02799147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110470468|NCT02799147|Antimetabolites|antimetabolites|mesh-ancestor
110470469|NCT02799147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110470470|NCT02799147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110470471|NCT02799147|Immunologic Factors|immunologic factors|mesh-ancestor
110534106|NCT00641004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110534107|NCT00641004|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110534108|NCT00641004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110534109|NCT00641004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110534110|NCT00641004|Antioxidants|antioxidants|mesh-ancestor
110534111|NCT00641004|Protective Agents|protective agents|mesh-ancestor
110197404|NCT00219739|Imatinib Mesylate|imatinib mesylate|mesh-list
110470472|NCT02799147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110470473|NCT02799147|Alkylating Agents|alkylating agents|mesh-ancestor
110470474|NCT02799147|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110470475|NCT02799147|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110470476|NCT02798913|Clopidogrel|clopidogrel|mesh-list
110470477|NCT02798913|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110470478|NCT02798913|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110470479|NCT02798913|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110470480|NCT02798913|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110470481|NCT02798913|Purinergic Agents|purinergic agents|mesh-ancestor
110470482|NCT02798913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110470483|NCT02798913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110470484|NCT02798913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110470485|NCT00762463|Celecoxib|celecoxib|mesh-list
110470486|NCT00762463|Diclofenac|diclofenac|mesh-list
110470487|NCT00762463|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110470488|NCT00762463|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110470489|NCT00762463|Analgesics|analgesics|mesh-ancestor
110470490|NCT00762463|Sensory System Agents|sensory system agents|mesh-ancestor
110470491|NCT00762463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110470492|NCT00762463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110470493|NCT00762463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110470494|NCT00762463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110470495|NCT00762463|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110470496|NCT00762463|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110470497|NCT00762463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110470498|NCT00762463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110470499|NCT05511909|Lofexidine|lofexidine|mesh-list
110470500|NCT05511909|Buspirone|buspirone|mesh-list
110470501|NCT05511909|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110470502|NCT05511909|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110470503|NCT05511909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110470504|NCT05511909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110470505|NCT05511909|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110470506|NCT05511909|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110470507|NCT05511909|Serotonin Agents|serotonin agents|mesh-ancestor
110470508|NCT05511909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110470509|NCT05511909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110470510|NCT05511909|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110470511|NCT05511909|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110470512|NCT05511909|Sensory System Agents|sensory system agents|mesh-ancestor
110470513|NCT05511909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110470514|NCT05511909|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110470515|NCT05511909|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110470516|NCT05511909|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110470517|NCT05511909|Adrenergic Agents|adrenergic agents|mesh-ancestor
110470518|NCT00906282|Carboplatin|carboplatin|mesh-list
110470519|NCT00906282|Pemetrexed|pemetrexed|mesh-list
110470520|NCT00906282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110470521|NCT00906282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110470522|NCT00906282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110470523|NCT00906282|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110470524|NCT00906282|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110470525|NCT02798757|Dapagliflozin|dapagliflozin|mesh-list
110470526|NCT02798757|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110470527|NCT02798757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110470528|NCT02798757|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110470529|NCT02798757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110470530|NCT02798367|Melatonin|melatonin|mesh-list
110470531|NCT02798367|Antioxidants|antioxidants|mesh-ancestor
110534112|NCT00641004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110534113|NCT02680080|Moxifloxacin|moxifloxacin|mesh-list
110534114|NCT02680080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110534115|NCT02680080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110534116|NCT02680080|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110534117|NCT02680080|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110534118|NCT02680080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110534119|NCT02680080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110534120|NCT02680080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110534121|NCT01009788|Temozolomide|temozolomide|mesh-list
110534122|NCT01009788|Veliparib|veliparib|mesh-list
110534123|NCT01009788|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110534124|NCT01009788|Alkylating Agents|alkylating agents|mesh-ancestor
110470532|NCT02798367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110470533|NCT02798367|Protective Agents|protective agents|mesh-ancestor
110470534|NCT02798367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110470535|NCT02798367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110470536|NCT00762229|Ezetimibe|ezetimibe|mesh-list
110470537|NCT00762229|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110470538|NCT00762229|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110470539|NCT00762229|Antimetabolites|antimetabolites|mesh-ancestor
110470540|NCT00762229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110470541|NCT00762229|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110470542|NCT00907374|Benazepril|benazepril|mesh-list
110470543|NCT00907374|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110470544|NCT00907374|Protease Inhibitors|protease inhibitors|mesh-ancestor
110470545|NCT00907374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110470546|NCT00907374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110470547|NCT00907374|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110470548|NCT02805231|Vitamin D|vitamin d|mesh-list
110470549|NCT02805231|Vitamins|vitamins|mesh-ancestor
110470550|NCT02805231|Micronutrients|micronutrients|mesh-ancestor
110470551|NCT02805231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110470552|NCT02805231|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110470553|NCT03230604|Z 350|z 350|mesh-list
110470554|NCT03230604|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
110470555|NCT03230604|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110470556|NCT03230604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110470557|NCT03230604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110470558|NCT03230604|Hormone Antagonists|hormone antagonists|mesh-ancestor
110470559|NCT03230604|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110470560|NCT03230604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110470561|NCT02798055|Bosentan|bosentan|mesh-list
110470562|NCT02798055|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110470563|NCT02798055|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
110470564|NCT02798055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110470565|NCT05331768|Terlipressin|terlipressin|mesh-list
110470566|NCT05331768|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110470567|NCT05331768|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110470568|NCT04235439|Insulin Lispro|insulin lispro|mesh-list
110470569|NCT04235439|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110470570|NCT04235439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110470571|NCT02640222|Vitamin K|vitamin k|mesh-list
110470572|NCT02640222|Rivaroxaban|rivaroxaban|mesh-list
110470573|NCT02640222|Apixaban|apixaban|mesh-list
110470574|NCT02640222|Dabigatran|dabigatran|mesh-list
110470575|NCT02640222|Vitamins|vitamins|mesh-ancestor
110470576|NCT02640222|Micronutrients|micronutrients|mesh-ancestor
110470577|NCT02640222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110470578|NCT02640222|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110470579|NCT02640222|Antithrombins|antithrombins|mesh-ancestor
110470580|NCT02640222|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110470581|NCT02640222|Protease Inhibitors|protease inhibitors|mesh-ancestor
110534125|NCT01009788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110534127|NCT01009788|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110534128|NCT01009788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110534129|NCT04183608|Adalimumab|adalimumab|mesh-list
110534130|NCT04183608|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110534131|NCT04183608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110534132|NCT04183608|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110470582|NCT02640222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110470583|NCT02640222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110470584|NCT02640222|Anticoagulants|anticoagulants|mesh-ancestor
110470585|NCT02640222|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110470586|NCT02640222|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110470587|NCT02640222|Hemostatics|hemostatics|mesh-ancestor
110470588|NCT02640222|Coagulants|coagulants|mesh-ancestor
110470589|NCT00818662|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110470590|NCT00818662|Immunoglobulins|immunoglobulins|mesh-list
110470591|NCT00818662|Antibodies|antibodies|mesh-list
110470592|NCT00818662|gamma-Globulins|gamma-globulins|mesh-list
110470593|NCT00818662|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110470594|NCT00818662|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110470595|NCT00818662|Immunoglobulin G|immunoglobulin g|mesh-list
110470596|NCT00818662|Immunologic Factors|immunologic factors|mesh-ancestor
110470597|NCT00818662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110470598|NCT03983031|Rituximab|rituximab|mesh-list
110117766|NCT01879917|Hormones|hormones|mesh-ancestor
110470599|NCT03983031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110470600|NCT03983031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110470601|NCT03983031|Immunologic Factors|immunologic factors|mesh-ancestor
110470602|NCT03983031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110470603|NCT03983031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110470604|NCT00703066|Vaccines|vaccines|mesh-list
110470605|NCT00703066|Immunologic Factors|immunologic factors|mesh-ancestor
110470606|NCT00703066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110470607|NCT00762073|Budesonide|budesonide|mesh-list
110470608|NCT00762073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110470609|NCT00762073|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110470610|NCT00762073|Autonomic Agents|autonomic agents|mesh-ancestor
110470611|NCT00762073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110470612|NCT00762073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110470613|NCT00762073|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110470614|NCT00762073|Respiratory System Agents|respiratory system agents|mesh-ancestor
110470615|NCT00762073|Glucocorticoids|glucocorticoids|mesh-ancestor
110470616|NCT00762073|Hormones|hormones|mesh-ancestor
110470617|NCT00762073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110470618|NCT03847857|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
110470619|NCT03847857|Hemostatics|hemostatics|mesh-ancestor
110470620|NCT03847857|Coagulants|coagulants|mesh-ancestor
110470621|NCT02630628|Mycophenolic Acid|mycophenolic acid|mesh-list
110470622|NCT02630628|Tacrolimus|tacrolimus|mesh-list
110470623|NCT02630628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110470624|NCT02630628|Immunologic Factors|immunologic factors|mesh-ancestor
110470625|NCT02630628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110470626|NCT02630628|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110470627|NCT02630628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110470628|NCT02630628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110470629|NCT02630628|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110470630|NCT02630628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110470631|NCT02630628|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110470632|NCT02630628|Antitubercular Agents|antitubercular agents|mesh-ancestor
110470633|NCT02630628|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110470634|NCT02630628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110470635|NCT00913588|Fluoxetine|fluoxetine|mesh-list
110470636|NCT00913588|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110470637|NCT00913588|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110470638|NCT00913588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110470639|NCT00913588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110534133|NCT00641082|Adefovir|adefovir|mesh-list
110534134|NCT00641082|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
110534135|NCT00641082|Clevudine|clevudine|mesh-list
110534136|NCT00641082|Antiviral Agents|antiviral agents|mesh-ancestor
110534137|NCT00641082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110534138|NCT00641082|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110534139|NCT00641082|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110534140|NCT00641082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110534141|NCT00641082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110470640|NCT00913588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110470641|NCT00913588|Serotonin Agents|serotonin agents|mesh-ancestor
110470642|NCT00913588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110470643|NCT00913588|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110470644|NCT00913588|Antidepressive Agents|antidepressive agents|mesh-ancestor
110470645|NCT00913588|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110470646|NCT00913588|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110470647|NCT00913588|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110470648|NCT00913588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110470649|NCT02797587|Nicotine|nicotine|mesh-list
110470650|NCT02797587|Varenicline|varenicline|mesh-list
110470651|NCT02797587|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110470652|NCT02797587|Autonomic Agents|autonomic agents|mesh-ancestor
110470653|NCT02797587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110470654|NCT02797587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110470655|NCT02797587|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110470656|NCT02797587|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110470657|NCT02797587|Cholinergic Agents|cholinergic agents|mesh-ancestor
110470658|NCT02797587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110470659|NCT02797587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110470660|NCT00761605|Paliperidone Palmitate|paliperidone palmitate|mesh-list
110470661|NCT00761605|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110470662|NCT00761605|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110470663|NCT00761605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110470664|NCT00761605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110164871|NCT00019318|Romidepsin|romidepsin|mesh-list
110470665|NCT00761605|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110470666|NCT00761605|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110470667|NCT00761605|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110470668|NCT00761605|Serotonin Agents|serotonin agents|mesh-ancestor
110470669|NCT00761605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110470670|NCT00761605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110470671|NCT00761605|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110470672|NCT00761605|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110470673|NCT00761605|Dopamine Agents|dopamine agents|mesh-ancestor
110470674|NCT00761527|Desloratadine|desloratadine|mesh-list
110470675|NCT00761527|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110470676|NCT00761527|Cholinergic Agents|cholinergic agents|mesh-ancestor
110470677|NCT00761527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110470678|NCT00761527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110470679|NCT00761527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110470680|NCT00761527|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110470681|NCT00761527|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110470682|NCT00761527|Histamine Antagonists|histamine antagonists|mesh-ancestor
110470683|NCT00761527|Histamine Agents|histamine agents|mesh-ancestor
110470684|NCT00770029|Botulinum Toxins|botulinum toxins|mesh-list
110470685|NCT00770029|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110470686|NCT00770029|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110470687|NCT00770029|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
110470688|NCT00770029|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110470689|NCT00770029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110470690|NCT00770029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110470691|NCT00770029|Cholinergic Agents|cholinergic agents|mesh-ancestor
110470692|NCT00770029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110470693|NCT00770029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110470694|NCT00770029|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110534142|NCT00641160|Vinorelbine|vinorelbine|mesh-list
110534143|NCT00641160|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110534144|NCT00641160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110181631|NCT00020358|Immunologic Factors|immunologic factors|mesh-ancestor
110534145|NCT00641160|Tubulin Modulators|tubulin modulators|mesh-ancestor
110534146|NCT00641160|Antimitotic Agents|antimitotic agents|mesh-ancestor
110534147|NCT00641160|Mitosis Modulators|mitosis modulators|mesh-ancestor
110534148|NCT00641160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110534150|NCT02679924|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110534151|NCT02679924|Immunologic Factors|immunologic factors|mesh-ancestor
110534152|NCT02679924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110534153|NCT02679924|Viscosupplements|viscosupplements|mesh-ancestor
110534154|NCT02679924|Protective Agents|protective agents|mesh-ancestor
110534155|NCT00618176|Lamivudine|lamivudine|mesh-list
110470695|NCT00770029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110470696|NCT04235985|Chlorhexidine|chlorhexidine|mesh-list
110470697|NCT04235985|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110470698|NCT04235985|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110470699|NCT04235985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110470700|NCT04235985|Disinfectants|disinfectants|mesh-ancestor
110470701|NCT04235985|Dermatologic Agents|dermatologic agents|mesh-ancestor
110470702|NCT00769561|Salicylic Acid|salicylic acid|mesh-list
110470703|NCT00769561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110470704|NCT00769561|Antifungal Agents|antifungal agents|mesh-ancestor
110470705|NCT00769561|Keratolytic Agents|keratolytic agents|mesh-ancestor
110470706|NCT00769561|Dermatologic Agents|dermatologic agents|mesh-ancestor
110470707|NCT02797041|Bortezomib|bortezomib|mesh-list
110470708|NCT02797041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110470709|NCT02794779|Oxytocin|oxytocin|mesh-list
110470710|NCT02794779|Oxytocics|oxytocics|mesh-ancestor
110470711|NCT02794779|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110470712|NCT02794779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110470713|NCT00761215|Tedizolid phosphate|tedizolid phosphate|mesh-list
110470714|NCT00761215|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110470715|NCT00761215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110470716|NCT05805098|Cytarabine|cytarabine|mesh-list
110470717|NCT05805098|Venetoclax|venetoclax|mesh-list
110470718|NCT05805098|Homoharringtonine|homoharringtonine|mesh-list
110470719|NCT05805098|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110470720|NCT05805098|Antimetabolites|antimetabolites|mesh-ancestor
110470721|NCT05805098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110470722|NCT05805098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110470723|NCT05805098|Antiviral Agents|antiviral agents|mesh-ancestor
110470724|NCT05805098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110470725|NCT05805098|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110470726|NCT05805098|Immunologic Factors|immunologic factors|mesh-ancestor
110470727|NCT05805098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110470728|NCT05805098|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110470729|NCT05805098|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110470730|NCT05805098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110470731|NCT05804903|Fexofenadine|fexofenadine|mesh-list
110470732|NCT05804903|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110470733|NCT05804903|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110470734|NCT05804903|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110470735|NCT05804903|Histamine Antagonists|histamine antagonists|mesh-ancestor
110470736|NCT05804903|Histamine Agents|histamine agents|mesh-ancestor
110470737|NCT05804903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110470738|NCT05804903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110470739|NCT05804903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110470740|NCT05804734|Vitamin K|vitamin k|mesh-list
110470741|NCT05804734|Anticoagulants|anticoagulants|mesh-list
110470742|NCT05804734|Vitamins|vitamins|mesh-ancestor
110470743|NCT05804734|Micronutrients|micronutrients|mesh-ancestor
110470744|NCT05804734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110534156|NCT00618176|Zidovudine|zidovudine|mesh-list
110534157|NCT00618176|Nevirapine|nevirapine|mesh-list
110534158|NCT00618176|Stavudine|stavudine|mesh-list
110534159|NCT00618176|Didanosine|didanosine|mesh-list
110534160|NCT00618176|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110534161|NCT00618176|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110534162|NCT00618176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110534163|NCT00618176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110534164|NCT00618176|Antiviral Agents|antiviral agents|mesh-ancestor
110534165|NCT00618176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110534166|NCT00618176|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110534167|NCT00618176|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110534168|NCT00618176|Antimetabolites|antimetabolites|mesh-ancestor
110534169|NCT00618176|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110470745|NCT05804734|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110470746|NCT05804734|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110470747|NCT05804734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110117920|NCT01881074|Listerine|listerine|mesh-list
110470748|NCT05804734|Hemostatics|hemostatics|mesh-ancestor
110470749|NCT05804734|Coagulants|coagulants|mesh-ancestor
110470750|NCT05804721|Aripiprazole|aripiprazole|mesh-list
110470751|NCT05804721|Antidepressive Agents|antidepressive agents|mesh-ancestor
110470752|NCT05804721|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110470753|NCT05804721|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110470754|NCT05804721|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110470755|NCT05804721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110470756|NCT05804721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110470757|NCT05804721|Dopamine Agonists|dopamine agonists|mesh-ancestor
110470758|NCT05804721|Dopamine Agents|dopamine agents|mesh-ancestor
110470759|NCT05804721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110470760|NCT05804721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110470761|NCT05804721|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110470762|NCT05804721|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110470763|NCT05804721|Serotonin Agents|serotonin agents|mesh-ancestor
110470764|NCT05804721|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110470765|NCT05804721|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110470766|NCT05804721|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110470767|NCT05804721|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110470768|NCT05804630|Lidocaine|lidocaine|mesh-list
110470769|NCT05804630|Anesthetics|anesthetics|mesh-list
110470770|NCT05804630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110470771|NCT05804630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110470772|NCT05804630|Anesthetics, Local|anesthetics, local|mesh-ancestor
110470773|NCT05804630|Sensory System Agents|sensory system agents|mesh-ancestor
110470774|NCT05804630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110470775|NCT05804630|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110470776|NCT05804630|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110470777|NCT05804630|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110470778|NCT05804630|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110470779|NCT05804630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110470780|NCT05804591|Pregabalin|pregabalin|mesh-list
110470781|NCT05804591|Analgesics|analgesics|mesh-ancestor
110470782|NCT05804591|Sensory System Agents|sensory system agents|mesh-ancestor
110470783|NCT05804591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110470784|NCT05804591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110470785|NCT05804591|Anticonvulsants|anticonvulsants|mesh-ancestor
110470786|NCT05804591|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110470787|NCT05804591|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110470788|NCT05804591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110470789|NCT05804591|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110470790|NCT05804591|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110534170|NCT00618176|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110534171|NCT04211558|Ozanimod|ozanimod|mesh-list
110534172|NCT04211558|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
110534173|NCT04211558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110534174|NCT04211558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110534175|NCT04211558|Immunologic Factors|immunologic factors|mesh-ancestor
110534176|NCT04211558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110534177|NCT05048498|Azacitidine|azacitidine|mesh-list
110470791|NCT05804591|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110470792|NCT05804591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110470793|NCT05804591|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110470794|NCT05804370|Aminolevulinic Acid|aminolevulinic acid|mesh-list
110470795|NCT05804370|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110470796|NCT05804370|Dermatologic Agents|dermatologic agents|mesh-ancestor
110470797|NCT05804305|Misoprostol|misoprostol|mesh-list
110470798|NCT05804305|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110470799|NCT05804305|Abortifacient Agents|abortifacient agents|mesh-ancestor
110470800|NCT05804305|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110470801|NCT05804305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110470802|NCT05804305|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110470803|NCT05804305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110470804|NCT05804305|Oxytocics|oxytocics|mesh-ancestor
110470805|NCT05803863|Atropine|atropine|mesh-list
110470806|NCT05803863|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110470807|NCT05803863|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110470808|NCT05803863|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110470809|NCT05803863|Autonomic Agents|autonomic agents|mesh-ancestor
110470810|NCT05803863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110470811|NCT05803863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110470812|NCT05803863|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110470813|NCT05803863|Respiratory System Agents|respiratory system agents|mesh-ancestor
110470814|NCT05803863|Mydriatics|mydriatics|mesh-ancestor
110470815|NCT05803863|Parasympatholytics|parasympatholytics|mesh-ancestor
110470816|NCT05803863|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110470817|NCT05803863|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110470818|NCT05803863|Cholinergic Agents|cholinergic agents|mesh-ancestor
110470819|NCT05803863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110470820|NCT05803863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110118000|NCT01882127|Hormones|hormones|mesh-ancestor
110470821|NCT05803746|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110470822|NCT05803746|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110470823|NCT05803746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110470824|NCT05803642|Haloperidol|haloperidol|mesh-list
110470825|NCT05803642|Olanzapine|olanzapine|mesh-list
110470826|NCT05803642|Haloperidol decanoate|haloperidol decanoate|mesh-list
110470827|NCT05803642|Antiemetics|antiemetics|mesh-ancestor
110470828|NCT05803642|Autonomic Agents|autonomic agents|mesh-ancestor
110470829|NCT05803642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110470830|NCT05803642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110470831|NCT05803642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110470832|NCT05803642|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110470833|NCT05803642|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110470834|NCT05803642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110470835|NCT05803642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110470836|NCT05803642|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110470837|NCT05803642|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110470838|NCT05803642|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110470839|NCT05803642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110470840|NCT05803642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110470841|NCT05803642|Serotonin Agents|serotonin agents|mesh-ancestor
110470842|NCT05803642|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110470843|NCT05803642|Dopamine Agents|dopamine agents|mesh-ancestor
110470844|NCT05803642|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110470845|NCT05803590|Chlorhexidine|chlorhexidine|mesh-list
110470846|NCT05803590|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110470847|NCT05803590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110470848|NCT05803590|Disinfectants|disinfectants|mesh-ancestor
110534178|NCT05048498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110534179|NCT05048498|Antimetabolites|antimetabolites|mesh-ancestor
110534180|NCT05048498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110534181|NCT05048498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110534182|NCT05048498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110534183|NCT00901901|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110534184|NCT00901901|Sorafenib|sorafenib|mesh-list
110534185|NCT00901901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110534186|NCT00901901|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110534187|NCT00901901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110197845|NCT00043004|Immunologic Factors|immunologic factors|mesh-ancestor
110470849|NCT05803135|Tofacitinib|tofacitinib|mesh-list
110470850|NCT05803135|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
110470851|NCT05803135|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110470852|NCT05803135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110470853|NCT05803135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110470854|NCT05803096|Nitrous Oxide|nitrous oxide|mesh-list
110470855|NCT05803096|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110470856|NCT05803096|Anesthetics, General|anesthetics, general|mesh-ancestor
110470857|NCT05803096|Anesthetics|anesthetics|mesh-ancestor
110470858|NCT05803096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110470859|NCT05803096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110470860|NCT05803096|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110470861|NCT05803096|Analgesics|analgesics|mesh-ancestor
110470862|NCT05803096|Sensory System Agents|sensory system agents|mesh-ancestor
110470863|NCT05803096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110470864|NCT05803070|Cetirizine|cetirizine|mesh-list
110470865|NCT05803070|Betamethasone|betamethasone|mesh-list
110470866|NCT05803070|Betamethasone Valerate|betamethasone valerate|mesh-list
110470867|NCT05803070|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
110470868|NCT05803070|Betamethasone benzoate|betamethasone benzoate|mesh-list
110470869|NCT05803070|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
110470871|NCT05803070|Glucocorticoids|glucocorticoids|mesh-ancestor
110470872|NCT05803070|Hormones|hormones|mesh-ancestor
110470873|NCT05803070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110470874|NCT05803070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110470875|NCT05803070|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110470876|NCT05803070|Respiratory System Agents|respiratory system agents|mesh-ancestor
110470877|NCT05803070|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110470878|NCT05803070|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110470879|NCT05803070|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110470880|NCT05803070|Histamine Antagonists|histamine antagonists|mesh-ancestor
110470881|NCT05803070|Histamine Agents|histamine agents|mesh-ancestor
110470882|NCT05803070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110470883|NCT05803070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110470884|NCT05803031|Tea Tree Oil|tea tree oil|mesh-list
110470885|NCT05803031|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110470886|NCT05803031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110470887|NCT05802992|Dexamethasone|dexamethasone|mesh-list
110470888|NCT05802992|Dexamethasone acetate|dexamethasone acetate|mesh-list
110470889|NCT05802992|Lenalidomide|lenalidomide|mesh-list
110470890|NCT05802992|Colchicine|colchicine|mesh-list
110470891|NCT05802992|BB 1101|bb 1101|mesh-list
110470892|NCT05802992|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110470893|NCT05802992|Antiemetics|antiemetics|mesh-ancestor
110470894|NCT05802992|Autonomic Agents|autonomic agents|mesh-ancestor
110470895|NCT05802992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110470896|NCT05802992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110470897|NCT05802992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110470898|NCT05802992|Glucocorticoids|glucocorticoids|mesh-ancestor
110470899|NCT05802992|Hormones|hormones|mesh-ancestor
110470900|NCT05802992|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110470901|NCT05802992|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110470902|NCT05802992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110470903|NCT05802992|Protease Inhibitors|protease inhibitors|mesh-ancestor
110534188|NCT00901901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110534189|NCT00618254|Granisetron|granisetron|mesh-list
110534190|NCT00618254|Antiemetics|antiemetics|mesh-ancestor
110534191|NCT00618254|Autonomic Agents|autonomic agents|mesh-ancestor
110534192|NCT00618254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110534193|NCT00618254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110534194|NCT00618254|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110534195|NCT00618254|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110197913|NCT00073827|Albuterol|albuterol|mesh-list
110470904|NCT05802992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110470905|NCT05802992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110470906|NCT05802992|Immunologic Factors|immunologic factors|mesh-ancestor
110470907|NCT05802992|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110470908|NCT05802992|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110470909|NCT05802992|Growth Substances|growth substances|mesh-ancestor
110470910|NCT05802992|Growth Inhibitors|growth inhibitors|mesh-ancestor
110470911|NCT05802992|Gout Suppressants|gout suppressants|mesh-ancestor
110470912|NCT05802992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110470913|NCT05802992|Tubulin Modulators|tubulin modulators|mesh-ancestor
110470914|NCT05802992|Antimitotic Agents|antimitotic agents|mesh-ancestor
110470915|NCT05802992|Mitosis Modulators|mitosis modulators|mesh-ancestor
110470916|NCT05802979|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-list
110470917|NCT05802888|Amoxicillin|amoxicillin|mesh-list
110470918|NCT05802888|Tetracycline|tetracycline|mesh-list
110470919|NCT05802888|Esomeprazole|esomeprazole|mesh-list
110470920|NCT05802888|Bismuth|bismuth|mesh-list
110470921|NCT05802888|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110470922|NCT05802888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110470923|NCT05802888|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110470924|NCT05802888|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110470925|NCT05802888|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110470926|NCT05802888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110470927|NCT05802888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110470928|NCT05802888|Antacids|antacids|mesh-ancestor
110470929|NCT05802888|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110470930|NCT05802862|Insulin|insulin|mesh-list
110470931|NCT05802862|Insulin Aspart|insulin aspart|mesh-list
110470932|NCT05802862|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
110470933|NCT05802862|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110470934|NCT05802862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110470935|NCT05800574|Cisplatin|cisplatin|mesh-list
110598655|NCT00723086|Docetaxel|docetaxel|mesh-list
110470936|NCT05800574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110470937|NCT05776290|Hyaluronic Acid|hyaluronic acid|mesh-list
110470938|NCT05776290|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110470939|NCT05776290|Immunologic Factors|immunologic factors|mesh-ancestor
110470940|NCT05776290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110470941|NCT05776290|Viscosupplements|viscosupplements|mesh-ancestor
110470942|NCT05776290|Protective Agents|protective agents|mesh-ancestor
110470943|NCT05766670|Vancomycin|vancomycin|mesh-list
110470944|NCT05766670|Gentamicins|gentamicins|mesh-list
110470945|NCT05766670|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110470946|NCT05766670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110470947|NCT05766670|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110470948|NCT05766670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110470949|NCT05766670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110470950|NCT05765227|Hydrogen Peroxide|hydrogen peroxide|mesh-list
110470951|NCT05765227|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110470952|NCT05765227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110470953|NCT05761444|Atorvastatin|atorvastatin|mesh-list
110470954|NCT05761444|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110470955|NCT05761444|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110470956|NCT05761444|Antimetabolites|antimetabolites|mesh-ancestor
110470957|NCT05761444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110470958|NCT05761444|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110470959|NCT05761444|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110470960|NCT05761444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110470961|NCT05758948|Formaldehyde|formaldehyde|mesh-list
110470962|NCT05758948|Disinfectants|disinfectants|mesh-ancestor
110534196|NCT00618254|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110534197|NCT00618254|Serotonin Agents|serotonin agents|mesh-ancestor
110534198|NCT00618254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110534199|NCT00618254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110534200|NCT04184466|Insulin|insulin|mesh-list
110534201|NCT04184466|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110534202|NCT04184466|Insulin Aspart|insulin aspart|mesh-list
110534203|NCT04184466|Insulin, Long-Acting|insulin, long-acting|mesh-list
110534204|NCT04184466|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
110534205|NCT04184466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110534206|NCT04184466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110534207|NCT04201769|Dexamethasone|dexamethasone|mesh-list
110470963|NCT05758948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110470964|NCT05757791|Empagliflozin|empagliflozin|mesh-list
110470965|NCT05757791|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110470966|NCT05757791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110470967|NCT05757791|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110470968|NCT05757791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110470969|NCT05728775|Propofol|propofol|mesh-list
110470970|NCT05728775|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110470971|NCT05728775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110470972|NCT05728775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110470973|NCT05728775|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110470974|NCT05728775|Anesthetics, General|anesthetics, general|mesh-ancestor
110470975|NCT05728775|Anesthetics|anesthetics|mesh-ancestor
110470976|NCT05715671|Esketamine|esketamine|mesh-list
110470977|NCT05715671|Antidepressive Agents|antidepressive agents|mesh-ancestor
110470978|NCT05715671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110470979|NCT05705089|Warfarin|warfarin|mesh-list
110470980|NCT05705089|Rivaroxaban|rivaroxaban|mesh-list
110470981|NCT05705089|Anticoagulants|anticoagulants|mesh-ancestor
110470982|NCT05705089|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110598671|NCT00849550|Everolimus|everolimus|mesh-list
110470983|NCT05705089|Antithrombins|antithrombins|mesh-ancestor
110470984|NCT05705089|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110470985|NCT05705089|Protease Inhibitors|protease inhibitors|mesh-ancestor
110470986|NCT05705089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110470987|NCT05705089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110470988|NCT05701917|Heparin|heparin|mesh-list
110470989|NCT05701917|Calcium heparin|calcium heparin|mesh-list
110470990|NCT05701917|Rivaroxaban|rivaroxaban|mesh-list
110470991|NCT05701917|Apixaban|apixaban|mesh-list
110470992|NCT05701917|Warfarin|warfarin|mesh-list
110470993|NCT05701917|Anticoagulants|anticoagulants|mesh-ancestor
110470994|NCT05701917|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110470995|NCT05701917|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110470996|NCT05701917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110470997|NCT05701917|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110470998|NCT05701917|Antithrombins|antithrombins|mesh-ancestor
110470999|NCT05701917|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110471000|NCT05701917|Protease Inhibitors|protease inhibitors|mesh-ancestor
110471001|NCT05701917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110471002|NCT05672901|Estradiol|estradiol|mesh-list
110471003|NCT05672901|Estrogens|estrogens|mesh-ancestor
110471004|NCT05672901|Hormones|hormones|mesh-ancestor
110471005|NCT05672901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110471006|NCT05672901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110471007|NCT05671822|Capecitabine|capecitabine|mesh-list
110471008|NCT05671822|Oxaliplatin|oxaliplatin|mesh-list
110471009|NCT05671822|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110471010|NCT05671822|Antimetabolites|antimetabolites|mesh-ancestor
110471011|NCT05671822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110471012|NCT05671822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110471013|NCT05649540|Amoxicillin|amoxicillin|mesh-list
110471014|NCT05649540|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110471015|NCT05649540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110471016|NCT05646693|Sertraline|sertraline|mesh-list
110534208|NCT04201769|Palonosetron|palonosetron|mesh-list
110534209|NCT04201769|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110534210|NCT04201769|Antiemetics|antiemetics|mesh-ancestor
110534211|NCT04201769|Autonomic Agents|autonomic agents|mesh-ancestor
110534212|NCT04201769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110534213|NCT04201769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110534214|NCT04201769|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110534215|NCT04201769|Glucocorticoids|glucocorticoids|mesh-ancestor
110534216|NCT04201769|Hormones|hormones|mesh-ancestor
110534217|NCT04201769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110534218|NCT04201769|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110534219|NCT04201769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110534220|NCT04201769|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110534221|NCT04201769|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110534222|NCT04201769|Serotonin Agents|serotonin agents|mesh-ancestor
110534223|NCT04201769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110534224|NCT04201769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110534225|NCT05336825|Lidocaine|lidocaine|mesh-list
110534226|NCT05336825|Anesthetics, Local|anesthetics, local|mesh-ancestor
110534227|NCT05336825|Anesthetics|anesthetics|mesh-ancestor
110471017|NCT05646693|Magnesium Oxide|magnesium oxide|mesh-list
110471018|NCT05646693|Antidepressive Agents|antidepressive agents|mesh-ancestor
110471019|NCT05646693|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110471020|NCT05646693|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110471021|NCT05646693|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110471022|NCT05646693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110471023|NCT05646693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110471024|NCT05646693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110471025|NCT05646693|Serotonin Agents|serotonin agents|mesh-ancestor
110471026|NCT05646693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110471027|NCT05646693|Antacids|antacids|mesh-ancestor
110471028|NCT05646693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110471029|NCT05624359|Ropivacaine|ropivacaine|mesh-list
110471030|NCT05624359|Anesthetics, Local|anesthetics, local|mesh-ancestor
110471031|NCT05624359|Anesthetics|anesthetics|mesh-ancestor
110471032|NCT05624359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110471033|NCT05624359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110471034|NCT05624359|Sensory System Agents|sensory system agents|mesh-ancestor
110471035|NCT05624359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110471036|NCT05616624|Gemcitabine|gemcitabine|mesh-list
110471037|NCT05616624|Docetaxel|docetaxel|mesh-list
110471038|NCT05616624|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110471039|NCT05616624|Antimetabolites|antimetabolites|mesh-ancestor
110471040|NCT05616624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110471041|NCT05616624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110471042|NCT05616624|Tubulin Modulators|tubulin modulators|mesh-ancestor
110471043|NCT05616624|Antimitotic Agents|antimitotic agents|mesh-ancestor
110471044|NCT05616624|Mitosis Modulators|mitosis modulators|mesh-ancestor
110471045|NCT05601817|Tocopherols|tocopherols|mesh-list
110471046|NCT05601817|Vitamin E|vitamin e|mesh-list
110118230|NCT01884298|Lidocaine|lidocaine|mesh-list
110471047|NCT05601817|alpha-Tocopherol|alpha-tocopherol|mesh-list
110471048|NCT05601817|Antioxidants|antioxidants|mesh-ancestor
110471049|NCT05601817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110471050|NCT05601817|Protective Agents|protective agents|mesh-ancestor
110471052|NCT05601817|Vitamins|vitamins|mesh-ancestor
110534228|NCT05336825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110534229|NCT05336825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110534230|NCT05336825|Sensory System Agents|sensory system agents|mesh-ancestor
110534231|NCT05336825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110534232|NCT05336825|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110534233|NCT05336825|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110534234|NCT05336825|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110534235|NCT05336825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110534236|NCT05336825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110534237|NCT04748783|Listerine|listerine|mesh-list
110534238|NCT04748783|Chlorhexidine|chlorhexidine|mesh-list
110534239|NCT04748783|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110534240|NCT04748783|Hydrogen Peroxide|hydrogen peroxide|mesh-list
110534241|NCT04748783|Sodium Fluoride|sodium fluoride|mesh-list
110534242|NCT04748783|Cariostatic Agents|cariostatic agents|mesh-ancestor
110534243|NCT04748783|Protective Agents|protective agents|mesh-ancestor
110534244|NCT04748783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110534245|NCT04748783|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110534246|NCT04748783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110534247|NCT04748783|Disinfectants|disinfectants|mesh-ancestor
110534248|NCT04748783|Dermatologic Agents|dermatologic agents|mesh-ancestor
110534249|NCT02777580|Tenecteplase|tenecteplase|mesh-list
110534250|NCT02777580|Clopidogrel|clopidogrel|mesh-list
110534251|NCT02777580|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110198095|NCT00124696|Dopamine Agents|dopamine agents|mesh-ancestor
110471053|NCT05601817|Micronutrients|micronutrients|mesh-ancestor
110471054|NCT05515978|Metformin|metformin|mesh-list
110471055|NCT05515978|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110471056|NCT05515978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110471057|NCT05513469|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
110471058|NCT05513469|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110471059|NCT05513469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110471060|NCT05484349|Clonidine|clonidine|mesh-list
110471061|NCT05484349|Tizanidine|tizanidine|mesh-list
110471062|NCT05484349|Analgesics|analgesics|mesh-ancestor
110471063|NCT05484349|Sensory System Agents|sensory system agents|mesh-ancestor
110471064|NCT05484349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110471065|NCT05484349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110471066|NCT05484349|Anticonvulsants|anticonvulsants|mesh-ancestor
110471067|NCT05484349|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110471068|NCT05484349|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110471069|NCT05484349|Parasympatholytics|parasympatholytics|mesh-ancestor
110471070|NCT05484349|Autonomic Agents|autonomic agents|mesh-ancestor
110471071|NCT05484349|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110471072|NCT05484349|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110471073|NCT05484349|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110471074|NCT05484349|Adrenergic Agents|adrenergic agents|mesh-ancestor
110471075|NCT05484349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110471076|NCT05484349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110471077|NCT05484349|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110471078|NCT05484349|Sympatholytics|sympatholytics|mesh-ancestor
110534252|NCT02777580|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110534253|NCT02777580|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110534254|NCT02777580|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110534256|NCT02777580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110534257|NCT02777580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110534258|NCT02777580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110534259|NCT02777580|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110534260|NCT02777580|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110534261|NCT04628663|Dexmedetomidine|dexmedetomidine|mesh-list
110534262|NCT04628663|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110471079|NCT05470244|Analgesics|analgesics|mesh-list
110471080|NCT05470244|Sensory System Agents|sensory system agents|mesh-ancestor
110471081|NCT05470244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110471082|NCT05470244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110471083|NCT05449548|Lenalidomide|lenalidomide|mesh-list
110471084|NCT05449548|Immunologic Factors|immunologic factors|mesh-ancestor
110471085|NCT05449548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110471086|NCT05449548|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110471087|NCT05449548|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110471088|NCT05449548|Growth Substances|growth substances|mesh-ancestor
110471089|NCT05449548|Growth Inhibitors|growth inhibitors|mesh-ancestor
110471090|NCT05449548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110471091|NCT05438264|Donepezil|donepezil|mesh-list
110471092|NCT05438264|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110471093|NCT05438264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110471094|NCT05438264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110471095|NCT05438264|Cholinergic Agents|cholinergic agents|mesh-ancestor
110471096|NCT05438264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110471097|NCT05438264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110471098|NCT05438264|Nootropic Agents|nootropic agents|mesh-ancestor
110471099|NCT05365035|Cytarabine|cytarabine|mesh-list
110471100|NCT05365035|Azacitidine|azacitidine|mesh-list
110471101|NCT05365035|Venetoclax|venetoclax|mesh-list
110471102|NCT05365035|Cladribine|cladribine|mesh-list
110471103|NCT05365035|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110471104|NCT05365035|Antimetabolites|antimetabolites|mesh-ancestor
110471105|NCT05365035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110471106|NCT05365035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110471107|NCT05365035|Antiviral Agents|antiviral agents|mesh-ancestor
110471108|NCT05365035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110471109|NCT05365035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110471110|NCT05365035|Immunologic Factors|immunologic factors|mesh-ancestor
110471111|NCT05365035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110471112|NCT05365035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110471113|NCT05359861|Bevacizumab|bevacizumab|mesh-list
110471114|NCT05359861|Atezolizumab|atezolizumab|mesh-list
110471115|NCT05359861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110471116|NCT05359861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110471117|NCT05359861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110471118|NCT05359861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110471119|NCT05359861|Growth Substances|growth substances|mesh-ancestor
110471120|NCT05359861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110471121|NCT05359861|Growth Inhibitors|growth inhibitors|mesh-ancestor
110471122|NCT05359861|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110471123|NCT05359861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110471124|NCT05355857|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110471125|NCT05355857|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110118297|NCT01884506|Iron|iron|mesh-list
110471126|NCT05355857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110471128|NCT05350085|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110471129|NCT05350085|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110471130|NCT05350085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110534263|NCT04628663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110534264|NCT04628663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110534265|NCT04628663|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110534266|NCT04628663|Analgesics|analgesics|mesh-ancestor
110534267|NCT04628663|Sensory System Agents|sensory system agents|mesh-ancestor
110534268|NCT04628663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110534269|NCT04628663|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110534270|NCT04628663|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110534271|NCT04628663|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110534272|NCT04628663|Adrenergic Agents|adrenergic agents|mesh-ancestor
110198215|NCT00125554|Metyrapone|metyrapone|mesh-list
110471131|NCT05350085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110471132|NCT05350085|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110471133|NCT05350085|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110471134|NCT05350085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110471135|NCT05350085|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110471136|NCT05350085|Anesthetics, General|anesthetics, general|mesh-ancestor
110471137|NCT05350085|Anesthetics|anesthetics|mesh-ancestor
110471138|NCT05350085|GABA Modulators|gaba modulators|mesh-ancestor
110471139|NCT05350085|GABA Agents|gaba agents|mesh-ancestor
110471140|NCT05350085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110164929|NCT00022126|Cyclophosphamide|cyclophosphamide|mesh-list
110471141|NCT05350085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110471143|NCT05313308|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110471144|NCT05313308|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110471145|NCT05313308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110471146|NCT05313308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110471147|NCT05313308|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110471148|NCT05313308|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110471149|NCT05313308|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110471150|NCT05313308|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110471157|NCT05273359|Benralizumab|benralizumab|mesh-list
110471158|NCT05273359|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110471159|NCT05273359|Respiratory System Agents|respiratory system agents|mesh-ancestor
110471160|NCT05169905|Vaccines|vaccines|mesh-list
110471161|NCT05169905|Immunologic Factors|immunologic factors|mesh-ancestor
110471162|NCT05169905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110471163|NCT05163223|Pembrolizumab|pembrolizumab|mesh-list
110471164|NCT05163223|Capecitabine|capecitabine|mesh-list
110471165|NCT05163223|Sargramostim|sargramostim|mesh-list
110471166|NCT05163223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110471167|NCT05163223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110471168|NCT05163223|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110471169|NCT05163223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110471170|NCT05163223|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110471171|NCT05163223|Antimetabolites|antimetabolites|mesh-ancestor
110471172|NCT05163223|Immunologic Factors|immunologic factors|mesh-ancestor
110471173|NCT05163223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110471174|NCT05101122|Dronabinol|dronabinol|mesh-list
110471175|NCT05101122|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
110471176|NCT05101122|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110471177|NCT05101122|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110471178|NCT05101122|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110471179|NCT05101122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110471180|NCT05101122|Adrenergic Agents|adrenergic agents|mesh-ancestor
110471181|NCT05101122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110471182|NCT05101122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110471183|NCT05101122|Hallucinogens|hallucinogens|mesh-ancestor
110471184|NCT05101122|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110471185|NCT05101122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110471186|NCT05101122|Analgesics|analgesics|mesh-ancestor
110471187|NCT05101122|Sensory System Agents|sensory system agents|mesh-ancestor
110471188|NCT05101122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110471189|NCT05101122|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
110534274|NCT04628663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110534275|NCT05663268|Infliximab|infliximab|mesh-list
110534276|NCT05663268|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110534277|NCT05663268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110534278|NCT05663268|Dermatologic Agents|dermatologic agents|mesh-ancestor
110534279|NCT05663268|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110534280|NCT05663268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110534281|NCT02822027|gamma-Globulins|gamma-globulins|mesh-list
110534282|NCT02822027|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110534283|NCT02822027|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110534284|NCT02822027|Immunologic Factors|immunologic factors|mesh-ancestor
110534285|NCT02822027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110534286|NCT00642096|Metoprolol|metoprolol|mesh-list
110534287|NCT00642096|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110534288|NCT00642096|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110534289|NCT00642096|Diuretics|diuretics|mesh-ancestor
110534290|NCT00642096|Natriuretic Agents|natriuretic agents|mesh-ancestor
110534656|NCT04178850|Dermatologic Agents|dermatologic agents|mesh-ancestor
110471190|NCT05101122|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110471191|NCT05101122|Hormones|hormones|mesh-ancestor
110471192|NCT05101122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110471193|NCT05092945|Niacin|niacin|mesh-list
110471194|NCT05092945|Nicotinic Acids|nicotinic acids|mesh-list
110471195|NCT05092945|Niacinamide|niacinamide|mesh-list
110471196|NCT05092945|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110471197|NCT05092945|Antimetabolites|antimetabolites|mesh-ancestor
110471198|NCT05092945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110471199|NCT05092945|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110471200|NCT05092945|Vasodilator Agents|vasodilator agents|mesh-ancestor
110471201|NCT05092945|Vitamin B Complex|vitamin b complex|mesh-ancestor
110471202|NCT05092945|Vitamins|vitamins|mesh-ancestor
110471203|NCT05092945|Micronutrients|micronutrients|mesh-ancestor
110471204|NCT05092945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110471205|NCT05087771|Naltrexone|naltrexone|mesh-list
110471206|NCT05087771|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110471207|NCT05087771|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110471208|NCT05087771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110471209|NCT05087771|Sensory System Agents|sensory system agents|mesh-ancestor
110471210|NCT05087771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110471211|NCT05084235|Empagliflozin|empagliflozin|mesh-list
110598735|NCT02545426|Dialysis Solutions|dialysis solutions|mesh-list
110471212|NCT05084235|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110471213|NCT05084235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110471214|NCT05084235|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110471215|NCT05084235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110471222|NCT05061017|Cyclophosphamide|cyclophosphamide|mesh-list
110471223|NCT05061017|Nivolumab|nivolumab|mesh-list
110471224|NCT05061017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110471225|NCT05061017|Immunologic Factors|immunologic factors|mesh-ancestor
110471226|NCT05061017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110471227|NCT05061017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110471228|NCT05061017|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110471229|NCT05061017|Alkylating Agents|alkylating agents|mesh-ancestor
110471230|NCT05061017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110471231|NCT05061017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110471232|NCT05061017|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110471233|NCT05061017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110534291|NCT00642096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110534292|NCT00642096|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110534293|NCT00642096|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110534294|NCT00642096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110534295|NCT00642096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110534296|NCT00642096|Sympatholytics|sympatholytics|mesh-ancestor
110534297|NCT00642096|Autonomic Agents|autonomic agents|mesh-ancestor
110534298|NCT00642096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110534299|NCT00642096|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110534300|NCT00642096|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110534301|NCT00642096|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110534302|NCT00642096|Adrenergic Agents|adrenergic agents|mesh-ancestor
110534303|NCT00642096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110534304|NCT05336513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
110534305|NCT02679456|Fluconazole|fluconazole|mesh-list
110534306|NCT02679456|Ibrexafungerp|ibrexafungerp|mesh-list
110534307|NCT02679456|Antifungal Agents|antifungal agents|mesh-ancestor
110534308|NCT02679456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110534309|NCT02679456|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110534310|NCT02679456|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110534311|NCT02679456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110534312|NCT02679456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110534313|NCT02679456|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110534314|NCT02679456|Hormone Antagonists|hormone antagonists|mesh-ancestor
110312311|NCT00293735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110471234|NCT05061017|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110471235|NCT05048901|Lanreotide|lanreotide|mesh-list
110471236|NCT05048901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110471237|NCT05042973|Empagliflozin|empagliflozin|mesh-list
110471238|NCT05042973|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110471239|NCT05042973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110471240|NCT05042973|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110471241|NCT05042973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110471242|NCT05030272|Nicotine|nicotine|mesh-list
110471243|NCT05030272|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110471244|NCT05030272|Autonomic Agents|autonomic agents|mesh-ancestor
110471245|NCT05030272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110471246|NCT05030272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110471247|NCT05030272|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110471248|NCT05030272|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110471249|NCT05030272|Cholinergic Agents|cholinergic agents|mesh-ancestor
110471250|NCT05030272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110471251|NCT05030272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110471252|NCT04976257|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
110471253|NCT04976257|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110471254|NCT04976257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110471255|NCT04954365|Amisulpride|amisulpride|mesh-list
110534315|NCT02679456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110534317|NCT02679456|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110534318|NCT02679456|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110534319|NCT00640458|Sildenafil Citrate|sildenafil citrate|mesh-list
110534320|NCT00640458|Vasodilator Agents|vasodilator agents|mesh-ancestor
110534321|NCT00640458|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110534322|NCT00640458|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110534323|NCT00640458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110534324|NCT00640458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110534325|NCT00640458|Urological Agents|urological agents|mesh-ancestor
110534326|NCT00909948|Fludarabine|fludarabine|mesh-list
110198362|NCT00043589|Cholinergic Agents|cholinergic agents|mesh-ancestor
110471256|NCT04954365|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110471257|NCT04954365|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110471258|NCT04954365|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110471259|NCT04954365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110471260|NCT04954365|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110471261|NCT04954365|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110471262|NCT04954365|Dopamine Agents|dopamine agents|mesh-ancestor
110471263|NCT04954365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110471264|NCT04954365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110471265|NCT04954365|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110471266|NCT04954365|Antidepressive Agents|antidepressive agents|mesh-ancestor
110471267|NCT04920617|Cyclophosphamide|cyclophosphamide|mesh-list
110471268|NCT04920617|Pembrolizumab|pembrolizumab|mesh-list
110471269|NCT04920617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110471270|NCT04920617|Immunologic Factors|immunologic factors|mesh-ancestor
110471271|NCT04920617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110471272|NCT04920617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110471273|NCT04920617|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110471274|NCT04920617|Alkylating Agents|alkylating agents|mesh-ancestor
110471275|NCT04920617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110164955|NCT00022126|Hormones|hormones|mesh-ancestor
110471276|NCT04920617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110471277|NCT04920617|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110471278|NCT04920617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110471279|NCT04920617|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110471281|NCT04860804|Ketamine|ketamine|mesh-list
110471282|NCT04860804|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110471283|NCT04860804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110471284|NCT04860804|Analgesics|analgesics|mesh-ancestor
110471285|NCT04860804|Sensory System Agents|sensory system agents|mesh-ancestor
110471286|NCT04860804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110471287|NCT04860804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110471288|NCT04860804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110471289|NCT04860804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110471290|NCT04860804|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110471291|NCT04860804|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110471292|NCT04860804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110471293|NCT04860804|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110471294|NCT04860804|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110471295|NCT04860804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110471296|NCT04860804|Antipyretics|antipyretics|mesh-ancestor
110471297|NCT04860804|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110471298|NCT04860804|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110471299|NCT04860804|Anesthetics, General|anesthetics, general|mesh-ancestor
110471310|NCT04764396|Heparin|heparin|mesh-list
110471311|NCT04764396|Calcium heparin|calcium heparin|mesh-list
110471312|NCT04764396|Anticoagulants|anticoagulants|mesh-ancestor
110471313|NCT04764396|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110033399|NCT03733119|TIC10 compound|tic10 compound|mesh-list
110534329|NCT02681562|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110534330|NCT02681562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110534331|NCT02681562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110534332|NCT02681562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110534333|NCT00633035|Esomeprazole|esomeprazole|mesh-list
110534334|NCT00633035|Famotidine|famotidine|mesh-list
110534335|NCT00633035|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110534336|NCT00633035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110198438|NCT00126373|Bupropion|bupropion|mesh-list
110471314|NCT04764396|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110471315|NCT04764396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110471316|NCT04684589|Tadalafil|tadalafil|mesh-list
110471317|NCT04684589|Vasodilator Agents|vasodilator agents|mesh-ancestor
110471318|NCT04684589|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110471319|NCT04684589|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110471320|NCT04684589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110471321|NCT04684589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110471322|NCT04684589|Urological Agents|urological agents|mesh-ancestor
110471323|NCT04609514|Nicotine|nicotine|mesh-list
110471324|NCT04609514|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110471325|NCT04609514|Autonomic Agents|autonomic agents|mesh-ancestor
110471326|NCT04609514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110471327|NCT04609514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110471328|NCT04609514|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110471329|NCT04609514|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110471330|NCT04609514|Cholinergic Agents|cholinergic agents|mesh-ancestor
110471331|NCT04609514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110471332|NCT04609514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110471342|NCT04527289|Amantadine|amantadine|mesh-list
110471343|NCT04527289|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110471344|NCT04527289|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110471345|NCT04527289|Antiviral Agents|antiviral agents|mesh-ancestor
110471346|NCT04527289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110471347|NCT04527289|Dopamine Agents|dopamine agents|mesh-ancestor
110118528|NCT01886079|Analgesics|analgesics|mesh-ancestor
110471348|NCT04527289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110471349|NCT04527289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110471350|NCT04527289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110471351|NCT04527289|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110471352|NCT04527289|Analgesics|analgesics|mesh-ancestor
110471353|NCT04527289|Sensory System Agents|sensory system agents|mesh-ancestor
110471354|NCT04527289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110471355|NCT04505735|Corticosterone|corticosterone|mesh-list
110598794|NCT00618748|Olanzapine|olanzapine|mesh-list
110471356|NCT04505735|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110471357|NCT04460872|Methyltestosterone|methyltestosterone|mesh-list
110471358|NCT04460872|Testosterone|testosterone|mesh-list
110471359|NCT04460872|Testosterone undecanoate|testosterone undecanoate|mesh-list
110471360|NCT04460872|Testosterone enanthate|testosterone enanthate|mesh-list
110471361|NCT04460872|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
110471362|NCT04460872|Androgens|androgens|mesh-ancestor
110471363|NCT04460872|Hormones|hormones|mesh-ancestor
110471364|NCT04460872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110471365|NCT04460872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110471366|NCT04460872|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110471367|NCT04460872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110471368|NCT04460872|Anabolic Agents|anabolic agents|mesh-ancestor
110471369|NCT04446351|Dostarlimab|dostarlimab|mesh-list
110471370|NCT04446351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110471371|NCT04422795|Ethyl Chloride|ethyl chloride|mesh-list
110471372|NCT04422795|Anesthetics, Local|anesthetics, local|mesh-ancestor
110471373|NCT04422795|Anesthetics|anesthetics|mesh-ancestor
110471374|NCT04422795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110471375|NCT04422795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110471376|NCT04422795|Sensory System Agents|sensory system agents|mesh-ancestor
110471377|NCT04422795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110534337|NCT00633035|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110534338|NCT00633035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110534339|NCT00633035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110534340|NCT00633035|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110534341|NCT00633035|Histamine Antagonists|histamine antagonists|mesh-ancestor
110534342|NCT00633035|Histamine Agents|histamine agents|mesh-ancestor
110534343|NCT00633035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110534344|NCT00633035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110534345|NCT02511132|Gemcitabine|gemcitabine|mesh-list
110534346|NCT02511132|Docetaxel|docetaxel|mesh-list
110534347|NCT02511132|Irinotecan|irinotecan|mesh-list
110534348|NCT02511132|Temozolomide|temozolomide|mesh-list
110534349|NCT02511132|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110534350|NCT02511132|Antimetabolites|antimetabolites|mesh-ancestor
110534351|NCT02511132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110534352|NCT02511132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110534353|NCT02511132|Tubulin Modulators|tubulin modulators|mesh-ancestor
110534354|NCT02511132|Antimitotic Agents|antimitotic agents|mesh-ancestor
110471378|NCT04413617|Tofacitinib|tofacitinib|mesh-list
110471379|NCT04413617|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
110471380|NCT04413617|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110471381|NCT04413617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110471382|NCT04413617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110471383|NCT04218565|Golimumab|golimumab|mesh-list
110471384|NCT04218565|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110471385|NCT04218565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110471386|NCT04218565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110471387|NCT04218565|Immunologic Factors|immunologic factors|mesh-ancestor
110471388|NCT04218565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110471389|NCT04129502|Carboplatin|carboplatin|mesh-list
110471390|NCT04129502|Pemetrexed|pemetrexed|mesh-list
110471391|NCT04129502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110471392|NCT04129502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110471393|NCT04129502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110471394|NCT04129502|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110471395|NCT04129502|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110471396|NCT04093362|Gemcitabine|gemcitabine|mesh-list
110471397|NCT04093362|Futibatinib|futibatinib|mesh-list
110471398|NCT04093362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110471399|NCT04093362|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110471400|NCT04093362|Antimetabolites|antimetabolites|mesh-ancestor
110471401|NCT04093362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110471402|NCT04060849|Ethanol|ethanol|mesh-list
110471403|NCT04060849|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110471404|NCT04060849|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110471405|NCT04060849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110471406|NCT04060849|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110471407|NCT04060849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110471408|NCT04055116|Lidocaine|lidocaine|mesh-list
110471409|NCT04055116|Anesthetics, Local|anesthetics, local|mesh-ancestor
110471410|NCT04055116|Anesthetics|anesthetics|mesh-ancestor
110471411|NCT04055116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110471412|NCT04055116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110471413|NCT04055116|Sensory System Agents|sensory system agents|mesh-ancestor
110471414|NCT04055116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110471415|NCT04055116|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110471416|NCT04055116|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110534355|NCT02511132|Mitosis Modulators|mitosis modulators|mesh-ancestor
110534356|NCT02511132|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110534357|NCT02511132|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110534358|NCT02511132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110534359|NCT02511132|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110534360|NCT02511132|Alkylating Agents|alkylating agents|mesh-ancestor
110534361|NCT02678520|Goserelin|goserelin|mesh-list
110534362|NCT02678520|Bicalutamide|bicalutamide|mesh-list
110534363|NCT02678520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110534364|NCT02678520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110534365|NCT02678520|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110534366|NCT02678520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110471417|NCT04055116|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110471418|NCT04055116|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110471419|NCT04055116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110471420|NCT04045028|Rituximab|rituximab|mesh-list
110471421|NCT04045028|Atezolizumab|atezolizumab|mesh-list
110471422|NCT04045028|Daratumumab|daratumumab|mesh-list
110471423|NCT04045028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110471424|NCT04045028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110471425|NCT04045028|Immunologic Factors|immunologic factors|mesh-ancestor
110471426|NCT04045028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110471427|NCT04045028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110471428|NCT04045028|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110471429|NCT04045028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110471431|NCT03990623|Hematinics|hematinics|mesh-ancestor
110471432|NCT03916328|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
110471433|NCT03916328|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110471434|NCT03916328|Contraceptive Agents|contraceptive agents|mesh-ancestor
110471435|NCT03916328|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110471436|NCT03916328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110471437|NCT03916328|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110471438|NCT03916328|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110471439|NCT03916328|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110471440|NCT03916328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110471441|NCT03867500|Niacin|niacin|mesh-list
110471442|NCT03867500|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110471443|NCT03867500|Antimetabolites|antimetabolites|mesh-ancestor
110471444|NCT03867500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110471445|NCT03867500|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110471446|NCT03867500|Vasodilator Agents|vasodilator agents|mesh-ancestor
110471447|NCT03867500|Vitamin B Complex|vitamin b complex|mesh-ancestor
110471449|NCT03867500|Micronutrients|micronutrients|mesh-ancestor
110471450|NCT03867500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110471451|NCT03839446|Etoposide|etoposide|mesh-list
110471452|NCT03839446|Mitoxantrone|mitoxantrone|mesh-list
110471453|NCT03839446|Gemtuzumab|gemtuzumab|mesh-list
110471454|NCT03839446|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110471455|NCT03839446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110471456|NCT03839446|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110471457|NCT03839446|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110471458|NCT03839446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110471459|NCT03839446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110471460|NCT03839446|Analgesics|analgesics|mesh-ancestor
110471461|NCT03839446|Sensory System Agents|sensory system agents|mesh-ancestor
110471462|NCT03839446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110471463|NCT03839446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110471464|NCT03839446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110471465|NCT03839446|Immunotoxins|immunotoxins|mesh-ancestor
110471466|NCT03839446|Immunoconjugates|immunoconjugates|mesh-ancestor
110471467|NCT03839446|Immunologic Factors|immunologic factors|mesh-ancestor
110471468|NCT03781986|Carboplatin|carboplatin|mesh-list
110534367|NCT02678520|Androgen Antagonists|androgen antagonists|mesh-ancestor
110534368|NCT02678520|Hormone Antagonists|hormone antagonists|mesh-ancestor
110534370|NCT00642252|Cariostatic Agents|cariostatic agents|mesh-ancestor
110534371|NCT00642252|Protective Agents|protective agents|mesh-ancestor
110534372|NCT00642252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110534373|NCT00642330|Ibuprofen|ibuprofen|mesh-list
110534374|NCT00642330|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110534375|NCT00642330|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110534376|NCT00642330|Analgesics|analgesics|mesh-ancestor
110534377|NCT00642330|Sensory System Agents|sensory system agents|mesh-ancestor
110534378|NCT00642330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110198615|NCT00127387|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110471469|NCT03781986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110471470|NCT03743402|Analgesics, Opioid|analgesics, opioid|mesh-list
110471471|NCT03743402|Narcotics|narcotics|mesh-ancestor
110471472|NCT03743402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110471473|NCT03743402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110471474|NCT03743402|Analgesics|analgesics|mesh-ancestor
110471475|NCT03743402|Sensory System Agents|sensory system agents|mesh-ancestor
110471476|NCT03743402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110471477|NCT03735433|Aspirin|aspirin|mesh-list
110471478|NCT03735433|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110471479|NCT03735433|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110471480|NCT03735433|Analgesics|analgesics|mesh-ancestor
110471481|NCT03735433|Sensory System Agents|sensory system agents|mesh-ancestor
110471482|NCT03735433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110471483|NCT03735433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110471484|NCT03735433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110471485|NCT03735433|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110471486|NCT03735433|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110471487|NCT03735433|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110471488|NCT03735433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110471489|NCT03735433|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110471490|NCT03735433|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110471491|NCT03735433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110471492|NCT03735433|Antipyretics|antipyretics|mesh-ancestor
110471493|NCT03729401|Aspirin|aspirin|mesh-list
110471494|NCT03729401|Clopidogrel|clopidogrel|mesh-list
110471495|NCT03729401|Ticagrelor|ticagrelor|mesh-list
110471496|NCT03729401|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110471497|NCT03729401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110471498|NCT03729401|Analgesics|analgesics|mesh-ancestor
110471499|NCT03729401|Sensory System Agents|sensory system agents|mesh-ancestor
110471501|NCT03729401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110471502|NCT03729401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110471503|NCT03729401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110471504|NCT03729401|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110471505|NCT03729401|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110471506|NCT03729401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110471507|NCT03729401|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110471508|NCT03729401|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110471509|NCT03729401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110471510|NCT03729401|Antipyretics|antipyretics|mesh-ancestor
110471511|NCT03729401|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110471512|NCT03729401|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110471513|NCT03729401|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110471514|NCT03729401|Purinergic Agents|purinergic agents|mesh-ancestor
110471515|NCT03729401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110471516|NCT03562416|Nintedanib|nintedanib|mesh-list
110471517|NCT03562416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110471518|NCT03562416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110471519|NCT03562416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110471520|NCT03562416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110534379|NCT00642330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110534380|NCT00642330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110534382|NCT00642330|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110534383|NCT00642330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110534384|NCT00642330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110534385|NCT02681796|Bupivacaine|bupivacaine|mesh-list
110534386|NCT02681796|Anesthetics, Local|anesthetics, local|mesh-ancestor
110534387|NCT02681796|Anesthetics|anesthetics|mesh-ancestor
110534388|NCT02681796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110534390|NCT02681796|Sensory System Agents|sensory system agents|mesh-ancestor
110534391|NCT02681796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110534392|NCT02842931|Prednisone|prednisone|mesh-list
110534393|NCT02842931|Cyclophosphamide|cyclophosphamide|mesh-list
110471521|NCT03512262|Abaloparatide|abaloparatide|mesh-list
110471522|NCT03512262|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
110471523|NCT03512262|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110471524|NCT03512262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110471525|NCT03512262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110471526|NCT03503058|Chloroquine|chloroquine|mesh-list
110471527|NCT03503058|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
110471528|NCT03503058|Amebicides|amebicides|mesh-ancestor
110471529|NCT03503058|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110471530|NCT03503058|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110471531|NCT03503058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110471532|NCT03503058|Antimalarials|antimalarials|mesh-ancestor
110471533|NCT03503058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110471534|NCT03503058|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110471535|NCT03503058|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110471536|NCT03503058|Analgesics|analgesics|mesh-ancestor
110471537|NCT03503058|Sensory System Agents|sensory system agents|mesh-ancestor
110471538|NCT03503058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110471539|NCT03503058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110471540|NCT03503058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110471541|NCT03503058|Filaricides|filaricides|mesh-ancestor
110471542|NCT03503058|Antinematodal Agents|antinematodal agents|mesh-ancestor
110471543|NCT03503058|Anthelmintics|anthelmintics|mesh-ancestor
110471544|NCT03396211|Nivolumab|nivolumab|mesh-list
110471545|NCT03396211|Apatinib|apatinib|mesh-list
110471546|NCT03396211|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110471547|NCT03396211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110471548|NCT03396211|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110471549|NCT03396211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110471550|NCT03396211|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110471551|NCT03396211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110471552|NCT03301896|Spartalizumab|spartalizumab|mesh-list
110471553|NCT03301896|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110471554|NCT03301896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110471555|NCT03301896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110471556|NCT03301896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110471557|NCT03260322|Pembrolizumab|pembrolizumab|mesh-list
110471558|NCT03260322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110471559|NCT03260322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110471560|NCT03260322|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110471561|NCT03260322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110471562|NCT03257761|Durvalumab|durvalumab|mesh-list
110471563|NCT03257761|Guadecitabine|guadecitabine|mesh-list
110471564|NCT03257761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110471565|NCT03257761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110471566|NCT03218085|Tenofovir|tenofovir|mesh-list
110471567|NCT03218085|Emtricitabine|emtricitabine|mesh-list
110534394|NCT02842931|Doxorubicin|doxorubicin|mesh-list
110534395|NCT02842931|Etoposide|etoposide|mesh-list
110534396|NCT02842931|Vincristine|vincristine|mesh-list
110534397|NCT02842931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110534398|NCT02842931|Immunologic Factors|immunologic factors|mesh-ancestor
110534399|NCT02842931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110534400|NCT02842931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110471568|NCT03218085|Antiviral Agents|antiviral agents|mesh-ancestor
110471569|NCT03218085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110471570|NCT03218085|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110471571|NCT03218085|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110471572|NCT03218085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110471573|NCT03218085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110471574|NCT03218085|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110471575|NCT03218085|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110471576|NCT03197077|Contraceptive Agents|contraceptive agents|mesh-list
110471577|NCT03197077|Desogestrel|desogestrel|mesh-list
110471578|NCT03197077|Contraceptives, Oral|contraceptives, oral|mesh-list
110471579|NCT03197077|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
110471580|NCT03197077|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
110471581|NCT03197077|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110471582|NCT03197077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110471583|NCT03197077|Hormones|hormones|mesh-ancestor
110471584|NCT03197077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110471585|NCT03197077|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110471586|NCT03197077|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110471587|NCT03197077|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110471588|NCT03197077|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110471589|NCT03197077|Progestins|progestins|mesh-ancestor
110471590|NCT03153280|Capecitabine|capecitabine|mesh-list
110471591|NCT03153280|Oxaliplatin|oxaliplatin|mesh-list
110471592|NCT03153280|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110471593|NCT03153280|Antimetabolites|antimetabolites|mesh-ancestor
110471594|NCT03153280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110471595|NCT03153280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110471596|NCT03098836|Prednisone|prednisone|mesh-list
110471597|NCT03098836|Abiraterone Acetate|abiraterone acetate|mesh-list
110471598|NCT03098836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110471599|NCT03098836|Glucocorticoids|glucocorticoids|mesh-ancestor
110471600|NCT03098836|Hormones|hormones|mesh-ancestor
110471601|NCT03098836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110471602|NCT03098836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110471603|NCT03098836|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110471604|NCT03098836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110471605|NCT03098836|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110471606|NCT03098836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110471607|NCT03098836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110471608|NCT03098836|Hormone Antagonists|hormone antagonists|mesh-ancestor
110471609|NCT03098836|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110471610|NCT03078855|Vitamin D|vitamin d|mesh-list
110471611|NCT03078855|Cholecalciferol|cholecalciferol|mesh-list
110471612|NCT03078855|Rituximab|rituximab|mesh-list
110471613|NCT03078855|Vitamins|vitamins|mesh-ancestor
110471614|NCT03078855|Micronutrients|micronutrients|mesh-ancestor
110471615|NCT03078855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110471616|NCT03078855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110471617|NCT03078855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110471618|NCT03078855|Immunologic Factors|immunologic factors|mesh-ancestor
110471619|NCT03078855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110471620|NCT03078855|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110471621|NCT03078855|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110471622|NCT03007979|Letrozole|letrozole|mesh-list
110471623|NCT03007979|Fulvestrant|fulvestrant|mesh-list
110471624|NCT03007979|Palbociclib|palbociclib|mesh-list
110471625|NCT03007979|Goserelin|goserelin|mesh-list
110471626|NCT03007979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110471627|NCT03007979|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110471628|NCT03007979|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110471629|NCT03007979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110033564|NCT03180294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110534401|NCT02842931|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110534402|NCT02842931|Alkylating Agents|alkylating agents|mesh-ancestor
110534403|NCT02842931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110534404|NCT02842931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110534405|NCT02842931|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110534406|NCT02842931|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110534407|NCT02842931|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110534408|NCT02842931|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110471630|NCT03007979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110471631|NCT03007979|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110471632|NCT03007979|Hormone Antagonists|hormone antagonists|mesh-ancestor
110471633|NCT03007979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110471634|NCT03007979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110471635|NCT03007979|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110471636|NCT03007979|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110471637|NCT03007979|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110471638|NCT02912572|Avelumab|avelumab|mesh-list
110471639|NCT02912572|Axitinib|axitinib|mesh-list
110471640|NCT02912572|Talazoparib|talazoparib|mesh-list
110471641|NCT02912572|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110471642|NCT02912572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110471643|NCT02912572|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110471645|NCT02912572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110471646|NCT02912572|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110471648|NCT02910414|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110471649|NCT02910414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110471650|NCT02910414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110471651|NCT02910414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110471652|NCT02867813|Evolocumab|evolocumab|mesh-list
110471653|NCT02867813|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
110471654|NCT02867813|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110471655|NCT02867813|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110471656|NCT02867813|Antimetabolites|antimetabolites|mesh-ancestor
110471657|NCT02867813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110471658|NCT02867813|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110471659|NCT02867813|Protease Inhibitors|protease inhibitors|mesh-ancestor
110471660|NCT02867813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110471661|NCT02867813|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110471662|NCT02845596|Cyclosporine|cyclosporine|mesh-list
110471663|NCT02845596|Cyclophosphamide|cyclophosphamide|mesh-list
110471664|NCT02845596|Methotrexate|methotrexate|mesh-list
110471665|NCT02845596|Fludarabine|fludarabine|mesh-list
110471666|NCT02845596|Cyclosporins|cyclosporins|mesh-list
110471667|NCT02845596|Thymoglobulin|thymoglobulin|mesh-list
110471668|NCT02845596|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110471669|NCT02845596|Immunosuppressive Agents|immunosuppressive agents|mesh-list
110471670|NCT02845596|Immunologic Factors|immunologic factors|mesh-ancestor
110471671|NCT02845596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110471672|NCT02845596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110471673|NCT02845596|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110471674|NCT02845596|Alkylating Agents|alkylating agents|mesh-ancestor
110471675|NCT02845596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110471676|NCT02845596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110471677|NCT02845596|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110471678|NCT02845596|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110471679|NCT02845596|Abortifacient Agents|abortifacient agents|mesh-ancestor
110471680|NCT02845596|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110471681|NCT02845596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110471682|NCT02845596|Antimetabolites|antimetabolites|mesh-ancestor
110471683|NCT02845596|Dermatologic Agents|dermatologic agents|mesh-ancestor
110471684|NCT02845596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110471685|NCT02845596|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110471686|NCT02845596|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110471687|NCT02845596|Antifungal Agents|antifungal agents|mesh-ancestor
110534409|NCT02842931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110534410|NCT02842931|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110534411|NCT02842931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110534412|NCT02842931|Glucocorticoids|glucocorticoids|mesh-ancestor
110534414|NCT02842931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110534415|NCT02842931|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110534416|NCT02842931|Tubulin Modulators|tubulin modulators|mesh-ancestor
110534417|NCT02842931|Antimitotic Agents|antimitotic agents|mesh-ancestor
110534418|NCT02842931|Mitosis Modulators|mitosis modulators|mesh-ancestor
110471688|NCT02845596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110471689|NCT02845596|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110471691|NCT02737787|Vaccines|vaccines|mesh-list
110471692|NCT02737787|Immunologic Factors|immunologic factors|mesh-ancestor
110471693|NCT02737787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110471694|NCT02737787|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110471695|NCT02737787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110471696|NCT02737787|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110471697|NCT02737787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110471698|NCT02646839|Biotin|biotin|mesh-list
110471699|NCT02646839|Vitamin B Complex|vitamin b complex|mesh-ancestor
110471700|NCT02646839|Vitamins|vitamins|mesh-ancestor
110471701|NCT02646839|Micronutrients|micronutrients|mesh-ancestor
110471702|NCT02646839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110471703|NCT02494570|Sirolimus|sirolimus|mesh-list
110471704|NCT02494570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110471705|NCT02494570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110471706|NCT02494570|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110471707|NCT02494570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110471708|NCT02494570|Antifungal Agents|antifungal agents|mesh-ancestor
110471709|NCT02494570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110471710|NCT02494570|Immunologic Factors|immunologic factors|mesh-ancestor
110471711|NCT02494570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110471712|NCT02437071|Pembrolizumab|pembrolizumab|mesh-list
110471713|NCT02437071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110471714|NCT02437071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110471715|NCT02437071|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110471716|NCT02437071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110471717|NCT02341274|Tacrolimus|tacrolimus|mesh-list
110471718|NCT02341274|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110471719|NCT02341274|Immunologic Factors|immunologic factors|mesh-ancestor
110471720|NCT02341274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110471721|NCT02341274|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110471722|NCT02341274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110471723|NCT02341274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110471724|NCT02256865|Ketoconazole|ketoconazole|mesh-list
110471725|NCT02256865|Hydrocortisone|hydrocortisone|mesh-list
110471726|NCT02256865|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
110471727|NCT02256865|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
110471728|NCT02256865|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
110471729|NCT02256865|Methyltestosterone|methyltestosterone|mesh-list
110471730|NCT02256865|Testosterone|testosterone|mesh-list
110471731|NCT02256865|Testosterone undecanoate|testosterone undecanoate|mesh-list
110471732|NCT02256865|Testosterone enanthate|testosterone enanthate|mesh-list
110471733|NCT02256865|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
110471734|NCT02256865|Androgens|androgens|mesh-ancestor
110471735|NCT02256865|Hormones|hormones|mesh-ancestor
110471736|NCT02256865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110471737|NCT02256865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110471738|NCT02256865|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110471739|NCT02256865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110471740|NCT02256865|Anabolic Agents|anabolic agents|mesh-ancestor
110471741|NCT02256865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110471742|NCT02256865|Antifungal Agents|antifungal agents|mesh-ancestor
110471743|NCT02256865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110534420|NCT04183296|Sevoflurane|sevoflurane|mesh-list
110534421|NCT04183296|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110534422|NCT04183296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110534423|NCT04183296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110534424|NCT04183296|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110534425|NCT04183296|Anesthetics, General|anesthetics, general|mesh-ancestor
110534426|NCT04183296|Anesthetics|anesthetics|mesh-ancestor
110534427|NCT04183296|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110534428|NCT04183296|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110534429|NCT00642408|Micronutrients|micronutrients|mesh-list
110471744|NCT02256865|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110471745|NCT02256865|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110471746|NCT02256865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110471747|NCT02256865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110471748|NCT02256865|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110471749|NCT02256865|Hormone Antagonists|hormone antagonists|mesh-ancestor
110471750|NCT02256865|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110471751|NCT02231879|Plerixafor|plerixafor|mesh-list
110471752|NCT02231879|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110471753|NCT02231879|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110471754|NCT02231879|Antiviral Agents|antiviral agents|mesh-ancestor
110471755|NCT02231879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110471756|NCT01968460|Pramipexole|pramipexole|mesh-list
110471757|NCT01968460|Rasagiline|rasagiline|mesh-list
110471758|NCT01968460|Antioxidants|antioxidants|mesh-ancestor
110471759|NCT01968460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110471760|NCT01968460|Protective Agents|protective agents|mesh-ancestor
110471761|NCT01968460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110471762|NCT01968460|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110471763|NCT01968460|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110471764|NCT01968460|Dopamine Agonists|dopamine agonists|mesh-ancestor
110471765|NCT01968460|Dopamine Agents|dopamine agents|mesh-ancestor
110471766|NCT01968460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110471767|NCT01968460|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
110471768|NCT01968460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110471769|NCT01968460|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110471770|NCT01712490|Doxorubicin|doxorubicin|mesh-list
110471771|NCT01712490|Bleomycin|bleomycin|mesh-list
110471772|NCT01712490|Dacarbazine|dacarbazine|mesh-list
110471773|NCT01712490|Brentuximab Vedotin|brentuximab vedotin|mesh-list
110471774|NCT01712490|Vinblastine|vinblastine|mesh-list
110471775|NCT01712490|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110471776|NCT01712490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110471777|NCT01712490|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110471778|NCT01712490|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110471779|NCT01712490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110471780|NCT01712490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110471781|NCT01712490|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110471782|NCT01712490|Alkylating Agents|alkylating agents|mesh-ancestor
110471783|NCT01712490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110471784|NCT01712490|Immunotoxins|immunotoxins|mesh-ancestor
110471785|NCT01712490|Immunoconjugates|immunoconjugates|mesh-ancestor
110471786|NCT01712490|Immunologic Factors|immunologic factors|mesh-ancestor
110471787|NCT01712490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110471788|NCT01712490|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110164992|NCT00022204|Antioxidants|antioxidants|mesh-ancestor
110471790|NCT01712490|Antimitotic Agents|antimitotic agents|mesh-ancestor
110471791|NCT01712490|Mitosis Modulators|mitosis modulators|mesh-ancestor
110471792|NCT01527747|Saxagliptin|saxagliptin|mesh-list
110471793|NCT01527747|Incretins|incretins|mesh-ancestor
110471794|NCT01527747|Hormones|hormones|mesh-ancestor
110471795|NCT01527747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110471796|NCT01527747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110471797|NCT01527747|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110471798|NCT01527747|Protease Inhibitors|protease inhibitors|mesh-ancestor
110534430|NCT00642408|Trace Elements|trace elements|mesh-list
110534431|NCT00642408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110534432|NCT02678598|Micafungin|micafungin|mesh-list
110534433|NCT02678598|Antifungal Agents|antifungal agents|mesh-ancestor
110534434|NCT02678598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110534435|NCT02359019|Pembrolizumab|pembrolizumab|mesh-list
110534436|NCT02359019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110534437|NCT02359019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110534438|NCT02359019|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110534439|NCT02359019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110534440|NCT02678364|Vitamin D|vitamin d|mesh-list
110534441|NCT02678364|Cholecalciferol|cholecalciferol|mesh-list
110534442|NCT02678364|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
110534443|NCT02678364|Calcifediol|calcifediol|mesh-list
110534444|NCT02678364|Vitamins|vitamins|mesh-ancestor
110534445|NCT02678364|Micronutrients|micronutrients|mesh-ancestor
110534446|NCT02678364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110534447|NCT02678364|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110534448|NCT02678364|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110534449|NCT02678208|Tranexamic Acid|tranexamic acid|mesh-list
110534450|NCT02678208|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110534451|NCT02678208|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110471799|NCT01527747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110471800|NCT01527747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110471801|NCT01527747|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110471802|NCT01439802|Copper|copper|mesh-list
110471803|NCT01439802|Trace Elements|trace elements|mesh-ancestor
110471804|NCT01439802|Micronutrients|micronutrients|mesh-ancestor
110471805|NCT01439802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110471806|NCT01434316|Veliparib|veliparib|mesh-list
110471807|NCT01434316|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110471808|NCT01434316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110471809|NCT01434316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110471810|NCT01434316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110471811|NCT00646230|Fenretinide|fenretinide|mesh-list
110471812|NCT00646230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110471813|NCT00646230|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110471814|NCT00646230|Protective Agents|protective agents|mesh-ancestor
110471815|NCT00646230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110471816|NCT00544414|Leucovorin|leucovorin|mesh-list
110471817|NCT00544414|Gemcitabine|gemcitabine|mesh-list
110471818|NCT00544414|Docetaxel|docetaxel|mesh-list
110471819|NCT00544414|Fluorouracil|fluorouracil|mesh-list
110471820|NCT00544414|Calcium|calcium|mesh-list
110471821|NCT00544414|Levoleucovorin|levoleucovorin|mesh-list
110471822|NCT00544414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110471823|NCT00544414|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110471824|NCT00544414|Antimetabolites|antimetabolites|mesh-ancestor
110471825|NCT00544414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110471826|NCT00544414|Tubulin Modulators|tubulin modulators|mesh-ancestor
110471827|NCT00544414|Antimitotic Agents|antimitotic agents|mesh-ancestor
110471828|NCT00544414|Mitosis Modulators|mitosis modulators|mesh-ancestor
110471829|NCT00544414|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110471830|NCT00544414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110471831|NCT00544414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110534452|NCT02678208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110534453|NCT02678208|Hemostatics|hemostatics|mesh-ancestor
110534454|NCT02678208|Coagulants|coagulants|mesh-ancestor
110534455|NCT05551182|Nicergoline|nicergoline|mesh-list
110534456|NCT05551182|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110534457|NCT05551182|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110534458|NCT05551182|Adrenergic Agents|adrenergic agents|mesh-ancestor
110534459|NCT05551182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110534460|NCT05551182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110534461|NCT05551182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110534462|NCT05551182|Vasodilator Agents|vasodilator agents|mesh-ancestor
110471832|NCT00544414|Immunologic Factors|immunologic factors|mesh-ancestor
110471833|NCT00544414|Antidotes|antidotes|mesh-ancestor
110471834|NCT00544414|Protective Agents|protective agents|mesh-ancestor
110471835|NCT00544414|Vitamin B Complex|vitamin b complex|mesh-ancestor
110471836|NCT00544414|Vitamins|vitamins|mesh-ancestor
110471837|NCT00544414|Micronutrients|micronutrients|mesh-ancestor
110471838|NCT00816556|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110471839|NCT00816556|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110471840|NCT00816556|Estradiol|estradiol|mesh-list
110471841|NCT00816556|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110471842|NCT00816556|Estrogens|estrogens|mesh-ancestor
110471843|NCT00816556|Hormones|hormones|mesh-ancestor
110471844|NCT00816556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110471845|NCT00816556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110471846|NCT00816556|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110471847|NCT00816556|Contraceptive Agents|contraceptive agents|mesh-ancestor
110471848|NCT00816556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110471849|NCT00816556|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110471850|NCT04100473|Insulin|insulin|mesh-list
110471851|NCT04100473|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110471852|NCT04100473|Insulin Lispro|insulin lispro|mesh-list
110471853|NCT04100473|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110471854|NCT04100473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110471855|NCT02796807|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
110471856|NCT02796807|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110471857|NCT02796807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110471858|NCT00760747|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
110471859|NCT00760747|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110471860|NCT00760747|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110471861|NCT00760747|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110471862|NCT00760747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110471863|NCT00760747|Adrenergic Agents|adrenergic agents|mesh-ancestor
110471864|NCT00760747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110471865|NCT00760747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110471866|NCT00760669|Infliximab|infliximab|mesh-list
110471867|NCT00760669|Methotrexate|methotrexate|mesh-list
110471868|NCT00760669|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110471869|NCT00760669|Abortifacient Agents|abortifacient agents|mesh-ancestor
110471870|NCT00760669|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110471871|NCT00760669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110471872|NCT00760669|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110471873|NCT00760669|Antimetabolites|antimetabolites|mesh-ancestor
110471874|NCT00760669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110471876|NCT00760669|Dermatologic Agents|dermatologic agents|mesh-ancestor
110471877|NCT00760669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110471878|NCT00760669|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110471879|NCT00760669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110471880|NCT00760669|Immunologic Factors|immunologic factors|mesh-ancestor
110471881|NCT00760669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110471882|NCT00760669|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110471883|NCT00760669|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110471884|NCT00760669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110534463|NCT05551182|Nootropic Agents|nootropic agents|mesh-ancestor
110534465|NCT02677584|Caffeine citrate|caffeine citrate|mesh-list
110534466|NCT02677584|Citric Acid|citric acid|mesh-list
110534467|NCT02677584|Sodium Citrate|sodium citrate|mesh-list
110534468|NCT02677584|Anticoagulants|anticoagulants|mesh-ancestor
110534469|NCT02677584|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110534470|NCT02677584|Chelating Agents|chelating agents|mesh-ancestor
110534471|NCT02677584|Sequestering Agents|sequestering agents|mesh-ancestor
110534472|NCT02677584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110534473|NCT02677584|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110534474|NCT02677584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110534475|NCT02677584|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110199114|NCT00079092|Thalidomide|thalidomide|mesh-list
110471885|NCT00760669|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110471886|NCT02796183|Bevacizumab|bevacizumab|mesh-list
110471887|NCT02796183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110471888|NCT02796183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110471889|NCT02796183|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110471890|NCT02796183|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110471891|NCT02796183|Growth Substances|growth substances|mesh-ancestor
110471892|NCT02796183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110471893|NCT02796183|Growth Inhibitors|growth inhibitors|mesh-ancestor
110471894|NCT02796105|Ganirelix|ganirelix|mesh-list
110471895|NCT02796105|Hormone Antagonists|hormone antagonists|mesh-ancestor
110471896|NCT02796105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110471897|NCT02796105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110471898|NCT02795949|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110471899|NCT02795949|Amoxicillin|amoxicillin|mesh-list
110471900|NCT02795949|Ciprofloxacin|ciprofloxacin|mesh-list
110471901|NCT02795949|Meropenem|meropenem|mesh-list
110471902|NCT02795949|Tazobactam|tazobactam|mesh-list
110471903|NCT02795949|Piperacillin|piperacillin|mesh-list
110471904|NCT02795949|Clavulanic Acid|clavulanic acid|mesh-list
110471905|NCT02795949|Imipenem|imipenem|mesh-list
110471906|NCT02795949|Ceftazidime|ceftazidime|mesh-list
110471907|NCT02795949|Ampicillin|ampicillin|mesh-list
110471908|NCT02795949|Cefepime|cefepime|mesh-list
110471909|NCT02795949|Ertapenem|ertapenem|mesh-list
110471910|NCT02795949|Cefuroxime|cefuroxime|mesh-list
110471911|NCT02795949|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
110471912|NCT02795949|Lactams|lactams|mesh-list
110471913|NCT02795949|Aztreonam|aztreonam|mesh-list
110471914|NCT02795949|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
110471915|NCT02795949|beta-Lactams|beta-lactams|mesh-list
110471916|NCT02795949|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
110471917|NCT02795949|Trimethoprim|trimethoprim|mesh-list
110471918|NCT02795949|Sulfamethoxazole|sulfamethoxazole|mesh-list
110471919|NCT02795949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110471920|NCT02795949|Antitubercular Agents|antitubercular agents|mesh-ancestor
110471921|NCT02795949|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110471922|NCT02795949|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110471923|NCT02795949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110471924|NCT02795949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110471925|NCT02795949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110471926|NCT02795949|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110471927|NCT02795949|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110471928|NCT02795949|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110471929|NCT02795949|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110471930|NCT02795949|Antimalarials|antimalarials|mesh-ancestor
110471931|NCT02795949|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110471933|NCT02795949|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110471934|NCT02795949|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110471935|NCT02795949|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
110471936|NCT00769483|Gemcitabine|gemcitabine|mesh-list
110534476|NCT02677584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110534477|NCT02677584|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110534478|NCT02677584|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110534479|NCT02677584|Purinergic Agents|purinergic agents|mesh-ancestor
110534480|NCT02677584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110534481|NCT05662956|Azacitidine|azacitidine|mesh-list
110534482|NCT05662956|Venetoclax|venetoclax|mesh-list
110534483|NCT05662956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110534484|NCT05662956|Antimetabolites|antimetabolites|mesh-ancestor
110534485|NCT05662956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110471937|NCT00769483|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110471938|NCT00769483|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110471939|NCT00769483|Antimetabolites|antimetabolites|mesh-ancestor
110471940|NCT00769483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110471941|NCT00769483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110471942|NCT00769483|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110471943|NCT00769483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110471944|NCT02794389|Acetylcysteine|acetylcysteine|mesh-list
110471945|NCT02794389|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110471946|NCT02794389|Antiviral Agents|antiviral agents|mesh-ancestor
110471947|NCT02794389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110471948|NCT02794389|Expectorants|expectorants|mesh-ancestor
110471949|NCT02794389|Respiratory System Agents|respiratory system agents|mesh-ancestor
110471950|NCT02794389|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110471951|NCT02794389|Antioxidants|antioxidants|mesh-ancestor
110471952|NCT02794389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110471953|NCT02794389|Protective Agents|protective agents|mesh-ancestor
110471954|NCT02794389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110471955|NCT02794389|Antidotes|antidotes|mesh-ancestor
110471956|NCT02601703|Tacrolimus|tacrolimus|mesh-list
110471957|NCT02601703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110471958|NCT02601703|Immunologic Factors|immunologic factors|mesh-ancestor
110471959|NCT02601703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110471960|NCT02601703|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110471961|NCT02601703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110471962|NCT02601703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110471963|NCT04234191|Buprenorphine|buprenorphine|mesh-list
110471964|NCT04234191|Hydromorphone|hydromorphone|mesh-list
110471965|NCT04234191|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
110471966|NCT04234191|Naloxone|naloxone|mesh-list
110471967|NCT04234191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110471968|NCT04234191|Narcotics|narcotics|mesh-ancestor
110471969|NCT04234191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110471970|NCT04234191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110471971|NCT04234191|Analgesics|analgesics|mesh-ancestor
110471972|NCT04234191|Sensory System Agents|sensory system agents|mesh-ancestor
110471973|NCT04234191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110471974|NCT04234191|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110471975|NCT02801799|Ropivacaine|ropivacaine|mesh-list
110471976|NCT02801799|Anesthetics, Local|anesthetics, local|mesh-ancestor
110471977|NCT02801799|Anesthetics|anesthetics|mesh-ancestor
110471978|NCT02801799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110471979|NCT02801799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110471980|NCT02801799|Sensory System Agents|sensory system agents|mesh-ancestor
110471981|NCT02801799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110471982|NCT02690103|Ribavirin|ribavirin|mesh-list
110471983|NCT02690103|Antimetabolites|antimetabolites|mesh-ancestor
110471984|NCT02690103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110471985|NCT02690103|Antiviral Agents|antiviral agents|mesh-ancestor
110471986|NCT02690103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110471987|NCT02790099|Morphine|morphine|mesh-list
110471988|NCT02790099|Bupivacaine|bupivacaine|mesh-list
110471989|NCT02790099|Anesthetics, Local|anesthetics, local|mesh-ancestor
110471990|NCT02790099|Anesthetics|anesthetics|mesh-ancestor
110471991|NCT02790099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110471992|NCT02790099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110534486|NCT05662956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110534487|NCT05662956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110534488|NCT02838173|Ropivacaine|ropivacaine|mesh-list
110534489|NCT02838173|Anesthetics, Local|anesthetics, local|mesh-ancestor
110534490|NCT02838173|Anesthetics|anesthetics|mesh-ancestor
110534491|NCT02838173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110534492|NCT02838173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110534493|NCT02838173|Sensory System Agents|sensory system agents|mesh-ancestor
110534494|NCT02838173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110534495|NCT00641472|Budesonide|budesonide|mesh-list
110534496|NCT00641472|Montelukast|montelukast|mesh-list
110534497|NCT00641472|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110534498|NCT00641472|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110534499|NCT00641472|Autonomic Agents|autonomic agents|mesh-ancestor
110534500|NCT00641472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110534501|NCT00641472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110534502|NCT00641472|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110534503|NCT00641472|Respiratory System Agents|respiratory system agents|mesh-ancestor
110534504|NCT00641472|Glucocorticoids|glucocorticoids|mesh-ancestor
110471993|NCT02790099|Sensory System Agents|sensory system agents|mesh-ancestor
110471994|NCT02790099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110471995|NCT02790099|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110471996|NCT02790099|Narcotics|narcotics|mesh-ancestor
110471997|NCT02790099|Analgesics|analgesics|mesh-ancestor
110471998|NCT02790177|Hyaluronic Acid|hyaluronic acid|mesh-list
110471999|NCT02790177|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110472000|NCT02790177|Immunologic Factors|immunologic factors|mesh-ancestor
110472001|NCT02790177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110472002|NCT02790177|Viscosupplements|viscosupplements|mesh-ancestor
110472003|NCT02790177|Protective Agents|protective agents|mesh-ancestor
110472004|NCT04100083|Spironolactone|spironolactone|mesh-list
110472005|NCT04100083|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110472006|NCT04100083|Hormone Antagonists|hormone antagonists|mesh-ancestor
110472007|NCT04100083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110472008|NCT04100083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110472009|NCT04100083|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110472010|NCT04100083|Diuretics|diuretics|mesh-ancestor
110472011|NCT04100083|Natriuretic Agents|natriuretic agents|mesh-ancestor
110472012|NCT02794155|Insulin|insulin|mesh-list
110472013|NCT02794155|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110472014|NCT02794155|Insulin Lispro|insulin lispro|mesh-list
110472015|NCT02794155|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110472016|NCT02794155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110472017|NCT02793843|Dexamethasone|dexamethasone|mesh-list
110472018|NCT02793843|Ondansetron|ondansetron|mesh-list
110472019|NCT02793843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110472020|NCT02793843|Antiemetics|antiemetics|mesh-ancestor
110472021|NCT02793843|Autonomic Agents|autonomic agents|mesh-ancestor
110472022|NCT02793843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110472023|NCT02793843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110472024|NCT02793843|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110472025|NCT02793843|Glucocorticoids|glucocorticoids|mesh-ancestor
110472026|NCT02793843|Hormones|hormones|mesh-ancestor
110472027|NCT02793843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110472028|NCT02793843|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110472029|NCT02793843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110472030|NCT02793843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110472031|NCT02793843|Antipruritics|antipruritics|mesh-ancestor
110534505|NCT00641472|Hormones|hormones|mesh-ancestor
110534506|NCT00641472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110534507|NCT00641472|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110534508|NCT00641472|Hormone Antagonists|hormone antagonists|mesh-ancestor
110534509|NCT00641472|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110534510|NCT00641472|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110534511|NCT00641472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110534512|NCT00896051|Ritonavir|ritonavir|mesh-list
110534513|NCT00896051|Atazanavir Sulfate|atazanavir sulfate|mesh-list
110534514|NCT00896051|Tenofovir|tenofovir|mesh-list
110472032|NCT02793843|Dermatologic Agents|dermatologic agents|mesh-ancestor
110472033|NCT02793843|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110472034|NCT02793843|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110472035|NCT02793843|Serotonin Agents|serotonin agents|mesh-ancestor
110472036|NCT02793843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110472037|NCT02793687|Emoxypine succinate|emoxypine succinate|mesh-list
110472038|NCT02793687|Antioxidants|antioxidants|mesh-ancestor
110472039|NCT02793687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110472040|NCT02793687|Protective Agents|protective agents|mesh-ancestor
110472041|NCT02793687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110472042|NCT02793687|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110472043|NCT02793687|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110472044|NCT02801487|Cisplatin|cisplatin|mesh-list
110472045|NCT02801487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110472046|NCT02793765|Docetaxel|docetaxel|mesh-list
110472047|NCT02793765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110472048|NCT02793765|Tubulin Modulators|tubulin modulators|mesh-ancestor
110472049|NCT02793765|Antimitotic Agents|antimitotic agents|mesh-ancestor
110472050|NCT02793765|Mitosis Modulators|mitosis modulators|mesh-ancestor
110472051|NCT02793765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110472052|NCT02793219|Docetaxel|docetaxel|mesh-list
110472053|NCT02793219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110472054|NCT02793219|Tubulin Modulators|tubulin modulators|mesh-ancestor
110472055|NCT02793219|Antimitotic Agents|antimitotic agents|mesh-ancestor
110472056|NCT02793219|Mitosis Modulators|mitosis modulators|mesh-ancestor
110472057|NCT02793219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110472058|NCT02801409|Anesthetics|anesthetics|mesh-list
110472059|NCT02801409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110472060|NCT02801409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110472061|NCT03787251|Apatinib|apatinib|mesh-list
110472062|NCT03787251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110472063|NCT03787251|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110472064|NCT03787251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110472065|NCT03787251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110472066|NCT02789865|Metronidazole|metronidazole|mesh-list
110472067|NCT02789865|Levofloxacin|levofloxacin|mesh-list
110472068|NCT02789865|Ertapenem|ertapenem|mesh-list
110472069|NCT02789865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110472070|NCT02789865|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110472071|NCT02789865|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110472072|NCT02789865|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110472073|NCT02789865|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110472074|NCT02789865|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110472075|NCT02789865|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110472076|NCT02789865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110472077|NCT02789865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110472078|NCT02789865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110472079|NCT02789865|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110472080|NCT02789865|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110472081|NCT02792673|Hyaluronic Acid|hyaluronic acid|mesh-list
110472082|NCT02792673|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110472083|NCT02792673|Immunologic Factors|immunologic factors|mesh-ancestor
110472084|NCT02792673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110472085|NCT02792673|Viscosupplements|viscosupplements|mesh-ancestor
110472086|NCT02792673|Protective Agents|protective agents|mesh-ancestor
110534516|NCT00896051|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
110534517|NCT00896051|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110182015|NCT00022191|Antimetabolites|antimetabolites|mesh-ancestor
110534518|NCT00896051|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110534519|NCT00896051|Protease Inhibitors|protease inhibitors|mesh-ancestor
110534520|NCT00896051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110199354|NCT00045539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110472087|NCT00906204|Thymoglobulin|thymoglobulin|mesh-list
110472088|NCT00906204|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110472089|NCT00906204|Immunologic Factors|immunologic factors|mesh-ancestor
110472090|NCT00906204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110472091|NCT00906204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110472092|NCT02794077|Cyclophosphamide|cyclophosphamide|mesh-list
110472093|NCT02794077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110472094|NCT02794077|Immunologic Factors|immunologic factors|mesh-ancestor
110472095|NCT02794077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110472096|NCT02794077|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110472097|NCT02794077|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110472098|NCT02794077|Alkylating Agents|alkylating agents|mesh-ancestor
110472099|NCT02794077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110472100|NCT02794077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110472101|NCT02794077|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110472102|NCT02791737|Coal Tar|coal tar|mesh-list
110472103|NCT02791737|Keratolytic Agents|keratolytic agents|mesh-ancestor
110472104|NCT02791737|Dermatologic Agents|dermatologic agents|mesh-ancestor
110472105|NCT02535936|Anesthetics|anesthetics|mesh-list
110472106|NCT02535936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110472107|NCT02535936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110472108|NCT05332470|Lamivudine|lamivudine|mesh-list
110472109|NCT05332470|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110472110|NCT05332470|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110472111|NCT05332470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110472112|NCT05332470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110472113|NCT05332470|Antiviral Agents|antiviral agents|mesh-ancestor
110472114|NCT05332470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110472115|NCT05332470|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110472116|NCT05332470|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110472117|NCT02791815|Selexipag|selexipag|mesh-list
110472118|NCT02791815|Midazolam|midazolam|mesh-list
110472119|NCT02791815|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110472120|NCT02791815|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110472121|NCT02791815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110472122|NCT02791815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110472123|NCT02791815|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110472124|NCT02791815|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110472125|NCT02791815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110472126|NCT02791815|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110472127|NCT02791815|Anesthetics, General|anesthetics, general|mesh-ancestor
110472128|NCT02791815|Anesthetics|anesthetics|mesh-ancestor
110472129|NCT02791815|GABA Modulators|gaba modulators|mesh-ancestor
110472130|NCT02791815|GABA Agents|gaba agents|mesh-ancestor
110472131|NCT02791815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110472132|NCT02791815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110472133|NCT02791815|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110472134|NCT02389374|Chloroquine|chloroquine|mesh-list
110472135|NCT02389374|Lumefantrine|lumefantrine|mesh-list
110472136|NCT02389374|Artemether|artemether|mesh-list
110472137|NCT02389374|Primaquine|primaquine|mesh-list
110472138|NCT02389374|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
110472139|NCT02389374|Amebicides|amebicides|mesh-ancestor
110472140|NCT02389374|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110472141|NCT02389374|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110472142|NCT02389374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110472143|NCT02389374|Antimalarials|antimalarials|mesh-ancestor
110472144|NCT02389374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110472145|NCT02789475|Amlodipine|amlodipine|mesh-list
110472146|NCT02789475|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110472147|NCT02789475|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110472148|NCT02789475|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110534521|NCT00896051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110534522|NCT00896051|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110534523|NCT00896051|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110534524|NCT00896051|Antiviral Agents|antiviral agents|mesh-ancestor
110534525|NCT00896051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110534526|NCT00896051|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110534527|NCT00896051|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110534528|NCT00896051|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110534529|NCT02673606|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110534530|NCT02673606|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110534532|NCT02673606|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110472149|NCT02789475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110472150|NCT02789475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110472151|NCT02789475|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110472152|NCT02789475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110472153|NCT02789475|Vasodilator Agents|vasodilator agents|mesh-ancestor
110472154|NCT02789475|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110472155|NCT02789475|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110472156|NCT02789475|Antimetabolites|antimetabolites|mesh-ancestor
110472157|NCT02789475|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110599099|NCT04742660|Glycyrrhizic Acid|glycyrrhizic acid|mesh-list
110472158|NCT02789475|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110472159|NCT02789475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110472160|NCT04202484|Oxaliplatin|oxaliplatin|mesh-list
110472161|NCT04202484|Tegafur|tegafur|mesh-list
110472162|NCT04202484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110472163|NCT04202484|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110472164|NCT04202484|Antimetabolites|antimetabolites|mesh-ancestor
110472165|NCT04202484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110472166|NCT03068910|Spironolactone|spironolactone|mesh-list
110472167|NCT03068910|Progesterone|progesterone|mesh-list
110472168|NCT03068910|Progestins|progestins|mesh-ancestor
110472169|NCT03068910|Hormones|hormones|mesh-ancestor
110472170|NCT03068910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110472171|NCT03068910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110472172|NCT03068910|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110472173|NCT03068910|Hormone Antagonists|hormone antagonists|mesh-ancestor
110472174|NCT03068910|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110472175|NCT03068910|Diuretics|diuretics|mesh-ancestor
110472176|NCT03068910|Natriuretic Agents|natriuretic agents|mesh-ancestor
110472177|NCT02790957|Plerixafor|plerixafor|mesh-list
110472178|NCT02790957|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110472179|NCT02790957|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110472180|NCT02790957|Antiviral Agents|antiviral agents|mesh-ancestor
110472181|NCT02790957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110472182|NCT00905424|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
110472183|NCT00905424|Antidepressive Agents|antidepressive agents|mesh-list
110472184|NCT00905424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110472185|NCT00905424|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110472186|NCT00905424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110472187|NCT00905424|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110472188|NCT00905424|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110472189|NCT00905424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110472190|NCT00905424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110472191|NCT00905424|Dopamine Agents|dopamine agents|mesh-ancestor
110472192|NCT00905424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110472194|NCT02791035|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110472195|NCT02791035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110472196|NCT02791035|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110472197|NCT02791035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110472198|NCT03753243|Pembrolizumab|pembrolizumab|mesh-list
110033566|NCT03071601|Epinephrine|epinephrine|mesh-list
110534533|NCT02673606|Estrogens|estrogens|mesh-ancestor
110534534|NCT02673606|Hormones|hormones|mesh-ancestor
110534535|NCT02673606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110534536|NCT02673606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110534537|NCT02673606|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110534538|NCT02673606|Contraceptive Agents|contraceptive agents|mesh-ancestor
110534539|NCT02673606|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110534540|NCT02673606|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110534541|NCT02675400|Methylphenidate|methylphenidate|mesh-list
110534542|NCT02675400|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
110472199|NCT03753243|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110472200|NCT03753243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110599129|NCT01005914|Hormones|hormones|mesh-ancestor
110472201|NCT03753243|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110472202|NCT03753243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110472203|NCT02339532|Carboplatin|carboplatin|mesh-list
110472204|NCT02339532|Docetaxel|docetaxel|mesh-list
110472205|NCT02339532|Trastuzumab|trastuzumab|mesh-list
110472206|NCT02339532|Pertuzumab|pertuzumab|mesh-list
110472207|NCT02339532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110472208|NCT02339532|Tubulin Modulators|tubulin modulators|mesh-ancestor
110472209|NCT02339532|Antimitotic Agents|antimitotic agents|mesh-ancestor
110472210|NCT02339532|Mitosis Modulators|mitosis modulators|mesh-ancestor
110472211|NCT02339532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110472212|NCT02339532|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110472213|NCT00632580|Ropivacaine|ropivacaine|mesh-list
110472214|NCT00632580|Anesthetics, Local|anesthetics, local|mesh-ancestor
110472215|NCT00632580|Anesthetics|anesthetics|mesh-ancestor
110472216|NCT00632580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110472217|NCT00632580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110472218|NCT00632580|Sensory System Agents|sensory system agents|mesh-ancestor
110472219|NCT00632580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110472220|NCT02789397|Rituximab|rituximab|mesh-list
110472221|NCT02789397|Azathioprine|azathioprine|mesh-list
110472222|NCT02789397|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110472223|NCT02789397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110472224|NCT02789397|Immunologic Factors|immunologic factors|mesh-ancestor
110472225|NCT02789397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110472226|NCT02789397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110472227|NCT02789397|Antimetabolites|antimetabolites|mesh-ancestor
110472228|NCT02789397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110472229|NCT02789397|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110472230|NCT02789397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110472231|NCT00816166|Aspirin|aspirin|mesh-list
110472232|NCT00816166|Clopidogrel|clopidogrel|mesh-list
110472233|NCT00816166|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110472234|NCT00816166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110472235|NCT00816166|Analgesics|analgesics|mesh-ancestor
110472236|NCT00816166|Sensory System Agents|sensory system agents|mesh-ancestor
110472237|NCT00816166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110472238|NCT00816166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110472239|NCT00816166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110472240|NCT00816166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110472241|NCT00816166|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110472242|NCT00816166|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110472243|NCT00816166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110472244|NCT00816166|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110472245|NCT00816166|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110472246|NCT00816166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110472247|NCT00816166|Antipyretics|antipyretics|mesh-ancestor
110472248|NCT00816166|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110472249|NCT00816166|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110472250|NCT00816166|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110472251|NCT00816166|Purinergic Agents|purinergic agents|mesh-ancestor
110472252|NCT00816166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110534543|NCT02675400|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110534544|NCT02675400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110534545|NCT02675400|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110534546|NCT02675400|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110534547|NCT02675400|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110599132|NCT01005914|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110534548|NCT02675400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110534549|NCT02675400|Dopamine Agents|dopamine agents|mesh-ancestor
110534550|NCT02675400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110534552|NCT00894647|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110534553|NCT00894647|Immunologic Factors|immunologic factors|mesh-ancestor
110199550|NCT01409161|Immunotoxins|immunotoxins|mesh-ancestor
110472253|NCT02788851|Guanfacine|guanfacine|mesh-list
110472255|NCT02788851|Amphetamine|amphetamine|mesh-list
110472256|NCT02788851|Adderall|adderall|mesh-list
110472257|NCT02788851|Dextroamphetamine|dextroamphetamine|mesh-list
110472258|NCT02788851|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
110472259|NCT02788851|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110472260|NCT02788851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110472261|NCT02788851|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110472262|NCT02788851|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110472263|NCT02788851|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110472264|NCT02788851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110472265|NCT02788851|Dopamine Agents|dopamine agents|mesh-ancestor
110472266|NCT02788851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110472267|NCT02788851|Sympathomimetics|sympathomimetics|mesh-ancestor
110472268|NCT02788851|Autonomic Agents|autonomic agents|mesh-ancestor
110472269|NCT02788851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110472270|NCT02788851|Adrenergic Agents|adrenergic agents|mesh-ancestor
110472271|NCT02788851|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110472272|NCT02788851|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110472273|NCT02788851|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110472274|NCT02788851|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110472275|NCT02788851|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110472276|NCT02786823|Folic Acid|folic acid|mesh-list
110472277|NCT02786823|Vitamin B 12|vitamin b 12|mesh-list
110472278|NCT02786823|Metformin|metformin|mesh-list
110472279|NCT02786823|Hypoglycemic Agents|hypoglycemic agents|mesh-list
110472280|NCT02786823|Vitamins|vitamins|mesh-ancestor
110472281|NCT02786823|Micronutrients|micronutrients|mesh-ancestor
110472282|NCT02786823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110472284|NCT02786823|Vitamin B Complex|vitamin b complex|mesh-ancestor
110472285|NCT05332314|Ibuprofen|ibuprofen|mesh-list
110472286|NCT05332314|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110472287|NCT05332314|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110472288|NCT05332314|Analgesics|analgesics|mesh-ancestor
110472289|NCT05332314|Sensory System Agents|sensory system agents|mesh-ancestor
110472290|NCT05332314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110472291|NCT05332314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110472292|NCT05332314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110472293|NCT05332314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110472294|NCT05332314|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110472295|NCT05332314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110472296|NCT05332314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110472297|NCT00815308|Paclitaxel|paclitaxel|mesh-list
110472298|NCT00815308|Cetuximab|cetuximab|mesh-list
110472299|NCT00815308|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110472300|NCT00815308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110472301|NCT00815308|Tubulin Modulators|tubulin modulators|mesh-ancestor
110472302|NCT00815308|Antimitotic Agents|antimitotic agents|mesh-ancestor
110472303|NCT00815308|Mitosis Modulators|mitosis modulators|mesh-ancestor
110472304|NCT00815308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110534554|NCT00894647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110534555|NCT00894647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110534556|NCT00894647|Interferon Inducers|interferon inducers|mesh-ancestor
110534557|NCT02839421|Moxifloxacin|moxifloxacin|mesh-list
110534558|NCT02839421|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110534559|NCT02839421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110534560|NCT02839421|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110534561|NCT02839421|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110534562|NCT02839421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110534563|NCT02839421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110534564|NCT02839421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110199610|NCT00130546|Tubulin Modulators|tubulin modulators|mesh-ancestor
110199611|NCT00130546|Antimitotic Agents|antimitotic agents|mesh-ancestor
110199612|NCT00130546|Mitosis Modulators|mitosis modulators|mesh-ancestor
110199613|NCT00130546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110472305|NCT00815308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110472306|NCT01039376|Ofatumumab|ofatumumab|mesh-list
110472307|NCT01039376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110472308|NCT02610712|Ketamine|ketamine|mesh-list
110472309|NCT02610712|Analgesics|analgesics|mesh-ancestor
110472310|NCT02610712|Sensory System Agents|sensory system agents|mesh-ancestor
110472311|NCT02610712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110472312|NCT02610712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110472313|NCT02610712|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110472314|NCT02610712|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110472315|NCT02610712|Anesthetics, General|anesthetics, general|mesh-ancestor
110472316|NCT02610712|Anesthetics|anesthetics|mesh-ancestor
110472317|NCT02610712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110472318|NCT02610712|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110472319|NCT02610712|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110472320|NCT02610712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110472321|NCT02610712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110472322|NCT00905034|Dexamethasone|dexamethasone|mesh-list
110472323|NCT00905034|Rituximab|rituximab|mesh-list
110472324|NCT00905034|Methotrexate|methotrexate|mesh-list
110472325|NCT00905034|Vincristine|vincristine|mesh-list
110472326|NCT00905034|Asparaginase|asparaginase|mesh-list
110119498|NCT01900015|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110472327|NCT00905034|Pegaspargase|pegaspargase|mesh-list
110472328|NCT00905034|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110472329|NCT00905034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110472330|NCT00905034|Immunologic Factors|immunologic factors|mesh-ancestor
110472331|NCT00905034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110472332|NCT00905034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110472333|NCT00905034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110472334|NCT00905034|Antiemetics|antiemetics|mesh-ancestor
110472335|NCT00905034|Autonomic Agents|autonomic agents|mesh-ancestor
110472336|NCT00905034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110472337|NCT00905034|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110472338|NCT00905034|Glucocorticoids|glucocorticoids|mesh-ancestor
110472339|NCT00905034|Hormones|hormones|mesh-ancestor
110472340|NCT00905034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110472341|NCT00905034|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110472342|NCT00905034|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110472343|NCT00905034|Abortifacient Agents|abortifacient agents|mesh-ancestor
110472344|NCT00905034|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110472345|NCT00905034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110472346|NCT00905034|Antimetabolites|antimetabolites|mesh-ancestor
110472347|NCT00905034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110534565|NCT02841839|Fluorides|fluorides|mesh-list
110534566|NCT02841839|Tin Fluorides|tin fluorides|mesh-list
110534567|NCT02841839|Cariostatic Agents|cariostatic agents|mesh-ancestor
110534568|NCT02841839|Protective Agents|protective agents|mesh-ancestor
110534569|NCT02841839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110534570|NCT04179942|Nitric Oxide|nitric oxide|mesh-list
110534571|NCT04179942|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110534572|NCT04179942|Autonomic Agents|autonomic agents|mesh-ancestor
110534573|NCT04179942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110534574|NCT04179942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110534575|NCT04179942|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110534576|NCT04179942|Respiratory System Agents|respiratory system agents|mesh-ancestor
110534577|NCT04179942|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110472348|NCT00905034|Dermatologic Agents|dermatologic agents|mesh-ancestor
110472349|NCT00905034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110472350|NCT00905034|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110472351|NCT00905034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110472352|NCT00905034|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110472353|NCT00905034|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110472354|NCT00905034|Tubulin Modulators|tubulin modulators|mesh-ancestor
110472355|NCT00905034|Antimitotic Agents|antimitotic agents|mesh-ancestor
110472356|NCT00905034|Mitosis Modulators|mitosis modulators|mesh-ancestor
110472358|NCT02611804|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110472359|NCT02611804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110472360|NCT02611804|Analgesics|analgesics|mesh-ancestor
110472361|NCT02611804|Sensory System Agents|sensory system agents|mesh-ancestor
110472362|NCT02611804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110472363|NCT02611804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110472364|NCT02611804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110472365|NCT02611804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110472366|NCT02611804|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110472367|NCT02611804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110472368|NCT02611804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110472369|NCT00706186|Sodium Oxybate|sodium oxybate|mesh-list
110472370|NCT00706186|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110472371|NCT00706186|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110472372|NCT00706186|Anesthetics, General|anesthetics, general|mesh-ancestor
110472373|NCT00706186|Anesthetics|anesthetics|mesh-ancestor
110472374|NCT00706186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110472375|NCT00706186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110472376|NCT02611492|Cytarabine|cytarabine|mesh-list
110472377|NCT02611492|Dexamethasone|dexamethasone|mesh-list
110472378|NCT02611492|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110472379|NCT02611492|Methotrexate|methotrexate|mesh-list
110472380|NCT02611492|Vincristine|vincristine|mesh-list
110472381|NCT02611492|Mercaptopurine|mercaptopurine|mesh-list
110472382|NCT02611492|Lenograstim|lenograstim|mesh-list
110472383|NCT02611492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110472384|NCT02611492|Antiemetics|antiemetics|mesh-ancestor
110472385|NCT02611492|Autonomic Agents|autonomic agents|mesh-ancestor
110472386|NCT02611492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110472387|NCT02611492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110472388|NCT02611492|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110472389|NCT02611492|Glucocorticoids|glucocorticoids|mesh-ancestor
110472390|NCT02611492|Hormones|hormones|mesh-ancestor
110472391|NCT02611492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110472392|NCT02611492|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110472393|NCT02611492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110472394|NCT02611492|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110472395|NCT02611492|Abortifacient Agents|abortifacient agents|mesh-ancestor
110472396|NCT02611492|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110472397|NCT02611492|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110472398|NCT02611492|Antimetabolites|antimetabolites|mesh-ancestor
110033567|NCT03071601|Prilocaine|prilocaine|mesh-list
110534578|NCT04179942|Antioxidants|antioxidants|mesh-ancestor
110534579|NCT04179942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110534580|NCT04179942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110534581|NCT04179942|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
110534582|NCT04179942|Vasodilator Agents|vasodilator agents|mesh-ancestor
110534583|NCT04179942|Gasotransmitters|gasotransmitters|mesh-ancestor
110534584|NCT04179942|Protective Agents|protective agents|mesh-ancestor
110534585|NCT04250831|Chromium|chromium|mesh-list
110534586|NCT04250831|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
110534587|NCT04250831|Trace Elements|trace elements|mesh-ancestor
110534588|NCT04250831|Micronutrients|micronutrients|mesh-ancestor
110534589|NCT04250831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110472399|NCT02611492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110472400|NCT02611492|Dermatologic Agents|dermatologic agents|mesh-ancestor
110472401|NCT02611492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110472402|NCT02611492|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110472403|NCT02611492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110472404|NCT02611492|Immunologic Factors|immunologic factors|mesh-ancestor
110472405|NCT02611492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110472406|NCT02611492|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110472407|NCT02611492|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110472408|NCT02611492|Tubulin Modulators|tubulin modulators|mesh-ancestor
110472409|NCT02611492|Antimitotic Agents|antimitotic agents|mesh-ancestor
110472410|NCT02611492|Mitosis Modulators|mitosis modulators|mesh-ancestor
110472411|NCT02611492|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110472412|NCT02611492|Antiviral Agents|antiviral agents|mesh-ancestor
110472413|NCT02611492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110472415|NCT00706576|Enkephalins|enkephalins|mesh-list
110472416|NCT00706576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110472417|NCT00706576|Mitosis Modulators|mitosis modulators|mesh-ancestor
110472418|NCT00706576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110472419|NCT00706576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110472420|NCT00828568|Imiquimod|imiquimod|mesh-list
110472421|NCT00828568|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110472422|NCT00828568|Immunologic Factors|immunologic factors|mesh-ancestor
110472423|NCT00828568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110472424|NCT00828568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110472425|NCT00828568|Interferon Inducers|interferon inducers|mesh-ancestor
110472426|NCT01038752|Suramin|suramin|mesh-list
110472427|NCT01038752|Carboplatin|carboplatin|mesh-list
110472428|NCT01038752|Docetaxel|docetaxel|mesh-list
110472429|NCT01038752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110472430|NCT01038752|Tubulin Modulators|tubulin modulators|mesh-ancestor
110472431|NCT01038752|Antimitotic Agents|antimitotic agents|mesh-ancestor
110472432|NCT01038752|Mitosis Modulators|mitosis modulators|mesh-ancestor
110472433|NCT01038752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110472434|NCT01038752|Antinematodal Agents|antinematodal agents|mesh-ancestor
110472435|NCT01038752|Anthelmintics|anthelmintics|mesh-ancestor
110472436|NCT01038752|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110472437|NCT01038752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110472438|NCT01038752|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
110472439|NCT01038752|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110472440|NCT00903630|Doxorubicin|doxorubicin|mesh-list
110472441|NCT00903630|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110472442|NCT00903630|Lenalidomide|lenalidomide|mesh-list
110472443|NCT00903630|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110472444|NCT00903630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110472445|NCT00903630|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110472446|NCT00903630|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110472447|NCT00903630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110472448|NCT00903630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110472449|NCT00903630|Immunologic Factors|immunologic factors|mesh-ancestor
110472450|NCT00903630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110472451|NCT00903630|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110534590|NCT04250831|Cathartics|cathartics|mesh-ancestor
110182088|NCT05551871|Simvastatin|simvastatin|mesh-list
110534591|NCT04250831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110534592|NCT00633191|Immunomodulating Agents|immunomodulating agents|mesh-list
110534593|NCT00633191|Immunologic Factors|immunologic factors|mesh-ancestor
110534594|NCT00633191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110534595|NCT00643500|Levetiracetam|levetiracetam|mesh-list
110534596|NCT00643500|Anticonvulsants|anticonvulsants|mesh-ancestor
110534597|NCT00643500|Nootropic Agents|nootropic agents|mesh-ancestor
110534598|NCT02837081|Anti-Infective Agents|anti-infective agents|mesh-list
110534599|NCT02837081|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110534601|NCT00633269|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110063383|NCT03008408|Everolimus|everolimus|mesh-list
110472452|NCT00903630|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110472453|NCT00903630|Growth Substances|growth substances|mesh-ancestor
110472454|NCT00903630|Growth Inhibitors|growth inhibitors|mesh-ancestor
110472455|NCT04302584|Vasopressins|vasopressins|mesh-list
110472456|NCT04302584|Arginine Vasopressin|arginine vasopressin|mesh-list
110472457|NCT04302584|Norepinephrine|norepinephrine|mesh-list
110472458|NCT04302584|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110472459|NCT04302584|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110472460|NCT04302584|Adrenergic Agents|adrenergic agents|mesh-ancestor
110472461|NCT04302584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110472462|NCT04302584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110472463|NCT04302584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110472464|NCT04302584|Sympathomimetics|sympathomimetics|mesh-ancestor
110472465|NCT04302584|Autonomic Agents|autonomic agents|mesh-ancestor
110472466|NCT04302584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110472467|NCT04302584|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110472468|NCT04302584|Hemostatics|hemostatics|mesh-ancestor
110472469|NCT04302584|Coagulants|coagulants|mesh-ancestor
110472470|NCT04302584|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
110472471|NCT04302584|Natriuretic Agents|natriuretic agents|mesh-ancestor
110472472|NCT00703144|Tazobactam|tazobactam|mesh-list
110472473|NCT00703144|Piperacillin|piperacillin|mesh-list
110472474|NCT00703144|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
110472475|NCT00703144|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110472476|NCT00703144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110472477|NCT00703144|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110472478|NCT00703144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110472479|NCT00703144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110472480|NCT01054820|Diclofenac|diclofenac|mesh-list
110472481|NCT01054820|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
110472482|NCT01054820|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110472483|NCT01054820|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110472484|NCT01054820|Analgesics|analgesics|mesh-ancestor
110472485|NCT01054820|Sensory System Agents|sensory system agents|mesh-ancestor
110472486|NCT01054820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110472487|NCT01054820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110472488|NCT01054820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110472489|NCT01054820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110472490|NCT01054820|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110472491|NCT01054820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110472492|NCT01054820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110472493|NCT03105843|Methacholine Chloride|methacholine chloride|mesh-list
110472495|NCT03105843|Autonomic Agents|autonomic agents|mesh-ancestor
110472496|NCT03105843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110378567|NCT00575861|Zileuton|zileuton|mesh-list
110472497|NCT03105843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110472498|NCT03105843|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110472499|NCT03105843|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
110472500|NCT03105843|Respiratory System Agents|respiratory system agents|mesh-ancestor
110472501|NCT03105843|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
110534603|NCT00633269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110534604|NCT00633269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110534605|NCT04181346|Pregabalin|pregabalin|mesh-list
110534606|NCT04181346|Analgesics|analgesics|mesh-ancestor
110534607|NCT04181346|Sensory System Agents|sensory system agents|mesh-ancestor
110534608|NCT04181346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110534609|NCT04181346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110534610|NCT04181346|Anticonvulsants|anticonvulsants|mesh-ancestor
110534611|NCT04181346|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110534612|NCT04181346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110199839|NCT00403663|Fentanyl|fentanyl|mesh-list
110199840|NCT00403663|Morphine|morphine|mesh-list
110472502|NCT03105843|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110472503|NCT03105843|Cholinergic Agents|cholinergic agents|mesh-ancestor
110472504|NCT03105843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110472505|NCT03105843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110472506|NCT02874248|Drospirenone|drospirenone|mesh-list
110472507|NCT02874248|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110472508|NCT02874248|Hormone Antagonists|hormone antagonists|mesh-ancestor
110472509|NCT02874248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110472510|NCT02874248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110472511|NCT02874248|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110472512|NCT02874248|Diuretics|diuretics|mesh-ancestor
110472513|NCT02874248|Natriuretic Agents|natriuretic agents|mesh-ancestor
110472514|NCT02787603|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110472515|NCT02787603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110472516|NCT02004834|Levobupivacaine|levobupivacaine|mesh-list
110472517|NCT02004834|Anesthetics, Local|anesthetics, local|mesh-ancestor
110472518|NCT02004834|Anesthetics|anesthetics|mesh-ancestor
110472519|NCT02004834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110472520|NCT02004834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110472521|NCT02004834|Sensory System Agents|sensory system agents|mesh-ancestor
110472522|NCT02004834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110472523|NCT02788305|Misoprostol|misoprostol|mesh-list
110472524|NCT02788305|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110472525|NCT02788305|Abortifacient Agents|abortifacient agents|mesh-ancestor
110472526|NCT02788305|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110472527|NCT02788305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110472528|NCT02788305|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110472529|NCT02788305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110472530|NCT02788305|Oxytocics|oxytocics|mesh-ancestor
110472531|NCT05758012|Oxytocin|oxytocin|mesh-list
110472532|NCT05758012|Carbetocin|carbetocin|mesh-list
110472533|NCT05758012|Oxytocics|oxytocics|mesh-ancestor
110472534|NCT05758012|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110472535|NCT05758012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110472536|NCT02786667|Rotigotine|rotigotine|mesh-list
110472537|NCT02786667|Dopamine Agonists|dopamine agonists|mesh-ancestor
110472538|NCT02786667|Dopamine Agents|dopamine agents|mesh-ancestor
110472539|NCT02786667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110472540|NCT02786667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110472541|NCT02786667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110472542|NCT00913276|Propofol|propofol|mesh-list
110472543|NCT00913276|Sevoflurane|sevoflurane|mesh-list
110472544|NCT00913276|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110472545|NCT00913276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110472546|NCT00913276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110472547|NCT00913276|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110472548|NCT00913276|Anesthetics, General|anesthetics, general|mesh-ancestor
110472549|NCT00913276|Anesthetics|anesthetics|mesh-ancestor
110472550|NCT00913276|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110472551|NCT00913276|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110534613|NCT04181346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110534614|NCT04181346|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110534615|NCT04181346|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110534616|NCT04181346|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110534617|NCT04181346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110199903|NCT00132106|Phentolamine|phentolamine|mesh-list
110472552|NCT04302116|Prednisolone|prednisolone|mesh-list
110472554|NCT04302116|Methylprednisolone|methylprednisolone|mesh-list
110119725|NCT01901003|Lorazepam|lorazepam|mesh-list
110472555|NCT04302116|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110472557|NCT04302116|Vigabatrin|vigabatrin|mesh-list
110472558|NCT04302116|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110472559|NCT04302116|Prednisolone phosphate|prednisolone phosphate|mesh-list
110472560|NCT04302116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110472561|NCT04302116|Glucocorticoids|glucocorticoids|mesh-ancestor
110472562|NCT04302116|Hormones|hormones|mesh-ancestor
110472563|NCT04302116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110472564|NCT04302116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110472565|NCT04302116|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110472566|NCT04302116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110472567|NCT04302116|Antiemetics|antiemetics|mesh-ancestor
110472568|NCT04302116|Autonomic Agents|autonomic agents|mesh-ancestor
110472569|NCT04302116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110472570|NCT04302116|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110472571|NCT04302116|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110472572|NCT04302116|Protective Agents|protective agents|mesh-ancestor
110472573|NCT04302116|Anticonvulsants|anticonvulsants|mesh-ancestor
110472574|NCT04302116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110472575|NCT04302116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110472576|NCT04302116|GABA Agents|gaba agents|mesh-ancestor
110472577|NCT04302116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110472578|NCT05756998|Copper|copper|mesh-list
110472579|NCT05756998|Trace Elements|trace elements|mesh-ancestor
110472580|NCT05756998|Micronutrients|micronutrients|mesh-ancestor
110472581|NCT05756998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110472582|NCT02890212|Selenium|selenium|mesh-list
110472583|NCT02890212|Antioxidants|antioxidants|mesh-ancestor
110472584|NCT02890212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110599236|NCT04019106|Budesonide|budesonide|mesh-list
110472585|NCT02890212|Protective Agents|protective agents|mesh-ancestor
110472586|NCT02890212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110472587|NCT02890212|Trace Elements|trace elements|mesh-ancestor
110472588|NCT02890212|Micronutrients|micronutrients|mesh-ancestor
110472589|NCT05387577|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110472590|NCT05387577|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110472591|NCT05387577|Estradiol|estradiol|mesh-list
110472592|NCT05387577|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110472593|NCT05387577|Estrogens|estrogens|mesh-ancestor
110472594|NCT05387577|Hormones|hormones|mesh-ancestor
110472595|NCT05387577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110472596|NCT05387577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110472597|NCT05387577|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110472598|NCT05387577|Contraceptive Agents|contraceptive agents|mesh-ancestor
110472599|NCT05387577|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110472600|NCT05387577|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110472601|NCT03044613|Paclitaxel|paclitaxel|mesh-list
110472602|NCT03044613|Carboplatin|carboplatin|mesh-list
110472603|NCT03044613|Nivolumab|nivolumab|mesh-list
110472604|NCT03044613|Relatlimab|relatlimab|mesh-list
110472605|NCT03044613|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110472606|NCT03044613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110472607|NCT03044613|Tubulin Modulators|tubulin modulators|mesh-ancestor
110472608|NCT03044613|Antimitotic Agents|antimitotic agents|mesh-ancestor
110472609|NCT03044613|Mitosis Modulators|mitosis modulators|mesh-ancestor
110472610|NCT03044613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110472611|NCT03044613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110472612|NCT03044613|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110472613|NCT01372254|Nicotine|nicotine|mesh-list
110472614|NCT01372254|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110472615|NCT01372254|Autonomic Agents|autonomic agents|mesh-ancestor
110472616|NCT01372254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110534618|NCT04181346|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110534619|NCT00642798|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110534620|NCT00642798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110599248|NCT02571608|Metformin|metformin|mesh-list
110534621|NCT00642798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110534622|NCT00642798|Incretins|incretins|mesh-ancestor
110534623|NCT00642798|Hormones|hormones|mesh-ancestor
110534624|NCT00642798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110534625|NCT00642798|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110534626|NCT00642798|Protease Inhibitors|protease inhibitors|mesh-ancestor
110534627|NCT00642798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110534628|NCT00642798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110534629|NCT05364996|Dimercaprol|dimercaprol|mesh-list
110534630|NCT05364996|Chelating Agents|chelating agents|mesh-ancestor
110199970|NCT00046748|Omalizumab|omalizumab|mesh-list
110472617|NCT01372254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110472618|NCT01372254|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110472619|NCT01372254|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110472620|NCT01372254|Cholinergic Agents|cholinergic agents|mesh-ancestor
110472621|NCT01372254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110472622|NCT01372254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110472623|NCT02785653|Sevoflurane|sevoflurane|mesh-list
110472624|NCT02785653|Rocuronium|rocuronium|mesh-list
110472625|NCT02785653|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110472626|NCT02785653|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110472627|NCT02785653|Anesthetics, General|anesthetics, general|mesh-ancestor
110472628|NCT02785653|Anesthetics|anesthetics|mesh-ancestor
110472629|NCT02785653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110472630|NCT02785653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110472631|NCT02785653|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110472632|NCT02785653|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110472633|NCT02785653|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110472634|NCT02785653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110472635|NCT02787447|Gefitinib|gefitinib|mesh-list
110472636|NCT02787447|Thymalfasin|thymalfasin|mesh-list
110472637|NCT02787447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110472638|NCT02787447|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110472639|NCT02787447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110472640|NCT02787447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110472641|NCT02787447|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110472642|NCT02787447|Immunologic Factors|immunologic factors|mesh-ancestor
110472643|NCT02787447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110472644|NCT00904722|Rituximab|rituximab|mesh-list
110472645|NCT00904722|Pidilizumab|pidilizumab|mesh-list
110472646|NCT00904722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110472647|NCT00904722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110472648|NCT00904722|Immunologic Factors|immunologic factors|mesh-ancestor
110472649|NCT00904722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110472650|NCT00904722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110472651|NCT02909361|Fulvestrant|fulvestrant|mesh-list
110472652|NCT02909361|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110472653|NCT02909361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110472654|NCT02909361|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110472655|NCT02909361|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110472656|NCT02909361|Hormone Antagonists|hormone antagonists|mesh-ancestor
110599292|NCT00865384|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110472657|NCT02909361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110472658|NCT02909361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110472659|NCT04301024|Nitrous Oxide|nitrous oxide|mesh-list
110472660|NCT04301024|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110472661|NCT04301024|Anesthetics, General|anesthetics, general|mesh-ancestor
110472662|NCT04301024|Anesthetics|anesthetics|mesh-ancestor
110871800|NCT04546620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110871801|NCT04546620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110871802|NCT04546620|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110871803|NCT04546620|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110871804|NCT04546620|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110871805|NCT04546620|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110871806|NCT04546620|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110871807|NCT04546620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110871808|NCT04546620|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110871809|NCT04546620|Tubulin Modulators|tubulin modulators|mesh-ancestor
110871810|NCT04546620|Antimitotic Agents|antimitotic agents|mesh-ancestor
110472663|NCT04301024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110472664|NCT04301024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110472665|NCT04301024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110472667|NCT04301024|Sensory System Agents|sensory system agents|mesh-ancestor
110472668|NCT04301024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110472669|NCT01340430|Trastuzumab|trastuzumab|mesh-list
110472670|NCT01340430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110472671|NCT01340430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110472672|NCT01029782|Cefazolin|cefazolin|mesh-list
110472673|NCT01029782|Cephalexin|cephalexin|mesh-list
110472674|NCT01029782|Probenecid|probenecid|mesh-list
110472675|NCT01029782|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110472676|NCT01029782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110472677|NCT01029782|Uricosuric Agents|uricosuric agents|mesh-ancestor
110472678|NCT01029782|Gout Suppressants|gout suppressants|mesh-ancestor
110472679|NCT01029782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110472680|NCT04232007|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
110472681|NCT02901717|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110472682|NCT02901717|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
110472683|NCT02901717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110472684|NCT02901717|Antitubercular Agents|antitubercular agents|mesh-ancestor
110472685|NCT02849730|Fentanyl|fentanyl|mesh-list
110472686|NCT02849730|Analgesics|analgesics|mesh-list
110472687|NCT02849730|Ropivacaine|ropivacaine|mesh-list
110472688|NCT02849730|Anesthetics, Local|anesthetics, local|mesh-ancestor
110472689|NCT02849730|Anesthetics|anesthetics|mesh-ancestor
110472690|NCT02849730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110472691|NCT02849730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110472692|NCT02849730|Sensory System Agents|sensory system agents|mesh-ancestor
110165072|NCT00022555|Vincristine|vincristine|mesh-list
110472693|NCT02849730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110472694|NCT02849730|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110472695|NCT02849730|Narcotics|narcotics|mesh-ancestor
110472696|NCT02849730|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110472697|NCT02849730|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110472698|NCT02849730|Anesthetics, General|anesthetics, general|mesh-ancestor
110472699|NCT02849340|Immunomodulating Agents|immunomodulating agents|mesh-list
110472700|NCT02849340|Immunologic Factors|immunologic factors|mesh-ancestor
110472701|NCT02849340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110472702|NCT03936192|Meloxicam|meloxicam|mesh-list
110472703|NCT03936192|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110472704|NCT03936192|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110472705|NCT03936192|Analgesics|analgesics|mesh-ancestor
110472706|NCT03936192|Sensory System Agents|sensory system agents|mesh-ancestor
110472707|NCT03936192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110472708|NCT03936192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110472709|NCT03936192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110472710|NCT03936192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110472711|NCT03936192|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110472712|NCT03936192|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110472713|NCT03936192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110472714|NCT03936192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110871812|NCT04546620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110871813|NCT04546620|Glucocorticoids|glucocorticoids|mesh-ancestor
110871814|NCT04546620|Hormones|hormones|mesh-ancestor
110871815|NCT04546620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110534631|NCT05364996|Sequestering Agents|sequestering agents|mesh-ancestor
110472715|NCT00930228|Flutamide|flutamide|mesh-list
110472716|NCT00930228|Androgen Antagonists|androgen antagonists|mesh-ancestor
110472717|NCT00930228|Hormone Antagonists|hormone antagonists|mesh-ancestor
110472718|NCT00930228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110472719|NCT00930228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110472720|NCT00930228|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110472721|NCT00930228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110472722|NCT01029704|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
110472723|NCT01029704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110472724|NCT01029704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110472725|NCT01029704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110472726|NCT02786979|Aspirin|aspirin|mesh-list
110472727|NCT02786979|Beraprost|beraprost|mesh-list
110472728|NCT02786979|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110472729|NCT02786979|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110472730|NCT02786979|Analgesics|analgesics|mesh-ancestor
110472731|NCT02786979|Sensory System Agents|sensory system agents|mesh-ancestor
110472732|NCT02786979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110472733|NCT02786979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110472734|NCT02786979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110472735|NCT02786979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110472736|NCT02786979|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110472737|NCT02786979|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110472738|NCT02786979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110472739|NCT02786979|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110472740|NCT02786979|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110472741|NCT02786979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110472742|NCT02786979|Antipyretics|antipyretics|mesh-ancestor
110472743|NCT02786979|Vasodilator Agents|vasodilator agents|mesh-ancestor
110472744|NCT02689869|Obinutuzumab|obinutuzumab|mesh-list
110472745|NCT02689869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110472746|NCT02689869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110472747|NCT02785809|Contraceptive Agents|contraceptive agents|mesh-list
110472748|NCT02785809|Contraceptives, Oral|contraceptives, oral|mesh-list
110472749|NCT02785809|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110472750|NCT02785809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110472751|NCT02785809|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110472752|NCT00221988|Levetiracetam|levetiracetam|mesh-list
110472753|NCT00221988|Anticonvulsants|anticonvulsants|mesh-ancestor
110472754|NCT00221988|Nootropic Agents|nootropic agents|mesh-ancestor
110472755|NCT02341911|Carboplatin|carboplatin|mesh-list
110472756|NCT02341911|Gemcitabine|gemcitabine|mesh-list
110472757|NCT02341911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110472758|NCT02341911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110472759|NCT02341911|Antimetabolites|antimetabolites|mesh-ancestor
110472760|NCT02341911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110472761|NCT02847000|Decitabine|decitabine|mesh-list
110472762|NCT02847000|Tetrahydrouridine|tetrahydrouridine|mesh-list
110472763|NCT02847000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110472764|NCT02847000|Antimetabolites|antimetabolites|mesh-ancestor
110472765|NCT02847000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110472766|NCT02847000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110472767|NCT02847000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110472768|NCT02784327|Ropivacaine|ropivacaine|mesh-list
110472769|NCT02784327|Anesthetics, Local|anesthetics, local|mesh-ancestor
110472770|NCT02784327|Anesthetics|anesthetics|mesh-ancestor
110472771|NCT02784327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110472772|NCT02784327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110472773|NCT02784327|Sensory System Agents|sensory system agents|mesh-ancestor
110472774|NCT02784327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110472775|NCT02845050|Cisplatin|cisplatin|mesh-list
110472776|NCT02845050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110472777|NCT02690922|Dexamethasone|dexamethasone|mesh-list
110871816|NCT04546620|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110871817|NCT04546620|Antiemetics|antiemetics|mesh-ancestor
110871818|NCT04546620|Autonomic Agents|autonomic agents|mesh-ancestor
110871819|NCT04546620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110871820|NCT04546620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110871821|NCT04546620|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110871822|NCT04546620|Protective Agents|protective agents|mesh-ancestor
110472778|NCT02690922|Prednisone|prednisone|mesh-list
110472779|NCT02690922|Methotrexate|methotrexate|mesh-list
110472780|NCT02690922|Dasatinib|dasatinib|mesh-list
110472781|NCT02690922|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110472782|NCT02690922|Antiemetics|antiemetics|mesh-ancestor
110472783|NCT02690922|Autonomic Agents|autonomic agents|mesh-ancestor
110472784|NCT02690922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110472785|NCT02690922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110472786|NCT02690922|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110472787|NCT02690922|Glucocorticoids|glucocorticoids|mesh-ancestor
110472788|NCT02690922|Hormones|hormones|mesh-ancestor
110472789|NCT02690922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110472790|NCT02690922|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110472791|NCT02690922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110472792|NCT02690922|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110472793|NCT02690922|Abortifacient Agents|abortifacient agents|mesh-ancestor
110472794|NCT02690922|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110472795|NCT02690922|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110472796|NCT02690922|Antimetabolites|antimetabolites|mesh-ancestor
110472797|NCT02690922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110472798|NCT02690922|Dermatologic Agents|dermatologic agents|mesh-ancestor
110472799|NCT02690922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110472800|NCT02690922|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110472801|NCT02690922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110472802|NCT02690922|Immunologic Factors|immunologic factors|mesh-ancestor
110472803|NCT02690922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110472804|NCT02690922|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110472805|NCT02690922|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110472806|NCT02848950|Metformin|metformin|mesh-list
110472807|NCT02848950|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110472808|NCT02848950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110472809|NCT04202406|Acetaminophen|acetaminophen|mesh-list
110472810|NCT04202406|Codeine|codeine|mesh-list
110472811|NCT04202406|Caffeine|caffeine|mesh-list
110472812|NCT04202406|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110472814|NCT04202406|Sensory System Agents|sensory system agents|mesh-ancestor
110472815|NCT04202406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110472816|NCT04202406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110472817|NCT04202406|Antipyretics|antipyretics|mesh-ancestor
110472818|NCT04202406|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110472819|NCT04202406|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110472820|NCT04202406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110472821|NCT04202406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110472822|NCT04202406|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110472823|NCT04202406|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110472824|NCT04202406|Purinergic Agents|purinergic agents|mesh-ancestor
110472825|NCT04202406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110472826|NCT04202406|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110472827|NCT04202406|Narcotics|narcotics|mesh-ancestor
110472828|NCT04202406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110472829|NCT04202406|Antitussive Agents|antitussive agents|mesh-ancestor
110472830|NCT04202406|Respiratory System Agents|respiratory system agents|mesh-ancestor
110472831|NCT02846766|Lenvatinib|lenvatinib|mesh-list
110472832|NCT02846766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110472833|NCT02846766|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110472834|NCT02846766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110472835|NCT02846766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110472837|NCT00839956|Vorinostat|vorinostat|mesh-list
110472838|NCT00839956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110472839|NCT00839956|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110472840|NCT00839956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110033649|NCT03011775|Hypoglycemic Agents|hypoglycemic agents|mesh-list
110871823|NCT04058210|Ivacaftor|ivacaftor|mesh-list
110871824|NCT04058210|Elexacaftor|elexacaftor|mesh-list
110871825|NCT04058210|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
110871826|NCT04058210|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110871827|NCT04058210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110871828|NCT02250300|Ixazomib|ixazomib|mesh-list
110871829|NCT02250300|Glycine|glycine|mesh-list
110871830|NCT02250300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110871831|NCT02250300|Protease Inhibitors|protease inhibitors|mesh-ancestor
110871832|NCT02250300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110871833|NCT02250300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110871834|NCT02250300|Glycine Agents|glycine agents|mesh-ancestor
110871835|NCT02250300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110871836|NCT02250300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110871837|NCT03020966|Acetaminophen|acetaminophen|mesh-list
110871838|NCT03020966|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110871839|NCT03020966|Analgesics|analgesics|mesh-ancestor
110871840|NCT03020966|Sensory System Agents|sensory system agents|mesh-ancestor
110871841|NCT03020966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110472841|NCT00839956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110472842|NCT00839800|Terbutaline|terbutaline|mesh-list
110472843|NCT00839800|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
110472844|NCT00839800|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110472845|NCT00839800|Respiratory System Agents|respiratory system agents|mesh-ancestor
110472846|NCT00839800|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110472847|NCT00839800|Autonomic Agents|autonomic agents|mesh-ancestor
110472848|NCT00839800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110472849|NCT00839800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110472850|NCT00839800|Sympathomimetics|sympathomimetics|mesh-ancestor
110472851|NCT00839800|Tocolytic Agents|tocolytic agents|mesh-ancestor
110472852|NCT00839800|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110472853|NCT00839800|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110472854|NCT00839800|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110472855|NCT00839800|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110472856|NCT00839800|Adrenergic Agents|adrenergic agents|mesh-ancestor
110472857|NCT00839800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110472858|NCT00839800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110472859|NCT00867321|Bevacizumab|bevacizumab|mesh-list
110472860|NCT00867321|Sorafenib|sorafenib|mesh-list
110472861|NCT00867321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110472862|NCT00867321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110472863|NCT00867321|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110472864|NCT00867321|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110472865|NCT00867321|Growth Substances|growth substances|mesh-ancestor
110472866|NCT00867321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110472867|NCT00867321|Growth Inhibitors|growth inhibitors|mesh-ancestor
110472868|NCT00867321|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110472869|NCT00867321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110472870|NCT00867321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110472871|NCT00913666|Interferons|interferons|mesh-list
110472872|NCT00913666|Interferon-beta|interferon-beta|mesh-list
110472873|NCT00913666|Interferon beta-1a|interferon beta-1a|mesh-list
110472874|NCT00913666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110472875|NCT00913666|Antiviral Agents|antiviral agents|mesh-ancestor
110472876|NCT00913666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110472877|NCT00913666|Immunologic Factors|immunologic factors|mesh-ancestor
110871842|NCT03020966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110871843|NCT03020966|Antipyretics|antipyretics|mesh-ancestor
110871844|NCT04051268|Vaccines|vaccines|mesh-list
110871845|NCT04051268|Immunologic Factors|immunologic factors|mesh-ancestor
110871846|NCT04051268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110871847|NCT04595786|Tranexamic Acid|tranexamic acid|mesh-list
110871848|NCT04595786|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110871849|NCT04595786|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110534657|NCT04178850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110472878|NCT00913666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110472879|NCT00913666|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110472880|NCT05756764|Liraglutide|liraglutide|mesh-list
110472881|NCT05756764|Topiramate|topiramate|mesh-list
110472882|NCT05756764|Phentermine|phentermine|mesh-list
110472883|NCT05756764|Glucagon|glucagon|mesh-list
110472884|NCT05756764|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
110472885|NCT05756764|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110395656|NCT00599274|Interferons|interferons|mesh-list
110472886|NCT05756764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110472887|NCT05756764|Incretins|incretins|mesh-ancestor
110472888|NCT05756764|Hormones|hormones|mesh-ancestor
110472889|NCT05756764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110472890|NCT05756764|Anticonvulsants|anticonvulsants|mesh-ancestor
110472891|NCT05756764|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110472892|NCT05756764|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110472893|NCT05756764|Appetite Depressants|appetite depressants|mesh-ancestor
110472894|NCT05756764|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110472895|NCT05756764|Sympathomimetics|sympathomimetics|mesh-ancestor
110472896|NCT05756764|Autonomic Agents|autonomic agents|mesh-ancestor
110472897|NCT05756764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110472898|NCT05756764|Adrenergic Agents|adrenergic agents|mesh-ancestor
110472899|NCT05756764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110472900|NCT05756764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110472901|NCT05308095|Hypoglycemic Agents|hypoglycemic agents|mesh-list
110472902|NCT05308095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110472903|NCT02601157|Aspirin|aspirin|mesh-list
110472904|NCT02601157|Clopidogrel|clopidogrel|mesh-list
110472905|NCT02601157|Ticagrelor|ticagrelor|mesh-list
110472906|NCT02601157|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
110472907|NCT02601157|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110472908|NCT02601157|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110472909|NCT02601157|Analgesics|analgesics|mesh-ancestor
110472910|NCT02601157|Sensory System Agents|sensory system agents|mesh-ancestor
110472911|NCT02601157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110472912|NCT02601157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110472913|NCT02601157|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110472914|NCT02601157|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110472915|NCT02601157|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110472916|NCT02601157|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110472917|NCT02601157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110472918|NCT02601157|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110472919|NCT02601157|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110472920|NCT02601157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110472921|NCT02601157|Antipyretics|antipyretics|mesh-ancestor
110472922|NCT02601157|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110472923|NCT02601157|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110472924|NCT02601157|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110472925|NCT02601157|Purinergic Agents|purinergic agents|mesh-ancestor
110472926|NCT02601157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110472927|NCT02784717|Rivaroxaban|rivaroxaban|mesh-list
110472928|NCT02784717|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110472929|NCT02784717|Antithrombins|antithrombins|mesh-ancestor
110472930|NCT02784717|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110472931|NCT02784717|Protease Inhibitors|protease inhibitors|mesh-ancestor
110472932|NCT02784717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110472933|NCT02784717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110472935|NCT00902304|Amlodipine|amlodipine|mesh-list
110472936|NCT00902304|Valsartan|valsartan|mesh-list
110871850|NCT04595786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110871851|NCT04595786|Hemostatics|hemostatics|mesh-ancestor
110871852|NCT04595786|Coagulants|coagulants|mesh-ancestor
110871853|NCT02108652|Atezolizumab|atezolizumab|mesh-list
110871854|NCT02108652|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110871855|NCT02108652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110871856|NCT02108652|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110871857|NCT02108652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110871858|NCT01381614|Bevacizumab|bevacizumab|mesh-list
110871860|NCT01381614|Sorafenib|sorafenib|mesh-list
110472937|NCT00902304|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110472938|NCT00902304|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
110472939|NCT00902304|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110472940|NCT00902304|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110472941|NCT00902304|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110472942|NCT00902304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110472943|NCT00902304|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110472944|NCT00902304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110472945|NCT00902304|Vasodilator Agents|vasodilator agents|mesh-ancestor
110472946|NCT00902304|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110472947|NCT00902304|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110472948|NCT00902304|Diuretics|diuretics|mesh-ancestor
110472949|NCT00902304|Natriuretic Agents|natriuretic agents|mesh-ancestor
110472950|NCT00902304|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110472951|NCT02784795|Carboplatin|carboplatin|mesh-list
110472952|NCT02784795|Gemcitabine|gemcitabine|mesh-list
110472953|NCT02784795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110472954|NCT02784795|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110472955|NCT02784795|Antimetabolites|antimetabolites|mesh-ancestor
110472956|NCT02784795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110472957|NCT05282277|Raclopride|raclopride|mesh-list
110472958|NCT05282277|Estradiol|estradiol|mesh-list
110472959|NCT05282277|Progesterone|progesterone|mesh-list
110472960|NCT05282277|Estrogens|estrogens|mesh-ancestor
110472961|NCT05282277|Hormones|hormones|mesh-ancestor
110472962|NCT05282277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110472963|NCT05282277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110472964|NCT05282277|Progestins|progestins|mesh-ancestor
110472965|NCT05282277|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110472966|NCT05282277|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110472967|NCT05282277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110472968|NCT05282277|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110472969|NCT05282277|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110472970|NCT05282277|Dopamine Agents|dopamine agents|mesh-ancestor
110472971|NCT05282277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110472972|NCT05282277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110472973|NCT00759109|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110472974|NCT00759109|Antiviral Agents|antiviral agents|mesh-ancestor
110599366|NCT00865540|Hormones|hormones|mesh-ancestor
110472975|NCT00759109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110472976|NCT02848794|Irinotecan|irinotecan|mesh-list
110472977|NCT02848794|Apatinib|apatinib|mesh-list
110472978|NCT02848794|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110472979|NCT02848794|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110472980|NCT02848794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110472981|NCT02848794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110472982|NCT02848794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110472983|NCT02848794|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110472984|NCT04096027|Cabergoline|cabergoline|mesh-list
110472985|NCT04096027|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110472986|NCT04096027|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110472987|NCT04096027|Dopamine Agonists|dopamine agonists|mesh-ancestor
110472988|NCT04096027|Dopamine Agents|dopamine agents|mesh-ancestor
110472989|NCT04096027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110033650|NCT03011775|Ramipril|ramipril|mesh-list
110871861|NCT01381614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110871862|NCT01381614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110871863|NCT01381614|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110871864|NCT01381614|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110871865|NCT01381614|Growth Substances|growth substances|mesh-ancestor
110871866|NCT01381614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110871867|NCT01381614|Growth Inhibitors|growth inhibitors|mesh-ancestor
110871868|NCT01381614|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110871869|NCT01381614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110871870|NCT01381614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110871872|NCT01381536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110871873|NCT01381536|Immunologic Factors|immunologic factors|mesh-ancestor
110472990|NCT04096027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110472991|NCT04096027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110472992|NCT04216134|Edetic Acid|edetic acid|mesh-list
110472993|NCT04216134|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
110472994|NCT04216134|Chelating Agents|chelating agents|mesh-ancestor
110472995|NCT04216134|Sequestering Agents|sequestering agents|mesh-ancestor
110472996|NCT04216134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110472997|NCT04216134|Anticoagulants|anticoagulants|mesh-ancestor
110472998|NCT04216134|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110472999|NCT04216134|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110473000|NCT00638079|Megestrol|megestrol|mesh-list
110473001|NCT00638079|Megestrol Acetate|megestrol acetate|mesh-list
110473002|NCT00638079|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110473003|NCT00638079|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110473004|NCT00638079|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110473005|NCT00638079|Contraceptive Agents|contraceptive agents|mesh-ancestor
110473006|NCT00638079|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110473007|NCT00638079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110473008|NCT00638079|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110473009|NCT00638079|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110473010|NCT00638079|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110473011|NCT00638079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110473012|NCT00638079|Appetite Stimulants|appetite stimulants|mesh-ancestor
110473013|NCT00638079|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110473015|NCT00759031|Triclosan|triclosan|mesh-list
110473016|NCT00759031|Fluorides|fluorides|mesh-list
110473017|NCT00759031|Sodium Fluoride|sodium fluoride|mesh-list
110473018|NCT00759031|Fluorophosphate|fluorophosphate|mesh-list
110473019|NCT00759031|Cariostatic Agents|cariostatic agents|mesh-ancestor
110473020|NCT00759031|Protective Agents|protective agents|mesh-ancestor
110473021|NCT00759031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110473022|NCT00759031|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110473023|NCT00759031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110599379|NCT00865540|Analgesics|analgesics|mesh-ancestor
110473024|NCT00759031|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
110473025|NCT00759031|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110473026|NCT00759031|Antimetabolites|antimetabolites|mesh-ancestor
110473027|NCT00759031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110473028|NCT00759031|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110473029|NCT04197219|Pembrolizumab|pembrolizumab|mesh-list
110473030|NCT04197219|Axitinib|axitinib|mesh-list
110473031|NCT04197219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110473032|NCT04197219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110473033|NCT04197219|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110473034|NCT04197219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110473035|NCT04197219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110473036|NCT04197219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110473037|NCT04834908|Immune Sera|immune sera|mesh-list
110473038|NCT04834908|Immunologic Factors|immunologic factors|mesh-ancestor
110871874|NCT01381536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110871875|NCT03162406|Vitamin D|vitamin d|mesh-list
110871876|NCT03162406|Cholecalciferol|cholecalciferol|mesh-list
110871877|NCT03162406|Vitamins|vitamins|mesh-ancestor
110871878|NCT03162406|Micronutrients|micronutrients|mesh-ancestor
110871879|NCT03162406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110871880|NCT03162406|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110871881|NCT03162406|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110871882|NCT02946385|Vaccines|vaccines|mesh-list
110871883|NCT02946385|Immunologic Factors|immunologic factors|mesh-ancestor
110871884|NCT02946385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110871885|NCT05676190|Immunomodulating Agents|immunomodulating agents|mesh-list
110871886|NCT05676190|Immunologic Factors|immunologic factors|mesh-ancestor
110871887|NCT05676190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110871888|NCT02694718|Capecitabine|capecitabine|mesh-list
110871889|NCT02694718|Oxaliplatin|oxaliplatin|mesh-list
110871890|NCT02694718|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110871891|NCT02694718|Antimetabolites|antimetabolites|mesh-ancestor
110871892|NCT02694718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110871893|NCT02694718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110871894|NCT05681299|Liraglutide|liraglutide|mesh-list
110871895|NCT05681299|Hormones|hormones|mesh-list
110871896|NCT05681299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110871897|NCT05681299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110871898|NCT05681299|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110871899|NCT05681299|Incretins|incretins|mesh-ancestor
110871900|NCT03161080|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110589419|NCT02566707|Lamivudine|lamivudine|mesh-list
110871901|NCT03161080|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110871920|NCT04923139|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110871921|NCT04923139|Protease Inhibitors|protease inhibitors|mesh-ancestor
110871922|NCT04923139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110871923|NCT04923139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110871924|NCT04923139|Anticoagulants|anticoagulants|mesh-ancestor
110871925|NCT05681221|Calcium|calcium|mesh-list
110871926|NCT05681221|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110871927|NCT05681221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110871928|NCT04303507|Hydroxychloroquine|hydroxychloroquine|mesh-list
110871929|NCT04303507|Chloroquine|chloroquine|mesh-list
110871930|NCT04303507|Antimalarials|antimalarials|mesh-ancestor
110871931|NCT04303507|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110871932|NCT04303507|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110473039|NCT04834908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110473040|NCT02512497|Fludarabine|fludarabine|mesh-list
110473041|NCT02512497|Fludarabine phosphate|fludarabine phosphate|mesh-list
110473042|NCT02512497|Busulfan|busulfan|mesh-list
110473043|NCT02512497|Romidepsin|romidepsin|mesh-list
110473044|NCT02512497|Thymoglobulin|thymoglobulin|mesh-list
110473045|NCT02512497|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110473046|NCT02512497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110473047|NCT02512497|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110473048|NCT02512497|Antimetabolites|antimetabolites|mesh-ancestor
110473049|NCT02512497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110473050|NCT02512497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110473051|NCT02512497|Immunologic Factors|immunologic factors|mesh-ancestor
110473052|NCT02512497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110473053|NCT02512497|Alkylating Agents|alkylating agents|mesh-ancestor
110473054|NCT02512497|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110473055|NCT02512497|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110473056|NCT02512497|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110473057|NCT02512497|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110473058|NCT02512497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110473059|NCT00916669|Etoposide|etoposide|mesh-list
110473060|NCT00916669|Enoxaparin|enoxaparin|mesh-list
110473061|NCT00916669|Enoxaparin sodium|enoxaparin sodium|mesh-list
110473062|NCT00916669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110473063|NCT00916669|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110473064|NCT00916669|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110473065|NCT00916669|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110473066|NCT00916669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110473067|NCT00916669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110473068|NCT00916669|Anticoagulants|anticoagulants|mesh-ancestor
110473069|NCT00916669|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110473070|NCT00916669|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110473071|NCT02784015|Cyclophosphamide|cyclophosphamide|mesh-list
110473072|NCT02784015|Melphalan|melphalan|mesh-list
110473073|NCT02784015|Ifosfamide|ifosfamide|mesh-list
110473074|NCT02784015|Thiotepa|thiotepa|mesh-list
110473075|NCT02784015|Carboplatin|carboplatin|mesh-list
110473076|NCT02784015|Doxorubicin|doxorubicin|mesh-list
110473077|NCT02784015|Etoposide|etoposide|mesh-list
110473078|NCT02784015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110473079|NCT02784015|Immunologic Factors|immunologic factors|mesh-ancestor
110473080|NCT02784015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110473081|NCT02784015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110473082|NCT02784015|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110473083|NCT02784015|Alkylating Agents|alkylating agents|mesh-ancestor
110473084|NCT02784015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110473085|NCT02784015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110473086|NCT02784015|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110473087|NCT02784015|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110473088|NCT02784015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110473089|NCT02784015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110871933|NCT04303507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110871934|NCT04303507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110871935|NCT04303507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110871936|NCT04303507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110871937|NCT04303507|Amebicides|amebicides|mesh-ancestor
110871938|NCT03202537|Dexlansoprazole|dexlansoprazole|mesh-list
110871939|NCT03202537|Lansoprazole|lansoprazole|mesh-list
110871940|NCT03202537|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110871941|NCT03202537|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110871942|NCT03202537|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110871943|NCT03202537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110200563|NCT00042861|Leucovorin|leucovorin|mesh-list
110473090|NCT02784015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110473091|NCT02784015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110473092|NCT02601235|Pyrilamine|pyrilamine|mesh-list
110473093|NCT02601235|Phenylephrine|phenylephrine|mesh-list
110473094|NCT02601235|Oxymetazoline|oxymetazoline|mesh-list
110473095|NCT02601235|Naphazoline|naphazoline|mesh-list
110473096|NCT02601235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110473097|NCT02601235|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110473098|NCT02601235|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110473099|NCT02601235|Adrenergic Agents|adrenergic agents|mesh-ancestor
110473100|NCT02601235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110473101|NCT02601235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110473102|NCT02601235|Sympathomimetics|sympathomimetics|mesh-ancestor
110473103|NCT02601235|Autonomic Agents|autonomic agents|mesh-ancestor
110473104|NCT02601235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110473105|NCT02601235|Nasal Decongestants|nasal decongestants|mesh-ancestor
110473106|NCT02601235|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110473107|NCT02601235|Respiratory System Agents|respiratory system agents|mesh-ancestor
110165104|NCT00010725|Vitamins|vitamins|mesh-list
110473108|NCT02601235|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110473109|NCT02601235|Mydriatics|mydriatics|mesh-ancestor
110473110|NCT02601235|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110473111|NCT02601235|Protective Agents|protective agents|mesh-ancestor
110473112|NCT02601235|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110473113|NCT02601235|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110473114|NCT02601235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110473115|NCT02601235|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110473116|NCT02601235|Histamine Antagonists|histamine antagonists|mesh-ancestor
110473117|NCT02601235|Histamine Agents|histamine agents|mesh-ancestor
110473118|NCT02601235|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110473119|NCT02783937|Lenograstim|lenograstim|mesh-list
110473120|NCT02783937|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110473121|NCT02783937|Immunologic Factors|immunologic factors|mesh-ancestor
110473122|NCT02783937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110473123|NCT02846142|Levonorgestrel|levonorgestrel|mesh-list
110473124|NCT02846142|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110473125|NCT02846142|Estradiol|estradiol|mesh-list
110473126|NCT02846142|Estrogens|estrogens|mesh-ancestor
110473127|NCT02846142|Hormones|hormones|mesh-ancestor
110473128|NCT02846142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110473129|NCT02846142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110473130|NCT02846142|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110473131|NCT02846142|Contraceptive Agents|contraceptive agents|mesh-ancestor
110473132|NCT02846142|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110473133|NCT02846142|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110473134|NCT02846142|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110473135|NCT02846142|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110473136|NCT02846142|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110473137|NCT00757783|Ritonavir|ritonavir|mesh-list
110473138|NCT00757783|Atazanavir Sulfate|atazanavir sulfate|mesh-list
110473139|NCT00757783|Darunavir|darunavir|mesh-list
110473140|NCT00757783|Tenofovir|tenofovir|mesh-list
110473141|NCT00757783|Emtricitabine|emtricitabine|mesh-list
110473142|NCT00757783|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110473143|NCT00757783|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110871944|NCT03202537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110871945|NCT03631134|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
110871946|NCT03631134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110871948|NCT03631134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110871949|NCT04138615|Morphine|morphine|mesh-list
110599421|NCT00724802|Triacetin|triacetin|mesh-list
110200627|NCT00047450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110200629|NCT00047450|Serotonin Agents|serotonin agents|mesh-ancestor
110473144|NCT00757783|Protease Inhibitors|protease inhibitors|mesh-ancestor
110473145|NCT00757783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110473146|NCT00757783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110473147|NCT00757783|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110473148|NCT00757783|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110473149|NCT00757783|Antiviral Agents|antiviral agents|mesh-ancestor
110473150|NCT00757783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110473151|NCT00757783|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110473152|NCT00757783|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110473153|NCT00757783|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110473154|NCT00757783|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110473155|NCT05242926|Docetaxel|docetaxel|mesh-list
110473156|NCT05242926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110473157|NCT05242926|Tubulin Modulators|tubulin modulators|mesh-ancestor
110473158|NCT05242926|Antimitotic Agents|antimitotic agents|mesh-ancestor
110473159|NCT05242926|Mitosis Modulators|mitosis modulators|mesh-ancestor
110473160|NCT05242926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110473161|NCT02782221|Hormones|hormones|mesh-list
110120322|NCT01904981|Valsartan|valsartan|mesh-list
110473162|NCT02782221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110473164|NCT04231617|Glyburide|glyburide|mesh-list
110473165|NCT04231617|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110473166|NCT04231617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110473167|NCT00757705|Paliperidone Palmitate|paliperidone palmitate|mesh-list
110473168|NCT00757705|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110473169|NCT00757705|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110473170|NCT00757705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110473171|NCT00757705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110473172|NCT00757705|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110473173|NCT00757705|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110473174|NCT00757705|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110473175|NCT00757705|Serotonin Agents|serotonin agents|mesh-ancestor
110473176|NCT00757705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110473177|NCT00757705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110473178|NCT00757705|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110473179|NCT00757705|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110473180|NCT00757705|Dopamine Agents|dopamine agents|mesh-ancestor
110473181|NCT02845908|Leucovorin|leucovorin|mesh-list
110473182|NCT02845908|Fluorouracil|fluorouracil|mesh-list
110473183|NCT02845908|Oxaliplatin|oxaliplatin|mesh-list
110473184|NCT02845908|Antimetabolites|antimetabolites|mesh-ancestor
110473185|NCT02845908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110473186|NCT02845908|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110473187|NCT02845908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110473188|NCT02845908|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110473189|NCT02845908|Immunologic Factors|immunologic factors|mesh-ancestor
110473190|NCT02845908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110473191|NCT02845908|Antidotes|antidotes|mesh-ancestor
110473192|NCT02845908|Protective Agents|protective agents|mesh-ancestor
110473193|NCT02845908|Vitamin B Complex|vitamin b complex|mesh-ancestor
110473195|NCT02845908|Micronutrients|micronutrients|mesh-ancestor
110473196|NCT02784483|Atezolizumab|atezolizumab|mesh-list
110473197|NCT02784483|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110473198|NCT02784483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110473199|NCT02784483|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110871950|NCT04138615|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110871951|NCT04138615|Narcotics|narcotics|mesh-ancestor
110871952|NCT04138615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110871953|NCT04138615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110871954|NCT04138615|Analgesics|analgesics|mesh-ancestor
110871955|NCT04138615|Sensory System Agents|sensory system agents|mesh-ancestor
110871956|NCT04138615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110871957|NCT01383330|Megestrol Acetate|megestrol acetate|mesh-list
110871958|NCT01383330|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110871959|NCT01383330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110871960|NCT01383330|Appetite Stimulants|appetite stimulants|mesh-ancestor
110871961|NCT01383330|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110063664|NCT01896999|Immunotoxins|immunotoxins|mesh-ancestor
110473200|NCT02784483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110473201|NCT02784561|Cytarabine|cytarabine|mesh-list
110473202|NCT02784561|Fludarabine|fludarabine|mesh-list
110473203|NCT02784561|Fludarabine phosphate|fludarabine phosphate|mesh-list
110473204|NCT02784561|Busulfan|busulfan|mesh-list
110473205|NCT02784561|Thymoglobulin|thymoglobulin|mesh-list
110473206|NCT02784561|Lenograstim|lenograstim|mesh-list
110473207|NCT02784561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110473208|NCT02784561|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110473209|NCT02784561|Antimetabolites|antimetabolites|mesh-ancestor
110473210|NCT02784561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110473211|NCT02784561|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110473212|NCT02784561|Immunologic Factors|immunologic factors|mesh-ancestor
110473213|NCT02784561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110473214|NCT02784561|Antiviral Agents|antiviral agents|mesh-ancestor
110473215|NCT02784561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110473216|NCT02784561|Alkylating Agents|alkylating agents|mesh-ancestor
110473217|NCT02784561|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110473218|NCT02784561|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110473219|NCT02784561|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110473220|NCT00757627|Etoricoxib|etoricoxib|mesh-list
110473221|NCT00757627|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110473222|NCT00757627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110473223|NCT00757627|Analgesics|analgesics|mesh-ancestor
110473224|NCT00757627|Sensory System Agents|sensory system agents|mesh-ancestor
110473225|NCT00757627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110473226|NCT00757627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110473227|NCT00757627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110473228|NCT00757627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110473229|NCT00757627|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110473230|NCT00757627|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110473231|NCT00757627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110473232|NCT00757627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110473233|NCT02600455|Abatacept|abatacept|mesh-list
110473234|NCT02600455|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110473235|NCT02600455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110473236|NCT02600455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110473237|NCT02600455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110473238|NCT02600455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110473239|NCT02600455|Immunologic Factors|immunologic factors|mesh-ancestor
110473240|NCT02600455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110473241|NCT02600455|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110473242|NCT01023308|Dexamethasone|dexamethasone|mesh-list
110473243|NCT01023308|Bortezomib|bortezomib|mesh-list
110473244|NCT01023308|Panobinostat|panobinostat|mesh-list
110473245|NCT01023308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110473246|NCT01023308|Antiemetics|antiemetics|mesh-ancestor
110473247|NCT01023308|Autonomic Agents|autonomic agents|mesh-ancestor
110473248|NCT01023308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110473249|NCT01023308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110871962|NCT01383330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110871963|NCT03018938|Insulin|insulin|mesh-list
110871964|NCT03018938|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110871965|NCT03018938|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110871966|NCT03018938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110871967|NCT04776499|Perphenazine|perphenazine|mesh-list
110871968|NCT04776499|Riociguat|riociguat|mesh-list
110473250|NCT01023308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110473251|NCT01023308|Glucocorticoids|glucocorticoids|mesh-ancestor
110473252|NCT01023308|Hormones|hormones|mesh-ancestor
110473253|NCT01023308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110473254|NCT01023308|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110473255|NCT01023308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110473256|NCT01023308|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110473257|NCT01023308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110473258|NCT01023308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110473259|NCT02781909|Ibuprofen|ibuprofen|mesh-list
110473260|NCT02781909|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110473261|NCT02781909|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110473262|NCT02781909|Analgesics|analgesics|mesh-ancestor
110473263|NCT02781909|Sensory System Agents|sensory system agents|mesh-ancestor
110473264|NCT02781909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110473265|NCT02781909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110473266|NCT02781909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110473268|NCT02781909|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110473269|NCT02781909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110473270|NCT02781909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110473271|NCT01022996|Everolimus|everolimus|mesh-list
110473272|NCT01022996|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110473273|NCT01022996|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110473274|NCT01022996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110473275|NCT01022996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110473276|NCT01022996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110473277|NCT01022996|Immunologic Factors|immunologic factors|mesh-ancestor
110473278|NCT01022996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110473279|NCT01022996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110473280|NCT02781597|Tranexamic Acid|tranexamic acid|mesh-list
110473281|NCT02781597|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110473282|NCT02781597|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110473283|NCT02781597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110473284|NCT02781597|Hemostatics|hemostatics|mesh-ancestor
110473285|NCT02781597|Coagulants|coagulants|mesh-ancestor
110473286|NCT00757237|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110473287|NCT00757237|Tobramycin|tobramycin|mesh-list
110473288|NCT00757237|Aztreonam|aztreonam|mesh-list
110473289|NCT00757237|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
110473290|NCT00757237|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110473291|NCT00757237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110473292|NCT00757237|Antitubercular Agents|antitubercular agents|mesh-ancestor
110473293|NCT01029392|Vitamin D|vitamin d|mesh-list
110473294|NCT01029392|Cholecalciferol|cholecalciferol|mesh-list
110473295|NCT01029392|Vitamins|vitamins|mesh-ancestor
110473296|NCT01029392|Micronutrients|micronutrients|mesh-ancestor
110473297|NCT01029392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110473298|NCT01029392|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110599449|NCT00854776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110473299|NCT01029392|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110473300|NCT02781753|Interferons|interferons|mesh-list
110473301|NCT02781753|Interferon-alpha|interferon-alpha|mesh-list
110473302|NCT02781753|Interferon alpha-2|interferon alpha-2|mesh-list
110473303|NCT02781753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110473304|NCT02781753|Antiviral Agents|antiviral agents|mesh-ancestor
110473305|NCT02781753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110473306|NCT02781753|Immunologic Factors|immunologic factors|mesh-ancestor
110473307|NCT02781753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110473308|NCT00903006|Dasatinib|dasatinib|mesh-list
110473309|NCT00903006|Fulvestrant|fulvestrant|mesh-list
110473310|NCT00903006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110473311|NCT00903006|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110473312|NCT00903006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110473313|NCT00903006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110871969|NCT04776499|Propylthiouracil|propylthiouracil|mesh-list
110871970|NCT04776499|Enzyme Activators|enzyme activators|mesh-ancestor
110871971|NCT04776499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110871972|NCT04776499|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110871973|NCT04776499|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110871974|NCT04776499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110871975|NCT04776499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110871976|NCT04776499|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110871977|NCT04776499|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110871978|NCT04776499|Dopamine Agents|dopamine agents|mesh-ancestor
110871979|NCT04776499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110871980|NCT04776499|Antimetabolites|antimetabolites|mesh-ancestor
110871981|NCT04776499|Antithyroid Agents|antithyroid agents|mesh-ancestor
110871982|NCT04776499|Hormone Antagonists|hormone antagonists|mesh-ancestor
110871983|NCT04776499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110473314|NCT00903006|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110473315|NCT00903006|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110473316|NCT00903006|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110473317|NCT00903006|Hormone Antagonists|hormone antagonists|mesh-ancestor
110473318|NCT00903006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110473319|NCT00903006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110473320|NCT04097899|Anti-Infective Agents|anti-infective agents|mesh-list
110473321|NCT04097899|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110473323|NCT02845986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110473324|NCT00839332|Gemcitabine|gemcitabine|mesh-list
110473325|NCT00839332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110473326|NCT00839332|Antimetabolites|antimetabolites|mesh-ancestor
110473327|NCT00839332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110473328|NCT00839332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110473329|NCT04095169|Complement System Proteins|complement system proteins|mesh-list
110473330|NCT04095169|Complement C3|complement c3|mesh-list
110473331|NCT04095169|Complement C3d|complement c3d|mesh-list
110473332|NCT04095169|Immunologic Factors|immunologic factors|mesh-ancestor
110473333|NCT04095169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110473334|NCT05241912|Dobutamine|dobutamine|mesh-list
110473335|NCT05241912|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110473336|NCT05241912|Sympathomimetics|sympathomimetics|mesh-ancestor
110473337|NCT05241912|Autonomic Agents|autonomic agents|mesh-ancestor
110473338|NCT05241912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110473339|NCT05241912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110473340|NCT05241912|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
110396097|NCT00602004|Losartan|losartan|mesh-list
110473342|NCT05241912|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110473343|NCT05241912|Adrenergic Agents|adrenergic agents|mesh-ancestor
110473344|NCT05241912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110473345|NCT05241912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110473346|NCT05241912|Protective Agents|protective agents|mesh-ancestor
110473347|NCT05217654|Dapagliflozin|dapagliflozin|mesh-list
110473348|NCT05217654|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110473349|NCT05217654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110473350|NCT05217654|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110473351|NCT05217654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110473352|NCT04229355|Sorafenib|sorafenib|mesh-list
110473353|NCT04229355|Lenvatinib|lenvatinib|mesh-list
110473354|NCT04229355|Chlorotrianisene|chlorotrianisene|mesh-list
110473355|NCT04229355|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
110473356|NCT04229355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110473357|NCT04229355|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110871984|NCT03668054|Bevacizumab|bevacizumab|mesh-list
110871985|NCT03668054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110871986|NCT03668054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110871987|NCT03668054|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110871988|NCT03668054|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110200873|NCT00146614|Methotrexate|methotrexate|mesh-list
110473358|NCT04229355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110473359|NCT04229355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110473360|NCT04229355|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
110473361|NCT04229355|Estrogens|estrogens|mesh-ancestor
110473362|NCT04229355|Hormones|hormones|mesh-ancestor
110473363|NCT04229355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110473364|NCT04229355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110473365|NCT04229355|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110473366|NCT04229355|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110473367|NCT02848170|Olmesartan|olmesartan|mesh-list
110473368|NCT02848170|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
110473369|NCT02848170|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110473370|NCT02848170|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110473371|NCT02848170|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110473372|NCT02848170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110473373|NCT05341401|Prednisolone|prednisolone|mesh-list
110473374|NCT05341401|Budesonide|budesonide|mesh-list
110473375|NCT05341401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110473376|NCT05341401|Glucocorticoids|glucocorticoids|mesh-ancestor
110473377|NCT05341401|Hormones|hormones|mesh-ancestor
110473378|NCT05341401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110473379|NCT05341401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110473380|NCT05341401|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110473381|NCT05341401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110473383|NCT05341401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110473384|NCT05341401|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110473385|NCT05341401|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110473386|NCT05341401|Respiratory System Agents|respiratory system agents|mesh-ancestor
110473387|NCT05340153|Lumefantrine|lumefantrine|mesh-list
110473388|NCT05340153|Artemether|artemether|mesh-list
110473389|NCT05340153|Piperaquine|piperaquine|mesh-list
110473390|NCT05340153|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
110473391|NCT05340153|Artenimol|artenimol|mesh-list
110473392|NCT05340153|Antimalarials|antimalarials|mesh-ancestor
110473393|NCT05340153|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110473394|NCT05340153|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110473395|NCT05340153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110473396|NCT05078502|Vitamin D|vitamin d|mesh-list
110473397|NCT05078502|Cholecalciferol|cholecalciferol|mesh-list
110473398|NCT05078502|Vitamins|vitamins|mesh-ancestor
110473399|NCT05078502|Micronutrients|micronutrients|mesh-ancestor
110473400|NCT05078502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110473401|NCT05078502|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110473402|NCT05078502|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110473403|NCT02844894|Dexmedetomidine|dexmedetomidine|mesh-list
110473404|NCT02844894|Esmolol|esmolol|mesh-list
110473405|NCT02844894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110473406|NCT02844894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110473407|NCT02844894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110473408|NCT02844894|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110473409|NCT02844894|Analgesics|analgesics|mesh-ancestor
110473410|NCT02844894|Sensory System Agents|sensory system agents|mesh-ancestor
110473411|NCT02844894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110473412|NCT02844894|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110473413|NCT02844894|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110473414|NCT02844894|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110473415|NCT02844894|Adrenergic Agents|adrenergic agents|mesh-ancestor
110473416|NCT02844894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110473417|NCT02844894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110473418|NCT02844894|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110473419|NCT02844894|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110473420|NCT02844894|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110871990|NCT03668054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110871991|NCT03668054|Growth Inhibitors|growth inhibitors|mesh-ancestor
110871992|NCT04698187|Nivolumab|nivolumab|mesh-list
110871993|NCT04698187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110871994|NCT04698187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110871995|NCT04698187|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110871996|NCT04698187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110871997|NCT03623048|Chlorhexidine|chlorhexidine|mesh-list
110871998|NCT03623048|Propolis|propolis|mesh-list
110871999|NCT03623048|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110200941|NCT00047801|Docetaxel|docetaxel|mesh-list
110473422|NCT04778904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110473423|NCT04778904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110473424|NCT04778904|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110473425|NCT04778904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110473426|NCT00634725|Gemcitabine|gemcitabine|mesh-list
110473427|NCT00634725|Capecitabine|capecitabine|mesh-list
110473428|NCT00634725|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110473429|NCT00634725|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110473430|NCT00634725|Antimetabolites|antimetabolites|mesh-ancestor
110473431|NCT00634725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110473432|NCT00634725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110473433|NCT00634725|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110473434|NCT00634725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110473435|NCT05325489|Budesonide|budesonide|mesh-list
110473436|NCT05325489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110473437|NCT05325489|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110473438|NCT05325489|Autonomic Agents|autonomic agents|mesh-ancestor
110473439|NCT05325489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110473440|NCT05325489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110473441|NCT05325489|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110473442|NCT05325489|Respiratory System Agents|respiratory system agents|mesh-ancestor
110473443|NCT05325489|Glucocorticoids|glucocorticoids|mesh-ancestor
110473444|NCT05325489|Hormones|hormones|mesh-ancestor
110473445|NCT05325489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110473446|NCT00902538|Amlodipine|amlodipine|mesh-list
110473447|NCT00902538|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110473448|NCT00902538|Olmesartan|olmesartan|mesh-list
110473449|NCT00902538|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
110599505|NCT00725114|Anesthetics|anesthetics|mesh-ancestor
110473450|NCT00902538|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110473451|NCT00902538|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110473452|NCT00902538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110473453|NCT00902538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110473454|NCT00902538|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110473455|NCT00902538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110473456|NCT00902538|Vasodilator Agents|vasodilator agents|mesh-ancestor
110473457|NCT00902538|Diuretics|diuretics|mesh-ancestor
110473458|NCT00902538|Natriuretic Agents|natriuretic agents|mesh-ancestor
110473459|NCT00902538|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110473460|NCT00902538|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110473461|NCT00902538|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110473462|NCT02780505|Ascorbic Acid|ascorbic acid|mesh-list
110473463|NCT02780505|Vitamins|vitamins|mesh-ancestor
110473464|NCT02780505|Micronutrients|micronutrients|mesh-ancestor
110473465|NCT02780505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110473466|NCT02780505|Antioxidants|antioxidants|mesh-ancestor
110473467|NCT02780505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110473468|NCT02780505|Protective Agents|protective agents|mesh-ancestor
110473469|NCT02690844|Clonazepam|clonazepam|mesh-list
110473470|NCT02690844|Anticonvulsants|anticonvulsants|mesh-ancestor
110473471|NCT02690844|GABA Modulators|gaba modulators|mesh-ancestor
110473472|NCT02690844|GABA Agents|gaba agents|mesh-ancestor
110872000|NCT03623048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110872001|NCT03623048|Disinfectants|disinfectants|mesh-ancestor
110872002|NCT03016598|Oxytocin|oxytocin|mesh-list
110872003|NCT03016598|Oxytocics|oxytocics|mesh-ancestor
110872004|NCT03016598|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110872005|NCT03016598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110872006|NCT03017846|Cantharidin|cantharidin|mesh-list
110872007|NCT03017846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110872008|NCT03017846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110872009|NCT03638401|Morphine|morphine|mesh-list
110473473|NCT02690844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110473474|NCT02690844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110473475|NCT02690844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110473476|NCT04201860|Hemostatics|hemostatics|mesh-list
110473477|NCT04201860|Coagulants|coagulants|mesh-ancestor
110473478|NCT02847702|Naproxen|naproxen|mesh-list
110473479|NCT02847702|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110473480|NCT02847702|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110473481|NCT02847702|Analgesics|analgesics|mesh-ancestor
110473482|NCT02847702|Sensory System Agents|sensory system agents|mesh-ancestor
110473483|NCT02847702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110473484|NCT02847702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110473485|NCT02847702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110473486|NCT02847702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110473487|NCT02847702|Gout Suppressants|gout suppressants|mesh-ancestor
110473488|NCT02847702|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110473489|NCT02847702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110473490|NCT02847702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110473491|NCT02779413|Insulin|insulin|mesh-list
110473492|NCT02779413|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110473493|NCT02779413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110473494|NCT04887402|Clomiphene|clomiphene|mesh-list
110473495|NCT04887402|Enclomiphene|enclomiphene|mesh-list
110473496|NCT04887402|Zuclomiphene|zuclomiphene|mesh-list
110473497|NCT04887402|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110473498|NCT04887402|Hormone Antagonists|hormone antagonists|mesh-ancestor
110473499|NCT04887402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110473500|NCT04887402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110473501|NCT04887402|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110473502|NCT04887402|Fertility Agents|fertility agents|mesh-ancestor
110473503|NCT04887402|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110473504|NCT04887402|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110473505|NCT04887402|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110473506|NCT04793568|Interferons|interferons|mesh-list
110473507|NCT04793568|Interferon-gamma|interferon-gamma|mesh-list
110473508|NCT04793568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110473509|NCT04793568|Antiviral Agents|antiviral agents|mesh-ancestor
110473510|NCT04793568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110473511|NCT01979211|Cetuximab|cetuximab|mesh-list
110473512|NCT01979211|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110473513|NCT01979211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110473514|NCT05339217|Aldesleukin|aldesleukin|mesh-list
110473515|NCT05339217|Interleukin-2|interleukin-2|mesh-list
110473516|NCT05339217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110473517|NCT05339217|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110473518|NCT05339217|Analgesics|analgesics|mesh-ancestor
110473519|NCT05339217|Sensory System Agents|sensory system agents|mesh-ancestor
110473520|NCT05339217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110473521|NCT05339217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110473522|NCT05339217|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110473523|NCT05339217|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110473524|NCT05339217|Antiviral Agents|antiviral agents|mesh-ancestor
110473525|NCT05339217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110473526|NCT04793490|Acetaminophen|acetaminophen|mesh-list
110473527|NCT04793490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110473528|NCT04793490|Analgesics|analgesics|mesh-ancestor
110473529|NCT04793490|Sensory System Agents|sensory system agents|mesh-ancestor
110033651|NCT03011775|Bisoprolol|bisoprolol|mesh-list
110872010|NCT03638401|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110872012|NCT03638401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110872013|NCT03638401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110872014|NCT03638401|Analgesics|analgesics|mesh-ancestor
110872015|NCT03638401|Sensory System Agents|sensory system agents|mesh-ancestor
110872016|NCT03638401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110872017|NCT03666650|Edoxaban|edoxaban|mesh-list
110872018|NCT03666650|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110872019|NCT03666650|Antithrombins|antithrombins|mesh-ancestor
110872020|NCT03666650|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110872021|NCT03666650|Protease Inhibitors|protease inhibitors|mesh-ancestor
110872022|NCT03666650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110872023|NCT03666650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110872024|NCT03666650|Anticoagulants|anticoagulants|mesh-ancestor
110473530|NCT04793490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110473531|NCT04793490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110473532|NCT04793490|Antipyretics|antipyretics|mesh-ancestor
110473533|NCT00779532|Moxifloxacin|moxifloxacin|mesh-list
110473534|NCT00779532|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
110473535|NCT00779532|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110473536|NCT00779532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110473537|NCT00779532|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110473538|NCT00779532|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110473539|NCT00779532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110473540|NCT00779532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110473541|NCT00779532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110473542|NCT00779532|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110473543|NCT00779532|Contraceptive Agents|contraceptive agents|mesh-ancestor
110473544|NCT00779532|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110473545|NCT00779532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110473546|NCT00779532|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110473547|NCT00779532|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110473548|NCT00779532|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110473549|NCT05319093|Ozanimod|ozanimod|mesh-list
110473550|NCT05319093|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
110473551|NCT05319093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110473552|NCT05319093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110473553|NCT05319093|Immunologic Factors|immunologic factors|mesh-ancestor
110473554|NCT05319093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110473555|NCT00752557|Calcium, Dietary|calcium, dietary|mesh-list
110473556|NCT00752557|Vitamin D|vitamin d|mesh-list
110473557|NCT00752557|Ergocalciferols|ergocalciferols|mesh-list
110473558|NCT00752557|Cholecalciferol|cholecalciferol|mesh-list
110473559|NCT00752557|Diphosphonates|diphosphonates|mesh-list
110473560|NCT00752557|Vitamins|vitamins|mesh-list
110473561|NCT00752557|Calcium|calcium|mesh-list
110473562|NCT00752557|Micronutrients|micronutrients|mesh-ancestor
110473563|NCT00752557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110473564|NCT00752557|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110473565|NCT00752557|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110473566|NCT04570176|Epinephrine|epinephrine|mesh-list
110473567|NCT04570176|Racepinephrine|racepinephrine|mesh-list
110473568|NCT04570176|Epinephryl borate|epinephryl borate|mesh-list
110473569|NCT04570176|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110473570|NCT04570176|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110473571|NCT04570176|Adrenergic Agents|adrenergic agents|mesh-ancestor
110473572|NCT04570176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110473573|NCT04570176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110473574|NCT04570176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110872025|NCT02942485|Metronidazole|metronidazole|mesh-list
110872026|NCT02942485|Tinidazole|tinidazole|mesh-list
110872027|NCT02942485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110872028|NCT02942485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110872029|NCT02942485|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110201131|NCT00147628|Anticoagulants|anticoagulants|mesh-ancestor
110473575|NCT04570176|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110473576|NCT04570176|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110473577|NCT04570176|Autonomic Agents|autonomic agents|mesh-ancestor
110473578|NCT04570176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110473579|NCT04570176|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110473580|NCT04570176|Respiratory System Agents|respiratory system agents|mesh-ancestor
110473581|NCT04570176|Mydriatics|mydriatics|mesh-ancestor
110599537|NCT02571426|Propofol|propofol|mesh-list
110473582|NCT04570176|Sympathomimetics|sympathomimetics|mesh-ancestor
110473583|NCT04570176|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110473584|NCT00751218|Cetirizine|cetirizine|mesh-list
110473585|NCT00751218|Desloratadine|desloratadine|mesh-list
110473586|NCT00751218|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110473587|NCT00751218|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110473588|NCT00751218|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110473589|NCT00751218|Histamine Antagonists|histamine antagonists|mesh-ancestor
110473591|NCT00751218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110473592|NCT00751218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110473593|NCT00751218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110473594|NCT00751218|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110473595|NCT00751218|Cholinergic Agents|cholinergic agents|mesh-ancestor
110473596|NCT02779569|Decitabine|decitabine|mesh-list
110473597|NCT02779569|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110473598|NCT02779569|Antimetabolites|antimetabolites|mesh-ancestor
110473599|NCT02779569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110473600|NCT02779569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110473601|NCT02779569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110473602|NCT04095013|Fentanyl|fentanyl|mesh-list
110473603|NCT04095013|Dexmedetomidine|dexmedetomidine|mesh-list
110473604|NCT04095013|Bupivacaine|bupivacaine|mesh-list
110473605|NCT04095013|Anesthetics, Local|anesthetics, local|mesh-ancestor
110473606|NCT04095013|Anesthetics|anesthetics|mesh-ancestor
110473607|NCT04095013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110473608|NCT04095013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110473609|NCT04095013|Sensory System Agents|sensory system agents|mesh-ancestor
110473610|NCT04095013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110473611|NCT04095013|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110473612|NCT04095013|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110473613|NCT04095013|Analgesics|analgesics|mesh-ancestor
110473614|NCT04095013|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110473615|NCT04095013|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110473616|NCT04095013|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110473617|NCT04095013|Adrenergic Agents|adrenergic agents|mesh-ancestor
110473618|NCT04095013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110473619|NCT04095013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110473620|NCT04095013|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110473621|NCT04095013|Narcotics|narcotics|mesh-ancestor
110473622|NCT04095013|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110473623|NCT04095013|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110473624|NCT04095013|Anesthetics, General|anesthetics, general|mesh-ancestor
110473625|NCT02779881|Caseins|caseins|mesh-list
110473626|NCT02779881|Chelating Agents|chelating agents|mesh-ancestor
110473627|NCT02779881|Sequestering Agents|sequestering agents|mesh-ancestor
110473628|NCT02779881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110473629|NCT00651378|Atorvastatin|atorvastatin|mesh-list
110473630|NCT00651378|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110473631|NCT00651378|Ezetimibe|ezetimibe|mesh-list
110473632|NCT00651378|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110473633|NCT00651378|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110473634|NCT00651378|Antimetabolites|antimetabolites|mesh-ancestor
110473635|NCT00651378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110473636|NCT00651378|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110473637|NCT00651378|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110473638|NCT00651378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110473639|NCT00747643|Varenicline|varenicline|mesh-list
110473640|NCT00747643|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110872030|NCT02942485|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110872031|NCT02942485|Alkylating Agents|alkylating agents|mesh-ancestor
110872032|NCT02942485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110872033|NCT02942485|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
110872034|NCT03666494|Fentanyl|fentanyl|mesh-list
110872035|NCT03666494|Ketamine|ketamine|mesh-list
110872036|NCT03666494|Propofol|propofol|mesh-list
110872037|NCT03666494|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110872038|NCT03666494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110872039|NCT03666494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110872040|NCT03666494|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110872041|NCT03666494|Anesthetics, General|anesthetics, general|mesh-ancestor
110872042|NCT03666494|Anesthetics|anesthetics|mesh-ancestor
110201208|NCT00148018|Hormones|hormones|mesh-ancestor
110473641|NCT00747643|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110473642|NCT00747643|Cholinergic Agents|cholinergic agents|mesh-ancestor
110473643|NCT00747643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110473644|NCT00747643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110473645|NCT00747643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110473646|NCT00627692|Prucalopride|prucalopride|mesh-list
110473647|NCT00627692|Laxatives|laxatives|mesh-ancestor
110473648|NCT00627692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110473649|NCT00627692|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
110473650|NCT00627692|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110473651|NCT00627692|Serotonin Agents|serotonin agents|mesh-ancestor
110473652|NCT00627692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110473653|NCT00627692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110473654|NCT00627692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110473655|NCT00634881|Alemtuzumab|alemtuzumab|mesh-list
110473656|NCT00634881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110473657|NCT00634881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110473658|NCT04301882|Interferons|interferons|mesh-list
110473659|NCT04301882|Ribavirin|ribavirin|mesh-list
110473660|NCT04301882|Antiviral Agents|antiviral agents|mesh-list
110473661|NCT04301882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110473662|NCT04301882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110473663|NCT04301882|Antimetabolites|antimetabolites|mesh-ancestor
110473664|NCT04301882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110473665|NCT04300322|Progesterone|progesterone|mesh-list
110473666|NCT04300322|Progestins|progestins|mesh-ancestor
110473667|NCT04300322|Hormones|hormones|mesh-ancestor
110473668|NCT04300322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110473669|NCT04300322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110473670|NCT01022762|Repaglinide|repaglinide|mesh-list
110473671|NCT01022762|Gliclazide|gliclazide|mesh-list
110473672|NCT01022762|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110473673|NCT01022762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110473674|NCT00311844|Desloratadine|desloratadine|mesh-list
110473675|NCT00311844|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110473676|NCT00311844|Cholinergic Agents|cholinergic agents|mesh-ancestor
110473677|NCT00311844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110473678|NCT00311844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110473679|NCT00311844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110473680|NCT00311844|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110473681|NCT00311844|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110473682|NCT00311844|Histamine Antagonists|histamine antagonists|mesh-ancestor
110473683|NCT00311844|Histamine Agents|histamine agents|mesh-ancestor
110473684|NCT02599675|Vitamin D|vitamin d|mesh-list
110473685|NCT02599675|Cholecalciferol|cholecalciferol|mesh-list
110473686|NCT02599675|Vitamins|vitamins|mesh-ancestor
110473687|NCT02599675|Micronutrients|micronutrients|mesh-ancestor
110473688|NCT02599675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110473689|NCT02599675|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110872043|NCT03666494|Analgesics|analgesics|mesh-ancestor
110872044|NCT03666494|Sensory System Agents|sensory system agents|mesh-ancestor
110872045|NCT03666494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110872046|NCT03666494|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110872047|NCT03666494|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110872048|NCT03666494|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110872049|NCT03666494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110872050|NCT03666494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110872051|NCT03666494|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110872052|NCT03666494|Narcotics|narcotics|mesh-ancestor
110872053|NCT03666494|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110872054|NCT03666884|Cyclosporine|cyclosporine|mesh-list
110872055|NCT03666884|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110473690|NCT02599675|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110473692|NCT02778789|Infliximab|infliximab|mesh-list
110473693|NCT02778789|Golimumab|golimumab|mesh-list
110473694|NCT02778789|Certolizumab Pegol|certolizumab pegol|mesh-list
110473695|NCT02778789|Etanercept|etanercept|mesh-list
110473696|NCT02778789|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110473697|NCT02778789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110473698|NCT02778789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110473699|NCT02778789|Dermatologic Agents|dermatologic agents|mesh-ancestor
110473700|NCT02778789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110473701|NCT02778789|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110473702|NCT02778789|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110473703|NCT02778789|Analgesics|analgesics|mesh-ancestor
110473704|NCT02778789|Sensory System Agents|sensory system agents|mesh-ancestor
110473705|NCT02778789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110473706|NCT02778789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110473707|NCT02778789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110473708|NCT02778789|Immunologic Factors|immunologic factors|mesh-ancestor
110473709|NCT00212784|Olanzapine|olanzapine|mesh-list
110473710|NCT00212784|Asenapine|asenapine|mesh-list
110473711|NCT00212784|Antiemetics|antiemetics|mesh-ancestor
110473712|NCT00212784|Autonomic Agents|autonomic agents|mesh-ancestor
110473713|NCT00212784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110473714|NCT00212784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110473715|NCT00212784|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110473716|NCT00212784|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110473717|NCT00212784|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110473718|NCT00212784|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110473719|NCT00212784|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110473720|NCT00212784|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110473721|NCT00212784|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110473722|NCT00212784|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110473723|NCT00212784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110473725|NCT00212784|Serotonin Agents|serotonin agents|mesh-ancestor
110473726|NCT00751933|Vaccines|vaccines|mesh-list
110473727|NCT00751933|Immunologic Factors|immunologic factors|mesh-ancestor
110473728|NCT00751933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110473729|NCT04092751|Ibrexafungerp|ibrexafungerp|mesh-list
110473730|NCT04092751|Antifungal Agents|antifungal agents|mesh-ancestor
110473731|NCT04092751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110473732|NCT02778945|Rocuronium|rocuronium|mesh-list
110473733|NCT02778945|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110473734|NCT02778945|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110473735|NCT02778945|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110473736|NCT02778945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110473737|NCT02778945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110473738|NCT02721342|Ramipril|ramipril|mesh-list
110473739|NCT02721342|Irbesartan|irbesartan|mesh-list
110473740|NCT02721342|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110473741|NCT02721342|Protease Inhibitors|protease inhibitors|mesh-ancestor
110872056|NCT03666884|Cyclosporins|cyclosporins|mesh-list
110872057|NCT03666884|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110872058|NCT03666884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110872059|NCT03666884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110872060|NCT03666884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110872061|NCT03666884|Immunologic Factors|immunologic factors|mesh-ancestor
110872062|NCT03666884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110872063|NCT03666884|Antifungal Agents|antifungal agents|mesh-ancestor
110872064|NCT03666884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110872065|NCT03666884|Dermatologic Agents|dermatologic agents|mesh-ancestor
110872066|NCT03666884|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110201335|NCT00148564|Serotonin Agents|serotonin agents|mesh-ancestor
110473742|NCT02721342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110473743|NCT02721342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110473744|NCT02721342|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110473745|NCT02721342|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110473746|NCT02721342|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110473747|NCT02779101|Pembrolizumab|pembrolizumab|mesh-list
110473748|NCT02779101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110473749|NCT02779101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110473750|NCT02779101|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110473751|NCT02779101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110473752|NCT02779959|Prochlorperazine|prochlorperazine|mesh-list
110473753|NCT02779959|Antiemetics|antiemetics|mesh-ancestor
110473754|NCT02779959|Autonomic Agents|autonomic agents|mesh-ancestor
110473755|NCT02779959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110473756|NCT02779959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110473757|NCT02779959|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110473758|NCT02779959|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110473759|NCT02779959|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110473760|NCT02779959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110473761|NCT02779959|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110473762|NCT02779959|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110473763|NCT02779959|Dopamine Agents|dopamine agents|mesh-ancestor
110120938|NCT01909557|Vitamins|vitamins|mesh-ancestor
110473764|NCT02779959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110473765|NCT02779959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110473766|NCT05335278|Nintedanib|nintedanib|mesh-list
110599618|NCT00725348|R 115866|r 115866|mesh-list
110473767|NCT05335278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110473768|NCT05335278|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110473769|NCT05335278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110473770|NCT05335278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110473771|NCT00092898|Ezetimibe|ezetimibe|mesh-list
110473772|NCT00092898|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110473773|NCT00092898|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110473774|NCT00092898|Antimetabolites|antimetabolites|mesh-ancestor
110473775|NCT00092898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110473776|NCT00092898|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110473777|NCT04094467|Leuprolide|leuprolide|mesh-list
110473778|NCT04094467|Cetrorelix|cetrorelix|mesh-list
110473779|NCT04094467|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110473780|NCT04094467|Fertility Agents|fertility agents|mesh-ancestor
110473781|NCT04094467|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110473782|NCT04094467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110473783|NCT04094467|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110473784|NCT04094467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110473785|NCT04094467|Hormone Antagonists|hormone antagonists|mesh-ancestor
110473786|NCT04094467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110473787|NCT04987281|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110473788|NCT00092820|Ezetimibe|ezetimibe|mesh-list
110473789|NCT00092820|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110473790|NCT00092820|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110473791|NCT00092820|Antimetabolites|antimetabolites|mesh-ancestor
110872067|NCT03666884|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110872069|NCT02942407|Apixaban|apixaban|mesh-list
110872070|NCT02942407|Anticoagulants|anticoagulants|mesh-ancestor
110872071|NCT02942407|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110872072|NCT02942407|Antithrombins|antithrombins|mesh-ancestor
110872073|NCT02942407|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110872074|NCT02942407|Protease Inhibitors|protease inhibitors|mesh-ancestor
110872075|NCT02942407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110872076|NCT02942407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110872077|NCT02921035|Interferons|interferons|mesh-list
110872078|NCT02921035|Interferon-beta|interferon-beta|mesh-list
110872079|NCT02921035|Interferon beta-1a|interferon beta-1a|mesh-list
110872080|NCT02921035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110473792|NCT00092820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110473793|NCT00092820|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110473794|NCT04228263|Aspirin|aspirin|mesh-list
110473795|NCT04228263|Folic Acid|folic acid|mesh-list
110473796|NCT04228263|Hydroxychloroquine|hydroxychloroquine|mesh-list
110473797|NCT04228263|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110473798|NCT04228263|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110473799|NCT04228263|Analgesics|analgesics|mesh-ancestor
110473800|NCT04228263|Sensory System Agents|sensory system agents|mesh-ancestor
110473801|NCT04228263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110473802|NCT04228263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110473803|NCT04228263|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110473804|NCT04228263|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110473805|NCT04228263|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110473806|NCT04228263|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110473807|NCT04228263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110473808|NCT04228263|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110473809|NCT04228263|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110473810|NCT04228263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110473811|NCT04228263|Antipyretics|antipyretics|mesh-ancestor
110473812|NCT04228263|Antimalarials|antimalarials|mesh-ancestor
110473813|NCT04228263|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110473814|NCT04228263|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110473815|NCT04228263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110473816|NCT04228263|Hematinics|hematinics|mesh-ancestor
110473817|NCT04228263|Vitamin B Complex|vitamin b complex|mesh-ancestor
110473818|NCT04228263|Vitamins|vitamins|mesh-ancestor
110473819|NCT04228263|Micronutrients|micronutrients|mesh-ancestor
110473820|NCT00092742|Diclofenac|diclofenac|mesh-list
110473821|NCT00092742|Etoricoxib|etoricoxib|mesh-list
110473822|NCT00092742|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110473823|NCT00092742|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110473824|NCT00092742|Analgesics|analgesics|mesh-ancestor
110473825|NCT00092742|Sensory System Agents|sensory system agents|mesh-ancestor
110473826|NCT00092742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110165191|NCT00023218|Ritonavir|ritonavir|mesh-list
110473827|NCT00092742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110473828|NCT00092742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110473829|NCT00092742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110473830|NCT00092742|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110473831|NCT00092742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110473832|NCT00092742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110473833|NCT00092742|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110473834|NCT02844270|Sirolimus|sirolimus|mesh-list
110473835|NCT02844270|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110473836|NCT02844270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110473837|NCT02844270|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110473838|NCT02844270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110473839|NCT02844270|Antifungal Agents|antifungal agents|mesh-ancestor
110473840|NCT02844270|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110473841|NCT02844270|Immunologic Factors|immunologic factors|mesh-ancestor
110872081|NCT02921035|Antiviral Agents|antiviral agents|mesh-ancestor
110872082|NCT02921035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110872083|NCT02921035|Immunologic Factors|immunologic factors|mesh-ancestor
110872084|NCT02921035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110872085|NCT02921035|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110872086|NCT04621981|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110872088|NCT03667352|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110872089|NCT03667352|Narcotics|narcotics|mesh-ancestor
110872090|NCT03667352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110872091|NCT03667352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110872092|NCT03667352|Analgesics|analgesics|mesh-ancestor
110872093|NCT03667352|Sensory System Agents|sensory system agents|mesh-ancestor
110473842|NCT02844270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110473843|NCT00634959|Maraviroc|maraviroc|mesh-list
110473844|NCT00634959|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110473845|NCT00634959|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110473846|NCT00634959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110473847|NCT00634959|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110473848|NCT00634959|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110473849|NCT00634959|Antiviral Agents|antiviral agents|mesh-ancestor
110473850|NCT00634959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110473851|NCT00634959|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
110473852|NCT02598427|Trastuzumab|trastuzumab|mesh-list
110473853|NCT02598427|Pertuzumab|pertuzumab|mesh-list
110473854|NCT02598427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110473855|NCT02598427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110473856|NCT04092595|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110473857|NCT04092595|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110473858|NCT04092595|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110473859|NCT04092595|Antimetabolites|antimetabolites|mesh-ancestor
110473860|NCT04092595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110473861|NCT04092595|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110473862|NCT04092595|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110473863|NCT04092595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110473864|NCT04092205|N,N'-Bis(2-mercaptoethyl)isophthalamide|n,n'-bis(2-mercaptoethyl)isophthalamide|mesh-list
110473865|NCT04092205|Chelating Agents|chelating agents|mesh-ancestor
110473866|NCT04092205|Sequestering Agents|sequestering agents|mesh-ancestor
110473867|NCT04092205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110473868|NCT05117853|Parathyroid Hormone|parathyroid hormone|mesh-list
110473869|NCT05117853|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110473870|NCT05117853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110473872|NCT01028222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110473873|NCT01028222|Alkylating Agents|alkylating agents|mesh-ancestor
110473874|NCT01028222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110473875|NCT01028222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110473876|NCT00586495|Sorafenib|sorafenib|mesh-list
110473877|NCT00586495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110473878|NCT00586495|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110473879|NCT00586495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110473880|NCT00586495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110473881|NCT02776137|Docetaxel|docetaxel|mesh-list
110473882|NCT02776137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110473883|NCT02776137|Tubulin Modulators|tubulin modulators|mesh-ancestor
110473884|NCT02776137|Antimitotic Agents|antimitotic agents|mesh-ancestor
110473885|NCT02776137|Mitosis Modulators|mitosis modulators|mesh-ancestor
110473886|NCT02776137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110473887|NCT01027754|Varenicline|varenicline|mesh-list
110473888|NCT01027754|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110473889|NCT01027754|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110473890|NCT01027754|Cholinergic Agents|cholinergic agents|mesh-ancestor
110473891|NCT01027754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110872094|NCT03667352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110872095|NCT03667352|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110872096|NCT03667352|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110872097|NCT03667352|Anesthetics, General|anesthetics, general|mesh-ancestor
110872098|NCT03667352|Anesthetics|anesthetics|mesh-ancestor
110872099|NCT03320941|Licogliflozin|licogliflozin|mesh-list
110872100|NCT03320941|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110473892|NCT01027754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110473893|NCT01027754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110473894|NCT02773017|Dexmedetomidine|dexmedetomidine|mesh-list
110473895|NCT02773017|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110473896|NCT02773017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110473897|NCT02773017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110473898|NCT02773017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110473899|NCT02773017|Analgesics|analgesics|mesh-ancestor
110473900|NCT02773017|Sensory System Agents|sensory system agents|mesh-ancestor
110473901|NCT02773017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110473902|NCT02773017|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110473903|NCT02773017|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110473904|NCT02773017|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110473905|NCT02773017|Adrenergic Agents|adrenergic agents|mesh-ancestor
110473906|NCT02773017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110473907|NCT02773017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110473908|NCT02776059|Prednisolone|prednisolone|mesh-list
110473909|NCT02776059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110473910|NCT02776059|Glucocorticoids|glucocorticoids|mesh-ancestor
110473912|NCT02776059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110473913|NCT02776059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110473914|NCT02776059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110473915|NCT02776059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110473916|NCT00774930|Lanreotide|lanreotide|mesh-list
110473917|NCT00774930|Somatostatin|somatostatin|mesh-list
110473918|NCT00774930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110473919|NCT00774930|Hormones|hormones|mesh-ancestor
110473920|NCT00774930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110473921|NCT00774930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110473922|NCT02841774|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110473923|NCT02841774|Pravastatin|pravastatin|mesh-list
110473924|NCT02841774|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110473925|NCT02841774|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110473926|NCT02841774|Antimetabolites|antimetabolites|mesh-ancestor
110473927|NCT02841774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110473928|NCT02841774|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110473929|NCT02841774|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110473930|NCT02841774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110473931|NCT02772237|Riboflavin|riboflavin|mesh-list
110473932|NCT02772237|Vitamins|vitamins|mesh-ancestor
110473933|NCT02772237|Micronutrients|micronutrients|mesh-ancestor
110473934|NCT02772237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110473935|NCT02772237|Vitamin B Complex|vitamin b complex|mesh-ancestor
110473936|NCT02772237|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110165257|NCT02024607|Vitamins|vitamins|mesh-ancestor
110473937|NCT02772237|Dermatologic Agents|dermatologic agents|mesh-ancestor
110473938|NCT02841306|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
110473939|NCT02841306|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
110473942|NCT01316250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110473943|NCT01316250|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110473944|NCT01316250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110599684|NCT00804531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110473945|NCT01316250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110473946|NCT02771925|Gabapentin|gabapentin|mesh-list
110473947|NCT02771925|Analgesics|analgesics|mesh-ancestor
110473948|NCT02771925|Sensory System Agents|sensory system agents|mesh-ancestor
110473949|NCT02771925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110473950|NCT02771925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110473951|NCT02771925|Anticonvulsants|anticonvulsants|mesh-ancestor
110473952|NCT02771925|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110473953|NCT02771925|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110872101|NCT03320941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110872103|NCT03320941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110872104|NCT04730947|Dapagliflozin|dapagliflozin|mesh-list
110872105|NCT04730947|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110872106|NCT04730947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110872107|NCT04730947|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110872108|NCT04730947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110872109|NCT03559699|Mitapivat|mitapivat|mesh-list
110872110|NCT03559699|Enzyme Activators|enzyme activators|mesh-ancestor
110534658|NCT04178850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110473954|NCT02771925|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110473955|NCT02771925|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110473956|NCT02771925|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110473957|NCT02771925|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110473958|NCT02771925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110473959|NCT02771925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110473960|NCT02771925|Antimanic Agents|antimanic agents|mesh-ancestor
110473961|NCT03205956|Levodopa|levodopa|mesh-list
110473962|NCT03205956|Carbidopa|carbidopa|mesh-list
110473963|NCT03205956|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110473964|NCT03205956|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110473965|NCT03205956|Dopamine Agents|dopamine agents|mesh-ancestor
110473966|NCT03205956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110473967|NCT03205956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110473968|NCT03205956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110473969|NCT03205956|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
110473970|NCT03205956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110473971|NCT02840994|Pembrolizumab|pembrolizumab|mesh-list
110473972|NCT02840994|Nivolumab|nivolumab|mesh-list
110473973|NCT02840994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110473974|NCT02840994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110473975|NCT02840994|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110473976|NCT02840994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110473977|NCT02771457|Infliximab|infliximab|mesh-list
110473978|NCT02771457|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110473979|NCT02771457|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110473980|NCT02771457|Dermatologic Agents|dermatologic agents|mesh-ancestor
110473981|NCT02771457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110473982|NCT02771457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110473983|NCT02843802|Immunomodulating Agents|immunomodulating agents|mesh-list
110473984|NCT02843802|Immunologic Factors|immunologic factors|mesh-ancestor
110473985|NCT02843802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110473986|NCT02771379|Idebenone|idebenone|mesh-list
110121158|NCT01910545|OTS167|ots167|mesh-list
110473987|NCT02771379|Antioxidants|antioxidants|mesh-ancestor
110473988|NCT02771379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110473990|NCT02771379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110473991|NCT01026870|Mometasone Furoate|mometasone furoate|mesh-list
110473992|NCT01026870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110473993|NCT01026870|Dermatologic Agents|dermatologic agents|mesh-ancestor
110473994|NCT01026870|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110473995|NCT02844114|Cisplatin|cisplatin|mesh-list
110473996|NCT02844114|Gemcitabine|gemcitabine|mesh-list
110473997|NCT02844114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110473998|NCT02844114|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110473999|NCT02844114|Antimetabolites|antimetabolites|mesh-ancestor
110474000|NCT02844114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110474001|NCT02696733|Cephalosporins|cephalosporins|mesh-list
110474002|NCT02696733|Lidocaine|lidocaine|mesh-list
110474003|NCT02696733|Anesthetics, Local|anesthetics, local|mesh-ancestor
110474004|NCT02696733|Anesthetics|anesthetics|mesh-ancestor
110474005|NCT02696733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110872111|NCT03559699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110872112|NCT03557281|GSK656|gsk656|mesh-list
110872113|NCT03557281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110872114|NCT03557281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110872115|NCT02573233|Fluticasone|fluticasone|mesh-list
110872116|NCT02573233|Xhance|xhance|mesh-list
110872117|NCT02573233|Mometasone Furoate|mometasone furoate|mesh-list
110872118|NCT02573233|Budesonide|budesonide|mesh-list
110872119|NCT02573233|Formoterol Fumarate|formoterol fumarate|mesh-list
110872120|NCT02573233|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110872121|NCT02573233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110872122|NCT02573233|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110872123|NCT02573233|Autonomic Agents|autonomic agents|mesh-ancestor
110872124|NCT02573233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110474006|NCT02696733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110474007|NCT02696733|Sensory System Agents|sensory system agents|mesh-ancestor
110474008|NCT02696733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110474009|NCT02696733|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110474010|NCT02696733|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110474011|NCT02696733|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110474012|NCT02696733|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110474013|NCT02696733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110474015|NCT02696733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110474016|NCT00897390|Metformin|metformin|mesh-list
110474017|NCT00897390|Saxagliptin|saxagliptin|mesh-list
110474018|NCT00897390|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110474019|NCT00897390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110474020|NCT00897390|Incretins|incretins|mesh-ancestor
110474021|NCT00897390|Hormones|hormones|mesh-ancestor
110474022|NCT00897390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110474023|NCT00897390|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110474024|NCT00897390|Protease Inhibitors|protease inhibitors|mesh-ancestor
110474025|NCT00897390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110474026|NCT00897390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110474027|NCT01034462|Milnacipran|milnacipran|mesh-list
110474028|NCT01034462|Levomilnacipran|levomilnacipran|mesh-list
110474029|NCT01034462|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110474030|NCT01034462|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110474031|NCT01034462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110474032|NCT01034462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110474033|NCT01034462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110474034|NCT01034462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110474035|NCT01034462|Antidepressive Agents|antidepressive agents|mesh-ancestor
110474036|NCT01034462|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110474037|NCT01034462|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110474038|NCT01034462|Analgesics|analgesics|mesh-ancestor
110474039|NCT01034462|Sensory System Agents|sensory system agents|mesh-ancestor
110474040|NCT01034462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110474041|NCT01033448|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110474042|NCT01033448|Antiviral Agents|antiviral agents|mesh-ancestor
110474043|NCT01033448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110474044|NCT02873234|Antidepressive Agents|antidepressive agents|mesh-list
110474045|NCT02873234|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110474046|NCT02774811|Bimatoprost|bimatoprost|mesh-list
110474047|NCT02774811|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110474048|NCT00817050|Fluticasone|fluticasone|mesh-list
110474049|NCT00817050|Mometasone Furoate|mometasone furoate|mesh-list
110474050|NCT00817050|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110474051|NCT00817050|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110474052|NCT00817050|Autonomic Agents|autonomic agents|mesh-ancestor
110474053|NCT00817050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110474054|NCT00817050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110872125|NCT02573233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110872126|NCT02573233|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110872127|NCT02573233|Respiratory System Agents|respiratory system agents|mesh-ancestor
110872128|NCT02573233|Dermatologic Agents|dermatologic agents|mesh-ancestor
110872129|NCT02573233|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110872130|NCT02573233|Glucocorticoids|glucocorticoids|mesh-ancestor
110872131|NCT02573233|Hormones|hormones|mesh-ancestor
110872132|NCT02573233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110872133|NCT02573233|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110474055|NCT00817050|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110474056|NCT00817050|Respiratory System Agents|respiratory system agents|mesh-ancestor
110474057|NCT00817050|Dermatologic Agents|dermatologic agents|mesh-ancestor
110474058|NCT00817050|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110474059|NCT04224831|Mitogens|mitogens|mesh-list
110474060|NCT04224831|Mitosis Modulators|mitosis modulators|mesh-ancestor
110121227|NCT01910987|Bortezomib|bortezomib|mesh-list
110474061|NCT04224831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110474063|NCT00816972|Mandelic Acids|mandelic acids|mesh-list
110474064|NCT00816972|Oxybutynin|oxybutynin|mesh-list
110474065|NCT00816972|Desloratadine|desloratadine|mesh-list
110474066|NCT00816972|Parasympatholytics|parasympatholytics|mesh-ancestor
110474067|NCT00816972|Autonomic Agents|autonomic agents|mesh-ancestor
110474068|NCT00816972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110474069|NCT00816972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110474070|NCT00816972|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110474071|NCT00816972|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110474072|NCT00816972|Cholinergic Agents|cholinergic agents|mesh-ancestor
110474073|NCT00816972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110474074|NCT00816972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110474075|NCT00816972|Urological Agents|urological agents|mesh-ancestor
110165272|NCT00023296|Gasotransmitters|gasotransmitters|mesh-ancestor
110474076|NCT00816972|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110474077|NCT00816972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110474078|NCT00816972|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110474079|NCT00816972|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110474080|NCT00816972|Histamine Antagonists|histamine antagonists|mesh-ancestor
110474081|NCT00816972|Histamine Agents|histamine agents|mesh-ancestor
110474082|NCT00816972|Antipruritics|antipruritics|mesh-ancestor
110474083|NCT00816972|Dermatologic Agents|dermatologic agents|mesh-ancestor
110474084|NCT00816972|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110474085|NCT02774499|Methadone|methadone|mesh-list
110474086|NCT02774499|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110474087|NCT02774499|Narcotics|narcotics|mesh-ancestor
110474088|NCT02774499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110474089|NCT02774499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110474090|NCT02774499|Analgesics|analgesics|mesh-ancestor
110474091|NCT02774499|Sensory System Agents|sensory system agents|mesh-ancestor
110474092|NCT02774499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110474093|NCT02774499|Antitussive Agents|antitussive agents|mesh-ancestor
110474094|NCT02774499|Respiratory System Agents|respiratory system agents|mesh-ancestor
110474095|NCT02770443|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
110474096|NCT02770443|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110474097|NCT02770443|Adrenergic Agents|adrenergic agents|mesh-ancestor
110474098|NCT02770443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110474099|NCT02770443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110474100|NCT02770443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110474102|NCT02774187|Fluorouracil|fluorouracil|mesh-list
110474103|NCT02774187|Oxaliplatin|oxaliplatin|mesh-list
110474104|NCT02774187|Sorafenib|sorafenib|mesh-list
110474105|NCT02774187|Antimetabolites|antimetabolites|mesh-ancestor
110474106|NCT02774187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110474107|NCT02774187|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110474108|NCT02774187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110474109|NCT02774187|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110474110|NCT02774187|Immunologic Factors|immunologic factors|mesh-ancestor
110474111|NCT02774187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110872134|NCT02573233|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110872135|NCT02573233|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110872136|NCT02573233|Adrenergic Agents|adrenergic agents|mesh-ancestor
110872137|NCT02573233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110872138|NCT02573233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110872139|NCT03867487|Empagliflozin|empagliflozin|mesh-list
110534659|NCT04178850|Hematinics|hematinics|mesh-ancestor
110474112|NCT02774187|Antidotes|antidotes|mesh-ancestor
110474113|NCT02774187|Protective Agents|protective agents|mesh-ancestor
110474114|NCT02774187|Vitamin B Complex|vitamin b complex|mesh-ancestor
110474115|NCT02774187|Vitamins|vitamins|mesh-ancestor
110474116|NCT02774187|Micronutrients|micronutrients|mesh-ancestor
110474117|NCT02774187|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110474118|NCT02774187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110474119|NCT02773797|Dexmedetomidine|dexmedetomidine|mesh-list
110474120|NCT02773797|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110474121|NCT02773797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110474122|NCT02773797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110474123|NCT02773797|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110474124|NCT02773797|Analgesics|analgesics|mesh-ancestor
110474125|NCT02773797|Sensory System Agents|sensory system agents|mesh-ancestor
110474126|NCT02773797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110474127|NCT02773797|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110474128|NCT02773797|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110474129|NCT02773797|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110474130|NCT02773797|Adrenergic Agents|adrenergic agents|mesh-ancestor
110474131|NCT02773797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110474132|NCT02773797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110474133|NCT02773875|Pancrelipase|pancrelipase|mesh-list
110474134|NCT02773875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110474135|NCT02768961|Sofosbuvir|sofosbuvir|mesh-list
110121304|NCT01911468|Incretins|incretins|mesh-ancestor
110474136|NCT02768961|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
110474137|NCT02768961|Ledipasvir|ledipasvir|mesh-list
110474138|NCT02768961|Antiviral Agents|antiviral agents|mesh-ancestor
110474139|NCT02768961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110474140|NCT02773641|Botulinum Toxins|botulinum toxins|mesh-list
110474141|NCT02773641|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110474142|NCT02773641|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110474143|NCT02773641|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110474144|NCT02773641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110474145|NCT02773641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110474146|NCT02773641|Cholinergic Agents|cholinergic agents|mesh-ancestor
110474147|NCT02773641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110474148|NCT02773641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110474149|NCT02773641|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110474150|NCT02773641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110474151|NCT02768805|Vaccines|vaccines|mesh-list
110474152|NCT02768805|Immunologic Factors|immunologic factors|mesh-ancestor
110474153|NCT02768805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110474154|NCT02773251|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
110474155|NCT02773251|Hyaluronic Acid|hyaluronic acid|mesh-list
110474156|NCT02773251|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110474157|NCT02773251|Immunologic Factors|immunologic factors|mesh-ancestor
110474158|NCT02773251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110474159|NCT02773251|Viscosupplements|viscosupplements|mesh-ancestor
110474160|NCT02773251|Protective Agents|protective agents|mesh-ancestor
110474161|NCT02773251|Laxatives|laxatives|mesh-ancestor
110474162|NCT02773251|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110474163|NCT02768649|Risperidone|risperidone|mesh-list
110474165|NCT02768649|Serotonin Agents|serotonin agents|mesh-ancestor
110474166|NCT02768649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110474167|NCT02768649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110474168|NCT02768649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110474169|NCT02768649|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110474170|NCT02768649|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110474171|NCT02768649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110474172|NCT02768649|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110474173|NCT02768649|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110872140|NCT03867487|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110872141|NCT03867487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110872142|NCT03867487|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110872143|NCT03867487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110872144|NCT01569048|Dexmedetomidine|dexmedetomidine|mesh-list
110872145|NCT01569048|Remifentanil|remifentanil|mesh-list
110872146|NCT01569048|Propofol|propofol|mesh-list
110872147|NCT01569048|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110534660|NCT04178850|Vitamins|vitamins|mesh-ancestor
110201834|NCT00151060|Alkylating Agents|alkylating agents|mesh-ancestor
110474174|NCT02768649|Dopamine Agents|dopamine agents|mesh-ancestor
110474175|NCT02773407|Azithromycin|azithromycin|mesh-list
110474176|NCT02773407|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
110474177|NCT02773407|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110474178|NCT02773407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110474179|NCT02773407|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110474180|NCT02773407|Antimalarials|antimalarials|mesh-ancestor
110474181|NCT02773407|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110474182|NCT02773407|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110474183|NCT04224675|Atenolol|atenolol|mesh-list
110474184|NCT04224675|Captopril|captopril|mesh-list
110474185|NCT04224675|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110474186|NCT04224675|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110474187|NCT04224675|Sympatholytics|sympatholytics|mesh-ancestor
110474188|NCT04224675|Autonomic Agents|autonomic agents|mesh-ancestor
110474189|NCT04224675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110599778|NCT00870298|Trimethoprim|trimethoprim|mesh-list
110474190|NCT04224675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110474191|NCT04224675|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110474192|NCT04224675|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110474193|NCT04224675|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110474194|NCT04224675|Adrenergic Agents|adrenergic agents|mesh-ancestor
110474195|NCT04224675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110474196|NCT04224675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110474197|NCT04224675|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110474198|NCT04224675|Protease Inhibitors|protease inhibitors|mesh-ancestor
110474199|NCT04224675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110474200|NCT02768493|Ropivacaine|ropivacaine|mesh-list
110474201|NCT02768493|Anesthetics, Local|anesthetics, local|mesh-ancestor
110474202|NCT02768493|Anesthetics|anesthetics|mesh-ancestor
110474203|NCT02768493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110474204|NCT02768493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110474205|NCT02768493|Sensory System Agents|sensory system agents|mesh-ancestor
110474206|NCT02768493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110474207|NCT02768415|Apatinib|apatinib|mesh-list
110474208|NCT02768415|Vinorelbine|vinorelbine|mesh-list
110474209|NCT02768415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110474210|NCT02768415|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110474211|NCT02768415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110474212|NCT02768415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110474213|NCT02768415|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110474214|NCT02768415|Tubulin Modulators|tubulin modulators|mesh-ancestor
110474215|NCT02768415|Antimitotic Agents|antimitotic agents|mesh-ancestor
110474216|NCT02768415|Mitosis Modulators|mitosis modulators|mesh-ancestor
110474217|NCT02773095|Lactitol|lactitol|mesh-list
110474218|NCT02773095|Cathartics|cathartics|mesh-ancestor
110474219|NCT02773095|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110474220|NCT02768337|Afatinib|afatinib|mesh-list
110474221|NCT02768337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110474222|NCT02768337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110474223|NCT02768337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110474224|NCT02768337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110474225|NCT02768571|Cerebrolysin|cerebrolysin|mesh-list
110474226|NCT02768571|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110474227|NCT02768571|Protective Agents|protective agents|mesh-ancestor
110474228|NCT02768571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110474229|NCT02768571|Nootropic Agents|nootropic agents|mesh-ancestor
110872148|NCT01569048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110872149|NCT01569048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110872150|NCT01569048|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110872151|NCT01569048|Analgesics|analgesics|mesh-ancestor
110872152|NCT01569048|Sensory System Agents|sensory system agents|mesh-ancestor
110872153|NCT01569048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110872154|NCT01569048|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110872155|NCT01569048|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110872156|NCT01569048|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110872157|NCT01569048|Adrenergic Agents|adrenergic agents|mesh-ancestor
110872158|NCT01569048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110872159|NCT01569048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110872160|NCT01569048|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110872161|NCT01569048|Anesthetics, General|anesthetics, general|mesh-ancestor
110474230|NCT02767713|Dexamethasone|dexamethasone|mesh-list
110474231|NCT02767713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110474232|NCT02767713|Antiemetics|antiemetics|mesh-ancestor
110474233|NCT02767713|Autonomic Agents|autonomic agents|mesh-ancestor
110474234|NCT02767713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110474235|NCT02767713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110599788|NCT00870298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110474236|NCT02767713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110474237|NCT02767713|Glucocorticoids|glucocorticoids|mesh-ancestor
110474238|NCT02767713|Hormones|hormones|mesh-ancestor
110474239|NCT02767713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110474241|NCT02767713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110474242|NCT02767245|Thiamine|thiamine|mesh-list
110474243|NCT02767245|Vitamins|vitamins|mesh-ancestor
110474244|NCT02767245|Micronutrients|micronutrients|mesh-ancestor
110474245|NCT02767245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110474246|NCT02767245|Vitamin B Complex|vitamin b complex|mesh-ancestor
110474247|NCT02767401|Aspirin|aspirin|mesh-list
110474248|NCT02767401|Metoprolol|metoprolol|mesh-list
110474249|NCT02767401|Clopidogrel|clopidogrel|mesh-list
110474250|NCT02767401|Ticagrelor|ticagrelor|mesh-list
110474251|NCT02767401|Atorvastatin|atorvastatin|mesh-list
110474252|NCT02767401|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110474253|NCT02767401|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110474254|NCT02767401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110474255|NCT02767401|Analgesics|analgesics|mesh-ancestor
110474256|NCT02767401|Sensory System Agents|sensory system agents|mesh-ancestor
110474257|NCT02767401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110474258|NCT02767401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110474259|NCT02767401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110474260|NCT02767401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110474261|NCT02767401|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110474262|NCT02767401|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110474263|NCT02767401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110474264|NCT02767401|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110474265|NCT02767401|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110474266|NCT02767401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110474267|NCT02767401|Antipyretics|antipyretics|mesh-ancestor
110474268|NCT02767401|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110474269|NCT02767401|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110474270|NCT02767401|Antimetabolites|antimetabolites|mesh-ancestor
110474271|NCT02767401|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110474272|NCT02767401|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110474273|NCT02767401|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110474274|NCT02767401|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110474275|NCT02767401|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110474276|NCT02767401|Purinergic Agents|purinergic agents|mesh-ancestor
110474277|NCT02767401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110872162|NCT01569048|Anesthetics|anesthetics|mesh-ancestor
110872163|NCT01569048|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110872164|NCT01569048|Narcotics|narcotics|mesh-ancestor
110872165|NCT01380912|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110872166|NCT01380912|Methylprednisolone|methylprednisolone|mesh-list
110872167|NCT01380912|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110872168|NCT01380912|Prednisolone|prednisolone|mesh-list
110872169|NCT01380912|Prednisolone acetate|prednisolone acetate|mesh-list
110872170|NCT01380912|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110474278|NCT02767401|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110474279|NCT02767401|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110474280|NCT02767401|Sympatholytics|sympatholytics|mesh-ancestor
110474281|NCT02767401|Autonomic Agents|autonomic agents|mesh-ancestor
110474282|NCT02767401|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110474283|NCT02767401|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110474284|NCT02767401|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110474285|NCT02767401|Adrenergic Agents|adrenergic agents|mesh-ancestor
110474286|NCT02767479|Esomeprazole|esomeprazole|mesh-list
110474287|NCT02767479|Rabeprazole|rabeprazole|mesh-list
110474289|NCT02767479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110474290|NCT02767479|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110474291|NCT02767479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110474292|NCT02767479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110474293|NCT02767635|Triamcinolone|triamcinolone|mesh-list
110474294|NCT02767635|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110474295|NCT02767635|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110474296|NCT02767635|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110474297|NCT02767635|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110474298|NCT02767635|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110474299|NCT02767635|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110474300|NCT02767635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110474301|NCT02767635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110474302|NCT02767635|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110474303|NCT02767635|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110474304|NCT02767635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110474305|NCT02767635|Cholinergic Agents|cholinergic agents|mesh-ancestor
110474306|NCT02767635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110474307|NCT02767635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110474308|NCT02767635|Glucocorticoids|glucocorticoids|mesh-ancestor
110474310|NCT02767635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110474311|NCT02767635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110474312|NCT02767635|Immunologic Factors|immunologic factors|mesh-ancestor
110474313|NCT02767635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110474314|NCT04224441|Temozolomide|temozolomide|mesh-list
110474315|NCT04224441|Chlorpromazine|chlorpromazine|mesh-list
110474316|NCT04224441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110474317|NCT04224441|Alkylating Agents|alkylating agents|mesh-ancestor
110474318|NCT04224441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110474319|NCT04224441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110474320|NCT04224441|Antiemetics|antiemetics|mesh-ancestor
110474321|NCT04224441|Autonomic Agents|autonomic agents|mesh-ancestor
110474322|NCT04224441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110474323|NCT04224441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110474324|NCT04224441|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110474325|NCT04224441|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110474326|NCT04224441|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110474327|NCT04224441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110474328|NCT04224441|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110474329|NCT04224441|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110474330|NCT04224441|Dopamine Agents|dopamine agents|mesh-ancestor
110474331|NCT04224441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110474332|NCT02767089|Prednisone|prednisone|mesh-list
110474333|NCT02767089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110474334|NCT02767089|Glucocorticoids|glucocorticoids|mesh-ancestor
110474335|NCT02767089|Hormones|hormones|mesh-ancestor
110474336|NCT02767089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110033652|NCT03011775|Isosorbide|isosorbide|mesh-list
110872171|NCT01380912|Prednisolone phosphate|prednisolone phosphate|mesh-list
110872172|NCT01380912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110872173|NCT01380912|Antiemetics|antiemetics|mesh-ancestor
110872174|NCT01380912|Autonomic Agents|autonomic agents|mesh-ancestor
110872175|NCT01380912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110872176|NCT01380912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110872177|NCT01380912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110872178|NCT01380912|Glucocorticoids|glucocorticoids|mesh-ancestor
110534661|NCT04178850|Micronutrients|micronutrients|mesh-ancestor
110474337|NCT02767089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110474338|NCT02767089|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110474339|NCT02767089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110474340|NCT02766855|Cysteamine|cysteamine|mesh-list
110474341|NCT02766855|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
110474342|NCT02766855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110474343|NCT02762643|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
110474344|NCT02762643|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110474345|NCT02762643|Hormone Antagonists|hormone antagonists|mesh-ancestor
110474346|NCT02762643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110474347|NCT02762643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110474348|NCT02762643|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110474349|NCT02762643|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110474350|NCT02762643|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110474351|NCT02762253|Riboflavin|riboflavin|mesh-list
110474352|NCT02762253|Vitamin B Complex|vitamin b complex|mesh-ancestor
110474353|NCT02762253|Vitamins|vitamins|mesh-ancestor
110474354|NCT02762253|Micronutrients|micronutrients|mesh-ancestor
110474355|NCT02762253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110474356|NCT02762253|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110474357|NCT02762253|Dermatologic Agents|dermatologic agents|mesh-ancestor
110474359|NCT00746941|Antimalarials|antimalarials|mesh-ancestor
110474360|NCT00746941|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110474361|NCT00746941|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110474362|NCT00746941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110474363|NCT04532463|Fluconazole|fluconazole|mesh-list
110474364|NCT04532463|Amphotericin B|amphotericin b|mesh-list
110474365|NCT04532463|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
110474366|NCT04532463|Flucytosine|flucytosine|mesh-list
110474367|NCT04532463|Antifungal Agents|antifungal agents|mesh-ancestor
110474368|NCT04532463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110474369|NCT04532463|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110474370|NCT04532463|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110474371|NCT04532463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110474372|NCT04532463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110474373|NCT04532463|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110474374|NCT04532463|Hormone Antagonists|hormone antagonists|mesh-ancestor
110474375|NCT04532463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110474376|NCT04532463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110474377|NCT04532463|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110474378|NCT04532463|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110474379|NCT04532463|Amebicides|amebicides|mesh-ancestor
110474380|NCT04532463|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110474381|NCT04532463|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110474382|NCT04532463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110474383|NCT04532463|Antimetabolites|antimetabolites|mesh-ancestor
110474384|NCT04091971|Ketamine|ketamine|mesh-list
110474385|NCT04091971|Analgesics|analgesics|mesh-ancestor
110474386|NCT04091971|Sensory System Agents|sensory system agents|mesh-ancestor
110474387|NCT04091971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110474388|NCT04091971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110474389|NCT04091971|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110474390|NCT04091971|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110474391|NCT04091971|Anesthetics, General|anesthetics, general|mesh-ancestor
110474393|NCT04091971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110033653|NCT03011775|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
110872180|NCT01380912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110872181|NCT01380912|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110872182|NCT01380912|Protective Agents|protective agents|mesh-ancestor
110872183|NCT01380912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110872184|NCT01380912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110872185|NCT03315793|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110872186|NCT03315793|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110872187|NCT03315793|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110872188|NCT03315793|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110872189|NCT03315793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110474394|NCT04091971|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110474395|NCT04091971|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110474396|NCT04091971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110474397|NCT04091971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110474399|NCT04091815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110474400|NCT04091815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110474401|NCT00746785|Olanzapine|olanzapine|mesh-list
110474402|NCT00746785|Antiemetics|antiemetics|mesh-ancestor
110474403|NCT00746785|Autonomic Agents|autonomic agents|mesh-ancestor
110474404|NCT00746785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110474405|NCT00746785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110474406|NCT00746785|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110474407|NCT00746785|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110474408|NCT00746785|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110474409|NCT00746785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110474410|NCT00746785|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110474411|NCT00746785|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110474412|NCT00746785|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110474413|NCT00746785|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110474414|NCT00746785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110474415|NCT00746785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110474416|NCT00746785|Serotonin Agents|serotonin agents|mesh-ancestor
110474417|NCT04090021|Amoxicillin|amoxicillin|mesh-list
110474418|NCT04090021|Metronidazole|metronidazole|mesh-list
110474419|NCT04090021|Clarithromycin|clarithromycin|mesh-list
110474420|NCT04090021|Levofloxacin|levofloxacin|mesh-list
110474421|NCT04090021|Rifabutin|rifabutin|mesh-list
110474422|NCT04090021|Esomeprazole|esomeprazole|mesh-list
110474423|NCT04090021|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110474424|NCT04090021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110474425|NCT04090021|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110474426|NCT04090021|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110474427|NCT04090021|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110474428|NCT04090021|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110474429|NCT04090021|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110380463|NCT04550702|Mirabegron|mirabegron|mesh-list
110474430|NCT04090021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110474431|NCT04090021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110474432|NCT04090021|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110474433|NCT04090021|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110474434|NCT04090021|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110474435|NCT04090021|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110474436|NCT04090021|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110474437|NCT04090021|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110474438|NCT04090021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110474439|NCT04090021|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110599844|NCT00798993|Calcifediol|calcifediol|mesh-list
110474440|NCT04090021|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110474441|NCT04090021|Antitubercular Agents|antitubercular agents|mesh-ancestor
110474442|NCT04223973|Insulin|insulin|mesh-list
110474443|NCT04223973|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110872190|NCT03315793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110872191|NCT03315793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110872192|NCT03315793|Analgesics|analgesics|mesh-ancestor
110872193|NCT03315793|Sensory System Agents|sensory system agents|mesh-ancestor
110872194|NCT03315793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110872195|NCT03315793|Antidepressive Agents|antidepressive agents|mesh-ancestor
110872196|NCT03315793|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110872197|NCT03315793|Dopamine Agents|dopamine agents|mesh-ancestor
110872198|NCT01569204|Dexamethasone|dexamethasone|mesh-list
110872199|NCT01569204|Prednisone|prednisone|mesh-list
110474444|NCT04223973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110474445|NCT00750919|Mirtazapine|mirtazapine|mesh-list
110474446|NCT00750919|Antidepressive Agents|antidepressive agents|mesh-ancestor
110474447|NCT00750919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110474448|NCT00750919|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110474449|NCT00750919|Histamine Antagonists|histamine antagonists|mesh-ancestor
110474450|NCT00750919|Histamine Agents|histamine agents|mesh-ancestor
110474451|NCT00750919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110474452|NCT00750919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110474453|NCT00750919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110474454|NCT00750919|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110474455|NCT00750919|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110474456|NCT00750919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110474457|NCT00750919|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
110474458|NCT00750919|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110474459|NCT00750919|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110474460|NCT00750919|Adrenergic Agents|adrenergic agents|mesh-ancestor
110474461|NCT00750919|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110474462|NCT00750919|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110474463|NCT00750919|Serotonin Agents|serotonin agents|mesh-ancestor
110474464|NCT00750919|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110474465|NCT02761161|Mianserin|mianserin|mesh-list
110474466|NCT02761161|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110474467|NCT02761161|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110474468|NCT02761161|Adrenergic Agents|adrenergic agents|mesh-ancestor
110474469|NCT02761161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110474470|NCT02761161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110474471|NCT02761161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110474472|NCT02761161|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110474473|NCT02761161|Histamine Antagonists|histamine antagonists|mesh-ancestor
110474474|NCT02761161|Histamine Agents|histamine agents|mesh-ancestor
110474475|NCT02761161|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110474476|NCT02761161|Serotonin Agents|serotonin agents|mesh-ancestor
110474477|NCT02761161|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110474478|NCT02761161|Antidepressive Agents|antidepressive agents|mesh-ancestor
110474479|NCT02761161|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110474480|NCT02761395|Deferasirox|deferasirox|mesh-list
110474481|NCT02761395|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110474482|NCT02761395|Chelating Agents|chelating agents|mesh-ancestor
110474483|NCT02761395|Sequestering Agents|sequestering agents|mesh-ancestor
110474484|NCT02761395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110474485|NCT02761317|Bisacodyl|bisacodyl|mesh-list
110474486|NCT02761317|Cathartics|cathartics|mesh-ancestor
110474487|NCT02761317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110474488|NCT02761317|Laxatives|laxatives|mesh-ancestor
110474489|NCT00746551|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
110474490|NCT00746551|Hematinics|hematinics|mesh-ancestor
110474491|NCT02696577|Aspirin|aspirin|mesh-list
110474492|NCT02696577|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110474493|NCT02696577|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110474494|NCT02696577|Analgesics|analgesics|mesh-ancestor
110474495|NCT02696577|Sensory System Agents|sensory system agents|mesh-ancestor
110474496|NCT02696577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110474497|NCT02696577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110474498|NCT02696577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110474499|NCT02696577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110872201|NCT01569204|Dacarbazine|dacarbazine|mesh-list
110872202|NCT01569204|Doxorubicin|doxorubicin|mesh-list
110872203|NCT01569204|Etoposide|etoposide|mesh-list
110872204|NCT01569204|Brentuximab Vedotin|brentuximab vedotin|mesh-list
110872205|NCT01569204|Procarbazine|procarbazine|mesh-list
110872206|NCT01569204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110872207|NCT01569204|Immunologic Factors|immunologic factors|mesh-ancestor
110872208|NCT01569204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110872209|NCT01569204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110474500|NCT02696577|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110474501|NCT02696577|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110474502|NCT02696577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110474503|NCT02696577|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110474504|NCT02696577|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110474505|NCT02696577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110474506|NCT02696577|Antipyretics|antipyretics|mesh-ancestor
110474507|NCT04222491|Immunomodulating Agents|immunomodulating agents|mesh-list
110474508|NCT04222491|Immunologic Factors|immunologic factors|mesh-ancestor
110474509|NCT04222491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110474510|NCT00750061|Lithium Carbonate|lithium carbonate|mesh-list
110474511|NCT00750061|Antidepressive Agents|antidepressive agents|mesh-ancestor
110474512|NCT00750061|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110474513|NCT00750061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110474514|NCT00750061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110474515|NCT00750061|Antimanic Agents|antimanic agents|mesh-ancestor
110474516|NCT00750061|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110474517|NCT00750061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110474518|NCT00750061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110474519|NCT04223739|Amiodarone|amiodarone|mesh-list
110474520|NCT04223739|Landiolol|landiolol|mesh-list
110474521|NCT04223739|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110474522|NCT04223739|Vasodilator Agents|vasodilator agents|mesh-ancestor
110474523|NCT04223739|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
110474524|NCT04223739|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110474525|NCT04223739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110474526|NCT04223739|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110474527|NCT04223739|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110474528|NCT04223739|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110474529|NCT04223739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110474530|NCT04223739|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110474531|NCT04223739|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110474532|NCT04223739|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110474533|NCT04223739|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110599876|NCT00862264|Hormones|hormones|mesh-ancestor
110474534|NCT04223739|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110474535|NCT04223739|Adrenergic Agents|adrenergic agents|mesh-ancestor
110474536|NCT04223739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110474537|NCT04223739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110474538|NCT02765373|Letrozole|letrozole|mesh-list
110474539|NCT02765373|Anastrozole|anastrozole|mesh-list
110474540|NCT02765373|Exemestane|exemestane|mesh-list
110474541|NCT02765373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110474542|NCT02765373|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110474543|NCT02765373|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110474544|NCT02765373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110474545|NCT02765373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110474546|NCT02765373|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110474547|NCT02765373|Hormone Antagonists|hormone antagonists|mesh-ancestor
110474548|NCT02765373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110474549|NCT02765373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110474550|NCT02765373|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110474551|NCT02760615|Losartan|losartan|mesh-list
110474552|NCT02760615|Midazolam|midazolam|mesh-list
110474553|NCT02760615|Dextromethorphan|dextromethorphan|mesh-list
110474554|NCT02760615|Caffeine|caffeine|mesh-list
110474555|NCT02760615|Omeprazole|omeprazole|mesh-list
110474556|NCT02760615|Vedolizumab|vedolizumab|mesh-list
110872210|NCT01569204|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110872211|NCT01569204|Alkylating Agents|alkylating agents|mesh-ancestor
110872212|NCT01569204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110872213|NCT01569204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110872214|NCT01569204|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110872215|NCT01569204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110872216|NCT01569204|Antiemetics|antiemetics|mesh-ancestor
110872217|NCT01569204|Autonomic Agents|autonomic agents|mesh-ancestor
110872218|NCT01569204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110872219|NCT01569204|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110872220|NCT01569204|Glucocorticoids|glucocorticoids|mesh-ancestor
110872221|NCT01569204|Hormones|hormones|mesh-ancestor
110202280|NCT04725214|Alkylating Agents|alkylating agents|mesh-ancestor
110474557|NCT02760615|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110474558|NCT02760615|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110474559|NCT02760615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110474560|NCT02760615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110474561|NCT02760615|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110474562|NCT02760615|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110474563|NCT02760615|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110474564|NCT02760615|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110474565|NCT02760615|Anesthetics, General|anesthetics, general|mesh-ancestor
110474566|NCT02760615|Anesthetics|anesthetics|mesh-ancestor
110474567|NCT02760615|GABA Modulators|gaba modulators|mesh-ancestor
110474568|NCT02760615|GABA Agents|gaba agents|mesh-ancestor
110474569|NCT02760615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110474570|NCT02760615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110474571|NCT02760615|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110474572|NCT02760615|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110474573|NCT02760615|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110474574|NCT02760615|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110474575|NCT02760615|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110474576|NCT02760615|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110474577|NCT02760615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110474578|NCT02760615|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110474579|NCT02760615|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110474580|NCT02760615|Purinergic Agents|purinergic agents|mesh-ancestor
110474581|NCT02760615|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110474582|NCT02760615|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110474583|NCT02760615|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110599898|NCT00725478|Piribedil|piribedil|mesh-list
110474584|NCT02760615|Antitussive Agents|antitussive agents|mesh-ancestor
110474585|NCT02760615|Respiratory System Agents|respiratory system agents|mesh-ancestor
110474586|NCT02760615|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110474587|NCT02760615|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110474588|NCT02760459|Dexamethasone|dexamethasone|mesh-list
110474589|NCT02760459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110474590|NCT02760459|Antiemetics|antiemetics|mesh-ancestor
110474591|NCT02760459|Autonomic Agents|autonomic agents|mesh-ancestor
110474592|NCT02760459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110474593|NCT02760459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110474594|NCT02760459|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110474595|NCT02760459|Glucocorticoids|glucocorticoids|mesh-ancestor
110474597|NCT02760459|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110474598|NCT02760459|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110474599|NCT02760459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110474600|NCT02765217|Amoxicillin|amoxicillin|mesh-list
110474601|NCT02765217|Clavulanic Acids|clavulanic acids|mesh-list
110474602|NCT02765217|Clavulanic Acid|clavulanic acid|mesh-list
110474603|NCT02765217|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
110474604|NCT02765217|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110474605|NCT02765217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110872222|NCT01569204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110872224|NCT01569204|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110872225|NCT01569204|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110872226|NCT01569204|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110872227|NCT01569204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110872228|NCT01569204|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110872229|NCT01569204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110872230|NCT01569204|Immunotoxins|immunotoxins|mesh-ancestor
110872231|NCT01569204|Immunoconjugates|immunoconjugates|mesh-ancestor
110872232|NCT02676466|Losartan|losartan|mesh-list
110872233|NCT02676466|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110872234|NCT02676466|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110872235|NCT02676466|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110872236|NCT02676466|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110202341|NCT00152893|Micronutrients|micronutrients|mesh-ancestor
110474606|NCT02765217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110474607|NCT02765217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110474608|NCT02765217|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110474609|NCT02760381|Acetic Acid|acetic acid|mesh-list
110474610|NCT02760381|Retinol acetate|retinol acetate|mesh-list
110474611|NCT02760381|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110474612|NCT02760381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110474613|NCT02760381|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110474614|NCT02760381|Immunologic Factors|immunologic factors|mesh-ancestor
110474615|NCT02760381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110474616|NCT02760381|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110474617|NCT02760381|Protective Agents|protective agents|mesh-ancestor
110474618|NCT02760381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110474619|NCT02760225|Pembrolizumab|pembrolizumab|mesh-list
110474620|NCT02760225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110474621|NCT02760225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110474622|NCT02760225|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110165315|NCT00023374|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110474623|NCT02760225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110474624|NCT00744757|Decitabine|decitabine|mesh-list
110474625|NCT00744757|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110474626|NCT00744757|Antimetabolites|antimetabolites|mesh-ancestor
110474627|NCT00744757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110474628|NCT00744757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110474629|NCT00744757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110474630|NCT00917527|Atorvastatin|atorvastatin|mesh-list
110474631|NCT00917527|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110474632|NCT00917527|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110474633|NCT00917527|Antimetabolites|antimetabolites|mesh-ancestor
110474634|NCT00917527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110474635|NCT00917527|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110474636|NCT00917527|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110474637|NCT00917527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110474638|NCT00745849|Esomeprazole|esomeprazole|mesh-list
110474639|NCT00745849|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110474640|NCT00745849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110474641|NCT00745849|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110474642|NCT00745849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110474643|NCT00745849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110474644|NCT02759991|Vaccines|vaccines|mesh-list
110872237|NCT02676466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110872239|NCT04439890|Pemetrexed|pemetrexed|mesh-list
110872240|NCT04439890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110872241|NCT04439890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110872242|NCT04439890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110872243|NCT04439890|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110872244|NCT04439890|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110474645|NCT02759991|Immunologic Factors|immunologic factors|mesh-ancestor
110474646|NCT02759991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110474647|NCT04112277|Morphine|morphine|mesh-list
110474648|NCT04112277|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110474649|NCT04112277|Narcotics|narcotics|mesh-ancestor
110474650|NCT04112277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110474651|NCT04112277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110474652|NCT04112277|Analgesics|analgesics|mesh-ancestor
110474653|NCT04112277|Sensory System Agents|sensory system agents|mesh-ancestor
110474654|NCT04112277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110474655|NCT00749203|Midazolam|midazolam|mesh-list
110474656|NCT00749203|Ketamine|ketamine|mesh-list
110474657|NCT00749203|Analgesics|analgesics|mesh-ancestor
110474658|NCT00749203|Sensory System Agents|sensory system agents|mesh-ancestor
110474659|NCT00749203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110474660|NCT00749203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110474661|NCT00749203|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110474662|NCT00749203|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110474663|NCT00749203|Anesthetics, General|anesthetics, general|mesh-ancestor
110474664|NCT00749203|Anesthetics|anesthetics|mesh-ancestor
110474665|NCT00749203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110474666|NCT00749203|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110474667|NCT00749203|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110474668|NCT00749203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110474669|NCT00749203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110474670|NCT00749203|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110474671|NCT00749203|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110474672|NCT00749203|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110474673|NCT00749203|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110474674|NCT00749203|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110474675|NCT00749203|GABA Modulators|gaba modulators|mesh-ancestor
110474676|NCT00749203|GABA Agents|gaba agents|mesh-ancestor
110474677|NCT02764515|Methotrexate|methotrexate|mesh-list
110474678|NCT02764515|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110474679|NCT02764515|Abortifacient Agents|abortifacient agents|mesh-ancestor
110474680|NCT02764515|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110474681|NCT02764515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110474682|NCT02764515|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110474683|NCT02764515|Antimetabolites|antimetabolites|mesh-ancestor
110474684|NCT02764515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110474685|NCT02764515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110474686|NCT02764515|Dermatologic Agents|dermatologic agents|mesh-ancestor
110474687|NCT02764515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110474688|NCT02764515|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110474689|NCT02764515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110474690|NCT02764515|Immunologic Factors|immunologic factors|mesh-ancestor
110474691|NCT02764515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110474692|NCT02764515|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110474693|NCT02764749|Phenol|phenol|mesh-list
110474694|NCT02764749|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110474695|NCT02764749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110474696|NCT02764749|Disinfectants|disinfectants|mesh-ancestor
110474697|NCT02764749|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
110474698|NCT02764749|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110474699|NCT02764359|Vancomycin|vancomycin|mesh-list
110474700|NCT02764359|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110474701|NCT02764359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110474702|NCT02764125|Levodopa|levodopa|mesh-list
110474703|NCT02764125|Carbidopa|carbidopa|mesh-list
110474704|NCT02764125|Entacapone|entacapone|mesh-list
110872246|NCT02324725|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110872247|NCT02324725|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110872248|NCT02324725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110872249|NCT02324725|Sensory System Agents|sensory system agents|mesh-ancestor
110872250|NCT02324725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110872251|NCT01380678|Bevacizumab|bevacizumab|mesh-list
110872252|NCT01380678|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
110872253|NCT01380678|Histamine Antagonists|histamine antagonists|mesh-list
110872254|NCT01380678|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
110202475|NCT00050531|Interferons|interferons|mesh-list
110474705|NCT02764125|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110474706|NCT02764125|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110474707|NCT02764125|Dopamine Agents|dopamine agents|mesh-ancestor
110474708|NCT02764125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110474709|NCT02764125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110474710|NCT02764125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110474711|NCT02764125|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
110474712|NCT02764125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110474713|NCT02764125|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
110474714|NCT02764281|Dexamethasone|dexamethasone|mesh-list
110474715|NCT02764281|Methotrexate|methotrexate|mesh-list
110474716|NCT02764281|Etoposide|etoposide|mesh-list
110474717|NCT02764281|Pegaspargase|pegaspargase|mesh-list
110474718|NCT02764281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110474719|NCT02764281|Antiemetics|antiemetics|mesh-ancestor
110474720|NCT02764281|Autonomic Agents|autonomic agents|mesh-ancestor
110474721|NCT02764281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110474722|NCT02764281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110474723|NCT02764281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110474724|NCT02764281|Glucocorticoids|glucocorticoids|mesh-ancestor
110474725|NCT02764281|Hormones|hormones|mesh-ancestor
110165375|NCT00000179|Trazodone|trazodone|mesh-list
110474726|NCT02764281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110474727|NCT02764281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110474728|NCT02764281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110474729|NCT02764281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110474730|NCT02764281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110474731|NCT02764281|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110474732|NCT02764281|Abortifacient Agents|abortifacient agents|mesh-ancestor
110474733|NCT02764281|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110474734|NCT02764281|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110474735|NCT02764281|Antimetabolites|antimetabolites|mesh-ancestor
110474736|NCT02764281|Dermatologic Agents|dermatologic agents|mesh-ancestor
110474737|NCT02764281|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110474739|NCT02764281|Immunologic Factors|immunologic factors|mesh-ancestor
110474740|NCT02764281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110474741|NCT02764281|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110474742|NCT02764281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110474743|NCT02764281|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110474744|NCT02764281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110474745|NCT02763969|Interferons|interferons|mesh-list
110474746|NCT02763969|Interferon-alpha|interferon-alpha|mesh-list
110474747|NCT02763969|Interferon alpha-2|interferon alpha-2|mesh-list
110474748|NCT02763969|Ustekinumab|ustekinumab|mesh-list
110474749|NCT02763969|Famotidine|famotidine|mesh-list
110474750|NCT02763969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110474751|NCT02763969|Antiviral Agents|antiviral agents|mesh-ancestor
110474752|NCT02763969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110474753|NCT02763969|Immunologic Factors|immunologic factors|mesh-ancestor
110474754|NCT02763969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110474755|NCT02763969|Dermatologic Agents|dermatologic agents|mesh-ancestor
110474756|NCT02763969|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110474757|NCT02763969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110474758|NCT02763969|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110474759|NCT02763969|Histamine Antagonists|histamine antagonists|mesh-ancestor
110872255|NCT01380678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110872256|NCT01380678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110872257|NCT01380678|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110872258|NCT01380678|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110872259|NCT01380678|Growth Substances|growth substances|mesh-ancestor
110872260|NCT01380678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110872261|NCT01380678|Growth Inhibitors|growth inhibitors|mesh-ancestor
110872262|NCT01380678|Histamine Agents|histamine agents|mesh-ancestor
110872263|NCT01380678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110872264|NCT01380678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110872265|NCT01380600|Molgramostim|molgramostim|mesh-list
110872266|NCT01380600|Sargramostim|sargramostim|mesh-list
110872267|NCT01380600|Immunologic Factors|immunologic factors|mesh-ancestor
110474761|NCT02763969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110474762|NCT02763969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110474763|NCT04660929|Pembrolizumab|pembrolizumab|mesh-list
110474764|NCT04660929|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110474765|NCT04660929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110474766|NCT04660929|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110474767|NCT04660929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110474768|NCT02758587|Pembrolizumab|pembrolizumab|mesh-list
110474769|NCT02758587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110474770|NCT02758587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110474771|NCT02758587|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110599950|NCT02544724|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110474772|NCT02758587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110474773|NCT02758509|Interferons|interferons|mesh-list
110474774|NCT02758509|Ritonavir|ritonavir|mesh-list
110474775|NCT02758509|Ribavirin|ribavirin|mesh-list
110474776|NCT02758509|Interferon-alpha|interferon-alpha|mesh-list
110474777|NCT02758509|Interferon alpha-2|interferon alpha-2|mesh-list
110474778|NCT02758509|Sofosbuvir|sofosbuvir|mesh-list
110474779|NCT02758509|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110474780|NCT02758509|Ledipasvir|ledipasvir|mesh-list
110474781|NCT02758509|Simeprevir|simeprevir|mesh-list
110474782|NCT02758509|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
110474783|NCT02758509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110474784|NCT02758509|Antiviral Agents|antiviral agents|mesh-ancestor
110474785|NCT02758509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110474786|NCT02758509|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110474787|NCT02758509|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110474788|NCT02758509|Protease Inhibitors|protease inhibitors|mesh-ancestor
110474789|NCT02758509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110474790|NCT02758509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110474791|NCT02758509|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110474792|NCT02758509|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110474793|NCT02758509|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110474794|NCT02758509|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110474795|NCT02758509|Antimetabolites|antimetabolites|mesh-ancestor
110474796|NCT02758509|Immunologic Factors|immunologic factors|mesh-ancestor
110474797|NCT02758509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110474798|NCT02762955|Adalimumab|adalimumab|mesh-list
110474799|NCT02762955|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110474800|NCT02762955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110474801|NCT02762955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110474802|NCT04191681|Valsartan|valsartan|mesh-list
110474803|NCT04191681|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
110474804|NCT04191681|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110474805|NCT04191681|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110474806|NCT04191681|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110474807|NCT04191681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110474808|NCT02757651|Hydrogen Peroxide|hydrogen peroxide|mesh-list
110872268|NCT01380600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110872269|NCT01380600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110872270|NCT03264118|Tolonium Chloride|tolonium chloride|mesh-list
110872271|NCT03264118|Hemostatics|hemostatics|mesh-ancestor
110872272|NCT03264118|Coagulants|coagulants|mesh-ancestor
110872273|NCT03264118|Heparin Antagonists|heparin antagonists|mesh-ancestor
110872274|NCT03264118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110872275|NCT02674204|Atorvastatin|atorvastatin|mesh-list
110872276|NCT02674204|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110872277|NCT02674204|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110872278|NCT02674204|Antimetabolites|antimetabolites|mesh-ancestor
110589787|NCT00742911|Copper|copper|mesh-list
110872279|NCT02674204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110202595|NCT00154024|Irbesartan|irbesartan|mesh-list
110474809|NCT02757651|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110474810|NCT02757651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110474811|NCT02752503|Nalmefene|nalmefene|mesh-list
110474812|NCT02752503|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110599961|NCT00862420|Purinergic Agents|purinergic agents|mesh-ancestor
110474813|NCT02752503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110474814|NCT02752503|Sensory System Agents|sensory system agents|mesh-ancestor
110474815|NCT02752503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110474816|NCT04479579|Apixaban|apixaban|mesh-list
110474817|NCT04479579|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110474818|NCT04479579|Antithrombins|antithrombins|mesh-ancestor
110474819|NCT04479579|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110474820|NCT04479579|Protease Inhibitors|protease inhibitors|mesh-ancestor
110474821|NCT04479579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110474822|NCT04479579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110474823|NCT04479579|Anticoagulants|anticoagulants|mesh-ancestor
110474824|NCT02757495|Dexmedetomidine|dexmedetomidine|mesh-list
110474825|NCT02757495|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110474826|NCT02757495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110474827|NCT02757495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110474828|NCT02757495|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110474829|NCT02757495|Analgesics|analgesics|mesh-ancestor
110474830|NCT02757495|Sensory System Agents|sensory system agents|mesh-ancestor
110474831|NCT02757495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110474832|NCT02757495|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110397591|NCT01076335|Docetaxel|docetaxel|mesh-list
110474834|NCT02757495|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110474835|NCT02757495|Adrenergic Agents|adrenergic agents|mesh-ancestor
110474836|NCT02757495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110474837|NCT02757495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110474838|NCT02757261|Salicylic Acid|salicylic acid|mesh-list
110474839|NCT02757261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110474840|NCT02757261|Antifungal Agents|antifungal agents|mesh-ancestor
110474841|NCT02757261|Keratolytic Agents|keratolytic agents|mesh-ancestor
110474842|NCT02757261|Dermatologic Agents|dermatologic agents|mesh-ancestor
110474843|NCT02752113|Metformin|metformin|mesh-list
110474844|NCT02752113|Empagliflozin|empagliflozin|mesh-list
110474845|NCT02752113|Linagliptin|linagliptin|mesh-list
110474846|NCT02752113|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110474847|NCT02752113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110474848|NCT02752113|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110474849|NCT02752113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110474850|NCT02752113|Incretins|incretins|mesh-ancestor
110474851|NCT02752113|Hormones|hormones|mesh-ancestor
110474852|NCT02752113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110474853|NCT02752113|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110474854|NCT02752113|Protease Inhibitors|protease inhibitors|mesh-ancestor
110474855|NCT02752113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110474856|NCT02756715|Propofol|propofol|mesh-list
110474857|NCT02756715|Desflurane|desflurane|mesh-list
110872280|NCT02674204|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110872281|NCT02674204|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110872282|NCT02674204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110872283|NCT05675644|Drospirenone|drospirenone|mesh-list
110872284|NCT05675644|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110872285|NCT05675644|Hormone Antagonists|hormone antagonists|mesh-ancestor
110534662|NCT04178850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110474858|NCT02756715|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110599981|NCT02569970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110474859|NCT02756715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110474860|NCT02756715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110474861|NCT02756715|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110474862|NCT02756715|Anesthetics, General|anesthetics, general|mesh-ancestor
110474863|NCT02756715|Anesthetics|anesthetics|mesh-ancestor
110474864|NCT02756715|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110474865|NCT04221321|Atorvastatin|atorvastatin|mesh-list
110474866|NCT04221321|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110474867|NCT04221321|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110474868|NCT04221321|Antimetabolites|antimetabolites|mesh-ancestor
110474869|NCT04221321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110474870|NCT04221321|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110474871|NCT04221321|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110474872|NCT04221321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110474873|NCT02755857|Itraconazole|itraconazole|mesh-list
110474874|NCT02755857|Antifungal Agents|antifungal agents|mesh-ancestor
110474875|NCT02755857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110474876|NCT02755857|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110474877|NCT02755857|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110474878|NCT02755857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110474879|NCT02755857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110474880|NCT02755857|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110474881|NCT02755857|Hormone Antagonists|hormone antagonists|mesh-ancestor
110474882|NCT02755857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110474883|NCT02755857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110474884|NCT02755857|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110474885|NCT02755545|Salicylic Acid|salicylic acid|mesh-list
110474886|NCT02755545|Adapalene|adapalene|mesh-list
110474887|NCT02755545|Salicylates|salicylates|mesh-list
110474888|NCT02755545|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110474889|NCT02755545|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110474890|NCT02755545|Analgesics|analgesics|mesh-ancestor
110474891|NCT02755545|Sensory System Agents|sensory system agents|mesh-ancestor
110474892|NCT02755545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110474893|NCT02755545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110474894|NCT02755545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110474895|NCT02755545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110474896|NCT02755545|Dermatologic Agents|dermatologic agents|mesh-ancestor
110474897|NCT02755545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110474898|NCT02755545|Antifungal Agents|antifungal agents|mesh-ancestor
110474899|NCT02755545|Keratolytic Agents|keratolytic agents|mesh-ancestor
110474900|NCT02755545|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110474901|NCT02755545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110474902|NCT02755545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110474903|NCT02695797|Prednisolone|prednisolone|mesh-list
110474904|NCT02695797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110474905|NCT02695797|Glucocorticoids|glucocorticoids|mesh-ancestor
110474906|NCT02695797|Hormones|hormones|mesh-ancestor
110474907|NCT02695797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110474908|NCT02695797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110474909|NCT02695797|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110474910|NCT02695797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110474912|NCT02755311|Carboplatin|carboplatin|mesh-list
110474913|NCT02755311|Fluorouracil|fluorouracil|mesh-list
110474914|NCT02755311|Epirubicin|epirubicin|mesh-list
110474915|NCT02755311|Ethiodized Oil|ethiodized oil|mesh-list
110474916|NCT02755311|Pirarubicin|pirarubicin|mesh-list
110474917|NCT02755311|Doxorubicin|doxorubicin|mesh-list
110474918|NCT02755311|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
110872286|NCT05675644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110872287|NCT05675644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110872288|NCT05675644|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110872290|NCT05675644|Natriuretic Agents|natriuretic agents|mesh-ancestor
110872292|NCT02579044|Lonafarnib|lonafarnib|mesh-list
110872293|NCT02579044|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110872294|NCT02579044|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110474919|NCT02755311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110474920|NCT02755311|Antimetabolites|antimetabolites|mesh-ancestor
110474921|NCT02755311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110474922|NCT02755311|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110474923|NCT02755311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110474924|NCT02755311|Immunologic Factors|immunologic factors|mesh-ancestor
110474925|NCT02755311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110474926|NCT02755311|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110474927|NCT02755311|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110474928|NCT02755311|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110474929|NCT02755311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110474930|NCT02755311|Hemostatics|hemostatics|mesh-ancestor
110474931|NCT02755311|Coagulants|coagulants|mesh-ancestor
110474932|NCT04554771|Paclitaxel|paclitaxel|mesh-list
110474933|NCT04554771|Carboplatin|carboplatin|mesh-list
110474934|NCT04554771|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110474935|NCT04554771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110474936|NCT04554771|Tubulin Modulators|tubulin modulators|mesh-ancestor
110474937|NCT04554771|Antimitotic Agents|antimitotic agents|mesh-ancestor
110474938|NCT04554771|Mitosis Modulators|mitosis modulators|mesh-ancestor
110474939|NCT04554771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110474940|NCT04358289|Anti-Infective Agents|anti-infective agents|mesh-list
110474941|NCT04358289|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110474942|NCT04090801|Ethanol|ethanol|mesh-list
110474943|NCT04090801|Minoxidil|minoxidil|mesh-list
110474944|NCT04090801|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110474945|NCT04090801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110474946|NCT04090801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110474947|NCT04090801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110474948|NCT04090801|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110474949|NCT04090801|Vasodilator Agents|vasodilator agents|mesh-ancestor
110474950|NCT04089631|Capecitabine|capecitabine|mesh-list
110474951|NCT04089631|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110474952|NCT04089631|Antimetabolites|antimetabolites|mesh-ancestor
110474953|NCT04089631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110474954|NCT04089631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110474955|NCT00917059|Bupropion|bupropion|mesh-list
110474956|NCT00917059|Escitalopram|escitalopram|mesh-list
110474957|NCT00917059|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110474958|NCT00917059|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110474959|NCT00917059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110474960|NCT00917059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110474961|NCT00917059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110474962|NCT00917059|Serotonin Agents|serotonin agents|mesh-ancestor
110474963|NCT00917059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110474964|NCT00917059|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110474965|NCT00917059|Antidepressive Agents|antidepressive agents|mesh-ancestor
110474966|NCT00917059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110474967|NCT00917059|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110474968|NCT00917059|Dopamine Agents|dopamine agents|mesh-ancestor
110474969|NCT00917059|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110474970|NCT00917059|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110474971|NCT00917059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110474972|NCT02754687|Nandrolone Decanoate|nandrolone decanoate|mesh-list
110474973|NCT02754687|Nandrolone|nandrolone|mesh-list
110474974|NCT02754687|Nandrolone phenpropionate|nandrolone phenpropionate|mesh-list
110474975|NCT02754687|Androgens|androgens|mesh-ancestor
110474976|NCT02754687|Hormones|hormones|mesh-ancestor
110034047|NCT01595620|Antipruritics|antipruritics|mesh-ancestor
110872295|NCT02579044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110872296|NCT02579044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110872297|NCT02579044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110872298|NCT02579044|Immunologic Factors|immunologic factors|mesh-ancestor
110872299|NCT02579044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110872300|NCT02579044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110872302|NCT03525379|Antioxidants|antioxidants|mesh-ancestor
110872303|NCT03525379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110872304|NCT03525379|Protective Agents|protective agents|mesh-ancestor
110872305|NCT03525379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110872306|NCT03525379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110534663|NCT02676336|Iodine|iodine|mesh-list
110474977|NCT02754687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110474978|NCT02754687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110474979|NCT02754687|Anabolic Agents|anabolic agents|mesh-ancestor
110474980|NCT02754687|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110474981|NCT05429775|Budesonide|budesonide|mesh-list
110474982|NCT05429775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110474983|NCT05429775|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110474985|NCT05429775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110474986|NCT05429775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110474987|NCT05429775|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110474988|NCT05429775|Respiratory System Agents|respiratory system agents|mesh-ancestor
110474989|NCT05429775|Glucocorticoids|glucocorticoids|mesh-ancestor
110474990|NCT05429775|Hormones|hormones|mesh-ancestor
110165416|NCT00000191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110474991|NCT05429775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110474992|NCT04220073|Antibodies|antibodies|mesh-list
110474993|NCT04220073|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110474994|NCT04220073|Immunologic Factors|immunologic factors|mesh-ancestor
110474995|NCT04220073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110474996|NCT05429151|Acyclovir|acyclovir|mesh-list
110474997|NCT05429151|Antiviral Agents|antiviral agents|mesh-ancestor
110474998|NCT05429151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110474999|NCT04219995|Methylprednisolone|methylprednisolone|mesh-list
110475000|NCT04219995|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110475001|NCT04219995|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110475002|NCT04219995|Prednisolone|prednisolone|mesh-list
110475003|NCT04219995|Prednisolone acetate|prednisolone acetate|mesh-list
110475004|NCT04219995|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110475005|NCT04219995|Prednisolone phosphate|prednisolone phosphate|mesh-list
110475006|NCT04219995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110475007|NCT04219995|Antiemetics|antiemetics|mesh-ancestor
110475008|NCT04219995|Autonomic Agents|autonomic agents|mesh-ancestor
110475009|NCT04219995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110475010|NCT04219995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110475011|NCT04219995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110475012|NCT04219995|Glucocorticoids|glucocorticoids|mesh-ancestor
110475013|NCT04219995|Hormones|hormones|mesh-ancestor
110475014|NCT04219995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110475015|NCT04219995|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110475016|NCT04219995|Protective Agents|protective agents|mesh-ancestor
110600025|NCT00726804|Etanercept|etanercept|mesh-list
110475017|NCT04219995|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110475018|NCT04219995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110475019|NCT04544475|Estrogens|estrogens|mesh-list
110475020|NCT04544475|Estradiol|estradiol|mesh-list
110475021|NCT04544475|Hormones|hormones|mesh-ancestor
110475022|NCT04544475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110475023|NCT04544475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110475024|NCT04200417|Mitomycins|mitomycins|mesh-list
110475025|NCT04200417|Mitomycin|mitomycin|mesh-list
110475026|NCT04200417|Ethiodized Oil|ethiodized oil|mesh-list
110872307|NCT03525379|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110872308|NCT03476551|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110872309|NCT03476551|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110872310|NCT03476551|Diuretics|diuretics|mesh-ancestor
110872311|NCT03476551|Natriuretic Agents|natriuretic agents|mesh-ancestor
110872312|NCT03476551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110872313|NCT03476551|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110872314|NCT03476551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110872315|NCT03476551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110872316|NCT04702789|Timolol|timolol|mesh-list
110872317|NCT04702789|Brimonidine Tartrate|brimonidine tartrate|mesh-list
110872318|NCT04702789|Dorzolamide|dorzolamide|mesh-list
110872319|NCT04702789|Latanoprost|latanoprost|mesh-list
110872320|NCT04702789|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110872321|NCT04702789|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110475027|NCT04200417|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110475028|NCT04200417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110475029|NCT04200417|Alkylating Agents|alkylating agents|mesh-ancestor
110475030|NCT04200417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110475031|NCT04200417|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110475032|NCT04200417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110475033|NCT02753205|Dexmedetomidine|dexmedetomidine|mesh-list
110475034|NCT02753205|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110475035|NCT02753205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110122197|NCT01917058|Immunologic Factors|immunologic factors|mesh-ancestor
110475036|NCT02753205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110475037|NCT02753205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110475038|NCT02753205|Analgesics|analgesics|mesh-ancestor
110475039|NCT02753205|Sensory System Agents|sensory system agents|mesh-ancestor
110475040|NCT02753205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110475041|NCT02753205|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110475042|NCT02753205|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110475043|NCT02753205|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110475044|NCT02753205|Adrenergic Agents|adrenergic agents|mesh-ancestor
110475045|NCT02753205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110475046|NCT02753205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110475047|NCT02695641|Bevacizumab|bevacizumab|mesh-list
110475048|NCT02695641|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110475049|NCT02695641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110475050|NCT02695641|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110475051|NCT02695641|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110475052|NCT02695641|Growth Substances|growth substances|mesh-ancestor
110475053|NCT02695641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110475054|NCT02695641|Growth Inhibitors|growth inhibitors|mesh-ancestor
110475055|NCT02750475|Sunscreening Agents|sunscreening agents|mesh-list
110475056|NCT02750475|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110475057|NCT02750475|Protective Agents|protective agents|mesh-ancestor
110475058|NCT02750475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110475059|NCT02750475|Dermatologic Agents|dermatologic agents|mesh-ancestor
110475060|NCT04217265|Letrozole|letrozole|mesh-list
110475061|NCT04217265|Misoprostol|misoprostol|mesh-list
110475062|NCT04217265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110475063|NCT04217265|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110475064|NCT04217265|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110475065|NCT04217265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110475066|NCT04217265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110475067|NCT04217265|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110475068|NCT04217265|Hormone Antagonists|hormone antagonists|mesh-ancestor
110872322|NCT04702789|Adrenergic Agents|adrenergic agents|mesh-ancestor
110872323|NCT04702789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110872324|NCT04702789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110872325|NCT04702789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110872326|NCT04702789|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110872327|NCT04702789|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110872328|NCT04702789|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110872329|NCT04702789|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110872330|NCT04702789|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110872331|NCT04702789|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110872332|NCT04702789|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110872333|NCT04702789|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110872334|NCT04702789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110872335|NCT03521934|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
110872336|NCT03521934|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110872337|NCT03521934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110872338|NCT03521934|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110872339|NCT03521934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110872340|NCT03374137|Obinutuzumab|obinutuzumab|mesh-list
110872341|NCT03374137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110872342|NCT03374137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110872343|NCT01380522|Metronidazole|metronidazole|mesh-list
110872344|NCT01380522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110872345|NCT01380522|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110872346|NCT01380522|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110872347|NCT01380522|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110475069|NCT04217265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110475070|NCT04217265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110475071|NCT04217265|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110475072|NCT04217265|Abortifacient Agents|abortifacient agents|mesh-ancestor
110475073|NCT04217265|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110475074|NCT04217265|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110475075|NCT04217265|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110475076|NCT04217265|Oxytocics|oxytocics|mesh-ancestor
110475077|NCT00635973|Gefitinib|gefitinib|mesh-list
110475078|NCT00635973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110475079|NCT00635973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110475080|NCT00635973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110475081|NCT00635973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110475082|NCT02752971|Diclofenac|diclofenac|mesh-list
110475083|NCT02752971|Bupivacaine|bupivacaine|mesh-list
110475084|NCT02752971|Anesthetics, Local|anesthetics, local|mesh-ancestor
110475085|NCT02752971|Anesthetics|anesthetics|mesh-ancestor
110475086|NCT02752971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110872348|NCT02913326|Warfarin|warfarin|mesh-list
110872349|NCT02913326|Dabigatran|dabigatran|mesh-list
110589875|NCT00745953|Valsartan|valsartan|mesh-list
110872350|NCT02913326|Anticoagulants|anticoagulants|mesh-ancestor
110872351|NCT02913326|Antithrombins|antithrombins|mesh-ancestor
110872352|NCT02913326|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110872353|NCT02913326|Protease Inhibitors|protease inhibitors|mesh-ancestor
110872354|NCT02913326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110872355|NCT02913326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110872356|NCT03725891|Aspirin|aspirin|mesh-list
110872357|NCT03725891|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110872358|NCT03725891|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110872359|NCT03725891|Analgesics|analgesics|mesh-ancestor
110872360|NCT03725891|Sensory System Agents|sensory system agents|mesh-ancestor
110202963|NCT00154414|Incretins|incretins|mesh-ancestor
110475087|NCT02752971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110475088|NCT02752971|Sensory System Agents|sensory system agents|mesh-ancestor
110475089|NCT02752971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110475090|NCT02752971|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110475091|NCT02752971|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110475092|NCT02752971|Analgesics|analgesics|mesh-ancestor
110475093|NCT02752971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110475094|NCT02752971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110475095|NCT02752971|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110475096|NCT02752971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110475097|NCT02752971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110475098|NCT02750163|Acetaminophen|acetaminophen|mesh-list
110475099|NCT02750163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110475100|NCT02750163|Analgesics|analgesics|mesh-ancestor
110475101|NCT02750163|Sensory System Agents|sensory system agents|mesh-ancestor
110475102|NCT02750163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110475103|NCT02750163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110475104|NCT02750163|Antipyretics|antipyretics|mesh-ancestor
110475105|NCT04217421|Allopurinol|allopurinol|mesh-list
110475106|NCT04217421|Mannitol|mannitol|mesh-list
110475107|NCT04217421|Antimetabolites|antimetabolites|mesh-ancestor
110475108|NCT04217421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110475109|NCT04217421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110475110|NCT04217421|Gout Suppressants|gout suppressants|mesh-ancestor
110475111|NCT04217421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110122272|NCT01917448|Morphine|morphine|mesh-list
110475112|NCT04217421|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110475113|NCT04217421|Antioxidants|antioxidants|mesh-ancestor
110475114|NCT04217421|Protective Agents|protective agents|mesh-ancestor
110475115|NCT04217421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110475116|NCT04217421|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110475117|NCT04217421|Diuretics|diuretics|mesh-ancestor
110475118|NCT04217421|Natriuretic Agents|natriuretic agents|mesh-ancestor
110475119|NCT04036929|Bazedoxifene|bazedoxifene|mesh-list
110475120|NCT04036929|Estrogens|estrogens|mesh-list
110475121|NCT04036929|Hormones|hormones|mesh-ancestor
110475122|NCT04036929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110475123|NCT04036929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110475124|NCT04036929|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110475125|NCT04036929|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110475126|NCT04036929|Hormone Antagonists|hormone antagonists|mesh-ancestor
110475127|NCT04036929|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110475128|NCT04281147|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
110475129|NCT04281147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110475130|NCT04218981|Antipsychotic Agents|antipsychotic agents|mesh-list
110475131|NCT04218981|Paroxetine|paroxetine|mesh-list
110475132|NCT04218981|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110475133|NCT04218981|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110872361|NCT03725891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110872362|NCT03725891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110872363|NCT03725891|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110872364|NCT03725891|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110872365|NCT03725891|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110872366|NCT03725891|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110872367|NCT03725891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110872368|NCT03725891|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110475134|NCT04218981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110475135|NCT04218981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110475136|NCT04218981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110475137|NCT04218981|Serotonin Agents|serotonin agents|mesh-ancestor
110475138|NCT04218981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110475139|NCT04218981|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110475140|NCT04218981|Antidepressive Agents|antidepressive agents|mesh-ancestor
110475141|NCT04218981|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110475142|NCT04218981|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110475143|NCT04218981|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110475144|NCT04218981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110475145|NCT04218981|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110475146|NCT04218981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110475147|NCT04218513|Edaravone|edaravone|mesh-list
110475148|NCT04218513|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110475149|NCT04218513|Antioxidants|antioxidants|mesh-ancestor
110475150|NCT04218513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110475151|NCT04218513|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110475152|NCT04218513|Protective Agents|protective agents|mesh-ancestor
110475153|NCT04218513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110475154|NCT04218435|Valsartan|valsartan|mesh-list
110475155|NCT04218435|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
110475156|NCT04218435|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110475157|NCT04218435|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110475158|NCT04218435|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110475159|NCT04218435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110475160|NCT04138875|Rituximab|rituximab|mesh-list
110475161|NCT04138875|Brentuximab Vedotin|brentuximab vedotin|mesh-list
110475162|NCT04138875|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110475163|NCT04138875|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110475164|NCT04138875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110475165|NCT04138875|Immunologic Factors|immunologic factors|mesh-ancestor
110475166|NCT04138875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110475167|NCT04138875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110475168|NCT04138875|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110475169|NCT04138875|Alkylating Agents|alkylating agents|mesh-ancestor
110475170|NCT04138875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110475171|NCT04138875|Immunotoxins|immunotoxins|mesh-ancestor
110475172|NCT04138875|Immunoconjugates|immunoconjugates|mesh-ancestor
110475173|NCT02748135|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110475174|NCT02748135|Immunologic Factors|immunologic factors|mesh-ancestor
110165443|NCT00000221|Analgesics|analgesics|mesh-ancestor
110475175|NCT02748135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110475176|NCT02695563|Lactoferrin|lactoferrin|mesh-list
110475177|NCT02695563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110475178|NCT02747823|Bevacizumab|bevacizumab|mesh-list
110475179|NCT02747823|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110475180|NCT02747823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110475181|NCT02747823|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110475182|NCT02747823|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110475183|NCT02747823|Growth Substances|growth substances|mesh-ancestor
110122407|NCT01918150|Cobalt|cobalt|mesh-list
110475184|NCT02747823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110475185|NCT02747823|Growth Inhibitors|growth inhibitors|mesh-ancestor
110872369|NCT03725891|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110872370|NCT03725891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110872371|NCT03725891|Antipyretics|antipyretics|mesh-ancestor
110872372|NCT03751163|Sunscreening Agents|sunscreening agents|mesh-list
110872373|NCT03751163|Tranexamic Acid|tranexamic acid|mesh-list
110872374|NCT03751163|Hydroquinone|hydroquinone|mesh-list
110872375|NCT03751163|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110872376|NCT03751163|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110600080|NCT02569814|Amlodipine|amlodipine|mesh-list
110872377|NCT03751163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110872378|NCT03751163|Hemostatics|hemostatics|mesh-ancestor
110872379|NCT03751163|Coagulants|coagulants|mesh-ancestor
110872380|NCT03751163|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110203092|NCT00157378|Dopamine Agents|dopamine agents|mesh-ancestor
110475187|NCT02747511|Haloperidol decanoate|haloperidol decanoate|mesh-list
110475188|NCT02747511|Antiemetics|antiemetics|mesh-ancestor
110475189|NCT02747511|Autonomic Agents|autonomic agents|mesh-ancestor
110475190|NCT02747511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110475191|NCT02747511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110475192|NCT02747511|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110475193|NCT02747511|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110475194|NCT02747511|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110475195|NCT02747511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110475196|NCT02747511|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110475197|NCT02747511|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110475198|NCT02747511|Dopamine Agents|dopamine agents|mesh-ancestor
110475199|NCT02747511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110475200|NCT02747511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110475201|NCT02747511|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110475202|NCT04217733|Ethosuximide|ethosuximide|mesh-list
110475203|NCT04217733|Mebeverine|mebeverine|mesh-list
110475204|NCT04217733|Alverine|alverine|mesh-list
110475206|NCT04217733|Parasympatholytics|parasympatholytics|mesh-ancestor
110475207|NCT04217733|Autonomic Agents|autonomic agents|mesh-ancestor
110475208|NCT04217733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110475209|NCT04217733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110475210|NCT00636285|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110475211|NCT00636285|Immunologic Factors|immunologic factors|mesh-ancestor
110475212|NCT00636285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110475213|NCT02746185|Heparin|heparin|mesh-list
110475214|NCT02746185|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
110475215|NCT02746185|Tinzaparin|tinzaparin|mesh-list
110475216|NCT02746185|Dalteparin|dalteparin|mesh-list
110475217|NCT02746185|Rivaroxaban|rivaroxaban|mesh-list
110475218|NCT02746185|Anticoagulants|anticoagulants|mesh-ancestor
110475219|NCT02746185|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110475220|NCT02746185|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110475221|NCT02746185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110475222|NCT02746185|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110475223|NCT02746185|Antithrombins|antithrombins|mesh-ancestor
110475224|NCT02746185|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110475225|NCT02746185|Protease Inhibitors|protease inhibitors|mesh-ancestor
110475226|NCT02746185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110475227|NCT02742051|Cyclophosphamide|cyclophosphamide|mesh-list
110475228|NCT02742051|Fluorouracil|fluorouracil|mesh-list
110475229|NCT02742051|Everolimus|everolimus|mesh-list
110475230|NCT02742051|Letrozole|letrozole|mesh-list
110475231|NCT02742051|Epirubicin|epirubicin|mesh-list
110475232|NCT02742051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110475233|NCT02742051|Immunologic Factors|immunologic factors|mesh-ancestor
110475234|NCT02742051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110475235|NCT02742051|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110475236|NCT02742051|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110475237|NCT02742051|Alkylating Agents|alkylating agents|mesh-ancestor
110475238|NCT02742051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110475239|NCT02742051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110475240|NCT02742051|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110872381|NCT03751163|Protective Agents|protective agents|mesh-ancestor
110872382|NCT03751163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110872383|NCT03751163|Dermatologic Agents|dermatologic agents|mesh-ancestor
110872384|NCT03751163|Antioxidants|antioxidants|mesh-ancestor
110872385|NCT03639545|Metformin|metformin|mesh-list
110872386|NCT03639545|Empagliflozin|empagliflozin|mesh-list
110872387|NCT03639545|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110872388|NCT03639545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110872389|NCT03639545|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110872390|NCT03639545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110872391|NCT03181386|Warfarin|warfarin|mesh-list
110872392|NCT03181386|Rivaroxaban|rivaroxaban|mesh-list
110475241|NCT02742051|Antimetabolites|antimetabolites|mesh-ancestor
110475242|NCT02742051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110475243|NCT02742051|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110475244|NCT02742051|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110475245|NCT02742051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110475246|NCT02742051|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110475247|NCT02742051|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110475248|NCT02742051|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110475249|NCT02742051|Hormone Antagonists|hormone antagonists|mesh-ancestor
110475250|NCT02742051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110475251|NCT02742051|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110475252|NCT02742051|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110475253|NCT02742051|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110475254|NCT02741817|Aspirin|aspirin|mesh-list
110475255|NCT02741817|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110475256|NCT02741817|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110475257|NCT02741817|Analgesics|analgesics|mesh-ancestor
110475258|NCT02741817|Sensory System Agents|sensory system agents|mesh-ancestor
110475259|NCT02741817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110475260|NCT02741817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110475261|NCT02741817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110475262|NCT02741817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110475263|NCT02741817|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110475264|NCT02741817|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110475265|NCT02741817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110475266|NCT02741817|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110475267|NCT02741817|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110475268|NCT02741817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110475270|NCT02745873|Ascorbic Acid|ascorbic acid|mesh-list
110475271|NCT02745873|Vitamins|vitamins|mesh-ancestor
110475272|NCT02745873|Micronutrients|micronutrients|mesh-ancestor
110475273|NCT02745873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110475274|NCT02745873|Antioxidants|antioxidants|mesh-ancestor
110475275|NCT02745873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110475276|NCT02745873|Protective Agents|protective agents|mesh-ancestor
110475277|NCT02745639|Capecitabine|capecitabine|mesh-list
110475278|NCT02745639|Oxaliplatin|oxaliplatin|mesh-list
110475279|NCT02745639|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110475280|NCT02745639|Antimetabolites|antimetabolites|mesh-ancestor
110475281|NCT02745639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110475282|NCT02745639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110475284|NCT02745717|Cyclosporins|cyclosporins|mesh-list
110475285|NCT02745717|Thymoglobulin|thymoglobulin|mesh-list
110475286|NCT02745717|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110475287|NCT02745717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110475288|NCT02745717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110475289|NCT02745717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110475290|NCT02745717|Immunologic Factors|immunologic factors|mesh-ancestor
110475291|NCT02745717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110475292|NCT02745717|Antifungal Agents|antifungal agents|mesh-ancestor
110475293|NCT02745717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110475294|NCT02745717|Dermatologic Agents|dermatologic agents|mesh-ancestor
110872393|NCT03181386|Dabigatran|dabigatran|mesh-list
110872394|NCT03181386|Apixaban|apixaban|mesh-list
110872395|NCT03181386|Anticoagulants|anticoagulants|mesh-ancestor
110872396|NCT03181386|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110872397|NCT03181386|Antithrombins|antithrombins|mesh-ancestor
110872398|NCT03181386|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110872399|NCT03181386|Protease Inhibitors|protease inhibitors|mesh-ancestor
110872400|NCT03181386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110872401|NCT03181386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110475295|NCT02745717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110475296|NCT02745717|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110475297|NCT02745561|Oxaliplatin|oxaliplatin|mesh-list
110475298|NCT02745561|Endostatins|endostatins|mesh-list
110475299|NCT02745561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110475300|NCT02745561|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110475301|NCT02745561|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110475302|NCT02745561|Growth Substances|growth substances|mesh-ancestor
110475303|NCT02745561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110475304|NCT02745561|Growth Inhibitors|growth inhibitors|mesh-ancestor
110475305|NCT02741427|Carbamide Peroxide|carbamide peroxide|mesh-list
110475306|NCT02741427|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110165461|NCT00023920|Growth Inhibitors|growth inhibitors|mesh-ancestor
110475308|NCT02745093|Misoprostol|misoprostol|mesh-list
110475309|NCT02745093|Mifepristone|mifepristone|mesh-list
110475310|NCT02745093|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110475311|NCT02745093|Abortifacient Agents|abortifacient agents|mesh-ancestor
110475312|NCT02745093|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110475313|NCT02745093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110475314|NCT02745093|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110475315|NCT02745093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110475316|NCT02745093|Oxytocics|oxytocics|mesh-ancestor
110475317|NCT02745093|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
110475318|NCT02745093|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110475319|NCT02745093|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110475320|NCT02745093|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110475321|NCT02745093|Contraceptive Agents|contraceptive agents|mesh-ancestor
110475322|NCT02745093|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
110475323|NCT02745093|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
110475324|NCT02745093|Hormone Antagonists|hormone antagonists|mesh-ancestor
110475325|NCT02745093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110475326|NCT02745093|Luteolytic Agents|luteolytic agents|mesh-ancestor
110475327|NCT02745093|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110475328|NCT02745093|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
110475329|NCT00839254|Vaccines|vaccines|mesh-list
110475330|NCT00839254|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110475331|NCT00839254|Immunologic Factors|immunologic factors|mesh-ancestor
110475332|NCT00839254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110475333|NCT02741115|Udenafil|udenafil|mesh-list
110475334|NCT02741115|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110475335|NCT02741115|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110475336|NCT02741115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110475337|NCT02741115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110475338|NCT02740803|Listerine|listerine|mesh-list
110475339|NCT02740803|Fluorides|fluorides|mesh-list
110475340|NCT02740803|Sodium Fluoride|sodium fluoride|mesh-list
110475341|NCT02740803|Tin Fluorides|tin fluorides|mesh-list
110475342|NCT02740803|Fluorophosphate|fluorophosphate|mesh-list
110475343|NCT02740803|Cariostatic Agents|cariostatic agents|mesh-ancestor
110475344|NCT02740803|Protective Agents|protective agents|mesh-ancestor
110475345|NCT02740803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110475346|NCT02740803|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110475347|NCT02740803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110475348|NCT02740647|Amoxicillin|amoxicillin|mesh-list
110475349|NCT02740647|Clavulanic Acid|clavulanic acid|mesh-list
110475350|NCT02740647|Clavulanic Acids|clavulanic acids|mesh-list
110475351|NCT02740647|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
110475352|NCT02740647|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110475353|NCT02740647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110872402|NCT02912468|Mometasone Furoate|mometasone furoate|mesh-list
110872403|NCT02912468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110872404|NCT02912468|Dermatologic Agents|dermatologic agents|mesh-ancestor
110872405|NCT02912468|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110872406|NCT03639467|Gemcitabine|gemcitabine|mesh-list
110872407|NCT03639467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110872408|NCT03639467|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110872409|NCT03639467|Antimetabolites|antimetabolites|mesh-ancestor
110872410|NCT03639467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110872411|NCT01382706|Docetaxel|docetaxel|mesh-list
110872412|NCT01382706|Lapatinib|lapatinib|mesh-list
110872413|NCT01382706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110872414|NCT01382706|Tubulin Modulators|tubulin modulators|mesh-ancestor
110872415|NCT01382706|Antimitotic Agents|antimitotic agents|mesh-ancestor
110872416|NCT01382706|Mitosis Modulators|mitosis modulators|mesh-ancestor
110475354|NCT02740647|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110475355|NCT02740647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110475356|NCT02740647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110475357|NCT03737253|Menotropins|menotropins|mesh-list
110475358|NCT03737253|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
110475359|NCT03737253|Hormones|hormones|mesh-ancestor
110475360|NCT03737253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110475361|NCT03737253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110475362|NCT03737253|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110475363|NCT03737253|Fertility Agents|fertility agents|mesh-ancestor
110475364|NCT03737253|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110475365|NCT00812968|Lenalidomide|lenalidomide|mesh-list
110475366|NCT00812968|Immunologic Factors|immunologic factors|mesh-ancestor
110475367|NCT00812968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110475368|NCT00812968|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110475369|NCT00812968|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110475370|NCT00812968|Growth Substances|growth substances|mesh-ancestor
110475371|NCT00812968|Growth Inhibitors|growth inhibitors|mesh-ancestor
110475372|NCT00812968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110475373|NCT02744703|Capecitabine|capecitabine|mesh-list
110475374|NCT02744703|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110475375|NCT02744703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110475376|NCT02744703|Antimetabolites|antimetabolites|mesh-ancestor
110475377|NCT02744703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110475378|NCT02744703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110475379|NCT02744937|Aspirin|aspirin|mesh-list
110475380|NCT02744937|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110475381|NCT02744937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110475382|NCT02744937|Analgesics|analgesics|mesh-ancestor
110475383|NCT02744937|Sensory System Agents|sensory system agents|mesh-ancestor
110475384|NCT02744937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110475385|NCT02744937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110475386|NCT02744937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110475387|NCT02744937|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110475388|NCT02744937|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110475389|NCT02744937|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110475390|NCT02744937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110475391|NCT02744937|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110475392|NCT02744937|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110475393|NCT02744937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110475394|NCT02744937|Antipyretics|antipyretics|mesh-ancestor
110475395|NCT02744625|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
110475396|NCT02744625|Propofol|propofol|mesh-list
110475397|NCT02744625|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110475398|NCT02744625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110475399|NCT02744625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110872417|NCT01382706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110872418|NCT01382706|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110872419|NCT01382706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110872420|NCT03665402|Isoniazid|isoniazid|mesh-list
110872421|NCT03665402|Antitubercular Agents|antitubercular agents|mesh-ancestor
110872422|NCT03665402|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110872423|NCT03665402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110589939|NCT00743847|Varenicline|varenicline|mesh-list
110872424|NCT03665402|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
110872425|NCT03665402|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110872426|NCT03665402|Antimetabolites|antimetabolites|mesh-ancestor
110872427|NCT03665402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110872428|NCT03665402|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110475400|NCT02744625|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110475401|NCT02744625|Anesthetics, General|anesthetics, general|mesh-ancestor
110475402|NCT02744625|Anesthetics|anesthetics|mesh-ancestor
110475403|NCT02610556|Cisplatin|cisplatin|mesh-list
110475404|NCT02610556|Docetaxel|docetaxel|mesh-list
110475405|NCT02610556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110475406|NCT02610556|Tubulin Modulators|tubulin modulators|mesh-ancestor
110475407|NCT02610556|Antimitotic Agents|antimitotic agents|mesh-ancestor
110475408|NCT02610556|Mitosis Modulators|mitosis modulators|mesh-ancestor
110475409|NCT02610556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110475410|NCT02740101|Oxytocin|oxytocin|mesh-list
110475411|NCT02740101|Oxytocics|oxytocics|mesh-ancestor
110475412|NCT02740101|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110475413|NCT02740101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110475415|NCT02612116|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110475416|NCT02612116|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110475417|NCT02612116|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110475418|NCT02612116|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110475419|NCT02612116|Purinergic Agents|purinergic agents|mesh-ancestor
110475420|NCT02612116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110475421|NCT02612116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110475422|NCT02612116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110475423|NCT00813748|Omalizumab|omalizumab|mesh-list
110475424|NCT00813748|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110475425|NCT00813748|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110475426|NCT00813748|Respiratory System Agents|respiratory system agents|mesh-ancestor
110475427|NCT00813592|Pasireotide|pasireotide|mesh-list
110475428|NCT00813592|Hormones|hormones|mesh-ancestor
110475429|NCT00813592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110475430|NCT00813592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110475431|NCT02739633|Paclitaxel|paclitaxel|mesh-list
110475432|NCT02739633|genexol-PM|genexol-pm|mesh-list
110475433|NCT02739633|Gemcitabine|gemcitabine|mesh-list
110475434|NCT02739633|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110475435|NCT02739633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110475436|NCT02739633|Tubulin Modulators|tubulin modulators|mesh-ancestor
110475437|NCT02739633|Antimitotic Agents|antimitotic agents|mesh-ancestor
110475438|NCT02739633|Mitosis Modulators|mitosis modulators|mesh-ancestor
110475439|NCT02739633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110475440|NCT02739633|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110475441|NCT02739633|Antimetabolites|antimetabolites|mesh-ancestor
110475442|NCT02739477|Favipiravir|favipiravir|mesh-list
110475443|NCT02739477|Antiviral Agents|antiviral agents|mesh-ancestor
110475444|NCT02739477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110475445|NCT02739399|Phenylephrine|phenylephrine|mesh-list
110475446|NCT02739399|Oxymetazoline|oxymetazoline|mesh-list
110475447|NCT02739399|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110475448|NCT02739399|Mydriatics|mydriatics|mesh-ancestor
110475449|NCT02739399|Autonomic Agents|autonomic agents|mesh-ancestor
110475450|NCT02739399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110872430|NCT01380288|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110872431|NCT01380288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110872432|NCT01380288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110872433|NCT01380288|Cholinergic Agents|cholinergic agents|mesh-ancestor
110872434|NCT01380288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110872435|NCT01380288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110872436|NCT01380288|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110872437|NCT01380288|Protective Agents|protective agents|mesh-ancestor
110872438|NCT03110484|Pemetrexed|pemetrexed|mesh-list
110872439|NCT03110484|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110872440|NCT03110484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110872441|NCT03110484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110872442|NCT03110484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110872443|NCT03110484|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110872444|NCT03110484|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110872445|NCT03110484|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110872446|NCT03110328|Pembrolizumab|pembrolizumab|mesh-list
110872447|NCT03110328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110872448|NCT03110328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110872449|NCT03110328|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110872450|NCT03110328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110872451|NCT00002874|Bicalutamide|bicalutamide|mesh-list
110203418|NCT00052052|Interferons|interferons|mesh-list
110475451|NCT02739399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110475452|NCT02739399|Sympathomimetics|sympathomimetics|mesh-ancestor
110475453|NCT02739399|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110475454|NCT02739399|Nasal Decongestants|nasal decongestants|mesh-ancestor
110475455|NCT02739399|Respiratory System Agents|respiratory system agents|mesh-ancestor
110475456|NCT02739399|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110475457|NCT02739399|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110475458|NCT02739399|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110475459|NCT02739399|Adrenergic Agents|adrenergic agents|mesh-ancestor
110475460|NCT02739399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110475461|NCT02739399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110475462|NCT02739399|Protective Agents|protective agents|mesh-ancestor
110475463|NCT02743065|Doxorubicin|doxorubicin|mesh-list
110475464|NCT02743065|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110475465|NCT02743065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110475466|NCT02743065|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110475467|NCT02743065|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110475468|NCT02743065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110475469|NCT02743065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110475470|NCT02742909|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
110475471|NCT02742909|Natriuretic Agents|natriuretic agents|mesh-ancestor
110475472|NCT02742909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110475473|NCT02742675|Leuprolide|leuprolide|mesh-list
110475474|NCT02742675|Goserelin|goserelin|mesh-list
110475475|NCT02742675|Triptorelin Pamoate|triptorelin pamoate|mesh-list
110475476|NCT02742675|Flutamide|flutamide|mesh-list
110872452|NCT00002874|Androgen Antagonists|androgen antagonists|mesh-ancestor
110872453|NCT00002874|Hormone Antagonists|hormone antagonists|mesh-ancestor
110872454|NCT00002874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110872455|NCT00002874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110872456|NCT00002874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110872457|NCT03001076|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
110872458|NCT03001076|Ezetimibe|ezetimibe|mesh-list
110872459|NCT03001076|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110475477|NCT02742675|Bicalutamide|bicalutamide|mesh-list
110475478|NCT02742675|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110475479|NCT02742675|Fertility Agents|fertility agents|mesh-ancestor
110475480|NCT02742675|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110475481|NCT02742675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110475482|NCT02742675|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110475483|NCT02742675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110475484|NCT02742675|Androgen Antagonists|androgen antagonists|mesh-ancestor
110475485|NCT02742675|Hormone Antagonists|hormone antagonists|mesh-ancestor
110475486|NCT02742675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110475487|NCT02742675|Luteolytic Agents|luteolytic agents|mesh-ancestor
110475488|NCT02742675|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110475489|NCT02742675|Contraceptive Agents|contraceptive agents|mesh-ancestor
110475490|NCT02742675|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110475491|NCT00812812|Paroxetine|paroxetine|mesh-list
110475492|NCT00812812|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110475493|NCT00812812|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110475494|NCT00812812|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110475495|NCT00812812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110475496|NCT00812812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110475497|NCT00812812|Serotonin Agents|serotonin agents|mesh-ancestor
110475498|NCT00812812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110475499|NCT00812812|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110475500|NCT00812812|Antidepressive Agents|antidepressive agents|mesh-ancestor
110475501|NCT00812812|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110475502|NCT00812812|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110475503|NCT00812812|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110475504|NCT00812812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110475505|NCT02742285|Lumefantrine|lumefantrine|mesh-list
110475506|NCT02742285|Artemether|artemether|mesh-list
110475507|NCT02742285|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
110475508|NCT02742285|Antimalarials|antimalarials|mesh-ancestor
110475509|NCT02742285|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110475510|NCT02742285|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110475511|NCT02742285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110475512|NCT03673527|Tacrolimus|tacrolimus|mesh-list
110475513|NCT03673527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110475514|NCT03673527|Immunologic Factors|immunologic factors|mesh-ancestor
110475515|NCT03673527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110475516|NCT03673527|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110475517|NCT03673527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110475518|NCT03673527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110475519|NCT02738931|Lamivudine|lamivudine|mesh-list
110475520|NCT02738931|Dolutegravir|dolutegravir|mesh-list
110475521|NCT02738931|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110475522|NCT02738931|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110475523|NCT02738931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110475524|NCT02738931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110475525|NCT02738931|Antiviral Agents|antiviral agents|mesh-ancestor
110475526|NCT02738931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110475527|NCT02738931|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110475528|NCT02738931|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110475529|NCT02738931|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110475530|NCT02738931|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110475531|NCT02738619|Vitamin D|vitamin d|mesh-list
110475532|NCT02738619|Ergocalciferols|ergocalciferols|mesh-list
110475533|NCT02738619|Cholecalciferol|cholecalciferol|mesh-list
110872460|NCT03001076|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110872461|NCT03001076|Antimetabolites|antimetabolites|mesh-ancestor
110872462|NCT03001076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110872463|NCT03001076|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110872464|NCT03001076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110872465|NCT03001076|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110872466|NCT03001076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110872467|NCT03555305|Insulin|insulin|mesh-list
110872468|NCT03555305|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110872469|NCT03555305|Insulin Glargine|insulin glargine|mesh-list
110872470|NCT03555305|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110872471|NCT03555305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110872472|NCT03018834|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
110872473|NCT03018834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110872474|NCT05422716|Baclofen|baclofen|mesh-list
110475534|NCT02738619|Vitamins|vitamins|mesh-list
110475535|NCT02738619|Micronutrients|micronutrients|mesh-ancestor
110475536|NCT02738619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110475537|NCT02738619|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110475538|NCT02738619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110475539|NCT04016116|Pembrolizumab|pembrolizumab|mesh-list
110475540|NCT04016116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110475541|NCT04016116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110475542|NCT04016116|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110475543|NCT04016116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110475544|NCT02736591|Hormones|hormones|mesh-list
110475545|NCT02736591|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
110475546|NCT02736591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110475547|NCT02736591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110475548|NCT05757466|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110475549|NCT05757466|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110475550|NCT05757466|Alkylating Agents|alkylating agents|mesh-ancestor
110475551|NCT05757466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110475552|NCT05757466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110475553|NCT02736513|Osimertinib|osimertinib|mesh-list
110475554|NCT02736513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110475555|NCT02736513|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110475556|NCT02736513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110475557|NCT02736513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110475558|NCT02736435|Leuprolide|leuprolide|mesh-list
110475559|NCT02736435|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110475560|NCT02736435|Fertility Agents|fertility agents|mesh-ancestor
110475561|NCT02736435|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110475562|NCT02736435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110475563|NCT02736435|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110475564|NCT02736435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110475565|NCT02736279|Dimethyl Fumarate|dimethyl fumarate|mesh-list
110475566|NCT02736279|Dermatologic Agents|dermatologic agents|mesh-ancestor
110475567|NCT02736279|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110475568|NCT02736279|Immunologic Factors|immunologic factors|mesh-ancestor
110475569|NCT02736279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110475570|NCT00748189|Ofatumumab|ofatumumab|mesh-list
110475571|NCT00748189|Chlorambucil|chlorambucil|mesh-list
110475572|NCT00748189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110475573|NCT00748189|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110475574|NCT00748189|Alkylating Agents|alkylating agents|mesh-ancestor
110165494|NCT00023998|Leucovorin|leucovorin|mesh-list
110475575|NCT00748189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110475576|NCT02609230|TIC10 compound|tic10 compound|mesh-list
110872475|NCT05422716|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110872476|NCT05422716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110872477|NCT05422716|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110872478|NCT05422716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110872479|NCT05422716|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
110872481|NCT05422716|GABA Agents|gaba agents|mesh-ancestor
110534664|NCT02676336|Cadexomer iodine|cadexomer iodine|mesh-list
110475577|NCT02609230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110475578|NCT00913822|Desipramine|desipramine|mesh-list
110475579|NCT00913822|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110475580|NCT00913822|Antidepressive Agents|antidepressive agents|mesh-ancestor
110475581|NCT00913822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110475582|NCT00913822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110475583|NCT00913822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110475584|NCT00913822|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110475585|NCT00913822|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110475586|NCT00913822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110475587|NCT00913822|Adrenergic Agents|adrenergic agents|mesh-ancestor
110475588|NCT00913822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110475589|NCT00913822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110475592|NCT02736123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110475593|NCT02736123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110475594|NCT02736123|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110475595|NCT02736123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110475596|NCT00744055|Prazosin|prazosin|mesh-list
110475597|NCT00744055|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110475598|NCT00744055|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110475599|NCT00744055|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110475600|NCT00744055|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110475601|NCT00744055|Adrenergic Agents|adrenergic agents|mesh-ancestor
110475602|NCT00744055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110475603|NCT00744055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110475604|NCT00744055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110475605|NCT02738073|Tranexamic Acid|tranexamic acid|mesh-list
110475606|NCT02738073|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110475607|NCT02738073|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110475608|NCT02738073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110475609|NCT02738073|Hemostatics|hemostatics|mesh-ancestor
110475610|NCT02738073|Coagulants|coagulants|mesh-ancestor
110475611|NCT03967483|Indomethacin|indomethacin|mesh-list
110475612|NCT03967483|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110475613|NCT03967483|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110475614|NCT03967483|Analgesics|analgesics|mesh-ancestor
110475615|NCT03967483|Sensory System Agents|sensory system agents|mesh-ancestor
110475616|NCT03967483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110475617|NCT03967483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110475618|NCT03967483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110475619|NCT03967483|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110475620|NCT03967483|Gout Suppressants|gout suppressants|mesh-ancestor
110475621|NCT03967483|Tocolytic Agents|tocolytic agents|mesh-ancestor
110475622|NCT03967483|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110475623|NCT03967483|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110475624|NCT03967483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110475625|NCT03967483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110475626|NCT00740779|Silodosin|silodosin|mesh-list
110475627|NCT00740779|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110475628|NCT00740779|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110475629|NCT00740779|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110475630|NCT00740779|Adrenergic Agents|adrenergic agents|mesh-ancestor
110475631|NCT00740779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110475632|NCT00740779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110475633|NCT00740779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110475634|NCT00740779|Urological Agents|urological agents|mesh-ancestor
110475635|NCT00735475|Vaccines|vaccines|mesh-list
110600179|NCT00805311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110872482|NCT05422716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110872483|NCT05422716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110872484|NCT03728777|Resveratrol|resveratrol|mesh-list
110872485|NCT03728777|Antioxidants|antioxidants|mesh-ancestor
110872486|NCT03728777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110872487|NCT03728777|Protective Agents|protective agents|mesh-ancestor
110872488|NCT03728777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110872489|NCT03728777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110872490|NCT03728777|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110872491|NCT05421936|Osimertinib|osimertinib|mesh-list
110872492|NCT05421936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110872493|NCT05421936|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110203656|NCT00052559|Fluorouracil|fluorouracil|mesh-list
110475636|NCT00735475|Immunologic Factors|immunologic factors|mesh-ancestor
110475637|NCT00735475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110475638|NCT01026818|Tadalafil|tadalafil|mesh-list
110475639|NCT01026818|Vasodilator Agents|vasodilator agents|mesh-ancestor
110475640|NCT01026818|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110475641|NCT01026818|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110475642|NCT01026818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110475643|NCT01026818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110475644|NCT01026818|Urological Agents|urological agents|mesh-ancestor
110475645|NCT02593747|Loratadine|loratadine|mesh-list
110475646|NCT02593747|Antipruritics|antipruritics|mesh-ancestor
110475647|NCT02593747|Dermatologic Agents|dermatologic agents|mesh-ancestor
110475648|NCT02593747|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110475649|NCT02593747|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110475650|NCT02593747|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110475651|NCT02593747|Histamine Antagonists|histamine antagonists|mesh-ancestor
110475652|NCT02593747|Histamine Agents|histamine agents|mesh-ancestor
110475653|NCT02593747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110475654|NCT02593747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110475655|NCT02593747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110475656|NCT00743509|Sirolimus|sirolimus|mesh-list
110475657|NCT00743509|Cyclophosphamide|cyclophosphamide|mesh-list
110475658|NCT00743509|Temsirolimus|temsirolimus|mesh-list
110475659|NCT00743509|MTOR Inhibitors|mtor inhibitors|mesh-list
110475660|NCT00743509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110475661|NCT00743509|Immunologic Factors|immunologic factors|mesh-ancestor
110475662|NCT00743509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110475663|NCT00743509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110475664|NCT00743509|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110475665|NCT00743509|Alkylating Agents|alkylating agents|mesh-ancestor
110475666|NCT00743509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110475667|NCT00743509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110475668|NCT00743509|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110475669|NCT00743509|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110475670|NCT00743509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110475671|NCT00743509|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110475672|NCT00743509|Antifungal Agents|antifungal agents|mesh-ancestor
110475673|NCT00743509|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110475674|NCT00743509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110475675|NCT00734929|Dexamethasone|dexamethasone|mesh-list
110475676|NCT00734929|Dexamethasone acetate|dexamethasone acetate|mesh-list
110475677|NCT00734929|Ondansetron|ondansetron|mesh-list
110475678|NCT00734929|Aprepitant|aprepitant|mesh-list
110475679|NCT00734929|BB 1101|bb 1101|mesh-list
110475680|NCT00734929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110475681|NCT00734929|Antiemetics|antiemetics|mesh-ancestor
110475682|NCT00734929|Autonomic Agents|autonomic agents|mesh-ancestor
110475683|NCT00734929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110475684|NCT00734929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110475685|NCT00734929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110872495|NCT05421936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110872496|NCT01382472|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110872497|NCT01382472|Simvastatin|simvastatin|mesh-list
110590008|NCT01090089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110872498|NCT01382472|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110872499|NCT01382472|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110872500|NCT01382472|Antimetabolites|antimetabolites|mesh-ancestor
110872501|NCT01382472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110475686|NCT00734929|Glucocorticoids|glucocorticoids|mesh-ancestor
110475687|NCT00734929|Hormones|hormones|mesh-ancestor
110475688|NCT00734929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110475689|NCT00734929|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110475690|NCT00734929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110475691|NCT00734929|Protease Inhibitors|protease inhibitors|mesh-ancestor
110475692|NCT00734929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110475693|NCT00734929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110475694|NCT00734929|Antipruritics|antipruritics|mesh-ancestor
110475695|NCT00734929|Dermatologic Agents|dermatologic agents|mesh-ancestor
110475696|NCT00734929|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110475697|NCT00734929|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110475698|NCT00734929|Serotonin Agents|serotonin agents|mesh-ancestor
110475699|NCT00734929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110475700|NCT00734929|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110475701|NCT00734851|Docetaxel|docetaxel|mesh-list
110475702|NCT00734851|Sunitinib|sunitinib|mesh-list
110475703|NCT00734851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110475704|NCT00734851|Tubulin Modulators|tubulin modulators|mesh-ancestor
110475705|NCT00734851|Antimitotic Agents|antimitotic agents|mesh-ancestor
110475706|NCT00734851|Mitosis Modulators|mitosis modulators|mesh-ancestor
110475707|NCT00734851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110475708|NCT00734851|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110475709|NCT00734851|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110475710|NCT00734851|Growth Substances|growth substances|mesh-ancestor
110475711|NCT00734851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110475712|NCT00734851|Growth Inhibitors|growth inhibitors|mesh-ancestor
110165518|NCT00023998|Immunologic Factors|immunologic factors|mesh-ancestor
110475713|NCT00734851|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110475714|NCT00734851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110475716|NCT00734617|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110475717|NCT00734617|Autonomic Agents|autonomic agents|mesh-ancestor
110475718|NCT00734617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110475719|NCT00734617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110475720|NCT00734617|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110475721|NCT00734617|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110475722|NCT00734617|Cholinergic Agents|cholinergic agents|mesh-ancestor
110475723|NCT00734617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110475724|NCT00734617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110475725|NCT00743431|Doxorubicin|doxorubicin|mesh-list
110475726|NCT00743431|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110475727|NCT00743431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110475728|NCT00743431|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110475729|NCT00743431|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110475730|NCT00743431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110475731|NCT00743431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110475732|NCT02737605|Moxifloxacin|moxifloxacin|mesh-list
110475733|NCT02737605|Esketamine|esketamine|mesh-list
110475734|NCT02737605|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110475735|NCT02737605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110475736|NCT02737605|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110475737|NCT02737605|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110475738|NCT02737605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110475739|NCT02737605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110475740|NCT02737605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110475741|NCT02737605|Antidepressive Agents|antidepressive agents|mesh-ancestor
110872502|NCT01382472|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110872503|NCT01382472|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110872504|NCT01382472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110872506|NCT03725423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110872507|NCT03725423|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110872508|NCT03725423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110872509|NCT03725423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110872510|NCT03521141|Nicotine|nicotine|mesh-list
110872511|NCT03521141|Varenicline|varenicline|mesh-list
110872512|NCT03521141|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110872513|NCT03521141|Autonomic Agents|autonomic agents|mesh-ancestor
110872514|NCT03521141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110872515|NCT03521141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110872516|NCT03521141|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110872517|NCT03521141|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110872518|NCT03521141|Cholinergic Agents|cholinergic agents|mesh-ancestor
110872519|NCT03521141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110872520|NCT03521141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110872521|NCT03725267|Melatonin|melatonin|mesh-list
110872522|NCT03725267|Antioxidants|antioxidants|mesh-ancestor
110872523|NCT03725267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110872524|NCT03725267|Protective Agents|protective agents|mesh-ancestor
110872525|NCT03725267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110872526|NCT03725267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110872527|NCT02997176|Talazoparib|talazoparib|mesh-list
110872529|NCT02997176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110872549|NCT01373164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110872550|NCT01373164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110872552|NCT02999984|Alkylating Agents|alkylating agents|mesh-ancestor
110872553|NCT02999984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110872554|NCT02999984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110872555|NCT02999984|Immunologic Factors|immunologic factors|mesh-ancestor
110872556|NCT02999984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110872557|NCT02999984|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110872558|NCT02999984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110872559|NCT02999984|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110872560|NCT03550313|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110872561|NCT03550313|Immunologic Factors|immunologic factors|mesh-ancestor
110872562|NCT03550313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110872563|NCT03312907|Rituximab|rituximab|mesh-list
110872564|NCT03312907|Belimumab|belimumab|mesh-list
110872565|NCT03312907|Immunosuppressive Agents|immunosuppressive agents|mesh-list
110872566|NCT03312907|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110872567|NCT03312907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110872568|NCT03312907|Immunologic Factors|immunologic factors|mesh-ancestor
110600223|NCT00732446|Moxifloxacin|moxifloxacin|mesh-list
110872569|NCT03312907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110872602|NCT04056182|Lofexidine|lofexidine|mesh-list
110872603|NCT04056182|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110872604|NCT04056182|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110872605|NCT04056182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110872606|NCT04056182|Sensory System Agents|sensory system agents|mesh-ancestor
110872607|NCT04056182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110872608|NCT04056182|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110872609|NCT04056182|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110872610|NCT04056182|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110872611|NCT04056182|Adrenergic Agents|adrenergic agents|mesh-ancestor
110872612|NCT04056182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110872668|NCT04220008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110872669|NCT04220008|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110872670|NCT04220008|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110872671|NCT04220008|Antitubercular Agents|antitubercular agents|mesh-ancestor
110872672|NCT04220008|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110872673|NCT04220008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110872674|NCT04220008|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110872675|NCT03721991|Butyric Acid|butyric acid|mesh-list
110872735|NCT03662984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110872736|NCT03662984|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110872737|NCT02994056|Sofosbuvir|sofosbuvir|mesh-list
110872738|NCT02994056|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
110872739|NCT02994056|Velpatasvir|velpatasvir|mesh-list
110872740|NCT02994056|Antiviral Agents|antiviral agents|mesh-ancestor
110872804|NCT02391688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110872805|NCT02391688|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110872806|NCT02391688|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110872807|NCT02391688|Purinergic Agents|purinergic agents|mesh-ancestor
110872808|NCT02391688|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110872876|NCT03158090|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110872877|NCT02670538|Cariprazine|cariprazine|mesh-list
110872878|NCT02670538|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110872879|NCT02670538|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110872880|NCT02670538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110872881|NCT02670538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110872882|NCT02670538|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110872884|NCT03727763|Vemurafenib|vemurafenib|mesh-list
110872885|NCT03727763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110872886|NCT03727763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110872887|NCT03727763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110872888|NCT03727763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110872889|NCT03727763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110872890|NCT01310621|Pulmonary Surfactants|pulmonary surfactants|mesh-list
110872891|NCT01310621|Respiratory System Agents|respiratory system agents|mesh-ancestor
110872892|NCT02991482|Gemcitabine|gemcitabine|mesh-list
110872893|NCT02991482|Pembrolizumab|pembrolizumab|mesh-list
110872894|NCT02991482|Vinorelbine|vinorelbine|mesh-list
110872895|NCT02991482|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110872896|NCT02991482|Antimetabolites|antimetabolites|mesh-ancestor
110872897|NCT02991482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110872898|NCT02991482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110872900|NCT02991482|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110872928|NCT01372618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110872930|NCT03304873|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110872931|NCT03304873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110872932|NCT04526509|Cyclophosphamide|cyclophosphamide|mesh-list
110872933|NCT04526509|Fludarabine|fludarabine|mesh-list
110872934|NCT04526509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110872935|NCT04526509|Immunologic Factors|immunologic factors|mesh-ancestor
110872936|NCT04526509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110872937|NCT04526509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110872990|NCT03659084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110872991|NCT01068626|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110872992|NCT01068626|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110872993|NCT01068626|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110872994|NCT01068626|Antimetabolites|antimetabolites|mesh-ancestor
110872995|NCT01068626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110872996|NCT01068626|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110872997|NCT01068626|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110872998|NCT01068626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110872999|NCT02921750|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
110873000|NCT02921750|Laxatives|laxatives|mesh-ancestor
110873001|NCT02921750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110873002|NCT03657836|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110873003|NCT03657836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110873004|NCT03622502|Dexmedetomidine|dexmedetomidine|mesh-list
110873005|NCT03622502|Remifentanil|remifentanil|mesh-list
110873006|NCT03622502|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110873007|NCT03622502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110873008|NCT03622502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110873009|NCT03622502|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110873010|NCT03622502|Analgesics|analgesics|mesh-ancestor
110873011|NCT03622502|Sensory System Agents|sensory system agents|mesh-ancestor
110873012|NCT03622502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110873013|NCT03622502|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110873014|NCT03622502|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110873015|NCT03622502|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110873016|NCT03622502|Adrenergic Agents|adrenergic agents|mesh-ancestor
110873017|NCT03622502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110873018|NCT03622502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110873019|NCT03622502|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110873020|NCT03622502|Narcotics|narcotics|mesh-ancestor
110873021|NCT04397354|Dexamethasone|dexamethasone|mesh-list
110873022|NCT04397354|Dexamethasone acetate|dexamethasone acetate|mesh-list
110873032|NCT04397354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110873033|NCT04397354|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110873034|NCT04397354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110873035|NCT04397354|Protease Inhibitors|protease inhibitors|mesh-ancestor
110873036|NCT04397354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110873037|NCT04397354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110873099|NCT05672212|Analgesics|analgesics|mesh-ancestor
110873100|NCT05672212|Sensory System Agents|sensory system agents|mesh-ancestor
110873101|NCT05672212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110873102|NCT05672212|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110873103|NCT05672212|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110873104|NCT05672212|Anesthetics, General|anesthetics, general|mesh-ancestor
110873105|NCT05672212|Anesthetics|anesthetics|mesh-ancestor
110873106|NCT02390674|Cyclosporine|cyclosporine|mesh-list
110873107|NCT02390674|Cyclosporins|cyclosporins|mesh-list
110873108|NCT02390674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110873109|NCT02390674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110873162|NCT02390440|Anesthetics, Local|anesthetics, local|mesh-ancestor
110873163|NCT02390440|Anesthetics|anesthetics|mesh-ancestor
110873164|NCT02390440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110873165|NCT02390440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110873166|NCT02390440|Sensory System Agents|sensory system agents|mesh-ancestor
110873167|NCT02390440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110873168|NCT03677830|Acetaminophen|acetaminophen|mesh-list
110873169|NCT03677830|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110873170|NCT03677830|Analgesics|analgesics|mesh-ancestor
110873171|NCT03677830|Sensory System Agents|sensory system agents|mesh-ancestor
110873172|NCT03677830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110873173|NCT03677830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110873174|NCT03677830|Antipyretics|antipyretics|mesh-ancestor
110873175|NCT02199691|Vaccines|vaccines|mesh-list
110873176|NCT02199691|Immunologic Factors|immunologic factors|mesh-ancestor
110873177|NCT02199691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110873178|NCT05667454|Atropine|atropine|mesh-list
110873179|NCT05667454|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110873180|NCT05667454|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110873181|NCT05667454|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110873182|NCT05667454|Autonomic Agents|autonomic agents|mesh-ancestor
110873183|NCT05667454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110873216|NCT02389582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110873217|NCT02389582|Antithrombins|antithrombins|mesh-ancestor
110873218|NCT02389582|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110873219|NCT02389582|Protease Inhibitors|protease inhibitors|mesh-ancestor
110873220|NCT02389582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110873221|NCT02389426|Bosentan|bosentan|mesh-list
110873222|NCT02389426|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110873223|NCT02389426|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
110873224|NCT02389426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110873225|NCT02389348|Artefenomel|artefenomel|mesh-list
110873226|NCT02389348|Antimalarials|antimalarials|mesh-ancestor
110873227|NCT02389348|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110873228|NCT02389348|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110873229|NCT02389348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110873230|NCT02387242|Rifampin|rifampin|mesh-list
110873277|NCT02387086|Leprostatic Agents|leprostatic agents|mesh-ancestor
110873278|NCT02387086|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110873279|NCT02387086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110873280|NCT02387086|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110873281|NCT02387086|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110873282|NCT02387086|Growth Substances|growth substances|mesh-ancestor
110873283|NCT02387086|Growth Inhibitors|growth inhibitors|mesh-ancestor
110873284|NCT02387086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110873285|NCT02387086|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110873286|NCT02383030|Fulvestrant|fulvestrant|mesh-list
110873287|NCT02383030|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110873341|NCT02388490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110873342|NCT02388490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110873343|NCT02388490|Immunotoxins|immunotoxins|mesh-ancestor
110873344|NCT02388490|Immunoconjugates|immunoconjugates|mesh-ancestor
110873345|NCT02388490|Immunologic Factors|immunologic factors|mesh-ancestor
110873346|NCT02388490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110873410|NCT02386072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110873411|NCT02386072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110873412|NCT02386072|Urological Agents|urological agents|mesh-ancestor
110873413|NCT02386072|Parasympatholytics|parasympatholytics|mesh-ancestor
110873414|NCT02386072|Autonomic Agents|autonomic agents|mesh-ancestor
110873415|NCT02386072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110873416|NCT02386072|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110873417|NCT02386072|Cholinergic Agents|cholinergic agents|mesh-ancestor
110873418|NCT03655730|Psychotropic Drugs|psychotropic drugs|mesh-list
110873419|NCT02381470|Amoxicillin|amoxicillin|mesh-list
110873420|NCT02381470|Rifampin|rifampin|mesh-list
110873421|NCT02381470|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
110873422|NCT02381470|Clavulanic Acids|clavulanic acids|mesh-list
110873423|NCT02381470|Clavulanic Acid|clavulanic acid|mesh-list
110873424|NCT02381470|Cefadroxil|cefadroxil|mesh-list
110873425|NCT02381470|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110873466|NCT02381080|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110873469|NCT04694248|Anticoagulants|anticoagulants|mesh-list
110873470|NCT04694248|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110873489|NCT02376478|Folic Acid|folic acid|mesh-list
110873537|NCT02385448|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110873538|NCT02385448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110873539|NCT02385448|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110591075|NCT00757185|Ganirelix|ganirelix|mesh-list
110873540|NCT02385448|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110873541|NCT02385448|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
110873542|NCT02385448|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
110873605|NCT03293485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110873606|NCT03293485|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110873607|NCT03309943|Propranolol|propranolol|mesh-list
110873608|NCT03309943|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110873609|NCT03309943|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110873610|NCT03309943|Adrenergic Agents|adrenergic agents|mesh-ancestor
110873611|NCT03309943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110873612|NCT03309943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110873613|NCT03309943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110873614|NCT03309943|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110591144|NCT02560155|Chlorhexidine|chlorhexidine|mesh-list
110873615|NCT03309943|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110873616|NCT03309943|Vasodilator Agents|vasodilator agents|mesh-ancestor
110873617|NCT01732627|Vaccines|vaccines|mesh-list
110873618|NCT01732627|Immunologic Factors|immunologic factors|mesh-ancestor
110873619|NCT01732627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110873620|NCT04296799|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110873621|NCT03331315|Celecoxib|celecoxib|mesh-list
110873661|NCT02380768|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110873662|NCT02380768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110873663|NCT02380768|Disinfectants|disinfectants|mesh-ancestor
110873664|NCT02385136|Temozolomide|temozolomide|mesh-list
110873665|NCT02385136|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110873666|NCT02385136|Alkylating Agents|alkylating agents|mesh-ancestor
110873667|NCT02385136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110873674|NCT04949269|Famotidine|famotidine|mesh-list
110873732|NCT03113344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110873733|NCT03113344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110873734|NCT03113344|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110873735|NCT03113266|Antibodies|antibodies|mesh-list
110873803|NCT01411267|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110873804|NCT01411267|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110873805|NCT01411267|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110873806|NCT01411267|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110873807|NCT01411267|Antiviral Agents|antiviral agents|mesh-ancestor
110873808|NCT01411267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110873809|NCT03113110|Empagliflozin|empagliflozin|mesh-list
110873810|NCT03113110|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110600284|NCT00732836|Paclitaxel|paclitaxel|mesh-list
110873811|NCT03113110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110873812|NCT03113110|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110873813|NCT03113110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110873814|NCT02383888|BI 425809|bi 425809|mesh-list
110873815|NCT02383888|Nootropic Agents|nootropic agents|mesh-ancestor
110873816|NCT02377960|Antihypertensive Agents|antihypertensive agents|mesh-list
110873817|NCT03130959|Nivolumab|nivolumab|mesh-list
110873818|NCT03130959|Ipilimumab|ipilimumab|mesh-list
110873819|NCT03130959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110873820|NCT03130959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110873821|NCT03130959|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110873822|NCT03130959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110873857|NCT04483960|Enoxaparin|enoxaparin|mesh-list
110873858|NCT04483960|Dalteparin|dalteparin|mesh-list
110873859|NCT04483960|Tinzaparin|tinzaparin|mesh-list
110873860|NCT04483960|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
110873861|NCT04483960|Anticoagulants|anticoagulants|mesh-ancestor
110873862|NCT04483960|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110873863|NCT04483960|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110873864|NCT04483960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110873926|NCT02377648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110873927|NCT02377648|Immunologic Factors|immunologic factors|mesh-ancestor
110873928|NCT02377648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110873929|NCT02377648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110873930|NCT02371408|Ribavirin|ribavirin|mesh-list
110873931|NCT02371408|Sofosbuvir|sofosbuvir|mesh-list
110873932|NCT02371408|Antimetabolites|antimetabolites|mesh-ancestor
110873933|NCT02371408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110873934|NCT02371408|Antiviral Agents|antiviral agents|mesh-ancestor
110873935|NCT02371408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110873936|NCT01364805|Ascorbic Acid|ascorbic acid|mesh-list
110873937|NCT01364805|Gemcitabine|gemcitabine|mesh-list
110873938|NCT01364805|Vitamins|vitamins|mesh-ancestor
110873991|NCT04381936|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
110873992|NCT04381936|Dimethyl Fumarate|dimethyl fumarate|mesh-list
110873993|NCT04381936|Antibodies|antibodies|mesh-list
110873994|NCT04381936|Immunoglobulins|immunoglobulins|mesh-list
110873995|NCT04381936|Immunologic Factors|immunologic factors|mesh-ancestor
110873996|NCT04381936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110874059|NCT02370862|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110874060|NCT03620578|Nivolumab|nivolumab|mesh-list
110874061|NCT03620578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110874062|NCT03620578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110874063|NCT03620578|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110874064|NCT03620578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110874128|NCT02364934|Anesthetics, General|anesthetics, general|mesh-ancestor
110874129|NCT02364934|Anesthetics|anesthetics|mesh-ancestor
110874130|NCT02364934|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110874131|NCT02364934|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110874132|NCT02372656|Metformin|metformin|mesh-list
110874198|NCT01368783|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110874199|NCT01509339|Vancomycin|vancomycin|mesh-list
110874200|NCT01509339|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110874201|NCT01509339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110874202|NCT03123471|Apremilast|apremilast|mesh-list
110874203|NCT03123471|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110874204|NCT03123471|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110874205|NCT03123471|Analgesics|analgesics|mesh-ancestor
110874206|NCT03123471|Sensory System Agents|sensory system agents|mesh-ancestor
110874207|NCT03123471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110874208|NCT03123471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110874209|NCT03123471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110874210|NCT03123471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110874211|NCT03123471|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
110874212|NCT03123471|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110874213|NCT03123471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110874214|NCT03123471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110874215|NCT02661178|Emodepside|emodepside|mesh-list
110874216|NCT02661178|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110591740|NCT02677545|Aspirin|aspirin|mesh-list
110874218|NCT01365117|Insulin|insulin|mesh-list
110874219|NCT01365117|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110874220|NCT01365117|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110874221|NCT01365117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110874222|NCT02372812|Dexamethasone|dexamethasone|mesh-list
110874249|NCT01365351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110874250|NCT01365351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110874251|NCT01372449|Memantine|memantine|mesh-list
110874254|NCT01372449|Dopamine Agents|dopamine agents|mesh-ancestor
110874316|NCT02038816|Deferasirox|deferasirox|mesh-list
110874317|NCT02038816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110874318|NCT02038816|Antimetabolites|antimetabolites|mesh-ancestor
110874319|NCT02038816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110874320|NCT02038816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110874321|NCT02038816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110874385|NCT03654794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110874386|NCT03654794|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110874387|NCT03654794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110874388|NCT03654794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110874389|NCT03654170|BI 425809|bi 425809|mesh-list
110874457|NCT02358304|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
110874459|NCT02358304|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110874460|NCT02358304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110874461|NCT02358304|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110874462|NCT02358304|Vasodilator Agents|vasodilator agents|mesh-ancestor
110874463|NCT02363530|Ethyl cellulose|ethyl cellulose|mesh-list
110874526|NCT03085914|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110874527|NCT03085914|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110874528|NCT03085914|Alkylating Agents|alkylating agents|mesh-ancestor
110874529|NCT03085914|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110874530|NCT03085914|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110874531|NCT03085914|Antimetabolites|antimetabolites|mesh-ancestor
110874532|NCT03085914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110874533|NCT03085914|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110874534|NCT03085914|Antidotes|antidotes|mesh-ancestor
110874535|NCT03085914|Protective Agents|protective agents|mesh-ancestor
110874593|NCT01382238|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110874596|NCT01382238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110874597|NCT01382238|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110874598|NCT01382238|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110874599|NCT01382238|Antiviral Agents|antiviral agents|mesh-ancestor
110874600|NCT01382238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110874601|NCT03112564|Fentanyl|fentanyl|mesh-list
110874602|NCT03112564|Sevoflurane|sevoflurane|mesh-list
110874603|NCT03112564|Rocuronium|rocuronium|mesh-list
110600315|NCT00732914|Sorafenib|sorafenib|mesh-list
110874604|NCT03112564|Cisatracurium|cisatracurium|mesh-list
110874605|NCT03112564|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110874606|NCT03112564|Narcotics|narcotics|mesh-ancestor
110874607|NCT03112564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110874608|NCT03112564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110874657|NCT02357212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110874658|NCT01382160|Adalimumab|adalimumab|mesh-list
110874659|NCT01382160|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110874660|NCT01382160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110874661|NCT01382160|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110874725|NCT02367118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110874726|NCT02367118|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110874727|NCT02367118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110874729|NCT00979212|Carboplatin|carboplatin|mesh-list
110874730|NCT00979212|Panitumumab|panitumumab|mesh-list
110874794|NCT02360644|Vitamins|vitamins|mesh-ancestor
110874795|NCT02360644|Micronutrients|micronutrients|mesh-ancestor
110874796|NCT02360644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110874797|NCT02360644|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110874865|NCT01377324|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110874866|NCT01377324|Estradiol|estradiol|mesh-list
110874867|NCT01377324|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110874868|NCT01377324|Estrogens|estrogens|mesh-ancestor
110874869|NCT01377324|Hormones|hormones|mesh-ancestor
110874871|NCT01377324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110874934|NCT01377246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110874935|NCT02353936|Afatinib|afatinib|mesh-list
110874936|NCT02353936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110874937|NCT02353936|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110874938|NCT02353936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110874939|NCT02353936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110874940|NCT02353858|Fluorouracil|fluorouracil|mesh-list
110874941|NCT02353858|Antimetabolites|antimetabolites|mesh-ancestor
110874942|NCT02353858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110874955|NCT02532660|Dexetimide|dexetimide|mesh-list
110874998|NCT03727607|Propofol|propofol|mesh-list
110874999|NCT03727607|Desflurane|desflurane|mesh-list
110875000|NCT03727607|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110875001|NCT03727607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110875002|NCT03727607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110875003|NCT03727607|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110875004|NCT03727607|Anesthetics, General|anesthetics, general|mesh-ancestor
110875005|NCT03727607|Anesthetics|anesthetics|mesh-ancestor
110875006|NCT03727607|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110875064|NCT03723941|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110875065|NCT03723941|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110875066|NCT03723941|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110875067|NCT03723941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110875068|NCT03723941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110875069|NCT03723941|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110875070|NCT03721679|Pembrolizumab|pembrolizumab|mesh-list
110875071|NCT03721679|Nivolumab|nivolumab|mesh-list
110875129|NCT01378650|Autonomic Agents|autonomic agents|mesh-ancestor
110875130|NCT01378650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110875131|NCT01378650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110875132|NCT01378650|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110875133|NCT01378650|Respiratory System Agents|respiratory system agents|mesh-ancestor
110875134|NCT01378650|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110875135|NCT01378650|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110875137|NCT01378650|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110875195|NCT03930186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110875196|NCT02351440|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110875197|NCT02351440|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110875198|NCT02351440|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110875199|NCT02351440|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110875200|NCT02351440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110875201|NCT02351440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110875260|NCT03723395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110875261|NCT03723395|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110875262|NCT03723395|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110875328|NCT02342002|Abortifacient Agents|abortifacient agents|mesh-ancestor
110875329|NCT02342002|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110875330|NCT02342002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110875331|NCT02342002|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110875332|NCT02342002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110875333|NCT02342002|Oxytocics|oxytocics|mesh-ancestor
110875334|NCT02342002|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
110875336|NCT02342002|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110875396|NCT02345746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110875397|NCT02345746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110875398|NCT02345746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110875399|NCT02345746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110875400|NCT02345746|Immunologic Factors|immunologic factors|mesh-ancestor
110875401|NCT02345746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110875402|NCT02345746|Antidotes|antidotes|mesh-ancestor
110875403|NCT02345746|Protective Agents|protective agents|mesh-ancestor
110875404|NCT02345746|Vitamin B Complex|vitamin b complex|mesh-ancestor
110875405|NCT02345746|Vitamins|vitamins|mesh-ancestor
110875406|NCT02345746|Micronutrients|micronutrients|mesh-ancestor
110875407|NCT02345746|Hematinics|hematinics|mesh-ancestor
110875408|NCT03794778|Paclitaxel|paclitaxel|mesh-list
110875409|NCT03794778|Carboplatin|carboplatin|mesh-list
110875410|NCT03794778|Doxorubicin|doxorubicin|mesh-list
110592931|NCT00669669|Plerixafor|plerixafor|mesh-list
110875422|NCT02341300|Iron|iron|mesh-list
110875456|NCT02345590|Hormone Antagonists|hormone antagonists|mesh-ancestor
110875457|NCT02345590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110875458|NCT02345590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110875459|NCT02345590|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110875460|NCT02345590|Diuretics|diuretics|mesh-ancestor
110875461|NCT02345590|Natriuretic Agents|natriuretic agents|mesh-ancestor
110875462|NCT02345590|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110875463|NCT03723083|Thalidomide|thalidomide|mesh-list
110875464|NCT03723083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110875465|NCT03723083|Immunologic Factors|immunologic factors|mesh-ancestor
110875524|NCT03197064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110875525|NCT03197064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110875526|NCT03197064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110875527|NCT03197064|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110875596|NCT02344888|Vitamins|vitamins|mesh-ancestor
110875597|NCT02344888|Micronutrients|micronutrients|mesh-ancestor
110875598|NCT02344888|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110875599|NCT02344888|Hormone Antagonists|hormone antagonists|mesh-ancestor
110875600|NCT02344888|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110875601|NCT02344888|Fertility Agents|fertility agents|mesh-ancestor
110875602|NCT02344888|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110875603|NCT02344888|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110875604|NCT02344888|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110875605|NCT03497429|Niraparib|niraparib|mesh-list
110875606|NCT03497429|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110875659|NCT02340988|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110875660|NCT02340988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110875661|NCT03145480|Obinutuzumab|obinutuzumab|mesh-list
110875662|NCT03145480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110875728|NCT03726281|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110875729|NCT03726281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110875730|NCT02344264|Ropivacaine|ropivacaine|mesh-list
110875731|NCT02344264|Anesthetics, Local|anesthetics, local|mesh-ancestor
110875732|NCT02344264|Anesthetics|anesthetics|mesh-ancestor
110875733|NCT02344264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110875734|NCT02344264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110875735|NCT02344264|Sensory System Agents|sensory system agents|mesh-ancestor
110875736|NCT02344264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110875737|NCT02344030|Pyrithione zinc|pyrithione zinc|mesh-list
110875738|NCT02344030|Keratolytic Agents|keratolytic agents|mesh-ancestor
110875739|NCT02344030|Dermatologic Agents|dermatologic agents|mesh-ancestor
110875740|NCT02339662|Gabapentin|gabapentin|mesh-list
110875741|NCT02339662|Amitriptyline|amitriptyline|mesh-list
110875742|NCT02339662|Analgesics|analgesics|mesh-ancestor
110875743|NCT02339662|Sensory System Agents|sensory system agents|mesh-ancestor
110875746|NCT02339662|Anticonvulsants|anticonvulsants|mesh-ancestor
110875786|NCT03148522|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110875787|NCT03148522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110875857|NCT02339428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110875858|NCT02339428|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110875859|NCT02339428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110875860|NCT02339428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110875861|NCT02337322|Ritonavir|ritonavir|mesh-list
110875862|NCT02337322|Darunavir|darunavir|mesh-list
110875863|NCT02337322|Dolutegravir|dolutegravir|mesh-list
110875864|NCT02337322|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110875925|NCT04824274|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110875926|NCT04824274|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110875927|NCT04824274|Anesthetics, General|anesthetics, general|mesh-ancestor
110875928|NCT04824274|Anesthetics|anesthetics|mesh-ancestor
110875929|NCT02509494|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
110875930|NCT02509494|Antiviral Agents|antiviral agents|mesh-ancestor
110875931|NCT02509494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110875932|NCT02348788|Chloroquine|chloroquine|mesh-list
110875993|NCT02336386|Doxorubicin|doxorubicin|mesh-list
110875994|NCT02336386|Bortezomib|bortezomib|mesh-list
110875995|NCT02336386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110876066|NCT05230654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110876067|NCT05230654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110876068|NCT02039518|Gemcitabine|gemcitabine|mesh-list
110876069|NCT02039518|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110876070|NCT02039518|Antimetabolites|antimetabolites|mesh-ancestor
110876072|NCT02039518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110876135|NCT03489551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110876137|NCT05762952|Dapagliflozin|dapagliflozin|mesh-list
110876138|NCT05762952|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110876203|NCT03105466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110876204|NCT03105466|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110876205|NCT03105466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110876206|NCT03105466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110876207|NCT03105466|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110876208|NCT03105466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110876209|NCT03105466|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110876210|NCT03105466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110876211|NCT03105466|Glucocorticoids|glucocorticoids|mesh-ancestor
110876213|NCT03105466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110876214|NCT02335372|Acetic Acid|acetic acid|mesh-list
110876215|NCT02335372|Proflavine|proflavine|mesh-list
110876269|NCT03488225|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110876270|NCT03488225|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110876271|NCT03488225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110876272|NCT03488225|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110876273|NCT03488225|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110876274|NCT03488225|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110876340|NCT03720041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110876341|NCT03720041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110876342|NCT03720041|Immunologic Factors|immunologic factors|mesh-ancestor
110876343|NCT03720041|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110876344|NCT03720041|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110876345|NCT03720041|Growth Substances|growth substances|mesh-ancestor
110876346|NCT03720041|Growth Inhibitors|growth inhibitors|mesh-ancestor
110876347|NCT03720041|Glycine Agents|glycine agents|mesh-ancestor
110876348|NCT03720041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110876349|NCT02326168|BCG Vaccine|bcg vaccine|mesh-list
110876350|NCT02326168|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110876351|NCT02326168|Immunologic Factors|immunologic factors|mesh-ancestor
110876352|NCT02326168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110876353|NCT02334670|Fluconazole|fluconazole|mesh-list
110876354|NCT02334670|Antifungal Agents|antifungal agents|mesh-ancestor
110876355|NCT02334670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110876398|NCT02334046|Anesthetics|anesthetics|mesh-ancestor
110876399|NCT02334046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110876400|NCT02334046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110876401|NCT02334046|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110876402|NCT02334046|Narcotics|narcotics|mesh-ancestor
110876403|NCT02334046|Analgesics|analgesics|mesh-ancestor
110876404|NCT02334046|Sensory System Agents|sensory system agents|mesh-ancestor
110876405|NCT02334046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110876406|NCT02330380|Adalimumab|adalimumab|mesh-list
110876407|NCT02330380|Etanercept|etanercept|mesh-list
110876408|NCT02330380|Methotrexate|methotrexate|mesh-list
110876409|NCT02330380|Ustekinumab|ustekinumab|mesh-list
110876410|NCT02330380|Acitretin|acitretin|mesh-list
110876464|NCT03697408|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110876465|NCT03697408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110876466|NCT03697408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110876467|NCT03697408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110876468|NCT03697408|Immunologic Factors|immunologic factors|mesh-ancestor
110876470|NCT03697408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110876532|NCT02974010|Sensory System Agents|sensory system agents|mesh-ancestor
110876533|NCT02974010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110876534|NCT02974010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110876535|NCT02974010|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110876536|NCT02974010|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110876537|NCT02974010|Anesthetics, General|anesthetics, general|mesh-ancestor
110876538|NCT02974010|Anesthetics|anesthetics|mesh-ancestor
110876539|NCT02974010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110876540|NCT02974010|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110876549|NCT02974010|Antimetabolites|antimetabolites|mesh-ancestor
110876596|NCT02329756|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110876597|NCT02329756|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110876598|NCT02329756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110876599|NCT02329756|Hemostatics|hemostatics|mesh-ancestor
110876600|NCT02329756|Coagulants|coagulants|mesh-ancestor
110876601|NCT02329288|Triamcinolone|triamcinolone|mesh-list
110876602|NCT02329288|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110876606|NCT02329288|Glucocorticoids|glucocorticoids|mesh-ancestor
110876661|NCT01372761|CKD732|ckd732|mesh-list
110876662|NCT01372761|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110876663|NCT01372761|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110876664|NCT01372761|Growth Substances|growth substances|mesh-ancestor
110876665|NCT01372761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110876666|NCT01372761|Growth Inhibitors|growth inhibitors|mesh-ancestor
110876667|NCT01372761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110876668|NCT03873675|Hormones|hormones|mesh-list
110876669|NCT03873675|Parathyroid Hormone|parathyroid hormone|mesh-list
110876670|NCT03873675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110876671|NCT03873675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110876672|NCT03873675|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110876673|NCT05173857|Paclitaxel|paclitaxel|mesh-list
110876674|NCT05173857|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110876722|NCT05077462|Antimitotic Agents|antimitotic agents|mesh-ancestor
110876723|NCT05077462|Mitosis Modulators|mitosis modulators|mesh-ancestor
110876724|NCT05077462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110876725|NCT05077462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110876726|NCT03714113|Antibodies|antibodies|mesh-list
110876727|NCT03714113|Immunologic Factors|immunologic factors|mesh-ancestor
110876728|NCT03714113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110876729|NCT03472547|Diacerein|diacerein|mesh-list
110876730|NCT03472547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110876731|NCT00799396|Aspirin|aspirin|mesh-list
110876732|NCT00799396|Clopidogrel|clopidogrel|mesh-list
110876733|NCT00799396|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110876734|NCT00799396|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110876735|NCT00799396|Analgesics|analgesics|mesh-ancestor
110876736|NCT00799396|Sensory System Agents|sensory system agents|mesh-ancestor
110876737|NCT00799396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110876783|NCT03719261|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110876784|NCT03719261|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110876785|NCT03719261|Antimetabolites|antimetabolites|mesh-ancestor
110876786|NCT03719261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110876787|NCT03719261|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110876788|NCT03719261|Chelating Agents|chelating agents|mesh-ancestor
110876789|NCT03719261|Sequestering Agents|sequestering agents|mesh-ancestor
110876790|NCT03719261|Hemostatics|hemostatics|mesh-ancestor
110876791|NCT03719261|Coagulants|coagulants|mesh-ancestor
110876792|NCT03719261|Disinfectants|disinfectants|mesh-ancestor
110876793|NCT03719261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110876794|NCT00069238|Prednisone|prednisone|mesh-list
110876849|NCT02030860|Gemcitabine|gemcitabine|mesh-list
110876850|NCT02030860|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110876851|NCT02030860|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110876852|NCT02030860|Antimetabolites|antimetabolites|mesh-ancestor
110876853|NCT02030860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110876854|NCT02030860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110876855|NCT01569984|Bevacizumab|bevacizumab|mesh-list
110876856|NCT01569984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110876857|NCT01569984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110876915|NCT02327728|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110876916|NCT02327728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110876917|NCT02918318|Esketamine|esketamine|mesh-list
110876952|NCT01065350|Ketamine|ketamine|mesh-list
110876985|NCT05078788|Hormones|hormones|mesh-ancestor
110876986|NCT05078788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110876987|NCT05078788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110876988|NCT02032654|Floxacillin|floxacillin|mesh-list
110876989|NCT02032654|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110876990|NCT02032654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110876991|NCT04734886|Vitamin D|vitamin d|mesh-list
110876992|NCT04734886|Ergocalciferols|ergocalciferols|mesh-list
110876993|NCT04734886|Cholecalciferol|cholecalciferol|mesh-list
110876994|NCT04734886|Vitamins|vitamins|mesh-list
110876995|NCT04734886|Micronutrients|micronutrients|mesh-ancestor
110876996|NCT04734886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110876997|NCT04734886|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110876998|NCT04734886|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110876999|NCT03114969|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
110877000|NCT03114969|Tiotropium Bromide|tiotropium bromide|mesh-list
110877005|NCT03114969|Autonomic Agents|autonomic agents|mesh-ancestor
110877042|NCT05124678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110877043|NCT05124678|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110877044|NCT03122145|Capsaicin|capsaicin|mesh-list
110877045|NCT03122145|Antipruritics|antipruritics|mesh-ancestor
110877046|NCT03122145|Dermatologic Agents|dermatologic agents|mesh-ancestor
110877047|NCT03122145|Sensory System Agents|sensory system agents|mesh-ancestor
110877048|NCT03122145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110877049|NCT03122145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110877050|NCT05081674|Pembrolizumab|pembrolizumab|mesh-list
110877109|NCT02327416|Antiviral Agents|antiviral agents|mesh-ancestor
110877110|NCT02327416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110877111|NCT02327416|Immunologic Factors|immunologic factors|mesh-ancestor
110877112|NCT02327416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110877113|NCT02327416|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110877114|NCT02327416|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110877115|NCT02327416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110877116|NCT02327416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110877117|NCT02327416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110877118|NCT02926950|Metformin|metformin|mesh-list
110877120|NCT02926950|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110877124|NCT01064414|Canagliflozin|canagliflozin|mesh-list
110877169|NCT05201352|Antimetabolites|antimetabolites|mesh-ancestor
110877170|NCT05201352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110877171|NCT05201352|Antiviral Agents|antiviral agents|mesh-ancestor
110877172|NCT05201352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110877173|NCT04128956|Aspirin|aspirin|mesh-list
110877174|NCT04128956|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110877175|NCT04128956|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110877176|NCT04128956|Analgesics|analgesics|mesh-ancestor
110877177|NCT04128956|Sensory System Agents|sensory system agents|mesh-ancestor
110877178|NCT04128956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110877179|NCT04128956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110877180|NCT04128956|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110877181|NCT04128956|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110877231|NCT03651674|GABA Agents|gaba agents|mesh-ancestor
110877232|NCT01061840|Molgramostim|molgramostim|mesh-list
110877233|NCT01061840|Vaccines|vaccines|mesh-list
110877234|NCT01061840|Sargramostim|sargramostim|mesh-list
110877235|NCT01061840|Immunologic Factors|immunologic factors|mesh-ancestor
110877236|NCT01061840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110877237|NCT01061840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110877238|NCT02926638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110877239|NCT02926638|Rilotumumab|rilotumumab|mesh-list
110877299|NCT01060124|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110877300|NCT01060124|Anesthetics, General|anesthetics, general|mesh-ancestor
110877301|NCT01060124|Anesthetics|anesthetics|mesh-ancestor
110877302|NCT03461003|Losartan|losartan|mesh-list
110877303|NCT03461003|Amlodipine|amlodipine|mesh-list
110877304|NCT03461003|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110877305|NCT03461003|Lisinopril|lisinopril|mesh-list
110877306|NCT03461003|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110877307|NCT03461003|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110877308|NCT03461003|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110877309|NCT03461003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110877310|NCT03461003|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110877311|NCT03461003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110877312|NCT03461003|Vasodilator Agents|vasodilator agents|mesh-ancestor
110877313|NCT03461003|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110877316|NCT03461003|Diuretics|diuretics|mesh-ancestor
110877358|NCT03650270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110877359|NCT03650270|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110877360|NCT03650270|Anesthetics, General|anesthetics, general|mesh-ancestor
110877361|NCT03650270|Anesthetics|anesthetics|mesh-ancestor
110877362|NCT03650270|GABA Modulators|gaba modulators|mesh-ancestor
110877363|NCT03650270|GABA Agents|gaba agents|mesh-ancestor
110877364|NCT03650270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110877365|NCT03650270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110877366|NCT03650270|Anticonvulsants|anticonvulsants|mesh-ancestor
110877427|NCT03649334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110877428|NCT03649334|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110877429|NCT03649334|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110877430|NCT03649334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110877498|NCT03712475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110877499|NCT03712475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110877500|NCT03712475|Anticonvulsants|anticonvulsants|mesh-ancestor
110877501|NCT03712475|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110877502|NCT03712475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110877503|NCT03712475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110877504|NCT03712475|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110877505|NCT03712475|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110877506|NCT03712475|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110877507|NCT03712475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110595031|NCT02573714|Ketamine|ketamine|mesh-list
110877509|NCT02435433|Ramucirumab|ramucirumab|mesh-list
110600443|NCT04066452|Antibodies|antibodies|mesh-list
110877510|NCT02435433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110877511|NCT01372371|Vancomycin|vancomycin|mesh-list
110877512|NCT01372371|Gentamicins|gentamicins|mesh-list
110877513|NCT01372371|Cefuroxime|cefuroxime|mesh-list
110877514|NCT01372371|Cefuroxime axetil|cefuroxime axetil|mesh-list
110877515|NCT01372371|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110877516|NCT01372371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110877517|NCT01372371|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110877518|NCT01372371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110877551|NCT02354703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110877552|NCT05008887|Fluorouracil|fluorouracil|mesh-list
110877553|NCT05008887|Methotrexate|methotrexate|mesh-list
110877554|NCT05008887|Antimetabolites|antimetabolites|mesh-ancestor
110877555|NCT05008887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110877556|NCT05008887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110877557|NCT05008887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110877558|NCT05008887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110877559|NCT05008887|Immunologic Factors|immunologic factors|mesh-ancestor
110877560|NCT05008887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110877561|NCT05008887|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110877562|NCT05008887|Abortifacient Agents|abortifacient agents|mesh-ancestor
110877563|NCT05008887|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110877612|NCT03633591|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110877613|NCT03633591|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110877614|NCT03633591|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
110877615|NCT03633591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110877616|NCT03633591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110877617|NCT01376271|Paroxetine|paroxetine|mesh-list
110877618|NCT01376271|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110877619|NCT01376271|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110877620|NCT01376271|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110877621|NCT01376271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110877622|NCT01376271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110877671|NCT01375335|Sympathomimetics|sympathomimetics|mesh-ancestor
110877672|NCT01375335|Autonomic Agents|autonomic agents|mesh-ancestor
110877673|NCT01375335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110877744|NCT01373697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110877745|NCT01375881|Ritonavir|ritonavir|mesh-list
110877746|NCT01375881|Darunavir|darunavir|mesh-list
110877747|NCT01375881|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110877748|NCT01375881|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110877749|NCT01375881|Protease Inhibitors|protease inhibitors|mesh-ancestor
110877811|NCT05213988|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110877812|NCT05213988|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110877813|NCT05213988|Antimetabolites|antimetabolites|mesh-ancestor
110877815|NCT05213988|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110877882|NCT03410901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110877883|NCT03357939|Adalimumab|adalimumab|mesh-list
110877884|NCT03357939|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110877885|NCT03357939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110877886|NCT03357939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110877953|NCT05733000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110877954|NCT05733000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110878028|NCT05253495|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110878029|NCT05253495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110878030|NCT05253495|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110878031|NCT05253495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110878032|NCT05253495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110878033|NCT05253495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110878034|NCT05253495|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110878035|NCT05253495|Antimetabolites|antimetabolites|mesh-ancestor
110878036|NCT05253495|Antiviral Agents|antiviral agents|mesh-ancestor
110878037|NCT05253495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110878038|NCT05253495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110878092|NCT03822975|Protease Inhibitors|protease inhibitors|mesh-ancestor
110878093|NCT03822975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110878094|NCT05732532|Dexamethasone|dexamethasone|mesh-list
110878095|NCT05732532|Lidocaine|lidocaine|mesh-list
110878096|NCT05732532|Bupivacaine|bupivacaine|mesh-list
110878098|NCT05732532|Antiemetics|antiemetics|mesh-ancestor
110878164|NCT05139849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110878165|NCT05139849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110878166|NCT05139849|Glucocorticoids|glucocorticoids|mesh-ancestor
110878167|NCT05139849|Hormones|hormones|mesh-ancestor
110878168|NCT05139849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110878169|NCT05139849|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110878231|NCT05588453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110878233|NCT05186454|Midazolam|midazolam|mesh-list
110878234|NCT05186454|Morphine|morphine|mesh-list
110878235|NCT05186454|Bupivacaine|bupivacaine|mesh-list
110878236|NCT05186454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110878237|NCT05186454|Antiemetics|antiemetics|mesh-ancestor
110878238|NCT05186454|Autonomic Agents|autonomic agents|mesh-ancestor
110878239|NCT05186454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110878240|NCT05186454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110878241|NCT05186454|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110878242|NCT05186454|Glucocorticoids|glucocorticoids|mesh-ancestor
110878243|NCT05186454|Hormones|hormones|mesh-ancestor
110878244|NCT05186454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110878245|NCT05186454|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110878246|NCT05186454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110878247|NCT05186454|Anesthetics, Local|anesthetics, local|mesh-ancestor
110878248|NCT05186454|Anesthetics|anesthetics|mesh-ancestor
110878249|NCT05186454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110878250|NCT05186454|Sensory System Agents|sensory system agents|mesh-ancestor
110878288|NCT03619824|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110878289|NCT03619824|Antimetabolites|antimetabolites|mesh-ancestor
110878290|NCT03619824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110878291|NCT01759836|Atorvastatin|atorvastatin|mesh-list
110878292|NCT01759836|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110878293|NCT01759836|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110878294|NCT01759836|Antimetabolites|antimetabolites|mesh-ancestor
110878295|NCT01759836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110878296|NCT01759836|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110878297|NCT01759836|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110878298|NCT01759836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110878299|NCT03447821|Rifamycins|rifamycins|mesh-list
110878300|NCT03447821|Rifamycin SV|rifamycin sv|mesh-list
110878301|NCT03447821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110878302|NCT03447821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110878303|NCT03447821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110878304|NCT05630339|Vitamin D|vitamin d|mesh-list
110878305|NCT05630339|Cholecalciferol|cholecalciferol|mesh-list
110878306|NCT05630339|Vitamins|vitamins|mesh-ancestor
110878307|NCT05630339|Micronutrients|micronutrients|mesh-ancestor
110878308|NCT05630339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110878309|NCT05630339|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110878310|NCT05630339|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110878311|NCT03447353|Acetaminophen|acetaminophen|mesh-list
110878312|NCT03447353|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
110878313|NCT03447353|Hydrocodone|hydrocodone|mesh-list
110878314|NCT03447353|Alprazolam|alprazolam|mesh-list
110878315|NCT03447353|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110878316|NCT03447353|Analgesics|analgesics|mesh-ancestor
110878317|NCT03447353|Sensory System Agents|sensory system agents|mesh-ancestor
110878318|NCT03447353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110878319|NCT03447353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110878320|NCT03447353|Antipyretics|antipyretics|mesh-ancestor
110878321|NCT03447353|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110878322|NCT03447353|Narcotics|narcotics|mesh-ancestor
110878330|NCT03447353|GABA Modulators|gaba modulators|mesh-ancestor
110878331|NCT03447353|GABA Agents|gaba agents|mesh-ancestor
110595846|NCT00803829|Sulfalene|sulfalene|mesh-list
110878332|NCT03447353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110878333|NCT03447353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110878334|NCT03447353|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110878335|NCT03447353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110878393|NCT02900378|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110878394|NCT02900378|Protease Inhibitors|protease inhibitors|mesh-ancestor
110878395|NCT02900378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110878396|NCT03058692|Vaccines|vaccines|mesh-list
110878466|NCT03646916|Protease Inhibitors|protease inhibitors|mesh-ancestor
110878467|NCT03646916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110878468|NCT03646916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110878469|NCT04305756|Enoxaparin|enoxaparin|mesh-list
110878474|NCT03645980|Sorafenib|sorafenib|mesh-list
110878534|NCT04233840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110878535|NCT04233840|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110878536|NCT04233840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110878537|NCT02896400|Nicotine|nicotine|mesh-list
110878538|NCT02896400|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110878539|NCT02896400|Autonomic Agents|autonomic agents|mesh-ancestor
110878540|NCT02896400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110878541|NCT02896400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110878542|NCT02896400|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110878600|NCT03422159|Thiamine|thiamine|mesh-list
110878601|NCT03422159|Hydrocortisone|hydrocortisone|mesh-list
110878602|NCT03422159|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
110878603|NCT03422159|Vitamins|vitamins|mesh-ancestor
110878604|NCT03422159|Micronutrients|micronutrients|mesh-ancestor
110878605|NCT03422159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110878606|NCT03422159|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110878607|NCT03422159|Antioxidants|antioxidants|mesh-ancestor
110878608|NCT03422159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110878609|NCT03422159|Protective Agents|protective agents|mesh-ancestor
110878610|NCT03422159|Vitamin B Complex|vitamin b complex|mesh-ancestor
110878611|NCT04538040|Tenofovir|tenofovir|mesh-list
110878612|NCT04538040|Emtricitabine|emtricitabine|mesh-list
110878613|NCT04538040|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
110878622|NCT02297412|Minocycline|minocycline|mesh-list
110878662|NCT01180374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110878663|NCT01180374|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110878664|NCT01180374|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110878665|NCT01180374|Analgesics|analgesics|mesh-ancestor
110600483|NCT00734318|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110878666|NCT01180374|Sensory System Agents|sensory system agents|mesh-ancestor
110878732|NCT03667716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110878733|NCT03667716|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110878734|NCT03667716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110878735|NCT03740334|Dexamethasone|dexamethasone|mesh-list
110878736|NCT03740334|Everolimus|everolimus|mesh-list
110878737|NCT03740334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110878738|NCT03740334|Antiemetics|antiemetics|mesh-ancestor
110878739|NCT03740334|Autonomic Agents|autonomic agents|mesh-ancestor
110878740|NCT03740334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110878741|NCT03740334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110878742|NCT03740334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110878743|NCT03740334|Glucocorticoids|glucocorticoids|mesh-ancestor
110878744|NCT03740334|Hormones|hormones|mesh-ancestor
110878745|NCT03740334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110878746|NCT03740334|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110878747|NCT03740334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110878748|NCT03740334|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110878749|NCT03740334|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110878790|NCT03389555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110878791|NCT03389555|Protective Agents|protective agents|mesh-ancestor
110878792|NCT03389555|Vitamin B Complex|vitamin b complex|mesh-ancestor
110878793|NCT03395639|Heparin|heparin|mesh-list
110878794|NCT03395639|Enoxaparin|enoxaparin|mesh-list
110878795|NCT03395639|Warfarin|warfarin|mesh-list
110878796|NCT03395639|Edoxaban|edoxaban|mesh-list
110878797|NCT03395639|Anticoagulants|anticoagulants|mesh-ancestor
110878798|NCT03395639|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110878799|NCT03395639|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110878800|NCT03395639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110878801|NCT03395639|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110878802|NCT03395639|Antithrombins|antithrombins|mesh-ancestor
110878803|NCT03395639|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110878804|NCT03395639|Protease Inhibitors|protease inhibitors|mesh-ancestor
110878805|NCT03395639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110878806|NCT03353922|Cyclobenzaprine|cyclobenzaprine|mesh-list
110878807|NCT03353922|Tolperisone|tolperisone|mesh-list
110878808|NCT03353922|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110878809|NCT03353922|Antidepressive Agents|antidepressive agents|mesh-ancestor
110878810|NCT03353922|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110878811|NCT03353922|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110878844|NCT02942004|GABA Agents|gaba agents|mesh-ancestor
110878845|NCT02942004|Anesthetics|anesthetics|mesh-ancestor
110878846|NCT02942004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110878847|NCT03414983|Leucovorin|leucovorin|mesh-list
110878848|NCT03414983|Bevacizumab|bevacizumab|mesh-list
110878849|NCT03414983|Nivolumab|nivolumab|mesh-list
110878850|NCT03414983|Fluorouracil|fluorouracil|mesh-list
110878851|NCT03414983|Oxaliplatin|oxaliplatin|mesh-list
110878852|NCT03414983|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110878853|NCT03414983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110878854|NCT03414983|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110878855|NCT03414983|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110878856|NCT03414983|Growth Substances|growth substances|mesh-ancestor
110596375|NCT00709644|Hematinics|hematinics|mesh-ancestor
110878857|NCT03414983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110878908|NCT04661137|Hormones|hormones|mesh-ancestor
110878909|NCT04661137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110878910|NCT04661137|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110878911|NCT04661137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110878912|NCT04661137|Immunologic Factors|immunologic factors|mesh-ancestor
110878974|NCT01942122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110878975|NCT04327999|Lubricant Eye Drops|lubricant eye drops|mesh-list
110878976|NCT04327999|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110878977|NCT04327999|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110878978|NCT02236806|Ramipril|ramipril|mesh-list
110878979|NCT02236806|Bisoprolol|bisoprolol|mesh-list
110878980|NCT02236806|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110878981|NCT02236806|Protease Inhibitors|protease inhibitors|mesh-ancestor
110878982|NCT02236806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110878983|NCT02236806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110878984|NCT02236806|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110878985|NCT02236806|Sympatholytics|sympatholytics|mesh-ancestor
110878986|NCT02236806|Autonomic Agents|autonomic agents|mesh-ancestor
110878987|NCT02236806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110878988|NCT02236806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110878989|NCT02236806|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110878990|NCT02236806|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110878991|NCT02236806|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110878992|NCT02236806|Adrenergic Agents|adrenergic agents|mesh-ancestor
110878993|NCT02236806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110879029|NCT03054870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110879030|NCT03054870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110879031|NCT03414047|Prexasertib|prexasertib|mesh-list
110879032|NCT03414047|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110879033|NCT03414047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110879034|NCT03414047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110879035|NCT05448677|Bevacizumab|bevacizumab|mesh-list
110879036|NCT05448677|Atezolizumab|atezolizumab|mesh-list
110879037|NCT05448677|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110879038|NCT05448677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110879095|NCT04811118|Antimitotic Agents|antimitotic agents|mesh-ancestor
110879096|NCT04811118|Mitosis Modulators|mitosis modulators|mesh-ancestor
110879097|NCT04811118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110879098|NCT05221164|Aspirin|aspirin|mesh-list
110879099|NCT05221164|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110879100|NCT05221164|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110879101|NCT05221164|Analgesics|analgesics|mesh-ancestor
110879102|NCT05221164|Sensory System Agents|sensory system agents|mesh-ancestor
110879103|NCT05221164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110879104|NCT05221164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110879105|NCT05221164|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110879106|NCT05221164|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110879107|NCT05221164|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110879108|NCT05221164|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110879109|NCT05221164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110879110|NCT05221164|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110879111|NCT05221164|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110879112|NCT05221164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110879150|NCT04765644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110879151|NCT04765644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110879152|NCT03052764|Botulinum Toxins|botulinum toxins|mesh-list
110879153|NCT03052764|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110879154|NCT03052764|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110596671|NCT05720988|Azacitidine|azacitidine|mesh-list
110879155|NCT03052764|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110879156|NCT03052764|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110879157|NCT03052764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110879158|NCT03052764|Cholinergic Agents|cholinergic agents|mesh-ancestor
110879159|NCT03052764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110879160|NCT03052764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110879161|NCT03052764|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110879162|NCT03052764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110879163|NCT05197374|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110879164|NCT05197374|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110879166|NCT05197374|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110879167|NCT05197374|Estrogens|estrogens|mesh-ancestor
110879168|NCT05197374|Hormones|hormones|mesh-ancestor
110879206|NCT05191290|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110879207|NCT05191290|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110879208|NCT05627544|Anesthetics|anesthetics|mesh-list
110879281|NCT05706090|Sensory System Agents|sensory system agents|mesh-ancestor
110879282|NCT05706090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110879283|NCT05706090|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110879284|NCT05706090|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110879285|NCT05706090|Anesthetics, General|anesthetics, general|mesh-ancestor
110879286|NCT03380429|Albuterol|albuterol|mesh-list
110879287|NCT03380429|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110879301|NCT05096442|Paclitaxel|paclitaxel|mesh-list
110879350|NCT04690231|Isophosphamide mustard|isophosphamide mustard|mesh-list
110879351|NCT04690231|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110879352|NCT04690231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110879353|NCT04690231|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110879354|NCT04690231|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110879355|NCT04690231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110879356|NCT04690231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110879416|NCT02891915|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110879417|NCT02891915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110879418|NCT02891915|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110879419|NCT02891915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110879420|NCT02891915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110879421|NCT03046446|FX006|fx006|mesh-list
110879422|NCT03046446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110879423|NCT03046446|Glucocorticoids|glucocorticoids|mesh-ancestor
110879484|NCT04385173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110879485|NCT04385173|Alkylating Agents|alkylating agents|mesh-ancestor
110879486|NCT04385173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110879487|NCT04385173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110879488|NCT03707249|Ferric Compounds|ferric compounds|mesh-list
110879489|NCT03707249|Hematinics|hematinics|mesh-ancestor
110879550|NCT03049488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110879551|NCT03049488|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110879552|NCT04484922|Dexmedetomidine|dexmedetomidine|mesh-list
110879553|NCT04484922|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110879554|NCT04484922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110879555|NCT04484922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110879617|NCT03196986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110879618|NCT03196986|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110879619|NCT03196986|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110879620|NCT03196986|Growth Substances|growth substances|mesh-ancestor
110879621|NCT03196986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110879622|NCT03196986|Growth Inhibitors|growth inhibitors|mesh-ancestor
110879623|NCT04051632|Insulin|insulin|mesh-list
110879624|NCT04051632|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110879625|NCT04051632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110879626|NCT04423237|Deferasirox|deferasirox|mesh-list
110879627|NCT04423237|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110879628|NCT04423237|Chelating Agents|chelating agents|mesh-ancestor
110879629|NCT04423237|Sequestering Agents|sequestering agents|mesh-ancestor
110879630|NCT04423237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110879631|NCT03043560|Ezogabine|ezogabine|mesh-list
110879632|NCT03043560|Anticonvulsants|anticonvulsants|mesh-ancestor
110879633|NCT03043560|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110879634|NCT03043560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110879673|NCT03646370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110879674|NCT03646370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110879675|NCT03646370|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110879676|NCT03646370|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110879677|NCT03646292|Pioglitazone|pioglitazone|mesh-list
110879678|NCT03646292|Empagliflozin|empagliflozin|mesh-list
110879679|NCT03646292|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110879680|NCT03646292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110879681|NCT03646292|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110879682|NCT03646292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110879683|NCT03345407|Albuterol|albuterol|mesh-list
110879706|NCT03626298|Niacin|niacin|mesh-list
110879738|NCT02298348|Alkylating Agents|alkylating agents|mesh-ancestor
110879739|NCT02298348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110879740|NCT02298348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110879741|NCT02298348|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110879742|NCT02298348|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110879743|NCT02298348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110879744|NCT02298348|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110879745|NCT02298348|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110879746|NCT03240133|Berotralstat|berotralstat|mesh-list
110879747|NCT03240133|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110879748|NCT03240133|Protease Inhibitors|protease inhibitors|mesh-ancestor
110879749|NCT03240133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110879751|NCT03814356|Methylphenidate|methylphenidate|mesh-list
110879799|NCT03372083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110879800|NCT03044886|Vitamin D|vitamin d|mesh-list
110879801|NCT03044886|Vitamins|vitamins|mesh-ancestor
110879802|NCT03044886|Micronutrients|micronutrients|mesh-ancestor
110879803|NCT03044886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110879804|NCT03044886|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110879868|NCT02951429|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110879869|NCT02951429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110879870|NCT02951429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110879871|NCT02951429|Urological Agents|urological agents|mesh-ancestor
110879872|NCT02951429|Analgesics|analgesics|mesh-ancestor
110879873|NCT02951429|Sensory System Agents|sensory system agents|mesh-ancestor
110879874|NCT02951429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110879875|NCT02951429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110879876|NCT02951429|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110879877|NCT02951429|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110879878|NCT02951429|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110879879|NCT02951429|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110879880|NCT02951429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110879881|NCT04622709|Furosemide|furosemide|mesh-list
110879882|NCT04622709|Diuretics|diuretics|mesh-list
110879883|NCT04622709|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
110879884|NCT04622709|Natriuretic Agents|natriuretic agents|mesh-ancestor
110879927|NCT04707183|Anesthetics, Local|anesthetics, local|mesh-ancestor
110879928|NCT04707183|Anesthetics|anesthetics|mesh-ancestor
110879929|NCT04707183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110879930|NCT04707183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110879931|NCT04707183|Sensory System Agents|sensory system agents|mesh-ancestor
110879932|NCT04707183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110879933|NCT04707183|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110879934|NCT04707183|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110879935|NCT04707183|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110879936|NCT04707183|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110879937|NCT04707183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110879990|NCT03708497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110879991|NCT03708497|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110879992|NCT03708497|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110879993|NCT03708497|Oxytocics|oxytocics|mesh-ancestor
110879994|NCT04608903|Sulforaphane|sulforaphane|mesh-list
110879995|NCT04608903|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110879996|NCT04608903|Protective Agents|protective agents|mesh-ancestor
110879999|NCT05681975|Antibodies|antibodies|mesh-list
110880061|NCT00769327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110880062|NCT00769327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110880063|NCT01068704|Letrozole|letrozole|mesh-list
110880064|NCT01068704|Lapatinib|lapatinib|mesh-list
110880065|NCT01068704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110880066|NCT01068704|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110880067|NCT01068704|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110880068|NCT01068704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110880069|NCT01068704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110880070|NCT01068704|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110880071|NCT01068704|Hormone Antagonists|hormone antagonists|mesh-ancestor
110880090|NCT03370289|Vaccines|vaccines|mesh-list
110880125|NCT05137496|Glucocorticoids|glucocorticoids|mesh-ancestor
110880126|NCT05137496|Hormones|hormones|mesh-ancestor
110880127|NCT05137496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110880128|NCT05137496|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110880129|NCT05137496|Protective Agents|protective agents|mesh-ancestor
110880130|NCT05137496|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110880192|NCT03367793|Methamphetamine|methamphetamine|mesh-list
110880193|NCT03367793|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110880194|NCT03367793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110880195|NCT03367793|Sympathomimetics|sympathomimetics|mesh-ancestor
110880196|NCT03367793|Autonomic Agents|autonomic agents|mesh-ancestor
110880197|NCT03367793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110880198|NCT03367793|Dopamine Agents|dopamine agents|mesh-ancestor
110880199|NCT03367793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110880200|NCT03367793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110880201|NCT03367793|Adrenergic Agents|adrenergic agents|mesh-ancestor
110600570|NCT00868426|Charcoal|charcoal|mesh-list
110880202|NCT03367793|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110880203|NCT03367793|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110880204|NCT03367793|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110880205|NCT03367793|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110880252|NCT03532555|Trace Elements|trace elements|mesh-ancestor
110880253|NCT03532555|Micronutrients|micronutrients|mesh-ancestor
110880321|NCT03707795|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
110880322|NCT03707795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110880323|NCT03707795|Glucocorticoids|glucocorticoids|mesh-ancestor
110880324|NCT03707795|Hormones|hormones|mesh-ancestor
110880325|NCT03707795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110880326|NCT03707795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110880327|NCT03707795|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110880328|NCT03707795|Respiratory System Agents|respiratory system agents|mesh-ancestor
110880388|NCT05681429|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110880389|NCT05681429|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110880390|NCT05681429|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110880391|NCT05681429|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110880392|NCT05681429|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110880393|NCT05681429|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110880394|NCT05681429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110880395|NCT05681429|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110880396|NCT05681429|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110880397|NCT05681429|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110880398|NCT05024760|Chlorhexidine|chlorhexidine|mesh-list
110880399|NCT05024760|Hydrogen Peroxide|hydrogen peroxide|mesh-list
110880400|NCT05024760|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110880401|NCT05024760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110880402|NCT05024760|Disinfectants|disinfectants|mesh-ancestor
110880403|NCT02949011|Oseltamivir|oseltamivir|mesh-list
110880404|NCT02949011|Baloxavir|baloxavir|mesh-list
110880405|NCT02949011|Antiviral Agents|antiviral agents|mesh-ancestor
110880446|NCT05175131|Emollients|emollients|mesh-ancestor
110880447|NCT05175131|Dermatologic Agents|dermatologic agents|mesh-ancestor
110880448|NCT05175131|Anticonvulsants|anticonvulsants|mesh-ancestor
110880449|NCT05175131|Parasympatholytics|parasympatholytics|mesh-ancestor
110880450|NCT05175131|Autonomic Agents|autonomic agents|mesh-ancestor
110880451|NCT05175131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110880452|NCT05175131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110880453|NCT04507373|Simvastatin|simvastatin|mesh-list
110880454|NCT04507373|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110880455|NCT04507373|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110880456|NCT04507373|Antimetabolites|antimetabolites|mesh-ancestor
110880457|NCT04507373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110880458|NCT04507373|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110880459|NCT04507373|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110880460|NCT04507373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110880461|NCT01312337|Gefitinib|gefitinib|mesh-list
110880462|NCT01312337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110880463|NCT01312337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110880503|NCT05283954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110880504|NCT05283954|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110880505|NCT05283954|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110880506|NCT05283954|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110880507|NCT05283954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110880508|NCT05283954|Serotonin Agents|serotonin agents|mesh-ancestor
110880509|NCT05283954|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110880510|NCT05283954|Antidepressive Agents|antidepressive agents|mesh-ancestor
110880511|NCT05283954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110880512|NCT05283954|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110880513|NCT05283954|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110880514|NCT05283954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110880515|NCT05283954|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110880516|NCT05283954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110880517|NCT05283954|Anthelmintics|anthelmintics|mesh-ancestor
110880563|NCT05438303|Dabigatran|dabigatran|mesh-list
110880564|NCT05438303|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110880565|NCT05438303|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110880566|NCT05438303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110880568|NCT05438303|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110880631|NCT04906889|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110880632|NCT04906889|Adrenergic Agents|adrenergic agents|mesh-ancestor
110880633|NCT04906889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110880634|NCT04906889|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110880635|NCT04906889|Narcotics|narcotics|mesh-ancestor
110880636|NCT02948777|Evolocumab|evolocumab|mesh-list
110880637|NCT02948777|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
110880638|NCT02948777|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110880639|NCT02948777|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110880640|NCT02948777|Antimetabolites|antimetabolites|mesh-ancestor
110880643|NCT02948777|Protease Inhibitors|protease inhibitors|mesh-ancestor
110880697|NCT05249699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110880698|NCT05249699|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110880699|NCT04751669|Trace Elements|trace elements|mesh-list
110880700|NCT04751669|Micronutrients|micronutrients|mesh-list
110880701|NCT04751669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110880702|NCT04731233|Triamcinolone|triamcinolone|mesh-list
110880703|NCT04731233|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110880704|NCT04731233|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110880705|NCT04731233|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110880706|NCT04731233|Mitogens|mitogens|mesh-list
110880707|NCT04731233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110880708|NCT04731233|Glucocorticoids|glucocorticoids|mesh-ancestor
110880709|NCT04731233|Hormones|hormones|mesh-ancestor
110880710|NCT04731233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110880711|NCT04731233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110880712|NCT04731233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110880713|NCT04731233|Immunologic Factors|immunologic factors|mesh-ancestor
110880714|NCT04731233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110880715|NCT04731233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110880716|NCT04731233|Mitosis Modulators|mitosis modulators|mesh-ancestor
110880717|NCT04695977|Nivolumab|nivolumab|mesh-list
110880718|NCT04695977|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110880748|NCT03629873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110880749|NCT03629873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110880750|NCT03629873|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110880751|NCT03629873|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110880752|NCT03629873|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110880753|NCT03629873|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110880754|NCT03629873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110880755|NCT03629873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110880756|NCT03629873|Antimetabolites|antimetabolites|mesh-ancestor
110880757|NCT03629873|Antiviral Agents|antiviral agents|mesh-ancestor
110880758|NCT03629873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110880759|NCT04294043|Gallium nitrate|gallium nitrate|mesh-list
110880760|NCT04294043|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110880761|NCT04294043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110880762|NCT04294043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110880763|NCT02899793|Pembrolizumab|pembrolizumab|mesh-list
110880764|NCT02899793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110880765|NCT02899793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110880766|NCT02899793|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110880767|NCT02899793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110880768|NCT04981145|Hydroxychloroquine|hydroxychloroquine|mesh-list
110880769|NCT04981145|Antimalarials|antimalarials|mesh-ancestor
110880770|NCT04981145|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110880771|NCT04981145|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110880772|NCT04981145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110880797|NCT03638063|Analgesics|analgesics|mesh-ancestor
110880798|NCT03638063|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110880799|NCT03638063|Vasodilator Agents|vasodilator agents|mesh-ancestor
110880800|NCT03638063|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
110880801|NCT03638063|Purinergic Agonists|purinergic agonists|mesh-ancestor
110880802|NCT03638063|Purinergic Agents|purinergic agents|mesh-ancestor
110880803|NCT03638063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110880864|NCT04741139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110880865|NCT04741139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110880866|NCT04741139|Antipyretics|antipyretics|mesh-ancestor
110880867|NCT04741139|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110880868|NCT04741139|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110880869|NCT04741139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110598410|NCT04018768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110880870|NCT04741139|Anesthetics, Local|anesthetics, local|mesh-ancestor
110880887|NCT04853147|Aprepitant|aprepitant|mesh-list
110880931|NCT04689347|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110880932|NCT04689347|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110880934|NCT04689347|Antidotes|antidotes|mesh-ancestor
110880935|NCT04689347|Protective Agents|protective agents|mesh-ancestor
110880936|NCT04689347|Vitamin B Complex|vitamin b complex|mesh-ancestor
110880937|NCT04689347|Vitamins|vitamins|mesh-ancestor
110880938|NCT04689347|Micronutrients|micronutrients|mesh-ancestor
110880939|NCT04689347|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110880940|NCT04689347|Alkylating Agents|alkylating agents|mesh-ancestor
110880941|NCT03313037|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110880942|NCT03313037|Immunologic Factors|immunologic factors|mesh-ancestor
110880943|NCT03313037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110598497|NCT00718172|Ribavirin|ribavirin|mesh-list
110880944|NCT01268579|Ribavirin|ribavirin|mesh-list
110880945|NCT01268579|Antimetabolites|antimetabolites|mesh-ancestor
110880946|NCT01268579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110880948|NCT01268579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110880949|NCT02420795|TIC10 compound|tic10 compound|mesh-list
110880950|NCT02420795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110880951|NCT02384759|Aflibercept|aflibercept|mesh-list
110880952|NCT02384759|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110880953|NCT02384759|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110880954|NCT02384759|Growth Substances|growth substances|mesh-ancestor
110880955|NCT02384759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110880956|NCT02384759|Growth Inhibitors|growth inhibitors|mesh-ancestor
110880957|NCT02384759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110880958|NCT05276687|Vancomycin|vancomycin|mesh-list
110880963|NCT03036150|Dapagliflozin|dapagliflozin|mesh-list
110880978|NCT03625830|Paclitaxel|paclitaxel|mesh-list
110880979|NCT03625830|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110880980|NCT03625830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110880981|NCT03625830|Tubulin Modulators|tubulin modulators|mesh-ancestor
110880982|NCT03625830|Antimitotic Agents|antimitotic agents|mesh-ancestor
110880983|NCT03625830|Mitosis Modulators|mitosis modulators|mesh-ancestor
110880984|NCT03625830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110880985|NCT04108104|Cyproheptadine|cyproheptadine|mesh-list
110880986|NCT04108104|Prazosin|prazosin|mesh-list
110880987|NCT04108104|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110880988|NCT04108104|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110880989|NCT04108104|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110881042|NCT01702571|Immunologic Factors|immunologic factors|mesh-ancestor
110881043|NCT01702571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110881044|NCT01578239|Octreotide|octreotide|mesh-list
110881045|NCT01578239|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
110881046|NCT01578239|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110881047|NCT01578239|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110881048|NCT01578239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110881049|NCT01578239|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110881050|NCT01578239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110881051|NCT05274893|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110881052|NCT05274893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110881053|NCT03231709|Alogliptin|alogliptin|mesh-list
110881054|NCT03231709|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110881056|NCT03231709|Incretins|incretins|mesh-ancestor
110881104|NCT03241927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110881105|NCT03241927|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110881106|NCT03241927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110881107|NCT02941523|Carboplatin|carboplatin|mesh-list
110881108|NCT02941523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110881109|NCT03666143|Tislelizumab|tislelizumab|mesh-list
110881110|NCT03666143|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110881111|NCT03666143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110881112|NCT00360425|Moxifloxacin|moxifloxacin|mesh-list
110881113|NCT00360425|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
110881114|NCT00360425|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110881115|NCT00360425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110881116|NCT00360425|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110881166|NCT03329573|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110881167|NCT03329573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110881168|NCT03329573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110881169|NCT03329573|Serotonin Agents|serotonin agents|mesh-ancestor
110881170|NCT03329573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110598709|NCT00723164|Fentanyl|fentanyl|mesh-list
110881171|NCT03329573|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110881172|NCT03329573|Antidepressive Agents|antidepressive agents|mesh-ancestor
110881173|NCT03329573|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110881174|NCT03329573|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110881175|NCT03329573|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110881176|NCT03329573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110881223|NCT05039489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110881224|NCT05039489|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110881226|NCT03665545|Pembrolizumab|pembrolizumab|mesh-list
110881296|NCT03273257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110881300|NCT02553473|Antimalarials|antimalarials|mesh-ancestor
110881369|NCT00972738|Respiratory System Agents|respiratory system agents|mesh-ancestor
110881370|NCT00972738|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110881371|NCT00972738|Hormone Antagonists|hormone antagonists|mesh-ancestor
110881372|NCT00972738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110881373|NCT00972738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110881374|NCT00972738|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110881375|NCT00972738|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110881435|NCT00442338|Theophylline|theophylline|mesh-list
110881436|NCT00442338|Montelukast|montelukast|mesh-list
110881437|NCT00442338|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110881438|NCT00442338|Respiratory System Agents|respiratory system agents|mesh-ancestor
110881439|NCT00442338|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110881440|NCT00442338|Hormone Antagonists|hormone antagonists|mesh-ancestor
110881441|NCT00442338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110881442|NCT00442338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110881443|NCT00442338|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110881444|NCT00442338|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110881445|NCT00442338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110881446|NCT00442338|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110881447|NCT00442338|Autonomic Agents|autonomic agents|mesh-ancestor
110881448|NCT00442338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110881449|NCT00442338|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110881450|NCT00442338|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110881451|NCT00442338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110881452|NCT00442338|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110881453|NCT00442338|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110881454|NCT00442338|Purinergic Agents|purinergic agents|mesh-ancestor
110881455|NCT00442338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110881456|NCT00442338|Protective Agents|protective agents|mesh-ancestor
110881457|NCT00442338|Vasodilator Agents|vasodilator agents|mesh-ancestor
110881458|NCT03506412|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
110881459|NCT03506412|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110881460|NCT03506412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110881461|NCT02316834|Talazoparib|talazoparib|mesh-list
110881462|NCT02316834|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110881463|NCT02316834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110599005|NCT00724022|Glucocorticoids|glucocorticoids|mesh-ancestor
110881464|NCT02316834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110881465|NCT02316834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110881466|NCT02879136|Methylphenidate|methylphenidate|mesh-list
110881469|NCT02879136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110881470|NCT02879136|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110881471|NCT02879136|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110881472|NCT02879136|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110881473|NCT02879136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110881541|NCT01498770|Dopamine Agents|dopamine agents|mesh-ancestor
110881542|NCT01498770|Antiemetics|antiemetics|mesh-ancestor
110881543|NCT01498770|Autonomic Agents|autonomic agents|mesh-ancestor
110881544|NCT01498770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110881545|NCT01498770|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110881546|NCT01498770|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110881547|NCT01498770|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110881548|NCT01498770|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110881549|NCT01498770|Antidepressive Agents|antidepressive agents|mesh-ancestor
110881603|NCT00920634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110881604|NCT00920634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110881605|NCT00092040|Alendronate|alendronate|mesh-list
110881606|NCT00092040|Risedronic Acid|risedronic acid|mesh-list
110881607|NCT00092040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110881608|NCT00092040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110881609|NCT00092040|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110881610|NCT00092040|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110881611|NCT00092040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110881612|NCT00092040|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110881613|NCT05224128|Imatinib Mesylate|imatinib mesylate|mesh-list
110881614|NCT05224128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110881615|NCT05224128|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110881616|NCT05224128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110881617|NCT05224128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110881618|NCT05416827|Dexamethasone|dexamethasone|mesh-list
110881619|NCT05416827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110881620|NCT05416827|Antiemetics|antiemetics|mesh-ancestor
110881621|NCT05416827|Autonomic Agents|autonomic agents|mesh-ancestor
110881622|NCT05416827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110881623|NCT05416827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110881624|NCT05416827|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110881625|NCT05416827|Glucocorticoids|glucocorticoids|mesh-ancestor
110881626|NCT05416827|Hormones|hormones|mesh-ancestor
110881627|NCT05416827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110881628|NCT05416827|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110881629|NCT05416827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110881630|NCT04961619|Trametinib|trametinib|mesh-list
110881631|NCT04961619|Dabrafenib|dabrafenib|mesh-list
110881632|NCT04961619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110881633|NCT04961619|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110881634|NCT04961619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110881635|NCT04961619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110881636|NCT05076513|Niraparib|niraparib|mesh-list
110881637|NCT05076513|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110881638|NCT05076513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110881639|NCT05076513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110881640|NCT05076513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110881641|NCT05418465|Dapagliflozin|dapagliflozin|mesh-list
110881642|NCT05418465|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110881643|NCT05418465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110881706|NCT05320926|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110881707|NCT05320926|Purinergic Agents|purinergic agents|mesh-ancestor
110881708|NCT05320926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110881709|NCT05296512|Pembrolizumab|pembrolizumab|mesh-list
110881710|NCT05296512|Lenvatinib|lenvatinib|mesh-list
110881711|NCT05296512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110881712|NCT05296512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110881713|NCT05296512|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110881714|NCT05296512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110881715|NCT05296512|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110881716|NCT05296512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110881717|NCT05417997|Clarithromycin|clarithromycin|mesh-list
110881718|NCT05417997|Ceftriaxone|ceftriaxone|mesh-list
110881719|NCT05417997|Favipiravir|favipiravir|mesh-list
110881720|NCT05417997|Methylprednisolone|methylprednisolone|mesh-list
110881721|NCT05417997|Enoxaparin|enoxaparin|mesh-list
110881722|NCT05417997|Lansoprazole|lansoprazole|mesh-list
110881723|NCT05417997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110881724|NCT05417997|Antiemetics|antiemetics|mesh-ancestor
110881725|NCT05417997|Autonomic Agents|autonomic agents|mesh-ancestor
110881726|NCT05417997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110881727|NCT05417997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110881762|NCT03242759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110881763|NCT03242759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110881764|NCT03242759|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110881765|NCT03242759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110881766|NCT03242759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110881767|NCT03242759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110881768|NCT03625050|Celecoxib|celecoxib|mesh-list
110881769|NCT03625050|Esomeprazole|esomeprazole|mesh-list
110881770|NCT03625050|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110881771|NCT03625050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110881772|NCT03625050|Analgesics|analgesics|mesh-ancestor
110881773|NCT03625050|Sensory System Agents|sensory system agents|mesh-ancestor
110881774|NCT03625050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110881775|NCT03625050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110881776|NCT03625050|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110881822|NCT02496611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110881823|NCT02496611|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110881824|NCT02496611|Incretins|incretins|mesh-ancestor
110881825|NCT02496611|Hormones|hormones|mesh-ancestor
110881826|NCT02496611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110881827|NCT03636295|Warfarin|warfarin|mesh-list
110881828|NCT03636295|Anticoagulants|anticoagulants|mesh-ancestor
110881829|NCT03237481|Bupivacaine|bupivacaine|mesh-list
110881892|NCT02117700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110881893|NCT02117700|Protective Agents|protective agents|mesh-ancestor
110881894|NCT02117700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110881895|NCT02117700|Antidotes|antidotes|mesh-ancestor
110881896|NCT02932579|Acetaminophen|acetaminophen|mesh-list
110881897|NCT02932579|Ibuprofen|ibuprofen|mesh-list
110881898|NCT02932579|Oxycodone|oxycodone|mesh-list
110881899|NCT02932579|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110881900|NCT02932579|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110881901|NCT02932579|Analgesics|analgesics|mesh-ancestor
110881902|NCT02932579|Sensory System Agents|sensory system agents|mesh-ancestor
110881903|NCT02932579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110881904|NCT02932579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110881905|NCT02932579|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110881906|NCT02932579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110881907|NCT02932579|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110881908|NCT02932579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110881909|NCT02932579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110881910|NCT02932579|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110881911|NCT02932579|Narcotics|narcotics|mesh-ancestor
110881912|NCT02932579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110881913|NCT02932579|Antipyretics|antipyretics|mesh-ancestor
110881915|NCT04748757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110881916|NCT04748757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110881917|NCT03207451|Aspirin|aspirin|mesh-list
110881918|NCT03207451|Clopidogrel|clopidogrel|mesh-list
110881919|NCT03207451|Vorapaxar|vorapaxar|mesh-list
110881942|NCT05089123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110881943|NCT02361125|Methylphenidate|methylphenidate|mesh-list
110881944|NCT02361125|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110881945|NCT02361125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110881946|NCT02361125|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110881947|NCT02361125|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110881948|NCT02361125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110881949|NCT02361125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110882005|NCT03255629|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
110882006|NCT03255629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110882008|NCT03255629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110882009|NCT03255629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110882010|NCT03255629|Incretins|incretins|mesh-ancestor
110882011|NCT01143779|Telbivudine|telbivudine|mesh-list
110882012|NCT01143779|Antiviral Agents|antiviral agents|mesh-ancestor
110882013|NCT01143779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110882014|NCT01143779|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110882015|NCT01143779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110882016|NCT01143779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110882017|NCT03703596|Docetaxel|docetaxel|mesh-list
110882018|NCT03703596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110882067|NCT04066023|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110882068|NCT04066023|Serotonin Agents|serotonin agents|mesh-ancestor
110882069|NCT04066023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110882070|NCT04066023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110882071|NCT04066023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110882073|NCT03106987|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110882074|NCT03106987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110882075|NCT03106987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110882076|NCT03106987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110882077|NCT02932267|Adapalene|adapalene|mesh-list
110882078|NCT02932267|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110882079|NCT02932267|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110882080|NCT02932267|Analgesics|analgesics|mesh-ancestor
110882081|NCT02932267|Sensory System Agents|sensory system agents|mesh-ancestor
110882082|NCT02932267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110882083|NCT02932267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110882084|NCT02932267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110882085|NCT02932267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110882087|NCT03217591|Praliciguat|praliciguat|mesh-list
110882120|NCT03697746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110882121|NCT03697746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110882122|NCT03697746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110882123|NCT03697746|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110882124|NCT03697746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110882125|NCT03697746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110882126|NCT03697746|Antipyretics|antipyretics|mesh-ancestor
110882127|NCT03697668|Piperaquine|piperaquine|mesh-list
110882128|NCT03697668|Artenimol|artenimol|mesh-list
110882129|NCT03697668|Imatinib Mesylate|imatinib mesylate|mesh-list
110882130|NCT03697668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110882131|NCT03697668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110882132|NCT03697668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110599688|NCT00866866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110882133|NCT03697668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110882134|NCT03697668|Antimalarials|antimalarials|mesh-ancestor
110882135|NCT03697668|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110882136|NCT03697668|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110882137|NCT03697668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110882139|NCT03702738|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110882140|NCT03702738|Antiviral Agents|antiviral agents|mesh-ancestor
110882142|NCT03702738|Expectorants|expectorants|mesh-ancestor
110882175|NCT03699774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110882176|NCT03699696|Propofol|propofol|mesh-list
110882177|NCT03699696|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110882178|NCT03699696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110882179|NCT03699696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110882180|NCT03699696|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110882243|NCT03696186|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110882244|NCT03696186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110882245|NCT03696186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110882246|NCT03696186|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110882247|NCT03696186|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110882248|NCT03696186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110882249|NCT03696186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110882250|NCT03696186|GABA Modulators|gaba modulators|mesh-ancestor
110882251|NCT03696186|GABA Agents|gaba agents|mesh-ancestor
110882307|NCT03698682|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110882308|NCT03698682|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110882309|NCT03698682|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110882310|NCT03698682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110882378|NCT04224558|Immunologic Factors|immunologic factors|mesh-ancestor
110882379|NCT04224558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110882380|NCT04224558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110882381|NCT04224558|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110882450|NCT03691896|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110882451|NCT03691818|Ibuprofen|ibuprofen|mesh-list
110882452|NCT03691818|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110882453|NCT03691818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110882454|NCT03691818|Analgesics|analgesics|mesh-ancestor
110882519|NCT03883581|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110882520|NCT03883581|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110882521|NCT03883581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110882522|NCT03883581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110882523|NCT03883581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110882524|NCT03883581|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110882586|NCT04733235|Progestins|progestins|mesh-ancestor
110882587|NCT05598177|Dexmedetomidine|dexmedetomidine|mesh-list
110882588|NCT05598177|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110882589|NCT05598177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110882590|NCT05598177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110882591|NCT05598177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110882656|NCT03158805|Liraglutide|liraglutide|mesh-list
110882657|NCT03158805|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110882658|NCT03158805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110882659|NCT03158805|Incretins|incretins|mesh-ancestor
110882660|NCT03158805|Hormones|hormones|mesh-ancestor
110882661|NCT03158805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110882726|NCT03682692|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
110882727|NCT03682692|Protease Inhibitors|protease inhibitors|mesh-ancestor
110882728|NCT03682692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110882730|NCT02886585|Pembrolizumab|pembrolizumab|mesh-list
110882793|NCT03681990|Dermatologic Agents|dermatologic agents|mesh-ancestor
110882795|NCT02740335|Protein S|protein s|mesh-list
110882796|NCT02740335|Thrombin|thrombin|mesh-list
110882797|NCT02740335|Hemostatics|hemostatics|mesh-ancestor
110882798|NCT02740335|Coagulants|coagulants|mesh-ancestor
110882799|NCT02740335|Anticoagulants|anticoagulants|mesh-ancestor
110882800|NCT02740335|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110882801|NCT02740335|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110882802|NCT02740335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110882803|NCT05351151|Lidocaine|lidocaine|mesh-list
110882804|NCT05351151|Anesthetics, Local|anesthetics, local|mesh-ancestor
110600359|NCT00728078|Immunologic Factors|immunologic factors|mesh-ancestor
110882805|NCT05351151|Anesthetics|anesthetics|mesh-ancestor
110882806|NCT05351151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110882855|NCT03685032|Glucocorticoids|glucocorticoids|mesh-ancestor
110882856|NCT03685032|Hormones|hormones|mesh-ancestor
110882857|NCT03685032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110882858|NCT03685032|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110882867|NCT02451111|Rituximab|rituximab|mesh-list
110882927|NCT03684330|Vitamins|vitamins|mesh-ancestor
110882928|NCT03684330|Micronutrients|micronutrients|mesh-ancestor
110882929|NCT03684330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110882930|NCT03684330|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110882931|NCT03503370|Chlorhexidine|chlorhexidine|mesh-list
110882932|NCT03503370|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110882933|NCT03503370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110882934|NCT03503370|Disinfectants|disinfectants|mesh-ancestor
110882935|NCT01381809|Epoetin Alfa|epoetin alfa|mesh-list
110882936|NCT01381809|Hematinics|hematinics|mesh-ancestor
110882937|NCT03677466|Tenecteplase|tenecteplase|mesh-list
110882938|NCT03677466|Streptokinase|streptokinase|mesh-list
110882942|NCT03447132|Fulvestrant|fulvestrant|mesh-list
110882991|NCT03679182|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110882992|NCT03679182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110882993|NCT03679182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110882994|NCT03679182|Serotonin Agents|serotonin agents|mesh-ancestor
110882995|NCT03184987|Albuterol|albuterol|mesh-list
110882996|NCT03184987|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110882997|NCT03184987|Autonomic Agents|autonomic agents|mesh-ancestor
110882998|NCT03184987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110883056|NCT03026088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110883057|NCT03678792|Morphine|morphine|mesh-list
110883058|NCT03678792|Buprenorphine|buprenorphine|mesh-list
110883131|NCT04058964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110883132|NCT04058964|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110883133|NCT04058964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110883134|NCT03246906|Cyclosporine|cyclosporine|mesh-list
110883135|NCT03246906|Sirolimus|sirolimus|mesh-list
110883136|NCT03246906|Mycophenolic Acid|mycophenolic acid|mesh-list
110883138|NCT03246906|Cyclosporins|cyclosporins|mesh-list
110883202|NCT03671070|Adrenergic Agents|adrenergic agents|mesh-ancestor
110883203|NCT03671070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110883204|NCT03671070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110883205|NCT03671070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110883206|NCT03671070|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110883207|NCT03671070|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110883208|NCT03671070|Autonomic Agents|autonomic agents|mesh-ancestor
110883209|NCT03671070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110883210|NCT03671070|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110883211|NCT03671070|Respiratory System Agents|respiratory system agents|mesh-ancestor
110600743|NCT00653523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110883265|NCT03670212|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
110883266|NCT03670212|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110883267|NCT03670212|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110883268|NCT03670212|Adrenergic Agents|adrenergic agents|mesh-ancestor
110883269|NCT03670212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110883270|NCT03670212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110883271|NCT03670212|Urological Agents|urological agents|mesh-ancestor
110883331|NCT03165721|Antimetabolites|antimetabolites|mesh-ancestor
110883332|NCT03165721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110883333|NCT03165721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110883334|NCT02224872|Mycophenolic Acid|mycophenolic acid|mesh-list
110883335|NCT02224872|Cyclophosphamide|cyclophosphamide|mesh-list
110883336|NCT02224872|Fludarabine|fludarabine|mesh-list
110883337|NCT02224872|Tacrolimus|tacrolimus|mesh-list
110883338|NCT02224872|Thymoglobulin|thymoglobulin|mesh-list
110883339|NCT02224872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110883340|NCT02224872|Immunologic Factors|immunologic factors|mesh-ancestor
110883341|NCT02224872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110883342|NCT02224872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110883395|NCT01829958|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110883396|NCT01829958|Glucocorticoids|glucocorticoids|mesh-ancestor
110883397|NCT01829958|Hormones|hormones|mesh-ancestor
110883398|NCT01829958|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110883399|NCT01829958|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110883400|NCT03021642|Tepotinib|tepotinib|mesh-list
110883401|NCT03021642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110883402|NCT00867048|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
110883403|NCT00867048|Antiviral Agents|antiviral agents|mesh-ancestor
110883404|NCT00867048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110883405|NCT03023046|Prednisone|prednisone|mesh-list
110600965|NCT00740168|Bevacizumab|bevacizumab|mesh-list
110883406|NCT03023046|Cortisone|cortisone|mesh-list
110883407|NCT03023046|Cyclophosphamide|cyclophosphamide|mesh-list
110883408|NCT03023046|Rituximab|rituximab|mesh-list
110883409|NCT03023046|Doxorubicin|doxorubicin|mesh-list
110883410|NCT03023046|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110883456|NCT03668262|Cholinergic Agents|cholinergic agents|mesh-ancestor
110883457|NCT03668262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110883458|NCT03668262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110883460|NCT03668964|Cholecalciferol|cholecalciferol|mesh-list
110883461|NCT03668964|Vitamins|vitamins|mesh-list
110883462|NCT03668964|Vitamin E|vitamin e|mesh-list
110883463|NCT03668964|Tocopherols|tocopherols|mesh-list
110883464|NCT03668964|alpha-Tocopherol|alpha-tocopherol|mesh-list
110883465|NCT03668964|Vitamin A|vitamin a|mesh-list
110883466|NCT03668964|Riboflavin|riboflavin|mesh-list
110883467|NCT03668964|Vitamin B Complex|vitamin b complex|mesh-list
110883468|NCT03668964|Micronutrients|micronutrients|mesh-ancestor
110883469|NCT03668964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110883470|NCT03668964|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110883471|NCT03668964|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110883472|NCT03668964|Antioxidants|antioxidants|mesh-ancestor
110883473|NCT03668964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110883474|NCT03668964|Protective Agents|protective agents|mesh-ancestor
110883475|NCT03668964|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110883477|NCT03668730|Paclitaxel|paclitaxel|mesh-list
110883512|NCT02509507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110883513|NCT03175549|Apremilast|apremilast|mesh-list
110883514|NCT03175549|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110883516|NCT03175549|Analgesics|analgesics|mesh-ancestor
110883583|NCT02924688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110883584|NCT02924688|Sympathomimetics|sympathomimetics|mesh-ancestor
110883585|NCT03668418|Camptothecin|camptothecin|mesh-list
110883586|NCT03668418|Docetaxel|docetaxel|mesh-list
110883587|NCT03668418|Gemcitabine|gemcitabine|mesh-list
110883588|NCT03668418|Fluorouracil|fluorouracil|mesh-list
110883589|NCT03668418|Oxaliplatin|oxaliplatin|mesh-list
110883590|NCT03668418|Irinotecan|irinotecan|mesh-list
110883591|NCT03668418|Epirubicin|epirubicin|mesh-list
110883592|NCT03668418|Taxane|taxane|mesh-list
110883593|NCT03668418|Antimetabolites|antimetabolites|mesh-list
110883594|NCT03668418|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110883595|NCT03668418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110883596|NCT03668418|Tubulin Modulators|tubulin modulators|mesh-ancestor
110883612|NCT03011892|Hormones|hormones|mesh-ancestor
110883647|NCT03012828|Antinematodal Agents|antinematodal agents|mesh-ancestor
110883648|NCT03666390|Midazolam|midazolam|mesh-list
110883649|NCT03666390|Ketamine|ketamine|mesh-list
110883650|NCT03666390|Analgesics|analgesics|mesh-ancestor
110883651|NCT03666390|Sensory System Agents|sensory system agents|mesh-ancestor
110883652|NCT03666390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110883653|NCT03666390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110883654|NCT03666390|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110883655|NCT03666390|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110883656|NCT03666390|Anesthetics, General|anesthetics, general|mesh-ancestor
110883657|NCT03666390|Anesthetics|anesthetics|mesh-ancestor
110883658|NCT03666390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110883659|NCT03666390|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110883660|NCT03666390|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110883661|NCT03666390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110883662|NCT03666390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110883663|NCT03666390|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110883664|NCT03666390|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110883665|NCT03666390|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110883666|NCT03666390|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110883702|NCT03665766|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110883704|NCT03665766|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110883705|NCT03665766|Antitubercular Agents|antitubercular agents|mesh-ancestor
110883706|NCT03665766|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110883707|NCT03665766|Antimetabolites|antimetabolites|mesh-ancestor
110883773|NCT03251963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110883774|NCT03287219|Methylene Blue|methylene blue|mesh-list
110883775|NCT03287219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110883776|NCT03287219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110883777|NCT03286751|Insulin Lispro|insulin lispro|mesh-list
110883778|NCT03286751|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110883779|NCT03286751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110883780|NCT03249935|Azithromycin|azithromycin|mesh-list
110883781|NCT03249935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110883782|NCT03249935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110883783|NCT03622073|Misoprostol|misoprostol|mesh-list
110883784|NCT03622073|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110883835|NCT03664440|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110883836|NCT03664440|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110883837|NCT03664440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110883838|NCT03664440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110883839|NCT03664440|Antiviral Agents|antiviral agents|mesh-ancestor
110883840|NCT03664440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110883841|NCT03664440|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110883842|NCT03664440|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110883843|NCT03664440|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110883844|NCT03664440|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110883845|NCT03664596|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
110883846|NCT03664596|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
110883847|NCT03664596|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110883848|NCT03282227|Oxazolidinones|oxazolidinones|mesh-list
110883849|NCT03282227|Zolmitriptan|zolmitriptan|mesh-list
110883850|NCT03282227|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110883893|NCT03690947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110883895|NCT02999178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110883896|NCT02999178|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110883897|NCT02999178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110883898|NCT02999178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110883899|NCT02999100|Oxytocin|oxytocin|mesh-list
110883900|NCT02999100|Oxytocics|oxytocics|mesh-ancestor
110883901|NCT02999100|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110883902|NCT02999100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110883961|NCT03617432|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110883962|NCT03617432|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110883963|NCT03617432|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110883964|NCT03617432|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110883965|NCT03617432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110883966|NCT03617432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110883967|NCT03617432|Glucocorticoids|glucocorticoids|mesh-ancestor
110883968|NCT03617432|Hormones|hormones|mesh-ancestor
110883969|NCT03617432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110883970|NCT03617432|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110883971|NCT03617432|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110883972|NCT03617432|Tubulin Modulators|tubulin modulators|mesh-ancestor
110883973|NCT03617432|Antimitotic Agents|antimitotic agents|mesh-ancestor
110883974|NCT03617432|Mitosis Modulators|mitosis modulators|mesh-ancestor
110883975|NCT02996682|Ribavirin|ribavirin|mesh-list
110883976|NCT02996682|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
110883977|NCT02996682|Antimetabolites|antimetabolites|mesh-ancestor
110883978|NCT02996682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110883979|NCT02996682|Antiviral Agents|antiviral agents|mesh-ancestor
110883980|NCT02996682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110883981|NCT02873702|Lansoprazole|lansoprazole|mesh-list
110883982|NCT02873702|Dexlansoprazole|dexlansoprazole|mesh-list
110883983|NCT02873702|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110883984|NCT02873702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110884012|NCT03664050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110884013|NCT03664050|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110884014|NCT03664050|Hormone Antagonists|hormone antagonists|mesh-ancestor
110884015|NCT03664050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110884016|NCT03664050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110884019|NCT04055844|Antimetabolites|antimetabolites|mesh-ancestor
110884080|NCT03663114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110884081|NCT03526679|Lenvatinib|lenvatinib|mesh-list
110884082|NCT03526679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110884083|NCT03526679|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110884084|NCT03526679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110884085|NCT03526679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110884086|NCT04057326|Pancreatin|pancreatin|mesh-list
110884087|NCT04057326|Pancrelipase|pancrelipase|mesh-list
110884148|NCT03662100|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110884149|NCT03662100|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110884150|NCT03662100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110884220|NCT03611426|Thrombin|thrombin|mesh-list
110884221|NCT03611426|Hemostatics|hemostatics|mesh-ancestor
110884222|NCT03611426|Coagulants|coagulants|mesh-ancestor
110884223|NCT03658746|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110884224|NCT03658746|Amoxicillin|amoxicillin|mesh-list
110884225|NCT03658746|Metronidazole|metronidazole|mesh-list
110884226|NCT03658746|Clarithromycin|clarithromycin|mesh-list
110884227|NCT03658746|Levofloxacin|levofloxacin|mesh-list
110884291|NCT03658590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110600781|NCT00729170|Calcium|calcium|mesh-list
110884292|NCT03658590|Glucocorticoids|glucocorticoids|mesh-ancestor
110884368|NCT02075671|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110884369|NCT02075671|Dermatologic Agents|dermatologic agents|mesh-ancestor
110884370|NCT02560298|Paclitaxel|paclitaxel|mesh-list
110884371|NCT02560298|Cisplatin|cisplatin|mesh-list
110884372|NCT02560298|Carboplatin|carboplatin|mesh-list
110884373|NCT02560298|Fluorouracil|fluorouracil|mesh-list
110884374|NCT02560298|Capecitabine|capecitabine|mesh-list
110884387|NCT01330615|Lidocaine|lidocaine|mesh-list
110884437|NCT03040141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110884438|NCT03040141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110884439|NCT02937701|Infliximab|infliximab|mesh-list
110884440|NCT02937701|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110884441|NCT02937701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110884442|NCT02937701|Dermatologic Agents|dermatologic agents|mesh-ancestor
110884443|NCT02937701|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110884444|NCT02937701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110884445|NCT05186623|Ustekinumab|ustekinumab|mesh-list
110884446|NCT05186623|Vedolizumab|vedolizumab|mesh-list
110884447|NCT05186623|Tofacitinib|tofacitinib|mesh-list
110884448|NCT05186623|Dermatologic Agents|dermatologic agents|mesh-ancestor
110884449|NCT05186623|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
110884450|NCT05186623|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110884451|NCT05186623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110884452|NCT05186623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110884453|NCT05186623|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110884454|NCT04602845|Flurbiprofen|flurbiprofen|mesh-list
110884455|NCT04602845|Fentanyl|fentanyl|mesh-list
110884456|NCT04602845|Midazolam|midazolam|mesh-list
110884457|NCT04602845|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110884458|NCT04602845|Narcotics|narcotics|mesh-ancestor
110884459|NCT04602845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110884460|NCT04602845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110884488|NCT04966325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110884489|NCT04966325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110884490|NCT03168919|Temozolomide|temozolomide|mesh-list
110884491|NCT03168919|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110884492|NCT03168919|Alkylating Agents|alkylating agents|mesh-ancestor
110884493|NCT03168919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110884494|NCT03168919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110884495|NCT03205163|Factor VIII|factor viii|mesh-list
110884496|NCT03205163|Coagulants|coagulants|mesh-ancestor
110884497|NCT03638947|Povidone-Iodine|povidone-iodine|mesh-list
110884498|NCT03638947|Povidone|povidone|mesh-list
110884499|NCT03638947|Plasma Substitutes|plasma substitutes|mesh-ancestor
110884500|NCT03638947|Blood Substitutes|blood substitutes|mesh-ancestor
110884501|NCT03638947|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110884502|NCT03638947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110884549|NCT04485325|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110884550|NCT04485325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110884551|NCT04485325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110884552|NCT03610178|Insulin|insulin|mesh-list
110884553|NCT03610178|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110884554|NCT03610178|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110884555|NCT03610178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110884556|NCT02033798|Tamsulosin|tamsulosin|mesh-list
110884611|NCT03203447|Hormones|hormones|mesh-ancestor
110602153|NCT00880828|Antipyretics|antipyretics|mesh-ancestor
110884612|NCT03203447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110884613|NCT03203447|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110884614|NCT03203447|Immunologic Factors|immunologic factors|mesh-ancestor
110884615|NCT03203447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110884616|NCT03203447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110884617|NCT01068678|Insulin|insulin|mesh-list
110884618|NCT01068678|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110884619|NCT01068678|Insulin Glargine|insulin glargine|mesh-list
110884620|NCT01068678|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110884621|NCT01068678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110884622|NCT03202511|Tenofovir|tenofovir|mesh-list
110884623|NCT03202511|Emtricitabine|emtricitabine|mesh-list
110884624|NCT03202511|Probenecid|probenecid|mesh-list
110884625|NCT03202511|Antiviral Agents|antiviral agents|mesh-ancestor
110884626|NCT03202511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110884627|NCT03202511|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110884628|NCT03202511|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110884669|NCT03657966|Paclitaxel|paclitaxel|mesh-list
110884670|NCT03657966|Carboplatin|carboplatin|mesh-list
110884671|NCT03657966|Gemcitabine|gemcitabine|mesh-list
110884672|NCT03657966|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110884673|NCT03657966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110884674|NCT03657966|Tubulin Modulators|tubulin modulators|mesh-ancestor
110884675|NCT03657966|Antimitotic Agents|antimitotic agents|mesh-ancestor
110884676|NCT03657966|Mitosis Modulators|mitosis modulators|mesh-ancestor
110884677|NCT03657966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110884678|NCT03657966|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110884679|NCT03657966|Antimetabolites|antimetabolites|mesh-ancestor
110884680|NCT03659292|Anesthetics|anesthetics|mesh-list
110884681|NCT03659292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110884683|NCT03659058|Colchicine|colchicine|mesh-list
110884732|NCT04458324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110884733|NCT04458324|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110884734|NCT04458324|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110884735|NCT04458324|Serotonin Agents|serotonin agents|mesh-ancestor
110884736|NCT04458324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110884737|NCT04458324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110884738|NCT03657420|Dexamethasone|dexamethasone|mesh-list
110884739|NCT03657420|Pomalidomide|pomalidomide|mesh-list
110884740|NCT03657420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110884741|NCT03657420|Antiemetics|antiemetics|mesh-ancestor
110884742|NCT03657420|Autonomic Agents|autonomic agents|mesh-ancestor
110884743|NCT03657420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110884744|NCT03657420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110884745|NCT03657420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110884746|NCT03657420|Glucocorticoids|glucocorticoids|mesh-ancestor
110884747|NCT03657420|Hormones|hormones|mesh-ancestor
110884748|NCT03657420|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110884749|NCT03657420|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110884750|NCT03657420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110884751|NCT03657420|Immunologic Factors|immunologic factors|mesh-ancestor
110884752|NCT03657420|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110884753|NCT03657420|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110884754|NCT03657420|Growth Substances|growth substances|mesh-ancestor
110884755|NCT03657420|Growth Inhibitors|growth inhibitors|mesh-ancestor
110884756|NCT02984982|Anticoagulants|anticoagulants|mesh-list
110884757|NCT02984982|Atorvastatin|atorvastatin|mesh-list
110884758|NCT02984982|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110884759|NCT02984982|Ezetimibe|ezetimibe|mesh-list
110884760|NCT02984982|Alirocumab|alirocumab|mesh-list
110884761|NCT02984982|Fenofibrate|fenofibrate|mesh-list
110884762|NCT02984982|Bezafibrate|bezafibrate|mesh-list
110884763|NCT02984982|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110884764|NCT02984982|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110884765|NCT02984982|Antimetabolites|antimetabolites|mesh-ancestor
110884770|NCT02984982|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
110884774|NCT03656484|Tetracycline|tetracycline|mesh-list
110884775|NCT03656484|Melatonin|melatonin|mesh-list
110884851|NCT03656094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110884852|NCT03656094|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110884853|NCT03656094|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110884854|NCT03656094|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110884855|NCT04298034|Labetalol|labetalol|mesh-list
110884856|NCT04298034|Nifedipine|nifedipine|mesh-list
110884857|NCT04298034|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110884858|NCT04298034|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110884859|NCT04298034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110884860|NCT04298034|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110884861|NCT04298034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110884862|NCT04298034|Vasodilator Agents|vasodilator agents|mesh-ancestor
110884863|NCT04298034|Tocolytic Agents|tocolytic agents|mesh-ancestor
110884864|NCT04298034|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110884865|NCT04298034|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110884866|NCT04298034|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110884867|NCT04298034|Adrenergic Agents|adrenergic agents|mesh-ancestor
110884868|NCT04298034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110884907|NCT02924389|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110884908|NCT02924389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110884909|NCT02924389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110884910|NCT02924389|Antiviral Agents|antiviral agents|mesh-ancestor
110884911|NCT02924389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110884977|NCT01314209|Analgesics|analgesics|mesh-ancestor
110884978|NCT01314209|Sensory System Agents|sensory system agents|mesh-ancestor
110884979|NCT01314209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110884980|NCT01314209|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110884981|NCT01314209|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110885050|NCT01331785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110885051|NCT01331785|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110885052|NCT01331785|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110885053|NCT01331785|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110885054|NCT01331785|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110885055|NCT01331785|Adrenergic Agents|adrenergic agents|mesh-ancestor
110885058|NCT01382589|Afamelanotide|afamelanotide|mesh-list
110885116|NCT01333891|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110885117|NCT01333891|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110885118|NCT01333891|Adrenergic Agents|adrenergic agents|mesh-ancestor
110885119|NCT01333891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110885120|NCT01333891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110885121|NCT01333891|Protective Agents|protective agents|mesh-ancestor
110885122|NCT01333891|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110885123|NCT01333891|Vasodilator Agents|vasodilator agents|mesh-ancestor
110885124|NCT01333891|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
110885126|NCT04853875|Metronidazole|metronidazole|mesh-list
110885127|NCT04853875|Clarithromycin|clarithromycin|mesh-list
110885128|NCT04853875|Tetracycline|tetracycline|mesh-list
110885129|NCT04853875|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
110885130|NCT04853875|Bismuth|bismuth|mesh-list
110885131|NCT04853875|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110885132|NCT04853875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110885133|NCT04853875|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110885134|NCT04853875|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110885135|NCT04853875|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110885140|NCT04853875|Antacids|antacids|mesh-ancestor
110885174|NCT01331941|Antimitotic Agents|antimitotic agents|mesh-ancestor
110885175|NCT01331941|Mitosis Modulators|mitosis modulators|mesh-ancestor
110885176|NCT01331941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110885177|NCT01331941|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110885247|NCT03635827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110885248|NCT03635827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110885250|NCT01338103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110885251|NCT01338103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110885255|NCT03621761|Modafinil|modafinil|mesh-list
110885315|NCT01381185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110885316|NCT01381185|Antipyretics|antipyretics|mesh-ancestor
110885317|NCT01381185|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110885318|NCT01381185|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110885319|NCT01381185|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110885320|NCT01381185|Purinergic Agents|purinergic agents|mesh-ancestor
110885321|NCT01381185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110885322|NCT02946047|Ixazomib|ixazomib|mesh-list
110885323|NCT02946047|Glycine|glycine|mesh-list
110885324|NCT02946047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110885325|NCT02946047|Protease Inhibitors|protease inhibitors|mesh-ancestor
110885326|NCT02946047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110885327|NCT02946047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110885328|NCT02946047|Glycine Agents|glycine agents|mesh-ancestor
110885329|NCT02946047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110885330|NCT02946047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110885331|NCT05421897|Cyclophosphamide|cyclophosphamide|mesh-list
110885332|NCT05421897|Temozolomide|temozolomide|mesh-list
110885333|NCT05421897|Irinotecan|irinotecan|mesh-list
110885334|NCT05421897|Topotecan|topotecan|mesh-list
110885335|NCT05421897|Dinutuximab|dinutuximab|mesh-list
110885336|NCT05421897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110885337|NCT05421897|Immunologic Factors|immunologic factors|mesh-ancestor
110885338|NCT05421897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110885339|NCT05421897|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110885340|NCT05421897|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110885367|NCT01377597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110885368|NCT03204695|Clopidogrel|clopidogrel|mesh-list
110885369|NCT03204695|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110885370|NCT03204695|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110885371|NCT03204695|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110885372|NCT03204695|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110885373|NCT03204695|Purinergic Agents|purinergic agents|mesh-ancestor
110885433|NCT03136055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110885434|NCT03136055|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110885435|NCT03136055|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110885436|NCT03136055|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110885437|NCT03136055|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110885503|NCT00480805|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110885504|NCT00480805|Protease Inhibitors|protease inhibitors|mesh-ancestor
110885505|NCT00480805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110885506|NCT00406783|Desloratadine|desloratadine|mesh-list
110885507|NCT00406783|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110885508|NCT00406783|Cholinergic Agents|cholinergic agents|mesh-ancestor
110885509|NCT00406783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110885510|NCT00406783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110885511|NCT00406783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110885512|NCT00406783|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110885513|NCT00406783|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110885514|NCT00406783|Histamine Antagonists|histamine antagonists|mesh-ancestor
110885515|NCT00406783|Histamine Agents|histamine agents|mesh-ancestor
110885516|NCT03179891|Diazepam|diazepam|mesh-list
110885517|NCT03179891|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110885518|NCT03179891|Anticonvulsants|anticonvulsants|mesh-ancestor
110885519|NCT03179891|Antiemetics|antiemetics|mesh-ancestor
110885520|NCT03179891|Autonomic Agents|autonomic agents|mesh-ancestor
110885521|NCT03179891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110885522|NCT03179891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110885523|NCT03179891|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110603062|NCT00886678|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110885524|NCT03179891|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110885525|NCT03179891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110885553|NCT01332565|Antiviral Agents|antiviral agents|mesh-ancestor
110885554|NCT01332565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110885555|NCT01314677|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110885556|NCT01314677|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110885557|NCT01314677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110885558|NCT02736227|Everolimus|everolimus|mesh-list
110885559|NCT02736227|Tacrolimus|tacrolimus|mesh-list
110885560|NCT02736227|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110885561|NCT02736227|Immunologic Factors|immunologic factors|mesh-ancestor
110885562|NCT02736227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110885563|NCT02736227|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110885564|NCT02736227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110885565|NCT02736227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110885566|NCT02736227|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110885567|NCT02736227|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110885568|NCT02736227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110885569|NCT01334905|Mirabegron|mirabegron|mesh-list
110885570|NCT01334905|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
110885571|NCT01334905|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110885572|NCT01334905|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110885573|NCT01334905|Adrenergic Agents|adrenergic agents|mesh-ancestor
110206028|NCT00175981|Serotonin Agents|serotonin agents|mesh-ancestor
110475742|NCT02737605|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110475743|NCT02737371|Antifungal Agents|antifungal agents|mesh-list
110475744|NCT02737371|Clotrimazole|clotrimazole|mesh-list
110475745|NCT02737371|Miconazole|miconazole|mesh-list
110475746|NCT02737371|Olorofim|olorofim|mesh-list
110475747|NCT02737371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110475748|NCT02737371|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110475749|NCT02737371|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110475750|NCT02737371|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110475751|NCT02737371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110475752|NCT02737371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110475753|NCT02737371|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110475754|NCT02737371|Hormone Antagonists|hormone antagonists|mesh-ancestor
110475755|NCT02737371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110475756|NCT02737371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110475757|NCT02737371|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110475758|NCT02737371|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110600863|NCT00729768|Cyclosporine|cyclosporine|mesh-list
110475759|NCT02737527|Levobupivacaine|levobupivacaine|mesh-list
110475760|NCT02737527|Anesthetics, Local|anesthetics, local|mesh-ancestor
110475761|NCT02737527|Anesthetics|anesthetics|mesh-ancestor
110475762|NCT02737527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110475763|NCT02737527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110475764|NCT02737527|Sensory System Agents|sensory system agents|mesh-ancestor
110475765|NCT02737527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110475766|NCT00734539|Fluconazole|fluconazole|mesh-list
110475767|NCT00734539|Antifungal Agents|antifungal agents|mesh-ancestor
110475768|NCT00734539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110475769|NCT00734539|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110475770|NCT00734539|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110475771|NCT00734539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110885574|NCT01334905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110885575|NCT01334905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110885576|NCT01334905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110885577|NCT01334905|Urological Agents|urological agents|mesh-ancestor
110885578|NCT01335139|Immunomodulating Agents|immunomodulating agents|mesh-list
110885579|NCT01335139|Immunologic Factors|immunologic factors|mesh-list
110885580|NCT01335139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110885582|NCT05030129|Pyridoxal|pyridoxal|mesh-list
110885583|NCT05030129|Pyridoxine|pyridoxine|mesh-list
110475772|NCT00734539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110475773|NCT00734539|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110475774|NCT00734539|Hormone Antagonists|hormone antagonists|mesh-ancestor
110475775|NCT00734539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110475776|NCT00734539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110475777|NCT00734539|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110475778|NCT00734539|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110475779|NCT02737059|Codeine|codeine|mesh-list
110475780|NCT02737059|Naloxegol|naloxegol|mesh-list
110475781|NCT02737059|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110475783|NCT02737059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110475784|NCT02737059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110475785|NCT02737059|Analgesics|analgesics|mesh-ancestor
110475786|NCT02737059|Sensory System Agents|sensory system agents|mesh-ancestor
110475787|NCT02737059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110475788|NCT02737059|Antitussive Agents|antitussive agents|mesh-ancestor
110475789|NCT02737059|Respiratory System Agents|respiratory system agents|mesh-ancestor
110475790|NCT02737059|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110475791|NCT02731911|Dexamethasone|dexamethasone|mesh-list
110475792|NCT02731911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110475793|NCT02731911|Antiemetics|antiemetics|mesh-ancestor
110475794|NCT02731911|Autonomic Agents|autonomic agents|mesh-ancestor
110475795|NCT02731911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110475796|NCT02731911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110475797|NCT02731911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110475798|NCT02731911|Glucocorticoids|glucocorticoids|mesh-ancestor
110475799|NCT02731911|Hormones|hormones|mesh-ancestor
110475800|NCT02731911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110475801|NCT02731911|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110475802|NCT02731911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110475803|NCT00734149|Prednisone|prednisone|mesh-list
110475804|NCT00734149|Bortezomib|bortezomib|mesh-list
110475805|NCT00734149|Melphalan|melphalan|mesh-list
110475806|NCT00734149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110475807|NCT00734149|Glucocorticoids|glucocorticoids|mesh-ancestor
110475808|NCT00734149|Hormones|hormones|mesh-ancestor
110475809|NCT00734149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110475810|NCT00734149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110475811|NCT00734149|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110475812|NCT00734149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110475813|NCT00734149|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110475814|NCT00734149|Alkylating Agents|alkylating agents|mesh-ancestor
110475815|NCT00734149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110475816|NCT00734149|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110475817|NCT00734149|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110475818|NCT00734149|Immunologic Factors|immunologic factors|mesh-ancestor
110475819|NCT04089163|Flucytosine|flucytosine|mesh-list
110475820|NCT04089163|Antifungal Agents|antifungal agents|mesh-ancestor
110475821|NCT04089163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110475822|NCT04089163|Antimetabolites|antimetabolites|mesh-ancestor
110475823|NCT04089163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110475824|NCT00743197|Aspirin|aspirin|mesh-list
110475825|NCT00743197|Lisinopril|lisinopril|mesh-list
110475826|NCT00743197|Simvastatin|simvastatin|mesh-list
110475827|NCT00743197|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110885585|NCT05030129|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
110885586|NCT05030129|Dihydroergotoxine|dihydroergotoxine|mesh-list
110885587|NCT05030129|Vitamins|vitamins|mesh-ancestor
110885588|NCT05030129|Micronutrients|micronutrients|mesh-ancestor
110885589|NCT05030129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110885590|NCT05030129|Vitamin B Complex|vitamin b complex|mesh-ancestor
110885591|NCT05030129|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110475828|NCT00743197|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110475829|NCT00743197|Analgesics|analgesics|mesh-ancestor
110475830|NCT00743197|Sensory System Agents|sensory system agents|mesh-ancestor
110475831|NCT00743197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110475832|NCT00743197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110475833|NCT00743197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110475834|NCT00743197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110475835|NCT00743197|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110475836|NCT00743197|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110475837|NCT00743197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110475838|NCT00743197|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110475839|NCT00743197|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110475840|NCT00743197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110475841|NCT00743197|Antipyretics|antipyretics|mesh-ancestor
110475842|NCT00743197|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110475843|NCT00743197|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110475844|NCT00743197|Antimetabolites|antimetabolites|mesh-ancestor
110475845|NCT00743197|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110475846|NCT00743197|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110475847|NCT00743197|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110475848|NCT00743197|Protease Inhibitors|protease inhibitors|mesh-ancestor
110475849|NCT00743197|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110475850|NCT00743197|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110475851|NCT00743197|Protective Agents|protective agents|mesh-ancestor
110475852|NCT02731287|Timolol|timolol|mesh-list
110475853|NCT02731287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110475854|NCT02731287|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110475855|NCT02731287|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110123034|NCT01930864|Metformin|metformin|mesh-list
110475856|NCT02731287|Adrenergic Agents|adrenergic agents|mesh-ancestor
110475857|NCT02731287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110475858|NCT02731287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110475859|NCT02731287|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110475860|NCT02731287|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110475861|NCT02735343|Ketamine|ketamine|mesh-list
110475862|NCT02735343|Prochlorperazine|prochlorperazine|mesh-list
110475863|NCT02735343|Analgesics|analgesics|mesh-ancestor
110475864|NCT02735343|Sensory System Agents|sensory system agents|mesh-ancestor
110475865|NCT02735343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110475866|NCT02735343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110475867|NCT02735343|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110475868|NCT02735343|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110475869|NCT02735343|Anesthetics, General|anesthetics, general|mesh-ancestor
110475870|NCT02735343|Anesthetics|anesthetics|mesh-ancestor
110475871|NCT02735343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110475872|NCT02735343|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110475873|NCT02735343|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110475874|NCT02735343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110475875|NCT02735343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110475876|NCT02735343|Antiemetics|antiemetics|mesh-ancestor
110475877|NCT02735343|Autonomic Agents|autonomic agents|mesh-ancestor
110475878|NCT02735343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110475879|NCT02735343|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110475880|NCT02735343|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110475881|NCT02735343|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110475882|NCT02735343|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110475883|NCT02735343|Dopamine Agents|dopamine agents|mesh-ancestor
110475884|NCT02730975|Abiraterone Acetate|abiraterone acetate|mesh-list
110475885|NCT02730975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110475886|NCT02730975|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110885593|NCT05030129|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110885594|NCT05030129|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110885595|NCT05030129|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110885596|NCT05030129|Adrenergic Agents|adrenergic agents|mesh-ancestor
110885597|NCT05030129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110885598|NCT05030129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110885599|NCT05030129|Vasodilator Agents|vasodilator agents|mesh-ancestor
110885600|NCT05030129|Nootropic Agents|nootropic agents|mesh-ancestor
110885601|NCT05030129|Dopamine Agonists|dopamine agonists|mesh-ancestor
110885602|NCT05030129|Dopamine Agents|dopamine agents|mesh-ancestor
110885603|NCT01339039|Plerixafor|plerixafor|mesh-list
110885604|NCT01339039|Bevacizumab|bevacizumab|mesh-list
110885605|NCT01339039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110885606|NCT01339039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110885607|NCT01339039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110885608|NCT01339039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110885609|NCT01339039|Growth Substances|growth substances|mesh-ancestor
110885610|NCT01339039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110885611|NCT01339039|Growth Inhibitors|growth inhibitors|mesh-ancestor
110885612|NCT01339039|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110885613|NCT01339039|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110885614|NCT01339039|Antiviral Agents|antiviral agents|mesh-ancestor
110475887|NCT02730975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110475888|NCT02730975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110475889|NCT02730975|Hormone Antagonists|hormone antagonists|mesh-ancestor
110475890|NCT02730975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110475891|NCT02730975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110475892|NCT02730975|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110475893|NCT00734071|Vortioxetine|vortioxetine|mesh-list
110475894|NCT00734071|Antidepressive Agents|antidepressive agents|mesh-ancestor
110475895|NCT00734071|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110475896|NCT00734071|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110475897|NCT00734071|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110475898|NCT00734071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110475899|NCT00734071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110475900|NCT00734071|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110475901|NCT00734071|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110475902|NCT00734071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110475903|NCT00734071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110475904|NCT00734071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110475905|NCT00734071|Serotonin Agents|serotonin agents|mesh-ancestor
110165543|NCT00011076|Pirfenidone|pirfenidone|mesh-list
110475906|NCT00734071|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110475907|NCT00734071|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110475908|NCT00734071|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110475909|NCT00734071|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110475910|NCT03255915|Tenofovir|tenofovir|mesh-list
110475911|NCT03255915|Emtricitabine|emtricitabine|mesh-list
110475912|NCT03255915|Antiviral Agents|antiviral agents|mesh-ancestor
110475913|NCT03255915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110885615|NCT01339039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110885616|NCT03176459|Bupivacaine|bupivacaine|mesh-list
110885617|NCT03176459|Anesthetics, Local|anesthetics, local|mesh-ancestor
110885618|NCT03176459|Anesthetics|anesthetics|mesh-ancestor
110885619|NCT03176459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110885620|NCT03176459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110885621|NCT03176459|Sensory System Agents|sensory system agents|mesh-ancestor
110885622|NCT03176459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110885623|NCT01332955|Ribavirin|ribavirin|mesh-list
110885624|NCT01332955|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110885625|NCT01332955|Antimetabolites|antimetabolites|mesh-ancestor
110885626|NCT01332955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110885627|NCT01332955|Antiviral Agents|antiviral agents|mesh-ancestor
110885628|NCT01332955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110885629|NCT05224895|Anesthetics|anesthetics|mesh-list
110885630|NCT05224895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110885631|NCT05224895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110885632|NCT01335373|Metronidazole|metronidazole|mesh-list
110885633|NCT01335373|Miconazole|miconazole|mesh-list
110885634|NCT01335373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110885635|NCT01335373|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110885636|NCT01335373|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110885649|NCT01333267|Hormones|hormones|mesh-list
110885660|NCT01335529|Ribavirin|ribavirin|mesh-list
110885661|NCT01335529|Interferon-alpha|interferon-alpha|mesh-list
110885662|NCT01335529|Interferon alpha-2|interferon alpha-2|mesh-list
110885663|NCT01335529|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110885664|NCT01335529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110885665|NCT01335529|Antiviral Agents|antiviral agents|mesh-ancestor
110885666|NCT01335529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110885667|NCT01335529|Antimetabolites|antimetabolites|mesh-ancestor
110885668|NCT01335529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110885669|NCT01335529|Immunologic Factors|immunologic factors|mesh-ancestor
110475914|NCT03255915|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110475915|NCT03255915|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110475916|NCT03255915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110475917|NCT03255915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110475918|NCT03255915|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110475919|NCT03255915|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110475920|NCT04188951|Pembrolizumab|pembrolizumab|mesh-list
110475921|NCT04188951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110475922|NCT04188951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110475923|NCT04188951|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110475924|NCT04188951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110475925|NCT00739297|Montelukast|montelukast|mesh-list
110475926|NCT00739297|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110475927|NCT00739297|Respiratory System Agents|respiratory system agents|mesh-ancestor
110123105|NCT01931293|Micronutrients|micronutrients|mesh-ancestor
110475928|NCT00739297|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110475929|NCT00739297|Hormone Antagonists|hormone antagonists|mesh-ancestor
110475930|NCT00739297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110475931|NCT00739297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110475932|NCT00739297|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110475933|NCT00739297|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110475934|NCT00739297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110475936|NCT05430243|Diuretics|diuretics|mesh-list
110475937|NCT05430243|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110475938|NCT05430243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110475939|NCT05430243|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110475940|NCT05430243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110475941|NCT05430243|Natriuretic Agents|natriuretic agents|mesh-ancestor
110475942|NCT02730117|Cephalosporins|cephalosporins|mesh-list
110475943|NCT02730117|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110475944|NCT02730117|Dobutamine|dobutamine|mesh-list
110475945|NCT02730117|Dopamine|dopamine|mesh-list
110475946|NCT02730117|Milrinone|milrinone|mesh-list
110475947|NCT02730117|Norepinephrine|norepinephrine|mesh-list
110475948|NCT02730117|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
110475949|NCT02730117|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110475950|NCT02730117|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110475951|NCT02730117|Adrenergic Agents|adrenergic agents|mesh-ancestor
110475952|NCT02730117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110475953|NCT02730117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110475954|NCT02730117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110475955|NCT02730117|Sympathomimetics|sympathomimetics|mesh-ancestor
110475956|NCT02730117|Autonomic Agents|autonomic agents|mesh-ancestor
110475957|NCT02730117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110475958|NCT02730117|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110475959|NCT02730117|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
110475960|NCT02730117|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110475961|NCT02730117|Protective Agents|protective agents|mesh-ancestor
110475962|NCT02730117|Dopamine Agents|dopamine agents|mesh-ancestor
110475963|NCT02730117|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110475964|NCT02730117|Vasodilator Agents|vasodilator agents|mesh-ancestor
110475965|NCT02730117|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110475966|NCT02730117|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110475967|NCT02730117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110475968|NCT02730117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110885670|NCT01335529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110885671|NCT00308347|Losartan|losartan|mesh-list
110885672|NCT00308347|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110603210|NCT01038037|Carboplatin|carboplatin|mesh-list
110885673|NCT00308347|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110885674|NCT00308347|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110885675|NCT00308347|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110885676|NCT00308347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110885678|NCT02186834|Doxorubicin|doxorubicin|mesh-list
110885679|NCT02186834|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110885680|NCT02186834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110885681|NCT02186834|Antiemetics|antiemetics|mesh-ancestor
110885682|NCT02186834|Autonomic Agents|autonomic agents|mesh-ancestor
110475969|NCT02595463|Lidocaine|lidocaine|mesh-list
110475970|NCT02595463|Anesthetics, Local|anesthetics, local|mesh-ancestor
110475971|NCT02595463|Anesthetics|anesthetics|mesh-ancestor
110475972|NCT02595463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110475973|NCT02595463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110475974|NCT02595463|Sensory System Agents|sensory system agents|mesh-ancestor
110475975|NCT02595463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110475976|NCT02595463|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110475977|NCT02595463|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110475978|NCT02595463|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110475979|NCT02595463|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110475980|NCT02595463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110475981|NCT02593669|Dexamethasone|dexamethasone|mesh-list
110475982|NCT02593669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110475983|NCT02593669|Antiemetics|antiemetics|mesh-ancestor
110475984|NCT02593669|Autonomic Agents|autonomic agents|mesh-ancestor
110475985|NCT02593669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110475986|NCT02593669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110475987|NCT02593669|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110475988|NCT02593669|Glucocorticoids|glucocorticoids|mesh-ancestor
110475989|NCT02593669|Hormones|hormones|mesh-ancestor
110475990|NCT02593669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110475991|NCT02593669|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110475992|NCT02593669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110475993|NCT02729961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110475994|NCT02729961|Brentuximab Vedotin|brentuximab vedotin|mesh-list
110475995|NCT02729961|Ceritinib|ceritinib|mesh-list
110475996|NCT02729961|Antibodies|antibodies|mesh-list
110475997|NCT02729961|Immunoglobulins|immunoglobulins|mesh-list
110475998|NCT02729961|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110475999|NCT02729961|Immunoconjugates|immunoconjugates|mesh-list
110476000|NCT02729961|Immunologic Factors|immunologic factors|mesh-ancestor
110476001|NCT02729961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110476002|NCT02729961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110476003|NCT02729961|Immunotoxins|immunotoxins|mesh-ancestor
110476004|NCT02729961|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110476005|NCT02729961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110476006|NCT02729961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110476007|NCT02735031|Exenatide|exenatide|mesh-list
110476008|NCT02735031|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110476009|NCT02735031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110476010|NCT02735031|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110476011|NCT02735031|Incretins|incretins|mesh-ancestor
110476012|NCT02735031|Hormones|hormones|mesh-ancestor
110476013|NCT02735031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110476014|NCT02595541|Milrinone|milrinone|mesh-list
110476015|NCT02595541|Sildenafil Citrate|sildenafil citrate|mesh-list
110476016|NCT02595541|Vasodilator Agents|vasodilator agents|mesh-ancestor
110476017|NCT02595541|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110476018|NCT02595541|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110885683|NCT02186834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110885684|NCT02186834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110885685|NCT02186834|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110885686|NCT02186834|Glucocorticoids|glucocorticoids|mesh-ancestor
110885687|NCT02186834|Hormones|hormones|mesh-ancestor
110885688|NCT02186834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110885689|NCT02186834|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110885690|NCT02186834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110885691|NCT02186834|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110885692|NCT02186834|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110206391|NCT00179062|Olanzapine|olanzapine|mesh-list
110476019|NCT02595541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110476020|NCT02595541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110476021|NCT02595541|Urological Agents|urological agents|mesh-ancestor
110476022|NCT02595541|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110476023|NCT02595541|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110476024|NCT02595541|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110476025|NCT02595541|Protective Agents|protective agents|mesh-ancestor
110476026|NCT02595541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110476027|NCT00739063|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110476028|NCT00739063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110476029|NCT00739063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110476030|NCT00739063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110476031|NCT00739063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110476032|NCT01026194|Pioglitazone|pioglitazone|mesh-list
110476033|NCT01026194|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110476034|NCT01026194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110476035|NCT02734875|Anticoagulants|anticoagulants|mesh-list
110476036|NCT04088461|Metformin|metformin|mesh-list
110476037|NCT04088461|Linagliptin|linagliptin|mesh-list
110476038|NCT04088461|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110476039|NCT04088461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110476040|NCT04088461|Incretins|incretins|mesh-ancestor
110476041|NCT04088461|Hormones|hormones|mesh-ancestor
110476042|NCT04088461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110476043|NCT04088461|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110476044|NCT04088461|Protease Inhibitors|protease inhibitors|mesh-ancestor
110476045|NCT04088461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110476046|NCT04088461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110476048|NCT00636519|Botulinum Antitoxin|botulinum antitoxin|mesh-list
110476049|NCT00636519|Immunologic Factors|immunologic factors|mesh-ancestor
110476050|NCT00636519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110476051|NCT00811954|Ritonavir|ritonavir|mesh-list
110476052|NCT00811954|Atazanavir Sulfate|atazanavir sulfate|mesh-list
110476053|NCT00811954|Darunavir|darunavir|mesh-list
110476054|NCT00811954|Tenofovir|tenofovir|mesh-list
110476055|NCT00811954|Emtricitabine|emtricitabine|mesh-list
110476056|NCT00811954|Raltegravir Potassium|raltegravir potassium|mesh-list
110476057|NCT00811954|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110476058|NCT00811954|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110476059|NCT00811954|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110476060|NCT00811954|Protease Inhibitors|protease inhibitors|mesh-ancestor
110476061|NCT00811954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110476062|NCT00811954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110476063|NCT00811954|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110476064|NCT00811954|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110476065|NCT00811954|Antiviral Agents|antiviral agents|mesh-ancestor
110476066|NCT00811954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110476067|NCT00811954|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110476068|NCT00811954|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110476069|NCT00811954|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110476070|NCT00811954|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110885693|NCT02186834|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110885694|NCT02186834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110885695|NCT02186834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110885696|NCT04335890|Vaccines|vaccines|mesh-list
110885697|NCT04335890|Immunologic Factors|immunologic factors|mesh-ancestor
110885698|NCT04335890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110885699|NCT01379157|Imipenem|imipenem|mesh-list
110885700|NCT01379157|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110885701|NCT01379157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110885702|NCT01538966|Octreotide|octreotide|mesh-list
110885703|NCT01538966|Lanreotide|lanreotide|mesh-list
110885704|NCT01538966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110885705|NCT01538966|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110885706|NCT01538966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110885707|NCT01377285|Pentoxifylline|pentoxifylline|mesh-list
110885708|NCT01377285|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
110206453|NCT00179608|Lenalidomide|lenalidomide|mesh-list
110476071|NCT00811954|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110476072|NCT00811954|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110476073|NCT00917839|Lamotrigine|lamotrigine|mesh-list
110476074|NCT00917839|Anticonvulsants|anticonvulsants|mesh-ancestor
110476075|NCT00917839|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110476076|NCT00917839|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110476077|NCT00917839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110476078|NCT00917839|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110476079|NCT00917839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110476080|NCT00917839|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110476081|NCT00917839|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110476082|NCT00917839|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110476083|NCT00917839|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110476084|NCT00917839|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110476085|NCT01032200|Modafinil|modafinil|mesh-list
110476086|NCT01032200|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110476087|NCT01032200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110476088|NCT01032200|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
110476089|NCT01032200|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110476090|NCT01032200|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110476091|NCT01032200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110476092|NCT03345771|Anti-Infective Agents|anti-infective agents|mesh-list
110476093|NCT03345771|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110476094|NCT00586105|Sorafenib|sorafenib|mesh-list
110476095|NCT00586105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110476096|NCT00586105|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110476097|NCT00586105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110476098|NCT00586105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110476099|NCT00743119|Dronabinol|dronabinol|mesh-list
110476100|NCT00743119|Hallucinogens|hallucinogens|mesh-ancestor
110476101|NCT00743119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110476102|NCT00743119|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110476103|NCT00743119|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110476104|NCT00743119|Analgesics|analgesics|mesh-ancestor
110476105|NCT00743119|Sensory System Agents|sensory system agents|mesh-ancestor
110476106|NCT00743119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110476107|NCT00743119|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
110476108|NCT00743119|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110476109|NCT00743119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110476110|NCT00743119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110476111|NCT00743119|Hormones|hormones|mesh-ancestor
110885709|NCT01377285|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110885710|NCT01377285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110885711|NCT01377285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110885712|NCT01377285|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110885713|NCT01377285|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110885714|NCT01377285|Protective Agents|protective agents|mesh-ancestor
110885715|NCT01377285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110885716|NCT01377285|Vasodilator Agents|vasodilator agents|mesh-ancestor
110885717|NCT01377285|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110885718|NCT01377285|Antioxidants|antioxidants|mesh-ancestor
110885719|NCT02905266|Nivolumab|nivolumab|mesh-list
110885720|NCT02905266|Ipilimumab|ipilimumab|mesh-list
110885721|NCT02905266|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110206508|NCT00180037|Ubiquinone|ubiquinone|mesh-list
110476112|NCT00743119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110476113|NCT02610010|Cisplatin|cisplatin|mesh-list
110476114|NCT02610010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110476115|NCT02610088|Dapagliflozin|dapagliflozin|mesh-list
110476116|NCT02610088|Gliclazide|gliclazide|mesh-list
110476117|NCT02610088|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110476118|NCT02610088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110476119|NCT02610088|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110476120|NCT02610088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110476121|NCT02734407|Aflibercept|aflibercept|mesh-list
110476122|NCT02734407|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110476123|NCT02734407|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110476124|NCT02734407|Growth Substances|growth substances|mesh-ancestor
110476125|NCT02734407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110476126|NCT02734407|Growth Inhibitors|growth inhibitors|mesh-ancestor
110476127|NCT02734407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110476128|NCT02734173|Ritonavir|ritonavir|mesh-list
110476129|NCT02734173|Ribavirin|ribavirin|mesh-list
110476130|NCT02734173|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110476131|NCT02734173|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110476132|NCT02734173|Protease Inhibitors|protease inhibitors|mesh-ancestor
110476133|NCT02734173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110476134|NCT02734173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110476135|NCT02734173|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110476136|NCT02734173|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110476137|NCT02734173|Antiviral Agents|antiviral agents|mesh-ancestor
110476138|NCT02734173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110476139|NCT02734173|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110476140|NCT02734173|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110476141|NCT02734173|Antimetabolites|antimetabolites|mesh-ancestor
110476142|NCT05297422|Ketamine|ketamine|mesh-list
110476143|NCT05297422|Ropivacaine|ropivacaine|mesh-list
110476144|NCT05297422|Analgesics|analgesics|mesh-ancestor
110476145|NCT05297422|Sensory System Agents|sensory system agents|mesh-ancestor
110476146|NCT05297422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110476147|NCT05297422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110476148|NCT05297422|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110476149|NCT05297422|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110476150|NCT05297422|Anesthetics, General|anesthetics, general|mesh-ancestor
110476151|NCT05297422|Anesthetics|anesthetics|mesh-ancestor
110476152|NCT05297422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110476153|NCT05297422|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110476154|NCT05297422|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110476155|NCT05297422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110476156|NCT05297422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110476157|NCT05297422|Anesthetics, Local|anesthetics, local|mesh-ancestor
110476158|NCT00813124|Fludarabine|fludarabine|mesh-list
110885722|NCT02905266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110885723|NCT02905266|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110885724|NCT02905266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110885725|NCT01380717|Calcium Channel Blockers|calcium channel blockers|mesh-list
110885726|NCT01380717|Calcium|calcium|mesh-list
110885727|NCT01380717|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
110885728|NCT01380717|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
110885729|NCT01380717|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110476159|NCT00813124|Fludarabine phosphate|fludarabine phosphate|mesh-list
110476160|NCT00813124|Azacitidine|azacitidine|mesh-list
110476161|NCT00813124|Busulfan|busulfan|mesh-list
110476162|NCT00813124|Thymoglobulin|thymoglobulin|mesh-list
110476163|NCT00813124|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110476164|NCT00813124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110476165|NCT00813124|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110476166|NCT00813124|Antimetabolites|antimetabolites|mesh-ancestor
110476167|NCT00813124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110476168|NCT00813124|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110476169|NCT00813124|Immunologic Factors|immunologic factors|mesh-ancestor
110476170|NCT00813124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110476171|NCT00813124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110476172|NCT00813124|Alkylating Agents|alkylating agents|mesh-ancestor
110476173|NCT00813124|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110476174|NCT00813124|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110476175|NCT00733291|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110476177|NCT02728869|Immunologic Factors|immunologic factors|mesh-ancestor
110476178|NCT02728869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110476179|NCT02594761|Trastuzumab|trastuzumab|mesh-list
110476180|NCT02594761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110476181|NCT02594761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110476182|NCT02728947|Rotigotine|rotigotine|mesh-list
110476183|NCT02728947|Dopamine Agonists|dopamine agonists|mesh-ancestor
110476184|NCT02728947|Dopamine Agents|dopamine agents|mesh-ancestor
110476185|NCT02728947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110476186|NCT02728947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110476187|NCT02728947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110476188|NCT02729103|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
110476189|NCT02729103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110476190|NCT02733705|Fentanyl|fentanyl|mesh-list
110476191|NCT02733705|Propofol|propofol|mesh-list
110476192|NCT02733705|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110476193|NCT02733705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110476194|NCT02733705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110476195|NCT02733705|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110476196|NCT02733705|Anesthetics, General|anesthetics, general|mesh-ancestor
110476197|NCT02733705|Anesthetics|anesthetics|mesh-ancestor
110476198|NCT02733705|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110476199|NCT02733705|Narcotics|narcotics|mesh-ancestor
110476200|NCT02733705|Analgesics|analgesics|mesh-ancestor
110476201|NCT02733705|Sensory System Agents|sensory system agents|mesh-ancestor
110476202|NCT02733705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110476203|NCT02733705|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110476204|NCT02597257|Lidocaine|lidocaine|mesh-list
110476205|NCT02597257|Anesthetics, Local|anesthetics, local|mesh-ancestor
110476206|NCT02597257|Anesthetics|anesthetics|mesh-ancestor
110476207|NCT02597257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110476208|NCT02597257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110476209|NCT02597257|Sensory System Agents|sensory system agents|mesh-ancestor
110476210|NCT02597257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110476211|NCT02597257|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110476212|NCT02597257|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110476213|NCT02597257|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110476214|NCT02597257|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110476215|NCT02597257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110476216|NCT02596555|Dabigatran|dabigatran|mesh-list
110476217|NCT02596555|Antithrombins|antithrombins|mesh-ancestor
110885730|NCT01380717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110885731|NCT01380717|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110885732|NCT01380717|Adrenergic Agents|adrenergic agents|mesh-ancestor
110885733|NCT01380717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110885734|NCT01380717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110885735|NCT01380717|Protease Inhibitors|protease inhibitors|mesh-ancestor
110885736|NCT01380717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110885737|NCT01380717|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110885738|NCT03080493|Acetaminophen|acetaminophen|mesh-list
110885739|NCT03080493|Ibuprofen|ibuprofen|mesh-list
110885740|NCT03080493|Gabapentin|gabapentin|mesh-list
110885741|NCT03080493|Codeine|codeine|mesh-list
110885742|NCT03080493|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
110476218|NCT02596555|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110601079|NCT00732186|Ipilimumab|ipilimumab|mesh-list
110476219|NCT02596555|Protease Inhibitors|protease inhibitors|mesh-ancestor
110476220|NCT02596555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110476221|NCT02596555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110476222|NCT02596555|Anticoagulants|anticoagulants|mesh-ancestor
110476223|NCT02733471|Lidocaine|lidocaine|mesh-list
110476224|NCT02733471|Anesthetics, Local|anesthetics, local|mesh-ancestor
110476225|NCT02733471|Anesthetics|anesthetics|mesh-ancestor
110476226|NCT02733471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110476227|NCT02733471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110476228|NCT02733471|Sensory System Agents|sensory system agents|mesh-ancestor
110476229|NCT02733471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110476230|NCT02733471|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110476231|NCT02733471|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110476232|NCT02733471|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110476233|NCT02733471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110476234|NCT02733471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110476235|NCT02733237|Oxytocin|oxytocin|mesh-list
110476236|NCT02733237|Oxytocics|oxytocics|mesh-ancestor
110476237|NCT02733237|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110476238|NCT02733237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110476239|NCT02728323|Levobupivacaine|levobupivacaine|mesh-list
110476240|NCT02728323|Anesthetics, Local|anesthetics, local|mesh-ancestor
110476241|NCT02728323|Anesthetics|anesthetics|mesh-ancestor
110476242|NCT02728323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110476243|NCT02728323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110399033|NCT01312961|Xhance|xhance|mesh-list
110476244|NCT02728323|Sensory System Agents|sensory system agents|mesh-ancestor
110476245|NCT02728323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110476246|NCT00811720|Nalmefene|nalmefene|mesh-list
110476247|NCT00811720|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110476248|NCT00811720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110476249|NCT00811720|Sensory System Agents|sensory system agents|mesh-ancestor
110476250|NCT00811720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110476251|NCT04202679|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
110476252|NCT04202679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110476253|NCT04202679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110476254|NCT00811642|Posaconazole|posaconazole|mesh-list
110476255|NCT00811642|Antifungal Agents|antifungal agents|mesh-ancestor
110476256|NCT00811642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110476257|NCT00811642|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
110476258|NCT00811642|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110476259|NCT00811642|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110476260|NCT00811642|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110476261|NCT00811642|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110476262|NCT00811642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110476263|NCT00811642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110476264|NCT00811642|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110476265|NCT00811642|Hormone Antagonists|hormone antagonists|mesh-ancestor
110885743|NCT03080493|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110885744|NCT03080493|Analgesics|analgesics|mesh-ancestor
110885745|NCT03080493|Sensory System Agents|sensory system agents|mesh-ancestor
110885746|NCT03080493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110603289|NCT01038583|Aspirin|aspirin|mesh-list
110885747|NCT03080493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110885748|NCT03080493|Antipyretics|antipyretics|mesh-ancestor
110601097|NCT00876772|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110885749|NCT03080493|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110885750|NCT03080493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110885751|NCT03080493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110476266|NCT00811642|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110476267|NCT00811642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110476268|NCT02609152|Esmolol|esmolol|mesh-list
110476269|NCT02609152|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110476270|NCT02609152|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110476271|NCT02609152|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110476272|NCT02609152|Adrenergic Agents|adrenergic agents|mesh-ancestor
110476273|NCT02609152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110476274|NCT02609152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110476275|NCT02609152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110476276|NCT02733393|Lidocaine|lidocaine|mesh-list
110476277|NCT02733393|Anesthetics, Local|anesthetics, local|mesh-ancestor
110476278|NCT02733393|Anesthetics|anesthetics|mesh-ancestor
110476279|NCT02733393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110476280|NCT02733393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110476281|NCT02733393|Sensory System Agents|sensory system agents|mesh-ancestor
110476282|NCT02733393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110476283|NCT02733393|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110476284|NCT02733393|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110476285|NCT02733393|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110476286|NCT02733393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110476287|NCT02733393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110476288|NCT00809926|Valsartan|valsartan|mesh-list
110476289|NCT00809926|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110476290|NCT00809926|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110476291|NCT00809926|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110476292|NCT00809926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110476293|NCT02728245|Dienogest|dienogest|mesh-list
110476294|NCT02728245|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110476295|NCT02728245|Contraceptive Agents|contraceptive agents|mesh-ancestor
110476296|NCT02728245|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110476297|NCT02728245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110476298|NCT02728245|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110476299|NCT02728245|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110476300|NCT02728245|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110476301|NCT02728245|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110476302|NCT02728245|Hormone Antagonists|hormone antagonists|mesh-ancestor
110476303|NCT02728245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110476304|NCT02728245|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110476305|NCT02728245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110476306|NCT02690415|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110476307|NCT02690415|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
110476308|NCT02690415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110476309|NCT02690415|Antitubercular Agents|antitubercular agents|mesh-ancestor
110476310|NCT05753722|Pembrolizumab|pembrolizumab|mesh-list
110476311|NCT05753722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110476312|NCT05753722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110476313|NCT05753722|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110476314|NCT05753722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110476315|NCT02727621|Dexmedetomidine|dexmedetomidine|mesh-list
110476316|NCT02727621|Propofol|propofol|mesh-list
110476317|NCT02727621|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110885752|NCT03080493|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110885753|NCT03080493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110885754|NCT03080493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110885756|NCT03080493|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110885757|NCT03080493|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110885758|NCT03080493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110885759|NCT03080493|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110885760|NCT03080493|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110885761|NCT03080493|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110885762|NCT03080493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110885763|NCT03080493|Antimanic Agents|antimanic agents|mesh-ancestor
110885764|NCT03080493|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110885766|NCT03080493|Antitussive Agents|antitussive agents|mesh-ancestor
110885767|NCT03080493|Respiratory System Agents|respiratory system agents|mesh-ancestor
110885768|NCT03080493|Laxatives|laxatives|mesh-ancestor
110885769|NCT03080493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110476318|NCT02727621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110476319|NCT02727621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110476320|NCT02727621|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110476321|NCT02727621|Analgesics|analgesics|mesh-ancestor
110476322|NCT02727621|Sensory System Agents|sensory system agents|mesh-ancestor
110476323|NCT02727621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110476324|NCT02727621|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110476325|NCT02727621|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110476326|NCT02727621|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110476327|NCT02727621|Adrenergic Agents|adrenergic agents|mesh-ancestor
110476328|NCT02727621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110476329|NCT02727621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110476330|NCT02727621|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110476331|NCT02727621|Anesthetics, General|anesthetics, general|mesh-ancestor
110476333|NCT02608606|Tacrolimus|tacrolimus|mesh-list
110476334|NCT02608606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110476335|NCT02608606|Immunologic Factors|immunologic factors|mesh-ancestor
110476336|NCT02608606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110476337|NCT02608606|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110476338|NCT02608606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110476339|NCT02608606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110476340|NCT02608918|BMS-955176|bms-955176|mesh-list
110476341|NCT02608918|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110476342|NCT02608918|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110476343|NCT02608918|Antiviral Agents|antiviral agents|mesh-ancestor
110476344|NCT02608918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110476345|NCT05755204|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110476346|NCT05755204|Cabotegravir|cabotegravir|mesh-list
110476347|NCT05755204|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110476348|NCT05755204|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110476349|NCT05755204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110476350|NCT05755204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110476351|NCT05755204|Antiviral Agents|antiviral agents|mesh-ancestor
110476352|NCT05755204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110476353|NCT05755204|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110476354|NCT05755204|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110476355|NCT05755204|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110885774|NCT01339910|Vidarabine|vidarabine|mesh-list
110885775|NCT01339910|Cyclophosphamide|cyclophosphamide|mesh-list
110885776|NCT01339910|Melphalan|melphalan|mesh-list
110885777|NCT01339910|Busulfan|busulfan|mesh-list
110885778|NCT01339910|Fludarabine|fludarabine|mesh-list
110885779|NCT01339910|Fludarabine phosphate|fludarabine phosphate|mesh-list
110885780|NCT01339910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110885781|NCT01339910|Immunologic Factors|immunologic factors|mesh-ancestor
110885782|NCT01339910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110885783|NCT01339910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110885784|NCT01339910|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110601125|NCT00876850|Linezolid|linezolid|mesh-list
110885785|NCT01339910|Alkylating Agents|alkylating agents|mesh-ancestor
110206796|NCT00182650|Immunologic Factors|immunologic factors|mesh-ancestor
110476356|NCT05755204|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110476357|NCT02727309|Apatinib|apatinib|mesh-list
110476358|NCT02727309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110476359|NCT02727309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110476360|NCT02727309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110476361|NCT02727309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110476362|NCT05755750|Genipin|genipin|mesh-list
110476363|NCT05755750|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
110476364|NCT05755750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110476365|NCT02732067|Anesthetics|anesthetics|mesh-list
110476366|NCT02732067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110476367|NCT02732067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110476368|NCT02609932|Interferons|interferons|mesh-list
110476369|NCT02609932|Interferon-gamma|interferon-gamma|mesh-list
110123557|NCT01934569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110476370|NCT02609932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110476372|NCT02609932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110476373|NCT02726919|Clobazam|clobazam|mesh-list
110476374|NCT02726919|Anticonvulsants|anticonvulsants|mesh-ancestor
110476375|NCT02726919|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110476376|NCT02726919|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110476377|NCT02726919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110476378|NCT02726919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110476379|NCT02726919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110476380|NCT02726919|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
110476381|NCT02726919|GABA Agonists|gaba agonists|mesh-ancestor
110476382|NCT02726919|GABA Agents|gaba agents|mesh-ancestor
110476383|NCT02726919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110476384|NCT02726919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110476385|NCT00590902|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110476386|NCT00590902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110476387|NCT00590902|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110476388|NCT00590902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110476389|NCT00590902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110476390|NCT05753566|Androgens|androgens|mesh-list
110476391|NCT05753566|Hormones|hormones|mesh-ancestor
110476392|NCT05753566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110476393|NCT05753566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110476394|NCT00590824|Interleukin-2|interleukin-2|mesh-list
110476395|NCT00590824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110476396|NCT00590824|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110476397|NCT00590824|Analgesics|analgesics|mesh-ancestor
110476398|NCT00590824|Sensory System Agents|sensory system agents|mesh-ancestor
110476399|NCT00590824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110476400|NCT00590824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110476401|NCT02720991|Misoprostol|misoprostol|mesh-list
110476402|NCT02720991|Mifepristone|mifepristone|mesh-list
110476403|NCT02720991|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110476404|NCT02720991|Abortifacient Agents|abortifacient agents|mesh-ancestor
110476405|NCT02720991|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110476406|NCT02720991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110885786|NCT01339910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110885787|NCT01339910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110885788|NCT01339910|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110885789|NCT01339910|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110885790|NCT01339910|Antimetabolites|antimetabolites|mesh-ancestor
110885791|NCT01339910|Antiviral Agents|antiviral agents|mesh-ancestor
110885792|NCT01339910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110885793|NCT02647827|Metformin|metformin|mesh-list
110885794|NCT02647827|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110885795|NCT02647827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110885796|NCT03655392|Nitric Oxide|nitric oxide|mesh-list
110885797|NCT03655392|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110476407|NCT02720991|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110476408|NCT02720991|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110476409|NCT02720991|Oxytocics|oxytocics|mesh-ancestor
110476410|NCT02720991|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
110476411|NCT02720991|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110476412|NCT02720991|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110476413|NCT02720991|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110476414|NCT02720991|Contraceptive Agents|contraceptive agents|mesh-ancestor
110476415|NCT02720991|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
110476416|NCT02720991|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
110476417|NCT02720991|Hormone Antagonists|hormone antagonists|mesh-ancestor
110476418|NCT02720991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110476419|NCT02720991|Luteolytic Agents|luteolytic agents|mesh-ancestor
110476420|NCT02720991|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110476421|NCT02720991|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
110476422|NCT02720601|Capecitabine|capecitabine|mesh-list
110476423|NCT02720601|Irinotecan|irinotecan|mesh-list
110476424|NCT02720601|Camptothecin|camptothecin|mesh-list
110476425|NCT02720601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110476426|NCT02720601|Antimetabolites|antimetabolites|mesh-ancestor
110476427|NCT02720601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110476428|NCT02720601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110476429|NCT02720601|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110476430|NCT02720601|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110476431|NCT02720601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110476432|NCT02720601|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110476433|NCT00590590|Diphenhydramine|diphenhydramine|mesh-list
110476434|NCT00590590|Promethazine|promethazine|mesh-list
110476435|NCT00590590|Lidocaine|lidocaine|mesh-list
110476436|NCT00590590|Anesthetics, Local|anesthetics, local|mesh-ancestor
110476437|NCT00590590|Anesthetics|anesthetics|mesh-ancestor
110476438|NCT00590590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110476439|NCT00590590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110476440|NCT00590590|Sensory System Agents|sensory system agents|mesh-ancestor
110476441|NCT00590590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110476442|NCT00590590|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110476443|NCT00590590|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110476444|NCT00590590|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110476445|NCT00590590|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110476446|NCT00590590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110476447|NCT00590590|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110476448|NCT00590590|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110476449|NCT00590590|Antiemetics|antiemetics|mesh-ancestor
110476450|NCT00590590|Autonomic Agents|autonomic agents|mesh-ancestor
110476451|NCT00590590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110476452|NCT00590590|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110476453|NCT00590590|Histamine Antagonists|histamine antagonists|mesh-ancestor
110476454|NCT00590590|Histamine Agents|histamine agents|mesh-ancestor
110476455|NCT00590590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110476456|NCT00590590|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110476457|NCT00590590|Antipruritics|antipruritics|mesh-ancestor
110885799|NCT03655392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110885800|NCT03655392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110885801|NCT03655392|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110885802|NCT03655392|Respiratory System Agents|respiratory system agents|mesh-ancestor
110885803|NCT03655392|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110885804|NCT03655392|Antioxidants|antioxidants|mesh-ancestor
110885805|NCT03655392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110885806|NCT03655392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110476458|NCT00590590|Dermatologic Agents|dermatologic agents|mesh-ancestor
110476459|NCT02720367|Gemcitabine|gemcitabine|mesh-list
110476460|NCT02720367|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110476461|NCT02720367|Antimetabolites|antimetabolites|mesh-ancestor
110165576|NCT00024193|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110476462|NCT02720367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110476463|NCT02720367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110476465|NCT02693769|Xhance|xhance|mesh-list
110476466|NCT02693769|Glycopyrrolate|glycopyrrolate|mesh-list
110476467|NCT02693769|Bromides|bromides|mesh-list
110476468|NCT02693769|Formoterol Fumarate|formoterol fumarate|mesh-list
110476469|NCT02693769|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110476470|NCT02693769|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110476471|NCT02693769|Autonomic Agents|autonomic agents|mesh-ancestor
110476472|NCT02693769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110476473|NCT02693769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110476474|NCT02693769|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110476475|NCT02693769|Respiratory System Agents|respiratory system agents|mesh-ancestor
110476476|NCT02693769|Dermatologic Agents|dermatologic agents|mesh-ancestor
110476477|NCT02693769|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110476478|NCT02693769|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110476479|NCT02693769|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110476480|NCT02693769|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110476481|NCT02693769|Adrenergic Agents|adrenergic agents|mesh-ancestor
110476482|NCT02693769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110476483|NCT02693769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110476484|NCT02693769|Anticonvulsants|anticonvulsants|mesh-ancestor
110476485|NCT02693769|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110476486|NCT02693769|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110476487|NCT02693769|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110476488|NCT02693769|Cholinergic Agents|cholinergic agents|mesh-ancestor
110476489|NCT02725359|Tizanidine|tizanidine|mesh-list
110476490|NCT02725359|Bupivacaine|bupivacaine|mesh-list
110476491|NCT02725359|Anesthetics, Local|anesthetics, local|mesh-ancestor
110476492|NCT02725359|Anesthetics|anesthetics|mesh-ancestor
110476493|NCT02725359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110476494|NCT02725359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110476495|NCT02725359|Sensory System Agents|sensory system agents|mesh-ancestor
110601256|NCT00735930|Growth Substances|growth substances|mesh-ancestor
110476496|NCT02725359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110476497|NCT02725359|Analgesics|analgesics|mesh-ancestor
110476498|NCT02725359|Anticonvulsants|anticonvulsants|mesh-ancestor
110476499|NCT02725359|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110476500|NCT02725359|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110476501|NCT02725359|Parasympatholytics|parasympatholytics|mesh-ancestor
110476502|NCT02725359|Autonomic Agents|autonomic agents|mesh-ancestor
110476503|NCT02725359|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110476504|NCT02725359|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110476505|NCT02725359|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110476506|NCT02725359|Adrenergic Agents|adrenergic agents|mesh-ancestor
110476507|NCT02725359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110476508|NCT02725359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110476509|NCT00731731|Temozolomide|temozolomide|mesh-list
110476510|NCT00731731|Vorinostat|vorinostat|mesh-list
110476511|NCT00731731|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110476512|NCT00731731|Alkylating Agents|alkylating agents|mesh-ancestor
110476513|NCT00731731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110476514|NCT00731731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110885807|NCT03655392|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
110885808|NCT03655392|Vasodilator Agents|vasodilator agents|mesh-ancestor
110885809|NCT03655392|Gasotransmitters|gasotransmitters|mesh-ancestor
110885810|NCT03655392|Protective Agents|protective agents|mesh-ancestor
110885811|NCT03608618|Cyclophosphamide|cyclophosphamide|mesh-list
110885812|NCT03608618|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110885813|NCT03608618|Immunologic Factors|immunologic factors|mesh-ancestor
110885814|NCT03608618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110476515|NCT00731731|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110476516|NCT00731731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110476518|NCT02719431|Anticoagulants|anticoagulants|mesh-ancestor
110476519|NCT00806494|Fesoterodine|fesoterodine|mesh-list
110476520|NCT00806494|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110476521|NCT00806494|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110476522|NCT00806494|Cholinergic Agents|cholinergic agents|mesh-ancestor
110476523|NCT00806494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110476524|NCT00806494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110476525|NCT00806494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110476526|NCT00806494|Urological Agents|urological agents|mesh-ancestor
110476527|NCT00806416|Vitamin D|vitamin d|mesh-list
110476528|NCT00806416|Cholecalciferol|cholecalciferol|mesh-list
110476529|NCT00806416|Alendronate|alendronate|mesh-list
110476530|NCT00806416|Vitamins|vitamins|mesh-ancestor
110476531|NCT00806416|Micronutrients|micronutrients|mesh-ancestor
110476532|NCT00806416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110476533|NCT00806416|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110476534|NCT00806416|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110476535|NCT00811252|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110476536|NCT00811252|Vortioxetine|vortioxetine|mesh-list
110165581|NCT00024193|Antimitotic Agents|antimitotic agents|mesh-ancestor
110476537|NCT00811252|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110476538|NCT00811252|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110476539|NCT00811252|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110476540|NCT00811252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110476541|NCT00811252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110476542|NCT00811252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110476543|NCT00811252|Analgesics|analgesics|mesh-ancestor
110476544|NCT00811252|Sensory System Agents|sensory system agents|mesh-ancestor
110476545|NCT00811252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110476546|NCT00811252|Antidepressive Agents|antidepressive agents|mesh-ancestor
110476547|NCT00811252|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110476548|NCT00811252|Dopamine Agents|dopamine agents|mesh-ancestor
110476549|NCT00811252|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110476550|NCT00811252|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110476551|NCT00811252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110476552|NCT00811252|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110476553|NCT00811252|Serotonin Agents|serotonin agents|mesh-ancestor
110476554|NCT00811252|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110476555|NCT00811252|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110476556|NCT00811252|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110476557|NCT00811252|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110476558|NCT02608996|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
110476559|NCT02608996|Natriuretic Agents|natriuretic agents|mesh-ancestor
110476560|NCT02608996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110476561|NCT00736957|Acetaminophen|acetaminophen|mesh-list
110476562|NCT00736957|Tramadol|tramadol|mesh-list
110476563|NCT00736957|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110476564|NCT00736957|Analgesics|analgesics|mesh-ancestor
110476565|NCT00736957|Sensory System Agents|sensory system agents|mesh-ancestor
110476566|NCT00736957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110476567|NCT00736957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110476568|NCT00736957|Antipyretics|antipyretics|mesh-ancestor
110476569|NCT00736957|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110476570|NCT00736957|Narcotics|narcotics|mesh-ancestor
110476571|NCT00736957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110476572|NCT05294523|Rocuronium|rocuronium|mesh-list
110885815|NCT03608618|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110885816|NCT03608618|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110885817|NCT03608618|Alkylating Agents|alkylating agents|mesh-ancestor
110885818|NCT03608618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110885819|NCT03608618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110885820|NCT03608618|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110885821|NCT04203290|Bupivacaine|bupivacaine|mesh-list
110476573|NCT05294523|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110476574|NCT05294523|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110476575|NCT05294523|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110476576|NCT05294523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110476577|NCT05294523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110476578|NCT00736879|Dapagliflozin|dapagliflozin|mesh-list
110476579|NCT00736879|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110476580|NCT00736879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110476581|NCT00736879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110476582|NCT00736879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110476583|NCT02718261|Pantoprazole|pantoprazole|mesh-list
110476584|NCT02718261|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110476585|NCT02718261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110476586|NCT02718261|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110476587|NCT02718261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110476588|NCT02718261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110476589|NCT00806260|Ethanol|ethanol|mesh-list
110476590|NCT00806260|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110476591|NCT00806260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110476592|NCT00806260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110476593|NCT00806260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110476594|NCT02718183|Hydrogen Peroxide|hydrogen peroxide|mesh-list
110476595|NCT02718183|Carbamide Peroxide|carbamide peroxide|mesh-list
110476596|NCT02718183|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110476597|NCT02718183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110476598|NCT00811174|gamma-Globulins|gamma-globulins|mesh-list
110476599|NCT00811174|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110476600|NCT00811174|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110476601|NCT00811174|Immunologic Factors|immunologic factors|mesh-ancestor
110476602|NCT00811174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110476603|NCT02723487|Bupivacaine|bupivacaine|mesh-list
110476604|NCT02723487|Anesthetics, Local|anesthetics, local|mesh-ancestor
110476605|NCT02723487|Anesthetics|anesthetics|mesh-ancestor
110476606|NCT02723487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110476607|NCT02723487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110476608|NCT02723487|Sensory System Agents|sensory system agents|mesh-ancestor
110476609|NCT02723487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110476610|NCT02717871|Moxifloxacin|moxifloxacin|mesh-list
110476611|NCT02717871|Ciprofloxacin|ciprofloxacin|mesh-list
110476612|NCT02717871|Levofloxacin|levofloxacin|mesh-list
110476613|NCT02717871|Ofloxacin|ofloxacin|mesh-list
110476614|NCT02717871|Gentamicins|gentamicins|mesh-list
110476615|NCT02717871|Cefazolin|cefazolin|mesh-list
110476616|NCT02717871|Tobramycin|tobramycin|mesh-list
110476617|NCT02717871|Gatifloxacin|gatifloxacin|mesh-list
110476618|NCT02717871|Fluoroquinolones|fluoroquinolones|mesh-list
110476619|NCT02717871|Besifloxacin|besifloxacin|mesh-list
110476620|NCT02717871|Prednisolone|prednisolone|mesh-list
110476621|NCT02717871|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110476622|NCT02717871|Methylprednisolone|methylprednisolone|mesh-list
110476623|NCT02717871|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110476624|NCT02717871|Prednisolone acetate|prednisolone acetate|mesh-list
110476625|NCT02717871|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110476626|NCT02717871|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110476627|NCT02717871|Prednisolone phosphate|prednisolone phosphate|mesh-list
110476628|NCT02717871|Cyclopentolate|cyclopentolate|mesh-list
110476629|NCT02717871|Mydriatics|mydriatics|mesh-list
110476630|NCT02717871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110476631|NCT02717871|Glucocorticoids|glucocorticoids|mesh-ancestor
110476632|NCT02717871|Hormones|hormones|mesh-ancestor
110476633|NCT02717871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110476634|NCT02717871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110034048|NCT01595620|Dermatologic Agents|dermatologic agents|mesh-ancestor
110885822|NCT04203290|Sevoflurane|sevoflurane|mesh-list
110885823|NCT04203290|Anesthetics, Local|anesthetics, local|mesh-ancestor
110885824|NCT04203290|Anesthetics|anesthetics|mesh-ancestor
110885825|NCT04203290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110885826|NCT04203290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110885827|NCT04203290|Sensory System Agents|sensory system agents|mesh-ancestor
110885828|NCT04203290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110885829|NCT04203290|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110885830|NCT04203290|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110885831|NCT04203290|Anesthetics, General|anesthetics, general|mesh-ancestor
110885832|NCT02981082|Dimethyl Fumarate|dimethyl fumarate|mesh-list
110885833|NCT02981082|Dermatologic Agents|dermatologic agents|mesh-ancestor
110885834|NCT02981082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110885835|NCT02981082|Immunologic Factors|immunologic factors|mesh-ancestor
110885836|NCT02981082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110885838|NCT03654612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110885839|NCT03654612|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110885840|NCT03654612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110885841|NCT03654612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110885842|NCT01066104|Omalizumab|omalizumab|mesh-list
110885843|NCT01066104|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110207124|NCT00185107|Ezetimibe|ezetimibe|mesh-list
110476635|NCT02717871|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110476636|NCT02717871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110476637|NCT02717871|Antiemetics|antiemetics|mesh-ancestor
110476638|NCT02717871|Autonomic Agents|autonomic agents|mesh-ancestor
110476639|NCT02717871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110476640|NCT02717871|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110476641|NCT02717871|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110476642|NCT02717871|Protective Agents|protective agents|mesh-ancestor
110476643|NCT02717871|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110476644|NCT02717871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110476645|NCT02717871|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110476646|NCT02717871|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110476647|NCT02717871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110476648|NCT02717871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110476649|NCT02717871|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110476650|NCT02717871|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110476651|NCT02717871|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110476652|NCT02717871|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110476653|NCT02717871|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110476654|NCT02717871|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110476655|NCT02717871|Parasympatholytics|parasympatholytics|mesh-ancestor
110476656|NCT02717871|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110476657|NCT02717871|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110476658|NCT02717871|Cholinergic Agents|cholinergic agents|mesh-ancestor
110476659|NCT02717871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110476660|NCT02723253|Raltitrexed|raltitrexed|mesh-list
110476661|NCT02723253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110476662|NCT02723253|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110476663|NCT02723253|Antimetabolites|antimetabolites|mesh-ancestor
110476664|NCT02723253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110034049|NCT01591629|Dronabinol|dronabinol|mesh-list
110885845|NCT01066104|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110885846|NCT01066104|Respiratory System Agents|respiratory system agents|mesh-ancestor
110885847|NCT01066104|Immunologic Factors|immunologic factors|mesh-ancestor
110885848|NCT01066104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110885849|NCT02736968|Auranofin|auranofin|mesh-list
110885850|NCT02736968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110885851|NCT03608306|Methamphetamine|methamphetamine|mesh-list
110885852|NCT03608306|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110885853|NCT03608306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110885854|NCT03608306|Sympathomimetics|sympathomimetics|mesh-ancestor
110885855|NCT03608306|Autonomic Agents|autonomic agents|mesh-ancestor
110885856|NCT03608306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110885857|NCT03608306|Dopamine Agents|dopamine agents|mesh-ancestor
110885858|NCT03608306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110476665|NCT02723253|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110476666|NCT02723253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110476667|NCT00730405|Albaconazole|albaconazole|mesh-list
110476668|NCT00730405|Antifungal Agents|antifungal agents|mesh-ancestor
110476669|NCT00730405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110476670|NCT02594449|Benzalkonium Compounds|benzalkonium compounds|mesh-list
110476671|NCT02594449|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110476672|NCT02594449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110476673|NCT02722083|Chlorpheniramine|chlorpheniramine|mesh-list
110476674|NCT02722083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110476675|NCT02722083|Antipruritics|antipruritics|mesh-ancestor
110476676|NCT02722083|Dermatologic Agents|dermatologic agents|mesh-ancestor
110476677|NCT02722083|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110476678|NCT02722083|Histamine Antagonists|histamine antagonists|mesh-ancestor
110476679|NCT02722083|Histamine Agents|histamine agents|mesh-ancestor
110476680|NCT02722083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110476681|NCT02722083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110476682|NCT02722083|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110476683|NCT05201079|Fidaxomicin|fidaxomicin|mesh-list
110476684|NCT05201079|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110476685|NCT05201079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110476686|NCT00736645|Selenium|selenium|mesh-list
110476687|NCT00736645|Finasteride|finasteride|mesh-list
110476688|NCT00736645|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
110476689|NCT00736645|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110476690|NCT00736645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110476691|NCT00736645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110476692|NCT00736645|Hormone Antagonists|hormone antagonists|mesh-ancestor
110476693|NCT00736645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110476694|NCT00736645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110476695|NCT00736645|Urological Agents|urological agents|mesh-ancestor
110476697|NCT00736645|Protective Agents|protective agents|mesh-ancestor
110476698|NCT00736645|Trace Elements|trace elements|mesh-ancestor
110476699|NCT00736645|Micronutrients|micronutrients|mesh-ancestor
110476700|NCT00736489|Formoterol Fumarate|formoterol fumarate|mesh-list
110476701|NCT00736489|AZD-3199|azd-3199|mesh-list
110476702|NCT00736489|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110476703|NCT00736489|Autonomic Agents|autonomic agents|mesh-ancestor
110476704|NCT00736489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110476705|NCT00736489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110476706|NCT00736489|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110476707|NCT00736489|Respiratory System Agents|respiratory system agents|mesh-ancestor
110476708|NCT00736489|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110476709|NCT00736489|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110476710|NCT00736489|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110476711|NCT00736489|Adrenergic Agents|adrenergic agents|mesh-ancestor
110885859|NCT03608306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110885860|NCT03608306|Adrenergic Agents|adrenergic agents|mesh-ancestor
110885861|NCT03608306|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110885862|NCT03608306|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110885863|NCT03608306|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110885864|NCT03608306|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110885866|NCT03654144|Contraceptive Agents|contraceptive agents|mesh-list
110885867|NCT03654144|Contraceptives, Oral|contraceptives, oral|mesh-list
110885868|NCT03654144|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
110885869|NCT03654144|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110476712|NCT00736489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110476713|NCT00736489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110476714|NCT02716233|Pegaspargase|pegaspargase|mesh-list
110476715|NCT02716233|Asparaginase|asparaginase|mesh-list
110476716|NCT02716233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110476717|NCT01999569|Letrozole|letrozole|mesh-list
110476718|NCT01999569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110476719|NCT01999569|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110476720|NCT01999569|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110476721|NCT01999569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110601342|NCT00736346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110476722|NCT01999569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110476723|NCT01999569|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110476724|NCT01999569|Hormone Antagonists|hormone antagonists|mesh-ancestor
110476725|NCT01999569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110476726|NCT01999569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110476727|NCT04087915|Evolocumab|evolocumab|mesh-list
110476728|NCT04087915|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
110476729|NCT04087915|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110476730|NCT04087915|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110476731|NCT04087915|Antimetabolites|antimetabolites|mesh-ancestor
110476732|NCT04087915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110476733|NCT04087915|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110476734|NCT04087915|Protease Inhibitors|protease inhibitors|mesh-ancestor
110476735|NCT04087915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110476736|NCT04087915|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110476737|NCT02715687|Amiodarone|amiodarone|mesh-list
110476738|NCT02715687|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110476739|NCT02715687|Vasodilator Agents|vasodilator agents|mesh-ancestor
110476740|NCT02715687|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
110165604|NCT00024271|Alkylating Agents|alkylating agents|mesh-ancestor
110476741|NCT02715687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110476742|NCT02715687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110476743|NCT02715687|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110476744|NCT02715687|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110476745|NCT02715687|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110476747|NCT02715687|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110476748|NCT02715687|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110476749|NCT02715687|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110476750|NCT02715531|Leucovorin|leucovorin|mesh-list
110476751|NCT02715531|Paclitaxel|paclitaxel|mesh-list
110476752|NCT02715531|Bevacizumab|bevacizumab|mesh-list
110476753|NCT02715531|Gemcitabine|gemcitabine|mesh-list
110476754|NCT02715531|Capecitabine|capecitabine|mesh-list
110476755|NCT02715531|Oxaliplatin|oxaliplatin|mesh-list
110476756|NCT02715531|Atezolizumab|atezolizumab|mesh-list
110476757|NCT02715531|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110476758|NCT02715531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110476759|NCT02715531|Tubulin Modulators|tubulin modulators|mesh-ancestor
110476760|NCT02715531|Antimitotic Agents|antimitotic agents|mesh-ancestor
110476761|NCT02715531|Mitosis Modulators|mitosis modulators|mesh-ancestor
110476762|NCT02715531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110885870|NCT03654144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110885871|NCT03654144|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110885872|NCT03654144|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110885873|NCT03654144|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110885874|NCT03654144|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110885875|NCT03654144|Hormone Antagonists|hormone antagonists|mesh-ancestor
110885876|NCT03654144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110885877|NCT03654144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110885878|NCT03654144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110476763|NCT02715531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110476764|NCT02715531|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110476765|NCT02715531|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110476766|NCT02715531|Growth Substances|growth substances|mesh-ancestor
110476767|NCT02715531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110476768|NCT02715531|Growth Inhibitors|growth inhibitors|mesh-ancestor
110476769|NCT02715531|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110476770|NCT02715531|Antimetabolites|antimetabolites|mesh-ancestor
110476771|NCT02715531|Antidotes|antidotes|mesh-ancestor
110476772|NCT02715531|Protective Agents|protective agents|mesh-ancestor
110476773|NCT02715531|Vitamin B Complex|vitamin b complex|mesh-ancestor
110476774|NCT02715531|Vitamins|vitamins|mesh-ancestor
110476775|NCT02715531|Micronutrients|micronutrients|mesh-ancestor
110476776|NCT02715531|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110476777|NCT00811018|Sitaxsentan|sitaxsentan|mesh-list
110476778|NCT00811018|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
110476779|NCT00811018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110476780|NCT04037085|Ketamine|ketamine|mesh-list
110476781|NCT04037085|Analgesics|analgesics|mesh-ancestor
110476782|NCT04037085|Sensory System Agents|sensory system agents|mesh-ancestor
110476783|NCT04037085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110476784|NCT04037085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110476785|NCT04037085|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110476786|NCT04037085|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110476787|NCT04037085|Anesthetics, General|anesthetics, general|mesh-ancestor
110476788|NCT04037085|Anesthetics|anesthetics|mesh-ancestor
110476789|NCT04037085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110476790|NCT04037085|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110476791|NCT04037085|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110476792|NCT04037085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110476793|NCT04037085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110476794|NCT00914056|Lactulose|lactulose|mesh-list
110476795|NCT00914056|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110476796|NCT00730171|Linaclotide|linaclotide|mesh-list
110476797|NCT00730171|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
110476798|NCT00730171|Enzyme Activators|enzyme activators|mesh-ancestor
110476799|NCT00730171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110476800|NCT00730171|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110476801|NCT04787835|Anesthetics|anesthetics|mesh-list
110476802|NCT04787835|Anesthetics, Local|anesthetics, local|mesh-list
110476803|NCT04787835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110476804|NCT04787835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110476805|NCT04787835|Sensory System Agents|sensory system agents|mesh-ancestor
110476806|NCT04787835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110476807|NCT00730015|Linaclotide|linaclotide|mesh-list
110476808|NCT00730015|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
110476809|NCT00730015|Enzyme Activators|enzyme activators|mesh-ancestor
110476810|NCT00730015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110476811|NCT00730015|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110476812|NCT00806026|Pregabalin|pregabalin|mesh-list
110476813|NCT00806026|Pramipexole|pramipexole|mesh-list
110476814|NCT00806026|Analgesics|analgesics|mesh-ancestor
110476815|NCT00806026|Sensory System Agents|sensory system agents|mesh-ancestor
110476816|NCT00806026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110885880|NCT02591615|Carboplatin|carboplatin|mesh-list
110885881|NCT02591615|Pembrolizumab|pembrolizumab|mesh-list
110885882|NCT02591615|Pemetrexed|pemetrexed|mesh-list
110885883|NCT02591615|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110885884|NCT02591615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110885885|NCT02591615|Tubulin Modulators|tubulin modulators|mesh-ancestor
110885886|NCT02591615|Antimitotic Agents|antimitotic agents|mesh-ancestor
110885887|NCT02591615|Mitosis Modulators|mitosis modulators|mesh-ancestor
110885888|NCT02591615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110885889|NCT02591615|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110476817|NCT00806026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110476818|NCT00806026|Anticonvulsants|anticonvulsants|mesh-ancestor
110476819|NCT00806026|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110476820|NCT00806026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110476821|NCT00806026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110476822|NCT00806026|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110476823|NCT00806026|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110476824|NCT00806026|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110476825|NCT00806026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110476826|NCT00806026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110476827|NCT00806026|Antioxidants|antioxidants|mesh-ancestor
110476828|NCT00806026|Protective Agents|protective agents|mesh-ancestor
110476829|NCT00806026|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110476830|NCT00806026|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110476831|NCT00806026|Dopamine Agonists|dopamine agonists|mesh-ancestor
110476832|NCT00806026|Dopamine Agents|dopamine agents|mesh-ancestor
110476833|NCT00806026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110476834|NCT04227093|Acetazolamide|acetazolamide|mesh-list
110476835|NCT04227093|Anticonvulsants|anticonvulsants|mesh-ancestor
110476836|NCT04227093|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110476837|NCT04227093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110476838|NCT04227093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110476839|NCT04227093|Diuretics|diuretics|mesh-ancestor
110476840|NCT04227093|Natriuretic Agents|natriuretic agents|mesh-ancestor
110476841|NCT04227093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110476842|NCT00805792|Donepezil|donepezil|mesh-list
110476843|NCT00805792|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110476844|NCT00805792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110476845|NCT00805792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110476846|NCT00805792|Cholinergic Agents|cholinergic agents|mesh-ancestor
110476847|NCT00805792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110476848|NCT00805792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110476849|NCT00805792|Nootropic Agents|nootropic agents|mesh-ancestor
110476850|NCT04777929|Progesterone|progesterone|mesh-list
110476851|NCT04777929|Estrogens|estrogens|mesh-list
110476852|NCT04777929|Progestins|progestins|mesh-ancestor
110476853|NCT04777929|Hormones|hormones|mesh-ancestor
110476854|NCT04777929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110476855|NCT04777929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110476856|NCT00590044|Insulin|insulin|mesh-list
110476857|NCT00590044|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110476858|NCT00590044|Insulin Glargine|insulin glargine|mesh-list
110476859|NCT00590044|Insulin, Isophane|insulin, isophane|mesh-list
110476860|NCT00590044|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110476861|NCT00590044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110476862|NCT02714361|Vitamin D|vitamin d|mesh-list
110476863|NCT02714361|Cholecalciferol|cholecalciferol|mesh-list
110476864|NCT02714361|Vitamins|vitamins|mesh-ancestor
110476865|NCT02714361|Micronutrients|micronutrients|mesh-ancestor
110476866|NCT02714361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110476867|NCT02714361|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110476868|NCT02714361|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110476869|NCT00248703|Docetaxel|docetaxel|mesh-list
110476870|NCT00248703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110476871|NCT00248703|Tubulin Modulators|tubulin modulators|mesh-ancestor
110885890|NCT02591615|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110885891|NCT02591615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110885892|NCT02591615|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110885893|NCT02591615|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110885894|NCT03077607|Itraconazole|itraconazole|mesh-list
110885895|NCT03077607|Rifampin|rifampin|mesh-list
110603427|NCT00641043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110885896|NCT03077607|Talazoparib|talazoparib|mesh-list
110885897|NCT03077607|Antifungal Agents|antifungal agents|mesh-ancestor
110885898|NCT03077607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110885899|NCT03077607|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110885900|NCT03077607|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110885901|NCT03077607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110885902|NCT03077607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110885903|NCT03077607|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110476872|NCT00248703|Antimitotic Agents|antimitotic agents|mesh-ancestor
110476873|NCT00248703|Mitosis Modulators|mitosis modulators|mesh-ancestor
110476874|NCT00248703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110476875|NCT02713893|Econazole|econazole|mesh-list
110476876|NCT02713893|Benzydamine|benzydamine|mesh-list
110476877|NCT02713893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110476878|NCT02713893|Antifungal Agents|antifungal agents|mesh-ancestor
110476879|NCT02713893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110476880|NCT02713893|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110476881|NCT02713893|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110476882|NCT02713893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110476883|NCT02713893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110476884|NCT02713893|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110476885|NCT02713893|Hormone Antagonists|hormone antagonists|mesh-ancestor
110476886|NCT02713893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110476887|NCT02713893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110476888|NCT00729937|Clindamycin|clindamycin|mesh-list
110476889|NCT00729937|Clindamycin palmitate|clindamycin palmitate|mesh-list
110476890|NCT00729937|Clindamycin phosphate|clindamycin phosphate|mesh-list
110476891|NCT00729937|Cephalexin|cephalexin|mesh-list
110476892|NCT00729937|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
110476893|NCT00729937|Trimethoprim|trimethoprim|mesh-list
110476894|NCT00729937|Sulfamethoxazole|sulfamethoxazole|mesh-list
110476895|NCT00729937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110124085|NCT01937325|Ivacaftor|ivacaftor|mesh-list
110476896|NCT00729937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110476897|NCT00729937|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110476898|NCT00729937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110476899|NCT00729937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110476900|NCT00729937|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110476902|NCT00729937|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110476903|NCT00729937|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110476904|NCT00729937|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110476905|NCT00729937|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110476906|NCT00729937|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
110476907|NCT00729937|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110476908|NCT00729859|Methyltestosterone|methyltestosterone|mesh-list
110476909|NCT00729859|Anastrozole|anastrozole|mesh-list
110476910|NCT00729859|Testosterone|testosterone|mesh-list
110476911|NCT00729859|Testosterone undecanoate|testosterone undecanoate|mesh-list
110476912|NCT00729859|Testosterone enanthate|testosterone enanthate|mesh-list
110476913|NCT00729859|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
110476914|NCT00729859|Acyline|acyline|mesh-list
110476915|NCT00729859|Androgens|androgens|mesh-ancestor
110885904|NCT03077607|Hormone Antagonists|hormone antagonists|mesh-ancestor
110885905|NCT03077607|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110885906|NCT03077607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110885907|NCT03077607|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110885908|NCT03077607|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110885909|NCT03077607|Antitubercular Agents|antitubercular agents|mesh-ancestor
110885910|NCT03077607|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110885911|NCT03077607|Leprostatic Agents|leprostatic agents|mesh-ancestor
110476916|NCT00729859|Hormones|hormones|mesh-ancestor
110476917|NCT00729859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110476918|NCT00729859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110476919|NCT00729859|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110476920|NCT00729859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110476921|NCT00729859|Anabolic Agents|anabolic agents|mesh-ancestor
110476922|NCT00729859|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110476923|NCT00729859|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110476924|NCT00729859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110476925|NCT00729859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110476926|NCT00729859|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110476927|NCT00729859|Hormone Antagonists|hormone antagonists|mesh-ancestor
110476928|NCT00810394|Sorafenib|sorafenib|mesh-list
110476929|NCT00810394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110476930|NCT00810394|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110476931|NCT00810394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110476932|NCT00810394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110476933|NCT00736333|Doxorubicin|doxorubicin|mesh-list
110476934|NCT00736333|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110476935|NCT00736333|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110476936|NCT00736333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110476937|NCT00736333|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110476938|NCT00736333|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110476939|NCT00736333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110476940|NCT00736333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110476941|NCT00736255|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
110165624|NCT00024349|Fluorouracil|fluorouracil|mesh-list
110476942|NCT00736255|Dextroamphetamine|dextroamphetamine|mesh-list
110476943|NCT00736255|Nicotine|nicotine|mesh-list
110476944|NCT00736255|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110476945|NCT00736255|Autonomic Agents|autonomic agents|mesh-ancestor
110476946|NCT00736255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110476947|NCT00736255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110476948|NCT00736255|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110476949|NCT00736255|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110476950|NCT00736255|Cholinergic Agents|cholinergic agents|mesh-ancestor
110476951|NCT00736255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110476952|NCT00736255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110476953|NCT00736255|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110476954|NCT00736255|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110476955|NCT00736255|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110476956|NCT00736255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110476957|NCT00736255|Dopamine Agents|dopamine agents|mesh-ancestor
110476958|NCT00742183|Silver Sulfadiazine|silver sulfadiazine|mesh-list
110476959|NCT00742183|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110476960|NCT00742183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110476961|NCT00808444|Vaccines|vaccines|mesh-list
110476962|NCT00808444|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110476963|NCT00808444|Immunologic Factors|immunologic factors|mesh-ancestor
110476964|NCT00808444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110476965|NCT00914134|Levodopa|levodopa|mesh-list
110476966|NCT00914134|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110476967|NCT00914134|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110476968|NCT00914134|Dopamine Agents|dopamine agents|mesh-ancestor
110476969|NCT00914134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110476970|NCT00914134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110885912|NCT03077607|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110885913|NCT03077607|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110885914|NCT03077607|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110885915|NCT03077607|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110885916|NCT03077607|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110885917|NCT03077607|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110885918|NCT03077607|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110476971|NCT00914134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110476972|NCT05754736|Bevacizumab|bevacizumab|mesh-list
110476973|NCT05754736|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110476974|NCT05754736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110476975|NCT05754736|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110476976|NCT05754736|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110476977|NCT05754736|Growth Substances|growth substances|mesh-ancestor
110476978|NCT05754736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110476979|NCT05754736|Growth Inhibitors|growth inhibitors|mesh-ancestor
110476980|NCT00742027|Panobinostat|panobinostat|mesh-list
110476981|NCT00742027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110476982|NCT00742027|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110476983|NCT00742027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110476984|NCT00742027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110476985|NCT02609698|Aspirin|aspirin|mesh-list
110476986|NCT02609698|Clopidogrel|clopidogrel|mesh-list
110476987|NCT02609698|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110476988|NCT02609698|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110476989|NCT02609698|Analgesics|analgesics|mesh-ancestor
110476990|NCT02609698|Sensory System Agents|sensory system agents|mesh-ancestor
110476991|NCT02609698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110476992|NCT02609698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110476993|NCT02609698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110476994|NCT02609698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110476995|NCT02609698|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110476996|NCT02609698|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110476997|NCT02609698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110476998|NCT02609698|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110476999|NCT02609698|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110477000|NCT02609698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110477001|NCT02609698|Antipyretics|antipyretics|mesh-ancestor
110477002|NCT02609698|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110477003|NCT02609698|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110477004|NCT02609698|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110477005|NCT02609698|Purinergic Agents|purinergic agents|mesh-ancestor
110477006|NCT02609698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110477007|NCT05750134|Pancrelipase|pancrelipase|mesh-list
110477008|NCT05750134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110477009|NCT05749822|Fenofibrate|fenofibrate|mesh-list
110477010|NCT05749822|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110477011|NCT05749822|Antimetabolites|antimetabolites|mesh-ancestor
110477012|NCT05749822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110477013|NCT05749822|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110477015|NCT02713191|Midazolam|midazolam|mesh-list
110477016|NCT02713191|Dexmedetomidine|dexmedetomidine|mesh-list
110477017|NCT02713191|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110477018|NCT02713191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110477019|NCT02713191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110477020|NCT02713191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110477021|NCT02713191|Analgesics|analgesics|mesh-ancestor
110477022|NCT02713191|Sensory System Agents|sensory system agents|mesh-ancestor
110477023|NCT02713191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110477024|NCT02713191|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110477025|NCT02713191|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110477026|NCT02713191|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110477027|NCT02713191|Adrenergic Agents|adrenergic agents|mesh-ancestor
110034050|NCT01591629|Naloxone|naloxone|mesh-list
110885919|NCT03077607|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110885920|NCT03077607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110885921|NCT04215588|Hemostatics|hemostatics|mesh-list
110885922|NCT04215588|Coagulants|coagulants|mesh-ancestor
110885923|NCT01377051|Maleic acid|maleic acid|mesh-list
110885924|NCT01377051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110885925|NCT01377051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110885926|NCT03217175|Glucagon|glucagon|mesh-list
110885927|NCT03217175|Pancrelipase|pancrelipase|mesh-list
110885928|NCT03217175|Pancreatin|pancreatin|mesh-list
110885929|NCT03217175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110885930|NCT03217175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110885931|NCT03217175|Hormones|hormones|mesh-ancestor
110477028|NCT02713191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110477029|NCT02713191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110477030|NCT02713191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110477031|NCT02713191|Narcotics|narcotics|mesh-ancestor
110477032|NCT02713191|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110477033|NCT02713191|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110477034|NCT02713191|Anesthetics, General|anesthetics, general|mesh-ancestor
110477035|NCT02713191|Anesthetics|anesthetics|mesh-ancestor
110477036|NCT02713191|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110477037|NCT02713191|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110477038|NCT02713191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110477039|NCT02713191|GABA Modulators|gaba modulators|mesh-ancestor
110477040|NCT02713191|GABA Agents|gaba agents|mesh-ancestor
110477041|NCT00611169|Tirofiban|tirofiban|mesh-list
110477042|NCT00611169|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110477043|NCT00611169|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110477044|NCT00611169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110477045|NCT00611169|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110477046|NCT05754502|Trastuzumab|trastuzumab|mesh-list
110477047|NCT05754502|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
110477048|NCT05754502|Maytansine|maytansine|mesh-list
110477049|NCT05754502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110477050|NCT05754502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110477051|NCT05754502|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110477052|NCT05754502|Tubulin Modulators|tubulin modulators|mesh-ancestor
110477053|NCT05754502|Antimitotic Agents|antimitotic agents|mesh-ancestor
110477054|NCT05754502|Mitosis Modulators|mitosis modulators|mesh-ancestor
110477055|NCT05754502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110477056|NCT05754502|Immunotoxins|immunotoxins|mesh-ancestor
110477057|NCT05754502|Immunoconjugates|immunoconjugates|mesh-ancestor
110477058|NCT05754502|Immunologic Factors|immunologic factors|mesh-ancestor
110477059|NCT05754502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110477060|NCT02712957|Naproxen|naproxen|mesh-list
110477061|NCT02712957|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110477062|NCT02712957|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110477063|NCT02712957|Analgesics|analgesics|mesh-ancestor
110477064|NCT02712957|Sensory System Agents|sensory system agents|mesh-ancestor
110477065|NCT02712957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110477066|NCT02712957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110477067|NCT02712957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110477068|NCT02712957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110477069|NCT02712957|Gout Suppressants|gout suppressants|mesh-ancestor
110477070|NCT02712957|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110477071|NCT02712957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110477072|NCT02712957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110477073|NCT04226625|Propofol|propofol|mesh-list
110477074|NCT04226625|Desflurane|desflurane|mesh-list
110477075|NCT04226625|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110477076|NCT04226625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110477077|NCT04226625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110477078|NCT04226625|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110477079|NCT04226625|Anesthetics, General|anesthetics, general|mesh-ancestor
110885932|NCT03217175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110885933|NCT01379079|Aspirin|aspirin|mesh-list
110885934|NCT01379079|Calcium, Dietary|calcium, dietary|mesh-list
110885935|NCT01379079|Acetylsalicylic acid lysinate|acetylsalicylic acid lysinate|mesh-list
110885936|NCT01379079|Carbaspirin calcium|carbaspirin calcium|mesh-list
110885937|NCT01379079|Calcium|calcium|mesh-list
110885938|NCT01379079|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110885939|NCT01379079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110885940|NCT01379079|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110477080|NCT04226625|Anesthetics|anesthetics|mesh-ancestor
110477081|NCT04226625|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110477082|NCT02777619|Dexmedetomidine|dexmedetomidine|mesh-list
110477083|NCT02777619|Propofol|propofol|mesh-list
110477084|NCT02777619|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110477085|NCT02777619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110477086|NCT02777619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110477087|NCT02777619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110477088|NCT02777619|Analgesics|analgesics|mesh-ancestor
110477089|NCT02777619|Sensory System Agents|sensory system agents|mesh-ancestor
110477090|NCT02777619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110477091|NCT02777619|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110477092|NCT02777619|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110477093|NCT02777619|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110477094|NCT02777619|Adrenergic Agents|adrenergic agents|mesh-ancestor
110477095|NCT02777619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110477096|NCT02777619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110477097|NCT02777619|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110477098|NCT02777619|Anesthetics, General|anesthetics, general|mesh-ancestor
110477099|NCT02777619|Anesthetics|anesthetics|mesh-ancestor
110477100|NCT05754424|Insulin Aspart|insulin aspart|mesh-list
110477101|NCT05754424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110477102|NCT05754424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110477103|NCT00636831|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110477104|NCT00636831|Cefazolin|cefazolin|mesh-list
110477105|NCT00636831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110477106|NCT04193631|Cannabidiol|cannabidiol|mesh-list
110477107|NCT04193631|Anticonvulsants|anticonvulsants|mesh-ancestor
110477108|NCT04856631|Cetuximab|cetuximab|mesh-list
110477109|NCT04856631|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110477110|NCT04856631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110477111|NCT00808210|Methylprednisolone|methylprednisolone|mesh-list
110477112|NCT00808210|Infliximab|infliximab|mesh-list
110477113|NCT00808210|Methotrexate|methotrexate|mesh-list
110477114|NCT00808210|Ocrelizumab|ocrelizumab|mesh-list
110477115|NCT00808210|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110477116|NCT00808210|Abortifacient Agents|abortifacient agents|mesh-ancestor
110477117|NCT00808210|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110477118|NCT00808210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110477119|NCT00808210|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110477120|NCT00808210|Antimetabolites|antimetabolites|mesh-ancestor
110124306|NCT01938729|Glucocorticoids|glucocorticoids|mesh-ancestor
110477121|NCT00808210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110477123|NCT00808210|Dermatologic Agents|dermatologic agents|mesh-ancestor
110477124|NCT00808210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110477125|NCT00808210|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110477126|NCT00808210|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110477127|NCT00808210|Immunologic Factors|immunologic factors|mesh-ancestor
110477128|NCT00808210|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110477129|NCT00808210|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110477130|NCT00808210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110477131|NCT00808210|Antiemetics|antiemetics|mesh-ancestor
110477132|NCT00808210|Autonomic Agents|autonomic agents|mesh-ancestor
110477133|NCT00808210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110477134|NCT00808210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110477135|NCT00808210|Glucocorticoids|glucocorticoids|mesh-ancestor
110477136|NCT00808210|Hormones|hormones|mesh-ancestor
110477137|NCT00808210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110885941|NCT01379079|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110885942|NCT01379079|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110885943|NCT01379079|Analgesics|analgesics|mesh-ancestor
110885944|NCT01379079|Sensory System Agents|sensory system agents|mesh-ancestor
110885945|NCT01379079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110885946|NCT01379079|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110885947|NCT01379079|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110885948|NCT01379079|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110885949|NCT01379079|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110885950|NCT01379079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110477138|NCT00808210|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110477139|NCT00808210|Protective Agents|protective agents|mesh-ancestor
110477140|NCT00808210|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110477141|NCT02777229|Tenofovir|tenofovir|mesh-list
110477142|NCT02777229|Lamivudine|lamivudine|mesh-list
110477143|NCT02777229|Efavirenz|efavirenz|mesh-list
110477144|NCT02777229|Dolutegravir|dolutegravir|mesh-list
110477145|NCT02777229|Antiviral Agents|antiviral agents|mesh-ancestor
110477146|NCT02777229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110477147|NCT02777229|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110477148|NCT02777229|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110477149|NCT02777229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110477150|NCT02777229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110477151|NCT02777229|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110477152|NCT02777229|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110477153|NCT02777229|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110477154|NCT02777229|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110165644|NCT00024388|Paclitaxel|paclitaxel|mesh-list
110477155|NCT02777229|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110477156|NCT02777229|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110477157|NCT02777229|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110477158|NCT02777229|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110477159|NCT02777229|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110477160|NCT02777229|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110477161|NCT02712177|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110477162|NCT02712177|Immunologic Factors|immunologic factors|mesh-ancestor
110477163|NCT02712177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110477164|NCT00635037|Bupivacaine|bupivacaine|mesh-list
110477165|NCT00635037|Anesthetics, Local|anesthetics, local|mesh-ancestor
110477166|NCT00635037|Anesthetics|anesthetics|mesh-ancestor
110477167|NCT00635037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110477168|NCT00635037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110477169|NCT00635037|Sensory System Agents|sensory system agents|mesh-ancestor
110477170|NCT00635037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110477171|NCT02777151|Atoltivimab, maftivimab, and odesivimab-ebgn drug combination|atoltivimab, maftivimab, and odesivimab-ebgn drug combination|mesh-list
110477172|NCT02777151|Atoltivimab|atoltivimab|mesh-list
110477173|NCT02777151|Antiviral Agents|antiviral agents|mesh-ancestor
110477174|NCT02777151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110477175|NCT02777073|Dapagliflozin|dapagliflozin|mesh-list
110477176|NCT02777073|Liraglutide|liraglutide|mesh-list
110477177|NCT02777073|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110477178|NCT02777073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110477179|NCT02777073|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110477180|NCT02777073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110477181|NCT02777073|Incretins|incretins|mesh-ancestor
110477182|NCT02777073|Hormones|hormones|mesh-ancestor
110477183|NCT02777073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110477184|NCT02711865|Antibodies|antibodies|mesh-list
110477185|NCT02711865|Immunologic Factors|immunologic factors|mesh-ancestor
110477186|NCT02711865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110477187|NCT02711943|Levofloxacin|levofloxacin|mesh-list
110477188|NCT02711943|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110477189|NCT02711943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110885952|NCT01379079|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110885953|NCT01379079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110885954|NCT01379079|Antipyretics|antipyretics|mesh-ancestor
110885955|NCT02034968|Nimotuzumab|nimotuzumab|mesh-list
110885956|NCT02034968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110885957|NCT02034968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110885958|NCT01379001|Scopolamine|scopolamine|mesh-list
110885959|NCT01379001|Donepezil|donepezil|mesh-list
110885960|NCT01379001|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
110207823|NCT00189748|Tacrolimus|tacrolimus|mesh-list
110477190|NCT02711943|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110477191|NCT02711943|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110477192|NCT02711943|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110477193|NCT02711943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110477194|NCT02711943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110477195|NCT02711943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110477196|NCT02711943|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110477197|NCT02711943|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110477199|NCT02776761|Immunologic Factors|immunologic factors|mesh-ancestor
110477200|NCT02776761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110477201|NCT00736099|Pioglitazone|pioglitazone|mesh-list
110477202|NCT00736099|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110477203|NCT00736099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110477204|NCT02711241|Dipyrone|dipyrone|mesh-list
110477205|NCT02711241|Papaverine|papaverine|mesh-list
110477206|NCT02711241|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110477207|NCT02711241|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110477208|NCT02711241|Analgesics|analgesics|mesh-ancestor
110477209|NCT02711241|Sensory System Agents|sensory system agents|mesh-ancestor
110477210|NCT02711241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110477211|NCT02711241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110477212|NCT02711241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110477213|NCT02711241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110477214|NCT02711241|Antipyretics|antipyretics|mesh-ancestor
110477215|NCT02711241|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110477216|NCT02711241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110477217|NCT02711241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110477218|NCT02711241|Vasodilator Agents|vasodilator agents|mesh-ancestor
110477219|NCT02711241|Urological Agents|urological agents|mesh-ancestor
110477221|NCT02711007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110477222|NCT02711007|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110477223|NCT02711007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110477224|NCT02711007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110477225|NCT02710539|Amlodipine|amlodipine|mesh-list
110477226|NCT02710539|Perindopril|perindopril|mesh-list
110477227|NCT02710539|Indapamide|indapamide|mesh-list
110477228|NCT02710539|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110477229|NCT02710539|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110477230|NCT02710539|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110477231|NCT02710539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110477232|NCT02710539|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110477233|NCT02710539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110477234|NCT02710539|Vasodilator Agents|vasodilator agents|mesh-ancestor
110477235|NCT02710539|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110477236|NCT02710539|Protease Inhibitors|protease inhibitors|mesh-ancestor
110477237|NCT02710539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110477238|NCT02710539|Diuretics|diuretics|mesh-ancestor
110477239|NCT02710539|Natriuretic Agents|natriuretic agents|mesh-ancestor
110477240|NCT02710539|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110477241|NCT00735709|Vortioxetine|vortioxetine|mesh-list
110477242|NCT00735709|Antidepressive Agents|antidepressive agents|mesh-ancestor
110477243|NCT00735709|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110477244|NCT00735709|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110477245|NCT00735709|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110885961|NCT01379001|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110885962|NCT01379001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110885963|NCT01379001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110885964|NCT01379001|Cholinergic Agents|cholinergic agents|mesh-ancestor
110885965|NCT01379001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110885966|NCT01379001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110885968|NCT01379001|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110885969|NCT01379001|Antiemetics|antiemetics|mesh-ancestor
110885970|NCT01379001|Autonomic Agents|autonomic agents|mesh-ancestor
110885971|NCT01379001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110477246|NCT00735709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110477247|NCT00735709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110601545|NCT00864838|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110477248|NCT00735709|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110477249|NCT00735709|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110477250|NCT00735709|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110477251|NCT00735709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110477252|NCT00735709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110477253|NCT00735709|Serotonin Agents|serotonin agents|mesh-ancestor
110477254|NCT00735709|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110477255|NCT00735709|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110477256|NCT00735709|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110477257|NCT00735709|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110477259|NCT02776527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110477260|NCT02776527|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110477261|NCT02776527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110477262|NCT02776527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110477263|NCT00729157|Deoxyglucose|deoxyglucose|mesh-list
110477264|NCT00729157|Aflibercept|aflibercept|mesh-list
110477265|NCT00729157|Endothelial Growth Factors|endothelial growth factors|mesh-list
110477266|NCT00729157|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110477267|NCT00729157|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110477268|NCT00729157|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110477269|NCT00729157|Growth Substances|growth substances|mesh-ancestor
110477270|NCT00729157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110477271|NCT00729157|Growth Inhibitors|growth inhibitors|mesh-ancestor
110477272|NCT00729157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110477273|NCT00729157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110477274|NCT00729157|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110477276|NCT00729157|Antiviral Agents|antiviral agents|mesh-ancestor
110477277|NCT00729157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110477278|NCT02710305|Lidocaine|lidocaine|mesh-list
110477279|NCT02710305|Scopolamine|scopolamine|mesh-list
110477280|NCT02710305|Bromides|bromides|mesh-list
110477281|NCT02710305|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
110477282|NCT02710305|Anesthetics, Local|anesthetics, local|mesh-ancestor
110477283|NCT02710305|Anesthetics|anesthetics|mesh-ancestor
110477284|NCT02710305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110477285|NCT02710305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110477286|NCT02710305|Sensory System Agents|sensory system agents|mesh-ancestor
110477287|NCT02710305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110477288|NCT02710305|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110477289|NCT02710305|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110400053|NCT01012219|Analgesics|analgesics|mesh-ancestor
110477290|NCT02710305|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110477291|NCT02710305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110477292|NCT02710305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110477293|NCT02710305|Anticonvulsants|anticonvulsants|mesh-ancestor
110477294|NCT02710305|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110477295|NCT02710305|Antiemetics|antiemetics|mesh-ancestor
110477296|NCT02710305|Autonomic Agents|autonomic agents|mesh-ancestor
110477297|NCT02710305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110885972|NCT01379001|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110885974|NCT01379001|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110885975|NCT01379001|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110885976|NCT01379001|Parasympatholytics|parasympatholytics|mesh-ancestor
110885977|NCT03172325|Folic Acid|folic acid|mesh-list
110885978|NCT03172325|Prednisolone|prednisolone|mesh-list
110477298|NCT02710305|Mydriatics|mydriatics|mesh-ancestor
110477299|NCT02710305|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110477300|NCT02710305|Cholinergic Agents|cholinergic agents|mesh-ancestor
110477301|NCT02710305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110477302|NCT02710305|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110477303|NCT02710305|Parasympatholytics|parasympatholytics|mesh-ancestor
110477305|NCT02708511|Trace Elements|trace elements|mesh-ancestor
110477306|NCT02708511|Micronutrients|micronutrients|mesh-ancestor
110477307|NCT02708511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110477308|NCT00728689|Tecovirimat|tecovirimat|mesh-list
110477309|NCT00728689|Antiviral Agents|antiviral agents|mesh-ancestor
110477310|NCT00728689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110477311|NCT02596243|Vaccines|vaccines|mesh-list
110477312|NCT02596243|Immunologic Factors|immunologic factors|mesh-ancestor
110477313|NCT02596243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110477314|NCT02717091|Paclitaxel|paclitaxel|mesh-list
110477315|NCT02717091|Gemcitabine|gemcitabine|mesh-list
110477316|NCT02717091|Folfirinox|folfirinox|mesh-list
110477317|NCT02717091|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110477318|NCT02717091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110477319|NCT02717091|Tubulin Modulators|tubulin modulators|mesh-ancestor
110477320|NCT02717091|Antimitotic Agents|antimitotic agents|mesh-ancestor
110477321|NCT02717091|Mitosis Modulators|mitosis modulators|mesh-ancestor
110477322|NCT02717091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110477323|NCT02717091|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110477324|NCT02717091|Antimetabolites|antimetabolites|mesh-ancestor
110477325|NCT00726895|Quinine|quinine|mesh-list
110477326|NCT00726895|Antimalarials|antimalarials|mesh-ancestor
110477327|NCT00726895|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110477328|NCT00726895|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110477329|NCT00726895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110477330|NCT00726895|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110477331|NCT00726895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110477332|NCT00726895|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110477333|NCT00726895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110477334|NCT00726895|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110477335|NCT00726895|Analgesics|analgesics|mesh-ancestor
110477336|NCT00726895|Sensory System Agents|sensory system agents|mesh-ancestor
110477337|NCT02593201|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110477338|NCT02593201|Cefazolin|cefazolin|mesh-list
110477339|NCT02593201|Ceftazidime|ceftazidime|mesh-list
110477340|NCT02593201|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
110477341|NCT02593201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110124534|NCT01939743|Diclofenac|diclofenac|mesh-list
110477342|NCT02593201|Antitubercular Agents|antitubercular agents|mesh-ancestor
110477343|NCT02707809|Dexmedetomidine|dexmedetomidine|mesh-list
110477345|NCT02707809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110477346|NCT02707809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110477347|NCT02707809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110477348|NCT02707809|Analgesics|analgesics|mesh-ancestor
110477349|NCT02707809|Sensory System Agents|sensory system agents|mesh-ancestor
110477350|NCT02707809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110477351|NCT02707809|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110477352|NCT02707809|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110477353|NCT02707809|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110477354|NCT02707809|Adrenergic Agents|adrenergic agents|mesh-ancestor
110477355|NCT02707809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110477356|NCT02707809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110477357|NCT00585325|Lidocaine|lidocaine|mesh-list
110477358|NCT00585325|Anesthetics, Local|anesthetics, local|mesh-ancestor
110477359|NCT00585325|Anesthetics|anesthetics|mesh-ancestor
110477360|NCT00585325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110477361|NCT00585325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110477362|NCT00585325|Sensory System Agents|sensory system agents|mesh-ancestor
110477363|NCT00585325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110885979|NCT03172325|Adalimumab|adalimumab|mesh-list
110885980|NCT03172325|Methotrexate|methotrexate|mesh-list
110885981|NCT03172325|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110885982|NCT03172325|Abortifacient Agents|abortifacient agents|mesh-ancestor
110885983|NCT03172325|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110885984|NCT03172325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110885985|NCT03172325|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110885986|NCT03172325|Antimetabolites|antimetabolites|mesh-ancestor
110885987|NCT03172325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110885988|NCT03172325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110885989|NCT03172325|Dermatologic Agents|dermatologic agents|mesh-ancestor
110885990|NCT03172325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110885991|NCT03172325|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110885992|NCT03172325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110885993|NCT03172325|Immunologic Factors|immunologic factors|mesh-ancestor
110208016|NCT00190606|Analgesics|analgesics|mesh-ancestor
110477364|NCT00585325|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110477365|NCT00585325|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110477366|NCT00585325|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110477367|NCT00585325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110477368|NCT00585325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110477369|NCT02716857|Oxycodone|oxycodone|mesh-list
110477370|NCT02716857|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110477371|NCT02716857|Narcotics|narcotics|mesh-ancestor
110477372|NCT02716857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110477373|NCT02716857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110477374|NCT02716857|Analgesics|analgesics|mesh-ancestor
110477375|NCT02716857|Sensory System Agents|sensory system agents|mesh-ancestor
110477376|NCT02716857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110477377|NCT00917761|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110477378|NCT00917761|Interferon-alpha|interferon-alpha|mesh-list
110477379|NCT00917761|Entecavir|entecavir|mesh-list
110477380|NCT00917761|Antiviral Agents|antiviral agents|mesh-ancestor
110477381|NCT00917761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110477382|NCT00917761|Immunologic Factors|immunologic factors|mesh-ancestor
110477383|NCT00917761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110477384|NCT02709603|Scopolamine|scopolamine|mesh-list
110477385|NCT02709603|Bromides|bromides|mesh-list
110477386|NCT02709603|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
110477387|NCT02709603|Anticonvulsants|anticonvulsants|mesh-ancestor
110477388|NCT02709603|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110477389|NCT02709603|Antiemetics|antiemetics|mesh-ancestor
110477390|NCT02709603|Autonomic Agents|autonomic agents|mesh-ancestor
110477391|NCT02709603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110477392|NCT02709603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110477393|NCT02709603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110477394|NCT02709603|Mydriatics|mydriatics|mesh-ancestor
110477395|NCT02709603|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110477396|NCT02709603|Cholinergic Agents|cholinergic agents|mesh-ancestor
110477397|NCT02709603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110477398|NCT02709603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110477399|NCT02709603|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110477400|NCT02709603|Parasympatholytics|parasympatholytics|mesh-ancestor
110477401|NCT00611793|Bevacizumab|bevacizumab|mesh-list
110477402|NCT00611793|Vatalanib|vatalanib|mesh-list
110477403|NCT00611793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110601621|NCT00577382|Sunitinib|sunitinib|mesh-list
110477404|NCT00611793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110477405|NCT00611793|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110477406|NCT00611793|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110477407|NCT00611793|Growth Substances|growth substances|mesh-ancestor
110885994|NCT03172325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110885995|NCT03172325|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110885996|NCT03172325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110885997|NCT03172325|Glucocorticoids|glucocorticoids|mesh-ancestor
110885998|NCT03172325|Hormones|hormones|mesh-ancestor
110885999|NCT03172325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110886000|NCT03172325|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110886001|NCT03172325|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110886002|NCT03172325|Hematinics|hematinics|mesh-ancestor
110886003|NCT03172325|Vitamin B Complex|vitamin b complex|mesh-ancestor
110886004|NCT03172325|Vitamins|vitamins|mesh-ancestor
110886005|NCT03172325|Micronutrients|micronutrients|mesh-ancestor
110886006|NCT03653520|Diazepam|diazepam|mesh-list
110886007|NCT03653520|Tramadol|tramadol|mesh-list
110886008|NCT03653520|Ondansetron|ondansetron|mesh-list
110886009|NCT03653520|Antiemetics|antiemetics|mesh-ancestor
110886010|NCT03653520|Autonomic Agents|autonomic agents|mesh-ancestor
110886011|NCT03653520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110886012|NCT03653520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110477408|NCT00611793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110477409|NCT00611793|Growth Inhibitors|growth inhibitors|mesh-ancestor
110477410|NCT00611793|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110477411|NCT00611793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110477412|NCT00611793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110477413|NCT00611871|Propranolol|propranolol|mesh-list
110477414|NCT00611871|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110477415|NCT00611871|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110477416|NCT00611871|Adrenergic Agents|adrenergic agents|mesh-ancestor
110477417|NCT00611871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110477418|NCT00611871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110477419|NCT00611871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110477420|NCT00611871|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110477421|NCT00611871|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110477422|NCT00611871|Vasodilator Agents|vasodilator agents|mesh-ancestor
110477423|NCT02709525|Hyaluronic Acid|hyaluronic acid|mesh-list
110477424|NCT02709525|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110477425|NCT02709525|Immunologic Factors|immunologic factors|mesh-ancestor
110477426|NCT02709525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110477427|NCT02709525|Viscosupplements|viscosupplements|mesh-ancestor
110477428|NCT02709525|Protective Agents|protective agents|mesh-ancestor
110477429|NCT05087589|Tofacitinib|tofacitinib|mesh-list
110477430|NCT05087589|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
110477431|NCT05087589|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110477432|NCT05087589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110477433|NCT05087589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110477434|NCT00612651|Temozolomide|temozolomide|mesh-list
110477435|NCT00612651|Lonafarnib|lonafarnib|mesh-list
110477436|NCT00612651|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110477437|NCT00612651|Alkylating Agents|alkylating agents|mesh-ancestor
110477438|NCT00612651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110477439|NCT00612651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110477440|NCT00612651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110477441|NCT00918307|Varenicline|varenicline|mesh-list
110477442|NCT00918307|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110477443|NCT00918307|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110477444|NCT00918307|Cholinergic Agents|cholinergic agents|mesh-ancestor
110477445|NCT00918307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110601631|NCT00733434|Alprostadil|alprostadil|mesh-list
110886013|NCT03653520|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110886014|NCT03653520|Antipruritics|antipruritics|mesh-ancestor
110886015|NCT03653520|Dermatologic Agents|dermatologic agents|mesh-ancestor
110886016|NCT03653520|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110886017|NCT03653520|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110886018|NCT03653520|Serotonin Agents|serotonin agents|mesh-ancestor
110886019|NCT03653520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110886020|NCT03653520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110886021|NCT03653520|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110886022|NCT03653520|Narcotics|narcotics|mesh-ancestor
110886023|NCT03653520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110886024|NCT03653520|Analgesics|analgesics|mesh-ancestor
110477446|NCT00918307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110477447|NCT00918307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110477448|NCT00741013|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
110477449|NCT00741013|Protein C|protein c|mesh-list
110477450|NCT00741013|Lovastatin|lovastatin|mesh-list
110477451|NCT00741013|L 647318|l 647318|mesh-list
110477452|NCT00741013|Dihydromevinolin|dihydromevinolin|mesh-list
110477453|NCT00741013|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110477454|NCT00741013|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110477455|NCT00741013|Antimetabolites|antimetabolites|mesh-ancestor
110477456|NCT00741013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110477457|NCT00741013|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110477458|NCT00741013|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110477459|NCT00741013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110477460|NCT00741013|Anticoagulants|anticoagulants|mesh-ancestor
110477461|NCT00741013|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110477462|NCT00741013|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110477463|NCT00741013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110477464|NCT04087759|Bedaquiline|bedaquiline|mesh-list
110477465|NCT04087759|Diarylquinolines|diarylquinolines|mesh-list
110477466|NCT04087759|Antitubercular Agents|antitubercular agents|mesh-ancestor
110477467|NCT04087759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110477468|NCT04087759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110477469|NCT00740857|Ibuprofen|ibuprofen|mesh-list
110477470|NCT00740857|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110477471|NCT00740857|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110477472|NCT00740857|Analgesics|analgesics|mesh-ancestor
110477473|NCT00740857|Sensory System Agents|sensory system agents|mesh-ancestor
110477474|NCT00740857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110477475|NCT00740857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110477476|NCT00740857|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110477477|NCT00740857|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110477478|NCT00740857|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110477479|NCT00740857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110477480|NCT00740857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110477481|NCT00808132|Bazedoxifene|bazedoxifene|mesh-list
110477482|NCT00808132|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
110477483|NCT00808132|Medroxyprogesterone|medroxyprogesterone|mesh-list
110477484|NCT00808132|Estrogens|estrogens|mesh-list
110477485|NCT00808132|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
110477486|NCT00808132|Hormones|hormones|mesh-ancestor
110477487|NCT00808132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110477488|NCT00808132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110477489|NCT00808132|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110477490|NCT00808132|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110477491|NCT00808132|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110477492|NCT00808132|Contraceptive Agents|contraceptive agents|mesh-ancestor
110477494|NCT00808132|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110477495|NCT00808132|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110886025|NCT03653520|Sensory System Agents|sensory system agents|mesh-ancestor
110886026|NCT03653520|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110886027|NCT03653520|Anticonvulsants|anticonvulsants|mesh-ancestor
110886028|NCT03653520|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110886029|NCT03653520|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110886030|NCT03653520|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110886031|NCT03653520|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110477496|NCT00808132|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110477497|NCT00808132|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110477498|NCT00808132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110477499|NCT00808132|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110477500|NCT00808132|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110477501|NCT00808132|Hormone Antagonists|hormone antagonists|mesh-ancestor
110477502|NCT00808132|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110477503|NCT00727441|Cyclophosphamide|cyclophosphamide|mesh-list
110477504|NCT00727441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110477505|NCT00727441|Immunologic Factors|immunologic factors|mesh-ancestor
110477506|NCT00727441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110477507|NCT00727441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110477508|NCT00727441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110477509|NCT00727441|Alkylating Agents|alkylating agents|mesh-ancestor
110477510|NCT00727441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110477511|NCT00727441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110477512|NCT00727441|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110477513|NCT00914368|Clopidogrel|clopidogrel|mesh-list
110477514|NCT00914368|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110477515|NCT00914368|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110400278|NCT01264887|Sensory System Agents|sensory system agents|mesh-ancestor
110477516|NCT00914368|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110477517|NCT00914368|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110477518|NCT00914368|Purinergic Agents|purinergic agents|mesh-ancestor
110477519|NCT00914368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110477520|NCT00914368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110477521|NCT00914368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110477522|NCT02607982|Paclitaxel|paclitaxel|mesh-list
110477523|NCT02607982|Oxaliplatin|oxaliplatin|mesh-list
110477524|NCT02607982|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110477525|NCT02607982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110477526|NCT02607982|Tubulin Modulators|tubulin modulators|mesh-ancestor
110477527|NCT02607982|Antimitotic Agents|antimitotic agents|mesh-ancestor
110477528|NCT02607982|Mitosis Modulators|mitosis modulators|mesh-ancestor
110477529|NCT02607982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110477530|NCT02692989|Anesthetics|anesthetics|mesh-list
110477531|NCT02692989|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110477532|NCT02692989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110477533|NCT03643276|Cytarabine|cytarabine|mesh-list
110477534|NCT03643276|Dexamethasone|dexamethasone|mesh-list
110477535|NCT03643276|Prednisone|prednisone|mesh-list
110477536|NCT03643276|Prednisolone|prednisolone|mesh-list
110477537|NCT03643276|Cyclophosphamide|cyclophosphamide|mesh-list
110477538|NCT03643276|Ifosfamide|ifosfamide|mesh-list
110477539|NCT03643276|Doxorubicin|doxorubicin|mesh-list
110477540|NCT03643276|Methotrexate|methotrexate|mesh-list
110477541|NCT03643276|Fludarabine|fludarabine|mesh-list
110477542|NCT03643276|Fludarabine phosphate|fludarabine phosphate|mesh-list
110477543|NCT03643276|Etoposide|etoposide|mesh-list
110477544|NCT03643276|Vincristine|vincristine|mesh-list
110477545|NCT03643276|Bortezomib|bortezomib|mesh-list
110477546|NCT03643276|Daunorubicin|daunorubicin|mesh-list
110477547|NCT03643276|Mercaptopurine|mercaptopurine|mesh-list
110477548|NCT03643276|Pegaspargase|pegaspargase|mesh-list
110477549|NCT03643276|Blinatumomab|blinatumomab|mesh-list
110477550|NCT03643276|Vindesine|vindesine|mesh-list
110477551|NCT03643276|Asparaginase|asparaginase|mesh-list
110477552|NCT03643276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110477553|NCT03643276|Immunologic Factors|immunologic factors|mesh-ancestor
110477554|NCT03643276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110477555|NCT03643276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110477556|NCT03643276|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110477557|NCT03643276|Alkylating Agents|alkylating agents|mesh-ancestor
110886032|NCT03653520|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110886033|NCT03653520|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110886034|NCT03653520|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110886035|NCT03653520|Anesthetics, General|anesthetics, general|mesh-ancestor
110886036|NCT03653520|Anesthetics|anesthetics|mesh-ancestor
110208243|NCT00059813|Oblimersen|oblimersen|mesh-list
110477558|NCT03643276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110477559|NCT03643276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110477560|NCT03643276|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110477561|NCT03643276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110477562|NCT03643276|Antiemetics|antiemetics|mesh-ancestor
110477563|NCT03643276|Autonomic Agents|autonomic agents|mesh-ancestor
110477564|NCT03643276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110477565|NCT03643276|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110477566|NCT03643276|Glucocorticoids|glucocorticoids|mesh-ancestor
110477567|NCT03643276|Hormones|hormones|mesh-ancestor
110477568|NCT03643276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110477569|NCT03643276|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110477570|NCT03643276|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110477571|NCT03643276|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110477572|NCT03643276|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110477573|NCT03643276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110477574|NCT03643276|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110477575|NCT03643276|Abortifacient Agents|abortifacient agents|mesh-ancestor
110477576|NCT03643276|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110477577|NCT03643276|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110477578|NCT03643276|Antimetabolites|antimetabolites|mesh-ancestor
110477579|NCT03643276|Dermatologic Agents|dermatologic agents|mesh-ancestor
110477580|NCT03643276|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110477581|NCT03643276|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110477582|NCT03643276|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110477583|NCT03643276|Antiviral Agents|antiviral agents|mesh-ancestor
110477584|NCT03643276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110477585|NCT03643276|Tubulin Modulators|tubulin modulators|mesh-ancestor
110477586|NCT03643276|Antimitotic Agents|antimitotic agents|mesh-ancestor
110477587|NCT03643276|Mitosis Modulators|mitosis modulators|mesh-ancestor
110477588|NCT04882293|Atorvastatin|atorvastatin|mesh-list
110477589|NCT04882293|Fenofibrate|fenofibrate|mesh-list
110477590|NCT04882293|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110477591|NCT04882293|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110477592|NCT04882293|Antimetabolites|antimetabolites|mesh-ancestor
110477593|NCT04882293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110477594|NCT04882293|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110477595|NCT04882293|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110477596|NCT04882293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110477598|NCT02608060|Hematinics|hematinics|mesh-ancestor
110477599|NCT04085575|Tranexamic Acid|tranexamic acid|mesh-list
110477600|NCT04085575|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110477601|NCT04085575|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110477602|NCT04085575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110477603|NCT04085575|Hemostatics|hemostatics|mesh-ancestor
110477604|NCT04085575|Coagulants|coagulants|mesh-ancestor
110477605|NCT00585169|Memantine|memantine|mesh-list
110477606|NCT00585169|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110477607|NCT00585169|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110477608|NCT00585169|Dopamine Agents|dopamine agents|mesh-ancestor
110477609|NCT00585169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110477610|NCT00585169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110477611|NCT00585169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110477612|NCT00585169|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110477613|NCT00585169|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110477614|NCT00807742|Nicotine|nicotine|mesh-list
110477615|NCT00807742|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110477616|NCT00807742|Autonomic Agents|autonomic agents|mesh-ancestor
110477617|NCT00807742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110477618|NCT00807742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110477619|NCT00807742|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110477620|NCT00807742|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110477621|NCT00807742|Cholinergic Agents|cholinergic agents|mesh-ancestor
110477622|NCT00807742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110886037|NCT03653520|GABA Modulators|gaba modulators|mesh-ancestor
110886038|NCT03653520|GABA Agents|gaba agents|mesh-ancestor
110886039|NCT01208090|Ponesimod|ponesimod|mesh-list
110886040|NCT01208090|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
110886041|NCT01208090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110886042|NCT01208090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110886043|NCT01208090|Immunologic Factors|immunologic factors|mesh-ancestor
110886044|NCT01208090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110886045|NCT01380483|Doxycycline|doxycycline|mesh-list
110208313|NCT00192595|Tenofovir|tenofovir|mesh-list
110477623|NCT00807742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110477624|NCT04741815|Carbon Fiber|carbon fiber|mesh-list
110477625|NCT04741815|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110477626|NCT04741815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110477627|NCT05738434|Apatinib|apatinib|mesh-list
110477628|NCT05738434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110477629|NCT05738434|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110477630|NCT05738434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110477631|NCT05738434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110477632|NCT00803452|Azithromycin|azithromycin|mesh-list
110477633|NCT00803452|Doxycycline|doxycycline|mesh-list
110477634|NCT00803452|Minocycline|minocycline|mesh-list
110477635|NCT00803452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110477636|NCT00803452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110477637|NCT00803452|Antimalarials|antimalarials|mesh-ancestor
110477638|NCT00803452|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110477639|NCT00803452|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110477640|NCT04546113|Ropivacaine|ropivacaine|mesh-list
110165686|NCT00395239|Budesonide|budesonide|mesh-list
110477641|NCT04546113|Anesthetics, Local|anesthetics, local|mesh-ancestor
110477642|NCT04546113|Anesthetics|anesthetics|mesh-ancestor
110477643|NCT04546113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110477644|NCT04546113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110477645|NCT04546113|Sensory System Agents|sensory system agents|mesh-ancestor
110477646|NCT04546113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110477647|NCT05737342|Red yeast rice|red yeast rice|mesh-list
110477648|NCT05737342|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110477649|NCT05737342|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110477650|NCT05737342|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110477651|NCT05737342|Antimetabolites|antimetabolites|mesh-ancestor
110601686|NCT00736970|Trastuzumab|trastuzumab|mesh-list
110477652|NCT05737342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110477653|NCT05737342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110477654|NCT05737342|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110477655|NCT00914212|Sibutramine|sibutramine|mesh-list
110477656|NCT00914212|Antidepressive Agents|antidepressive agents|mesh-ancestor
110477657|NCT00914212|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110477658|NCT00914212|Appetite Depressants|appetite depressants|mesh-ancestor
110477659|NCT00914212|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110477660|NCT04456023|Tisagenlecleucel|tisagenlecleucel|mesh-list
110477661|NCT04456023|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110477662|NCT04456023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110477663|NCT04188483|Selenium|selenium|mesh-list
110477664|NCT04188483|Antioxidants|antioxidants|mesh-ancestor
110477665|NCT04188483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110477666|NCT04188483|Protective Agents|protective agents|mesh-ancestor
110477667|NCT04188483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110477668|NCT04188483|Trace Elements|trace elements|mesh-ancestor
110477669|NCT04188483|Micronutrients|micronutrients|mesh-ancestor
110477670|NCT02693145|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
110477671|NCT02693145|Antiviral Agents|antiviral agents|mesh-ancestor
110477672|NCT02693145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110477673|NCT00717067|Ritonavir|ritonavir|mesh-list
110477674|NCT00717067|Saquinavir|saquinavir|mesh-list
110477675|NCT00717067|Maraviroc|maraviroc|mesh-list
110477676|NCT00717067|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110477677|NCT00717067|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110477678|NCT00717067|Protease Inhibitors|protease inhibitors|mesh-ancestor
110477679|NCT00717067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110886047|NCT01380483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110886048|NCT01380483|Antimalarials|antimalarials|mesh-ancestor
110886049|NCT01380483|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110886050|NCT01380483|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110886051|NCT02745392|Zolmitriptan|zolmitriptan|mesh-list
110886052|NCT02745392|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110886053|NCT02745392|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110886054|NCT02745392|Serotonin Agents|serotonin agents|mesh-ancestor
110886055|NCT02745392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110886056|NCT02745392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110208381|NCT00193102|Leprostatic Agents|leprostatic agents|mesh-ancestor
110477680|NCT00717067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110477681|NCT00717067|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110477682|NCT00717067|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110477683|NCT00717067|Antiviral Agents|antiviral agents|mesh-ancestor
110477684|NCT00717067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110477685|NCT00717067|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110477686|NCT00717067|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110477687|NCT00717067|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110477688|NCT00717067|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110477689|NCT00717067|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
110477690|NCT05731960|Dexamethasone|dexamethasone|mesh-list
110477691|NCT05731960|Metoclopramide|metoclopramide|mesh-list
110477692|NCT05731960|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110477693|NCT05731960|Antiemetics|antiemetics|mesh-ancestor
110477694|NCT05731960|Autonomic Agents|autonomic agents|mesh-ancestor
110477695|NCT05731960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110477696|NCT05731960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110477697|NCT05731960|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110477698|NCT05731960|Glucocorticoids|glucocorticoids|mesh-ancestor
110477699|NCT05731960|Hormones|hormones|mesh-ancestor
110165695|NCT00395239|Hormones|hormones|mesh-ancestor
110477700|NCT05731960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110477701|NCT05731960|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110477702|NCT05731960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110477703|NCT05731960|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110477704|NCT05731960|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110477705|NCT05731960|Dopamine Agents|dopamine agents|mesh-ancestor
110477706|NCT05731960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110477707|NCT05731960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110477708|NCT04393311|Urinastatin|urinastatin|mesh-list
110477709|NCT04393311|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
110477710|NCT04393311|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110477711|NCT04393311|Protease Inhibitors|protease inhibitors|mesh-ancestor
110477712|NCT04393311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110477713|NCT04393311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110477714|NCT02607436|Aspirin|aspirin|mesh-list
110477715|NCT02607436|Sarpogrelate|sarpogrelate|mesh-list
110477716|NCT02607436|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110477717|NCT02607436|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110477718|NCT02607436|Analgesics|analgesics|mesh-ancestor
110477719|NCT02607436|Sensory System Agents|sensory system agents|mesh-ancestor
110477720|NCT02607436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110477721|NCT02607436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110477722|NCT02607436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110477724|NCT02607436|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110477725|NCT02607436|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110477726|NCT02607436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110477727|NCT02607436|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110477728|NCT02607436|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110477729|NCT02607436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110886057|NCT02745392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110886059|NCT01378845|Alprostadil|alprostadil|mesh-list
110886060|NCT01378845|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110886061|NCT01378845|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
110886062|NCT01378845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110886063|NCT01378845|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110886064|NCT01378845|Vasodilator Agents|vasodilator agents|mesh-ancestor
110886065|NCT01378845|Urological Agents|urological agents|mesh-ancestor
110886066|NCT04884399|Ranibizumab|ranibizumab|mesh-list
110886067|NCT04884399|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110477730|NCT02607436|Antipyretics|antipyretics|mesh-ancestor
110477731|NCT02607436|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110477732|NCT02607436|Serotonin Agents|serotonin agents|mesh-ancestor
110477733|NCT02607436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110477734|NCT02607592|Pemetrexed|pemetrexed|mesh-list
110477735|NCT02607592|Nedaplatin|nedaplatin|mesh-list
110477736|NCT02607592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110477737|NCT02607592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110477738|NCT02607592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110477739|NCT02607592|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110477740|NCT02607592|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110477741|NCT04356339|Interferons|interferons|mesh-list
110477742|NCT04356339|Interferon-beta|interferon-beta|mesh-list
110477743|NCT04356339|Interferon beta-1b|interferon beta-1b|mesh-list
110477744|NCT04356339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110477745|NCT04356339|Antiviral Agents|antiviral agents|mesh-ancestor
110477746|NCT04356339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110477747|NCT04356339|Immunologic Factors|immunologic factors|mesh-ancestor
110477748|NCT04356339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110477749|NCT04356339|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110477750|NCT03511846|Capsaicin|capsaicin|mesh-list
110477751|NCT03511846|Antipruritics|antipruritics|mesh-ancestor
110477752|NCT03511846|Dermatologic Agents|dermatologic agents|mesh-ancestor
110477753|NCT03511846|Sensory System Agents|sensory system agents|mesh-ancestor
110477754|NCT03511846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110477755|NCT03511846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110477756|NCT04331145|Ticagrelor|ticagrelor|mesh-list
110477757|NCT04331145|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110477758|NCT04331145|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110477759|NCT04331145|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110477760|NCT04331145|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110477761|NCT04331145|Purinergic Agents|purinergic agents|mesh-ancestor
110477762|NCT04331145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110477763|NCT04331145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110477764|NCT04331145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110477765|NCT03460522|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
110477766|NCT03460522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110477767|NCT03460522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110477768|NCT03460522|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110477769|NCT03460522|Immunotoxins|immunotoxins|mesh-ancestor
110477770|NCT03460522|Immunoconjugates|immunoconjugates|mesh-ancestor
110477771|NCT03460522|Immunologic Factors|immunologic factors|mesh-ancestor
110477772|NCT03460522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110477773|NCT02605720|Piperaquine|piperaquine|mesh-list
110477775|NCT02605720|Antimalarials|antimalarials|mesh-ancestor
110477776|NCT02605720|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110477777|NCT02605720|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110477778|NCT02605720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110477779|NCT04188561|Hyaluronic Acid|hyaluronic acid|mesh-list
110477780|NCT04188561|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110477781|NCT04188561|Immunologic Factors|immunologic factors|mesh-ancestor
110477782|NCT04188561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110477783|NCT04188561|Viscosupplements|viscosupplements|mesh-ancestor
110477784|NCT04188561|Protective Agents|protective agents|mesh-ancestor
110477785|NCT00588952|Ketamine|ketamine|mesh-list
110886068|NCT04884399|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110886069|NCT04884399|Growth Substances|growth substances|mesh-ancestor
110886070|NCT04884399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110886071|NCT04884399|Growth Inhibitors|growth inhibitors|mesh-ancestor
110886072|NCT04884399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110886073|NCT04904549|Vaccines|vaccines|mesh-list
110886074|NCT04904549|Immunologic Factors|immunologic factors|mesh-ancestor
110886075|NCT04904549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110886076|NCT03607916|Morphine|morphine|mesh-list
110886077|NCT03607916|Prilocaine|prilocaine|mesh-list
110886078|NCT03607916|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110886079|NCT03607916|Narcotics|narcotics|mesh-ancestor
110886080|NCT03607916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110477786|NCT00588952|Analgesics|analgesics|mesh-ancestor
110477787|NCT00588952|Sensory System Agents|sensory system agents|mesh-ancestor
110477788|NCT00588952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110477789|NCT00588952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110477790|NCT00588952|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110477791|NCT00588952|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110477792|NCT00588952|Anesthetics, General|anesthetics, general|mesh-ancestor
110124992|NCT01942343|Droperidol|droperidol|mesh-list
110477793|NCT00588952|Anesthetics|anesthetics|mesh-ancestor
110477794|NCT00588952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110477796|NCT00588952|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110477797|NCT00588952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110477798|NCT00588952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110477799|NCT04885257|Methylphenidate|methylphenidate|mesh-list
110477800|NCT04885257|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110477801|NCT04885257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110477802|NCT04885257|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110477803|NCT04885257|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110477804|NCT04885257|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110477805|NCT04885257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110477806|NCT04885257|Dopamine Agents|dopamine agents|mesh-ancestor
110477807|NCT04885257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110477808|NCT03484923|Spartalizumab|spartalizumab|mesh-list
110477809|NCT03484923|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110477810|NCT03484923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110477811|NCT03484923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110477812|NCT03484923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110477813|NCT00802360|Menotropins|menotropins|mesh-list
110477814|NCT00802360|Progesterone|progesterone|mesh-list
110477815|NCT00802360|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
110477816|NCT00802360|Ganirelix|ganirelix|mesh-list
110477817|NCT00802360|Progestins|progestins|mesh-ancestor
110477818|NCT00802360|Hormones|hormones|mesh-ancestor
110477819|NCT00802360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110477820|NCT00802360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110477821|NCT00802360|Hormone Antagonists|hormone antagonists|mesh-ancestor
110477822|NCT00802360|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110477823|NCT00802360|Fertility Agents|fertility agents|mesh-ancestor
110477824|NCT00802360|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110477825|NCT04908423|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
110477826|NCT04908423|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110477827|NCT04908423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110477828|NCT04908423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110477829|NCT04908423|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110477830|NCT04908423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110477831|NCT04908423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110477832|NCT04908423|Cholinergic Agents|cholinergic agents|mesh-ancestor
110477833|NCT04908423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110477834|NCT04811625|Aspirin|aspirin|mesh-list
110886081|NCT03607916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110886082|NCT03607916|Analgesics|analgesics|mesh-ancestor
110886083|NCT03607916|Sensory System Agents|sensory system agents|mesh-ancestor
110886084|NCT03607916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110886085|NCT03607916|Anesthetics, Local|anesthetics, local|mesh-ancestor
110886086|NCT03607916|Anesthetics|anesthetics|mesh-ancestor
110886087|NCT01141712|Cytarabine|cytarabine|mesh-list
110886088|NCT01141712|Etoposide|etoposide|mesh-list
110886089|NCT01141712|Melphalan|melphalan|mesh-list
110886090|NCT01141712|Carmustine|carmustine|mesh-list
110886091|NCT01141712|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110477835|NCT04811625|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110477836|NCT04811625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110477837|NCT04811625|Analgesics|analgesics|mesh-ancestor
110477838|NCT04811625|Sensory System Agents|sensory system agents|mesh-ancestor
110477839|NCT04811625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110477840|NCT04811625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110477841|NCT04811625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110477842|NCT04811625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110477843|NCT04811625|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110477844|NCT04811625|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110477845|NCT04811625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110477846|NCT04811625|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110477847|NCT04811625|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110477848|NCT04811625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110477849|NCT04811625|Antipyretics|antipyretics|mesh-ancestor
110477850|NCT02764593|Nivolumab|nivolumab|mesh-list
110477851|NCT02764593|Cetuximab|cetuximab|mesh-list
110477852|NCT02764593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110477853|NCT02764593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110477854|NCT02764593|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110477855|NCT02764593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110477856|NCT04028596|Acetaminophen|acetaminophen|mesh-list
110477857|NCT04028596|Nimodipine|nimodipine|mesh-list
110477858|NCT04028596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110477859|NCT04028596|Analgesics|analgesics|mesh-ancestor
110477860|NCT04028596|Sensory System Agents|sensory system agents|mesh-ancestor
110477861|NCT04028596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110477862|NCT04028596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110477863|NCT04028596|Antipyretics|antipyretics|mesh-ancestor
110477864|NCT04028596|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110477865|NCT04028596|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110477866|NCT04028596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110477867|NCT04028596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110477868|NCT04028596|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110477869|NCT04028596|Vasodilator Agents|vasodilator agents|mesh-ancestor
110477871|NCT02692599|Immunologic Factors|immunologic factors|mesh-ancestor
110477872|NCT02692599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110477873|NCT01026038|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110477874|NCT01026038|Immunologic Factors|immunologic factors|mesh-ancestor
110477875|NCT01026038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110477876|NCT02606266|Valganciclovir|valganciclovir|mesh-list
110477877|NCT02606266|Antiviral Agents|antiviral agents|mesh-ancestor
110477878|NCT02606266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110477879|NCT04115020|Naltrexone|naltrexone|mesh-list
110477880|NCT04115020|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110477881|NCT04115020|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110477882|NCT04115020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110477883|NCT04115020|Sensory System Agents|sensory system agents|mesh-ancestor
110477884|NCT04115020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110477885|NCT02801266|Contraceptive Agents|contraceptive agents|mesh-list
110477886|NCT02801266|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110477887|NCT02801266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110477888|NCT03292666|Warfarin|warfarin|mesh-list
110477889|NCT03292666|Rivaroxaban|rivaroxaban|mesh-list
110477890|NCT03292666|Dabigatran|dabigatran|mesh-list
110477891|NCT03292666|Apixaban|apixaban|mesh-list
110886092|NCT01141712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110886093|NCT01141712|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110886094|NCT01141712|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110886095|NCT01141712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110886096|NCT01141712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110886097|NCT01141712|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110886098|NCT01141712|Antimetabolites|antimetabolites|mesh-ancestor
110886099|NCT01141712|Antiviral Agents|antiviral agents|mesh-ancestor
110886100|NCT01141712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110886101|NCT01141712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110886102|NCT01141712|Immunologic Factors|immunologic factors|mesh-ancestor
110886103|NCT01141712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110886104|NCT01141712|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110208658|NCT00195286|Tazobactam|tazobactam|mesh-list
110477892|NCT03292666|Anticoagulants|anticoagulants|mesh-list
110477893|NCT03292666|Edoxaban|edoxaban|mesh-list
110477894|NCT03292666|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110477895|NCT03292666|Antithrombins|antithrombins|mesh-ancestor
110477896|NCT03292666|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110477897|NCT03292666|Protease Inhibitors|protease inhibitors|mesh-ancestor
110477899|NCT03292666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110477900|NCT02707653|Misoprostol|misoprostol|mesh-list
110477901|NCT02707653|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110477902|NCT02707653|Abortifacient Agents|abortifacient agents|mesh-ancestor
110477903|NCT02707653|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110477904|NCT02707653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110477905|NCT02707653|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110477906|NCT02707653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110477907|NCT02707653|Oxytocics|oxytocics|mesh-ancestor
110477908|NCT03901131|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110477909|NCT03901131|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110477910|NCT03901131|Norethindrone|norethindrone|mesh-list
110477911|NCT03901131|Norethindrone Acetate|norethindrone acetate|mesh-list
110477912|NCT03901131|Norethindrone enanthate|norethindrone enanthate|mesh-list
110477913|NCT03901131|Estradiol|estradiol|mesh-list
110477914|NCT03901131|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110477915|NCT03901131|Estrogens|estrogens|mesh-ancestor
110477916|NCT03901131|Hormones|hormones|mesh-ancestor
110477917|NCT03901131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110477918|NCT03901131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110477919|NCT03901131|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110477920|NCT03901131|Contraceptive Agents|contraceptive agents|mesh-ancestor
110477921|NCT03901131|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110477922|NCT03901131|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110477923|NCT03901131|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110477924|NCT03901131|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110477925|NCT03901131|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110477926|NCT02607202|Paclitaxel|paclitaxel|mesh-list
110477927|NCT02607202|Carboplatin|carboplatin|mesh-list
110477928|NCT02607202|Gemcitabine|gemcitabine|mesh-list
110477929|NCT02607202|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110477930|NCT02607202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110477931|NCT02607202|Tubulin Modulators|tubulin modulators|mesh-ancestor
110477932|NCT02607202|Antimitotic Agents|antimitotic agents|mesh-ancestor
110477933|NCT02607202|Mitosis Modulators|mitosis modulators|mesh-ancestor
110477934|NCT02607202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110477935|NCT02607202|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110477936|NCT02607202|Antimetabolites|antimetabolites|mesh-ancestor
110477937|NCT02731612|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
110477938|NCT02731612|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110477939|NCT02731612|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110886105|NCT01141712|Alkylating Agents|alkylating agents|mesh-ancestor
110886106|NCT01141712|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110886107|NCT02034890|Hyaluronic Acid|hyaluronic acid|mesh-list
110886108|NCT02034890|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110886109|NCT02034890|Immunologic Factors|immunologic factors|mesh-ancestor
110886110|NCT02034890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110886111|NCT02034890|Viscosupplements|viscosupplements|mesh-ancestor
110886112|NCT02034890|Protective Agents|protective agents|mesh-ancestor
110886113|NCT02015351|Bevacizumab|bevacizumab|mesh-list
110886114|NCT02015351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110477940|NCT02731612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110477941|NCT02731612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110477942|NCT02731612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110601783|NCT04039126|Plasma Substitutes|plasma substitutes|mesh-ancestor
110477943|NCT02731612|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
110477944|NCT02731612|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110477945|NCT02731612|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110477946|NCT02731612|Adrenergic Agents|adrenergic agents|mesh-ancestor
110477947|NCT02731612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110477948|NCT02731612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110477949|NCT02731612|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110477950|NCT02731612|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110477951|NCT02731612|Serotonin Agents|serotonin agents|mesh-ancestor
110477952|NCT02731612|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110477953|NCT02731612|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110477954|NCT02731612|Dopamine Agents|dopamine agents|mesh-ancestor
110477955|NCT04371393|Remestemcel-l|remestemcel-l|mesh-list
110477956|NCT04371393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110477957|NCT04371393|Antiviral Agents|antiviral agents|mesh-ancestor
110477958|NCT04371393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110477959|NCT00923182|Alemtuzumab|alemtuzumab|mesh-list
110477960|NCT00923182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110477961|NCT00923182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110477962|NCT03868839|Telmisartan|telmisartan|mesh-list
110477963|NCT03868839|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110477964|NCT03868839|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110477965|NCT03868839|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110477966|NCT03868839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110477968|NCT00589420|Sorafenib|sorafenib|mesh-list
110477969|NCT00589420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110477970|NCT00589420|Tubulin Modulators|tubulin modulators|mesh-ancestor
110477971|NCT00589420|Antimitotic Agents|antimitotic agents|mesh-ancestor
110477972|NCT00589420|Mitosis Modulators|mitosis modulators|mesh-ancestor
110477973|NCT00589420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110477974|NCT00589420|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110477975|NCT00589420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110477976|NCT04114630|Erenumab|erenumab|mesh-list
110477977|NCT04114630|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
110477978|NCT04114630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110477980|NCT04114630|Sensory System Agents|sensory system agents|mesh-ancestor
110477981|NCT04114630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110477982|NCT04114630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110477983|NCT00914524|Olmesartan|olmesartan|mesh-list
110477984|NCT00914524|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
110477985|NCT00914524|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110477986|NCT00914524|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110477987|NCT00914524|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110477988|NCT00914524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110477989|NCT03787095|Cemiplimab|cemiplimab|mesh-list
110477990|NCT03787095|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110477991|NCT03787095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110477992|NCT04103385|Risedronic Acid|risedronic acid|mesh-list
110477993|NCT04103385|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110034051|NCT01591629|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110886115|NCT02015351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110886116|NCT02015351|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110886117|NCT02015351|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110886118|NCT02015351|Growth Substances|growth substances|mesh-ancestor
110886119|NCT02015351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110886120|NCT02015351|Growth Inhibitors|growth inhibitors|mesh-ancestor
110886121|NCT03604796|Acetaminophen|acetaminophen|mesh-list
110886122|NCT03604796|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110886123|NCT03604796|Analgesics|analgesics|mesh-ancestor
110886124|NCT03604796|Sensory System Agents|sensory system agents|mesh-ancestor
110886125|NCT03604796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110886126|NCT03604796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110886128|NCT02237534|Calcium Carbonate|calcium carbonate|mesh-list
110886129|NCT02237534|Calcium|calcium|mesh-list
110886130|NCT02237534|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110477994|NCT04103385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110477995|NCT04103385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110477996|NCT04103385|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110477997|NCT04103385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110477998|NCT04103385|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110477999|NCT00796978|Trastuzumab|trastuzumab|mesh-list
110478000|NCT00796978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110478001|NCT00796978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110478002|NCT03779295|Clindamycin|clindamycin|mesh-list
110478003|NCT03779295|Clindamycin palmitate|clindamycin palmitate|mesh-list
110478004|NCT03779295|Clindamycin phosphate|clindamycin phosphate|mesh-list
110478005|NCT03779295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110478006|NCT03779295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110478007|NCT03779295|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110478008|NCT03779295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110478009|NCT03779295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110478010|NCT00613665|Vaccines|vaccines|mesh-list
110478011|NCT00613665|Immunologic Factors|immunologic factors|mesh-ancestor
110478012|NCT00613665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110478013|NCT00923572|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
110478014|NCT00923572|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110478015|NCT00923572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110478016|NCT03746769|Gastrins|gastrins|mesh-list
110478017|NCT03746769|Hormones|hormones|mesh-ancestor
110478018|NCT03746769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110478019|NCT03746769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110478020|NCT00796822|Pentoxifylline|pentoxifylline|mesh-list
110478021|NCT00796822|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110478022|NCT00796822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110478023|NCT00796822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110478024|NCT00796822|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110478025|NCT00796822|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110478026|NCT00796822|Protective Agents|protective agents|mesh-ancestor
110478027|NCT00796822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110478028|NCT00796822|Vasodilator Agents|vasodilator agents|mesh-ancestor
110478029|NCT00796822|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110478030|NCT00796822|Antioxidants|antioxidants|mesh-ancestor
110478031|NCT04007991|Ecopipam|ecopipam|mesh-list
110478032|NCT04007991|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110478033|NCT04007991|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110478034|NCT04007991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110478035|NCT04007991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110378919|NCT04558424|Vitamins|vitamins|mesh-ancestor
110478036|NCT04007991|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110478037|NCT04007991|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110886132|NCT02237534|Antacids|antacids|mesh-ancestor
110886133|NCT02237534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110886134|NCT02237534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110886135|NCT03606902|Fentanyl|fentanyl|mesh-list
110886136|NCT03606902|Bupivacaine|bupivacaine|mesh-list
110886137|NCT03606902|Anesthetics, Local|anesthetics, local|mesh-ancestor
110886138|NCT03606902|Anesthetics|anesthetics|mesh-ancestor
110886139|NCT03606902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110886140|NCT03606902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110886141|NCT03606902|Sensory System Agents|sensory system agents|mesh-ancestor
110208838|NCT00060476|Rofecoxib|rofecoxib|mesh-list
110478038|NCT04007991|Dopamine Agents|dopamine agents|mesh-ancestor
110478039|NCT04007991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110478040|NCT04007991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110478041|NCT03822507|Cinacalcet|cinacalcet|mesh-list
110478042|NCT03822507|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110478043|NCT03822507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110478044|NCT03822507|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
110478045|NCT03822507|Hormone Antagonists|hormone antagonists|mesh-ancestor
110478046|NCT03822507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110478047|NCT04301726|Tetrabenazine|tetrabenazine|mesh-list
110478048|NCT04301726|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110478049|NCT04301726|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110478050|NCT04301726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110478051|NCT04301726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110478052|NCT04301726|Adrenergic Agents|adrenergic agents|mesh-ancestor
110478053|NCT04301726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110478054|NCT04301726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110478055|NCT00614679|Tigecycline|tigecycline|mesh-list
110478056|NCT00614679|Heparin|heparin|mesh-list
110478057|NCT00614679|Anticoagulants|anticoagulants|mesh-ancestor
110478058|NCT00614679|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110478059|NCT00614679|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110478060|NCT00614679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110478061|NCT00614679|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110478062|NCT00614679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110478063|NCT00614679|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110478064|NCT00614679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110478065|NCT03760965|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
110478066|NCT03760965|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110478067|NCT03760965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110478068|NCT03760965|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110478069|NCT03760965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110478070|NCT03703869|Insulin Glargine|insulin glargine|mesh-list
110478071|NCT03703869|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110478072|NCT03703869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110478073|NCT01024946|Everolimus|everolimus|mesh-list
110478074|NCT01024946|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110478075|NCT01024946|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110478076|NCT01024946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110478077|NCT01024946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110478078|NCT01024946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110478079|NCT01024946|Immunologic Factors|immunologic factors|mesh-ancestor
110601831|NCT00874042|Antimetabolites|antimetabolites|mesh-ancestor
110478080|NCT01024946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110478081|NCT01024946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110478082|NCT00724867|Belimumab|belimumab|mesh-list
110478083|NCT00724867|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110478084|NCT00724867|Immunologic Factors|immunologic factors|mesh-ancestor
110478085|NCT00724867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110478086|NCT00627536|Mitogens|mitogens|mesh-list
110886142|NCT03606902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110886143|NCT03606902|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110886144|NCT03606902|Narcotics|narcotics|mesh-ancestor
110886145|NCT03606902|Analgesics|analgesics|mesh-ancestor
110886146|NCT03606902|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110886147|NCT03606902|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110886148|NCT03606902|Anesthetics, General|anesthetics, general|mesh-ancestor
110886149|NCT03602378|Hydrocortisone|hydrocortisone|mesh-list
110886150|NCT03602378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110886151|NCT03606824|Pitavastatin|pitavastatin|mesh-list
110886152|NCT03606824|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110478087|NCT00627536|Mitosis Modulators|mitosis modulators|mesh-ancestor
110478088|NCT00627536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110478089|NCT00724711|Tenofovir|tenofovir|mesh-list
110478090|NCT00724711|Lamivudine|lamivudine|mesh-list
110478091|NCT00724711|Emtricitabine|emtricitabine|mesh-list
110478092|NCT00724711|Abacavir|abacavir|mesh-list
110478093|NCT00724711|Antiviral Agents|antiviral agents|mesh-ancestor
110478094|NCT00724711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110478095|NCT00724711|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110478096|NCT00724711|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110478097|NCT00724711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110478098|NCT00724711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110478099|NCT00724711|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110478100|NCT00724711|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110478101|NCT00721279|Pramipexole|pramipexole|mesh-list
110478102|NCT00721279|Antioxidants|antioxidants|mesh-ancestor
110478103|NCT00721279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110478104|NCT00721279|Protective Agents|protective agents|mesh-ancestor
110478105|NCT00721279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110478106|NCT00721279|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110478107|NCT00721279|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110478108|NCT00721279|Dopamine Agonists|dopamine agonists|mesh-ancestor
110478109|NCT00721279|Dopamine Agents|dopamine agents|mesh-ancestor
110478110|NCT00721279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110478111|NCT01030952|Acarbose|acarbose|mesh-list
110478112|NCT01030952|Nateglinide|nateglinide|mesh-list
110478113|NCT01030952|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
110478114|NCT01030952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110478115|NCT01030952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110478116|NCT01030952|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110478117|NCT01030952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110478118|NCT03611751|Apremilast|apremilast|mesh-list
110478119|NCT03611751|Deucravacitinib|deucravacitinib|mesh-list
110478120|NCT03611751|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110478121|NCT03611751|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110478122|NCT03611751|Analgesics|analgesics|mesh-ancestor
110478123|NCT03611751|Sensory System Agents|sensory system agents|mesh-ancestor
110478124|NCT03611751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110478125|NCT03611751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110478126|NCT03611751|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110478127|NCT03611751|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110478128|NCT03611751|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
110478129|NCT03611751|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110478130|NCT03611751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110478131|NCT03611751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110478132|NCT03611751|Dermatologic Agents|dermatologic agents|mesh-ancestor
110478133|NCT03611751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110478134|NCT00613743|Morphine|morphine|mesh-list
110478135|NCT00613743|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110478136|NCT00613743|Narcotics|narcotics|mesh-ancestor
110478137|NCT00613743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110478138|NCT00613743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110478139|NCT00613743|Analgesics|analgesics|mesh-ancestor
110478140|NCT00613743|Sensory System Agents|sensory system agents|mesh-ancestor
110034505|NCT01399463|Tubulin Modulators|tubulin modulators|mesh-ancestor
110886153|NCT03606824|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110886154|NCT03606824|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110886155|NCT03606824|Antimetabolites|antimetabolites|mesh-ancestor
110886156|NCT03606824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110886157|NCT03606824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110886158|NCT03606824|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110886159|NCT03604016|Tenofovir|tenofovir|mesh-list
110886160|NCT03604016|Antiviral Agents|antiviral agents|mesh-ancestor
110886161|NCT03604016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110886162|NCT03604016|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110886163|NCT03604016|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110478141|NCT00613743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110478142|NCT00614757|Acetylcysteine|acetylcysteine|mesh-list
110478143|NCT00614757|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110478144|NCT00614757|Antiviral Agents|antiviral agents|mesh-ancestor
110478145|NCT00614757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110478146|NCT00614757|Expectorants|expectorants|mesh-ancestor
110478147|NCT00614757|Respiratory System Agents|respiratory system agents|mesh-ancestor
110478148|NCT00614757|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110478149|NCT00614757|Antioxidants|antioxidants|mesh-ancestor
110478150|NCT00614757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110478151|NCT00614757|Protective Agents|protective agents|mesh-ancestor
110478152|NCT00614757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110478153|NCT00614757|Antidotes|antidotes|mesh-ancestor
110478154|NCT02692365|Manganese|manganese|mesh-list
110478155|NCT02692365|Trace Elements|trace elements|mesh-ancestor
110478156|NCT02692365|Micronutrients|micronutrients|mesh-ancestor
110478157|NCT02692365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110478158|NCT03492099|Buprenorphine|buprenorphine|mesh-list
110478159|NCT03492099|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110125362|NCT01945437|Anesthetics|anesthetics|mesh-ancestor
110478160|NCT03492099|Narcotics|narcotics|mesh-ancestor
110478161|NCT03492099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110478162|NCT03492099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110478163|NCT03492099|Analgesics|analgesics|mesh-ancestor
110478164|NCT03492099|Sensory System Agents|sensory system agents|mesh-ancestor
110478165|NCT03492099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110478166|NCT03492099|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110478167|NCT03481959|Methylphenidate|methylphenidate|mesh-list
110478168|NCT03481959|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110478169|NCT03481959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110478170|NCT03481959|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110478171|NCT03481959|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110478172|NCT03481959|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110478173|NCT03481959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110478174|NCT03481959|Dopamine Agents|dopamine agents|mesh-ancestor
110478175|NCT03481959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110478176|NCT03245229|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110478177|NCT03245229|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110478178|NCT03245229|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110478179|NCT03245229|Antimetabolites|antimetabolites|mesh-ancestor
110478180|NCT03245229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110478181|NCT03245229|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110478182|NCT03245229|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110478183|NCT03245229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110478184|NCT03462069|Empagliflozin|empagliflozin|mesh-list
110478185|NCT03462069|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
110478186|NCT03462069|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110478187|NCT03462069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110478188|NCT03462069|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110478189|NCT03462069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110886164|NCT03604016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110886165|NCT03604016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110886166|NCT03604016|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110886167|NCT03604016|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110886168|NCT01064622|Hydrocortisone|hydrocortisone|mesh-list
110886169|NCT01064622|Gemcitabine|gemcitabine|mesh-list
110886170|NCT01064622|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110886171|NCT01064622|Antimetabolites|antimetabolites|mesh-ancestor
110886172|NCT01064622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110886173|NCT01064622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110886174|NCT01064622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110886175|NCT01063764|Levetiracetam|levetiracetam|mesh-list
110886176|NCT01063764|Anticonvulsants|anticonvulsants|mesh-ancestor
110886177|NCT01063764|Nootropic Agents|nootropic agents|mesh-ancestor
110886178|NCT04053972|Lenvatinib|lenvatinib|mesh-list
110886179|NCT04053972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110886180|NCT04053972|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110886181|NCT04053972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110886182|NCT04053972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110886183|NCT01380249|Bromides|bromides|mesh-list
110886184|NCT01380249|Anticonvulsants|anticonvulsants|mesh-ancestor
110886185|NCT04054518|Durvalumab|durvalumab|mesh-list
110886186|NCT04054518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110886187|NCT04054518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110886188|NCT03652896|Liver Extracts|liver extracts|mesh-list
110478190|NCT03414723|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
110478192|NCT03414723|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110478193|NCT03414723|Protease Inhibitors|protease inhibitors|mesh-ancestor
110478194|NCT03414723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110478195|NCT03414723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110478196|NCT03414723|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110478197|NCT03414723|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110478198|NCT03414723|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110478199|NCT03414723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110478200|NCT03387657|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
110478201|NCT03387657|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110478202|NCT03387657|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110478203|NCT03387657|Diuretics|diuretics|mesh-ancestor
110478204|NCT03387657|Natriuretic Agents|natriuretic agents|mesh-ancestor
110478205|NCT03387657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110478206|NCT03387657|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110478207|NCT03387657|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110478208|NCT03387657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110478209|NCT03387657|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110478210|NCT03387657|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110478211|NCT00720499|Bromides|bromides|mesh-list
110478212|NCT00720499|Tiotropium Bromide|tiotropium bromide|mesh-list
110478213|NCT00720499|Olodaterol|olodaterol|mesh-list
110886190|NCT04565847|Albuterol|albuterol|mesh-list
110886191|NCT04565847|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110886192|NCT04565847|Autonomic Agents|autonomic agents|mesh-ancestor
110886193|NCT04565847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110886194|NCT04565847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110886195|NCT04565847|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110886196|NCT04565847|Respiratory System Agents|respiratory system agents|mesh-ancestor
110886197|NCT04565847|Tocolytic Agents|tocolytic agents|mesh-ancestor
110886198|NCT04565847|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110478214|NCT00720499|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110478215|NCT00720499|Autonomic Agents|autonomic agents|mesh-ancestor
110478216|NCT00720499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110478217|NCT00720499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110478218|NCT00720499|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110478219|NCT00720499|Respiratory System Agents|respiratory system agents|mesh-ancestor
110478220|NCT00720499|Parasympatholytics|parasympatholytics|mesh-ancestor
110478221|NCT00720499|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110478222|NCT00720499|Cholinergic Agents|cholinergic agents|mesh-ancestor
110478223|NCT00720499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110478224|NCT00720499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110478225|NCT00720499|Anticonvulsants|anticonvulsants|mesh-ancestor
110478226|NCT00724243|Infliximab|infliximab|mesh-list
110478227|NCT00724243|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110478228|NCT00724243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110478229|NCT00724243|Dermatologic Agents|dermatologic agents|mesh-ancestor
110478230|NCT00724243|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110478232|NCT02590705|Lidocaine|lidocaine|mesh-list
110478233|NCT02590705|Anesthetics, Local|anesthetics, local|mesh-ancestor
110478234|NCT02590705|Anesthetics|anesthetics|mesh-ancestor
110478235|NCT02590705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110478236|NCT02590705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110478237|NCT02590705|Sensory System Agents|sensory system agents|mesh-ancestor
110478238|NCT02590705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110478239|NCT02590705|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110478240|NCT02590705|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110478241|NCT02590705|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110478242|NCT02590705|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110478243|NCT02590705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110478244|NCT00720343|Choline|choline|mesh-list
110478245|NCT00720343|Lipotropic Agents|lipotropic agents|mesh-ancestor
110478246|NCT00720343|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110478247|NCT00720343|Antimetabolites|antimetabolites|mesh-ancestor
110478248|NCT00720343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110478249|NCT00720343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110478250|NCT00720343|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110478251|NCT00720343|Nootropic Agents|nootropic agents|mesh-ancestor
110478252|NCT00720109|Calcium, Dietary|calcium, dietary|mesh-list
110478253|NCT00720109|Leucovorin|leucovorin|mesh-list
110478254|NCT00720109|Folic Acid|folic acid|mesh-list
110478255|NCT00720109|Cytarabine|cytarabine|mesh-list
110478256|NCT00720109|Dexamethasone|dexamethasone|mesh-list
110478257|NCT00720109|Dexamethasone acetate|dexamethasone acetate|mesh-list
110478258|NCT00720109|Prednisone|prednisone|mesh-list
110478259|NCT00720109|Methylprednisolone|methylprednisolone|mesh-list
110478260|NCT00720109|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110478261|NCT00720109|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110478262|NCT00720109|Prednisolone|prednisolone|mesh-list
110478263|NCT00720109|Prednisolone acetate|prednisolone acetate|mesh-list
110478264|NCT00720109|Hydrocortisone|hydrocortisone|mesh-list
110478265|NCT00720109|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
110478266|NCT00720109|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
110478267|NCT00720109|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
110478268|NCT00720109|Cortisone|cortisone|mesh-list
110478269|NCT00720109|Cyclophosphamide|cyclophosphamide|mesh-list
110478270|NCT00720109|Ifosfamide|ifosfamide|mesh-list
110478271|NCT00720109|Isophosphamide mustard|isophosphamide mustard|mesh-list
110478272|NCT00720109|Methotrexate|methotrexate|mesh-list
110886199|NCT04565847|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110886200|NCT04565847|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110603731|NCT04061538|Zinc|zinc|mesh-list
110886201|NCT04565847|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110886202|NCT04565847|Adrenergic Agents|adrenergic agents|mesh-ancestor
110886203|NCT04565847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110886204|NCT04565847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110886205|NCT03075891|Doxycycline|doxycycline|mesh-list
110886206|NCT03075891|Ivermectin|ivermectin|mesh-list
110886207|NCT03075891|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110886208|NCT03075891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110886209|NCT03075891|Antimalarials|antimalarials|mesh-ancestor
110886210|NCT03075891|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110886211|NCT03075891|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110886212|NCT02013167|Blinatumomab|blinatumomab|mesh-list
110886213|NCT02013167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110478273|NCT00720109|Etoposide|etoposide|mesh-list
110478274|NCT00720109|Vincristine|vincristine|mesh-list
110478275|NCT00720109|Etoposide phosphate|etoposide phosphate|mesh-list
110478276|NCT00720109|Daunorubicin|daunorubicin|mesh-list
110478277|NCT00720109|Asparaginase|asparaginase|mesh-list
110478278|NCT00720109|Dasatinib|dasatinib|mesh-list
110478279|NCT00720109|Mercaptopurine|mercaptopurine|mesh-list
110601926|NCT05523440|Bevacizumab|bevacizumab|mesh-list
110478280|NCT00720109|Podophyllotoxin|podophyllotoxin|mesh-list
110478281|NCT00720109|Pegaspargase|pegaspargase|mesh-list
110478282|NCT00720109|Lenograstim|lenograstim|mesh-list
110478283|NCT00720109|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110478284|NCT00720109|Prednisolone phosphate|prednisolone phosphate|mesh-list
110478285|NCT00720109|BB 1101|bb 1101|mesh-list
110478286|NCT00720109|Calcium|calcium|mesh-list
110478287|NCT00720109|Levoleucovorin|levoleucovorin|mesh-list
110478288|NCT00720109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110478289|NCT00720109|Immunologic Factors|immunologic factors|mesh-ancestor
110478290|NCT00720109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110478291|NCT00720109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110478292|NCT00720109|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110478293|NCT00720109|Alkylating Agents|alkylating agents|mesh-ancestor
110478294|NCT00720109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110478295|NCT00720109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110478296|NCT00720109|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110478297|NCT00720109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110478298|NCT00720109|Antiemetics|antiemetics|mesh-ancestor
110478299|NCT00720109|Autonomic Agents|autonomic agents|mesh-ancestor
110478300|NCT00720109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110478301|NCT00720109|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110478302|NCT00720109|Glucocorticoids|glucocorticoids|mesh-ancestor
110478303|NCT00720109|Hormones|hormones|mesh-ancestor
110478304|NCT00720109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110478305|NCT00720109|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110478306|NCT00720109|Protease Inhibitors|protease inhibitors|mesh-ancestor
110478307|NCT00720109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110478308|NCT00720109|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110478309|NCT00720109|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110478310|NCT00720109|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110478311|NCT00720109|Abortifacient Agents|abortifacient agents|mesh-ancestor
110478312|NCT00720109|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110478313|NCT00720109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110478314|NCT00720109|Antimetabolites|antimetabolites|mesh-ancestor
110478315|NCT00720109|Dermatologic Agents|dermatologic agents|mesh-ancestor
110478316|NCT00720109|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110478317|NCT00720109|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110165750|NCT00025168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110034506|NCT01399463|Antimitotic Agents|antimitotic agents|mesh-ancestor
110886214|NCT01378533|Paclitaxel|paclitaxel|mesh-list
110886215|NCT01378533|Cyclophosphamide|cyclophosphamide|mesh-list
110886216|NCT01378533|Carboplatin|carboplatin|mesh-list
110886217|NCT01378533|Epirubicin|epirubicin|mesh-list
110886218|NCT01378533|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110886219|NCT01378533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110886220|NCT01378533|Tubulin Modulators|tubulin modulators|mesh-ancestor
110886221|NCT01378533|Antimitotic Agents|antimitotic agents|mesh-ancestor
110886222|NCT01378533|Mitosis Modulators|mitosis modulators|mesh-ancestor
110886223|NCT01378533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110886224|NCT01378533|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110886225|NCT01378533|Immunologic Factors|immunologic factors|mesh-ancestor
110478318|NCT00720109|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110478319|NCT00720109|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110478320|NCT00720109|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110478321|NCT00720109|Antiviral Agents|antiviral agents|mesh-ancestor
110478322|NCT00720109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110478323|NCT00720109|Antidotes|antidotes|mesh-ancestor
110478324|NCT00720109|Protective Agents|protective agents|mesh-ancestor
110478325|NCT00720109|Vitamin B Complex|vitamin b complex|mesh-ancestor
110478326|NCT00720109|Vitamins|vitamins|mesh-ancestor
110478327|NCT00720109|Micronutrients|micronutrients|mesh-ancestor
110478328|NCT00720109|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110478329|NCT00720109|Tubulin Modulators|tubulin modulators|mesh-ancestor
110478330|NCT00720109|Antimitotic Agents|antimitotic agents|mesh-ancestor
110478331|NCT00720109|Mitosis Modulators|mitosis modulators|mesh-ancestor
110478332|NCT00720109|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110478333|NCT00720109|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110478334|NCT00720109|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110478335|NCT00720109|Hematinics|hematinics|mesh-ancestor
110478336|NCT00720109|Keratolytic Agents|keratolytic agents|mesh-ancestor
110478337|NCT02590627|Lumefantrine|lumefantrine|mesh-list
110478338|NCT02590627|Artemether|artemether|mesh-list
110478339|NCT02590627|Piperaquine|piperaquine|mesh-list
110478340|NCT02590627|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
110478341|NCT02590627|Artenimol|artenimol|mesh-list
110478343|NCT02590627|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110478344|NCT02590627|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110478345|NCT02590627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110478346|NCT01015118|Paclitaxel|paclitaxel|mesh-list
110478347|NCT01015118|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110478348|NCT01015118|Carboplatin|carboplatin|mesh-list
110478349|NCT01015118|Nintedanib|nintedanib|mesh-list
110478350|NCT01015118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110478351|NCT01015118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110478352|NCT01015118|Tubulin Modulators|tubulin modulators|mesh-ancestor
110478353|NCT01015118|Antimitotic Agents|antimitotic agents|mesh-ancestor
110478354|NCT01015118|Mitosis Modulators|mitosis modulators|mesh-ancestor
110478355|NCT01015118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110478356|NCT01015118|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110478357|NCT01015118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110478358|NCT02415153|Pomalidomide|pomalidomide|mesh-list
110478359|NCT02415153|Immunologic Factors|immunologic factors|mesh-ancestor
110478360|NCT02415153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110478361|NCT02415153|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110478362|NCT02415153|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110478363|NCT02415153|Growth Substances|growth substances|mesh-ancestor
110478364|NCT02415153|Growth Inhibitors|growth inhibitors|mesh-ancestor
110478365|NCT02415153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110478366|NCT04111822|Tranexamic Acid|tranexamic acid|mesh-list
110478367|NCT04111822|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110478368|NCT04111822|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110478369|NCT04111822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110478370|NCT04111822|Hemostatics|hemostatics|mesh-ancestor
110478371|NCT04111822|Coagulants|coagulants|mesh-ancestor
110478372|NCT00628160|Terlipressin|terlipressin|mesh-list
110478373|NCT00628160|Dopamine|dopamine|mesh-list
110478374|NCT00628160|Norepinephrine|norepinephrine|mesh-list
110886226|NCT01378533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110886228|NCT01378533|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110886229|NCT01378533|Alkylating Agents|alkylating agents|mesh-ancestor
110886230|NCT01378533|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110886231|NCT01378533|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110886232|NCT01378533|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110886233|NCT01378533|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110886234|NCT01378533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110886235|NCT02630199|Paclitaxel|paclitaxel|mesh-list
110478375|NCT00628160|Adrenergic Agents|adrenergic agents|mesh-list
110478376|NCT00628160|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110478377|NCT00628160|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110478378|NCT00628160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110478379|NCT00628160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110478380|NCT00628160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110478381|NCT00628160|Sympathomimetics|sympathomimetics|mesh-ancestor
110478382|NCT00628160|Autonomic Agents|autonomic agents|mesh-ancestor
110478383|NCT00628160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110478384|NCT00628160|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110478385|NCT00628160|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110478386|NCT00628160|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110478387|NCT00628160|Dopamine Agents|dopamine agents|mesh-ancestor
110478388|NCT00628160|Protective Agents|protective agents|mesh-ancestor
110478389|NCT02274285|Vaccines|vaccines|mesh-list
110478390|NCT02274285|Immunologic Factors|immunologic factors|mesh-ancestor
110478391|NCT02274285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110478392|NCT02283112|Anti-Infective Agents|anti-infective agents|mesh-list
110478393|NCT02283112|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110478394|NCT02283112|Antiviral Agents|antiviral agents|mesh-list
110478395|NCT02283112|Contraceptive Agents|contraceptive agents|mesh-list
110478396|NCT02283112|Contraceptives, Oral|contraceptives, oral|mesh-list
110478397|NCT02283112|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110478398|NCT02283112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110478399|NCT02283112|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110478400|NCT00614835|Gemcitabine|gemcitabine|mesh-list
110478401|NCT00614835|Docetaxel|docetaxel|mesh-list
110478402|NCT00614835|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110478403|NCT00614835|Antimetabolites|antimetabolites|mesh-ancestor
110478404|NCT00614835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110478405|NCT00614835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110478406|NCT00614835|Tubulin Modulators|tubulin modulators|mesh-ancestor
110478407|NCT00614835|Antimitotic Agents|antimitotic agents|mesh-ancestor
110478408|NCT00614835|Mitosis Modulators|mitosis modulators|mesh-ancestor
110478409|NCT00715429|Vitamin D|vitamin d|mesh-list
110478410|NCT00715429|Ergocalciferols|ergocalciferols|mesh-list
110478411|NCT00715429|Vitamins|vitamins|mesh-ancestor
110478412|NCT00715429|Micronutrients|micronutrients|mesh-ancestor
110478413|NCT00715429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110478414|NCT00715429|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110478415|NCT00715429|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110478416|NCT02606032|Metronidazole|metronidazole|mesh-list
110478417|NCT02606032|Doxycycline|doxycycline|mesh-list
110478418|NCT02606032|Terbinafine|terbinafine|mesh-list
110478419|NCT02606032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110478420|NCT02606032|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110478421|NCT02606032|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110478422|NCT02606032|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110478423|NCT02606032|Antimalarials|antimalarials|mesh-ancestor
110478424|NCT02606032|Antifungal Agents|antifungal agents|mesh-ancestor
110478425|NCT02606032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110478426|NCT02606032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110478427|NCT02145507|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110478429|NCT01743651|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110478430|NCT01743651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110478431|NCT01743651|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110034507|NCT01399463|Mitosis Modulators|mitosis modulators|mesh-ancestor
110886236|NCT02630199|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110886237|NCT02630199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110886238|NCT02630199|Tubulin Modulators|tubulin modulators|mesh-ancestor
110886239|NCT02630199|Antimitotic Agents|antimitotic agents|mesh-ancestor
110886240|NCT02630199|Mitosis Modulators|mitosis modulators|mesh-ancestor
110534672|NCT02672358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110478432|NCT01743651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110478433|NCT01743651|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
110478434|NCT01743651|GABA Agonists|gaba agonists|mesh-ancestor
110478435|NCT01743651|GABA Agents|gaba agents|mesh-ancestor
110478436|NCT01743651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110478437|NCT01743651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110478438|NCT00715117|Naltrexone|naltrexone|mesh-list
110478439|NCT00715117|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110478440|NCT00715117|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110478441|NCT00715117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110478442|NCT00715117|Sensory System Agents|sensory system agents|mesh-ancestor
110478443|NCT00715117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110478444|NCT00723229|Acyclovir|acyclovir|mesh-list
110478445|NCT00723229|Antiviral Agents|antiviral agents|mesh-ancestor
110478446|NCT00723229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110478447|NCT01093521|Gallium nitrate|gallium nitrate|mesh-list
110478448|NCT01093521|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110478449|NCT01093521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110478450|NCT01093521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110478451|NCT01030718|Dasatinib|dasatinib|mesh-list
110478452|NCT01030718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110478453|NCT01030718|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110478454|NCT01030718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110478455|NCT01030718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110478456|NCT00722761|Drospirenone|drospirenone|mesh-list
110478457|NCT00722761|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110478458|NCT00722761|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
110478459|NCT00722761|Estradiol|estradiol|mesh-list
110478460|NCT00722761|Estrogens|estrogens|mesh-ancestor
110478461|NCT00722761|Hormones|hormones|mesh-ancestor
110478462|NCT00722761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110478463|NCT00722761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110478464|NCT00722761|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110478465|NCT00722761|Contraceptive Agents|contraceptive agents|mesh-ancestor
110478466|NCT00722761|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110478467|NCT00722761|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110478468|NCT00722761|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110478469|NCT00722761|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110478470|NCT00722761|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110478471|NCT00722761|Hormone Antagonists|hormone antagonists|mesh-ancestor
110478472|NCT00722761|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110478474|NCT00722761|Natriuretic Agents|natriuretic agents|mesh-ancestor
110478475|NCT00628238|Rituximab|rituximab|mesh-list
110478476|NCT00628238|Lenalidomide|lenalidomide|mesh-list
110478477|NCT00628238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110478478|NCT00628238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110478479|NCT00628238|Immunologic Factors|immunologic factors|mesh-ancestor
110478480|NCT00628238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110478481|NCT00628238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110478482|NCT00628238|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110478483|NCT00628238|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110478484|NCT00628238|Growth Substances|growth substances|mesh-ancestor
110478485|NCT00628238|Growth Inhibitors|growth inhibitors|mesh-ancestor
110478486|NCT05132179|Sodium Hypochlorite|sodium hypochlorite|mesh-list
110478487|NCT05132179|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110478488|NCT05132179|Disinfectants|disinfectants|mesh-ancestor
110478489|NCT05132179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110478490|NCT01019486|Regadenoson|regadenoson|mesh-list
110478491|NCT01019486|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
110478492|NCT01019486|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
110478493|NCT01019486|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
110478494|NCT01019486|Purinergic Agonists|purinergic agonists|mesh-ancestor
110478495|NCT01019486|Purinergic Agents|purinergic agents|mesh-ancestor
110886241|NCT02630199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110886242|NCT02588781|Pemetrexed|pemetrexed|mesh-list
110886243|NCT02588781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110886244|NCT02588781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110886245|NCT02588781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110886246|NCT02588781|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110886247|NCT02588781|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110886248|NCT01063062|Methotrexate|methotrexate|mesh-list
110886249|NCT01063062|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110886250|NCT01063062|Abortifacient Agents|abortifacient agents|mesh-ancestor
110886251|NCT01063062|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110886252|NCT01063062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110886253|NCT01063062|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110886254|NCT01063062|Antimetabolites|antimetabolites|mesh-ancestor
110886255|NCT01063062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110886256|NCT01063062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110886257|NCT01063062|Dermatologic Agents|dermatologic agents|mesh-ancestor
110886258|NCT01063062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110886259|NCT01063062|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110886260|NCT01063062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110886261|NCT01063062|Immunologic Factors|immunologic factors|mesh-ancestor
110886262|NCT01063062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110886263|NCT01063062|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110886264|NCT01314989|Cyproheptadine|cyproheptadine|mesh-list
110886265|NCT01314989|Antipruritics|antipruritics|mesh-ancestor
110886266|NCT01314989|Dermatologic Agents|dermatologic agents|mesh-ancestor
110886267|NCT01314989|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110886268|NCT01314989|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110886269|NCT01314989|Histamine Antagonists|histamine antagonists|mesh-ancestor
110886270|NCT01314989|Histamine Agents|histamine agents|mesh-ancestor
110886271|NCT01314989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110886274|NCT01314989|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110886282|NCT04483115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110886283|NCT04483115|Urological Agents|urological agents|mesh-ancestor
110886284|NCT04054362|Paclitaxel|paclitaxel|mesh-list
110886285|NCT04054362|Gemcitabine|gemcitabine|mesh-list
110886286|NCT04054362|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110886287|NCT04054362|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110886288|NCT04054362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110886289|NCT04054362|Tubulin Modulators|tubulin modulators|mesh-ancestor
110886290|NCT04054362|Antimitotic Agents|antimitotic agents|mesh-ancestor
110886291|NCT04054362|Mitosis Modulators|mitosis modulators|mesh-ancestor
110534674|NCT02672358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110478496|NCT01019486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110478497|NCT01019486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110478498|NCT01019486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110478499|NCT01019486|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110478500|NCT02803203|Bevacizumab|bevacizumab|mesh-list
110478501|NCT02803203|Osimertinib|osimertinib|mesh-list
110478502|NCT02803203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110478503|NCT02803203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110478504|NCT02803203|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110478505|NCT02803203|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110478506|NCT02803203|Growth Substances|growth substances|mesh-ancestor
110478507|NCT02803203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110478508|NCT02803203|Growth Inhibitors|growth inhibitors|mesh-ancestor
110478509|NCT02803203|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110478510|NCT02803203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110478511|NCT02803203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110478512|NCT00714493|Infliximab|infliximab|mesh-list
110478513|NCT00714493|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110478514|NCT00714493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110478515|NCT00714493|Dermatologic Agents|dermatologic agents|mesh-ancestor
110478516|NCT00714493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110478517|NCT00714493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110478518|NCT01013870|Atorvastatin|atorvastatin|mesh-list
110478519|NCT01013870|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110478520|NCT01013870|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110478521|NCT01013870|Antimetabolites|antimetabolites|mesh-ancestor
110478522|NCT01013870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110478523|NCT01013870|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110478524|NCT01013870|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110478525|NCT01013870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110478526|NCT05020184|Cimetidine|cimetidine|mesh-list
110478527|NCT05020184|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110478528|NCT05020184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110478529|NCT05020184|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110478530|NCT05020184|Histamine Antagonists|histamine antagonists|mesh-ancestor
110478531|NCT05020184|Histamine Agents|histamine agents|mesh-ancestor
110478532|NCT05020184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110478533|NCT05020184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110478534|NCT05020184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110478535|NCT05020184|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110478536|NCT05020184|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110478537|NCT05020184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110478538|NCT00628316|Caffeine|caffeine|mesh-list
110478539|NCT00628316|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110478540|NCT00628316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110478541|NCT00628316|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110478542|NCT00628316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110478543|NCT00628316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110478544|NCT00628316|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110478545|NCT00628316|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110478546|NCT00628316|Purinergic Agents|purinergic agents|mesh-ancestor
110034680|NCT01400750|Colistin|colistin|mesh-list
110870390|NCT02693002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110870391|NCT02693002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110870392|NCT02693002|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110870393|NCT02693002|Contraceptive Agents|contraceptive agents|mesh-ancestor
110870394|NCT02693002|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110870395|NCT02693002|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110870396|NCT02693002|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110870397|NCT02693002|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110870398|NCT02693002|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110870399|NCT05408923|Chlorhexidine|chlorhexidine|mesh-list
110870400|NCT05408923|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110068227|NCT01549431|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110870401|NCT05408923|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110870402|NCT05408923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110870403|NCT05408923|Disinfectants|disinfectants|mesh-ancestor
110870404|NCT05408923|Dermatologic Agents|dermatologic agents|mesh-ancestor
110870405|NCT03707509|Gemcitabine|gemcitabine|mesh-list
110870406|NCT03707509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110870407|NCT03707509|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110870408|NCT03707509|Antimetabolites|antimetabolites|mesh-ancestor
110068297|NCT01549743|Antioxidants|antioxidants|mesh-ancestor
110870409|NCT03707509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110870410|NCT03710395|Nifedipine|nifedipine|mesh-list
110870411|NCT03710395|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110870412|NCT03710395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110870413|NCT03710395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110068359|NCT01550302|Bupivacaine|bupivacaine|mesh-list
110870414|NCT03710395|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110870415|NCT03710395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110870416|NCT03710395|Vasodilator Agents|vasodilator agents|mesh-ancestor
110870417|NCT03710395|Tocolytic Agents|tocolytic agents|mesh-ancestor
110870418|NCT03710395|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110870419|NCT03093870|Capecitabine|capecitabine|mesh-list
110870420|NCT03093870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110870421|NCT03093870|Antimetabolites|antimetabolites|mesh-ancestor
110870422|NCT03093870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110870423|NCT03093870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110870424|NCT05744908|Pentosan Sulfuric Polyester|pentosan sulfuric polyester|mesh-list
110870425|NCT05744908|Anticoagulants|anticoagulants|mesh-ancestor
110870426|NCT02394106|Ofatumumab|ofatumumab|mesh-list
110870427|NCT02394106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110870428|NCT04793646|Acetylcysteine|acetylcysteine|mesh-list
110870429|NCT04793646|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110870430|NCT04793646|Antiviral Agents|antiviral agents|mesh-ancestor
110870431|NCT04793646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110870432|NCT04793646|Expectorants|expectorants|mesh-ancestor
110870433|NCT04793646|Respiratory System Agents|respiratory system agents|mesh-ancestor
110870434|NCT04793646|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110870435|NCT04793646|Antioxidants|antioxidants|mesh-ancestor
110870436|NCT04793646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110870437|NCT04793646|Protective Agents|protective agents|mesh-ancestor
110870438|NCT04793646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110870439|NCT04793646|Antidotes|antidotes|mesh-ancestor
110870440|NCT02393482|Cholecalciferol|cholecalciferol|mesh-list
110870441|NCT02393482|Vitamin D|vitamin d|mesh-list
110870442|NCT02393482|Leuprolide|leuprolide|mesh-list
110870444|NCT02393482|Calcium Carbonate|calcium carbonate|mesh-list
110870445|NCT02393482|Hormones|hormones|mesh-list
110870446|NCT02393482|Estradiol|estradiol|mesh-list
110870447|NCT02393482|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110870448|NCT02393482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110870449|NCT02393482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110870450|NCT02393482|Estrogens|estrogens|mesh-ancestor
110870451|NCT02393482|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110870452|NCT02393482|Antacids|antacids|mesh-ancestor
110870453|NCT02393482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110870454|NCT02393482|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110870455|NCT02393482|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110870456|NCT02393482|Fertility Agents|fertility agents|mesh-ancestor
110870457|NCT02393482|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110870458|NCT02393482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110870459|NCT02393482|Androgen Antagonists|androgen antagonists|mesh-ancestor
110870460|NCT02393482|Hormone Antagonists|hormone antagonists|mesh-ancestor
110870461|NCT02393482|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110870462|NCT02393482|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110870463|NCT02393482|Anabolic Agents|anabolic agents|mesh-ancestor
110870464|NCT02393482|Vitamins|vitamins|mesh-ancestor
110870465|NCT02393482|Micronutrients|micronutrients|mesh-ancestor
110870466|NCT02393482|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110870467|NCT03346057|Glycopyrrolate|glycopyrrolate|mesh-list
110870468|NCT03346057|Rocuronium|rocuronium|mesh-list
110870469|NCT03346057|Vecuronium Bromide|vecuronium bromide|mesh-list
110870470|NCT03346057|Neostigmine|neostigmine|mesh-list
110870471|NCT03346057|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110870472|NCT03346057|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110870473|NCT03346057|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110870474|NCT03346057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110870475|NCT03346057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110068602|NCT01551823|Vaccines|vaccines|mesh-list
110870476|NCT03346057|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110870477|NCT03346057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110870478|NCT03346057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110870479|NCT03346057|Cholinergic Agents|cholinergic agents|mesh-ancestor
110870480|NCT03346057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110870481|NCT03346057|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110870482|NCT03346057|Autonomic Agents|autonomic agents|mesh-ancestor
110870483|NCT03346057|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110870484|NCT03346057|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110870485|NCT03346057|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110870486|NCT03346057|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
110870487|NCT03166306|Bevacizumab|bevacizumab|mesh-list
110870488|NCT03166306|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110870489|NCT03166306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110870490|NCT03166306|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110870491|NCT03166306|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110870492|NCT03166306|Growth Substances|growth substances|mesh-ancestor
110870493|NCT03166306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110870494|NCT03166306|Growth Inhibitors|growth inhibitors|mesh-ancestor
110870495|NCT02398630|Hormones|hormones|mesh-list
110870496|NCT02398630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110870497|NCT02398630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110870498|NCT02398552|Sunitinib|sunitinib|mesh-list
110870499|NCT02398552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110870500|NCT02398552|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110870501|NCT02398552|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110870502|NCT02398552|Growth Substances|growth substances|mesh-ancestor
110870503|NCT02398552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110870504|NCT02398552|Growth Inhibitors|growth inhibitors|mesh-ancestor
110870505|NCT02398552|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110870506|NCT02398552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110870507|NCT02398552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110870508|NCT03345979|Aripiprazole|aripiprazole|mesh-list
110870509|NCT03345979|Paliperidone Palmitate|paliperidone palmitate|mesh-list
110870510|NCT03345979|Aripiprazole lauroxil|aripiprazole lauroxil|mesh-list
110870511|NCT03345979|Antidepressive Agents|antidepressive agents|mesh-ancestor
110870512|NCT03345979|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110068669|NCT01552330|Artesunate|artesunate|mesh-list
110870513|NCT03345979|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110870514|NCT03345979|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110870515|NCT03345979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110870516|NCT03345979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110870517|NCT03345979|Dopamine Agonists|dopamine agonists|mesh-ancestor
110870518|NCT03345979|Dopamine Agents|dopamine agents|mesh-ancestor
110602139|NCT00737724|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110870519|NCT03345979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110870520|NCT03345979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110068703|NCT01552798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110870521|NCT03345979|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110870522|NCT03345979|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110870524|NCT03345979|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110870525|NCT03345979|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110870526|NCT03345979|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110870527|NCT03345979|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110870528|NCT02696434|Naltrexone|naltrexone|mesh-list
110870529|NCT02696434|Buprenorphine|buprenorphine|mesh-list
110870530|NCT02696434|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110870531|NCT02696434|Narcotics|narcotics|mesh-ancestor
110870532|NCT02696434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110870533|NCT02696434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110870534|NCT02696434|Analgesics|analgesics|mesh-ancestor
110870535|NCT02696434|Sensory System Agents|sensory system agents|mesh-ancestor
110870536|NCT02696434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110870537|NCT02696434|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110870538|NCT02696434|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110870539|NCT03709147|Metformin|metformin|mesh-list
110870540|NCT03709147|Carboplatin|carboplatin|mesh-list
110870541|NCT03709147|Pembrolizumab|pembrolizumab|mesh-list
110870542|NCT03709147|Pemetrexed|pemetrexed|mesh-list
110870543|NCT03709147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110870544|NCT03709147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110870545|NCT03709147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110870546|NCT03709147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110870547|NCT03709147|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110870548|NCT03709147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110870549|NCT03709147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110870550|NCT03709147|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110870551|NCT03709147|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110870552|NCT02398474|Ropivacaine|ropivacaine|mesh-list
110870553|NCT02398474|Anesthetics, Local|anesthetics, local|mesh-ancestor
110870554|NCT02398474|Anesthetics|anesthetics|mesh-ancestor
110870555|NCT02398474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110870556|NCT02398474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110870557|NCT02398474|Sensory System Agents|sensory system agents|mesh-ancestor
110870558|NCT02398474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110870559|NCT03710317|Misoprostol|misoprostol|mesh-list
110870560|NCT03710317|Tranexamic Acid|tranexamic acid|mesh-list
110870561|NCT03710317|Carbetocin|carbetocin|mesh-list
110870562|NCT03710317|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110068775|NCT01553357|Hormones|hormones|mesh-ancestor
110870563|NCT03710317|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110602154|NCT00712920|Azelastine|azelastine|mesh-list
110870564|NCT03710317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110870565|NCT03710317|Hemostatics|hemostatics|mesh-ancestor
110870566|NCT03710317|Coagulants|coagulants|mesh-ancestor
110870567|NCT03710317|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110870568|NCT03710317|Abortifacient Agents|abortifacient agents|mesh-ancestor
110870569|NCT03710317|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110870570|NCT03710317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110870571|NCT03710317|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110870572|NCT03710317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110870573|NCT03710317|Oxytocics|oxytocics|mesh-ancestor
110870574|NCT02392780|Methylprednisolone|methylprednisolone|mesh-list
110870575|NCT02392780|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110870576|NCT02392780|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110870577|NCT02392780|Prednisolone|prednisolone|mesh-list
110870578|NCT02392780|Prednisolone acetate|prednisolone acetate|mesh-list
110870579|NCT02392780|Cannabidiol|cannabidiol|mesh-list
110870580|NCT02392780|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110870581|NCT02392780|Prednisolone phosphate|prednisolone phosphate|mesh-list
110870582|NCT02392780|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
110870583|NCT02392780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110870584|NCT02392780|Antiemetics|antiemetics|mesh-ancestor
110870585|NCT02392780|Autonomic Agents|autonomic agents|mesh-ancestor
110870586|NCT02392780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110870587|NCT02392780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110870588|NCT02392780|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110870589|NCT02392780|Glucocorticoids|glucocorticoids|mesh-ancestor
110870591|NCT02392780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110870592|NCT02392780|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110870593|NCT02392780|Protective Agents|protective agents|mesh-ancestor
110870594|NCT02392780|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110870595|NCT02392780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110870596|NCT02392780|Anticonvulsants|anticonvulsants|mesh-ancestor
110870597|NCT02392780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110870598|NCT02392780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110870599|NCT04053478|Phenylephrine|phenylephrine|mesh-list
110870600|NCT04053478|Vasopressins|vasopressins|mesh-list
110870601|NCT04053478|Arginine Vasopressin|arginine vasopressin|mesh-list
110870602|NCT04053478|Oxymetazoline|oxymetazoline|mesh-list
110870603|NCT04053478|Norepinephrine|norepinephrine|mesh-list
110870604|NCT04053478|Ephedrine|ephedrine|mesh-list
110870605|NCT04053478|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110870606|NCT04053478|Mydriatics|mydriatics|mesh-ancestor
110870607|NCT04053478|Autonomic Agents|autonomic agents|mesh-ancestor
110870608|NCT04053478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110870609|NCT04053478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110870611|NCT04053478|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110870612|NCT04053478|Nasal Decongestants|nasal decongestants|mesh-ancestor
110870613|NCT04053478|Respiratory System Agents|respiratory system agents|mesh-ancestor
110870614|NCT04053478|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110870615|NCT04053478|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110870616|NCT04053478|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110870617|NCT04053478|Adrenergic Agents|adrenergic agents|mesh-ancestor
110870618|NCT04053478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110870619|NCT04053478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110870620|NCT04053478|Protective Agents|protective agents|mesh-ancestor
110870621|NCT04053478|Hemostatics|hemostatics|mesh-ancestor
110870622|NCT04053478|Coagulants|coagulants|mesh-ancestor
110870623|NCT04053478|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
110870624|NCT04053478|Natriuretic Agents|natriuretic agents|mesh-ancestor
110870625|NCT04053478|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110870626|NCT02392390|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
110870627|NCT02392390|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110870628|NCT02392390|Dermatologic Agents|dermatologic agents|mesh-ancestor
110870629|NCT03593915|Azacitidine|azacitidine|mesh-list
110870630|NCT03593915|Decitabine|decitabine|mesh-list
110870631|NCT03593915|Alvocidib|alvocidib|mesh-list
110870632|NCT03593915|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110870633|NCT03593915|Antimetabolites|antimetabolites|mesh-ancestor
110870634|NCT03593915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110870635|NCT03593915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110870636|NCT03593915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110870637|NCT03593915|Growth Inhibitors|growth inhibitors|mesh-ancestor
110870638|NCT03593915|Growth Substances|growth substances|mesh-ancestor
110870639|NCT03593915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110870640|NCT03593915|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110870642|NCT02392702|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
110602264|NCT00881140|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110870643|NCT02392702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110870644|NCT02392702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110870645|NCT02392468|BI 409306|bi 409306|mesh-list
110870646|NCT02392468|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110870647|NCT02392468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110069112|NCT01556191|Gefitinib|gefitinib|mesh-list
110602336|NCT00738192|Fentanyl|fentanyl|mesh-list
110870648|NCT02392468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110870650|NCT02397928|Pemetrexed|pemetrexed|mesh-list
110870651|NCT02397928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110870652|NCT02397928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110870653|NCT02397928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110870654|NCT02397928|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110870655|NCT02397928|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110870656|NCT03734627|Acetaminophen|acetaminophen|mesh-list
110870657|NCT03734627|Sulfasalazine|sulfasalazine|mesh-list
110870658|NCT03734627|Octreotide|octreotide|mesh-list
110870659|NCT03734627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110870660|NCT03734627|Analgesics|analgesics|mesh-ancestor
110870661|NCT03734627|Sensory System Agents|sensory system agents|mesh-ancestor
110870662|NCT03734627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110870663|NCT03734627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110870664|NCT03734627|Antipyretics|antipyretics|mesh-ancestor
110870665|NCT03734627|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110870666|NCT03734627|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110870667|NCT03734627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110870668|NCT03734627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110870669|NCT03734627|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110870670|NCT03734627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110870671|NCT03734627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110870673|NCT02397772|Anthelmintics|anthelmintics|mesh-ancestor
110870674|NCT02397772|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110870675|NCT02397772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110870676|NCT02397772|Anticestodal Agents|anticestodal agents|mesh-ancestor
110870677|NCT02397772|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110870678|NCT02397772|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110870679|NCT02397772|Tubulin Modulators|tubulin modulators|mesh-ancestor
110870680|NCT02397772|Antimitotic Agents|antimitotic agents|mesh-ancestor
110870681|NCT02397772|Mitosis Modulators|mitosis modulators|mesh-ancestor
110870682|NCT02397772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110870683|NCT02397772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110870685|NCT03592277|Ascorbic Acid|ascorbic acid|mesh-list
110870686|NCT03592277|Thiamine|thiamine|mesh-list
110870687|NCT03592277|Micronutrients|micronutrients|mesh-ancestor
110602615|NCT00800319|ALKS-33|alks-33|mesh-list
110870688|NCT03592277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110870689|NCT03592277|Antioxidants|antioxidants|mesh-ancestor
110870690|NCT03592277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110870691|NCT03592277|Protective Agents|protective agents|mesh-ancestor
110870692|NCT03592277|Vitamin B Complex|vitamin b complex|mesh-ancestor
110870693|NCT03106402|Bromfenac|bromfenac|mesh-list
110602675|NCT00642759|Paclitaxel|paclitaxel|mesh-list
110870694|NCT03106402|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110870695|NCT03106402|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110870696|NCT03106402|Analgesics|analgesics|mesh-ancestor
110870697|NCT03106402|Sensory System Agents|sensory system agents|mesh-ancestor
110870698|NCT03106402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110870699|NCT03106402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110870701|NCT03106402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110870702|NCT03734159|Ropivacaine|ropivacaine|mesh-list
110870703|NCT03734159|Anesthetics, Local|anesthetics, local|mesh-ancestor
110870704|NCT03734159|Anesthetics|anesthetics|mesh-ancestor
110870705|NCT03734159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110870706|NCT03734159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110870707|NCT03734159|Sensory System Agents|sensory system agents|mesh-ancestor
110870708|NCT03734159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110870709|NCT02397382|Midazolam|midazolam|mesh-list
110870710|NCT02397382|Dextromethorphan|dextromethorphan|mesh-list
110870711|NCT02397382|Caffeine|caffeine|mesh-list
110870712|NCT02397382|Omeprazole|omeprazole|mesh-list
110870713|NCT02397382|Warfarin|warfarin|mesh-list
110870714|NCT02397382|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110870715|NCT02397382|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110870716|NCT02397382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110870717|NCT02397382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110870719|NCT02397382|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110870720|NCT02397382|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110870721|NCT02397382|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110870722|NCT02397382|Anesthetics, General|anesthetics, general|mesh-ancestor
110870723|NCT02397382|Anesthetics|anesthetics|mesh-ancestor
110870724|NCT02397382|GABA Modulators|gaba modulators|mesh-ancestor
110870725|NCT02397382|GABA Agents|gaba agents|mesh-ancestor
110870726|NCT02397382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110870727|NCT02397382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110870728|NCT02397382|Anticoagulants|anticoagulants|mesh-ancestor
110870729|NCT02397382|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110870730|NCT02397382|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110870731|NCT02397382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110870732|NCT02397382|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110870733|NCT02397382|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110870734|NCT02397382|Purinergic Agents|purinergic agents|mesh-ancestor
110870735|NCT02397382|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110870736|NCT02397382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110870737|NCT02397382|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110870738|NCT02397382|Antitussive Agents|antitussive agents|mesh-ancestor
110069569|NCT05686005|Tranexamic Acid|tranexamic acid|mesh-list
110069570|NCT05686005|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110069571|NCT05686005|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110069572|NCT05686005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110870739|NCT02397382|Respiratory System Agents|respiratory system agents|mesh-ancestor
110870740|NCT02397382|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110870741|NCT02397382|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110870742|NCT02697916|Aspirin|aspirin|mesh-list
110870743|NCT02697916|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110870744|NCT02697916|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110870745|NCT02697916|Analgesics|analgesics|mesh-ancestor
110870746|NCT02697916|Sensory System Agents|sensory system agents|mesh-ancestor
110870747|NCT02697916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110870748|NCT02697916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110870749|NCT02697916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110603084|NCT00886990|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110870750|NCT02697916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110870751|NCT02697916|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110870752|NCT02697916|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110870753|NCT02697916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110870754|NCT02697916|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110870755|NCT02697916|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110870756|NCT02697916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110870757|NCT02697916|Antipyretics|antipyretics|mesh-ancestor
110870758|NCT04762680|Vaccines|vaccines|mesh-list
110870759|NCT04762680|Immunologic Factors|immunologic factors|mesh-ancestor
110870760|NCT04762680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110870761|NCT03650387|Lidocaine|lidocaine|mesh-list
110870762|NCT03650387|Anesthetics, Local|anesthetics, local|mesh-ancestor
110870763|NCT03650387|Anesthetics|anesthetics|mesh-ancestor
110603220|NCT00645099|Olanzapine|olanzapine|mesh-list
110870764|NCT03650387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110870765|NCT03650387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110870766|NCT03650387|Sensory System Agents|sensory system agents|mesh-ancestor
110870767|NCT03650387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110870768|NCT03650387|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110870769|NCT03650387|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110870770|NCT03650387|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110870771|NCT03650387|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110588280|NCT00733083|Analgesics|analgesics|mesh-ancestor
110870772|NCT03650387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110870774|NCT02392156|Coagulants|coagulants|mesh-ancestor
110870775|NCT03115060|Plasma-lyte 148|plasma-lyte 148|mesh-list
110870776|NCT03115060|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110870777|NCT03115060|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110870778|NCT03359473|GSK2881078|gsk2881078|mesh-list
110870779|NCT03359473|Anabolic Agents|anabolic agents|mesh-ancestor
110870780|NCT03359473|Hormones|hormones|mesh-ancestor
110870781|NCT03359473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110870782|NCT03359473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110870783|NCT03632304|Anesthetics|anesthetics|mesh-list
110870784|NCT03632304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110870785|NCT03632304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110870786|NCT02397538|Amlodipine|amlodipine|mesh-list
110870787|NCT02397538|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110870788|NCT02397538|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110870789|NCT02397538|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110870790|NCT02397538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110870791|NCT02397538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110870792|NCT02397538|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110870793|NCT02397538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110603460|NCT00818415|Analgesics|analgesics|mesh-ancestor
110870794|NCT02397538|Vasodilator Agents|vasodilator agents|mesh-ancestor
110870795|NCT02397538|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110870796|NCT02397538|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110870797|NCT02397538|Antimetabolites|antimetabolites|mesh-ancestor
110870798|NCT02397538|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110870799|NCT02397538|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110870800|NCT02397538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110870801|NCT03589469|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
110870802|NCT03589469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110870803|NCT03589469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110870804|NCT03359395|Alfentanil|alfentanil|mesh-list
110870805|NCT03359395|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110870806|NCT03359395|Narcotics|narcotics|mesh-ancestor
110603526|NCT02566824|Sympathomimetics|sympathomimetics|mesh-ancestor
110870807|NCT03359395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110870808|NCT03359395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110870809|NCT03359395|Analgesics|analgesics|mesh-ancestor
110870810|NCT03359395|Sensory System Agents|sensory system agents|mesh-ancestor
110870811|NCT03359395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110870812|NCT03359395|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110870813|NCT03359395|Anesthetics, General|anesthetics, general|mesh-ancestor
110870814|NCT03359395|Anesthetics|anesthetics|mesh-ancestor
110870815|NCT03733691|Lenalidomide|lenalidomide|mesh-list
110870816|NCT03733691|Ixazomib|ixazomib|mesh-list
110870817|NCT03733691|Immunologic Factors|immunologic factors|mesh-ancestor
110870818|NCT03733691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110870819|NCT03733691|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110870820|NCT03733691|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110870821|NCT03733691|Growth Substances|growth substances|mesh-ancestor
110603676|NCT00643851|Metformin|metformin|mesh-list
110870822|NCT03733691|Growth Inhibitors|growth inhibitors|mesh-ancestor
110870823|NCT03733691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110870824|NCT03733691|Protease Inhibitors|protease inhibitors|mesh-ancestor
110870825|NCT03733691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110870826|NCT03733691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110870827|NCT03358147|Tiotropium Bromide|tiotropium bromide|mesh-list
110870828|NCT03358147|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110870829|NCT03358147|Autonomic Agents|autonomic agents|mesh-ancestor
110870830|NCT03358147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110870831|NCT03358147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110870832|NCT03358147|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110603873|NCT00609466|Morphine|morphine|mesh-list
110870833|NCT03358147|Respiratory System Agents|respiratory system agents|mesh-ancestor
110870834|NCT03358147|Parasympatholytics|parasympatholytics|mesh-ancestor
110870835|NCT03358147|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110870836|NCT03358147|Cholinergic Agents|cholinergic agents|mesh-ancestor
110870837|NCT03358147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110070149|NCT04137536|Antibodies|antibodies|mesh-list
110870838|NCT03358147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110870839|NCT03093402|Dronabinol|dronabinol|mesh-list
110870840|NCT03093402|Lenabasum|lenabasum|mesh-list
110870841|NCT03093402|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
110870842|NCT03093402|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110870843|NCT03093402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110070212|NCT03983993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110604075|NCT01566565|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110870844|NCT03093402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110870846|NCT03093402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110870847|NCT03093402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110870848|NCT03093402|Hallucinogens|hallucinogens|mesh-ancestor
110870849|NCT03093402|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110870850|NCT03093402|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110870851|NCT03093402|Analgesics|analgesics|mesh-ancestor
110870852|NCT03093402|Sensory System Agents|sensory system agents|mesh-ancestor
110870853|NCT03093402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110870854|NCT02397070|Salicylic Acid|salicylic acid|mesh-list
110870855|NCT02397070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110870856|NCT02397070|Antifungal Agents|antifungal agents|mesh-ancestor
110870857|NCT02397070|Keratolytic Agents|keratolytic agents|mesh-ancestor
110870858|NCT02397070|Dermatologic Agents|dermatologic agents|mesh-ancestor
110870859|NCT03733379|Amoxicillin|amoxicillin|mesh-list
110870860|NCT03733379|Metronidazole|metronidazole|mesh-list
110870861|NCT03733379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110870862|NCT03733379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110870863|NCT03733379|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110870864|NCT03733379|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110870866|NCT05733676|Fluorides|fluorides|mesh-list
110870867|NCT05733676|Caseins|caseins|mesh-list
110870868|NCT05733676|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110604275|NCT00400153|Respiratory System Agents|respiratory system agents|mesh-ancestor
110870869|NCT05733676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110870870|NCT05733676|Cariostatic Agents|cariostatic agents|mesh-ancestor
110870871|NCT05733676|Protective Agents|protective agents|mesh-ancestor
110870872|NCT05733676|Chelating Agents|chelating agents|mesh-ancestor
110070408|NCT03588754|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110070409|NCT03588754|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110070410|NCT03588754|Adrenergic Agents|adrenergic agents|mesh-ancestor
110070411|NCT03588754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110070412|NCT03588754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110070413|NCT03588754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110070414|NCT03588754|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110070415|NCT03588754|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110070416|NCT03588754|Vasodilator Agents|vasodilator agents|mesh-ancestor
110070417|NCT03569085|Sevoflurane|sevoflurane|mesh-list
110870873|NCT05733676|Sequestering Agents|sequestering agents|mesh-ancestor
110870874|NCT05733676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110870875|NCT03343639|Serlopitant|serlopitant|mesh-list
110870876|NCT03343639|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110870877|NCT03343639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110870878|NCT03343639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110870879|NCT03343639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110870880|NCT04479748|Dexamethasone|dexamethasone|mesh-list
110870881|NCT04479748|Prednisolone|prednisolone|mesh-list
110870882|NCT04479748|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110870883|NCT04479748|Methylprednisolone|methylprednisolone|mesh-list
110870884|NCT04479748|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110870885|NCT04479748|Prednisolone acetate|prednisolone acetate|mesh-list
110368810|NCT00553943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110070515|NCT03384784|Galantamine|galantamine|mesh-list
110070516|NCT03384784|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110070517|NCT03384784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110070518|NCT03384784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110070519|NCT03384784|Cholinergic Agents|cholinergic agents|mesh-ancestor
110070520|NCT03384784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110604767|NCT00823641|Infliximab|infliximab|mesh-list
110070521|NCT03384784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110070522|NCT03384784|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110070523|NCT03384784|Autonomic Agents|autonomic agents|mesh-ancestor
110070524|NCT03384784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110070525|NCT03384784|Nootropic Agents|nootropic agents|mesh-ancestor
110070526|NCT03383094|Pembrolizumab|pembrolizumab|mesh-list
110070527|NCT03383094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110070528|NCT03383094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110070529|NCT03383094|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110070530|NCT03383094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110070531|NCT03366103|Navitoclax|navitoclax|mesh-list
110070532|NCT03366103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110070533|NCT03344419|Ketamine|ketamine|mesh-list
110070534|NCT03344419|Analgesics|analgesics|mesh-ancestor
110070535|NCT03344419|Sensory System Agents|sensory system agents|mesh-ancestor
110070536|NCT03344419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110870887|NCT04479748|Prednisolone phosphate|prednisolone phosphate|mesh-list
110870888|NCT04479748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110870889|NCT04479748|Antiemetics|antiemetics|mesh-ancestor
110870890|NCT04479748|Autonomic Agents|autonomic agents|mesh-ancestor
110870891|NCT04479748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110870892|NCT04479748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110870893|NCT04479748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110870894|NCT04479748|Glucocorticoids|glucocorticoids|mesh-ancestor
110870896|NCT04479748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110870897|NCT04479748|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110870898|NCT04479748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110070606|NCT03185819|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110870899|NCT04479748|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110870900|NCT04479748|Protective Agents|protective agents|mesh-ancestor
110870901|NCT02690974|Valsartan|valsartan|mesh-list
110870902|NCT02690974|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
110870903|NCT02690974|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110870904|NCT02690974|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110870905|NCT02690974|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110870906|NCT02690974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110870907|NCT03093324|Dimethyl Fumarate|dimethyl fumarate|mesh-list
110870908|NCT03093324|Dermatologic Agents|dermatologic agents|mesh-ancestor
110870909|NCT03093324|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110870910|NCT03093324|Immunologic Factors|immunologic factors|mesh-ancestor
110870911|NCT03093324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110870912|NCT03584009|Venetoclax|venetoclax|mesh-list
110870913|NCT03584009|Fulvestrant|fulvestrant|mesh-list
110870914|NCT03584009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110870915|NCT03584009|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110870916|NCT03584009|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110870917|NCT03584009|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110870918|NCT03584009|Hormone Antagonists|hormone antagonists|mesh-ancestor
110870919|NCT03584009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110870920|NCT03584009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110870921|NCT03709927|Moxifloxacin|moxifloxacin|mesh-list
110870922|NCT03709927|Fosfomycin|fosfomycin|mesh-list
110870923|NCT03709927|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110870924|NCT03709927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110870925|NCT03709927|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110870926|NCT03709927|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110605248|NCT00901732|Calcium|calcium|mesh-list
110870927|NCT03709927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110605295|NCT00908362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110870928|NCT03709927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110870929|NCT03709927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110870930|NCT04167462|Deucravacitinib|deucravacitinib|mesh-list
110886382|NCT03603626|Analgesics|analgesics|mesh-ancestor
110870931|NCT04167462|Dermatologic Agents|dermatologic agents|mesh-ancestor
110870932|NCT04167462|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110870933|NCT04167462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110870934|NCT04167462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110870935|NCT04160520|Morphine|morphine|mesh-list
110870936|NCT04160520|Pramipexole|pramipexole|mesh-list
110870937|NCT04160520|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110870938|NCT04160520|Narcotics|narcotics|mesh-ancestor
110605368|NCT00837837|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110870939|NCT04160520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110870940|NCT04160520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110870941|NCT04160520|Analgesics|analgesics|mesh-ancestor
110870942|NCT04160520|Sensory System Agents|sensory system agents|mesh-ancestor
110870943|NCT04160520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110870944|NCT04160520|Antioxidants|antioxidants|mesh-ancestor
110605446|NCT00908986|Rituximab|rituximab|mesh-list
110870945|NCT04160520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110870946|NCT04160520|Protective Agents|protective agents|mesh-ancestor
110870947|NCT04160520|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110870948|NCT04160520|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110870949|NCT04160520|Dopamine Agonists|dopamine agonists|mesh-ancestor
110870951|NCT04160520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110870952|NCT03583385|Metformin|metformin|mesh-list
110870953|NCT03583385|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110870954|NCT03583385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110870955|NCT05288335|Methamphetamine|methamphetamine|mesh-list
110870956|NCT05288335|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110870957|NCT05288335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110870958|NCT05288335|Sympathomimetics|sympathomimetics|mesh-ancestor
110870959|NCT05288335|Autonomic Agents|autonomic agents|mesh-ancestor
110870960|NCT05288335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110870961|NCT05288335|Dopamine Agents|dopamine agents|mesh-ancestor
110605783|NCT04034524|Insulin|insulin|mesh-list
110870962|NCT05288335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110870963|NCT05288335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110870964|NCT05288335|Adrenergic Agents|adrenergic agents|mesh-ancestor
110870965|NCT05288335|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110870966|NCT05288335|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110870967|NCT05288335|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110870968|NCT05288335|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110870969|NCT04792801|Choline|choline|mesh-list
110870970|NCT04792801|Lipotropic Agents|lipotropic agents|mesh-ancestor
110870971|NCT04792801|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110870972|NCT04792801|Antimetabolites|antimetabolites|mesh-ancestor
110870973|NCT04792801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110870974|NCT04792801|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110870975|NCT04792801|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110870976|NCT04792801|Nootropic Agents|nootropic agents|mesh-ancestor
110870977|NCT05420922|Lenvatinib|lenvatinib|mesh-list
110870978|NCT05420922|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
110870979|NCT05420922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110870980|NCT05420922|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110870981|NCT05420922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110870982|NCT05420922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110870983|NCT05420922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110870984|NCT03582215|Salicylates|salicylates|mesh-list
110870985|NCT03582215|Avobenzone|avobenzone|mesh-list
110870986|NCT03582215|Oxybenzone|oxybenzone|mesh-list
110870987|NCT03582215|Homosalate|homosalate|mesh-list
110870988|NCT03582215|2-ethylhexyl salicylate|2-ethylhexyl salicylate|mesh-list
110870989|NCT03582215|Octylmethoxycinnamate|octylmethoxycinnamate|mesh-list
110870990|NCT03582215|Sunscreening Agents|sunscreening agents|mesh-ancestor
110870991|NCT03582215|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110870992|NCT03582215|Protective Agents|protective agents|mesh-ancestor
110870993|NCT03582215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110870994|NCT03582215|Dermatologic Agents|dermatologic agents|mesh-ancestor
110870995|NCT03582215|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110870996|NCT03582215|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110870997|NCT03582215|Analgesics|analgesics|mesh-ancestor
110870999|NCT03582215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110871000|NCT03582215|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110871001|NCT03582215|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110605993|NCT00375505|Zoledronic Acid|zoledronic acid|mesh-list
110871002|NCT03582215|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110871003|NCT03582215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110871004|NCT03582215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110871005|NCT05175703|Paclitaxel|paclitaxel|mesh-list
110871006|NCT05175703|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110606108|NCT00929812|Hormones|hormones|mesh-ancestor
110871007|NCT05175703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110871008|NCT05175703|Tubulin Modulators|tubulin modulators|mesh-ancestor
110871009|NCT05175703|Antimitotic Agents|antimitotic agents|mesh-ancestor
110871010|NCT05175703|Mitosis Modulators|mitosis modulators|mesh-ancestor
110871011|NCT05175703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110871012|NCT04102800|Benralizumab|benralizumab|mesh-list
110871013|NCT04102800|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110871014|NCT04102800|Respiratory System Agents|respiratory system agents|mesh-ancestor
110871015|NCT03323346|Disulfiram|disulfiram|mesh-list
110606201|NCT00392665|Sulindac|sulindac|mesh-list
110871016|NCT03323346|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110871017|NCT03323346|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
110871018|NCT03323346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110606247|NCT00366457|Antimetabolites|antimetabolites|mesh-ancestor
110871019|NCT03323346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110871020|NCT05628571|Fluorides|fluorides|mesh-list
110871021|NCT05628571|Cariostatic Agents|cariostatic agents|mesh-ancestor
110871022|NCT05628571|Protective Agents|protective agents|mesh-ancestor
110871023|NCT05628571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110871024|NCT05255016|Riboflavin|riboflavin|mesh-list
110871025|NCT05255016|Lubricant Eye Drops|lubricant eye drops|mesh-list
110871026|NCT05255016|Vitamin B Complex|vitamin b complex|mesh-ancestor
110871027|NCT05255016|Vitamins|vitamins|mesh-ancestor
110871028|NCT05255016|Micronutrients|micronutrients|mesh-ancestor
110871029|NCT05255016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110871030|NCT05255016|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110871031|NCT05255016|Dermatologic Agents|dermatologic agents|mesh-ancestor
110871032|NCT05255016|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110871033|NCT05255016|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110871034|NCT05178888|Palbociclib|palbociclib|mesh-list
110871035|NCT05178888|Adagrasib|adagrasib|mesh-list
110871036|NCT05178888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110871037|NCT05178888|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110871038|NCT05178888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110871039|NCT05178888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110871040|NCT03342001|Calcitonin|calcitonin|mesh-list
110871041|NCT03342001|Salmon calcitonin|salmon calcitonin|mesh-list
110871042|NCT03342001|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
110871043|NCT03342001|Katacalcin|katacalcin|mesh-list
110606824|NCT00931138|Antiviral Agents|antiviral agents|mesh-ancestor
110871044|NCT03342001|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110871045|NCT03342001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110871046|NCT03342001|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110871047|NCT03342001|Vasodilator Agents|vasodilator agents|mesh-ancestor
110871048|NCT03579719|Itraconazole|itraconazole|mesh-list
110871049|NCT03579719|Balovaptan|balovaptan|mesh-list
110871050|NCT03579719|Antifungal Agents|antifungal agents|mesh-ancestor
110871051|NCT03579719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110607043|NCT00829881|Betahistine|betahistine|mesh-list
110871052|NCT03579719|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110871053|NCT03579719|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110871054|NCT03579719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110871055|NCT03579719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110871056|NCT03579719|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110871057|NCT03579719|Hormone Antagonists|hormone antagonists|mesh-ancestor
110871058|NCT03579719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110871059|NCT03579719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110871060|NCT03579719|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110871061|NCT03579719|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
110871062|NCT03579719|Natriuretic Agents|natriuretic agents|mesh-ancestor
110070887|NCT01703949|Nivolumab|nivolumab|mesh-list
110871063|NCT03631602|Antifungal Agents|antifungal agents|mesh-list
110871064|NCT03631602|Clotrimazole|clotrimazole|mesh-list
110871065|NCT03631602|Miconazole|miconazole|mesh-list
110871066|NCT03631602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110871067|NCT03631602|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110871068|NCT03631602|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110871069|NCT03631602|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110588584|NCT02583828|Letrozole|letrozole|mesh-list
110871070|NCT03631602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110871071|NCT03631602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110871072|NCT03631602|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110871073|NCT03631602|Hormone Antagonists|hormone antagonists|mesh-ancestor
110871074|NCT03631602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110871075|NCT03631602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110871076|NCT03631602|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110871077|NCT03631602|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110871078|NCT02688088|Midazolam|midazolam|mesh-list
110871079|NCT02688088|Dextromethorphan|dextromethorphan|mesh-list
110871080|NCT02688088|Caffeine|caffeine|mesh-list
110871081|NCT02688088|Warfarin|warfarin|mesh-list
110871082|NCT02688088|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110871083|NCT02688088|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110871084|NCT02688088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110871085|NCT02688088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110871086|NCT02688088|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110871087|NCT02688088|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110871088|NCT02688088|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110871089|NCT02688088|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110871090|NCT02688088|Anesthetics, General|anesthetics, general|mesh-ancestor
110871091|NCT02688088|Anesthetics|anesthetics|mesh-ancestor
110871092|NCT02688088|GABA Modulators|gaba modulators|mesh-ancestor
110871093|NCT02688088|GABA Agents|gaba agents|mesh-ancestor
110871094|NCT02688088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110871095|NCT02688088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110871096|NCT02688088|Anticoagulants|anticoagulants|mesh-ancestor
110871097|NCT02688088|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110607501|NCT05667428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110871098|NCT02688088|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110871099|NCT02688088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110871100|NCT02688088|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110871101|NCT02688088|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110871102|NCT02688088|Purinergic Agents|purinergic agents|mesh-ancestor
110871103|NCT02688088|Antitussive Agents|antitussive agents|mesh-ancestor
110871104|NCT02688088|Respiratory System Agents|respiratory system agents|mesh-ancestor
110871105|NCT02688088|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110871106|NCT02688088|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110871107|NCT03641651|Frovatriptan|frovatriptan|mesh-list
110871108|NCT03641651|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110871109|NCT03641651|Serotonin Agents|serotonin agents|mesh-ancestor
110871110|NCT03641651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110871111|NCT03641651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110871112|NCT03641651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110871113|NCT03341299|Insulin Lispro|insulin lispro|mesh-list
110871114|NCT03341299|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110871115|NCT03341299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110871116|NCT05666219|Aminophylline|aminophylline|mesh-list
110871117|NCT05666219|Theophylline|theophylline|mesh-list
110871118|NCT05666219|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110871119|NCT05666219|Autonomic Agents|autonomic agents|mesh-ancestor
110871120|NCT05666219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110871121|NCT05666219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110871122|NCT05666219|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110871123|NCT05666219|Respiratory System Agents|respiratory system agents|mesh-ancestor
110871124|NCT05666219|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110871125|NCT05666219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110871126|NCT05666219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110871127|NCT05666219|Vasodilator Agents|vasodilator agents|mesh-ancestor
110871128|NCT05666219|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110608087|NCT02562144|Lidocaine|lidocaine|mesh-list
110871129|NCT05666219|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110871130|NCT05666219|Purinergic Agents|purinergic agents|mesh-ancestor
110070889|NCT01703949|Antibodies|antibodies|mesh-list
110871132|NCT05666219|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110871133|NCT05666219|Protective Agents|protective agents|mesh-ancestor
110871134|NCT02949271|Fentanyl|fentanyl|mesh-list
110871135|NCT02949271|Ropivacaine|ropivacaine|mesh-list
110871136|NCT02949271|Anesthetics, Local|anesthetics, local|mesh-ancestor
110871137|NCT02949271|Anesthetics|anesthetics|mesh-ancestor
110871138|NCT02949271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110871139|NCT02949271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110871140|NCT02949271|Sensory System Agents|sensory system agents|mesh-ancestor
110871141|NCT02949271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110871142|NCT02949271|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110871143|NCT02949271|Narcotics|narcotics|mesh-ancestor
110871144|NCT02949271|Analgesics|analgesics|mesh-ancestor
110871145|NCT02949271|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110871146|NCT02949271|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110608405|NCT00688740|Docetaxel|docetaxel|mesh-list
110871147|NCT02949271|Anesthetics, General|anesthetics, general|mesh-ancestor
110871148|NCT03339583|Zopiclone|zopiclone|mesh-list
110608476|NCT00951574|Nadroparin|nadroparin|mesh-list
110871149|NCT03339583|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110871150|NCT03339583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110871151|NCT03339583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110871152|NCT03639779|Sodium thiosulfate|sodium thiosulfate|mesh-list
110871153|NCT03639779|Antidotes|antidotes|mesh-ancestor
110871154|NCT03639779|Protective Agents|protective agents|mesh-ancestor
110871155|NCT03639779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110871156|NCT03639779|Antioxidants|antioxidants|mesh-ancestor
110871157|NCT03639779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110871158|NCT03639779|Antitubercular Agents|antitubercular agents|mesh-ancestor
110871159|NCT03639779|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110871160|NCT03639779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110871161|NCT03639779|Chelating Agents|chelating agents|mesh-ancestor
110871162|NCT03639779|Sequestering Agents|sequestering agents|mesh-ancestor
110871163|NCT05682547|Lubricant Eye Drops|lubricant eye drops|mesh-list
110871164|NCT05682547|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110871165|NCT05682547|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110871166|NCT05173441|Immunoglobulins|immunoglobulins|mesh-list
110871167|NCT05173441|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110871168|NCT05173441|Antibodies|antibodies|mesh-list
110871169|NCT05173441|Immunologic Factors|immunologic factors|mesh-ancestor
110871170|NCT05173441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110871171|NCT03708133|Nifurtimox|nifurtimox|mesh-list
110871172|NCT03708133|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
110871173|NCT03708133|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110871174|NCT03708133|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110871175|NCT03708133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110871176|NCT05075161|Pirfenidone|pirfenidone|mesh-list
110871177|NCT05075161|Analgesics|analgesics|mesh-ancestor
110871178|NCT05075161|Sensory System Agents|sensory system agents|mesh-ancestor
110871179|NCT05075161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110871180|NCT05075161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110871181|NCT05075161|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110871182|NCT05075161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110871183|NCT05075161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110871184|NCT05075161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110871185|NCT05075161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110871187|NCT05095831|Pancreatin|pancreatin|mesh-list
110871188|NCT05095831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110871189|NCT03638869|Methadone|methadone|mesh-list
110871190|NCT03638869|D-methadone|d-methadone|mesh-list
110871191|NCT03638869|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110871192|NCT03638869|Narcotics|narcotics|mesh-ancestor
110871193|NCT03638869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110871194|NCT03638869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110871195|NCT03638869|Analgesics|analgesics|mesh-ancestor
110871196|NCT03638869|Sensory System Agents|sensory system agents|mesh-ancestor
110608986|NCT00862095|Anticonvulsants|anticonvulsants|mesh-ancestor
110871197|NCT03638869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110871198|NCT03638869|Antitussive Agents|antitussive agents|mesh-ancestor
110070898|NCT01703949|Immunotoxins|immunotoxins|mesh-ancestor
110871199|NCT03638869|Respiratory System Agents|respiratory system agents|mesh-ancestor
110871200|NCT03638869|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110871201|NCT03091920|Praliciguat|praliciguat|mesh-list
110871202|NCT03091920|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
110871203|NCT03091920|Enzyme Activators|enzyme activators|mesh-ancestor
110871204|NCT03091920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110871205|NCT03091920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110871206|NCT03338569|Ascorbic Acid|ascorbic acid|mesh-list
110871207|NCT03338569|Vitamins|vitamins|mesh-ancestor
110871208|NCT03338569|Micronutrients|micronutrients|mesh-ancestor
110871209|NCT03338569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110871210|NCT03338569|Antioxidants|antioxidants|mesh-ancestor
110871211|NCT03338569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110871212|NCT03338569|Protective Agents|protective agents|mesh-ancestor
110871213|NCT03338023|Insulin Lispro|insulin lispro|mesh-list
110871214|NCT03338023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110871215|NCT03338023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110871216|NCT05053633|Anesthetics|anesthetics|mesh-list
110871217|NCT05053633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110871218|NCT05053633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110871219|NCT03337477|Insulin|insulin|mesh-list
110871220|NCT03337477|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110871221|NCT03337477|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110871222|NCT03337477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110871224|NCT03707899|Telmisartan|telmisartan|mesh-list
110871225|NCT03707899|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
110871226|NCT03707899|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110871227|NCT03707899|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110871228|NCT03707899|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110871229|NCT03707899|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110871230|NCT03707899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110871231|NCT03707899|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110871232|NCT03707899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110871233|NCT03707899|Vasodilator Agents|vasodilator agents|mesh-ancestor
110871234|NCT03707899|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110871235|NCT03707899|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110871236|NCT03707899|Antimetabolites|antimetabolites|mesh-ancestor
110871237|NCT03707899|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110871238|NCT03707899|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110871239|NCT03707899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110871240|NCT03707899|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110871241|NCT03707899|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110871242|NCT03336619|Nitazoxanide|nitazoxanide|mesh-list
110871243|NCT03336619|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110871244|NCT03336619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110871245|NCT03114904|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
110871246|NCT03114904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110609763|NCT04011124|Rifampin|rifampin|mesh-list
110871247|NCT03114904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110871248|NCT03706339|Tranexamic Acid|tranexamic acid|mesh-list
110871250|NCT03706339|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110871251|NCT03706339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110871252|NCT03706339|Hemostatics|hemostatics|mesh-ancestor
110871253|NCT03706339|Coagulants|coagulants|mesh-ancestor
110871254|NCT03739476|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110871255|NCT03739476|Antidepressive Agents|antidepressive agents|mesh-ancestor
110609815|NCT00955162|Narcotics|narcotics|mesh-ancestor
110871256|NCT03739476|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110871257|NCT03739476|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110871258|NCT03739476|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110609881|NCT02544243|Antimitotic Agents|antimitotic agents|mesh-ancestor
110610060|NCT00371761|Immunologic Factors|immunologic factors|mesh-ancestor
110871259|NCT03739476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110871260|NCT03739476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110871261|NCT03639558|Promethazine|promethazine|mesh-list
110871262|NCT03639558|Diphenhydramine|diphenhydramine|mesh-list
110871263|NCT03639558|Haloperidol|haloperidol|mesh-list
110871264|NCT03639558|Chlorpromazine|chlorpromazine|mesh-list
110871265|NCT03639558|Haloperidol decanoate|haloperidol decanoate|mesh-list
110871266|NCT03639558|Antiemetics|antiemetics|mesh-ancestor
110871267|NCT03639558|Autonomic Agents|autonomic agents|mesh-ancestor
110871268|NCT03639558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110871269|NCT03639558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110871270|NCT03639558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110871271|NCT03639558|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110871272|NCT03639558|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110871273|NCT03639558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110871275|NCT03639558|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110871276|NCT03639558|Dopamine Agents|dopamine agents|mesh-ancestor
110610421|NCT00864591|Analgesics|analgesics|mesh-ancestor
110871277|NCT03639558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110871278|NCT03639558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110871279|NCT03639558|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110871280|NCT03639558|Antipruritics|antipruritics|mesh-ancestor
110871281|NCT03639558|Dermatologic Agents|dermatologic agents|mesh-ancestor
110871282|NCT03639558|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110871283|NCT03639558|Histamine Antagonists|histamine antagonists|mesh-ancestor
110871284|NCT03639558|Histamine Agents|histamine agents|mesh-ancestor
110871285|NCT03639558|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110871286|NCT03639558|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110871287|NCT03639558|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110871288|NCT03639558|Anesthetics, Local|anesthetics, local|mesh-ancestor
110871289|NCT03639558|Anesthetics|anesthetics|mesh-ancestor
110871290|NCT03639558|Sensory System Agents|sensory system agents|mesh-ancestor
110871291|NCT01353508|Valsartan|valsartan|mesh-list
110871292|NCT01353508|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
110871293|NCT01353508|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110871294|NCT01353508|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110871295|NCT01353508|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110871296|NCT01353508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110871297|NCT01568268|Palonosetron|palonosetron|mesh-list
110871298|NCT01568268|Antiemetics|antiemetics|mesh-ancestor
110871299|NCT01568268|Autonomic Agents|autonomic agents|mesh-ancestor
110871300|NCT01568268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110871301|NCT01568268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110871302|NCT01568268|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110871303|NCT01568268|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110871304|NCT01568268|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110871305|NCT01568268|Serotonin Agents|serotonin agents|mesh-ancestor
110871306|NCT01568268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110871307|NCT01568268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110871308|NCT04911361|Dexamethasone|dexamethasone|mesh-list
110871309|NCT04911361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110871310|NCT04911361|Antiemetics|antiemetics|mesh-ancestor
110871311|NCT04911361|Autonomic Agents|autonomic agents|mesh-ancestor
110871312|NCT04911361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110871313|NCT04911361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110871314|NCT04911361|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110871315|NCT04911361|Glucocorticoids|glucocorticoids|mesh-ancestor
110871316|NCT04911361|Hormones|hormones|mesh-ancestor
110871317|NCT04911361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110871318|NCT04911361|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110871319|NCT04911361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110871320|NCT04475731|Ponatinib|ponatinib|mesh-list
110871321|NCT04475731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110871322|NCT04475731|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110871323|NCT04475731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110871324|NCT04475731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110871325|NCT03087786|Nicotine|nicotine|mesh-list
110871326|NCT03087786|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110871327|NCT03087786|Autonomic Agents|autonomic agents|mesh-ancestor
110871328|NCT03087786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110871329|NCT03087786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110871330|NCT03087786|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110871331|NCT03087786|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110871332|NCT03087786|Cholinergic Agents|cholinergic agents|mesh-ancestor
110871333|NCT03087786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110386233|NCT04947631|Dutasteride|dutasteride|mesh-list
110871334|NCT03087786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110871335|NCT03635957|Folic Acid|folic acid|mesh-list
110871336|NCT03635957|Methotrexate|methotrexate|mesh-list
110871337|NCT03635957|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110871338|NCT03635957|Abortifacient Agents|abortifacient agents|mesh-ancestor
110871339|NCT03635957|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110871340|NCT03635957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110871341|NCT03635957|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110871342|NCT03635957|Antimetabolites|antimetabolites|mesh-ancestor
110871343|NCT03635957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110871344|NCT03635957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110871345|NCT03635957|Dermatologic Agents|dermatologic agents|mesh-ancestor
110871346|NCT03635957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110871347|NCT03635957|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110871348|NCT03635957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110871349|NCT03635957|Immunologic Factors|immunologic factors|mesh-ancestor
110871350|NCT03635957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110871351|NCT03635957|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110871352|NCT03635957|Hematinics|hematinics|mesh-ancestor
110871353|NCT03635957|Vitamin B Complex|vitamin b complex|mesh-ancestor
110871354|NCT03635957|Vitamins|vitamins|mesh-ancestor
110871355|NCT03635957|Micronutrients|micronutrients|mesh-ancestor
110871356|NCT05005507|Tenofovir|tenofovir|mesh-list
110871357|NCT05005507|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110871358|NCT05005507|Antiviral Agents|antiviral agents|mesh-ancestor
110871359|NCT05005507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110871360|NCT05005507|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110871361|NCT05005507|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110871362|NCT05005507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110871363|NCT05005507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110871364|NCT05005507|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110871365|NCT05005507|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110871366|NCT04739358|Tepotinib|tepotinib|mesh-list
110871367|NCT04739358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110871368|NCT04893343|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110871369|NCT04893343|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
110871370|NCT04893343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110871371|NCT04893343|Antitubercular Agents|antitubercular agents|mesh-ancestor
110871372|NCT05399641|Ibrexafungerp|ibrexafungerp|mesh-list
110871373|NCT05399641|Antifungal Agents|antifungal agents|mesh-ancestor
110871374|NCT05399641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110871375|NCT05593666|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
110871376|NCT05593666|Antifungal Agents|antifungal agents|mesh-ancestor
110871377|NCT05593666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110612280|NCT05389813|Narcotics|narcotics|mesh-ancestor
110871378|NCT05593666|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110871379|NCT05593666|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110871381|NCT02684344|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110871382|NCT02684344|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110871383|NCT02684344|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110871384|NCT02684344|Adrenergic Agents|adrenergic agents|mesh-ancestor
110886461|NCT03651726|Analgesics|analgesics|mesh-ancestor
110871385|NCT02684344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110871386|NCT02684344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110871387|NCT02684344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110871388|NCT02684344|Urological Agents|urological agents|mesh-ancestor
110871389|NCT03974100|Denosumab|denosumab|mesh-list
110871390|NCT03974100|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110871391|NCT03974100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110871392|NCT02689804|Contraceptive Agents|contraceptive agents|mesh-list
110871393|NCT02689804|Levonorgestrel|levonorgestrel|mesh-list
110871394|NCT02689804|Ulipristal acetate|ulipristal acetate|mesh-list
110871395|NCT02689804|Contraceptives, Postcoital|contraceptives, postcoital|mesh-list
110871396|NCT02689804|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110871397|NCT02689804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110871398|NCT02689804|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110871399|NCT02689804|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110871400|NCT02689804|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110871401|NCT02689804|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110871402|NCT04353271|Hydroxychloroquine|hydroxychloroquine|mesh-list
110871403|NCT04353271|Antimalarials|antimalarials|mesh-ancestor
110871404|NCT04353271|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110612481|NCT04910815|Rifaximin|rifaximin|mesh-list
110871405|NCT04353271|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110387288|NCT04246151|Vancomycin|vancomycin|mesh-list
110871406|NCT04353271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110871407|NCT04353271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110871408|NCT04353271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110871409|NCT04353271|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110871410|NCT01374568|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110871411|NCT01374568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110871412|NCT01374568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110871413|NCT01374568|Incretins|incretins|mesh-ancestor
110871414|NCT01374568|Hormones|hormones|mesh-ancestor
110871415|NCT01374568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110612812|NCT03942328|Growth Substances|growth substances|mesh-ancestor
110871416|NCT01374568|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110871417|NCT01374568|Protease Inhibitors|protease inhibitors|mesh-ancestor
110871418|NCT01374568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110612889|NCT03643107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110871419|NCT01374568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110871420|NCT01312441|Ergocalciferols|ergocalciferols|mesh-list
110871421|NCT01312441|Vitamin D|vitamin d|mesh-list
110871422|NCT01312441|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110871423|NCT01312441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110871424|NCT01312441|Vitamins|vitamins|mesh-ancestor
110871425|NCT01312441|Micronutrients|micronutrients|mesh-ancestor
110613042|NCT03165994|Paclitaxel|paclitaxel|mesh-list
110871426|NCT01312441|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110871427|NCT02682784|Oxytocin|oxytocin|mesh-list
110871428|NCT02682784|Oxytocics|oxytocics|mesh-ancestor
110871429|NCT02682784|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110871430|NCT02682784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110871431|NCT03705949|Lubricant Eye Drops|lubricant eye drops|mesh-list
110871432|NCT03705949|Hyaluronic Acid|hyaluronic acid|mesh-list
110871433|NCT03705949|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110871434|NCT03705949|Immunologic Factors|immunologic factors|mesh-ancestor
110871435|NCT03705949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110871436|NCT03705949|Viscosupplements|viscosupplements|mesh-ancestor
110871437|NCT03705949|Protective Agents|protective agents|mesh-ancestor
110871438|NCT03705949|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110613316|NCT02036372|Insulin|insulin|mesh-list
110871439|NCT03705949|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110871440|NCT03162562|Oregovomab|oregovomab|mesh-list
110871441|NCT03162562|Poly ICLC|poly iclc|mesh-list
110871442|NCT03162562|Interferon Inducers|interferon inducers|mesh-ancestor
110613389|NCT00920621|Ergocalciferols|ergocalciferols|mesh-list
110871443|NCT03162562|Immunologic Factors|immunologic factors|mesh-ancestor
110871444|NCT03162562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110871445|NCT03162562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110871446|NCT03162562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110871447|NCT03164590|Dexmedetomidine|dexmedetomidine|mesh-list
110871448|NCT03164590|Ketamine|ketamine|mesh-list
110871449|NCT03164590|Bupivacaine|bupivacaine|mesh-list
110871450|NCT03164590|Anesthetics, Local|anesthetics, local|mesh-ancestor
110871451|NCT03164590|Anesthetics|anesthetics|mesh-ancestor
110871452|NCT03164590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110871453|NCT03164590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110871454|NCT03164590|Sensory System Agents|sensory system agents|mesh-ancestor
110871455|NCT03164590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110871456|NCT03164590|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110871457|NCT03164590|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110871458|NCT03164590|Analgesics|analgesics|mesh-ancestor
110871459|NCT03164590|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110871460|NCT03164590|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110871461|NCT03164590|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110871462|NCT03164590|Adrenergic Agents|adrenergic agents|mesh-ancestor
110871463|NCT03164590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110871464|NCT03164590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110871465|NCT03164590|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110871466|NCT03164590|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110871467|NCT03164590|Anesthetics, General|anesthetics, general|mesh-ancestor
110871468|NCT03164590|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110871469|NCT03164590|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110871470|NCT05119075|Dopamine|dopamine|mesh-list
110871471|NCT05119075|Dopamine Agonists|dopamine agonists|mesh-list
110613929|NCT05279482|Methylprednisolone|methylprednisolone|mesh-list
110871472|NCT05119075|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110871473|NCT05119075|Sympathomimetics|sympathomimetics|mesh-ancestor
110871474|NCT05119075|Autonomic Agents|autonomic agents|mesh-ancestor
110871475|NCT05119075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110871476|NCT05119075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110871477|NCT05119075|Dopamine Agents|dopamine agents|mesh-ancestor
110871478|NCT05119075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110871479|NCT05119075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110871480|NCT05119075|Protective Agents|protective agents|mesh-ancestor
110871481|NCT03387852|Fluticasone|fluticasone|mesh-list
110871482|NCT03387852|Xhance|xhance|mesh-list
110871483|NCT03387852|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110871484|NCT03387852|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
110871485|NCT03387852|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110871486|NCT03387852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110871487|NCT03387852|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110871488|NCT03387852|Autonomic Agents|autonomic agents|mesh-ancestor
110871489|NCT03387852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110871490|NCT03387852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110871491|NCT03387852|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110871492|NCT03387852|Respiratory System Agents|respiratory system agents|mesh-ancestor
110871493|NCT03387852|Dermatologic Agents|dermatologic agents|mesh-ancestor
110871494|NCT03387852|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110871495|NCT03387852|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110871496|NCT03387852|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110871497|NCT03387852|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110871498|NCT03387852|Adrenergic Agents|adrenergic agents|mesh-ancestor
110871499|NCT03387852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110871500|NCT03387852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110871501|NCT03387852|Immunologic Factors|immunologic factors|mesh-ancestor
110871502|NCT03387852|Glucocorticoids|glucocorticoids|mesh-ancestor
110871503|NCT03387852|Hormones|hormones|mesh-ancestor
110871504|NCT03387852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110871505|NCT03387852|Sympathomimetics|sympathomimetics|mesh-ancestor
110871506|NCT02679274|Methyltestosterone|methyltestosterone|mesh-list
110871507|NCT02679274|Testosterone|testosterone|mesh-list
110871508|NCT02679274|Testosterone undecanoate|testosterone undecanoate|mesh-list
110871509|NCT02679274|Testosterone enanthate|testosterone enanthate|mesh-list
110871510|NCT02679274|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
110871511|NCT02679274|Androgens|androgens|mesh-ancestor
110871512|NCT02679274|Hormones|hormones|mesh-ancestor
110614694|NCT00976768|Oxaliplatin|oxaliplatin|mesh-list
110871513|NCT02679274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110871514|NCT02679274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110614763|NCT00980356|Vildagliptin|vildagliptin|mesh-list
110871515|NCT02679274|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110614911|NCT00869193|Antioxidants|antioxidants|mesh-ancestor
110871516|NCT02679274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110871517|NCT02679274|Anabolic Agents|anabolic agents|mesh-ancestor
110871518|NCT03620929|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110871519|NCT03620929|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110871520|NCT03620929|Estradiol|estradiol|mesh-list
110871521|NCT03620929|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110871522|NCT03620929|Dydrogesterone|dydrogesterone|mesh-list
110871523|NCT03620929|Estrogens|estrogens|mesh-ancestor
110589040|NCT04255602|Purinergic Agents|purinergic agents|mesh-ancestor
110871525|NCT03620929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110871526|NCT03620929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110871527|NCT03620929|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110871528|NCT03620929|Contraceptive Agents|contraceptive agents|mesh-ancestor
110871529|NCT03620929|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110871530|NCT03620929|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110871531|NCT03620929|Progestins|progestins|mesh-ancestor
110871532|NCT04969861|Pembrolizumab|pembrolizumab|mesh-list
110871533|NCT04969861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110871534|NCT04969861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110615371|NCT01052311|Niacin|niacin|mesh-list
110615401|NCT00982540|Caspofungin|caspofungin|mesh-list
110871535|NCT04969861|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110871536|NCT04969861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110871537|NCT05308849|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110871538|NCT05308849|beta-Lactams|beta-lactams|mesh-list
110871539|NCT05308849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110871540|NCT02678416|Acetaminophen|acetaminophen|mesh-list
110871541|NCT02678416|Morphine|morphine|mesh-list
110871542|NCT02678416|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110871543|NCT02678416|Narcotics|narcotics|mesh-ancestor
110871544|NCT02678416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110871545|NCT02678416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110871546|NCT02678416|Analgesics|analgesics|mesh-ancestor
110871547|NCT02678416|Sensory System Agents|sensory system agents|mesh-ancestor
110871548|NCT02678416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110871549|NCT02678416|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110871550|NCT02678416|Antipyretics|antipyretics|mesh-ancestor
110871551|NCT03164668|Menthol|menthol|mesh-list
110871552|NCT03164668|Antipruritics|antipruritics|mesh-ancestor
110871553|NCT03164668|Dermatologic Agents|dermatologic agents|mesh-ancestor
110871554|NCT03164512|Cannabidiol|cannabidiol|mesh-list
110871555|NCT03164512|Anticonvulsants|anticonvulsants|mesh-ancestor
110871556|NCT02680756|Ferric maltol|ferric maltol|mesh-list
110871557|NCT02680756|Hematinics|hematinics|mesh-ancestor
110871558|NCT03631836|Bevacizumab|bevacizumab|mesh-list
110871559|NCT03631836|Antibodies|antibodies|mesh-list
110871560|NCT03631836|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110871561|NCT03631836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110871562|NCT03631836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110871563|NCT03631836|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110615630|NCT04034823|Docetaxel|docetaxel|mesh-list
110871564|NCT03631836|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110871565|NCT03631836|Growth Substances|growth substances|mesh-ancestor
110871566|NCT03631836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110871567|NCT03631836|Growth Inhibitors|growth inhibitors|mesh-ancestor
110871568|NCT03631836|Immunologic Factors|immunologic factors|mesh-ancestor
110871569|NCT03162094|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110871570|NCT03162094|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110871571|NCT03086460|Formoterol Fumarate|formoterol fumarate|mesh-list
110871572|NCT03086460|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110871573|NCT03086460|Autonomic Agents|autonomic agents|mesh-ancestor
110871574|NCT03086460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110871575|NCT03086460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110871576|NCT03086460|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110871577|NCT03086460|Respiratory System Agents|respiratory system agents|mesh-ancestor
110871578|NCT03086460|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110871579|NCT03086460|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110871580|NCT03086460|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110871581|NCT03086460|Adrenergic Agents|adrenergic agents|mesh-ancestor
110871582|NCT03086460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110871583|NCT03086460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110871584|NCT03670706|Analgesics|analgesics|mesh-list
110871585|NCT03670706|Sensory System Agents|sensory system agents|mesh-ancestor
110871586|NCT03670706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110871587|NCT03670706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110871588|NCT03114280|Carboplatin|carboplatin|mesh-list
110871589|NCT03114280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110871590|NCT01312363|Rivastigmine|rivastigmine|mesh-list
110871591|NCT01312363|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110871592|NCT01312363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110871593|NCT01312363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110871594|NCT01312363|Cholinergic Agents|cholinergic agents|mesh-ancestor
110871595|NCT01312363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110871596|NCT01312363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110871597|NCT01312363|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110871598|NCT01312363|Protective Agents|protective agents|mesh-ancestor
110871599|NCT03161678|Clopidogrel|clopidogrel|mesh-list
110871600|NCT03161678|Ticagrelor|ticagrelor|mesh-list
110871601|NCT03161678|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110871602|NCT03161678|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110871603|NCT03161678|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110871604|NCT03161678|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110871605|NCT03161678|Purinergic Agents|purinergic agents|mesh-ancestor
110871606|NCT03161678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110871607|NCT03161678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110871608|NCT03161678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110871610|NCT03674606|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110871611|NCT03674606|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110871612|NCT03674606|Analgesics|analgesics|mesh-ancestor
110071014|NCT01556737|Genistein|genistein|mesh-list
110871613|NCT03674606|Sensory System Agents|sensory system agents|mesh-ancestor
110871614|NCT03674606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110871615|NCT03674606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110871616|NCT03674606|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110871617|NCT03674606|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110871618|NCT03674606|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110871619|NCT03674606|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110871620|NCT03674606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110871621|NCT03674606|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110871622|NCT03674606|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110871623|NCT03674606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110871625|NCT02677324|Venetoclax|venetoclax|mesh-list
110871626|NCT02677324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110871627|NCT03163966|Methotrexate|methotrexate|mesh-list
110871628|NCT03163966|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110871629|NCT03163966|Abortifacient Agents|abortifacient agents|mesh-ancestor
110871630|NCT03163966|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110886514|NCT01560585|Isotretinoin|isotretinoin|mesh-list
110871631|NCT03163966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110871632|NCT03163966|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110871633|NCT03163966|Antimetabolites|antimetabolites|mesh-ancestor
110871634|NCT03163966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110871635|NCT03163966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110871636|NCT03163966|Dermatologic Agents|dermatologic agents|mesh-ancestor
110871637|NCT03163966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110871638|NCT03163966|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110871639|NCT03163966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110871640|NCT03163966|Immunologic Factors|immunologic factors|mesh-ancestor
110871641|NCT03163966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110871642|NCT03163966|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110871644|NCT03678116|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110871645|NCT03678116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110871646|NCT03678116|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110871647|NCT03678116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110871648|NCT03678116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110871649|NCT03678116|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110871650|NCT03678116|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110871651|NCT03678116|Purinergic Agents|purinergic agents|mesh-ancestor
110871652|NCT03678116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110871653|NCT03678038|Triamcinolone|triamcinolone|mesh-list
110871654|NCT03678038|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110871655|NCT03678038|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110871656|NCT03678038|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110871657|NCT03678038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110871658|NCT03678038|Glucocorticoids|glucocorticoids|mesh-ancestor
110871659|NCT03678038|Hormones|hormones|mesh-ancestor
110871660|NCT03678038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110871661|NCT03678038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110871662|NCT03678038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110871663|NCT03678038|Immunologic Factors|immunologic factors|mesh-ancestor
110871664|NCT03678038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110871665|NCT03678038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110871666|NCT03163420|Diclofenac|diclofenac|mesh-list
110871667|NCT03163420|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110871668|NCT03163420|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110871669|NCT03163420|Analgesics|analgesics|mesh-ancestor
110871671|NCT03163420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110871672|NCT03163420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110871673|NCT03163420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110871674|NCT03163420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110871675|NCT03163420|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110871676|NCT03163420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110871677|NCT03163420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110871678|NCT04440436|Cyclophosphamide|cyclophosphamide|mesh-list
110871679|NCT04440436|Fludarabine|fludarabine|mesh-list
110871680|NCT04440436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110871681|NCT04440436|Immunologic Factors|immunologic factors|mesh-ancestor
110871682|NCT04440436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110871683|NCT04440436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110871684|NCT04440436|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110871685|NCT04440436|Alkylating Agents|alkylating agents|mesh-ancestor
110871686|NCT04440436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110871687|NCT04440436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110871688|NCT04440436|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110871690|NCT05405686|Hormones|hormones|mesh-ancestor
110871691|NCT05405686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110615979|NCT01059955|BB 1101|bb 1101|mesh-list
110871692|NCT05405686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110871693|NCT04711122|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110871694|NCT04711122|Cephalosporins|cephalosporins|mesh-list
110871695|NCT04711122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110871696|NCT05272696|Paclitaxel|paclitaxel|mesh-list
110871697|NCT05272696|Pembrolizumab|pembrolizumab|mesh-list
110871698|NCT05272696|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110871699|NCT05272696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110871700|NCT05272696|Tubulin Modulators|tubulin modulators|mesh-ancestor
110616046|NCT00671658|Cyclophosphamide|cyclophosphamide|mesh-list
110871701|NCT05272696|Antimitotic Agents|antimitotic agents|mesh-ancestor
110871702|NCT05272696|Mitosis Modulators|mitosis modulators|mesh-ancestor
110871703|NCT05272696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110871704|NCT05272696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110871705|NCT05272696|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110871706|NCT05563116|Calcium|calcium|mesh-list
110871707|NCT05563116|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110871708|NCT05563116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110871709|NCT03520946|Ramucirumab|ramucirumab|mesh-list
110871710|NCT03520946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110871711|NCT03709758|Cytarabine|cytarabine|mesh-list
110871712|NCT03709758|Daunorubicin|daunorubicin|mesh-list
110871713|NCT03709758|Venetoclax|venetoclax|mesh-list
110871714|NCT03709758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110871715|NCT03709758|Antimetabolites|antimetabolites|mesh-ancestor
110871716|NCT03709758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110871717|NCT03709758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110871718|NCT03709758|Antiviral Agents|antiviral agents|mesh-ancestor
110871719|NCT03709758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110871720|NCT03709758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110871721|NCT03709758|Immunologic Factors|immunologic factors|mesh-ancestor
110871722|NCT03709758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110871723|NCT03709758|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110871724|NCT03709758|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110871725|NCT03709758|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110871726|NCT03709758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110871727|NCT03674060|Sorafenib|sorafenib|mesh-list
110871728|NCT03674060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110871729|NCT03674060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110871730|NCT03674060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110871731|NCT03674060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110871732|NCT03163576|Niacin|niacin|mesh-list
110871733|NCT03163576|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110871734|NCT03163576|Antimetabolites|antimetabolites|mesh-ancestor
110871735|NCT03163576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110871736|NCT03163576|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110871737|NCT03163576|Vasodilator Agents|vasodilator agents|mesh-ancestor
110871738|NCT03163576|Vitamin B Complex|vitamin b complex|mesh-ancestor
110871739|NCT03163576|Vitamins|vitamins|mesh-ancestor
110871740|NCT03163576|Micronutrients|micronutrients|mesh-ancestor
110871741|NCT03163576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110871742|NCT01374178|Insulin Glargine|insulin glargine|mesh-list
110871743|NCT01374178|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110871744|NCT01374178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110871745|NCT03673280|Morphine|morphine|mesh-list
110871746|NCT03673280|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110871747|NCT03673280|Narcotics|narcotics|mesh-ancestor
110589263|NCT00698685|Alemtuzumab|alemtuzumab|mesh-list
110871748|NCT03673280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110871749|NCT03673280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110871750|NCT03673280|Analgesics|analgesics|mesh-ancestor
110871751|NCT03673280|Sensory System Agents|sensory system agents|mesh-ancestor
110871752|NCT03673280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110871753|NCT05420220|Axitinib|axitinib|mesh-list
110871754|NCT05420220|Antibodies|antibodies|mesh-list
110871755|NCT05420220|Immunologic Factors|immunologic factors|mesh-ancestor
110871756|NCT05420220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110871757|NCT05420220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110871758|NCT05420220|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110871759|NCT05420220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110871760|NCT05420220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110871761|NCT05383560|Vaccines|vaccines|mesh-list
110871762|NCT05383560|Immunologic Factors|immunologic factors|mesh-ancestor
110871763|NCT05383560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110871764|NCT01382004|Azithromycin|azithromycin|mesh-list
110871765|NCT01382004|Penicillins|penicillins|mesh-list
110871766|NCT01382004|Penicillin G|penicillin g|mesh-list
110871767|NCT01382004|Penicillin G Benzathine|penicillin g benzathine|mesh-list
110871768|NCT01382004|Penicillin G Procaine|penicillin g procaine|mesh-list
110871769|NCT01382004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110871770|NCT01382004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110871771|NCT03669224|Chlorhexidine|chlorhexidine|mesh-list
110871772|NCT03669224|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110871773|NCT03669224|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110871774|NCT03669224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110871775|NCT03669224|Disinfectants|disinfectants|mesh-ancestor
110828169|NCT01101113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110828170|NCT01288261|Paclitaxel|paclitaxel|mesh-list
110828171|NCT01288261|Bavituximab|bavituximab|mesh-list
110828172|NCT01288261|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110828173|NCT01288261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110828174|NCT01288261|Tubulin Modulators|tubulin modulators|mesh-ancestor
110828175|NCT01288261|Antimitotic Agents|antimitotic agents|mesh-ancestor
110828176|NCT01288261|Mitosis Modulators|mitosis modulators|mesh-ancestor
110828177|NCT01288261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110828178|NCT01288261|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110828179|NCT01174303|Insulin|insulin|mesh-list
110828180|NCT01174303|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110828181|NCT01174303|Insulin Aspart|insulin aspart|mesh-list
110828182|NCT01174303|Insulin, Long-Acting|insulin, long-acting|mesh-list
110828183|NCT01174303|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
110828184|NCT01174303|Biphasic Insulins|biphasic insulins|mesh-list
110828185|NCT01174303|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
110828186|NCT01174303|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110828187|NCT01174303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110828188|NCT01285453|Vadimezan|vadimezan|mesh-list
110828189|NCT01285453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110828190|NCT01288339|Leucovorin|leucovorin|mesh-list
110828191|NCT01288339|Fluorouracil|fluorouracil|mesh-list
110828192|NCT01288339|Oxaliplatin|oxaliplatin|mesh-list
110828193|NCT01288339|Panitumumab|panitumumab|mesh-list
110828194|NCT01288339|Antimetabolites|antimetabolites|mesh-ancestor
110828195|NCT01288339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110616398|NCT00605319|Cholinergic Agents|cholinergic agents|mesh-ancestor
110828196|NCT01288339|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110828197|NCT01288339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110828198|NCT01288339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110828199|NCT01288339|Immunologic Factors|immunologic factors|mesh-ancestor
110828200|NCT01288339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110828201|NCT01288339|Antidotes|antidotes|mesh-ancestor
110828202|NCT01288339|Protective Agents|protective agents|mesh-ancestor
110828203|NCT01288339|Vitamin B Complex|vitamin b complex|mesh-ancestor
110828204|NCT01288339|Vitamins|vitamins|mesh-ancestor
110828205|NCT01288339|Micronutrients|micronutrients|mesh-ancestor
110616656|NCT03990103|Oxaliplatin|oxaliplatin|mesh-list
110390848|NCT04866017|Durvalumab|durvalumab|mesh-list
110828206|NCT01288339|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110828207|NCT00006389|Bryostatin 1|bryostatin 1|mesh-list
110828208|NCT00006389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110828209|NCT00006389|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110828210|NCT00006389|Immunologic Factors|immunologic factors|mesh-ancestor
110616806|NCT01053871|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110828211|NCT00006389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110828212|NCT04965311|Botulinum Toxins|botulinum toxins|mesh-list
110616888|NCT01054105|Iloprost|iloprost|mesh-list
110828213|NCT04965311|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110616953|NCT03986905|Mydriatics|mydriatics|mesh-ancestor
110828214|NCT04965311|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110828215|NCT04965311|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
110828216|NCT04965311|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110617083|NCT00689936|Leprostatic Agents|leprostatic agents|mesh-ancestor
110828217|NCT04965311|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110828218|NCT04965311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110828219|NCT04965311|Cholinergic Agents|cholinergic agents|mesh-ancestor
110828220|NCT04965311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110828221|NCT04965311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110828222|NCT04965311|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110828223|NCT04965311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110828225|NCT01105481|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110828226|NCT01105481|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110828227|NCT01105481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110828228|NCT01105481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110828229|NCT01105481|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110828230|NCT01105481|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110828231|NCT01105481|Dopamine Agents|dopamine agents|mesh-ancestor
110828232|NCT01105481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110828233|NCT01105481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110617366|NCT00329407|Topiramate|topiramate|mesh-list
110828234|NCT01105481|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110828235|NCT01105481|Antidepressive Agents|antidepressive agents|mesh-ancestor
110828237|NCT01178203|Tramadol|tramadol|mesh-list
110828238|NCT01178203|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110828239|NCT01178203|Narcotics|narcotics|mesh-ancestor
110617512|NCT00776646|Diuretics|diuretics|mesh-ancestor
110828240|NCT01178203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110828241|NCT01178203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110828242|NCT01178203|Analgesics|analgesics|mesh-ancestor
110828243|NCT01178203|Sensory System Agents|sensory system agents|mesh-ancestor
110828244|NCT01178203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110617659|NCT02556060|Lamotrigine|lamotrigine|mesh-list
110828245|NCT01178203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110828246|NCT01178203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110828247|NCT01178203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110828248|NCT01178203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110828249|NCT01178203|Gout Suppressants|gout suppressants|mesh-ancestor
110828250|NCT01178203|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110617795|NCT00689390|Ribavirin|ribavirin|mesh-list
110828251|NCT01178203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110828252|NCT01178203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110828253|NCT01286701|Terbinafine|terbinafine|mesh-list
110828254|NCT01286701|Antifungal Agents|antifungal agents|mesh-ancestor
110174310|NCT00065455|Vitamin A|vitamin a|mesh-list
110828255|NCT01286701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110828256|NCT01286701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110828257|NCT01286701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110828258|NCT00006305|Biguanides|biguanides|mesh-list
110828259|NCT00006305|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
110828260|NCT00006305|Calcium Channel Blockers|calcium channel blockers|mesh-list
110828261|NCT00006305|Calcium|calcium|mesh-list
110828262|NCT00006305|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
110828263|NCT00006305|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
110828264|NCT00006305|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
110828265|NCT00006305|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110828266|NCT00006305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110828267|NCT00006305|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110828268|NCT00006305|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110828269|NCT00006305|Adrenergic Agents|adrenergic agents|mesh-ancestor
110828270|NCT00006305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110828271|NCT00006305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110828272|NCT00006305|Protease Inhibitors|protease inhibitors|mesh-ancestor
110886566|NCT05764317|Amlodipine|amlodipine|mesh-list
110828273|NCT00006305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110828274|NCT00006305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110828275|NCT01284907|Vitamin D|vitamin d|mesh-list
110828276|NCT01284907|Cholecalciferol|cholecalciferol|mesh-list
110828277|NCT01284907|Vitamins|vitamins|mesh-ancestor
110828278|NCT01284907|Micronutrients|micronutrients|mesh-ancestor
110828279|NCT01284907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110828280|NCT01284907|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110828281|NCT01284907|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110828282|NCT01286857|Silicon|silicon|mesh-list
110828283|NCT01286857|Trace Elements|trace elements|mesh-ancestor
110828284|NCT01286857|Micronutrients|micronutrients|mesh-ancestor
110828285|NCT01286857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110828286|NCT01101269|Lisinopril|lisinopril|mesh-list
110828287|NCT01101269|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110828288|NCT01101269|Protease Inhibitors|protease inhibitors|mesh-ancestor
110071101|NCT01557270|Analgesics|analgesics|mesh-ancestor
110828289|NCT01101269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110828290|NCT01101269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110828291|NCT01101269|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110828292|NCT01101269|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110828293|NCT01101269|Protective Agents|protective agents|mesh-ancestor
110828294|NCT01101269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110828295|NCT01103375|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110828296|NCT01103375|Isotretinoin|isotretinoin|mesh-list
110828297|NCT01103375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110828298|NCT01103375|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110828299|NCT01103375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110174653|NCT00392457|Hormones|hormones|mesh-list
110828300|NCT01103375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110828301|NCT01103375|Dermatologic Agents|dermatologic agents|mesh-ancestor
110828302|NCT03949049|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
110828303|NCT03949049|Nootropic Agents|nootropic agents|mesh-ancestor
110828304|NCT01288417|Raltegravir Potassium|raltegravir potassium|mesh-list
110828305|NCT01288417|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110828306|NCT01288417|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110828307|NCT01288417|Antiviral Agents|antiviral agents|mesh-ancestor
110828308|NCT01288417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110828309|NCT01288417|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110828310|NCT01288417|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110828311|NCT01288417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110828312|NCT01288417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110828313|NCT01285765|Rituximab|rituximab|mesh-list
110828314|NCT01285765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110828315|NCT01285765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110174748|NCT00069550|Donepezil|donepezil|mesh-list
110828316|NCT01285765|Immunologic Factors|immunologic factors|mesh-ancestor
110828317|NCT01285765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110828318|NCT01285765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110828319|NCT03864913|Testosterone|testosterone|mesh-list
110828320|NCT03864913|Androgens|androgens|mesh-ancestor
110828321|NCT03864913|Hormones|hormones|mesh-ancestor
110828322|NCT03864913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110828323|NCT03864913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110828324|NCT03865147|Acetaminophen|acetaminophen|mesh-list
110828325|NCT03865147|Cetrimonium|cetrimonium|mesh-list
110828326|NCT03865147|Ibuprofen|ibuprofen|mesh-list
110828327|NCT03865147|Lidocaine|lidocaine|mesh-list
110828328|NCT03865147|Epinephrine|epinephrine|mesh-list
110828329|NCT03865147|Racepinephrine|racepinephrine|mesh-list
110828330|NCT03865147|Bupivacaine|bupivacaine|mesh-list
110828331|NCT03865147|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
110828332|NCT03865147|Epinephryl borate|epinephryl borate|mesh-list
110828333|NCT03865147|Anesthetics, Local|anesthetics, local|mesh-ancestor
110828334|NCT03865147|Anesthetics|anesthetics|mesh-ancestor
110828335|NCT03865147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110828336|NCT03865147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110828337|NCT03865147|Sensory System Agents|sensory system agents|mesh-ancestor
110828338|NCT03865147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110828339|NCT03865147|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110828340|NCT03865147|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110828341|NCT03865147|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110828342|NCT03865147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110828343|NCT03865147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110828344|NCT03865147|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110828345|NCT03865147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110828346|NCT03865147|Analgesics|analgesics|mesh-ancestor
110828347|NCT03865147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110828348|NCT03865147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110828349|NCT03865147|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110828350|NCT03865147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110828351|NCT03865147|Antipyretics|antipyretics|mesh-ancestor
110828352|NCT03865147|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110828353|NCT03865147|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110828354|NCT03865147|Adrenergic Agents|adrenergic agents|mesh-ancestor
110828355|NCT03865147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110828356|NCT03865147|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110828357|NCT03865147|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110828358|NCT03865147|Autonomic Agents|autonomic agents|mesh-ancestor
110828359|NCT03865147|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110828360|NCT03865147|Respiratory System Agents|respiratory system agents|mesh-ancestor
110828361|NCT03865147|Mydriatics|mydriatics|mesh-ancestor
110828362|NCT03865147|Sympathomimetics|sympathomimetics|mesh-ancestor
110828363|NCT03865147|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110828364|NCT03865147|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
110828365|NCT03865147|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110828366|NCT03865147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110828367|NCT03722823|Tucatinib|tucatinib|mesh-list
110828368|NCT03722823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110828369|NCT03722823|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110828370|NCT03722823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110828371|NCT03722823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110828372|NCT03862651|Cangrelor|cangrelor|mesh-list
110828373|NCT03862651|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110828374|NCT03862651|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110828375|NCT03862651|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110828376|NCT03862651|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110828377|NCT03862651|Purinergic Agents|purinergic agents|mesh-ancestor
110828378|NCT03862651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110828379|NCT03862651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110828380|NCT03862651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110828381|NCT03349710|Nivolumab|nivolumab|mesh-list
110828382|NCT03349710|Cetuximab|cetuximab|mesh-list
110828383|NCT03349710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110828384|NCT03349710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110828385|NCT03349710|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110828386|NCT03349710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110828387|NCT01288495|Psyllium|psyllium|mesh-list
110828388|NCT01288495|Cathartics|cathartics|mesh-ancestor
110828389|NCT01288495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110828390|NCT01105793|Danazol|danazol|mesh-list
110828391|NCT01105793|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110828392|NCT01105793|Hormone Antagonists|hormone antagonists|mesh-ancestor
110828393|NCT01105793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110828394|NCT01105793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110828395|NCT04934579|Rituximab|rituximab|mesh-list
110828396|NCT04934579|Methotrexate|methotrexate|mesh-list
110828397|NCT04934579|Lenalidomide|lenalidomide|mesh-list
110175170|NCT00072163|Thalidomide|thalidomide|mesh-list
110828398|NCT04934579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110828399|NCT04934579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110828400|NCT04934579|Immunologic Factors|immunologic factors|mesh-ancestor
110828401|NCT04934579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110175235|NCT00072553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110828403|NCT04934579|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110828404|NCT04934579|Abortifacient Agents|abortifacient agents|mesh-ancestor
110175307|NCT00072943|Antiviral Agents|antiviral agents|mesh-ancestor
110828405|NCT04934579|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110828406|NCT04934579|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110828407|NCT04934579|Antimetabolites|antimetabolites|mesh-ancestor
110175381|NCT02966041|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110828408|NCT04934579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110828409|NCT04934579|Dermatologic Agents|dermatologic agents|mesh-ancestor
110828410|NCT04934579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110828411|NCT04934579|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110828412|NCT04934579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110828413|NCT04934579|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110175458|NCT00074191|Antiviral Agents|antiviral agents|mesh-ancestor
110828414|NCT04934579|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110828415|NCT04934579|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110828416|NCT04934579|Growth Substances|growth substances|mesh-ancestor
110828417|NCT04934579|Growth Inhibitors|growth inhibitors|mesh-ancestor
110828418|NCT03134131|TIC10 compound|tic10 compound|mesh-list
110828419|NCT03134131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110828420|NCT01103609|Warfarin|warfarin|mesh-list
110828421|NCT01103609|Anticoagulants|anticoagulants|mesh-ancestor
110828422|NCT03528369|Capsaicin|capsaicin|mesh-list
110828423|NCT03528369|Antipruritics|antipruritics|mesh-ancestor
110828424|NCT03528369|Dermatologic Agents|dermatologic agents|mesh-ancestor
110828425|NCT03528369|Sensory System Agents|sensory system agents|mesh-ancestor
110828426|NCT03528369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110828427|NCT03528369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110828428|NCT01288573|Plerixafor|plerixafor|mesh-list
110828429|NCT01288573|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110828430|NCT01288573|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110828431|NCT01288573|Antiviral Agents|antiviral agents|mesh-ancestor
110545952|NCT00681174|Narcotics|narcotics|mesh-ancestor
110828432|NCT01288573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110828433|NCT01174693|Clopidogrel|clopidogrel|mesh-list
110828434|NCT01174693|Triflusal|triflusal|mesh-list
110828435|NCT01174693|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110828436|NCT01174693|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110828437|NCT01174693|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110828438|NCT01174693|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110828439|NCT01174693|Purinergic Agents|purinergic agents|mesh-ancestor
110828440|NCT01174693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110828441|NCT01174693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110828442|NCT01174693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110828443|NCT00006011|Paclitaxel|paclitaxel|mesh-list
110828444|NCT00006011|Doxorubicin|doxorubicin|mesh-list
110828445|NCT00006011|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110828446|NCT00006011|Lenograstim|lenograstim|mesh-list
110828447|NCT00006011|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110828448|NCT00006011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110828449|NCT00006011|Tubulin Modulators|tubulin modulators|mesh-ancestor
110828450|NCT00006011|Antimitotic Agents|antimitotic agents|mesh-ancestor
110828451|NCT00006011|Mitosis Modulators|mitosis modulators|mesh-ancestor
110828452|NCT00006011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110828453|NCT00006011|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110828454|NCT00006011|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110828455|NCT00006011|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110828456|NCT00006011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110828457|NCT00006011|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110828458|NCT00006011|Immunologic Factors|immunologic factors|mesh-ancestor
110828459|NCT00006011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110828460|NCT01105871|Naloxone|naloxone|mesh-list
110828461|NCT01105871|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110828462|NCT01105871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110828463|NCT01105871|Sensory System Agents|sensory system agents|mesh-ancestor
110828464|NCT01105871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110828465|NCT03377556|Talazoparib|talazoparib|mesh-list
110828466|NCT03377556|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110828467|NCT03377556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110828468|NCT03377556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110828469|NCT03377556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110828470|NCT05625581|Cyclophosphamide|cyclophosphamide|mesh-list
110828471|NCT05625581|Tofacitinib|tofacitinib|mesh-list
110828472|NCT05625581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110828473|NCT05625581|Immunologic Factors|immunologic factors|mesh-ancestor
110828474|NCT05625581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110828475|NCT05625581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110828476|NCT05625581|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110828477|NCT05625581|Alkylating Agents|alkylating agents|mesh-ancestor
110828478|NCT05625581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110828479|NCT05625581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110828480|NCT05625581|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110828481|NCT05625581|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
110828482|NCT05625581|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110176261|NCT00392886|Thiotepa|thiotepa|mesh-list
110828483|NCT05625581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110828484|NCT01176175|Progesterone|progesterone|mesh-list
110828485|NCT01176175|Progestins|progestins|mesh-ancestor
110828487|NCT01176175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110828488|NCT01176175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110828489|NCT05624099|Paclitaxel|paclitaxel|mesh-list
110828490|NCT05624099|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110828491|NCT05624099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110176413|NCT00080665|Docetaxel|docetaxel|mesh-list
110828492|NCT05624099|Tubulin Modulators|tubulin modulators|mesh-ancestor
110828493|NCT05624099|Antimitotic Agents|antimitotic agents|mesh-ancestor
110828494|NCT05624099|Mitosis Modulators|mitosis modulators|mesh-ancestor
110828495|NCT05624099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110828496|NCT03864601|JNJ-56136379|jnj-56136379|mesh-list
110828497|NCT03864601|Antiviral Agents|antiviral agents|mesh-ancestor
110828498|NCT03864601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110828499|NCT03864523|Pioglitazone|pioglitazone|mesh-list
110176546|NCT00081757|Thalidomide|thalidomide|mesh-list
110828500|NCT03864523|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110828501|NCT03864523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110828502|NCT01174849|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110828503|NCT01174849|Immunologic Factors|immunologic factors|mesh-ancestor
110828504|NCT01174849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110828505|NCT03583359|Lidocaine|lidocaine|mesh-list
110828506|NCT03583359|Anesthetics, Local|anesthetics, local|mesh-ancestor
110828507|NCT03583359|Anesthetics|anesthetics|mesh-ancestor
110176617|NCT03152097|Protective Agents|protective agents|mesh-ancestor
110828508|NCT03583359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110828509|NCT03583359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110828510|NCT03583359|Sensory System Agents|sensory system agents|mesh-ancestor
110828511|NCT03583359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110828512|NCT03583359|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110828513|NCT03583359|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110828514|NCT03583359|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110828515|NCT03583359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110828516|NCT03583359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110828517|NCT05619887|Fentanyl|fentanyl|mesh-list
110828518|NCT05619887|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110828519|NCT05619887|Narcotics|narcotics|mesh-ancestor
110828520|NCT05619887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110828521|NCT05619887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110828522|NCT05619887|Analgesics|analgesics|mesh-ancestor
110828523|NCT05619887|Sensory System Agents|sensory system agents|mesh-ancestor
110828524|NCT05619887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110828525|NCT05619887|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110828526|NCT05619887|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110828527|NCT05619887|Anesthetics, General|anesthetics, general|mesh-ancestor
110176705|NCT00083161|Etoposide|etoposide|mesh-list
110828528|NCT05619887|Anesthetics|anesthetics|mesh-ancestor
110828529|NCT01174927|Heroin|heroin|mesh-list
110828530|NCT01174927|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110828531|NCT01174927|Narcotics|narcotics|mesh-ancestor
110886616|NCT02978495|Paclitaxel|paclitaxel|mesh-list
110828532|NCT01174927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110828533|NCT01174927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110828535|NCT01174927|Sensory System Agents|sensory system agents|mesh-ancestor
110828536|NCT01174927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110828537|NCT03510663|Moxifloxacin|moxifloxacin|mesh-list
110828538|NCT03510663|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110828539|NCT03510663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110828540|NCT03510663|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110828541|NCT03510663|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110828542|NCT03510663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110828543|NCT03510663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110828544|NCT03510663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110828545|NCT03948737|Tocopherols|tocopherols|mesh-list
110828546|NCT03948737|Vitamin E|vitamin e|mesh-list
110828547|NCT03948737|Tocotrienols|tocotrienols|mesh-list
110828548|NCT03948737|alpha-Tocopherol|alpha-tocopherol|mesh-list
110828549|NCT03948737|Antioxidants|antioxidants|mesh-ancestor
110828550|NCT03948737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110828551|NCT03948737|Protective Agents|protective agents|mesh-ancestor
110828552|NCT03948737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110828553|NCT03948737|Vitamins|vitamins|mesh-ancestor
110828554|NCT03948737|Micronutrients|micronutrients|mesh-ancestor
110828555|NCT01287247|Botulinum Toxins|botulinum toxins|mesh-list
110828556|NCT01287247|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
110828557|NCT01287247|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110828558|NCT01287247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110828559|NCT01287247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110828560|NCT01287247|Cholinergic Agents|cholinergic agents|mesh-ancestor
110828561|NCT01287247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110828562|NCT01287247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110828563|NCT01287247|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110828564|NCT01287247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110828565|NCT01327859|Donepezil|donepezil|mesh-list
110828566|NCT01327859|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110828567|NCT01327859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110828568|NCT01327859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110828569|NCT01327859|Cholinergic Agents|cholinergic agents|mesh-ancestor
110828570|NCT01327859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110828571|NCT01327859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110828572|NCT01327859|Nootropic Agents|nootropic agents|mesh-ancestor
110828573|NCT01176409|Valacyclovir|valacyclovir|mesh-list
110828574|NCT01176409|Antiviral Agents|antiviral agents|mesh-ancestor
110828575|NCT01176409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110828576|NCT03480009|Oxycodone|oxycodone|mesh-list
110177184|NCT00137761|Gefitinib|gefitinib|mesh-list
110828577|NCT03480009|Dextromethorphan|dextromethorphan|mesh-list
110828578|NCT03480009|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110828579|NCT03480009|Narcotics|narcotics|mesh-ancestor
110828580|NCT03480009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110828581|NCT03480009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110828582|NCT03480009|Analgesics|analgesics|mesh-ancestor
110828583|NCT03480009|Sensory System Agents|sensory system agents|mesh-ancestor
110177253|NCT00138229|Antiviral Agents|antiviral agents|mesh-ancestor
110828584|NCT03480009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110828586|NCT03480009|Respiratory System Agents|respiratory system agents|mesh-ancestor
110828587|NCT03480009|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110828588|NCT03480009|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110828589|NCT03480009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110828590|NCT03480009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110828591|NCT03859375|Disinfectants|disinfectants|mesh-list
110828592|NCT03859375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110828594|NCT01310751|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110828595|NCT01310751|Vasodilator Agents|vasodilator agents|mesh-ancestor
110828596|NCT01180933|Folic Acid|folic acid|mesh-list
110828597|NCT01180933|Vitamin B Complex|vitamin b complex|mesh-list
110828598|NCT01180933|Hematinics|hematinics|mesh-ancestor
110828599|NCT01180933|Vitamins|vitamins|mesh-ancestor
110828600|NCT01180933|Micronutrients|micronutrients|mesh-ancestor
110177557|NCT03150459|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110828601|NCT01180933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110828602|NCT03639363|Chlorhexidine|chlorhexidine|mesh-list
110828603|NCT03639363|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110828604|NCT03639363|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110828605|NCT03639363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110828606|NCT03639363|Disinfectants|disinfectants|mesh-ancestor
110828607|NCT03639363|Dermatologic Agents|dermatologic agents|mesh-ancestor
110828608|NCT03859141|Vaccines|vaccines|mesh-list
110828609|NCT03859141|Immunologic Factors|immunologic factors|mesh-ancestor
110828610|NCT03859141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110828611|NCT03859219|Rozanolixizumab|rozanolixizumab|mesh-list
110828612|NCT03859219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110828613|NCT03859219|Immunologic Factors|immunologic factors|mesh-ancestor
110828614|NCT03859219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110828615|NCT03374358|Raltegravir Potassium|raltegravir potassium|mesh-list
110828616|NCT03374358|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110828617|NCT03374358|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110828618|NCT03374358|Antiviral Agents|antiviral agents|mesh-ancestor
110828619|NCT03374358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110828620|NCT03374358|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110828621|NCT03374358|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110828622|NCT03374358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110828623|NCT03374358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110828624|NCT03711708|Sertraline|sertraline|mesh-list
110828625|NCT03711708|Antidepressive Agents|antidepressive agents|mesh-ancestor
110828626|NCT03711708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110828627|NCT03711708|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110828628|NCT03711708|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110828629|NCT03711708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110828630|NCT03711708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110828631|NCT03711708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110828632|NCT03711708|Serotonin Agents|serotonin agents|mesh-ancestor
110828633|NCT03711708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110828634|NCT01179529|Omalizumab|omalizumab|mesh-list
110828635|NCT01179529|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110828636|NCT01179529|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110828637|NCT01179529|Respiratory System Agents|respiratory system agents|mesh-ancestor
110828638|NCT00004859|Thalidomide|thalidomide|mesh-list
110828639|NCT00004859|Paclitaxel|paclitaxel|mesh-list
110828640|NCT00004859|Carboplatin|carboplatin|mesh-list
110828641|NCT00004859|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110828642|NCT00004859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110828643|NCT00004859|Tubulin Modulators|tubulin modulators|mesh-ancestor
110828644|NCT00004859|Antimitotic Agents|antimitotic agents|mesh-ancestor
110828645|NCT00004859|Mitosis Modulators|mitosis modulators|mesh-ancestor
110828646|NCT00004859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110828647|NCT00004859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110828648|NCT00004859|Immunologic Factors|immunologic factors|mesh-ancestor
110828649|NCT00004859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110828650|NCT00004859|Leprostatic Agents|leprostatic agents|mesh-ancestor
110828651|NCT00004859|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110828652|NCT00004859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110828653|NCT00004859|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110828654|NCT00004859|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110828655|NCT00004859|Growth Substances|growth substances|mesh-ancestor
110828656|NCT00004859|Growth Inhibitors|growth inhibitors|mesh-ancestor
110828658|NCT03348930|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110828659|NCT03348930|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110828660|NCT03348930|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
110828661|NCT03348930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110828662|NCT03348930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110828664|NCT03500211|Anesthetics, Local|anesthetics, local|mesh-ancestor
110828665|NCT03500211|Anesthetics|anesthetics|mesh-ancestor
110828666|NCT03500211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110828667|NCT03500211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110828668|NCT03500211|Sensory System Agents|sensory system agents|mesh-ancestor
110828669|NCT03500211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110828670|NCT03500211|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110828671|NCT03500211|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110178187|NCT00144157|Nevirapine|nevirapine|mesh-list
110828672|NCT03500211|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110828673|NCT03500211|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110828674|NCT03500211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110828675|NCT01288885|Ipragliflozin|ipragliflozin|mesh-list
110828676|NCT01288885|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110828677|NCT01288885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110178276|NCT00404794|Hormones|hormones|mesh-ancestor
110828678|NCT01288885|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110828679|NCT01288885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110828680|NCT04760717|Spironolactone|spironolactone|mesh-list
110871776|NCT03669224|Dermatologic Agents|dermatologic agents|mesh-ancestor
110828681|NCT04760717|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110828682|NCT04760717|Hormone Antagonists|hormone antagonists|mesh-ancestor
110828683|NCT04760717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110828684|NCT04760717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110828685|NCT04760717|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110828686|NCT04760717|Diuretics|diuretics|mesh-ancestor
110828687|NCT04760717|Natriuretic Agents|natriuretic agents|mesh-ancestor
110828688|NCT03478683|Budesonide|budesonide|mesh-list
110828689|NCT03478683|Albuterol|albuterol|mesh-list
110828690|NCT03478683|Formoterol Fumarate|formoterol fumarate|mesh-list
110828691|NCT03478683|Tiotropium Bromide|tiotropium bromide|mesh-list
110871777|NCT01381848|Doripenem|doripenem|mesh-list
110828692|NCT03478683|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
110828693|NCT03478683|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110828694|NCT03478683|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110828695|NCT03478683|Autonomic Agents|autonomic agents|mesh-ancestor
110828696|NCT03478683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110828697|NCT03478683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110828698|NCT03478683|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110828699|NCT03478683|Respiratory System Agents|respiratory system agents|mesh-ancestor
110828700|NCT03478683|Glucocorticoids|glucocorticoids|mesh-ancestor
110828701|NCT03478683|Hormones|hormones|mesh-ancestor
110828702|NCT03478683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110178542|NCT01806753|Anesthetics|anesthetics|mesh-ancestor
110828703|NCT03478683|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110828704|NCT03478683|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110828705|NCT03478683|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110828706|NCT03478683|Adrenergic Agents|adrenergic agents|mesh-ancestor
110828707|NCT03478683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110828708|NCT03478683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110828709|NCT03478683|Parasympatholytics|parasympatholytics|mesh-ancestor
110828710|NCT03478683|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110828711|NCT03478683|Cholinergic Agents|cholinergic agents|mesh-ancestor
110828712|NCT03478683|Tocolytic Agents|tocolytic agents|mesh-ancestor
110828713|NCT03478683|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110828714|NCT01176799|Cyclophosphamide|cyclophosphamide|mesh-list
110828715|NCT01176799|Doxorubicin|doxorubicin|mesh-list
110828716|NCT01176799|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110828717|NCT01176799|Sunitinib|sunitinib|mesh-list
110828718|NCT01176799|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110828719|NCT01176799|Immunologic Factors|immunologic factors|mesh-ancestor
110828720|NCT01176799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110828721|NCT01176799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110828722|NCT01176799|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110828723|NCT01176799|Alkylating Agents|alkylating agents|mesh-ancestor
110828724|NCT01176799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110828725|NCT01176799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110828726|NCT01176799|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110828727|NCT01176799|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110828728|NCT01176799|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110828729|NCT01176799|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110828730|NCT01176799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110178835|NCT01805700|Caffeine|caffeine|mesh-list
110828731|NCT01176799|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110828732|NCT01176799|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110828733|NCT01176799|Growth Substances|growth substances|mesh-ancestor
110178890|NCT01903421|Fentanyl|fentanyl|mesh-list
110828734|NCT01176799|Growth Inhibitors|growth inhibitors|mesh-ancestor
110828735|NCT01176799|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110828736|NCT03861403|Cyclophosphamide|cyclophosphamide|mesh-list
110828737|NCT03861403|Avelumab|avelumab|mesh-list
110828738|NCT03861403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110828739|NCT03861403|Immunologic Factors|immunologic factors|mesh-ancestor
110828740|NCT03861403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110828741|NCT03861403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110828742|NCT03861403|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110828743|NCT03861403|Alkylating Agents|alkylating agents|mesh-ancestor
110828744|NCT03861403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110179048|NCT01466478|Vitamins|vitamins|mesh-ancestor
110828745|NCT03861403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110828746|NCT03861403|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110828747|NCT03861403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110828749|NCT03477903|Antiemetics|antiemetics|mesh-ancestor
110828750|NCT03477903|Autonomic Agents|autonomic agents|mesh-ancestor
110828751|NCT03477903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110828752|NCT03477903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110828753|NCT03477903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110828754|NCT03477903|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110828755|NCT03477903|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110828756|NCT03477903|Dopamine Agents|dopamine agents|mesh-ancestor
110828757|NCT03477903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110828758|NCT03477903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110828759|NCT04728425|Immunoglobulins|immunoglobulins|mesh-list
110828760|NCT04728425|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110828761|NCT04728425|Antibodies|antibodies|mesh-list
110828762|NCT04728425|gamma-Globulins|gamma-globulins|mesh-list
110179187|NCT00009776|Paclitaxel|paclitaxel|mesh-list
110828763|NCT04728425|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110828764|NCT04728425|Immunoglobulin G|immunoglobulin g|mesh-list
110828765|NCT04728425|Immunologic Factors|immunologic factors|mesh-ancestor
110828766|NCT04728425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110828767|NCT01181401|Cisplatin|cisplatin|mesh-list
110828768|NCT01181401|Docetaxel|docetaxel|mesh-list
110828769|NCT01181401|Cetuximab|cetuximab|mesh-list
110828770|NCT01181401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110828771|NCT01181401|Tubulin Modulators|tubulin modulators|mesh-ancestor
110828772|NCT01181401|Antimitotic Agents|antimitotic agents|mesh-ancestor
110828773|NCT01181401|Mitosis Modulators|mitosis modulators|mesh-ancestor
110828774|NCT01181401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110828775|NCT01181401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110828776|NCT01287715|Etanercept|etanercept|mesh-list
110828777|NCT01287715|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110828778|NCT01287715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110828779|NCT01287715|Analgesics|analgesics|mesh-ancestor
110828780|NCT01287715|Sensory System Agents|sensory system agents|mesh-ancestor
110828781|NCT01287715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110828782|NCT01287715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110828783|NCT01287715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110828784|NCT01287715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110179325|NCT01465113|Vitamins|vitamins|mesh-list
110828785|NCT01287715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110828786|NCT01287715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110828787|NCT01287715|Immunologic Factors|immunologic factors|mesh-ancestor
110828788|NCT03474081|Albuterol|albuterol|mesh-list
110828789|NCT03474081|Tiotropium Bromide|tiotropium bromide|mesh-list
110828790|NCT03474081|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110828791|NCT03474081|Autonomic Agents|autonomic agents|mesh-ancestor
110828792|NCT03474081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110828793|NCT03474081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110828794|NCT03474081|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110828795|NCT03474081|Respiratory System Agents|respiratory system agents|mesh-ancestor
110828796|NCT03474081|Parasympatholytics|parasympatholytics|mesh-ancestor
110828797|NCT03474081|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110179463|NCT00011297|Anticonvulsants|anticonvulsants|mesh-ancestor
110828799|NCT03474081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110828800|NCT03474081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110828801|NCT03474081|Tocolytic Agents|tocolytic agents|mesh-ancestor
110828802|NCT03474081|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110828803|NCT03474081|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110828804|NCT03474081|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110828805|NCT03474081|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110828806|NCT03474081|Adrenergic Agents|adrenergic agents|mesh-ancestor
110828807|NCT03393000|Vitamin A|vitamin a|mesh-list
110828808|NCT03393000|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
110828810|NCT03393000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110828811|NCT03393000|Protective Agents|protective agents|mesh-ancestor
110828812|NCT03393000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110828813|NCT03393000|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110828814|NCT03393000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110828815|NCT03393000|Vitamins|vitamins|mesh-ancestor
110828816|NCT03393000|Micronutrients|micronutrients|mesh-ancestor
110828817|NCT01311804|Parecoxib|parecoxib|mesh-list
110828818|NCT01311804|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110828819|NCT01311804|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110828820|NCT01311804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110828821|NCT01311804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110828822|NCT01311804|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110828823|NCT01311804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110828824|NCT01311804|Analgesics|analgesics|mesh-ancestor
110828825|NCT01311804|Sensory System Agents|sensory system agents|mesh-ancestor
110828826|NCT01311804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110828827|NCT01311804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110828828|NCT01311804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110828829|NCT01311804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110828830|NCT03370770|Osimertinib|osimertinib|mesh-list
110828831|NCT03370770|Afatinib|afatinib|mesh-list
110828832|NCT03370770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110828833|NCT03370770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110828834|NCT03370770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110828835|NCT03370770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110828836|NCT01180075|Ritonavir|ritonavir|mesh-list
110828837|NCT01180075|Atazanavir Sulfate|atazanavir sulfate|mesh-list
110828838|NCT01180075|Tenofovir|tenofovir|mesh-list
110828839|NCT01180075|Emtricitabine|emtricitabine|mesh-list
110828840|NCT01180075|Efavirenz|efavirenz|mesh-list
110208599|NCT00194818|Mesalamine|mesalamine|mesh-list
110828841|NCT01180075|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110828842|NCT01180075|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110828843|NCT01180075|Protease Inhibitors|protease inhibitors|mesh-ancestor
110828844|NCT01180075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110828845|NCT01180075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110828846|NCT01180075|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110828847|NCT01180075|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110828848|NCT01180075|Antiviral Agents|antiviral agents|mesh-ancestor
110828849|NCT01180075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110828850|NCT01180075|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110828851|NCT01180075|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110828853|NCT01180075|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110828854|NCT01180075|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110828855|NCT01180075|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110828856|NCT01180075|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110828857|NCT01180075|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110828858|NCT01180075|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110828859|NCT01311882|Zopiclone|zopiclone|mesh-list
110828860|NCT01311882|Suvorexant|suvorexant|mesh-list
110828861|NCT01311882|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110828862|NCT01311882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110180142|NCT00014534|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110828863|NCT01311882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110828864|NCT01311882|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110828865|NCT01311882|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
110828866|NCT01311882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110828867|NCT01311882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110828868|NCT01287793|Moxifloxacin|moxifloxacin|mesh-list
110828869|NCT01287793|Tigecycline|tigecycline|mesh-list
110828870|NCT01287793|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110180358|NCT00275535|Immunologic Factors|immunologic factors|mesh-ancestor
110828871|NCT01287793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110828872|NCT01287793|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110828873|NCT01287793|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110828874|NCT01287793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110180433|NCT00015860|Prednisone|prednisone|mesh-list
110828875|NCT01287793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110828876|NCT01287793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110828877|NCT01287793|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110828878|NCT03391284|Acetaminophen|acetaminophen|mesh-list
110828879|NCT03391284|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110828880|NCT03391284|Analgesics|analgesics|mesh-ancestor
110828881|NCT03391284|Sensory System Agents|sensory system agents|mesh-ancestor
110828882|NCT03391284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110828883|NCT03391284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110828884|NCT03391284|Antipyretics|antipyretics|mesh-ancestor
110828885|NCT01180153|Oxaliplatin|oxaliplatin|mesh-list
110828886|NCT01180153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110828887|NCT03719625|Norepinephrine|norepinephrine|mesh-list
110828889|NCT03719625|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110828890|NCT03719625|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110828891|NCT03719625|Adrenergic Agents|adrenergic agents|mesh-ancestor
110828892|NCT03719625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110828893|NCT03719625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110828894|NCT03719625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110828895|NCT03719625|Sympathomimetics|sympathomimetics|mesh-ancestor
110828896|NCT03719625|Autonomic Agents|autonomic agents|mesh-ancestor
110071524|NCT05570084|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110828897|NCT03719625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110828898|NCT03719625|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110828899|NCT03719625|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110828900|NCT01289743|Etanercept|etanercept|mesh-list
110828901|NCT01289743|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110828902|NCT01289743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110828903|NCT01289743|Analgesics|analgesics|mesh-ancestor
110180726|NCT00130065|Pyrimethamine|pyrimethamine|mesh-list
110828904|NCT01289743|Sensory System Agents|sensory system agents|mesh-ancestor
110828905|NCT01289743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110828906|NCT01289743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110828907|NCT01289743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110828908|NCT01289743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110828909|NCT01289743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110828910|NCT01289743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110828911|NCT01289743|Immunologic Factors|immunologic factors|mesh-ancestor
110828912|NCT03390426|Anesthetics|anesthetics|mesh-list
110828913|NCT03390426|Mepivacaine|mepivacaine|mesh-list
110828914|NCT03390426|Anesthetics, Local|anesthetics, local|mesh-list
110828915|NCT03390426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110828916|NCT03390426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110828917|NCT03390426|Sensory System Agents|sensory system agents|mesh-ancestor
110828918|NCT03390426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110828919|NCT03472521|Gabapentin|gabapentin|mesh-list
110828920|NCT03472521|Analgesics|analgesics|mesh-ancestor
110828921|NCT03472521|Sensory System Agents|sensory system agents|mesh-ancestor
110828922|NCT03472521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110828923|NCT03472521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110828924|NCT03472521|Anticonvulsants|anticonvulsants|mesh-ancestor
110828925|NCT03472521|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110828926|NCT03472521|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110828927|NCT03472521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110828928|NCT03472521|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110828929|NCT03472521|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110828930|NCT03472521|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110828931|NCT03472521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110828932|NCT03472521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110828934|NCT02906020|Venglustat|venglustat|mesh-list
110828935|NCT02906020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110828936|NCT02906020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110828937|NCT01177423|Anesthetics|anesthetics|mesh-list
110181081|NCT00128895|Azathioprine|azathioprine|mesh-list
110828938|NCT01177423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110828939|NCT01177423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110828940|NCT01180231|Moxonidine|moxonidine|mesh-list
110828941|NCT01180231|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110828942|NCT01177501|Topotecan|topotecan|mesh-list
110828943|NCT01177501|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110071598|NCT05522582|Abortifacient Agents|abortifacient agents|mesh-ancestor
110828944|NCT01177501|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110828946|NCT01177501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110828947|NCT01177501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110828948|NCT03478150|Zinc Oxide|zinc oxide|mesh-list
110828949|NCT03478150|Dermatologic Agents|dermatologic agents|mesh-ancestor
110828950|NCT03478150|Sunscreening Agents|sunscreening agents|mesh-ancestor
110828951|NCT03478150|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110828952|NCT03478150|Protective Agents|protective agents|mesh-ancestor
110828953|NCT03478150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110828954|NCT03499353|Talazoparib|talazoparib|mesh-list
110828955|NCT03499353|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110546481|NCT00990223|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110828956|NCT03499353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110828957|NCT03499353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110828958|NCT03499353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110828960|NCT00004259|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110828961|NCT00004259|Alkylating Agents|alkylating agents|mesh-ancestor
110828962|NCT00004259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110828963|NCT00004259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110828964|NCT01177579|Copper|copper|mesh-list
110828965|NCT01177579|Trace Elements|trace elements|mesh-ancestor
110828966|NCT01177579|Micronutrients|micronutrients|mesh-ancestor
110828967|NCT01177579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110828968|NCT03722355|Carmustine|carmustine|mesh-list
110828969|NCT03722355|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110828970|NCT03722355|Alkylating Agents|alkylating agents|mesh-ancestor
110828971|NCT03722355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110828972|NCT03722355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110828973|NCT03857815|Antibodies|antibodies|mesh-list
110828974|NCT03857815|Immunologic Factors|immunologic factors|mesh-ancestor
110828975|NCT03857815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110828976|NCT03365934|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110828977|NCT03365934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110828978|NCT04682405|Melphalan|melphalan|mesh-list
110828979|NCT04682405|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110828980|NCT04682405|Alkylating Agents|alkylating agents|mesh-ancestor
110181328|NCT00018200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110828981|NCT04682405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110828982|NCT04682405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110828983|NCT04682405|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110828984|NCT04682405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110828985|NCT04682405|Immunologic Factors|immunologic factors|mesh-ancestor
110828986|NCT04682405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110828987|NCT03477994|Clonidine|clonidine|mesh-list
110828988|NCT03477994|Dexmedetomidine|dexmedetomidine|mesh-list
110828989|NCT03477994|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110886750|NCT02238392|Vasodilator Agents|vasodilator agents|mesh-ancestor
110181473|NCT00019383|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110828990|NCT03477994|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110828991|NCT03477994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110828992|NCT03477994|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110828993|NCT03477994|Analgesics|analgesics|mesh-ancestor
110828994|NCT03477994|Sensory System Agents|sensory system agents|mesh-ancestor
110828995|NCT03477994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110181543|NCT00019812|Paclitaxel|paclitaxel|mesh-list
110828996|NCT03477994|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110828997|NCT03477994|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110828998|NCT03477994|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110828999|NCT03477994|Adrenergic Agents|adrenergic agents|mesh-ancestor
110829000|NCT03477994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110181616|NCT05576675|Analgesics|analgesics|mesh-ancestor
110829001|NCT03477994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110829002|NCT03477994|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110829003|NCT03477994|Sympatholytics|sympatholytics|mesh-ancestor
110829004|NCT03477994|Autonomic Agents|autonomic agents|mesh-ancestor
110829005|NCT04668131|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110829006|NCT04668131|Lubricant Eye Drops|lubricant eye drops|mesh-list
110829007|NCT04668131|Hyaluronic Acid|hyaluronic acid|mesh-list
110829008|NCT04668131|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110829009|NCT04668131|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110829011|NCT04668131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110829012|NCT04668131|Viscosupplements|viscosupplements|mesh-ancestor
110829013|NCT04668131|Protective Agents|protective agents|mesh-ancestor
110829014|NCT03857581|Olanzapine|olanzapine|mesh-list
110829015|NCT03857581|Clozapine|clozapine|mesh-list
110829016|NCT03857581|Antiemetics|antiemetics|mesh-ancestor
110829017|NCT03857581|Autonomic Agents|autonomic agents|mesh-ancestor
110829018|NCT03857581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110829019|NCT03857581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110829020|NCT03857581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110829021|NCT03857581|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110829022|NCT03857581|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110829023|NCT03857581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110829024|NCT03857581|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110829025|NCT03857581|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110829026|NCT03857581|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110829027|NCT03857581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110546556|NCT05360953|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110829028|NCT03857581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110829029|NCT03857581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110829030|NCT03857581|Serotonin Agents|serotonin agents|mesh-ancestor
110829031|NCT03857581|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110829032|NCT03857581|GABA Antagonists|gaba antagonists|mesh-ancestor
110829033|NCT03857581|GABA Agents|gaba agents|mesh-ancestor
110829034|NCT01103843|Clopidogrel|clopidogrel|mesh-list
110829035|NCT01103843|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
110829036|NCT01103843|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110829037|NCT01103843|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110829038|NCT01103843|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110829039|NCT01103843|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110829040|NCT01103843|Purinergic Agents|purinergic agents|mesh-ancestor
110829041|NCT01103843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110829042|NCT01103843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110829043|NCT01103843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110829044|NCT03738865|Glucagon|glucagon|mesh-list
110829045|NCT03738865|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
110829046|NCT03738865|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110829047|NCT03738865|Hormones|hormones|mesh-ancestor
110829048|NCT03738865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110829049|NCT03738865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110829050|NCT03738865|Incretins|incretins|mesh-ancestor
110829051|NCT03524157|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110829052|NCT03524157|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110829053|NCT03524157|Hyaluronic Acid|hyaluronic acid|mesh-list
110829054|NCT03524157|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110829055|NCT03524157|Immunologic Factors|immunologic factors|mesh-ancestor
110829056|NCT03524157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110829057|NCT03524157|Viscosupplements|viscosupplements|mesh-ancestor
110829058|NCT03524157|Protective Agents|protective agents|mesh-ancestor
110829059|NCT03719391|Nicotine|nicotine|mesh-list
110829060|NCT03719391|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110829061|NCT03719391|Autonomic Agents|autonomic agents|mesh-ancestor
110829062|NCT03719391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110829063|NCT03719391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110829064|NCT03719391|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110071742|NCT04410406|Filaricides|filaricides|mesh-ancestor
110182491|NCT00024492|Mitoxantrone|mitoxantrone|mesh-list
110829065|NCT03719391|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110829066|NCT03719391|Cholinergic Agents|cholinergic agents|mesh-ancestor
110829067|NCT03719391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110829068|NCT03719391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110829069|NCT03468543|Memantine|memantine|mesh-list
110829070|NCT03468543|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110829071|NCT03468543|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110829072|NCT03468543|Dopamine Agents|dopamine agents|mesh-ancestor
110829073|NCT03468543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110829074|NCT03468543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110829075|NCT03468543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110829076|NCT03468543|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110829077|NCT03468543|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110829078|NCT03467763|Metformin|metformin|mesh-list
110829079|NCT03467763|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110829080|NCT03467763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110829081|NCT00004031|Prednisone|prednisone|mesh-list
110829082|NCT00004031|Cyclophosphamide|cyclophosphamide|mesh-list
110829083|NCT00004031|Carmustine|carmustine|mesh-list
110829084|NCT00004031|Rituximab|rituximab|mesh-list
110829085|NCT00004031|Doxorubicin|doxorubicin|mesh-list
110182624|NCT00025272|Etoposide|etoposide|mesh-list
110829086|NCT00004031|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110829087|NCT00004031|Etoposide|etoposide|mesh-list
110829088|NCT00004031|Vincristine|vincristine|mesh-list
110829089|NCT00004031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110829090|NCT00004031|Immunologic Factors|immunologic factors|mesh-ancestor
110829091|NCT00004031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110829092|NCT00004031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110829093|NCT00004031|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110829094|NCT00004031|Alkylating Agents|alkylating agents|mesh-ancestor
110829095|NCT00004031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110829096|NCT00004031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110829097|NCT00004031|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110829098|NCT00004031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110829099|NCT00004031|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110829100|NCT00004031|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110829101|NCT00004031|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110829102|NCT00004031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110829103|NCT00004031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110829104|NCT00004031|Glucocorticoids|glucocorticoids|mesh-ancestor
110829105|NCT00004031|Hormones|hormones|mesh-ancestor
110829106|NCT00004031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110829107|NCT00004031|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110829108|NCT00004031|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110829109|NCT00004031|Tubulin Modulators|tubulin modulators|mesh-ancestor
110829110|NCT00004031|Antimitotic Agents|antimitotic agents|mesh-ancestor
110829111|NCT00004031|Mitosis Modulators|mitosis modulators|mesh-ancestor
110829112|NCT01184443|Olanzapine|olanzapine|mesh-list
110829113|NCT01184443|Antiemetics|antiemetics|mesh-ancestor
110829114|NCT01184443|Autonomic Agents|autonomic agents|mesh-ancestor
110829115|NCT01184443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110829116|NCT01184443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110829117|NCT01184443|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110829118|NCT01184443|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110071753|NCT04349826|Cefixime|cefixime|mesh-list
110829119|NCT01184443|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110829120|NCT01184443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110829121|NCT01184443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110829122|NCT01184443|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110829123|NCT01184443|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110829124|NCT01184443|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110829125|NCT01184443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110829126|NCT01184443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110829127|NCT01184443|Serotonin Agents|serotonin agents|mesh-ancestor
110829128|NCT01180621|Vaccines|vaccines|mesh-list
110829129|NCT01180621|Immunologic Factors|immunologic factors|mesh-ancestor
110829130|NCT01180621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110829131|NCT01290133|Vestipitant|vestipitant|mesh-list
110829132|NCT01290133|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110829133|NCT01290133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110829134|NCT01290133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110829135|NCT01290133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110829136|NCT03467217|Losartan|losartan|mesh-list
110829137|NCT03467217|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110829138|NCT03467217|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110829139|NCT03467217|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110829140|NCT03467217|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110829141|NCT03467217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110829142|NCT00003875|Aldesleukin|aldesleukin|mesh-list
110829143|NCT00003875|Etoposide|etoposide|mesh-list
110829144|NCT00003875|Etoposide phosphate|etoposide phosphate|mesh-list
110829145|NCT00003875|Busulfan|busulfan|mesh-list
110829146|NCT00003875|Interleukin-2|interleukin-2|mesh-list
110829147|NCT00003875|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110829148|NCT00003875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110829150|NCT00003875|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110071777|NCT04227483|Hormones|hormones|mesh-ancestor
110829152|NCT00003875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110829153|NCT00003875|Alkylating Agents|alkylating agents|mesh-ancestor
110829154|NCT00003875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110829155|NCT00003875|Immunologic Factors|immunologic factors|mesh-ancestor
110829156|NCT00003875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110829157|NCT00003875|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110829158|NCT00003875|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110829159|NCT00003875|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110829160|NCT00003875|Analgesics|analgesics|mesh-ancestor
110829161|NCT00003875|Sensory System Agents|sensory system agents|mesh-ancestor
110829162|NCT00003875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110829163|NCT00003875|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110829164|NCT00003875|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110829165|NCT00003875|Antiviral Agents|antiviral agents|mesh-ancestor
110829166|NCT00003875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110829167|NCT01327625|Azithromycin|azithromycin|mesh-list
110829168|NCT01327625|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110829169|NCT01327625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110829170|NCT01290211|Ritonavir|ritonavir|mesh-list
110829171|NCT01290211|Fosamprenavir|fosamprenavir|mesh-list
110829172|NCT01290211|Maraviroc|maraviroc|mesh-list
110829173|NCT01290211|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110829174|NCT01290211|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110829175|NCT01290211|Protease Inhibitors|protease inhibitors|mesh-ancestor
110829176|NCT01290211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110829177|NCT01290211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110829178|NCT01290211|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110829179|NCT01290211|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110829180|NCT01290211|Antiviral Agents|antiviral agents|mesh-ancestor
110829181|NCT01290211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110829182|NCT01290211|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110829183|NCT01290211|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110829184|NCT01290211|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110829185|NCT01290211|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110071817|NCT03893435|Valsartan|valsartan|mesh-list
110829186|NCT01290211|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
110829187|NCT03720873|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110829188|NCT03720873|Gefitinib|gefitinib|mesh-list
110829189|NCT03720873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110829190|NCT03720873|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110182704|NCT04964414|Budesonide|budesonide|mesh-list
110829191|NCT03720873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110829192|NCT03720873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110829193|NCT01311960|Bevacizumab|bevacizumab|mesh-list
110829194|NCT01311960|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110829195|NCT01311960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110829196|NCT01311960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110829197|NCT01311960|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110829198|NCT01311960|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110829199|NCT01311960|Growth Substances|growth substances|mesh-ancestor
110071855|NCT03676725|Lidocaine|lidocaine|mesh-list
110829200|NCT01311960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110829201|NCT01311960|Growth Inhibitors|growth inhibitors|mesh-ancestor
110829202|NCT01311960|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110829204|NCT03709056|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110829205|NCT03709056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110829206|NCT03709056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110829207|NCT03709056|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110829208|NCT03709056|Anesthetics, General|anesthetics, general|mesh-ancestor
110829210|NCT05663307|Aspirin|aspirin|mesh-list
110829211|NCT05663307|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110829212|NCT05663307|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110829213|NCT05663307|Analgesics|analgesics|mesh-ancestor
110829214|NCT05663307|Sensory System Agents|sensory system agents|mesh-ancestor
110829215|NCT05663307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110829216|NCT05663307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110829217|NCT05663307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110829218|NCT05663307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110829219|NCT05663307|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110829220|NCT05663307|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110829221|NCT05663307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110829222|NCT05663307|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110829223|NCT05663307|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110829224|NCT05663307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110829225|NCT05663307|Antipyretics|antipyretics|mesh-ancestor
110829226|NCT01106495|Simvastatin|simvastatin|mesh-list
110829227|NCT01106495|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110829228|NCT01106495|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110829229|NCT01106495|Antimetabolites|antimetabolites|mesh-ancestor
110829230|NCT01106495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110829231|NCT01106495|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110071916|NCT02918006|Vaccines|vaccines|mesh-list
110829232|NCT01106495|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110829234|NCT01184833|Interferons|interferons|mesh-list
110829235|NCT01184833|Interferon-beta|interferon-beta|mesh-list
110829236|NCT01184833|Interferon beta-1b|interferon beta-1b|mesh-list
110829237|NCT01184833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110829238|NCT01184833|Antiviral Agents|antiviral agents|mesh-ancestor
110829239|NCT01184833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110829240|NCT01184833|Immunologic Factors|immunologic factors|mesh-ancestor
110829241|NCT01184833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110829242|NCT01184833|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110829243|NCT01184911|Pyrimethamine|pyrimethamine|mesh-list
110829244|NCT01184911|Sulfadoxine|sulfadoxine|mesh-list
110829245|NCT01184911|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
110829246|NCT01184911|Antimalarials|antimalarials|mesh-ancestor
110829247|NCT01184911|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110829248|NCT01184911|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110829249|NCT01184911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110829250|NCT01184911|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110071955|NCT02713373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110071956|NCT02686593|Mitoxantrone|mitoxantrone|mesh-list
110071957|NCT02686593|Clofarabine|clofarabine|mesh-list
110071958|NCT02686593|Analgesics|analgesics|mesh-ancestor
110071959|NCT02686593|Sensory System Agents|sensory system agents|mesh-ancestor
110071960|NCT02686593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110071961|NCT02686593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110071962|NCT02686593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110071963|NCT02686593|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110071964|NCT02686593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110829251|NCT01184911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110829252|NCT01184911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110829253|NCT01184911|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110829254|NCT01185067|Grape Seed Extract|grape seed extract|mesh-list
110829255|NCT01185067|Resveratrol|resveratrol|mesh-list
110829256|NCT01185067|Antioxidants|antioxidants|mesh-list
110829257|NCT01185067|Quercetin|quercetin|mesh-list
110886845|NCT03586154|Ketamine|ketamine|mesh-list
110829258|NCT01185067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110829259|NCT01185067|Protective Agents|protective agents|mesh-ancestor
110829260|NCT01185067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110829261|NCT01185067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110829262|NCT01185067|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110829263|NCT01185067|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110829264|NCT01185067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110829266|NCT03364686|Vitamin B Complex|vitamin b complex|mesh-ancestor
110829267|NCT03364686|Vitamins|vitamins|mesh-ancestor
110829268|NCT03364686|Micronutrients|micronutrients|mesh-ancestor
110829269|NCT03364686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110829270|NCT03437577|Tacrolimus|tacrolimus|mesh-list
110829271|NCT03437577|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110829272|NCT03437577|Immunologic Factors|immunologic factors|mesh-ancestor
110829273|NCT03437577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110829274|NCT03437577|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110829275|NCT03437577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110829276|NCT03437577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110829277|NCT03336528|Insulin Glargine|insulin glargine|mesh-list
110829278|NCT03336528|Insulin Aspart|insulin aspart|mesh-list
110829279|NCT03336528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110829280|NCT03336528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110829281|NCT03364608|Albuterol|albuterol|mesh-list
110829282|NCT03364608|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110829283|NCT03364608|Autonomic Agents|autonomic agents|mesh-ancestor
110072023|NCT02065609|Trastuzumab|trastuzumab|mesh-list
110829284|NCT03364608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110829285|NCT03364608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110829286|NCT03364608|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110829287|NCT03364608|Respiratory System Agents|respiratory system agents|mesh-ancestor
110829288|NCT03364608|Tocolytic Agents|tocolytic agents|mesh-ancestor
110829289|NCT03364608|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110182760|NCT00025740|Clonazepam|clonazepam|mesh-list
110829290|NCT03364608|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110829291|NCT03364608|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110829292|NCT03364608|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110829293|NCT03364608|Adrenergic Agents|adrenergic agents|mesh-ancestor
110829294|NCT03364608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110829295|NCT03364608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110829296|NCT03719157|Anesthetics|anesthetics|mesh-list
110829297|NCT03719157|Anesthetics, Local|anesthetics, local|mesh-list
110829298|NCT03719157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110829299|NCT03719157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110829300|NCT03719157|Sensory System Agents|sensory system agents|mesh-ancestor
110829301|NCT03719157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110829302|NCT01185223|Valganciclovir|valganciclovir|mesh-list
110829303|NCT01185223|Ganciclovir|ganciclovir|mesh-list
110829304|NCT01185223|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
110829305|NCT01185223|Antiviral Agents|antiviral agents|mesh-ancestor
110829306|NCT01185223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110072052|NCT01562704|Antipyretics|antipyretics|mesh-ancestor
110829307|NCT01185223|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110829308|NCT01185223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110829309|NCT01185223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110829310|NCT03852979|Paclitaxel|paclitaxel|mesh-list
110829311|NCT03852979|Carboplatin|carboplatin|mesh-list
110829312|NCT03852979|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110829313|NCT03852979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110829314|NCT03852979|Tubulin Modulators|tubulin modulators|mesh-ancestor
110829315|NCT03852979|Antimitotic Agents|antimitotic agents|mesh-ancestor
110829316|NCT03852979|Mitosis Modulators|mitosis modulators|mesh-ancestor
110829317|NCT03852979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110829318|NCT01188031|Alprazolam|alprazolam|mesh-list
110829319|NCT01188031|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110829320|NCT01188031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110886859|NCT03586154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110829321|NCT01188031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110829322|NCT01188031|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110829323|NCT01188031|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110829324|NCT01188031|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110829325|NCT01188031|GABA Modulators|gaba modulators|mesh-ancestor
110829326|NCT01188031|GABA Agents|gaba agents|mesh-ancestor
110829327|NCT01188031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110829328|NCT01188031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110546854|NCT02772965|Dermatologic Agents|dermatologic agents|mesh-ancestor
110829329|NCT01182883|Sirolimus|sirolimus|mesh-list
110829330|NCT01182883|Temsirolimus|temsirolimus|mesh-list
110829331|NCT01182883|MTOR Inhibitors|mtor inhibitors|mesh-list
110829332|NCT01182883|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110829333|NCT01182883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110829334|NCT01182883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110829335|NCT01182883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110829336|NCT01182883|Immunologic Factors|immunologic factors|mesh-ancestor
110829337|NCT01182883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110829338|NCT01182883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110182778|NCT00025779|Guanfacine|guanfacine|mesh-list
110829339|NCT01182883|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110829340|NCT01182883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110829341|NCT01182883|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110829342|NCT01182883|Antifungal Agents|antifungal agents|mesh-ancestor
110829343|NCT01188265|Valproic Acid|valproic acid|mesh-list
110829344|NCT01188265|Dextromethorphan|dextromethorphan|mesh-list
110829345|NCT01188265|Antitussive Agents|antitussive agents|mesh-ancestor
110829346|NCT01188265|Respiratory System Agents|respiratory system agents|mesh-ancestor
110829347|NCT01188265|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110829348|NCT01188265|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110829349|NCT01188265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110829350|NCT01188265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110829351|NCT01188265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110829352|NCT01188265|Anticonvulsants|anticonvulsants|mesh-ancestor
110829353|NCT01188265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110829354|NCT01188265|GABA Agents|gaba agents|mesh-ancestor
110829355|NCT01188265|Antimanic Agents|antimanic agents|mesh-ancestor
110829356|NCT01188265|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110829357|NCT01188265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110829358|NCT01188265|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110829359|NCT01291069|Tadalafil|tadalafil|mesh-list
110829360|NCT01291069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110829361|NCT01291069|Vasodilator Agents|vasodilator agents|mesh-ancestor
110829362|NCT01291069|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110829363|NCT01291069|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110829364|NCT01291069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110829365|NCT01291069|Urological Agents|urological agents|mesh-ancestor
110829366|NCT00003869|Carboxyamido-triazole|carboxyamido-triazole|mesh-list
110829367|NCT00003869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110829368|NCT00003869|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110829369|NCT00003869|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110829370|NCT00003869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110829371|NCT00003869|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110829372|NCT00003869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110829373|NCT01588639|Insulin|insulin|mesh-list
110829374|NCT01588639|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110829375|NCT01588639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110829376|NCT01588639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110829377|NCT02524639|Sirolimus|sirolimus|mesh-list
110829378|NCT02524639|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110886870|NCT01314833|Paclitaxel|paclitaxel|mesh-list
110829380|NCT02524639|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110829381|NCT02524639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110829382|NCT02524639|Antifungal Agents|antifungal agents|mesh-ancestor
110829383|NCT02524639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110829384|NCT02524639|Immunologic Factors|immunologic factors|mesh-ancestor
110829385|NCT02524639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110829386|NCT01185535|Anesthetics|anesthetics|mesh-list
110829387|NCT01185535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110829388|NCT01185535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110829389|NCT00003659|Cyclophosphamide|cyclophosphamide|mesh-list
110829390|NCT00003659|Rituximab|rituximab|mesh-list
110829391|NCT00003659|Fludarabine|fludarabine|mesh-list
110829392|NCT00003659|Fludarabine phosphate|fludarabine phosphate|mesh-list
110829393|NCT00003659|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110829394|NCT00003659|Immunologic Factors|immunologic factors|mesh-ancestor
110829395|NCT00003659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110829396|NCT00003659|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110829397|NCT00003659|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110829398|NCT00003659|Alkylating Agents|alkylating agents|mesh-ancestor
110829399|NCT00003659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110182793|NCT00026052|Riluzole|riluzole|mesh-list
110829400|NCT00003659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110829401|NCT00003659|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110829402|NCT00003659|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110829403|NCT00003659|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110829404|NCT00003659|Antimetabolites|antimetabolites|mesh-ancestor
110829405|NCT01101581|Epratuzumab|epratuzumab|mesh-list
110829406|NCT01101581|Veltuzumab|veltuzumab|mesh-list
110829407|NCT01101581|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
110829408|NCT01101581|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110829409|NCT01101581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110829410|NCT01101581|Chelating Agents|chelating agents|mesh-ancestor
110829411|NCT01101581|Sequestering Agents|sequestering agents|mesh-ancestor
110829412|NCT01101581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110829413|NCT01183585|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110829414|NCT01183585|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110829415|NCT01183585|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110829416|NCT01183585|Antimetabolites|antimetabolites|mesh-ancestor
110829417|NCT01183585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110829418|NCT01183585|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110829419|NCT01183585|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110829420|NCT01183585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110829421|NCT03494985|Muramidase|muramidase|mesh-list
110829422|NCT03494985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110829423|NCT01185769|Tocotrienols|tocotrienols|mesh-list
110829424|NCT01185769|Vitamin E|vitamin e|mesh-list
110829425|NCT01185769|Tocopherols|tocopherols|mesh-list
110829426|NCT01185769|Antioxidants|antioxidants|mesh-ancestor
110829427|NCT01185769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110829428|NCT01185769|Protective Agents|protective agents|mesh-ancestor
110829429|NCT01185769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110829430|NCT01185769|Vitamins|vitamins|mesh-ancestor
110829431|NCT01185769|Micronutrients|micronutrients|mesh-ancestor
110829432|NCT01185847|Gemcitabine|gemcitabine|mesh-list
110829433|NCT01185847|Pemetrexed|pemetrexed|mesh-list
110829434|NCT01185847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110829435|NCT01185847|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110829436|NCT01185847|Antimetabolites|antimetabolites|mesh-ancestor
110829437|NCT01185847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110829438|NCT01185847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110829439|NCT01185847|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110829440|NCT01185847|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110829441|NCT03720483|Acetylcysteine|acetylcysteine|mesh-list
110829442|NCT03720483|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110182822|NCT04808414|Polymyxins|polymyxins|mesh-list
110829443|NCT03720483|Antiviral Agents|antiviral agents|mesh-ancestor
110829444|NCT03720483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110829445|NCT03720483|Expectorants|expectorants|mesh-ancestor
110829446|NCT03720483|Respiratory System Agents|respiratory system agents|mesh-ancestor
110829447|NCT03720483|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110829448|NCT03720483|Antioxidants|antioxidants|mesh-ancestor
110829449|NCT03720483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110829450|NCT03720483|Protective Agents|protective agents|mesh-ancestor
110829451|NCT03720483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110829452|NCT03720483|Antidotes|antidotes|mesh-ancestor
110829453|NCT01183663|Leucovorin|leucovorin|mesh-list
110829454|NCT01183663|Sirolimus|sirolimus|mesh-list
110829455|NCT01183663|Bevacizumab|bevacizumab|mesh-list
110829456|NCT01183663|Lenalidomide|lenalidomide|mesh-list
110829457|NCT01183663|Fluorouracil|fluorouracil|mesh-list
110829458|NCT01183663|Oxaliplatin|oxaliplatin|mesh-list
110829459|NCT01183663|Sorafenib|sorafenib|mesh-list
110829460|NCT01183663|Temsirolimus|temsirolimus|mesh-list
110829461|NCT01183663|MTOR Inhibitors|mtor inhibitors|mesh-list
110829462|NCT01183663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110829463|NCT01183663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110829464|NCT01183663|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110829465|NCT01183663|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110829466|NCT01183663|Growth Substances|growth substances|mesh-ancestor
110829467|NCT01183663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110072344|NCT01571024|Leucovorin|leucovorin|mesh-list
110829468|NCT01183663|Growth Inhibitors|growth inhibitors|mesh-ancestor
110829469|NCT01183663|Antimetabolites|antimetabolites|mesh-ancestor
110829470|NCT01183663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110829471|NCT01183663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110829472|NCT01183663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110829473|NCT01183663|Immunologic Factors|immunologic factors|mesh-ancestor
110829474|NCT01183663|Antidotes|antidotes|mesh-ancestor
110829475|NCT01183663|Protective Agents|protective agents|mesh-ancestor
110829476|NCT01183663|Vitamin B Complex|vitamin b complex|mesh-ancestor
110829477|NCT01183663|Vitamins|vitamins|mesh-ancestor
110829478|NCT01183663|Micronutrients|micronutrients|mesh-ancestor
110829479|NCT01183663|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110829480|NCT01183663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110829481|NCT01183663|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110829482|NCT01183663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110829483|NCT01183663|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110829484|NCT01183663|Antifungal Agents|antifungal agents|mesh-ancestor
110829485|NCT01291927|Pancrelipase|pancrelipase|mesh-list
110829486|NCT01291927|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110829487|NCT03344172|Hydroxychloroquine|hydroxychloroquine|mesh-list
110829488|NCT03344172|Paclitaxel|paclitaxel|mesh-list
110829489|NCT03344172|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110829490|NCT03344172|Gemcitabine|gemcitabine|mesh-list
110829491|NCT03344172|Avelumab|avelumab|mesh-list
110829492|NCT03344172|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110829493|NCT03344172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110829494|NCT03344172|Tubulin Modulators|tubulin modulators|mesh-ancestor
110829495|NCT03344172|Antimitotic Agents|antimitotic agents|mesh-ancestor
110829496|NCT03344172|Mitosis Modulators|mitosis modulators|mesh-ancestor
110829497|NCT03344172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110829498|NCT03344172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110829499|NCT03344172|Antimetabolites|antimetabolites|mesh-ancestor
110829500|NCT03344172|Antimalarials|antimalarials|mesh-ancestor
110829501|NCT03344172|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110829502|NCT03344172|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110829503|NCT03344172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110829504|NCT03344172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110829505|NCT03344172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110829506|NCT03344172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110829507|NCT01188733|Octreotide|octreotide|mesh-list
110829508|NCT01188733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110829509|NCT01188733|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110886899|NCT02737826|Buprenorphine|buprenorphine|mesh-list
110829510|NCT01188733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110829512|NCT01101659|Analgesics|analgesics|mesh-ancestor
110829513|NCT01101659|Sensory System Agents|sensory system agents|mesh-ancestor
110829514|NCT01101659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110829515|NCT01101659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110829516|NCT01101659|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110829517|NCT01101659|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110829518|NCT01101659|Anesthetics, General|anesthetics, general|mesh-ancestor
110829519|NCT01101659|Anesthetics|anesthetics|mesh-ancestor
110829520|NCT01101659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110829521|NCT01101659|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110829522|NCT01101659|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110829523|NCT01101659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110072427|NCT01571570|Simeprevir|simeprevir|mesh-list
110829524|NCT01101659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110829525|NCT03855865|Vortioxetine|vortioxetine|mesh-list
110829526|NCT03855865|Antidepressive Agents|antidepressive agents|mesh-ancestor
110829527|NCT03855865|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110829528|NCT03855865|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110829529|NCT03855865|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110829530|NCT03855865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110829531|NCT03855865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110829532|NCT03855865|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110829533|NCT03855865|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110829534|NCT03855865|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110829535|NCT03855865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110829536|NCT03855865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110829537|NCT03855865|Serotonin Agents|serotonin agents|mesh-ancestor
110829538|NCT03855865|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110829539|NCT03855865|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110829540|NCT03855865|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110829541|NCT03855865|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110829542|NCT01290367|Hyaluronic Acid|hyaluronic acid|mesh-list
110829543|NCT01290367|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110829544|NCT01290367|Immunologic Factors|immunologic factors|mesh-ancestor
110829545|NCT01290367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110829546|NCT01290367|Viscosupplements|viscosupplements|mesh-ancestor
110829547|NCT01290367|Protective Agents|protective agents|mesh-ancestor
110829548|NCT03465891|Atezolizumab|atezolizumab|mesh-list
110829549|NCT03465891|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110829550|NCT03465891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110829551|NCT03465891|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110829552|NCT03465891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110829553|NCT03363906|Dulaglutide|dulaglutide|mesh-list
110829554|NCT03363906|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
110547086|NCT04069234|Clopidogrel|clopidogrel|mesh-list
110829555|NCT03363906|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110829556|NCT03363906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110829558|NCT03948191|Methylene diphosphonate|methylene diphosphonate|mesh-list
110829559|NCT03948191|Methylprednisolone|methylprednisolone|mesh-list
110829560|NCT03948191|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110182865|NCT00026520|Interferons|interferons|mesh-list
110829561|NCT03948191|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110829562|NCT03948191|Prednisolone|prednisolone|mesh-list
110829563|NCT03948191|Prednisolone acetate|prednisolone acetate|mesh-list
110072473|NCT01571791|Analgesics|analgesics|mesh-ancestor
110829564|NCT03948191|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110829565|NCT03948191|Prednisolone phosphate|prednisolone phosphate|mesh-list
110829566|NCT03948191|Technetium Tc 99m Medronate|technetium tc 99m medronate|mesh-list
110829567|NCT03948191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110829568|NCT03948191|Antiemetics|antiemetics|mesh-ancestor
110829569|NCT03948191|Autonomic Agents|autonomic agents|mesh-ancestor
110829570|NCT03948191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110829571|NCT03948191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110829572|NCT03948191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110829573|NCT03948191|Glucocorticoids|glucocorticoids|mesh-ancestor
110829575|NCT03948191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110829576|NCT03948191|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110829577|NCT03948191|Protective Agents|protective agents|mesh-ancestor
110829578|NCT03948191|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110829579|NCT03948191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110829580|NCT03948191|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110829581|NCT03948191|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110829582|NCT03948191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110829583|NCT01292083|Azacitidine|azacitidine|mesh-list
110829584|NCT01292083|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110829585|NCT01292083|Antimetabolites|antimetabolites|mesh-ancestor
110829586|NCT01292083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110829587|NCT01292083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110829588|NCT01292083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110829589|NCT01104467|Salivary plasminogen activator alpha 1, Desmodus rotundus|salivary plasminogen activator alpha 1, desmodus rotundus|mesh-list
110829590|NCT01104467|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110829591|NCT01104467|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110829592|NCT01104467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110829593|NCT01292161|Silymarin|silymarin|mesh-list
110829594|NCT01292161|Antioxidants|antioxidants|mesh-ancestor
110829595|NCT01292161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110829596|NCT01292161|Protective Agents|protective agents|mesh-ancestor
110829597|NCT01292161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110829598|NCT01185925|Sildenafil Citrate|sildenafil citrate|mesh-list
110829599|NCT01185925|Vasodilator Agents|vasodilator agents|mesh-ancestor
110829600|NCT01185925|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110072506|NCT01571921|Antioxidants|antioxidants|mesh-ancestor
110829601|NCT01185925|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110829602|NCT01185925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110829603|NCT01185925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110829604|NCT01185925|Urological Agents|urological agents|mesh-ancestor
110829605|NCT01188889|Imatinib Mesylate|imatinib mesylate|mesh-list
110829606|NCT01188889|Everolimus|everolimus|mesh-list
110829607|NCT01188889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110829608|NCT01188889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110829609|NCT01188889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110829610|NCT01188889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110829611|NCT01188889|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110829612|NCT01188889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110829613|NCT01188889|Immunologic Factors|immunologic factors|mesh-ancestor
110829614|NCT01188889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110829615|NCT01184287|Ranpirnase|ranpirnase|mesh-list
110829616|NCT01184287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110829617|NCT01184287|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110829618|NCT01184287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110829619|NCT01184287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110829620|NCT01107431|Chromium|chromium|mesh-list
110829621|NCT01107431|Trace Elements|trace elements|mesh-ancestor
110829622|NCT01107431|Micronutrients|micronutrients|mesh-ancestor
110829623|NCT01107431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110829624|NCT01186159|Parecoxib|parecoxib|mesh-list
110829625|NCT01186159|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110829626|NCT01186159|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110829627|NCT01186159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110829628|NCT01186159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110829629|NCT01186159|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110829631|NCT01186159|Analgesics|analgesics|mesh-ancestor
110829632|NCT01186159|Sensory System Agents|sensory system agents|mesh-ancestor
110829633|NCT01186159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110829634|NCT01186159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110829635|NCT01186159|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110829636|NCT01186159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110829637|NCT01107509|Everolimus|everolimus|mesh-list
110829638|NCT01107509|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110829639|NCT01107509|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110829640|NCT01107509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110829641|NCT01107509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110829642|NCT01107509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110829643|NCT01107509|Immunologic Factors|immunologic factors|mesh-ancestor
110829644|NCT01107509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110829645|NCT01107509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110829646|NCT01101815|Naltrexone|naltrexone|mesh-list
110829647|NCT01101815|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110829648|NCT01101815|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110829649|NCT01101815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110829650|NCT01101815|Sensory System Agents|sensory system agents|mesh-ancestor
110829651|NCT01101815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110829652|NCT01104935|Trastuzumab|trastuzumab|mesh-list
110829653|NCT01104935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110829654|NCT01104935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110829655|NCT01293643|Clindamycin|clindamycin|mesh-list
110829656|NCT01293643|Clindamycin palmitate|clindamycin palmitate|mesh-list
110829657|NCT01293643|Clindamycin phosphate|clindamycin phosphate|mesh-list
110829658|NCT01293643|Amphotericin B|amphotericin b|mesh-list
110829659|NCT01293643|Tetracycline|tetracycline|mesh-list
110829660|NCT01293643|Ketoconazole|ketoconazole|mesh-list
110829661|NCT01293643|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
110829662|NCT01293643|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110829663|NCT01293643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110829664|NCT01293643|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110829665|NCT01293643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110829666|NCT01293643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110829667|NCT01293643|Antifungal Agents|antifungal agents|mesh-ancestor
110829668|NCT01293643|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110829669|NCT01293643|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110829670|NCT01293643|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110829671|NCT01293643|Hormone Antagonists|hormone antagonists|mesh-ancestor
110829672|NCT01293643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110829673|NCT01293643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110829674|NCT01293643|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110829676|NCT01293643|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110829677|NCT01293643|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110829678|NCT01105013|Clotrimazole|clotrimazole|mesh-list
110829679|NCT01105013|Miconazole|miconazole|mesh-list
110829680|NCT01105013|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110829681|NCT01105013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110829682|NCT01105013|Antifungal Agents|antifungal agents|mesh-ancestor
110829683|NCT01105013|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110829684|NCT01105013|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110829685|NCT01105013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110829686|NCT01105013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110829687|NCT01105013|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110829688|NCT01105013|Hormone Antagonists|hormone antagonists|mesh-ancestor
110829689|NCT01105013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110829690|NCT01105013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110829691|NCT01105013|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110829692|NCT01105013|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110829693|NCT03851731|Naltrexone|naltrexone|mesh-list
110829694|NCT03851731|Naloxone|naloxone|mesh-list
110829695|NCT03851731|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110829696|NCT03851731|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110829697|NCT03851731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110829698|NCT03851731|Sensory System Agents|sensory system agents|mesh-ancestor
110829699|NCT03851731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110829700|NCT03707652|Vitamins|vitamins|mesh-list
110829701|NCT03707652|Niacinamide|niacinamide|mesh-list
110829702|NCT03707652|Niacin|niacin|mesh-list
110547225|NCT05590117|Leucovorin|leucovorin|mesh-list
110829703|NCT03707652|Nicotinic Acids|nicotinic acids|mesh-list
110829704|NCT03707652|Vitamin B Complex|vitamin b complex|mesh-list
110829705|NCT03707652|Micronutrients|micronutrients|mesh-ancestor
110072627|NCT01572324|Antidotes|antidotes|mesh-ancestor
110829707|NCT03707652|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110829708|NCT03707652|Antimetabolites|antimetabolites|mesh-ancestor
110829709|NCT03707652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110829710|NCT03707652|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110829711|NCT03707652|Vasodilator Agents|vasodilator agents|mesh-ancestor
110829712|NCT01588093|Mecasermin|mecasermin|mesh-list
110829713|NCT01588093|Growth Substances|growth substances|mesh-ancestor
110829714|NCT01588093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110829715|NCT01186471|Nicotine|nicotine|mesh-list
110829716|NCT01186471|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110829717|NCT01186471|Autonomic Agents|autonomic agents|mesh-ancestor
110829718|NCT01186471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110829719|NCT01186471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110829720|NCT01186471|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110829721|NCT01186471|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110829722|NCT01186471|Cholinergic Agents|cholinergic agents|mesh-ancestor
110829723|NCT01186471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110829724|NCT01186471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110829725|NCT01292551|Bosentan|bosentan|mesh-list
110829726|NCT01292551|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110829727|NCT01292551|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
110829728|NCT01292551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110829729|NCT03854383|Isosorbide|isosorbide|mesh-list
110829730|NCT03854383|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
110829731|NCT03854383|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
110829732|NCT03854383|Misoprostol|misoprostol|mesh-list
110829733|NCT03854383|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110829734|NCT03854383|Abortifacient Agents|abortifacient agents|mesh-ancestor
110829735|NCT03854383|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110829736|NCT03854383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110829737|NCT03854383|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110829738|NCT03854383|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110829739|NCT03854383|Oxytocics|oxytocics|mesh-ancestor
110829740|NCT03854383|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110829741|NCT03854383|Diuretics|diuretics|mesh-ancestor
110829742|NCT03854383|Natriuretic Agents|natriuretic agents|mesh-ancestor
110829743|NCT03854383|Vasodilator Agents|vasodilator agents|mesh-ancestor
110829744|NCT03854383|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
110829745|NCT03854383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110829746|NCT03854617|Vinorelbine|vinorelbine|mesh-list
110829747|NCT03854617|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110829748|NCT03854617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110829749|NCT03854617|Tubulin Modulators|tubulin modulators|mesh-ancestor
110829750|NCT03854617|Antimitotic Agents|antimitotic agents|mesh-ancestor
110829751|NCT03854617|Mitosis Modulators|mitosis modulators|mesh-ancestor
110829752|NCT03854617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110829753|NCT01186549|Lidocaine|lidocaine|mesh-list
110829754|NCT01186549|Ephedrine|ephedrine|mesh-list
110829755|NCT01186549|Pseudoephedrine|pseudoephedrine|mesh-list
110829756|NCT01186549|Anesthetics, Local|anesthetics, local|mesh-ancestor
110829757|NCT01186549|Anesthetics|anesthetics|mesh-ancestor
110829758|NCT01186549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110829759|NCT01186549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110829760|NCT01186549|Sensory System Agents|sensory system agents|mesh-ancestor
110829761|NCT01186549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110829762|NCT01186549|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110829763|NCT01186549|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110829764|NCT01186549|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110829765|NCT01186549|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110829766|NCT01186549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110829767|NCT01186549|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110829768|NCT01186549|Sympathomimetics|sympathomimetics|mesh-ancestor
110829769|NCT01186549|Autonomic Agents|autonomic agents|mesh-ancestor
110829770|NCT01186549|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110829771|NCT01186549|Adrenergic Agents|adrenergic agents|mesh-ancestor
110829772|NCT01186549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110829773|NCT01186549|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110829774|NCT01186549|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110829775|NCT01186549|Respiratory System Agents|respiratory system agents|mesh-ancestor
110829776|NCT01186549|Nasal Decongestants|nasal decongestants|mesh-ancestor
110829777|NCT03851341|Metformin|metformin|mesh-list
110547300|NCT00673296|Growth Inhibitors|growth inhibitors|mesh-ancestor
110829778|NCT03851341|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110829779|NCT03851341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110829780|NCT03851341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110829781|NCT03851341|Incretins|incretins|mesh-ancestor
110829782|NCT03851341|Hormones|hormones|mesh-ancestor
110829783|NCT03851341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110829784|NCT03851341|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110829785|NCT03851341|Protease Inhibitors|protease inhibitors|mesh-ancestor
110829786|NCT03851341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110829787|NCT03851341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110829788|NCT03362190|Ranibizumab|ranibizumab|mesh-list
110829789|NCT03362190|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110829790|NCT03362190|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110829791|NCT03362190|Growth Substances|growth substances|mesh-ancestor
110829792|NCT03362190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110829793|NCT03362190|Growth Inhibitors|growth inhibitors|mesh-ancestor
110829794|NCT03362190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110829795|NCT01292785|Hormones|hormones|mesh-list
110829796|NCT01292785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110829797|NCT01292785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110829798|NCT02323126|Nivolumab|nivolumab|mesh-list
110829799|NCT02323126|Nazartinib|nazartinib|mesh-list
110829800|NCT02323126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110829801|NCT02323126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110829802|NCT02323126|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110829803|NCT02323126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110829804|NCT01291459|Tenofovir|tenofovir|mesh-list
110829805|NCT01291459|Emtricitabine|emtricitabine|mesh-list
110829806|NCT01291459|Raltegravir Potassium|raltegravir potassium|mesh-list
110829807|NCT01291459|Maraviroc|maraviroc|mesh-list
110829808|NCT01291459|Antiviral Agents|antiviral agents|mesh-ancestor
110829809|NCT01291459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110829810|NCT01291459|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110829811|NCT01291459|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110829812|NCT01291459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110829813|NCT01291459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110829814|NCT01291459|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110829815|NCT01291459|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110072748|NCT01572831|Tin Fluorides|tin fluorides|mesh-list
110829816|NCT01291459|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110829817|NCT01291459|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110829818|NCT01291459|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110829819|NCT01291459|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110829820|NCT01291459|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
110829822|NCT00003377|Cisplatin|cisplatin|mesh-list
110829823|NCT00003377|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110829824|NCT00003377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110829825|NCT00003377|Tubulin Modulators|tubulin modulators|mesh-ancestor
110829826|NCT00003377|Antimitotic Agents|antimitotic agents|mesh-ancestor
110829827|NCT00003377|Mitosis Modulators|mitosis modulators|mesh-ancestor
110829828|NCT00003377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110829829|NCT01291537|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
110829830|NCT01291537|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110829831|NCT01291537|Immunologic Factors|immunologic factors|mesh-ancestor
110829832|NCT01291537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110829833|NCT01291537|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110829834|NCT01291537|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110829835|NCT01291537|Dopamine Agonists|dopamine agonists|mesh-ancestor
110829836|NCT01291537|Dopamine Agents|dopamine agents|mesh-ancestor
110829837|NCT01291537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110829838|NCT01291537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110829839|NCT01328015|Oxybutynin|oxybutynin|mesh-list
110829840|NCT01328015|Cholinergic Antagonists|cholinergic antagonists|mesh-list
110829841|NCT01328015|Parasympatholytics|parasympatholytics|mesh-ancestor
110829842|NCT01328015|Autonomic Agents|autonomic agents|mesh-ancestor
110829843|NCT01328015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110829844|NCT01328015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110829845|NCT01328015|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110829846|NCT01328015|Cholinergic Agents|cholinergic agents|mesh-ancestor
110829847|NCT01328015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110829848|NCT01328015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110829849|NCT01328015|Urological Agents|urological agents|mesh-ancestor
110829850|NCT01101893|Raltegravir Potassium|raltegravir potassium|mesh-list
110829851|NCT01101893|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110829852|NCT01101893|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110829853|NCT01101893|Antiviral Agents|antiviral agents|mesh-ancestor
110829854|NCT01101893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110829855|NCT01101893|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110829856|NCT01101893|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110829857|NCT01101893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110182946|NCT00027339|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110829858|NCT01101893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110829859|NCT01292863|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110829860|NCT01292863|Dialysis Solutions|dialysis solutions|mesh-list
110829861|NCT00002651|Goserelin|goserelin|mesh-list
110829862|NCT00002651|Bicalutamide|bicalutamide|mesh-list
110829863|NCT00002651|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110829864|NCT00002651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110829865|NCT00002651|Androgen Antagonists|androgen antagonists|mesh-ancestor
110829866|NCT00002651|Hormone Antagonists|hormone antagonists|mesh-ancestor
110829867|NCT00002651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110829868|NCT00002651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110829869|NCT03853993|Vaccines|vaccines|mesh-list
110829870|NCT03853993|Immunologic Factors|immunologic factors|mesh-ancestor
110886971|NCT03620513|Protective Agents|protective agents|mesh-ancestor
110829871|NCT03853993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110829873|NCT03473626|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110829874|NCT03473626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110829875|NCT03473626|Immunologic Factors|immunologic factors|mesh-ancestor
110829876|NCT03473626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110829877|NCT05154682|Acetaminophen|acetaminophen|mesh-list
110829878|NCT05154682|Naproxen|naproxen|mesh-list
110829879|NCT05154682|Oxycodone|oxycodone|mesh-list
110829880|NCT05154682|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110829881|NCT05154682|Analgesics|analgesics|mesh-ancestor
110829882|NCT05154682|Sensory System Agents|sensory system agents|mesh-ancestor
110829883|NCT05154682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110829884|NCT05154682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110829885|NCT05154682|Antipyretics|antipyretics|mesh-ancestor
110829886|NCT05154682|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110829887|NCT05154682|Narcotics|narcotics|mesh-ancestor
110829888|NCT05154682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110829889|NCT05154682|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110829890|NCT05154682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110829891|NCT05154682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110829892|NCT05154682|Gout Suppressants|gout suppressants|mesh-ancestor
110829893|NCT05154682|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110829894|NCT05154682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110829895|NCT05154682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110829896|NCT04312841|Acetic Acid|acetic acid|mesh-list
110829897|NCT04312841|Letermovir|letermovir|mesh-list
110829898|NCT04312841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110829899|NCT04312841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110829900|NCT04312841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110829901|NCT04312841|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110829902|NCT04312841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110829903|NCT04312841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110829904|NCT04312841|Antiviral Agents|antiviral agents|mesh-ancestor
110829905|NCT01294735|Temozolomide|temozolomide|mesh-list
110829906|NCT01294735|Niraparib|niraparib|mesh-list
110829907|NCT01294735|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110829908|NCT01294735|Alkylating Agents|alkylating agents|mesh-ancestor
110829909|NCT01294735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110829910|NCT01294735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110829911|NCT01294735|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110072875|NCT01573806|Exenatide|exenatide|mesh-list
110829912|NCT01294735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110829913|NCT03851263|Evolocumab|evolocumab|mesh-list
110829914|NCT03851263|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
110829915|NCT03851263|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110829916|NCT03851263|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110829917|NCT03851263|Antimetabolites|antimetabolites|mesh-ancestor
110829918|NCT03851263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110829919|NCT03851263|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110829920|NCT03851263|Protease Inhibitors|protease inhibitors|mesh-ancestor
110829921|NCT03851263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110829922|NCT03851263|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110829923|NCT03849235|Glucagon|glucagon|mesh-list
110829924|NCT03849235|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110829925|NCT03849235|Hormones|hormones|mesh-ancestor
110829926|NCT03849235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110829927|NCT03849235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110829929|NCT03477448|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110829930|NCT03477448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110829931|NCT01187485|Methyltestosterone|methyltestosterone|mesh-list
110829932|NCT01187485|Testosterone|testosterone|mesh-list
110829933|NCT01187485|Testosterone undecanoate|testosterone undecanoate|mesh-list
110829934|NCT01187485|Testosterone enanthate|testosterone enanthate|mesh-list
110829935|NCT01187485|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
110829936|NCT01187485|Androgens|androgens|mesh-ancestor
110829937|NCT01187485|Hormones|hormones|mesh-ancestor
110829938|NCT01187485|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110829939|NCT01187485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110829940|NCT01187485|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110829941|NCT01187485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110829942|NCT01187485|Anabolic Agents|anabolic agents|mesh-ancestor
110829943|NCT00002597|Leuprolide|leuprolide|mesh-list
110829944|NCT00002597|Goserelin|goserelin|mesh-list
110829945|NCT00002597|Flutamide|flutamide|mesh-list
110829946|NCT00002597|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110829947|NCT00002597|Fertility Agents|fertility agents|mesh-ancestor
110829948|NCT00002597|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110829949|NCT00002597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110072904|NCT01574092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110829950|NCT00002597|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110829951|NCT00002597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110829952|NCT00002597|Androgen Antagonists|androgen antagonists|mesh-ancestor
110829953|NCT00002597|Hormone Antagonists|hormone antagonists|mesh-ancestor
110829954|NCT00002597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110829956|NCT03853525|Emollients|emollients|mesh-ancestor
110829957|NCT03853525|Dermatologic Agents|dermatologic agents|mesh-ancestor
110829958|NCT03716583|Melatonin|melatonin|mesh-list
110829959|NCT03716583|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
110829960|NCT03716583|Antioxidants|antioxidants|mesh-ancestor
110829961|NCT03716583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110829962|NCT03716583|Protective Agents|protective agents|mesh-ancestor
110829963|NCT03716583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110829964|NCT03716583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110829965|NCT03716583|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
110829966|NCT03716583|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110829967|NCT02738008|Tenofovir|tenofovir|mesh-list
110829968|NCT02738008|Entecavir|entecavir|mesh-list
110829969|NCT02738008|Histamine Antagonists|histamine antagonists|mesh-list
110829970|NCT02738008|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
110829971|NCT02738008|Antiviral Agents|antiviral agents|mesh-ancestor
110829972|NCT02738008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110829973|NCT02738008|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110829974|NCT02738008|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110829975|NCT02738008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110829976|NCT02738008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110829977|NCT02738008|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110829978|NCT02738008|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110829979|NCT02738008|Histamine Agents|histamine agents|mesh-ancestor
110829980|NCT02738008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110829981|NCT02738008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110829982|NCT03720249|Vitamins|vitamins|mesh-list
110829983|NCT03720249|Vitamin B 12|vitamin b 12|mesh-list
110829984|NCT03720249|Vitamin B 6|vitamin b 6|mesh-list
110286663|NCT00211328|Anecortave|anecortave|mesh-list
110829985|NCT03720249|Vitamin B Complex|vitamin b complex|mesh-list
110829986|NCT03720249|Betaine|betaine|mesh-list
110829987|NCT03720249|Micronutrients|micronutrients|mesh-ancestor
110829988|NCT03720249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110829989|NCT03720249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110072944|NCT01574638|Rifapentine|rifapentine|mesh-list
110829990|NCT03720249|Lipotropic Agents|lipotropic agents|mesh-ancestor
110829991|NCT03720249|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110829993|NCT03720249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110829994|NCT03720249|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110829995|NCT01294969|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
110829996|NCT01294969|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110829997|NCT01294969|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110829998|NCT01294969|Analgesics|analgesics|mesh-ancestor
110829999|NCT01294969|Sensory System Agents|sensory system agents|mesh-ancestor
110830000|NCT01294969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110830001|NCT01294969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110830002|NCT01294969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110830003|NCT01294969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110830004|NCT01294969|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110830005|NCT01294969|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110830006|NCT01294969|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110830007|NCT01294969|Histamine Antagonists|histamine antagonists|mesh-ancestor
110830008|NCT01294969|Histamine Agents|histamine agents|mesh-ancestor
110830009|NCT01294969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110830010|NCT01294969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110830011|NCT03850561|Ubiquinone|ubiquinone|mesh-list
110830012|NCT03850561|Coenzyme Q10|coenzyme q10|mesh-list
110830013|NCT03850561|Micronutrients|micronutrients|mesh-ancestor
110830014|NCT03850561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110830015|NCT03850561|Vitamins|vitamins|mesh-ancestor
110830016|NCT01190137|Cholecalciferol|cholecalciferol|mesh-list
110830017|NCT01190137|Vitamin D|vitamin d|mesh-list
110830018|NCT01190137|Ergocalciferols|ergocalciferols|mesh-list
110830019|NCT01190137|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110830020|NCT01190137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110830021|NCT01190137|Vitamins|vitamins|mesh-ancestor
110830022|NCT01190137|Micronutrients|micronutrients|mesh-ancestor
110830023|NCT01190137|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110830024|NCT02529839|Cyclophosphamide|cyclophosphamide|mesh-list
110830025|NCT02529839|Fludarabine|fludarabine|mesh-list
110830026|NCT02529839|Alemtuzumab|alemtuzumab|mesh-list
110830027|NCT02529839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110830028|NCT02529839|Immunologic Factors|immunologic factors|mesh-ancestor
110830029|NCT02529839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110830030|NCT02529839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110830031|NCT02529839|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110830032|NCT02529839|Alkylating Agents|alkylating agents|mesh-ancestor
110830033|NCT02529839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110830034|NCT02529839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110830035|NCT02529839|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110072982|NCT01575405|Glycerol|glycerol|mesh-list
110830036|NCT02529839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110830037|NCT03473314|Nitric Oxide|nitric oxide|mesh-list
110830038|NCT03473314|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110830039|NCT03473314|Autonomic Agents|autonomic agents|mesh-ancestor
110830040|NCT03473314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110830041|NCT03473314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110830042|NCT03473314|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110830043|NCT03473314|Respiratory System Agents|respiratory system agents|mesh-ancestor
110830044|NCT03473314|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110830045|NCT03473314|Antioxidants|antioxidants|mesh-ancestor
110830046|NCT03473314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110830047|NCT03473314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110830048|NCT03473314|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
110830049|NCT03473314|Vasodilator Agents|vasodilator agents|mesh-ancestor
110830050|NCT03473314|Gasotransmitters|gasotransmitters|mesh-ancestor
110830051|NCT03473314|Protective Agents|protective agents|mesh-ancestor
110830052|NCT03945539|Itraconazole|itraconazole|mesh-list
110830053|NCT03945539|JNJ-56136379|jnj-56136379|mesh-list
110830054|NCT03945539|Antifungal Agents|antifungal agents|mesh-ancestor
110830055|NCT03945539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110830056|NCT03945539|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110830057|NCT03945539|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110830058|NCT03945539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110830059|NCT03945539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110830060|NCT03945539|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110830061|NCT03945539|Hormone Antagonists|hormone antagonists|mesh-ancestor
110830062|NCT03945539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110830063|NCT03945539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110830064|NCT03945539|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110830065|NCT03945539|Antiviral Agents|antiviral agents|mesh-ancestor
110830067|NCT01190293|Maraviroc|maraviroc|mesh-list
110830068|NCT01190293|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110830069|NCT01190293|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110830070|NCT01190293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110830071|NCT01190293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110830072|NCT01190293|Antiviral Agents|antiviral agents|mesh-ancestor
110830073|NCT01190293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110830074|NCT01190293|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110830075|NCT01190293|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110830076|NCT01190293|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110830077|NCT01190293|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110547601|NCT00684216|Tamoxifen|tamoxifen|mesh-list
110830078|NCT01190293|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110830079|NCT01190293|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110830080|NCT01190293|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110830081|NCT01190293|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110830082|NCT01190293|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110830083|NCT01190293|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110830084|NCT01190293|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
110830085|NCT03945227|Spartalizumab|spartalizumab|mesh-list
110830086|NCT03945227|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110830087|NCT03945227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110830088|NCT03945227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110830089|NCT03945227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110830090|NCT01108133|Dexamethasone|dexamethasone|mesh-list
110830091|NCT01108133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110830092|NCT01108133|Antiemetics|antiemetics|mesh-ancestor
110830093|NCT01108133|Autonomic Agents|autonomic agents|mesh-ancestor
110830094|NCT01108133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110830095|NCT01108133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110830096|NCT01108133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110830097|NCT01108133|Glucocorticoids|glucocorticoids|mesh-ancestor
110830098|NCT01108133|Hormones|hormones|mesh-ancestor
110830099|NCT01108133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110830100|NCT01108133|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110830101|NCT01108133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110830102|NCT01108289|Oxytocin|oxytocin|mesh-list
110830103|NCT01108289|Oxytocics|oxytocics|mesh-ancestor
110830104|NCT01108289|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110830105|NCT01108289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110830106|NCT03947489|Sarpogrelate|sarpogrelate|mesh-list
110830107|NCT03947489|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110830108|NCT03947489|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110830109|NCT03947489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110830110|NCT03947489|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110830111|NCT03947489|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110830112|NCT03947489|Serotonin Agents|serotonin agents|mesh-ancestor
110830113|NCT03947489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110830114|NCT03947489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110830115|NCT03947411|Oseltamivir|oseltamivir|mesh-list
110830116|NCT03947411|Antiviral Agents|antiviral agents|mesh-ancestor
110830117|NCT03947411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110830119|NCT03947411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110830120|NCT03257254|Polidocanol|polidocanol|mesh-list
110830121|NCT03257254|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
110830122|NCT03257254|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110830123|NCT01327469|Albendazole|albendazole|mesh-list
110830124|NCT01327469|Mebendazole|mebendazole|mesh-list
110830125|NCT01327469|Piperazine|piperazine|mesh-list
110830126|NCT01327469|Piperazine citrate|piperazine citrate|mesh-list
110830127|NCT01327469|Pyrantel|pyrantel|mesh-list
110830128|NCT01327469|Oxantel|oxantel|mesh-list
110830129|NCT01327469|DMP 777|dmp 777|mesh-list
110830130|NCT01327469|Anthelmintics|anthelmintics|mesh-ancestor
110830131|NCT01327469|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110830132|NCT01327469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110830133|NCT01327469|Anticestodal Agents|anticestodal agents|mesh-ancestor
110830134|NCT01327469|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110830135|NCT01327469|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110830136|NCT01327469|Tubulin Modulators|tubulin modulators|mesh-ancestor
110830137|NCT01327469|Antimitotic Agents|antimitotic agents|mesh-ancestor
110830138|NCT01327469|Mitosis Modulators|mitosis modulators|mesh-ancestor
110830139|NCT01327469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110830140|NCT01327469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110830141|NCT01327469|Antinematodal Agents|antinematodal agents|mesh-ancestor
110830142|NCT01327469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110830143|NCT01327469|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
110830144|NCT01327469|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110830145|NCT01327469|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110183018|NCT00027807|Aldesleukin|aldesleukin|mesh-list
110830146|NCT01327469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110830147|NCT01327469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110830148|NCT03950141|Apatinib|apatinib|mesh-list
110830149|NCT03950141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110830150|NCT03950141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110830151|NCT03950141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110830152|NCT03950141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110547677|NCT00991627|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110830154|NCT01108601|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110830155|NCT01108601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110830156|NCT01108601|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110830157|NCT01108601|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110830158|NCT01108601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110830159|NCT01108601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110830160|NCT01108601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110830161|NCT01108601|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110830162|NCT01108601|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110830163|NCT03084718|Beclomethasone|beclomethasone|mesh-list
110830164|NCT03084718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110830165|NCT03084718|Glucocorticoids|glucocorticoids|mesh-ancestor
110830166|NCT03084718|Hormones|hormones|mesh-ancestor
110830167|NCT03084718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110830168|NCT03084718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110830169|NCT03084718|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110830170|NCT03084718|Respiratory System Agents|respiratory system agents|mesh-ancestor
110830171|NCT02938624|Pembrolizumab|pembrolizumab|mesh-list
110830172|NCT02938624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110830173|NCT02938624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110830174|NCT02938624|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110830175|NCT02938624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110830176|NCT03469804|Pembrolizumab|pembrolizumab|mesh-list
110830177|NCT03469804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110830178|NCT03469804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110830179|NCT03469804|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110830180|NCT03469804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110830181|NCT03944291|Bupivacaine|bupivacaine|mesh-list
110830182|NCT03944291|Anesthetics, Local|anesthetics, local|mesh-ancestor
110830183|NCT03944291|Anesthetics|anesthetics|mesh-ancestor
110830184|NCT03944291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110830185|NCT03944291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110830186|NCT03944291|Sensory System Agents|sensory system agents|mesh-ancestor
110830187|NCT03944291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110830188|NCT01102439|Aspirin|aspirin|mesh-list
110830189|NCT01102439|Clopidogrel|clopidogrel|mesh-list
110830190|NCT01102439|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110830191|NCT01102439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110830192|NCT01102439|Analgesics|analgesics|mesh-ancestor
110830193|NCT01102439|Sensory System Agents|sensory system agents|mesh-ancestor
110830194|NCT01102439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110830195|NCT01102439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110830196|NCT01102439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110830197|NCT01102439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110830198|NCT01102439|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110830199|NCT01102439|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110830200|NCT01102439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110830201|NCT01102439|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110830202|NCT01102439|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110830203|NCT01102439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110830204|NCT01102439|Antipyretics|antipyretics|mesh-ancestor
110830205|NCT01102439|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110830206|NCT01102439|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110830207|NCT01102439|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110830208|NCT01102439|Purinergic Agents|purinergic agents|mesh-ancestor
110830209|NCT01102439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110830210|NCT03949985|Hemostatics|hemostatics|mesh-list
110830211|NCT03949985|Contraceptive Agents|contraceptive agents|mesh-list
110830212|NCT03949985|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110830213|NCT03949985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110830214|NCT03949985|Coagulants|coagulants|mesh-ancestor
110830216|NCT01584791|Clopidogrel|clopidogrel|mesh-list
110830217|NCT01584791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110830218|NCT01584791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110830219|NCT01584791|Analgesics|analgesics|mesh-ancestor
110830220|NCT01584791|Sensory System Agents|sensory system agents|mesh-ancestor
110830221|NCT01584791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110830222|NCT01584791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110830223|NCT01584791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110830224|NCT01584791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110830225|NCT01584791|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110830226|NCT01584791|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110830227|NCT01584791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110830228|NCT01584791|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110830229|NCT01584791|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110830230|NCT01584791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110830231|NCT01584791|Antipyretics|antipyretics|mesh-ancestor
110830232|NCT01584791|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110830233|NCT01584791|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110830234|NCT01584791|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110830235|NCT01584791|Purinergic Agents|purinergic agents|mesh-ancestor
110830236|NCT01584791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110830237|NCT04285684|Ketamine|ketamine|mesh-list
110830238|NCT04285684|Analgesics|analgesics|mesh-ancestor
110830239|NCT04285684|Sensory System Agents|sensory system agents|mesh-ancestor
110830240|NCT04285684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110830241|NCT04285684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110830242|NCT04285684|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110830243|NCT04285684|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110830244|NCT04285684|Anesthetics, General|anesthetics, general|mesh-ancestor
110830245|NCT04285684|Anesthetics|anesthetics|mesh-ancestor
110183079|NCT00027924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110830246|NCT04285684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110830247|NCT04285684|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110830248|NCT04285684|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110830249|NCT04285684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110830250|NCT04285684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110830251|NCT01310985|Capecitabine|capecitabine|mesh-list
110830252|NCT01310985|Cetuximab|cetuximab|mesh-list
110830253|NCT01310985|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110830254|NCT01310985|Antimetabolites|antimetabolites|mesh-ancestor
110830255|NCT01310985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110830256|NCT01310985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110830257|NCT01310985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110830258|NCT03433677|Insulin Lispro|insulin lispro|mesh-list
110830259|NCT03433677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110830260|NCT03433677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110830261|NCT02492711|Trastuzumab|trastuzumab|mesh-list
110830262|NCT02492711|Margetuximab|margetuximab|mesh-list
110830263|NCT02492711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110830264|NCT02492711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110830265|NCT03716427|Tolbutamide|tolbutamide|mesh-list
110830266|NCT03716427|Midazolam|midazolam|mesh-list
110830267|NCT03716427|Dextromethorphan|dextromethorphan|mesh-list
110830268|NCT03716427|Omeprazole|omeprazole|mesh-list
110830269|NCT03716427|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110830270|NCT03716427|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110830271|NCT03716427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110830272|NCT03716427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110830273|NCT03716427|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110830274|NCT03716427|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110830275|NCT03716427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110830276|NCT03716427|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110830277|NCT03716427|Anesthetics, General|anesthetics, general|mesh-ancestor
110830278|NCT03716427|Anesthetics|anesthetics|mesh-ancestor
110830279|NCT03716427|GABA Modulators|gaba modulators|mesh-ancestor
110830280|NCT03716427|GABA Agents|gaba agents|mesh-ancestor
110830281|NCT03716427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110830282|NCT03716427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110830283|NCT03716427|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110830284|NCT03716427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110830285|NCT03716427|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110830286|NCT03716427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110830287|NCT03716427|Antitussive Agents|antitussive agents|mesh-ancestor
110830288|NCT03716427|Respiratory System Agents|respiratory system agents|mesh-ancestor
110830289|NCT03716427|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110830290|NCT03716427|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110830291|NCT03716427|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110830292|NCT01147822|Sunitinib|sunitinib|mesh-list
110830293|NCT01147822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110830294|NCT01147822|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110830295|NCT01147822|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110830296|NCT01147822|Growth Substances|growth substances|mesh-ancestor
110830297|NCT01147822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110830298|NCT01147822|Growth Inhibitors|growth inhibitors|mesh-ancestor
110830299|NCT01147822|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110830301|NCT01147822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110830302|NCT03431337|Amoxicillin|amoxicillin|mesh-list
110830303|NCT03431337|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110830304|NCT03431337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110830305|NCT01293097|Atorvastatin|atorvastatin|mesh-list
110830306|NCT01293097|Pravastatin|pravastatin|mesh-list
110830307|NCT01293097|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110830308|NCT01293097|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110830309|NCT01293097|Antimetabolites|antimetabolites|mesh-ancestor
110830310|NCT01293097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110830311|NCT01293097|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110830312|NCT01293097|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110830313|NCT01293097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110830314|NCT03516292|Mitogens|mitogens|mesh-list
110830315|NCT03516292|Mitosis Modulators|mitosis modulators|mesh-ancestor
110830316|NCT03516292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110830317|NCT01291615|Gemcitabine|gemcitabine|mesh-list
110830318|NCT01291615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110830319|NCT01291615|Antimetabolites|antimetabolites|mesh-ancestor
110830320|NCT01291615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110830321|NCT01291615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110830322|NCT01295047|Atenolol|atenolol|mesh-list
110830323|NCT01295047|Verapamil|verapamil|mesh-list
110830324|NCT01295047|Perindopril|perindopril|mesh-list
110830325|NCT01295047|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110830326|NCT01295047|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110830327|NCT01295047|Sympatholytics|sympatholytics|mesh-ancestor
110830328|NCT01295047|Autonomic Agents|autonomic agents|mesh-ancestor
110830329|NCT01295047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110830330|NCT01295047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110830331|NCT01295047|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110830332|NCT01295047|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110830333|NCT01295047|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110830334|NCT01295047|Adrenergic Agents|adrenergic agents|mesh-ancestor
110830335|NCT01295047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110830336|NCT01295047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110830337|NCT01295047|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110830338|NCT01295047|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110830339|NCT01295047|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110830340|NCT01295047|Vasodilator Agents|vasodilator agents|mesh-ancestor
110830341|NCT01295047|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110830342|NCT01295047|Protease Inhibitors|protease inhibitors|mesh-ancestor
110830343|NCT01295047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110830344|NCT03472846|Teriparatide|teriparatide|mesh-list
110830345|NCT03472846|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110830346|NCT03472846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110830347|NCT03472846|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110830349|NCT01190371|Antimalarials|antimalarials|mesh-ancestor
110830350|NCT01190371|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110830351|NCT01190371|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110830352|NCT01190371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110830353|NCT01190371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110830354|NCT01190371|Antiviral Agents|antiviral agents|mesh-ancestor
110830355|NCT01190371|Schistosomicides|schistosomicides|mesh-ancestor
110830356|NCT01190371|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110830357|NCT01190371|Anthelmintics|anthelmintics|mesh-ancestor
110830358|NCT05158426|Propofol|propofol|mesh-list
110830359|NCT05158426|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110073457|NCT01578343|Hormones|hormones|mesh-ancestor
110183130|NCT00395499|Dopamine Agents|dopamine agents|mesh-ancestor
110830360|NCT05158426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110830361|NCT05158426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110830362|NCT05158426|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110830363|NCT05158426|Anesthetics, General|anesthetics, general|mesh-ancestor
110830365|NCT03853369|Nifekalant|nifekalant|mesh-list
110830366|NCT03853369|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110830367|NCT05158348|Lidocaine|lidocaine|mesh-list
110830368|NCT05158348|Dexmedetomidine|dexmedetomidine|mesh-list
110830369|NCT05158348|Anesthetics, Local|anesthetics, local|mesh-ancestor
110830370|NCT05158348|Anesthetics|anesthetics|mesh-ancestor
110830371|NCT05158348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110830372|NCT05158348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110830373|NCT05158348|Sensory System Agents|sensory system agents|mesh-ancestor
110830374|NCT05158348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110830376|NCT05158348|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110830377|NCT05158348|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110830378|NCT05158348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110830379|NCT05158348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110830380|NCT05158348|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110830381|NCT05158348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110830382|NCT05158348|Analgesics|analgesics|mesh-ancestor
110830383|NCT05158348|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110830384|NCT05158348|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110830385|NCT05158348|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110830386|NCT05158348|Adrenergic Agents|adrenergic agents|mesh-ancestor
110830387|NCT05158348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110830388|NCT01187719|Phenytoin|phenytoin|mesh-list
110830389|NCT01187719|Anticonvulsants|anticonvulsants|mesh-ancestor
110830390|NCT01187719|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110830391|NCT01187719|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110830392|NCT01187719|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110830393|NCT01187719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110830394|NCT01187719|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110830395|NCT01187719|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110830396|NCT01102595|Bevacizumab|bevacizumab|mesh-list
110830397|NCT01102595|Temozolomide|temozolomide|mesh-list
110830398|NCT01102595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110830399|NCT01102595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110830400|NCT01102595|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110830401|NCT01102595|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110830402|NCT01102595|Growth Substances|growth substances|mesh-ancestor
110830403|NCT01102595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110830404|NCT01102595|Growth Inhibitors|growth inhibitors|mesh-ancestor
110830405|NCT01102595|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110830406|NCT01102595|Alkylating Agents|alkylating agents|mesh-ancestor
110830407|NCT01102595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110830408|NCT03949517|Piperidine|piperidine|mesh-list
110830409|NCT03949517|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
110830410|NCT03949517|Bombesin|bombesin|mesh-list
110183143|NCT00395655|Valproic Acid|valproic acid|mesh-list
110871778|NCT01381848|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110830411|NCT03949517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110830413|NCT03949517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110830414|NCT03949517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110830415|NCT03949517|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110830416|NCT03949517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110830417|NCT03949517|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110830418|NCT03848611|Vorolanib|vorolanib|mesh-list
110830419|NCT03848611|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110830420|NCT03848611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110830421|NCT03848611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110830422|NCT01584947|Bupivacaine|bupivacaine|mesh-list
110830423|NCT01584947|Anesthetics, Local|anesthetics, local|mesh-ancestor
110830424|NCT01584947|Anesthetics|anesthetics|mesh-ancestor
110830425|NCT01584947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110830426|NCT01584947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110830427|NCT01584947|Sensory System Agents|sensory system agents|mesh-ancestor
110830428|NCT01584947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110830429|NCT03848767|Insulin Lispro|insulin lispro|mesh-list
110830430|NCT03848767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110830431|NCT03848767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110830432|NCT01109615|Gemcitabine|gemcitabine|mesh-list
110830433|NCT01109615|Pemetrexed|pemetrexed|mesh-list
110830434|NCT01109615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110830435|NCT01109615|Antimetabolites|antimetabolites|mesh-ancestor
110830436|NCT01109615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110830437|NCT01109615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110830438|NCT01109615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110830439|NCT01109615|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110830440|NCT01109615|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110830441|NCT01209065|Ritonavir|ritonavir|mesh-list
110830442|NCT01209065|Fosamprenavir|fosamprenavir|mesh-list
110830443|NCT01209065|Dolutegravir|dolutegravir|mesh-list
110830444|NCT01209065|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110830445|NCT01209065|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110830446|NCT01209065|Protease Inhibitors|protease inhibitors|mesh-ancestor
110830447|NCT01209065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110830448|NCT01209065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110830449|NCT01209065|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110830450|NCT01209065|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110830451|NCT01209065|Antiviral Agents|antiviral agents|mesh-ancestor
110830452|NCT01209065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110830453|NCT01209065|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110830454|NCT01209065|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110830455|NCT01209065|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110830456|NCT01209065|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110830457|NCT02782702|Botulinum Toxins|botulinum toxins|mesh-list
110830458|NCT02782702|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110830459|NCT02782702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110830460|NCT02782702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110830461|NCT02782702|Cholinergic Agents|cholinergic agents|mesh-ancestor
110830462|NCT02782702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110830463|NCT02782702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110830464|NCT01102673|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1h-imidazol-1-yl)propanamido)nicotinic acid|mesh-list
110830465|NCT01102673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110830466|NCT01102673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110830468|NCT03481725|Keratolytic Agents|keratolytic agents|mesh-ancestor
110830469|NCT03481725|Dermatologic Agents|dermatologic agents|mesh-ancestor
110830470|NCT03472456|Eugenol|eugenol|mesh-list
110830471|NCT03472456|Carticaine|carticaine|mesh-list
110830472|NCT03472456|Anesthetics, Local|anesthetics, local|mesh-ancestor
110830473|NCT03472456|Anesthetics|anesthetics|mesh-ancestor
110183171|NCT03959969|Oxycodone|oxycodone|mesh-list
110830474|NCT03472456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110830475|NCT03472456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110830476|NCT03472456|Sensory System Agents|sensory system agents|mesh-ancestor
110830477|NCT03472456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110830478|NCT03472456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110830479|NCT01193881|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110830480|NCT01193881|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
110830481|NCT01193881|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-list
110830482|NCT01193881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110830483|NCT01193881|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110830484|NCT01193881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110830485|NCT01193881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110830486|NCT01194037|Interferons|interferons|mesh-list
110830487|NCT01194037|Interferon-alpha|interferon-alpha|mesh-list
110830488|NCT01194037|Interferon alpha-2|interferon alpha-2|mesh-list
110830489|NCT01194037|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110830490|NCT01194037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110830491|NCT01194037|Antiviral Agents|antiviral agents|mesh-ancestor
110830492|NCT01194037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110830493|NCT01194037|Immunologic Factors|immunologic factors|mesh-ancestor
110830494|NCT01194037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110830495|NCT03480243|Erythromycin|erythromycin|mesh-list
110830496|NCT03480243|Erythromycin Estolate|erythromycin estolate|mesh-list
110830497|NCT03480243|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
110830498|NCT03480243|Erythromycin stearate|erythromycin stearate|mesh-list
110830499|NCT03480243|Padsevonil|padsevonil|mesh-list
110830500|NCT03480243|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110830501|NCT03480243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110830502|NCT03480243|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110830503|NCT03480243|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110830504|NCT03480243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110830505|NCT03480243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110830506|NCT03480243|Anticonvulsants|anticonvulsants|mesh-ancestor
110830507|NCT01109693|Mirtazapine|mirtazapine|mesh-list
110830508|NCT01109693|Sertraline|sertraline|mesh-list
110830509|NCT01109693|Antidepressive Agents|antidepressive agents|mesh-ancestor
110830510|NCT01109693|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110830511|NCT01109693|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110830512|NCT01109693|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110830513|NCT01109693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110073617|NCT01579058|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110830514|NCT01109693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110830515|NCT01109693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110830516|NCT01109693|Serotonin Agents|serotonin agents|mesh-ancestor
110830517|NCT01109693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110548055|NCT00691236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110830518|NCT01109693|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110830519|NCT01109693|Histamine Antagonists|histamine antagonists|mesh-ancestor
110830520|NCT01109693|Histamine Agents|histamine agents|mesh-ancestor
110830521|NCT01109693|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110830522|NCT01109693|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110830523|NCT01109693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110830524|NCT01109693|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
110830525|NCT01109693|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110830526|NCT01109693|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110830527|NCT01109693|Adrenergic Agents|adrenergic agents|mesh-ancestor
110830528|NCT01109693|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110830529|NCT01109693|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110830530|NCT01109693|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110830531|NCT01190683|Calcium, Dietary|calcium, dietary|mesh-list
110830532|NCT01190683|Vitamin D|vitamin d|mesh-list
110830533|NCT01190683|Ergocalciferols|ergocalciferols|mesh-list
110830534|NCT01190683|Cholecalciferol|cholecalciferol|mesh-list
110830535|NCT01190683|Vitamins|vitamins|mesh-list
110830536|NCT01190683|Calcium Carbonate|calcium carbonate|mesh-list
110830537|NCT01190683|Calcium|calcium|mesh-list
110830538|NCT01190683|Micronutrients|micronutrients|mesh-ancestor
110830539|NCT01190683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110830540|NCT01190683|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110830541|NCT01190683|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110830542|NCT01190683|Antacids|antacids|mesh-ancestor
110830543|NCT01190683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110830544|NCT01190683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110830545|NCT01190761|Galantamine|galantamine|mesh-list
110830546|NCT01190761|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110830547|NCT01190761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110830548|NCT01190761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110830549|NCT01190761|Cholinergic Agents|cholinergic agents|mesh-ancestor
110830550|NCT01190761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110830551|NCT01190761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110830552|NCT01190761|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110830553|NCT01190761|Autonomic Agents|autonomic agents|mesh-ancestor
110830554|NCT01190761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110830555|NCT01190761|Nootropic Agents|nootropic agents|mesh-ancestor
110830557|NCT01209455|Chlorpheniramine|chlorpheniramine|mesh-list
110830558|NCT01209455|Ranitidine|ranitidine|mesh-list
110830559|NCT01209455|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
110830560|NCT01209455|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110830561|NCT01209455|Analgesics|analgesics|mesh-ancestor
110830562|NCT01209455|Sensory System Agents|sensory system agents|mesh-ancestor
110830563|NCT01209455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110830564|NCT01209455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110830565|NCT01209455|Antipyretics|antipyretics|mesh-ancestor
110830566|NCT01209455|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110830567|NCT01209455|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110830568|NCT01209455|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110830569|NCT01209455|Histamine Antagonists|histamine antagonists|mesh-ancestor
110830570|NCT01209455|Histamine Agents|histamine agents|mesh-ancestor
110830571|NCT01209455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110830572|NCT01209455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110830573|NCT01209455|Antipruritics|antipruritics|mesh-ancestor
110830574|NCT01209455|Dermatologic Agents|dermatologic agents|mesh-ancestor
110830575|NCT01209455|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110830576|NCT01209455|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110830577|NCT01194115|Metronidazole|metronidazole|mesh-list
110830578|NCT01194115|Cephalexin|cephalexin|mesh-list
110830579|NCT01194115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110830580|NCT01194115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110830581|NCT01194115|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110830582|NCT01194115|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110830584|NCT01209533|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110830585|NCT01209533|Vasodilator Agents|vasodilator agents|mesh-ancestor
110830586|NCT03847363|Anesthetics|anesthetics|mesh-list
110830587|NCT03847363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110830588|NCT03847363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110830589|NCT01207739|Hydroxychloroquine|hydroxychloroquine|mesh-list
110830590|NCT01207739|Doxycycline|doxycycline|mesh-list
110830591|NCT01207739|Clarithromycin|clarithromycin|mesh-list
110830592|NCT01207739|Antimalarials|antimalarials|mesh-ancestor
110830593|NCT01207739|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110830594|NCT01207739|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110830595|NCT01207739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110830596|NCT01207739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110830597|NCT01207739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110830598|NCT01207739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110830599|NCT01207739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110830600|NCT01207739|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110830601|NCT01207739|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110830602|NCT01207739|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110830603|NCT03941951|Anti-Infective Agents|anti-infective agents|mesh-list
110830604|NCT03941951|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110830605|NCT03847207|Pasireotide|pasireotide|mesh-list
110830607|NCT03847207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110830608|NCT03847207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110830609|NCT01192087|Cetuximab|cetuximab|mesh-list
110830610|NCT01192087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110830611|NCT01192087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110830612|NCT03942029|Fluconazole|fluconazole|mesh-list
110830613|NCT03942029|Antifungal Agents|antifungal agents|mesh-ancestor
110830614|NCT03942029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110830615|NCT03942029|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110830616|NCT03942029|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110830617|NCT03942029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110830618|NCT03942029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110830619|NCT03942029|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110073733|NCT01579630|Pemetrexed|pemetrexed|mesh-list
110830620|NCT03942029|Hormone Antagonists|hormone antagonists|mesh-ancestor
110830621|NCT03942029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110830622|NCT03942029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110830623|NCT03942029|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110183233|NCT00028431|Ipilimumab|ipilimumab|mesh-list
110830624|NCT03942029|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110830625|NCT03740945|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
110830626|NCT03740945|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110830627|NCT03740945|Immunologic Factors|immunologic factors|mesh-ancestor
110830628|NCT03740945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110830630|NCT01192165|Docetaxel|docetaxel|mesh-list
110830631|NCT01192165|Carboplatin|carboplatin|mesh-list
110830632|NCT01192165|Pemetrexed|pemetrexed|mesh-list
110830633|NCT01192165|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110830634|NCT01192165|Trametinib|trametinib|mesh-list
110830635|NCT01192165|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110830636|NCT01192165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110830637|NCT01192165|Tubulin Modulators|tubulin modulators|mesh-ancestor
110830638|NCT01192165|Antimitotic Agents|antimitotic agents|mesh-ancestor
110830639|NCT01192165|Mitosis Modulators|mitosis modulators|mesh-ancestor
110830640|NCT01192165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110830642|NCT01192165|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110830643|NCT01192165|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110830644|NCT01192165|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110830645|NCT01192243|Carboplatin|carboplatin|mesh-list
110830646|NCT01192243|Pemetrexed|pemetrexed|mesh-list
110830647|NCT01192243|Gefitinib|gefitinib|mesh-list
110830648|NCT01192243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110830649|NCT01192243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110830650|NCT01192243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110830651|NCT01192243|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110830652|NCT01192243|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110830653|NCT01192243|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110830654|NCT01209845|Ketamine|ketamine|mesh-list
110830655|NCT01209845|Analgesics|analgesics|mesh-ancestor
110830656|NCT01209845|Sensory System Agents|sensory system agents|mesh-ancestor
110830657|NCT01209845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110830658|NCT01209845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110830659|NCT01209845|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110830660|NCT01209845|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110830661|NCT01209845|Anesthetics, General|anesthetics, general|mesh-ancestor
110830662|NCT01209845|Anesthetics|anesthetics|mesh-ancestor
110830663|NCT01209845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110830664|NCT01209845|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110830665|NCT01209845|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110830666|NCT01209845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110830667|NCT01209845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110548217|NCT00721552|Prednisolone|prednisolone|mesh-list
110830668|NCT01112813|Lithium Carbonate|lithium carbonate|mesh-list
110830669|NCT01112813|Antidepressive Agents|antidepressive agents|mesh-ancestor
110830670|NCT01112813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110830671|NCT01112813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110830672|NCT01112813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110830673|NCT01112813|Antimanic Agents|antimanic agents|mesh-ancestor
110830674|NCT01112813|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110183252|NCT04733196|Hydrogen Peroxide|hydrogen peroxide|mesh-list
110830675|NCT01112813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110830676|NCT01112813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110830677|NCT01196767|Ropivacaine|ropivacaine|mesh-list
110830678|NCT01196767|Anesthetics, Local|anesthetics, local|mesh-ancestor
110830679|NCT01196767|Anesthetics|anesthetics|mesh-ancestor
110830680|NCT01196767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110830681|NCT01196767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110830682|NCT01196767|Sensory System Agents|sensory system agents|mesh-ancestor
110830683|NCT01196767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110830684|NCT03451773|Gemcitabine|gemcitabine|mesh-list
110830685|NCT03451773|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110830686|NCT03451773|Antimetabolites|antimetabolites|mesh-ancestor
110830687|NCT03451773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110830688|NCT03451773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110830689|NCT01112891|Vitamin D|vitamin d|mesh-list
110830690|NCT01112891|Ergocalciferols|ergocalciferols|mesh-list
110830691|NCT01112891|Cholecalciferol|cholecalciferol|mesh-list
110830692|NCT01112891|Vitamins|vitamins|mesh-list
110830693|NCT01112891|Micronutrients|micronutrients|mesh-ancestor
110073867|NCT01583972|Retinol palmitate|retinol palmitate|mesh-list
110830694|NCT01112891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110830695|NCT01112891|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110830696|NCT01112891|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110830698|NCT03847441|Cholecalciferol|cholecalciferol|mesh-list
110830699|NCT03847441|Calcipotriene|calcipotriene|mesh-list
110830700|NCT03847441|Vitamins|vitamins|mesh-ancestor
110830701|NCT03847441|Micronutrients|micronutrients|mesh-ancestor
110830702|NCT03847441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110830703|NCT03847441|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110830704|NCT03847441|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110830705|NCT03847441|Dermatologic Agents|dermatologic agents|mesh-ancestor
110830706|NCT02529683|NuvaRing|nuvaring|mesh-list
110830707|NCT02529683|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110830708|NCT02529683|Contraceptive Agents|contraceptive agents|mesh-ancestor
110830709|NCT02529683|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110830710|NCT02529683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110830711|NCT05406895|Lidocaine|lidocaine|mesh-list
110830712|NCT05406895|Epinephrine|epinephrine|mesh-list
110830713|NCT05406895|Anesthetics, Local|anesthetics, local|mesh-ancestor
110830714|NCT05406895|Anesthetics|anesthetics|mesh-ancestor
110830715|NCT05406895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110830716|NCT05406895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110830717|NCT05406895|Sensory System Agents|sensory system agents|mesh-ancestor
110830718|NCT05406895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110830719|NCT05406895|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110830720|NCT05406895|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110887239|NCT02586675|Tamoxifen|tamoxifen|mesh-list
110830721|NCT05406895|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110830722|NCT05406895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110830723|NCT05406895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110830724|NCT05406895|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110830725|NCT05406895|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110830726|NCT05406895|Adrenergic Agents|adrenergic agents|mesh-ancestor
110830727|NCT05406895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110830728|NCT05406895|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110830729|NCT05406895|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110830730|NCT05406895|Autonomic Agents|autonomic agents|mesh-ancestor
110830731|NCT05406895|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110830732|NCT05406895|Respiratory System Agents|respiratory system agents|mesh-ancestor
110830733|NCT05406895|Mydriatics|mydriatics|mesh-ancestor
110830734|NCT05406895|Sympathomimetics|sympathomimetics|mesh-ancestor
110830735|NCT05406895|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110830736|NCT03425253|Lidocaine|lidocaine|mesh-list
110183285|NCT00028743|Paclitaxel|paclitaxel|mesh-list
110830737|NCT03425253|Anesthetics, Local|anesthetics, local|mesh-ancestor
110830738|NCT03425253|Anesthetics|anesthetics|mesh-ancestor
110830739|NCT03425253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110830740|NCT03425253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110830741|NCT03425253|Sensory System Agents|sensory system agents|mesh-ancestor
110830742|NCT03425253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110830743|NCT03425253|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110830744|NCT03425253|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110830745|NCT03425253|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110830746|NCT03425253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110830747|NCT03425253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110830748|NCT03941561|Tegafur|tegafur|mesh-list
110830749|NCT03941561|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110830750|NCT03941561|Antimetabolites|antimetabolites|mesh-ancestor
110830751|NCT03941561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110830752|NCT03941561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110830753|NCT05403229|Topiramate|topiramate|mesh-list
110830754|NCT05403229|Anticonvulsants|anticonvulsants|mesh-ancestor
110830755|NCT05403229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110830756|NCT05403229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110830757|NCT03424239|Vitamin D|vitamin d|mesh-list
110830758|NCT03424239|Ergocalciferols|ergocalciferols|mesh-list
110830759|NCT03424239|Cholecalciferol|cholecalciferol|mesh-list
110830760|NCT03424239|Zoledronic Acid|zoledronic acid|mesh-list
110830762|NCT03424239|Micronutrients|micronutrients|mesh-ancestor
110830763|NCT03424239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110830764|NCT03424239|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110830765|NCT03424239|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110830766|NCT03941795|Axitinib|axitinib|mesh-list
110830767|NCT03941795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110830768|NCT03941795|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110830769|NCT03941795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110830770|NCT03941795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110830771|NCT01197001|Losartan|losartan|mesh-list
110830772|NCT01197001|Amlodipine|amlodipine|mesh-list
110830773|NCT01197001|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110830774|NCT01197001|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110887269|NCT01813929|Metformin|metformin|mesh-list
110830775|NCT01197001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110830776|NCT01197001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110830777|NCT01197001|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110830778|NCT01197001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110830779|NCT01197001|Vasodilator Agents|vasodilator agents|mesh-ancestor
110830780|NCT01197001|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110830781|NCT01197001|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110830782|NCT01197001|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110830783|NCT01113047|Amlodipine|amlodipine|mesh-list
110830784|NCT01113047|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110830785|NCT01113047|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110830786|NCT01113047|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110830787|NCT01113047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110830788|NCT01113047|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110830789|NCT01113047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110830790|NCT01113047|Vasodilator Agents|vasodilator agents|mesh-ancestor
110830791|NCT01113125|Fusidic Acid|fusidic acid|mesh-list
110830792|NCT01113125|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110830793|NCT01113125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110830794|NCT01113125|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110830795|NCT01113125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110830796|NCT01113125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110830798|NCT01210391|Chelating Agents|chelating agents|mesh-ancestor
110830799|NCT01210391|Sequestering Agents|sequestering agents|mesh-ancestor
110830800|NCT01210391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110830801|NCT03846739|Oxytocin|oxytocin|mesh-list
110830802|NCT03846739|Oxytocics|oxytocics|mesh-ancestor
110183301|NCT03959501|Incretins|incretins|mesh-ancestor
110830803|NCT03846739|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110830804|NCT03846739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110830805|NCT03716115|Budesonide|budesonide|mesh-list
110830806|NCT03716115|Teduglutide|teduglutide|mesh-list
110830807|NCT03716115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110830808|NCT03716115|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110830809|NCT03716115|Autonomic Agents|autonomic agents|mesh-ancestor
110830810|NCT03716115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110830811|NCT03716115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110830812|NCT03716115|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110830813|NCT03716115|Respiratory System Agents|respiratory system agents|mesh-ancestor
110830814|NCT03716115|Glucocorticoids|glucocorticoids|mesh-ancestor
110830815|NCT03716115|Hormones|hormones|mesh-ancestor
110830816|NCT03716115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110830817|NCT03716115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110830818|NCT03716115|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110830819|NCT03716115|Protective Agents|protective agents|mesh-ancestor
110830820|NCT01113281|Vaccines|vaccines|mesh-list
110830821|NCT01113281|Immunologic Factors|immunologic factors|mesh-ancestor
110830822|NCT01113281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110830823|NCT01295593|Cladribine|cladribine|mesh-list
110830824|NCT01295593|Valproic Acid|valproic acid|mesh-list
110830825|NCT01295593|Anticonvulsants|anticonvulsants|mesh-ancestor
110830826|NCT01295593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110830827|NCT01295593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110830828|NCT01295593|GABA Agents|gaba agents|mesh-ancestor
110830829|NCT01295593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110830830|NCT01295593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110830831|NCT01295593|Antimanic Agents|antimanic agents|mesh-ancestor
110830832|NCT01295593|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110830833|NCT01295593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110830834|NCT01295593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110830835|NCT01295593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110830836|NCT01295593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110830837|NCT01295593|Immunologic Factors|immunologic factors|mesh-ancestor
110830838|NCT03845881|Oxycodone|oxycodone|mesh-list
110830839|NCT03845881|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110830840|NCT03845881|Narcotics|narcotics|mesh-ancestor
110830841|NCT03845881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110830842|NCT03845881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110830843|NCT03845881|Analgesics|analgesics|mesh-ancestor
110830844|NCT03845881|Sensory System Agents|sensory system agents|mesh-ancestor
110830845|NCT03845881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110830846|NCT01197157|Nitazoxanide|nitazoxanide|mesh-list
110830847|NCT01197157|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110830848|NCT01197157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110830849|NCT01296997|Calcium|calcium|mesh-list
110830850|NCT01296997|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110830851|NCT01296997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110830852|NCT01114841|Tazarotene|tazarotene|mesh-list
110830853|NCT01114841|Dermatologic Agents|dermatologic agents|mesh-ancestor
110830854|NCT01114841|Keratolytic Agents|keratolytic agents|mesh-ancestor
110830855|NCT01113437|Omalizumab|omalizumab|mesh-list
110830856|NCT01113437|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110830857|NCT01113437|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110830858|NCT01113437|Respiratory System Agents|respiratory system agents|mesh-ancestor
110830859|NCT01197235|Darbepoetin alfa|darbepoetin alfa|mesh-list
110830860|NCT01197235|Hematinics|hematinics|mesh-ancestor
110830861|NCT01192789|Amoxicillin|amoxicillin|mesh-list
110830862|NCT01192789|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110830863|NCT01192789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110830864|NCT01211171|Telmisartan|telmisartan|mesh-list
110830865|NCT01211171|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110830866|NCT01211171|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110830867|NCT01211171|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110830868|NCT01211171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110830869|NCT03846973|Tranexamic Acid|tranexamic acid|mesh-list
110830870|NCT03846973|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110830871|NCT03846973|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110830872|NCT03846973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110830873|NCT03846973|Hemostatics|hemostatics|mesh-ancestor
110830874|NCT03846973|Coagulants|coagulants|mesh-ancestor
110830875|NCT01113515|Esmolol|esmolol|mesh-list
110830876|NCT01113515|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110830877|NCT01113515|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110830878|NCT01113515|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110830879|NCT01113515|Adrenergic Agents|adrenergic agents|mesh-ancestor
110830880|NCT01113515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110830881|NCT01113515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110830882|NCT01113515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110830883|NCT01211327|Cyclosporine|cyclosporine|mesh-list
110830884|NCT01211327|Dexamethasone|dexamethasone|mesh-list
110830885|NCT01211327|Cyclosporins|cyclosporins|mesh-list
110830886|NCT01211327|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110830887|NCT01211327|Antiemetics|antiemetics|mesh-ancestor
110830888|NCT01211327|Autonomic Agents|autonomic agents|mesh-ancestor
110830889|NCT01211327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110830890|NCT01211327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110548434|NCT04186871|Abatacept|abatacept|mesh-list
110830891|NCT01211327|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110830892|NCT01211327|Glucocorticoids|glucocorticoids|mesh-ancestor
110830893|NCT01211327|Hormones|hormones|mesh-ancestor
110830894|NCT01211327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110830895|NCT01211327|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110830896|NCT01211327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110830897|NCT01211327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110830898|NCT01211327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110830899|NCT01211327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110830900|NCT01211327|Immunologic Factors|immunologic factors|mesh-ancestor
110830901|NCT01211327|Antifungal Agents|antifungal agents|mesh-ancestor
110830902|NCT01211327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110830903|NCT01211327|Dermatologic Agents|dermatologic agents|mesh-ancestor
110830904|NCT01211327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110830905|NCT01211327|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110830907|NCT05601895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110830908|NCT05601895|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110830909|NCT05601895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110830910|NCT05601895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110830911|NCT01113671|Vitamin E|vitamin e|mesh-list
110830912|NCT01113671|Tocopherols|tocopherols|mesh-list
110830913|NCT01113671|alpha-Tocopherol|alpha-tocopherol|mesh-list
110830914|NCT01113671|Vitamins|vitamins|mesh-ancestor
110830915|NCT01113671|Micronutrients|micronutrients|mesh-ancestor
110830916|NCT01113671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110830917|NCT01113671|Antioxidants|antioxidants|mesh-ancestor
110887326|NCT03647670|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110830918|NCT01113671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110830920|NCT03943043|Paclitaxel|paclitaxel|mesh-list
110830921|NCT03943043|Gemcitabine|gemcitabine|mesh-list
110830922|NCT03943043|Oxaliplatin|oxaliplatin|mesh-list
110830923|NCT03943043|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110830924|NCT03943043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110830925|NCT03943043|Tubulin Modulators|tubulin modulators|mesh-ancestor
110830926|NCT03943043|Antimitotic Agents|antimitotic agents|mesh-ancestor
110830927|NCT03943043|Mitosis Modulators|mitosis modulators|mesh-ancestor
110830928|NCT03943043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110830929|NCT03943043|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110830931|NCT01109927|Insulin|insulin|mesh-list
110830932|NCT01109927|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110830933|NCT01109927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110830934|NCT01211795|Ketoprofen|ketoprofen|mesh-list
110830935|NCT01211795|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110830936|NCT01211795|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110830937|NCT01211795|Analgesics|analgesics|mesh-ancestor
110830938|NCT01211795|Sensory System Agents|sensory system agents|mesh-ancestor
110830939|NCT01211795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110830940|NCT01211795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110830941|NCT01211795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110830942|NCT01211795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110830943|NCT01211795|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110830944|NCT01211795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110830945|NCT01211795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110830946|NCT01193491|Geldanamycin|geldanamycin|mesh-list
110830947|NCT01193491|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110830948|NCT01193491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110830949|NCT01193491|Antiviral Agents|antiviral agents|mesh-ancestor
110830950|NCT01193491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110830951|NCT01193491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110830952|NCT01193491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110830953|NCT01193491|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
110830954|NCT01193491|Protease Inhibitors|protease inhibitors|mesh-ancestor
110830955|NCT01110317|Paliperidone Palmitate|paliperidone palmitate|mesh-list
110830956|NCT01110317|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110830957|NCT01110317|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110830958|NCT01110317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110830959|NCT01110317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110830960|NCT01110317|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110830961|NCT01110317|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110830962|NCT01110317|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110830963|NCT01110317|Serotonin Agents|serotonin agents|mesh-ancestor
110830964|NCT01110317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110830965|NCT01110317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110830966|NCT01110317|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110830967|NCT01110317|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110830968|NCT01110317|Dopamine Agents|dopamine agents|mesh-ancestor
110830969|NCT01208285|Ivacaftor|ivacaftor|mesh-list
110830970|NCT01208285|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
110830971|NCT01208285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110830972|NCT01208285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110830974|NCT01208363|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110830975|NCT01208363|Chelating Agents|chelating agents|mesh-ancestor
110830976|NCT01208363|Sequestering Agents|sequestering agents|mesh-ancestor
110887363|NCT05205837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110830977|NCT01208363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110830978|NCT01208441|Letrozole|letrozole|mesh-list
110871779|NCT01381848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110830979|NCT01208441|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
110830980|NCT01208441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110830981|NCT01208441|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110830982|NCT01208441|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110830983|NCT01208441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110830984|NCT01208441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110830985|NCT01208441|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110830986|NCT01208441|Hormone Antagonists|hormone antagonists|mesh-ancestor
110183329|NCT00028860|Carboplatin|carboplatin|mesh-list
110830987|NCT01208441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110830988|NCT01208441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110830989|NCT01208441|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
110830990|NCT03718377|Anesthetics|anesthetics|mesh-list
110830991|NCT03718377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110830992|NCT03718377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110830993|NCT01197469|Tadalafil|tadalafil|mesh-list
110830994|NCT01197469|Vasodilator Agents|vasodilator agents|mesh-ancestor
110830995|NCT01197469|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110074444|NCT01593033|Micronutrients|micronutrients|mesh-list
110830996|NCT01197469|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110830998|NCT01197469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110830999|NCT01197469|Urological Agents|urological agents|mesh-ancestor
110831000|NCT01211561|Selenium|selenium|mesh-list
110831001|NCT01211561|Antioxidants|antioxidants|mesh-ancestor
110831002|NCT01211561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110831003|NCT01211561|Protective Agents|protective agents|mesh-ancestor
110831004|NCT01211561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110831005|NCT01211561|Trace Elements|trace elements|mesh-ancestor
110831006|NCT01211561|Micronutrients|micronutrients|mesh-ancestor
110831007|NCT01213355|Scopolamine|scopolamine|mesh-list
110831008|NCT01213355|Donepezil|donepezil|mesh-list
110831009|NCT01213355|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
110831010|NCT01213355|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110831011|NCT01213355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110831012|NCT01213355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110831013|NCT01213355|Cholinergic Agents|cholinergic agents|mesh-ancestor
110831014|NCT01213355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110831015|NCT01213355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110831016|NCT01213355|Nootropic Agents|nootropic agents|mesh-ancestor
110831017|NCT01213355|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110831018|NCT01213355|Antiemetics|antiemetics|mesh-ancestor
110831019|NCT01213355|Autonomic Agents|autonomic agents|mesh-ancestor
110831020|NCT01213355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110831021|NCT01213355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110831022|NCT01213355|Mydriatics|mydriatics|mesh-ancestor
110831023|NCT01213355|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110831024|NCT01213355|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110831025|NCT01213355|Parasympatholytics|parasympatholytics|mesh-ancestor
110831026|NCT03938363|Botulinum Toxins|botulinum toxins|mesh-list
110831027|NCT03938363|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110831028|NCT03938363|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110831029|NCT03938363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110831030|NCT03938363|Cholinergic Agents|cholinergic agents|mesh-ancestor
110831031|NCT03938363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110831032|NCT03938363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110831033|NCT03848065|Vaccines|vaccines|mesh-list
110831034|NCT03848065|Immunologic Factors|immunologic factors|mesh-ancestor
110831035|NCT03848065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110831037|NCT01110473|Ilorasertib|ilorasertib|mesh-list
110831038|NCT01110473|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110831039|NCT01110473|Antimetabolites|antimetabolites|mesh-ancestor
110831040|NCT01110473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110074781|NCT01594619|Diltiazem|diltiazem|mesh-list
110831041|NCT01110473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110831042|NCT01110473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110831043|NCT01110473|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110831044|NCT05558761|Pentoxifylline|pentoxifylline|mesh-list
110074845|NCT01594918|Prednisone|prednisone|mesh-list
110831045|NCT05558761|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110831046|NCT05558761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110831047|NCT05558761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110831048|NCT05558761|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110831049|NCT05558761|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110831050|NCT05558761|Protective Agents|protective agents|mesh-ancestor
110831051|NCT05558761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110831052|NCT05558761|Vasodilator Agents|vasodilator agents|mesh-ancestor
110831053|NCT05558761|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110831054|NCT05558761|Antioxidants|antioxidants|mesh-ancestor
110831055|NCT03940391|Chlorpheniramine|chlorpheniramine|mesh-list
110831056|NCT03940391|Midazolam|midazolam|mesh-list
110831057|NCT03940391|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110831058|NCT03940391|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110831059|NCT03940391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110831060|NCT03940391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110831061|NCT03940391|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110831062|NCT03940391|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110831063|NCT03940391|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110831064|NCT03940391|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110831065|NCT03940391|Anesthetics, General|anesthetics, general|mesh-ancestor
110831067|NCT03940391|GABA Modulators|gaba modulators|mesh-ancestor
110831068|NCT03940391|GABA Agents|gaba agents|mesh-ancestor
110831069|NCT03940391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110831070|NCT03940391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110831071|NCT03940391|Antipruritics|antipruritics|mesh-ancestor
110831072|NCT03940391|Dermatologic Agents|dermatologic agents|mesh-ancestor
110831073|NCT03940391|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110831074|NCT03940391|Histamine Antagonists|histamine antagonists|mesh-ancestor
110831075|NCT03940391|Histamine Agents|histamine agents|mesh-ancestor
110831076|NCT03940391|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110831078|NCT03715881|Epoetin Alfa|epoetin alfa|mesh-list
110831079|NCT03715881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110831080|NCT03715881|Glucocorticoids|glucocorticoids|mesh-ancestor
110831081|NCT03715881|Hormones|hormones|mesh-ancestor
110831082|NCT03715881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110831083|NCT03715881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110831084|NCT03715881|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110831085|NCT03715881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110831086|NCT03715881|Hematinics|hematinics|mesh-ancestor
110831087|NCT01197781|Verapamil|verapamil|mesh-list
110831088|NCT01197781|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110831089|NCT01197781|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110871780|NCT04546620|Prednisolone|prednisolone|mesh-list
110831090|NCT01197781|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110831091|NCT01197781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110831092|NCT01197781|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110831093|NCT01197781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110831094|NCT01197781|Vasodilator Agents|vasodilator agents|mesh-ancestor
110831095|NCT01110551|Vaccines|vaccines|mesh-list
110831096|NCT01110551|Immunologic Factors|immunologic factors|mesh-ancestor
110831097|NCT01110551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110831098|NCT01296139|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
110831099|NCT01296139|Hematinics|hematinics|mesh-ancestor
110831100|NCT01296139|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
110831101|NCT01296139|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110831102|NCT03940469|Dexamethasone|dexamethasone|mesh-list
110831103|NCT03940469|Dexamethasone acetate|dexamethasone acetate|mesh-list
110831104|NCT03940469|Dexmedetomidine|dexmedetomidine|mesh-list
110831105|NCT03940469|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110831106|NCT03940469|Antiemetics|antiemetics|mesh-ancestor
110831107|NCT03940469|Autonomic Agents|autonomic agents|mesh-ancestor
110831108|NCT03940469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110831109|NCT03940469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110831110|NCT03940469|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110287657|NCT00214682|Vitamins|vitamins|mesh-ancestor
110831111|NCT03940469|Glucocorticoids|glucocorticoids|mesh-ancestor
110831112|NCT03940469|Hormones|hormones|mesh-ancestor
110831113|NCT03940469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110831114|NCT03940469|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110831115|NCT03940469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110831116|NCT03940469|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110831117|NCT03940469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110831118|NCT03940469|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110831119|NCT03940469|Analgesics|analgesics|mesh-ancestor
110831120|NCT03940469|Sensory System Agents|sensory system agents|mesh-ancestor
110831121|NCT03940469|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110831122|NCT03940469|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110831123|NCT03940469|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110831124|NCT03940469|Adrenergic Agents|adrenergic agents|mesh-ancestor
110831125|NCT03940469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110831126|NCT03940469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110831127|NCT01110785|Panitumumab|panitumumab|mesh-list
110831128|NCT01110785|Simvastatin|simvastatin|mesh-list
110831129|NCT01110785|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110831130|NCT01110785|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110831131|NCT01110785|Antimetabolites|antimetabolites|mesh-ancestor
110831132|NCT01110785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110831133|NCT01110785|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110831134|NCT01110785|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110831135|NCT01110785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110831136|NCT01110785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110831137|NCT01110785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110831139|NCT03846271|Oxytocics|oxytocics|mesh-ancestor
110831140|NCT03846271|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110831141|NCT03846271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110831143|NCT01110941|Oxaliplatin|oxaliplatin|mesh-list
110831144|NCT01110941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110831145|NCT01110941|Antidotes|antidotes|mesh-ancestor
110831146|NCT01110941|Protective Agents|protective agents|mesh-ancestor
110831147|NCT01110941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110831148|NCT01110941|Vitamin B Complex|vitamin b complex|mesh-ancestor
110831149|NCT01110941|Vitamins|vitamins|mesh-ancestor
110831150|NCT01110941|Micronutrients|micronutrients|mesh-ancestor
110831151|NCT03448419|Empagliflozin|empagliflozin|mesh-list
110831152|NCT03448419|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110831153|NCT03448419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110831154|NCT03448419|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110831155|NCT03448419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110831156|NCT01118039|Sunitinib|sunitinib|mesh-list
110831157|NCT01118039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110831158|NCT01118039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110831159|NCT01118039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110831160|NCT01118039|Growth Substances|growth substances|mesh-ancestor
110831161|NCT01118039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110831162|NCT01118039|Growth Inhibitors|growth inhibitors|mesh-ancestor
110831163|NCT01118039|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110831164|NCT01118039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110831165|NCT01118039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110831166|NCT01213433|Artesunate|artesunate|mesh-list
110831167|NCT01213433|Amodiaquine|amodiaquine|mesh-list
110831168|NCT01213433|Antimalarials|antimalarials|mesh-ancestor
110831169|NCT01213433|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110183375|NCT00028938|Hematinics|hematinics|mesh-ancestor
110831170|NCT01213433|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110831171|NCT01213433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110831172|NCT01213433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110831173|NCT01213433|Antiviral Agents|antiviral agents|mesh-ancestor
110831174|NCT01213433|Schistosomicides|schistosomicides|mesh-ancestor
110831175|NCT01213433|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110831176|NCT01213433|Anthelmintics|anthelmintics|mesh-ancestor
110831177|NCT03848533|Metformin|metformin|mesh-list
110831178|NCT03848533|Melatonin|melatonin|mesh-list
110075561|NCT01598051|Antithrombins|antithrombins|mesh-ancestor
110831179|NCT03848533|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110831180|NCT03848533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110831181|NCT03848533|Antioxidants|antioxidants|mesh-ancestor
110831182|NCT03848533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110831183|NCT03848533|Protective Agents|protective agents|mesh-ancestor
110831184|NCT03848533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110831185|NCT01111253|Amoxicillin|amoxicillin|mesh-list
110831186|NCT01111253|Clavulanic Acid|clavulanic acid|mesh-list
110831187|NCT01111253|Clavulanic Acids|clavulanic acids|mesh-list
110831188|NCT01111253|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
110831189|NCT01111253|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110831190|NCT01111253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110831191|NCT01111253|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110887447|NCT04284657|Citric Acid|citric acid|mesh-list
110548738|NCT04070482|Tenofovir|tenofovir|mesh-list
110831193|NCT01111253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110831194|NCT01213667|Ranibizumab|ranibizumab|mesh-list
110831195|NCT01213667|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110831196|NCT01213667|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110831197|NCT01213667|Growth Substances|growth substances|mesh-ancestor
110831198|NCT01213667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110831199|NCT01213667|Growth Inhibitors|growth inhibitors|mesh-ancestor
110831200|NCT01213667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110831201|NCT01196065|Memantine|memantine|mesh-list
110831202|NCT01196065|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110831203|NCT01196065|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110831204|NCT01196065|Dopamine Agents|dopamine agents|mesh-ancestor
110831205|NCT01196065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110831206|NCT01196065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110831207|NCT01196065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110831208|NCT01196065|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110075667|NCT01598623|Oxytocin|oxytocin|mesh-list
110831209|NCT01196065|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110831211|NCT05258773|Antiemetics|antiemetics|mesh-ancestor
110831212|NCT05258773|Autonomic Agents|autonomic agents|mesh-ancestor
110831213|NCT05258773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110831214|NCT05258773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110831215|NCT05258773|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110075728|NCT01599078|Paclitaxel|paclitaxel|mesh-list
110831216|NCT05258773|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110831217|NCT05258773|Serotonin Agents|serotonin agents|mesh-ancestor
110831218|NCT05258773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110831219|NCT05258773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110831220|NCT03845179|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110831221|NCT03845179|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
110831222|NCT03845179|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110831223|NCT03845179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110831224|NCT03845179|Incretins|incretins|mesh-ancestor
110831225|NCT03845179|Hormones|hormones|mesh-ancestor
110183391|NCT03959150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110831226|NCT03845179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110831227|NCT03845179|Protease Inhibitors|protease inhibitors|mesh-ancestor
110831228|NCT03845179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110831229|NCT03845179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110831230|NCT01121705|Interferons|interferons|mesh-list
110831231|NCT01121705|Ribavirin|ribavirin|mesh-list
110831232|NCT01121705|Interferon-alpha|interferon-alpha|mesh-list
110831233|NCT01121705|Interferon alpha-2|interferon alpha-2|mesh-list
110831234|NCT01121705|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110831235|NCT01121705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110831236|NCT01121705|Antiviral Agents|antiviral agents|mesh-ancestor
110831237|NCT01121705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110831238|NCT01121705|Antimetabolites|antimetabolites|mesh-ancestor
110831239|NCT01121705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110831240|NCT01121705|Immunologic Factors|immunologic factors|mesh-ancestor
110831241|NCT01121705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110831242|NCT01196455|Capecitabine|capecitabine|mesh-list
110831243|NCT01196455|Mitomycins|mitomycins|mesh-list
110831244|NCT01196455|Mitomycin|mitomycin|mesh-list
110831245|NCT01196455|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110831246|NCT01196455|Antimetabolites|antimetabolites|mesh-ancestor
110831247|NCT01196455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110831248|NCT01196455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110831249|NCT01196455|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110831250|NCT01196455|Alkylating Agents|alkylating agents|mesh-ancestor
110831251|NCT01196455|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110831252|NCT01196455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110831253|NCT03846583|Trastuzumab|trastuzumab|mesh-list
110831254|NCT03846583|Tucatinib|tucatinib|mesh-list
110831256|NCT03846583|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110831257|NCT03846583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110831258|NCT03846583|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110831259|NCT03846583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110831260|NCT03846583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110831261|NCT03846583|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110831262|NCT03846583|Hormone Antagonists|hormone antagonists|mesh-ancestor
110831263|NCT03846583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110831264|NCT03846583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110075831|NCT05689983|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110831265|NCT03846583|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110831266|NCT01115543|Calcitriol|calcitriol|mesh-list
110831267|NCT01115543|Alfacalcidol|alfacalcidol|mesh-list
110831268|NCT01115543|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
110831269|NCT01115543|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110831270|NCT01115543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110831271|NCT01115543|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
110831272|NCT01115543|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110831273|NCT01115543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110831274|NCT01115543|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110831275|NCT01115543|Vitamins|vitamins|mesh-ancestor
110831276|NCT01115543|Micronutrients|micronutrients|mesh-ancestor
110831277|NCT01115543|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110831279|NCT01216007|Sevoflurane|sevoflurane|mesh-list
110831280|NCT01216007|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110831281|NCT01216007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110831282|NCT01216007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110831283|NCT01216007|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110831284|NCT01216007|Anesthetics, General|anesthetics, general|mesh-ancestor
110831286|NCT01216007|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110831287|NCT01216007|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110831288|NCT01198249|Losartan|losartan|mesh-list
110831289|NCT01198249|Amlodipine|amlodipine|mesh-list
110831290|NCT01198249|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110831291|NCT01198249|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110831292|NCT01198249|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110831293|NCT01198249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110076125|NCT04541173|Bevacizumab|bevacizumab|mesh-list
110831294|NCT01198249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110831295|NCT01198249|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110831296|NCT01198249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110831297|NCT01198249|Vasodilator Agents|vasodilator agents|mesh-ancestor
110831298|NCT01198249|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110831299|NCT01198249|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110831300|NCT01198249|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110831301|NCT01198249|Diuretics|diuretics|mesh-ancestor
110831302|NCT01198249|Natriuretic Agents|natriuretic agents|mesh-ancestor
110831303|NCT01198249|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110831305|NCT02529761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110831306|NCT02529761|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110831307|NCT02529761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110831308|NCT02529761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110831309|NCT03844243|Mitogens|mitogens|mesh-list
110831310|NCT03844243|Mitosis Modulators|mitosis modulators|mesh-ancestor
110831311|NCT03844243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110831312|NCT05479591|Xultophy|xultophy|mesh-list
110831313|NCT05479591|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110831314|NCT05479591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110831315|NCT05479591|Incretins|incretins|mesh-ancestor
110831316|NCT05479591|Hormones|hormones|mesh-ancestor
110831317|NCT05479591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110831318|NCT01119209|Ropivacaine|ropivacaine|mesh-list
110831319|NCT01119209|Anesthetics, Local|anesthetics, local|mesh-ancestor
110831320|NCT01119209|Anesthetics|anesthetics|mesh-ancestor
110831321|NCT01119209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110831322|NCT01119209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110831323|NCT01119209|Sensory System Agents|sensory system agents|mesh-ancestor
110831324|NCT01119209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110831325|NCT01213901|Insulin Lispro|insulin lispro|mesh-list
110831326|NCT01213901|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110831327|NCT01213901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110831328|NCT01116167|Letrozole|letrozole|mesh-list
110831329|NCT01116167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110831330|NCT01116167|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110831331|NCT01116167|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110831332|NCT01116167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110831333|NCT01116167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110831334|NCT01116167|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110831335|NCT01116167|Hormone Antagonists|hormone antagonists|mesh-ancestor
110831336|NCT01116167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110831337|NCT01116167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110831338|NCT01119521|Isoniazid|isoniazid|mesh-list
110831339|NCT01119521|Antitubercular Agents|antitubercular agents|mesh-ancestor
110831340|NCT01119521|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110831341|NCT01119521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110831342|NCT01119521|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
110831343|NCT01119521|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110831344|NCT01119521|Antimetabolites|antimetabolites|mesh-ancestor
110831345|NCT01119521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110831346|NCT01119521|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110831347|NCT03939923|Glycopyrrolate|glycopyrrolate|mesh-list
110831348|NCT03939923|Rocuronium|rocuronium|mesh-list
110831349|NCT03939923|Neostigmine|neostigmine|mesh-list
110831350|NCT03939923|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110831351|NCT03939923|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110831352|NCT03939923|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110831353|NCT03939923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110831354|NCT03939923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110831355|NCT03939923|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110831356|NCT03939923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110831357|NCT03939923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110831358|NCT03939923|Cholinergic Agents|cholinergic agents|mesh-ancestor
110831359|NCT03939923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110831360|NCT03939923|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110831361|NCT03939923|Autonomic Agents|autonomic agents|mesh-ancestor
110831362|NCT03939923|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110831363|NCT03939923|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110831364|NCT03939923|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110831365|NCT01119599|Temozolomide|temozolomide|mesh-list
110831366|NCT01119599|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
110831367|NCT01119599|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-list
110831368|NCT01119599|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110831369|NCT01119599|Alkylating Agents|alkylating agents|mesh-ancestor
110831370|NCT01119599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110831371|NCT01119599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110831372|NCT01119599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110831373|NCT03419403|Temozolomide|temozolomide|mesh-list
110831374|NCT03419403|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
110831375|NCT03419403|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110831376|NCT03419403|ABT-414|abt-414|mesh-list
110831377|NCT03419403|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110831378|NCT03419403|Alkylating Agents|alkylating agents|mesh-ancestor
110831379|NCT03419403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110831380|NCT03419403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110831381|NCT03419403|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110831382|NCT03419403|Immunoconjugates|immunoconjugates|mesh-ancestor
110831383|NCT03419403|Immunologic Factors|immunologic factors|mesh-ancestor
110831384|NCT03419403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110831385|NCT05156437|Amoxicillin|amoxicillin|mesh-list
110831386|NCT05156437|Vancomycin|vancomycin|mesh-list
110831387|NCT05156437|Levofloxacin|levofloxacin|mesh-list
110831388|NCT05156437|Rifampin|rifampin|mesh-list
110831390|NCT05156437|Linezolid|linezolid|mesh-list
110831391|NCT05156437|Daptomycin|daptomycin|mesh-list
110831392|NCT05156437|Cephalexin|cephalexin|mesh-list
110831393|NCT05156437|Ampicillin|ampicillin|mesh-list
110831395|NCT05156437|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
110831396|NCT05156437|Oxacillin|oxacillin|mesh-list
110831397|NCT05156437|Dicloxacillin|dicloxacillin|mesh-list
110831398|NCT05156437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110076538|NCT04558892|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110076539|NCT04558892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110076540|NCT04077515|Sirolimus|sirolimus|mesh-list
110076541|NCT04077515|Temsirolimus|temsirolimus|mesh-list
110076542|NCT04077515|MTOR Inhibitors|mtor inhibitors|mesh-list
110076543|NCT04077515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110076544|NCT04077515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110076545|NCT04077515|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110076546|NCT04077515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110076547|NCT04077515|Antifungal Agents|antifungal agents|mesh-ancestor
110831399|NCT05156437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110831400|NCT05156437|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110831401|NCT05156437|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110831402|NCT05156437|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110831403|NCT05156437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110831404|NCT05156437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110831405|NCT05156437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110831406|NCT05156437|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110831407|NCT05156437|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110831408|NCT05156437|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110831409|NCT05156437|Antitubercular Agents|antitubercular agents|mesh-ancestor
110183431|NCT00029679|Borage oil|borage oil|mesh-list
110831410|NCT05156437|Leprostatic Agents|leprostatic agents|mesh-ancestor
110831411|NCT05156437|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110831412|NCT05156437|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110831413|NCT05156437|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110831414|NCT05156437|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110548955|NCT00873366|Tamoxifen|tamoxifen|mesh-list
110831415|NCT05156437|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110831416|NCT05156437|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110831417|NCT05156437|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110831418|NCT05156437|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110831419|NCT01119677|Interferon beta-1a|interferon beta-1a|mesh-list
110831420|NCT01119677|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110831421|NCT01119677|Immunologic Factors|immunologic factors|mesh-ancestor
110831422|NCT01119677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110831423|NCT01119677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110831424|NCT01119677|Antiviral Agents|antiviral agents|mesh-ancestor
110831425|NCT01119677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110831427|NCT03715725|Rivaroxaban|rivaroxaban|mesh-list
110831428|NCT03715725|Dabigatran|dabigatran|mesh-list
110831429|NCT03715725|Apixaban|apixaban|mesh-list
110831430|NCT03715725|Anticoagulants|anticoagulants|mesh-ancestor
110831431|NCT03715725|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110831432|NCT03715725|Antithrombins|antithrombins|mesh-ancestor
110831433|NCT03715725|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110831434|NCT03715725|Protease Inhibitors|protease inhibitors|mesh-ancestor
110076659|NCT03624127|Apremilast|apremilast|mesh-list
110831435|NCT03715725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110831436|NCT03715725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110831437|NCT01212653|Golimumab|golimumab|mesh-list
110831438|NCT01212653|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110831439|NCT01212653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110831440|NCT01212653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110831441|NCT01212653|Immunologic Factors|immunologic factors|mesh-ancestor
110831442|NCT01212653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110831444|NCT01213979|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
110831445|NCT01213979|Ferric Compounds|ferric compounds|mesh-list
110831446|NCT01213979|Trace Elements|trace elements|mesh-ancestor
110831447|NCT01213979|Micronutrients|micronutrients|mesh-ancestor
110831448|NCT01213979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110831449|NCT01213979|Hematinics|hematinics|mesh-ancestor
110831450|NCT05282719|Azacitidine|azacitidine|mesh-list
110831451|NCT05282719|Venetoclax|venetoclax|mesh-list
110076879|NCT01746173|Plerixafor|plerixafor|mesh-list
110831452|NCT05282719|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110831453|NCT05282719|Antimetabolites|antimetabolites|mesh-ancestor
110831454|NCT05282719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110831455|NCT05282719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110831456|NCT05282719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110831457|NCT01118429|Oxybutynin|oxybutynin|mesh-list
110831458|NCT01118429|Parasympatholytics|parasympatholytics|mesh-ancestor
110831459|NCT01118429|Autonomic Agents|autonomic agents|mesh-ancestor
110831460|NCT01118429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110076943|NCT03187769|Antiemetics|antiemetics|mesh-ancestor
110831461|NCT01118429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110831462|NCT01118429|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110831463|NCT01118429|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110831464|NCT01118429|Cholinergic Agents|cholinergic agents|mesh-ancestor
110831465|NCT01118429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110831466|NCT01118429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110831467|NCT01118429|Urological Agents|urological agents|mesh-ancestor
110831468|NCT03447249|Ivacaftor|ivacaftor|mesh-list
110831469|NCT03447249|VX-659|vx-659|mesh-list
110831470|NCT03447249|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
110831471|NCT03447249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110831472|NCT03447249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110831473|NCT04156555|Amoxicillin|amoxicillin|mesh-list
110831474|NCT04156555|Clavulanic Acid|clavulanic acid|mesh-list
110831475|NCT04156555|Clavulanic Acids|clavulanic acids|mesh-list
110831476|NCT04156555|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
110831477|NCT04156555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110831478|NCT04156555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110831479|NCT04156555|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110831480|NCT04156555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110831481|NCT04156555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110831483|NCT01200121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110831484|NCT01200121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110831485|NCT01200121|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110831486|NCT01200121|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110831487|NCT01200121|Growth Substances|growth substances|mesh-ancestor
110831488|NCT01200121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110831489|NCT01200121|Growth Inhibitors|growth inhibitors|mesh-ancestor
110831490|NCT01214291|Toremifene|toremifene|mesh-list
110549028|NCT00687258|Vitamin E|vitamin e|mesh-list
110831491|NCT01214291|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110831492|NCT01214291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110831493|NCT01214291|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110831494|NCT01214291|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110831495|NCT01214291|Hormone Antagonists|hormone antagonists|mesh-ancestor
110831496|NCT01214291|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110831497|NCT01214291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110831498|NCT01214291|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110831499|NCT01116635|Doxorubicin|doxorubicin|mesh-list
110831500|NCT01116635|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110077218|NCT01599871|Purinergic Agents|purinergic agents|mesh-ancestor
110831501|NCT01116635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110831502|NCT01116635|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110831503|NCT01116635|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110831504|NCT01116635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110831505|NCT01116635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110831506|NCT01566799|Metformin|metformin|mesh-list
110831507|NCT01566799|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110831508|NCT01566799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110831509|NCT04642807|Calpastatin|calpastatin|mesh-list
110831510|NCT04642807|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
110831511|NCT04642807|Protease Inhibitors|protease inhibitors|mesh-ancestor
110831512|NCT04642807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110831513|NCT04642807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110831514|NCT01216085|Imatinib Mesylate|imatinib mesylate|mesh-list
110831515|NCT01216085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110831516|NCT01216085|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110831517|NCT01216085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110831518|NCT01216085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110831519|NCT01198639|Remifentanil|remifentanil|mesh-list
110831520|NCT01198639|Propofol|propofol|mesh-list
110831521|NCT01198639|Anesthetics|anesthetics|mesh-list
110831522|NCT01198639|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110077482|NCT01610778|Aminolevulinic Acid|aminolevulinic acid|mesh-list
110831523|NCT01198639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110831524|NCT01198639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110831525|NCT01198639|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110831526|NCT01198639|Anesthetics, General|anesthetics, general|mesh-ancestor
110831527|NCT01198639|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110831529|NCT01198639|Analgesics|analgesics|mesh-ancestor
110077554|NCT01611142|Mogamulizumab|mogamulizumab|mesh-list
110831530|NCT01198639|Sensory System Agents|sensory system agents|mesh-ancestor
110831531|NCT01198639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110831532|NCT01116713|Dexamethasone|dexamethasone|mesh-list
110831533|NCT01116713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110831534|NCT01116713|Antiemetics|antiemetics|mesh-ancestor
110831535|NCT01116713|Autonomic Agents|autonomic agents|mesh-ancestor
110831536|NCT01116713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110831537|NCT01116713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110831538|NCT01116713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110831539|NCT01116713|Glucocorticoids|glucocorticoids|mesh-ancestor
110831540|NCT01116713|Hormones|hormones|mesh-ancestor
110831541|NCT01116713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110831542|NCT01116713|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110831543|NCT01116713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110831544|NCT01202149|Pimecrolimus|pimecrolimus|mesh-list
110831545|NCT01202149|Emollients|emollients|mesh-list
110831546|NCT01202149|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110831547|NCT01202149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110831548|NCT01202149|Analgesics|analgesics|mesh-ancestor
110831549|NCT01202149|Sensory System Agents|sensory system agents|mesh-ancestor
110831550|NCT01202149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110831551|NCT01202149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110831552|NCT01202149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110831553|NCT01202149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110831554|NCT01202149|Dermatologic Agents|dermatologic agents|mesh-ancestor
110831555|NCT01202149|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110831556|NCT01202149|Immunologic Factors|immunologic factors|mesh-ancestor
110831557|NCT01202149|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110831558|NCT01202149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110831559|NCT01202149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110831560|NCT01116791|Cisplatin|cisplatin|mesh-list
110831561|NCT01116791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110831562|NCT03940001|Paclitaxel|paclitaxel|mesh-list
110831564|NCT03940001|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110831565|NCT03940001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110831566|NCT03940001|Tubulin Modulators|tubulin modulators|mesh-ancestor
110831567|NCT03940001|Antimitotic Agents|antimitotic agents|mesh-ancestor
110831568|NCT03940001|Mitosis Modulators|mitosis modulators|mesh-ancestor
110831569|NCT03940001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110831570|NCT01120769|Acetaminophen|acetaminophen|mesh-list
110831571|NCT01120769|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110831572|NCT01120769|Analgesics|analgesics|mesh-ancestor
110831573|NCT01120769|Sensory System Agents|sensory system agents|mesh-ancestor
110831574|NCT01120769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110831575|NCT01120769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110831576|NCT01120769|Antipyretics|antipyretics|mesh-ancestor
110831577|NCT03715413|Tamoxifen|tamoxifen|mesh-list
110831578|NCT03715413|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110831579|NCT03715413|Hormone Antagonists|hormone antagonists|mesh-ancestor
110831580|NCT03715413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110831581|NCT03715413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110831582|NCT03715413|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110831583|NCT03715413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110831584|NCT03715413|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110831585|NCT03715413|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110831586|NCT03715413|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110831587|NCT01122251|Valsartan|valsartan|mesh-list
110831588|NCT01122251|Lercanidipine|lercanidipine|mesh-list
110831589|NCT01122251|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110078023|NCT01613963|Analgesics|analgesics|mesh-ancestor
110831590|NCT01122251|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110831591|NCT01122251|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110831592|NCT01122251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110831593|NCT01122251|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110831594|NCT01122251|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110831595|NCT01122251|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110831596|NCT01122251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110831597|NCT04600999|Favipiravir|favipiravir|mesh-list
110831598|NCT04600999|Antiviral Agents|antiviral agents|mesh-ancestor
110831599|NCT04600999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110831601|NCT01199029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110831602|NCT01199029|Glucocorticoids|glucocorticoids|mesh-ancestor
110831603|NCT01199029|Hormones|hormones|mesh-ancestor
110831604|NCT01199029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110831605|NCT01199029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110831606|NCT01199029|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110831607|NCT01199029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110831608|NCT01200745|Capsaicin|capsaicin|mesh-list
110831609|NCT01200745|Antipruritics|antipruritics|mesh-ancestor
110831610|NCT01200745|Dermatologic Agents|dermatologic agents|mesh-ancestor
110831611|NCT01200745|Sensory System Agents|sensory system agents|mesh-ancestor
110831612|NCT01200745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110831613|NCT01200745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110831614|NCT01585415|Aldesleukin|aldesleukin|mesh-list
110831615|NCT01585415|Cyclophosphamide|cyclophosphamide|mesh-list
110831616|NCT01585415|Fludarabine|fludarabine|mesh-list
110831617|NCT01585415|Vemurafenib|vemurafenib|mesh-list
110831618|NCT01585415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110831619|NCT01585415|Immunologic Factors|immunologic factors|mesh-ancestor
110831620|NCT01585415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110831621|NCT01585415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110831622|NCT01585415|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110831623|NCT01585415|Alkylating Agents|alkylating agents|mesh-ancestor
110831624|NCT01585415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110831625|NCT01585415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110831626|NCT01585415|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110831627|NCT01585415|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110831628|NCT01585415|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110831629|NCT01585415|Antiviral Agents|antiviral agents|mesh-ancestor
110831630|NCT01585415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110831631|NCT01585415|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110831632|NCT01585415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110831633|NCT01566643|Metronidazole|metronidazole|mesh-list
110831634|NCT01566643|Rabeprazole|rabeprazole|mesh-list
110831635|NCT01566643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110831636|NCT01566643|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110831637|NCT01566643|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110831638|NCT01566643|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110831639|NCT01566643|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110831640|NCT01566643|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110831641|NCT01566643|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110831642|NCT01566643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110831643|NCT01566643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110831644|NCT03841747|Paclitaxel|paclitaxel|mesh-list
110831645|NCT03841747|Pembrolizumab|pembrolizumab|mesh-list
110183474|NCT00029874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110831646|NCT03841747|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110831647|NCT03841747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110831648|NCT03841747|Tubulin Modulators|tubulin modulators|mesh-ancestor
110831649|NCT03841747|Antimitotic Agents|antimitotic agents|mesh-ancestor
110831650|NCT03841747|Mitosis Modulators|mitosis modulators|mesh-ancestor
110831651|NCT03841747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110831652|NCT03841747|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110831653|NCT03841747|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110831654|NCT01121237|Epoetin Alfa|epoetin alfa|mesh-list
110831655|NCT01121237|Hematinics|hematinics|mesh-ancestor
110831656|NCT03841591|Metformin|metformin|mesh-list
110831657|NCT03841591|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110831658|NCT03841591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110831659|NCT05667727|Epinephrine|epinephrine|mesh-list
110831660|NCT05667727|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110831661|NCT05667727|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110831662|NCT05667727|Adrenergic Agents|adrenergic agents|mesh-ancestor
110831663|NCT05667727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110831664|NCT05667727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110831665|NCT05667727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110831666|NCT05667727|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110887633|NCT01569945|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110831667|NCT05667727|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110831668|NCT05667727|Autonomic Agents|autonomic agents|mesh-ancestor
110831669|NCT05667727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110831670|NCT05667727|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110831671|NCT05667727|Respiratory System Agents|respiratory system agents|mesh-ancestor
110831672|NCT05667727|Mydriatics|mydriatics|mesh-ancestor
110831673|NCT05667727|Sympathomimetics|sympathomimetics|mesh-ancestor
110831674|NCT05667727|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110831675|NCT01200901|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110831676|NCT01200901|Antidepressive Agents|antidepressive agents|mesh-ancestor
110831677|NCT01200901|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110831678|NCT01200901|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110831679|NCT01200901|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110831680|NCT01200901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110831681|NCT01200901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110831682|NCT01212809|Hyaluronic Acid|hyaluronic acid|mesh-list
110831683|NCT01212809|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110831684|NCT01212809|Immunologic Factors|immunologic factors|mesh-ancestor
110831685|NCT01212809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110831686|NCT01212809|Viscosupplements|viscosupplements|mesh-ancestor
110831687|NCT01212809|Protective Agents|protective agents|mesh-ancestor
110831688|NCT01214993|Dolutegravir|dolutegravir|mesh-list
110831689|NCT01214993|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110831690|NCT01214993|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110831691|NCT01214993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110831692|NCT01214993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110831693|NCT01214993|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110831694|NCT01214993|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110831695|NCT01214993|Antiviral Agents|antiviral agents|mesh-ancestor
110831696|NCT01214993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110831697|NCT03843229|Bufanolides|bufanolides|mesh-list
110831698|NCT03843229|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110831699|NCT03843229|Protective Agents|protective agents|mesh-ancestor
110183517|NCT00030381|Esorubicin|esorubicin|mesh-list
110831700|NCT03843229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110831701|NCT01212887|Aldesleukin|aldesleukin|mesh-list
110078423|NCT01616615|Aspirin|aspirin|mesh-list
110831702|NCT01212887|Cyclophosphamide|cyclophosphamide|mesh-list
110831703|NCT01212887|Fludarabine|fludarabine|mesh-list
110831704|NCT01212887|Fludarabine phosphate|fludarabine phosphate|mesh-list
110831705|NCT01212887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110831706|NCT01212887|Immunologic Factors|immunologic factors|mesh-ancestor
110078493|NCT01616992|Bupivacaine|bupivacaine|mesh-list
110831707|NCT01212887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110831708|NCT01212887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110831709|NCT01212887|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110831710|NCT01212887|Alkylating Agents|alkylating agents|mesh-ancestor
110831711|NCT01212887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110831712|NCT01212887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110831713|NCT01212887|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110078563|NCT01617356|Lidocaine|lidocaine|mesh-list
110831714|NCT01212887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110549249|NCT03415828|Prednisolone phosphate|prednisolone phosphate|mesh-list
110831716|NCT01212887|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110831717|NCT01212887|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110831718|NCT01212887|Antiviral Agents|antiviral agents|mesh-ancestor
110831719|NCT01212887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110831721|NCT01215149|Immunologic Factors|immunologic factors|mesh-ancestor
110831722|NCT01215149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110831723|NCT03843307|Immunologic Factors|immunologic factors|mesh-list
110831724|NCT03843307|Immunomodulating Agents|immunomodulating agents|mesh-list
110831725|NCT03843307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110831726|NCT04961281|Triamcinolone|triamcinolone|mesh-list
110831727|NCT04961281|Dexmedetomidine|dexmedetomidine|mesh-list
110831728|NCT04961281|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110831729|NCT04961281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110831730|NCT04961281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110831731|NCT04961281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110831732|NCT04961281|Analgesics|analgesics|mesh-ancestor
110831733|NCT04961281|Sensory System Agents|sensory system agents|mesh-ancestor
110078836|NCT01618877|Anticonvulsants|anticonvulsants|mesh-ancestor
110831734|NCT04961281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110831735|NCT04961281|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110831736|NCT04961281|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110078911|NCT01619436|Clonidine|clonidine|mesh-list
110831737|NCT04961281|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110831738|NCT04961281|Adrenergic Agents|adrenergic agents|mesh-ancestor
110831739|NCT04961281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110831740|NCT04961281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110831741|NCT04961281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110831742|NCT04961281|Glucocorticoids|glucocorticoids|mesh-ancestor
110831743|NCT04961281|Hormones|hormones|mesh-ancestor
110079056|NCT01620307|Sirolimus|sirolimus|mesh-list
110831744|NCT04961281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110831745|NCT01212965|Selenium|selenium|mesh-list
110831746|NCT01212965|Antioxidants|antioxidants|mesh-ancestor
110831747|NCT01212965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110831748|NCT01212965|Protective Agents|protective agents|mesh-ancestor
110831749|NCT01212965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110831750|NCT01212965|Trace Elements|trace elements|mesh-ancestor
110831751|NCT01212965|Micronutrients|micronutrients|mesh-ancestor
110831752|NCT02529449|Ipragliflozin|ipragliflozin|mesh-list
110831753|NCT02529449|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110831754|NCT02529449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110831755|NCT02529449|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110831756|NCT02529449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110831757|NCT01216709|Iron|iron|mesh-list
110831758|NCT01216709|Trace Elements|trace elements|mesh-ancestor
110831759|NCT01216709|Micronutrients|micronutrients|mesh-ancestor
110288222|NCT00244920|Squalamine|squalamine|mesh-list
110831760|NCT01216709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110871781|NCT04546620|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110831761|NCT01216787|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
110831762|NCT01216787|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
110831763|NCT01216787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110831764|NCT01216787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110831766|NCT05282251|Anesthetics, Local|anesthetics, local|mesh-ancestor
110831767|NCT05282251|Anesthetics|anesthetics|mesh-ancestor
110831768|NCT05282251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110831769|NCT05282251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110831770|NCT05282251|Sensory System Agents|sensory system agents|mesh-ancestor
110831771|NCT05282251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110831772|NCT01199341|Warfarin|warfarin|mesh-list
110831773|NCT01199341|Anticoagulants|anticoagulants|mesh-ancestor
110831774|NCT01215539|Panitumumab|panitumumab|mesh-list
110831775|NCT01215539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110831776|NCT01215539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110831777|NCT01203709|Mycophenolic Acid|mycophenolic acid|mesh-list
110831778|NCT01203709|Tacrolimus|tacrolimus|mesh-list
110831779|NCT01203709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110831780|NCT01203709|Immunologic Factors|immunologic factors|mesh-ancestor
110079453|NCT01622439|Antimanic Agents|antimanic agents|mesh-ancestor
110831781|NCT01203709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110831782|NCT01203709|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110831783|NCT01203709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110831784|NCT01203709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110831785|NCT01203709|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110831786|NCT01203709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110831787|NCT01203709|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110831788|NCT01203709|Antitubercular Agents|antitubercular agents|mesh-ancestor
110831789|NCT01203709|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110831790|NCT01203709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110831792|NCT01122407|Trimethaphan camsylate|trimethaphan camsylate|mesh-list
110831793|NCT01122407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110831794|NCT01122407|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110831795|NCT01122407|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110831796|NCT01122407|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
110831797|NCT01122407|Autonomic Agents|autonomic agents|mesh-ancestor
110831798|NCT01122407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110831799|NCT01122407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110831800|NCT01122407|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
110871782|NCT04546620|Methylprednisolone|methylprednisolone|mesh-list
110831801|NCT01122407|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110831802|NCT01122407|Cholinergic Agents|cholinergic agents|mesh-ancestor
110831803|NCT01122407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110831804|NCT01122407|Vasodilator Agents|vasodilator agents|mesh-ancestor
110831805|NCT01213121|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110831806|NCT01213121|Antidepressive Agents|antidepressive agents|mesh-ancestor
110831807|NCT01213121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110831808|NCT01213121|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110831809|NCT01213121|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110831810|NCT01213121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110831811|NCT01213121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110831813|NCT01124435|Carboplatin|carboplatin|mesh-list
110831814|NCT01124435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110831815|NCT01124435|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110831816|NCT01124435|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110831817|NCT01124435|Analgesics|analgesics|mesh-ancestor
110831818|NCT01124435|Sensory System Agents|sensory system agents|mesh-ancestor
110831819|NCT01124435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110831820|NCT01124435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110831821|NCT01124435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110831822|NCT01124435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110831823|NCT01124435|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110079869|NCT01625715|Ketotifen|ketotifen|mesh-list
110831824|NCT01124435|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110831825|NCT01124435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110831826|NCT01124435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110831827|NCT03294304|Gemcitabine|gemcitabine|mesh-list
110831828|NCT03294304|Nivolumab|nivolumab|mesh-list
110831829|NCT03294304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110079935|NCT01626222|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110831830|NCT03294304|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110831831|NCT03294304|Antimetabolites|antimetabolites|mesh-ancestor
110831832|NCT03294304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110831833|NCT03294304|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110831834|NCT03294304|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110831835|NCT01201213|Anesthetics|anesthetics|mesh-list
110831836|NCT01201213|Anesthetics, Local|anesthetics, local|mesh-list
110080075|NCT01627223|Entecavir|entecavir|mesh-list
110831837|NCT01201213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110831838|NCT01201213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110831839|NCT01201213|Sensory System Agents|sensory system agents|mesh-ancestor
110831840|NCT01201213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110831841|NCT03472378|Celecoxib|celecoxib|mesh-list
110831842|NCT03472378|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110831843|NCT03472378|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110831844|NCT03472378|Analgesics|analgesics|mesh-ancestor
110831845|NCT03472378|Sensory System Agents|sensory system agents|mesh-ancestor
110831846|NCT03472378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110831847|NCT03472378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110831848|NCT03472378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110831849|NCT03472378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110831850|NCT03472378|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110080211|NCT01627717|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110831851|NCT03472378|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110831852|NCT03472378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110831853|NCT03472378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110831854|NCT03408873|Aripiprazole|aripiprazole|mesh-list
110831855|NCT03408873|Antidepressive Agents|antidepressive agents|mesh-ancestor
110831856|NCT03408873|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110831857|NCT03408873|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110831858|NCT03408873|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110831859|NCT03408873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110831860|NCT03408873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110831861|NCT03408873|Dopamine Agonists|dopamine agonists|mesh-ancestor
110831862|NCT03408873|Dopamine Agents|dopamine agents|mesh-ancestor
110549398|NCT00655772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110831863|NCT03408873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110831864|NCT03408873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110831865|NCT03408873|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110080345|NCT01628952|Curare|curare|mesh-list
110831866|NCT03408873|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110831867|NCT03408873|Serotonin Agents|serotonin agents|mesh-ancestor
110831868|NCT03408873|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110831869|NCT03408873|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110831870|NCT03408873|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110831871|NCT03408873|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110831872|NCT03715101|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110831873|NCT03715101|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110831874|NCT03715101|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110831876|NCT03715101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110831877|NCT03715101|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110831878|NCT03715101|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110080484|NCT01629680|Moxaverine|moxaverine|mesh-list
110831879|NCT03715101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110831881|NCT03780959|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110831882|NCT03780959|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110831884|NCT03780959|Sensory System Agents|sensory system agents|mesh-ancestor
110831885|NCT03780959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110831886|NCT03780959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110831887|NCT03780959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110831888|NCT03780959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110831889|NCT03780959|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110831890|NCT03780959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110831891|NCT03780959|Immunologic Factors|immunologic factors|mesh-ancestor
110831892|NCT03838783|Insulin|insulin|mesh-list
110831893|NCT03838783|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110831894|NCT03838783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110831895|NCT03408639|Vitamin B 12|vitamin b 12|mesh-list
110831896|NCT03408639|Hydroxocobalamin|hydroxocobalamin|mesh-list
110831897|NCT03408639|Epoetin Alfa|epoetin alfa|mesh-list
110831898|NCT03408639|Vitamins|vitamins|mesh-ancestor
110831899|NCT03408639|Micronutrients|micronutrients|mesh-ancestor
110831900|NCT03408639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110831901|NCT03408639|Vitamin B Complex|vitamin b complex|mesh-ancestor
110831902|NCT03408639|Hematinics|hematinics|mesh-ancestor
110831903|NCT01219205|Bevacizumab|bevacizumab|mesh-list
110831904|NCT01219205|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110831905|NCT01219205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110831906|NCT01219205|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110831907|NCT01219205|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110831908|NCT01219205|Growth Substances|growth substances|mesh-ancestor
110831909|NCT01219205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110831910|NCT01219205|Growth Inhibitors|growth inhibitors|mesh-ancestor
110831911|NCT03810235|Lidocaine|lidocaine|mesh-list
110831912|NCT03810235|Anesthetics, Local|anesthetics, local|mesh-ancestor
110831913|NCT03810235|Anesthetics|anesthetics|mesh-ancestor
110831914|NCT03810235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110831915|NCT03810235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110831916|NCT03810235|Sensory System Agents|sensory system agents|mesh-ancestor
110831917|NCT03810235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110831918|NCT03810235|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110831919|NCT03810235|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110831920|NCT03810235|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110831921|NCT03810235|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110831922|NCT03810235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110831923|NCT03408483|Epinephrine|epinephrine|mesh-list
110183572|NCT00030615|Decitabine|decitabine|mesh-list
110831924|NCT03408483|Analgesics, Opioid|analgesics, opioid|mesh-list
110831925|NCT03408483|Bupivacaine|bupivacaine|mesh-list
110831926|NCT03408483|Anesthetics, Local|anesthetics, local|mesh-ancestor
110831927|NCT03408483|Anesthetics|anesthetics|mesh-ancestor
110831928|NCT03408483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110831929|NCT03408483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110831930|NCT03408483|Sensory System Agents|sensory system agents|mesh-ancestor
110831931|NCT03408483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110831932|NCT03408483|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110831933|NCT03408483|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110831934|NCT03408483|Adrenergic Agents|adrenergic agents|mesh-ancestor
110831935|NCT03408483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110831936|NCT03408483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110080867|NCT01632046|Dialysis Solutions|dialysis solutions|mesh-list
110831937|NCT03408483|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110831938|NCT03408483|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110831940|NCT03408483|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110831941|NCT03408483|Respiratory System Agents|respiratory system agents|mesh-ancestor
110831942|NCT03408483|Mydriatics|mydriatics|mesh-ancestor
110831943|NCT03408483|Sympathomimetics|sympathomimetics|mesh-ancestor
110831944|NCT03408483|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110831945|NCT03408483|Narcotics|narcotics|mesh-ancestor
110831946|NCT03408483|Analgesics|analgesics|mesh-ancestor
110831947|NCT03777917|Hyaluronic Acid|hyaluronic acid|mesh-list
110831948|NCT03777917|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110831949|NCT03777917|Immunologic Factors|immunologic factors|mesh-ancestor
110831950|NCT03777917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110831951|NCT03777917|Viscosupplements|viscosupplements|mesh-ancestor
110831952|NCT03777917|Protective Agents|protective agents|mesh-ancestor
110831953|NCT03715023|PC-786|pc-786|mesh-list
110831954|NCT03715023|Antiviral Agents|antiviral agents|mesh-ancestor
110831955|NCT03715023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110831956|NCT03715023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110831957|NCT03715023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110831958|NCT03714867|Pregabalin|pregabalin|mesh-list
110831959|NCT03714867|Analgesics|analgesics|mesh-ancestor
110831960|NCT03714867|Sensory System Agents|sensory system agents|mesh-ancestor
110831961|NCT03714867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110831962|NCT03714867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110831963|NCT03714867|Anticonvulsants|anticonvulsants|mesh-ancestor
110831964|NCT03714867|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110831965|NCT03714867|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110831966|NCT03714867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110831967|NCT03714867|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110831968|NCT03714867|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110831969|NCT03714867|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110831970|NCT03714867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110831971|NCT03714867|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110831973|NCT01204177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110831974|NCT01204177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110831975|NCT01204177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110831976|NCT01204177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110831977|NCT01217099|Azithromycin|azithromycin|mesh-list
110831978|NCT01217099|Methylprednisolone|methylprednisolone|mesh-list
110831979|NCT01217099|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110831980|NCT01217099|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110887688|NCT04052178|Capsaicin|capsaicin|mesh-list
110831982|NCT01217099|Prednisolone acetate|prednisolone acetate|mesh-list
110831983|NCT01217099|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110831984|NCT01217099|Prednisolone phosphate|prednisolone phosphate|mesh-list
110831985|NCT01217099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110831986|NCT01217099|Antiemetics|antiemetics|mesh-ancestor
110831987|NCT01217099|Autonomic Agents|autonomic agents|mesh-ancestor
110831988|NCT01217099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110831989|NCT01217099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110831990|NCT01217099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110831991|NCT01217099|Glucocorticoids|glucocorticoids|mesh-ancestor
110831992|NCT01217099|Hormones|hormones|mesh-ancestor
110831993|NCT01217099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110831994|NCT01217099|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110831995|NCT01217099|Protective Agents|protective agents|mesh-ancestor
110831996|NCT01217099|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110831997|NCT01217099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110831998|NCT01217099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110831999|NCT01217099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110832000|NCT04305457|Nitric Oxide|nitric oxide|mesh-list
110832001|NCT04305457|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110832002|NCT04305457|Autonomic Agents|autonomic agents|mesh-ancestor
110832003|NCT04305457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110832004|NCT04305457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110832005|NCT04305457|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110832006|NCT04305457|Respiratory System Agents|respiratory system agents|mesh-ancestor
110832007|NCT04305457|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110832009|NCT04305457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110832010|NCT04305457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110832011|NCT04305457|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
110832012|NCT04305457|Vasodilator Agents|vasodilator agents|mesh-ancestor
110832013|NCT04305457|Gasotransmitters|gasotransmitters|mesh-ancestor
110832014|NCT04305457|Protective Agents|protective agents|mesh-ancestor
110832015|NCT01122563|Solifenacin Succinate|solifenacin succinate|mesh-list
110832016|NCT01122563|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110832017|NCT01122563|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110832018|NCT01122563|Cholinergic Agents|cholinergic agents|mesh-ancestor
110832019|NCT01122563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110832020|NCT01122563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110832021|NCT01122563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110832022|NCT01122563|Urological Agents|urological agents|mesh-ancestor
110832024|NCT01217177|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110832025|NCT01217177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110832026|NCT01217177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110832027|NCT01217177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110832028|NCT01217177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110832029|NCT01217177|Immunologic Factors|immunologic factors|mesh-ancestor
110832030|NCT01217177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110832031|NCT01217177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110832033|NCT01204333|Anticoagulants|anticoagulants|mesh-ancestor
110832034|NCT01204333|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110832035|NCT01204333|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110832036|NCT01204333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110832037|NCT02529059|Tenofovir|tenofovir|mesh-list
110832038|NCT02529059|Emtricitabine|emtricitabine|mesh-list
110832039|NCT02529059|Rilpivirine|rilpivirine|mesh-list
110832040|NCT02529059|Antiviral Agents|antiviral agents|mesh-ancestor
110832041|NCT02529059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110832042|NCT02529059|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110832043|NCT02529059|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110887711|NCT03768492|Caffeine|caffeine|mesh-list
110832044|NCT02529059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110832045|NCT02529059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110832046|NCT02529059|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110832047|NCT02529059|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110832048|NCT03100058|Licogliflozin|licogliflozin|mesh-list
110832049|NCT03100058|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110832050|NCT03100058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110832051|NCT03100058|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110832052|NCT03100058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110832054|NCT03933761|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110832055|NCT03933761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110832056|NCT03933761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110832057|NCT03933761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110832058|NCT03932123|Vancomycin|vancomycin|mesh-list
110832060|NCT03932123|Tazobactam|tazobactam|mesh-list
110832061|NCT03932123|Piperacillin|piperacillin|mesh-list
110832062|NCT03932123|Cefotaxime|cefotaxime|mesh-list
110832063|NCT03932123|Cefoxitin|cefoxitin|mesh-list
110832064|NCT03932123|Azlocillin|azlocillin|mesh-list
110832065|NCT03932123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110832066|NCT03932123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110832067|NCT03932123|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110832068|NCT03932123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110832069|NCT03932123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110832070|NCT02866279|Contraceptive Agents|contraceptive agents|mesh-list
110832071|NCT02866279|Etonogestrel|etonogestrel|mesh-list
110832072|NCT02866279|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110832073|NCT02866279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110832074|NCT02866279|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110832075|NCT02866279|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110832076|NCT01222169|Propofol|propofol|mesh-list
110832077|NCT01222169|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110832078|NCT01222169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110081650|NCT01636908|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110832079|NCT01222169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110832080|NCT01222169|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110832081|NCT01222169|Anesthetics, General|anesthetics, general|mesh-ancestor
110832082|NCT01222169|Anesthetics|anesthetics|mesh-ancestor
110832083|NCT02871778|Ivacaftor|ivacaftor|mesh-list
110832084|NCT02871778|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
110832085|NCT02871778|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110081713|NCT01637233|Antimetabolites|antimetabolites|mesh-ancestor
110832086|NCT02871778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110832087|NCT04947592|Fluconazole|fluconazole|mesh-list
110832088|NCT04947592|Antifungal Agents|antifungal agents|mesh-ancestor
110832089|NCT04947592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110832090|NCT04947592|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110081781|NCT01637545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110832091|NCT04947592|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110832092|NCT04947592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110832093|NCT04947592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110832094|NCT04947592|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110832095|NCT04947592|Hormone Antagonists|hormone antagonists|mesh-ancestor
110832096|NCT04947592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110832097|NCT04947592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110832098|NCT04947592|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110832099|NCT04947592|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110832100|NCT02735473|Choline|choline|mesh-list
110832101|NCT02735473|Lipotropic Agents|lipotropic agents|mesh-ancestor
110832102|NCT02735473|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110832103|NCT02735473|Antimetabolites|antimetabolites|mesh-ancestor
110832104|NCT02735473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110832105|NCT02735473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110832106|NCT02735473|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110832109|NCT04199767|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110832110|NCT04199767|Insulin, Isophane|insulin, isophane|mesh-list
110832111|NCT04199767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110832112|NCT04199767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110832113|NCT01125059|Methadone|methadone|mesh-list
110832114|NCT01125059|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110832115|NCT01125059|Narcotics|narcotics|mesh-ancestor
110832116|NCT01125059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110832117|NCT01125059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110832118|NCT01125059|Analgesics|analgesics|mesh-ancestor
110832119|NCT01125059|Sensory System Agents|sensory system agents|mesh-ancestor
110832120|NCT01125059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110832121|NCT01125059|Antitussive Agents|antitussive agents|mesh-ancestor
110832122|NCT01125059|Respiratory System Agents|respiratory system agents|mesh-ancestor
110832123|NCT01204411|Artesunate|artesunate|mesh-list
110832124|NCT01204411|Amodiaquine|amodiaquine|mesh-list
110832125|NCT01204411|Antimalarials|antimalarials|mesh-ancestor
110832126|NCT01204411|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110832127|NCT01204411|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110832128|NCT01204411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110832129|NCT01204411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110832130|NCT01204411|Antiviral Agents|antiviral agents|mesh-ancestor
110832131|NCT01204411|Schistosomicides|schistosomicides|mesh-ancestor
110832132|NCT01204411|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110832133|NCT01204411|Anthelmintics|anthelmintics|mesh-ancestor
110832134|NCT01471444|Methotrexate|methotrexate|mesh-list
110832135|NCT01471444|Fludarabine phosphate|fludarabine phosphate|mesh-list
110832136|NCT01471444|Clofarabine|clofarabine|mesh-list
110832137|NCT01471444|Fludarabine|fludarabine|mesh-list
110832138|NCT01471444|Busulfan|busulfan|mesh-list
110832139|NCT01471444|Tacrolimus|tacrolimus|mesh-list
110832140|NCT01471444|Thymoglobulin|thymoglobulin|mesh-list
110832141|NCT01471444|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110832142|NCT01471444|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110832143|NCT01471444|Abortifacient Agents|abortifacient agents|mesh-ancestor
110832144|NCT01471444|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110832145|NCT01471444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110832146|NCT01471444|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110832147|NCT01471444|Antimetabolites|antimetabolites|mesh-ancestor
110832148|NCT01471444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110832149|NCT01471444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110832150|NCT01471444|Dermatologic Agents|dermatologic agents|mesh-ancestor
110832151|NCT01471444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110832152|NCT01471444|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110832153|NCT01471444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110832154|NCT01471444|Immunologic Factors|immunologic factors|mesh-ancestor
110832155|NCT01471444|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110832156|NCT01471444|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110832157|NCT01471444|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110832158|NCT01471444|Alkylating Agents|alkylating agents|mesh-ancestor
110832159|NCT01471444|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110832160|NCT01471444|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110832161|NCT05282407|Tenofovir|tenofovir|mesh-list
110082023|NCT01638663|Tolvaptan|tolvaptan|mesh-list
110832162|NCT05282407|Antiviral Agents|antiviral agents|mesh-ancestor
110832163|NCT05282407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110549703|NCT00713986|Tin Fluorides|tin fluorides|mesh-list
110832164|NCT05282407|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110832165|NCT05282407|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110832167|NCT05282407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110832168|NCT05282407|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110832169|NCT05282407|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110832170|NCT01125215|Capsaicin|capsaicin|mesh-list
110832172|NCT01125215|Dermatologic Agents|dermatologic agents|mesh-ancestor
110832173|NCT01125215|Sensory System Agents|sensory system agents|mesh-ancestor
110832174|NCT01125215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110832175|NCT01125215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110832176|NCT01217723|Thymoglobulin|thymoglobulin|mesh-list
110832177|NCT01217723|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110832178|NCT01217723|Immunologic Factors|immunologic factors|mesh-ancestor
110832179|NCT01217723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110832180|NCT01217723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110832181|NCT05162872|Niraparib|niraparib|mesh-list
110832182|NCT05162872|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110832183|NCT05162872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110832184|NCT05162872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110832185|NCT05162872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110832186|NCT01567111|Metomidate|metomidate|mesh-list
110832187|NCT01567111|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110832188|NCT01567111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110832189|NCT01567111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110832190|NCT03955211|Acetaminophen|acetaminophen|mesh-list
110832191|NCT03955211|Ibuprofen|ibuprofen|mesh-list
110832192|NCT03955211|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110832193|NCT03955211|Analgesics|analgesics|mesh-ancestor
110832194|NCT03955211|Sensory System Agents|sensory system agents|mesh-ancestor
110832195|NCT03955211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110832196|NCT03955211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110832197|NCT03955211|Antipyretics|antipyretics|mesh-ancestor
110871783|NCT04546620|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110832198|NCT03955211|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110832199|NCT03955211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110832200|NCT03955211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110832201|NCT03955211|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110832202|NCT03955211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110832203|NCT03955211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110832204|NCT03933605|Midazolam|midazolam|mesh-list
110832205|NCT03933605|Palonosetron|palonosetron|mesh-list
110082437|NCT01648218|Insulin|insulin|mesh-list
110832206|NCT03933605|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110832207|NCT03933605|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110832208|NCT03933605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110832209|NCT03933605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110832210|NCT03933605|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110832211|NCT03933605|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110832212|NCT03933605|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110832213|NCT03933605|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110832214|NCT03933605|Anesthetics, General|anesthetics, general|mesh-ancestor
110832215|NCT03933605|Anesthetics|anesthetics|mesh-ancestor
110832216|NCT03933605|GABA Modulators|gaba modulators|mesh-ancestor
110832217|NCT03933605|GABA Agents|gaba agents|mesh-ancestor
110832218|NCT03933605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110832219|NCT03933605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110832220|NCT03933605|Antiemetics|antiemetics|mesh-ancestor
110832221|NCT03933605|Autonomic Agents|autonomic agents|mesh-ancestor
110832222|NCT03933605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110832223|NCT03933605|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110183648|NCT03823274|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110832224|NCT03933605|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110832225|NCT03933605|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110832226|NCT03933605|Serotonin Agents|serotonin agents|mesh-ancestor
110832227|NCT03714789|Dialysis Solutions|dialysis solutions|mesh-list
110832228|NCT03714789|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110832229|NCT01127477|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
110832230|NCT01127477|Plasma Substitutes|plasma substitutes|mesh-ancestor
110832231|NCT01127477|Blood Substitutes|blood substitutes|mesh-ancestor
110832232|NCT05281861|Lithium Carbonate|lithium carbonate|mesh-list
110832234|NCT05281861|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110832235|NCT05281861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110832236|NCT05281861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110832237|NCT05281861|Antimanic Agents|antimanic agents|mesh-ancestor
110832238|NCT05281861|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110832239|NCT05281861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110832240|NCT05281861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110832241|NCT01311141|Doripenem|doripenem|mesh-list
110832242|NCT01311141|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110832243|NCT01311141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110832244|NCT01122641|Vildagliptin|vildagliptin|mesh-list
110832245|NCT01122641|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110832246|NCT01122641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110832247|NCT01122641|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110082864|NCT01652157|Pancreatin|pancreatin|mesh-list
110832248|NCT01122641|Protease Inhibitors|protease inhibitors|mesh-ancestor
110832249|NCT01122641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110832250|NCT01122641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110832252|NCT03714555|Paclitaxel|paclitaxel|mesh-list
110832253|NCT03714555|Gemcitabine|gemcitabine|mesh-list
110832254|NCT03714555|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110832255|NCT03714555|Folfirinox|folfirinox|mesh-list
110832256|NCT03714555|Disulfiram|disulfiram|mesh-list
110871784|NCT04546620|Prednisolone acetate|prednisolone acetate|mesh-list
110832257|NCT03714555|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110832258|NCT03714555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110832259|NCT03714555|Tubulin Modulators|tubulin modulators|mesh-ancestor
110832260|NCT03714555|Antimitotic Agents|antimitotic agents|mesh-ancestor
110832261|NCT03714555|Mitosis Modulators|mitosis modulators|mesh-ancestor
110832262|NCT03714555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110832263|NCT03714555|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110832264|NCT03714555|Antimetabolites|antimetabolites|mesh-ancestor
110832265|NCT03714555|Trace Elements|trace elements|mesh-ancestor
110832266|NCT03714555|Micronutrients|micronutrients|mesh-ancestor
110832267|NCT03714555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110832268|NCT03714555|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110832269|NCT03714555|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
110832270|NCT03714555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110832271|NCT01125449|Ascorbic Acid|ascorbic acid|mesh-list
110832272|NCT01125449|Vitamins|vitamins|mesh-ancestor
110832273|NCT01125449|Micronutrients|micronutrients|mesh-ancestor
110832274|NCT01125449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110832275|NCT01125449|Antioxidants|antioxidants|mesh-ancestor
110832276|NCT01125449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110832278|NCT01206049|Bevacizumab|bevacizumab|mesh-list
110832279|NCT01206049|Panitumumab|panitumumab|mesh-list
110832280|NCT01206049|Gemcitabine|gemcitabine|mesh-list
110832281|NCT01206049|Capecitabine|capecitabine|mesh-list
110832282|NCT01206049|Oxaliplatin|oxaliplatin|mesh-list
110832283|NCT01206049|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110832284|NCT01206049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110083105|NCT01653067|Dexamethasone|dexamethasone|mesh-list
110832285|NCT01206049|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110832286|NCT01206049|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110832287|NCT01206049|Growth Substances|growth substances|mesh-ancestor
110832288|NCT01206049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110832289|NCT01206049|Growth Inhibitors|growth inhibitors|mesh-ancestor
110832290|NCT01206049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110832291|NCT01206049|Antimetabolites|antimetabolites|mesh-ancestor
110832292|NCT01206049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110832294|NCT03931889|Cholecalciferol|cholecalciferol|mesh-list
110832295|NCT03931889|Vitamins|vitamins|mesh-ancestor
110832296|NCT03931889|Micronutrients|micronutrients|mesh-ancestor
110832297|NCT03931889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110832298|NCT03931889|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110832299|NCT03931889|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110832300|NCT02953821|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
110832301|NCT02953821|Hormones|hormones|mesh-ancestor
110832302|NCT02953821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110832303|NCT02953821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110832304|NCT01206205|Lenalidomide|lenalidomide|mesh-list
110832305|NCT01206205|Bortezomib|bortezomib|mesh-list
110832306|NCT01206205|Immunologic Factors|immunologic factors|mesh-ancestor
110832307|NCT01206205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110832308|NCT01206205|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110832309|NCT01206205|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110832310|NCT01206205|Growth Substances|growth substances|mesh-ancestor
110832311|NCT01206205|Growth Inhibitors|growth inhibitors|mesh-ancestor
110832312|NCT01206205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110832313|NCT03783923|Deflazacort|deflazacort|mesh-list
110832314|NCT03783923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110832315|NCT03783923|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110832316|NCT03783923|Immunologic Factors|immunologic factors|mesh-ancestor
110832317|NCT03783923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110832318|NCT03472144|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110832319|NCT03472144|Levofloxacin|levofloxacin|mesh-list
110832320|NCT03472144|Ofloxacin|ofloxacin|mesh-list
110832321|NCT03472144|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
110832322|NCT03472144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110832323|NCT03472144|Antitubercular Agents|antitubercular agents|mesh-ancestor
110832324|NCT03472144|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110832325|NCT03472144|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110832326|NCT03472144|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110832327|NCT03472144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110832328|NCT03472144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110832329|NCT03472144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110832330|NCT03472144|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110832331|NCT03472144|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110832332|NCT03417141|Mechlorethamine|mechlorethamine|mesh-list
110832333|NCT03417141|Alkylating Agents|alkylating agents|mesh-ancestor
110832334|NCT03417141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110832335|NCT03417141|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110832336|NCT03417141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110832337|NCT01219751|Sunitinib|sunitinib|mesh-list
110832338|NCT01219751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110832339|NCT01219751|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110832340|NCT01219751|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110832341|NCT01219751|Growth Substances|growth substances|mesh-ancestor
110832342|NCT01219751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110832343|NCT01219751|Growth Inhibitors|growth inhibitors|mesh-ancestor
110832344|NCT01219751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110832345|NCT01219751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110832346|NCT01219751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110832347|NCT04823091|Cyclophosphamide|cyclophosphamide|mesh-list
110832348|NCT04823091|Fludarabine|fludarabine|mesh-list
110832349|NCT04823091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110832350|NCT04823091|Immunologic Factors|immunologic factors|mesh-ancestor
110832351|NCT04823091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110832352|NCT04823091|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110832353|NCT04823091|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110832354|NCT04823091|Alkylating Agents|alkylating agents|mesh-ancestor
110832355|NCT04823091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110832356|NCT04823091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110832357|NCT04823091|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110832358|NCT01125527|Vaccines|vaccines|mesh-list
110832359|NCT01125527|Immunologic Factors|immunologic factors|mesh-ancestor
110832360|NCT01125527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110832361|NCT01298401|Gemcitabine|gemcitabine|mesh-list
110832362|NCT01298401|Capecitabine|capecitabine|mesh-list
110887757|NCT03644706|Potassium Citrate|potassium citrate|mesh-list
110832363|NCT01298401|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110832364|NCT01298401|Antimetabolites|antimetabolites|mesh-ancestor
110832365|NCT01298401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110832366|NCT01298401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110832367|NCT03931343|Epinephrine|epinephrine|mesh-list
110832368|NCT03931343|Racepinephrine|racepinephrine|mesh-list
110832369|NCT03931343|Bupivacaine|bupivacaine|mesh-list
110832370|NCT03931343|Epinephryl borate|epinephryl borate|mesh-list
110832371|NCT03931343|Anesthetics, Local|anesthetics, local|mesh-ancestor
110832372|NCT03931343|Anesthetics|anesthetics|mesh-ancestor
110832373|NCT03931343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110832374|NCT03931343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110832375|NCT03931343|Sensory System Agents|sensory system agents|mesh-ancestor
110832376|NCT03931343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110871785|NCT04546620|Prednisone|prednisone|mesh-list
110832377|NCT03931343|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110832378|NCT03931343|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110832379|NCT03931343|Adrenergic Agents|adrenergic agents|mesh-ancestor
110832380|NCT03931343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110832381|NCT03931343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110832382|NCT03931343|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110832383|NCT03931343|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110832384|NCT03931343|Autonomic Agents|autonomic agents|mesh-ancestor
110832385|NCT03931343|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110832386|NCT03931343|Respiratory System Agents|respiratory system agents|mesh-ancestor
110832387|NCT03931343|Mydriatics|mydriatics|mesh-ancestor
110832388|NCT03931343|Sympathomimetics|sympathomimetics|mesh-ancestor
110832389|NCT03931343|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110832390|NCT04867798|Tenofovir|tenofovir|mesh-list
110549930|NCT02723981|Vitamin K|vitamin k|mesh-list
110832391|NCT04867798|Lamivudine|lamivudine|mesh-list
110832392|NCT04867798|Antiviral Agents|antiviral agents|mesh-ancestor
110832393|NCT04867798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110832394|NCT04867798|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110832395|NCT04867798|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110832396|NCT04867798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110832397|NCT04867798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110832398|NCT04867798|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110832399|NCT04867798|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110832400|NCT01122953|Phenytoin|phenytoin|mesh-list
110832401|NCT01122953|Anticonvulsants|anticonvulsants|mesh-ancestor
110832402|NCT01122953|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110832403|NCT01122953|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110832404|NCT01122953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110832405|NCT01122953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110832406|NCT01122953|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110832407|NCT01122953|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110832408|NCT01125683|Donepezil|donepezil|mesh-list
110832409|NCT01125683|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110832410|NCT01125683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110832411|NCT01125683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110832412|NCT01125683|Cholinergic Agents|cholinergic agents|mesh-ancestor
110832413|NCT01125683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110832414|NCT01125683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110832415|NCT01125683|Nootropic Agents|nootropic agents|mesh-ancestor
110832416|NCT01127555|Leucovorin|leucovorin|mesh-list
110832417|NCT01127555|Fluorouracil|fluorouracil|mesh-list
110832418|NCT01127555|Oxaliplatin|oxaliplatin|mesh-list
110832419|NCT01127555|Antimetabolites|antimetabolites|mesh-ancestor
110832420|NCT01127555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110832421|NCT01127555|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110832422|NCT01127555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110832423|NCT01127555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110832424|NCT01127555|Immunologic Factors|immunologic factors|mesh-ancestor
110832425|NCT01127555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110832426|NCT01127555|Antidotes|antidotes|mesh-ancestor
110887769|NCT01335685|Prednisone|prednisone|mesh-list
110832427|NCT01127555|Protective Agents|protective agents|mesh-ancestor
110832428|NCT01127555|Vitamin B Complex|vitamin b complex|mesh-ancestor
110832429|NCT01127555|Vitamins|vitamins|mesh-ancestor
110832430|NCT01127555|Micronutrients|micronutrients|mesh-ancestor
110832431|NCT01219907|Cyclophosphamide|cyclophosphamide|mesh-list
110832432|NCT01219907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110832433|NCT01219907|Immunologic Factors|immunologic factors|mesh-ancestor
110832435|NCT01219907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110832436|NCT01219907|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110832437|NCT01219907|Alkylating Agents|alkylating agents|mesh-ancestor
110832438|NCT01219907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110832439|NCT01219907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110832440|NCT01219907|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110832441|NCT03471988|Voriconazole|voriconazole|mesh-list
110832442|NCT03471988|Antifungal Agents|antifungal agents|mesh-ancestor
110832443|NCT03471988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110832444|NCT03471988|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110832445|NCT03471988|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110832446|NCT03471988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110832447|NCT03471988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110832448|NCT03471988|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110832449|NCT03471988|Hormone Antagonists|hormone antagonists|mesh-ancestor
110832450|NCT03471988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110832451|NCT03471988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110832452|NCT03471988|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110832453|NCT03724981|Dulaglutide|dulaglutide|mesh-list
110832454|NCT03724981|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110183716|NCT00031083|Immunologic Factors|immunologic factors|mesh-ancestor
110832455|NCT03724981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110832456|NCT03442569|Nivolumab|nivolumab|mesh-list
110832457|NCT03442569|Ipilimumab|ipilimumab|mesh-list
110832458|NCT03442569|Panitumumab|panitumumab|mesh-list
110083475|NCT01655212|Antiviral Agents|antiviral agents|mesh-ancestor
110832459|NCT03442569|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110832460|NCT03442569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110832461|NCT03442569|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110832462|NCT03442569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110832463|NCT01123031|Esomeprazole|esomeprazole|mesh-list
110832464|NCT01123031|Lansoprazole|lansoprazole|mesh-list
110832465|NCT01123031|Dexlansoprazole|dexlansoprazole|mesh-list
110832466|NCT01123031|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110832467|NCT01123031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110832468|NCT01123031|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110832469|NCT01123031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110832470|NCT01123031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110832471|NCT01220063|Irinotecan|irinotecan|mesh-list
110832472|NCT01220063|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110832473|NCT01220063|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110832474|NCT01220063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110832475|NCT01220063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110832476|NCT01220063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110832477|NCT01223339|Ertugliflozin|ertugliflozin|mesh-list
110832478|NCT01223339|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110832479|NCT01223339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110832480|NCT01223339|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110832481|NCT01223339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110832482|NCT01217879|Telmisartan|telmisartan|mesh-list
110832483|NCT01217879|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110832484|NCT01217879|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110832485|NCT01217879|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110832486|NCT01217879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110832487|NCT01218035|Zoledronic Acid|zoledronic acid|mesh-list
110832488|NCT01218035|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110832489|NCT01218035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110832490|NCT04249310|Tiotropium Bromide|tiotropium bromide|mesh-list
110832492|NCT04249310|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110832493|NCT04249310|Autonomic Agents|autonomic agents|mesh-ancestor
110832494|NCT04249310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110832495|NCT04249310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110832496|NCT04249310|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110832497|NCT04249310|Respiratory System Agents|respiratory system agents|mesh-ancestor
110832498|NCT04249310|Parasympatholytics|parasympatholytics|mesh-ancestor
110832499|NCT04249310|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110832500|NCT04249310|Cholinergic Agents|cholinergic agents|mesh-ancestor
110832501|NCT04249310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110832502|NCT04249310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110832503|NCT05665075|Cytarabine|cytarabine|mesh-list
110832504|NCT05665075|Cyclophosphamide|cyclophosphamide|mesh-list
110832505|NCT05665075|Fludarabine|fludarabine|mesh-list
110832506|NCT05665075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110832507|NCT05665075|Immunologic Factors|immunologic factors|mesh-ancestor
110832508|NCT05665075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110832509|NCT05665075|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110832510|NCT05665075|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110832511|NCT05665075|Alkylating Agents|alkylating agents|mesh-ancestor
110832512|NCT05665075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110832513|NCT05665075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110832514|NCT05665075|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110832515|NCT05665075|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110832516|NCT05665075|Antimetabolites|antimetabolites|mesh-ancestor
110832517|NCT05665075|Antiviral Agents|antiviral agents|mesh-ancestor
110832518|NCT05665075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110832519|NCT03714165|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110832521|NCT03714165|Defensins|defensins|mesh-list
110832522|NCT03714165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110832523|NCT03442101|Antipsychotic Agents|antipsychotic agents|mesh-list
110832524|NCT03442101|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110832525|NCT03442101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110832526|NCT03442101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110832527|NCT03442101|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110832528|NCT03932825|Nitrous Oxide|nitrous oxide|mesh-list
110832529|NCT03932825|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110832530|NCT03932825|Anesthetics, General|anesthetics, general|mesh-ancestor
110832531|NCT03932825|Anesthetics|anesthetics|mesh-ancestor
110832532|NCT03932825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110832533|NCT03932825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110832534|NCT03932825|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110832535|NCT03932825|Analgesics|analgesics|mesh-ancestor
110083618|NCT01655927|Hemostatics|hemostatics|mesh-ancestor
110832536|NCT03932825|Sensory System Agents|sensory system agents|mesh-ancestor
110887796|NCT01339663|Cyclophosphamide|cyclophosphamide|mesh-list
110832537|NCT03932825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110832538|NCT03932981|Temozolomide|temozolomide|mesh-list
110550085|NCT02451553|Capecitabine|capecitabine|mesh-list
110832539|NCT03932981|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110832540|NCT03932981|Alkylating Agents|alkylating agents|mesh-ancestor
110832541|NCT03932981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110832542|NCT03932981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110832544|NCT01220219|Analgesics|analgesics|mesh-ancestor
110832545|NCT01220219|Sensory System Agents|sensory system agents|mesh-ancestor
110832546|NCT01220219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110832547|NCT01220219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110832548|NCT01220219|Anticonvulsants|anticonvulsants|mesh-ancestor
110832549|NCT01220219|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110832550|NCT01220219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110832551|NCT01220219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110832552|NCT01220219|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110832553|NCT01220219|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110832554|NCT01220219|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110832555|NCT01220219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110832556|NCT01220219|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110832557|NCT03441789|Betamethasone|betamethasone|mesh-list
110832558|NCT03441789|Betamethasone Valerate|betamethasone valerate|mesh-list
110832559|NCT03441789|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
110832560|NCT03441789|Betamethasone benzoate|betamethasone benzoate|mesh-list
110832561|NCT03441789|Calcipotriene|calcipotriene|mesh-list
110832562|NCT03441789|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
110832563|NCT03441789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110832564|NCT03441789|Glucocorticoids|glucocorticoids|mesh-ancestor
110832566|NCT03441789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110832567|NCT03441789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110832568|NCT03441789|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110832569|NCT03441789|Respiratory System Agents|respiratory system agents|mesh-ancestor
110832570|NCT03441789|Dermatologic Agents|dermatologic agents|mesh-ancestor
110832571|NCT03359005|Vincristine|vincristine|mesh-list
110832572|NCT03359005|Temozolomide|temozolomide|mesh-list
110832573|NCT03359005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110832574|NCT03359005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110832575|NCT03359005|Tubulin Modulators|tubulin modulators|mesh-ancestor
110832576|NCT03359005|Antimitotic Agents|antimitotic agents|mesh-ancestor
110832577|NCT03359005|Mitosis Modulators|mitosis modulators|mesh-ancestor
110083673|NCT01656005|Hormones|hormones|mesh-ancestor
110832578|NCT03359005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110832579|NCT03359005|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110832580|NCT03359005|Alkylating Agents|alkylating agents|mesh-ancestor
110832581|NCT04321174|Ritonavir|ritonavir|mesh-list
110832582|NCT04321174|Lopinavir|lopinavir|mesh-list
110832583|NCT04321174|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110832584|NCT04321174|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110832585|NCT04321174|Protease Inhibitors|protease inhibitors|mesh-ancestor
110832586|NCT04321174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110832587|NCT04321174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110832588|NCT04321174|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110832589|NCT04321174|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110832590|NCT04321174|Antiviral Agents|antiviral agents|mesh-ancestor
110832591|NCT04321174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110832592|NCT04321174|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110832593|NCT04321174|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110832594|NCT01123265|Methotrexate|methotrexate|mesh-list
110832595|NCT01123265|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110832596|NCT01123265|Abortifacient Agents|abortifacient agents|mesh-ancestor
110832597|NCT01123265|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110832598|NCT01123265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110832599|NCT01123265|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110832600|NCT01123265|Antimetabolites|antimetabolites|mesh-ancestor
110832601|NCT01123265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110832602|NCT01123265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110832603|NCT01123265|Dermatologic Agents|dermatologic agents|mesh-ancestor
110832604|NCT01123265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110832605|NCT01123265|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110832606|NCT01123265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110832607|NCT01123265|Immunologic Factors|immunologic factors|mesh-ancestor
110832608|NCT01123265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110832609|NCT01123265|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110832610|NCT01204723|Aprepitant|aprepitant|mesh-list
110832611|NCT01204723|Fosaprepitant|fosaprepitant|mesh-list
110832612|NCT01204723|Antiemetics|antiemetics|mesh-ancestor
110832614|NCT01204723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110832615|NCT01204723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110832616|NCT01204723|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110832617|NCT01204723|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110832618|NCT01204723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110832619|NCT01204723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110832620|NCT01204801|Doxorubicin|doxorubicin|mesh-list
110832621|NCT01204801|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110832622|NCT01204801|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110832623|NCT01204801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110832624|NCT01204801|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110832625|NCT01204801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110832626|NCT01204801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110832627|NCT01204801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110832628|NCT04194814|Betamethasone|betamethasone|mesh-list
110832629|NCT04194814|Betamethasone Valerate|betamethasone valerate|mesh-list
110832630|NCT04194814|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
110832631|NCT04194814|Betamethasone benzoate|betamethasone benzoate|mesh-list
110832632|NCT04194814|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
110832633|NCT04194814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110832634|NCT04194814|Glucocorticoids|glucocorticoids|mesh-ancestor
110832635|NCT04194814|Hormones|hormones|mesh-ancestor
110832636|NCT04194814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110832637|NCT04194814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110832638|NCT04194814|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110832639|NCT04194814|Respiratory System Agents|respiratory system agents|mesh-ancestor
110832640|NCT03832621|Nivolumab|nivolumab|mesh-list
110832641|NCT03832621|Ipilimumab|ipilimumab|mesh-list
110832642|NCT03832621|Temozolomide|temozolomide|mesh-list
110832643|NCT03832621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110083800|NCT01656811|Albuterol|albuterol|mesh-list
110832644|NCT03832621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110832645|NCT03832621|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110832646|NCT03832621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110832647|NCT03832621|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110832648|NCT03832621|Alkylating Agents|alkylating agents|mesh-ancestor
110832650|NCT01220375|Vinorelbine|vinorelbine|mesh-list
110832651|NCT01220375|Lenograstim|lenograstim|mesh-list
110832652|NCT01220375|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110832653|NCT01220375|Immunologic Factors|immunologic factors|mesh-ancestor
110832654|NCT01220375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110832655|NCT01220375|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110832656|NCT01220375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110832657|NCT01220375|Tubulin Modulators|tubulin modulators|mesh-ancestor
110832658|NCT01220375|Antimitotic Agents|antimitotic agents|mesh-ancestor
110832659|NCT01220375|Mitosis Modulators|mitosis modulators|mesh-ancestor
110832660|NCT01220375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110832661|NCT01220375|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110832662|NCT01220375|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110832663|NCT01220375|Antiviral Agents|antiviral agents|mesh-ancestor
110832664|NCT01220375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110832665|NCT01223729|Acetylcarnitine|acetylcarnitine|mesh-list
110832666|NCT01223729|Vitamin B Complex|vitamin b complex|mesh-ancestor
110832668|NCT01223729|Micronutrients|micronutrients|mesh-ancestor
110832669|NCT01223729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110832670|NCT01223729|Nootropic Agents|nootropic agents|mesh-ancestor
110832671|NCT01126073|Niacin|niacin|mesh-list
110832672|NCT01126073|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110832673|NCT01126073|Antimetabolites|antimetabolites|mesh-ancestor
110832674|NCT01126073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110832675|NCT01126073|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110832676|NCT01126073|Vasodilator Agents|vasodilator agents|mesh-ancestor
110832677|NCT01126073|Vitamin B Complex|vitamin b complex|mesh-ancestor
110832678|NCT01126073|Vitamins|vitamins|mesh-ancestor
110832679|NCT01126073|Micronutrients|micronutrients|mesh-ancestor
110832680|NCT01126073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110832681|NCT03287050|Pembrolizumab|pembrolizumab|mesh-list
110832682|NCT03287050|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110832683|NCT03287050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110832684|NCT03287050|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110832685|NCT03287050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110832686|NCT05470881|Atropine|atropine|mesh-list
110832687|NCT05470881|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110832688|NCT05470881|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110832689|NCT05470881|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110832690|NCT05470881|Autonomic Agents|autonomic agents|mesh-ancestor
110832691|NCT05470881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110832692|NCT05470881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110832693|NCT05470881|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110832694|NCT05470881|Respiratory System Agents|respiratory system agents|mesh-ancestor
110832695|NCT05470881|Mydriatics|mydriatics|mesh-ancestor
110183779|NCT04711668|Lidocaine|lidocaine|mesh-list
110832696|NCT05470881|Parasympatholytics|parasympatholytics|mesh-ancestor
110832697|NCT05470881|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110832698|NCT05470881|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110832699|NCT05470881|Cholinergic Agents|cholinergic agents|mesh-ancestor
110832700|NCT05470881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110832701|NCT05470881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110832702|NCT03130504|Progesterone|progesterone|mesh-list
110832703|NCT03130504|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
110832704|NCT03130504|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
110832705|NCT03130504|Progestins|progestins|mesh-ancestor
110832707|NCT03130504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110832708|NCT03130504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110832709|NCT03130504|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110832710|NCT03130504|Hormone Antagonists|hormone antagonists|mesh-ancestor
110832712|NCT03819127|Vildagliptin|vildagliptin|mesh-list
110832713|NCT03819127|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110832714|NCT03819127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110832715|NCT03819127|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110832716|NCT03819127|Protease Inhibitors|protease inhibitors|mesh-ancestor
110832717|NCT03819127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110832718|NCT03819127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110832719|NCT02908789|Anti-Infective Agents|anti-infective agents|mesh-list
110832720|NCT02908789|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110832721|NCT05607550|Aflutinib|aflutinib|mesh-list
110083927|NCT01657487|Xhance|xhance|mesh-list
110832722|NCT05607550|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110832724|NCT05607550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110887848|NCT00092209|Losartan|losartan|mesh-list
110832725|NCT01299181|Atorvastatin|atorvastatin|mesh-list
110832726|NCT01299181|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110832727|NCT01299181|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110832728|NCT01299181|Antimetabolites|antimetabolites|mesh-ancestor
110832729|NCT01299181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110832730|NCT01299181|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110832731|NCT01299181|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110832732|NCT01299181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110832733|NCT03930875|Aspirin|aspirin|mesh-list
110832734|NCT03930875|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110832735|NCT03930875|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110832736|NCT03930875|Analgesics|analgesics|mesh-ancestor
110832737|NCT03930875|Sensory System Agents|sensory system agents|mesh-ancestor
110832738|NCT03930875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110832739|NCT03930875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110832740|NCT03930875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110832742|NCT03930875|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110832743|NCT03930875|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110832744|NCT03930875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110832745|NCT03930875|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110832746|NCT03930875|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110832747|NCT03930875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110832748|NCT03930875|Antipyretics|antipyretics|mesh-ancestor
110832749|NCT01206907|Oxymorphone|oxymorphone|mesh-list
110832750|NCT01206907|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110832751|NCT01206907|Narcotics|narcotics|mesh-ancestor
110832752|NCT01206907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110832753|NCT01206907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110832754|NCT01206907|Analgesics|analgesics|mesh-ancestor
110832755|NCT01206907|Sensory System Agents|sensory system agents|mesh-ancestor
110832756|NCT01206907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110832757|NCT01206907|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110832758|NCT03925246|Nivolumab|nivolumab|mesh-list
110832759|NCT03925246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110832760|NCT03925246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110550307|NCT00689598|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110832761|NCT03925246|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110832762|NCT03925246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110832763|NCT01218347|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110832764|NCT01218347|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110832765|NCT01218347|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110832766|NCT01218347|Antimetabolites|antimetabolites|mesh-ancestor
110832767|NCT01218347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110832768|NCT01218347|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110832769|NCT01218347|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110832770|NCT01218347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110832771|NCT01126229|Resveratrol|resveratrol|mesh-list
110832772|NCT01126229|Antioxidants|antioxidants|mesh-ancestor
110832773|NCT01126229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110832774|NCT01126229|Protective Agents|protective agents|mesh-ancestor
110832775|NCT01126229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110832776|NCT01126229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110083994|NCT01657825|Warfarin|warfarin|mesh-list
110832777|NCT01126229|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110832779|NCT03474640|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110832780|NCT03474640|Immunologic Factors|immunologic factors|mesh-ancestor
110832781|NCT03474640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110832782|NCT01126307|Verapamil|verapamil|mesh-list
110832783|NCT01126307|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110832784|NCT01126307|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110832785|NCT01126307|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110832786|NCT01126307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110832787|NCT01126307|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110887860|NCT01339741|Vitamin D|vitamin d|mesh-list
110832788|NCT01126307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110832790|NCT03439137|Darbepoetin alfa|darbepoetin alfa|mesh-list
110832791|NCT03439137|Hematinics|hematinics|mesh-ancestor
110832792|NCT04173338|Pemetrexed|pemetrexed|mesh-list
110832793|NCT04173338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110832794|NCT04173338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110832795|NCT04173338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110832796|NCT04173338|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110832797|NCT04173338|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110832798|NCT03936491|Methylphenidate|methylphenidate|mesh-list
110832799|NCT03936491|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
110832800|NCT03936491|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110832801|NCT03936491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110832802|NCT03936491|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110832803|NCT03936491|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110832804|NCT03936491|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110871786|NCT04546620|Cyclophosphamide|cyclophosphamide|mesh-list
110832805|NCT03936491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110832806|NCT03936491|Dopamine Agents|dopamine agents|mesh-ancestor
110832807|NCT03936491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110832808|NCT03936491|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110832809|NCT03936491|Adrenergic Agents|adrenergic agents|mesh-ancestor
110832810|NCT00890617|Prednisone|prednisone|mesh-list
110871787|NCT04546620|Rituximab|rituximab|mesh-list
110832811|NCT00890617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110832812|NCT00890617|Glucocorticoids|glucocorticoids|mesh-ancestor
110832813|NCT00890617|Hormones|hormones|mesh-ancestor
110084224|NCT01658891|Hormones|hormones|mesh-ancestor
110832814|NCT00890617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110183799|NCT00031161|Nitisinone|nitisinone|mesh-list
110832815|NCT00890617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110832816|NCT00890617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110832817|NCT00890617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110832818|NCT03468946|Caffeine|caffeine|mesh-list
110832819|NCT03468946|Citric Acid|citric acid|mesh-list
110832820|NCT03468946|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110832821|NCT03468946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110832822|NCT03468946|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110832823|NCT03468946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110832824|NCT03468946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110832825|NCT03468946|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110832826|NCT03468946|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110832827|NCT03468946|Purinergic Agents|purinergic agents|mesh-ancestor
110832828|NCT03468946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110832829|NCT03468946|Anticoagulants|anticoagulants|mesh-ancestor
110832830|NCT03468946|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110832831|NCT03468946|Chelating Agents|chelating agents|mesh-ancestor
110832832|NCT03468946|Sequestering Agents|sequestering agents|mesh-ancestor
110832833|NCT01218425|Levodopa|levodopa|mesh-list
110832834|NCT01218425|Carbidopa|carbidopa|mesh-list
110832835|NCT01218425|Domperidone|domperidone|mesh-list
110832836|NCT01218425|Methylphenidate|methylphenidate|mesh-list
110832837|NCT01218425|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110832838|NCT01218425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110832839|NCT01218425|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110832840|NCT01218425|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110832841|NCT01218425|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110832842|NCT01218425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110832843|NCT01218425|Dopamine Agents|dopamine agents|mesh-ancestor
110832844|NCT01218425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110832845|NCT01218425|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110832846|NCT01218425|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110887867|NCT00003777|Fluorouracil|fluorouracil|mesh-list
110832848|NCT01218425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110832849|NCT01218425|Antiemetics|antiemetics|mesh-ancestor
110832850|NCT01218425|Autonomic Agents|autonomic agents|mesh-ancestor
110832851|NCT01218425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110832852|NCT01218425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110832853|NCT01218425|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110832854|NCT05621005|Rifaximin|rifaximin|mesh-list
110832855|NCT05621005|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110832856|NCT05621005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110832857|NCT05621005|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110832858|NCT01224041|Tacrolimus|tacrolimus|mesh-list
110832859|NCT01224041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110832860|NCT01224041|Immunologic Factors|immunologic factors|mesh-ancestor
110832861|NCT01224041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110832862|NCT01224041|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110832863|NCT01224041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110832864|NCT01224041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110084685|NCT01661335|Dexamethasone|dexamethasone|mesh-list
110832865|NCT03181828|Acetohydroxamic acid|acetohydroxamic acid|mesh-list
110832866|NCT03181828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110832867|NCT03181828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110832868|NCT01123811|Cetuximab|cetuximab|mesh-list
110832869|NCT01123811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110871788|NCT04546620|Doxorubicin|doxorubicin|mesh-list
110832870|NCT01123811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110832871|NCT01128101|Spironolactone|spironolactone|mesh-list
110832872|NCT01128101|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110832873|NCT01128101|Hormone Antagonists|hormone antagonists|mesh-ancestor
110832874|NCT01128101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110084824|NCT01662518|Dexamethasone|dexamethasone|mesh-list
110832875|NCT01128101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110832876|NCT01128101|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110832877|NCT01128101|Diuretics|diuretics|mesh-ancestor
110832878|NCT01128101|Natriuretic Agents|natriuretic agents|mesh-ancestor
110832879|NCT01299415|Vadimezan|vadimezan|mesh-list
110832880|NCT01299415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110832881|NCT01123967|Nicotine|nicotine|mesh-list
110832882|NCT01123967|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110832883|NCT01123967|Autonomic Agents|autonomic agents|mesh-ancestor
110832884|NCT01123967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110832885|NCT01123967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110832886|NCT01123967|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110832887|NCT01123967|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110832888|NCT01123967|Cholinergic Agents|cholinergic agents|mesh-ancestor
110832889|NCT01123967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110832890|NCT01123967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110832891|NCT01126463|Ethiodized Oil|ethiodized oil|mesh-list
110832892|NCT01126463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110832894|NCT01126697|Coenzyme Q10|coenzyme q10|mesh-list
110832895|NCT01126697|Lisinopril|lisinopril|mesh-list
110832896|NCT01126697|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110832897|NCT01126697|Protease Inhibitors|protease inhibitors|mesh-ancestor
110832898|NCT01126697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110832899|NCT01126697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110832900|NCT01126697|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110832901|NCT01126697|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110832902|NCT01126697|Protective Agents|protective agents|mesh-ancestor
110832903|NCT01126697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110832904|NCT01126697|Micronutrients|micronutrients|mesh-ancestor
110832905|NCT01126697|Vitamins|vitamins|mesh-ancestor
110832906|NCT01220843|Sevelamer|sevelamer|mesh-list
110832907|NCT01220843|Chelating Agents|chelating agents|mesh-ancestor
110832908|NCT01220843|Sequestering Agents|sequestering agents|mesh-ancestor
110832909|NCT01220843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110832910|NCT02804932|Methamphetamine|methamphetamine|mesh-list
110832911|NCT02804932|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110832912|NCT02804932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110832913|NCT02804932|Sympathomimetics|sympathomimetics|mesh-ancestor
110832914|NCT02804932|Autonomic Agents|autonomic agents|mesh-ancestor
110832915|NCT02804932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110832916|NCT02804932|Dopamine Agents|dopamine agents|mesh-ancestor
110832917|NCT02804932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110832918|NCT02804932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110832919|NCT02804932|Adrenergic Agents|adrenergic agents|mesh-ancestor
110832920|NCT02804932|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110832921|NCT02804932|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110832922|NCT02804932|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110832923|NCT02804932|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110832924|NCT03468790|Fluticasone|fluticasone|mesh-list
110832927|NCT03468790|Albuterol|albuterol|mesh-list
110832928|NCT03468790|Formoterol Fumarate|formoterol fumarate|mesh-list
110832929|NCT03468790|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110832930|NCT03468790|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
110832931|NCT03468790|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
110832932|NCT03468790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110183825|NCT00031317|GABA Agents|gaba agents|mesh-ancestor
110832933|NCT03468790|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110832934|NCT03468790|Autonomic Agents|autonomic agents|mesh-ancestor
110832935|NCT03468790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110832936|NCT03468790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110832937|NCT03468790|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110832938|NCT03468790|Respiratory System Agents|respiratory system agents|mesh-ancestor
110832939|NCT03468790|Dermatologic Agents|dermatologic agents|mesh-ancestor
110832940|NCT03468790|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110832941|NCT03468790|Glucocorticoids|glucocorticoids|mesh-ancestor
110832942|NCT03468790|Hormones|hormones|mesh-ancestor
110832943|NCT03468790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110832944|NCT03468790|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110832945|NCT03468790|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110832946|NCT03468790|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110832947|NCT03468790|Adrenergic Agents|adrenergic agents|mesh-ancestor
110832948|NCT03468790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110832949|NCT03468790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110832950|NCT03468790|Tocolytic Agents|tocolytic agents|mesh-ancestor
110832951|NCT03468790|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110832952|NCT03468790|Sympathomimetics|sympathomimetics|mesh-ancestor
110832953|NCT01224197|Simeprevir|simeprevir|mesh-list
110832954|NCT01224197|Antiviral Agents|antiviral agents|mesh-ancestor
110832955|NCT01224197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110832956|NCT01224197|Protease Inhibitors|protease inhibitors|mesh-ancestor
110832957|NCT01224197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110832958|NCT01224197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110832959|NCT01224353|Thioctic Acid|thioctic acid|mesh-list
110832960|NCT01224353|Antioxidants|antioxidants|mesh-ancestor
110832961|NCT01224353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110832962|NCT01224353|Protective Agents|protective agents|mesh-ancestor
110832963|NCT01224353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110832964|NCT01224353|Vitamin B Complex|vitamin b complex|mesh-ancestor
110832966|NCT01224353|Micronutrients|micronutrients|mesh-ancestor
110832967|NCT01207297|Cyclophosphamide|cyclophosphamide|mesh-list
110832968|NCT01207297|Tacrolimus|tacrolimus|mesh-list
110832969|NCT01207297|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110832970|NCT01207297|Immunologic Factors|immunologic factors|mesh-ancestor
110832971|NCT01207297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110832972|NCT01207297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110832973|NCT01207297|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110832974|NCT01207297|Alkylating Agents|alkylating agents|mesh-ancestor
110832975|NCT01207297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110832976|NCT01207297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110832977|NCT01207297|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110832978|NCT01207297|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110832979|NCT01207297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110085096|NCT01664871|Fluorides|fluorides|mesh-list
110832980|NCT03932435|Bepotastine besilate|bepotastine besilate|mesh-list
110832981|NCT03932435|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110832983|NCT03720847|Progesterone|progesterone|mesh-list
110832984|NCT03720847|Estrogens|estrogens|mesh-ancestor
110832985|NCT03720847|Hormones|hormones|mesh-ancestor
110832986|NCT03720847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110832987|NCT03720847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110832988|NCT03720847|Progestins|progestins|mesh-ancestor
110832989|NCT01128257|Alendronate|alendronate|mesh-list
110832990|NCT01128257|Ibandronic Acid|ibandronic acid|mesh-list
110832991|NCT01128257|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110832992|NCT01128257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110832993|NCT01205347|Simvastatin|simvastatin|mesh-list
110832994|NCT01205347|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110832995|NCT01205347|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110832996|NCT01205347|Antimetabolites|antimetabolites|mesh-ancestor
110832997|NCT01205347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110832998|NCT01205347|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110832999|NCT01205347|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110833000|NCT01205347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110833001|NCT01218737|Gatifloxacin|gatifloxacin|mesh-list
110833002|NCT01218737|Prednisolone|prednisolone|mesh-list
110833003|NCT01218737|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110833004|NCT01218737|Methylprednisolone|methylprednisolone|mesh-list
110833005|NCT01218737|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110833006|NCT01218737|Prednisolone acetate|prednisolone acetate|mesh-list
110833007|NCT01218737|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110833008|NCT01218737|Prednisolone phosphate|prednisolone phosphate|mesh-list
110871789|NCT04546620|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110833009|NCT01218737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110833010|NCT01218737|Glucocorticoids|glucocorticoids|mesh-ancestor
110833012|NCT01218737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110833013|NCT01218737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110833014|NCT01218737|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110833015|NCT01218737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110833016|NCT01218737|Antiemetics|antiemetics|mesh-ancestor
110833017|NCT01218737|Autonomic Agents|autonomic agents|mesh-ancestor
110833018|NCT01218737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110833019|NCT01218737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110833020|NCT01218737|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110833021|NCT01218737|Protective Agents|protective agents|mesh-ancestor
110833022|NCT01218737|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110833023|NCT01218737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110833024|NCT01218737|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110833025|NCT01218737|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110833026|NCT01218737|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110833027|NCT01218737|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110833028|NCT01218737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110833029|NCT01218737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110833030|NCT03818113|Cardioplegic Solutions|cardioplegic solutions|mesh-list
110833031|NCT03818113|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110833033|NCT01224509|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
110833034|NCT01224509|Abortifacient Agents|abortifacient agents|mesh-ancestor
110833035|NCT01224509|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110833036|NCT01224509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110833037|NCT01224509|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110833038|NCT01224509|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110833039|NCT01224509|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110833040|NCT01224509|Contraceptive Agents|contraceptive agents|mesh-ancestor
110833041|NCT01224509|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
110833042|NCT01224509|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
110833043|NCT01224509|Hormone Antagonists|hormone antagonists|mesh-ancestor
110183854|NCT00031395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110833044|NCT01224509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110833045|NCT01224509|Luteolytic Agents|luteolytic agents|mesh-ancestor
110833046|NCT01224509|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110833047|NCT01224509|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
110833048|NCT01301053|Insulin|insulin|mesh-list
110833049|NCT01301053|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110833050|NCT01301053|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110833051|NCT01301053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110833052|NCT01218581|Letrozole|letrozole|mesh-list
110833053|NCT01218581|Goserelin|goserelin|mesh-list
110833054|NCT01218581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110833055|NCT01218581|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110833056|NCT01218581|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110833057|NCT01218581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110833058|NCT01218581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110833059|NCT01218581|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110833060|NCT01218581|Hormone Antagonists|hormone antagonists|mesh-ancestor
110833061|NCT01218581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110085703|NCT01668901|Antipyretics|antipyretics|mesh-ancestor
110833062|NCT01218581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110833063|NCT01218581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110833065|NCT03825133|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110833066|NCT03825133|Immunologic Factors|immunologic factors|mesh-ancestor
110833067|NCT03825133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110833068|NCT03825133|Viscosupplements|viscosupplements|mesh-ancestor
110833069|NCT03825133|Protective Agents|protective agents|mesh-ancestor
110833070|NCT03817567|Antibodies|antibodies|mesh-list
110833071|NCT03817567|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110085840|NCT01669707|Endostar protein|endostar protein|mesh-list
110833072|NCT03817567|Immunologic Factors|immunologic factors|mesh-ancestor
110833073|NCT03817567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110833074|NCT01127009|Cytarabine|cytarabine|mesh-list
110833075|NCT01127009|Etoposide|etoposide|mesh-list
110833076|NCT01127009|Podophyllotoxin|podophyllotoxin|mesh-list
110833077|NCT01127009|Mitoxantrone|mitoxantrone|mesh-list
110833078|NCT01127009|Etoposide phosphate|etoposide phosphate|mesh-list
110833079|NCT01127009|Bortezomib|bortezomib|mesh-list
110833080|NCT01127009|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110833081|NCT01127009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110833082|NCT01127009|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110833083|NCT01127009|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110833084|NCT01127009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110833085|NCT01127009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110085981|NCT01675115|Antipyretics|antipyretics|mesh-ancestor
110833086|NCT01127009|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110833087|NCT01127009|Antimetabolites|antimetabolites|mesh-ancestor
110833088|NCT01127009|Antiviral Agents|antiviral agents|mesh-ancestor
110833089|NCT01127009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110833090|NCT01127009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110833091|NCT01127009|Immunologic Factors|immunologic factors|mesh-ancestor
110833092|NCT01127009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110833093|NCT01127009|Analgesics|analgesics|mesh-ancestor
110833094|NCT01127009|Sensory System Agents|sensory system agents|mesh-ancestor
110833095|NCT01127009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110833096|NCT01127009|Keratolytic Agents|keratolytic agents|mesh-ancestor
110833097|NCT01127009|Dermatologic Agents|dermatologic agents|mesh-ancestor
110833098|NCT01127009|Tubulin Modulators|tubulin modulators|mesh-ancestor
110833099|NCT01127009|Antimitotic Agents|antimitotic agents|mesh-ancestor
110833100|NCT01127009|Mitosis Modulators|mitosis modulators|mesh-ancestor
110833101|NCT03817411|Capecitabine|capecitabine|mesh-list
110833102|NCT03817411|Oxaliplatin|oxaliplatin|mesh-list
110833103|NCT03817411|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110833104|NCT03817411|Antimetabolites|antimetabolites|mesh-ancestor
110833105|NCT03817411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110833106|NCT03817411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110833107|NCT01205737|Rituximab|rituximab|mesh-list
110833108|NCT01205737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110833109|NCT01205737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110833110|NCT01205737|Immunologic Factors|immunologic factors|mesh-ancestor
110833111|NCT01205737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110833112|NCT01205737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110833113|NCT01218893|Chloroquine|chloroquine|mesh-list
110833114|NCT01218893|Proguanil|proguanil|mesh-list
110086105|NCT01679093|Antiemetics|antiemetics|mesh-ancestor
110833115|NCT01218893|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
110833116|NCT01218893|Amebicides|amebicides|mesh-ancestor
110833117|NCT01218893|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110833118|NCT01218893|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110833119|NCT01218893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110833120|NCT01218893|Antimalarials|antimalarials|mesh-ancestor
110833121|NCT01218893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110833122|NCT01218893|Antimetabolites|antimetabolites|mesh-ancestor
110833123|NCT01218893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110833124|NCT03824119|Ibuprofen|ibuprofen|mesh-list
110833125|NCT03824119|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110833126|NCT03824119|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110833127|NCT03824119|Analgesics|analgesics|mesh-ancestor
110833128|NCT03824119|Sensory System Agents|sensory system agents|mesh-ancestor
110086169|NCT05596669|Ketamine|ketamine|mesh-list
110833129|NCT03824119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110833130|NCT03824119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110833131|NCT03824119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110833132|NCT03824119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110833133|NCT03824119|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110550694|NCT00866307|Hormones|hormones|mesh-ancestor
110833134|NCT03824119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110833135|NCT03824119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110833136|NCT03823417|Tranexamic Acid|tranexamic acid|mesh-list
110833137|NCT03823417|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110833138|NCT03823417|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110833139|NCT03823417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110833140|NCT03823417|Hemostatics|hemostatics|mesh-ancestor
110833141|NCT03823417|Coagulants|coagulants|mesh-ancestor
110833142|NCT01297777|Imatinib Mesylate|imatinib mesylate|mesh-list
110833143|NCT01297777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110833144|NCT01297777|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110833145|NCT01297777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110833146|NCT01297777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110833147|NCT01225913|Fluticasone|fluticasone|mesh-list
110833149|NCT01225913|Budesonide|budesonide|mesh-list
110833150|NCT01225913|Formoterol Fumarate|formoterol fumarate|mesh-list
110833151|NCT01225913|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110833152|NCT01225913|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
110833153|NCT01225913|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
110833154|NCT01225913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110833155|NCT01225913|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110833156|NCT01225913|Autonomic Agents|autonomic agents|mesh-ancestor
110833157|NCT01225913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110833158|NCT01225913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110833159|NCT01225913|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110833160|NCT01225913|Respiratory System Agents|respiratory system agents|mesh-ancestor
110833161|NCT01225913|Dermatologic Agents|dermatologic agents|mesh-ancestor
110833162|NCT01225913|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110833163|NCT01225913|Glucocorticoids|glucocorticoids|mesh-ancestor
110833164|NCT01225913|Hormones|hormones|mesh-ancestor
110183900|NCT03152084|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110833165|NCT01225913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110833166|NCT01225913|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110833167|NCT01225913|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110833169|NCT01225913|Adrenergic Agents|adrenergic agents|mesh-ancestor
110833170|NCT01225913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110833171|NCT01225913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110833172|NCT01225913|Sympathomimetics|sympathomimetics|mesh-ancestor
110833173|NCT01224977|Azithromycin|azithromycin|mesh-list
110833174|NCT01224977|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110833175|NCT01224977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110833176|NCT01226069|Magnesium Sulfate|magnesium sulfate|mesh-list
110833177|NCT01226069|Glycerol|glycerol|mesh-list
110833178|NCT01226069|Analgesics|analgesics|mesh-ancestor
110833179|NCT01226069|Sensory System Agents|sensory system agents|mesh-ancestor
110833180|NCT01226069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110833181|NCT01226069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110833182|NCT01226069|Anesthetics|anesthetics|mesh-ancestor
110833183|NCT01226069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110833184|NCT01226069|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110833185|NCT01226069|Anticonvulsants|anticonvulsants|mesh-ancestor
110833186|NCT01226069|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110833187|NCT01226069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110871790|NCT04546620|Vincristine|vincristine|mesh-list
110833188|NCT01226069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110833189|NCT01226069|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110833190|NCT01226069|Tocolytic Agents|tocolytic agents|mesh-ancestor
110833191|NCT01226069|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110833192|NCT01226069|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
110833193|NCT01226069|Protective Agents|protective agents|mesh-ancestor
110833194|NCT03928691|Magnesium Sulfate|magnesium sulfate|mesh-list
110833195|NCT03928691|Analgesics|analgesics|mesh-ancestor
110833196|NCT03928691|Sensory System Agents|sensory system agents|mesh-ancestor
110086622|NCT04002258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110833197|NCT03928691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110833198|NCT03928691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110833199|NCT03928691|Anesthetics|anesthetics|mesh-ancestor
110833200|NCT03928691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110833201|NCT03928691|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110833202|NCT03928691|Anticonvulsants|anticonvulsants|mesh-ancestor
110833203|NCT03928691|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110833204|NCT03928691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110871791|NCT04546620|Acalabrutinib|acalabrutinib|mesh-list
110086713|NCT03554200|Empagliflozin|empagliflozin|mesh-list
110086714|NCT03554200|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110086715|NCT03554200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110086716|NCT03554200|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110086717|NCT03554200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110086718|NCT03518086|Mirikizumab|mirikizumab|mesh-list
110086719|NCT03518086|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110086720|NCT03518086|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110086721|NCT03518086|Analgesics|analgesics|mesh-ancestor
110086722|NCT03518086|Sensory System Agents|sensory system agents|mesh-ancestor
110086723|NCT03518086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110086724|NCT03518086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110086725|NCT03518086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110086726|NCT03518086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110086727|NCT03518086|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110086728|NCT03518086|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110086729|NCT03517176|Paclitaxel|paclitaxel|mesh-list
110086730|NCT03517176|Gemcitabine|gemcitabine|mesh-list
110086731|NCT03517176|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110086732|NCT03517176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110086733|NCT03517176|Tubulin Modulators|tubulin modulators|mesh-ancestor
110086734|NCT03517176|Antimitotic Agents|antimitotic agents|mesh-ancestor
110086735|NCT03517176|Mitosis Modulators|mitosis modulators|mesh-ancestor
110086736|NCT03517176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110833205|NCT03928691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110833206|NCT03928691|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110550766|NCT00731302|Antipyretics|antipyretics|mesh-ancestor
110833207|NCT03928691|Tocolytic Agents|tocolytic agents|mesh-ancestor
110833208|NCT03928691|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110833209|NCT01297855|Rifampin|rifampin|mesh-list
110833210|NCT01297855|Colistin|colistin|mesh-list
110833211|NCT01297855|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110833212|NCT01297855|Antitubercular Agents|antitubercular agents|mesh-ancestor
110833213|NCT01297855|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110833214|NCT01297855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110833215|NCT01297855|Leprostatic Agents|leprostatic agents|mesh-ancestor
110833216|NCT01297855|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110833217|NCT01297855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110833218|NCT01297855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110833219|NCT01297855|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110833220|NCT01297855|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110833221|NCT01297855|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110833222|NCT01297855|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110833223|NCT01297855|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110833224|NCT01297855|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110833225|NCT02631070|Luspatercept|luspatercept|mesh-list
110833226|NCT02631070|Hematinics|hematinics|mesh-ancestor
110833227|NCT01298011|Paclitaxel|paclitaxel|mesh-list
110833228|NCT01298011|Gemcitabine|gemcitabine|mesh-list
110833229|NCT01298011|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110833230|NCT01298011|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110833231|NCT01298011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110833232|NCT01298011|Tubulin Modulators|tubulin modulators|mesh-ancestor
110833233|NCT01298011|Antimitotic Agents|antimitotic agents|mesh-ancestor
110087032|NCT05837689|Blinatumomab|blinatumomab|mesh-list
110833234|NCT01298011|Mitosis Modulators|mitosis modulators|mesh-ancestor
110833235|NCT01298011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110833236|NCT01298011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110833237|NCT01298011|Antimetabolites|antimetabolites|mesh-ancestor
110833238|NCT01221935|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
110833239|NCT01221935|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
110833240|NCT01221935|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-list
110833241|NCT01221935|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110833242|NCT01221935|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110887966|NCT02962284|Prednisolone|prednisolone|mesh-list
110833243|NCT01221935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110833244|NCT01221935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110833245|NCT01221935|Serotonin Agents|serotonin agents|mesh-ancestor
110087113|NCT05797558|Eplerenone|eplerenone|mesh-list
110833246|NCT01221935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110833248|NCT01221935|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110833249|NCT05137678|Glyburide|glyburide|mesh-list
110833250|NCT05137678|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110833251|NCT05137678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110833252|NCT01226303|Tretinoin|tretinoin|mesh-list
110833253|NCT01226303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110833254|NCT01226303|Keratolytic Agents|keratolytic agents|mesh-ancestor
110833255|NCT01226303|Dermatologic Agents|dermatologic agents|mesh-ancestor
110833256|NCT03814759|Cisplatin|cisplatin|mesh-list
110833257|NCT03814759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110833259|NCT05101018|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110833260|NCT05101018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110833261|NCT03929861|Fluconazole|fluconazole|mesh-list
110833262|NCT03929861|Antifungal Agents|antifungal agents|mesh-ancestor
110833263|NCT03929861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110833264|NCT03929861|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110087379|NCT04280562|Antipyretics|antipyretics|mesh-ancestor
110833265|NCT03929861|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110833266|NCT03929861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110833267|NCT03929861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110833268|NCT03929861|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110833269|NCT03929861|Hormone Antagonists|hormone antagonists|mesh-ancestor
110833270|NCT03929861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110833271|NCT03929861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110833272|NCT03929861|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110833273|NCT03929861|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110833274|NCT03821623|Niacinamide|niacinamide|mesh-list
110833275|NCT03821623|Niacin|niacin|mesh-list
110833276|NCT03821623|Nicotinic Acids|nicotinic acids|mesh-list
110833277|NCT03821623|Vitamin B Complex|vitamin b complex|mesh-ancestor
110833279|NCT03821623|Micronutrients|micronutrients|mesh-ancestor
110833280|NCT03821623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110833282|NCT03821623|Antimetabolites|antimetabolites|mesh-ancestor
110833283|NCT03821623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110833284|NCT03821623|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110833285|NCT03821623|Vasodilator Agents|vasodilator agents|mesh-ancestor
110833286|NCT03928145|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110833287|NCT03928145|Chlorthalidone|chlorthalidone|mesh-list
110833288|NCT03928145|Amiloride|amiloride|mesh-list
110833289|NCT03928145|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110833290|NCT03928145|Diuretics|diuretics|mesh-ancestor
110833291|NCT03928145|Natriuretic Agents|natriuretic agents|mesh-ancestor
110833292|NCT03928145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110087664|NCT01685489|Docetaxel|docetaxel|mesh-list
110833293|NCT03928145|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110833294|NCT03928145|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110833295|NCT03928145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110833296|NCT03928145|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
110833297|NCT03928145|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110833298|NCT03928145|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
110833299|NCT03928145|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110833300|NCT01129271|Clopidogrel|clopidogrel|mesh-list
110833301|NCT01129271|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110087792|NCT01690221|Vasodilator Agents|vasodilator agents|mesh-ancestor
110833302|NCT01129271|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110833303|NCT01129271|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110833304|NCT01129271|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110833305|NCT01129271|Purinergic Agents|purinergic agents|mesh-ancestor
110833306|NCT01129271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110833307|NCT01129271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110833308|NCT01129271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110833309|NCT01222013|Imatinib Mesylate|imatinib mesylate|mesh-list
110833310|NCT01222013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110833311|NCT01222013|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110833312|NCT01222013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110833313|NCT01222013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110833315|NCT00741988|Carboplatin|carboplatin|mesh-list
110833316|NCT00741988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110833317|NCT00741988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110833318|NCT00741988|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110833319|NCT00741988|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110833320|NCT00741988|Growth Substances|growth substances|mesh-ancestor
110833321|NCT00741988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110833322|NCT00741988|Growth Inhibitors|growth inhibitors|mesh-ancestor
110833323|NCT01131377|Acetazolamide|acetazolamide|mesh-list
110833324|NCT01131377|Anticonvulsants|anticonvulsants|mesh-ancestor
110833325|NCT01131377|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110833326|NCT01131377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110833327|NCT01131377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110833328|NCT01131377|Diuretics|diuretics|mesh-ancestor
110833329|NCT01131377|Natriuretic Agents|natriuretic agents|mesh-ancestor
110833330|NCT01131377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110833331|NCT04457050|Ribavirin|ribavirin|mesh-list
110833332|NCT04457050|Sofosbuvir|sofosbuvir|mesh-list
110833333|NCT04457050|Ledipasvir|ledipasvir|mesh-list
110833334|NCT04457050|Antimetabolites|antimetabolites|mesh-ancestor
110871792|NCT04546620|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110833335|NCT04457050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110833337|NCT04457050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110833338|NCT01228409|Acitretin|acitretin|mesh-list
110833339|NCT01228409|Keratolytic Agents|keratolytic agents|mesh-ancestor
110833340|NCT01228409|Dermatologic Agents|dermatologic agents|mesh-ancestor
110833341|NCT03470350|Capecitabine|capecitabine|mesh-list
110833342|NCT03470350|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110833343|NCT03470350|Antimetabolites|antimetabolites|mesh-ancestor
110833344|NCT03470350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110833345|NCT03470350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110833346|NCT04565392|Famotidine|famotidine|mesh-list
110833347|NCT04565392|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110833348|NCT04565392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110833349|NCT04565392|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110833350|NCT04565392|Histamine Antagonists|histamine antagonists|mesh-ancestor
110833351|NCT04565392|Histamine Agents|histamine agents|mesh-ancestor
110833352|NCT04565392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110833353|NCT04565392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110550912|NCT02752841|Vitamins|vitamins|mesh-ancestor
110833354|NCT04565392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110833355|NCT05654233|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
110833356|NCT05654233|Anticoagulants|anticoagulants|mesh-ancestor
110088198|NCT01692808|Vitamin D|vitamin d|mesh-list
110833358|NCT05654233|Antimetabolites|antimetabolites|mesh-ancestor
110833359|NCT05654233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110833360|NCT05654233|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110833361|NCT05654233|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110833362|NCT05654233|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110833363|NCT05654233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110833364|NCT05654233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110833365|NCT01226771|Ribavirin|ribavirin|mesh-list
110833366|NCT01226771|Antimetabolites|antimetabolites|mesh-ancestor
110833367|NCT01226771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110887989|NCT03642600|Folic Acid|folic acid|mesh-list
110833369|NCT01226771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110833370|NCT03814447|Cyclophosphamide|cyclophosphamide|mesh-list
110833371|NCT03814447|Fludarabine|fludarabine|mesh-list
110833372|NCT03814447|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110833373|NCT03814447|Immunologic Factors|immunologic factors|mesh-ancestor
110088394|NCT05288738|Analgesics|analgesics|mesh-ancestor
110833374|NCT03814447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110833375|NCT03814447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110833376|NCT03814447|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110833377|NCT03814447|Alkylating Agents|alkylating agents|mesh-ancestor
110833378|NCT03814447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110833379|NCT03814447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110833380|NCT03814447|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110833381|NCT01129427|Pantoprazole|pantoprazole|mesh-list
110833382|NCT01129427|Clopidogrel|clopidogrel|mesh-list
110833383|NCT01129427|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110833384|NCT01129427|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110833385|NCT01129427|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110833386|NCT01129427|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110833388|NCT01129427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110833389|NCT01129427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110833391|NCT01129427|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110833392|NCT01129427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110833393|NCT01129427|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110833394|NCT01129427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110833395|NCT03814291|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
110833396|NCT03814291|Immunologic Factors|immunologic factors|mesh-ancestor
110833397|NCT03814291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110833398|NCT03354429|Ticagrelor|ticagrelor|mesh-list
110833399|NCT03354429|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110833400|NCT03354429|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110833401|NCT03354429|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110833402|NCT03354429|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110833403|NCT03354429|Purinergic Agents|purinergic agents|mesh-ancestor
110833404|NCT03354429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110833405|NCT03354429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110833406|NCT03354429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110833407|NCT05164198|Adalimumab|adalimumab|mesh-list
110833408|NCT05164198|Infliximab|infliximab|mesh-list
110833409|NCT05164198|Golimumab|golimumab|mesh-list
110833410|NCT05164198|Etanercept|etanercept|mesh-list
110833411|NCT05164198|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110833412|NCT05164198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110833413|NCT05164198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110833414|NCT05164198|Dermatologic Agents|dermatologic agents|mesh-ancestor
110833415|NCT05164198|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110833416|NCT05164198|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110833418|NCT05164198|Analgesics|analgesics|mesh-ancestor
110833419|NCT05164198|Sensory System Agents|sensory system agents|mesh-ancestor
110833420|NCT05164198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110833421|NCT05164198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110833422|NCT05164198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110833423|NCT05164198|Immunologic Factors|immunologic factors|mesh-ancestor
110833424|NCT03740399|Anesthetics|anesthetics|mesh-list
110833425|NCT03740399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110833426|NCT03740399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110550986|NCT04000633|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110833427|NCT05160220|Psilocybin|psilocybin|mesh-list
110833428|NCT05160220|Hallucinogens|hallucinogens|mesh-ancestor
110833429|NCT05160220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110833430|NCT05160220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110833431|NCT03924245|Olaparib|olaparib|mesh-list
110833432|NCT03924245|Entinostat|entinostat|mesh-list
110833433|NCT03924245|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110833434|NCT03924245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110888002|NCT01069692|Hematinics|hematinics|mesh-ancestor
110833435|NCT03924245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110833436|NCT03924245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110833437|NCT03924245|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110833438|NCT05647447|SR 142801|sr 142801|mesh-list
110833439|NCT05647447|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110833440|NCT05647447|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110833441|NCT05647447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110833442|NCT05647447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110833443|NCT05647447|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110833444|NCT01225445|Ramipril|ramipril|mesh-list
110833445|NCT01225445|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110833446|NCT01225445|Protease Inhibitors|protease inhibitors|mesh-ancestor
110089007|NCT05192629|Analgesics|analgesics|mesh-ancestor
110833447|NCT01225445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110833448|NCT01225445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110833449|NCT01225445|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110833450|NCT05555329|Thalidomide|thalidomide|mesh-list
110833451|NCT05555329|Pomalidomide|pomalidomide|mesh-list
110833452|NCT05555329|Immunologic Factors|immunologic factors|mesh-ancestor
110833453|NCT05555329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110833454|NCT05555329|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110833455|NCT05555329|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110833456|NCT05555329|Growth Substances|growth substances|mesh-ancestor
110833457|NCT05555329|Growth Inhibitors|growth inhibitors|mesh-ancestor
110833458|NCT05555329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110833459|NCT05555329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110833460|NCT05555329|Leprostatic Agents|leprostatic agents|mesh-ancestor
110833461|NCT05555329|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110833462|NCT05555329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110833464|NCT05390710|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110833465|NCT05390710|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110833466|NCT05390710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110833467|NCT05390710|Tubulin Modulators|tubulin modulators|mesh-ancestor
110833468|NCT05390710|Antimitotic Agents|antimitotic agents|mesh-ancestor
110833469|NCT05390710|Mitosis Modulators|mitosis modulators|mesh-ancestor
110089214|NCT04869605|Analgesics|analgesics|mesh-ancestor
110833470|NCT05390710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110833471|NCT01228565|Cetuximab|cetuximab|mesh-list
110833472|NCT01228565|OTD70DERM|otd70derm|mesh-list
110833473|NCT01228565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110833474|NCT01228565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110833475|NCT01228565|Protective Agents|protective agents|mesh-ancestor
110871793|NCT04546620|Prednisolone phosphate|prednisolone phosphate|mesh-list
110833476|NCT01228565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110833477|NCT01226849|Rituximab|rituximab|mesh-list
110833478|NCT01226849|Carboplatin|carboplatin|mesh-list
110833479|NCT01226849|Etoposide|etoposide|mesh-list
110833480|NCT01226849|Bortezomib|bortezomib|mesh-list
110833481|NCT01226849|Ifosfamide|ifosfamide|mesh-list
110833482|NCT01226849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110833483|NCT01226849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110833484|NCT01226849|Immunologic Factors|immunologic factors|mesh-ancestor
110833485|NCT01226849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110833486|NCT01226849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110833487|NCT01226849|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110833488|NCT01226849|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110833489|NCT01226849|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110833490|NCT01226849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110833491|NCT01226849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110833492|NCT01226849|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110833493|NCT01226849|Alkylating Agents|alkylating agents|mesh-ancestor
110833494|NCT05159674|Dexmedetomidine|dexmedetomidine|mesh-list
110833495|NCT05159674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110833496|NCT05159674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110833497|NCT05159674|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110089556|NCT04096066|Glucocorticoids|glucocorticoids|mesh-ancestor
110833498|NCT05159674|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110833499|NCT05159674|Analgesics|analgesics|mesh-ancestor
110833500|NCT05159674|Sensory System Agents|sensory system agents|mesh-ancestor
110833501|NCT05159674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110833502|NCT05159674|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110833503|NCT05159674|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110833504|NCT05159674|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110833505|NCT05159674|Adrenergic Agents|adrenergic agents|mesh-ancestor
110833507|NCT05159674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110833508|NCT03813979|Dolutegravir|dolutegravir|mesh-list
110833509|NCT03813979|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110833510|NCT03813979|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110833511|NCT03813979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110871794|NCT04546620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110833512|NCT03813979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110833513|NCT03813979|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110833514|NCT03813979|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110833515|NCT03813979|Antiviral Agents|antiviral agents|mesh-ancestor
110833516|NCT03813979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110833517|NCT05555121|Progesterone|progesterone|mesh-list
110833518|NCT05555121|Progestins|progestins|mesh-ancestor
110833519|NCT05555121|Hormones|hormones|mesh-ancestor
110833520|NCT05555121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110833521|NCT05555121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110833522|NCT05446467|Pembrolizumab|pembrolizumab|mesh-list
110833523|NCT05446467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110833524|NCT05446467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110833525|NCT05446467|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110833526|NCT05446467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110833527|NCT05553613|Clopidogrel|clopidogrel|mesh-list
110833528|NCT05553613|Ticagrelor|ticagrelor|mesh-list
110833529|NCT05553613|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110833530|NCT05553613|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110833531|NCT05553613|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110833532|NCT05553613|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110833533|NCT05553613|Purinergic Agents|purinergic agents|mesh-ancestor
110833534|NCT05553613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110833535|NCT05553613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110833536|NCT05553613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110833537|NCT03901144|Glycerol|glycerol|mesh-list
110833538|NCT03901144|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
110833539|NCT03901144|Protective Agents|protective agents|mesh-ancestor
110871795|NCT04546620|Immunologic Factors|immunologic factors|mesh-ancestor
110089848|NCT05800197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110089849|NCT05800197|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110833540|NCT03901144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110833541|NCT01129739|Cyclosporine|cyclosporine|mesh-list
110833542|NCT01129739|Cyclosporins|cyclosporins|mesh-list
110833543|NCT01129739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110833544|NCT01129739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110833545|NCT01129739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110833546|NCT01129739|Immunologic Factors|immunologic factors|mesh-ancestor
110833547|NCT01129739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110833548|NCT01129739|Antifungal Agents|antifungal agents|mesh-ancestor
110833549|NCT01129739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110833550|NCT01129739|Dermatologic Agents|dermatologic agents|mesh-ancestor
110833551|NCT01129739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110888035|NCT03573284|Antioxidants|antioxidants|mesh-ancestor
110833552|NCT01129739|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110833553|NCT01301599|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
110833554|NCT01301599|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-list
110833555|NCT01301599|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110833556|NCT01301599|Adrenergic Agents|adrenergic agents|mesh-ancestor
110833557|NCT01301599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110833558|NCT01301599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110833559|NCT01301599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110833560|NCT01301599|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110833561|NCT01301599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110833562|NCT01301599|Hormone Antagonists|hormone antagonists|mesh-ancestor
110871796|NCT04546620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110833563|NCT01301599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110833564|NCT03384693|Defibrotide|defibrotide|mesh-list
110833565|NCT03384693|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110833566|NCT03384693|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110833567|NCT03384693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110833568|NCT03384693|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110833569|NCT05533281|Dexamethasone|dexamethasone|mesh-list
110833570|NCT05533281|Metoclopramide|metoclopramide|mesh-list
110833571|NCT05533281|Tropisetron|tropisetron|mesh-list
110833572|NCT05533281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110833573|NCT05533281|Antiemetics|antiemetics|mesh-ancestor
110833574|NCT05533281|Autonomic Agents|autonomic agents|mesh-ancestor
110833575|NCT05533281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110833576|NCT05533281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110833577|NCT05533281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110833578|NCT05533281|Glucocorticoids|glucocorticoids|mesh-ancestor
110833579|NCT05533281|Hormones|hormones|mesh-ancestor
110833580|NCT05533281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110833581|NCT05533281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110090188|NCT04835506|Infliximab|infliximab|mesh-list
110833582|NCT05533281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110833583|NCT05533281|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110833584|NCT05533281|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110833585|NCT05533281|Dopamine Agents|dopamine agents|mesh-ancestor
110833586|NCT05533281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110833587|NCT05533281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110833588|NCT05533281|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110833589|NCT05533281|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110833591|NCT03923075|Dexmedetomidine|dexmedetomidine|mesh-list
110833592|NCT03923075|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110833593|NCT03923075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110833594|NCT03923075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110833595|NCT03923075|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110833596|NCT03923075|Analgesics|analgesics|mesh-ancestor
110833597|NCT03923075|Sensory System Agents|sensory system agents|mesh-ancestor
110833598|NCT03923075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110833599|NCT03923075|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110833600|NCT03923075|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110833601|NCT03923075|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110833602|NCT03923075|Adrenergic Agents|adrenergic agents|mesh-ancestor
110833603|NCT03923075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110833604|NCT03923075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110833605|NCT03923231|Ritonavir|ritonavir|mesh-list
110833606|NCT03923231|Atazanavir Sulfate|atazanavir sulfate|mesh-list
110833607|NCT03923231|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110833608|NCT03923231|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110833609|NCT03923231|Protease Inhibitors|protease inhibitors|mesh-ancestor
110833610|NCT03923231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110833611|NCT03923231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110833612|NCT03923231|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110833613|NCT03923231|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110833614|NCT03923231|Antiviral Agents|antiviral agents|mesh-ancestor
110833615|NCT03923231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110833616|NCT03923231|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110833617|NCT03923231|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110833619|NCT01227239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110833620|NCT01301677|Hydrocortisone|hydrocortisone|mesh-list
110833621|NCT01301677|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110833622|NCT02618980|Hemostatics|hemostatics|mesh-list
110833623|NCT02618980|Coagulants|coagulants|mesh-ancestor
110833624|NCT02613598|Bortezomib|bortezomib|mesh-list
110833625|NCT02613598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110833626|NCT03718429|Rivaroxaban|rivaroxaban|mesh-list
110833627|NCT03718429|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110833628|NCT03718429|Antithrombins|antithrombins|mesh-ancestor
110833629|NCT03718429|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110833630|NCT03718429|Protease Inhibitors|protease inhibitors|mesh-ancestor
110833631|NCT03718429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110833632|NCT03718429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110833633|NCT03718429|Anticoagulants|anticoagulants|mesh-ancestor
110833634|NCT01225523|Paclitaxel|paclitaxel|mesh-list
110833635|NCT01225523|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110833636|NCT01225523|Cisplatin|cisplatin|mesh-list
110833637|NCT01225523|Fluorouracil|fluorouracil|mesh-list
110833638|NCT01225523|Capecitabine|capecitabine|mesh-list
110833639|NCT01225523|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110833640|NCT01225523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110833641|NCT01225523|Tubulin Modulators|tubulin modulators|mesh-ancestor
110833642|NCT01225523|Antimitotic Agents|antimitotic agents|mesh-ancestor
110833643|NCT01225523|Mitosis Modulators|mitosis modulators|mesh-ancestor
110833644|NCT01225523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110833645|NCT01225523|Antimetabolites|antimetabolites|mesh-ancestor
110833646|NCT01225523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110833647|NCT01225523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110833648|NCT01225523|Immunologic Factors|immunologic factors|mesh-ancestor
110833649|NCT01225523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110833650|NCT03815539|Hyaluronic Acid|hyaluronic acid|mesh-list
110833651|NCT03815539|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110833652|NCT03815539|Immunologic Factors|immunologic factors|mesh-ancestor
110833653|NCT03815539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110833654|NCT03815539|Viscosupplements|viscosupplements|mesh-ancestor
110833655|NCT03815539|Protective Agents|protective agents|mesh-ancestor
110833656|NCT03922919|Ceftriaxone|ceftriaxone|mesh-list
110833657|NCT03922919|Cefotaxime|cefotaxime|mesh-list
110833658|NCT03922919|Cefoxitin|cefoxitin|mesh-list
110833659|NCT03922919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110833660|NCT03922919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110833661|NCT03813277|Dexmedetomidine|dexmedetomidine|mesh-list
110833662|NCT03813277|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110833663|NCT03813277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110833664|NCT03813277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110090701|NCT01817751|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110090702|NCT01817751|Urological Agents|urological agents|mesh-ancestor
110090703|NCT01817751|Anticonvulsants|anticonvulsants|mesh-ancestor
110090704|NCT01817751|GABA Agents|gaba agents|mesh-ancestor
110090705|NCT01817751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110090707|NCT01817751|Antimanic Agents|antimanic agents|mesh-ancestor
110833665|NCT03813277|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110833666|NCT03813277|Analgesics|analgesics|mesh-ancestor
110833667|NCT03813277|Sensory System Agents|sensory system agents|mesh-ancestor
110833668|NCT03813277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110833669|NCT03813277|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110833670|NCT03813277|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110833671|NCT03813277|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110833672|NCT03813277|Adrenergic Agents|adrenergic agents|mesh-ancestor
110833673|NCT03813277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110833674|NCT03813277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110833676|NCT03815461|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110833677|NCT03815461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110833678|NCT03815461|Tubulin Modulators|tubulin modulators|mesh-ancestor
110833679|NCT03815461|Antimitotic Agents|antimitotic agents|mesh-ancestor
110833680|NCT03815461|Mitosis Modulators|mitosis modulators|mesh-ancestor
110833681|NCT03815461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110833682|NCT01285102|Irinotecan|irinotecan|mesh-list
110833683|NCT01285102|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110833684|NCT01285102|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110833685|NCT01285102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110833686|NCT01285102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110833687|NCT01285102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110833688|NCT03740243|Buprenorphine|buprenorphine|mesh-list
110833689|NCT03740243|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
110833690|NCT03740243|Naloxone|naloxone|mesh-list
110833691|NCT03740243|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110833692|NCT03740243|Narcotics|narcotics|mesh-ancestor
110833693|NCT03740243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110833694|NCT03740243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110833695|NCT03740243|Analgesics|analgesics|mesh-ancestor
110833696|NCT03740243|Sensory System Agents|sensory system agents|mesh-ancestor
110833697|NCT03740243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110833698|NCT03740243|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110833699|NCT03813043|Midazolam|midazolam|mesh-list
110833700|NCT03813043|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110833701|NCT03813043|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110833702|NCT03813043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110090971|NCT03569475|Fluoxetine|fluoxetine|mesh-list
110833703|NCT03813043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110833704|NCT03813043|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110833705|NCT03813043|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110833706|NCT03813043|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110833707|NCT03813043|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110833708|NCT03813043|Anesthetics, General|anesthetics, general|mesh-ancestor
110833710|NCT03813043|GABA Modulators|gaba modulators|mesh-ancestor
110833711|NCT03813043|GABA Agents|gaba agents|mesh-ancestor
110833712|NCT03813043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110833713|NCT03813043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110833714|NCT03382899|Pembrolizumab|pembrolizumab|mesh-list
110833715|NCT03382899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110833716|NCT03382899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110833717|NCT03382899|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110833718|NCT03382899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110833720|NCT03815305|Emollients|emollients|mesh-ancestor
110833721|NCT03815305|Dermatologic Agents|dermatologic agents|mesh-ancestor
110833722|NCT01560013|Naltrexone|naltrexone|mesh-list
110833723|NCT01560013|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110833724|NCT01560013|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110833725|NCT01560013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110833726|NCT01560013|Sensory System Agents|sensory system agents|mesh-ancestor
110833727|NCT01560013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110833728|NCT01302145|Metformin|metformin|mesh-list
110833729|NCT01302145|Ipragliflozin|ipragliflozin|mesh-list
110833730|NCT01302145|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110833731|NCT01302145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110833732|NCT01302145|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110833733|NCT01302145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110833734|NCT01560091|Tamsulosin|tamsulosin|mesh-list
110833736|NCT01560091|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110833737|NCT01560091|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110833738|NCT01560091|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110833739|NCT01560091|Adrenergic Agents|adrenergic agents|mesh-ancestor
110833740|NCT01560091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110833741|NCT01560091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110833742|NCT01560091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110833744|NCT03382041|Carbon Fiber|carbon fiber|mesh-list
110833745|NCT03382041|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110833746|NCT03382041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110833747|NCT03807271|Anesthetics|anesthetics|mesh-list
110833748|NCT03807271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110833749|NCT03807271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110833751|NCT03812731|Ropivacaine|ropivacaine|mesh-list
110833752|NCT03812731|Anesthetics, Local|anesthetics, local|mesh-ancestor
110833753|NCT03812731|Anesthetics|anesthetics|mesh-ancestor
110833754|NCT03812731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110833755|NCT03812731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110833756|NCT03812731|Sensory System Agents|sensory system agents|mesh-ancestor
110833757|NCT03812731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110833758|NCT03812731|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110833759|NCT03812731|Narcotics|narcotics|mesh-ancestor
110833760|NCT03812731|Analgesics|analgesics|mesh-ancestor
110833761|NCT03812731|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110833762|NCT03812731|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110833763|NCT03812731|Anesthetics, General|anesthetics, general|mesh-ancestor
110833765|NCT03351231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110184099|NCT03151382|Nootropic Agents|nootropic agents|mesh-ancestor
110833766|NCT03351231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110833767|NCT03351231|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110833768|NCT03351231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110833769|NCT03922373|Benzonatate|benzonatate|mesh-list
110833770|NCT03922373|Antitussive Agents|antitussive agents|mesh-ancestor
110833771|NCT03922373|Respiratory System Agents|respiratory system agents|mesh-ancestor
110833772|NCT03709719|Blinatumomab|blinatumomab|mesh-list
110833773|NCT03709719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110833774|NCT03926663|Dexmedetomidine|dexmedetomidine|mesh-list
110833775|NCT03926663|Bupivacaine|bupivacaine|mesh-list
110833776|NCT03926663|Anesthetics, Local|anesthetics, local|mesh-ancestor
110833777|NCT03926663|Anesthetics|anesthetics|mesh-ancestor
110833778|NCT03926663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110833779|NCT03926663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110833780|NCT03926663|Sensory System Agents|sensory system agents|mesh-ancestor
110833781|NCT03926663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110833782|NCT03926663|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110833783|NCT03926663|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110833784|NCT03926663|Analgesics|analgesics|mesh-ancestor
110833785|NCT03926663|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110833786|NCT03926663|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110833787|NCT03926663|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110833788|NCT03926663|Adrenergic Agents|adrenergic agents|mesh-ancestor
110091860|NCT02040857|Exemestane|exemestane|mesh-list
110833789|NCT03926663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110833790|NCT03926663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110833791|NCT05481775|Immunomodulating Agents|immunomodulating agents|mesh-list
110833792|NCT05481775|Immunologic Factors|immunologic factors|mesh-ancestor
110833793|NCT05481775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110833794|NCT05165914|Midazolam|midazolam|mesh-list
110833795|NCT05165914|Anesthetics|anesthetics|mesh-list
110833796|NCT05165914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110833797|NCT05165914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110833798|NCT05165914|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110833799|NCT05165914|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110833800|NCT05165914|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110833801|NCT05165914|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110833802|NCT05165914|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110833803|NCT05165914|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110551364|NCT02712203|Vaccines|vaccines|mesh-list
110833804|NCT05165914|Anesthetics, General|anesthetics, general|mesh-ancestor
110833805|NCT05165914|GABA Modulators|gaba modulators|mesh-ancestor
110833806|NCT05165914|GABA Agents|gaba agents|mesh-ancestor
110833807|NCT05165914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110871797|NCT04546620|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110833808|NCT05165914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110833810|NCT04420975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110833811|NCT04420975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110833812|NCT04420975|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110092142|NCT00579527|Antiemetics|antiemetics|mesh-ancestor
110833813|NCT04420975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110833814|NCT01132157|Propofol|propofol|mesh-list
110833815|NCT01132157|Desflurane|desflurane|mesh-list
110833816|NCT01132157|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110833817|NCT01132157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110833818|NCT01132157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110833819|NCT01132157|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110833820|NCT01132157|Anesthetics, General|anesthetics, general|mesh-ancestor
110833821|NCT01132157|Anesthetics|anesthetics|mesh-ancestor
110833822|NCT01132157|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110833823|NCT05389150|Pregabalin|pregabalin|mesh-list
110833824|NCT05389150|Tramadol|tramadol|mesh-list
110833825|NCT05389150|Analgesics|analgesics|mesh-ancestor
110833826|NCT05389150|Sensory System Agents|sensory system agents|mesh-ancestor
110833827|NCT05389150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110833828|NCT05389150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110833829|NCT05389150|Anticonvulsants|anticonvulsants|mesh-ancestor
110833830|NCT05389150|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110833831|NCT05389150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110833832|NCT05389150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110833833|NCT05389150|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110833834|NCT05389150|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110833835|NCT05389150|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110833836|NCT05389150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110833837|NCT05389150|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110833838|NCT05389150|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110833839|NCT05389150|Narcotics|narcotics|mesh-ancestor
110833840|NCT03806101|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110833841|NCT03806101|Abrocitinib|abrocitinib|mesh-list
110833842|NCT03806101|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110833843|NCT03806101|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110833844|NCT03806101|Antimetabolites|antimetabolites|mesh-ancestor
110833845|NCT03806101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110833846|NCT03806101|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110092482|NCT01696617|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110833847|NCT03806101|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110833849|NCT03806101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110833850|NCT03812419|Esomeprazole|esomeprazole|mesh-list
110833851|NCT03812419|Pantoprazole|pantoprazole|mesh-list
110833852|NCT03812419|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110833853|NCT03812419|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110833854|NCT03812419|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110833855|NCT03812419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110833856|NCT03812419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110833857|NCT01132235|Etanercept|etanercept|mesh-list
110833858|NCT01132235|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110833859|NCT01132235|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110833860|NCT01132235|Analgesics|analgesics|mesh-ancestor
110833861|NCT01132235|Sensory System Agents|sensory system agents|mesh-ancestor
110833862|NCT01132235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110833863|NCT01132235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110833864|NCT01132235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110833865|NCT01132235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110833866|NCT01132235|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110092693|NCT01697787|Artesunate|artesunate|mesh-list
110833867|NCT01132235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110833868|NCT01132235|Immunologic Factors|immunologic factors|mesh-ancestor
110833869|NCT01131689|Sorafenib|sorafenib|mesh-list
110888080|NCT02847494|Hormones|hormones|mesh-ancestor
110833870|NCT01131689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110833871|NCT01131689|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110833872|NCT01131689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110833873|NCT01131689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110833874|NCT03401229|Mometasone Furoate|mometasone furoate|mesh-list
110833875|NCT03401229|Benralizumab|benralizumab|mesh-list
110833876|NCT03401229|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110833877|NCT03401229|Dermatologic Agents|dermatologic agents|mesh-ancestor
110551437|NCT05167513|Incretins|incretins|mesh-ancestor
110833878|NCT03401229|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110833879|NCT03401229|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110833880|NCT03401229|Respiratory System Agents|respiratory system agents|mesh-ancestor
110833881|NCT01132391|Nitroglycerin|nitroglycerin|mesh-list
110833882|NCT01132391|Vasodilator Agents|vasodilator agents|mesh-ancestor
110833884|NCT05281081|Levobupivacaine|levobupivacaine|mesh-list
110833885|NCT05281081|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110833886|NCT05281081|Narcotics|narcotics|mesh-ancestor
110833887|NCT05281081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110092897|NCT01699412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110833888|NCT05281081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110833889|NCT05281081|Analgesics|analgesics|mesh-ancestor
110833890|NCT05281081|Sensory System Agents|sensory system agents|mesh-ancestor
110833891|NCT05281081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110833892|NCT05281081|Anesthetics, Local|anesthetics, local|mesh-ancestor
110833893|NCT05281081|Anesthetics|anesthetics|mesh-ancestor
110833894|NCT03812965|Botulinum Toxins|botulinum toxins|mesh-list
110833895|NCT03812965|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110833896|NCT03812965|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110833897|NCT03812965|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110833898|NCT03812965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110833899|NCT03812965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110833900|NCT03812965|Cholinergic Agents|cholinergic agents|mesh-ancestor
110833902|NCT03812965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110833903|NCT03812965|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110833904|NCT03812965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110833905|NCT01303237|Cetuximab|cetuximab|mesh-list
110833906|NCT01303237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110888087|NCT02847494|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110833908|NCT01227863|Dexamethasone, neomycin, polymyxin B drug combination|dexamethasone, neomycin, polymyxin b drug combination|mesh-list
110833909|NCT01227863|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110833910|NCT01227863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110833911|NCT03349515|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110833912|NCT01227941|Doxorubicin|doxorubicin|mesh-list
110833913|NCT01227941|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110833914|NCT01227941|Niraparib|niraparib|mesh-list
110833915|NCT01227941|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110833916|NCT01227941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110833917|NCT01227941|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110833918|NCT01227941|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110833919|NCT01227941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110833920|NCT01227941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110093243|NCT01701349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110833921|NCT01227941|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110833923|NCT03919565|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110833924|NCT03919565|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110833925|NCT03919565|Antiviral Agents|antiviral agents|mesh-ancestor
110833926|NCT03919565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110833927|NCT03919565|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110833928|NCT03919565|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110833929|NCT03919565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110833930|NCT03919565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110833931|NCT03919565|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110833932|NCT03919565|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110833933|NCT03380091|Vitamin D|vitamin d|mesh-list
110833934|NCT03380091|Cholecalciferol|cholecalciferol|mesh-list
110833936|NCT03380091|Vitamins|vitamins|mesh-ancestor
110833937|NCT03380091|Micronutrients|micronutrients|mesh-ancestor
110833938|NCT03380091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110833939|NCT03380091|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110833940|NCT03380091|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110833941|NCT03380091|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110833942|NCT02529293|Insulin Lispro|insulin lispro|mesh-list
110833943|NCT02529293|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110833944|NCT02529293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110833945|NCT03919253|Paclitaxel|paclitaxel|mesh-list
110833946|NCT03919253|Maleic acid|maleic acid|mesh-list
110833947|NCT03919253|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110833948|NCT03919253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110833949|NCT03919253|Tubulin Modulators|tubulin modulators|mesh-ancestor
110833950|NCT03919253|Antimitotic Agents|antimitotic agents|mesh-ancestor
110833951|NCT03919253|Mitosis Modulators|mitosis modulators|mesh-ancestor
110833952|NCT03919253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110833953|NCT03919253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110833954|NCT05165290|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110833955|NCT05165290|Latanoprost|latanoprost|mesh-list
110833956|NCT05165290|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110833957|NCT01132703|Glyburide|glyburide|mesh-list
110833958|NCT01132703|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110833959|NCT01132703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110833960|NCT01377922|Amifampridine|amifampridine|mesh-list
110833961|NCT01377922|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110833962|NCT01377922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110833963|NCT01377922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110833964|NCT01377922|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
110833965|NCT01377922|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110093672|NCT01704027|Androgens|androgens|mesh-list
110833966|NCT01377922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110833967|NCT03919175|Rituximab|rituximab|mesh-list
110833968|NCT03919175|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110833969|NCT03919175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110093724|NCT01704482|Antidotes|antidotes|mesh-ancestor
110833970|NCT03919175|Immunologic Factors|immunologic factors|mesh-ancestor
110888124|NCT03575234|Immunologic Factors|immunologic factors|mesh-ancestor
110833971|NCT03919175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110833972|NCT03919175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110833974|NCT01303471|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110833975|NCT01303471|Narcotics|narcotics|mesh-ancestor
110833976|NCT01303471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110833977|NCT01303471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110833978|NCT01303471|Analgesics|analgesics|mesh-ancestor
110833979|NCT01303471|Sensory System Agents|sensory system agents|mesh-ancestor
110833980|NCT01303471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110833981|NCT03804541|Ensartinib|ensartinib|mesh-list
110833982|NCT03804541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110833983|NCT03804541|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110833984|NCT03804541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110833985|NCT03804541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110833986|NCT01377844|Bexagliflozin|bexagliflozin|mesh-list
110833987|NCT01377844|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110833988|NCT01377844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110833989|NCT03710811|Insulin|insulin|mesh-list
110833990|NCT03710811|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110833991|NCT03710811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110833992|NCT01303549|Amphotericin B|amphotericin b|mesh-list
110833993|NCT01303549|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
110833994|NCT01303549|Anidulafungin|anidulafungin|mesh-list
110833995|NCT01303549|Amebicides|amebicides|mesh-ancestor
110833996|NCT01303549|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110833997|NCT01303549|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110833998|NCT01303549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110833999|NCT01303549|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110834000|NCT01303549|Antifungal Agents|antifungal agents|mesh-ancestor
110834001|NCT03796975|Metformin|metformin|mesh-list
110834002|NCT03796975|Pioglitazone|pioglitazone|mesh-list
110834003|NCT03796975|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110834004|NCT03796975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110094077|NCT01706874|Listerine|listerine|mesh-list
110834005|NCT01130753|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110834006|NCT01130753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110834007|NCT01130753|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110834008|NCT01130753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110834009|NCT01130753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110834010|NCT05400070|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
110834011|NCT05400070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110834012|NCT05400070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110834013|NCT05400070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110834014|NCT01302613|Leucovorin|leucovorin|mesh-list
110834015|NCT01302613|Capecitabine|capecitabine|mesh-list
110834016|NCT01302613|Oxaliplatin|oxaliplatin|mesh-list
110834017|NCT01302613|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110834018|NCT01302613|Antimetabolites|antimetabolites|mesh-ancestor
110834019|NCT01302613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110834020|NCT01302613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110834021|NCT01302613|Antidotes|antidotes|mesh-ancestor
110834022|NCT01302613|Protective Agents|protective agents|mesh-ancestor
110834023|NCT01302613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110834024|NCT01302613|Vitamin B Complex|vitamin b complex|mesh-ancestor
110834025|NCT01302613|Vitamins|vitamins|mesh-ancestor
110834026|NCT01302613|Micronutrients|micronutrients|mesh-ancestor
110834027|NCT03803371|Acetaminophen|acetaminophen|mesh-list
110834028|NCT03803371|Tramadol|tramadol|mesh-list
110834029|NCT03803371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110834030|NCT03803371|Analgesics|analgesics|mesh-ancestor
110834031|NCT03803371|Sensory System Agents|sensory system agents|mesh-ancestor
110551608|NCT01004575|Cobalt|cobalt|mesh-list
110888134|NCT04508855|Heparin|heparin|mesh-list
110834032|NCT03803371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110834033|NCT03803371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110834034|NCT03803371|Antipyretics|antipyretics|mesh-ancestor
110834035|NCT03803371|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110834036|NCT03803371|Narcotics|narcotics|mesh-ancestor
110834037|NCT03803371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110834038|NCT01130909|Ketamine|ketamine|mesh-list
110834039|NCT01130909|Analgesics|analgesics|mesh-ancestor
110834040|NCT01130909|Sensory System Agents|sensory system agents|mesh-ancestor
110834041|NCT01130909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110834042|NCT01130909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110834043|NCT01130909|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110834045|NCT01130909|Anesthetics, General|anesthetics, general|mesh-ancestor
110834046|NCT01130909|Anesthetics|anesthetics|mesh-ancestor
110834047|NCT01130909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110834048|NCT01130909|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110834049|NCT01130909|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110834050|NCT01130909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110834051|NCT01130909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110834052|NCT03918551|Febuxostat|febuxostat|mesh-list
110834053|NCT03918551|Gout Suppressants|gout suppressants|mesh-ancestor
110834054|NCT03918551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110834055|NCT04453930|Irinotecan|irinotecan|mesh-list
110834056|NCT04453930|Apatinib|apatinib|mesh-list
110834057|NCT04453930|Antibodies|antibodies|mesh-list
110834058|NCT04453930|Immunologic Factors|immunologic factors|mesh-ancestor
110834059|NCT04453930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110834060|NCT04453930|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110834061|NCT04453930|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110834062|NCT04453930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110834063|NCT04453930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110834064|NCT04453930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110834065|NCT04453930|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110834067|NCT03796507|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110834068|NCT03796507|Alkylating Agents|alkylating agents|mesh-ancestor
110094825|NCT01711437|Protective Agents|protective agents|mesh-ancestor
110834069|NCT03796507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110834070|NCT03796507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110834071|NCT04586062|Plasminogen|plasminogen|mesh-list
110834072|NCT04586062|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110834073|NCT04586062|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110834074|NCT04586062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110834075|NCT01132781|Theophylline|theophylline|mesh-list
110094912|NCT01711671|Hormones|hormones|mesh-ancestor
110834076|NCT01132781|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110834077|NCT01132781|Autonomic Agents|autonomic agents|mesh-ancestor
110094970|NCT01711931|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110834078|NCT01132781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110834079|NCT01132781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110834080|NCT01132781|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110834081|NCT01132781|Respiratory System Agents|respiratory system agents|mesh-ancestor
110834082|NCT01132781|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110834083|NCT01132781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110834084|NCT01132781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110834085|NCT01132781|Vasodilator Agents|vasodilator agents|mesh-ancestor
110834086|NCT01132781|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110834087|NCT01132781|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110834088|NCT01132781|Purinergic Agents|purinergic agents|mesh-ancestor
110834089|NCT01132781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110834090|NCT03497767|Osimertinib|osimertinib|mesh-list
110834091|NCT03497767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110834092|NCT03497767|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110834093|NCT03497767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110888148|NCT03157583|Glycerol|glycerol|mesh-list
110834094|NCT03497767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110834095|NCT01303705|Cyclophosphamide|cyclophosphamide|mesh-list
110834096|NCT01303705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110834097|NCT01303705|Immunologic Factors|immunologic factors|mesh-ancestor
110834098|NCT01303705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110834099|NCT01303705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110095246|NCT01713426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110834100|NCT01303705|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110834101|NCT01303705|Alkylating Agents|alkylating agents|mesh-ancestor
110834102|NCT01303705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110834103|NCT01303705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110834104|NCT01303705|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110834105|NCT01134341|Vitamins|vitamins|mesh-list
110834106|NCT01134341|Folic Acid|folic acid|mesh-list
110834108|NCT01134341|Vitamin B Complex|vitamin b complex|mesh-list
110834109|NCT01134341|Bexarotene|bexarotene|mesh-list
110834110|NCT01134341|10-deazaaminopterin|10-deazaaminopterin|mesh-list
110834111|NCT01134341|Aminopterin|aminopterin|mesh-list
110834112|NCT01134341|Micronutrients|micronutrients|mesh-ancestor
110834113|NCT01134341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110834114|NCT01134341|Hematinics|hematinics|mesh-ancestor
110834115|NCT01134341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110834116|NCT01134341|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110834117|NCT01134341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110834118|NCT01134341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110834119|NCT04308304|Donepezil|donepezil|mesh-list
110834120|NCT04308304|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110834121|NCT04308304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110834122|NCT04308304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110834123|NCT04308304|Cholinergic Agents|cholinergic agents|mesh-ancestor
110834124|NCT04308304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110834125|NCT04308304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110834126|NCT04308304|Nootropic Agents|nootropic agents|mesh-ancestor
110834127|NCT05397262|Fluorouracil|fluorouracil|mesh-list
110834128|NCT05397262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110834129|NCT05397262|Antimetabolites|antimetabolites|mesh-ancestor
110834130|NCT05397262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110834131|NCT05397262|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110834132|NCT05397262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110834133|NCT05397262|Immunologic Factors|immunologic factors|mesh-ancestor
110834134|NCT05397262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110834135|NCT01230359|Pyridoxine|pyridoxine|mesh-list
110834136|NCT01230359|Vitamin B 6|vitamin b 6|mesh-list
110834137|NCT01230359|Vitamins|vitamins|mesh-ancestor
110834138|NCT01230359|Micronutrients|micronutrients|mesh-ancestor
110834139|NCT01230359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110834140|NCT01230359|Vitamin B Complex|vitamin b complex|mesh-ancestor
110834141|NCT05396326|Oxaliplatin|oxaliplatin|mesh-list
110834142|NCT05396326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110834143|NCT03795571|Dexamethasone|dexamethasone|mesh-list
110834144|NCT03795571|Rituximab|rituximab|mesh-list
110834145|NCT03795571|Gemcitabine|gemcitabine|mesh-list
110834146|NCT03795571|Oxaliplatin|oxaliplatin|mesh-list
110834147|NCT03795571|Lenalidomide|lenalidomide|mesh-list
110834148|NCT03795571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110834149|NCT03795571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110834150|NCT03795571|Immunologic Factors|immunologic factors|mesh-ancestor
110834151|NCT03795571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110834152|NCT03795571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110834153|NCT03795571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110834154|NCT03795571|Antiemetics|antiemetics|mesh-ancestor
110834155|NCT03795571|Autonomic Agents|autonomic agents|mesh-ancestor
110834156|NCT03795571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110834157|NCT03795571|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110834158|NCT03795571|Glucocorticoids|glucocorticoids|mesh-ancestor
110834160|NCT03795571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110834161|NCT03795571|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110095716|NCT01715909|Oseltamivir|oseltamivir|mesh-list
110834162|NCT03795571|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110834163|NCT03795571|Antimetabolites|antimetabolites|mesh-ancestor
110834164|NCT03795571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110834165|NCT03795571|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110834166|NCT03795571|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110834167|NCT03795571|Growth Substances|growth substances|mesh-ancestor
110834168|NCT03795571|Growth Inhibitors|growth inhibitors|mesh-ancestor
110834169|NCT03795649|Tranexamic Acid|tranexamic acid|mesh-list
110834170|NCT03795649|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110834171|NCT03795649|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110834172|NCT03795649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110834174|NCT03795649|Coagulants|coagulants|mesh-ancestor
110834175|NCT04211272|Sildenafil Citrate|sildenafil citrate|mesh-list
110834176|NCT04211272|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110834177|NCT04211272|Macitentan|macitentan|mesh-list
110834179|NCT04211272|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110834180|NCT04211272|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110834181|NCT04211272|Antimetabolites|antimetabolites|mesh-ancestor
110834182|NCT04211272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110834183|NCT04211272|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110834184|NCT04211272|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110834185|NCT04211272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110834186|NCT04211272|Vasodilator Agents|vasodilator agents|mesh-ancestor
110834187|NCT04211272|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110834188|NCT04211272|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110834189|NCT04211272|Urological Agents|urological agents|mesh-ancestor
110834190|NCT04211272|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
110834191|NCT04211272|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
110096056|NCT01718288|Aspirin|aspirin|mesh-list
110834192|NCT04211272|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
110834194|NCT05402189|Fentanyl|fentanyl|mesh-list
110834195|NCT05402189|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110834196|NCT05402189|Narcotics|narcotics|mesh-ancestor
110834197|NCT05402189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110834198|NCT05402189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110834199|NCT05402189|Analgesics|analgesics|mesh-ancestor
110834201|NCT05402189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110834202|NCT05402189|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110834203|NCT05402189|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110834204|NCT05402189|Anesthetics, General|anesthetics, general|mesh-ancestor
110834205|NCT05402189|Anesthetics|anesthetics|mesh-ancestor
110834206|NCT01304563|Vaccines|vaccines|mesh-list
110834207|NCT01304563|Immunologic Factors|immunologic factors|mesh-ancestor
110834208|NCT01304563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110834209|NCT01231997|Udenafil|udenafil|mesh-list
110834210|NCT01231997|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110834211|NCT01231997|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110834212|NCT01231997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110834213|NCT01231997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110834214|NCT03795805|Lidocaine|lidocaine|mesh-list
110834215|NCT03795805|Anesthetics, Local|anesthetics, local|mesh-ancestor
110834216|NCT03795805|Anesthetics|anesthetics|mesh-ancestor
110834217|NCT03795805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110834218|NCT03795805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110834219|NCT03795805|Sensory System Agents|sensory system agents|mesh-ancestor
110834220|NCT03795805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110834221|NCT03795805|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110834222|NCT03795805|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110834223|NCT03795805|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110834224|NCT03795805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110834225|NCT03795805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110834226|NCT04072042|Apatinib|apatinib|mesh-list
110888168|NCT04475705|Propofol|propofol|mesh-list
110834227|NCT04072042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110834228|NCT04072042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110834229|NCT04072042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110834230|NCT04072042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110834231|NCT03799315|Nicotine|nicotine|mesh-list
110834232|NCT03799315|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110834233|NCT03799315|Autonomic Agents|autonomic agents|mesh-ancestor
110834234|NCT03799315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110834235|NCT03799315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110834236|NCT03799315|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110834237|NCT03799315|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110834238|NCT03799315|Cholinergic Agents|cholinergic agents|mesh-ancestor
110834239|NCT03799315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110834240|NCT03799315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110834241|NCT05387200|Alendronate|alendronate|mesh-list
110834242|NCT05387200|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110834243|NCT05387200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110834244|NCT03442972|Teduglutide|teduglutide|mesh-list
110834245|NCT03442972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110834246|NCT03442972|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110834247|NCT03442972|Protective Agents|protective agents|mesh-ancestor
110834248|NCT03442972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110834250|NCT03921671|Carboplatin|carboplatin|mesh-list
110834251|NCT03921671|Ramucirumab|ramucirumab|mesh-list
110096757|NCT01731067|Dopamine Agents|dopamine agents|mesh-ancestor
110834252|NCT03921671|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110834253|NCT03921671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110834254|NCT03921671|Tubulin Modulators|tubulin modulators|mesh-ancestor
110834255|NCT03921671|Antimitotic Agents|antimitotic agents|mesh-ancestor
110834256|NCT03921671|Mitosis Modulators|mitosis modulators|mesh-ancestor
110834257|NCT03921671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110834259|NCT03921593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110834260|NCT03369951|Minocycline|minocycline|mesh-list
110834261|NCT03369951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110834262|NCT03369951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110834263|NCT01131767|Naproxen|naproxen|mesh-list
110834264|NCT01131767|Pseudoephedrine|pseudoephedrine|mesh-list
110834265|NCT01131767|Ephedrine|ephedrine|mesh-list
110834266|NCT01131767|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110834267|NCT01131767|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110834268|NCT01131767|Analgesics|analgesics|mesh-ancestor
110834269|NCT01131767|Sensory System Agents|sensory system agents|mesh-ancestor
110834270|NCT01131767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110096967|NCT01732094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110834271|NCT01131767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110834272|NCT01131767|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110834273|NCT01131767|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110834274|NCT01131767|Gout Suppressants|gout suppressants|mesh-ancestor
110834275|NCT01131767|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110834276|NCT01131767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110834277|NCT01131767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110834278|NCT01131767|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110834279|NCT01131767|Autonomic Agents|autonomic agents|mesh-ancestor
110834280|NCT01131767|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110834281|NCT01131767|Respiratory System Agents|respiratory system agents|mesh-ancestor
110834282|NCT01131767|Nasal Decongestants|nasal decongestants|mesh-ancestor
110834283|NCT01131767|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110834284|NCT01131767|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110834285|NCT01131767|Sympathomimetics|sympathomimetics|mesh-ancestor
110834286|NCT01131767|Adrenergic Agents|adrenergic agents|mesh-ancestor
110834287|NCT01131767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110834288|NCT03795259|Rocuronium|rocuronium|mesh-list
110888178|NCT03158311|Fluticasone|fluticasone|mesh-list
110834289|NCT03795259|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110834290|NCT03795259|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110834291|NCT03795259|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110834292|NCT03795259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110834293|NCT03795259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110834294|NCT01229189|Vitamin D|vitamin d|mesh-list
110834295|NCT01229189|Vitamins|vitamins|mesh-ancestor
110834296|NCT01229189|Micronutrients|micronutrients|mesh-ancestor
110834297|NCT01229189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110834298|NCT01229189|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110834299|NCT05481489|Atropine|atropine|mesh-list
110834300|NCT05481489|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110834301|NCT05481489|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110834302|NCT05481489|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110834303|NCT05481489|Autonomic Agents|autonomic agents|mesh-ancestor
110834304|NCT05481489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110834305|NCT05481489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110834306|NCT05481489|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110834307|NCT05481489|Respiratory System Agents|respiratory system agents|mesh-ancestor
110834308|NCT05481489|Mydriatics|mydriatics|mesh-ancestor
110834309|NCT05481489|Parasympatholytics|parasympatholytics|mesh-ancestor
110834310|NCT05481489|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110834311|NCT05481489|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110834312|NCT05481489|Cholinergic Agents|cholinergic agents|mesh-ancestor
110834313|NCT05481489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110834314|NCT05481489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110834315|NCT05341180|Lactulose|lactulose|mesh-list
110834316|NCT05341180|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110834317|NCT05341180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110834318|NCT01133483|Fexofenadine|fexofenadine|mesh-list
110834319|NCT01133483|Pseudoephedrine|pseudoephedrine|mesh-list
110834320|NCT01133483|Ephedrine|ephedrine|mesh-list
110834321|NCT01133483|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110834322|NCT01133483|Autonomic Agents|autonomic agents|mesh-ancestor
110097445|NCT01735747|Tubulin Modulators|tubulin modulators|mesh-ancestor
110834323|NCT01133483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110834324|NCT01133483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110834325|NCT01133483|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110834326|NCT01133483|Respiratory System Agents|respiratory system agents|mesh-ancestor
110834327|NCT01133483|Nasal Decongestants|nasal decongestants|mesh-ancestor
110834328|NCT01133483|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110834329|NCT01133483|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110834330|NCT01133483|Sympathomimetics|sympathomimetics|mesh-ancestor
110834331|NCT01133483|Adrenergic Agents|adrenergic agents|mesh-ancestor
110834332|NCT01133483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110834333|NCT01133483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110834334|NCT01133483|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110834335|NCT01133483|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110834336|NCT01133483|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110834337|NCT01133483|Histamine Antagonists|histamine antagonists|mesh-ancestor
110834338|NCT01133483|Histamine Agents|histamine agents|mesh-ancestor
110834339|NCT05401721|Arginine Vasopressin|arginine vasopressin|mesh-list
110834340|NCT05401721|Hemostatics|hemostatics|mesh-ancestor
110834341|NCT05401721|Coagulants|coagulants|mesh-ancestor
110834342|NCT05401721|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110834343|NCT05401721|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
110834344|NCT05401721|Natriuretic Agents|natriuretic agents|mesh-ancestor
110834345|NCT05401721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110834347|NCT01560481|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110834348|NCT01560481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110834349|NCT04795531|Insulin|insulin|mesh-list
110834350|NCT04795531|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110834351|NCT04795531|Insulin, Long-Acting|insulin, long-acting|mesh-list
110834352|NCT04795531|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110834353|NCT04795531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110834354|NCT05238844|Tenofovir|tenofovir|mesh-list
110834355|NCT05238844|Antiviral Agents|antiviral agents|mesh-ancestor
110834356|NCT05238844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110097785|NCT01738100|Analgesics|analgesics|mesh-ancestor
110834357|NCT05238844|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110834358|NCT05238844|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110834359|NCT05238844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110834360|NCT05238844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110834361|NCT05238844|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110834362|NCT05238844|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110834363|NCT04785625|Bupivacaine|bupivacaine|mesh-list
110834364|NCT04785625|Anesthetics, Local|anesthetics, local|mesh-ancestor
110834365|NCT04785625|Anesthetics|anesthetics|mesh-ancestor
110834366|NCT04785625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110834367|NCT04785625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110834368|NCT04785625|Sensory System Agents|sensory system agents|mesh-ancestor
110834369|NCT04785625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110834371|NCT03368859|Bevacizumab|bevacizumab|mesh-list
110834372|NCT03368859|Fluorouracil|fluorouracil|mesh-list
110834373|NCT03368859|Irinotecan|irinotecan|mesh-list
110834374|NCT03368859|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110834375|NCT03368859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110834376|NCT03368859|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110834377|NCT03368859|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110834378|NCT03368859|Growth Substances|growth substances|mesh-ancestor
110834379|NCT03368859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110834380|NCT03368859|Growth Inhibitors|growth inhibitors|mesh-ancestor
110834381|NCT03368859|Antimetabolites|antimetabolites|mesh-ancestor
110184257|NCT00033111|Dopamine Agents|dopamine agents|mesh-ancestor
110834382|NCT03368859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110834383|NCT03368859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110834384|NCT03368859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110834386|NCT03368859|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110834387|NCT03368859|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110834388|NCT03368859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110834390|NCT03368859|Protective Agents|protective agents|mesh-ancestor
110834391|NCT03368859|Vitamin B Complex|vitamin b complex|mesh-ancestor
110834392|NCT03368859|Vitamins|vitamins|mesh-ancestor
110834393|NCT03368859|Micronutrients|micronutrients|mesh-ancestor
110834394|NCT01134965|Digoxin|digoxin|mesh-list
110834395|NCT01134965|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110834396|NCT01134965|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110834397|NCT01134965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110834398|NCT01134965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110834399|NCT01134965|Protective Agents|protective agents|mesh-ancestor
110834400|NCT01134965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110834401|NCT03810547|Ketamine|ketamine|mesh-list
110834402|NCT03810547|Propofol|propofol|mesh-list
110834403|NCT03810547|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110834404|NCT03810547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110834405|NCT03810547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110834406|NCT03810547|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110834407|NCT03810547|Anesthetics, General|anesthetics, general|mesh-ancestor
110551974|NCT01005433|Analgesics|analgesics|mesh-ancestor
110834408|NCT03810547|Anesthetics|anesthetics|mesh-ancestor
110834409|NCT03810547|Analgesics|analgesics|mesh-ancestor
110834410|NCT03810547|Sensory System Agents|sensory system agents|mesh-ancestor
110834412|NCT03810547|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110834413|NCT03810547|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110834414|NCT03810547|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110834415|NCT03810547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110098472|NCT01742689|Natriuretic Agents|natriuretic agents|mesh-ancestor
110834416|NCT03810547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110834417|NCT03096314|Vitamin D|vitamin d|mesh-list
110834418|NCT03096314|Cholecalciferol|cholecalciferol|mesh-list
110834419|NCT03096314|Vitamins|vitamins|mesh-ancestor
110834420|NCT03096314|Micronutrients|micronutrients|mesh-ancestor
110834421|NCT03096314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110834422|NCT03096314|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110834423|NCT03096314|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110834424|NCT03917459|Enalapril|enalapril|mesh-list
110834425|NCT03917459|Enalaprilat|enalaprilat|mesh-list
110834426|NCT03917459|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
110834427|NCT03917459|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110834428|NCT03917459|Protease Inhibitors|protease inhibitors|mesh-ancestor
110834429|NCT03917459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110834430|NCT03917459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110834431|NCT03917459|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110834432|NCT03917459|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110834433|NCT03129646|Paromomycin|paromomycin|mesh-list
110834435|NCT03129646|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
110834436|NCT03129646|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110834437|NCT03129646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110834438|NCT03129646|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110834439|NCT03129646|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110834440|NCT03129646|Antifungal Agents|antifungal agents|mesh-ancestor
110834441|NCT03129646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110834442|NCT03129646|Schistosomicides|schistosomicides|mesh-ancestor
110834443|NCT03129646|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110834444|NCT03129646|Anthelmintics|anthelmintics|mesh-ancestor
110834445|NCT03710655|Histamine|histamine|mesh-list
110834446|NCT03710655|Histamine Agonists|histamine agonists|mesh-ancestor
110834447|NCT03710655|Histamine Agents|histamine agents|mesh-ancestor
110834448|NCT03710655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110834449|NCT03710655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110834450|NCT03710655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110834451|NCT01135199|Pomalidomide|pomalidomide|mesh-list
110834452|NCT01135199|Immunologic Factors|immunologic factors|mesh-ancestor
110834453|NCT01135199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110834454|NCT01135199|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110834455|NCT01135199|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110834456|NCT01135199|Growth Substances|growth substances|mesh-ancestor
110834457|NCT01135199|Growth Inhibitors|growth inhibitors|mesh-ancestor
110834458|NCT01135199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110834459|NCT03917537|Nivolumab|nivolumab|mesh-list
110834460|NCT03917537|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110834461|NCT03917537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110834462|NCT03917537|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110834463|NCT03917537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110834464|NCT03335163|Topiramate|topiramate|mesh-list
110834465|NCT03335163|Anticonvulsants|anticonvulsants|mesh-ancestor
110834466|NCT03335163|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110834467|NCT03335163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110834468|NCT04749602|Nivolumab|nivolumab|mesh-list
110834469|NCT04749602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110834470|NCT04749602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110834471|NCT04749602|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110834472|NCT04749602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110834473|NCT03461302|Coal Tar|coal tar|mesh-list
110834475|NCT03461302|Dermatologic Agents|dermatologic agents|mesh-ancestor
110834476|NCT01232075|Letrozole|letrozole|mesh-list
110834477|NCT01232075|Citric Acid|citric acid|mesh-list
110834478|NCT01232075|Sodium Citrate|sodium citrate|mesh-list
110834479|NCT01232075|Clomiphene|clomiphene|mesh-list
110834480|NCT01232075|Enclomiphene|enclomiphene|mesh-list
110834481|NCT01232075|Zuclomiphene|zuclomiphene|mesh-list
110834482|NCT01232075|Anticoagulants|anticoagulants|mesh-ancestor
110834483|NCT01232075|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110834484|NCT01232075|Chelating Agents|chelating agents|mesh-ancestor
110834485|NCT01232075|Sequestering Agents|sequestering agents|mesh-ancestor
110552038|NCT01005979|Rituximab|rituximab|mesh-list
110834486|NCT01232075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110834487|NCT01232075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110834488|NCT01232075|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110834489|NCT01232075|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110834490|NCT01232075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110834491|NCT01232075|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110834492|NCT01232075|Hormone Antagonists|hormone antagonists|mesh-ancestor
110834493|NCT01232075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110834494|NCT01232075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110834495|NCT01232075|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110834496|NCT01232075|Fertility Agents|fertility agents|mesh-ancestor
110834497|NCT01232075|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110834498|NCT01232075|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110834499|NCT01232075|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110834500|NCT03773822|Hydrocortisone|hydrocortisone|mesh-list
110834501|NCT03773822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110834502|NCT01131845|Treprostinil|treprostinil|mesh-list
110834503|NCT01131845|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110834505|NCT03711422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110834506|NCT03711422|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110834507|NCT03711422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110834508|NCT03711422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110834509|NCT03460678|Pemetrexed|pemetrexed|mesh-list
110834510|NCT03460678|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110834511|NCT03460678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110148942|NCT00006133|Estradiol|estradiol|mesh-list
110834512|NCT03460678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110834513|NCT03460678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110834514|NCT03460678|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110834515|NCT03460678|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110834516|NCT03460678|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110834517|NCT03810391|Butorphanol|butorphanol|mesh-list
110834518|NCT03810391|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110834519|NCT03810391|Narcotics|narcotics|mesh-ancestor
110834521|NCT03810391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110834522|NCT03810391|Analgesics|analgesics|mesh-ancestor
110834523|NCT03810391|Sensory System Agents|sensory system agents|mesh-ancestor
110834524|NCT03810391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110834525|NCT03810391|Antitussive Agents|antitussive agents|mesh-ancestor
110834526|NCT03810391|Respiratory System Agents|respiratory system agents|mesh-ancestor
110834527|NCT03810391|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110834528|NCT01229579|Zinc Sulfate|zinc sulfate|mesh-list
110834529|NCT01229579|Astringents|astringents|mesh-ancestor
110834530|NCT01229579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110834531|NCT01229579|Dermatologic Agents|dermatologic agents|mesh-ancestor
110834532|NCT01131923|Amlodipine|amlodipine|mesh-list
110834533|NCT01131923|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110834534|NCT01131923|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110834535|NCT01131923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110149181|NCT00006250|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110834536|NCT01131923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110834537|NCT01131923|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110834538|NCT01131923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110834539|NCT01131923|Vasodilator Agents|vasodilator agents|mesh-ancestor
110834540|NCT03794557|Pam2CSK4 acetate and ODN M362 combination|pam2csk4 acetate and odn m362 combination|mesh-list
110834541|NCT03794557|Respiratory System Agents|respiratory system agents|mesh-ancestor
110834542|NCT01230983|Leucovorin|leucovorin|mesh-list
110834543|NCT01230983|Cytarabine|cytarabine|mesh-list
110834544|NCT01230983|Prednisone|prednisone|mesh-list
110834545|NCT01230983|Hydrocortisone|hydrocortisone|mesh-list
110834546|NCT01230983|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
110834547|NCT01230983|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
110834548|NCT01230983|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
110834549|NCT01230983|Doxorubicin|doxorubicin|mesh-list
110834550|NCT01230983|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110834551|NCT01230983|Dexrazoxane|dexrazoxane|mesh-list
110834552|NCT01230983|Methotrexate|methotrexate|mesh-list
110834553|NCT01230983|Vincristine|vincristine|mesh-list
110834554|NCT01230983|Asparaginase|asparaginase|mesh-list
110834555|NCT01230983|Mercaptopurine|mercaptopurine|mesh-list
110834556|NCT01230983|Razoxane|razoxane|mesh-list
110834557|NCT01230983|Levoleucovorin|levoleucovorin|mesh-list
110888219|NCT00449111|Losartan|losartan|mesh-list
110834558|NCT01230983|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110834560|NCT01230983|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110552117|NCT03999775|Vitamin D|vitamin d|mesh-list
110834561|NCT01230983|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110834562|NCT01230983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110834563|NCT01230983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110834564|NCT01230983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110834565|NCT01230983|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110834566|NCT01230983|Glucocorticoids|glucocorticoids|mesh-ancestor
110834567|NCT01230983|Hormones|hormones|mesh-ancestor
110834568|NCT01230983|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110834569|NCT01230983|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110834570|NCT01230983|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110834571|NCT01230983|Abortifacient Agents|abortifacient agents|mesh-ancestor
110834572|NCT01230983|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110834573|NCT01230983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110834574|NCT01230983|Antimetabolites|antimetabolites|mesh-ancestor
110834575|NCT01230983|Dermatologic Agents|dermatologic agents|mesh-ancestor
110834576|NCT01230983|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110834577|NCT01230983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110834578|NCT01230983|Immunologic Factors|immunologic factors|mesh-ancestor
110834579|NCT01230983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110834580|NCT01230983|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110834581|NCT01230983|Antiviral Agents|antiviral agents|mesh-ancestor
110149657|NCT00008151|Immunotoxins|immunotoxins|mesh-ancestor
110834582|NCT01230983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110834583|NCT01230983|Antidotes|antidotes|mesh-ancestor
110834584|NCT01230983|Protective Agents|protective agents|mesh-ancestor
110834585|NCT01230983|Vitamin B Complex|vitamin b complex|mesh-ancestor
110834586|NCT01230983|Vitamins|vitamins|mesh-ancestor
110834587|NCT01230983|Micronutrients|micronutrients|mesh-ancestor
110834588|NCT01230983|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110834589|NCT01230983|Tubulin Modulators|tubulin modulators|mesh-ancestor
110834590|NCT01230983|Antimitotic Agents|antimitotic agents|mesh-ancestor
110834591|NCT01230983|Mitosis Modulators|mitosis modulators|mesh-ancestor
110834592|NCT01230983|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110834593|NCT01304797|Cyclophosphamide|cyclophosphamide|mesh-list
110834594|NCT01304797|Trastuzumab|trastuzumab|mesh-list
110834596|NCT01304797|Gancotamab|gancotamab|mesh-list
110834597|NCT01304797|Immunoconjugates|immunoconjugates|mesh-list
110834598|NCT01304797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110834599|NCT01304797|Immunologic Factors|immunologic factors|mesh-ancestor
110834600|NCT01304797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110834601|NCT01304797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110834602|NCT01304797|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110834603|NCT01304797|Alkylating Agents|alkylating agents|mesh-ancestor
110834604|NCT01304797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110834605|NCT01304797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110184324|NCT00393263|Clobetasol|clobetasol|mesh-list
110834606|NCT01304797|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110834607|NCT01304797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110834608|NCT01304797|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110834609|NCT01304797|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110834610|NCT01304797|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110834611|NCT01304797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110834612|NCT03707535|Infliximab|infliximab|mesh-list
110834613|NCT03707535|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110834614|NCT03707535|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110834615|NCT03707535|Dermatologic Agents|dermatologic agents|mesh-ancestor
110834616|NCT03707535|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110834617|NCT03707535|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110834618|NCT01133795|Midodrine|midodrine|mesh-list
110150002|NCT00007774|Olanzapine|olanzapine|mesh-list
110834619|NCT01133795|Sympathomimetics|sympathomimetics|mesh-ancestor
110834620|NCT01133795|Autonomic Agents|autonomic agents|mesh-ancestor
110834621|NCT01133795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110834622|NCT01133795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110834623|NCT01133795|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110834624|NCT01133795|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110834625|NCT01133795|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110834626|NCT01133795|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110834627|NCT01133795|Adrenergic Agents|adrenergic agents|mesh-ancestor
110834628|NCT01133795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110834629|NCT01133795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110834630|NCT01133873|Dextropropoxyphene|dextropropoxyphene|mesh-list
110834631|NCT01133873|Levopropoxyphene|levopropoxyphene|mesh-list
110834632|NCT01133873|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110834633|NCT01133873|Narcotics|narcotics|mesh-ancestor
110834634|NCT01133873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110834635|NCT01133873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110834636|NCT01133873|Analgesics|analgesics|mesh-ancestor
110834637|NCT01133873|Sensory System Agents|sensory system agents|mesh-ancestor
110834638|NCT01133873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110834639|NCT01133873|Antitussive Agents|antitussive agents|mesh-ancestor
110834640|NCT01133873|Respiratory System Agents|respiratory system agents|mesh-ancestor
110834641|NCT01229813|Bevacizumab|bevacizumab|mesh-list
110834642|NCT01229813|Capecitabine|capecitabine|mesh-list
110834643|NCT01229813|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110834644|NCT01229813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110834645|NCT01229813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110834646|NCT01229813|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110834647|NCT01229813|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110834648|NCT01229813|Growth Substances|growth substances|mesh-ancestor
110834649|NCT01229813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110834650|NCT01229813|Growth Inhibitors|growth inhibitors|mesh-ancestor
110834651|NCT01229813|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110834652|NCT01229813|Antimetabolites|antimetabolites|mesh-ancestor
110834653|NCT01229813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110834654|NCT01229813|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110834655|NCT01229813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110834656|NCT03920813|Mercaptopurine|mercaptopurine|mesh-list
110834657|NCT03920813|Antimetabolites|antimetabolites|mesh-ancestor
110834658|NCT03920813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110834659|NCT03920813|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110834660|NCT03920813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110184350|NCT00033696|Paclitaxel|paclitaxel|mesh-list
110834661|NCT03920813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110834662|NCT03920813|Immunologic Factors|immunologic factors|mesh-ancestor
110834663|NCT03920813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110834664|NCT03920813|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110834665|NCT03920813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110834666|NCT01649947|Hydroxychloroquine|hydroxychloroquine|mesh-list
110834667|NCT01649947|Paclitaxel|paclitaxel|mesh-list
110834668|NCT01649947|Bevacizumab|bevacizumab|mesh-list
110834669|NCT01649947|Carboplatin|carboplatin|mesh-list
110834670|NCT01649947|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110150239|NCT05636566|Dexmedetomidine|dexmedetomidine|mesh-list
110834672|NCT01649947|Tubulin Modulators|tubulin modulators|mesh-ancestor
110834673|NCT01649947|Antimitotic Agents|antimitotic agents|mesh-ancestor
110834674|NCT01649947|Mitosis Modulators|mitosis modulators|mesh-ancestor
110834675|NCT01649947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110834676|NCT01649947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110834677|NCT01649947|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110834678|NCT01649947|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110834679|NCT01649947|Growth Substances|growth substances|mesh-ancestor
110834680|NCT01649947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110834681|NCT01649947|Growth Inhibitors|growth inhibitors|mesh-ancestor
110834682|NCT01649947|Antimalarials|antimalarials|mesh-ancestor
110834683|NCT01649947|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110834684|NCT01649947|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110834685|NCT01649947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110834686|NCT01649947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110834687|NCT01649947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110834688|NCT03793075|Ketamine|ketamine|mesh-list
110834689|NCT03793075|Propofol|propofol|mesh-list
110834690|NCT03793075|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110150370|NCT00000136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110834691|NCT03793075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110834692|NCT03793075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110834693|NCT03793075|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110834694|NCT03793075|Anesthetics, General|anesthetics, general|mesh-ancestor
110834695|NCT03793075|Anesthetics|anesthetics|mesh-ancestor
110834696|NCT03793075|Analgesics|analgesics|mesh-ancestor
110834697|NCT03793075|Sensory System Agents|sensory system agents|mesh-ancestor
110150434|NCT00000175|Testosterone|testosterone|mesh-list
110834698|NCT03793075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110834699|NCT03793075|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110834700|NCT03793075|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110834701|NCT03793075|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110834702|NCT03793075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110834703|NCT03793075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110834704|NCT01233167|Clopidogrel|clopidogrel|mesh-list
110834705|NCT01233167|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110834706|NCT01233167|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110834707|NCT01233167|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110834708|NCT01233167|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110834709|NCT01233167|Purinergic Agents|purinergic agents|mesh-ancestor
110834710|NCT01233167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110834711|NCT01233167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110834712|NCT01233167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110834714|NCT01304095|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110834715|NCT01304095|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110834716|NCT01304095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110834717|NCT03707457|Nivolumab|nivolumab|mesh-list
110834718|NCT03707457|Ipilimumab|ipilimumab|mesh-list
110834719|NCT03707457|MK-4166|mk-4166|mesh-list
110834720|NCT03707457|Antibodies|antibodies|mesh-list
110834721|NCT03707457|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110834722|NCT03707457|Immunologic Factors|immunologic factors|mesh-ancestor
110834723|NCT03707457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110834724|NCT03707457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110834725|NCT03707457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110834726|NCT03707457|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110834727|NCT03707457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110834729|NCT01568294|Immunologic Factors|immunologic factors|mesh-ancestor
110834730|NCT01568294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110834731|NCT01568294|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110834732|NCT01568294|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110834733|NCT01568294|Growth Substances|growth substances|mesh-ancestor
110834734|NCT01568294|Growth Inhibitors|growth inhibitors|mesh-ancestor
110834735|NCT01568294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110834736|NCT03422666|Teduglutide|teduglutide|mesh-list
110834737|NCT03422666|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110834738|NCT03422666|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110834739|NCT03422666|Protective Agents|protective agents|mesh-ancestor
110834740|NCT03422666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110834741|NCT03453190|Apremilast|apremilast|mesh-list
110834742|NCT03453190|Clobetasol|clobetasol|mesh-list
110834743|NCT03453190|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110834744|NCT03453190|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110834745|NCT03453190|Analgesics|analgesics|mesh-ancestor
110834746|NCT03453190|Sensory System Agents|sensory system agents|mesh-ancestor
110150977|NCT00000715|Trimethoprim|trimethoprim|mesh-list
110834747|NCT03453190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110888244|NCT03571490|Anesthetics|anesthetics|mesh-ancestor
110834748|NCT03453190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110834749|NCT03453190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110834750|NCT03453190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110834751|NCT03453190|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
110834752|NCT03453190|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110834753|NCT03453190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110834754|NCT03453190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110834756|NCT03453190|Hormones|hormones|mesh-ancestor
110834757|NCT03453190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110834758|NCT01231139|Acetaminophen|acetaminophen|mesh-list
110834759|NCT01231139|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110834761|NCT01231139|Sensory System Agents|sensory system agents|mesh-ancestor
110834762|NCT01231139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110834763|NCT01231139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110834764|NCT01231139|Antipyretics|antipyretics|mesh-ancestor
110834765|NCT03382574|Denosumab|denosumab|mesh-list
110834766|NCT03382574|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110834767|NCT03382574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110834768|NCT01137695|Pramlintide|pramlintide|mesh-list
110834769|NCT01137695|Islet Amyloid Polypeptide|islet amyloid polypeptide|mesh-list
110834770|NCT01137695|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110834771|NCT01137695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110834772|NCT01137695|Appetite Depressants|appetite depressants|mesh-ancestor
110834773|NCT01137695|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110151330|NCT00000922|Lamivudine|lamivudine|mesh-list
110834775|NCT01137695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110834776|NCT03451396|Lifitegrast|lifitegrast|mesh-list
110834777|NCT03451396|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110834778|NCT03451396|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110834779|NCT02528825|Remifentanil|remifentanil|mesh-list
110834780|NCT02528825|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110834782|NCT02528825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110834783|NCT02528825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110834784|NCT02528825|Analgesics|analgesics|mesh-ancestor
110834785|NCT02528825|Sensory System Agents|sensory system agents|mesh-ancestor
110834786|NCT02528825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110834788|NCT01233245|Interferon-beta|interferon-beta|mesh-list
110834789|NCT01233245|Interferon beta-1b|interferon beta-1b|mesh-list
110834790|NCT01233245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110834791|NCT01233245|Antiviral Agents|antiviral agents|mesh-ancestor
110834792|NCT01233245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110834793|NCT01233245|Immunologic Factors|immunologic factors|mesh-ancestor
110834794|NCT01233245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110834795|NCT01233245|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110834796|NCT03776812|Paclitaxel|paclitaxel|mesh-list
110834797|NCT03776812|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110834798|NCT03776812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110834799|NCT03776812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110834800|NCT03776812|Tubulin Modulators|tubulin modulators|mesh-ancestor
110834801|NCT03776812|Antimitotic Agents|antimitotic agents|mesh-ancestor
110834802|NCT03776812|Mitosis Modulators|mitosis modulators|mesh-ancestor
110834803|NCT03776812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110834804|NCT03361605|Propofol|propofol|mesh-list
110834805|NCT03361605|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110834806|NCT03361605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110834807|NCT03361605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110834808|NCT03361605|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110834809|NCT03361605|Anesthetics, General|anesthetics, general|mesh-ancestor
110834810|NCT03361605|Anesthetics|anesthetics|mesh-ancestor
110834811|NCT03794167|Cyclophosphamide|cyclophosphamide|mesh-list
110834812|NCT03794167|Melphalan|melphalan|mesh-list
110834813|NCT03794167|Busulfan|busulfan|mesh-list
110834814|NCT03794167|Etoposide|etoposide|mesh-list
110834815|NCT03794167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110834816|NCT03794167|Immunologic Factors|immunologic factors|mesh-ancestor
110834817|NCT03794167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110834818|NCT03794167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110834819|NCT03794167|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110834820|NCT03794167|Alkylating Agents|alkylating agents|mesh-ancestor
110834821|NCT03794167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110834822|NCT03794167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110834823|NCT03794167|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110834824|NCT03794167|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110834825|NCT03794167|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110834826|NCT03794167|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110834827|NCT03794167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110834828|NCT05332821|Bevacizumab|bevacizumab|mesh-list
110834829|NCT05332821|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
110834830|NCT05332821|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110834831|NCT05332821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110834832|NCT05332821|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110834833|NCT05332821|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110834834|NCT05332821|Growth Substances|growth substances|mesh-ancestor
110834835|NCT05332821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110834836|NCT05332821|Growth Inhibitors|growth inhibitors|mesh-ancestor
110834837|NCT05332821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110834838|NCT05331651|Glycopyrrolate|glycopyrrolate|mesh-list
110834839|NCT05331651|Tropisetron|tropisetron|mesh-list
110834840|NCT05331651|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110834841|NCT05331651|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110834842|NCT05331651|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110834843|NCT05331651|Cholinergic Agents|cholinergic agents|mesh-ancestor
110834844|NCT05331651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110834845|NCT05331651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110834846|NCT05331651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110834847|NCT05331651|Antiemetics|antiemetics|mesh-ancestor
110834848|NCT05331651|Autonomic Agents|autonomic agents|mesh-ancestor
110834849|NCT05331651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110834850|NCT05331651|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110834851|NCT05331651|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110834852|NCT05331651|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110834853|NCT05331651|Serotonin Agents|serotonin agents|mesh-ancestor
110834854|NCT01134185|Prucalopride|prucalopride|mesh-list
110834855|NCT01134185|Laxatives|laxatives|mesh-ancestor
110834856|NCT01134185|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110834857|NCT01134185|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
110834858|NCT01134185|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110151770|NCT00001303|Antioxidants|antioxidants|mesh-ancestor
110834859|NCT01134185|Serotonin Agents|serotonin agents|mesh-ancestor
110834860|NCT01134185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110552414|NCT04018690|Hormones|hormones|mesh-ancestor
110834861|NCT01134185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110834862|NCT01134185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110834863|NCT03829046|Evolocumab|evolocumab|mesh-list
110834864|NCT03829046|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
110151835|NCT00001474|Interleukin-2|interleukin-2|mesh-list
110834865|NCT03829046|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110834866|NCT03829046|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110834867|NCT03829046|Antimetabolites|antimetabolites|mesh-ancestor
110834868|NCT03829046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110834869|NCT03829046|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110834870|NCT03829046|Protease Inhibitors|protease inhibitors|mesh-ancestor
110834871|NCT03829046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110834872|NCT03829046|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110834873|NCT05320588|Pembrolizumab|pembrolizumab|mesh-list
110888272|NCT03570320|Analgesics, Opioid|analgesics, opioid|mesh-list
110834874|NCT05320588|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110834875|NCT05320588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110151968|NCT00389428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110834877|NCT05320588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110834878|NCT01231529|Dolutegravir|dolutegravir|mesh-list
110834879|NCT01231529|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110834880|NCT01231529|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110834881|NCT01231529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110184424|NCT00034047|Nafarelin|nafarelin|mesh-list
110834882|NCT01231529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110834883|NCT01231529|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110834884|NCT01231529|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110834885|NCT01231529|Antiviral Agents|antiviral agents|mesh-ancestor
110834886|NCT01231529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110834887|NCT05306704|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
110834888|NCT05306704|Calcifediol|calcifediol|mesh-list
110834889|NCT05306704|Vitamins|vitamins|mesh-ancestor
110834890|NCT05306704|Micronutrients|micronutrients|mesh-ancestor
110834891|NCT05306704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110834892|NCT05306704|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110834893|NCT01231685|Ritonavir|ritonavir|mesh-list
110834894|NCT01231685|Lopinavir|lopinavir|mesh-list
110834895|NCT01231685|Atazanavir Sulfate|atazanavir sulfate|mesh-list
110834896|NCT01231685|Darunavir|darunavir|mesh-list
110834897|NCT01231685|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
110834899|NCT01231685|Protease Inhibitors|protease inhibitors|mesh-list
110834900|NCT01231685|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110834901|NCT01231685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110834902|NCT01231685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110834903|NCT01231685|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110834904|NCT01231685|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110834905|NCT01231685|Antiviral Agents|antiviral agents|mesh-ancestor
110834906|NCT01231685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110834907|NCT01231685|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110834908|NCT01231685|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110834909|NCT01231685|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110834910|NCT01231685|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110834911|NCT05402735|Uric Acid|uric acid|mesh-list
110834912|NCT05402735|Antioxidants|antioxidants|mesh-ancestor
110834913|NCT05402735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110834914|NCT05402735|Protective Agents|protective agents|mesh-ancestor
110834915|NCT05402735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110834916|NCT01138085|Trametinib|trametinib|mesh-list
110834917|NCT01138085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110834918|NCT01138085|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110834919|NCT01138085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110834920|NCT01138085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110834921|NCT05278858|Triamcinolone|triamcinolone|mesh-list
110834922|NCT05278858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110834923|NCT05278858|Glucocorticoids|glucocorticoids|mesh-ancestor
110834924|NCT05278858|Hormones|hormones|mesh-ancestor
110834925|NCT05278858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110834926|NCT05278858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110834927|NCT03792217|Sodium Hypochlorite|sodium hypochlorite|mesh-list
110834929|NCT03792217|Disinfectants|disinfectants|mesh-ancestor
110834930|NCT03792217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110834931|NCT03359811|Bupivacaine|bupivacaine|mesh-list
110834932|NCT03359811|Anesthetics, Local|anesthetics, local|mesh-list
110834933|NCT03359811|Anesthetics|anesthetics|mesh-list
110834934|NCT03359811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110834935|NCT03359811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110834936|NCT03359811|Sensory System Agents|sensory system agents|mesh-ancestor
110834937|NCT03359811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110834938|NCT03728426|Letermovir|letermovir|mesh-list
110834939|NCT03728426|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110834940|NCT03728426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110834941|NCT03728426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110834942|NCT03728426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110834943|NCT03728426|Antiviral Agents|antiviral agents|mesh-ancestor
110834944|NCT03728426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110834945|NCT01140581|Dronedarone|dronedarone|mesh-list
110834946|NCT01140581|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110834947|NCT03792139|Itraconazole|itraconazole|mesh-list
110834948|NCT03792139|Antifungal Agents|antifungal agents|mesh-ancestor
110834949|NCT03792139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110834950|NCT03792139|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110152700|NCT00000639|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110834951|NCT03792139|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110834952|NCT03792139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110834953|NCT03792139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110834954|NCT03792139|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110834955|NCT03792139|Hormone Antagonists|hormone antagonists|mesh-ancestor
110834956|NCT03792139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110152765|NCT00389025|Histamine Antagonists|histamine antagonists|mesh-ancestor
110834957|NCT03792139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110834958|NCT03792139|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110834961|NCT03792295|Oxycodone|oxycodone|mesh-list
110834962|NCT03792295|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110834963|NCT03792295|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110834964|NCT03792295|Analgesics|analgesics|mesh-ancestor
110834965|NCT03792295|Sensory System Agents|sensory system agents|mesh-ancestor
110834966|NCT03792295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110152915|NCT00000696|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110834967|NCT03792295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110834968|NCT03792295|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110834969|NCT03792295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110834970|NCT03792295|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110834971|NCT03792295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110834972|NCT03792295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110834973|NCT03792295|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110834974|NCT03792295|Narcotics|narcotics|mesh-ancestor
110153049|NCT04038346|Antipyretics|antipyretics|mesh-ancestor
110834975|NCT03792295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110834976|NCT03792295|Antipyretics|antipyretics|mesh-ancestor
110834977|NCT03449056|Albuterol|albuterol|mesh-list
110834978|NCT03449056|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110834979|NCT03449056|Autonomic Agents|autonomic agents|mesh-ancestor
110834980|NCT03449056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110834981|NCT03449056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110834982|NCT03449056|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110834983|NCT03449056|Respiratory System Agents|respiratory system agents|mesh-ancestor
110834984|NCT03449056|Tocolytic Agents|tocolytic agents|mesh-ancestor
110834985|NCT03449056|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110834986|NCT03449056|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110834987|NCT03449056|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110834988|NCT03449056|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110834989|NCT03449056|Adrenergic Agents|adrenergic agents|mesh-ancestor
110834990|NCT03449056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110834991|NCT03449056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110834992|NCT01135433|Metformin|metformin|mesh-list
110834993|NCT01135433|Ipragliflozin|ipragliflozin|mesh-list
110834994|NCT01135433|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110834995|NCT01135433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110834996|NCT01135433|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110834997|NCT01135433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110834998|NCT04745273|Ondansetron|ondansetron|mesh-list
110834999|NCT04745273|Antiemetics|antiemetics|mesh-ancestor
110835000|NCT04745273|Autonomic Agents|autonomic agents|mesh-ancestor
110835001|NCT04745273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110835002|NCT04745273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110835003|NCT04745273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110835004|NCT04745273|Antipruritics|antipruritics|mesh-ancestor
110835005|NCT04745273|Dermatologic Agents|dermatologic agents|mesh-ancestor
110835006|NCT04745273|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110835007|NCT04745273|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110835008|NCT04745273|Serotonin Agents|serotonin agents|mesh-ancestor
110835009|NCT04745273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110835010|NCT04745273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110835011|NCT01305187|Hyaluronic Acid|hyaluronic acid|mesh-list
110835012|NCT01305187|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110835013|NCT01305187|Immunologic Factors|immunologic factors|mesh-ancestor
110835014|NCT01305187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110835015|NCT01305187|Viscosupplements|viscosupplements|mesh-ancestor
110835016|NCT01305187|Protective Agents|protective agents|mesh-ancestor
110835017|NCT01138397|Vaccines|vaccines|mesh-list
110835018|NCT01138397|Immunologic Factors|immunologic factors|mesh-ancestor
110835019|NCT01138397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110835020|NCT03448744|Entecavir|entecavir|mesh-list
110835021|NCT03448744|Thymalfasin|thymalfasin|mesh-list
110835022|NCT03448744|Antiviral Agents|antiviral agents|mesh-ancestor
110835023|NCT03448744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110835024|NCT03448744|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110835025|NCT03448744|Immunologic Factors|immunologic factors|mesh-ancestor
110835027|NCT03448588|Selenium|selenium|mesh-list
110835028|NCT03448588|Antioxidants|antioxidants|mesh-ancestor
110835029|NCT03448588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110835030|NCT03448588|Protective Agents|protective agents|mesh-ancestor
110835031|NCT03448588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110835032|NCT03448588|Trace Elements|trace elements|mesh-ancestor
110835033|NCT03448588|Micronutrients|micronutrients|mesh-ancestor
110835034|NCT03797443|Ascorbic Acid|ascorbic acid|mesh-list
110835035|NCT03797443|Paclitaxel|paclitaxel|mesh-list
110835036|NCT03797443|Gemcitabine|gemcitabine|mesh-list
110835037|NCT03797443|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110835038|NCT03797443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110835039|NCT03797443|Tubulin Modulators|tubulin modulators|mesh-ancestor
110835040|NCT03797443|Antimitotic Agents|antimitotic agents|mesh-ancestor
110835041|NCT03797443|Mitosis Modulators|mitosis modulators|mesh-ancestor
110835042|NCT03797443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110835043|NCT03797443|Vitamins|vitamins|mesh-ancestor
110835044|NCT03797443|Micronutrients|micronutrients|mesh-ancestor
110835045|NCT03797443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110835046|NCT03797443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110835047|NCT03797443|Antimetabolites|antimetabolites|mesh-ancestor
110835048|NCT03797443|Antioxidants|antioxidants|mesh-ancestor
110835049|NCT03797443|Protective Agents|protective agents|mesh-ancestor
110835051|NCT01135589|Antifungal Agents|antifungal agents|mesh-ancestor
110835052|NCT01135589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110835053|NCT01140737|Axitinib|axitinib|mesh-list
110835054|NCT01140737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110835055|NCT01140737|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110835056|NCT01140737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110835057|NCT01140737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110835058|NCT05594095|Everolimus|everolimus|mesh-list
110835059|NCT05594095|Fulvestrant|fulvestrant|mesh-list
110835060|NCT05594095|Goserelin|goserelin|mesh-list
110835061|NCT05594095|Fluzoparib|fluzoparib|mesh-list
110835062|NCT05594095|Aromatase Inhibitors|aromatase inhibitors|mesh-list
110835063|NCT05594095|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110835064|NCT05594095|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110835065|NCT05594095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110835066|NCT05594095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110835067|NCT05594095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110835068|NCT05594095|Immunologic Factors|immunologic factors|mesh-ancestor
110835069|NCT05594095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110835070|NCT05594095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110835071|NCT05594095|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110835072|NCT05594095|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110835073|NCT05594095|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110835074|NCT05594095|Hormone Antagonists|hormone antagonists|mesh-ancestor
110871798|NCT04546620|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110835075|NCT05594095|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110835076|NCT05594095|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110835077|NCT05594095|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110835078|NCT04951063|Immunomodulating Agents|immunomodulating agents|mesh-list
110835079|NCT04951063|Immunologic Factors|immunologic factors|mesh-ancestor
110835080|NCT04951063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110835081|NCT05624671|Fentanyl|fentanyl|mesh-list
110835082|NCT05624671|Bupivacaine|bupivacaine|mesh-list
110835083|NCT05624671|Anesthetics, Local|anesthetics, local|mesh-ancestor
110835084|NCT05624671|Anesthetics|anesthetics|mesh-ancestor
110835085|NCT05624671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110835086|NCT05624671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110835087|NCT05624671|Sensory System Agents|sensory system agents|mesh-ancestor
110153552|NCT00001002|Zidovudine|zidovudine|mesh-list
110835088|NCT05624671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110835089|NCT05624671|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110835090|NCT05624671|Narcotics|narcotics|mesh-ancestor
110835091|NCT05624671|Analgesics|analgesics|mesh-ancestor
110835092|NCT05624671|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110835093|NCT05624671|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110835094|NCT05624671|Anesthetics, General|anesthetics, general|mesh-ancestor
110835095|NCT03578965|Cefazolin|cefazolin|mesh-list
110835096|NCT03578965|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110835097|NCT03578965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110835098|NCT03791905|Leucovorin|leucovorin|mesh-list
110835099|NCT03791905|Paclitaxel|paclitaxel|mesh-list
110835100|NCT03791905|Fluorouracil|fluorouracil|mesh-list
110835101|NCT03791905|Oxaliplatin|oxaliplatin|mesh-list
110835102|NCT03791905|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110835103|NCT03791905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110835104|NCT03791905|Tubulin Modulators|tubulin modulators|mesh-ancestor
110835105|NCT03791905|Antimitotic Agents|antimitotic agents|mesh-ancestor
110835106|NCT03791905|Mitosis Modulators|mitosis modulators|mesh-ancestor
110835107|NCT03791905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110835108|NCT03791905|Antimetabolites|antimetabolites|mesh-ancestor
110835109|NCT03791905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110835110|NCT03791905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110835111|NCT03791905|Immunologic Factors|immunologic factors|mesh-ancestor
110835112|NCT03791905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110835113|NCT03791905|Antidotes|antidotes|mesh-ancestor
110835114|NCT03791905|Protective Agents|protective agents|mesh-ancestor
110835115|NCT03791905|Vitamin B Complex|vitamin b complex|mesh-ancestor
110835116|NCT03791905|Vitamins|vitamins|mesh-ancestor
110835117|NCT03791905|Micronutrients|micronutrients|mesh-ancestor
110835118|NCT01138553|Mifepristone|mifepristone|mesh-list
110835119|NCT01138553|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
110835120|NCT01138553|Abortifacient Agents|abortifacient agents|mesh-ancestor
110871799|NCT04546620|Alkylating Agents|alkylating agents|mesh-ancestor
110835121|NCT01138553|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110835122|NCT01138553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110835123|NCT01138553|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110835124|NCT01138553|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110835125|NCT01138553|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110835126|NCT01138553|Contraceptive Agents|contraceptive agents|mesh-ancestor
110835127|NCT01138553|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
110835128|NCT01138553|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
110835129|NCT01138553|Hormone Antagonists|hormone antagonists|mesh-ancestor
110835130|NCT01138553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110835131|NCT01138553|Luteolytic Agents|luteolytic agents|mesh-ancestor
110835132|NCT01138553|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110835133|NCT01138553|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
110835134|NCT05171374|Trametinib|trametinib|mesh-list
110835135|NCT05171374|Dabrafenib|dabrafenib|mesh-list
110835136|NCT05171374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110835137|NCT05171374|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110835138|NCT05171374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110835139|NCT05171374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110835140|NCT03447184|Androgens|androgens|mesh-list
110835141|NCT03447184|Aromatase Inhibitors|aromatase inhibitors|mesh-list
110835142|NCT03447184|Hormones|hormones|mesh-ancestor
110835143|NCT03447184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110835144|NCT03447184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110835145|NCT03447184|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110835146|NCT03447184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110835147|NCT03447184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110835149|NCT03447184|Hormone Antagonists|hormone antagonists|mesh-ancestor
110835150|NCT03739541|Benzonidazole|benzonidazole|mesh-list
110835151|NCT03739541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110835152|NCT03739541|Immunologic Factors|immunologic factors|mesh-ancestor
110835153|NCT03739541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110835154|NCT03739541|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
110835155|NCT03739541|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110835156|NCT03739541|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110835157|NCT03739541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110835159|NCT01135667|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
110835160|NCT01135667|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110835161|NCT01135667|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110835162|NCT01135667|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110835163|NCT01135667|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110835164|NCT01135667|Purinergic Agents|purinergic agents|mesh-ancestor
110835165|NCT01135667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110835166|NCT01135667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110835167|NCT01135667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110835168|NCT03446872|Leucovorin|leucovorin|mesh-list
110835169|NCT03446872|Fluorouracil|fluorouracil|mesh-list
110835170|NCT03446872|Antimetabolites|antimetabolites|mesh-ancestor
110835171|NCT03446872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110888359|NCT01336621|Ezogabine|ezogabine|mesh-list
110835172|NCT03446872|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110552799|NCT00738868|Cetuximab|cetuximab|mesh-list
110835173|NCT03446872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110835174|NCT03446872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110835175|NCT03446872|Immunologic Factors|immunologic factors|mesh-ancestor
110835176|NCT03446872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110835177|NCT03446872|Antidotes|antidotes|mesh-ancestor
110835178|NCT03446872|Protective Agents|protective agents|mesh-ancestor
110835179|NCT03446872|Vitamin B Complex|vitamin b complex|mesh-ancestor
110835180|NCT03446872|Vitamins|vitamins|mesh-ancestor
110835181|NCT03446872|Micronutrients|micronutrients|mesh-ancestor
110835182|NCT03446638|Cytarabine|cytarabine|mesh-list
110835183|NCT03446638|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110835184|NCT03446638|Antimetabolites|antimetabolites|mesh-ancestor
110835185|NCT03446638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110835186|NCT03446638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110835187|NCT03446638|Antiviral Agents|antiviral agents|mesh-ancestor
110835188|NCT03446638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110835189|NCT03446638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110835190|NCT03446638|Immunologic Factors|immunologic factors|mesh-ancestor
110835191|NCT03446638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110835192|NCT05401019|Pramipexole|pramipexole|mesh-list
110835193|NCT05401019|Risperidone|risperidone|mesh-list
110835194|NCT05401019|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110835195|NCT05401019|Serotonin Agents|serotonin agents|mesh-ancestor
110835196|NCT05401019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110835197|NCT05401019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110835198|NCT05401019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110835199|NCT05401019|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110835200|NCT05401019|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110835201|NCT05401019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110835202|NCT05401019|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110835203|NCT05401019|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110835204|NCT05401019|Dopamine Agents|dopamine agents|mesh-ancestor
110835205|NCT05401019|Antioxidants|antioxidants|mesh-ancestor
110835206|NCT05401019|Protective Agents|protective agents|mesh-ancestor
110835207|NCT05401019|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110835208|NCT05401019|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110835209|NCT05401019|Dopamine Agonists|dopamine agonists|mesh-ancestor
110835210|NCT03788863|Diflucortolone|diflucortolone|mesh-list
110835211|NCT03788863|Diflucortolone valerate|diflucortolone valerate|mesh-list
110835212|NCT03788863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110835213|NCT03788863|Glucocorticoids|glucocorticoids|mesh-ancestor
110835214|NCT03788863|Hormones|hormones|mesh-ancestor
110835215|NCT03788863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110835216|NCT03788863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110835218|NCT04659161|Trospium chloride|trospium chloride|mesh-list
110835219|NCT04659161|Parasympatholytics|parasympatholytics|mesh-ancestor
110835220|NCT04659161|Autonomic Agents|autonomic agents|mesh-ancestor
110835221|NCT04659161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110835222|NCT04659161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110835223|NCT04659161|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110835224|NCT04659161|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110835225|NCT04659161|Cholinergic Agents|cholinergic agents|mesh-ancestor
110835226|NCT04659161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110835227|NCT04659161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110835228|NCT04659161|Urological Agents|urological agents|mesh-ancestor
110835229|NCT04659161|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110835230|NCT04659161|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110154259|NCT00010036|Irinotecan|irinotecan|mesh-list
110835231|NCT04659161|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
110835232|NCT04659161|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110835233|NCT03129256|Apatinib|apatinib|mesh-list
110835234|NCT03129256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110835235|NCT03129256|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110835237|NCT03129256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110835238|NCT05682807|Caffeine|caffeine|mesh-list
110835239|NCT05682807|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110835240|NCT05682807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110835241|NCT05682807|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110835242|NCT05682807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110835243|NCT05682807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110835244|NCT05682807|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110835245|NCT05682807|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110835246|NCT05682807|Purinergic Agents|purinergic agents|mesh-ancestor
110835247|NCT05682807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110835248|NCT03445780|Ethyl Chloride|ethyl chloride|mesh-list
110835249|NCT03445780|Anesthetics, Local|anesthetics, local|mesh-ancestor
110835250|NCT03445780|Anesthetics|anesthetics|mesh-ancestor
110835251|NCT03445780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110835252|NCT03445780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110835253|NCT03445780|Sensory System Agents|sensory system agents|mesh-ancestor
110835254|NCT03445780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110835256|NCT05364099|Lidocaine|lidocaine|mesh-list
110835257|NCT05364099|Anesthetics, Local|anesthetics, local|mesh-ancestor
110835259|NCT05364099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110835260|NCT05364099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110835261|NCT05364099|Sensory System Agents|sensory system agents|mesh-ancestor
110835262|NCT05364099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110835263|NCT05364099|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110835264|NCT05364099|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110835265|NCT05364099|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110154601|NCT00012259|Troxacitabine|troxacitabine|mesh-list
110835266|NCT05364099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110835267|NCT05364099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110835268|NCT05364099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110184574|NCT00034710|Capsaicin|capsaicin|mesh-list
110835269|NCT05364099|Glucocorticoids|glucocorticoids|mesh-ancestor
110835270|NCT05364099|Hormones|hormones|mesh-ancestor
110835271|NCT05364099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110835272|NCT03445702|Metformin|metformin|mesh-list
110835273|NCT03445702|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110835274|NCT03445702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110835275|NCT03445624|Infliximab|infliximab|mesh-list
110835276|NCT03445624|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110835277|NCT03445624|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110835278|NCT03445624|Dermatologic Agents|dermatologic agents|mesh-ancestor
110835279|NCT03445624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110835280|NCT03445624|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110835281|NCT01312077|Morphine|morphine|mesh-list
110835282|NCT01312077|Levobupivacaine|levobupivacaine|mesh-list
110835283|NCT01312077|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110835284|NCT01312077|Narcotics|narcotics|mesh-ancestor
110835285|NCT01312077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110835286|NCT01312077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110835287|NCT01312077|Analgesics|analgesics|mesh-ancestor
110835288|NCT01312077|Sensory System Agents|sensory system agents|mesh-ancestor
110835289|NCT01312077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110835290|NCT01312077|Anesthetics, Local|anesthetics, local|mesh-ancestor
110835291|NCT01312077|Anesthetics|anesthetics|mesh-ancestor
110835292|NCT03793309|Vitamin D|vitamin d|mesh-list
110835293|NCT03793309|Ergocalciferols|ergocalciferols|mesh-list
110835294|NCT03793309|Cholecalciferol|cholecalciferol|mesh-list
110835295|NCT03793309|Vitamins|vitamins|mesh-list
110835296|NCT03793309|Micronutrients|micronutrients|mesh-ancestor
110835297|NCT03793309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110835298|NCT03793309|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110835299|NCT03793309|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110835300|NCT01140893|Exenatide|exenatide|mesh-list
110835301|NCT01140893|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110835302|NCT01140893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110835303|NCT01140893|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110835304|NCT01140893|Incretins|incretins|mesh-ancestor
110835305|NCT01140893|Hormones|hormones|mesh-ancestor
110835306|NCT01140893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110835307|NCT03445468|Vaccines|vaccines|mesh-list
110835308|NCT03445468|Immunologic Factors|immunologic factors|mesh-ancestor
110835309|NCT03445468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110835310|NCT03791827|Cyclosporine|cyclosporine|mesh-list
110835311|NCT03791827|Mycophenolic Acid|mycophenolic acid|mesh-list
110835312|NCT03791827|Hydroxychloroquine|hydroxychloroquine|mesh-list
110835313|NCT03791827|Prednisone|prednisone|mesh-list
110835315|NCT03791827|Cyclophosphamide|cyclophosphamide|mesh-list
110835316|NCT03791827|Rituximab|rituximab|mesh-list
110835317|NCT03791827|Azathioprine|azathioprine|mesh-list
110835318|NCT03791827|Tacrolimus|tacrolimus|mesh-list
110835319|NCT03791827|Cyclosporins|cyclosporins|mesh-list
110835320|NCT03791827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110835321|NCT03791827|Immunologic Factors|immunologic factors|mesh-ancestor
110835322|NCT03791827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110835323|NCT03791827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110835324|NCT03791827|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110835325|NCT03791827|Alkylating Agents|alkylating agents|mesh-ancestor
110835326|NCT03791827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110835327|NCT03791827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110835328|NCT03791827|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110835329|NCT03791827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110835330|NCT03791827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110835331|NCT03791827|Glucocorticoids|glucocorticoids|mesh-ancestor
110835332|NCT03791827|Hormones|hormones|mesh-ancestor
110835333|NCT03791827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110835334|NCT03791827|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110835335|NCT03791827|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110835336|NCT03791827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110835337|NCT03791827|Antifungal Agents|antifungal agents|mesh-ancestor
110835338|NCT03791827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110835339|NCT03791827|Dermatologic Agents|dermatologic agents|mesh-ancestor
110835340|NCT03791827|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110835341|NCT03791827|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110835342|NCT03791827|Antitubercular Agents|antitubercular agents|mesh-ancestor
110835343|NCT03791827|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110835344|NCT03791827|Antimalarials|antimalarials|mesh-ancestor
110835345|NCT03791827|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110835346|NCT03791827|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110835348|NCT03791827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110835349|NCT03708861|Ritonavir|ritonavir|mesh-list
110835350|NCT03708861|Atazanavir Sulfate|atazanavir sulfate|mesh-list
110835351|NCT03708861|Maraviroc|maraviroc|mesh-list
110835352|NCT03708861|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110835353|NCT03708861|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110835354|NCT03708861|Protease Inhibitors|protease inhibitors|mesh-ancestor
110835355|NCT03708861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110835356|NCT03708861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110835357|NCT03708861|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110835358|NCT03708861|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110835359|NCT03708861|Antiviral Agents|antiviral agents|mesh-ancestor
110835360|NCT03708861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110155120|NCT00015886|Docetaxel|docetaxel|mesh-list
110835361|NCT03708861|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110835362|NCT03708861|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110835363|NCT03708861|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110835364|NCT03708861|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110835365|NCT03708861|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
110835366|NCT01308229|Paclitaxel|paclitaxel|mesh-list
110835367|NCT01308229|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110835368|NCT01308229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110835369|NCT01308229|Tubulin Modulators|tubulin modulators|mesh-ancestor
110835370|NCT01308229|Antimitotic Agents|antimitotic agents|mesh-ancestor
110835371|NCT01308229|Mitosis Modulators|mitosis modulators|mesh-ancestor
110835372|NCT01308229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110835373|NCT03445078|Selenium|selenium|mesh-list
110835374|NCT03445078|Antioxidants|antioxidants|mesh-ancestor
110835375|NCT03445078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110835376|NCT03445078|Protective Agents|protective agents|mesh-ancestor
110835377|NCT03445078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110835378|NCT03445078|Trace Elements|trace elements|mesh-ancestor
110835379|NCT03445078|Micronutrients|micronutrients|mesh-ancestor
110835380|NCT01233791|Diazepam|diazepam|mesh-list
110835381|NCT01233791|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110835382|NCT01233791|Anticonvulsants|anticonvulsants|mesh-ancestor
110835383|NCT01233791|Antiemetics|antiemetics|mesh-ancestor
110835384|NCT01233791|Autonomic Agents|autonomic agents|mesh-ancestor
110835385|NCT01233791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110184611|NCT00034905|Serotonin Agents|serotonin agents|mesh-ancestor
110835386|NCT01233791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110835387|NCT01233791|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110835388|NCT01233791|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110835389|NCT01233791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110835390|NCT01233791|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110835391|NCT01233791|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110835392|NCT01233791|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110835393|NCT01233791|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110835394|NCT01233791|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110835395|NCT01233791|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110835396|NCT01233791|Anesthetics, General|anesthetics, general|mesh-ancestor
110835397|NCT01233791|Anesthetics|anesthetics|mesh-ancestor
110835398|NCT01233791|GABA Modulators|gaba modulators|mesh-ancestor
110835399|NCT01233791|GABA Agents|gaba agents|mesh-ancestor
110835400|NCT01233791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110835401|NCT01233791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110835402|NCT01140971|Misoprostol|misoprostol|mesh-list
110835403|NCT01140971|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110155435|NCT00006029|Gemcitabine|gemcitabine|mesh-list
110835404|NCT01140971|Abortifacient Agents|abortifacient agents|mesh-ancestor
110835405|NCT01140971|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110835406|NCT01140971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110835407|NCT01140971|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110835408|NCT01140971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110835409|NCT01140971|Oxytocics|oxytocics|mesh-ancestor
110835410|NCT01306357|Hormones|hormones|mesh-list
110835411|NCT01306357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110835412|NCT01306357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110835413|NCT03129022|Anesthetics|anesthetics|mesh-list
110835414|NCT03129022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110835415|NCT03129022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110835417|NCT03342963|Sertraline|sertraline|mesh-list
110835418|NCT03342963|Antidepressive Agents|antidepressive agents|mesh-ancestor
110835419|NCT03342963|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110835420|NCT03342963|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110835421|NCT03342963|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110835422|NCT03342963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110835423|NCT03342963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110835424|NCT03342963|Dopamine Agonists|dopamine agonists|mesh-ancestor
110835425|NCT03342963|Dopamine Agents|dopamine agents|mesh-ancestor
110835426|NCT03342963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110835427|NCT03342963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110835428|NCT03342963|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110835429|NCT03342963|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110835430|NCT03342963|Serotonin Agents|serotonin agents|mesh-ancestor
110835431|NCT03342963|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110835432|NCT03342963|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110835433|NCT03342963|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110835434|NCT03342963|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110835435|NCT03342963|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110835436|NCT03342963|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110835437|NCT03342963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110835438|NCT03706755|Norepinephrine|norepinephrine|mesh-list
110835439|NCT03706755|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110835440|NCT03706755|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110155634|NCT00006041|Vaccines|vaccines|mesh-list
110835441|NCT03706755|Adrenergic Agents|adrenergic agents|mesh-ancestor
110835442|NCT03706755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110835443|NCT03706755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110835444|NCT03706755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110835445|NCT03706755|Sympathomimetics|sympathomimetics|mesh-ancestor
110835446|NCT03706755|Autonomic Agents|autonomic agents|mesh-ancestor
110835447|NCT03706755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110835448|NCT03706755|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110835450|NCT03791515|Salmon calcitonin|salmon calcitonin|mesh-list
110835451|NCT03791515|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
110835452|NCT03791515|Katacalcin|katacalcin|mesh-list
110835453|NCT03791515|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110835454|NCT03791515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110835455|NCT03791515|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110835456|NCT03791515|Vasodilator Agents|vasodilator agents|mesh-ancestor
110835457|NCT03361956|JNJ-56136379|jnj-56136379|mesh-list
110835458|NCT03361956|Antiviral Agents|antiviral agents|mesh-ancestor
110835459|NCT03361956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110835460|NCT04595591|Remifentanil|remifentanil|mesh-list
110835461|NCT04595591|Rocuronium|rocuronium|mesh-list
110155717|NCT00017758|Nelfinavir|nelfinavir|mesh-list
110835463|NCT04595591|Narcotics|narcotics|mesh-ancestor
110835464|NCT04595591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110835465|NCT04595591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110835466|NCT04595591|Analgesics|analgesics|mesh-ancestor
110835467|NCT04595591|Sensory System Agents|sensory system agents|mesh-ancestor
110835468|NCT04595591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110835469|NCT04595591|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110835470|NCT04595591|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110835471|NCT04595591|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110835472|NCT03709953|Apatinib|apatinib|mesh-list
110835473|NCT03709953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110835474|NCT03709953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110835475|NCT03709953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110835476|NCT03709953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110835478|NCT03444142|Dulaglutide|dulaglutide|mesh-list
110155746|NCT00017992|Ritonavir|ritonavir|mesh-list
110835479|NCT03444142|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110835480|NCT03444142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110835481|NCT03444142|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110835482|NCT03444142|Incretins|incretins|mesh-ancestor
110835483|NCT03444142|Hormones|hormones|mesh-ancestor
110835484|NCT03444142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110835485|NCT01305733|Ketorolac|ketorolac|mesh-list
110835486|NCT01305733|Epinephrine|epinephrine|mesh-list
110835487|NCT01305733|Racepinephrine|racepinephrine|mesh-list
110835488|NCT01305733|Levobupivacaine|levobupivacaine|mesh-list
110835489|NCT01305733|Epinephryl borate|epinephryl borate|mesh-list
110835490|NCT01305733|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110835491|NCT01305733|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110835492|NCT01305733|Analgesics|analgesics|mesh-ancestor
110835493|NCT01305733|Sensory System Agents|sensory system agents|mesh-ancestor
110835494|NCT01305733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110835495|NCT01305733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110835496|NCT01305733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110835497|NCT01305733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110835498|NCT01305733|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110835499|NCT01305733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110835500|NCT01305733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110835501|NCT01305733|Anesthetics, Local|anesthetics, local|mesh-ancestor
110835502|NCT01305733|Anesthetics|anesthetics|mesh-ancestor
110835503|NCT01305733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110835504|NCT01305733|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110155818|NCT00018343|Estrogens|estrogens|mesh-list
110835505|NCT01305733|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110835506|NCT01305733|Adrenergic Agents|adrenergic agents|mesh-ancestor
110835507|NCT01305733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110835508|NCT01305733|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110835509|NCT01305733|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110835510|NCT01305733|Autonomic Agents|autonomic agents|mesh-ancestor
110835511|NCT01305733|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110835512|NCT01305733|Respiratory System Agents|respiratory system agents|mesh-ancestor
110835513|NCT01305733|Mydriatics|mydriatics|mesh-ancestor
110835514|NCT01305733|Sympathomimetics|sympathomimetics|mesh-ancestor
110835515|NCT01305733|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110835516|NCT05210153|Sertraline|sertraline|mesh-list
110835517|NCT05210153|Antidepressive Agents|antidepressive agents|mesh-ancestor
110835518|NCT05210153|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110835519|NCT05210153|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110835520|NCT05210153|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110835521|NCT05210153|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110835522|NCT05210153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110835523|NCT05210153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110835524|NCT05210153|Serotonin Agents|serotonin agents|mesh-ancestor
110835525|NCT05210153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110835526|NCT04749459|Sunscreening Agents|sunscreening agents|mesh-list
110835527|NCT04749459|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110835528|NCT04749459|Protective Agents|protective agents|mesh-ancestor
110835529|NCT04749459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110835530|NCT04749459|Dermatologic Agents|dermatologic agents|mesh-ancestor
110835531|NCT04585295|Betaine|betaine|mesh-list
110835532|NCT04585295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110835533|NCT04585295|Lipotropic Agents|lipotropic agents|mesh-ancestor
110835534|NCT04585295|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110835535|NCT04585295|Antimetabolites|antimetabolites|mesh-ancestor
110835536|NCT04585295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110835537|NCT04585295|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110835538|NCT01136213|Fluoxetine|fluoxetine|mesh-list
110835539|NCT01136213|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110835540|NCT01136213|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110835542|NCT01136213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110835543|NCT01136213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110835544|NCT01136213|Serotonin Agents|serotonin agents|mesh-ancestor
110835545|NCT01136213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110682911|NCT05277701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110682913|NCT00605345|Hematinics|hematinics|mesh-ancestor
110682914|NCT00903851|Lidocaine|lidocaine|mesh-list
110682915|NCT00903851|Anesthetics, Local|anesthetics, local|mesh-ancestor
110553164|NCT00711802|Daptomycin|daptomycin|mesh-list
110835546|NCT01136213|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110835547|NCT01136213|Antidepressive Agents|antidepressive agents|mesh-ancestor
110835549|NCT01136213|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110835550|NCT01136213|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110835551|NCT01136213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110835552|NCT03361176|Triamcinolone|triamcinolone|mesh-list
110835553|NCT03361176|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110835554|NCT03361176|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110835555|NCT03361176|Deoxycholic Acid|deoxycholic acid|mesh-list
110835556|NCT03361176|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110835557|NCT03361176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110835558|NCT03361176|Glucocorticoids|glucocorticoids|mesh-ancestor
110835559|NCT03361176|Hormones|hormones|mesh-ancestor
110835560|NCT03361176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110835561|NCT03361176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110835562|NCT03361176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110835563|NCT03361176|Immunologic Factors|immunologic factors|mesh-ancestor
110835564|NCT03361176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110835565|NCT03361176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110835566|NCT03361176|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
110835567|NCT03361176|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110835568|NCT03438214|Vancomycin|vancomycin|mesh-list
110835569|NCT03438214|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110835570|NCT03438214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110835571|NCT01141127|Tranexamic Acid|tranexamic acid|mesh-list
110835572|NCT01141127|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110835573|NCT01141127|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110835574|NCT01141127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110835576|NCT01141127|Coagulants|coagulants|mesh-ancestor
110835577|NCT03708822|Docetaxel|docetaxel|mesh-list
110835578|NCT03708822|Nimotuzumab|nimotuzumab|mesh-list
110835579|NCT03708822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110835580|NCT03708822|Tubulin Modulators|tubulin modulators|mesh-ancestor
110835581|NCT03708822|Antimitotic Agents|antimitotic agents|mesh-ancestor
110835582|NCT03708822|Mitosis Modulators|mitosis modulators|mesh-ancestor
110184645|NCT01806272|Vitamins|vitamins|mesh-ancestor
110835583|NCT03708822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110835584|NCT03708822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110835585|NCT05280444|Idarubicin|idarubicin|mesh-list
110835586|NCT05280444|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110835587|NCT05280444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110835588|NCT05280444|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110835589|NCT05280444|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110835590|NCT05280444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110835591|NCT05280444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110835592|NCT01308541|Propofol|propofol|mesh-list
110835593|NCT01308541|Fospropofol|fospropofol|mesh-list
110835594|NCT01308541|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110835595|NCT01308541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110156365|NCT03958708|Rifaximin|rifaximin|mesh-list
110835596|NCT01308541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110835597|NCT01308541|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110835598|NCT01308541|Anesthetics, General|anesthetics, general|mesh-ancestor
110835599|NCT01308541|Anesthetics|anesthetics|mesh-ancestor
110835600|NCT05679765|Dexamethasone|dexamethasone|mesh-list
110835601|NCT05679765|Dexamethasone acetate|dexamethasone acetate|mesh-list
110835602|NCT05679765|Lidocaine|lidocaine|mesh-list
110835603|NCT05679765|BB 1101|bb 1101|mesh-list
110835604|NCT05679765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110835605|NCT05679765|Antiemetics|antiemetics|mesh-ancestor
110835606|NCT05679765|Autonomic Agents|autonomic agents|mesh-ancestor
110835607|NCT05679765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110835608|NCT05679765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110835609|NCT05679765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110835610|NCT05679765|Glucocorticoids|glucocorticoids|mesh-ancestor
110835611|NCT05679765|Hormones|hormones|mesh-ancestor
110156494|NCT05634564|Tubulin Modulators|tubulin modulators|mesh-ancestor
110835612|NCT05679765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110835613|NCT05679765|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110835614|NCT05679765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110835615|NCT05679765|Protease Inhibitors|protease inhibitors|mesh-ancestor
110835616|NCT05679765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110156560|NCT03151525|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110835617|NCT05679765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110835618|NCT05679765|Anesthetics, Local|anesthetics, local|mesh-ancestor
110835619|NCT05679765|Anesthetics|anesthetics|mesh-ancestor
110835620|NCT05679765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110835621|NCT05679765|Sensory System Agents|sensory system agents|mesh-ancestor
110835622|NCT05679765|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110835623|NCT05679765|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110835624|NCT05679765|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110835625|NCT05679765|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110835627|NCT03437980|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110835628|NCT03437980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110835629|NCT03437980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110835630|NCT03437980|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110835631|NCT03437980|Anesthetics, General|anesthetics, general|mesh-ancestor
110835632|NCT03437980|Anesthetics|anesthetics|mesh-ancestor
110835633|NCT05176119|Ketamine|ketamine|mesh-list
110835634|NCT05176119|Nalbuphine|nalbuphine|mesh-list
110835635|NCT05176119|Analgesics|analgesics|mesh-ancestor
110835636|NCT05176119|Sensory System Agents|sensory system agents|mesh-ancestor
110835637|NCT05176119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110835638|NCT05176119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110835639|NCT05176119|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110835640|NCT05176119|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110835641|NCT05176119|Anesthetics, General|anesthetics, general|mesh-ancestor
110835642|NCT05176119|Anesthetics|anesthetics|mesh-ancestor
110835643|NCT05176119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110835644|NCT05176119|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110835645|NCT05176119|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110835646|NCT05176119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110835647|NCT05176119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110835648|NCT05176119|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110835649|NCT05176119|Narcotics|narcotics|mesh-ancestor
110835650|NCT03437902|Vitamins|vitamins|mesh-list
110835651|NCT03437902|Ascorbic Acid|ascorbic acid|mesh-list
110835652|NCT03437902|Micronutrients|micronutrients|mesh-ancestor
110835653|NCT03437902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110835654|NCT03437902|Antioxidants|antioxidants|mesh-ancestor
110156751|NCT02285179|Hormone Antagonists|hormone antagonists|mesh-ancestor
110835655|NCT03437902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110835656|NCT03437902|Protective Agents|protective agents|mesh-ancestor
110835657|NCT05283499|Analgesics, Opioid|analgesics, opioid|mesh-list
110835658|NCT05283499|Analgesics|analgesics|mesh-list
110835659|NCT05283499|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
110835660|NCT05283499|Narcotics|narcotics|mesh-ancestor
110835661|NCT05283499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110835662|NCT05283499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110156816|NCT00393328|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110835663|NCT05283499|Sensory System Agents|sensory system agents|mesh-ancestor
110835664|NCT05283499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110835665|NCT03437824|Vitamin B 12|vitamin b 12|mesh-list
110835666|NCT03437824|Hydroxocobalamin|hydroxocobalamin|mesh-list
110835667|NCT03437824|Vitamins|vitamins|mesh-ancestor
110835668|NCT03437824|Micronutrients|micronutrients|mesh-ancestor
110835669|NCT03437824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110835670|NCT03437824|Vitamin B Complex|vitamin b complex|mesh-ancestor
110835671|NCT03437824|Hematinics|hematinics|mesh-ancestor
110835672|NCT03437590|JNJ-55308942|jnj-55308942|mesh-list
110835673|NCT03437590|Purinergic P2X Receptor Antagonists|purinergic p2x receptor antagonists|mesh-ancestor
110835674|NCT03437590|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110835675|NCT03437590|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110835676|NCT03437590|Purinergic Agents|purinergic agents|mesh-ancestor
110835677|NCT03437590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110157028|NCT01466452|Antipyretics|antipyretics|mesh-ancestor
110835678|NCT03437590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110835679|NCT03437590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110835681|NCT01136525|Antiviral Agents|antiviral agents|mesh-ancestor
110835682|NCT01136525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110835683|NCT05632445|Apixaban|apixaban|mesh-list
110157093|NCT01465438|Adalimumab|adalimumab|mesh-list
110835684|NCT05632445|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110835685|NCT05632445|Antithrombins|antithrombins|mesh-ancestor
110835686|NCT05632445|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110835687|NCT05632445|Protease Inhibitors|protease inhibitors|mesh-ancestor
110835688|NCT05632445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110835689|NCT05632445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110835690|NCT05632445|Anticoagulants|anticoagulants|mesh-ancestor
110835691|NCT01235117|Azacitidine|azacitidine|mesh-list
110835692|NCT01235117|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110157160|NCT01464697|Progesterone|progesterone|mesh-list
110835693|NCT01235117|Antimetabolites|antimetabolites|mesh-ancestor
110835694|NCT01235117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110835695|NCT01235117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110835696|NCT01235117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110835698|NCT01306591|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110835699|NCT01306591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110835700|NCT01306591|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110835701|NCT01306591|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110835702|NCT01306591|Growth Substances|growth substances|mesh-ancestor
110835703|NCT01306591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110835704|NCT01306591|Growth Inhibitors|growth inhibitors|mesh-ancestor
110835706|NCT03098030|Topotecan|topotecan|mesh-list
110835707|NCT03098030|Dinutuximab|dinutuximab|mesh-list
110835708|NCT03098030|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110835709|NCT03098030|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110835710|NCT03098030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110835711|NCT03098030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110835712|NCT03098030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110835713|NCT01233947|Fulvestrant|fulvestrant|mesh-list
110835714|NCT01233947|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110835715|NCT01233947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110835716|NCT01233947|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110835717|NCT01233947|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110835718|NCT01233947|Hormone Antagonists|hormone antagonists|mesh-ancestor
110835719|NCT01233947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110835720|NCT01233947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110835721|NCT01139645|Esomeprazole|esomeprazole|mesh-list
110835722|NCT01139645|Rabeprazole|rabeprazole|mesh-list
110835723|NCT01139645|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110835724|NCT01139645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110835725|NCT01139645|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110835726|NCT01139645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110835727|NCT01139645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110835728|NCT03706287|Cisplatin|cisplatin|mesh-list
110835729|NCT03706287|Carboplatin|carboplatin|mesh-list
110835730|NCT03706287|Pemetrexed|pemetrexed|mesh-list
110835731|NCT03706287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110835732|NCT03706287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110835733|NCT03706287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110835734|NCT03706287|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110835735|NCT03706287|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110835736|NCT05115201|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110835738|NCT05107193|Afatinib|afatinib|mesh-list
110835739|NCT05107193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110835740|NCT05107193|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110835741|NCT05107193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110835742|NCT05107193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110835743|NCT03788395|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
110835744|NCT03788395|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110835745|NCT03788395|Respiratory System Agents|respiratory system agents|mesh-ancestor
110835746|NCT02522650|Amiloride|amiloride|mesh-list
110835747|NCT02522650|Triamterene|triamterene|mesh-list
110835748|NCT02522650|Diuretics|diuretics|mesh-ancestor
110835749|NCT02522650|Natriuretic Agents|natriuretic agents|mesh-ancestor
110835750|NCT02522650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110157633|NCT00276601|Methotrexate|methotrexate|mesh-list
110835751|NCT02522650|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
110835752|NCT02522650|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110835753|NCT02522650|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110835754|NCT02522650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110835755|NCT02522650|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
110835757|NCT05681871|Folic Acid|folic acid|mesh-list
110835758|NCT05681871|Ferrous fumarate|ferrous fumarate|mesh-list
110835759|NCT05681871|Ferrous gluconate|ferrous gluconate|mesh-list
110835760|NCT05681871|Hematinics|hematinics|mesh-ancestor
110835761|NCT05681871|Vitamin B Complex|vitamin b complex|mesh-ancestor
110835762|NCT05681871|Vitamins|vitamins|mesh-ancestor
110835763|NCT05681871|Micronutrients|micronutrients|mesh-ancestor
110157762|NCT00276640|Carboplatin|carboplatin|mesh-list
110835764|NCT05681871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110835765|NCT05681871|Trace Elements|trace elements|mesh-ancestor
110835766|NCT04455958|Ritonavir|ritonavir|mesh-list
110835767|NCT04455958|Lopinavir|lopinavir|mesh-list
110835768|NCT04455958|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110835769|NCT04455958|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110835770|NCT04455958|Protease Inhibitors|protease inhibitors|mesh-ancestor
110835771|NCT04455958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110553434|NCT00636935|Dapsone|dapsone|mesh-list
110835772|NCT04455958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110835774|NCT04455958|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110835775|NCT04455958|Antiviral Agents|antiviral agents|mesh-ancestor
110835776|NCT04455958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110835777|NCT04455958|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110835778|NCT04455958|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110835779|NCT03791125|Salvianolic acid A|salvianolic acid a|mesh-list
110835780|NCT03791125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110835781|NCT03791125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110835782|NCT03791125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110835783|NCT03791125|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110835784|NCT03788317|Botulinum Toxins|botulinum toxins|mesh-list
110835785|NCT03788317|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110835786|NCT03788317|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110835787|NCT03788317|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110835788|NCT03788317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110835789|NCT03788317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110835790|NCT03788317|Cholinergic Agents|cholinergic agents|mesh-ancestor
110835791|NCT03788317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110835792|NCT03788317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110835793|NCT03788317|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110835794|NCT03788317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110835795|NCT01378858|Varenicline|varenicline|mesh-list
110835796|NCT01378858|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110835797|NCT01378858|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110835798|NCT01378858|Cholinergic Agents|cholinergic agents|mesh-ancestor
110835799|NCT01378858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110835800|NCT01378858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110158116|NCT00083824|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110835801|NCT01378858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110835802|NCT02891850|Sildenafil Citrate|sildenafil citrate|mesh-list
110835804|NCT02891850|Riociguat|riociguat|mesh-list
110835805|NCT02891850|Vasodilator Agents|vasodilator agents|mesh-ancestor
110835806|NCT02891850|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110835807|NCT02891850|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110835809|NCT02891850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110835810|NCT02891850|Urological Agents|urological agents|mesh-ancestor
110835811|NCT02891850|Enzyme Activators|enzyme activators|mesh-ancestor
110835812|NCT05175027|Povidone-Iodine|povidone-iodine|mesh-list
110835813|NCT05175027|Povidone|povidone|mesh-list
110835814|NCT05175027|Plasma Substitutes|plasma substitutes|mesh-ancestor
110835815|NCT05175027|Blood Substitutes|blood substitutes|mesh-ancestor
110835816|NCT05175027|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110835817|NCT05175027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110835818|NCT03707418|Heparin|heparin|mesh-list
110835819|NCT03707418|Calcium heparin|calcium heparin|mesh-list
110835820|NCT03707418|Bivalirudin|bivalirudin|mesh-list
110835821|NCT03707418|Anticoagulants|anticoagulants|mesh-ancestor
110835822|NCT03707418|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110835823|NCT03707418|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110835824|NCT03707418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110835825|NCT03707418|Antithrombins|antithrombins|mesh-ancestor
110835826|NCT03707418|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110835827|NCT03707418|Protease Inhibitors|protease inhibitors|mesh-ancestor
110835828|NCT03707418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110835830|NCT03785041|Levobupivacaine|levobupivacaine|mesh-list
110835831|NCT03785041|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110835832|NCT03785041|Narcotics|narcotics|mesh-ancestor
110835833|NCT03785041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110835834|NCT03785041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110835835|NCT03785041|Analgesics|analgesics|mesh-ancestor
110835836|NCT03785041|Sensory System Agents|sensory system agents|mesh-ancestor
110835837|NCT03785041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110835838|NCT03785041|Anesthetics, Local|anesthetics, local|mesh-ancestor
110835839|NCT03785041|Anesthetics|anesthetics|mesh-ancestor
110835840|NCT03710304|Misoprostol|misoprostol|mesh-list
110835841|NCT03710304|Tranexamic Acid|tranexamic acid|mesh-list
110835842|NCT03710304|Oxytocin|oxytocin|mesh-list
110835843|NCT03710304|Oxytocics|oxytocics|mesh-ancestor
110835844|NCT03710304|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110835845|NCT03710304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110835846|NCT03710304|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110835847|NCT03710304|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110835848|NCT03710304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110835849|NCT03710304|Hemostatics|hemostatics|mesh-ancestor
110835850|NCT03710304|Coagulants|coagulants|mesh-ancestor
110835851|NCT03710304|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110835852|NCT03710304|Abortifacient Agents|abortifacient agents|mesh-ancestor
110835853|NCT03710304|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110835854|NCT03710304|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110835855|NCT05605639|Bupivacaine|bupivacaine|mesh-list
110835856|NCT05605639|Anesthetics, Local|anesthetics, local|mesh-ancestor
110835857|NCT05605639|Anesthetics|anesthetics|mesh-ancestor
110835858|NCT05605639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110835859|NCT05605639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110835860|NCT05605639|Sensory System Agents|sensory system agents|mesh-ancestor
110835861|NCT05605639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110835862|NCT03790345|Vitamins|vitamins|mesh-list
110835863|NCT03790345|Vitamin B 12|vitamin b 12|mesh-list
110835864|NCT03790345|Pyridoxine|pyridoxine|mesh-list
110835865|NCT03790345|Vitamin B 6|vitamin b 6|mesh-list
110835866|NCT03790345|Vitamin B Complex|vitamin b complex|mesh-list
110158604|NCT00086359|Ritonavir|ritonavir|mesh-list
110835868|NCT03790345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110835869|NCT05416190|Anticoagulants|anticoagulants|mesh-list
110835870|NCT05416190|Lupus Coagulation Inhibitor|lupus coagulation inhibitor|mesh-list
110835871|NCT05416190|Immunologic Factors|immunologic factors|mesh-ancestor
110835872|NCT05416190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110835873|NCT04454788|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
110835874|NCT04454788|Tenecteplase|tenecteplase|mesh-list
110835875|NCT04454788|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110835876|NCT04454788|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110835877|NCT04454788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110835878|NCT04862650|Paclitaxel|paclitaxel|mesh-list
110835879|NCT04862650|Carboplatin|carboplatin|mesh-list
110835880|NCT04862650|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110835881|NCT04862650|Cemiplimab|cemiplimab|mesh-list
110835882|NCT04862650|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110835883|NCT04862650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110158655|NCT00006104|Docetaxel|docetaxel|mesh-list
110835884|NCT04862650|Tubulin Modulators|tubulin modulators|mesh-ancestor
110835885|NCT04862650|Antimitotic Agents|antimitotic agents|mesh-ancestor
110835886|NCT04862650|Mitosis Modulators|mitosis modulators|mesh-ancestor
110835887|NCT04862650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110835888|NCT04862650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110835889|NCT05163561|Vaccines|vaccines|mesh-list
110835890|NCT05163561|Immunologic Factors|immunologic factors|mesh-ancestor
110835891|NCT05163561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110835892|NCT05681403|Cytarabine|cytarabine|mesh-list
110835893|NCT05681403|Carmustine|carmustine|mesh-list
110835894|NCT05681403|Melphalan|melphalan|mesh-list
110835895|NCT05681403|Etoposide|etoposide|mesh-list
110835896|NCT05681403|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110835897|NCT05681403|Alkylating Agents|alkylating agents|mesh-ancestor
110835898|NCT05681403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110835899|NCT05681403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110835900|NCT05681403|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110835901|NCT05681403|Antimetabolites|antimetabolites|mesh-ancestor
110835902|NCT05681403|Antiviral Agents|antiviral agents|mesh-ancestor
110835903|NCT05681403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110158707|NCT00006113|Sargramostim|sargramostim|mesh-list
110835904|NCT05681403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110835905|NCT05681403|Immunologic Factors|immunologic factors|mesh-ancestor
110835906|NCT05681403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110835907|NCT05681403|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110835908|NCT05681403|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110835909|NCT05681403|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110835910|NCT05681403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110835911|NCT05681403|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110835912|NCT01309009|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110835913|NCT01309009|MEN 11420|men 11420|mesh-list
110835914|NCT01309009|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110835915|NCT01309009|Autonomic Agents|autonomic agents|mesh-ancestor
110158761|NCT04762953|Immunologic Factors|immunologic factors|mesh-ancestor
110835916|NCT01309009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110682916|NCT00903851|Anesthetics|anesthetics|mesh-ancestor
110835917|NCT01309009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110835918|NCT01309009|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110835919|NCT01309009|Respiratory System Agents|respiratory system agents|mesh-ancestor
110835920|NCT03339453|Glucagon|glucagon|mesh-list
110835921|NCT03339453|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
110835922|NCT03339453|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110835923|NCT03339453|Hormones|hormones|mesh-ancestor
110835924|NCT03339453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110835925|NCT03339453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110835927|NCT05418686|Colchicine|colchicine|mesh-list
110835928|NCT05418686|Gout Suppressants|gout suppressants|mesh-ancestor
110835929|NCT05418686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110835930|NCT05418686|Tubulin Modulators|tubulin modulators|mesh-ancestor
110835931|NCT05418686|Antimitotic Agents|antimitotic agents|mesh-ancestor
110835932|NCT05418686|Mitosis Modulators|mitosis modulators|mesh-ancestor
110835933|NCT05418686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110835934|NCT05418686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110835935|NCT01306981|Ranibizumab|ranibizumab|mesh-list
110835936|NCT01306981|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110835937|NCT01306981|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110835938|NCT01306981|Growth Substances|growth substances|mesh-ancestor
110158957|NCT00088582|Hormones|hormones|mesh-ancestor
110835939|NCT01306981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110835940|NCT01306981|Growth Inhibitors|growth inhibitors|mesh-ancestor
110835941|NCT01306981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110835942|NCT05552157|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110835943|NCT05552157|Immunologic Factors|immunologic factors|mesh-ancestor
110835944|NCT05552157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110835945|NCT05076799|Lactulose|lactulose|mesh-list
110835946|NCT05076799|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110835947|NCT03784495|Melatonin|melatonin|mesh-list
110835948|NCT03784495|Antioxidants|antioxidants|mesh-ancestor
110835949|NCT03784495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110835950|NCT03784495|Protective Agents|protective agents|mesh-ancestor
110835951|NCT03784495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110835952|NCT03784495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110835953|NCT04120246|Acetic Acid|acetic acid|mesh-list
110835954|NCT04120246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110835955|NCT04120246|Trastuzumab|trastuzumab|mesh-list
110835956|NCT04120246|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
110835957|NCT04120246|Antibodies|antibodies|mesh-list
110835958|NCT04120246|Immunoglobulins|immunoglobulins|mesh-list
110835959|NCT04120246|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110835960|NCT04120246|Immunologic Factors|immunologic factors|mesh-ancestor
110835961|NCT04120246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110835962|NCT04120246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110835963|NCT04120246|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110835964|NCT04120246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110835965|NCT05659147|Secretin|secretin|mesh-list
110835966|NCT05659147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110835967|NCT05659147|Hormones|hormones|mesh-ancestor
110888606|NCT01342939|Protease Inhibitors|protease inhibitors|mesh-ancestor
110835968|NCT05659147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110835969|NCT05659147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110835970|NCT05234697|Remifentanil|remifentanil|mesh-list
110835971|NCT05234697|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110835972|NCT05234697|Narcotics|narcotics|mesh-ancestor
110835973|NCT05234697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110835974|NCT05234697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110835975|NCT05234697|Analgesics|analgesics|mesh-ancestor
110835976|NCT05234697|Sensory System Agents|sensory system agents|mesh-ancestor
110835977|NCT05234697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110835978|NCT03490760|Durvalumab|durvalumab|mesh-list
110835979|NCT03490760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110835980|NCT03490760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110835981|NCT02133404|Cinacalcet|cinacalcet|mesh-list
110835982|NCT02133404|ASP7991|asp7991|mesh-list
110835983|NCT02133404|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110835984|NCT02133404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110835985|NCT02133404|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
110835986|NCT02133404|Hormone Antagonists|hormone antagonists|mesh-ancestor
110835987|NCT02133404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110835989|NCT01307215|Anesthetics, Local|anesthetics, local|mesh-ancestor
110835990|NCT01307215|Anesthetics|anesthetics|mesh-ancestor
110835991|NCT01307215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110835992|NCT01307215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110835993|NCT01307215|Sensory System Agents|sensory system agents|mesh-ancestor
110835994|NCT01307215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110835995|NCT03420794|Analgesics|analgesics|mesh-list
110835996|NCT03420794|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
110835997|NCT03420794|Sensory System Agents|sensory system agents|mesh-ancestor
110835998|NCT03420794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110835999|NCT03420794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110836000|NCT01568450|Oxycodone|oxycodone|mesh-list
110836001|NCT01568450|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110836002|NCT01568450|Narcotics|narcotics|mesh-ancestor
110836003|NCT01568450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110836004|NCT01568450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110836005|NCT01568450|Analgesics|analgesics|mesh-ancestor
110836006|NCT01568450|Sensory System Agents|sensory system agents|mesh-ancestor
110836007|NCT01568450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110836008|NCT05410496|Tenofovir|tenofovir|mesh-list
110836009|NCT05410496|Antiviral Agents|antiviral agents|mesh-ancestor
110159413|NCT00006200|Leprostatic Agents|leprostatic agents|mesh-ancestor
110836010|NCT05410496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110836011|NCT05410496|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110836012|NCT05410496|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110836013|NCT05410496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110836014|NCT05410496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110836015|NCT05410496|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110836016|NCT05410496|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110836017|NCT03784105|Codeine|codeine|mesh-list
110836018|NCT03784105|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110836019|NCT03784105|Narcotics|narcotics|mesh-ancestor
110836020|NCT03784105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110836021|NCT03784105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110836022|NCT03784105|Analgesics|analgesics|mesh-ancestor
110836023|NCT03784105|Sensory System Agents|sensory system agents|mesh-ancestor
110836024|NCT03784105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110836025|NCT03784105|Antitussive Agents|antitussive agents|mesh-ancestor
110836026|NCT03784105|Respiratory System Agents|respiratory system agents|mesh-ancestor
110836027|NCT03784261|Abatacept|abatacept|mesh-list
110836028|NCT03784261|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110888616|NCT05708690|Hemostatics|hemostatics|mesh-ancestor
110836029|NCT03784261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110836030|NCT03784261|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110836031|NCT03784261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110836032|NCT03784261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110836033|NCT03784261|Immunologic Factors|immunologic factors|mesh-ancestor
110836034|NCT03784261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110836035|NCT03784261|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110836037|NCT02989402|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110836038|NCT02989402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110836039|NCT02989402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110836040|NCT02989402|Cholinergic Agents|cholinergic agents|mesh-ancestor
110836041|NCT02989402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110836042|NCT02989402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110836043|NCT02989402|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110836044|NCT02989402|Protective Agents|protective agents|mesh-ancestor
110836045|NCT02861950|Bupivacaine|bupivacaine|mesh-list
110836046|NCT02861950|Ropivacaine|ropivacaine|mesh-list
110836047|NCT02861950|Anesthetics, Local|anesthetics, local|mesh-ancestor
110836048|NCT02861950|Anesthetics|anesthetics|mesh-ancestor
110836049|NCT02861950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110836050|NCT02861950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110836051|NCT02861950|Sensory System Agents|sensory system agents|mesh-ancestor
110836052|NCT02861950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110836053|NCT05681247|Ezetimibe|ezetimibe|mesh-list
110836054|NCT05681247|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110836055|NCT05681247|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110836056|NCT05681247|Antimetabolites|antimetabolites|mesh-ancestor
110836057|NCT05681247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110836058|NCT05681247|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110836059|NCT03787927|Aspirin|aspirin|mesh-list
110836060|NCT03787927|Clopidogrel|clopidogrel|mesh-list
110836061|NCT03787927|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110836062|NCT03787927|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110836063|NCT03787927|Analgesics|analgesics|mesh-ancestor
110836064|NCT03787927|Sensory System Agents|sensory system agents|mesh-ancestor
110836065|NCT03787927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110836066|NCT03787927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110836067|NCT03787927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110836068|NCT03787927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110836069|NCT03787927|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110836070|NCT03787927|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110836071|NCT03787927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110836072|NCT03787927|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110553677|NCT01840007|Metformin|metformin|mesh-list
110836073|NCT03787927|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110836074|NCT03787927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110836076|NCT03787927|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110836077|NCT03787927|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110836078|NCT03787927|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110836079|NCT03787927|Purinergic Agents|purinergic agents|mesh-ancestor
110836080|NCT03787927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110836081|NCT00602576|Temozolomide|temozolomide|mesh-list
110836082|NCT00602576|Sorafenib|sorafenib|mesh-list
110836083|NCT00602576|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110836084|NCT00602576|Alkylating Agents|alkylating agents|mesh-ancestor
110836085|NCT00602576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110836086|NCT00602576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110836087|NCT00602576|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110836088|NCT00602576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110836089|NCT03359850|Niraparib|niraparib|mesh-list
110836090|NCT03359850|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110836091|NCT03359850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110888631|NCT02247128|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110836092|NCT03359850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110836094|NCT01306123|Vitamin B 12|vitamin b 12|mesh-list
110836095|NCT01306123|Hydroxocobalamin|hydroxocobalamin|mesh-list
110836096|NCT01306123|Vitamins|vitamins|mesh-ancestor
110836097|NCT01306123|Micronutrients|micronutrients|mesh-ancestor
110836098|NCT01306123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110836099|NCT01306123|Vitamin B Complex|vitamin b complex|mesh-ancestor
110836100|NCT01306123|Hematinics|hematinics|mesh-ancestor
110836101|NCT04803994|Bevacizumab|bevacizumab|mesh-list
110836102|NCT04803994|Atezolizumab|atezolizumab|mesh-list
110836103|NCT04803994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110836104|NCT04803994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110836105|NCT04803994|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110836106|NCT04803994|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110836107|NCT04803994|Growth Substances|growth substances|mesh-ancestor
110836108|NCT04803994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110836109|NCT04803994|Growth Inhibitors|growth inhibitors|mesh-ancestor
110836110|NCT04803994|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110836111|NCT04803994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110836113|NCT03130426|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110836114|NCT03130426|Metformin|metformin|mesh-list
110836115|NCT03130426|Insulin Glargine|insulin glargine|mesh-list
110836117|NCT03130426|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110888640|NCT02247128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110836118|NCT03130426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110836119|NCT00114140|Temozolomide|temozolomide|mesh-list
110836120|NCT00114140|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110836121|NCT00114140|Alkylating Agents|alkylating agents|mesh-ancestor
110836122|NCT00114140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110836123|NCT00114140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110836124|NCT03130582|Etoposide|etoposide|mesh-list
110836125|NCT03130582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110836126|NCT03130582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110836127|NCT03130582|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110836128|NCT03130582|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110836129|NCT03130582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110836130|NCT03130582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110836131|NCT04752540|Olorofim|olorofim|mesh-list
110836132|NCT04752540|Antifungal Agents|antifungal agents|mesh-ancestor
110836133|NCT04752540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110836134|NCT04341454|Fexuprazan|fexuprazan|mesh-list
110836135|NCT04341454|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110836136|NCT03712345|Vilobelimab|vilobelimab|mesh-list
110836137|NCT03712345|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
110836138|NCT03712345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110836139|NCT03712345|Immunologic Factors|immunologic factors|mesh-ancestor
110836140|NCT03712345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110836141|NCT03130348|Dexamethasone|dexamethasone|mesh-list
110836142|NCT03130348|Dexamethasone acetate|dexamethasone acetate|mesh-list
110836143|NCT03130348|Bortezomib|bortezomib|mesh-list
110836144|NCT03130348|Ichthammol|ichthammol|mesh-list
110836145|NCT03130348|BB 1101|bb 1101|mesh-list
110836146|NCT03130348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110836147|NCT03130348|Antiemetics|antiemetics|mesh-ancestor
110836148|NCT03130348|Autonomic Agents|autonomic agents|mesh-ancestor
110836149|NCT03130348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110836150|NCT03130348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110836151|NCT03130348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110836152|NCT03130348|Glucocorticoids|glucocorticoids|mesh-ancestor
110836153|NCT03130348|Hormones|hormones|mesh-ancestor
110836154|NCT03130348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110836155|NCT03130348|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110836156|NCT03130348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110836157|NCT03130348|Protease Inhibitors|protease inhibitors|mesh-ancestor
110836158|NCT03130348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110836159|NCT03130348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110159875|NCT00095134|Risperidone|risperidone|mesh-list
110836160|NCT03130348|Dermatologic Agents|dermatologic agents|mesh-ancestor
110836162|NCT01307527|Vitamin B Complex|vitamin b complex|mesh-ancestor
110836163|NCT01307527|Vitamins|vitamins|mesh-ancestor
110836164|NCT01307527|Micronutrients|micronutrients|mesh-ancestor
110836165|NCT01307527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110836166|NCT01307527|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110836167|NCT01307527|Dermatologic Agents|dermatologic agents|mesh-ancestor
110836168|NCT03789799|Titanium dioxide|titanium dioxide|mesh-list
110836169|NCT03789799|Sunscreening Agents|sunscreening agents|mesh-ancestor
110836170|NCT03789799|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110836171|NCT03789799|Protective Agents|protective agents|mesh-ancestor
110836172|NCT03789799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110836173|NCT03789799|Dermatologic Agents|dermatologic agents|mesh-ancestor
110836174|NCT03789799|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110836175|NCT05439772|Ondansetron|ondansetron|mesh-list
110836176|NCT05439772|Antiemetics|antiemetics|mesh-ancestor
110836177|NCT05439772|Autonomic Agents|autonomic agents|mesh-ancestor
110836178|NCT05439772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110836179|NCT05439772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110836180|NCT05439772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110836181|NCT05439772|Antipruritics|antipruritics|mesh-ancestor
110836182|NCT05439772|Dermatologic Agents|dermatologic agents|mesh-ancestor
110888689|NCT02247986|Dopamine Agents|dopamine agents|mesh-ancestor
110836183|NCT05439772|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110836184|NCT05439772|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110836185|NCT05439772|Serotonin Agents|serotonin agents|mesh-ancestor
110836186|NCT05439772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110836187|NCT05439772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110836188|NCT05694715|Irinotecan|irinotecan|mesh-list
110836189|NCT05694715|Niraparib|niraparib|mesh-list
110836190|NCT05694715|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110836191|NCT05694715|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110836192|NCT05694715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110836193|NCT05694715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110836194|NCT05694715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110836195|NCT05694715|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110836196|NCT01309399|Teriparatide|teriparatide|mesh-list
110836197|NCT01309399|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110836198|NCT01309399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110836199|NCT01309399|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110836200|NCT03311828|Daratumumab|daratumumab|mesh-list
110836201|NCT03311828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110836202|NCT01309477|Tacrolimus|tacrolimus|mesh-list
110836203|NCT01309477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110836204|NCT01309477|Immunologic Factors|immunologic factors|mesh-ancestor
110836205|NCT01309477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110836206|NCT01309477|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110836207|NCT01309477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110836208|NCT01309477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110836209|NCT03709992|Tamsulosin|tamsulosin|mesh-list
110836210|NCT03709992|Trospium chloride|trospium chloride|mesh-list
110836211|NCT03709992|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110836212|NCT03709992|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110836213|NCT03709992|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110836214|NCT03709992|Adrenergic Agents|adrenergic agents|mesh-ancestor
110836215|NCT03709992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110836216|NCT03709992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110836217|NCT03709992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110836218|NCT03709992|Urological Agents|urological agents|mesh-ancestor
110836219|NCT03709992|Parasympatholytics|parasympatholytics|mesh-ancestor
110836220|NCT03709992|Autonomic Agents|autonomic agents|mesh-ancestor
110160047|NCT00095914|Paclitaxel|paclitaxel|mesh-list
110836221|NCT03709992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110836222|NCT03709992|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110836223|NCT03709992|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110836224|NCT03709992|Cholinergic Agents|cholinergic agents|mesh-ancestor
110836226|NCT05438992|Anesthetics, Local|anesthetics, local|mesh-ancestor
110836227|NCT05438992|Anesthetics|anesthetics|mesh-ancestor
110836228|NCT05438992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110836229|NCT05438992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110836230|NCT05438992|Sensory System Agents|sensory system agents|mesh-ancestor
110836231|NCT05438992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110836232|NCT05361486|Primaquine|primaquine|mesh-list
110836233|NCT05361486|Tafenoquine|tafenoquine|mesh-list
110836234|NCT05361486|Antimalarials|antimalarials|mesh-ancestor
110836235|NCT05361486|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110836236|NCT05361486|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110836237|NCT05361486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110836238|NCT03089216|Calcium Carbonate|calcium carbonate|mesh-list
110836239|NCT03089216|Calcium|calcium|mesh-list
110836240|NCT03089216|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110836241|NCT03089216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110836242|NCT03089216|Antacids|antacids|mesh-ancestor
110836243|NCT03089216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110836244|NCT03089216|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110836245|NCT03339726|Phenylephrine|phenylephrine|mesh-list
110836246|NCT03339726|Oxymetazoline|oxymetazoline|mesh-list
110836247|NCT03339726|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110836248|NCT03339726|Mydriatics|mydriatics|mesh-ancestor
110836249|NCT03339726|Autonomic Agents|autonomic agents|mesh-ancestor
110836250|NCT03339726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110836251|NCT03339726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110836252|NCT03339726|Sympathomimetics|sympathomimetics|mesh-ancestor
110836253|NCT03339726|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110836254|NCT03339726|Nasal Decongestants|nasal decongestants|mesh-ancestor
110836255|NCT03339726|Respiratory System Agents|respiratory system agents|mesh-ancestor
110836256|NCT03339726|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110836257|NCT03339726|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110836258|NCT03339726|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110184782|NCT04732377|Bupivacaine|bupivacaine|mesh-list
110836259|NCT03339726|Adrenergic Agents|adrenergic agents|mesh-ancestor
110836260|NCT03339726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110836261|NCT03339726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110836262|NCT03339726|Protective Agents|protective agents|mesh-ancestor
110836264|NCT03339297|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110836265|NCT03339297|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110836266|NCT03339297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110836267|NCT03339297|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110836268|NCT05434624|Midazolam|midazolam|mesh-list
110836269|NCT05434624|Propofol|propofol|mesh-list
110836270|NCT05434624|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110836271|NCT05434624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110836272|NCT05434624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110836273|NCT05434624|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110836274|NCT05434624|Anesthetics, General|anesthetics, general|mesh-ancestor
110836275|NCT05434624|Anesthetics|anesthetics|mesh-ancestor
110836276|NCT05434624|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110836277|NCT05434624|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110836278|NCT05434624|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110836279|NCT05434624|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110836280|NCT05434624|GABA Modulators|gaba modulators|mesh-ancestor
110836281|NCT05434624|GABA Agents|gaba agents|mesh-ancestor
110836282|NCT05434624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110836283|NCT05434624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110836284|NCT01309633|Bevacizumab|bevacizumab|mesh-list
110836285|NCT01309633|Sunitinib|sunitinib|mesh-list
110836286|NCT01309633|Cisplatin|cisplatin|mesh-list
110836287|NCT01309633|Gemcitabine|gemcitabine|mesh-list
110836288|NCT01309633|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110836289|NCT01309633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110836290|NCT01309633|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110836291|NCT01309633|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110836292|NCT01309633|Growth Substances|growth substances|mesh-ancestor
110836293|NCT01309633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110836294|NCT01309633|Growth Inhibitors|growth inhibitors|mesh-ancestor
110836295|NCT01309633|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110836296|NCT01309633|Antimetabolites|antimetabolites|mesh-ancestor
110836297|NCT01309633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110836298|NCT01309633|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110836299|NCT01309633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110836300|NCT05215431|Antioxidants|antioxidants|mesh-list
110836301|NCT05215431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110836302|NCT05215431|Protective Agents|protective agents|mesh-ancestor
110836303|NCT05215431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110836304|NCT03706950|Elsulfavirine|elsulfavirine|mesh-list
110836305|NCT03706950|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110836306|NCT03706950|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110836307|NCT03706950|Antiviral Agents|antiviral agents|mesh-ancestor
110836308|NCT03706950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110836310|NCT01310647|Testosterone|testosterone|mesh-list
110888719|NCT03000374|Vitamins|vitamins|mesh-ancestor
110836311|NCT01310647|Estrogens|estrogens|mesh-ancestor
110836313|NCT01310647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110160389|NCT00006347|Antibodies|antibodies|mesh-list
110836314|NCT01310647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110836316|NCT05560399|Dexamethasone|dexamethasone|mesh-list
110836317|NCT05560399|Elotuzumab|elotuzumab|mesh-list
110836318|NCT05560399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110836319|NCT05560399|Antiemetics|antiemetics|mesh-ancestor
110836320|NCT05560399|Autonomic Agents|autonomic agents|mesh-ancestor
110836321|NCT05560399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110836322|NCT05560399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110836323|NCT05560399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110836324|NCT05560399|Glucocorticoids|glucocorticoids|mesh-ancestor
110836325|NCT05560399|Hormones|hormones|mesh-ancestor
110836326|NCT05560399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110836327|NCT05560399|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110836328|NCT05560399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110836329|NCT02949024|Triamcinolone|triamcinolone|mesh-list
110836330|NCT02949024|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110836331|NCT02949024|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110836332|NCT02949024|Aflibercept|aflibercept|mesh-list
110836333|NCT02949024|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110836334|NCT02949024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110836335|NCT02949024|Glucocorticoids|glucocorticoids|mesh-ancestor
110836336|NCT02949024|Hormones|hormones|mesh-ancestor
110836337|NCT02949024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110836338|NCT02949024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110836339|NCT02949024|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110836340|NCT02949024|Immunologic Factors|immunologic factors|mesh-ancestor
110836341|NCT02949024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110836342|NCT02949024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110836343|NCT02949024|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110836344|NCT02949024|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110836345|NCT02949024|Growth Substances|growth substances|mesh-ancestor
110836346|NCT02949024|Growth Inhibitors|growth inhibitors|mesh-ancestor
110836347|NCT02949024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110836348|NCT04394481|Dexamethasone|dexamethasone|mesh-list
110836349|NCT04394481|Dexmedetomidine|dexmedetomidine|mesh-list
110836350|NCT04394481|Ropivacaine|ropivacaine|mesh-list
110836351|NCT04394481|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110836352|NCT04394481|Antiemetics|antiemetics|mesh-ancestor
110836353|NCT04394481|Autonomic Agents|autonomic agents|mesh-ancestor
110836354|NCT04394481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110836355|NCT04394481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110836356|NCT04394481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110836357|NCT04394481|Glucocorticoids|glucocorticoids|mesh-ancestor
110836358|NCT04394481|Hormones|hormones|mesh-ancestor
110836359|NCT04394481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110836360|NCT04394481|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110836361|NCT04394481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110836362|NCT04394481|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110836363|NCT04394481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110836364|NCT04394481|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110836365|NCT04394481|Analgesics|analgesics|mesh-ancestor
110836366|NCT04394481|Sensory System Agents|sensory system agents|mesh-ancestor
110836367|NCT04394481|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110836368|NCT04394481|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110836369|NCT04394481|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110836370|NCT04394481|Adrenergic Agents|adrenergic agents|mesh-ancestor
110836371|NCT04394481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110836372|NCT04394481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110836373|NCT04394481|Anesthetics, Local|anesthetics, local|mesh-ancestor
110836375|NCT03782935|Choline|choline|mesh-list
110836376|NCT03782935|Lipotropic Agents|lipotropic agents|mesh-ancestor
110836377|NCT03782935|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110836378|NCT03782935|Antimetabolites|antimetabolites|mesh-ancestor
110836379|NCT03782935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110836380|NCT03782935|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110836381|NCT03782935|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110836382|NCT03782935|Nootropic Agents|nootropic agents|mesh-ancestor
110836383|NCT04370847|Ephedrine|ephedrine|mesh-list
110836384|NCT04370847|Fentanyl|fentanyl|mesh-list
110836385|NCT04370847|Bupivacaine|bupivacaine|mesh-list
110836386|NCT04370847|Oxytocin|oxytocin|mesh-list
110836387|NCT04370847|Anesthetics, Local|anesthetics, local|mesh-ancestor
110836388|NCT04370847|Anesthetics|anesthetics|mesh-ancestor
110836389|NCT04370847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110836390|NCT04370847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110836391|NCT04370847|Sensory System Agents|sensory system agents|mesh-ancestor
110836392|NCT04370847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110836393|NCT04370847|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110836394|NCT04370847|Narcotics|narcotics|mesh-ancestor
110836395|NCT04370847|Analgesics|analgesics|mesh-ancestor
110836396|NCT04370847|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110184814|NCT01805726|Narcotics|narcotics|mesh-ancestor
110836397|NCT04370847|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110836398|NCT04370847|Anesthetics, General|anesthetics, general|mesh-ancestor
110836399|NCT04370847|Oxytocics|oxytocics|mesh-ancestor
110836400|NCT04370847|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110836401|NCT04370847|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110836402|NCT04370847|Sympathomimetics|sympathomimetics|mesh-ancestor
110836403|NCT04370847|Autonomic Agents|autonomic agents|mesh-ancestor
110836404|NCT04370847|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110836405|NCT04370847|Adrenergic Agents|adrenergic agents|mesh-ancestor
110836406|NCT04370847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110836407|NCT04370847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110836408|NCT03708120|Insect Repellents|insect repellents|mesh-list
110836409|NCT03708120|Protective Agents|protective agents|mesh-ancestor
110836410|NCT03708120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110836411|NCT03093428|Pembrolizumab|pembrolizumab|mesh-list
110836412|NCT03093428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110836413|NCT03093428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110836414|NCT03093428|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110836415|NCT03093428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110836416|NCT02735980|Prexasertib|prexasertib|mesh-list
110836417|NCT02735980|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110836418|NCT02735980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110836419|NCT02735980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110836420|NCT01309789|Prednisone|prednisone|mesh-list
110836421|NCT01309789|Cyclophosphamide|cyclophosphamide|mesh-list
110836422|NCT01309789|Doxorubicin|doxorubicin|mesh-list
110836423|NCT01309789|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110836424|NCT01309789|Vincristine|vincristine|mesh-list
110836425|NCT01309789|Brentuximab Vedotin|brentuximab vedotin|mesh-list
110836426|NCT01309789|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110836427|NCT01309789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110836428|NCT01309789|Immunologic Factors|immunologic factors|mesh-ancestor
110836429|NCT01309789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110836430|NCT01309789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110836431|NCT01309789|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110836432|NCT01309789|Alkylating Agents|alkylating agents|mesh-ancestor
110888742|NCT01336049|Nimotuzumab|nimotuzumab|mesh-list
110836433|NCT01309789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110836434|NCT01309789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110836435|NCT01309789|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110836436|NCT01309789|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110836437|NCT01309789|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110836438|NCT01309789|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110836439|NCT01309789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110836440|NCT01309789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110836443|NCT01309789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110836444|NCT01309789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110836445|NCT01309789|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110836446|NCT01309789|Tubulin Modulators|tubulin modulators|mesh-ancestor
110836447|NCT01309789|Antimitotic Agents|antimitotic agents|mesh-ancestor
110836448|NCT01309789|Mitosis Modulators|mitosis modulators|mesh-ancestor
110836449|NCT01309789|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110836450|NCT01309789|Immunotoxins|immunotoxins|mesh-ancestor
110836451|NCT01309789|Immunoconjugates|immunoconjugates|mesh-ancestor
110836452|NCT03707847|Etoposide|etoposide|mesh-list
110836453|NCT03707847|Crizotinib|crizotinib|mesh-list
110836454|NCT03707847|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110836455|NCT03707847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110836456|NCT03707847|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110836457|NCT03707847|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110836458|NCT03707847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110836459|NCT03707847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110836460|NCT03707847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110836461|NCT03338400|Dexamethasone|dexamethasone|mesh-list
110836462|NCT03338400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110836463|NCT03338400|Antiemetics|antiemetics|mesh-ancestor
110836464|NCT03338400|Autonomic Agents|autonomic agents|mesh-ancestor
110836465|NCT03338400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110836466|NCT03338400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110836467|NCT03338400|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110836468|NCT03338400|Glucocorticoids|glucocorticoids|mesh-ancestor
110836469|NCT03338400|Hormones|hormones|mesh-ancestor
110836470|NCT03338400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110836471|NCT03338400|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110836472|NCT03338400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110836473|NCT03787147|Lidocaine|lidocaine|mesh-list
110836474|NCT03787147|Bupivacaine|bupivacaine|mesh-list
110836475|NCT03787147|Anesthetics, Local|anesthetics, local|mesh-ancestor
110836476|NCT03787147|Anesthetics|anesthetics|mesh-ancestor
110836477|NCT03787147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110836478|NCT03787147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110836479|NCT03787147|Sensory System Agents|sensory system agents|mesh-ancestor
110836480|NCT03787147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110836481|NCT03787147|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110836482|NCT03787147|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110836483|NCT03787147|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110836484|NCT03787147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110836485|NCT03787147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110836486|NCT02620306|Losartan|losartan|mesh-list
110836487|NCT02620306|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110836488|NCT02620306|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110836489|NCT02620306|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110836490|NCT02620306|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110836491|NCT02620306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110836492|NCT03781843|Lidocaine|lidocaine|mesh-list
110836493|NCT03781843|Anesthetics, Local|anesthetics, local|mesh-ancestor
110836494|NCT03781843|Anesthetics|anesthetics|mesh-ancestor
110836495|NCT03781843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110836496|NCT03781843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110836497|NCT03781843|Sensory System Agents|sensory system agents|mesh-ancestor
110836498|NCT03781843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110836499|NCT03781843|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110836500|NCT03781843|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110836501|NCT03781843|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110836502|NCT03781843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110836503|NCT03781843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110836504|NCT05205447|Itraconazole|itraconazole|mesh-list
110836505|NCT05205447|Carbamazepine|carbamazepine|mesh-list
110836506|NCT05205447|Antifungal Agents|antifungal agents|mesh-ancestor
110836507|NCT05205447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110836508|NCT05205447|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110836509|NCT05205447|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110836510|NCT05205447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110836511|NCT05205447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110836512|NCT05205447|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110836513|NCT05205447|Hormone Antagonists|hormone antagonists|mesh-ancestor
110836514|NCT05205447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110184850|NCT01805687|Analgesics|analgesics|mesh-ancestor
110836515|NCT05205447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110836516|NCT05205447|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110836517|NCT05205447|Anticonvulsants|anticonvulsants|mesh-ancestor
110836518|NCT05205447|Antimanic Agents|antimanic agents|mesh-ancestor
110836519|NCT05205447|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110836520|NCT05205447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110836521|NCT05205447|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110836522|NCT05205447|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110836523|NCT05205447|Analgesics|analgesics|mesh-ancestor
110836524|NCT05205447|Sensory System Agents|sensory system agents|mesh-ancestor
110836525|NCT05205447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110836526|NCT05205447|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110836527|NCT05205447|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110836528|NCT05205447|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110836529|NCT05205447|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110836530|NCT03781687|Morphine|morphine|mesh-list
110836531|NCT03781687|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110836532|NCT03781687|Narcotics|narcotics|mesh-ancestor
110836533|NCT03781687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110836534|NCT03781687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110836535|NCT03781687|Analgesics|analgesics|mesh-ancestor
110836536|NCT03781687|Sensory System Agents|sensory system agents|mesh-ancestor
110836537|NCT03781687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110836538|NCT03092726|ASP8062|asp8062|mesh-list
110836539|NCT03092726|Analgesics|analgesics|mesh-ancestor
110836540|NCT03092726|Sensory System Agents|sensory system agents|mesh-ancestor
110836541|NCT03092726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110836542|NCT03092726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110836543|NCT03092726|GABA Modulators|gaba modulators|mesh-ancestor
110836544|NCT03092726|GABA Agents|gaba agents|mesh-ancestor
110836545|NCT03092726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110836546|NCT03092726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110836547|NCT03786757|Rivaroxaban|rivaroxaban|mesh-list
110836548|NCT03786757|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110836549|NCT03786757|Antithrombins|antithrombins|mesh-ancestor
110836550|NCT03786757|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110836551|NCT03786757|Protease Inhibitors|protease inhibitors|mesh-ancestor
110836552|NCT03786757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110836553|NCT03786757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110836554|NCT03786757|Anticoagulants|anticoagulants|mesh-ancestor
110888770|NCT01333085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110836555|NCT05126511|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
110836556|NCT05126511|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
110836557|NCT05126511|beta-Endorphin|beta-endorphin|mesh-list
110836558|NCT05126511|Hormones|hormones|mesh-ancestor
110836559|NCT05126511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110836560|NCT05126511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110836561|NCT05126511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110836562|NCT05126511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110836563|NCT05598242|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110836564|NCT05598242|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110836565|NCT04494789|Fludrocortisone|fludrocortisone|mesh-list
110836566|NCT04494789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110836567|NCT05598164|Botulinum Toxins|botulinum toxins|mesh-list
110836568|NCT05598164|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110836569|NCT05598164|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110836570|NCT05598164|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110836571|NCT05598164|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110836572|NCT05598164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110836573|NCT05598164|Cholinergic Agents|cholinergic agents|mesh-ancestor
110836574|NCT05598164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110836575|NCT05598164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110836576|NCT05598164|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110836577|NCT05598164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110836578|NCT03787069|Lidocaine|lidocaine|mesh-list
110836579|NCT03787069|Anesthetics, Local|anesthetics, local|mesh-ancestor
110836580|NCT03787069|Anesthetics|anesthetics|mesh-ancestor
110836581|NCT03787069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110836582|NCT03787069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110836583|NCT03787069|Sensory System Agents|sensory system agents|mesh-ancestor
110836584|NCT03787069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110836585|NCT03787069|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110836586|NCT03787069|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110836587|NCT03787069|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110836588|NCT03787069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110836589|NCT03787069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110836590|NCT04447118|Docetaxel|docetaxel|mesh-list
110836591|NCT04447118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110836592|NCT04447118|Tubulin Modulators|tubulin modulators|mesh-ancestor
110836593|NCT04447118|Antimitotic Agents|antimitotic agents|mesh-ancestor
110836594|NCT04447118|Mitosis Modulators|mitosis modulators|mesh-ancestor
110836595|NCT04447118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110836596|NCT05532319|Lenvatinib|lenvatinib|mesh-list
110836597|NCT05532319|Tislelizumab|tislelizumab|mesh-list
110836598|NCT05532319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110836599|NCT05532319|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110836600|NCT05532319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110836601|NCT05532319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110836602|NCT05532319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110836603|NCT01553032|Cetuximab|cetuximab|mesh-list
110836604|NCT01553032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110836605|NCT01553032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110836606|NCT05181124|Naproxen|naproxen|mesh-list
110836607|NCT05181124|Meloxicam|meloxicam|mesh-list
110836608|NCT05181124|Aceclofenac|aceclofenac|mesh-list
110836609|NCT05181124|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110836610|NCT05181124|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110836611|NCT05181124|Analgesics|analgesics|mesh-ancestor
110160915|NCT00101842|Gemcitabine|gemcitabine|mesh-list
110836612|NCT05181124|Sensory System Agents|sensory system agents|mesh-ancestor
110836613|NCT05181124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110836614|NCT05181124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110836615|NCT05181124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110836616|NCT05181124|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110836617|NCT05181124|Gout Suppressants|gout suppressants|mesh-ancestor
110836618|NCT05181124|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110836619|NCT05181124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110836620|NCT05181124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110836621|NCT05181124|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110836624|NCT02897648|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110836625|NCT02897648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110836626|NCT03338010|Insulin Glargine|insulin glargine|mesh-list
110836627|NCT03338010|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110836628|NCT03338010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110836629|NCT04959591|Acetaminophen|acetaminophen|mesh-list
110836630|NCT04959591|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110836631|NCT04959591|Analgesics|analgesics|mesh-ancestor
110836632|NCT04959591|Sensory System Agents|sensory system agents|mesh-ancestor
110836633|NCT04959591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110836634|NCT04959591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110836635|NCT04959591|Antipyretics|antipyretics|mesh-ancestor
110836636|NCT05598086|Tranexamic Acid|tranexamic acid|mesh-list
110836637|NCT05598086|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110836638|NCT05598086|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110836639|NCT05598086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110836640|NCT05598086|Hemostatics|hemostatics|mesh-ancestor
110836641|NCT05598086|Coagulants|coagulants|mesh-ancestor
110836642|NCT00753532|Vitamin E|vitamin e|mesh-list
110836643|NCT00753532|Tocopherols|tocopherols|mesh-list
110836644|NCT00753532|Tocotrienols|tocotrienols|mesh-list
110836645|NCT00753532|Tocovid|tocovid|mesh-list
110836646|NCT00753532|Vitamins|vitamins|mesh-ancestor
110836647|NCT00753532|Micronutrients|micronutrients|mesh-ancestor
110836648|NCT00753532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110836649|NCT00753532|Antioxidants|antioxidants|mesh-ancestor
110836650|NCT00753532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110836651|NCT00753532|Protective Agents|protective agents|mesh-ancestor
110836652|NCT03632408|Zopiclone|zopiclone|mesh-list
110836653|NCT03632408|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110836654|NCT03632408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110836655|NCT03632408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110836656|NCT01307839|Lidocaine|lidocaine|mesh-list
110836657|NCT01307839|Anesthetics, Local|anesthetics, local|mesh-ancestor
110836658|NCT01307839|Anesthetics|anesthetics|mesh-ancestor
110836659|NCT01307839|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110836660|NCT01307839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110836661|NCT01307839|Sensory System Agents|sensory system agents|mesh-ancestor
110836662|NCT01307839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110836663|NCT01307839|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110836664|NCT01307839|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110161173|NCT03879408|Naproxen|naproxen|mesh-list
110836665|NCT01307839|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110836666|NCT01307839|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110836667|NCT01307839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110836668|NCT03777085|Rituximab|rituximab|mesh-list
110836669|NCT03777085|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110836670|NCT03777085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110836671|NCT03777085|Immunologic Factors|immunologic factors|mesh-ancestor
110836672|NCT03777085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110836673|NCT03777085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110836674|NCT01328548|Vaccines|vaccines|mesh-list
110554275|NCT02633618|Anticonvulsants|anticonvulsants|mesh-ancestor
110836675|NCT01328548|Immunologic Factors|immunologic factors|mesh-ancestor
110836676|NCT01328548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110836678|NCT04453306|Anticonvulsants|anticonvulsants|mesh-ancestor
110836679|NCT04453306|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110836680|NCT04453306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110836681|NCT03777163|Vaccines|vaccines|mesh-list
110836682|NCT03777163|Immunologic Factors|immunologic factors|mesh-ancestor
110836683|NCT03777163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110836684|NCT03786289|Epoetin Alfa|epoetin alfa|mesh-list
110836685|NCT03786289|Hematinics|hematinics|mesh-ancestor
110836686|NCT05597540|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110836687|NCT05597540|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
110836688|NCT05597540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110836689|NCT05597540|Antitubercular Agents|antitubercular agents|mesh-ancestor
110836690|NCT03776851|Epoetin Alfa|epoetin alfa|mesh-list
110836691|NCT03776851|Hematinics|hematinics|mesh-ancestor
110836692|NCT03337308|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
110836693|NCT03337308|Ezetimibe|ezetimibe|mesh-list
110836694|NCT03337308|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110836695|NCT03337308|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110836696|NCT03337308|Antimetabolites|antimetabolites|mesh-ancestor
110836697|NCT03337308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110836698|NCT03337308|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110836699|NCT03337308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110836700|NCT03337308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110836701|NCT03337308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110836702|NCT03631862|Apatinib|apatinib|mesh-list
110836703|NCT03631862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110836704|NCT03631862|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110836705|NCT03631862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110836706|NCT03631862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110836708|NCT03468010|Cisplatin|cisplatin|mesh-list
110836709|NCT03468010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110836710|NCT03468010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110836711|NCT03468010|Tubulin Modulators|tubulin modulators|mesh-ancestor
110836712|NCT03468010|Antimitotic Agents|antimitotic agents|mesh-ancestor
110836713|NCT03468010|Mitosis Modulators|mitosis modulators|mesh-ancestor
110836714|NCT03468010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110836715|NCT03337152|Chloroquine|chloroquine|mesh-list
110836716|NCT03337152|Primaquine|primaquine|mesh-list
110836717|NCT03337152|Amebicides|amebicides|mesh-ancestor
110836718|NCT03337152|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110836719|NCT03337152|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110836720|NCT03337152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110836721|NCT03337152|Antimalarials|antimalarials|mesh-ancestor
110836722|NCT03337152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110836723|NCT03467620|Cannabidiol|cannabidiol|mesh-list
110836724|NCT03467620|Anticonvulsants|anticonvulsants|mesh-ancestor
110836725|NCT03780205|Methamphetamine|methamphetamine|mesh-list
110836726|NCT03780205|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110836727|NCT03780205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110836728|NCT03780205|Sympathomimetics|sympathomimetics|mesh-ancestor
110836729|NCT03780205|Autonomic Agents|autonomic agents|mesh-ancestor
110161544|NCT00401362|Naltrexone|naltrexone|mesh-list
110836730|NCT03780205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110836731|NCT03780205|Dopamine Agents|dopamine agents|mesh-ancestor
110836732|NCT03780205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110836733|NCT03780205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110836734|NCT03780205|Adrenergic Agents|adrenergic agents|mesh-ancestor
110836735|NCT03780205|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110161604|NCT00006578|Protease Inhibitors|protease inhibitors|mesh-ancestor
110836737|NCT03780205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110836738|NCT03780205|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110836739|NCT04305249|Nivolumab|nivolumab|mesh-list
110836740|NCT04305249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110836741|NCT04305249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110836742|NCT04305249|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110836743|NCT04305249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110836744|NCT03707808|Nivolumab|nivolumab|mesh-list
110836745|NCT03707808|Ipilimumab|ipilimumab|mesh-list
110836746|NCT03707808|Avelumab|avelumab|mesh-list
110836747|NCT03707808|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110836748|NCT03707808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110836749|NCT03707808|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110836750|NCT03707808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110836751|NCT03091400|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
110836752|NCT03091400|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110836753|NCT03091400|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110836754|NCT03091400|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110836755|NCT03091400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110836756|NCT03091400|Adrenergic Agents|adrenergic agents|mesh-ancestor
110836757|NCT03091400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110836758|NCT03091400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110836760|NCT04716634|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110836761|NCT04716634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110836762|NCT02761070|Bevacizumab|bevacizumab|mesh-list
110836763|NCT02761070|Temozolomide|temozolomide|mesh-list
110836764|NCT02761070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110836765|NCT02761070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110836766|NCT02761070|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110836767|NCT02761070|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110836768|NCT02761070|Growth Substances|growth substances|mesh-ancestor
110836769|NCT02761070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110836770|NCT02761070|Growth Inhibitors|growth inhibitors|mesh-ancestor
110836771|NCT02761070|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110836772|NCT02761070|Alkylating Agents|alkylating agents|mesh-ancestor
110836773|NCT02761070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110836774|NCT03090152|Bupivacaine|bupivacaine|mesh-list
110836775|NCT03090152|Anesthetics, Local|anesthetics, local|mesh-ancestor
110836776|NCT03090152|Anesthetics|anesthetics|mesh-ancestor
110836777|NCT03090152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110836778|NCT03090152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110836779|NCT03090152|Sensory System Agents|sensory system agents|mesh-ancestor
110836780|NCT03090152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110836781|NCT03466528|Thiamine|thiamine|mesh-list
110836782|NCT03466528|Vitamin B Complex|vitamin b complex|mesh-list
110836783|NCT03466528|Magnesium Sulfate|magnesium sulfate|mesh-list
110836784|NCT03466528|Vitamins|vitamins|mesh-ancestor
110836785|NCT03466528|Micronutrients|micronutrients|mesh-ancestor
110836786|NCT03466528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110836787|NCT03466528|Analgesics|analgesics|mesh-ancestor
110836788|NCT03466528|Sensory System Agents|sensory system agents|mesh-ancestor
110836789|NCT03466528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110836790|NCT03466528|Anesthetics|anesthetics|mesh-ancestor
110836791|NCT03466528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110836792|NCT03466528|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110836793|NCT03466528|Anticonvulsants|anticonvulsants|mesh-ancestor
110836794|NCT03466528|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110836795|NCT03466528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110836796|NCT03466528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110836797|NCT03466528|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110836798|NCT03466528|Tocolytic Agents|tocolytic agents|mesh-ancestor
110836799|NCT03466528|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110836800|NCT03466216|Octreotide|octreotide|mesh-list
110836801|NCT03466216|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110836802|NCT03466216|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110836803|NCT03466216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110836804|NCT03098654|Metformin|metformin|mesh-list
110836805|NCT03098654|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110836806|NCT03098654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110836807|NCT05175066|Bisoprolol|bisoprolol|mesh-list
110836808|NCT05175066|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110836809|NCT05175066|Sympatholytics|sympatholytics|mesh-ancestor
110184907|NCT00036153|Methotrexate|methotrexate|mesh-list
110836810|NCT05175066|Autonomic Agents|autonomic agents|mesh-ancestor
110836811|NCT05175066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110836812|NCT05175066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110836813|NCT05175066|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110836814|NCT05175066|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110836815|NCT05175066|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110836816|NCT05175066|Adrenergic Agents|adrenergic agents|mesh-ancestor
110836817|NCT05175066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110836818|NCT05175066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110836819|NCT03130114|Azithromycin|azithromycin|mesh-list
110836820|NCT03130114|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110836821|NCT03130114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110836822|NCT03130270|Apatinib|apatinib|mesh-list
110836823|NCT03130270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110836824|NCT03130270|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110836825|NCT03130270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110836826|NCT03130270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110836827|NCT03780361|Aflibercept|aflibercept|mesh-list
110836828|NCT03780361|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110836829|NCT03780361|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110836830|NCT03780361|Growth Substances|growth substances|mesh-ancestor
110836831|NCT03780361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110836832|NCT03780361|Growth Inhibitors|growth inhibitors|mesh-ancestor
110836833|NCT03780361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110836834|NCT05183646|Propagermanium|propagermanium|mesh-list
110836835|NCT05183646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110836836|NCT05183646|Interferon Inducers|interferon inducers|mesh-ancestor
110836837|NCT05183646|Immunologic Factors|immunologic factors|mesh-ancestor
110836838|NCT05183646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110836839|NCT04943445|Paclitaxel|paclitaxel|mesh-list
110836840|NCT04943445|Carboplatin|carboplatin|mesh-list
110836841|NCT04943445|Pembrolizumab|pembrolizumab|mesh-list
110836842|NCT04943445|Immunomodulating Agents|immunomodulating agents|mesh-list
110836843|NCT04943445|Immunologic Factors|immunologic factors|mesh-list
110836844|NCT04943445|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110836845|NCT04943445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110836846|NCT04943445|Tubulin Modulators|tubulin modulators|mesh-ancestor
110836847|NCT04943445|Antimitotic Agents|antimitotic agents|mesh-ancestor
110836848|NCT04943445|Mitosis Modulators|mitosis modulators|mesh-ancestor
110836849|NCT04943445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110836850|NCT04943445|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110836851|NCT04943445|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110836852|NCT04943445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110836853|NCT02522572|Plerixafor|plerixafor|mesh-list
110836854|NCT02522572|Bortezomib|bortezomib|mesh-list
110836855|NCT02522572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110836856|NCT02522572|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110836857|NCT02522572|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110162067|NCT00110851|Metformin|metformin|mesh-list
110836858|NCT02522572|Antiviral Agents|antiviral agents|mesh-ancestor
110836859|NCT02522572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110836860|NCT04602507|Ivermectin|ivermectin|mesh-list
110836861|NCT04602507|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110836862|NCT04602507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110836863|NCT04645966|Acetaminophen|acetaminophen|mesh-list
110836864|NCT04645966|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110836865|NCT04645966|Analgesics|analgesics|mesh-ancestor
110836866|NCT04645966|Sensory System Agents|sensory system agents|mesh-ancestor
110836867|NCT04645966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110836868|NCT04645966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110836869|NCT04645966|Antipyretics|antipyretics|mesh-ancestor
110888825|NCT03564704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110836870|NCT03773809|Vitamin D|vitamin d|mesh-list
110836871|NCT03773809|Ergocalciferols|ergocalciferols|mesh-list
110162208|NCT00111904|Paclitaxel|paclitaxel|mesh-list
110836872|NCT03773809|Cholecalciferol|cholecalciferol|mesh-list
110836873|NCT03773809|Vitamins|vitamins|mesh-list
110836874|NCT03773809|Micronutrients|micronutrients|mesh-ancestor
110836875|NCT03773809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110836876|NCT03773809|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110836877|NCT03773809|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110836878|NCT01313611|Rituximab|rituximab|mesh-list
110836879|NCT01313611|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110836880|NCT01313611|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110836881|NCT01313611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110836882|NCT01313611|Immunologic Factors|immunologic factors|mesh-ancestor
110836883|NCT01313611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110836884|NCT01313611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110836885|NCT01313611|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110836886|NCT01313611|Alkylating Agents|alkylating agents|mesh-ancestor
110836887|NCT01313611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110836888|NCT03776383|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110836889|NCT03776383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110836891|NCT04534582|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110836892|NCT04534582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110836893|NCT03780049|Leucovorin|leucovorin|mesh-list
110836894|NCT03780049|Fluorouracil|fluorouracil|mesh-list
110836895|NCT03780049|Oxaliplatin|oxaliplatin|mesh-list
110836896|NCT03780049|Antimetabolites|antimetabolites|mesh-ancestor
110836897|NCT03780049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110836898|NCT03780049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110554499|NCT00879710|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110836899|NCT03780049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110836900|NCT03780049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110836901|NCT03780049|Immunologic Factors|immunologic factors|mesh-ancestor
110836902|NCT03780049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110836903|NCT03780049|Antidotes|antidotes|mesh-ancestor
110836904|NCT03780049|Protective Agents|protective agents|mesh-ancestor
110836905|NCT03780049|Vitamin B Complex|vitamin b complex|mesh-ancestor
110836906|NCT03780049|Vitamins|vitamins|mesh-ancestor
110836907|NCT03780049|Micronutrients|micronutrients|mesh-ancestor
110836908|NCT04252287|Canagliflozin|canagliflozin|mesh-list
110836909|NCT04252287|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110836910|NCT04252287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110836911|NCT04252287|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110836912|NCT04252287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110836913|NCT05681754|Calcium, Dietary|calcium, dietary|mesh-list
110836914|NCT05681754|Calcium|calcium|mesh-list
110836915|NCT05681754|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110836916|NCT05681754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110836917|NCT05681754|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110836918|NCT03465202|Capecitabine|capecitabine|mesh-list
110836919|NCT03465202|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110836920|NCT03465202|Antimetabolites|antimetabolites|mesh-ancestor
110836921|NCT03465202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110836922|NCT03465202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110836923|NCT04195958|Omalizumab|omalizumab|mesh-list
110836924|NCT04195958|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110836925|NCT04195958|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110836926|NCT04195958|Respiratory System Agents|respiratory system agents|mesh-ancestor
110836927|NCT05540262|Edaravone|edaravone|mesh-list
110836928|NCT05540262|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110836929|NCT05540262|Antioxidants|antioxidants|mesh-ancestor
110836930|NCT05540262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110836931|NCT05540262|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110836932|NCT05540262|Protective Agents|protective agents|mesh-ancestor
110836933|NCT05540262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110836934|NCT04245423|Analgesics, Opioid|analgesics, opioid|mesh-list
110836935|NCT04245423|Narcotics|narcotics|mesh-ancestor
110836936|NCT04245423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110888844|NCT03564704|Antimetabolites|antimetabolites|mesh-ancestor
110184941|NCT00036309|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110836937|NCT04245423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110836938|NCT04245423|Analgesics|analgesics|mesh-ancestor
110836939|NCT04245423|Sensory System Agents|sensory system agents|mesh-ancestor
110836940|NCT04245423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110836941|NCT02735200|Vitamin D|vitamin d|mesh-list
110836942|NCT02735200|Ergocalciferols|ergocalciferols|mesh-list
110836943|NCT02735200|Cholecalciferol|cholecalciferol|mesh-list
110836944|NCT02735200|Vitamins|vitamins|mesh-list
110836945|NCT02735200|Micronutrients|micronutrients|mesh-ancestor
110836946|NCT02735200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110836947|NCT02735200|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110836948|NCT02735200|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110836949|NCT01312311|Docetaxel|docetaxel|mesh-list
110836950|NCT01312311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110836951|NCT01312311|Tubulin Modulators|tubulin modulators|mesh-ancestor
110836952|NCT01312311|Antimitotic Agents|antimitotic agents|mesh-ancestor
110836953|NCT01312311|Mitosis Modulators|mitosis modulators|mesh-ancestor
110836954|NCT01312311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110836955|NCT03464968|Leucovorin|leucovorin|mesh-list
110836956|NCT03464968|Oxaliplatin|oxaliplatin|mesh-list
110836957|NCT03464968|Irinotecan|irinotecan|mesh-list
110836958|NCT03464968|Fluorouracil|fluorouracil|mesh-list
110836959|NCT03464968|Levoleucovorin|levoleucovorin|mesh-list
110836960|NCT03464968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110836961|NCT03464968|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110836962|NCT03464968|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110836963|NCT03464968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110836964|NCT03464968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110836965|NCT03464968|Antidotes|antidotes|mesh-ancestor
110836966|NCT03464968|Protective Agents|protective agents|mesh-ancestor
110836967|NCT03464968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110836968|NCT03464968|Vitamin B Complex|vitamin b complex|mesh-ancestor
110836969|NCT03464968|Vitamins|vitamins|mesh-ancestor
110836970|NCT03464968|Micronutrients|micronutrients|mesh-ancestor
110836971|NCT03464968|Antimetabolites|antimetabolites|mesh-ancestor
110836972|NCT03464968|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110836973|NCT03464968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110836974|NCT03464968|Immunologic Factors|immunologic factors|mesh-ancestor
110836975|NCT05073744|Morphine|morphine|mesh-list
110836976|NCT05073744|Nalbuphine|nalbuphine|mesh-list
110836977|NCT05073744|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110836978|NCT05073744|Narcotics|narcotics|mesh-ancestor
110836979|NCT05073744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110836981|NCT05073744|Analgesics|analgesics|mesh-ancestor
110836982|NCT05073744|Sensory System Agents|sensory system agents|mesh-ancestor
110836983|NCT05073744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110836984|NCT05681598|Hydroxyurea|hydroxyurea|mesh-list
110836985|NCT05681598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110836986|NCT05681598|Antisickling Agents|antisickling agents|mesh-ancestor
110836987|NCT05681598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110836988|NCT05681598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110836989|NCT05681598|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110836990|NCT01312350|Docetaxel|docetaxel|mesh-list
110836991|NCT01312350|Fluorouracil|fluorouracil|mesh-list
110836992|NCT01312350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110836993|NCT01312350|Tubulin Modulators|tubulin modulators|mesh-ancestor
110836994|NCT01312350|Antimitotic Agents|antimitotic agents|mesh-ancestor
110836995|NCT01312350|Mitosis Modulators|mitosis modulators|mesh-ancestor
110836996|NCT01312350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110184961|NCT00036387|Infliximab|infliximab|mesh-list
110836997|NCT01312350|Antimetabolites|antimetabolites|mesh-ancestor
110836998|NCT01312350|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110836999|NCT01312350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110837000|NCT01312350|Immunologic Factors|immunologic factors|mesh-ancestor
110837001|NCT01312350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110837002|NCT03464656|Antioxidants|antioxidants|mesh-list
110837003|NCT03464656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110837005|NCT03464656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110837006|NCT04343248|Nitazoxanide|nitazoxanide|mesh-list
110837007|NCT04343248|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110837008|NCT04343248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110837009|NCT03705858|Lintuzumab|lintuzumab|mesh-list
110837010|NCT03705858|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110837011|NCT03705858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110837012|NCT03463642|Vitamin D|vitamin d|mesh-list
110837013|NCT03463642|Cholecalciferol|cholecalciferol|mesh-list
110837014|NCT03463642|Mineral Oil|mineral oil|mesh-list
110837015|NCT03463642|Vitamins|vitamins|mesh-ancestor
110837016|NCT03463642|Micronutrients|micronutrients|mesh-ancestor
110837017|NCT03463642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110837018|NCT03463642|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110837019|NCT03463642|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110837020|NCT03463642|Emollients|emollients|mesh-ancestor
110837021|NCT03463642|Dermatologic Agents|dermatologic agents|mesh-ancestor
110837023|NCT03463564|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110837024|NCT03463564|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110837025|NCT03463564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110837026|NCT05092386|Vaccines|vaccines|mesh-list
110837027|NCT05092386|Immunologic Factors|immunologic factors|mesh-ancestor
110837028|NCT05092386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110837029|NCT03463252|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
110837030|NCT03463252|Medroxyprogesterone|medroxyprogesterone|mesh-list
110837031|NCT03463252|Progesterone|progesterone|mesh-list
110837032|NCT03463252|Progestins|progestins|mesh-ancestor
110837033|NCT03463252|Hormones|hormones|mesh-ancestor
110837034|NCT03463252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110837035|NCT03463252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110837036|NCT03463252|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110837037|NCT03463252|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110837038|NCT03463252|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110163274|NCT04727515|Analgesics|analgesics|mesh-ancestor
110837039|NCT03463252|Contraceptive Agents|contraceptive agents|mesh-ancestor
110837040|NCT03463252|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110837041|NCT03463252|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110837042|NCT03463252|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110837043|NCT03463252|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110163338|NCT00118183|Cetuximab|cetuximab|mesh-list
110837044|NCT03463252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110837045|NCT03463252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110837046|NCT05309538|Betahistine|betahistine|mesh-list
110837047|NCT05309538|Vasodilator Agents|vasodilator agents|mesh-ancestor
110837048|NCT05309538|Histamine Agonists|histamine agonists|mesh-ancestor
110837049|NCT05309538|Histamine Agents|histamine agents|mesh-ancestor
110837050|NCT05309538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110837051|NCT05309538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110837052|NCT05309538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110837053|NCT03462940|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
110837054|NCT03462940|Antiviral Agents|antiviral agents|mesh-ancestor
110837055|NCT03462940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110837056|NCT03462940|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
110837057|NCT03462940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110837059|NCT03011450|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110837060|NCT03011450|Antimetabolites|antimetabolites|mesh-ancestor
110837061|NCT03011450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110837062|NCT03011450|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110837063|NCT03638856|Misoprostol|misoprostol|mesh-list
110837064|NCT03638856|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110837065|NCT03638856|Abortifacient Agents|abortifacient agents|mesh-ancestor
110837066|NCT03638856|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110837067|NCT03638856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110163403|NCT02710734|Mitomycins|mitomycins|mesh-list
110837068|NCT03638856|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110837069|NCT03638856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110837070|NCT03638856|Oxytocics|oxytocics|mesh-ancestor
110837071|NCT03705780|Fentanyl|fentanyl|mesh-list
110837072|NCT03705780|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110837073|NCT03705780|Narcotics|narcotics|mesh-ancestor
110837074|NCT03705780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110837075|NCT03705780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110837076|NCT03705780|Analgesics|analgesics|mesh-ancestor
110837077|NCT03705780|Sensory System Agents|sensory system agents|mesh-ancestor
110163450|NCT00118768|Interferons|interferons|mesh-list
110837078|NCT03705780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110837079|NCT03705780|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110837080|NCT03705780|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110837081|NCT03705780|Anesthetics, General|anesthetics, general|mesh-ancestor
110837082|NCT03705780|Anesthetics|anesthetics|mesh-ancestor
110837083|NCT04976790|Flurbiprofen|flurbiprofen|mesh-list
110837084|NCT04976790|Analgesics|analgesics|mesh-ancestor
110837085|NCT04976790|Sensory System Agents|sensory system agents|mesh-ancestor
110837086|NCT04976790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110837087|NCT04976790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110837088|NCT04976790|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110837089|NCT04976790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110837090|NCT04976790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110837091|NCT04976790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110837092|NCT04976790|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110837093|NCT04976790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110837094|NCT04976790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110837095|NCT04452838|Fesoterodine|fesoterodine|mesh-list
110837096|NCT04452838|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110837097|NCT04452838|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110837098|NCT04452838|Cholinergic Agents|cholinergic agents|mesh-ancestor
110837099|NCT04452838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110837100|NCT04452838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110837101|NCT04452838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110837102|NCT04452838|Urological Agents|urological agents|mesh-ancestor
110837103|NCT02967848|Technetium Tc 99m mebrofenin|technetium tc 99m mebrofenin|mesh-list
110837104|NCT02967848|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110837105|NCT02967848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110837107|NCT04188860|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110837108|NCT04188860|Antibodies|antibodies|mesh-list
110837109|NCT04188860|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110837110|NCT04188860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110837111|NCT04188860|Tubulin Modulators|tubulin modulators|mesh-ancestor
110837112|NCT04188860|Antimitotic Agents|antimitotic agents|mesh-ancestor
110837113|NCT04188860|Mitosis Modulators|mitosis modulators|mesh-ancestor
110837114|NCT04188860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110837115|NCT04188860|Immunologic Factors|immunologic factors|mesh-ancestor
110837116|NCT04188860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110837117|NCT01383668|Sirolimus|sirolimus|mesh-list
110163568|NCT00120172|Bevacizumab|bevacizumab|mesh-list
110837118|NCT01383668|Gold Sodium Thiomalate|gold sodium thiomalate|mesh-list
110837119|NCT01383668|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110184999|NCT00036582|Clozapine|clozapine|mesh-list
110837120|NCT01383668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110837121|NCT01383668|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110837122|NCT01383668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110888878|NCT05352854|Miotics|miotics|mesh-ancestor
110837123|NCT01383668|Antifungal Agents|antifungal agents|mesh-ancestor
110837124|NCT01383668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110837125|NCT01383668|Immunologic Factors|immunologic factors|mesh-ancestor
110837126|NCT01383668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110554721|NCT04215965|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110837127|NCT01383668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110837128|NCT03656068|Nitazoxanide|nitazoxanide|mesh-list
110837129|NCT03656068|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110837130|NCT03656068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110837131|NCT01381796|Sumatriptan|sumatriptan|mesh-list
110837132|NCT01381796|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110837133|NCT01381796|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110837134|NCT01381796|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110837135|NCT01381796|Serotonin Agents|serotonin agents|mesh-ancestor
110837136|NCT01381796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110837137|NCT01381796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110837138|NCT01381796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110837140|NCT04375228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110837141|NCT04375228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110837142|NCT04375228|Immunologic Factors|immunologic factors|mesh-ancestor
110837143|NCT04375228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110837144|NCT04375228|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110837145|NCT02521714|Lenalidomide|lenalidomide|mesh-list
110837146|NCT02521714|Immunologic Factors|immunologic factors|mesh-ancestor
110837147|NCT02521714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110837148|NCT02521714|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110837149|NCT02521714|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110837150|NCT02521714|Growth Substances|growth substances|mesh-ancestor
110837151|NCT02521714|Growth Inhibitors|growth inhibitors|mesh-ancestor
110837152|NCT02521714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110837153|NCT03768089|Ivacaftor|ivacaftor|mesh-list
110837154|NCT03768089|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
110837155|NCT03768089|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110837156|NCT03768089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110837158|NCT03548584|Serotonin Agents|serotonin agents|mesh-ancestor
110837159|NCT03548584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110837160|NCT03548584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110837161|NCT03548584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110837162|NCT03548584|Dopamine Agonists|dopamine agonists|mesh-ancestor
110837163|NCT03548584|Dopamine Agents|dopamine agents|mesh-ancestor
110837164|NCT01381640|Acetaminophen|acetaminophen|mesh-list
110837165|NCT01381640|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110837167|NCT01381640|Sensory System Agents|sensory system agents|mesh-ancestor
110837168|NCT01381640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110837169|NCT01381640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110837170|NCT01381640|Antipyretics|antipyretics|mesh-ancestor
110837171|NCT04483973|Ebselen|ebselen|mesh-list
110837172|NCT04483973|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110837173|NCT04483973|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110837174|NCT04483973|Analgesics|analgesics|mesh-ancestor
110185010|NCT00036582|GABA Agents|gaba agents|mesh-ancestor
110837175|NCT04483973|Sensory System Agents|sensory system agents|mesh-ancestor
110837176|NCT04483973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110837177|NCT04483973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110837178|NCT04483973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110837179|NCT04483973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110837180|NCT04483973|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110837181|NCT04483973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110837182|NCT04483973|Antioxidants|antioxidants|mesh-ancestor
110837183|NCT04483973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110837184|NCT04483973|Protective Agents|protective agents|mesh-ancestor
110837185|NCT04483973|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110837186|NCT04483973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110837187|NCT04483973|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110837189|NCT04283890|Ipilimumab|ipilimumab|mesh-list
110837190|NCT04283890|Melphalan|melphalan|mesh-list
110837191|NCT04283890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110837192|NCT04283890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110837193|NCT04283890|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110837194|NCT04283890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110837195|NCT04283890|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110837196|NCT04283890|Alkylating Agents|alkylating agents|mesh-ancestor
110837197|NCT04283890|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110837198|NCT04283890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110837199|NCT04283890|Immunologic Factors|immunologic factors|mesh-ancestor
110837200|NCT04283890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110837201|NCT01139723|Bevacizumab|bevacizumab|mesh-list
110837202|NCT01139723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110837203|NCT01139723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110837204|NCT01139723|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110837205|NCT01139723|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110837206|NCT01139723|Growth Substances|growth substances|mesh-ancestor
110837207|NCT01139723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110837208|NCT01139723|Growth Inhibitors|growth inhibitors|mesh-ancestor
110837209|NCT05068037|Antiemetics|antiemetics|mesh-list
110837211|NCT05068037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110837212|NCT05068037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110837213|NCT05068037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110837215|NCT01136759|Antiviral Agents|antiviral agents|mesh-ancestor
110837216|NCT01136759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110837217|NCT01136759|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110837218|NCT01136759|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110837220|NCT01136759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110837221|NCT01136759|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110837222|NCT01136759|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110837223|NCT01141439|Fluticasone|fluticasone|mesh-list
110837224|NCT01141439|Xhance|xhance|mesh-list
110837225|NCT01141439|Beclomethasone|beclomethasone|mesh-list
110837226|NCT01141439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110837227|NCT01141439|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110837228|NCT01141439|Autonomic Agents|autonomic agents|mesh-ancestor
110837229|NCT01141439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110837230|NCT01141439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110837231|NCT01141439|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110164579|NCT00020488|Vitamins|vitamins|mesh-ancestor
110837232|NCT01141439|Respiratory System Agents|respiratory system agents|mesh-ancestor
110837233|NCT01141439|Dermatologic Agents|dermatologic agents|mesh-ancestor
110837234|NCT01141439|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110837235|NCT01141439|Glucocorticoids|glucocorticoids|mesh-ancestor
110837237|NCT01141439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110837238|NCT05549531|Itraconazole|itraconazole|mesh-list
110837239|NCT05549531|Antifungal Agents|antifungal agents|mesh-ancestor
110837240|NCT05549531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110164641|NCT00020761|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110837242|NCT05549531|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110837243|NCT05549531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110837244|NCT05549531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110837245|NCT05549531|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110837246|NCT05549531|Hormone Antagonists|hormone antagonists|mesh-ancestor
110837247|NCT05549531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110837248|NCT05549531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110837249|NCT05549531|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110837250|NCT04452370|Etoposide|etoposide|mesh-list
110837251|NCT04452370|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110837252|NCT04452370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110837253|NCT04452370|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110837255|NCT04452370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110837256|NCT04452370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110837257|NCT01232777|Bevacizumab|bevacizumab|mesh-list
110837258|NCT01232777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110837259|NCT01232777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110837260|NCT01232777|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110837261|NCT01232777|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110837262|NCT01232777|Growth Substances|growth substances|mesh-ancestor
110837263|NCT01232777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110837264|NCT01232777|Growth Inhibitors|growth inhibitors|mesh-ancestor
110837265|NCT03248271|Insulin Lispro|insulin lispro|mesh-list
110837266|NCT03248271|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110837267|NCT03248271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110837268|NCT04213677|Dapagliflozin|dapagliflozin|mesh-list
110837269|NCT04213677|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110837270|NCT04213677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110837271|NCT04213677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110837272|NCT04213677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110837273|NCT03247036|Fibrinolytic Agents|fibrinolytic agents|mesh-list
110837274|NCT03247036|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110837275|NCT03247036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110837276|NCT04921995|Tislelizumab|tislelizumab|mesh-list
110554881|NCT00665990|Sorafenib|sorafenib|mesh-list
110837277|NCT04921995|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110837278|NCT04921995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110837279|NCT03129867|Ticagrelor|ticagrelor|mesh-list
110837280|NCT03129867|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110837281|NCT03129867|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110837282|NCT03129867|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110837283|NCT03129867|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110837284|NCT03129867|Purinergic Agents|purinergic agents|mesh-ancestor
110837285|NCT03129867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110837286|NCT03129867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110837287|NCT03129867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110837289|NCT01235273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110837290|NCT01235273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110837291|NCT01140035|Insulin|insulin|mesh-list
110837292|NCT01140035|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110837293|NCT01140035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110837294|NCT00872950|Amifampridine|amifampridine|mesh-list
110837295|NCT00872950|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110837296|NCT00872950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110185050|NCT00396513|Metformin|metformin|mesh-list
110837297|NCT00872950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110837298|NCT00872950|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
110837299|NCT00872950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110837300|NCT00872950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110837301|NCT03233217|Vaccines|vaccines|mesh-list
110837302|NCT03233217|Immunologic Factors|immunologic factors|mesh-ancestor
110837303|NCT03233217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110837304|NCT01568996|Sulforaphane|sulforaphane|mesh-list
110837305|NCT01568996|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110837306|NCT01568996|Protective Agents|protective agents|mesh-ancestor
110837307|NCT01568996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110837308|NCT01568996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110837309|NCT02943993|Edoxaban|edoxaban|mesh-list
110837310|NCT02943993|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110837311|NCT02943993|Antithrombins|antithrombins|mesh-ancestor
110837312|NCT02943993|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110837313|NCT02943993|Protease Inhibitors|protease inhibitors|mesh-ancestor
110837314|NCT02943993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110837315|NCT02943993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110837316|NCT02943993|Anticoagulants|anticoagulants|mesh-ancestor
110837318|NCT02620150|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110837319|NCT02620150|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110837320|NCT02620150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110837321|NCT02620150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110837322|NCT02620150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110837323|NCT02620150|Serotonin Agents|serotonin agents|mesh-ancestor
110837324|NCT02620150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110837325|NCT04098302|Dutasteride|dutasteride|mesh-list
110837326|NCT04098302|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
110837327|NCT04098302|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110837328|NCT04098302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110837329|NCT04098302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110837330|NCT04098302|Hormone Antagonists|hormone antagonists|mesh-ancestor
110837331|NCT04098302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110837332|NCT04098302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110837333|NCT02596126|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
110560570|NCT00856856|Everolimus|everolimus|mesh-list
110837335|NCT05488613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110837336|NCT05488613|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110837337|NCT05488613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110837338|NCT05488613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110837339|NCT05420168|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110837340|NCT05420168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110837341|NCT01137383|Interferons|interferons|mesh-list
110837342|NCT01137383|Ribavirin|ribavirin|mesh-list
110837343|NCT01137383|Interferon-alpha|interferon-alpha|mesh-list
110837344|NCT01137383|Interferon alpha-2|interferon alpha-2|mesh-list
110837345|NCT01137383|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110837346|NCT01137383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110837347|NCT01137383|Antiviral Agents|antiviral agents|mesh-ancestor
110837348|NCT01137383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110555005|NCT02702843|Xenon|xenon|mesh-list
110837350|NCT01137383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110837351|NCT01137383|Immunologic Factors|immunologic factors|mesh-ancestor
110837352|NCT01137383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110837353|NCT03449836|Fluticasone|fluticasone|mesh-list
110837354|NCT03449836|Mometasone Furoate|mometasone furoate|mesh-list
110837355|NCT03449836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110837356|NCT03449836|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110837357|NCT03449836|Autonomic Agents|autonomic agents|mesh-ancestor
110837358|NCT03449836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110837359|NCT03449836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110837360|NCT03449836|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110837361|NCT03449836|Respiratory System Agents|respiratory system agents|mesh-ancestor
110837362|NCT03449836|Dermatologic Agents|dermatologic agents|mesh-ancestor
110837363|NCT03449836|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110837364|NCT03449524|CXA-10|cxa-10|mesh-list
110837365|NCT03449524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110837366|NCT03961256|Exenatide|exenatide|mesh-list
110837367|NCT03961256|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110837368|NCT03961256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110837369|NCT03961256|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110837370|NCT03961256|Incretins|incretins|mesh-ancestor
110837371|NCT03961256|Hormones|hormones|mesh-ancestor
110560833|NCT00601523|Pramipexole|pramipexole|mesh-list
110837372|NCT03961256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110837373|NCT03443518|Remifentanil|remifentanil|mesh-list
110837374|NCT03443518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110837375|NCT03443518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110837376|NCT03443518|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110888921|NCT03145207|Lidocaine|lidocaine|mesh-list
110837377|NCT03443518|Narcotics|narcotics|mesh-ancestor
110837378|NCT03443518|Analgesics|analgesics|mesh-ancestor
110837379|NCT03443518|Sensory System Agents|sensory system agents|mesh-ancestor
110837380|NCT03443518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110837382|NCT01142843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110837383|NCT04330625|Volagidemab|volagidemab|mesh-list
110837384|NCT04330625|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110837385|NCT04330625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110837386|NCT03747497|Linezolid|linezolid|mesh-list
110837387|NCT03747497|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110837388|NCT03747497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110560959|NCT02676011|Autonomic Agents|autonomic agents|mesh-ancestor
110837389|NCT03747497|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110837390|NCT03747497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110837391|NCT03747497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110837392|NCT03109600|Vaccines|vaccines|mesh-list
110837393|NCT03109600|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110837394|NCT03109600|Immunologic Factors|immunologic factors|mesh-ancestor
110837395|NCT03109600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110837396|NCT03679013|Acetaminophen|acetaminophen|mesh-list
110837397|NCT03679013|Gabapentin|gabapentin|mesh-list
110837398|NCT03679013|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110837399|NCT03679013|Analgesics|analgesics|mesh-ancestor
110185113|NCT00037206|Anidulafungin|anidulafungin|mesh-list
110837400|NCT03679013|Sensory System Agents|sensory system agents|mesh-ancestor
110837401|NCT03679013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110837402|NCT03679013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110837403|NCT03679013|Antipyretics|antipyretics|mesh-ancestor
110837404|NCT03679013|Anticonvulsants|anticonvulsants|mesh-ancestor
110837405|NCT03679013|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110837406|NCT03679013|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110837407|NCT03679013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110837408|NCT03679013|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110837409|NCT03679013|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110837410|NCT03679013|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110837411|NCT03679013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110837412|NCT03679013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110837413|NCT03679013|Antimanic Agents|antimanic agents|mesh-ancestor
110837414|NCT01140425|Moxifloxacin|moxifloxacin|mesh-list
110837415|NCT01140425|PF 232798|pf 232798|mesh-list
110837416|NCT01140425|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110837417|NCT01140425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110837418|NCT01140425|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110837419|NCT01140425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110837420|NCT01140425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110837421|NCT01140425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110837422|NCT01140425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110837423|NCT01140425|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
110837424|NCT01140425|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110837425|NCT01140425|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110837426|NCT01140425|Antiviral Agents|antiviral agents|mesh-ancestor
110837427|NCT03991013|Dolutegravir|dolutegravir|mesh-list
110837428|NCT03991013|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110837429|NCT03991013|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110837430|NCT03991013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110837431|NCT03991013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110837432|NCT03991013|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110837433|NCT03991013|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110837434|NCT03991013|Antiviral Agents|antiviral agents|mesh-ancestor
110837435|NCT03991013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110837436|NCT03441412|Metoprolol|metoprolol|mesh-list
110837437|NCT03441412|Epinephrine|epinephrine|mesh-list
110837438|NCT03441412|Ticagrelor|ticagrelor|mesh-list
110888933|NCT02836652|Aspirin|aspirin|mesh-list
110837439|NCT03441412|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110837440|NCT03441412|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110837441|NCT03441412|Adrenergic Agents|adrenergic agents|mesh-ancestor
110837442|NCT03441412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110561148|NCT02677259|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110837443|NCT03441412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110837444|NCT03441412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110837445|NCT03441412|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110837446|NCT03441412|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110837447|NCT03441412|Autonomic Agents|autonomic agents|mesh-ancestor
110837448|NCT03441412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110837449|NCT03441412|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110837450|NCT03441412|Respiratory System Agents|respiratory system agents|mesh-ancestor
110837451|NCT03441412|Mydriatics|mydriatics|mesh-ancestor
110837452|NCT03441412|Sympathomimetics|sympathomimetics|mesh-ancestor
110837453|NCT03441412|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110837454|NCT03441412|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110837455|NCT03441412|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110837456|NCT03441412|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110837457|NCT03441412|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110837458|NCT03441412|Purinergic Agents|purinergic agents|mesh-ancestor
110837459|NCT03441412|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110837460|NCT03441412|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110837461|NCT03441412|Sympatholytics|sympatholytics|mesh-ancestor
110837462|NCT03441412|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110837463|NCT03441412|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110837464|NCT03441412|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110837465|NCT01235819|Insulin|insulin|mesh-list
110837466|NCT01235819|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110837468|NCT01235819|Exenatide|exenatide|mesh-list
110837469|NCT01235819|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
110837470|NCT01235819|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110837471|NCT01235819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110837472|NCT01235819|Incretins|incretins|mesh-ancestor
110837473|NCT01235819|Hormones|hormones|mesh-ancestor
110561397|NCT01019083|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110837474|NCT01235819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110837475|NCT01235819|Protease Inhibitors|protease inhibitors|mesh-ancestor
110837476|NCT01235819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110837477|NCT01235819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110837478|NCT01235819|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110837479|NCT05275569|Antiemetics|antiemetics|mesh-list
110837480|NCT05275569|Autonomic Agents|autonomic agents|mesh-ancestor
110837481|NCT05275569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110837482|NCT05275569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110837483|NCT05275569|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110837484|NCT04599933|Pilocarpine|pilocarpine|mesh-list
110837485|NCT04599933|Miotics|miotics|mesh-ancestor
110837486|NCT04599933|Autonomic Agents|autonomic agents|mesh-ancestor
110837487|NCT04599933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110561532|NCT04176887|Phenytoin|phenytoin|mesh-list
110837488|NCT04599933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110837489|NCT04599933|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
110837490|NCT04599933|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110837491|NCT04599933|Cholinergic Agents|cholinergic agents|mesh-ancestor
110837492|NCT04599933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110888946|NCT02836652|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110837493|NCT04599933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110837494|NCT03440788|Brentuximab Vedotin|brentuximab vedotin|mesh-list
110837495|NCT03440788|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110837496|NCT03440788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110837498|NCT03440788|Immunoconjugates|immunoconjugates|mesh-ancestor
110837499|NCT03440788|Immunologic Factors|immunologic factors|mesh-ancestor
110837500|NCT03440788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110837502|NCT02824575|Rebastinib|rebastinib|mesh-list
110837503|NCT02824575|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110837504|NCT02824575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110837505|NCT02824575|Tubulin Modulators|tubulin modulators|mesh-ancestor
110837506|NCT02824575|Antimitotic Agents|antimitotic agents|mesh-ancestor
110837507|NCT02824575|Mitosis Modulators|mitosis modulators|mesh-ancestor
110837508|NCT02824575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110837509|NCT02824575|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110837510|NCT02824575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110837511|NCT03780608|Durvalumab|durvalumab|mesh-list
110837512|NCT03780608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110837513|NCT03780608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110837515|NCT03631316|Antiviral Agents|antiviral agents|mesh-ancestor
110837516|NCT03631316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110837517|NCT03608865|Durvalumab|durvalumab|mesh-list
110837518|NCT03608865|Tremelimumab|tremelimumab|mesh-list
110837519|NCT03608865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110837520|NCT03608865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110837521|NCT03532451|Nivolumab|nivolumab|mesh-list
110837522|NCT03532451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110837523|NCT03532451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110837524|NCT03532451|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110837525|NCT03532451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110837526|NCT04704531|Hyaluronic Acid|hyaluronic acid|mesh-list
110837527|NCT04704531|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110837528|NCT04704531|Immunologic Factors|immunologic factors|mesh-ancestor
110837529|NCT04704531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110837530|NCT04704531|Viscosupplements|viscosupplements|mesh-ancestor
110837531|NCT04704531|Protective Agents|protective agents|mesh-ancestor
110837532|NCT02637531|Nivolumab|nivolumab|mesh-list
110837533|NCT02637531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110837534|NCT02637531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110837535|NCT02637531|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110837536|NCT02637531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110837537|NCT01237925|Chlorpheniramine|chlorpheniramine|mesh-list
110837538|NCT01237925|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
110561725|NCT00910637|Hormones|hormones|mesh-ancestor
110837539|NCT01237925|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110837540|NCT01237925|Histamine Antagonists|histamine antagonists|mesh-ancestor
110837541|NCT01237925|Histamine Agents|histamine agents|mesh-ancestor
110837542|NCT01237925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110837543|NCT01237925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110837544|NCT01237925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110837545|NCT01237925|Antipruritics|antipruritics|mesh-ancestor
110837546|NCT01237925|Dermatologic Agents|dermatologic agents|mesh-ancestor
110837547|NCT01237925|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110837548|NCT01380548|Iron|iron|mesh-list
110837549|NCT01380548|Aminolevulinic Acid|aminolevulinic acid|mesh-list
110837550|NCT01380548|Trace Elements|trace elements|mesh-ancestor
110837551|NCT01380548|Micronutrients|micronutrients|mesh-ancestor
110837552|NCT01380548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110837553|NCT01380548|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110837554|NCT01380548|Dermatologic Agents|dermatologic agents|mesh-ancestor
110837555|NCT01313247|Acetaminophen|acetaminophen|mesh-list
110837556|NCT01313247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110837557|NCT01313247|Analgesics|analgesics|mesh-ancestor
110837558|NCT01313247|Sensory System Agents|sensory system agents|mesh-ancestor
110837559|NCT01313247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110837560|NCT01313247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110837561|NCT01313247|Antipyretics|antipyretics|mesh-ancestor
110837562|NCT01142453|Interferons|interferons|mesh-list
110837563|NCT01142453|Interferon-beta|interferon-beta|mesh-list
110837564|NCT01142453|Interferon beta-1a|interferon beta-1a|mesh-list
110561916|NCT00648401|Verapamil|verapamil|mesh-list
110837565|NCT01142453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110837567|NCT01142453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110837568|NCT01142453|Immunologic Factors|immunologic factors|mesh-ancestor
110837569|NCT01142453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110837570|NCT01142453|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110837571|NCT04701424|Insulin|insulin|mesh-list
110837572|NCT04701424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110837573|NCT04701424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110837574|NCT03560193|Chlorhexidine|chlorhexidine|mesh-list
110837575|NCT03560193|Ethanol|ethanol|mesh-list
110561980|NCT02656121|Vitamin D|vitamin d|mesh-list
110837576|NCT03560193|Povidone-Iodine|povidone-iodine|mesh-list
110837577|NCT03560193|Povidone|povidone|mesh-list
110837578|NCT03560193|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110837579|NCT03560193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110837580|NCT03560193|Disinfectants|disinfectants|mesh-ancestor
110837581|NCT03560193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110837582|NCT03560193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110837583|NCT03560193|Plasma Substitutes|plasma substitutes|mesh-ancestor
110837584|NCT03560193|Blood Substitutes|blood substitutes|mesh-ancestor
110837585|NCT04451200|Busulfan|busulfan|mesh-list
110837586|NCT04451200|Alkylating Agents|alkylating agents|mesh-ancestor
110837587|NCT04451200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110837588|NCT04451200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110837589|NCT04451200|Immunologic Factors|immunologic factors|mesh-ancestor
110837590|NCT04451200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110562101|NCT04171349|Anesthetics|anesthetics|mesh-ancestor
110837591|NCT04451200|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110837592|NCT04451200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110837593|NCT04451200|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110837595|NCT04678479|Neurosteroids|neurosteroids|mesh-ancestor
110837596|NCT04678479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110562163|NCT02655029|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110837597|NCT04678479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110837598|NCT04678479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110837600|NCT04678479|GABA Agents|gaba agents|mesh-ancestor
110837601|NCT04668118|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110837602|NCT04668118|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110837603|NCT02251821|Mycophenolic Acid|mycophenolic acid|mesh-list
110562237|NCT02654093|Vitamin D|vitamin d|mesh-list
110837605|NCT02251821|Melphalan|melphalan|mesh-list
110837606|NCT02251821|Busulfan|busulfan|mesh-list
110837607|NCT02251821|Mechlorethamine|mechlorethamine|mesh-list
110837608|NCT02251821|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
110837609|NCT02251821|Methotrexate|methotrexate|mesh-list
110837610|NCT02251821|Fludarabine|fludarabine|mesh-list
110837611|NCT02251821|Fludarabine phosphate|fludarabine phosphate|mesh-list
110837612|NCT02251821|Tacrolimus|tacrolimus|mesh-list
110837613|NCT02251821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110837614|NCT02251821|Immunologic Factors|immunologic factors|mesh-ancestor
110837615|NCT02251821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110837616|NCT02251821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110837617|NCT02251821|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110837618|NCT02251821|Alkylating Agents|alkylating agents|mesh-ancestor
110837619|NCT02251821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110837620|NCT02251821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110837621|NCT02251821|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110837622|NCT02251821|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110837623|NCT02251821|Abortifacient Agents|abortifacient agents|mesh-ancestor
110837624|NCT02251821|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110837625|NCT02251821|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110837626|NCT02251821|Antimetabolites|antimetabolites|mesh-ancestor
110837627|NCT02251821|Dermatologic Agents|dermatologic agents|mesh-ancestor
110837628|NCT02251821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110837629|NCT02251821|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110837630|NCT02251821|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110837631|NCT02251821|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110837632|NCT02251821|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110837633|NCT02251821|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110837634|NCT02251821|Antitubercular Agents|antitubercular agents|mesh-ancestor
110185192|NCT00037596|Cytarabine|cytarabine|mesh-list
110837635|NCT02251821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110837636|NCT02251821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110837637|NCT03784781|Dimercaprol|dimercaprol|mesh-list
110837638|NCT03784781|Chelating Agents|chelating agents|mesh-ancestor
110837639|NCT03784781|Sequestering Agents|sequestering agents|mesh-ancestor
110837640|NCT03784781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110837641|NCT03428477|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
110837642|NCT03428477|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110837643|NCT03428477|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110837644|NCT03438604|Donepezil|donepezil|mesh-list
110837645|NCT03438604|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110837646|NCT03438604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110837647|NCT03438604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110837648|NCT03438604|Cholinergic Agents|cholinergic agents|mesh-ancestor
110837649|NCT03438604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110837650|NCT03438604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110837651|NCT03438604|Nootropic Agents|nootropic agents|mesh-ancestor
110555263|NCT00667472|Ranibizumab|ranibizumab|mesh-list
110837652|NCT03433378|Tretinoin|tretinoin|mesh-list
110837653|NCT03433378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110837654|NCT03433378|Keratolytic Agents|keratolytic agents|mesh-ancestor
110562551|NCT00600353|Glucocorticoids|glucocorticoids|mesh-ancestor
110837655|NCT03433378|Dermatologic Agents|dermatologic agents|mesh-ancestor
110837656|NCT03433222|Coal Tar|coal tar|mesh-list
110837657|NCT03433222|Keratolytic Agents|keratolytic agents|mesh-ancestor
110837658|NCT03433222|Dermatologic Agents|dermatologic agents|mesh-ancestor
110837659|NCT05016076|Dexamethasone|dexamethasone|mesh-list
110837660|NCT05016076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110837661|NCT05016076|Antiemetics|antiemetics|mesh-ancestor
110837662|NCT05016076|Autonomic Agents|autonomic agents|mesh-ancestor
110837663|NCT05016076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110837664|NCT05016076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110837665|NCT05016076|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110837666|NCT05016076|Glucocorticoids|glucocorticoids|mesh-ancestor
110837667|NCT05016076|Hormones|hormones|mesh-ancestor
110837668|NCT05016076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110837669|NCT05016076|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110837670|NCT05016076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110837672|NCT03319953|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110837673|NCT03319953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110837674|NCT03319953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110837675|NCT03319953|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110837676|NCT03433144|Tranexamic Acid|tranexamic acid|mesh-list
110837677|NCT03433144|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110837678|NCT03433144|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110837679|NCT03433144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110837680|NCT03433144|Hemostatics|hemostatics|mesh-ancestor
110837681|NCT03433144|Coagulants|coagulants|mesh-ancestor
110837682|NCT01384214|Botulinum Toxins|botulinum toxins|mesh-list
110837683|NCT01384214|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110837684|NCT01384214|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110837685|NCT01384214|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110837686|NCT01384214|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110837687|NCT01384214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110837688|NCT01384214|Cholinergic Agents|cholinergic agents|mesh-ancestor
110837689|NCT01384214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110837690|NCT01384214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110837691|NCT01384214|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110185204|NCT00037596|Immunotoxins|immunotoxins|mesh-ancestor
110837692|NCT01384214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110837693|NCT02927834|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
110837694|NCT02927834|Prednisone|prednisone|mesh-list
110837695|NCT02927834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110837696|NCT02927834|Glucocorticoids|glucocorticoids|mesh-ancestor
110837697|NCT02927834|Hormones|hormones|mesh-ancestor
110837698|NCT02927834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110837699|NCT02927834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110837700|NCT02927834|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110837701|NCT02927834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110837702|NCT02927834|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110837703|NCT02927834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110837704|NCT02927834|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110837705|NCT02927834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110837706|NCT02927834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110837707|NCT03170180|Sunitinib|sunitinib|mesh-list
110837708|NCT03170180|Imatinib Mesylate|imatinib mesylate|mesh-list
110837709|NCT03170180|Gefitinib|gefitinib|mesh-list
110837710|NCT03170180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110562682|NCT02564536|Decitabine|decitabine|mesh-list
110837711|NCT03170180|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110837712|NCT03170180|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110837713|NCT03170180|Growth Substances|growth substances|mesh-ancestor
110837714|NCT03170180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110837715|NCT03170180|Growth Inhibitors|growth inhibitors|mesh-ancestor
110837716|NCT03170180|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110837717|NCT03170180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110837718|NCT03170180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110837719|NCT03319667|Dexamethasone|dexamethasone|mesh-list
110837720|NCT03319667|Lenalidomide|lenalidomide|mesh-list
110837721|NCT03319667|Bortezomib|bortezomib|mesh-list
110837722|NCT03319667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110837723|NCT03319667|Antiemetics|antiemetics|mesh-ancestor
110837724|NCT03319667|Autonomic Agents|autonomic agents|mesh-ancestor
110837725|NCT03319667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110837726|NCT03319667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110837727|NCT03319667|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110562709|NCT00649103|Quinapril|quinapril|mesh-list
110837728|NCT03319667|Glucocorticoids|glucocorticoids|mesh-ancestor
110837729|NCT03319667|Hormones|hormones|mesh-ancestor
110837730|NCT03319667|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110837731|NCT03319667|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110837732|NCT03319667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110837733|NCT03319667|Immunologic Factors|immunologic factors|mesh-ancestor
110837734|NCT03319667|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110837735|NCT03319667|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110837736|NCT03319667|Growth Substances|growth substances|mesh-ancestor
110837737|NCT03319667|Growth Inhibitors|growth inhibitors|mesh-ancestor
110837738|NCT03432676|Pembrolizumab|pembrolizumab|mesh-list
110837739|NCT03432676|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110837740|NCT03432676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110837741|NCT03432676|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110837742|NCT03432676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110837743|NCT03432598|Paclitaxel|paclitaxel|mesh-list
110837744|NCT03432598|Etoposide|etoposide|mesh-list
110837745|NCT03432598|Carboplatin|carboplatin|mesh-list
110837746|NCT03432598|Gemcitabine|gemcitabine|mesh-list
110837747|NCT03432598|Pemetrexed|pemetrexed|mesh-list
110837748|NCT03432598|Tislelizumab|tislelizumab|mesh-list
110837749|NCT03432598|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110837750|NCT03432598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110837751|NCT03432598|Tubulin Modulators|tubulin modulators|mesh-ancestor
110837752|NCT03432598|Antimitotic Agents|antimitotic agents|mesh-ancestor
110837753|NCT03432598|Mitosis Modulators|mitosis modulators|mesh-ancestor
110837754|NCT03432598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110562770|NCT02648633|Anticonvulsants|anticonvulsants|mesh-ancestor
110837755|NCT03432598|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110837756|NCT03432598|Antimetabolites|antimetabolites|mesh-ancestor
110837757|NCT03432598|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110837758|NCT03432598|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110837759|NCT03432598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110837760|NCT03432598|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110837761|NCT03432598|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110837762|NCT03432598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110837763|NCT03432442|Ivermectin|ivermectin|mesh-list
110837764|NCT03432442|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110837765|NCT03432442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110837766|NCT01964547|Nabiximols|nabiximols|mesh-list
110837767|NCT01964547|Analgesics|analgesics|mesh-ancestor
110837768|NCT01964547|Sensory System Agents|sensory system agents|mesh-ancestor
110837769|NCT01964547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110837770|NCT01964547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110837771|NCT01380314|Miltefosine|miltefosine|mesh-list
110837772|NCT01380314|Imiquimod|imiquimod|mesh-list
110837773|NCT01380314|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110837774|NCT01380314|Immunologic Factors|immunologic factors|mesh-ancestor
110837775|NCT01380314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110837776|NCT01380314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110837777|NCT01380314|Interferon Inducers|interferon inducers|mesh-ancestor
110837778|NCT01380314|Antifungal Agents|antifungal agents|mesh-ancestor
110837779|NCT01380314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110837780|NCT01380314|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110837781|NCT01380314|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110837782|NCT03110510|Leucovorin|leucovorin|mesh-list
110837783|NCT03110510|Fluorouracil|fluorouracil|mesh-list
110837784|NCT03110510|Irinotecan|irinotecan|mesh-list
110837785|NCT03110510|Calcium|calcium|mesh-list
110837787|NCT03110510|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110837788|NCT03110510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110837789|NCT03110510|Antimetabolites|antimetabolites|mesh-ancestor
110837790|NCT03110510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110837791|NCT03110510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110837792|NCT03110510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110837793|NCT03110510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110837794|NCT03110510|Immunologic Factors|immunologic factors|mesh-ancestor
110837795|NCT03110510|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110837796|NCT03110510|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110837797|NCT03110510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110837798|NCT03110510|Antidotes|antidotes|mesh-ancestor
110837799|NCT03110510|Protective Agents|protective agents|mesh-ancestor
110837800|NCT03110510|Vitamin B Complex|vitamin b complex|mesh-ancestor
110837801|NCT03110510|Vitamins|vitamins|mesh-ancestor
110837802|NCT03110510|Micronutrients|micronutrients|mesh-ancestor
110837803|NCT01238237|Cetuximab|cetuximab|mesh-list
110837804|NCT01238237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110837805|NCT01238237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110837807|NCT03319719|Hyaluronic Acid|hyaluronic acid|mesh-list
110837808|NCT03319719|Anesthetics, Local|anesthetics, local|mesh-ancestor
110837809|NCT03319719|Anesthetics|anesthetics|mesh-ancestor
110837810|NCT03319719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110837811|NCT03319719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110837812|NCT03319719|Sensory System Agents|sensory system agents|mesh-ancestor
110837813|NCT03319719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110837814|NCT03319719|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110837815|NCT03319719|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110837816|NCT03319719|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110837817|NCT03319719|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110837818|NCT03319719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110837819|NCT03319719|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110837820|NCT03319719|Immunologic Factors|immunologic factors|mesh-ancestor
110837821|NCT03319719|Viscosupplements|viscosupplements|mesh-ancestor
110837822|NCT03319719|Protective Agents|protective agents|mesh-ancestor
110837823|NCT03128242|Oxytocin|oxytocin|mesh-list
110837824|NCT03128242|Oxytocics|oxytocics|mesh-ancestor
110837825|NCT03128242|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110837826|NCT03128242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110837827|NCT01313689|Ofatumumab|ofatumumab|mesh-list
110837828|NCT01313689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110837829|NCT03431272|Lifitegrast|lifitegrast|mesh-list
110837830|NCT03431272|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110837831|NCT03431272|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110837832|NCT02528513|Fentanyl|fentanyl|mesh-list
110837833|NCT02528513|Midazolam|midazolam|mesh-list
110837834|NCT02528513|Dexmedetomidine|dexmedetomidine|mesh-list
110837835|NCT02528513|Propofol|propofol|mesh-list
110837836|NCT02528513|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110837837|NCT02528513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110837838|NCT02528513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110837839|NCT02528513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110837840|NCT02528513|Analgesics|analgesics|mesh-ancestor
110837841|NCT02528513|Sensory System Agents|sensory system agents|mesh-ancestor
110837842|NCT02528513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110837843|NCT02528513|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110837844|NCT02528513|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110837845|NCT02528513|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110837846|NCT02528513|Adrenergic Agents|adrenergic agents|mesh-ancestor
110837847|NCT02528513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110563122|NCT02640989|Vaccines|vaccines|mesh-list
110837848|NCT02528513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110837849|NCT02528513|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110837850|NCT02528513|Anesthetics, General|anesthetics, general|mesh-ancestor
110837851|NCT02528513|Anesthetics|anesthetics|mesh-ancestor
110837852|NCT02528513|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110837853|NCT02528513|Narcotics|narcotics|mesh-ancestor
110837854|NCT02528513|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110837855|NCT02528513|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110837856|NCT02528513|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110837857|NCT02528513|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110837858|NCT02528513|GABA Modulators|gaba modulators|mesh-ancestor
110837859|NCT02528513|GABA Agents|gaba agents|mesh-ancestor
110837860|NCT01320007|Furosemide|furosemide|mesh-list
110837861|NCT01320007|Diuretics|diuretics|mesh-ancestor
110837862|NCT01320007|Natriuretic Agents|natriuretic agents|mesh-ancestor
110837863|NCT01320007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110837864|NCT01320007|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110837865|NCT01320007|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110837866|NCT01320007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110837867|NCT03318315|Vaccines|vaccines|mesh-list
110837868|NCT03318315|Immunologic Factors|immunologic factors|mesh-ancestor
110837869|NCT03318315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110837870|NCT04460183|Nitric Oxide|nitric oxide|mesh-list
110837871|NCT04460183|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110837872|NCT04460183|Autonomic Agents|autonomic agents|mesh-ancestor
110837873|NCT04460183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110837874|NCT04460183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110837875|NCT04460183|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110837876|NCT04460183|Respiratory System Agents|respiratory system agents|mesh-ancestor
110837877|NCT04460183|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110837878|NCT04460183|Antioxidants|antioxidants|mesh-ancestor
110837879|NCT04460183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110837880|NCT04460183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110837881|NCT04460183|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
110837882|NCT04460183|Vasodilator Agents|vasodilator agents|mesh-ancestor
110555471|NCT00505921|Alemtuzumab|alemtuzumab|mesh-list
110837883|NCT04460183|Gasotransmitters|gasotransmitters|mesh-ancestor
110837884|NCT04460183|Protective Agents|protective agents|mesh-ancestor
110837885|NCT01243697|Desogestrel|desogestrel|mesh-list
110837886|NCT01243697|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110837887|NCT01243697|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110563309|NCT00655265|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110837888|NCT01243697|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110837889|NCT01243697|Contraceptive Agents|contraceptive agents|mesh-ancestor
110837890|NCT01243697|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110837891|NCT01243697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110837892|NCT01243697|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110837893|NCT01243697|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110837894|NCT01243697|Progestins|progestins|mesh-ancestor
110837895|NCT01243697|Hormones|hormones|mesh-ancestor
110563364|NCT00689338|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110837896|NCT01243697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110837897|NCT04703101|Leucovorin|leucovorin|mesh-list
110837898|NCT04703101|Fluorouracil|fluorouracil|mesh-list
110837899|NCT04703101|Capecitabine|capecitabine|mesh-list
110837900|NCT04703101|Oxaliplatin|oxaliplatin|mesh-list
110837901|NCT04703101|Antimetabolites|antimetabolites|mesh-ancestor
110837902|NCT04703101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110837903|NCT04703101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110837904|NCT04703101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110889066|NCT02677298|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110837905|NCT04703101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110837906|NCT04703101|Immunologic Factors|immunologic factors|mesh-ancestor
110563441|NCT00837876|Sorafenib|sorafenib|mesh-list
110837907|NCT04703101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110837908|NCT04703101|Antidotes|antidotes|mesh-ancestor
110837909|NCT04703101|Protective Agents|protective agents|mesh-ancestor
110837910|NCT04703101|Vitamin B Complex|vitamin b complex|mesh-ancestor
110837911|NCT04703101|Vitamins|vitamins|mesh-ancestor
110837912|NCT04703101|Micronutrients|micronutrients|mesh-ancestor
110837913|NCT01145573|Calcium|calcium|mesh-list
110837914|NCT01145573|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110837915|NCT01145573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110837916|NCT01320709|Piroxicam|piroxicam|mesh-list
110185282|NCT00038220|Antiviral Agents|antiviral agents|mesh-ancestor
110837917|NCT01320709|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110837918|NCT01320709|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110837919|NCT01320709|Analgesics|analgesics|mesh-ancestor
110837920|NCT01320709|Sensory System Agents|sensory system agents|mesh-ancestor
110837921|NCT01320709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110837922|NCT01320709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110837923|NCT01320709|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110837924|NCT01320709|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110837925|NCT01320709|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110837926|NCT01320709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110837927|NCT01320709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110837928|NCT01238393|Ranibizumab|ranibizumab|mesh-list
110837929|NCT01238393|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110837930|NCT01238393|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110837931|NCT01238393|Growth Substances|growth substances|mesh-ancestor
110837932|NCT01238393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110837933|NCT01238393|Growth Inhibitors|growth inhibitors|mesh-ancestor
110837934|NCT01238393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110837935|NCT03776305|Imipenem|imipenem|mesh-list
110837936|NCT03776305|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110837937|NCT03776305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110837938|NCT01146509|Donepezil|donepezil|mesh-list
110837939|NCT01146509|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110837940|NCT01146509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110837941|NCT01146509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110837942|NCT01146509|Cholinergic Agents|cholinergic agents|mesh-ancestor
110837943|NCT01146509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110837944|NCT01146509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110837945|NCT01146509|Nootropic Agents|nootropic agents|mesh-ancestor
110837947|NCT03775993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110837948|NCT03775993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110837949|NCT03316131|Dapagliflozin|dapagliflozin|mesh-list
110837950|NCT03316131|Febuxostat|febuxostat|mesh-list
110837951|NCT03316131|Verinurad|verinurad|mesh-list
110563684|NCT02118467|Mydriatics|mydriatics|mesh-ancestor
110837952|NCT03316131|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110837953|NCT03316131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110837954|NCT03316131|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110837955|NCT03316131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110837956|NCT03316131|Gout Suppressants|gout suppressants|mesh-ancestor
110837957|NCT03316131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110555553|NCT04213781|Anesthetics|anesthetics|mesh-ancestor
110837958|NCT03779659|Anesthetics|anesthetics|mesh-list
110837959|NCT03779659|Benzocaine|benzocaine|mesh-list
110837960|NCT03779659|Anesthetics, Local|anesthetics, local|mesh-list
110837961|NCT03779659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110837962|NCT03779659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110837963|NCT03779659|Sensory System Agents|sensory system agents|mesh-ancestor
110837964|NCT03779659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110837966|NCT01145807|Antifungal Agents|antifungal agents|mesh-ancestor
110837967|NCT01145807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110837968|NCT01145807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110837969|NCT01145807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110837970|NCT03898895|Antibodies|antibodies|mesh-list
110837971|NCT03898895|Immunologic Factors|immunologic factors|mesh-ancestor
110837972|NCT03898895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110837973|NCT01245569|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
110837974|NCT01245569|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110837975|NCT01245569|Autonomic Agents|autonomic agents|mesh-ancestor
110837976|NCT01245569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110837977|NCT01245569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110837978|NCT01245569|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110837979|NCT01245569|Respiratory System Agents|respiratory system agents|mesh-ancestor
110837980|NCT01245569|Glucocorticoids|glucocorticoids|mesh-ancestor
110837981|NCT01245569|Hormones|hormones|mesh-ancestor
110837982|NCT01245569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110837983|NCT01245569|Sympathomimetics|sympathomimetics|mesh-ancestor
110837984|NCT01314859|Nifedipine|nifedipine|mesh-list
110837985|NCT01314859|Atosiban|atosiban|mesh-list
110837986|NCT01314859|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110837987|NCT01314859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110837988|NCT01314859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110837989|NCT01314859|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110837990|NCT01314859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110837991|NCT01314859|Vasodilator Agents|vasodilator agents|mesh-ancestor
110837992|NCT01314859|Tocolytic Agents|tocolytic agents|mesh-ancestor
110837993|NCT01314859|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110563864|NCT00686374|Adalimumab|adalimumab|mesh-list
110837994|NCT01314859|Hormone Antagonists|hormone antagonists|mesh-ancestor
110837995|NCT01314859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110837996|NCT02528279|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
110837997|NCT02528279|Antimalarials|antimalarials|mesh-ancestor
110837998|NCT02528279|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110837999|NCT02528279|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110838000|NCT02528279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110838001|NCT01238627|Nicotine|nicotine|mesh-list
110838002|NCT01238627|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110838003|NCT01238627|Autonomic Agents|autonomic agents|mesh-ancestor
110838004|NCT01238627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110838005|NCT01238627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110838006|NCT01238627|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110838007|NCT01238627|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110838008|NCT01238627|Cholinergic Agents|cholinergic agents|mesh-ancestor
110838009|NCT01238627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110838010|NCT01238627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110838011|NCT01321021|Diphenhydramine|diphenhydramine|mesh-list
110838012|NCT01321021|Promethazine|promethazine|mesh-list
110838013|NCT01321021|Losartan|losartan|mesh-list
110838014|NCT01321021|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110838015|NCT01321021|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110838016|NCT01321021|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110563990|NCT00657761|Enfuvirtide|enfuvirtide|mesh-list
110838017|NCT01321021|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110838018|NCT01321021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110838019|NCT01321021|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110838020|NCT01321021|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110838021|NCT01321021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110838022|NCT01321021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110838023|NCT01321021|Anesthetics, Local|anesthetics, local|mesh-ancestor
110838024|NCT01321021|Anesthetics|anesthetics|mesh-ancestor
110838025|NCT01321021|Sensory System Agents|sensory system agents|mesh-ancestor
110889097|NCT02745080|Adalimumab|adalimumab|mesh-list
110838026|NCT01321021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110838027|NCT01321021|Antiemetics|antiemetics|mesh-ancestor
110838029|NCT01321021|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110838030|NCT01321021|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110838031|NCT01321021|Histamine Antagonists|histamine antagonists|mesh-ancestor
110838032|NCT01321021|Histamine Agents|histamine agents|mesh-ancestor
110838033|NCT01321021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110838034|NCT01321021|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110838035|NCT01321021|Antipruritics|antipruritics|mesh-ancestor
110838036|NCT01321021|Dermatologic Agents|dermatologic agents|mesh-ancestor
110838037|NCT01238705|Metoprolol|metoprolol|mesh-list
110838038|NCT01238705|Felodipine|felodipine|mesh-list
110838039|NCT01238705|Irbesartan|irbesartan|mesh-list
110838040|NCT01238705|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110838041|NCT01238705|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110838042|NCT01238705|Sympatholytics|sympatholytics|mesh-ancestor
110838043|NCT01238705|Autonomic Agents|autonomic agents|mesh-ancestor
110838044|NCT01238705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110838045|NCT01238705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110838046|NCT01238705|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110838047|NCT01238705|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110838048|NCT01238705|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110838049|NCT01238705|Adrenergic Agents|adrenergic agents|mesh-ancestor
110838050|NCT01238705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110838051|NCT01238705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110838052|NCT01238705|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110838053|NCT01238705|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110838054|NCT01238705|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110838055|NCT01238705|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110838056|NCT01238705|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110838057|NCT01238705|Vasodilator Agents|vasodilator agents|mesh-ancestor
110838059|NCT03779347|Anthelmintics|anthelmintics|mesh-ancestor
110838060|NCT03779347|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110838061|NCT03779347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110838062|NCT01321099|Fe(III)-EDTA|fe(iii)-edta|mesh-list
110838063|NCT01321099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110838064|NCT01321099|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110838065|NCT01321099|Chelating Agents|chelating agents|mesh-ancestor
110838066|NCT01321099|Sequestering Agents|sequestering agents|mesh-ancestor
110838067|NCT01245725|Tirofiban|tirofiban|mesh-list
110838068|NCT01245725|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110838069|NCT01245725|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110838070|NCT01245725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110838071|NCT01245725|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110838072|NCT01143545|Celecoxib|celecoxib|mesh-list
110838073|NCT01143545|Cyclophosphamide|cyclophosphamide|mesh-list
110838074|NCT01143545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110564244|NCT05863195|Cetuximab|cetuximab|mesh-list
110838075|NCT01143545|Immunologic Factors|immunologic factors|mesh-ancestor
110838076|NCT01143545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110838077|NCT01143545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110838078|NCT01143545|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110838079|NCT01143545|Alkylating Agents|alkylating agents|mesh-ancestor
110838080|NCT01143545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110838081|NCT01143545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110838082|NCT01143545|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110838083|NCT01143545|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110838084|NCT01143545|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110838085|NCT01143545|Analgesics|analgesics|mesh-ancestor
110838086|NCT01143545|Sensory System Agents|sensory system agents|mesh-ancestor
110838087|NCT01143545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110838088|NCT01143545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110838089|NCT01143545|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110838090|NCT01143545|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110838091|NCT01143545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110838094|NCT03779035|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110838095|NCT03779035|Antimetabolites|antimetabolites|mesh-ancestor
110838096|NCT03779035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110838097|NCT03779035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110838098|NCT01586117|Amifostine|amifostine|mesh-list
110838099|NCT01586117|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110838100|NCT01586117|Protective Agents|protective agents|mesh-ancestor
110838101|NCT01586117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110838102|NCT03301415|Valganciclovir|valganciclovir|mesh-list
110838103|NCT03301415|Antiviral Agents|antiviral agents|mesh-ancestor
110555700|NCT02697851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110838104|NCT03301415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110838105|NCT05449015|Atropine|atropine|mesh-list
110838106|NCT05449015|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110838107|NCT05449015|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110838108|NCT05449015|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110838109|NCT05449015|Autonomic Agents|autonomic agents|mesh-ancestor
110838110|NCT05449015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110838111|NCT05449015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110838112|NCT05449015|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110838113|NCT05449015|Respiratory System Agents|respiratory system agents|mesh-ancestor
110838114|NCT05449015|Mydriatics|mydriatics|mesh-ancestor
110838115|NCT05449015|Parasympatholytics|parasympatholytics|mesh-ancestor
110838116|NCT05449015|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110838117|NCT05449015|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110838118|NCT05449015|Cholinergic Agents|cholinergic agents|mesh-ancestor
110838119|NCT05449015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110838120|NCT05449015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110838121|NCT01239017|Fasinumab|fasinumab|mesh-list
110838122|NCT01239017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110838123|NCT01239017|Analgesics|analgesics|mesh-ancestor
110838124|NCT01239017|Sensory System Agents|sensory system agents|mesh-ancestor
110564486|NCT05765071|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110838125|NCT01239017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110838126|NCT01239017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110838127|NCT02732938|Paclitaxel|paclitaxel|mesh-list
110838128|NCT02732938|Gemcitabine|gemcitabine|mesh-list
110838129|NCT02732938|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110838130|NCT02732938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110838131|NCT02732938|Tubulin Modulators|tubulin modulators|mesh-ancestor
110838132|NCT02732938|Antimitotic Agents|antimitotic agents|mesh-ancestor
110838133|NCT02732938|Mitosis Modulators|mitosis modulators|mesh-ancestor
110564548|NCT05456685|Antimitotic Agents|antimitotic agents|mesh-ancestor
110838134|NCT02732938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110838135|NCT02732938|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110838136|NCT02732938|Antimetabolites|antimetabolites|mesh-ancestor
110838137|NCT03778723|Fentanyl|fentanyl|mesh-list
110838138|NCT03778723|Anesthetics|anesthetics|mesh-list
110838139|NCT03778723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110838140|NCT03778723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110838141|NCT03778723|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110838142|NCT03778723|Narcotics|narcotics|mesh-ancestor
110838143|NCT03778723|Analgesics|analgesics|mesh-ancestor
110838144|NCT03778723|Sensory System Agents|sensory system agents|mesh-ancestor
110838145|NCT03778723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110838146|NCT03778723|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110838147|NCT03778723|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110838148|NCT03778723|Anesthetics, General|anesthetics, general|mesh-ancestor
110838149|NCT01245959|Cisplatin|cisplatin|mesh-list
110838150|NCT01245959|Docetaxel|docetaxel|mesh-list
110838151|NCT01245959|Fluorouracil|fluorouracil|mesh-list
110838152|NCT01245959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110838153|NCT01245959|Tubulin Modulators|tubulin modulators|mesh-ancestor
110838154|NCT01245959|Antimitotic Agents|antimitotic agents|mesh-ancestor
110838155|NCT01245959|Mitosis Modulators|mitosis modulators|mesh-ancestor
110838156|NCT01245959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110838157|NCT01245959|Antimetabolites|antimetabolites|mesh-ancestor
110838158|NCT01245959|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110838159|NCT01245959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110838160|NCT01245959|Immunologic Factors|immunologic factors|mesh-ancestor
110838161|NCT01245959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110838162|NCT03778645|Epinephrine|epinephrine|mesh-list
110838163|NCT03778645|Racepinephrine|racepinephrine|mesh-list
110838164|NCT03778645|Epinephryl borate|epinephryl borate|mesh-list
110838165|NCT03778645|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110838166|NCT03778645|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110838167|NCT03778645|Adrenergic Agents|adrenergic agents|mesh-ancestor
110838168|NCT03778645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110838169|NCT03778645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110838170|NCT03778645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110838171|NCT03778645|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110838172|NCT03778645|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110838173|NCT03778645|Autonomic Agents|autonomic agents|mesh-ancestor
110838174|NCT03778645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110838175|NCT03778645|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110838176|NCT03778645|Respiratory System Agents|respiratory system agents|mesh-ancestor
110838177|NCT03778645|Mydriatics|mydriatics|mesh-ancestor
110838178|NCT03778645|Sympathomimetics|sympathomimetics|mesh-ancestor
110838179|NCT03778645|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110838181|NCT04326478|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110555775|NCT00505375|Immunologic Factors|immunologic factors|mesh-ancestor
110838182|NCT04326478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110838183|NCT04647721|Hyaluronic Acid|hyaluronic acid|mesh-list
110838184|NCT04647721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110838185|NCT04647721|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110838186|NCT04647721|Immunologic Factors|immunologic factors|mesh-ancestor
110838187|NCT04647721|Viscosupplements|viscosupplements|mesh-ancestor
110838188|NCT04647721|Protective Agents|protective agents|mesh-ancestor
110838189|NCT03470038|Mitogens|mitogens|mesh-list
110838190|NCT03470038|Mitosis Modulators|mitosis modulators|mesh-ancestor
110838191|NCT03470038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110838192|NCT03250325|Cyclophosphamide|cyclophosphamide|mesh-list
110838193|NCT03250325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110838194|NCT03250325|Immunologic Factors|immunologic factors|mesh-ancestor
110838195|NCT03250325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110838196|NCT03250325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110838197|NCT03250325|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110838198|NCT03250325|Alkylating Agents|alkylating agents|mesh-ancestor
110838199|NCT03250325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110838200|NCT03250325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110564799|NCT04560660|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110564800|NCT04560660|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110564801|NCT04560660|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110564802|NCT04560660|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110564803|NCT04560660|GABA Modulators|gaba modulators|mesh-ancestor
110838201|NCT03250325|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110838202|NCT03778567|Lamivudine|lamivudine|mesh-list
110838203|NCT03778567|Telbivudine|telbivudine|mesh-list
110838204|NCT03778567|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110838205|NCT03778567|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110838206|NCT03778567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110838207|NCT03778567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110838208|NCT03778567|Antiviral Agents|antiviral agents|mesh-ancestor
110838209|NCT03778567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110838210|NCT03778567|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110838211|NCT03778567|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110838212|NCT03784066|Durvalumab|durvalumab|mesh-list
110838213|NCT03784066|Tremelimumab|tremelimumab|mesh-list
110889128|NCT01346215|Heparin|heparin|mesh-list
110838215|NCT03784066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110838216|NCT03784066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110838217|NCT03784066|Immunologic Factors|immunologic factors|mesh-ancestor
110838218|NCT03784066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110838219|NCT05168683|Rasburicase|rasburicase|mesh-list
110838220|NCT05168683|Uric Acid|uric acid|mesh-list
110838221|NCT05168683|Antioxidants|antioxidants|mesh-ancestor
110838222|NCT05168683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110838223|NCT05168683|Protective Agents|protective agents|mesh-ancestor
110838224|NCT05168683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110838225|NCT05168683|Gout Suppressants|gout suppressants|mesh-ancestor
110838226|NCT05168683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110838227|NCT03113123|Tenofovir|tenofovir|mesh-list
110838228|NCT03113123|Emtricitabine|emtricitabine|mesh-list
110838229|NCT03113123|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110838230|NCT03113123|Antiviral Agents|antiviral agents|mesh-ancestor
110838231|NCT03113123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110838232|NCT03113123|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110838233|NCT03113123|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110838234|NCT03113123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110838235|NCT03113123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110838236|NCT03113123|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110838237|NCT03113123|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110838238|NCT04451122|Tea Tree Oil|tea tree oil|mesh-list
110838239|NCT04451122|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110838240|NCT04451122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110838241|NCT01143857|Varenicline|varenicline|mesh-list
110838242|NCT01143857|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110838243|NCT01143857|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110838244|NCT01143857|Cholinergic Agents|cholinergic agents|mesh-ancestor
110838245|NCT01143857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110838246|NCT01143857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110838247|NCT01143857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110838248|NCT05159284|Hydrocortisone|hydrocortisone|mesh-list
110838249|NCT05159284|Lubricant Eye Drops|lubricant eye drops|mesh-list
110838250|NCT05159284|Hyaluronic Acid|hyaluronic acid|mesh-list
110838251|NCT05159284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110838252|NCT05159284|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110838253|NCT05159284|Immunologic Factors|immunologic factors|mesh-ancestor
110838254|NCT05159284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110838255|NCT05159284|Viscosupplements|viscosupplements|mesh-ancestor
110838256|NCT05159284|Protective Agents|protective agents|mesh-ancestor
110838257|NCT05159284|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110838258|NCT05159284|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110838259|NCT01239173|Propranolol|propranolol|mesh-list
110838260|NCT01239173|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110838261|NCT01239173|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110838262|NCT01239173|Adrenergic Agents|adrenergic agents|mesh-ancestor
110838263|NCT01239173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110838264|NCT01239173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110838265|NCT01239173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110838266|NCT01239173|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110838267|NCT01239173|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110838268|NCT01239173|Vasodilator Agents|vasodilator agents|mesh-ancestor
110889136|NCT02834390|Idarubicin|idarubicin|mesh-list
110838270|NCT03063203|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110838271|NCT03063203|Antimetabolites|antimetabolites|mesh-ancestor
110838272|NCT03063203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110838273|NCT03063203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110838274|NCT03063203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110838275|NCT03435094|Alendronate|alendronate|mesh-list
110838276|NCT03435094|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110838277|NCT03435094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110838278|NCT03772483|Anesthetics|anesthetics|mesh-list
110838279|NCT03772483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110838280|NCT03772483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110838281|NCT01236911|Calcium|calcium|mesh-list
110838282|NCT01236911|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110185378|NCT00846950|Autonomic Agents|autonomic agents|mesh-ancestor
110838283|NCT01236911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110838284|NCT03772561|Durvalumab|durvalumab|mesh-list
110838285|NCT03772561|Olaparib|olaparib|mesh-list
110838286|NCT03772561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110838287|NCT03772561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110838288|NCT03772561|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110838289|NCT03772561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110838290|NCT03772561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110838291|NCT01239485|Irinotecan|irinotecan|mesh-list
110838292|NCT01239485|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110838293|NCT01239485|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110838294|NCT01239485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110565022|NCT03516656|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110838295|NCT01239485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110838296|NCT01239485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110838298|NCT01146041|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110838299|NCT01146041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110838300|NCT01146041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110838301|NCT01146041|Cholinergic Agents|cholinergic agents|mesh-ancestor
110838302|NCT01146041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110838303|NCT01146041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110838304|NCT01146041|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110838305|NCT01146041|Protective Agents|protective agents|mesh-ancestor
110838306|NCT04450576|Chrysarobin|chrysarobin|mesh-list
110838307|NCT04450576|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110838308|NCT04450576|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110838309|NCT04450576|Analgesics|analgesics|mesh-ancestor
110838310|NCT04450576|Sensory System Agents|sensory system agents|mesh-ancestor
110838311|NCT04450576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110838312|NCT04450576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110838313|NCT04450576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110838314|NCT04450576|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110838315|NCT03430180|Naloxone|naloxone|mesh-list
110838316|NCT03430180|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110838317|NCT03430180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110838318|NCT03430180|Sensory System Agents|sensory system agents|mesh-ancestor
110838319|NCT03430180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110838320|NCT03777787|Denatonium|denatonium|mesh-list
110838321|NCT03777787|Aversive Agents|aversive agents|mesh-ancestor
110838322|NCT03777787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110838323|NCT03777787|Abuse-Deterrent Formulations|abuse-deterrent formulations|mesh-ancestor
110838324|NCT03777787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110838325|NCT03777787|Sensory System Agents|sensory system agents|mesh-ancestor
110838326|NCT03777787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110838327|NCT03430024|Estrogens|estrogens|mesh-list
110838328|NCT03430024|Hormones|hormones|mesh-ancestor
110185386|NCT00846950|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110838329|NCT03430024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110838330|NCT03430024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110838331|NCT03434782|Listerine|listerine|mesh-list
110838332|NCT03434782|Hydrogen Peroxide|hydrogen peroxide|mesh-list
110838334|NCT03434782|Sodium Fluoride|sodium fluoride|mesh-list
110838335|NCT03434782|Cariostatic Agents|cariostatic agents|mesh-ancestor
110838336|NCT03434782|Protective Agents|protective agents|mesh-ancestor
110838337|NCT03434782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110838338|NCT03434782|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110838339|NCT03434782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110838340|NCT01320397|Losartan|losartan|mesh-list
110838341|NCT01320397|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110838342|NCT01320397|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110838343|NCT01320397|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110838344|NCT01320397|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110838345|NCT01320397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110838346|NCT03434704|Antifungal Agents|antifungal agents|mesh-list
110838347|NCT03434704|Clotrimazole|clotrimazole|mesh-list
110838349|NCT03434704|Fludarabine|fludarabine|mesh-list
110838350|NCT03434704|Thiotepa|thiotepa|mesh-list
110838351|NCT03434704|Treosulfan|treosulfan|mesh-list
110838352|NCT03434704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110838353|NCT03434704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110838354|NCT03434704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110838355|NCT03434704|Immunologic Factors|immunologic factors|mesh-ancestor
110838356|NCT03434704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110838357|NCT03434704|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110838358|NCT03434704|Alkylating Agents|alkylating agents|mesh-ancestor
110838359|NCT03434704|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110838360|NCT03434704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110838361|NCT03434704|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110838362|NCT03434704|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110838363|NCT03434704|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110838364|NCT03434704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110838365|NCT03434704|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110838366|NCT03434704|Hormone Antagonists|hormone antagonists|mesh-ancestor
110565366|NCT00665717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110838367|NCT03434704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110838368|NCT03434704|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110838369|NCT03434704|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110838370|NCT02521636|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110838371|NCT02521636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110838372|NCT04779151|Niraparib|niraparib|mesh-list
110838373|NCT04779151|Dostarlimab|dostarlimab|mesh-list
110838374|NCT04779151|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110838375|NCT04779151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110838376|NCT04779151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110838377|NCT04779151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110838378|NCT02891226|Mirikizumab|mirikizumab|mesh-list
110838379|NCT02891226|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110838380|NCT02891226|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110838381|NCT02891226|Analgesics|analgesics|mesh-ancestor
110838382|NCT02891226|Sensory System Agents|sensory system agents|mesh-ancestor
110838383|NCT02891226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110565497|NCT00661973|Hormones|hormones|mesh-ancestor
110838384|NCT02891226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110838385|NCT02891226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110838387|NCT02891226|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110838388|NCT02891226|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110838389|NCT03771781|Empagliflozin|empagliflozin|mesh-list
110838390|NCT03771781|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110565567|NCT02631473|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110838391|NCT03771781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110838392|NCT03771781|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110838393|NCT03771781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110838394|NCT04140721|Moxonidine|moxonidine|mesh-list
110838395|NCT04140721|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110838396|NCT03224104|Temozolomide|temozolomide|mesh-list
110889156|NCT01317433|Antimalarials|antimalarials|mesh-ancestor
110838397|NCT03224104|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110838398|NCT03224104|Alkylating Agents|alkylating agents|mesh-ancestor
110565633|NCT00667979|Urological Agents|urological agents|mesh-ancestor
110838399|NCT03224104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110838400|NCT03224104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110838401|NCT01320475|Sufentanil|sufentanil|mesh-list
110838402|NCT01320475|Ketamine|ketamine|mesh-list
110838403|NCT01320475|Analgesics|analgesics|mesh-ancestor
110838404|NCT01320475|Sensory System Agents|sensory system agents|mesh-ancestor
110838405|NCT01320475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110555998|NCT02629718|Tubulin Modulators|tubulin modulators|mesh-ancestor
110838406|NCT01320475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110838407|NCT01320475|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110838408|NCT01320475|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110838409|NCT01320475|Anesthetics, General|anesthetics, general|mesh-ancestor
110838410|NCT01320475|Anesthetics|anesthetics|mesh-ancestor
110838411|NCT01320475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110838412|NCT01320475|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110838413|NCT01320475|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110838414|NCT01320475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110838415|NCT01320475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110838416|NCT01320475|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110838417|NCT01320475|Narcotics|narcotics|mesh-ancestor
110838418|NCT01320475|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110838419|NCT05177406|Erenumab|erenumab|mesh-list
110838420|NCT05177406|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
110838421|NCT05177406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110838422|NCT05177406|Analgesics|analgesics|mesh-ancestor
110838423|NCT05177406|Sensory System Agents|sensory system agents|mesh-ancestor
110838424|NCT05177406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110838425|NCT05177406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110838426|NCT02521246|Losartan|losartan|mesh-list
110838427|NCT02521246|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110838428|NCT02521246|Candesartan|candesartan|mesh-list
110838429|NCT02521246|Candesartan cilexetil|candesartan cilexetil|mesh-list
110838430|NCT02521246|Chlorthalidone|chlorthalidone|mesh-list
110838431|NCT02521246|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110838432|NCT02521246|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110838433|NCT02521246|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110838434|NCT02521246|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110838435|NCT02521246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110838436|NCT02521246|Diuretics|diuretics|mesh-ancestor
110838437|NCT02521246|Natriuretic Agents|natriuretic agents|mesh-ancestor
110838438|NCT02521246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110838439|NCT02521246|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110838440|NCT02521246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110838441|NCT05309070|Acetylcysteine|acetylcysteine|mesh-list
110838442|NCT05309070|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110838443|NCT05309070|Antiviral Agents|antiviral agents|mesh-ancestor
110838444|NCT05309070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110838445|NCT05309070|Expectorants|expectorants|mesh-ancestor
110838446|NCT05309070|Respiratory System Agents|respiratory system agents|mesh-ancestor
110838447|NCT05309070|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110838448|NCT05309070|Antioxidants|antioxidants|mesh-ancestor
110838449|NCT05309070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110838450|NCT05309070|Protective Agents|protective agents|mesh-ancestor
110838451|NCT05309070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110838452|NCT05309070|Antidotes|antidotes|mesh-ancestor
110838453|NCT04763928|Decitabine|decitabine|mesh-list
110838454|NCT04763928|Venetoclax|venetoclax|mesh-list
110838455|NCT04763928|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110838456|NCT04763928|Antimetabolites|antimetabolites|mesh-ancestor
110838457|NCT04763928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110838458|NCT04763928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110838460|NCT01567501|Cetirizine|cetirizine|mesh-list
110838461|NCT01567501|Levocetirizine|levocetirizine|mesh-list
110838462|NCT01567501|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110838463|NCT01567501|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110838464|NCT01567501|Histamine Antagonists|histamine antagonists|mesh-ancestor
110838465|NCT01567501|Histamine Agents|histamine agents|mesh-ancestor
110838466|NCT01567501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110838467|NCT01567501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110185486|NCT00846326|Phenylephrine|phenylephrine|mesh-list
110838468|NCT01567501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110838469|NCT01567501|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110838470|NCT01321957|Bevacizumab|bevacizumab|mesh-list
110838471|NCT01321957|Oxaliplatin|oxaliplatin|mesh-list
110838472|NCT01321957|Irinotecan|irinotecan|mesh-list
110838473|NCT01321957|Fluorouracil|fluorouracil|mesh-list
110838474|NCT01321957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110838475|NCT01321957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110838476|NCT01321957|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110838477|NCT01321957|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110838478|NCT01321957|Growth Substances|growth substances|mesh-ancestor
110838479|NCT01321957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110556076|NCT01015339|Antimetabolites|antimetabolites|mesh-ancestor
110838480|NCT01321957|Growth Inhibitors|growth inhibitors|mesh-ancestor
110838481|NCT01321957|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110838482|NCT01321957|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110838483|NCT01321957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110565997|NCT00664703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110838484|NCT01321957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110838485|NCT01321957|Antimetabolites|antimetabolites|mesh-ancestor
110838486|NCT01321957|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110838487|NCT01321957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110838488|NCT01321957|Immunologic Factors|immunologic factors|mesh-ancestor
110838489|NCT05363592|Metformin|metformin|mesh-list
110838490|NCT05363592|Alogliptin|alogliptin|mesh-list
110838491|NCT05363592|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110838492|NCT05363592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110838493|NCT05363592|Incretins|incretins|mesh-ancestor
110838494|NCT05363592|Hormones|hormones|mesh-ancestor
110566055|NCT00911651|Autonomic Agents|autonomic agents|mesh-ancestor
110838495|NCT05363592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110838496|NCT05363592|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110838498|NCT05363592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110838499|NCT05363592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110838500|NCT03708211|Esomeprazole|esomeprazole|mesh-list
110838501|NCT03708211|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110838502|NCT03708211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110838503|NCT03708211|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110838504|NCT03708211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110838505|NCT03708211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110838506|NCT03770923|Montelukast|montelukast|mesh-list
110566198|NCT00672113|Nifedipine|nifedipine|mesh-list
110838507|NCT03770923|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110838508|NCT03770923|Respiratory System Agents|respiratory system agents|mesh-ancestor
110838509|NCT03770923|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110838510|NCT03770923|Hormone Antagonists|hormone antagonists|mesh-ancestor
110838511|NCT03770923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110566254|NCT00595127|Alkylating Agents|alkylating agents|mesh-ancestor
110838512|NCT03770923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110838513|NCT03770923|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110838514|NCT03770923|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110838515|NCT03770923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110838517|NCT03433534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110838518|NCT03433534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110838519|NCT03433534|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110838520|NCT03433534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110838521|NCT05445895|Clopidogrel|clopidogrel|mesh-list
110838522|NCT05445895|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110838523|NCT05445895|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110838524|NCT05445895|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110838525|NCT05445895|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110838526|NCT05445895|Purinergic Agents|purinergic agents|mesh-ancestor
110838527|NCT05445895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110838528|NCT05445895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110838529|NCT05445895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110838530|NCT03367299|Blinatumomab|blinatumomab|mesh-list
110838531|NCT03367299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110838532|NCT03705793|Mometasone Furoate|mometasone furoate|mesh-list
110838533|NCT03705793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110838534|NCT03705793|Dermatologic Agents|dermatologic agents|mesh-ancestor
110838535|NCT03705793|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110838536|NCT04449718|Vitamin D|vitamin d|mesh-list
110838537|NCT04449718|Vitamins|vitamins|mesh-ancestor
110838538|NCT04449718|Micronutrients|micronutrients|mesh-ancestor
110838539|NCT04449718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110838540|NCT04449718|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110838541|NCT03763279|Triclosan|triclosan|mesh-list
110838542|NCT03763279|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110838543|NCT03763279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110838544|NCT03763279|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
110838545|NCT03763279|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110838546|NCT03763279|Antimetabolites|antimetabolites|mesh-ancestor
110838547|NCT03763279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110838548|NCT03763279|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110838549|NCT03638037|Vitamin D|vitamin d|mesh-list
110838550|NCT03638037|Vitamins|vitamins|mesh-ancestor
110838551|NCT03638037|Micronutrients|micronutrients|mesh-ancestor
110838552|NCT03638037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110556168|NCT00920998|Z 338|z 338|mesh-list
110838553|NCT03638037|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110838554|NCT03763123|Paclitaxel|paclitaxel|mesh-list
110838555|NCT03763123|Topotecan|topotecan|mesh-list
110838556|NCT03763123|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110838557|NCT03763123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110838558|NCT03763123|Tubulin Modulators|tubulin modulators|mesh-ancestor
110838559|NCT03763123|Antimitotic Agents|antimitotic agents|mesh-ancestor
110838560|NCT03763123|Mitosis Modulators|mitosis modulators|mesh-ancestor
110838561|NCT03763123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110838562|NCT03763123|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110838563|NCT03763123|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110838564|NCT03763123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110838565|NCT03429400|Morphine|morphine|mesh-list
110838566|NCT03429400|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110838567|NCT03429400|Narcotics|narcotics|mesh-ancestor
110838568|NCT03429400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110838569|NCT03429400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110838570|NCT03429400|Analgesics|analgesics|mesh-ancestor
110838571|NCT03429400|Sensory System Agents|sensory system agents|mesh-ancestor
110838572|NCT03429400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110838573|NCT03429010|Anesthetics|anesthetics|mesh-list
110566652|NCT04276857|Irinotecan|irinotecan|mesh-list
110838574|NCT03429010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110838575|NCT03429010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110838577|NCT02944656|Analgesics|analgesics|mesh-ancestor
110838578|NCT02944656|Sensory System Agents|sensory system agents|mesh-ancestor
110838579|NCT02944656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110838580|NCT02944656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110838581|NCT02944656|Anticonvulsants|anticonvulsants|mesh-ancestor
110838582|NCT02944656|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110838583|NCT02944656|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110838584|NCT02944656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110838585|NCT02944656|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110838586|NCT02944656|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110838587|NCT02944656|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110838588|NCT02944656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110838589|NCT02944656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110838591|NCT02713529|Pembrolizumab|pembrolizumab|mesh-list
110838592|NCT02713529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110838593|NCT02713529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110838594|NCT02713529|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110838595|NCT02713529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110838596|NCT03763045|Sildenafil Citrate|sildenafil citrate|mesh-list
110838597|NCT03763045|Vasodilator Agents|vasodilator agents|mesh-ancestor
110838598|NCT03763045|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110838599|NCT03763045|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110838600|NCT03763045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110838601|NCT03763045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110838602|NCT03763045|Urological Agents|urological agents|mesh-ancestor
110838603|NCT01321489|Sildenafil Citrate|sildenafil citrate|mesh-list
110838604|NCT01321489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110838605|NCT01321489|Vasodilator Agents|vasodilator agents|mesh-ancestor
110838606|NCT01321489|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110838607|NCT01321489|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110838608|NCT01321489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110838609|NCT01321489|Urological Agents|urological agents|mesh-ancestor
110838611|NCT04800627|Enzyme Inhibitors|enzyme inhibitors|mesh-list
110838612|NCT04800627|Pevonedistat|pevonedistat|mesh-list
110838613|NCT04800627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110838614|NCT04800627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110838615|NCT04800627|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110838616|NCT04800627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110838617|NCT05308602|Vaccines|vaccines|mesh-list
110838618|NCT05308602|Immunologic Factors|immunologic factors|mesh-ancestor
110838619|NCT05308602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110838620|NCT03768037|Pemetrexed|pemetrexed|mesh-list
110838621|NCT03768037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110838622|NCT03768037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110838623|NCT03768037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110838624|NCT03768037|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110838625|NCT03768037|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110838626|NCT01146977|Cytarabine|cytarabine|mesh-list
110838627|NCT01146977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110838629|NCT01146977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110838631|NCT01146977|Antiviral Agents|antiviral agents|mesh-ancestor
110838632|NCT01146977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110838633|NCT01146977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110838634|NCT01146977|Immunologic Factors|immunologic factors|mesh-ancestor
110838635|NCT01146977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110838636|NCT03762967|Hormones|hormones|mesh-list
110567256|NCT05647551|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110567257|NCT05647551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110567258|NCT05647551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110567259|NCT05647551|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110567260|NCT05647551|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110567261|NCT05647551|Cholinergic Agents|cholinergic agents|mesh-ancestor
110567262|NCT05647551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110567263|NCT05627479|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110567264|NCT05626478|Dexamethasone|dexamethasone|mesh-list
110567265|NCT05626478|Prednisolone|prednisolone|mesh-list
110567266|NCT05626478|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110567267|NCT05626478|Methylprednisolone|methylprednisolone|mesh-list
110889199|NCT01346917|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110567268|NCT05626478|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110567269|NCT05626478|Prednisolone acetate|prednisolone acetate|mesh-list
110838637|NCT03762967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110838638|NCT03762967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110838639|NCT03762889|Anesthetics|anesthetics|mesh-list
110838640|NCT03762889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110838641|NCT03762889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110838642|NCT03746041|Abaloparatide|abaloparatide|mesh-list
110838643|NCT03746041|Bevacizumab|bevacizumab|mesh-list
110838644|NCT03746041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110838645|NCT03746041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110838646|NCT03746041|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110838647|NCT03746041|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110838648|NCT03746041|Growth Substances|growth substances|mesh-ancestor
110838649|NCT03746041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110838650|NCT03746041|Growth Inhibitors|growth inhibitors|mesh-ancestor
110838651|NCT03746041|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110838652|NCT01236989|Liver Extracts|liver extracts|mesh-list
110838653|NCT01236989|Hematinics|hematinics|mesh-ancestor
110838654|NCT03423472|Vitamin A|vitamin a|mesh-list
110838655|NCT03423472|Vitamins|vitamins|mesh-ancestor
110838656|NCT03423472|Micronutrients|micronutrients|mesh-ancestor
110838657|NCT03423472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110838658|NCT01239563|Thymoglobulin|thymoglobulin|mesh-list
110838659|NCT01239563|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110838660|NCT01239563|Basiliximab|basiliximab|mesh-list
110838661|NCT01239563|Immunologic Factors|immunologic factors|mesh-ancestor
110838662|NCT01239563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110838663|NCT01239563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110838664|NCT01321255|Aspirin|aspirin|mesh-list
110838665|NCT01321255|Ramipril|ramipril|mesh-list
110838666|NCT01321255|Simvastatin|simvastatin|mesh-list
110838667|NCT01321255|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110838668|NCT01321255|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110838669|NCT01321255|Analgesics|analgesics|mesh-ancestor
110838670|NCT01321255|Sensory System Agents|sensory system agents|mesh-ancestor
110838671|NCT01321255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110838672|NCT01321255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110838673|NCT01321255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110838674|NCT01321255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110838675|NCT01321255|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110838676|NCT01321255|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110838677|NCT01321255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110838678|NCT01321255|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110838679|NCT01321255|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110838680|NCT01321255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110838681|NCT01321255|Antipyretics|antipyretics|mesh-ancestor
110838682|NCT01321255|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110838683|NCT01321255|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110838684|NCT01321255|Antimetabolites|antimetabolites|mesh-ancestor
110838685|NCT01321255|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110838686|NCT01321255|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110838687|NCT01321255|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110838688|NCT01321255|Protease Inhibitors|protease inhibitors|mesh-ancestor
110838689|NCT01321255|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110838690|NCT01883297|Aldesleukin|aldesleukin|mesh-list
110838691|NCT01883297|Cyclophosphamide|cyclophosphamide|mesh-list
110838692|NCT01883297|Interleukin-2|interleukin-2|mesh-list
110567585|NCT04939142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110567587|NCT04909450|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110838694|NCT01883297|Immunologic Factors|immunologic factors|mesh-ancestor
110838695|NCT01883297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110838696|NCT01883297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110567655|NCT04521140|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110838697|NCT01883297|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110838698|NCT01883297|Alkylating Agents|alkylating agents|mesh-ancestor
110838699|NCT01883297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110838700|NCT01883297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110838701|NCT01883297|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110838702|NCT01883297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110567729|NCT04392375|Tocolytic Agents|tocolytic agents|mesh-ancestor
110838704|NCT01883297|Sensory System Agents|sensory system agents|mesh-ancestor
110838705|NCT01883297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110838706|NCT01883297|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110838707|NCT01883297|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110838708|NCT01883297|Antiviral Agents|antiviral agents|mesh-ancestor
110838709|NCT01883297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110838711|NCT04546581|Immunoglobulins|immunoglobulins|mesh-list
110838712|NCT04546581|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110838713|NCT04546581|Antibodies|antibodies|mesh-list
110838714|NCT04546581|Immunologic Factors|immunologic factors|mesh-ancestor
110838715|NCT04546581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110838716|NCT04546581|Antimetabolites|antimetabolites|mesh-ancestor
110838717|NCT04546581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110567865|NCT03714308|Growth Substances|growth substances|mesh-ancestor
110567866|NCT03714308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110567867|NCT03714308|Growth Inhibitors|growth inhibitors|mesh-ancestor
110838718|NCT04546581|Antiviral Agents|antiviral agents|mesh-ancestor
110838719|NCT04546581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110838720|NCT02204254|Doxycycline|doxycycline|mesh-list
110838721|NCT02204254|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110838722|NCT02204254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110838723|NCT02204254|Antimalarials|antimalarials|mesh-ancestor
110838724|NCT02204254|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110838725|NCT02204254|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110838726|NCT03417076|Bexagliflozin|bexagliflozin|mesh-list
110838727|NCT03417076|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110838728|NCT03417076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110838729|NCT05294172|Cisplatin|cisplatin|mesh-list
110838730|NCT05294172|Gemcitabine|gemcitabine|mesh-list
110838731|NCT05294172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110838732|NCT05294172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110838733|NCT05294172|Antimetabolites|antimetabolites|mesh-ancestor
110838734|NCT05294172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110838735|NCT03164655|Leucovorin|leucovorin|mesh-list
110838736|NCT03164655|Bevacizumab|bevacizumab|mesh-list
110838737|NCT03164655|Cetuximab|cetuximab|mesh-list
110838738|NCT03164655|Panitumumab|panitumumab|mesh-list
110838739|NCT03164655|Fluorouracil|fluorouracil|mesh-list
110838740|NCT03164655|Oxaliplatin|oxaliplatin|mesh-list
110838741|NCT03164655|Irinotecan|irinotecan|mesh-list
110838742|NCT03164655|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110838743|NCT03164655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110838744|NCT03164655|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110838745|NCT03164655|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110838746|NCT03164655|Growth Substances|growth substances|mesh-ancestor
110838747|NCT03164655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110838748|NCT03164655|Growth Inhibitors|growth inhibitors|mesh-ancestor
110838749|NCT03164655|Antimetabolites|antimetabolites|mesh-ancestor
110838750|NCT03164655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110838751|NCT03164655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110838752|NCT03164655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110838753|NCT03164655|Immunologic Factors|immunologic factors|mesh-ancestor
110838754|NCT03164655|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110838755|NCT03164655|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110838756|NCT03164655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110838758|NCT03164655|Protective Agents|protective agents|mesh-ancestor
110838759|NCT03164655|Vitamin B Complex|vitamin b complex|mesh-ancestor
110838760|NCT03164655|Vitamins|vitamins|mesh-ancestor
110838761|NCT03164655|Micronutrients|micronutrients|mesh-ancestor
110838762|NCT02561273|Prednisone|prednisone|mesh-list
110838763|NCT02561273|Cortisone|cortisone|mesh-list
110838764|NCT02561273|Cyclophosphamide|cyclophosphamide|mesh-list
110838765|NCT02561273|Doxorubicin|doxorubicin|mesh-list
110838766|NCT02561273|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110838767|NCT02561273|Etoposide|etoposide|mesh-list
110838768|NCT02561273|Vincristine|vincristine|mesh-list
110838769|NCT02561273|Lenalidomide|lenalidomide|mesh-list
110838770|NCT02561273|Etoposide phosphate|etoposide phosphate|mesh-list
110838772|NCT02561273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110838773|NCT02561273|Immunologic Factors|immunologic factors|mesh-ancestor
110838774|NCT02561273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110838775|NCT02561273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110838776|NCT02561273|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110556370|NCT00664586|Antioxidants|antioxidants|mesh-ancestor
110838777|NCT02561273|Alkylating Agents|alkylating agents|mesh-ancestor
110838778|NCT02561273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110838779|NCT02561273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110838780|NCT02561273|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110838781|NCT02561273|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110838782|NCT02561273|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110838783|NCT02561273|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110838784|NCT02561273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110838785|NCT02561273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110838786|NCT02561273|Glucocorticoids|glucocorticoids|mesh-ancestor
110838787|NCT02561273|Hormones|hormones|mesh-ancestor
110838788|NCT02561273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110838789|NCT02561273|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110568399|NCT00757978|Memantine|memantine|mesh-list
110838790|NCT02561273|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110838791|NCT02561273|Tubulin Modulators|tubulin modulators|mesh-ancestor
110838792|NCT02561273|Antimitotic Agents|antimitotic agents|mesh-ancestor
110838793|NCT02561273|Mitosis Modulators|mitosis modulators|mesh-ancestor
110838794|NCT02561273|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110838795|NCT02561273|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110838796|NCT02561273|Growth Substances|growth substances|mesh-ancestor
110838797|NCT02561273|Growth Inhibitors|growth inhibitors|mesh-ancestor
110838798|NCT02561273|Keratolytic Agents|keratolytic agents|mesh-ancestor
110838799|NCT02561273|Dermatologic Agents|dermatologic agents|mesh-ancestor
110838800|NCT02521012|Vitamin D|vitamin d|mesh-list
110838801|NCT02521012|Ergocalciferols|ergocalciferols|mesh-list
110838802|NCT02521012|Cholecalciferol|cholecalciferol|mesh-list
110838803|NCT02521012|Vitamins|vitamins|mesh-list
110838804|NCT02521012|Micronutrients|micronutrients|mesh-ancestor
110838805|NCT02521012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110838806|NCT02521012|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110838807|NCT02521012|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110838808|NCT04756128|Colchicine|colchicine|mesh-list
110838809|NCT04756128|Naltrexone|naltrexone|mesh-list
110838810|NCT04756128|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110838811|NCT04756128|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110838812|NCT04756128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110838813|NCT04756128|Sensory System Agents|sensory system agents|mesh-ancestor
110838814|NCT04756128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110838815|NCT04756128|Gout Suppressants|gout suppressants|mesh-ancestor
110838816|NCT04756128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110838817|NCT04756128|Tubulin Modulators|tubulin modulators|mesh-ancestor
110838818|NCT04756128|Antimitotic Agents|antimitotic agents|mesh-ancestor
110838819|NCT04756128|Mitosis Modulators|mitosis modulators|mesh-ancestor
110838820|NCT04756128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110838821|NCT04756128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110838822|NCT03427216|Diazepam|diazepam|mesh-list
110838823|NCT03427216|Baclofen|baclofen|mesh-list
110838824|NCT03427216|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110838825|NCT03427216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110838826|NCT03427216|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110838827|NCT03427216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110838828|NCT03427216|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
110838829|NCT03427216|GABA Agonists|gaba agonists|mesh-ancestor
110838830|NCT03427216|GABA Agents|gaba agents|mesh-ancestor
110838831|NCT03427216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110889226|NCT01348243|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110838832|NCT03427216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110838833|NCT03427216|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110838835|NCT03427216|Antiemetics|antiemetics|mesh-ancestor
110838836|NCT03427216|Autonomic Agents|autonomic agents|mesh-ancestor
110838837|NCT03427216|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110838838|NCT03427216|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110838839|NCT03427216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110568733|NCT00761020|Mefloquine|mefloquine|mesh-list
110838840|NCT03427216|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110838841|NCT03427216|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110838842|NCT03427216|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110838843|NCT03427216|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110838844|NCT03427216|Anesthetics, General|anesthetics, general|mesh-ancestor
110838845|NCT03427216|Anesthetics|anesthetics|mesh-ancestor
110838846|NCT03427216|GABA Modulators|gaba modulators|mesh-ancestor
110838847|NCT01144091|Pentoxifylline|pentoxifylline|mesh-list
110838848|NCT01144091|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110838849|NCT01144091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110838850|NCT01144091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110838851|NCT01144091|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110838852|NCT01144091|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110838853|NCT01144091|Protective Agents|protective agents|mesh-ancestor
110838854|NCT01144091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110838855|NCT01144091|Vasodilator Agents|vasodilator agents|mesh-ancestor
110838856|NCT01144091|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110838857|NCT01144091|Antioxidants|antioxidants|mesh-ancestor
110838858|NCT02392559|Evolocumab|evolocumab|mesh-list
110838859|NCT02392559|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
110838860|NCT02392559|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110838861|NCT02392559|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110838862|NCT02392559|Antimetabolites|antimetabolites|mesh-ancestor
110838863|NCT02392559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110838864|NCT02392559|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110838865|NCT02392559|Protease Inhibitors|protease inhibitors|mesh-ancestor
110838866|NCT02392559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110838867|NCT02392559|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110838868|NCT03332589|Dabrafenib|dabrafenib|mesh-list
110838869|NCT03332589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110838870|NCT03332589|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110838871|NCT03332589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110838872|NCT03332589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110838873|NCT03767569|Folic Acid|folic acid|mesh-list
110838874|NCT03767569|Inositol|inositol|mesh-list
110838875|NCT03767569|Hematinics|hematinics|mesh-ancestor
110838876|NCT03767569|Vitamin B Complex|vitamin b complex|mesh-ancestor
110838877|NCT03767569|Vitamins|vitamins|mesh-ancestor
110838879|NCT03767569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110838880|NCT03620916|Morphine|morphine|mesh-list
110838881|NCT03620916|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110838882|NCT03620916|Narcotics|narcotics|mesh-ancestor
110838883|NCT03620916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110838884|NCT03620916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110838885|NCT03620916|Analgesics|analgesics|mesh-ancestor
110838886|NCT03620916|Sensory System Agents|sensory system agents|mesh-ancestor
110838887|NCT03620916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110838888|NCT01237067|Carboplatin|carboplatin|mesh-list
110838889|NCT01237067|Olaparib|olaparib|mesh-list
110838890|NCT01237067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110838891|NCT01237067|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110838892|NCT01237067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110838893|NCT01237067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110838894|NCT03426982|Heparin|heparin|mesh-list
110568923|NCT00673894|Hormones|hormones|mesh-ancestor
110838895|NCT03426982|Calcium heparin|calcium heparin|mesh-list
110838896|NCT03426982|Anticoagulants|anticoagulants|mesh-ancestor
110889249|NCT01343329|Esmolol|esmolol|mesh-list
110838897|NCT03426982|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110838898|NCT03426982|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110838899|NCT03426982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110838900|NCT01546948|Methadone|methadone|mesh-list
110838901|NCT01546948|Hydromorphone|hydromorphone|mesh-list
110838902|NCT01546948|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110838903|NCT01546948|Narcotics|narcotics|mesh-ancestor
110568979|NCT00758914|Vitamin E|vitamin e|mesh-list
110838904|NCT01546948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110838905|NCT01546948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110838906|NCT01546948|Analgesics|analgesics|mesh-ancestor
110838907|NCT01546948|Sensory System Agents|sensory system agents|mesh-ancestor
110838908|NCT01546948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110838909|NCT01546948|Antitussive Agents|antitussive agents|mesh-ancestor
110838910|NCT01546948|Respiratory System Agents|respiratory system agents|mesh-ancestor
110838911|NCT00458003|Phenylephrine|phenylephrine|mesh-list
110838912|NCT00458003|Oxymetazoline|oxymetazoline|mesh-list
110838914|NCT00458003|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110838915|NCT00458003|Mydriatics|mydriatics|mesh-ancestor
110838916|NCT00458003|Autonomic Agents|autonomic agents|mesh-ancestor
110838917|NCT00458003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110838918|NCT00458003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110838919|NCT00458003|Sympathomimetics|sympathomimetics|mesh-ancestor
110838920|NCT00458003|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110838921|NCT00458003|Nasal Decongestants|nasal decongestants|mesh-ancestor
110838922|NCT00458003|Respiratory System Agents|respiratory system agents|mesh-ancestor
110838923|NCT00458003|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110838924|NCT00458003|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110838925|NCT00458003|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110838926|NCT00458003|Adrenergic Agents|adrenergic agents|mesh-ancestor
110838927|NCT00458003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110838928|NCT00458003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110838929|NCT00458003|Protective Agents|protective agents|mesh-ancestor
110838930|NCT00458003|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110838931|NCT04599972|Pilocarpine|pilocarpine|mesh-list
110838932|NCT04599972|Miotics|miotics|mesh-ancestor
110838933|NCT04599972|Autonomic Agents|autonomic agents|mesh-ancestor
110838934|NCT04599972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110838935|NCT04599972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110838936|NCT04599972|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
110838937|NCT04599972|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110838938|NCT04599972|Cholinergic Agents|cholinergic agents|mesh-ancestor
110838939|NCT04599972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110838940|NCT04599972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110838941|NCT03008616|Digoxin|digoxin|mesh-list
110838942|NCT03008616|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110838943|NCT03008616|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110838944|NCT03008616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110838945|NCT03008616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110838946|NCT03008616|Protective Agents|protective agents|mesh-ancestor
110838947|NCT03008616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110185674|NCT00276692|Irinotecan|irinotecan|mesh-list
110838948|NCT03422146|Tea Tree Oil|tea tree oil|mesh-list
110838949|NCT03422146|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110838950|NCT03422146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110838951|NCT03426592|Vitamin D|vitamin d|mesh-list
110838952|NCT03426592|Cholecalciferol|cholecalciferol|mesh-list
110838953|NCT03426592|Vitamins|vitamins|mesh-ancestor
110838954|NCT03426592|Micronutrients|micronutrients|mesh-ancestor
110838955|NCT03426592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110889251|NCT01343329|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110838956|NCT03426592|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110838957|NCT03426592|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110838959|NCT01567657|Meperidine|meperidine|mesh-list
110838960|NCT01567657|Propofol|propofol|mesh-list
110838961|NCT01567657|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110838962|NCT01567657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110838963|NCT01567657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110838964|NCT01567657|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110838965|NCT01567657|Anesthetics, General|anesthetics, general|mesh-ancestor
110838966|NCT01567657|Anesthetics|anesthetics|mesh-ancestor
110838967|NCT01567657|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110569426|NCT00767494|Brinzolamide|brinzolamide|mesh-list
110838968|NCT01567657|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110838969|NCT01567657|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110838970|NCT01567657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110838971|NCT01567657|GABA Modulators|gaba modulators|mesh-ancestor
110838972|NCT01567657|GABA Agents|gaba agents|mesh-ancestor
110838973|NCT01567657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110838974|NCT01567657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110838975|NCT01567657|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110838976|NCT01567657|Narcotics|narcotics|mesh-ancestor
110838977|NCT01567657|Analgesics|analgesics|mesh-ancestor
110838978|NCT01567657|Sensory System Agents|sensory system agents|mesh-ancestor
110838979|NCT01567657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110838980|NCT03416062|Niacinamide|niacinamide|mesh-list
110838981|NCT03416062|Vitamin B Complex|vitamin b complex|mesh-ancestor
110838982|NCT03416062|Vitamins|vitamins|mesh-ancestor
110838983|NCT03416062|Micronutrients|micronutrients|mesh-ancestor
110838984|NCT03416062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110838985|NCT03761485|Fluorides|fluorides|mesh-list
110838986|NCT03761485|Cariostatic Agents|cariostatic agents|mesh-ancestor
110838987|NCT03761485|Protective Agents|protective agents|mesh-ancestor
110838988|NCT03761485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110838989|NCT03766867|Vortioxetine|vortioxetine|mesh-list
110838990|NCT03766867|Antidepressive Agents|antidepressive agents|mesh-ancestor
110838991|NCT03766867|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110838992|NCT03766867|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110838993|NCT03766867|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110838994|NCT03766867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110838995|NCT03766867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110838996|NCT03766867|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110569620|NCT02634515|Insulin|insulin|mesh-list
110838997|NCT03766867|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110838998|NCT03766867|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110838999|NCT03766867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110839000|NCT03766867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110839001|NCT03766867|Serotonin Agents|serotonin agents|mesh-ancestor
110569687|NCT00779350|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110839002|NCT03766867|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110839003|NCT03766867|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110839004|NCT03766867|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110839005|NCT03766867|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110839008|NCT02061293|Psilocybin|psilocybin|mesh-list
110839009|NCT02061293|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110556598|NCT00665522|Anesthetics, General|anesthetics, general|mesh-ancestor
110839010|NCT02061293|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110839011|NCT02061293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110839012|NCT02061293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110839013|NCT02061293|Anesthetics, Local|anesthetics, local|mesh-ancestor
110839014|NCT02061293|Anesthetics|anesthetics|mesh-ancestor
110839015|NCT02061293|Sensory System Agents|sensory system agents|mesh-ancestor
110839016|NCT02061293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110839017|NCT02061293|Antiemetics|antiemetics|mesh-ancestor
110839018|NCT02061293|Autonomic Agents|autonomic agents|mesh-ancestor
110839019|NCT02061293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110839020|NCT02061293|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110839021|NCT02061293|Histamine Antagonists|histamine antagonists|mesh-ancestor
110839022|NCT02061293|Histamine Agents|histamine agents|mesh-ancestor
110839023|NCT02061293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110839024|NCT02061293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110839025|NCT02061293|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110839026|NCT02061293|Antipruritics|antipruritics|mesh-ancestor
110839027|NCT02061293|Dermatologic Agents|dermatologic agents|mesh-ancestor
110839028|NCT02061293|Hallucinogens|hallucinogens|mesh-ancestor
110839029|NCT02061293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110839030|NCT03761329|Lidocaine|lidocaine|mesh-list
110839031|NCT03761329|Anesthetics|anesthetics|mesh-list
110839032|NCT03761329|Anesthetics, Local|anesthetics, local|mesh-ancestor
110839033|NCT03761329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110839034|NCT03761329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110839035|NCT03761329|Sensory System Agents|sensory system agents|mesh-ancestor
110839036|NCT03761329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110839037|NCT03761329|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110839038|NCT03761329|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110839039|NCT03761329|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110569769|NCT04150757|Ketamine|ketamine|mesh-list
110839040|NCT03761329|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110839041|NCT03761329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110839043|NCT03415906|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
110839044|NCT03415906|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
110839045|NCT03415906|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110839046|NCT03415906|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110839047|NCT03415906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110839048|NCT03415750|Mycophenolic Acid|mycophenolic acid|mesh-list
110839049|NCT03415750|Everolimus|everolimus|mesh-list
110839050|NCT03415750|Tacrolimus|tacrolimus|mesh-list
110839051|NCT03415750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110839052|NCT03415750|Immunologic Factors|immunologic factors|mesh-ancestor
110839053|NCT03415750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110839054|NCT03415750|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110839055|NCT03415750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110839056|NCT03415750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110185732|NCT04201665|Oxytocin|oxytocin|mesh-list
110839057|NCT03415750|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110839058|NCT03415750|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110839059|NCT03415750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110839060|NCT03415750|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110839061|NCT03415750|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110839062|NCT03415750|Antitubercular Agents|antitubercular agents|mesh-ancestor
110839063|NCT03415750|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110839064|NCT03415750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110839065|NCT01239719|Clemastine|clemastine|mesh-list
110839066|NCT01239719|Dexamethasone|dexamethasone|mesh-list
110839067|NCT01239719|Dexamethasone acetate|dexamethasone acetate|mesh-list
110839068|NCT01239719|BB 1101|bb 1101|mesh-list
110839069|NCT01239719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110839070|NCT01239719|Antiemetics|antiemetics|mesh-ancestor
110839071|NCT01239719|Autonomic Agents|autonomic agents|mesh-ancestor
110839072|NCT01239719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110839073|NCT01239719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110839074|NCT01239719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110839075|NCT01239719|Glucocorticoids|glucocorticoids|mesh-ancestor
110839076|NCT01239719|Hormones|hormones|mesh-ancestor
110839077|NCT01239719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110839078|NCT01239719|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110839079|NCT01239719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110839080|NCT01239719|Protease Inhibitors|protease inhibitors|mesh-ancestor
110839081|NCT01239719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110839082|NCT01239719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110839083|NCT01239719|Antipruritics|antipruritics|mesh-ancestor
110839084|NCT01239719|Dermatologic Agents|dermatologic agents|mesh-ancestor
110839085|NCT01239719|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110839086|NCT01239719|Histamine Antagonists|histamine antagonists|mesh-ancestor
110839087|NCT01239719|Histamine Agents|histamine agents|mesh-ancestor
110839088|NCT01239719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110839089|NCT01239719|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110839090|NCT03916679|Cyclophosphamide|cyclophosphamide|mesh-list
110839092|NCT03916679|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110839093|NCT03916679|Immunologic Factors|immunologic factors|mesh-ancestor
110839094|NCT03916679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110839095|NCT03916679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110839096|NCT03916679|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110839097|NCT03916679|Alkylating Agents|alkylating agents|mesh-ancestor
110839098|NCT03916679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110839099|NCT03916679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110839100|NCT03916679|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110839101|NCT03421990|Anesthetics|anesthetics|mesh-list
110839102|NCT03421990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110839103|NCT03421990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110839104|NCT02913612|Timolol|timolol|mesh-list
110839105|NCT02913612|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110839106|NCT02913612|Maleic acid|maleic acid|mesh-list
110839107|NCT02913612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110839108|NCT02913612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110839109|NCT02913612|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110839110|NCT02913612|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110839111|NCT02913612|Adrenergic Agents|adrenergic agents|mesh-ancestor
110839112|NCT02913612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110839113|NCT02913612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110839114|NCT02913612|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110839115|NCT02913612|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110839116|NCT03426202|Modafinil|modafinil|mesh-list
110839117|NCT03426202|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110839118|NCT03426202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110839119|NCT03426202|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
110839120|NCT03426202|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110839121|NCT03426202|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110839122|NCT03426202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110839123|NCT01248299|Cisplatin|cisplatin|mesh-list
110839124|NCT01248299|Docetaxel|docetaxel|mesh-list
110839125|NCT01248299|Oxaliplatin|oxaliplatin|mesh-list
110839126|NCT01248299|Fluorouracil|fluorouracil|mesh-list
110839127|NCT01248299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110839128|NCT01248299|Tubulin Modulators|tubulin modulators|mesh-ancestor
110839129|NCT01248299|Antimitotic Agents|antimitotic agents|mesh-ancestor
110839130|NCT01248299|Mitosis Modulators|mitosis modulators|mesh-ancestor
110839131|NCT01248299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110839132|NCT01248299|Antimetabolites|antimetabolites|mesh-ancestor
110839133|NCT01248299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110839134|NCT01248299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110839135|NCT01248299|Immunologic Factors|immunologic factors|mesh-ancestor
110839136|NCT01248299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110839137|NCT01239875|Vaccines|vaccines|mesh-list
110839138|NCT01239875|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110839139|NCT01239875|Immunologic Factors|immunologic factors|mesh-ancestor
110839140|NCT01239875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110839141|NCT03415594|Glucagon|glucagon|mesh-list
110839142|NCT03415594|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
110839143|NCT03415594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110839144|NCT03415594|Hormones|hormones|mesh-ancestor
110839145|NCT03415594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110839146|NCT03415594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110839147|NCT03415594|Incretins|incretins|mesh-ancestor
110839148|NCT04219254|Pembrolizumab|pembrolizumab|mesh-list
110839149|NCT04219254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110570005|NCT02633579|Mydriatics|mydriatics|mesh-ancestor
110839150|NCT04219254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110839151|NCT04219254|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110839152|NCT04219254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110839153|NCT01144169|Hydroxychloroquine|hydroxychloroquine|mesh-list
110839154|NCT01144169|Antimalarials|antimalarials|mesh-ancestor
110839155|NCT01144169|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110839156|NCT01144169|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110839157|NCT01144169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110839158|NCT01144169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110839159|NCT01144169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110839160|NCT01144169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110556743|NCT00617513|Serotonin Agents|serotonin agents|mesh-ancestor
110839161|NCT02709954|Ethanol|ethanol|mesh-list
110839162|NCT02709954|Dronabinol|dronabinol|mesh-list
110839163|NCT02709954|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110839164|NCT02709954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110839165|NCT02709954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110839166|NCT02709954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110839167|NCT02709954|Hallucinogens|hallucinogens|mesh-ancestor
110839168|NCT02709954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110570065|NCT00667732|Exenatide|exenatide|mesh-list
110839169|NCT02709954|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110839170|NCT02709954|Analgesics|analgesics|mesh-ancestor
110839171|NCT02709954|Sensory System Agents|sensory system agents|mesh-ancestor
110839172|NCT02709954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110839173|NCT02709954|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
110839174|NCT02709954|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110839175|NCT02709954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110839176|NCT02709954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110839177|NCT02709954|Hormones|hormones|mesh-ancestor
110839178|NCT02709954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110839179|NCT03620838|Contraceptive Agents|contraceptive agents|mesh-list
110839180|NCT03620838|Contraceptives, Oral|contraceptives, oral|mesh-list
110839181|NCT03620838|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
110839182|NCT03620838|Progesterone|progesterone|mesh-list
110839183|NCT03620838|Progestins|progestins|mesh-ancestor
110839184|NCT03620838|Hormones|hormones|mesh-ancestor
110839185|NCT03620838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110839186|NCT03620838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110839187|NCT03620838|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110839188|NCT03620838|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110839189|NCT01239953|Paclitaxel|paclitaxel|mesh-list
110839190|NCT01239953|Everolimus|everolimus|mesh-list
110570115|NCT02626481|Dexamethasone|dexamethasone|mesh-list
110839191|NCT01239953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110839192|NCT01239953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110839193|NCT01239953|Tubulin Modulators|tubulin modulators|mesh-ancestor
110839194|NCT01239953|Antimitotic Agents|antimitotic agents|mesh-ancestor
110839195|NCT01239953|Mitosis Modulators|mitosis modulators|mesh-ancestor
110839196|NCT01239953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110839197|NCT01239953|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110839198|NCT01239953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110839199|NCT01239953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110839200|NCT01239953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110839201|NCT01239953|Immunologic Factors|immunologic factors|mesh-ancestor
110839202|NCT01239953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110839203|NCT01322191|Morphine|morphine|mesh-list
110839205|NCT01322191|Narcotics|narcotics|mesh-ancestor
110839206|NCT01322191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110839207|NCT01322191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110839208|NCT01322191|Analgesics|analgesics|mesh-ancestor
110570230|NCT00777478|Sunitinib|sunitinib|mesh-list
110839210|NCT01322191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110839211|NCT03620760|Aspirin|aspirin|mesh-list
110839212|NCT03620760|Ticagrelor|ticagrelor|mesh-list
110839213|NCT03620760|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110839214|NCT03620760|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110839215|NCT03620760|Analgesics|analgesics|mesh-ancestor
110839216|NCT03620760|Sensory System Agents|sensory system agents|mesh-ancestor
110839217|NCT03620760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110839218|NCT03620760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110839219|NCT03620760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110839220|NCT03620760|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110839221|NCT03620760|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110839222|NCT03620760|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110839223|NCT03620760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110839224|NCT03620760|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110839225|NCT03620760|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110839226|NCT03620760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110839227|NCT03620760|Antipyretics|antipyretics|mesh-ancestor
110839228|NCT03620760|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110839229|NCT03620760|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110839230|NCT03620760|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110839231|NCT03620760|Purinergic Agents|purinergic agents|mesh-ancestor
110839232|NCT03620760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110839233|NCT03765931|Amoxicillin|amoxicillin|mesh-list
110839234|NCT03765931|Doxycycline|doxycycline|mesh-list
110556821|NCT00684866|Tocolytic Agents|tocolytic agents|mesh-ancestor
110839235|NCT03765931|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110839236|NCT03765931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110839237|NCT03765931|Antimalarials|antimalarials|mesh-ancestor
110839238|NCT03765931|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110839239|NCT03765931|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110839240|NCT01240265|Vitamin D|vitamin d|mesh-list
110839241|NCT01240265|Ergocalciferols|ergocalciferols|mesh-list
110839242|NCT01240265|Cholecalciferol|cholecalciferol|mesh-list
110839243|NCT01240265|Vitamins|vitamins|mesh-list
110839244|NCT01240265|Micronutrients|micronutrients|mesh-ancestor
110839245|NCT01240265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110839246|NCT01240265|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110839247|NCT01240265|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110839248|NCT02327455|Dobutamine|dobutamine|mesh-list
110839249|NCT02327455|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110839250|NCT02327455|Sympathomimetics|sympathomimetics|mesh-ancestor
110839251|NCT02327455|Autonomic Agents|autonomic agents|mesh-ancestor
110839252|NCT02327455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110839253|NCT02327455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110839254|NCT02327455|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
110839255|NCT02327455|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110839256|NCT02327455|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110839257|NCT02327455|Adrenergic Agents|adrenergic agents|mesh-ancestor
110570558|NCT00781300|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110839258|NCT02327455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110839259|NCT02327455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110839260|NCT02327455|Protective Agents|protective agents|mesh-ancestor
110839262|NCT03638076|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110839263|NCT03638076|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110839264|NCT03638076|Protease Inhibitors|protease inhibitors|mesh-ancestor
110839265|NCT03638076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110839266|NCT03638076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110839268|NCT03638076|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110839269|NCT03638076|Antiviral Agents|antiviral agents|mesh-ancestor
110839270|NCT03638076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110839271|NCT03638076|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110839272|NCT03638076|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110839274|NCT01329731|Cariostatic Agents|cariostatic agents|mesh-ancestor
110839275|NCT01329731|Protective Agents|protective agents|mesh-ancestor
110839276|NCT01329731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110839277|NCT03765697|Lidocaine|lidocaine|mesh-list
110839278|NCT03765697|Anesthetics, Local|anesthetics, local|mesh-ancestor
110839279|NCT03765697|Anesthetics|anesthetics|mesh-ancestor
110839280|NCT03765697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110839281|NCT03765697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110839282|NCT03765697|Sensory System Agents|sensory system agents|mesh-ancestor
110839283|NCT03765697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110839284|NCT03765697|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110839285|NCT03765697|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110839286|NCT03765697|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110839287|NCT03765697|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110839288|NCT03765697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110839290|NCT03311841|Midazolam|midazolam|mesh-list
110839291|NCT03311841|Dabigatran|dabigatran|mesh-list
110839292|NCT03311841|Atorvastatin|atorvastatin|mesh-list
110839293|NCT03311841|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110839294|NCT03311841|Pitavastatin|pitavastatin|mesh-list
110839295|NCT03311841|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110839296|NCT03311841|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110839297|NCT03311841|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110839298|NCT03311841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110839299|NCT03311841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110839300|NCT03311841|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110839301|NCT03311841|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110839302|NCT03311841|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110839303|NCT03311841|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110839304|NCT03311841|Anesthetics, General|anesthetics, general|mesh-ancestor
110839305|NCT03311841|Anesthetics|anesthetics|mesh-ancestor
110839306|NCT03311841|GABA Modulators|gaba modulators|mesh-ancestor
110839307|NCT03311841|GABA Agents|gaba agents|mesh-ancestor
110839308|NCT03311841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110839309|NCT03311841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110839310|NCT03311841|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110556898|NCT00823719|Ofatumumab|ofatumumab|mesh-list
110839311|NCT03311841|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110839312|NCT03311841|Antimetabolites|antimetabolites|mesh-ancestor
110839313|NCT03311841|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110839314|NCT03311841|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110839315|NCT03311841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110839316|NCT03311841|Antithrombins|antithrombins|mesh-ancestor
110839317|NCT03311841|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110839318|NCT03311841|Protease Inhibitors|protease inhibitors|mesh-ancestor
110839319|NCT03311841|Anticoagulants|anticoagulants|mesh-ancestor
110839320|NCT03311841|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110839321|NCT03311841|Antitubercular Agents|antitubercular agents|mesh-ancestor
110839322|NCT03311841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110839323|NCT03311841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110839324|NCT03311841|Leprostatic Agents|leprostatic agents|mesh-ancestor
110839325|NCT03311841|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110889328|NCT03563144|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110839326|NCT03311841|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110839327|NCT03311841|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110839328|NCT03311841|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110839329|NCT03311841|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110839330|NCT03311841|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110839331|NCT03311841|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110839332|NCT01249937|Triamcinolone|triamcinolone|mesh-list
110839333|NCT01249937|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110839334|NCT01249937|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110839335|NCT01249937|Ranibizumab|ranibizumab|mesh-list
110839336|NCT01249937|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110185830|NCT00275639|Losartan|losartan|mesh-list
110839337|NCT01249937|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110839338|NCT01249937|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110839339|NCT01249937|Growth Substances|growth substances|mesh-ancestor
110839340|NCT01249937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110839341|NCT01249937|Growth Inhibitors|growth inhibitors|mesh-ancestor
110839342|NCT01249937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110570912|NCT00784420|Antiviral Agents|antiviral agents|mesh-ancestor
110839343|NCT01249937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110839344|NCT01249937|Glucocorticoids|glucocorticoids|mesh-ancestor
110839346|NCT01249937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110839347|NCT01249937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110839348|NCT01249937|Immunologic Factors|immunologic factors|mesh-ancestor
110839349|NCT01249937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110839350|NCT01249937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110839352|NCT02528201|Diclofenac|diclofenac|mesh-list
110839353|NCT02528201|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110839354|NCT02528201|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110839355|NCT02528201|Analgesics|analgesics|mesh-ancestor
110839356|NCT02528201|Sensory System Agents|sensory system agents|mesh-ancestor
110839357|NCT02528201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110839358|NCT02528201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110839359|NCT02528201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110839360|NCT02528201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110839361|NCT02528201|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110839362|NCT02528201|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110839363|NCT02528201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110839364|NCT02528201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110839365|NCT03758677|Gemcitabine|gemcitabine|mesh-list
110839366|NCT03758677|Docetaxel|docetaxel|mesh-list
110839367|NCT03758677|Pemetrexed|pemetrexed|mesh-list
110839368|NCT03758677|Apatinib|apatinib|mesh-list
110839369|NCT03758677|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110839370|NCT03758677|Antimetabolites|antimetabolites|mesh-ancestor
110839371|NCT03758677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110839372|NCT03758677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110839373|NCT03758677|Tubulin Modulators|tubulin modulators|mesh-ancestor
110839374|NCT03758677|Antimitotic Agents|antimitotic agents|mesh-ancestor
110839375|NCT03758677|Mitosis Modulators|mitosis modulators|mesh-ancestor
110839376|NCT03758677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110839377|NCT03758677|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110839378|NCT03758677|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110839379|NCT03758677|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110839380|NCT03764683|Suvorexant|suvorexant|mesh-list
110839381|NCT03764683|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110839382|NCT03764683|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110839383|NCT03764683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110839384|NCT03764683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110839385|NCT03764683|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
110839386|NCT03764683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110839387|NCT03764683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110839388|NCT03414892|Globalagliatin|globalagliatin|mesh-list
110839389|NCT03414892|Enzyme Activators|enzyme activators|mesh-ancestor
110839390|NCT03414892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110839391|NCT01242605|Gemcitabine|gemcitabine|mesh-list
110839392|NCT01242605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110839393|NCT01242605|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110839394|NCT01242605|Antimetabolites|antimetabolites|mesh-ancestor
110839395|NCT01242605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110839396|NCT03414814|Osimertinib|osimertinib|mesh-list
110839397|NCT03414814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110839398|NCT03414814|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110839399|NCT03414814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110839400|NCT03414814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110839401|NCT03421366|Posaconazole|posaconazole|mesh-list
110839402|NCT03421366|Antifungal Agents|antifungal agents|mesh-ancestor
110839403|NCT03421366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110839404|NCT03421366|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
110839405|NCT03421366|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110839406|NCT03421366|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110839407|NCT03421366|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110839408|NCT03421366|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110839409|NCT03421366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110839410|NCT03421366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110839411|NCT03421366|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110839412|NCT03421366|Hormone Antagonists|hormone antagonists|mesh-ancestor
110839413|NCT03421366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110839414|NCT03421366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110839415|NCT03764605|Metformin|metformin|mesh-list
110839416|NCT03764605|Tolvaptan|tolvaptan|mesh-list
110839417|NCT03764605|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110839418|NCT03764605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110839419|NCT03764605|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
110839420|NCT03764605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110839421|NCT03764605|Natriuretic Agents|natriuretic agents|mesh-ancestor
110839423|NCT03764527|Lumefantrine|lumefantrine|mesh-list
110839424|NCT03764527|Artemether|artemether|mesh-list
110839425|NCT03764527|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
110839426|NCT03764527|Amodiaquine|amodiaquine|mesh-list
110839427|NCT03764527|Antimalarials|antimalarials|mesh-ancestor
110505257|NCT03508232|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110505258|NCT03508232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110505259|NCT03508232|Antimalarials|antimalarials|mesh-ancestor
110505260|NCT03508232|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110505261|NCT03508232|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110505262|NCT00704223|Insulin Aspart|insulin aspart|mesh-list
110505263|NCT00704223|Biphasic Insulins|biphasic insulins|mesh-list
110505264|NCT00704223|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110505265|NCT00704223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110505266|NCT00704301|Rivastigmine|rivastigmine|mesh-list
110505267|NCT00704301|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110505268|NCT00704301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110505269|NCT00704301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110505270|NCT00704301|Cholinergic Agents|cholinergic agents|mesh-ancestor
110505534|NCT02841800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110505535|NCT02841800|GABA Modulators|gaba modulators|mesh-ancestor
110505536|NCT02841800|GABA Agents|gaba agents|mesh-ancestor
110505537|NCT02841800|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110505538|NCT02841800|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110505539|NCT02841800|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110505540|NCT02832336|Caffeine|caffeine|mesh-list
110505541|NCT02832336|Caffeine citrate|caffeine citrate|mesh-list
110505542|NCT02832336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110505543|NCT02832336|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110505544|NCT02832336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110505545|NCT02832336|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110505546|NCT02832336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110505547|NCT02832336|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110505548|NCT02832336|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110505549|NCT02832336|Purinergic Agents|purinergic agents|mesh-ancestor
110505550|NCT02832336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110505551|NCT00621751|Carbamazepine|carbamazepine|mesh-list
110505552|NCT00621751|Anticonvulsants|anticonvulsants|mesh-ancestor
110505553|NCT00621751|Antimanic Agents|antimanic agents|mesh-ancestor
110505554|NCT00621751|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110505555|NCT00621751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110505556|NCT00621751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110505557|NCT00621751|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110505558|NCT00621751|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110505559|NCT00621751|Analgesics|analgesics|mesh-ancestor
110505560|NCT00621751|Sensory System Agents|sensory system agents|mesh-ancestor
110505561|NCT00621751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110172553|NCT00052273|Capecitabine|capecitabine|mesh-list
110505772|NCT02844062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110505773|NCT02844062|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110505775|NCT02830230|Cefixime|cefixime|mesh-list
110505776|NCT02830230|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110505777|NCT02830230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110505966|NCT02829060|Nitrofurantoin|nitrofurantoin|mesh-list
110505967|NCT02829060|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110505968|NCT02829060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110505969|NCT02829060|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110505970|NCT02829060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110506118|NCT00832039|Micronutrients|micronutrients|mesh-ancestor
110506119|NCT00832039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110506120|NCT02826564|Pembrolizumab|pembrolizumab|mesh-list
110506121|NCT02826564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110506122|NCT02826564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110506123|NCT02826564|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110506124|NCT02826564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110506125|NCT02837978|Methotrexate|methotrexate|mesh-list
110506126|NCT02837978|Tacrolimus|tacrolimus|mesh-list
110506127|NCT02837978|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110506128|NCT02837978|Abortifacient Agents|abortifacient agents|mesh-ancestor
110506129|NCT02837978|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110506130|NCT02837978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110506131|NCT02837978|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110506196|NCT04244448|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110506197|NCT04244448|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110222095|NCT00304993|Niacin|niacin|mesh-list
110506198|NCT02547025|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110506199|NCT02547025|Amoxicillin|amoxicillin|mesh-list
110506200|NCT02547025|Clarithromycin|clarithromycin|mesh-list
110506201|NCT02547025|Levofloxacin|levofloxacin|mesh-list
110506202|NCT02547025|Ofloxacin|ofloxacin|mesh-list
110506203|NCT02547025|Tetracycline|tetracycline|mesh-list
110506204|NCT02547025|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
110506205|NCT02547025|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
110506206|NCT02547025|Rabeprazole|rabeprazole|mesh-list
110506207|NCT02547025|Bismuth|bismuth|mesh-list
110506208|NCT02547025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110506797|NCT00842491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110506798|NCT00842491|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110506934|NCT00964223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110506935|NCT00964223|Dermatologic Agents|dermatologic agents|mesh-ancestor
110506936|NCT00964223|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110506937|NCT00964223|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110506993|NCT04622904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110506994|NCT04622904|Sensory System Agents|sensory system agents|mesh-ancestor
110506995|NCT04622904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110506996|NCT04622904|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110506997|NCT04622904|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110506998|NCT04622904|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110506999|NCT04622904|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110507100|NCT04519476|Methylprednisolone|methylprednisolone|mesh-list
110507101|NCT04519476|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110507102|NCT04519476|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110507103|NCT04519476|Prednisolone|prednisolone|mesh-list
110507104|NCT04519476|Prednisolone acetate|prednisolone acetate|mesh-list
110507105|NCT04519476|Lenalidomide|lenalidomide|mesh-list
110507106|NCT04519476|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110507107|NCT04519476|Prednisolone phosphate|prednisolone phosphate|mesh-list
110507108|NCT04519476|Immunologic Factors|immunologic factors|mesh-ancestor
110507109|NCT04519476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110507110|NCT04519476|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110507111|NCT04519476|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110507112|NCT04519476|Growth Substances|growth substances|mesh-ancestor
110507113|NCT04519476|Growth Inhibitors|growth inhibitors|mesh-ancestor
110507184|NCT00851461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110507185|NCT04205136|Spironolactone|spironolactone|mesh-list
110507186|NCT04205136|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110507239|NCT00962741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110507240|NCT00962741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110507241|NCT00962741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110507242|NCT00962741|Immunologic Factors|immunologic factors|mesh-ancestor
110507244|NCT00851929|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110507245|NCT02813382|Bupivacaine|bupivacaine|mesh-list
110507246|NCT02813382|Prilocaine|prilocaine|mesh-list
110507247|NCT02813382|Chloroprocaine|chloroprocaine|mesh-list
110507248|NCT02813382|Procaine|procaine|mesh-list
110507249|NCT02813382|Anesthetics, Local|anesthetics, local|mesh-ancestor
110507250|NCT02813382|Anesthetics|anesthetics|mesh-ancestor
110507251|NCT02813382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110507252|NCT02813382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110507253|NCT02813382|Sensory System Agents|sensory system agents|mesh-ancestor
110507254|NCT02813382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110507255|NCT00619645|Cyclosporine|cyclosporine|mesh-list
110507256|NCT00619645|Mycophenolic Acid|mycophenolic acid|mesh-list
110507257|NCT00619645|Fludarabine|fludarabine|mesh-list
110507258|NCT00619645|Fludarabine phosphate|fludarabine phosphate|mesh-list
110507259|NCT00619645|Busulfan|busulfan|mesh-list
110507260|NCT00619645|Cyclosporins|cyclosporins|mesh-list
110507261|NCT00619645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110507262|NCT00619645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110507263|NCT00619645|Antimetabolites|antimetabolites|mesh-ancestor
110185900|NCT00041574|Antioxidants|antioxidants|mesh-ancestor
110507264|NCT00619645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110507265|NCT00619645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110507266|NCT00619645|Immunologic Factors|immunologic factors|mesh-ancestor
110507267|NCT00619645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110507268|NCT00619645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110507269|NCT00619645|Antifungal Agents|antifungal agents|mesh-ancestor
110507270|NCT00619645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110507271|NCT00619645|Dermatologic Agents|dermatologic agents|mesh-ancestor
110507272|NCT00619645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110507273|NCT00619645|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110507274|NCT00619645|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110507275|NCT00619645|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110507276|NCT00619645|Antitubercular Agents|antitubercular agents|mesh-ancestor
110507277|NCT00619645|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110507278|NCT00619645|Alkylating Agents|alkylating agents|mesh-ancestor
110507279|NCT00619645|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110507289|NCT00852163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110507290|NCT00852163|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110507291|NCT00852163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110507292|NCT00852163|Antimetabolites|antimetabolites|mesh-ancestor
110507293|NCT00855517|Latanoprost|latanoprost|mesh-list
110507294|NCT00855517|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110507295|NCT00855517|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110507297|NCT02544919|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
110507298|NCT02544919|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
110507299|NCT02544919|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110507300|NCT00818259|Dexamethasone|dexamethasone|mesh-list
110507301|NCT00818259|Ondansetron|ondansetron|mesh-list
110507302|NCT00818259|Aprepitant|aprepitant|mesh-list
110507303|NCT00818259|Fosaprepitant|fosaprepitant|mesh-list
110507304|NCT00818259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110507305|NCT00818259|Antiemetics|antiemetics|mesh-ancestor
110507306|NCT00818259|Autonomic Agents|autonomic agents|mesh-ancestor
110507307|NCT00818259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110507308|NCT00818259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110507309|NCT00818259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110507310|NCT00818259|Glucocorticoids|glucocorticoids|mesh-ancestor
110507311|NCT00818259|Hormones|hormones|mesh-ancestor
110507312|NCT00818259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110507313|NCT00818259|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110507314|NCT00818259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110507315|NCT00818259|Antipruritics|antipruritics|mesh-ancestor
110507316|NCT00818259|Dermatologic Agents|dermatologic agents|mesh-ancestor
110507317|NCT00818259|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110507318|NCT00818259|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110507319|NCT00818259|Serotonin Agents|serotonin agents|mesh-ancestor
110507320|NCT00818259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110507321|NCT00818259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110507322|NCT00818259|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110507323|NCT05578482|Mometasone Furoate|mometasone furoate|mesh-list
110507324|NCT05578482|Dicloxacillin|dicloxacillin|mesh-list
110507325|NCT05578482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110507326|NCT05578482|Dermatologic Agents|dermatologic agents|mesh-ancestor
110507327|NCT05578482|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110507328|NCT05578482|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110507329|NCT05578482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110507330|NCT02809404|Everolimus|everolimus|mesh-list
110507331|NCT02809404|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110507332|NCT02809404|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110507333|NCT02809404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110507334|NCT02809404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110507335|NCT02809404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110507336|NCT02809404|Immunologic Factors|immunologic factors|mesh-ancestor
110507337|NCT02809404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110507338|NCT02809404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110507339|NCT00619099|Decitabine|decitabine|mesh-list
110507340|NCT00619099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110507341|NCT00619099|Antimetabolites|antimetabolites|mesh-ancestor
110507342|NCT00619099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110507343|NCT00619099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110507344|NCT00619099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110507346|NCT02812992|Gemcitabine|gemcitabine|mesh-list
110507347|NCT02812992|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110507364|NCT02812602|Anesthetics, Local|anesthetics, local|mesh-ancestor
110311951|NCT00291785|Leucovorin|leucovorin|mesh-list
110507366|NCT02812602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110507367|NCT02812602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110507368|NCT02812602|Sensory System Agents|sensory system agents|mesh-ancestor
110507369|NCT02812602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110507370|NCT02812602|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110507371|NCT02812602|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110507372|NCT02812602|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110507373|NCT02812602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110507374|NCT02812602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110507375|NCT00837187|Dexmedetomidine|dexmedetomidine|mesh-list
110507376|NCT00837187|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110507377|NCT00837187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110507378|NCT00837187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110507379|NCT00837187|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110507381|NCT00837187|Sensory System Agents|sensory system agents|mesh-ancestor
110507382|NCT00837187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110507383|NCT00837187|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110507384|NCT00837187|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110507385|NCT00837187|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110507386|NCT00837187|Adrenergic Agents|adrenergic agents|mesh-ancestor
110507387|NCT00837187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110507388|NCT00837187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110507389|NCT00962585|Equol|equol|mesh-list
110507390|NCT00962585|Phytoestrogens|phytoestrogens|mesh-ancestor
110507391|NCT00962585|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
110507392|NCT00962585|Estrogens|estrogens|mesh-ancestor
110507393|NCT00962585|Hormones|hormones|mesh-ancestor
110507394|NCT00962585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110507395|NCT00962585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110507396|NCT00621985|Dexamethasone|dexamethasone|mesh-list
110507397|NCT00621985|Hydrocortisone|hydrocortisone|mesh-list
110507398|NCT00621985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110507399|NCT00621985|Antiemetics|antiemetics|mesh-ancestor
110507400|NCT00621985|Autonomic Agents|autonomic agents|mesh-ancestor
110507401|NCT00621985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110507402|NCT00621985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110507403|NCT00621985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110507413|NCT02812368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110507414|NCT02812368|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110507415|NCT02812368|Sympatholytics|sympatholytics|mesh-ancestor
110507416|NCT02812368|Autonomic Agents|autonomic agents|mesh-ancestor
110507417|NCT02812368|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110507418|NCT02812368|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110507419|NCT02812368|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110507420|NCT02812368|Adrenergic Agents|adrenergic agents|mesh-ancestor
110507421|NCT02812368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110507422|NCT02812368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110507423|NCT03312257|Atropine|atropine|mesh-list
110507424|NCT03312257|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110507425|NCT03312257|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110507426|NCT03312257|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110507427|NCT03312257|Autonomic Agents|autonomic agents|mesh-ancestor
110507428|NCT03312257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110154793|NCT00014209|Dexamethasone|dexamethasone|mesh-list
110507429|NCT03312257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110507430|NCT03312257|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110507431|NCT03312257|Respiratory System Agents|respiratory system agents|mesh-ancestor
110507432|NCT03312257|Mydriatics|mydriatics|mesh-ancestor
110507433|NCT03312257|Parasympatholytics|parasympatholytics|mesh-ancestor
110507434|NCT03312257|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110507435|NCT03312257|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110507436|NCT03312257|Cholinergic Agents|cholinergic agents|mesh-ancestor
110507437|NCT03312257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110311953|NCT00291785|Fluorouracil|fluorouracil|mesh-list
110507438|NCT03312257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110507439|NCT00856687|Montelukast|montelukast|mesh-list
110507440|NCT00856687|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110507441|NCT00856687|Respiratory System Agents|respiratory system agents|mesh-ancestor
110507442|NCT00856687|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110507443|NCT00856687|Hormone Antagonists|hormone antagonists|mesh-ancestor
110507444|NCT00856687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110507445|NCT00856687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110507446|NCT00856687|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110507447|NCT00856687|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110507448|NCT00856687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110507449|NCT02862665|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
110507450|NCT02862665|Hematinics|hematinics|mesh-ancestor
110507451|NCT02807922|Zopiclone|zopiclone|mesh-list
110185972|NCT00275015|Cytarabine|cytarabine|mesh-list
110507452|NCT02807922|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110507453|NCT02807922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110507454|NCT02807922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110507455|NCT00861367|Aspirin|aspirin|mesh-list
110507456|NCT00861367|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110507457|NCT00861367|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110507458|NCT00861367|Analgesics|analgesics|mesh-ancestor
110507459|NCT00861367|Sensory System Agents|sensory system agents|mesh-ancestor
110507460|NCT00861367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110507461|NCT00861367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110507462|NCT00861367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110507463|NCT00861367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110507464|NCT00861367|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110507465|NCT00861367|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110507466|NCT00861367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110507490|NCT00852709|Clofarabine|clofarabine|mesh-list
110507491|NCT00852709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110507492|NCT00852709|Immunologic Factors|immunologic factors|mesh-ancestor
110507493|NCT00852709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110507494|NCT00852709|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110507495|NCT00852709|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110507496|NCT00852709|Alkylating Agents|alkylating agents|mesh-ancestor
110507497|NCT00852709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110507498|NCT00852709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110507499|NCT00852709|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110507500|NCT00852709|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110154866|NCT00014404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110507501|NCT00852709|Antimetabolites|antimetabolites|mesh-ancestor
110507502|NCT00861523|Thiamine|thiamine|mesh-list
110507503|NCT00861523|Promethazine|promethazine|mesh-list
110507504|NCT00861523|Diphenhydramine|diphenhydramine|mesh-list
110507505|NCT00861523|Vitamin B Complex|vitamin b complex|mesh-ancestor
110507506|NCT00861523|Vitamins|vitamins|mesh-ancestor
110507507|NCT00861523|Micronutrients|micronutrients|mesh-ancestor
110507508|NCT00861523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110311954|NCT00291785|Levoleucovorin|levoleucovorin|mesh-list
110507509|NCT00861523|Antipruritics|antipruritics|mesh-ancestor
110507510|NCT00861523|Dermatologic Agents|dermatologic agents|mesh-ancestor
110507511|NCT00861523|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110507512|NCT00861523|Histamine Antagonists|histamine antagonists|mesh-ancestor
110507514|NCT00861523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110507515|NCT00861523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110507516|NCT00861523|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110507517|NCT00861523|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110507534|NCT02811978|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110507535|NCT02811978|Glucocorticoids|glucocorticoids|mesh-ancestor
110507536|NCT02811978|Hormones|hormones|mesh-ancestor
110507537|NCT02811978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110507538|NCT02811978|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110507539|NCT02811978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110507540|NCT00630149|Pemetrexed|pemetrexed|mesh-list
110507541|NCT00630149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110507542|NCT00630149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110507543|NCT00630149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110507544|NCT00630149|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110507545|NCT00630149|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110507546|NCT04204577|Apatinib|apatinib|mesh-list
110507547|NCT04204577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110507548|NCT04204577|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110507549|NCT04204577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110507550|NCT04204577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110507551|NCT00852787|Digoxin|digoxin|mesh-list
110507552|NCT00852787|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110507553|NCT00852787|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110507554|NCT00852787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110507555|NCT00852787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110507556|NCT00852787|Protective Agents|protective agents|mesh-ancestor
110507557|NCT00852787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110507558|NCT02545465|Riociguat|riociguat|mesh-list
110507559|NCT02545465|Enzyme Activators|enzyme activators|mesh-ancestor
110507560|NCT02545465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110507561|NCT00961259|Fenofibric acid|fenofibric acid|mesh-list
110507562|NCT00961259|Fenofibrate|fenofibrate|mesh-list
110507563|NCT00961259|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110507564|NCT00961259|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110507565|NCT00961259|Antimetabolites|antimetabolites|mesh-ancestor
110507566|NCT00961259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110507567|NCT00961259|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110507568|NCT04283747|Immunoglobulins|immunoglobulins|mesh-list
110507569|NCT04283747|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110507570|NCT04283747|Antibodies|antibodies|mesh-list
110507571|NCT04283747|Immunologic Factors|immunologic factors|mesh-ancestor
110507572|NCT04283747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110507573|NCT04111926|Dexmedetomidine|dexmedetomidine|mesh-list
110507574|NCT04111926|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110154940|NCT00005987|Interferons|interferons|mesh-list
110507575|NCT04111926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110507576|NCT04111926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110507577|NCT04111926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110507578|NCT04111926|Analgesics|analgesics|mesh-ancestor
110507589|NCT04041349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110507591|NCT00961181|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110507592|NCT00961181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110507593|NCT00961181|Tubulin Modulators|tubulin modulators|mesh-ancestor
110507594|NCT00961181|Antimitotic Agents|antimitotic agents|mesh-ancestor
110507595|NCT00961181|Mitosis Modulators|mitosis modulators|mesh-ancestor
110507596|NCT00961181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110507597|NCT02807610|Propofol|propofol|mesh-list
110507598|NCT02807610|Etomidate|etomidate|mesh-list
110507599|NCT02807610|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110507600|NCT02807610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110507601|NCT02807610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110507602|NCT02807610|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110507603|NCT02807610|Anesthetics, General|anesthetics, general|mesh-ancestor
110507605|NCT00857077|Pyrimethamine|pyrimethamine|mesh-list
110507606|NCT00857077|Sulfadoxine|sulfadoxine|mesh-list
110507607|NCT00857077|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
110507608|NCT00857077|Antimalarials|antimalarials|mesh-ancestor
110507609|NCT00857077|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110507610|NCT00857077|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110507611|NCT00857077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110507612|NCT00857077|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110507613|NCT00857077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110507614|NCT00857077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110507615|NCT00857077|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110507616|NCT00857155|Clopidogrel|clopidogrel|mesh-list
110507617|NCT00857155|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110507618|NCT00857155|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110507619|NCT00857155|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110507620|NCT00857155|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110507621|NCT00857155|Purinergic Agents|purinergic agents|mesh-ancestor
110507622|NCT00857155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110507623|NCT00857155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110507624|NCT00857155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110507625|NCT00817635|Eplerenone|eplerenone|mesh-list
110507626|NCT00817635|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110507627|NCT00817635|Hormone Antagonists|hormone antagonists|mesh-ancestor
110507628|NCT00817635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110507629|NCT00817635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110507630|NCT00817635|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110507631|NCT00817635|Diuretics|diuretics|mesh-ancestor
110507632|NCT00817635|Natriuretic Agents|natriuretic agents|mesh-ancestor
110507633|NCT00817635|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110507634|NCT00853177|Lidocaine|lidocaine|mesh-list
110507635|NCT00853177|Anesthetics, Local|anesthetics, local|mesh-ancestor
110507636|NCT00853177|Anesthetics|anesthetics|mesh-ancestor
110507637|NCT00853177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110507638|NCT00853177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110507639|NCT00853177|Sensory System Agents|sensory system agents|mesh-ancestor
110507640|NCT00853177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110507641|NCT00853177|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110175952|NCT00078442|Interferons|interferons|mesh-list
110507655|NCT00817479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110507657|NCT00817479|Autonomic Agents|autonomic agents|mesh-ancestor
110507658|NCT00817479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110507659|NCT00817479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110507660|NCT00817479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110507661|NCT00817479|Glucocorticoids|glucocorticoids|mesh-ancestor
110507663|NCT00817479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110507664|NCT00817479|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110507665|NCT00817479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110507666|NCT00853411|Prednisone|prednisone|mesh-list
110507667|NCT00853411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110507668|NCT00853411|Glucocorticoids|glucocorticoids|mesh-ancestor
110507669|NCT00853411|Hormones|hormones|mesh-ancestor
110507670|NCT00853411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110507671|NCT00853411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110507672|NCT00853411|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110507673|NCT00853411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110507674|NCT04030533|Ustekinumab|ustekinumab|mesh-list
110507675|NCT04030533|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110507676|NCT04030533|Dermatologic Agents|dermatologic agents|mesh-ancestor
110507677|NCT04030533|Immunologic Factors|immunologic factors|mesh-ancestor
110507678|NCT04030533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110507679|NCT02807298|Lidocaine|lidocaine|mesh-list
110507680|NCT02807298|Epinephrine|epinephrine|mesh-list
110507681|NCT02807298|Carticaine|carticaine|mesh-list
110507682|NCT02807298|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110507683|NCT02807298|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110507684|NCT02807298|Adrenergic Agents|adrenergic agents|mesh-ancestor
110507685|NCT02807298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110507686|NCT02807298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110507687|NCT02807298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110507688|NCT02807298|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110507689|NCT02807298|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110507690|NCT02807298|Autonomic Agents|autonomic agents|mesh-ancestor
110507691|NCT02807298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110507692|NCT02807298|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110507693|NCT02807298|Respiratory System Agents|respiratory system agents|mesh-ancestor
110507694|NCT02807298|Mydriatics|mydriatics|mesh-ancestor
110507695|NCT02807298|Sympathomimetics|sympathomimetics|mesh-ancestor
110507696|NCT02807298|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110507697|NCT02807298|Anesthetics, Local|anesthetics, local|mesh-ancestor
110507698|NCT02807298|Anesthetics|anesthetics|mesh-ancestor
110507699|NCT02807298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110507700|NCT02807298|Sensory System Agents|sensory system agents|mesh-ancestor
110507701|NCT02807298|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110507702|NCT02807298|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110507703|NCT02807298|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110507725|NCT00961961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110507726|NCT00961961|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110507728|NCT00961961|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110507729|NCT00961961|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110507730|NCT00961961|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110507731|NCT00961961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110507732|NCT00961961|Antimanic Agents|antimanic agents|mesh-ancestor
110507733|NCT00961961|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110507734|NCT00961961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110507735|NCT02610933|Vitamin K|vitamin k|mesh-list
110507736|NCT02610933|Vitamin K 2|vitamin k 2|mesh-list
110507737|NCT02610933|Rivaroxaban|rivaroxaban|mesh-list
110507738|NCT02610933|Vitamins|vitamins|mesh-ancestor
110507739|NCT02610933|Micronutrients|micronutrients|mesh-ancestor
110507740|NCT02610933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110507741|NCT02610933|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110507742|NCT02610933|Antithrombins|antithrombins|mesh-ancestor
110507743|NCT02610933|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110507744|NCT02610933|Protease Inhibitors|protease inhibitors|mesh-ancestor
110507745|NCT02610933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110507746|NCT02610933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110507747|NCT02610933|Anticoagulants|anticoagulants|mesh-ancestor
110507748|NCT02610933|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110507749|NCT02610933|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110507750|NCT02610933|Hemostatics|hemostatics|mesh-ancestor
110507751|NCT02610933|Coagulants|coagulants|mesh-ancestor
110507752|NCT04042441|Insulin|insulin|mesh-list
110507753|NCT04042441|Insulin Aspart|insulin aspart|mesh-list
110507754|NCT04042441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110507755|NCT04042441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110507756|NCT00817089|Naltrexone|naltrexone|mesh-list
110507757|NCT00817089|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110889464|NCT02821910|Metformin|metformin|mesh-list
110507758|NCT00817089|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110175976|NCT00078793|Analgesics|analgesics|mesh-ancestor
110507775|NCT05758389|Tubulin Modulators|tubulin modulators|mesh-ancestor
110507776|NCT05758389|Antimitotic Agents|antimitotic agents|mesh-ancestor
110507777|NCT05758389|Mitosis Modulators|mitosis modulators|mesh-ancestor
110507778|NCT05758389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110507779|NCT05758389|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110507780|NCT00857935|Permethrin|permethrin|mesh-list
110507781|NCT00857935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110507782|NCT00857935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110507783|NCT00853879|Vitamins|vitamins|mesh-list
110507784|NCT00853879|Folic Acid|folic acid|mesh-list
110507785|NCT00853879|Hydroxocobalamin|hydroxocobalamin|mesh-list
110507786|NCT00853879|Vitamin B 12|vitamin b 12|mesh-list
110507787|NCT00853879|Vitamin B 6|vitamin b 6|mesh-list
110507788|NCT00853879|Pyridoxal|pyridoxal|mesh-list
110507789|NCT00853879|Pyridoxine|pyridoxine|mesh-list
110507790|NCT00853879|Vitamin B Complex|vitamin b complex|mesh-list
110507791|NCT00853879|Micronutrients|micronutrients|mesh-ancestor
110507792|NCT00853879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110507793|NCT00853879|Hematinics|hematinics|mesh-ancestor
110507794|NCT00815919|Prednisone|prednisone|mesh-list
110507795|NCT00815919|Bortezomib|bortezomib|mesh-list
110507796|NCT00815919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110507797|NCT00815919|Glucocorticoids|glucocorticoids|mesh-ancestor
110507798|NCT00815919|Hormones|hormones|mesh-ancestor
110507799|NCT00815919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110507800|NCT00815919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110507801|NCT00815919|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110507802|NCT00815919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110507803|NCT02545153|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
110507804|NCT02545153|Aprotinin|aprotinin|mesh-list
110507805|NCT02545153|Hemostatics|hemostatics|mesh-ancestor
110507807|NCT02545153|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
110507808|NCT02545153|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110507809|NCT02545153|Protease Inhibitors|protease inhibitors|mesh-ancestor
110507810|NCT02545153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110507811|NCT02545153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110507812|NCT00913653|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
110507813|NCT00913653|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110507814|NCT00913653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110507815|NCT00854035|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110507816|NCT00854035|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110507817|NCT00854035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110507818|NCT00854035|Incretins|incretins|mesh-ancestor
110507819|NCT00854035|Hormones|hormones|mesh-ancestor
110175993|NCT00078832|Hormone Antagonists|hormone antagonists|mesh-ancestor
110507835|NCT00957905|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110507836|NCT00957905|Antimetabolites|antimetabolites|mesh-ancestor
110507837|NCT00957905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110507838|NCT00957905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110507839|NCT00957905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110507840|NCT00957905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110507841|NCT00957905|Immunologic Factors|immunologic factors|mesh-ancestor
110507843|NCT00957905|Protective Agents|protective agents|mesh-ancestor
110507844|NCT00957905|Vitamin B Complex|vitamin b complex|mesh-ancestor
110507845|NCT00957905|Vitamins|vitamins|mesh-ancestor
110507846|NCT00957905|Micronutrients|micronutrients|mesh-ancestor
110507847|NCT00957905|Hematinics|hematinics|mesh-ancestor
110507848|NCT00957905|Growth Inhibitors|growth inhibitors|mesh-ancestor
110507849|NCT00957905|Growth Substances|growth substances|mesh-ancestor
110507850|NCT00957905|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110507851|NCT00957905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110507852|NCT02804646|Carboplatin|carboplatin|mesh-list
110507853|NCT02804646|Pemetrexed|pemetrexed|mesh-list
110507854|NCT02804646|Endostatins|endostatins|mesh-list
110507855|NCT02804646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110507856|NCT02804646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110507857|NCT02804646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110507858|NCT02804646|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110507859|NCT02804646|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110507860|NCT02804646|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110507861|NCT02804646|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110507862|NCT02804646|Growth Substances|growth substances|mesh-ancestor
110507863|NCT02804646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110507864|NCT02804646|Growth Inhibitors|growth inhibitors|mesh-ancestor
110507865|NCT02858297|Triamcinolone|triamcinolone|mesh-list
110507866|NCT02858297|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110507867|NCT02858297|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110507868|NCT02858297|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110507869|NCT02858297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110507870|NCT02858297|Glucocorticoids|glucocorticoids|mesh-ancestor
110507871|NCT02858297|Hormones|hormones|mesh-ancestor
110507872|NCT02858297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110186124|NCT00129506|Antimetabolites|antimetabolites|mesh-ancestor
110507873|NCT02858297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110507874|NCT02858297|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110507875|NCT02858297|Immunologic Factors|immunologic factors|mesh-ancestor
110507876|NCT02858297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110507877|NCT02858297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110507878|NCT00858325|Daptomycin|daptomycin|mesh-list
110507879|NCT00858325|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110507880|NCT00858325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110507881|NCT02804490|Vitamin A|vitamin a|mesh-list
110507913|NCT00617929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110507914|NCT00617929|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110507915|NCT00617929|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110507916|NCT00617929|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110507917|NCT00617929|Antimetabolites|antimetabolites|mesh-ancestor
110507918|NCT00617929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110507919|NCT00862381|Hydrocortisone|hydrocortisone|mesh-list
110507920|NCT00862381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110507921|NCT02800590|Abp-700|abp-700|mesh-list
110507922|NCT02800590|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
110507923|NCT02800590|GABA Agonists|gaba agonists|mesh-ancestor
110507924|NCT02800590|GABA Agents|gaba agents|mesh-ancestor
110507925|NCT02800590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110507926|NCT02800590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110507927|NCT02800590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110507928|NCT00815295|Cetuximab|cetuximab|mesh-list
110507929|NCT00815295|Sorafenib|sorafenib|mesh-list
110507948|NCT02806752|Growth Substances|growth substances|mesh-ancestor
110507949|NCT02806752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110507950|NCT02806752|Growth Inhibitors|growth inhibitors|mesh-ancestor
110507951|NCT02806752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110507952|NCT02806752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110507953|NCT02806752|Glucocorticoids|glucocorticoids|mesh-ancestor
110155314|NCT00006023|Antimetabolites|antimetabolites|mesh-ancestor
110507954|NCT02806752|Hormones|hormones|mesh-ancestor
110311960|NCT00291785|Immunologic Factors|immunologic factors|mesh-ancestor
110507968|NCT02544529|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110507969|NCT02544529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110186152|NCT00129155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110507970|NCT02544529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110507971|NCT02544529|Cholinergic Agents|cholinergic agents|mesh-ancestor
110507972|NCT02544529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110507973|NCT02544529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110507975|NCT02544529|Autonomic Agents|autonomic agents|mesh-ancestor
110507976|NCT02544529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110507977|NCT02544529|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110507978|NCT02806596|Sevoflurane|sevoflurane|mesh-list
110507979|NCT02806596|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110507980|NCT02806596|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110507981|NCT02806596|Anesthetics, General|anesthetics, general|mesh-ancestor
110507982|NCT02806596|Anesthetics|anesthetics|mesh-ancestor
110507983|NCT02806596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110507984|NCT02806596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110507998|NCT00854503|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110507999|NCT00854503|Simvastatin|simvastatin|mesh-list
110508000|NCT00854503|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110508001|NCT00854503|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110508002|NCT00854503|Antimetabolites|antimetabolites|mesh-ancestor
110508003|NCT00854503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110508004|NCT00854503|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110508005|NCT00854503|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110508006|NCT00854503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110508007|NCT00858715|Aspirin|aspirin|mesh-list
110508008|NCT00858715|Clopidogrel|clopidogrel|mesh-list
110508009|NCT00858715|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110508010|NCT00858715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110176056|NCT00079105|Bleomycin|bleomycin|mesh-list
110508031|NCT02806284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110508033|NCT00960869|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110508034|NCT00960869|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110508035|NCT00960869|Analgesics|analgesics|mesh-ancestor
110508036|NCT00960869|Sensory System Agents|sensory system agents|mesh-ancestor
110508037|NCT00960869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110508038|NCT00960869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110508039|NCT00960869|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110508040|NCT00960869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110508041|NCT00960869|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110508042|NCT00960869|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110508043|NCT00960869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110508044|NCT00960869|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110508045|NCT00960869|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110508046|NCT00960869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110508047|NCT00960869|Antipyretics|antipyretics|mesh-ancestor
110508048|NCT02799888|Cyclosporine|cyclosporine|mesh-list
110508049|NCT02799888|Maraviroc|maraviroc|mesh-list
110508050|NCT02799888|Methotrexate|methotrexate|mesh-list
110508051|NCT02799888|Tacrolimus|tacrolimus|mesh-list
110508052|NCT02799888|Cyclosporins|cyclosporins|mesh-list
110508053|NCT02799888|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110508054|NCT02799888|Abortifacient Agents|abortifacient agents|mesh-ancestor
110508055|NCT02799888|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110508056|NCT02799888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110508057|NCT02799888|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110508058|NCT02799888|Antimetabolites|antimetabolites|mesh-ancestor
110508059|NCT02799888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110508060|NCT02799888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110508061|NCT02799888|Dermatologic Agents|dermatologic agents|mesh-ancestor
110176078|NCT00079105|Hormones|hormones|mesh-ancestor
110508074|NCT02799888|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110508075|NCT02799888|Antiviral Agents|antiviral agents|mesh-ancestor
110508076|NCT02799888|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
110508077|NCT00859105|Imiquimod|imiquimod|mesh-list
110508078|NCT00859105|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110508079|NCT00859105|Immunologic Factors|immunologic factors|mesh-ancestor
110508080|NCT00859105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110508081|NCT00859105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110508082|NCT00859105|Interferon Inducers|interferon inducers|mesh-ancestor
110508083|NCT00859183|Sirolimus|sirolimus|mesh-list
110508084|NCT00859183|Temsirolimus|temsirolimus|mesh-list
110508085|NCT00859183|MTOR Inhibitors|mtor inhibitors|mesh-list
110508086|NCT00859183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110508087|NCT00859183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110508088|NCT00859183|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110508089|NCT00859183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110508090|NCT00859183|Antifungal Agents|antifungal agents|mesh-ancestor
110508091|NCT00859183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110508092|NCT00859183|Immunologic Factors|immunologic factors|mesh-ancestor
110508093|NCT00859183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110508094|NCT00859183|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110508095|NCT00859183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110508096|NCT00859183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110508097|NCT02803944|Azithromycin|azithromycin|mesh-list
110508098|NCT02803944|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110508099|NCT02803944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110508100|NCT05980260|Analgesics, Opioid|analgesics, opioid|mesh-list
110508101|NCT05980260|Narcotics|narcotics|mesh-ancestor
110508102|NCT05980260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110508103|NCT05980260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110155466|NCT00001482|Anticonvulsants|anticonvulsants|mesh-ancestor
110508104|NCT05980260|Analgesics|analgesics|mesh-ancestor
110508105|NCT05980260|Sensory System Agents|sensory system agents|mesh-ancestor
110508106|NCT05980260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110508107|NCT05980156|Hydroxychloroquine|hydroxychloroquine|mesh-list
110508108|NCT05980156|Chloroquine|chloroquine|mesh-list
110508109|NCT05980156|Pyrimethamine|pyrimethamine|mesh-list
110508110|NCT05980156|Piperaquine|piperaquine|mesh-list
110508111|NCT05980156|Sulfadoxine|sulfadoxine|mesh-list
110508112|NCT05980156|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
110508113|NCT05980156|Artenimol|artenimol|mesh-list
110508114|NCT05980156|Antimalarials|antimalarials|mesh-ancestor
110508115|NCT05980156|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110508116|NCT05980156|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110508117|NCT05980156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110508118|NCT05980156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110508119|NCT05980156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110508120|NCT05980156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110508121|NCT05980156|Amebicides|amebicides|mesh-ancestor
110508122|NCT05980156|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110508123|NCT05980156|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110508124|NCT05980000|Pembrolizumab|pembrolizumab|mesh-list
110508125|NCT05980000|Ramucirumab|ramucirumab|mesh-list
110508126|NCT05980000|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110508149|NCT05979818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110508150|NCT05979818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110508152|NCT05979818|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110508153|NCT05979818|Vasodilator Agents|vasodilator agents|mesh-ancestor
110508154|NCT05979636|Fluorides|fluorides|mesh-list
110508155|NCT05979636|Cariostatic Agents|cariostatic agents|mesh-ancestor
110508156|NCT05979636|Protective Agents|protective agents|mesh-ancestor
110508157|NCT05979636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110508158|NCT05979558|Dexmedetomidine|dexmedetomidine|mesh-list
110508159|NCT05979558|Ropivacaine|ropivacaine|mesh-list
110508160|NCT05979558|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110508161|NCT05979558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110508162|NCT05979558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110508163|NCT05979558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110508164|NCT05979558|Analgesics|analgesics|mesh-ancestor
110508165|NCT05979558|Sensory System Agents|sensory system agents|mesh-ancestor
110508166|NCT05979558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110508167|NCT05979558|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110508168|NCT05979558|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110508169|NCT05979558|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110508170|NCT05979558|Adrenergic Agents|adrenergic agents|mesh-ancestor
110508171|NCT05979558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110508172|NCT05979558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110508173|NCT05979558|Anesthetics, Local|anesthetics, local|mesh-ancestor
110508174|NCT05979558|Anesthetics|anesthetics|mesh-ancestor
110508201|NCT05979298|Antimetabolites|antimetabolites|mesh-ancestor
110508202|NCT05979298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110508203|NCT05979298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110508204|NCT05979220|Letrozole|letrozole|mesh-list
110508205|NCT05979220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110508206|NCT05979220|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110508207|NCT05979220|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110508208|NCT05979220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110508209|NCT05979220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110508210|NCT05979220|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110508211|NCT05979220|Hormone Antagonists|hormone antagonists|mesh-ancestor
110508212|NCT05979220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110508213|NCT05979220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110508214|NCT05978726|Aspirin|aspirin|mesh-list
110508215|NCT05978726|Clopidogrel|clopidogrel|mesh-list
110508216|NCT05978726|Ticagrelor|ticagrelor|mesh-list
110508217|NCT05978726|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110508218|NCT05978726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110508219|NCT05978726|Analgesics|analgesics|mesh-ancestor
110508220|NCT05978726|Sensory System Agents|sensory system agents|mesh-ancestor
110508221|NCT05978726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110508222|NCT05978726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110508223|NCT05978726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110508224|NCT05978726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110508225|NCT05978726|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110508226|NCT05978726|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110508227|NCT05978726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110508228|NCT05978726|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110508229|NCT05978726|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110508230|NCT05978726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110508231|NCT05978726|Antipyretics|antipyretics|mesh-ancestor
110508232|NCT05978726|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110508233|NCT05978726|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110508234|NCT05978726|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110508235|NCT05978726|Purinergic Agents|purinergic agents|mesh-ancestor
110508239|NCT05978713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110508240|NCT05978713|Incretins|incretins|mesh-ancestor
110508241|NCT05978713|Hormones|hormones|mesh-ancestor
110508242|NCT05978713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110508243|NCT05978687|Lidocaine|lidocaine|mesh-list
110508244|NCT05978687|Epinephrine|epinephrine|mesh-list
110508245|NCT05978687|Anesthetics, Local|anesthetics, local|mesh-ancestor
110508246|NCT05978687|Anesthetics|anesthetics|mesh-ancestor
110508247|NCT05978687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110508248|NCT05978687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110508249|NCT05978687|Sensory System Agents|sensory system agents|mesh-ancestor
110508250|NCT05978687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110508251|NCT05978687|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110508252|NCT05978687|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110508253|NCT05978687|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110508254|NCT05978687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110508255|NCT05978687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110508256|NCT05978687|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110508257|NCT05978687|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110508258|NCT05978687|Adrenergic Agents|adrenergic agents|mesh-ancestor
110508259|NCT05978687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110508260|NCT05978687|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110508261|NCT05978687|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110508262|NCT05978687|Autonomic Agents|autonomic agents|mesh-ancestor
110508263|NCT05978687|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110508264|NCT05978687|Respiratory System Agents|respiratory system agents|mesh-ancestor
110508265|NCT05978687|Mydriatics|mydriatics|mesh-ancestor
110508266|NCT05978687|Sympathomimetics|sympathomimetics|mesh-ancestor
110508267|NCT05978687|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110508268|NCT05978648|Paclitaxel|paclitaxel|mesh-list
110508269|NCT05978648|Docetaxel|docetaxel|mesh-list
110508270|NCT05978648|Cyclophosphamide|cyclophosphamide|mesh-list
110508271|NCT05978648|Carboplatin|carboplatin|mesh-list
110508272|NCT05978648|Trastuzumab|trastuzumab|mesh-list
110508273|NCT05978648|Epirubicin|epirubicin|mesh-list
110508274|NCT05978648|Pertuzumab|pertuzumab|mesh-list
110508275|NCT05978648|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110508276|NCT05978648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110508277|NCT05978648|Tubulin Modulators|tubulin modulators|mesh-ancestor
110508278|NCT05978648|Antimitotic Agents|antimitotic agents|mesh-ancestor
110508279|NCT05978648|Mitosis Modulators|mitosis modulators|mesh-ancestor
110508280|NCT05978648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110508281|NCT05978648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110508282|NCT05978648|Immunologic Factors|immunologic factors|mesh-ancestor
110508283|NCT05978648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110508284|NCT05978648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110508285|NCT05978648|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110508286|NCT05978648|Alkylating Agents|alkylating agents|mesh-ancestor
110508287|NCT05978648|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110508288|NCT05978648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110508289|NCT05978648|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110508290|NCT05978648|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110508291|NCT05978648|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110508292|NCT05978648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110508293|NCT05978609|Gemcitabine|gemcitabine|mesh-list
110508294|NCT05978609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110508295|NCT05978609|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110508296|NCT05978609|Antimetabolites|antimetabolites|mesh-ancestor
110508297|NCT05978609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110508298|NCT05978505|Reboxetine|reboxetine|mesh-list
110508299|NCT05978505|Antidepressive Agents|antidepressive agents|mesh-ancestor
110508300|NCT05978505|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110508301|NCT05978505|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110508302|NCT05978505|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110508303|NCT05978505|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110508304|NCT05978505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110508305|NCT05978505|Adrenergic Agents|adrenergic agents|mesh-ancestor
110508306|NCT05978505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110508307|NCT05978505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110508308|NCT05978401|Paclitaxel|paclitaxel|mesh-list
110508329|NCT05978193|Immunomodulating Agents|immunomodulating agents|mesh-list
110508330|NCT05978193|Immunologic Factors|immunologic factors|mesh-ancestor
110508331|NCT05978193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110508332|NCT05978167|Methylphenidate|methylphenidate|mesh-list
110508333|NCT05978167|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110508334|NCT05978167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110508335|NCT05978167|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110508336|NCT05978167|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110508337|NCT05978167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110508338|NCT05978167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110186301|NCT00038532|Ritonavir|ritonavir|mesh-list
110508339|NCT05978167|Dopamine Agents|dopamine agents|mesh-ancestor
110889548|NCT02036060|Hormones|hormones|mesh-ancestor
110508340|NCT05978167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110508341|NCT05978102|Pembrolizumab|pembrolizumab|mesh-list
110508342|NCT05978102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110508343|NCT05978102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110508344|NCT05978102|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110508345|NCT05978102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110508346|NCT05978050|Paclitaxel|paclitaxel|mesh-list
110508347|NCT05978050|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110508348|NCT05978050|Nimotuzumab|nimotuzumab|mesh-list
110508349|NCT05978050|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110508350|NCT05978050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110508351|NCT05978050|Tubulin Modulators|tubulin modulators|mesh-ancestor
110508352|NCT05978050|Antimitotic Agents|antimitotic agents|mesh-ancestor
110508353|NCT05978050|Mitosis Modulators|mitosis modulators|mesh-ancestor
110508354|NCT05978050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110508355|NCT05978050|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110508356|NCT05977920|Caffeine|caffeine|mesh-list
110508357|NCT05977920|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110508358|NCT05977920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110508359|NCT05977920|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110508360|NCT05977920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110508361|NCT05977920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110508362|NCT05977920|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110176157|NCT00079300|Imiquimod|imiquimod|mesh-list
110508392|NCT05977868|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
110508394|NCT05977868|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
110508395|NCT05977868|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
110508396|NCT05977868|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
110508398|NCT05977868|Sulbactam|sulbactam|mesh-list
110508399|NCT05977868|Dalbavancin|dalbavancin|mesh-list
110508400|NCT05977868|Oritavancin|oritavancin|mesh-list
110508401|NCT05977868|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
110508402|NCT05977868|Oxacillin|oxacillin|mesh-list
110508403|NCT05977868|Cefadroxil|cefadroxil|mesh-list
110508404|NCT05977868|Cefpodoxime|cefpodoxime|mesh-list
110508405|NCT05977868|Sultamicillin|sultamicillin|mesh-list
110155767|NCT04734067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110508406|NCT05977868|Trimethoprim|trimethoprim|mesh-list
110508407|NCT05977868|Sulfamethoxazole|sulfamethoxazole|mesh-list
110508408|NCT05977868|Delafloxacin|delafloxacin|mesh-list
110508409|NCT05977868|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110508410|NCT05977868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110508411|NCT05977868|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110508412|NCT05977868|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110508413|NCT05977868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110508414|NCT05977868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110508415|NCT05977868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110508416|NCT05977868|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110508417|NCT05977868|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110508418|NCT05977868|Antimalarials|antimalarials|mesh-ancestor
110176169|NCT00079378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110508428|NCT05977868|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110508429|NCT05977868|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110508430|NCT05977868|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110508431|NCT05977868|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110508432|NCT05977868|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110508433|NCT05977868|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110508434|NCT05977868|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110508435|NCT05977868|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110508436|NCT05977868|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
110508437|NCT05975307|Carboplatin|carboplatin|mesh-list
110508438|NCT05975307|Gemcitabine|gemcitabine|mesh-list
110508439|NCT05975307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110508440|NCT05975307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110508441|NCT05975307|Antimetabolites|antimetabolites|mesh-ancestor
110508442|NCT05975307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110508443|NCT05974241|Aripiprazole|aripiprazole|mesh-list
110508444|NCT05974241|Methylphenidate|methylphenidate|mesh-list
110508445|NCT05974241|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110508446|NCT05974241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110508447|NCT05974241|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110508448|NCT05974241|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110508449|NCT05974241|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110508450|NCT05974241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110508451|NCT05974241|Dopamine Agents|dopamine agents|mesh-ancestor
110508452|NCT05974241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110508453|NCT05974241|Antidepressive Agents|antidepressive agents|mesh-ancestor
110508454|NCT05974241|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110508455|NCT05974241|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110508456|NCT05974241|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110508457|NCT05974241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110508458|NCT05974241|Dopamine Agonists|dopamine agonists|mesh-ancestor
110508459|NCT05974241|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110508460|NCT05974241|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110508461|NCT05974241|Serotonin Agents|serotonin agents|mesh-ancestor
110508462|NCT05974241|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110508463|NCT05974241|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110508464|NCT05974241|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110508465|NCT05974241|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110508467|NCT05969587|Hydroquinone|hydroquinone|mesh-list
110508468|NCT05969587|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
110508469|NCT05969587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110508470|NCT05969587|Antioxidants|antioxidants|mesh-ancestor
110508471|NCT05969587|Protective Agents|protective agents|mesh-ancestor
110508472|NCT05969587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110508473|NCT05969587|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110508474|NCT05964868|Epinephrine|epinephrine|mesh-list
110508475|NCT05964868|Bupivacaine|bupivacaine|mesh-list
110508476|NCT05964868|Anesthetics, Local|anesthetics, local|mesh-ancestor
110508477|NCT05964868|Anesthetics|anesthetics|mesh-ancestor
110508478|NCT05964868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110508479|NCT05964868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110508480|NCT05964868|Sensory System Agents|sensory system agents|mesh-ancestor
110508481|NCT05964868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110508506|NCT05948579|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110508507|NCT05948553|Fluoxetine|fluoxetine|mesh-list
110508508|NCT05948553|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110508509|NCT05948553|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110508510|NCT05948553|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110508511|NCT05948553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110508512|NCT05948553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110508513|NCT05948553|Serotonin Agents|serotonin agents|mesh-ancestor
110508514|NCT05948553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110508515|NCT05948553|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110508516|NCT05948553|Antidepressive Agents|antidepressive agents|mesh-ancestor
110508517|NCT05948553|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110508518|NCT05948553|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110508519|NCT05948553|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110508520|NCT05948553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110508521|NCT05929898|Dopamine|dopamine|mesh-list
110508522|NCT05929898|Dopamine Agonists|dopamine agonists|mesh-list
110508523|NCT05929898|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110508524|NCT05929898|Sympathomimetics|sympathomimetics|mesh-ancestor
110508525|NCT05929898|Autonomic Agents|autonomic agents|mesh-ancestor
110508526|NCT05929898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110508527|NCT05929898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110508528|NCT05929898|Dopamine Agents|dopamine agents|mesh-ancestor
110508529|NCT05929898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110508589|NCT05750992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110508590|NCT05750992|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110508591|NCT05750992|Narcotics|narcotics|mesh-ancestor
110508592|NCT05750992|Analgesics|analgesics|mesh-ancestor
110508593|NCT05750992|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110508594|NCT05750992|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110508595|NCT05750992|Anesthetics, General|anesthetics, general|mesh-ancestor
110508596|NCT05748483|Topiramate|topiramate|mesh-list
110508597|NCT05748483|Anticonvulsants|anticonvulsants|mesh-ancestor
110508598|NCT05748483|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110508599|NCT05748483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110508600|NCT05698524|Temozolomide|temozolomide|mesh-list
110508601|NCT05698524|Abexinostat|abexinostat|mesh-list
110508602|NCT05698524|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110508603|NCT05698524|Alkylating Agents|alkylating agents|mesh-ancestor
110508604|NCT05698524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110508605|NCT05698524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110508606|NCT05698524|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110508607|NCT05698524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110508608|NCT05660941|Insulin Lispro|insulin lispro|mesh-list
110508609|NCT05660941|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110508610|NCT05660941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110508611|NCT05602636|Midazolam|midazolam|mesh-list
110508612|NCT05602636|Bupivacaine|bupivacaine|mesh-list
110508613|NCT05602636|Anesthetics, Local|anesthetics, local|mesh-ancestor
110508614|NCT05602636|Anesthetics|anesthetics|mesh-ancestor
110508615|NCT05602636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110508616|NCT05602636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110508617|NCT05602636|Sensory System Agents|sensory system agents|mesh-ancestor
110508618|NCT05602636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110508619|NCT05602636|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110508620|NCT05602636|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110508621|NCT05602636|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110508622|NCT05602636|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110508623|NCT05602636|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110508624|NCT05602636|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110508625|NCT05602636|Anesthetics, General|anesthetics, general|mesh-ancestor
110508627|NCT05602636|GABA Agents|gaba agents|mesh-ancestor
110508628|NCT05602636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110508629|NCT05602636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110508630|NCT05602519|Fentanyl|fentanyl|mesh-list
110508631|NCT05602519|Propofol|propofol|mesh-list
110508632|NCT05602519|Rocuronium|rocuronium|mesh-list
110508634|NCT05602519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110508635|NCT05602519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110508636|NCT05602519|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110508637|NCT05602519|Anesthetics, General|anesthetics, general|mesh-ancestor
110508638|NCT05602519|Anesthetics|anesthetics|mesh-ancestor
110508675|NCT05487885|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110508676|NCT05487885|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110508677|NCT05487885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110508678|NCT05487885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110508682|NCT05465330|Propofol|propofol|mesh-list
110508683|NCT05465330|Desflurane|desflurane|mesh-list
110508684|NCT05465330|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110508685|NCT05465330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110508686|NCT05465330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110508687|NCT05465330|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110508688|NCT05465330|Anesthetics, General|anesthetics, general|mesh-ancestor
110508690|NCT05465330|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110508691|NCT05458856|Triptorelin Pamoate|triptorelin pamoate|mesh-list
110508692|NCT05458856|Luteolytic Agents|luteolytic agents|mesh-ancestor
110508693|NCT05458856|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110508694|NCT05458856|Contraceptive Agents|contraceptive agents|mesh-ancestor
110508695|NCT05458856|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110508696|NCT05458856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110508697|NCT05458856|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110508698|NCT05458856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110508699|NCT05458856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110508700|NCT05445609|Nivolumab|nivolumab|mesh-list
110508701|NCT05445609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110508702|NCT05445609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110508703|NCT05445609|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110186464|NCT05697783|Methadone|methadone|mesh-list
110508704|NCT05445609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110508705|NCT05442060|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110508706|NCT05442060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110508707|NCT05442060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110508708|NCT05442060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110508709|NCT05442060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110508710|NCT05406388|Fentanyl|fentanyl|mesh-list
110508711|NCT05406388|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110508712|NCT05406388|Narcotics|narcotics|mesh-ancestor
110508713|NCT05406388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110508743|NCT05230810|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110508744|NCT05230810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110508745|NCT05230810|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110508747|NCT05230810|Hormone Antagonists|hormone antagonists|mesh-ancestor
110508748|NCT05230810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110508749|NCT05230810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110508750|NCT05230810|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110508751|NCT05230810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110508752|NCT05230810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110508753|NCT05204927|Prednisone|prednisone|mesh-list
110508754|NCT05204927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110508755|NCT05204927|Glucocorticoids|glucocorticoids|mesh-ancestor
110508756|NCT05204927|Hormones|hormones|mesh-ancestor
110508757|NCT05204927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110508758|NCT05204927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110176355|NCT00393003|Anesthetics|anesthetics|mesh-list
110508769|NCT05183126|Antimitotic Agents|antimitotic agents|mesh-ancestor
110508770|NCT05183126|Mitosis Modulators|mitosis modulators|mesh-ancestor
110508771|NCT05183126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110508772|NCT05173831|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
110508773|NCT05173831|Hallucinogens|hallucinogens|mesh-ancestor
110508774|NCT05173831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110508775|NCT05173831|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110508776|NCT05173831|Serotonin Agents|serotonin agents|mesh-ancestor
110508777|NCT05173831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110508778|NCT05173831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110508779|NCT05173831|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110508780|NCT05173831|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110508781|NCT05173831|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110508782|NCT05173831|Adrenergic Agents|adrenergic agents|mesh-ancestor
110508784|NCT05168657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110508785|NCT05135910|Terbinafine|terbinafine|mesh-list
110508786|NCT05135910|Antifungal Agents|antifungal agents|mesh-ancestor
110889589|NCT01854385|Sumatriptan|sumatriptan|mesh-list
110508787|NCT05135910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110508788|NCT05135910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110508789|NCT05135910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110508790|NCT05105035|Meropenem|meropenem|mesh-list
110508791|NCT05105035|Ceftazidime|ceftazidime|mesh-list
110508792|NCT05105035|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110508793|NCT05105035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110508794|NCT05074121|Acetylcysteine|acetylcysteine|mesh-list
110508795|NCT05074121|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110508796|NCT05074121|Antiviral Agents|antiviral agents|mesh-ancestor
110508797|NCT05074121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110508798|NCT05074121|Expectorants|expectorants|mesh-ancestor
110508799|NCT05074121|Respiratory System Agents|respiratory system agents|mesh-ancestor
110508800|NCT05074121|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110508801|NCT05074121|Antioxidants|antioxidants|mesh-ancestor
110508802|NCT05074121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110508803|NCT05074121|Protective Agents|protective agents|mesh-ancestor
110508804|NCT05074121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110508805|NCT05074121|Antidotes|antidotes|mesh-ancestor
110508806|NCT05053503|Lofexidine|lofexidine|mesh-list
110508807|NCT05053503|Naltrexone|naltrexone|mesh-list
110508808|NCT05053503|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110508809|NCT05053503|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110508810|NCT05053503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110508811|NCT05053503|Sensory System Agents|sensory system agents|mesh-ancestor
110508812|NCT05053503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110508813|NCT05053503|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110508814|NCT05053503|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110508815|NCT05053503|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110508816|NCT05053503|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110508817|NCT05053503|Adrenergic Agents|adrenergic agents|mesh-ancestor
110508818|NCT05053503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110508819|NCT05053503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110508820|NCT04969991|Varespladib methyl|varespladib methyl|mesh-list
110508821|NCT04969991|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
110508822|NCT04969991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110508823|NCT04969991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110508824|NCT04960709|Durvalumab|durvalumab|mesh-list
110508863|NCT04900792|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
110508865|NCT04900792|Micronutrients|micronutrients|mesh-ancestor
110508866|NCT04900792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110508867|NCT04900792|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110508868|NCT04900792|Alkylating Agents|alkylating agents|mesh-ancestor
110508869|NCT04900792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110508870|NCT04900792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110508871|NCT04900792|Antioxidants|antioxidants|mesh-ancestor
110508872|NCT04900792|Protective Agents|protective agents|mesh-ancestor
110508873|NCT04900792|Hematinics|hematinics|mesh-ancestor
110508874|NCT04900792|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
110508875|NCT04900792|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110508876|NCT04882202|Acetaminophen|acetaminophen|mesh-list
110508877|NCT04882202|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110508878|NCT04882202|Analgesics|analgesics|mesh-ancestor
110508879|NCT04882202|Sensory System Agents|sensory system agents|mesh-ancestor
110508880|NCT04882202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110508881|NCT04882202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110508882|NCT04882202|Antipyretics|antipyretics|mesh-ancestor
110508883|NCT04878432|Azacitidine|azacitidine|mesh-list
110508884|NCT04878432|Decitabine|decitabine|mesh-list
110508885|NCT04878432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110508886|NCT04878432|Antimetabolites|antimetabolites|mesh-ancestor
110508887|NCT04878432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110889601|NCT01318681|Fluticasone|fluticasone|mesh-list
110508888|NCT04878432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110508889|NCT04878432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110508890|NCT04822350|Avelumab|avelumab|mesh-list
110508891|NCT04822350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110508892|NCT04822350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110508893|NCT04782245|Dapagliflozin|dapagliflozin|mesh-list
110508894|NCT04782245|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110508895|NCT04782245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110508896|NCT04782245|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110508897|NCT04782245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110508898|NCT04776148|Trifluridine|trifluridine|mesh-list
110508899|NCT04776148|Pembrolizumab|pembrolizumab|mesh-list
110508900|NCT04776148|Lenvatinib|lenvatinib|mesh-list
110508901|NCT04776148|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110508902|NCT04776148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110508903|NCT04776148|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110508904|NCT04776148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110508905|NCT04776148|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110508906|NCT04776148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110508907|NCT04776148|Antimetabolites|antimetabolites|mesh-ancestor
110508908|NCT04776148|Antiviral Agents|antiviral agents|mesh-ancestor
110508936|NCT04644029|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110508938|NCT04644029|Antiviral Agents|antiviral agents|mesh-ancestor
110508939|NCT04644029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110508940|NCT04644029|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110508941|NCT04644029|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110508942|NCT04644029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110508943|NCT04644029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110508944|NCT04644029|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110508945|NCT04644029|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110508946|NCT04594694|Bezafibrate|bezafibrate|mesh-list
110508947|NCT04594694|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110508948|NCT04594694|Antimetabolites|antimetabolites|mesh-ancestor
110508949|NCT04594694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110508950|NCT04594694|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110508951|NCT04586504|Midazolam|midazolam|mesh-list
110508952|NCT04586504|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110508953|NCT04586504|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110508954|NCT04586504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110508955|NCT04586504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110508956|NCT04586504|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110508957|NCT04586504|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110508958|NCT04586504|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110508959|NCT04586504|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110508960|NCT04586504|Anesthetics, General|anesthetics, general|mesh-ancestor
110508961|NCT04586504|Anesthetics|anesthetics|mesh-ancestor
110508962|NCT04586504|GABA Modulators|gaba modulators|mesh-ancestor
110508963|NCT04586504|GABA Agents|gaba agents|mesh-ancestor
110508964|NCT04586504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110508965|NCT04586504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110508966|NCT04583501|Omalizumab|omalizumab|mesh-list
110508967|NCT04583501|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110508968|NCT04583501|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110508969|NCT04583501|Respiratory System Agents|respiratory system agents|mesh-ancestor
110508976|NCT04544995|Niraparib|niraparib|mesh-list
110508977|NCT04544995|Dostarlimab|dostarlimab|mesh-list
110508978|NCT04544995|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110508979|NCT04544995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110508980|NCT04544995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110508981|NCT04544995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110508982|NCT04512235|Dexamethasone|dexamethasone|mesh-list
110508984|NCT04512235|Bortezomib|bortezomib|mesh-list
110176407|NCT00080626|Docetaxel|docetaxel|mesh-list
110509008|NCT04474353|Temozolomide|temozolomide|mesh-list
110509009|NCT04474353|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110509010|NCT04474353|Alkylating Agents|alkylating agents|mesh-ancestor
110509011|NCT04474353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110509012|NCT04474353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110509013|NCT04449952|Listerine|listerine|mesh-list
110509014|NCT04449952|Sodium Fluoride|sodium fluoride|mesh-list
110509015|NCT04449952|Cariostatic Agents|cariostatic agents|mesh-ancestor
110509016|NCT04449952|Protective Agents|protective agents|mesh-ancestor
110509017|NCT04449952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110509018|NCT04449952|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110509019|NCT04449952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110509020|NCT04419389|Rituximab|rituximab|mesh-list
110509021|NCT04419389|Venetoclax|venetoclax|mesh-list
110509022|NCT04419389|Acalabrutinib|acalabrutinib|mesh-list
110509023|NCT04419389|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110509024|NCT04419389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110509025|NCT04419389|Immunologic Factors|immunologic factors|mesh-ancestor
110509026|NCT04419389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110509027|NCT04419389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110509028|NCT04410991|Teriflunomide|teriflunomide|mesh-list
110509029|NCT04410991|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110509030|NCT04410991|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110509031|NCT04410991|Analgesics|analgesics|mesh-ancestor
110509032|NCT04410991|Sensory System Agents|sensory system agents|mesh-ancestor
110509033|NCT04410991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110509043|NCT04410978|Sensory System Agents|sensory system agents|mesh-ancestor
110509044|NCT04410978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110509045|NCT04410978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110509046|NCT04410978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110509047|NCT04410978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110509048|NCT04410978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110509049|NCT04410978|Immunologic Factors|immunologic factors|mesh-ancestor
110509050|NCT04405349|Atezolizumab|atezolizumab|mesh-list
110509051|NCT04405349|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110509052|NCT04405349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110509053|NCT04405349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110509054|NCT04405349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110509055|NCT04373707|Enoxaparin|enoxaparin|mesh-list
110509056|NCT04373707|Dalteparin|dalteparin|mesh-list
110509057|NCT04373707|Tinzaparin|tinzaparin|mesh-list
110509058|NCT04373707|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
110509060|NCT04373707|Enoxaparin sodium|enoxaparin sodium|mesh-list
110509061|NCT04373707|Anticoagulants|anticoagulants|mesh-ancestor
110509062|NCT04373707|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110509063|NCT04373707|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110509064|NCT04373707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110509066|NCT04335383|Immunologic Factors|immunologic factors|mesh-ancestor
110509067|NCT04335383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110509068|NCT04211259|Loratadine|loratadine|mesh-list
110509069|NCT04211259|Antipruritics|antipruritics|mesh-ancestor
110509070|NCT04211259|Dermatologic Agents|dermatologic agents|mesh-ancestor
110509071|NCT04211259|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110509072|NCT04211259|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110509073|NCT04211259|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110509074|NCT04211259|Histamine Antagonists|histamine antagonists|mesh-ancestor
110509075|NCT04211259|Histamine Agents|histamine agents|mesh-ancestor
110509076|NCT04211259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110509077|NCT04211259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110509078|NCT04211259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110509079|NCT04158258|Bevacizumab|bevacizumab|mesh-list
110509080|NCT04158258|Trastuzumab|trastuzumab|mesh-list
110509081|NCT04158258|Atezolizumab|atezolizumab|mesh-list
110509082|NCT04158258|Pertuzumab|pertuzumab|mesh-list
110509083|NCT04158258|Capecitabine|capecitabine|mesh-list
110509084|NCT04158258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110509085|NCT04158258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110890089|NCT01337375|Interferon-alpha|interferon-alpha|mesh-list
110509086|NCT04158258|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110509087|NCT04158258|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110509088|NCT04158258|Growth Substances|growth substances|mesh-ancestor
110509089|NCT04158258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110509090|NCT04158258|Growth Inhibitors|growth inhibitors|mesh-ancestor
110509091|NCT04158258|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110509092|NCT04158258|Antimetabolites|antimetabolites|mesh-ancestor
110186612|NCT05298696|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110509093|NCT04158258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110509094|NCT04158258|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110509095|NCT04154189|Etoposide|etoposide|mesh-list
110509096|NCT04154189|Lenvatinib|lenvatinib|mesh-list
110509097|NCT04154189|Ifosfamide|ifosfamide|mesh-list
110509098|NCT04154189|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110509099|NCT04154189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110509100|NCT04154189|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110509101|NCT04154189|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110509124|NCT03934905|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110509125|NCT03934905|Protective Agents|protective agents|mesh-ancestor
110509126|NCT03934905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110509127|NCT03934905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110509129|NCT03916263|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110509130|NCT03916263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110509131|NCT03889418|Analgesics, Opioid|analgesics, opioid|mesh-list
110509132|NCT03889418|Narcotics|narcotics|mesh-ancestor
110509133|NCT03889418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110509134|NCT03889418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110509135|NCT03889418|Analgesics|analgesics|mesh-ancestor
110509136|NCT03889418|Sensory System Agents|sensory system agents|mesh-ancestor
110509137|NCT03889418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110509138|NCT03856658|Floxuridine|floxuridine|mesh-list
110509139|NCT03856658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110509140|NCT03856658|Antimetabolites|antimetabolites|mesh-ancestor
110509141|NCT03856658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110509142|NCT03856658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110509143|NCT03788694|Ketamine|ketamine|mesh-list
110509144|NCT03788694|Analgesics|analgesics|mesh-ancestor
110509145|NCT03788694|Sensory System Agents|sensory system agents|mesh-ancestor
110509146|NCT03788694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110509147|NCT03788694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110509148|NCT03788694|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110509149|NCT03788694|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110509150|NCT03788694|Anesthetics, General|anesthetics, general|mesh-ancestor
110509151|NCT03788694|Anesthetics|anesthetics|mesh-ancestor
110509152|NCT03788694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110509153|NCT03788694|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110509154|NCT03788694|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110509162|NCT03749109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110509164|NCT03709706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110509165|NCT03709706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110509166|NCT03709706|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110509167|NCT03709706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110509168|NCT03653832|Clonidine|clonidine|mesh-list
110509169|NCT03653832|Dexmedetomidine|dexmedetomidine|mesh-list
110509170|NCT03653832|Propofol|propofol|mesh-list
110509171|NCT03653832|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110509172|NCT03653832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110509173|NCT03653832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110509174|NCT03653832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110509175|NCT03653832|Analgesics|analgesics|mesh-ancestor
110509176|NCT03653832|Sensory System Agents|sensory system agents|mesh-ancestor
110509177|NCT03653832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110509178|NCT03653832|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110509179|NCT03653832|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110509180|NCT03653832|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110509181|NCT03653832|Adrenergic Agents|adrenergic agents|mesh-ancestor
110509182|NCT03653832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110509183|NCT03653832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110509184|NCT03653832|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110509185|NCT03653832|Anesthetics, General|anesthetics, general|mesh-ancestor
110509186|NCT03653832|Anesthetics|anesthetics|mesh-ancestor
110509187|NCT03653832|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110509188|NCT03653832|Sympatholytics|sympatholytics|mesh-ancestor
110509189|NCT03653832|Autonomic Agents|autonomic agents|mesh-ancestor
110509191|NCT03555188|Antiemetics|antiemetics|mesh-ancestor
110509192|NCT03555188|Autonomic Agents|autonomic agents|mesh-ancestor
110509193|NCT03555188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110509194|NCT03555188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110509195|NCT03555188|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110509196|NCT03555188|Antipruritics|antipruritics|mesh-ancestor
110509198|NCT03555188|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110509199|NCT03555188|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110509200|NCT03555188|Serotonin Agents|serotonin agents|mesh-ancestor
110509201|NCT03555188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110890375|NCT02060318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110509202|NCT03555188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110509204|NCT03547115|Voruciclib|voruciclib|mesh-list
110509205|NCT03547115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110509206|NCT03547115|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110509207|NCT03547115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110509208|NCT03547115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110509209|NCT03497689|Treprostinil|treprostinil|mesh-list
110509210|NCT03497689|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110509211|NCT03492437|Tepotinib|tepotinib|mesh-list
110509212|NCT03492437|Dabigatran|dabigatran|mesh-list
110509213|NCT03492437|Antithrombins|antithrombins|mesh-ancestor
110890445|NCT02060396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110890455|NCT02058212|Vitamin E|vitamin e|mesh-list
110509217|NCT03492437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110509219|NCT03492437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110509220|NCT03471182|Cocaine|cocaine|mesh-list
110509221|NCT03471182|Anesthetics, Local|anesthetics, local|mesh-ancestor
110509222|NCT03471182|Anesthetics|anesthetics|mesh-ancestor
110509223|NCT03471182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110509224|NCT03471182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110509225|NCT03471182|Sensory System Agents|sensory system agents|mesh-ancestor
110186665|NCT05105919|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110509226|NCT03471182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110509242|NCT03363867|Atezolizumab|atezolizumab|mesh-list
110509243|NCT03363867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110509244|NCT03363867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110509245|NCT03363867|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110509246|NCT03363867|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110509247|NCT03363867|Growth Substances|growth substances|mesh-ancestor
110509248|NCT03363867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110509249|NCT03363867|Growth Inhibitors|growth inhibitors|mesh-ancestor
110509250|NCT03363867|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110509251|NCT03363867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110509252|NCT03310125|Colchicine|colchicine|mesh-list
110509253|NCT03310125|Gout Suppressants|gout suppressants|mesh-ancestor
110509254|NCT03310125|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110509255|NCT03310125|Tubulin Modulators|tubulin modulators|mesh-ancestor
110509256|NCT03310125|Antimitotic Agents|antimitotic agents|mesh-ancestor
110509257|NCT03310125|Mitosis Modulators|mitosis modulators|mesh-ancestor
110509258|NCT03310125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110509259|NCT03310125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110509260|NCT03252938|Avelumab|avelumab|mesh-list
110509261|NCT03252938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110509262|NCT03252938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110509266|NCT03193853|Paclitaxel|paclitaxel|mesh-list
110509267|NCT03193853|Serabelisib|serabelisib|mesh-list
110509268|NCT03193853|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110509269|NCT03193853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110509270|NCT03193853|Tubulin Modulators|tubulin modulators|mesh-ancestor
110509271|NCT03193853|Antimitotic Agents|antimitotic agents|mesh-ancestor
110509272|NCT03193853|Mitosis Modulators|mitosis modulators|mesh-ancestor
110509273|NCT03193853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110509275|NCT03191084|Dronabinol|dronabinol|mesh-list
110509276|NCT03191084|Hallucinogens|hallucinogens|mesh-ancestor
110890698|NCT03139279|Sensory System Agents|sensory system agents|mesh-ancestor
110509277|NCT03191084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110509278|NCT03191084|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110509279|NCT03191084|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110509281|NCT03191084|Sensory System Agents|sensory system agents|mesh-ancestor
110509282|NCT03191084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110509283|NCT03191084|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
110509284|NCT03191084|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110509285|NCT03191084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110890839|NCT03614052|Tamsulosin|tamsulosin|mesh-list
110890911|NCT02061800|Immunologic Factors|immunologic factors|mesh-ancestor
110509286|NCT03191084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110509287|NCT03191084|Hormones|hormones|mesh-ancestor
110509312|NCT02738866|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110509313|NCT02738866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110509314|NCT02738866|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110509315|NCT02738866|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110509316|NCT02738866|Hormone Antagonists|hormone antagonists|mesh-ancestor
110509317|NCT02738866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110509318|NCT02738866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110186693|NCT05037162|Coagulants|coagulants|mesh-ancestor
110509319|NCT02738866|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110509320|NCT02738866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110509321|NCT02738866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110509323|NCT02576912|Hallucinogens|hallucinogens|mesh-ancestor
110509324|NCT02576912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110509325|NCT02576912|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110509326|NCT02576912|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110509327|NCT02576912|Analgesics|analgesics|mesh-ancestor
110509328|NCT02576912|Sensory System Agents|sensory system agents|mesh-ancestor
110509329|NCT02576912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110509330|NCT02576912|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
110509331|NCT02576912|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110509332|NCT02576912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110509333|NCT02576912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110509334|NCT02576912|Hormones|hormones|mesh-ancestor
110891055|NCT05089643|Antimetabolites|antimetabolites|mesh-ancestor
110891058|NCT02871492|Acyclovir|acyclovir|mesh-list
110509335|NCT02576912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110509336|NCT02232152|Thioctic Acid|thioctic acid|mesh-list
110509353|NCT02211755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110509354|NCT02211755|Antimetabolites|antimetabolites|mesh-ancestor
110509355|NCT02211755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110509357|NCT02127073|Oxytocics|oxytocics|mesh-ancestor
110509358|NCT02127073|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110509359|NCT02127073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110509361|NCT02102113|Hallucinogens|hallucinogens|mesh-ancestor
110509362|NCT02102113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110509363|NCT02102113|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110509364|NCT02102113|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110509365|NCT02102113|Analgesics|analgesics|mesh-ancestor
110509366|NCT02102113|Sensory System Agents|sensory system agents|mesh-ancestor
110509367|NCT02102113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110509368|NCT02102113|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
110509369|NCT02102113|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110509370|NCT02102113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110509371|NCT02102113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110509372|NCT02102113|Hormones|hormones|mesh-ancestor
110509373|NCT02102113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110509374|NCT02070705|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
110509375|NCT02070705|Hematinics|hematinics|mesh-ancestor
110509376|NCT02070705|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
110509377|NCT02070705|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110509378|NCT01980355|Tranexamic Acid|tranexamic acid|mesh-list
110509379|NCT01980355|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110509380|NCT01980355|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110509381|NCT01980355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110509382|NCT01980355|Hemostatics|hemostatics|mesh-ancestor
110509383|NCT01980355|Coagulants|coagulants|mesh-ancestor
110509384|NCT01950520|Topiramate|topiramate|mesh-list
110891420|NCT04065789|Hormones|hormones|mesh-ancestor
110509385|NCT01950520|Phentermine|phentermine|mesh-list
110186730|NCT05012189|Baloxavir|baloxavir|mesh-list
110509386|NCT01950520|Magnesium Sulfate|magnesium sulfate|mesh-list
110509387|NCT01950520|Propranolol|propranolol|mesh-list
110509388|NCT01950520|Pindolol|pindolol|mesh-list
110509389|NCT01950520|Naltrexone|naltrexone|mesh-list
110509390|NCT01950520|Caffeine|caffeine|mesh-list
110509391|NCT01950520|Dantrolene|dantrolene|mesh-list
110509392|NCT01950520|Mirabegron|mirabegron|mesh-list
110509393|NCT01950520|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110509394|NCT01950520|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110509395|NCT01950520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110509396|NCT01950520|Sensory System Agents|sensory system agents|mesh-ancestor
110509397|NCT01950520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110509398|NCT01950520|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110509399|NCT01950520|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110509413|NCT01950520|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110891691|NCT05697003|Hormones|hormones|mesh-ancestor
110509415|NCT01950520|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110509416|NCT01950520|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110509418|NCT01950520|Adrenergic Agents|adrenergic agents|mesh-ancestor
110509419|NCT01950520|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110509420|NCT01950520|Vasodilator Agents|vasodilator agents|mesh-ancestor
110509421|NCT01950520|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110509422|NCT01950520|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
110509423|NCT01950520|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110509424|NCT01950520|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110891781|NCT02072330|Amlodipine|amlodipine|mesh-list
110509426|NCT01950520|Appetite Depressants|appetite depressants|mesh-ancestor
110509427|NCT01950520|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110509428|NCT01950520|Sympathomimetics|sympathomimetics|mesh-ancestor
110509429|NCT01950520|Autonomic Agents|autonomic agents|mesh-ancestor
110509430|NCT01950520|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110891906|NCT02077556|Everolimus|everolimus|mesh-list
110509431|NCT01950520|Serotonin Agents|serotonin agents|mesh-ancestor
110509432|NCT01950520|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110509433|NCT01950520|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110509434|NCT01771107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110509436|NCT01771107|Doxorubicin|doxorubicin|mesh-list
110509437|NCT01771107|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110509438|NCT01771107|Dacarbazine|dacarbazine|mesh-list
110509439|NCT01771107|Vinblastine|vinblastine|mesh-list
110509440|NCT01771107|Antibodies|antibodies|mesh-list
110509441|NCT01771107|Immunoglobulins|immunoglobulins|mesh-list
110509442|NCT01771107|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110509443|NCT01771107|Imidazole|imidazole|mesh-list
110509444|NCT01771107|Immunoconjugates|immunoconjugates|mesh-list
110509445|NCT01771107|Immunologic Factors|immunologic factors|mesh-ancestor
110892043|NCT02930005|Analgesics|analgesics|mesh-ancestor
110509447|NCT01771107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110509448|NCT01771107|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110509449|NCT01771107|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110509450|NCT01771107|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110509451|NCT01771107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110509452|NCT01771107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110509453|NCT01771107|Immunotoxins|immunotoxins|mesh-ancestor
110509454|NCT01771107|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110156807|NCT00393328|Dopamine Agonists|dopamine agonists|mesh-ancestor
110509455|NCT01771107|Alkylating Agents|alkylating agents|mesh-ancestor
110509456|NCT01771107|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110509457|NCT01771107|Tubulin Modulators|tubulin modulators|mesh-ancestor
110509458|NCT01771107|Antimitotic Agents|antimitotic agents|mesh-ancestor
110509459|NCT01771107|Mitosis Modulators|mitosis modulators|mesh-ancestor
110509460|NCT01758432|Apixaban|apixaban|mesh-list
110509461|NCT01758432|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110509462|NCT01758432|Antithrombins|antithrombins|mesh-ancestor
110509473|NCT01583218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110509474|NCT01583218|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110509476|NCT01583218|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110509477|NCT01583218|Protease Inhibitors|protease inhibitors|mesh-ancestor
110509478|NCT01583218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110509479|NCT00742859|Warfarin|warfarin|mesh-list
110509480|NCT00742859|Acenocoumarol|acenocoumarol|mesh-list
110509481|NCT00742859|Betrixaban|betrixaban|mesh-list
110509482|NCT00742859|Anticoagulants|anticoagulants|mesh-ancestor
110509483|NCT00742859|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110509484|NCT00742859|Antithrombins|antithrombins|mesh-ancestor
110509485|NCT00742859|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110509486|NCT00742859|Protease Inhibitors|protease inhibitors|mesh-ancestor
110509487|NCT00742859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110509488|NCT00742859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110509489|NCT00667342|Bevacizumab|bevacizumab|mesh-list
110509490|NCT00667342|Doxorubicin|doxorubicin|mesh-list
110509491|NCT00667342|Methotrexate|methotrexate|mesh-list
110509492|NCT00667342|Etoposide|etoposide|mesh-list
110509493|NCT00667342|Ifosfamide|ifosfamide|mesh-list
110509494|NCT00667342|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110509495|NCT00667342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110509496|NCT00667342|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110509497|NCT00667342|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110509498|NCT00667342|Growth Substances|growth substances|mesh-ancestor
110509499|NCT00667342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110509500|NCT00667342|Growth Inhibitors|growth inhibitors|mesh-ancestor
110509501|NCT00667342|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110509502|NCT00667342|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110509503|NCT00667342|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110892216|NCT01370707|Metformin|metformin|mesh-list
110509504|NCT00667342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110509505|NCT00667342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110509506|NCT00667342|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110509507|NCT00667342|Abortifacient Agents|abortifacient agents|mesh-ancestor
110509508|NCT00667342|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110509509|NCT00667342|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110509510|NCT00667342|Antimetabolites|antimetabolites|mesh-ancestor
110509511|NCT00667342|Dermatologic Agents|dermatologic agents|mesh-ancestor
110509512|NCT00667342|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110509513|NCT00667342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110509514|NCT00667342|Immunologic Factors|immunologic factors|mesh-ancestor
110509515|NCT00667342|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110509516|NCT00667342|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110509517|NCT00667342|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110509518|NCT00667342|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110509519|NCT00667342|Alkylating Agents|alkylating agents|mesh-ancestor
110509521|NCT00375609|Betrixaban|betrixaban|mesh-list
110509522|NCT00375609|Anticoagulants|anticoagulants|mesh-ancestor
110509523|NCT00375609|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110509524|NCT00375609|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110509525|NCT00375609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110509526|NCT00375609|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110509527|NCT00375609|Antithrombins|antithrombins|mesh-ancestor
110509528|NCT00375609|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110509529|NCT00375609|Protease Inhibitors|protease inhibitors|mesh-ancestor
110509548|NCT02803788|Glucocorticoids|glucocorticoids|mesh-ancestor
110509549|NCT02803788|Hormones|hormones|mesh-ancestor
110509550|NCT02803788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110509551|NCT02803788|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110509552|NCT02803788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110509553|NCT02803788|Antipruritics|antipruritics|mesh-ancestor
110509554|NCT02803788|Dermatologic Agents|dermatologic agents|mesh-ancestor
110892414|NCT02078648|Poly I-C|poly i-c|mesh-list
110509555|NCT02803788|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110509556|NCT02803788|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110509557|NCT02803788|Serotonin Agents|serotonin agents|mesh-ancestor
110509558|NCT02803788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110509559|NCT02803788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110509560|NCT02610153|Vitamin K|vitamin k|mesh-list
110509561|NCT02610153|Vitamins|vitamins|mesh-ancestor
110509562|NCT02610153|Micronutrients|micronutrients|mesh-ancestor
110509563|NCT02610153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110509564|NCT02610153|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110509565|NCT02610153|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110509566|NCT02610153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110509567|NCT02610153|Hemostatics|hemostatics|mesh-ancestor
110509568|NCT02610153|Coagulants|coagulants|mesh-ancestor
110509569|NCT00862693|Calcitriol|calcitriol|mesh-list
110509570|NCT00862693|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110509571|NCT00862693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110509572|NCT00862693|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
110509573|NCT00862693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110509574|NCT00862693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110509575|NCT00862693|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110509576|NCT00862693|Vitamins|vitamins|mesh-ancestor
110509577|NCT00862693|Micronutrients|micronutrients|mesh-ancestor
110892551|NCT02079350|Polygeline|polygeline|mesh-list
110509578|NCT00862693|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110509579|NCT05757063|Dexmedetomidine|dexmedetomidine|mesh-list
110509580|NCT05757063|Propofol|propofol|mesh-list
110509581|NCT05757063|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110509582|NCT05757063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110509583|NCT05757063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110509584|NCT05757063|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110509585|NCT05757063|Analgesics|analgesics|mesh-ancestor
110509586|NCT05757063|Sensory System Agents|sensory system agents|mesh-ancestor
110509587|NCT05757063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110509603|NCT02799498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110509604|NCT02799498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110509605|NCT02799498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110509606|NCT02799498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110509607|NCT02799498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110509608|NCT02799498|Immunologic Factors|immunologic factors|mesh-ancestor
110509610|NCT00617851|Immunologic Factors|immunologic factors|mesh-ancestor
110509611|NCT00617851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110509612|NCT02806440|Naltrexone|naltrexone|mesh-list
110509613|NCT02806440|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110509614|NCT02806440|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110509615|NCT02806440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110509616|NCT02806440|Sensory System Agents|sensory system agents|mesh-ancestor
110509617|NCT02806440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110509618|NCT00913809|Desipramine|desipramine|mesh-list
110509619|NCT00913809|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110509620|NCT00913809|Antidepressive Agents|antidepressive agents|mesh-ancestor
110509621|NCT00913809|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110509622|NCT00913809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110509623|NCT00913809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110509624|NCT00913809|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110509625|NCT00913809|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110509626|NCT00913809|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110509627|NCT00913809|Adrenergic Agents|adrenergic agents|mesh-ancestor
110509628|NCT00913809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110509629|NCT00913809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110509631|NCT02806362|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110509632|NCT02806362|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110509633|NCT02806362|Protease Inhibitors|protease inhibitors|mesh-ancestor
110509634|NCT02806362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110509635|NCT02806362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110509636|NCT02806362|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110509637|NCT02806362|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110509638|NCT02806362|Antiviral Agents|antiviral agents|mesh-ancestor
110509639|NCT02806362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110892798|NCT05188859|Pemetrexed|pemetrexed|mesh-list
110509640|NCT02806362|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110509641|NCT02806362|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110509642|NCT00855049|Acetaminophen|acetaminophen|mesh-list
110509643|NCT00855049|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110509644|NCT00855049|Analgesics|analgesics|mesh-ancestor
110509645|NCT00855049|Sensory System Agents|sensory system agents|mesh-ancestor
110509646|NCT00855049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110892916|NCT01364701|Urological Agents|urological agents|mesh-ancestor
110509647|NCT00855049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110509648|NCT00855049|Antipyretics|antipyretics|mesh-ancestor
110509664|NCT04235478|Hormones|hormones|mesh-ancestor
110509665|NCT04235478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110509666|NCT04235478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110509667|NCT04235478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110509668|NCT04235478|Immunologic Factors|immunologic factors|mesh-ancestor
110509669|NCT00619489|Vedolizumab|vedolizumab|mesh-list
110509670|NCT00619489|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110509671|NCT02806206|Prucalopride|prucalopride|mesh-list
110509672|NCT02806206|Laxatives|laxatives|mesh-ancestor
110509673|NCT02806206|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110892990|NCT02533232|Minocycline|minocycline|mesh-list
110509674|NCT02806206|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
110509675|NCT02806206|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110509676|NCT02806206|Serotonin Agents|serotonin agents|mesh-ancestor
110509677|NCT02806206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110893053|NCT02085590|BCG Vaccine|bcg vaccine|mesh-list
110509678|NCT02806206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110509679|NCT02806206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110509680|NCT00855205|Rituximab|rituximab|mesh-list
110509681|NCT00855205|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110509682|NCT00855205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110509683|NCT00855205|Immunologic Factors|immunologic factors|mesh-ancestor
110509684|NCT00855205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110509685|NCT00855205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110509686|NCT00859807|Amodiaquine|amodiaquine|mesh-list
110509687|NCT00859807|Antimalarials|antimalarials|mesh-ancestor
110509688|NCT00859807|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110509689|NCT00859807|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110509690|NCT00859807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110509691|NCT00859885|Clopidogrel|clopidogrel|mesh-list
110509692|NCT00859885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110893189|NCT02086292|Anesthetics, Local|anesthetics, local|mesh-ancestor
110893260|NCT02086838|Plasma Substitutes|plasma substitutes|mesh-ancestor
110509693|NCT00859885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110509694|NCT00859885|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110509695|NCT00859885|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110509696|NCT00859885|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110509697|NCT00859885|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110509698|NCT00859885|Purinergic Agents|purinergic agents|mesh-ancestor
110509699|NCT00859885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110509700|NCT02798874|Clopidogrel|clopidogrel|mesh-list
110509701|NCT02798874|Ticagrelor|ticagrelor|mesh-list
110509702|NCT02798874|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110186908|NCT04598815|Antifungal Agents|antifungal agents|mesh-ancestor
110509703|NCT02798874|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110509704|NCT02798874|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110509705|NCT02798874|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110509706|NCT02798874|Purinergic Agents|purinergic agents|mesh-ancestor
110509707|NCT02798874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110509708|NCT02798874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110509709|NCT02798874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110509720|NCT00959699|Ribavirin|ribavirin|mesh-list
110509721|NCT00959699|Interferon-alpha|interferon-alpha|mesh-list
110509722|NCT00959699|Interferon alpha-2|interferon alpha-2|mesh-list
110509723|NCT00959699|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110509724|NCT00959699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110509725|NCT00959699|Antiviral Agents|antiviral agents|mesh-ancestor
110509726|NCT00959699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110509727|NCT00959699|Antimetabolites|antimetabolites|mesh-ancestor
110509728|NCT00959699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110509729|NCT00959699|Immunologic Factors|immunologic factors|mesh-ancestor
110509730|NCT00959699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110509731|NCT02806128|Kallikreins|kallikreins|mesh-list
110509732|NCT02806128|Coagulants|coagulants|mesh-ancestor
110509733|NCT02806128|Fertility Agents, Male|fertility agents, male|mesh-ancestor
110509734|NCT02806128|Fertility Agents|fertility agents|mesh-ancestor
110509735|NCT02806128|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110509736|NCT02806128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110509737|NCT00860119|Alprazolam|alprazolam|mesh-list
110509738|NCT00860119|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110509739|NCT00860119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110509740|NCT00860119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110509741|NCT00860119|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110509742|NCT00860119|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110509743|NCT00860119|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110509744|NCT00860119|GABA Modulators|gaba modulators|mesh-ancestor
110509745|NCT00860119|GABA Agents|gaba agents|mesh-ancestor
110509746|NCT00860119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110509747|NCT00860119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110509748|NCT00855283|Glycopyrrolate|glycopyrrolate|mesh-list
110509749|NCT00855283|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110509750|NCT00855283|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110509751|NCT00855283|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110509752|NCT00855283|Cholinergic Agents|cholinergic agents|mesh-ancestor
110509753|NCT00855283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110509754|NCT00855283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110509755|NCT00855283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110509756|NCT02805738|Tenofovir|tenofovir|mesh-list
110509757|NCT02805738|Antiviral Agents|antiviral agents|mesh-ancestor
110509758|NCT02805738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110509759|NCT02805738|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110509760|NCT02805738|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110509761|NCT02805738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110509762|NCT02805738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110509763|NCT02805738|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110509764|NCT02805738|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110509766|NCT00855361|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110509767|NCT00855361|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110509768|NCT00855361|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110509769|NCT00855361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110509770|NCT00855361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110509771|NCT02798406|Pembrolizumab|pembrolizumab|mesh-list
110509772|NCT02798406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110509773|NCT02798406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110509774|NCT02798406|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110509775|NCT02798406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110509776|NCT05550636|Midazolam|midazolam|mesh-list
110509795|NCT02857829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110509796|NCT02857829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110509797|NCT02857829|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110509798|NCT02857829|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110509799|NCT02857829|Purinergic Agents|purinergic agents|mesh-ancestor
110509800|NCT02857829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110509801|NCT00860275|Fluconazole|fluconazole|mesh-list
110509802|NCT00860275|Ketoconazole|ketoconazole|mesh-list
110509803|NCT00860275|BMS 708163|bms 708163|mesh-list
110509804|NCT00860275|Antifungal Agents|antifungal agents|mesh-ancestor
110509805|NCT00860275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110509806|NCT00860275|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110509807|NCT00860275|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110509808|NCT00860275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110509809|NCT00860275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110509810|NCT00860275|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110509811|NCT00860275|Hormone Antagonists|hormone antagonists|mesh-ancestor
110509812|NCT00860275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110509813|NCT00860275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110509814|NCT00860275|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110893805|NCT02099240|Contraceptive Agents|contraceptive agents|mesh-ancestor
110509815|NCT00860275|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110509816|NCT00860275|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110509817|NCT00860275|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
110509819|NCT02798250|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110509820|NCT02798250|Glucagon|glucagon|mesh-list
110509821|NCT02798250|Hormones|hormones|mesh-list
110509822|NCT02798250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110509823|NCT02798250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110509824|NCT02798250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110509825|NCT02798250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110509826|NCT00865111|Bupropion|bupropion|mesh-list
110509827|NCT00865111|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110509828|NCT00865111|Antidepressive Agents|antidepressive agents|mesh-ancestor
110509829|NCT00865111|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110509830|NCT00865111|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110509831|NCT00865111|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110509844|NCT02802696|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110509845|NCT02802696|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110509846|NCT02802696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110509847|NCT00865267|Halobetasol|halobetasol|mesh-list
110509848|NCT00865267|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110509849|NCT02798172|Metformin|metformin|mesh-list
110509850|NCT02798172|Alogliptin|alogliptin|mesh-list
110509851|NCT02798172|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110509852|NCT02798172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110509853|NCT02798172|Incretins|incretins|mesh-ancestor
110509854|NCT02798172|Hormones|hormones|mesh-ancestor
110509855|NCT02798172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110893943|NCT02065635|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110509856|NCT02798172|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110509857|NCT02798172|Protease Inhibitors|protease inhibitors|mesh-ancestor
110509858|NCT02798172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110509859|NCT02798172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110509860|NCT00865423|Gabapentin|gabapentin|mesh-list
110509861|NCT00865423|Analgesics|analgesics|mesh-ancestor
110509862|NCT00865423|Sensory System Agents|sensory system agents|mesh-ancestor
110509863|NCT00865423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110509864|NCT00865423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110509865|NCT00865423|Anticonvulsants|anticonvulsants|mesh-ancestor
110509866|NCT00865423|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110509867|NCT00865423|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110509868|NCT00865423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110509869|NCT00865423|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110187085|NCT04199026|Alkylating Agents|alkylating agents|mesh-ancestor
110509870|NCT00865423|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110509871|NCT00865423|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110509872|NCT00865423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110509873|NCT00865423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110509874|NCT00865423|Antimanic Agents|antimanic agents|mesh-ancestor
110509875|NCT00955721|Gemcitabine|gemcitabine|mesh-list
110509876|NCT00955721|Oxaliplatin|oxaliplatin|mesh-list
110509877|NCT00955721|Sorafenib|sorafenib|mesh-list
110894064|NCT05665725|Siltuximab|siltuximab|mesh-list
110509878|NCT00955721|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110509880|NCT00955721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110509881|NCT00955721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110509882|NCT00955721|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110509883|NCT00955721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110509884|NCT02802540|Nabilone|nabilone|mesh-list
110509885|NCT02802540|Antiemetics|antiemetics|mesh-ancestor
110509886|NCT02802540|Autonomic Agents|autonomic agents|mesh-ancestor
110509887|NCT02802540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110509888|NCT02802540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110509889|NCT02802540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110509890|NCT02802540|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110509891|NCT02802540|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110509892|NCT02802540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110509893|NCT02802540|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110509894|NCT00865501|Spironolactone|spironolactone|mesh-list
110509914|NCT04281095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110509915|NCT04281095|Cholinergic Agents|cholinergic agents|mesh-ancestor
110509916|NCT04281095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110509917|NCT04281095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110509918|NCT04281095|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110509919|NCT04281095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110509920|NCT00863161|Lesogaberan|lesogaberan|mesh-list
110509921|NCT00863161|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110509922|NCT00863161|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
110509923|NCT00863161|GABA Agonists|gaba agonists|mesh-ancestor
110509924|NCT00863161|GABA Agents|gaba agents|mesh-ancestor
110509925|NCT00863161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110509926|NCT00863161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110509927|NCT00863161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110509928|NCT00863239|Interferons|interferons|mesh-list
110509929|NCT00863239|Ribavirin|ribavirin|mesh-list
110509930|NCT00863239|Interferon-alpha|interferon-alpha|mesh-list
110509931|NCT00863239|Interferon alpha-2|interferon alpha-2|mesh-list
110509932|NCT00863239|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110509933|NCT00863239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110509934|NCT00863239|Antiviral Agents|antiviral agents|mesh-ancestor
110509935|NCT00863239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110509936|NCT00863239|Antimetabolites|antimetabolites|mesh-ancestor
110509937|NCT00863239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110509938|NCT00863239|Immunologic Factors|immunologic factors|mesh-ancestor
110509939|NCT00863239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110509940|NCT02802072|Aspirin|aspirin|mesh-list
110509941|NCT02802072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110509942|NCT02802072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110509943|NCT02802072|Analgesics|analgesics|mesh-ancestor
110509945|NCT02802072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110509946|NCT02802072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110509947|NCT02802072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110509948|NCT02802072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110509949|NCT02802072|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110509968|NCT00863395|Anesthetics, Local|anesthetics, local|mesh-ancestor
110509969|NCT00863395|Anesthetics|anesthetics|mesh-ancestor
110509970|NCT00863395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110509971|NCT00863395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110509972|NCT00863395|Sensory System Agents|sensory system agents|mesh-ancestor
110509973|NCT00863395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110509974|NCT00863395|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110509975|NCT00863395|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110509976|NCT00863395|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110509977|NCT00863395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110509978|NCT00863395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110509979|NCT02939183|Dexamethasone|dexamethasone|mesh-list
110509980|NCT02939183|Pomalidomide|pomalidomide|mesh-list
110157345|NCT00847093|Lidocaine|lidocaine|mesh-list
110509981|NCT02939183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110509982|NCT02939183|Antiemetics|antiemetics|mesh-ancestor
110509983|NCT02939183|Autonomic Agents|autonomic agents|mesh-ancestor
110894517|NCT01941589|Glucocorticoids|glucocorticoids|mesh-ancestor
110509984|NCT02939183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110509985|NCT02939183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110509986|NCT02939183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110509987|NCT02939183|Glucocorticoids|glucocorticoids|mesh-ancestor
110509988|NCT02939183|Hormones|hormones|mesh-ancestor
110509989|NCT02939183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110509990|NCT02939183|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110509991|NCT02939183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110509992|NCT02939183|Immunologic Factors|immunologic factors|mesh-ancestor
110509993|NCT02939183|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110894588|NCT01343901|Growth Substances|growth substances|mesh-ancestor
110509994|NCT02939183|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110509995|NCT02939183|Growth Substances|growth substances|mesh-ancestor
110509996|NCT02939183|Growth Inhibitors|growth inhibitors|mesh-ancestor
110509997|NCT02801838|Morphine|morphine|mesh-list
110509998|NCT02801838|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110509999|NCT02801838|Narcotics|narcotics|mesh-ancestor
110510000|NCT02801838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110510001|NCT02801838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110894729|NCT01318083|Alogliptin|alogliptin|mesh-list
110510003|NCT02801838|Sensory System Agents|sensory system agents|mesh-ancestor
110187135|NCT04042233|Vancomycin|vancomycin|mesh-list
110510004|NCT02801838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110510005|NCT04276025|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110510063|NCT00863785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110510065|NCT02801526|Amlodipine|amlodipine|mesh-list
110510066|NCT02801526|Candesartan|candesartan|mesh-list
110510067|NCT02801526|Candesartan cilexetil|candesartan cilexetil|mesh-list
110510068|NCT02801526|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110510069|NCT02801526|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110510070|NCT02801526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110510071|NCT02801526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110510072|NCT02801526|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110510073|NCT02801526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110510074|NCT02801526|Vasodilator Agents|vasodilator agents|mesh-ancestor
110510075|NCT02801526|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110510076|NCT02801526|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110510077|NCT02805426|Misoprostol|misoprostol|mesh-list
110510078|NCT02805426|Tranexamic Acid|tranexamic acid|mesh-list
110510079|NCT02805426|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110510080|NCT02805426|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110510081|NCT02805426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110510082|NCT02805426|Hemostatics|hemostatics|mesh-ancestor
110510083|NCT02805426|Coagulants|coagulants|mesh-ancestor
110510084|NCT02805426|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110510085|NCT02805426|Abortifacient Agents|abortifacient agents|mesh-ancestor
110176735|NCT03151746|Gabapentin|gabapentin|mesh-list
110510098|NCT02801292|Anesthetics, General|anesthetics, general|mesh-ancestor
110510099|NCT02801292|Anesthetics|anesthetics|mesh-ancestor
110510100|NCT02801292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110510101|NCT02801292|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110510102|NCT02801292|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110510103|NCT02801292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110894856|NCT02114528|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110510104|NCT02801292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110510105|NCT02544061|Interleukin-12|interleukin-12|mesh-list
110510106|NCT02544061|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110510107|NCT02544061|Immunologic Factors|immunologic factors|mesh-ancestor
110510108|NCT02544061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110510109|NCT02544061|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110510110|NCT02544061|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110510111|NCT02544061|Growth Substances|growth substances|mesh-ancestor
110510112|NCT02544061|Growth Inhibitors|growth inhibitors|mesh-ancestor
110510113|NCT02544061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110510114|NCT00863863|Griseofulvin|griseofulvin|mesh-list
110510115|NCT00863863|Antifungal Agents|antifungal agents|mesh-ancestor
110510116|NCT00863863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110510117|NCT03853044|Prednisone|prednisone|mesh-list
110510118|NCT03853044|Cyclophosphamide|cyclophosphamide|mesh-list
110510119|NCT03853044|Doxorubicin|doxorubicin|mesh-list
110510120|NCT03853044|Vincristine|vincristine|mesh-list
110510121|NCT03853044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110510122|NCT03853044|Immunologic Factors|immunologic factors|mesh-ancestor
110510123|NCT03853044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110510124|NCT03853044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110510125|NCT03853044|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110510126|NCT03853044|Alkylating Agents|alkylating agents|mesh-ancestor
110510127|NCT03853044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110510128|NCT03853044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110510129|NCT03853044|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110510130|NCT03853044|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110510131|NCT03853044|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110510132|NCT03853044|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110510133|NCT03853044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110510134|NCT03853044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110510135|NCT03853044|Glucocorticoids|glucocorticoids|mesh-ancestor
110510137|NCT03853044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110510138|NCT03853044|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110510139|NCT03853044|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110510140|NCT03853044|Tubulin Modulators|tubulin modulators|mesh-ancestor
110510141|NCT03853044|Antimitotic Agents|antimitotic agents|mesh-ancestor
110510142|NCT03853044|Mitosis Modulators|mitosis modulators|mesh-ancestor
110510143|NCT00870337|Everolimus|everolimus|mesh-list
110510144|NCT00870337|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110510145|NCT00870337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110510146|NCT00870337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110895171|NCT03717129|Elvitegravir|elvitegravir|mesh-list
110510147|NCT00870337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110510148|NCT00870337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110510161|NCT00866437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110510163|NCT00866437|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110510164|NCT00866437|Contraceptive Agents|contraceptive agents|mesh-ancestor
110510165|NCT00866437|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110510166|NCT00866437|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110510167|NCT00866437|Progestins|progestins|mesh-ancestor
110510168|NCT00863941|Bupropion|bupropion|mesh-list
110895460|NCT04454515|Dexmedetomidine|dexmedetomidine|mesh-list
110510169|NCT00863941|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110510170|NCT00863941|Antidepressive Agents|antidepressive agents|mesh-ancestor
110510171|NCT00863941|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110895528|NCT02122484|Gout Suppressants|gout suppressants|mesh-ancestor
110510172|NCT00863941|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110510173|NCT00863941|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110510174|NCT00863941|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110510175|NCT00863941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110510176|NCT00863941|Dopamine Agents|dopamine agents|mesh-ancestor
110510177|NCT00863941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110510178|NCT00863941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110510179|NCT00863941|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110510180|NCT00863941|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110895626|NCT02127164|Eusol|eusol|mesh-list
110510181|NCT00863941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110510182|NCT00812565|gamma-Globulins|gamma-globulins|mesh-list
110510183|NCT00812565|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110510184|NCT00812565|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110510185|NCT00812565|Immunologic Factors|immunologic factors|mesh-ancestor
110510186|NCT00812565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110510187|NCT00866515|Ketoconazole|ketoconazole|mesh-list
110510188|NCT00866515|Antifungal Agents|antifungal agents|mesh-ancestor
110510189|NCT00866515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110510190|NCT00866515|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110510191|NCT00866515|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110510192|NCT00866515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110510193|NCT00866515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110510194|NCT00866515|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110510195|NCT00866515|Hormone Antagonists|hormone antagonists|mesh-ancestor
110510196|NCT00866515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110510197|NCT00866515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110510198|NCT00866515|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110510199|NCT02795754|Ritonavir|ritonavir|mesh-list
110510200|NCT02795754|GSK-2838232|gsk-2838232|mesh-list
110510201|NCT02795754|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110510202|NCT02795754|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110510203|NCT02795754|Protease Inhibitors|protease inhibitors|mesh-ancestor
110510204|NCT02795754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110510205|NCT02795754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110510207|NCT02795754|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110510208|NCT02795754|Antiviral Agents|antiviral agents|mesh-ancestor
110510209|NCT02795754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110510210|NCT02795754|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110187272|NCT03255473|Protease Inhibitors|protease inhibitors|mesh-ancestor
110510211|NCT02795754|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110510213|NCT00864019|Antidepressive Agents|antidepressive agents|mesh-ancestor
110510224|NCT00812487|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110510225|NCT00812487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110510226|NCT04235868|Mitogens|mitogens|mesh-list
110510227|NCT04235868|Mitosis Modulators|mitosis modulators|mesh-ancestor
110510228|NCT04235868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110510229|NCT02800902|Atorvastatin|atorvastatin|mesh-list
110510230|NCT02800902|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110510231|NCT02800902|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110510232|NCT02800902|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110510233|NCT02800902|Antimetabolites|antimetabolites|mesh-ancestor
110510234|NCT02800902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110510235|NCT02800902|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110510236|NCT02800902|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110510237|NCT02800902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110510238|NCT05756595|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110510239|NCT00617461|Gabapentin|gabapentin|mesh-list
110510240|NCT00617461|Analgesics|analgesics|mesh-ancestor
110510241|NCT00617461|Sensory System Agents|sensory system agents|mesh-ancestor
110510242|NCT00617461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110510243|NCT00617461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110510244|NCT00617461|Anticonvulsants|anticonvulsants|mesh-ancestor
110510245|NCT00617461|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110510246|NCT00617461|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110510247|NCT00617461|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110510248|NCT00617461|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110510249|NCT00617461|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110510250|NCT00617461|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110510251|NCT00617461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110510252|NCT00617461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110510253|NCT00617461|Antimanic Agents|antimanic agents|mesh-ancestor
110510255|NCT00812331|Antiviral Agents|antiviral agents|mesh-ancestor
110510256|NCT00812331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110187375|NCT02471430|Panobinostat|panobinostat|mesh-list
110187376|NCT02471430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110187378|NCT02471430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110187379|NCT02471430|Immunologic Factors|immunologic factors|mesh-ancestor
110510257|NCT00812331|Protease Inhibitors|protease inhibitors|mesh-ancestor
110510258|NCT00812331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110510259|NCT00812331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110510260|NCT04233996|Meropenem|meropenem|mesh-list
110510261|NCT04233996|Tazobactam|tazobactam|mesh-list
110510262|NCT04233996|Piperacillin|piperacillin|mesh-list
110510263|NCT04233996|Cefepime|cefepime|mesh-list
110510264|NCT04233996|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
110510265|NCT04233996|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110510266|NCT04233996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110510267|NCT04233996|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110510268|NCT04233996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110613388|NCT00920621|Vitamin D|vitamin d|mesh-list
110510269|NCT04233996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110510270|NCT00812253|Insulin|insulin|mesh-list
110510271|NCT00812253|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110510272|NCT00812253|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110510273|NCT00812253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110510274|NCT00870571|Amlodipine|amlodipine|mesh-list
110510275|NCT00870571|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110510276|NCT00870571|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110510277|NCT00870571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110510282|NCT05756439|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
110510283|NCT05756439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110510284|NCT05756439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110510286|NCT00616759|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110510287|NCT00616759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110510288|NCT00616759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110510289|NCT00616759|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110510290|NCT00616759|Anesthetics, General|anesthetics, general|mesh-ancestor
110510291|NCT00616759|Anesthetics|anesthetics|mesh-ancestor
110510292|NCT00866593|Dexetimide|dexetimide|mesh-list
110510293|NCT00866593|Citalopram|citalopram|mesh-list
110510294|NCT00866593|Escitalopram|escitalopram|mesh-list
110510295|NCT00866593|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110510296|NCT00866593|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110510297|NCT00866593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110510298|NCT00866593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110510299|NCT00866593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110510300|NCT00866593|Serotonin Agents|serotonin agents|mesh-ancestor
110510301|NCT00866593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110510302|NCT00866593|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110510303|NCT00866593|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110510304|NCT00866593|Parasympatholytics|parasympatholytics|mesh-ancestor
110510305|NCT00866593|Autonomic Agents|autonomic agents|mesh-ancestor
110510306|NCT00866593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110510307|NCT00866593|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110510308|NCT00866593|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110510309|NCT00866593|Cholinergic Agents|cholinergic agents|mesh-ancestor
110510310|NCT00866593|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110510311|NCT00866593|Antidepressive Agents|antidepressive agents|mesh-ancestor
110510312|NCT00866593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110510313|NCT02796378|Ubiquinone|ubiquinone|mesh-list
110510314|NCT02796378|Coenzyme Q10|coenzyme q10|mesh-list
110510315|NCT02796378|Simvastatin|simvastatin|mesh-list
110187449|NCT01604135|Micronutrients|micronutrients|mesh-ancestor
110510316|NCT02796378|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110510317|NCT02796378|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110510318|NCT02796378|Antimetabolites|antimetabolites|mesh-ancestor
110510319|NCT02796378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110510320|NCT02796378|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110510321|NCT02796378|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110510322|NCT02796378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110510323|NCT02796378|Micronutrients|micronutrients|mesh-ancestor
110510324|NCT02796378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110510326|NCT00864409|Ropivacaine|ropivacaine|mesh-list
110510327|NCT00864409|Anesthetics, Local|anesthetics, local|mesh-ancestor
110510328|NCT00864409|Anesthetics|anesthetics|mesh-ancestor
110510329|NCT00864409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110510330|NCT00864409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110510331|NCT00864409|Sensory System Agents|sensory system agents|mesh-ancestor
110510332|NCT00864409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110510333|NCT00866983|Sildenafil Citrate|sildenafil citrate|mesh-list
110510334|NCT00866983|Vasodilator Agents|vasodilator agents|mesh-ancestor
110510335|NCT00866983|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110510336|NCT00866983|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110510337|NCT00866983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110510338|NCT00866983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110510339|NCT00866983|Urological Agents|urological agents|mesh-ancestor
110510340|NCT05226013|Rasburicase|rasburicase|mesh-list
110510341|NCT05226013|Gout Suppressants|gout suppressants|mesh-ancestor
110510342|NCT05226013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110510343|NCT00870961|Cholecalciferol|cholecalciferol|mesh-list
110510344|NCT00870961|Vitamin D|vitamin d|mesh-list
110510345|NCT00870961|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110510348|NCT00870961|Micronutrients|micronutrients|mesh-ancestor
110510349|NCT00870961|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110510351|NCT00811941|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110510352|NCT00811941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110510353|NCT00811941|Sensory System Agents|sensory system agents|mesh-ancestor
110157709|NCT00394186|Solabegron|solabegron|mesh-list
110510354|NCT00811941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110510355|NCT00864565|Fentanyl|fentanyl|mesh-list
110510356|NCT00864565|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110510357|NCT00864565|Narcotics|narcotics|mesh-ancestor
110510358|NCT00864565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110510359|NCT00864565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110510360|NCT00864565|Analgesics|analgesics|mesh-ancestor
110510361|NCT00864565|Sensory System Agents|sensory system agents|mesh-ancestor
110510362|NCT00864565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110510363|NCT00864565|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110510364|NCT00864565|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110510365|NCT00864565|Anesthetics, General|anesthetics, general|mesh-ancestor
110510366|NCT00864565|Anesthetics|anesthetics|mesh-ancestor
110510367|NCT00864643|Atorvastatin|atorvastatin|mesh-list
110510368|NCT00864643|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110510369|NCT00864643|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110510370|NCT00864643|Antimetabolites|antimetabolites|mesh-ancestor
110510371|NCT00864643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110510372|NCT00864643|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110510373|NCT00864643|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110510374|NCT00864643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110510375|NCT00871039|Midazolam|midazolam|mesh-list
110510376|NCT00871039|Propofol|propofol|mesh-list
110510377|NCT00871039|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110510378|NCT00871039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110510379|NCT00871039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110510380|NCT00871039|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110510381|NCT00871039|Anesthetics, General|anesthetics, general|mesh-ancestor
110510382|NCT00871039|Anesthetics|anesthetics|mesh-ancestor
110510383|NCT00871039|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110510384|NCT00871039|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110510385|NCT00871039|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110510386|NCT00871039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110510387|NCT00871039|GABA Modulators|gaba modulators|mesh-ancestor
110510388|NCT00871039|GABA Agents|gaba agents|mesh-ancestor
110510389|NCT00871039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110510390|NCT00871039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110510391|NCT00867061|ON 01910|on 01910|mesh-list
110510392|NCT00867061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110896297|NCT05548660|Analgesics|analgesics|mesh-list
110510393|NCT00867061|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110311991|NCT00291980|Vaccines|vaccines|mesh-list
110510394|NCT00867061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110510395|NCT00867061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110510397|NCT00864799|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110510399|NCT00864799|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110510400|NCT00864799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110510401|NCT00864799|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110510402|NCT00864799|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110510403|NCT00864799|Oxytocics|oxytocics|mesh-ancestor
110510404|NCT04234776|Ketamine|ketamine|mesh-list
110896472|NCT05283408|Esketamine|esketamine|mesh-list
110510405|NCT04234776|Aripiprazole|aripiprazole|mesh-list
110510406|NCT04234776|Escitalopram|escitalopram|mesh-list
110510407|NCT04234776|Analgesics|analgesics|mesh-ancestor
110510408|NCT04234776|Sensory System Agents|sensory system agents|mesh-ancestor
110510409|NCT04234776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110510410|NCT04234776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110510411|NCT04234776|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110510412|NCT04234776|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110510413|NCT04234776|Anesthetics, General|anesthetics, general|mesh-ancestor
110510415|NCT04234776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110510416|NCT04234776|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110896653|NCT04928391|Nalbuphine|nalbuphine|mesh-list
110510418|NCT04234776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110176783|NCT03151707|Niacinamide|niacinamide|mesh-list
110510433|NCT04234776|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110510434|NCT04234776|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110510436|NCT05756049|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110510437|NCT05756049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110510438|NCT00871273|Capecitabine|capecitabine|mesh-list
110510439|NCT00871273|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110510440|NCT00871273|Antimetabolites|antimetabolites|mesh-ancestor
110510441|NCT00871273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110510442|NCT00871273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110510443|NCT00867295|Cefazolin|cefazolin|mesh-list
110510444|NCT00867295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110510445|NCT00867295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110510446|NCT02794506|Propolis|propolis|mesh-list
110510447|NCT02794506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110510448|NCT04040491|Gemcitabine|gemcitabine|mesh-list
110510449|NCT04040491|Lenalidomide|lenalidomide|mesh-list
110510450|NCT04040491|Antibodies|antibodies|mesh-list
110510451|NCT04040491|Antibodies, Blocking|antibodies, blocking|mesh-list
110510452|NCT04040491|Immunologic Factors|immunologic factors|mesh-ancestor
110510453|NCT04040491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110510454|NCT04040491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110510455|NCT04040491|Antimetabolites|antimetabolites|mesh-ancestor
110510456|NCT04040491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110510457|NCT04040491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110510458|NCT04040491|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110510459|NCT04040491|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110510460|NCT04040491|Growth Substances|growth substances|mesh-ancestor
110510461|NCT04040491|Growth Inhibitors|growth inhibitors|mesh-ancestor
110510462|NCT02794584|Sufentanil|sufentanil|mesh-list
110510463|NCT02794584|Dsuvia|dsuvia|mesh-list
110510464|NCT02794584|Anesthetics|anesthetics|mesh-ancestor
110187575|NCT05771194|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110510465|NCT02794584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110510466|NCT02794584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110510467|NCT02794584|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110510468|NCT02794584|Narcotics|narcotics|mesh-ancestor
110510469|NCT02794584|Analgesics|analgesics|mesh-ancestor
110510470|NCT02794584|Sensory System Agents|sensory system agents|mesh-ancestor
110510471|NCT02794584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110510472|NCT02794584|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110510473|NCT02794584|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110510474|NCT02794584|Anesthetics, General|anesthetics, general|mesh-ancestor
110510475|NCT00811473|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110510476|NCT00811473|Antidepressive Agents|antidepressive agents|mesh-ancestor
110510477|NCT00811473|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110510478|NCT00811473|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110510479|NCT00811473|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110510492|NCT00865033|Metformin|metformin|mesh-list
110510493|NCT00865033|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110510494|NCT00865033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110510495|NCT04234932|Latanoprost|latanoprost|mesh-list
110510496|NCT04234932|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110510497|NCT04234932|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110510498|NCT02789592|Clonazepam|clonazepam|mesh-list
110510499|NCT02789592|Melatonin|melatonin|mesh-list
110510500|NCT02789592|Antioxidants|antioxidants|mesh-ancestor
110510501|NCT02789592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110510502|NCT02789592|Protective Agents|protective agents|mesh-ancestor
110896794|NCT04624906|Acalabrutinib|acalabrutinib|mesh-list
110510503|NCT02789592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110157860|NCT00390000|Pemetrexed|pemetrexed|mesh-list
110510504|NCT02789592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110510505|NCT02789592|Anticonvulsants|anticonvulsants|mesh-ancestor
110510507|NCT02789592|GABA Agents|gaba agents|mesh-ancestor
110510508|NCT02789592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110510509|NCT00876421|Tolterodine Tartrate|tolterodine tartrate|mesh-list
110510510|NCT00876421|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110510511|NCT00876421|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110510512|NCT00876421|Cholinergic Agents|cholinergic agents|mesh-ancestor
110510513|NCT00876421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110510514|NCT00876421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110187601|NCT05770960|Codeine|codeine|mesh-list
110510515|NCT00876421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110510516|NCT00876421|Urological Agents|urological agents|mesh-ancestor
110510517|NCT00872131|Sertraline|sertraline|mesh-list
110510518|NCT00872131|Antidepressive Agents|antidepressive agents|mesh-ancestor
110510519|NCT00872131|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110510520|NCT00872131|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110510521|NCT00872131|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110510522|NCT00872131|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110510523|NCT00872131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110510524|NCT00872131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110510525|NCT00872131|Serotonin Agents|serotonin agents|mesh-ancestor
110510526|NCT00872131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110510527|NCT04233294|Decitabine|decitabine|mesh-list
110510528|NCT04233294|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110510529|NCT04233294|Antimetabolites|antimetabolites|mesh-ancestor
110510530|NCT04233294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110510531|NCT04233294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110510532|NCT04233294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110510533|NCT00872209|Ciprofloxacin|ciprofloxacin|mesh-list
110510534|NCT00872209|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110510535|NCT00872209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110510536|NCT00872209|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110510537|NCT00872209|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110510538|NCT00872209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110510539|NCT00872209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110510540|NCT00872209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110510565|NCT02789358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110510566|NCT02789358|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110510567|NCT02789358|Vasodilator Agents|vasodilator agents|mesh-ancestor
110510568|NCT02789358|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
110510569|NCT02789358|Purinergic Agonists|purinergic agonists|mesh-ancestor
110510570|NCT02789358|Purinergic Agents|purinergic agents|mesh-ancestor
110510571|NCT02789358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110510572|NCT02789358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110510573|NCT03847506|Amlodipine|amlodipine|mesh-list
110510574|NCT03847506|Candesartan|candesartan|mesh-list
110510575|NCT03847506|Candesartan cilexetil|candesartan cilexetil|mesh-list
110510576|NCT03847506|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110510577|NCT03847506|Ezetimibe|ezetimibe|mesh-list
110510578|NCT03847506|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110510579|NCT03847506|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110510580|NCT03847506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110510581|NCT03847506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110510582|NCT03847506|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110510583|NCT03847506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110510584|NCT03847506|Vasodilator Agents|vasodilator agents|mesh-ancestor
110510585|NCT03847506|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110510586|NCT03847506|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110510587|NCT03847506|Antimetabolites|antimetabolites|mesh-ancestor
110896999|NCT04082442|Evolocumab|evolocumab|mesh-list
110510588|NCT03847506|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110510589|NCT03847506|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110510590|NCT03847506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110510591|NCT03847506|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110510592|NCT03847506|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110510593|NCT00617305|Ambrisentan|ambrisentan|mesh-list
110510594|NCT00617305|Sildenafil Citrate|sildenafil citrate|mesh-list
110510596|NCT00617305|Vasodilator Agents|vasodilator agents|mesh-ancestor
110510611|NCT02792712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110510612|NCT02792712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110510613|NCT00870883|Acetylcysteine|acetylcysteine|mesh-list
110510614|NCT00870883|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110510615|NCT00870883|Deferoxamine|deferoxamine|mesh-list
110510616|NCT00870883|Antiviral Agents|antiviral agents|mesh-ancestor
110510617|NCT00870883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110510619|NCT00870883|Respiratory System Agents|respiratory system agents|mesh-ancestor
110510620|NCT00870883|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110510621|NCT00870883|Antioxidants|antioxidants|mesh-ancestor
110510622|NCT00870883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110510623|NCT00870883|Protective Agents|protective agents|mesh-ancestor
110510624|NCT00870883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110510625|NCT00870883|Antidotes|antidotes|mesh-ancestor
110510626|NCT00870883|Siderophores|siderophores|mesh-ancestor
110510627|NCT00870883|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110510628|NCT00870883|Chelating Agents|chelating agents|mesh-ancestor
110510629|NCT00870883|Sequestering Agents|sequestering agents|mesh-ancestor
110510630|NCT02789202|Fluorides|fluorides|mesh-list
110897131|NCT03869268|Aspirin|aspirin|mesh-list
110510631|NCT02789202|Sodium Fluoride|sodium fluoride|mesh-list
110510632|NCT02789202|Fluorides, Topical|fluorides, topical|mesh-list
110510633|NCT02789202|Cariostatic Agents|cariostatic agents|mesh-ancestor
110510634|NCT02789202|Protective Agents|protective agents|mesh-ancestor
110510635|NCT02789202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110510637|NCT00811395|Interferon-beta|interferon-beta|mesh-list
110510638|NCT00811395|Teriflunomide|teriflunomide|mesh-list
110510639|NCT00811395|Glatiramer Acetate|glatiramer acetate|mesh-list
110510640|NCT00811395|Interferon beta-1b|interferon beta-1b|mesh-list
110510641|NCT00811395|(T,G)-A-L|(t,g)-a-l|mesh-list
110897332|NCT03279289|Antidotes|antidotes|mesh-ancestor
110187664|NCT05750875|Anticonvulsants|anticonvulsants|mesh-ancestor
110510642|NCT00811395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110510643|NCT00811395|Antiviral Agents|antiviral agents|mesh-ancestor
110510644|NCT00811395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110510645|NCT00811395|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110510646|NCT00811395|Immunologic Factors|immunologic factors|mesh-ancestor
110510647|NCT00811395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110510648|NCT00811395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110510649|NCT00811395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110510650|NCT00811395|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110510651|NCT00811395|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110510652|NCT00811395|Analgesics|analgesics|mesh-ancestor
110510653|NCT00811395|Sensory System Agents|sensory system agents|mesh-ancestor
110510654|NCT00811395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110510655|NCT00811395|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110510656|NCT02792946|Ambroxol|ambroxol|mesh-list
110510657|NCT02792946|Expectorants|expectorants|mesh-ancestor
110510658|NCT02792946|Respiratory System Agents|respiratory system agents|mesh-ancestor
110510659|NCT00876577|Moxifloxacin|moxifloxacin|mesh-list
110176835|NCT04733508|Incretins|incretins|mesh-ancestor
110510677|NCT02787798|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110510678|NCT02787798|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110510679|NCT02787798|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110510680|NCT02787798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110510681|NCT02609997|Dexamethasone|dexamethasone|mesh-list
110510682|NCT02609997|Proxymetacaine|proxymetacaine|mesh-list
110510683|NCT02609997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110510684|NCT02609997|Antiemetics|antiemetics|mesh-ancestor
110510685|NCT02609997|Autonomic Agents|autonomic agents|mesh-ancestor
110510686|NCT02609997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110510687|NCT02609997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110510688|NCT02609997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110510689|NCT02609997|Glucocorticoids|glucocorticoids|mesh-ancestor
110510690|NCT02609997|Hormones|hormones|mesh-ancestor
110897623|NCT01446133|Rituximab|rituximab|mesh-list
110510691|NCT02609997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110897672|NCT01187199|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110510692|NCT02609997|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110510693|NCT02609997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110510694|NCT02609997|Anesthetics, Local|anesthetics, local|mesh-ancestor
110510695|NCT02609997|Anesthetics|anesthetics|mesh-ancestor
110510696|NCT02609997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110510697|NCT02609997|Sensory System Agents|sensory system agents|mesh-ancestor
110510698|NCT00876655|Tedizolid phosphate|tedizolid phosphate|mesh-list
110510699|NCT00876655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110510700|NCT00876655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110897818|NCT05759845|Adrenergic Agents|adrenergic agents|mesh-ancestor
110510701|NCT02609919|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
110510702|NCT02609919|Chelating Agents|chelating agents|mesh-ancestor
110510703|NCT02609919|Sequestering Agents|sequestering agents|mesh-ancestor
110510704|NCT02609919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110510706|NCT04114500|Progesterone|progesterone|mesh-list
110510707|NCT04114500|Estrogens|estrogens|mesh-ancestor
110510708|NCT04114500|Hormones|hormones|mesh-ancestor
110510709|NCT04114500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110510710|NCT04114500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110510711|NCT04114500|Progestins|progestins|mesh-ancestor
110510712|NCT05755659|Fosaprepitant|fosaprepitant|mesh-list
110510713|NCT05755659|Aprepitant|aprepitant|mesh-list
110510723|NCT00913887|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110510725|NCT00913887|Analgesics|analgesics|mesh-ancestor
110510726|NCT00913887|Sensory System Agents|sensory system agents|mesh-ancestor
110510727|NCT00913887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110510728|NCT00913887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110510729|NCT00913887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110510730|NCT00913887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110510731|NCT00913887|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110510733|NCT00913887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110510734|NCT02792400|Empagliflozin|empagliflozin|mesh-list
110510735|NCT02792400|Linagliptin|linagliptin|mesh-list
110510736|NCT02792400|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110510737|NCT02792400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110510738|NCT02792400|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110510739|NCT02792400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110510740|NCT02792400|Incretins|incretins|mesh-ancestor
110510741|NCT02792400|Hormones|hormones|mesh-ancestor
110510742|NCT02792400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110510743|NCT02792400|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110510744|NCT02792400|Protease Inhibitors|protease inhibitors|mesh-ancestor
110898313|NCT01360151|Verteporfin|verteporfin|mesh-list
110510745|NCT02792400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110510746|NCT04040023|Vitamins|vitamins|mesh-list
110510747|NCT04040023|Micronutrients|micronutrients|mesh-ancestor
110898380|NCT01360463|Methadone|methadone|mesh-list
110510748|NCT04040023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110510749|NCT05755581|Antineoplastic Agents|antineoplastic agents|mesh-list
110510750|NCT05755581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-list
110510751|NCT05017155|Mexiletine|mexiletine|mesh-list
110510752|NCT05017155|Lamotrigine|lamotrigine|mesh-list
110510753|NCT05017155|Anticonvulsants|anticonvulsants|mesh-ancestor
110510754|NCT05017155|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110510755|NCT05017155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110510756|NCT05017155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110510757|NCT05017155|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110510758|NCT05017155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110510759|NCT05017155|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110510760|NCT05017155|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110510761|NCT05017155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110510762|NCT05017155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110510763|NCT05017155|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110510764|NCT05017155|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110510765|NCT05017155|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110510766|NCT05162131|Ticagrelor|ticagrelor|mesh-list
110510767|NCT05162131|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110510768|NCT05162131|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110898509|NCT03548714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110510769|NCT05162131|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110510770|NCT05162131|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110510771|NCT05162131|Purinergic Agents|purinergic agents|mesh-ancestor
110510772|NCT05162131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110510773|NCT05162131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110510774|NCT05162131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110510775|NCT00868153|Levonorgestrel|levonorgestrel|mesh-list
110510776|NCT00868153|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110510777|NCT00868153|Contraceptive Agents|contraceptive agents|mesh-ancestor
110510778|NCT00868153|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110898722|NCT03862170|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110510789|NCT00876889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110510790|NCT00876889|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110510791|NCT00876889|Protective Agents|protective agents|mesh-ancestor
110510792|NCT00868465|Lumefantrine|lumefantrine|mesh-list
110510793|NCT00868465|Artemether|artemether|mesh-list
110510794|NCT00868465|Piperaquine|piperaquine|mesh-list
110510795|NCT00868465|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
110510796|NCT00868465|Artenimol|artenimol|mesh-list
110510797|NCT00868465|Antimalarials|antimalarials|mesh-ancestor
110510798|NCT00868465|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110510799|NCT00868465|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110510800|NCT00868465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110510801|NCT02689986|Rituximab|rituximab|mesh-list
110510802|NCT02689986|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110510803|NCT02689986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110510804|NCT02689986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110510805|NCT02689986|Immunologic Factors|immunologic factors|mesh-ancestor
110898933|NCT02253446|Analgesics|analgesics|mesh-ancestor
110510806|NCT02689986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110510807|NCT02689986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110510808|NCT02689986|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110510809|NCT02689986|Alkylating Agents|alkylating agents|mesh-ancestor
110899002|NCT03432065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110510810|NCT02689986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110510811|NCT00876967|Pyrithione zinc|pyrithione zinc|mesh-list
110510812|NCT00876967|Keratolytic Agents|keratolytic agents|mesh-ancestor
110510813|NCT00876967|Dermatologic Agents|dermatologic agents|mesh-ancestor
110510814|NCT00955409|Saponin QA-21V1|saponin qa-21v1|mesh-list
110510815|NCT00955409|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110510816|NCT00955409|Immunologic Factors|immunologic factors|mesh-ancestor
110899148|NCT02250534|Nicotine|nicotine|mesh-list
110510817|NCT00955409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110510819|NCT00877123|Vitamins|vitamins|mesh-ancestor
110510820|NCT00877123|Micronutrients|micronutrients|mesh-ancestor
110899289|NCT02239458|Saxagliptin|saxagliptin|mesh-list
110510821|NCT00877123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110510822|NCT00877123|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110510823|NCT00873223|Liraglutide|liraglutide|mesh-list
110510824|NCT00873223|Insulin Detemir|insulin detemir|mesh-list
110510825|NCT00873223|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110510826|NCT00873223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110510827|NCT00873223|Incretins|incretins|mesh-ancestor
110510828|NCT00873223|Hormones|hormones|mesh-ancestor
110510829|NCT00873223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110510830|NCT00873379|Melatonin|melatonin|mesh-list
110510831|NCT00873379|Antioxidants|antioxidants|mesh-ancestor
110510832|NCT00873379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110510833|NCT00873379|Protective Agents|protective agents|mesh-ancestor
110510834|NCT00873379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110510835|NCT00873379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110510836|NCT00868855|Bradykinin|bradykinin|mesh-list
110510837|NCT00868855|Kininogens|kininogens|mesh-list
110510838|NCT00868855|Vasodilator Agents|vasodilator agents|mesh-ancestor
110510839|NCT00868855|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
110510840|NCT00868855|Protease Inhibitors|protease inhibitors|mesh-ancestor
110510841|NCT00868855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110510842|NCT00868855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110510843|NCT00615901|Cyclophosphamide|cyclophosphamide|mesh-list
110510844|NCT00615901|Fluorouracil|fluorouracil|mesh-list
110510854|NCT00615901|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110510855|NCT00615901|Antimetabolites|antimetabolites|mesh-ancestor
110510856|NCT00615901|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110510857|NCT00615901|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110510858|NCT00615901|Abortifacient Agents|abortifacient agents|mesh-ancestor
110510859|NCT00615901|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110510860|NCT00615901|Dermatologic Agents|dermatologic agents|mesh-ancestor
110510861|NCT00615901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110510862|NCT00615901|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110510863|NCT00615901|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110510864|NCT00616603|Dexamethasone|dexamethasone|mesh-list
110510865|NCT00616603|Dexamethasone acetate|dexamethasone acetate|mesh-list
110510866|NCT00616603|Ropivacaine|ropivacaine|mesh-list
110510868|NCT00616603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110510869|NCT00616603|Antiemetics|antiemetics|mesh-ancestor
110510870|NCT00616603|Autonomic Agents|autonomic agents|mesh-ancestor
110510871|NCT00616603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110510872|NCT00616603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110510873|NCT00616603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110899666|NCT04894994|Ipilimumab|ipilimumab|mesh-list
110510874|NCT00616603|Glucocorticoids|glucocorticoids|mesh-ancestor
110510876|NCT00616603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110510877|NCT00616603|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110510878|NCT00616603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110510879|NCT00616603|Protease Inhibitors|protease inhibitors|mesh-ancestor
110510880|NCT00616603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110510881|NCT00616603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110510882|NCT00616603|Anesthetics, Local|anesthetics, local|mesh-ancestor
110510883|NCT00616603|Anesthetics|anesthetics|mesh-ancestor
110187805|NCT05375942|Infliximab|infliximab|mesh-list
110510884|NCT00616603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110510885|NCT00616603|Sensory System Agents|sensory system agents|mesh-ancestor
110510886|NCT00873535|Varenicline|varenicline|mesh-list
110510887|NCT00873535|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110510888|NCT00873535|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110510889|NCT00873535|Cholinergic Agents|cholinergic agents|mesh-ancestor
110899753|NCT03318770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110510890|NCT00873535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110510891|NCT00873535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110510892|NCT00873535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110510894|NCT02790996|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110510895|NCT02790996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110510896|NCT00810693|Riociguat|riociguat|mesh-list
110510897|NCT00810693|Enzyme Activators|enzyme activators|mesh-ancestor
110510898|NCT00810693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110510899|NCT02790840|Omeprazole|omeprazole|mesh-list
110510900|NCT02790840|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110899901|NCT03571230|Antacids|antacids|mesh-ancestor
110510901|NCT02790840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110510902|NCT02790840|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110510903|NCT02790840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110510904|NCT02790840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110510906|NCT02790684|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110510907|NCT02790684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110510908|NCT02790450|Benzbromarone|benzbromarone|mesh-list
110510909|NCT02790450|Uricosuric Agents|uricosuric agents|mesh-ancestor
110176890|NCT03151434|Narcotics|narcotics|mesh-ancestor
110510917|NCT02790528|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110899973|NCT02143934|Artemether|artemether|mesh-list
110510918|NCT02790528|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110510920|NCT00953615|Thalidomide|thalidomide|mesh-list
110510921|NCT00953615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110510922|NCT00953615|Immunologic Factors|immunologic factors|mesh-ancestor
110510923|NCT00953615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110510924|NCT00953615|Leprostatic Agents|leprostatic agents|mesh-ancestor
110510925|NCT00953615|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110510926|NCT00953615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110510927|NCT00953615|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110900031|NCT02846532|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110510928|NCT00953615|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110510929|NCT00953615|Growth Substances|growth substances|mesh-ancestor
110510930|NCT00953615|Growth Inhibitors|growth inhibitors|mesh-ancestor
110510931|NCT00953615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110510933|NCT00873769|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110510934|NCT00873769|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110510935|NCT00873769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110510936|NCT00873769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110510937|NCT00873769|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110510938|NCT00873769|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110510939|NCT00873769|Dopamine Agents|dopamine agents|mesh-ancestor
110510940|NCT00873769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110510941|NCT00873769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110510942|NCT02785614|Trazodone|trazodone|mesh-list
110510943|NCT02785614|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110510944|NCT02785614|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110510945|NCT02785614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110510946|NCT02785614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110510947|NCT02785614|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110510948|NCT02785614|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110510949|NCT02785614|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110510950|NCT02785614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110510951|NCT02785614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110510952|NCT02785614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110510953|NCT02785614|Serotonin Agents|serotonin agents|mesh-ancestor
110158327|NCT00084721|Celecoxib|celecoxib|mesh-list
110510954|NCT02785614|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110510955|NCT02785614|Antidepressive Agents|antidepressive agents|mesh-ancestor
110510957|NCT02787018|Dexmedetomidine|dexmedetomidine|mesh-list
110510958|NCT02787018|Ropivacaine|ropivacaine|mesh-list
110510959|NCT02787018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110510960|NCT02787018|Antiemetics|antiemetics|mesh-ancestor
110510962|NCT02787018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110510963|NCT02787018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110510964|NCT02787018|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110510965|NCT02787018|Glucocorticoids|glucocorticoids|mesh-ancestor
110510966|NCT02787018|Hormones|hormones|mesh-ancestor
110510967|NCT02787018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110510968|NCT02787018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110510969|NCT02787018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110510970|NCT02787018|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110900577|NCT03110848|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110510971|NCT02787018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110510973|NCT02787018|Analgesics|analgesics|mesh-ancestor
110510974|NCT02787018|Sensory System Agents|sensory system agents|mesh-ancestor
110510975|NCT02787018|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110176899|NCT04061798|Anticoagulants|anticoagulants|mesh-ancestor
110510989|NCT03412266|Cyclophosphamide|cyclophosphamide|mesh-list
110510990|NCT03412266|Busulfan|busulfan|mesh-list
110510991|NCT03412266|Semustine|semustine|mesh-list
110510992|NCT03412266|Fludarabine|fludarabine|mesh-list
110510993|NCT03412266|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110510994|NCT03412266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110510995|NCT03412266|Immunologic Factors|immunologic factors|mesh-ancestor
110510996|NCT03412266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110510997|NCT03412266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110510999|NCT03412266|Alkylating Agents|alkylating agents|mesh-ancestor
110511000|NCT03412266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110511001|NCT03412266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110511002|NCT03412266|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110511003|NCT03412266|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110511004|NCT03412266|Antimetabolites|antimetabolites|mesh-ancestor
110511005|NCT03412266|Antiviral Agents|antiviral agents|mesh-ancestor
110511006|NCT03412266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110511007|NCT00877591|Ritonavir|ritonavir|mesh-list
110511008|NCT00877591|Darunavir|darunavir|mesh-list
110511009|NCT00877591|Fosamprenavir|fosamprenavir|mesh-list
110511010|NCT00877591|Rifampin|rifampin|mesh-list
110511011|NCT00877591|Rifabutin|rifabutin|mesh-list
110511012|NCT00877591|Buprenorphine|buprenorphine|mesh-list
110511013|NCT00877591|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110511014|NCT00877591|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110511015|NCT00877591|Protease Inhibitors|protease inhibitors|mesh-ancestor
110511016|NCT00877591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110511017|NCT00877591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110511018|NCT00877591|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110511019|NCT00877591|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110511020|NCT00877591|Antiviral Agents|antiviral agents|mesh-ancestor
110511021|NCT00877591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110511022|NCT00877591|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110511023|NCT00877591|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110511024|NCT00877591|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110511025|NCT00877591|Narcotics|narcotics|mesh-ancestor
110511026|NCT00877591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110900905|NCT05418907|Incretins|incretins|mesh-ancestor
110511027|NCT00877591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110511028|NCT00877591|Analgesics|analgesics|mesh-ancestor
110511029|NCT00877591|Sensory System Agents|sensory system agents|mesh-ancestor
110511030|NCT00877591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110511031|NCT00877591|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110511032|NCT00877591|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110511033|NCT00877591|Antitubercular Agents|antitubercular agents|mesh-ancestor
110511034|NCT00877591|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110511035|NCT00877591|Leprostatic Agents|leprostatic agents|mesh-ancestor
110511036|NCT00877591|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110511037|NCT00877591|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110511038|NCT00877591|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110511039|NCT00877591|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110511040|NCT00877591|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110176908|NCT00135811|Autonomic Agents|autonomic agents|mesh-ancestor
110511050|NCT00874003|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110511051|NCT00874003|Histamine Antagonists|histamine antagonists|mesh-ancestor
110511052|NCT00874003|Histamine Agents|histamine agents|mesh-ancestor
110511053|NCT00874003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110511054|NCT00874003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110511055|NCT00874003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110511056|NCT00874003|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110511057|NCT00874003|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110511058|NCT00874003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110511061|NCT00874003|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110511062|NCT00874003|Adrenergic Agents|adrenergic agents|mesh-ancestor
110511063|NCT00874003|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110511064|NCT00874003|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110511065|NCT00874003|Serotonin Agents|serotonin agents|mesh-ancestor
110511066|NCT00874003|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110511067|NCT04915365|Acetazolamide|acetazolamide|mesh-list
110511068|NCT04915365|Anticonvulsants|anticonvulsants|mesh-ancestor
110511069|NCT04915365|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110511070|NCT04915365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110511071|NCT04915365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110511072|NCT04915365|Diuretics|diuretics|mesh-ancestor
110511073|NCT04915365|Natriuretic Agents|natriuretic agents|mesh-ancestor
110511074|NCT04915365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110511075|NCT02785146|Calcium, Dietary|calcium, dietary|mesh-list
110511077|NCT02785146|Fluorouracil|fluorouracil|mesh-list
110511078|NCT02785146|Oxaliplatin|oxaliplatin|mesh-list
110511080|NCT02785146|Levoleucovorin|levoleucovorin|mesh-list
110901324|NCT03136666|Candesartan|candesartan|mesh-list
110511081|NCT02785146|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110511082|NCT02785146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110511083|NCT02785146|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110511084|NCT02785146|Antimetabolites|antimetabolites|mesh-ancestor
110901382|NCT04531059|Expectorants|expectorants|mesh-ancestor
110511085|NCT02785146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110511086|NCT02785146|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110511087|NCT02785146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110901456|NCT03097315|Glucocorticoids|glucocorticoids|mesh-ancestor
110511088|NCT02785146|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110511089|NCT02785146|Immunologic Factors|immunologic factors|mesh-ancestor
110511090|NCT02785146|Antidotes|antidotes|mesh-ancestor
110511091|NCT02785146|Protective Agents|protective agents|mesh-ancestor
110511092|NCT02785146|Vitamin B Complex|vitamin b complex|mesh-ancestor
110511093|NCT02785146|Vitamins|vitamins|mesh-ancestor
110511094|NCT02785146|Micronutrients|micronutrients|mesh-ancestor
110511095|NCT00913965|Atenolol|atenolol|mesh-list
110511096|NCT00913965|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110511097|NCT00913965|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110511098|NCT00913965|Sympatholytics|sympatholytics|mesh-ancestor
110511099|NCT00913965|Autonomic Agents|autonomic agents|mesh-ancestor
110511100|NCT00913965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110511101|NCT00913965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110511102|NCT00913965|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110511103|NCT00913965|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110511104|NCT00913965|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110158470|NCT00006080|Fenretinide|fenretinide|mesh-list
110511105|NCT00913965|Adrenergic Agents|adrenergic agents|mesh-ancestor
110511107|NCT00913965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110511109|NCT05753865|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110176920|NCT00135811|Immunologic Factors|immunologic factors|mesh-ancestor
110511127|NCT00874315|Busulfan|busulfan|mesh-list
110511128|NCT00874315|Tacrolimus|tacrolimus|mesh-list
110511129|NCT00874315|Cyclosporins|cyclosporins|mesh-list
110511130|NCT00874315|Thymoglobulin|thymoglobulin|mesh-list
110511131|NCT00874315|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110511132|NCT00874315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110511133|NCT00874315|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110511134|NCT00874315|Antimetabolites|antimetabolites|mesh-ancestor
110511135|NCT00874315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110511136|NCT00874315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110901805|NCT01374737|Dexmedetomidine|dexmedetomidine|mesh-list
110511137|NCT00874315|Immunologic Factors|immunologic factors|mesh-ancestor
110511138|NCT00874315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110511139|NCT00874315|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110511140|NCT00874315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110511141|NCT00874315|Antifungal Agents|antifungal agents|mesh-ancestor
110511142|NCT00874315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110511143|NCT00874315|Dermatologic Agents|dermatologic agents|mesh-ancestor
110511144|NCT00874315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110511145|NCT00874315|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110511146|NCT00874315|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110511147|NCT00874315|Antitubercular Agents|antitubercular agents|mesh-ancestor
110511148|NCT00874315|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110511149|NCT00874315|Alkylating Agents|alkylating agents|mesh-ancestor
110511150|NCT00874315|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110511151|NCT00874315|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110511152|NCT00874393|Hydrocortisone|hydrocortisone|mesh-list
110511153|NCT00874393|Dopamine|dopamine|mesh-list
110511154|NCT00874393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110511155|NCT00874393|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110511156|NCT00874393|Sympathomimetics|sympathomimetics|mesh-ancestor
110511157|NCT00874393|Autonomic Agents|autonomic agents|mesh-ancestor
110511158|NCT00874393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110511159|NCT00874393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110511160|NCT00874393|Dopamine Agents|dopamine agents|mesh-ancestor
110511161|NCT00874393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110511162|NCT00874393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110902153|NCT05597527|Apatinib|apatinib|mesh-list
110511163|NCT00874393|Protective Agents|protective agents|mesh-ancestor
110511164|NCT04199364|Poractant alfa|poractant alfa|mesh-list
110511165|NCT04199364|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
110511166|NCT04199364|Respiratory System Agents|respiratory system agents|mesh-ancestor
110511167|NCT00870025|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
110511168|NCT00870025|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110511169|NCT00870025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110511170|NCT00877981|Parathyroid Hormone|parathyroid hormone|mesh-list
110511171|NCT00877981|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110511172|NCT00877981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110511183|NCT02786550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110511184|NCT02784054|Cyclophosphamide|cyclophosphamide|mesh-list
110511186|NCT02784054|Thiotepa|thiotepa|mesh-list
110511187|NCT02784054|Carboplatin|carboplatin|mesh-list
110511188|NCT02784054|Etoposide|etoposide|mesh-list
110511189|NCT02784054|Bleomycin|bleomycin|mesh-list
110511190|NCT02784054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110511191|NCT02784054|Immunologic Factors|immunologic factors|mesh-ancestor
110511192|NCT02784054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110511193|NCT02784054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110511194|NCT02784054|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110511195|NCT02784054|Alkylating Agents|alkylating agents|mesh-ancestor
110902356|NCT04905563|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110511196|NCT02784054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110511197|NCT02784054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110511198|NCT02784054|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110902427|NCT02047422|Hormone Antagonists|hormone antagonists|mesh-ancestor
110511199|NCT02784054|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110511200|NCT02784054|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110511201|NCT02784054|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110511202|NCT02784054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110511203|NCT02784054|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110511204|NCT00874861|Poly ICLC|poly iclc|mesh-list
110511205|NCT00874861|Interferon Inducers|interferon inducers|mesh-ancestor
110511206|NCT00874861|Immunologic Factors|immunologic factors|mesh-ancestor
110312000|NCT00324597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110511207|NCT00874861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110511209|NCT04038853|Cholecalciferol|cholecalciferol|mesh-list
110511210|NCT04038853|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
110511211|NCT04038853|Calcitriol|calcitriol|mesh-list
110511212|NCT04038853|Vitamins|vitamins|mesh-ancestor
110511213|NCT04038853|Micronutrients|micronutrients|mesh-ancestor
110511214|NCT04038853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110511215|NCT04038853|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110511216|NCT04038853|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110511217|NCT04038853|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
110511218|NCT04038853|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110511219|NCT04038853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110511220|NCT04038853|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110511221|NCT02066220|Cyclophosphamide|cyclophosphamide|mesh-list
110511222|NCT02066220|Lomustine|lomustine|mesh-list
110511223|NCT02066220|Cisplatin|cisplatin|mesh-list
110511224|NCT02066220|Carboplatin|carboplatin|mesh-list
110511225|NCT02066220|Vincristine|vincristine|mesh-list
110511226|NCT02066220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110511227|NCT02066220|Immunologic Factors|immunologic factors|mesh-ancestor
110511228|NCT02066220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110511229|NCT02066220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110511230|NCT02066220|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110511231|NCT02066220|Alkylating Agents|alkylating agents|mesh-ancestor
110511232|NCT02066220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110511233|NCT02066220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110511234|NCT02066220|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110511235|NCT02066220|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110511249|NCT00573391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110511250|NCT00573391|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110902617|NCT02049762|Antipyretics|antipyretics|mesh-ancestor
110511251|NCT00573391|Glucocorticoids|glucocorticoids|mesh-ancestor
110511252|NCT00573391|Hormones|hormones|mesh-ancestor
110511253|NCT00573391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110158623|NCT00086359|Antimetabolites|antimetabolites|mesh-ancestor
110511254|NCT00573391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110511255|NCT00573391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110511256|NCT00573391|Protease Inhibitors|protease inhibitors|mesh-ancestor
110511257|NCT00573391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110511258|NCT00573391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110511259|NCT00573391|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110511260|NCT00573391|Alkylating Agents|alkylating agents|mesh-ancestor
110511261|NCT00573391|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110511262|NCT00573391|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110511263|NCT00573391|Immunologic Factors|immunologic factors|mesh-ancestor
110511264|NCT00573391|Leprostatic Agents|leprostatic agents|mesh-ancestor
110511265|NCT00573391|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110511266|NCT00573391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110511267|NCT00573391|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110511268|NCT00573391|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110511269|NCT00573391|Growth Substances|growth substances|mesh-ancestor
110511270|NCT00573391|Growth Inhibitors|growth inhibitors|mesh-ancestor
110511272|NCT00590967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110511273|NCT02783976|Sofosbuvir|sofosbuvir|mesh-list
110511274|NCT02783976|Antiviral Agents|antiviral agents|mesh-ancestor
110511275|NCT02783976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110511276|NCT00878371|Morphine|morphine|mesh-list
110902811|NCT04390399|Antidotes|antidotes|mesh-ancestor
110511278|NCT00878371|Narcotics|narcotics|mesh-ancestor
110511279|NCT00878371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110511280|NCT00878371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110511282|NCT00878371|Sensory System Agents|sensory system agents|mesh-ancestor
110511283|NCT00878371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110511284|NCT00923299|Trastuzumab|trastuzumab|mesh-list
110511285|NCT00923299|Cetuximab|cetuximab|mesh-list
110511286|NCT00923299|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110511287|NCT00923299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110511289|NCT05753397|Anesthetics, Local|anesthetics, local|mesh-ancestor
110511290|NCT05753397|Anesthetics|anesthetics|mesh-ancestor
110903096|NCT01593241|Carboplatin|carboplatin|mesh-list
110511291|NCT05753397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110511292|NCT05753397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110511293|NCT05753397|Sensory System Agents|sensory system agents|mesh-ancestor
110511294|NCT05753397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110511295|NCT00875173|Selenium|selenium|mesh-list
110511296|NCT00875173|Antioxidants|antioxidants|mesh-list
110511297|NCT00875173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110511298|NCT00875173|Protective Agents|protective agents|mesh-ancestor
110511299|NCT00875173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110511300|NCT00875173|Trace Elements|trace elements|mesh-ancestor
110511301|NCT00875173|Micronutrients|micronutrients|mesh-ancestor
110511316|NCT04029831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110511317|NCT04029831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110511319|NCT00878449|Navitoclax|navitoclax|mesh-list
110511320|NCT00878449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110511321|NCT00878449|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110511322|NCT00878449|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110511323|NCT00878449|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110511324|NCT00878449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110511325|NCT00878449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110903243|NCT05909696|Rocuronium|rocuronium|mesh-list
110511326|NCT00875407|3-iodo-2-hydroxy-6-methoxy-N-((1-ethyl-2-pyrrolidinyl)methyl)benzamide|3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide|mesh-list
110511327|NCT00875407|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110511328|NCT00875407|Dopamine Agents|dopamine agents|mesh-ancestor
110511329|NCT00875407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110511330|NCT00875407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110511331|NCT00875407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110511332|NCT00875875|Rifaximin|rifaximin|mesh-list
110511333|NCT00875875|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110511334|NCT00875875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110511335|NCT00875875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110511337|NCT01716312|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110511338|NCT01716312|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110511339|NCT01716312|Respiratory System Agents|respiratory system agents|mesh-ancestor
110511340|NCT00880243|Cytarabine|cytarabine|mesh-list
110511341|NCT00880243|Etoposide|etoposide|mesh-list
110511342|NCT00880243|Mitoxantrone|mitoxantrone|mesh-list
110511343|NCT00880243|Daunorubicin|daunorubicin|mesh-list
110511344|NCT00880243|Molgramostim|molgramostim|mesh-list
110511345|NCT00880243|Sargramostim|sargramostim|mesh-list
110511346|NCT00880243|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110187961|NCT04752163|Vitamins|vitamins|mesh-ancestor
110511347|NCT00880243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110511348|NCT00880243|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110903430|NCT05494385|Antimanic Agents|antimanic agents|mesh-ancestor
110511349|NCT00880243|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110511350|NCT00880243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110903507|NCT05232825|Anesthetics|anesthetics|mesh-ancestor
110511351|NCT00880243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110511352|NCT00880243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110511353|NCT00880243|Antimetabolites|antimetabolites|mesh-ancestor
110511354|NCT00880243|Antiviral Agents|antiviral agents|mesh-ancestor
110511355|NCT00880243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110511356|NCT00880243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110511358|NCT00880243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110511359|NCT00880243|Analgesics|analgesics|mesh-ancestor
110511360|NCT00880243|Sensory System Agents|sensory system agents|mesh-ancestor
110511361|NCT00880243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110511362|NCT00880243|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110511368|NCT02783586|Sensory System Agents|sensory system agents|mesh-ancestor
110511369|NCT02783586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110511371|NCT00590577|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110511372|NCT00590577|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110511373|NCT00590577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110511374|NCT00590577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110511375|NCT00590577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110511376|NCT00590577|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110511377|NCT00590577|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110511378|NCT00590577|Serotonin Agents|serotonin agents|mesh-ancestor
110511379|NCT00590577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110511380|NCT00590577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110511381|NCT00590577|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110511382|NCT00590577|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110511383|NCT00590577|Dopamine Agents|dopamine agents|mesh-ancestor
110511385|NCT00880321|Midazolam|midazolam|mesh-list
110511386|NCT00880321|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110511387|NCT00880321|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110511388|NCT00880321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110511389|NCT00880321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110511390|NCT00880321|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110511391|NCT00880321|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110511392|NCT00880321|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110511393|NCT00880321|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110511394|NCT00880321|Anesthetics, General|anesthetics, general|mesh-ancestor
110511395|NCT00880321|Anesthetics|anesthetics|mesh-ancestor
110511396|NCT00880321|GABA Modulators|gaba modulators|mesh-ancestor
110511397|NCT00880321|GABA Agents|gaba agents|mesh-ancestor
110511398|NCT00880321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110903838|NCT04393103|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110511399|NCT00880321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110511400|NCT00880321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110511401|NCT00880321|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110511402|NCT00880321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110511403|NCT02608437|Ipilimumab|ipilimumab|mesh-list
110511404|NCT02608437|Guadecitabine|guadecitabine|mesh-list
110511405|NCT02608437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110158770|NCT00087334|Gefitinib|gefitinib|mesh-list
110511406|NCT02608437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110511407|NCT02608437|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110511408|NCT02608437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110511410|NCT04230330|Gemcitabine|gemcitabine|mesh-list
110511411|NCT04230330|Nivolumab|nivolumab|mesh-list
110511412|NCT04230330|Asparaginase|asparaginase|mesh-list
110511413|NCT04230330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110511414|NCT04230330|Antiemetics|antiemetics|mesh-ancestor
110511415|NCT04230330|Autonomic Agents|autonomic agents|mesh-ancestor
110511416|NCT04230330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110511417|NCT04230330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110511418|NCT04230330|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110511419|NCT04230330|Glucocorticoids|glucocorticoids|mesh-ancestor
110511420|NCT04230330|Hormones|hormones|mesh-ancestor
110904045|NCT03548155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110511421|NCT04230330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110511423|NCT04230330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110511424|NCT04230330|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110511425|NCT04230330|Antimetabolites|antimetabolites|mesh-ancestor
110511426|NCT04230330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110511427|NCT04230330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110511428|NCT04230330|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110511430|NCT02785068|Fluorouracil|fluorouracil|mesh-list
110511431|NCT02785068|Antimetabolites|antimetabolites|mesh-ancestor
110511432|NCT02785068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110176982|NCT00136474|Amifostine|amifostine|mesh-list
110511444|NCT05752929|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110511445|NCT05752929|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110511446|NCT05752929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110511447|NCT00880477|Edetic Acid|edetic acid|mesh-list
110511448|NCT00880477|Vaccines|vaccines|mesh-list
110511449|NCT00880477|Pentetic Acid|pentetic acid|mesh-list
110511450|NCT00880477|Immunologic Factors|immunologic factors|mesh-ancestor
110511451|NCT00880477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110511452|NCT00880477|Antidotes|antidotes|mesh-ancestor
110511453|NCT00880477|Protective Agents|protective agents|mesh-ancestor
110511454|NCT00880477|Chelating Agents|chelating agents|mesh-ancestor
110511455|NCT00880477|Sequestering Agents|sequestering agents|mesh-ancestor
110511456|NCT00880477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110511457|NCT00880477|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110511458|NCT00880477|Anticoagulants|anticoagulants|mesh-ancestor
110511459|NCT00880477|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110188018|NCT04671966|Cetrorelix|cetrorelix|mesh-list
110511460|NCT05293938|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
110511461|NCT05293938|Cathartics|cathartics|mesh-ancestor
110511462|NCT05293938|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110511463|NCT00882739|Clopidogrel|clopidogrel|mesh-list
110511464|NCT00882739|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110511465|NCT00882739|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110511466|NCT00882739|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110511467|NCT00882739|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110511468|NCT00882739|Purinergic Agents|purinergic agents|mesh-ancestor
110511469|NCT00882739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110511470|NCT00882739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110511471|NCT00882739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110511473|NCT02783040|Midazolam|midazolam|mesh-list
110511474|NCT02783040|BI 425809|bi 425809|mesh-list
110511475|NCT02783040|Omeprazole|omeprazole|mesh-list
110511476|NCT02783040|Warfarin|warfarin|mesh-list
110511477|NCT02783040|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110511478|NCT02783040|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110511479|NCT02783040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110511480|NCT02783040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110511481|NCT02783040|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110511482|NCT02783040|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110511483|NCT02783040|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110511484|NCT02783040|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110511485|NCT02783040|Anesthetics, General|anesthetics, general|mesh-ancestor
110511487|NCT02783040|GABA Modulators|gaba modulators|mesh-ancestor
110511488|NCT02783040|GABA Agents|gaba agents|mesh-ancestor
110511489|NCT02783040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110511490|NCT02783040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110511491|NCT02783040|Anticoagulants|anticoagulants|mesh-ancestor
110511492|NCT02783040|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110511493|NCT02783040|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110511494|NCT02783040|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110511495|NCT02783040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110511496|NCT02783040|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110511497|NCT02783040|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110511498|NCT02783040|Protective Agents|protective agents|mesh-ancestor
110511499|NCT02783040|Nootropic Agents|nootropic agents|mesh-ancestor
110511500|NCT02786082|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
110511501|NCT02786082|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110511519|NCT01503606|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110511520|NCT01503606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110511521|NCT01503606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110511522|NCT01503606|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110511523|NCT01503606|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110511524|NCT00882973|genexol-PM|genexol-pm|mesh-list
110511525|NCT00882973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110511526|NCT00882973|Tubulin Modulators|tubulin modulators|mesh-ancestor
110511527|NCT00882973|Antimitotic Agents|antimitotic agents|mesh-ancestor
110511528|NCT00882973|Mitosis Modulators|mitosis modulators|mesh-ancestor
110511529|NCT00882973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110511530|NCT00805935|Leuprolide|leuprolide|mesh-list
110511531|NCT00805935|Menotropins|menotropins|mesh-list
110511532|NCT00805935|Progesterone|progesterone|mesh-list
110511533|NCT00805935|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
110511534|NCT00805935|Progestins|progestins|mesh-ancestor
110511535|NCT00805935|Hormones|hormones|mesh-ancestor
110188044|NCT04624750|Mexiletine|mexiletine|mesh-list
110511536|NCT00805935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110511537|NCT00805935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110511538|NCT00805935|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110511539|NCT00805935|Fertility Agents|fertility agents|mesh-ancestor
110511540|NCT00805935|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110511541|NCT00805935|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110511542|NCT00805935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110511543|NCT00878917|Dorzolamide|dorzolamide|mesh-list
110511544|NCT00878917|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110511545|NCT00878917|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110511546|NCT00878917|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110511547|NCT00878917|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110511548|NCT00878917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110511549|NCT00878917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110511550|NCT00638118|Fexofenadine|fexofenadine|mesh-list
110511551|NCT00638118|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110511552|NCT00638118|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110511553|NCT00638118|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110511554|NCT00638118|Histamine Antagonists|histamine antagonists|mesh-ancestor
110511555|NCT00638118|Histamine Agents|histamine agents|mesh-ancestor
110511556|NCT00638118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110511557|NCT00638118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110158918|NCT00088387|Valproic Acid|valproic acid|mesh-list
110511558|NCT00638118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110511559|NCT00805545|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110511560|NCT00805545|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
110511590|NCT02782338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110511591|NCT02782338|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110511592|NCT02782338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110511593|NCT02782338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110511595|NCT02782260|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110511596|NCT02782260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110511597|NCT02782260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110511598|NCT02782260|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110511599|NCT02782260|Vasodilator Agents|vasodilator agents|mesh-ancestor
110511600|NCT05031936|Ropivacaine|ropivacaine|mesh-list
110511601|NCT05031936|Anesthetics, Local|anesthetics, local|mesh-ancestor
110511602|NCT05031936|Anesthetics|anesthetics|mesh-ancestor
110511603|NCT05031936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110511604|NCT05031936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110511605|NCT05031936|Sensory System Agents|sensory system agents|mesh-ancestor
110511606|NCT05031936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110511615|NCT03577704|Immunoglobulins|immunoglobulins|mesh-list
110511616|NCT03577704|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110511617|NCT03577704|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110511618|NCT03577704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110511619|NCT03577704|Tubulin Modulators|tubulin modulators|mesh-ancestor
110511620|NCT03577704|Antimitotic Agents|antimitotic agents|mesh-ancestor
110511621|NCT03577704|Mitosis Modulators|mitosis modulators|mesh-ancestor
110511622|NCT03577704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110511623|NCT03577704|Immunologic Factors|immunologic factors|mesh-ancestor
110511624|NCT03577704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110511625|NCT03577704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110511626|NCT03577704|Antimetabolites|antimetabolites|mesh-ancestor
110511627|NCT05176626|Phentermine|phentermine|mesh-list
110904889|NCT02154074|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110511628|NCT05176626|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110511629|NCT05176626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110511630|NCT05176626|Appetite Depressants|appetite depressants|mesh-ancestor
110511631|NCT05176626|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110511632|NCT05176626|Sympathomimetics|sympathomimetics|mesh-ancestor
110511633|NCT05176626|Autonomic Agents|autonomic agents|mesh-ancestor
110511634|NCT05176626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110511635|NCT05176626|Adrenergic Agents|adrenergic agents|mesh-ancestor
110511636|NCT05176626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110511637|NCT05176626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110511638|NCT05030766|Nicotine|nicotine|mesh-list
110511639|NCT05030766|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110511640|NCT05030766|Autonomic Agents|autonomic agents|mesh-ancestor
110511641|NCT05030766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110511642|NCT05030766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110511643|NCT05030766|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110511644|NCT05030766|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110511645|NCT05030766|Cholinergic Agents|cholinergic agents|mesh-ancestor
110511646|NCT05030766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110511647|NCT05030766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110511648|NCT00615199|Tofacitinib|tofacitinib|mesh-list
110511649|NCT00615199|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
110511650|NCT00615199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110511651|NCT00615199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110904945|NCT01384279|Anticonvulsants|anticonvulsants|mesh-ancestor
110511652|NCT00615199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110511653|NCT05328024|Immunomodulating Agents|immunomodulating agents|mesh-list
110511654|NCT05328024|Immunologic Factors|immunologic factors|mesh-ancestor
110511655|NCT05328024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110511656|NCT00879073|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110511657|NCT00879073|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110511658|NCT00879073|Alkylating Agents|alkylating agents|mesh-ancestor
110904996|NCT01382017|Carbamazepine|carbamazepine|mesh-list
110511659|NCT00879073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110511660|NCT00879073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110511662|NCT00880867|Interferon Inducers|interferon inducers|mesh-ancestor
110905068|NCT04113083|Vitamins|vitamins|mesh-ancestor
110511663|NCT00880867|Immunologic Factors|immunologic factors|mesh-ancestor
110511664|NCT00880867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110511665|NCT04228926|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110622586|NCT05355610|Protease Inhibitors|protease inhibitors|mesh-ancestor
110511667|NCT02782182|Leucovorin|leucovorin|mesh-list
110511668|NCT02782182|Oxaliplatin|oxaliplatin|mesh-list
110511669|NCT02782182|Irinotecan|irinotecan|mesh-list
110511670|NCT02782182|Folfirinox|folfirinox|mesh-list
110511671|NCT02782182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110511672|NCT02782182|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110905204|NCT04200963|Nivolumab|nivolumab|mesh-list
110511673|NCT02782182|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110511674|NCT02782182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110511675|NCT02782182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110511676|NCT02782182|Antidotes|antidotes|mesh-ancestor
110198073|NCT00124384|Modafinil|modafinil|mesh-list
110511704|NCT00883909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110511705|NCT00883909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110511707|NCT00634686|Calcium|calcium|mesh-list
110511708|NCT00634686|Vitamins|vitamins|mesh-ancestor
110511709|NCT00634686|Micronutrients|micronutrients|mesh-ancestor
110905421|NCT03388749|Annamycin|annamycin|mesh-list
110511710|NCT00634686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110905484|NCT02154932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110511711|NCT00634686|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110511714|NCT05340192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110511715|NCT05340192|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110511716|NCT05340192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110511717|NCT03955861|Adalimumab|adalimumab|mesh-list
110511718|NCT03955861|Golimumab|golimumab|mesh-list
110511719|NCT03955861|Certolizumab Pegol|certolizumab pegol|mesh-list
110511720|NCT03955861|Etanercept|etanercept|mesh-list
110511721|NCT03955861|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110511722|NCT03955861|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110511723|NCT03955861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110511724|NCT03955861|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110905562|NCT02160704|Clomiphene|clomiphene|mesh-list
110511725|NCT03955861|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110511726|NCT03955861|Analgesics|analgesics|mesh-ancestor
110511735|NCT00881179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110511736|NCT00881179|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110511737|NCT00881179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110511738|NCT00881179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110511739|NCT00881179|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110511740|NCT00881179|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110511741|NCT02781246|Dexmedetomidine|dexmedetomidine|mesh-list
110511742|NCT02781246|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110511743|NCT02781246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110511744|NCT02781246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110511745|NCT02781246|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110511746|NCT02781246|Analgesics|analgesics|mesh-ancestor
110905617|NCT00651807|Etonogestrel|etonogestrel|mesh-list
110511747|NCT02781246|Sensory System Agents|sensory system agents|mesh-ancestor
110511748|NCT02781246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110511749|NCT02781246|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110511750|NCT02781246|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110905678|NCT01377259|Anesthetics|anesthetics|mesh-list
110511751|NCT02781246|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110511752|NCT02781246|Adrenergic Agents|adrenergic agents|mesh-ancestor
110511753|NCT02781246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110511754|NCT02781246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110905747|NCT04795869|Immunoglobulins|immunoglobulins|mesh-list
110511756|NCT00613951|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110511757|NCT00613951|Metformin|metformin|mesh-list
110511758|NCT00613951|Insulin Aspart|insulin aspart|mesh-list
110511759|NCT00613951|Insulin, Long-Acting|insulin, long-acting|mesh-list
110511760|NCT00613951|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
110511761|NCT00613951|Biphasic Insulins|biphasic insulins|mesh-list
110511762|NCT00613951|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110038303|NCT01423747|Etoposide|etoposide|mesh-list
110511763|NCT00613951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110511764|NCT00881413|Esomeprazole|esomeprazole|mesh-list
110511765|NCT00881413|Pantoprazole|pantoprazole|mesh-list
110511766|NCT00881413|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110511767|NCT00881413|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110511768|NCT00881413|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110511769|NCT00881413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110511770|NCT00881413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110511771|NCT00881491|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110511772|NCT00881491|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
110511773|NCT00881491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110511774|NCT00881491|Antitubercular Agents|antitubercular agents|mesh-ancestor
110511775|NCT00958841|Pasireotide|pasireotide|mesh-list
110511777|NCT00958841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110511778|NCT00958841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110511779|NCT02937116|Cisplatin|cisplatin|mesh-list
110511780|NCT02937116|Gemcitabine|gemcitabine|mesh-list
110511781|NCT02937116|Capecitabine|capecitabine|mesh-list
110511782|NCT02937116|Oxaliplatin|oxaliplatin|mesh-list
110511783|NCT02937116|Irinotecan|irinotecan|mesh-list
110905956|NCT03700749|Iodine|iodine|mesh-list
110511785|NCT02937116|Pemetrexed|pemetrexed|mesh-list
110511786|NCT02937116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110511787|NCT02937116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110511788|NCT02937116|Antimetabolites|antimetabolites|mesh-ancestor
110511789|NCT02937116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110511790|NCT02937116|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110511791|NCT02937116|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110511792|NCT02937116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110511793|NCT02937116|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110511805|NCT00613327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110511806|NCT00613327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110511807|NCT00613327|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110511808|NCT00613327|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110511809|NCT00613327|Cholinergic Agents|cholinergic agents|mesh-ancestor
110511810|NCT00613327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110511811|NCT00613327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110511812|NCT00613327|Urological Agents|urological agents|mesh-ancestor
110511813|NCT04273997|Metronidazole|metronidazole|mesh-list
110906074|NCT04649229|Aprepitant|aprepitant|mesh-list
110511814|NCT04273997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110511815|NCT04273997|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110511816|NCT04273997|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110511817|NCT04273997|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110511819|NCT05339802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110511820|NCT05339802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110511821|NCT05339802|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110511822|NCT05339802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110511823|NCT05339802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110511824|NCT04649203|Niacinamide|niacinamide|mesh-list
110511825|NCT04649203|Niacin|niacin|mesh-list
110511826|NCT04649203|Nicotinic Acids|nicotinic acids|mesh-list
110511827|NCT04649203|Riboflavin|riboflavin|mesh-list
110511828|NCT04649203|Vitamin B Complex|vitamin b complex|mesh-ancestor
110511829|NCT04649203|Vitamins|vitamins|mesh-ancestor
110906214|NCT02170844|Dabigatran|dabigatran|mesh-list
110511830|NCT04649203|Micronutrients|micronutrients|mesh-ancestor
110511831|NCT04649203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110511832|NCT04649203|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110511833|NCT04649203|Antimetabolites|antimetabolites|mesh-ancestor
110511834|NCT04649203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110511835|NCT04649203|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110511836|NCT04649203|Vasodilator Agents|vasodilator agents|mesh-ancestor
110511837|NCT04649203|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110511838|NCT04649203|Dermatologic Agents|dermatologic agents|mesh-ancestor
110511839|NCT00881725|Metformin|metformin|mesh-list
110511840|NCT00881725|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110511841|NCT00881725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110511842|NCT00954941|Ondansetron|ondansetron|mesh-list
110511843|NCT00954941|Aprepitant|aprepitant|mesh-list
110511844|NCT00954941|Antiemetics|antiemetics|mesh-ancestor
110511845|NCT00954941|Autonomic Agents|autonomic agents|mesh-ancestor
110511846|NCT00954941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110511847|NCT00954941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110511848|NCT00954941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110511849|NCT00954941|Antipruritics|antipruritics|mesh-ancestor
110511850|NCT00954941|Dermatologic Agents|dermatologic agents|mesh-ancestor
110511851|NCT00954941|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110511852|NCT00954941|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110511853|NCT00954941|Serotonin Agents|serotonin agents|mesh-ancestor
110511854|NCT00954941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110511855|NCT00954941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110511856|NCT00954941|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110511857|NCT05339646|Ritonavir|ritonavir|mesh-list
110511858|NCT05339646|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110511873|NCT00630695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110511874|NCT00630695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110511876|NCT00954707|Aspirin|aspirin|mesh-list
110511877|NCT00954707|Clopidogrel|clopidogrel|mesh-list
110511878|NCT00954707|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
110511879|NCT00954707|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110511880|NCT00954707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110511881|NCT00954707|Analgesics|analgesics|mesh-ancestor
110511882|NCT00954707|Sensory System Agents|sensory system agents|mesh-ancestor
110511883|NCT00954707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110511884|NCT00954707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110906545|NCT03502031|Diuretics|diuretics|mesh-ancestor
110511885|NCT00954707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110511886|NCT00954707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110511887|NCT00954707|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110511888|NCT00954707|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110511889|NCT00954707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110511890|NCT00954707|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110511891|NCT00954707|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110511892|NCT00954707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110511893|NCT00954707|Antipyretics|antipyretics|mesh-ancestor
110511894|NCT00954707|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110511895|NCT00954707|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110511896|NCT00954707|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110511897|NCT00954707|Purinergic Agents|purinergic agents|mesh-ancestor
110511898|NCT00954707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110511900|NCT00630851|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110511902|NCT00630851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110511903|NCT00630851|Cholinergic Agents|cholinergic agents|mesh-ancestor
110511904|NCT00630851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110511905|NCT00630851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110511906|NCT00630851|Nootropic Agents|nootropic agents|mesh-ancestor
110511907|NCT00613171|Imatinib Mesylate|imatinib mesylate|mesh-list
110511908|NCT00613171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110511909|NCT00613171|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110511910|NCT00613171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110511911|NCT00613171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110511912|NCT05156892|Tamoxifen|tamoxifen|mesh-list
110511913|NCT05156892|Itraconazole|itraconazole|mesh-list
110511914|NCT05156892|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110511915|NCT05156892|Hormone Antagonists|hormone antagonists|mesh-ancestor
110906971|NCT03694587|Ibuprofen|ibuprofen|mesh-list
110511916|NCT05156892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110511917|NCT05156892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110511918|NCT05156892|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110511919|NCT05156892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110511927|NCT05156892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110907046|NCT02178488|Vitamin D|vitamin d|mesh-list
110511928|NCT05156892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110511929|NCT05156892|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110511930|NCT05156892|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110511932|NCT03894345|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110159294|NCT00090025|Antidotes|antidotes|mesh-ancestor
110511933|NCT03894345|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110511934|NCT03894345|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110511935|NCT03894345|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110511936|NCT03894345|Adrenergic Agents|adrenergic agents|mesh-ancestor
110511937|NCT03894345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110511938|NCT03894345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110511939|NCT03894345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110511940|NCT02859077|Carboplatin|carboplatin|mesh-list
110511941|NCT02859077|Gemcitabine|gemcitabine|mesh-list
110511943|NCT02859077|Gefitinib|gefitinib|mesh-list
110511944|NCT02859077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110907180|NCT02174588|Midazolam|midazolam|mesh-list
110511945|NCT02859077|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110511946|NCT02859077|Antimetabolites|antimetabolites|mesh-ancestor
110511947|NCT02859077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110511948|NCT02859077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110511949|NCT02859077|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110511950|NCT02859077|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110511951|NCT02859077|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110511952|NCT00879307|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110511953|NCT00879307|Antidepressive Agents|antidepressive agents|mesh-ancestor
110511954|NCT00879307|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110511955|NCT00879307|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110511956|NCT00879307|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110511957|NCT00879307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110511958|NCT00879307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110511959|NCT03851835|Ondansetron|ondansetron|mesh-list
110511960|NCT03851835|Antiemetics|antiemetics|mesh-ancestor
110511961|NCT03851835|Autonomic Agents|autonomic agents|mesh-ancestor
110511962|NCT03851835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110511963|NCT03851835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110511964|NCT03851835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110511965|NCT03851835|Antipruritics|antipruritics|mesh-ancestor
110511966|NCT03851835|Dermatologic Agents|dermatologic agents|mesh-ancestor
110511967|NCT03851835|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110511968|NCT03851835|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110511969|NCT03851835|Serotonin Agents|serotonin agents|mesh-ancestor
110511970|NCT03851835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110511971|NCT03851835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110511973|NCT00879385|Panitumumab|panitumumab|mesh-list
110511974|NCT00879385|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110511975|NCT00879385|Antimetabolites|antimetabolites|mesh-ancestor
110907367|NCT02182622|Glucocorticoids|glucocorticoids|mesh-ancestor
110511976|NCT00879385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110511977|NCT00879385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110511978|NCT00879385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110511979|NCT00879385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110511980|NCT00914121|Moxifloxacin|moxifloxacin|mesh-list
110511981|NCT00914121|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110511982|NCT00914121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110511983|NCT00914121|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110511984|NCT00914121|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110511985|NCT00914121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110512003|NCT00613015|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
110512004|NCT00613015|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110512005|NCT00613015|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110512006|NCT00613015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110512007|NCT00613015|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110512008|NCT00613015|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110512009|NCT00613015|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110512010|NCT00613015|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110512011|NCT00613015|Adrenergic Agents|adrenergic agents|mesh-ancestor
110512012|NCT00613015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110512013|NCT02779608|Docetaxel|docetaxel|mesh-list
110512014|NCT02779608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110512015|NCT02779608|Tubulin Modulators|tubulin modulators|mesh-ancestor
110512016|NCT02779608|Antimitotic Agents|antimitotic agents|mesh-ancestor
110512017|NCT02779608|Mitosis Modulators|mitosis modulators|mesh-ancestor
110512018|NCT02779608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110512019|NCT02543671|Vitamin D|vitamin d|mesh-list
110512020|NCT02543671|Cholecalciferol|cholecalciferol|mesh-list
110512021|NCT02543671|Vitamins|vitamins|mesh-ancestor
110512022|NCT02543671|Micronutrients|micronutrients|mesh-ancestor
110512023|NCT02543671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110512024|NCT02543671|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110188183|NCT04332341|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110512025|NCT02543671|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110512026|NCT02838992|Cyclosporine|cyclosporine|mesh-list
110512027|NCT02838992|Cyclophosphamide|cyclophosphamide|mesh-list
110512028|NCT02838992|Cyclosporins|cyclosporins|mesh-list
110512029|NCT02838992|Thymoglobulin|thymoglobulin|mesh-list
110512030|NCT02838992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110512031|NCT02838992|Immunologic Factors|immunologic factors|mesh-ancestor
110512032|NCT02838992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110512033|NCT02838992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110512034|NCT02838992|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110512035|NCT02838992|Alkylating Agents|alkylating agents|mesh-ancestor
110512036|NCT02838992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110512037|NCT02838992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110512038|NCT02838992|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110512039|NCT02838992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110512040|NCT02838992|Antifungal Agents|antifungal agents|mesh-ancestor
110512041|NCT02838992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110512042|NCT02838992|Dermatologic Agents|dermatologic agents|mesh-ancestor
110512043|NCT02838992|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110512060|NCT05338476|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110512061|NCT05338476|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110512062|NCT05338476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110512063|NCT05338476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110512064|NCT05338476|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110512065|NCT05338476|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110512066|NCT05338476|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110512067|NCT05338476|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110512068|NCT05338476|Anesthetics, General|anesthetics, general|mesh-ancestor
110512069|NCT05338476|Anesthetics|anesthetics|mesh-ancestor
110907607|NCT02180516|Etodolac|etodolac|mesh-list
110512070|NCT05338476|GABA Modulators|gaba modulators|mesh-ancestor
110512071|NCT05338476|GABA Agents|gaba agents|mesh-ancestor
110512072|NCT05338476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110512073|NCT05338476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110512074|NCT02838758|Lidocaine|lidocaine|mesh-list
110512075|NCT02838758|Anesthetics, Local|anesthetics, local|mesh-ancestor
110512076|NCT02838758|Anesthetics|anesthetics|mesh-ancestor
110512077|NCT02838758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110512078|NCT02838758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110512079|NCT02838758|Sensory System Agents|sensory system agents|mesh-ancestor
110512080|NCT02838758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110512081|NCT02838758|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110512082|NCT02838758|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110512083|NCT02838758|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110512084|NCT02838758|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110512085|NCT02838758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110512086|NCT00803595|Oseltamivir|oseltamivir|mesh-list
110907683|NCT03684837|Vitamin D|vitamin d|mesh-list
110512087|NCT00803595|Antiviral Agents|antiviral agents|mesh-ancestor
110512088|NCT00803595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110512089|NCT00803595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110512090|NCT00803595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110512091|NCT02843204|Pembrolizumab|pembrolizumab|mesh-list
110512092|NCT02843204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110512093|NCT02843204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110512094|NCT02843204|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110512095|NCT02843204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110512096|NCT02606565|Chlorhexidine|chlorhexidine|mesh-list
110512097|NCT02606565|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110512098|NCT02606565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110512099|NCT02606565|Disinfectants|disinfectants|mesh-ancestor
110512100|NCT04227990|Cyclophosphamide|cyclophosphamide|mesh-list
110512102|NCT04227990|Doxorubicin|doxorubicin|mesh-list
110512103|NCT04227990|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110512104|NCT04227990|Immunologic Factors|immunologic factors|mesh-ancestor
110177129|NCT00137254|Insulin|insulin|mesh-list
110512120|NCT02606409|Propofol|propofol|mesh-list
110512121|NCT02606409|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110512122|NCT02606409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110512123|NCT02606409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110512124|NCT02606409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110512125|NCT02606409|Analgesics|analgesics|mesh-ancestor
110512126|NCT02606409|Sensory System Agents|sensory system agents|mesh-ancestor
110512127|NCT02606409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110907723|NCT02181218|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110512128|NCT02606409|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110512129|NCT02606409|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110512130|NCT02606409|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110512131|NCT02606409|Adrenergic Agents|adrenergic agents|mesh-ancestor
110512132|NCT02606409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110512133|NCT02606409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110512134|NCT02606409|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110512135|NCT02606409|Anesthetics, General|anesthetics, general|mesh-ancestor
110512137|NCT00611767|Thiopental|thiopental|mesh-list
110512138|NCT00611767|Anticonvulsants|anticonvulsants|mesh-ancestor
110512139|NCT00611767|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110512140|NCT00611767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110512141|NCT00611767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110512142|NCT00611767|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110512143|NCT00611767|Anesthetics, General|anesthetics, general|mesh-ancestor
110512144|NCT00611767|Anesthetics|anesthetics|mesh-ancestor
110188251|NCT04124991|Durvalumab|durvalumab|mesh-list
110512145|NCT00611767|GABA Modulators|gaba modulators|mesh-ancestor
110512146|NCT00611767|GABA Agents|gaba agents|mesh-ancestor
110512147|NCT00611767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110512148|NCT00611767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110512149|NCT04967508|Ustekinumab|ustekinumab|mesh-list
110512150|NCT04967508|Dermatologic Agents|dermatologic agents|mesh-ancestor
110512151|NCT00803361|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110512152|NCT00803361|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110512153|NCT00803361|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110512154|NCT00803361|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110512155|NCT00803361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110512156|NCT00803361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110512157|NCT00803361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110512158|NCT00803361|Analgesics|analgesics|mesh-ancestor
110512159|NCT00803361|Sensory System Agents|sensory system agents|mesh-ancestor
110512160|NCT00803361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110512161|NCT00803361|Antidepressive Agents|antidepressive agents|mesh-ancestor
110512162|NCT00803361|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110512163|NCT00803361|Dopamine Agents|dopamine agents|mesh-ancestor
110512177|NCT00611533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110512178|NCT00611533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110512180|NCT04038307|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110512181|NCT04038307|Analgesics|analgesics|mesh-ancestor
110512182|NCT04038307|Sensory System Agents|sensory system agents|mesh-ancestor
110512183|NCT04038307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110512184|NCT04038307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110512185|NCT04038307|Antipyretics|antipyretics|mesh-ancestor
110512186|NCT00884533|Moxifloxacin|moxifloxacin|mesh-list
110512187|NCT00884533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110512188|NCT00884533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110512189|NCT00884533|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110512190|NCT00884533|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110512191|NCT00884533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110512192|NCT00884533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110512193|NCT00884533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110512194|NCT02842814|Hydroxychloroquine|hydroxychloroquine|mesh-list
110512195|NCT02842814|Glucocorticoids|glucocorticoids|mesh-list
110512196|NCT02842814|Antimalarials|antimalarials|mesh-ancestor
110512197|NCT02842814|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110512198|NCT02842814|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110512199|NCT02842814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110512200|NCT02842814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110512201|NCT02842814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110512202|NCT02842814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110512203|NCT02842814|Hormones|hormones|mesh-ancestor
110512204|NCT02842814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110512205|NCT02842814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110512206|NCT02778360|Methylphenidate|methylphenidate|mesh-list
110512207|NCT02778360|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110512208|NCT02778360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110512209|NCT02778360|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110512210|NCT02778360|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110512211|NCT02778360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110512212|NCT02778360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110512213|NCT02778360|Dopamine Agents|dopamine agents|mesh-ancestor
110512214|NCT02778360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110512215|NCT00953147|Ciclesonide|ciclesonide|mesh-list
110512216|NCT00953147|Glucocorticoids|glucocorticoids|mesh-ancestor
110512217|NCT00953147|Hormones|hormones|mesh-ancestor
110908070|NCT02187614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110512218|NCT00953147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110512219|NCT00953147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110512220|NCT00953147|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110512222|NCT05333744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110512223|NCT05333744|Glucocorticoids|glucocorticoids|mesh-ancestor
110512224|NCT05333744|Hormones|hormones|mesh-ancestor
110512233|NCT04250246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110512235|NCT04250246|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110512236|NCT04250246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110512237|NCT04250246|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110512238|NCT04250246|Antimetabolites|antimetabolites|mesh-ancestor
110512239|NCT04250246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110512240|NCT04273529|Thalidomide|thalidomide|mesh-list
110512241|NCT04273529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110512242|NCT04273529|Immunologic Factors|immunologic factors|mesh-ancestor
110512243|NCT04273529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110512244|NCT04273529|Leprostatic Agents|leprostatic agents|mesh-ancestor
110512245|NCT04273529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110512246|NCT04273529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110512247|NCT04273529|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110512248|NCT04273529|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110512249|NCT04273529|Growth Substances|growth substances|mesh-ancestor
110512250|NCT04273529|Growth Inhibitors|growth inhibitors|mesh-ancestor
110512251|NCT04273529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110512252|NCT02858843|Ivacaftor|ivacaftor|mesh-list
110512253|NCT02858843|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
110512254|NCT02858843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110512255|NCT02858843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110512256|NCT02779530|Diclofenac|diclofenac|mesh-list
110512257|NCT02779530|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110512258|NCT02779530|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110512259|NCT02779530|Analgesics|analgesics|mesh-ancestor
110512260|NCT02779530|Sensory System Agents|sensory system agents|mesh-ancestor
110512261|NCT02779530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110512262|NCT02779530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110512263|NCT02779530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110512264|NCT02779530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110512265|NCT02779530|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110512266|NCT02779530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110512267|NCT02779530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110512268|NCT00952523|Adapalene|adapalene|mesh-list
110512269|NCT00952523|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
110512270|NCT00952523|Tretinoin|tretinoin|mesh-list
110512271|NCT00952523|Benzoyl Peroxide|benzoyl peroxide|mesh-list
110512272|NCT00952523|Dermatologic Agents|dermatologic agents|mesh-ancestor
110512273|NCT00952523|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110512274|NCT00952523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110512275|NCT00952523|Analgesics|analgesics|mesh-ancestor
110512276|NCT00952523|Sensory System Agents|sensory system agents|mesh-ancestor
110512277|NCT00952523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110512278|NCT00952523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110512279|NCT00952523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110512280|NCT00952523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110512281|NCT00952523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110512282|NCT00952523|Keratolytic Agents|keratolytic agents|mesh-ancestor
110512283|NCT04249154|Leuprolide|leuprolide|mesh-list
110512284|NCT04249154|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110512286|NCT04249154|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110512287|NCT04249154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110512288|NCT04249154|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110512289|NCT04249154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110512290|NCT02857361|Ketamine|ketamine|mesh-list
110512291|NCT02857361|Analgesics|analgesics|mesh-ancestor
110512292|NCT02857361|Sensory System Agents|sensory system agents|mesh-ancestor
110512314|NCT02232737|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110512315|NCT02232737|Cholinergic Agents|cholinergic agents|mesh-ancestor
110512316|NCT02232737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110512317|NCT02232737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110512318|NCT04272359|Hypoglycemic Agents|hypoglycemic agents|mesh-list
110512319|NCT04272359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110512320|NCT02777814|Entecavir|entecavir|mesh-list
110512321|NCT02777814|Antiviral Agents|antiviral agents|mesh-ancestor
110512322|NCT02777814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110512324|NCT02778906|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110512325|NCT02778906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110512326|NCT02778906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110512327|NCT02778906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110512328|NCT02778906|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110512329|NCT02778906|Immunologic Factors|immunologic factors|mesh-ancestor
110512330|NCT02778906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110512331|NCT02778906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110512332|NCT00630929|Ibuprofen|ibuprofen|mesh-list
110512333|NCT00630929|Celecoxib|celecoxib|mesh-list
110512334|NCT00630929|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110512335|NCT00630929|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110512336|NCT00630929|Analgesics|analgesics|mesh-ancestor
110512337|NCT00630929|Sensory System Agents|sensory system agents|mesh-ancestor
110512338|NCT00630929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110908223|NCT02057094|Sequestering Agents|sequestering agents|mesh-ancestor
110512339|NCT00630929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110512340|NCT00630929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110512341|NCT00630929|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110512342|NCT00630929|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110512343|NCT00630929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110512344|NCT00630929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110512345|NCT00630929|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110512346|NCT04204928|Pralsetinib|pralsetinib|mesh-list
110512360|NCT04227912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110512361|NCT04227912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110512362|NCT04227912|Sensory System Agents|sensory system agents|mesh-ancestor
110512363|NCT04227912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110512364|NCT04227912|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110512366|NCT04227912|Analgesics|analgesics|mesh-ancestor
110512367|NCT04227912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110512368|NCT04227912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110512369|NCT02854787|Phenylephrine|phenylephrine|mesh-list
110512370|NCT02854787|Oxymetazoline|oxymetazoline|mesh-list
110512371|NCT02854787|Norepinephrine|norepinephrine|mesh-list
110512372|NCT02854787|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110512373|NCT02854787|Mydriatics|mydriatics|mesh-ancestor
110512374|NCT02854787|Autonomic Agents|autonomic agents|mesh-ancestor
110512375|NCT02854787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110512376|NCT02854787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110512377|NCT02854787|Sympathomimetics|sympathomimetics|mesh-ancestor
110512378|NCT02854787|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110512379|NCT02854787|Nasal Decongestants|nasal decongestants|mesh-ancestor
110512380|NCT02854787|Respiratory System Agents|respiratory system agents|mesh-ancestor
110512381|NCT02854787|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110512382|NCT02854787|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110512383|NCT02854787|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110512384|NCT02854787|Adrenergic Agents|adrenergic agents|mesh-ancestor
110512385|NCT02854787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110512386|NCT02854787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110512387|NCT02854787|Protective Agents|protective agents|mesh-ancestor
110512388|NCT02778828|Linezolid|linezolid|mesh-list
110512389|NCT02778828|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110512390|NCT02778828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110512391|NCT02778828|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110512392|NCT02778828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110512393|NCT02778828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110512394|NCT02777736|Methotrexate|methotrexate|mesh-list
110312012|NCT00304317|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110512395|NCT02777736|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110512396|NCT02777736|Abortifacient Agents|abortifacient agents|mesh-ancestor
110512397|NCT02777736|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110908392|NCT02057796|Antimetabolites|antimetabolites|mesh-ancestor
110512398|NCT02777736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110512399|NCT02777736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110512400|NCT02777736|Antimetabolites|antimetabolites|mesh-ancestor
110512401|NCT02777736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110512402|NCT02777736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110512403|NCT02777736|Dermatologic Agents|dermatologic agents|mesh-ancestor
110512404|NCT02777736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110512405|NCT02777736|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110512406|NCT02777736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110512407|NCT02777736|Immunologic Factors|immunologic factors|mesh-ancestor
110512417|NCT02836184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110512419|NCT02836184|Vasodilator Agents|vasodilator agents|mesh-ancestor
110512420|NCT02836184|Vitamin B Complex|vitamin b complex|mesh-ancestor
110512421|NCT02836184|Vitamins|vitamins|mesh-ancestor
110512422|NCT02836184|Micronutrients|micronutrients|mesh-ancestor
110512423|NCT02836184|Antacids|antacids|mesh-ancestor
110512424|NCT02836184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110512425|NCT04824144|Dexmedetomidine|dexmedetomidine|mesh-list
110512426|NCT04824144|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110512427|NCT04824144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110512429|NCT04824144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110512430|NCT04824144|Analgesics|analgesics|mesh-ancestor
110512431|NCT04824144|Sensory System Agents|sensory system agents|mesh-ancestor
110512432|NCT04824144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110512433|NCT04824144|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110512434|NCT04824144|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110512435|NCT04824144|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110512436|NCT04824144|Adrenergic Agents|adrenergic agents|mesh-ancestor
110512437|NCT04824144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110512438|NCT04824144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110512439|NCT02775474|Fentanyl|fentanyl|mesh-list
110512440|NCT02775474|Methadone|methadone|mesh-list
110512441|NCT02775474|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110512442|NCT02775474|Narcotics|narcotics|mesh-ancestor
110512443|NCT02775474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110512444|NCT02775474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110512445|NCT02775474|Analgesics|analgesics|mesh-ancestor
110512446|NCT02775474|Sensory System Agents|sensory system agents|mesh-ancestor
110188307|NCT03671811|Appetite Stimulants|appetite stimulants|mesh-ancestor
110512447|NCT02775474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110512448|NCT02775474|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110512449|NCT02775474|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110512450|NCT02775474|Anesthetics, General|anesthetics, general|mesh-ancestor
110512451|NCT02775474|Anesthetics|anesthetics|mesh-ancestor
110512452|NCT02775474|Antitussive Agents|antitussive agents|mesh-ancestor
110512453|NCT02775474|Respiratory System Agents|respiratory system agents|mesh-ancestor
110512455|NCT05158686|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110512456|NCT05158686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110512457|NCT05158686|Tubulin Modulators|tubulin modulators|mesh-ancestor
110512458|NCT05158686|Antimitotic Agents|antimitotic agents|mesh-ancestor
110512459|NCT05158686|Mitosis Modulators|mitosis modulators|mesh-ancestor
110512460|NCT05158686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110512461|NCT02835794|Azacitidine|azacitidine|mesh-list
110512462|NCT02835794|Homoharringtonine|homoharringtonine|mesh-list
110512463|NCT02835794|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110908634|NCT02915835|Riociguat|riociguat|mesh-list
110512464|NCT02835794|Antimetabolites|antimetabolites|mesh-ancestor
110512465|NCT02835794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110512466|NCT02835794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110512467|NCT02835794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110512468|NCT02835794|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110512469|NCT02835794|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110512470|NCT02836028|Temozolomide|temozolomide|mesh-list
110512472|NCT02836028|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110512473|NCT02836028|Alkylating Agents|alkylating agents|mesh-ancestor
110512474|NCT02836028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110177211|NCT00137995|Antiemetics|antiemetics|mesh-ancestor
110512489|NCT04227210|Immunologic Factors|immunologic factors|mesh-ancestor
110512490|NCT04227210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110512491|NCT02833766|Doxorubicin|doxorubicin|mesh-list
110512492|NCT02833766|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110512493|NCT02833766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110512494|NCT02833766|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110512495|NCT02833766|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110512496|NCT02833766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110512497|NCT02833766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110512498|NCT04813380|Immunomodulating Agents|immunomodulating agents|mesh-list
110512499|NCT04813380|Immunologic Factors|immunologic factors|mesh-ancestor
110512500|NCT04813380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110512502|NCT04951362|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110512503|NCT04951362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110512504|NCT02833610|Denosumab|denosumab|mesh-list
110512505|NCT02833610|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110512506|NCT02833610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110512508|NCT04225728|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
110512509|NCT04225728|Teferrol|teferrol|mesh-list
110512510|NCT04225728|Trace Elements|trace elements|mesh-ancestor
110512511|NCT04225728|Micronutrients|micronutrients|mesh-ancestor
110512512|NCT04225728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110512513|NCT04225728|Hematinics|hematinics|mesh-ancestor
110512514|NCT02835716|Ustekinumab|ustekinumab|mesh-list
110512515|NCT02835716|Dermatologic Agents|dermatologic agents|mesh-ancestor
110512516|NCT04247984|Bevacizumab|bevacizumab|mesh-list
110512517|NCT04247984|Fluorouracil|fluorouracil|mesh-list
110512518|NCT04247984|Capecitabine|capecitabine|mesh-list
110512519|NCT04247984|Irinotecan|irinotecan|mesh-list
110512520|NCT04247984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110512521|NCT04247984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110512522|NCT04247984|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110512523|NCT04247984|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110512524|NCT04247984|Growth Substances|growth substances|mesh-ancestor
110512525|NCT04247984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110512526|NCT04247984|Growth Inhibitors|growth inhibitors|mesh-ancestor
110512527|NCT04247984|Antimetabolites|antimetabolites|mesh-ancestor
110512528|NCT04247984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110512529|NCT04247984|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110512530|NCT04247984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110512531|NCT04247984|Immunologic Factors|immunologic factors|mesh-ancestor
110512532|NCT04247984|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110512533|NCT04247984|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110908888|NCT02197988|Fentanyl|fentanyl|mesh-list
110512534|NCT04247984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110512535|NCT00948389|Dasatinib|dasatinib|mesh-list
110512536|NCT00948389|Lomustine|lomustine|mesh-list
110512537|NCT00948389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110177225|NCT00137995|Antimetabolites|antimetabolites|mesh-ancestor
110512547|NCT02775318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110512548|NCT02775318|Sensory System Agents|sensory system agents|mesh-ancestor
110512549|NCT02775318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110512551|NCT00948155|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110512552|NCT00948155|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110512553|NCT00948155|Cholinergic Agents|cholinergic agents|mesh-ancestor
110512554|NCT00948155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110512555|NCT00948155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110512556|NCT00948155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110512557|NCT02776956|Atorvastatin|atorvastatin|mesh-list
110512558|NCT02776956|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110512559|NCT02776956|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110512560|NCT02776956|Antimetabolites|antimetabolites|mesh-ancestor
110512561|NCT02776956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110512562|NCT02776956|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110909061|NCT02064504|Fluticasone|fluticasone|mesh-list
110512563|NCT02776956|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110512564|NCT02776956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110512565|NCT04910178|Empagliflozin|empagliflozin|mesh-list
110512566|NCT04910178|Pentoxifylline|pentoxifylline|mesh-list
110512567|NCT04910178|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
110512568|NCT04910178|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110512569|NCT04910178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110512570|NCT04910178|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110512571|NCT04910178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110512572|NCT04910178|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110512573|NCT04910178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110512574|NCT04910178|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110512575|NCT04910178|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110512576|NCT04910178|Protective Agents|protective agents|mesh-ancestor
110512577|NCT04910178|Vasodilator Agents|vasodilator agents|mesh-ancestor
110512578|NCT04910178|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110512579|NCT04910178|Antioxidants|antioxidants|mesh-ancestor
110512580|NCT04910178|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
110512581|NCT04910178|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110512582|NCT02778594|Levodopa|levodopa|mesh-list
110512583|NCT02778594|Benserazide|benserazide|mesh-list
110512584|NCT02778594|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110512585|NCT02778594|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110512586|NCT02778594|Dopamine Agents|dopamine agents|mesh-ancestor
110512587|NCT02778594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110512588|NCT02778594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110512589|NCT02778594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110512590|NCT02778594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110512592|NCT02775006|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110512593|NCT02775006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110512594|NCT02775006|Tubulin Modulators|tubulin modulators|mesh-ancestor
110512595|NCT02775006|Antimitotic Agents|antimitotic agents|mesh-ancestor
110512596|NCT02775006|Mitosis Modulators|mitosis modulators|mesh-ancestor
110512597|NCT02775006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110512598|NCT02775006|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110512599|NCT02775006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110512600|NCT04851834|Cisplatin|cisplatin|mesh-list
110512608|NCT02776722|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110512610|NCT02776722|Sequestering Agents|sequestering agents|mesh-ancestor
110512611|NCT02776722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110512612|NCT02776878|Dasatinib|dasatinib|mesh-list
110512613|NCT02776878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110512614|NCT02776878|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110512615|NCT02776878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110512616|NCT02776878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110512617|NCT02772822|Rituximab|rituximab|mesh-list
110512618|NCT02772822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110512619|NCT02772822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110512620|NCT02772822|Immunologic Factors|immunologic factors|mesh-ancestor
110512621|NCT02772822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110512622|NCT02772822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110512624|NCT00635076|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110512625|NCT00635076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110512626|NCT00635076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110512627|NCT00635076|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110512628|NCT00635076|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110512629|NCT00635076|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110512630|NCT00635076|GABA Modulators|gaba modulators|mesh-ancestor
110512631|NCT00635076|GABA Agents|gaba agents|mesh-ancestor
110512632|NCT00635076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110512633|NCT00635076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110512634|NCT02772744|Ribavirin|ribavirin|mesh-list
110512635|NCT02772744|Sofosbuvir|sofosbuvir|mesh-list
110512636|NCT02772744|Antimetabolites|antimetabolites|mesh-ancestor
110512637|NCT02772744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110512638|NCT02772744|Antiviral Agents|antiviral agents|mesh-ancestor
110512639|NCT02772744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110512640|NCT02774382|Vancomycin|vancomycin|mesh-list
110512641|NCT02774382|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110512642|NCT02774382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110512643|NCT02774460|Amlodipine|amlodipine|mesh-list
110512644|NCT02774460|Candesartan|candesartan|mesh-list
110512645|NCT02774460|Candesartan cilexetil|candesartan cilexetil|mesh-list
110512646|NCT02774460|Lisinopril|lisinopril|mesh-list
110512647|NCT02774460|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110512648|NCT02774460|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110512649|NCT02774460|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110512650|NCT02774460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110909392|NCT02066532|Trastuzumab|trastuzumab|mesh-list
110512651|NCT02774460|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110512652|NCT02774460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110512653|NCT02774460|Vasodilator Agents|vasodilator agents|mesh-ancestor
110512654|NCT02774460|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110512655|NCT02774460|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110512656|NCT02774460|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110512657|NCT02774460|Protease Inhibitors|protease inhibitors|mesh-ancestor
110512658|NCT02774460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110512659|NCT02774460|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110512660|NCT02774460|Protective Agents|protective agents|mesh-ancestor
110512662|NCT02772354|Verapamil|verapamil|mesh-list
110512663|NCT02772354|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110512664|NCT02772354|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110512665|NCT02772354|Sympatholytics|sympatholytics|mesh-ancestor
110512666|NCT02772354|Autonomic Agents|autonomic agents|mesh-ancestor
110909502|NCT02069808|Menotropins|menotropins|mesh-list
110512667|NCT02772354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110512668|NCT02772354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110512669|NCT02772354|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110512677|NCT02772354|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110512679|NCT00611455|Ofatumumab|ofatumumab|mesh-list
110512680|NCT00611455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110512682|NCT02767752|Capecitabine|capecitabine|mesh-list
110512683|NCT02767752|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110512684|NCT02767752|Antimetabolites|antimetabolites|mesh-ancestor
110512685|NCT02767752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110512686|NCT02767752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110512687|NCT00885625|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110512688|NCT00885625|Immunologic Factors|immunologic factors|mesh-ancestor
110512689|NCT00885625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110512691|NCT02835404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110512692|NCT00885781|SMOFlipid|smoflipid|mesh-list
110512693|NCT00885781|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
110512694|NCT00885781|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
110512695|NCT00885781|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110512696|NCT02767674|Prednisone|prednisone|mesh-list
110512697|NCT02767674|Cyclophosphamide|cyclophosphamide|mesh-list
110512698|NCT02767674|Rituximab|rituximab|mesh-list
110512699|NCT02767674|Gemcitabine|gemcitabine|mesh-list
110512700|NCT02767674|Oxaliplatin|oxaliplatin|mesh-list
110512701|NCT02767674|Epirubicin|epirubicin|mesh-list
110512702|NCT02767674|Vindesine|vindesine|mesh-list
110512703|NCT02767674|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110512704|NCT02767674|Immunologic Factors|immunologic factors|mesh-ancestor
110512705|NCT02767674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110512706|NCT02767674|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110512707|NCT02767674|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110512708|NCT02767674|Alkylating Agents|alkylating agents|mesh-ancestor
110512709|NCT02767674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110512710|NCT02767674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110512711|NCT02767674|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110512712|NCT02767674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110512713|NCT02767674|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110512714|NCT02767674|Antimetabolites|antimetabolites|mesh-ancestor
110512715|NCT02767674|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110512716|NCT02767674|Glucocorticoids|glucocorticoids|mesh-ancestor
110512717|NCT02767674|Hormones|hormones|mesh-ancestor
110909896|NCT03402841|Olaparib|olaparib|mesh-list
110512718|NCT02767674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110512719|NCT02767674|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110512720|NCT02767674|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110512721|NCT02767674|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110512722|NCT02767674|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110910045|NCT03777319|Prednisolone|prednisolone|mesh-list
110512723|NCT02767674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110512724|NCT02767674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110512725|NCT02767674|Tubulin Modulators|tubulin modulators|mesh-ancestor
110512726|NCT02767674|Antimitotic Agents|antimitotic agents|mesh-ancestor
110512727|NCT02767674|Mitosis Modulators|mitosis modulators|mesh-ancestor
110512728|NCT02833688|Dexmedetomidine|dexmedetomidine|mesh-list
110512729|NCT02833688|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110512730|NCT02833688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110512731|NCT02833688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110512732|NCT02833688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110512733|NCT02833688|Analgesics|analgesics|mesh-ancestor
110512734|NCT02833688|Sensory System Agents|sensory system agents|mesh-ancestor
110512735|NCT02833688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110177247|NCT00138229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110512750|NCT00612313|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110512751|NCT00612313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110512752|NCT00612313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110512753|NCT00612313|Serotonin Agents|serotonin agents|mesh-ancestor
110512754|NCT00612313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110512755|NCT00612313|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110512756|NCT00612313|Antidepressive Agents|antidepressive agents|mesh-ancestor
110512757|NCT00612313|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110512758|NCT00612313|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110512759|NCT00612313|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110512760|NCT00612313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110512761|NCT00890552|Dexamethasone|dexamethasone|mesh-list
110512762|NCT00890552|Dexamethasone acetate|dexamethasone acetate|mesh-list
110512763|NCT00890552|Lenalidomide|lenalidomide|mesh-list
110512764|NCT00890552|Melphalan|melphalan|mesh-list
110512765|NCT00890552|BB 1101|bb 1101|mesh-list
110512767|NCT00890552|Antiemetics|antiemetics|mesh-ancestor
110512768|NCT00890552|Autonomic Agents|autonomic agents|mesh-ancestor
110512769|NCT00890552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110512770|NCT00890552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110512771|NCT00890552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110512772|NCT00890552|Glucocorticoids|glucocorticoids|mesh-ancestor
110512773|NCT00890552|Hormones|hormones|mesh-ancestor
110512774|NCT00890552|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110512775|NCT00890552|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110512776|NCT00890552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110512777|NCT00890552|Protease Inhibitors|protease inhibitors|mesh-ancestor
110512778|NCT00890552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110512779|NCT00890552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110512780|NCT00890552|Immunologic Factors|immunologic factors|mesh-ancestor
110512781|NCT00890552|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110512782|NCT00890552|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110512783|NCT00890552|Growth Substances|growth substances|mesh-ancestor
110512784|NCT00890552|Growth Inhibitors|growth inhibitors|mesh-ancestor
110512785|NCT00890552|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110512786|NCT00890552|Alkylating Agents|alkylating agents|mesh-ancestor
110512787|NCT00890552|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110512788|NCT00890552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110512789|NCT02856503|Vitamin D|vitamin d|mesh-list
110512790|NCT02856503|Cholecalciferol|cholecalciferol|mesh-list
110512791|NCT02856503|Vitamins|vitamins|mesh-ancestor
110512792|NCT02856503|Micronutrients|micronutrients|mesh-ancestor
110512793|NCT02856503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110512794|NCT02856503|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110512795|NCT02856503|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110512806|NCT02772120|Hormones|hormones|mesh-ancestor
110512807|NCT02772120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110512808|NCT02772120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110512809|NCT04248608|Morphine|morphine|mesh-list
110512810|NCT04248608|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110512811|NCT04248608|Narcotics|narcotics|mesh-ancestor
110512812|NCT04248608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110512813|NCT04248608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110512815|NCT04248608|Sensory System Agents|sensory system agents|mesh-ancestor
110512816|NCT04248608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110512818|NCT04783194|Bupivacaine|bupivacaine|mesh-list
110512819|NCT04783194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110512820|NCT04783194|Antiemetics|antiemetics|mesh-ancestor
110512821|NCT04783194|Autonomic Agents|autonomic agents|mesh-ancestor
110512822|NCT04783194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110512823|NCT04783194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110512824|NCT04783194|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110512825|NCT04783194|Glucocorticoids|glucocorticoids|mesh-ancestor
110512826|NCT04783194|Hormones|hormones|mesh-ancestor
110512827|NCT04783194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110512828|NCT04783194|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110512829|NCT04783194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110512830|NCT04783194|Anesthetics, Local|anesthetics, local|mesh-ancestor
110512831|NCT04783194|Anesthetics|anesthetics|mesh-ancestor
110512832|NCT04783194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110512833|NCT04783194|Sensory System Agents|sensory system agents|mesh-ancestor
110512834|NCT02854241|Liver Extracts|liver extracts|mesh-list
110512835|NCT02854241|Hematinics|hematinics|mesh-ancestor
110512836|NCT02835170|Immunoglobulins|immunoglobulins|mesh-list
110512837|NCT02835170|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110512838|NCT02835170|Antibodies|antibodies|mesh-list
110512839|NCT02835170|Immunologic Factors|immunologic factors|mesh-ancestor
110512840|NCT02835170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110512841|NCT00946985|Risperidone|risperidone|mesh-list
110512842|NCT00946985|Paliperidone Palmitate|paliperidone palmitate|mesh-list
110512843|NCT00946985|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110512845|NCT00946985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110512846|NCT00946985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110910630|NCT02075112|Hormones|hormones|mesh-ancestor
110512847|NCT00946985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110512848|NCT00946985|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110512849|NCT00946985|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110512850|NCT00946985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110512851|NCT00946985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110512852|NCT00946985|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110512853|NCT00946985|Dopamine Agents|dopamine agents|mesh-ancestor
110512854|NCT00946985|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110512855|NCT00946985|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110512857|NCT00611923|Androgen Antagonists|androgen antagonists|mesh-ancestor
110512858|NCT00611923|Hormone Antagonists|hormone antagonists|mesh-ancestor
110512859|NCT00611923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110512860|NCT00611923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110910826|NCT02751320|Citric Acid|citric acid|mesh-list
110512861|NCT00611923|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110512862|NCT00611923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110512863|NCT04246502|Capecitabine|capecitabine|mesh-list
110512864|NCT04246502|Trastuzumab|trastuzumab|mesh-list
110512877|NCT02767362|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110512878|NCT02767362|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110512879|NCT02767362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110512880|NCT00609973|Ciprofloxacin|ciprofloxacin|mesh-list
110512881|NCT00609973|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110512882|NCT00609973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110512883|NCT00609973|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110512884|NCT00609973|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110512885|NCT00609973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110512886|NCT00609973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110910953|NCT02223884|Carboplatin|carboplatin|mesh-list
110512887|NCT00609973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110512888|NCT00609973|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110512889|NCT00609973|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110512891|NCT02541643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110512892|NCT02696694|Progesterone|progesterone|mesh-list
110512893|NCT02696694|Progestins|progestins|mesh-ancestor
110512894|NCT02696694|Hormones|hormones|mesh-ancestor
110512895|NCT02696694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110512896|NCT02696694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110512898|NCT04038073|Antistreptolysin|antistreptolysin|mesh-list
110512899|NCT04038073|Immunologic Factors|immunologic factors|mesh-ancestor
110512900|NCT04038073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110512902|NCT04739592|Cholecalciferol|cholecalciferol|mesh-list
110512903|NCT04739592|Alendronate|alendronate|mesh-list
110512904|NCT04739592|Vitamins|vitamins|mesh-ancestor
110512905|NCT04739592|Micronutrients|micronutrients|mesh-ancestor
110512906|NCT04739592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110512907|NCT04739592|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110512908|NCT04739592|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110512909|NCT00633386|Celecoxib|celecoxib|mesh-list
110512910|NCT00633386|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110512911|NCT00633386|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110512912|NCT00633386|Analgesics|analgesics|mesh-ancestor
110911164|NCT02232308|Lisinopril|lisinopril|mesh-list
110512913|NCT00633386|Sensory System Agents|sensory system agents|mesh-ancestor
110512914|NCT00633386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110512915|NCT00633386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110512916|NCT00633386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110911219|NCT03068455|Nivolumab|nivolumab|mesh-list
110512917|NCT00633386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110512918|NCT00633386|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110512919|NCT00633386|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110512920|NCT00633386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110512921|NCT00633386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110512922|NCT02771418|Anesthetics|anesthetics|mesh-list
110512924|NCT02771418|Sevoflurane|sevoflurane|mesh-list
110512925|NCT02771418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110512926|NCT02771418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110512945|NCT00888901|Glucocorticoids|glucocorticoids|mesh-ancestor
110512946|NCT00888901|Hormones|hormones|mesh-ancestor
110512947|NCT00888901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110512948|NCT00888901|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110512949|NCT00888901|Protective Agents|protective agents|mesh-ancestor
110911351|NCT02233244|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110512950|NCT00888901|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110512951|NCT00888901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110512952|NCT00803049|Teriflunomide|teriflunomide|mesh-list
110512953|NCT00803049|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110512954|NCT00803049|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110512955|NCT00803049|Analgesics|analgesics|mesh-ancestor
110512956|NCT00803049|Sensory System Agents|sensory system agents|mesh-ancestor
110512957|NCT00803049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110512958|NCT00803049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110512959|NCT00803049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110512960|NCT00803049|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110512961|NCT00803049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110512962|NCT00803049|Immunologic Factors|immunologic factors|mesh-ancestor
110512965|NCT00884767|Oxaliplatin|oxaliplatin|mesh-list
110512966|NCT00884767|Calcium|calcium|mesh-list
110512967|NCT00884767|Levoleucovorin|levoleucovorin|mesh-list
110512968|NCT00884767|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110512969|NCT00884767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110512970|NCT00884767|Antimetabolites|antimetabolites|mesh-ancestor
110512971|NCT00884767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110512972|NCT00884767|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110512973|NCT00884767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110512974|NCT00884767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110512975|NCT00884767|Immunologic Factors|immunologic factors|mesh-ancestor
110512976|NCT00884767|Antidotes|antidotes|mesh-ancestor
110512977|NCT00884767|Protective Agents|protective agents|mesh-ancestor
110512978|NCT00884767|Vitamin B Complex|vitamin b complex|mesh-ancestor
110512979|NCT00884767|Vitamins|vitamins|mesh-ancestor
110512980|NCT00884767|Micronutrients|micronutrients|mesh-ancestor
110512981|NCT00890084|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110160351|NCT00097942|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110911708|NCT04539808|Vitamins|vitamins|mesh-ancestor
110512982|NCT00890084|Telmisartan|telmisartan|mesh-list
110512983|NCT00890084|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
110512984|NCT00890084|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110512996|NCT00884845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110512997|NCT00884845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110512998|NCT02773602|Dexamethasone|dexamethasone|mesh-list
110513000|NCT02773602|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110513001|NCT02773602|Antiemetics|antiemetics|mesh-ancestor
110513002|NCT02773602|Autonomic Agents|autonomic agents|mesh-ancestor
110513003|NCT02773602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110513004|NCT02773602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110513005|NCT02773602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110513006|NCT02773602|Glucocorticoids|glucocorticoids|mesh-ancestor
110513007|NCT02773602|Hormones|hormones|mesh-ancestor
110513008|NCT02773602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110513009|NCT02773602|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110513010|NCT02773602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110513011|NCT02773602|Analgesics|analgesics|mesh-ancestor
110188539|NCT02250326|Paclitaxel|paclitaxel|mesh-list
110513012|NCT02773602|Sensory System Agents|sensory system agents|mesh-ancestor
110513013|NCT02773602|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110513014|NCT02773602|Sympatholytics|sympatholytics|mesh-ancestor
110513015|NCT02773602|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110513016|NCT02773602|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110513017|NCT02773602|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110513018|NCT02773602|Adrenergic Agents|adrenergic agents|mesh-ancestor
110513019|NCT02773602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110513020|NCT02773602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110513021|NCT02770950|Indomethacin|indomethacin|mesh-list
110513022|NCT02770950|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110513023|NCT02770950|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110513024|NCT02770950|Analgesics|analgesics|mesh-ancestor
110513025|NCT02770950|Sensory System Agents|sensory system agents|mesh-ancestor
110513026|NCT02770950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110513027|NCT02770950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110513028|NCT02770950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110513029|NCT02770950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110513030|NCT02770950|Gout Suppressants|gout suppressants|mesh-ancestor
110513031|NCT02770950|Tocolytic Agents|tocolytic agents|mesh-ancestor
110513032|NCT02770950|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110513033|NCT02770950|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110513034|NCT02770950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110513035|NCT02770950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110513036|NCT00889057|Sorafenib|sorafenib|mesh-list
110513037|NCT00889057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110188551|NCT02225600|Oxytocin|oxytocin|mesh-list
110513038|NCT00889057|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110513039|NCT00889057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110513040|NCT00889057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110513041|NCT02829008|Bevacizumab|bevacizumab|mesh-list
110513042|NCT02829008|Pemetrexed|pemetrexed|mesh-list
110513043|NCT02829008|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110513044|NCT02829008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110911939|NCT01418222|Antidotes|antidotes|mesh-ancestor
110513045|NCT02829008|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110513069|NCT02696928|Lumefantrine|lumefantrine|mesh-list
110513070|NCT02696928|Primaquine|primaquine|mesh-list
110513071|NCT02696928|Antimalarials|antimalarials|mesh-ancestor
110513072|NCT02696928|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110513073|NCT02696928|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110513074|NCT02696928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110513075|NCT00886405|Nitroglycerin|nitroglycerin|mesh-list
110513076|NCT00886405|Vasodilator Agents|vasodilator agents|mesh-ancestor
110513077|NCT00889369|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110513078|NCT00889369|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110513079|NCT00889369|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110513080|NCT00889369|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110912078|NCT04069585|Lidocaine|lidocaine|mesh-list
110513081|NCT00889369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110513082|NCT00889369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110513083|NCT00889369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110513084|NCT00889369|Analgesics|analgesics|mesh-ancestor
110513085|NCT00889369|Sensory System Agents|sensory system agents|mesh-ancestor
110513086|NCT00889369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110513087|NCT00889369|Antidepressive Agents|antidepressive agents|mesh-ancestor
110513088|NCT00889369|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110513089|NCT00889369|Dopamine Agents|dopamine agents|mesh-ancestor
110513090|NCT02766192|Ketamine|ketamine|mesh-list
110513091|NCT02766192|Analgesics|analgesics|mesh-ancestor
110513092|NCT02766192|Sensory System Agents|sensory system agents|mesh-ancestor
110513093|NCT02766192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110513094|NCT02766192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110513095|NCT02766192|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110513096|NCT02766192|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110513097|NCT02766192|Anesthetics, General|anesthetics, general|mesh-ancestor
110513098|NCT02766192|Anesthetics|anesthetics|mesh-ancestor
110177318|NCT03893825|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110513113|NCT00889525|Dopamine Agonists|dopamine agonists|mesh-ancestor
110513115|NCT00889525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110513116|NCT00889525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110513117|NCT00889525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110513119|NCT02770794|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110912270|NCT02268890|Bortezomib|bortezomib|mesh-list
110513120|NCT02770794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110513121|NCT02770794|Dermatologic Agents|dermatologic agents|mesh-ancestor
110513122|NCT02770794|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110513123|NCT02770794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110513124|NCT04224246|Sodium Oxybate|sodium oxybate|mesh-list
110513125|NCT04224246|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110513126|NCT04224246|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110513127|NCT04224246|Anesthetics, General|anesthetics, general|mesh-ancestor
110513128|NCT04224246|Anesthetics|anesthetics|mesh-ancestor
110513129|NCT04224246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110513130|NCT04224246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110513131|NCT02766270|Temozolomide|temozolomide|mesh-list
110513132|NCT02766270|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110312023|NCT00324792|Insulin|insulin|mesh-list
110513133|NCT02766270|Alkylating Agents|alkylating agents|mesh-ancestor
110513134|NCT02766270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110513135|NCT02766270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110513136|NCT04300010|Benzoyl Peroxide|benzoyl peroxide|mesh-list
110513137|NCT04300010|Dermatologic Agents|dermatologic agents|mesh-ancestor
110513138|NCT02766348|Gemcitabine|gemcitabine|mesh-list
110513139|NCT02766348|Cisplatin|cisplatin|mesh-list
110912344|NCT04691128|Propofol|propofol|mesh-list
110513140|NCT02766348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110513141|NCT02766348|Antimetabolites|antimetabolites|mesh-ancestor
110513142|NCT02766348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110513143|NCT02766348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110513144|NCT00608569|Ritonavir|ritonavir|mesh-list
110513145|NCT00608569|Lopinavir|lopinavir|mesh-list
110513146|NCT00608569|Tenofovir|tenofovir|mesh-list
110513147|NCT00608569|Emtricitabine|emtricitabine|mesh-list
110513148|NCT00608569|Zidovudine|zidovudine|mesh-list
110513149|NCT00608569|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110513150|NCT00608569|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110513151|NCT00608569|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110513152|NCT00608569|Protease Inhibitors|protease inhibitors|mesh-ancestor
110513153|NCT00608569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110513154|NCT00608569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110513155|NCT00608569|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110513156|NCT00608569|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110513157|NCT00608569|Antiviral Agents|antiviral agents|mesh-ancestor
110513158|NCT00608569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110513173|NCT02828384|Cathartics|cathartics|mesh-ancestor
110513174|NCT02828384|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110513176|NCT00886717|genexol-PM|genexol-pm|mesh-list
110912599|NCT02085018|Omeprazole|omeprazole|mesh-list
110513177|NCT00886717|Carboplatin|carboplatin|mesh-list
110513178|NCT00886717|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110513179|NCT00886717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110513180|NCT00886717|Tubulin Modulators|tubulin modulators|mesh-ancestor
110513181|NCT00886717|Antimitotic Agents|antimitotic agents|mesh-ancestor
110513182|NCT00886717|Mitosis Modulators|mitosis modulators|mesh-ancestor
110513183|NCT00886717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110513184|NCT00889837|Loxapine|loxapine|mesh-list
110513185|NCT00889837|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110513187|NCT00889837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110513188|NCT00889837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110513189|NCT00889837|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110513190|NCT00889837|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110513191|NCT00889837|Dopamine Agents|dopamine agents|mesh-ancestor
110513192|NCT00889837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110513193|NCT00889837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110513194|NCT02770404|Nafithromycin|nafithromycin|mesh-list
110513195|NCT02770404|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110513196|NCT02770404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110513197|NCT02770404|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110513199|NCT02770404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110513200|NCT00886873|Mifepristone|mifepristone|mesh-list
110513201|NCT00886873|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
110513202|NCT00886873|Abortifacient Agents|abortifacient agents|mesh-ancestor
110513203|NCT00886873|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110513204|NCT00886873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110513205|NCT00886873|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110513206|NCT00886873|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110160578|NCT00100009|Triamcinolone|triamcinolone|mesh-list
110513207|NCT00886873|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110513208|NCT00886873|Contraceptive Agents|contraceptive agents|mesh-ancestor
110513209|NCT00886873|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
110513210|NCT00886873|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
110513211|NCT00886873|Hormone Antagonists|hormone antagonists|mesh-ancestor
110513212|NCT00886873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110513213|NCT00886873|Luteolytic Agents|luteolytic agents|mesh-ancestor
110513214|NCT00886873|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110513215|NCT00886873|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
110513217|NCT04243850|Caffeine|caffeine|mesh-list
110513218|NCT04243850|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110513244|NCT00633542|Thalidomide|thalidomide|mesh-list
110513245|NCT00633542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110513246|NCT00633542|Antiviral Agents|antiviral agents|mesh-ancestor
110513247|NCT00633542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110513248|NCT00633542|Immunologic Factors|immunologic factors|mesh-ancestor
110513249|NCT00633542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110513250|NCT00633542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110513251|NCT00633542|Leprostatic Agents|leprostatic agents|mesh-ancestor
110513252|NCT00633542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110513253|NCT00633542|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110513254|NCT00633542|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110513255|NCT00633542|Growth Substances|growth substances|mesh-ancestor
110513256|NCT00633542|Growth Inhibitors|growth inhibitors|mesh-ancestor
110513257|NCT02766036|Propolis|propolis|mesh-list
110513258|NCT02766036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110513259|NCT00610675|Mirtazapine|mirtazapine|mesh-list
110513260|NCT00610675|Antidepressive Agents|antidepressive agents|mesh-ancestor
110513261|NCT00610675|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110913358|NCT03667677|Tandospirone|tandospirone|mesh-list
110513262|NCT00610675|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110513263|NCT00610675|Histamine Antagonists|histamine antagonists|mesh-ancestor
110513264|NCT00610675|Histamine Agents|histamine agents|mesh-ancestor
110513265|NCT00610675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110188639|NCT00018668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110513266|NCT00610675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110513267|NCT00610675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110513282|NCT02828228|Micronutrients|micronutrients|mesh-ancestor
110513283|NCT02828228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110513284|NCT02828228|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110513285|NCT02828228|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110513287|NCT02769936|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110513288|NCT02769936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110513289|NCT02769936|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110513290|NCT02769936|Antitubercular Agents|antitubercular agents|mesh-ancestor
110513291|NCT02769936|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110513292|NCT02769936|Antimetabolites|antimetabolites|mesh-ancestor
110513293|NCT02769936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110513294|NCT00887029|Timolol|timolol|mesh-list
110513295|NCT00887029|Travoprost|travoprost|mesh-list
110513296|NCT00887029|Latanoprost|latanoprost|mesh-list
110513297|NCT00887029|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110513298|NCT00887029|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110513299|NCT00887029|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110513300|NCT00887029|Adrenergic Agents|adrenergic agents|mesh-ancestor
110513301|NCT00887029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110513302|NCT00887029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110513303|NCT00887029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110513304|NCT00887029|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110513305|NCT00887029|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110513306|NCT00887029|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110513307|NCT00635310|Liver Extracts|liver extracts|mesh-list
110513308|NCT00635310|Hematinics|hematinics|mesh-ancestor
110513309|NCT02762448|Asunaprevir|asunaprevir|mesh-list
110513310|NCT02762448|Protease Inhibitors|protease inhibitors|mesh-ancestor
110513311|NCT02762448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110513312|NCT02762448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110513313|NCT00573157|Mycophenolic Acid|mycophenolic acid|mesh-list
110513314|NCT00573157|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110513315|NCT00573157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110513316|NCT00573157|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110913542|NCT01941875|Progesterone|progesterone|mesh-list
110513317|NCT00573157|Antitubercular Agents|antitubercular agents|mesh-ancestor
110513318|NCT00573157|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110513319|NCT00573157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110513320|NCT00573157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110513321|NCT00573157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110513322|NCT00890383|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
110513323|NCT00890383|Plasma Substitutes|plasma substitutes|mesh-ancestor
110513324|NCT00890383|Blood Substitutes|blood substitutes|mesh-ancestor
110513326|NCT00887107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110513327|NCT00887107|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110513328|NCT00887107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110177395|NCT00139165|Hormones|hormones|mesh-ancestor
110513357|NCT02769390|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110513358|NCT02769390|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110513360|NCT02769390|Anesthetics|anesthetics|mesh-ancestor
110513361|NCT02769390|GABA Modulators|gaba modulators|mesh-ancestor
110513362|NCT02769390|GABA Agents|gaba agents|mesh-ancestor
110513363|NCT00890539|Methacholine Chloride|methacholine chloride|mesh-list
110513364|NCT00890539|Miotics|miotics|mesh-ancestor
110513365|NCT00890539|Autonomic Agents|autonomic agents|mesh-ancestor
110513366|NCT00890539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110513367|NCT00890539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110513368|NCT00890539|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110513369|NCT00890539|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
110513370|NCT00890539|Respiratory System Agents|respiratory system agents|mesh-ancestor
110513371|NCT00890539|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
110513372|NCT00890539|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110513373|NCT00890539|Cholinergic Agents|cholinergic agents|mesh-ancestor
110913886|NCT05212597|Amlodipine|amlodipine|mesh-list
110513374|NCT00890539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110513375|NCT00890539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110513376|NCT00887263|Budesonide|budesonide|mesh-list
110513377|NCT00887263|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110513378|NCT00887263|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110513396|NCT00914667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110913958|NCT05211583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110513397|NCT00914667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110513398|NCT00914667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110513399|NCT00914667|Urological Agents|urological agents|mesh-ancestor
110513400|NCT00887978|Treprostinil|treprostinil|mesh-list
110513401|NCT00887978|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110513402|NCT00608023|Tesamorelin|tesamorelin|mesh-list
110513403|NCT00608023|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
110513404|NCT00608023|Growth Substances|growth substances|mesh-ancestor
110513405|NCT00608023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110513406|NCT00608023|Hormones|hormones|mesh-ancestor
110513407|NCT00608023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110513408|NCT02765022|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
110513409|NCT02765022|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
110513410|NCT02765022|beta-Endorphin|beta-endorphin|mesh-list
110513411|NCT02765022|Hormones|hormones|mesh-ancestor
110513412|NCT02765022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110513413|NCT02765022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110513414|NCT02765022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110513415|NCT02765022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110513416|NCT04224636|Bevacizumab|bevacizumab|mesh-list
110513417|NCT04224636|Atezolizumab|atezolizumab|mesh-list
110914162|NCT03072719|Tin Fluorides|tin fluorides|mesh-list
110513418|NCT04224636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110513419|NCT04224636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110513420|NCT04224636|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110914241|NCT00927914|Ranirestat|ranirestat|mesh-list
110513421|NCT04224636|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110513422|NCT04224636|Growth Substances|growth substances|mesh-ancestor
110513423|NCT04224636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110513424|NCT04224636|Growth Inhibitors|growth inhibitors|mesh-ancestor
110513425|NCT04224636|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110513426|NCT04224636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110513427|NCT00607789|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110513428|NCT00607789|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110513429|NCT00607789|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110160797|NCT00101179|Antimetabolites|antimetabolites|mesh-ancestor
110513430|NCT00607789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110513431|NCT00607789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110513432|NCT00607789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110513452|NCT00893269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110513453|NCT00893269|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
110513455|NCT00893269|GABA Agents|gaba agents|mesh-ancestor
110513456|NCT00893269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110513457|NCT00893269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110513458|NCT05672667|Oxytocin|oxytocin|mesh-list
110513459|NCT05672667|Oxytocics|oxytocics|mesh-ancestor
110513460|NCT05672667|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110914367|NCT05202275|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110513461|NCT05672667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110513462|NCT04115397|Zoledronic Acid|zoledronic acid|mesh-list
110513463|NCT04115397|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110513464|NCT04115397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110513465|NCT00887822|Bevacizumab|bevacizumab|mesh-list
110513466|NCT00887822|Capecitabine|capecitabine|mesh-list
110513467|NCT00887822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110513468|NCT00887822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110513469|NCT00887822|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110513470|NCT00887822|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110513471|NCT00887822|Growth Substances|growth substances|mesh-ancestor
110513472|NCT00887822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110513473|NCT00887822|Growth Inhibitors|growth inhibitors|mesh-ancestor
110513474|NCT00887822|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110513475|NCT00887822|Antimetabolites|antimetabolites|mesh-ancestor
110914422|NCT04695106|Purinergic Agents|purinergic agents|mesh-ancestor
110513476|NCT00887822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110513477|NCT04222920|Adalimumab|adalimumab|mesh-list
110513478|NCT04222920|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110513479|NCT04222920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110513480|NCT04222920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110513481|NCT02542111|Dexamethasone|dexamethasone|mesh-list
110513482|NCT02542111|Gemcitabine|gemcitabine|mesh-list
110513483|NCT02542111|Bortezomib|bortezomib|mesh-list
110513484|NCT02542111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110513485|NCT02542111|Antiemetics|antiemetics|mesh-ancestor
110513486|NCT02542111|Autonomic Agents|autonomic agents|mesh-ancestor
110914483|NCT03383224|Autonomic Agents|autonomic agents|mesh-ancestor
110513487|NCT02542111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110513488|NCT02542111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110513489|NCT02542111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110513490|NCT02542111|Glucocorticoids|glucocorticoids|mesh-ancestor
110513491|NCT02542111|Hormones|hormones|mesh-ancestor
110513514|NCT00891163|Anesthetics, Local|anesthetics, local|mesh-ancestor
110513515|NCT00891163|Anesthetics|anesthetics|mesh-ancestor
110513516|NCT00891163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110513517|NCT00891163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110513518|NCT00891163|Sensory System Agents|sensory system agents|mesh-ancestor
110513519|NCT00891163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110513520|NCT00891163|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110513521|NCT00891163|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110513522|NCT00891163|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110513523|NCT00891163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110513524|NCT00891163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110513525|NCT02541331|Broncho-Vaxom|broncho-vaxom|mesh-list
110513526|NCT02541331|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110513527|NCT02541331|Immunologic Factors|immunologic factors|mesh-ancestor
110513528|NCT02541331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110513529|NCT00893425|Ramipril|ramipril|mesh-list
110513530|NCT00893425|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110513531|NCT00893425|Protease Inhibitors|protease inhibitors|mesh-ancestor
110513532|NCT00893425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110513533|NCT00893425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110513534|NCT00893425|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110513535|NCT00951665|Paclitaxel|paclitaxel|mesh-list
110513536|NCT00951665|Maytansine|maytansine|mesh-list
110513537|NCT00951665|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
110513538|NCT00951665|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110513539|NCT00951665|Trastuzumab|trastuzumab|mesh-list
110513540|NCT00951665|Pertuzumab|pertuzumab|mesh-list
110513541|NCT00951665|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110513542|NCT00951665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110177477|NCT03844412|Hormones|hormones|mesh-ancestor
110513574|NCT04036201|Protective Agents|protective agents|mesh-ancestor
110513575|NCT00801099|Amoxicillin|amoxicillin|mesh-list
110513576|NCT00801099|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
110513577|NCT00801099|Clavulanic Acids|clavulanic acids|mesh-list
110160943|NCT00102310|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110513578|NCT00801099|Clavulanic Acid|clavulanic acid|mesh-list
110513579|NCT00801099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110513580|NCT00801099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110513581|NCT00801099|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110513582|NCT00801099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110513583|NCT00801099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110513585|NCT02768610|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110513586|NCT02768610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110513587|NCT02768610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110513588|NCT02768610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110513600|NCT02764710|Clavulanic Acids|clavulanic acids|mesh-list
110513601|NCT02764710|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
110513602|NCT02764710|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110513603|NCT02764710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110513604|NCT02764710|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110513605|NCT02764710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110513606|NCT02764710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110513608|NCT00923169|Mitosis Modulators|mitosis modulators|mesh-ancestor
110513609|NCT00923169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110513610|NCT02541019|Ondansetron|ondansetron|mesh-list
110513611|NCT02541019|Palonosetron|palonosetron|mesh-list
110513612|NCT02541019|Antiemetics|antiemetics|mesh-ancestor
110513613|NCT02541019|Autonomic Agents|autonomic agents|mesh-ancestor
110513614|NCT02541019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110513615|NCT02541019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110513616|NCT02541019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110513617|NCT02541019|Antipruritics|antipruritics|mesh-ancestor
110513618|NCT02541019|Dermatologic Agents|dermatologic agents|mesh-ancestor
110513619|NCT02541019|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110513620|NCT02541019|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110513621|NCT02541019|Serotonin Agents|serotonin agents|mesh-ancestor
110513622|NCT02541019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110513623|NCT02541019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110513624|NCT00893581|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110513625|NCT00893581|Antidepressive Agents|antidepressive agents|mesh-ancestor
110513626|NCT00893581|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110513627|NCT00893581|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110513628|NCT00893581|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110513629|NCT00893581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110513630|NCT00893581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110513631|NCT04114383|Deuterium Oxide|deuterium oxide|mesh-list
110513632|NCT04114383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110513633|NCT04114383|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110513634|NCT04114383|Protective Agents|protective agents|mesh-ancestor
110513635|NCT04114383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110513636|NCT04114461|Tofacitinib|tofacitinib|mesh-list
110513637|NCT04114461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110513638|NCT04114461|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
110513639|NCT04114461|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110513640|NCT04114461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110513641|NCT02768454|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110513642|NCT02768454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110513643|NCT02768376|Fentanyl|fentanyl|mesh-list
110513644|NCT02768376|Bupivacaine|bupivacaine|mesh-list
110513645|NCT02768376|Anesthetics|anesthetics|mesh-list
110513646|NCT02768376|Anesthetics, Local|anesthetics, local|mesh-ancestor
110513647|NCT02768376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110513648|NCT02768376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110513649|NCT02768376|Sensory System Agents|sensory system agents|mesh-ancestor
110513650|NCT02768376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110513652|NCT02768376|Narcotics|narcotics|mesh-ancestor
110513653|NCT02768376|Analgesics|analgesics|mesh-ancestor
110513669|NCT02696460|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110513670|NCT02696460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110513671|NCT02696460|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
110513672|NCT00888043|Bevacizumab|bevacizumab|mesh-list
110513673|NCT00888043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110513674|NCT00888043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110513675|NCT00888043|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110914571|NCT02675842|Hormones|hormones|mesh-ancestor
110513676|NCT00888043|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110513677|NCT00888043|Growth Substances|growth substances|mesh-ancestor
110513678|NCT00888043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110513679|NCT00888043|Growth Inhibitors|growth inhibitors|mesh-ancestor
110513680|NCT02768220|Empagliflozin|empagliflozin|mesh-list
110513681|NCT02768220|Linagliptin|linagliptin|mesh-list
110513682|NCT02768220|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110513683|NCT02768220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110513684|NCT02768220|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110513685|NCT02768220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110513686|NCT02768220|Incretins|incretins|mesh-ancestor
110513687|NCT02768220|Hormones|hormones|mesh-ancestor
110513688|NCT02768220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110513689|NCT02768220|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110513690|NCT02768220|Protease Inhibitors|protease inhibitors|mesh-ancestor
110513691|NCT02768220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110513692|NCT02760888|Diclofenac|diclofenac|mesh-list
110513693|NCT02760888|Tramadol|tramadol|mesh-list
110513694|NCT02760888|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110513695|NCT02760888|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110513696|NCT02760888|Analgesics|analgesics|mesh-ancestor
110513697|NCT02760888|Sensory System Agents|sensory system agents|mesh-ancestor
110513698|NCT02760888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110513699|NCT02760888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110513700|NCT02760888|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110513701|NCT02760888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110513702|NCT02760888|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110513703|NCT02760888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110513704|NCT02760888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110298856|NCT04023331|Copper|copper|mesh-list
110513705|NCT02760888|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110513706|NCT02760888|Narcotics|narcotics|mesh-ancestor
110513707|NCT02760888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110513708|NCT00799617|Methyltestosterone|methyltestosterone|mesh-list
110513709|NCT00799617|Testosterone|testosterone|mesh-list
110513710|NCT00799617|Testosterone undecanoate|testosterone undecanoate|mesh-list
110513711|NCT00799617|Testosterone enanthate|testosterone enanthate|mesh-list
110177538|NCT00139750|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110513737|NCT00799383|Vitamins|vitamins|mesh-ancestor
110513738|NCT00799383|Micronutrients|micronutrients|mesh-ancestor
110513739|NCT00799383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110513740|NCT00799383|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110513741|NCT00799383|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110513742|NCT02763852|Benserazide, levodopa drug combination|benserazide, levodopa drug combination|mesh-list
110513743|NCT02763852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110513744|NCT02763852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110513745|NCT02763852|Dopamine Agents|dopamine agents|mesh-ancestor
110513746|NCT02763852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110513747|NCT02763852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110513748|NCT04114149|Analgesics, Opioid|analgesics, opioid|mesh-list
110513750|NCT04114149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110513751|NCT04114149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110513752|NCT04114149|Analgesics|analgesics|mesh-ancestor
110513753|NCT04114149|Sensory System Agents|sensory system agents|mesh-ancestor
110513754|NCT04114149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110513755|NCT00891397|Pregabalin|pregabalin|mesh-list
110513756|NCT00891397|Analgesics|analgesics|mesh-ancestor
110513757|NCT00891397|Sensory System Agents|sensory system agents|mesh-ancestor
110513758|NCT00891397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110513759|NCT00891397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110513760|NCT00891397|Anticonvulsants|anticonvulsants|mesh-ancestor
110513761|NCT00891397|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110513762|NCT00891397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110513763|NCT00891397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110177554|NCT03150459|Rifaximin|rifaximin|mesh-list
110513770|NCT02767596|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110513771|NCT02767596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110513772|NCT02826902|Remifentanil|remifentanil|mesh-list
110513773|NCT02826902|Propofol|propofol|mesh-list
110513774|NCT02826902|Desflurane|desflurane|mesh-list
110513775|NCT02826902|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110513776|NCT02826902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110513777|NCT02826902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110513778|NCT02826902|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110513779|NCT02826902|Anesthetics, General|anesthetics, general|mesh-ancestor
110513780|NCT02826902|Anesthetics|anesthetics|mesh-ancestor
110513781|NCT02826902|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110513782|NCT02826902|Narcotics|narcotics|mesh-ancestor
110513783|NCT02826902|Analgesics|analgesics|mesh-ancestor
110513784|NCT02826902|Sensory System Agents|sensory system agents|mesh-ancestor
110513785|NCT02826902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110513786|NCT02826902|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110513787|NCT00798759|Travoprost|travoprost|mesh-list
110513788|NCT00798759|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110513789|NCT00798759|Latanoprost|latanoprost|mesh-list
110513790|NCT00798759|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110513791|NCT00798759|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110513792|NCT00891475|Interferons|interferons|mesh-list
110513793|NCT00891475|Interferon-alpha|interferon-alpha|mesh-list
110513794|NCT00891475|Sunitinib|sunitinib|mesh-list
110513795|NCT00891475|Maleic acid|maleic acid|mesh-list
110513796|NCT00891475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110513797|NCT00891475|Antiviral Agents|antiviral agents|mesh-ancestor
110513798|NCT00891475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110513799|NCT00891475|Immunologic Factors|immunologic factors|mesh-ancestor
110513800|NCT00891475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110513801|NCT00891475|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110513802|NCT00891475|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110513803|NCT00891475|Growth Substances|growth substances|mesh-ancestor
110161172|NCT03879408|Acetaminophen|acetaminophen|mesh-list
110513804|NCT00891475|Growth Inhibitors|growth inhibitors|mesh-ancestor
110513805|NCT00891475|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110513806|NCT00891475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110513807|NCT00891475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110513809|NCT00887432|Cholecalciferol|cholecalciferol|mesh-list
110513810|NCT00887432|Vitamins|vitamins|mesh-ancestor
110513811|NCT00887432|Micronutrients|micronutrients|mesh-ancestor
110513812|NCT00887432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110513813|NCT00887432|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110513814|NCT00887432|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110513815|NCT04222686|Losartan|losartan|mesh-list
110513816|NCT04222686|Perindopril|perindopril|mesh-list
110513817|NCT04222686|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110513818|NCT04222686|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110513819|NCT04222686|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110513820|NCT04222686|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110513821|NCT04222686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110513822|NCT04222686|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110513823|NCT04222686|Protease Inhibitors|protease inhibitors|mesh-ancestor
110513824|NCT04222686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110513825|NCT04113915|Cyclosporine|cyclosporine|mesh-list
110513826|NCT04113915|Dexamethasone|dexamethasone|mesh-list
110513827|NCT04113915|Cyclosporins|cyclosporins|mesh-list
110513828|NCT04113915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110513829|NCT04113915|Immunologic Factors|immunologic factors|mesh-ancestor
110513830|NCT04113915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110513831|NCT04113915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110513832|NCT04113915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110513833|NCT04113915|Antiemetics|antiemetics|mesh-ancestor
110513834|NCT04113915|Autonomic Agents|autonomic agents|mesh-ancestor
110177574|NCT00140101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110513846|NCT04113915|Dermatologic Agents|dermatologic agents|mesh-ancestor
110513847|NCT04113915|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110513848|NCT03590821|Aspirin|aspirin|mesh-list
110513849|NCT03590821|Celecoxib|celecoxib|mesh-list
110513850|NCT03590821|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110513851|NCT03590821|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110513852|NCT03590821|Analgesics|analgesics|mesh-ancestor
110513853|NCT03590821|Sensory System Agents|sensory system agents|mesh-ancestor
110513854|NCT03590821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110513855|NCT03590821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110188826|NCT00039156|IDN 5109|idn 5109|mesh-list
110513856|NCT03590821|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110513857|NCT03590821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110513858|NCT03590821|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110513859|NCT03590821|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110513860|NCT03590821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110513861|NCT03590821|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110513862|NCT03590821|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110513863|NCT03590821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110513864|NCT03590821|Antipyretics|antipyretics|mesh-ancestor
110513865|NCT03590821|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110513866|NCT04113993|Bazedoxifene|bazedoxifene|mesh-list
110513867|NCT04113993|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110513868|NCT04113993|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110513869|NCT04113993|Hormone Antagonists|hormone antagonists|mesh-ancestor
110513870|NCT04113993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110513871|NCT04113993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110513872|NCT04113993|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110513873|NCT02758470|Acetazolamide|acetazolamide|mesh-list
110513874|NCT02758470|Methazolamide|methazolamide|mesh-list
110513875|NCT02758470|Anticonvulsants|anticonvulsants|mesh-ancestor
110914624|NCT04436536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110513876|NCT02758470|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110513877|NCT02758470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110513878|NCT02758470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110513880|NCT02758470|Natriuretic Agents|natriuretic agents|mesh-ancestor
110513881|NCT02758470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110513882|NCT04223076|Chlorhexidine|chlorhexidine|mesh-list
110513883|NCT04223076|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110513884|NCT04223076|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110513885|NCT04223076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110513886|NCT04223076|Disinfectants|disinfectants|mesh-ancestor
110513887|NCT04223076|Dermatologic Agents|dermatologic agents|mesh-ancestor
110513888|NCT00951275|Antirheumatic Agents|antirheumatic agents|mesh-list
110513889|NCT02764008|Bupivacaine|bupivacaine|mesh-list
110513890|NCT02764008|Anesthetics, Local|anesthetics, local|mesh-ancestor
110513891|NCT02764008|Anesthetics|anesthetics|mesh-ancestor
110513892|NCT02764008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110513893|NCT02764008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110513894|NCT02764008|Sensory System Agents|sensory system agents|mesh-ancestor
110513895|NCT02764008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110513896|NCT00798603|Bevacizumab|bevacizumab|mesh-list
110513897|NCT00798603|Carboplatin|carboplatin|mesh-list
110513913|NCT04036981|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110513914|NCT04036981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110513915|NCT04036981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110513916|NCT04036981|Cholinergic Agents|cholinergic agents|mesh-ancestor
110513917|NCT04036981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110513918|NCT04036981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110513919|NCT04036981|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110513920|NCT04036981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110513921|NCT00887354|Vitamin D|vitamin d|mesh-list
110513922|NCT00887354|Teriparatide|teriparatide|mesh-list
110513923|NCT00887354|Risedronic Acid|risedronic acid|mesh-list
110513924|NCT00887354|Calcium|calcium|mesh-list
110513925|NCT00887354|Vitamins|vitamins|mesh-ancestor
110513926|NCT00887354|Micronutrients|micronutrients|mesh-ancestor
110513927|NCT00887354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110513928|NCT00887354|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110513929|NCT00887354|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110513930|NCT00887354|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110513931|NCT00887354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110513932|NCT00887354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110513933|NCT00951041|Vaccines|vaccines|mesh-list
110513934|NCT00951041|Immunologic Factors|immunologic factors|mesh-ancestor
110513935|NCT00951041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110513936|NCT02832596|Norepinephrine|norepinephrine|mesh-list
110513937|NCT02832596|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110513938|NCT02832596|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110513939|NCT02832596|Adrenergic Agents|adrenergic agents|mesh-ancestor
110513940|NCT02832596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110513941|NCT02832596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110513942|NCT02832596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110513943|NCT02832596|Sympathomimetics|sympathomimetics|mesh-ancestor
110513944|NCT02832596|Autonomic Agents|autonomic agents|mesh-ancestor
110513945|NCT02832596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110513946|NCT02832596|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110513947|NCT02760420|Amoxicillin|amoxicillin|mesh-list
110513948|NCT02760420|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110513949|NCT02760420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110513951|NCT04612530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110513952|NCT04612530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110513953|NCT04612530|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110513954|NCT04612530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110513955|NCT00945815|Cytarabine|cytarabine|mesh-list
110513956|NCT00945815|Clofarabine|clofarabine|mesh-list
110513976|NCT00798369|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110513977|NCT00798369|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110513978|NCT00798369|Glucocorticoids|glucocorticoids|mesh-ancestor
110513979|NCT00798369|Hormones|hormones|mesh-ancestor
110513980|NCT00798369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110513981|NCT00798369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110513982|NCT00798369|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110513983|NCT00798369|Immunologic Factors|immunologic factors|mesh-ancestor
110513984|NCT00798369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110513985|NCT00798369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110513986|NCT00608959|Chlorhexidine|chlorhexidine|mesh-list
110513987|NCT00608959|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110513988|NCT00608959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110513989|NCT00608959|Disinfectants|disinfectants|mesh-ancestor
110513990|NCT02760342|Metformin|metformin|mesh-list
110513991|NCT02760342|Peficitinib|peficitinib|mesh-list
110513992|NCT02760342|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110513993|NCT02760342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110513994|NCT02760342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110513995|NCT02760342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110513996|NCT02760342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110513997|NCT02760342|Immunologic Factors|immunologic factors|mesh-ancestor
110513998|NCT04221282|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
110513999|NCT04221282|Anticonvulsants|anticonvulsants|mesh-ancestor
110514000|NCT04221282|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110514001|NCT04221282|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110514002|NCT04221282|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110514003|NCT04221282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110514004|NCT00894283|Enoxaparin|enoxaparin|mesh-list
110514005|NCT00894283|PENTA|penta|mesh-list
110514006|NCT00894283|Fondaparinux|fondaparinux|mesh-list
110514007|NCT00894283|Anticoagulants|anticoagulants|mesh-ancestor
110514008|NCT00894283|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110514009|NCT00894283|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110514010|NCT00894283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110514011|NCT00894283|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110514021|NCT00895609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110514022|NCT00895609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110514023|NCT00895609|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110514024|NCT00895609|Autonomic Agents|autonomic agents|mesh-ancestor
110514025|NCT00895609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110161397|NCT00006479|Levoleucovorin|levoleucovorin|mesh-list
110514028|NCT00894439|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110914668|NCT04094012|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110514029|NCT00894439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110514030|NCT00894439|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110514031|NCT00894439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110514032|NCT00894439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110514033|NCT04035889|Melatonin|melatonin|mesh-list
110514034|NCT04035889|Antioxidants|antioxidants|mesh-ancestor
110514035|NCT04035889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110514036|NCT04035889|Protective Agents|protective agents|mesh-ancestor
110514037|NCT04035889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110514038|NCT04035889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110514039|NCT00895687|Bortezomib|bortezomib|mesh-list
110514040|NCT00895687|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110514041|NCT00895687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110514042|NCT00895687|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110514043|NCT00895687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110514044|NCT00895687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110514045|NCT00798135|Itraconazole|itraconazole|mesh-list
110514046|NCT00798135|Antifungal Agents|antifungal agents|mesh-ancestor
110514047|NCT00798135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110514048|NCT00798135|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110514049|NCT00798135|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110514050|NCT00798135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110514051|NCT00798135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110514052|NCT00798135|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110514053|NCT00798135|Hormone Antagonists|hormone antagonists|mesh-ancestor
110514054|NCT00798135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110514055|NCT00798135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110514056|NCT00798135|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110514057|NCT02762838|Folic Acid|folic acid|mesh-list
110514058|NCT02762838|Infliximab|infliximab|mesh-list
110514059|NCT02762838|Methotrexate|methotrexate|mesh-list
110514060|NCT02762838|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110514061|NCT02762838|Abortifacient Agents|abortifacient agents|mesh-ancestor
110514062|NCT02762838|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110514063|NCT02762838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110514064|NCT02762838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110514065|NCT02762838|Antimetabolites|antimetabolites|mesh-ancestor
110514066|NCT02762838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110514067|NCT02762838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110514068|NCT02762838|Dermatologic Agents|dermatologic agents|mesh-ancestor
110514069|NCT02762838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110514070|NCT02762838|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110514071|NCT02762838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110514072|NCT02762838|Immunologic Factors|immunologic factors|mesh-ancestor
110514073|NCT02762838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110514074|NCT02762838|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110041271|NCT05382312|GSK656|gsk656|mesh-list
110514075|NCT02762838|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110514091|NCT02753166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110514093|NCT02753166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110514094|NCT02753088|Glatiramer Acetate|glatiramer acetate|mesh-list
110514095|NCT02753088|Mannitol|mannitol|mesh-list
110514096|NCT02753088|(T,G)-A-L|(t,g)-a-l|mesh-list
110514097|NCT02753088|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110514098|NCT02753088|Diuretics|diuretics|mesh-ancestor
110514099|NCT02753088|Natriuretic Agents|natriuretic agents|mesh-ancestor
110514100|NCT02753088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110514101|NCT02753088|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110514102|NCT02753088|Immunologic Factors|immunologic factors|mesh-ancestor
110514103|NCT02753088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110514104|NCT02753088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110514105|NCT02757534|Domperidone|domperidone|mesh-list
110514106|NCT02757534|Antiemetics|antiemetics|mesh-ancestor
110514107|NCT02757534|Autonomic Agents|autonomic agents|mesh-ancestor
110514108|NCT02757534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110514109|NCT02757534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110514110|NCT02757534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110514111|NCT02757534|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110514112|NCT02757534|Dopamine Agents|dopamine agents|mesh-ancestor
110514113|NCT02757534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110514114|NCT02757534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110514115|NCT00914901|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110514116|NCT00914901|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110514117|NCT00914901|Autonomic Agents|autonomic agents|mesh-ancestor
110514118|NCT00914901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110514119|NCT00914901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110514120|NCT00914901|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110514121|NCT00914901|Respiratory System Agents|respiratory system agents|mesh-ancestor
110514122|NCT00914901|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110514123|NCT00914901|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110514124|NCT00914901|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110514125|NCT00914901|Adrenergic Agents|adrenergic agents|mesh-ancestor
110514126|NCT00914901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110514127|NCT00914901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110514128|NCT00797823|Insulin|insulin|mesh-list
110514129|NCT00797823|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110514130|NCT00797823|Glucagon|glucagon|mesh-list
110514131|NCT00797823|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110514132|NCT00797823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110514133|NCT00797823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110514134|NCT00797823|Hormones|hormones|mesh-ancestor
110188977|NCT00019760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110514135|NCT00797823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110514136|NCT02757144|Esomeprazole|esomeprazole|mesh-list
110514137|NCT02757144|Fexuprazan|fexuprazan|mesh-list
110514138|NCT02757144|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110514154|NCT00950807|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110514155|NCT00950807|Autonomic Agents|autonomic agents|mesh-ancestor
110514156|NCT00950807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110514157|NCT00950807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110514158|NCT00950807|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110514159|NCT00950807|Respiratory System Agents|respiratory system agents|mesh-ancestor
110514160|NCT00950807|Parasympatholytics|parasympatholytics|mesh-ancestor
110514161|NCT00950807|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110514162|NCT00950807|Cholinergic Agents|cholinergic agents|mesh-ancestor
110514163|NCT00950807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110514164|NCT00950807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110514165|NCT00608881|Ubiquinone|ubiquinone|mesh-list
110514166|NCT00608881|Coenzyme Q10|coenzyme q10|mesh-list
110514167|NCT00608881|Micronutrients|micronutrients|mesh-ancestor
110514168|NCT00608881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110514169|NCT00608881|Vitamins|vitamins|mesh-ancestor
110514170|NCT05608395|Carbon-11 methionine|carbon-11 methionine|mesh-list
110514171|NCT05608395|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110514172|NCT05608395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110514173|NCT04221906|Betamethasone|betamethasone|mesh-list
110514174|NCT04221906|Calcipotriene|calcipotriene|mesh-list
110514175|NCT04221906|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
110514176|NCT04221906|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110514177|NCT04221906|Glucocorticoids|glucocorticoids|mesh-ancestor
110514179|NCT04221906|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110514180|NCT04221906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110514181|NCT04221906|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110514182|NCT04221906|Respiratory System Agents|respiratory system agents|mesh-ancestor
110514183|NCT04221906|Dermatologic Agents|dermatologic agents|mesh-ancestor
110514184|NCT00945191|Paclitaxel|paclitaxel|mesh-list
110514185|NCT00945191|Carboplatin|carboplatin|mesh-list
110514186|NCT00945191|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110514187|NCT00945191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110514188|NCT00945191|Tubulin Modulators|tubulin modulators|mesh-ancestor
110514189|NCT00945191|Antimitotic Agents|antimitotic agents|mesh-ancestor
110514190|NCT00945191|Mitosis Modulators|mitosis modulators|mesh-ancestor
110189007|NCT00019838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110514191|NCT00945191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110514192|NCT01082393|Mometasone Furoate|mometasone furoate|mesh-list
110514193|NCT01082393|Pimecrolimus|pimecrolimus|mesh-list
110514194|NCT01082393|Tacrolimus|tacrolimus|mesh-list
110514195|NCT01082393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110514196|NCT01082393|Immunologic Factors|immunologic factors|mesh-ancestor
110514197|NCT01082393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110514198|NCT01082393|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110514208|NCT01082393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110514209|NCT01082393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110514210|NCT02757066|Melatonin|melatonin|mesh-list
110514211|NCT02757066|Antioxidants|antioxidants|mesh-ancestor
110514212|NCT02757066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110514213|NCT02757066|Protective Agents|protective agents|mesh-ancestor
110514214|NCT02757066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110514215|NCT02757066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110514216|NCT00894673|Heparin|heparin|mesh-list
110514217|NCT00894673|Calcium heparin|calcium heparin|mesh-list
110514218|NCT00894673|Anticoagulants|anticoagulants|mesh-ancestor
110514219|NCT00894673|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110514220|NCT00894673|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110514221|NCT00894673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110514222|NCT00892489|Paliperidone Palmitate|paliperidone palmitate|mesh-list
110514223|NCT00892489|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110514224|NCT00892489|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110514225|NCT00892489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110514226|NCT00892489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110514227|NCT00892489|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110514228|NCT00892489|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110514229|NCT00892489|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110514230|NCT00892489|Serotonin Agents|serotonin agents|mesh-ancestor
110514231|NCT00892489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110514232|NCT00892489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110514233|NCT00892489|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110514234|NCT00892489|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110514235|NCT00892489|Dopamine Agents|dopamine agents|mesh-ancestor
110514236|NCT02752308|Atropine|atropine|mesh-list
110514237|NCT02752308|Epinephrine|epinephrine|mesh-list
110514238|NCT02752308|Fentanyl|fentanyl|mesh-list
110514239|NCT02752308|Bupivacaine|bupivacaine|mesh-list
110514240|NCT02752308|Neostigmine|neostigmine|mesh-list
110514241|NCT02752308|Anesthetics, Local|anesthetics, local|mesh-ancestor
110514242|NCT02752308|Anesthetics|anesthetics|mesh-ancestor
110514243|NCT02752308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110514244|NCT02752308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110514245|NCT02752308|Sensory System Agents|sensory system agents|mesh-ancestor
110514246|NCT02752308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110514247|NCT02752308|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110514248|NCT02752308|Narcotics|narcotics|mesh-ancestor
110514249|NCT02752308|Analgesics|analgesics|mesh-ancestor
110514250|NCT02752308|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110514251|NCT02752308|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110514252|NCT02752308|Anesthetics, General|anesthetics, general|mesh-ancestor
110514253|NCT02752308|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110514254|NCT02752308|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110514255|NCT02752308|Adrenergic Agents|adrenergic agents|mesh-ancestor
110514256|NCT02752308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110514257|NCT02752308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110514258|NCT02752308|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110514259|NCT02752308|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110514260|NCT02752308|Autonomic Agents|autonomic agents|mesh-ancestor
110514261|NCT02752308|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110514262|NCT02752308|Respiratory System Agents|respiratory system agents|mesh-ancestor
110514263|NCT02752308|Mydriatics|mydriatics|mesh-ancestor
110514264|NCT02752308|Sympathomimetics|sympathomimetics|mesh-ancestor
110514265|NCT02752308|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110514301|NCT00896077|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110514302|NCT00896077|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110514303|NCT00896077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110514304|NCT00792909|Vaccines|vaccines|mesh-list
110514305|NCT00792909|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110514324|NCT02751996|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110161696|NCT00107848|Modafinil|modafinil|mesh-list
110514325|NCT02751996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110514326|NCT02751996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110514327|NCT02751996|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110514328|NCT02751996|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110514330|NCT00944645|Niacinamide|niacinamide|mesh-list
110514331|NCT00944645|Nicotinic Acids|nicotinic acids|mesh-list
110189087|NCT00020189|Aspirin|aspirin|mesh-list
110514332|NCT00944645|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110514333|NCT00944645|Antimetabolites|antimetabolites|mesh-ancestor
110514334|NCT00944645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110514335|NCT00944645|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110514336|NCT00944645|Vasodilator Agents|vasodilator agents|mesh-ancestor
110514337|NCT00944645|Vitamin B Complex|vitamin b complex|mesh-ancestor
110514338|NCT00944645|Vitamins|vitamins|mesh-ancestor
110514339|NCT00944645|Micronutrients|micronutrients|mesh-ancestor
110514340|NCT00944645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110514341|NCT02751918|Doxorubicin|doxorubicin|mesh-list
110514342|NCT02751918|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110514343|NCT02751918|Maytansine|maytansine|mesh-list
110514344|NCT02751918|Anetumab ravtansine|anetumab ravtansine|mesh-list
110514345|NCT02751918|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110514346|NCT02751918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110514347|NCT02751918|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110514348|NCT02751918|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110514349|NCT02751918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110514350|NCT02751918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110514351|NCT02751918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110514352|NCT02751918|Tubulin Modulators|tubulin modulators|mesh-ancestor
110514353|NCT02751918|Antimitotic Agents|antimitotic agents|mesh-ancestor
110514354|NCT02751918|Mitosis Modulators|mitosis modulators|mesh-ancestor
110514355|NCT02751918|Immunoconjugates|immunoconjugates|mesh-ancestor
110514356|NCT02751918|Immunologic Factors|immunologic factors|mesh-ancestor
110514357|NCT02751918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110514358|NCT00901069|Cyclophosphamide|cyclophosphamide|mesh-list
110514359|NCT00901069|Rituximab|rituximab|mesh-list
110514360|NCT00901069|Vincristine|vincristine|mesh-list
110514361|NCT00901069|Azacitidine|azacitidine|mesh-list
110514362|NCT00901069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110514375|NCT00901069|Mitosis Modulators|mitosis modulators|mesh-ancestor
110514376|NCT00901069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110514377|NCT00901069|Antimetabolites|antimetabolites|mesh-ancestor
110514378|NCT00901069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110514379|NCT02853539|Denosumab|denosumab|mesh-list
110514380|NCT02853539|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110514381|NCT02853539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110514382|NCT02751840|Caffeine|caffeine|mesh-list
110514383|NCT02751840|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110514384|NCT02751840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110514385|NCT02751840|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110514386|NCT02751840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110514387|NCT02751840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110514388|NCT02751840|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110514389|NCT02751840|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110514390|NCT02751840|Purinergic Agents|purinergic agents|mesh-ancestor
110514391|NCT02751840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110514392|NCT00894829|Heparin|heparin|mesh-list
110514393|NCT00894829|Calcium heparin|calcium heparin|mesh-list
110514394|NCT00894829|Anticoagulants|anticoagulants|mesh-ancestor
110514395|NCT00894829|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110514396|NCT00894829|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110514397|NCT00894829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110514398|NCT04108845|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110161773|NCT00108511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110514399|NCT04108845|Immunologic Factors|immunologic factors|mesh-ancestor
110514400|NCT04108845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110514401|NCT00606229|Aripiprazole|aripiprazole|mesh-list
110514402|NCT00606229|Antidepressive Agents|antidepressive agents|mesh-ancestor
110514403|NCT00606229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110514404|NCT00606229|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110514405|NCT00606229|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110514406|NCT00606229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110514407|NCT00606229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110514408|NCT00606229|Dopamine Agonists|dopamine agonists|mesh-ancestor
110514409|NCT00606229|Dopamine Agents|dopamine agents|mesh-ancestor
110514410|NCT00606229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110514411|NCT00606229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110514412|NCT00606229|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110514413|NCT00606229|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110514414|NCT00606229|Serotonin Agents|serotonin agents|mesh-ancestor
110514415|NCT00606229|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110514416|NCT00606229|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110514417|NCT00606229|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110514418|NCT00606229|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110514419|NCT02756598|Sufentanil|sufentanil|mesh-list
110514420|NCT02756598|Dsuvia|dsuvia|mesh-list
110514421|NCT02756598|Propofol|propofol|mesh-list
110514422|NCT02756598|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110514433|NCT02756598|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110514434|NCT00950651|Tramadol|tramadol|mesh-list
110514435|NCT00950651|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110514436|NCT00950651|Narcotics|narcotics|mesh-ancestor
110514437|NCT00950651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110514438|NCT00950651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110514439|NCT00950651|Analgesics|analgesics|mesh-ancestor
110514440|NCT00950651|Sensory System Agents|sensory system agents|mesh-ancestor
110514441|NCT00950651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110514442|NCT00901147|Bortezomib|bortezomib|mesh-list
110514443|NCT00901147|Panobinostat|panobinostat|mesh-list
110514444|NCT00901147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110514445|NCT00901147|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110514446|NCT00901147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110514447|NCT00901147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110514448|NCT04268537|Antibodies|antibodies|mesh-list
110514449|NCT04268537|Antibodies, Blocking|antibodies, blocking|mesh-list
110514450|NCT04268537|Immunologic Factors|immunologic factors|mesh-ancestor
110514451|NCT04268537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110514452|NCT02756130|Carboplatin|carboplatin|mesh-list
110514453|NCT02756130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110514454|NCT05598723|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110514455|NCT05598723|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
110514456|NCT05598723|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110514457|NCT05598723|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110514458|NCT05598723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110514459|NCT05598723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110514460|NCT05598723|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110514461|NCT05598723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110514462|NCT05598723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110514463|NCT05598723|Cholinergic Agents|cholinergic agents|mesh-ancestor
110514464|NCT05598723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110514465|NCT00605293|Epoetin Alfa|epoetin alfa|mesh-list
110514466|NCT00605293|Hematinics|hematinics|mesh-ancestor
110514467|NCT04221126|Aminolevulinic Acid|aminolevulinic acid|mesh-list
110514468|NCT04221126|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110514469|NCT04221126|Dermatologic Agents|dermatologic agents|mesh-ancestor
110514470|NCT05594589|Lemborexant|lemborexant|mesh-list
110514471|NCT05594589|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
110514472|NCT05594589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110161841|NCT00109057|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110514473|NCT05594589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110914783|NCT00829868|GABA Modulators|gaba modulators|mesh-ancestor
110514474|NCT05594589|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110514475|NCT05594589|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110514476|NCT05594589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110514477|NCT05594589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110514479|NCT00602303|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110514480|NCT00602303|Diuretics|diuretics|mesh-ancestor
110514481|NCT00602303|Natriuretic Agents|natriuretic agents|mesh-ancestor
110514482|NCT00602303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110514483|NCT00602303|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110514484|NCT00602303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110514485|NCT00602303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110514486|NCT00631085|Tocopherols|tocopherols|mesh-list
110514487|NCT00631085|Vitamin E|vitamin e|mesh-list
110514488|NCT00631085|Tocotrienols|tocotrienols|mesh-list
110514502|NCT04269863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110514503|NCT04269863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110514504|NCT04269863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110514505|NCT04269863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110514506|NCT04269863|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110514507|NCT04269863|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110514508|NCT04269863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110514509|NCT04269863|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110514510|NCT04269863|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110514511|NCT04269863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110514513|NCT00901381|Lenograstim|lenograstim|mesh-list
110514514|NCT00901381|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110514515|NCT00901381|Immunologic Factors|immunologic factors|mesh-ancestor
110514516|NCT00901381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110514517|NCT00602381|Lithium Carbonate|lithium carbonate|mesh-list
110514518|NCT00602381|Antidepressive Agents|antidepressive agents|mesh-ancestor
110514519|NCT00602381|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110514520|NCT00602381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110514521|NCT00602381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110514522|NCT00602381|Antimanic Agents|antimanic agents|mesh-ancestor
110514523|NCT00602381|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110514524|NCT00602381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110514525|NCT00602381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110514526|NCT02751528|Vaccines|vaccines|mesh-list
110514527|NCT02751528|Immunologic Factors|immunologic factors|mesh-ancestor
110514528|NCT02751528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110514529|NCT00901537|Azacitidine|azacitidine|mesh-list
110514530|NCT00901537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110514531|NCT00901537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110514532|NCT00901537|Antimetabolites|antimetabolites|mesh-ancestor
110514533|NCT00901537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110514534|NCT00901537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110514535|NCT00894985|Heparin|heparin|mesh-list
110514536|NCT00894985|Calcium heparin|calcium heparin|mesh-list
110514537|NCT00894985|Anticoagulants|anticoagulants|mesh-ancestor
110514538|NCT00894985|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110514539|NCT00894985|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110514540|NCT00894985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110514541|NCT04585152|Rituximab|rituximab|mesh-list
110514542|NCT04585152|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110514543|NCT04585152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110514544|NCT04585152|Immunologic Factors|immunologic factors|mesh-ancestor
110514545|NCT04585152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110514546|NCT04585152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110514547|NCT00943787|Hypoglycemic Agents|hypoglycemic agents|mesh-list
110514548|NCT00943787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110514549|NCT00895063|Botulinum Toxins|botulinum toxins|mesh-list
110514550|NCT00895063|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110177760|NCT00141388|Pregabalin|pregabalin|mesh-list
110514560|NCT02751294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110514561|NCT00901615|Lenalidomide|lenalidomide|mesh-list
110514562|NCT00901615|Immunologic Factors|immunologic factors|mesh-ancestor
110514563|NCT00901615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110514564|NCT00901615|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110514565|NCT00901615|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110514566|NCT00901615|Growth Substances|growth substances|mesh-ancestor
110514567|NCT00901615|Growth Inhibitors|growth inhibitors|mesh-ancestor
110514568|NCT00901615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110514569|NCT00949325|Sirolimus|sirolimus|mesh-list
110514570|NCT00949325|Doxorubicin|doxorubicin|mesh-list
110514571|NCT00949325|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110514572|NCT00949325|Temsirolimus|temsirolimus|mesh-list
110514573|NCT00949325|MTOR Inhibitors|mtor inhibitors|mesh-list
110514574|NCT00949325|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110514575|NCT00949325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110514576|NCT00949325|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110514577|NCT00949325|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110514578|NCT00949325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110514579|NCT00949325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110514580|NCT00949325|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110514581|NCT00949325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110514582|NCT00949325|Immunologic Factors|immunologic factors|mesh-ancestor
110514583|NCT00949325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110514584|NCT00949325|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110514585|NCT00949325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110514586|NCT00949325|Antifungal Agents|antifungal agents|mesh-ancestor
110514587|NCT02853071|Estramustine|estramustine|mesh-list
110514588|NCT02853071|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110514589|NCT02853071|Alkylating Agents|alkylating agents|mesh-ancestor
110514590|NCT02853071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110514591|NCT02853071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110514592|NCT02853071|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110514593|NCT02603757|Vitamin D|vitamin d|mesh-list
110514594|NCT02603757|Cholecalciferol|cholecalciferol|mesh-list
110514595|NCT02603757|Vitamins|vitamins|mesh-ancestor
110514596|NCT02603757|Micronutrients|micronutrients|mesh-ancestor
110514597|NCT02603757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110514598|NCT02603757|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110514599|NCT02603757|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110514600|NCT02758782|Celecoxib|celecoxib|mesh-list
110514601|NCT02758782|Golimumab|golimumab|mesh-list
110514602|NCT02758782|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110514603|NCT02758782|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110514604|NCT02758782|Analgesics|analgesics|mesh-ancestor
110514605|NCT02758782|Sensory System Agents|sensory system agents|mesh-ancestor
110514606|NCT02758782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110514607|NCT02758782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110514608|NCT02758782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110514609|NCT02758782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110514610|NCT02758782|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110514611|NCT02758782|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110514612|NCT02758782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110514613|NCT02758782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110312043|NCT00324831|Sargramostim|sargramostim|mesh-list
110514614|NCT02758782|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110514615|NCT02758782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110514633|NCT00943319|Alkylating Agents|alkylating agents|mesh-ancestor
110514634|NCT00943319|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110514635|NCT00943319|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110514636|NCT00943319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110514638|NCT02603991|Anticonvulsants|anticonvulsants|mesh-ancestor
110514639|NCT02603991|Nootropic Agents|nootropic agents|mesh-ancestor
110514640|NCT02540785|Levofloxacin|levofloxacin|mesh-list
110514641|NCT02540785|Ofloxacin|ofloxacin|mesh-list
110514642|NCT02540785|Tobramycin|tobramycin|mesh-list
110514643|NCT02540785|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
110514644|NCT02540785|Dexamethasone|dexamethasone|mesh-list
110514645|NCT02540785|Dexamethasone acetate|dexamethasone acetate|mesh-list
110514646|NCT02540785|BB 1101|bb 1101|mesh-list
110514647|NCT02540785|Hyaluronic Acid|hyaluronic acid|mesh-list
110514648|NCT02540785|Dipivefrin|dipivefrin|mesh-list
110514649|NCT02540785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110514650|NCT02540785|Antiemetics|antiemetics|mesh-ancestor
110514651|NCT02540785|Autonomic Agents|autonomic agents|mesh-ancestor
110514652|NCT02540785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110514653|NCT02540785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110514654|NCT02540785|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110514655|NCT02540785|Glucocorticoids|glucocorticoids|mesh-ancestor
110514656|NCT02540785|Hormones|hormones|mesh-ancestor
110514657|NCT02540785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110514658|NCT02540785|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110514659|NCT02540785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110514660|NCT02540785|Protease Inhibitors|protease inhibitors|mesh-ancestor
110514661|NCT02540785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110514662|NCT02540785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110514663|NCT02540785|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110514664|NCT02540785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110514665|NCT02540785|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110514666|NCT02540785|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110514667|NCT02540785|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110514668|NCT02540785|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110514669|NCT02540785|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110514670|NCT02540785|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110514671|NCT02540785|Immunologic Factors|immunologic factors|mesh-ancestor
110514672|NCT02540785|Viscosupplements|viscosupplements|mesh-ancestor
110514673|NCT02540785|Protective Agents|protective agents|mesh-ancestor
110514674|NCT02540785|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110514675|NCT02540785|Adrenergic Agents|adrenergic agents|mesh-ancestor
110514676|NCT02540785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110514693|NCT04243278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110514695|NCT00915369|Paclitaxel|paclitaxel|mesh-list
110514696|NCT00915369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110514697|NCT00915369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110514698|NCT00915369|Tubulin Modulators|tubulin modulators|mesh-ancestor
110514699|NCT00915369|Antimitotic Agents|antimitotic agents|mesh-ancestor
110514700|NCT00915369|Mitosis Modulators|mitosis modulators|mesh-ancestor
110162064|NCT00110773|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110514701|NCT00915369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110514703|NCT00901849|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110514704|NCT00901849|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110514705|NCT00901849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110514706|NCT00901849|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110514707|NCT00901849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110514708|NCT00901849|Antifungal Agents|antifungal agents|mesh-ancestor
110514709|NCT00901849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110514710|NCT00901849|Immunologic Factors|immunologic factors|mesh-ancestor
110514711|NCT00901849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110514712|NCT00901849|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110514713|NCT00901849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110514714|NCT00901849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110514715|NCT04268927|Letrozole|letrozole|mesh-list
110514716|NCT04268927|LHRH, N-acetyl-(4-chlorophenylalanyl)(1)-(4-chlorophenylalanyl)(2)-tryptophyl(3)-arginyl(6)-alanine(10)-|lhrh, n-acetyl-(4-chlorophenylalanyl)(1)-(4-chlorophenylalanyl)(2)-tryptophyl(3)-arginyl(6)-alanine(10)-|mesh-list
110514717|NCT04268927|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
110514718|NCT04268927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110514719|NCT04268927|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110514720|NCT04268927|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110514721|NCT04268927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110514722|NCT04268927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110514723|NCT04268927|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110514724|NCT04268927|Hormone Antagonists|hormone antagonists|mesh-ancestor
110514725|NCT04268927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110514726|NCT04268927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110514727|NCT04268927|Hormones|hormones|mesh-ancestor
110514728|NCT05429580|Tranexamic Acid|tranexamic acid|mesh-list
110514729|NCT05429580|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110514730|NCT05429580|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110514731|NCT05429580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110514742|NCT00790647|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110514743|NCT00790647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110514744|NCT00286013|Gemcitabine|gemcitabine|mesh-list
110514745|NCT00286013|Oxaliplatin|oxaliplatin|mesh-list
110514746|NCT00286013|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110514747|NCT00286013|Antimetabolites|antimetabolites|mesh-ancestor
110514748|NCT00286013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110514749|NCT00286013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110514750|NCT02754882|Paclitaxel|paclitaxel|mesh-list
110514751|NCT02754882|Bevacizumab|bevacizumab|mesh-list
110514752|NCT02754882|Carboplatin|carboplatin|mesh-list
110514753|NCT02754882|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110514754|NCT02754882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110514755|NCT02754882|Tubulin Modulators|tubulin modulators|mesh-ancestor
110514756|NCT02754882|Antimitotic Agents|antimitotic agents|mesh-ancestor
110514757|NCT02754882|Mitosis Modulators|mitosis modulators|mesh-ancestor
110514758|NCT02754882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110514759|NCT02754882|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110514760|NCT02754882|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110514761|NCT02754882|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110514762|NCT02754882|Growth Substances|growth substances|mesh-ancestor
110514763|NCT02754882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110514764|NCT02754882|Growth Inhibitors|growth inhibitors|mesh-ancestor
110514765|NCT00790569|Nicotine|nicotine|mesh-list
110514766|NCT00790569|Varenicline|varenicline|mesh-list
110189413|NCT00021281|Vitamins|vitamins|mesh-ancestor
110514767|NCT00790569|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110514768|NCT00790569|Autonomic Agents|autonomic agents|mesh-ancestor
110514769|NCT00790569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110514770|NCT00790569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110514771|NCT00790569|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110514772|NCT00790569|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110514773|NCT00790569|Cholinergic Agents|cholinergic agents|mesh-ancestor
110514774|NCT00790569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110514775|NCT00790569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110514777|NCT00939029|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110514778|NCT00939029|Autonomic Agents|autonomic agents|mesh-ancestor
110514779|NCT00939029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110514780|NCT00939029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110514781|NCT00939029|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110514782|NCT00939029|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110514783|NCT00939029|Cholinergic Agents|cholinergic agents|mesh-ancestor
110514784|NCT00939029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110514785|NCT00939029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110514786|NCT00602615|Torsemide|torsemide|mesh-list
110514787|NCT00602615|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110514788|NCT00602615|Diuretics|diuretics|mesh-ancestor
110514789|NCT00602615|Natriuretic Agents|natriuretic agents|mesh-ancestor
110514790|NCT00602615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110514791|NCT00602615|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110514792|NCT00602615|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110514793|NCT00602615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110514794|NCT00604253|Insulin|insulin|mesh-list
110514795|NCT00604253|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110514796|NCT00604253|Insulin Detemir|insulin detemir|mesh-list
110514797|NCT00604253|Isophane Insulin, Human|isophane insulin, human|mesh-list
110514798|NCT00604253|Insulin, Isophane|insulin, isophane|mesh-list
110514812|NCT02754960|Growth Inhibitors|growth inhibitors|mesh-ancestor
110514813|NCT02754960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110514814|NCT00587847|Alemtuzumab|alemtuzumab|mesh-list
110514815|NCT00587847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110189453|NCT00021359|Glucocorticoids|glucocorticoids|mesh-ancestor
110514816|NCT00587847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110514817|NCT02540239|Simethicone|simethicone|mesh-list
110514818|NCT02540239|Antifoaming Agents|antifoaming agents|mesh-ancestor
110514819|NCT02540239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110514820|NCT02540239|Emollients|emollients|mesh-ancestor
110514821|NCT02540239|Dermatologic Agents|dermatologic agents|mesh-ancestor
110514822|NCT02540395|Mycophenolic Acid|mycophenolic acid|mesh-list
110514823|NCT02540395|Prednisolone|prednisolone|mesh-list
110514824|NCT02540395|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110514825|NCT02540395|Methylprednisolone|methylprednisolone|mesh-list
110514826|NCT02540395|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110514827|NCT02540395|Prednisolone acetate|prednisolone acetate|mesh-list
110514828|NCT02540395|Tacrolimus|tacrolimus|mesh-list
110514829|NCT02540395|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110514830|NCT02540395|Prednisolone phosphate|prednisolone phosphate|mesh-list
110514831|NCT02540395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110514832|NCT02540395|Immunologic Factors|immunologic factors|mesh-ancestor
110514833|NCT02540395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110514834|NCT02540395|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110514835|NCT02540395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110514836|NCT02540395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110514837|NCT02540395|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110514838|NCT02540395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110514839|NCT02540395|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110514840|NCT02540395|Antitubercular Agents|antitubercular agents|mesh-ancestor
110514841|NCT02540395|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110514842|NCT02540395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110514843|NCT02540395|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110514844|NCT02540395|Glucocorticoids|glucocorticoids|mesh-ancestor
110514846|NCT02540395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110514847|NCT02540395|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110514848|NCT02540395|Antiemetics|antiemetics|mesh-ancestor
110514849|NCT02540395|Autonomic Agents|autonomic agents|mesh-ancestor
110514850|NCT02540395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110514851|NCT02540395|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110514852|NCT02540395|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110514853|NCT02540395|Protective Agents|protective agents|mesh-ancestor
110514855|NCT05565729|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110514856|NCT05565729|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110514857|NCT05565729|Histamine Antagonists|histamine antagonists|mesh-ancestor
110514858|NCT05565729|Histamine Agents|histamine agents|mesh-ancestor
110514859|NCT05565729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110514860|NCT05565729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110514861|NCT05565729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110177813|NCT00141427|Pregabalin|pregabalin|mesh-list
110514877|NCT00602693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110514878|NCT00602693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110514879|NCT00602693|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110514880|NCT00602693|Alkylating Agents|alkylating agents|mesh-ancestor
110514881|NCT00602693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110514882|NCT00602693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110514883|NCT00602693|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110514884|NCT00602693|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110514885|NCT00602693|Antimetabolites|antimetabolites|mesh-ancestor
110514886|NCT00602693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110514887|NCT00602693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110514888|NCT00602693|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110514889|NCT00602693|Antifungal Agents|antifungal agents|mesh-ancestor
110514890|NCT00602693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110514891|NCT00602693|Gout Suppressants|gout suppressants|mesh-ancestor
110514892|NCT00602693|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110514893|NCT00602693|Antioxidants|antioxidants|mesh-ancestor
110514894|NCT00602693|Protective Agents|protective agents|mesh-ancestor
110514895|NCT00902395|Midazolam|midazolam|mesh-list
110514896|NCT00902395|Ketamine|ketamine|mesh-list
110514897|NCT00902395|Analgesics|analgesics|mesh-ancestor
110514898|NCT00902395|Sensory System Agents|sensory system agents|mesh-ancestor
110514899|NCT00902395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110514900|NCT00902395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110514901|NCT00902395|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110514902|NCT00902395|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110514903|NCT00902395|Anesthetics, General|anesthetics, general|mesh-ancestor
110514904|NCT00902395|Anesthetics|anesthetics|mesh-ancestor
110514905|NCT00902395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110514906|NCT00902395|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110514907|NCT00902395|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110514908|NCT00902395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110514909|NCT00902395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110514910|NCT00902395|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110514911|NCT00902395|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110514912|NCT00902395|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110514913|NCT00902395|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110514914|NCT00902395|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110514915|NCT00902395|GABA Modulators|gaba modulators|mesh-ancestor
110514916|NCT00902395|GABA Agents|gaba agents|mesh-ancestor
110514917|NCT04213404|Spartalizumab|spartalizumab|mesh-list
110514918|NCT04213404|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110514919|NCT04213404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110514920|NCT04213404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110514921|NCT04213404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110514922|NCT00604409|Capecitabine|capecitabine|mesh-list
110514923|NCT00604409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110514939|NCT00902473|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110514940|NCT00902473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110514941|NCT05177484|Ferric maltol|ferric maltol|mesh-list
110514942|NCT05177484|Hematinics|hematinics|mesh-ancestor
110514943|NCT04104789|Oxymetazoline|oxymetazoline|mesh-list
110514944|NCT04104789|Tetracaine|tetracaine|mesh-list
110514945|NCT04104789|Carticaine|carticaine|mesh-list
110514946|NCT04104789|Anesthetics, Local|anesthetics, local|mesh-ancestor
110514947|NCT04104789|Anesthetics|anesthetics|mesh-ancestor
110514948|NCT04104789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110514949|NCT04104789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110514950|NCT04104789|Sensory System Agents|sensory system agents|mesh-ancestor
110514951|NCT04104789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110514952|NCT04104789|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110514953|NCT04104789|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110514954|NCT04104789|Adrenergic Agents|adrenergic agents|mesh-ancestor
110514955|NCT04104789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110514956|NCT04104789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110514957|NCT04104789|Sympathomimetics|sympathomimetics|mesh-ancestor
110514958|NCT04104789|Autonomic Agents|autonomic agents|mesh-ancestor
110514959|NCT04104789|Nasal Decongestants|nasal decongestants|mesh-ancestor
110514960|NCT04104789|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110514961|NCT04104789|Respiratory System Agents|respiratory system agents|mesh-ancestor
110514962|NCT00938717|Linaclotide|linaclotide|mesh-list
110514963|NCT00938717|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
110514964|NCT00938717|Enzyme Activators|enzyme activators|mesh-ancestor
110514965|NCT00938717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110514966|NCT00938717|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110514967|NCT00905983|Gemcitabine|gemcitabine|mesh-list
110514968|NCT00905983|Docetaxel|docetaxel|mesh-list
110514969|NCT00905983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110514970|NCT00905983|Antimetabolites|antimetabolites|mesh-ancestor
110514971|NCT00905983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110189547|NCT00049101|Levoleucovorin|levoleucovorin|mesh-list
110514972|NCT00905983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110514973|NCT00905983|Tubulin Modulators|tubulin modulators|mesh-ancestor
110514974|NCT00905983|Antimitotic Agents|antimitotic agents|mesh-ancestor
110514975|NCT00905983|Mitosis Modulators|mitosis modulators|mesh-ancestor
110514976|NCT00906061|Gemcitabine|gemcitabine|mesh-list
110514977|NCT00906061|Docetaxel|docetaxel|mesh-list
110514978|NCT00906061|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110514979|NCT00906061|Antimetabolites|antimetabolites|mesh-ancestor
110514980|NCT00906061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110514981|NCT00906061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110514982|NCT00906061|Tubulin Modulators|tubulin modulators|mesh-ancestor
110514983|NCT00906061|Antimitotic Agents|antimitotic agents|mesh-ancestor
110514984|NCT00906061|Mitosis Modulators|mitosis modulators|mesh-ancestor
110514986|NCT02602509|Pyrazinamide|pyrazinamide|mesh-list
110514987|NCT02602509|Celecoxib|celecoxib|mesh-list
110514998|NCT02602509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110514999|NCT02602509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110162364|NCT00112645|Dermatologic Agents|dermatologic agents|mesh-ancestor
110515000|NCT02602509|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110515001|NCT02602509|Antitubercular Agents|antitubercular agents|mesh-ancestor
110515002|NCT02602509|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110515003|NCT02602509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110515004|NCT02602509|Leprostatic Agents|leprostatic agents|mesh-ancestor
110515005|NCT02602509|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110515006|NCT02602509|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110515007|NCT02602509|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110515008|NCT02602509|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110515009|NCT02602509|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110515010|NCT02602509|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110189595|NCT00049296|Thalidomide|thalidomide|mesh-list
110515011|NCT02602509|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110515013|NCT02852837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110515014|NCT00897871|Cyclophosphamide|cyclophosphamide|mesh-list
110515015|NCT00897871|Carboplatin|carboplatin|mesh-list
110515016|NCT00897871|Etoposide|etoposide|mesh-list
110515017|NCT00897871|Etoposide phosphate|etoposide phosphate|mesh-list
110515018|NCT00897871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110515019|NCT00897871|Immunologic Factors|immunologic factors|mesh-ancestor
110515020|NCT00897871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110515021|NCT00897871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110515022|NCT00897871|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110515023|NCT00897871|Alkylating Agents|alkylating agents|mesh-ancestor
110515024|NCT00897871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110515025|NCT00897871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110515026|NCT00897871|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110515027|NCT00897871|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110515028|NCT00897871|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110515029|NCT00897871|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110515030|NCT00897871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110515031|NCT00902707|Phenylpropanolamine|phenylpropanolamine|mesh-list
110515032|NCT00902707|Guaifenesin|guaifenesin|mesh-list
110515033|NCT00902707|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
110515034|NCT00902707|Expectorants|expectorants|mesh-ancestor
110515035|NCT00902707|Respiratory System Agents|respiratory system agents|mesh-ancestor
110515036|NCT00902707|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110515037|NCT00902707|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110515038|NCT00902707|Adrenergic Agents|adrenergic agents|mesh-ancestor
110515039|NCT00902707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110515040|NCT00902707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110515041|NCT00902707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110515042|NCT00902707|Appetite Depressants|appetite depressants|mesh-ancestor
110515043|NCT00902707|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110515044|NCT00902707|Sympathomimetics|sympathomimetics|mesh-ancestor
110515045|NCT00902707|Autonomic Agents|autonomic agents|mesh-ancestor
110515046|NCT00902707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110515047|NCT00902707|Nasal Decongestants|nasal decongestants|mesh-ancestor
110515048|NCT00902707|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110515049|NCT00906139|Fentanyl|fentanyl|mesh-list
110515050|NCT00906139|Midazolam|midazolam|mesh-list
110515063|NCT00906139|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110515064|NCT00906139|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110515065|NCT00906139|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110515066|NCT00906139|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110515067|NCT00906139|GABA Modulators|gaba modulators|mesh-ancestor
110515068|NCT00906139|GABA Agents|gaba agents|mesh-ancestor
110515069|NCT00906139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110515070|NCT00906139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110515071|NCT00906295|Chrysarobin|chrysarobin|mesh-list
110515072|NCT00906295|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110515073|NCT00906295|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110515074|NCT00906295|Analgesics|analgesics|mesh-ancestor
110515075|NCT00906295|Sensory System Agents|sensory system agents|mesh-ancestor
110515076|NCT00906295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110515077|NCT00906295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110515078|NCT00906295|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110515080|NCT02754102|Sunscreening Agents|sunscreening agents|mesh-list
110515081|NCT02754102|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110515082|NCT02754102|Protective Agents|protective agents|mesh-ancestor
110515083|NCT02754102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110515084|NCT02754102|Dermatologic Agents|dermatologic agents|mesh-ancestor
110515085|NCT00134303|Metformin|metformin|mesh-list
110515086|NCT00134303|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110515087|NCT00134303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110515088|NCT00902941|Rasagiline|rasagiline|mesh-list
110515089|NCT00902941|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
110515090|NCT00902941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110515091|NCT00902941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110515092|NCT00902941|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110515093|NCT00902941|Protective Agents|protective agents|mesh-ancestor
110515094|NCT00902941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110515095|NCT02754258|Methylphenidate|methylphenidate|mesh-list
110515096|NCT02754258|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110515097|NCT02754258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110515098|NCT02754258|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110515099|NCT02754258|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110515100|NCT02754258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110515101|NCT02754258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110515102|NCT02754258|Dopamine Agents|dopamine agents|mesh-ancestor
110515103|NCT02754258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110515104|NCT04267991|Tacrolimus|tacrolimus|mesh-list
110515105|NCT04267991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110515106|NCT04267991|Immunologic Factors|immunologic factors|mesh-ancestor
110515107|NCT04267991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110515108|NCT04267991|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110515109|NCT04267991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110515110|NCT04267991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110515111|NCT02852681|Drospirenone|drospirenone|mesh-list
110515112|NCT02852681|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110515113|NCT02852681|Hormone Antagonists|hormone antagonists|mesh-ancestor
110515114|NCT02852681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110515115|NCT02852681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110177865|NCT00141895|Oxytocics|oxytocics|mesh-ancestor
110515127|NCT00602849|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110515128|NCT00602849|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110515130|NCT00602849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110515131|NCT00602849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110515132|NCT00602849|Serotonin Agents|serotonin agents|mesh-ancestor
110515133|NCT00602849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110515134|NCT00906451|Simvastatin|simvastatin|mesh-list
110515135|NCT00906451|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110515136|NCT00906451|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110515137|NCT00906451|Antimetabolites|antimetabolites|mesh-ancestor
110515138|NCT00906451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110515139|NCT00906451|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110515140|NCT00906451|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110515141|NCT00906451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110515142|NCT00898417|Paclitaxel|paclitaxel|mesh-list
110515143|NCT00898417|Bevacizumab|bevacizumab|mesh-list
110515144|NCT00898417|Carboplatin|carboplatin|mesh-list
110515145|NCT00898417|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110162523|NCT00007826|Aluminum Hydroxide|aluminum hydroxide|mesh-list
110515146|NCT00898417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110189719|NCT00049569|Glucocorticoids|glucocorticoids|mesh-ancestor
110515147|NCT00898417|Tubulin Modulators|tubulin modulators|mesh-ancestor
110515148|NCT00898417|Antimitotic Agents|antimitotic agents|mesh-ancestor
110515149|NCT00898417|Mitosis Modulators|mitosis modulators|mesh-ancestor
110515150|NCT00898417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110515151|NCT00898417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110515152|NCT00898417|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110515153|NCT00898417|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110515154|NCT00898417|Growth Substances|growth substances|mesh-ancestor
110515155|NCT00898417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110515156|NCT00898417|Growth Inhibitors|growth inhibitors|mesh-ancestor
110515157|NCT05381363|Interferons|interferons|mesh-list
110515158|NCT05381363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110515159|NCT05381363|Antiviral Agents|antiviral agents|mesh-ancestor
110515160|NCT05381363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110515161|NCT00906529|Insulin Aspart|insulin aspart|mesh-list
110515162|NCT00906529|Insulin Detemir|insulin detemir|mesh-list
110515163|NCT00906529|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110515164|NCT00906529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110515165|NCT00783705|Inositol|inositol|mesh-list
110515166|NCT00783705|Vitamin B Complex|vitamin b complex|mesh-ancestor
110515167|NCT00783705|Vitamins|vitamins|mesh-ancestor
110515168|NCT00783705|Micronutrients|micronutrients|mesh-ancestor
110515169|NCT00783705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110515170|NCT02755350|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110515171|NCT02755350|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110515172|NCT02755350|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110515173|NCT02755350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110515174|NCT02755350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110515175|NCT02755350|Antiviral Agents|antiviral agents|mesh-ancestor
110515176|NCT02755350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110515177|NCT02755350|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110515200|NCT02851745|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110515201|NCT02851745|Protease Inhibitors|protease inhibitors|mesh-ancestor
110515202|NCT02851745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110312051|NCT00324831|Alkylating Agents|alkylating agents|mesh-ancestor
110515203|NCT02851745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110515204|NCT02602197|Acetaminophen|acetaminophen|mesh-list
110515205|NCT02602197|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
110515206|NCT02602197|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110515207|NCT02602197|Analgesics|analgesics|mesh-ancestor
110515208|NCT02602197|Sensory System Agents|sensory system agents|mesh-ancestor
110515209|NCT02602197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110515210|NCT02602197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110515211|NCT02602197|Antipyretics|antipyretics|mesh-ancestor
110515212|NCT02602197|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110515213|NCT02602197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110515214|NCT02602197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110515215|NCT02753712|Fluticasone|fluticasone|mesh-list
110515216|NCT02753712|Xhance|xhance|mesh-list
110515217|NCT02753712|Formoterol Fumarate|formoterol fumarate|mesh-list
110515218|NCT02753712|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110162591|NCT00007904|Tubulin Modulators|tubulin modulators|mesh-ancestor
110515219|NCT02753712|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110515220|NCT02753712|Autonomic Agents|autonomic agents|mesh-ancestor
110515221|NCT02753712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110045831|NCT06019728|Acetaminophen|acetaminophen|mesh-list
110515222|NCT02753712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110515223|NCT02753712|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110515224|NCT02753712|Respiratory System Agents|respiratory system agents|mesh-ancestor
110515225|NCT02753712|Dermatologic Agents|dermatologic agents|mesh-ancestor
110515226|NCT02753712|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110515227|NCT02753712|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110515228|NCT02753712|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110515229|NCT02753712|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110515261|NCT00887198|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110515262|NCT04342585|Progesterone|progesterone|mesh-list
110515263|NCT04342585|Progestins|progestins|mesh-ancestor
110515264|NCT04342585|Hormones|hormones|mesh-ancestor
110515265|NCT04342585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110515266|NCT04342585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110515267|NCT02831894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
110515268|NCT02831894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110515269|NCT02831894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110515270|NCT00782067|Midostaurin|midostaurin|mesh-list
110177903|NCT00142207|Antimalarials|antimalarials|mesh-ancestor
110515282|NCT05520723|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110515284|NCT02826746|Magnesium Sulfate|magnesium sulfate|mesh-list
110515285|NCT02826746|Analgesics|analgesics|mesh-ancestor
110515286|NCT02826746|Sensory System Agents|sensory system agents|mesh-ancestor
110515287|NCT02826746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110515288|NCT02826746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110515289|NCT02826746|Anesthetics|anesthetics|mesh-ancestor
110515290|NCT02826746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110515291|NCT02826746|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110515292|NCT02826746|Anticonvulsants|anticonvulsants|mesh-ancestor
110515293|NCT02826746|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110162666|NCT00114361|Ribavirin|ribavirin|mesh-list
110515294|NCT02826746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110515295|NCT02826746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110515296|NCT02826746|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110515297|NCT02826746|Tocolytic Agents|tocolytic agents|mesh-ancestor
110515298|NCT02826746|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110515300|NCT02750904|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110515301|NCT02750904|Autonomic Agents|autonomic agents|mesh-ancestor
110515302|NCT02750904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110515303|NCT02750904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110515304|NCT02750904|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110515305|NCT02750904|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110515306|NCT02750904|Cholinergic Agents|cholinergic agents|mesh-ancestor
110515307|NCT02750904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110515308|NCT02750904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110515309|NCT02831972|Itraconazole|itraconazole|mesh-list
110914964|NCT05156879|Aspirin|aspirin|mesh-list
110515310|NCT02831972|Antifungal Agents|antifungal agents|mesh-ancestor
110515311|NCT02831972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110515312|NCT02831972|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110515313|NCT02831972|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110515314|NCT02831972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110515315|NCT02831972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110515316|NCT02831972|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110515317|NCT02831972|Hormone Antagonists|hormone antagonists|mesh-ancestor
110189740|NCT00049569|Antimitotic Agents|antimitotic agents|mesh-ancestor
110515318|NCT02831972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110515319|NCT02831972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110515320|NCT02831972|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110515321|NCT02695758|Bupivacaine|bupivacaine|mesh-list
110515322|NCT02695758|Anesthetics, Local|anesthetics, local|mesh-ancestor
110515323|NCT02695758|Anesthetics|anesthetics|mesh-ancestor
110515324|NCT02695758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110515325|NCT02695758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110515326|NCT02695758|Sensory System Agents|sensory system agents|mesh-ancestor
110515327|NCT02695758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110515328|NCT00605215|Interferons|interferons|mesh-list
110515329|NCT00605215|Interferon beta-1a|interferon beta-1a|mesh-list
110515330|NCT00605215|Interferon-beta|interferon-beta|mesh-list
110515331|NCT00605215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110515332|NCT00605215|Antiviral Agents|antiviral agents|mesh-ancestor
110515333|NCT00605215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110515341|NCT02826200|Anticoagulants|anticoagulants|mesh-ancestor
110515342|NCT04244708|Temozolomide|temozolomide|mesh-list
110515343|NCT04244708|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110515344|NCT04244708|Alkylating Agents|alkylating agents|mesh-ancestor
110515345|NCT04244708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110515346|NCT04244708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110515347|NCT02750748|Naltrexone|naltrexone|mesh-list
110515348|NCT02750748|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110515349|NCT02750748|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110515350|NCT02750748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110515351|NCT02750748|Sensory System Agents|sensory system agents|mesh-ancestor
110515352|NCT02750748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110515353|NCT00604279|Risperidone|risperidone|mesh-list
110515354|NCT00604279|Paliperidone Palmitate|paliperidone palmitate|mesh-list
110515355|NCT00604279|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110515356|NCT00604279|Serotonin Agents|serotonin agents|mesh-ancestor
110515357|NCT00604279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110515358|NCT00604279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110515359|NCT00604279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110515360|NCT00604279|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110515361|NCT00604279|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110515362|NCT00604279|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110515363|NCT00604279|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110515364|NCT00604279|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110515365|NCT00604279|Dopamine Agents|dopamine agents|mesh-ancestor
110515366|NCT00604279|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110515367|NCT00604279|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110515368|NCT00635856|Gefitinib|gefitinib|mesh-list
110515369|NCT00635856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110515370|NCT00635856|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110515371|NCT00635856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110515372|NCT00635856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110515373|NCT00906685|Bevacizumab|bevacizumab|mesh-list
110515374|NCT00906685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110515375|NCT00906685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110515376|NCT00906685|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110914995|NCT05156879|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110515377|NCT00906685|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110515378|NCT00906685|Growth Substances|growth substances|mesh-ancestor
110515379|NCT00906685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110515380|NCT00906685|Growth Inhibitors|growth inhibitors|mesh-ancestor
110515381|NCT05660720|Moxifloxacin|moxifloxacin|mesh-list
110515382|NCT05660720|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
110515383|NCT05660720|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110515384|NCT05660720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110515385|NCT05660720|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110515386|NCT05660720|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110515387|NCT05660720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110515388|NCT05660720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110515389|NCT05660720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110515390|NCT05660720|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110515391|NCT05660720|Contraceptive Agents|contraceptive agents|mesh-ancestor
110515392|NCT05660720|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110515393|NCT05660720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110515394|NCT05660720|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110515395|NCT05660720|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110515396|NCT05660720|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110515397|NCT02695212|Apremilast|apremilast|mesh-list
110515398|NCT02695212|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110515399|NCT02695212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110515400|NCT02695212|Analgesics|analgesics|mesh-ancestor
110515407|NCT02695212|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110515408|NCT02695212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110515409|NCT02695212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110515410|NCT05381207|Fluticasone|fluticasone|mesh-list
110515411|NCT05381207|Xhance|xhance|mesh-list
110515412|NCT05381207|Montelukast|montelukast|mesh-list
110515413|NCT05381207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110515414|NCT05381207|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110515415|NCT05381207|Autonomic Agents|autonomic agents|mesh-ancestor
110515416|NCT05381207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110515417|NCT05381207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110515418|NCT05381207|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110515421|NCT05381207|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110515422|NCT05381207|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110515423|NCT05381207|Hormone Antagonists|hormone antagonists|mesh-ancestor
110515424|NCT05381207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110515425|NCT05381207|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110515426|NCT05381207|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110515427|NCT05381207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110515428|NCT02750670|Dexamethasone|dexamethasone|mesh-list
110515429|NCT02750670|Gemcitabine|gemcitabine|mesh-list
110515430|NCT02750670|Obinutuzumab|obinutuzumab|mesh-list
110515431|NCT02750670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110515432|NCT02750670|Antiemetics|antiemetics|mesh-ancestor
110515433|NCT02750670|Autonomic Agents|autonomic agents|mesh-ancestor
110515434|NCT02750670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110515435|NCT02750670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110515436|NCT02750670|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110515437|NCT02750670|Glucocorticoids|glucocorticoids|mesh-ancestor
110515438|NCT02750670|Hormones|hormones|mesh-ancestor
110515439|NCT02750670|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110515440|NCT02750670|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110515441|NCT02750670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110515442|NCT02750670|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110515443|NCT02750670|Antimetabolites|antimetabolites|mesh-ancestor
110515444|NCT02750670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110515445|NCT02750670|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110515446|NCT00605891|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110515447|NCT00605891|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110515448|NCT00605891|Autonomic Agents|autonomic agents|mesh-ancestor
110515449|NCT00605891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110515450|NCT00605891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110515451|NCT00605891|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110515452|NCT00605891|Respiratory System Agents|respiratory system agents|mesh-ancestor
110515453|NCT00605891|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110515454|NCT00605891|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110515455|NCT00605891|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110515456|NCT00605891|Adrenergic Agents|adrenergic agents|mesh-ancestor
110515457|NCT00605891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110515458|NCT00605891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110515459|NCT05122208|Famotidine|famotidine|mesh-list
110515460|NCT05122208|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110515461|NCT05122208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110515462|NCT05122208|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110515463|NCT05122208|Histamine Antagonists|histamine antagonists|mesh-ancestor
110515464|NCT05122208|Histamine Agents|histamine agents|mesh-ancestor
110515465|NCT05122208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110515466|NCT05122208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110515467|NCT05122208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110515468|NCT00781911|Octreotide|octreotide|mesh-list
110515469|NCT00781911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110515485|NCT04919096|Growth Substances|growth substances|mesh-ancestor
110515486|NCT04919096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110515487|NCT04919096|Growth Inhibitors|growth inhibitors|mesh-ancestor
110515488|NCT04919096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110515489|NCT02746848|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110515490|NCT02746848|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110515492|NCT00781599|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110515493|NCT00781599|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110515494|NCT00781599|Cholinergic Agents|cholinergic agents|mesh-ancestor
110515495|NCT00781599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110515496|NCT00781599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110515497|NCT00781599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110515498|NCT00904111|Lidocaine|lidocaine|mesh-list
110515499|NCT00904111|Anesthetics, Local|anesthetics, local|mesh-ancestor
110515500|NCT00904111|Anesthetics|anesthetics|mesh-ancestor
110189808|NCT00397761|Antimetabolites|antimetabolites|mesh-ancestor
110515501|NCT00904111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110515502|NCT00904111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110915035|NCT03065933|Clonidine|clonidine|mesh-list
110515503|NCT00904111|Sensory System Agents|sensory system agents|mesh-ancestor
110515504|NCT00904111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110515505|NCT00904111|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110515506|NCT00904111|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110515507|NCT00904111|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110515508|NCT00904111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110515509|NCT00904111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110515510|NCT03240211|Pembrolizumab|pembrolizumab|mesh-list
110515511|NCT03240211|Decitabine|decitabine|mesh-list
110162907|NCT00115492|Hormones|hormones|mesh-ancestor
110515512|NCT03240211|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110515513|NCT03240211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110515514|NCT03240211|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110515515|NCT03240211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110515516|NCT03240211|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110515517|NCT03240211|Antimetabolites|antimetabolites|mesh-ancestor
110515518|NCT03240211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110515519|NCT00899197|Tamoxifen|tamoxifen|mesh-list
110515520|NCT00899197|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110515521|NCT00899197|Hormone Antagonists|hormone antagonists|mesh-ancestor
110515522|NCT00899197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110515523|NCT00899197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110515524|NCT00899197|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110515525|NCT00899197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110515534|NCT00603083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110515535|NCT00603083|Sensory System Agents|sensory system agents|mesh-ancestor
110515536|NCT00603083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110515537|NCT00603083|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110515538|NCT00603083|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110515540|NCT00603083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110515541|NCT00603083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110515542|NCT00603083|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110515543|NCT00603083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110515544|NCT00603083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110515545|NCT05379257|Furosemide|furosemide|mesh-list
110515546|NCT05379257|Diuretics|diuretics|mesh-ancestor
110515547|NCT05379257|Natriuretic Agents|natriuretic agents|mesh-ancestor
110515548|NCT05379257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110515549|NCT05379257|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110515550|NCT05379257|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110515551|NCT05379257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110515552|NCT04241744|Vancomycin|vancomycin|mesh-list
110515553|NCT04241744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110515554|NCT04241744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110515555|NCT02824094|Crizotinib|crizotinib|mesh-list
110515556|NCT02824094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110515557|NCT02824094|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110515558|NCT02824094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110515559|NCT02824094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110515560|NCT00899587|Enalapril|enalapril|mesh-list
110515561|NCT00899587|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110515562|NCT00899587|Protease Inhibitors|protease inhibitors|mesh-ancestor
110515563|NCT00899587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110515564|NCT00899587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110515565|NCT00899587|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110515566|NCT04268069|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110515567|NCT04268069|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110515570|NCT02824406|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110515571|NCT02824406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110515572|NCT02824406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110515573|NCT02824406|Diuretics|diuretics|mesh-ancestor
110515574|NCT02824406|Natriuretic Agents|natriuretic agents|mesh-ancestor
110515575|NCT02824406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110515576|NCT04267679|Cannabidiol|cannabidiol|mesh-list
110515577|NCT04267679|Anticonvulsants|anticonvulsants|mesh-ancestor
110515578|NCT04951388|Somatomedin B|somatomedin b|mesh-list
110515579|NCT04951388|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
110515580|NCT04951388|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110515581|NCT04951388|Protease Inhibitors|protease inhibitors|mesh-ancestor
110515582|NCT04951388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110515583|NCT04951388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110162973|NCT00008294|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110515584|NCT04242914|Midazolam|midazolam|mesh-list
110515585|NCT04242914|Ketamine|ketamine|mesh-list
110515586|NCT04242914|Analgesics|analgesics|mesh-ancestor
110515587|NCT04242914|Sensory System Agents|sensory system agents|mesh-ancestor
110515588|NCT04242914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110515589|NCT04242914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110515590|NCT04242914|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110515591|NCT04242914|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110515615|NCT00780273|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110515616|NCT00780273|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110515617|NCT00780273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110515618|NCT02827136|Lidocaine|lidocaine|mesh-list
110515619|NCT02827136|Anesthetics, Local|anesthetics, local|mesh-ancestor
110515620|NCT02827136|Anesthetics|anesthetics|mesh-ancestor
110515621|NCT02827136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110515622|NCT02827136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110515623|NCT02827136|Sensory System Agents|sensory system agents|mesh-ancestor
110515624|NCT02827136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110515625|NCT02827136|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110515626|NCT02827136|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110515627|NCT02827136|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110515628|NCT02827136|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110515629|NCT02827136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110515630|NCT04102995|Pregnanolone|pregnanolone|mesh-list
110515631|NCT04102995|Anesthetics|anesthetics|mesh-ancestor
110915072|NCT05125523|Sirolimus|sirolimus|mesh-list
110515632|NCT04102995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110515633|NCT04102995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110515635|NCT00899821|Interleukin-12|interleukin-12|mesh-list
110515636|NCT00899821|Sargramostim|sargramostim|mesh-list
110515637|NCT00899821|Immunologic Factors|immunologic factors|mesh-ancestor
110515638|NCT00899821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110515639|NCT00899821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110515640|NCT00899821|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110515641|NCT00899821|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110515642|NCT00899821|Antiviral Agents|antiviral agents|mesh-ancestor
110515657|NCT04218552|Telmisartan|telmisartan|mesh-list
110515658|NCT04218552|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110515659|NCT04218552|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110515660|NCT04218552|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110515661|NCT04218552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110515662|NCT04218552|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110515663|NCT04218552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110515664|NCT04218552|Vasodilator Agents|vasodilator agents|mesh-ancestor
110515665|NCT04218552|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110515666|NCT04218552|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110515667|NCT00904657|Sunitinib|sunitinib|mesh-list
110515668|NCT00904657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110515669|NCT00904657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110515670|NCT00904657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110515671|NCT00904657|Growth Substances|growth substances|mesh-ancestor
110515672|NCT00904657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110515673|NCT00904657|Growth Inhibitors|growth inhibitors|mesh-ancestor
110515674|NCT00904657|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110515675|NCT00904657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110515676|NCT00904657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110515677|NCT00904735|Imatinib Mesylate|imatinib mesylate|mesh-list
110515678|NCT00904735|Hydroxyurea|hydroxyurea|mesh-list
110515679|NCT00904735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110515680|NCT00904735|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110515681|NCT00904735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110515682|NCT00904735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110515683|NCT00904735|Antisickling Agents|antisickling agents|mesh-ancestor
110515684|NCT00904735|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110515685|NCT02823626|Spironolactone|spironolactone|mesh-list
110515686|NCT02823626|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110515687|NCT02823626|Hormone Antagonists|hormone antagonists|mesh-ancestor
110515688|NCT02823626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110515689|NCT02823626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110515690|NCT02823626|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110515691|NCT02823626|Diuretics|diuretics|mesh-ancestor
110515692|NCT02823626|Natriuretic Agents|natriuretic agents|mesh-ancestor
110515693|NCT00779259|Quinine|quinine|mesh-list
110515694|NCT00779259|Theophylline|theophylline|mesh-list
110515695|NCT00779259|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110515696|NCT00779259|Autonomic Agents|autonomic agents|mesh-ancestor
110515697|NCT00779259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110515698|NCT00779259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110515699|NCT00779259|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110515700|NCT00779259|Respiratory System Agents|respiratory system agents|mesh-ancestor
110515701|NCT00779259|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110515702|NCT00779259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110515720|NCT02746380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110515722|NCT02745990|Epoetin Alfa|epoetin alfa|mesh-list
110515723|NCT02745990|Hematinics|hematinics|mesh-ancestor
110515724|NCT00915915|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110515725|NCT00915915|Gestodene|gestodene|mesh-list
110515726|NCT00915915|Femovan|femovan|mesh-list
110515727|NCT00915915|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110515728|NCT00915915|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110515730|NCT00915915|Contraceptive Agents|contraceptive agents|mesh-ancestor
110515731|NCT00915915|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110515732|NCT00915915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110515733|NCT00915915|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110515734|NCT00915915|Estrogens|estrogens|mesh-ancestor
110515735|NCT00915915|Hormones|hormones|mesh-ancestor
110515736|NCT00915915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110515737|NCT00915915|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110515738|NCT00915915|Progestins|progestins|mesh-ancestor
110515739|NCT00915915|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110515740|NCT02538367|Prucalopride|prucalopride|mesh-list
110515741|NCT02538367|YH12852|yh12852|mesh-list
110515742|NCT02538367|Laxatives|laxatives|mesh-ancestor
110515743|NCT02538367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110515744|NCT02538367|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
110515745|NCT02538367|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110515746|NCT02538367|Serotonin Agents|serotonin agents|mesh-ancestor
110515747|NCT02538367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110515748|NCT02538367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110515749|NCT02538367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110515750|NCT00900445|Prednisone|prednisone|mesh-list
110515751|NCT00900445|Prednisolone|prednisolone|mesh-list
110515752|NCT00900445|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110515753|NCT00900445|Methylprednisolone|methylprednisolone|mesh-list
110515754|NCT00900445|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110515755|NCT00900445|Prednisolone acetate|prednisolone acetate|mesh-list
110515756|NCT00900445|Hydrocortisone|hydrocortisone|mesh-list
110515757|NCT00900445|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
110515758|NCT00900445|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
110515759|NCT00900445|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
110515779|NCT00900445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110515780|NCT00900445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110515781|NCT00900445|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110515782|NCT00900445|Protective Agents|protective agents|mesh-ancestor
110515783|NCT00900445|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110515784|NCT00900445|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110515785|NCT00900445|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110515786|NCT00900445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110515788|NCT03994419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110515789|NCT03994419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110515790|NCT00936065|Etanercept|etanercept|mesh-list
110515791|NCT00936065|Acitretin|acitretin|mesh-list
110515792|NCT00936065|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110515793|NCT00936065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110515794|NCT00936065|Analgesics|analgesics|mesh-ancestor
110515795|NCT00936065|Sensory System Agents|sensory system agents|mesh-ancestor
110515796|NCT00936065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110515797|NCT00936065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110515798|NCT00936065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110515799|NCT00936065|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110515800|NCT00936065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110515801|NCT00936065|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110515802|NCT00936065|Immunologic Factors|immunologic factors|mesh-ancestor
110515803|NCT00936065|Keratolytic Agents|keratolytic agents|mesh-ancestor
110515804|NCT00936065|Dermatologic Agents|dermatologic agents|mesh-ancestor
110515805|NCT04241276|Paclitaxel|paclitaxel|mesh-list
110515806|NCT04241276|Gemcitabine|gemcitabine|mesh-list
110515807|NCT04241276|Tretinoin|tretinoin|mesh-list
110515808|NCT04241276|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110515809|NCT04241276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110515810|NCT04241276|Tubulin Modulators|tubulin modulators|mesh-ancestor
110515811|NCT04241276|Antimitotic Agents|antimitotic agents|mesh-ancestor
110515812|NCT04241276|Mitosis Modulators|mitosis modulators|mesh-ancestor
110515813|NCT04241276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110915111|NCT03943342|Venetoclax|venetoclax|mesh-list
110515814|NCT04241276|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110515815|NCT04241276|Antimetabolites|antimetabolites|mesh-ancestor
110515816|NCT04241276|Keratolytic Agents|keratolytic agents|mesh-ancestor
110515847|NCT02823236|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110515848|NCT02823236|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110515850|NCT02823236|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110515851|NCT02823236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110515852|NCT02823236|Glucocorticoids|glucocorticoids|mesh-ancestor
110515854|NCT02823236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110515855|NCT02823236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110515856|NCT02823236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110515857|NCT02823236|Immunologic Factors|immunologic factors|mesh-ancestor
110515858|NCT02823236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110515859|NCT02823236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110515860|NCT02823236|Analgesics|analgesics|mesh-ancestor
110515861|NCT02823236|Sensory System Agents|sensory system agents|mesh-ancestor
110515862|NCT02823236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110178047|NCT00143221|Vasodilator Agents|vasodilator agents|mesh-ancestor
110515883|NCT02825342|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110515884|NCT02825342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110515885|NCT02825342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110515886|NCT02825342|Serotonin Agents|serotonin agents|mesh-ancestor
110515887|NCT02825342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110515888|NCT02825342|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110515889|NCT02825342|Antidepressive Agents|antidepressive agents|mesh-ancestor
110515890|NCT02825342|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110515891|NCT02825342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110515892|NCT02749890|Insulin Glargine|insulin glargine|mesh-list
110515893|NCT02749890|Lixisenatide|lixisenatide|mesh-list
110515894|NCT02749890|Hypoglycemic Agents|hypoglycemic agents|mesh-list
110515895|NCT02749890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110515896|NCT04242758|Dapagliflozin|dapagliflozin|mesh-list
110515897|NCT04242758|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110515898|NCT04242758|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110515899|NCT04242758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110515900|NCT04242758|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110515901|NCT04242758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110515902|NCT04242758|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110515903|NCT04242758|Diuretics|diuretics|mesh-ancestor
110515904|NCT04242758|Natriuretic Agents|natriuretic agents|mesh-ancestor
110515905|NCT04242758|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110515906|NCT04242758|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110515908|NCT02745912|Naltrexone|naltrexone|mesh-list
110515909|NCT02745912|Bupropion|bupropion|mesh-list
110515910|NCT02745912|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110515911|NCT02745912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110515912|NCT02745912|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110515913|NCT02745912|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110515914|NCT02745912|Sensory System Agents|sensory system agents|mesh-ancestor
110515915|NCT02745912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110515916|NCT02745912|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110515917|NCT02745912|Antidepressive Agents|antidepressive agents|mesh-ancestor
110515918|NCT02745912|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110178077|NCT00143377|Urological Agents|urological agents|mesh-ancestor
110515940|NCT00604825|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
110515941|NCT00604825|Estrogens|estrogens|mesh-ancestor
110515942|NCT00604825|Hormones|hormones|mesh-ancestor
110515943|NCT00604825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110515944|NCT00604825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110515945|NCT04239560|Boron|boron|mesh-list
110515946|NCT04239560|Trace Elements|trace elements|mesh-ancestor
110515947|NCT04239560|Micronutrients|micronutrients|mesh-ancestor
110515948|NCT04239560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110515949|NCT04218162|Lasmiditan|lasmiditan|mesh-list
110515950|NCT04218162|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110515951|NCT04218162|Serotonin Agents|serotonin agents|mesh-ancestor
110515952|NCT04218162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110515953|NCT04218162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110515954|NCT04218162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110515955|NCT00606125|Sorafenib|sorafenib|mesh-list
110515956|NCT00606125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110515957|NCT00606125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110515958|NCT00606125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110515959|NCT00606125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110163351|NCT00390975|Tegaserod|tegaserod|mesh-list
110515960|NCT04242212|Misoprostol|misoprostol|mesh-list
110515961|NCT04242212|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110515962|NCT04242212|Abortifacient Agents|abortifacient agents|mesh-ancestor
110515963|NCT04242212|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110515964|NCT04242212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110515965|NCT04242212|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110515966|NCT04242212|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110515967|NCT04242212|Oxytocics|oxytocics|mesh-ancestor
110515968|NCT02851433|Anesthetics|anesthetics|mesh-list
110515969|NCT02851433|Propofol|propofol|mesh-list
110515970|NCT02851433|Sevoflurane|sevoflurane|mesh-list
110515971|NCT02851433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110178096|NCT00143533|Irinotecan|irinotecan|mesh-list
110515997|NCT04242368|Respiratory System Agents|respiratory system agents|mesh-ancestor
110515998|NCT04242368|Dermatologic Agents|dermatologic agents|mesh-ancestor
110515999|NCT04242368|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110516000|NCT04217148|Dexamethasone|dexamethasone|mesh-list
110516001|NCT04217148|Dexamethasone acetate|dexamethasone acetate|mesh-list
110516002|NCT04217148|Tretinoin|tretinoin|mesh-list
110516003|NCT04217148|BB 1101|bb 1101|mesh-list
110516004|NCT04217148|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110516005|NCT04217148|Antiemetics|antiemetics|mesh-ancestor
110516006|NCT04217148|Autonomic Agents|autonomic agents|mesh-ancestor
110516007|NCT04217148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110516008|NCT04217148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110516009|NCT04217148|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110516010|NCT04217148|Glucocorticoids|glucocorticoids|mesh-ancestor
110516011|NCT04217148|Hormones|hormones|mesh-ancestor
110516012|NCT04217148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110516013|NCT04217148|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110915147|NCT00694928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110516014|NCT04217148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110516015|NCT04217148|Protease Inhibitors|protease inhibitors|mesh-ancestor
110516016|NCT04217148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110516017|NCT04217148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110516018|NCT04217148|Keratolytic Agents|keratolytic agents|mesh-ancestor
110516019|NCT04217148|Dermatologic Agents|dermatologic agents|mesh-ancestor
110516020|NCT00900913|Ropivacaine|ropivacaine|mesh-list
110516021|NCT00900913|Anesthetics, Local|anesthetics, local|mesh-ancestor
110516022|NCT00900913|Anesthetics|anesthetics|mesh-ancestor
110516023|NCT00900913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110178117|NCT00143689|Ritonavir|ritonavir|mesh-list
110516033|NCT00937157|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110516034|NCT00937157|Immunologic Factors|immunologic factors|mesh-ancestor
110516035|NCT00937157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110516036|NCT00937157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110516037|NCT00937157|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110516038|NCT04034173|Leucovorin|leucovorin|mesh-list
110516039|NCT04034173|Folic Acid|folic acid|mesh-list
110516040|NCT04034173|Irinotecan|irinotecan|mesh-list
110516041|NCT04034173|Panitumumab|panitumumab|mesh-list
110516042|NCT04034173|Levoleucovorin|levoleucovorin|mesh-list
110516043|NCT04034173|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110516044|NCT04034173|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110516045|NCT04034173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110516046|NCT04034173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110516047|NCT04034173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110516048|NCT04034173|Antidotes|antidotes|mesh-ancestor
110516049|NCT04034173|Protective Agents|protective agents|mesh-ancestor
110516050|NCT04034173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110516051|NCT04034173|Vitamin B Complex|vitamin b complex|mesh-ancestor
110516052|NCT04034173|Vitamins|vitamins|mesh-ancestor
110516053|NCT04034173|Micronutrients|micronutrients|mesh-ancestor
110516054|NCT04034173|Hematinics|hematinics|mesh-ancestor
110516055|NCT04034173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110516056|NCT00606203|Milnacipran|milnacipran|mesh-list
110516057|NCT00606203|Levomilnacipran|levomilnacipran|mesh-list
110516058|NCT00606203|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110516059|NCT00606203|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110516060|NCT00606203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110516061|NCT00606203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110516062|NCT00606203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110915172|NCT00136903|Prednisone|prednisone|mesh-list
110516063|NCT00606203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110516064|NCT00606203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110516065|NCT00606203|Analgesics|analgesics|mesh-ancestor
110516066|NCT00606203|Sensory System Agents|sensory system agents|mesh-ancestor
110516067|NCT00606203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110516068|NCT00606203|Antidepressive Agents|antidepressive agents|mesh-ancestor
110516069|NCT00606203|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110516070|NCT02539849|Adalimumab|adalimumab|mesh-list
110516071|NCT02539849|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110516072|NCT02539849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110516073|NCT02539849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110516074|NCT02749578|Atorvastatin|atorvastatin|mesh-list
110516075|NCT02749578|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110516076|NCT02749578|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110516077|NCT02749578|Antimetabolites|antimetabolites|mesh-ancestor
110516078|NCT02749578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110516079|NCT02749578|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110516080|NCT02749578|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110516081|NCT02749578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110516082|NCT05378867|Bevacizumab|bevacizumab|mesh-list
110516083|NCT05378867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110516084|NCT05378867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110516085|NCT05378867|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110516086|NCT05378867|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110516087|NCT05378867|Growth Substances|growth substances|mesh-ancestor
110516088|NCT05378867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110516108|NCT02745522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110516109|NCT02824718|Teriparatide|teriparatide|mesh-list
110516110|NCT02824718|Alfacalcidol|alfacalcidol|mesh-list
110516111|NCT02824718|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
110516112|NCT02824718|Sodium Channel Blockers|sodium channel blockers|mesh-list
110516113|NCT02824718|Diuretics|diuretics|mesh-list
110516114|NCT02824718|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-list
110516115|NCT02824718|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110516116|NCT02824718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110516117|NCT02824718|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110516118|NCT02824718|Natriuretic Agents|natriuretic agents|mesh-ancestor
110516119|NCT02824718|Vitamins|vitamins|mesh-ancestor
110516120|NCT02824718|Micronutrients|micronutrients|mesh-ancestor
110516121|NCT02824718|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110516122|NCT02824718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110516123|NCT05378711|Fluoxetine|fluoxetine|mesh-list
110516124|NCT05378711|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110516125|NCT05378711|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110516126|NCT05378711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110516127|NCT05378711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110516128|NCT05378711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110516129|NCT05378711|Serotonin Agents|serotonin agents|mesh-ancestor
110516130|NCT05378711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110516131|NCT05378711|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110516132|NCT05378711|Antidepressive Agents|antidepressive agents|mesh-ancestor
110516133|NCT05378711|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110516134|NCT05378711|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110516135|NCT05378711|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110516136|NCT05378711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110516137|NCT00777153|Cediranib|cediranib|mesh-list
110516138|NCT00777153|Lomustine|lomustine|mesh-list
110516139|NCT00777153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110516140|NCT00777153|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110516141|NCT00777153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110516142|NCT00777153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110516143|NCT00777153|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110516144|NCT00777153|Alkylating Agents|alkylating agents|mesh-ancestor
110516145|NCT02821520|Verteporfin|verteporfin|mesh-list
110516160|NCT04266509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110516161|NCT04266509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110516162|NCT04266509|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110516163|NCT04266509|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110516164|NCT04266509|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110516165|NCT04266509|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110516166|NCT04266509|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110516167|NCT04266509|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110516168|NCT02824874|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110516169|NCT02824874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110516170|NCT02824874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110516172|NCT02824874|Hormones|hormones|mesh-ancestor
110516173|NCT02824874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110516174|NCT02824874|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110516175|NCT02824874|Protease Inhibitors|protease inhibitors|mesh-ancestor
110516176|NCT02824874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110516177|NCT02824874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110516178|NCT04204265|Hyaluronic Acid|hyaluronic acid|mesh-list
110516179|NCT04204265|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110516180|NCT04204265|Immunologic Factors|immunologic factors|mesh-ancestor
110516181|NCT04204265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110516182|NCT04204265|Viscosupplements|viscosupplements|mesh-ancestor
110516183|NCT04204265|Protective Agents|protective agents|mesh-ancestor
110516184|NCT04267913|Dexamethasone|dexamethasone|mesh-list
110516185|NCT04267913|Dexamethasone acetate|dexamethasone acetate|mesh-list
110516186|NCT04267913|Docetaxel|docetaxel|mesh-list
110516187|NCT04267913|Ramucirumab|ramucirumab|mesh-list
110516188|NCT04267913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110516189|NCT04267913|Antibodies|antibodies|mesh-list
110516190|NCT04267913|Immunoglobulins|immunoglobulins|mesh-list
110516191|NCT04267913|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110516192|NCT04267913|Lexatumumab|lexatumumab|mesh-list
110516193|NCT04267913|BB 1101|bb 1101|mesh-list
110516194|NCT04267913|Immunologic Factors|immunologic factors|mesh-ancestor
110516195|NCT04267913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110516196|NCT04267913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110516197|NCT04267913|Antiemetics|antiemetics|mesh-ancestor
110516198|NCT04267913|Autonomic Agents|autonomic agents|mesh-ancestor
110516199|NCT04267913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110516200|NCT04267913|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110516201|NCT04267913|Glucocorticoids|glucocorticoids|mesh-ancestor
110516202|NCT04267913|Hormones|hormones|mesh-ancestor
110516203|NCT04267913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110516204|NCT04267913|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110516205|NCT04267913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110516206|NCT04267913|Protease Inhibitors|protease inhibitors|mesh-ancestor
110178179|NCT00144118|Isoflurane|isoflurane|mesh-list
110516237|NCT00908089|Methylprednisolone|methylprednisolone|mesh-list
110915220|NCT04189510|Pancrelipase|pancrelipase|mesh-list
110516238|NCT00908089|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110516239|NCT00908089|Prednisolone acetate|prednisolone acetate|mesh-list
110516241|NCT00908089|Naltrexone|naltrexone|mesh-list
110516242|NCT00908089|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110516243|NCT00908089|Prednisolone phosphate|prednisolone phosphate|mesh-list
110516244|NCT00908089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110516245|NCT00908089|Glucocorticoids|glucocorticoids|mesh-ancestor
110516246|NCT00908089|Hormones|hormones|mesh-ancestor
110516247|NCT00908089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110516248|NCT00908089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110516249|NCT00908089|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110516250|NCT00908089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110516251|NCT00908089|Antiemetics|antiemetics|mesh-ancestor
110516252|NCT00908089|Autonomic Agents|autonomic agents|mesh-ancestor
110516253|NCT00908089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110178182|NCT00144118|Anesthetics, General|anesthetics, general|mesh-ancestor
110516274|NCT04758416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110516275|NCT03553446|Sevoflurane|sevoflurane|mesh-list
110516276|NCT03553446|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110516277|NCT03553446|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110516278|NCT03553446|Anesthetics, General|anesthetics, general|mesh-ancestor
110516279|NCT03553446|Anesthetics|anesthetics|mesh-ancestor
110516280|NCT03553446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110516281|NCT03553446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110516282|NCT00908167|Cytarabine|cytarabine|mesh-list
110516283|NCT00908167|Clofarabine|clofarabine|mesh-list
110516284|NCT00908167|Sorafenib|sorafenib|mesh-list
110046779|NCT04975308|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110516285|NCT00908167|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110516286|NCT00908167|Antimetabolites|antimetabolites|mesh-ancestor
110516287|NCT00908167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110516288|NCT00908167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110516289|NCT00908167|Antiviral Agents|antiviral agents|mesh-ancestor
110516290|NCT00908167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110516291|NCT00908167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110516292|NCT00908167|Immunologic Factors|immunologic factors|mesh-ancestor
110516293|NCT00908167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110516294|NCT00908167|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110516295|NCT00908167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110516296|NCT02821052|Insulin|insulin|mesh-list
110516297|NCT02821052|Insulin Aspart|insulin aspart|mesh-list
110516298|NCT02821052|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110516299|NCT02821052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110516300|NCT05659628|Tislelizumab|tislelizumab|mesh-list
110516301|NCT05659628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110516302|NCT05659628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110516303|NCT00606515|Paclitaxel|paclitaxel|mesh-list
110516304|NCT00606515|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110516305|NCT00606515|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110516306|NCT00606515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110516307|NCT00606515|Tubulin Modulators|tubulin modulators|mesh-ancestor
110516308|NCT00606515|Antimitotic Agents|antimitotic agents|mesh-ancestor
110516309|NCT00606515|Mitosis Modulators|mitosis modulators|mesh-ancestor
110516326|NCT00908713|Methylprednisolone|methylprednisolone|mesh-list
110516327|NCT00908713|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110516328|NCT00908713|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110516329|NCT00908713|Prednisolone|prednisolone|mesh-list
110516330|NCT00908713|Prednisolone acetate|prednisolone acetate|mesh-list
110516331|NCT00908713|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110516332|NCT00908713|Prednisolone phosphate|prednisolone phosphate|mesh-list
110516333|NCT00908713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110516334|NCT00908713|Antiemetics|antiemetics|mesh-ancestor
110516335|NCT00908713|Autonomic Agents|autonomic agents|mesh-ancestor
110516336|NCT00908713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110516337|NCT00908713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110163734|NCT00121381|Analgesics|analgesics|mesh-ancestor
110516338|NCT00908713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110516339|NCT00908713|Glucocorticoids|glucocorticoids|mesh-ancestor
110516340|NCT00908713|Hormones|hormones|mesh-ancestor
110516341|NCT00908713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110516342|NCT00908713|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110516343|NCT00908713|Protective Agents|protective agents|mesh-ancestor
110516344|NCT00908713|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110516345|NCT00908713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110516346|NCT00908869|Interferons|interferons|mesh-list
110516347|NCT00908869|Interferon-alpha|interferon-alpha|mesh-list
110516348|NCT00908869|Interferon alpha-2|interferon alpha-2|mesh-list
110516349|NCT00908869|Cyclophosphamide|cyclophosphamide|mesh-list
110516350|NCT00908869|Vinorelbine|vinorelbine|mesh-list
110516351|NCT00908869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110516352|NCT00908869|Immunologic Factors|immunologic factors|mesh-ancestor
110516353|NCT00908869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110516354|NCT00908869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110516355|NCT00908869|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110516356|NCT00908869|Alkylating Agents|alkylating agents|mesh-ancestor
110516357|NCT00908869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110516358|NCT00908869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110516359|NCT00908869|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110516360|NCT00908869|Antiviral Agents|antiviral agents|mesh-ancestor
110516361|NCT00908869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110516362|NCT00908869|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110516363|NCT00908869|Tubulin Modulators|tubulin modulators|mesh-ancestor
110516364|NCT00908869|Antimitotic Agents|antimitotic agents|mesh-ancestor
110516365|NCT00908869|Mitosis Modulators|mitosis modulators|mesh-ancestor
110516366|NCT00605111|Insulin Aspart|insulin aspart|mesh-list
110516367|NCT00605111|Biphasic Insulins|biphasic insulins|mesh-list
110516368|NCT00605111|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110516386|NCT00909571|Tacrolimus|tacrolimus|mesh-list
110516387|NCT00909571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110516388|NCT00909571|Immunologic Factors|immunologic factors|mesh-ancestor
110516389|NCT00909571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110516390|NCT00909571|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110915277|NCT02281058|Abatacept|abatacept|mesh-list
110516391|NCT00909571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110516392|NCT00909571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110516393|NCT04015375|Dapsone|dapsone|mesh-list
110516394|NCT04015375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110516395|NCT04015375|Antimalarials|antimalarials|mesh-ancestor
110516396|NCT04015375|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110516397|NCT04015375|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110516398|NCT04015375|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110516399|NCT04015375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110516400|NCT04015375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110516401|NCT04015375|Leprostatic Agents|leprostatic agents|mesh-ancestor
110516402|NCT04015375|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110516403|NCT04239794|Propofol|propofol|mesh-list
110516404|NCT04239794|Sevoflurane|sevoflurane|mesh-list
110516405|NCT04239794|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110516406|NCT04239794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110516407|NCT04239794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110516408|NCT04239794|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110516409|NCT04239794|Anesthetics, General|anesthetics, general|mesh-ancestor
110516410|NCT04239794|Anesthetics|anesthetics|mesh-ancestor
110516411|NCT04239794|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110516412|NCT04239794|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110516413|NCT02850887|Anesthetics|anesthetics|mesh-list
110516414|NCT02850887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110516415|NCT02850887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110516416|NCT00931645|Cytarabine|cytarabine|mesh-list
110516417|NCT00931645|Dexamethasone|dexamethasone|mesh-list
110516418|NCT00931645|Cyclophosphamide|cyclophosphamide|mesh-list
110516419|NCT00931645|Cisplatin|cisplatin|mesh-list
110516420|NCT00931645|Fludarabine|fludarabine|mesh-list
110516421|NCT00931645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110516422|NCT00931645|Immunologic Factors|immunologic factors|mesh-ancestor
110516423|NCT00931645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110516424|NCT00931645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110516425|NCT00931645|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110516426|NCT00931645|Alkylating Agents|alkylating agents|mesh-ancestor
110178254|NCT00404794|Prednisolone|prednisolone|mesh-list
110516443|NCT05658692|Anti-Infective Agents|anti-infective agents|mesh-list
110516444|NCT05658692|Dexamethasone|dexamethasone|mesh-list
110516445|NCT05658692|Hydrocortisone|hydrocortisone|mesh-list
110516446|NCT05658692|Simendan|simendan|mesh-list
110516447|NCT05658692|Dopamine|dopamine|mesh-list
110516448|NCT05658692|Isoproterenol|isoproterenol|mesh-list
110516449|NCT05658692|Olprinone|olprinone|mesh-list
110516450|NCT05658692|Epinephrine|epinephrine|mesh-list
110516451|NCT05658692|Norepinephrine|norepinephrine|mesh-list
110516452|NCT05658692|Metaraminol|metaraminol|mesh-list
110516453|NCT05658692|Midazolam|midazolam|mesh-list
110516454|NCT05658692|Dexmedetomidine|dexmedetomidine|mesh-list
110516455|NCT05658692|Bromides|bromides|mesh-list
110516456|NCT05658692|Propofol|propofol|mesh-list
110516457|NCT05658692|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
110516458|NCT05658692|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110516459|NCT05658692|Simvastatin|simvastatin|mesh-list
110516460|NCT05658692|Glucocorticoids|glucocorticoids|mesh-list
110516461|NCT05658692|Succinylcholine|succinylcholine|mesh-list
110516462|NCT05658692|Vecuronium Bromide|vecuronium bromide|mesh-list
110516463|NCT05658692|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110516464|NCT05658692|Antiemetics|antiemetics|mesh-ancestor
110516465|NCT05658692|Autonomic Agents|autonomic agents|mesh-ancestor
110915283|NCT02281058|Immunologic Factors|immunologic factors|mesh-ancestor
110516466|NCT05658692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110516467|NCT05658692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110516468|NCT05658692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110516469|NCT05658692|Hormones|hormones|mesh-ancestor
110516470|NCT05658692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110516471|NCT05658692|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110516472|NCT05658692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110516473|NCT05658692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110516474|NCT05658692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110516475|NCT05658692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110516476|NCT05658692|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110516477|NCT05658692|Analgesics|analgesics|mesh-ancestor
110516478|NCT05658692|Sensory System Agents|sensory system agents|mesh-ancestor
110516479|NCT05658692|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110516480|NCT05658692|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110516481|NCT05658692|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110516482|NCT05658692|Adrenergic Agents|adrenergic agents|mesh-ancestor
110516483|NCT05658692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110516484|NCT05658692|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110516485|NCT05658692|Anesthetics, General|anesthetics, general|mesh-ancestor
110516486|NCT05658692|Anesthetics|anesthetics|mesh-ancestor
110516487|NCT05658692|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110516488|NCT05658692|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110516509|NCT05658692|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110516510|NCT05658692|Protective Agents|protective agents|mesh-ancestor
110516511|NCT05658692|Dopamine Agents|dopamine agents|mesh-ancestor
110516512|NCT05658692|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
110516513|NCT05658692|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110516514|NCT05658692|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110516515|NCT05658692|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110516516|NCT05658692|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
110516517|NCT05658692|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110516518|NCT05658692|Cholinergic Agents|cholinergic agents|mesh-ancestor
110516519|NCT05658692|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110516520|NCT02744508|Dexamethasone|dexamethasone|mesh-list
110516521|NCT02744508|Palonosetron|palonosetron|mesh-list
110516522|NCT02744508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110516523|NCT02744508|Antiemetics|antiemetics|mesh-ancestor
110516524|NCT02744508|Autonomic Agents|autonomic agents|mesh-ancestor
110516525|NCT02744508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110516526|NCT02744508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110516527|NCT02744508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110516528|NCT02744508|Glucocorticoids|glucocorticoids|mesh-ancestor
110516529|NCT02744508|Hormones|hormones|mesh-ancestor
110516530|NCT02744508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110189986|NCT00050856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110516531|NCT02744508|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110516532|NCT02744508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110516533|NCT02744508|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110516534|NCT02744508|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110516535|NCT02744508|Serotonin Agents|serotonin agents|mesh-ancestor
110516536|NCT02744508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110516537|NCT02744508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110516538|NCT00927511|Fulvestrant|fulvestrant|mesh-list
110516539|NCT00927511|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110516540|NCT00927511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110516541|NCT00927511|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110516542|NCT00927511|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110516543|NCT00927511|Hormone Antagonists|hormone antagonists|mesh-ancestor
110178278|NCT00404794|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110516564|NCT02744196|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110516565|NCT02744196|Abortifacient Agents|abortifacient agents|mesh-ancestor
110516566|NCT02744196|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110163958|NCT00129298|Tiagabine|tiagabine|mesh-list
110516567|NCT02744196|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110516569|NCT02744196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110516570|NCT02744196|Dermatologic Agents|dermatologic agents|mesh-ancestor
110516571|NCT02744196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110516572|NCT02744196|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110516573|NCT02744196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110516574|NCT02744196|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110516575|NCT02139852|Capsaicin|capsaicin|mesh-list
110516576|NCT02139852|Antipruritics|antipruritics|mesh-ancestor
110516577|NCT02139852|Dermatologic Agents|dermatologic agents|mesh-ancestor
110516578|NCT02139852|Sensory System Agents|sensory system agents|mesh-ancestor
110516579|NCT02139852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110516580|NCT02139852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110516581|NCT05379647|Cyclophosphamide|cyclophosphamide|mesh-list
110516582|NCT05379647|Rituximab|rituximab|mesh-list
110516583|NCT05379647|Fludarabine|fludarabine|mesh-list
110516584|NCT05379647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110516585|NCT05379647|Immunologic Factors|immunologic factors|mesh-ancestor
110516586|NCT05379647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110516587|NCT05379647|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110516588|NCT05379647|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110516589|NCT05379647|Alkylating Agents|alkylating agents|mesh-ancestor
110516590|NCT05379647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110516591|NCT05379647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110516592|NCT05379647|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110516593|NCT05379647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110516594|NCT02748330|Aspirin|aspirin|mesh-list
110516595|NCT02748330|Clopidogrel|clopidogrel|mesh-list
110516596|NCT02748330|Ticagrelor|ticagrelor|mesh-list
110516619|NCT05379569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110516620|NCT05379569|Immunologic Factors|immunologic factors|mesh-ancestor
110516621|NCT05379569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110516622|NCT05379569|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110516623|NCT05379569|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110516624|NCT05379569|Alkylating Agents|alkylating agents|mesh-ancestor
110189997|NCT00023348|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110516625|NCT05379569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110516626|NCT05379569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110516627|NCT05379569|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110516628|NCT02818556|Hyaluronic Acid|hyaluronic acid|mesh-list
110516629|NCT02818556|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110516630|NCT02818556|Immunologic Factors|immunologic factors|mesh-ancestor
110516631|NCT02818556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110516632|NCT02818556|Viscosupplements|viscosupplements|mesh-ancestor
110516633|NCT02818556|Protective Agents|protective agents|mesh-ancestor
110516634|NCT04171128|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110516635|NCT04171128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110516636|NCT04238936|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
110516637|NCT04238936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110516638|NCT04627142|Irinotecan|irinotecan|mesh-list
110516639|NCT04627142|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110516640|NCT04627142|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110516641|NCT04627142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110516642|NCT04627142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110516643|NCT04627142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110516644|NCT00936221|Dacarbazine|dacarbazine|mesh-list
110516645|NCT00936221|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110516646|NCT00936221|Alkylating Agents|alkylating agents|mesh-ancestor
110516647|NCT00936221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110516657|NCT00776919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110516660|NCT05657678|Ergocalciferols|ergocalciferols|mesh-list
110516661|NCT05657678|Cholecalciferol|cholecalciferol|mesh-list
110516662|NCT05657678|Vitamins|vitamins|mesh-list
110516663|NCT05657678|Micronutrients|micronutrients|mesh-ancestor
110516664|NCT05657678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110516665|NCT05657678|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110516666|NCT05657678|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110516667|NCT02747940|Pregabalin|pregabalin|mesh-list
110516668|NCT02747940|Flunarizine|flunarizine|mesh-list
110516669|NCT02747940|Analgesics|analgesics|mesh-ancestor
110516670|NCT02747940|Sensory System Agents|sensory system agents|mesh-ancestor
110516671|NCT02747940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110516672|NCT02747940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110516673|NCT02747940|Anticonvulsants|anticonvulsants|mesh-ancestor
110516674|NCT02747940|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110516675|NCT02747940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110516676|NCT02747940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110516677|NCT02747940|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110516678|NCT02747940|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110516679|NCT02747940|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110516680|NCT02747940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110516681|NCT02747940|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110516682|NCT02747940|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110516683|NCT02747940|Histamine Antagonists|histamine antagonists|mesh-ancestor
110516684|NCT02747940|Histamine Agents|histamine agents|mesh-ancestor
110516685|NCT02747940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110516686|NCT02747940|Vasodilator Agents|vasodilator agents|mesh-ancestor
110516687|NCT04238702|Empagliflozin|empagliflozin|mesh-list
110516689|NCT04238702|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110516690|NCT04238702|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110516691|NCT04238702|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110516692|NCT04238702|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110190024|NCT00023387|Isoniazid|isoniazid|mesh-list
110516693|NCT04238702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110516694|NCT04238702|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110516695|NCT04238702|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110516696|NCT04238702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110516697|NCT00603785|Omalizumab|omalizumab|mesh-list
110516698|NCT00603785|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110516699|NCT00603785|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110516700|NCT00603785|Respiratory System Agents|respiratory system agents|mesh-ancestor
110516701|NCT00633776|Formoterol Fumarate|formoterol fumarate|mesh-list
110516702|NCT00633776|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110516703|NCT00633776|Autonomic Agents|autonomic agents|mesh-ancestor
110516704|NCT00633776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110516705|NCT00633776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110516706|NCT00633776|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110516707|NCT00633776|Respiratory System Agents|respiratory system agents|mesh-ancestor
110516708|NCT00633776|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110516709|NCT00633776|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110516710|NCT00633776|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110516711|NCT00633776|Adrenergic Agents|adrenergic agents|mesh-ancestor
110516712|NCT00633776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110516713|NCT00633776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110516714|NCT05382923|Melatonin|melatonin|mesh-list
110516728|NCT00775593|MTOR Inhibitors|mtor inhibitors|mesh-list
110516729|NCT00775593|Clofarabine|clofarabine|mesh-list
110516730|NCT00775593|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110516731|NCT00775593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110516732|NCT00775593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110516733|NCT00775593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110516734|NCT00775593|Immunologic Factors|immunologic factors|mesh-ancestor
110516735|NCT00775593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110516736|NCT00775593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110516737|NCT00775593|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110516738|NCT00775593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110516739|NCT00775593|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110516740|NCT00775593|Antifungal Agents|antifungal agents|mesh-ancestor
110516741|NCT00775593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110516742|NCT00775593|Antimetabolites|antimetabolites|mesh-ancestor
110516743|NCT00606983|Tamsulosin|tamsulosin|mesh-list
110516744|NCT00606983|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110516745|NCT00606983|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110516746|NCT00606983|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110516747|NCT00606983|Adrenergic Agents|adrenergic agents|mesh-ancestor
110516748|NCT00606983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110516749|NCT00606983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110516750|NCT00606983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110516751|NCT00606983|Urological Agents|urological agents|mesh-ancestor
110516752|NCT02817932|Ranolazine|ranolazine|mesh-list
110516753|NCT02817932|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110516754|NCT02817932|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110190035|NCT00023387|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110516755|NCT02817932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110516756|NCT02743260|Metformin|metformin|mesh-list
110516757|NCT02743260|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110516758|NCT02743260|Adefovir|adefovir|mesh-list
110516759|NCT02743260|Digoxin|digoxin|mesh-list
110516760|NCT02743260|Pitavastatin|pitavastatin|mesh-list
110516761|NCT02743260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110516762|NCT02743260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110516763|NCT02743260|Incretins|incretins|mesh-ancestor
110516764|NCT02743260|Hormones|hormones|mesh-ancestor
110516765|NCT02743260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110516766|NCT02743260|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110516767|NCT02743260|Protease Inhibitors|protease inhibitors|mesh-ancestor
110516768|NCT02743260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110516769|NCT02743260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110516770|NCT02743260|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110516771|NCT02743260|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110516772|NCT02743260|Protective Agents|protective agents|mesh-ancestor
110516773|NCT02743260|Antiviral Agents|antiviral agents|mesh-ancestor
110516774|NCT02743260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110516775|NCT02743260|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110516776|NCT02743260|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110178349|NCT01807494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110516788|NCT02819648|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110516789|NCT02819648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110516790|NCT00934661|Morphine|morphine|mesh-list
110516791|NCT00934661|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110516792|NCT00934661|Narcotics|narcotics|mesh-ancestor
110516793|NCT00934661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110516794|NCT00934661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110516795|NCT00934661|Analgesics|analgesics|mesh-ancestor
110516796|NCT00934661|Sensory System Agents|sensory system agents|mesh-ancestor
110516797|NCT00934661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110516798|NCT02743182|Interferons|interferons|mesh-list
110516799|NCT02743182|Interferon-alpha|interferon-alpha|mesh-list
110516800|NCT02743182|Interferon alpha-2|interferon alpha-2|mesh-list
110516801|NCT02743182|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110516802|NCT02743182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110516803|NCT02743182|Antiviral Agents|antiviral agents|mesh-ancestor
110516804|NCT02743182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110516805|NCT02743182|Immunologic Factors|immunologic factors|mesh-ancestor
110516806|NCT02743182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110516807|NCT00775437|Adalimumab|adalimumab|mesh-list
110516808|NCT00775437|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110516809|NCT00775437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110516810|NCT00775437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110516811|NCT04238078|Contraceptive Agents|contraceptive agents|mesh-list
110516812|NCT04238078|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110516813|NCT04238078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110516814|NCT02742168|HYNIC-3PRGD(2)|hynic-3prgd(2)|mesh-list
110516815|NCT02742168|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110516816|NCT02742168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110516817|NCT02819414|Acetaminophen|acetaminophen|mesh-list
110516818|NCT02819414|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110516819|NCT02819414|Analgesics|analgesics|mesh-ancestor
110516820|NCT02819414|Sensory System Agents|sensory system agents|mesh-ancestor
110516821|NCT02819414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110516822|NCT02819414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110516823|NCT02819414|Antipyretics|antipyretics|mesh-ancestor
110516824|NCT02743104|Lidocaine|lidocaine|mesh-list
110516825|NCT02743104|Atropine|atropine|mesh-list
110516826|NCT02743104|Midazolam|midazolam|mesh-list
110516827|NCT02743104|Ketamine|ketamine|mesh-list
110516828|NCT02743104|Propofol|propofol|mesh-list
110516829|NCT02743104|Anesthetics, Local|anesthetics, local|mesh-ancestor
110516830|NCT02743104|Anesthetics|anesthetics|mesh-ancestor
110516831|NCT02743104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110516832|NCT02743104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110516833|NCT02743104|Sensory System Agents|sensory system agents|mesh-ancestor
110516834|NCT02743104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110516835|NCT02743104|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110516836|NCT02743104|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110516837|NCT02743104|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110516838|NCT02743104|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110516839|NCT02743104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110516840|NCT02743104|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110516873|NCT00775203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110516874|NCT00775203|Serotonin Agents|serotonin agents|mesh-ancestor
110516875|NCT00775203|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110516876|NCT00775203|Antidepressive Agents|antidepressive agents|mesh-ancestor
110516877|NCT02816684|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110516878|NCT02816684|Antiviral Agents|antiviral agents|mesh-ancestor
110516879|NCT02816684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110516880|NCT00607217|Vaccines|vaccines|mesh-list
110516881|NCT00607217|Immunologic Factors|immunologic factors|mesh-ancestor
110516882|NCT00607217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110516896|NCT02742948|Ceftriaxone|ceftriaxone|mesh-list
110516897|NCT02742948|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110516898|NCT02742948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110516899|NCT00636246|Sertraline|sertraline|mesh-list
110516900|NCT00636246|Reboxetine|reboxetine|mesh-list
110516901|NCT00636246|Antidepressive Agents|antidepressive agents|mesh-ancestor
110516902|NCT00636246|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110516903|NCT00636246|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110516904|NCT00636246|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110516905|NCT00636246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110516906|NCT00636246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110516907|NCT00636246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110516908|NCT00636246|Serotonin Agents|serotonin agents|mesh-ancestor
110516909|NCT00636246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110516910|NCT00636246|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110516911|NCT00636246|Adrenergic Agents|adrenergic agents|mesh-ancestor
110516912|NCT02819570|Ampicillin|ampicillin|mesh-list
110516913|NCT02819570|Cefuroxime|cefuroxime|mesh-list
110516914|NCT02819570|Cefuroxime axetil|cefuroxime axetil|mesh-list
110516915|NCT02819570|Roxithromycin|roxithromycin|mesh-list
110516916|NCT02819570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110516917|NCT02819570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110516918|NCT04239170|Gemcitabine|gemcitabine|mesh-list
110516919|NCT04239170|Oxaliplatin|oxaliplatin|mesh-list
110516920|NCT04239170|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110516921|NCT04239170|Antimetabolites|antimetabolites|mesh-ancestor
110516922|NCT04239170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110516923|NCT04239170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110516924|NCT04480190|Gemcitabine|gemcitabine|mesh-list
110516926|NCT04480190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110516927|NCT04480190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110516928|NCT04480190|Antimetabolites|antimetabolites|mesh-ancestor
110516929|NCT04480190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110516930|NCT04480190|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110190076|NCT00051090|Abacavir|abacavir|mesh-list
110516931|NCT04480190|Immunologic Factors|immunologic factors|mesh-ancestor
110516932|NCT04480190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110516933|NCT02741856|Paclitaxel|paclitaxel|mesh-list
110516934|NCT02741856|Carboplatin|carboplatin|mesh-list
110516935|NCT02741856|Capecitabine|capecitabine|mesh-list
110516936|NCT02741856|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110516937|NCT02741856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110516938|NCT02741856|Tubulin Modulators|tubulin modulators|mesh-ancestor
110516939|NCT02741856|Antimitotic Agents|antimitotic agents|mesh-ancestor
110516940|NCT02741856|Mitosis Modulators|mitosis modulators|mesh-ancestor
110516941|NCT02741856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110516942|NCT02741856|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110516943|NCT02741856|Antimetabolites|antimetabolites|mesh-ancestor
110516944|NCT02741232|Lidocaine|lidocaine|mesh-list
110516945|NCT02741232|Epinephrine|epinephrine|mesh-list
110516946|NCT02741232|Racepinephrine|racepinephrine|mesh-list
110178405|NCT03090737|Nivolumab|nivolumab|mesh-list
110516966|NCT02741232|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110516967|NCT02741232|Respiratory System Agents|respiratory system agents|mesh-ancestor
110516968|NCT02741232|Mydriatics|mydriatics|mesh-ancestor
110516969|NCT02741232|Sympathomimetics|sympathomimetics|mesh-ancestor
110516970|NCT02741232|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110516972|NCT04239014|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110516973|NCT04239014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110516974|NCT04239014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110516975|NCT04239014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110516976|NCT00568321|Tanezumab|tanezumab|mesh-list
110516977|NCT00568321|Analgesics|analgesics|mesh-ancestor
110516978|NCT00568321|Sensory System Agents|sensory system agents|mesh-ancestor
110516979|NCT00568321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110516980|NCT00568321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110516981|NCT02742480|Dabigatran|dabigatran|mesh-list
110516982|NCT02742480|Acenocoumarol|acenocoumarol|mesh-list
110516983|NCT02742480|Antithrombins|antithrombins|mesh-ancestor
110516984|NCT02742480|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110516985|NCT02742480|Protease Inhibitors|protease inhibitors|mesh-ancestor
110516986|NCT02742480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110516987|NCT02742480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110516988|NCT02742480|Anticoagulants|anticoagulants|mesh-ancestor
110516989|NCT00774345|Lenalidomide|lenalidomide|mesh-list
110516990|NCT00774345|Immunologic Factors|immunologic factors|mesh-ancestor
110516991|NCT00774345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110516992|NCT00774345|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110516993|NCT00774345|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110516994|NCT00774345|Growth Substances|growth substances|mesh-ancestor
110516995|NCT00774345|Growth Inhibitors|growth inhibitors|mesh-ancestor
110516996|NCT00774345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110516997|NCT02819102|Berotralstat|berotralstat|mesh-list
110516998|NCT02819102|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110516999|NCT02819102|Protease Inhibitors|protease inhibitors|mesh-ancestor
110517000|NCT02819102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110517001|NCT02819102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110517019|NCT02815046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110915357|NCT02281370|Antifungal Agents|antifungal agents|mesh-ancestor
110517020|NCT02815046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110517021|NCT02815046|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110517022|NCT02815046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110517023|NCT02601963|Minocycline|minocycline|mesh-list
110517024|NCT02601963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110517025|NCT02601963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110517026|NCT00927979|Ropivacaine|ropivacaine|mesh-list
110517027|NCT00927979|Anesthetics, Local|anesthetics, local|mesh-ancestor
110517028|NCT00927979|Anesthetics|anesthetics|mesh-ancestor
110517029|NCT00927979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110517030|NCT00927979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110517031|NCT00927979|Sensory System Agents|sensory system agents|mesh-ancestor
110517032|NCT00927979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110517033|NCT00931957|Prednisolone|prednisolone|mesh-list
110517034|NCT00931957|Etanercept|etanercept|mesh-list
110517035|NCT00931957|Methotrexate|methotrexate|mesh-list
110517036|NCT00931957|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110517037|NCT00931957|Abortifacient Agents|abortifacient agents|mesh-ancestor
110517038|NCT00931957|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110517039|NCT00931957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110517040|NCT00931957|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110517041|NCT00931957|Antimetabolites|antimetabolites|mesh-ancestor
110517042|NCT00931957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110517043|NCT00931957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110517044|NCT00931957|Dermatologic Agents|dermatologic agents|mesh-ancestor
110517045|NCT00931957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110517046|NCT00931957|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110517047|NCT00931957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110517048|NCT00931957|Immunologic Factors|immunologic factors|mesh-ancestor
110517049|NCT00931957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110517050|NCT00931957|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110517051|NCT00931957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110517053|NCT00931957|Hormones|hormones|mesh-ancestor
110517054|NCT00931957|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110517055|NCT00931957|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110517056|NCT00931957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110517057|NCT00931957|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110517058|NCT00931957|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110178438|NCT05461807|Rivaroxaban|rivaroxaban|mesh-list
110517075|NCT02731950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110517076|NCT02731950|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110517078|NCT02731950|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110517079|NCT00773253|Botulinum Toxins|botulinum toxins|mesh-list
110517080|NCT00773253|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110517081|NCT00773253|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110517082|NCT00773253|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110517083|NCT00773253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110517084|NCT00773253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110517085|NCT00773253|Cholinergic Agents|cholinergic agents|mesh-ancestor
110517086|NCT00773253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110517087|NCT00773253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110517088|NCT00773253|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110517089|NCT00773253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110517090|NCT00928213|Heparin|heparin|mesh-list
110517091|NCT00928213|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
110517092|NCT00928213|Tinzaparin|tinzaparin|mesh-list
110517093|NCT00928213|Dalteparin|dalteparin|mesh-list
110517095|NCT00928213|Hormones|hormones|mesh-ancestor
110517096|NCT00928213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110517097|NCT00928213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110517098|NCT00928213|Anticoagulants|anticoagulants|mesh-ancestor
110517099|NCT00928213|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110517100|NCT00928213|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110517101|NCT00928213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110517102|NCT00928213|Progestins|progestins|mesh-ancestor
110517103|NCT00928291|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110517104|NCT00928291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110517105|NCT02736240|Vaccines|vaccines|mesh-list
110517106|NCT02736240|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110517107|NCT02736240|Immunologic Factors|immunologic factors|mesh-ancestor
110517108|NCT02736240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110517109|NCT02741154|Letrozole|letrozole|mesh-list
110517110|NCT02741154|Triptorelin Pamoate|triptorelin pamoate|mesh-list
110517111|NCT02741154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110517112|NCT02741154|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110517113|NCT02741154|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110517114|NCT02741154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110517115|NCT02741154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110517116|NCT02741154|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110517117|NCT02741154|Hormone Antagonists|hormone antagonists|mesh-ancestor
110517133|NCT02735928|Doxorubicin|doxorubicin|mesh-list
110517134|NCT02735928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110517135|NCT02735928|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110517136|NCT02735928|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110517137|NCT02735928|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110517138|NCT02735928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110517139|NCT02735928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110517140|NCT02731560|Rituximab|rituximab|mesh-list
110517141|NCT02731560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110517142|NCT02731560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110517143|NCT02731560|Immunologic Factors|immunologic factors|mesh-ancestor
110517144|NCT02731560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110517145|NCT02731560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110517146|NCT00773097|Poly ICLC|poly iclc|mesh-list
110517147|NCT00773097|Interferon Inducers|interferon inducers|mesh-ancestor
110517148|NCT00773097|Immunologic Factors|immunologic factors|mesh-ancestor
110517149|NCT00773097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110517150|NCT00933335|Tositumomab I-131|tositumomab i-131|mesh-list
110517151|NCT00933335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110517152|NCT02814110|Lenograstim|lenograstim|mesh-list
110517153|NCT02814110|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110517154|NCT02814110|Immunologic Factors|immunologic factors|mesh-ancestor
110517155|NCT02814110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110517156|NCT00928525|Imatinib Mesylate|imatinib mesylate|mesh-list
110517157|NCT00928525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110517158|NCT00928525|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110517159|NCT00928525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110517160|NCT00928525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110517161|NCT04264481|Lidocaine|lidocaine|mesh-list
110517162|NCT04264481|Anesthetics, Local|anesthetics, local|mesh-ancestor
110517163|NCT04264481|Anesthetics|anesthetics|mesh-ancestor
110517164|NCT04264481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110517165|NCT04264481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110517166|NCT04264481|Sensory System Agents|sensory system agents|mesh-ancestor
110517167|NCT04264481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110517168|NCT04264481|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110517169|NCT04264481|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110517170|NCT04264481|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110517171|NCT04264481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110517172|NCT04264481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110517173|NCT05303909|Gentamicins|gentamicins|mesh-list
110517174|NCT05303909|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110517175|NCT05303909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110517192|NCT04306692|Vitamin B Complex|vitamin b complex|mesh-ancestor
110517194|NCT04306692|Micronutrients|micronutrients|mesh-ancestor
110517195|NCT00772941|Varenicline|varenicline|mesh-list
110517196|NCT00772941|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110517197|NCT00772941|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110517198|NCT00772941|Cholinergic Agents|cholinergic agents|mesh-ancestor
110517199|NCT00772941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110517200|NCT00772941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110517201|NCT00772941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110517202|NCT02735694|Cycloserine|cycloserine|mesh-list
110517203|NCT02735694|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110517204|NCT02735694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110517205|NCT02735694|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110517206|NCT02735694|Antitubercular Agents|antitubercular agents|mesh-ancestor
110517207|NCT02735694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110517208|NCT02735694|Antimetabolites|antimetabolites|mesh-ancestor
110517209|NCT02735694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110517210|NCT04237532|Dexmedetomidine|dexmedetomidine|mesh-list
110517211|NCT04237532|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110517212|NCT04237532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110517213|NCT04237532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110517214|NCT04237532|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110517215|NCT04237532|Analgesics|analgesics|mesh-ancestor
110517216|NCT04237532|Sensory System Agents|sensory system agents|mesh-ancestor
110517217|NCT04237532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110517218|NCT04237532|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110517219|NCT04237532|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110517220|NCT04237532|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110517221|NCT04237532|Adrenergic Agents|adrenergic agents|mesh-ancestor
110517222|NCT04237532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110517223|NCT04237532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110517224|NCT02731092|Lactoferrin|lactoferrin|mesh-list
110517225|NCT02731092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110517226|NCT00928837|Naproxen|naproxen|mesh-list
110517227|NCT00928837|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110517228|NCT00928837|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110517229|NCT00928837|Analgesics|analgesics|mesh-ancestor
110517230|NCT00928837|Sensory System Agents|sensory system agents|mesh-ancestor
110517231|NCT00928837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110517232|NCT00928837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110517233|NCT00928837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110178494|NCT02958163|Doxorubicin|doxorubicin|mesh-list
110517247|NCT00925093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110517248|NCT00925093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110517249|NCT01562977|Rituximab|rituximab|mesh-list
110517250|NCT01562977|Gemcitabine|gemcitabine|mesh-list
110517251|NCT01562977|Oxaliplatin|oxaliplatin|mesh-list
110517252|NCT01562977|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110517253|NCT01562977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110517254|NCT01562977|Immunologic Factors|immunologic factors|mesh-ancestor
110517255|NCT01562977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110517256|NCT01562977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110517257|NCT01562977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110517258|NCT01562977|Antimetabolites|antimetabolites|mesh-ancestor
110517259|NCT01562977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110517260|NCT00607685|Fluorouracil|fluorouracil|mesh-list
110517261|NCT00607685|Hyaluronic Acid|hyaluronic acid|mesh-list
110517262|NCT00607685|Antimetabolites|antimetabolites|mesh-ancestor
110517263|NCT00607685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110517264|NCT00607685|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110517265|NCT00607685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110517266|NCT00607685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110517267|NCT00607685|Immunologic Factors|immunologic factors|mesh-ancestor
110517268|NCT00607685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110517269|NCT00607685|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110517270|NCT00607685|Viscosupplements|viscosupplements|mesh-ancestor
110517271|NCT00607685|Protective Agents|protective agents|mesh-ancestor
110517272|NCT04265027|Opicapone|opicapone|mesh-list
110517273|NCT04265027|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
110517274|NCT04265027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110517275|NCT04265027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110517276|NCT04265027|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110517277|NCT04265027|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110517278|NCT00607763|Micafungin|micafungin|mesh-list
110517279|NCT00607763|Antifungal Agents|antifungal agents|mesh-ancestor
110517280|NCT00607763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110517281|NCT00928915|Thrombin|thrombin|mesh-list
110517282|NCT00928915|Hemostatics|hemostatics|mesh-ancestor
110517283|NCT00928915|Coagulants|coagulants|mesh-ancestor
110517284|NCT02814500|Amlodipine|amlodipine|mesh-list
110517285|NCT02814500|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110517286|NCT02814500|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110517287|NCT02814500|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110517288|NCT02814500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110517289|NCT02814500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110517290|NCT02814500|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110517291|NCT02814500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110517292|NCT02814500|Vasodilator Agents|vasodilator agents|mesh-ancestor
110517293|NCT02814500|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110517294|NCT02814500|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110517295|NCT02814500|Antimetabolites|antimetabolites|mesh-ancestor
110517296|NCT02814500|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110517304|NCT00939341|Autonomic Agents|autonomic agents|mesh-ancestor
110517305|NCT00939341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110517306|NCT00939341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110517307|NCT00939341|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110517308|NCT00939341|Respiratory System Agents|respiratory system agents|mesh-ancestor
110517309|NCT00939341|Glucocorticoids|glucocorticoids|mesh-ancestor
110517311|NCT00939341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110517312|NCT00939341|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110517313|NCT00939341|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110517314|NCT00939341|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110517315|NCT00939341|Adrenergic Agents|adrenergic agents|mesh-ancestor
110517316|NCT00939341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110517317|NCT00939341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110517319|NCT00925327|Vitamin B Complex|vitamin b complex|mesh-ancestor
110517320|NCT00925327|Vitamins|vitamins|mesh-ancestor
110517321|NCT00925327|Micronutrients|micronutrients|mesh-ancestor
110517322|NCT00925327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110517323|NCT00925327|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110517324|NCT00925327|Dermatologic Agents|dermatologic agents|mesh-ancestor
110517325|NCT04237376|Tenofovir|tenofovir|mesh-list
110517326|NCT04237376|Antiviral Agents|antiviral agents|mesh-ancestor
110517327|NCT04237376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110517328|NCT04237376|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110517329|NCT04237376|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110517330|NCT04237376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110517331|NCT04237376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110517332|NCT04237376|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110517333|NCT04237376|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110517334|NCT04015687|Lamotrigine|lamotrigine|mesh-list
110517335|NCT04015687|Anticonvulsants|anticonvulsants|mesh-ancestor
110517336|NCT04015687|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110517337|NCT04015687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110517338|NCT04015687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110517339|NCT04015687|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110517340|NCT04015687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110517341|NCT04015687|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110517342|NCT04015687|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110517343|NCT04015687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110517344|NCT04015687|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110517345|NCT04015687|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110517346|NCT02739906|Insulin|insulin|mesh-list
110517347|NCT02739906|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110517348|NCT02739906|Insulin Lispro|insulin lispro|mesh-list
110517349|NCT02739906|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110517350|NCT02739906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110517351|NCT02739672|Amlodipine|amlodipine|mesh-list
110517352|NCT02739672|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110517353|NCT02739672|Telmisartan|telmisartan|mesh-list
110517354|NCT02739672|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
110517355|NCT02739672|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110517356|NCT02739672|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110517357|NCT02739672|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110517358|NCT02739672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110517359|NCT02739672|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110517360|NCT02739672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110517361|NCT02739672|Vasodilator Agents|vasodilator agents|mesh-ancestor
110517362|NCT02739672|Diuretics|diuretics|mesh-ancestor
110517363|NCT02739672|Natriuretic Agents|natriuretic agents|mesh-ancestor
110517388|NCT05382143|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110517389|NCT00933049|Amoxicillin|amoxicillin|mesh-list
110517390|NCT00933049|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
110517391|NCT00933049|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110517392|NCT00933049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110517393|NCT00933049|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110517394|NCT00933049|Antimalarials|antimalarials|mesh-ancestor
110517395|NCT00933049|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110915450|NCT00607256|Reboxetine|reboxetine|mesh-list
110517396|NCT00933049|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110517398|NCT05788393|Dexmedetomidine|dexmedetomidine|mesh-list
110517399|NCT05788393|Anesthetics, Local|anesthetics, local|mesh-ancestor
110517400|NCT05788393|Anesthetics|anesthetics|mesh-ancestor
110517401|NCT05788393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110517402|NCT05788393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110517403|NCT05788393|Sensory System Agents|sensory system agents|mesh-ancestor
110517404|NCT05788393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110517405|NCT05788393|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110517406|NCT05788393|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110517407|NCT05788393|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110517408|NCT05788393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110312074|NCT00292253|Antiviral Agents|antiviral agents|mesh-ancestor
110517409|NCT05788393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110517410|NCT05788393|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110517411|NCT05788393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110517425|NCT05788094|Piperaquine|piperaquine|mesh-list
110517426|NCT05788094|Artenimol|artenimol|mesh-list
110517427|NCT05788094|Tafenoquine|tafenoquine|mesh-list
110517428|NCT05788094|Amebicides|amebicides|mesh-ancestor
110517429|NCT05788094|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110517430|NCT05788094|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110517431|NCT05788094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110517432|NCT05788094|Antimalarials|antimalarials|mesh-ancestor
110517433|NCT05788094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110517434|NCT05787925|Vitamin E|vitamin e|mesh-list
110517435|NCT05787925|Vitamins|vitamins|mesh-ancestor
110517436|NCT05787925|Micronutrients|micronutrients|mesh-ancestor
110517437|NCT05787925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110517438|NCT05787925|Antioxidants|antioxidants|mesh-ancestor
110517439|NCT05787925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110517440|NCT05787925|Protective Agents|protective agents|mesh-ancestor
110517441|NCT05787912|Hyaluronic Acid|hyaluronic acid|mesh-list
110517442|NCT05787912|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110517443|NCT05787912|Immunologic Factors|immunologic factors|mesh-ancestor
110517444|NCT05787912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110517445|NCT05787912|Viscosupplements|viscosupplements|mesh-ancestor
110517446|NCT05787912|Protective Agents|protective agents|mesh-ancestor
110517447|NCT05787808|Vitamin D|vitamin d|mesh-list
110517448|NCT05787808|Vitamins|vitamins|mesh-ancestor
110517449|NCT05787808|Micronutrients|micronutrients|mesh-ancestor
110517450|NCT05787808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110517451|NCT05787808|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110517452|NCT05787743|Tocotrienols|tocotrienols|mesh-list
110517453|NCT05787743|Vitamin E|vitamin e|mesh-list
110517454|NCT05787743|Tocopherols|tocopherols|mesh-list
110517455|NCT05787743|Antioxidants|antioxidants|mesh-ancestor
110915467|NCT02774590|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110517456|NCT05787743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110517457|NCT05787743|Protective Agents|protective agents|mesh-ancestor
110517458|NCT05787743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110517459|NCT05787743|Vitamins|vitamins|mesh-ancestor
110517460|NCT05787743|Micronutrients|micronutrients|mesh-ancestor
110517461|NCT05787574|Dexamethasone|dexamethasone|mesh-list
110517462|NCT05787574|Fludarabine|fludarabine|mesh-list
110517463|NCT05787574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110517464|NCT05787574|Antiemetics|antiemetics|mesh-ancestor
110517465|NCT05787574|Autonomic Agents|autonomic agents|mesh-ancestor
110517466|NCT05787574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110164867|NCT00021814|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110517467|NCT05787574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110517468|NCT05787574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110517469|NCT05787574|Glucocorticoids|glucocorticoids|mesh-ancestor
110517470|NCT05787574|Hormones|hormones|mesh-ancestor
110517471|NCT05787574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110517472|NCT05787574|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110517473|NCT05787574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110517474|NCT05787535|Cyclophosphamide|cyclophosphamide|mesh-list
110517475|NCT05787535|Fludarabine|fludarabine|mesh-list
110517476|NCT05787535|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110517488|NCT05787509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110517490|NCT05787002|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110517491|NCT05787002|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110517492|NCT05787002|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110190186|NCT00398034|Hormones|hormones|mesh-ancestor
110517493|NCT05787002|Antimetabolites|antimetabolites|mesh-ancestor
110517494|NCT05787002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110517495|NCT05787002|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110517496|NCT05787002|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110517497|NCT05787002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110517498|NCT05786950|Bromides|bromides|mesh-list
110517499|NCT05786950|Albuterol|albuterol|mesh-list
110517500|NCT05786950|Ipratropium|ipratropium|mesh-list
110517501|NCT05786950|Anticonvulsants|anticonvulsants|mesh-ancestor
110517502|NCT05786950|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110517503|NCT05786950|Autonomic Agents|autonomic agents|mesh-ancestor
110517504|NCT05786950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110517505|NCT05786950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110517506|NCT05786950|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110517507|NCT05786950|Respiratory System Agents|respiratory system agents|mesh-ancestor
110517508|NCT05786950|Tocolytic Agents|tocolytic agents|mesh-ancestor
110517509|NCT05786950|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110517510|NCT05786950|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110517511|NCT05786950|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110517512|NCT05786950|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110517513|NCT05786950|Adrenergic Agents|adrenergic agents|mesh-ancestor
110517514|NCT05786950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110517515|NCT05786950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110517516|NCT05786950|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110517517|NCT05786950|Cholinergic Agents|cholinergic agents|mesh-ancestor
110517518|NCT05786885|Vitamins|vitamins|mesh-list
110517519|NCT05786885|Ascorbic Acid|ascorbic acid|mesh-list
110517521|NCT05786885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110517522|NCT05786885|Antioxidants|antioxidants|mesh-ancestor
110517523|NCT05786885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110517524|NCT05786885|Protective Agents|protective agents|mesh-ancestor
110517525|NCT05786859|Rifaximin|rifaximin|mesh-list
110517526|NCT05786859|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110517527|NCT05786859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110517528|NCT05786859|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110517529|NCT05786768|Rituximab|rituximab|mesh-list
110517530|NCT05786768|Obinutuzumab|obinutuzumab|mesh-list
110517531|NCT05786768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110517532|NCT05786768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110517533|NCT05786768|Immunologic Factors|immunologic factors|mesh-ancestor
110517534|NCT05786768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110517535|NCT05786768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110517536|NCT05786638|Immunomodulating Agents|immunomodulating agents|mesh-list
110517537|NCT05786638|Immunologic Factors|immunologic factors|mesh-ancestor
110517538|NCT05786638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110517539|NCT05785897|Sirolimus|sirolimus|mesh-list
110517540|NCT05785897|Ticagrelor|ticagrelor|mesh-list
110517565|NCT05776459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110517566|NCT05776459|Glucocorticoids|glucocorticoids|mesh-ancestor
110517567|NCT05776459|Hormones|hormones|mesh-ancestor
110517568|NCT05776459|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110517569|NCT05776459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110517570|NCT05776459|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110517571|NCT05776459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110517572|NCT05764044|Gemcitabine|gemcitabine|mesh-list
110517573|NCT05764044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110517574|NCT05764044|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110517575|NCT05764044|Antimetabolites|antimetabolites|mesh-ancestor
110517576|NCT05764044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110517577|NCT05739136|Norethindrone|norethindrone|mesh-list
110517578|NCT05739136|Norethindrone Acetate|norethindrone acetate|mesh-list
110517579|NCT05739136|Estradiol|estradiol|mesh-list
110517580|NCT05739136|Relugolix|relugolix|mesh-list
110517581|NCT05739136|Estrogens|estrogens|mesh-ancestor
110517582|NCT05739136|Hormones|hormones|mesh-ancestor
110517583|NCT05739136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110517584|NCT05739136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110517585|NCT05739136|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110517586|NCT05739136|Contraceptive Agents|contraceptive agents|mesh-ancestor
110178575|NCT05065567|Antipruritics|antipruritics|mesh-ancestor
110517604|NCT05706844|Anesthetics|anesthetics|mesh-list
110517605|NCT05706844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110517606|NCT05706844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110517607|NCT05702827|Meloxicam|meloxicam|mesh-list
110517608|NCT05702827|Bupivacaine|bupivacaine|mesh-list
110517609|NCT05702827|Anesthetics, Local|anesthetics, local|mesh-ancestor
110517610|NCT05702827|Anesthetics|anesthetics|mesh-ancestor
110915526|NCT03314181|Dexamethasone|dexamethasone|mesh-list
110517611|NCT05702827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110165019|NCT00388739|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110517614|NCT05702827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110517615|NCT05702827|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110517616|NCT05702827|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110517617|NCT05702827|Analgesics|analgesics|mesh-ancestor
110517618|NCT05702827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110517619|NCT05702827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110517620|NCT05702827|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110517621|NCT05702827|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110517622|NCT05702827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110517623|NCT05702827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110517624|NCT05685628|Charcoal|charcoal|mesh-list
110517625|NCT05685628|Antidotes|antidotes|mesh-ancestor
110517626|NCT05685628|Protective Agents|protective agents|mesh-ancestor
110517627|NCT05685628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110517628|NCT05673889|Dabigatran|dabigatran|mesh-list
110517629|NCT05673889|Antithrombins|antithrombins|mesh-ancestor
110517630|NCT05673889|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110517631|NCT05673889|Protease Inhibitors|protease inhibitors|mesh-ancestor
110517632|NCT05673889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110517633|NCT05673889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110517634|NCT05673889|Anticoagulants|anticoagulants|mesh-ancestor
110517636|NCT05654298|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110517637|NCT05654298|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110517638|NCT05654298|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110517639|NCT05654298|Serotonin Agents|serotonin agents|mesh-ancestor
110517640|NCT05654298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110517641|NCT05654298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110178599|NCT04871308|Analgesics|analgesics|mesh-ancestor
110517652|NCT05639972|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110517653|NCT05639972|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110517654|NCT05639972|Antiviral Agents|antiviral agents|mesh-ancestor
110517655|NCT05639972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110517656|NCT05618613|Onapristone|onapristone|mesh-list
110517657|NCT05618613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110517658|NCT05618613|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110517659|NCT05618613|Fertility Agents|fertility agents|mesh-ancestor
110517660|NCT05618613|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110517661|NCT05618613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110517662|NCT05618613|Hormone Antagonists|hormone antagonists|mesh-ancestor
110517663|NCT05618613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110517664|NCT05617963|Durvalumab|durvalumab|mesh-list
110517665|NCT05617963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110517666|NCT05617963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110517667|NCT05587036|Rifaximin|rifaximin|mesh-list
110517668|NCT05587036|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110517669|NCT05587036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110517670|NCT05587036|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110517676|NCT05567731|Hormones|hormones|mesh-list
110517677|NCT05567731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110517678|NCT05567731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110517679|NCT05506046|Nicotine|nicotine|mesh-list
110517680|NCT05506046|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110517681|NCT05506046|Autonomic Agents|autonomic agents|mesh-ancestor
110517682|NCT05506046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110517683|NCT05506046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110517684|NCT05506046|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110517685|NCT05506046|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110517686|NCT05506046|Cholinergic Agents|cholinergic agents|mesh-ancestor
110517687|NCT05506046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110517688|NCT05506046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110517690|NCT05503875|Methotrexate|methotrexate|mesh-list
110517691|NCT05503875|Ixekizumab|ixekizumab|mesh-list
110517692|NCT05503875|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
110517693|NCT05503875|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110517694|NCT05503875|Abortifacient Agents|abortifacient agents|mesh-ancestor
110517695|NCT05503875|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110517696|NCT05503875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110517697|NCT05503875|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110517698|NCT05503875|Antimetabolites|antimetabolites|mesh-ancestor
110517699|NCT05503875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110517700|NCT05503875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110517701|NCT05503875|Dermatologic Agents|dermatologic agents|mesh-ancestor
110517702|NCT05503875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110517703|NCT05503875|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110517704|NCT05503875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110517705|NCT05503875|Immunologic Factors|immunologic factors|mesh-ancestor
110517706|NCT05503875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110517707|NCT05503875|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110178615|NCT01806363|Natriuretic Agents|natriuretic agents|mesh-ancestor
110517731|NCT05432089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110517732|NCT05428826|Prednisone|prednisone|mesh-list
110517733|NCT05428826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110517734|NCT05428826|Glucocorticoids|glucocorticoids|mesh-ancestor
110517735|NCT05428826|Hormones|hormones|mesh-ancestor
110517736|NCT05428826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110517737|NCT05428826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110517738|NCT05428826|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110190241|NCT00024050|Cyclosporine|cyclosporine|mesh-list
110517739|NCT05428826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110517740|NCT05427513|Tranexamic Acid|tranexamic acid|mesh-list
110517741|NCT05427513|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110517742|NCT05427513|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110517743|NCT05427513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110517744|NCT05427513|Hemostatics|hemostatics|mesh-ancestor
110517745|NCT05427513|Coagulants|coagulants|mesh-ancestor
110517746|NCT05403723|Carboplatin|carboplatin|mesh-list
110517747|NCT05403723|Etoposide|etoposide|mesh-list
110517748|NCT05403723|Durvalumab|durvalumab|mesh-list
110517749|NCT05403723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110517750|NCT05403723|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110517751|NCT05403723|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110517752|NCT05403723|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110517753|NCT05403723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110517754|NCT05403723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110517755|NCT05403723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110517756|NCT05386095|Bupivacaine|bupivacaine|mesh-list
110517757|NCT05386095|Anesthetics, Local|anesthetics, local|mesh-ancestor
110517758|NCT05386095|Anesthetics|anesthetics|mesh-ancestor
110517759|NCT05386095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110517760|NCT05386095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110517761|NCT05386095|Sensory System Agents|sensory system agents|mesh-ancestor
110517762|NCT05386095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110517763|NCT05360264|Decitabine|decitabine|mesh-list
110517764|NCT05360264|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110178625|NCT02964403|Indomethacin|indomethacin|mesh-list
110517776|NCT05280457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110517778|NCT05280457|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110517779|NCT05280457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110517780|NCT05247268|Letrozole|letrozole|mesh-list
110517782|NCT05247268|Megestrol|megestrol|mesh-list
110517783|NCT05247268|Megestrol Acetate|megestrol acetate|mesh-list
110517784|NCT05247268|Medroxyprogesterone|medroxyprogesterone|mesh-list
110517785|NCT05247268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110517786|NCT05247268|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110517787|NCT05247268|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110517788|NCT05247268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110517789|NCT05247268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110517790|NCT05247268|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110517791|NCT05247268|Hormone Antagonists|hormone antagonists|mesh-ancestor
110517792|NCT05247268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110517793|NCT05247268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110517794|NCT05247268|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110517795|NCT05247268|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110517796|NCT05247268|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110517797|NCT05247268|Contraceptive Agents|contraceptive agents|mesh-ancestor
110517798|NCT05247268|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110517799|NCT05247268|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110517800|NCT05247268|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110517801|NCT05247268|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110190267|NCT00024089|Gefitinib|gefitinib|mesh-list
110517802|NCT05247268|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110517803|NCT05247268|Appetite Stimulants|appetite stimulants|mesh-ancestor
110517804|NCT05247268|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110517807|NCT05211804|Ranibizumab|ranibizumab|mesh-list
110517808|NCT05211804|Aflibercept|aflibercept|mesh-list
110517809|NCT05211804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110517810|NCT05211804|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110517811|NCT05211804|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110517812|NCT05211804|Growth Substances|growth substances|mesh-ancestor
110517813|NCT05211804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110517814|NCT05211804|Growth Inhibitors|growth inhibitors|mesh-ancestor
110517815|NCT05136560|Dexamethasone|dexamethasone|mesh-list
110517816|NCT05136560|Dexamethasone acetate|dexamethasone acetate|mesh-list
110517817|NCT05136560|BB 1101|bb 1101|mesh-list
110517818|NCT05136560|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110517819|NCT05136560|Antiemetics|antiemetics|mesh-ancestor
110517820|NCT05136560|Autonomic Agents|autonomic agents|mesh-ancestor
110517821|NCT05136560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110517822|NCT05136560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110517823|NCT05136560|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110517824|NCT05136560|Glucocorticoids|glucocorticoids|mesh-ancestor
110517825|NCT05136560|Hormones|hormones|mesh-ancestor
110517826|NCT05136560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110517827|NCT05136560|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110517828|NCT05136560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110517829|NCT05136560|Protease Inhibitors|protease inhibitors|mesh-ancestor
110517830|NCT05136560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110178643|NCT04749043|Anesthetics|anesthetics|mesh-ancestor
110517841|NCT05084586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110517842|NCT05084586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110517843|NCT05077085|Vancomycin|vancomycin|mesh-list
110517844|NCT05077085|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110517845|NCT05077085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110517846|NCT04975958|Atezolizumab|atezolizumab|mesh-list
110517847|NCT04975958|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110517848|NCT04975958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110517849|NCT04975958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110517850|NCT04975958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110517851|NCT04930744|Metformin|metformin|mesh-list
110517852|NCT04930744|Rifampin|rifampin|mesh-list
110517853|NCT04930744|Isoniazid|isoniazid|mesh-list
110517854|NCT04930744|Pyrazinamide|pyrazinamide|mesh-list
110517855|NCT04930744|Ethambutol|ethambutol|mesh-list
110517856|NCT04930744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110517857|NCT04930744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110517858|NCT04930744|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110517859|NCT04930744|Antitubercular Agents|antitubercular agents|mesh-ancestor
110517860|NCT04930744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110517861|NCT04930744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110517862|NCT04930744|Leprostatic Agents|leprostatic agents|mesh-ancestor
110517863|NCT04930744|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110517864|NCT04930744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110915568|NCT00673478|Parasympatholytics|parasympatholytics|mesh-ancestor
110517865|NCT04930744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110517866|NCT04930744|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110517867|NCT04930744|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110517868|NCT04930744|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110517869|NCT04930744|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110517870|NCT04930744|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110517871|NCT04930744|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110517872|NCT04930744|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
110517873|NCT04930744|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110517874|NCT04930744|Antimetabolites|antimetabolites|mesh-ancestor
110517875|NCT04930744|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110517877|NCT04877093|Analgesics|analgesics|mesh-ancestor
110517878|NCT04877093|Sensory System Agents|sensory system agents|mesh-ancestor
110517879|NCT04877093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110517880|NCT04877093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110517881|NCT04877093|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110517882|NCT04877093|Sympatholytics|sympatholytics|mesh-ancestor
110517883|NCT04877093|Autonomic Agents|autonomic agents|mesh-ancestor
110517884|NCT04877093|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110517885|NCT04877093|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110517886|NCT04877093|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110517887|NCT04877093|Adrenergic Agents|adrenergic agents|mesh-ancestor
110517888|NCT04877093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110915575|NCT00673478|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110517889|NCT04877093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110517890|NCT04850911|Ketamine|ketamine|mesh-list
110517891|NCT04850911|Analgesics|analgesics|mesh-ancestor
110517892|NCT04850911|Sensory System Agents|sensory system agents|mesh-ancestor
110517893|NCT04850911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110517894|NCT04850911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110517895|NCT04850911|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110517917|NCT04827056|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110517918|NCT04827056|Adrenergic Agents|adrenergic agents|mesh-ancestor
110517919|NCT04827056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110517920|NCT04827056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110517921|NCT04827056|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110517922|NCT04827056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110517923|NCT04807127|Pembrolizumab|pembrolizumab|mesh-list
110517924|NCT04807127|Durvalumab|durvalumab|mesh-list
110517925|NCT04807127|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
110517926|NCT04807127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110517927|NCT04807127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110517928|NCT04807127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110517929|NCT04807114|Pembrolizumab|pembrolizumab|mesh-list
110517930|NCT04807114|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
110517931|NCT04807114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110517932|NCT04807114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110517933|NCT04807114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110517935|NCT04759664|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110517936|NCT04759664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110517937|NCT04759664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110517938|NCT04642404|Cannabidiol|cannabidiol|mesh-list
110517939|NCT04642404|Anticonvulsants|anticonvulsants|mesh-ancestor
110517940|NCT04642352|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110517941|NCT04642352|Bupivacaine|bupivacaine|mesh-list
110517942|NCT04642352|Anesthetics, Local|anesthetics, local|mesh-ancestor
110517943|NCT04642352|Anesthetics|anesthetics|mesh-ancestor
110517944|NCT04642352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110517945|NCT04642352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110517946|NCT04642352|Sensory System Agents|sensory system agents|mesh-ancestor
110517947|NCT04642352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110178665|NCT00405262|Analgesics|analgesics|mesh-ancestor
110517975|NCT04594408|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110517976|NCT04594408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110517977|NCT04594408|Hemostatics|hemostatics|mesh-ancestor
110517978|NCT04594408|Coagulants|coagulants|mesh-ancestor
110517979|NCT04594408|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110517980|NCT04594408|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110517981|NCT04594408|Adrenergic Agents|adrenergic agents|mesh-ancestor
110517982|NCT04594408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110517983|NCT04594408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110517984|NCT04594408|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110517985|NCT04594408|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110165397|NCT00023725|Semaxinib|semaxinib|mesh-list
110517986|NCT04594408|Autonomic Agents|autonomic agents|mesh-ancestor
110517987|NCT04594408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110517988|NCT04594408|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110517989|NCT04594408|Respiratory System Agents|respiratory system agents|mesh-ancestor
110517990|NCT04594408|Mydriatics|mydriatics|mesh-ancestor
110517991|NCT04594408|Sympathomimetics|sympathomimetics|mesh-ancestor
110517992|NCT04594408|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110517993|NCT04557215|Acetylcysteine|acetylcysteine|mesh-list
110517994|NCT04557215|Rifaximin|rifaximin|mesh-list
110517995|NCT04557215|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110517996|NCT04557215|Antiviral Agents|antiviral agents|mesh-ancestor
110518010|NCT04423627|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110518011|NCT04423627|Diuretics|diuretics|mesh-ancestor
110518012|NCT04423627|Natriuretic Agents|natriuretic agents|mesh-ancestor
110518013|NCT04423627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110518014|NCT04423627|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110518015|NCT04423627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110518016|NCT04423627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110518017|NCT04423627|Analgesics|analgesics|mesh-ancestor
110518018|NCT04423627|Sensory System Agents|sensory system agents|mesh-ancestor
110518019|NCT04423627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110518020|NCT04423627|Sympatholytics|sympatholytics|mesh-ancestor
110518021|NCT04423627|Autonomic Agents|autonomic agents|mesh-ancestor
110518022|NCT04423627|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110518023|NCT04423627|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110518024|NCT04423627|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110518025|NCT04423627|Adrenergic Agents|adrenergic agents|mesh-ancestor
110518026|NCT04423627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110518027|NCT04395001|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110518028|NCT04395001|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110518029|NCT04395001|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110518030|NCT04395001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110518031|NCT04395001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110518032|NCT04395001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110518033|NCT04395001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110518034|NCT04395001|Analgesics|analgesics|mesh-ancestor
110518035|NCT04395001|Sensory System Agents|sensory system agents|mesh-ancestor
110518036|NCT04395001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110518037|NCT04395001|Antidepressive Agents|antidepressive agents|mesh-ancestor
110518038|NCT04395001|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110518039|NCT04395001|Dopamine Agents|dopamine agents|mesh-ancestor
110518040|NCT04391764|Naltrexone|naltrexone|mesh-list
110518041|NCT04391764|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110518042|NCT04391764|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110518043|NCT04391764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110048242|NCT01256593|Pregabalin|pregabalin|mesh-list
110518044|NCT04391764|Sensory System Agents|sensory system agents|mesh-ancestor
110518045|NCT04391764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110518046|NCT04339062|Sirolimus|sirolimus|mesh-list
110518047|NCT04339062|Prednisone|prednisone|mesh-list
110518048|NCT04339062|Everolimus|everolimus|mesh-list
110518049|NCT04339062|Cemiplimab|cemiplimab|mesh-list
110518050|NCT04339062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110518051|NCT04339062|Glucocorticoids|glucocorticoids|mesh-ancestor
110518052|NCT04339062|Hormones|hormones|mesh-ancestor
110518053|NCT04339062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110518054|NCT04339062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110518055|NCT04339062|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110518056|NCT04339062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110518057|NCT04339062|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110518087|NCT04292470|Adrenergic Agents|adrenergic agents|mesh-ancestor
110518088|NCT04292470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110518089|NCT04208334|Curcumin|curcumin|mesh-list
110518090|NCT04208334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110518091|NCT04208334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110518092|NCT04208334|Analgesics|analgesics|mesh-ancestor
110518093|NCT04208334|Sensory System Agents|sensory system agents|mesh-ancestor
110518094|NCT04208334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110518095|NCT04208334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110518096|NCT04208334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110518097|NCT04208334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110518098|NCT04208334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110518099|NCT04208334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110518100|NCT04208334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110518101|NCT04074967|Nivolumab|nivolumab|mesh-list
110518119|NCT04060017|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110518120|NCT04060017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110518121|NCT04060017|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110518123|NCT04060017|Protective Agents|protective agents|mesh-ancestor
110518124|NCT04060017|Vitamin B Complex|vitamin b complex|mesh-ancestor
110518125|NCT04060017|Vitamins|vitamins|mesh-ancestor
110518126|NCT04060017|Micronutrients|micronutrients|mesh-ancestor
110518127|NCT04052334|Cyclophosphamide|cyclophosphamide|mesh-list
110518128|NCT04052334|Fludarabine|fludarabine|mesh-list
110518129|NCT04052334|Interleukin-2|interleukin-2|mesh-list
110518130|NCT04052334|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110518131|NCT04052334|Immunologic Factors|immunologic factors|mesh-ancestor
110518132|NCT04052334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110518133|NCT04052334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110518134|NCT04052334|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110518135|NCT04052334|Alkylating Agents|alkylating agents|mesh-ancestor
110518136|NCT04052334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110518137|NCT04052334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110518138|NCT04052334|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110518139|NCT04052334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110518140|NCT04052334|Analgesics|analgesics|mesh-ancestor
110518141|NCT04052334|Sensory System Agents|sensory system agents|mesh-ancestor
110518142|NCT04052334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110518143|NCT04046549|Abatacept|abatacept|mesh-list
110518144|NCT04046549|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110518145|NCT04046549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110518146|NCT04046549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110518147|NCT04046549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110518148|NCT04046549|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110518149|NCT04046549|Immunologic Factors|immunologic factors|mesh-ancestor
110518150|NCT04046549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110518151|NCT04046549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110518152|NCT04027309|Midostaurin|midostaurin|mesh-list
110518153|NCT04027309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110518154|NCT04027309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110518155|NCT04027309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110518156|NCT04027309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110518158|NCT03988933|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110518159|NCT03988933|Antitubercular Agents|antitubercular agents|mesh-ancestor
110518160|NCT03988933|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110178758|NCT04341181|Immunotoxins|immunotoxins|mesh-ancestor
110518175|NCT03958565|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
110518176|NCT03958565|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110518177|NCT03958565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110518178|NCT03958565|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110518179|NCT03958565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110518180|NCT03958565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110518181|NCT03785925|Nivolumab|nivolumab|mesh-list
110518182|NCT03785925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110518183|NCT03785925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110518184|NCT03785925|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110518185|NCT03785925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110518186|NCT03752398|Ipilimumab|ipilimumab|mesh-list
110518187|NCT03752398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110518188|NCT03752398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110518189|NCT03752398|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110518190|NCT03752398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110518191|NCT03734692|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
110518192|NCT03734692|Pembrolizumab|pembrolizumab|mesh-list
110518193|NCT03734692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110518194|NCT03734692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110518195|NCT03734692|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110518196|NCT03734692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110518197|NCT03734692|Antiviral Agents|antiviral agents|mesh-ancestor
110518198|NCT03734692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110518199|NCT03700476|Gemcitabine|gemcitabine|mesh-list
110518200|NCT03700476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110518201|NCT03700476|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110518202|NCT03700476|Antimetabolites|antimetabolites|mesh-ancestor
110518203|NCT03700476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110518204|NCT03644667|Mycophenolic Acid|mycophenolic acid|mesh-list
110518205|NCT03644667|Prednisone|prednisone|mesh-list
110518206|NCT03644667|Methylprednisolone|methylprednisolone|mesh-list
110518207|NCT03644667|Tacrolimus|tacrolimus|mesh-list
110518208|NCT03644667|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
110518209|NCT03644667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110518210|NCT03644667|Glucocorticoids|glucocorticoids|mesh-ancestor
110518211|NCT03644667|Hormones|hormones|mesh-ancestor
110518212|NCT03644667|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110518213|NCT03644667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110518214|NCT03644667|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110518215|NCT03644667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110518216|NCT03644667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110518217|NCT03644667|Immunologic Factors|immunologic factors|mesh-ancestor
110178775|NCT02423876|Hydromorphone|hydromorphone|mesh-list
110518235|NCT03330106|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110518237|NCT03330106|Tubulin Modulators|tubulin modulators|mesh-ancestor
110518238|NCT03330106|Antimitotic Agents|antimitotic agents|mesh-ancestor
110518239|NCT03330106|Mitosis Modulators|mitosis modulators|mesh-ancestor
110518240|NCT03330106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110190343|NCT00024323|Cisplatin|cisplatin|mesh-list
110518241|NCT03330106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110518242|NCT03239145|Pembrolizumab|pembrolizumab|mesh-list
110518243|NCT03239145|Trebananib|trebananib|mesh-list
110518244|NCT03239145|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110518245|NCT03239145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110518246|NCT03239145|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110518247|NCT03239145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110518248|NCT03239145|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110518249|NCT03239145|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110518250|NCT03239145|Growth Substances|growth substances|mesh-ancestor
110518251|NCT03239145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110518252|NCT03239145|Growth Inhibitors|growth inhibitors|mesh-ancestor
110518253|NCT03164564|Tenofovir|tenofovir|mesh-list
110518254|NCT03164564|Emtricitabine|emtricitabine|mesh-list
110518255|NCT03164564|Cabotegravir|cabotegravir|mesh-list
110518256|NCT03164564|Antiviral Agents|antiviral agents|mesh-ancestor
110518257|NCT03164564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110518258|NCT03164564|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110518259|NCT03164564|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110518261|NCT03164564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110518262|NCT03164564|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110518263|NCT03164564|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110518264|NCT03164564|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110518265|NCT03164564|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110518266|NCT03113422|Venetoclax|venetoclax|mesh-list
110518267|NCT03113422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110518268|NCT03070886|Docetaxel|docetaxel|mesh-list
110518269|NCT03070886|Leuprolide|leuprolide|mesh-list
110518270|NCT03070886|Goserelin|goserelin|mesh-list
110518271|NCT03070886|Bicalutamide|bicalutamide|mesh-list
110518272|NCT03070886|Flutamide|flutamide|mesh-list
110518273|NCT03070886|Nilutamide|nilutamide|mesh-list
110518274|NCT03070886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110518275|NCT03070886|Tubulin Modulators|tubulin modulators|mesh-ancestor
110518276|NCT03070886|Antimitotic Agents|antimitotic agents|mesh-ancestor
110518277|NCT03070886|Mitosis Modulators|mitosis modulators|mesh-ancestor
110518278|NCT03070886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110518279|NCT03070886|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110518300|NCT02987257|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110518301|NCT02987257|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110518302|NCT02987257|Analgesics|analgesics|mesh-ancestor
110518303|NCT02987257|Sensory System Agents|sensory system agents|mesh-ancestor
110518304|NCT02987257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110518305|NCT02987257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110518306|NCT02987257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110518307|NCT02913274|Paclitaxel|paclitaxel|mesh-list
110518308|NCT02913274|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110518309|NCT02913274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110518310|NCT02913274|Tubulin Modulators|tubulin modulators|mesh-ancestor
110518311|NCT02913274|Antimitotic Agents|antimitotic agents|mesh-ancestor
110518312|NCT02913274|Mitosis Modulators|mitosis modulators|mesh-ancestor
110518313|NCT02913274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110518314|NCT02896335|Palbociclib|palbociclib|mesh-list
110518315|NCT02896335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110518316|NCT02896335|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110518317|NCT02896335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110518318|NCT02896335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110518319|NCT02821754|Durvalumab|durvalumab|mesh-list
110518320|NCT02821754|Tremelimumab|tremelimumab|mesh-list
110518321|NCT02821754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110518322|NCT02821754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110518323|NCT02781883|Decitabine|decitabine|mesh-list
110518324|NCT02781883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110518325|NCT02781883|Antimetabolites|antimetabolites|mesh-ancestor
110518326|NCT02781883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110518327|NCT02781883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110518328|NCT02781883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110518329|NCT02772003|Interleukin-12|interleukin-12|mesh-list
110518330|NCT02772003|Vaccines|vaccines|mesh-list
110518331|NCT02772003|Immunologic Factors|immunologic factors|mesh-ancestor
110518332|NCT02772003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110518333|NCT02772003|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110518334|NCT02772003|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110518335|NCT02772003|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110518336|NCT02772003|Growth Substances|growth substances|mesh-ancestor
110518354|NCT02617589|Nivolumab|nivolumab|mesh-list
110518355|NCT02617589|Temozolomide|temozolomide|mesh-list
110518356|NCT02617589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110518357|NCT02617589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110518358|NCT02617589|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110518359|NCT02617589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110518360|NCT02617589|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110518362|NCT02540707|Solifenacin Succinate|solifenacin succinate|mesh-list
110518364|NCT02540707|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110518365|NCT02540707|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110518366|NCT02540707|Cholinergic Agents|cholinergic agents|mesh-ancestor
110518367|NCT02540707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110518368|NCT02540707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110518369|NCT02540707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110518370|NCT02540707|Urological Agents|urological agents|mesh-ancestor
110518371|NCT02540707|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
110518372|NCT02540707|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110518373|NCT02540707|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110518374|NCT02540707|Adrenergic Agents|adrenergic agents|mesh-ancestor
110518375|NCT02531932|Carboplatin|carboplatin|mesh-list
110518376|NCT02531932|Everolimus|everolimus|mesh-list
110518377|NCT02531932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110518378|NCT02531932|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110518379|NCT02531932|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110518380|NCT02531932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110518381|NCT02531932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110518382|NCT02531932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110518383|NCT02531932|Immunologic Factors|immunologic factors|mesh-ancestor
110518384|NCT02531932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110518385|NCT02504346|Osimertinib|osimertinib|mesh-list
110518386|NCT02504346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110518387|NCT02504346|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110518388|NCT02504346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110190365|NCT00024440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110518389|NCT02504346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110518390|NCT02345265|Olaparib|olaparib|mesh-list
110518391|NCT02345265|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
110518392|NCT02345265|Cediranib|cediranib|mesh-list
110518393|NCT02345265|Maleic acid|maleic acid|mesh-list
110518394|NCT02345265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110518395|NCT02345265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110518396|NCT02345265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110518397|NCT02345265|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110518411|NCT02179086|Temozolomide|temozolomide|mesh-list
110518412|NCT02179086|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110518413|NCT02179086|Alkylating Agents|alkylating agents|mesh-ancestor
110518414|NCT02179086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110518415|NCT02179086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110518416|NCT01899326|Desipramine|desipramine|mesh-list
110518417|NCT01899326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110518418|NCT01899326|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110518419|NCT01899326|Antidepressive Agents|antidepressive agents|mesh-ancestor
110518420|NCT01899326|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110518421|NCT01899326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110518422|NCT01899326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110518423|NCT01899326|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110518424|NCT01899326|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110518425|NCT01899326|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110518426|NCT01899326|Adrenergic Agents|adrenergic agents|mesh-ancestor
110518427|NCT01899326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110518428|NCT01572480|Dexamethasone|dexamethasone|mesh-list
110518429|NCT01572480|Lenalidomide|lenalidomide|mesh-list
110518430|NCT01572480|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110518431|NCT01572480|Antiemetics|antiemetics|mesh-ancestor
110518432|NCT01572480|Autonomic Agents|autonomic agents|mesh-ancestor
110518433|NCT01572480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110518434|NCT01572480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110518435|NCT01572480|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110518436|NCT01572480|Glucocorticoids|glucocorticoids|mesh-ancestor
110518438|NCT01572480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110518439|NCT01572480|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110518440|NCT01572480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110518441|NCT01572480|Immunologic Factors|immunologic factors|mesh-ancestor
110518442|NCT01572480|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110518443|NCT01572480|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110518444|NCT01572480|Growth Substances|growth substances|mesh-ancestor
110518445|NCT01572480|Growth Inhibitors|growth inhibitors|mesh-ancestor
110518447|NCT01515137|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110518448|NCT01515137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110518449|NCT01515137|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110518450|NCT01515137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110518451|NCT01515137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110518452|NCT01515137|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110518453|NCT01515137|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110518454|NCT01515137|Analgesics|analgesics|mesh-ancestor
110518455|NCT01515137|Sensory System Agents|sensory system agents|mesh-ancestor
110518456|NCT01515137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110518457|NCT01515137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110518458|NCT01515137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110518473|NCT01375829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110518474|NCT01375829|Immunologic Factors|immunologic factors|mesh-ancestor
110518475|NCT01375829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110518476|NCT01375829|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110518477|NCT01375829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110518478|NCT01375829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110518479|NCT01375829|Tubulin Modulators|tubulin modulators|mesh-ancestor
110518480|NCT01375829|Antimitotic Agents|antimitotic agents|mesh-ancestor
110518481|NCT01375829|Mitosis Modulators|mitosis modulators|mesh-ancestor
110518482|NCT01126190|Docetaxel|docetaxel|mesh-list
110518483|NCT01126190|Doxorubicin|doxorubicin|mesh-list
110518484|NCT01126190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110518485|NCT01126190|Tubulin Modulators|tubulin modulators|mesh-ancestor
110518486|NCT01126190|Antimitotic Agents|antimitotic agents|mesh-ancestor
110518487|NCT01126190|Mitosis Modulators|mitosis modulators|mesh-ancestor
110518488|NCT01126190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110518489|NCT01126190|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110518490|NCT01126190|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110518491|NCT01126190|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110518492|NCT01126190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110518493|NCT00472654|Vitamin D|vitamin d|mesh-list
110518494|NCT00472654|Vitamins|vitamins|mesh-ancestor
110518495|NCT00472654|Micronutrients|micronutrients|mesh-ancestor
110518496|NCT00472654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110518497|NCT00472654|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110518498|NCT00323037|Carvedilol|carvedilol|mesh-list
110518499|NCT00323037|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110518500|NCT00323037|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110518501|NCT00323037|Adrenergic Agents|adrenergic agents|mesh-ancestor
110518502|NCT00323037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110518503|NCT00323037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110518504|NCT00323037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110518505|NCT00323037|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110518506|NCT00323037|Antioxidants|antioxidants|mesh-ancestor
110518507|NCT00323037|Protective Agents|protective agents|mesh-ancestor
110518508|NCT00323037|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110518509|NCT00323037|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110518510|NCT00323037|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110518511|NCT00323037|Vasodilator Agents|vasodilator agents|mesh-ancestor
110518512|NCT00323037|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110518513|NCT00323037|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110518514|NCT00128297|Pamidronate|pamidronate|mesh-list
110518515|NCT00128297|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110518516|NCT00128297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110518517|NCT00939185|Azithromycin|azithromycin|mesh-list
110518518|NCT00939185|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110518519|NCT00939185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110518536|NCT02730624|Tazobactam|tazobactam|mesh-list
110518537|NCT02730624|Piperacillin|piperacillin|mesh-list
110518538|NCT02730624|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
110518539|NCT02730624|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110518540|NCT02730624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110518541|NCT02730624|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110518542|NCT02730624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110518543|NCT02730624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110518544|NCT02807870|Methylphenidate|methylphenidate|mesh-list
110518545|NCT02807870|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110518546|NCT02807870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110518547|NCT02807870|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110518548|NCT02807870|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110518549|NCT02807870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110518550|NCT02807870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110518551|NCT02807870|Dopamine Agents|dopamine agents|mesh-ancestor
110518552|NCT02807870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110518553|NCT00925873|Vidarabine|vidarabine|mesh-list
110518554|NCT00925873|Fludarabine|fludarabine|mesh-list
110518555|NCT00925873|Fludarabine phosphate|fludarabine phosphate|mesh-list
110518556|NCT00925873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110518557|NCT00925873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110518558|NCT00925873|Antimetabolites|antimetabolites|mesh-ancestor
110518559|NCT00925873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110518560|NCT00925873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110518561|NCT00925873|Immunologic Factors|immunologic factors|mesh-ancestor
110518562|NCT00925873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110518563|NCT00925873|Antiviral Agents|antiviral agents|mesh-ancestor
110518564|NCT00925873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110518565|NCT00925951|Acetaminophen|acetaminophen|mesh-list
110518566|NCT00925951|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110518567|NCT00925951|Analgesics|analgesics|mesh-ancestor
110518568|NCT00925951|Sensory System Agents|sensory system agents|mesh-ancestor
110518569|NCT00925951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110518570|NCT00925951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110518571|NCT00925951|Antipyretics|antipyretics|mesh-ancestor
110518572|NCT00933205|Tipranavir|tipranavir|mesh-list
110518573|NCT00933205|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110518574|NCT00933205|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110518575|NCT00933205|Antiviral Agents|antiviral agents|mesh-ancestor
110518576|NCT00933205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110518586|NCT02739516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110518588|NCT02739516|Hormone Antagonists|hormone antagonists|mesh-ancestor
110518589|NCT02739516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110518590|NCT02739516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110518591|NCT02739516|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110518592|NCT00933283|Methadone|methadone|mesh-list
110518593|NCT00933283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110518594|NCT00933283|Narcotics|narcotics|mesh-ancestor
110518595|NCT00933283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110518596|NCT00933283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110518597|NCT00933283|Analgesics|analgesics|mesh-ancestor
110518598|NCT00933283|Sensory System Agents|sensory system agents|mesh-ancestor
110518599|NCT00933283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110518600|NCT00933283|Antitussive Agents|antitussive agents|mesh-ancestor
110518601|NCT00933283|Respiratory System Agents|respiratory system agents|mesh-ancestor
110518602|NCT02813018|Ropivacaine|ropivacaine|mesh-list
110518603|NCT02813018|Anesthetics, Local|anesthetics, local|mesh-ancestor
110518604|NCT02813018|Anesthetics|anesthetics|mesh-ancestor
110518605|NCT02813018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110518606|NCT02813018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110518607|NCT02813018|Sensory System Agents|sensory system agents|mesh-ancestor
110518608|NCT02813018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110518609|NCT04253964|Paclitaxel|paclitaxel|mesh-list
110518610|NCT04253964|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110518611|NCT04253964|Carboplatin|carboplatin|mesh-list
110518612|NCT04253964|Pembrolizumab|pembrolizumab|mesh-list
110518613|NCT04253964|Pemetrexed|pemetrexed|mesh-list
110518614|NCT04253964|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110518615|NCT04253964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110518616|NCT04253964|Tubulin Modulators|tubulin modulators|mesh-ancestor
110518617|NCT04253964|Antimitotic Agents|antimitotic agents|mesh-ancestor
110518618|NCT04253964|Mitosis Modulators|mitosis modulators|mesh-ancestor
110518619|NCT04253964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110518620|NCT04253964|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110518621|NCT04253964|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110518622|NCT04253964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110518623|NCT04253964|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110518624|NCT04253964|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110518625|NCT02810132|Metformin|metformin|mesh-list
110518626|NCT02810132|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110518627|NCT02810132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110518628|NCT02734524|Carboplatin|carboplatin|mesh-list
110518629|NCT02734524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110518630|NCT04173962|Midazolam|midazolam|mesh-list
110518631|NCT04173962|Ketamine|ketamine|mesh-list
110518632|NCT04173962|Analgesics|analgesics|mesh-ancestor
110518633|NCT04173962|Sensory System Agents|sensory system agents|mesh-ancestor
110518634|NCT04173962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110518635|NCT04173962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110518636|NCT04173962|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110518637|NCT04173962|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110518638|NCT04173962|Anesthetics, General|anesthetics, general|mesh-ancestor
110518639|NCT04173962|Anesthetics|anesthetics|mesh-ancestor
110518640|NCT04173962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110518641|NCT04173962|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110518642|NCT04173962|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110518643|NCT04173962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110518656|NCT00772005|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110518657|NCT00772005|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110518658|NCT00772005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110518659|NCT03333408|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110518660|NCT03333408|Clindamycin|clindamycin|mesh-list
110518661|NCT03333408|Clindamycin palmitate|clindamycin palmitate|mesh-list
110518662|NCT03333408|Clindamycin phosphate|clindamycin phosphate|mesh-list
110518663|NCT03333408|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
110518664|NCT03333408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110518665|NCT03333408|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110518666|NCT03333408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110518667|NCT03333408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110518668|NCT03333408|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110518669|NCT04262999|Levetiracetam|levetiracetam|mesh-list
110518670|NCT04262999|Valproic Acid|valproic acid|mesh-list
110518671|NCT04262999|Anticonvulsants|anticonvulsants|mesh-ancestor
110518672|NCT04262999|Nootropic Agents|nootropic agents|mesh-ancestor
110518673|NCT04262999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110518674|NCT04262999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110518675|NCT04262999|GABA Agents|gaba agents|mesh-ancestor
110518676|NCT04262999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110518677|NCT04262999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110518678|NCT04262999|Antimanic Agents|antimanic agents|mesh-ancestor
110518679|NCT04262999|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110518680|NCT04262999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110518681|NCT04262999|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110518682|NCT00926107|Sirolimus|sirolimus|mesh-list
110518683|NCT00926107|Temsirolimus|temsirolimus|mesh-list
110518684|NCT00926107|MTOR Inhibitors|mtor inhibitors|mesh-list
110518685|NCT00926107|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110518686|NCT00926107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110518687|NCT00926107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110518688|NCT00926107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110518689|NCT00926107|Immunologic Factors|immunologic factors|mesh-ancestor
110518690|NCT00926107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110518691|NCT00926107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110518692|NCT00926107|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110518693|NCT00926107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110518694|NCT00926107|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110518695|NCT00926107|Antifungal Agents|antifungal agents|mesh-ancestor
110518696|NCT02729766|Empagliflozin|empagliflozin|mesh-list
110518697|NCT02729766|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110518698|NCT02729766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110518699|NCT02729766|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110518700|NCT02729766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110518701|NCT02812940|Everolimus|everolimus|mesh-list
110518702|NCT02812940|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110518703|NCT02812940|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110518704|NCT02812940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110518727|NCT00608075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110518728|NCT00608075|Antimanic Agents|antimanic agents|mesh-ancestor
110518729|NCT00608075|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110518730|NCT00608075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110518731|NCT00608075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110518732|NCT02809742|Ropivacaine|ropivacaine|mesh-list
110518733|NCT02809742|Anesthetics, Local|anesthetics, local|mesh-ancestor
110518734|NCT02809742|Anesthetics|anesthetics|mesh-ancestor
110518735|NCT02809742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110518736|NCT02809742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110518737|NCT02809742|Sensory System Agents|sensory system agents|mesh-ancestor
110190490|NCT00052611|Celecoxib|celecoxib|mesh-list
110518738|NCT02809742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110518739|NCT00929851|Formoterol Fumarate|formoterol fumarate|mesh-list
110518740|NCT00929851|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110518741|NCT00929851|Autonomic Agents|autonomic agents|mesh-ancestor
110518742|NCT00929851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110518743|NCT00929851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110518744|NCT00929851|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110518745|NCT00929851|Respiratory System Agents|respiratory system agents|mesh-ancestor
110518746|NCT00929851|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110518747|NCT00929851|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110518748|NCT00929851|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110518749|NCT00929851|Adrenergic Agents|adrenergic agents|mesh-ancestor
110518750|NCT00929851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110518751|NCT00929851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110518752|NCT02729376|3-hydroxy-17-(1H-benzimidazole-1-yl)androsta-5,16-diene|3-hydroxy-17-(1h-benzimidazole-1-yl)androsta-5,16-diene|mesh-list
110518753|NCT02729376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110518777|NCT00926341|Telmisartan|telmisartan|mesh-list
110518778|NCT00926341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110518779|NCT00926341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110518780|NCT00926341|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110518781|NCT00926341|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110518782|NCT00926341|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110518783|NCT00926341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110518785|NCT00926419|Immunologic Factors|immunologic factors|mesh-ancestor
110518786|NCT00926419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110518787|NCT00608231|Dexmedetomidine|dexmedetomidine|mesh-list
110518788|NCT00608231|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110518789|NCT00608231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110518790|NCT00608231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110518791|NCT00608231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110518792|NCT00608231|Analgesics|analgesics|mesh-ancestor
110518793|NCT00608231|Sensory System Agents|sensory system agents|mesh-ancestor
110518794|NCT00608231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110518795|NCT00608231|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110518796|NCT00608231|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110518797|NCT00608231|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110518798|NCT00608231|Adrenergic Agents|adrenergic agents|mesh-ancestor
110518799|NCT00608231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110518800|NCT00608231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110166235|NCT00027391|Androgens|androgens|mesh-ancestor
110518801|NCT02739204|Celecoxib|celecoxib|mesh-list
110518802|NCT02739204|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110518803|NCT02739204|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110518823|NCT00927485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110518824|NCT00927485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110518825|NCT00927485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110518827|NCT00926653|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110518828|NCT00926653|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110518829|NCT00926653|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110518830|NCT00926653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110518831|NCT00926653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110518832|NCT00926653|Serotonin Agents|serotonin agents|mesh-ancestor
110518833|NCT00926653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110518834|NCT02733822|Naloxone|naloxone|mesh-list
110190511|NCT00052689|Bortezomib|bortezomib|mesh-list
110518835|NCT02733822|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110518836|NCT02733822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110518837|NCT02733822|Sensory System Agents|sensory system agents|mesh-ancestor
110518838|NCT02733822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110518839|NCT00930241|Tacrolimus|tacrolimus|mesh-list
110518840|NCT00930241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110518841|NCT00930241|Immunologic Factors|immunologic factors|mesh-ancestor
110518842|NCT00930241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110518843|NCT00930241|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110518844|NCT00930241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110518845|NCT00930241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110518846|NCT04260269|Trifluridine|trifluridine|mesh-list
110518847|NCT04260269|Fluorouracil|fluorouracil|mesh-list
110518848|NCT04260269|Capecitabine|capecitabine|mesh-list
110518849|NCT04260269|Tegafur|tegafur|mesh-list
110518850|NCT04260269|Antimetabolites|antimetabolites|mesh-ancestor
110518851|NCT04260269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110518852|NCT04260269|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110518853|NCT04260269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110518854|NCT04260269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110518855|NCT04260269|Immunologic Factors|immunologic factors|mesh-ancestor
110518856|NCT04260269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110518857|NCT04260269|Antiviral Agents|antiviral agents|mesh-ancestor
110518877|NCT00926809|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
110518878|NCT00926809|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110518879|NCT00926809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110518880|NCT00926809|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110518881|NCT00926809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110518882|NCT00926809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110518883|NCT00926809|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110518884|NCT00926809|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110518885|NCT00926809|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110518886|NCT00926809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110518887|NCT02805920|Bupivacaine|bupivacaine|mesh-list
110518888|NCT02805920|Anesthetics, Local|anesthetics, local|mesh-ancestor
110518889|NCT02805920|Anesthetics|anesthetics|mesh-ancestor
110518890|NCT02805920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110518891|NCT02805920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110518892|NCT02805920|Sensory System Agents|sensory system agents|mesh-ancestor
110518893|NCT02805920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110518895|NCT04262765|Ramipril|ramipril|mesh-list
110518896|NCT04262765|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
110518897|NCT04262765|Atorvastatin|atorvastatin|mesh-list
110518898|NCT04262765|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110518899|NCT04262765|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110518900|NCT04262765|Antimetabolites|antimetabolites|mesh-ancestor
110518901|NCT04262765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110518902|NCT04262765|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110518903|NCT04262765|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110518904|NCT04262765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110518905|NCT04262765|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110518906|NCT04262765|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110518907|NCT04262765|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110518908|NCT04262765|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110518909|NCT04262765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110518910|NCT04262765|Vasodilator Agents|vasodilator agents|mesh-ancestor
110518911|NCT04262765|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110518912|NCT04262765|Protease Inhibitors|protease inhibitors|mesh-ancestor
110518913|NCT03112434|Botulinum Toxins|botulinum toxins|mesh-list
110518914|NCT03112434|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110518928|NCT02738814|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110518929|NCT02738814|Anesthetics, General|anesthetics, general|mesh-ancestor
110518930|NCT02738814|Anesthetics|anesthetics|mesh-ancestor
110518931|NCT02805608|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110518932|NCT02805608|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110518933|NCT02805608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110518935|NCT02729064|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110518936|NCT02729064|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110518937|NCT02729064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110518938|NCT00609401|Sorafenib|sorafenib|mesh-list
110518939|NCT00609401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110518940|NCT00609401|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110518941|NCT00609401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110518942|NCT00609401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110518943|NCT02805842|Tacrolimus|tacrolimus|mesh-list
110518944|NCT02805842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110518945|NCT02805842|Immunologic Factors|immunologic factors|mesh-ancestor
110518946|NCT02805842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110518947|NCT02805842|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110518948|NCT02805842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110518949|NCT02805842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110518951|NCT00926965|Antipsychotic Agents|antipsychotic agents|mesh-list
110518952|NCT00926965|Amisulpride|amisulpride|mesh-list
110518953|NCT00926965|Antiemetics|antiemetics|mesh-ancestor
110518954|NCT00926965|Autonomic Agents|autonomic agents|mesh-ancestor
110518955|NCT00926965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110518956|NCT00926965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110518957|NCT00926965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110518958|NCT00926965|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110518959|NCT00926965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110518960|NCT00926965|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110518961|NCT00926965|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110518962|NCT00926965|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110518963|NCT00926965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110518964|NCT00926965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110518965|NCT00926965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110518966|NCT00926965|Serotonin Agents|serotonin agents|mesh-ancestor
110518967|NCT00926965|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110518968|NCT00926965|Dopamine Agents|dopamine agents|mesh-ancestor
110518969|NCT00926965|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110518970|NCT00926965|Antidepressive Agents|antidepressive agents|mesh-ancestor
110518971|NCT04260113|Apatinib|apatinib|mesh-list
110518972|NCT04260113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110518973|NCT04260113|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110518974|NCT04260113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110178988|NCT02825641|Oxytocin|oxytocin|mesh-list
110518987|NCT02733510|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110518989|NCT02733510|Prednisolone acetate|prednisolone acetate|mesh-list
110518990|NCT02733510|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110518991|NCT02733510|Prednisolone phosphate|prednisolone phosphate|mesh-list
110518992|NCT02733510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110518993|NCT02733510|Antiemetics|antiemetics|mesh-ancestor
110518994|NCT02733510|Autonomic Agents|autonomic agents|mesh-ancestor
110518995|NCT02733510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110518996|NCT02733510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110518997|NCT02733510|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110518998|NCT02733510|Glucocorticoids|glucocorticoids|mesh-ancestor
110519000|NCT02733510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110519001|NCT02733510|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110519002|NCT02733510|Protective Agents|protective agents|mesh-ancestor
110519003|NCT02733510|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110519004|NCT02733510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110519005|NCT00927095|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
110519006|NCT00927095|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110519007|NCT00927095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110519008|NCT00933985|Doxorubicin|doxorubicin|mesh-list
110519009|NCT00933985|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110519010|NCT00933985|Dexrazoxane|dexrazoxane|mesh-list
110519011|NCT00933985|Vincristine|vincristine|mesh-list
110519012|NCT00933985|Razoxane|razoxane|mesh-list
110519013|NCT00933985|Obatoclax|obatoclax|mesh-list
110519014|NCT00933985|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110519015|NCT00933985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110519016|NCT00933985|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110519017|NCT00933985|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110519018|NCT00933985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110519019|NCT00933985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110519020|NCT00933985|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110519021|NCT00933985|Tubulin Modulators|tubulin modulators|mesh-ancestor
110519022|NCT00933985|Antimitotic Agents|antimitotic agents|mesh-ancestor
110519024|NCT00933985|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110519025|NCT00933985|Protective Agents|protective agents|mesh-ancestor
110519026|NCT00933985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110519027|NCT02812394|Levodopa|levodopa|mesh-list
110519028|NCT02812394|Carbidopa|carbidopa|mesh-list
110519029|NCT02812394|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
110519030|NCT02812394|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110519031|NCT02812394|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110519032|NCT02812394|Dopamine Agents|dopamine agents|mesh-ancestor
110519033|NCT02812394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110519034|NCT02812394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110519035|NCT02812394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110519036|NCT02812394|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
110519037|NCT02812394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110519054|NCT05623592|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110519055|NCT05623592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110519056|NCT05623592|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110519057|NCT05623592|Antimetabolites|antimetabolites|mesh-ancestor
110519058|NCT05623592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110519059|NCT05623592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110519060|NCT05623592|Dermatologic Agents|dermatologic agents|mesh-ancestor
110519061|NCT05623592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110519062|NCT05623592|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110519063|NCT05623592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110519064|NCT05623592|Immunologic Factors|immunologic factors|mesh-ancestor
110519065|NCT05623592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110519066|NCT05623592|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110190558|NCT00024986|Tenofovir|tenofovir|mesh-list
110519068|NCT02728518|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110519069|NCT02728518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110519070|NCT00634400|Candesartan|candesartan|mesh-list
110519071|NCT00634400|Candesartan cilexetil|candesartan cilexetil|mesh-list
110519072|NCT00634400|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110519073|NCT00634400|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110519074|NCT00634400|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110519075|NCT00634400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110519076|NCT04262375|Durvalumab|durvalumab|mesh-list
110519077|NCT04262375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110519078|NCT04262375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110519079|NCT00936793|Ritonavir|ritonavir|mesh-list
110519080|NCT00936793|Darunavir|darunavir|mesh-list
110519081|NCT00936793|Beclomethasone|beclomethasone|mesh-list
110519082|NCT00936793|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110519083|NCT00936793|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110519084|NCT00936793|Protease Inhibitors|protease inhibitors|mesh-ancestor
110519085|NCT00936793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110519086|NCT00936793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110519088|NCT00936793|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110519089|NCT00936793|Antiviral Agents|antiviral agents|mesh-ancestor
110519090|NCT00936793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110519091|NCT00936793|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110519092|NCT00936793|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110519093|NCT00936793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110519094|NCT00936793|Glucocorticoids|glucocorticoids|mesh-ancestor
110519095|NCT00936793|Hormones|hormones|mesh-ancestor
110519096|NCT00936793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110179019|NCT00391313|Chloroquine|chloroquine|mesh-list
110519110|NCT00937027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110519111|NCT00937027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110519112|NCT02738502|Ritonavir|ritonavir|mesh-list
110519113|NCT02738502|Darunavir|darunavir|mesh-list
110519114|NCT02738502|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110519115|NCT02738502|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110519116|NCT02738502|Protease Inhibitors|protease inhibitors|mesh-ancestor
110519117|NCT02738502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110519118|NCT02738502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110519119|NCT02738502|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110519120|NCT02738502|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110519121|NCT02738502|Antiviral Agents|antiviral agents|mesh-ancestor
110519122|NCT02738502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110519123|NCT02738502|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110519124|NCT02738502|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110519125|NCT04261907|Ritonavir|ritonavir|mesh-list
110519126|NCT04261907|Lopinavir|lopinavir|mesh-list
110915860|NCT02282384|Oseltamivir|oseltamivir|mesh-list
110519127|NCT04261907|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110519128|NCT04261907|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110519129|NCT04261907|Protease Inhibitors|protease inhibitors|mesh-ancestor
110519130|NCT04261907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110519131|NCT04261907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110519132|NCT04261907|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110519133|NCT04261907|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110519134|NCT04261907|Antiviral Agents|antiviral agents|mesh-ancestor
110519135|NCT04261907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110519136|NCT04261907|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110519137|NCT04261907|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110519138|NCT00930709|Botulinum Toxins|botulinum toxins|mesh-list
110519139|NCT00930709|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110519140|NCT00930709|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110519141|NCT00930709|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110519142|NCT00930709|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110519143|NCT00930709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110519144|NCT00930709|Cholinergic Agents|cholinergic agents|mesh-ancestor
110519145|NCT00930709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110519146|NCT00930709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110519147|NCT00930709|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110519148|NCT00930709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110519150|NCT02738346|Etoposide|etoposide|mesh-list
110519151|NCT02738346|Topotecan|topotecan|mesh-list
110519152|NCT02738346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110519153|NCT02738346|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110519154|NCT02738346|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110519155|NCT02738346|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110519156|NCT02738346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110519157|NCT02738346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110519176|NCT00937261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110519177|NCT00937261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110519178|NCT00937261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110519179|NCT00937261|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110519180|NCT00937261|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110519181|NCT00937261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110519182|NCT00937261|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110519183|NCT00937261|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110519184|NCT00937261|Dopamine Agents|dopamine agents|mesh-ancestor
110519185|NCT00937261|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110519186|NCT00937261|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110519187|NCT05906433|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110519189|NCT05906433|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110519190|NCT05906433|Bupivacaine|bupivacaine|mesh-list
110519191|NCT05906433|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110519192|NCT05906433|Anesthetics, Local|anesthetics, local|mesh-ancestor
110519193|NCT05906433|Anesthetics|anesthetics|mesh-ancestor
110519194|NCT05906433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110519195|NCT05906433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110519196|NCT05906433|Sensory System Agents|sensory system agents|mesh-ancestor
110519197|NCT05906433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110519198|NCT05906433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110519199|NCT05906433|Glucocorticoids|glucocorticoids|mesh-ancestor
110519200|NCT05906433|Hormones|hormones|mesh-ancestor
110519201|NCT05906433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110519202|NCT05906433|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110519203|NCT05906433|Immunologic Factors|immunologic factors|mesh-ancestor
110519204|NCT05906433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110519205|NCT05906433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110519206|NCT05906225|Anesthetics|anesthetics|mesh-list
110519207|NCT05906225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110519208|NCT05906225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110519209|NCT05906199|Aspirin|aspirin|mesh-list
110519210|NCT05906199|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110519211|NCT05906199|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110519212|NCT05906199|Analgesics|analgesics|mesh-ancestor
110519213|NCT05906199|Sensory System Agents|sensory system agents|mesh-ancestor
110519214|NCT05906199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110519227|NCT05905965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110519229|NCT05905965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110519230|NCT05905913|Meropenem|meropenem|mesh-list
110519231|NCT05905913|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110519233|NCT05905887|Paclitaxel|paclitaxel|mesh-list
110519234|NCT05905887|Apatinib|apatinib|mesh-list
110190598|NCT00025064|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110519235|NCT05905887|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110519236|NCT05905887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110519237|NCT05905887|Tubulin Modulators|tubulin modulators|mesh-ancestor
110519238|NCT05905887|Antimitotic Agents|antimitotic agents|mesh-ancestor
110519239|NCT05905887|Mitosis Modulators|mitosis modulators|mesh-ancestor
110519240|NCT05905887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110519241|NCT05905887|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110519242|NCT05905887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110519243|NCT05905757|Tramadol|tramadol|mesh-list
110519244|NCT05905757|Dexmedetomidine|dexmedetomidine|mesh-list
110519245|NCT05905757|Bupivacaine|bupivacaine|mesh-list
110519246|NCT05905757|Anesthetics, Local|anesthetics, local|mesh-ancestor
110519248|NCT05905757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110519249|NCT05905757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110519250|NCT05905757|Sensory System Agents|sensory system agents|mesh-ancestor
110519251|NCT05905757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110519252|NCT05905757|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110519253|NCT05905757|Narcotics|narcotics|mesh-ancestor
110519254|NCT05905757|Analgesics|analgesics|mesh-ancestor
110519255|NCT05905757|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110519256|NCT05905757|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110519257|NCT05905757|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110519258|NCT05905757|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110519259|NCT05905757|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110519260|NCT05905757|Adrenergic Agents|adrenergic agents|mesh-ancestor
110519261|NCT05905757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110519262|NCT05905757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110519263|NCT05905653|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110519264|NCT05905653|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110519265|NCT05905484|Moxifloxacin|moxifloxacin|mesh-list
110519266|NCT05905484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110519267|NCT05905484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110190609|NCT00025064|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110519268|NCT05905484|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110519269|NCT05905484|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110519270|NCT05905484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110519271|NCT05905484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110519272|NCT05905484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110519273|NCT05905367|Fentanyl|fentanyl|mesh-list
110519274|NCT05905367|Morphine|morphine|mesh-list
110519275|NCT05905367|Methadone|methadone|mesh-list
110519276|NCT05905367|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110519277|NCT05905367|Narcotics|narcotics|mesh-ancestor
110519278|NCT05905367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110519296|NCT05905315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110519298|NCT05905185|Tocopherols|tocopherols|mesh-list
110519299|NCT05905185|Tocotrienols|tocotrienols|mesh-list
110519300|NCT05905185|Vitamins|vitamins|mesh-ancestor
110519301|NCT05905185|Micronutrients|micronutrients|mesh-ancestor
110519302|NCT05905185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110519303|NCT05905185|Antioxidants|antioxidants|mesh-ancestor
110519304|NCT05905185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110519305|NCT05905185|Protective Agents|protective agents|mesh-ancestor
110519306|NCT05905055|Cefepime|cefepime|mesh-list
110519307|NCT05905055|Aztreonam|aztreonam|mesh-list
110519308|NCT05905055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110519309|NCT05905055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110519310|NCT05904912|Bupivacaine|bupivacaine|mesh-list
110519311|NCT05904912|Anesthetics, Local|anesthetics, local|mesh-ancestor
110519312|NCT05904912|Anesthetics|anesthetics|mesh-ancestor
110519313|NCT05904912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110519314|NCT05904912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110519315|NCT05904912|Sensory System Agents|sensory system agents|mesh-ancestor
110519316|NCT05904912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110519317|NCT05898841|Tenofovir|tenofovir|mesh-list
110519318|NCT05898841|Emtricitabine|emtricitabine|mesh-list
110519319|NCT05898841|Dolutegravir|dolutegravir|mesh-list
110519320|NCT05898841|Rilpivirine|rilpivirine|mesh-list
110519321|NCT05898841|Antiviral Agents|antiviral agents|mesh-ancestor
110519322|NCT05898841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110519323|NCT05898841|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110519324|NCT05898841|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110519325|NCT05898841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110519326|NCT05898841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110519327|NCT05898841|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110519328|NCT05898841|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110519329|NCT05898841|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110519330|NCT05898841|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110519331|NCT05893069|Oxandrolone|oxandrolone|mesh-list
110519332|NCT05893069|Androgens|androgens|mesh-ancestor
110519333|NCT05893069|Hormones|hormones|mesh-ancestor
110519334|NCT05893069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110519335|NCT05893069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110519336|NCT05893069|Anabolic Agents|anabolic agents|mesh-ancestor
110519337|NCT05881811|Probenecid|probenecid|mesh-list
110519338|NCT05881811|Cimetidine|cimetidine|mesh-list
110519339|NCT05881811|Uricosuric Agents|uricosuric agents|mesh-ancestor
110179078|NCT00001832|Fludarabine|fludarabine|mesh-list
110519353|NCT05867654|Amoxicillin|amoxicillin|mesh-list
110519354|NCT05867654|Levofloxacin|levofloxacin|mesh-list
110519355|NCT05867654|Clindamycin|clindamycin|mesh-list
110519356|NCT05867654|Clindamycin palmitate|clindamycin palmitate|mesh-list
110519357|NCT05867654|Clindamycin phosphate|clindamycin phosphate|mesh-list
110519358|NCT05867654|Clavulanic Acid|clavulanic acid|mesh-list
110519359|NCT05867654|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
110519360|NCT05867654|Ampicillin|ampicillin|mesh-list
110519361|NCT05867654|Sulbactam|sulbactam|mesh-list
110519362|NCT05867654|Sultamicillin|sultamicillin|mesh-list
110519363|NCT05867654|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110519364|NCT05867654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110519365|NCT05867654|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110519366|NCT05867654|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110519367|NCT05867654|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110519368|NCT05867654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110915981|NCT05204069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110519369|NCT05867654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110519370|NCT05867654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110519371|NCT05867654|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110519372|NCT05867654|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110519373|NCT05867654|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110519374|NCT05867654|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110519376|NCT05843565|Trace Elements|trace elements|mesh-ancestor
110519377|NCT05843565|Micronutrients|micronutrients|mesh-ancestor
110519378|NCT05843565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110519379|NCT05838703|Bromides|bromides|mesh-list
110519380|NCT05838703|Tiotropium Bromide|tiotropium bromide|mesh-list
110519381|NCT05838703|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110519382|NCT05838703|Autonomic Agents|autonomic agents|mesh-ancestor
110519383|NCT05838703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110519384|NCT05838703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110519385|NCT05838703|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110519386|NCT05838703|Respiratory System Agents|respiratory system agents|mesh-ancestor
110519387|NCT05838703|Parasympatholytics|parasympatholytics|mesh-ancestor
110519388|NCT05838703|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110519389|NCT05838703|Cholinergic Agents|cholinergic agents|mesh-ancestor
110519390|NCT05838703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110519391|NCT05838703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110519392|NCT05838703|Anticonvulsants|anticonvulsants|mesh-ancestor
110519394|NCT05825924|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110519395|NCT05825924|Autonomic Agents|autonomic agents|mesh-ancestor
110519396|NCT05825924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110519397|NCT05825924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110519398|NCT05825924|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110519399|NCT05825924|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110519400|NCT05825924|Cholinergic Agents|cholinergic agents|mesh-ancestor
110519401|NCT05825924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110179090|NCT00001832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110519413|NCT05789992|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110519414|NCT05789992|Narcotics|narcotics|mesh-ancestor
110519415|NCT05789992|Analgesics|analgesics|mesh-ancestor
110519416|NCT05789992|Sensory System Agents|sensory system agents|mesh-ancestor
110519417|NCT05789992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110519418|NCT05765266|Methylprednisolone|methylprednisolone|mesh-list
110519419|NCT05765266|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110519420|NCT05765266|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110519421|NCT05765266|Prednisolone|prednisolone|mesh-list
110519422|NCT05765266|Prednisolone acetate|prednisolone acetate|mesh-list
110519423|NCT05765266|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110190677|NCT00025142|Antidotes|antidotes|mesh-ancestor
110519424|NCT05765266|Prednisolone phosphate|prednisolone phosphate|mesh-list
110519425|NCT05765266|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110519426|NCT05765266|Antiemetics|antiemetics|mesh-ancestor
110519427|NCT05765266|Autonomic Agents|autonomic agents|mesh-ancestor
110519428|NCT05765266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110519429|NCT05765266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110519430|NCT05765266|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110519431|NCT05765266|Glucocorticoids|glucocorticoids|mesh-ancestor
110519433|NCT05765266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110519434|NCT05765266|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110519435|NCT05765266|Protective Agents|protective agents|mesh-ancestor
110519436|NCT05765266|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110519437|NCT05765266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110519438|NCT05764993|Immunoglobulins|immunoglobulins|mesh-list
110519439|NCT05764993|gamma-Globulins|gamma-globulins|mesh-list
110519440|NCT05764993|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110519441|NCT05764993|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110519442|NCT05764993|Immunologic Factors|immunologic factors|mesh-ancestor
110519443|NCT05764993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110519444|NCT05743192|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110519445|NCT05743192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110519446|NCT05727176|Futibatinib|futibatinib|mesh-list
110519447|NCT05727176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110519448|NCT05720325|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110519449|NCT05720325|Immunologic Factors|immunologic factors|mesh-ancestor
110519450|NCT05720325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110519451|NCT05701501|Pantothenic Acid|pantothenic acid|mesh-list
110519452|NCT05701501|Vitamins|vitamins|mesh-ancestor
110519453|NCT05701501|Micronutrients|micronutrients|mesh-ancestor
110519454|NCT05701501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110519455|NCT05701501|Vitamin B Complex|vitamin b complex|mesh-ancestor
110519456|NCT05700812|Levonorgestrel|levonorgestrel|mesh-list
110519457|NCT05700812|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110519458|NCT05700812|Contraceptive Agents|contraceptive agents|mesh-ancestor
110519459|NCT05700812|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110312107|NCT00304473|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110519460|NCT05700812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110519461|NCT05700812|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110519462|NCT05700812|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110519463|NCT05700812|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110519464|NCT05681273|Empagliflozin|empagliflozin|mesh-list
110519465|NCT05681273|Valsartan|valsartan|mesh-list
110519466|NCT05681273|Atorvastatin|atorvastatin|mesh-list
110179104|NCT01466127|Oxytocin|oxytocin|mesh-list
110916032|NCT01318915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110519487|NCT05549505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110519488|NCT05549505|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110519489|NCT05549505|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110519490|NCT05549505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110519491|NCT05549505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110519492|NCT05549505|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110519493|NCT05549505|Hormone Antagonists|hormone antagonists|mesh-ancestor
110519494|NCT05549505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110519495|NCT05549505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110519496|NCT05538767|Albendazole|albendazole|mesh-list
110519498|NCT05538767|Anthelmintics|anthelmintics|mesh-ancestor
110519499|NCT05538767|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110519500|NCT05538767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110519501|NCT05538767|Anticestodal Agents|anticestodal agents|mesh-ancestor
110519502|NCT05538767|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110519503|NCT05538767|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110519504|NCT05538767|Tubulin Modulators|tubulin modulators|mesh-ancestor
110519505|NCT05538767|Antimitotic Agents|antimitotic agents|mesh-ancestor
110519506|NCT05538767|Mitosis Modulators|mitosis modulators|mesh-ancestor
110519507|NCT05538767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110519508|NCT05538767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110519509|NCT05524168|Gemcitabine|gemcitabine|mesh-list
110519510|NCT05524168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110519511|NCT05524168|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110519512|NCT05524168|Antimetabolites|antimetabolites|mesh-ancestor
110519513|NCT05524168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110519514|NCT05488847|Acetaminophen|acetaminophen|mesh-list
110519515|NCT05488847|Dexamethasone|dexamethasone|mesh-list
110519516|NCT05488847|Ibuprofen|ibuprofen|mesh-list
110519517|NCT05488847|Celecoxib|celecoxib|mesh-list
110519518|NCT05488847|Ketorolac|ketorolac|mesh-list
110519519|NCT05488847|Pregabalin|pregabalin|mesh-list
110519520|NCT05488847|Epinephrine|epinephrine|mesh-list
110519521|NCT05488847|Oxycodone|oxycodone|mesh-list
110519532|NCT05488847|Hormones|hormones|mesh-ancestor
110519533|NCT05488847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110916073|NCT00402428|Ribavirin|ribavirin|mesh-list
110519534|NCT05488847|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110519535|NCT05488847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110519536|NCT05488847|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110519537|NCT05488847|Analgesics|analgesics|mesh-ancestor
110519538|NCT05488847|Sensory System Agents|sensory system agents|mesh-ancestor
110519539|NCT05488847|Antipyretics|antipyretics|mesh-ancestor
110519540|NCT05488847|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110519541|NCT05488847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110519542|NCT05488847|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110519543|NCT05488847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110519544|NCT05488847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110519545|NCT05488847|Anticonvulsants|anticonvulsants|mesh-ancestor
110519546|NCT05488847|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110519547|NCT05488847|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110519548|NCT05488847|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110519549|NCT05488847|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110519550|NCT05488847|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110519551|NCT05488847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110519552|NCT05488847|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110519553|NCT05488847|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110519554|NCT05488847|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110519555|NCT05488847|Adrenergic Agents|adrenergic agents|mesh-ancestor
110519556|NCT05488847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110519557|NCT05488847|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110519558|NCT05488847|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110519559|NCT05488847|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110519560|NCT05488847|Respiratory System Agents|respiratory system agents|mesh-ancestor
110519561|NCT05488847|Mydriatics|mydriatics|mesh-ancestor
110519562|NCT05488847|Sympathomimetics|sympathomimetics|mesh-ancestor
110519563|NCT05488847|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110519564|NCT05488847|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110519565|NCT05488847|Narcotics|narcotics|mesh-ancestor
110519566|NCT05488847|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110519567|NCT05488847|Antacids|antacids|mesh-ancestor
110519568|NCT05488847|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110519569|NCT05488847|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110519570|NCT05488847|Parasympatholytics|parasympatholytics|mesh-ancestor
110519571|NCT05488847|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110519572|NCT05464420|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110519573|NCT05464420|Immunologic Factors|immunologic factors|mesh-ancestor
110519574|NCT05464420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110519575|NCT05431582|Bevacizumab|bevacizumab|mesh-list
110519576|NCT05431582|Pembrolizumab|pembrolizumab|mesh-list
110519577|NCT05431582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110519578|NCT05431582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110519579|NCT05431582|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110519580|NCT05431582|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110519581|NCT05431582|Growth Substances|growth substances|mesh-ancestor
110519582|NCT05431582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110519583|NCT05431582|Growth Inhibitors|growth inhibitors|mesh-ancestor
110519584|NCT05431582|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110519585|NCT05431582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110519586|NCT05418556|Aspirin|aspirin|mesh-list
110519587|NCT05418556|Clopidogrel|clopidogrel|mesh-list
110519588|NCT05418556|Ticagrelor|ticagrelor|mesh-list
110519600|NCT05418556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110519601|NCT05418556|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110519602|NCT05418556|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110519604|NCT05418556|Antipyretics|antipyretics|mesh-ancestor
110519605|NCT05418556|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110519606|NCT05418556|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110519607|NCT05418556|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110519608|NCT05418556|Purinergic Agents|purinergic agents|mesh-ancestor
110519609|NCT05418556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110519610|NCT05412030|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110519611|NCT05412030|Immunologic Factors|immunologic factors|mesh-ancestor
110519612|NCT05412030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110519613|NCT05384756|Sirolimus|sirolimus|mesh-list
110519614|NCT05384756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110519615|NCT05384756|Alemtuzumab|alemtuzumab|mesh-list
110519616|NCT05384756|Antibodies|antibodies|mesh-list
110519617|NCT05384756|Immunoglobulins|immunoglobulins|mesh-list
110519618|NCT05384756|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110519619|NCT05384756|Immunologic Factors|immunologic factors|mesh-ancestor
110519620|NCT05384756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110519621|NCT05384756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110519622|NCT05384756|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110519623|NCT05384756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110519624|NCT05384756|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110519625|NCT05384756|Antifungal Agents|antifungal agents|mesh-ancestor
110519626|NCT05384756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110519627|NCT05364866|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
110519628|NCT05331027|Sevoflurane|sevoflurane|mesh-list
110519629|NCT05331027|Desflurane|desflurane|mesh-list
110519630|NCT05331027|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110519631|NCT05331027|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110519632|NCT05331027|Anesthetics, General|anesthetics, general|mesh-ancestor
110519633|NCT05331027|Anesthetics|anesthetics|mesh-ancestor
110519634|NCT05331027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110519635|NCT05331027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110519636|NCT05299242|Adalimumab|adalimumab|mesh-list
110519637|NCT05299242|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110519638|NCT05299242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110519639|NCT05299242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110519646|NCT05282706|Peppermint oil|peppermint oil|mesh-list
110519647|NCT05282706|Antiemetics|antiemetics|mesh-ancestor
110519648|NCT05282706|Autonomic Agents|autonomic agents|mesh-ancestor
110519649|NCT05282706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110519650|NCT05282706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110916202|NCT00151892|Mesalamine|mesalamine|mesh-list
110519652|NCT05282706|Parasympatholytics|parasympatholytics|mesh-ancestor
110519663|NCT05177848|Autonomic Agents|autonomic agents|mesh-ancestor
110519664|NCT05177848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110519665|NCT05177848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110519666|NCT05177848|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110519667|NCT05177848|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110519668|NCT05177848|Cholinergic Agents|cholinergic agents|mesh-ancestor
110519669|NCT05177848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110519670|NCT05177848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110519671|NCT05169008|Vaccines|vaccines|mesh-list
110519672|NCT05169008|Immunologic Factors|immunologic factors|mesh-ancestor
110519673|NCT05169008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110519674|NCT05067933|Vaccines|vaccines|mesh-list
110519675|NCT05067933|Immunologic Factors|immunologic factors|mesh-ancestor
110519676|NCT05067933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110519677|NCT05059860|Insulin|insulin|mesh-list
110519678|NCT05059860|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110519679|NCT05059860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110519680|NCT05022524|Acetic Acid|acetic acid|mesh-list
110519681|NCT05022524|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110519682|NCT05022524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110519683|NCT04852068|Vaccines|vaccines|mesh-list
110519684|NCT04852068|Immunologic Factors|immunologic factors|mesh-ancestor
110519685|NCT04852068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110519686|NCT04806100|Carbon Fiber|carbon fiber|mesh-list
110519687|NCT04806100|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110519688|NCT04806100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110519689|NCT04761822|Vaccines|vaccines|mesh-list
110519690|NCT04761822|Immunologic Factors|immunologic factors|mesh-ancestor
110519691|NCT04761822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110519692|NCT04716725|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
110519693|NCT04716725|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110519694|NCT04716725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110519695|NCT04707235|Hydroxyurea|hydroxyurea|mesh-list
110519696|NCT04707235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110519697|NCT04707235|Antisickling Agents|antisickling agents|mesh-ancestor
110633832|NCT00612534|Dsuvia|dsuvia|mesh-list
110519698|NCT04707235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110519699|NCT04707235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110519700|NCT04707235|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110519701|NCT04668157|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
110519702|NCT04668157|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110519703|NCT04668157|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110051963|NCT01477268|Sertraline|sertraline|mesh-list
110519704|NCT04668157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110519706|NCT04639466|Immunologic Factors|immunologic factors|mesh-ancestor
110519707|NCT04639466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110519708|NCT04548999|Methylprednisolone|methylprednisolone|mesh-list
110519709|NCT04548999|Ocrelizumab|ocrelizumab|mesh-list
110519710|NCT04548999|Histamine Antagonists|histamine antagonists|mesh-list
110519711|NCT04548999|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
110519712|NCT04548999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110519713|NCT04548999|Antiemetics|antiemetics|mesh-ancestor
110519714|NCT04548999|Autonomic Agents|autonomic agents|mesh-ancestor
110519715|NCT04548999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110519716|NCT04548999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110519717|NCT04548999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110519718|NCT04548999|Glucocorticoids|glucocorticoids|mesh-ancestor
110519720|NCT04548999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110519732|NCT04544436|Antiemetics|antiemetics|mesh-ancestor
110519733|NCT04544436|Autonomic Agents|autonomic agents|mesh-ancestor
110519734|NCT04544436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110519735|NCT04544436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110519736|NCT04544436|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110519737|NCT04544436|Glucocorticoids|glucocorticoids|mesh-ancestor
110519739|NCT04544436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110519740|NCT04544436|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110519741|NCT04544436|Protective Agents|protective agents|mesh-ancestor
110519742|NCT04544436|Immunologic Factors|immunologic factors|mesh-ancestor
110519743|NCT04544436|Histamine Agents|histamine agents|mesh-ancestor
110519744|NCT04544436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110519745|NCT04544436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110519746|NCT04537156|Vaccines|vaccines|mesh-list
110519747|NCT04537156|Immunologic Factors|immunologic factors|mesh-ancestor
110519748|NCT04537156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110519749|NCT04465318|Nicotine|nicotine|mesh-list
110519750|NCT04465318|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110519751|NCT04465318|Autonomic Agents|autonomic agents|mesh-ancestor
110519752|NCT04465318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110519753|NCT04465318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110519754|NCT04465318|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110519755|NCT04465318|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110519756|NCT04465318|Cholinergic Agents|cholinergic agents|mesh-ancestor
110519757|NCT04465318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110519758|NCT04465318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110519759|NCT04462523|Prednisolone|prednisolone|mesh-list
110519760|NCT04462523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110519762|NCT04462523|Hormones|hormones|mesh-ancestor
110519763|NCT04462523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110190868|NCT00025688|Paclitaxel|paclitaxel|mesh-list
110519764|NCT04462523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110519765|NCT04462523|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110519766|NCT04462523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110519767|NCT04437108|Solifenacin Succinate|solifenacin succinate|mesh-list
110519768|NCT04437108|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110519769|NCT04437108|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110519770|NCT04437108|Cholinergic Agents|cholinergic agents|mesh-ancestor
110519771|NCT04437108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110519772|NCT04437108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110519773|NCT04437108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110519774|NCT04437108|Urological Agents|urological agents|mesh-ancestor
110519775|NCT04395079|Durvalumab|durvalumab|mesh-list
110519776|NCT04395079|Ipilimumab|ipilimumab|mesh-list
110519777|NCT04395079|Tremelimumab|tremelimumab|mesh-list
110519778|NCT04395079|Immunoglobulins|immunoglobulins|mesh-list
110519779|NCT04395079|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110519780|NCT04395079|Immunoglobulin G|immunoglobulin g|mesh-list
110519781|NCT04395079|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110167246|NCT00030589|Bexarotene|bexarotene|mesh-list
110519782|NCT04395079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110519784|NCT04395079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110519785|NCT04395079|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110206083|NCT00056693|Sunitinib|sunitinib|mesh-list
110519797|NCT04381897|Respiratory System Agents|respiratory system agents|mesh-ancestor
110519799|NCT04381897|Antioxidants|antioxidants|mesh-ancestor
110519800|NCT04381897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110519801|NCT04381897|Protective Agents|protective agents|mesh-ancestor
110519802|NCT04381897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110519803|NCT04381897|Antidotes|antidotes|mesh-ancestor
110519804|NCT04356690|Etoposide|etoposide|mesh-list
110519805|NCT04356690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110519806|NCT04356690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110519807|NCT04356690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110519808|NCT04356690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110519809|NCT04356690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110519810|NCT04356690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110519811|NCT04352205|Thalidomide|thalidomide|mesh-list
110519812|NCT04352205|Dexamethasone|dexamethasone|mesh-list
110519813|NCT04352205|Dexamethasone acetate|dexamethasone acetate|mesh-list
110519814|NCT04352205|Lenalidomide|lenalidomide|mesh-list
110519815|NCT04352205|Bortezomib|bortezomib|mesh-list
110519816|NCT04352205|Daratumumab|daratumumab|mesh-list
110519817|NCT04352205|Ichthammol|ichthammol|mesh-list
110519818|NCT04352205|BB 1101|bb 1101|mesh-list
110519819|NCT04352205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110519820|NCT04352205|Antiemetics|antiemetics|mesh-ancestor
110519821|NCT04352205|Autonomic Agents|autonomic agents|mesh-ancestor
110519822|NCT04352205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110519823|NCT04352205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110519824|NCT04352205|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110519825|NCT04352205|Glucocorticoids|glucocorticoids|mesh-ancestor
110519826|NCT04352205|Hormones|hormones|mesh-ancestor
110519827|NCT04352205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110519828|NCT04352205|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110519829|NCT04352205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110519830|NCT04352205|Protease Inhibitors|protease inhibitors|mesh-ancestor
110519831|NCT04352205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110519832|NCT04352205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110519833|NCT04352205|Immunologic Factors|immunologic factors|mesh-ancestor
110519834|NCT04352205|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110519835|NCT04352205|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110519838|NCT04352205|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110519839|NCT04352205|Leprostatic Agents|leprostatic agents|mesh-ancestor
110519840|NCT04352205|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110519841|NCT04352205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110519842|NCT04352205|Dermatologic Agents|dermatologic agents|mesh-ancestor
110519843|NCT04339140|Zafirlukast|zafirlukast|mesh-list
110519844|NCT04339140|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110519845|NCT04339140|Respiratory System Agents|respiratory system agents|mesh-ancestor
110519846|NCT04339140|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110519847|NCT04339140|Hormone Antagonists|hormone antagonists|mesh-ancestor
110519848|NCT04339140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110519849|NCT04339140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110519850|NCT04337827|Rituximab|rituximab|mesh-list
110519851|NCT04337827|Acalabrutinib|acalabrutinib|mesh-list
110519852|NCT04337827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110519863|NCT04251117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110519864|NCT04251117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110519865|NCT04251117|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110519866|NCT04251117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110916351|NCT02095782|Carboplatin|carboplatin|mesh-list
110519869|NCT04249622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110519870|NCT04249622|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110519872|NCT04246047|Bortezomib|bortezomib|mesh-list
110519873|NCT04246047|Daratumumab|daratumumab|mesh-list
110519874|NCT04246047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110519875|NCT04246047|Antiemetics|antiemetics|mesh-ancestor
110519876|NCT04246047|Autonomic Agents|autonomic agents|mesh-ancestor
110519877|NCT04246047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110519878|NCT04246047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110519879|NCT04246047|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110519880|NCT04246047|Glucocorticoids|glucocorticoids|mesh-ancestor
110519881|NCT04246047|Hormones|hormones|mesh-ancestor
110519882|NCT04246047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110519883|NCT04246047|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110519884|NCT04246047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110519885|NCT04221529|Atezolizumab|atezolizumab|mesh-list
110519886|NCT04221529|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110519887|NCT04221529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110519888|NCT04221529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110519889|NCT04221529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110519890|NCT04219774|Aspirin|aspirin|mesh-list
110519891|NCT04219774|Clopidogrel|clopidogrel|mesh-list
110519892|NCT04219774|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110519893|NCT04219774|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110519894|NCT04219774|Analgesics|analgesics|mesh-ancestor
110519895|NCT04219774|Sensory System Agents|sensory system agents|mesh-ancestor
110519896|NCT04219774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110519897|NCT04219774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110519898|NCT04219774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110519899|NCT04219774|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110519900|NCT04219774|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110519901|NCT04219774|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110190897|NCT00053820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110519902|NCT04219774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110519903|NCT04219774|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110519904|NCT04219774|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110519905|NCT04219774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110519906|NCT04219774|Antipyretics|antipyretics|mesh-ancestor
110519907|NCT04219774|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110519908|NCT04219774|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110519909|NCT04219774|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110519910|NCT04219774|Purinergic Agents|purinergic agents|mesh-ancestor
110519911|NCT04219774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110519912|NCT04195139|Nivolumab|nivolumab|mesh-list
110519913|NCT04195139|Temozolomide|temozolomide|mesh-list
110519914|NCT04195139|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110519915|NCT04195139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110519916|NCT04195139|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110519940|NCT04136756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110519941|NCT04136756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110519942|NCT04123366|Pembrolizumab|pembrolizumab|mesh-list
110519943|NCT04123366|Olaparib|olaparib|mesh-list
110519944|NCT04123366|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110519945|NCT04123366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110519946|NCT04123366|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110519947|NCT04123366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110519948|NCT04123366|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110519949|NCT04123366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110519950|NCT04056624|Carotenoids|carotenoids|mesh-list
110519951|NCT04056624|Antioxidants|antioxidants|mesh-ancestor
110519952|NCT04056624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110519953|NCT04056624|Protective Agents|protective agents|mesh-ancestor
110916363|NCT02094378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110519954|NCT04056624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110519955|NCT04052880|Dexamethasone|dexamethasone|mesh-list
110519956|NCT04052880|Lenalidomide|lenalidomide|mesh-list
110519957|NCT04052880|Bortezomib|bortezomib|mesh-list
110519958|NCT04052880|Daratumumab|daratumumab|mesh-list
110519959|NCT04052880|Ixazomib|ixazomib|mesh-list
110519960|NCT04052880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110519961|NCT04052880|Antiemetics|antiemetics|mesh-ancestor
110519962|NCT04052880|Autonomic Agents|autonomic agents|mesh-ancestor
110519963|NCT04052880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110179195|NCT00009776|Tubulin Modulators|tubulin modulators|mesh-ancestor
110519974|NCT04052880|Growth Substances|growth substances|mesh-ancestor
110519975|NCT04052880|Growth Inhibitors|growth inhibitors|mesh-ancestor
110519976|NCT04052880|Protease Inhibitors|protease inhibitors|mesh-ancestor
110519977|NCT04052880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110519978|NCT04052880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110519979|NCT04007276|Brimonidine Tartrate|brimonidine tartrate|mesh-list
110519981|NCT04007276|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110519982|NCT04007276|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110519983|NCT04007276|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110519984|NCT04007276|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110519985|NCT04007276|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110519986|NCT04007276|Adrenergic Agents|adrenergic agents|mesh-ancestor
110519987|NCT04007276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110519988|NCT04007276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110190919|NCT00053937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110519989|NCT04007276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110519991|NCT03969446|Decitabine|decitabine|mesh-list
110519992|NCT03969446|Venetoclax|venetoclax|mesh-list
110519993|NCT03969446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110519994|NCT03969446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110519995|NCT03969446|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110519996|NCT03969446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110519997|NCT03969446|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110519998|NCT03969446|Antimetabolites|antimetabolites|mesh-ancestor
110519999|NCT03969446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110520000|NCT03927690|Ranibizumab|ranibizumab|mesh-list
110520001|NCT03927690|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110520002|NCT03927690|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110520003|NCT03927690|Growth Substances|growth substances|mesh-ancestor
110520004|NCT03927690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110520005|NCT03927690|Growth Inhibitors|growth inhibitors|mesh-ancestor
110520006|NCT03927690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110520007|NCT03900715|Luspatercept|luspatercept|mesh-list
110520008|NCT03900715|Hematinics|hematinics|mesh-ancestor
110520009|NCT03870763|Dimethyl Fumarate|dimethyl fumarate|mesh-list
110520010|NCT03870763|Dermatologic Agents|dermatologic agents|mesh-ancestor
110520011|NCT03870763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110520012|NCT03870763|Immunologic Factors|immunologic factors|mesh-ancestor
110520013|NCT03870763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110520014|NCT03858231|Acetaminophen|acetaminophen|mesh-list
110520015|NCT03858231|Ibuprofen|ibuprofen|mesh-list
110520016|NCT03858231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110520017|NCT03858231|Analgesics|analgesics|mesh-ancestor
110520018|NCT03858231|Sensory System Agents|sensory system agents|mesh-ancestor
110520019|NCT03858231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110520020|NCT03858231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110520021|NCT03858231|Antipyretics|antipyretics|mesh-ancestor
110520022|NCT03858231|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110520023|NCT03858231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110520024|NCT03858231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110520025|NCT03858231|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110520026|NCT03858231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110520027|NCT03858231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110520028|NCT03853954|Methoxyflurane|methoxyflurane|mesh-list
110520056|NCT03728556|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110520057|NCT03728556|Immunologic Factors|immunologic factors|mesh-ancestor
110520058|NCT03728556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110520060|NCT03634228|Venetoclax|venetoclax|mesh-list
110916375|NCT02285738|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110520061|NCT03634228|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110520063|NCT03634228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110520064|NCT03634228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110520065|NCT03634228|Antiviral Agents|antiviral agents|mesh-ancestor
110520066|NCT03634228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110520067|NCT03634228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110520068|NCT03634228|Immunologic Factors|immunologic factors|mesh-ancestor
110520069|NCT03634228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110520070|NCT03612973|Insulin|insulin|mesh-list
110520071|NCT03612973|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110520072|NCT03612973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110520073|NCT03603223|Pembrolizumab|pembrolizumab|mesh-list
110520074|NCT03603223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110520075|NCT03603223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110520076|NCT03603223|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110520077|NCT03603223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110520078|NCT03593590|Ocrelizumab|ocrelizumab|mesh-list
110520079|NCT03593590|Immunologic Factors|immunologic factors|mesh-ancestor
110520080|NCT03593590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110520081|NCT03587142|Buspirone|buspirone|mesh-list
110520082|NCT03587142|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110520083|NCT03587142|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110520084|NCT03587142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110520085|NCT03587142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110520086|NCT03587142|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110520087|NCT03587142|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110520088|NCT03587142|Serotonin Agents|serotonin agents|mesh-ancestor
110520089|NCT03587142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110520090|NCT03587142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110520091|NCT03535688|Cycloserine|cycloserine|mesh-list
110520092|NCT03535688|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110520093|NCT03535688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110520094|NCT03535688|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110520095|NCT03535688|Antitubercular Agents|antitubercular agents|mesh-ancestor
110520096|NCT03535688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110520097|NCT03535688|Antimetabolites|antimetabolites|mesh-ancestor
110520098|NCT03535688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110520099|NCT03532139|Enoxaparin|enoxaparin|mesh-list
110179234|NCT00009854|Carmustine|carmustine|mesh-list
110520107|NCT03532139|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110520108|NCT03532139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110520109|NCT03532139|Anticoagulants|anticoagulants|mesh-ancestor
110520110|NCT03532139|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110520111|NCT03532139|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110520112|NCT03509584|Nivolumab|nivolumab|mesh-list
110520113|NCT03509584|Ipilimumab|ipilimumab|mesh-list
110520114|NCT03509584|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110520115|NCT03509584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110520116|NCT03509584|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110520117|NCT03509584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110520118|NCT03493854|Paclitaxel|paclitaxel|mesh-list
110520119|NCT03493854|Docetaxel|docetaxel|mesh-list
110520120|NCT03493854|Cyclophosphamide|cyclophosphamide|mesh-list
110520121|NCT03493854|Doxorubicin|doxorubicin|mesh-list
110520122|NCT03493854|Trastuzumab|trastuzumab|mesh-list
110520123|NCT03493854|Pertuzumab|pertuzumab|mesh-list
110520124|NCT03493854|Hormones|hormones|mesh-list
110520125|NCT03493854|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110520126|NCT03493854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110520127|NCT03493854|Tubulin Modulators|tubulin modulators|mesh-ancestor
110520128|NCT03493854|Antimitotic Agents|antimitotic agents|mesh-ancestor
110520129|NCT03493854|Mitosis Modulators|mitosis modulators|mesh-ancestor
110520130|NCT03493854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110520131|NCT03493854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110520132|NCT03493854|Immunologic Factors|immunologic factors|mesh-ancestor
110520133|NCT03493854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110520134|NCT03493854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110520135|NCT03493854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110520136|NCT03493854|Alkylating Agents|alkylating agents|mesh-ancestor
110520137|NCT03493854|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110520138|NCT03493854|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110520139|NCT03493854|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110520140|NCT03493854|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110520141|NCT03493854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110520142|NCT03493854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110190960|NCT00054054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110520143|NCT03493854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110520144|NCT03384277|Cyclophosphamide|cyclophosphamide|mesh-list
110520145|NCT03384277|Rituximab|rituximab|mesh-list
110520146|NCT03384277|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110520147|NCT03384277|Immunologic Factors|immunologic factors|mesh-ancestor
110520148|NCT03384277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110520149|NCT03384277|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110520150|NCT03384277|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110520151|NCT03384277|Alkylating Agents|alkylating agents|mesh-ancestor
110520152|NCT03384277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110520153|NCT03384277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110520154|NCT03384277|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110167595|NCT00032305|Visilizumab|visilizumab|mesh-list
110520155|NCT03384277|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110520157|NCT03370367|Isotretinoin|isotretinoin|mesh-list
110520158|NCT03370367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110520159|NCT03370367|Keratolytic Agents|keratolytic agents|mesh-ancestor
110520160|NCT03370367|Dermatologic Agents|dermatologic agents|mesh-ancestor
110520161|NCT03341689|Psilocybin|psilocybin|mesh-list
110520162|NCT03341689|Hallucinogens|hallucinogens|mesh-ancestor
110231571|NCT00326131|Taxane|taxane|mesh-list
110520163|NCT03341689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110520164|NCT03341689|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110520165|NCT03324425|Simvastatin|simvastatin|mesh-list
110520166|NCT03324425|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110520167|NCT03324425|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110520168|NCT03324425|Antimetabolites|antimetabolites|mesh-ancestor
110520179|NCT03317457|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110520180|NCT03317457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110520181|NCT03317457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110520182|NCT03317457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110520183|NCT03267836|Avelumab|avelumab|mesh-list
110520184|NCT03267836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110520185|NCT03267836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110520186|NCT03197506|Pembrolizumab|pembrolizumab|mesh-list
110520187|NCT03197506|Temozolomide|temozolomide|mesh-list
110520188|NCT03197506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110520189|NCT03197506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110520190|NCT03197506|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110520191|NCT03197506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110520192|NCT03197506|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110520193|NCT03197506|Alkylating Agents|alkylating agents|mesh-ancestor
110520194|NCT03188705|Aspirin|aspirin|mesh-list
110520195|NCT03188705|Clopidogrel|clopidogrel|mesh-list
110520196|NCT03188705|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110520197|NCT03188705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110520198|NCT03188705|Analgesics|analgesics|mesh-ancestor
110520199|NCT03188705|Sensory System Agents|sensory system agents|mesh-ancestor
110520200|NCT03188705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110520201|NCT03188705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110520202|NCT03188705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110520203|NCT03188705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110520204|NCT03188705|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110520205|NCT03188705|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110520206|NCT03188705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110190971|NCT00026078|Alkylating Agents|alkylating agents|mesh-ancestor
110520207|NCT03188705|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110520208|NCT03188705|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110520209|NCT03188705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110520210|NCT03188705|Antipyretics|antipyretics|mesh-ancestor
110520211|NCT03188705|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110520212|NCT03188705|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110520213|NCT03188705|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110520214|NCT03188705|Purinergic Agents|purinergic agents|mesh-ancestor
110520215|NCT03188705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110520216|NCT03113487|Pembrolizumab|pembrolizumab|mesh-list
110520217|NCT03113487|Vaccines|vaccines|mesh-list
110520218|NCT03113487|Immunologic Factors|immunologic factors|mesh-ancestor
110520219|NCT03113487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110520220|NCT03113487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110520221|NCT03113487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110520222|NCT03113487|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110520223|NCT03113487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110520224|NCT03032484|Bevacizumab|bevacizumab|mesh-list
110520225|NCT03032484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110520226|NCT03032484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110520227|NCT03032484|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110520228|NCT03032484|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110520229|NCT03032484|Growth Substances|growth substances|mesh-ancestor
110520230|NCT03032484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110520231|NCT03032484|Growth Inhibitors|growth inhibitors|mesh-ancestor
110520251|NCT02996825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110520252|NCT02996825|Immunoconjugates|immunoconjugates|mesh-ancestor
110520253|NCT02996825|Immunologic Factors|immunologic factors|mesh-ancestor
110520254|NCT02996825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110520255|NCT02996825|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110520256|NCT02996825|Tubulin Modulators|tubulin modulators|mesh-ancestor
110520257|NCT02996825|Antimitotic Agents|antimitotic agents|mesh-ancestor
110520258|NCT02996825|Mitosis Modulators|mitosis modulators|mesh-ancestor
110520260|NCT02981173|Hallucinogens|hallucinogens|mesh-ancestor
110520261|NCT02981173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110520262|NCT02981173|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110520263|NCT02975349|Dimethyl Fumarate|dimethyl fumarate|mesh-list
110520264|NCT02975349|Dermatologic Agents|dermatologic agents|mesh-ancestor
110520265|NCT02975349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110520266|NCT02975349|Immunologic Factors|immunologic factors|mesh-ancestor
110520267|NCT02975349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110520268|NCT02955394|Fulvestrant|fulvestrant|mesh-list
110520269|NCT02955394|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110520270|NCT02955394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110520271|NCT02955394|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110520272|NCT02955394|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110520273|NCT02955394|Hormone Antagonists|hormone antagonists|mesh-ancestor
110520274|NCT02955394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110520275|NCT02955394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110520276|NCT02768532|Vedolizumab|vedolizumab|mesh-list
110520277|NCT02768532|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110520278|NCT02710851|Vaccines|vaccines|mesh-list
110520279|NCT02710851|Immunologic Factors|immunologic factors|mesh-ancestor
110520280|NCT02710851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110520281|NCT02675829|Trastuzumab|trastuzumab|mesh-list
110520282|NCT02675829|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
110520283|NCT02675829|Maytansine|maytansine|mesh-list
110520284|NCT02675829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110520285|NCT02675829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110520286|NCT02675829|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110520287|NCT02675829|Tubulin Modulators|tubulin modulators|mesh-ancestor
110520288|NCT02675829|Antimitotic Agents|antimitotic agents|mesh-ancestor
110520289|NCT02675829|Mitosis Modulators|mitosis modulators|mesh-ancestor
110520307|NCT02513875|Vitamin D|vitamin d|mesh-list
110520308|NCT02513875|Vitamins|vitamins|mesh-ancestor
110520309|NCT02513875|Micronutrients|micronutrients|mesh-ancestor
110520310|NCT02513875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110520311|NCT02513875|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110520313|NCT02513394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110520314|NCT02513394|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110520315|NCT02513394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110520316|NCT02513394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110520317|NCT02329847|Nivolumab|nivolumab|mesh-list
110520318|NCT02329847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110520319|NCT02329847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110520320|NCT02329847|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110520321|NCT02329847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110520322|NCT02287428|Pembrolizumab|pembrolizumab|mesh-list
110520323|NCT02287428|Temozolomide|temozolomide|mesh-list
110520324|NCT02287428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110520325|NCT02287428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110520326|NCT02287428|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110520327|NCT02287428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110520328|NCT02287428|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110520329|NCT02287428|Alkylating Agents|alkylating agents|mesh-ancestor
110520335|NCT02255227|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110520336|NCT02255227|Immunologic Factors|immunologic factors|mesh-ancestor
110520337|NCT02255227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110520338|NCT02192359|Irinotecan|irinotecan|mesh-list
110520339|NCT02192359|Camptothecin|camptothecin|mesh-list
110520340|NCT02192359|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110520341|NCT02192359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110520342|NCT02192359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110520343|NCT02192359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110520344|NCT02192359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110520345|NCT02192359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110520346|NCT02145143|Vemurafenib|vemurafenib|mesh-list
110520347|NCT02145143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110520348|NCT02145143|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110520349|NCT02145143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110520350|NCT02145143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110520351|NCT02119468|Dexamethasone|dexamethasone|mesh-list
110520352|NCT02119468|Pomalidomide|pomalidomide|mesh-list
110520364|NCT02119468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110520365|NCT02119468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110520366|NCT02119468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110520367|NCT02119468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110520368|NCT02119468|Immunologic Factors|immunologic factors|mesh-ancestor
110520369|NCT02119468|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110520370|NCT02119468|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110520371|NCT02119468|Growth Substances|growth substances|mesh-ancestor
110520372|NCT02119468|Growth Inhibitors|growth inhibitors|mesh-ancestor
110520373|NCT02119468|Protease Inhibitors|protease inhibitors|mesh-ancestor
110520374|NCT02119468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110520375|NCT02119468|Glycine Agents|glycine agents|mesh-ancestor
110520376|NCT02119468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110520377|NCT01935921|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110520379|NCT01935921|Ipilimumab|ipilimumab|mesh-list
110520380|NCT01935921|Antibodies|antibodies|mesh-list
110520381|NCT01935921|Immunoglobulins|immunoglobulins|mesh-list
110520382|NCT01935921|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110520383|NCT01935921|Immunologic Factors|immunologic factors|mesh-ancestor
110520384|NCT01935921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110520385|NCT01935921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110520386|NCT01935921|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110520387|NCT01935921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110520388|NCT01863550|Dexamethasone|dexamethasone|mesh-list
110520389|NCT01863550|Dexamethasone acetate|dexamethasone acetate|mesh-list
110520390|NCT01863550|Lenalidomide|lenalidomide|mesh-list
110520391|NCT01863550|Bortezomib|bortezomib|mesh-list
110520392|NCT01863550|Ichthammol|ichthammol|mesh-list
110520393|NCT01863550|BB 1101|bb 1101|mesh-list
110520394|NCT01863550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110520395|NCT01863550|Antiemetics|antiemetics|mesh-ancestor
110520396|NCT01863550|Autonomic Agents|autonomic agents|mesh-ancestor
110520397|NCT01863550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110520398|NCT01863550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110520399|NCT01863550|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110520400|NCT01863550|Glucocorticoids|glucocorticoids|mesh-ancestor
110520401|NCT01863550|Hormones|hormones|mesh-ancestor
110520402|NCT01863550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110520403|NCT01863550|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110520404|NCT01863550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110520405|NCT01863550|Immunologic Factors|immunologic factors|mesh-ancestor
110520406|NCT01863550|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110520407|NCT01863550|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110520408|NCT01863550|Growth Substances|growth substances|mesh-ancestor
110520409|NCT01863550|Growth Inhibitors|growth inhibitors|mesh-ancestor
110520410|NCT01863550|Protease Inhibitors|protease inhibitors|mesh-ancestor
110520411|NCT01863550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110520412|NCT01863550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110520413|NCT01863550|Dermatologic Agents|dermatologic agents|mesh-ancestor
110520414|NCT01824836|Anastrozole|anastrozole|mesh-list
110520415|NCT01824836|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110520416|NCT01824836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110520417|NCT01824836|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110520418|NCT01824836|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110520439|NCT01552434|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110520440|NCT01552434|Growth Substances|growth substances|mesh-ancestor
110520441|NCT01552434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110520442|NCT01552434|Growth Inhibitors|growth inhibitors|mesh-ancestor
110520443|NCT01552434|Immunologic Factors|immunologic factors|mesh-ancestor
110520444|NCT01552434|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110520445|NCT01552434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110520446|NCT01552434|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110520447|NCT01552434|Antifungal Agents|antifungal agents|mesh-ancestor
110520448|NCT01552434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110520449|NCT01552434|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110520450|NCT01552434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110191029|NCT00026273|Leucovorin|leucovorin|mesh-list
110520451|NCT01552434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110520452|NCT01552434|Anticonvulsants|anticonvulsants|mesh-ancestor
110520453|NCT01552434|GABA Agents|gaba agents|mesh-ancestor
110167899|NCT00033553|Paclitaxel|paclitaxel|mesh-list
110520454|NCT01552434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110520455|NCT01552434|Antimanic Agents|antimanic agents|mesh-ancestor
110520456|NCT01552434|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110520457|NCT01552434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110520458|NCT01552434|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110520459|NCT01415752|Rituximab|rituximab|mesh-list
110520460|NCT01415752|Lenalidomide|lenalidomide|mesh-list
110520461|NCT01415752|Bortezomib|bortezomib|mesh-list
110520462|NCT01415752|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110520463|NCT01415752|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110520464|NCT01415752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110520465|NCT01415752|Immunologic Factors|immunologic factors|mesh-ancestor
110520466|NCT01415752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110520467|NCT01415752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110520468|NCT01415752|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110520469|NCT01415752|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110520470|NCT01415752|Growth Substances|growth substances|mesh-ancestor
110520471|NCT01415752|Growth Inhibitors|growth inhibitors|mesh-ancestor
110520472|NCT01415752|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110520473|NCT01415752|Alkylating Agents|alkylating agents|mesh-ancestor
110520474|NCT01415752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110520500|NCT00641030|Melphalan|melphalan|mesh-list
110520501|NCT00641030|Clofarabine|clofarabine|mesh-list
110520502|NCT00641030|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110520503|NCT00641030|Alkylating Agents|alkylating agents|mesh-ancestor
110520504|NCT00641030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110520505|NCT00641030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110520506|NCT00641030|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110520507|NCT00641030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110520508|NCT00641030|Immunologic Factors|immunologic factors|mesh-ancestor
110520509|NCT00641030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110520510|NCT00641030|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110520511|NCT00641030|Antimetabolites|antimetabolites|mesh-ancestor
110520512|NCT00554515|Aldesleukin|aldesleukin|mesh-list
110520513|NCT00554515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110520514|NCT00554515|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110520515|NCT00554515|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110520516|NCT00554515|Antiviral Agents|antiviral agents|mesh-ancestor
110520517|NCT00554515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110520518|NCT00329043|Sunitinib|sunitinib|mesh-list
110520519|NCT00329043|Leuprolide|leuprolide|mesh-list
110520520|NCT00329043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110520521|NCT00329043|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110520522|NCT00329043|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110520523|NCT00329043|Growth Substances|growth substances|mesh-ancestor
110520524|NCT00329043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110520525|NCT00329043|Growth Inhibitors|growth inhibitors|mesh-ancestor
110167975|NCT00000641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110520526|NCT00329043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110520540|NCT00107289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110520541|NCT00107289|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110520543|NCT00082797|Methotrexate|methotrexate|mesh-list
110520544|NCT00082797|Calcium|calcium|mesh-list
110520545|NCT00082797|Levoleucovorin|levoleucovorin|mesh-list
110520546|NCT00082797|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110520547|NCT00082797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110520548|NCT00082797|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110520549|NCT00082797|Abortifacient Agents|abortifacient agents|mesh-ancestor
110520550|NCT00082797|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110520551|NCT00082797|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110520552|NCT00082797|Antimetabolites|antimetabolites|mesh-ancestor
110520553|NCT00082797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110520554|NCT00082797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110520555|NCT00082797|Dermatologic Agents|dermatologic agents|mesh-ancestor
110520556|NCT00082797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110520557|NCT00082797|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110520558|NCT00082797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110312135|NCT00325026|Misoprostol|misoprostol|mesh-list
110520559|NCT00082797|Immunologic Factors|immunologic factors|mesh-ancestor
110520560|NCT00082797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110520561|NCT00082797|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110520562|NCT00082797|Antidotes|antidotes|mesh-ancestor
110520563|NCT00082797|Protective Agents|protective agents|mesh-ancestor
110520564|NCT00082797|Vitamin B Complex|vitamin b complex|mesh-ancestor
110520565|NCT00082797|Vitamins|vitamins|mesh-ancestor
110520566|NCT00082797|Micronutrients|micronutrients|mesh-ancestor
110520567|NCT00060398|Dexamethasone|dexamethasone|mesh-list
110520568|NCT00060398|Epoetin Alfa|epoetin alfa|mesh-list
110520569|NCT00060398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110520570|NCT00060398|Antiemetics|antiemetics|mesh-ancestor
110520571|NCT00060398|Autonomic Agents|autonomic agents|mesh-ancestor
110520572|NCT00060398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110520573|NCT00060398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110520574|NCT00060398|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110520575|NCT00060398|Glucocorticoids|glucocorticoids|mesh-ancestor
110520576|NCT00060398|Hormones|hormones|mesh-ancestor
110520577|NCT00060398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110520578|NCT00060398|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110520579|NCT00060398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110520580|NCT00060398|Hematinics|hematinics|mesh-ancestor
110520581|NCT00054561|Vitamin E|vitamin e|mesh-list
110520582|NCT00054561|Interferons|interferons|mesh-list
110916564|NCT03658317|Uric Acid|uric acid|mesh-list
110520583|NCT00054561|Interferon-alpha|interferon-alpha|mesh-list
110520585|NCT00054561|Vitamins|vitamins|mesh-ancestor
110520586|NCT00054561|Micronutrients|micronutrients|mesh-ancestor
110520587|NCT00054561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110520588|NCT00054561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110520589|NCT00054561|Antiviral Agents|antiviral agents|mesh-ancestor
110520590|NCT00054561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110520622|NCT00041314|Sulindac sulfone|sulindac sulfone|mesh-list
110520623|NCT00041314|Carboplatin|carboplatin|mesh-list
110520624|NCT00041314|Gemcitabine|gemcitabine|mesh-list
110520625|NCT00041314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110520626|NCT00041314|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110520627|NCT00041314|Antimetabolites|antimetabolites|mesh-ancestor
110520628|NCT00041314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110520629|NCT00041314|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110520630|NCT00041314|Protective Agents|protective agents|mesh-ancestor
110520631|NCT00041314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110520632|NCT00041314|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110191079|NCT00054444|Topotecan|topotecan|mesh-list
110520633|NCT00041314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110520634|NCT00041314|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110520635|NCT00041314|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110520636|NCT00041314|Analgesics|analgesics|mesh-ancestor
110520637|NCT00041314|Sensory System Agents|sensory system agents|mesh-ancestor
110520638|NCT00041314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110520675|NCT00027859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110520676|NCT00027859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110520677|NCT00027859|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110520712|NCT00006004|Antimitotic Agents|antimitotic agents|mesh-ancestor
110520713|NCT00006004|Mitosis Modulators|mitosis modulators|mesh-ancestor
110520714|NCT00006004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110520715|NCT00006004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110520716|NCT00006004|Antimetabolites|antimetabolites|mesh-ancestor
110520717|NCT00004860|Leucovorin|leucovorin|mesh-list
110520718|NCT00004860|Tegafur|tegafur|mesh-list
110520719|NCT00004860|Calcium|calcium|mesh-list
110520728|NCT00004860|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110520729|NCT00004860|Antimetabolites|antimetabolites|mesh-ancestor
110520730|NCT00004860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110520731|NCT00004860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110520733|NCT00003864|Docetaxel|docetaxel|mesh-list
110520734|NCT00003864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110520735|NCT00003864|Tubulin Modulators|tubulin modulators|mesh-ancestor
110520736|NCT00003864|Antimitotic Agents|antimitotic agents|mesh-ancestor
110520737|NCT00003864|Mitosis Modulators|mitosis modulators|mesh-ancestor
110520738|NCT00003864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110520739|NCT00003810|Gemcitabine|gemcitabine|mesh-list
110520740|NCT00003810|Docetaxel|docetaxel|mesh-list
110520741|NCT00003810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110520742|NCT00003810|Antimetabolites|antimetabolites|mesh-ancestor
110520743|NCT00003810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110520744|NCT00003810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110520745|NCT00003810|Tubulin Modulators|tubulin modulators|mesh-ancestor
110520746|NCT00003810|Antimitotic Agents|antimitotic agents|mesh-ancestor
110520747|NCT00003810|Mitosis Modulators|mitosis modulators|mesh-ancestor
110520748|NCT00003701|Paclitaxel|paclitaxel|mesh-list
110520749|NCT00003701|Vinblastine|vinblastine|mesh-list
110520750|NCT00003701|Carboplatin|carboplatin|mesh-list
110520751|NCT00003701|Doxorubicin|doxorubicin|mesh-list
110520752|NCT00003701|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110520753|NCT00003701|Methotrexate|methotrexate|mesh-list
110520754|NCT00003701|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110520755|NCT00003701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110168201|NCT00014040|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110520756|NCT00003701|Tubulin Modulators|tubulin modulators|mesh-ancestor
110520757|NCT00003701|Antimitotic Agents|antimitotic agents|mesh-ancestor
110520758|NCT00003701|Mitosis Modulators|mitosis modulators|mesh-ancestor
110520759|NCT00003701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110520760|NCT00003701|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110520761|NCT00003701|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110520762|NCT00003701|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110520763|NCT00003701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110520764|NCT00003701|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110520765|NCT00003701|Abortifacient Agents|abortifacient agents|mesh-ancestor
110520766|NCT00003701|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110520767|NCT00003701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110520768|NCT00003701|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110520769|NCT00003701|Antimetabolites|antimetabolites|mesh-ancestor
110520770|NCT00003701|Dermatologic Agents|dermatologic agents|mesh-ancestor
110520771|NCT00003701|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110520772|NCT00003701|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110520773|NCT00003701|Immunologic Factors|immunologic factors|mesh-ancestor
110916640|NCT04087408|Hormones|hormones|mesh-list
110520775|NCT00003701|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110520776|NCT00003615|Denileukin diftitox|denileukin diftitox|mesh-list
110520777|NCT00003615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110520778|NCT00003614|Paclitaxel|paclitaxel|mesh-list
110520779|NCT00003614|Estramustine|estramustine|mesh-list
110520780|NCT00003614|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110520781|NCT00003614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110520782|NCT00003614|Tubulin Modulators|tubulin modulators|mesh-ancestor
110520783|NCT00003614|Antimitotic Agents|antimitotic agents|mesh-ancestor
110520784|NCT00003614|Mitosis Modulators|mitosis modulators|mesh-ancestor
110312137|NCT00325026|Abortifacient Agents|abortifacient agents|mesh-ancestor
110520785|NCT00003614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110179473|NCT00011297|Antiemetics|antiemetics|mesh-ancestor
110520815|NCT00003283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110520816|NCT00003283|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110520817|NCT00003283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110520818|NCT00003283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110520820|NCT00003235|Carboplatin|carboplatin|mesh-list
110520821|NCT00003235|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110520822|NCT00003235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110520823|NCT00003235|Tubulin Modulators|tubulin modulators|mesh-ancestor
110520824|NCT00003235|Antimitotic Agents|antimitotic agents|mesh-ancestor
110520825|NCT00003235|Mitosis Modulators|mitosis modulators|mesh-ancestor
110520826|NCT00003235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110520827|NCT00003206|Paclitaxel|paclitaxel|mesh-list
110520828|NCT00003206|Carboplatin|carboplatin|mesh-list
110520829|NCT00003206|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110520830|NCT00003206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110520831|NCT00003206|Tubulin Modulators|tubulin modulators|mesh-ancestor
110520832|NCT00003206|Antimitotic Agents|antimitotic agents|mesh-ancestor
110520852|NCT00003008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110520853|NCT00003008|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110520854|NCT00003008|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110520855|NCT00003008|Antiviral Agents|antiviral agents|mesh-ancestor
110520856|NCT00003008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110520857|NCT00003008|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110520858|NCT00003008|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110520859|NCT00002996|Flecainide|flecainide|mesh-list
110520860|NCT00002996|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110520861|NCT00002996|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110520862|NCT00002996|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110520863|NCT00002996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110520864|NCT00002996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110520865|NCT00002878|Dexamethasone|dexamethasone|mesh-list
110520866|NCT00002878|Doxorubicin|doxorubicin|mesh-list
110520867|NCT00002878|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110520868|NCT00002878|Vincristine|vincristine|mesh-list
110520869|NCT00002878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110520870|NCT00002878|Antiemetics|antiemetics|mesh-ancestor
110520871|NCT00002878|Autonomic Agents|autonomic agents|mesh-ancestor
110520872|NCT00002878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110520873|NCT00002878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110520874|NCT00002878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110520875|NCT00002878|Glucocorticoids|glucocorticoids|mesh-ancestor
110520876|NCT00002878|Hormones|hormones|mesh-ancestor
110520877|NCT00002878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110520878|NCT00002878|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110520879|NCT00002878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110520880|NCT00002878|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110520881|NCT00002878|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110520882|NCT00002878|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110520883|NCT00002878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110520884|NCT00002878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110520885|NCT00002878|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110520886|NCT00002878|Tubulin Modulators|tubulin modulators|mesh-ancestor
110520887|NCT00002878|Antimitotic Agents|antimitotic agents|mesh-ancestor
110520888|NCT00002878|Mitosis Modulators|mitosis modulators|mesh-ancestor
110520889|NCT00002632|Paclitaxel|paclitaxel|mesh-list
110520906|NCT00609557|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110520907|NCT00609557|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110520908|NCT00609557|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110520909|NCT00609557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110520910|NCT00609557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110520911|NCT00609557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110520912|NCT00609557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110520913|NCT00609557|Analgesics|analgesics|mesh-ancestor
110520914|NCT00609557|Sensory System Agents|sensory system agents|mesh-ancestor
110520915|NCT00609557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110520916|NCT00609557|Antidepressive Agents|antidepressive agents|mesh-ancestor
110520917|NCT00609557|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110520918|NCT00609557|Dopamine Agents|dopamine agents|mesh-ancestor
110520919|NCT05122481|Ascorbic Acid|ascorbic acid|mesh-list
110520921|NCT05122481|Micronutrients|micronutrients|mesh-ancestor
110520922|NCT05122481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110520923|NCT05122481|Antioxidants|antioxidants|mesh-ancestor
110520924|NCT05122481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110520925|NCT05122481|Protective Agents|protective agents|mesh-ancestor
110520927|NCT00937417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110520928|NCT00937417|Tubulin Modulators|tubulin modulators|mesh-ancestor
110191146|NCT00026819|Rofecoxib|rofecoxib|mesh-list
110520929|NCT00937417|Antimitotic Agents|antimitotic agents|mesh-ancestor
110520930|NCT00937417|Mitosis Modulators|mitosis modulators|mesh-ancestor
110520931|NCT00937417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110520932|NCT02728440|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
110520933|NCT02728440|Menotropins|menotropins|mesh-list
110520934|NCT02728440|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110520935|NCT02728440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110520936|NCT02728440|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110520937|NCT02728440|Fertility Agents|fertility agents|mesh-ancestor
110520938|NCT05358912|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
110520939|NCT04261517|Hydroxychloroquine|hydroxychloroquine|mesh-list
110520940|NCT04261517|Antimalarials|antimalarials|mesh-ancestor
110520941|NCT04261517|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110520942|NCT04261517|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110520943|NCT04261517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110520944|NCT04261517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110520945|NCT04261517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110520957|NCT02737800|Triptorelin Pamoate|triptorelin pamoate|mesh-list
110520958|NCT02737800|Luteolytic Agents|luteolytic agents|mesh-ancestor
110520959|NCT02737800|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110520960|NCT02737800|Contraceptive Agents|contraceptive agents|mesh-ancestor
110520961|NCT02737800|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110520962|NCT02737800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110520963|NCT02737800|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110520964|NCT02737800|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110520965|NCT02737800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110520966|NCT00934531|Donepezil|donepezil|mesh-list
110520967|NCT00934531|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110520968|NCT00934531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110520969|NCT00934531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110520970|NCT00934531|Cholinergic Agents|cholinergic agents|mesh-ancestor
110520971|NCT00934531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110520972|NCT00934531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110520973|NCT00934531|Nootropic Agents|nootropic agents|mesh-ancestor
110520974|NCT00931021|Nicotine|nicotine|mesh-list
110520975|NCT00931021|Varenicline|varenicline|mesh-list
110520976|NCT00931021|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110520977|NCT00931021|Autonomic Agents|autonomic agents|mesh-ancestor
110520978|NCT00931021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110520979|NCT00931021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110520980|NCT00931021|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110520981|NCT00931021|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110520982|NCT00931021|Cholinergic Agents|cholinergic agents|mesh-ancestor
110520983|NCT00931021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110520984|NCT00931021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110520985|NCT00937807|Sevoflurane|sevoflurane|mesh-list
110520986|NCT00937807|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110520987|NCT00937807|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110520988|NCT00937807|Anesthetics, General|anesthetics, general|mesh-ancestor
110520989|NCT00937807|Anesthetics|anesthetics|mesh-ancestor
110520990|NCT00937807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110520991|NCT00937807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110520992|NCT00934687|Botulinum Toxins|botulinum toxins|mesh-list
110520993|NCT00934687|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110520994|NCT00934687|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110520995|NCT00934687|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110520996|NCT00934687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110520997|NCT00934687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110520998|NCT00934687|Cholinergic Agents|cholinergic agents|mesh-ancestor
110520999|NCT00934687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110521000|NCT00934687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110521001|NCT00934687|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110521002|NCT00934687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110521003|NCT02808728|Bupivacaine|bupivacaine|mesh-list
110521004|NCT02808728|Ropivacaine|ropivacaine|mesh-list
110521005|NCT02808728|Anesthetics, Local|anesthetics, local|mesh-ancestor
110521006|NCT02808728|Anesthetics|anesthetics|mesh-ancestor
110521007|NCT02808728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110521008|NCT02808728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110521014|NCT05331053|Antimetabolites|antimetabolites|mesh-ancestor
110521015|NCT05331053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110521016|NCT05331053|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110521017|NCT05331053|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110521018|NCT05331053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110521019|NCT02732730|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110521020|NCT02732730|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110521021|NCT02732730|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110521022|NCT02732730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110521023|NCT02732730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110521024|NCT02732730|Antiviral Agents|antiviral agents|mesh-ancestor
110521025|NCT02732730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110521026|NCT02732730|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110521027|NCT02732730|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110521028|NCT04996667|Nitric Oxide|nitric oxide|mesh-list
110521029|NCT04996667|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110521030|NCT04996667|Autonomic Agents|autonomic agents|mesh-ancestor
110521031|NCT04996667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110521032|NCT04996667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110521033|NCT04996667|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110521034|NCT04996667|Respiratory System Agents|respiratory system agents|mesh-ancestor
110521035|NCT04996667|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110521036|NCT04996667|Antioxidants|antioxidants|mesh-ancestor
110521037|NCT04996667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110521038|NCT04996667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110521039|NCT04996667|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
110521040|NCT04996667|Vasodilator Agents|vasodilator agents|mesh-ancestor
110521041|NCT04996667|Gasotransmitters|gasotransmitters|mesh-ancestor
110521042|NCT04996667|Protective Agents|protective agents|mesh-ancestor
110521043|NCT00929669|Pasireotide|pasireotide|mesh-list
110521044|NCT00929669|Hormones|hormones|mesh-ancestor
110521045|NCT00929669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110521046|NCT00929669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110521047|NCT02804360|Dexamethasone|dexamethasone|mesh-list
110521048|NCT02804360|Dexamethasone acetate|dexamethasone acetate|mesh-list
110521049|NCT02804360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110521050|NCT02804360|Antiemetics|antiemetics|mesh-ancestor
110521051|NCT02804360|Autonomic Agents|autonomic agents|mesh-ancestor
110521052|NCT02804360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110521053|NCT02804360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110521054|NCT02804360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110521055|NCT02804360|Glucocorticoids|glucocorticoids|mesh-ancestor
110521056|NCT02804360|Hormones|hormones|mesh-ancestor
110521057|NCT02804360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110521058|NCT02804360|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110521059|NCT02804360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110521060|NCT02727738|Selenium|selenium|mesh-list
110521061|NCT02727738|Methimazole|methimazole|mesh-list
110521062|NCT02727738|Antioxidants|antioxidants|mesh-ancestor
110521063|NCT02727738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110521064|NCT02727738|Protective Agents|protective agents|mesh-ancestor
110521065|NCT02727738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110916735|NCT02097264|Adalimumab|adalimumab|mesh-list
110521066|NCT02727738|Trace Elements|trace elements|mesh-ancestor
110521067|NCT02727738|Micronutrients|micronutrients|mesh-ancestor
110521068|NCT02727738|Antithyroid Agents|antithyroid agents|mesh-ancestor
110521069|NCT02727738|Hormone Antagonists|hormone antagonists|mesh-ancestor
110521070|NCT02727738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110521071|NCT02732418|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
110521072|NCT02732418|Contraceptive Agents|contraceptive agents|mesh-list
110521073|NCT02732418|Medroxyprogesterone|medroxyprogesterone|mesh-list
110521074|NCT02732418|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110521075|NCT02732418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110521076|NCT02732418|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110521086|NCT02811692|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110521087|NCT02811692|Growth Substances|growth substances|mesh-ancestor
110521088|NCT02811692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110521089|NCT02811692|Growth Inhibitors|growth inhibitors|mesh-ancestor
110521090|NCT02811692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110521091|NCT04004078|Antifungal Agents|antifungal agents|mesh-list
110521093|NCT04004078|Miconazole|miconazole|mesh-list
110521094|NCT04004078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110521095|NCT04004078|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110521096|NCT04004078|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110521097|NCT04004078|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110521098|NCT04004078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110521099|NCT04004078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110521100|NCT04004078|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110521101|NCT04004078|Hormone Antagonists|hormone antagonists|mesh-ancestor
110521102|NCT04004078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110521103|NCT04004078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110521104|NCT04004078|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110521105|NCT04004078|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110521106|NCT02732262|Oxycodone|oxycodone|mesh-list
110521107|NCT02732262|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110521108|NCT02732262|Narcotics|narcotics|mesh-ancestor
110521109|NCT02732262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110521110|NCT02732262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110521111|NCT02732262|Analgesics|analgesics|mesh-ancestor
110521112|NCT02732262|Sensory System Agents|sensory system agents|mesh-ancestor
110521113|NCT02732262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110521114|NCT00926393|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110521115|NCT00926393|Antidepressive Agents|antidepressive agents|mesh-ancestor
110521116|NCT00926393|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110521117|NCT00926393|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110521118|NCT00926393|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110521119|NCT00926393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110521120|NCT00926393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110521121|NCT02737254|Oxytocin|oxytocin|mesh-list
110521122|NCT02737254|Oxytocics|oxytocics|mesh-ancestor
110521123|NCT02737254|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110521124|NCT02737254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110521125|NCT00938197|Amlodipine|amlodipine|mesh-list
110521126|NCT00938197|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110521127|NCT00938197|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110521128|NCT00938197|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110521129|NCT00938197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110521130|NCT00938197|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110521131|NCT00938197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110521132|NCT00938197|Vasodilator Agents|vasodilator agents|mesh-ancestor
110521133|NCT02727504|Dobutamine|dobutamine|mesh-list
110521134|NCT02727504|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110521135|NCT02727504|Sympathomimetics|sympathomimetics|mesh-ancestor
110521136|NCT02727504|Autonomic Agents|autonomic agents|mesh-ancestor
110521137|NCT02727504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110521138|NCT02727504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110521139|NCT02727504|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
110521140|NCT02727504|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110521147|NCT02727348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110521148|NCT02727348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110521149|NCT02804126|Acetaminophen|acetaminophen|mesh-list
110521150|NCT02804126|Dipyrone|dipyrone|mesh-list
110521151|NCT02804126|Ketoprofen|ketoprofen|mesh-list
110521152|NCT02804126|Morphine|morphine|mesh-list
110521153|NCT02804126|Bupivacaine|bupivacaine|mesh-list
110521154|NCT02804126|Anesthetics, Local|anesthetics, local|mesh-ancestor
110521155|NCT02804126|Anesthetics|anesthetics|mesh-ancestor
110521156|NCT02804126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110521157|NCT02804126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110521158|NCT02804126|Sensory System Agents|sensory system agents|mesh-ancestor
110521159|NCT02804126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110521160|NCT02804126|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110521161|NCT02804126|Narcotics|narcotics|mesh-ancestor
110521162|NCT02804126|Analgesics|analgesics|mesh-ancestor
110521163|NCT02804126|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110521164|NCT02804126|Antipyretics|antipyretics|mesh-ancestor
110521165|NCT02804126|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110521166|NCT02804126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110521167|NCT02804126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110521168|NCT02804126|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110521169|NCT02804126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110521170|NCT02804126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110521171|NCT04013815|Ropivacaine|ropivacaine|mesh-list
110521172|NCT04013815|Anesthetics, Local|anesthetics, local|mesh-ancestor
110521173|NCT04013815|Anesthetics|anesthetics|mesh-ancestor
110916751|NCT04294498|Entecavir|entecavir|mesh-list
110521174|NCT04013815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110521175|NCT04013815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110521176|NCT04013815|Sensory System Agents|sensory system agents|mesh-ancestor
110521177|NCT04013815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110521178|NCT00610103|Apomorphine|apomorphine|mesh-list
110521179|NCT00610103|Emetics|emetics|mesh-ancestor
110521180|NCT00610103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110521181|NCT00610103|Autonomic Agents|autonomic agents|mesh-ancestor
110521182|NCT00610103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110521183|NCT00610103|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110521184|NCT00610103|Dopamine Agonists|dopamine agonists|mesh-ancestor
110521185|NCT00610103|Dopamine Agents|dopamine agents|mesh-ancestor
110521186|NCT00610103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110521187|NCT00610103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110521188|NCT05624190|Plasminogen|plasminogen|mesh-list
110521189|NCT05624190|Tenecteplase|tenecteplase|mesh-list
110521190|NCT05624190|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
110521191|NCT05624190|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110521192|NCT05624190|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110521193|NCT05624190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110521194|NCT00938353|Beclomethasone|beclomethasone|mesh-list
110521195|NCT00938353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110521196|NCT00938353|Glucocorticoids|glucocorticoids|mesh-ancestor
110521197|NCT00938353|Hormones|hormones|mesh-ancestor
110521198|NCT00938353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110521199|NCT00938353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110521200|NCT00938353|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110521201|NCT00938353|Respiratory System Agents|respiratory system agents|mesh-ancestor
110521202|NCT04259333|Acetaminophen|acetaminophen|mesh-list
110521203|NCT04259333|Celecoxib|celecoxib|mesh-list
110521204|NCT04259333|Codeine|codeine|mesh-list
110521205|NCT04259333|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110521206|NCT04259333|Analgesics|analgesics|mesh-ancestor
110521207|NCT04259333|Sensory System Agents|sensory system agents|mesh-ancestor
110521208|NCT04259333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110521209|NCT04259333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110521210|NCT04259333|Antipyretics|antipyretics|mesh-ancestor
110521211|NCT04259333|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110521224|NCT02721420|Artenimol|artenimol|mesh-list
110521225|NCT02721420|Antimalarials|antimalarials|mesh-ancestor
110521226|NCT02721420|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110521227|NCT02721420|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110521228|NCT02721420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110521229|NCT00608699|Niacin|niacin|mesh-list
110521230|NCT00608699|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110521231|NCT00608699|Antimetabolites|antimetabolites|mesh-ancestor
110521232|NCT00608699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110521233|NCT00608699|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110521234|NCT00608699|Vasodilator Agents|vasodilator agents|mesh-ancestor
110521235|NCT00608699|Vitamin B Complex|vitamin b complex|mesh-ancestor
110521236|NCT00608699|Vitamins|vitamins|mesh-ancestor
110521237|NCT00608699|Micronutrients|micronutrients|mesh-ancestor
110521238|NCT00608699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110521239|NCT05193396|Hydrocortisone|hydrocortisone|mesh-list
110521240|NCT05193396|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110521241|NCT02726490|Metformin|metformin|mesh-list
110521242|NCT02726490|Glyburide|glyburide|mesh-list
110521243|NCT02726490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110521244|NCT02726490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110521245|NCT02726646|Doxycycline|doxycycline|mesh-list
110521246|NCT02726646|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110521247|NCT02726646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110521248|NCT02726646|Antimalarials|antimalarials|mesh-ancestor
110521249|NCT02726646|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110521250|NCT02726646|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110521251|NCT02803892|Vildagliptin|vildagliptin|mesh-list
110521252|NCT02803892|Sirolimus|sirolimus|mesh-list
110521253|NCT02803892|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110521254|NCT02803892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110521255|NCT02803892|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110521256|NCT02803892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110521257|NCT02803892|Antifungal Agents|antifungal agents|mesh-ancestor
110521258|NCT02803892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110521259|NCT02803892|Immunologic Factors|immunologic factors|mesh-ancestor
110521260|NCT02803892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110521261|NCT02803892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110521262|NCT02803892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110521263|NCT02803892|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110521264|NCT02803892|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110521265|NCT02803892|Protease Inhibitors|protease inhibitors|mesh-ancestor
110521266|NCT02721186|Primaquine|primaquine|mesh-list
110521267|NCT02721186|Piperaquine|piperaquine|mesh-list
110521268|NCT02721186|Artenimol|artenimol|mesh-list
110521269|NCT02721186|Antimalarials|antimalarials|mesh-ancestor
110521270|NCT02721186|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110521271|NCT02721186|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110521272|NCT02721186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110521273|NCT02716428|Ribavirin|ribavirin|mesh-list
110521274|NCT02716428|Antimetabolites|antimetabolites|mesh-ancestor
110521275|NCT02716428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110521276|NCT02716428|Antiviral Agents|antiviral agents|mesh-ancestor
110521277|NCT02716428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110521278|NCT00931463|Ritonavir|ritonavir|mesh-list
110521287|NCT00931463|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110521288|NCT00931463|Antiviral Agents|antiviral agents|mesh-ancestor
110521289|NCT00931463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110521290|NCT00931463|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110521291|NCT00931463|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110521292|NCT00931463|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110521293|NCT00931463|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110521294|NCT03974594|Trifluridine|trifluridine|mesh-list
110521295|NCT03974594|Antimetabolites|antimetabolites|mesh-ancestor
110521296|NCT03974594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110521297|NCT03974594|Antiviral Agents|antiviral agents|mesh-ancestor
110521298|NCT03974594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110521299|NCT03964688|Ascorbic Acid|ascorbic acid|mesh-list
110521300|NCT03964688|Vitamins|vitamins|mesh-ancestor
110521301|NCT03964688|Micronutrients|micronutrients|mesh-ancestor
110521302|NCT03964688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110521303|NCT03964688|Antioxidants|antioxidants|mesh-ancestor
110521304|NCT03964688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110521305|NCT03964688|Protective Agents|protective agents|mesh-ancestor
110521306|NCT00929201|Metformin|metformin|mesh-list
110521307|NCT00929201|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110521308|NCT00929201|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110521309|NCT00929201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110521310|NCT00929201|Incretins|incretins|mesh-ancestor
110521311|NCT00929201|Hormones|hormones|mesh-ancestor
110521312|NCT00929201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110521313|NCT00929201|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110521314|NCT00929201|Protease Inhibitors|protease inhibitors|mesh-ancestor
110521315|NCT00929201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110521316|NCT00929201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110521317|NCT02800772|Acetic Acid|acetic acid|mesh-list
110521318|NCT02800772|Retinol acetate|retinol acetate|mesh-list
110521319|NCT02800772|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110521320|NCT02800772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110521321|NCT02800772|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110521322|NCT02800772|Immunologic Factors|immunologic factors|mesh-ancestor
110521323|NCT02800772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110521324|NCT02800772|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110521325|NCT02800772|Protective Agents|protective agents|mesh-ancestor
110521326|NCT02800772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110521327|NCT02773212|Amphetamine|amphetamine|mesh-list
110521328|NCT02773212|Dextroamphetamine|dextroamphetamine|mesh-list
110521329|NCT02773212|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110521330|NCT02773212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110521331|NCT02773212|Sympathomimetics|sympathomimetics|mesh-ancestor
110521332|NCT02773212|Autonomic Agents|autonomic agents|mesh-ancestor
110521333|NCT02773212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110521334|NCT02773212|Dopamine Agents|dopamine agents|mesh-ancestor
110521335|NCT02773212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110521336|NCT02773212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110521337|NCT02773212|Adrenergic Agents|adrenergic agents|mesh-ancestor
110521338|NCT02773212|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110521339|NCT02773212|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110521340|NCT02773212|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110521341|NCT02773212|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110521342|NCT00610493|Sirolimus|sirolimus|mesh-list
110521343|NCT00610493|Bevacizumab|bevacizumab|mesh-list
110521344|NCT00610493|Temsirolimus|temsirolimus|mesh-list
110521345|NCT00610493|MTOR Inhibitors|mtor inhibitors|mesh-list
110179578|NCT00011921|Etoposide|etoposide|mesh-list
110521364|NCT02716272|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110521365|NCT02716272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110521366|NCT02716272|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110521367|NCT02716272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110521369|NCT02720406|Analgesics|analgesics|mesh-ancestor
110521370|NCT02720406|Sensory System Agents|sensory system agents|mesh-ancestor
110521371|NCT02720406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110521372|NCT02720406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110916839|NCT00150176|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110521373|NCT02720406|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110521374|NCT02720406|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110521375|NCT02720406|Anesthetics, General|anesthetics, general|mesh-ancestor
110521376|NCT02720406|Anesthetics|anesthetics|mesh-ancestor
110521377|NCT02720406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110521378|NCT02720406|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110521379|NCT02720406|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110521380|NCT02720406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110521381|NCT02720406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110521382|NCT05504876|Midazolam|midazolam|mesh-list
110521383|NCT05504876|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110521384|NCT05504876|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110521385|NCT05504876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110521386|NCT05504876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110521387|NCT05504876|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110521388|NCT05504876|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110521389|NCT05504876|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110521390|NCT05504876|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110521391|NCT05504876|Anesthetics, General|anesthetics, general|mesh-ancestor
110521392|NCT05504876|Anesthetics|anesthetics|mesh-ancestor
110521393|NCT05504876|GABA Modulators|gaba modulators|mesh-ancestor
110521394|NCT05504876|GABA Agents|gaba agents|mesh-ancestor
110521395|NCT05504876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110521396|NCT05504876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110521397|NCT02802722|Vitamin D|vitamin d|mesh-list
110521398|NCT02802722|Cholecalciferol|cholecalciferol|mesh-list
110521399|NCT02802722|Vitamins|vitamins|mesh-ancestor
110521400|NCT02802722|Micronutrients|micronutrients|mesh-ancestor
110521401|NCT02802722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110521402|NCT02802722|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110179587|NCT00011921|Mitosis Modulators|mitosis modulators|mesh-ancestor
110521408|NCT02802644|Hormones|hormones|mesh-ancestor
110521409|NCT02802644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110521410|NCT02802644|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110521411|NCT02802644|Protease Inhibitors|protease inhibitors|mesh-ancestor
110521412|NCT02802644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110521413|NCT02802644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110521414|NCT02744976|Metformin|metformin|mesh-list
110521415|NCT02744976|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110521416|NCT02744976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110521417|NCT00928889|Acarbose|acarbose|mesh-list
110521418|NCT00928889|Nateglinide|nateglinide|mesh-list
110521419|NCT00928889|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
110521420|NCT00928889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110521421|NCT00928889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110521422|NCT00928889|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110521423|NCT00928889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110521424|NCT02725398|Scopolamine|scopolamine|mesh-list
110521425|NCT02725398|Bromides|bromides|mesh-list
110521426|NCT02725398|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
110521427|NCT02725398|Anticonvulsants|anticonvulsants|mesh-ancestor
110521428|NCT02725398|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110521429|NCT02725398|Antiemetics|antiemetics|mesh-ancestor
110521430|NCT02725398|Autonomic Agents|autonomic agents|mesh-ancestor
110521431|NCT02725398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110521432|NCT02725398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110521433|NCT02725398|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110521434|NCT02725398|Mydriatics|mydriatics|mesh-ancestor
110521435|NCT02725398|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110521436|NCT02725398|Cholinergic Agents|cholinergic agents|mesh-ancestor
110521437|NCT02725398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110521438|NCT02725398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110521439|NCT02725398|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110521440|NCT02725398|Parasympatholytics|parasympatholytics|mesh-ancestor
110521441|NCT02795546|Alendronate|alendronate|mesh-list
110521442|NCT02795546|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110521443|NCT02795546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110521444|NCT03978091|Ceftazidime|ceftazidime|mesh-list
110521445|NCT03978091|Avibactam|avibactam|mesh-list
110521446|NCT03978091|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
110521447|NCT03978091|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110521448|NCT03978091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110521451|NCT03978091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110521452|NCT00610571|Temozolomide|temozolomide|mesh-list
110521453|NCT00610571|Topotecan|topotecan|mesh-list
110521454|NCT00610571|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110521455|NCT00610571|Alkylating Agents|alkylating agents|mesh-ancestor
110521456|NCT00610571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110521457|NCT00610571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110521458|NCT00610571|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110521459|NCT00610571|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110521460|NCT00610571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110521461|NCT02725242|Budesonide|budesonide|mesh-list
110521462|NCT02725242|Formoterol Fumarate|formoterol fumarate|mesh-list
110521463|NCT02725242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110521464|NCT02725242|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110521465|NCT02725242|Autonomic Agents|autonomic agents|mesh-ancestor
110521466|NCT02725242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110521467|NCT02725242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110521468|NCT02725242|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110521469|NCT02725242|Respiratory System Agents|respiratory system agents|mesh-ancestor
110521470|NCT02725242|Glucocorticoids|glucocorticoids|mesh-ancestor
110521471|NCT02725242|Hormones|hormones|mesh-ancestor
110521472|NCT02725242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110521473|NCT02725242|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110521484|NCT00564733|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110521485|NCT00564733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110521486|NCT00564733|Tubulin Modulators|tubulin modulators|mesh-ancestor
110521487|NCT00564733|Antimitotic Agents|antimitotic agents|mesh-ancestor
110521488|NCT00564733|Mitosis Modulators|mitosis modulators|mesh-ancestor
110521489|NCT00564733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110521490|NCT00564733|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110521491|NCT00564733|Antimetabolites|antimetabolites|mesh-ancestor
110521492|NCT00564733|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110521493|NCT02725164|Nitrous Oxide|nitrous oxide|mesh-list
110521494|NCT02725164|Sevoflurane|sevoflurane|mesh-list
110521495|NCT02725164|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110521496|NCT02725164|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110521497|NCT02725164|Anesthetics, General|anesthetics, general|mesh-ancestor
110521498|NCT02725164|Anesthetics|anesthetics|mesh-ancestor
110521499|NCT02725164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110521500|NCT02725164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110521501|NCT02725164|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110521502|NCT02725164|Analgesics|analgesics|mesh-ancestor
110521503|NCT02725164|Sensory System Agents|sensory system agents|mesh-ancestor
110521504|NCT02725164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110521505|NCT02800694|Fentanyl|fentanyl|mesh-list
110521506|NCT02800694|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110521507|NCT02800694|Narcotics|narcotics|mesh-ancestor
110521508|NCT02800694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110521509|NCT02800694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110521510|NCT02800694|Analgesics|analgesics|mesh-ancestor
110521511|NCT02800694|Sensory System Agents|sensory system agents|mesh-ancestor
110521512|NCT02800694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110521513|NCT02800694|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110521514|NCT02800694|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110521515|NCT02800694|Anesthetics, General|anesthetics, general|mesh-ancestor
110521516|NCT02800694|Anesthetics|anesthetics|mesh-ancestor
110521517|NCT00931385|Formoterol Fumarate|formoterol fumarate|mesh-list
110521518|NCT00931385|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110521519|NCT00931385|Autonomic Agents|autonomic agents|mesh-ancestor
110521520|NCT00931385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110521521|NCT00931385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110521522|NCT00931385|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110521524|NCT00931385|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110521525|NCT00931385|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110521526|NCT00931385|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110521527|NCT00931385|Adrenergic Agents|adrenergic agents|mesh-ancestor
110521528|NCT00931385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110521529|NCT00931385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110521530|NCT00938509|Ibuprofen|ibuprofen|mesh-list
110521531|NCT00938509|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110521532|NCT00938509|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110521533|NCT00938509|Analgesics|analgesics|mesh-ancestor
110521534|NCT00938509|Sensory System Agents|sensory system agents|mesh-ancestor
110521535|NCT00938509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110521536|NCT00938509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110521537|NCT00938509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110521538|NCT00938509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110521539|NCT00938509|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110521540|NCT00938509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110179613|NCT00847314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110521544|NCT02724618|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110521545|NCT02724618|Analgesics|analgesics|mesh-ancestor
110521546|NCT02724618|Sensory System Agents|sensory system agents|mesh-ancestor
110521547|NCT02724618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110521548|NCT02724618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110521549|NCT02724618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110521550|NCT02724618|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110521551|NCT02724618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110521552|NCT02724618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110521553|NCT02724618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110521554|NCT02801786|Tamoxifen|tamoxifen|mesh-list
110521555|NCT02801786|Lidocaine|lidocaine|mesh-list
110521556|NCT02801786|Anesthetics, Local|anesthetics, local|mesh-ancestor
110521557|NCT02801786|Anesthetics|anesthetics|mesh-ancestor
110521558|NCT02801786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110521559|NCT02801786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110521560|NCT02801786|Sensory System Agents|sensory system agents|mesh-ancestor
110521561|NCT02801786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110521562|NCT02801786|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110521563|NCT02801786|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110521564|NCT02801786|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110521565|NCT02801786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110521566|NCT02801786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110521567|NCT02801786|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110521568|NCT02801786|Hormone Antagonists|hormone antagonists|mesh-ancestor
110521569|NCT02801786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110521570|NCT02801786|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110521571|NCT02801786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110521572|NCT02801786|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110521573|NCT02801786|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110521574|NCT02801786|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110521575|NCT04258553|Antioxidants|antioxidants|mesh-list
110521576|NCT04258553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110521577|NCT04258553|Protective Agents|protective agents|mesh-ancestor
110521578|NCT04258553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110521579|NCT00938743|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
110521580|NCT00938743|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110521581|NCT00938743|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110521582|NCT00938743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110521583|NCT00938743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110521584|NCT00938743|Adrenergic Agents|adrenergic agents|mesh-ancestor
110521585|NCT00938743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110521586|NCT00938743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110521587|NCT02719392|Acetylcysteine|acetylcysteine|mesh-list
110521588|NCT02719392|Minocycline|minocycline|mesh-list
110521589|NCT02719392|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110521590|NCT02719392|Antiviral Agents|antiviral agents|mesh-ancestor
110521591|NCT02719392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110521592|NCT02719392|Expectorants|expectorants|mesh-ancestor
110521593|NCT02719392|Respiratory System Agents|respiratory system agents|mesh-ancestor
110521594|NCT02719392|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110521595|NCT02719392|Antioxidants|antioxidants|mesh-ancestor
110521596|NCT02719392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110521597|NCT02719392|Protective Agents|protective agents|mesh-ancestor
110916923|NCT05037994|Gabapentin|gabapentin|mesh-list
110521598|NCT02719392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110521599|NCT02719392|Antidotes|antidotes|mesh-ancestor
110521600|NCT02719392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110521601|NCT02802098|Bevacizumab|bevacizumab|mesh-list
110521602|NCT02802098|Durvalumab|durvalumab|mesh-list
110521603|NCT02802098|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110521604|NCT02802098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110521605|NCT02802098|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110521606|NCT02802098|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110521607|NCT02802098|Growth Substances|growth substances|mesh-ancestor
110521608|NCT02802098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110521609|NCT02802098|Growth Inhibitors|growth inhibitors|mesh-ancestor
110521612|NCT00938821|Anesthetics, Local|anesthetics, local|mesh-ancestor
110521614|NCT00938821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110521615|NCT00938821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110521616|NCT00938821|Sensory System Agents|sensory system agents|mesh-ancestor
110521617|NCT00938821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110521618|NCT00938821|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110521619|NCT00938821|Narcotics|narcotics|mesh-ancestor
110521620|NCT00938821|Analgesics|analgesics|mesh-ancestor
110521621|NCT04013581|Empagliflozin|empagliflozin|mesh-list
110521622|NCT04013581|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110521623|NCT04013581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110521624|NCT04013581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110521625|NCT04013581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110521626|NCT02715960|Vitamin A|vitamin a|mesh-list
110521627|NCT02715960|Tretinoin|tretinoin|mesh-list
110521628|NCT02715960|Acitretin|acitretin|mesh-list
110521629|NCT02715960|Vitamins|vitamins|mesh-ancestor
110521630|NCT02715960|Micronutrients|micronutrients|mesh-ancestor
110521631|NCT02715960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110521632|NCT02715960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110521633|NCT02715960|Keratolytic Agents|keratolytic agents|mesh-ancestor
110521634|NCT02715960|Dermatologic Agents|dermatologic agents|mesh-ancestor
110521635|NCT03983018|Rituximab|rituximab|mesh-list
110521636|NCT03983018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110521637|NCT03983018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110521638|NCT03983018|Immunologic Factors|immunologic factors|mesh-ancestor
110521639|NCT03983018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110521640|NCT03983018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110521641|NCT02794922|Vitamin B Complex|vitamin b complex|mesh-list
110521642|NCT02794922|Vitamins|vitamins|mesh-ancestor
110521643|NCT02794922|Micronutrients|micronutrients|mesh-ancestor
110521644|NCT02794922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110521645|NCT00935467|Saxagliptin|saxagliptin|mesh-list
110521646|NCT00935467|Incretins|incretins|mesh-ancestor
110521648|NCT00935467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110521649|NCT00935467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110521650|NCT00935467|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110521651|NCT00935467|Protease Inhibitors|protease inhibitors|mesh-ancestor
110521652|NCT00935467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110521653|NCT00935467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110521654|NCT00935467|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110521655|NCT00935545|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
110521656|NCT00935545|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110521657|NCT00935545|Immunologic Factors|immunologic factors|mesh-ancestor
110521658|NCT00935545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110521662|NCT00936013|Oseltamivir|oseltamivir|mesh-list
110521663|NCT00936013|Antiviral Agents|antiviral agents|mesh-ancestor
110521664|NCT00936013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110521665|NCT00936013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110521666|NCT00936013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110521667|NCT00936091|Vitamin A|vitamin a|mesh-list
110521668|NCT00936091|Vitamins|vitamins|mesh-ancestor
110521669|NCT00936091|Micronutrients|micronutrients|mesh-ancestor
110521670|NCT00936091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110521671|NCT00563797|Mecamylamine|mecamylamine|mesh-list
110521672|NCT00563797|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110521673|NCT00563797|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
110521674|NCT00563797|Autonomic Agents|autonomic agents|mesh-ancestor
110521675|NCT00563797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110521676|NCT00563797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110521677|NCT00563797|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
110521678|NCT00563797|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110521679|NCT00563797|Cholinergic Agents|cholinergic agents|mesh-ancestor
110521680|NCT00563797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110521681|NCT00563797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110521682|NCT01192698|Interferons|interferons|mesh-list
110521683|NCT01192698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110521684|NCT01192698|Antiviral Agents|antiviral agents|mesh-ancestor
110521685|NCT01192698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110521686|NCT04014361|Itraconazole|itraconazole|mesh-list
110521687|NCT04014361|Antifungal Agents|antifungal agents|mesh-ancestor
110521688|NCT04014361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110521691|NCT04014361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110521692|NCT04014361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110521693|NCT04014361|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110521694|NCT04014361|Hormone Antagonists|hormone antagonists|mesh-ancestor
110191369|NCT00055887|Gemcitabine|gemcitabine|mesh-list
110521695|NCT04014361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110521696|NCT04014361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110521697|NCT04014361|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110521698|NCT00771927|Lacosamide|lacosamide|mesh-list
110521699|NCT00771927|Anticonvulsants|anticonvulsants|mesh-ancestor
110521700|NCT00771927|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110521701|NCT00771927|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110521702|NCT00771927|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110521703|NCT00771927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110521704|NCT02715492|Enoxaparin|enoxaparin|mesh-list
110521705|NCT02715492|Anticoagulants|anticoagulants|mesh-ancestor
110521706|NCT02715492|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110521707|NCT02715492|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110521708|NCT02715492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110521709|NCT03940196|Paclitaxel|paclitaxel|mesh-list
110521710|NCT03940196|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110521711|NCT03940196|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110521712|NCT03940196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110521713|NCT03940196|Tubulin Modulators|tubulin modulators|mesh-ancestor
110521714|NCT03940196|Antimitotic Agents|antimitotic agents|mesh-ancestor
110521715|NCT03940196|Mitosis Modulators|mitosis modulators|mesh-ancestor
110521716|NCT03940196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110521717|NCT03988179|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
110521718|NCT03988179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110521719|NCT03988179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110521720|NCT03988179|Cholinergic Agents|cholinergic agents|mesh-ancestor
110521721|NCT03988179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110521722|NCT03988179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110521723|NCT02724150|Omeprazole|omeprazole|mesh-list
110521724|NCT02724150|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110521725|NCT02724150|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110521726|NCT02724150|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110521727|NCT02724150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110521728|NCT02724150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110521729|NCT00936247|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110169190|NCT00037804|Irinotecan|irinotecan|mesh-list
110521731|NCT02715336|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110521732|NCT02715336|Fertility Agents|fertility agents|mesh-ancestor
110521733|NCT02715336|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110521734|NCT02715336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110521735|NCT02715336|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110521736|NCT02715336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110521737|NCT02794610|Tacrolimus|tacrolimus|mesh-list
110521738|NCT02794610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110521739|NCT02794610|Immunologic Factors|immunologic factors|mesh-ancestor
110521740|NCT02794610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110521741|NCT02794610|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110521742|NCT02794610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110521743|NCT02794610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110521744|NCT02799758|Pitavastatin|pitavastatin|mesh-list
110521745|NCT02799758|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110521746|NCT02799758|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110521747|NCT02799758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110521748|NCT02799758|Antimetabolites|antimetabolites|mesh-ancestor
110521749|NCT02799758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110521750|NCT02799758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110521751|NCT02799758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110521752|NCT00938899|Simeprevir|simeprevir|mesh-list
110521753|NCT00938899|Antiviral Agents|antiviral agents|mesh-ancestor
110521754|NCT00938899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110521755|NCT00938899|Protease Inhibitors|protease inhibitors|mesh-ancestor
110521756|NCT00938899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110521757|NCT00938899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110521758|NCT03259165|Diuretics|diuretics|mesh-list
110521766|NCT04013659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110521767|NCT00939133|Tretinoin|tretinoin|mesh-list
110521768|NCT00939133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110521769|NCT00939133|Keratolytic Agents|keratolytic agents|mesh-ancestor
110521770|NCT00939133|Dermatologic Agents|dermatologic agents|mesh-ancestor
110521771|NCT02799446|Reslizumab|reslizumab|mesh-list
110521772|NCT02799446|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110521773|NCT02799446|Respiratory System Agents|respiratory system agents|mesh-ancestor
110521774|NCT00564889|Dexamethasone|dexamethasone|mesh-list
110521775|NCT00564889|Cyclophosphamide|cyclophosphamide|mesh-list
110521776|NCT00564889|Lenalidomide|lenalidomide|mesh-list
110521777|NCT00564889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110521778|NCT00564889|Immunologic Factors|immunologic factors|mesh-ancestor
110521779|NCT00564889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110521780|NCT00564889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110521781|NCT00564889|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110521782|NCT00564889|Alkylating Agents|alkylating agents|mesh-ancestor
110521783|NCT00564889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110521784|NCT00564889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110521785|NCT00564889|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110521786|NCT00564889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110521787|NCT00564889|Antiemetics|antiemetics|mesh-ancestor
110521788|NCT00564889|Autonomic Agents|autonomic agents|mesh-ancestor
110521789|NCT00564889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110521790|NCT00564889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110521791|NCT00564889|Glucocorticoids|glucocorticoids|mesh-ancestor
110521792|NCT00564889|Hormones|hormones|mesh-ancestor
110521793|NCT00564889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110521794|NCT00564889|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110521795|NCT00564889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110521796|NCT00564889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110521797|NCT00564889|Growth Substances|growth substances|mesh-ancestor
110521798|NCT00564889|Growth Inhibitors|growth inhibitors|mesh-ancestor
110521799|NCT02790164|Rocuronium|rocuronium|mesh-list
110521800|NCT02790164|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110521801|NCT02790164|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110521802|NCT02790164|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110521803|NCT02790164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110521804|NCT02790164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110521806|NCT00939757|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
110521807|NCT00939757|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110521808|NCT00939757|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110521809|NCT00939757|Adrenergic Agents|adrenergic agents|mesh-ancestor
110521810|NCT00939757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110521811|NCT00939757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110312152|NCT00292526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110521812|NCT00939757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110521813|NCT00939757|Urological Agents|urological agents|mesh-ancestor
110521815|NCT05415644|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110521816|NCT05415644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110521817|NCT00939835|Dexetimide|dexetimide|mesh-list
110521818|NCT00939835|Citalopram|citalopram|mesh-list
110521819|NCT00939835|Escitalopram|escitalopram|mesh-list
110521820|NCT00939835|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110521821|NCT00939835|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110521822|NCT00939835|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110521823|NCT00939835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110521824|NCT00939835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110521825|NCT00939835|Serotonin Agents|serotonin agents|mesh-ancestor
110521835|NCT00939835|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110521836|NCT00939835|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110521837|NCT00939835|Cholinergic Agents|cholinergic agents|mesh-ancestor
110521838|NCT02690012|Magnesium citrate|magnesium citrate|mesh-list
110521839|NCT02690012|Magnesium Oxide|magnesium oxide|mesh-list
110521840|NCT02690012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110521841|NCT02690012|Cathartics|cathartics|mesh-ancestor
110521842|NCT02690012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110521843|NCT02690012|Antacids|antacids|mesh-ancestor
110521844|NCT02793986|Dexmedetomidine|dexmedetomidine|mesh-list
110521845|NCT02793986|Propofol|propofol|mesh-list
110521846|NCT02793986|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110521847|NCT02793986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110521848|NCT02793986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110521849|NCT02793986|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110521850|NCT02793986|Analgesics|analgesics|mesh-ancestor
110521851|NCT02793986|Sensory System Agents|sensory system agents|mesh-ancestor
110521852|NCT02793986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110521853|NCT02793986|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110521854|NCT02793986|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110521855|NCT02793986|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110521856|NCT02793986|Adrenergic Agents|adrenergic agents|mesh-ancestor
110521857|NCT02793986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110521858|NCT02793986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110521859|NCT02793986|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110521860|NCT02793986|Anesthetics, General|anesthetics, general|mesh-ancestor
110521861|NCT02793986|Anesthetics|anesthetics|mesh-ancestor
110521862|NCT00940069|Pemetrexed|pemetrexed|mesh-list
110521863|NCT00940069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110521864|NCT00940069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110521865|NCT00940069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110521866|NCT00940069|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110521867|NCT00940069|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110521868|NCT00940303|Leucovorin|leucovorin|mesh-list
110521869|NCT00940303|Bevacizumab|bevacizumab|mesh-list
110521870|NCT00940303|Oxaliplatin|oxaliplatin|mesh-list
110521871|NCT00940303|Irinotecan|irinotecan|mesh-list
110521872|NCT00940303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110521873|NCT00940303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110521874|NCT00940303|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110521875|NCT00940303|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110521876|NCT00940303|Growth Substances|growth substances|mesh-ancestor
110521877|NCT00940303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110521878|NCT00940303|Growth Inhibitors|growth inhibitors|mesh-ancestor
110521879|NCT00940303|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110521880|NCT00940303|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110521881|NCT00940303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110521882|NCT00940303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110521883|NCT00940303|Antidotes|antidotes|mesh-ancestor
110521884|NCT00940303|Protective Agents|protective agents|mesh-ancestor
110521885|NCT00940303|Vitamin B Complex|vitamin b complex|mesh-ancestor
110521886|NCT00940303|Vitamins|vitamins|mesh-ancestor
110521887|NCT00940303|Micronutrients|micronutrients|mesh-ancestor
110521888|NCT02794220|Nicotine|nicotine|mesh-list
110521889|NCT02794220|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110521890|NCT02794220|Autonomic Agents|autonomic agents|mesh-ancestor
110521891|NCT02794220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110179633|NCT00847119|Bevacizumab|bevacizumab|mesh-list
110521906|NCT00941083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110521908|NCT04405999|Expectorants|expectorants|mesh-ancestor
110521909|NCT04405999|Respiratory System Agents|respiratory system agents|mesh-ancestor
110521910|NCT02793908|Progesterone|progesterone|mesh-list
110521911|NCT02793908|Progestins|progestins|mesh-ancestor
110521912|NCT02793908|Hormones|hormones|mesh-ancestor
110521913|NCT02793908|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110521914|NCT02793908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110521915|NCT02789930|Anesthetics|anesthetics|mesh-list
110521916|NCT02789930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110521917|NCT02789930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110521918|NCT00560833|Mirtazapine|mirtazapine|mesh-list
110521919|NCT00560833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110521920|NCT00560833|Antidepressive Agents|antidepressive agents|mesh-ancestor
110521921|NCT00560833|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110521922|NCT00560833|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110521923|NCT00560833|Histamine Antagonists|histamine antagonists|mesh-ancestor
110521924|NCT00560833|Histamine Agents|histamine agents|mesh-ancestor
110521925|NCT00560833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110521926|NCT00560833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110521927|NCT00560833|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110521928|NCT00560833|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110521929|NCT00560833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110521930|NCT00560833|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
110521931|NCT00560833|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110191478|NCT00056082|Analgesics|analgesics|mesh-ancestor
110521932|NCT00560833|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110521933|NCT00560833|Adrenergic Agents|adrenergic agents|mesh-ancestor
110521934|NCT00560833|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110521935|NCT00560833|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110521936|NCT00560833|Serotonin Agents|serotonin agents|mesh-ancestor
110521937|NCT00560833|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110521938|NCT00941161|Metformin|metformin|mesh-list
110521939|NCT00941161|Glimepiride|glimepiride|mesh-list
110521940|NCT00941161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110521941|NCT00941161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110521942|NCT00941161|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110521943|NCT00941161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110521944|NCT00941161|Immunologic Factors|immunologic factors|mesh-ancestor
110521945|NCT00944515|Azithromycin|azithromycin|mesh-list
110521946|NCT00944515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110521947|NCT00944515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110521948|NCT00771654|Phentermine|phentermine|mesh-list
110521949|NCT00771654|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110521950|NCT00771654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110521951|NCT00771654|Appetite Depressants|appetite depressants|mesh-ancestor
110521952|NCT00771654|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110521966|NCT04235426|Micronutrients|micronutrients|mesh-ancestor
110521967|NCT04235426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110521968|NCT04235426|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110521969|NCT04235426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110521970|NCT04235426|Analgesics|analgesics|mesh-ancestor
110521971|NCT04235426|Sensory System Agents|sensory system agents|mesh-ancestor
110521972|NCT04235426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110521973|NCT04235426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110521974|NCT04235426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110521975|NCT04235426|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110521976|NCT04235426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110521977|NCT04235426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110521978|NCT04235426|Vitamin B Complex|vitamin b complex|mesh-ancestor
110521979|NCT04235426|Hematinics|hematinics|mesh-ancestor
110521980|NCT02793440|Cortivazol|cortivazol|mesh-list
110521981|NCT02793440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110521982|NCT02723838|Gemcitabine|gemcitabine|mesh-list
110521983|NCT02723838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110521984|NCT02723838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110521985|NCT02723838|Antimetabolites|antimetabolites|mesh-ancestor
110521986|NCT02723838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110521987|NCT02789150|Norepinephrine|norepinephrine|mesh-list
110521988|NCT02789150|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110521989|NCT02789150|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110521990|NCT02789150|Adrenergic Agents|adrenergic agents|mesh-ancestor
110521991|NCT02789150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110521992|NCT02789150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110521993|NCT02789150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110521994|NCT02789150|Sympathomimetics|sympathomimetics|mesh-ancestor
110521995|NCT02789150|Autonomic Agents|autonomic agents|mesh-ancestor
110521996|NCT02789150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110521997|NCT02789150|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110521998|NCT02715024|Tamsulosin|tamsulosin|mesh-list
110521999|NCT02715024|Solifenacin Succinate|solifenacin succinate|mesh-list
110917100|NCT01066923|Aspirin|aspirin|mesh-list
110191505|NCT00028496|Vaccines|vaccines|mesh-list
110522001|NCT02715024|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110522002|NCT02715024|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110522003|NCT02715024|Adrenergic Agents|adrenergic agents|mesh-ancestor
110522004|NCT02715024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110522005|NCT02715024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110522006|NCT02715024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110522007|NCT02715024|Urological Agents|urological agents|mesh-ancestor
110522008|NCT02715024|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110522009|NCT02715024|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110522010|NCT02715024|Cholinergic Agents|cholinergic agents|mesh-ancestor
110522011|NCT02798744|Empagliflozin|empagliflozin|mesh-list
110522012|NCT02798744|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110522013|NCT02798744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110522014|NCT02798744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110522015|NCT02798744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110522016|NCT00925769|Bevacizumab|bevacizumab|mesh-list
110522017|NCT00925769|Capecitabine|capecitabine|mesh-list
110522031|NCT00770913|Rabeprazole|rabeprazole|mesh-list
110522032|NCT00770913|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110522033|NCT00770913|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110522034|NCT00770913|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110522035|NCT00770913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110522036|NCT00770913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110522038|NCT00562861|Carbamazepine|carbamazepine|mesh-list
110522039|NCT00562861|Valproic Acid|valproic acid|mesh-list
110522040|NCT00562861|Citalopram|citalopram|mesh-list
110522041|NCT00562861|Anticonvulsants|anticonvulsants|mesh-ancestor
110522042|NCT00562861|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110522043|NCT00562861|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110522044|NCT00562861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110522045|NCT00562861|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110522046|NCT00562861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110522047|NCT00562861|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110522048|NCT00562861|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110917123|NCT03530150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110917124|NCT03530150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110917125|NCT03530150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110917126|NCT02098590|Chloroquine|chloroquine|mesh-list
110917127|NCT02098590|Atovaquone|atovaquone|mesh-list
110917128|NCT02098590|Proguanil|proguanil|mesh-list
110917129|NCT02098590|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
110917130|NCT02098590|Amebicides|amebicides|mesh-ancestor
110917131|NCT02098590|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110917132|NCT02098590|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110522049|NCT00562861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110522050|NCT00562861|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110522051|NCT00562861|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110522052|NCT00562861|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110522053|NCT00562861|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110522054|NCT00562861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110522055|NCT00562861|Serotonin Agents|serotonin agents|mesh-ancestor
110522056|NCT00562861|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110522057|NCT00562861|Antidepressive Agents|antidepressive agents|mesh-ancestor
110522058|NCT00562861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110522059|NCT00562861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110522060|NCT00562861|GABA Agents|gaba agents|mesh-ancestor
110522061|NCT00562861|Antimanic Agents|antimanic agents|mesh-ancestor
110522062|NCT00562861|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110522063|NCT00562861|Analgesics|analgesics|mesh-ancestor
110522064|NCT00562861|Sensory System Agents|sensory system agents|mesh-ancestor
110522065|NCT00562861|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110522066|NCT00562861|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110522067|NCT02723448|Aclarubicin|aclarubicin|mesh-list
110522068|NCT02723448|Aclacinomycins|aclacinomycins|mesh-list
110522069|NCT02723448|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110522070|NCT02723448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110522071|NCT02723448|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110522072|NCT02723448|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110522073|NCT02723448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110522074|NCT02723448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110522075|NCT02723448|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110522076|NCT02723448|Immunologic Factors|immunologic factors|mesh-ancestor
110522077|NCT02723448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110522078|NCT02798510|Gemcitabine|gemcitabine|mesh-list
110522079|NCT02798510|Capecitabine|capecitabine|mesh-list
110522080|NCT02798510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110522094|NCT04258475|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110522095|NCT04258475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110522096|NCT04258475|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110522097|NCT04258475|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110522098|NCT04258475|Antiviral Agents|antiviral agents|mesh-ancestor
110522099|NCT04258475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110522100|NCT04258475|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110522101|NCT04258475|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110522102|NCT04258475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110522103|NCT04258475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110522104|NCT00609011|Temozolomide|temozolomide|mesh-list
110522105|NCT00609011|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110522106|NCT00609011|Alkylating Agents|alkylating agents|mesh-ancestor
110522107|NCT00609011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110522108|NCT00609011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110522110|NCT00770679|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110522111|NCT00770679|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110522112|NCT00770679|Antimetabolites|antimetabolites|mesh-ancestor
110522113|NCT00770679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110522114|NCT00770679|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110522115|NCT00770679|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110522116|NCT00770679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110522118|NCT04042116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110522119|NCT04042116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110522120|NCT04042116|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110522121|NCT04042116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110522122|NCT04260581|Amantadine|amantadine|mesh-list
110522123|NCT04260581|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110522124|NCT04260581|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110522125|NCT04260581|Antiviral Agents|antiviral agents|mesh-ancestor
110522126|NCT04260581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110522127|NCT04260581|Dopamine Agents|dopamine agents|mesh-ancestor
110522128|NCT04260581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110522129|NCT04260581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110522130|NCT04260581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110522131|NCT04260581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110522132|NCT04260581|Analgesics|analgesics|mesh-ancestor
110522133|NCT04260581|Sensory System Agents|sensory system agents|mesh-ancestor
110522134|NCT04260581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110522135|NCT00770367|Pioglitazone|pioglitazone|mesh-list
110522136|NCT00770367|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110522137|NCT00770367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110522138|NCT00941785|Amodiaquine|amodiaquine|mesh-list
110522139|NCT00941785|Antimalarials|antimalarials|mesh-ancestor
110522140|NCT00941785|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110522141|NCT00941785|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110522142|NCT00941785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110522146|NCT02793050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110522147|NCT02793050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110522148|NCT00944905|MDX-1203|mdx-1203|mesh-list
110522149|NCT00944905|Immunoconjugates|immunoconjugates|mesh-ancestor
110522150|NCT00944905|Immunologic Factors|immunologic factors|mesh-ancestor
110522151|NCT00944905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110522152|NCT00942253|Dopamine|dopamine|mesh-list
110522153|NCT00942253|Dopamine Agonists|dopamine agonists|mesh-list
110522154|NCT00942253|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110522155|NCT00942253|Sympathomimetics|sympathomimetics|mesh-ancestor
110522156|NCT00942253|Autonomic Agents|autonomic agents|mesh-ancestor
110522157|NCT00942253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110522158|NCT00942253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110522159|NCT00942253|Dopamine Agents|dopamine agents|mesh-ancestor
110522160|NCT00942253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110522161|NCT00942253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110522162|NCT00942253|Protective Agents|protective agents|mesh-ancestor
110522163|NCT02792816|Artesunate|artesunate|mesh-list
110522165|NCT02792816|Piperaquine|piperaquine|mesh-list
110522166|NCT02792816|Artenimol|artenimol|mesh-list
110522167|NCT02792816|Mefloquine|mefloquine|mesh-list
110522168|NCT02792816|Antimalarials|antimalarials|mesh-list
110522169|NCT02792816|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110522170|NCT02792816|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110522171|NCT02792816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110522172|NCT02792816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110522173|NCT02792816|Antiviral Agents|antiviral agents|mesh-ancestor
110522174|NCT02792816|Schistosomicides|schistosomicides|mesh-ancestor
110522175|NCT02792816|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110522176|NCT02792816|Anthelmintics|anthelmintics|mesh-ancestor
110522177|NCT00940381|Sirolimus|sirolimus|mesh-list
110522178|NCT00940381|Cetuximab|cetuximab|mesh-list
110522179|NCT00940381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110522180|NCT00940381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110522181|NCT00940381|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110522182|NCT00940381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110522183|NCT00940381|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110522184|NCT00940381|Antifungal Agents|antifungal agents|mesh-ancestor
110522185|NCT00940381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110522186|NCT00940381|Immunologic Factors|immunologic factors|mesh-ancestor
110522187|NCT00940381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110522190|NCT00637988|Esomeprazole|esomeprazole|mesh-list
110522191|NCT00637988|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110522192|NCT00637988|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110522193|NCT00637988|Analgesics|analgesics|mesh-ancestor
110522194|NCT00637988|Sensory System Agents|sensory system agents|mesh-ancestor
110522195|NCT00637988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110522196|NCT00637988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110522197|NCT00637988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110522198|NCT00637988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110522199|NCT00637988|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110522200|NCT00637988|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110522201|NCT00637988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110522202|NCT00637988|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110522203|NCT00637988|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110522204|NCT00637988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110522205|NCT00637988|Antipyretics|antipyretics|mesh-ancestor
110522206|NCT00637988|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110522207|NCT00637988|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110522208|NCT00637988|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110522209|NCT00637988|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110522210|NCT04258163|Gemcitabine|gemcitabine|mesh-list
110522211|NCT04258163|Capecitabine|capecitabine|mesh-list
110522212|NCT04258163|Doxorubicin|doxorubicin|mesh-list
110522213|NCT04258163|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110522214|NCT04258163|Letrozole|letrozole|mesh-list
110522215|NCT04258163|Fulvestrant|fulvestrant|mesh-list
110522216|NCT04258163|Anastrozole|anastrozole|mesh-list
110522217|NCT04258163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110522218|NCT04258163|Antimetabolites|antimetabolites|mesh-ancestor
110522219|NCT04258163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110522220|NCT04258163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110522232|NCT04258163|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110522233|NCT00942487|Nebivolol|nebivolol|mesh-list
110522234|NCT00942487|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110522235|NCT00942487|Vasodilator Agents|vasodilator agents|mesh-ancestor
110522236|NCT00942487|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
110522237|NCT00942487|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110522238|NCT00942487|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110522239|NCT00942487|Adrenergic Agents|adrenergic agents|mesh-ancestor
110522240|NCT00942487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110522241|NCT00942487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110522242|NCT00942487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110522243|NCT00611039|Ritonavir|ritonavir|mesh-list
110522244|NCT00611039|Darunavir|darunavir|mesh-list
110522245|NCT00611039|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110522246|NCT00611039|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110522247|NCT00611039|Protease Inhibitors|protease inhibitors|mesh-ancestor
110522248|NCT00611039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110522249|NCT00611039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110522250|NCT00611039|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110522251|NCT00611039|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110522252|NCT00611039|Antiviral Agents|antiviral agents|mesh-ancestor
110522253|NCT00611039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110522254|NCT00611039|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110522255|NCT00611039|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110522256|NCT00942565|Acetaminophen|acetaminophen|mesh-list
110522257|NCT00942565|Tramadol|tramadol|mesh-list
110522258|NCT00942565|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110522260|NCT00942565|Sensory System Agents|sensory system agents|mesh-ancestor
110522261|NCT00942565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110522262|NCT00942565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110522263|NCT00942565|Antipyretics|antipyretics|mesh-ancestor
110522264|NCT00942565|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110522265|NCT00942565|Narcotics|narcotics|mesh-ancestor
110522266|NCT00942565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110522267|NCT00945373|Calcium Dobesilate|calcium dobesilate|mesh-list
110522268|NCT00945373|Calcium|calcium|mesh-list
110522269|NCT00945373|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110522270|NCT00945373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110522271|NCT00945373|Hemostatics|hemostatics|mesh-ancestor
110522272|NCT00945373|Coagulants|coagulants|mesh-ancestor
110522273|NCT04100655|Molgramostim|molgramostim|mesh-list
110522274|NCT04100655|Estradiol|estradiol|mesh-list
110522275|NCT04100655|Sargramostim|sargramostim|mesh-list
110522276|NCT04100655|Estrogens|estrogens|mesh-ancestor
110522277|NCT04100655|Hormones|hormones|mesh-ancestor
110522278|NCT04100655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110522279|NCT04100655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110522280|NCT04100655|Immunologic Factors|immunologic factors|mesh-ancestor
110522281|NCT04100655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110522282|NCT02792426|Nicotine|nicotine|mesh-list
110522283|NCT02792426|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110522284|NCT02792426|Autonomic Agents|autonomic agents|mesh-ancestor
110522285|NCT02792426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110522299|NCT00770211|Cholinergic Agents|cholinergic agents|mesh-ancestor
110522300|NCT00770211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110522301|NCT00770211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110522302|NCT00770211|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110522303|NCT00770211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110522304|NCT02792036|Carboplatin|carboplatin|mesh-list
110522305|NCT02792036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110522306|NCT02797340|Metformin|metformin|mesh-list
110522307|NCT02797340|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110522308|NCT02797340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110522309|NCT00928187|Ritonavir|ritonavir|mesh-list
110522310|NCT00928187|Lopinavir|lopinavir|mesh-list
110522311|NCT00928187|Darunavir|darunavir|mesh-list
110522312|NCT00928187|Tenofovir|tenofovir|mesh-list
110522313|NCT00928187|Emtricitabine|emtricitabine|mesh-list
110522314|NCT00928187|Abacavir|abacavir|mesh-list
110522315|NCT00928187|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110522316|NCT00928187|Didanosine|didanosine|mesh-list
110522317|NCT00928187|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110522318|NCT00928187|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110522319|NCT00928187|Protease Inhibitors|protease inhibitors|mesh-ancestor
110522320|NCT00928187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110522321|NCT00928187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110522322|NCT00928187|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110522323|NCT00928187|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110522324|NCT00928187|Antiviral Agents|antiviral agents|mesh-ancestor
110522325|NCT00928187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110522326|NCT00928187|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110522327|NCT00928187|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110522328|NCT00928187|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110522329|NCT00928187|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110522330|NCT00928187|Antimetabolites|antimetabolites|mesh-ancestor
110169797|NCT00015990|Thalidomide|thalidomide|mesh-list
110522332|NCT04235270|Macitentan|macitentan|mesh-list
110522333|NCT04235270|Vasodilator Agents|vasodilator agents|mesh-ancestor
110522334|NCT04235270|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110522335|NCT04235270|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110522336|NCT04235270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110522337|NCT04235270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110522338|NCT04235270|Urological Agents|urological agents|mesh-ancestor
110522339|NCT04235270|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
110522340|NCT04235270|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
110522341|NCT04235270|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
110522343|NCT04256525|Heparin|heparin|mesh-list
110522344|NCT04256525|Rivaroxaban|rivaroxaban|mesh-list
110522345|NCT04256525|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110522346|NCT04256525|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110179707|NCT00012389|Irinotecan|irinotecan|mesh-list
110522356|NCT04256525|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110522357|NCT04256525|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110522358|NCT04256525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110522359|NCT04256525|Antipyretics|antipyretics|mesh-ancestor
110522360|NCT04256525|Anticoagulants|anticoagulants|mesh-ancestor
110522361|NCT04256525|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110522362|NCT04256525|Antithrombins|antithrombins|mesh-ancestor
110522363|NCT04256525|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110522364|NCT04256525|Protease Inhibitors|protease inhibitors|mesh-ancestor
110522366|NCT02791958|Atorvastatin|atorvastatin|mesh-list
110522367|NCT02791958|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110522368|NCT02791958|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110522369|NCT02791958|Antimetabolites|antimetabolites|mesh-ancestor
110522370|NCT02791958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110522371|NCT02791958|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110522372|NCT02791958|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110522373|NCT02791958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110522374|NCT02791958|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110522375|NCT02791958|Protease Inhibitors|protease inhibitors|mesh-ancestor
110522376|NCT02791958|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110522377|NCT02601651|Lidocaine|lidocaine|mesh-list
110522378|NCT02601651|Anesthetics, Local|anesthetics, local|mesh-ancestor
110522379|NCT02601651|Anesthetics|anesthetics|mesh-ancestor
110522380|NCT02601651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110522381|NCT02601651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110522382|NCT02601651|Sensory System Agents|sensory system agents|mesh-ancestor
110522383|NCT02601651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110522384|NCT02601651|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110522385|NCT02601651|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110522386|NCT02601651|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110522387|NCT02601651|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110522388|NCT02601651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110522389|NCT00943267|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
110522390|NCT00943267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110522391|NCT00945919|Oxymorphone|oxymorphone|mesh-list
110522392|NCT00945919|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110522393|NCT00945919|Narcotics|narcotics|mesh-ancestor
110917290|NCT02361801|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110522394|NCT00945919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110522395|NCT00945919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110522397|NCT00945919|Sensory System Agents|sensory system agents|mesh-ancestor
110522398|NCT00945919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110522399|NCT00945919|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110522400|NCT00945997|Misoprostol|misoprostol|mesh-list
110522401|NCT00945997|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110522402|NCT00945997|Abortifacient Agents|abortifacient agents|mesh-ancestor
110522403|NCT00945997|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110522404|NCT00945997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110522405|NCT00945997|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110522406|NCT00945997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110522407|NCT00945997|Oxytocics|oxytocics|mesh-ancestor
110522408|NCT00943345|Indomethacin|indomethacin|mesh-list
110522409|NCT00943345|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110522410|NCT00943345|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110522411|NCT00943345|Analgesics|analgesics|mesh-ancestor
110522417|NCT00943345|Gout Suppressants|gout suppressants|mesh-ancestor
110522418|NCT00943345|Tocolytic Agents|tocolytic agents|mesh-ancestor
110522419|NCT00943345|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110522420|NCT00943345|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110522421|NCT00943345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110522422|NCT00943345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110522423|NCT02797028|Allopurinol|allopurinol|mesh-list
110522424|NCT02797028|Antimetabolites|antimetabolites|mesh-ancestor
110522425|NCT02797028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110522426|NCT02797028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110522427|NCT02797028|Gout Suppressants|gout suppressants|mesh-ancestor
110522428|NCT02797028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110522429|NCT02797028|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110522430|NCT02797028|Antioxidants|antioxidants|mesh-ancestor
110522431|NCT02797028|Protective Agents|protective agents|mesh-ancestor
110522432|NCT02797028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110522433|NCT00916461|Minocycline|minocycline|mesh-list
110522434|NCT00916461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110522435|NCT00916461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110522436|NCT04260035|Vasoactive Intestinal Peptide|vasoactive intestinal peptide|mesh-list
110917327|NCT03965728|Anesthetics|anesthetics|mesh-ancestor
110522437|NCT04260035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110522438|NCT04260035|Vasodilator Agents|vasodilator agents|mesh-ancestor
110522439|NCT04260035|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110522440|NCT04260035|Protective Agents|protective agents|mesh-ancestor
110522441|NCT04260035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110522442|NCT00768651|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110522443|NCT00768651|Pantoprazole|pantoprazole|mesh-list
110522444|NCT00768651|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110522445|NCT00768651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110522446|NCT00768651|Incretins|incretins|mesh-ancestor
110522447|NCT00768651|Hormones|hormones|mesh-ancestor
110522448|NCT00768651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110522449|NCT00768651|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110522450|NCT00768651|Protease Inhibitors|protease inhibitors|mesh-ancestor
110522451|NCT00768651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110522452|NCT00768651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110522453|NCT00768651|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110522454|NCT00768651|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110522455|NCT00768651|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110522456|NCT00943501|Liraglutide|liraglutide|mesh-list
110522457|NCT00943501|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110522458|NCT00943501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110522459|NCT00943501|Incretins|incretins|mesh-ancestor
110522460|NCT00943501|Hormones|hormones|mesh-ancestor
110522461|NCT00943501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110522462|NCT04258241|Bupivacaine|bupivacaine|mesh-list
110522463|NCT04258241|Anesthetics, Local|anesthetics, local|mesh-list
110522464|NCT04258241|Anesthetics|anesthetics|mesh-list
110522465|NCT04258241|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110522466|NCT04258241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110522467|NCT04258241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110522468|NCT04258241|Sensory System Agents|sensory system agents|mesh-ancestor
110522469|NCT04258241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110522470|NCT02796794|Genistein|genistein|mesh-list
110522471|NCT02796794|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110522472|NCT02796794|Protective Agents|protective agents|mesh-ancestor
110522473|NCT02796794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110522474|NCT02796794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110522475|NCT02796794|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110522476|NCT02796794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110522477|NCT02796794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110522478|NCT02796794|Phytoestrogens|phytoestrogens|mesh-ancestor
110522479|NCT02796794|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
110169937|NCT00016302|Antiemetics|antiemetics|mesh-ancestor
110522492|NCT04097613|Respiratory System Agents|respiratory system agents|mesh-ancestor
110522493|NCT04097613|Glucocorticoids|glucocorticoids|mesh-ancestor
110522494|NCT04097613|Hormones|hormones|mesh-ancestor
110522495|NCT04097613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110522496|NCT04097613|Plasma Substitutes|plasma substitutes|mesh-ancestor
110522497|NCT04097613|Blood Substitutes|blood substitutes|mesh-ancestor
110522498|NCT04097613|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110522499|NCT04097613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110522500|NCT00946387|Ondansetron|ondansetron|mesh-list
110522501|NCT00946387|Antiemetics|antiemetics|mesh-ancestor
110522502|NCT00946387|Autonomic Agents|autonomic agents|mesh-ancestor
110522503|NCT00946387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110522504|NCT00946387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110522505|NCT00946387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110522506|NCT00946387|Antipruritics|antipruritics|mesh-ancestor
110522507|NCT00946387|Dermatologic Agents|dermatologic agents|mesh-ancestor
110522508|NCT00946387|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110522509|NCT00946387|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110522510|NCT00946387|Serotonin Agents|serotonin agents|mesh-ancestor
110522511|NCT00946387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110522512|NCT00946387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110522513|NCT00916695|Everolimus|everolimus|mesh-list
110522514|NCT00916695|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110522515|NCT00916695|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110522516|NCT00916695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110522517|NCT00916695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110522518|NCT00916695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110522519|NCT00916695|Immunologic Factors|immunologic factors|mesh-ancestor
110522520|NCT00916695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110522521|NCT00916695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110522522|NCT00946465|Ramipril|ramipril|mesh-list
110522523|NCT00946465|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110522524|NCT00946465|Protease Inhibitors|protease inhibitors|mesh-ancestor
110522525|NCT00946465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110522526|NCT00946465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110522527|NCT00946465|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110522528|NCT00756717|3-(4-((4-chlorophenyl)sulfonyl)-4-(2,5-difluorophenyl)cyclohexyl)propanoic acid|3-(4-((4-chlorophenyl)sulfonyl)-4-(2,5-difluorophenyl)cyclohexyl)propanoic acid|mesh-list
110522529|NCT00756717|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
110522530|NCT00756717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110522531|NCT00756717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110522532|NCT06005714|Cyclosporine|cyclosporine|mesh-list
110522533|NCT06005714|Clarithromycin|clarithromycin|mesh-list
110522534|NCT06005714|Cyclosporins|cyclosporins|mesh-list
110522535|NCT06005714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110522536|NCT06005714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110522537|NCT06005714|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110522538|NCT06005714|Immunologic Factors|immunologic factors|mesh-ancestor
110522539|NCT06005714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110522540|NCT06005714|Antifungal Agents|antifungal agents|mesh-ancestor
110522541|NCT06005714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110522576|NCT06005363|Adrenergic Agents|adrenergic agents|mesh-ancestor
110522577|NCT06005363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110522578|NCT06005363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110522579|NCT06005324|Paclitaxel|paclitaxel|mesh-list
110522580|NCT06005324|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110522581|NCT06005324|Carboplatin|carboplatin|mesh-list
110522582|NCT06005324|Fluorouracil|fluorouracil|mesh-list
110522583|NCT06005324|Cetuximab|cetuximab|mesh-list
110522584|NCT06005324|Hydroxyurea|hydroxyurea|mesh-list
110522585|NCT06005324|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110522586|NCT06005324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110522587|NCT06005324|Tubulin Modulators|tubulin modulators|mesh-ancestor
110522588|NCT06005324|Antimitotic Agents|antimitotic agents|mesh-ancestor
110522589|NCT06005324|Mitosis Modulators|mitosis modulators|mesh-ancestor
110522590|NCT06005324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110522591|NCT06005324|Antimetabolites|antimetabolites|mesh-ancestor
110522592|NCT06005324|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110522602|NCT06005259|Hormone Antagonists|hormone antagonists|mesh-ancestor
110522603|NCT06005259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110522604|NCT06005259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110522605|NCT06005259|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110522607|NCT06005259|Natriuretic Agents|natriuretic agents|mesh-ancestor
110522608|NCT06005207|Progesterone|progesterone|mesh-list
110522609|NCT06005207|Progestins|progestins|mesh-ancestor
110522610|NCT06005207|Hormones|hormones|mesh-ancestor
110522611|NCT06005207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110522612|NCT06005207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110522613|NCT06005168|Cefazolin|cefazolin|mesh-list
110522614|NCT06005168|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110522615|NCT06005168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110522616|NCT06005155|Valproic Acid|valproic acid|mesh-list
110522617|NCT06005155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110522618|NCT06005155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110522619|NCT06005155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110522620|NCT06005155|Antimanic Agents|antimanic agents|mesh-ancestor
110522621|NCT06005155|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110522622|NCT06005155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110522623|NCT06005155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110522624|NCT06005155|Anticonvulsants|anticonvulsants|mesh-ancestor
110522625|NCT06005155|GABA Agents|gaba agents|mesh-ancestor
110522626|NCT06005155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110522627|NCT06004947|Itraconazole|itraconazole|mesh-list
110170084|NCT01140516|Antimalarials|antimalarials|mesh-ancestor
110522628|NCT06004947|Rifampin|rifampin|mesh-list
110522629|NCT06004947|Celecoxib|celecoxib|mesh-list
110522630|NCT06004947|Midazolam|midazolam|mesh-list
110522631|NCT06004947|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110522632|NCT06004947|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110522633|NCT06004947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110522634|NCT06004947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110522635|NCT06004947|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110522636|NCT06004947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110522637|NCT06004947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110522638|NCT06004947|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110522639|NCT06004947|Anesthetics, General|anesthetics, general|mesh-ancestor
110522640|NCT06004947|Anesthetics|anesthetics|mesh-ancestor
110522641|NCT06004947|GABA Modulators|gaba modulators|mesh-ancestor
110522642|NCT06004947|GABA Agents|gaba agents|mesh-ancestor
110522643|NCT06004947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110522644|NCT06004947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110522645|NCT06004947|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110522646|NCT06004947|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110522647|NCT06004947|Analgesics|analgesics|mesh-ancestor
110522648|NCT06004947|Sensory System Agents|sensory system agents|mesh-ancestor
110522649|NCT06004947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110522650|NCT06004947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110522651|NCT06004947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110522652|NCT06004947|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110522653|NCT06004947|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110522654|NCT06004947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110522655|NCT06004947|Antifungal Agents|antifungal agents|mesh-ancestor
110522656|NCT06004947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110522657|NCT06004947|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110522660|NCT06004947|Hormone Antagonists|hormone antagonists|mesh-ancestor
110191796|NCT02970084|Hemostatics|hemostatics|mesh-ancestor
110522661|NCT06004947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110522662|NCT06004947|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110522663|NCT06004947|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110522664|NCT06004947|Antitubercular Agents|antitubercular agents|mesh-ancestor
110522665|NCT06004947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110522666|NCT06004947|Leprostatic Agents|leprostatic agents|mesh-ancestor
110522667|NCT06004947|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110522668|NCT06004947|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110522669|NCT06004947|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110522670|NCT06004947|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110522671|NCT06004947|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110522672|NCT06004947|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110522673|NCT06004947|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110522674|NCT06004882|Triamcinolone|triamcinolone|mesh-list
110522675|NCT06004882|Bupivacaine|bupivacaine|mesh-list
110522676|NCT06004882|Anesthetics, Local|anesthetics, local|mesh-ancestor
110522677|NCT06004882|Anesthetics|anesthetics|mesh-ancestor
110522678|NCT06004882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110522679|NCT06004882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110522680|NCT06004882|Sensory System Agents|sensory system agents|mesh-ancestor
110522681|NCT06004882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110522682|NCT06004882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110522683|NCT06004882|Glucocorticoids|glucocorticoids|mesh-ancestor
110522684|NCT06004882|Hormones|hormones|mesh-ancestor
110522685|NCT06004882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110522686|NCT06004843|Propofol|propofol|mesh-list
110522687|NCT06004843|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110522688|NCT06004843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110522689|NCT06004843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110522690|NCT06004843|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110522691|NCT06004843|Anesthetics, General|anesthetics, general|mesh-ancestor
110522692|NCT06004843|Anesthetics|anesthetics|mesh-ancestor
110522693|NCT06004765|Lenalidomide|lenalidomide|mesh-list
110522694|NCT06004765|Azacitidine|azacitidine|mesh-list
110522695|NCT06004765|Immunologic Factors|immunologic factors|mesh-ancestor
110522696|NCT06004765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110522697|NCT06004765|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110522698|NCT06004765|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110522699|NCT06004765|Growth Substances|growth substances|mesh-ancestor
110522700|NCT06004765|Growth Inhibitors|growth inhibitors|mesh-ancestor
110522701|NCT06004765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110522702|NCT06004765|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110522703|NCT06004765|Antimetabolites|antimetabolites|mesh-ancestor
110522704|NCT06004765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110522705|NCT06004765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110522706|NCT06004687|Acetaminophen|acetaminophen|mesh-list
110522708|NCT06004687|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110522709|NCT06004687|Analgesics|analgesics|mesh-ancestor
110522710|NCT06004687|Sensory System Agents|sensory system agents|mesh-ancestor
110522711|NCT06004687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110522712|NCT06004687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110522713|NCT06004687|Antipyretics|antipyretics|mesh-ancestor
110522714|NCT06004687|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110522715|NCT06004687|Diuretics|diuretics|mesh-ancestor
110522716|NCT06004687|Natriuretic Agents|natriuretic agents|mesh-ancestor
110522722|NCT06004661|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
110522723|NCT06004661|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110522724|NCT06004661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110522725|NCT06004479|Carotenoids|carotenoids|mesh-list
110522726|NCT06004479|Antioxidants|antioxidants|mesh-ancestor
110522727|NCT06004479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110522728|NCT06004479|Protective Agents|protective agents|mesh-ancestor
110522729|NCT06004479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110522730|NCT06004401|Amoxicillin|amoxicillin|mesh-list
110522731|NCT06004401|Metronidazole|metronidazole|mesh-list
110522732|NCT06004401|Clarithromycin|clarithromycin|mesh-list
110522733|NCT06004401|Minocycline|minocycline|mesh-list
110522734|NCT06004401|Rabeprazole|rabeprazole|mesh-list
110522735|NCT06004401|Bismuth|bismuth|mesh-list
110522736|NCT06004401|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110917469|NCT02250924|Caffeine|caffeine|mesh-list
110522743|NCT06004401|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110522744|NCT06004401|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110522745|NCT06004401|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110522746|NCT06004401|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110522747|NCT06004401|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110522748|NCT06004401|Antacids|antacids|mesh-ancestor
110522749|NCT06004336|Pembrolizumab|pembrolizumab|mesh-list
110522750|NCT06004336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110522751|NCT06004336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110522752|NCT06004336|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110522753|NCT06004336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110522754|NCT06004115|Lorazepam|lorazepam|mesh-list
110522755|NCT06004115|Anticonvulsants|anticonvulsants|mesh-ancestor
110522756|NCT06004115|Antiemetics|antiemetics|mesh-ancestor
110522757|NCT06004115|Autonomic Agents|autonomic agents|mesh-ancestor
110522758|NCT06004115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110522759|NCT06004115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110522760|NCT06004115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110522761|NCT06004115|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110522762|NCT06004115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110522763|NCT06004115|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110522764|NCT06004115|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110522765|NCT06004115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110522766|NCT06004115|GABA Modulators|gaba modulators|mesh-ancestor
110522767|NCT06004115|GABA Agents|gaba agents|mesh-ancestor
110522768|NCT06004115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110522769|NCT06004115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110522770|NCT06003998|Bevacizumab|bevacizumab|mesh-list
110522771|NCT06003998|Oxaliplatin|oxaliplatin|mesh-list
110522772|NCT06003998|Irinotecan|irinotecan|mesh-list
110522773|NCT06003998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110522774|NCT06003998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110522775|NCT06003998|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110522776|NCT06003998|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110522777|NCT06003998|Growth Substances|growth substances|mesh-ancestor
110522778|NCT06003998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110522779|NCT06003998|Growth Inhibitors|growth inhibitors|mesh-ancestor
110522780|NCT06003998|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110522781|NCT06003998|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110522782|NCT06003998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110191837|NCT00395915|Serotonin Agents|serotonin agents|mesh-ancestor
110522783|NCT06003998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110522784|NCT06003972|Glatiramer Acetate|glatiramer acetate|mesh-list
110522785|NCT06003972|(T,G)-A-L|(t,g)-a-l|mesh-list
110522786|NCT06003972|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110522787|NCT06003972|Immunologic Factors|immunologic factors|mesh-ancestor
110522788|NCT06003972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110522789|NCT06003972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110522790|NCT06003972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110522791|NCT06003608|Levodopa|levodopa|mesh-list
110522792|NCT06003608|Carbidopa|carbidopa|mesh-list
110522793|NCT06003608|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
110522794|NCT06003608|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110522795|NCT06003608|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110522796|NCT06003608|Dopamine Agents|dopamine agents|mesh-ancestor
110522797|NCT06003608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110522798|NCT06003608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110522799|NCT06003608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110522800|NCT06003608|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
110522801|NCT06003608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110522802|NCT06003608|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110522803|NCT06003608|Immunologic Factors|immunologic factors|mesh-ancestor
110522804|NCT06003608|Dopamine Agonists|dopamine agonists|mesh-ancestor
110522805|NCT06003218|Dexmedetomidine|dexmedetomidine|mesh-list
110522812|NCT06003218|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110522814|NCT06003218|Sensory System Agents|sensory system agents|mesh-ancestor
110522815|NCT06003218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110522816|NCT06003218|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110522817|NCT06003218|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110522818|NCT06003218|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110522819|NCT06003218|Adrenergic Agents|adrenergic agents|mesh-ancestor
110522820|NCT06003218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110522821|NCT06003218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110522822|NCT06003218|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110522824|NCT06003218|Antidepressive Agents|antidepressive agents|mesh-ancestor
110522825|NCT06003218|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110522826|NCT05999630|Lubricant Eye Drops|lubricant eye drops|mesh-list
110522827|NCT05999630|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110522828|NCT05999630|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110522829|NCT05999175|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110522830|NCT05999175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110522831|NCT05998317|Dexamethasone|dexamethasone|mesh-list
110522832|NCT05998317|Dexamethasone acetate|dexamethasone acetate|mesh-list
110522833|NCT05998317|BB 1101|bb 1101|mesh-list
110522834|NCT05998317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110522835|NCT05998317|Antiemetics|antiemetics|mesh-ancestor
110522836|NCT05998317|Autonomic Agents|autonomic agents|mesh-ancestor
110522837|NCT05998317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110522838|NCT05998317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110522839|NCT05998317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110522840|NCT05998317|Glucocorticoids|glucocorticoids|mesh-ancestor
110522841|NCT05998317|Hormones|hormones|mesh-ancestor
110522842|NCT05998317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110522843|NCT05998317|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110522844|NCT05998317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110522845|NCT05998317|Protease Inhibitors|protease inhibitors|mesh-ancestor
110522846|NCT05998317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110312165|NCT00418509|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110522847|NCT05998317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110522848|NCT05994638|Niacinamide|niacinamide|mesh-list
110522849|NCT05994638|Hyaluronic Acid|hyaluronic acid|mesh-list
110522850|NCT05994638|Vitamins|vitamins|mesh-ancestor
110522851|NCT05994638|Micronutrients|micronutrients|mesh-ancestor
110522852|NCT05994638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110522853|NCT05994638|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110522854|NCT05994638|Immunologic Factors|immunologic factors|mesh-ancestor
110522855|NCT05994638|Viscosupplements|viscosupplements|mesh-ancestor
110522856|NCT05994638|Protective Agents|protective agents|mesh-ancestor
110522857|NCT05994638|Vitamin B Complex|vitamin b complex|mesh-ancestor
110522858|NCT05969730|Azathioprine|azathioprine|mesh-list
110522859|NCT05969730|Antimetabolites|antimetabolites|mesh-ancestor
110522860|NCT05969730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110522861|NCT05969730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110522862|NCT05969730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110522863|NCT05969730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110522864|NCT05969730|Immunologic Factors|immunologic factors|mesh-ancestor
110522865|NCT05969730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110522866|NCT05969730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110522867|NCT05966025|Antihypertensive Agents|antihypertensive agents|mesh-list
110522868|NCT05966025|Hypolipidemic Agents|hypolipidemic agents|mesh-list
110522869|NCT05966025|Antimetabolites|antimetabolites|mesh-ancestor
110522870|NCT05966025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110522871|NCT05966025|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110522872|NCT05949281|Colchicine|colchicine|mesh-list
110522873|NCT05949281|Gout Suppressants|gout suppressants|mesh-ancestor
110522874|NCT05949281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110522875|NCT05949281|Tubulin Modulators|tubulin modulators|mesh-ancestor
110522888|NCT05933603|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110522889|NCT05933603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110522891|NCT05933603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110522892|NCT05933603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110522893|NCT05933603|Parasympatholytics|parasympatholytics|mesh-ancestor
110522894|NCT05933603|Autonomic Agents|autonomic agents|mesh-ancestor
110522895|NCT05933603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110522896|NCT05933603|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110522897|NCT05933603|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110522898|NCT05933603|Cholinergic Agents|cholinergic agents|mesh-ancestor
110522899|NCT05933603|Urological Agents|urological agents|mesh-ancestor
110522900|NCT05893862|Moxifloxacin|moxifloxacin|mesh-list
110522901|NCT05893862|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110522902|NCT05893862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110522903|NCT05893862|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110522904|NCT05893862|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110522905|NCT05893862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110522906|NCT05893862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110522907|NCT05893862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110522908|NCT05888233|Allopurinol|allopurinol|mesh-list
110522909|NCT05888233|Antimetabolites|antimetabolites|mesh-ancestor
110522910|NCT05888233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110522911|NCT05888233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110522912|NCT05888233|Gout Suppressants|gout suppressants|mesh-ancestor
110522913|NCT05888233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110522914|NCT05888233|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110522915|NCT05888233|Antioxidants|antioxidants|mesh-ancestor
110522916|NCT05888233|Protective Agents|protective agents|mesh-ancestor
110522917|NCT05888233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110522918|NCT05887882|Mitogens|mitogens|mesh-list
110522919|NCT05887882|Mitosis Modulators|mitosis modulators|mesh-ancestor
110522920|NCT05887882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110522921|NCT05874219|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110522923|NCT05874219|Neomycin|neomycin|mesh-list
110522924|NCT05874219|Bacitracin|bacitracin|mesh-list
110522925|NCT05874219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110522926|NCT05874219|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110522927|NCT05874219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110522928|NCT05874219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110522929|NCT05874219|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110522930|NCT05873244|Sorafenib|sorafenib|mesh-list
110170383|NCT00039520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110522931|NCT05873244|Lenvatinib|lenvatinib|mesh-list
110522932|NCT05873244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110522933|NCT05873244|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110522934|NCT05873244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110522935|NCT05873244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110522936|NCT05869136|Hyaluronic Acid|hyaluronic acid|mesh-list
110522942|NCT05862194|Lazertinib|lazertinib|mesh-list
110522943|NCT05862194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110522944|NCT05862194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110522945|NCT05862194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110522946|NCT05855811|Dostarlimab|dostarlimab|mesh-list
110522947|NCT05855811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110522948|NCT05825781|Pertuzumab|pertuzumab|mesh-list
110522949|NCT05825781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110522950|NCT05825781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110522951|NCT05825417|Selexipag|selexipag|mesh-list
110522952|NCT05825417|Riociguat|riociguat|mesh-list
110522953|NCT05825417|Enzyme Activators|enzyme activators|mesh-ancestor
110522954|NCT05825417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110522955|NCT05825417|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110522956|NCT05795062|Warfarin|warfarin|mesh-list
110522957|NCT05795062|Apixaban|apixaban|mesh-list
110522958|NCT05795062|Anticoagulants|anticoagulants|mesh-ancestor
110522959|NCT05795062|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110522960|NCT05795062|Antithrombins|antithrombins|mesh-ancestor
110522961|NCT05795062|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110522962|NCT05795062|Protease Inhibitors|protease inhibitors|mesh-ancestor
110522963|NCT05795062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110522964|NCT05795062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110522965|NCT05790044|Clonidine|clonidine|mesh-list
110522966|NCT05790044|Bupivacaine|bupivacaine|mesh-list
110522967|NCT05790044|Anesthetics, Local|anesthetics, local|mesh-ancestor
110522968|NCT05790044|Anesthetics|anesthetics|mesh-ancestor
110522969|NCT05790044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110522970|NCT05790044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110522971|NCT05790044|Sensory System Agents|sensory system agents|mesh-ancestor
110522972|NCT05790044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110522973|NCT05790044|Analgesics|analgesics|mesh-ancestor
110522974|NCT05790044|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110522975|NCT05790044|Sympatholytics|sympatholytics|mesh-ancestor
110522976|NCT05790044|Autonomic Agents|autonomic agents|mesh-ancestor
110522977|NCT05790044|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110522978|NCT05790044|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110522979|NCT05790044|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110522980|NCT05790044|Adrenergic Agents|adrenergic agents|mesh-ancestor
110522981|NCT05790044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110522982|NCT05790044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110522983|NCT05776030|Methamphetamine|methamphetamine|mesh-list
110522984|NCT05776030|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110522985|NCT05776030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110917529|NCT02107170|Propofol|propofol|mesh-list
110522986|NCT05776030|Sympathomimetics|sympathomimetics|mesh-ancestor
110522987|NCT05776030|Autonomic Agents|autonomic agents|mesh-ancestor
110522988|NCT05776030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110522989|NCT05776030|Dopamine Agents|dopamine agents|mesh-ancestor
110522990|NCT05776030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110522991|NCT05776030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110522992|NCT05776030|Adrenergic Agents|adrenergic agents|mesh-ancestor
110522993|NCT05776030|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110522994|NCT05776030|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110522995|NCT05776030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110522996|NCT05776030|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110522998|NCT05773950|Aprepitant|aprepitant|mesh-list
110522999|NCT05773950|Antiemetics|antiemetics|mesh-ancestor
110523000|NCT05773950|Autonomic Agents|autonomic agents|mesh-ancestor
110523001|NCT05773950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110523002|NCT05773950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110523003|NCT05773950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110191924|NCT00057564|Growth Inhibitors|growth inhibitors|mesh-ancestor
110523004|NCT05773950|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110523005|NCT05773950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110523006|NCT05773950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110523008|NCT05766553|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110209186|NCT00084708|Calcitriol|calcitriol|mesh-list
110523039|NCT05739981|Bevacizumab|bevacizumab|mesh-list
110523040|NCT05739981|Carboplatin|carboplatin|mesh-list
110523041|NCT05739981|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110523042|NCT05739981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110523043|NCT05739981|Tubulin Modulators|tubulin modulators|mesh-ancestor
110523044|NCT05739981|Antimitotic Agents|antimitotic agents|mesh-ancestor
110523045|NCT05739981|Mitosis Modulators|mitosis modulators|mesh-ancestor
110523046|NCT05739981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110523047|NCT05739981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110523048|NCT05739981|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110523049|NCT05739981|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110523050|NCT05739981|Growth Substances|growth substances|mesh-ancestor
110523051|NCT05739981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110523052|NCT05739981|Growth Inhibitors|growth inhibitors|mesh-ancestor
110523071|NCT05685342|Analgesics|analgesics|mesh-ancestor
110523072|NCT05685342|Sensory System Agents|sensory system agents|mesh-ancestor
110523073|NCT05685342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110523074|NCT05685342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110523075|NCT05685342|Antipyretics|antipyretics|mesh-ancestor
110523076|NCT05685342|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110523077|NCT05685342|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110523078|NCT05685342|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110523079|NCT05685342|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110523080|NCT05685342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110523081|NCT05685342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110523082|NCT05681312|Amoxicillin|amoxicillin|mesh-list
110523083|NCT05681312|Metronidazole|metronidazole|mesh-list
110523084|NCT05681312|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110523085|NCT05681312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110523086|NCT05681312|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110523087|NCT05681312|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110523088|NCT05672251|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
110523089|NCT05672251|Antibodies, Bispecific|antibodies, bispecific|mesh-list
110523090|NCT05672251|Immunologic Factors|immunologic factors|mesh-ancestor
110523091|NCT05672251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110523092|NCT05672251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110523093|NCT05672251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110523094|NCT05661708|Chitosan|chitosan|mesh-list
110523095|NCT05661708|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110523096|NCT05661708|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110523097|NCT05661708|Antimetabolites|antimetabolites|mesh-ancestor
110523098|NCT05661708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110523099|NCT05661708|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110523101|NCT05661708|Sequestering Agents|sequestering agents|mesh-ancestor
110523102|NCT05661708|Hemostatics|hemostatics|mesh-ancestor
110523103|NCT05661708|Coagulants|coagulants|mesh-ancestor
110523104|NCT05658575|Dapansutrile|dapansutrile|mesh-list
110523105|NCT05658575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110523106|NCT05625503|Verapamil|verapamil|mesh-list
110523107|NCT05625503|Nicardipine|nicardipine|mesh-list
110523108|NCT05625503|Calcium Channel Blockers|calcium channel blockers|mesh-list
110523109|NCT05625503|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110523110|NCT05625503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110523111|NCT05625503|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110523116|NCT05553834|Cemiplimab|cemiplimab|mesh-list
110523117|NCT05553834|Alirocumab|alirocumab|mesh-list
110523118|NCT05553834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110523119|NCT05553834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110523120|NCT05553834|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
110523121|NCT05553834|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110523122|NCT05553834|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110523123|NCT05553834|Antimetabolites|antimetabolites|mesh-ancestor
110523124|NCT05553834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110523125|NCT05553834|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110523126|NCT05553834|Protease Inhibitors|protease inhibitors|mesh-ancestor
110523127|NCT05553834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110523128|NCT05553834|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110523129|NCT05537402|Bevacizumab|bevacizumab|mesh-list
110523130|NCT05537402|Atezolizumab|atezolizumab|mesh-list
110523131|NCT05537402|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110523132|NCT05537402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110523133|NCT05537402|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110523134|NCT05537402|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110523135|NCT05537402|Growth Substances|growth substances|mesh-ancestor
110523136|NCT05537402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110523137|NCT05537402|Growth Inhibitors|growth inhibitors|mesh-ancestor
110523138|NCT05537402|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110523139|NCT05537402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110523140|NCT05529290|Acetaminophen|acetaminophen|mesh-list
110523141|NCT05529290|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
110523142|NCT05529290|Ketoprofen|ketoprofen|mesh-list
110523143|NCT05529290|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110523144|NCT05529290|Analgesics|analgesics|mesh-ancestor
110523145|NCT05529290|Sensory System Agents|sensory system agents|mesh-ancestor
110523146|NCT05529290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110523147|NCT05529290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110523149|NCT05529290|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110523150|NCT05529290|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110523151|NCT05529290|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110523152|NCT05529290|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110523153|NCT05529290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110523154|NCT05529290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110523155|NCT05435677|Insulin|insulin|mesh-list
110523156|NCT05435677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110523158|NCT05415917|Gemcitabine|gemcitabine|mesh-list
110523159|NCT05415917|Capecitabine|capecitabine|mesh-list
110917577|NCT02107716|Lidocaine|lidocaine|mesh-list
110523160|NCT05415917|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110523161|NCT05415917|Antimetabolites|antimetabolites|mesh-ancestor
110523162|NCT05415917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110523163|NCT05415917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110523164|NCT05407441|Nivolumab|nivolumab|mesh-list
110523165|NCT05407441|Ipilimumab|ipilimumab|mesh-list
110523166|NCT05407441|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110523167|NCT05407441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110523168|NCT05407441|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110523169|NCT05407441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110523170|NCT05371054|Prednisone|prednisone|mesh-list
110523171|NCT05371054|Venetoclax|venetoclax|mesh-list
110523172|NCT05371054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110523173|NCT05371054|Glucocorticoids|glucocorticoids|mesh-ancestor
110523174|NCT05371054|Hormones|hormones|mesh-ancestor
110523175|NCT05371054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110523176|NCT05371054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110523177|NCT05371054|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110523178|NCT05371054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110523179|NCT05367687|Apatinib|apatinib|mesh-list
110523180|NCT05367687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110523181|NCT05367687|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110523182|NCT05367687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110523183|NCT05367687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110523201|NCT05353829|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110523202|NCT05353829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110523203|NCT05353829|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110523204|NCT05353829|Antimetabolites|antimetabolites|mesh-ancestor
110523205|NCT05353829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110523206|NCT05353829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110523207|NCT05353829|Dermatologic Agents|dermatologic agents|mesh-ancestor
110523208|NCT05353829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110523209|NCT05353829|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110523210|NCT05353829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110523211|NCT05353829|Immunologic Factors|immunologic factors|mesh-ancestor
110523212|NCT05353829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110523213|NCT05353829|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110523215|NCT05345509|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110523216|NCT05345509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110523217|NCT05345509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110523218|NCT05345509|Cholinergic Agents|cholinergic agents|mesh-ancestor
110523219|NCT05345509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110523220|NCT05345509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110523221|NCT05345509|Nootropic Agents|nootropic agents|mesh-ancestor
110523223|NCT05307731|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
110523224|NCT05307731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110523225|NCT05307731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110523226|NCT05307731|Immunologic Factors|immunologic factors|mesh-ancestor
110523227|NCT05307731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110523228|NCT05297565|Nivolumab|nivolumab|mesh-list
110170683|NCT00041548|Autonomic Agents|autonomic agents|mesh-ancestor
110523229|NCT05297565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110523230|NCT05297565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110523231|NCT05297565|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110523232|NCT05297565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110523233|NCT05287035|Dexamethasone|dexamethasone|mesh-list
110523234|NCT05287035|Dexamethasone acetate|dexamethasone acetate|mesh-list
110523235|NCT05287035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110523236|NCT05287035|Antiemetics|antiemetics|mesh-ancestor
110523237|NCT05287035|Autonomic Agents|autonomic agents|mesh-ancestor
110523238|NCT05287035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110523246|NCT05282069|Solifenacin Succinate|solifenacin succinate|mesh-list
110523247|NCT05282069|DA-8010|da-8010|mesh-list
110523248|NCT05282069|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110523249|NCT05282069|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110523250|NCT05282069|Cholinergic Agents|cholinergic agents|mesh-ancestor
110523251|NCT05282069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110523252|NCT05282069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110523253|NCT05282069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110523254|NCT05282069|Urological Agents|urological agents|mesh-ancestor
110523255|NCT05275426|Gemcitabine|gemcitabine|mesh-list
110523256|NCT05275426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110523257|NCT05275426|Antimetabolites|antimetabolites|mesh-ancestor
110523258|NCT05275426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110523259|NCT05275426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110523260|NCT05275010|Trastuzumab|trastuzumab|mesh-list
110523261|NCT05275010|Pertuzumab|pertuzumab|mesh-list
110523262|NCT05275010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110523263|NCT05275010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110523264|NCT05251090|Factor VIII|factor viii|mesh-list
110523265|NCT05251090|Coagulants|coagulants|mesh-ancestor
110523266|NCT05249920|Edaravone|edaravone|mesh-list
110523267|NCT05249920|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110523268|NCT05249920|Antioxidants|antioxidants|mesh-ancestor
110523269|NCT05249920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110523270|NCT05249920|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110523271|NCT05249920|Protective Agents|protective agents|mesh-ancestor
110523272|NCT05249920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110523273|NCT05193071|Aspirin|aspirin|mesh-list
110523274|NCT05193071|Clopidogrel|clopidogrel|mesh-list
110523275|NCT05193071|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110523276|NCT05193071|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110523277|NCT05193071|Analgesics|analgesics|mesh-ancestor
110523278|NCT05193071|Sensory System Agents|sensory system agents|mesh-ancestor
110523279|NCT05193071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110523280|NCT05193071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110523281|NCT05193071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110523282|NCT05193071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110523283|NCT05193071|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110523284|NCT05193071|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110917618|NCT02105610|Anesthetics, General|anesthetics, general|mesh-ancestor
110523285|NCT05193071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110523286|NCT05193071|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110523287|NCT05193071|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110523288|NCT05193071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110523289|NCT05193071|Antipyretics|antipyretics|mesh-ancestor
110523290|NCT05193071|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110523291|NCT05193071|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110523292|NCT05193071|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110523294|NCT05193071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110523295|NCT05145010|Infigratinib|infigratinib|mesh-list
110523296|NCT05145010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110523297|NCT05113940|Midazolam|midazolam|mesh-list
110523298|NCT05113940|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110523299|NCT05113940|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110523300|NCT05113940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110523301|NCT05113940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110523302|NCT05113940|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110523303|NCT05113940|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110523304|NCT05113940|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110523305|NCT05113940|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110523306|NCT05113940|Anesthetics, General|anesthetics, general|mesh-ancestor
110523307|NCT05113940|Anesthetics|anesthetics|mesh-ancestor
110523333|NCT05096884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110523335|NCT05082259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110523336|NCT05082259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110523337|NCT05082259|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110523338|NCT05082259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110523339|NCT05073172|Sulfadiazine|sulfadiazine|mesh-list
110523340|NCT05073172|Silver Sulfadiazine|silver sulfadiazine|mesh-list
110523341|NCT05073172|Hydrocortisone|hydrocortisone|mesh-list
110523342|NCT05073172|Petrolatum|petrolatum|mesh-list
110523343|NCT05073172|Mineral Oil|mineral oil|mesh-list
110523344|NCT05073172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110523345|NCT05073172|Emollients|emollients|mesh-ancestor
110523346|NCT05073172|Dermatologic Agents|dermatologic agents|mesh-ancestor
110523347|NCT05073172|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110523348|NCT05073172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110523349|NCT05073172|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110523350|NCT05073172|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110523351|NCT05073172|Coccidiostats|coccidiostats|mesh-ancestor
110523352|NCT05073172|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110523353|NCT05065372|Metformin|metformin|mesh-list
110523354|NCT05065372|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110523355|NCT05065372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110523356|NCT05063565|Durvalumab|durvalumab|mesh-list
110523357|NCT05063565|Tremelimumab|tremelimumab|mesh-list
110523358|NCT05063565|Immunomodulating Agents|immunomodulating agents|mesh-list
110523359|NCT05063565|Immunologic Factors|immunologic factors|mesh-list
110523360|NCT05063565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110523361|NCT05063565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110523362|NCT05063565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110523363|NCT05042505|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110523364|NCT05042505|Dapagliflozin|dapagliflozin|mesh-list
110523365|NCT05042505|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110523366|NCT05042505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110523368|NCT05042505|Hormones|hormones|mesh-ancestor
110534641|NCT00643734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110523379|NCT04962672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110523380|NCT04962672|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110523381|NCT04962672|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110523382|NCT04962672|Anesthetics, General|anesthetics, general|mesh-ancestor
110523383|NCT04962672|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110523384|NCT04962672|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110523386|NCT04951206|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110523387|NCT04951206|Glucocorticoids|glucocorticoids|mesh-ancestor
110523388|NCT04951206|Hormones|hormones|mesh-ancestor
110523389|NCT04951206|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110523390|NCT04951206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110523391|NCT04936126|Amantadine|amantadine|mesh-list
110523392|NCT04936126|Pramipexole|pramipexole|mesh-list
110523393|NCT04936126|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110523394|NCT04936126|Antidepressive Agents|antidepressive agents|mesh-ancestor
110523395|NCT04936126|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110523396|NCT04936126|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110523397|NCT04936126|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110523398|NCT04936126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110523399|NCT04936126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110523400|NCT04936126|Antioxidants|antioxidants|mesh-ancestor
110523401|NCT04936126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110523402|NCT04936126|Protective Agents|protective agents|mesh-ancestor
110523403|NCT04936126|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110523404|NCT04936126|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110523405|NCT04936126|Dopamine Agonists|dopamine agonists|mesh-ancestor
110523406|NCT04936126|Dopamine Agents|dopamine agents|mesh-ancestor
110523407|NCT04936126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110523408|NCT04936126|Antiviral Agents|antiviral agents|mesh-ancestor
110523409|NCT04936126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110523410|NCT04936126|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110523411|NCT04936126|Analgesics|analgesics|mesh-ancestor
110523412|NCT04936126|Sensory System Agents|sensory system agents|mesh-ancestor
110523413|NCT04936126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110523414|NCT04896073|14-O-phosphonooxymethyltriptolide disodium salt|14-o-phosphonooxymethyltriptolide disodium salt|mesh-list
110523415|NCT04896073|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110523416|NCT04896073|Alkylating Agents|alkylating agents|mesh-ancestor
110523417|NCT04896073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110523418|NCT04896073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110523419|NCT04846491|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110523420|NCT04846491|Interferon-alpha|interferon-alpha|mesh-list
110523421|NCT04846491|Antiviral Agents|antiviral agents|mesh-ancestor
110523422|NCT04846491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110523423|NCT04846491|Immunologic Factors|immunologic factors|mesh-ancestor
110917658|NCT03077620|Suvorexant|suvorexant|mesh-list
110523424|NCT04846491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110523425|NCT04839042|Cloricromen|cloricromen|mesh-list
110523426|NCT04839042|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110523427|NCT04732286|Bevacizumab|bevacizumab|mesh-list
110523428|NCT04732286|Atezolizumab|atezolizumab|mesh-list
110523429|NCT04732286|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110523430|NCT04732286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110523457|NCT04676477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110523458|NCT04676477|Immunologic Factors|immunologic factors|mesh-ancestor
110523459|NCT04676477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110523460|NCT04676477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110523461|NCT04664946|Neuroprotective Agents|neuroprotective agents|mesh-list
110523462|NCT04664946|Protective Agents|protective agents|mesh-ancestor
110523463|NCT04664946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110523465|NCT04546009|Palbociclib|palbociclib|mesh-list
110523466|NCT04546009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110523467|NCT04546009|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110523468|NCT04546009|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110523469|NCT04546009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110523470|NCT04546009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110523471|NCT04546009|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110523472|NCT04546009|Hormone Antagonists|hormone antagonists|mesh-ancestor
110523473|NCT04546009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110523474|NCT04546009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110523475|NCT04546009|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110523476|NCT04541355|Sodium thiosulfate|sodium thiosulfate|mesh-list
110523477|NCT04541355|Cisplatin|cisplatin|mesh-list
110523478|NCT04541355|Antidotes|antidotes|mesh-list
110523479|NCT04541355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110523480|NCT04541355|Protective Agents|protective agents|mesh-ancestor
110523481|NCT04541355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110523482|NCT04541355|Antioxidants|antioxidants|mesh-ancestor
110523483|NCT04541355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110523484|NCT04541355|Antitubercular Agents|antitubercular agents|mesh-ancestor
110523485|NCT04541355|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110523486|NCT04541355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110523487|NCT04541355|Chelating Agents|chelating agents|mesh-ancestor
110523488|NCT04541355|Sequestering Agents|sequestering agents|mesh-ancestor
110523489|NCT04516915|Oseltamivir|oseltamivir|mesh-list
110523490|NCT04516915|Antiviral Agents|antiviral agents|mesh-ancestor
110523491|NCT04516915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110523492|NCT04516915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110523493|NCT04516915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110523494|NCT04493853|Abiraterone Acetate|abiraterone acetate|mesh-list
110523495|NCT04493853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110523496|NCT04493853|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110523497|NCT04493853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110523498|NCT04493853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110179924|NCT00680628|Enoxaparin|enoxaparin|mesh-list
110523508|NCT04483466|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110523509|NCT04483466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110523510|NCT04483466|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110523511|NCT04483466|Antimetabolites|antimetabolites|mesh-ancestor
110523512|NCT04483466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110523513|NCT04483466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110523514|NCT04483466|Dermatologic Agents|dermatologic agents|mesh-ancestor
110523515|NCT04483466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110523516|NCT04483466|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110523517|NCT04483466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110523518|NCT04483466|Immunologic Factors|immunologic factors|mesh-ancestor
110523519|NCT04483466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110192085|NCT00030797|Irinotecan|irinotecan|mesh-list
110523520|NCT04483466|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110523521|NCT04482244|Cannabidiol|cannabidiol|mesh-list
110523522|NCT04482244|Anticonvulsants|anticonvulsants|mesh-ancestor
110523523|NCT04376268|Chlorhexidine|chlorhexidine|mesh-list
110523524|NCT04376268|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110170985|NCT00043147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110523526|NCT04376268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110523527|NCT04376268|Disinfectants|disinfectants|mesh-ancestor
110523528|NCT04376268|Dermatologic Agents|dermatologic agents|mesh-ancestor
110523529|NCT04365088|Deflazacort|deflazacort|mesh-list
110523530|NCT04365088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110523531|NCT04365088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110523532|NCT04365088|Immunologic Factors|immunologic factors|mesh-ancestor
110523533|NCT04365088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110523534|NCT04360421|Bupivacaine|bupivacaine|mesh-list
110523535|NCT04360421|Anesthetics, Local|anesthetics, local|mesh-ancestor
110523536|NCT04360421|Anesthetics|anesthetics|mesh-ancestor
110523537|NCT04360421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110523538|NCT04360421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110523539|NCT04360421|Sensory System Agents|sensory system agents|mesh-ancestor
110523540|NCT04360421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110523542|NCT04349579|Rifamycin SV|rifamycin sv|mesh-list
110523543|NCT04349579|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110523544|NCT04349579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110523545|NCT04349579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110523546|NCT04300296|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110523547|NCT04300296|Immunologic Factors|immunologic factors|mesh-ancestor
110523548|NCT04300296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110523549|NCT04223752|Tazobactam|tazobactam|mesh-list
110523550|NCT04223752|Ceftolozane|ceftolozane|mesh-list
110523551|NCT04223752|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
110523552|NCT04223752|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110523553|NCT04223752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110523554|NCT04223752|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110523555|NCT04223752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110523556|NCT04223752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110523557|NCT04223752|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110523558|NCT04194203|Paclitaxel|paclitaxel|mesh-list
110523559|NCT04194203|Bevacizumab|bevacizumab|mesh-list
110523560|NCT04194203|Carboplatin|carboplatin|mesh-list
110523561|NCT04194203|Pemetrexed|pemetrexed|mesh-list
110523562|NCT04194203|Atezolizumab|atezolizumab|mesh-list
110523563|NCT04194203|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110523635|NCT04047836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110523637|NCT03994146|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110523638|NCT03994146|Narcotics|narcotics|mesh-ancestor
110523639|NCT03994146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110523640|NCT03994146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110523641|NCT03994146|Analgesics|analgesics|mesh-ancestor
110523642|NCT03994146|Sensory System Agents|sensory system agents|mesh-ancestor
110523643|NCT03994146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110523644|NCT03973268|Complement Factor H|complement factor h|mesh-list
110523645|NCT03973268|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
110523646|NCT03973268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110523647|NCT03973268|Immunologic Factors|immunologic factors|mesh-ancestor
110192123|NCT00058227|Rituximab|rituximab|mesh-list
110523648|NCT03973268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110523650|NCT03962465|Prednisone|prednisone|mesh-list
110523651|NCT03962465|Methotrexate|methotrexate|mesh-list
110523652|NCT03962465|Vincristine|vincristine|mesh-list
110523653|NCT03962465|Daunorubicin|daunorubicin|mesh-list
110523654|NCT03962465|Pegaspargase|pegaspargase|mesh-list
110523655|NCT03962465|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
110523656|NCT03962465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110523658|NCT03962465|Hormones|hormones|mesh-ancestor
110523659|NCT03962465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110523660|NCT03962465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110523661|NCT03962465|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110523662|NCT03962465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110523663|NCT03962465|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110523664|NCT03962465|Abortifacient Agents|abortifacient agents|mesh-ancestor
110523665|NCT03962465|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110523666|NCT03962465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110523667|NCT03962465|Antimetabolites|antimetabolites|mesh-ancestor
110523668|NCT03962465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110523669|NCT03962465|Dermatologic Agents|dermatologic agents|mesh-ancestor
110523670|NCT03962465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110523671|NCT03962465|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110523672|NCT03962465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110523673|NCT03962465|Immunologic Factors|immunologic factors|mesh-ancestor
110523674|NCT03962465|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110523696|NCT03952299|Cholinergic Agents|cholinergic agents|mesh-ancestor
110523697|NCT03952299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110523698|NCT03952299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110523699|NCT03952299|Urological Agents|urological agents|mesh-ancestor
110523700|NCT03952299|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110523701|NCT03952299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110523702|NCT03908437|Buprenorphine|buprenorphine|mesh-list
110523703|NCT03908437|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
110523704|NCT03908437|Naloxone|naloxone|mesh-list
110523705|NCT03908437|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110523706|NCT03908437|Narcotics|narcotics|mesh-ancestor
110523707|NCT03908437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110523708|NCT03908437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110523709|NCT03908437|Analgesics|analgesics|mesh-ancestor
110523710|NCT03908437|Sensory System Agents|sensory system agents|mesh-ancestor
110523711|NCT03908437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110523712|NCT03908437|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110523713|NCT03903185|Sofosbuvir|sofosbuvir|mesh-list
110523714|NCT03903185|Ledipasvir|ledipasvir|mesh-list
110523715|NCT03903185|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
110523716|NCT03903185|Antiviral Agents|antiviral agents|mesh-ancestor
110523717|NCT03903185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110523718|NCT03834948|Paclitaxel|paclitaxel|mesh-list
110523719|NCT03834948|Pembrolizumab|pembrolizumab|mesh-list
110523720|NCT03834948|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110523721|NCT03834948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110523722|NCT03834948|Tubulin Modulators|tubulin modulators|mesh-ancestor
110523723|NCT03834948|Antimitotic Agents|antimitotic agents|mesh-ancestor
110523724|NCT03834948|Mitosis Modulators|mitosis modulators|mesh-ancestor
110523725|NCT03834948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110523726|NCT03834948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110523727|NCT03834948|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110523728|NCT03728933|Rotigotine|rotigotine|mesh-list
110523738|NCT03695250|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110523739|NCT03695250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110523740|NCT03695250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110523742|NCT03678753|Anticonvulsants|anticonvulsants|mesh-ancestor
110523743|NCT03663543|Estrogens|estrogens|mesh-list
110523744|NCT03663543|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
110523745|NCT03663543|Hormones|hormones|mesh-ancestor
110917713|NCT02113800|Everolimus|everolimus|mesh-list
110523746|NCT03663543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110523747|NCT03663543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110523748|NCT03615105|Cyclophosphamide|cyclophosphamide|mesh-list
110523750|NCT03615105|Busulfan|busulfan|mesh-list
110523751|NCT03615105|Thiotepa|thiotepa|mesh-list
110523752|NCT03615105|Rituximab|rituximab|mesh-list
110523753|NCT03615105|Fludarabine|fludarabine|mesh-list
110523754|NCT03615105|Clofarabine|clofarabine|mesh-list
110523755|NCT03615105|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110523756|NCT03615105|Thymoglobulin|thymoglobulin|mesh-list
110523757|NCT03615105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110523758|NCT03615105|Immunologic Factors|immunologic factors|mesh-ancestor
110523759|NCT03615105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110523760|NCT03615105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110523761|NCT03615105|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110523762|NCT03615105|Alkylating Agents|alkylating agents|mesh-ancestor
110523763|NCT03615105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110523764|NCT03615105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110523765|NCT03615105|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110523766|NCT03615105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110523767|NCT03615105|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110523768|NCT03615105|Antimetabolites|antimetabolites|mesh-ancestor
110523769|NCT03603899|Xenon|xenon|mesh-list
110523770|NCT03603899|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110523771|NCT03603899|Anesthetics, General|anesthetics, general|mesh-ancestor
110523772|NCT03603899|Anesthetics|anesthetics|mesh-ancestor
110523773|NCT03603899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110523774|NCT03603899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110523775|NCT03537014|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
110523776|NCT03537014|Hallucinogens|hallucinogens|mesh-ancestor
110523777|NCT03537014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110523778|NCT03537014|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110523779|NCT03537014|Serotonin Agents|serotonin agents|mesh-ancestor
110523780|NCT03537014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110523781|NCT03537014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110523782|NCT03537014|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110523783|NCT03537014|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110523784|NCT03537014|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110523785|NCT03537014|Adrenergic Agents|adrenergic agents|mesh-ancestor
110523786|NCT03526354|Antipsychotic Agents|antipsychotic agents|mesh-list
110523787|NCT03526354|Brexpiprazole|brexpiprazole|mesh-list
110523788|NCT03526354|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110523789|NCT03526354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110192160|NCT00031070|Antiviral Agents|antiviral agents|mesh-ancestor
110523790|NCT03526354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110523791|NCT03526354|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110523792|NCT03526354|Serotonin Agents|serotonin agents|mesh-ancestor
110523793|NCT03526354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110523794|NCT03526354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110523799|NCT03393884|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110523800|NCT03393884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110523801|NCT03393884|Tubulin Modulators|tubulin modulators|mesh-ancestor
110523802|NCT03393884|Antimitotic Agents|antimitotic agents|mesh-ancestor
110523803|NCT03393884|Mitosis Modulators|mitosis modulators|mesh-ancestor
110523804|NCT03393884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110523805|NCT03329378|Paclitaxel|paclitaxel|mesh-list
110523806|NCT03329378|Docetaxel|docetaxel|mesh-list
110523807|NCT03329378|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110523808|NCT03329378|Cyclophosphamide|cyclophosphamide|mesh-list
110523809|NCT03329378|Carboplatin|carboplatin|mesh-list
110523810|NCT03329378|Doxorubicin|doxorubicin|mesh-list
110523811|NCT03329378|Trastuzumab|trastuzumab|mesh-list
110523812|NCT03329378|Pertuzumab|pertuzumab|mesh-list
110523813|NCT03329378|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110523814|NCT03329378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110523815|NCT03329378|Tubulin Modulators|tubulin modulators|mesh-ancestor
110523816|NCT03329378|Antimitotic Agents|antimitotic agents|mesh-ancestor
110523817|NCT03329378|Mitosis Modulators|mitosis modulators|mesh-ancestor
110523818|NCT03329378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110523819|NCT03329378|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110523820|NCT03329378|Immunologic Factors|immunologic factors|mesh-ancestor
110523821|NCT03329378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110523822|NCT03329378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110523823|NCT03329378|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110523824|NCT03329378|Alkylating Agents|alkylating agents|mesh-ancestor
110523825|NCT03329378|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110523826|NCT03329378|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110523827|NCT03329378|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110523828|NCT03329378|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110523829|NCT03329378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110523830|NCT03329378|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110523831|NCT03274895|Biguanides|biguanides|mesh-list
110523832|NCT03274895|Polihexanide|polihexanide|mesh-list
110523833|NCT03274895|Dibrompropamidine|dibrompropamidine|mesh-list
110523834|NCT03274895|Propamidine|propamidine|mesh-list
110523835|NCT03274895|Disinfectants|disinfectants|mesh-ancestor
110523836|NCT03274895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110523837|NCT03274895|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110523838|NCT03274895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110523839|NCT03274895|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110523840|NCT03274895|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110523841|NCT03274895|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110523842|NCT03258593|Durvalumab|durvalumab|mesh-list
110523843|NCT03258593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110523844|NCT03258593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110523845|NCT03250975|Azithromycin|azithromycin|mesh-list
110523846|NCT03250975|Budesonide|budesonide|mesh-list
110523847|NCT03250975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110523848|NCT03250975|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110523849|NCT03250975|Autonomic Agents|autonomic agents|mesh-ancestor
110523850|NCT03250975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110523851|NCT03250975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110523852|NCT03250975|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110523853|NCT03250975|Respiratory System Agents|respiratory system agents|mesh-ancestor
110523854|NCT03250975|Glucocorticoids|glucocorticoids|mesh-ancestor
110523855|NCT03250975|Hormones|hormones|mesh-ancestor
110523856|NCT03250975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110523857|NCT03250975|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110523858|NCT03250975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110523888|NCT03057106|Durvalumab|durvalumab|mesh-list
110523889|NCT03057106|Tremelimumab|tremelimumab|mesh-list
110523890|NCT03057106|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110523891|NCT03057106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110523892|NCT03054831|Oxycodone|oxycodone|mesh-list
110523893|NCT03054831|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110523894|NCT03054831|Narcotics|narcotics|mesh-ancestor
110523895|NCT03054831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110523896|NCT03054831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110523897|NCT03054831|Analgesics|analgesics|mesh-ancestor
110179993|NCT00276978|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110523912|NCT03049189|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110523913|NCT03025087|Hydroxychloroquine|hydroxychloroquine|mesh-list
110523914|NCT03025087|Antimalarials|antimalarials|mesh-ancestor
110523915|NCT03025087|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110523916|NCT03025087|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110523917|NCT03025087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110523918|NCT03025087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110523919|NCT03025087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110523920|NCT03025087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110523921|NCT03003065|Temoporfin|temoporfin|mesh-list
110523922|NCT03003065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110523923|NCT03003065|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110523924|NCT03003065|Dermatologic Agents|dermatologic agents|mesh-ancestor
110523925|NCT02906332|Dexamethasone|dexamethasone|mesh-list
110523926|NCT02906332|Pembrolizumab|pembrolizumab|mesh-list
110523927|NCT02906332|Lenalidomide|lenalidomide|mesh-list
110523928|NCT02906332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110523929|NCT02906332|Antiemetics|antiemetics|mesh-ancestor
110523930|NCT02906332|Autonomic Agents|autonomic agents|mesh-ancestor
110523931|NCT02906332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110523932|NCT02906332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110523933|NCT02906332|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110523934|NCT02906332|Glucocorticoids|glucocorticoids|mesh-ancestor
110523935|NCT02906332|Hormones|hormones|mesh-ancestor
110523936|NCT02906332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110523937|NCT02906332|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110523938|NCT02906332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110523939|NCT02906332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110523940|NCT02906332|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110523941|NCT02906332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110523942|NCT02906332|Immunologic Factors|immunologic factors|mesh-ancestor
110523943|NCT02906332|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110523944|NCT02906332|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110523945|NCT02906332|Growth Substances|growth substances|mesh-ancestor
110523946|NCT02906332|Growth Inhibitors|growth inhibitors|mesh-ancestor
110523947|NCT02870920|Durvalumab|durvalumab|mesh-list
110523948|NCT02870920|Tremelimumab|tremelimumab|mesh-list
110523949|NCT02870920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110523950|NCT02870920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110523951|NCT02827877|Copper|copper|mesh-list
110523952|NCT02827877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110523953|NCT02827877|Trastuzumab|trastuzumab|mesh-list
110523954|NCT02827877|Pertuzumab|pertuzumab|mesh-list
110523955|NCT02827877|Antibodies|antibodies|mesh-list
110523956|NCT02827877|Immunoglobulins|immunoglobulins|mesh-list
110523957|NCT02827877|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110523958|NCT02827877|Immunologic Factors|immunologic factors|mesh-ancestor
110523959|NCT02827877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110523960|NCT02827877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110523968|NCT02823665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110523969|NCT02823665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110523970|NCT02823665|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110523971|NCT02823665|Respiratory System Agents|respiratory system agents|mesh-ancestor
110523972|NCT02823665|Mydriatics|mydriatics|mesh-ancestor
110523973|NCT02823665|Parasympatholytics|parasympatholytics|mesh-ancestor
110523974|NCT02823665|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110523975|NCT02823665|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110523976|NCT02823665|Cholinergic Agents|cholinergic agents|mesh-ancestor
110523977|NCT02823665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110523978|NCT02823665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110523979|NCT02755597|Dexamethasone|dexamethasone|mesh-list
110523980|NCT02755597|Bortezomib|bortezomib|mesh-list
110523981|NCT02755597|Venetoclax|venetoclax|mesh-list
110523982|NCT02755597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110523983|NCT02755597|Antiemetics|antiemetics|mesh-ancestor
110523984|NCT02755597|Autonomic Agents|autonomic agents|mesh-ancestor
110523985|NCT02755597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110523986|NCT02755597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110523987|NCT02755597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110523988|NCT02755597|Glucocorticoids|glucocorticoids|mesh-ancestor
110523989|NCT02755597|Hormones|hormones|mesh-ancestor
110523990|NCT02755597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110523991|NCT02755597|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110523992|NCT02755597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110523993|NCT02715284|Dostarlimab|dostarlimab|mesh-list
110192221|NCT04711889|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
110523994|NCT02715284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110523995|NCT02705300|Leucovorin|leucovorin|mesh-list
110523996|NCT02705300|Tocotrienols|tocotrienols|mesh-list
110523998|NCT02705300|Tocopherols|tocopherols|mesh-list
110523999|NCT02705300|Fluorouracil|fluorouracil|mesh-list
110524000|NCT02705300|Oxaliplatin|oxaliplatin|mesh-list
110524001|NCT02705300|Irinotecan|irinotecan|mesh-list
110524002|NCT02705300|Levoleucovorin|levoleucovorin|mesh-list
110524003|NCT02705300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110524004|NCT02705300|Antimetabolites|antimetabolites|mesh-ancestor
110524005|NCT02705300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110524006|NCT02705300|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110524007|NCT02705300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110524008|NCT02705300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110524009|NCT02705300|Immunologic Factors|immunologic factors|mesh-ancestor
110524010|NCT02705300|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110524011|NCT02705300|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110524012|NCT02705300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110524013|NCT02705300|Antidotes|antidotes|mesh-ancestor
110524014|NCT02705300|Protective Agents|protective agents|mesh-ancestor
110524015|NCT02705300|Vitamin B Complex|vitamin b complex|mesh-ancestor
110524016|NCT02705300|Vitamins|vitamins|mesh-ancestor
110524017|NCT02705300|Micronutrients|micronutrients|mesh-ancestor
110524018|NCT02705300|Antioxidants|antioxidants|mesh-ancestor
110524019|NCT02598557|Exemestane|exemestane|mesh-list
110524020|NCT02598557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110524021|NCT02598557|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110524022|NCT02598557|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110524023|NCT02598557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110524024|NCT02598557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110524025|NCT02598557|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110524026|NCT02598557|Hormone Antagonists|hormone antagonists|mesh-ancestor
110524027|NCT02598557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110524028|NCT02598557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110524029|NCT02576574|Paclitaxel|paclitaxel|mesh-list
110524030|NCT02576574|Carboplatin|carboplatin|mesh-list
110524031|NCT02576574|Gemcitabine|gemcitabine|mesh-list
110524032|NCT02576574|Pemetrexed|pemetrexed|mesh-list
110524033|NCT02576574|Avelumab|avelumab|mesh-list
110524034|NCT02576574|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110524035|NCT02576574|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110524057|NCT02317783|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110524058|NCT02044497|Oxycodone|oxycodone|mesh-list
110524059|NCT02044497|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110524060|NCT02044497|Narcotics|narcotics|mesh-ancestor
110524061|NCT02044497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110524062|NCT02044497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110524063|NCT02044497|Analgesics|analgesics|mesh-ancestor
110524064|NCT02044497|Sensory System Agents|sensory system agents|mesh-ancestor
110524065|NCT02044497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110524066|NCT02033993|Paclitaxel|paclitaxel|mesh-list
110524067|NCT02033993|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110524068|NCT02033993|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110524069|NCT02033993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110524070|NCT02033993|Tubulin Modulators|tubulin modulators|mesh-ancestor
110524071|NCT02033993|Antimitotic Agents|antimitotic agents|mesh-ancestor
110524072|NCT02033993|Mitosis Modulators|mitosis modulators|mesh-ancestor
110524073|NCT02033993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110524074|NCT01997879|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110524075|NCT01997879|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110524076|NCT01772472|Trastuzumab|trastuzumab|mesh-list
110524077|NCT01772472|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
110524078|NCT01772472|Maytansine|maytansine|mesh-list
110524079|NCT01772472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110524080|NCT01772472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110524081|NCT01772472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110524082|NCT01772472|Tubulin Modulators|tubulin modulators|mesh-ancestor
110524083|NCT01772472|Antimitotic Agents|antimitotic agents|mesh-ancestor
110524084|NCT01772472|Mitosis Modulators|mitosis modulators|mesh-ancestor
110524085|NCT01772472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110524086|NCT01772472|Immunotoxins|immunotoxins|mesh-ancestor
110524087|NCT01772472|Immunoconjugates|immunoconjugates|mesh-ancestor
110524088|NCT01772472|Immunologic Factors|immunologic factors|mesh-ancestor
110524102|NCT01463072|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110524103|NCT01463072|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110524104|NCT01463072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110524105|NCT01463072|Tubulin Modulators|tubulin modulators|mesh-ancestor
110524106|NCT01463072|Antimitotic Agents|antimitotic agents|mesh-ancestor
110524107|NCT01463072|Mitosis Modulators|mitosis modulators|mesh-ancestor
110192284|NCT00058968|Analgesics|analgesics|mesh-ancestor
110524108|NCT01463072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110524110|NCT01409772|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110524111|NCT01409772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110524112|NCT01409772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110524113|NCT01409772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110524115|NCT01241708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110524116|NCT01208766|Dexamethasone|dexamethasone|mesh-list
110524117|NCT01208766|Prednisone|prednisone|mesh-list
110524118|NCT01208766|Lenalidomide|lenalidomide|mesh-list
110524119|NCT01208766|Bortezomib|bortezomib|mesh-list
110524120|NCT01208766|Melphalan|melphalan|mesh-list
110524121|NCT01208766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110524122|NCT01208766|Antiemetics|antiemetics|mesh-ancestor
110524123|NCT01208766|Autonomic Agents|autonomic agents|mesh-ancestor
110524124|NCT01208766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110524125|NCT01208766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110524126|NCT01208766|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110524127|NCT01208766|Glucocorticoids|glucocorticoids|mesh-ancestor
110524128|NCT01208766|Hormones|hormones|mesh-ancestor
110524129|NCT01208766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110524130|NCT01208766|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110524131|NCT01208766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110524132|NCT01208766|Immunologic Factors|immunologic factors|mesh-ancestor
110524133|NCT01208766|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110524134|NCT01208766|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110524135|NCT01208766|Growth Substances|growth substances|mesh-ancestor
110524136|NCT01208766|Growth Inhibitors|growth inhibitors|mesh-ancestor
110171591|NCT00045877|Rituximab|rituximab|mesh-list
110524137|NCT01208766|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110524138|NCT01208766|Alkylating Agents|alkylating agents|mesh-ancestor
110524139|NCT01208766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110524140|NCT01208766|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110524141|NCT01208766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110524142|NCT01121588|Crizotinib|crizotinib|mesh-list
110524143|NCT01121588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110524144|NCT01121588|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110524145|NCT01121588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110524146|NCT01121588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110524147|NCT00999336|Betrixaban|betrixaban|mesh-list
110524148|NCT00999336|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110524149|NCT00999336|Antithrombins|antithrombins|mesh-ancestor
110524150|NCT00999336|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110524151|NCT00999336|Protease Inhibitors|protease inhibitors|mesh-ancestor
110524171|NCT00992901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110524173|NCT00992901|Hormones|hormones|mesh-ancestor
110524174|NCT00992901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110524175|NCT00820248|Panitumumab|panitumumab|mesh-list
110524176|NCT00820248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110524177|NCT00820248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110524178|NCT00795340|Paclitaxel|paclitaxel|mesh-list
110524179|NCT00795340|Carboplatin|carboplatin|mesh-list
110524181|NCT00795340|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110524182|NCT00795340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110524183|NCT00795340|Tubulin Modulators|tubulin modulators|mesh-ancestor
110524184|NCT00795340|Antimitotic Agents|antimitotic agents|mesh-ancestor
110524185|NCT00795340|Mitosis Modulators|mitosis modulators|mesh-ancestor
110524186|NCT00795340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110524187|NCT00795340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110524188|NCT00795340|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110524189|NCT00668642|Dutasteride|dutasteride|mesh-list
110524190|NCT00668642|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
110524191|NCT00668642|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110524192|NCT00668642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110524193|NCT00668642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110524194|NCT00668642|Hormone Antagonists|hormone antagonists|mesh-ancestor
110524195|NCT00668642|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110524196|NCT00668642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110524197|NCT00609791|Paclitaxel|paclitaxel|mesh-list
110524198|NCT00609791|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110524199|NCT00609791|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110524200|NCT00609791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110524201|NCT00609791|Tubulin Modulators|tubulin modulators|mesh-ancestor
110524202|NCT00609791|Antimitotic Agents|antimitotic agents|mesh-ancestor
110524203|NCT00609791|Mitosis Modulators|mitosis modulators|mesh-ancestor
110524204|NCT00609791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110524205|NCT00489710|Enzyme Inhibitors|enzyme inhibitors|mesh-list
110524206|NCT00489710|Immunomodulating Agents|immunomodulating agents|mesh-list
110524238|NCT00101101|Antiemetics|antiemetics|mesh-ancestor
110524239|NCT00101101|Autonomic Agents|autonomic agents|mesh-ancestor
110524240|NCT00101101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110524241|NCT00101101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110524242|NCT00101101|Glucocorticoids|glucocorticoids|mesh-ancestor
110524243|NCT00101101|Hormones|hormones|mesh-ancestor
110524244|NCT00101101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110524245|NCT00101101|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110524246|NCT00101101|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110524247|NCT00101101|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110524248|NCT00101101|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110524249|NCT00101101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110524250|NCT00101101|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110524251|NCT00101101|Tubulin Modulators|tubulin modulators|mesh-ancestor
110524264|NCT00946621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110524265|NCT00946621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110524266|NCT00946621|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110524267|NCT02600793|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
110524268|NCT02600793|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110524269|NCT02600793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110524271|NCT04235894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110524272|NCT04235894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110524273|NCT04235894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110524274|NCT04235894|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110524275|NCT04235894|Anesthetics, General|anesthetics, general|mesh-ancestor
110524276|NCT04235894|Anesthetics|anesthetics|mesh-ancestor
110524277|NCT04096599|Fluorides|fluorides|mesh-list
110524278|NCT04096599|Cariostatic Agents|cariostatic agents|mesh-ancestor
110524279|NCT04096599|Protective Agents|protective agents|mesh-ancestor
110524280|NCT04096599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110524281|NCT00923351|Vaccines|vaccines|mesh-list
110524282|NCT00923351|Immunologic Factors|immunologic factors|mesh-ancestor
110524283|NCT00923351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110524284|NCT02788292|Acetylcysteine|acetylcysteine|mesh-list
110524285|NCT02788292|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110524286|NCT02788292|Antiviral Agents|antiviral agents|mesh-ancestor
110524287|NCT02788292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110524288|NCT02788292|Expectorants|expectorants|mesh-ancestor
110524289|NCT02788292|Respiratory System Agents|respiratory system agents|mesh-ancestor
110524290|NCT02788292|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110524291|NCT02788292|Antioxidants|antioxidants|mesh-ancestor
110524292|NCT02788292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110524293|NCT02788292|Protective Agents|protective agents|mesh-ancestor
110524294|NCT02788292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110524295|NCT02788292|Antidotes|antidotes|mesh-ancestor
110524297|NCT00944359|Trace Elements|trace elements|mesh-ancestor
110524298|NCT00944359|Micronutrients|micronutrients|mesh-ancestor
110524299|NCT00944359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110524300|NCT02791256|Ribavirin|ribavirin|mesh-list
110524301|NCT02791256|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110524302|NCT02791256|Antimetabolites|antimetabolites|mesh-ancestor
110524303|NCT02791256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110524304|NCT02791256|Antiviral Agents|antiviral agents|mesh-ancestor
110524305|NCT02791256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110524306|NCT04258007|Neostigmine|neostigmine|mesh-list
110524307|NCT04258007|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110524308|NCT04258007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110524309|NCT04258007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110524310|NCT04258007|Cholinergic Agents|cholinergic agents|mesh-ancestor
110524311|NCT04258007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110524312|NCT04258007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110524313|NCT04258007|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110524314|NCT04258007|Autonomic Agents|autonomic agents|mesh-ancestor
110524315|NCT04258007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110524316|NCT02787824|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
110524317|NCT02787824|Hematinics|hematinics|mesh-ancestor
110524326|NCT00755079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110524328|NCT00950209|Heparin|heparin|mesh-list
110524329|NCT00950209|Anticoagulants|anticoagulants|mesh-ancestor
110524330|NCT00950209|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110524331|NCT00950209|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110524332|NCT00950209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110524333|NCT05370326|Analgesics, Opioid|analgesics, opioid|mesh-list
110524334|NCT05370326|Narcotics|narcotics|mesh-ancestor
110524335|NCT05370326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110524337|NCT05370326|Analgesics|analgesics|mesh-ancestor
110524338|NCT05370326|Sensory System Agents|sensory system agents|mesh-ancestor
110524339|NCT05370326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110524340|NCT00947323|Simvastatin|simvastatin|mesh-list
110524341|NCT00947323|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110524342|NCT00947323|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110524343|NCT00947323|Antimetabolites|antimetabolites|mesh-ancestor
110524344|NCT00947323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110524345|NCT00947323|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110524346|NCT00947323|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110524347|NCT00947323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110524348|NCT04236050|Rocuronium|rocuronium|mesh-list
110524349|NCT04236050|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110524350|NCT04236050|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110524351|NCT04236050|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110524352|NCT04236050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110524353|NCT04236050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110524354|NCT02790632|Nimodipine|nimodipine|mesh-list
110524355|NCT02790632|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110524356|NCT02790632|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110524357|NCT02790632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110524358|NCT02790632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110524359|NCT02790632|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110524360|NCT02790632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110524361|NCT02790632|Vasodilator Agents|vasodilator agents|mesh-ancestor
110524362|NCT03633110|Pembrolizumab|pembrolizumab|mesh-list
110524364|NCT03633110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110524365|NCT03633110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110524366|NCT03633110|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110524367|NCT03633110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110524368|NCT02788136|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
110524369|NCT02788136|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110524370|NCT02788136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110524371|NCT02788058|Gefitinib|gefitinib|mesh-list
110524372|NCT02788058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110524373|NCT02788058|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110524374|NCT02788058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110524375|NCT02788058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110524376|NCT04200092|Granisetron|granisetron|mesh-list
110524377|NCT04200092|Antiemetics|antiemetics|mesh-ancestor
110524378|NCT04200092|Autonomic Agents|autonomic agents|mesh-ancestor
110524379|NCT04200092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110524380|NCT04200092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110524381|NCT04200092|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110524382|NCT04200092|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110524383|NCT04200092|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110524391|NCT00754065|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
110524392|NCT00754065|Estradiol|estradiol|mesh-list
110524393|NCT00754065|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110524394|NCT00754065|Estrogens|estrogens|mesh-ancestor
110524395|NCT00754065|Hormones|hormones|mesh-ancestor
110524396|NCT00754065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110524397|NCT00754065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110524398|NCT00754065|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110524399|NCT00754065|Contraceptive Agents|contraceptive agents|mesh-ancestor
110524400|NCT00754065|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110524401|NCT00754065|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110524402|NCT00754065|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110524403|NCT00754065|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110524404|NCT00754065|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110524405|NCT00754065|Hormone Antagonists|hormone antagonists|mesh-ancestor
110524406|NCT00754065|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110524407|NCT00754065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110524408|NCT00754065|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110524409|NCT00754065|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110524410|NCT00754065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110524411|NCT00754065|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110524412|NCT00754065|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110524413|NCT00754065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110524414|NCT00754065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110524416|NCT02787746|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110524417|NCT02787746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110524418|NCT02787746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110524419|NCT02787746|Cholinergic Agents|cholinergic agents|mesh-ancestor
110524420|NCT02787746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110524421|NCT02787746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110524422|NCT02787746|Nootropic Agents|nootropic agents|mesh-ancestor
110524423|NCT03254654|Apatinib|apatinib|mesh-list
110524424|NCT03254654|Vinorelbine|vinorelbine|mesh-list
110524425|NCT03254654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110524426|NCT03254654|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110524427|NCT03254654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110917799|NCT02108886|Montelukast|montelukast|mesh-list
110524428|NCT03254654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110524429|NCT03254654|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110524430|NCT03254654|Tubulin Modulators|tubulin modulators|mesh-ancestor
110524431|NCT03254654|Antimitotic Agents|antimitotic agents|mesh-ancestor
110524432|NCT03254654|Mitosis Modulators|mitosis modulators|mesh-ancestor
110524433|NCT02785718|Hemostatics|hemostatics|mesh-list
110524434|NCT02785718|Coagulants|coagulants|mesh-ancestor
110524435|NCT04094805|Calcitriol|calcitriol|mesh-list
110524436|NCT04094805|Dexamethasone|dexamethasone|mesh-list
110524437|NCT04094805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110524438|NCT04094805|Antiemetics|antiemetics|mesh-ancestor
110524439|NCT04094805|Autonomic Agents|autonomic agents|mesh-ancestor
110524440|NCT04094805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110524441|NCT04094805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110524442|NCT04094805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110524443|NCT04094805|Glucocorticoids|glucocorticoids|mesh-ancestor
110524444|NCT04094805|Hormones|hormones|mesh-ancestor
110524445|NCT04094805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110524446|NCT04094805|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110524447|NCT04094805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110524448|NCT04094805|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110524449|NCT04094805|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
110524450|NCT04094805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110524451|NCT04094805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110524456|NCT04094727|Lumefantrine|lumefantrine|mesh-list
110524457|NCT04094727|Artemether|artemether|mesh-list
110524458|NCT04094727|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
110524459|NCT04094727|Antimalarials|antimalarials|mesh-ancestor
110524460|NCT04094727|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110524461|NCT04094727|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110524462|NCT04094727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110524463|NCT00638066|Botulinum Toxins|botulinum toxins|mesh-list
110524464|NCT00638066|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110524465|NCT00638066|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110524466|NCT00638066|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110524467|NCT00638066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110524468|NCT00638066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110524469|NCT00638066|Cholinergic Agents|cholinergic agents|mesh-ancestor
110524470|NCT00638066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110524471|NCT00638066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110524472|NCT00638066|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110524473|NCT00638066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110524474|NCT02786732|Ustekinumab|ustekinumab|mesh-list
110524475|NCT02786732|Brodalumab|brodalumab|mesh-list
110524476|NCT02786732|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110524477|NCT02786732|Dermatologic Agents|dermatologic agents|mesh-ancestor
110524478|NCT02786732|Immunologic Factors|immunologic factors|mesh-ancestor
110524479|NCT02786732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110524480|NCT02785250|Cyclophosphamide|cyclophosphamide|mesh-list
110524481|NCT02785250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110524483|NCT02785250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110524484|NCT02785250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110524485|NCT02785250|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110524486|NCT02785250|Alkylating Agents|alkylating agents|mesh-ancestor
110524487|NCT02785250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110524488|NCT02785250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110524489|NCT02785250|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110524490|NCT03110822|Methylprednisolone|methylprednisolone|mesh-list
110524491|NCT03110822|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110524492|NCT03110822|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110524493|NCT03110822|Prednisolone|prednisolone|mesh-list
110524494|NCT03110822|Prednisolone acetate|prednisolone acetate|mesh-list
110524495|NCT03110822|Lenalidomide|lenalidomide|mesh-list
110524496|NCT03110822|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110524497|NCT03110822|Prednisolone phosphate|prednisolone phosphate|mesh-list
110524498|NCT03110822|Immunologic Factors|immunologic factors|mesh-ancestor
110524499|NCT03110822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110524500|NCT03110822|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110524501|NCT03110822|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110524502|NCT03110822|Growth Substances|growth substances|mesh-ancestor
110524503|NCT03110822|Growth Inhibitors|growth inhibitors|mesh-ancestor
110192441|NCT00031928|Mafosfamide|mafosfamide|mesh-list
110524504|NCT03110822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110524505|NCT03110822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110524506|NCT03110822|Antiemetics|antiemetics|mesh-ancestor
110524507|NCT03110822|Autonomic Agents|autonomic agents|mesh-ancestor
110524508|NCT03110822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110524509|NCT03110822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110524510|NCT03110822|Glucocorticoids|glucocorticoids|mesh-ancestor
110524511|NCT03110822|Hormones|hormones|mesh-ancestor
110524512|NCT03110822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110524513|NCT03110822|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110524514|NCT03110822|Protective Agents|protective agents|mesh-ancestor
110524515|NCT03110822|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110524517|NCT02787356|Anesthetics, Local|anesthetics, local|mesh-ancestor
110524518|NCT02787356|Anesthetics|anesthetics|mesh-ancestor
110524519|NCT02787356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110524520|NCT02787356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110524521|NCT02787356|Sensory System Agents|sensory system agents|mesh-ancestor
110524522|NCT02787356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110524523|NCT02787356|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110524524|NCT02787356|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110524525|NCT02787356|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110524538|NCT04232150|Anesthetics|anesthetics|mesh-list
110524539|NCT04232150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110524540|NCT04232150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110524541|NCT04232150|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110524542|NCT04232150|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110524543|NCT04232150|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110524544|NCT04232150|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110524545|NCT04232150|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110524546|NCT04232150|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110524547|NCT04232150|Anesthetics, General|anesthetics, general|mesh-ancestor
110524548|NCT04232150|GABA Modulators|gaba modulators|mesh-ancestor
110524549|NCT04232150|GABA Agents|gaba agents|mesh-ancestor
110524550|NCT04232150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110524551|NCT04232150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110524552|NCT04197752|Anesthetics|anesthetics|mesh-list
110524553|NCT04197752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110524554|NCT04197752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110524555|NCT02336750|Aprepitant|aprepitant|mesh-list
110524556|NCT02336750|Fosaprepitant|fosaprepitant|mesh-list
110524557|NCT02336750|Mirtazapine|mirtazapine|mesh-list
110524558|NCT02336750|Antiemetics|antiemetics|mesh-ancestor
110524559|NCT02336750|Autonomic Agents|autonomic agents|mesh-ancestor
110524560|NCT02336750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110524561|NCT02336750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110524562|NCT02336750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110524563|NCT02336750|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110524564|NCT02336750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110524565|NCT02336750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110192461|NCT00059826|Immunologic Factors|immunologic factors|mesh-ancestor
110524566|NCT02336750|Antidepressive Agents|antidepressive agents|mesh-ancestor
110524567|NCT02336750|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110524568|NCT02336750|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110524569|NCT02336750|Histamine Antagonists|histamine antagonists|mesh-ancestor
110524570|NCT02336750|Histamine Agents|histamine agents|mesh-ancestor
110524571|NCT02336750|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110524572|NCT02336750|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110524573|NCT02336750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110524574|NCT02336750|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
110524575|NCT02336750|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110524576|NCT02336750|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110524577|NCT02336750|Adrenergic Agents|adrenergic agents|mesh-ancestor
110524578|NCT02336750|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110524579|NCT02336750|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110524580|NCT02336750|Serotonin Agents|serotonin agents|mesh-ancestor
110524581|NCT02336750|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110524582|NCT02784392|Metoclopramide|metoclopramide|mesh-list
110524583|NCT02784392|Antiemetics|antiemetics|mesh-ancestor
110524584|NCT02784392|Autonomic Agents|autonomic agents|mesh-ancestor
110524585|NCT02784392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110524586|NCT02784392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110524587|NCT02784392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110180132|NCT00276393|Insulin|insulin|mesh-list
110524592|NCT02784392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110524594|NCT00634556|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
110524595|NCT00634556|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110524596|NCT00634556|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110524597|NCT00634556|Dopamine Agents|dopamine agents|mesh-ancestor
110524598|NCT00634556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110524599|NCT00634556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110524600|NCT00634556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110524601|NCT02784080|Isoantibodies|isoantibodies|mesh-list
110524602|NCT02784080|Immunologic Factors|immunologic factors|mesh-ancestor
110524603|NCT02784080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110524604|NCT02784860|Lidocaine|lidocaine|mesh-list
110524605|NCT02784860|Anesthetics, Local|anesthetics, local|mesh-ancestor
110524606|NCT02784860|Anesthetics|anesthetics|mesh-ancestor
110524607|NCT02784860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110524608|NCT02784860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110524609|NCT02784860|Sensory System Agents|sensory system agents|mesh-ancestor
110524610|NCT02784860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110524611|NCT02784860|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110524612|NCT02784860|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110524613|NCT02784860|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110524614|NCT02784860|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110524615|NCT02784860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110524616|NCT02783924|Cholecalciferol|cholecalciferol|mesh-list
110524617|NCT02783924|Vitamin D|vitamin d|mesh-list
110524618|NCT02783924|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110524619|NCT02783924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110524620|NCT02783924|Vitamins|vitamins|mesh-ancestor
110524621|NCT02783924|Micronutrients|micronutrients|mesh-ancestor
110524622|NCT02783924|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110524623|NCT02783846|Dexmedetomidine|dexmedetomidine|mesh-list
110524624|NCT02783846|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110524625|NCT02783846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110192484|NCT00032084|Nicotine|nicotine|mesh-list
110524626|NCT02783846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110524627|NCT02783846|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110524628|NCT02783846|Analgesics|analgesics|mesh-ancestor
110524629|NCT02783846|Sensory System Agents|sensory system agents|mesh-ancestor
110524630|NCT02783846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110524631|NCT02783846|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110524632|NCT02783846|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110524633|NCT02783846|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110524634|NCT02783846|Adrenergic Agents|adrenergic agents|mesh-ancestor
110524635|NCT02783846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110524636|NCT02783846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110524637|NCT02783378|Alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|mesh-list
110524639|NCT02783378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110524640|NCT02783378|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110524641|NCT05237726|Heparin|heparin|mesh-list
110524642|NCT05237726|Enoxaparin|enoxaparin|mesh-list
110524643|NCT05237726|Calcium heparin|calcium heparin|mesh-list
110524644|NCT05237726|Enoxaparin sodium|enoxaparin sodium|mesh-list
110524645|NCT05237726|Anticoagulants|anticoagulants|mesh-ancestor
110524646|NCT05237726|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110524647|NCT05237726|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110524648|NCT05237726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110524649|NCT02783144|Dexamethasone|dexamethasone|mesh-list
110524650|NCT02783144|Dexamethasone acetate|dexamethasone acetate|mesh-list
110524651|NCT02783144|BB 1101|bb 1101|mesh-list
110524652|NCT02783144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110524653|NCT02783144|Antiemetics|antiemetics|mesh-ancestor
110524654|NCT02783144|Autonomic Agents|autonomic agents|mesh-ancestor
110524655|NCT02783144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110524656|NCT02783144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110524657|NCT02783144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110524665|NCT02783144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110524666|NCT05260320|Anesthetics|anesthetics|mesh-list
110524667|NCT05260320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110524668|NCT05260320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110524669|NCT02783222|Paclitaxel|paclitaxel|mesh-list
110524670|NCT02783222|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110524671|NCT02783222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110524672|NCT02783222|Tubulin Modulators|tubulin modulators|mesh-ancestor
110524673|NCT02783222|Antimitotic Agents|antimitotic agents|mesh-ancestor
110524674|NCT02783222|Mitosis Modulators|mitosis modulators|mesh-ancestor
110524675|NCT02783222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110524676|NCT02689856|Hydrocortisone|hydrocortisone|mesh-list
110524677|NCT02689856|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
110524678|NCT02689856|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
110524679|NCT02689856|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
110524680|NCT02689856|Lidocaine|lidocaine|mesh-list
110524681|NCT02689856|Anesthetics, Local|anesthetics, local|mesh-ancestor
110524682|NCT02689856|Anesthetics|anesthetics|mesh-ancestor
110524683|NCT02689856|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110524684|NCT02689856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110524685|NCT02689856|Sensory System Agents|sensory system agents|mesh-ancestor
110524686|NCT02689856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110524687|NCT02689856|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110524688|NCT02689856|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110524689|NCT02689856|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110524690|NCT02689856|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110524691|NCT02689856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110524692|NCT02689856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110524693|NCT02722902|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
110524694|NCT02722902|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
110524695|NCT02722902|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
110524696|NCT02722902|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110524697|NCT05206448|Letrozole|letrozole|mesh-list
110524698|NCT05206448|Clomiphene|clomiphene|mesh-list
110524699|NCT05206448|Enclomiphene|enclomiphene|mesh-list
110524700|NCT05206448|Zuclomiphene|zuclomiphene|mesh-list
110524701|NCT05206448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110524702|NCT05206448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110524703|NCT05206448|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110524704|NCT05206448|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110524705|NCT05206448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110524706|NCT05206448|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110524707|NCT05206448|Hormone Antagonists|hormone antagonists|mesh-ancestor
110524708|NCT05206448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110524709|NCT05206448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110524710|NCT05206448|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110524711|NCT05206448|Fertility Agents|fertility agents|mesh-ancestor
110524712|NCT05206448|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110524713|NCT05206448|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110524714|NCT05206448|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110524716|NCT02722746|Ropivacaine|ropivacaine|mesh-list
110524717|NCT02722746|Anesthetics, Local|anesthetics, local|mesh-ancestor
110524718|NCT02722746|Anesthetics|anesthetics|mesh-ancestor
110524719|NCT02722746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110917845|NCT02114658|Sorafenib|sorafenib|mesh-list
110524720|NCT02722746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110524721|NCT02722746|Sensory System Agents|sensory system agents|mesh-ancestor
110524722|NCT02722746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110524729|NCT02722746|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110524730|NCT02722746|Autonomic Agents|autonomic agents|mesh-ancestor
110524731|NCT02722746|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110524732|NCT02722746|Respiratory System Agents|respiratory system agents|mesh-ancestor
110524733|NCT02722746|Mydriatics|mydriatics|mesh-ancestor
110524734|NCT02722746|Sympathomimetics|sympathomimetics|mesh-ancestor
110172183|NCT00049387|Tipifarnib|tipifarnib|mesh-list
110524735|NCT02722746|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110524736|NCT02784626|Dexmedetomidine|dexmedetomidine|mesh-list
110524737|NCT02784626|Propofol|propofol|mesh-list
110524738|NCT02784626|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110524739|NCT02784626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110524740|NCT02784626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110524741|NCT02784626|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110524742|NCT02784626|Analgesics|analgesics|mesh-ancestor
110524743|NCT02784626|Sensory System Agents|sensory system agents|mesh-ancestor
110524744|NCT02784626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110524745|NCT02784626|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110524746|NCT02784626|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110524747|NCT02784626|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110524748|NCT02784626|Adrenergic Agents|adrenergic agents|mesh-ancestor
110524749|NCT02784626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110524750|NCT02784626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110524751|NCT02784626|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110524752|NCT02784626|Anesthetics, General|anesthetics, general|mesh-ancestor
110524753|NCT02784626|Anesthetics|anesthetics|mesh-ancestor
110524754|NCT02782754|Cyclophosphamide|cyclophosphamide|mesh-list
110524755|NCT02782754|Carboplatin|carboplatin|mesh-list
110524756|NCT02782754|Etoposide|etoposide|mesh-list
110524757|NCT02782754|Bleomycin|bleomycin|mesh-list
110524758|NCT02782754|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110524759|NCT02782754|Immunologic Factors|immunologic factors|mesh-ancestor
110524760|NCT02782754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110524761|NCT02782754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110524762|NCT02782754|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110524763|NCT02782754|Alkylating Agents|alkylating agents|mesh-ancestor
110524764|NCT02782754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110524765|NCT02782754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110524766|NCT02782754|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110524767|NCT02782754|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110524768|NCT02782754|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110524769|NCT02782754|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110524770|NCT02782754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110524771|NCT02782754|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110524772|NCT05341076|Oxytocin|oxytocin|mesh-list
110524773|NCT05341076|Oxytocics|oxytocics|mesh-ancestor
110312185|NCT00292760|Alemtuzumab|alemtuzumab|mesh-list
110524774|NCT05341076|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110524775|NCT05341076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110524776|NCT05133518|Midazolam|midazolam|mesh-list
110524777|NCT05133518|Ketamine|ketamine|mesh-list
110524778|NCT05133518|Analgesics|analgesics|mesh-ancestor
110524779|NCT05133518|Sensory System Agents|sensory system agents|mesh-ancestor
110524780|NCT05133518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110524781|NCT05133518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110524782|NCT05133518|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110524783|NCT05133518|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110524784|NCT05133518|Anesthetics, General|anesthetics, general|mesh-ancestor
110524785|NCT05133518|Anesthetics|anesthetics|mesh-ancestor
110524786|NCT05133518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110524787|NCT05133518|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110524788|NCT05133518|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110524789|NCT05133518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110534642|NCT00643734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110524792|NCT05133518|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110524793|NCT05133518|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110524794|NCT05133518|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110524795|NCT05133518|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110524796|NCT05133518|GABA Modulators|gaba modulators|mesh-ancestor
110524797|NCT05133518|GABA Agents|gaba agents|mesh-ancestor
110524798|NCT02714712|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110524799|NCT02714712|Antiviral Agents|antiviral agents|mesh-ancestor
110524800|NCT02714712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110524801|NCT02714166|Sunscreening Agents|sunscreening agents|mesh-list
110524802|NCT02714166|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110524803|NCT02714166|Protective Agents|protective agents|mesh-ancestor
110524804|NCT02714166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110524805|NCT02714166|Dermatologic Agents|dermatologic agents|mesh-ancestor
110524807|NCT04231682|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110192544|NCT00032396|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
110524808|NCT04231682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110524809|NCT02722356|Oxytocin|oxytocin|mesh-list
110524810|NCT02722356|Oxytocics|oxytocics|mesh-ancestor
110524811|NCT02722356|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110524812|NCT02722356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110524813|NCT00753675|Gemcitabine|gemcitabine|mesh-list
110524814|NCT00753675|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110524815|NCT00753675|Antimetabolites|antimetabolites|mesh-ancestor
110524816|NCT00753675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110524817|NCT00753675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110524818|NCT05131178|Bupivacaine|bupivacaine|mesh-list
110524819|NCT05131178|Anesthetics, Local|anesthetics, local|mesh-ancestor
110524820|NCT05131178|Anesthetics|anesthetics|mesh-ancestor
110524821|NCT05131178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110524822|NCT05131178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110524823|NCT05131178|Sensory System Agents|sensory system agents|mesh-ancestor
110524824|NCT05131178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110524825|NCT02546934|Cisplatin|cisplatin|mesh-list
110524826|NCT02546934|Gemcitabine|gemcitabine|mesh-list
110524827|NCT02546934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110524828|NCT02546934|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110524829|NCT02546934|Antimetabolites|antimetabolites|mesh-ancestor
110524830|NCT02546934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110524831|NCT00586521|Factor VIII|factor viii|mesh-list
110524832|NCT00586521|Coagulants|coagulants|mesh-ancestor
110524833|NCT02782286|Ketorolac|ketorolac|mesh-list
110524834|NCT02782286|Morphine|morphine|mesh-list
110524835|NCT02782286|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110524836|NCT02782286|Narcotics|narcotics|mesh-ancestor
110524837|NCT02782286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110524838|NCT02782286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110524839|NCT02782286|Analgesics|analgesics|mesh-ancestor
110524840|NCT02782286|Sensory System Agents|sensory system agents|mesh-ancestor
110524841|NCT02782286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110524842|NCT02782286|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110524843|NCT02782286|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110524844|NCT02782286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110524845|NCT02782286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110524846|NCT02782286|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110524847|NCT02782286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110524848|NCT02782286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110524850|NCT02600247|Celecoxib|celecoxib|mesh-list
110524851|NCT02600247|Pregabalin|pregabalin|mesh-list
110524852|NCT02600247|Oxycodone|oxycodone|mesh-list
110524853|NCT02600247|Tramadol|tramadol|mesh-list
110524854|NCT02600247|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110524855|NCT02600247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110524856|NCT02600247|Analgesics|analgesics|mesh-ancestor
110524857|NCT02600247|Sensory System Agents|sensory system agents|mesh-ancestor
110524858|NCT02600247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110524859|NCT02600247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110524860|NCT02600247|Antipyretics|antipyretics|mesh-ancestor
110524861|NCT02600247|Anticonvulsants|anticonvulsants|mesh-ancestor
110524863|NCT02600247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110180160|NCT00014573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110524868|NCT02600247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110524869|NCT02600247|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110524870|NCT02600247|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110524871|NCT02600247|Narcotics|narcotics|mesh-ancestor
110524872|NCT02600247|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110524873|NCT02600247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110524874|NCT02600247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110524875|NCT02600247|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110524876|NCT02600247|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110524877|NCT02600247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110524878|NCT02600247|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110524879|NCT02600247|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110524880|NCT02600247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110524881|NCT02600247|Antidepressive Agents|antidepressive agents|mesh-ancestor
110524882|NCT02600247|Dopamine Agents|dopamine agents|mesh-ancestor
110524883|NCT05453253|Vaccines|vaccines|mesh-list
110524884|NCT05453253|Immunologic Factors|immunologic factors|mesh-ancestor
110524885|NCT05453253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110172326|NCT00050401|Vancomycin|vancomycin|mesh-list
110524886|NCT04229498|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110524887|NCT04229498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110524888|NCT02717052|Ketamine|ketamine|mesh-list
110524889|NCT02717052|Esketamine|esketamine|mesh-list
110524890|NCT02717052|Analgesics|analgesics|mesh-ancestor
110524891|NCT02717052|Sensory System Agents|sensory system agents|mesh-ancestor
110524892|NCT02717052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110524893|NCT02717052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110524894|NCT02717052|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110524895|NCT02717052|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110524896|NCT02717052|Anesthetics, General|anesthetics, general|mesh-ancestor
110524897|NCT02717052|Anesthetics|anesthetics|mesh-ancestor
110524898|NCT02717052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110524899|NCT02717052|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110524900|NCT02717052|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110524901|NCT02717052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110524902|NCT02717052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110524903|NCT02717052|Antidepressive Agents|antidepressive agents|mesh-ancestor
110524904|NCT02717052|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110524905|NCT05342558|Fluticasone|fluticasone|mesh-list
110524906|NCT05342558|Xhance|xhance|mesh-list
110524907|NCT05342558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110524908|NCT05342558|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110524909|NCT05342558|Autonomic Agents|autonomic agents|mesh-ancestor
110524910|NCT05342558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110524911|NCT05342558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110524912|NCT05342558|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110524913|NCT05342558|Respiratory System Agents|respiratory system agents|mesh-ancestor
110524914|NCT05342558|Dermatologic Agents|dermatologic agents|mesh-ancestor
110524915|NCT05342558|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110524916|NCT00923273|Folic Acid|folic acid|mesh-list
110524917|NCT00923273|Vitamin B 12|vitamin b 12|mesh-list
110524918|NCT00923273|Sirolimus|sirolimus|mesh-list
110524919|NCT00923273|Dexamethasone|dexamethasone|mesh-list
110524920|NCT00923273|Pemetrexed|pemetrexed|mesh-list
110524921|NCT00923273|Vitamins|vitamins|mesh-ancestor
110524922|NCT00923273|Micronutrients|micronutrients|mesh-ancestor
110524923|NCT00923273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110524924|NCT00923273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110524925|NCT00923273|Antiemetics|antiemetics|mesh-ancestor
110524926|NCT00923273|Autonomic Agents|autonomic agents|mesh-ancestor
110917864|NCT02114736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110524927|NCT00923273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110524928|NCT00923273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110524929|NCT00923273|Glucocorticoids|glucocorticoids|mesh-ancestor
110524930|NCT00923273|Hormones|hormones|mesh-ancestor
110524931|NCT00923273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110524932|NCT00923273|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110524933|NCT00923273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110524934|NCT00923273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110524936|NCT00923273|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110524937|NCT00923273|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110524938|NCT00923273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110524939|NCT00923273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110524940|NCT00923273|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110524941|NCT00923273|Antifungal Agents|antifungal agents|mesh-ancestor
110524942|NCT00923273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110524943|NCT00923273|Immunologic Factors|immunologic factors|mesh-ancestor
110524944|NCT00923273|Hematinics|hematinics|mesh-ancestor
110524945|NCT00923273|Vitamin B Complex|vitamin b complex|mesh-ancestor
110524946|NCT04231370|Lenalidomide|lenalidomide|mesh-list
110524947|NCT04231370|Immunologic Factors|immunologic factors|mesh-ancestor
110524948|NCT04231370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110524949|NCT04231370|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110524950|NCT04231370|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110524951|NCT04231370|Growth Substances|growth substances|mesh-ancestor
110524952|NCT04231370|Growth Inhibitors|growth inhibitors|mesh-ancestor
110524953|NCT04231370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110524954|NCT05340530|Meropenem|meropenem|mesh-list
110524955|NCT05340530|Avibactam|avibactam|mesh-list
110524956|NCT05340530|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110524957|NCT05340530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110524958|NCT05340530|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110524959|NCT05340530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110524960|NCT05340530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110524961|NCT00634712|Candesartan|candesartan|mesh-list
110524962|NCT00634712|Candesartan cilexetil|candesartan cilexetil|mesh-list
110524963|NCT00634712|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110524964|NCT00634712|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110524965|NCT00634712|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110524966|NCT00634712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110524968|NCT00923195|Cyclophosphamide|cyclophosphamide|mesh-list
110524969|NCT00923195|Fludarabine|fludarabine|mesh-list
110524970|NCT00923195|Interleukin-2|interleukin-2|mesh-list
110524971|NCT00923195|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
110524972|NCT00923195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110524973|NCT00923195|Immunologic Factors|immunologic factors|mesh-ancestor
110524974|NCT00923195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110524975|NCT00923195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110524976|NCT00923195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110524977|NCT00923195|Alkylating Agents|alkylating agents|mesh-ancestor
110524978|NCT00923195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110524979|NCT00923195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110524980|NCT00923195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110524981|NCT00923195|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110524982|NCT00923195|Analgesics|analgesics|mesh-ancestor
110524983|NCT00923195|Sensory System Agents|sensory system agents|mesh-ancestor
110524984|NCT00923195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110524985|NCT00923195|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110524986|NCT00923195|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110524987|NCT00923195|Antiviral Agents|antiviral agents|mesh-ancestor
110524988|NCT00923195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110524989|NCT00923195|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110524990|NCT02721888|Liraglutide|liraglutide|mesh-list
110524991|NCT02721888|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110524992|NCT02721888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110524993|NCT02721888|Incretins|incretins|mesh-ancestor
110524994|NCT02721888|Hormones|hormones|mesh-ancestor
110524995|NCT02721888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110524996|NCT04256057|Magnesium Sulfate|magnesium sulfate|mesh-list
110524997|NCT04256057|Analgesics|analgesics|mesh-ancestor
110524998|NCT04256057|Sensory System Agents|sensory system agents|mesh-ancestor
110524999|NCT04256057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110525000|NCT04256057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110525001|NCT04256057|Anesthetics|anesthetics|mesh-ancestor
110525002|NCT04256057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110525003|NCT04256057|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110525004|NCT04256057|Anticonvulsants|anticonvulsants|mesh-ancestor
110525005|NCT04256057|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110525006|NCT04256057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110525007|NCT04256057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110534643|NCT00643734|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110525015|NCT02714010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110525016|NCT02714010|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110525017|NCT02714010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110525018|NCT02714010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110525019|NCT00917241|Dexamethasone|dexamethasone|mesh-list
110525020|NCT00917241|Methimazole|methimazole|mesh-list
110525021|NCT00917241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110525022|NCT00917241|Antiemetics|antiemetics|mesh-ancestor
110525023|NCT00917241|Autonomic Agents|autonomic agents|mesh-ancestor
110525024|NCT00917241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110525025|NCT00917241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110525026|NCT00917241|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110525027|NCT00917241|Glucocorticoids|glucocorticoids|mesh-ancestor
110525028|NCT00917241|Hormones|hormones|mesh-ancestor
110525029|NCT00917241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110525030|NCT00917241|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110525031|NCT00917241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110525032|NCT00917241|Antithyroid Agents|antithyroid agents|mesh-ancestor
110525033|NCT00917241|Hormone Antagonists|hormone antagonists|mesh-ancestor
110525034|NCT00919061|Gemcitabine|gemcitabine|mesh-list
110525035|NCT00919061|Sorafenib|sorafenib|mesh-list
110525036|NCT00919061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110525037|NCT00919061|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110525038|NCT00919061|Antimetabolites|antimetabolites|mesh-ancestor
110525039|NCT00919061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110525040|NCT00919061|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110525041|NCT00919061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110525042|NCT05106296|Cyclophosphamide|cyclophosphamide|mesh-list
110525043|NCT05106296|Etoposide|etoposide|mesh-list
110525044|NCT05106296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110525045|NCT05106296|Immunologic Factors|immunologic factors|mesh-ancestor
110525046|NCT05106296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110525047|NCT05106296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110525048|NCT05106296|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110525049|NCT05106296|Alkylating Agents|alkylating agents|mesh-ancestor
110525050|NCT05106296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110525051|NCT05106296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110525052|NCT05106296|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110525053|NCT05106296|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110525054|NCT05106296|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110525056|NCT05106296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110525057|NCT02598687|Paclitaxel|paclitaxel|mesh-list
110525058|NCT02598687|Carboplatin|carboplatin|mesh-list
110525059|NCT02598687|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110525060|NCT02598687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110525061|NCT02598687|Tubulin Modulators|tubulin modulators|mesh-ancestor
110525062|NCT02598687|Antimitotic Agents|antimitotic agents|mesh-ancestor
110525063|NCT02598687|Mitosis Modulators|mitosis modulators|mesh-ancestor
110525064|NCT02598687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110525065|NCT04908605|Melatonin|melatonin|mesh-list
110525066|NCT04908605|Mirtazapine|mirtazapine|mesh-list
110525067|NCT04908605|Antioxidants|antioxidants|mesh-ancestor
110525068|NCT04908605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110525069|NCT04908605|Protective Agents|protective agents|mesh-ancestor
110525070|NCT04908605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110525071|NCT04908605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110525072|NCT04908605|Antidepressive Agents|antidepressive agents|mesh-ancestor
110525073|NCT04908605|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110525074|NCT04908605|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110525075|NCT04908605|Histamine Antagonists|histamine antagonists|mesh-ancestor
110525081|NCT04908605|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110525082|NCT04908605|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110525084|NCT04908605|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110525085|NCT04908605|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110525086|NCT04908605|Serotonin Agents|serotonin agents|mesh-ancestor
110525087|NCT04908605|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110525088|NCT02782208|Acipimox|acipimox|mesh-list
110525089|NCT02782208|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110525090|NCT02782208|Antimetabolites|antimetabolites|mesh-ancestor
110192650|NCT00060489|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110525091|NCT02782208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110525092|NCT02782208|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110525093|NCT02598453|Ibandronic Acid|ibandronic acid|mesh-list
110525094|NCT02598453|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110525095|NCT02598453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110525096|NCT00611286|Sirolimus|sirolimus|mesh-list
110525097|NCT00611286|Paclitaxel|paclitaxel|mesh-list
110525098|NCT00611286|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110525099|NCT00611286|Everolimus|everolimus|mesh-list
110525100|NCT00611286|Clopidogrel|clopidogrel|mesh-list
110525101|NCT00611286|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-list
110525102|NCT00611286|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110525103|NCT00611286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110525104|NCT00611286|Tubulin Modulators|tubulin modulators|mesh-ancestor
110525105|NCT00611286|Antimitotic Agents|antimitotic agents|mesh-ancestor
110525106|NCT00611286|Mitosis Modulators|mitosis modulators|mesh-ancestor
110525107|NCT00611286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110525108|NCT00611286|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110525109|NCT00611286|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110525110|NCT00611286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110525111|NCT00611286|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110525112|NCT00611286|Immunologic Factors|immunologic factors|mesh-ancestor
110525113|NCT00611286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110525114|NCT00611286|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110525115|NCT00611286|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110525116|NCT00611286|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110525117|NCT00611286|Purinergic Agents|purinergic agents|mesh-ancestor
110525118|NCT00611286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110525119|NCT00611286|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110525120|NCT00611286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110525121|NCT00611286|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110525122|NCT00611286|Antifungal Agents|antifungal agents|mesh-ancestor
110525123|NCT04257851|Sumatriptan|sumatriptan|mesh-list
110525124|NCT04257851|Theophylline|theophylline|mesh-list
110525125|NCT04257851|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110525126|NCT04257851|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110525127|NCT04257851|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110525128|NCT04257851|Serotonin Agents|serotonin agents|mesh-ancestor
110917938|NCT02109900|Progesterone|progesterone|mesh-list
110525129|NCT04257851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110525130|NCT04257851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110525131|NCT04257851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110525132|NCT04257851|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110525133|NCT04257851|Autonomic Agents|autonomic agents|mesh-ancestor
110525134|NCT04257851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110525135|NCT04257851|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110525136|NCT04257851|Respiratory System Agents|respiratory system agents|mesh-ancestor
110525137|NCT04257851|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110525138|NCT04257851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110525139|NCT04257851|Vasodilator Agents|vasodilator agents|mesh-ancestor
110525140|NCT04257851|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110525141|NCT04257851|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110525142|NCT04257851|Purinergic Agents|purinergic agents|mesh-ancestor
110525143|NCT02780102|Methylphenidate|methylphenidate|mesh-list
110525144|NCT02780102|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110525146|NCT02780102|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110525147|NCT02780102|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110525148|NCT02780102|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110525149|NCT02780102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110525150|NCT02780102|Dopamine Agents|dopamine agents|mesh-ancestor
110525151|NCT02780102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110525152|NCT04197050|Valsartan|valsartan|mesh-list
110525153|NCT04197050|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
110525154|NCT04197050|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110525155|NCT04197050|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110525156|NCT04197050|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110525157|NCT04197050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110525158|NCT04090047|Itraconazole|itraconazole|mesh-list
110525159|NCT04090047|PF-06700841|pf-06700841|mesh-list
110525160|NCT04090047|Antifungal Agents|antifungal agents|mesh-ancestor
110525161|NCT04090047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110525162|NCT04090047|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110525163|NCT04090047|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110525164|NCT04090047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110525165|NCT04090047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110525166|NCT04090047|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110525167|NCT04090047|Hormone Antagonists|hormone antagonists|mesh-ancestor
110525168|NCT04090047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110525169|NCT04090047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110525170|NCT04090047|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110525171|NCT04090047|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110525172|NCT02782052|Bromides|bromides|mesh-list
110525173|NCT02782052|Albuterol|albuterol|mesh-list
110525174|NCT02782052|Ipratropium|ipratropium|mesh-list
110525175|NCT02782052|Anticonvulsants|anticonvulsants|mesh-ancestor
110525176|NCT02782052|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110525177|NCT02782052|Autonomic Agents|autonomic agents|mesh-ancestor
110525178|NCT02782052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110525179|NCT02782052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110525180|NCT02782052|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110525181|NCT02782052|Respiratory System Agents|respiratory system agents|mesh-ancestor
110525182|NCT02782052|Tocolytic Agents|tocolytic agents|mesh-ancestor
110525183|NCT02782052|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110525184|NCT02782052|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110525185|NCT02782052|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110525186|NCT02782052|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110525187|NCT02782052|Adrenergic Agents|adrenergic agents|mesh-ancestor
110525188|NCT02782052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110525189|NCT02782052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110525190|NCT02782052|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110917990|NCT02115204|Antimetabolites|antimetabolites|mesh-ancestor
110525191|NCT02782052|Cholinergic Agents|cholinergic agents|mesh-ancestor
110525193|NCT02708628|Allantoin|allantoin|mesh-list
110525194|NCT02708628|Anticoagulants|anticoagulants|mesh-ancestor
110525195|NCT02708628|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110525196|NCT02708628|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110525197|NCT02708628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110525198|NCT02708628|Dermatologic Agents|dermatologic agents|mesh-ancestor
110525199|NCT00746733|Amphetamine|amphetamine|mesh-list
110525200|NCT00746733|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
110525201|NCT00746733|Adderall|adderall|mesh-list
110525202|NCT00746733|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110525203|NCT00746733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110525204|NCT00746733|Sympathomimetics|sympathomimetics|mesh-ancestor
110525205|NCT00746733|Autonomic Agents|autonomic agents|mesh-ancestor
110525206|NCT00746733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110525207|NCT00746733|Dopamine Agents|dopamine agents|mesh-ancestor
110525208|NCT00746733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110525209|NCT00746733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110525210|NCT00746733|Adrenergic Agents|adrenergic agents|mesh-ancestor
110525211|NCT00746733|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110525212|NCT00746733|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110525213|NCT00746733|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110525214|NCT00746733|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110525215|NCT00636870|Fexofenadine|fexofenadine|mesh-list
110525216|NCT00636870|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110525221|NCT00636870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110525222|NCT00636870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110525223|NCT00636870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110525224|NCT00634790|Alprazolam|alprazolam|mesh-list
110525225|NCT00634790|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110525226|NCT00634790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110525227|NCT00634790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110525228|NCT00634790|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110525229|NCT00634790|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110525230|NCT00634790|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110525231|NCT00634790|GABA Modulators|gaba modulators|mesh-ancestor
110525232|NCT00634790|GABA Agents|gaba agents|mesh-ancestor
110525233|NCT00634790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110525234|NCT00634790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110525235|NCT04831151|Cyproterone acetate, ethinyl estradiol drug combination|cyproterone acetate, ethinyl estradiol drug combination|mesh-list
110525236|NCT04831151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110525237|NCT04831151|Androgen Antagonists|androgen antagonists|mesh-ancestor
110525238|NCT04831151|Hormone Antagonists|hormone antagonists|mesh-ancestor
110525239|NCT04831151|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110525240|NCT00917397|Sertraline|sertraline|mesh-list
110525241|NCT00917397|Antidepressive Agents|antidepressive agents|mesh-ancestor
110525242|NCT00917397|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110525243|NCT00917397|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110525244|NCT00917397|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110525245|NCT00917397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110525246|NCT00917397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110525247|NCT00917397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110525248|NCT00917397|Serotonin Agents|serotonin agents|mesh-ancestor
110525249|NCT00917397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110525250|NCT02708160|Fluorides|fluorides|mesh-list
110525251|NCT02708160|Cariostatic Agents|cariostatic agents|mesh-ancestor
110525252|NCT02708160|Protective Agents|protective agents|mesh-ancestor
110918001|NCT02115204|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110525253|NCT02708160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110525255|NCT04257461|Oxaliplatin|oxaliplatin|mesh-list
110525256|NCT04257461|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110525257|NCT04257461|Antimetabolites|antimetabolites|mesh-ancestor
110172702|NCT00053092|Antimetabolites|antimetabolites|mesh-ancestor
110525258|NCT04257461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110525259|NCT04257461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110525260|NCT02712528|Sufentanil|sufentanil|mesh-list
110525261|NCT02712528|Remifentanil|remifentanil|mesh-list
110525262|NCT02712528|Sevoflurane|sevoflurane|mesh-list
110525263|NCT02712528|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110525264|NCT02712528|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110525265|NCT02712528|Anesthetics, General|anesthetics, general|mesh-ancestor
110525266|NCT02712528|Anesthetics|anesthetics|mesh-ancestor
110525267|NCT02712528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110525268|NCT02712528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110525269|NCT02712528|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110525270|NCT02712528|Narcotics|narcotics|mesh-ancestor
110525271|NCT02712528|Analgesics|analgesics|mesh-ancestor
110525272|NCT02712528|Sensory System Agents|sensory system agents|mesh-ancestor
110525273|NCT02712528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110525274|NCT02712528|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110525275|NCT02712528|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110525276|NCT04089657|Apatinib|apatinib|mesh-list
110525277|NCT04089657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110525278|NCT04089657|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110525279|NCT04089657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110525280|NCT04089657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110525281|NCT02713074|Povidone-Iodine|povidone-iodine|mesh-list
110525282|NCT02713074|Povidone|povidone|mesh-list
110525283|NCT02713074|Plasma Substitutes|plasma substitutes|mesh-ancestor
110525284|NCT02713074|Blood Substitutes|blood substitutes|mesh-ancestor
110525285|NCT02713074|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110525289|NCT00637793|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110525290|NCT00637793|Cholinergic Agents|cholinergic agents|mesh-ancestor
110192751|NCT02968641|Ritonavir|ritonavir|mesh-list
110525291|NCT00637793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110525292|NCT00637793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110525293|NCT00637793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110525294|NCT00745875|Pemetrexed|pemetrexed|mesh-list
110525295|NCT00745875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110525296|NCT00745875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110525297|NCT00745875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110525298|NCT00745875|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110525299|NCT00745875|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110525300|NCT04089813|Metformin|metformin|mesh-list
110525301|NCT04089813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110525302|NCT04089813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110525303|NCT00555217|Losartan|losartan|mesh-list
110525304|NCT00555217|Lisinopril|lisinopril|mesh-list
110525305|NCT00555217|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110525306|NCT00555217|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110525307|NCT00555217|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110525308|NCT00555217|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110525309|NCT00555217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110525310|NCT00555217|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110525311|NCT00555217|Protease Inhibitors|protease inhibitors|mesh-ancestor
110525312|NCT00555217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110525313|NCT00555217|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110525314|NCT00555217|Protective Agents|protective agents|mesh-ancestor
110525315|NCT00555217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110525316|NCT02711904|Remifentanil|remifentanil|mesh-list
110525317|NCT02711904|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110525318|NCT02711904|Narcotics|narcotics|mesh-ancestor
110525319|NCT02711904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110525320|NCT02711904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110525321|NCT02711904|Analgesics|analgesics|mesh-ancestor
110525322|NCT02711904|Sensory System Agents|sensory system agents|mesh-ancestor
110525323|NCT02711904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110525324|NCT05326490|Metformin|metformin|mesh-list
110525325|NCT05326490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110525326|NCT05326490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110525327|NCT02693808|Hyaluronic Acid|hyaluronic acid|mesh-list
110525328|NCT02693808|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110525329|NCT02693808|Immunologic Factors|immunologic factors|mesh-ancestor
110525330|NCT02693808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110525331|NCT02693808|Viscosupplements|viscosupplements|mesh-ancestor
110172778|NCT00053638|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110525333|NCT02711982|Methylprednisolone|methylprednisolone|mesh-list
110525334|NCT02711982|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110525335|NCT02711982|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110525336|NCT02711982|Prednisolone|prednisolone|mesh-list
110525337|NCT02711982|Prednisolone acetate|prednisolone acetate|mesh-list
110525338|NCT02711982|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110525339|NCT02711982|Prednisolone phosphate|prednisolone phosphate|mesh-list
110525340|NCT02711982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110525341|NCT02711982|Antiemetics|antiemetics|mesh-ancestor
110525342|NCT02711982|Autonomic Agents|autonomic agents|mesh-ancestor
110525343|NCT02711982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110525344|NCT02711982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110192771|NCT00033176|Micronutrients|micronutrients|mesh-ancestor
110525345|NCT02711982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110525346|NCT02711982|Glucocorticoids|glucocorticoids|mesh-ancestor
110525347|NCT02711982|Hormones|hormones|mesh-ancestor
110525348|NCT02711982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110525349|NCT02711982|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110525350|NCT02711982|Protective Agents|protective agents|mesh-ancestor
110525351|NCT02711982|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110525352|NCT02711982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110525353|NCT00745095|Neostigmine|neostigmine|mesh-list
110525354|NCT00745095|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110525355|NCT00745095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110534644|NCT00643734|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110525376|NCT00612612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110525377|NCT00612612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110525378|NCT00612612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110525380|NCT00612612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110525381|NCT00612612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110525382|NCT00612612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110525383|NCT00947713|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
110525384|NCT00947713|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110525385|NCT00947713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110525386|NCT00940693|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110525387|NCT00940693|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110525388|NCT00940693|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110525389|NCT00940693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110525390|NCT00940693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110525391|NCT00940693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110525392|NCT00940693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110525393|NCT00940693|Analgesics|analgesics|mesh-ancestor
110525394|NCT00940693|Sensory System Agents|sensory system agents|mesh-ancestor
110525395|NCT00940693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110525396|NCT00940693|Antidepressive Agents|antidepressive agents|mesh-ancestor
110525397|NCT00940693|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110525398|NCT00940693|Dopamine Agents|dopamine agents|mesh-ancestor
110525399|NCT02598063|Lamivudine|lamivudine|mesh-list
110525400|NCT02598063|Adefovir|adefovir|mesh-list
110525401|NCT02598063|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
110525402|NCT02598063|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110525403|NCT02598063|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110918021|NCT02432404|NuvaRing|nuvaring|mesh-list
110525404|NCT02598063|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110525405|NCT02598063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110525406|NCT02598063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110525407|NCT02598063|Antiviral Agents|antiviral agents|mesh-ancestor
110525408|NCT02598063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110525409|NCT02598063|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110525413|NCT02707458|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110525414|NCT02707458|Antimetabolites|antimetabolites|mesh-ancestor
110525415|NCT02707458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110525416|NCT02707458|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110525418|NCT02707458|Protective Agents|protective agents|mesh-ancestor
110525419|NCT02707458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110525420|NCT00950677|Exenatide|exenatide|mesh-list
110525421|NCT00950677|Pramlintide|pramlintide|mesh-list
110525422|NCT00950677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110525423|NCT00950677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110525424|NCT00950677|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110525425|NCT00950677|Incretins|incretins|mesh-ancestor
110525426|NCT00950677|Hormones|hormones|mesh-ancestor
110525427|NCT00950677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110525428|NCT05174598|Calcitriol|calcitriol|mesh-list
110525429|NCT05174598|Calcipotriene|calcipotriene|mesh-list
110525430|NCT05174598|Dermatologic Agents|dermatologic agents|mesh-ancestor
110525431|NCT05174598|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110525432|NCT05174598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110525433|NCT05174598|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
110525434|NCT05174598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110525435|NCT05174598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110525436|NCT05174598|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110525437|NCT05174598|Vitamins|vitamins|mesh-ancestor
110525438|NCT05174598|Micronutrients|micronutrients|mesh-ancestor
110525439|NCT05174598|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110525440|NCT05341856|Isosorbide|isosorbide|mesh-list
110525441|NCT05341856|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
110525442|NCT05341856|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
110525443|NCT05341856|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110525444|NCT05341856|Diuretics|diuretics|mesh-ancestor
110525445|NCT05341856|Natriuretic Agents|natriuretic agents|mesh-ancestor
110525446|NCT05341856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110525447|NCT05341856|Vasodilator Agents|vasodilator agents|mesh-ancestor
110525448|NCT05341856|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
110525449|NCT05341856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110525450|NCT00951223|Interferons|interferons|mesh-list
110525451|NCT00951223|Interferon alfacon-1|interferon alfacon-1|mesh-list
110525452|NCT00951223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110525453|NCT00951223|Antiviral Agents|antiviral agents|mesh-ancestor
110525454|NCT00951223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110525455|NCT02711592|Analgesics|analgesics|mesh-list
110525456|NCT02711592|Sensory System Agents|sensory system agents|mesh-ancestor
110525457|NCT02711592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110525458|NCT02711592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110525459|NCT00948103|Nitrous Oxide|nitrous oxide|mesh-list
110525460|NCT00948103|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110525461|NCT00948103|Anesthetics, General|anesthetics, general|mesh-ancestor
110525462|NCT00948103|Anesthetics|anesthetics|mesh-ancestor
110525463|NCT00948103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110525464|NCT00948103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110525465|NCT00948103|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110525466|NCT00948103|Analgesics|analgesics|mesh-ancestor
110525467|NCT00948103|Sensory System Agents|sensory system agents|mesh-ancestor
110525468|NCT00948103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110525469|NCT02012114|Cysteamine|cysteamine|mesh-list
110525470|NCT02012114|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
110525471|NCT02012114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110525472|NCT05301205|Gabapentin|gabapentin|mesh-list
110525473|NCT05301205|Analgesics|analgesics|mesh-ancestor
110525474|NCT05301205|Sensory System Agents|sensory system agents|mesh-ancestor
110235737|NCT00334360|Serotonin Agents|serotonin agents|mesh-ancestor
110525475|NCT05301205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110525476|NCT05301205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110525478|NCT05301205|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110525479|NCT05301205|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110525480|NCT05301205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110525481|NCT05301205|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110172930|NCT00054535|Antiviral Agents|antiviral agents|mesh-ancestor
110525482|NCT05301205|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110525488|NCT02707224|Candesartan cilexetil|candesartan cilexetil|mesh-list
110525489|NCT02707224|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110525490|NCT02707224|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110525491|NCT02707224|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110525492|NCT02707224|Antimetabolites|antimetabolites|mesh-ancestor
110525493|NCT02707224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110525494|NCT02707224|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110525495|NCT02707224|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110525496|NCT02707224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110525497|NCT02707224|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110525498|NCT02707224|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110525499|NCT02707224|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110525502|NCT04229264|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110525503|NCT04229264|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110525504|NCT04229264|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110525505|NCT04229264|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110525506|NCT04229264|Purinergic Agents|purinergic agents|mesh-ancestor
110525507|NCT04229264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110525508|NCT04229264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110525509|NCT04229264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110525510|NCT04229264|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110525511|NCT04229264|Antithrombins|antithrombins|mesh-ancestor
110525512|NCT04229264|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110525513|NCT04229264|Protease Inhibitors|protease inhibitors|mesh-ancestor
110525514|NCT04229264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110525515|NCT04229264|Anticoagulants|anticoagulants|mesh-ancestor
110525516|NCT02597829|Certolizumab Pegol|certolizumab pegol|mesh-list
110525517|NCT02597829|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110192846|NCT00061113|Fluoxetine|fluoxetine|mesh-list
110525518|NCT02597829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110525519|NCT02597829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110525520|NCT02597829|Immunologic Factors|immunologic factors|mesh-ancestor
110525521|NCT02597829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110525522|NCT02597829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110525523|NCT02711202|Sirolimus|sirolimus|mesh-list
110525524|NCT02711202|Infliximab|infliximab|mesh-list
110525525|NCT02711202|Alemtuzumab|alemtuzumab|mesh-list
110525526|NCT02711202|Tacrolimus|tacrolimus|mesh-list
110525527|NCT02711202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110525528|NCT02711202|Immunologic Factors|immunologic factors|mesh-ancestor
110525529|NCT02711202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110525530|NCT02711202|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110525531|NCT02711202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110525532|NCT02711202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110525533|NCT02711202|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110525534|NCT02711202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110525535|NCT02711202|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110525536|NCT02711202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110525537|NCT02711202|Antifungal Agents|antifungal agents|mesh-ancestor
110525538|NCT02711202|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110525539|NCT02711202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110525540|NCT02711202|Dermatologic Agents|dermatologic agents|mesh-ancestor
110525541|NCT02711202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110525542|NCT02711202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110525543|NCT02711202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110525544|NCT04227938|ALPN-101|alpn-101|mesh-list
110525545|NCT04227938|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110525546|NCT04227938|Immunologic Factors|immunologic factors|mesh-ancestor
110525547|NCT04227938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110525548|NCT02711358|Indomethacin|indomethacin|mesh-list
110525549|NCT02711358|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110525550|NCT02711358|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110525551|NCT02711358|Analgesics|analgesics|mesh-ancestor
110525552|NCT02711358|Sensory System Agents|sensory system agents|mesh-ancestor
110525557|NCT02711358|Gout Suppressants|gout suppressants|mesh-ancestor
110525559|NCT02711358|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110525560|NCT02711358|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110525561|NCT02711358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110525562|NCT02711358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110525563|NCT04962152|Nalbuphine|nalbuphine|mesh-list
110525564|NCT04962152|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110525565|NCT04962152|Narcotics|narcotics|mesh-ancestor
110525566|NCT04962152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110525567|NCT04962152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110525568|NCT04962152|Analgesics|analgesics|mesh-ancestor
110525569|NCT04962152|Sensory System Agents|sensory system agents|mesh-ancestor
110525570|NCT04962152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110525571|NCT00744627|Vortioxetine|vortioxetine|mesh-list
110525572|NCT00744627|Antidepressive Agents|antidepressive agents|mesh-ancestor
110525573|NCT00744627|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110525574|NCT00744627|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110525575|NCT00744627|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110192874|NCT00033566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110525576|NCT00744627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110525577|NCT00744627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110525578|NCT00744627|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110525579|NCT00744627|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110525580|NCT00744627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110525581|NCT00744627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110525582|NCT00744627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110525584|NCT00744627|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110525585|NCT00744627|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110525586|NCT00744627|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110525587|NCT00744627|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110525588|NCT04942886|Entecavir|entecavir|mesh-list
110525589|NCT04942886|Antiviral Agents|antiviral agents|mesh-ancestor
110525590|NCT04942886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110525591|NCT00951847|Oxcarbazepine|oxcarbazepine|mesh-list
110525592|NCT00951847|Anticonvulsants|anticonvulsants|mesh-ancestor
110525593|NCT00951847|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110525594|NCT00951847|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110525595|NCT00951847|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110525596|NCT00951847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110525597|NCT00951847|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110525598|NCT00951847|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110525599|NCT02711280|Propofol|propofol|mesh-list
110525600|NCT02711280|Sevoflurane|sevoflurane|mesh-list
110525601|NCT02711280|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110525602|NCT02711280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110525603|NCT02711280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110525604|NCT02711280|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110918060|NCT02115594|Fulvestrant|fulvestrant|mesh-list
110525605|NCT02711280|Anesthetics, General|anesthetics, general|mesh-ancestor
110525606|NCT02711280|Anesthetics|anesthetics|mesh-ancestor
110525607|NCT02711280|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110525608|NCT02711280|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110525609|NCT00948493|Insulin|insulin|mesh-list
110525610|NCT00948493|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110525611|NCT00948493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110525612|NCT00948493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110525613|NCT00952003|Bevacizumab|bevacizumab|mesh-list
110525614|NCT00952003|Docetaxel|docetaxel|mesh-list
110525615|NCT00952003|Oxaliplatin|oxaliplatin|mesh-list
110525616|NCT00952003|Irinotecan|irinotecan|mesh-list
110525617|NCT00952003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110525618|NCT00952003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110525619|NCT00952003|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110525620|NCT00952003|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110525621|NCT00952003|Growth Substances|growth substances|mesh-ancestor
110525622|NCT00952003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110192897|NCT00033683|Tamoxifen|tamoxifen|mesh-list
110525623|NCT00952003|Growth Inhibitors|growth inhibitors|mesh-ancestor
110525624|NCT00952003|Tubulin Modulators|tubulin modulators|mesh-ancestor
110525630|NCT00952003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110525631|NCT00612144|Metformin|metformin|mesh-list
110525632|NCT00612144|Glimepiride|glimepiride|mesh-list
110525633|NCT00612144|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110525634|NCT00612144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110525635|NCT00612144|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110525636|NCT00612144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110525637|NCT00612144|Immunologic Factors|immunologic factors|mesh-ancestor
110525638|NCT02597361|Irbesartan|irbesartan|mesh-list
110525639|NCT02597361|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110525640|NCT02597361|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110525641|NCT02597361|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110525642|NCT02597361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110525643|NCT00562627|Ketorolac|ketorolac|mesh-list
110525644|NCT00562627|Epinephrine|epinephrine|mesh-list
110525645|NCT00562627|Racepinephrine|racepinephrine|mesh-list
110525646|NCT00562627|Fentanyl|fentanyl|mesh-list
110525647|NCT00562627|Morphine|morphine|mesh-list
110525648|NCT00562627|Bupivacaine|bupivacaine|mesh-list
110525649|NCT00562627|Ropivacaine|ropivacaine|mesh-list
110525650|NCT00562627|Epinephryl borate|epinephryl borate|mesh-list
110525651|NCT00562627|Anesthetics, Local|anesthetics, local|mesh-ancestor
110525652|NCT00562627|Anesthetics|anesthetics|mesh-ancestor
110525653|NCT00562627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110525654|NCT00562627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110525655|NCT00562627|Sensory System Agents|sensory system agents|mesh-ancestor
110525656|NCT00562627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110525657|NCT00562627|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110525658|NCT00562627|Narcotics|narcotics|mesh-ancestor
110525659|NCT00562627|Analgesics|analgesics|mesh-ancestor
110525660|NCT00562627|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110525661|NCT00562627|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110525662|NCT00562627|Anesthetics, General|anesthetics, general|mesh-ancestor
110525663|NCT00562627|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110525664|NCT00562627|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110525665|NCT00562627|Adrenergic Agents|adrenergic agents|mesh-ancestor
110525666|NCT00562627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110525667|NCT00562627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110525668|NCT00562627|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110525669|NCT00562627|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110525670|NCT00562627|Autonomic Agents|autonomic agents|mesh-ancestor
110525671|NCT00562627|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110525672|NCT00562627|Respiratory System Agents|respiratory system agents|mesh-ancestor
110525673|NCT00562627|Mydriatics|mydriatics|mesh-ancestor
110525674|NCT00562627|Sympathomimetics|sympathomimetics|mesh-ancestor
110525675|NCT00562627|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110525676|NCT00562627|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110525677|NCT00562627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110525678|NCT00562627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110525679|NCT00562627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110525680|NCT00562627|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110525681|NCT00562627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110525683|NCT02597283|Temsirolimus|temsirolimus|mesh-list
110525684|NCT02597283|MTOR Inhibitors|mtor inhibitors|mesh-list
110525685|NCT02597283|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110525686|NCT02597283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110525687|NCT02597283|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110525688|NCT02597283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110525689|NCT02597283|Antifungal Agents|antifungal agents|mesh-ancestor
110525690|NCT02597283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110192935|NCT00061308|Topotecan|topotecan|mesh-list
110525691|NCT02597283|Immunologic Factors|immunologic factors|mesh-ancestor
110525692|NCT02597283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110525693|NCT02597283|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110525694|NCT02597283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110525695|NCT02597283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110525696|NCT00948649|Varenicline|varenicline|mesh-list
110525701|NCT00948649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110525702|NCT00948649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110525704|NCT00952159|O-demethyltramadol|o-demethyltramadol|mesh-list
110525705|NCT00952159|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110525706|NCT00952159|Narcotics|narcotics|mesh-ancestor
110525707|NCT00952159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110525708|NCT00952159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110525709|NCT00952159|Analgesics|analgesics|mesh-ancestor
110525710|NCT00952159|Sensory System Agents|sensory system agents|mesh-ancestor
110525711|NCT00952159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110525712|NCT00948727|Cyclosporine|cyclosporine|mesh-list
110525713|NCT00948727|Cyclosporins|cyclosporins|mesh-list
110525714|NCT00948727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110525715|NCT00948727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110525716|NCT00948727|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110525717|NCT00948727|Immunologic Factors|immunologic factors|mesh-ancestor
110525718|NCT00948727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110525719|NCT00948727|Antifungal Agents|antifungal agents|mesh-ancestor
110525720|NCT00948727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110525721|NCT00948727|Dermatologic Agents|dermatologic agents|mesh-ancestor
110525722|NCT00948727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110525723|NCT00948727|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110525724|NCT02778776|Metformin|metformin|mesh-list
110525725|NCT02778776|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110525726|NCT02778776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110525727|NCT00948805|Goserelin|goserelin|mesh-list
110525728|NCT00948805|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
110525729|NCT00948805|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110525730|NCT00948805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110525731|NCT00948805|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110525732|NCT00948805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110525734|NCT02710656|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110525735|NCT02710656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110525736|NCT02710656|Tubulin Modulators|tubulin modulators|mesh-ancestor
110525737|NCT02710656|Antimitotic Agents|antimitotic agents|mesh-ancestor
110525738|NCT02710656|Mitosis Modulators|mitosis modulators|mesh-ancestor
110525739|NCT02710656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110525740|NCT02780882|Pasireotide|pasireotide|mesh-list
110525741|NCT02780882|Hormones|hormones|mesh-ancestor
110525742|NCT02780882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110525743|NCT02780882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110525744|NCT02710266|Gabexate|gabexate|mesh-list
110525745|NCT02710266|Anticoagulants|anticoagulants|mesh-ancestor
110525746|NCT02710266|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110525747|NCT02710266|Protease Inhibitors|protease inhibitors|mesh-ancestor
110525748|NCT02710266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110525749|NCT02710266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110525750|NCT00562159|Fluticasone|fluticasone|mesh-list
110525751|NCT00562159|Xhance|xhance|mesh-list
110525752|NCT00562159|Mometasone Furoate|mometasone furoate|mesh-list
110525753|NCT00562159|Loratadine|loratadine|mesh-list
110525754|NCT00562159|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
110525755|NCT00562159|Prednisone|prednisone|mesh-list
110525756|NCT00562159|Albuterol|albuterol|mesh-list
110525757|NCT00562159|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110525758|NCT00562159|Glucocorticoids|glucocorticoids|mesh-ancestor
110525759|NCT00562159|Hormones|hormones|mesh-ancestor
110525760|NCT00562159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110525761|NCT00562159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110525762|NCT00562159|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110525763|NCT00562159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110525764|NCT00562159|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110525765|NCT00562159|Autonomic Agents|autonomic agents|mesh-ancestor
110525766|NCT00562159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110525767|NCT00562159|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110525768|NCT00562159|Respiratory System Agents|respiratory system agents|mesh-ancestor
110525769|NCT00562159|Dermatologic Agents|dermatologic agents|mesh-ancestor
110525775|NCT00562159|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110525776|NCT00562159|Adrenergic Agents|adrenergic agents|mesh-ancestor
110525777|NCT00562159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110525778|NCT00562159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110525779|NCT00562159|Antipruritics|antipruritics|mesh-ancestor
110525780|NCT00562159|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110173234|NCT00056797|Interleukin-2|interleukin-2|mesh-list
110525781|NCT00562159|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110525782|NCT00562159|Histamine Antagonists|histamine antagonists|mesh-ancestor
110525783|NCT00562159|Histamine Agents|histamine agents|mesh-ancestor
110525784|NCT00562159|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110525785|NCT00562159|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110525786|NCT00562159|Analgesics|analgesics|mesh-ancestor
110525787|NCT00562159|Sensory System Agents|sensory system agents|mesh-ancestor
110525788|NCT00562159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110525789|NCT02710110|Capsaicin|capsaicin|mesh-list
110525790|NCT02710110|Antipruritics|antipruritics|mesh-ancestor
110525791|NCT02710110|Dermatologic Agents|dermatologic agents|mesh-ancestor
110525792|NCT02710110|Sensory System Agents|sensory system agents|mesh-ancestor
110525793|NCT02710110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110525794|NCT02710110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110525795|NCT00952627|Pycnogenols|pycnogenols|mesh-list
110525796|NCT00952627|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110525797|NCT00952627|Immunologic Factors|immunologic factors|mesh-ancestor
110525798|NCT00952627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110525799|NCT00952627|Antioxidants|antioxidants|mesh-ancestor
110525800|NCT00952627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110525801|NCT00952627|Protective Agents|protective agents|mesh-ancestor
110525802|NCT00952627|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110525803|NCT00611676|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
110525804|NCT00611676|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110525805|NCT00611676|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110525806|NCT00611676|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110525807|NCT00611676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110525808|NCT00611676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110525809|NCT00611676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110525810|NCT00611676|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110525811|NCT00611676|Antidepressive Agents|antidepressive agents|mesh-ancestor
110525812|NCT00611676|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110525814|NCT04848714|Immunologic Factors|immunologic factors|mesh-ancestor
110525815|NCT04848714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110525816|NCT00952861|Doxycycline|doxycycline|mesh-list
110525817|NCT00952861|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110525818|NCT00952861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110525819|NCT00952861|Antimalarials|antimalarials|mesh-ancestor
110525820|NCT00952861|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110525821|NCT00952861|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110525822|NCT05137730|Parathyroid Hormone|parathyroid hormone|mesh-list
110525823|NCT05137730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110525824|NCT05137730|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110525825|NCT04223778|Islatravir|islatravir|mesh-list
110525826|NCT04223778|Antiviral Agents|antiviral agents|mesh-ancestor
110525827|NCT04223778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110525828|NCT04223778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110525829|NCT04223778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110525830|NCT04223778|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110525831|NCT04223778|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110525832|NCT04223778|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110525833|NCT05109416|Bupivacaine|bupivacaine|mesh-list
110525834|NCT05109416|Anesthetics, Local|anesthetics, local|mesh-ancestor
110525835|NCT05109416|Anesthetics|anesthetics|mesh-ancestor
110525836|NCT05109416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110525837|NCT05109416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110525845|NCT04074564|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110525847|NCT04074564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110525848|NCT02778308|Gemcitabine|gemcitabine|mesh-list
110525849|NCT02778308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110525850|NCT02778308|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110525851|NCT02778308|Antimetabolites|antimetabolites|mesh-ancestor
110525852|NCT02778308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110525853|NCT02776202|Mycophenolic Acid|mycophenolic acid|mesh-list
110525854|NCT02776202|Sirolimus|sirolimus|mesh-list
110525855|NCT02776202|Fludarabine|fludarabine|mesh-list
110525856|NCT02776202|Fludarabine phosphate|fludarabine phosphate|mesh-list
110525857|NCT02776202|Melphalan|melphalan|mesh-list
110525858|NCT02776202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110525859|NCT02776202|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110525860|NCT02776202|Antimetabolites|antimetabolites|mesh-ancestor
110525861|NCT02776202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110525862|NCT02776202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110525863|NCT02776202|Immunologic Factors|immunologic factors|mesh-ancestor
110525864|NCT02776202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110525865|NCT02776202|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110525866|NCT02776202|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110525867|NCT02776202|Antitubercular Agents|antitubercular agents|mesh-ancestor
110525868|NCT02776202|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110525869|NCT02776202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110525870|NCT02776202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110525871|NCT02776202|Antifungal Agents|antifungal agents|mesh-ancestor
110525872|NCT02776202|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110525873|NCT02776202|Alkylating Agents|alkylating agents|mesh-ancestor
110525874|NCT02776202|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110525875|NCT00921557|Vitamin D|vitamin d|mesh-list
110525876|NCT00921557|Alendronate|alendronate|mesh-list
110525880|NCT00921557|Micronutrients|micronutrients|mesh-ancestor
110525881|NCT00921557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110525882|NCT00921557|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110525883|NCT00921557|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110525884|NCT00921557|Antacids|antacids|mesh-ancestor
110525885|NCT00921557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110525886|NCT00921557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110525887|NCT00611754|Fluorouracil|fluorouracil|mesh-list
110525888|NCT00611754|Oxaliplatin|oxaliplatin|mesh-list
110525889|NCT00611754|Antimetabolites|antimetabolites|mesh-ancestor
110525890|NCT00611754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110525891|NCT00611754|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110525892|NCT00611754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110525893|NCT00611754|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110525894|NCT00611754|Immunologic Factors|immunologic factors|mesh-ancestor
110525895|NCT00611754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110525896|NCT02709720|Cisplatin|cisplatin|mesh-list
110525897|NCT02709720|Vinorelbine|vinorelbine|mesh-list
110525898|NCT02709720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110525899|NCT02709720|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110525900|NCT02709720|Tubulin Modulators|tubulin modulators|mesh-ancestor
110525901|NCT02709720|Antimitotic Agents|antimitotic agents|mesh-ancestor
110525902|NCT02709720|Mitosis Modulators|mitosis modulators|mesh-ancestor
110525903|NCT02709720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110525904|NCT02779634|Coenzyme Q10|coenzyme q10|mesh-list
110525905|NCT02779634|Micronutrients|micronutrients|mesh-ancestor
110525906|NCT02779634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110525907|NCT02779634|Vitamins|vitamins|mesh-ancestor
110525908|NCT04255589|Ethanol|ethanol|mesh-list
110525914|NCT00744471|Analgesics|analgesics|mesh-ancestor
110525915|NCT00744471|Sensory System Agents|sensory system agents|mesh-ancestor
110525916|NCT00744471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110525917|NCT00744471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110525918|NCT02776436|Dexamethasone|dexamethasone|mesh-list
110525919|NCT02776436|Prednisone|prednisone|mesh-list
110525920|NCT02776436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110525921|NCT02776436|Antiemetics|antiemetics|mesh-ancestor
110525922|NCT02776436|Autonomic Agents|autonomic agents|mesh-ancestor
110525923|NCT02776436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110525924|NCT02776436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110525925|NCT02776436|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110525926|NCT02776436|Glucocorticoids|glucocorticoids|mesh-ancestor
110525927|NCT02776436|Hormones|hormones|mesh-ancestor
110525928|NCT02776436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110525929|NCT02776436|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110525930|NCT02776436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110525931|NCT02775968|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110525932|NCT02775968|Azithromycin|azithromycin|mesh-list
110525933|NCT02775968|Ceftriaxone|ceftriaxone|mesh-list
110525934|NCT02775968|Erythromycin|erythromycin|mesh-list
110525935|NCT02775968|Cephalosporins|cephalosporins|mesh-list
110525936|NCT02775968|Cefamandole|cefamandole|mesh-list
110525937|NCT02775968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110525938|NCT02775968|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110525939|NCT02775968|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110525940|NCT02775968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110525941|NCT02775968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110525943|NCT02775734|Clomiphene|clomiphene|mesh-list
110525944|NCT02775734|Enclomiphene|enclomiphene|mesh-list
110525945|NCT02775734|Zuclomiphene|zuclomiphene|mesh-list
110525946|NCT02775734|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110525947|NCT02775734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110525948|NCT02775734|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110525949|NCT02775734|Hormone Antagonists|hormone antagonists|mesh-ancestor
110525950|NCT02775734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110525951|NCT02775734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110525952|NCT02775734|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110525953|NCT02775734|Fertility Agents|fertility agents|mesh-ancestor
110525954|NCT02775734|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110525955|NCT02775734|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110525956|NCT02775734|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110525957|NCT02775734|Antiviral Agents|antiviral agents|mesh-ancestor
110525958|NCT02775734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110525959|NCT02775734|Expectorants|expectorants|mesh-ancestor
110525960|NCT02775734|Respiratory System Agents|respiratory system agents|mesh-ancestor
110525961|NCT02775734|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110525962|NCT02775734|Antioxidants|antioxidants|mesh-ancestor
110525963|NCT02775734|Protective Agents|protective agents|mesh-ancestor
110525964|NCT02775734|Antidotes|antidotes|mesh-ancestor
110525965|NCT02772926|Benphothiamine|benphothiamine|mesh-list
110525966|NCT02772926|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110525967|NCT02772926|Immunologic Factors|immunologic factors|mesh-ancestor
110525968|NCT02772926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110525969|NCT02772926|Chelating Agents|chelating agents|mesh-ancestor
110525970|NCT02772926|Sequestering Agents|sequestering agents|mesh-ancestor
110525971|NCT02772926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110525972|NCT02709564|Misoprostol|misoprostol|mesh-list
110525973|NCT02709564|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110525974|NCT02709564|Abortifacient Agents|abortifacient agents|mesh-ancestor
110525975|NCT02709564|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110525976|NCT02709564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110525977|NCT02709564|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110525978|NCT02709564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110525979|NCT02709564|Oxytocics|oxytocics|mesh-ancestor
110525980|NCT04688814|Morphine|morphine|mesh-list
110525987|NCT04688814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110525988|NCT00744237|Metoprolol|metoprolol|mesh-list
110525989|NCT00744237|Nebivolol|nebivolol|mesh-list
110525990|NCT00744237|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110525991|NCT00744237|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110525992|NCT00744237|Sympatholytics|sympatholytics|mesh-ancestor
110525993|NCT00744237|Autonomic Agents|autonomic agents|mesh-ancestor
110525994|NCT00744237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110525995|NCT00744237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110525996|NCT00744237|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110525997|NCT00744237|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110525998|NCT00744237|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110525999|NCT00744237|Adrenergic Agents|adrenergic agents|mesh-ancestor
110526000|NCT00744237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110526001|NCT00744237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110526002|NCT00744237|Vasodilator Agents|vasodilator agents|mesh-ancestor
110526003|NCT00744237|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
110526004|NCT00744237|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110526005|NCT00744237|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110526006|NCT05260554|Fosfomycin|fosfomycin|mesh-list
110526007|NCT05260554|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110526008|NCT05260554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110526009|NCT04089345|Ustekinumab|ustekinumab|mesh-list
110526010|NCT04089345|Dermatologic Agents|dermatologic agents|mesh-ancestor
110526011|NCT02693574|Amoxicillin|amoxicillin|mesh-list
110526012|NCT02693574|Clarithromycin|clarithromycin|mesh-list
110526013|NCT02693574|Levofloxacin|levofloxacin|mesh-list
110526014|NCT02693574|Esomeprazole|esomeprazole|mesh-list
110526015|NCT02693574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110526016|NCT02693574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110526017|NCT02693574|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110526018|NCT02693574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110526019|NCT02693574|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110526020|NCT02693574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110526021|NCT02693574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110526022|NCT02693574|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110526023|NCT02693574|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110526024|NCT02693574|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110526025|NCT02693574|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110526026|NCT02693574|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110526027|NCT02693574|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110526028|NCT02693574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110526029|NCT02693574|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110526031|NCT04179266|Analgesics|analgesics|mesh-ancestor
110526032|NCT04179266|Sensory System Agents|sensory system agents|mesh-ancestor
110526033|NCT04179266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110526034|NCT04179266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110526035|NCT04179266|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110526036|NCT04179266|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110526037|NCT04179266|Anesthetics, General|anesthetics, general|mesh-ancestor
110526038|NCT04179266|Anesthetics|anesthetics|mesh-ancestor
110526039|NCT04179266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110526040|NCT04179266|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110526041|NCT04179266|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110526042|NCT04179266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110526043|NCT04179266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110526045|NCT00743145|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110526046|NCT00743145|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110526047|NCT00743145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110526048|NCT00743145|Sensory System Agents|sensory system agents|mesh-ancestor
110526049|NCT00743145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110526050|NCT04875728|Cefazolin|cefazolin|mesh-list
110526056|NCT00611910|MTOR Inhibitors|mtor inhibitors|mesh-list
110526057|NCT00611910|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110526058|NCT00611910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110526059|NCT00611910|Tubulin Modulators|tubulin modulators|mesh-ancestor
110526060|NCT00611910|Antimitotic Agents|antimitotic agents|mesh-ancestor
110526061|NCT00611910|Mitosis Modulators|mitosis modulators|mesh-ancestor
110526062|NCT00611910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110526063|NCT00611910|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110526064|NCT00611910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110526065|NCT00611910|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110526066|NCT00611910|Antifungal Agents|antifungal agents|mesh-ancestor
110526067|NCT00611910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110526068|NCT00611910|Immunologic Factors|immunologic factors|mesh-ancestor
110526069|NCT00611910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110526070|NCT00611910|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110526071|NCT00611910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110526072|NCT00920855|Bortezomib|bortezomib|mesh-list
110526073|NCT00920855|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110526074|NCT00920855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110526075|NCT00920855|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110526076|NCT00920855|Alkylating Agents|alkylating agents|mesh-ancestor
110526077|NCT00920855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110526078|NCT04251845|Melatonin|melatonin|mesh-list
110526079|NCT04251845|Antioxidants|antioxidants|mesh-ancestor
110526080|NCT04251845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110526081|NCT04251845|Protective Agents|protective agents|mesh-ancestor
110526082|NCT04251845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110526083|NCT04251845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110526084|NCT05207358|Mycophenolic Acid|mycophenolic acid|mesh-list
110526085|NCT05207358|Cyclophosphamide|cyclophosphamide|mesh-list
110526086|NCT05207358|Rituximab|rituximab|mesh-list
110526087|NCT05207358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110526088|NCT05207358|Immunologic Factors|immunologic factors|mesh-ancestor
110526089|NCT05207358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110526090|NCT05207358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110526091|NCT05207358|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110526092|NCT05207358|Alkylating Agents|alkylating agents|mesh-ancestor
110526093|NCT05207358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110526094|NCT05207358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110526095|NCT05207358|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110526096|NCT05207358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110526097|NCT05207358|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110526098|NCT05207358|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110526099|NCT05207358|Antitubercular Agents|antitubercular agents|mesh-ancestor
110526100|NCT05207358|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110526101|NCT05207358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110526102|NCT05207358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110526103|NCT04256993|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
110526104|NCT04256993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110526105|NCT05387031|Ustekinumab|ustekinumab|mesh-list
110526106|NCT05387031|Dermatologic Agents|dermatologic agents|mesh-ancestor
110526107|NCT04570644|Cromolyn Sodium|cromolyn sodium|mesh-list
110526108|NCT04570644|Ibuprofen|ibuprofen|mesh-list
110526109|NCT04570644|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110526110|NCT04570644|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110526111|NCT04570644|Analgesics|analgesics|mesh-ancestor
110526112|NCT04570644|Sensory System Agents|sensory system agents|mesh-ancestor
110526113|NCT04570644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110526114|NCT04570644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110526115|NCT04570644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110526116|NCT04570644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110526117|NCT04570644|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110526118|NCT04570644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110526119|NCT04570644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110526120|NCT04570644|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
110526121|NCT04570644|Immunologic Factors|immunologic factors|mesh-ancestor
110526136|NCT01524926|Crizotinib|crizotinib|mesh-list
110526137|NCT01524926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110526138|NCT01524926|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110526139|NCT01524926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110526140|NCT01524926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110526141|NCT03738228|Cisplatin|cisplatin|mesh-list
110526142|NCT03738228|Atezolizumab|atezolizumab|mesh-list
110526143|NCT03738228|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110526144|NCT03738228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110526145|NCT03738228|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110526146|NCT03738228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110526147|NCT03738228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110526148|NCT03738228|Immunologic Factors|immunologic factors|mesh-ancestor
110526149|NCT03738228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110526150|NCT04756232|Mecamylamine|mecamylamine|mesh-list
110526151|NCT04756232|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110526152|NCT04756232|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
110526153|NCT04756232|Autonomic Agents|autonomic agents|mesh-ancestor
110526154|NCT04756232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110526155|NCT04756232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110526156|NCT04756232|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
110526157|NCT04756232|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110526158|NCT04756232|Cholinergic Agents|cholinergic agents|mesh-ancestor
110526159|NCT04756232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110526160|NCT04756232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110526161|NCT02774876|Insulin|insulin|mesh-list
110526162|NCT02774876|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110526163|NCT02774876|Hormones|hormones|mesh-list
110526164|NCT02774876|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110526165|NCT02774876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110526166|NCT02774876|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110526167|NCT04225364|Paclitaxel|paclitaxel|mesh-list
110526168|NCT04225364|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110526169|NCT04225364|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110526170|NCT04225364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110526171|NCT04225364|Tubulin Modulators|tubulin modulators|mesh-ancestor
110526172|NCT04225364|Antimitotic Agents|antimitotic agents|mesh-ancestor
110526173|NCT04225364|Mitosis Modulators|mitosis modulators|mesh-ancestor
110526174|NCT04225364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110526175|NCT02771834|Vitamin D|vitamin d|mesh-list
110526176|NCT02771834|Vitamins|vitamins|mesh-ancestor
110526177|NCT02771834|Micronutrients|micronutrients|mesh-ancestor
110526178|NCT02771834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110526179|NCT02771834|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110526180|NCT02774564|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
110526181|NCT02774564|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110526182|NCT02774564|Immunologic Factors|immunologic factors|mesh-ancestor
110526183|NCT02774564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110526197|NCT00613470|Serotonin Agents|serotonin agents|mesh-ancestor
110526198|NCT00613470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110526199|NCT00613470|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110526200|NCT00613470|Antidepressive Agents|antidepressive agents|mesh-ancestor
110526201|NCT00613470|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110526202|NCT02771912|Propofol|propofol|mesh-list
110526203|NCT02771912|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
110526204|NCT02771912|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110526205|NCT02771912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110526206|NCT02771912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110526207|NCT02771912|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110526208|NCT02771912|Anesthetics, General|anesthetics, general|mesh-ancestor
110526209|NCT02771912|Anesthetics|anesthetics|mesh-ancestor
110526210|NCT02771912|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
110526211|NCT02771912|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
110526212|NCT02771912|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110526213|NCT00741819|Treprostinil|treprostinil|mesh-list
110526214|NCT00741819|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110526215|NCT04457466|Mitogens|mitogens|mesh-list
110526216|NCT04457466|Mitosis Modulators|mitosis modulators|mesh-ancestor
110526217|NCT04457466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110526218|NCT04954742|Riociguat|riociguat|mesh-list
110526219|NCT04954742|Enzyme Activators|enzyme activators|mesh-ancestor
110526220|NCT04954742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110526221|NCT04193696|Immunomodulating Agents|immunomodulating agents|mesh-list
110526222|NCT04193696|Immunologic Factors|immunologic factors|mesh-ancestor
110526223|NCT04193696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110526224|NCT02774096|Xenon|xenon|mesh-list
110526225|NCT02774096|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110918179|NCT05122780|Anticoagulants|anticoagulants|mesh-list
110526226|NCT02774096|Anesthetics, General|anesthetics, general|mesh-ancestor
110526228|NCT02774096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110526229|NCT02774096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110526230|NCT04181385|Bromocriptine|bromocriptine|mesh-list
110526231|NCT04181385|Olanzapine|olanzapine|mesh-list
110526232|NCT04181385|Antiemetics|antiemetics|mesh-ancestor
110526233|NCT04181385|Autonomic Agents|autonomic agents|mesh-ancestor
110526234|NCT04181385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110526235|NCT04181385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110526236|NCT04181385|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110526237|NCT04181385|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110526238|NCT04181385|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110526239|NCT04181385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110526240|NCT04181385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110526241|NCT04181385|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110526242|NCT04181385|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110526243|NCT04181385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110180275|NCT00015275|Cocaine|cocaine|mesh-list
110526262|NCT02677155|Immunologic Factors|immunologic factors|mesh-ancestor
110526263|NCT02677155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110526264|NCT02677155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110526265|NCT02677155|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110526266|NCT02677155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110526267|NCT02537691|Theophylline|theophylline|mesh-list
110526268|NCT02537691|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110526269|NCT02537691|Autonomic Agents|autonomic agents|mesh-ancestor
110526270|NCT02537691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110526271|NCT02537691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110526272|NCT02537691|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110526273|NCT02537691|Respiratory System Agents|respiratory system agents|mesh-ancestor
110526274|NCT02537691|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110526275|NCT02537691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110526276|NCT02537691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110526277|NCT02537691|Vasodilator Agents|vasodilator agents|mesh-ancestor
110526278|NCT02537691|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110526279|NCT02537691|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110526280|NCT02537691|Purinergic Agents|purinergic agents|mesh-ancestor
110526281|NCT02537691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110526282|NCT04225052|Varenicline|varenicline|mesh-list
110526283|NCT04225052|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110526284|NCT04225052|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110526285|NCT04225052|Cholinergic Agents|cholinergic agents|mesh-ancestor
110526286|NCT04225052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110526287|NCT04225052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110526288|NCT04225052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110526290|NCT04255121|Epinephrine|epinephrine|mesh-list
110526291|NCT04255121|Racepinephrine|racepinephrine|mesh-list
110526292|NCT04255121|Epinephryl borate|epinephryl borate|mesh-list
110526293|NCT04255121|Anesthetics, Local|anesthetics, local|mesh-ancestor
110526294|NCT04255121|Anesthetics|anesthetics|mesh-ancestor
110526295|NCT04255121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110526296|NCT04255121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110526297|NCT04255121|Sensory System Agents|sensory system agents|mesh-ancestor
110526298|NCT04255121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110526299|NCT04255121|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110526300|NCT04255121|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110526309|NCT04255121|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110526310|NCT04255121|Autonomic Agents|autonomic agents|mesh-ancestor
110526311|NCT04255121|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110526312|NCT04255121|Respiratory System Agents|respiratory system agents|mesh-ancestor
110526314|NCT04255121|Sympathomimetics|sympathomimetics|mesh-ancestor
110526315|NCT04255121|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110635717|NCT00895362|Cetuximab|cetuximab|mesh-list
110526317|NCT03521232|Anticestodal Agents|anticestodal agents|mesh-ancestor
110526318|NCT03521232|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110526319|NCT03521232|Anthelmintics|anthelmintics|mesh-ancestor
110526320|NCT03521232|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110526321|NCT03521232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110526322|NCT03521232|Antinematodal Agents|antinematodal agents|mesh-ancestor
110526323|NCT00924287|Aldesleukin|aldesleukin|mesh-list
110526324|NCT00924287|Cyclophosphamide|cyclophosphamide|mesh-list
110526325|NCT00924287|Fludarabine|fludarabine|mesh-list
110526326|NCT00924287|Interleukin-2|interleukin-2|mesh-list
110526328|NCT00924287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110526329|NCT00924287|Immunologic Factors|immunologic factors|mesh-ancestor
110526330|NCT00924287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110526331|NCT00924287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110526332|NCT00924287|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110526333|NCT00924287|Alkylating Agents|alkylating agents|mesh-ancestor
110526334|NCT00924287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110526335|NCT00924287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110526336|NCT00924287|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110526337|NCT00924287|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110526338|NCT00924287|Analgesics|analgesics|mesh-ancestor
110526339|NCT00924287|Sensory System Agents|sensory system agents|mesh-ancestor
110526340|NCT00924287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110526341|NCT00924287|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110526342|NCT00924287|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110526343|NCT00924287|Antiviral Agents|antiviral agents|mesh-ancestor
110526344|NCT00924287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110526345|NCT00924287|Protective Agents|protective agents|mesh-ancestor
110526346|NCT02696954|Lumefantrine|lumefantrine|mesh-list
110526347|NCT02696954|Artemether|artemether|mesh-list
110526348|NCT02696954|Primaquine|primaquine|mesh-list
110526349|NCT02696954|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
110526350|NCT02696954|Amodiaquine|amodiaquine|mesh-list
110526351|NCT02696954|Antimalarials|antimalarials|mesh-ancestor
110526352|NCT02696954|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110526353|NCT02696954|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110526354|NCT02696954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110526355|NCT02677077|Natalizumab|natalizumab|mesh-list
110526356|NCT02677077|Immunologic Factors|immunologic factors|mesh-ancestor
110526357|NCT02677077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110526358|NCT02771600|Anesthetics|anesthetics|mesh-list
110526359|NCT02771600|Anesthetics, Local|anesthetics, local|mesh-list
110526360|NCT02771600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110526361|NCT02771600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110526362|NCT02771600|Sensory System Agents|sensory system agents|mesh-ancestor
110526363|NCT02771600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110526364|NCT02773316|Morphine|morphine|mesh-list
110526365|NCT02773316|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110526366|NCT02773316|Narcotics|narcotics|mesh-ancestor
110526367|NCT02773316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110526368|NCT02773316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110526369|NCT02773316|Analgesics|analgesics|mesh-ancestor
110526370|NCT02773316|Sensory System Agents|sensory system agents|mesh-ancestor
110526375|NCT02773550|Prednisone|prednisone|mesh-list
110526376|NCT02773550|Bortezomib|bortezomib|mesh-list
110526377|NCT02773550|Melphalan|melphalan|mesh-list
110526378|NCT02773550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110526379|NCT02773550|Glucocorticoids|glucocorticoids|mesh-ancestor
110526380|NCT02773550|Hormones|hormones|mesh-ancestor
110526381|NCT02773550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110526382|NCT02773550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110526383|NCT02773550|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110173835|NCT00061438|Meropenem|meropenem|mesh-list
110526384|NCT02773550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110526385|NCT02773550|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110526386|NCT02773550|Alkylating Agents|alkylating agents|mesh-ancestor
110526387|NCT02773550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110526388|NCT02773550|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110526389|NCT02773550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110526390|NCT02773550|Immunologic Factors|immunologic factors|mesh-ancestor
110526392|NCT02773472|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110526393|NCT02773472|Narcotics|narcotics|mesh-ancestor
110526394|NCT02773472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110526395|NCT02773472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110526396|NCT02773472|Analgesics|analgesics|mesh-ancestor
110526397|NCT02773472|Sensory System Agents|sensory system agents|mesh-ancestor
110526398|NCT02773472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110526399|NCT00637871|Tamoxifen|tamoxifen|mesh-list
110526400|NCT00637871|Bicalutamide|bicalutamide|mesh-list
110526401|NCT00637871|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110526403|NCT00637871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110526404|NCT00637871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110526405|NCT00637871|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110526406|NCT00637871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110526407|NCT00637871|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110526408|NCT00637871|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110526409|NCT00637871|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110526410|NCT00637871|Androgen Antagonists|androgen antagonists|mesh-ancestor
110526411|NCT00635258|Triptorelin Pamoate|triptorelin pamoate|mesh-list
110526412|NCT00635258|Ganirelix|ganirelix|mesh-list
110526413|NCT00635258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110526414|NCT00635258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110526415|NCT00635258|Luteolytic Agents|luteolytic agents|mesh-ancestor
110526416|NCT00635258|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110526417|NCT00635258|Contraceptive Agents|contraceptive agents|mesh-ancestor
110526418|NCT00635258|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110526419|NCT00635258|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110526420|NCT00635258|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110526421|NCT00635258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110526422|NCT00635258|Hormone Antagonists|hormone antagonists|mesh-ancestor
110526423|NCT00642837|Acetaminophen|acetaminophen|mesh-list
110526424|NCT00642837|Tramadol|tramadol|mesh-list
110526425|NCT00642837|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110526426|NCT00642837|Analgesics|analgesics|mesh-ancestor
110526427|NCT00642837|Sensory System Agents|sensory system agents|mesh-ancestor
110526428|NCT00642837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110526429|NCT00642837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110526430|NCT00642837|Antipyretics|antipyretics|mesh-ancestor
110526431|NCT00642837|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110526432|NCT00642837|Narcotics|narcotics|mesh-ancestor
110526433|NCT00642837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110526434|NCT02776748|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110918216|NCT02119884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110526435|NCT02776748|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110526436|NCT02776748|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110526437|NCT02776748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110526438|NCT02776748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110526439|NCT02776748|Antiviral Agents|antiviral agents|mesh-ancestor
110526440|NCT02776748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110526446|NCT00642915|Insulin Glargine|insulin glargine|mesh-list
110526447|NCT00642915|Glimepiride|glimepiride|mesh-list
110526448|NCT00642915|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110526449|NCT00642915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110526450|NCT00642915|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110526451|NCT00642915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110526452|NCT00642915|Immunologic Factors|immunologic factors|mesh-ancestor
110526453|NCT02676297|Tiotropium Bromide|tiotropium bromide|mesh-list
110526454|NCT02676297|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110526455|NCT02676297|Autonomic Agents|autonomic agents|mesh-ancestor
110526456|NCT02676297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110526457|NCT02676297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110526458|NCT02676297|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110526459|NCT02676297|Respiratory System Agents|respiratory system agents|mesh-ancestor
110173909|NCT05219825|Psychotropic Drugs|psychotropic drugs|mesh-list
110526460|NCT02676297|Parasympatholytics|parasympatholytics|mesh-ancestor
110526461|NCT02676297|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110526462|NCT02676297|Cholinergic Agents|cholinergic agents|mesh-ancestor
110526463|NCT02676297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110526464|NCT02676297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110526466|NCT02696720|Anesthetics, Local|anesthetics, local|mesh-ancestor
110526467|NCT02696720|Anesthetics|anesthetics|mesh-ancestor
110526468|NCT02696720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110526469|NCT02696720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110526470|NCT02696720|Sensory System Agents|sensory system agents|mesh-ancestor
110526471|NCT02696720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110526472|NCT02696720|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110526473|NCT02696720|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110526474|NCT02696720|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110526475|NCT02696720|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110526476|NCT02696720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110526477|NCT00643071|Tacrolimus|tacrolimus|mesh-list
110526478|NCT00643071|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110526479|NCT00643071|Immunologic Factors|immunologic factors|mesh-ancestor
110526480|NCT00643071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110526481|NCT00643071|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110526482|NCT00643071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110526483|NCT00643071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110526484|NCT03728634|Vitamin A|vitamin a|mesh-list
110526485|NCT03728634|Vitamins|vitamins|mesh-ancestor
110526486|NCT03728634|Micronutrients|micronutrients|mesh-ancestor
110526487|NCT03728634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110526488|NCT02767310|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110526489|NCT02767310|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110526490|NCT02767310|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110526491|NCT02767310|Antimetabolites|antimetabolites|mesh-ancestor
110526492|NCT02767310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110526493|NCT02767310|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110526494|NCT02767310|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110526495|NCT02767310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110526496|NCT04353414|Bupivacaine|bupivacaine|mesh-list
110526497|NCT04353414|Anesthetics, Local|anesthetics, local|mesh-ancestor
110526498|NCT04353414|Anesthetics|anesthetics|mesh-ancestor
110526499|NCT04353414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110526500|NCT04353414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110526501|NCT04353414|Sensory System Agents|sensory system agents|mesh-ancestor
110526502|NCT04353414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110526504|NCT00643149|Azithromycin|azithromycin|mesh-list
110526505|NCT00643149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110526506|NCT00643149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110526507|NCT05141682|Azacitidine|azacitidine|mesh-list
110526508|NCT05141682|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110526509|NCT05141682|Antimetabolites|antimetabolites|mesh-ancestor
110526527|NCT02537457|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110526528|NCT02537457|Antithrombins|antithrombins|mesh-ancestor
110526529|NCT02537457|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110526530|NCT02537457|Protease Inhibitors|protease inhibitors|mesh-ancestor
110526531|NCT02537457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110526532|NCT02537457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110526533|NCT02537457|Anticoagulants|anticoagulants|mesh-ancestor
110526534|NCT02762864|Clopidogrel|clopidogrel|mesh-list
110526535|NCT02762864|Ticagrelor|ticagrelor|mesh-list
110526536|NCT02762864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110526537|NCT02762864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110526538|NCT02762864|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110526539|NCT02762864|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110526540|NCT02762864|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110526541|NCT02762864|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110526542|NCT02762864|Purinergic Agents|purinergic agents|mesh-ancestor
110526543|NCT02762864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110526544|NCT02767154|Mannitol|mannitol|mesh-list
110526545|NCT02767154|Dextrans|dextrans|mesh-list
110526546|NCT02767154|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110526547|NCT02767154|Diuretics|diuretics|mesh-ancestor
110526548|NCT02767154|Natriuretic Agents|natriuretic agents|mesh-ancestor
110526549|NCT02767154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110526550|NCT02767154|Anticoagulants|anticoagulants|mesh-ancestor
110526551|NCT02767154|Plasma Substitutes|plasma substitutes|mesh-ancestor
110526552|NCT02767154|Blood Substitutes|blood substitutes|mesh-ancestor
110526553|NCT02767232|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
110526554|NCT02767232|Plasminogen|plasminogen|mesh-list
110526555|NCT02767232|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110526556|NCT02767232|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110193224|NCT00034892|Olanzapine|olanzapine|mesh-list
110526557|NCT02767232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110526558|NCT02767076|Anesthetics|anesthetics|mesh-list
110526559|NCT02767076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110526560|NCT02767076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110526561|NCT02766764|Hormones|hormones|mesh-list
110526562|NCT02766764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110526563|NCT02766764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110526564|NCT04658654|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-list
110526565|NCT04658654|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110526580|NCT02770508|Antiviral Agents|antiviral agents|mesh-ancestor
110526581|NCT02770508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110526582|NCT02770508|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110526583|NCT02770508|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110526584|NCT02770508|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110526585|NCT02770508|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110526586|NCT02762942|Misoprostol|misoprostol|mesh-list
110526587|NCT02762942|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110526588|NCT02762942|Abortifacient Agents|abortifacient agents|mesh-ancestor
110526589|NCT02762942|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110526590|NCT02762942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110526591|NCT02762942|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110526592|NCT02762942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110526593|NCT02762942|Oxytocics|oxytocics|mesh-ancestor
110526594|NCT02770430|Infliximab|infliximab|mesh-list
110526595|NCT02770430|Basiliximab|basiliximab|mesh-list
110526596|NCT02770430|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110526597|NCT02770430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110526598|NCT02770430|Dermatologic Agents|dermatologic agents|mesh-ancestor
110526599|NCT02770430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110526600|NCT02770430|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110526601|NCT02770430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110526602|NCT02770430|Immunologic Factors|immunologic factors|mesh-ancestor
110526603|NCT02770430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110526604|NCT00918203|Paclitaxel|paclitaxel|mesh-list
110526605|NCT00918203|Carboplatin|carboplatin|mesh-list
110526606|NCT00918203|Olaratumab|olaratumab|mesh-list
110526607|NCT00918203|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110526608|NCT00918203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110526609|NCT00918203|Tubulin Modulators|tubulin modulators|mesh-ancestor
110526610|NCT00918203|Antimitotic Agents|antimitotic agents|mesh-ancestor
110526611|NCT00918203|Mitosis Modulators|mitosis modulators|mesh-ancestor
110526612|NCT00918203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110526613|NCT00644319|Ibuprofen|ibuprofen|mesh-list
110526614|NCT00644319|Morphine|morphine|mesh-list
110526615|NCT00644319|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110526616|NCT00644319|Narcotics|narcotics|mesh-ancestor
110526617|NCT00644319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110526618|NCT00644319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110526619|NCT00644319|Analgesics|analgesics|mesh-ancestor
110526620|NCT00644319|Sensory System Agents|sensory system agents|mesh-ancestor
110526621|NCT00644319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110526622|NCT00644319|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110526623|NCT00644319|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110526624|NCT00644319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110526625|NCT00644319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110526626|NCT00644319|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110526627|NCT00644319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110526628|NCT00644319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110526638|NCT02672709|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110193251|NCT00035009|Aprepitant|aprepitant|mesh-list
110526639|NCT02672709|Protease Inhibitors|protease inhibitors|mesh-ancestor
110526640|NCT02672709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110526641|NCT02672709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110526642|NCT02672709|Anticoagulants|anticoagulants|mesh-ancestor
110526643|NCT02770274|Aspirin|aspirin|mesh-list
110526644|NCT02770274|Cilostazol|cilostazol|mesh-list
110526645|NCT02770274|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110526646|NCT02770274|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110526647|NCT02770274|Analgesics|analgesics|mesh-ancestor
110526648|NCT02770274|Sensory System Agents|sensory system agents|mesh-ancestor
110526649|NCT02770274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110526650|NCT02770274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110526651|NCT02770274|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110526652|NCT02770274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110526653|NCT02770274|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110526654|NCT02770274|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110526655|NCT02770274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110526656|NCT02770274|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110526657|NCT02770274|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110526658|NCT02770274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110526659|NCT02770274|Antipyretics|antipyretics|mesh-ancestor
110526660|NCT02770274|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110526661|NCT02770274|Autonomic Agents|autonomic agents|mesh-ancestor
110526662|NCT02770274|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110526663|NCT02770274|Respiratory System Agents|respiratory system agents|mesh-ancestor
110526664|NCT02770274|Vasodilator Agents|vasodilator agents|mesh-ancestor
110526665|NCT02770274|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110526666|NCT02770274|Protective Agents|protective agents|mesh-ancestor
110526667|NCT02770274|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110526668|NCT02770274|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110526670|NCT00910221|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110526671|NCT00910221|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110526672|NCT00910221|Antimetabolites|antimetabolites|mesh-ancestor
110526673|NCT00910221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110526674|NCT00910221|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110526675|NCT00910221|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110526676|NCT00910221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110526677|NCT04657562|Tacrolimus|tacrolimus|mesh-list
110526678|NCT04657562|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110526679|NCT04657562|Immunologic Factors|immunologic factors|mesh-ancestor
110526680|NCT04657562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110526681|NCT04657562|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110526682|NCT04657562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110526683|NCT04657562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110174128|NCT00063076|Bexarotene|bexarotene|mesh-list
110526684|NCT05252117|Mepivacaine|mepivacaine|mesh-list
110526685|NCT05252117|Carticaine|carticaine|mesh-list
110526686|NCT05252117|Anesthetics, Local|anesthetics, local|mesh-ancestor
110526687|NCT05252117|Anesthetics|anesthetics|mesh-ancestor
110526688|NCT05252117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110526689|NCT05252117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110526690|NCT05252117|Sensory System Agents|sensory system agents|mesh-ancestor
110526691|NCT05252117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110526692|NCT04224350|Tacrolimus|tacrolimus|mesh-list
110526693|NCT04224350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110526694|NCT04224350|Immunologic Factors|immunologic factors|mesh-ancestor
110180345|NCT00275535|Sirolimus|sirolimus|mesh-list
110526715|NCT04177875|Tubulin Modulators|tubulin modulators|mesh-ancestor
110526716|NCT04177875|Antimitotic Agents|antimitotic agents|mesh-ancestor
110526717|NCT04177875|Mitosis Modulators|mitosis modulators|mesh-ancestor
110526718|NCT04177875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110526719|NCT00917579|Atorvastatin|atorvastatin|mesh-list
110526720|NCT00917579|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110526721|NCT00917579|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110526722|NCT00917579|Antimetabolites|antimetabolites|mesh-ancestor
110526723|NCT00917579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110526724|NCT00917579|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110526725|NCT00917579|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110526726|NCT00917579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110526727|NCT03808740|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
110526728|NCT03808740|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110526729|NCT03808740|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110526730|NCT03808740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110526731|NCT03808740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110526732|NCT03808740|Adrenergic Agents|adrenergic agents|mesh-ancestor
110526733|NCT03808740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110526734|NCT03808740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110526735|NCT02766140|Docetaxel|docetaxel|mesh-list
110526736|NCT02766140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110526737|NCT02766140|Tubulin Modulators|tubulin modulators|mesh-ancestor
110526738|NCT02766140|Antimitotic Agents|antimitotic agents|mesh-ancestor
110526739|NCT02766140|Mitosis Modulators|mitosis modulators|mesh-ancestor
110526740|NCT02766140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110526741|NCT04177641|Antioxidants|antioxidants|mesh-list
110526742|NCT04177641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110526743|NCT04177641|Protective Agents|protective agents|mesh-ancestor
110526744|NCT04177641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110526745|NCT04178109|Acetaminophen|acetaminophen|mesh-list
110526746|NCT04178109|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
110526747|NCT04178109|Tramadol|tramadol|mesh-list
110526748|NCT04178109|Ropivacaine|ropivacaine|mesh-list
110526749|NCT04178109|Levobupivacaine|levobupivacaine|mesh-list
110180368|NCT00015626|Metformin|metformin|mesh-list
110526755|NCT04178109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110526756|NCT04178109|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110174205|NCT05141357|Pembrolizumab|pembrolizumab|mesh-list
110526758|NCT04178109|Antipyretics|antipyretics|mesh-ancestor
110635804|NCT00906048|Levofloxacin|levofloxacin|mesh-list
110526759|NCT04178109|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110526760|NCT04178109|Narcotics|narcotics|mesh-ancestor
110526761|NCT04178109|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110526762|NCT04178109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110526763|NCT04178109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110526764|NCT00644475|Candesartan|candesartan|mesh-list
110526765|NCT00644475|Candesartan cilexetil|candesartan cilexetil|mesh-list
110526766|NCT00644475|Imidapril|imidapril|mesh-list
110526767|NCT00644475|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110526768|NCT00644475|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110526769|NCT00644475|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110526770|NCT00644475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110526771|NCT00644475|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110526772|NCT00644475|Protease Inhibitors|protease inhibitors|mesh-ancestor
110526773|NCT00644475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110526774|NCT04177719|Oxytocin|oxytocin|mesh-list
110526775|NCT04177719|Oxytocics|oxytocics|mesh-ancestor
110526776|NCT04177719|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110526777|NCT04177719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110526778|NCT00644553|Amoxicillin|amoxicillin|mesh-list
110526779|NCT00644553|Clarithromycin|clarithromycin|mesh-list
110526780|NCT00644553|Clavulanic Acid|clavulanic acid|mesh-list
110526781|NCT00644553|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
110526782|NCT00644553|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110526783|NCT00644553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110526784|NCT00644553|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110526785|NCT00644553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110526786|NCT00644553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110526787|NCT00644553|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110526788|NCT00644553|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110526789|NCT00644553|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110526790|NCT02762474|Paclitaxel|paclitaxel|mesh-list
110526791|NCT02762474|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110526792|NCT02762474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110526793|NCT02762474|Tubulin Modulators|tubulin modulators|mesh-ancestor
110526794|NCT02762474|Antimitotic Agents|antimitotic agents|mesh-ancestor
110526795|NCT02762474|Mitosis Modulators|mitosis modulators|mesh-ancestor
110526796|NCT02762474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110526797|NCT00915473|Methylprednisolone|methylprednisolone|mesh-list
110526798|NCT00915473|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110526799|NCT00915473|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110526800|NCT00915473|Prednisolone|prednisolone|mesh-list
110526801|NCT00915473|Prednisolone acetate|prednisolone acetate|mesh-list
110526802|NCT00915473|Lidocaine|lidocaine|mesh-list
110526803|NCT00915473|Bupivacaine|bupivacaine|mesh-list
110526804|NCT00915473|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110526805|NCT00915473|Prednisolone phosphate|prednisolone phosphate|mesh-list
110526806|NCT00915473|Anesthetics, Local|anesthetics, local|mesh-ancestor
110526807|NCT00915473|Anesthetics|anesthetics|mesh-ancestor
110526808|NCT00915473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110526809|NCT00915473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110526810|NCT00915473|Sensory System Agents|sensory system agents|mesh-ancestor
110526811|NCT00915473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110526812|NCT00915473|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110918282|NCT03622047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110918283|NCT03622047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110918284|NCT03622047|Analgesics|analgesics|mesh-ancestor
110526813|NCT00915473|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110526814|NCT00915473|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110526815|NCT00915473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110526816|NCT00915473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110526817|NCT00915473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110526843|NCT04691726|Narcotics|narcotics|mesh-ancestor
110526844|NCT04691726|Analgesics|analgesics|mesh-ancestor
110526845|NCT04691726|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110526846|NCT04691726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110526847|NCT04691726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110526848|NCT04691726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110526849|NCT04691726|Antipyretics|antipyretics|mesh-ancestor
110526850|NCT00614328|Naltrexone|naltrexone|mesh-list
110526851|NCT00614328|Baclofen|baclofen|mesh-list
110526852|NCT00614328|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110526853|NCT00614328|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110526854|NCT00614328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110526855|NCT00614328|Sensory System Agents|sensory system agents|mesh-ancestor
110526856|NCT00614328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110526857|NCT00614328|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110526858|NCT00614328|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110526859|NCT00614328|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
110526860|NCT00614328|GABA Agonists|gaba agonists|mesh-ancestor
110526861|NCT00614328|GABA Agents|gaba agents|mesh-ancestor
110526862|NCT00614328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110526863|NCT00614328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110526864|NCT04177173|Methotrexate|methotrexate|mesh-list
110526865|NCT04177173|Simvastatin|simvastatin|mesh-list
110526866|NCT04177173|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110526867|NCT04177173|Abortifacient Agents|abortifacient agents|mesh-ancestor
110526872|NCT04177173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110526874|NCT04177173|Dermatologic Agents|dermatologic agents|mesh-ancestor
110526875|NCT04177173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110526876|NCT04177173|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110526877|NCT04177173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110526878|NCT04177173|Immunologic Factors|immunologic factors|mesh-ancestor
110526879|NCT04177173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110526880|NCT04177173|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110526881|NCT04177173|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110526882|NCT04177173|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110526883|NCT04177173|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110526884|NCT04177173|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110526885|NCT04224818|Triptorelin Pamoate|triptorelin pamoate|mesh-list
110526886|NCT04224818|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
110526887|NCT04224818|Luteolytic Agents|luteolytic agents|mesh-ancestor
110526888|NCT04224818|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110526889|NCT04224818|Contraceptive Agents|contraceptive agents|mesh-ancestor
110526890|NCT04224818|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110526891|NCT04224818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110526892|NCT04224818|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110526893|NCT04224818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110526894|NCT04224818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110526895|NCT03651804|Acetaminophen|acetaminophen|mesh-list
110526896|NCT03651804|Diphosphonates|diphosphonates|mesh-list
110526897|NCT03651804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
110526898|NCT03651804|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
110526899|NCT03651804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110526900|NCT03651804|Analgesics|analgesics|mesh-ancestor
110526901|NCT03651804|Sensory System Agents|sensory system agents|mesh-ancestor
110526902|NCT03651804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110526903|NCT03651804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110526904|NCT03651804|Antipyretics|antipyretics|mesh-ancestor
110526905|NCT03651804|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110526906|NCT03651804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110526907|NCT00917267|Exenatide|exenatide|mesh-list
110526908|NCT00917267|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110526909|NCT00917267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110526910|NCT00917267|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110526911|NCT00917267|Incretins|incretins|mesh-ancestor
110526912|NCT00917267|Hormones|hormones|mesh-ancestor
110526913|NCT00917267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110526914|NCT02670759|Bupivacaine|bupivacaine|mesh-list
110526915|NCT02670759|Anesthetics, Local|anesthetics, local|mesh-ancestor
110526916|NCT02670759|Anesthetics|anesthetics|mesh-ancestor
110526917|NCT02670759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110526918|NCT02670759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110526919|NCT02670759|Sensory System Agents|sensory system agents|mesh-ancestor
110526920|NCT02670759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110526921|NCT00644943|Amoxicillin|amoxicillin|mesh-list
110526922|NCT00644943|Cefdinir|cefdinir|mesh-list
110526923|NCT00644943|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110526924|NCT00644943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110526925|NCT02762006|Durvalumab|durvalumab|mesh-list
110526926|NCT02762006|Tremelimumab|tremelimumab|mesh-list
110526927|NCT02762006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110526928|NCT02762006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110526929|NCT02769884|Pancrelipase|pancrelipase|mesh-list
110526930|NCT02769884|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110526931|NCT05213507|Amikacin|amikacin|mesh-list
110526932|NCT05213507|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110526933|NCT05213507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110526934|NCT02670603|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110526935|NCT04253873|Temozolomide|temozolomide|mesh-list
110526936|NCT04253873|Apatinib|apatinib|mesh-list
110526937|NCT04253873|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110526938|NCT04253873|Alkylating Agents|alkylating agents|mesh-ancestor
110526949|NCT05147727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110526951|NCT05147727|Hormone Antagonists|hormone antagonists|mesh-ancestor
110526952|NCT05147727|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110526953|NCT05147727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110526954|NCT05147727|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110526955|NCT05147727|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110526956|NCT02765594|Hydroxychloroquine|hydroxychloroquine|mesh-list
110526957|NCT02765594|Valsartan|valsartan|mesh-list
110526958|NCT02765594|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110526959|NCT02765594|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110526960|NCT02765594|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110526961|NCT02765594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110526962|NCT02765594|Antimalarials|antimalarials|mesh-ancestor
110526963|NCT02765594|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110526964|NCT02765594|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110526965|NCT02765594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110526966|NCT02765594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110526967|NCT02765594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110526968|NCT00920699|Ubiquinone|ubiquinone|mesh-list
110526969|NCT00920699|Coenzyme Q10|coenzyme q10|mesh-list
110526970|NCT00920699|Micronutrients|micronutrients|mesh-ancestor
110526971|NCT00920699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110526972|NCT00920699|Vitamins|vitamins|mesh-ancestor
110526973|NCT02670135|Triclosan|triclosan|mesh-list
110526974|NCT02670135|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110526975|NCT02670135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110526976|NCT02670135|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
110526977|NCT02670135|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110526978|NCT02670135|Antimetabolites|antimetabolites|mesh-ancestor
110526979|NCT02670135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110526980|NCT02670135|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110526981|NCT02769494|Riboflavin|riboflavin|mesh-list
110526982|NCT02769494|Flavin Mononucleotide|flavin mononucleotide|mesh-list
110526983|NCT02769494|Mesalamine|mesalamine|mesh-list
110526984|NCT02769494|Vitamin B Complex|vitamin b complex|mesh-ancestor
110526985|NCT02769494|Vitamins|vitamins|mesh-ancestor
110526986|NCT02769494|Micronutrients|micronutrients|mesh-ancestor
110526987|NCT02769494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110526988|NCT02769494|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110526989|NCT02769494|Dermatologic Agents|dermatologic agents|mesh-ancestor
110526991|NCT02769494|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110526992|NCT02769494|Analgesics|analgesics|mesh-ancestor
110526993|NCT02769494|Sensory System Agents|sensory system agents|mesh-ancestor
110526994|NCT02769494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110526995|NCT02769494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110526996|NCT02769494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110526997|NCT02769572|Diclofenac|diclofenac|mesh-list
110526998|NCT02769572|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110526999|NCT02769572|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110527000|NCT02769572|Analgesics|analgesics|mesh-ancestor
110527001|NCT02769572|Sensory System Agents|sensory system agents|mesh-ancestor
110527002|NCT02769572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110534645|NCT02674308|Vedolizumab|vedolizumab|mesh-list
110527008|NCT02769572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110527010|NCT02669589|Anticoagulants|anticoagulants|mesh-ancestor
110527011|NCT02669589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110527012|NCT02669589|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110527013|NCT02669589|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110527014|NCT02765204|Dapagliflozin|dapagliflozin|mesh-list
110527015|NCT02765204|Saxagliptin|saxagliptin|mesh-list
110527016|NCT02765204|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110527017|NCT02765204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110527018|NCT02765204|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110527019|NCT02765204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110527020|NCT02765204|Incretins|incretins|mesh-ancestor
110527021|NCT02765204|Hormones|hormones|mesh-ancestor
110527022|NCT02765204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110527023|NCT02765204|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110527024|NCT02765204|Protease Inhibitors|protease inhibitors|mesh-ancestor
110527025|NCT02765204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110527026|NCT03342456|Amoxicillin|amoxicillin|mesh-list
110527027|NCT03342456|Doxycycline|doxycycline|mesh-list
110527028|NCT03342456|Furazolidone|furazolidone|mesh-list
110527029|NCT03342456|Potassium Citrate|potassium citrate|mesh-list
110527030|NCT03342456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110527031|NCT03342456|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110527032|NCT03342456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110527033|NCT03342456|Antimalarials|antimalarials|mesh-ancestor
110527034|NCT03342456|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110527035|NCT03342456|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110527036|NCT03342456|Diuretics|diuretics|mesh-ancestor
110527037|NCT03342456|Natriuretic Agents|natriuretic agents|mesh-ancestor
110527038|NCT03342456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110527039|NCT03342456|Expectorants|expectorants|mesh-ancestor
110527040|NCT03342456|Respiratory System Agents|respiratory system agents|mesh-ancestor
110527041|NCT03342456|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110527042|NCT03342456|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110527043|NCT03342456|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
110527044|NCT03342456|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
110527045|NCT03342456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110527046|NCT02669277|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110527047|NCT02669277|gamma-Globulins|gamma-globulins|mesh-list
110527048|NCT02669277|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110527049|NCT02669277|Immunologic Factors|immunologic factors|mesh-ancestor
110527050|NCT02669277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110527051|NCT02769104|Docetaxel|docetaxel|mesh-list
110527052|NCT02769104|Letrozole|letrozole|mesh-list
110527053|NCT02769104|Aromatase Inhibitors|aromatase inhibitors|mesh-list
110527054|NCT02769104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110527055|NCT02769104|Tubulin Modulators|tubulin modulators|mesh-ancestor
110527056|NCT02769104|Antimitotic Agents|antimitotic agents|mesh-ancestor
110527057|NCT02769104|Mitosis Modulators|mitosis modulators|mesh-ancestor
110527058|NCT02769104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110527059|NCT02769104|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110527060|NCT02769104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110527061|NCT02769104|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110527062|NCT02769104|Hormone Antagonists|hormone antagonists|mesh-ancestor
110527063|NCT02769104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110527064|NCT02769104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110527065|NCT02545842|Insulin Glargine|insulin glargine|mesh-list
110527066|NCT02545842|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110527067|NCT02545842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110527068|NCT00645255|Sibutramine|sibutramine|mesh-list
110527069|NCT00645255|Antidepressive Agents|antidepressive agents|mesh-ancestor
110527070|NCT00645255|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110527071|NCT00645255|Appetite Depressants|appetite depressants|mesh-ancestor
110527072|NCT00645255|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110527082|NCT04679012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110527083|NCT04679012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110527084|NCT04679012|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110527085|NCT04679012|Alkylating Agents|alkylating agents|mesh-ancestor
110527086|NCT04679012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110527087|NCT04679012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110527088|NCT04679012|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110527089|NCT04679012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110527090|NCT04679012|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110527091|NCT04679012|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110527092|NCT04679012|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110527093|NCT04679012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110527094|NCT04679012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110527095|NCT04679012|Glucocorticoids|glucocorticoids|mesh-ancestor
110527097|NCT04679012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110527098|NCT04679012|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110527099|NCT04679012|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110527100|NCT04679012|Immunoconjugates|immunoconjugates|mesh-ancestor
110527101|NCT00910455|SRX246|srx246|mesh-list
110527102|NCT00910455|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
110527103|NCT00910455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110527104|NCT00910455|Natriuretic Agents|natriuretic agents|mesh-ancestor
110527105|NCT00910455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110527106|NCT02765126|Vaccines|vaccines|mesh-list
110527107|NCT02765126|Immunologic Factors|immunologic factors|mesh-ancestor
110527108|NCT02765126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110527109|NCT02668965|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
110527110|NCT02668965|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110193442|NCT00062946|Fallypride|fallypride|mesh-list
110527111|NCT02668965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110918354|NCT04054089|Antiviral Agents|antiviral agents|mesh-ancestor
110527112|NCT00916721|Propranolol|propranolol|mesh-list
110527113|NCT00916721|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110527114|NCT00916721|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110527115|NCT00916721|Adrenergic Agents|adrenergic agents|mesh-ancestor
110527116|NCT00916721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110527117|NCT00916721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110527118|NCT00916721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110527119|NCT00916721|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110527120|NCT00916721|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110527121|NCT00916721|Vasodilator Agents|vasodilator agents|mesh-ancestor
110527122|NCT00613782|Methyltestosterone|methyltestosterone|mesh-list
110527123|NCT00613782|Testosterone|testosterone|mesh-list
110527124|NCT00613782|Testosterone undecanoate|testosterone undecanoate|mesh-list
110527125|NCT00613782|Testosterone enanthate|testosterone enanthate|mesh-list
110527126|NCT00613782|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
110527127|NCT00613782|Androgens|androgens|mesh-ancestor
110527128|NCT00613782|Hormones|hormones|mesh-ancestor
110527129|NCT00613782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110527130|NCT00613782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110527131|NCT00613782|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110527132|NCT00613782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110527133|NCT00613782|Anabolic Agents|anabolic agents|mesh-ancestor
110527135|NCT02764736|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110527136|NCT02764736|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110527137|NCT02764736|Antimetabolites|antimetabolites|mesh-ancestor
110527138|NCT02764736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110527139|NCT02764736|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110527147|NCT00646737|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110527148|NCT00646737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110527149|NCT00646737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110527150|NCT00646737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110527151|NCT00646815|Hormones|hormones|mesh-list
110527152|NCT00646815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110527153|NCT00646815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110527154|NCT00915005|Paclitaxel|paclitaxel|mesh-list
110527155|NCT00915005|Carboplatin|carboplatin|mesh-list
110527156|NCT00915005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110527157|NCT00915005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110527158|NCT00915005|Tubulin Modulators|tubulin modulators|mesh-ancestor
110527159|NCT00915005|Antimitotic Agents|antimitotic agents|mesh-ancestor
110527160|NCT00915005|Mitosis Modulators|mitosis modulators|mesh-ancestor
110527161|NCT00915005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110527162|NCT00910533|Ceftriaxone|ceftriaxone|mesh-list
110527163|NCT00910533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110527164|NCT00910533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110527165|NCT02696642|Maytansine|maytansine|mesh-list
110527166|NCT02696642|Anetumab ravtansine|anetumab ravtansine|mesh-list
110527167|NCT02696642|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110527168|NCT02696642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110527169|NCT02696642|Tubulin Modulators|tubulin modulators|mesh-ancestor
110527170|NCT02696642|Antimitotic Agents|antimitotic agents|mesh-ancestor
110527171|NCT02696642|Mitosis Modulators|mitosis modulators|mesh-ancestor
110527172|NCT02696642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110527173|NCT02696642|Immunoconjugates|immunoconjugates|mesh-ancestor
110527174|NCT02696642|Immunologic Factors|immunologic factors|mesh-ancestor
110527175|NCT02696642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110527176|NCT00647049|Cytarabine|cytarabine|mesh-list
110527177|NCT00647049|Rituximab|rituximab|mesh-list
110527178|NCT00647049|Methotrexate|methotrexate|mesh-list
110527179|NCT00647049|Thiotepa|thiotepa|mesh-list
110918362|NCT04054089|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110527180|NCT00647049|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110527181|NCT00647049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110527182|NCT00647049|Immunologic Factors|immunologic factors|mesh-ancestor
110527183|NCT00647049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110527184|NCT00647049|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110527185|NCT00647049|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110527186|NCT00647049|Abortifacient Agents|abortifacient agents|mesh-ancestor
110527187|NCT00647049|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110527188|NCT00647049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110527190|NCT00647049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110527191|NCT00647049|Dermatologic Agents|dermatologic agents|mesh-ancestor
110527192|NCT00647049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110527193|NCT00647049|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110527194|NCT00647049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110527195|NCT00647049|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110527196|NCT00647049|Antiviral Agents|antiviral agents|mesh-ancestor
110527197|NCT00647049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110527198|NCT00647049|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110527199|NCT00647049|Alkylating Agents|alkylating agents|mesh-ancestor
110527200|NCT00647049|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110527201|NCT02696330|Enoxaparin|enoxaparin|mesh-list
110527202|NCT02696330|Clopidogrel|clopidogrel|mesh-list
110527203|NCT02696330|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110527204|NCT02696330|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110527205|NCT02696330|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110527206|NCT02696330|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110527214|NCT04172727|Bupivacaine|bupivacaine|mesh-list
110527215|NCT04172727|Anesthetics, Local|anesthetics, local|mesh-ancestor
110527216|NCT04172727|Anesthetics|anesthetics|mesh-ancestor
110527217|NCT04172727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110527218|NCT04172727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110527219|NCT04172727|Sensory System Agents|sensory system agents|mesh-ancestor
110527220|NCT04172727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110527221|NCT04648319|Nivolumab|nivolumab|mesh-list
110527222|NCT04648319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110527223|NCT04648319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110527224|NCT04648319|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110527225|NCT04648319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110527226|NCT00647127|Fentanyl|fentanyl|mesh-list
110527227|NCT00647127|Buprenorphine|buprenorphine|mesh-list
110527228|NCT00647127|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110527229|NCT00647127|Narcotics|narcotics|mesh-ancestor
110527230|NCT00647127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110527231|NCT00647127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110527232|NCT00647127|Analgesics|analgesics|mesh-ancestor
110527233|NCT00647127|Sensory System Agents|sensory system agents|mesh-ancestor
110527234|NCT00647127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110527235|NCT00647127|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110527236|NCT00647127|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110527237|NCT00647127|Anesthetics, General|anesthetics, general|mesh-ancestor
110527238|NCT00647127|Anesthetics|anesthetics|mesh-ancestor
110527239|NCT00647127|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110527240|NCT04750070|Dopamine|dopamine|mesh-list
110527241|NCT04750070|Epinephrine|epinephrine|mesh-list
110527242|NCT04750070|Racepinephrine|racepinephrine|mesh-list
110527243|NCT04750070|Epinephryl borate|epinephryl borate|mesh-list
110527244|NCT04750070|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110527245|NCT04750070|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110527246|NCT04750070|Adrenergic Agents|adrenergic agents|mesh-ancestor
110527247|NCT04750070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110527248|NCT04750070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110527249|NCT04750070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110527250|NCT04750070|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110527251|NCT04750070|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110527252|NCT04750070|Autonomic Agents|autonomic agents|mesh-ancestor
110527253|NCT04750070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110527254|NCT04750070|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110527255|NCT04750070|Respiratory System Agents|respiratory system agents|mesh-ancestor
110527256|NCT04750070|Mydriatics|mydriatics|mesh-ancestor
110527257|NCT04750070|Sympathomimetics|sympathomimetics|mesh-ancestor
110527258|NCT04750070|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110527259|NCT04750070|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110527260|NCT04750070|Dopamine Agents|dopamine agents|mesh-ancestor
110527261|NCT04750070|Protective Agents|protective agents|mesh-ancestor
110527262|NCT02763722|Emollients|emollients|mesh-list
110527263|NCT02763722|Dermatologic Agents|dermatologic agents|mesh-ancestor
110527264|NCT01143246|Terlipressin|terlipressin|mesh-list
110527265|NCT01143246|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110527266|NCT01143246|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110527267|NCT00647673|Verapamil|verapamil|mesh-list
110527268|NCT00647673|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110527269|NCT00647673|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110527270|NCT00647673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110527271|NCT00647673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110527272|NCT00647673|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110527273|NCT00647673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110527274|NCT00647673|Vasodilator Agents|vasodilator agents|mesh-ancestor
110527275|NCT00561925|Nevirapine|nevirapine|mesh-list
110527280|NCT00561925|Antiviral Agents|antiviral agents|mesh-ancestor
110527281|NCT00561925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110527282|NCT00561925|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110527283|NCT00561925|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110527284|NCT00561925|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110527285|NCT00561925|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110527288|NCT02760992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110527289|NCT02760992|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110527290|NCT02760992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110527291|NCT02760992|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
110527292|NCT02760992|GABA Agonists|gaba agonists|mesh-ancestor
110527293|NCT02760992|GABA Agents|gaba agents|mesh-ancestor
110527294|NCT02760992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110527295|NCT02760992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110527296|NCT04172259|Cyclophosphamide|cyclophosphamide|mesh-list
110527297|NCT04172259|Docetaxel|docetaxel|mesh-list
110527298|NCT04172259|Doxorubicin|doxorubicin|mesh-list
110527299|NCT04172259|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110527300|NCT04172259|Trastuzumab|trastuzumab|mesh-list
110527301|NCT04172259|Epirubicin|epirubicin|mesh-list
110527302|NCT04172259|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110527303|NCT04172259|Immunologic Factors|immunologic factors|mesh-ancestor
110527304|NCT04172259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110527305|NCT04172259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110527306|NCT04172259|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110527307|NCT04172259|Alkylating Agents|alkylating agents|mesh-ancestor
110527308|NCT04172259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110527309|NCT04172259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110527310|NCT04172259|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110527311|NCT04172259|Tubulin Modulators|tubulin modulators|mesh-ancestor
110527312|NCT04172259|Antimitotic Agents|antimitotic agents|mesh-ancestor
110527313|NCT04172259|Mitosis Modulators|mitosis modulators|mesh-ancestor
110527314|NCT04172259|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110527315|NCT04172259|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110527316|NCT04172259|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110527317|NCT04172259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110527318|NCT04172259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110527319|NCT00647751|Lamotrigine|lamotrigine|mesh-list
110527320|NCT00647751|Anticonvulsants|anticonvulsants|mesh-ancestor
110527321|NCT00647751|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110527322|NCT00647751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110527323|NCT00647751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110918383|NCT02120274|Vitamin D|vitamin d|mesh-list
110527324|NCT00647751|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110527325|NCT00647751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110527326|NCT00647751|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110527327|NCT00647751|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110527328|NCT00647751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110527329|NCT00647751|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110527330|NCT00647751|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110527331|NCT02536989|Omeprazole|omeprazole|mesh-list
110527332|NCT02536989|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110527333|NCT02536989|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110527334|NCT02536989|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110527335|NCT02536989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110527336|NCT02536989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110527337|NCT00647829|Valdecoxib|valdecoxib|mesh-list
110527338|NCT00647829|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110527339|NCT00647829|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110527340|NCT00647829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110527341|NCT00647829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110527342|NCT00647829|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110527343|NCT00647829|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110527344|NCT00647829|Analgesics|analgesics|mesh-ancestor
110527345|NCT00647829|Sensory System Agents|sensory system agents|mesh-ancestor
110527346|NCT00647829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110527376|NCT00647907|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110527377|NCT00647907|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110527378|NCT00647907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110527379|NCT00647907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110527380|NCT00647907|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110527381|NCT00647907|Hormone Antagonists|hormone antagonists|mesh-ancestor
110924809|NCT03098680|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110527382|NCT00647907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110527383|NCT00647907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110527384|NCT00647907|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110527386|NCT04017546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110527387|NCT04171791|Venetoclax|venetoclax|mesh-list
110527388|NCT04171791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110527389|NCT04003818|Teicoplanin|teicoplanin|mesh-list
110527394|NCT00949663|Incretins|incretins|mesh-ancestor
110527395|NCT00949663|Hormones|hormones|mesh-ancestor
110527396|NCT00949663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110527397|NCT00949663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110527398|NCT00647985|Fexofenadine|fexofenadine|mesh-list
110527399|NCT00647985|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110527400|NCT00647985|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110527401|NCT00647985|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110527402|NCT00647985|Histamine Antagonists|histamine antagonists|mesh-ancestor
110527403|NCT00647985|Histamine Agents|histamine agents|mesh-ancestor
110527404|NCT00647985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110527405|NCT00647985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110527406|NCT00647985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110527407|NCT02664051|Cromolyn Sodium|cromolyn sodium|mesh-list
110527408|NCT02664051|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
110527409|NCT02664051|Immunologic Factors|immunologic factors|mesh-ancestor
110527410|NCT02664051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110527411|NCT02664051|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110527412|NCT02664051|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110527413|NCT02664051|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110527414|NCT02664051|Respiratory System Agents|respiratory system agents|mesh-ancestor
110527415|NCT00648063|Letrozole|letrozole|mesh-list
110527416|NCT00648063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110527417|NCT00648063|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110527418|NCT00648063|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110527419|NCT00648063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110527420|NCT00648063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110527421|NCT00648063|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110527422|NCT00648063|Hormone Antagonists|hormone antagonists|mesh-ancestor
110527423|NCT00648063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110527424|NCT00648063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110527427|NCT00648141|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110527428|NCT00648141|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110174881|NCT00070252|Antimetabolites|antimetabolites|mesh-ancestor
110527430|NCT00648141|Sensory System Agents|sensory system agents|mesh-ancestor
110527431|NCT00648141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110527432|NCT00648141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110527433|NCT00648141|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110527434|NCT00648141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110527435|NCT00648141|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110527436|NCT00648141|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110527437|NCT00648141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110527438|NCT00648141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110527439|NCT00953641|Misoprostol|misoprostol|mesh-list
110527440|NCT00953641|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110527441|NCT00953641|Abortifacient Agents|abortifacient agents|mesh-ancestor
110527442|NCT00953641|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110527443|NCT00953641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110527444|NCT00953641|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110527445|NCT00953641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110527446|NCT00953641|Oxytocics|oxytocics|mesh-ancestor
110527447|NCT02763098|Remifentanil|remifentanil|mesh-list
110527448|NCT02763098|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110527449|NCT02763098|Narcotics|narcotics|mesh-ancestor
110527450|NCT02763098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110527451|NCT02763098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110527452|NCT02763098|Analgesics|analgesics|mesh-ancestor
110527453|NCT02763098|Sensory System Agents|sensory system agents|mesh-ancestor
110527454|NCT02763098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110527455|NCT00648219|Olmesartan|olmesartan|mesh-list
110527456|NCT00648219|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
110527457|NCT00648219|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110527458|NCT00648219|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110527459|NCT00648219|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110527484|NCT00648453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110527485|NCT00648453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110527486|NCT00648453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110527488|NCT00549445|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110527489|NCT00549445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110527490|NCT00637026|Gefitinib|gefitinib|mesh-list
110527491|NCT00637026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110527492|NCT00637026|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110527493|NCT00637026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110527494|NCT00637026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110527495|NCT00649155|Ciprofloxacin|ciprofloxacin|mesh-list
110527496|NCT00649155|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110527497|NCT00649155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110527498|NCT00649155|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110527499|NCT00649155|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110527500|NCT00649155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110174956|NCT00071188|Paclitaxel|paclitaxel|mesh-list
110527501|NCT00649155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110527502|NCT00649155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110924810|NCT03098680|Vasodilator Agents|vasodilator agents|mesh-ancestor
110527503|NCT00649155|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110527504|NCT00649155|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110527505|NCT02758340|Misoprostol|misoprostol|mesh-list
110918408|NCT01061775|Incretins|incretins|mesh-ancestor
110527506|NCT02758340|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110527514|NCT02768168|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110527515|NCT02768168|Narcotics|narcotics|mesh-ancestor
110527516|NCT02768168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110527517|NCT02768168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110527518|NCT02768168|Analgesics|analgesics|mesh-ancestor
110527519|NCT02768168|Sensory System Agents|sensory system agents|mesh-ancestor
110527520|NCT02768168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110527521|NCT03739554|Venetoclax|venetoclax|mesh-list
110527522|NCT03739554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110527523|NCT02659683|Esomeprazole|esomeprazole|mesh-list
110527524|NCT02659683|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110527525|NCT02659683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110527526|NCT02659683|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110527527|NCT02659683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110527528|NCT02659683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110527535|NCT02659761|Lamivudine|lamivudine|mesh-list
110527536|NCT02659761|Abacavir|abacavir|mesh-list
110527537|NCT02659761|Dolutegravir|dolutegravir|mesh-list
110527538|NCT02659761|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110527539|NCT02659761|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110527540|NCT02659761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110527541|NCT02659761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110527542|NCT02659761|Antiviral Agents|antiviral agents|mesh-ancestor
110527543|NCT02659761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110527544|NCT02659761|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110527545|NCT02659761|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110527546|NCT02659761|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110527547|NCT02659761|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110527548|NCT05343546|Copper|copper|mesh-list
110527549|NCT05343546|Levonorgestrel|levonorgestrel|mesh-list
110527550|NCT05343546|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110527551|NCT05343546|Contraceptive Agents|contraceptive agents|mesh-ancestor
110527552|NCT05343546|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110527553|NCT05343546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110527554|NCT05343546|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110193659|NCT00037115|Interferon-beta|interferon-beta|mesh-list
110527555|NCT05343546|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110527556|NCT05343546|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110527557|NCT05343546|Trace Elements|trace elements|mesh-ancestor
110527558|NCT05343546|Micronutrients|micronutrients|mesh-ancestor
110527559|NCT02659917|Methamphetamine|methamphetamine|mesh-list
110527560|NCT02659917|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110527561|NCT02659917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110527562|NCT02659917|Sympathomimetics|sympathomimetics|mesh-ancestor
110527563|NCT02659917|Autonomic Agents|autonomic agents|mesh-ancestor
110312216|NCT00292838|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110527564|NCT02659917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110527565|NCT02659917|Dopamine Agents|dopamine agents|mesh-ancestor
110527566|NCT02659917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110527567|NCT02659917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110527568|NCT02659917|Adrenergic Agents|adrenergic agents|mesh-ancestor
110527569|NCT02659917|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110527570|NCT02659917|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110527571|NCT02659917|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110527572|NCT02659917|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110527573|NCT00954265|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
110527574|NCT00954265|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110527575|NCT00954265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110527576|NCT04500236|Anesthetics|anesthetics|mesh-list
110527577|NCT04500236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110527578|NCT04500236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110527579|NCT02658825|Moxifloxacin|moxifloxacin|mesh-list
110527580|NCT02658825|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
110527596|NCT00649233|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110527597|NCT00649233|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110527598|NCT00649233|Diuretics|diuretics|mesh-ancestor
110527599|NCT00649233|Natriuretic Agents|natriuretic agents|mesh-ancestor
110527600|NCT00649233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110527601|NCT00649233|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110527602|NCT00649233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110527603|NCT00649233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110527604|NCT00649233|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110527605|NCT00649233|Sympatholytics|sympatholytics|mesh-ancestor
110527606|NCT00649233|Autonomic Agents|autonomic agents|mesh-ancestor
110527607|NCT00649233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110527608|NCT00649233|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110527609|NCT00649233|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110527610|NCT00649233|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110527611|NCT00649233|Adrenergic Agents|adrenergic agents|mesh-ancestor
110527612|NCT00649233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110527613|NCT00954811|Progesterone|progesterone|mesh-list
110527614|NCT00954811|Progestins|progestins|mesh-ancestor
110527615|NCT00954811|Hormones|hormones|mesh-ancestor
110527616|NCT00954811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110527617|NCT00954811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110527618|NCT00954889|Tamsulosin|tamsulosin|mesh-list
110527619|NCT00954889|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110527620|NCT00954889|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110527621|NCT00954889|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110527622|NCT00954889|Adrenergic Agents|adrenergic agents|mesh-ancestor
110527623|NCT00954889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110527624|NCT00954889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110527625|NCT00954889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110527626|NCT00954889|Urological Agents|urological agents|mesh-ancestor
110527627|NCT03666000|Cyclophosphamide|cyclophosphamide|mesh-list
110527628|NCT03666000|Fludarabine|fludarabine|mesh-list
110527629|NCT03666000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110527630|NCT03666000|Immunologic Factors|immunologic factors|mesh-ancestor
110527631|NCT03666000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110527632|NCT03666000|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110527633|NCT03666000|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110527634|NCT03666000|Alkylating Agents|alkylating agents|mesh-ancestor
110527635|NCT03666000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110527636|NCT03666000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110527637|NCT03666000|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110527638|NCT02692248|Dexamethasone|dexamethasone|mesh-list
110527639|NCT02692248|Rituximab|rituximab|mesh-list
110180526|NCT00274989|Rituximab|rituximab|mesh-list
110527651|NCT02692248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110527652|NCT02692248|Glucocorticoids|glucocorticoids|mesh-ancestor
110527653|NCT02692248|Hormones|hormones|mesh-ancestor
110527654|NCT02692248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110527655|NCT02692248|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110527656|NCT02692248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110527657|NCT02692248|Antimetabolites|antimetabolites|mesh-ancestor
110527658|NCT02692248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110527659|NCT02851290|Anesthetics|anesthetics|mesh-list
110527660|NCT02851290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110527661|NCT02851290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110527662|NCT02757404|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110527663|NCT02757404|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110527664|NCT02757404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110527665|NCT02757404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110527666|NCT02757404|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110527667|NCT02757404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110527668|NCT02757404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110527669|NCT02757404|Cholinergic Agents|cholinergic agents|mesh-ancestor
110527670|NCT02757404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110527672|NCT00955045|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
110527673|NCT00955045|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110527674|NCT00955045|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110527675|NCT00955045|Purinergic Agents|purinergic agents|mesh-ancestor
110527676|NCT00955045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110527677|NCT00955045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110527678|NCT00955045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110527679|NCT00601107|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
110527680|NCT00601107|Vitamins|vitamins|mesh-ancestor
110527681|NCT00601107|Micronutrients|micronutrients|mesh-ancestor
110527682|NCT00601107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110527683|NCT00601107|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110527684|NCT00957385|Lenalidomide|lenalidomide|mesh-list
110527685|NCT00957385|Immunologic Factors|immunologic factors|mesh-ancestor
110527686|NCT00957385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110527687|NCT00957385|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110527688|NCT00957385|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110527689|NCT00957385|Growth Substances|growth substances|mesh-ancestor
110527690|NCT00957385|Growth Inhibitors|growth inhibitors|mesh-ancestor
110527691|NCT00957385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110527692|NCT04169841|Durvalumab|durvalumab|mesh-list
110527693|NCT04169841|Olaparib|olaparib|mesh-list
110527694|NCT04169841|Tremelimumab|tremelimumab|mesh-list
110527695|NCT04169841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110527696|NCT04169841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110527697|NCT04169841|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110527698|NCT04169841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110527699|NCT04169841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110527700|NCT02462538|Imatinib Mesylate|imatinib mesylate|mesh-list
110527701|NCT02462538|Brentuximab Vedotin|brentuximab vedotin|mesh-list
110527702|NCT02462538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110527715|NCT02752646|Analgesics|analgesics|mesh-ancestor
110527716|NCT02752646|Sensory System Agents|sensory system agents|mesh-ancestor
110527717|NCT02752646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110527718|NCT02752646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110527719|NCT02752646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110527720|NCT02752646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110527721|NCT02752646|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110527722|NCT02752646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110527723|NCT02752646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110527724|NCT04169919|Povidone-Iodine|povidone-iodine|mesh-list
110527725|NCT04169919|Povidone|povidone|mesh-list
110527726|NCT04169919|Plasma Substitutes|plasma substitutes|mesh-ancestor
110527727|NCT04169919|Blood Substitutes|blood substitutes|mesh-ancestor
110527728|NCT04169919|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110527729|NCT04169919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110527730|NCT02757248|Romidepsin|romidepsin|mesh-list
110527731|NCT02757248|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110527732|NCT02757248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110527733|NCT02757248|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110527734|NCT02757248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110527735|NCT02757248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110527736|NCT00649311|Losartan|losartan|mesh-list
110527737|NCT00649311|Eplerenone|eplerenone|mesh-list
110527738|NCT00649311|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110527739|NCT00649311|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110527740|NCT00649311|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110527741|NCT00649311|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110527742|NCT00649311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110527743|NCT00649311|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110527744|NCT00649311|Hormone Antagonists|hormone antagonists|mesh-ancestor
110527745|NCT00649311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110527746|NCT00649311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110527747|NCT00649311|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110527748|NCT00649311|Diuretics|diuretics|mesh-ancestor
110527749|NCT00649311|Natriuretic Agents|natriuretic agents|mesh-ancestor
110527750|NCT02704494|Losartan|losartan|mesh-list
110527751|NCT02704494|Resveratrol|resveratrol|mesh-list
110527752|NCT02704494|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110527753|NCT02704494|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110527754|NCT02704494|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110527755|NCT02704494|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110527756|NCT02704494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110527757|NCT02704494|Antioxidants|antioxidants|mesh-ancestor
110527758|NCT02704494|Protective Agents|protective agents|mesh-ancestor
110527759|NCT02704494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110527760|NCT02704494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110527761|NCT02704494|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110527762|NCT00649467|Topiramate|topiramate|mesh-list
110527763|NCT00649467|Anticonvulsants|anticonvulsants|mesh-ancestor
110527764|NCT00649467|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110527765|NCT00649467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110527766|NCT00649545|Adalimumab|adalimumab|mesh-list
110527777|NCT02658435|Antimalarials|antimalarials|mesh-ancestor
110527778|NCT02658435|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110527779|NCT02658435|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110527780|NCT02658435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110527781|NCT02756546|Hydroxychloroquine|hydroxychloroquine|mesh-list
110527782|NCT02756546|Hydrocortisone|hydrocortisone|mesh-list
110527783|NCT02756546|Cyclophosphamide|cyclophosphamide|mesh-list
110527784|NCT02756546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110527785|NCT02756546|Immunologic Factors|immunologic factors|mesh-ancestor
110527786|NCT02756546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110527787|NCT02756546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110527788|NCT02756546|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110527789|NCT02756546|Alkylating Agents|alkylating agents|mesh-ancestor
110527790|NCT02756546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110527791|NCT02756546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110527792|NCT02756546|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110527793|NCT02756546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110527794|NCT02756546|Antimalarials|antimalarials|mesh-ancestor
110527795|NCT02756546|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110527796|NCT02756546|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110527797|NCT02756546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110527798|NCT02756546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110527799|NCT02759666|Fluzoparib|fluzoparib|mesh-list
110527800|NCT02759666|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110527801|NCT02759666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110527802|NCT02759666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110527803|NCT02759666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110527804|NCT02752724|Ketamine|ketamine|mesh-list
110527805|NCT02752724|Methohexital|methohexital|mesh-list
110527806|NCT02752724|Analgesics|analgesics|mesh-ancestor
110527807|NCT02752724|Sensory System Agents|sensory system agents|mesh-ancestor
110527808|NCT02752724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110527809|NCT02752724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110527810|NCT02752724|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110527811|NCT02752724|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110527812|NCT02752724|Anesthetics, General|anesthetics, general|mesh-ancestor
110527813|NCT02752724|Anesthetics|anesthetics|mesh-ancestor
110918454|NCT02651116|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110527814|NCT02752724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110527815|NCT02752724|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110527816|NCT02752724|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110527817|NCT02752724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110527818|NCT02752724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110527819|NCT00649623|Olmesartan|olmesartan|mesh-list
110527820|NCT00649623|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
110527821|NCT00649623|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110527822|NCT00649623|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110527823|NCT00649623|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110527824|NCT00649623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110527825|NCT02756312|Anesthetics|anesthetics|mesh-list
110527826|NCT02756312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110527827|NCT02756312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110527828|NCT02657187|Rocuronium|rocuronium|mesh-list
110527829|NCT02657187|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110527830|NCT02657187|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110527831|NCT02657187|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110527838|NCT00649779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110527839|NCT00649779|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110527840|NCT00649779|Respiratory System Agents|respiratory system agents|mesh-ancestor
110527841|NCT00649779|Tocolytic Agents|tocolytic agents|mesh-ancestor
110527842|NCT00649779|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110527843|NCT00649779|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110527844|NCT00649779|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110527845|NCT00649779|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110527846|NCT00649779|Adrenergic Agents|adrenergic agents|mesh-ancestor
110527847|NCT00649779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110527848|NCT00649779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110527849|NCT00615186|Temozolomide|temozolomide|mesh-list
110527850|NCT00615186|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110527851|NCT00615186|Alkylating Agents|alkylating agents|mesh-ancestor
110527852|NCT00615186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110527853|NCT00615186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110312220|NCT00304668|Dapivirine|dapivirine|mesh-list
110527854|NCT00616044|Anesthetics|anesthetics|mesh-list
110527855|NCT00616044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110527856|NCT00616044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110527857|NCT02536911|Eliglustat|eliglustat|mesh-list
110527858|NCT02536911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110527859|NCT02536911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110527860|NCT04221152|Empagliflozin|empagliflozin|mesh-list
110527861|NCT04221152|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110527862|NCT04221152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110527863|NCT04221152|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110527864|NCT04221152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110527865|NCT02656563|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
110527866|NCT02656563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110527867|NCT02759510|Phenylephrine|phenylephrine|mesh-list
110527868|NCT02759510|Oxymetazoline|oxymetazoline|mesh-list
110527869|NCT02759510|Norepinephrine|norepinephrine|mesh-list
110175332|NCT04711291|Tacrolimus|tacrolimus|mesh-list
110527870|NCT02759510|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110527871|NCT02759510|Mydriatics|mydriatics|mesh-ancestor
110527872|NCT02759510|Autonomic Agents|autonomic agents|mesh-ancestor
110527873|NCT02759510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110527874|NCT02759510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110527875|NCT02759510|Sympathomimetics|sympathomimetics|mesh-ancestor
110527876|NCT02759510|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110527877|NCT02759510|Nasal Decongestants|nasal decongestants|mesh-ancestor
110527878|NCT02759510|Respiratory System Agents|respiratory system agents|mesh-ancestor
110527879|NCT02759510|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110527880|NCT02759510|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110527881|NCT02759510|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110527882|NCT02759510|Adrenergic Agents|adrenergic agents|mesh-ancestor
110527883|NCT02759510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110527884|NCT02759510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110527885|NCT02759510|Protective Agents|protective agents|mesh-ancestor
110527886|NCT04220528|Capecitabine|capecitabine|mesh-list
110527887|NCT04220528|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110527888|NCT04220528|Antimetabolites|antimetabolites|mesh-ancestor
110527889|NCT04220528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110527890|NCT04220528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110527891|NCT02759042|Leronlimab|leronlimab|mesh-list
110527892|NCT02759042|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110527893|NCT02759042|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110527894|NCT02759042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110527895|NCT02759042|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110527896|NCT02759042|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110527897|NCT02759042|Antiviral Agents|antiviral agents|mesh-ancestor
110527905|NCT02755532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110527907|NCT02755376|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110527908|NCT02755376|Immunologic Factors|immunologic factors|mesh-ancestor
110527909|NCT02755376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110527910|NCT02755376|Viscosupplements|viscosupplements|mesh-ancestor
110527911|NCT02755376|Protective Agents|protective agents|mesh-ancestor
110527912|NCT02752334|Magnesium Sulfate|magnesium sulfate|mesh-list
110527913|NCT02752334|Bupivacaine|bupivacaine|mesh-list
110527914|NCT02752334|Anesthetics, Local|anesthetics, local|mesh-ancestor
110527915|NCT02752334|Anesthetics|anesthetics|mesh-ancestor
110527916|NCT02752334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110527917|NCT02752334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110527918|NCT02752334|Sensory System Agents|sensory system agents|mesh-ancestor
110527919|NCT02752334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110527920|NCT02752334|Analgesics|analgesics|mesh-ancestor
110527921|NCT02752334|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110527922|NCT02752334|Anticonvulsants|anticonvulsants|mesh-ancestor
110527923|NCT02752334|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110527924|NCT02752334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110527925|NCT02752334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110527926|NCT02752334|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110527927|NCT02752334|Tocolytic Agents|tocolytic agents|mesh-ancestor
110527928|NCT02752334|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110527929|NCT02755298|Acetazolamide|acetazolamide|mesh-list
110527930|NCT02755298|Anticonvulsants|anticonvulsants|mesh-ancestor
110527931|NCT02755298|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110527932|NCT02755298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110527933|NCT02755298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110527934|NCT02755298|Diuretics|diuretics|mesh-ancestor
110527935|NCT02755298|Natriuretic Agents|natriuretic agents|mesh-ancestor
110527936|NCT02755298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110527937|NCT02755142|Aminolevulinic Acid|aminolevulinic acid|mesh-list
110527938|NCT02755142|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110527939|NCT02755142|Dermatologic Agents|dermatologic agents|mesh-ancestor
110527940|NCT02759198|Celecoxib|celecoxib|mesh-list
110527941|NCT02759198|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110527942|NCT02759198|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110175406|NCT00073879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110527943|NCT02759198|Analgesics|analgesics|mesh-ancestor
110527944|NCT02759198|Sensory System Agents|sensory system agents|mesh-ancestor
110527945|NCT02759198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110193774|NCT00064974|Lenalidomide|lenalidomide|mesh-list
110527946|NCT02759198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110527948|NCT02759198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110527949|NCT02759198|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110527950|NCT02759198|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110527951|NCT02759198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110527952|NCT02759198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110527953|NCT04220606|Nitroglycerin|nitroglycerin|mesh-list
110527954|NCT04220606|Vasodilator Agents|vasodilator agents|mesh-ancestor
110527955|NCT02755064|Erythromycin|erythromycin|mesh-list
110527956|NCT02755064|Erythromycin Estolate|erythromycin estolate|mesh-list
110527957|NCT02755064|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
110527958|NCT02755064|Erythromycin stearate|erythromycin stearate|mesh-list
110527959|NCT02755064|Erythromycin lactobionate|erythromycin lactobionate|mesh-list
110527960|NCT02755064|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110527961|NCT02755064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110527962|NCT02755064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110527963|NCT02755064|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110180572|NCT00274950|Carboplatin|carboplatin|mesh-list
110527972|NCT02752412|Lixisenatide|lixisenatide|mesh-list
110527973|NCT02752412|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110527974|NCT02752412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110527975|NCT02703090|Remifentanil|remifentanil|mesh-list
110527976|NCT02703090|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110527977|NCT02703090|Narcotics|narcotics|mesh-ancestor
110527978|NCT02703090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110527979|NCT02703090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110527980|NCT02703090|Analgesics|analgesics|mesh-ancestor
110527981|NCT02703090|Sensory System Agents|sensory system agents|mesh-ancestor
110527982|NCT02703090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110527983|NCT02754362|Bevacizumab|bevacizumab|mesh-list
110527984|NCT02754362|Poly ICLC|poly iclc|mesh-list
110527985|NCT02754362|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
110527986|NCT02754362|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
110527987|NCT02754362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110527988|NCT02754362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110527989|NCT02754362|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110527990|NCT02754362|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110527991|NCT02754362|Growth Substances|growth substances|mesh-ancestor
110527992|NCT02754362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110527993|NCT02754362|Growth Inhibitors|growth inhibitors|mesh-ancestor
110527994|NCT02754362|Interferon Inducers|interferon inducers|mesh-ancestor
110527995|NCT02754362|Immunologic Factors|immunologic factors|mesh-ancestor
110527996|NCT03373188|Nivolumab|nivolumab|mesh-list
110527997|NCT03373188|Ipilimumab|ipilimumab|mesh-list
110527998|NCT03373188|Antibodies|antibodies|mesh-list
110527999|NCT03373188|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110528000|NCT03373188|Immunologic Factors|immunologic factors|mesh-ancestor
110528001|NCT03373188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110528002|NCT03373188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110528003|NCT03373188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110528004|NCT03373188|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110528005|NCT03373188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110528007|NCT02698098|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110528008|NCT02698098|Narcotics|narcotics|mesh-ancestor
110528009|NCT02698098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110528010|NCT02698098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110528011|NCT02698098|Analgesics|analgesics|mesh-ancestor
110528012|NCT02698098|Sensory System Agents|sensory system agents|mesh-ancestor
110528013|NCT02698098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110528014|NCT02698098|Antitussive Agents|antitussive agents|mesh-ancestor
110528015|NCT02698098|Respiratory System Agents|respiratory system agents|mesh-ancestor
110528016|NCT04220996|Vortioxetine|vortioxetine|mesh-list
110528017|NCT04220996|Antidepressive Agents|antidepressive agents|mesh-ancestor
110918494|NCT03552432|Alirocumab|alirocumab|mesh-list
110175480|NCT00392691|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110528018|NCT04220996|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110528019|NCT04220996|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110528020|NCT04220996|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110528021|NCT04220996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110528022|NCT04220996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110528023|NCT04220996|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110528024|NCT04220996|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110528025|NCT04220996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110528026|NCT04220996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110528027|NCT04220996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110528028|NCT04220996|Serotonin Agents|serotonin agents|mesh-ancestor
110528029|NCT04220996|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110528030|NCT04220996|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110528031|NCT04220996|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110528039|NCT02702622|Micronutrients|micronutrients|mesh-ancestor
110528040|NCT02702622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110528041|NCT04214808|Dutasteride|dutasteride|mesh-list
110528042|NCT04214808|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
110528043|NCT04214808|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110528044|NCT04214808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110528045|NCT04214808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110528046|NCT04214808|Hormone Antagonists|hormone antagonists|mesh-ancestor
110528047|NCT04214808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110528048|NCT04214808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110528049|NCT02702778|Prednisone|prednisone|mesh-list
110528050|NCT02702778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110528051|NCT02702778|Glucocorticoids|glucocorticoids|mesh-ancestor
110528052|NCT02702778|Hormones|hormones|mesh-ancestor
110528053|NCT02702778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110528054|NCT02702778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110528055|NCT02702778|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110528056|NCT02702778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110528057|NCT02753738|Escitalopram|escitalopram|mesh-list
110528058|NCT02753738|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110528059|NCT02753738|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110528060|NCT02753738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110528061|NCT02753738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110528062|NCT02753738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110528063|NCT02753738|Serotonin Agents|serotonin agents|mesh-ancestor
110528064|NCT02753738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110528065|NCT02751632|Fluoxetine|fluoxetine|mesh-list
110528066|NCT02751632|Antidepressive Agents|antidepressive agents|mesh-list
110061527|NCT05781321|Temozolomide|temozolomide|mesh-list
110528067|NCT02751632|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110528068|NCT02751632|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110528069|NCT02751632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110528070|NCT02751632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110528071|NCT02751632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110918501|NCT03552432|Protease Inhibitors|protease inhibitors|mesh-ancestor
110528073|NCT02751632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110528074|NCT02751632|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110528075|NCT02751632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110528076|NCT02751632|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110528077|NCT02751632|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110528078|NCT02751632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110528079|NCT04805268|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110528080|NCT04805268|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110528081|NCT04805268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110528082|NCT02751476|Disinfectants|disinfectants|mesh-list
110528083|NCT02751476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110528085|NCT02705664|Bifonazole|bifonazole|mesh-list
110528086|NCT02705664|Antifungal Agents|antifungal agents|mesh-ancestor
110528087|NCT02705664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110528088|NCT02753426|Doxycycline|doxycycline|mesh-list
110528089|NCT02753426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110528090|NCT02753426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110528091|NCT02753426|Antimalarials|antimalarials|mesh-ancestor
110528092|NCT02753426|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110528093|NCT02753426|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110528094|NCT04219124|Dapagliflozin|dapagliflozin|mesh-list
110528095|NCT04219124|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
110528096|NCT04219124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110528097|NCT04219124|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110528098|NCT04219124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110528099|NCT02702076|Apomorphine|apomorphine|mesh-list
110528100|NCT02702076|Emetics|emetics|mesh-ancestor
110528102|NCT02702076|Autonomic Agents|autonomic agents|mesh-ancestor
110528103|NCT02702076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110528104|NCT02702076|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110528105|NCT02702076|Dopamine Agonists|dopamine agonists|mesh-ancestor
110528106|NCT02702076|Dopamine Agents|dopamine agents|mesh-ancestor
110528107|NCT02702076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110528108|NCT02702076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110528109|NCT02751398|Dapagliflozin|dapagliflozin|mesh-list
110528110|NCT02751398|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110528111|NCT02751398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110528112|NCT02751398|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110528113|NCT02751398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110528114|NCT02753114|Ketamine|ketamine|mesh-list
110528115|NCT02753114|Analgesics|analgesics|mesh-ancestor
110528116|NCT02753114|Sensory System Agents|sensory system agents|mesh-ancestor
110528117|NCT02753114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110528118|NCT02753114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110528119|NCT02753114|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110528120|NCT02753114|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110528121|NCT02753114|Anesthetics, General|anesthetics, general|mesh-ancestor
110528122|NCT02753114|Anesthetics|anesthetics|mesh-ancestor
110528123|NCT02753114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110528124|NCT02753114|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110528125|NCT02753114|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110528126|NCT02753114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110528127|NCT02753114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110528128|NCT05324748|Methylprednisolone|methylprednisolone|mesh-list
110528129|NCT05324748|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110528130|NCT05324748|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110528131|NCT05324748|Prednisolone|prednisolone|mesh-list
110528132|NCT05324748|Prednisolone acetate|prednisolone acetate|mesh-list
110528133|NCT05324748|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110528134|NCT05324748|Prednisolone phosphate|prednisolone phosphate|mesh-list
110528135|NCT05324748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110528136|NCT05324748|Antiemetics|antiemetics|mesh-ancestor
110528137|NCT05324748|Autonomic Agents|autonomic agents|mesh-ancestor
110528138|NCT05324748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110528139|NCT05324748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110528140|NCT05324748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110528141|NCT05324748|Glucocorticoids|glucocorticoids|mesh-ancestor
110528142|NCT05324748|Hormones|hormones|mesh-ancestor
110528143|NCT05324748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110528144|NCT05324748|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110528145|NCT05324748|Protective Agents|protective agents|mesh-ancestor
110528146|NCT05324748|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110528147|NCT05324748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110528149|NCT02705274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110528150|NCT02705274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110528151|NCT02705274|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110528152|NCT02705274|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110528153|NCT02705274|Growth Substances|growth substances|mesh-ancestor
110528154|NCT02705274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110528155|NCT02705274|Growth Inhibitors|growth inhibitors|mesh-ancestor
110528156|NCT00914849|Plerixafor|plerixafor|mesh-list
110528157|NCT00914849|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110528158|NCT00914849|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110528159|NCT00914849|Antiviral Agents|antiviral agents|mesh-ancestor
110528160|NCT00914849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110528161|NCT02704962|Olanzapine|olanzapine|mesh-list
110528162|NCT02704962|Antiemetics|antiemetics|mesh-ancestor
110528163|NCT02704962|Autonomic Agents|autonomic agents|mesh-ancestor
110528164|NCT02704962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110175645|NCT00075634|Antimetabolites|antimetabolites|mesh-ancestor
110528165|NCT02704962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110528166|NCT02704962|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110528167|NCT02704962|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110528168|NCT02704962|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110528169|NCT02704962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110528170|NCT02704962|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110528171|NCT02704962|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110528172|NCT02704962|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110528173|NCT02704962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110528191|NCT05429684|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
110528193|NCT05429684|Trastuzumab|trastuzumab|mesh-list
110528194|NCT05429684|Everolimus|everolimus|mesh-list
110528195|NCT05429684|Letrozole|letrozole|mesh-list
110528196|NCT05429684|Palbociclib|palbociclib|mesh-list
110528197|NCT05429684|Pertuzumab|pertuzumab|mesh-list
110528198|NCT05429684|Antibodies|antibodies|mesh-list
110528199|NCT05429684|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110528200|NCT05429684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110528201|NCT05429684|Tubulin Modulators|tubulin modulators|mesh-ancestor
110528202|NCT05429684|Antimitotic Agents|antimitotic agents|mesh-ancestor
110528203|NCT05429684|Mitosis Modulators|mitosis modulators|mesh-ancestor
110528204|NCT05429684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110528205|NCT05429684|Immunologic Factors|immunologic factors|mesh-ancestor
110528206|NCT05429684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110528207|NCT05429684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110528208|NCT05429684|Antimetabolites|antimetabolites|mesh-ancestor
110528209|NCT05429684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110528210|NCT05429684|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110528211|NCT05429684|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110528212|NCT05429684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110528213|NCT05429684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110528214|NCT05429684|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110528215|NCT05429684|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110528216|NCT05429684|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110528217|NCT05429684|Hormone Antagonists|hormone antagonists|mesh-ancestor
110528218|NCT05429684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110528219|NCT05429684|Immunotoxins|immunotoxins|mesh-ancestor
110528220|NCT05429684|Immunoconjugates|immunoconjugates|mesh-ancestor
110528221|NCT05324592|Aflibercept|aflibercept|mesh-list
110528222|NCT05324592|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110528223|NCT05324592|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110528224|NCT05324592|Growth Substances|growth substances|mesh-ancestor
110528225|NCT05324592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110528226|NCT05324592|Growth Inhibitors|growth inhibitors|mesh-ancestor
110528227|NCT05324592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110528228|NCT04433858|Psilocybin|psilocybin|mesh-list
110528229|NCT04433858|Hallucinogens|hallucinogens|mesh-ancestor
110528230|NCT04433858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110528231|NCT04433858|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110528245|NCT02750696|Respiratory System Agents|respiratory system agents|mesh-ancestor
110528247|NCT02695550|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110528248|NCT02695550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110528249|NCT02695550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110528250|NCT00912743|Olaparib|olaparib|mesh-list
110528251|NCT00912743|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110528252|NCT00912743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110528253|NCT00912743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110528254|NCT00912743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110528255|NCT04432610|Nebivolol|nebivolol|mesh-list
110528256|NCT04432610|Bisoprolol|bisoprolol|mesh-list
110528257|NCT04432610|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110528258|NCT04432610|Vasodilator Agents|vasodilator agents|mesh-ancestor
110528259|NCT04432610|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
110528260|NCT04432610|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110528261|NCT04432610|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110528262|NCT04432610|Adrenergic Agents|adrenergic agents|mesh-ancestor
110528263|NCT04432610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110528264|NCT04432610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110528265|NCT04432610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110528266|NCT04432610|Sympatholytics|sympatholytics|mesh-ancestor
110528267|NCT04432610|Autonomic Agents|autonomic agents|mesh-ancestor
110528268|NCT04432610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110528269|NCT04432610|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110528270|NCT04432610|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110528271|NCT04432610|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110528272|NCT04643093|Ezetimibe|ezetimibe|mesh-list
110528273|NCT04643093|Pitavastatin|pitavastatin|mesh-list
110528274|NCT04643093|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110528275|NCT04643093|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110528276|NCT04643093|Antimetabolites|antimetabolites|mesh-ancestor
110528277|NCT04643093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110528278|NCT04643093|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110528279|NCT04643093|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110528280|NCT04643093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110528281|NCT00914459|Factor VIII|factor viii|mesh-list
110528282|NCT00914459|Coagulants|coagulants|mesh-ancestor
110528283|NCT02701608|Levofloxacin|levofloxacin|mesh-list
110528284|NCT02701608|Rifampin|rifampin|mesh-list
110528285|NCT02701608|Fluoroquinolones|fluoroquinolones|mesh-list
110528286|NCT02701608|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110528287|NCT02701608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110528288|NCT02701608|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110528289|NCT02701608|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110528290|NCT02701608|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110528291|NCT02701608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110528292|NCT02701608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110528294|NCT02701608|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110528295|NCT02701608|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110528300|NCT02701608|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110528301|NCT02701608|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110528302|NCT02701608|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110193867|NCT00038168|Tubulin Modulators|tubulin modulators|mesh-ancestor
110528303|NCT02701608|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110528304|NCT02701608|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110528305|NCT02701608|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110918539|NCT02788656|Valsartan|valsartan|mesh-list
110528307|NCT00635960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110528308|NCT00635960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110528309|NCT05429294|Paclitaxel|paclitaxel|mesh-list
110528310|NCT05429294|Trastuzumab|trastuzumab|mesh-list
110528311|NCT05429294|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110528312|NCT05429294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110528313|NCT05429294|Tubulin Modulators|tubulin modulators|mesh-ancestor
110528314|NCT05429294|Antimitotic Agents|antimitotic agents|mesh-ancestor
110528315|NCT05429294|Mitosis Modulators|mitosis modulators|mesh-ancestor
110528316|NCT05429294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110528317|NCT05429294|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110528318|NCT04219046|Naloxegol|naloxegol|mesh-list
110528319|NCT04219046|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110528320|NCT04219046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110528321|NCT04219046|Sensory System Agents|sensory system agents|mesh-ancestor
110528322|NCT04219046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110528323|NCT00912509|Riboflavin|riboflavin|mesh-list
110528324|NCT00912509|Vitamin B Complex|vitamin b complex|mesh-ancestor
110528325|NCT00912509|Vitamins|vitamins|mesh-ancestor
110528326|NCT00912509|Micronutrients|micronutrients|mesh-ancestor
110528327|NCT00912509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110528328|NCT00912509|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110528329|NCT00912509|Dermatologic Agents|dermatologic agents|mesh-ancestor
110528330|NCT02873598|Paclitaxel|paclitaxel|mesh-list
110528331|NCT02873598|Gemcitabine|gemcitabine|mesh-list
110528332|NCT02873598|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110528333|NCT02873598|Folfirinox|folfirinox|mesh-list
110528334|NCT02873598|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110528335|NCT02873598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110528336|NCT02873598|Tubulin Modulators|tubulin modulators|mesh-ancestor
110528337|NCT02873598|Antimitotic Agents|antimitotic agents|mesh-ancestor
110528338|NCT02873598|Mitosis Modulators|mitosis modulators|mesh-ancestor
110528339|NCT02873598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110528340|NCT02873598|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110528341|NCT02873598|Antimetabolites|antimetabolites|mesh-ancestor
110528342|NCT02749994|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110528343|NCT02749994|Ezetimibe|ezetimibe|mesh-list
110528344|NCT02749994|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110528345|NCT02749994|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110528346|NCT02749994|Antimetabolites|antimetabolites|mesh-ancestor
110528347|NCT02749994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110528348|NCT02749994|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110528349|NCT02749994|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110528350|NCT02749994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110528351|NCT04417049|Pentoxifylline|pentoxifylline|mesh-list
110528352|NCT04417049|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110528353|NCT04417049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110528354|NCT04417049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110528355|NCT04417049|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110528356|NCT04417049|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110528357|NCT04417049|Protective Agents|protective agents|mesh-ancestor
110528358|NCT04417049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110528359|NCT04417049|Vasodilator Agents|vasodilator agents|mesh-ancestor
110528360|NCT04417049|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110528361|NCT04417049|Antioxidants|antioxidants|mesh-ancestor
110528362|NCT02862210|Lithium Carbonate|lithium carbonate|mesh-list
110528363|NCT02862210|Antidepressive Agents|antidepressive agents|mesh-ancestor
110528364|NCT02862210|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110528373|NCT05323422|Sensory System Agents|sensory system agents|mesh-ancestor
110528374|NCT05323422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110528375|NCT05323422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110528376|NCT05323422|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110528377|NCT05323422|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110528378|NCT05323422|Anesthetics, General|anesthetics, general|mesh-ancestor
110528379|NCT05323422|Anesthetics|anesthetics|mesh-ancestor
110918553|NCT05258110|Midazolam|midazolam|mesh-list
110528380|NCT05323422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110528381|NCT05323422|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110528382|NCT05323422|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110528383|NCT05323422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110528384|NCT05323422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110528386|NCT02700906|Anesthetics, Local|anesthetics, local|mesh-ancestor
110528387|NCT02700906|Anesthetics|anesthetics|mesh-ancestor
110528388|NCT02700906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110528389|NCT02700906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110528390|NCT02700906|Sensory System Agents|sensory system agents|mesh-ancestor
110528391|NCT02700906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110528392|NCT02700906|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110528393|NCT02700906|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110528394|NCT02700906|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110528395|NCT02700906|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110528396|NCT02700906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110528397|NCT00636038|Beta Carotene|beta carotene|mesh-list
110528398|NCT00636038|Carotenoids|carotenoids|mesh-list
110528399|NCT00636038|Antioxidants|antioxidants|mesh-ancestor
110528400|NCT00636038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110528401|NCT00636038|Protective Agents|protective agents|mesh-ancestor
110528402|NCT00636038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110528403|NCT00636038|Provitamins|provitamins|mesh-ancestor
110528404|NCT00636038|Vitamins|vitamins|mesh-ancestor
110528405|NCT00636038|Micronutrients|micronutrients|mesh-ancestor
110528406|NCT04213716|Calcium, Dietary|calcium, dietary|mesh-list
110528407|NCT04213716|Calcium|calcium|mesh-list
110528408|NCT04213716|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110528409|NCT04213716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110528410|NCT04213716|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110528411|NCT04218890|Lipoprotein-associated coagulation inhibitor|lipoprotein-associated coagulation inhibitor|mesh-list
110528412|NCT04218890|Thromboplastin|thromboplastin|mesh-list
110528413|NCT04218890|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110528414|NCT04218890|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110528415|NCT04218890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110528416|NCT04218890|Hemostatics|hemostatics|mesh-ancestor
110528417|NCT04218890|Coagulants|coagulants|mesh-ancestor
110528418|NCT04218890|Anticoagulants|anticoagulants|mesh-ancestor
110528419|NCT04218890|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110528420|NCT04218890|Protease Inhibitors|protease inhibitors|mesh-ancestor
110528421|NCT04218890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110528422|NCT04218890|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110528423|NCT04218890|Antithrombins|antithrombins|mesh-ancestor
110528424|NCT00636116|Antivenins|antivenins|mesh-list
110528425|NCT00636116|Immunologic Factors|immunologic factors|mesh-ancestor
110528426|NCT00636116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110528427|NCT04772196|Vitamin D|vitamin d|mesh-list
110528428|NCT04772196|Cholecalciferol|cholecalciferol|mesh-list
110528429|NCT04772196|Vitamins|vitamins|mesh-ancestor
110528430|NCT04772196|Micronutrients|micronutrients|mesh-ancestor
110528431|NCT04772196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110528442|NCT05428670|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110528443|NCT05428670|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110528444|NCT05428670|Growth Substances|growth substances|mesh-ancestor
110528445|NCT05428670|Growth Inhibitors|growth inhibitors|mesh-ancestor
110528446|NCT05428670|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110528447|NCT05428670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110528448|NCT05428670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110528450|NCT00635726|Gemcitabine|gemcitabine|mesh-list
110528451|NCT00635726|Doxorubicin|doxorubicin|mesh-list
110528452|NCT00635726|Methotrexate|methotrexate|mesh-list
110528453|NCT00635726|Vinblastine|vinblastine|mesh-list
110528454|NCT00635726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110528455|NCT00635726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110528456|NCT00635726|Antimetabolites|antimetabolites|mesh-ancestor
110528457|NCT00635726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110528458|NCT00635726|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110528459|NCT00635726|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110528460|NCT00635726|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110528461|NCT00635726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110528462|NCT00635726|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110528463|NCT00635726|Abortifacient Agents|abortifacient agents|mesh-ancestor
110528464|NCT00635726|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110528465|NCT00635726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110528466|NCT00635726|Dermatologic Agents|dermatologic agents|mesh-ancestor
110528467|NCT00635726|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110528468|NCT00635726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110528469|NCT00635726|Immunologic Factors|immunologic factors|mesh-ancestor
110528470|NCT00635726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110528471|NCT00635726|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110528472|NCT00635726|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110528473|NCT00635726|Tubulin Modulators|tubulin modulators|mesh-ancestor
110528474|NCT00635726|Antimitotic Agents|antimitotic agents|mesh-ancestor
110528475|NCT00635726|Mitosis Modulators|mitosis modulators|mesh-ancestor
110528476|NCT04219982|Scopolamine|scopolamine|mesh-list
110528477|NCT04219982|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
110528478|NCT04219982|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110528479|NCT04219982|Antiemetics|antiemetics|mesh-ancestor
110528480|NCT04219982|Autonomic Agents|autonomic agents|mesh-ancestor
110528481|NCT04219982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110528482|NCT04219982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110528483|NCT04219982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110528484|NCT04219982|Mydriatics|mydriatics|mesh-ancestor
110528485|NCT04219982|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110528486|NCT04219982|Cholinergic Agents|cholinergic agents|mesh-ancestor
110528487|NCT04219982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110528488|NCT04219982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110528489|NCT04219982|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110528490|NCT04219982|Parasympatholytics|parasympatholytics|mesh-ancestor
110528491|NCT02700438|Nitroglycerin|nitroglycerin|mesh-list
110528492|NCT02700438|Vasodilator Agents|vasodilator agents|mesh-ancestor
110528493|NCT04216706|Calcium Channel Blockers|calcium channel blockers|mesh-list
110528494|NCT04216706|Sympatholytics|sympatholytics|mesh-list
110528495|NCT04216706|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110528496|NCT04216706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110528497|NCT04216706|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110180644|NCT00016133|Leucovorin|leucovorin|mesh-list
110312229|NCT00293072|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110528509|NCT00913835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110528510|NCT05322720|Paclitaxel|paclitaxel|mesh-list
110528511|NCT05322720|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110528512|NCT05322720|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110528513|NCT05322720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110528514|NCT05322720|Tubulin Modulators|tubulin modulators|mesh-ancestor
110528515|NCT05322720|Antimitotic Agents|antimitotic agents|mesh-ancestor
110528516|NCT05322720|Mitosis Modulators|mitosis modulators|mesh-ancestor
110528517|NCT05322720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110528518|NCT04213170|Bevacizumab|bevacizumab|mesh-list
110918578|NCT02117466|Cetuximab|cetuximab|mesh-list
110528519|NCT04213170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110528520|NCT04213170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110528521|NCT04213170|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110528522|NCT04213170|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110528523|NCT04213170|Growth Substances|growth substances|mesh-ancestor
110528524|NCT04213170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110528525|NCT04213170|Growth Inhibitors|growth inhibitors|mesh-ancestor
110528526|NCT05322564|Opiate Alkaloids|opiate alkaloids|mesh-list
110528527|NCT05322564|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110528528|NCT05322564|Narcotics|narcotics|mesh-ancestor
110528529|NCT05322564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110528530|NCT05322564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110528531|NCT05322564|Analgesics|analgesics|mesh-ancestor
110528532|NCT05322564|Sensory System Agents|sensory system agents|mesh-ancestor
110528533|NCT05322564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110528534|NCT02749136|Gemcitabine|gemcitabine|mesh-list
110528535|NCT02749136|Folfirinox|folfirinox|mesh-list
110528536|NCT02749136|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110528537|NCT02749136|Antimetabolites|antimetabolites|mesh-ancestor
110528538|NCT02749136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110528539|NCT02749136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110528540|NCT00631631|Mifamurtide|mifamurtide|mesh-list
110528541|NCT00631631|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110528542|NCT00631631|Immunologic Factors|immunologic factors|mesh-ancestor
110528543|NCT00631631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110528544|NCT04238741|Anesthetics|anesthetics|mesh-list
110528545|NCT04238741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110528546|NCT04238741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110528547|NCT02691858|Hydrocortisone|hydrocortisone|mesh-list
110528548|NCT02691858|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
110528549|NCT02691858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110528550|NCT04218500|Niacinamide|niacinamide|mesh-list
110528551|NCT04218500|Niacin|niacin|mesh-list
110528552|NCT04218500|Nicotinic Acids|nicotinic acids|mesh-list
110528553|NCT04218500|Vitamin B Complex|vitamin b complex|mesh-ancestor
110528554|NCT04218500|Vitamins|vitamins|mesh-ancestor
110528555|NCT04218500|Micronutrients|micronutrients|mesh-ancestor
110528556|NCT04218500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110528557|NCT04218500|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110528558|NCT04218500|Antimetabolites|antimetabolites|mesh-ancestor
110528559|NCT04218500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110528560|NCT04218500|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110528561|NCT04218500|Vasodilator Agents|vasodilator agents|mesh-ancestor
110528574|NCT04217096|Antimitotic Agents|antimitotic agents|mesh-ancestor
110528575|NCT04217096|Mitosis Modulators|mitosis modulators|mesh-ancestor
110528576|NCT04217096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110528577|NCT05411978|Ubiquinone|ubiquinone|mesh-list
110528578|NCT05411978|Idebenone|idebenone|mesh-list
110528579|NCT05411978|Antioxidants|antioxidants|mesh-ancestor
110528580|NCT05411978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110528581|NCT05411978|Protective Agents|protective agents|mesh-ancestor
110528582|NCT05411978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110528583|NCT05411978|Micronutrients|micronutrients|mesh-ancestor
110528585|NCT00617370|Cyclophosphamide|cyclophosphamide|mesh-list
110528586|NCT00617370|Epirubicin|epirubicin|mesh-list
110528587|NCT00617370|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110528588|NCT00617370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110528589|NCT00617370|Tubulin Modulators|tubulin modulators|mesh-ancestor
110528590|NCT00617370|Antimitotic Agents|antimitotic agents|mesh-ancestor
110528591|NCT00617370|Mitosis Modulators|mitosis modulators|mesh-ancestor
110528592|NCT00617370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110528593|NCT00617370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110528594|NCT00617370|Immunologic Factors|immunologic factors|mesh-ancestor
110528595|NCT00617370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110528596|NCT00617370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110528597|NCT00617370|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110528598|NCT00617370|Alkylating Agents|alkylating agents|mesh-ancestor
110528599|NCT00617370|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110528600|NCT00617370|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110528601|NCT00617370|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110528602|NCT00617370|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110528603|NCT00617370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110528604|NCT02699658|Levofloxacin|levofloxacin|mesh-list
110528605|NCT02699658|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110528606|NCT02699658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110528607|NCT02699658|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110528608|NCT02699658|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110528609|NCT02699658|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110528610|NCT02699658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110528611|NCT02699658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110528612|NCT02699658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110528613|NCT02699658|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110528614|NCT02699658|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110528615|NCT04218734|Metformin|metformin|mesh-list
110528616|NCT04218734|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110176127|NCT00079261|Prednisone|prednisone|mesh-list
110528617|NCT04218734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110528618|NCT04066478|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
110528619|NCT04066478|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110528620|NCT04066478|Immunologic Factors|immunologic factors|mesh-ancestor
110528621|NCT04066478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110528622|NCT04496063|Ustekinumab|ustekinumab|mesh-list
110528623|NCT04496063|Dermatologic Agents|dermatologic agents|mesh-ancestor
110528624|NCT04032626|Lenalidomide|lenalidomide|mesh-list
110528638|NCT02747732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110528639|NCT02747732|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110528641|NCT02747732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110528642|NCT02695862|Terlipressin|terlipressin|mesh-list
110528643|NCT02695862|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110528644|NCT02695862|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110528645|NCT00617448|Anesthetics|anesthetics|mesh-list
110528646|NCT00617448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110528647|NCT00617448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110528648|NCT04308863|Chitosan|chitosan|mesh-list
110528649|NCT04308863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110528650|NCT04308863|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110528651|NCT04308863|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110528652|NCT04308863|Antimetabolites|antimetabolites|mesh-ancestor
110528653|NCT04308863|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110528654|NCT04308863|Chelating Agents|chelating agents|mesh-ancestor
110528655|NCT04308863|Sequestering Agents|sequestering agents|mesh-ancestor
110528656|NCT04308863|Hemostatics|hemostatics|mesh-ancestor
110528657|NCT04308863|Coagulants|coagulants|mesh-ancestor
110528659|NCT00615810|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110528660|NCT00615810|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110528661|NCT00615810|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110528662|NCT00615810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110528663|NCT00615810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110528664|NCT00615810|Antiviral Agents|antiviral agents|mesh-ancestor
110528665|NCT00615810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110528666|NCT00615810|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110528667|NCT00615810|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110528668|NCT00615810|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110528669|NCT00615810|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110528670|NCT00615810|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110528671|NCT00615810|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110528672|NCT00615810|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110528673|NCT00615810|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110528674|NCT03355157|Tamoxifen|tamoxifen|mesh-list
110528675|NCT03355157|Paclitaxel|paclitaxel|mesh-list
110528676|NCT03355157|Vinorelbine|vinorelbine|mesh-list
110528677|NCT03355157|Capecitabine|capecitabine|mesh-list
110528678|NCT03355157|Letrozole|letrozole|mesh-list
110528679|NCT03355157|Epirubicin|epirubicin|mesh-list
110528680|NCT03355157|Fulvestrant|fulvestrant|mesh-list
110528681|NCT03355157|Palbociclib|palbociclib|mesh-list
110528682|NCT03355157|Exemestane|exemestane|mesh-list
110528683|NCT03355157|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110528684|NCT03355157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110528685|NCT03355157|Tubulin Modulators|tubulin modulators|mesh-ancestor
110528686|NCT03355157|Antimitotic Agents|antimitotic agents|mesh-ancestor
110528687|NCT03355157|Mitosis Modulators|mitosis modulators|mesh-ancestor
110534646|NCT02674308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110528705|NCT03355157|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110528706|NCT03355157|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110528708|NCT04215432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110528709|NCT02747342|Fluzoparib|fluzoparib|mesh-list
110528710|NCT02747342|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110528711|NCT02747342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110528712|NCT02747342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110528713|NCT02747342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110528714|NCT03324035|Tramadol|tramadol|mesh-list
110528715|NCT03324035|Amitriptyline|amitriptyline|mesh-list
110528716|NCT03324035|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110528717|NCT03324035|Narcotics|narcotics|mesh-ancestor
110528718|NCT03324035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110528719|NCT03324035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110528720|NCT03324035|Analgesics|analgesics|mesh-ancestor
110528721|NCT03324035|Sensory System Agents|sensory system agents|mesh-ancestor
110528722|NCT03324035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110528723|NCT03324035|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110528724|NCT03324035|Antidepressive Agents|antidepressive agents|mesh-ancestor
110528725|NCT03324035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110528726|NCT03324035|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110528727|NCT03324035|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110528728|NCT03324035|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110528729|NCT03324035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110528730|NCT03324035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110528731|NCT03324035|Adrenergic Agents|adrenergic agents|mesh-ancestor
110528732|NCT03324035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110528734|NCT00616746|Nicotine|nicotine|mesh-list
110528735|NCT00616746|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110528736|NCT00616746|Autonomic Agents|autonomic agents|mesh-ancestor
110528737|NCT00616746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110528738|NCT00616746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110528739|NCT00616746|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110528740|NCT00616746|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110528741|NCT00616746|Cholinergic Agents|cholinergic agents|mesh-ancestor
110180684|NCT00394368|Autonomic Agents|autonomic agents|mesh-ancestor
110528767|NCT04203485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110528768|NCT04203485|Tubulin Modulators|tubulin modulators|mesh-ancestor
110528769|NCT04203485|Antimitotic Agents|antimitotic agents|mesh-ancestor
110528770|NCT04203485|Mitosis Modulators|mitosis modulators|mesh-ancestor
110528771|NCT04203485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110528772|NCT04203485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110528773|NCT04203485|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110528774|NCT04203485|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110528775|NCT04203485|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110528777|NCT03851627|Testosterone|testosterone|mesh-list
110528778|NCT03851627|Testosterone undecanoate|testosterone undecanoate|mesh-list
110528779|NCT03851627|Testosterone enanthate|testosterone enanthate|mesh-list
110528780|NCT03851627|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
110528781|NCT03851627|Androgens|androgens|mesh-ancestor
110528783|NCT03851627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110528784|NCT03851627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110528785|NCT03851627|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110528786|NCT03851627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110528787|NCT03851627|Anabolic Agents|anabolic agents|mesh-ancestor
110528788|NCT03116126|Guanfacine|guanfacine|mesh-list
110528789|NCT03116126|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110528790|NCT03116126|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110528791|NCT03116126|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110528795|NCT03116126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110528796|NCT03116126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110528797|NCT02983682|Lidocaine|lidocaine|mesh-list
110528798|NCT02983682|Anesthetics, Local|anesthetics, local|mesh-ancestor
110528799|NCT02983682|Anesthetics|anesthetics|mesh-ancestor
110528800|NCT02983682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110528801|NCT02983682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110528802|NCT02983682|Sensory System Agents|sensory system agents|mesh-ancestor
110528803|NCT02983682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110528804|NCT02983682|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110528805|NCT02983682|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110528806|NCT02983682|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110528807|NCT02983682|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110528808|NCT02983682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110528809|NCT00910247|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
110528810|NCT00910247|Anticonvulsants|anticonvulsants|mesh-ancestor
110528811|NCT00910247|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110528812|NCT00910247|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110528813|NCT00910247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110528814|NCT00910247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110528815|NCT04217798|Etoposide|etoposide|mesh-list
110528816|NCT04217798|Niraparib|niraparib|mesh-list
110528817|NCT04217798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110528818|NCT04217798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110528819|NCT04217798|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110528820|NCT04217798|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110528821|NCT04217798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110528822|NCT04217798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110528823|NCT04217798|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110528824|NCT02742038|Fluorides|fluorides|mesh-list
110528825|NCT02742038|Fluorides, Topical|fluorides, topical|mesh-list
110528826|NCT02742038|Cariostatic Agents|cariostatic agents|mesh-ancestor
110528827|NCT02742038|Protective Agents|protective agents|mesh-ancestor
110528828|NCT02742038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110528829|NCT02022098|Cisplatin|cisplatin|mesh-list
110528830|NCT02022098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110528831|NCT02746250|Amitriptyline|amitriptyline|mesh-list
110528832|NCT02746250|Antidepressive Agents|antidepressive agents|mesh-list
110528833|NCT02746250|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-list
110194044|NCT00396734|Topiramate|topiramate|mesh-list
110528834|NCT02746250|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110528835|NCT02746250|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110528836|NCT02746250|Analgesics|analgesics|mesh-ancestor
110528837|NCT02746250|Sensory System Agents|sensory system agents|mesh-ancestor
110528838|NCT02746250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110528839|NCT02746250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110918633|NCT05284656|Folic Acid|folic acid|mesh-list
110528840|NCT02746250|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110528841|NCT02746250|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110528842|NCT02746250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110528843|NCT02746250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110528845|NCT02746250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110528846|NCT02741960|Metformin|metformin|mesh-list
110528847|NCT02741960|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110528848|NCT02741960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110528849|NCT00910091|Megestrol|megestrol|mesh-list
110528850|NCT00910091|Megestrol Acetate|megestrol acetate|mesh-list
110528851|NCT00910091|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110528852|NCT00910091|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110528853|NCT00910091|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110528854|NCT00910091|Contraceptive Agents|contraceptive agents|mesh-ancestor
110528855|NCT00910091|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110528856|NCT00910091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110528857|NCT00910091|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110528858|NCT00910091|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110528859|NCT00910091|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110528860|NCT00910091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110180725|NCT00130065|Folic Acid|folic acid|mesh-list
110528865|NCT04216550|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110528866|NCT04216550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110528867|NCT04216550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110528868|NCT01442792|Rivaroxaban|rivaroxaban|mesh-list
110528869|NCT01442792|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110528870|NCT01442792|Antithrombins|antithrombins|mesh-ancestor
110528871|NCT01442792|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110528872|NCT01442792|Protease Inhibitors|protease inhibitors|mesh-ancestor
110528873|NCT01442792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110528874|NCT01442792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110528875|NCT01442792|Anticoagulants|anticoagulants|mesh-ancestor
110528876|NCT00909857|Dienogest|dienogest|mesh-list
110528877|NCT00909857|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110528878|NCT00909857|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110528879|NCT00909857|Levonorgestrel|levonorgestrel|mesh-list
110528880|NCT00909857|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110528881|NCT00909857|Estradiol|estradiol|mesh-list
110528882|NCT00909857|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110528883|NCT00909857|Estrogens|estrogens|mesh-ancestor
110528884|NCT00909857|Hormones|hormones|mesh-ancestor
110528885|NCT00909857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110528886|NCT00909857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110528887|NCT00909857|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110528888|NCT00909857|Contraceptive Agents|contraceptive agents|mesh-ancestor
110528889|NCT00909857|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110528890|NCT00909857|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110528891|NCT00909857|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110528892|NCT00909857|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110528893|NCT00909857|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110528894|NCT00909857|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110528895|NCT00909857|Hormone Antagonists|hormone antagonists|mesh-ancestor
110528896|NCT00909857|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110528897|NCT00909857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110528898|NCT00911807|Cerebrolysin|cerebrolysin|mesh-list
110528899|NCT00911807|Donepezil|donepezil|mesh-list
110528900|NCT00911807|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110528901|NCT00911807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110528902|NCT00911807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110528903|NCT00911807|Cholinergic Agents|cholinergic agents|mesh-ancestor
110528904|NCT00911807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110528905|NCT00911807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110528906|NCT00911807|Nootropic Agents|nootropic agents|mesh-ancestor
110528907|NCT00911807|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110528908|NCT00911807|Protective Agents|protective agents|mesh-ancestor
110528909|NCT04127981|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110528910|NCT04127981|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110528911|NCT04127981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110528912|NCT04117451|Propolis|propolis|mesh-list
110528913|NCT04117451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110528914|NCT03690089|Atropine|atropine|mesh-list
110528915|NCT03690089|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110528916|NCT03690089|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110528917|NCT03690089|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110528918|NCT03690089|Autonomic Agents|autonomic agents|mesh-ancestor
110528919|NCT03690089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110528920|NCT03690089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110528921|NCT03690089|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110528922|NCT03690089|Respiratory System Agents|respiratory system agents|mesh-ancestor
110528924|NCT03690089|Parasympatholytics|parasympatholytics|mesh-ancestor
110528925|NCT03690089|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110528926|NCT03690089|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110528927|NCT03690089|Cholinergic Agents|cholinergic agents|mesh-ancestor
110528928|NCT03690089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110528929|NCT03690089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110528930|NCT03812588|Escitalopram|escitalopram|mesh-list
110528931|NCT03812588|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110528932|NCT03812588|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110528950|NCT04788641|Tacrolimus|tacrolimus|mesh-list
110528951|NCT04788641|Cyclosporins|cyclosporins|mesh-list
110528952|NCT04788641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110528953|NCT04788641|Immunologic Factors|immunologic factors|mesh-ancestor
110528954|NCT04788641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110528955|NCT04788641|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110528956|NCT04788641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110528957|NCT04788641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110528958|NCT04788641|Antifungal Agents|antifungal agents|mesh-ancestor
110528959|NCT04788641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110528960|NCT04788641|Dermatologic Agents|dermatologic agents|mesh-ancestor
110528961|NCT04788641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110528962|NCT02745470|Lixisenatide|lixisenatide|mesh-list
110528963|NCT02745470|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110528964|NCT02745470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110528965|NCT02741414|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110528966|NCT02741414|Amoxicillin|amoxicillin|mesh-list
110528967|NCT02741414|Metronidazole|metronidazole|mesh-list
110528968|NCT02741414|Clarithromycin|clarithromycin|mesh-list
110528969|NCT02741414|Levofloxacin|levofloxacin|mesh-list
110528970|NCT02741414|Tetracycline|tetracycline|mesh-list
110528971|NCT02741414|Furazolidone|furazolidone|mesh-list
110528972|NCT02741414|Esomeprazole|esomeprazole|mesh-list
110528973|NCT02741414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110528974|NCT02741414|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110528975|NCT02741414|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110528976|NCT02741414|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110528977|NCT02741414|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110528978|NCT02741414|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110528979|NCT02741414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110528980|NCT02741414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110528981|NCT02741414|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110528982|NCT02741414|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110528983|NCT02741414|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110528984|NCT02741414|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110528985|NCT02741414|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110528986|NCT02741414|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110528987|NCT02741414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110528988|NCT02741414|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110528989|NCT02741414|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110528990|NCT02741414|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
110528991|NCT02741414|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
110528994|NCT02736500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110528995|NCT05629598|Epoetin Alfa|epoetin alfa|mesh-list
110528996|NCT05629598|Hematinics|hematinics|mesh-ancestor
110528997|NCT02736032|Triptorelin Pamoate|triptorelin pamoate|mesh-list
110528998|NCT02736032|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110528999|NCT02736032|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110529000|NCT02736032|Estradiol|estradiol|mesh-list
110529001|NCT02736032|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110529002|NCT02736032|Progesterone|progesterone|mesh-list
110529003|NCT02736032|Estrogens|estrogens|mesh-ancestor
110529004|NCT02736032|Hormones|hormones|mesh-ancestor
110529005|NCT02736032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110529006|NCT02736032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110529007|NCT02736032|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110529008|NCT02736032|Contraceptive Agents|contraceptive agents|mesh-ancestor
110529009|NCT02736032|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110529010|NCT02736032|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110529011|NCT02736032|Progestins|progestins|mesh-ancestor
110529012|NCT02736032|Luteolytic Agents|luteolytic agents|mesh-ancestor
110529013|NCT02736032|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110529014|NCT02736032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110529015|NCT02744768|Dasatinib|dasatinib|mesh-list
110529016|NCT02744768|Blinatumomab|blinatumomab|mesh-list
110529017|NCT02744768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110529018|NCT02744768|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110529019|NCT02744768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110529020|NCT02744768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110529021|NCT00909779|Formoterol Fumarate|formoterol fumarate|mesh-list
110529022|NCT00909779|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110529023|NCT00909779|Autonomic Agents|autonomic agents|mesh-ancestor
110529024|NCT00909779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110529025|NCT00909779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110529026|NCT00909779|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110529027|NCT00909779|Respiratory System Agents|respiratory system agents|mesh-ancestor
110529028|NCT00909779|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110529029|NCT00909779|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110529030|NCT00909779|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110529031|NCT00909779|Adrenergic Agents|adrenergic agents|mesh-ancestor
110529032|NCT00909779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110529033|NCT00909779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110529034|NCT04096391|Analgesics|analgesics|mesh-list
110529035|NCT04096391|Sensory System Agents|sensory system agents|mesh-ancestor
110529036|NCT04096391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110529037|NCT04096391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110529038|NCT02744378|Clobetasol|clobetasol|mesh-list
110529039|NCT02744378|Tacrolimus|tacrolimus|mesh-list
110529040|NCT02744378|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110529041|NCT02744378|Immunologic Factors|immunologic factors|mesh-ancestor
110529042|NCT02744378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110529043|NCT02744378|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110529044|NCT02744378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110529045|NCT02744378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110529046|NCT02744378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110529047|NCT02744378|Glucocorticoids|glucocorticoids|mesh-ancestor
110529048|NCT02744378|Hormones|hormones|mesh-ancestor
110529049|NCT02744378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110529050|NCT04318730|Apatinib|apatinib|mesh-list
110529051|NCT04318730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110529052|NCT04318730|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110529053|NCT04318730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110529054|NCT04318730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110529055|NCT00632333|Fluorouracil|fluorouracil|mesh-list
110529056|NCT00632333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110529057|NCT00632333|Antimetabolites|antimetabolites|mesh-ancestor
110529058|NCT00632333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110529059|NCT00632333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110529060|NCT00632333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110529061|NCT00632333|Immunologic Factors|immunologic factors|mesh-ancestor
110529062|NCT00632333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110529063|NCT02744456|Losartan|losartan|mesh-list
110529064|NCT02744456|Amlodipine|amlodipine|mesh-list
110529071|NCT02744456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110529072|NCT02744456|Vasodilator Agents|vasodilator agents|mesh-ancestor
110529073|NCT02744456|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110529074|NCT02744456|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110529075|NCT02744456|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110529077|NCT02744456|Natriuretic Agents|natriuretic agents|mesh-ancestor
110529078|NCT02744456|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110529079|NCT02744222|Interferons|interferons|mesh-list
110529080|NCT02744222|Interferon-beta|interferon-beta|mesh-list
110529081|NCT02744222|Interferon beta-1a|interferon beta-1a|mesh-list
110529082|NCT02744222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110529083|NCT02744222|Antiviral Agents|antiviral agents|mesh-ancestor
110529084|NCT02744222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110529085|NCT02744222|Immunologic Factors|immunologic factors|mesh-ancestor
110529086|NCT02744222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110529087|NCT02744222|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110529088|NCT02741024|Artesunate|artesunate|mesh-list
110529089|NCT02741024|Lumefantrine|lumefantrine|mesh-list
110529090|NCT02741024|Artemether|artemether|mesh-list
110194108|NCT00070122|Vitamins|vitamins|mesh-ancestor
110529091|NCT02741024|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
110529092|NCT02741024|Amodiaquine|amodiaquine|mesh-list
110529093|NCT02741024|Antimalarials|antimalarials|mesh-ancestor
110529094|NCT02741024|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110529095|NCT02741024|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110529096|NCT02741024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110529097|NCT02741024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110529098|NCT02741024|Antiviral Agents|antiviral agents|mesh-ancestor
110529099|NCT02741024|Schistosomicides|schistosomicides|mesh-ancestor
110529100|NCT02741024|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110529101|NCT02741024|Anthelmintics|anthelmintics|mesh-ancestor
110529102|NCT02735876|Rituximab|rituximab|mesh-list
110529103|NCT02735876|Acalabrutinib|acalabrutinib|mesh-list
110529104|NCT02735876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110529105|NCT02735876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110529106|NCT02735876|Immunologic Factors|immunologic factors|mesh-ancestor
110529107|NCT02735876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110529108|NCT02735876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110529109|NCT00910871|Bedaquiline|bedaquiline|mesh-list
110529110|NCT00910871|Antitubercular Agents|antitubercular agents|mesh-ancestor
110529111|NCT00910871|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110529112|NCT00910871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110529113|NCT04230707|Melatonin|melatonin|mesh-list
110529114|NCT04230707|Antioxidants|antioxidants|mesh-ancestor
110529115|NCT04230707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110529116|NCT04230707|Protective Agents|protective agents|mesh-ancestor
110529117|NCT04230707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110529118|NCT04230707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110529119|NCT03943667|Paclitaxel|paclitaxel|mesh-list
110529120|NCT03943667|Gemcitabine|gemcitabine|mesh-list
110529121|NCT03943667|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110529122|NCT03943667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110529123|NCT03943667|Tubulin Modulators|tubulin modulators|mesh-ancestor
110529124|NCT03943667|Antimitotic Agents|antimitotic agents|mesh-ancestor
110529125|NCT03943667|Mitosis Modulators|mitosis modulators|mesh-ancestor
110529126|NCT03943667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110529127|NCT03943667|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110529128|NCT03943667|Antimetabolites|antimetabolites|mesh-ancestor
110529129|NCT02735798|Trastuzumab|trastuzumab|mesh-list
110529130|NCT02735798|Gancotamab|gancotamab|mesh-list
110529131|NCT02735798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110529132|NCT02735798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110529133|NCT02735798|Immunoconjugates|immunoconjugates|mesh-ancestor
110529134|NCT02735798|Immunologic Factors|immunologic factors|mesh-ancestor
110180756|NCT00130026|Caffeine|caffeine|mesh-list
110529149|NCT05590286|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110529150|NCT05590286|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110529151|NCT05590286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110529152|NCT05590286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110529153|NCT05580029|Triamcinolone|triamcinolone|mesh-list
110529154|NCT05580029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110529155|NCT05580029|Glucocorticoids|glucocorticoids|mesh-ancestor
110529156|NCT05580029|Hormones|hormones|mesh-ancestor
110529157|NCT05580029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110529158|NCT05580029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110529159|NCT03724994|Paclitaxel|paclitaxel|mesh-list
110529160|NCT03724994|Gemcitabine|gemcitabine|mesh-list
110529161|NCT03724994|Fluorouracil|fluorouracil|mesh-list
110529162|NCT03724994|Folfirinox|folfirinox|mesh-list
110529163|NCT03724994|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110529164|NCT03724994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110529165|NCT03724994|Tubulin Modulators|tubulin modulators|mesh-ancestor
110529166|NCT03724994|Antimitotic Agents|antimitotic agents|mesh-ancestor
110529167|NCT03724994|Mitosis Modulators|mitosis modulators|mesh-ancestor
110529168|NCT03724994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110529169|NCT03724994|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110529170|NCT03724994|Antimetabolites|antimetabolites|mesh-ancestor
110529171|NCT03724994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110529172|NCT03724994|Immunologic Factors|immunologic factors|mesh-ancestor
110529173|NCT03724994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110529174|NCT02735330|Ethanol|ethanol|mesh-list
110529175|NCT02735330|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110529176|NCT02735330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110529177|NCT02735330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110529178|NCT02735330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110529179|NCT02631941|Budesonide|budesonide|mesh-list
110529180|NCT02631941|Formoterol Fumarate|formoterol fumarate|mesh-list
110529181|NCT02631941|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
110529182|NCT02631941|Charcoal|charcoal|mesh-list
110529183|NCT02631941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110529184|NCT02631941|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110529185|NCT02631941|Autonomic Agents|autonomic agents|mesh-ancestor
110529186|NCT02631941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110529187|NCT02631941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110529188|NCT02631941|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110529189|NCT02631941|Respiratory System Agents|respiratory system agents|mesh-ancestor
110529190|NCT02631941|Glucocorticoids|glucocorticoids|mesh-ancestor
110529191|NCT02631941|Hormones|hormones|mesh-ancestor
110529192|NCT02631941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110529193|NCT02631941|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110529194|NCT02631941|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110180766|NCT00016367|Cisplatin|cisplatin|mesh-list
110529210|NCT02740166|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110529211|NCT02740166|Adrenergic Agents|adrenergic agents|mesh-ancestor
110529212|NCT02740166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110529213|NCT02740166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110529214|NCT02740166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110529215|NCT02740166|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110529216|NCT02740166|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110529217|NCT02740166|Vasodilator Agents|vasodilator agents|mesh-ancestor
110529218|NCT02735018|Epinephrine|epinephrine|mesh-list
110529219|NCT02735018|Racepinephrine|racepinephrine|mesh-list
110529220|NCT02735018|Epinephryl borate|epinephryl borate|mesh-list
110529221|NCT02735018|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110529222|NCT02735018|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110529223|NCT02735018|Adrenergic Agents|adrenergic agents|mesh-ancestor
110529224|NCT02735018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110529225|NCT02735018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110529226|NCT02735018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110529227|NCT02735018|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110529228|NCT02735018|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110529229|NCT02735018|Autonomic Agents|autonomic agents|mesh-ancestor
110529230|NCT02735018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110529231|NCT02735018|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110529232|NCT02735018|Respiratory System Agents|respiratory system agents|mesh-ancestor
110529233|NCT02735018|Mydriatics|mydriatics|mesh-ancestor
110529234|NCT02735018|Sympathomimetics|sympathomimetics|mesh-ancestor
110529235|NCT02735018|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110529236|NCT00908375|Pregabalin|pregabalin|mesh-list
110529237|NCT00908375|Analgesics|analgesics|mesh-ancestor
110529238|NCT00908375|Sensory System Agents|sensory system agents|mesh-ancestor
110529239|NCT00908375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110529240|NCT00908375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110529241|NCT00908375|Anticonvulsants|anticonvulsants|mesh-ancestor
110529242|NCT00908375|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110529243|NCT00908375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110529244|NCT00908375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110529245|NCT00908375|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110529246|NCT00908375|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110529247|NCT00908375|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110529249|NCT00908375|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110529250|NCT04247867|Psyllium|psyllium|mesh-list
110529251|NCT04247867|Cathartics|cathartics|mesh-ancestor
110529252|NCT04247867|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110529253|NCT02731664|Glucagon|glucagon|mesh-list
110529254|NCT02731664|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
110529255|NCT02731664|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110529256|NCT02731664|Hormones|hormones|mesh-ancestor
110534647|NCT04179006|Antidepressive Agents|antidepressive agents|mesh-list
110529262|NCT02543255|Abiraterone Acetate|abiraterone acetate|mesh-list
110529263|NCT02543255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110529264|NCT02543255|Glucocorticoids|glucocorticoids|mesh-ancestor
110529265|NCT02543255|Hormones|hormones|mesh-ancestor
110529266|NCT02543255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110529267|NCT02543255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110529268|NCT02543255|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110529269|NCT02543255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110529270|NCT02543255|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110529271|NCT02543255|Fertility Agents|fertility agents|mesh-ancestor
110529272|NCT02543255|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110529273|NCT02543255|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110529274|NCT02543255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110529275|NCT02543255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110529276|NCT02543255|Hormone Antagonists|hormone antagonists|mesh-ancestor
110529277|NCT02543255|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110529278|NCT02695004|Donepezil|donepezil|mesh-list
110529279|NCT02695004|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110529280|NCT02695004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110529281|NCT02695004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110529282|NCT02695004|Cholinergic Agents|cholinergic agents|mesh-ancestor
110529283|NCT02695004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110529284|NCT02695004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110529285|NCT02695004|Nootropic Agents|nootropic agents|mesh-ancestor
110529286|NCT00909389|Simvastatin|simvastatin|mesh-list
110529287|NCT00909389|Ezetimibe|ezetimibe|mesh-list
110529288|NCT00909389|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
110529289|NCT00909389|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110176784|NCT03151707|Niacin|niacin|mesh-list
110529290|NCT00909389|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110529291|NCT00909389|Antimetabolites|antimetabolites|mesh-ancestor
110529292|NCT00909389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110529293|NCT00909389|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110529294|NCT00909389|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110529295|NCT00909389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110529297|NCT00910715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110529298|NCT00910715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110529299|NCT00910715|Antimalarials|antimalarials|mesh-ancestor
110529300|NCT00910715|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110529301|NCT00910715|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110529302|NCT02731430|Morphine|morphine|mesh-list
110529303|NCT02731430|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110529304|NCT02731430|Narcotics|narcotics|mesh-ancestor
110529305|NCT02731430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110529306|NCT02731430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110529307|NCT02731430|Analgesics|analgesics|mesh-ancestor
110529308|NCT02731430|Sensory System Agents|sensory system agents|mesh-ancestor
110529309|NCT02731430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110529310|NCT04232969|Exenatide|exenatide|mesh-list
110529311|NCT04232969|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110529312|NCT04232969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110529313|NCT04232969|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110529314|NCT04232969|Incretins|incretins|mesh-ancestor
110529315|NCT04232969|Hormones|hormones|mesh-ancestor
110529316|NCT04232969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110529317|NCT03695510|Pembrolizumab|pembrolizumab|mesh-list
110529318|NCT03695510|Afatinib|afatinib|mesh-list
110529319|NCT03695510|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110529320|NCT03695510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110529321|NCT03695510|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110529322|NCT03695510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110529324|NCT03695510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110529325|NCT02731040|Ibandronic Acid|ibandronic acid|mesh-list
110529326|NCT02731040|Zoledronic Acid|zoledronic acid|mesh-list
110529327|NCT02731040|Diphosphonates|diphosphonates|mesh-list
110529328|NCT02731040|Etidronic Acid|etidronic acid|mesh-list
110529336|NCT02730572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110529337|NCT02730572|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110529338|NCT02730572|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110529339|NCT02730572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110529340|NCT02730572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110529341|NCT02730572|Dopamine Agents|dopamine agents|mesh-ancestor
110529342|NCT02730572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110529343|NCT02730026|Ketoprofen|ketoprofen|mesh-list
110529344|NCT02730026|Omeprazole|omeprazole|mesh-list
110529345|NCT02730026|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110529346|NCT02730026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110529347|NCT02730026|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110529348|NCT02730026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110529349|NCT02730026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110529350|NCT02730026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110529351|NCT02730026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110529352|NCT02730026|Analgesics|analgesics|mesh-ancestor
110529353|NCT02730026|Sensory System Agents|sensory system agents|mesh-ancestor
110529354|NCT02730026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110529355|NCT02730026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110529356|NCT02730026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110529357|NCT02730026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110529358|NCT02730026|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110529359|NCT02738918|Abatacept|abatacept|mesh-list
110529360|NCT02738918|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110529361|NCT02738918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110529362|NCT02738918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110529363|NCT02738918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110529364|NCT02738918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110529365|NCT02738918|Immunologic Factors|immunologic factors|mesh-ancestor
110529366|NCT02738918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110529367|NCT02738918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110194183|NCT00066378|Gefitinib|gefitinib|mesh-list
110529368|NCT03195374|Analgesics, Opioid|analgesics, opioid|mesh-list
110529370|NCT03195374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110529371|NCT03195374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110529372|NCT03195374|Analgesics|analgesics|mesh-ancestor
110529373|NCT03195374|Sensory System Agents|sensory system agents|mesh-ancestor
110529374|NCT03195374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110529375|NCT02739386|Ipilimumab|ipilimumab|mesh-list
110529376|NCT02739386|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110529377|NCT02739386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110529378|NCT02739386|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110529379|NCT02739386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110529380|NCT00636428|Midazolam|midazolam|mesh-list
110529381|NCT00636428|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110529382|NCT00636428|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110529383|NCT00636428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110529384|NCT00636428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110529385|NCT00636428|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110529386|NCT00636428|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110529387|NCT00636428|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110529388|NCT00636428|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110529389|NCT00636428|Anesthetics, General|anesthetics, general|mesh-ancestor
110529390|NCT00636428|Anesthetics|anesthetics|mesh-ancestor
110529391|NCT00636428|GABA Modulators|gaba modulators|mesh-ancestor
110529392|NCT00636428|GABA Agents|gaba agents|mesh-ancestor
110529393|NCT00636428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110529394|NCT00636428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110529395|NCT02729870|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
110529399|NCT05628662|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110529400|NCT05628662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110529402|NCT02694848|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110529403|NCT02694848|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110529404|NCT02694848|Analgesics|analgesics|mesh-ancestor
110529405|NCT02694848|Sensory System Agents|sensory system agents|mesh-ancestor
110529406|NCT02694848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110529407|NCT02694848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110529408|NCT02694848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110529409|NCT02694848|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110529410|NCT02694848|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110529411|NCT02694848|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110529412|NCT02694848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110529413|NCT02694848|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110529414|NCT02694848|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110529415|NCT02694848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110529416|NCT02694848|Antipyretics|antipyretics|mesh-ancestor
110529417|NCT02729324|Protective Agents|protective agents|mesh-list
110529418|NCT02729324|Radiation-Protective Agents|radiation-protective agents|mesh-list
110918733|NCT01525329|Fluorouracil|fluorouracil|mesh-list
110529419|NCT02729324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110529420|NCT02733458|Dexamethasone|dexamethasone|mesh-list
110529421|NCT02733458|Gemcitabine|gemcitabine|mesh-list
110529422|NCT02733458|Etoposide|etoposide|mesh-list
110529423|NCT02733458|Pegaspargase|pegaspargase|mesh-list
110529424|NCT02733458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110529425|NCT02733458|Antiemetics|antiemetics|mesh-ancestor
110529426|NCT02733458|Autonomic Agents|autonomic agents|mesh-ancestor
110529427|NCT02733458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110529428|NCT02733458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110529429|NCT02733458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110529430|NCT02733458|Glucocorticoids|glucocorticoids|mesh-ancestor
110529431|NCT02733458|Hormones|hormones|mesh-ancestor
110529432|NCT02733458|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110529433|NCT02733458|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110529434|NCT02733458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110529435|NCT02733458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110529436|NCT02733458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110529437|NCT02733458|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110529438|NCT02733458|Antimetabolites|antimetabolites|mesh-ancestor
110529439|NCT02733458|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110529440|NCT02733458|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110529441|NCT02733458|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110529442|NCT03658772|Pembrolizumab|pembrolizumab|mesh-list
110529443|NCT03658772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110529444|NCT03658772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110529445|NCT03658772|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110529446|NCT03658772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110529447|NCT02729012|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110529448|NCT02728856|Sunscreening Agents|sunscreening agents|mesh-list
110529449|NCT02728856|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110529450|NCT02728856|Protective Agents|protective agents|mesh-ancestor
110529451|NCT02728856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110529452|NCT02728856|Dermatologic Agents|dermatologic agents|mesh-ancestor
110529453|NCT02728934|Infliximab|infliximab|mesh-list
110529454|NCT02728934|Golimumab|golimumab|mesh-list
110529455|NCT02728934|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110529456|NCT02728934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110529457|NCT02728934|Dermatologic Agents|dermatologic agents|mesh-ancestor
110529458|NCT02728934|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110529459|NCT02728934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110529460|NCT02728934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110529461|NCT02728934|Immunologic Factors|immunologic factors|mesh-ancestor
110529462|NCT02728934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110529463|NCT02728700|Mycophenolic Acid|mycophenolic acid|mesh-list
110529464|NCT02728700|Sirolimus|sirolimus|mesh-list
110529465|NCT02728700|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110529466|NCT02728700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110529467|NCT02728700|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110180802|NCT00016445|Hormones|hormones|mesh-list
110529476|NCT02728700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110529477|NCT02728622|Tamoxifen|tamoxifen|mesh-list
110529478|NCT02728622|Paclitaxel|paclitaxel|mesh-list
110529479|NCT02728622|Doxorubicin|doxorubicin|mesh-list
110529480|NCT02728622|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110529481|NCT02728622|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110529482|NCT02728622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110529483|NCT02728622|Tubulin Modulators|tubulin modulators|mesh-ancestor
110529484|NCT02728622|Antimitotic Agents|antimitotic agents|mesh-ancestor
110529485|NCT02728622|Mitosis Modulators|mitosis modulators|mesh-ancestor
110529486|NCT02728622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110529487|NCT02728622|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110529488|NCT02728622|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110529489|NCT02728622|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110529490|NCT02728622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110529491|NCT02728622|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110529492|NCT02728622|Hormone Antagonists|hormone antagonists|mesh-ancestor
110529493|NCT02728622|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110529494|NCT02728622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110529495|NCT02728622|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110529496|NCT02728622|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110529497|NCT02728622|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110529498|NCT02728622|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110529499|NCT02728466|Proanthocyanidin|proanthocyanidin|mesh-list
110529500|NCT02728466|Procyanidin|procyanidin|mesh-list
110529501|NCT02728466|Antioxidants|antioxidants|mesh-ancestor
110529502|NCT02728466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110529503|NCT02728466|Protective Agents|protective agents|mesh-ancestor
110529504|NCT02728466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110529505|NCT02728466|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110529506|NCT02728466|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110529507|NCT02728466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110529508|NCT02733380|Thalidomide|thalidomide|mesh-list
110529509|NCT02733380|Dexamethasone|dexamethasone|mesh-list
110529510|NCT02733380|Doxorubicin|doxorubicin|mesh-list
110529511|NCT02733380|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110529512|NCT02733380|Vinorelbine|vinorelbine|mesh-list
110529513|NCT02733380|Mitoxantrone|mitoxantrone|mesh-list
110529514|NCT02733380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110529515|NCT02733380|Antiemetics|antiemetics|mesh-ancestor
110529516|NCT02733380|Autonomic Agents|autonomic agents|mesh-ancestor
110529517|NCT02733380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110529518|NCT02733380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110529519|NCT02733380|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110529520|NCT02733380|Glucocorticoids|glucocorticoids|mesh-ancestor
110529522|NCT02733380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110529523|NCT02733380|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110529524|NCT02733380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110529525|NCT02733380|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110529526|NCT02733380|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110529527|NCT02733380|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110529528|NCT02733380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110529529|NCT02733380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110529530|NCT02733380|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110529531|NCT02733380|Tubulin Modulators|tubulin modulators|mesh-ancestor
110529532|NCT02733380|Antimitotic Agents|antimitotic agents|mesh-ancestor
110529533|NCT02733380|Mitosis Modulators|mitosis modulators|mesh-ancestor
110529534|NCT02733380|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110529535|NCT02733380|Immunologic Factors|immunologic factors|mesh-ancestor
110529536|NCT02733380|Leprostatic Agents|leprostatic agents|mesh-ancestor
110312241|NCT00293111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110529545|NCT02737670|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
110529547|NCT02737670|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110529548|NCT02737670|Antimetabolites|antimetabolites|mesh-ancestor
110529549|NCT02737670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110529550|NCT02737670|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110529551|NCT02737670|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110529552|NCT02737670|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110529553|NCT02737670|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110529554|NCT02737670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110529555|NCT02728310|Levobupivacaine|levobupivacaine|mesh-list
110529556|NCT02728310|Anesthetics, Local|anesthetics, local|mesh-ancestor
110529557|NCT02728310|Anesthetics|anesthetics|mesh-ancestor
110529558|NCT02728310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110529559|NCT02728310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110529560|NCT02728310|Sensory System Agents|sensory system agents|mesh-ancestor
110529561|NCT02728310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110529562|NCT00636584|Nitroprusside|nitroprusside|mesh-list
110529563|NCT00636584|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110529564|NCT00636584|Vasodilator Agents|vasodilator agents|mesh-ancestor
110529565|NCT00636584|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
110529566|NCT00636584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110529567|NCT02732756|Oxymetazoline|oxymetazoline|mesh-list
110529568|NCT02732756|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110529569|NCT02732756|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110529570|NCT02732756|Adrenergic Agents|adrenergic agents|mesh-ancestor
110529571|NCT02732756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110529572|NCT02732756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110529573|NCT02732756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110529574|NCT02732756|Sympathomimetics|sympathomimetics|mesh-ancestor
110529575|NCT02732756|Autonomic Agents|autonomic agents|mesh-ancestor
110529576|NCT02732756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110529577|NCT02732756|Nasal Decongestants|nasal decongestants|mesh-ancestor
110529578|NCT02732756|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110529579|NCT02732756|Respiratory System Agents|respiratory system agents|mesh-ancestor
110529580|NCT02732522|Misoprostol|misoprostol|mesh-list
110529581|NCT02732522|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110529582|NCT02732522|Abortifacient Agents|abortifacient agents|mesh-ancestor
110529583|NCT02732522|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110529584|NCT02732522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110529585|NCT02732522|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110529586|NCT02732522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110529587|NCT02732522|Oxytocics|oxytocics|mesh-ancestor
110529588|NCT02732678|Propranolol|propranolol|mesh-list
110529589|NCT02732678|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110529590|NCT02732678|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110529591|NCT02732678|Adrenergic Agents|adrenergic agents|mesh-ancestor
110529592|NCT02732678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110529593|NCT02732678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110529594|NCT02732678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110529595|NCT02732678|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110529596|NCT02732678|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110529597|NCT02732678|Vasodilator Agents|vasodilator agents|mesh-ancestor
110529598|NCT02727608|Eculizumab|eculizumab|mesh-list
110529599|NCT02727608|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
110529600|NCT02727608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110529601|NCT02727608|Immunologic Factors|immunologic factors|mesh-ancestor
110529602|NCT02727608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110529603|NCT02727296|Propofol|propofol|mesh-list
110529607|NCT02727296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110529608|NCT02727296|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110529609|NCT02727296|Anesthetics, General|anesthetics, general|mesh-ancestor
110529610|NCT02727296|Anesthetics|anesthetics|mesh-ancestor
110529611|NCT02727296|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110529612|NCT02727296|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110529613|NCT02732132|Fentanyl|fentanyl|mesh-list
110529614|NCT02732132|Midazolam|midazolam|mesh-list
110529615|NCT02732132|Ketamine|ketamine|mesh-list
110529616|NCT02732132|Propofol|propofol|mesh-list
110529617|NCT02732132|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110529618|NCT02732132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110529619|NCT02732132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110529620|NCT02732132|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110529621|NCT02732132|Anesthetics, General|anesthetics, general|mesh-ancestor
110529622|NCT02732132|Anesthetics|anesthetics|mesh-ancestor
110529623|NCT02732132|Analgesics|analgesics|mesh-ancestor
110529624|NCT02732132|Sensory System Agents|sensory system agents|mesh-ancestor
110529625|NCT02732132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110529626|NCT02732132|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110529627|NCT02732132|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110529628|NCT02732132|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110529629|NCT02732132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110529630|NCT02732132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110529631|NCT02732132|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110529632|NCT02732132|Narcotics|narcotics|mesh-ancestor
110529633|NCT02732132|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110529635|NCT02732132|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110529636|NCT02732132|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110529637|NCT02732132|GABA Modulators|gaba modulators|mesh-ancestor
110529638|NCT02732132|GABA Agents|gaba agents|mesh-ancestor
110529639|NCT02737202|Saracatinib|saracatinib|mesh-list
110529640|NCT02737202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110529641|NCT02737202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110529642|NCT02737202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110529643|NCT02721368|Lidocaine|lidocaine|mesh-list
110529644|NCT02721368|Anesthetics, Local|anesthetics, local|mesh-ancestor
110529645|NCT02721368|Anesthetics|anesthetics|mesh-ancestor
110529646|NCT02721368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110529647|NCT02721368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110529648|NCT02721368|Sensory System Agents|sensory system agents|mesh-ancestor
110529649|NCT02721368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110529650|NCT02721368|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110529651|NCT02721368|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110529652|NCT02721368|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110529653|NCT02721368|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110529654|NCT02721368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110529655|NCT02737124|Acetaminophen|acetaminophen|mesh-list
110529656|NCT02737124|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110529657|NCT02737124|Analgesics|analgesics|mesh-ancestor
110529658|NCT02737124|Sensory System Agents|sensory system agents|mesh-ancestor
110529659|NCT02737124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110529660|NCT02737124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110529661|NCT02737124|Antipyretics|antipyretics|mesh-ancestor
110529662|NCT02721290|Ropivacaine|ropivacaine|mesh-list
110529663|NCT02721290|Anesthetics, Local|anesthetics, local|mesh-ancestor
110529664|NCT02721290|Anesthetics|anesthetics|mesh-ancestor
110529665|NCT02721290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110529666|NCT02721290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110529667|NCT02721290|Sensory System Agents|sensory system agents|mesh-ancestor
110529668|NCT02721290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110529669|NCT02720978|Oxytocin|oxytocin|mesh-list
110529670|NCT02720978|Oxytocics|oxytocics|mesh-ancestor
110529671|NCT02720978|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110529672|NCT02720978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110529673|NCT02726984|Listerine|listerine|mesh-list
110529674|NCT02726984|Fluorides|fluorides|mesh-list
110529675|NCT02726984|Sodium Fluoride|sodium fluoride|mesh-list
110529676|NCT02726984|Cariostatic Agents|cariostatic agents|mesh-ancestor
110529677|NCT02726984|Protective Agents|protective agents|mesh-ancestor
110529692|NCT02726828|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110529693|NCT02726828|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110529694|NCT02726828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110529695|NCT02726828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110529697|NCT02726828|Narcotics|narcotics|mesh-ancestor
110529698|NCT02799134|Dexamethasone|dexamethasone|mesh-list
110529699|NCT02799134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110529700|NCT02799134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110529701|NCT02799134|Antiemetics|antiemetics|mesh-ancestor
110529702|NCT02799134|Autonomic Agents|autonomic agents|mesh-ancestor
110529703|NCT02799134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110529704|NCT02799134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110529705|NCT02799134|Glucocorticoids|glucocorticoids|mesh-ancestor
110529706|NCT02799134|Hormones|hormones|mesh-ancestor
110529707|NCT02799134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110529708|NCT02799134|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110529709|NCT02799134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110529710|NCT02720822|Morphine|morphine|mesh-list
110529711|NCT02720822|Laxatives|laxatives|mesh-list
110529712|NCT02720822|Cathartics|cathartics|mesh-list
110529713|NCT02720822|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110529714|NCT02720822|Narcotics|narcotics|mesh-ancestor
110529715|NCT02720822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110529716|NCT02720822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110529717|NCT02720822|Analgesics|analgesics|mesh-ancestor
110529718|NCT02720822|Sensory System Agents|sensory system agents|mesh-ancestor
110529719|NCT02720822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110529720|NCT02720822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110529721|NCT02757872|Vitamin D|vitamin d|mesh-list
110529722|NCT02757872|Ergocalciferols|ergocalciferols|mesh-list
110529723|NCT02757872|Cholecalciferol|cholecalciferol|mesh-list
110529724|NCT02757872|Vitamins|vitamins|mesh-list
110529725|NCT02757872|Micronutrients|micronutrients|mesh-ancestor
110529726|NCT02757872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110529727|NCT02757872|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110529728|NCT02757872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110529729|NCT02746796|Capecitabine|capecitabine|mesh-list
110529730|NCT02746796|Tegafur|tegafur|mesh-list
110529731|NCT02746796|Oxaliplatin|oxaliplatin|mesh-list
110529732|NCT02746796|Nivolumab|nivolumab|mesh-list
110529733|NCT02746796|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110529734|NCT02746796|Antimetabolites|antimetabolites|mesh-ancestor
110529735|NCT02746796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110529736|NCT02746796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110529737|NCT02746796|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110529738|NCT02746796|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110529739|NCT04167176|Lidocaine|lidocaine|mesh-list
110529740|NCT04167176|Bupivacaine|bupivacaine|mesh-list
110529754|NCT02720120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110529755|NCT04189250|Carbon Monoxide|carbon monoxide|mesh-list
110529756|NCT04189250|Antimetabolites|antimetabolites|mesh-ancestor
110529757|NCT04189250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110529758|NCT04189250|Gasotransmitters|gasotransmitters|mesh-ancestor
110529759|NCT04189250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110529760|NCT04189250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110529762|NCT02726126|Melatonin|melatonin|mesh-list
110529763|NCT02726126|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110529764|NCT02726126|Narcotics|narcotics|mesh-ancestor
110529765|NCT02726126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110529766|NCT02726126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110529767|NCT02726126|Analgesics|analgesics|mesh-ancestor
110529768|NCT02726126|Sensory System Agents|sensory system agents|mesh-ancestor
110529769|NCT02726126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110529770|NCT02726126|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110529771|NCT02726126|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110529772|NCT02726126|Anesthetics, General|anesthetics, general|mesh-ancestor
110529773|NCT02726126|Anesthetics|anesthetics|mesh-ancestor
110529774|NCT02726126|Antioxidants|antioxidants|mesh-ancestor
110529775|NCT02726126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110529776|NCT02726126|Protective Agents|protective agents|mesh-ancestor
110529777|NCT02694458|Vancomycin|vancomycin|mesh-list
110529778|NCT02694458|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110529779|NCT02694458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110529780|NCT02719808|Tenofovir|tenofovir|mesh-list
110529781|NCT02719808|Antiviral Agents|antiviral agents|mesh-ancestor
110529782|NCT02719808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110529783|NCT02719808|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110529784|NCT02719808|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110529785|NCT02719808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110529786|NCT02719808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110529787|NCT02719808|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110529788|NCT02719808|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110529789|NCT02719418|Tinzaparin|tinzaparin|mesh-list
110529790|NCT02719418|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
110529791|NCT02719418|Dalteparin|dalteparin|mesh-list
110529792|NCT02719418|Anticoagulants|anticoagulants|mesh-ancestor
110529793|NCT02719418|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110529794|NCT02719418|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110529795|NCT02719418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110529796|NCT02129348|Lithium Carbonate|lithium carbonate|mesh-list
110529797|NCT02129348|Antidepressive Agents|antidepressive agents|mesh-ancestor
110529798|NCT02129348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110529799|NCT02129348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110529800|NCT02129348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110529801|NCT02129348|Antimanic Agents|antimanic agents|mesh-ancestor
110529802|NCT02129348|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110529814|NCT02725736|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110529815|NCT02725736|Hormone Antagonists|hormone antagonists|mesh-ancestor
110529816|NCT02725736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110529817|NCT02716142|Misoprostol|misoprostol|mesh-list
110529818|NCT02716142|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110529819|NCT02716142|Abortifacient Agents|abortifacient agents|mesh-ancestor
110529820|NCT02716142|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110529821|NCT02716142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110529822|NCT02716142|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110529823|NCT02716142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110529825|NCT03015974|Mycophenolic Acid|mycophenolic acid|mesh-list
110529826|NCT03015974|Prednisone|prednisone|mesh-list
110529827|NCT03015974|Prednisolone|prednisolone|mesh-list
110529828|NCT03015974|Deflazacort|deflazacort|mesh-list
110529829|NCT03015974|Cyclophosphamide|cyclophosphamide|mesh-list
110529830|NCT03015974|Dipyridamole|dipyridamole|mesh-list
110529831|NCT03015974|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
110529832|NCT03015974|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
110529833|NCT03015974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110529834|NCT03015974|Immunologic Factors|immunologic factors|mesh-ancestor
110529835|NCT03015974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110529836|NCT03015974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110529837|NCT03015974|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110529838|NCT03015974|Alkylating Agents|alkylating agents|mesh-ancestor
110529839|NCT03015974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110529840|NCT03015974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110529842|NCT03015974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110529843|NCT03015974|Glucocorticoids|glucocorticoids|mesh-ancestor
110529844|NCT03015974|Hormones|hormones|mesh-ancestor
110529845|NCT03015974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110529846|NCT03015974|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110529847|NCT03015974|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110529848|NCT03015974|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110529849|NCT03015974|Antitubercular Agents|antitubercular agents|mesh-ancestor
110529850|NCT03015974|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110529851|NCT03015974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110529852|NCT03015974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110529853|NCT03015974|Protease Inhibitors|protease inhibitors|mesh-ancestor
110529854|NCT03015974|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110529855|NCT03015974|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110529856|NCT03015974|Vasodilator Agents|vasodilator agents|mesh-ancestor
110529857|NCT02718950|Liraglutide|liraglutide|mesh-list
110529858|NCT02718950|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110529859|NCT02718950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110529860|NCT02718950|Incretins|incretins|mesh-ancestor
110529861|NCT02718950|Hormones|hormones|mesh-ancestor
110529862|NCT02718950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110529863|NCT02725502|Linagliptin|linagliptin|mesh-list
110529864|NCT02725502|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110529865|NCT02725502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110529866|NCT02725502|Incretins|incretins|mesh-ancestor
110529867|NCT02725502|Hormones|hormones|mesh-ancestor
110529880|NCT01959464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110529882|NCT02718482|Gemcitabine|gemcitabine|mesh-list
110529883|NCT02718482|Docetaxel|docetaxel|mesh-list
110529884|NCT02718482|Ifosfamide|ifosfamide|mesh-list
110529885|NCT02718482|Isophosphamide mustard|isophosphamide mustard|mesh-list
110529886|NCT02718482|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110529887|NCT02718482|Antimetabolites|antimetabolites|mesh-ancestor
110529888|NCT02718482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110529889|NCT02718482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110529890|NCT02718482|Tubulin Modulators|tubulin modulators|mesh-ancestor
110529891|NCT02718482|Antimitotic Agents|antimitotic agents|mesh-ancestor
110177359|NCT00139009|Cyclosporine|cyclosporine|mesh-list
110529892|NCT02718482|Mitosis Modulators|mitosis modulators|mesh-ancestor
110529893|NCT02718482|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110529894|NCT02718482|Alkylating Agents|alkylating agents|mesh-ancestor
110529895|NCT05087030|Denosumab|denosumab|mesh-list
110529896|NCT05087030|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110529897|NCT05087030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110529898|NCT02717858|Liraglutide|liraglutide|mesh-list
110529899|NCT02717858|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110529900|NCT02717858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110529901|NCT02717858|Incretins|incretins|mesh-ancestor
110529902|NCT02717858|Hormones|hormones|mesh-ancestor
110529903|NCT02717858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110529904|NCT02725112|Pregabalin|pregabalin|mesh-list
110529905|NCT02725112|Analgesics|analgesics|mesh-ancestor
110529906|NCT02725112|Sensory System Agents|sensory system agents|mesh-ancestor
110529907|NCT02725112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110529908|NCT02725112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110529909|NCT02725112|Anticonvulsants|anticonvulsants|mesh-ancestor
110529910|NCT02725112|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110529911|NCT02725112|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110529912|NCT02725112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110529913|NCT02725112|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110529914|NCT02725112|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110529915|NCT02725112|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110529916|NCT02725112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110529917|NCT02725112|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110529918|NCT02724332|Sirolimus|sirolimus|mesh-list
110529919|NCT02724332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110529920|NCT02724332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110529921|NCT02724332|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110529922|NCT02724332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110529923|NCT02724332|Antifungal Agents|antifungal agents|mesh-ancestor
110529924|NCT02724332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110529925|NCT02724332|Immunologic Factors|immunologic factors|mesh-ancestor
110529926|NCT02724332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110529927|NCT02717780|Fentanyl|fentanyl|mesh-list
110918816|NCT05724446|Clobetasol|clobetasol|mesh-list
110529962|NCT04138316|Candesartan cilexetil|candesartan cilexetil|mesh-list
110529963|NCT04138316|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110529964|NCT04138316|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110529965|NCT04138316|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110529966|NCT04138316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110529967|NCT05291390|Pyronaridine|pyronaridine|mesh-list
110529968|NCT05291390|Antimalarials|antimalarials|mesh-ancestor
110529969|NCT05291390|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110529970|NCT05291390|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110529987|NCT00636740|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110529988|NCT00636740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110529991|NCT02716766|Sorafenib|sorafenib|mesh-list
110529992|NCT02716766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110529993|NCT02716766|Antimetabolites|antimetabolites|mesh-ancestor
110529994|NCT02716766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110529995|NCT02716766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110529996|NCT02716766|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110529997|NCT02716766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110529998|NCT02716610|Insulin Lispro|insulin lispro|mesh-list
110529999|NCT02716610|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110530000|NCT02716610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110530001|NCT02694224|Paclitaxel|paclitaxel|mesh-list
110530002|NCT02694224|Cyclophosphamide|cyclophosphamide|mesh-list
110530003|NCT02694224|Epirubicin|epirubicin|mesh-list
110530004|NCT02694224|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110530005|NCT02694224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110530006|NCT02694224|Tubulin Modulators|tubulin modulators|mesh-ancestor
110530007|NCT02694224|Antimitotic Agents|antimitotic agents|mesh-ancestor
110530008|NCT02694224|Mitosis Modulators|mitosis modulators|mesh-ancestor
110530009|NCT02694224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110530010|NCT02694224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110530011|NCT02694224|Immunologic Factors|immunologic factors|mesh-ancestor
110530012|NCT02694224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110530013|NCT02694224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110530014|NCT02694224|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110530015|NCT02694224|Alkylating Agents|alkylating agents|mesh-ancestor
110530016|NCT02694224|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110530017|NCT02694224|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110530018|NCT02694224|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110530019|NCT02694224|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110530020|NCT02694224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110530021|NCT00782288|Digitoxin|digitoxin|mesh-list
110530022|NCT00782288|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110530023|NCT00782288|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110530024|NCT00782288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110530025|NCT00782288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110530026|NCT00782288|Protective Agents|protective agents|mesh-ancestor
110530027|NCT00782288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110530028|NCT04189094|Etoposide|etoposide|mesh-list
110530029|NCT04189094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110530030|NCT04189094|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110530031|NCT04189094|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110530039|NCT02712944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110530040|NCT02712866|Vedolizumab|vedolizumab|mesh-list
110530041|NCT02712866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110530042|NCT00600483|Gentamicins|gentamicins|mesh-list
110530043|NCT00600483|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110530044|NCT00600483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110530045|NCT00600483|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110530046|NCT00600483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110530047|NCT00600483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110530048|NCT04132232|Carbon Monoxide|carbon monoxide|mesh-list
110530049|NCT04132232|Antimetabolites|antimetabolites|mesh-ancestor
110530050|NCT04132232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110530051|NCT04132232|Gasotransmitters|gasotransmitters|mesh-ancestor
110530052|NCT04132232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110530053|NCT04132232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110530054|NCT00649857|Cetirizine|cetirizine|mesh-list
110530055|NCT00649857|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110312254|NCT00293150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110530056|NCT00649857|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110530057|NCT00649857|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110530058|NCT00649857|Histamine Antagonists|histamine antagonists|mesh-ancestor
110530059|NCT00649857|Histamine Agents|histamine agents|mesh-ancestor
110530060|NCT00649857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110530061|NCT00649857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110530062|NCT00649857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110530063|NCT00764270|Thioctic Acid|thioctic acid|mesh-list
110530064|NCT00764270|Antioxidants|antioxidants|mesh-ancestor
110530065|NCT00764270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110530066|NCT00764270|Protective Agents|protective agents|mesh-ancestor
110530067|NCT00764270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110530068|NCT00764270|Vitamin B Complex|vitamin b complex|mesh-ancestor
110530069|NCT00764270|Vitamins|vitamins|mesh-ancestor
110530070|NCT00764270|Micronutrients|micronutrients|mesh-ancestor
110530071|NCT00650481|Oxybutynin|oxybutynin|mesh-list
110530072|NCT00650481|Parasympatholytics|parasympatholytics|mesh-ancestor
110530073|NCT00650481|Autonomic Agents|autonomic agents|mesh-ancestor
110530074|NCT00650481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110530075|NCT00650481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110530076|NCT00650481|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110530077|NCT00650481|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110530078|NCT00650481|Cholinergic Agents|cholinergic agents|mesh-ancestor
110530079|NCT00650481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110530080|NCT00650481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110530081|NCT00650481|Urological Agents|urological agents|mesh-ancestor
110530082|NCT02712476|Furosemide|furosemide|mesh-list
110530083|NCT02712476|Mannitol|mannitol|mesh-list
110530084|NCT02712476|Diuretics|diuretics|mesh-ancestor
110530085|NCT02712476|Natriuretic Agents|natriuretic agents|mesh-ancestor
110530086|NCT02712476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110194339|NCT00066768|Tubulin Modulators|tubulin modulators|mesh-ancestor
110530087|NCT02712476|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110530088|NCT02712476|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110530089|NCT02712476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110530090|NCT02712476|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110530091|NCT02651727|Paclitaxel|paclitaxel|mesh-list
110530092|NCT02651727|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110530093|NCT02651727|Gemcitabine|gemcitabine|mesh-list
110530094|NCT02651727|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110530095|NCT02651727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110530096|NCT02651727|Tubulin Modulators|tubulin modulators|mesh-ancestor
110530097|NCT02651727|Antimitotic Agents|antimitotic agents|mesh-ancestor
110530098|NCT02651727|Mitosis Modulators|mitosis modulators|mesh-ancestor
110530102|NCT02650791|Tranexamic Acid|tranexamic acid|mesh-list
110530103|NCT02650791|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110530104|NCT02650791|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110530105|NCT02650791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110530106|NCT02650791|Hemostatics|hemostatics|mesh-ancestor
110530107|NCT02650791|Coagulants|coagulants|mesh-ancestor
110530108|NCT04035668|Remibrutinib|remibrutinib|mesh-list
110530109|NCT04035668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110530110|NCT04035668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110530111|NCT04035668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110530112|NCT02650713|Atezolizumab|atezolizumab|mesh-list
110530113|NCT02650713|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110530114|NCT02650713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110530115|NCT02650713|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110530116|NCT02650713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110530117|NCT02650635|Cyclophosphamide|cyclophosphamide|mesh-list
110530118|NCT02650635|Lenograstim|lenograstim|mesh-list
110530119|NCT02650635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110530120|NCT02650635|Immunologic Factors|immunologic factors|mesh-ancestor
110530121|NCT02650635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110530122|NCT02650635|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110530123|NCT02650635|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110530124|NCT02650635|Alkylating Agents|alkylating agents|mesh-ancestor
110530125|NCT02650635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110530126|NCT02650635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110312259|NCT00293228|Isoniazid|isoniazid|mesh-list
110530127|NCT02650635|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110530128|NCT02650635|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110530129|NCT00650637|Calcium, Dietary|calcium, dietary|mesh-list
110530130|NCT00650637|Lamivudine|lamivudine|mesh-list
110530131|NCT00650637|Zidovudine|zidovudine|mesh-list
110530132|NCT00650637|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
110530133|NCT00650637|Nelfinavir|nelfinavir|mesh-list
110530134|NCT00650637|Calcium Carbonate|calcium carbonate|mesh-list
110530135|NCT00650637|Loperamide|loperamide|mesh-list
110530136|NCT00650637|Antidiarrheals|antidiarrheals|mesh-list
110530137|NCT00650637|Calcium|calcium|mesh-list
110530138|NCT00650637|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110530139|NCT00650637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110530140|NCT00650637|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110530141|NCT00650637|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110194365|NCT00066846|Immunologic Factors|immunologic factors|mesh-ancestor
110530142|NCT00650637|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110530143|NCT00650637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110530144|NCT00650637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110530145|NCT00650637|Antiviral Agents|antiviral agents|mesh-ancestor
110530146|NCT00650637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110530147|NCT00650637|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110530148|NCT00650637|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110530149|NCT00650637|Antimetabolites|antimetabolites|mesh-ancestor
110530150|NCT00650637|Antacids|antacids|mesh-ancestor
110530151|NCT00650637|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110530152|NCT00650637|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110530153|NCT00650637|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110530154|NCT00650637|Protease Inhibitors|protease inhibitors|mesh-ancestor
110530155|NCT02650479|Exenatide|exenatide|mesh-list
110530156|NCT02650479|Moxifloxacin|moxifloxacin|mesh-list
110530157|NCT02650479|Palonosetron|palonosetron|mesh-list
110530158|NCT02650479|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110530159|NCT02650479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110530160|NCT02650479|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110530161|NCT02650479|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110530162|NCT02650479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110530163|NCT02650479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110530164|NCT02650479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110530165|NCT02650479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110530166|NCT02650479|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110530167|NCT02650479|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110530168|NCT02650479|Incretins|incretins|mesh-ancestor
110180926|NCT00129363|Antioxidants|antioxidants|mesh-ancestor
110530224|NCT02722694|Immunologic Factors|immunologic factors|mesh-ancestor
110530225|NCT02722694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110530226|NCT02722694|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110530227|NCT02722694|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110530228|NCT02722694|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110530229|NCT00650871|Casopitant|casopitant|mesh-list
110530230|NCT00650871|Antiemetics|antiemetics|mesh-ancestor
110530231|NCT00650871|Autonomic Agents|autonomic agents|mesh-ancestor
110530232|NCT00650871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110530233|NCT00650871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110530234|NCT00650871|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110530235|NCT00650871|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110530236|NCT00650871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110530237|NCT00650871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110530238|NCT02649621|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110530239|NCT02649621|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110530240|NCT02649465|Glimepiride|glimepiride|mesh-list
110530241|NCT02649465|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3H),2'-(2H)pyran)-3',4',5'-triol|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3h),2'-(2h)pyran)-3',4',5'-triol|mesh-list
110530242|NCT02649465|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110530243|NCT02649465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110530244|NCT02649465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110530245|NCT02649465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110530246|NCT02649465|Immunologic Factors|immunologic factors|mesh-ancestor
110530247|NCT02649465|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110530248|NCT02649465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110530249|NCT00651105|Vildagliptin|vildagliptin|mesh-list
110530250|NCT00651105|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110530251|NCT00651105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110530252|NCT00651105|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110530253|NCT00651105|Protease Inhibitors|protease inhibitors|mesh-ancestor
110530254|NCT00651105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110530255|NCT00651105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110530260|NCT04167267|Fexuprazan|fexuprazan|mesh-list
110530261|NCT04167267|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110530262|NCT02649075|Immunoglobulins|immunoglobulins|mesh-list
110530263|NCT02649075|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110530264|NCT02649075|Antibodies|antibodies|mesh-list
110530265|NCT02649075|Immunologic Factors|immunologic factors|mesh-ancestor
110530266|NCT02649075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110530267|NCT02644785|Protamines|protamines|mesh-list
110530268|NCT02644785|Heparin Antagonists|heparin antagonists|mesh-ancestor
110530269|NCT02644785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110530270|NCT02644785|Coagulants|coagulants|mesh-ancestor
110530271|NCT02644707|Selenium|selenium|mesh-list
110530272|NCT02644707|Antioxidants|antioxidants|mesh-ancestor
110530273|NCT02644707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110530274|NCT02644707|Protective Agents|protective agents|mesh-ancestor
110530275|NCT02644707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110530276|NCT02644707|Trace Elements|trace elements|mesh-ancestor
110530277|NCT02644707|Micronutrients|micronutrients|mesh-ancestor
110530278|NCT02711228|Immunoglobulins|immunoglobulins|mesh-list
110530279|NCT02711228|Antibodies|antibodies|mesh-list
110530280|NCT02711228|gamma-Globulins|gamma-globulins|mesh-list
110530281|NCT02711228|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110530282|NCT02711228|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110530283|NCT02711228|Immunologic Factors|immunologic factors|mesh-ancestor
110530284|NCT02711228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110530285|NCT02644863|Paclitaxel|paclitaxel|mesh-list
110530286|NCT02644863|Cisplatin|cisplatin|mesh-list
110530287|NCT02644863|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110530288|NCT02644863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110530289|NCT02644863|Tubulin Modulators|tubulin modulators|mesh-ancestor
110530290|NCT02644863|Antimitotic Agents|antimitotic agents|mesh-ancestor
110530291|NCT02644863|Mitosis Modulators|mitosis modulators|mesh-ancestor
110530292|NCT02644863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110530293|NCT00302744|Niacin|niacin|mesh-list
110530294|NCT00302744|Psilocybin|psilocybin|mesh-list
110530295|NCT00302744|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110530296|NCT00302744|Antimetabolites|antimetabolites|mesh-ancestor
110530297|NCT00302744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110530298|NCT00302744|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110530299|NCT00302744|Vasodilator Agents|vasodilator agents|mesh-ancestor
110530300|NCT00302744|Vitamin B Complex|vitamin b complex|mesh-ancestor
110530301|NCT00302744|Vitamins|vitamins|mesh-ancestor
110530302|NCT00302744|Micronutrients|micronutrients|mesh-ancestor
110530303|NCT00302744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110530304|NCT00302744|Hallucinogens|hallucinogens|mesh-ancestor
110530305|NCT00302744|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110530306|NCT02644629|Ketamine|ketamine|mesh-list
110530307|NCT02644629|Analgesics|analgesics|mesh-ancestor
110530308|NCT02644629|Sensory System Agents|sensory system agents|mesh-ancestor
110530309|NCT02644629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110530310|NCT02644629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110530311|NCT02644629|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110194407|NCT04732598|Bevacizumab|bevacizumab|mesh-list
110530312|NCT02644629|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110530313|NCT02644629|Anesthetics, General|anesthetics, general|mesh-ancestor
110530314|NCT02644629|Anesthetics|anesthetics|mesh-ancestor
110530315|NCT02644629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110530316|NCT02644629|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110530317|NCT02644629|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110530318|NCT02644629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110530319|NCT02644629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110530320|NCT00652665|Leflunomide|leflunomide|mesh-list
110530321|NCT00652665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110530322|NCT00652665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110530323|NCT00652665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110530324|NCT00652665|Immunologic Factors|immunologic factors|mesh-ancestor
110530325|NCT00652665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110530326|NCT02644551|Ciclopirox|ciclopirox|mesh-list
110530327|NCT02644551|Antifungal Agents|antifungal agents|mesh-ancestor
110530328|NCT02644551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110530329|NCT02644395|Amlodipine|amlodipine|mesh-list
110530330|NCT02644395|Chlorthalidone|chlorthalidone|mesh-list
110530338|NCT02644395|Diuretics|diuretics|mesh-ancestor
110530339|NCT02644395|Natriuretic Agents|natriuretic agents|mesh-ancestor
110530340|NCT02644395|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110530341|NCT04166565|Dexamethasone|dexamethasone|mesh-list
110530342|NCT04166565|Cyclophosphamide|cyclophosphamide|mesh-list
110530343|NCT04166565|Bortezomib|bortezomib|mesh-list
110530344|NCT04166565|Daratumumab|daratumumab|mesh-list
110530345|NCT04166565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110530346|NCT04166565|Immunologic Factors|immunologic factors|mesh-ancestor
110530347|NCT04166565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110530348|NCT04166565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110530349|NCT04166565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110530350|NCT04166565|Alkylating Agents|alkylating agents|mesh-ancestor
110530351|NCT04166565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110530352|NCT04166565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110530353|NCT04166565|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110530354|NCT04166565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110530355|NCT04166565|Antiemetics|antiemetics|mesh-ancestor
110530356|NCT04166565|Autonomic Agents|autonomic agents|mesh-ancestor
110530357|NCT04166565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110530358|NCT04166565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110530359|NCT04166565|Glucocorticoids|glucocorticoids|mesh-ancestor
110530360|NCT04166565|Hormones|hormones|mesh-ancestor
110530361|NCT04166565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110530362|NCT04166565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110530363|NCT02644473|Tranexamic Acid|tranexamic acid|mesh-list
110530364|NCT02644473|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110530365|NCT02644473|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110530366|NCT02644473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110530367|NCT02644473|Hemostatics|hemostatics|mesh-ancestor
110530368|NCT02644473|Coagulants|coagulants|mesh-ancestor
110530369|NCT02644083|Dimethyl Fumarate|dimethyl fumarate|mesh-list
110530370|NCT02644083|Dermatologic Agents|dermatologic agents|mesh-ancestor
110530371|NCT02644083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110530372|NCT02644083|Immunologic Factors|immunologic factors|mesh-ancestor
110530373|NCT02644083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110530374|NCT04005872|Calcium|calcium|mesh-list
110530375|NCT04005872|Fluorides|fluorides|mesh-list
110530376|NCT04005872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110530377|NCT04005872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110530378|NCT04005872|Cariostatic Agents|cariostatic agents|mesh-ancestor
110530379|NCT04005872|Protective Agents|protective agents|mesh-ancestor
110530380|NCT00652821|Tramadol|tramadol|mesh-list
110530381|NCT00652821|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110530382|NCT00652821|Narcotics|narcotics|mesh-ancestor
110530383|NCT00652821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110530384|NCT00652821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110530385|NCT00652821|Analgesics|analgesics|mesh-ancestor
110530386|NCT00652821|Sensory System Agents|sensory system agents|mesh-ancestor
110530387|NCT00652821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110530388|NCT02644161|Antidepressive Agents|antidepressive agents|mesh-list
110530389|NCT02644161|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110530390|NCT02535975|Metformin|metformin|mesh-list
110530391|NCT02535975|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110530392|NCT02535975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110530393|NCT02714036|Ibudilast|ibudilast|mesh-list
110530394|NCT02714036|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110530395|NCT02714036|Autonomic Agents|autonomic agents|mesh-ancestor
110530396|NCT02714036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110530397|NCT02714036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110530398|NCT02714036|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110530415|NCT04166253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110530416|NCT04166253|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110530417|NCT00653055|Cabergoline|cabergoline|mesh-list
110530418|NCT00653055|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110530419|NCT00653055|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110530420|NCT00653055|Dopamine Agonists|dopamine agonists|mesh-ancestor
110530421|NCT00653055|Dopamine Agents|dopamine agents|mesh-ancestor
110530422|NCT00653055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110530423|NCT00653055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110530424|NCT00653055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110530425|NCT02643147|Furosemide|furosemide|mesh-list
110530426|NCT02643147|Diuretics|diuretics|mesh-list
110530427|NCT02643147|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
110530428|NCT02643147|Natriuretic Agents|natriuretic agents|mesh-ancestor
110530429|NCT02643147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110530430|NCT02643147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110918894|NCT00260078|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110530431|NCT02643147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110530432|NCT02642913|Sorafenib|sorafenib|mesh-list
110530433|NCT02642913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110530434|NCT02642913|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110530435|NCT02642913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110530436|NCT02642913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110530437|NCT04165629|Aspirin|aspirin|mesh-list
110530438|NCT04165629|Clopidogrel|clopidogrel|mesh-list
110530439|NCT04165629|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110530440|NCT04165629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110530441|NCT04165629|Analgesics|analgesics|mesh-ancestor
110530442|NCT04165629|Sensory System Agents|sensory system agents|mesh-ancestor
110530443|NCT04165629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110530444|NCT04165629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110530445|NCT04165629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110530446|NCT04165629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110194453|NCT00399165|Testosterone|testosterone|mesh-list
110530447|NCT04165629|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110530448|NCT04165629|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110530449|NCT04165629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110530450|NCT04165629|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110530451|NCT04165629|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110530452|NCT04165629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110530453|NCT04165629|Antipyretics|antipyretics|mesh-ancestor
110530454|NCT04165629|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110530455|NCT04165629|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110530456|NCT04165629|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110180998|NCT00017147|Carmustine|carmustine|mesh-list
110530480|NCT02642601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110530481|NCT02642601|Gout Suppressants|gout suppressants|mesh-ancestor
110530482|NCT02642601|Tocolytic Agents|tocolytic agents|mesh-ancestor
110530483|NCT02642601|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110530484|NCT02642601|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110530485|NCT02642601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110530486|NCT02642601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110530487|NCT02709902|Adapalene|adapalene|mesh-list
110530488|NCT02709902|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
110530489|NCT02709902|Benzoyl Peroxide|benzoyl peroxide|mesh-list
110530490|NCT02709902|Dermatologic Agents|dermatologic agents|mesh-ancestor
110530491|NCT02709902|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110530492|NCT02709902|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110530493|NCT02709902|Analgesics|analgesics|mesh-ancestor
110530494|NCT02709902|Sensory System Agents|sensory system agents|mesh-ancestor
110530495|NCT02709902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110530496|NCT02709902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110530497|NCT02709902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110530498|NCT02709902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110530499|NCT02710604|Tenofovir|tenofovir|mesh-list
110530500|NCT02710604|Hexadecyloxypropyl 9-(2-(phosphonomethoxy)propyl)adenine|hexadecyloxypropyl 9-(2-(phosphonomethoxy)propyl)adenine|mesh-list
110530501|NCT02710604|Antiviral Agents|antiviral agents|mesh-ancestor
110530502|NCT02710604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110530503|NCT02710604|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110530504|NCT02710604|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110530505|NCT02710604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110530506|NCT02710604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110530507|NCT02710604|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110530508|NCT02710604|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110531062|NCT04302896|Dolutegravir|dolutegravir|mesh-list
110531063|NCT04302896|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
110918914|NCT04469114|Tofacitinib|tofacitinib|mesh-list
110531064|NCT04302896|Antiviral Agents|antiviral agents|mesh-ancestor
110531065|NCT04302896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110531066|NCT04302896|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110531067|NCT04302896|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110531068|NCT04302896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110531069|NCT04302896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110531070|NCT04302896|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110531071|NCT04302896|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110531072|NCT04302896|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110531372|NCT02632071|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110531374|NCT02632071|Tubulin Modulators|tubulin modulators|mesh-ancestor
110531375|NCT02632071|Antimitotic Agents|antimitotic agents|mesh-ancestor
110531376|NCT02632071|Mitosis Modulators|mitosis modulators|mesh-ancestor
110531377|NCT02632071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110531378|NCT02632071|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110531379|NCT02632071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110531381|NCT00879333|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110531382|NCT00879333|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110531383|NCT00879333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110531384|NCT00879333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110531385|NCT00879333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110531386|NCT00879333|Immunologic Factors|immunologic factors|mesh-ancestor
110531387|NCT00879333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110531388|NCT00879333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110531389|NCT02630823|Paclitaxel|paclitaxel|mesh-list
110531390|NCT02630823|Carboplatin|carboplatin|mesh-list
110531391|NCT02630823|Pembrolizumab|pembrolizumab|mesh-list
110531392|NCT02630823|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110531393|NCT02630823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110531394|NCT02630823|Tubulin Modulators|tubulin modulators|mesh-ancestor
110531470|NCT00666939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110531472|NCT00666939|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110531473|NCT00666939|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110531474|NCT00666939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110531475|NCT00666939|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110531476|NCT00666939|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110531477|NCT00666939|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110531478|NCT00666939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110531479|NCT00666939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110531480|NCT00666939|Antimanic Agents|antimanic agents|mesh-ancestor
110531481|NCT00667407|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110531482|NCT00667407|Albuterol|albuterol|mesh-list
110531483|NCT00667407|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110531484|NCT00667407|Autonomic Agents|autonomic agents|mesh-ancestor
110531485|NCT00667407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110531486|NCT00667407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110531487|NCT00667407|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110531488|NCT00667407|Respiratory System Agents|respiratory system agents|mesh-ancestor
110531489|NCT00667407|Tocolytic Agents|tocolytic agents|mesh-ancestor
110531490|NCT00667407|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110531491|NCT00667407|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110531492|NCT00667407|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110531493|NCT00667407|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110531494|NCT00667407|Adrenergic Agents|adrenergic agents|mesh-ancestor
110871902|NCT04908787|Paclitaxel|paclitaxel|mesh-list
110871903|NCT04908787|Doxorubicin|doxorubicin|mesh-list
110871904|NCT04908787|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110871905|NCT04908787|Topotecan|topotecan|mesh-list
110871906|NCT04908787|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110871907|NCT04908787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110871908|NCT04908787|Tubulin Modulators|tubulin modulators|mesh-ancestor
110871909|NCT04908787|Antimitotic Agents|antimitotic agents|mesh-ancestor
110871910|NCT04908787|Mitosis Modulators|mitosis modulators|mesh-ancestor
110871911|NCT04908787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110871912|NCT04908787|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110871913|NCT04908787|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110871914|NCT04908787|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110871915|NCT04908787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110871916|NCT04908787|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110871917|NCT04923139|Rivaroxaban|rivaroxaban|mesh-list
110871918|NCT04923139|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110871919|NCT04923139|Antithrombins|antithrombins|mesh-ancestor
110200475|NCT00047294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110872528|NCT02997176|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110872530|NCT02997176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110872531|NCT02997176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110872532|NCT03000452|Durvalumab|durvalumab|mesh-list
110872533|NCT03000452|Daratumumab|daratumumab|mesh-list
110872534|NCT03000452|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110872535|NCT03000452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110872536|NCT03664388|Clopidogrel|clopidogrel|mesh-list
110872537|NCT03664388|Ticagrelor|ticagrelor|mesh-list
110872538|NCT03664388|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110872539|NCT03664388|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110872540|NCT03664388|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110872541|NCT03664388|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110872542|NCT03664388|Purinergic Agents|purinergic agents|mesh-ancestor
110872543|NCT03664388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110872544|NCT03664388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110872545|NCT03664388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110872546|NCT01373164|Gemcitabine|gemcitabine|mesh-list
110872547|NCT01373164|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110872548|NCT01373164|Antimetabolites|antimetabolites|mesh-ancestor
110872570|NCT03312907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110872571|NCT02999672|Trastuzumab|trastuzumab|mesh-list
110872572|NCT02999672|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
110872573|NCT02999672|Maytansine|maytansine|mesh-list
110872574|NCT02999672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110872575|NCT02999672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110872576|NCT02999672|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110872577|NCT02999672|Tubulin Modulators|tubulin modulators|mesh-ancestor
110872578|NCT02999672|Antimitotic Agents|antimitotic agents|mesh-ancestor
110872579|NCT02999672|Mitosis Modulators|mitosis modulators|mesh-ancestor
110872580|NCT02999672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110872581|NCT02999672|Immunotoxins|immunotoxins|mesh-ancestor
110872582|NCT02999672|Immunoconjugates|immunoconjugates|mesh-ancestor
110872583|NCT02999672|Immunologic Factors|immunologic factors|mesh-ancestor
110872584|NCT02999672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110872585|NCT03664622|Ketamine|ketamine|mesh-list
110872586|NCT03664622|Morphine|morphine|mesh-list
110872587|NCT03664622|Analgesics|analgesics|mesh-ancestor
110872588|NCT03664622|Sensory System Agents|sensory system agents|mesh-ancestor
110872589|NCT03664622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110872590|NCT03664622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110872591|NCT03664622|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110872592|NCT03664622|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110872593|NCT03664622|Anesthetics, General|anesthetics, general|mesh-ancestor
110872594|NCT03664622|Anesthetics|anesthetics|mesh-ancestor
110872595|NCT03664622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110872596|NCT03664622|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110872597|NCT03664622|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110872598|NCT03664622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110872599|NCT03664622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110872600|NCT03664622|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110872601|NCT03664622|Narcotics|narcotics|mesh-ancestor
110872613|NCT04056182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110872614|NCT03573323|Ixekizumab|ixekizumab|mesh-list
110872615|NCT03573323|Dermatologic Agents|dermatologic agents|mesh-ancestor
110872616|NCT04058054|Histamine|histamine|mesh-list
110872617|NCT04058054|Histamine Agonists|histamine agonists|mesh-ancestor
110872618|NCT04058054|Histamine Agents|histamine agents|mesh-ancestor
110872619|NCT04058054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110872620|NCT04058054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110872621|NCT04058054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110872622|NCT04498286|Antibodies|antibodies|mesh-list
110872623|NCT04498286|Immunologic Factors|immunologic factors|mesh-ancestor
110872624|NCT04498286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110872625|NCT01069172|Dipivefrin|dipivefrin|mesh-list
110872626|NCT01069172|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110872627|NCT01069172|Adrenergic Agents|adrenergic agents|mesh-ancestor
110872628|NCT01069172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110872629|NCT01069172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110872630|NCT01069172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110872631|NCT04245280|Ropivacaine|ropivacaine|mesh-list
110872632|NCT04245280|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110872633|NCT04245280|Anesthetics, Local|anesthetics, local|mesh-ancestor
110872634|NCT04245280|Anesthetics|anesthetics|mesh-ancestor
110872635|NCT04245280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110872636|NCT04245280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110872637|NCT04245280|Sensory System Agents|sensory system agents|mesh-ancestor
110872638|NCT04245280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110872639|NCT03724955|Estradiol|estradiol|mesh-list
110872640|NCT03724955|Estrogens|estrogens|mesh-ancestor
110872641|NCT03724955|Hormones|hormones|mesh-ancestor
110872642|NCT03724955|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110872643|NCT03724955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110872644|NCT04220008|Mycophenolic Acid|mycophenolic acid|mesh-list
110872645|NCT04220008|Cyclophosphamide|cyclophosphamide|mesh-list
110872646|NCT04220008|Busulfan|busulfan|mesh-list
110872647|NCT04220008|Rituximab|rituximab|mesh-list
110872648|NCT04220008|Gemcitabine|gemcitabine|mesh-list
110872649|NCT04220008|Vorinostat|vorinostat|mesh-list
110872650|NCT04220008|Clofarabine|clofarabine|mesh-list
110872651|NCT04220008|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110872652|NCT04220008|Tacrolimus|tacrolimus|mesh-list
110872653|NCT04220008|Antibodies|antibodies|mesh-list
110872654|NCT04220008|Immunoglobulins|immunoglobulins|mesh-list
110872655|NCT04220008|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110872656|NCT04220008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110872657|NCT04220008|Immunologic Factors|immunologic factors|mesh-ancestor
110872658|NCT04220008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110872659|NCT04220008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110194522|NCT00067431|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110872660|NCT04220008|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110872661|NCT04220008|Alkylating Agents|alkylating agents|mesh-ancestor
110872662|NCT04220008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110872663|NCT04220008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110872664|NCT04220008|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110872665|NCT04220008|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110872666|NCT04220008|Antimetabolites|antimetabolites|mesh-ancestor
110872667|NCT04220008|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110872676|NCT03721991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110872677|NCT03721991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110872678|NCT03721991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110872679|NCT03721991|Histamine Antagonists|histamine antagonists|mesh-ancestor
110872680|NCT03721991|Histamine Agents|histamine agents|mesh-ancestor
110872681|NCT02911688|Vitamin E|vitamin e|mesh-list
110872682|NCT02911688|Tocopherols|tocopherols|mesh-list
110872684|NCT02911688|alpha-Tocopherol|alpha-tocopherol|mesh-list
110872685|NCT02911688|gamma-Tocopherol|gamma-tocopherol|mesh-list
110872686|NCT02911688|Vitamins|vitamins|mesh-ancestor
110872687|NCT02911688|Micronutrients|micronutrients|mesh-ancestor
110872688|NCT02911688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110872689|NCT02911688|Antioxidants|antioxidants|mesh-ancestor
110872690|NCT02911688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110872691|NCT02911688|Protective Agents|protective agents|mesh-ancestor
110872692|NCT05580250|Metformin|metformin|mesh-list
110872693|NCT05580250|Simvastatin|simvastatin|mesh-list
110872694|NCT05580250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110872695|NCT05580250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110872696|NCT05580250|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110872697|NCT05580250|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110872698|NCT05580250|Antimetabolites|antimetabolites|mesh-ancestor
110872699|NCT05580250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110872700|NCT05580250|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110872701|NCT05580250|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110872702|NCT05580250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110872703|NCT03431948|Nivolumab|nivolumab|mesh-list
110872704|NCT03431948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110872705|NCT03431948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110872706|NCT03431948|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110872707|NCT03431948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110872708|NCT03662516|Levonorgestrel|levonorgestrel|mesh-list
110872709|NCT03662516|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110872710|NCT03662516|Contraceptive Agents|contraceptive agents|mesh-list
110872711|NCT03662516|Contraceptives, Oral|contraceptives, oral|mesh-list
110872712|NCT03662516|Estradiol|estradiol|mesh-list
110872713|NCT03662516|Abrocitinib|abrocitinib|mesh-list
110872714|NCT03662516|Estrogens|estrogens|mesh-ancestor
110872715|NCT03662516|Hormones|hormones|mesh-ancestor
110872716|NCT03662516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110872717|NCT03662516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110872718|NCT03662516|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110872719|NCT03662516|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110872720|NCT03662516|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110590256|NCT00747279|Insulin|insulin|mesh-list
110872721|NCT03662516|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110872722|NCT03662516|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110872723|NCT03662516|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110872724|NCT03662516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110872725|NCT03662516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110872726|NCT03728465|Nivolumab|nivolumab|mesh-list
110872727|NCT03728465|Ipilimumab|ipilimumab|mesh-list
110872728|NCT03728465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110872729|NCT03728465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110872730|NCT03728465|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110872731|NCT03728465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110872732|NCT03662984|Ciprofibrate|ciprofibrate|mesh-list
110872733|NCT03662984|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110872734|NCT03662984|Antimetabolites|antimetabolites|mesh-ancestor
110872741|NCT02994056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110872742|NCT03728153|Fluoxetine|fluoxetine|mesh-list
110872743|NCT03728153|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110872744|NCT03728153|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110872745|NCT03728153|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110872746|NCT03728153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110918976|NCT02971605|Psilocybin|psilocybin|mesh-list
110872747|NCT03728153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110872748|NCT03728153|Serotonin Agents|serotonin agents|mesh-ancestor
110872749|NCT03728153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110872750|NCT03728153|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110872751|NCT03728153|Antidepressive Agents|antidepressive agents|mesh-ancestor
110872752|NCT03728153|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110872753|NCT03728153|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110872754|NCT03728153|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110872755|NCT03728153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110872756|NCT04056806|Ceftriaxone|ceftriaxone|mesh-list
110872757|NCT04056806|Terlipressin|terlipressin|mesh-list
110872758|NCT04056806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110872759|NCT04056806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110872760|NCT04056806|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110872761|NCT04056806|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110872762|NCT03305575|Bupivacaine|bupivacaine|mesh-list
110872763|NCT03305575|Chloroprocaine|chloroprocaine|mesh-list
110872764|NCT03305575|Anesthetics, Local|anesthetics, local|mesh-ancestor
110872765|NCT03305575|Anesthetics|anesthetics|mesh-ancestor
110872766|NCT03305575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110872767|NCT03305575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110872768|NCT03305575|Sensory System Agents|sensory system agents|mesh-ancestor
110872769|NCT03305575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110872770|NCT02993822|Maleic acid|maleic acid|mesh-list
110872771|NCT02993822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110872772|NCT02993822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110872773|NCT02391844|Oxycodone|oxycodone|mesh-list
110872774|NCT02391844|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110872775|NCT02391844|Narcotics|narcotics|mesh-ancestor
110872776|NCT02391844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110872777|NCT02391844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110872778|NCT02391844|Analgesics|analgesics|mesh-ancestor
110872779|NCT02391844|Sensory System Agents|sensory system agents|mesh-ancestor
110872780|NCT02391844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110872781|NCT02391688|Fexofenadine|fexofenadine|mesh-list
110872782|NCT02391688|Flurbiprofen|flurbiprofen|mesh-list
110872783|NCT02391688|Midazolam|midazolam|mesh-list
110872784|NCT02391688|Dextromethorphan|dextromethorphan|mesh-list
110872785|NCT02391688|Caffeine|caffeine|mesh-list
110872786|NCT02391688|Bupropion|bupropion|mesh-list
110872787|NCT02391688|Omeprazole|omeprazole|mesh-list
110872788|NCT02391688|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110872789|NCT02391688|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110872790|NCT02391688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110872791|NCT02391688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110872792|NCT02391688|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110872793|NCT02391688|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110872794|NCT02391688|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110872795|NCT02391688|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110872796|NCT02391688|Anesthetics, General|anesthetics, general|mesh-ancestor
110590313|NCT00751959|Poractant alfa|poractant alfa|mesh-list
110872797|NCT02391688|Anesthetics|anesthetics|mesh-ancestor
110872798|NCT02391688|GABA Modulators|gaba modulators|mesh-ancestor
110872799|NCT02391688|GABA Agents|gaba agents|mesh-ancestor
110872800|NCT02391688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110872801|NCT02391688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110872802|NCT02391688|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110872803|NCT02391688|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110872809|NCT02391688|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110872810|NCT02391688|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110872811|NCT02391688|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110872812|NCT02391688|Antidepressive Agents|antidepressive agents|mesh-ancestor
110872813|NCT02391688|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110872814|NCT02391688|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110872815|NCT02391688|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110872816|NCT02391688|Dopamine Agents|dopamine agents|mesh-ancestor
110872817|NCT02391688|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110872818|NCT02391688|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110872819|NCT02391688|Antitussive Agents|antitussive agents|mesh-ancestor
110872820|NCT02391688|Respiratory System Agents|respiratory system agents|mesh-ancestor
110872821|NCT02391688|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110872822|NCT02391688|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110872824|NCT02391688|Sensory System Agents|sensory system agents|mesh-ancestor
110872825|NCT02391688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110872826|NCT02391688|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110872827|NCT02391688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110872828|NCT02391688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110872829|NCT02391688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110872830|NCT02391688|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110872831|NCT02391688|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110872832|NCT02391688|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110872833|NCT02391688|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110872834|NCT02391688|Histamine Antagonists|histamine antagonists|mesh-ancestor
110872835|NCT02391688|Histamine Agents|histamine agents|mesh-ancestor
110872836|NCT01068860|Insulin|insulin|mesh-list
110872837|NCT01068860|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110872838|NCT01068860|Metformin|metformin|mesh-list
110872839|NCT01068860|Glimepiride|glimepiride|mesh-list
110872840|NCT01068860|Insulin Lispro|insulin lispro|mesh-list
110872841|NCT01068860|Insulin, Isophane|insulin, isophane|mesh-list
110872842|NCT01068860|Glyburide|glyburide|mesh-list
110872843|NCT01068860|Glipizide|glipizide|mesh-list
110872844|NCT01068860|Troglitazone|troglitazone|mesh-list
110872845|NCT01068860|Tolbutamide|tolbutamide|mesh-list
110872846|NCT01068860|Acetohexamide|acetohexamide|mesh-list
110872847|NCT01068860|Insulin, Regular, Pork|insulin, regular, pork|mesh-list
110872848|NCT01068860|Tolazamide|tolazamide|mesh-list
110872849|NCT01068860|Chlorpropamide|chlorpropamide|mesh-list
110872850|NCT01068860|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110872851|NCT01068860|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110872852|NCT01068860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110872853|NCT01068860|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110872854|NCT01068860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110872855|NCT01068860|Immunologic Factors|immunologic factors|mesh-ancestor
110872856|NCT04056650|Caffeine|caffeine|mesh-list
110872857|NCT04056650|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110872858|NCT04056650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110872859|NCT04056650|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110872860|NCT04056650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110872861|NCT04056650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110872862|NCT04056650|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110872863|NCT04056650|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110872864|NCT04056650|Purinergic Agents|purinergic agents|mesh-ancestor
110872865|NCT04056650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110872866|NCT04055480|Insulin|insulin|mesh-list
110872867|NCT04055480|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110872868|NCT04055480|Insulin Aspart|insulin aspart|mesh-list
110872869|NCT04055480|Insulin, Short-Acting|insulin, short-acting|mesh-list
110872870|NCT04055480|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110872871|NCT04055480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110872872|NCT03158090|Lanreotide|lanreotide|mesh-list
110872873|NCT03158090|Octreotide|octreotide|mesh-list
110872874|NCT03158090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110872875|NCT03158090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110872899|NCT02991482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110872901|NCT02991482|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110872902|NCT02991482|Tubulin Modulators|tubulin modulators|mesh-ancestor
110872903|NCT02991482|Antimitotic Agents|antimitotic agents|mesh-ancestor
110872904|NCT02991482|Mitosis Modulators|mitosis modulators|mesh-ancestor
110872905|NCT02391142|Lidocaine|lidocaine|mesh-list
110872906|NCT02391142|Ropivacaine|ropivacaine|mesh-list
110872907|NCT02391142|Anesthetics, Local|anesthetics, local|mesh-ancestor
110872908|NCT02391142|Anesthetics|anesthetics|mesh-ancestor
110872909|NCT02391142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110872910|NCT02391142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110872911|NCT02391142|Sensory System Agents|sensory system agents|mesh-ancestor
110872912|NCT02391142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110872913|NCT02391142|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110872914|NCT02391142|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110872915|NCT02391142|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110872916|NCT02391142|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110872917|NCT02391142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110872918|NCT02987972|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110872919|NCT02987972|Immunologic Factors|immunologic factors|mesh-ancestor
110872920|NCT02987972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110872921|NCT04479202|Bentonite|bentonite|mesh-list
110872922|NCT04479202|Antidotes|antidotes|mesh-ancestor
110872923|NCT04479202|Protective Agents|protective agents|mesh-ancestor
110872924|NCT04479202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110872925|NCT01372618|Pasireotide|pasireotide|mesh-list
110872926|NCT01372618|Hormones|hormones|mesh-ancestor
110872927|NCT01372618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110872938|NCT04526509|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110872939|NCT04526509|Alkylating Agents|alkylating agents|mesh-ancestor
110872940|NCT04526509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110872941|NCT04526509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110872942|NCT04526509|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110872943|NCT03660020|Anesthetics|anesthetics|mesh-list
110872944|NCT03660020|Anesthetics, Local|anesthetics, local|mesh-list
110872945|NCT03660020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110872946|NCT03660020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110872947|NCT03660020|Sensory System Agents|sensory system agents|mesh-ancestor
110872948|NCT03660020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110872949|NCT03661892|Dronabinol|dronabinol|mesh-list
110872950|NCT03661892|Hallucinogens|hallucinogens|mesh-ancestor
110872951|NCT03661892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110872952|NCT03661892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110872953|NCT03661892|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110872954|NCT03661892|Analgesics|analgesics|mesh-ancestor
110872955|NCT03661892|Sensory System Agents|sensory system agents|mesh-ancestor
110872956|NCT03661892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110872957|NCT03661892|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
110872958|NCT03661892|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110872959|NCT03661892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110872960|NCT03661892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110872961|NCT03661892|Hormones|hormones|mesh-ancestor
110872962|NCT03661892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110872963|NCT03658850|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110872964|NCT03658850|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110872965|NCT03658850|Diuretics|diuretics|mesh-ancestor
110872966|NCT03658850|Natriuretic Agents|natriuretic agents|mesh-ancestor
110872967|NCT03658850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110872968|NCT03658850|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110872969|NCT03658850|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110872970|NCT03658850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110872971|NCT03659162|Antifungal Agents|antifungal agents|mesh-list
110872972|NCT03659162|Clotrimazole|clotrimazole|mesh-list
110872973|NCT03659162|Miconazole|miconazole|mesh-list
110872974|NCT03659162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110872975|NCT03659162|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110872976|NCT03659162|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110872977|NCT03659162|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110872978|NCT03659162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110872979|NCT03659162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110872980|NCT03659162|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110872981|NCT03659162|Hormone Antagonists|hormone antagonists|mesh-ancestor
110872982|NCT03659162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110872983|NCT03659162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110872984|NCT03659162|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110872985|NCT03659162|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110872987|NCT03659084|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110872988|NCT03659084|Chelating Agents|chelating agents|mesh-ancestor
110872989|NCT03659084|Sequestering Agents|sequestering agents|mesh-ancestor
110203889|NCT00053105|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110873023|NCT04397354|BB 1101|bb 1101|mesh-list
110873024|NCT04397354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110873025|NCT04397354|Antiemetics|antiemetics|mesh-ancestor
110873026|NCT04397354|Autonomic Agents|autonomic agents|mesh-ancestor
110873027|NCT04397354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110873028|NCT04397354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110873029|NCT04397354|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110873030|NCT04397354|Glucocorticoids|glucocorticoids|mesh-ancestor
110873031|NCT04397354|Hormones|hormones|mesh-ancestor
110873038|NCT03657758|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110873039|NCT03657758|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110873040|NCT03657758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110873041|NCT03657758|Antimetabolites|antimetabolites|mesh-ancestor
110873042|NCT03657758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110873043|NCT03657758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110873044|NCT03657758|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110873045|NCT03657758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110873046|NCT01068158|Ivermectin|ivermectin|mesh-list
110873047|NCT01068158|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110873048|NCT01068158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110873049|NCT03303079|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110873050|NCT03303079|Immunologic Factors|immunologic factors|mesh-ancestor
110873051|NCT03303079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110873052|NCT01067846|Cycloserine|cycloserine|mesh-list
110873053|NCT01067846|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110873054|NCT01067846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110873055|NCT01067846|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110873056|NCT01067846|Antitubercular Agents|antitubercular agents|mesh-ancestor
110873057|NCT01067846|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110873058|NCT01067846|Antimetabolites|antimetabolites|mesh-ancestor
110873059|NCT01067846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110873060|NCT03874234|GSK3186899|gsk3186899|mesh-list
110873061|NCT03874234|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110873062|NCT03874234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110873063|NCT03874234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110873064|NCT03657446|Moxifloxacin|moxifloxacin|mesh-list
110873065|NCT03657446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110873066|NCT03657446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110873067|NCT03657446|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110873068|NCT03657446|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110873069|NCT03657446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110873070|NCT03657446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110873071|NCT03657446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110873072|NCT05276323|Hydrocortisone|hydrocortisone|mesh-list
110194704|NCT00144703|Sirolimus|sirolimus|mesh-list
110873073|NCT05276323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110873074|NCT05275777|Paclitaxel|paclitaxel|mesh-list
110873075|NCT05275777|Cyclophosphamide|cyclophosphamide|mesh-list
110873076|NCT05275777|Doxorubicin|doxorubicin|mesh-list
110873077|NCT05275777|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110873078|NCT05275777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110873079|NCT05275777|Tubulin Modulators|tubulin modulators|mesh-ancestor
110873080|NCT05275777|Antimitotic Agents|antimitotic agents|mesh-ancestor
110873081|NCT05275777|Mitosis Modulators|mitosis modulators|mesh-ancestor
110873082|NCT05275777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110873083|NCT05275777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110873084|NCT05275777|Immunologic Factors|immunologic factors|mesh-ancestor
110873085|NCT05275777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110873086|NCT05275777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110873087|NCT05275777|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110919007|NCT04441112|Ketorolac|ketorolac|mesh-list
110873088|NCT05275777|Alkylating Agents|alkylating agents|mesh-ancestor
110873089|NCT05275777|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110873090|NCT05275777|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110873091|NCT05275777|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110873092|NCT05275777|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110873093|NCT05275777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110873095|NCT05672212|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110873096|NCT05672212|Narcotics|narcotics|mesh-ancestor
110873097|NCT05672212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110873098|NCT05672212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110873110|NCT02390674|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110873111|NCT02390674|Immunologic Factors|immunologic factors|mesh-ancestor
110873112|NCT02390674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110873113|NCT02390674|Antifungal Agents|antifungal agents|mesh-ancestor
110873114|NCT02390674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110873115|NCT02390674|Dermatologic Agents|dermatologic agents|mesh-ancestor
110873116|NCT02390674|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110873117|NCT02390674|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110873118|NCT02390596|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
110873119|NCT02390596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110873120|NCT02663674|Fluconazole|fluconazole|mesh-list
110873121|NCT02663674|Antifungal Agents|antifungal agents|mesh-ancestor
110873122|NCT02663674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110873123|NCT02663674|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110873124|NCT02663674|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110873125|NCT02663674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110873126|NCT02663674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110873127|NCT02663674|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110873128|NCT02663674|Hormone Antagonists|hormone antagonists|mesh-ancestor
110873129|NCT02663674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110873130|NCT02663674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110873131|NCT02663674|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110873132|NCT02663674|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110873133|NCT03657212|Zolpidem|zolpidem|mesh-list
110873134|NCT03657212|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110873135|NCT03657212|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110194729|NCT00071643|Serotonin Agents|serotonin agents|mesh-ancestor
110873136|NCT03657212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110873137|NCT03657212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110873138|NCT03657212|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
110873139|NCT03657212|GABA Agonists|gaba agonists|mesh-ancestor
110873140|NCT03657212|GABA Agents|gaba agents|mesh-ancestor
110873141|NCT03657212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110873142|NCT03657212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110873143|NCT03310411|Sumatriptan|sumatriptan|mesh-list
110873144|NCT03310411|Lasmiditan|lasmiditan|mesh-list
110873145|NCT03310411|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110873146|NCT03310411|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110873147|NCT03310411|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110873148|NCT03310411|Serotonin Agents|serotonin agents|mesh-ancestor
110873149|NCT03310411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110873150|NCT03310411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110873151|NCT03310411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110873152|NCT02909504|Lithium Carbonate|lithium carbonate|mesh-list
110873153|NCT02909504|Antidepressive Agents|antidepressive agents|mesh-ancestor
110873154|NCT02909504|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110873155|NCT02909504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110873156|NCT02909504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110873157|NCT02909504|Antimanic Agents|antimanic agents|mesh-ancestor
110873158|NCT02909504|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110873159|NCT02909504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110873160|NCT02909504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110873161|NCT02390440|Bupivacaine|bupivacaine|mesh-list
110873184|NCT05667454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110873185|NCT05667454|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110873186|NCT05667454|Respiratory System Agents|respiratory system agents|mesh-ancestor
110873187|NCT05667454|Mydriatics|mydriatics|mesh-ancestor
110873188|NCT05667454|Parasympatholytics|parasympatholytics|mesh-ancestor
110873189|NCT05667454|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110873190|NCT05667454|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110873191|NCT05667454|Cholinergic Agents|cholinergic agents|mesh-ancestor
110873192|NCT05667454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110873193|NCT05667454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110873194|NCT02389972|Dasatinib|dasatinib|mesh-list
110873195|NCT02389972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110873196|NCT02389972|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110873197|NCT02389972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110873198|NCT02389972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110873199|NCT03495232|Cimetidine|cimetidine|mesh-list
110873200|NCT03495232|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110873201|NCT03495232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110873202|NCT03495232|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110873203|NCT03495232|Histamine Antagonists|histamine antagonists|mesh-ancestor
110873204|NCT03495232|Histamine Agents|histamine agents|mesh-ancestor
110873205|NCT03495232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110873206|NCT03495232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110873207|NCT03495232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110873208|NCT03495232|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110873209|NCT03495232|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110873210|NCT03495232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110873211|NCT02389582|Enoxaparin|enoxaparin|mesh-list
110873212|NCT02389582|Dabigatran|dabigatran|mesh-list
110873213|NCT02389582|Anticoagulants|anticoagulants|mesh-ancestor
110873214|NCT02389582|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110873215|NCT02389582|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110203951|NCT00162643|Lamivudine|lamivudine|mesh-list
110873231|NCT02387242|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110873232|NCT02387242|Antitubercular Agents|antitubercular agents|mesh-ancestor
110873233|NCT02387242|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110873234|NCT02387242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110873235|NCT02387242|Leprostatic Agents|leprostatic agents|mesh-ancestor
110873236|NCT02387242|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110873237|NCT02387242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110873238|NCT02387242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110873239|NCT02387242|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110873240|NCT02387242|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110873241|NCT02387242|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110873242|NCT02387242|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110873243|NCT02387242|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110873244|NCT02387242|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110873245|NCT03656588|Iodine|iodine|mesh-list
110873246|NCT03656588|Chlorhexidine|chlorhexidine|mesh-list
110873247|NCT03656588|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110873248|NCT03656588|Cadexomer iodine|cadexomer iodine|mesh-list
110873249|NCT03656588|Hydrogen Peroxide|hydrogen peroxide|mesh-list
110873250|NCT03656588|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110873251|NCT03656588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110873252|NCT03656588|Disinfectants|disinfectants|mesh-ancestor
110873253|NCT03656588|Dermatologic Agents|dermatologic agents|mesh-ancestor
110873254|NCT03656588|Trace Elements|trace elements|mesh-ancestor
110873255|NCT03656588|Micronutrients|micronutrients|mesh-ancestor
110873256|NCT03656588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110873257|NCT02387086|Aspirin|aspirin|mesh-list
110873258|NCT02387086|Thalidomide|thalidomide|mesh-list
110873259|NCT02387086|Gefitinib|gefitinib|mesh-list
110919026|NCT02121990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110873260|NCT02387086|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110873261|NCT02387086|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110873262|NCT02387086|Analgesics|analgesics|mesh-ancestor
110873263|NCT02387086|Sensory System Agents|sensory system agents|mesh-ancestor
110873264|NCT02387086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110873265|NCT02387086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110873266|NCT02387086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110873267|NCT02387086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110873268|NCT02387086|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110873269|NCT02387086|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110873270|NCT02387086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110873271|NCT02387086|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110873272|NCT02387086|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110873273|NCT02387086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110873274|NCT02387086|Antipyretics|antipyretics|mesh-ancestor
110873275|NCT02387086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110873276|NCT02387086|Immunologic Factors|immunologic factors|mesh-ancestor
110873288|NCT02383030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110873289|NCT02383030|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110873290|NCT02383030|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110873291|NCT02383030|Hormone Antagonists|hormone antagonists|mesh-ancestor
110873292|NCT02383030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110873293|NCT02383030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110873294|NCT02388802|Immunosuppressive Agents|immunosuppressive agents|mesh-list
110873295|NCT02388802|Immunologic Factors|immunologic factors|mesh-ancestor
110873296|NCT02388802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110873297|NCT02983604|Fulvestrant|fulvestrant|mesh-list
110873298|NCT02983604|Exemestane|exemestane|mesh-list
110873299|NCT02983604|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110873300|NCT02983604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110873301|NCT02983604|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110873302|NCT02983604|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110873303|NCT02983604|Hormone Antagonists|hormone antagonists|mesh-ancestor
110873304|NCT02983604|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110873305|NCT02983604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110873306|NCT02983604|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110873307|NCT02983604|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110873308|NCT02983604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110873309|NCT02983604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110873310|NCT03656432|Fluorides|fluorides|mesh-list
110873311|NCT03656432|Cariostatic Agents|cariostatic agents|mesh-ancestor
110873312|NCT03656432|Protective Agents|protective agents|mesh-ancestor
110873313|NCT03656432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110873314|NCT02386462|Dexmedetomidine|dexmedetomidine|mesh-list
110873315|NCT02386462|Propofol|propofol|mesh-list
110873316|NCT02386462|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110873317|NCT02386462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110873318|NCT02386462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110590838|NCT00715520|Levodopa|levodopa|mesh-list
110873320|NCT02386462|Analgesics|analgesics|mesh-ancestor
110873321|NCT02386462|Sensory System Agents|sensory system agents|mesh-ancestor
110873322|NCT02386462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110873323|NCT02386462|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110873324|NCT02386462|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110873325|NCT02386462|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110873326|NCT02386462|Adrenergic Agents|adrenergic agents|mesh-ancestor
110873327|NCT02386462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110873328|NCT02386462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110873329|NCT02386462|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110873330|NCT02386462|Anesthetics, General|anesthetics, general|mesh-ancestor
110873331|NCT02386462|Anesthetics|anesthetics|mesh-ancestor
110873332|NCT02382328|Thioctic Acid|thioctic acid|mesh-list
110873333|NCT02382328|Antioxidants|antioxidants|mesh-ancestor
110873334|NCT02382328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110873335|NCT02382328|Protective Agents|protective agents|mesh-ancestor
110873336|NCT02382328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110873337|NCT02382328|Vitamin B Complex|vitamin b complex|mesh-ancestor
110873338|NCT02382328|Vitamins|vitamins|mesh-ancestor
110873339|NCT02382328|Micronutrients|micronutrients|mesh-ancestor
110873340|NCT02388490|Brentuximab Vedotin|brentuximab vedotin|mesh-list
110873347|NCT02382094|Bicalutamide|bicalutamide|mesh-list
110873348|NCT02382094|Androgen Antagonists|androgen antagonists|mesh-ancestor
110873349|NCT02382094|Hormone Antagonists|hormone antagonists|mesh-ancestor
110873350|NCT02382094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110873351|NCT02382094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110873352|NCT02382094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110873353|NCT02386150|Vaccines|vaccines|mesh-list
110873354|NCT02386150|Immunologic Factors|immunologic factors|mesh-ancestor
110873355|NCT02386150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110873356|NCT02377180|Anesthetics|anesthetics|mesh-list
110873357|NCT02377180|Anesthetics, Local|anesthetics, local|mesh-list
110873358|NCT02377180|Capsaicin|capsaicin|mesh-list
110873359|NCT02377180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110873360|NCT02377180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110873361|NCT02377180|Sensory System Agents|sensory system agents|mesh-ancestor
110873362|NCT02377180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110873363|NCT02377180|Antipruritics|antipruritics|mesh-ancestor
110873364|NCT02377180|Dermatologic Agents|dermatologic agents|mesh-ancestor
110873365|NCT03656042|Lenograstim|lenograstim|mesh-list
110873366|NCT03656042|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110873367|NCT03656042|Immunologic Factors|immunologic factors|mesh-ancestor
110873368|NCT03656042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110873369|NCT03655964|Olmesartan|olmesartan|mesh-list
110873370|NCT03655964|Nebivolol|nebivolol|mesh-list
110873371|NCT03655964|Antihypertensive Agents|antihypertensive agents|mesh-list
110873372|NCT03655964|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110873373|NCT03655964|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110873374|NCT03655964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110873375|NCT03655964|Vasodilator Agents|vasodilator agents|mesh-ancestor
110873376|NCT03655964|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
110873377|NCT03655964|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110873378|NCT03655964|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110873379|NCT03655964|Adrenergic Agents|adrenergic agents|mesh-ancestor
110873380|NCT03655964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110873381|NCT03655964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110873382|NCT02982590|Warfarin|warfarin|mesh-list
110873383|NCT02982590|Apixaban|apixaban|mesh-list
110873384|NCT02982590|Anticoagulants|anticoagulants|mesh-ancestor
110873385|NCT02982590|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110873386|NCT02982590|Antithrombins|antithrombins|mesh-ancestor
110873387|NCT02982590|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110873388|NCT02982590|Protease Inhibitors|protease inhibitors|mesh-ancestor
110873389|NCT02982590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110873390|NCT02982590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110873391|NCT02381548|Belinostat|belinostat|mesh-list
110590911|NCT00715208|Alkylating Agents|alkylating agents|mesh-ancestor
110873392|NCT02381548|Adavosertib|adavosertib|mesh-list
110873393|NCT02381548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110873394|NCT02381548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110873395|NCT02381548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110873396|NCT02381548|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110873397|NCT02381314|Ipilimumab|ipilimumab|mesh-list
110873398|NCT02381314|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110873399|NCT02381314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110873400|NCT02381314|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110873401|NCT02381314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110873402|NCT02386072|Mirabegron|mirabegron|mesh-list
110873403|NCT02386072|Oxybutynin|oxybutynin|mesh-list
110873404|NCT02386072|Muscarinic Antagonists|muscarinic antagonists|mesh-list
110873405|NCT02386072|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
110873406|NCT02386072|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110919049|NCT01060059|Exenatide|exenatide|mesh-list
110873407|NCT02386072|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110873408|NCT02386072|Adrenergic Agents|adrenergic agents|mesh-ancestor
110873409|NCT02386072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110873426|NCT02381470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110194868|NCT00203125|Adrenergic Agents|adrenergic agents|mesh-ancestor
110873427|NCT02381470|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110873428|NCT02381470|Antitubercular Agents|antitubercular agents|mesh-ancestor
110873429|NCT02381470|Leprostatic Agents|leprostatic agents|mesh-ancestor
110873430|NCT02381470|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110873431|NCT02381470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110873432|NCT02381470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110873433|NCT02381470|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110873434|NCT02381470|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110873435|NCT02381470|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110873436|NCT02381470|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110873437|NCT02381470|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110873438|NCT02381470|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110873439|NCT02381470|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110873440|NCT02381158|Beclomethasone|beclomethasone|mesh-list
110873441|NCT02381158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110873442|NCT02381158|Glucocorticoids|glucocorticoids|mesh-ancestor
110873443|NCT02381158|Hormones|hormones|mesh-ancestor
110873444|NCT02381158|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110873445|NCT02381158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110873446|NCT02381158|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110873447|NCT02381158|Respiratory System Agents|respiratory system agents|mesh-ancestor
110873448|NCT02381080|Voriconazole|voriconazole|mesh-list
110873449|NCT02381080|Erythromycin|erythromycin|mesh-list
110873450|NCT02381080|Erythromycin Estolate|erythromycin estolate|mesh-list
110873451|NCT02381080|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
110873452|NCT02381080|Erythromycin stearate|erythromycin stearate|mesh-list
110873453|NCT02381080|Antifungal Agents|antifungal agents|mesh-ancestor
110873454|NCT02381080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110873455|NCT02381080|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110873456|NCT02381080|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110873457|NCT02381080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110873458|NCT02381080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110873459|NCT02381080|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110873460|NCT02381080|Hormone Antagonists|hormone antagonists|mesh-ancestor
110873461|NCT02381080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110873462|NCT02381080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110873463|NCT02381080|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110873464|NCT02381080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110873465|NCT02381080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110590988|NCT00683475|Prednisone|prednisone|mesh-list
110204010|NCT00162799|Triflusal|triflusal|mesh-list
110873471|NCT04694248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110873472|NCT04694248|Analgesics|analgesics|mesh-ancestor
110873473|NCT04694248|Sensory System Agents|sensory system agents|mesh-ancestor
110873474|NCT04694248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110873475|NCT04694248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110873476|NCT04694248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110873477|NCT04694248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110873478|NCT04694248|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110873479|NCT04694248|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110873480|NCT04694248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110873481|NCT04694248|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110873482|NCT04694248|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110873483|NCT04694248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110873484|NCT04694248|Antipyretics|antipyretics|mesh-ancestor
110873485|NCT04694248|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110873486|NCT04694248|Antithrombins|antithrombins|mesh-ancestor
110919054|NCT01060059|Hormones|hormones|mesh-ancestor
110873487|NCT04694248|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110873488|NCT04694248|Protease Inhibitors|protease inhibitors|mesh-ancestor
110873490|NCT02376478|Sulfasalazine|sulfasalazine|mesh-list
110873491|NCT02376478|Adalimumab|adalimumab|mesh-list
110873492|NCT02376478|Infliximab|infliximab|mesh-list
110873493|NCT02376478|Etanercept|etanercept|mesh-list
110873494|NCT02376478|Methotrexate|methotrexate|mesh-list
110873495|NCT02376478|Mercaptopurine|mercaptopurine|mesh-list
110873496|NCT02376478|Folic Acid Antagonists|folic acid antagonists|mesh-list
110873497|NCT02376478|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110873498|NCT02376478|Abortifacient Agents|abortifacient agents|mesh-ancestor
110873499|NCT02376478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110873500|NCT02376478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110873501|NCT02376478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110873502|NCT02376478|Antimetabolites|antimetabolites|mesh-ancestor
110873503|NCT02376478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110873504|NCT02376478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110873505|NCT02376478|Dermatologic Agents|dermatologic agents|mesh-ancestor
110873506|NCT02376478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110873507|NCT02376478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110873508|NCT02376478|Immunologic Factors|immunologic factors|mesh-ancestor
110873509|NCT02376478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110873510|NCT02376478|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110873511|NCT02376478|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110873512|NCT02376478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110873513|NCT02376478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110873514|NCT02376478|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110873515|NCT02376478|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110873516|NCT02376478|Analgesics|analgesics|mesh-ancestor
110873517|NCT02376478|Sensory System Agents|sensory system agents|mesh-ancestor
110873518|NCT02376478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110873519|NCT02376478|Hematinics|hematinics|mesh-ancestor
110873520|NCT02376478|Vitamin B Complex|vitamin b complex|mesh-ancestor
110873521|NCT02376478|Vitamins|vitamins|mesh-ancestor
110873522|NCT02376478|Micronutrients|micronutrients|mesh-ancestor
110873523|NCT02376478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110873524|NCT02385448|Dienogest|dienogest|mesh-list
110873525|NCT02385448|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
110873526|NCT02385448|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
110873527|NCT02385448|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110873528|NCT02385448|Contraceptive Agents|contraceptive agents|mesh-ancestor
110873529|NCT02385448|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110873530|NCT02385448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110873531|NCT02385448|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110873532|NCT02385448|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110873533|NCT02385448|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110873534|NCT02385448|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110873535|NCT02385448|Hormone Antagonists|hormone antagonists|mesh-ancestor
110873536|NCT02385448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110204015|NCT00044811|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110873543|NCT02385448|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
110873544|NCT02376400|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
110873545|NCT02376400|Antiviral Agents|antiviral agents|mesh-ancestor
110873546|NCT02376400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110873547|NCT02385058|Mebendazole|mebendazole|mesh-list
110873548|NCT02385058|Piperazine|piperazine|mesh-list
110873549|NCT02385058|Piperazine citrate|piperazine citrate|mesh-list
110873550|NCT02385058|DMP 777|dmp 777|mesh-list
110873551|NCT02385058|Antinematodal Agents|antinematodal agents|mesh-ancestor
110873552|NCT02385058|Anthelmintics|anthelmintics|mesh-ancestor
110873553|NCT02385058|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110873554|NCT02385058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110873555|NCT02385058|Tubulin Modulators|tubulin modulators|mesh-ancestor
110873556|NCT02385058|Antimitotic Agents|antimitotic agents|mesh-ancestor
110873557|NCT02385058|Mitosis Modulators|mitosis modulators|mesh-ancestor
110873558|NCT02385058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110873559|NCT02385058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110873560|NCT02385058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110873561|NCT02376088|Methimazole|methimazole|mesh-list
110873562|NCT02376088|Antithyroid Agents|antithyroid agents|mesh-ancestor
110873563|NCT02376088|Hormone Antagonists|hormone antagonists|mesh-ancestor
110873564|NCT02376088|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110873565|NCT02376088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110873566|NCT03310021|Rivaroxaban|rivaroxaban|mesh-list
110873567|NCT03310021|Apixaban|apixaban|mesh-list
110873568|NCT03310021|Edoxaban|edoxaban|mesh-list
110873569|NCT03310021|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110873570|NCT03310021|Antithrombins|antithrombins|mesh-ancestor
110873571|NCT03310021|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110873572|NCT03310021|Protease Inhibitors|protease inhibitors|mesh-ancestor
110873573|NCT03310021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110873574|NCT03310021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110873575|NCT03310021|Anticoagulants|anticoagulants|mesh-ancestor
110873576|NCT03333109|Erenumab|erenumab|mesh-list
110873577|NCT03333109|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
110873578|NCT03333109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110873579|NCT03333109|Analgesics|analgesics|mesh-ancestor
110873580|NCT03333109|Sensory System Agents|sensory system agents|mesh-ancestor
110873581|NCT03333109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110873582|NCT03333109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110873583|NCT02940223|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
110873584|NCT02940223|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110873585|NCT02940223|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110194934|NCT00038831|Melphalan|melphalan|mesh-list
110873586|NCT01312831|Vitamin B 12|vitamin b 12|mesh-list
110873587|NCT01312831|Hydroxocobalamin|hydroxocobalamin|mesh-list
110873588|NCT01312831|Vitamins|vitamins|mesh-ancestor
110873589|NCT01312831|Micronutrients|micronutrients|mesh-ancestor
110873590|NCT01312831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110873591|NCT01312831|Vitamin B Complex|vitamin b complex|mesh-ancestor
110873592|NCT01312831|Hematinics|hematinics|mesh-ancestor
110873593|NCT04431193|Oxytocin|oxytocin|mesh-list
110873594|NCT04431193|Oxytocics|oxytocics|mesh-ancestor
110873595|NCT04431193|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110873596|NCT04431193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110873597|NCT03293485|Imipenem|imipenem|mesh-list
110873598|NCT03293485|Relebactam|relebactam|mesh-list
110873599|NCT03293485|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
110873600|NCT03293485|Cilastatin|cilastatin|mesh-list
110873601|NCT03293485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110873602|NCT03293485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110873603|NCT03293485|Protease Inhibitors|protease inhibitors|mesh-ancestor
110873604|NCT03293485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110873622|NCT03331315|Ketorolac|ketorolac|mesh-list
110873623|NCT03331315|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110873624|NCT03331315|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110873625|NCT03331315|Analgesics|analgesics|mesh-ancestor
110873626|NCT03331315|Sensory System Agents|sensory system agents|mesh-ancestor
110873627|NCT03331315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110873628|NCT03331315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110873629|NCT03331315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110873630|NCT03331315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110873631|NCT03331315|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110873632|NCT03331315|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110873633|NCT03331315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110873634|NCT03331315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110873635|NCT03287869|Brexpiprazole|brexpiprazole|mesh-list
110873636|NCT03287869|Serotonin Agents|serotonin agents|mesh-ancestor
110873637|NCT03287869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110873638|NCT03287869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110873639|NCT03287869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110873640|NCT03287869|Dopamine Agonists|dopamine agonists|mesh-ancestor
110873641|NCT03287869|Dopamine Agents|dopamine agents|mesh-ancestor
110873642|NCT02661490|Vaccines|vaccines|mesh-list
110873643|NCT02661490|Immunologic Factors|immunologic factors|mesh-ancestor
110873644|NCT02661490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110873645|NCT03287791|Azelaic acid|azelaic acid|mesh-list
110873646|NCT03287791|Sunscreening Agents|sunscreening agents|mesh-list
110873647|NCT03287791|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110873648|NCT03287791|Protective Agents|protective agents|mesh-ancestor
110873649|NCT03287791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110873650|NCT03287791|Dermatologic Agents|dermatologic agents|mesh-ancestor
110873651|NCT03287791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110873652|NCT03287635|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
110873653|NCT03287635|Hormones|hormones|mesh-ancestor
110873654|NCT03287635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110873655|NCT03287635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110873656|NCT03287089|Nitrofurantoin|nitrofurantoin|mesh-list
110873657|NCT03287089|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110873658|NCT03287089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110873659|NCT03287089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110873660|NCT02380768|Chlorhexidine|chlorhexidine|mesh-list
110873668|NCT02385136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110873669|NCT02940691|Grazoprevir|grazoprevir|mesh-list
110873670|NCT02940691|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
110873671|NCT02940691|Antiviral Agents|antiviral agents|mesh-ancestor
110873672|NCT02940691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110873673|NCT04949269|Deucravacitinib|deucravacitinib|mesh-list
110873675|NCT04949269|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110873676|NCT04949269|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110873677|NCT04949269|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110873678|NCT04949269|Histamine Antagonists|histamine antagonists|mesh-ancestor
110873679|NCT04949269|Histamine Agents|histamine agents|mesh-ancestor
110873680|NCT04949269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110873681|NCT04949269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110873682|NCT04949269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110873683|NCT04949269|Dermatologic Agents|dermatologic agents|mesh-ancestor
110873684|NCT04949269|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110873685|NCT04949269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110873686|NCT02379754|Gentamicins|gentamicins|mesh-list
110873687|NCT02379754|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110873688|NCT02379754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110873689|NCT02379754|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110873690|NCT02379754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110873691|NCT02379754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110873692|NCT04914793|Anti-Infective Agents|anti-infective agents|mesh-list
110873693|NCT04914793|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110873695|NCT01313377|Oxaliplatin|oxaliplatin|mesh-list
110873696|NCT01313377|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110873697|NCT01313377|Antimetabolites|antimetabolites|mesh-ancestor
110873698|NCT01313377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110873699|NCT01313377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110873700|NCT02384746|Fulvestrant|fulvestrant|mesh-list
110873701|NCT02384746|Ixazomib|ixazomib|mesh-list
110873702|NCT02384746|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110873703|NCT02384746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110873704|NCT02384746|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110873705|NCT02384746|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110873706|NCT02384746|Hormone Antagonists|hormone antagonists|mesh-ancestor
110873707|NCT02384746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110873708|NCT02384746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110873709|NCT02384746|Protease Inhibitors|protease inhibitors|mesh-ancestor
110873710|NCT02384746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110873711|NCT02384746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110873712|NCT02375464|Octreotide|octreotide|mesh-list
110873713|NCT02375464|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110873714|NCT02375464|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110873715|NCT02375464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110873716|NCT03113344|Amoxicillin|amoxicillin|mesh-list
110873717|NCT03113344|Azithromycin|azithromycin|mesh-list
110873718|NCT03113344|Meropenem|meropenem|mesh-list
110873719|NCT03113344|Ceftriaxone|ceftriaxone|mesh-list
110873720|NCT03113344|Penicillins|penicillins|mesh-list
110873721|NCT03113344|Imipenem|imipenem|mesh-list
110873722|NCT03113344|Erythromycin|erythromycin|mesh-list
110873723|NCT03113344|Ceftazidime|ceftazidime|mesh-list
110873724|NCT03113344|Ampicillin|ampicillin|mesh-list
110873725|NCT03113344|Cephalosporins|cephalosporins|mesh-list
110873726|NCT03113344|Acyclovir|acyclovir|mesh-list
110873727|NCT03113344|Ganciclovir|ganciclovir|mesh-list
110873728|NCT03113344|Antiviral Agents|antiviral agents|mesh-list
110873729|NCT03113344|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110873730|NCT03113344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110873731|NCT03113344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110873736|NCT03113266|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110873737|NCT03113266|Immunologic Factors|immunologic factors|mesh-ancestor
110873738|NCT03113266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110873739|NCT02379676|Clopidogrel|clopidogrel|mesh-list
110873740|NCT02379676|Ticagrelor|ticagrelor|mesh-list
110873741|NCT02379676|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110873742|NCT02379676|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110873743|NCT02379676|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110873744|NCT02379676|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110873745|NCT02379676|Purinergic Agents|purinergic agents|mesh-ancestor
110873746|NCT02379676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110873747|NCT02379676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110873748|NCT02379676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110873749|NCT04715230|Lorazepam|lorazepam|mesh-list
110873750|NCT04715230|Haloperidol|haloperidol|mesh-list
110873751|NCT04715230|Haloperidol decanoate|haloperidol decanoate|mesh-list
110873752|NCT04715230|Antiemetics|antiemetics|mesh-ancestor
110873753|NCT04715230|Autonomic Agents|autonomic agents|mesh-ancestor
110873754|NCT04715230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110873755|NCT04715230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110873756|NCT04715230|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110873757|NCT04715230|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110873758|NCT04715230|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110873759|NCT04715230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110873760|NCT04715230|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110873761|NCT04715230|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110873762|NCT04715230|Dopamine Agents|dopamine agents|mesh-ancestor
110873763|NCT04715230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110873764|NCT04715230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110873765|NCT04715230|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110873766|NCT04715230|Anticonvulsants|anticonvulsants|mesh-ancestor
110873767|NCT04715230|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110873768|NCT04715230|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110873769|NCT04715230|GABA Modulators|gaba modulators|mesh-ancestor
110873770|NCT04715230|GABA Agents|gaba agents|mesh-ancestor
110873771|NCT02378740|Ketamine|ketamine|mesh-list
110873772|NCT02378740|Analgesics|analgesics|mesh-ancestor
110873773|NCT02378740|Sensory System Agents|sensory system agents|mesh-ancestor
110873774|NCT02378740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110873775|NCT02378740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110873776|NCT02378740|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110873777|NCT02378740|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110873778|NCT02378740|Anesthetics, General|anesthetics, general|mesh-ancestor
110873779|NCT02378740|Anesthetics|anesthetics|mesh-ancestor
110873780|NCT02378740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110873781|NCT02378740|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110873782|NCT02378740|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110873783|NCT02378740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110873784|NCT02378740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110873785|NCT01411267|Cytarabine|cytarabine|mesh-list
110873786|NCT01411267|Methotrexate|methotrexate|mesh-list
110873787|NCT01411267|Etoposide|etoposide|mesh-list
110873788|NCT01411267|Etoposide phosphate|etoposide phosphate|mesh-list
110873789|NCT01411267|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110873790|NCT01411267|Abortifacient Agents|abortifacient agents|mesh-ancestor
110873791|NCT01411267|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110873792|NCT01411267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110873793|NCT01411267|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110873795|NCT01411267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110873796|NCT01411267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110873797|NCT01411267|Dermatologic Agents|dermatologic agents|mesh-ancestor
110873798|NCT01411267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110873799|NCT01411267|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110873800|NCT01411267|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110873801|NCT01411267|Immunologic Factors|immunologic factors|mesh-ancestor
110873802|NCT01411267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110873823|NCT01370031|Charcoal|charcoal|mesh-list
110873824|NCT01370031|Antidotes|antidotes|mesh-ancestor
110873825|NCT01370031|Protective Agents|protective agents|mesh-ancestor
110873826|NCT01370031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110873827|NCT02373514|Acetaminophen|acetaminophen|mesh-list
110873828|NCT02373514|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
110873829|NCT02373514|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110873830|NCT02373514|Analgesics|analgesics|mesh-ancestor
110873831|NCT02373514|Sensory System Agents|sensory system agents|mesh-ancestor
110873832|NCT02373514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110873833|NCT02373514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110873834|NCT02373514|Antipyretics|antipyretics|mesh-ancestor
110873835|NCT02373514|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110873836|NCT02373514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110873837|NCT02373514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110873838|NCT01364493|Capecitabine|capecitabine|mesh-list
110873839|NCT01364493|Oxaliplatin|oxaliplatin|mesh-list
110873840|NCT01364493|Trastuzumab|trastuzumab|mesh-list
110873841|NCT01364493|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110873842|NCT01364493|Antimetabolites|antimetabolites|mesh-ancestor
110873843|NCT01364493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110873844|NCT01364493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110873845|NCT01364493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110873846|NCT01370187|Montelukast|montelukast|mesh-list
110873847|NCT01370187|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110873848|NCT01370187|Respiratory System Agents|respiratory system agents|mesh-ancestor
110873849|NCT01370187|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110873850|NCT01370187|Hormone Antagonists|hormone antagonists|mesh-ancestor
110873851|NCT01370187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110873852|NCT01370187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110873853|NCT01370187|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110873854|NCT01370187|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110873855|NCT01370187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110873865|NCT04483960|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110873866|NCT04483960|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110873867|NCT04483960|Analgesics|analgesics|mesh-ancestor
110873868|NCT04483960|Sensory System Agents|sensory system agents|mesh-ancestor
110873869|NCT04483960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110873870|NCT04483960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110873871|NCT04483960|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110062063|NCT05255601|Relatlimab|relatlimab|mesh-list
110873872|NCT04483960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110873873|NCT04483960|Protease Inhibitors|protease inhibitors|mesh-ancestor
110873874|NCT04483960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110873875|NCT04483960|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
110873876|NCT04483960|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110873877|NCT04483960|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
110873878|NCT04483960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110873879|NCT04483960|Immunologic Factors|immunologic factors|mesh-ancestor
110873880|NCT01370343|Nicotinic Acids|nicotinic acids|mesh-list
110873881|NCT01370343|Cyclosporine|cyclosporine|mesh-list
110873882|NCT01370343|Cyclosporins|cyclosporins|mesh-list
110873883|NCT01370343|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1h-imidazol-1-yl)propanamido)nicotinic acid|mesh-list
110873884|NCT01370343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110873885|NCT01370343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110873886|NCT01370343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110873887|NCT01370343|Immunologic Factors|immunologic factors|mesh-ancestor
110873888|NCT01370343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110873889|NCT01370343|Antifungal Agents|antifungal agents|mesh-ancestor
110873890|NCT01370343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110873891|NCT01370343|Dermatologic Agents|dermatologic agents|mesh-ancestor
110873892|NCT01370343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110873893|NCT01370343|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110873894|NCT01370343|Vitamin B Complex|vitamin b complex|mesh-ancestor
110873895|NCT01370343|Vitamins|vitamins|mesh-ancestor
110873896|NCT01370343|Micronutrients|micronutrients|mesh-ancestor
110873897|NCT01368003|Dutasteride|dutasteride|mesh-list
110873898|NCT01368003|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
110873899|NCT01368003|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110873900|NCT01368003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110873901|NCT01368003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110873902|NCT01368003|Hormone Antagonists|hormone antagonists|mesh-ancestor
110873903|NCT01368003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110873904|NCT01368003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110873905|NCT01364571|Vaccines|vaccines|mesh-list
110873906|NCT01364571|Immunologic Factors|immunologic factors|mesh-ancestor
110873907|NCT01364571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110873912|NCT03933904|Sirolimus|sirolimus|mesh-list
110873913|NCT03933904|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110873914|NCT03933904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110873915|NCT03933904|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110873916|NCT03933904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110591455|NCT04082858|Midazolam|midazolam|mesh-list
110873917|NCT03933904|Antifungal Agents|antifungal agents|mesh-ancestor
110873918|NCT03933904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110873919|NCT03933904|Immunologic Factors|immunologic factors|mesh-ancestor
110873920|NCT03933904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110873921|NCT02377648|Everolimus|everolimus|mesh-list
110873922|NCT02377648|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110873923|NCT02377648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110873924|NCT02377648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110873925|NCT02377648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110873939|NCT01364805|Micronutrients|micronutrients|mesh-ancestor
110873940|NCT01364805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110873941|NCT01364805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110873942|NCT01364805|Antimetabolites|antimetabolites|mesh-ancestor
110873943|NCT01364805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110873944|NCT01364805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110873945|NCT01364805|Antioxidants|antioxidants|mesh-ancestor
110873946|NCT01364805|Protective Agents|protective agents|mesh-ancestor
110873947|NCT01370889|Resveratrol|resveratrol|mesh-list
110873948|NCT01370889|Antioxidants|antioxidants|mesh-ancestor
110873949|NCT01370889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110873950|NCT01370889|Protective Agents|protective agents|mesh-ancestor
110873951|NCT01370889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110873952|NCT01370889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110873953|NCT01370889|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110873954|NCT02373046|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
110873955|NCT02373046|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110873956|NCT02373046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110873957|NCT02373046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110873958|NCT02373046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110873959|NCT04382404|Sofosbuvir|sofosbuvir|mesh-list
110873960|NCT04382404|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
110873961|NCT04382404|Velpatasvir|velpatasvir|mesh-list
110873962|NCT04382404|Antiviral Agents|antiviral agents|mesh-ancestor
110873963|NCT04382404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110873964|NCT02371096|Rituximab|rituximab|mesh-list
110873965|NCT02371096|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110873966|NCT02371096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110873967|NCT02371096|Immunologic Factors|immunologic factors|mesh-ancestor
110873968|NCT02371096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110873969|NCT02371096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110873970|NCT04420455|Enoximone|enoximone|mesh-list
110873971|NCT04420455|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110873972|NCT04420455|Vasodilator Agents|vasodilator agents|mesh-ancestor
110873973|NCT04420455|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110873974|NCT04420455|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110873975|NCT04420455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110873976|NCT04420455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110873977|NCT04420455|Protective Agents|protective agents|mesh-ancestor
110873978|NCT04420455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110873979|NCT04381936|Aspirin|aspirin|mesh-list
110873980|NCT04381936|Empagliflozin|empagliflozin|mesh-list
110873981|NCT04381936|Ritonavir|ritonavir|mesh-list
110873982|NCT04381936|Lopinavir|lopinavir|mesh-list
110873983|NCT04381936|Azithromycin|azithromycin|mesh-list
110873984|NCT04381936|Hydroxychloroquine|hydroxychloroquine|mesh-list
110873985|NCT04381936|Nirmatrelvir|nirmatrelvir|mesh-list
110873986|NCT04381936|Sotrovimab|sotrovimab|mesh-list
110873987|NCT04381936|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
110873988|NCT04381936|Molnupiravir|molnupiravir|mesh-list
110873989|NCT04381936|Casirivimab and imdevimab drug combination|casirivimab and imdevimab drug combination|mesh-list
110873997|NCT04381936|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110873998|NCT04381936|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110873999|NCT04381936|Analgesics|analgesics|mesh-ancestor
110874000|NCT04381936|Sensory System Agents|sensory system agents|mesh-ancestor
110874001|NCT04381936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110874002|NCT04381936|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110874003|NCT04381936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110874004|NCT04381936|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110874005|NCT04381936|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110874006|NCT04381936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110874007|NCT04381936|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110874008|NCT04381936|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110874009|NCT04381936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110874010|NCT04381936|Antipyretics|antipyretics|mesh-ancestor
110874011|NCT04381936|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110874012|NCT04381936|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110874013|NCT04381936|Protease Inhibitors|protease inhibitors|mesh-ancestor
110874014|NCT04381936|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110874015|NCT04381936|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110874016|NCT04381936|Antiviral Agents|antiviral agents|mesh-ancestor
110874017|NCT04381936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110874018|NCT04381936|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110874019|NCT04381936|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110874020|NCT04381936|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110874021|NCT04381936|Antimalarials|antimalarials|mesh-ancestor
110874022|NCT04381936|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110874023|NCT04381936|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110874024|NCT04381936|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110874025|NCT04381936|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110874026|NCT04381936|Gout Suppressants|gout suppressants|mesh-ancestor
110874027|NCT04381936|Tubulin Modulators|tubulin modulators|mesh-ancestor
110874028|NCT04381936|Antimitotic Agents|antimitotic agents|mesh-ancestor
110874029|NCT04381936|Mitosis Modulators|mitosis modulators|mesh-ancestor
110874030|NCT04381936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110919132|NCT03651531|Metformin|metformin|mesh-list
110874031|NCT04381936|Dermatologic Agents|dermatologic agents|mesh-ancestor
110874032|NCT04381936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110874033|NCT03124407|Capsaicin|capsaicin|mesh-list
110874034|NCT03124407|Antipruritics|antipruritics|mesh-ancestor
110874035|NCT03124407|Dermatologic Agents|dermatologic agents|mesh-ancestor
110874036|NCT03124407|Sensory System Agents|sensory system agents|mesh-ancestor
110874037|NCT03124407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110874038|NCT03124407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110874039|NCT01364961|Resveratrol|resveratrol|mesh-list
110874040|NCT01364961|Antioxidants|antioxidants|mesh-ancestor
110874041|NCT01364961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110874042|NCT01364961|Protective Agents|protective agents|mesh-ancestor
110874043|NCT01364961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110874044|NCT01364961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110874045|NCT01364961|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110874046|NCT02370862|Glycopyrrolate|glycopyrrolate|mesh-list
110874047|NCT02370862|Neostigmine|neostigmine|mesh-list
110874048|NCT02370862|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110874049|NCT02370862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110874050|NCT02370862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110874051|NCT02370862|Cholinergic Agents|cholinergic agents|mesh-ancestor
110874052|NCT02370862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110874053|NCT02370862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110874054|NCT02370862|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110874055|NCT02370862|Autonomic Agents|autonomic agents|mesh-ancestor
110874056|NCT02370862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110874057|NCT02370862|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110874058|NCT02370862|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110874065|NCT02373280|Amoxicillin|amoxicillin|mesh-list
110591581|NCT02559141|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110874066|NCT02373280|Moxifloxacin|moxifloxacin|mesh-list
110874067|NCT02373280|Metronidazole|metronidazole|mesh-list
110874068|NCT02373280|Clarithromycin|clarithromycin|mesh-list
110874069|NCT02373280|Esomeprazole|esomeprazole|mesh-list
110874070|NCT02373280|Bismuth|bismuth|mesh-list
110874071|NCT02373280|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
110874072|NCT02373280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110874073|NCT02373280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110874074|NCT02373280|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110874075|NCT02373280|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110874076|NCT02373280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110874077|NCT02373280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110874078|NCT02373280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110874079|NCT02373280|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110874080|NCT02373280|Contraceptive Agents|contraceptive agents|mesh-ancestor
110874081|NCT02373280|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110874082|NCT02373280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110874083|NCT02373280|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110874084|NCT02373280|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110874085|NCT02373280|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110874086|NCT02373280|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110874087|NCT02373280|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110874088|NCT02373280|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110874089|NCT02373280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110874090|NCT02373280|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110874091|NCT02373280|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110874092|NCT02373280|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110874093|NCT02373280|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110874094|NCT02373280|Antacids|antacids|mesh-ancestor
110874095|NCT02370550|Cyclosporine|cyclosporine|mesh-list
110874096|NCT02370550|Prednisone|prednisone|mesh-list
110874097|NCT02370550|Calcium Carbonate|calcium carbonate|mesh-list
110874098|NCT02370550|Calcium|calcium|mesh-list
110874099|NCT02370550|Cyclosporins|cyclosporins|mesh-list
110874100|NCT02370550|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110874101|NCT02370550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110874102|NCT02370550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110874103|NCT02370550|Glucocorticoids|glucocorticoids|mesh-ancestor
110874104|NCT02370550|Hormones|hormones|mesh-ancestor
110874105|NCT02370550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110874106|NCT02370550|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110874107|NCT02370550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110874108|NCT02370550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110874109|NCT02370550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110874110|NCT02370550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110874111|NCT02370550|Immunologic Factors|immunologic factors|mesh-ancestor
110874112|NCT02370550|Antifungal Agents|antifungal agents|mesh-ancestor
110874113|NCT02370550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110874114|NCT02370550|Dermatologic Agents|dermatologic agents|mesh-ancestor
110874115|NCT02370550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110874116|NCT02370550|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110874117|NCT02370550|Antacids|antacids|mesh-ancestor
110874118|NCT02370550|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110874119|NCT02365402|Entecavir|entecavir|mesh-list
110874120|NCT02365402|Antiviral Agents|antiviral agents|mesh-ancestor
110874121|NCT02365402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110874122|NCT02364934|Propofol|propofol|mesh-list
110874123|NCT02364934|Sevoflurane|sevoflurane|mesh-list
110874124|NCT02364934|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110874125|NCT02364934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110874126|NCT02364934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110874127|NCT02364934|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110874133|NCT02372656|Simvastatin|simvastatin|mesh-list
110874134|NCT02372656|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110874135|NCT02372656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110874136|NCT02372656|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110874137|NCT02372656|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110874138|NCT02372656|Antimetabolites|antimetabolites|mesh-ancestor
110874139|NCT02372656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110874140|NCT02372656|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110874141|NCT02372656|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110874142|NCT02372656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110591666|NCT00761241|Docetaxel|docetaxel|mesh-list
110874143|NCT03123939|Tisagenlecleucel|tisagenlecleucel|mesh-list
110874144|NCT03123939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110874145|NCT03123939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110874146|NCT01368627|Sirolimus|sirolimus|mesh-list
110874147|NCT01368627|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110874148|NCT01368627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110874149|NCT01368627|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110874150|NCT01368627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110874151|NCT01368627|Antifungal Agents|antifungal agents|mesh-ancestor
110874152|NCT01368627|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110874153|NCT01368627|Immunologic Factors|immunologic factors|mesh-ancestor
110874154|NCT01368627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110874155|NCT02358681|Ketorolac|ketorolac|mesh-list
110874156|NCT02358681|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
110874157|NCT02358681|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110874158|NCT02358681|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110874159|NCT02358681|Analgesics|analgesics|mesh-ancestor
110874160|NCT02358681|Sensory System Agents|sensory system agents|mesh-ancestor
110874161|NCT02358681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110874162|NCT02358681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110874163|NCT02358681|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110874164|NCT02358681|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110874165|NCT02358681|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110874166|NCT02358681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110874167|NCT02358681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110874168|NCT03123861|Gabapentin|gabapentin|mesh-list
110874169|NCT03123861|Analgesics|analgesics|mesh-ancestor
110874170|NCT03123861|Sensory System Agents|sensory system agents|mesh-ancestor
110874171|NCT03123861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110874172|NCT03123861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110874173|NCT03123861|Anticonvulsants|anticonvulsants|mesh-ancestor
110874174|NCT03123861|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110874175|NCT03123861|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110874176|NCT03123861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110874177|NCT03123861|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110874178|NCT03123861|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110874179|NCT03123861|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110874180|NCT03123861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110874181|NCT03123861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110874182|NCT03123861|Antimanic Agents|antimanic agents|mesh-ancestor
110874183|NCT01368783|Ritonavir|ritonavir|mesh-list
110874184|NCT01368783|Atazanavir Sulfate|atazanavir sulfate|mesh-list
110874185|NCT01368783|Tenofovir|tenofovir|mesh-list
110874186|NCT01368783|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110874187|NCT01368783|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110874188|NCT01368783|Protease Inhibitors|protease inhibitors|mesh-ancestor
110874189|NCT01368783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110874190|NCT01368783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110874191|NCT01368783|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110874192|NCT01368783|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110874193|NCT01368783|Antiviral Agents|antiviral agents|mesh-ancestor
110874194|NCT01368783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110874195|NCT01368783|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110874196|NCT01368783|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110874197|NCT01368783|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110874223|NCT02372812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110874224|NCT02372812|Antiemetics|antiemetics|mesh-ancestor
110874225|NCT02372812|Autonomic Agents|autonomic agents|mesh-ancestor
110874226|NCT02372812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110874227|NCT02372812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110874228|NCT02372812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110874229|NCT02372812|Glucocorticoids|glucocorticoids|mesh-ancestor
110874230|NCT02372812|Hormones|hormones|mesh-ancestor
110874231|NCT02372812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110874232|NCT02372812|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110874233|NCT02372812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110874234|NCT02365012|Midodrine|midodrine|mesh-list
110874235|NCT02365012|Sympathomimetics|sympathomimetics|mesh-ancestor
110874236|NCT02365012|Autonomic Agents|autonomic agents|mesh-ancestor
110874237|NCT02365012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110874238|NCT02365012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110874239|NCT02365012|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110874240|NCT02365012|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110874241|NCT02365012|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110874242|NCT02365012|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110874243|NCT02365012|Adrenergic Agents|adrenergic agents|mesh-ancestor
110874244|NCT02365012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110874245|NCT02365012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110874246|NCT01369017|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
110874247|NCT01369017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110874248|NCT01365351|Hormones|hormones|mesh-list
110874252|NCT01372449|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110874253|NCT01372449|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110874255|NCT01372449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110874256|NCT01372449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110874257|NCT01372449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110874258|NCT01372449|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110874259|NCT01372449|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110874260|NCT04666389|Atorvastatin|atorvastatin|mesh-list
110874261|NCT04666389|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110874262|NCT04666389|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110874263|NCT04666389|Antimetabolites|antimetabolites|mesh-ancestor
110874264|NCT04666389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110874265|NCT04666389|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110874266|NCT04666389|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110874267|NCT04666389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110874269|NCT02372110|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110874270|NCT02372110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110874271|NCT02372110|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110874272|NCT02372110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110874273|NCT02372110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110874274|NCT02372110|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110874275|NCT02372110|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110874276|NCT02372110|Purinergic Agents|purinergic agents|mesh-ancestor
110874277|NCT02372110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110874278|NCT02372188|Caffeine|caffeine|mesh-list
110874279|NCT02372188|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110874280|NCT02372188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110874281|NCT02372188|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110874282|NCT02372188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110874283|NCT02372188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110874284|NCT02372188|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110874285|NCT02372188|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110874286|NCT02372188|Purinergic Agents|purinergic agents|mesh-ancestor
110874287|NCT02372188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110874288|NCT01371435|Paroxetine|paroxetine|mesh-list
110874289|NCT01371435|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110874290|NCT01371435|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110874291|NCT01371435|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110874292|NCT01371435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110874293|NCT01371435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110874294|NCT01371435|Serotonin Agents|serotonin agents|mesh-ancestor
110874295|NCT01371435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110874296|NCT01371435|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110874297|NCT01371435|Antidepressive Agents|antidepressive agents|mesh-ancestor
110874298|NCT01371435|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110874299|NCT01371435|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110874300|NCT01371435|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110874301|NCT01371435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110874302|NCT01369719|Deferasirox|deferasirox|mesh-list
110874303|NCT01369719|Deferoxamine|deferoxamine|mesh-list
110874304|NCT01369719|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110874305|NCT01369719|Chelating Agents|chelating agents|mesh-ancestor
110874306|NCT01369719|Sequestering Agents|sequestering agents|mesh-ancestor
110874307|NCT01369719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110874308|NCT01369719|Siderophores|siderophores|mesh-ancestor
110874309|NCT02369380|Hyaluronic Acid|hyaluronic acid|mesh-list
110874310|NCT02369380|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110874311|NCT02369380|Immunologic Factors|immunologic factors|mesh-ancestor
110874312|NCT02369380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110874313|NCT02369380|Viscosupplements|viscosupplements|mesh-ancestor
110874314|NCT02369380|Protective Agents|protective agents|mesh-ancestor
110874315|NCT02038816|Azacitidine|azacitidine|mesh-list
110204129|NCT00053300|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110874322|NCT02038816|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110874323|NCT02038816|Chelating Agents|chelating agents|mesh-ancestor
110874324|NCT02038816|Sequestering Agents|sequestering agents|mesh-ancestor
110874325|NCT04809831|Chlorhexidine|chlorhexidine|mesh-list
110874326|NCT04809831|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110874327|NCT04809831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110874328|NCT04809831|Disinfectants|disinfectants|mesh-ancestor
110874329|NCT02359162|Prednisone|prednisone|mesh-list
110874330|NCT02359162|Cyclophosphamide|cyclophosphamide|mesh-list
110874331|NCT02359162|Gemcitabine|gemcitabine|mesh-list
110874332|NCT02359162|Doxorubicin|doxorubicin|mesh-list
110874333|NCT02359162|Oxaliplatin|oxaliplatin|mesh-list
110874334|NCT02359162|Etoposide|etoposide|mesh-list
110874335|NCT02359162|Vincristine|vincristine|mesh-list
110874336|NCT02359162|Pegaspargase|pegaspargase|mesh-list
110874337|NCT02359162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110874338|NCT02359162|Immunologic Factors|immunologic factors|mesh-ancestor
110874339|NCT02359162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110874340|NCT02359162|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110874341|NCT02359162|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110874342|NCT02359162|Alkylating Agents|alkylating agents|mesh-ancestor
110874343|NCT02359162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110874344|NCT02359162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110874345|NCT02359162|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110874346|NCT02359162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110874347|NCT02359162|Antimetabolites|antimetabolites|mesh-ancestor
110874348|NCT02359162|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110874349|NCT02359162|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110874350|NCT02359162|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110874351|NCT02359162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110874352|NCT02359162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110874353|NCT02359162|Glucocorticoids|glucocorticoids|mesh-ancestor
110874354|NCT02359162|Hormones|hormones|mesh-ancestor
110874355|NCT02359162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110874356|NCT02359162|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110874357|NCT02359162|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110874358|NCT02359162|Tubulin Modulators|tubulin modulators|mesh-ancestor
110874359|NCT02359162|Antimitotic Agents|antimitotic agents|mesh-ancestor
110874360|NCT02359162|Mitosis Modulators|mitosis modulators|mesh-ancestor
110874361|NCT03634605|Tetracycline|tetracycline|mesh-list
110874362|NCT03634605|Lidocaine|lidocaine|mesh-list
110874363|NCT03634605|Anesthetics, Local|anesthetics, local|mesh-ancestor
110874364|NCT03634605|Anesthetics|anesthetics|mesh-ancestor
110591881|NCT02582996|Acetaminophen|acetaminophen|mesh-list
110195150|NCT00410995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110874365|NCT03634605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110874366|NCT03634605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110874367|NCT03634605|Sensory System Agents|sensory system agents|mesh-ancestor
110874368|NCT03634605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110874369|NCT03634605|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110874370|NCT03634605|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110874371|NCT03634605|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110874372|NCT03634605|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110874373|NCT03634605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110874374|NCT03634605|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110874375|NCT03634605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110874376|NCT03634605|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110874377|NCT03634605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110874379|NCT02363764|Chelating Agents|chelating agents|mesh-ancestor
110874380|NCT02363764|Sequestering Agents|sequestering agents|mesh-ancestor
110874381|NCT02363764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110874382|NCT03654794|Tacrolimus|tacrolimus|mesh-list
110874383|NCT03654794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110874384|NCT03654794|Immunologic Factors|immunologic factors|mesh-ancestor
110204133|NCT00053300|Growth Substances|growth substances|mesh-ancestor
110874390|NCT03654170|Nootropic Agents|nootropic agents|mesh-ancestor
110874391|NCT02369146|UB-421|ub-421|mesh-list
110874392|NCT02369146|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110874393|NCT02369146|Antiviral Agents|antiviral agents|mesh-ancestor
110874394|NCT02369146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110874395|NCT02363452|Lamivudine|lamivudine|mesh-list
110874396|NCT02363452|Zidovudine|zidovudine|mesh-list
110874397|NCT02363452|Abacavir|abacavir|mesh-list
110874398|NCT02363452|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
110874399|NCT02363452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110874400|NCT02363452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110874401|NCT02363452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110874402|NCT02363452|Antiviral Agents|antiviral agents|mesh-ancestor
110874403|NCT02363452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110874404|NCT02363452|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110874405|NCT02363452|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110874406|NCT02363452|Antimetabolites|antimetabolites|mesh-ancestor
110874407|NCT03634137|Afamelanotide|afamelanotide|mesh-list
110874408|NCT03634137|alpha-MSH|alpha-msh|mesh-list
110874409|NCT03634137|Dermatologic Agents|dermatologic agents|mesh-ancestor
110874411|NCT03634137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110874412|NCT03634137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110195184|NCT00072345|Thalidomide|thalidomide|mesh-list
110874413|NCT02358694|Immunoglobulins|immunoglobulins|mesh-list
110874414|NCT02358694|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110874415|NCT02358694|Antibodies|antibodies|mesh-list
110874416|NCT02358694|Immunologic Factors|immunologic factors|mesh-ancestor
110874417|NCT02358694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110874418|NCT04473807|Sotalol|sotalol|mesh-list
110874419|NCT04473807|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110874420|NCT04473807|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110874421|NCT04473807|Adrenergic Agents|adrenergic agents|mesh-ancestor
110874422|NCT04473807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110874423|NCT04473807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110874424|NCT04473807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110874425|NCT04473807|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110874426|NCT04473807|Sympatholytics|sympatholytics|mesh-ancestor
110874427|NCT04473807|Autonomic Agents|autonomic agents|mesh-ancestor
110874428|NCT04473807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110874429|NCT02323659|Interferons|interferons|mesh-list
110874430|NCT02323659|Interferon-alpha|interferon-alpha|mesh-list
110874431|NCT02323659|Interferon alpha-2|interferon alpha-2|mesh-list
110874432|NCT02323659|Methotrexate|methotrexate|mesh-list
110874433|NCT02323659|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110874434|NCT02323659|Abortifacient Agents|abortifacient agents|mesh-ancestor
110874435|NCT02323659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110874436|NCT02323659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110874437|NCT02323659|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110874438|NCT02323659|Antimetabolites|antimetabolites|mesh-ancestor
110874439|NCT02323659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110874440|NCT02323659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110874441|NCT02323659|Dermatologic Agents|dermatologic agents|mesh-ancestor
110874442|NCT02323659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110874443|NCT02323659|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110874444|NCT02323659|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110874445|NCT02323659|Immunologic Factors|immunologic factors|mesh-ancestor
110874446|NCT02323659|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110874447|NCT02323659|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110874448|NCT02323659|Antiviral Agents|antiviral agents|mesh-ancestor
110874449|NCT02323659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110874450|NCT03634059|Apatinib|apatinib|mesh-list
110874451|NCT03634059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110874452|NCT03634059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110874453|NCT03634059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110874454|NCT03634059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110874455|NCT02358304|Calcitonin|calcitonin|mesh-list
110874456|NCT02358304|Salmon calcitonin|salmon calcitonin|mesh-list
110874464|NCT02363530|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
110874465|NCT02363530|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110874466|NCT02362906|Azithromycin|azithromycin|mesh-list
110874467|NCT02362906|Erythromycin|erythromycin|mesh-list
110874468|NCT02362906|Erythromycin Estolate|erythromycin estolate|mesh-list
110874469|NCT02362906|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
110874470|NCT02362906|Erythromycin stearate|erythromycin stearate|mesh-list
110874471|NCT02362906|Cephalosporins|cephalosporins|mesh-list
110874472|NCT02362906|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110874473|NCT02362906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110874474|NCT02362906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110195211|NCT00205231|Etanercept|etanercept|mesh-list
110874475|NCT02362906|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110874476|NCT02362906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110874477|NCT02362906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110874478|NCT04469530|Sirolimus|sirolimus|mesh-list
110874479|NCT04469530|Celecoxib|celecoxib|mesh-list
110874480|NCT04469530|Cyclophosphamide|cyclophosphamide|mesh-list
110874481|NCT04469530|Etoposide|etoposide|mesh-list
110874482|NCT04469530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110874483|NCT04469530|Immunologic Factors|immunologic factors|mesh-ancestor
110874484|NCT04469530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110874485|NCT04469530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110874486|NCT04469530|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110874487|NCT04469530|Alkylating Agents|alkylating agents|mesh-ancestor
110874488|NCT04469530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110874489|NCT04469530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110874490|NCT04469530|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110874491|NCT04469530|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110874492|NCT04469530|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110874493|NCT04469530|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110874494|NCT04469530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110874495|NCT04469530|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110874496|NCT04469530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110874497|NCT04469530|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110874498|NCT04469530|Antifungal Agents|antifungal agents|mesh-ancestor
110874499|NCT04469530|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110874500|NCT04469530|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110874501|NCT04469530|Analgesics|analgesics|mesh-ancestor
110874502|NCT04469530|Sensory System Agents|sensory system agents|mesh-ancestor
110874503|NCT04469530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110874504|NCT04469530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110874505|NCT04469530|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110874506|NCT04469530|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110874507|NCT03085914|Leucovorin|leucovorin|mesh-list
110874508|NCT03085914|Paclitaxel|paclitaxel|mesh-list
110874509|NCT03085914|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110874510|NCT03085914|Cyclophosphamide|cyclophosphamide|mesh-list
110874511|NCT03085914|Carboplatin|carboplatin|mesh-list
110874512|NCT03085914|Gemcitabine|gemcitabine|mesh-list
110874513|NCT03085914|Pembrolizumab|pembrolizumab|mesh-list
110874514|NCT03085914|Fluorouracil|fluorouracil|mesh-list
110874515|NCT03085914|Oxaliplatin|oxaliplatin|mesh-list
110874516|NCT03085914|Pemetrexed|pemetrexed|mesh-list
110874517|NCT03085914|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110874518|NCT03085914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110874519|NCT03085914|Tubulin Modulators|tubulin modulators|mesh-ancestor
110874520|NCT03085914|Antimitotic Agents|antimitotic agents|mesh-ancestor
110874521|NCT03085914|Mitosis Modulators|mitosis modulators|mesh-ancestor
110874522|NCT03085914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110874523|NCT03085914|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110874524|NCT03085914|Immunologic Factors|immunologic factors|mesh-ancestor
110874525|NCT03085914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110204145|NCT00053339|Tamoxifen|tamoxifen|mesh-list
110874536|NCT03085914|Vitamin B Complex|vitamin b complex|mesh-ancestor
110874537|NCT03085914|Vitamins|vitamins|mesh-ancestor
110874538|NCT03085914|Micronutrients|micronutrients|mesh-ancestor
110874539|NCT03085914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110874540|NCT03085914|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110874541|NCT03085914|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110874542|NCT02467608|Isoniazid|isoniazid|mesh-list
110874543|NCT02467608|Antitubercular Agents|antitubercular agents|mesh-ancestor
110874544|NCT02467608|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110874545|NCT02467608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110874546|NCT02467608|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
110874547|NCT02467608|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110874548|NCT02467608|Antimetabolites|antimetabolites|mesh-ancestor
110874549|NCT02467608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110874550|NCT02467608|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110874551|NCT02368288|Entecavir|entecavir|mesh-list
110874552|NCT02368288|Antiviral Agents|antiviral agents|mesh-ancestor
110874553|NCT02368288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110874554|NCT02357524|Oritavancin|oritavancin|mesh-list
110874555|NCT02357524|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110874556|NCT02357524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110874557|NCT02368054|Epinephrine|epinephrine|mesh-list
110874558|NCT02368054|Racepinephrine|racepinephrine|mesh-list
110874559|NCT02368054|Bupivacaine|bupivacaine|mesh-list
110874560|NCT02368054|Epinephryl borate|epinephryl borate|mesh-list
110874561|NCT02368054|Anesthetics, Local|anesthetics, local|mesh-ancestor
110874562|NCT02368054|Anesthetics|anesthetics|mesh-ancestor
110874563|NCT02368054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110874564|NCT02368054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110874565|NCT02368054|Sensory System Agents|sensory system agents|mesh-ancestor
110874566|NCT02368054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110874567|NCT02368054|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110874568|NCT02368054|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110919194|NCT02125812|Moxifloxacin|moxifloxacin|mesh-list
110874569|NCT02368054|Adrenergic Agents|adrenergic agents|mesh-ancestor
110874570|NCT02368054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110874571|NCT02368054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110874572|NCT02368054|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110874573|NCT02368054|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110874574|NCT02368054|Autonomic Agents|autonomic agents|mesh-ancestor
110874575|NCT02368054|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110874576|NCT02368054|Respiratory System Agents|respiratory system agents|mesh-ancestor
110874577|NCT02368054|Mydriatics|mydriatics|mesh-ancestor
110874578|NCT02368054|Sympathomimetics|sympathomimetics|mesh-ancestor
110874579|NCT02368054|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110874580|NCT02357602|Tenofovir|tenofovir|mesh-list
110874581|NCT02357602|Antiviral Agents|antiviral agents|mesh-ancestor
110874582|NCT02357602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110874583|NCT02357602|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110874584|NCT02357602|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110874585|NCT02357602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110874586|NCT02357602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110874587|NCT02357602|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110874588|NCT02357602|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110874589|NCT01379196|Azithromycin|azithromycin|mesh-list
110874590|NCT01379196|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110874591|NCT01379196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110874592|NCT01382238|Dolutegravir|dolutegravir|mesh-list
110874609|NCT03112564|Analgesics|analgesics|mesh-ancestor
110874610|NCT03112564|Sensory System Agents|sensory system agents|mesh-ancestor
110874611|NCT03112564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110874612|NCT03112564|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110874613|NCT03112564|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110874614|NCT03112564|Anesthetics, General|anesthetics, general|mesh-ancestor
110874615|NCT03112564|Anesthetics|anesthetics|mesh-ancestor
110874616|NCT03112564|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110874617|NCT03112564|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110874618|NCT03112564|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110874619|NCT03112564|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110874620|NCT03112564|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110874621|NCT01379976|Acetylcarnitine|acetylcarnitine|mesh-list
110874622|NCT01379976|Vitamin B Complex|vitamin b complex|mesh-ancestor
110874623|NCT01379976|Vitamins|vitamins|mesh-ancestor
110874624|NCT01379976|Micronutrients|micronutrients|mesh-ancestor
110874625|NCT01379976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110874626|NCT01379976|Nootropic Agents|nootropic agents|mesh-ancestor
110874627|NCT01379898|Doxazosin|doxazosin|mesh-list
110874628|NCT01379898|Phenoxybenzamine|phenoxybenzamine|mesh-list
110874629|NCT01379898|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110874630|NCT01379898|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110874631|NCT01379898|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110874632|NCT01379898|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110874633|NCT01379898|Adrenergic Agents|adrenergic agents|mesh-ancestor
110874634|NCT01379898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110874635|NCT01379898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110874636|NCT01379898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110874637|NCT01379898|Vasodilator Agents|vasodilator agents|mesh-ancestor
110874638|NCT02362516|BI 425809|bi 425809|mesh-list
110874639|NCT02362516|Nootropic Agents|nootropic agents|mesh-ancestor
110874640|NCT02367664|Vaccines|vaccines|mesh-list
110874641|NCT02367664|Immunologic Factors|immunologic factors|mesh-ancestor
110874642|NCT02367664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110874643|NCT05421000|Anesthetics|anesthetics|mesh-list
110919210|NCT05287984|Rituximab|rituximab|mesh-list
110874644|NCT05421000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110874645|NCT05421000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110874646|NCT02357212|Adenosine|adenosine|mesh-list
110874647|NCT02357212|Analgesics|analgesics|mesh-ancestor
110874648|NCT02357212|Sensory System Agents|sensory system agents|mesh-ancestor
110874649|NCT02357212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110874650|NCT02357212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110874651|NCT02357212|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110874652|NCT02357212|Vasodilator Agents|vasodilator agents|mesh-ancestor
110874653|NCT02357212|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
110874654|NCT02357212|Purinergic Agonists|purinergic agonists|mesh-ancestor
110874655|NCT02357212|Purinergic Agents|purinergic agents|mesh-ancestor
110874656|NCT02357212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110874662|NCT00735748|Tramadol|tramadol|mesh-list
110874663|NCT00735748|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110874664|NCT00735748|Narcotics|narcotics|mesh-ancestor
110874665|NCT00735748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110874666|NCT00735748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110874667|NCT00735748|Analgesics|analgesics|mesh-ancestor
110874668|NCT00735748|Sensory System Agents|sensory system agents|mesh-ancestor
110592185|NCT02558283|Lidocaine|lidocaine|mesh-list
110874669|NCT00735748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110874670|NCT02367196|Rituximab|rituximab|mesh-list
110874671|NCT02367196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110874672|NCT02367196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110874673|NCT02367196|Immunologic Factors|immunologic factors|mesh-ancestor
110874674|NCT02367196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110874675|NCT02367196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110874676|NCT05418504|Anesthetics|anesthetics|mesh-list
110874677|NCT05418504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110874678|NCT05418504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110874679|NCT03408886|Vancomycin|vancomycin|mesh-list
110874680|NCT03408886|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110874681|NCT03408886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110874682|NCT02361892|Ulipristal acetate|ulipristal acetate|mesh-list
110874683|NCT02361892|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110874684|NCT02361892|Contraceptive Agents|contraceptive agents|mesh-ancestor
110874685|NCT02361892|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110874686|NCT02361892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110874687|NCT02361892|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110874688|NCT04013334|Nivolumab|nivolumab|mesh-list
110874689|NCT04013334|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110874690|NCT04013334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110874691|NCT04013334|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110874692|NCT04013334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110874693|NCT02366884|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110874694|NCT02366884|Antifungal Agents|antifungal agents|mesh-list
110874695|NCT02366884|Clotrimazole|clotrimazole|mesh-list
110874696|NCT02366884|Miconazole|miconazole|mesh-list
110874697|NCT02366884|Antiprotozoal Agents|antiprotozoal agents|mesh-list
110874698|NCT02366884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110874699|NCT02366884|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110874700|NCT02366884|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110874701|NCT02366884|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110874702|NCT02366884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110874703|NCT02366884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110874704|NCT02366884|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110874705|NCT02366884|Hormone Antagonists|hormone antagonists|mesh-ancestor
110874706|NCT02366884|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110874707|NCT02366884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110195308|NCT04732247|Oxytocin|oxytocin|mesh-list
110874708|NCT02366884|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110874709|NCT02366884|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110874710|NCT02366884|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110874711|NCT02361502|Mirabegron|mirabegron|mesh-list
110874712|NCT02361502|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
110874713|NCT02361502|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110874714|NCT02361502|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110874715|NCT02361502|Adrenergic Agents|adrenergic agents|mesh-ancestor
110874716|NCT02361502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110874717|NCT02361502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110874718|NCT02361502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110874719|NCT02361502|Urological Agents|urological agents|mesh-ancestor
110874720|NCT02367118|Prednisone|prednisone|mesh-list
110874721|NCT02367118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110874722|NCT02367118|Glucocorticoids|glucocorticoids|mesh-ancestor
110874723|NCT02367118|Hormones|hormones|mesh-ancestor
110874724|NCT02367118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110874731|NCT00979212|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110874732|NCT00979212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110874733|NCT00979212|Tubulin Modulators|tubulin modulators|mesh-ancestor
110874734|NCT00979212|Antimitotic Agents|antimitotic agents|mesh-ancestor
110874735|NCT00979212|Mitosis Modulators|mitosis modulators|mesh-ancestor
110874736|NCT00979212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110874737|NCT00979212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110874738|NCT02361190|Methyltestosterone|methyltestosterone|mesh-list
110874739|NCT02361190|Testosterone|testosterone|mesh-list
110874740|NCT02361190|Testosterone undecanoate|testosterone undecanoate|mesh-list
110874741|NCT02361190|Testosterone enanthate|testosterone enanthate|mesh-list
110874742|NCT02361190|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
110592260|NCT00767715|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110874743|NCT02361190|Androgens|androgens|mesh-ancestor
110874744|NCT02361190|Hormones|hormones|mesh-ancestor
110874745|NCT02361190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110874746|NCT02361190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110874747|NCT02361190|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110874748|NCT02361190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110874749|NCT02361190|Anabolic Agents|anabolic agents|mesh-ancestor
110874750|NCT02361112|Capecitabine|capecitabine|mesh-list
110874751|NCT02361112|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110874752|NCT02361112|Antimetabolites|antimetabolites|mesh-ancestor
110874753|NCT02361112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110874754|NCT02361112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110874755|NCT02360956|Olmesartan|olmesartan|mesh-list
110874756|NCT02360956|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
110874757|NCT02360956|Antihypertensive Agents|antihypertensive agents|mesh-list
110874758|NCT02360956|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110874759|NCT02360956|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110874760|NCT02360956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110874761|NCT02360800|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
110874762|NCT02360800|Hemostatics|hemostatics|mesh-list
110874763|NCT02360800|Coagulants|coagulants|mesh-ancestor
110874764|NCT03501966|Acetazolamide|acetazolamide|mesh-list
110874765|NCT03501966|Diuretics|diuretics|mesh-list
110874766|NCT03501966|Natriuretic Agents|natriuretic agents|mesh-ancestor
110874767|NCT03501966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110874768|NCT03501966|Anticonvulsants|anticonvulsants|mesh-ancestor
110874769|NCT03501966|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110874770|NCT03501966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110874771|NCT03501966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110874772|NCT02355184|Leronlimab|leronlimab|mesh-list
110874773|NCT02355184|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110874774|NCT02355184|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110874775|NCT02355184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110874776|NCT02355184|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110874777|NCT02355184|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110874778|NCT02355184|Antiviral Agents|antiviral agents|mesh-ancestor
110874779|NCT02355184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110874780|NCT03477630|Hyaluronic Acid|hyaluronic acid|mesh-list
110874781|NCT03477630|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110874782|NCT03477630|Immunologic Factors|immunologic factors|mesh-ancestor
110874783|NCT03477630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110874784|NCT03477630|Viscosupplements|viscosupplements|mesh-ancestor
110874785|NCT03477630|Protective Agents|protective agents|mesh-ancestor
110874786|NCT02981342|Gemcitabine|gemcitabine|mesh-list
110874787|NCT02981342|Capecitabine|capecitabine|mesh-list
110874788|NCT02981342|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110874789|NCT02981342|Antimetabolites|antimetabolites|mesh-ancestor
110874790|NCT02981342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110874791|NCT02981342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110874792|NCT02360644|Vitamin D|vitamin d|mesh-list
110874793|NCT02360644|Cholecalciferol|cholecalciferol|mesh-list
110874798|NCT02360644|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110874799|NCT02365948|Certolizumab Pegol|certolizumab pegol|mesh-list
110874800|NCT02365948|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110874801|NCT02365948|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110874802|NCT02365948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110874803|NCT02365948|Immunologic Factors|immunologic factors|mesh-ancestor
110874804|NCT02365948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110874805|NCT02365948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110874806|NCT02354950|Cabotegravir|cabotegravir|mesh-list
110874807|NCT02354950|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110874808|NCT02354950|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110874809|NCT02354950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110874810|NCT02354950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110874811|NCT02354950|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110874812|NCT02354950|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110874813|NCT02354950|Antiviral Agents|antiviral agents|mesh-ancestor
110874814|NCT02354950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110874815|NCT02980874|Triamcinolone|triamcinolone|mesh-list
110874816|NCT02980874|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110874817|NCT02980874|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110874818|NCT02980874|Aflibercept|aflibercept|mesh-list
110592359|NCT02558751|Vaccines|vaccines|mesh-list
110874819|NCT02980874|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110874820|NCT02980874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110874821|NCT02980874|Glucocorticoids|glucocorticoids|mesh-ancestor
110874822|NCT02980874|Hormones|hormones|mesh-ancestor
110874823|NCT02980874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110874824|NCT02980874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110874825|NCT02980874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110874826|NCT02980874|Immunologic Factors|immunologic factors|mesh-ancestor
110874827|NCT02980874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110874828|NCT02980874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110874829|NCT02980874|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110874830|NCT02980874|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110874831|NCT02980874|Growth Substances|growth substances|mesh-ancestor
110874832|NCT02980874|Growth Inhibitors|growth inhibitors|mesh-ancestor
110874833|NCT02980874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110874834|NCT02354872|Nicotine|nicotine|mesh-list
110874835|NCT02354872|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110874836|NCT02354872|Autonomic Agents|autonomic agents|mesh-ancestor
110874837|NCT02354872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110874838|NCT02354872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110874839|NCT02354872|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110874840|NCT02354872|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110874841|NCT02354872|Cholinergic Agents|cholinergic agents|mesh-ancestor
110874842|NCT02354872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110874843|NCT02354872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110874844|NCT02354638|Nicotine|nicotine|mesh-list
110874845|NCT02354638|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110874846|NCT02354638|Autonomic Agents|autonomic agents|mesh-ancestor
110874847|NCT02354638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110874848|NCT02354638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110874849|NCT02354638|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110874850|NCT02354638|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110874851|NCT02354638|Cholinergic Agents|cholinergic agents|mesh-ancestor
110874852|NCT02354638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110874853|NCT02354638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110874854|NCT02360254|Insulin|insulin|mesh-list
110874855|NCT02360254|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110874856|NCT02360254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110874857|NCT03112642|Anesthetics|anesthetics|mesh-list
110874858|NCT03112642|Bupivacaine|bupivacaine|mesh-list
110874859|NCT03112642|Anesthetics, Local|anesthetics, local|mesh-list
110874860|NCT03112642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110874861|NCT03112642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110874862|NCT03112642|Sensory System Agents|sensory system agents|mesh-ancestor
110874863|NCT03112642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110874864|NCT01377324|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110874870|NCT01377324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110874872|NCT01377324|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110874873|NCT01377324|Contraceptive Agents|contraceptive agents|mesh-ancestor
110874874|NCT01377324|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110874875|NCT01377324|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110874876|NCT02359942|Citric Acid|citric acid|mesh-list
110874877|NCT02359942|Sodium Citrate|sodium citrate|mesh-list
110874878|NCT02359942|Anticoagulants|anticoagulants|mesh-ancestor
110874879|NCT02359942|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110874880|NCT02359942|Chelating Agents|chelating agents|mesh-ancestor
110874881|NCT02359942|Sequestering Agents|sequestering agents|mesh-ancestor
110874882|NCT02359942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110874883|NCT02354560|Erythromycin|erythromycin|mesh-list
110874884|NCT02354560|Erythromycin Estolate|erythromycin estolate|mesh-list
110874885|NCT02354560|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
110874886|NCT02354560|Erythromycin stearate|erythromycin stearate|mesh-list
110874887|NCT02354560|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110874888|NCT02354560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110874889|NCT02354560|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110874890|NCT02354560|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110874891|NCT02354560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110195409|NCT00411190|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110874892|NCT02354560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110874893|NCT01378884|Domperidone|domperidone|mesh-list
110874894|NCT01378884|Antiemetics|antiemetics|mesh-ancestor
110874895|NCT01378884|Autonomic Agents|autonomic agents|mesh-ancestor
110874896|NCT01378884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110874897|NCT01378884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110874898|NCT01378884|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110874899|NCT01378884|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110874900|NCT01378884|Dopamine Agents|dopamine agents|mesh-ancestor
110874901|NCT01378884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110874902|NCT01378884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110874903|NCT02039050|Tiotropium Bromide|tiotropium bromide|mesh-list
110874904|NCT02039050|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110874905|NCT02039050|Autonomic Agents|autonomic agents|mesh-ancestor
110874906|NCT02039050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110874907|NCT02039050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110874908|NCT02039050|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110874909|NCT02039050|Respiratory System Agents|respiratory system agents|mesh-ancestor
110874910|NCT02039050|Parasympatholytics|parasympatholytics|mesh-ancestor
110874911|NCT02039050|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110874912|NCT02039050|Cholinergic Agents|cholinergic agents|mesh-ancestor
110874913|NCT02039050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110874914|NCT02039050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110874915|NCT02354170|Mifepristone|mifepristone|mesh-list
110874916|NCT02354170|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
110874917|NCT02354170|Abortifacient Agents|abortifacient agents|mesh-ancestor
110874918|NCT02354170|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110874919|NCT02354170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110874920|NCT02354170|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110874921|NCT02354170|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110874923|NCT02354170|Contraceptive Agents|contraceptive agents|mesh-ancestor
110874924|NCT02354170|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
110874925|NCT02354170|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
110874926|NCT02354170|Hormone Antagonists|hormone antagonists|mesh-ancestor
110874927|NCT02354170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110874928|NCT02354170|Luteolytic Agents|luteolytic agents|mesh-ancestor
110874929|NCT02354170|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110874930|NCT02354170|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
110874931|NCT01377246|Octreotide|octreotide|mesh-list
110874932|NCT01377246|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110874933|NCT01377246|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110874943|NCT02353858|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110874944|NCT02353858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110874945|NCT02353858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110874946|NCT02353858|Immunologic Factors|immunologic factors|mesh-ancestor
110874947|NCT02353858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110874948|NCT02353702|Ropivacaine|ropivacaine|mesh-list
110874949|NCT02353702|Anesthetics, Local|anesthetics, local|mesh-ancestor
110874950|NCT02353702|Anesthetics|anesthetics|mesh-ancestor
110874951|NCT02353702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110874952|NCT02353702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110874953|NCT02353702|Sensory System Agents|sensory system agents|mesh-ancestor
110874954|NCT02353702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110874956|NCT02532660|Citalopram|citalopram|mesh-list
110874957|NCT02532660|Escitalopram|escitalopram|mesh-list
110874958|NCT02532660|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110874959|NCT02532660|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110874960|NCT02532660|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110874961|NCT02532660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110874962|NCT02532660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110874963|NCT02532660|Serotonin Agents|serotonin agents|mesh-ancestor
110874964|NCT02532660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110874965|NCT02532660|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110592485|NCT04048707|Sympathomimetics|sympathomimetics|mesh-ancestor
110874966|NCT02532660|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110874967|NCT02532660|Parasympatholytics|parasympatholytics|mesh-ancestor
110874968|NCT02532660|Autonomic Agents|autonomic agents|mesh-ancestor
110874969|NCT02532660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110874970|NCT02532660|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110874971|NCT02532660|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110874972|NCT02532660|Cholinergic Agents|cholinergic agents|mesh-ancestor
110874973|NCT02532660|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110874974|NCT02532660|Antidepressive Agents|antidepressive agents|mesh-ancestor
110874975|NCT02532660|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110874976|NCT01377168|Naltrexone|naltrexone|mesh-list
110874977|NCT01377168|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110874978|NCT01377168|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110874979|NCT01377168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110874980|NCT01377168|Sensory System Agents|sensory system agents|mesh-ancestor
110874981|NCT01377168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110874982|NCT02892149|Darbepoetin alfa|darbepoetin alfa|mesh-list
110874983|NCT02892149|Hematinics|hematinics|mesh-ancestor
110874984|NCT02348398|Topotecan|topotecan|mesh-list
110874985|NCT02348398|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110874986|NCT02348398|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110874987|NCT02348398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110874988|NCT02348398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110874989|NCT02348398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110874990|NCT05278338|Denosumab|denosumab|mesh-list
110062311|NCT04849364|Pembrolizumab|pembrolizumab|mesh-list
110874991|NCT05278338|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110874992|NCT05278338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110874993|NCT03721757|Nivolumab|nivolumab|mesh-list
110874994|NCT03721757|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110874995|NCT03721757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110874996|NCT03721757|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110874997|NCT03721757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110875007|NCT02348242|Lubricant Eye Drops|lubricant eye drops|mesh-list
110875008|NCT02348242|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110875009|NCT02348242|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110875010|NCT03157414|Empagliflozin|empagliflozin|mesh-list
110875011|NCT03157414|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110875012|NCT03157414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110875013|NCT03157414|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110875014|NCT03157414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110875015|NCT03147196|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
110875016|NCT03147196|Bicalutamide|bicalutamide|mesh-list
110875017|NCT03147196|Androgen Antagonists|androgen antagonists|mesh-ancestor
110875018|NCT03147196|Hormone Antagonists|hormone antagonists|mesh-ancestor
110875019|NCT03147196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110875020|NCT03147196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110875021|NCT03147196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110875022|NCT03147196|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110875023|NCT03147196|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110875024|NCT03147196|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110875025|NCT03147196|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110875026|NCT03153436|Inositol|inositol|mesh-list
110875027|NCT03153436|Vitamin B Complex|vitamin b complex|mesh-ancestor
110875028|NCT03153436|Vitamins|vitamins|mesh-ancestor
110875029|NCT03153436|Micronutrients|micronutrients|mesh-ancestor
110875030|NCT03153436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110875031|NCT03544229|Maleic acid|maleic acid|mesh-list
110875032|NCT03544229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110875033|NCT03544229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110875034|NCT02351908|Tenofovir|tenofovir|mesh-list
110875035|NCT02351908|Raltegravir Potassium|raltegravir potassium|mesh-list
110875036|NCT02351908|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110875037|NCT02351908|Dolutegravir|dolutegravir|mesh-list
110875038|NCT02351908|Cobicistat|cobicistat|mesh-list
110875039|NCT02351908|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110875040|NCT02351908|Elvitegravir|elvitegravir|mesh-list
110875041|NCT02351908|Antiviral Agents|antiviral agents|mesh-ancestor
110875042|NCT02351908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110875043|NCT02351908|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110875044|NCT02351908|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110875045|NCT02351908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110875046|NCT02351908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110875047|NCT02351908|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110875048|NCT02351908|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110875049|NCT02351908|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110875050|NCT02351908|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110875051|NCT02351908|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110875052|NCT02351908|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110875053|NCT01371240|Secretin|secretin|mesh-list
110875054|NCT01371240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110875055|NCT01371240|Hormones|hormones|mesh-ancestor
110875056|NCT01371240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110875057|NCT01371240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110875058|NCT02352064|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110875059|NCT02352064|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110875060|NCT02352064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110875061|NCT03723941|Etoposide|etoposide|mesh-list
110875062|NCT03723941|Mitotane|mitotane|mesh-list
110875072|NCT03721679|Atezolizumab|atezolizumab|mesh-list
110875073|NCT03721679|Durvalumab|durvalumab|mesh-list
110875074|NCT03721679|Poly ICLC|poly iclc|mesh-list
110875075|NCT03721679|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110875076|NCT03721679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110875077|NCT03721679|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110875078|NCT03721679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110875079|NCT03721679|Interferon Inducers|interferon inducers|mesh-ancestor
110875080|NCT03721679|Immunologic Factors|immunologic factors|mesh-ancestor
110875081|NCT03721679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110875082|NCT03639948|Carboplatin|carboplatin|mesh-list
110875083|NCT03639948|Docetaxel|docetaxel|mesh-list
110875084|NCT03639948|Pembrolizumab|pembrolizumab|mesh-list
110875085|NCT03639948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110875086|NCT03639948|Tubulin Modulators|tubulin modulators|mesh-ancestor
110875087|NCT03639948|Antimitotic Agents|antimitotic agents|mesh-ancestor
110875088|NCT03639948|Mitosis Modulators|mitosis modulators|mesh-ancestor
110875089|NCT03639948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110875090|NCT03639948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110875091|NCT03639948|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110875092|NCT03510455|Infigratinib|infigratinib|mesh-list
110875093|NCT03510455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110875094|NCT03509675|Ibuprofen|ibuprofen|mesh-list
110875095|NCT03509675|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110875096|NCT03509675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110875097|NCT03509675|Analgesics|analgesics|mesh-ancestor
110875098|NCT03509675|Sensory System Agents|sensory system agents|mesh-ancestor
110875099|NCT03509675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110875100|NCT03509675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110875101|NCT03509675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110875102|NCT03509675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110875103|NCT03509675|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110875104|NCT03509675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110875105|NCT03509675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110875106|NCT02351752|Hydroxychloroquine|hydroxychloroquine|mesh-list
110875107|NCT02351752|Antimalarials|antimalarials|mesh-ancestor
110875108|NCT02351752|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110875109|NCT02351752|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110875110|NCT02351752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110875111|NCT02351752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110875112|NCT02351752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110875113|NCT02351752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110592632|NCT00771459|Ropivacaine|ropivacaine|mesh-list
110875115|NCT02353078|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110875116|NCT02353078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110875117|NCT03509207|Vorinostat|vorinostat|mesh-list
110875118|NCT03509207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110875119|NCT03509207|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110875120|NCT03509207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110875121|NCT03509207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110875122|NCT03727295|Idebenone|idebenone|mesh-list
110875123|NCT03727295|Antioxidants|antioxidants|mesh-ancestor
110875124|NCT03727295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110875125|NCT03727295|Protective Agents|protective agents|mesh-ancestor
110875126|NCT03727295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110875127|NCT01378650|Cilostazol|cilostazol|mesh-list
110875128|NCT01378650|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110875136|NCT01378650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110875138|NCT01378650|Vasodilator Agents|vasodilator agents|mesh-ancestor
110875139|NCT01378650|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110875140|NCT01378650|Protective Agents|protective agents|mesh-ancestor
110875141|NCT01378650|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110875142|NCT01378650|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110875143|NCT01378650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110875144|NCT04796922|Rituximab|rituximab|mesh-list
110875145|NCT04796922|Obinutuzumab|obinutuzumab|mesh-list
110875146|NCT04796922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110875147|NCT04796922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110875148|NCT04796922|Immunologic Factors|immunologic factors|mesh-ancestor
110875149|NCT04796922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110875150|NCT04796922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110875151|NCT03723785|Insulin|insulin|mesh-list
110875152|NCT03723785|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110875153|NCT03723785|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110875154|NCT03723785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110875155|NCT03543137|Nicotine|nicotine|mesh-list
110875156|NCT03543137|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110875157|NCT03543137|Autonomic Agents|autonomic agents|mesh-ancestor
110875158|NCT03543137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110875159|NCT03543137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110875160|NCT03543137|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110875161|NCT03543137|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110875162|NCT03543137|Cholinergic Agents|cholinergic agents|mesh-ancestor
110875163|NCT03543137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110875164|NCT03543137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110875165|NCT03146650|Nivolumab|nivolumab|mesh-list
110875166|NCT03146650|Ipilimumab|ipilimumab|mesh-list
110875167|NCT03146650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110875168|NCT03146650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110875169|NCT03146650|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110875170|NCT03146650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110875171|NCT02343484|Ethanol|ethanol|mesh-list
110875172|NCT02343484|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110875173|NCT02343484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110875174|NCT02343484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110875175|NCT02343484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110875176|NCT03073980|Acetaminophen|acetaminophen|mesh-list
110875177|NCT03073980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110875178|NCT03073980|Analgesics|analgesics|mesh-ancestor
110875179|NCT03073980|Sensory System Agents|sensory system agents|mesh-ancestor
110875180|NCT03073980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110875181|NCT03073980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110875182|NCT03073980|Antipyretics|antipyretics|mesh-ancestor
110875183|NCT03930186|Apremilast|apremilast|mesh-list
110875184|NCT03930186|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110875185|NCT03930186|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110875186|NCT03930186|Analgesics|analgesics|mesh-ancestor
110875187|NCT03930186|Sensory System Agents|sensory system agents|mesh-ancestor
110875188|NCT03930186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110875189|NCT03930186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110875190|NCT03930186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110875191|NCT03930186|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110875192|NCT03930186|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
110875193|NCT03930186|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110875194|NCT03930186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110204219|NCT00164242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110875202|NCT02351440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110875203|NCT02351440|Analgesics|analgesics|mesh-ancestor
110875204|NCT02351440|Sensory System Agents|sensory system agents|mesh-ancestor
110875205|NCT02351440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110875206|NCT02351440|Antidepressive Agents|antidepressive agents|mesh-ancestor
110875207|NCT02351440|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110875208|NCT02351440|Dopamine Agents|dopamine agents|mesh-ancestor
110875210|NCT03504917|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
110875211|NCT03504917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110875212|NCT03504917|Natriuretic Agents|natriuretic agents|mesh-ancestor
110875213|NCT03504917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110875214|NCT02351128|Lanreotide|lanreotide|mesh-list
110875215|NCT02351128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110875216|NCT02343250|Valsartan|valsartan|mesh-list
110875217|NCT02343250|Cilnidipine|cilnidipine|mesh-list
110875218|NCT02343250|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110875219|NCT02343250|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110875220|NCT02343250|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110875221|NCT02343250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110875222|NCT02343250|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110875223|NCT02343250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110875224|NCT02343250|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110875225|NCT02343250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110875226|NCT03565211|Progesterone|progesterone|mesh-list
110875227|NCT03565211|Progestins|progestins|mesh-ancestor
110875228|NCT03565211|Hormones|hormones|mesh-ancestor
110875229|NCT03565211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110875230|NCT03565211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110875231|NCT03723395|Repaglinide|repaglinide|mesh-list
110875232|NCT03723395|Tolbutamide|tolbutamide|mesh-list
110875233|NCT03723395|Itraconazole|itraconazole|mesh-list
110875234|NCT03723395|Rifampin|rifampin|mesh-list
110875235|NCT03723395|Tucatinib|tucatinib|mesh-list
110875236|NCT03723395|Digoxin|digoxin|mesh-list
110875237|NCT03723395|Midazolam|midazolam|mesh-list
110875238|NCT03723395|Gemfibrozil|gemfibrozil|mesh-list
110875239|NCT03723395|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110875240|NCT03723395|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110875241|NCT03723395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110875242|NCT03723395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110875243|NCT03723395|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110875244|NCT03723395|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110875245|NCT03723395|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110875246|NCT03723395|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110875247|NCT03723395|Anesthetics, General|anesthetics, general|mesh-ancestor
110875248|NCT03723395|Anesthetics|anesthetics|mesh-ancestor
110875249|NCT03723395|GABA Modulators|gaba modulators|mesh-ancestor
110875250|NCT03723395|GABA Agents|gaba agents|mesh-ancestor
110875251|NCT03723395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110875252|NCT03723395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110875253|NCT03723395|Antifungal Agents|antifungal agents|mesh-ancestor
110195633|NCT00207766|Infliximab|infliximab|mesh-list
110875254|NCT03723395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110875255|NCT03723395|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110875256|NCT03723395|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110875257|NCT03723395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110875258|NCT03723395|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110875259|NCT03723395|Hormone Antagonists|hormone antagonists|mesh-ancestor
110534665|NCT02676336|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110875263|NCT03723395|Antitubercular Agents|antitubercular agents|mesh-ancestor
110875264|NCT03723395|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110875265|NCT03723395|Leprostatic Agents|leprostatic agents|mesh-ancestor
110875266|NCT03723395|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110875267|NCT03723395|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110875268|NCT03723395|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110875269|NCT03723395|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110875270|NCT03723395|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110875271|NCT03723395|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110875272|NCT03723395|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110875273|NCT03723395|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110875274|NCT03723395|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110875275|NCT03723395|Protective Agents|protective agents|mesh-ancestor
110875276|NCT03723395|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110875277|NCT03723395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110875278|NCT03723395|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110875279|NCT03723395|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110875280|NCT03723395|Antimetabolites|antimetabolites|mesh-ancestor
110875281|NCT03723395|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110875282|NCT03723395|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
110875283|NCT03531905|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
110875284|NCT03531905|Ezetimibe|ezetimibe|mesh-list
110875285|NCT03531905|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110875286|NCT03531905|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110875287|NCT03531905|Antimetabolites|antimetabolites|mesh-ancestor
110875288|NCT03531905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110875289|NCT03531905|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110875290|NCT03531905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110875291|NCT03531905|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110875292|NCT03531905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110875293|NCT02350426|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110875294|NCT02350426|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110875295|NCT02350426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110875296|NCT02346682|Clonazepam|clonazepam|mesh-list
110875297|NCT02346682|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
110875298|NCT02346682|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110875299|NCT02346682|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110875300|NCT02346682|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110195659|NCT00207844|Selenium|selenium|mesh-list
110875301|NCT02346682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110875302|NCT02346682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110875303|NCT02346682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110875304|NCT02346682|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110875305|NCT02346682|Antidepressive Agents|antidepressive agents|mesh-ancestor
110875306|NCT02346682|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110875307|NCT02346682|Anticonvulsants|anticonvulsants|mesh-ancestor
110875308|NCT02346682|GABA Modulators|gaba modulators|mesh-ancestor
110875309|NCT02346682|GABA Agents|gaba agents|mesh-ancestor
110875310|NCT05764590|Sevelamer|sevelamer|mesh-list
110875311|NCT05764590|Chelating Agents|chelating agents|mesh-ancestor
110875312|NCT05764590|Sequestering Agents|sequestering agents|mesh-ancestor
110875313|NCT05764590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110875314|NCT05764512|Endorphins|endorphins|mesh-list
110875315|NCT05764512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110875316|NCT05764512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110875317|NCT05764512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110875318|NCT02342392|Ranibizumab|ranibizumab|mesh-list
110875319|NCT02342392|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110875320|NCT02342392|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110875321|NCT02342392|Growth Substances|growth substances|mesh-ancestor
110875322|NCT02342392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110875323|NCT02342392|Growth Inhibitors|growth inhibitors|mesh-ancestor
110875324|NCT02342392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110875325|NCT02342002|Misoprostol|misoprostol|mesh-list
110875326|NCT02342002|Mifepristone|mifepristone|mesh-list
110875327|NCT02342002|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110875335|NCT02342002|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110875337|NCT02342002|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110875338|NCT02342002|Contraceptive Agents|contraceptive agents|mesh-ancestor
110875339|NCT02342002|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
110875340|NCT02342002|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
110875341|NCT02342002|Hormone Antagonists|hormone antagonists|mesh-ancestor
110875342|NCT02342002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110875343|NCT02342002|Luteolytic Agents|luteolytic agents|mesh-ancestor
110875344|NCT02342002|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110875345|NCT02342002|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
110875346|NCT03657264|Moxifloxacin|moxifloxacin|mesh-list
110875347|NCT03657264|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110875348|NCT03657264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110875349|NCT03657264|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110875350|NCT03657264|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110875351|NCT03657264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110875352|NCT03657264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110875353|NCT03657264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110875354|NCT02345902|Haloperidol|haloperidol|mesh-list
110875355|NCT02345902|Haloperidol decanoate|haloperidol decanoate|mesh-list
110875356|NCT02345902|Antiemetics|antiemetics|mesh-ancestor
110875357|NCT02345902|Autonomic Agents|autonomic agents|mesh-ancestor
110875358|NCT02345902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110875359|NCT02345902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110875360|NCT02345902|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110875361|NCT02345902|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110875362|NCT02345902|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110875363|NCT02345902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110875364|NCT02345902|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110875365|NCT02345902|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110875366|NCT02345902|Dopamine Agents|dopamine agents|mesh-ancestor
110875367|NCT02345902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110875368|NCT02345902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110875369|NCT02345902|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110875370|NCT03601806|Thalidomide|thalidomide|mesh-list
110875371|NCT03601806|Pomalidomide|pomalidomide|mesh-list
110875372|NCT03601806|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110875373|NCT03601806|Immunologic Factors|immunologic factors|mesh-ancestor
110875374|NCT03601806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110875375|NCT03601806|Leprostatic Agents|leprostatic agents|mesh-ancestor
110875376|NCT03601806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110875377|NCT03601806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110875378|NCT03601806|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110875379|NCT03601806|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110875380|NCT03601806|Growth Substances|growth substances|mesh-ancestor
110875381|NCT03601806|Growth Inhibitors|growth inhibitors|mesh-ancestor
110875382|NCT03601806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110875383|NCT02345980|Sildenafil Citrate|sildenafil citrate|mesh-list
110875384|NCT02345980|Vasodilator Agents|vasodilator agents|mesh-ancestor
110875385|NCT02345980|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110875386|NCT02345980|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110875387|NCT02345980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110875388|NCT02345980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110875389|NCT02345980|Urological Agents|urological agents|mesh-ancestor
110875390|NCT02345746|Leucovorin|leucovorin|mesh-list
110875391|NCT02345746|Folic Acid|folic acid|mesh-list
110875392|NCT02345746|Fluorouracil|fluorouracil|mesh-list
110875393|NCT02345746|Oxaliplatin|oxaliplatin|mesh-list
110875394|NCT02345746|Levoleucovorin|levoleucovorin|mesh-list
110875395|NCT02345746|Antimetabolites|antimetabolites|mesh-ancestor
110875411|NCT03794778|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110875412|NCT03794778|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110875413|NCT03794778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110875414|NCT03794778|Tubulin Modulators|tubulin modulators|mesh-ancestor
110875415|NCT03794778|Antimitotic Agents|antimitotic agents|mesh-ancestor
110875416|NCT03794778|Mitosis Modulators|mitosis modulators|mesh-ancestor
110875417|NCT03794778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110875418|NCT03794778|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110875419|NCT03794778|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110875420|NCT03794778|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110875421|NCT03794778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110875423|NCT02341300|Trace Elements|trace elements|mesh-ancestor
110875424|NCT02341300|Micronutrients|micronutrients|mesh-ancestor
110875425|NCT02341300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110875426|NCT05462496|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110875427|NCT05462496|Metronidazole|metronidazole|mesh-list
110875428|NCT05462496|Ciprofloxacin|ciprofloxacin|mesh-list
110875429|NCT05462496|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
110875430|NCT05462496|Pembrolizumab|pembrolizumab|mesh-list
110875431|NCT05462496|Folfirinox|folfirinox|mesh-list
110875432|NCT05462496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110875433|NCT05462496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110875434|NCT05462496|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110875435|NCT05462496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110875436|NCT05462496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110875437|NCT05462496|Antitubercular Agents|antitubercular agents|mesh-ancestor
110875438|NCT05462496|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110875439|NCT05462496|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110875440|NCT05462496|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110875441|NCT05462496|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110875442|NCT05462496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110875443|NCT05462496|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110875444|NCT05462496|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110875445|NCT03785340|Brimonidine Tartrate|brimonidine tartrate|mesh-list
110875446|NCT03785340|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110875447|NCT03785340|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110875448|NCT03785340|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110875449|NCT03785340|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110875450|NCT03785340|Adrenergic Agents|adrenergic agents|mesh-ancestor
110875451|NCT03785340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110875452|NCT03785340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110875453|NCT03785340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110875454|NCT02345590|Eplerenone|eplerenone|mesh-list
110875455|NCT02345590|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110875466|NCT03723083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110875467|NCT03723083|Leprostatic Agents|leprostatic agents|mesh-ancestor
110875468|NCT03723083|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110875469|NCT03723083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110875470|NCT03723083|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110875471|NCT03723083|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110875472|NCT03723083|Growth Substances|growth substances|mesh-ancestor
110875473|NCT03723083|Growth Inhibitors|growth inhibitors|mesh-ancestor
110875474|NCT03723083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110875475|NCT03562481|Lidocaine|lidocaine|mesh-list
110875476|NCT03562481|Epinephrine|epinephrine|mesh-list
110875477|NCT03562481|Racepinephrine|racepinephrine|mesh-list
110875478|NCT03562481|Epinephryl borate|epinephryl borate|mesh-list
110875479|NCT03562481|Anesthetics, Local|anesthetics, local|mesh-ancestor
110875480|NCT03562481|Anesthetics|anesthetics|mesh-ancestor
110875481|NCT03562481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110875482|NCT03562481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110875483|NCT03562481|Sensory System Agents|sensory system agents|mesh-ancestor
110875484|NCT03562481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110875485|NCT03562481|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110919349|NCT02131350|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110875486|NCT03562481|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110875488|NCT03562481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110875489|NCT03562481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110875490|NCT03562481|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110875491|NCT03562481|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110875492|NCT03562481|Adrenergic Agents|adrenergic agents|mesh-ancestor
110875493|NCT03562481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110875494|NCT03562481|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110875495|NCT03562481|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110875496|NCT03562481|Autonomic Agents|autonomic agents|mesh-ancestor
110875497|NCT03562481|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110875498|NCT03562481|Respiratory System Agents|respiratory system agents|mesh-ancestor
110875499|NCT03562481|Mydriatics|mydriatics|mesh-ancestor
110875500|NCT03562481|Sympathomimetics|sympathomimetics|mesh-ancestor
110875501|NCT03562481|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110875502|NCT03726593|Artesunate|artesunate|mesh-list
110875503|NCT03726593|Mefloquine|mefloquine|mesh-list
110875504|NCT03726593|Atovaquone|atovaquone|mesh-list
110875505|NCT03726593|Pyronaridine|pyronaridine|mesh-list
110875506|NCT03726593|Proguanil|proguanil|mesh-list
110875507|NCT03726593|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
110875508|NCT03726593|Antimalarials|antimalarials|mesh-ancestor
110875509|NCT03726593|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110875510|NCT03726593|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110875511|NCT03726593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110875512|NCT03726593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110875513|NCT03726593|Antiviral Agents|antiviral agents|mesh-ancestor
110875514|NCT03726593|Schistosomicides|schistosomicides|mesh-ancestor
110875515|NCT03726593|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110875516|NCT03726593|Anthelmintics|anthelmintics|mesh-ancestor
110875517|NCT03726593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110875518|NCT03726593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110875519|NCT03726593|Antimetabolites|antimetabolites|mesh-ancestor
110875520|NCT03197064|Fosaprepitant|fosaprepitant|mesh-list
110875521|NCT03197064|Aprepitant|aprepitant|mesh-list
110875522|NCT03197064|Antiemetics|antiemetics|mesh-ancestor
110875523|NCT03197064|Autonomic Agents|autonomic agents|mesh-ancestor
110204263|NCT00164359|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110875528|NCT03197064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110875529|NCT03197064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110875530|NCT02345044|Eplerenone|eplerenone|mesh-list
110875531|NCT02345044|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110875532|NCT02345044|Hormone Antagonists|hormone antagonists|mesh-ancestor
110875533|NCT02345044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110875534|NCT02345044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110875535|NCT02345044|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110875536|NCT02345044|Diuretics|diuretics|mesh-ancestor
110875537|NCT02345044|Natriuretic Agents|natriuretic agents|mesh-ancestor
110875538|NCT02345044|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110875539|NCT02349802|Exenatide|exenatide|mesh-list
110875540|NCT02349802|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110875541|NCT02349802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110875542|NCT02349802|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110875543|NCT02349802|Incretins|incretins|mesh-ancestor
110875544|NCT02349802|Hormones|hormones|mesh-ancestor
110875545|NCT02349802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110875546|NCT03145714|Dexmedetomidine|dexmedetomidine|mesh-list
110875547|NCT03145714|Anesthetics|anesthetics|mesh-list
110875548|NCT03145714|Propofol|propofol|mesh-list
110875549|NCT03145714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110875550|NCT03145714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110875551|NCT03145714|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110875552|NCT03145714|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110875553|NCT03145714|Analgesics|analgesics|mesh-ancestor
110875554|NCT03145714|Sensory System Agents|sensory system agents|mesh-ancestor
110919355|NCT02128308|Moxifloxacin|moxifloxacin|mesh-list
110875555|NCT03145714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110875556|NCT03145714|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110875557|NCT03145714|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110875558|NCT03145714|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110875559|NCT03145714|Adrenergic Agents|adrenergic agents|mesh-ancestor
110875560|NCT03145714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110593079|NCT05673980|Vitamins|vitamins|mesh-ancestor
110875561|NCT03145714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110875562|NCT03145714|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110875563|NCT03145714|Anesthetics, General|anesthetics, general|mesh-ancestor
110875565|NCT02349958|Cisplatin|cisplatin|mesh-list
110875566|NCT02349958|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110875567|NCT02349958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110875568|NCT02349958|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110875569|NCT02349958|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110875570|NCT02349958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110875571|NCT02349958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110875572|NCT04872426|Insulin|insulin|mesh-list
110875573|NCT04872426|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110875574|NCT04872426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110875575|NCT02344888|Folic Acid|folic acid|mesh-list
110875576|NCT02344888|Vitamin B Complex|vitamin b complex|mesh-list
110875577|NCT02344888|Prednisolone|prednisolone|mesh-list
110875578|NCT02344888|Citric Acid|citric acid|mesh-list
110875579|NCT02344888|Sodium Citrate|sodium citrate|mesh-list
110875580|NCT02344888|Clomiphene|clomiphene|mesh-list
110875581|NCT02344888|Enclomiphene|enclomiphene|mesh-list
110875582|NCT02344888|Zuclomiphene|zuclomiphene|mesh-list
110875583|NCT02344888|Anticoagulants|anticoagulants|mesh-ancestor
110875584|NCT02344888|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110875585|NCT02344888|Chelating Agents|chelating agents|mesh-ancestor
110875586|NCT02344888|Sequestering Agents|sequestering agents|mesh-ancestor
110875587|NCT02344888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110875588|NCT02344888|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110875589|NCT02344888|Glucocorticoids|glucocorticoids|mesh-ancestor
110875590|NCT02344888|Hormones|hormones|mesh-ancestor
110875591|NCT02344888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110875592|NCT02344888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110875593|NCT02344888|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110875594|NCT02344888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110875607|NCT03497429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110875608|NCT03497429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110875609|NCT03497429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110875610|NCT03146104|Propofol|propofol|mesh-list
110875611|NCT03146104|Isoflurane|isoflurane|mesh-list
110875612|NCT03146104|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110875613|NCT03146104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110875614|NCT03146104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110875615|NCT03146104|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110875616|NCT03146104|Anesthetics, General|anesthetics, general|mesh-ancestor
110875617|NCT03146104|Anesthetics|anesthetics|mesh-ancestor
110875618|NCT03146104|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110875619|NCT03497039|Diclofenac|diclofenac|mesh-list
110875620|NCT03497039|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110875621|NCT03497039|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110875622|NCT03497039|Analgesics|analgesics|mesh-ancestor
110875623|NCT03497039|Sensory System Agents|sensory system agents|mesh-ancestor
110875624|NCT03497039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110875625|NCT03497039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110875626|NCT03497039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110875627|NCT03497039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110875628|NCT03497039|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110875629|NCT03497039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110875630|NCT03497039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110875631|NCT02340910|Oxymetazoline|oxymetazoline|mesh-list
110875632|NCT02340910|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110875633|NCT02340910|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110875634|NCT02340910|Adrenergic Agents|adrenergic agents|mesh-ancestor
110875635|NCT02340910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110875636|NCT02340910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110875637|NCT02340910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110875638|NCT02340910|Sympathomimetics|sympathomimetics|mesh-ancestor
110875639|NCT02340910|Autonomic Agents|autonomic agents|mesh-ancestor
110875640|NCT02340910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110875641|NCT02340910|Nasal Decongestants|nasal decongestants|mesh-ancestor
110875642|NCT02340910|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110875643|NCT02340910|Respiratory System Agents|respiratory system agents|mesh-ancestor
110875644|NCT02349490|Hemostatics|hemostatics|mesh-list
110875645|NCT02349490|Coagulants|coagulants|mesh-ancestor
110875646|NCT03720899|Nicotine|nicotine|mesh-list
110875647|NCT03720899|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110875648|NCT03720899|Autonomic Agents|autonomic agents|mesh-ancestor
110875649|NCT03720899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110875650|NCT03720899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110875651|NCT03720899|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110875652|NCT03720899|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110875653|NCT03720899|Cholinergic Agents|cholinergic agents|mesh-ancestor
110875654|NCT03720899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110875655|NCT03720899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110875656|NCT02340988|Oritavancin|oritavancin|mesh-list
110875657|NCT02340988|Warfarin|warfarin|mesh-list
110875658|NCT02340988|Anticoagulants|anticoagulants|mesh-ancestor
110204277|NCT00164710|Artesunate|artesunate|mesh-list
110875663|NCT03145480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110875664|NCT03726515|Pembrolizumab|pembrolizumab|mesh-list
110875665|NCT03726515|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110875666|NCT03726515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110875667|NCT03726515|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110875668|NCT03726515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110875669|NCT05665283|Ensartinib|ensartinib|mesh-list
110875670|NCT05665283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110875671|NCT05665283|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110875672|NCT05665283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110875673|NCT05665283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110875674|NCT03071094|Nivolumab|nivolumab|mesh-list
110875675|NCT03071094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110875676|NCT03071094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110875677|NCT03071094|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110195780|NCT00208195|GABA Agents|gaba agents|mesh-ancestor
110875678|NCT03071094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110875679|NCT03148990|Vaccines|vaccines|mesh-list
110875680|NCT03148990|Immunologic Factors|immunologic factors|mesh-ancestor
110875681|NCT03148990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110875682|NCT04477642|Abatacept|abatacept|mesh-list
110875683|NCT04477642|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110875684|NCT04477642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110875685|NCT04477642|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110875686|NCT04477642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110875687|NCT04477642|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110875688|NCT04477642|Immunologic Factors|immunologic factors|mesh-ancestor
110875689|NCT04477642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110875690|NCT04477642|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110875691|NCT02344732|Polymyxins|polymyxins|mesh-list
110875692|NCT02344732|Neomycin|neomycin|mesh-list
110875693|NCT02344732|Polymyxin B|polymyxin b|mesh-list
110875694|NCT02344732|Dexamethasone|dexamethasone|mesh-list
110875695|NCT02344732|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110875696|NCT02344732|Homatropine|homatropine|mesh-list
110875697|NCT02344732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110875698|NCT02344732|Antiemetics|antiemetics|mesh-ancestor
110875699|NCT02344732|Autonomic Agents|autonomic agents|mesh-ancestor
110875700|NCT02344732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110875701|NCT02344732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110875702|NCT02344732|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110875703|NCT02344732|Glucocorticoids|glucocorticoids|mesh-ancestor
110875705|NCT02344732|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110875706|NCT02344732|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110875707|NCT02344732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110875708|NCT02344732|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110875709|NCT02344732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110875710|NCT02344732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110875711|NCT02344732|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110593230|NCT00778011|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110875712|NCT02344732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110875713|NCT02344732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110875714|NCT02344732|Parasympatholytics|parasympatholytics|mesh-ancestor
110875715|NCT03720665|Caffeine|caffeine|mesh-list
110875716|NCT03720665|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110875717|NCT03720665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110875718|NCT03720665|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110875719|NCT03720665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110875720|NCT03720665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110875721|NCT03720665|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110875722|NCT03720665|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110875723|NCT03720665|Purinergic Agents|purinergic agents|mesh-ancestor
110875724|NCT03720665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110875725|NCT03726281|Nivolumab|nivolumab|mesh-list
110875726|NCT03726281|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110875727|NCT03726281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110875744|NCT02339662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110875745|NCT02339662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110875747|NCT02339662|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110875748|NCT02339662|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110875749|NCT02339662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110875750|NCT02339662|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110875751|NCT02339662|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110875752|NCT02339662|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110875753|NCT02339662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110875754|NCT02339662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110875755|NCT02339662|Antimanic Agents|antimanic agents|mesh-ancestor
110875756|NCT02339662|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110875757|NCT02339662|Antidepressive Agents|antidepressive agents|mesh-ancestor
110875758|NCT02339662|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110875759|NCT02339662|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110875760|NCT02339662|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110875761|NCT02339662|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110875762|NCT02339662|Adrenergic Agents|adrenergic agents|mesh-ancestor
110875763|NCT02343718|Sirolimus|sirolimus|mesh-list
110875764|NCT02343718|Temsirolimus|temsirolimus|mesh-list
110875765|NCT02343718|MTOR Inhibitors|mtor inhibitors|mesh-list
110875766|NCT02343718|Vinblastine|vinblastine|mesh-list
110875767|NCT02343718|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110875768|NCT02343718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110919394|NCT02131506|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110875769|NCT02343718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110875770|NCT02343718|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110875771|NCT02343718|Immunologic Factors|immunologic factors|mesh-ancestor
110875772|NCT02343718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110875773|NCT02343718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110875774|NCT02343718|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110875775|NCT02343718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110875776|NCT02343718|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110875777|NCT02343718|Antifungal Agents|antifungal agents|mesh-ancestor
110875778|NCT02343718|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110875779|NCT02343718|Tubulin Modulators|tubulin modulators|mesh-ancestor
110875780|NCT02343718|Antimitotic Agents|antimitotic agents|mesh-ancestor
110875781|NCT02343718|Mitosis Modulators|mitosis modulators|mesh-ancestor
110875782|NCT03148522|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110875783|NCT03148522|Mirtazapine|mirtazapine|mesh-list
110875784|NCT03148522|Escitalopram|escitalopram|mesh-list
110875785|NCT03148522|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110204294|NCT00164710|Anthelmintics|anthelmintics|mesh-ancestor
110875788|NCT03148522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110875789|NCT03148522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110875790|NCT03148522|Serotonin Agents|serotonin agents|mesh-ancestor
110875791|NCT03148522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110875792|NCT03148522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110875793|NCT03148522|Antidepressive Agents|antidepressive agents|mesh-ancestor
110875794|NCT03148522|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110875795|NCT03148522|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110875796|NCT03148522|Analgesics|analgesics|mesh-ancestor
110875797|NCT03148522|Sensory System Agents|sensory system agents|mesh-ancestor
110875798|NCT03148522|Dopamine Agents|dopamine agents|mesh-ancestor
110875799|NCT03148522|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110875800|NCT03148522|Histamine Antagonists|histamine antagonists|mesh-ancestor
110875801|NCT03148522|Histamine Agents|histamine agents|mesh-ancestor
110875802|NCT03148522|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110875803|NCT03148522|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110875804|NCT03148522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110875805|NCT03148522|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
110875806|NCT03148522|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110875807|NCT03148522|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110875808|NCT03148522|Adrenergic Agents|adrenergic agents|mesh-ancestor
110875809|NCT03148522|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110875810|NCT03148522|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110875811|NCT03148522|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110875813|NCT03148444|Roxithromycin|roxithromycin|mesh-list
110875814|NCT03148444|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110875815|NCT03148444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110875816|NCT03148132|Bevacizumab|bevacizumab|mesh-list
110875817|NCT03148132|Ranibizumab|ranibizumab|mesh-list
110875818|NCT03148132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110875819|NCT03148132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110875820|NCT03148132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110875821|NCT03148132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110875822|NCT03148132|Growth Substances|growth substances|mesh-ancestor
110875823|NCT03148132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110875824|NCT03148132|Growth Inhibitors|growth inhibitors|mesh-ancestor
110875825|NCT02339350|Methotrexate|methotrexate|mesh-list
110875826|NCT02339350|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110875827|NCT02339350|Abortifacient Agents|abortifacient agents|mesh-ancestor
110875828|NCT02339350|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110875829|NCT02339350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110875830|NCT02339350|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110875831|NCT02339350|Antimetabolites|antimetabolites|mesh-ancestor
110919408|NCT01674010|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110875832|NCT02339350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110875833|NCT02339350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110875834|NCT02339350|Dermatologic Agents|dermatologic agents|mesh-ancestor
110875835|NCT02339350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110875836|NCT02339350|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110875837|NCT02339350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110875838|NCT02339350|Immunologic Factors|immunologic factors|mesh-ancestor
110875839|NCT02339350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110875840|NCT02339350|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110875841|NCT05166304|Rebamipide|rebamipide|mesh-list
110875842|NCT05166304|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110875843|NCT05166304|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110875844|NCT05166304|Antioxidants|antioxidants|mesh-ancestor
110875845|NCT05166304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110875846|NCT05166304|Protective Agents|protective agents|mesh-ancestor
110875847|NCT05166304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110875848|NCT05166304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110875849|NCT02339428|Diclofenac|diclofenac|mesh-list
110875850|NCT02339428|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110195856|NCT00040859|Capecitabine|capecitabine|mesh-list
110875851|NCT02339428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110875852|NCT02339428|Analgesics|analgesics|mesh-ancestor
110875853|NCT02339428|Sensory System Agents|sensory system agents|mesh-ancestor
110875854|NCT02339428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110875855|NCT02339428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110875856|NCT02339428|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110875865|NCT02337322|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110875866|NCT02337322|Protease Inhibitors|protease inhibitors|mesh-ancestor
110875867|NCT02337322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110875868|NCT02337322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110875869|NCT02337322|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110875870|NCT02337322|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110875871|NCT02337322|Antiviral Agents|antiviral agents|mesh-ancestor
110875872|NCT02337322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110875873|NCT02337322|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110875874|NCT02337322|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110875875|NCT02337322|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110875876|NCT02337322|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110875877|NCT02337166|Hyaluronic Acid|hyaluronic acid|mesh-list
110875878|NCT02337166|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110875879|NCT02337166|Immunologic Factors|immunologic factors|mesh-ancestor
110875880|NCT02337166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110875881|NCT02337166|Viscosupplements|viscosupplements|mesh-ancestor
110875882|NCT02337166|Protective Agents|protective agents|mesh-ancestor
110875883|NCT03148288|Vitamin D|vitamin d|mesh-list
110875884|NCT03148288|Vitamins|vitamins|mesh-ancestor
110875885|NCT03148288|Micronutrients|micronutrients|mesh-ancestor
110875886|NCT03148288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110875887|NCT03148288|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110875888|NCT02039362|Tenofovir|tenofovir|mesh-list
110875889|NCT02039362|Antiviral Agents|antiviral agents|mesh-ancestor
110875890|NCT02039362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110875891|NCT02039362|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110875892|NCT02039362|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110875893|NCT02039362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110875894|NCT02039362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110875895|NCT02039362|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110875896|NCT02039362|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110875897|NCT02339116|Bevacizumab|bevacizumab|mesh-list
110875898|NCT02339116|Oxaliplatin|oxaliplatin|mesh-list
110875899|NCT02339116|Irinotecan|irinotecan|mesh-list
110875900|NCT02339116|Fluorouracil|fluorouracil|mesh-list
110875901|NCT02339116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110875902|NCT02339116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110875903|NCT02339116|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110875904|NCT02339116|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110875905|NCT02339116|Growth Substances|growth substances|mesh-ancestor
110875906|NCT02339116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110875907|NCT02339116|Growth Inhibitors|growth inhibitors|mesh-ancestor
110875908|NCT02339116|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110875909|NCT02339116|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110875910|NCT02339116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110875911|NCT02339116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110875912|NCT02339116|Antimetabolites|antimetabolites|mesh-ancestor
110875913|NCT02339116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110875914|NCT02339116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110875915|NCT02339116|Immunologic Factors|immunologic factors|mesh-ancestor
110875916|NCT04824274|Fentanyl|fentanyl|mesh-list
110875917|NCT04824274|Morphine|morphine|mesh-list
110875918|NCT04824274|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110875919|NCT04824274|Narcotics|narcotics|mesh-ancestor
110875920|NCT04824274|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110875921|NCT04824274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110875922|NCT04824274|Analgesics|analgesics|mesh-ancestor
110875923|NCT04824274|Sensory System Agents|sensory system agents|mesh-ancestor
110875924|NCT04824274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110875933|NCT02348788|Lumefantrine|lumefantrine|mesh-list
110875934|NCT02348788|Artemether|artemether|mesh-list
110875935|NCT02348788|Primaquine|primaquine|mesh-list
110875937|NCT02348788|Amebicides|amebicides|mesh-ancestor
110875938|NCT02348788|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110875939|NCT02348788|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110875940|NCT02348788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110875941|NCT02348788|Antimalarials|antimalarials|mesh-ancestor
110875942|NCT02348788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110875943|NCT02337010|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
110875944|NCT02338570|Everolimus|everolimus|mesh-list
110875945|NCT02338570|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110875946|NCT02338570|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110875947|NCT02338570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110875948|NCT02338570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110875949|NCT02338570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110875950|NCT02338570|Immunologic Factors|immunologic factors|mesh-ancestor
110875951|NCT02338570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110875952|NCT02338570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110875953|NCT02336854|Tacrolimus|tacrolimus|mesh-list
110875954|NCT02336854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110875955|NCT02336854|Immunologic Factors|immunologic factors|mesh-ancestor
110875956|NCT02336854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110875957|NCT02336854|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110875958|NCT02336854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110875959|NCT02336854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110875960|NCT02338024|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
110875961|NCT02338024|Antiviral Agents|antiviral agents|mesh-ancestor
110875962|NCT02338024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110875963|NCT02332174|Rufinamide|rufinamide|mesh-list
110875964|NCT02332174|Anticonvulsants|anticonvulsants|mesh-ancestor
110875965|NCT02332174|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110875966|NCT02332174|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110875967|NCT02332174|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110875968|NCT02332174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110875969|NCT03493451|Tislelizumab|tislelizumab|mesh-list
110875970|NCT03493451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110875971|NCT03493451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110875972|NCT03726125|Insulin|insulin|mesh-list
110875973|NCT03726125|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110875974|NCT03726125|Insulin, Long-Acting|insulin, long-acting|mesh-list
110875975|NCT03726125|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110875976|NCT03726125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110875977|NCT02336308|Ketamine|ketamine|mesh-list
110875978|NCT02336308|Analgesics|analgesics|mesh-ancestor
110875979|NCT02336308|Sensory System Agents|sensory system agents|mesh-ancestor
110875980|NCT02336308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110875981|NCT02336308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110875982|NCT02336308|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110875983|NCT02336308|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110875984|NCT02336308|Anesthetics, General|anesthetics, general|mesh-ancestor
110875985|NCT02336308|Anesthetics|anesthetics|mesh-ancestor
110875986|NCT02336308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110875987|NCT02336308|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110875988|NCT02336308|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110875989|NCT02336308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110875990|NCT02336308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110204320|NCT00164788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110875991|NCT02336386|Dexamethasone|dexamethasone|mesh-list
110875992|NCT02336386|Cyclophosphamide|cyclophosphamide|mesh-list
110875996|NCT02336386|Immunologic Factors|immunologic factors|mesh-ancestor
110875997|NCT02336386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110875998|NCT02336386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110875999|NCT02336386|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110876000|NCT02336386|Alkylating Agents|alkylating agents|mesh-ancestor
110876001|NCT02336386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110876002|NCT02336386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110876003|NCT02336386|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110876004|NCT02336386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110876005|NCT02336386|Antiemetics|antiemetics|mesh-ancestor
110876006|NCT02336386|Autonomic Agents|autonomic agents|mesh-ancestor
110876007|NCT02336386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110876008|NCT02336386|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110876009|NCT02336386|Glucocorticoids|glucocorticoids|mesh-ancestor
110876010|NCT02336386|Hormones|hormones|mesh-ancestor
110876011|NCT02336386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110876012|NCT02336386|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110876013|NCT02336386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110876014|NCT02336386|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110876015|NCT02336386|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110876016|NCT02336386|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110876018|NCT02337712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110876019|NCT02337712|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110876020|NCT02337712|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110876021|NCT02337712|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110876022|NCT02337712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110876023|NCT02337712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110876024|NCT03492281|Tolterodine Tartrate|tolterodine tartrate|mesh-list
110876025|NCT03492281|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110876026|NCT03492281|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110876027|NCT03492281|Cholinergic Agents|cholinergic agents|mesh-ancestor
110876028|NCT03492281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110876029|NCT03492281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110919451|NCT02136030|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110876030|NCT03492281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110876031|NCT03492281|Urological Agents|urological agents|mesh-ancestor
110876032|NCT02336152|Anesthetics|anesthetics|mesh-list
110876033|NCT02336152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110876034|NCT02336152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110876035|NCT02331862|Methylprednisolone|methylprednisolone|mesh-list
110876036|NCT02331862|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110876037|NCT02331862|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110876038|NCT02331862|Prednisolone|prednisolone|mesh-list
110876039|NCT02331862|Prednisolone acetate|prednisolone acetate|mesh-list
110876040|NCT02331862|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110876041|NCT02331862|Prednisolone phosphate|prednisolone phosphate|mesh-list
110876042|NCT02331862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110876043|NCT02331862|Antiemetics|antiemetics|mesh-ancestor
110876044|NCT02331862|Autonomic Agents|autonomic agents|mesh-ancestor
110876045|NCT02331862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110876046|NCT02331862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110876047|NCT02331862|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110876048|NCT02331862|Glucocorticoids|glucocorticoids|mesh-ancestor
110876049|NCT02331862|Hormones|hormones|mesh-ancestor
110876050|NCT02331862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110876051|NCT02331862|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110876052|NCT02331862|Protective Agents|protective agents|mesh-ancestor
110876053|NCT02331862|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110876054|NCT02331862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110876055|NCT03525119|Vaccines|vaccines|mesh-list
110876056|NCT03525119|Immunologic Factors|immunologic factors|mesh-ancestor
110876057|NCT03525119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110876058|NCT05230654|Fosaprepitant|fosaprepitant|mesh-list
110876059|NCT05230654|Aprepitant|aprepitant|mesh-list
110876060|NCT05230654|Antiemetics|antiemetics|mesh-ancestor
110876061|NCT05230654|Autonomic Agents|autonomic agents|mesh-ancestor
110876062|NCT05230654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110876063|NCT05230654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110876064|NCT05230654|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110876065|NCT05230654|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110876071|NCT02039518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110876073|NCT03722381|Amlodipine|amlodipine|mesh-list
110876074|NCT03722381|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110876075|NCT03722381|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110876076|NCT03722381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110876077|NCT03722381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110876078|NCT03722381|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110876079|NCT03722381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110876080|NCT03722381|Vasodilator Agents|vasodilator agents|mesh-ancestor
110876081|NCT04352608|Vaccines|vaccines|mesh-list
110876082|NCT04352608|Immunologic Factors|immunologic factors|mesh-ancestor
110593606|NCT02557945|Antimanic Agents|antimanic agents|mesh-ancestor
110876083|NCT04352608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110876085|NCT03722303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110876086|NCT03558503|Mitomycins|mitomycins|mesh-list
110876087|NCT03558503|Mitomycin|mitomycin|mesh-list
110876088|NCT03558503|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110876089|NCT03558503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110876090|NCT03558503|Alkylating Agents|alkylating agents|mesh-ancestor
110876091|NCT03558503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110876092|NCT03558503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110876093|NCT03558503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110876094|NCT02331706|Interferons|interferons|mesh-list
110876095|NCT02331706|Interferon-alpha|interferon-alpha|mesh-list
110876096|NCT02331706|Interferon alpha-2|interferon alpha-2|mesh-list
110876097|NCT02331706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110876098|NCT02331706|Antiviral Agents|antiviral agents|mesh-ancestor
110876099|NCT02331706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110876100|NCT02331706|Immunologic Factors|immunologic factors|mesh-ancestor
110876101|NCT02331706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110876103|NCT03489863|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
110876104|NCT03489863|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110876105|NCT03489863|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110876106|NCT03489863|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110876107|NCT03489863|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110876108|NCT03489863|Purinergic Agents|purinergic agents|mesh-ancestor
110876109|NCT03489863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110876110|NCT03489863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110876111|NCT03489863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110876112|NCT04344444|Azithromycin|azithromycin|mesh-list
110876113|NCT04344444|Hydroxychloroquine|hydroxychloroquine|mesh-list
110876114|NCT04344444|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110876115|NCT04344444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110876116|NCT04344444|Antimalarials|antimalarials|mesh-ancestor
110876117|NCT04344444|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110876118|NCT04344444|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110876119|NCT04344444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110876120|NCT04344444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110876121|NCT04344444|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110876122|NCT03489551|Haloperidol|haloperidol|mesh-list
110876123|NCT03489551|Antiemetics|antiemetics|mesh-ancestor
110876124|NCT03489551|Autonomic Agents|autonomic agents|mesh-ancestor
110876125|NCT03489551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110876126|NCT03489551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110876127|NCT03489551|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110876128|NCT03489551|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110876129|NCT03489551|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110876130|NCT03489551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110876131|NCT03489551|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110876132|NCT03489551|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110876133|NCT03489551|Dopamine Agents|dopamine agents|mesh-ancestor
110876134|NCT03489551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110876139|NCT05762952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110876140|NCT05762952|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110876141|NCT05762952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110876142|NCT02335684|Methamphetamine|methamphetamine|mesh-list
110876143|NCT02335684|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110876144|NCT02335684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110876145|NCT02335684|Sympathomimetics|sympathomimetics|mesh-ancestor
110876146|NCT02335684|Autonomic Agents|autonomic agents|mesh-ancestor
110876147|NCT02335684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110876148|NCT02335684|Dopamine Agents|dopamine agents|mesh-ancestor
110876149|NCT02335684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110876150|NCT02335684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110876151|NCT02335684|Adrenergic Agents|adrenergic agents|mesh-ancestor
110876152|NCT02335684|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110876153|NCT02335684|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110876154|NCT02335684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110876155|NCT02335684|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110876156|NCT05198388|Endorphins|endorphins|mesh-list
110876157|NCT05198388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110876158|NCT05198388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110876159|NCT05198388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110876160|NCT04210180|Varenicline|varenicline|mesh-list
110876161|NCT04210180|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110876162|NCT04210180|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110876163|NCT04210180|Cholinergic Agents|cholinergic agents|mesh-ancestor
110876164|NCT04210180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110876165|NCT04210180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110876166|NCT04210180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110876167|NCT03523715|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
110876168|NCT03523715|Antidiarrheals|antidiarrheals|mesh-ancestor
110876169|NCT03523715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110876170|NCT03523091|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110876171|NCT03523091|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110876172|NCT03523091|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110876173|NCT03523091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110876174|NCT03523091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110876175|NCT03523091|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110876176|NCT03523091|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110876177|NCT03523091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110876178|NCT03523091|Cholinergic Agents|cholinergic agents|mesh-ancestor
110876179|NCT03523091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110876180|NCT03105310|Interferons|interferons|mesh-list
110876181|NCT03105310|Interferon-alpha|interferon-alpha|mesh-list
110876182|NCT03105310|Ezetimibe|ezetimibe|mesh-list
110876183|NCT03105310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110876184|NCT03105310|Antiviral Agents|antiviral agents|mesh-ancestor
110876185|NCT03105310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110876186|NCT03105310|Immunologic Factors|immunologic factors|mesh-ancestor
110876187|NCT03105310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110876188|NCT03105310|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110876189|NCT03105310|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110876190|NCT03105310|Antimetabolites|antimetabolites|mesh-ancestor
110876191|NCT03105310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110876192|NCT03105310|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110876193|NCT03144466|Pembrolizumab|pembrolizumab|mesh-list
110876194|NCT03144466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110876195|NCT03144466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110876196|NCT03144466|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110876197|NCT03144466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110876198|NCT03105466|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
110876199|NCT03105466|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110876200|NCT03105466|Tacrolimus|tacrolimus|mesh-list
110876201|NCT03105466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110876202|NCT03105466|Immunologic Factors|immunologic factors|mesh-ancestor
110876216|NCT02335372|Retinol acetate|retinol acetate|mesh-list
110876217|NCT02335372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110876218|NCT02335372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110876219|NCT02335372|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110876220|NCT02335372|Immunologic Factors|immunologic factors|mesh-ancestor
110876221|NCT02335372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110876222|NCT02335372|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110876223|NCT02335372|Protective Agents|protective agents|mesh-ancestor
110876224|NCT02335372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110876225|NCT02335372|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110876226|NCT03488225|Calcium, Dietary|calcium, dietary|mesh-list
110876227|NCT03488225|Leucovorin|leucovorin|mesh-list
110876228|NCT03488225|Folic Acid|folic acid|mesh-list
110876229|NCT03488225|Cytarabine|cytarabine|mesh-list
110876230|NCT03488225|Dexamethasone|dexamethasone|mesh-list
110876231|NCT03488225|Prednisone|prednisone|mesh-list
110876232|NCT03488225|Dexamethasone acetate|dexamethasone acetate|mesh-list
110876233|NCT03488225|Cortisone|cortisone|mesh-list
110876234|NCT03488225|Cyclophosphamide|cyclophosphamide|mesh-list
110876235|NCT03488225|Rituximab|rituximab|mesh-list
110876236|NCT03488225|Doxorubicin|doxorubicin|mesh-list
110876237|NCT03488225|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110876238|NCT03488225|Methotrexate|methotrexate|mesh-list
110876239|NCT03488225|Vincristine|vincristine|mesh-list
110876240|NCT03488225|Mercaptopurine|mercaptopurine|mesh-list
110876241|NCT03488225|Ofatumumab|ofatumumab|mesh-list
110876242|NCT03488225|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
110876243|NCT03488225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110876244|NCT03488225|Antibodies|antibodies|mesh-list
110876245|NCT03488225|Immunoglobulins|immunoglobulins|mesh-list
110876246|NCT03488225|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110876247|NCT03488225|BB 1101|bb 1101|mesh-list
110876248|NCT03488225|Calcium|calcium|mesh-list
110876249|NCT03488225|Levoleucovorin|levoleucovorin|mesh-list
110876250|NCT03488225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110876251|NCT03488225|Immunologic Factors|immunologic factors|mesh-ancestor
110876252|NCT03488225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110876253|NCT03488225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110876254|NCT03488225|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110876255|NCT03488225|Alkylating Agents|alkylating agents|mesh-ancestor
110876256|NCT03488225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110876257|NCT03488225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110876258|NCT03488225|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110876259|NCT03488225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110876260|NCT03488225|Antiemetics|antiemetics|mesh-ancestor
110876261|NCT03488225|Autonomic Agents|autonomic agents|mesh-ancestor
110876262|NCT03488225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110876263|NCT03488225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110876264|NCT03488225|Glucocorticoids|glucocorticoids|mesh-ancestor
110876265|NCT03488225|Hormones|hormones|mesh-ancestor
110196022|NCT00041093|Docetaxel|docetaxel|mesh-list
110876266|NCT03488225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110876267|NCT03488225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110876268|NCT03488225|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110876275|NCT03488225|Abortifacient Agents|abortifacient agents|mesh-ancestor
110876276|NCT03488225|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110876277|NCT03488225|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110876278|NCT03488225|Antimetabolites|antimetabolites|mesh-ancestor
110876279|NCT03488225|Dermatologic Agents|dermatologic agents|mesh-ancestor
110876280|NCT03488225|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110876281|NCT03488225|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110876282|NCT03488225|Antiviral Agents|antiviral agents|mesh-ancestor
110876283|NCT03488225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110876284|NCT03488225|Antidotes|antidotes|mesh-ancestor
110876285|NCT03488225|Protective Agents|protective agents|mesh-ancestor
110876286|NCT03488225|Vitamin B Complex|vitamin b complex|mesh-ancestor
110876287|NCT03488225|Vitamins|vitamins|mesh-ancestor
110876288|NCT03488225|Micronutrients|micronutrients|mesh-ancestor
110876289|NCT03488225|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110876290|NCT03488225|Tubulin Modulators|tubulin modulators|mesh-ancestor
110876291|NCT03488225|Antimitotic Agents|antimitotic agents|mesh-ancestor
110876292|NCT03488225|Mitosis Modulators|mitosis modulators|mesh-ancestor
110876293|NCT03488225|Hematinics|hematinics|mesh-ancestor
110876294|NCT03488225|Protease Inhibitors|protease inhibitors|mesh-ancestor
110876295|NCT03488225|Immunotoxins|immunotoxins|mesh-ancestor
110876296|NCT03488225|Immunoconjugates|immunoconjugates|mesh-ancestor
110876297|NCT02334904|Risperidone|risperidone|mesh-list
110876298|NCT02334904|Aripiprazole|aripiprazole|mesh-list
110876299|NCT02334904|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110876300|NCT02334904|Serotonin Agents|serotonin agents|mesh-ancestor
110876301|NCT02334904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110876302|NCT02334904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110876303|NCT02334904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110876304|NCT02334904|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110593840|NCT04038086|Insulin|insulin|mesh-list
110876305|NCT02334904|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110876306|NCT02334904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110876307|NCT02334904|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110876308|NCT02334904|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110876309|NCT02334904|Dopamine Agents|dopamine agents|mesh-ancestor
110876310|NCT02334904|Antidepressive Agents|antidepressive agents|mesh-ancestor
110876311|NCT02334904|Dopamine Agonists|dopamine agonists|mesh-ancestor
110876312|NCT02334904|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110876313|NCT02334904|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110876314|NCT02334904|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110876315|NCT02334904|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110876316|NCT02326090|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110876317|NCT02326090|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110876319|NCT03437447|Anthelmintics|anthelmintics|mesh-ancestor
110876320|NCT03437447|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110876321|NCT03437447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110876322|NCT03720041|Dexamethasone|dexamethasone|mesh-list
110876323|NCT03720041|Dexamethasone acetate|dexamethasone acetate|mesh-list
110876324|NCT03720041|Lenalidomide|lenalidomide|mesh-list
110876325|NCT03720041|Ixazomib|ixazomib|mesh-list
110876326|NCT03720041|BB 1101|bb 1101|mesh-list
110876327|NCT03720041|Glycine|glycine|mesh-list
110876328|NCT03720041|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110876329|NCT03720041|Antiemetics|antiemetics|mesh-ancestor
110876330|NCT03720041|Autonomic Agents|autonomic agents|mesh-ancestor
110876331|NCT03720041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110876332|NCT03720041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110876333|NCT03720041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110876334|NCT03720041|Glucocorticoids|glucocorticoids|mesh-ancestor
110876335|NCT03720041|Hormones|hormones|mesh-ancestor
110876336|NCT03720041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110876337|NCT03720041|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110876338|NCT03720041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110876339|NCT03720041|Protease Inhibitors|protease inhibitors|mesh-ancestor
110876356|NCT02334670|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110876357|NCT02334670|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110876358|NCT02334670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110876359|NCT02334670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110876360|NCT02334670|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110876361|NCT02334670|Hormone Antagonists|hormone antagonists|mesh-ancestor
110876362|NCT02334670|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110876363|NCT02334670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110876364|NCT02334670|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110876365|NCT02334670|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110876366|NCT02974868|PF-06700841|pf-06700841|mesh-list
110876367|NCT02974868|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110876368|NCT02974868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110876369|NCT02974868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110876370|NCT02330770|Triptorelin Pamoate|triptorelin pamoate|mesh-list
110876371|NCT02330770|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
110876372|NCT02330770|Luteolytic Agents|luteolytic agents|mesh-ancestor
110876373|NCT02330770|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110196076|NCT00209716|Cisplatin|cisplatin|mesh-list
110876374|NCT02330770|Contraceptive Agents|contraceptive agents|mesh-ancestor
110876375|NCT02330770|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110876376|NCT02330770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110876377|NCT02330770|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110876378|NCT02330770|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110876379|NCT02330770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110876380|NCT05076526|Hyaluronic Acid|hyaluronic acid|mesh-list
110876381|NCT05076526|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110876382|NCT05076526|Immunologic Factors|immunologic factors|mesh-ancestor
110876383|NCT05076526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110876384|NCT05076526|Viscosupplements|viscosupplements|mesh-ancestor
110876385|NCT05076526|Protective Agents|protective agents|mesh-ancestor
110876386|NCT02330614|Carbamide Peroxide|carbamide peroxide|mesh-list
110876387|NCT02330614|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110876388|NCT02330614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110876389|NCT03143998|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
110876390|NCT03143998|Grazoprevir|grazoprevir|mesh-list
110876391|NCT03143998|Antiviral Agents|antiviral agents|mesh-ancestor
110876392|NCT03143998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110876393|NCT02334046|Remifentanil|remifentanil|mesh-list
110876394|NCT02334046|Sevoflurane|sevoflurane|mesh-list
110876395|NCT02334046|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110876396|NCT02334046|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110876397|NCT02334046|Anesthetics, General|anesthetics, general|mesh-ancestor
110876411|NCT02330380|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110876412|NCT02330380|Abortifacient Agents|abortifacient agents|mesh-ancestor
110876413|NCT02330380|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110876414|NCT02330380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110876415|NCT02330380|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110876416|NCT02330380|Antimetabolites|antimetabolites|mesh-ancestor
110876417|NCT02330380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110876418|NCT02330380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110876419|NCT02330380|Dermatologic Agents|dermatologic agents|mesh-ancestor
110876420|NCT02330380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110876421|NCT02330380|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110876422|NCT02330380|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110876423|NCT02330380|Immunologic Factors|immunologic factors|mesh-ancestor
110876424|NCT02330380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110876425|NCT02330380|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110876426|NCT02330380|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110876427|NCT02330380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110876428|NCT02330380|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110876429|NCT02330380|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110876430|NCT02330380|Analgesics|analgesics|mesh-ancestor
110876431|NCT02330380|Sensory System Agents|sensory system agents|mesh-ancestor
110876432|NCT02330380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110876433|NCT02330380|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110876434|NCT02330380|Keratolytic Agents|keratolytic agents|mesh-ancestor
110876435|NCT02333890|Chloroquine|chloroquine|mesh-list
110876436|NCT02333890|Amebicides|amebicides|mesh-ancestor
110876437|NCT02333890|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110876438|NCT02333890|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110876439|NCT02333890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110876440|NCT02333890|Antimalarials|antimalarials|mesh-ancestor
110876441|NCT02333890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110876442|NCT02330302|Ropivacaine|ropivacaine|mesh-list
110876443|NCT02330302|Anesthetics, Local|anesthetics, local|mesh-ancestor
110876444|NCT02330302|Anesthetics|anesthetics|mesh-ancestor
110876445|NCT02330302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110876446|NCT02330302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110876447|NCT02330302|Sensory System Agents|sensory system agents|mesh-ancestor
110876448|NCT02330302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110876449|NCT03143530|Ropivacaine|ropivacaine|mesh-list
110876450|NCT03143530|Anesthetics, Local|anesthetics, local|mesh-ancestor
110876451|NCT03143530|Anesthetics|anesthetics|mesh-ancestor
110876452|NCT03143530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110876453|NCT03143530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110876454|NCT03143530|Sensory System Agents|sensory system agents|mesh-ancestor
110876455|NCT03143530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110876456|NCT01065818|Telbivudine|telbivudine|mesh-list
110876457|NCT01065818|Antiviral Agents|antiviral agents|mesh-ancestor
110876458|NCT01065818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110876459|NCT01065818|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110876460|NCT01065818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110876461|NCT01065818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110876463|NCT03697408|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110876469|NCT03697408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110876471|NCT02318277|Durvalumab|durvalumab|mesh-list
110876472|NCT02318277|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110876473|NCT02318277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110876474|NCT03143452|Lidocaine|lidocaine|mesh-list
110876475|NCT03143452|Tetracaine|tetracaine|mesh-list
110876476|NCT03143452|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110876477|NCT03143452|Anesthetics, Local|anesthetics, local|mesh-ancestor
110876478|NCT03143452|Anesthetics|anesthetics|mesh-ancestor
110876479|NCT03143452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110876480|NCT03143452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110876481|NCT03143452|Sensory System Agents|sensory system agents|mesh-ancestor
110876482|NCT03143452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110876483|NCT03143452|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110876484|NCT03143452|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110876485|NCT03143452|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110876486|NCT03143452|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110876487|NCT03143452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110876488|NCT03143452|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110876489|NCT01063868|Oxycodone|oxycodone|mesh-list
110876490|NCT01063868|Tapentadol|tapentadol|mesh-list
110876491|NCT01063868|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110876492|NCT01063868|Narcotics|narcotics|mesh-ancestor
110876493|NCT01063868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110876494|NCT01063868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110876495|NCT01063868|Analgesics|analgesics|mesh-ancestor
110876496|NCT01063868|Sensory System Agents|sensory system agents|mesh-ancestor
110876497|NCT01063868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110876498|NCT01063868|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110876499|NCT01063868|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110876500|NCT01063868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110876501|NCT01063868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110196125|NCT00041210|Doxorubicin|doxorubicin|mesh-list
110876502|NCT01063868|Adrenergic Agents|adrenergic agents|mesh-ancestor
110876503|NCT01063868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110876504|NCT04993924|Cetrorelix|cetrorelix|mesh-list
110876505|NCT04993924|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110876506|NCT04993924|Fertility Agents|fertility agents|mesh-ancestor
110876507|NCT04993924|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110876508|NCT04993924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110876509|NCT04993924|Hormone Antagonists|hormone antagonists|mesh-ancestor
110876510|NCT04993924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110876511|NCT02330068|Citalopram|citalopram|mesh-list
110876512|NCT02330068|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110876513|NCT02330068|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110876514|NCT02330068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110876515|NCT02330068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110876516|NCT02330068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110876517|NCT02330068|Serotonin Agents|serotonin agents|mesh-ancestor
110876518|NCT02330068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110876519|NCT02330068|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110876520|NCT02330068|Antidepressive Agents|antidepressive agents|mesh-ancestor
110876521|NCT02330068|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110876522|NCT02333344|Zoledronic Acid|zoledronic acid|mesh-list
110876523|NCT02333344|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110876524|NCT02333344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110876525|NCT01312857|Panitumumab|panitumumab|mesh-list
110876526|NCT01312857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110876527|NCT01312857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110876528|NCT02974010|Cycloserine|cycloserine|mesh-list
110876529|NCT02974010|Ketamine|ketamine|mesh-list
110876530|NCT02974010|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
110876541|NCT02974010|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110876542|NCT02974010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110876543|NCT02974010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110876544|NCT02974010|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110876545|NCT02974010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110876546|NCT02974010|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110876547|NCT02974010|Antitubercular Agents|antitubercular agents|mesh-ancestor
110876548|NCT02974010|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110876550|NCT02974010|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110876551|NCT02974010|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110876552|NCT02974010|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110876553|NCT02974010|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
110876554|NCT02974010|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110876555|NCT02974010|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110876556|NCT02974010|Adrenergic Agents|adrenergic agents|mesh-ancestor
110876557|NCT02974010|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110876558|NCT02974010|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110876559|NCT02974010|Serotonin Agents|serotonin agents|mesh-ancestor
110876560|NCT02974010|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110876561|NCT02974010|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110876562|NCT02974010|Dopamine Agents|dopamine agents|mesh-ancestor
110876563|NCT01061606|Sirolimus|sirolimus|mesh-list
110876564|NCT01061606|Temsirolimus|temsirolimus|mesh-list
110876565|NCT01061606|MTOR Inhibitors|mtor inhibitors|mesh-list
110876566|NCT01061606|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110876567|NCT01061606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110876568|NCT01061606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110876569|NCT01061606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110876570|NCT01061606|Immunologic Factors|immunologic factors|mesh-ancestor
110876571|NCT01061606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110876572|NCT01061606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110876573|NCT01061606|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110876574|NCT01061606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110876575|NCT01061606|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110876576|NCT01061606|Antifungal Agents|antifungal agents|mesh-ancestor
110876577|NCT04696822|Epinephrine|epinephrine|mesh-list
110876578|NCT04696822|Racepinephrine|racepinephrine|mesh-list
110876579|NCT04696822|Epinephryl borate|epinephryl borate|mesh-list
110876580|NCT04696822|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110876581|NCT04696822|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110876582|NCT04696822|Adrenergic Agents|adrenergic agents|mesh-ancestor
110876583|NCT04696822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110876584|NCT04696822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110876585|NCT04696822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110876586|NCT04696822|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110876587|NCT04696822|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110876588|NCT04696822|Autonomic Agents|autonomic agents|mesh-ancestor
110876589|NCT04696822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110876590|NCT04696822|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110876591|NCT04696822|Respiratory System Agents|respiratory system agents|mesh-ancestor
110876592|NCT04696822|Mydriatics|mydriatics|mesh-ancestor
110876593|NCT04696822|Sympathomimetics|sympathomimetics|mesh-ancestor
110876594|NCT04696822|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110876603|NCT02329288|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110876604|NCT02329288|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110876605|NCT02329288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110594123|NCT00791739|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110876607|NCT02329288|Hormones|hormones|mesh-ancestor
110876608|NCT02329288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110876609|NCT02329288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110876611|NCT02329288|Immunologic Factors|immunologic factors|mesh-ancestor
110876612|NCT02329288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110876613|NCT02329288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110876614|NCT02329054|Favipiravir|favipiravir|mesh-list
110876615|NCT02329054|Antiviral Agents|antiviral agents|mesh-ancestor
110876616|NCT02329054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110876617|NCT03122457|C 1027|c 1027|mesh-list
110876618|NCT03122457|Benzoyl Peroxide|benzoyl peroxide|mesh-list
110196179|NCT00209950|Gaboxadol|gaboxadol|mesh-list
110876619|NCT03122457|Dermatologic Agents|dermatologic agents|mesh-ancestor
110919552|NCT02136888|Moxifloxacin|moxifloxacin|mesh-list
110876620|NCT03122457|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110876621|NCT03122457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110876622|NCT04407988|Letrozole|letrozole|mesh-list
110876623|NCT04407988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110876624|NCT04407988|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110876625|NCT04407988|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110876626|NCT04407988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110876627|NCT04407988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110876628|NCT04407988|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110876629|NCT04407988|Hormone Antagonists|hormone antagonists|mesh-ancestor
110876630|NCT04407988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110876631|NCT04407988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110876632|NCT02329132|Ranibizumab|ranibizumab|mesh-list
110876633|NCT02329132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110876634|NCT02329132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110876635|NCT02329132|Growth Substances|growth substances|mesh-ancestor
110876636|NCT02329132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110876637|NCT02329132|Growth Inhibitors|growth inhibitors|mesh-ancestor
110876638|NCT02329132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110876639|NCT04342078|Vitamin D|vitamin d|mesh-list
110876640|NCT04342078|Vitamins|vitamins|mesh-ancestor
110876641|NCT04342078|Micronutrients|micronutrients|mesh-ancestor
110876642|NCT04342078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110876643|NCT04342078|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110876644|NCT02332954|Vortioxetine|vortioxetine|mesh-list
110876645|NCT02332954|Antidepressive Agents|antidepressive agents|mesh-ancestor
110876646|NCT02332954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110876647|NCT02332954|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110876648|NCT02332954|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110876649|NCT02332954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110876650|NCT02332954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110876651|NCT02332954|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110876652|NCT02332954|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110876653|NCT02332954|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110876654|NCT02332954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110876655|NCT02332954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110876656|NCT02332954|Serotonin Agents|serotonin agents|mesh-ancestor
110876657|NCT02332954|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110876658|NCT02332954|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110876659|NCT02332954|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110876660|NCT02332954|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110876675|NCT05173857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110876676|NCT05173857|Tubulin Modulators|tubulin modulators|mesh-ancestor
110876677|NCT05173857|Antimitotic Agents|antimitotic agents|mesh-ancestor
110876678|NCT05173857|Mitosis Modulators|mitosis modulators|mesh-ancestor
110876679|NCT05173857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110876680|NCT03417999|Dexmedetomidine|dexmedetomidine|mesh-list
110876681|NCT03417999|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110876682|NCT03417999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110876683|NCT03417999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110876684|NCT03417999|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110876685|NCT03417999|Analgesics|analgesics|mesh-ancestor
110876686|NCT03417999|Sensory System Agents|sensory system agents|mesh-ancestor
110196202|NCT00041288|Cyclosporine|cyclosporine|mesh-list
110876687|NCT03417999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110876688|NCT03417999|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110876689|NCT03417999|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110876690|NCT03417999|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110876691|NCT03417999|Adrenergic Agents|adrenergic agents|mesh-ancestor
110876692|NCT03417999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110876693|NCT03417999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110876694|NCT03142516|Leucovorin|leucovorin|mesh-list
110876695|NCT03142516|Folic Acid|folic acid|mesh-list
110876696|NCT03142516|Fluorouracil|fluorouracil|mesh-list
110876697|NCT03142516|Irinotecan|irinotecan|mesh-list
110876698|NCT03142516|Panitumumab|panitumumab|mesh-list
110876699|NCT03142516|Levoleucovorin|levoleucovorin|mesh-list
110876700|NCT03142516|Antimetabolites|antimetabolites|mesh-ancestor
110876701|NCT03142516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110876702|NCT03142516|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110876703|NCT03142516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110876704|NCT03142516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110876705|NCT03142516|Immunologic Factors|immunologic factors|mesh-ancestor
110876706|NCT03142516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110876707|NCT03142516|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110876708|NCT03142516|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110876709|NCT03142516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110876710|NCT03142516|Antidotes|antidotes|mesh-ancestor
110876711|NCT03142516|Protective Agents|protective agents|mesh-ancestor
110876712|NCT03142516|Vitamin B Complex|vitamin b complex|mesh-ancestor
110876713|NCT03142516|Vitamins|vitamins|mesh-ancestor
110876714|NCT03142516|Micronutrients|micronutrients|mesh-ancestor
110876715|NCT03142516|Hematinics|hematinics|mesh-ancestor
110876716|NCT03142516|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110876717|NCT03719729|Rifaximin|rifaximin|mesh-list
110876718|NCT03719729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110876719|NCT03719729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110876720|NCT03719729|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110876721|NCT05077462|Cryptophycin 52|cryptophycin 52|mesh-list
110204413|NCT00165178|Asparaginase|asparaginase|mesh-list
110876738|NCT00799396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110876739|NCT00799396|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110876740|NCT00799396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110876741|NCT00799396|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110876742|NCT00799396|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110876743|NCT00799396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110876744|NCT00799396|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110876745|NCT00799396|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110876746|NCT00799396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110876747|NCT00799396|Antipyretics|antipyretics|mesh-ancestor
110876748|NCT00799396|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110876749|NCT00799396|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110876750|NCT00799396|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110196236|NCT00073164|Olanzapine|olanzapine|mesh-list
110876751|NCT00799396|Purinergic Agents|purinergic agents|mesh-ancestor
110876752|NCT00799396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110876753|NCT02624128|Cetuximab|cetuximab|mesh-list
110876754|NCT02624128|Valproic Acid|valproic acid|mesh-list
110876755|NCT02624128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110876756|NCT02624128|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110876757|NCT02624128|Anticonvulsants|anticonvulsants|mesh-ancestor
110876758|NCT02624128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110876759|NCT02624128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110876760|NCT02624128|GABA Agents|gaba agents|mesh-ancestor
110876761|NCT02624128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110876762|NCT02624128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110876763|NCT02624128|Antimanic Agents|antimanic agents|mesh-ancestor
110876764|NCT02624128|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110876765|NCT02624128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110876766|NCT02624128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110876767|NCT03469349|Actovegin|actovegin|mesh-list
110876768|NCT03469349|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110876769|NCT03469349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110876770|NCT03469349|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110876771|NCT03469349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110876772|NCT03469349|Antioxidants|antioxidants|mesh-ancestor
110876773|NCT03469349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110876774|NCT03469349|Protective Agents|protective agents|mesh-ancestor
110876775|NCT03469349|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110876776|NCT03467945|Metformin|metformin|mesh-list
110876777|NCT03467945|Gliclazide|gliclazide|mesh-list
110876778|NCT03467945|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110876779|NCT03467945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110876780|NCT03719261|Sodium Hypochlorite|sodium hypochlorite|mesh-list
110876781|NCT03719261|Eusol|eusol|mesh-list
110876782|NCT03719261|Chitosan|chitosan|mesh-list
110876795|NCT00069238|Cyclophosphamide|cyclophosphamide|mesh-list
110876796|NCT00069238|Doxorubicin|doxorubicin|mesh-list
110876797|NCT00069238|Etoposide|etoposide|mesh-list
110876798|NCT00069238|Vincristine|vincristine|mesh-list
110876799|NCT00069238|Alemtuzumab|alemtuzumab|mesh-list
110876800|NCT00069238|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110876801|NCT00069238|Immunologic Factors|immunologic factors|mesh-ancestor
110876802|NCT00069238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110876803|NCT00069238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110876804|NCT00069238|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110876805|NCT00069238|Alkylating Agents|alkylating agents|mesh-ancestor
110876806|NCT00069238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110876807|NCT00069238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110876808|NCT00069238|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110876809|NCT00069238|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110876810|NCT00069238|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110876811|NCT00069238|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110876812|NCT00069238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110876813|NCT00069238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110876814|NCT00069238|Glucocorticoids|glucocorticoids|mesh-ancestor
110876815|NCT00069238|Hormones|hormones|mesh-ancestor
110876816|NCT00069238|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110876817|NCT00069238|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110876818|NCT00069238|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110876819|NCT00069238|Tubulin Modulators|tubulin modulators|mesh-ancestor
110876820|NCT00069238|Antimitotic Agents|antimitotic agents|mesh-ancestor
110876821|NCT00069238|Mitosis Modulators|mitosis modulators|mesh-ancestor
110876822|NCT00069238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110876823|NCT03639155|Glycine|glycine|mesh-list
110876824|NCT03639155|Glycine Agents|glycine agents|mesh-ancestor
110876825|NCT03639155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110876826|NCT03639155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110876827|NCT03639155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110876828|NCT05080348|Ropivacaine|ropivacaine|mesh-list
110876829|NCT05080348|Anesthetics, Local|anesthetics, local|mesh-ancestor
110876830|NCT05080348|Anesthetics|anesthetics|mesh-ancestor
110876831|NCT05080348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110876832|NCT05080348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110876833|NCT05080348|Sensory System Agents|sensory system agents|mesh-ancestor
110876834|NCT05080348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110876835|NCT03073200|Etanercept|etanercept|mesh-list
110876837|NCT03073200|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110876838|NCT03073200|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110876839|NCT03073200|Analgesics|analgesics|mesh-ancestor
110876840|NCT03073200|Sensory System Agents|sensory system agents|mesh-ancestor
110876841|NCT03073200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110876842|NCT03073200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110876843|NCT03073200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110876844|NCT03073200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110876845|NCT03073200|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110876846|NCT03073200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110876847|NCT03073200|Immunologic Factors|immunologic factors|mesh-ancestor
110876848|NCT03073200|Dermatologic Agents|dermatologic agents|mesh-ancestor
110876858|NCT01569984|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110876859|NCT01569984|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110876860|NCT01569984|Growth Substances|growth substances|mesh-ancestor
110876861|NCT01569984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110876862|NCT01569984|Growth Inhibitors|growth inhibitors|mesh-ancestor
110876863|NCT02328118|Triamcinolone|triamcinolone|mesh-list
110876864|NCT02328118|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110876865|NCT02328118|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110876866|NCT02328118|Ranibizumab|ranibizumab|mesh-list
110876867|NCT02328118|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110876868|NCT02328118|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110876869|NCT02328118|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110876870|NCT02328118|Growth Substances|growth substances|mesh-ancestor
110876871|NCT02328118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110876872|NCT02328118|Growth Inhibitors|growth inhibitors|mesh-ancestor
110876873|NCT02328118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110196273|NCT00411541|Dexamethasone|dexamethasone|mesh-list
110876874|NCT02328118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110876875|NCT02328118|Glucocorticoids|glucocorticoids|mesh-ancestor
110876876|NCT02328118|Hormones|hormones|mesh-ancestor
110876877|NCT02328118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110876878|NCT02328118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110876879|NCT02328118|Immunologic Factors|immunologic factors|mesh-ancestor
110876880|NCT02328118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110876881|NCT02328118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110876882|NCT02602314|Imatinib Mesylate|imatinib mesylate|mesh-list
110876883|NCT02602314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110876884|NCT02602314|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110876885|NCT02602314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110876886|NCT02602314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110876887|NCT05079880|Caffeine|caffeine|mesh-list
110876888|NCT05079880|Caffeine citrate|caffeine citrate|mesh-list
110876889|NCT05079880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110876890|NCT05079880|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110876891|NCT05079880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110876892|NCT05079880|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110876893|NCT05079880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110876894|NCT05079880|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110876895|NCT05079880|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110876896|NCT05079880|Purinergic Agents|purinergic agents|mesh-ancestor
110876897|NCT05079880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110876898|NCT03716765|Vitamin D|vitamin d|mesh-list
110876899|NCT03716765|Vitamins|vitamins|mesh-ancestor
110876900|NCT03716765|Micronutrients|micronutrients|mesh-ancestor
110876901|NCT03716765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110876902|NCT03716765|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110876903|NCT03070002|Denosumab|denosumab|mesh-list
110876904|NCT03070002|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110876905|NCT03070002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110876906|NCT02327728|Botulinum Toxins|botulinum toxins|mesh-list
110876907|NCT02327728|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110196291|NCT00210379|Rituximab|rituximab|mesh-list
110876908|NCT02327728|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110876909|NCT02327728|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110876910|NCT02327728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110876911|NCT02327728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110876912|NCT02327728|Cholinergic Agents|cholinergic agents|mesh-ancestor
110876913|NCT02327728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110876918|NCT02918318|Antidepressive Agents|antidepressive agents|mesh-ancestor
110876919|NCT02918318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110876920|NCT04926454|Dexmedetomidine|dexmedetomidine|mesh-list
110876921|NCT04926454|Bupivacaine|bupivacaine|mesh-list
110876922|NCT04926454|Anesthetics, Local|anesthetics, local|mesh-ancestor
110876923|NCT04926454|Anesthetics|anesthetics|mesh-ancestor
110876924|NCT04926454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110876925|NCT04926454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110876926|NCT04926454|Sensory System Agents|sensory system agents|mesh-ancestor
110876927|NCT04926454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110876928|NCT04926454|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110876929|NCT04926454|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110876930|NCT04926454|Analgesics|analgesics|mesh-ancestor
110876931|NCT04926454|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110876932|NCT04926454|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110876933|NCT04926454|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110876934|NCT04926454|Adrenergic Agents|adrenergic agents|mesh-ancestor
110876935|NCT04926454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110876936|NCT04926454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110876937|NCT03652376|Benralizumab|benralizumab|mesh-list
110876938|NCT03652376|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110876939|NCT03652376|Respiratory System Agents|respiratory system agents|mesh-ancestor
110876940|NCT03142828|Chlorhexidine|chlorhexidine|mesh-list
110876941|NCT03142828|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110876942|NCT03142828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110876943|NCT03142828|Disinfectants|disinfectants|mesh-ancestor
110876944|NCT01372839|Atorvastatin|atorvastatin|mesh-list
110876945|NCT01372839|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110876946|NCT01372839|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110876947|NCT01372839|Antimetabolites|antimetabolites|mesh-ancestor
110876948|NCT01372839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110876949|NCT01372839|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110876950|NCT01372839|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110876951|NCT01372839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110876953|NCT01065350|Propofol|propofol|mesh-list
110876954|NCT01065350|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110876955|NCT01065350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110876956|NCT01065350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110876957|NCT01065350|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110876958|NCT01065350|Anesthetics, General|anesthetics, general|mesh-ancestor
110876959|NCT01065350|Anesthetics|anesthetics|mesh-ancestor
110876960|NCT01065350|Analgesics|analgesics|mesh-ancestor
110876961|NCT01065350|Sensory System Agents|sensory system agents|mesh-ancestor
110876962|NCT01065350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110876963|NCT01065350|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110876964|NCT01065350|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110876965|NCT01065350|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110876966|NCT01065350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110876967|NCT01065350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110876968|NCT02914977|Daunorubicin|daunorubicin|mesh-list
110876969|NCT02914977|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110876970|NCT02914977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110876971|NCT02914977|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110876972|NCT02914977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110876973|NCT02914977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110876974|NCT02914977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110876975|NCT03718715|Metformin|metformin|mesh-list
110876976|NCT03718715|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110876977|NCT03718715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110876978|NCT05079022|Aflutinib|aflutinib|mesh-list
110876979|NCT05079022|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110876980|NCT05079022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110876981|NCT05079022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110876982|NCT05078788|Triamcinolone|triamcinolone|mesh-list
110876983|NCT05078788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110225689|NCT05843188|Leucovorin|leucovorin|mesh-list
110877001|NCT03114969|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
110877002|NCT03114969|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110877003|NCT03114969|Respiratory System Agents|respiratory system agents|mesh-ancestor
110877004|NCT03114969|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110877006|NCT03114969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110919610|NCT02132442|Vitamin D|vitamin d|mesh-list
110877007|NCT03114969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110877008|NCT03114969|Parasympatholytics|parasympatholytics|mesh-ancestor
110877009|NCT03114969|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110877010|NCT03114969|Cholinergic Agents|cholinergic agents|mesh-ancestor
110877011|NCT03114969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110877012|NCT03114969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110877013|NCT03114969|Glucocorticoids|glucocorticoids|mesh-ancestor
110877014|NCT03114969|Hormones|hormones|mesh-ancestor
110877015|NCT03114969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110877016|NCT03114969|Sympathomimetics|sympathomimetics|mesh-ancestor
110877017|NCT05078710|Immunosuppressive Agents|immunosuppressive agents|mesh-list
110877018|NCT05078710|Immunologic Factors|immunologic factors|mesh-ancestor
110877019|NCT05078710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110877020|NCT03144778|Durvalumab|durvalumab|mesh-list
110877021|NCT03144778|Ipilimumab|ipilimumab|mesh-list
110877022|NCT03144778|Tremelimumab|tremelimumab|mesh-list
110877023|NCT03144778|Immunoglobulins|immunoglobulins|mesh-list
110877024|NCT03144778|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110877025|NCT03144778|Immunoglobulin G|immunoglobulin g|mesh-list
110877026|NCT03144778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110877027|NCT03144778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110877028|NCT03144778|Immunologic Factors|immunologic factors|mesh-ancestor
110877029|NCT03144778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110877030|NCT03144778|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110877031|NCT03144778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110877032|NCT03142360|Beraprost|beraprost|mesh-list
110877033|NCT03142360|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110877034|NCT03142360|Vasodilator Agents|vasodilator agents|mesh-ancestor
110877035|NCT05124678|Isoniazid|isoniazid|mesh-list
110877036|NCT05124678|Antitubercular Agents|antitubercular agents|mesh-ancestor
110877037|NCT05124678|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110877038|NCT05124678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110877039|NCT05124678|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
110877040|NCT05124678|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110877041|NCT05124678|Antimetabolites|antimetabolites|mesh-ancestor
110877051|NCT05081674|Nivolumab|nivolumab|mesh-list
110877052|NCT05081674|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110877053|NCT05081674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110877054|NCT05081674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110877055|NCT05081674|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110877056|NCT05081674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110877057|NCT05081674|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110877058|NCT05081674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110877059|NCT05003076|Methamphetamine|methamphetamine|mesh-list
110196347|NCT00041327|Antimetabolites|antimetabolites|mesh-ancestor
110877060|NCT05003076|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110877061|NCT05003076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110877062|NCT05003076|Sympathomimetics|sympathomimetics|mesh-ancestor
110877063|NCT05003076|Autonomic Agents|autonomic agents|mesh-ancestor
110877064|NCT05003076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110877065|NCT05003076|Dopamine Agents|dopamine agents|mesh-ancestor
110877066|NCT05003076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110877067|NCT05003076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110877068|NCT05003076|Adrenergic Agents|adrenergic agents|mesh-ancestor
110877069|NCT05003076|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110877070|NCT05003076|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110877071|NCT05003076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110877072|NCT05003076|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110877074|NCT03144856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110877075|NCT03144856|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110877076|NCT03144856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110877077|NCT03144856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110877078|NCT03141970|Prednisone|prednisone|mesh-list
110877079|NCT03141970|Prednisolone|prednisolone|mesh-list
110877080|NCT03141970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110877081|NCT03141970|Glucocorticoids|glucocorticoids|mesh-ancestor
110877082|NCT03141970|Hormones|hormones|mesh-ancestor
110877083|NCT03141970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110877084|NCT03141970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110877085|NCT03141970|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110877086|NCT03141970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110877087|NCT04949022|Insulin|insulin|mesh-list
110877088|NCT04949022|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110877089|NCT04949022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110877090|NCT02327338|Ibuprofen|ibuprofen|mesh-list
110877091|NCT02327338|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110877092|NCT02327338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110877093|NCT02327338|Analgesics|analgesics|mesh-ancestor
110877094|NCT02327338|Sensory System Agents|sensory system agents|mesh-ancestor
110877095|NCT02327338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110877096|NCT02327338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110877097|NCT02327338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110877098|NCT02327338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110877099|NCT02327338|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110877100|NCT02327338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110877101|NCT02327338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110877102|NCT02327416|Entecavir|entecavir|mesh-list
110877103|NCT02327416|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110877104|NCT02327416|Interferon-alpha|interferon-alpha|mesh-list
110877105|NCT02327416|Adefovir|adefovir|mesh-list
110877106|NCT02327416|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
110877107|NCT02327416|Molgramostim|molgramostim|mesh-list
110877108|NCT02327416|Sargramostim|sargramostim|mesh-list
110877119|NCT02926950|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
110196359|NCT00210535|Topiramate|topiramate|mesh-list
110877121|NCT02926950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110877122|NCT02926950|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110877123|NCT02926950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110877125|NCT01064414|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110877126|NCT01064414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110877127|NCT01064414|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110877128|NCT01064414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110877129|NCT03433703|Lenvatinib|lenvatinib|mesh-list
110877130|NCT03433703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110877131|NCT03433703|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110877132|NCT03433703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110877133|NCT03433703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110877134|NCT01374633|Sevoflurane|sevoflurane|mesh-list
110877135|NCT01374633|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110877136|NCT01374633|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110877137|NCT01374633|Anesthetics, General|anesthetics, general|mesh-ancestor
110877138|NCT01374633|Anesthetics|anesthetics|mesh-ancestor
110877139|NCT01374633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110877140|NCT01374633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110877141|NCT01178814|Lenalidomide|lenalidomide|mesh-list
110877142|NCT01178814|Immunologic Factors|immunologic factors|mesh-ancestor
110877143|NCT01178814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110877144|NCT01178814|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110877145|NCT01178814|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110877146|NCT01178814|Growth Substances|growth substances|mesh-ancestor
110877147|NCT01178814|Growth Inhibitors|growth inhibitors|mesh-ancestor
110877148|NCT01178814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110877149|NCT05202288|Atoltivimab, maftivimab, and odesivimab-ebgn drug combination|atoltivimab, maftivimab, and odesivimab-ebgn drug combination|mesh-list
110877150|NCT05202288|Antiviral Agents|antiviral agents|mesh-ancestor
110877151|NCT05202288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110877152|NCT05762484|Clindamycin|clindamycin|mesh-list
110877153|NCT05762484|Clindamycin palmitate|clindamycin palmitate|mesh-list
110877154|NCT05762484|Clindamycin phosphate|clindamycin phosphate|mesh-list
110877155|NCT05762484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110877156|NCT05762484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110877157|NCT05762484|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110877158|NCT05762484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110877159|NCT05762484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110877160|NCT03462641|Flumazenil|flumazenil|mesh-list
110877161|NCT03462641|Antidotes|antidotes|mesh-ancestor
110877162|NCT03462641|Protective Agents|protective agents|mesh-ancestor
110877163|NCT03462641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110877164|NCT03462641|GABA Modulators|gaba modulators|mesh-ancestor
110877165|NCT03462641|GABA Agents|gaba agents|mesh-ancestor
110877166|NCT03462641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110877167|NCT03462641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110877168|NCT05201352|Trifluridine|trifluridine|mesh-list
110877182|NCT04128956|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110877183|NCT04128956|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110877184|NCT04128956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110877185|NCT04128956|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110877186|NCT04128956|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110877187|NCT04128956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110877188|NCT04128956|Antipyretics|antipyretics|mesh-ancestor
110877189|NCT05761704|Anticoagulants|anticoagulants|mesh-list
110877190|NCT03652142|Nivolumab|nivolumab|mesh-list
110877191|NCT03652142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110877192|NCT03652142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110877193|NCT03652142|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110877194|NCT03652142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110877195|NCT05762328|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110877196|NCT05762328|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
110877197|NCT05762328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110877198|NCT05762328|Antitubercular Agents|antitubercular agents|mesh-ancestor
110877199|NCT04629378|Amoxicillin|amoxicillin|mesh-list
110877200|NCT04629378|Meropenem|meropenem|mesh-list
110877201|NCT04629378|Clavulanic Acid|clavulanic acid|mesh-list
110877202|NCT04629378|Clavulanic Acids|clavulanic acids|mesh-list
110877203|NCT04629378|Pyrazinamide|pyrazinamide|mesh-list
110877204|NCT04629378|Bedaquiline|bedaquiline|mesh-list
110877205|NCT04629378|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
110877206|NCT04629378|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110877208|NCT04629378|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110877209|NCT04629378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110877210|NCT04629378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110877211|NCT04629378|Antitubercular Agents|antitubercular agents|mesh-ancestor
110877212|NCT03651674|Olanzapine|olanzapine|mesh-list
110877213|NCT03651674|Clozapine|clozapine|mesh-list
110877214|NCT03651674|Antiemetics|antiemetics|mesh-ancestor
110877215|NCT03651674|Autonomic Agents|autonomic agents|mesh-ancestor
110877216|NCT03651674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110877217|NCT03651674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110877218|NCT03651674|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110877219|NCT03651674|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110877220|NCT03651674|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110877221|NCT03651674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110877222|NCT03651674|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110877223|NCT03651674|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110877224|NCT03651674|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110877225|NCT03651674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110877226|NCT03651674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110877227|NCT03651674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110877228|NCT03651674|Serotonin Agents|serotonin agents|mesh-ancestor
110877229|NCT03651674|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110877230|NCT03651674|GABA Antagonists|gaba antagonists|mesh-ancestor
110225946|NCT05733351|Docetaxel|docetaxel|mesh-list
110877240|NCT02926638|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110877241|NCT02926638|Antibodies|antibodies|mesh-list
110877242|NCT02926638|Immunoglobulins|immunoglobulins|mesh-list
110877243|NCT02926638|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110877244|NCT02926638|Immunologic Factors|immunologic factors|mesh-ancestor
110877245|NCT02926638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110877246|NCT02926638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110877247|NCT02926638|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110877248|NCT02926638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110196421|NCT00210925|Topiramate|topiramate|mesh-list
110877249|NCT02926638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110877251|NCT03650582|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110877252|NCT03650582|Hormones|hormones|mesh-ancestor
110877253|NCT03650582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110877254|NCT03650582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110877255|NCT02903030|Silicon|silicon|mesh-list
110877256|NCT02903030|Trace Elements|trace elements|mesh-ancestor
110877257|NCT02903030|Micronutrients|micronutrients|mesh-ancestor
110877258|NCT02903030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110877259|NCT02969408|Albuterol|albuterol|mesh-list
110877260|NCT02969408|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110877261|NCT02969408|Autonomic Agents|autonomic agents|mesh-ancestor
110877262|NCT02969408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110877263|NCT02969408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110877264|NCT02969408|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110877265|NCT02969408|Respiratory System Agents|respiratory system agents|mesh-ancestor
110877266|NCT02969408|Tocolytic Agents|tocolytic agents|mesh-ancestor
110877267|NCT02969408|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110877268|NCT02969408|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110877269|NCT02969408|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110877270|NCT02969408|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110877271|NCT02969408|Adrenergic Agents|adrenergic agents|mesh-ancestor
110877272|NCT02969408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110877273|NCT02969408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110877274|NCT05180214|Ketorolac|ketorolac|mesh-list
110877275|NCT05180214|Bupivacaine|bupivacaine|mesh-list
110877276|NCT05180214|Anesthetics, Local|anesthetics, local|mesh-ancestor
110877277|NCT05180214|Anesthetics|anesthetics|mesh-ancestor
110877278|NCT05180214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110877279|NCT05180214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110877280|NCT05180214|Sensory System Agents|sensory system agents|mesh-ancestor
110877281|NCT05180214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110877282|NCT05180214|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110877283|NCT05180214|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110877284|NCT05180214|Analgesics|analgesics|mesh-ancestor
110877285|NCT05180214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110877286|NCT05180214|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110877287|NCT05180214|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110877288|NCT05180214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110877289|NCT05180214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110877290|NCT01060124|Fentanyl|fentanyl|mesh-list
110877291|NCT01060124|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110877292|NCT01060124|Narcotics|narcotics|mesh-ancestor
110877293|NCT01060124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110877294|NCT01060124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110877295|NCT01060124|Analgesics|analgesics|mesh-ancestor
110877296|NCT01060124|Sensory System Agents|sensory system agents|mesh-ancestor
110877297|NCT01060124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110877298|NCT01060124|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110877314|NCT03461003|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110877315|NCT03461003|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110877317|NCT03461003|Natriuretic Agents|natriuretic agents|mesh-ancestor
110877318|NCT03461003|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110877319|NCT03461003|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110877321|NCT03461003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110877322|NCT03461003|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110877323|NCT03461003|Protective Agents|protective agents|mesh-ancestor
110877324|NCT03650348|Atezolizumab|atezolizumab|mesh-list
110877325|NCT03650348|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110877326|NCT03650348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110877327|NCT03650348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110877328|NCT03650348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110877329|NCT05761470|Paclitaxel|paclitaxel|mesh-list
110877330|NCT05761470|Fluzoparib|fluzoparib|mesh-list
110877331|NCT05761470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110877332|NCT05761470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110877333|NCT05761470|Tubulin Modulators|tubulin modulators|mesh-ancestor
110877334|NCT05761470|Antimitotic Agents|antimitotic agents|mesh-ancestor
110877335|NCT05761470|Mitosis Modulators|mitosis modulators|mesh-ancestor
110877336|NCT05761470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110877337|NCT05761470|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110877338|NCT05761470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110877339|NCT01372293|Contraceptive Agents|contraceptive agents|mesh-list
110877340|NCT01372293|Contraceptives, Oral|contraceptives, oral|mesh-list
110877341|NCT01372293|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
110877342|NCT01372293|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110877343|NCT01372293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110877344|NCT01372293|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110877345|NCT02904902|Adalimumab|adalimumab|mesh-list
110877346|NCT02904902|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110877347|NCT02904902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110877348|NCT02904902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110877349|NCT03650270|Phenytoin|phenytoin|mesh-list
110877350|NCT03650270|Midazolam|midazolam|mesh-list
110877351|NCT03650270|Phenobarbital|phenobarbital|mesh-list
110877352|NCT03650270|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110877353|NCT03650270|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110877354|NCT03650270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110877355|NCT03650270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110877356|NCT03650270|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110877357|NCT03650270|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110204529|NCT00165490|Irinotecan|irinotecan|mesh-list
110877367|NCT03650270|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110877368|NCT03650270|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110877369|NCT03650270|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110877370|NCT03650270|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110877371|NCT03650270|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110877372|NCT03650270|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110877373|NCT03650270|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110877374|NCT03650270|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110877375|NCT03650270|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110877377|NCT05285228|Fluorides, Topical|fluorides, topical|mesh-list
110877378|NCT05285228|Cariostatic Agents|cariostatic agents|mesh-ancestor
110877379|NCT05285228|Protective Agents|protective agents|mesh-ancestor
110877380|NCT05285228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110877381|NCT04075526|Vancomycin|vancomycin|mesh-list
110877382|NCT04075526|Povidone-Iodine|povidone-iodine|mesh-list
110877383|NCT04075526|Povidone|povidone|mesh-list
110877384|NCT04075526|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110877385|NCT04075526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110877386|NCT04075526|Plasma Substitutes|plasma substitutes|mesh-ancestor
110877387|NCT04075526|Blood Substitutes|blood substitutes|mesh-ancestor
110877388|NCT04075526|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110877389|NCT05204628|Crizotinib|crizotinib|mesh-list
110877390|NCT05204628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110877391|NCT05204628|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110877392|NCT05204628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110877393|NCT05204628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110877394|NCT03650738|Paclitaxel|paclitaxel|mesh-list
110877395|NCT03650738|Carboplatin|carboplatin|mesh-list
110877396|NCT03650738|Apatinib|apatinib|mesh-list
110877397|NCT03650738|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110877398|NCT03650738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110877399|NCT03650738|Tubulin Modulators|tubulin modulators|mesh-ancestor
110877400|NCT03650738|Antimitotic Agents|antimitotic agents|mesh-ancestor
110877401|NCT03650738|Mitosis Modulators|mitosis modulators|mesh-ancestor
110877402|NCT03650738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110877403|NCT03650738|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110877404|NCT03650738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110877405|NCT02904200|Silicon|silicon|mesh-list
110877406|NCT02904200|Trace Elements|trace elements|mesh-ancestor
110877407|NCT02904200|Micronutrients|micronutrients|mesh-ancestor
110877408|NCT02904200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110877409|NCT03432533|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110877410|NCT03432533|Immunologic Factors|immunologic factors|mesh-ancestor
110877411|NCT03432533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110877412|NCT03621800|Menthol|menthol|mesh-list
110877413|NCT03621800|Antipruritics|antipruritics|mesh-ancestor
110877414|NCT03621800|Dermatologic Agents|dermatologic agents|mesh-ancestor
110877415|NCT03649334|Ketorolac|ketorolac|mesh-list
110877416|NCT03649334|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
110877417|NCT03649334|Fentanyl|fentanyl|mesh-list
110877418|NCT03649334|Ketamine|ketamine|mesh-list
110877419|NCT03649334|Analgesics|analgesics|mesh-ancestor
110877420|NCT03649334|Sensory System Agents|sensory system agents|mesh-ancestor
110877421|NCT03649334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110877422|NCT03649334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110877423|NCT03649334|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110877424|NCT03649334|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110877425|NCT03649334|Anesthetics, General|anesthetics, general|mesh-ancestor
110877426|NCT03649334|Anesthetics|anesthetics|mesh-ancestor
110204537|NCT00165568|Bevacizumab|bevacizumab|mesh-list
110877431|NCT03649334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110877432|NCT03649334|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110877433|NCT03649334|Narcotics|narcotics|mesh-ancestor
110877434|NCT03649334|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110877435|NCT03649334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110877436|NCT03649334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110877437|NCT03649334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110877438|NCT03649334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110877439|NCT03649334|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110877440|NCT03649334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110877441|NCT02901548|Durvalumab|durvalumab|mesh-list
110877442|NCT02901548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110877443|NCT02901548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110877444|NCT03457727|Omeprazole|omeprazole|mesh-list
110877445|NCT03457727|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110877446|NCT03457727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110877447|NCT03457727|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110877448|NCT03457727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110877449|NCT03457727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110877450|NCT03648554|Dulaglutide|dulaglutide|mesh-list
110877451|NCT03648554|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110877452|NCT03648554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110877453|NCT03648320|Immunomodulating Agents|immunomodulating agents|mesh-list
110877454|NCT03648320|Immunologic Factors|immunologic factors|mesh-ancestor
110877455|NCT03648320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110877456|NCT05284994|Osimertinib|osimertinib|mesh-list
110877457|NCT05284994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110877458|NCT05284994|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110877459|NCT05284994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110877460|NCT05284994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110877461|NCT03068754|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
110877462|NCT03068754|Hormones|hormones|mesh-ancestor
110877463|NCT03068754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110877464|NCT03068754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110877465|NCT02965820|Contact Lens Solutions|contact lens solutions|mesh-list
110877466|NCT02965820|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110877467|NCT02965820|Disinfectants|disinfectants|mesh-ancestor
110877468|NCT02965820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110877469|NCT03430895|Durvalumab|durvalumab|mesh-list
110877470|NCT03430895|Tremelimumab|tremelimumab|mesh-list
110877471|NCT03430895|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110877472|NCT03430895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110877473|NCT05745480|Analgesics, Opioid|analgesics, opioid|mesh-list
110877474|NCT05745480|Narcotics|narcotics|mesh-ancestor
110877475|NCT05745480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110877476|NCT05745480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110877477|NCT05745480|Analgesics|analgesics|mesh-ancestor
110877478|NCT05745480|Sensory System Agents|sensory system agents|mesh-ancestor
110877479|NCT05745480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110877480|NCT03452189|Vancomycin|vancomycin|mesh-list
110877481|NCT03452189|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110877482|NCT03452189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110877483|NCT00603954|Fludarabine|fludarabine|mesh-list
110877484|NCT00603954|Fludarabine phosphate|fludarabine phosphate|mesh-list
110877485|NCT00603954|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110877486|NCT00603954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110877487|NCT00603954|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110877488|NCT00603954|Antimetabolites|antimetabolites|mesh-ancestor
110877489|NCT00603954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110877490|NCT00603954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110877491|NCT00603954|Immunologic Factors|immunologic factors|mesh-ancestor
110877492|NCT00603954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110877493|NCT03427619|Picibanil|picibanil|mesh-list
110877494|NCT03427619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110877495|NCT03712475|Pregabalin|pregabalin|mesh-list
110877496|NCT03712475|Analgesics|analgesics|mesh-ancestor
110877497|NCT03712475|Sensory System Agents|sensory system agents|mesh-ancestor
110877519|NCT01372371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110877520|NCT03120351|Lidocaine|lidocaine|mesh-list
110877521|NCT03120351|Anesthetics, Local|anesthetics, local|mesh-ancestor
110877522|NCT03120351|Anesthetics|anesthetics|mesh-ancestor
110877523|NCT03120351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110877524|NCT03120351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110877525|NCT03120351|Sensory System Agents|sensory system agents|mesh-ancestor
110877526|NCT03120351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110877527|NCT03120351|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110877528|NCT03120351|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110877529|NCT03120351|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110877530|NCT03120351|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110877531|NCT03120351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110877532|NCT05165355|Aflutinib|aflutinib|mesh-list
110877533|NCT05165355|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110877534|NCT05165355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110877535|NCT05165355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110877536|NCT01374789|Panitumumab|panitumumab|mesh-list
110877537|NCT01374789|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110877538|NCT01374789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110877539|NCT02354703|Ondansetron|ondansetron|mesh-list
110877540|NCT02354703|Antiemetics|antiemetics|mesh-ancestor
110877541|NCT02354703|Autonomic Agents|autonomic agents|mesh-ancestor
110877542|NCT02354703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110877543|NCT02354703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110877544|NCT02354703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110877545|NCT02354703|Antipruritics|antipruritics|mesh-ancestor
110877546|NCT02354703|Dermatologic Agents|dermatologic agents|mesh-ancestor
110877547|NCT02354703|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110877548|NCT02354703|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110877549|NCT02354703|Serotonin Agents|serotonin agents|mesh-ancestor
110877550|NCT02354703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110204551|NCT00045279|Interferon-alpha|interferon-alpha|mesh-list
110877564|NCT05008887|Dermatologic Agents|dermatologic agents|mesh-ancestor
110877565|NCT05008887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110877566|NCT05008887|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110877567|NCT05008887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110877568|NCT05008887|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110877569|NCT01376193|Naratriptan|naratriptan|mesh-list
110877570|NCT01376193|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110877571|NCT01376193|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110877572|NCT01376193|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110877573|NCT01376193|Serotonin Agents|serotonin agents|mesh-ancestor
110877574|NCT01376193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110877575|NCT01376193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110877576|NCT01376193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110877577|NCT04944771|Rabeprazole|rabeprazole|mesh-list
110877578|NCT04944771|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110877579|NCT04944771|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110877580|NCT04944771|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110877581|NCT04944771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110877582|NCT04944771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110877583|NCT01375023|Thymoglobulin|thymoglobulin|mesh-list
110877584|NCT01375023|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110877585|NCT01375023|Immunologic Factors|immunologic factors|mesh-ancestor
110877586|NCT01375023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110877587|NCT01375023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110877589|NCT05197101|Oxytocics|oxytocics|mesh-ancestor
110877590|NCT05197101|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110877591|NCT05197101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110877592|NCT01375101|Quercetin|quercetin|mesh-list
110877593|NCT01375101|Antioxidants|antioxidants|mesh-ancestor
110877594|NCT01375101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110877595|NCT01375101|Protective Agents|protective agents|mesh-ancestor
110877596|NCT01375101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110877597|NCT04865289|Paclitaxel|paclitaxel|mesh-list
110877598|NCT04865289|Carboplatin|carboplatin|mesh-list
110877599|NCT04865289|Pembrolizumab|pembrolizumab|mesh-list
110877600|NCT04865289|Lenvatinib|lenvatinib|mesh-list
110877601|NCT04865289|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110877602|NCT04865289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110877603|NCT04865289|Tubulin Modulators|tubulin modulators|mesh-ancestor
110877604|NCT04865289|Antimitotic Agents|antimitotic agents|mesh-ancestor
110877605|NCT04865289|Mitosis Modulators|mitosis modulators|mesh-ancestor
110877606|NCT04865289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110877607|NCT04865289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110877608|NCT04865289|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110877609|NCT04865289|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110877610|NCT04865289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110877611|NCT03633591|Tolcapone|tolcapone|mesh-list
110877623|NCT01376271|Serotonin Agents|serotonin agents|mesh-ancestor
110877624|NCT01376271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110877625|NCT01376271|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110877626|NCT01376271|Antidepressive Agents|antidepressive agents|mesh-ancestor
110877627|NCT01376271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110877628|NCT01376271|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110877629|NCT01376271|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110877630|NCT01376271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110877631|NCT04885881|Lidocaine|lidocaine|mesh-list
110877632|NCT04885881|Anesthetics, Local|anesthetics, local|mesh-ancestor
110877633|NCT04885881|Anesthetics|anesthetics|mesh-ancestor
110877634|NCT04885881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110877635|NCT04885881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110877636|NCT04885881|Sensory System Agents|sensory system agents|mesh-ancestor
110877637|NCT04885881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110877638|NCT04885881|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110877639|NCT04885881|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110877640|NCT04885881|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110877641|NCT04885881|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110877642|NCT04885881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110877643|NCT04820205|Dexmedetomidine|dexmedetomidine|mesh-list
110877645|NCT04820205|Chloral Hydrate|chloral hydrate|mesh-list
110877646|NCT04820205|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110877647|NCT04820205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110877648|NCT04820205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110877649|NCT04820205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110877650|NCT04820205|Analgesics|analgesics|mesh-ancestor
110877651|NCT04820205|Sensory System Agents|sensory system agents|mesh-ancestor
110877652|NCT04820205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110877653|NCT04820205|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110877654|NCT04820205|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110877655|NCT04820205|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110877656|NCT04820205|Adrenergic Agents|adrenergic agents|mesh-ancestor
110877657|NCT04820205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110877658|NCT04820205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110877659|NCT04820205|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110877660|NCT04820205|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110877661|NCT04820205|Anesthetics, General|anesthetics, general|mesh-ancestor
110877662|NCT04820205|Anesthetics|anesthetics|mesh-ancestor
110877663|NCT04820205|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110877664|NCT04820205|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110877665|NCT01375257|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110877666|NCT01375257|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
110877667|NCT01375257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110877668|NCT01375257|Antitubercular Agents|antitubercular agents|mesh-ancestor
110877669|NCT01375335|Dobutamine|dobutamine|mesh-list
110877670|NCT01375335|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110204585|NCT00054002|Trioxsalen|trioxsalen|mesh-list
110877674|NCT01375335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110877675|NCT01375335|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
110877676|NCT01375335|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110877677|NCT01375335|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110877678|NCT01375335|Adrenergic Agents|adrenergic agents|mesh-ancestor
110877679|NCT01375335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110877680|NCT01375335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110877681|NCT01375335|Protective Agents|protective agents|mesh-ancestor
110877682|NCT01373463|Carboplatin|carboplatin|mesh-list
110877683|NCT01373463|Pemetrexed|pemetrexed|mesh-list
110877684|NCT01373463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110877685|NCT01373463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110877686|NCT01373463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110877687|NCT01373463|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110877688|NCT01373463|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110877689|NCT04573647|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110877690|NCT04573647|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110877691|NCT03113409|Naltrexone|naltrexone|mesh-list
110877692|NCT03113409|Buprenorphine|buprenorphine|mesh-list
110877693|NCT03113409|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110877694|NCT03113409|Narcotics|narcotics|mesh-ancestor
110877695|NCT03113409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110877696|NCT03113409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110877697|NCT03113409|Analgesics|analgesics|mesh-ancestor
110877698|NCT03113409|Sensory System Agents|sensory system agents|mesh-ancestor
110877699|NCT03113409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110877700|NCT03113409|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110877701|NCT03113409|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110877702|NCT05193747|Anesthetics|anesthetics|mesh-list
110877703|NCT05193747|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110877704|NCT05193747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110877705|NCT03634293|Alirocumab|alirocumab|mesh-list
110877706|NCT03634293|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
110877707|NCT03634293|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110877708|NCT03634293|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110877709|NCT03634293|Antimetabolites|antimetabolites|mesh-ancestor
110877710|NCT03634293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110877711|NCT03634293|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110877712|NCT03634293|Protease Inhibitors|protease inhibitors|mesh-ancestor
110877713|NCT03634293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110877714|NCT03634293|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110877715|NCT01373541|Palmitic Acid|palmitic acid|mesh-list
110877716|NCT01373541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110877717|NCT01373541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110877718|NCT03633747|Propranolol|propranolol|mesh-list
110877719|NCT03633747|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110877720|NCT03633747|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110877721|NCT03633747|Adrenergic Agents|adrenergic agents|mesh-ancestor
110877722|NCT03633747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110877723|NCT03633747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110877724|NCT03633747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110877725|NCT03633747|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110877726|NCT03633747|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110196547|NCT00212212|Selenium|selenium|mesh-list
110877727|NCT03633747|Vasodilator Agents|vasodilator agents|mesh-ancestor
110877728|NCT01376817|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
110877729|NCT01376817|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
110877730|NCT01376817|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
110877731|NCT01376817|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110877732|NCT01373697|Ibuprofen|ibuprofen|mesh-list
110877733|NCT01373697|Ketoprofen|ketoprofen|mesh-list
110877734|NCT01373697|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110877735|NCT01373697|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110877736|NCT01373697|Analgesics|analgesics|mesh-ancestor
110877737|NCT01373697|Sensory System Agents|sensory system agents|mesh-ancestor
110877738|NCT01373697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110877739|NCT01373697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110877740|NCT01373697|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110877741|NCT01373697|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110877742|NCT01373697|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110877750|NCT01375881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110877751|NCT01375881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110877752|NCT01375881|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110877753|NCT01375881|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110877754|NCT01375881|Antiviral Agents|antiviral agents|mesh-ancestor
110877755|NCT01375881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110877756|NCT01375881|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110877757|NCT01375881|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110877758|NCT04690023|Ropivacaine|ropivacaine|mesh-list
110877759|NCT04690023|Anesthetics, Local|anesthetics, local|mesh-ancestor
110877760|NCT04690023|Anesthetics|anesthetics|mesh-ancestor
110877761|NCT04690023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110877762|NCT04690023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110877763|NCT04690023|Sensory System Agents|sensory system agents|mesh-ancestor
110877764|NCT04690023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110877765|NCT03066804|Valsartan|valsartan|mesh-list
110877766|NCT03066804|Enalapril|enalapril|mesh-list
110877767|NCT03066804|Enalaprilat|enalaprilat|mesh-list
110877768|NCT03066804|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
110877769|NCT03066804|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110877770|NCT03066804|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110877771|NCT03066804|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110877772|NCT03066804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110877773|NCT03066804|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110877774|NCT03066804|Protease Inhibitors|protease inhibitors|mesh-ancestor
110877775|NCT03066804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110877776|NCT03629262|Sufentanil|sufentanil|mesh-list
110877777|NCT03629262|Dexmedetomidine|dexmedetomidine|mesh-list
110877778|NCT03629262|Dsuvia|dsuvia|mesh-list
110877779|NCT03629262|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110877780|NCT03629262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110877781|NCT03629262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110877782|NCT03629262|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110877783|NCT03629262|Analgesics|analgesics|mesh-ancestor
110877784|NCT03629262|Sensory System Agents|sensory system agents|mesh-ancestor
110877785|NCT03629262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110877786|NCT03629262|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110877787|NCT03629262|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110877788|NCT03629262|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110877789|NCT03629262|Adrenergic Agents|adrenergic agents|mesh-ancestor
110877790|NCT03629262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110877791|NCT03629262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110877792|NCT03629262|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110877793|NCT03629262|Narcotics|narcotics|mesh-ancestor
110877794|NCT03629262|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110877795|NCT03629262|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110877796|NCT03629262|Anesthetics, General|anesthetics, general|mesh-ancestor
110877797|NCT03629262|Anesthetics|anesthetics|mesh-ancestor
110877798|NCT05208294|Sulpiride|sulpiride|mesh-list
110877799|NCT05208294|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110877800|NCT05208294|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110877801|NCT05208294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110877802|NCT05208294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110877803|NCT05208294|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110877804|NCT05208294|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110877805|NCT05208294|Dopamine Agents|dopamine agents|mesh-ancestor
110877806|NCT05208294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110877807|NCT05208294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110877808|NCT05208294|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110877809|NCT05208294|Antidepressive Agents|antidepressive agents|mesh-ancestor
110877810|NCT05213988|Clofibric Acid|clofibric acid|mesh-list
110877814|NCT05213988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110877817|NCT05207904|Carboplatin|carboplatin|mesh-list
110877818|NCT05207904|Tislelizumab|tislelizumab|mesh-list
110877819|NCT05207904|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110877820|NCT05207904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110877821|NCT05207904|Tubulin Modulators|tubulin modulators|mesh-ancestor
110877822|NCT05207904|Antimitotic Agents|antimitotic agents|mesh-ancestor
110877823|NCT05207904|Mitosis Modulators|mitosis modulators|mesh-ancestor
110877824|NCT05207904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110877825|NCT05207904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110877826|NCT05207514|Ethanol|ethanol|mesh-list
110877827|NCT05207514|Cyclophosphamide|cyclophosphamide|mesh-list
110877828|NCT05207514|Docetaxel|docetaxel|mesh-list
110877829|NCT05207514|Doxorubicin|doxorubicin|mesh-list
110877830|NCT05207514|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110877831|NCT05207514|Immunologic Factors|immunologic factors|mesh-ancestor
110877832|NCT05207514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110877833|NCT05207514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110877834|NCT05207514|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110877835|NCT05207514|Alkylating Agents|alkylating agents|mesh-ancestor
110877836|NCT05207514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110877837|NCT05207514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110877838|NCT05207514|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110877839|NCT05207514|Tubulin Modulators|tubulin modulators|mesh-ancestor
110877840|NCT05207514|Antimitotic Agents|antimitotic agents|mesh-ancestor
110877841|NCT05207514|Mitosis Modulators|mitosis modulators|mesh-ancestor
110877842|NCT05207514|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110877843|NCT05207514|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110877844|NCT05207514|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110877845|NCT05207514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110877846|NCT05207514|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110877847|NCT05207514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110877848|NCT05207514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110877849|NCT03118947|Pimavanserin|pimavanserin|mesh-list
110877850|NCT03118947|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110877851|NCT03118947|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110877852|NCT03118947|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110877853|NCT03118947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110877854|NCT03118947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110877855|NCT03118947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110877856|NCT03118947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110877857|NCT03118947|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110196568|NCT00073203|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110877858|NCT03118947|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110877859|NCT03118947|Serotonin Agents|serotonin agents|mesh-ancestor
110877860|NCT03118947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110877861|NCT03118947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110877862|NCT03998319|Tenecteplase|tenecteplase|mesh-list
110877863|NCT03998319|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110877864|NCT03998319|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110877865|NCT03998319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110877866|NCT03953079|Sunitinib|sunitinib|mesh-list
110877867|NCT03953079|Aflibercept|aflibercept|mesh-list
110877868|NCT03953079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110877869|NCT03953079|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110877870|NCT03953079|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110877871|NCT03953079|Growth Substances|growth substances|mesh-ancestor
110877872|NCT03953079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110877873|NCT03953079|Growth Inhibitors|growth inhibitors|mesh-ancestor
110877874|NCT03953079|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110877875|NCT03953079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110877876|NCT03953079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110877877|NCT03794427|Anesthetics|anesthetics|mesh-list
110877878|NCT03794427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110877879|NCT03794427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110877880|NCT03410901|Antibodies|antibodies|mesh-list
110877881|NCT03410901|Immunologic Factors|immunologic factors|mesh-ancestor
110204607|NCT00054197|Tubulin Modulators|tubulin modulators|mesh-ancestor
110877887|NCT03567057|Amantadine|amantadine|mesh-list
110877888|NCT03567057|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110877889|NCT03567057|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110877890|NCT03567057|Antiviral Agents|antiviral agents|mesh-ancestor
110877891|NCT03567057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110877892|NCT03567057|Dopamine Agents|dopamine agents|mesh-ancestor
110877893|NCT03567057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110877894|NCT03567057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110877895|NCT03567057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110877896|NCT03567057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110877897|NCT03567057|Analgesics|analgesics|mesh-ancestor
110877898|NCT03567057|Sensory System Agents|sensory system agents|mesh-ancestor
110877899|NCT03567057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110877900|NCT03057600|Paclitaxel|paclitaxel|mesh-list
110877901|NCT03057600|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110877902|NCT03057600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110877903|NCT03057600|Tubulin Modulators|tubulin modulators|mesh-ancestor
110877904|NCT03057600|Antimitotic Agents|antimitotic agents|mesh-ancestor
110877905|NCT03057600|Mitosis Modulators|mitosis modulators|mesh-ancestor
110877906|NCT03057600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110877907|NCT04382937|Ribavirin|ribavirin|mesh-list
110877908|NCT04382937|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110877909|NCT04382937|Antimetabolites|antimetabolites|mesh-ancestor
110877910|NCT04382937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110877911|NCT04382937|Antiviral Agents|antiviral agents|mesh-ancestor
110877912|NCT04382937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110877913|NCT05206890|Fluzoparib|fluzoparib|mesh-list
110877914|NCT05206890|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110877915|NCT05206890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110877916|NCT05206890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110877917|NCT05206890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110877918|NCT02966301|Arsenic Trioxide|arsenic trioxide|mesh-list
110877919|NCT02966301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110877920|NCT03107091|Terlipressin|terlipressin|mesh-list
110877921|NCT03107091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110877922|NCT03107091|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110877923|NCT03849768|Gefitinib|gefitinib|mesh-list
110877924|NCT03849768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110877925|NCT03849768|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110877926|NCT03849768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110877927|NCT03849768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110877928|NCT03189693|Anesthetics|anesthetics|mesh-list
110877929|NCT03189693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110877930|NCT03189693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110877931|NCT03065400|Pembrolizumab|pembrolizumab|mesh-list
110877932|NCT03065400|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110877933|NCT03065400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110877934|NCT03065400|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110877935|NCT03065400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110877936|NCT05734716|Epoetin Alfa|epoetin alfa|mesh-list
110877937|NCT05734716|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
110877938|NCT05734716|Hematinics|hematinics|mesh-ancestor
110877939|NCT05733000|Thioctic Acid|thioctic acid|mesh-list
110877940|NCT05733000|Hydroxychloroquine|hydroxychloroquine|mesh-list
110877941|NCT05733000|Gemcitabine|gemcitabine|mesh-list
110877942|NCT05733000|Fluorouracil|fluorouracil|mesh-list
110877943|NCT05733000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110877944|NCT05733000|Antimetabolites|antimetabolites|mesh-ancestor
110877945|NCT05733000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110877946|NCT05733000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110877947|NCT05733000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110877948|NCT05733000|Immunologic Factors|immunologic factors|mesh-ancestor
110877949|NCT05733000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110877950|NCT05733000|Antimalarials|antimalarials|mesh-ancestor
110877951|NCT05733000|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110877952|NCT05733000|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110877957|NCT05733000|Protective Agents|protective agents|mesh-ancestor
110877958|NCT05733000|Vitamin B Complex|vitamin b complex|mesh-ancestor
110877959|NCT05733000|Vitamins|vitamins|mesh-ancestor
110877960|NCT05733000|Micronutrients|micronutrients|mesh-ancestor
110877961|NCT03417180|Remifentanil|remifentanil|mesh-list
110877962|NCT03417180|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110877963|NCT03417180|Narcotics|narcotics|mesh-ancestor
110877964|NCT03417180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110877965|NCT03417180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110877966|NCT03417180|Analgesics|analgesics|mesh-ancestor
110877967|NCT03417180|Sensory System Agents|sensory system agents|mesh-ancestor
110877968|NCT03417180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110877969|NCT03085095|Leuprolide|leuprolide|mesh-list
110877970|NCT03085095|Relugolix|relugolix|mesh-list
110877971|NCT03085095|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110877972|NCT03085095|Fertility Agents|fertility agents|mesh-ancestor
110877973|NCT03085095|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110877974|NCT03085095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110877975|NCT03085095|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110877976|NCT03085095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110877977|NCT03085095|Androgen Antagonists|androgen antagonists|mesh-ancestor
110877978|NCT03085095|Hormone Antagonists|hormone antagonists|mesh-ancestor
110877979|NCT03085095|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110877980|NCT02811783|Naloxone|naloxone|mesh-list
110877981|NCT02811783|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110877982|NCT02811783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110877983|NCT02811783|Sensory System Agents|sensory system agents|mesh-ancestor
110877984|NCT02811783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110877985|NCT02649855|Docetaxel|docetaxel|mesh-list
110877986|NCT02649855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110877987|NCT02649855|Tubulin Modulators|tubulin modulators|mesh-ancestor
110877988|NCT02649855|Antimitotic Agents|antimitotic agents|mesh-ancestor
110877989|NCT02649855|Mitosis Modulators|mitosis modulators|mesh-ancestor
110877990|NCT02649855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110877991|NCT02310867|Abatacept|abatacept|mesh-list
110877992|NCT02310867|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110877993|NCT02310867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110919735|NCT04491682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110877994|NCT02310867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110877995|NCT02310867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110877996|NCT02310867|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110877997|NCT02310867|Immunologic Factors|immunologic factors|mesh-ancestor
110877998|NCT02310867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110877999|NCT02310867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110878000|NCT05757219|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
110878001|NCT05757219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110878002|NCT05757219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110878003|NCT03106077|Maytansine|maytansine|mesh-list
110878004|NCT03106077|Mirvetuximab soravtansine|mirvetuximab soravtansine|mesh-list
110878005|NCT03106077|Immunoconjugates|immunoconjugates|mesh-ancestor
110878006|NCT03106077|Immunologic Factors|immunologic factors|mesh-ancestor
110878007|NCT03106077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110878008|NCT03106077|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110878009|NCT03106077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110878010|NCT03106077|Tubulin Modulators|tubulin modulators|mesh-ancestor
110878011|NCT03106077|Antimitotic Agents|antimitotic agents|mesh-ancestor
110878012|NCT03106077|Mitosis Modulators|mitosis modulators|mesh-ancestor
110878013|NCT03106077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110878014|NCT03648008|Morphine|morphine|mesh-list
110878015|NCT03648008|Hydromorphone|hydromorphone|mesh-list
110878016|NCT03648008|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110878017|NCT03648008|Narcotics|narcotics|mesh-ancestor
110878018|NCT03648008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110878019|NCT03648008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110878020|NCT03648008|Analgesics|analgesics|mesh-ancestor
110878021|NCT03648008|Sensory System Agents|sensory system agents|mesh-ancestor
110878022|NCT03648008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110878023|NCT05702541|Hydrogen Peroxide|hydrogen peroxide|mesh-list
110878024|NCT05702541|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110878025|NCT05702541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110878026|NCT05253495|Cytarabine|cytarabine|mesh-list
110878027|NCT05253495|Etoposide|etoposide|mesh-list
110878039|NCT05253495|Immunologic Factors|immunologic factors|mesh-ancestor
110878040|NCT05253495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110878041|NCT05054751|Fulvestrant|fulvestrant|mesh-list
110878042|NCT05054751|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110878043|NCT05054751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110878044|NCT05054751|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110878045|NCT05054751|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110878046|NCT05054751|Hormone Antagonists|hormone antagonists|mesh-ancestor
110878047|NCT05054751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110878048|NCT05054751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110878049|NCT00604617|Interferons|interferons|mesh-list
110878050|NCT00604617|Interferon-gamma|interferon-gamma|mesh-list
110878051|NCT00604617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110878052|NCT00604617|Antiviral Agents|antiviral agents|mesh-ancestor
110878053|NCT00604617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110878054|NCT03426995|Cantharidin|cantharidin|mesh-list
110878055|NCT03426995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110878056|NCT03426995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110878057|NCT05200299|Leucovorin|leucovorin|mesh-list
110878058|NCT05200299|Fluorouracil|fluorouracil|mesh-list
110878059|NCT05200299|Capecitabine|capecitabine|mesh-list
110878060|NCT05200299|Oxaliplatin|oxaliplatin|mesh-list
110878061|NCT05200299|Irinotecan|irinotecan|mesh-list
110878062|NCT05200299|Levoleucovorin|levoleucovorin|mesh-list
110878063|NCT05200299|Antimetabolites|antimetabolites|mesh-ancestor
110878064|NCT05200299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110878065|NCT05200299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110878066|NCT05200299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110878067|NCT05200299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110878068|NCT05200299|Immunologic Factors|immunologic factors|mesh-ancestor
110878069|NCT05200299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110878070|NCT05200299|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110878071|NCT05200299|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110878072|NCT05200299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110878073|NCT05200299|Antidotes|antidotes|mesh-ancestor
110878074|NCT05200299|Protective Agents|protective agents|mesh-ancestor
110878075|NCT05200299|Vitamin B Complex|vitamin b complex|mesh-ancestor
110878076|NCT05200299|Vitamins|vitamins|mesh-ancestor
110878077|NCT05200299|Micronutrients|micronutrients|mesh-ancestor
110878078|NCT03322566|Pembrolizumab|pembrolizumab|mesh-list
110878079|NCT03322566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110878080|NCT03322566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110878081|NCT03322566|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110878082|NCT03322566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110878083|NCT03822975|Heparin|heparin|mesh-list
110878084|NCT03822975|Calcium heparin|calcium heparin|mesh-list
110878085|NCT03822975|Bivalirudin|bivalirudin|mesh-list
110878086|NCT03822975|Anticoagulants|anticoagulants|mesh-ancestor
110878087|NCT03822975|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110878088|NCT03822975|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110878089|NCT03822975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110878090|NCT03822975|Antithrombins|antithrombins|mesh-ancestor
110878091|NCT03822975|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110204625|NCT00166426|Analgesics|analgesics|mesh-ancestor
110878097|NCT05732532|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110878099|NCT05732532|Autonomic Agents|autonomic agents|mesh-ancestor
110878100|NCT05732532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110878101|NCT05732532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110878102|NCT05732532|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110878103|NCT05732532|Glucocorticoids|glucocorticoids|mesh-ancestor
110878104|NCT05732532|Hormones|hormones|mesh-ancestor
110878105|NCT05732532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110878106|NCT05732532|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110878107|NCT05732532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110878108|NCT05732532|Anesthetics, Local|anesthetics, local|mesh-ancestor
110878110|NCT05732532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110878111|NCT05732532|Sensory System Agents|sensory system agents|mesh-ancestor
110878112|NCT05732532|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110878113|NCT05732532|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110878114|NCT05732532|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110878115|NCT05732532|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110878116|NCT05732532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110878117|NCT05178225|Ubiquinone|ubiquinone|mesh-list
110878118|NCT05178225|Coenzyme Q10|coenzyme q10|mesh-list
110878119|NCT05178225|Anticoagulants|anticoagulants|mesh-list
110878120|NCT05178225|Micronutrients|micronutrients|mesh-ancestor
110878121|NCT05178225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110878122|NCT05178225|Vitamins|vitamins|mesh-ancestor
110878123|NCT02969018|PF-06700841|pf-06700841|mesh-list
110878124|NCT02969018|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110878125|NCT02969018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110878126|NCT02969018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110878127|NCT03255096|Rituximab|rituximab|mesh-list
110878128|NCT03255096|Venetoclax|venetoclax|mesh-list
110878129|NCT03255096|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110878130|NCT03255096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110878131|NCT03255096|Immunologic Factors|immunologic factors|mesh-ancestor
110878132|NCT03255096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110878133|NCT03255096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110878134|NCT01319721|Mitomycins|mitomycins|mesh-list
110878135|NCT01319721|Mitomycin|mitomycin|mesh-list
110878136|NCT01319721|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110878137|NCT01319721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110878138|NCT01319721|Alkylating Agents|alkylating agents|mesh-ancestor
110878139|NCT01319721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110878140|NCT01319721|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110878141|NCT01319721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110878142|NCT03792867|Doxorubicin|doxorubicin|mesh-list
110878143|NCT03792867|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110878144|NCT03792867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110919749|NCT05193968|Autonomic Agents|autonomic agents|mesh-ancestor
110878145|NCT03792867|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110878146|NCT03792867|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110878147|NCT03792867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110878148|NCT03792867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110878149|NCT03015324|Hydroxychloroquine|hydroxychloroquine|mesh-list
110878150|NCT03015324|Antimalarials|antimalarials|mesh-ancestor
110878151|NCT03015324|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110878152|NCT03015324|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110878153|NCT03015324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110878154|NCT03015324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110878155|NCT03015324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110878156|NCT03015324|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110878157|NCT05139849|Methylprednisolone|methylprednisolone|mesh-list
110878158|NCT05139849|Hydrocortisone|hydrocortisone|mesh-list
110878159|NCT05139849|Vasopressins|vasopressins|mesh-list
110878160|NCT05139849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110878161|NCT05139849|Antiemetics|antiemetics|mesh-ancestor
110878162|NCT05139849|Autonomic Agents|autonomic agents|mesh-ancestor
110878163|NCT05139849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110204628|NCT00166426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110878170|NCT05139849|Protective Agents|protective agents|mesh-ancestor
110878171|NCT05139849|Hemostatics|hemostatics|mesh-ancestor
110878172|NCT05139849|Coagulants|coagulants|mesh-ancestor
110878173|NCT05139849|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110878174|NCT05139849|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
110878175|NCT05139849|Natriuretic Agents|natriuretic agents|mesh-ancestor
110878176|NCT03315741|Pirfenidone|pirfenidone|mesh-list
110878177|NCT03315741|Analgesics|analgesics|mesh-ancestor
110878178|NCT03315741|Sensory System Agents|sensory system agents|mesh-ancestor
110878179|NCT03315741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110878180|NCT03315741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110878181|NCT03315741|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110878182|NCT03315741|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110878183|NCT03315741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110878184|NCT03315741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110878185|NCT03315741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110878187|NCT05077449|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110878188|NCT05077449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110878189|NCT05077449|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110878190|NCT05077449|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110878191|NCT05077449|Hormone Antagonists|hormone antagonists|mesh-ancestor
110878192|NCT05077449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110878193|NCT05077449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110878194|NCT03632733|Tetracycline|tetracycline|mesh-list
110878195|NCT03632733|Clotrimazole|clotrimazole|mesh-list
110878196|NCT03632733|Miconazole|miconazole|mesh-list
110878197|NCT03632733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110878198|NCT03632733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110878199|NCT03632733|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110878200|NCT03632733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110878201|NCT03632733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110878202|NCT03632733|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110878203|NCT03632733|Antifungal Agents|antifungal agents|mesh-ancestor
110878204|NCT03632733|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110878205|NCT03632733|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110878206|NCT03632733|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110878207|NCT03632733|Hormone Antagonists|hormone antagonists|mesh-ancestor
110878208|NCT03632733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110878209|NCT03632733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110878210|NCT03632733|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110878211|NCT03632733|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110878212|NCT05074485|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
110878213|NCT05074485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110878215|NCT03259425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110878216|NCT03259425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110878217|NCT03259425|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110878218|NCT03259425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110878219|NCT03061188|Nivolumab|nivolumab|mesh-list
110878220|NCT03061188|Veliparib|veliparib|mesh-list
110878221|NCT03061188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110878222|NCT03061188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110878223|NCT03061188|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110878224|NCT03061188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110878225|NCT03061188|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110878226|NCT03061188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110878227|NCT05588453|Temozolomide|temozolomide|mesh-list
110878228|NCT05588453|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110878229|NCT05588453|Alkylating Agents|alkylating agents|mesh-ancestor
110878230|NCT05588453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110878251|NCT05186454|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110878252|NCT05186454|Narcotics|narcotics|mesh-ancestor
110878253|NCT05186454|Analgesics|analgesics|mesh-ancestor
110878254|NCT05186454|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110878255|NCT05186454|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110878256|NCT05186454|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110878257|NCT05186454|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110878258|NCT05186454|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110196665|NCT00214084|Allopurinol|allopurinol|mesh-list
110878259|NCT05186454|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110878260|NCT05186454|Anesthetics, General|anesthetics, general|mesh-ancestor
110878261|NCT05186454|GABA Modulators|gaba modulators|mesh-ancestor
110878262|NCT05186454|GABA Agents|gaba agents|mesh-ancestor
110878263|NCT05186454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110878264|NCT05186454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110878265|NCT02113878|Cisplatin|cisplatin|mesh-list
110878266|NCT02113878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110878267|NCT05162898|Lenvatinib|lenvatinib|mesh-list
110878268|NCT05162898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110878269|NCT05162898|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110878270|NCT05162898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110878271|NCT05162898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110878272|NCT05113290|Sorafenib|sorafenib|mesh-list
110878273|NCT05113290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110878274|NCT05113290|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110878275|NCT05113290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110878276|NCT05113290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110878277|NCT03477162|Metformin|metformin|mesh-list
110878278|NCT03477162|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110878279|NCT03477162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110878280|NCT03461952|Nivolumab|nivolumab|mesh-list
110878281|NCT03461952|Ipilimumab|ipilimumab|mesh-list
110878282|NCT03461952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110878283|NCT03461952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110878284|NCT03461952|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110878285|NCT03461952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110878286|NCT03619824|Gemcitabine|gemcitabine|mesh-list
110878287|NCT03619824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110204640|NCT00166465|Antidotes|antidotes|mesh-ancestor
110878323|NCT03447353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110878324|NCT03447353|Antitussive Agents|antitussive agents|mesh-ancestor
110878325|NCT03447353|Respiratory System Agents|respiratory system agents|mesh-ancestor
110878326|NCT03447353|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110919778|NCT05137288|Antiemetics|antiemetics|mesh-ancestor
110878327|NCT03447353|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110878328|NCT03447353|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110878329|NCT03447353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110878336|NCT03447353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110878337|NCT03446885|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
110878338|NCT03446885|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110878339|NCT03446885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110878340|NCT03446885|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110878341|NCT03446885|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110878342|NCT03446885|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110878343|NCT03446885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110878344|NCT03446885|Dopamine Agents|dopamine agents|mesh-ancestor
110878345|NCT03446885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110878346|NCT00710970|Tamoxifen|tamoxifen|mesh-list
110878347|NCT00710970|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
110878348|NCT00710970|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110878349|NCT00710970|Hormone Antagonists|hormone antagonists|mesh-ancestor
110878350|NCT00710970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110878351|NCT00710970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110878352|NCT00710970|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110878353|NCT00710970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110878354|NCT00710970|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110878355|NCT00710970|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110878356|NCT00710970|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110878357|NCT03421379|Glucagon|glucagon|mesh-list
110878358|NCT03421379|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
110878359|NCT03421379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110878360|NCT03421379|Hormones|hormones|mesh-ancestor
110878361|NCT03421379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110878362|NCT03421379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110878363|NCT03421379|Incretins|incretins|mesh-ancestor
110878364|NCT03712241|Indomethacin|indomethacin|mesh-list
110878365|NCT03712241|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110878366|NCT03712241|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110878367|NCT03712241|Analgesics|analgesics|mesh-ancestor
110878368|NCT03712241|Sensory System Agents|sensory system agents|mesh-ancestor
110878369|NCT03712241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110878370|NCT03712241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110878371|NCT03712241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110878372|NCT03712241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110878373|NCT03712241|Gout Suppressants|gout suppressants|mesh-ancestor
110878374|NCT03712241|Tocolytic Agents|tocolytic agents|mesh-ancestor
110878375|NCT03712241|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110878376|NCT03712241|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110878377|NCT03712241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110878378|NCT03712241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110878379|NCT02675946|Pembrolizumab|pembrolizumab|mesh-list
110878380|NCT02675946|Cetuximab|cetuximab|mesh-list
110878381|NCT02675946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110878382|NCT02675946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110878383|NCT02675946|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110878384|NCT02675946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110878385|NCT02900378|Valsartan|valsartan|mesh-list
110878386|NCT02900378|Enalapril|enalapril|mesh-list
110878387|NCT02900378|Enalaprilat|enalaprilat|mesh-list
110878388|NCT02900378|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
110878389|NCT02900378|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110878390|NCT02900378|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110878391|NCT02900378|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110878392|NCT02900378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110204693|NCT00166816|Sirolimus|sirolimus|mesh-list
110878397|NCT03058692|Immunologic Factors|immunologic factors|mesh-ancestor
110878398|NCT03058692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110878399|NCT03647150|Amoxicillin|amoxicillin|mesh-list
110878400|NCT03647150|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110878401|NCT03647150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110878402|NCT03056352|Diphenhydramine|diphenhydramine|mesh-list
110878403|NCT03056352|Promethazine|promethazine|mesh-list
110878404|NCT03056352|Metoclopramide|metoclopramide|mesh-list
110878405|NCT03056352|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110878406|NCT03056352|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110878407|NCT03056352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110878408|NCT03056352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110878409|NCT03056352|Anesthetics, Local|anesthetics, local|mesh-ancestor
110878410|NCT03056352|Anesthetics|anesthetics|mesh-ancestor
110878411|NCT03056352|Sensory System Agents|sensory system agents|mesh-ancestor
110878412|NCT03056352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110878413|NCT03056352|Antiemetics|antiemetics|mesh-ancestor
110878414|NCT03056352|Autonomic Agents|autonomic agents|mesh-ancestor
110878415|NCT03056352|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110878416|NCT03056352|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110878417|NCT03056352|Histamine Antagonists|histamine antagonists|mesh-ancestor
110878418|NCT03056352|Histamine Agents|histamine agents|mesh-ancestor
110878419|NCT03056352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110878420|NCT03056352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110878421|NCT03056352|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110878422|NCT03056352|Antipruritics|antipruritics|mesh-ancestor
110878423|NCT03056352|Dermatologic Agents|dermatologic agents|mesh-ancestor
110878424|NCT03056352|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110878425|NCT03056352|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110878426|NCT03056352|Dopamine Agents|dopamine agents|mesh-ancestor
110878427|NCT04360980|Colchicine|colchicine|mesh-list
110878428|NCT04360980|Gout Suppressants|gout suppressants|mesh-ancestor
110878429|NCT04360980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110878430|NCT04360980|Tubulin Modulators|tubulin modulators|mesh-ancestor
110878431|NCT04360980|Antimitotic Agents|antimitotic agents|mesh-ancestor
110878432|NCT04360980|Mitosis Modulators|mitosis modulators|mesh-ancestor
110878433|NCT04360980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110878434|NCT04360980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110878435|NCT03647072|Famotidine|famotidine|mesh-list
110878436|NCT03647072|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110878437|NCT03647072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110878438|NCT03647072|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110878439|NCT03647072|Histamine Antagonists|histamine antagonists|mesh-ancestor
110878440|NCT03647072|Histamine Agents|histamine agents|mesh-ancestor
110878441|NCT03647072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110878442|NCT03647072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110878443|NCT03647072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110878444|NCT05284136|Prednisolone|prednisolone|mesh-list
110878445|NCT05284136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110878446|NCT05284136|Glucocorticoids|glucocorticoids|mesh-ancestor
110878447|NCT05284136|Hormones|hormones|mesh-ancestor
110878448|NCT05284136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110878449|NCT05284136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110878450|NCT05284136|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110878451|NCT05284136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110878452|NCT03646916|Dexamethasone|dexamethasone|mesh-list
110878453|NCT03646916|Dexamethasone acetate|dexamethasone acetate|mesh-list
110878454|NCT03646916|BB 1101|bb 1101|mesh-list
110878455|NCT03646916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110878456|NCT03646916|Antiemetics|antiemetics|mesh-ancestor
110878457|NCT03646916|Autonomic Agents|autonomic agents|mesh-ancestor
110878458|NCT03646916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110878459|NCT03646916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110878460|NCT03646916|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110878461|NCT03646916|Glucocorticoids|glucocorticoids|mesh-ancestor
110878463|NCT03646916|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110878464|NCT03646916|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110204700|NCT00166816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110878470|NCT04305756|Anticoagulants|anticoagulants|mesh-ancestor
110878471|NCT04305756|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110878472|NCT04305756|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110878473|NCT04305756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110878475|NCT03645980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110878476|NCT03645980|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110878477|NCT03645980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110878478|NCT03645980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110878479|NCT04315038|Anesthetics|anesthetics|mesh-list
110595993|NCT00798213|Immunotoxins|immunotoxins|mesh-ancestor
110878480|NCT04315038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110878481|NCT04315038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110878483|NCT03645200|Fluzoparib|fluzoparib|mesh-list
110878484|NCT03645200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110878485|NCT03645200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110878486|NCT03645200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110878487|NCT03645200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110878488|NCT03645200|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110878489|NCT03055338|Risperidone|risperidone|mesh-list
110878490|NCT03055338|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110878491|NCT03055338|Serotonin Agents|serotonin agents|mesh-ancestor
110878492|NCT03055338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110878493|NCT03055338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110878494|NCT03055338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110878495|NCT03055338|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110878496|NCT03055338|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110878497|NCT03055338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110878498|NCT03055338|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110878499|NCT03055338|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110878500|NCT03055338|Dopamine Agents|dopamine agents|mesh-ancestor
110878501|NCT03645668|Meropenem|meropenem|mesh-list
110878502|NCT03645668|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110878503|NCT03645668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110878504|NCT04186494|Liraglutide|liraglutide|mesh-list
110878505|NCT04186494|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110878506|NCT04186494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110878507|NCT04186494|Incretins|incretins|mesh-ancestor
110878508|NCT04186494|Hormones|hormones|mesh-ancestor
110878509|NCT04186494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110878510|NCT03712163|Ketotifen|ketotifen|mesh-list
110878511|NCT03712163|Antipruritics|antipruritics|mesh-ancestor
110878512|NCT03712163|Dermatologic Agents|dermatologic agents|mesh-ancestor
110878513|NCT03712163|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110878514|NCT03712163|Histamine Antagonists|histamine antagonists|mesh-ancestor
110878515|NCT03712163|Histamine Agents|histamine agents|mesh-ancestor
110878516|NCT03712163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110878517|NCT03712163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110878518|NCT03712163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110878519|NCT03712163|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110878520|NCT01311167|Dexamethasone|dexamethasone|mesh-list
110878521|NCT01311167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110878522|NCT01311167|Antiemetics|antiemetics|mesh-ancestor
110878523|NCT01311167|Autonomic Agents|autonomic agents|mesh-ancestor
110878524|NCT01311167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110878525|NCT01311167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110878526|NCT01311167|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110878527|NCT01311167|Glucocorticoids|glucocorticoids|mesh-ancestor
110878528|NCT01311167|Hormones|hormones|mesh-ancestor
110878529|NCT01311167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110878530|NCT01311167|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110878531|NCT01311167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110878532|NCT04233840|Nivolumab|nivolumab|mesh-list
110878533|NCT04233840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110878543|NCT02896400|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110878544|NCT02896400|Cholinergic Agents|cholinergic agents|mesh-ancestor
110878545|NCT02896400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110878546|NCT02896400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110878548|NCT03404843|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110878549|NCT03404843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110878550|NCT03404843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110878551|NCT03404843|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110878552|NCT03404843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110878553|NCT03404843|Vasodilator Agents|vasodilator agents|mesh-ancestor
110878554|NCT03404843|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110878555|NCT03404843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110878556|NCT05284448|Pentoxifylline|pentoxifylline|mesh-list
110878557|NCT05284448|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110878558|NCT05284448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110196720|NCT00214552|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110878559|NCT05284448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110878560|NCT05284448|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110878561|NCT05284448|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110878562|NCT05284448|Protective Agents|protective agents|mesh-ancestor
110878563|NCT05284448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110878564|NCT05284448|Vasodilator Agents|vasodilator agents|mesh-ancestor
110878565|NCT05284448|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110878566|NCT05284448|Antioxidants|antioxidants|mesh-ancestor
110878567|NCT03032250|Hydrocortisone|hydrocortisone|mesh-list
110878568|NCT03032250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110878569|NCT03444155|Folic Acid|folic acid|mesh-list
110878570|NCT03444155|Vitamin B Complex|vitamin b complex|mesh-list
110878571|NCT03444155|Vitamins|vitamins|mesh-ancestor
110878572|NCT03444155|Micronutrients|micronutrients|mesh-ancestor
110878573|NCT03444155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110878574|NCT03444155|Hematinics|hematinics|mesh-ancestor
110878575|NCT02898116|Durvalumab|durvalumab|mesh-list
110878576|NCT02898116|Ensartinib|ensartinib|mesh-list
110878577|NCT02898116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110878578|NCT02898116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110878579|NCT02898116|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110878580|NCT02898116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110878581|NCT02898116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110878582|NCT03717701|Metformin|metformin|mesh-list
110878583|NCT03717701|Esomeprazole|esomeprazole|mesh-list
110878584|NCT03717701|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110878585|NCT03717701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110878586|NCT03717701|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110878587|NCT03717701|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110878588|NCT03717701|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110878589|NCT03717701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110878590|NCT03717701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110878591|NCT03658304|Mitomycins|mitomycins|mesh-list
110878592|NCT03658304|Mitomycin|mitomycin|mesh-list
110878593|NCT03658304|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110878594|NCT03658304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110878595|NCT03658304|Alkylating Agents|alkylating agents|mesh-ancestor
110878596|NCT03658304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110878597|NCT03658304|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110878598|NCT03658304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110878599|NCT03422159|Ascorbic Acid|ascorbic acid|mesh-list
110878614|NCT04538040|Antiviral Agents|antiviral agents|mesh-ancestor
110878615|NCT04538040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110878616|NCT04538040|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110878617|NCT04538040|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110878618|NCT04538040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110878619|NCT04538040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110878620|NCT04538040|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110878621|NCT04538040|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110919813|NCT02137434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110919814|NCT02137434|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110919815|NCT02137668|Vancomycin|vancomycin|mesh-list
110919816|NCT02137668|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110878623|NCT02297412|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110878624|NCT02297412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110878625|NCT03644576|Pseudoephedrine|pseudoephedrine|mesh-list
110878626|NCT03644576|Ephedrine|ephedrine|mesh-list
110878627|NCT03644576|Ozanimod|ozanimod|mesh-list
110878628|NCT03644576|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110878629|NCT03644576|Autonomic Agents|autonomic agents|mesh-ancestor
110878630|NCT03644576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110878631|NCT03644576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110878632|NCT03644576|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110878633|NCT03644576|Respiratory System Agents|respiratory system agents|mesh-ancestor
110878634|NCT03644576|Nasal Decongestants|nasal decongestants|mesh-ancestor
110878635|NCT03644576|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110878636|NCT03644576|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110878637|NCT03644576|Sympathomimetics|sympathomimetics|mesh-ancestor
110878638|NCT03644576|Adrenergic Agents|adrenergic agents|mesh-ancestor
110878639|NCT03644576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110878640|NCT03644576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110878641|NCT03644576|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
110878642|NCT03644576|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110878643|NCT03644576|Immunologic Factors|immunologic factors|mesh-ancestor
110878644|NCT03418727|Brimonidine Tartrate|brimonidine tartrate|mesh-list
110878645|NCT03418727|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
110878646|NCT03418727|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110878647|NCT03418727|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110878648|NCT03418727|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110878649|NCT03418727|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110878650|NCT03418727|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110878651|NCT03418727|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110878652|NCT03418727|Adrenergic Agents|adrenergic agents|mesh-ancestor
110878653|NCT03418727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110878654|NCT03418727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110878655|NCT03418727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110878656|NCT03418727|Laxatives|laxatives|mesh-ancestor
110878657|NCT03418727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110878658|NCT01180374|Dronabinol|dronabinol|mesh-list
110878659|NCT01180374|Cannabidiol|cannabidiol|mesh-list
110878660|NCT01180374|Anticonvulsants|anticonvulsants|mesh-ancestor
110878661|NCT01180374|Hallucinogens|hallucinogens|mesh-ancestor
110204724|NCT00054470|Trastuzumab|trastuzumab|mesh-list
110878667|NCT01180374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110878668|NCT01180374|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
110878669|NCT01180374|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110878670|NCT01180374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110878671|NCT01180374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110878672|NCT01180374|Hormones|hormones|mesh-ancestor
110878673|NCT01180374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110878674|NCT03418571|Gontivimab|gontivimab|mesh-list
110878675|NCT03418571|Antiviral Agents|antiviral agents|mesh-ancestor
110878676|NCT03418571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110878677|NCT03715517|Morphine|morphine|mesh-list
110878678|NCT03715517|Hydromorphone|hydromorphone|mesh-list
110878679|NCT03715517|Bupivacaine|bupivacaine|mesh-list
110878680|NCT03715517|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110878681|NCT03715517|Anesthetics, Local|anesthetics, local|mesh-ancestor
110878682|NCT03715517|Anesthetics|anesthetics|mesh-ancestor
110878683|NCT03715517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110878684|NCT03715517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110878685|NCT03715517|Sensory System Agents|sensory system agents|mesh-ancestor
110196743|NCT00214630|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110878686|NCT03715517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110878687|NCT03715517|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110878688|NCT03715517|Narcotics|narcotics|mesh-ancestor
110878689|NCT03715517|Analgesics|analgesics|mesh-ancestor
110878690|NCT03717467|Magnesium Sulfate|magnesium sulfate|mesh-list
110878691|NCT03717467|Analgesics|analgesics|mesh-ancestor
110878692|NCT03717467|Sensory System Agents|sensory system agents|mesh-ancestor
110878693|NCT03717467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110878694|NCT03717467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110919828|NCT03522428|Vitamin B 12|vitamin b 12|mesh-list
110919829|NCT03522428|Hydroxocobalamin|hydroxocobalamin|mesh-list
110878695|NCT03717467|Anesthetics|anesthetics|mesh-ancestor
110878696|NCT03717467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110878697|NCT03717467|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110878698|NCT03717467|Anticonvulsants|anticonvulsants|mesh-ancestor
110878699|NCT03717467|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110878700|NCT03717467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110878701|NCT03717467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110878702|NCT03717467|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110878703|NCT03717467|Tocolytic Agents|tocolytic agents|mesh-ancestor
110878704|NCT03717467|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110878705|NCT01318122|Pioglitazone|pioglitazone|mesh-list
110878706|NCT01318122|Alogliptin|alogliptin|mesh-list
110878707|NCT01318122|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110878708|NCT01318122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110878709|NCT01318122|Incretins|incretins|mesh-ancestor
110878711|NCT01318122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110878712|NCT01318122|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110878713|NCT01318122|Protease Inhibitors|protease inhibitors|mesh-ancestor
110878714|NCT01318122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110878715|NCT01318122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110878716|NCT02954159|Vedolizumab|vedolizumab|mesh-list
110878717|NCT02954159|Tacrolimus|tacrolimus|mesh-list
110878718|NCT02954159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110878719|NCT02954159|Immunologic Factors|immunologic factors|mesh-ancestor
110878720|NCT02954159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110878721|NCT02954159|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110878722|NCT02954159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110878723|NCT02954159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110878724|NCT02954159|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110878725|NCT03763422|Temozolomide|temozolomide|mesh-list
110878726|NCT03763422|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110878727|NCT03763422|Alkylating Agents|alkylating agents|mesh-ancestor
110878728|NCT03763422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110878729|NCT03763422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110878730|NCT03667716|Nivolumab|nivolumab|mesh-list
110878731|NCT03667716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110204736|NCT00045513|Fludarabine|fludarabine|mesh-list
110878750|NCT03740334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110878751|NCT03740334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110878752|NCT03740334|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110878753|NCT03740334|Immunologic Factors|immunologic factors|mesh-ancestor
110878754|NCT03440411|Dexamethasone|dexamethasone|mesh-list
110878755|NCT03440411|Cyclophosphamide|cyclophosphamide|mesh-list
110878756|NCT03440411|Pomalidomide|pomalidomide|mesh-list
110878757|NCT03440411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110878758|NCT03440411|Immunologic Factors|immunologic factors|mesh-ancestor
110878759|NCT03440411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110878760|NCT03440411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110878761|NCT03440411|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110878762|NCT03440411|Alkylating Agents|alkylating agents|mesh-ancestor
110878763|NCT03440411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110878764|NCT03440411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110878765|NCT03440411|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110878766|NCT03440411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110878767|NCT03440411|Antiemetics|antiemetics|mesh-ancestor
110878768|NCT03440411|Autonomic Agents|autonomic agents|mesh-ancestor
110878769|NCT03440411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110878770|NCT03440411|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110878771|NCT03440411|Glucocorticoids|glucocorticoids|mesh-ancestor
110878772|NCT03440411|Hormones|hormones|mesh-ancestor
110878773|NCT03440411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110878774|NCT03440411|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110878775|NCT03440411|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110878776|NCT03440411|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110878777|NCT03440411|Growth Substances|growth substances|mesh-ancestor
110878778|NCT03440411|Growth Inhibitors|growth inhibitors|mesh-ancestor
110878779|NCT03714737|Vaccines|vaccines|mesh-list
110596294|NCT02576340|Bromides|bromides|mesh-list
110878780|NCT03714737|Immunologic Factors|immunologic factors|mesh-ancestor
110878781|NCT03714737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110878783|NCT03389555|Ascorbic Acid|ascorbic acid|mesh-list
110878784|NCT03389555|Thiamine|thiamine|mesh-list
110878785|NCT03389555|Hydrocortisone|hydrocortisone|mesh-list
110878786|NCT03389555|Micronutrients|micronutrients|mesh-ancestor
110878787|NCT03389555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110878788|NCT03389555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110878789|NCT03389555|Antioxidants|antioxidants|mesh-ancestor
110878812|NCT03353922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110878813|NCT03353922|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110878814|NCT03353922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110878815|NCT03353922|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110878816|NCT03353922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110878817|NCT03395405|Nitazoxanide|nitazoxanide|mesh-list
110878818|NCT03395405|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110878819|NCT03395405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110878820|NCT03387683|Dapagliflozin|dapagliflozin|mesh-list
110878821|NCT03387683|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110878822|NCT03387683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110878823|NCT03387683|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110878824|NCT03387683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110878825|NCT05467553|Tenofovir|tenofovir|mesh-list
110878826|NCT05467553|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
110878827|NCT05467553|Antiviral Agents|antiviral agents|mesh-ancestor
110878828|NCT05467553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110878829|NCT05467553|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110878830|NCT05467553|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110878831|NCT05467553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110878832|NCT05467553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110878833|NCT05467553|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110878834|NCT05467553|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110878835|NCT05467553|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
110878836|NCT05467553|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110878837|NCT02942004|Pregnanolone|pregnanolone|mesh-list
110878838|NCT02942004|Brexanolone|brexanolone|mesh-list
110878839|NCT02942004|Neurosteroids|neurosteroids|mesh-ancestor
110878840|NCT02942004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110878841|NCT02942004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110878842|NCT02942004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110878843|NCT02942004|GABA Modulators|gaba modulators|mesh-ancestor
110204755|NCT00167479|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110878858|NCT03414983|Growth Inhibitors|growth inhibitors|mesh-ancestor
110878859|NCT03414983|Antimetabolites|antimetabolites|mesh-ancestor
110878860|NCT03414983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110878861|NCT03414983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110878862|NCT03414983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110878863|NCT03414983|Immunologic Factors|immunologic factors|mesh-ancestor
110878864|NCT03414983|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110878865|NCT03414983|Antidotes|antidotes|mesh-ancestor
110878866|NCT03414983|Protective Agents|protective agents|mesh-ancestor
110878867|NCT03414983|Vitamin B Complex|vitamin b complex|mesh-ancestor
110878868|NCT03414983|Vitamins|vitamins|mesh-ancestor
110878869|NCT03414983|Micronutrients|micronutrients|mesh-ancestor
110878870|NCT03414359|Lidocaine|lidocaine|mesh-list
110878871|NCT03414359|Chloroprocaine|chloroprocaine|mesh-list
110878872|NCT03414359|Anesthetics, Local|anesthetics, local|mesh-ancestor
110878873|NCT03414359|Anesthetics|anesthetics|mesh-ancestor
110878874|NCT03414359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110878875|NCT03414359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110878876|NCT03414359|Sensory System Agents|sensory system agents|mesh-ancestor
110878877|NCT03414359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110878878|NCT03414359|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110878879|NCT03414359|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110878880|NCT03414359|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110878881|NCT03414359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110878882|NCT03414359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110878883|NCT03285295|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
110878884|NCT03285295|Immunologic Factors|immunologic factors|mesh-ancestor
110878885|NCT03285295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110878886|NCT02583048|Dolutegravir|dolutegravir|mesh-list
110878887|NCT02583048|Bedaquiline|bedaquiline|mesh-list
110878888|NCT02583048|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110878889|NCT02583048|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110878890|NCT02583048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110878891|NCT02583048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110878892|NCT02583048|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110878893|NCT02583048|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110878894|NCT02583048|Antiviral Agents|antiviral agents|mesh-ancestor
110878895|NCT02583048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110878896|NCT02583048|Antitubercular Agents|antitubercular agents|mesh-ancestor
110878897|NCT02583048|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110878898|NCT04661137|Dexamethasone|dexamethasone|mesh-list
110878899|NCT04661137|Daratumumab|daratumumab|mesh-list
110878900|NCT04661137|Pomalidomide|pomalidomide|mesh-list
110878901|NCT04661137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110878902|NCT04661137|Antiemetics|antiemetics|mesh-ancestor
110878903|NCT04661137|Autonomic Agents|autonomic agents|mesh-ancestor
110878904|NCT04661137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110878905|NCT04661137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110878906|NCT04661137|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110878913|NCT04661137|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110878914|NCT04661137|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110878915|NCT04661137|Growth Substances|growth substances|mesh-ancestor
110878916|NCT04661137|Growth Inhibitors|growth inhibitors|mesh-ancestor
110878918|NCT03274687|Hormones|hormones|mesh-ancestor
110878919|NCT03274687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110878920|NCT03274687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110878921|NCT02542956|Bupivacaine|bupivacaine|mesh-list
110878922|NCT02542956|Anesthetics, Local|anesthetics, local|mesh-ancestor
110878923|NCT02542956|Anesthetics|anesthetics|mesh-ancestor
110878924|NCT02542956|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110878925|NCT02542956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110878926|NCT02542956|Sensory System Agents|sensory system agents|mesh-ancestor
110878927|NCT02542956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110878928|NCT03274453|Ketamine|ketamine|mesh-list
110878929|NCT03274453|Analgesics|analgesics|mesh-ancestor
110878930|NCT03274453|Sensory System Agents|sensory system agents|mesh-ancestor
110878931|NCT03274453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110878932|NCT03274453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110878933|NCT03274453|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110878934|NCT03274453|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110878935|NCT03274453|Anesthetics, General|anesthetics, general|mesh-ancestor
110878936|NCT03274453|Anesthetics|anesthetics|mesh-ancestor
110878937|NCT03274453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110878938|NCT03274453|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110878940|NCT03274453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110878941|NCT03274453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110878942|NCT02313870|Clobetasol|clobetasol|mesh-list
110878943|NCT02313870|Methotrexate|methotrexate|mesh-list
110878944|NCT02313870|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110878945|NCT02313870|Abortifacient Agents|abortifacient agents|mesh-ancestor
110878946|NCT02313870|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110878947|NCT02313870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110878948|NCT02313870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110878949|NCT02313870|Antimetabolites|antimetabolites|mesh-ancestor
110878950|NCT02313870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110878951|NCT02313870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110878952|NCT02313870|Dermatologic Agents|dermatologic agents|mesh-ancestor
110878953|NCT02313870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110878954|NCT02313870|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110878955|NCT02313870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110878956|NCT02313870|Immunologic Factors|immunologic factors|mesh-ancestor
110878957|NCT02313870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110878958|NCT02313870|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110878959|NCT02313870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110878960|NCT02313870|Glucocorticoids|glucocorticoids|mesh-ancestor
110878961|NCT02313870|Hormones|hormones|mesh-ancestor
110878962|NCT02313870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110878963|NCT01942122|Mefenamic Acid|mefenamic acid|mesh-list
110878964|NCT01942122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110878965|NCT01942122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110878966|NCT01942122|Analgesics|analgesics|mesh-ancestor
110878967|NCT01942122|Sensory System Agents|sensory system agents|mesh-ancestor
110878968|NCT01942122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110878969|NCT01942122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110878970|NCT01942122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110878971|NCT01942122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110878972|NCT01942122|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110878973|NCT01942122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110204793|NCT00167518|Hormones|hormones|mesh-ancestor
110878994|NCT01578954|Lenalidomide|lenalidomide|mesh-list
110878995|NCT01578954|Immunologic Factors|immunologic factors|mesh-ancestor
110878996|NCT01578954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110878997|NCT01578954|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110878998|NCT01578954|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110878999|NCT01578954|Growth Substances|growth substances|mesh-ancestor
110879000|NCT01578954|Growth Inhibitors|growth inhibitors|mesh-ancestor
110879001|NCT01578954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110879002|NCT00659646|Levofloxacin|levofloxacin|mesh-list
110879003|NCT00659646|Ofloxacin|ofloxacin|mesh-list
110879004|NCT00659646|Gentamicins|gentamicins|mesh-list
110879005|NCT00659646|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110879006|NCT00659646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110879007|NCT00659646|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110879008|NCT00659646|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110879009|NCT00659646|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110879010|NCT00659646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110879011|NCT00659646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110879012|NCT00659646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110879013|NCT00659646|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110879014|NCT00659646|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110879015|NCT00659646|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110879017|NCT02236572|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110879018|NCT02236572|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110879019|NCT02236572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110879020|NCT02236572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110919877|NCT05136508|Anesthetics|anesthetics|mesh-ancestor
110879022|NCT02236572|Immunologic Factors|immunologic factors|mesh-ancestor
110879023|NCT02236572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110879024|NCT02236572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110879025|NCT03054870|Xenon|xenon|mesh-list
110879026|NCT03054870|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110879027|NCT03054870|Anesthetics, General|anesthetics, general|mesh-ancestor
110879028|NCT03054870|Anesthetics|anesthetics|mesh-ancestor
110879039|NCT05448677|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110879040|NCT05448677|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110879041|NCT05448677|Growth Substances|growth substances|mesh-ancestor
110879042|NCT05448677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110879043|NCT05448677|Growth Inhibitors|growth inhibitors|mesh-ancestor
110879044|NCT05448677|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110879045|NCT05448677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110879046|NCT05222646|Metoclopramide|metoclopramide|mesh-list
110879047|NCT05222646|Antiemetics|antiemetics|mesh-ancestor
110879048|NCT05222646|Autonomic Agents|autonomic agents|mesh-ancestor
110879049|NCT05222646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110879050|NCT05222646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110879051|NCT05222646|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110879052|NCT05222646|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110879053|NCT05222646|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110879054|NCT05222646|Dopamine Agents|dopamine agents|mesh-ancestor
110879055|NCT05222646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110879056|NCT05222646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110879057|NCT05222334|Bupivacaine|bupivacaine|mesh-list
110879058|NCT05222334|Anesthetics, Local|anesthetics, local|mesh-ancestor
110879059|NCT05222334|Anesthetics|anesthetics|mesh-ancestor
110879060|NCT05222334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110879061|NCT05222334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110879062|NCT05222334|Sensory System Agents|sensory system agents|mesh-ancestor
110879063|NCT05222334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110879064|NCT04465266|Tolperisone|tolperisone|mesh-list
110879065|NCT04465266|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110879066|NCT04465266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110879067|NCT04465266|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110879068|NCT04465266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110879069|NCT04434300|Daptomycin|daptomycin|mesh-list
110879070|NCT04434300|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110879071|NCT04434300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110879072|NCT04315896|Hydroxychloroquine|hydroxychloroquine|mesh-list
110879073|NCT04315896|Antimalarials|antimalarials|mesh-ancestor
110879074|NCT04315896|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110879075|NCT04315896|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110879076|NCT04315896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110879077|NCT04315896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110879078|NCT04315896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110879079|NCT04315896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110879080|NCT05178654|Nirmatrelvir|nirmatrelvir|mesh-list
110879081|NCT05178654|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110879082|NCT05178654|Protease Inhibitors|protease inhibitors|mesh-ancestor
110879083|NCT05178654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110879084|NCT05178654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110879086|NCT05178654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110879087|NCT04108962|Benralizumab|benralizumab|mesh-list
110879088|NCT04108962|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110879089|NCT04108962|Respiratory System Agents|respiratory system agents|mesh-ancestor
110879090|NCT04865796|Lactoferrin|lactoferrin|mesh-list
110879091|NCT04865796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110879092|NCT04811118|Docetaxel|docetaxel|mesh-list
110879093|NCT04811118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110879094|NCT04811118|Tubulin Modulators|tubulin modulators|mesh-ancestor
110879113|NCT05221164|Antipyretics|antipyretics|mesh-ancestor
110879115|NCT03627546|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
110879116|NCT03627546|Velpatasvir|velpatasvir|mesh-list
110879117|NCT03627546|Antiviral Agents|antiviral agents|mesh-ancestor
110879118|NCT03627546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110879119|NCT04620798|Antibodies|antibodies|mesh-list
110879120|NCT04620798|Immunologic Factors|immunologic factors|mesh-ancestor
110879121|NCT04620798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110879122|NCT05220228|Prucalopride|prucalopride|mesh-list
110879123|NCT05220228|Laxatives|laxatives|mesh-ancestor
110879124|NCT05220228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110879125|NCT05220228|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
110879126|NCT05220228|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110879127|NCT05220228|Serotonin Agents|serotonin agents|mesh-ancestor
110879128|NCT05220228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110879129|NCT05220228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110879130|NCT05220228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110879131|NCT03822780|Hydroxychloroquine|hydroxychloroquine|mesh-list
110879132|NCT03822780|Antimalarials|antimalarials|mesh-ancestor
110879133|NCT03822780|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110879134|NCT03822780|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110879135|NCT03822780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110879136|NCT03822780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110879137|NCT03822780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110879138|NCT03822780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110879139|NCT04765644|Celecoxib|celecoxib|mesh-list
110879140|NCT04765644|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110879141|NCT04765644|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110879142|NCT04765644|Analgesics|analgesics|mesh-ancestor
110879143|NCT04765644|Sensory System Agents|sensory system agents|mesh-ancestor
110879144|NCT04765644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110879145|NCT04765644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110879146|NCT04765644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110879147|NCT04765644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110879148|NCT04765644|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110879149|NCT04765644|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110204825|NCT00167713|Sensory System Agents|sensory system agents|mesh-ancestor
110879169|NCT05197374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110879170|NCT05197374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110879171|NCT05197374|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110879172|NCT05197374|Contraceptive Agents|contraceptive agents|mesh-ancestor
110879173|NCT05197374|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110879174|NCT05197374|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110879175|NCT02951819|Dexamethasone|dexamethasone|mesh-list
110879176|NCT02951819|Cyclophosphamide|cyclophosphamide|mesh-list
110879177|NCT02951819|Bortezomib|bortezomib|mesh-list
110879178|NCT02951819|Daratumumab|daratumumab|mesh-list
110879179|NCT02951819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110879180|NCT02951819|Immunologic Factors|immunologic factors|mesh-ancestor
110879181|NCT02951819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110879182|NCT02951819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110879183|NCT02951819|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110879184|NCT02951819|Alkylating Agents|alkylating agents|mesh-ancestor
110879185|NCT02951819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110879186|NCT02951819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110879187|NCT02951819|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110879188|NCT02951819|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110879189|NCT02951819|Antiemetics|antiemetics|mesh-ancestor
110879190|NCT02951819|Autonomic Agents|autonomic agents|mesh-ancestor
110879191|NCT02951819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110879192|NCT02951819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110879193|NCT02951819|Glucocorticoids|glucocorticoids|mesh-ancestor
110879194|NCT02951819|Hormones|hormones|mesh-ancestor
110919898|NCT05221411|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110879195|NCT02951819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110879196|NCT02951819|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110879197|NCT05191290|Heparin|heparin|mesh-list
110879198|NCT05191290|Calcium heparin|calcium heparin|mesh-list
110879199|NCT05191290|Citric Acid|citric acid|mesh-list
110879200|NCT05191290|Sodium Citrate|sodium citrate|mesh-list
110879201|NCT05191290|Anticoagulants|anticoagulants|mesh-ancestor
110879202|NCT05191290|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110879203|NCT05191290|Chelating Agents|chelating agents|mesh-ancestor
110879204|NCT05191290|Sequestering Agents|sequestering agents|mesh-ancestor
110879205|NCT05191290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110879209|NCT05627544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110879210|NCT05627544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110879211|NCT05189028|Gemcitabine|gemcitabine|mesh-list
110879212|NCT05189028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110879213|NCT05189028|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110879214|NCT05189028|Antimetabolites|antimetabolites|mesh-ancestor
110879215|NCT05189028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110879216|NCT03383783|Listerine|listerine|mesh-list
110879217|NCT03383783|Fluorides|fluorides|mesh-list
110879218|NCT03383783|Sodium Fluoride|sodium fluoride|mesh-list
110879219|NCT03383783|Cariostatic Agents|cariostatic agents|mesh-ancestor
110879220|NCT03383783|Protective Agents|protective agents|mesh-ancestor
110879221|NCT03383783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110879222|NCT03383783|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110879223|NCT03383783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110879224|NCT03627390|Molybdenum|molybdenum|mesh-list
110879225|NCT03627390|Trace Elements|trace elements|mesh-ancestor
110879226|NCT03627390|Micronutrients|micronutrients|mesh-ancestor
110879227|NCT03627390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110879228|NCT03709745|Ranibizumab|ranibizumab|mesh-list
110879229|NCT03709745|Aflibercept|aflibercept|mesh-list
110879230|NCT03709745|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110879231|NCT03709745|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110879232|NCT03709745|Growth Substances|growth substances|mesh-ancestor
110879233|NCT03709745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110879234|NCT03709745|Growth Inhibitors|growth inhibitors|mesh-ancestor
110879235|NCT03709745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110879237|NCT05570526|Antioxidants|antioxidants|mesh-ancestor
110924811|NCT03098680|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
110879238|NCT05570526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110879239|NCT05570526|Protective Agents|protective agents|mesh-ancestor
110879240|NCT05570526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110879241|NCT05570526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110879242|NCT03707639|Apatinib|apatinib|mesh-list
110879243|NCT03707639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110879244|NCT03707639|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110879245|NCT03707639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110879246|NCT03707639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110879247|NCT03334721|Gabapentin|gabapentin|mesh-list
110879248|NCT03334721|Analgesics|analgesics|mesh-ancestor
110879249|NCT03334721|Sensory System Agents|sensory system agents|mesh-ancestor
110879250|NCT03334721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110879251|NCT03334721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110879252|NCT03334721|Anticonvulsants|anticonvulsants|mesh-ancestor
110879253|NCT03334721|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110879254|NCT03334721|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110879255|NCT03334721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110879256|NCT03334721|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110879257|NCT03334721|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110879258|NCT03334721|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110879259|NCT03334721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110879260|NCT03334721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110879261|NCT03334721|Antimanic Agents|antimanic agents|mesh-ancestor
110879262|NCT05706402|Acetylcysteine|acetylcysteine|mesh-list
110879263|NCT05706402|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110879264|NCT05706402|Antiviral Agents|antiviral agents|mesh-ancestor
110879265|NCT05706402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110879266|NCT05706402|Expectorants|expectorants|mesh-ancestor
110879267|NCT05706402|Respiratory System Agents|respiratory system agents|mesh-ancestor
110879268|NCT05706402|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110879269|NCT05706402|Antioxidants|antioxidants|mesh-ancestor
110879270|NCT05706402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110879271|NCT05706402|Protective Agents|protective agents|mesh-ancestor
110879272|NCT05706402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110879273|NCT05706402|Antidotes|antidotes|mesh-ancestor
110879274|NCT05706090|Fentanyl|fentanyl|mesh-list
110879275|NCT05706090|Anesthetics|anesthetics|mesh-ancestor
110879276|NCT05706090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110879277|NCT05706090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110879278|NCT05706090|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110879279|NCT05706090|Narcotics|narcotics|mesh-ancestor
110879280|NCT05706090|Analgesics|analgesics|mesh-ancestor
110879288|NCT03380429|Autonomic Agents|autonomic agents|mesh-ancestor
110879289|NCT03380429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110879290|NCT03380429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110879291|NCT03380429|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110879292|NCT03380429|Respiratory System Agents|respiratory system agents|mesh-ancestor
110879293|NCT03380429|Tocolytic Agents|tocolytic agents|mesh-ancestor
110879294|NCT03380429|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110879295|NCT03380429|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110879296|NCT03380429|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110879297|NCT03380429|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110879298|NCT03380429|Adrenergic Agents|adrenergic agents|mesh-ancestor
110879299|NCT03380429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110879300|NCT03380429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110879302|NCT05096442|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110879303|NCT05096442|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110879304|NCT05096442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110879305|NCT05096442|Tubulin Modulators|tubulin modulators|mesh-ancestor
110879306|NCT05096442|Antimitotic Agents|antimitotic agents|mesh-ancestor
110879307|NCT05096442|Mitosis Modulators|mitosis modulators|mesh-ancestor
110879308|NCT05096442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110879309|NCT01313143|Esmolol|esmolol|mesh-list
110879310|NCT01313143|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110879311|NCT01313143|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110879312|NCT01313143|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110879313|NCT01313143|Adrenergic Agents|adrenergic agents|mesh-ancestor
110879314|NCT01313143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110879315|NCT01313143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110879316|NCT01313143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110879318|NCT05071794|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110879319|NCT05071794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110879320|NCT05071794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110879321|NCT05071794|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110879322|NCT05071794|Anesthetics, General|anesthetics, general|mesh-ancestor
110879323|NCT05071794|Anesthetics|anesthetics|mesh-ancestor
110879324|NCT03280537|Omalizumab|omalizumab|mesh-list
110879325|NCT03280537|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110879326|NCT03280537|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110879327|NCT03280537|Respiratory System Agents|respiratory system agents|mesh-ancestor
110879328|NCT05029050|Clonidine|clonidine|mesh-list
110879329|NCT05029050|Dexmedetomidine|dexmedetomidine|mesh-list
110879330|NCT05029050|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110879331|NCT05029050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110879332|NCT05029050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110879333|NCT05029050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110879334|NCT05029050|Analgesics|analgesics|mesh-ancestor
110879335|NCT05029050|Sensory System Agents|sensory system agents|mesh-ancestor
110879336|NCT05029050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110879337|NCT05029050|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110879338|NCT05029050|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110879339|NCT05029050|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110879340|NCT05029050|Adrenergic Agents|adrenergic agents|mesh-ancestor
110879341|NCT05029050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110879342|NCT05029050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110879343|NCT05029050|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110879344|NCT05029050|Sympatholytics|sympatholytics|mesh-ancestor
110879345|NCT05029050|Autonomic Agents|autonomic agents|mesh-ancestor
110879346|NCT04690231|Etoposide|etoposide|mesh-list
110879347|NCT04690231|Etoposide phosphate|etoposide phosphate|mesh-list
110879348|NCT04690231|Apatinib|apatinib|mesh-list
110879357|NCT04690231|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110879358|NCT04690231|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110879359|NCT04690231|Alkylating Agents|alkylating agents|mesh-ancestor
110879360|NCT03270085|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
110879361|NCT03270085|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110879362|NCT03270085|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110879363|NCT03270085|Antimetabolites|antimetabolites|mesh-ancestor
110879364|NCT03270085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110879365|NCT03270085|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110879366|NCT04998006|Ethanol|ethanol|mesh-list
110879367|NCT04998006|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110879368|NCT04998006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110879369|NCT04998006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110879370|NCT04998006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110879371|NCT04234945|Doxycycline|doxycycline|mesh-list
110879372|NCT04234945|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110879373|NCT04234945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110879374|NCT04234945|Antimalarials|antimalarials|mesh-ancestor
110879375|NCT04234945|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110879376|NCT04234945|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110879377|NCT03316807|Vaccines|vaccines|mesh-list
110879378|NCT03316807|Immunologic Factors|immunologic factors|mesh-ancestor
110596903|NCT05335148|Colchicine|colchicine|mesh-list
110879379|NCT03316807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110879380|NCT03379259|Tislelizumab|tislelizumab|mesh-list
110879381|NCT03379259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110879382|NCT03379259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110879384|NCT03328897|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110879385|NCT03328897|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110879386|NCT03328897|Respiratory System Agents|respiratory system agents|mesh-ancestor
110879387|NCT04918758|Sucralfate|sucralfate|mesh-list
110879388|NCT04918758|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110879389|NCT04918758|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110879390|NCT03378635|Glucagon|glucagon|mesh-list
110879391|NCT03378635|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110879392|NCT03378635|Hormones|hormones|mesh-ancestor
110879393|NCT03378635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110879394|NCT03378635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110879395|NCT01182727|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
110879396|NCT01182727|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110879397|NCT01182727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110879398|NCT01182727|Analgesics|analgesics|mesh-ancestor
110879399|NCT01182727|Sensory System Agents|sensory system agents|mesh-ancestor
110879400|NCT01182727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110879401|NCT01182727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110879402|NCT01182727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110879403|NCT01182727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110879404|NCT03334409|Vitamins|vitamins|mesh-list
110879405|NCT03334409|Ascorbic Acid|ascorbic acid|mesh-list
110879406|NCT03334409|Micronutrients|micronutrients|mesh-ancestor
110879407|NCT03334409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110879408|NCT03334409|Antioxidants|antioxidants|mesh-ancestor
110879409|NCT03334409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110879410|NCT03334409|Protective Agents|protective agents|mesh-ancestor
110879411|NCT02891915|Amoxicillin|amoxicillin|mesh-list
110879412|NCT02891915|Clavulanic Acid|clavulanic acid|mesh-list
110879413|NCT02891915|Clavulanic Acids|clavulanic acids|mesh-list
110879414|NCT02891915|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
110879415|NCT02891915|Cefdinir|cefdinir|mesh-list
110204872|NCT00167986|Vancomycin|vancomycin|mesh-list
110879424|NCT03046446|Hormones|hormones|mesh-ancestor
110879425|NCT03046446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110879426|NCT03046446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110879427|NCT03046446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110879428|NCT03046446|Immunologic Factors|immunologic factors|mesh-ancestor
110879429|NCT03051217|Certolizumab Pegol|certolizumab pegol|mesh-list
110879430|NCT03051217|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110879431|NCT03051217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110062712|NCT04336982|Antimetabolites|antimetabolites|mesh-ancestor
110879432|NCT03051217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110879433|NCT03051217|Immunologic Factors|immunologic factors|mesh-ancestor
110879434|NCT03051217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110879435|NCT03051217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110879436|NCT05035303|Epinephrine|epinephrine|mesh-list
110879437|NCT05035303|Norepinephrine|norepinephrine|mesh-list
110879438|NCT05035303|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110879439|NCT05035303|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110879440|NCT05035303|Adrenergic Agents|adrenergic agents|mesh-ancestor
110879441|NCT05035303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110879442|NCT05035303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110879443|NCT05035303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110879444|NCT05035303|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110879445|NCT05035303|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110879446|NCT05035303|Autonomic Agents|autonomic agents|mesh-ancestor
110879447|NCT05035303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110879448|NCT05035303|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110879449|NCT05035303|Respiratory System Agents|respiratory system agents|mesh-ancestor
110879450|NCT05035303|Mydriatics|mydriatics|mesh-ancestor
110879451|NCT05035303|Sympathomimetics|sympathomimetics|mesh-ancestor
110879452|NCT05035303|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110879453|NCT03347279|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110879454|NCT03347279|Immunologic Factors|immunologic factors|mesh-ancestor
110597046|NCT04977830|Xenon|xenon|mesh-list
110879455|NCT03347279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110879457|NCT03262441|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110879458|NCT03262441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110879459|NCT03262441|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110879460|NCT03262441|Antitubercular Agents|antitubercular agents|mesh-ancestor
110879461|NCT03262441|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110879462|NCT03262441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110879463|NCT03262441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110879464|NCT03262441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110879465|NCT04580394|Oxybutynin|oxybutynin|mesh-list
110879466|NCT04580394|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
110879467|NCT04580394|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110879468|NCT04580394|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110196990|NCT00216346|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110879469|NCT04580394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110879470|NCT04580394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110879471|NCT04580394|Adrenergic Agents|adrenergic agents|mesh-ancestor
110879472|NCT04580394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110879473|NCT04580394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110879474|NCT04580394|Parasympatholytics|parasympatholytics|mesh-ancestor
110879475|NCT04580394|Autonomic Agents|autonomic agents|mesh-ancestor
110879476|NCT04580394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110879477|NCT04580394|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110879478|NCT04580394|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110879479|NCT04580394|Cholinergic Agents|cholinergic agents|mesh-ancestor
110879480|NCT04580394|Urological Agents|urological agents|mesh-ancestor
110879481|NCT01343082|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110879482|NCT01343082|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110879490|NCT05682911|Simvastatin|simvastatin|mesh-list
110879491|NCT05682911|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110879492|NCT05682911|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110879493|NCT05682911|Antimetabolites|antimetabolites|mesh-ancestor
110879494|NCT05682911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110879495|NCT05682911|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110879496|NCT05682911|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110879497|NCT05682911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110879498|NCT04625088|Atropine|atropine|mesh-list
110879499|NCT04625088|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110879500|NCT04625088|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110879501|NCT04625088|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110879502|NCT04625088|Autonomic Agents|autonomic agents|mesh-ancestor
110879503|NCT04625088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110879504|NCT04625088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110879505|NCT04625088|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110879506|NCT04625088|Respiratory System Agents|respiratory system agents|mesh-ancestor
110879507|NCT04625088|Mydriatics|mydriatics|mesh-ancestor
110879508|NCT04625088|Parasympatholytics|parasympatholytics|mesh-ancestor
110879509|NCT04625088|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110879510|NCT04625088|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110879511|NCT04625088|Cholinergic Agents|cholinergic agents|mesh-ancestor
110879512|NCT04625088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110879513|NCT04625088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110879514|NCT03568422|Paclitaxel|paclitaxel|mesh-list
110879515|NCT03568422|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110879516|NCT03568422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110879517|NCT03568422|Tubulin Modulators|tubulin modulators|mesh-ancestor
110879518|NCT03568422|Antimitotic Agents|antimitotic agents|mesh-ancestor
110879519|NCT03568422|Mitosis Modulators|mitosis modulators|mesh-ancestor
110879520|NCT03568422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110879521|NCT02547493|Abatacept|abatacept|mesh-list
110879522|NCT02547493|Vaccines|vaccines|mesh-list
110879523|NCT02547493|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110879524|NCT02547493|Immunologic Factors|immunologic factors|mesh-ancestor
110879525|NCT02547493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110879526|NCT02547493|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110879527|NCT02547493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110879528|NCT02547493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110879529|NCT02547493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110879530|NCT02547493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110879531|NCT02547493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110879532|NCT03259789|Bexagliflozin|bexagliflozin|mesh-list
110879533|NCT03259789|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110879534|NCT03259789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110879535|NCT03259555|Brexpiprazole|brexpiprazole|mesh-list
110879536|NCT03259555|Serotonin Agents|serotonin agents|mesh-ancestor
110879537|NCT03259555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110879538|NCT03259555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110879539|NCT03259555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110879540|NCT03259555|Dopamine Agonists|dopamine agonists|mesh-ancestor
110879541|NCT03259555|Dopamine Agents|dopamine agents|mesh-ancestor
110879542|NCT03257995|Maleic acid|maleic acid|mesh-list
110879543|NCT03257995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110879544|NCT03257995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110879545|NCT03049488|Aluminum Hydroxide|aluminum hydroxide|mesh-list
110879546|NCT03049488|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110879547|NCT03049488|Immunologic Factors|immunologic factors|mesh-ancestor
110879548|NCT03049488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110879549|NCT03049488|Antacids|antacids|mesh-ancestor
110534666|NCT02676336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110879556|NCT04484922|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110879557|NCT04484922|Analgesics|analgesics|mesh-ancestor
110879558|NCT04484922|Sensory System Agents|sensory system agents|mesh-ancestor
110879559|NCT04484922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110879560|NCT04484922|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110879561|NCT04484922|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110879562|NCT04484922|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110879563|NCT04484922|Adrenergic Agents|adrenergic agents|mesh-ancestor
110879564|NCT04484922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110879565|NCT04484922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110879566|NCT04446390|Listerine|listerine|mesh-list
110879567|NCT04446390|Sodium Fluoride|sodium fluoride|mesh-list
110879568|NCT04446390|Cariostatic Agents|cariostatic agents|mesh-ancestor
110879569|NCT04446390|Protective Agents|protective agents|mesh-ancestor
110879570|NCT04446390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110879572|NCT04446390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110879573|NCT02338921|Metformin|metformin|mesh-list
110879574|NCT02338921|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110879575|NCT02338921|Dapagliflozin|dapagliflozin|mesh-list
110879576|NCT02338921|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110879577|NCT02338921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110879578|NCT02338921|Incretins|incretins|mesh-ancestor
110879579|NCT02338921|Hormones|hormones|mesh-ancestor
110879580|NCT02338921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110879581|NCT02338921|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110879582|NCT02338921|Protease Inhibitors|protease inhibitors|mesh-ancestor
110879583|NCT02338921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110879584|NCT02338921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110879585|NCT02338921|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110879586|NCT01313845|Amantadine|amantadine|mesh-list
110879587|NCT01313845|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110879588|NCT01313845|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110879589|NCT01313845|Antiviral Agents|antiviral agents|mesh-ancestor
110879590|NCT01313845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110879591|NCT01313845|Dopamine Agents|dopamine agents|mesh-ancestor
110879592|NCT01313845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110879593|NCT01313845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110879594|NCT01313845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110879595|NCT01313845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110879596|NCT01313845|Analgesics|analgesics|mesh-ancestor
110879597|NCT01313845|Sensory System Agents|sensory system agents|mesh-ancestor
110879598|NCT01313845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110879599|NCT04400058|gamma-Globulins|gamma-globulins|mesh-list
110879600|NCT04400058|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110879601|NCT04400058|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110879602|NCT04400058|Immunologic Factors|immunologic factors|mesh-ancestor
110597129|NCT04690608|Hormones|hormones|mesh-ancestor
110879603|NCT04400058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110879604|NCT04745845|Norepinephrine|norepinephrine|mesh-list
110879605|NCT04745845|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110879606|NCT04745845|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110879607|NCT04745845|Adrenergic Agents|adrenergic agents|mesh-ancestor
110879608|NCT04745845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110879609|NCT04745845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110879610|NCT04745845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110879611|NCT04745845|Sympathomimetics|sympathomimetics|mesh-ancestor
110879612|NCT04745845|Autonomic Agents|autonomic agents|mesh-ancestor
110879613|NCT04745845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110879614|NCT04745845|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110879615|NCT03196986|Bevacizumab|bevacizumab|mesh-list
110879616|NCT03196986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110879635|NCT02145403|Tacrolimus|tacrolimus|mesh-list
110879636|NCT02145403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110879637|NCT02145403|Immunologic Factors|immunologic factors|mesh-ancestor
110879638|NCT02145403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110879639|NCT02145403|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110879640|NCT02145403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110879641|NCT02145403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110879642|NCT02899988|Mirikizumab|mirikizumab|mesh-list
110879643|NCT02899988|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110879644|NCT02899988|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110879645|NCT02899988|Analgesics|analgesics|mesh-ancestor
110879646|NCT02899988|Sensory System Agents|sensory system agents|mesh-ancestor
110879647|NCT02899988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110879648|NCT02899988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110879649|NCT02899988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110879650|NCT02899988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110879651|NCT02899988|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110920023|NCT04488874|Diuretics|diuretics|mesh-ancestor
110879652|NCT02899988|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110879654|NCT03646526|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110879655|NCT03646526|Antidepressive Agents|antidepressive agents|mesh-ancestor
110879656|NCT03646526|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110879657|NCT03646526|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110879658|NCT03646526|Analgesics|analgesics|mesh-ancestor
110879659|NCT03646526|Sensory System Agents|sensory system agents|mesh-ancestor
110879660|NCT03646526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110879661|NCT03646526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110879662|NCT03646526|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110879663|NCT03646526|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110879664|NCT03646526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110879665|NCT03646526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110879666|NCT03646526|Adrenergic Agents|adrenergic agents|mesh-ancestor
110879667|NCT03646526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110879668|NCT03646370|Tenofovir|tenofovir|mesh-list
110879669|NCT03646370|Antiviral Agents|antiviral agents|mesh-ancestor
110879670|NCT03646370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110879671|NCT03646370|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110879672|NCT03646370|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110879684|NCT03345407|Nemiralisib|nemiralisib|mesh-list
110879685|NCT03345407|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110879686|NCT03345407|Autonomic Agents|autonomic agents|mesh-ancestor
110879687|NCT03345407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110879688|NCT03345407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110879689|NCT03345407|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110879690|NCT03345407|Respiratory System Agents|respiratory system agents|mesh-ancestor
110879691|NCT03345407|Tocolytic Agents|tocolytic agents|mesh-ancestor
110879692|NCT03345407|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110879693|NCT03345407|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110879694|NCT03345407|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110879695|NCT03345407|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110879696|NCT03345407|Adrenergic Agents|adrenergic agents|mesh-ancestor
110879697|NCT03345407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110879698|NCT03345407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110879699|NCT03345407|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110879700|NCT03345407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110879701|NCT02537418|Durvalumab|durvalumab|mesh-list
110879702|NCT02537418|Tremelimumab|tremelimumab|mesh-list
110879703|NCT02537418|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110879704|NCT02537418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110879705|NCT03626298|Niacinamide|niacinamide|mesh-list
110879707|NCT03626298|Nicotinic Acids|nicotinic acids|mesh-list
110879708|NCT03626298|Adapalene|adapalene|mesh-list
110879709|NCT03626298|Vitamin B Complex|vitamin b complex|mesh-ancestor
110879710|NCT03626298|Vitamins|vitamins|mesh-ancestor
110879711|NCT03626298|Micronutrients|micronutrients|mesh-ancestor
110879712|NCT03626298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110879713|NCT03626298|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110879714|NCT03626298|Antimetabolites|antimetabolites|mesh-ancestor
110879715|NCT03626298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110879716|NCT03626298|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110879717|NCT03626298|Vasodilator Agents|vasodilator agents|mesh-ancestor
110879718|NCT03626298|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110879719|NCT03626298|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110879720|NCT03626298|Analgesics|analgesics|mesh-ancestor
110879721|NCT03626298|Sensory System Agents|sensory system agents|mesh-ancestor
110879722|NCT03626298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110879723|NCT03626298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110879724|NCT03626298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110879725|NCT03626298|Dermatologic Agents|dermatologic agents|mesh-ancestor
110879726|NCT03644264|Sevelamer|sevelamer|mesh-list
110879727|NCT03644264|Chelating Agents|chelating agents|mesh-ancestor
110879728|NCT03644264|Sequestering Agents|sequestering agents|mesh-ancestor
110879729|NCT03644264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110879730|NCT02298348|Cyclophosphamide|cyclophosphamide|mesh-list
110879731|NCT02298348|Sorafenib|sorafenib|mesh-list
110879732|NCT02298348|Topotecan|topotecan|mesh-list
110879733|NCT02298348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110879734|NCT02298348|Immunologic Factors|immunologic factors|mesh-ancestor
110879735|NCT02298348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110879736|NCT02298348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110879737|NCT02298348|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110879750|NCT03240133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110879752|NCT03814356|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110879753|NCT03814356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110879754|NCT03814356|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110879755|NCT03814356|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110879756|NCT03814356|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110879757|NCT03814356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110879758|NCT03814356|Dopamine Agents|dopamine agents|mesh-ancestor
110879759|NCT03814356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110879760|NCT03707171|Liraglutide|liraglutide|mesh-list
110879761|NCT03707171|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110879762|NCT03707171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110879763|NCT03707171|Incretins|incretins|mesh-ancestor
110879764|NCT03707171|Hormones|hormones|mesh-ancestor
110879765|NCT03707171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110879766|NCT02030964|Eflornithine|eflornithine|mesh-list
110879767|NCT02030964|Celecoxib|celecoxib|mesh-list
110879768|NCT02030964|Cyclophosphamide|cyclophosphamide|mesh-list
110879769|NCT02030964|Topotecan|topotecan|mesh-list
110879770|NCT02030964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110879771|NCT02030964|Immunologic Factors|immunologic factors|mesh-ancestor
110879772|NCT02030964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110879773|NCT02030964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110879774|NCT02030964|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110879775|NCT02030964|Alkylating Agents|alkylating agents|mesh-ancestor
110879776|NCT02030964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110879777|NCT02030964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110879778|NCT02030964|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110879779|NCT02030964|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110879780|NCT02030964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110879781|NCT02030964|Analgesics|analgesics|mesh-ancestor
110879782|NCT02030964|Sensory System Agents|sensory system agents|mesh-ancestor
110879783|NCT02030964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110879784|NCT02030964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110879785|NCT02030964|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110879786|NCT02030964|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110879787|NCT02030964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110879788|NCT02030964|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110879789|NCT02030964|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110879790|NCT02030964|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
110920060|NCT05304598|Analgesics|analgesics|mesh-ancestor
110879791|NCT02030964|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110879792|NCT02030964|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110879793|NCT02030964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110879794|NCT02030964|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
110879796|NCT03372083|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110879797|NCT03372083|Chelating Agents|chelating agents|mesh-ancestor
110879798|NCT03372083|Sequestering Agents|sequestering agents|mesh-ancestor
110879805|NCT02961764|Dalbavancin|dalbavancin|mesh-list
110879806|NCT02961764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110879807|NCT02961764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110879808|NCT03371459|Albuterol|albuterol|mesh-list
110879809|NCT03371459|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110879810|NCT03371459|Autonomic Agents|autonomic agents|mesh-ancestor
110879811|NCT03371459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110879812|NCT03371459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110879813|NCT03371459|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110879814|NCT03371459|Respiratory System Agents|respiratory system agents|mesh-ancestor
110879815|NCT03371459|Tocolytic Agents|tocolytic agents|mesh-ancestor
110879816|NCT03371459|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110879817|NCT03371459|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110879818|NCT03371459|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110879819|NCT03371459|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110879820|NCT03371459|Adrenergic Agents|adrenergic agents|mesh-ancestor
110879821|NCT03371459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110879822|NCT03371459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110879823|NCT03371381|Nivolumab|nivolumab|mesh-list
110879824|NCT03371381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110879825|NCT03371381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110879826|NCT03371381|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110597355|NCT04216524|Hormones|hormones|mesh-ancestor
110879827|NCT03371381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110879828|NCT03044730|Pembrolizumab|pembrolizumab|mesh-list
110879829|NCT03044730|Capecitabine|capecitabine|mesh-list
110879830|NCT03044730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110879831|NCT03044730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110879832|NCT03044730|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110879833|NCT03044730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110879834|NCT03044730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110879835|NCT03044730|Antimetabolites|antimetabolites|mesh-ancestor
110879836|NCT03738852|Insulin|insulin|mesh-list
110879837|NCT03738852|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110879838|NCT03738852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110879839|NCT02961374|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110879840|NCT02961374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110879841|NCT02961374|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110879842|NCT02961374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110879843|NCT02961374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110879844|NCT04783233|Chitosan|chitosan|mesh-list
110879845|NCT04783233|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
110879846|NCT04783233|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110879847|NCT04783233|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110879848|NCT04783233|Antimetabolites|antimetabolites|mesh-ancestor
110879849|NCT04783233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110879850|NCT04783233|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110879851|NCT04783233|Chelating Agents|chelating agents|mesh-ancestor
110879852|NCT04783233|Sequestering Agents|sequestering agents|mesh-ancestor
110879853|NCT04783233|Hemostatics|hemostatics|mesh-ancestor
110879854|NCT04783233|Coagulants|coagulants|mesh-ancestor
110879855|NCT04777539|Natalizumab|natalizumab|mesh-list
110879856|NCT04777539|Immunologic Factors|immunologic factors|mesh-ancestor
110879857|NCT04777539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110920076|NCT05134558|Xenon|xenon|mesh-list
110879859|NCT04664829|Bexarotene|bexarotene|mesh-list
110879860|NCT04664829|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110879861|NCT04664829|Antimetabolites|antimetabolites|mesh-ancestor
110879862|NCT04664829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110879863|NCT04664829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110879864|NCT02951429|Pirfenidone|pirfenidone|mesh-list
110879865|NCT02951429|Sildenafil Citrate|sildenafil citrate|mesh-list
110879866|NCT02951429|Vasodilator Agents|vasodilator agents|mesh-ancestor
110879867|NCT02951429|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110879885|NCT04622709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110879886|NCT04622709|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110879887|NCT04622709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110879888|NCT05214807|Chitosan|chitosan|mesh-list
110879889|NCT05214807|Hylan|hylan|mesh-list
110879890|NCT05214807|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110879891|NCT05214807|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110879892|NCT05214807|Antimetabolites|antimetabolites|mesh-ancestor
110879893|NCT05214807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110879894|NCT05214807|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110879895|NCT05214807|Chelating Agents|chelating agents|mesh-ancestor
110879896|NCT05214807|Sequestering Agents|sequestering agents|mesh-ancestor
110879897|NCT05214807|Hemostatics|hemostatics|mesh-ancestor
110879898|NCT05214807|Coagulants|coagulants|mesh-ancestor
110879899|NCT05214807|Viscosupplements|viscosupplements|mesh-ancestor
110879900|NCT05214807|Protective Agents|protective agents|mesh-ancestor
110879901|NCT05214807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110879902|NCT02454855|Melatonin|melatonin|mesh-list
110879903|NCT02454855|Antioxidants|antioxidants|mesh-ancestor
110879904|NCT02454855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110879905|NCT02454855|Protective Agents|protective agents|mesh-ancestor
110879906|NCT02454855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110879907|NCT02454855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110879908|NCT03343067|Norethindrone|norethindrone|mesh-list
110879909|NCT03343067|Norethindrone Acetate|norethindrone acetate|mesh-list
110879910|NCT03343067|Estradiol|estradiol|mesh-list
110879911|NCT03343067|Estrogens|estrogens|mesh-ancestor
110879912|NCT03343067|Hormones|hormones|mesh-ancestor
110879913|NCT03343067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110879914|NCT03343067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110879915|NCT03343067|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110879916|NCT03343067|Contraceptive Agents|contraceptive agents|mesh-ancestor
110879917|NCT03343067|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110879918|NCT03343067|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110879919|NCT03343067|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110879920|NCT03343067|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110879921|NCT03343067|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110879922|NCT05205525|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110879923|NCT05205525|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
110879924|NCT05205525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110879925|NCT05205525|Antitubercular Agents|antitubercular agents|mesh-ancestor
110879938|NCT04703205|Ivermectin|ivermectin|mesh-list
110879939|NCT04703205|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110879940|NCT04703205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110879941|NCT03706781|Cetylpyridinium|cetylpyridinium|mesh-list
110879942|NCT03706781|Benzydamine|benzydamine|mesh-list
110879943|NCT03706781|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110879944|NCT03706781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110879945|NCT03706781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110879946|NCT03706703|Carboplatin|carboplatin|mesh-list
110879947|NCT03706703|Docetaxel|docetaxel|mesh-list
110879948|NCT03706703|Pemetrexed|pemetrexed|mesh-list
110879949|NCT03706703|Endostar protein|endostar protein|mesh-list
110879950|NCT03706703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110879951|NCT03706703|Tubulin Modulators|tubulin modulators|mesh-ancestor
110879952|NCT03706703|Antimitotic Agents|antimitotic agents|mesh-ancestor
110879953|NCT03706703|Mitosis Modulators|mitosis modulators|mesh-ancestor
110879954|NCT03706703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110879955|NCT03706703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110879956|NCT03706703|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110879957|NCT03706703|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110879958|NCT03706703|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110879959|NCT03706703|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110879960|NCT03706703|Growth Substances|growth substances|mesh-ancestor
110879961|NCT03706703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110879962|NCT03706703|Growth Inhibitors|growth inhibitors|mesh-ancestor
110879963|NCT05642403|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110879964|NCT03706547|Cyclophosphamide|cyclophosphamide|mesh-list
110879965|NCT03706547|Fludarabine|fludarabine|mesh-list
110879966|NCT03706547|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110879967|NCT03706547|Immunologic Factors|immunologic factors|mesh-ancestor
110879968|NCT03706547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110879969|NCT03706547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110879970|NCT03706547|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110879971|NCT03706547|Alkylating Agents|alkylating agents|mesh-ancestor
110879972|NCT03706547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110879973|NCT03706547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110879974|NCT03706547|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110879975|NCT05682209|Octreotide|octreotide|mesh-list
110879976|NCT05682209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110879977|NCT05682209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110879979|NCT03708497|Misoprostol|misoprostol|mesh-list
110879980|NCT03708497|Tranexamic Acid|tranexamic acid|mesh-list
110879981|NCT03708497|Carbetocin|carbetocin|mesh-list
110879982|NCT03708497|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110879983|NCT03708497|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110879984|NCT03708497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110879985|NCT03708497|Hemostatics|hemostatics|mesh-ancestor
110879986|NCT03708497|Coagulants|coagulants|mesh-ancestor
110879987|NCT03708497|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110879988|NCT03708497|Abortifacient Agents|abortifacient agents|mesh-ancestor
110879989|NCT03708497|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110879997|NCT04608903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110879998|NCT04608903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110880000|NCT05681975|Immunoglobulins|immunoglobulins|mesh-list
110880001|NCT05681975|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110880002|NCT05681975|Immunoglobulin G|immunoglobulin g|mesh-list
110880003|NCT05681975|Immunologic Factors|immunologic factors|mesh-ancestor
110880004|NCT05681975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110880005|NCT05216744|Doxycycline|doxycycline|mesh-list
110880006|NCT05216744|Ceftriaxone|ceftriaxone|mesh-list
110880007|NCT05216744|Cefixime|cefixime|mesh-list
110880008|NCT05216744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110880009|NCT05216744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110880010|NCT05216744|Antimalarials|antimalarials|mesh-ancestor
110880011|NCT05216744|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110880012|NCT05216744|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110880013|NCT05681897|Minoxidil|minoxidil|mesh-list
110880014|NCT05681897|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110880015|NCT05681897|Vasodilator Agents|vasodilator agents|mesh-ancestor
110880016|NCT01345058|Lacosamide|lacosamide|mesh-list
110880017|NCT01345058|Levetiracetam|levetiracetam|mesh-list
110880018|NCT01345058|Anticonvulsants|anticonvulsants|mesh-ancestor
110880019|NCT01345058|Nootropic Agents|nootropic agents|mesh-ancestor
110880020|NCT01345058|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110880021|NCT01345058|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110880022|NCT01345058|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110880023|NCT01345058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110880024|NCT01345292|Listerine|listerine|mesh-list
110880025|NCT01345292|Fluorides|fluorides|mesh-list
110880026|NCT01345292|Sodium Fluoride|sodium fluoride|mesh-list
110880027|NCT01345292|Cariostatic Agents|cariostatic agents|mesh-ancestor
110880028|NCT01345292|Protective Agents|protective agents|mesh-ancestor
110880029|NCT01345292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110880030|NCT01345292|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110880031|NCT01345292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110880032|NCT03340961|Doxycycline|doxycycline|mesh-list
110880033|NCT03340961|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110880034|NCT03340961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110880035|NCT03340961|Antimalarials|antimalarials|mesh-ancestor
110880036|NCT03340961|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110880037|NCT03340961|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110880038|NCT03643874|Albuterol|albuterol|mesh-list
110880039|NCT03643874|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110880040|NCT03643874|Autonomic Agents|autonomic agents|mesh-ancestor
110880041|NCT03643874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110880042|NCT03643874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110880043|NCT03643874|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110880044|NCT03643874|Respiratory System Agents|respiratory system agents|mesh-ancestor
110880045|NCT03643874|Tocolytic Agents|tocolytic agents|mesh-ancestor
110880046|NCT03643874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110880047|NCT03643874|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110880048|NCT03643874|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110880049|NCT03643874|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110880050|NCT03643874|Adrenergic Agents|adrenergic agents|mesh-ancestor
110880051|NCT03643874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110880052|NCT03643874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110880053|NCT03254485|Praliciguat|praliciguat|mesh-list
110880054|NCT03254485|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
110880055|NCT03254485|Enzyme Activators|enzyme activators|mesh-ancestor
110880056|NCT03254485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110880057|NCT03254485|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110880058|NCT00769327|Imatinib Mesylate|imatinib mesylate|mesh-list
110880059|NCT00769327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110880060|NCT00769327|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110880072|NCT01068704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110880073|NCT01068704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110880074|NCT01068704|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110880075|NCT03339401|Brincidofovir|brincidofovir|mesh-list
110880076|NCT03339401|Antiviral Agents|antiviral agents|mesh-ancestor
110880077|NCT03339401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110880078|NCT05179525|Risperidone|risperidone|mesh-list
110880079|NCT05179525|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110880080|NCT05179525|Serotonin Agents|serotonin agents|mesh-ancestor
110880081|NCT05179525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110880082|NCT05179525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110880083|NCT05179525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110880084|NCT05179525|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110880085|NCT05179525|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110880086|NCT05179525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110880087|NCT05179525|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110880088|NCT05179525|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110880089|NCT05179525|Dopamine Agents|dopamine agents|mesh-ancestor
110880091|NCT03370289|Immunologic Factors|immunologic factors|mesh-ancestor
110880092|NCT03370289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110880093|NCT01344824|Bevacizumab|bevacizumab|mesh-list
110880094|NCT01344824|Carboplatin|carboplatin|mesh-list
110880095|NCT01344824|Pemetrexed|pemetrexed|mesh-list
110880096|NCT01344824|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110880097|NCT01344824|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110880098|NCT01344824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110880099|NCT01344824|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110880100|NCT01344824|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110880101|NCT01344824|Growth Substances|growth substances|mesh-ancestor
110880102|NCT01344824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110880103|NCT01344824|Growth Inhibitors|growth inhibitors|mesh-ancestor
110880104|NCT01344824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110880105|NCT01344824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110880106|NCT01344824|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110880107|NCT01344824|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110880108|NCT01344824|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110880109|NCT01311947|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110880110|NCT01311947|Antiviral Agents|antiviral agents|mesh-ancestor
110880111|NCT01311947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110880112|NCT05137496|Methylprednisolone|methylprednisolone|mesh-list
110880113|NCT05137496|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110880114|NCT05137496|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110880115|NCT05137496|Prednisolone|prednisolone|mesh-list
110880116|NCT05137496|Prednisolone acetate|prednisolone acetate|mesh-list
110880117|NCT05137496|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110880118|NCT05137496|Prednisolone phosphate|prednisolone phosphate|mesh-list
110880119|NCT05137496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110880120|NCT05137496|Antiemetics|antiemetics|mesh-ancestor
110880121|NCT05137496|Autonomic Agents|autonomic agents|mesh-ancestor
110880122|NCT05137496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110880123|NCT05137496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110880124|NCT05137496|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110880131|NCT05137496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110880132|NCT03339245|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110880133|NCT02959892|Amphetamine|amphetamine|mesh-list
110880134|NCT02959892|Naxagolide|naxagolide|mesh-list
110880135|NCT02959892|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110880136|NCT02959892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110880137|NCT02959892|Sympathomimetics|sympathomimetics|mesh-ancestor
110880138|NCT02959892|Autonomic Agents|autonomic agents|mesh-ancestor
110880139|NCT02959892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110880140|NCT02959892|Dopamine Agents|dopamine agents|mesh-ancestor
110880141|NCT02959892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110880142|NCT02959892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110880143|NCT02959892|Adrenergic Agents|adrenergic agents|mesh-ancestor
110880144|NCT02959892|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110880145|NCT02959892|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110880146|NCT02959892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110880147|NCT02959892|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110880148|NCT02959892|Dopamine Agonists|dopamine agonists|mesh-ancestor
110880149|NCT01661400|Thalidomide|thalidomide|mesh-list
110880150|NCT01661400|Cyclophosphamide|cyclophosphamide|mesh-list
110880151|NCT01661400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110880152|NCT01661400|Immunologic Factors|immunologic factors|mesh-ancestor
110880153|NCT01661400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110880154|NCT01661400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110880155|NCT01661400|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110880156|NCT01661400|Alkylating Agents|alkylating agents|mesh-ancestor
110920132|NCT02902965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110880157|NCT01661400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110880158|NCT01661400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110880159|NCT01661400|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110880160|NCT01661400|Leprostatic Agents|leprostatic agents|mesh-ancestor
110880161|NCT01661400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110880162|NCT01661400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110880163|NCT01661400|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110880164|NCT01661400|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110880165|NCT01661400|Growth Substances|growth substances|mesh-ancestor
110880166|NCT01661400|Growth Inhibitors|growth inhibitors|mesh-ancestor
110880167|NCT05158166|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110880168|NCT05158166|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110880169|NCT05158166|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110880170|NCT05158166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110880171|NCT05158166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110880172|NCT05158166|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110880173|NCT05158166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110880174|NCT05158166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110880175|NCT05158166|Cholinergic Agents|cholinergic agents|mesh-ancestor
110880176|NCT05158166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110880178|NCT03368807|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110880179|NCT03368807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110880180|NCT05179213|Azacitidine|azacitidine|mesh-list
110880181|NCT05179213|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110880182|NCT05179213|Antimetabolites|antimetabolites|mesh-ancestor
110880183|NCT05179213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110880184|NCT05179213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110197315|NCT00218569|Naltrexone|naltrexone|mesh-list
110880185|NCT05179213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110880186|NCT03338855|Dapagliflozin|dapagliflozin|mesh-list
110880187|NCT03338855|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110880188|NCT03338855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110880189|NCT03338855|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110880190|NCT03338855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110880191|NCT03367793|Metronidazole|metronidazole|mesh-list
110880206|NCT03367793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110880207|NCT03367793|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110880208|NCT03367793|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110880209|NCT03367793|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110880210|NCT05178745|Fluorouracil|fluorouracil|mesh-list
110880212|NCT05178745|Aflibercept|aflibercept|mesh-list
110880213|NCT05178745|Antimetabolites|antimetabolites|mesh-ancestor
110880214|NCT05178745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110880215|NCT05178745|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110880216|NCT05178745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110880217|NCT05178745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110880218|NCT05178745|Immunologic Factors|immunologic factors|mesh-ancestor
110880219|NCT05178745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110880220|NCT05178745|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110880221|NCT05178745|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110880222|NCT05178745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110880223|NCT05178745|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110880224|NCT05178745|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110880225|NCT05178745|Growth Substances|growth substances|mesh-ancestor
110880226|NCT05178745|Growth Inhibitors|growth inhibitors|mesh-ancestor
110880228|NCT05178511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110880229|NCT05178511|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110880230|NCT05178511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110880231|NCT05178511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110880232|NCT05571163|Sotorasib|sotorasib|mesh-list
110880233|NCT05571163|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110880234|NCT05571163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110880235|NCT05571163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110880236|NCT05571163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110880237|NCT03995641|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110880238|NCT03995641|Bupivacaine|bupivacaine|mesh-list
110880239|NCT03995641|Anesthetics, Local|anesthetics, local|mesh-ancestor
110880240|NCT03995641|Anesthetics|anesthetics|mesh-ancestor
110880241|NCT03995641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110880242|NCT03995641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110880243|NCT03995641|Sensory System Agents|sensory system agents|mesh-ancestor
110880244|NCT03995641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110880245|NCT03995641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110880246|NCT03995641|Glucocorticoids|glucocorticoids|mesh-ancestor
110880247|NCT03995641|Hormones|hormones|mesh-ancestor
110880248|NCT03995641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110880249|NCT03995641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110880250|NCT03995641|Immunologic Factors|immunologic factors|mesh-ancestor
110205006|NCT04731909|Cisplatin|cisplatin|mesh-list
110880254|NCT03532555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110880255|NCT03993457|Bupropion|bupropion|mesh-list
110880256|NCT03993457|Escitalopram|escitalopram|mesh-list
110880257|NCT03993457|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110880258|NCT03993457|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110880259|NCT03993457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110880260|NCT03993457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110880261|NCT03993457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110880262|NCT03993457|Serotonin Agents|serotonin agents|mesh-ancestor
110880263|NCT03993457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110880264|NCT03993457|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110880265|NCT03993457|Antidepressive Agents|antidepressive agents|mesh-ancestor
110880266|NCT03993457|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110880267|NCT03993457|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110880268|NCT03993457|Dopamine Agents|dopamine agents|mesh-ancestor
110880269|NCT03993457|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110880270|NCT03993457|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110880271|NCT03993457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110880272|NCT04677439|Flumatinib|flumatinib|mesh-list
110880273|NCT04677439|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110880274|NCT04677439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110880275|NCT04677439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110880276|NCT02777424|Thrombin|thrombin|mesh-list
110597820|NCT01718873|Antidotes|antidotes|mesh-ancestor
110880277|NCT02777424|Hemostatics|hemostatics|mesh-ancestor
110880278|NCT02777424|Coagulants|coagulants|mesh-ancestor
110880279|NCT01347073|Glycerol|glycerol|mesh-list
110880280|NCT01347073|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
110880281|NCT01347073|Protective Agents|protective agents|mesh-ancestor
110880282|NCT01347073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110880283|NCT01315236|Amikacin|amikacin|mesh-list
110880284|NCT01315236|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110880285|NCT01315236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110880286|NCT03730051|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
110880287|NCT03730051|Chelating Agents|chelating agents|mesh-ancestor
110880288|NCT03730051|Sequestering Agents|sequestering agents|mesh-ancestor
110880289|NCT03730051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110880290|NCT03364049|Pembrolizumab|pembrolizumab|mesh-list
110920158|NCT02134626|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110880291|NCT03364049|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110880292|NCT03364049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110880293|NCT03364049|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110880294|NCT03364049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110880295|NCT05343078|Dapagliflozin|dapagliflozin|mesh-list
110880296|NCT05343078|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110880297|NCT05343078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110880298|NCT05343078|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110880299|NCT05343078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110880300|NCT03710369|Sildenafil Citrate|sildenafil citrate|mesh-list
110880301|NCT03710369|Vasodilator Agents|vasodilator agents|mesh-ancestor
110880302|NCT03710369|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110880303|NCT03710369|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110880304|NCT03710369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110880305|NCT03710369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110880306|NCT03710369|Urological Agents|urological agents|mesh-ancestor
110880307|NCT03706157|Doxorubicin|doxorubicin|mesh-list
110880308|NCT03706157|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110880309|NCT03706157|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110880310|NCT03706157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110880311|NCT03706157|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110880312|NCT03706157|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110880313|NCT03706157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110880314|NCT03706157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110880315|NCT03707795|Betamethasone|betamethasone|mesh-list
110880316|NCT03707795|Betamethasone Valerate|betamethasone valerate|mesh-list
110880317|NCT03707795|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
110880318|NCT03707795|Betamethasone benzoate|betamethasone benzoate|mesh-list
110880319|NCT03707795|Betamethasone acetate|betamethasone acetate|mesh-list
110880320|NCT03707795|Betamethasone acetate phosphate|betamethasone acetate phosphate|mesh-list
110880329|NCT03707795|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110880330|NCT03707795|Autonomic Agents|autonomic agents|mesh-ancestor
110880331|NCT03707795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110880332|NCT03042312|177Lu-PSMA-617|177lu-psma-617|mesh-list
110880333|NCT03042312|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110880334|NCT03042312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110880335|NCT05171231|Hemostatics|hemostatics|mesh-list
110880336|NCT05171231|Coagulants|coagulants|mesh-ancestor
110880337|NCT05692986|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110880338|NCT05692986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110880339|NCT03360071|Immunomodulating Agents|immunomodulating agents|mesh-list
110880340|NCT03360071|Immunologic Factors|immunologic factors|mesh-list
110880341|NCT03360071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110880342|NCT05058924|Aspirin|aspirin|mesh-list
110880343|NCT05058924|Heparin|heparin|mesh-list
110880344|NCT05058924|Calcium heparin|calcium heparin|mesh-list
110880345|NCT05058924|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
110880346|NCT05058924|Tinzaparin|tinzaparin|mesh-list
110880347|NCT05058924|Dalteparin|dalteparin|mesh-list
110880348|NCT05058924|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110880349|NCT05058924|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110597886|NCT00802646|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110880350|NCT05058924|Analgesics|analgesics|mesh-ancestor
110880351|NCT05058924|Sensory System Agents|sensory system agents|mesh-ancestor
110880352|NCT05058924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110880353|NCT05058924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110880354|NCT05058924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110880355|NCT05058924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110880356|NCT05058924|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110880357|NCT05058924|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110880358|NCT05058924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110880359|NCT05058924|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110880360|NCT05058924|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110880361|NCT05058924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110880362|NCT05058924|Antipyretics|antipyretics|mesh-ancestor
110880363|NCT05058924|Anticoagulants|anticoagulants|mesh-ancestor
110880364|NCT05681429|Acetaminophen|acetaminophen|mesh-list
110880365|NCT05681429|Parecoxib|parecoxib|mesh-list
110880366|NCT05681429|Lidocaine|lidocaine|mesh-list
110880367|NCT05681429|Dexmedetomidine|dexmedetomidine|mesh-list
110880368|NCT05681429|Sevoflurane|sevoflurane|mesh-list
110880369|NCT05681429|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110880370|NCT05681429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110880371|NCT05681429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110880372|NCT05681429|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110880373|NCT05681429|Analgesics|analgesics|mesh-ancestor
110880374|NCT05681429|Sensory System Agents|sensory system agents|mesh-ancestor
110880375|NCT05681429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110880376|NCT05681429|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110880377|NCT05681429|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110880378|NCT05681429|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110880379|NCT05681429|Adrenergic Agents|adrenergic agents|mesh-ancestor
110880380|NCT05681429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110880381|NCT05681429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110880382|NCT05681429|Antipyretics|antipyretics|mesh-ancestor
110880383|NCT05681429|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110880384|NCT05681429|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110880385|NCT05681429|Anesthetics, General|anesthetics, general|mesh-ancestor
110880386|NCT05681429|Anesthetics|anesthetics|mesh-ancestor
110880387|NCT05681429|Anesthetics, Local|anesthetics, local|mesh-ancestor
110880406|NCT02949011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110880407|NCT02949011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110880408|NCT02949011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110880409|NCT03705533|Telmisartan|telmisartan|mesh-list
110880410|NCT03705533|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110880411|NCT03705533|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110880412|NCT03705533|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110880413|NCT03705533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110880414|NCT03357731|Nitroglycerin|nitroglycerin|mesh-list
110880415|NCT03357731|Vasodilator Agents|vasodilator agents|mesh-ancestor
110880416|NCT03357341|Albuterol|albuterol|mesh-list
110880417|NCT03357341|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110880418|NCT03357341|Autonomic Agents|autonomic agents|mesh-ancestor
110880419|NCT03357341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110880420|NCT03357341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110880421|NCT03357341|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110880422|NCT03357341|Respiratory System Agents|respiratory system agents|mesh-ancestor
110880423|NCT03357341|Tocolytic Agents|tocolytic agents|mesh-ancestor
110880424|NCT03357341|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110880425|NCT03357341|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110880426|NCT03357341|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110880427|NCT03357341|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110880428|NCT03357341|Adrenergic Agents|adrenergic agents|mesh-ancestor
110880429|NCT03357341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110880430|NCT03357341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110880431|NCT05177237|Endostar protein|endostar protein|mesh-list
110880432|NCT05177237|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110880433|NCT05177237|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110880434|NCT05177237|Growth Substances|growth substances|mesh-ancestor
110880435|NCT05177237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110880436|NCT05177237|Growth Inhibitors|growth inhibitors|mesh-ancestor
110880437|NCT05177237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110880439|NCT05176925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110880440|NCT05176925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110880441|NCT05175131|Mebeverine|mebeverine|mesh-list
110880442|NCT05175131|Simethicone|simethicone|mesh-list
110880443|NCT05175131|Alverine|alverine|mesh-list
110880444|NCT05175131|Antifoaming Agents|antifoaming agents|mesh-ancestor
110880445|NCT05175131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110880464|NCT01312337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110880465|NCT01312337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110880466|NCT05229653|Ketamine|ketamine|mesh-list
110880467|NCT05229653|Analgesics|analgesics|mesh-ancestor
110880468|NCT05229653|Sensory System Agents|sensory system agents|mesh-ancestor
110880469|NCT05229653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110880470|NCT05229653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110880471|NCT05229653|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110880472|NCT05229653|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110880473|NCT05229653|Anesthetics, General|anesthetics, general|mesh-ancestor
110880475|NCT05229653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110880476|NCT05229653|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110880477|NCT05229653|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110880478|NCT05229653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110880479|NCT05229653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110880480|NCT05551949|Estradiol|estradiol|mesh-list
110880481|NCT05551949|Estrogens|estrogens|mesh-ancestor
110880482|NCT05551949|Hormones|hormones|mesh-ancestor
110880483|NCT05551949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110880484|NCT05551949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110880485|NCT05541497|Varenicline|varenicline|mesh-list
110880486|NCT05541497|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110880487|NCT05541497|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110880488|NCT05541497|Cholinergic Agents|cholinergic agents|mesh-ancestor
110880489|NCT05541497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110880490|NCT05541497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110880491|NCT05541497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110880492|NCT05283954|Ivermectin|ivermectin|mesh-list
110880493|NCT05283954|Albendazole|albendazole|mesh-list
110880494|NCT05283954|Prednisolone|prednisolone|mesh-list
110880495|NCT05283954|Fluoxetine|fluoxetine|mesh-list
110880496|NCT05283954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110880497|NCT05283954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110880498|NCT05283954|Glucocorticoids|glucocorticoids|mesh-ancestor
110880499|NCT05283954|Hormones|hormones|mesh-ancestor
110880500|NCT05283954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110880501|NCT05283954|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110880502|NCT05283954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110880518|NCT05283954|Anticestodal Agents|anticestodal agents|mesh-ancestor
110880519|NCT05283954|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110880520|NCT05283954|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110880521|NCT05283954|Tubulin Modulators|tubulin modulators|mesh-ancestor
110880522|NCT05283954|Antimitotic Agents|antimitotic agents|mesh-ancestor
110880523|NCT05283954|Mitosis Modulators|mitosis modulators|mesh-ancestor
110880524|NCT01312415|Morphine|morphine|mesh-list
110880525|NCT01312415|Levobupivacaine|levobupivacaine|mesh-list
110880526|NCT01312415|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110880527|NCT01312415|Narcotics|narcotics|mesh-ancestor
110880528|NCT01312415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110880529|NCT01312415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110880530|NCT01312415|Analgesics|analgesics|mesh-ancestor
110880531|NCT01312415|Sensory System Agents|sensory system agents|mesh-ancestor
110880532|NCT01312415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110880533|NCT01312415|Anesthetics, Local|anesthetics, local|mesh-ancestor
110880534|NCT01312415|Anesthetics|anesthetics|mesh-ancestor
110880535|NCT03036852|Sofosbuvir|sofosbuvir|mesh-list
110880536|NCT03036852|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
110880537|NCT03036852|Velpatasvir|velpatasvir|mesh-list
110880538|NCT03036852|Antiviral Agents|antiviral agents|mesh-ancestor
110880539|NCT03036852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110880540|NCT01312493|Panitumumab|panitumumab|mesh-list
110880541|NCT01312493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110880542|NCT01312493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110880543|NCT04313244|Vaccines|vaccines|mesh-list
110880544|NCT04313244|Immunologic Factors|immunologic factors|mesh-ancestor
110880545|NCT04313244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110880546|NCT05309694|Copper|copper|mesh-list
110880547|NCT05309694|Contraceptive Agents|contraceptive agents|mesh-list
110880548|NCT05309694|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110880549|NCT05309694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110880550|NCT05309694|Trace Elements|trace elements|mesh-ancestor
110880551|NCT05309694|Micronutrients|micronutrients|mesh-ancestor
110880552|NCT05268510|Pembrolizumab|pembrolizumab|mesh-list
110880553|NCT05268510|Olaparib|olaparib|mesh-list
110880554|NCT05268510|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110880555|NCT05268510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110880556|NCT05268510|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110880557|NCT05268510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110880558|NCT05268510|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110880559|NCT05268510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110880560|NCT05438303|Celecoxib|celecoxib|mesh-list
110880561|NCT05438303|Midazolam|midazolam|mesh-list
110880562|NCT05438303|Omeprazole|omeprazole|mesh-list
110880567|NCT05438303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110880569|NCT05438303|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110880570|NCT05438303|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110880571|NCT05438303|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110880572|NCT05438303|Anesthetics, General|anesthetics, general|mesh-ancestor
110880573|NCT05438303|Anesthetics|anesthetics|mesh-ancestor
110880574|NCT05438303|GABA Modulators|gaba modulators|mesh-ancestor
110880575|NCT05438303|GABA Agents|gaba agents|mesh-ancestor
110598110|NCT00712140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110880576|NCT05438303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110880577|NCT05438303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110880578|NCT05438303|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110880579|NCT05438303|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110880580|NCT05438303|Analgesics|analgesics|mesh-ancestor
110880581|NCT05438303|Sensory System Agents|sensory system agents|mesh-ancestor
110880582|NCT05438303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110880583|NCT05438303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110880584|NCT05438303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110880585|NCT05438303|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110880586|NCT05438303|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110880587|NCT05438303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110880588|NCT05438303|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110880589|NCT05438303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110880590|NCT05438303|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110880591|NCT05438303|Antithrombins|antithrombins|mesh-ancestor
110880592|NCT05438303|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110880593|NCT05438303|Protease Inhibitors|protease inhibitors|mesh-ancestor
110880594|NCT05438303|Anticoagulants|anticoagulants|mesh-ancestor
110880595|NCT05432141|Vaccines|vaccines|mesh-list
110880596|NCT05432141|Immunologic Factors|immunologic factors|mesh-ancestor
110880597|NCT05432141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110880598|NCT04956809|Dapagliflozin|dapagliflozin|mesh-list
110880599|NCT04956809|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110880600|NCT04956809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110880601|NCT04956809|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110880602|NCT04956809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110880603|NCT04735913|Abiraterone Acetate|abiraterone acetate|mesh-list
110880604|NCT04735913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110880605|NCT04735913|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110880606|NCT04735913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110880607|NCT04735913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110880608|NCT04735913|Hormone Antagonists|hormone antagonists|mesh-ancestor
110880609|NCT04735913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110880610|NCT04735913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110880611|NCT04735913|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110880612|NCT04906889|Lidocaine|lidocaine|mesh-list
110880613|NCT04906889|Dexmedetomidine|dexmedetomidine|mesh-list
110880614|NCT04906889|Remifentanil|remifentanil|mesh-list
110880615|NCT04906889|Anesthetics, Local|anesthetics, local|mesh-ancestor
110880616|NCT04906889|Anesthetics|anesthetics|mesh-ancestor
110880617|NCT04906889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110880618|NCT04906889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110880619|NCT04906889|Sensory System Agents|sensory system agents|mesh-ancestor
110880620|NCT04906889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110880621|NCT04906889|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110880622|NCT04906889|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110880623|NCT04906889|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110880624|NCT04906889|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110197478|NCT00042536|Naltrexone|naltrexone|mesh-list
110880625|NCT04906889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110880626|NCT04906889|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110880627|NCT04906889|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110880629|NCT04906889|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110880630|NCT04906889|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110880641|NCT02948777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110880642|NCT02948777|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110880644|NCT02948777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110880645|NCT02948777|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110880646|NCT04868747|Lidocaine|lidocaine|mesh-list
110880647|NCT04868747|Anesthetics, Local|anesthetics, local|mesh-ancestor
110880648|NCT04868747|Anesthetics|anesthetics|mesh-ancestor
110880649|NCT04868747|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110880650|NCT04868747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110880651|NCT04868747|Sensory System Agents|sensory system agents|mesh-ancestor
110880652|NCT04868747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110880653|NCT04868747|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110880654|NCT04868747|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110880655|NCT04868747|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110880656|NCT04868747|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110880657|NCT04868747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110880659|NCT05330273|Lumefantrine|lumefantrine|mesh-list
110880660|NCT05330273|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110880661|NCT05330273|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110880662|NCT05330273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110880663|NCT05330273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110880664|NCT05330273|Antiviral Agents|antiviral agents|mesh-ancestor
110880665|NCT05330273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110880666|NCT05330273|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110880667|NCT05330273|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110880668|NCT05330273|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110880669|NCT05330273|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110880670|NCT05330273|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110880671|NCT05330273|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110880672|NCT05330273|Antimalarials|antimalarials|mesh-ancestor
110880673|NCT05330273|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110880674|NCT05330273|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110880675|NCT05329259|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110880676|NCT05329259|Immunologic Factors|immunologic factors|mesh-ancestor
110880677|NCT05329259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110880678|NCT04533737|Brodalumab|brodalumab|mesh-list
110880679|NCT04533737|Dermatologic Agents|dermatologic agents|mesh-ancestor
110880680|NCT05254847|Capecitabine|capecitabine|mesh-list
110880681|NCT05254847|Lenvatinib|lenvatinib|mesh-list
110880682|NCT05254847|Tislelizumab|tislelizumab|mesh-list
110880683|NCT05254847|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110880684|NCT05254847|Antimetabolites|antimetabolites|mesh-ancestor
110880685|NCT05254847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110880686|NCT05254847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110880687|NCT05254847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110880688|NCT05254847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110880689|NCT05254847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110880690|NCT05249699|Isoniazid|isoniazid|mesh-list
110880691|NCT05249699|Antitubercular Agents|antitubercular agents|mesh-list
110880692|NCT05249699|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110880693|NCT05249699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110880694|NCT05249699|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
110880695|NCT05249699|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110880696|NCT05249699|Antimetabolites|antimetabolites|mesh-ancestor
110880719|NCT04695977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110880720|NCT04695977|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110880721|NCT04695977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110880722|NCT03093155|Bevacizumab|bevacizumab|mesh-list
110598262|NCT00712686|Dopamine Agents|dopamine agents|mesh-ancestor
110880723|NCT03093155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110880724|NCT03093155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110880725|NCT03093155|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110880726|NCT03093155|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110880727|NCT03093155|Growth Substances|growth substances|mesh-ancestor
110880728|NCT03093155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110880729|NCT03093155|Growth Inhibitors|growth inhibitors|mesh-ancestor
110880730|NCT03324581|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
110880731|NCT03324581|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110880732|NCT03324581|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110880733|NCT03324581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110880734|NCT03324581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110880735|NCT03324581|Adrenergic Agents|adrenergic agents|mesh-ancestor
110880736|NCT03324581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110880737|NCT03324581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110880738|NCT03629873|Cytarabine|cytarabine|mesh-list
110880739|NCT03629873|Cyclophosphamide|cyclophosphamide|mesh-list
110880740|NCT03629873|Carmustine|carmustine|mesh-list
110880741|NCT03629873|Etoposide|etoposide|mesh-list
110880742|NCT03629873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110880743|NCT03629873|Immunologic Factors|immunologic factors|mesh-ancestor
110880744|NCT03629873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110880745|NCT03629873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110880746|NCT03629873|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110880747|NCT03629873|Alkylating Agents|alkylating agents|mesh-ancestor
110205115|NCT00169156|Hormones|hormones|mesh-ancestor
110880773|NCT04981145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110880774|NCT04981145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110880775|NCT04981145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110880776|NCT04258631|Hydromorphone|hydromorphone|mesh-list
110880777|NCT04258631|Bupivacaine|bupivacaine|mesh-list
110880778|NCT04258631|Anesthetics, Local|anesthetics, local|mesh-ancestor
110880779|NCT04258631|Anesthetics|anesthetics|mesh-ancestor
110880780|NCT04258631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110880781|NCT04258631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110880782|NCT04258631|Sensory System Agents|sensory system agents|mesh-ancestor
110880783|NCT04258631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110880784|NCT04258631|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110880785|NCT04258631|Narcotics|narcotics|mesh-ancestor
110880786|NCT04258631|Analgesics|analgesics|mesh-ancestor
110880787|NCT02931695|Hormones|hormones|mesh-list
110880788|NCT02931695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110880789|NCT02931695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110880790|NCT03638063|Adenosine|adenosine|mesh-list
110880791|NCT03638063|Capsaicin|capsaicin|mesh-list
110880792|NCT03638063|Antipruritics|antipruritics|mesh-ancestor
110880793|NCT03638063|Dermatologic Agents|dermatologic agents|mesh-ancestor
110880794|NCT03638063|Sensory System Agents|sensory system agents|mesh-ancestor
110880795|NCT03638063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110880796|NCT03638063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110880804|NCT03638063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110880805|NCT04869371|Prednisone|prednisone|mesh-list
110880806|NCT04869371|Docetaxel|docetaxel|mesh-list
110880807|NCT04869371|Triptorelin Pamoate|triptorelin pamoate|mesh-list
110880808|NCT04869371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110880809|NCT04869371|Tubulin Modulators|tubulin modulators|mesh-ancestor
110880810|NCT04869371|Antimitotic Agents|antimitotic agents|mesh-ancestor
110880811|NCT04869371|Mitosis Modulators|mitosis modulators|mesh-ancestor
110880812|NCT04869371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110880813|NCT04869371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110880814|NCT04869371|Glucocorticoids|glucocorticoids|mesh-ancestor
110880815|NCT04869371|Hormones|hormones|mesh-ancestor
110880816|NCT04869371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110880817|NCT04869371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110880818|NCT04869371|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110880819|NCT04869371|Luteolytic Agents|luteolytic agents|mesh-ancestor
110880820|NCT04869371|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110880821|NCT04869371|Contraceptive Agents|contraceptive agents|mesh-ancestor
110880822|NCT04869371|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110880823|NCT04869371|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110880824|NCT02710331|Ethanol|ethanol|mesh-list
110880825|NCT02710331|Dronabinol|dronabinol|mesh-list
110880826|NCT02710331|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110880827|NCT02710331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110880828|NCT02710331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110880829|NCT02710331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110880830|NCT02710331|Hallucinogens|hallucinogens|mesh-ancestor
110880831|NCT02710331|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110880832|NCT02710331|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110880833|NCT02710331|Analgesics|analgesics|mesh-ancestor
110880834|NCT02710331|Sensory System Agents|sensory system agents|mesh-ancestor
110880835|NCT02710331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110880836|NCT02710331|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
110880837|NCT02710331|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110880838|NCT02710331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110880839|NCT02710331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110880840|NCT02710331|Hormones|hormones|mesh-ancestor
110880841|NCT02710331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110880842|NCT03320057|Mifepristone|mifepristone|mesh-list
110880843|NCT03320057|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
110880844|NCT03320057|Abortifacient Agents|abortifacient agents|mesh-ancestor
110880845|NCT03320057|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110880846|NCT03320057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110880847|NCT03320057|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110880848|NCT03320057|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110880849|NCT03320057|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110880850|NCT03320057|Contraceptive Agents|contraceptive agents|mesh-ancestor
110880851|NCT03320057|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
110880852|NCT03320057|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
110880853|NCT03320057|Hormone Antagonists|hormone antagonists|mesh-ancestor
110880854|NCT03320057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110880855|NCT03320057|Luteolytic Agents|luteolytic agents|mesh-ancestor
110880856|NCT03320057|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110880857|NCT03320057|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
110880858|NCT04741139|Acetaminophen|acetaminophen|mesh-list
110880859|NCT04741139|Diphenhydramine|diphenhydramine|mesh-list
110880860|NCT04741139|Promethazine|promethazine|mesh-list
110880861|NCT04741139|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110880862|NCT04741139|Analgesics|analgesics|mesh-ancestor
110880863|NCT04741139|Sensory System Agents|sensory system agents|mesh-ancestor
110880871|NCT04741139|Anesthetics|anesthetics|mesh-ancestor
110880872|NCT04741139|Antiemetics|antiemetics|mesh-ancestor
110880873|NCT04741139|Autonomic Agents|autonomic agents|mesh-ancestor
110880874|NCT04741139|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110880875|NCT04741139|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110880876|NCT04741139|Histamine Antagonists|histamine antagonists|mesh-ancestor
110880877|NCT04741139|Histamine Agents|histamine agents|mesh-ancestor
110880878|NCT04741139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110880879|NCT04741139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110880880|NCT04741139|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110880881|NCT04741139|Antipruritics|antipruritics|mesh-ancestor
110880882|NCT04741139|Dermatologic Agents|dermatologic agents|mesh-ancestor
110880883|NCT04853147|Dexamethasone|dexamethasone|mesh-list
110880884|NCT04853147|Dexamethasone acetate|dexamethasone acetate|mesh-list
110880885|NCT04853147|Palonosetron|palonosetron|mesh-list
110880886|NCT04853147|Fosaprepitant|fosaprepitant|mesh-list
110880888|NCT04853147|BB 1101|bb 1101|mesh-list
110880889|NCT04853147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110880890|NCT04853147|Antiemetics|antiemetics|mesh-ancestor
110880891|NCT04853147|Autonomic Agents|autonomic agents|mesh-ancestor
110880892|NCT04853147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110880893|NCT04853147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110880894|NCT04853147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110880895|NCT04853147|Glucocorticoids|glucocorticoids|mesh-ancestor
110880896|NCT04853147|Hormones|hormones|mesh-ancestor
110880897|NCT04853147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110197574|NCT00073593|Heparin Antagonists|heparin antagonists|mesh-ancestor
110880898|NCT04853147|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110880899|NCT04853147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110880900|NCT04853147|Protease Inhibitors|protease inhibitors|mesh-ancestor
110880901|NCT04853147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110880902|NCT04853147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110880903|NCT04853147|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110880904|NCT04853147|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110880905|NCT04853147|Serotonin Agents|serotonin agents|mesh-ancestor
110880906|NCT04853147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110880907|NCT04853147|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110880908|NCT03473561|Racecadotril|racecadotril|mesh-list
110880909|NCT03473561|Antidiarrheals|antidiarrheals|mesh-ancestor
110880910|NCT03473561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110880911|NCT03473561|Protease Inhibitors|protease inhibitors|mesh-ancestor
110880912|NCT03473561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110880913|NCT03473561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110880914|NCT04689347|Leucovorin|leucovorin|mesh-list
110880915|NCT04689347|Bevacizumab|bevacizumab|mesh-list
110880916|NCT04689347|Fluorouracil|fluorouracil|mesh-list
110880917|NCT04689347|Irinotecan|irinotecan|mesh-list
110880918|NCT04689347|Temozolomide|temozolomide|mesh-list
110880919|NCT04689347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110880920|NCT04689347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110880921|NCT04689347|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110880922|NCT04689347|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110880923|NCT04689347|Growth Substances|growth substances|mesh-ancestor
110880924|NCT04689347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110880925|NCT04689347|Growth Inhibitors|growth inhibitors|mesh-ancestor
110880926|NCT04689347|Antimetabolites|antimetabolites|mesh-ancestor
110880927|NCT04689347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110880928|NCT04689347|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110880929|NCT04689347|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110880930|NCT04689347|Immunologic Factors|immunologic factors|mesh-ancestor
110880959|NCT05276687|Povidone-Iodine|povidone-iodine|mesh-list
110880960|NCT05276687|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110880961|NCT05276687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110880962|NCT05276687|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110880964|NCT03036150|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110880965|NCT03036150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110880966|NCT03036150|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110880967|NCT03036150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110880968|NCT03332771|Metformin|metformin|mesh-list
110880969|NCT03332771|Glimepiride|glimepiride|mesh-list
110880970|NCT03332771|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
110880971|NCT03332771|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110880972|NCT03332771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110880973|NCT03332771|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110880974|NCT03332771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110880975|NCT03332771|Immunologic Factors|immunologic factors|mesh-ancestor
110880976|NCT03332771|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110880977|NCT03332771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110880990|NCT04108104|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110880991|NCT04108104|Adrenergic Agents|adrenergic agents|mesh-ancestor
110880992|NCT04108104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110880993|NCT04108104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110880994|NCT04108104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110880995|NCT04108104|Antipruritics|antipruritics|mesh-ancestor
110880996|NCT04108104|Dermatologic Agents|dermatologic agents|mesh-ancestor
110880997|NCT04108104|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110880998|NCT04108104|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110880999|NCT04108104|Histamine Antagonists|histamine antagonists|mesh-ancestor
110881000|NCT04108104|Histamine Agents|histamine agents|mesh-ancestor
110881001|NCT04108104|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110881002|NCT04108104|Serotonin Agents|serotonin agents|mesh-ancestor
110881003|NCT04108104|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110881004|NCT05304468|Cisplatin|cisplatin|mesh-list
110881005|NCT05304468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110881006|NCT04731480|Propofol|propofol|mesh-list
110881007|NCT04731480|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110881008|NCT04731480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110881009|NCT04731480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110881010|NCT04731480|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110881011|NCT04731480|Anesthetics, General|anesthetics, general|mesh-ancestor
110881012|NCT04731480|Anesthetics|anesthetics|mesh-ancestor
110881013|NCT03039192|Esketamine|esketamine|mesh-list
110881014|NCT03039192|Antidepressive Agents|antidepressive agents|mesh-ancestor
110881015|NCT03039192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110881016|NCT03698279|Vaccines|vaccines|mesh-list
110881017|NCT03698279|Immunologic Factors|immunologic factors|mesh-ancestor
110881018|NCT03698279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110881019|NCT03038880|Ranibizumab|ranibizumab|mesh-list
110881020|NCT03038880|Faricimab|faricimab|mesh-list
110881021|NCT03038880|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110881022|NCT03038880|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110881023|NCT03038880|Growth Substances|growth substances|mesh-ancestor
110881024|NCT03038880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110881025|NCT03038880|Growth Inhibitors|growth inhibitors|mesh-ancestor
110881026|NCT03038880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110881027|NCT03035916|Anesthetics|anesthetics|mesh-list
110881028|NCT03035916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110881029|NCT03035916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110881030|NCT01702571|Trastuzumab|trastuzumab|mesh-list
110881031|NCT01702571|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
110881032|NCT01702571|Maytansine|maytansine|mesh-list
110881033|NCT01702571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110881034|NCT01702571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110881035|NCT01702571|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110881036|NCT01702571|Tubulin Modulators|tubulin modulators|mesh-ancestor
110881037|NCT01702571|Antimitotic Agents|antimitotic agents|mesh-ancestor
110881038|NCT01702571|Mitosis Modulators|mitosis modulators|mesh-ancestor
110881039|NCT01702571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110881040|NCT01702571|Immunotoxins|immunotoxins|mesh-ancestor
110881041|NCT01702571|Immunoconjugates|immunoconjugates|mesh-ancestor
110205191|NCT00407680|Valsartan|valsartan|mesh-list
110197623|NCT00220987|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110881055|NCT03231709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110881057|NCT03231709|Hormones|hormones|mesh-ancestor
110881058|NCT03231709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110881059|NCT03231709|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110881060|NCT03231709|Protease Inhibitors|protease inhibitors|mesh-ancestor
110881061|NCT03231709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110881062|NCT03231709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110881063|NCT01220531|Cyclosporine|cyclosporine|mesh-list
110881064|NCT01220531|Mycophenolic Acid|mycophenolic acid|mesh-list
110881065|NCT01220531|Methylprednisolone|methylprednisolone|mesh-list
110881066|NCT01220531|Prednisolone|prednisolone|mesh-list
110881067|NCT01220531|Tacrolimus|tacrolimus|mesh-list
110881068|NCT01220531|Cyclosporins|cyclosporins|mesh-list
110881069|NCT01220531|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110881070|NCT01220531|Thymoglobulin|thymoglobulin|mesh-list
110881071|NCT01220531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110881072|NCT01220531|Immunologic Factors|immunologic factors|mesh-ancestor
110881073|NCT01220531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110881074|NCT01220531|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110881075|NCT01220531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110881076|NCT01220531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110881077|NCT01220531|Antifungal Agents|antifungal agents|mesh-ancestor
110881078|NCT01220531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110881079|NCT01220531|Dermatologic Agents|dermatologic agents|mesh-ancestor
110881080|NCT01220531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110881081|NCT01220531|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110881082|NCT01220531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110881083|NCT01220531|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110881084|NCT01220531|Antitubercular Agents|antitubercular agents|mesh-ancestor
110881085|NCT01220531|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110881086|NCT01220531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110881087|NCT01220531|Antiemetics|antiemetics|mesh-ancestor
110881088|NCT01220531|Autonomic Agents|autonomic agents|mesh-ancestor
110881089|NCT01220531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110881090|NCT01220531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110881091|NCT01220531|Glucocorticoids|glucocorticoids|mesh-ancestor
110881092|NCT01220531|Hormones|hormones|mesh-ancestor
110881093|NCT01220531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110881094|NCT01220531|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110881095|NCT01220531|Protective Agents|protective agents|mesh-ancestor
110881096|NCT01220531|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110881097|NCT05255471|Olaparib|olaparib|mesh-list
110881098|NCT05255471|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110881099|NCT05255471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110920274|NCT05285397|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110881100|NCT05255471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110881101|NCT05255471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110881102|NCT03241927|Pembrolizumab|pembrolizumab|mesh-list
110881103|NCT03241927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110881117|NCT00360425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110881118|NCT00360425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110881119|NCT00360425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110881120|NCT00360425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110881121|NCT00360425|Hematinics|hematinics|mesh-ancestor
110881122|NCT00360425|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
110881123|NCT00360425|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110881124|NCT02938585|Factor VIII|factor viii|mesh-list
110881125|NCT02938585|Coagulants|coagulants|mesh-ancestor
110881126|NCT00233597|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
110881127|NCT00233597|Hematinics|hematinics|mesh-ancestor
110881128|NCT00233597|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
110881129|NCT00233597|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110881130|NCT04282811|Venetoclax|venetoclax|mesh-list
110881131|NCT04282811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110881132|NCT03229759|Octenidine|octenidine|mesh-list
110881133|NCT03229759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110881134|NCT03229759|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110881135|NCT03476681|Pembrolizumab|pembrolizumab|mesh-list
110881136|NCT03476681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110881137|NCT03476681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110881138|NCT03476681|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110881139|NCT03476681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110881140|NCT03620825|Indomethacin|indomethacin|mesh-list
110881141|NCT03620825|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110881142|NCT03620825|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110881143|NCT03620825|Analgesics|analgesics|mesh-ancestor
110881144|NCT03620825|Sensory System Agents|sensory system agents|mesh-ancestor
110881145|NCT03620825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110881146|NCT03620825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110881147|NCT03620825|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110881148|NCT03620825|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110881149|NCT03620825|Gout Suppressants|gout suppressants|mesh-ancestor
110881150|NCT03620825|Tocolytic Agents|tocolytic agents|mesh-ancestor
110881151|NCT03620825|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110881152|NCT03620825|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110881153|NCT03620825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110881154|NCT03620825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110881155|NCT03527537|Insulin|insulin|mesh-list
110881156|NCT03527537|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110881157|NCT03527537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110881158|NCT01496118|Panobinostat|panobinostat|mesh-list
110881159|NCT01496118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110881160|NCT01496118|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110881161|NCT01496118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110881162|NCT01496118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110881163|NCT03329573|Paroxetine|paroxetine|mesh-list
110881164|NCT03329573|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110881165|NCT03329573|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110881177|NCT00492349|Varenicline|varenicline|mesh-list
110881178|NCT00492349|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110881179|NCT00492349|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110881180|NCT00492349|Cholinergic Agents|cholinergic agents|mesh-ancestor
110881181|NCT00492349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110881182|NCT00492349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110881183|NCT00492349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110881184|NCT03924193|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
110881185|NCT03924193|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110881186|NCT03924193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110920298|NCT03648333|Niacin|niacin|mesh-list
110881187|NCT03924193|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110881188|NCT03924193|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110881189|NCT03924193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110881190|NCT03924193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110881191|NCT03924193|Dopamine Agents|dopamine agents|mesh-ancestor
110881192|NCT03924193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110881193|NCT03308825|Vaccines|vaccines|mesh-list
110881194|NCT03308825|Immunologic Factors|immunologic factors|mesh-ancestor
110881195|NCT03308825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110881196|NCT04235855|Liver Extracts|liver extracts|mesh-list
110881197|NCT04235855|Hematinics|hematinics|mesh-ancestor
110881198|NCT03328325|Vaccines|vaccines|mesh-list
110881199|NCT03328325|Immunologic Factors|immunologic factors|mesh-ancestor
110881200|NCT03328325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110881201|NCT03476603|Irbesartan|irbesartan|mesh-list
110881202|NCT03476603|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110881203|NCT03476603|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110881204|NCT03476603|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110881205|NCT03476603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110881206|NCT03476525|Fluoxetine|fluoxetine|mesh-list
110881207|NCT03476525|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110881208|NCT03476525|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110881209|NCT03476525|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110881210|NCT03476525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110881211|NCT03476525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110881212|NCT03476525|Serotonin Agents|serotonin agents|mesh-ancestor
110881213|NCT03476525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110881214|NCT03476525|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110881215|NCT03476525|Antidepressive Agents|antidepressive agents|mesh-ancestor
110881216|NCT03476525|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110881217|NCT03476525|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110881218|NCT03476525|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110881219|NCT03476525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110881220|NCT05039489|Antipsychotic Agents|antipsychotic agents|mesh-list
110881221|NCT05039489|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110881222|NCT05039489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110881227|NCT03665545|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
110881228|NCT03665545|Poly ICLC|poly iclc|mesh-list
110881229|NCT03665545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110881230|NCT03665545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110881231|NCT03665545|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110881232|NCT03665545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110881233|NCT03665545|Interferon Inducers|interferon inducers|mesh-ancestor
110881234|NCT03665545|Immunologic Factors|immunologic factors|mesh-ancestor
110881235|NCT03665545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110881236|NCT03665545|Laxatives|laxatives|mesh-ancestor
110881237|NCT03665545|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110881238|NCT03665545|Antiviral Agents|antiviral agents|mesh-ancestor
110881239|NCT03665545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110881240|NCT03305081|Copper|copper|mesh-list
110881241|NCT03305081|Levonorgestrel|levonorgestrel|mesh-list
110881242|NCT03305081|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110881243|NCT03305081|Contraceptive Agents|contraceptive agents|mesh-ancestor
110881244|NCT03305081|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110881245|NCT03305081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110881246|NCT03305081|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110881247|NCT03305081|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110881248|NCT03305081|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110881249|NCT03305081|Trace Elements|trace elements|mesh-ancestor
110881250|NCT03305081|Micronutrients|micronutrients|mesh-ancestor
110881251|NCT04079881|Insulin|insulin|mesh-list
110881252|NCT04079881|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110881253|NCT04079881|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110881254|NCT04079881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110881255|NCT03223909|Hyaluronic Acid|hyaluronic acid|mesh-list
110881256|NCT03223909|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110881257|NCT03223909|Immunologic Factors|immunologic factors|mesh-ancestor
110881258|NCT03223909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110881259|NCT03223909|Viscosupplements|viscosupplements|mesh-ancestor
110881260|NCT03223909|Protective Agents|protective agents|mesh-ancestor
110881261|NCT03733925|Golimumab|golimumab|mesh-list
110881262|NCT03733925|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110881263|NCT03733925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110881264|NCT03733925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110881265|NCT03733925|Immunologic Factors|immunologic factors|mesh-ancestor
110881266|NCT03733925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110881267|NCT03649711|Aspirin|aspirin|mesh-list
110881268|NCT03649711|Clopidogrel|clopidogrel|mesh-list
110881269|NCT03649711|Ticagrelor|ticagrelor|mesh-list
110881270|NCT03649711|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110881271|NCT03649711|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110881272|NCT03649711|Analgesics|analgesics|mesh-ancestor
110881273|NCT03649711|Sensory System Agents|sensory system agents|mesh-ancestor
110881274|NCT03649711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110881275|NCT03649711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110881276|NCT03649711|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110881277|NCT03649711|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110881278|NCT03649711|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110881279|NCT03649711|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110881280|NCT03649711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110881281|NCT03649711|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110881282|NCT03649711|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110881283|NCT03649711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110881284|NCT03649711|Antipyretics|antipyretics|mesh-ancestor
110881285|NCT03649711|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110881286|NCT03649711|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110881287|NCT03649711|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110881288|NCT03649711|Purinergic Agents|purinergic agents|mesh-ancestor
110881289|NCT03649711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110881290|NCT03897673|Iron|iron|mesh-list
110881291|NCT03897673|Trace Elements|trace elements|mesh-ancestor
110881292|NCT03897673|Micronutrients|micronutrients|mesh-ancestor
110881293|NCT03897673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110881294|NCT03273257|Riociguat|riociguat|mesh-list
110881295|NCT03273257|Enzyme Activators|enzyme activators|mesh-ancestor
110205240|NCT02964091|Sofosbuvir|sofosbuvir|mesh-list
110881298|NCT02553473|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110881299|NCT02553473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110881301|NCT02553473|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110881302|NCT02553473|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110881303|NCT04270877|Naltrexone|naltrexone|mesh-list
110881304|NCT04270877|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110881305|NCT04270877|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110881306|NCT04270877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110881307|NCT04270877|Sensory System Agents|sensory system agents|mesh-ancestor
110881308|NCT04270877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110881309|NCT03271151|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110881310|NCT03271151|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110881311|NCT03271151|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110881312|NCT03271151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110881313|NCT03271151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110881314|NCT03271151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110881315|NCT03271151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110881316|NCT03271151|Analgesics|analgesics|mesh-ancestor
110598861|NCT02571842|Rituximab|rituximab|mesh-list
110881317|NCT03271151|Sensory System Agents|sensory system agents|mesh-ancestor
110881318|NCT03271151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110881319|NCT03271151|Antidepressive Agents|antidepressive agents|mesh-ancestor
110881321|NCT03271151|Dopamine Agents|dopamine agents|mesh-ancestor
110881322|NCT03301649|Ivermectin|ivermectin|mesh-list
110881323|NCT03301649|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110881324|NCT03301649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110881325|NCT01144416|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
110881326|NCT01144416|Hormones|hormones|mesh-ancestor
110920315|NCT03648333|Vitamins|vitamins|mesh-ancestor
110881327|NCT01144416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110881328|NCT01144416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110881329|NCT00335777|Dihydroergotamine|dihydroergotamine|mesh-list
110881330|NCT00335777|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110881331|NCT00335777|Dopamine Agonists|dopamine agonists|mesh-ancestor
110881332|NCT00335777|Dopamine Agents|dopamine agents|mesh-ancestor
110881333|NCT00335777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110881334|NCT00335777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110881335|NCT00335777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110881336|NCT00335777|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110881337|NCT00335777|Analgesics|analgesics|mesh-ancestor
110881338|NCT00335777|Sensory System Agents|sensory system agents|mesh-ancestor
110881339|NCT00335777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110881340|NCT03764137|Panitumumab|panitumumab|mesh-list
110881341|NCT03764137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110881342|NCT03764137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110881343|NCT02889809|Fluticasone|fluticasone|mesh-list
110881345|NCT02889809|Montelukast|montelukast|mesh-list
110881346|NCT02889809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110881347|NCT02889809|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110881348|NCT02889809|Autonomic Agents|autonomic agents|mesh-ancestor
110881349|NCT02889809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110881350|NCT02889809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110881351|NCT02889809|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110881352|NCT02889809|Respiratory System Agents|respiratory system agents|mesh-ancestor
110881353|NCT02889809|Dermatologic Agents|dermatologic agents|mesh-ancestor
110881354|NCT02889809|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110881355|NCT02889809|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110881356|NCT02889809|Hormone Antagonists|hormone antagonists|mesh-ancestor
110881357|NCT02889809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110881358|NCT02889809|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110881359|NCT02889809|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110881360|NCT02889809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110881361|NCT03625518|Oxytocin|oxytocin|mesh-list
110881362|NCT03625518|Dinoprostone|dinoprostone|mesh-list
110881363|NCT03625518|Oxytocics|oxytocics|mesh-ancestor
110881364|NCT03625518|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110881365|NCT03625518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110881366|NCT00972738|Loratadine|loratadine|mesh-list
110881367|NCT00972738|Montelukast|montelukast|mesh-list
110881376|NCT00972738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110881377|NCT00972738|Antipruritics|antipruritics|mesh-ancestor
110881378|NCT00972738|Dermatologic Agents|dermatologic agents|mesh-ancestor
110881379|NCT00972738|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110881380|NCT00972738|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110881381|NCT00972738|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110881382|NCT00972738|Histamine Antagonists|histamine antagonists|mesh-ancestor
110881383|NCT00972738|Histamine Agents|histamine agents|mesh-ancestor
110881384|NCT00972738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110881385|NCT03452839|Meropenem|meropenem|mesh-list
110881386|NCT03452839|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110881387|NCT03452839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110881388|NCT04701281|Capecitabine|capecitabine|mesh-list
110881389|NCT04701281|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110881390|NCT04701281|Antimetabolites|antimetabolites|mesh-ancestor
110881391|NCT04701281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110598930|NCT00853294|Hydrocodone|hydrocodone|mesh-list
110881393|NCT03882918|Gaboxadol|gaboxadol|mesh-list
110881394|NCT03882918|Analgesics|analgesics|mesh-ancestor
110881395|NCT03882918|Sensory System Agents|sensory system agents|mesh-ancestor
110881396|NCT03882918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110881397|NCT03882918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110881398|NCT03882918|Anticonvulsants|anticonvulsants|mesh-ancestor
110881399|NCT03882918|GABA Agonists|gaba agonists|mesh-ancestor
110881400|NCT03882918|GABA Agents|gaba agents|mesh-ancestor
110881401|NCT03882918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110920320|NCT02252796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110881402|NCT03882918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110881404|NCT04180397|Diuretics|diuretics|mesh-ancestor
110881405|NCT04180397|Natriuretic Agents|natriuretic agents|mesh-ancestor
110881406|NCT04180397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110881407|NCT04180397|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110881408|NCT04180397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110881409|NCT04180397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110881410|NCT04174859|Rivaroxaban|rivaroxaban|mesh-list
110881411|NCT04174859|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110881412|NCT04174859|Antithrombins|antithrombins|mesh-ancestor
110881413|NCT04174859|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110881414|NCT04174859|Protease Inhibitors|protease inhibitors|mesh-ancestor
110881415|NCT04174859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110881416|NCT04174859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110881417|NCT04174859|Anticoagulants|anticoagulants|mesh-ancestor
110881418|NCT03295721|Bupivacaine|bupivacaine|mesh-list
110881419|NCT03295721|Anesthetics, Local|anesthetics, local|mesh-ancestor
110881420|NCT03295721|Anesthetics|anesthetics|mesh-ancestor
110881421|NCT03295721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110881422|NCT03295721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110881423|NCT03295721|Sensory System Agents|sensory system agents|mesh-ancestor
110881424|NCT03295721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110881425|NCT00803790|Vitamin D|vitamin d|mesh-list
110881426|NCT00803790|Ergocalciferols|ergocalciferols|mesh-list
110881427|NCT00803790|Cholecalciferol|cholecalciferol|mesh-list
110881428|NCT00803790|Alendronate|alendronate|mesh-list
110881429|NCT00803790|Vitamins|vitamins|mesh-list
110881430|NCT00803790|Micronutrients|micronutrients|mesh-ancestor
110881431|NCT00803790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110881432|NCT00803790|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110881433|NCT00803790|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110881467|NCT02879136|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
110881468|NCT02879136|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110534667|NCT02676336|Trace Elements|trace elements|mesh-ancestor
110881474|NCT02879136|Dopamine Agents|dopamine agents|mesh-ancestor
110881475|NCT02879136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110881476|NCT02879136|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110881477|NCT02879136|Adrenergic Agents|adrenergic agents|mesh-ancestor
110881478|NCT00250458|Rizatriptan|rizatriptan|mesh-list
110881479|NCT00250458|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110881480|NCT00250458|Serotonin Agents|serotonin agents|mesh-ancestor
110881481|NCT00250458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110881482|NCT00250458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110881483|NCT00250458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110881485|NCT01965132|Infliximab|infliximab|mesh-list
110881486|NCT01965132|Golimumab|golimumab|mesh-list
110881487|NCT01965132|Etanercept|etanercept|mesh-list
110881488|NCT01965132|Abatacept|abatacept|mesh-list
110881489|NCT01965132|Upadacitinib|upadacitinib|mesh-list
110881490|NCT01965132|Ustekinumab|ustekinumab|mesh-list
110881491|NCT01965132|Ixekizumab|ixekizumab|mesh-list
110881492|NCT01965132|Tofacitinib|tofacitinib|mesh-list
110881493|NCT01965132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110881494|NCT01965132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110881495|NCT01965132|Immunologic Factors|immunologic factors|mesh-ancestor
110881496|NCT01965132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110881497|NCT01965132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110881498|NCT01965132|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110881499|NCT01965132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110881500|NCT01965132|Dermatologic Agents|dermatologic agents|mesh-ancestor
110881501|NCT01965132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110881502|NCT01965132|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110197774|NCT00397319|Hormones|hormones|mesh-list
110881503|NCT01965132|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110881504|NCT01965132|Analgesics|analgesics|mesh-ancestor
110881505|NCT01965132|Sensory System Agents|sensory system agents|mesh-ancestor
110881506|NCT01965132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110881507|NCT01965132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110881508|NCT01965132|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110881509|NCT01965132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110881510|NCT01965132|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
110881511|NCT01965132|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110881512|NCT01965132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110881514|NCT01667133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110881515|NCT01667133|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110881516|NCT01667133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110881517|NCT01667133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110881518|NCT01498770|Olanzapine|olanzapine|mesh-list
110881519|NCT01498770|Risperidone|risperidone|mesh-list
110881520|NCT01498770|Aripiprazole|aripiprazole|mesh-list
110881521|NCT01498770|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110881522|NCT01498770|Paliperidone Palmitate|paliperidone palmitate|mesh-list
110881523|NCT01498770|Ziprasidone|ziprasidone|mesh-list
110881524|NCT01498770|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
110881525|NCT01498770|Clozapine|clozapine|mesh-list
110881526|NCT01498770|Asenapine|asenapine|mesh-list
110881527|NCT01498770|Amisulpride|amisulpride|mesh-list
110881528|NCT01498770|Iloperidone|iloperidone|mesh-list
110881529|NCT01498770|Sertindole|sertindole|mesh-list
110881530|NCT01498770|Zotepine|zotepine|mesh-list
110881531|NCT01498770|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110881532|NCT01498770|Serotonin Agents|serotonin agents|mesh-ancestor
110881533|NCT01498770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110881534|NCT01498770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110881535|NCT01498770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110881536|NCT01498770|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110881537|NCT01498770|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110881538|NCT01498770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110881539|NCT01498770|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110599081|NCT00724178|Antacids|antacids|mesh-ancestor
110881540|NCT01498770|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110881550|NCT01498770|Dopamine Agonists|dopamine agonists|mesh-ancestor
110881551|NCT01498770|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110881552|NCT01498770|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110881553|NCT01498770|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110881554|NCT01498770|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110881555|NCT01498770|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
110881556|NCT01498770|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110881557|NCT01498770|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110881558|NCT01498770|Adrenergic Agents|adrenergic agents|mesh-ancestor
110881559|NCT01498770|GABA Antagonists|gaba antagonists|mesh-ancestor
110881560|NCT01498770|GABA Agents|gaba agents|mesh-ancestor
110881561|NCT01498770|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110881562|NCT00140946|Montelukast|montelukast|mesh-list
110881563|NCT00140946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110881564|NCT00140946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110881565|NCT00140946|Respiratory System Agents|respiratory system agents|mesh-ancestor
110881566|NCT00140946|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110881567|NCT00140946|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110881568|NCT00140946|Hormone Antagonists|hormone antagonists|mesh-ancestor
110881569|NCT00140946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110881570|NCT00140946|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110881571|NCT00140946|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110881572|NCT00095004|Rizatriptan|rizatriptan|mesh-list
110881573|NCT00095004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110881574|NCT00095004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110881575|NCT00095004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110881576|NCT00095004|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110881577|NCT00095004|Serotonin Agents|serotonin agents|mesh-ancestor
110881578|NCT00967746|Etonogestrel|etonogestrel|mesh-list
110881579|NCT00967746|Desogestrel|desogestrel|mesh-list
110881580|NCT00967746|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110881581|NCT00967746|Contraceptive Agents|contraceptive agents|mesh-ancestor
110881582|NCT00967746|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110920336|NCT04166474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110881583|NCT00967746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110881584|NCT00967746|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110881585|NCT00967746|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110881586|NCT00967746|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110881587|NCT00967746|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110881589|NCT00967746|Hormones|hormones|mesh-ancestor
110881590|NCT00967746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110881591|NCT00092118|Montelukast|montelukast|mesh-list
110881592|NCT00092118|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110881593|NCT00092118|Respiratory System Agents|respiratory system agents|mesh-ancestor
110881594|NCT00092118|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110881595|NCT00092118|Hormone Antagonists|hormone antagonists|mesh-ancestor
110881596|NCT00092118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110881597|NCT00092118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110881598|NCT00092118|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110881599|NCT00092118|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110881600|NCT00092118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110881601|NCT00920634|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
110881602|NCT00920634|Hormones|hormones|mesh-ancestor
110881644|NCT05418465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110881645|NCT05418465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110881646|NCT03261167|Botulinum Toxins|botulinum toxins|mesh-list
110881647|NCT03261167|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110881648|NCT03261167|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110881649|NCT03261167|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110881650|NCT03261167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110881651|NCT03261167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110881652|NCT03261167|Cholinergic Agents|cholinergic agents|mesh-ancestor
110881653|NCT03261167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110881654|NCT03261167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110881655|NCT03261167|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110881656|NCT03261167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110881657|NCT05391126|Irinotecan|irinotecan|mesh-list
110881658|NCT05391126|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110881659|NCT05391126|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110881660|NCT05391126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110881661|NCT05391126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110881662|NCT05391126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110881663|NCT05418309|Paclitaxel|paclitaxel|mesh-list
110881664|NCT05418309|Tislelizumab|tislelizumab|mesh-list
110881665|NCT05418309|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110881666|NCT05418309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110881667|NCT05418309|Tubulin Modulators|tubulin modulators|mesh-ancestor
110881668|NCT05418309|Antimitotic Agents|antimitotic agents|mesh-ancestor
110881669|NCT05418309|Mitosis Modulators|mitosis modulators|mesh-ancestor
110881670|NCT05418309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110881671|NCT05418309|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110881672|NCT05137548|Tenofovir|tenofovir|mesh-list
110881673|NCT05137548|Antiviral Agents|antiviral agents|mesh-ancestor
110881674|NCT05137548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110881675|NCT05137548|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110881676|NCT05137548|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110881677|NCT05137548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110881678|NCT05137548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110881679|NCT05137548|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110881680|NCT05137548|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110881681|NCT05091294|Anesthetics|anesthetics|mesh-list
110881682|NCT05091294|Anesthetics, Local|anesthetics, local|mesh-list
110881683|NCT05091294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110881684|NCT05091294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110881685|NCT05091294|Sensory System Agents|sensory system agents|mesh-ancestor
110881686|NCT05091294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110881688|NCT05320926|Clopidogrel|clopidogrel|mesh-list
110881689|NCT05320926|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110881690|NCT05320926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110881691|NCT05320926|Analgesics|analgesics|mesh-ancestor
110881692|NCT05320926|Sensory System Agents|sensory system agents|mesh-ancestor
110881693|NCT05320926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110881694|NCT05320926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110881695|NCT05320926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110881696|NCT05320926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110881697|NCT05320926|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110881698|NCT05320926|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110197849|NCT00043004|Vitamins|vitamins|mesh-ancestor
110881699|NCT05320926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110881700|NCT05320926|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110881701|NCT05320926|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110881702|NCT05320926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110881703|NCT05320926|Antipyretics|antipyretics|mesh-ancestor
110881704|NCT05320926|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110881705|NCT05320926|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110881728|NCT05417997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110881729|NCT05417997|Glucocorticoids|glucocorticoids|mesh-ancestor
110881730|NCT05417997|Hormones|hormones|mesh-ancestor
110881731|NCT05417997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110881732|NCT05417997|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110881733|NCT05417997|Protective Agents|protective agents|mesh-ancestor
110881734|NCT05417997|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110881735|NCT05417997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110881736|NCT05417997|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110881737|NCT05417997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110881738|NCT05417997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110881739|NCT05417997|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110881740|NCT05417997|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110881741|NCT05417997|Anticoagulants|anticoagulants|mesh-ancestor
110881742|NCT05417997|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110881743|NCT05417997|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110881744|NCT05417997|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110881745|NCT05417997|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110881746|NCT05417997|Antiviral Agents|antiviral agents|mesh-ancestor
110881747|NCT03856788|Bupivacaine|bupivacaine|mesh-list
110881748|NCT03856788|Anesthetics, Local|anesthetics, local|mesh-ancestor
110881749|NCT03856788|Anesthetics|anesthetics|mesh-ancestor
110881750|NCT03856788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110881751|NCT03856788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110881752|NCT03856788|Sensory System Agents|sensory system agents|mesh-ancestor
110881753|NCT03856788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110881754|NCT03242759|Pirfenidone|pirfenidone|mesh-list
110881755|NCT03242759|Nintedanib|nintedanib|mesh-list
110881756|NCT03242759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110881757|NCT03242759|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110881759|NCT03242759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110881760|NCT03242759|Analgesics|analgesics|mesh-ancestor
110881761|NCT03242759|Sensory System Agents|sensory system agents|mesh-ancestor
110534668|NCT02676336|Micronutrients|micronutrients|mesh-ancestor
110881777|NCT03625050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110881778|NCT03625050|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110881779|NCT03625050|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110881780|NCT03625050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110881781|NCT03625050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110881782|NCT03625050|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110881783|NCT03625050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110881784|NCT03625050|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110881785|NCT03257813|Timolol|timolol|mesh-list
110881786|NCT03257813|Brimonidine Tartrate|brimonidine tartrate|mesh-list
110881787|NCT03257813|Dorzolamide|dorzolamide|mesh-list
110881788|NCT03257813|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110881789|NCT03257813|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110881790|NCT03257813|Adrenergic Agents|adrenergic agents|mesh-ancestor
110881791|NCT03257813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110881792|NCT03257813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110881793|NCT03257813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110881794|NCT03257813|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110881795|NCT03257813|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110881796|NCT03257813|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110881797|NCT03257813|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110881798|NCT03257813|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110881799|NCT03257813|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110881800|NCT03257813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110881801|NCT03210259|Adalimumab|adalimumab|mesh-list
110881802|NCT03210259|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110881803|NCT03210259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110881804|NCT03210259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110881805|NCT04319757|Cyclophosphamide|cyclophosphamide|mesh-list
110881806|NCT04319757|Fludarabine|fludarabine|mesh-list
110881807|NCT04319757|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110881808|NCT04319757|Immunologic Factors|immunologic factors|mesh-ancestor
110881809|NCT04319757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110881810|NCT04319757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110881811|NCT04319757|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110881812|NCT04319757|Alkylating Agents|alkylating agents|mesh-ancestor
110881813|NCT04319757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110881814|NCT04319757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110881815|NCT04319757|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110881816|NCT05180461|Ivermectin|ivermectin|mesh-list
110881817|NCT05180461|Emodepside|emodepside|mesh-list
110881818|NCT05180461|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110881819|NCT05180461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110881820|NCT02496611|Exenatide|exenatide|mesh-list
110881821|NCT02496611|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110881830|NCT03237481|Anesthetics, Local|anesthetics, local|mesh-ancestor
110881831|NCT03237481|Anesthetics|anesthetics|mesh-ancestor
110881832|NCT03237481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110881833|NCT03237481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110881834|NCT03237481|Sensory System Agents|sensory system agents|mesh-ancestor
110881835|NCT03237481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110881836|NCT03704220|Warfarin|warfarin|mesh-list
110881837|NCT03704220|Anticoagulants|anticoagulants|mesh-ancestor
110881838|NCT03222349|Diazepam|diazepam|mesh-list
110881839|NCT03222349|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110881840|NCT03222349|Anticonvulsants|anticonvulsants|mesh-ancestor
110881841|NCT03222349|Antiemetics|antiemetics|mesh-ancestor
110881842|NCT03222349|Autonomic Agents|autonomic agents|mesh-ancestor
110881843|NCT03222349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110881844|NCT03222349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110881845|NCT03222349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110881846|NCT03222349|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110197887|NCT00077805|Enoxaparin|enoxaparin|mesh-list
110881847|NCT03222349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110881848|NCT03222349|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110881849|NCT03222349|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110881850|NCT03222349|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110881851|NCT03222349|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110881852|NCT03222349|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110881853|NCT03222349|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110881854|NCT03222349|Anesthetics, General|anesthetics, general|mesh-ancestor
110881855|NCT03222349|Anesthetics|anesthetics|mesh-ancestor
110881856|NCT03222349|GABA Modulators|gaba modulators|mesh-ancestor
110881857|NCT03222349|GABA Agents|gaba agents|mesh-ancestor
110881858|NCT03222349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110881859|NCT03222349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110881860|NCT02927925|Daratumumab|daratumumab|mesh-list
110881861|NCT02927925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110881862|NCT03208933|Pirfenidone|pirfenidone|mesh-list
110881863|NCT03208933|Analgesics|analgesics|mesh-ancestor
110881864|NCT03208933|Sensory System Agents|sensory system agents|mesh-ancestor
110920357|NCT05579418|Evolocumab|evolocumab|mesh-list
110881865|NCT03208933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110881866|NCT03208933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110881867|NCT03208933|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110881868|NCT03208933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110881869|NCT03208933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110881870|NCT03208933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110881871|NCT03208933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110881872|NCT02415036|Melphalan|melphalan|mesh-list
110881873|NCT02415036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110881874|NCT02415036|Alkylating Agents|alkylating agents|mesh-ancestor
110881875|NCT02415036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110881876|NCT02415036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110881877|NCT02415036|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110881878|NCT02415036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110881879|NCT02415036|Immunologic Factors|immunologic factors|mesh-ancestor
110881880|NCT02415036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110881881|NCT04752267|Clevudine|clevudine|mesh-list
110881882|NCT04752267|Antiviral Agents|antiviral agents|mesh-ancestor
110881883|NCT04752267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110881884|NCT02117700|Acetylcysteine|acetylcysteine|mesh-list
110881885|NCT02117700|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110881886|NCT02117700|Antiviral Agents|antiviral agents|mesh-ancestor
110881887|NCT02117700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110881888|NCT02117700|Expectorants|expectorants|mesh-ancestor
110881889|NCT02117700|Respiratory System Agents|respiratory system agents|mesh-ancestor
110881890|NCT02117700|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110881891|NCT02117700|Antioxidants|antioxidants|mesh-ancestor
110881920|NCT03207451|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110881921|NCT03207451|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110881922|NCT03207451|Analgesics|analgesics|mesh-ancestor
110881923|NCT03207451|Sensory System Agents|sensory system agents|mesh-ancestor
110197907|NCT00123916|Immunologic Factors|immunologic factors|mesh-ancestor
110881924|NCT03207451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110881925|NCT03207451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110881926|NCT03207451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110881927|NCT03207451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110881928|NCT03207451|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110881929|NCT03207451|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110881930|NCT03207451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110881931|NCT03207451|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110881932|NCT03207451|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110881933|NCT03207451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110881934|NCT03207451|Antipyretics|antipyretics|mesh-ancestor
110881935|NCT03207451|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110881936|NCT03207451|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110881937|NCT03207451|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110881938|NCT03207451|Purinergic Agents|purinergic agents|mesh-ancestor
110881939|NCT03207451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110881940|NCT05089123|Vaccines|vaccines|mesh-list
110205394|NCT00171496|Cyclosporine|cyclosporine|mesh-list
110881950|NCT02361125|Dopamine Agents|dopamine agents|mesh-ancestor
110881951|NCT02361125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110881952|NCT03701256|Atracurium|atracurium|mesh-list
110881953|NCT03701256|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110881954|NCT03701256|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110881955|NCT03701256|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110881956|NCT03701256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110881957|NCT03701256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110881958|NCT03701256|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
110881959|NCT03701256|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110881960|NCT03701256|Cholinergic Agents|cholinergic agents|mesh-ancestor
110881961|NCT03701256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110881962|NCT03701256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110881963|NCT04780581|Dexamethasone|dexamethasone|mesh-list
110881964|NCT04780581|Methylprednisolone|methylprednisolone|mesh-list
110881965|NCT04780581|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110881966|NCT04780581|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110881967|NCT04780581|Prednisolone|prednisolone|mesh-list
110881968|NCT04780581|Prednisolone acetate|prednisolone acetate|mesh-list
110881969|NCT04780581|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110881970|NCT04780581|Prednisolone phosphate|prednisolone phosphate|mesh-list
110881971|NCT04780581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110881972|NCT04780581|Antiemetics|antiemetics|mesh-ancestor
110881973|NCT04780581|Autonomic Agents|autonomic agents|mesh-ancestor
110881974|NCT04780581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110881975|NCT04780581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110881976|NCT04780581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110881977|NCT04780581|Glucocorticoids|glucocorticoids|mesh-ancestor
110881978|NCT04780581|Hormones|hormones|mesh-ancestor
110881979|NCT04780581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110881980|NCT04780581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110881981|NCT04780581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110881982|NCT04780581|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110881983|NCT04780581|Protective Agents|protective agents|mesh-ancestor
110881984|NCT01526135|Gemcitabine|gemcitabine|mesh-list
110881985|NCT01526135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110881986|NCT01526135|Antimetabolites|antimetabolites|mesh-ancestor
110881987|NCT01526135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110881988|NCT01526135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110881989|NCT05417139|Immunomodulating Agents|immunomodulating agents|mesh-list
110881990|NCT05417139|Immunologic Factors|immunologic factors|mesh-ancestor
110881991|NCT05417139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110881993|NCT03701022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110881994|NCT03701022|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110881995|NCT03701022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110881996|NCT03701022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110881997|NCT04221165|Analgesics, Opioid|analgesics, opioid|mesh-list
110881998|NCT04221165|Narcotics|narcotics|mesh-ancestor
110881999|NCT04221165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110882000|NCT04221165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110882001|NCT04221165|Analgesics|analgesics|mesh-ancestor
110882002|NCT04221165|Sensory System Agents|sensory system agents|mesh-ancestor
110882003|NCT04221165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110882004|NCT03255629|Glucagon|glucagon|mesh-list
110205418|NCT00171574|Valsartan|valsartan|mesh-list
110882019|NCT03703596|Tubulin Modulators|tubulin modulators|mesh-ancestor
110882020|NCT03703596|Antimitotic Agents|antimitotic agents|mesh-ancestor
110882021|NCT03703596|Mitosis Modulators|mitosis modulators|mesh-ancestor
110882022|NCT03703596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110882023|NCT01137773|Insulin|insulin|mesh-list
110882024|NCT01137773|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110882025|NCT01137773|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110882026|NCT01137773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110882027|NCT03698292|Metoclopramide|metoclopramide|mesh-list
110882028|NCT03698292|Antiemetics|antiemetics|mesh-ancestor
110882029|NCT03698292|Autonomic Agents|autonomic agents|mesh-ancestor
110882030|NCT03698292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110882031|NCT03698292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110882032|NCT03698292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110882033|NCT03698292|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110882034|NCT03698292|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110882035|NCT03698292|Dopamine Agents|dopamine agents|mesh-ancestor
110882036|NCT03698292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110882037|NCT03698292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110882038|NCT04613271|Azithromycin|azithromycin|mesh-list
110882039|NCT04613271|Favipiravir|favipiravir|mesh-list
110882040|NCT04613271|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110882041|NCT04613271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110882042|NCT04613271|Antiviral Agents|antiviral agents|mesh-ancestor
110920384|NCT00495508|Lumefantrine|lumefantrine|mesh-list
110882043|NCT03094611|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
110882044|NCT03094611|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110882045|NCT03094611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110882046|NCT03094611|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110882047|NCT03094611|Immunotoxins|immunotoxins|mesh-ancestor
110882048|NCT03094611|Immunoconjugates|immunoconjugates|mesh-ancestor
110882049|NCT03094611|Immunologic Factors|immunologic factors|mesh-ancestor
110882050|NCT03094611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110882052|NCT03631953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110882053|NCT03631953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110882054|NCT03631953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110882055|NCT03631953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110882056|NCT01030575|Inositol|inositol|mesh-list
110882057|NCT01030575|Vitamin B Complex|vitamin b complex|mesh-ancestor
110882058|NCT01030575|Vitamins|vitamins|mesh-ancestor
110882059|NCT01030575|Micronutrients|micronutrients|mesh-ancestor
110882060|NCT01030575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110882061|NCT04215471|Antibodies|antibodies|mesh-list
110882062|NCT04215471|Immunoglobulins|immunoglobulins|mesh-list
110882063|NCT04215471|Immunologic Factors|immunologic factors|mesh-ancestor
110882064|NCT04215471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110882065|NCT04066023|Zolmitriptan|zolmitriptan|mesh-list
110882066|NCT04066023|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110205430|NCT00171613|Octreotide|octreotide|mesh-list
110882086|NCT02932267|Dermatologic Agents|dermatologic agents|mesh-ancestor
110882088|NCT03217591|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
110882089|NCT03217591|Enzyme Activators|enzyme activators|mesh-ancestor
110882090|NCT03217591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110882091|NCT03217591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110882092|NCT03697824|Cyclophosphamide|cyclophosphamide|mesh-list
110882093|NCT03697824|Pembrolizumab|pembrolizumab|mesh-list
110882094|NCT03697824|Fludarabine|fludarabine|mesh-list
110882095|NCT03697824|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110882096|NCT03697824|Immunologic Factors|immunologic factors|mesh-ancestor
110882097|NCT03697824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110882098|NCT03697824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110882099|NCT03697824|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110882100|NCT03697824|Alkylating Agents|alkylating agents|mesh-ancestor
110882101|NCT03697824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110882102|NCT03697824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110882103|NCT03697824|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110882104|NCT03697824|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110882105|NCT03697824|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110882106|NCT03702894|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
110882107|NCT03702894|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110882108|NCT03702894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110882109|NCT03702894|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110882110|NCT03702894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110882111|NCT03702894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110882112|NCT03697746|Acetaminophen|acetaminophen|mesh-list
110882113|NCT03697746|Ibuprofen|ibuprofen|mesh-list
110882114|NCT03697746|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
110882115|NCT03697746|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110882116|NCT03697746|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110882117|NCT03697746|Analgesics|analgesics|mesh-ancestor
110882118|NCT03697746|Sensory System Agents|sensory system agents|mesh-ancestor
110882119|NCT03697746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110882141|NCT03702738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110882143|NCT03702738|Respiratory System Agents|respiratory system agents|mesh-ancestor
110882144|NCT03702738|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110882145|NCT03702738|Antioxidants|antioxidants|mesh-ancestor
110882146|NCT03702738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110882147|NCT03702738|Protective Agents|protective agents|mesh-ancestor
110882148|NCT03702738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110882149|NCT03702738|Antidotes|antidotes|mesh-ancestor
110882150|NCT03702582|Warfarin|warfarin|mesh-list
110882151|NCT03702582|Rivaroxaban|rivaroxaban|mesh-list
110882152|NCT03702582|Anticoagulants|anticoagulants|mesh-ancestor
110882153|NCT03702582|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110882154|NCT03702582|Antithrombins|antithrombins|mesh-ancestor
110882155|NCT03702582|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110882156|NCT03702582|Protease Inhibitors|protease inhibitors|mesh-ancestor
110882157|NCT03702582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110882158|NCT03702582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110882159|NCT03697044|Irinotecan|irinotecan|mesh-list
110882160|NCT03697044|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110882161|NCT03697044|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110882162|NCT03697044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110882163|NCT03697044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110882164|NCT03697044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110882165|NCT03699774|Firuglipel|firuglipel|mesh-list
110882166|NCT03699774|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110882167|NCT03699774|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110882168|NCT03699774|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110882169|NCT03699774|Antimetabolites|antimetabolites|mesh-ancestor
110882170|NCT03699774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110882171|NCT03699774|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110882172|NCT03699774|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110882173|NCT03699774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110882174|NCT03699774|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110882181|NCT03699696|Anesthetics, General|anesthetics, general|mesh-ancestor
110882182|NCT03699696|Anesthetics|anesthetics|mesh-ancestor
110882183|NCT03702426|Norfloxacin|norfloxacin|mesh-list
110882184|NCT03702426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110882185|NCT03702426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110882186|NCT03702426|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110882187|NCT03702426|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110882188|NCT03702426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110882189|NCT03702426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110882190|NCT03702426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110882191|NCT03702426|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110882192|NCT03702426|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110882193|NCT00265941|Cetuximab|cetuximab|mesh-list
110882194|NCT00265941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110882195|NCT00265941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110882196|NCT03699384|Azacitidine|azacitidine|mesh-list
110882197|NCT03699384|Avelumab|avelumab|mesh-list
110882198|NCT03699384|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110882199|NCT03699384|Antimetabolites|antimetabolites|mesh-ancestor
110882200|NCT03699384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110882201|NCT03699384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110882202|NCT03699384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110882203|NCT03699384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110882204|NCT05378763|Docetaxel|docetaxel|mesh-list
110882205|NCT05378763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110882206|NCT05378763|Tubulin Modulators|tubulin modulators|mesh-ancestor
110599764|NCT00807807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110882207|NCT05378763|Antimitotic Agents|antimitotic agents|mesh-ancestor
110882208|NCT05378763|Mitosis Modulators|mitosis modulators|mesh-ancestor
110882209|NCT05378763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110882210|NCT02937571|Dexamethasone|dexamethasone|mesh-list
110882211|NCT02937571|Lenalidomide|lenalidomide|mesh-list
110882212|NCT02937571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110882213|NCT02937571|Antiemetics|antiemetics|mesh-ancestor
110882214|NCT02937571|Autonomic Agents|autonomic agents|mesh-ancestor
110882215|NCT02937571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110882216|NCT02937571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110882217|NCT02937571|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110882218|NCT02937571|Glucocorticoids|glucocorticoids|mesh-ancestor
110882219|NCT02937571|Hormones|hormones|mesh-ancestor
110882220|NCT02937571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110882221|NCT02937571|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110882222|NCT02937571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110882223|NCT02937571|Immunologic Factors|immunologic factors|mesh-ancestor
110882224|NCT02937571|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110882225|NCT02937571|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110882226|NCT02937571|Growth Substances|growth substances|mesh-ancestor
110882227|NCT02937571|Growth Inhibitors|growth inhibitors|mesh-ancestor
110882228|NCT03201211|Vaccines|vaccines|mesh-list
110882229|NCT03201211|Immunologic Factors|immunologic factors|mesh-ancestor
110882230|NCT03201211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110882231|NCT04472949|Carboplatin|carboplatin|mesh-list
110882232|NCT04472949|Etoposide|etoposide|mesh-list
110882233|NCT04472949|Durvalumab|durvalumab|mesh-list
110882234|NCT04472949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110882235|NCT04472949|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110882236|NCT04472949|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110882237|NCT04472949|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110882238|NCT04472949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110882239|NCT04472949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110882240|NCT04472949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110882241|NCT03696186|Phenobarbital|phenobarbital|mesh-list
110882242|NCT03696186|Anticonvulsants|anticonvulsants|mesh-ancestor
110882252|NCT03696186|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110882253|NCT03696186|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110882254|NCT03696186|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110882255|NCT03698916|Celecoxib|celecoxib|mesh-list
110882256|NCT03698916|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110882257|NCT03698916|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110882258|NCT03698916|Analgesics|analgesics|mesh-ancestor
110882259|NCT03698916|Sensory System Agents|sensory system agents|mesh-ancestor
110882260|NCT03698916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110882261|NCT03698916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110882262|NCT03698916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110882263|NCT03698916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110882264|NCT03698916|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110882265|NCT03698916|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110882266|NCT03698916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110882267|NCT03698916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110882268|NCT03336333|Rituximab|rituximab|mesh-list
110882269|NCT03336333|Venetoclax|venetoclax|mesh-list
110882270|NCT03336333|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110882271|NCT03336333|Zanubrutinib|zanubrutinib|mesh-list
110882272|NCT03336333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110882273|NCT03336333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110882274|NCT03336333|Immunologic Factors|immunologic factors|mesh-ancestor
110882275|NCT03336333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110882276|NCT03336333|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110882277|NCT03336333|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110882278|NCT03336333|Alkylating Agents|alkylating agents|mesh-ancestor
110920427|NCT03049735|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110882279|NCT03336333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110882282|NCT03695952|Pembrolizumab|pembrolizumab|mesh-list
110882283|NCT03695952|Nivolumab|nivolumab|mesh-list
110198080|NCT00077883|Cisplatin|cisplatin|mesh-list
110882284|NCT03695952|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
110882285|NCT03695952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110882286|NCT03695952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110882287|NCT03695952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110882288|NCT03695640|Magnesium Sulfate|magnesium sulfate|mesh-list
110882289|NCT03695640|Analgesics|analgesics|mesh-ancestor
110882290|NCT03695640|Sensory System Agents|sensory system agents|mesh-ancestor
110882291|NCT03695640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110882292|NCT03695640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110882293|NCT03695640|Anesthetics|anesthetics|mesh-ancestor
110882294|NCT03695640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110882295|NCT03695640|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110882296|NCT03695640|Anticonvulsants|anticonvulsants|mesh-ancestor
110882297|NCT03695640|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110882298|NCT03695640|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110882299|NCT03695640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110882300|NCT03695640|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110882301|NCT03695640|Tocolytic Agents|tocolytic agents|mesh-ancestor
110882302|NCT03695640|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110882303|NCT03698682|Levofloxacin|levofloxacin|mesh-list
110882304|NCT03698682|Ofloxacin|ofloxacin|mesh-list
110882305|NCT03698682|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110882306|NCT03698682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110882311|NCT03698682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110882312|NCT03698682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110882313|NCT03698682|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110882314|NCT03698682|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110882315|NCT03029832|Atezolizumab|atezolizumab|mesh-list
110882316|NCT03029832|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110882317|NCT03029832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110882318|NCT03029832|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110882319|NCT03029832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110882320|NCT05598567|Anesthetics|anesthetics|mesh-list
110882321|NCT05598567|Sevoflurane|sevoflurane|mesh-list
110882322|NCT05598567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110882323|NCT05598567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110882324|NCT05598567|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110882325|NCT05598567|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110882326|NCT05598567|Anesthetics, General|anesthetics, general|mesh-ancestor
110882327|NCT03701880|Bisoprolol|bisoprolol|mesh-list
110882328|NCT03701880|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110882329|NCT03701880|Sympatholytics|sympatholytics|mesh-ancestor
110882330|NCT03701880|Autonomic Agents|autonomic agents|mesh-ancestor
110882331|NCT03701880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110882332|NCT03701880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110882333|NCT03701880|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110882334|NCT03701880|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110882335|NCT03701880|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110882336|NCT03701880|Adrenergic Agents|adrenergic agents|mesh-ancestor
110882337|NCT03701880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110882338|NCT03701880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110882339|NCT03692754|Calcium, Dietary|calcium, dietary|mesh-list
110882340|NCT03692754|Dexamethasone|dexamethasone|mesh-list
110882341|NCT03692754|Atorvastatin|atorvastatin|mesh-list
110882342|NCT03692754|Calcium|calcium|mesh-list
110882343|NCT03692754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110882344|NCT03692754|Antiemetics|antiemetics|mesh-ancestor
110882345|NCT03692754|Autonomic Agents|autonomic agents|mesh-ancestor
110882346|NCT03692754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110882347|NCT03692754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110882348|NCT03692754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110882349|NCT03692754|Glucocorticoids|glucocorticoids|mesh-ancestor
110882350|NCT03692754|Hormones|hormones|mesh-ancestor
110882351|NCT03692754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110882352|NCT03692754|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110882353|NCT03692754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110882354|NCT03692754|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110882355|NCT03692754|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110882356|NCT03692754|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110882357|NCT03692754|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110882358|NCT03692754|Antimetabolites|antimetabolites|mesh-ancestor
110882359|NCT03692754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110882360|NCT03692754|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110882361|NCT03692754|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110882362|NCT03692754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110882363|NCT04224558|Acetaminophen|acetaminophen|mesh-list
110882364|NCT04224558|Diphenhydramine|diphenhydramine|mesh-list
110882365|NCT04224558|Promethazine|promethazine|mesh-list
110882366|NCT04224558|Methylprednisolone|methylprednisolone|mesh-list
110882367|NCT04224558|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110882368|NCT04224558|Cyclophosphamide|cyclophosphamide|mesh-list
110882369|NCT04224558|Fludarabine|fludarabine|mesh-list
110882370|NCT04224558|Thymoglobulin|thymoglobulin|mesh-list
110882371|NCT04224558|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110882372|NCT04224558|Immunoglobulins|immunoglobulins|mesh-list
110882373|NCT04224558|Antibodies|antibodies|mesh-list
110882374|NCT04224558|gamma-Globulins|gamma-globulins|mesh-list
110882375|NCT04224558|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110882376|NCT04224558|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110882377|NCT04224558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110882382|NCT04224558|Alkylating Agents|alkylating agents|mesh-ancestor
110882383|NCT04224558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110882384|NCT04224558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110882385|NCT04224558|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110882386|NCT04224558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110882387|NCT04224558|Analgesics|analgesics|mesh-ancestor
110882388|NCT04224558|Sensory System Agents|sensory system agents|mesh-ancestor
110882389|NCT04224558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110882390|NCT04224558|Antipyretics|antipyretics|mesh-ancestor
110882391|NCT04224558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110882392|NCT04224558|Antiemetics|antiemetics|mesh-ancestor
110882393|NCT04224558|Autonomic Agents|autonomic agents|mesh-ancestor
110882394|NCT04224558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110882395|NCT04224558|Glucocorticoids|glucocorticoids|mesh-ancestor
110882396|NCT04224558|Hormones|hormones|mesh-ancestor
110882397|NCT04224558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110882398|NCT04224558|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110882399|NCT04224558|Protective Agents|protective agents|mesh-ancestor
110882400|NCT04224558|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110882401|NCT04224558|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110882402|NCT04224558|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110882403|NCT04224558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110882404|NCT04224558|Anesthetics, Local|anesthetics, local|mesh-ancestor
110882405|NCT04224558|Anesthetics|anesthetics|mesh-ancestor
110882406|NCT04224558|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110882407|NCT04224558|Histamine Antagonists|histamine antagonists|mesh-ancestor
110882408|NCT04224558|Histamine Agents|histamine agents|mesh-ancestor
110882409|NCT04224558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110882410|NCT04224558|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110882411|NCT04224558|Antipruritics|antipruritics|mesh-ancestor
110882412|NCT04224558|Dermatologic Agents|dermatologic agents|mesh-ancestor
110882413|NCT05598411|Methylprednisolone|methylprednisolone|mesh-list
110882414|NCT05598411|Glucocorticoids|glucocorticoids|mesh-list
110882415|NCT05598411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110882416|NCT05598411|Antiemetics|antiemetics|mesh-ancestor
110882417|NCT05598411|Autonomic Agents|autonomic agents|mesh-ancestor
110882418|NCT05598411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110882419|NCT05598411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110882420|NCT05598411|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110882421|NCT05598411|Hormones|hormones|mesh-ancestor
110882422|NCT05598411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110882423|NCT05598411|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110882424|NCT05598411|Protective Agents|protective agents|mesh-ancestor
110882426|NCT03688230|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110882427|NCT03688230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110882428|NCT03694236|Durvalumab|durvalumab|mesh-list
110882429|NCT03694236|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110882430|NCT03694236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110882432|NCT03692286|Calcium|calcium|mesh-list
110882433|NCT03692286|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110882434|NCT03692286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110198178|NCT00125203|Botulinum Toxins|botulinum toxins|mesh-list
110882435|NCT03692286|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110882436|NCT03694080|Calcium|calcium|mesh-list
110882437|NCT03694080|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110882438|NCT03694080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110882439|NCT04203498|Nabiximols|nabiximols|mesh-list
110882440|NCT04203498|Analgesics|analgesics|mesh-ancestor
110882441|NCT04203498|Sensory System Agents|sensory system agents|mesh-ancestor
110882442|NCT04203498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110882443|NCT04203498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110882444|NCT03691896|Cholecalciferol|cholecalciferol|mesh-list
110882445|NCT03691896|Vitamin D|vitamin d|mesh-list
110882446|NCT03691896|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110882447|NCT03691896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110882448|NCT03691896|Vitamins|vitamins|mesh-ancestor
110882449|NCT03691896|Micronutrients|micronutrients|mesh-ancestor
110205500|NCT00171808|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110882455|NCT03691818|Sensory System Agents|sensory system agents|mesh-ancestor
110882456|NCT03691818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110882457|NCT03691818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110882458|NCT03691818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110882459|NCT03691818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110882460|NCT03691818|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110882461|NCT03691818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110882462|NCT03691818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110882463|NCT03687606|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
110882464|NCT03687606|Menotropins|menotropins|mesh-list
110882465|NCT03687606|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110882466|NCT03687606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110882467|NCT03687606|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110882468|NCT03687606|Fertility Agents|fertility agents|mesh-ancestor
110882469|NCT04059978|Remifentanil|remifentanil|mesh-list
110882470|NCT04059978|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110882471|NCT04059978|Narcotics|narcotics|mesh-ancestor
110882472|NCT04059978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110882473|NCT04059978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110882474|NCT04059978|Analgesics|analgesics|mesh-ancestor
110882475|NCT04059978|Sensory System Agents|sensory system agents|mesh-ancestor
110882476|NCT04059978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110882477|NCT03199963|Tamoxifen|tamoxifen|mesh-list
110882478|NCT03199963|Afimoxifene|afimoxifene|mesh-list
110882479|NCT03199963|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110882480|NCT03199963|Hormone Antagonists|hormone antagonists|mesh-ancestor
110882481|NCT03199963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110882482|NCT03199963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110882483|NCT03199963|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110882484|NCT03199963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110882485|NCT03199963|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110882486|NCT03199963|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110882487|NCT03199963|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110882488|NCT03636685|Paclitaxel|paclitaxel|mesh-list
110882489|NCT03636685|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110882490|NCT03636685|Carboplatin|carboplatin|mesh-list
110882492|NCT03636685|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110882493|NCT03636685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110882494|NCT03636685|Tubulin Modulators|tubulin modulators|mesh-ancestor
110882495|NCT03636685|Antimitotic Agents|antimitotic agents|mesh-ancestor
110882496|NCT03636685|Mitosis Modulators|mitosis modulators|mesh-ancestor
110882497|NCT03636685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110882498|NCT03636685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110882499|NCT03636685|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110882500|NCT03636685|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110882501|NCT03257631|Thalidomide|thalidomide|mesh-list
110882502|NCT03257631|Pomalidomide|pomalidomide|mesh-list
110882503|NCT03257631|Immunologic Factors|immunologic factors|mesh-ancestor
110882504|NCT03257631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110600075|NCT02950766|Ipilimumab|ipilimumab|mesh-list
110882505|NCT03257631|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110882506|NCT03257631|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110882507|NCT03257631|Growth Substances|growth substances|mesh-ancestor
110882508|NCT03257631|Growth Inhibitors|growth inhibitors|mesh-ancestor
110882509|NCT03257631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110882510|NCT03257631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110882511|NCT03257631|Leprostatic Agents|leprostatic agents|mesh-ancestor
110882512|NCT03257631|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110882513|NCT03257631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110882514|NCT03883581|Quinidine|quinidine|mesh-list
110882515|NCT03883581|Quinidine gluconate|quinidine gluconate|mesh-list
110882516|NCT03883581|Dextromethorphan|dextromethorphan|mesh-list
110882517|NCT03883581|Antitussive Agents|antitussive agents|mesh-ancestor
110882518|NCT03883581|Respiratory System Agents|respiratory system agents|mesh-ancestor
110205504|NCT00171847|Trastuzumab|trastuzumab|mesh-list
110882525|NCT03883581|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110882526|NCT03883581|Adrenergic Agents|adrenergic agents|mesh-ancestor
110882527|NCT03883581|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110882529|NCT03883581|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110882530|NCT03883581|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110882531|NCT03883581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110882532|NCT03883581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110882533|NCT03883581|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110882534|NCT03883581|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110882535|NCT03883581|Cholinergic Agents|cholinergic agents|mesh-ancestor
110882536|NCT03883581|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110882537|NCT03883581|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110882538|NCT03883581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110882539|NCT03883581|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110882540|NCT03883581|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110882541|NCT03824535|Deoxyglucose|deoxyglucose|mesh-list
110882542|NCT03824535|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110882543|NCT03824535|Fluorides|fluorides|mesh-list
110882544|NCT03824535|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110882545|NCT03824535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110882546|NCT03824535|Cariostatic Agents|cariostatic agents|mesh-ancestor
110882547|NCT03824535|Protective Agents|protective agents|mesh-ancestor
110882548|NCT03824535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110882549|NCT03824535|Antimetabolites|antimetabolites|mesh-ancestor
110882550|NCT03824535|Antiviral Agents|antiviral agents|mesh-ancestor
110882551|NCT03824535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110882552|NCT03113643|Azacitidine|azacitidine|mesh-list
110882553|NCT03113643|Venetoclax|venetoclax|mesh-list
110882554|NCT03113643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110882555|NCT03113643|Antimetabolites|antimetabolites|mesh-ancestor
110882556|NCT03113643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110882557|NCT03113643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110882558|NCT03113643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110882559|NCT03091491|Nivolumab|nivolumab|mesh-list
110882560|NCT03091491|Ipilimumab|ipilimumab|mesh-list
110920467|NCT04742348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110882561|NCT03091491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110882562|NCT03091491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110882563|NCT03091491|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110882564|NCT03091491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110882565|NCT05598255|Dexamethasone|dexamethasone|mesh-list
110882566|NCT05598255|Levobupivacaine|levobupivacaine|mesh-list
110882567|NCT05598255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110882568|NCT05598255|Antiemetics|antiemetics|mesh-ancestor
110882569|NCT05598255|Autonomic Agents|autonomic agents|mesh-ancestor
110882570|NCT05598255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110882571|NCT05598255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110882572|NCT05598255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110882573|NCT05598255|Glucocorticoids|glucocorticoids|mesh-ancestor
110882574|NCT05598255|Hormones|hormones|mesh-ancestor
110882575|NCT05598255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110882576|NCT05598255|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110882577|NCT05598255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110882578|NCT05598255|Anesthetics, Local|anesthetics, local|mesh-ancestor
110600139|NCT00726726|Hemostatics|hemostatics|mesh-ancestor
110882579|NCT05598255|Anesthetics|anesthetics|mesh-ancestor
110882580|NCT05598255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110882581|NCT05598255|Sensory System Agents|sensory system agents|mesh-ancestor
110882583|NCT04733235|Hormones|hormones|mesh-ancestor
110882584|NCT04733235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110882585|NCT04733235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110882592|NCT05598177|Analgesics|analgesics|mesh-ancestor
110882593|NCT05598177|Sensory System Agents|sensory system agents|mesh-ancestor
110882594|NCT05598177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110882595|NCT05598177|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110882596|NCT05598177|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110882597|NCT05598177|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110882598|NCT05598177|Adrenergic Agents|adrenergic agents|mesh-ancestor
110882599|NCT05598177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110882600|NCT05598177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110882601|NCT03740529|Rituximab|rituximab|mesh-list
110882602|NCT03740529|Venetoclax|venetoclax|mesh-list
110882603|NCT03740529|Pirtobrutinib|pirtobrutinib|mesh-list
110882604|NCT03740529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110882605|NCT03740529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110882606|NCT03740529|Immunologic Factors|immunologic factors|mesh-ancestor
110882607|NCT03740529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110882608|NCT03740529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110882609|NCT03740529|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110882610|NCT03740529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110882611|NCT03740529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110882612|NCT03029208|Darbepoetin alfa|darbepoetin alfa|mesh-list
110882613|NCT03029208|Hematinics|hematinics|mesh-ancestor
110882614|NCT05212623|Vaccines|vaccines|mesh-list
110882615|NCT05212623|Immunologic Factors|immunologic factors|mesh-ancestor
110882616|NCT05212623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110882617|NCT03693222|Morphine|morphine|mesh-list
110882618|NCT03693222|Tramadol|tramadol|mesh-list
110882619|NCT03693222|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110882620|NCT03693222|Narcotics|narcotics|mesh-ancestor
110882621|NCT03693222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110882622|NCT03693222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110882623|NCT03693222|Analgesics|analgesics|mesh-ancestor
110882624|NCT03693222|Sensory System Agents|sensory system agents|mesh-ancestor
110882625|NCT03693222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110882626|NCT03693066|Chlorhexidine|chlorhexidine|mesh-list
110882627|NCT03693066|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110882628|NCT03693066|Disinfectants|disinfectants|mesh-list
110882629|NCT03693066|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110882630|NCT03693066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110882631|NCT03693066|Dermatologic Agents|dermatologic agents|mesh-ancestor
110882632|NCT03631641|Nivolumab|nivolumab|mesh-list
110882633|NCT03631641|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110882634|NCT03631641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110882635|NCT03631641|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110882636|NCT03631641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110882637|NCT03631875|Ketamine|ketamine|mesh-list
110882638|NCT03631875|Propofol|propofol|mesh-list
110882639|NCT03631875|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110882640|NCT03631875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110882641|NCT03631875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110882642|NCT03631875|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110882643|NCT03631875|Anesthetics, General|anesthetics, general|mesh-ancestor
110882644|NCT03631875|Anesthetics|anesthetics|mesh-ancestor
110882645|NCT03631875|Analgesics|analgesics|mesh-ancestor
110882646|NCT03631875|Sensory System Agents|sensory system agents|mesh-ancestor
110882647|NCT03631875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110882648|NCT03631875|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110882649|NCT03631875|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110882650|NCT03631875|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110882651|NCT03631875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110882652|NCT03631875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110882653|NCT03631563|Immunosuppressive Agents|immunosuppressive agents|mesh-list
110882654|NCT03631563|Immunologic Factors|immunologic factors|mesh-ancestor
110882655|NCT03631563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110882662|NCT03197935|Paclitaxel|paclitaxel|mesh-list
110882663|NCT03197935|Cyclophosphamide|cyclophosphamide|mesh-list
110882664|NCT03197935|Doxorubicin|doxorubicin|mesh-list
110882665|NCT03197935|Atezolizumab|atezolizumab|mesh-list
110882666|NCT03197935|Antibodies|antibodies|mesh-list
110882667|NCT03197935|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110882668|NCT03197935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110882669|NCT03197935|Tubulin Modulators|tubulin modulators|mesh-ancestor
110882670|NCT03197935|Antimitotic Agents|antimitotic agents|mesh-ancestor
110882671|NCT03197935|Mitosis Modulators|mitosis modulators|mesh-ancestor
110882672|NCT03197935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110882673|NCT03197935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110882674|NCT03197935|Immunologic Factors|immunologic factors|mesh-ancestor
110882675|NCT03197935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110882676|NCT03197935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110882677|NCT03197935|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110882678|NCT03197935|Alkylating Agents|alkylating agents|mesh-ancestor
110882679|NCT03197935|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110882680|NCT03197935|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110882681|NCT03197935|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110882682|NCT03197935|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110882683|NCT03197935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110882684|NCT03197935|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110882685|NCT03197935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110882686|NCT04941261|Vaccines|vaccines|mesh-list
110882687|NCT04941261|Immunologic Factors|immunologic factors|mesh-ancestor
110882688|NCT04941261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110882689|NCT05597709|Insulin|insulin|mesh-list
110882690|NCT05597709|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110882691|NCT05597709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110882692|NCT02917629|Pioglitazone|pioglitazone|mesh-list
110882693|NCT02917629|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110882694|NCT02917629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110882695|NCT05417841|Insulin|insulin|mesh-list
110882696|NCT05417841|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110882697|NCT05417841|Insulin Aspart|insulin aspart|mesh-list
110882698|NCT05417841|Insulin, Long-Acting|insulin, long-acting|mesh-list
110882699|NCT05417841|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
110882700|NCT05417841|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110882701|NCT05417841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110882702|NCT03691038|Pregabalin|pregabalin|mesh-list
110882703|NCT03691038|Analgesics|analgesics|mesh-ancestor
110882704|NCT03691038|Sensory System Agents|sensory system agents|mesh-ancestor
110882705|NCT03691038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110882706|NCT03691038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110882707|NCT03691038|Anticonvulsants|anticonvulsants|mesh-ancestor
110882708|NCT03691038|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110882709|NCT03691038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110882710|NCT03691038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110882711|NCT03691038|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110882712|NCT03691038|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110882713|NCT03691038|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110882714|NCT03691038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110882715|NCT03691038|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110882716|NCT02927847|Nicotine|nicotine|mesh-list
110882717|NCT02927847|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110882718|NCT02927847|Autonomic Agents|autonomic agents|mesh-ancestor
110882719|NCT02927847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110882720|NCT02927847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110882721|NCT02927847|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110882722|NCT02927847|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110882723|NCT02927847|Cholinergic Agents|cholinergic agents|mesh-ancestor
110882724|NCT02927847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110882725|NCT02927847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110882729|NCT03682692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110882731|NCT02886585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110882732|NCT02886585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110882733|NCT02886585|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110882734|NCT02886585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110882735|NCT01568853|Norepinephrine|norepinephrine|mesh-list
110882736|NCT01568853|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110882737|NCT01568853|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110882738|NCT01568853|Adrenergic Agents|adrenergic agents|mesh-ancestor
110882739|NCT01568853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110882740|NCT01568853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110882741|NCT01568853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110882742|NCT01568853|Sympathomimetics|sympathomimetics|mesh-ancestor
110882743|NCT01568853|Autonomic Agents|autonomic agents|mesh-ancestor
110882744|NCT01568853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110882745|NCT01568853|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110882746|NCT02960438|Quetmolimab|quetmolimab|mesh-list
110882747|NCT02960438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110882748|NCT03926052|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
110882749|NCT03926052|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110882750|NCT03926052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110882751|NCT03926052|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110882752|NCT03926052|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110882753|NCT03926052|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110882754|NCT03926052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110882755|NCT03926052|Dopamine Agents|dopamine agents|mesh-ancestor
110920511|NCT05479578|Dexamethasone|dexamethasone|mesh-list
110882756|NCT03926052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110882757|NCT03690414|Atropine|atropine|mesh-list
110882758|NCT03690414|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110882759|NCT03690414|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110882760|NCT03690414|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110882761|NCT03690414|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110882762|NCT03690414|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110882763|NCT03690414|Autonomic Agents|autonomic agents|mesh-ancestor
110882764|NCT03690414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110882765|NCT03690414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110882766|NCT03690414|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110882767|NCT03690414|Respiratory System Agents|respiratory system agents|mesh-ancestor
110882768|NCT03690414|Mydriatics|mydriatics|mesh-ancestor
110882769|NCT03690414|Parasympatholytics|parasympatholytics|mesh-ancestor
110882770|NCT03690414|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110882771|NCT03690414|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110882772|NCT03690414|Cholinergic Agents|cholinergic agents|mesh-ancestor
110882773|NCT03690414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110882774|NCT03690414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110882775|NCT02959970|Dapsone|dapsone|mesh-list
110882776|NCT02959970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110882777|NCT02959970|Antimalarials|antimalarials|mesh-ancestor
110882778|NCT02959970|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110882779|NCT02959970|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110882780|NCT02959970|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110882781|NCT02959970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110882782|NCT02959970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110882783|NCT02959970|Leprostatic Agents|leprostatic agents|mesh-ancestor
110882784|NCT02959970|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110882785|NCT03681990|Ethanol|ethanol|mesh-list
110882786|NCT03681990|Chlorhexidine|chlorhexidine|mesh-list
110882787|NCT03681990|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110882788|NCT03681990|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110882789|NCT03681990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110882790|NCT03681990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110882791|NCT03681990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110882792|NCT03681990|Disinfectants|disinfectants|mesh-ancestor
110205524|NCT00055679|Alkylating Agents|alkylating agents|mesh-ancestor
110205525|NCT00055679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110882807|NCT05351151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110882808|NCT05351151|Sensory System Agents|sensory system agents|mesh-ancestor
110882809|NCT05351151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110882810|NCT05351151|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110882811|NCT05351151|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110882812|NCT05351151|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110882813|NCT05351151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110882814|NCT05351151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110882816|NCT01568931|Keratolytic Agents|keratolytic agents|mesh-ancestor
110882817|NCT01568931|Dermatologic Agents|dermatologic agents|mesh-ancestor
110882818|NCT04800367|Denosumab|denosumab|mesh-list
110882819|NCT04800367|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110882820|NCT04800367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110882821|NCT03713658|Risperidone|risperidone|mesh-list
110882822|NCT03713658|Paliperidone Palmitate|paliperidone palmitate|mesh-list
110882823|NCT03713658|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110882824|NCT03713658|Serotonin Agents|serotonin agents|mesh-ancestor
110882825|NCT03713658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110882826|NCT03713658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110882827|NCT03713658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110882828|NCT03713658|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110882829|NCT03713658|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110882830|NCT03713658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110882831|NCT03713658|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110882832|NCT03713658|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110882833|NCT03713658|Dopamine Agents|dopamine agents|mesh-ancestor
110882834|NCT03713658|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110882835|NCT03713658|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110882836|NCT05475717|Alprostadil|alprostadil|mesh-list
110882837|NCT05475717|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110882838|NCT05475717|Vasodilator Agents|vasodilator agents|mesh-ancestor
110882839|NCT05475717|Urological Agents|urological agents|mesh-ancestor
110882840|NCT05133687|Bupivacaine|bupivacaine|mesh-list
110882841|NCT05133687|Anesthetics, Local|anesthetics, local|mesh-ancestor
110882842|NCT05133687|Anesthetics|anesthetics|mesh-ancestor
110882843|NCT05133687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110882844|NCT05133687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110882845|NCT05133687|Sensory System Agents|sensory system agents|mesh-ancestor
110882846|NCT05133687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110882847|NCT03685032|Dexamethasone|dexamethasone|mesh-list
110882848|NCT03685032|Ondansetron|ondansetron|mesh-list
110882849|NCT03685032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110882850|NCT03685032|Antiemetics|antiemetics|mesh-ancestor
110882851|NCT03685032|Autonomic Agents|autonomic agents|mesh-ancestor
110882852|NCT03685032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110882853|NCT03685032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110882854|NCT03685032|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110205534|NCT00171886|Octreotide|octreotide|mesh-list
110882859|NCT03685032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110882860|NCT03685032|Antipruritics|antipruritics|mesh-ancestor
110882861|NCT03685032|Dermatologic Agents|dermatologic agents|mesh-ancestor
110882862|NCT03685032|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110882863|NCT03685032|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110882864|NCT03685032|Serotonin Agents|serotonin agents|mesh-ancestor
110882865|NCT03685032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110882866|NCT03685032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110882868|NCT02451111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110882869|NCT02451111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110882870|NCT02451111|Immunologic Factors|immunologic factors|mesh-ancestor
110882871|NCT02451111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110882872|NCT02451111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110882873|NCT03689010|Azelaic acid|azelaic acid|mesh-list
110882874|NCT03689010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110882875|NCT03689010|Dermatologic Agents|dermatologic agents|mesh-ancestor
110882876|NCT05451771|Dexamethasone|dexamethasone|mesh-list
110882877|NCT05451771|Dexamethasone acetate|dexamethasone acetate|mesh-list
110882878|NCT05451771|Venetoclax|venetoclax|mesh-list
110882879|NCT05451771|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110882880|NCT05451771|Daratumumab|daratumumab|mesh-list
110882881|NCT05451771|Pomalidomide|pomalidomide|mesh-list
110882882|NCT05451771|Ixazomib|ixazomib|mesh-list
110882883|NCT05451771|BB 1101|bb 1101|mesh-list
110882884|NCT05451771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110882885|NCT05451771|Antiemetics|antiemetics|mesh-ancestor
110882886|NCT05451771|Autonomic Agents|autonomic agents|mesh-ancestor
110882887|NCT05451771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110882888|NCT05451771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110882889|NCT05451771|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110882890|NCT05451771|Glucocorticoids|glucocorticoids|mesh-ancestor
110882891|NCT05451771|Hormones|hormones|mesh-ancestor
110882892|NCT05451771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110882893|NCT05451771|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110882894|NCT05451771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110882895|NCT05451771|Protease Inhibitors|protease inhibitors|mesh-ancestor
110882896|NCT05451771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110882897|NCT05451771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110882898|NCT05451771|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110882899|NCT05451771|Alkylating Agents|alkylating agents|mesh-ancestor
110882900|NCT05451771|Immunologic Factors|immunologic factors|mesh-ancestor
110882901|NCT05451771|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110882902|NCT05451771|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110882903|NCT05451771|Growth Substances|growth substances|mesh-ancestor
110882904|NCT05451771|Growth Inhibitors|growth inhibitors|mesh-ancestor
110882906|NCT03680976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110882907|NCT05387343|Vaccines|vaccines|mesh-list
110882908|NCT05387343|Immunologic Factors|immunologic factors|mesh-ancestor
110882909|NCT05387343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110882910|NCT04220775|Atezolizumab|atezolizumab|mesh-list
110882911|NCT04220775|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110882912|NCT04220775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110882913|NCT04220775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110882914|NCT04220775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110882915|NCT01381887|Canagliflozin|canagliflozin|mesh-list
110882916|NCT01381887|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110882917|NCT01381887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110882918|NCT01381887|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110882919|NCT01381887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110882920|NCT04877379|Ceftibuten|ceftibuten|mesh-list
110882921|NCT04877379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110882922|NCT04877379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110882923|NCT01382745|Nimotuzumab|nimotuzumab|mesh-list
110882924|NCT01382745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110882925|NCT01382745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110882926|NCT03684330|Vitamin D|vitamin d|mesh-list
110882939|NCT03677466|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110882940|NCT03677466|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110882941|NCT03677466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110882943|NCT03447132|Goserelin|goserelin|mesh-list
110882944|NCT03447132|Palbociclib|palbociclib|mesh-list
110882945|NCT03447132|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110882946|NCT03447132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110882947|NCT03447132|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110882948|NCT03447132|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110882949|NCT03447132|Hormone Antagonists|hormone antagonists|mesh-ancestor
110882950|NCT03447132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110882951|NCT03447132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110882952|NCT03447132|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110600517|NCT00728312|Dopamine Agents|dopamine agents|mesh-ancestor
110882953|NCT03447132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110882954|NCT03447132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110882955|NCT04133623|Ibuprofen|ibuprofen|mesh-list
110882956|NCT04133623|Ketorolac|ketorolac|mesh-list
110882957|NCT04133623|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110882958|NCT04133623|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110882959|NCT04133623|Analgesics|analgesics|mesh-ancestor
110882960|NCT04133623|Sensory System Agents|sensory system agents|mesh-ancestor
110882961|NCT04133623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110882962|NCT04133623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110882963|NCT04133623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110882964|NCT04133623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110882965|NCT04133623|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110882966|NCT04133623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110882967|NCT04133623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110882968|NCT03188185|Naltrexone|naltrexone|mesh-list
110882969|NCT03188185|Buprenorphine|buprenorphine|mesh-list
110882970|NCT03188185|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110882971|NCT03188185|Narcotics|narcotics|mesh-ancestor
110882972|NCT03188185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110882973|NCT03188185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110882974|NCT03188185|Analgesics|analgesics|mesh-ancestor
110882975|NCT03188185|Sensory System Agents|sensory system agents|mesh-ancestor
110882976|NCT03188185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110882977|NCT03188185|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110882978|NCT03188185|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110882979|NCT03679182|Olanzapine|olanzapine|mesh-list
110882980|NCT03679182|Antiemetics|antiemetics|mesh-ancestor
110882981|NCT03679182|Autonomic Agents|autonomic agents|mesh-ancestor
110882982|NCT03679182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110882983|NCT03679182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110882984|NCT03679182|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110882985|NCT03679182|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110882986|NCT03679182|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110882987|NCT03679182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110882988|NCT03679182|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110198404|NCT00126256|Immunologic Factors|immunologic factors|mesh-ancestor
110882989|NCT03679182|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110882990|NCT03679182|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110882999|NCT03184987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110883000|NCT03184987|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110883001|NCT03184987|Respiratory System Agents|respiratory system agents|mesh-ancestor
110883002|NCT03184987|Tocolytic Agents|tocolytic agents|mesh-ancestor
110883003|NCT03184987|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110883004|NCT03184987|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110883005|NCT03184987|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110883006|NCT03184987|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110883007|NCT03184987|Adrenergic Agents|adrenergic agents|mesh-ancestor
110883008|NCT03184987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110883009|NCT03184987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110883010|NCT03193333|Timolol|timolol|mesh-list
110883011|NCT03193333|Brimonidine Tartrate|brimonidine tartrate|mesh-list
110883012|NCT03193333|Dorzolamide|dorzolamide|mesh-list
110883013|NCT03193333|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110883014|NCT03193333|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110883015|NCT03193333|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110883016|NCT03193333|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110883017|NCT03193333|Adrenergic Agents|adrenergic agents|mesh-ancestor
110883018|NCT03193333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110883019|NCT03193333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110883020|NCT03193333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110883021|NCT03193333|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110883022|NCT03193333|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110883023|NCT03193333|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110883024|NCT03193333|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110883025|NCT03193333|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110883026|NCT03193333|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110883027|NCT03193333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110883028|NCT03026166|Nivolumab|nivolumab|mesh-list
110600584|NCT00868426|Adrenergic Agents|adrenergic agents|mesh-ancestor
110883029|NCT03026166|Ipilimumab|ipilimumab|mesh-list
110883030|NCT03026166|Rovalpituzumab tesirine|rovalpituzumab tesirine|mesh-list
110883031|NCT03026166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110883032|NCT03026166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110883033|NCT03026166|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110883034|NCT03026166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110883035|NCT03026166|Immunoconjugates|immunoconjugates|mesh-ancestor
110883036|NCT03026166|Immunologic Factors|immunologic factors|mesh-ancestor
110883037|NCT03026166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110883038|NCT03573648|Palbociclib|palbociclib|mesh-list
110883039|NCT03573648|Avelumab|avelumab|mesh-list
110883040|NCT03573648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110883041|NCT03573648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110883042|NCT03573648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110883043|NCT03573648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110883044|NCT03573648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110883045|NCT03026088|Bisoprolol|bisoprolol|mesh-list
110883046|NCT03026088|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110883047|NCT03026088|Sympatholytics|sympatholytics|mesh-ancestor
110883048|NCT03026088|Autonomic Agents|autonomic agents|mesh-ancestor
110883049|NCT03026088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110883050|NCT03026088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110883051|NCT03026088|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110883052|NCT03026088|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110883053|NCT03026088|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110883054|NCT03026088|Adrenergic Agents|adrenergic agents|mesh-ancestor
110883055|NCT03026088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110883059|NCT03678792|Tramadol|tramadol|mesh-list
110883060|NCT03678792|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
110883061|NCT03678792|Naloxone|naloxone|mesh-list
110883062|NCT03678792|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110883063|NCT03678792|Narcotics|narcotics|mesh-ancestor
110883064|NCT03678792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110883065|NCT03678792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110883066|NCT03678792|Analgesics|analgesics|mesh-ancestor
110883067|NCT03678792|Sensory System Agents|sensory system agents|mesh-ancestor
110883068|NCT03678792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110883069|NCT03678792|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110883070|NCT03678480|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
110883071|NCT03678480|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
110883072|NCT03678480|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110883073|NCT03181789|Interleukin-12|interleukin-12|mesh-list
110883074|NCT03181789|Vaccines|vaccines|mesh-list
110883075|NCT03181789|Immunologic Factors|immunologic factors|mesh-ancestor
110883076|NCT03181789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110883077|NCT03181789|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110883078|NCT03181789|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110883079|NCT03181789|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110883080|NCT03181789|Growth Substances|growth substances|mesh-ancestor
110883081|NCT03181789|Growth Inhibitors|growth inhibitors|mesh-ancestor
110883082|NCT03181789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110883083|NCT03678090|Plasminogen|plasminogen|mesh-list
110883084|NCT03678090|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
110883085|NCT03678090|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110883086|NCT03678090|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110883087|NCT03678090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110883088|NCT03678012|Hydrogen Peroxide|hydrogen peroxide|mesh-list
110883089|NCT03678012|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
110883090|NCT03678012|Hematinics|hematinics|mesh-ancestor
110883091|NCT03678012|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
110883092|NCT03678012|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110883093|NCT03678012|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110883094|NCT03678012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110883095|NCT03676296|Puerarin|puerarin|mesh-list
110883096|NCT03676296|Vasodilator Agents|vasodilator agents|mesh-ancestor
110883097|NCT03676140|Azithromycin|azithromycin|mesh-list
110883098|NCT03676140|Ivermectin|ivermectin|mesh-list
110883099|NCT03676140|Albendazole|albendazole|mesh-list
110883100|NCT03676140|Diethylcarbamazine|diethylcarbamazine|mesh-list
110883101|NCT03676140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110883102|NCT03676140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110883103|NCT03676140|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110883104|NCT03676140|Anthelmintics|anthelmintics|mesh-ancestor
110883105|NCT03676140|Anticestodal Agents|anticestodal agents|mesh-ancestor
110883106|NCT03676140|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110883107|NCT03676140|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110883108|NCT03676140|Tubulin Modulators|tubulin modulators|mesh-ancestor
110883109|NCT03676140|Antimitotic Agents|antimitotic agents|mesh-ancestor
110883110|NCT03676140|Mitosis Modulators|mitosis modulators|mesh-ancestor
110883111|NCT03676140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110883112|NCT03676140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110883113|NCT03676140|Filaricides|filaricides|mesh-ancestor
110883114|NCT03676140|Antinematodal Agents|antinematodal agents|mesh-ancestor
110883115|NCT03676140|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
110883116|NCT03676140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110883117|NCT03504774|Immunomodulating Agents|immunomodulating agents|mesh-list
110883118|NCT03504774|Immunologic Factors|immunologic factors|mesh-ancestor
110883119|NCT03504774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110883120|NCT04059198|Tenofovir|tenofovir|mesh-list
110883121|NCT04059198|Antiviral Agents|antiviral agents|mesh-ancestor
110883122|NCT04059198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110883123|NCT04059198|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110883124|NCT04059198|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110883125|NCT04059198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110883126|NCT04059198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110883127|NCT04059198|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110883128|NCT04059198|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110883129|NCT04058964|Pembrolizumab|pembrolizumab|mesh-list
110883130|NCT04058964|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110883137|NCT03246906|Cyclophosphamide|cyclophosphamide|mesh-list
110883139|NCT03246906|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110883140|NCT03246906|Immunologic Factors|immunologic factors|mesh-ancestor
110883141|NCT03246906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110883142|NCT03246906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110883143|NCT03246906|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110883144|NCT03246906|Alkylating Agents|alkylating agents|mesh-ancestor
110883145|NCT03246906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110883146|NCT03246906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110883147|NCT03246906|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110883148|NCT03246906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110883149|NCT03246906|Antifungal Agents|antifungal agents|mesh-ancestor
110883150|NCT03246906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110883151|NCT03246906|Dermatologic Agents|dermatologic agents|mesh-ancestor
110883152|NCT03246906|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110883153|NCT03246906|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110883154|NCT03246906|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110883155|NCT03246906|Antitubercular Agents|antitubercular agents|mesh-ancestor
110883156|NCT03246906|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110883157|NCT03675594|Cobalt|cobalt|mesh-list
110883158|NCT03675594|Chromium|chromium|mesh-list
110883159|NCT03675594|Trace Elements|trace elements|mesh-ancestor
110883160|NCT03675594|Micronutrients|micronutrients|mesh-ancestor
110883161|NCT03675594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110883162|NCT03671538|Pemetrexed|pemetrexed|mesh-list
110883163|NCT03671538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110883164|NCT03671538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110883165|NCT03671538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110883166|NCT03671538|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110883167|NCT03671538|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110883168|NCT05420467|Paclitaxel|paclitaxel|mesh-list
110883169|NCT05420467|Docetaxel|docetaxel|mesh-list
110883170|NCT05420467|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110883171|NCT05420467|Cyclophosphamide|cyclophosphamide|mesh-list
110883172|NCT05420467|Carboplatin|carboplatin|mesh-list
110883173|NCT05420467|Trastuzumab|trastuzumab|mesh-list
110883174|NCT05420467|Epirubicin|epirubicin|mesh-list
110883175|NCT05420467|Pertuzumab|pertuzumab|mesh-list
110883176|NCT05420467|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110883177|NCT05420467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110883178|NCT05420467|Tubulin Modulators|tubulin modulators|mesh-ancestor
110883179|NCT05420467|Antimitotic Agents|antimitotic agents|mesh-ancestor
110883180|NCT05420467|Mitosis Modulators|mitosis modulators|mesh-ancestor
110883181|NCT05420467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110883182|NCT05420467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110883183|NCT05420467|Immunologic Factors|immunologic factors|mesh-ancestor
110883184|NCT05420467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110883185|NCT05420467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110883186|NCT05420467|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110883187|NCT05420467|Alkylating Agents|alkylating agents|mesh-ancestor
110883188|NCT05420467|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110883189|NCT05420467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110883190|NCT05420467|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110883191|NCT05420467|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110883192|NCT05420467|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110883193|NCT05420467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110883195|NCT03022578|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110883196|NCT03022578|Alkylating Agents|alkylating agents|mesh-ancestor
110883197|NCT03022578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110883198|NCT03022578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110883199|NCT03671070|Epinephrine|epinephrine|mesh-list
110883200|NCT03671070|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110883201|NCT03671070|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110883213|NCT03671070|Sympathomimetics|sympathomimetics|mesh-ancestor
110883214|NCT03671070|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110883215|NCT03670758|Protein S|protein s|mesh-list
110883216|NCT03670758|Anticoagulants|anticoagulants|mesh-ancestor
110883217|NCT03674658|Propafenone|propafenone|mesh-list
110883218|NCT03674658|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110883219|NCT03674658|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110883220|NCT03674658|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110883221|NCT03674658|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110883222|NCT03674658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110883223|NCT03623256|Fentanyl|fentanyl|mesh-list
110883224|NCT03623256|Bupivacaine|bupivacaine|mesh-list
110883225|NCT03623256|Anesthetics, Local|anesthetics, local|mesh-ancestor
110883226|NCT03623256|Anesthetics|anesthetics|mesh-ancestor
110883227|NCT03623256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110883228|NCT03623256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110883229|NCT03623256|Sensory System Agents|sensory system agents|mesh-ancestor
110883230|NCT03623256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110883231|NCT03623256|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110883232|NCT03623256|Narcotics|narcotics|mesh-ancestor
110883233|NCT03623256|Analgesics|analgesics|mesh-ancestor
110883234|NCT03623256|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110883235|NCT03623256|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110883236|NCT03623256|Anesthetics, General|anesthetics, general|mesh-ancestor
110883237|NCT03082014|Losartan|losartan|mesh-list
110883238|NCT03082014|Atenolol|atenolol|mesh-list
110883239|NCT03082014|Amlodipine|amlodipine|mesh-list
110883240|NCT03082014|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110883241|NCT03082014|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110883242|NCT03082014|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110883243|NCT03082014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110883244|NCT03082014|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110883245|NCT03082014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110883246|NCT03082014|Vasodilator Agents|vasodilator agents|mesh-ancestor
110883247|NCT03082014|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110883248|NCT03082014|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110883249|NCT03082014|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110883250|NCT03082014|Sympatholytics|sympatholytics|mesh-ancestor
110883251|NCT03082014|Autonomic Agents|autonomic agents|mesh-ancestor
110883252|NCT03082014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110883253|NCT03082014|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110883254|NCT03082014|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110883255|NCT03082014|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110883256|NCT03082014|Adrenergic Agents|adrenergic agents|mesh-ancestor
110883257|NCT03082014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110883258|NCT03670212|Hydrocortisone|hydrocortisone|mesh-list
110883259|NCT03670212|Yohimbine|yohimbine|mesh-list
110883260|NCT03670212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110883261|NCT03670212|Mydriatics|mydriatics|mesh-ancestor
110883262|NCT03670212|Autonomic Agents|autonomic agents|mesh-ancestor
110883263|NCT03670212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110883264|NCT03670212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110205572|NCT00055835|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110883272|NCT03165955|Paclitaxel|paclitaxel|mesh-list
110883273|NCT03165955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110883274|NCT03165955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110883275|NCT03165955|Tubulin Modulators|tubulin modulators|mesh-ancestor
110883276|NCT03165955|Antimitotic Agents|antimitotic agents|mesh-ancestor
110883277|NCT03165955|Mitosis Modulators|mitosis modulators|mesh-ancestor
110883278|NCT03165955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110883279|NCT05263921|Ritonavir|ritonavir|mesh-list
110883280|NCT05263921|Nirmatrelvir|nirmatrelvir|mesh-list
110883281|NCT05263921|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110883282|NCT05263921|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110883283|NCT05263921|Protease Inhibitors|protease inhibitors|mesh-ancestor
110883284|NCT05263921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110883285|NCT05263921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110883286|NCT05263921|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110883287|NCT05263921|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110883288|NCT05263921|Antiviral Agents|antiviral agents|mesh-ancestor
110883289|NCT05263921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110883290|NCT05263921|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110883291|NCT05263921|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110883292|NCT03673332|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
110883293|NCT03673332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110883294|NCT03673332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110883295|NCT03673332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110883296|NCT03048084|Levetiracetam|levetiracetam|mesh-list
110883297|NCT03048084|Valproic Acid|valproic acid|mesh-list
110883298|NCT03048084|Anticonvulsants|anticonvulsants|mesh-ancestor
110883299|NCT03048084|Nootropic Agents|nootropic agents|mesh-ancestor
110883300|NCT03048084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110883301|NCT03048084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110883302|NCT03048084|GABA Agents|gaba agents|mesh-ancestor
110883303|NCT03048084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110883304|NCT03048084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110883305|NCT03048084|Antimanic Agents|antimanic agents|mesh-ancestor
110883306|NCT03048084|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110198497|NCT00074178|Abortifacient Agents|abortifacient agents|mesh-ancestor
110883307|NCT03048084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110883308|NCT03048084|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110883309|NCT02329860|Apatinib|apatinib|mesh-list
110883310|NCT02329860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110883311|NCT02329860|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110883312|NCT02329860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110883313|NCT02329860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110883314|NCT02251548|Cyclophosphamide|cyclophosphamide|mesh-list
110883315|NCT02251548|Rituximab|rituximab|mesh-list
110883316|NCT02251548|Fludarabine|fludarabine|mesh-list
110883317|NCT02251548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110248961|NCT00402662|Everolimus|everolimus|mesh-list
110883318|NCT02251548|Immunologic Factors|immunologic factors|mesh-ancestor
110883319|NCT02251548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110883320|NCT02251548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110883321|NCT02251548|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110883322|NCT02251548|Alkylating Agents|alkylating agents|mesh-ancestor
110883323|NCT02251548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110883324|NCT02251548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110883325|NCT02251548|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110883326|NCT02251548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110883327|NCT03165721|Guadecitabine|guadecitabine|mesh-list
110883328|NCT03165721|Azacitidine|azacitidine|mesh-list
110883329|NCT03165721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110883330|NCT03165721|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110600882|NCT00871156|Chloroquine|chloroquine|mesh-list
110883343|NCT02224872|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110883344|NCT02224872|Alkylating Agents|alkylating agents|mesh-ancestor
110883345|NCT02224872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110883346|NCT02224872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110883347|NCT02224872|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110883348|NCT02224872|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110883349|NCT02224872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110883350|NCT02224872|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110883351|NCT02224872|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110883352|NCT02224872|Antitubercular Agents|antitubercular agents|mesh-ancestor
110883353|NCT02224872|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110883354|NCT02224872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110883355|NCT02187198|Buprenorphine|buprenorphine|mesh-list
110883356|NCT02187198|Naloxone|naloxone|mesh-list
110883357|NCT02187198|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110883358|NCT02187198|Narcotics|narcotics|mesh-ancestor
110883359|NCT02187198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110883360|NCT02187198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110883361|NCT02187198|Analgesics|analgesics|mesh-ancestor
110883362|NCT02187198|Sensory System Agents|sensory system agents|mesh-ancestor
110883363|NCT02187198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110883364|NCT02187198|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110883365|NCT04969705|Dexmedetomidine|dexmedetomidine|mesh-list
110883366|NCT04969705|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110883367|NCT04969705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110883368|NCT04969705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110883369|NCT04969705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110883370|NCT04969705|Analgesics|analgesics|mesh-ancestor
110883371|NCT04969705|Sensory System Agents|sensory system agents|mesh-ancestor
110883372|NCT04969705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110883373|NCT04969705|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110883374|NCT04969705|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110883375|NCT04969705|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110883376|NCT04969705|Adrenergic Agents|adrenergic agents|mesh-ancestor
110883377|NCT04969705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110883378|NCT04969705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110883379|NCT03676374|Prucalopride|prucalopride|mesh-list
110883380|NCT03676374|Laxatives|laxatives|mesh-ancestor
110883381|NCT03676374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110883382|NCT03676374|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
110883383|NCT03676374|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110883384|NCT03676374|Serotonin Agents|serotonin agents|mesh-ancestor
110883385|NCT03676374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110883386|NCT03676374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110883387|NCT03676374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110883388|NCT01829958|Prednisone|prednisone|mesh-list
110883389|NCT01829958|Rituximab|rituximab|mesh-list
110883390|NCT01829958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110883391|NCT01829958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110883392|NCT01829958|Immunologic Factors|immunologic factors|mesh-ancestor
110883393|NCT01829958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110883394|NCT01829958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110883411|NCT03023046|Etoposide|etoposide|mesh-list
110883412|NCT03023046|Vincristine|vincristine|mesh-list
110883413|NCT03023046|Etoposide phosphate|etoposide phosphate|mesh-list
110883414|NCT03023046|Imatinib Mesylate|imatinib mesylate|mesh-list
110883415|NCT03023046|Daunorubicin|daunorubicin|mesh-list
110883416|NCT03023046|Dasatinib|dasatinib|mesh-list
110883417|NCT03023046|Podophyllotoxin|podophyllotoxin|mesh-list
110883418|NCT03023046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110883419|NCT03023046|Antibodies|antibodies|mesh-list
110883420|NCT03023046|Immunoglobulins|immunoglobulins|mesh-list
110883421|NCT03023046|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110883422|NCT03023046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110883423|NCT03023046|Immunologic Factors|immunologic factors|mesh-ancestor
110883424|NCT03023046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110883425|NCT03023046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110883426|NCT03023046|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110883427|NCT03023046|Alkylating Agents|alkylating agents|mesh-ancestor
110883428|NCT03023046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110883429|NCT03023046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110883430|NCT03023046|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110883431|NCT03023046|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110883432|NCT03023046|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110883433|NCT03023046|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110883434|NCT03023046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110883435|NCT03023046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110883436|NCT03023046|Glucocorticoids|glucocorticoids|mesh-ancestor
110883437|NCT03023046|Hormones|hormones|mesh-ancestor
110883438|NCT03023046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110883439|NCT03023046|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110883440|NCT03023046|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110883441|NCT03023046|Tubulin Modulators|tubulin modulators|mesh-ancestor
110883442|NCT03023046|Antimitotic Agents|antimitotic agents|mesh-ancestor
110883443|NCT03023046|Mitosis Modulators|mitosis modulators|mesh-ancestor
110883444|NCT03023046|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110883445|NCT03023046|Keratolytic Agents|keratolytic agents|mesh-ancestor
110883446|NCT03023046|Dermatologic Agents|dermatologic agents|mesh-ancestor
110883447|NCT03668262|Atracurium|atracurium|mesh-list
110883448|NCT03668262|Cisatracurium|cisatracurium|mesh-list
110883449|NCT03668262|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110883450|NCT03668262|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110883451|NCT03668262|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110883452|NCT03668262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110883453|NCT03668262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110883454|NCT03668262|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
110883455|NCT03668262|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110205602|NCT00055913|Bevacizumab|bevacizumab|mesh-list
110883476|NCT03668964|Dermatologic Agents|dermatologic agents|mesh-ancestor
110883478|NCT03668730|Fluorouracil|fluorouracil|mesh-list
110883479|NCT03668730|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110883480|NCT03668730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110883481|NCT03668730|Tubulin Modulators|tubulin modulators|mesh-ancestor
110883482|NCT03668730|Antimitotic Agents|antimitotic agents|mesh-ancestor
110601035|NCT00729794|Antiemetics|antiemetics|mesh-ancestor
110883483|NCT03668730|Mitosis Modulators|mitosis modulators|mesh-ancestor
110883484|NCT03668730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110883485|NCT03668730|Antimetabolites|antimetabolites|mesh-ancestor
110883486|NCT03668730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110883487|NCT03668730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110883488|NCT03668730|Immunologic Factors|immunologic factors|mesh-ancestor
110883489|NCT03668730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110883490|NCT03021018|Lorazepam|lorazepam|mesh-list
110883491|NCT03021018|Brivaracetam|brivaracetam|mesh-list
110883492|NCT03021018|Anticonvulsants|anticonvulsants|mesh-ancestor
110883493|NCT03021018|Antiemetics|antiemetics|mesh-ancestor
110883494|NCT03021018|Autonomic Agents|autonomic agents|mesh-ancestor
110883495|NCT03021018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110883496|NCT03021018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110883497|NCT03021018|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110883498|NCT03021018|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110883499|NCT03021018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110883500|NCT03021018|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110883501|NCT03021018|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110883502|NCT03021018|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110883503|NCT03021018|GABA Modulators|gaba modulators|mesh-ancestor
110883504|NCT03021018|GABA Agents|gaba agents|mesh-ancestor
110883505|NCT03021018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110883506|NCT03021018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110883507|NCT02509507|Pembrolizumab|pembrolizumab|mesh-list
110883508|NCT02509507|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
110883509|NCT02509507|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110883510|NCT02509507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110883511|NCT02509507|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110534669|NCT02676336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110883515|NCT03175549|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110883517|NCT03175549|Sensory System Agents|sensory system agents|mesh-ancestor
110883518|NCT03175549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110883519|NCT03175549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110883520|NCT03175549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110883521|NCT03175549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110883522|NCT03175549|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
110883523|NCT03175549|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110883524|NCT03175549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110883525|NCT03175549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110883526|NCT01314937|Mebendazole|mebendazole|mesh-list
110883527|NCT01314937|Piperazine|piperazine|mesh-list
110198566|NCT00043784|Enoxaparin|enoxaparin|mesh-list
110883528|NCT01314937|Piperazine citrate|piperazine citrate|mesh-list
110883529|NCT01314937|DMP 777|dmp 777|mesh-list
110883530|NCT01314937|Antinematodal Agents|antinematodal agents|mesh-ancestor
110883531|NCT01314937|Anthelmintics|anthelmintics|mesh-ancestor
110883532|NCT01314937|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110883533|NCT01314937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110883534|NCT01314937|Tubulin Modulators|tubulin modulators|mesh-ancestor
110883535|NCT01314937|Antimitotic Agents|antimitotic agents|mesh-ancestor
110883536|NCT01314937|Mitosis Modulators|mitosis modulators|mesh-ancestor
110883537|NCT01314937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110883538|NCT01314937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110883539|NCT01314937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110883540|NCT04718155|Atorvastatin|atorvastatin|mesh-list
110883541|NCT04718155|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110883542|NCT04718155|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110883543|NCT04718155|Antimetabolites|antimetabolites|mesh-ancestor
110883544|NCT04718155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110883545|NCT04718155|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110883546|NCT04718155|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110883547|NCT04718155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110883548|NCT04668859|Midodrine|midodrine|mesh-list
110883549|NCT04668859|Sympathomimetics|sympathomimetics|mesh-ancestor
110883550|NCT04668859|Autonomic Agents|autonomic agents|mesh-ancestor
110883551|NCT04668859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110883552|NCT04668859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110883553|NCT04668859|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110883554|NCT04668859|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110883555|NCT04668859|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110883556|NCT04668859|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110883557|NCT04668859|Adrenergic Agents|adrenergic agents|mesh-ancestor
110883558|NCT04668859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110883559|NCT04668859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110883560|NCT02924688|Fluticasone|fluticasone|mesh-list
110883561|NCT02924688|Albuterol|albuterol|mesh-list
110883562|NCT02924688|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110883563|NCT02924688|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
110883564|NCT02924688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110883565|NCT02924688|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110883566|NCT02924688|Autonomic Agents|autonomic agents|mesh-ancestor
110883567|NCT02924688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110883568|NCT02924688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110883569|NCT02924688|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110883570|NCT02924688|Respiratory System Agents|respiratory system agents|mesh-ancestor
110883571|NCT02924688|Dermatologic Agents|dermatologic agents|mesh-ancestor
110883572|NCT02924688|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110883573|NCT02924688|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110883574|NCT02924688|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110883575|NCT02924688|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110883576|NCT02924688|Adrenergic Agents|adrenergic agents|mesh-ancestor
110883577|NCT02924688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110883578|NCT02924688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110883579|NCT02924688|Tocolytic Agents|tocolytic agents|mesh-ancestor
110883580|NCT02924688|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110883581|NCT02924688|Glucocorticoids|glucocorticoids|mesh-ancestor
110883582|NCT02924688|Hormones|hormones|mesh-ancestor
110883597|NCT03668418|Antimitotic Agents|antimitotic agents|mesh-ancestor
110883598|NCT03668418|Mitosis Modulators|mitosis modulators|mesh-ancestor
110883599|NCT03668418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110883600|NCT03668418|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110883601|NCT03668418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110883602|NCT03668418|Immunologic Factors|immunologic factors|mesh-ancestor
110883603|NCT03668418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110883604|NCT03668418|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110883605|NCT03668418|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110883606|NCT03668418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110883607|NCT03668418|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110883608|NCT03668418|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110883609|NCT03011892|Triamcinolone|triamcinolone|mesh-list
110883610|NCT03011892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110883611|NCT03011892|Glucocorticoids|glucocorticoids|mesh-ancestor
110883613|NCT03011892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110883614|NCT03011892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110883615|NCT02125513|Paclitaxel|paclitaxel|mesh-list
110883616|NCT02125513|Carboplatin|carboplatin|mesh-list
110883617|NCT02125513|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110883618|NCT02125513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110883619|NCT02125513|Tubulin Modulators|tubulin modulators|mesh-ancestor
110883620|NCT02125513|Antimitotic Agents|antimitotic agents|mesh-ancestor
110883621|NCT02125513|Mitosis Modulators|mitosis modulators|mesh-ancestor
110883622|NCT02125513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110883623|NCT04575948|Chlorhexidine|chlorhexidine|mesh-list
110883624|NCT04575948|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110883625|NCT04575948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110883626|NCT04575948|Disinfectants|disinfectants|mesh-ancestor
110883627|NCT03666546|Methamphetamine|methamphetamine|mesh-list
110883628|NCT03666546|Lactulose|lactulose|mesh-list
110883629|NCT03666546|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110883630|NCT03666546|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110883631|NCT03666546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110883632|NCT03666546|Sympathomimetics|sympathomimetics|mesh-ancestor
110601194|NCT00872248|Anesthetics|anesthetics|mesh-list
110883633|NCT03666546|Autonomic Agents|autonomic agents|mesh-ancestor
110883634|NCT03666546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110883636|NCT03666546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110883637|NCT03666546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110883638|NCT03666546|Adrenergic Agents|adrenergic agents|mesh-ancestor
110883639|NCT03666546|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110883640|NCT03666546|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110883641|NCT03666546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110883642|NCT03666546|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110883643|NCT03012828|Moxidectin|moxidectin|mesh-list
110883644|NCT03012828|Anthelmintics|anthelmintics|mesh-ancestor
110883645|NCT03012828|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110883646|NCT03012828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110883667|NCT03666390|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110883668|NCT03666390|GABA Modulators|gaba modulators|mesh-ancestor
110883669|NCT03666390|GABA Agents|gaba agents|mesh-ancestor
110883670|NCT03003390|Enoxaparin|enoxaparin|mesh-list
110883671|NCT03003390|Anticoagulants|anticoagulants|mesh-ancestor
110883672|NCT03003390|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110883673|NCT03003390|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110883674|NCT03003390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110883675|NCT03003000|Ibuprofen|ibuprofen|mesh-list
110883676|NCT03003000|Caffeine|caffeine|mesh-list
110883677|NCT03003000|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110883678|NCT03003000|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110883679|NCT03003000|Analgesics|analgesics|mesh-ancestor
110883680|NCT03003000|Sensory System Agents|sensory system agents|mesh-ancestor
110883681|NCT03003000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110883682|NCT03003000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110883683|NCT03003000|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110883684|NCT03003000|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110883685|NCT03003000|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110883686|NCT03003000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110883687|NCT03003000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110883688|NCT03003000|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110883689|NCT03003000|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110883690|NCT03003000|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110883691|NCT03003000|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110883692|NCT03003000|Purinergic Agents|purinergic agents|mesh-ancestor
110883693|NCT03003000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110883694|NCT03665766|Cycloserine|cycloserine|mesh-list
110883695|NCT03665766|Tacrolimus|tacrolimus|mesh-list
110883696|NCT03665766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110883697|NCT03665766|Immunologic Factors|immunologic factors|mesh-ancestor
110883698|NCT03665766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110883699|NCT03665766|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110883700|NCT03665766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110883701|NCT03665766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110883708|NCT03637361|Methadone|methadone|mesh-list
110883709|NCT03637361|D-methadone|d-methadone|mesh-list
110883710|NCT03637361|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110883712|NCT03637361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110883713|NCT03637361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110883714|NCT03637361|Analgesics|analgesics|mesh-ancestor
110883715|NCT03637361|Sensory System Agents|sensory system agents|mesh-ancestor
110883716|NCT03637361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110883717|NCT03637361|Antitussive Agents|antitussive agents|mesh-ancestor
110883718|NCT03637361|Respiratory System Agents|respiratory system agents|mesh-ancestor
110883719|NCT03637361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110883720|NCT00038675|Imatinib Mesylate|imatinib mesylate|mesh-list
110883721|NCT00038675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110883722|NCT00038675|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110883723|NCT00038675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110883724|NCT00038675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110883725|NCT03254459|Morphine|morphine|mesh-list
110883726|NCT03254459|Oxycodone|oxycodone|mesh-list
110883727|NCT03254459|Buprenorphine|buprenorphine|mesh-list
110883728|NCT03254459|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110883729|NCT03254459|Narcotics|narcotics|mesh-ancestor
110883730|NCT03254459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110883731|NCT03254459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110883732|NCT03254459|Analgesics|analgesics|mesh-ancestor
110883733|NCT03254459|Sensory System Agents|sensory system agents|mesh-ancestor
110883734|NCT03254459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110883735|NCT03254459|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110883736|NCT03620591|Lidocaine|lidocaine|mesh-list
110883737|NCT03620591|Anesthetics, Local|anesthetics, local|mesh-ancestor
110883738|NCT03620591|Anesthetics|anesthetics|mesh-ancestor
110883739|NCT03620591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110883740|NCT03620591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110883741|NCT03620591|Sensory System Agents|sensory system agents|mesh-ancestor
110883742|NCT03620591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110883743|NCT03620591|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110883744|NCT03620591|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110883745|NCT03620591|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110883746|NCT03620591|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110883747|NCT03620591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110883748|NCT05178953|Zinc|zinc|mesh-list
110883749|NCT05178953|Pentoxifylline|pentoxifylline|mesh-list
110883750|NCT05178953|Zinc Sulfate|zinc sulfate|mesh-list
110883751|NCT05178953|Trace Elements|trace elements|mesh-ancestor
110883752|NCT05178953|Micronutrients|micronutrients|mesh-ancestor
110883753|NCT05178953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110883754|NCT05178953|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110883755|NCT05178953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110883756|NCT05178953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110883757|NCT05178953|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110883758|NCT05178953|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110883759|NCT05178953|Protective Agents|protective agents|mesh-ancestor
110883760|NCT05178953|Vasodilator Agents|vasodilator agents|mesh-ancestor
110883761|NCT05178953|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110883762|NCT05178953|Antioxidants|antioxidants|mesh-ancestor
110883763|NCT05178953|Astringents|astringents|mesh-ancestor
110883764|NCT05178953|Dermatologic Agents|dermatologic agents|mesh-ancestor
110883765|NCT02736617|Obinutuzumab|obinutuzumab|mesh-list
110883766|NCT02736617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110883767|NCT02736617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110883768|NCT03251963|Enoxaparin|enoxaparin|mesh-list
110883769|NCT03251963|Enoxaparin sodium|enoxaparin sodium|mesh-list
110883770|NCT03251963|Anticoagulants|anticoagulants|mesh-ancestor
110883771|NCT03251963|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110883772|NCT03251963|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110534671|NCT02672358|Dabrafenib|dabrafenib|mesh-list
110883785|NCT03622073|Abortifacient Agents|abortifacient agents|mesh-ancestor
110883786|NCT03622073|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110883787|NCT03622073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110883788|NCT03622073|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110883789|NCT03622073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110883790|NCT03622073|Oxytocics|oxytocics|mesh-ancestor
110883791|NCT03000348|Cysteamine|cysteamine|mesh-list
110883792|NCT03000348|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
110883793|NCT03000348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110883794|NCT03664986|Bupivacaine|bupivacaine|mesh-list
110883795|NCT03664986|Anesthetics, Local|anesthetics, local|mesh-ancestor
110883796|NCT03664986|Anesthetics|anesthetics|mesh-ancestor
110395570|NCT00598923|Topiramate|topiramate|mesh-list
110883797|NCT03664986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110883798|NCT03664986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110883799|NCT03664986|Sensory System Agents|sensory system agents|mesh-ancestor
110883800|NCT03664986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110883801|NCT03492918|Pembrolizumab|pembrolizumab|mesh-list
110883802|NCT03492918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110883803|NCT03492918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110883804|NCT03492918|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110883805|NCT03492918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110883806|NCT03247673|Bevacizumab|bevacizumab|mesh-list
110883807|NCT03247673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110883808|NCT03247673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110883809|NCT03247673|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110883810|NCT03247673|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110883811|NCT03247673|Growth Substances|growth substances|mesh-ancestor
110883812|NCT03247673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110883813|NCT03247673|Growth Inhibitors|growth inhibitors|mesh-ancestor
110883814|NCT03665610|Ozanimod|ozanimod|mesh-list
110883815|NCT03665610|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
110883816|NCT03665610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110883817|NCT03665610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110883818|NCT03665610|Immunologic Factors|immunologic factors|mesh-ancestor
110883819|NCT03665610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110883820|NCT03664908|Antibodies|antibodies|mesh-list
110883821|NCT03664908|Immunologic Factors|immunologic factors|mesh-ancestor
110883822|NCT03664908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110883823|NCT03665454|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
110883824|NCT03665454|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110883825|NCT03665454|Immunologic Factors|immunologic factors|mesh-ancestor
110883826|NCT03665454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110883827|NCT03665454|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110883828|NCT03665454|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110883829|NCT03665454|Dopamine Agonists|dopamine agonists|mesh-ancestor
110883830|NCT03665454|Dopamine Agents|dopamine agents|mesh-ancestor
110883831|NCT03665454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110883832|NCT03665454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110883833|NCT03664440|Nevirapine|nevirapine|mesh-list
110883834|NCT03664440|Rilpivirine|rilpivirine|mesh-list
110883851|NCT03282227|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110883852|NCT03282227|Serotonin Agents|serotonin agents|mesh-ancestor
110883853|NCT03282227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110883854|NCT03282227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110883855|NCT03282227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110883856|NCT03282227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110883857|NCT03282227|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110883858|NCT03282227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110883859|NCT03240575|Fluticasone|fluticasone|mesh-list
110883861|NCT03240575|Tiotropium Bromide|tiotropium bromide|mesh-list
110883862|NCT03240575|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110883863|NCT03240575|Olodaterol|olodaterol|mesh-list
110883864|NCT03240575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110883865|NCT03240575|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110883866|NCT03240575|Autonomic Agents|autonomic agents|mesh-ancestor
110883867|NCT03240575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110883868|NCT03240575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110883869|NCT03240575|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110883870|NCT03240575|Respiratory System Agents|respiratory system agents|mesh-ancestor
110883871|NCT03240575|Dermatologic Agents|dermatologic agents|mesh-ancestor
110883872|NCT03240575|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110883873|NCT03240575|Parasympatholytics|parasympatholytics|mesh-ancestor
110883874|NCT03240575|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110883875|NCT03240575|Cholinergic Agents|cholinergic agents|mesh-ancestor
110883876|NCT03240575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110883877|NCT03240575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110883878|NCT03240575|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110883879|NCT03240575|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110883880|NCT03240575|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110883881|NCT03240575|Adrenergic Agents|adrenergic agents|mesh-ancestor
110883882|NCT04034225|Pembrolizumab|pembrolizumab|mesh-list
110883883|NCT04034225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110883884|NCT04034225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110883885|NCT04034225|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110883886|NCT04034225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110883887|NCT03690947|Ranibizumab|ranibizumab|mesh-list
110883888|NCT03690947|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110883889|NCT03690947|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110883890|NCT03690947|Growth Substances|growth substances|mesh-ancestor
110883891|NCT03690947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110883892|NCT03690947|Growth Inhibitors|growth inhibitors|mesh-ancestor
110205707|NCT00174304|Amlodipine|amlodipine|mesh-list
110883903|NCT02749370|Etanercept|etanercept|mesh-list
110883904|NCT02749370|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110883905|NCT02749370|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110883906|NCT02749370|Analgesics|analgesics|mesh-ancestor
110883907|NCT02749370|Sensory System Agents|sensory system agents|mesh-ancestor
110883908|NCT02749370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110883909|NCT02749370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110883910|NCT02749370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110883911|NCT02749370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110883912|NCT02749370|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110883913|NCT02749370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110883914|NCT02749370|Immunologic Factors|immunologic factors|mesh-ancestor
110883915|NCT03618758|Paclitaxel|paclitaxel|mesh-list
110883916|NCT03618758|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110883917|NCT03618758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110883918|NCT03618758|Tubulin Modulators|tubulin modulators|mesh-ancestor
110883919|NCT03618758|Antimitotic Agents|antimitotic agents|mesh-ancestor
110883920|NCT03618758|Mitosis Modulators|mitosis modulators|mesh-ancestor
110883921|NCT03618758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110883922|NCT03617900|Acetaminophen|acetaminophen|mesh-list
110883923|NCT03617900|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110883924|NCT03617900|Analgesics|analgesics|mesh-ancestor
110883925|NCT03617900|Sensory System Agents|sensory system agents|mesh-ancestor
110883926|NCT03617900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110883927|NCT03617900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110883928|NCT03617900|Antipyretics|antipyretics|mesh-ancestor
110883929|NCT05384366|Paclitaxel|paclitaxel|mesh-list
110883930|NCT05384366|Carboplatin|carboplatin|mesh-list
110883931|NCT05384366|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110883932|NCT05384366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110883933|NCT05384366|Tubulin Modulators|tubulin modulators|mesh-ancestor
110883934|NCT05384366|Antimitotic Agents|antimitotic agents|mesh-ancestor
110198665|NCT00127777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110883936|NCT05384366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110883937|NCT03616808|Hemostatics|hemostatics|mesh-list
110883938|NCT03616808|Coagulants|coagulants|mesh-ancestor
110883939|NCT03617510|Biphenylylacetic acid|biphenylylacetic acid|mesh-list
110883940|NCT03617510|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110883941|NCT03617510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110883942|NCT03617510|Analgesics|analgesics|mesh-ancestor
110883943|NCT03617510|Sensory System Agents|sensory system agents|mesh-ancestor
110883944|NCT03617510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110883945|NCT03617510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110883946|NCT03617510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110883947|NCT03617510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110883948|NCT03617432|Prednisone|prednisone|mesh-list
110883949|NCT03617432|Cyclophosphamide|cyclophosphamide|mesh-list
110883950|NCT03617432|Doxorubicin|doxorubicin|mesh-list
110883951|NCT03617432|Etoposide|etoposide|mesh-list
110883952|NCT03617432|Vincristine|vincristine|mesh-list
110883953|NCT03617432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110883954|NCT03617432|Immunologic Factors|immunologic factors|mesh-ancestor
110883955|NCT03617432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110883956|NCT03617432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110883957|NCT03617432|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110883958|NCT03617432|Alkylating Agents|alkylating agents|mesh-ancestor
110883959|NCT03617432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110883960|NCT03617432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110883985|NCT02873702|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110883986|NCT02873702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110883987|NCT02873702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110883988|NCT03616262|Lidocaine|lidocaine|mesh-list
110883989|NCT03616262|Anesthetics, Local|anesthetics, local|mesh-ancestor
110883990|NCT03616262|Anesthetics|anesthetics|mesh-ancestor
110883991|NCT03616262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110883992|NCT03616262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110883993|NCT03616262|Sensory System Agents|sensory system agents|mesh-ancestor
110883994|NCT03616262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110883995|NCT03616262|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110883996|NCT03616262|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110883997|NCT03616262|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110883998|NCT03616262|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110883999|NCT03616262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110884000|NCT03615950|Vitamin D|vitamin d|mesh-list
110884001|NCT03615950|Vitamins|vitamins|mesh-ancestor
110884002|NCT03615950|Micronutrients|micronutrients|mesh-ancestor
110884003|NCT03615950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110884004|NCT03615950|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110884005|NCT02911116|Ustekinumab|ustekinumab|mesh-list
110884006|NCT02911116|Dermatologic Agents|dermatologic agents|mesh-ancestor
110884007|NCT03664050|Letrozole|letrozole|mesh-list
110884008|NCT03664050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110884009|NCT03664050|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110884010|NCT03664050|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110884011|NCT03664050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110884018|NCT04055844|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110884020|NCT04055844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110884021|NCT04055844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110884022|NCT04055844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110884023|NCT04055688|Aminolevulinic Acid|aminolevulinic acid|mesh-list
110884024|NCT04055688|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110884025|NCT04055688|Dermatologic Agents|dermatologic agents|mesh-ancestor
110884026|NCT04054284|Hypoglycemic Agents|hypoglycemic agents|mesh-list
110884027|NCT04054284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110884028|NCT04494438|Rituximab|rituximab|mesh-list
110198690|NCT00402610|Rifampin|rifampin|mesh-list
110884029|NCT04494438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110884030|NCT04494438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110884031|NCT04494438|Immunologic Factors|immunologic factors|mesh-ancestor
110884032|NCT04494438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110884033|NCT04494438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110884034|NCT04057482|Dequalinium|dequalinium|mesh-list
110884035|NCT04057482|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110884036|NCT04057482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110884037|NCT03662412|Sirolimus|sirolimus|mesh-list
110920730|NCT03547362|Caseins|caseins|mesh-list
110884038|NCT03662412|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110884039|NCT03662412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110884040|NCT03662412|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110884041|NCT03662412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110884042|NCT03662412|Antifungal Agents|antifungal agents|mesh-ancestor
110884043|NCT03662412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110884044|NCT03662412|Immunologic Factors|immunologic factors|mesh-ancestor
110884045|NCT03662412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110884046|NCT02870972|Berotralstat|berotralstat|mesh-list
110884047|NCT02870972|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110884048|NCT02870972|Protease Inhibitors|protease inhibitors|mesh-ancestor
110884049|NCT02870972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110884050|NCT02870972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110884051|NCT03214367|Insulin|insulin|mesh-list
110884052|NCT03214367|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110884053|NCT03214367|Insulin Glargine|insulin glargine|mesh-list
110884054|NCT03214367|Insulin Lispro|insulin lispro|mesh-list
110884055|NCT03214367|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110884056|NCT03214367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110884057|NCT03662958|Leuprolide|leuprolide|mesh-list
110884058|NCT03662958|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110884059|NCT03662958|Fertility Agents|fertility agents|mesh-ancestor
110884060|NCT03662958|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110884061|NCT03662958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110884062|NCT03662958|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110884063|NCT03662958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110884064|NCT03231371|Adenosine|adenosine|mesh-list
110884065|NCT03231371|Analgesics|analgesics|mesh-ancestor
110884066|NCT03231371|Sensory System Agents|sensory system agents|mesh-ancestor
110884067|NCT03231371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110884068|NCT03231371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110884069|NCT03231371|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110884070|NCT03231371|Vasodilator Agents|vasodilator agents|mesh-ancestor
110884071|NCT03231371|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
110884072|NCT03231371|Purinergic Agonists|purinergic agonists|mesh-ancestor
110884073|NCT03231371|Purinergic Agents|purinergic agents|mesh-ancestor
110884074|NCT03231371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110884075|NCT03231371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110884076|NCT03663114|Lenvatinib|lenvatinib|mesh-list
110884077|NCT03663114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110884078|NCT03663114|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110884079|NCT03663114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110884088|NCT04057326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110884089|NCT02870348|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
110884090|NCT02870348|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
110884091|NCT02870348|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110884092|NCT02870348|Protease Inhibitors|protease inhibitors|mesh-ancestor
110884093|NCT02870348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110884094|NCT02870348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110884095|NCT05384210|Gabapentin|gabapentin|mesh-list
110884096|NCT05384210|Milnacipran|milnacipran|mesh-list
110884097|NCT05384210|Levomilnacipran|levomilnacipran|mesh-list
110884098|NCT05384210|Analgesics|analgesics|mesh-ancestor
110884099|NCT05384210|Sensory System Agents|sensory system agents|mesh-ancestor
110884100|NCT05384210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110884101|NCT05384210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110884102|NCT05384210|Anticonvulsants|anticonvulsants|mesh-ancestor
110884103|NCT05384210|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110884104|NCT05384210|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110884105|NCT05384210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110884106|NCT05384210|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110884107|NCT05384210|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110884108|NCT05384210|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110884109|NCT05384210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110884110|NCT05384210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110884111|NCT05384210|Antimanic Agents|antimanic agents|mesh-ancestor
110884112|NCT05384210|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110884113|NCT05384210|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110884114|NCT05384210|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110884115|NCT05384210|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110884116|NCT05384210|Antidepressive Agents|antidepressive agents|mesh-ancestor
110884117|NCT02032394|Chlorhexidine|chlorhexidine|mesh-list
110884118|NCT02032394|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110884119|NCT02032394|Povidone-Iodine|povidone-iodine|mesh-list
110884120|NCT02032394|Povidone|povidone|mesh-list
110884121|NCT02032394|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110884122|NCT02032394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110884123|NCT02032394|Disinfectants|disinfectants|mesh-ancestor
110884124|NCT02032394|Dermatologic Agents|dermatologic agents|mesh-ancestor
110884125|NCT02032394|Plasma Substitutes|plasma substitutes|mesh-ancestor
110884126|NCT02032394|Blood Substitutes|blood substitutes|mesh-ancestor
110884127|NCT03239483|Dapivirine|dapivirine|mesh-list
110884128|NCT03239483|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110884129|NCT03239483|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110884130|NCT03239483|Antiviral Agents|antiviral agents|mesh-ancestor
110884131|NCT03239483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110884132|NCT01068912|Favipiravir|favipiravir|mesh-list
110198722|NCT00402766|Hormones|hormones|mesh-ancestor
110884133|NCT01068912|Antiviral Agents|antiviral agents|mesh-ancestor
110884134|NCT01068912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110884135|NCT04056702|Ivacaftor|ivacaftor|mesh-list
110884136|NCT04056702|Elexacaftor|elexacaftor|mesh-list
110884137|NCT04056702|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
110884138|NCT04056702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110884139|NCT04056702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110884140|NCT03662100|Mirikizumab|mirikizumab|mesh-list
110884141|NCT03662100|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110884142|NCT03662100|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110884143|NCT03662100|Analgesics|analgesics|mesh-ancestor
110884144|NCT03662100|Sensory System Agents|sensory system agents|mesh-ancestor
110884145|NCT03662100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110884146|NCT03662100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110884147|NCT03662100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110884151|NCT03612440|Dexmedetomidine|dexmedetomidine|mesh-list
110884152|NCT03612440|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110884153|NCT03612440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110884154|NCT03612440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110884155|NCT03612440|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110884156|NCT03612440|Analgesics|analgesics|mesh-ancestor
110884157|NCT03612440|Sensory System Agents|sensory system agents|mesh-ancestor
110884158|NCT03612440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110884159|NCT03612440|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110884160|NCT03612440|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110884161|NCT03612440|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110884162|NCT03612440|Adrenergic Agents|adrenergic agents|mesh-ancestor
110884163|NCT03612440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110884164|NCT03612440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110884165|NCT03662724|Venetoclax|venetoclax|mesh-list
110884166|NCT03662724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110884167|NCT03662568|Ritonavir|ritonavir|mesh-list
110884168|NCT03662568|Tenofovir|tenofovir|mesh-list
110884169|NCT03662568|Entecavir|entecavir|mesh-list
110884170|NCT03662568|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110884171|NCT03662568|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110884172|NCT03662568|Protease Inhibitors|protease inhibitors|mesh-ancestor
110884173|NCT03662568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110884174|NCT03662568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110884175|NCT03662568|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110884176|NCT03662568|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110884177|NCT03662568|Antiviral Agents|antiviral agents|mesh-ancestor
110884178|NCT03662568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110884179|NCT03662568|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110884180|NCT03662568|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110884181|NCT03662568|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110884182|NCT03662568|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110884183|NCT02993250|Simeprevir|simeprevir|mesh-list
110884184|NCT02993250|Odalasvir|odalasvir|mesh-list
110884185|NCT02993250|Antiviral Agents|antiviral agents|mesh-ancestor
110884186|NCT02993250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110884187|NCT02993250|Protease Inhibitors|protease inhibitors|mesh-ancestor
110884188|NCT02993250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110884189|NCT02993250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110884190|NCT03661788|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
110884191|NCT03661788|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110884192|NCT03661788|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110884193|NCT03661788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110884194|NCT03661788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110884195|NCT03661788|Adrenergic Agents|adrenergic agents|mesh-ancestor
110884196|NCT03661788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110884197|NCT03661788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110884198|NCT05383820|Ketorolac|ketorolac|mesh-list
110884199|NCT05383820|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110884200|NCT05383820|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110884201|NCT05383820|Analgesics|analgesics|mesh-ancestor
110884202|NCT05383820|Sensory System Agents|sensory system agents|mesh-ancestor
110884203|NCT05383820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110884204|NCT05383820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110884205|NCT05383820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110884206|NCT05383820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110884207|NCT05383820|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110884208|NCT05383820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110884209|NCT05383820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110884210|NCT03611504|Hemostatics|hemostatics|mesh-list
110884211|NCT03611504|Coagulants|coagulants|mesh-ancestor
110884212|NCT02954510|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
110884213|NCT02954510|Hematinics|hematinics|mesh-ancestor
110884214|NCT02954510|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
110884215|NCT02954510|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110884216|NCT02032784|Octreotide|octreotide|mesh-list
110884217|NCT02032784|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110884218|NCT02032784|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110884219|NCT02032784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110884228|NCT03658746|Ofloxacin|ofloxacin|mesh-list
110884229|NCT03658746|Tetracycline|tetracycline|mesh-list
110884230|NCT03658746|Tinidazole|tinidazole|mesh-list
110884231|NCT03658746|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
110884232|NCT03658746|Furazolidone|furazolidone|mesh-list
110884233|NCT03658746|Bismuth|bismuth|mesh-list
110884234|NCT03658746|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
110884235|NCT03658746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110884236|NCT03658746|Antitubercular Agents|antitubercular agents|mesh-ancestor
110884237|NCT03658746|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110884238|NCT03658746|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110884239|NCT03658746|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110884240|NCT03658746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110884241|NCT03658746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110884242|NCT03658746|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110884243|NCT03658746|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110884244|NCT03658746|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110884245|NCT03658746|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110884246|NCT03658746|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110198779|NCT00044135|Clevudine|clevudine|mesh-list
110884247|NCT03658746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110884248|NCT03658746|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110884249|NCT03658746|Antacids|antacids|mesh-ancestor
110884250|NCT03658746|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110884251|NCT03658746|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110884252|NCT03658746|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
110884253|NCT03658746|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
110884254|NCT03658746|Alkylating Agents|alkylating agents|mesh-ancestor
110884255|NCT02990910|Analgesics, Opioid|analgesics, opioid|mesh-list
110884256|NCT02990910|Narcotics|narcotics|mesh-ancestor
110884257|NCT02990910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110884258|NCT02990910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110884259|NCT02990910|Analgesics|analgesics|mesh-ancestor
110884260|NCT02990910|Sensory System Agents|sensory system agents|mesh-ancestor
110884261|NCT02990910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110884262|NCT04056000|Caffeine|caffeine|mesh-list
110884263|NCT04056000|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110884264|NCT04056000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110884265|NCT04056000|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110884266|NCT04056000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110884267|NCT04056000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110884268|NCT04056000|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110884269|NCT04056000|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110884270|NCT04056000|Purinergic Agents|purinergic agents|mesh-ancestor
110884271|NCT04056000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110884272|NCT03611348|Latanoprost|latanoprost|mesh-list
110884273|NCT03611348|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110884274|NCT03611348|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110884275|NCT02033018|Aflibercept|aflibercept|mesh-list
110884276|NCT02033018|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110884277|NCT02033018|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110884278|NCT02033018|Growth Substances|growth substances|mesh-ancestor
110884279|NCT02033018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110884280|NCT02033018|Growth Inhibitors|growth inhibitors|mesh-ancestor
110884281|NCT02033018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110884282|NCT02033096|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
110884283|NCT02033096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110884284|NCT02033096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110884285|NCT03658590|Dexamethasone|dexamethasone|mesh-list
110884286|NCT03658590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110884287|NCT03658590|Antiemetics|antiemetics|mesh-ancestor
110884288|NCT03658590|Autonomic Agents|autonomic agents|mesh-ancestor
110884289|NCT03658590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110884290|NCT03658590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110884293|NCT03658590|Hormones|hormones|mesh-ancestor
110884294|NCT03658590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110884295|NCT03658590|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110884296|NCT03658590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110884297|NCT03428945|Hydroxychloroquine|hydroxychloroquine|mesh-list
110884298|NCT03428945|Antimalarials|antimalarials|mesh-ancestor
110884299|NCT03428945|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110884300|NCT03428945|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110884301|NCT03428945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110884302|NCT03428945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110884303|NCT03428945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110884304|NCT03428945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110884305|NCT03208127|Antiviral Agents|antiviral agents|mesh-list
110884306|NCT03208127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110884307|NCT03941093|Leucovorin|leucovorin|mesh-list
110884308|NCT03941093|Paclitaxel|paclitaxel|mesh-list
110884309|NCT03941093|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110884310|NCT03941093|Gemcitabine|gemcitabine|mesh-list
110884311|NCT03941093|Irinotecan|irinotecan|mesh-list
110884312|NCT03941093|Fluorouracil|fluorouracil|mesh-list
110884313|NCT03941093|Folfirinox|folfirinox|mesh-list
110884314|NCT03941093|Levoleucovorin|levoleucovorin|mesh-list
110884315|NCT03941093|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110884317|NCT03941093|Tubulin Modulators|tubulin modulators|mesh-ancestor
110884318|NCT03941093|Antimitotic Agents|antimitotic agents|mesh-ancestor
110884319|NCT03941093|Mitosis Modulators|mitosis modulators|mesh-ancestor
110884320|NCT03941093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110884321|NCT03941093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110884322|NCT03941093|Antimetabolites|antimetabolites|mesh-ancestor
110884323|NCT03941093|Antidotes|antidotes|mesh-ancestor
110884324|NCT03941093|Protective Agents|protective agents|mesh-ancestor
110884325|NCT03941093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110884326|NCT03941093|Vitamin B Complex|vitamin b complex|mesh-ancestor
110884327|NCT03941093|Vitamins|vitamins|mesh-ancestor
110884328|NCT03941093|Micronutrients|micronutrients|mesh-ancestor
110884329|NCT03941093|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110884330|NCT03941093|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110884331|NCT03941093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110884332|NCT03941093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110884333|NCT03941093|Immunologic Factors|immunologic factors|mesh-ancestor
110884334|NCT02033408|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110884335|NCT02033408|Amoxicillin|amoxicillin|mesh-list
110884336|NCT02033408|Metronidazole|metronidazole|mesh-list
110884337|NCT02033408|Vancomycin|vancomycin|mesh-list
110884338|NCT02033408|Doxycycline|doxycycline|mesh-list
110884339|NCT02033408|Ciprofloxacin|ciprofloxacin|mesh-list
110884340|NCT02033408|Gentamicins|gentamicins|mesh-list
110884341|NCT02033408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110884342|NCT02033408|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110884343|NCT02033408|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110884344|NCT02033408|Antimalarials|antimalarials|mesh-ancestor
110884345|NCT02033408|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110884346|NCT02033408|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110884347|NCT02033408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110198829|NCT00044408|Ruboxistaurin|ruboxistaurin|mesh-list
110884348|NCT02033408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110884349|NCT02033408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110884350|NCT02033408|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110884351|NCT02033408|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110884352|NCT02033408|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110884353|NCT03610880|Yimitasvir|yimitasvir|mesh-list
110884354|NCT03610880|Antiviral Agents|antiviral agents|mesh-ancestor
110884355|NCT03610880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110884356|NCT02097121|Botulinum Toxins|botulinum toxins|mesh-list
110884357|NCT02097121|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110884358|NCT02097121|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110884359|NCT02097121|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110884360|NCT02097121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110884361|NCT02097121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110884362|NCT02097121|Cholinergic Agents|cholinergic agents|mesh-ancestor
110884363|NCT02097121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110884364|NCT02097121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110884365|NCT02097121|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110884366|NCT02097121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110884367|NCT02075671|Aminolevulinic Acid|aminolevulinic acid|mesh-list
110884375|NCT02560298|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110884376|NCT02560298|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110884377|NCT02560298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110884378|NCT02560298|Tubulin Modulators|tubulin modulators|mesh-ancestor
110884379|NCT02560298|Antimitotic Agents|antimitotic agents|mesh-ancestor
110884380|NCT02560298|Mitosis Modulators|mitosis modulators|mesh-ancestor
110884381|NCT02560298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110884382|NCT02560298|Antimetabolites|antimetabolites|mesh-ancestor
110884383|NCT02560298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110884384|NCT02560298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110884385|NCT02560298|Immunologic Factors|immunologic factors|mesh-ancestor
110884386|NCT02560298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110884388|NCT01330615|Prilocaine|prilocaine|mesh-list
110884389|NCT01330615|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
110884390|NCT01330615|Anesthetics, Local|anesthetics, local|mesh-ancestor
110884391|NCT01330615|Anesthetics|anesthetics|mesh-ancestor
110884392|NCT01330615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110884393|NCT01330615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110884394|NCT01330615|Sensory System Agents|sensory system agents|mesh-ancestor
110884395|NCT01330615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110884396|NCT01330615|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110884397|NCT01330615|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110884398|NCT01330615|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110884399|NCT01330615|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110884400|NCT01330615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110884401|NCT01330615|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
110884402|NCT05034029|Metformin|metformin|mesh-list
110884403|NCT05034029|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110884404|NCT05034029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110920765|NCT02253420|Rifampin|rifampin|mesh-list
110884405|NCT03237065|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
110884406|NCT03237065|Hematinics|hematinics|mesh-ancestor
110884407|NCT03620461|Gemcitabine|gemcitabine|mesh-list
110884408|NCT03620461|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110884409|NCT03620461|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110884410|NCT03620461|Antimetabolites|antimetabolites|mesh-ancestor
110884411|NCT03620461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110884412|NCT03620461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110884413|NCT01314781|Solifenacin Succinate|solifenacin succinate|mesh-list
110884414|NCT01314781|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110884415|NCT01314781|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110884416|NCT01314781|Cholinergic Agents|cholinergic agents|mesh-ancestor
110884417|NCT01314781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110884418|NCT01314781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110884419|NCT01314781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110884420|NCT01314781|Urological Agents|urological agents|mesh-ancestor
110884421|NCT01330693|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
110884422|NCT01330693|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110884423|NCT01330693|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110884424|NCT01330693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110884425|NCT01330693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110884426|NCT01330693|Adrenergic Agents|adrenergic agents|mesh-ancestor
110884427|NCT01330693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110884428|NCT01330693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110884429|NCT02863328|Empagliflozin|empagliflozin|mesh-list
110884430|NCT02863328|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110884431|NCT02863328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110884432|NCT02863328|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110884433|NCT02863328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110884434|NCT03040141|Oseltamivir|oseltamivir|mesh-list
110884435|NCT03040141|Antiviral Agents|antiviral agents|mesh-ancestor
110884461|NCT04602845|Analgesics|analgesics|mesh-ancestor
110884462|NCT04602845|Sensory System Agents|sensory system agents|mesh-ancestor
110884463|NCT04602845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110884464|NCT04602845|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110884465|NCT04602845|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110884466|NCT04602845|Anesthetics, General|anesthetics, general|mesh-ancestor
110884467|NCT04602845|Anesthetics|anesthetics|mesh-ancestor
110884468|NCT04602845|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110884469|NCT04602845|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110884470|NCT04602845|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110884471|NCT04602845|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110884472|NCT04602845|GABA Modulators|gaba modulators|mesh-ancestor
110884473|NCT04602845|GABA Agents|gaba agents|mesh-ancestor
110884474|NCT04602845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110884475|NCT04602845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110884476|NCT04602845|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110884477|NCT04602845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110884478|NCT04602845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110884479|NCT04602845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110884480|NCT04602845|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110884481|NCT04602845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110884482|NCT04966325|Moxifloxacin|moxifloxacin|mesh-list
110884483|NCT04966325|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110884484|NCT04966325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110884485|NCT04966325|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110884486|NCT04966325|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110884487|NCT04966325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110205775|NCT00056225|Vitamins|vitamins|mesh-list
110884503|NCT03502681|Avelumab|avelumab|mesh-list
110884504|NCT03502681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110884505|NCT03502681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110884506|NCT04938817|Pembrolizumab|pembrolizumab|mesh-list
110884507|NCT04938817|Lenvatinib|lenvatinib|mesh-list
110884508|NCT04938817|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110884509|NCT04938817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110884510|NCT04938817|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110884511|NCT04938817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110884512|NCT04938817|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110884513|NCT04938817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110884514|NCT03636373|Triamcinolone|triamcinolone|mesh-list
110884515|NCT03636373|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110884516|NCT03636373|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110884517|NCT03636373|Etanercept|etanercept|mesh-list
110884518|NCT03636373|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110884519|NCT03636373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110884520|NCT03636373|Glucocorticoids|glucocorticoids|mesh-ancestor
110884521|NCT03636373|Hormones|hormones|mesh-ancestor
110884522|NCT03636373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110884523|NCT03636373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110884524|NCT03636373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110884525|NCT03636373|Immunologic Factors|immunologic factors|mesh-ancestor
110884526|NCT03636373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110884527|NCT03636373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110884528|NCT03636373|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110884529|NCT03636373|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110884530|NCT03636373|Analgesics|analgesics|mesh-ancestor
110884531|NCT03636373|Sensory System Agents|sensory system agents|mesh-ancestor
110884532|NCT03636373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110884533|NCT03636373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110884534|NCT03636373|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110884535|NCT04485325|Etanercept|etanercept|mesh-list
110884536|NCT04485325|Tofacitinib|tofacitinib|mesh-list
110602082|NCT00614614|Vaccines|vaccines|mesh-list
110884537|NCT04485325|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110884538|NCT04485325|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110884539|NCT04485325|Analgesics|analgesics|mesh-ancestor
110884540|NCT04485325|Sensory System Agents|sensory system agents|mesh-ancestor
110884541|NCT04485325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110884542|NCT04485325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110884543|NCT04485325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110884544|NCT04485325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110884545|NCT04485325|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110884546|NCT04485325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110884547|NCT04485325|Immunologic Factors|immunologic factors|mesh-ancestor
110884557|NCT02033798|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110884558|NCT02033798|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110884559|NCT02033798|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110884560|NCT02033798|Adrenergic Agents|adrenergic agents|mesh-ancestor
110884561|NCT02033798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110884562|NCT02033798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110884563|NCT02033798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110884564|NCT02033798|Urological Agents|urological agents|mesh-ancestor
110884565|NCT02887183|Valsartan|valsartan|mesh-list
110884566|NCT02887183|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
110884567|NCT02887183|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110884568|NCT02887183|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110884569|NCT02887183|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110884570|NCT02887183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110884571|NCT03660306|Analgesics, Opioid|analgesics, opioid|mesh-list
110884572|NCT03660306|Anesthetics|anesthetics|mesh-list
110884573|NCT03660306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110884574|NCT03660306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110884575|NCT03660306|Narcotics|narcotics|mesh-ancestor
110884576|NCT03660306|Analgesics|analgesics|mesh-ancestor
110884577|NCT03660306|Sensory System Agents|sensory system agents|mesh-ancestor
110884578|NCT03660306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110884579|NCT01067352|Hormones|hormones|mesh-list
110884580|NCT01067352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110884581|NCT01067352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110884582|NCT02920242|Rifaximin|rifaximin|mesh-list
110884583|NCT02920242|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110884584|NCT02920242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110884585|NCT02920242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110884586|NCT02985996|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110884587|NCT02985996|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110884588|NCT02985996|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110884589|NCT02985996|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110884590|NCT02985996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110884591|NCT02985996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110884592|NCT02985996|Antiviral Agents|antiviral agents|mesh-ancestor
110884593|NCT02985996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110884594|NCT02985996|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110884595|NCT02985996|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110884596|NCT03203447|Triamcinolone|triamcinolone|mesh-list
110884597|NCT03203447|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110884598|NCT03203447|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110884599|NCT03203447|Bevacizumab|bevacizumab|mesh-list
110884600|NCT03203447|Ranibizumab|ranibizumab|mesh-list
110884601|NCT03203447|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110884602|NCT03203447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110884603|NCT03203447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110884604|NCT03203447|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110884605|NCT03203447|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110884606|NCT03203447|Growth Substances|growth substances|mesh-ancestor
110884607|NCT03203447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110884608|NCT03203447|Growth Inhibitors|growth inhibitors|mesh-ancestor
110884609|NCT03203447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110884610|NCT03203447|Glucocorticoids|glucocorticoids|mesh-ancestor
110884629|NCT03202511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110884630|NCT03202511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110884631|NCT03202511|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110884632|NCT03202511|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110884633|NCT03202511|Uricosuric Agents|uricosuric agents|mesh-ancestor
110884634|NCT03202511|Gout Suppressants|gout suppressants|mesh-ancestor
110884635|NCT03202511|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110884636|NCT03637049|Midazolam|midazolam|mesh-list
110884637|NCT03637049|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110884638|NCT03637049|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110884639|NCT03637049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110884640|NCT03637049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110884641|NCT03637049|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110884642|NCT03637049|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110884643|NCT03637049|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110198902|NCT00044642|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110884644|NCT03637049|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110884645|NCT03637049|Anesthetics, General|anesthetics, general|mesh-ancestor
110884646|NCT03637049|Anesthetics|anesthetics|mesh-ancestor
110884647|NCT03637049|GABA Modulators|gaba modulators|mesh-ancestor
110884648|NCT03637049|GABA Agents|gaba agents|mesh-ancestor
110884649|NCT03637049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110884650|NCT03637049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110884651|NCT03636971|Mannitol|mannitol|mesh-list
110884652|NCT03636971|Sorbitol|sorbitol|mesh-list
110884653|NCT03636971|Hyaluronic Acid|hyaluronic acid|mesh-list
110884654|NCT03636971|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110884655|NCT03636971|Immunologic Factors|immunologic factors|mesh-ancestor
110884656|NCT03636971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110884657|NCT03636971|Viscosupplements|viscosupplements|mesh-ancestor
110884658|NCT03636971|Protective Agents|protective agents|mesh-ancestor
110884659|NCT03636971|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110884660|NCT03636971|Diuretics|diuretics|mesh-ancestor
110884661|NCT03636971|Natriuretic Agents|natriuretic agents|mesh-ancestor
110884662|NCT03636971|Cathartics|cathartics|mesh-ancestor
110884663|NCT03636971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110884664|NCT03610100|Gemcitabine|gemcitabine|mesh-list
110884665|NCT03610100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110884666|NCT03610100|Antimetabolites|antimetabolites|mesh-ancestor
110884667|NCT03610100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110884668|NCT03610100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110884682|NCT03659292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110884684|NCT03659058|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
110884685|NCT03659058|Antioxidants|antioxidants|mesh-list
110884686|NCT03659058|Silymarin|silymarin|mesh-list
110884687|NCT03659058|Gout Suppressants|gout suppressants|mesh-ancestor
110884688|NCT03659058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110884689|NCT03659058|Tubulin Modulators|tubulin modulators|mesh-ancestor
110884691|NCT03659058|Mitosis Modulators|mitosis modulators|mesh-ancestor
110884692|NCT03659058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110884693|NCT03659058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110884694|NCT03659058|Protective Agents|protective agents|mesh-ancestor
110884695|NCT03659058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110884696|NCT03659058|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
110884697|NCT03659058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110884698|NCT03635905|Gabapentin|gabapentin|mesh-list
110884699|NCT03635905|Analgesics|analgesics|mesh-ancestor
110884700|NCT03635905|Sensory System Agents|sensory system agents|mesh-ancestor
110884701|NCT03635905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110884702|NCT03635905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110884703|NCT03635905|Anticonvulsants|anticonvulsants|mesh-ancestor
110884704|NCT03635905|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110884705|NCT03635905|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110884706|NCT03635905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110884707|NCT03635905|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110884708|NCT03635905|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110884709|NCT03635905|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110884710|NCT03635905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110884711|NCT03635905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110884712|NCT03635905|Antimanic Agents|antimanic agents|mesh-ancestor
110884713|NCT02960113|Scopolamine|scopolamine|mesh-list
110884714|NCT02960113|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
110884715|NCT02960113|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110884716|NCT02960113|Antiemetics|antiemetics|mesh-ancestor
110884717|NCT02960113|Autonomic Agents|autonomic agents|mesh-ancestor
110884718|NCT02960113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110884719|NCT02960113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110884720|NCT02960113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110884721|NCT02960113|Mydriatics|mydriatics|mesh-ancestor
110884722|NCT02960113|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110884723|NCT02960113|Cholinergic Agents|cholinergic agents|mesh-ancestor
110884724|NCT02960113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110884725|NCT02960113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110884726|NCT02960113|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110884727|NCT02960113|Parasympatholytics|parasympatholytics|mesh-ancestor
110884728|NCT04458324|Buspirone|buspirone|mesh-list
110884729|NCT04458324|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110884730|NCT04458324|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110884731|NCT04458324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110205841|NCT02963779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110884766|NCT02984982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110884767|NCT02984982|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110884768|NCT02984982|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110884769|NCT02984982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110884771|NCT02984982|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110884772|NCT02984982|Protease Inhibitors|protease inhibitors|mesh-ancestor
110884773|NCT03656484|Metronidazole|metronidazole|mesh-list
110205854|NCT00046176|Antiviral Agents|antiviral agents|mesh-ancestor
110205886|NCT00175357|Methadone|methadone|mesh-list
110884776|NCT03656484|Hyaluronic Acid|hyaluronic acid|mesh-list
110884777|NCT03656484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110884778|NCT03656484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110884779|NCT03656484|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110884780|NCT03656484|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110884781|NCT03656484|Antioxidants|antioxidants|mesh-ancestor
110884782|NCT03656484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110884783|NCT03656484|Protective Agents|protective agents|mesh-ancestor
110884784|NCT03656484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110884785|NCT03656484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110884786|NCT03656484|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110884787|NCT03656484|Immunologic Factors|immunologic factors|mesh-ancestor
110884788|NCT03656484|Viscosupplements|viscosupplements|mesh-ancestor
110884789|NCT03656484|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110884790|NCT03656484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110884791|NCT04309578|Capecitabine|capecitabine|mesh-list
110884792|NCT04309578|Trastuzumab|trastuzumab|mesh-list
110884793|NCT04309578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110884794|NCT04309578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110884795|NCT04309578|Antimetabolites|antimetabolites|mesh-ancestor
110884796|NCT04309578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110884797|NCT04309578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110884798|NCT03656952|Moxifloxacin|moxifloxacin|mesh-list
110884799|NCT03656952|PF-06700841|pf-06700841|mesh-list
110884800|NCT03656952|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110884801|NCT03656952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110884802|NCT03656952|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110884803|NCT03656952|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110884804|NCT03656952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110884805|NCT03656952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110884806|NCT03656952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110884807|NCT03656952|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110884808|NCT02981472|Vitamin K|vitamin k|mesh-list
110884809|NCT02981472|Heparin|heparin|mesh-list
110884810|NCT02981472|Enoxaparin|enoxaparin|mesh-list
110884811|NCT02981472|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
110884812|NCT02981472|Tinzaparin|tinzaparin|mesh-list
110884813|NCT02981472|Dalteparin|dalteparin|mesh-list
110884814|NCT02981472|Warfarin|warfarin|mesh-list
110884815|NCT02981472|Apixaban|apixaban|mesh-list
110884816|NCT02981472|Vitamins|vitamins|mesh-ancestor
110884817|NCT02981472|Micronutrients|micronutrients|mesh-ancestor
110884818|NCT02981472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110884819|NCT02981472|Anticoagulants|anticoagulants|mesh-ancestor
110884820|NCT02981472|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110884821|NCT02981472|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110884822|NCT02981472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110884823|NCT02981472|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110884824|NCT02981472|Antithrombins|antithrombins|mesh-ancestor
110884825|NCT02981472|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110884826|NCT02981472|Protease Inhibitors|protease inhibitors|mesh-ancestor
110884827|NCT02981472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110884828|NCT02981472|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110884829|NCT02981472|Hemostatics|hemostatics|mesh-ancestor
110884830|NCT02981472|Coagulants|coagulants|mesh-ancestor
110884831|NCT03656172|Chrysarobin|chrysarobin|mesh-list
110884832|NCT03656172|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110884833|NCT03656172|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110884834|NCT03656172|Analgesics|analgesics|mesh-ancestor
110884835|NCT03656172|Sensory System Agents|sensory system agents|mesh-ancestor
110884836|NCT03656172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110884837|NCT03656172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110884838|NCT03656172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110884839|NCT03656172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110884840|NCT03656094|Docetaxel|docetaxel|mesh-list
110884841|NCT03656094|Pembrolizumab|pembrolizumab|mesh-list
110884842|NCT03656094|Pemetrexed|pemetrexed|mesh-list
110884843|NCT03656094|Vinorelbine|vinorelbine|mesh-list
110884844|NCT03656094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110884845|NCT03656094|Tubulin Modulators|tubulin modulators|mesh-ancestor
110884846|NCT03656094|Antimitotic Agents|antimitotic agents|mesh-ancestor
110884847|NCT03656094|Mitosis Modulators|mitosis modulators|mesh-ancestor
110884848|NCT03656094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110884849|NCT03656094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110884850|NCT03656094|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110884869|NCT04298034|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110884870|NCT04298034|Sympathomimetics|sympathomimetics|mesh-ancestor
110884871|NCT04298034|Autonomic Agents|autonomic agents|mesh-ancestor
110884872|NCT04298034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110884873|NCT04298034|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110884874|NCT04298034|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110884875|NCT02982720|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110884876|NCT02982720|Pembrolizumab|pembrolizumab|mesh-list
110884877|NCT02982720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110884878|NCT02982720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110884879|NCT02982720|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110884880|NCT02982720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110884881|NCT02982720|Antiviral Agents|antiviral agents|mesh-ancestor
110884882|NCT02982720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110884883|NCT00849667|Carboplatin|carboplatin|mesh-list
110884884|NCT00849667|Taxane|taxane|mesh-list
110884885|NCT00849667|Farletuzumab|farletuzumab|mesh-list
110884886|NCT00849667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110884887|NCT03201419|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
110884888|NCT03201419|Hemostatics|hemostatics|mesh-ancestor
110884889|NCT03201419|Coagulants|coagulants|mesh-ancestor
110884890|NCT03201419|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
110884891|NCT03201419|Natriuretic Agents|natriuretic agents|mesh-ancestor
110884892|NCT03201419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110884893|NCT01764633|Evolocumab|evolocumab|mesh-list
110884894|NCT01764633|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
110884895|NCT01764633|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110884896|NCT01764633|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110884897|NCT01764633|Antimetabolites|antimetabolites|mesh-ancestor
110884898|NCT01764633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110884899|NCT01764633|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110884900|NCT01764633|Protease Inhibitors|protease inhibitors|mesh-ancestor
110884901|NCT01764633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110884902|NCT01764633|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110884903|NCT02924389|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110884904|NCT02924389|Dolutegravir|dolutegravir|mesh-list
110884905|NCT02924389|Abacavir, dolutegravir, and lamivudine drug combination|abacavir, dolutegravir, and lamivudine drug combination|mesh-list
110884906|NCT02924389|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110884912|NCT02924389|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110884913|NCT02924389|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110884914|NCT02924389|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110884915|NCT02924389|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110884916|NCT01315093|Heparin|heparin|mesh-list
110884917|NCT01315093|Calcium heparin|calcium heparin|mesh-list
110884918|NCT01315093|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
110884920|NCT01315093|Dalteparin|dalteparin|mesh-list
110884921|NCT01315093|Anticoagulants|anticoagulants|mesh-ancestor
110884922|NCT01315093|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110884923|NCT01315093|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110884924|NCT01315093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110884925|NCT01331707|Everolimus|everolimus|mesh-list
110884926|NCT01331707|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110884927|NCT01331707|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110884928|NCT01331707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110884929|NCT01331707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110884930|NCT01331707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110884931|NCT01331707|Immunologic Factors|immunologic factors|mesh-ancestor
110884932|NCT01331707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110884933|NCT01331707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110884934|NCT03953807|Dexamethasone|dexamethasone|mesh-list
110884935|NCT03953807|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110884936|NCT03953807|Antiemetics|antiemetics|mesh-ancestor
110884937|NCT03953807|Autonomic Agents|autonomic agents|mesh-ancestor
110884938|NCT03953807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110884939|NCT03953807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110884940|NCT03953807|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110884941|NCT03953807|Glucocorticoids|glucocorticoids|mesh-ancestor
110884942|NCT03953807|Hormones|hormones|mesh-ancestor
110884943|NCT03953807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110884944|NCT03953807|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110884945|NCT03953807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110884946|NCT03662711|Bronchodilator Agents|bronchodilator agents|mesh-list
110884947|NCT03662711|Olodaterol|olodaterol|mesh-list
110884948|NCT03662711|Autonomic Agents|autonomic agents|mesh-ancestor
110884949|NCT03662711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110884950|NCT03662711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110884951|NCT03662711|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110884952|NCT03662711|Respiratory System Agents|respiratory system agents|mesh-ancestor
110884953|NCT02923531|Nivolumab|nivolumab|mesh-list
110884954|NCT02923531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110884955|NCT02923531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110884956|NCT02923531|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110884957|NCT02923531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110884958|NCT02934503|Carboplatin|carboplatin|mesh-list
110884959|NCT02934503|Pembrolizumab|pembrolizumab|mesh-list
110884960|NCT02934503|Etoposide|etoposide|mesh-list
110884961|NCT02934503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110884962|NCT02934503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110884963|NCT02934503|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110884964|NCT02934503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110884965|NCT02934503|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110884966|NCT02934503|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110884967|NCT02934503|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110884968|NCT02934503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110884969|NCT04563247|Antibodies|antibodies|mesh-list
110884970|NCT04563247|Immunologic Factors|immunologic factors|mesh-ancestor
110884971|NCT04563247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110884972|NCT01314209|Dexmedetomidine|dexmedetomidine|mesh-list
110884973|NCT01314209|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110884974|NCT01314209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110884975|NCT01314209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110884976|NCT01314209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110884982|NCT01314209|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110884983|NCT01314209|Adrenergic Agents|adrenergic agents|mesh-ancestor
110884984|NCT01314209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110884985|NCT01314209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110884986|NCT05431075|Amoxicillin|amoxicillin|mesh-list
110884987|NCT05431075|Tetracycline|tetracycline|mesh-list
110884988|NCT05431075|Potassium Citrate|potassium citrate|mesh-list
110884989|NCT05431075|Esomeprazole|esomeprazole|mesh-list
110884990|NCT05431075|Bismuth|bismuth|mesh-list
110884991|NCT05431075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110884992|NCT05431075|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110884993|NCT05431075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110884994|NCT05431075|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110884995|NCT05431075|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110884996|NCT05431075|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110884997|NCT05431075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110884998|NCT05431075|Antacids|antacids|mesh-ancestor
110884999|NCT05431075|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110885000|NCT05431075|Diuretics|diuretics|mesh-ancestor
110885001|NCT05431075|Natriuretic Agents|natriuretic agents|mesh-ancestor
110885002|NCT05431075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110885003|NCT05431075|Expectorants|expectorants|mesh-ancestor
110885004|NCT05431075|Respiratory System Agents|respiratory system agents|mesh-ancestor
110885005|NCT03636659|Amphotericin B|amphotericin b|mesh-list
110885006|NCT03636659|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
110885007|NCT03636659|Amebicides|amebicides|mesh-ancestor
110199003|NCT00074841|Analgesics|analgesics|mesh-ancestor
110885008|NCT03636659|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110885009|NCT03636659|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110885010|NCT03636659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110885011|NCT03636659|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110885012|NCT03636659|Antifungal Agents|antifungal agents|mesh-ancestor
110885013|NCT04892173|Cetuximab|cetuximab|mesh-list
110885014|NCT04892173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110885015|NCT04892173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110885016|NCT03198767|Licogliflozin|licogliflozin|mesh-list
110885017|NCT03198767|Calcium Carbonate|calcium carbonate|mesh-list
110885018|NCT03198767|Psyllium|psyllium|mesh-list
110885019|NCT03198767|Calcium|calcium|mesh-list
110885020|NCT03198767|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110885021|NCT03198767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110885022|NCT03198767|Antacids|antacids|mesh-ancestor
110885023|NCT03198767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110885024|NCT03198767|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110885025|NCT03198767|Cathartics|cathartics|mesh-ancestor
110885026|NCT03198767|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110885027|NCT03198767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110885028|NCT03162055|Glycopyrrolate|glycopyrrolate|mesh-list
110885029|NCT03162055|Formoterol Fumarate|formoterol fumarate|mesh-list
110885030|NCT03162055|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110885031|NCT03162055|Autonomic Agents|autonomic agents|mesh-ancestor
110885032|NCT03162055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110885033|NCT03162055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110885034|NCT03162055|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110885035|NCT03162055|Respiratory System Agents|respiratory system agents|mesh-ancestor
110885036|NCT03162055|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110885037|NCT03162055|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110885038|NCT03162055|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110885039|NCT03162055|Adrenergic Agents|adrenergic agents|mesh-ancestor
110885040|NCT03162055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110885041|NCT03162055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110885042|NCT03162055|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110885043|NCT03162055|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110885044|NCT03162055|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110885045|NCT03162055|Cholinergic Agents|cholinergic agents|mesh-ancestor
110885046|NCT01331785|Midodrine|midodrine|mesh-list
110885047|NCT01331785|Sympathomimetics|sympathomimetics|mesh-ancestor
110885048|NCT01331785|Autonomic Agents|autonomic agents|mesh-ancestor
110885056|NCT01331785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110885057|NCT01331785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110885059|NCT01382589|Dermatologic Agents|dermatologic agents|mesh-ancestor
110885060|NCT03671759|Caffeine|caffeine|mesh-list
110885061|NCT03671759|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110885062|NCT03671759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110885063|NCT03671759|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110885064|NCT03671759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110885065|NCT03671759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110885066|NCT03671759|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110885067|NCT03671759|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110199024|NCT00044837|Hormones|hormones|mesh-ancestor
110885068|NCT03671759|Purinergic Agents|purinergic agents|mesh-ancestor
110885069|NCT03671759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110885070|NCT01384227|Proflavine|proflavine|mesh-list
110885071|NCT01384227|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110885072|NCT01384227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110885073|NCT01382511|Simvastatin|simvastatin|mesh-list
110885074|NCT01382511|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110885075|NCT01382511|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110885076|NCT01382511|Antimetabolites|antimetabolites|mesh-ancestor
110885077|NCT01382511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110885078|NCT01382511|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110885079|NCT01382511|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110885080|NCT01382511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110885081|NCT03684447|Propofol|propofol|mesh-list
110885082|NCT03684447|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110885083|NCT03684447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110885084|NCT03684447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110885085|NCT03684447|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110885086|NCT03684447|Anesthetics, General|anesthetics, general|mesh-ancestor
110885087|NCT03684447|Anesthetics|anesthetics|mesh-ancestor
110885088|NCT04505059|Anesthetics|anesthetics|mesh-list
110885089|NCT04505059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110885090|NCT04505059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110885091|NCT01314599|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110885092|NCT04217135|Hydralazine|hydralazine|mesh-list
110885093|NCT04217135|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110885094|NCT04217135|Vasodilator Agents|vasodilator agents|mesh-ancestor
110885095|NCT01337401|Cediranib|cediranib|mesh-list
110885096|NCT01337401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110885097|NCT01337401|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110885098|NCT01337401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110885099|NCT01337401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110885100|NCT04178603|Insulin|insulin|mesh-list
110885101|NCT04178603|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110885102|NCT04178603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110885103|NCT01333891|Nitroprusside|nitroprusside|mesh-list
110885104|NCT01333891|Phenylephrine|phenylephrine|mesh-list
110885105|NCT01333891|Oxymetazoline|oxymetazoline|mesh-list
110885106|NCT01333891|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110885107|NCT01333891|Mydriatics|mydriatics|mesh-ancestor
110885108|NCT01333891|Autonomic Agents|autonomic agents|mesh-ancestor
110885109|NCT01333891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110885110|NCT01333891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110885111|NCT01333891|Sympathomimetics|sympathomimetics|mesh-ancestor
110885112|NCT01333891|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110885113|NCT01333891|Nasal Decongestants|nasal decongestants|mesh-ancestor
110885114|NCT01333891|Respiratory System Agents|respiratory system agents|mesh-ancestor
110885115|NCT01333891|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110885136|NCT04853875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110885137|NCT04853875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110885138|NCT04853875|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110885139|NCT04853875|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110885141|NCT04853875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110885142|NCT04853875|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110885143|NCT03196973|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110885144|NCT03196973|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
110885145|NCT03196973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110885146|NCT03196973|Antitubercular Agents|antitubercular agents|mesh-ancestor
110885147|NCT03196505|Bupivacaine|bupivacaine|mesh-list
110885148|NCT03196505|Anesthetics, Local|anesthetics, local|mesh-ancestor
110885149|NCT03196505|Anesthetics|anesthetics|mesh-ancestor
110885150|NCT03196505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110199044|NCT00044876|Ulipristal acetate|ulipristal acetate|mesh-list
110885151|NCT03196505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110885152|NCT03196505|Sensory System Agents|sensory system agents|mesh-ancestor
110885153|NCT03196505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110885154|NCT01334047|Vaccines|vaccines|mesh-list
110885155|NCT01334047|Immunologic Factors|immunologic factors|mesh-ancestor
110885156|NCT01334047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110885157|NCT01337557|Bepotastine besilate|bepotastine besilate|mesh-list
110885158|NCT01337557|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110885159|NCT03196349|Warfarin|warfarin|mesh-list
110885160|NCT03196349|Rivaroxaban|rivaroxaban|mesh-list
110885161|NCT03196349|Apixaban|apixaban|mesh-list
110885162|NCT03196349|Anticoagulants|anticoagulants|mesh-ancestor
110885163|NCT03196349|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110885164|NCT03196349|Antithrombins|antithrombins|mesh-ancestor
110885165|NCT03196349|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110885166|NCT03196349|Protease Inhibitors|protease inhibitors|mesh-ancestor
110885167|NCT03196349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110885168|NCT03196349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110885169|NCT01331941|Paclitaxel|paclitaxel|mesh-list
110885170|NCT01331941|Trebananib|trebananib|mesh-list
110885171|NCT01331941|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110885172|NCT01331941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110885173|NCT01331941|Tubulin Modulators|tubulin modulators|mesh-ancestor
110885178|NCT01331941|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110885179|NCT01331941|Growth Substances|growth substances|mesh-ancestor
110885180|NCT01331941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110885181|NCT01331941|Growth Inhibitors|growth inhibitors|mesh-ancestor
110885182|NCT02886715|Nicotinic Acids|nicotinic acids|mesh-list
110885183|NCT02886715|Tazarotene|tazarotene|mesh-list
110885184|NCT02886715|Dermatologic Agents|dermatologic agents|mesh-ancestor
110885185|NCT02886715|Keratolytic Agents|keratolytic agents|mesh-ancestor
110885186|NCT02886715|Vitamin B Complex|vitamin b complex|mesh-ancestor
110885187|NCT02886715|Vitamins|vitamins|mesh-ancestor
110885188|NCT02886715|Micronutrients|micronutrients|mesh-ancestor
110885189|NCT02886715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110885190|NCT01337791|Telbivudine|telbivudine|mesh-list
110885191|NCT01337791|Antiviral Agents|antiviral agents|mesh-ancestor
110885192|NCT01337791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110885193|NCT01337791|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110885194|NCT01337791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110885195|NCT01337791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110885196|NCT01334203|Ranolazine|ranolazine|mesh-list
110885197|NCT01334203|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110885198|NCT01334203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110885199|NCT01334203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110885200|NCT03085797|Mometasone Furoate|mometasone furoate|mesh-list
110885201|NCT03085797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110885202|NCT03085797|Dermatologic Agents|dermatologic agents|mesh-ancestor
110885203|NCT03085797|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110885204|NCT01569165|Fluorides|fluorides|mesh-list
110885205|NCT01569165|Fluorides, Topical|fluorides, topical|mesh-list
110885206|NCT01569165|Cariostatic Agents|cariostatic agents|mesh-ancestor
110885207|NCT01569165|Protective Agents|protective agents|mesh-ancestor
110199062|NCT00397475|Vitamins|vitamins|mesh-ancestor
110885208|NCT01569165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110885209|NCT04259749|Menthol|menthol|mesh-list
110885210|NCT04259749|Antipruritics|antipruritics|mesh-ancestor
110885211|NCT04259749|Dermatologic Agents|dermatologic agents|mesh-ancestor
110885212|NCT02535091|Cenobamate|cenobamate|mesh-list
110885213|NCT02535091|Anticonvulsants|anticonvulsants|mesh-ancestor
110885214|NCT01382277|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110885215|NCT01382277|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110885216|NCT01382277|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110885217|NCT01382277|Antimetabolites|antimetabolites|mesh-ancestor
110885218|NCT01382277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110885219|NCT01382277|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110885220|NCT01382277|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110885221|NCT01382277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110885222|NCT01382199|Lactoferrin|lactoferrin|mesh-list
110885223|NCT01382199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110885224|NCT01381497|Naproxen|naproxen|mesh-list
110885225|NCT01381497|Sumatriptan|sumatriptan|mesh-list
110885226|NCT01381497|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110885227|NCT01381497|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110885228|NCT01381497|Analgesics|analgesics|mesh-ancestor
110885229|NCT01381497|Sensory System Agents|sensory system agents|mesh-ancestor
110885230|NCT01381497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110885231|NCT01381497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110885232|NCT01381497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110885233|NCT01381497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110885234|NCT01381497|Gout Suppressants|gout suppressants|mesh-ancestor
110885235|NCT01381497|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110885236|NCT01381497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110885237|NCT01381497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110885238|NCT01381497|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110885239|NCT01381497|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110885240|NCT01381497|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110885241|NCT01381497|Serotonin Agents|serotonin agents|mesh-ancestor
110885242|NCT01381497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110885243|NCT03635827|Xenon|xenon|mesh-list
110885244|NCT03635827|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110885245|NCT03635827|Anesthetics, General|anesthetics, general|mesh-ancestor
110885246|NCT03635827|Anesthetics|anesthetics|mesh-ancestor
110885252|NCT01338103|Immunologic Factors|immunologic factors|mesh-ancestor
110885253|NCT01338103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110885254|NCT01338103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110885256|NCT03621761|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110885257|NCT03621761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110885258|NCT03621761|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
110885259|NCT03621761|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110885260|NCT03621761|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110885261|NCT03621761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110885262|NCT03318861|Cyclophosphamide|cyclophosphamide|mesh-list
110885263|NCT03318861|Fludarabine|fludarabine|mesh-list
110885264|NCT03318861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110885265|NCT03318861|Immunologic Factors|immunologic factors|mesh-ancestor
110885266|NCT03318861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110885267|NCT03318861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110885268|NCT03318861|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110885269|NCT03318861|Alkylating Agents|alkylating agents|mesh-ancestor
110885270|NCT03318861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110885271|NCT03318861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110885272|NCT03318861|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110885273|NCT03084315|Nicotine|nicotine|mesh-list
110885274|NCT03084315|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110885275|NCT03084315|Autonomic Agents|autonomic agents|mesh-ancestor
110885276|NCT03084315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110885277|NCT03084315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110885278|NCT03084315|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110885279|NCT03084315|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110885280|NCT03084315|Cholinergic Agents|cholinergic agents|mesh-ancestor
110885281|NCT03084315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110885282|NCT03084315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110885283|NCT03187301|Moxifloxacin|moxifloxacin|mesh-list
110885284|NCT03187301|Apomorphine|apomorphine|mesh-list
110885285|NCT03187301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110885286|NCT03187301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110885287|NCT03187301|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110885288|NCT03187301|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110885289|NCT03187301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110885290|NCT03187301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110885291|NCT03187301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110885292|NCT03187301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110885293|NCT03187301|Emetics|emetics|mesh-ancestor
110885294|NCT03187301|Autonomic Agents|autonomic agents|mesh-ancestor
110885295|NCT03187301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110885296|NCT03187301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110885297|NCT03187301|Dopamine Agonists|dopamine agonists|mesh-ancestor
110885298|NCT03187301|Dopamine Agents|dopamine agents|mesh-ancestor
110885299|NCT03187301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110885300|NCT01381185|Aspirin|aspirin|mesh-list
110885301|NCT01381185|Clopidogrel|clopidogrel|mesh-list
110885302|NCT01381185|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110885303|NCT01381185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110885304|NCT01381185|Analgesics|analgesics|mesh-ancestor
110885305|NCT01381185|Sensory System Agents|sensory system agents|mesh-ancestor
110885306|NCT01381185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110885307|NCT01381185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110885308|NCT01381185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110885309|NCT01381185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110885310|NCT01381185|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110885311|NCT01381185|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110885312|NCT01381185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110885313|NCT01381185|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110885314|NCT01381185|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110885341|NCT05421897|Alkylating Agents|alkylating agents|mesh-ancestor
110885342|NCT05421897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110885343|NCT05421897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110885344|NCT05421897|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110885345|NCT05421897|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110885346|NCT05421897|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110885347|NCT05421897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110885348|NCT03077919|Ropivacaine|ropivacaine|mesh-list
110885349|NCT03077919|Anesthetics, Local|anesthetics, local|mesh-ancestor
110885350|NCT03077919|Anesthetics|anesthetics|mesh-ancestor
110885351|NCT03077919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110885352|NCT03077919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110885353|NCT03077919|Sensory System Agents|sensory system agents|mesh-ancestor
110885354|NCT03077919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110885355|NCT01380951|Telbivudine|telbivudine|mesh-list
110885356|NCT01380951|Antiviral Agents|antiviral agents|mesh-ancestor
110885357|NCT01380951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110885358|NCT01380951|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110885359|NCT01380951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110885360|NCT01380951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110885361|NCT01377597|Ranibizumab|ranibizumab|mesh-list
110885362|NCT01377597|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110885363|NCT01377597|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110885364|NCT01377597|Growth Substances|growth substances|mesh-ancestor
110885365|NCT01377597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110885374|NCT03204695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110920897|NCT04671355|Fluticasone|fluticasone|mesh-list
110885375|NCT03204695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110885376|NCT03204695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110885377|NCT03287375|Cisplatin|cisplatin|mesh-list
110885378|NCT03287375|Doxorubicin|doxorubicin|mesh-list
110885379|NCT03287375|Oxaliplatin|oxaliplatin|mesh-list
110885380|NCT03287375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110885381|NCT03287375|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110885382|NCT03287375|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110885383|NCT03287375|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110885384|NCT03287375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110885385|NCT03287375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110885386|NCT03881059|Ustekinumab|ustekinumab|mesh-list
110885387|NCT03881059|Deucravacitinib|deucravacitinib|mesh-list
110885388|NCT03881059|Dermatologic Agents|dermatologic agents|mesh-ancestor
110885389|NCT03881059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110885390|NCT03881059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110885391|NCT03881059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110885392|NCT01338337|Azacitidine|azacitidine|mesh-list
110885393|NCT01338337|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110885394|NCT01338337|Antimetabolites|antimetabolites|mesh-ancestor
110885395|NCT01338337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110885396|NCT01338337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110885397|NCT01338337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110885398|NCT03083847|Chloroquine|chloroquine|mesh-list
110885399|NCT03083847|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
110885400|NCT03083847|Pyrimethamine|pyrimethamine|mesh-list
110885401|NCT03083847|Amebicides|amebicides|mesh-ancestor
110885402|NCT03083847|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110885403|NCT03083847|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110885404|NCT03083847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110885405|NCT03083847|Antimalarials|antimalarials|mesh-ancestor
110885406|NCT03083847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110885407|NCT03083847|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110885408|NCT03083847|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110885409|NCT03083847|Analgesics|analgesics|mesh-ancestor
110885410|NCT03083847|Sensory System Agents|sensory system agents|mesh-ancestor
110885411|NCT03083847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110885412|NCT03083847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110885413|NCT03083847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110885414|NCT03083847|Filaricides|filaricides|mesh-ancestor
110885415|NCT03083847|Antinematodal Agents|antinematodal agents|mesh-ancestor
110885416|NCT03083847|Anthelmintics|anthelmintics|mesh-ancestor
110885417|NCT03083847|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110885418|NCT03083847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110885419|NCT03083847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110885420|NCT03082677|Ixazomib|ixazomib|mesh-list
110885421|NCT03082677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110885422|NCT03082677|Protease Inhibitors|protease inhibitors|mesh-ancestor
110885423|NCT03082677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110885424|NCT03082677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110885425|NCT03136055|Paclitaxel|paclitaxel|mesh-list
110885426|NCT03136055|Pembrolizumab|pembrolizumab|mesh-list
110885427|NCT03136055|Irinotecan|irinotecan|mesh-list
110885428|NCT03136055|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110885429|NCT03136055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110885430|NCT03136055|Tubulin Modulators|tubulin modulators|mesh-ancestor
110885431|NCT03136055|Antimitotic Agents|antimitotic agents|mesh-ancestor
110885432|NCT03136055|Mitosis Modulators|mitosis modulators|mesh-ancestor
110205983|NCT00175903|Levetiracetam|levetiracetam|mesh-list
110885438|NCT03136055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110885439|NCT03221309|Analgesics, Opioid|analgesics, opioid|mesh-list
110885440|NCT03221309|Narcotics|narcotics|mesh-ancestor
110885441|NCT03221309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110885442|NCT03221309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110885443|NCT03221309|Analgesics|analgesics|mesh-ancestor
110885444|NCT03221309|Sensory System Agents|sensory system agents|mesh-ancestor
110885445|NCT03221309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110885447|NCT03426657|Tremelimumab|tremelimumab|mesh-list
110885448|NCT03426657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110885449|NCT03426657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110885450|NCT02858180|Sofosbuvir|sofosbuvir|mesh-list
110885452|NCT02858180|Antiviral Agents|antiviral agents|mesh-ancestor
110885453|NCT02858180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110885454|NCT03609086|Melatonin|melatonin|mesh-list
110885455|NCT03609086|Antioxidants|antioxidants|mesh-ancestor
110885456|NCT03609086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110885457|NCT03609086|Protective Agents|protective agents|mesh-ancestor
110885458|NCT03609086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110885459|NCT03609086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110885460|NCT00730717|Adalimumab|adalimumab|mesh-list
110885461|NCT00730717|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110885462|NCT00730717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110885463|NCT00730717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110885464|NCT01332409|Fluticasone|fluticasone|mesh-list
110885465|NCT01332409|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110885466|NCT01332409|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
110885467|NCT01332409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110885468|NCT01332409|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110885469|NCT01332409|Autonomic Agents|autonomic agents|mesh-ancestor
110885470|NCT01332409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110885471|NCT01332409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110885472|NCT01332409|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110885473|NCT01332409|Respiratory System Agents|respiratory system agents|mesh-ancestor
110885474|NCT01332409|Dermatologic Agents|dermatologic agents|mesh-ancestor
110885475|NCT01332409|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110885476|NCT01332409|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110885477|NCT01332409|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110885478|NCT01332409|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110885479|NCT01332409|Adrenergic Agents|adrenergic agents|mesh-ancestor
110885480|NCT01332409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110885481|NCT01332409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110885482|NCT01332409|Glucocorticoids|glucocorticoids|mesh-ancestor
110885483|NCT01332409|Hormones|hormones|mesh-ancestor
110885484|NCT01332409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110885485|NCT01332409|Sympathomimetics|sympathomimetics|mesh-ancestor
110885486|NCT03181451|Ferric maltol|ferric maltol|mesh-list
110885487|NCT03181451|Hematinics|hematinics|mesh-ancestor
110885488|NCT03495973|Ustekinumab|ustekinumab|mesh-list
110885489|NCT03495973|Dermatologic Agents|dermatologic agents|mesh-ancestor
110885490|NCT00480805|Losartan|losartan|mesh-list
110885491|NCT00480805|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110885492|NCT00480805|Ramipril|ramipril|mesh-list
110885493|NCT00480805|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110885494|NCT00480805|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110885495|NCT00480805|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110885496|NCT00480805|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110885497|NCT00480805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110885498|NCT00480805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110885499|NCT00480805|Diuretics|diuretics|mesh-ancestor
110885500|NCT00480805|Natriuretic Agents|natriuretic agents|mesh-ancestor
110885501|NCT00480805|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110885502|NCT00480805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110885526|NCT03179891|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110885527|NCT03179891|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110885528|NCT03179891|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110885529|NCT03179891|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110885530|NCT03179891|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110885531|NCT03179891|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110885532|NCT03179891|Anesthetics, General|anesthetics, general|mesh-ancestor
110885533|NCT03179891|Anesthetics|anesthetics|mesh-ancestor
110885534|NCT03179891|GABA Modulators|gaba modulators|mesh-ancestor
110885535|NCT03179891|GABA Agents|gaba agents|mesh-ancestor
110885536|NCT03179891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110885537|NCT03179891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110885538|NCT01334671|Atorvastatin|atorvastatin|mesh-list
110885539|NCT01334671|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110885540|NCT01334671|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110885541|NCT01334671|Antimetabolites|antimetabolites|mesh-ancestor
110885542|NCT01334671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110885543|NCT01334671|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110885544|NCT01334671|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110885545|NCT01334671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110885546|NCT01332565|Dolutegravir|dolutegravir|mesh-list
110885547|NCT01332565|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110885548|NCT01332565|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110885549|NCT01332565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110885550|NCT01332565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110885551|NCT01332565|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110885552|NCT01332565|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110885637|NCT01335373|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110885638|NCT01335373|Antifungal Agents|antifungal agents|mesh-ancestor
110885639|NCT01335373|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110885640|NCT01335373|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110885641|NCT01335373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110885642|NCT01335373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110885643|NCT01335373|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110885644|NCT01335373|Hormone Antagonists|hormone antagonists|mesh-ancestor
110924812|NCT03098680|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110885645|NCT01335373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110885646|NCT01335373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110885647|NCT01335373|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110885648|NCT01335373|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110885650|NCT01333267|Anabolic Androgenic Steroids|anabolic androgenic steroids|mesh-list
110885651|NCT01333267|Testosterone Congeners|testosterone congeners|mesh-list
110885652|NCT01333267|Parathyroid Hormone|parathyroid hormone|mesh-list
110885653|NCT01333267|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
110885654|NCT01333267|Anabolic Agents|anabolic agents|mesh-list
110885655|NCT01333267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110885656|NCT01333267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110885657|NCT01333267|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110885658|NCT01333267|Performance-Enhancing Substances|performance-enhancing substances|mesh-ancestor
110885659|NCT01335529|Interferons|interferons|mesh-list
110206251|NCT00177853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110206252|NCT00177853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110206253|NCT00177853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110206254|NCT00177853|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110206255|NCT00177853|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110206256|NCT00177853|Analgesics|analgesics|mesh-ancestor
110886272|NCT01314989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110886273|NCT01314989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110886275|NCT01314989|Serotonin Agents|serotonin agents|mesh-ancestor
110886276|NCT01314989|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110886277|NCT04483115|Tadalafil|tadalafil|mesh-list
110886278|NCT04483115|Vasodilator Agents|vasodilator agents|mesh-ancestor
110886279|NCT04483115|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110886280|NCT04483115|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110886281|NCT04483115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110534673|NCT02672358|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110886292|NCT04054362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110886293|NCT04054362|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110886294|NCT04054362|Antimetabolites|antimetabolites|mesh-ancestor
110886295|NCT04467281|Daratumumab|daratumumab|mesh-list
110886296|NCT04467281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110886297|NCT01378143|Pentamidine|pentamidine|mesh-list
110886298|NCT01378143|Antifungal Agents|antifungal agents|mesh-ancestor
110886299|NCT01378143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110886300|NCT01378143|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110886301|NCT01378143|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110209491|NCT00410254|Midazolam|midazolam|mesh-list
110886302|NCT01378143|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
110886303|NCT02973048|Bupivacaine|bupivacaine|mesh-list
110886304|NCT02973048|Prilocaine|prilocaine|mesh-list
110886305|NCT02973048|Anesthetics, Local|anesthetics, local|mesh-ancestor
110886306|NCT02973048|Anesthetics|anesthetics|mesh-ancestor
110886307|NCT02973048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110886308|NCT02973048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110886309|NCT02973048|Sensory System Agents|sensory system agents|mesh-ancestor
110886310|NCT02973048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110886311|NCT04054206|Ibudilast|ibudilast|mesh-list
110886312|NCT04054206|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110886313|NCT04054206|Autonomic Agents|autonomic agents|mesh-ancestor
110886314|NCT04054206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110886315|NCT04054206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110886316|NCT04054206|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110886317|NCT04054206|Respiratory System Agents|respiratory system agents|mesh-ancestor
110886318|NCT04054206|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110886319|NCT04054206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110886320|NCT04054206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110199170|NCT00403156|Ranibizumab|ranibizumab|mesh-list
110886321|NCT04054206|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110886322|NCT04054206|Vasodilator Agents|vasodilator agents|mesh-ancestor
110886323|NCT03603938|Losartan|losartan|mesh-list
110886324|NCT03603938|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110886325|NCT03603938|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110886326|NCT03603938|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110886327|NCT03603938|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110886328|NCT03603938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110886329|NCT03652116|Meperidine|meperidine|mesh-list
110886330|NCT03652116|Bupivacaine|bupivacaine|mesh-list
110886331|NCT03652116|Anesthetics, Local|anesthetics, local|mesh-ancestor
110886332|NCT03652116|Anesthetics|anesthetics|mesh-ancestor
110886333|NCT03652116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110886334|NCT03652116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110886335|NCT03652116|Sensory System Agents|sensory system agents|mesh-ancestor
110886336|NCT03652116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110886337|NCT03652116|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110886338|NCT03652116|Narcotics|narcotics|mesh-ancestor
110886339|NCT03652116|Analgesics|analgesics|mesh-ancestor
110886340|NCT03652116|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110886341|NCT02232087|Fluticasone|fluticasone|mesh-list
110886342|NCT02232087|Xhance|xhance|mesh-list
110886343|NCT02232087|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110886344|NCT02232087|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
110886345|NCT02232087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110886346|NCT02232087|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110886347|NCT02232087|Autonomic Agents|autonomic agents|mesh-ancestor
110886348|NCT02232087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110886349|NCT02232087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110886350|NCT02232087|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110886351|NCT02232087|Respiratory System Agents|respiratory system agents|mesh-ancestor
110886352|NCT02232087|Dermatologic Agents|dermatologic agents|mesh-ancestor
110886353|NCT02232087|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110886354|NCT02232087|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110886355|NCT02232087|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110886356|NCT02232087|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110886357|NCT02232087|Adrenergic Agents|adrenergic agents|mesh-ancestor
110886358|NCT02232087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110886359|NCT02232087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110886361|NCT02232087|Hormones|hormones|mesh-ancestor
110886362|NCT02232087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110886363|NCT02232087|Sympathomimetics|sympathomimetics|mesh-ancestor
110886364|NCT01380015|Rosmarinic acid|rosmarinic acid|mesh-list
110886365|NCT01380015|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110886366|NCT01380015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110886367|NCT01380015|Analgesics|analgesics|mesh-ancestor
110886368|NCT01380015|Sensory System Agents|sensory system agents|mesh-ancestor
110886369|NCT01380015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110886370|NCT01380015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110886371|NCT01380015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110886372|NCT01380015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110886373|NCT01380015|Antioxidants|antioxidants|mesh-ancestor
110886374|NCT01380015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110886375|NCT01380015|Protective Agents|protective agents|mesh-ancestor
110199181|NCT00045227|Docetaxel|docetaxel|mesh-list
110886376|NCT01380015|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110886377|NCT01380015|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110886378|NCT01380015|Protease Inhibitors|protease inhibitors|mesh-ancestor
110886379|NCT01380015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110886380|NCT03603626|Pregabalin|pregabalin|mesh-list
110886381|NCT03603626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110886383|NCT03603626|Sensory System Agents|sensory system agents|mesh-ancestor
110886384|NCT03603626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110886385|NCT03603626|Anticonvulsants|anticonvulsants|mesh-ancestor
110886386|NCT03603626|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110886387|NCT03603626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110886388|NCT03603626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110886389|NCT03603626|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110886390|NCT03603626|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110886391|NCT03603626|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110886392|NCT03603626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110886393|NCT03603626|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110886394|NCT01765218|Topiramate|topiramate|mesh-list
110886395|NCT01765218|Anticonvulsants|anticonvulsants|mesh-ancestor
110886396|NCT01765218|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110886397|NCT01765218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110886398|NCT02972502|Diphenhydramine|diphenhydramine|mesh-list
110886399|NCT02972502|Promethazine|promethazine|mesh-list
110886400|NCT02972502|Haloperidol|haloperidol|mesh-list
110886401|NCT02972502|Metoclopramide|metoclopramide|mesh-list
110886402|NCT02972502|Haloperidol decanoate|haloperidol decanoate|mesh-list
110886403|NCT02972502|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110886404|NCT02972502|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110886405|NCT02972502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110886406|NCT02972502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110886407|NCT02972502|Anesthetics, Local|anesthetics, local|mesh-ancestor
110886408|NCT02972502|Anesthetics|anesthetics|mesh-ancestor
110886409|NCT02972502|Sensory System Agents|sensory system agents|mesh-ancestor
110886410|NCT02972502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110886412|NCT02972502|Autonomic Agents|autonomic agents|mesh-ancestor
110886413|NCT02972502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110886414|NCT02972502|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110886415|NCT02972502|Histamine Antagonists|histamine antagonists|mesh-ancestor
110886416|NCT02972502|Histamine Agents|histamine agents|mesh-ancestor
110886417|NCT02972502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110886418|NCT02972502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110886419|NCT02972502|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110886420|NCT02972502|Antipruritics|antipruritics|mesh-ancestor
110886421|NCT02972502|Dermatologic Agents|dermatologic agents|mesh-ancestor
110886422|NCT02972502|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110886423|NCT02972502|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110886424|NCT02972502|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110886425|NCT02972502|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110886426|NCT02972502|Dopamine Agents|dopamine agents|mesh-ancestor
110886427|NCT02972502|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110886428|NCT02972502|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110886429|NCT03606590|Sorafenib|sorafenib|mesh-list
110886430|NCT03606590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110886431|NCT03606590|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110886432|NCT03606590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110886433|NCT03606590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110886434|NCT03163667|Everolimus|everolimus|mesh-list
110886435|NCT03163667|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110886436|NCT03163667|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110886437|NCT03163667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110886438|NCT03163667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110886439|NCT03163667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110886440|NCT03163667|Immunologic Factors|immunologic factors|mesh-ancestor
110886441|NCT03163667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110886442|NCT03163667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110886443|NCT03603548|Tacrolimus|tacrolimus|mesh-list
110886444|NCT03603548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110886445|NCT03603548|Immunologic Factors|immunologic factors|mesh-ancestor
110886446|NCT03603548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110886447|NCT03603548|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110886448|NCT03603548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110886449|NCT03603548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110886450|NCT03954782|Nintedanib|nintedanib|mesh-list
110886451|NCT03954782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110210328|NCT00224809|Antipyretics|antipyretics|mesh-ancestor
110886452|NCT03954782|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110886453|NCT03954782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110886454|NCT03954782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110886455|NCT03651726|Palmidrol|palmidrol|mesh-list
110886456|NCT03651726|Dronabinol|dronabinol|mesh-list
110886457|NCT03651726|Hallucinogens|hallucinogens|mesh-ancestor
110886458|NCT03651726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110886459|NCT03651726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110886460|NCT03651726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110886462|NCT03651726|Sensory System Agents|sensory system agents|mesh-ancestor
110886463|NCT03651726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110886464|NCT03651726|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
110886465|NCT03651726|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110886466|NCT03651726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110886467|NCT03651726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110886468|NCT03651726|Hormones|hormones|mesh-ancestor
110886469|NCT03651726|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110886470|NCT03651726|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110886471|NCT03651726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110063210|NCT03364868|Insulin|insulin|mesh-list
110886472|NCT03651726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110886473|NCT03651726|Antiviral Agents|antiviral agents|mesh-ancestor
110920978|NCT04562779|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110886474|NCT03651726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110886475|NCT00107250|Paclitaxel|paclitaxel|mesh-list
110886476|NCT00107250|Carboplatin|carboplatin|mesh-list
110886477|NCT00107250|Capecitabine|capecitabine|mesh-list
110886478|NCT00107250|Cediranib|cediranib|mesh-list
110886479|NCT00107250|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110886480|NCT00107250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110886481|NCT00107250|Tubulin Modulators|tubulin modulators|mesh-ancestor
110886482|NCT00107250|Antimitotic Agents|antimitotic agents|mesh-ancestor
110886483|NCT00107250|Mitosis Modulators|mitosis modulators|mesh-ancestor
110886484|NCT00107250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110886485|NCT00107250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110886486|NCT00107250|Antimetabolites|antimetabolites|mesh-ancestor
110886487|NCT00107250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110886488|NCT00107250|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110886489|NCT03167411|Exenatide|exenatide|mesh-list
110886490|NCT03167411|Bexagliflozin|bexagliflozin|mesh-list
110886491|NCT03167411|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110886492|NCT03167411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110886493|NCT03167411|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110886494|NCT03167411|Incretins|incretins|mesh-ancestor
110886495|NCT03167411|Hormones|hormones|mesh-ancestor
110886496|NCT03167411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110886497|NCT02237768|Dirithromycin|dirithromycin|mesh-list
110886498|NCT02237768|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110886499|NCT02237768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110886500|NCT05461833|Octylonium|octylonium|mesh-list
110886501|NCT05461833|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110886502|NCT05461833|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110886503|NCT05461833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110886504|NCT05461833|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110886505|NCT05461833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110886506|NCT05461833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110886507|NCT05461833|Parasympatholytics|parasympatholytics|mesh-ancestor
110886509|NCT05461833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110886510|NCT05461833|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110886511|NCT05461833|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110886512|NCT05461833|Cholinergic Agents|cholinergic agents|mesh-ancestor
110886513|NCT05461833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110886515|NCT01560585|Dermatologic Agents|dermatologic agents|mesh-ancestor
110886516|NCT01376427|Dexamethasone|dexamethasone|mesh-list
110886517|NCT01376427|Methotrexate|methotrexate|mesh-list
110886518|NCT01376427|Vincristine|vincristine|mesh-list
110886519|NCT01376427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110886520|NCT01376427|Antiemetics|antiemetics|mesh-ancestor
110886521|NCT01376427|Autonomic Agents|autonomic agents|mesh-ancestor
110886522|NCT01376427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110886523|NCT01376427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110886524|NCT01376427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110886525|NCT01376427|Glucocorticoids|glucocorticoids|mesh-ancestor
110886526|NCT01376427|Hormones|hormones|mesh-ancestor
110210685|NCT00226330|Pioglitazone|pioglitazone|mesh-list
110886527|NCT01376427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110886528|NCT01376427|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110886529|NCT01376427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110886530|NCT01376427|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110886531|NCT01376427|Abortifacient Agents|abortifacient agents|mesh-ancestor
110886532|NCT01376427|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110886533|NCT01376427|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110886534|NCT01376427|Antimetabolites|antimetabolites|mesh-ancestor
110886535|NCT01376427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110886536|NCT01376427|Dermatologic Agents|dermatologic agents|mesh-ancestor
110886537|NCT01376427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110886538|NCT01376427|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110886539|NCT01376427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110886540|NCT01376427|Immunologic Factors|immunologic factors|mesh-ancestor
110886541|NCT01376427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110886542|NCT01376427|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110886543|NCT01376427|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110886544|NCT01376427|Tubulin Modulators|tubulin modulators|mesh-ancestor
110886545|NCT01376427|Antimitotic Agents|antimitotic agents|mesh-ancestor
110886546|NCT01376427|Mitosis Modulators|mitosis modulators|mesh-ancestor
110886547|NCT03075501|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
110886548|NCT03075501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110886549|NCT03075501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110886550|NCT05462535|Losartan|losartan|mesh-list
110886551|NCT05462535|Amlodipine|amlodipine|mesh-list
110886552|NCT05462535|Chlorthalidone|chlorthalidone|mesh-list
110886553|NCT05462535|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110886554|NCT05462535|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110886555|NCT05462535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110886556|NCT05462535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110886557|NCT05462535|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110886558|NCT05462535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110886559|NCT05462535|Vasodilator Agents|vasodilator agents|mesh-ancestor
110886560|NCT05462535|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110886561|NCT05462535|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110886562|NCT05462535|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110886563|NCT05462535|Diuretics|diuretics|mesh-ancestor
110886564|NCT05462535|Natriuretic Agents|natriuretic agents|mesh-ancestor
110210877|NCT00227656|Interferons|interferons|mesh-list
110886565|NCT05462535|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110886567|NCT05764317|Perindopril|perindopril|mesh-list
110886568|NCT05764317|Atorvastatin|atorvastatin|mesh-list
110886569|NCT05764317|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110886570|NCT05764317|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110886571|NCT05764317|Antimetabolites|antimetabolites|mesh-ancestor
110886572|NCT05764317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110886573|NCT05764317|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110886574|NCT05764317|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110886575|NCT05764317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110886576|NCT05764317|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110886577|NCT05764317|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110886578|NCT05764317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110886579|NCT05764317|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110886580|NCT05764317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110886581|NCT05764317|Vasodilator Agents|vasodilator agents|mesh-ancestor
110886582|NCT05764317|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110886583|NCT05764317|Protease Inhibitors|protease inhibitors|mesh-ancestor
110886584|NCT05461365|Insulin|insulin|mesh-list
110886585|NCT05461365|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110886586|NCT05461365|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110886587|NCT05461365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110199273|NCT03739411|Temozolomide|temozolomide|mesh-list
110886588|NCT03602846|Hypoglycemic Agents|hypoglycemic agents|mesh-list
110886589|NCT03602846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110886590|NCT02317991|Paclitaxel|paclitaxel|mesh-list
110886591|NCT02317991|Ramucirumab|ramucirumab|mesh-list
110886592|NCT02317991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110886593|NCT02317991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110886594|NCT02317991|Tubulin Modulators|tubulin modulators|mesh-ancestor
110886595|NCT02317991|Antimitotic Agents|antimitotic agents|mesh-ancestor
110886596|NCT02317991|Mitosis Modulators|mitosis modulators|mesh-ancestor
110886597|NCT02317991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110886598|NCT03602690|Ritonavir|ritonavir|mesh-list
110886599|NCT03602690|Darunavir|darunavir|mesh-list
110886600|NCT03602690|Dolutegravir|dolutegravir|mesh-list
110886601|NCT03602690|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110886602|NCT03602690|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110886603|NCT03602690|Protease Inhibitors|protease inhibitors|mesh-ancestor
110886604|NCT03602690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110211123|NCT00228592|gamma-Globulins|gamma-globulins|mesh-list
110886605|NCT03602690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110886606|NCT03602690|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110886607|NCT03602690|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110886608|NCT03602690|Antiviral Agents|antiviral agents|mesh-ancestor
110886609|NCT03602690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110886610|NCT03602690|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110886611|NCT03602690|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110886612|NCT03602690|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110886613|NCT03602690|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110886614|NCT01379547|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110886615|NCT01379547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110886617|NCT02978495|Cyclophosphamide|cyclophosphamide|mesh-list
110886618|NCT02978495|Carboplatin|carboplatin|mesh-list
110886619|NCT02978495|Doxorubicin|doxorubicin|mesh-list
110886620|NCT02978495|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110886621|NCT02978495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110886622|NCT02978495|Tubulin Modulators|tubulin modulators|mesh-ancestor
110886623|NCT02978495|Antimitotic Agents|antimitotic agents|mesh-ancestor
110886624|NCT02978495|Mitosis Modulators|mitosis modulators|mesh-ancestor
110886625|NCT02978495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110886626|NCT02978495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110886627|NCT02978495|Immunologic Factors|immunologic factors|mesh-ancestor
110886628|NCT02978495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110886629|NCT02978495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110886630|NCT02978495|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110886631|NCT02978495|Alkylating Agents|alkylating agents|mesh-ancestor
110886632|NCT02978495|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110886633|NCT02978495|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110886634|NCT02978495|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110886635|NCT02978495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110886636|NCT02978495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110886637|NCT02237690|Doxorubicin|doxorubicin|mesh-list
110886638|NCT02237690|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110886639|NCT02237690|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110886640|NCT02237690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110886641|NCT02237690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110886642|NCT02237690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110886643|NCT02237690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110886644|NCT02237690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110886645|NCT04788017|Ziresovir|ziresovir|mesh-list
110886646|NCT04788017|Antiviral Agents|antiviral agents|mesh-ancestor
110886647|NCT04788017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110886648|NCT03600974|Domperidone|domperidone|mesh-list
110886649|NCT03600974|Citalopram|citalopram|mesh-list
110886650|NCT03600974|Esomeprazole|esomeprazole|mesh-list
110886651|NCT03600974|Omeprazole|omeprazole|mesh-list
110886652|NCT03600974|Rabeprazole|rabeprazole|mesh-list
110886653|NCT03600974|Pantoprazole|pantoprazole|mesh-list
110604172|NCT00696072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110886654|NCT03600974|Lansoprazole|lansoprazole|mesh-list
110886655|NCT03600974|Mosapride|mosapride|mesh-list
110886656|NCT03600974|Neurotransmitter Agents|neurotransmitter agents|mesh-list
110886657|NCT03600974|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110886658|NCT03600974|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110886659|NCT03600974|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110886660|NCT03600974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110886661|NCT03600974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110886662|NCT03600974|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110886663|NCT03600974|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110886664|NCT03600974|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110886665|NCT03600974|Serotonin Agents|serotonin agents|mesh-ancestor
110886666|NCT03600974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110886667|NCT03600974|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110886668|NCT03600974|Antidepressive Agents|antidepressive agents|mesh-ancestor
110886669|NCT03600974|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110886670|NCT03600974|Autonomic Agents|autonomic agents|mesh-ancestor
110886671|NCT03600974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110886672|NCT03600974|Antiemetics|antiemetics|mesh-ancestor
110886673|NCT03600974|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110886674|NCT03600974|Dopamine Agents|dopamine agents|mesh-ancestor
110886675|NCT03600974|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110886676|NCT03075267|Budesonide|budesonide|mesh-list
110886677|NCT03075267|Glycopyrrolate|glycopyrrolate|mesh-list
110886678|NCT03075267|Formoterol Fumarate|formoterol fumarate|mesh-list
110886679|NCT03075267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110886680|NCT03075267|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110886681|NCT03075267|Autonomic Agents|autonomic agents|mesh-ancestor
110886682|NCT03075267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110886683|NCT03075267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110886684|NCT03075267|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110886685|NCT03075267|Respiratory System Agents|respiratory system agents|mesh-ancestor
110886686|NCT03075267|Glucocorticoids|glucocorticoids|mesh-ancestor
110886687|NCT03075267|Hormones|hormones|mesh-ancestor
110886688|NCT03075267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110886689|NCT03075267|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110886690|NCT03075267|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110886691|NCT03075267|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110886692|NCT03075267|Adrenergic Agents|adrenergic agents|mesh-ancestor
110886693|NCT03075267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110211346|NCT00230035|Antimetabolites|antimetabolites|mesh-ancestor
110886694|NCT03075267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110886695|NCT03075267|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110886696|NCT03075267|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110886697|NCT03075267|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110886698|NCT03075267|Cholinergic Agents|cholinergic agents|mesh-ancestor
110886699|NCT03600506|Dexmedetomidine|dexmedetomidine|mesh-list
110886700|NCT03600506|Sympatholytics|sympatholytics|mesh-list
110886701|NCT03600506|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110199303|NCT00075231|Antimetabolites|antimetabolites|mesh-ancestor
110886702|NCT03600506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110886703|NCT03600506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110886704|NCT03600506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110886705|NCT03600506|Analgesics|analgesics|mesh-ancestor
110886706|NCT03600506|Sensory System Agents|sensory system agents|mesh-ancestor
110886707|NCT03600506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110886708|NCT03600506|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110886709|NCT03600506|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110886710|NCT03600506|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110886711|NCT03600506|Adrenergic Agents|adrenergic agents|mesh-ancestor
110886712|NCT03600506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110886713|NCT03600506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110886714|NCT03600506|Autonomic Agents|autonomic agents|mesh-ancestor
110886715|NCT03074331|Sofosbuvir|sofosbuvir|mesh-list
110886716|NCT03074331|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
110886717|NCT03074331|Velpatasvir|velpatasvir|mesh-list
110886718|NCT03074331|Antiviral Agents|antiviral agents|mesh-ancestor
110886719|NCT03074331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110886720|NCT02237924|Endostar protein|endostar protein|mesh-list
110886721|NCT02237924|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110886722|NCT02237924|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110886723|NCT02237924|Growth Substances|growth substances|mesh-ancestor
110886724|NCT02237924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110886725|NCT02237924|Growth Inhibitors|growth inhibitors|mesh-ancestor
110886726|NCT02237924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110886727|NCT03825302|Mannitol|mannitol|mesh-list
110886728|NCT03825302|Methacholine Chloride|methacholine chloride|mesh-list
110886729|NCT03825302|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110604260|NCT00697788|Analgesics|analgesics|mesh-ancestor
110886730|NCT03825302|Diuretics|diuretics|mesh-ancestor
110886731|NCT03825302|Natriuretic Agents|natriuretic agents|mesh-ancestor
110886732|NCT03825302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110886733|NCT03825302|Miotics|miotics|mesh-ancestor
110886734|NCT03825302|Autonomic Agents|autonomic agents|mesh-ancestor
110886735|NCT03825302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110886736|NCT03825302|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110886737|NCT03825302|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
110886738|NCT03825302|Respiratory System Agents|respiratory system agents|mesh-ancestor
110886739|NCT03825302|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
110886740|NCT03825302|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110886741|NCT03825302|Cholinergic Agents|cholinergic agents|mesh-ancestor
110886742|NCT03825302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110886743|NCT03825302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110886744|NCT02238392|Adenosine|adenosine|mesh-list
110886745|NCT02238392|Analgesics|analgesics|mesh-ancestor
110886746|NCT02238392|Sensory System Agents|sensory system agents|mesh-ancestor
110886747|NCT02238392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110886748|NCT02238392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110211523|NCT02967380|Pentetic Acid|pentetic acid|mesh-list
110886749|NCT02238392|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110886751|NCT02238392|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
110886752|NCT02238392|Purinergic Agonists|purinergic agonists|mesh-ancestor
110886753|NCT02238392|Purinergic Agents|purinergic agents|mesh-ancestor
110886754|NCT02238392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110886755|NCT02238392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110886756|NCT02260193|Glycine|glycine|mesh-list
110886757|NCT02260193|Glycine Agents|glycine agents|mesh-ancestor
110886758|NCT02260193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110886759|NCT02260193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110886760|NCT02260193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110886761|NCT02849678|Lidocaine|lidocaine|mesh-list
110886762|NCT02849678|Ropivacaine|ropivacaine|mesh-list
110886763|NCT02849678|Anesthetics, Local|anesthetics, local|mesh-ancestor
110886764|NCT02849678|Anesthetics|anesthetics|mesh-ancestor
110886765|NCT02849678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110886766|NCT02849678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110886767|NCT02849678|Sensory System Agents|sensory system agents|mesh-ancestor
110886768|NCT02849678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110886769|NCT02849678|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110886770|NCT02849678|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110886771|NCT02849678|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110886772|NCT02849678|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110886773|NCT02849678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110886774|NCT04295577|Niraparib|niraparib|mesh-list
110886775|NCT04295577|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110886776|NCT04295577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110211640|NCT00097227|Tubulin Modulators|tubulin modulators|mesh-ancestor
110886777|NCT04295577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110886778|NCT04295577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110886779|NCT02238158|Ipratropium|ipratropium|mesh-list
110886780|NCT02238158|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110886781|NCT02238158|Autonomic Agents|autonomic agents|mesh-ancestor
110886782|NCT02238158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110886783|NCT02238158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110886784|NCT02238158|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110886785|NCT02238158|Respiratory System Agents|respiratory system agents|mesh-ancestor
110886786|NCT02238158|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110886787|NCT02238158|Cholinergic Agents|cholinergic agents|mesh-ancestor
110886788|NCT02238158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110886789|NCT02238158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110886790|NCT02238314|Ritonavir|ritonavir|mesh-list
110886791|NCT02238314|Tipranavir|tipranavir|mesh-list
110886792|NCT02238314|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
110886793|NCT02238314|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110886794|NCT02238314|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110886795|NCT02238314|Protease Inhibitors|protease inhibitors|mesh-ancestor
110886796|NCT02238314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110886797|NCT02238314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110886798|NCT02238314|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110886799|NCT02238314|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110886800|NCT02238314|Antiviral Agents|antiviral agents|mesh-ancestor
110886801|NCT02238314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110886802|NCT02238314|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110604324|NCT00631917|Ramipril|ramipril|mesh-list
110886803|NCT02238314|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110211700|NCT00232531|Niacin|niacin|mesh-list
110886804|NCT02238314|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110886805|NCT02238470|Warfarin|warfarin|mesh-list
110886806|NCT02238470|Rivaroxaban|rivaroxaban|mesh-list
110886807|NCT02238470|Dabigatran|dabigatran|mesh-list
110886808|NCT02238470|Apixaban|apixaban|mesh-list
110886809|NCT02238470|Anticoagulants|anticoagulants|mesh-list
110886810|NCT02238470|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110886811|NCT02238470|Antithrombins|antithrombins|mesh-ancestor
110886812|NCT02238470|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110886813|NCT02238470|Protease Inhibitors|protease inhibitors|mesh-ancestor
110886814|NCT02238470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110886815|NCT02238470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110886816|NCT03586934|Acetaminophen|acetaminophen|mesh-list
110886817|NCT03586934|Celecoxib|celecoxib|mesh-list
110886818|NCT03586934|Ketorolac|ketorolac|mesh-list
110886819|NCT03586934|Meloxicam|meloxicam|mesh-list
110886820|NCT03586934|Morphine|morphine|mesh-list
110886821|NCT03586934|Oxycodone|oxycodone|mesh-list
110886822|NCT03586934|Tramadol|tramadol|mesh-list
110886823|NCT03586934|Hydrocodone|hydrocodone|mesh-list
110886824|NCT03586934|Ropivacaine|ropivacaine|mesh-list
110886825|NCT03586934|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110886826|NCT03586934|Narcotics|narcotics|mesh-ancestor
110886827|NCT03586934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110886828|NCT03586934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110886829|NCT03586934|Analgesics|analgesics|mesh-ancestor
110886830|NCT03586934|Sensory System Agents|sensory system agents|mesh-ancestor
110886831|NCT03586934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110886832|NCT03586934|Anesthetics, Local|anesthetics, local|mesh-ancestor
110886833|NCT03586934|Anesthetics|anesthetics|mesh-ancestor
110886834|NCT03586934|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110886835|NCT03586934|Antipyretics|antipyretics|mesh-ancestor
110886836|NCT03586934|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110886837|NCT03586934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110886838|NCT03586934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110886839|NCT03586934|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110886840|NCT03586934|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110886841|NCT03586934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110886842|NCT03586934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110886843|NCT03586934|Antitussive Agents|antitussive agents|mesh-ancestor
110886844|NCT03586934|Respiratory System Agents|respiratory system agents|mesh-ancestor
110886846|NCT03586154|Bupivacaine|bupivacaine|mesh-list
110886847|NCT03586154|Anesthetics, Local|anesthetics, local|mesh-ancestor
110886848|NCT03586154|Anesthetics|anesthetics|mesh-ancestor
110886849|NCT03586154|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110886850|NCT03586154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110886851|NCT03586154|Sensory System Agents|sensory system agents|mesh-ancestor
110199370|NCT00079248|Hormones|hormones|mesh-ancestor
110886852|NCT03586154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110886853|NCT03586154|Analgesics|analgesics|mesh-ancestor
110886854|NCT03586154|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110886855|NCT03586154|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110886856|NCT03586154|Anesthetics, General|anesthetics, general|mesh-ancestor
110886857|NCT03586154|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110886858|NCT03586154|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110886860|NCT03586154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110886861|NCT03629847|Everolimus|everolimus|mesh-list
110886862|NCT03629847|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110886863|NCT03629847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110886864|NCT03629847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110886865|NCT03629847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110886866|NCT03629847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110886867|NCT03629847|Immunologic Factors|immunologic factors|mesh-ancestor
110211919|NCT00064142|Coccidiostats|coccidiostats|mesh-ancestor
110886868|NCT03629847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110886869|NCT03629847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110886871|NCT01314833|Docetaxel|docetaxel|mesh-list
110886872|NCT01314833|Cyclophosphamide|cyclophosphamide|mesh-list
110886873|NCT01314833|Fluorouracil|fluorouracil|mesh-list
110886874|NCT01314833|Epirubicin|epirubicin|mesh-list
110886875|NCT01314833|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110886876|NCT01314833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110886877|NCT01314833|Tubulin Modulators|tubulin modulators|mesh-ancestor
110886878|NCT01314833|Antimitotic Agents|antimitotic agents|mesh-ancestor
110886879|NCT01314833|Mitosis Modulators|mitosis modulators|mesh-ancestor
110886880|NCT01314833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110886881|NCT01314833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110886883|NCT01314833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110886884|NCT01314833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110886885|NCT01314833|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110886886|NCT01314833|Alkylating Agents|alkylating agents|mesh-ancestor
110886887|NCT01314833|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110886888|NCT01314833|Antimetabolites|antimetabolites|mesh-ancestor
110886889|NCT01314833|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110886890|NCT01314833|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110886891|NCT01314833|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110886892|NCT01314833|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110886893|NCT01314833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110886894|NCT03579836|Gemcitabine|gemcitabine|mesh-list
110886895|NCT03579836|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110886896|NCT03579836|Antimetabolites|antimetabolites|mesh-ancestor
110886897|NCT03579836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110886898|NCT03579836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110886900|NCT02737826|Gabapentin|gabapentin|mesh-list
110886901|NCT02737826|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110886902|NCT02737826|Narcotics|narcotics|mesh-ancestor
110886903|NCT02737826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110886904|NCT02737826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110886905|NCT02737826|Analgesics|analgesics|mesh-ancestor
110212117|NCT00064415|Autonomic Agents|autonomic agents|mesh-ancestor
110886906|NCT02737826|Sensory System Agents|sensory system agents|mesh-ancestor
110886907|NCT02737826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110921070|NCT04481724|Analgesics|analgesics|mesh-ancestor
110886908|NCT02737826|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110886909|NCT02737826|Anticonvulsants|anticonvulsants|mesh-ancestor
110886910|NCT02737826|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110886911|NCT02737826|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110886912|NCT02737826|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110886913|NCT02737826|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110886914|NCT02737826|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110886915|NCT02737826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110886916|NCT02737826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110886917|NCT02737826|Antimanic Agents|antimanic agents|mesh-ancestor
110886918|NCT03367715|Nivolumab|nivolumab|mesh-list
110886919|NCT03367715|Ipilimumab|ipilimumab|mesh-list
110886920|NCT03367715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110886921|NCT03367715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110886922|NCT03367715|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110886923|NCT03367715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110886924|NCT04064931|Niacin|niacin|mesh-list
110886925|NCT04064931|Vitamins|vitamins|mesh-ancestor
110886926|NCT04064931|Micronutrients|micronutrients|mesh-ancestor
110886927|NCT04064931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110886928|NCT04064931|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110886929|NCT04064931|Antimetabolites|antimetabolites|mesh-ancestor
110212244|NCT00235261|Dexamethasone|dexamethasone|mesh-list
110886930|NCT04064931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110886931|NCT04064931|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110886932|NCT04064931|Vasodilator Agents|vasodilator agents|mesh-ancestor
110886933|NCT04064931|Vitamin B Complex|vitamin b complex|mesh-ancestor
110886934|NCT03577652|Ticagrelor|ticagrelor|mesh-list
110886935|NCT03577652|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110886936|NCT03577652|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110886937|NCT03577652|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110886938|NCT03577652|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110886939|NCT03577652|Purinergic Agents|purinergic agents|mesh-ancestor
110886940|NCT03577652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110886941|NCT03577652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110199429|NCT00079287|Antimetabolites|antimetabolites|mesh-ancestor
110886942|NCT03577652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110886943|NCT03620513|Lidocaine|lidocaine|mesh-list
110886944|NCT03620513|Phenylephrine|phenylephrine|mesh-list
110886945|NCT03620513|Oxymetazoline|oxymetazoline|mesh-list
110886946|NCT03620513|Nasal Decongestants|nasal decongestants|mesh-list
110886947|NCT03620513|Pseudoephedrine|pseudoephedrine|mesh-list
110886948|NCT03620513|Ephedrine|ephedrine|mesh-list
110886949|NCT03620513|Anesthetics|anesthetics|mesh-list
110886950|NCT03620513|Anesthetics, Local|anesthetics, local|mesh-ancestor
110886951|NCT03620513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110886952|NCT03620513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110886953|NCT03620513|Sensory System Agents|sensory system agents|mesh-ancestor
110886954|NCT03620513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110886955|NCT03620513|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110212367|NCT00236392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110886956|NCT03620513|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110886957|NCT03620513|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110886958|NCT03620513|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110886959|NCT03620513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110886960|NCT03620513|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110886961|NCT03620513|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110886962|NCT03620513|Adrenergic Agents|adrenergic agents|mesh-ancestor
110886963|NCT03620513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110886965|NCT03620513|Autonomic Agents|autonomic agents|mesh-ancestor
110886966|NCT03620513|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110886967|NCT03620513|Respiratory System Agents|respiratory system agents|mesh-ancestor
110886968|NCT03620513|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110886969|NCT03620513|Mydriatics|mydriatics|mesh-ancestor
110886970|NCT03620513|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110886972|NCT03620513|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110886973|NCT03620513|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110886974|NCT03620513|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110886975|NCT03585062|Paclitaxel|paclitaxel|mesh-list
110886976|NCT03585062|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110886977|NCT03585062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110886978|NCT03585062|Tubulin Modulators|tubulin modulators|mesh-ancestor
110886979|NCT03585062|Antimitotic Agents|antimitotic agents|mesh-ancestor
110886980|NCT03585062|Mitosis Modulators|mitosis modulators|mesh-ancestor
110886981|NCT03585062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110886982|NCT03584360|Calcitriol|calcitriol|mesh-list
110886983|NCT03584360|Betamethasone|betamethasone|mesh-list
110886984|NCT03584360|Betamethasone Valerate|betamethasone valerate|mesh-list
110886985|NCT03584360|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
110886986|NCT03584360|Betamethasone benzoate|betamethasone benzoate|mesh-list
110886987|NCT03584360|Calcipotriene|calcipotriene|mesh-list
110886988|NCT03584360|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
110886989|NCT03584360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110886990|NCT03584360|Glucocorticoids|glucocorticoids|mesh-ancestor
110886991|NCT03584360|Hormones|hormones|mesh-ancestor
110886992|NCT03584360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110886993|NCT03584360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110886994|NCT03584360|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110886995|NCT03584360|Respiratory System Agents|respiratory system agents|mesh-ancestor
110886996|NCT03584360|Dermatologic Agents|dermatologic agents|mesh-ancestor
110886997|NCT03584360|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110212551|NCT00237250|Vildagliptin|vildagliptin|mesh-list
110886998|NCT03584360|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
110886999|NCT03584360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110887000|NCT03584360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110887001|NCT03584360|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110887002|NCT03584360|Vitamins|vitamins|mesh-ancestor
110887003|NCT03584360|Micronutrients|micronutrients|mesh-ancestor
110887004|NCT03584360|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110887005|NCT03579758|Gemcitabine|gemcitabine|mesh-list
110887006|NCT03579758|Capecitabine|capecitabine|mesh-list
110887007|NCT03579758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110887008|NCT03579758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110887009|NCT03579758|Antimetabolites|antimetabolites|mesh-ancestor
110887010|NCT03579758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110887011|NCT03577574|Anesthetics|anesthetics|mesh-list
110887012|NCT03577574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110887013|NCT03577574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110887014|NCT01330901|Ustekinumab|ustekinumab|mesh-list
110887015|NCT01330901|Dermatologic Agents|dermatologic agents|mesh-ancestor
110887016|NCT02428647|Zinc|zinc|mesh-list
110887017|NCT02428647|Trace Elements|trace elements|mesh-ancestor
110887018|NCT02428647|Micronutrients|micronutrients|mesh-ancestor
110887019|NCT02428647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110887020|NCT01071395|Amantadine|amantadine|mesh-list
110887021|NCT01071395|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110887022|NCT01071395|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110887023|NCT01071395|Antiviral Agents|antiviral agents|mesh-ancestor
110887024|NCT01071395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110887025|NCT01071395|Dopamine Agents|dopamine agents|mesh-ancestor
110887026|NCT01071395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110887027|NCT01071395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110887028|NCT01071395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110887029|NCT01071395|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110887030|NCT01071395|Analgesics|analgesics|mesh-ancestor
110887031|NCT01071395|Sensory System Agents|sensory system agents|mesh-ancestor
110887032|NCT01071395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110887033|NCT00335816|Leucovorin|leucovorin|mesh-list
110887034|NCT00335816|Fluorouracil|fluorouracil|mesh-list
110887035|NCT00335816|Oxaliplatin|oxaliplatin|mesh-list
110887036|NCT00335816|Calcium|calcium|mesh-list
110887037|NCT00335816|Levoleucovorin|levoleucovorin|mesh-list
110887038|NCT00335816|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110887039|NCT00335816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110887040|NCT00335816|Antimetabolites|antimetabolites|mesh-ancestor
110212743|NCT04721119|Anesthetics|anesthetics|mesh-list
110887041|NCT00335816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110887042|NCT00335816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110887043|NCT00335816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110887044|NCT00335816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110887045|NCT00335816|Immunologic Factors|immunologic factors|mesh-ancestor
110887046|NCT00335816|Antidotes|antidotes|mesh-ancestor
110887047|NCT00335816|Protective Agents|protective agents|mesh-ancestor
110887048|NCT00335816|Vitamin B Complex|vitamin b complex|mesh-ancestor
110887049|NCT00335816|Vitamins|vitamins|mesh-ancestor
110887050|NCT00335816|Micronutrients|micronutrients|mesh-ancestor
110887051|NCT03577496|Peppermint oil|peppermint oil|mesh-list
110887052|NCT03577496|Antiemetics|antiemetics|mesh-ancestor
110887053|NCT03577496|Autonomic Agents|autonomic agents|mesh-ancestor
110887054|NCT03577496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110887055|NCT03577496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110887056|NCT03577496|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110887057|NCT03577496|Parasympatholytics|parasympatholytics|mesh-ancestor
110887058|NCT03582878|Mycophenolic Acid|mycophenolic acid|mesh-list
110887059|NCT03582878|Sirolimus|sirolimus|mesh-list
110887060|NCT03582878|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110887061|NCT03582878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110887062|NCT03582878|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110887063|NCT03582878|Antitubercular Agents|antitubercular agents|mesh-ancestor
110887064|NCT03582878|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110887065|NCT03582878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110887066|NCT03582878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110887067|NCT03582878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110887068|NCT03582878|Antifungal Agents|antifungal agents|mesh-ancestor
110887069|NCT03582878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110212867|NCT00065624|Vitamins|vitamins|mesh-ancestor
110887070|NCT03582878|Immunologic Factors|immunologic factors|mesh-ancestor
110887071|NCT03582878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110887072|NCT05763693|Azithromycin|azithromycin|mesh-list
110887073|NCT05763693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110887074|NCT05763693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110887075|NCT02238704|Calcium, Dietary|calcium, dietary|mesh-list
110887076|NCT02238704|Iron|iron|mesh-list
110887077|NCT02238704|Folic Acid|folic acid|mesh-list
110887078|NCT02238704|Vitamin B Complex|vitamin b complex|mesh-list
110887079|NCT02238704|Calcium|calcium|mesh-list
110887080|NCT02238704|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110887081|NCT02238704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110887082|NCT02238704|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110887083|NCT02238704|Trace Elements|trace elements|mesh-ancestor
110887084|NCT02238704|Micronutrients|micronutrients|mesh-ancestor
110212922|NCT00239200|Lapatinib|lapatinib|mesh-list
110887085|NCT02238704|Hematinics|hematinics|mesh-ancestor
110887086|NCT02238704|Vitamins|vitamins|mesh-ancestor
110887087|NCT01331135|Sirolimus|sirolimus|mesh-list
110887088|NCT01331135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110887089|NCT01331135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110887090|NCT01331135|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110887091|NCT01331135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110887092|NCT01331135|Antifungal Agents|antifungal agents|mesh-ancestor
110887093|NCT01331135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110887094|NCT01331135|Immunologic Factors|immunologic factors|mesh-ancestor
110887095|NCT01331135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110887096|NCT03577184|Metformin|metformin|mesh-list
110887097|NCT03577184|Vildagliptin|vildagliptin|mesh-list
110887098|NCT03577184|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110887099|NCT03577184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110887100|NCT03577184|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110887101|NCT03577184|Protease Inhibitors|protease inhibitors|mesh-ancestor
110887102|NCT03577184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110887103|NCT03577184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110887104|NCT02849171|Choline|choline|mesh-list
110887105|NCT02849171|Lipotropic Agents|lipotropic agents|mesh-ancestor
110887106|NCT02849171|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110887107|NCT02849171|Antimetabolites|antimetabolites|mesh-ancestor
110887108|NCT02849171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110887109|NCT02849171|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110887110|NCT02849171|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110887112|NCT02238860|Tenofovir|tenofovir|mesh-list
110887113|NCT02238860|Antiviral Agents|antiviral agents|mesh-ancestor
110887114|NCT02238860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110638625|NCT00508144|Pemetrexed|pemetrexed|mesh-list
110887115|NCT02238860|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110887116|NCT02238860|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110887117|NCT02238860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110887118|NCT02238860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110887119|NCT02238860|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110887120|NCT02238860|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110887121|NCT01333709|Folfirinox|folfirinox|mesh-list
110887122|NCT01333709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110887123|NCT04869137|Pembrolizumab|pembrolizumab|mesh-list
110887124|NCT04869137|Lenvatinib|lenvatinib|mesh-list
110887125|NCT04869137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110887126|NCT04869137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110887127|NCT04869137|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110887128|NCT04869137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110887129|NCT04869137|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110887130|NCT04869137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110887131|NCT00364637|Anesthetics|anesthetics|mesh-list
110887132|NCT00364637|Sevoflurane|sevoflurane|mesh-list
110887133|NCT00364637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110887134|NCT00364637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110887135|NCT00364637|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110887136|NCT00364637|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110887137|NCT00364637|Anesthetics, General|anesthetics, general|mesh-ancestor
110887138|NCT00493961|Hormones|hormones|mesh-list
110887139|NCT00493961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110887140|NCT00493961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110887141|NCT02903238|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110887142|NCT02903238|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110887143|NCT02903238|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110887144|NCT02903238|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110887145|NCT02903238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110887146|NCT02903238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110887147|NCT02903238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110887148|NCT02903238|Analgesics|analgesics|mesh-ancestor
110887149|NCT02903238|Sensory System Agents|sensory system agents|mesh-ancestor
110887150|NCT02903238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110887151|NCT02903238|Antidepressive Agents|antidepressive agents|mesh-ancestor
110887152|NCT02903238|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110887153|NCT02903238|Dopamine Agents|dopamine agents|mesh-ancestor
110887154|NCT01329809|Molgramostim|molgramostim|mesh-list
110887155|NCT01329809|Sargramostim|sargramostim|mesh-list
110887156|NCT01329809|Immunologic Factors|immunologic factors|mesh-ancestor
110887157|NCT01329809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110887158|NCT01329809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110887159|NCT02847260|Treprostinil|treprostinil|mesh-list
110887160|NCT02847260|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110887161|NCT01331447|Exemestane|exemestane|mesh-list
110887162|NCT01331447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110887163|NCT01331447|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110887164|NCT01331447|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110887165|NCT01331447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110887166|NCT01331447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110887167|NCT01331447|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110887168|NCT01331447|Hormone Antagonists|hormone antagonists|mesh-ancestor
110887169|NCT01331447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110887170|NCT01331447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110887171|NCT02968563|Obinutuzumab|obinutuzumab|mesh-list
110887172|NCT02968563|Idelalisib|idelalisib|mesh-list
110887173|NCT02968563|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110213199|NCT00240448|Telmisartan|telmisartan|mesh-list
110887174|NCT02968563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110887175|NCT02968563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110887176|NCT02968563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110887177|NCT01329887|Ketanserin|ketanserin|mesh-list
110887178|NCT01329887|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110887179|NCT01329887|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110887180|NCT01329887|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110887181|NCT01329887|Serotonin Agents|serotonin agents|mesh-ancestor
110887182|NCT01329887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110887183|NCT01329887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110887184|NCT01329887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110887185|NCT01334099|Tremelimumab|tremelimumab|mesh-list
110887186|NCT01334099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110887187|NCT01331525|Ipilimumab|ipilimumab|mesh-list
110887188|NCT01331525|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110887189|NCT01331525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110887190|NCT01331525|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110887191|NCT01331525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110887192|NCT01334177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110887193|NCT01334177|Cetuximab|cetuximab|mesh-list
110887194|NCT01334177|Antibodies|antibodies|mesh-list
110887195|NCT01334177|Immunoglobulins|immunoglobulins|mesh-list
110887196|NCT01334177|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110887197|NCT01334177|Immunologic Factors|immunologic factors|mesh-ancestor
110887198|NCT01334177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110887199|NCT01334177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110887200|NCT04098393|Fludarabine|fludarabine|mesh-list
110887201|NCT04098393|Melphalan|melphalan|mesh-list
110887202|NCT04098393|Busulfan|busulfan|mesh-list
110887203|NCT04098393|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110887204|NCT04098393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110887205|NCT04098393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110887206|NCT04098393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110887207|NCT04098393|Immunologic Factors|immunologic factors|mesh-ancestor
110887208|NCT04098393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110887209|NCT04098393|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110887210|NCT04098393|Alkylating Agents|alkylating agents|mesh-ancestor
110887211|NCT04098393|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110887212|NCT05762523|Vaccines|vaccines|mesh-list
110887213|NCT05762523|Immunologic Factors|immunologic factors|mesh-ancestor
110887214|NCT05762523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110887215|NCT02796261|Eflornithine|eflornithine|mesh-list
110887216|NCT02796261|Lomustine|lomustine|mesh-list
110887217|NCT02796261|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110887218|NCT02796261|Alkylating Agents|alkylating agents|mesh-ancestor
110887219|NCT02796261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110887220|NCT02796261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110887221|NCT02796261|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
110887222|NCT02796261|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110887223|NCT02796261|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110887224|NCT02796261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110063293|NCT03186638|Ibuprofen|ibuprofen|mesh-list
110887225|NCT02796261|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
110887226|NCT02796261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110887227|NCT02904096|Lidocaine|lidocaine|mesh-list
110887228|NCT02904096|Anesthetics, Local|anesthetics, local|mesh-ancestor
110887229|NCT02904096|Anesthetics|anesthetics|mesh-ancestor
110887230|NCT02904096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110887231|NCT02904096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110887232|NCT02904096|Sensory System Agents|sensory system agents|mesh-ancestor
110887233|NCT02904096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110887234|NCT02904096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110887235|NCT02904096|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110887236|NCT02904096|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110887237|NCT02904096|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110887238|NCT02904096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110887240|NCT02586675|Goserelin|goserelin|mesh-list
110887241|NCT02586675|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110887242|NCT02586675|Hormone Antagonists|hormone antagonists|mesh-ancestor
110887243|NCT02586675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110887244|NCT02586675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110887245|NCT02586675|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110887246|NCT02586675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110887247|NCT02586675|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110887248|NCT02586675|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110887249|NCT02586675|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110887250|NCT03648528|Cholecalciferol|cholecalciferol|mesh-list
110887251|NCT03648528|Vitamin D|vitamin d|mesh-list
110887252|NCT03648528|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110887253|NCT03648528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110887254|NCT03648528|Vitamins|vitamins|mesh-ancestor
110887255|NCT03648528|Micronutrients|micronutrients|mesh-ancestor
110887256|NCT03648528|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110887257|NCT03161405|Itraconazole|itraconazole|mesh-list
110887258|NCT03161405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110887259|NCT03161405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110887260|NCT03161405|Antifungal Agents|antifungal agents|mesh-ancestor
110213345|NCT00241189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110887261|NCT03161405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110887262|NCT03161405|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110887263|NCT03161405|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110887264|NCT03161405|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110887265|NCT03161405|Hormone Antagonists|hormone antagonists|mesh-ancestor
110887266|NCT03161405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110887267|NCT03161405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110887268|NCT03161405|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110887270|NCT01813929|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110887271|NCT01813929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110887272|NCT01502085|Dexamethasone|dexamethasone|mesh-list
110887273|NCT01502085|Vorinostat|vorinostat|mesh-list
110887274|NCT01502085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110199554|NCT00079638|Niacin|niacin|mesh-list
110887275|NCT01502085|Antiemetics|antiemetics|mesh-ancestor
110887276|NCT01502085|Autonomic Agents|autonomic agents|mesh-ancestor
110887277|NCT01502085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110887278|NCT01502085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110887279|NCT01502085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110887280|NCT01502085|Glucocorticoids|glucocorticoids|mesh-ancestor
110887281|NCT01502085|Hormones|hormones|mesh-ancestor
110213394|NCT00098982|Fluorouracil|fluorouracil|mesh-list
110887282|NCT01502085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110887283|NCT01502085|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110887284|NCT01502085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110887285|NCT01502085|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110887286|NCT01502085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110887287|NCT01502085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110887288|NCT03648684|Caffeine|caffeine|mesh-list
110887289|NCT03648684|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110887290|NCT03648684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110887291|NCT03648684|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110887292|NCT03648684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110887293|NCT03648684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110887294|NCT03648684|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110887295|NCT03648684|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110887296|NCT03648684|Purinergic Agents|purinergic agents|mesh-ancestor
110887297|NCT03648684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110887298|NCT03647982|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110887299|NCT03647982|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110887300|NCT03647982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110887301|NCT03647982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110887302|NCT03647982|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110887303|NCT03647982|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110887304|NCT03647982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110887305|NCT03647982|Cholinergic Agents|cholinergic agents|mesh-ancestor
110887306|NCT03647982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110887307|NCT02901054|Ondansetron|ondansetron|mesh-list
110887308|NCT02901054|Antiemetics|antiemetics|mesh-ancestor
110887309|NCT02901054|Autonomic Agents|autonomic agents|mesh-ancestor
110887310|NCT02901054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110887311|NCT02901054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110887312|NCT02901054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110887313|NCT02901054|Antipruritics|antipruritics|mesh-ancestor
110887314|NCT02901054|Dermatologic Agents|dermatologic agents|mesh-ancestor
110887315|NCT02901054|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110887316|NCT02901054|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110887317|NCT02901054|Serotonin Agents|serotonin agents|mesh-ancestor
110887318|NCT02901054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110887319|NCT02901054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110887320|NCT03647670|Midazolam|midazolam|mesh-list
110887321|NCT03647670|Abrocitinib|abrocitinib|mesh-list
110887322|NCT03647670|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110887323|NCT03647670|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110887324|NCT03647670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110887325|NCT03647670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110887327|NCT03647670|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110887328|NCT03647670|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110887329|NCT03647670|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110887330|NCT03647670|Anesthetics, General|anesthetics, general|mesh-ancestor
110887331|NCT03647670|Anesthetics|anesthetics|mesh-ancestor
110887332|NCT03647670|GABA Modulators|gaba modulators|mesh-ancestor
110887333|NCT03647670|GABA Agents|gaba agents|mesh-ancestor
110887334|NCT03647670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110887335|NCT03647670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110887336|NCT03647670|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110887337|NCT03647670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110887338|NCT02966340|Prazosin|prazosin|mesh-list
110887339|NCT02966340|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110887340|NCT02966340|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110887341|NCT02966340|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110887342|NCT02966340|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110887343|NCT02966340|Adrenergic Agents|adrenergic agents|mesh-ancestor
110887344|NCT02966340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110887345|NCT02966340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110887346|NCT02966340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110887347|NCT05284734|Anesthetics|anesthetics|mesh-list
110887348|NCT05284734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110887349|NCT05284734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110887350|NCT03629379|Ustekinumab|ustekinumab|mesh-list
110887351|NCT03629379|Vedolizumab|vedolizumab|mesh-list
110887352|NCT03629379|Dermatologic Agents|dermatologic agents|mesh-ancestor
110887353|NCT03629379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110887354|NCT05055999|Atezolizumab|atezolizumab|mesh-list
110887355|NCT05055999|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110887356|NCT05055999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110887357|NCT05055999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110887358|NCT05055999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110887359|NCT05205837|Letrozole|letrozole|mesh-list
110887360|NCT05205837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110887361|NCT05205837|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110887362|NCT05205837|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110887364|NCT05205837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110887365|NCT05205837|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110887366|NCT05205837|Hormone Antagonists|hormone antagonists|mesh-ancestor
110887367|NCT05205837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110887368|NCT05205837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110887369|NCT05205603|Infliximab|infliximab|mesh-list
110887370|NCT05205603|Mesalamine|mesalamine|mesh-list
110887371|NCT05205603|Vedolizumab|vedolizumab|mesh-list
110887372|NCT05205603|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110887373|NCT05205603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110887374|NCT05205603|Dermatologic Agents|dermatologic agents|mesh-ancestor
110887375|NCT05205603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110887376|NCT05205603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110887377|NCT05205603|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110887378|NCT05205603|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110887379|NCT05205603|Analgesics|analgesics|mesh-ancestor
110887380|NCT05205603|Sensory System Agents|sensory system agents|mesh-ancestor
110887381|NCT05205603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110887382|NCT05205603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110887383|NCT03578900|Citric Acid|citric acid|mesh-list
110887384|NCT03578900|Sodium Citrate|sodium citrate|mesh-list
110887385|NCT03578900|Anticoagulants|anticoagulants|mesh-ancestor
110887386|NCT03578900|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110887387|NCT03578900|Chelating Agents|chelating agents|mesh-ancestor
110887388|NCT03578900|Sequestering Agents|sequestering agents|mesh-ancestor
110887389|NCT03578900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110887390|NCT02550002|Aflibercept|aflibercept|mesh-list
110887391|NCT02550002|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110887392|NCT02550002|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110887393|NCT02550002|Growth Substances|growth substances|mesh-ancestor
110887394|NCT02550002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110887395|NCT02550002|Growth Inhibitors|growth inhibitors|mesh-ancestor
110887396|NCT02550002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110887397|NCT03574376|Bupivacaine|bupivacaine|mesh-list
110887398|NCT03574376|Anesthetics, Local|anesthetics, local|mesh-ancestor
110887399|NCT03574376|Anesthetics|anesthetics|mesh-ancestor
110887400|NCT03574376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110887401|NCT03574376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110887402|NCT03574376|Sensory System Agents|sensory system agents|mesh-ancestor
110887403|NCT03574376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110887404|NCT03576794|Prednisolone|prednisolone|mesh-list
110887405|NCT03576794|Leflunomide|leflunomide|mesh-list
110887406|NCT03576794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110887407|NCT03576794|Glucocorticoids|glucocorticoids|mesh-ancestor
110887408|NCT03576794|Hormones|hormones|mesh-ancestor
110887409|NCT03576794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110887410|NCT03576794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110887411|NCT03576794|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110887412|NCT03576794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110887413|NCT03576794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110887414|NCT03576794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110887415|NCT03576794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110887416|NCT03576794|Immunologic Factors|immunologic factors|mesh-ancestor
110887417|NCT03578822|Aspirin|aspirin|mesh-list
110887418|NCT03578822|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110887419|NCT03578822|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110887420|NCT03578822|Analgesics|analgesics|mesh-ancestor
110887421|NCT03578822|Sensory System Agents|sensory system agents|mesh-ancestor
110921229|NCT03517982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110887423|NCT03578822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110887424|NCT03578822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110887425|NCT03578822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110887426|NCT03578822|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110887427|NCT03578822|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110887428|NCT03578822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110887429|NCT03578822|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110887430|NCT03578822|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110887431|NCT03578822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110887432|NCT03578822|Antipyretics|antipyretics|mesh-ancestor
110887433|NCT03576638|Levodopa|levodopa|mesh-list
110887434|NCT03576638|Carbidopa|carbidopa|mesh-list
110887435|NCT03576638|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
110887436|NCT03576638|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110887437|NCT03576638|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110887438|NCT03576638|Dopamine Agents|dopamine agents|mesh-ancestor
110887439|NCT03576638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110199615|NCT00130546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110887440|NCT03576638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110887441|NCT03576638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110887442|NCT03576638|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
110887443|NCT03576638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110213750|NCT00244309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110887444|NCT03576638|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110887445|NCT03576638|Immunologic Factors|immunologic factors|mesh-ancestor
110887446|NCT03576638|Dopamine Agonists|dopamine agonists|mesh-ancestor
110887448|NCT04284657|Sodium Citrate|sodium citrate|mesh-list
110887449|NCT04284657|Pravastatin|pravastatin|mesh-list
110887450|NCT04284657|Anticoagulants|anticoagulants|mesh-ancestor
110887451|NCT04284657|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110887452|NCT04284657|Chelating Agents|chelating agents|mesh-ancestor
110887453|NCT04284657|Sequestering Agents|sequestering agents|mesh-ancestor
110887454|NCT04284657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110887455|NCT04284657|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110887456|NCT04284657|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110887457|NCT04284657|Antimetabolites|antimetabolites|mesh-ancestor
110887458|NCT04284657|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110887459|NCT04284657|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110887460|NCT04284657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110887461|NCT03574220|Pembrolizumab|pembrolizumab|mesh-list
110887462|NCT03574220|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110887463|NCT03574220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110887464|NCT03574220|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110887465|NCT03574220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110887466|NCT04876677|Beclomethasone|beclomethasone|mesh-list
110887467|NCT04876677|Glycopyrrolate|glycopyrrolate|mesh-list
110887468|NCT04876677|Formoterol Fumarate|formoterol fumarate|mesh-list
110887469|NCT04876677|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110887470|NCT04876677|Autonomic Agents|autonomic agents|mesh-ancestor
110887471|NCT04876677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110887472|NCT04876677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110887473|NCT04876677|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110887474|NCT04876677|Respiratory System Agents|respiratory system agents|mesh-ancestor
110887475|NCT04876677|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110887476|NCT04876677|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110887477|NCT04876677|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110887478|NCT04876677|Adrenergic Agents|adrenergic agents|mesh-ancestor
110887479|NCT04876677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110604994|NCT00606580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110887480|NCT04876677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110887481|NCT04876677|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110887483|NCT04876677|Hormones|hormones|mesh-ancestor
110887484|NCT04876677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110921236|NCT03869944|Antiviral Agents|antiviral agents|mesh-ancestor
110921237|NCT03869944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110921238|NCT03869944|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110921239|NCT03869944|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110252008|NCT00137501|Nifedipine|nifedipine|mesh-list
110887485|NCT04876677|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110887486|NCT04876677|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110213866|NCT00245089|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110887487|NCT04876677|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110887488|NCT04876677|Cholinergic Agents|cholinergic agents|mesh-ancestor
110887489|NCT03578432|Everolimus|everolimus|mesh-list
110887490|NCT03578432|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110887491|NCT03578432|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110887492|NCT03578432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110887493|NCT03578432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110887494|NCT03578432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110887495|NCT03578432|Immunologic Factors|immunologic factors|mesh-ancestor
110887496|NCT03578432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110887497|NCT03578432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110887498|NCT03578354|Atenolol|atenolol|mesh-list
110887499|NCT03578354|4-Aminopyridine|4-aminopyridine|mesh-list
110887500|NCT03578354|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110887501|NCT03578354|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110887502|NCT03578354|Sympatholytics|sympatholytics|mesh-ancestor
110887503|NCT03578354|Autonomic Agents|autonomic agents|mesh-ancestor
110887504|NCT03578354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110887505|NCT03578354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110887506|NCT03578354|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110887507|NCT03578354|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110887508|NCT03578354|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110887509|NCT03578354|Adrenergic Agents|adrenergic agents|mesh-ancestor
110887510|NCT03578354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110887511|NCT03578354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110887512|NCT03578354|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
110887513|NCT03578354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110887514|NCT05204979|Misoprostol|misoprostol|mesh-list
110887515|NCT05204979|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110887516|NCT05204979|Abortifacient Agents|abortifacient agents|mesh-ancestor
110887517|NCT05204979|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110887518|NCT05204979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110887519|NCT05204979|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110213927|NCT00245401|Sirolimus|sirolimus|mesh-list
110887520|NCT05204979|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110887521|NCT05204979|Oxytocics|oxytocics|mesh-ancestor
110887522|NCT03647514|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110887523|NCT03647514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110887524|NCT02239952|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110887525|NCT02239952|Sunitinib|sunitinib|mesh-list
110887526|NCT02239952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110887527|NCT02239952|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110887528|NCT02239952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110887529|NCT02239952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110887530|NCT02239952|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110887531|NCT02239952|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110887532|NCT02239952|Growth Substances|growth substances|mesh-ancestor
110887533|NCT02239952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110887534|NCT02239952|Growth Inhibitors|growth inhibitors|mesh-ancestor
110887535|NCT03647280|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110887536|NCT03647280|Epirubicin|epirubicin|mesh-list
110887537|NCT03647280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110887538|NCT03647280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110887539|NCT03647280|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110887540|NCT03647280|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110887541|NCT03647280|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110887542|NCT03647280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110887543|NCT03578042|Losartan|losartan|mesh-list
110887544|NCT03578042|Amlodipine|amlodipine|mesh-list
110887545|NCT03578042|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110887546|NCT03578042|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110887547|NCT03578042|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110887548|NCT03578042|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110199655|NCT00130897|Sunitinib|sunitinib|mesh-list
110887549|NCT03578042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110034762|NCT01401192|Gemcitabine|gemcitabine|mesh-list
110034764|NCT01401192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110034765|NCT01401192|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110034766|NCT01401192|Antimetabolites|antimetabolites|mesh-ancestor
110034767|NCT01401192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110034768|NCT01401192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110034769|NCT01401192|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110887550|NCT03578042|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110887551|NCT03578042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110887553|NCT03578042|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110887554|NCT03578042|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110887555|NCT03578042|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110887557|NCT03578042|Natriuretic Agents|natriuretic agents|mesh-ancestor
110887558|NCT03578042|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110887559|NCT03646500|Remifentanil|remifentanil|mesh-list
110887560|NCT03646500|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110887561|NCT03646500|Narcotics|narcotics|mesh-ancestor
110887562|NCT03646500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110887563|NCT03646500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110887564|NCT03646500|Analgesics|analgesics|mesh-ancestor
110887565|NCT03646500|Sensory System Agents|sensory system agents|mesh-ancestor
110887566|NCT03646500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110887567|NCT03574064|Glucagon|glucagon|mesh-list
110887568|NCT03574064|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
110887569|NCT03574064|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
110887570|NCT03574064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110887571|NCT03574064|Hormones|hormones|mesh-ancestor
110887572|NCT03574064|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110887573|NCT03574064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110887574|NCT03574064|Incretins|incretins|mesh-ancestor
110887575|NCT03573986|Bevacizumab|bevacizumab|mesh-list
110887576|NCT03573986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110887577|NCT03573986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110887578|NCT03573986|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110887579|NCT03573986|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110887580|NCT03573986|Growth Substances|growth substances|mesh-ancestor
110887581|NCT03573986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110887582|NCT03573986|Growth Inhibitors|growth inhibitors|mesh-ancestor
110887583|NCT03959592|Carotenoids|carotenoids|mesh-list
110887584|NCT03959592|Antioxidants|antioxidants|mesh-ancestor
110887585|NCT03959592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110887586|NCT03959592|Protective Agents|protective agents|mesh-ancestor
110887587|NCT03959592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110887588|NCT04087395|Lidocaine|lidocaine|mesh-list
110887589|NCT04087395|Anesthetics|anesthetics|mesh-list
110887590|NCT04087395|Anesthetics, Local|anesthetics, local|mesh-ancestor
110887591|NCT04087395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110887592|NCT04087395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110887593|NCT04087395|Sensory System Agents|sensory system agents|mesh-ancestor
110887594|NCT04087395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110887595|NCT04087395|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110887596|NCT04087395|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110887597|NCT04087395|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110887598|NCT04087395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110887599|NCT04087395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110887600|NCT03573596|Dasatinib|dasatinib|mesh-list
110887601|NCT03573596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110887602|NCT03573596|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110887603|NCT03573596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110887604|NCT03573596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110887605|NCT03621618|Dobutamine|dobutamine|mesh-list
110887606|NCT03621618|Norepinephrine|norepinephrine|mesh-list
110887607|NCT03621618|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110887608|NCT03621618|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110887609|NCT03621618|Adrenergic Agents|adrenergic agents|mesh-ancestor
110887610|NCT03621618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110887611|NCT03621618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110887612|NCT03621618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110887613|NCT03621618|Sympathomimetics|sympathomimetics|mesh-ancestor
110887614|NCT03621618|Autonomic Agents|autonomic agents|mesh-ancestor
110887615|NCT03621618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110887616|NCT03621618|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110887617|NCT03621618|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110887618|NCT03621618|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
110887619|NCT03621618|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110887620|NCT03621618|Protective Agents|protective agents|mesh-ancestor
110887621|NCT03944304|Paclitaxel|paclitaxel|mesh-list
110887622|NCT03944304|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110887623|NCT03944304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110887624|NCT03944304|Tubulin Modulators|tubulin modulators|mesh-ancestor
110887625|NCT03944304|Antimitotic Agents|antimitotic agents|mesh-ancestor
110605154|NCT00605566|Sorafenib|sorafenib|mesh-list
110887626|NCT03944304|Mitosis Modulators|mitosis modulators|mesh-ancestor
110887627|NCT03944304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110887628|NCT05204121|Elsulfavirine|elsulfavirine|mesh-list
110887629|NCT05204121|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110887630|NCT05204121|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110887631|NCT05204121|Antiviral Agents|antiviral agents|mesh-ancestor
110887632|NCT05204121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110887634|NCT01569945|Clomiphene|clomiphene|mesh-list
110887635|NCT01569945|Menotropins|menotropins|mesh-list
110887636|NCT01569945|Estradiol|estradiol|mesh-list
110887637|NCT01569945|Estrogens|estrogens|mesh-ancestor
110887638|NCT01569945|Hormones|hormones|mesh-ancestor
110887639|NCT01569945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110887640|NCT01569945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110887641|NCT01569945|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110887642|NCT01569945|Contraceptive Agents|contraceptive agents|mesh-ancestor
110887643|NCT01569945|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110887644|NCT01569945|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110887645|NCT01569945|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110887646|NCT01569945|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110887647|NCT01569945|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110887648|NCT01569945|Hormone Antagonists|hormone antagonists|mesh-ancestor
110887649|NCT01569945|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110887650|NCT01569945|Fertility Agents|fertility agents|mesh-ancestor
110887651|NCT01569945|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110887652|NCT01569945|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110887653|NCT03645876|Capecitabine|capecitabine|mesh-list
110887654|NCT03645876|Oxaliplatin|oxaliplatin|mesh-list
110887655|NCT03645876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110887656|NCT03645876|Antimetabolites|antimetabolites|mesh-ancestor
110214356|NCT00248716|Hematinics|hematinics|mesh-ancestor
110887657|NCT03645876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110887658|NCT03645876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110887659|NCT02899728|Cisplatin|cisplatin|mesh-list
110887660|NCT02899728|Carboplatin|carboplatin|mesh-list
110887661|NCT02899728|Etoposide|etoposide|mesh-list
110887662|NCT02899728|Etoposide phosphate|etoposide phosphate|mesh-list
110887663|NCT02899728|Olaparib|olaparib|mesh-list
110887664|NCT02899728|Podophyllotoxin|podophyllotoxin|mesh-list
110887665|NCT02899728|Cediranib|cediranib|mesh-list
110887666|NCT02899728|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
110887667|NCT02899728|Maleic acid|maleic acid|mesh-list
110887668|NCT02899728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110887669|NCT02899728|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110887670|NCT02899728|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110887671|NCT02899728|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110887672|NCT02899728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110887673|NCT02899728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110887674|NCT02899728|Keratolytic Agents|keratolytic agents|mesh-ancestor
110638795|NCT00845156|Vitamins|vitamins|mesh-ancestor
110921275|NCT05573802|Dexamethasone|dexamethasone|mesh-list
110921276|NCT05573802|Lenalidomide|lenalidomide|mesh-list
110921277|NCT05573802|Nirogacestat|nirogacestat|mesh-list
110921278|NCT05573802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110921279|NCT05573802|Antiemetics|antiemetics|mesh-ancestor
110921280|NCT05573802|Autonomic Agents|autonomic agents|mesh-ancestor
110887675|NCT02899728|Dermatologic Agents|dermatologic agents|mesh-ancestor
110887676|NCT02899728|Tubulin Modulators|tubulin modulators|mesh-ancestor
110887677|NCT02899728|Antimitotic Agents|antimitotic agents|mesh-ancestor
110887678|NCT02899728|Mitosis Modulators|mitosis modulators|mesh-ancestor
110887679|NCT02899728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110887681|NCT03646266|Rocuronium|rocuronium|mesh-list
110887682|NCT03646266|Anticonvulsants|anticonvulsants|mesh-ancestor
110887683|NCT03646266|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110887684|NCT03646266|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110887685|NCT03646266|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110887686|NCT03646266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110887687|NCT03646266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110887689|NCT04052178|Antipruritics|antipruritics|mesh-ancestor
110887690|NCT04052178|Dermatologic Agents|dermatologic agents|mesh-ancestor
110887691|NCT04052178|Sensory System Agents|sensory system agents|mesh-ancestor
110887692|NCT04052178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110887693|NCT04052178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110887694|NCT03645642|Midodrine|midodrine|mesh-list
110887695|NCT03645642|Diuretics|diuretics|mesh-list
110887696|NCT03645642|Natriuretic Agents|natriuretic agents|mesh-ancestor
110887697|NCT03645642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110887698|NCT03645642|Sympathomimetics|sympathomimetics|mesh-ancestor
110887699|NCT03645642|Autonomic Agents|autonomic agents|mesh-ancestor
110887700|NCT03645642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110887701|NCT03645642|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110887702|NCT03645642|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110887703|NCT03645642|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110887705|NCT03645642|Adrenergic Agents|adrenergic agents|mesh-ancestor
110887706|NCT03645642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110887707|NCT03645642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110887708|NCT03066609|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110887709|NCT03066609|Immunologic Factors|immunologic factors|mesh-ancestor
110887710|NCT03066609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110214672|NCT00250861|Antiviral Agents|antiviral agents|mesh-ancestor
110887712|NCT03768492|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110887713|NCT03768492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110887714|NCT03768492|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110887715|NCT03768492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110887716|NCT03768492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110887717|NCT03768492|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110887718|NCT03768492|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110887719|NCT03768492|Purinergic Agents|purinergic agents|mesh-ancestor
110887720|NCT03768492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110887721|NCT01345188|Ranolazine|ranolazine|mesh-list
110887722|NCT01345188|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110887723|NCT01345188|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110887724|NCT01345188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110887725|NCT03852459|Ibuprofen|ibuprofen|mesh-list
110887726|NCT03852459|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110887727|NCT03852459|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110887728|NCT03852459|Analgesics|analgesics|mesh-ancestor
110887729|NCT03852459|Sensory System Agents|sensory system agents|mesh-ancestor
110887730|NCT03852459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110887731|NCT03852459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110887732|NCT03852459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110887733|NCT03852459|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110887734|NCT03852459|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110887735|NCT03852459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110921284|NCT05573802|Glucocorticoids|glucocorticoids|mesh-ancestor
110887736|NCT03852459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110887737|NCT03580902|Buprenorphine|buprenorphine|mesh-list
110887738|NCT03580902|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
110887739|NCT03580902|Naloxone|naloxone|mesh-list
110887740|NCT03580902|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110887741|NCT03580902|Narcotics|narcotics|mesh-ancestor
110887742|NCT03580902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110887743|NCT03580902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110887744|NCT03580902|Analgesics|analgesics|mesh-ancestor
110887745|NCT03580902|Sensory System Agents|sensory system agents|mesh-ancestor
110887746|NCT03580902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110887747|NCT03580902|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110887748|NCT02896296|Buprenorphine|buprenorphine|mesh-list
110887749|NCT02896296|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110887750|NCT02896296|Narcotics|narcotics|mesh-ancestor
110887751|NCT02896296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110887752|NCT02896296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110887753|NCT02896296|Analgesics|analgesics|mesh-ancestor
110887754|NCT02896296|Sensory System Agents|sensory system agents|mesh-ancestor
110887755|NCT02896296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110887756|NCT02896296|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110887758|NCT03644706|Diuretics|diuretics|mesh-ancestor
110887759|NCT03644706|Natriuretic Agents|natriuretic agents|mesh-ancestor
110887760|NCT03644706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110887761|NCT03644706|Expectorants|expectorants|mesh-ancestor
110887762|NCT03644706|Respiratory System Agents|respiratory system agents|mesh-ancestor
110887763|NCT03740919|Insulin|insulin|mesh-list
110887764|NCT03740919|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110887765|NCT03740919|Insulin Glargine|insulin glargine|mesh-list
110887766|NCT03740919|Insulin Lispro|insulin lispro|mesh-list
110214991|NCT00252811|Gefitinib|gefitinib|mesh-list
110887767|NCT03740919|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110887768|NCT03740919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110887770|NCT01335685|Melphalan|melphalan|mesh-list
110887771|NCT01335685|Ixazomib|ixazomib|mesh-list
110887772|NCT01335685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110887773|NCT01335685|Glucocorticoids|glucocorticoids|mesh-ancestor
110887774|NCT01335685|Hormones|hormones|mesh-ancestor
110887775|NCT01335685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110887776|NCT01335685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110887777|NCT01335685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110887778|NCT01335685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110887780|NCT01335685|Alkylating Agents|alkylating agents|mesh-ancestor
110887781|NCT01335685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110887782|NCT01335685|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110887783|NCT01335685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110887784|NCT01335685|Immunologic Factors|immunologic factors|mesh-ancestor
110887785|NCT01335685|Protease Inhibitors|protease inhibitors|mesh-ancestor
110887786|NCT01335685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110887787|NCT01335763|Insulin Glargine|insulin glargine|mesh-list
110921297|NCT04435522|Maraviroc|maraviroc|mesh-list
110887788|NCT01335763|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110887789|NCT01335763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110887790|NCT04462965|Temozolomide|temozolomide|mesh-list
110887791|NCT04462965|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110887792|NCT04462965|Alkylating Agents|alkylating agents|mesh-ancestor
110887793|NCT04462965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110887794|NCT04462965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110887795|NCT01339663|Aldesleukin|aldesleukin|mesh-list
110887797|NCT01339663|Interleukin-2|interleukin-2|mesh-list
110887798|NCT01339663|Vaccines|vaccines|mesh-list
110887799|NCT01339663|Immunologic Factors|immunologic factors|mesh-ancestor
110887800|NCT01339663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110887801|NCT01339663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110887802|NCT01339663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110887803|NCT01339663|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110887804|NCT01339663|Alkylating Agents|alkylating agents|mesh-ancestor
110887805|NCT01339663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110887806|NCT01339663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110887807|NCT01339663|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110921344|NCT02298530|Caffeine|caffeine|mesh-list
110887808|NCT01339663|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110887809|NCT01339663|Analgesics|analgesics|mesh-ancestor
110887810|NCT01339663|Sensory System Agents|sensory system agents|mesh-ancestor
110887811|NCT01339663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110887812|NCT01339663|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110887813|NCT01339663|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110887814|NCT01339663|Antiviral Agents|antiviral agents|mesh-ancestor
110887815|NCT01339663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110887816|NCT00092599|Ezetimibe|ezetimibe|mesh-list
110887817|NCT00092599|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110887818|NCT00092599|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110887819|NCT00092599|Antimetabolites|antimetabolites|mesh-ancestor
110887820|NCT00092599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110887821|NCT00092599|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110887822|NCT03737565|Tryptophan|tryptophan|mesh-list
110887823|NCT03737565|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110887824|NCT03737565|Antidepressive Agents|antidepressive agents|mesh-ancestor
110887825|NCT03737565|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110887826|NCT02889133|Iron|iron|mesh-list
110887827|NCT02889133|Dextrans|dextrans|mesh-list
110887828|NCT02889133|Iron-Dextran Complex|iron-dextran complex|mesh-list
110887829|NCT02889133|Trace Elements|trace elements|mesh-ancestor
110887830|NCT02889133|Micronutrients|micronutrients|mesh-ancestor
110887831|NCT02889133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110887832|NCT02889133|Anticoagulants|anticoagulants|mesh-ancestor
110887833|NCT02889133|Plasma Substitutes|plasma substitutes|mesh-ancestor
110887834|NCT02889133|Blood Substitutes|blood substitutes|mesh-ancestor
110887835|NCT02889133|Hematinics|hematinics|mesh-ancestor
110887836|NCT01333423|Roscovitine|roscovitine|mesh-list
110887837|NCT01333423|Doxorubicin|doxorubicin|mesh-list
110887838|NCT01333423|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110887839|NCT01333423|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110887840|NCT01333423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110887841|NCT01333423|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110887842|NCT01333423|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110887843|NCT01333423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110215294|NCT00254917|Vaccines|vaccines|mesh-list
110887844|NCT01333423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110887845|NCT01333423|Antiviral Agents|antiviral agents|mesh-ancestor
110887846|NCT01333423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110887847|NCT01333423|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110887849|NCT00092209|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110887850|NCT00092209|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110605367|NCT00837837|Dermatologic Agents|dermatologic agents|mesh-ancestor
110887851|NCT00092209|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110887852|NCT00092209|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110887853|NCT00092209|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110887854|NCT00092209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110887855|NCT00092209|Diuretics|diuretics|mesh-ancestor
110887856|NCT00092209|Natriuretic Agents|natriuretic agents|mesh-ancestor
110887857|NCT00092209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110887858|NCT00092209|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110887859|NCT00092209|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110887861|NCT01339741|Cholecalciferol|cholecalciferol|mesh-list
110887862|NCT01339741|Vitamins|vitamins|mesh-ancestor
110887863|NCT01339741|Micronutrients|micronutrients|mesh-ancestor
110887864|NCT01339741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110887865|NCT01339741|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110887866|NCT01339741|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110887868|NCT00003777|Amifostine|amifostine|mesh-list
110887869|NCT00003777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110887870|NCT00003777|Antimetabolites|antimetabolites|mesh-ancestor
110887871|NCT00003777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110887872|NCT00003777|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110887873|NCT00003777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110887874|NCT00003777|Immunologic Factors|immunologic factors|mesh-ancestor
110887875|NCT00003777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110887876|NCT00003777|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110887877|NCT00003777|Protective Agents|protective agents|mesh-ancestor
110887878|NCT01339819|Dabigatran|dabigatran|mesh-list
110887879|NCT01339819|Phenprocoumon|phenprocoumon|mesh-list
110887880|NCT01339819|Antithrombins|antithrombins|mesh-ancestor
110887881|NCT01339819|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110887882|NCT01339819|Protease Inhibitors|protease inhibitors|mesh-ancestor
110887883|NCT01339819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110887884|NCT01339819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110887885|NCT01339819|Anticoagulants|anticoagulants|mesh-ancestor
110887886|NCT02963922|Liraglutide|liraglutide|mesh-list
110887887|NCT02963922|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110887888|NCT02963922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110887889|NCT02963922|Incretins|incretins|mesh-ancestor
110887890|NCT02963922|Hormones|hormones|mesh-ancestor
110887891|NCT02963922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110887892|NCT00090181|Diclofenac|diclofenac|mesh-list
110887893|NCT00090181|Etoricoxib|etoricoxib|mesh-list
110887894|NCT00090181|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110887895|NCT00090181|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110887896|NCT00090181|Analgesics|analgesics|mesh-ancestor
110887897|NCT00090181|Sensory System Agents|sensory system agents|mesh-ancestor
110887898|NCT00090181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110887899|NCT00090181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110887900|NCT00090181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110887901|NCT00090181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110887902|NCT00090181|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110887903|NCT00090181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110887904|NCT00090181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110887905|NCT00090181|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110887906|NCT03619785|Acetaminophen|acetaminophen|mesh-list
110887907|NCT03619785|Ibuprofen|ibuprofen|mesh-list
110887908|NCT03619785|Ketorolac|ketorolac|mesh-list
110887909|NCT03619785|Fentanyl|fentanyl|mesh-list
110887910|NCT03619785|Ketamine|ketamine|mesh-list
110887911|NCT03619785|Morphine|morphine|mesh-list
110887912|NCT03619785|Gabapentin|gabapentin|mesh-list
110887913|NCT03619785|Hydromorphone|hydromorphone|mesh-list
110887914|NCT03619785|Hydrocodone|hydrocodone|mesh-list
110887915|NCT03619785|Bupivacaine|bupivacaine|mesh-list
110887916|NCT03619785|Anesthetics, Local|anesthetics, local|mesh-ancestor
110887917|NCT03619785|Anesthetics|anesthetics|mesh-ancestor
110887918|NCT03619785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110887919|NCT03619785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110887920|NCT03619785|Sensory System Agents|sensory system agents|mesh-ancestor
110887921|NCT03619785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110887922|NCT03619785|Analgesics|analgesics|mesh-ancestor
110887923|NCT03619785|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110215659|NCT00257023|Dopamine Agents|dopamine agents|mesh-ancestor
110887924|NCT03619785|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110887925|NCT03619785|Anesthetics, General|anesthetics, general|mesh-ancestor
110887926|NCT03619785|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110887927|NCT03619785|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110887928|NCT03619785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110887929|NCT03619785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110887930|NCT03619785|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110887931|NCT03619785|Narcotics|narcotics|mesh-ancestor
110887932|NCT03619785|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110887933|NCT03619785|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110887934|NCT03619785|Antipyretics|antipyretics|mesh-ancestor
110887935|NCT03619785|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110887936|NCT03619785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110887937|NCT03619785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110887938|NCT03619785|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110887939|NCT03619785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110887940|NCT03619785|Anticonvulsants|anticonvulsants|mesh-ancestor
110887941|NCT03619785|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110887942|NCT03619785|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110887943|NCT03619785|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110887944|NCT03619785|Antimanic Agents|antimanic agents|mesh-ancestor
110887945|NCT03619785|Antitussive Agents|antitussive agents|mesh-ancestor
110887946|NCT03619785|Respiratory System Agents|respiratory system agents|mesh-ancestor
110887947|NCT02881567|Daclizumab|daclizumab|mesh-list
110887948|NCT02881567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110887949|NCT02881567|Immunologic Factors|immunologic factors|mesh-ancestor
110887950|NCT02881567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110887951|NCT05184517|Cyclosporine|cyclosporine|mesh-list
110887952|NCT05184517|Cyclosporins|cyclosporins|mesh-list
110887953|NCT05184517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110887954|NCT05184517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110887955|NCT05184517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110887956|NCT05184517|Immunologic Factors|immunologic factors|mesh-ancestor
110887957|NCT05184517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110887958|NCT05184517|Antifungal Agents|antifungal agents|mesh-ancestor
110887959|NCT05184517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110887960|NCT05184517|Dermatologic Agents|dermatologic agents|mesh-ancestor
110887961|NCT05184517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110887962|NCT05184517|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110887963|NCT02962284|Methylprednisolone|methylprednisolone|mesh-list
110887964|NCT02962284|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110215839|NCT00258115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110887965|NCT02962284|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110887967|NCT02962284|Prednisolone acetate|prednisolone acetate|mesh-list
110887968|NCT02962284|Abiraterone Acetate|abiraterone acetate|mesh-list
110887969|NCT02962284|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110887970|NCT02962284|Prednisolone phosphate|prednisolone phosphate|mesh-list
110887971|NCT02962284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110887972|NCT02962284|Antiemetics|antiemetics|mesh-ancestor
110887973|NCT02962284|Autonomic Agents|autonomic agents|mesh-ancestor
110887974|NCT02962284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110887975|NCT02962284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110887976|NCT02962284|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110887977|NCT02962284|Glucocorticoids|glucocorticoids|mesh-ancestor
110887978|NCT02962284|Hormones|hormones|mesh-ancestor
110887979|NCT02962284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110887980|NCT02962284|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110887981|NCT02962284|Protective Agents|protective agents|mesh-ancestor
110887982|NCT02962284|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110887983|NCT02962284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110887984|NCT02962284|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110887985|NCT02962284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110887986|NCT02962284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110887987|NCT02962284|Hormone Antagonists|hormone antagonists|mesh-ancestor
110887988|NCT02962284|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110887990|NCT03642600|Inositol|inositol|mesh-list
110887991|NCT03642600|Liraglutide|liraglutide|mesh-list
110887992|NCT03642600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110887993|NCT03642600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110887994|NCT03642600|Incretins|incretins|mesh-ancestor
110887995|NCT03642600|Hormones|hormones|mesh-ancestor
110921415|NCT01344759|Anesthetics|anesthetics|mesh-ancestor
110887996|NCT03642600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110887997|NCT03642600|Hematinics|hematinics|mesh-ancestor
110887998|NCT03642600|Vitamin B Complex|vitamin b complex|mesh-ancestor
110887999|NCT03642600|Vitamins|vitamins|mesh-ancestor
110888000|NCT03642600|Micronutrients|micronutrients|mesh-ancestor
110888001|NCT01069692|Ferric Compounds|ferric compounds|mesh-list
110888003|NCT05183178|Ticagrelor|ticagrelor|mesh-list
110888004|NCT05183178|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
110888005|NCT05183178|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110888006|NCT05183178|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110888007|NCT05183178|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110063385|NCT03008408|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110888008|NCT05183178|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110888009|NCT05183178|Purinergic Agents|purinergic agents|mesh-ancestor
110888010|NCT05183178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110888011|NCT05183178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110888012|NCT05183178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110888013|NCT03161093|Naproxen|naproxen|mesh-list
110888014|NCT03161093|Fasinumab|fasinumab|mesh-list
110888015|NCT03161093|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110888016|NCT03161093|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110888017|NCT03161093|Analgesics|analgesics|mesh-ancestor
110888018|NCT03161093|Sensory System Agents|sensory system agents|mesh-ancestor
110888019|NCT03161093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110888020|NCT03161093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110888021|NCT03161093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110888022|NCT03161093|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110888023|NCT03161093|Gout Suppressants|gout suppressants|mesh-ancestor
110888024|NCT03161093|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110888025|NCT03161093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110888026|NCT03161093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110888027|NCT03573284|Nitric Oxide|nitric oxide|mesh-list
110888028|NCT03573284|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110888029|NCT03573284|Autonomic Agents|autonomic agents|mesh-ancestor
110888030|NCT03573284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110888031|NCT03573284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110888032|NCT03573284|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110888033|NCT03573284|Respiratory System Agents|respiratory system agents|mesh-ancestor
110888034|NCT03573284|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110888036|NCT03573284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110888037|NCT03573284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110888038|NCT03573284|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
110888039|NCT03573284|Vasodilator Agents|vasodilator agents|mesh-ancestor
110888040|NCT03573284|Gasotransmitters|gasotransmitters|mesh-ancestor
110888041|NCT03573284|Protective Agents|protective agents|mesh-ancestor
110888042|NCT03575780|Tirbanibulin|tirbanibulin|mesh-list
110888043|NCT03575780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110216286|NCT00261820|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110888044|NCT03575780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110888045|NCT01334333|Tacrolimus|tacrolimus|mesh-list
110888046|NCT01334333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110888047|NCT01334333|Immunologic Factors|immunologic factors|mesh-ancestor
110888048|NCT01334333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110921418|NCT05885386|Alkylating Agents|alkylating agents|mesh-ancestor
110888049|NCT01334333|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110888050|NCT01334333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110888051|NCT01334333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110888052|NCT03573050|Rivastigmine|rivastigmine|mesh-list
110888053|NCT03573050|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110888054|NCT03573050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110888055|NCT03573050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110888056|NCT03573050|Cholinergic Agents|cholinergic agents|mesh-ancestor
110888057|NCT03573050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110888058|NCT03573050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110216418|NCT00262405|Glucocorticoids|glucocorticoids|mesh-ancestor
110888059|NCT03573050|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110888060|NCT03573050|Protective Agents|protective agents|mesh-ancestor
110888061|NCT03575312|Enrofloxacin|enrofloxacin|mesh-list
110888062|NCT03575312|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110888063|NCT03575312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110888064|NCT02847494|Dexamethasone|dexamethasone|mesh-list
110888065|NCT02847494|Methylprednisolone|methylprednisolone|mesh-list
110888066|NCT02847494|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110888067|NCT02847494|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110888068|NCT02847494|Prednisolone|prednisolone|mesh-list
110888069|NCT02847494|Prednisolone acetate|prednisolone acetate|mesh-list
110888070|NCT02847494|Metoclopramide|metoclopramide|mesh-list
110888071|NCT02847494|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110888072|NCT02847494|Prednisolone phosphate|prednisolone phosphate|mesh-list
110888073|NCT02847494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110888074|NCT02847494|Antiemetics|antiemetics|mesh-ancestor
110888075|NCT02847494|Autonomic Agents|autonomic agents|mesh-ancestor
110888076|NCT02847494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110888077|NCT02847494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110888078|NCT02847494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110888079|NCT02847494|Glucocorticoids|glucocorticoids|mesh-ancestor
110888081|NCT02847494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110888082|NCT02847494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110605590|NCT00924430|Simvastatin|simvastatin|mesh-list
110888084|NCT02847494|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110888085|NCT02847494|Protective Agents|protective agents|mesh-ancestor
110216546|NCT00263458|Buprenorphine|buprenorphine|mesh-list
110888086|NCT02847494|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110888088|NCT02847494|Dopamine Agents|dopamine agents|mesh-ancestor
110888089|NCT02847494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110888090|NCT02847494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110888091|NCT02554253|Ketamine|ketamine|mesh-list
110888092|NCT02554253|Propofol|propofol|mesh-list
110888093|NCT02554253|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110888094|NCT02554253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110888095|NCT02554253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110888096|NCT02554253|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110888097|NCT02554253|Anesthetics, General|anesthetics, general|mesh-ancestor
110888098|NCT02554253|Anesthetics|anesthetics|mesh-ancestor
110888099|NCT02554253|Analgesics|analgesics|mesh-ancestor
110888100|NCT02554253|Sensory System Agents|sensory system agents|mesh-ancestor
110888101|NCT02554253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110888102|NCT02554253|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110888103|NCT02554253|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110888104|NCT02554253|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110888105|NCT02554253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110888106|NCT02554253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110888107|NCT02239484|Tadalafil|tadalafil|mesh-list
110888108|NCT02239484|Tamsulosin|tamsulosin|mesh-list
110888109|NCT02239484|Vasodilator Agents|vasodilator agents|mesh-ancestor
110888110|NCT02239484|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110888111|NCT02239484|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110888112|NCT02239484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110888113|NCT02239484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110888114|NCT02239484|Urological Agents|urological agents|mesh-ancestor
110888115|NCT02239484|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110888116|NCT02239484|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110888117|NCT02239484|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110888118|NCT02239484|Adrenergic Agents|adrenergic agents|mesh-ancestor
110888119|NCT02239484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110888120|NCT02239484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110888121|NCT03575234|Cyclophosphamide|cyclophosphamide|mesh-list
110888122|NCT03575234|Nivolumab|nivolumab|mesh-list
110888123|NCT03575234|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110888125|NCT03575234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110888126|NCT03575234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110888127|NCT03575234|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110888128|NCT03575234|Alkylating Agents|alkylating agents|mesh-ancestor
110888129|NCT03575234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110888130|NCT03575234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110888131|NCT03575234|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110888132|NCT03575234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110888133|NCT03575234|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110888135|NCT04508855|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
110888136|NCT04508855|Tinzaparin|tinzaparin|mesh-list
110888137|NCT04508855|Dalteparin|dalteparin|mesh-list
110888138|NCT04508855|Anticoagulants|anticoagulants|mesh-ancestor
110888139|NCT04508855|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110888140|NCT04508855|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110888141|NCT04508855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110888142|NCT03575078|Olaparib|olaparib|mesh-list
110888143|NCT03575078|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110888144|NCT03575078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110888145|NCT03575078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110888146|NCT03575078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110888147|NCT03157583|Sunscreening Agents|sunscreening agents|mesh-list
110888149|NCT03157583|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110888150|NCT03157583|Protective Agents|protective agents|mesh-ancestor
110888151|NCT03157583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110888152|NCT03157583|Dermatologic Agents|dermatologic agents|mesh-ancestor
110888153|NCT03157583|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
110888154|NCT03570710|Tranexamic Acid|tranexamic acid|mesh-list
110888155|NCT03570710|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110888156|NCT03570710|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110888157|NCT03570710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110216773|NCT00415831|Carbidopa|carbidopa|mesh-list
110888158|NCT03570710|Hemostatics|hemostatics|mesh-ancestor
110888159|NCT03570710|Coagulants|coagulants|mesh-ancestor
110888160|NCT01337765|Dactolisib|dactolisib|mesh-list
110888161|NCT01337765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110888162|NCT01307033|Losartan|losartan|mesh-list
110888163|NCT01307033|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110888164|NCT01307033|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110888165|NCT01307033|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110921452|NCT05884970|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110888166|NCT01307033|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110888167|NCT01307033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110888169|NCT04475705|Sevoflurane|sevoflurane|mesh-list
110888170|NCT04475705|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110888171|NCT04475705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110888172|NCT04475705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110888173|NCT04475705|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110888174|NCT04475705|Anesthetics, General|anesthetics, general|mesh-ancestor
110888175|NCT04475705|Anesthetics|anesthetics|mesh-ancestor
110888176|NCT04475705|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110888177|NCT04475705|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110888179|NCT03158311|Tiotropium Bromide|tiotropium bromide|mesh-list
110888180|NCT03158311|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110888181|NCT03158311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110888182|NCT03158311|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110888183|NCT03158311|Autonomic Agents|autonomic agents|mesh-ancestor
110888184|NCT03158311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110888185|NCT03158311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110888186|NCT03158311|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110888187|NCT03158311|Respiratory System Agents|respiratory system agents|mesh-ancestor
110888188|NCT03158311|Dermatologic Agents|dermatologic agents|mesh-ancestor
110888189|NCT03158311|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110888190|NCT03158311|Parasympatholytics|parasympatholytics|mesh-ancestor
110216966|NCT00268177|Xhance|xhance|mesh-list
110888191|NCT03158311|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110888192|NCT03158311|Cholinergic Agents|cholinergic agents|mesh-ancestor
110888193|NCT03158311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110888194|NCT03158311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110888195|NCT03158311|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110888196|NCT03158311|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110888197|NCT03158311|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110888198|NCT03158311|Adrenergic Agents|adrenergic agents|mesh-ancestor
110888199|NCT02244866|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
110888200|NCT02244866|Hormones|hormones|mesh-ancestor
110888201|NCT02244866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110888202|NCT02244866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110888203|NCT01334567|Tenofovir|tenofovir|mesh-list
110888204|NCT01334567|Antiviral Agents|antiviral agents|mesh-ancestor
110888205|NCT01334567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110888206|NCT01334567|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110888207|NCT01334567|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110888208|NCT01334567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110217107|NCT00268489|Bevacizumab|bevacizumab|mesh-list
110888209|NCT01334567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110888210|NCT01334567|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110888211|NCT01334567|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110888212|NCT04398329|Bupivacaine|bupivacaine|mesh-list
110888213|NCT04398329|Anesthetics, Local|anesthetics, local|mesh-ancestor
110888214|NCT04398329|Anesthetics|anesthetics|mesh-ancestor
110888215|NCT04398329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110888216|NCT04398329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110888217|NCT04398329|Sensory System Agents|sensory system agents|mesh-ancestor
110888218|NCT04398329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110888220|NCT00449111|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110888221|NCT00449111|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110888222|NCT00449111|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110888223|NCT00449111|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110888224|NCT00449111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110888225|NCT03568916|Rivaroxaban|rivaroxaban|mesh-list
110888226|NCT03568916|Apixaban|apixaban|mesh-list
110888227|NCT03568916|Dabigatran|dabigatran|mesh-list
110888228|NCT03568916|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110888229|NCT03568916|Antithrombins|antithrombins|mesh-ancestor
110888230|NCT03568916|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110888232|NCT03568916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110888233|NCT03568916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110888234|NCT03568916|Anticoagulants|anticoagulants|mesh-ancestor
110888235|NCT01334645|Arginine Vasopressin|arginine vasopressin|mesh-list
110888236|NCT01334645|Hemostatics|hemostatics|mesh-ancestor
110888237|NCT01334645|Coagulants|coagulants|mesh-ancestor
110888238|NCT01334645|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110888239|NCT01334645|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
110888240|NCT01334645|Natriuretic Agents|natriuretic agents|mesh-ancestor
110888241|NCT01334645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110888242|NCT03571490|Ropivacaine|ropivacaine|mesh-list
110888243|NCT03571490|Anesthetics, Local|anesthetics, local|mesh-ancestor
110888245|NCT03571490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110199848|NCT00403663|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110888246|NCT03571490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110888247|NCT03571490|Sensory System Agents|sensory system agents|mesh-ancestor
110888248|NCT03571490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110888249|NCT01331993|Naproxen|naproxen|mesh-list
110888250|NCT01331993|Esomeprazole|esomeprazole|mesh-list
110888251|NCT01331993|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110888252|NCT01331993|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110888253|NCT01331993|Analgesics|analgesics|mesh-ancestor
110888254|NCT01331993|Sensory System Agents|sensory system agents|mesh-ancestor
110888255|NCT01331993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110888256|NCT01331993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110888257|NCT01331993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110888258|NCT01331993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110888259|NCT01331993|Gout Suppressants|gout suppressants|mesh-ancestor
110217451|NCT00107016|Letrozole|letrozole|mesh-list
110888260|NCT01331993|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110888261|NCT01331993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110888262|NCT01331993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110888263|NCT01331993|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110888264|NCT01331993|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110888265|NCT01331993|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110888266|NCT01338077|Omeprazole|omeprazole|mesh-list
110888267|NCT01338077|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110888268|NCT01338077|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110888269|NCT01338077|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110217485|NCT00270322|Fentanyl|fentanyl|mesh-list
110888270|NCT01338077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110888271|NCT01338077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110888273|NCT03570320|Narcotics|narcotics|mesh-ancestor
110888274|NCT03570320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110888275|NCT03570320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110888276|NCT03570320|Analgesics|analgesics|mesh-ancestor
110888277|NCT03570320|Sensory System Agents|sensory system agents|mesh-ancestor
110888278|NCT03570320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110888279|NCT04266665|Dexmedetomidine|dexmedetomidine|mesh-list
110888280|NCT04266665|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110888281|NCT04266665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110888282|NCT04266665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110888283|NCT04266665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110888284|NCT04266665|Analgesics|analgesics|mesh-ancestor
110888285|NCT04266665|Sensory System Agents|sensory system agents|mesh-ancestor
110888286|NCT04266665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110888287|NCT04266665|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110888288|NCT04266665|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110888289|NCT04266665|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110888290|NCT04266665|Adrenergic Agents|adrenergic agents|mesh-ancestor
110888291|NCT04266665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110888292|NCT04266665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110888293|NCT03571100|Chlorhexidine|chlorhexidine|mesh-list
110888294|NCT03571100|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110888295|NCT03571100|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110888296|NCT03571100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110888297|NCT03571100|Disinfectants|disinfectants|mesh-ancestor
110888298|NCT03571100|Dermatologic Agents|dermatologic agents|mesh-ancestor
110888299|NCT01338311|Albuterol|albuterol|mesh-list
110888300|NCT01338311|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110888301|NCT01338311|Autonomic Agents|autonomic agents|mesh-ancestor
110888302|NCT01338311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110888303|NCT01338311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110888304|NCT01338311|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110605813|NCT02710890|Lacosamide|lacosamide|mesh-list
110888305|NCT01338311|Respiratory System Agents|respiratory system agents|mesh-ancestor
110888306|NCT01338311|Tocolytic Agents|tocolytic agents|mesh-ancestor
110888307|NCT01338311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110888308|NCT01338311|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110888309|NCT01338311|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110888310|NCT01338311|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110888311|NCT01338311|Adrenergic Agents|adrenergic agents|mesh-ancestor
110888312|NCT01338311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110888313|NCT01338311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110888314|NCT01334879|Ranibizumab|ranibizumab|mesh-list
110888315|NCT01334879|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110888316|NCT01334879|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110888317|NCT01334879|Growth Substances|growth substances|mesh-ancestor
110888318|NCT01334879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110888319|NCT01334879|Growth Inhibitors|growth inhibitors|mesh-ancestor
110217673|NCT00271492|Atrasentan|atrasentan|mesh-list
110888320|NCT01334879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110888321|NCT01315795|Lanreotide|lanreotide|mesh-list
110888322|NCT01315795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110888323|NCT03570164|Sevoflurane|sevoflurane|mesh-list
110888324|NCT03570164|Desflurane|desflurane|mesh-list
110888325|NCT03570164|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110888326|NCT03570164|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110888327|NCT03570164|Anesthetics, General|anesthetics, general|mesh-ancestor
110888328|NCT03570164|Anesthetics|anesthetics|mesh-ancestor
110888329|NCT03570164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110888330|NCT03570164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110888331|NCT01315951|Petrolatum|petrolatum|mesh-list
110888332|NCT01315951|Emollients|emollients|mesh-ancestor
110888333|NCT01315951|Dermatologic Agents|dermatologic agents|mesh-ancestor
110888334|NCT05184049|Vitamin B 12|vitamin b 12|mesh-list
110888335|NCT05184049|Epalrestat|epalrestat|mesh-list
110888336|NCT05184049|Vitamin B Complex|vitamin b complex|mesh-ancestor
110888337|NCT05184049|Vitamins|vitamins|mesh-ancestor
110888338|NCT05184049|Micronutrients|micronutrients|mesh-ancestor
110888339|NCT05184049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110888340|NCT05184049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110888341|NCT05184049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110888342|NCT01336543|Cisplatin|cisplatin|mesh-list
110888343|NCT01336543|Gemcitabine|gemcitabine|mesh-list
110888344|NCT01336543|Etoposide|etoposide|mesh-list
110888345|NCT01336543|Pemetrexed|pemetrexed|mesh-list
110888346|NCT01336543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110888347|NCT01336543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110888348|NCT01336543|Antimetabolites|antimetabolites|mesh-ancestor
110888349|NCT01336543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110888350|NCT01336543|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110888351|NCT01336543|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110888352|NCT01336543|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110888353|NCT01336543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110888354|NCT01336543|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110888355|NCT01336543|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110888356|NCT03568136|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110888357|NCT03568136|Immunologic Factors|immunologic factors|mesh-ancestor
110888358|NCT03568136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110888360|NCT01336621|Anticonvulsants|anticonvulsants|mesh-ancestor
110217845|NCT00401427|Trastuzumab|trastuzumab|mesh-list
110921492|NCT05884463|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110888362|NCT01336621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110888363|NCT00383435|Mometasone Furoate|mometasone furoate|mesh-list
110888364|NCT00383435|Formoterol Fumarate|formoterol fumarate|mesh-list
110888365|NCT00383435|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110888366|NCT00383435|Autonomic Agents|autonomic agents|mesh-ancestor
110888367|NCT00383435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110888368|NCT00383435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110888369|NCT00383435|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110888370|NCT00383435|Respiratory System Agents|respiratory system agents|mesh-ancestor
110888371|NCT00383435|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110888372|NCT00383435|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110888373|NCT00383435|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110888374|NCT00383435|Adrenergic Agents|adrenergic agents|mesh-ancestor
110888375|NCT00383435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110888376|NCT00383435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110888377|NCT00383435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110888378|NCT00383435|Dermatologic Agents|dermatologic agents|mesh-ancestor
110888379|NCT00383435|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110888380|NCT01340521|Clomiphene|clomiphene|mesh-list
110888381|NCT01340521|Enclomiphene|enclomiphene|mesh-list
110888383|NCT01340521|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110888384|NCT01340521|Hormone Antagonists|hormone antagonists|mesh-ancestor
110888385|NCT01340521|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110888386|NCT01340521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110888387|NCT01340521|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110888388|NCT01340521|Fertility Agents|fertility agents|mesh-ancestor
110888389|NCT01340521|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110888390|NCT01340521|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110888391|NCT01340521|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110888392|NCT01340599|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
110888393|NCT01340599|Antioxidants|antioxidants|mesh-ancestor
110888394|NCT01340599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110888395|NCT01340599|Protective Agents|protective agents|mesh-ancestor
110888396|NCT01340599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110888397|NCT01340599|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
110888398|NCT01340599|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110888399|NCT01340599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110888400|NCT01340599|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110888401|NCT01335035|Deferasirox|deferasirox|mesh-list
110888402|NCT01335035|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110888403|NCT01335035|Chelating Agents|chelating agents|mesh-ancestor
110888404|NCT01335035|Sequestering Agents|sequestering agents|mesh-ancestor
110888405|NCT01335035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110888406|NCT01340677|Canagliflozin|canagliflozin|mesh-list
110888407|NCT01340677|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110888408|NCT01340677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110888409|NCT01340677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110888410|NCT01340677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110888411|NCT05163535|Elsulfavirine|elsulfavirine|mesh-list
110888412|NCT05163535|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110888413|NCT05163535|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110888414|NCT05163535|Antiviral Agents|antiviral agents|mesh-ancestor
110888415|NCT05163535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110888416|NCT01338389|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
110888417|NCT01338389|Nootropic Agents|nootropic agents|mesh-ancestor
110888418|NCT01340833|Dabrafenib|dabrafenib|mesh-list
110888419|NCT01340833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110888420|NCT01340833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110888421|NCT01340833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110888422|NCT01340833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110888423|NCT01332383|Naratriptan|naratriptan|mesh-list
110888424|NCT01332383|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110888425|NCT01332383|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110888426|NCT01332383|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110888427|NCT01332383|Serotonin Agents|serotonin agents|mesh-ancestor
110888428|NCT01332383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110888429|NCT01332383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110888430|NCT01332383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110888431|NCT01342237|Carboplatin|carboplatin|mesh-list
110888432|NCT01342237|Etoposide|etoposide|mesh-list
110888433|NCT01342237|Melphalan|melphalan|mesh-list
110888434|NCT01342237|Topotecan|topotecan|mesh-list
110888435|NCT01342237|Thiotepa|thiotepa|mesh-list
110888436|NCT01342237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110888437|NCT01342237|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110888438|NCT01342237|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110888439|NCT01342237|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110888440|NCT01342237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110888441|NCT01342237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110888442|NCT01342237|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110888443|NCT01342237|Alkylating Agents|alkylating agents|mesh-ancestor
110888444|NCT01342237|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110888445|NCT01342237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110888446|NCT01342237|Immunologic Factors|immunologic factors|mesh-ancestor
110888447|NCT01342237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110888448|NCT01342237|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110888449|NCT01337323|Fluticasone|fluticasone|mesh-list
110888450|NCT01337323|Xhance|xhance|mesh-list
110888451|NCT01337323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110888452|NCT01337323|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110888453|NCT01337323|Autonomic Agents|autonomic agents|mesh-ancestor
110888454|NCT01337323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110888455|NCT01337323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110888456|NCT01337323|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110888457|NCT01337323|Respiratory System Agents|respiratory system agents|mesh-ancestor
110888458|NCT01337323|Dermatologic Agents|dermatologic agents|mesh-ancestor
110888459|NCT01337323|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110888460|NCT03157037|Immunoglobulins|immunoglobulins|mesh-list
110888461|NCT03157037|Immunoglobulin G|immunoglobulin g|mesh-list
110888462|NCT03157037|Immunologic Factors|immunologic factors|mesh-ancestor
110888463|NCT03157037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110888464|NCT04830943|Cerebrolysin|cerebrolysin|mesh-list
110888465|NCT04830943|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110888466|NCT04830943|Protective Agents|protective agents|mesh-ancestor
110888467|NCT04830943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110888468|NCT04830943|Nootropic Agents|nootropic agents|mesh-ancestor
110888469|NCT04429321|Nivolumab|nivolumab|mesh-list
110888470|NCT04429321|Ipilimumab|ipilimumab|mesh-list
110888471|NCT04429321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110888472|NCT04429321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110888473|NCT04429321|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110888474|NCT04429321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110888475|NCT03067610|Paclitaxel|paclitaxel|mesh-list
110888476|NCT03067610|Cisplatin|cisplatin|mesh-list
110888477|NCT03067610|Carboplatin|carboplatin|mesh-list
110888478|NCT03067610|Cetuximab|cetuximab|mesh-list
110888479|NCT03067610|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110888480|NCT03067610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110888481|NCT03067610|Tubulin Modulators|tubulin modulators|mesh-ancestor
110888482|NCT03067610|Antimitotic Agents|antimitotic agents|mesh-ancestor
110218246|NCT00278278|Prednisone|prednisone|mesh-list
110888483|NCT03067610|Mitosis Modulators|mitosis modulators|mesh-ancestor
110888484|NCT03067610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110888485|NCT03067610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110921515|NCT05884151|Hemostatics|hemostatics|mesh-ancestor
110888486|NCT00381485|Mometasone Furoate|mometasone furoate|mesh-list
110888487|NCT00381485|Formoterol Fumarate|formoterol fumarate|mesh-list
110888488|NCT00381485|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110888489|NCT00381485|Autonomic Agents|autonomic agents|mesh-ancestor
110888490|NCT00381485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110888491|NCT00381485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110218307|NCT00278824|Analgesics|analgesics|mesh-ancestor
110888492|NCT00381485|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110888493|NCT00381485|Respiratory System Agents|respiratory system agents|mesh-ancestor
110888494|NCT00381485|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110888495|NCT00381485|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110888496|NCT00381485|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110888497|NCT00381485|Adrenergic Agents|adrenergic agents|mesh-ancestor
110888498|NCT00381485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110888499|NCT00381485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110888500|NCT00381485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110888501|NCT00381485|Dermatologic Agents|dermatologic agents|mesh-ancestor
110888502|NCT00381485|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110888503|NCT05182957|Lenalidomide|lenalidomide|mesh-list
110888504|NCT05182957|Azacitidine|azacitidine|mesh-list
110888505|NCT05182957|Antibodies|antibodies|mesh-list
110888506|NCT05182957|Immunoglobulins|immunoglobulins|mesh-list
110888507|NCT05182957|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110888508|NCT05182957|Immunologic Factors|immunologic factors|mesh-list
110888509|NCT05182957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110888510|NCT05182957|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110888511|NCT05182957|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110888512|NCT05182957|Growth Substances|growth substances|mesh-ancestor
110888513|NCT05182957|Growth Inhibitors|growth inhibitors|mesh-ancestor
110888514|NCT05182957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110888515|NCT05182957|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110888516|NCT05182957|Antimetabolites|antimetabolites|mesh-ancestor
110888517|NCT05182957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110888518|NCT05182957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110888519|NCT00092651|Simvastatin|simvastatin|mesh-list
110888520|NCT00092651|Ezetimibe|ezetimibe|mesh-list
110888521|NCT00092651|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
110888522|NCT00092651|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110888523|NCT00092651|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110888524|NCT00092651|Antimetabolites|antimetabolites|mesh-ancestor
110888525|NCT00092651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110888526|NCT00092651|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110888527|NCT00092651|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110888528|NCT00092651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110888529|NCT04889599|Docetaxel|docetaxel|mesh-list
110888530|NCT04889599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110888531|NCT04889599|Tubulin Modulators|tubulin modulators|mesh-ancestor
110888532|NCT04889599|Antimitotic Agents|antimitotic agents|mesh-ancestor
110888533|NCT04889599|Mitosis Modulators|mitosis modulators|mesh-ancestor
110888534|NCT04889599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110888536|NCT01342627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110888537|NCT01342627|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110888538|NCT01342627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110888539|NCT01342627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110888540|NCT03160703|Fluorides|fluorides|mesh-list
110888541|NCT03160703|Tin Fluorides|tin fluorides|mesh-list
110888542|NCT03160703|Fluorophosphate|fluorophosphate|mesh-list
110888543|NCT03160703|Cariostatic Agents|cariostatic agents|mesh-ancestor
110888544|NCT03160703|Protective Agents|protective agents|mesh-ancestor
110218421|NCT00075998|Interferons|interferons|mesh-list
110888545|NCT03160703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110888546|NCT01332617|Zoledronic Acid|zoledronic acid|mesh-list
110888547|NCT01332617|Methylprednisolone|methylprednisolone|mesh-list
110888548|NCT01332617|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110888549|NCT01332617|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110888551|NCT01332617|Prednisolone acetate|prednisolone acetate|mesh-list
110888552|NCT01332617|Diclofenac|diclofenac|mesh-list
110888553|NCT01332617|Bortezomib|bortezomib|mesh-list
110888554|NCT01332617|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110888555|NCT01332617|Simvastatin|simvastatin|mesh-list
110888556|NCT01332617|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110888557|NCT01332617|Prednisolone phosphate|prednisolone phosphate|mesh-list
110888558|NCT01332617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110888559|NCT01332617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110888560|NCT01332617|Antiemetics|antiemetics|mesh-ancestor
110888561|NCT01332617|Autonomic Agents|autonomic agents|mesh-ancestor
110888562|NCT01332617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110888563|NCT01332617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110888564|NCT01332617|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110888565|NCT01332617|Glucocorticoids|glucocorticoids|mesh-ancestor
110888566|NCT01332617|Hormones|hormones|mesh-ancestor
110888567|NCT01332617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110888568|NCT01332617|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110888569|NCT01332617|Protective Agents|protective agents|mesh-ancestor
110888570|NCT01332617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110888571|NCT01332617|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110888572|NCT01332617|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110888573|NCT01332617|Antimetabolites|antimetabolites|mesh-ancestor
110888574|NCT01332617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110888575|NCT01332617|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110888576|NCT01332617|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110888577|NCT01332617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110888578|NCT01332617|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110888579|NCT01332617|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110888580|NCT01332617|Analgesics|analgesics|mesh-ancestor
110888581|NCT01332617|Sensory System Agents|sensory system agents|mesh-ancestor
110888582|NCT01332617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110888583|NCT01332617|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110888584|NCT01332617|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110888585|NCT01332617|Alkylating Agents|alkylating agents|mesh-ancestor
110888586|NCT01332617|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110888587|NCT03569696|Nivolumab|nivolumab|mesh-list
110888588|NCT03569696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110888589|NCT03569696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110888590|NCT03569696|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110888591|NCT03569696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110888592|NCT00092573|Ezetimibe|ezetimibe|mesh-list
110888593|NCT00092573|Fenofibrate|fenofibrate|mesh-list
110888594|NCT00092573|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110888595|NCT00092573|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110888596|NCT00092573|Antimetabolites|antimetabolites|mesh-ancestor
110888597|NCT00092573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110888598|NCT00092573|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110888599|NCT01342939|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110888600|NCT01342939|Incretins|incretins|mesh-list
110888601|NCT01342939|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110888602|NCT01342939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110888604|NCT01342939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110888605|NCT01342939|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110218592|NCT00109551|Folic Acid|folic acid|mesh-list
110888607|NCT01342939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110888608|NCT01342939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110888609|NCT03569540|Glyburide|glyburide|mesh-list
110888610|NCT03569540|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110888611|NCT03569540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110888612|NCT05708690|Tranexamic Acid|tranexamic acid|mesh-list
110888613|NCT05708690|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110888614|NCT05708690|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110888615|NCT05708690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110888617|NCT05708690|Coagulants|coagulants|mesh-ancestor
110888618|NCT04851821|Quercetin|quercetin|mesh-list
110888619|NCT04851821|Antioxidants|antioxidants|mesh-ancestor
110888620|NCT04851821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110888621|NCT04851821|Protective Agents|protective agents|mesh-ancestor
110888622|NCT04851821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110888623|NCT03379727|Midostaurin|midostaurin|mesh-list
110888624|NCT03379727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110888625|NCT03379727|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110888626|NCT03379727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110888627|NCT03379727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110888628|NCT02247128|Aspirin|aspirin|mesh-list
110888629|NCT02247128|Clopidogrel|clopidogrel|mesh-list
110888630|NCT02247128|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110888632|NCT02247128|Analgesics|analgesics|mesh-ancestor
110888633|NCT02247128|Sensory System Agents|sensory system agents|mesh-ancestor
110888634|NCT02247128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110888635|NCT02247128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110888636|NCT02247128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110888637|NCT02247128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110888638|NCT02247128|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110888639|NCT02247128|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110218745|NCT00109941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110888641|NCT02247128|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110888642|NCT02247128|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110888643|NCT02247128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110888644|NCT02247128|Antipyretics|antipyretics|mesh-ancestor
110888645|NCT02247128|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110888646|NCT02247128|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110888647|NCT02247128|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110888648|NCT02247128|Purinergic Agents|purinergic agents|mesh-ancestor
110888649|NCT02247128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110888650|NCT01339481|Abatacept|abatacept|mesh-list
110888651|NCT01339481|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110888652|NCT01339481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110888653|NCT01339481|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110888654|NCT01339481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110888655|NCT01339481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110888656|NCT01339481|Immunologic Factors|immunologic factors|mesh-ancestor
110888657|NCT01339481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110888658|NCT01339481|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110888659|NCT01344031|Fulvestrant|fulvestrant|mesh-list
110888660|NCT01344031|Anastrozole|anastrozole|mesh-list
110888661|NCT01344031|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110888662|NCT01344031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110888663|NCT01344031|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110888664|NCT01344031|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110888665|NCT01344031|Hormone Antagonists|hormone antagonists|mesh-ancestor
110888666|NCT01344031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110888667|NCT01344031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110888668|NCT01344031|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110888669|NCT01344031|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110888670|NCT01344031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110888671|NCT01344031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110888673|NCT01332929|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110888674|NCT01332929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110199939|NCT00132418|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110888675|NCT01332929|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110888676|NCT01332929|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110888677|NCT01332929|Growth Substances|growth substances|mesh-ancestor
110888678|NCT01332929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110606182|NCT00393367|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110888679|NCT01332929|Growth Inhibitors|growth inhibitors|mesh-ancestor
110888680|NCT03566966|Antiviral Agents|antiviral agents|mesh-list
110888681|NCT03566966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110888682|NCT02247986|Methylphenidate|methylphenidate|mesh-list
110888683|NCT02247986|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110888684|NCT02247986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110888685|NCT02247986|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110888686|NCT02247986|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110888687|NCT02247986|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110888688|NCT02247986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110888690|NCT02247986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110888692|NCT03567434|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110888693|NCT03567434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110888694|NCT03567434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110888695|NCT03567434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110888696|NCT05708534|Abatacept|abatacept|mesh-list
110888697|NCT05708534|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110218830|NCT00110058|Interferon-alpha|interferon-alpha|mesh-list
110888698|NCT05708534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110888699|NCT05708534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110888700|NCT05708534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110888701|NCT05708534|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110888702|NCT05708534|Immunologic Factors|immunologic factors|mesh-ancestor
110888703|NCT05708534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110888704|NCT05708534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110888705|NCT03000374|Leucovorin|leucovorin|mesh-list
110888706|NCT03000374|Fluorouracil|fluorouracil|mesh-list
110888707|NCT03000374|Oxaliplatin|oxaliplatin|mesh-list
110888708|NCT03000374|Panitumumab|panitumumab|mesh-list
110888709|NCT03000374|Antimetabolites|antimetabolites|mesh-ancestor
110888710|NCT03000374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110888711|NCT03000374|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110888712|NCT03000374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110888713|NCT03000374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110888714|NCT03000374|Immunologic Factors|immunologic factors|mesh-ancestor
110888715|NCT03000374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110888716|NCT03000374|Antidotes|antidotes|mesh-ancestor
110888717|NCT03000374|Protective Agents|protective agents|mesh-ancestor
110888718|NCT03000374|Vitamin B Complex|vitamin b complex|mesh-ancestor
110888720|NCT03000374|Micronutrients|micronutrients|mesh-ancestor
110888721|NCT03000374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110888722|NCT03566576|Docetaxel|docetaxel|mesh-list
110888723|NCT03566576|Pemetrexed|pemetrexed|mesh-list
110888724|NCT03566576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110888725|NCT03566576|Tubulin Modulators|tubulin modulators|mesh-ancestor
110888726|NCT03566576|Antimitotic Agents|antimitotic agents|mesh-ancestor
110888727|NCT03566576|Mitosis Modulators|mitosis modulators|mesh-ancestor
110888728|NCT03566576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110888729|NCT03566576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110888730|NCT03566576|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110888731|NCT03566576|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110888732|NCT04377997|Heparin|heparin|mesh-list
110888733|NCT04377997|Calcium heparin|calcium heparin|mesh-list
110888734|NCT04377997|Enoxaparin|enoxaparin|mesh-list
110888735|NCT04377997|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
110888736|NCT04377997|Tinzaparin|tinzaparin|mesh-list
110888737|NCT04377997|Dalteparin|dalteparin|mesh-list
110888738|NCT04377997|Anticoagulants|anticoagulants|mesh-ancestor
110888739|NCT04377997|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110888740|NCT04377997|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110888741|NCT04377997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110888743|NCT01336049|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110888744|NCT01336049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110888745|NCT04758949|Nivolumab|nivolumab|mesh-list
110888746|NCT04758949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110888747|NCT04758949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110888748|NCT04758949|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110888749|NCT04758949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110888750|NCT03566030|Tenofovir|tenofovir|mesh-list
110606277|NCT01049425|Docetaxel|docetaxel|mesh-list
110888751|NCT03566030|Antiviral Agents|antiviral agents|mesh-ancestor
110888752|NCT03566030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110888753|NCT03566030|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110888754|NCT03566030|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110888755|NCT03566030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110888756|NCT03566030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110888757|NCT03566030|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110888758|NCT03566030|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110888759|NCT01333085|Paclitaxel|paclitaxel|mesh-list
110888760|NCT01333085|Carboplatin|carboplatin|mesh-list
110888761|NCT01333085|Everolimus|everolimus|mesh-list
110888762|NCT01333085|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110888763|NCT01333085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110888764|NCT01333085|Tubulin Modulators|tubulin modulators|mesh-ancestor
110888765|NCT01333085|Antimitotic Agents|antimitotic agents|mesh-ancestor
110888766|NCT01333085|Mitosis Modulators|mitosis modulators|mesh-ancestor
110888767|NCT01333085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110888768|NCT01333085|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110888769|NCT01333085|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110888771|NCT01333085|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110888772|NCT01333085|Immunologic Factors|immunologic factors|mesh-ancestor
110888773|NCT01333085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110888774|NCT01344655|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110888775|NCT01344655|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110888776|NCT01344655|Autonomic Agents|autonomic agents|mesh-ancestor
110888777|NCT01344655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110888778|NCT01344655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110888779|NCT01344655|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110888780|NCT01344655|Respiratory System Agents|respiratory system agents|mesh-ancestor
110888781|NCT01344655|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110888782|NCT01344655|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110888783|NCT01344655|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110888784|NCT01344655|Adrenergic Agents|adrenergic agents|mesh-ancestor
110888785|NCT01344655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110219265|NCT00110760|Sensory System Agents|sensory system agents|mesh-ancestor
110888786|NCT01344655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110888787|NCT03565406|Nivolumab|nivolumab|mesh-list
110888788|NCT03565406|Ipilimumab|ipilimumab|mesh-list
110888789|NCT03565406|Mocetinostat|mocetinostat|mesh-list
110888790|NCT03565406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110888791|NCT03565406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110888792|NCT03565406|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110199977|NCT00132886|Natriuretic Agents|natriuretic agents|mesh-ancestor
110888793|NCT03565406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110888794|NCT03565406|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110888795|NCT03565406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110888796|NCT04734379|Fasudil|fasudil|mesh-list
110888797|NCT04734379|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110888798|NCT04734379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110888799|NCT04734379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110888800|NCT04734379|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110888801|NCT04734379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110888802|NCT04734379|Vasodilator Agents|vasodilator agents|mesh-ancestor
110888803|NCT04734379|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110219405|NCT00077558|Fludarabine|fludarabine|mesh-list
110888804|NCT04734379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110888805|NCT01339871|Vorinostat|vorinostat|mesh-list
110888806|NCT01339871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110888807|NCT01339871|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110888808|NCT01339871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110888809|NCT01339871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110888810|NCT04693429|Bepotastine besilate|bepotastine besilate|mesh-list
110888811|NCT04693429|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110888812|NCT03564704|Cytarabine|cytarabine|mesh-list
110888813|NCT03564704|Dexamethasone|dexamethasone|mesh-list
110888814|NCT03564704|Cyclophosphamide|cyclophosphamide|mesh-list
110888815|NCT03564704|Methotrexate|methotrexate|mesh-list
110888816|NCT03564704|Etoposide|etoposide|mesh-list
110888817|NCT03564704|Vincristine|vincristine|mesh-list
110888818|NCT03564704|Doxorubicin|doxorubicin|mesh-list
110888819|NCT03564704|Mercaptopurine|mercaptopurine|mesh-list
110888820|NCT03564704|Idarubicin|idarubicin|mesh-list
110888821|NCT03564704|Pegaspargase|pegaspargase|mesh-list
110888822|NCT03564704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110888823|NCT03564704|Immunologic Factors|immunologic factors|mesh-ancestor
110888824|NCT03564704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110219465|NCT00111072|Hormones|hormones|mesh-ancestor
110888826|NCT03564704|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110888827|NCT03564704|Alkylating Agents|alkylating agents|mesh-ancestor
110606350|NCT00391807|Estradiol|estradiol|mesh-list
110888828|NCT03564704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110888829|NCT03564704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110888830|NCT03564704|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110888831|NCT03564704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110888832|NCT03564704|Antiemetics|antiemetics|mesh-ancestor
110888833|NCT03564704|Autonomic Agents|autonomic agents|mesh-ancestor
110888834|NCT03564704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110888835|NCT03564704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110888836|NCT03564704|Glucocorticoids|glucocorticoids|mesh-ancestor
110888838|NCT03564704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110888839|NCT03564704|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110888840|NCT03564704|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110888841|NCT03564704|Abortifacient Agents|abortifacient agents|mesh-ancestor
110888842|NCT03564704|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110888843|NCT03564704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110888845|NCT03564704|Dermatologic Agents|dermatologic agents|mesh-ancestor
110888846|NCT03564704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110199989|NCT00132925|Hormones|hormones|mesh-ancestor
110888847|NCT03564704|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110888848|NCT03564704|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110888849|NCT03564704|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110888850|NCT03564704|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110888851|NCT03564704|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110888852|NCT03564704|Antiviral Agents|antiviral agents|mesh-ancestor
110888853|NCT03564704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110888854|NCT03564704|Tubulin Modulators|tubulin modulators|mesh-ancestor
110888855|NCT03564704|Antimitotic Agents|antimitotic agents|mesh-ancestor
110219644|NCT00111345|Cladribine|cladribine|mesh-list
110888856|NCT03564704|Mitosis Modulators|mitosis modulators|mesh-ancestor
110888857|NCT03564704|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110888858|NCT03564548|Morphine|morphine|mesh-list
110888859|NCT03564548|Oxycodone|oxycodone|mesh-list
110888860|NCT03564548|Hydromorphone|hydromorphone|mesh-list
110888861|NCT03564548|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110888862|NCT03564548|Narcotics|narcotics|mesh-ancestor
110888863|NCT03564548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110888864|NCT03564548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110888865|NCT03564548|Analgesics|analgesics|mesh-ancestor
110888866|NCT03564548|Sensory System Agents|sensory system agents|mesh-ancestor
110888867|NCT03564548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110888869|NCT05353010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110888870|NCT05353010|Immunologic Factors|immunologic factors|mesh-ancestor
110888871|NCT05353010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110888872|NCT05353010|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110888873|NCT05353010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110888874|NCT05353010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110888875|NCT05352854|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110888876|NCT05352854|Pilocarpine|pilocarpine|mesh-list
110888877|NCT05352854|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110888879|NCT05352854|Autonomic Agents|autonomic agents|mesh-ancestor
110888880|NCT05352854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110888881|NCT05352854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110888882|NCT05352854|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
110888883|NCT05352854|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110888884|NCT05352854|Cholinergic Agents|cholinergic agents|mesh-ancestor
110888885|NCT05352854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110888886|NCT05352854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110888887|NCT01841177|Milrinone|milrinone|mesh-list
110888888|NCT01841177|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110888889|NCT01841177|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110888890|NCT01841177|Vasodilator Agents|vasodilator agents|mesh-ancestor
110888891|NCT01841177|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110888892|NCT01841177|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110888893|NCT01841177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110888894|NCT01841177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110888895|NCT01841177|Protective Agents|protective agents|mesh-ancestor
110219838|NCT00399464|Alfuzosin|alfuzosin|mesh-list
110888896|NCT01841177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110888897|NCT02838134|Rocuronium|rocuronium|mesh-list
110888898|NCT02838134|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110888899|NCT02838134|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110888900|NCT02838134|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110888901|NCT02838134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110888902|NCT02838134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110606414|NCT00828087|Cobalt|cobalt|mesh-list
110888904|NCT03150589|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110888905|NCT03150589|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110888906|NCT03150589|Growth Substances|growth substances|mesh-ancestor
110888907|NCT03150589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110888908|NCT03150589|Growth Inhibitors|growth inhibitors|mesh-ancestor
110888909|NCT03150589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110888910|NCT05708300|Vaccines|vaccines|mesh-list
110888911|NCT05708300|Immunologic Factors|immunologic factors|mesh-ancestor
110888912|NCT05708300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110888913|NCT05340452|Clarithromycin|clarithromycin|mesh-list
110888914|NCT05340452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110888915|NCT05340452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110888916|NCT05340452|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110888917|NCT05340452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110888918|NCT05340452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110219969|NCT00078260|Pemetrexed|pemetrexed|mesh-list
110888919|NCT05340452|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110888920|NCT05340452|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110888922|NCT03145207|Anesthetics, Local|anesthetics, local|mesh-ancestor
110888923|NCT03145207|Anesthetics|anesthetics|mesh-ancestor
110888924|NCT03145207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110888925|NCT03145207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110888926|NCT03145207|Sensory System Agents|sensory system agents|mesh-ancestor
110888927|NCT03145207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110888928|NCT03145207|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110888929|NCT03145207|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110888930|NCT03145207|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110888931|NCT03145207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110888932|NCT03145207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110888934|NCT02836652|Warfarin|warfarin|mesh-list
110888935|NCT02836652|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110888936|NCT02836652|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110888937|NCT02836652|Analgesics|analgesics|mesh-ancestor
110888938|NCT02836652|Sensory System Agents|sensory system agents|mesh-ancestor
110888939|NCT02836652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110888940|NCT02836652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110888941|NCT02836652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110888942|NCT02836652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110888943|NCT02836652|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110888944|NCT02836652|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110888945|NCT02836652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110888947|NCT02836652|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110888948|NCT02836652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110888949|NCT02836652|Antipyretics|antipyretics|mesh-ancestor
110888950|NCT02836652|Anticoagulants|anticoagulants|mesh-ancestor
110888951|NCT02836496|Prednisone|prednisone|mesh-list
110888952|NCT02836496|Prednisolone|prednisolone|mesh-list
110888953|NCT02836496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110888954|NCT02836496|Glucocorticoids|glucocorticoids|mesh-ancestor
110888955|NCT02836496|Hormones|hormones|mesh-ancestor
110888956|NCT02836496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110888957|NCT02836496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110888958|NCT02836496|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110888959|NCT02836496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110888960|NCT01344967|Zoledronic Acid|zoledronic acid|mesh-list
110888961|NCT01344967|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110888962|NCT01344967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110888963|NCT05250661|Propolis|propolis|mesh-list
110220139|NCT00112476|Sirolimus|sirolimus|mesh-list
110888964|NCT05250661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110888965|NCT04044781|BPN14770|bpn14770|mesh-list
110888966|NCT04044781|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
110888967|NCT04044781|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110888968|NCT04044781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110888969|NCT04044781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110888970|NCT01345279|Paclitaxel|paclitaxel|mesh-list
110888971|NCT01345279|Topotecan|topotecan|mesh-list
110888972|NCT01345279|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110888973|NCT01345279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110888974|NCT01345279|Tubulin Modulators|tubulin modulators|mesh-ancestor
110888975|NCT01345279|Antimitotic Agents|antimitotic agents|mesh-ancestor
110888976|NCT01345279|Mitosis Modulators|mitosis modulators|mesh-ancestor
110888977|NCT01345279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110888978|NCT01345279|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110220188|NCT00291772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110888979|NCT01345279|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110888980|NCT01345279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110888982|NCT02833844|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
110888983|NCT02833844|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110888984|NCT02833844|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110888985|NCT02833844|Antimetabolites|antimetabolites|mesh-ancestor
110888986|NCT02833844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110888987|NCT02833844|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110888988|NCT02833844|Protease Inhibitors|protease inhibitors|mesh-ancestor
110888989|NCT02833844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110888990|NCT02833844|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110888991|NCT01345357|Gemcitabine|gemcitabine|mesh-list
110888992|NCT01345357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110888993|NCT01345357|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110888994|NCT01345357|Antimetabolites|antimetabolites|mesh-ancestor
110888995|NCT01345357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110888996|NCT01333631|Valproic Acid|valproic acid|mesh-list
110888997|NCT01333631|Anticonvulsants|anticonvulsants|mesh-ancestor
110888998|NCT01333631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110888999|NCT01333631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110889000|NCT01333631|GABA Agents|gaba agents|mesh-ancestor
110889001|NCT01333631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110889002|NCT01333631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110889003|NCT01333631|Antimanic Agents|antimanic agents|mesh-ancestor
110889004|NCT01333631|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110889005|NCT01333631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110889006|NCT01333631|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110889007|NCT04611763|Flurbiprofen|flurbiprofen|mesh-list
110889008|NCT04611763|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
110889009|NCT04611763|Analgesics|analgesics|mesh-ancestor
110889010|NCT04611763|Sensory System Agents|sensory system agents|mesh-ancestor
110889011|NCT04611763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110889012|NCT04611763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110889013|NCT04611763|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110889014|NCT04611763|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110889015|NCT04611763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110889016|NCT04611763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110889017|NCT04611763|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110889018|NCT04611763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110889019|NCT04611763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110889020|NCT01341782|Ergocalciferols|ergocalciferols|mesh-list
110889021|NCT01341782|Calcitriol|calcitriol|mesh-list
110889022|NCT01341782|Maxacalcitol|maxacalcitol|mesh-list
110889023|NCT01341782|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110889024|NCT01341782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110889025|NCT01341782|Vitamins|vitamins|mesh-ancestor
110889026|NCT01341782|Micronutrients|micronutrients|mesh-ancestor
110889027|NCT01341782|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110889028|NCT01341782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110889029|NCT01341782|Dermatologic Agents|dermatologic agents|mesh-ancestor
110889030|NCT01341782|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110889031|NCT01341782|Protective Agents|protective agents|mesh-ancestor
110889032|NCT01341782|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
110889033|NCT01341782|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110889034|NCT01341782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110889035|NCT01341782|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110889036|NCT02250157|Irinotecan|irinotecan|mesh-list
110889037|NCT02250157|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110889038|NCT02250157|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110889039|NCT02250157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110889040|NCT02250157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110889041|NCT02250157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110889042|NCT05063149|Broncho-Vaxom|broncho-vaxom|mesh-list
110889043|NCT05063149|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110889044|NCT05063149|Immunologic Factors|immunologic factors|mesh-ancestor
110889045|NCT05063149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110889046|NCT03564158|Moxifloxacin|moxifloxacin|mesh-list
110889047|NCT03564158|Meropenem|meropenem|mesh-list
110889048|NCT03564158|Vaborbactam|vaborbactam|mesh-list
110889049|NCT03564158|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110889050|NCT03564158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110606557|NCT00839553|Minocycline|minocycline|mesh-list
110889051|NCT03564158|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110889052|NCT03564158|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110889054|NCT03564158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110889055|NCT03564158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110889056|NCT03564158|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110889057|NCT02677298|Botulinum Toxins|botulinum toxins|mesh-list
110889058|NCT02677298|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110889059|NCT02677298|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110889060|NCT02677298|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110889061|NCT02677298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110889062|NCT02677298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110889063|NCT02677298|Cholinergic Agents|cholinergic agents|mesh-ancestor
110889064|NCT02677298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110889065|NCT02677298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110889067|NCT02677298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110889068|NCT01345981|Lidocaine|lidocaine|mesh-list
110889069|NCT01345981|Anesthetics, Local|anesthetics, local|mesh-ancestor
110889070|NCT01345981|Anesthetics|anesthetics|mesh-ancestor
110889071|NCT01345981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110889072|NCT01345981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110889073|NCT01345981|Sensory System Agents|sensory system agents|mesh-ancestor
110889074|NCT01345981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110889076|NCT01345981|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110889077|NCT01345981|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110889078|NCT01345981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110889079|NCT01345981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110889080|NCT00871351|Atorvastatin|atorvastatin|mesh-list
110889081|NCT00871351|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110889082|NCT00871351|Ezetimibe|ezetimibe|mesh-list
110889083|NCT00871351|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110889084|NCT00871351|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110889085|NCT00871351|Antimetabolites|antimetabolites|mesh-ancestor
110889086|NCT00871351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110889087|NCT00871351|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110889088|NCT00871351|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110889089|NCT00871351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110889090|NCT04920331|Erenumab|erenumab|mesh-list
110220558|NCT00079352|Growth Substances|growth substances|mesh-ancestor
110889091|NCT04920331|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
110889092|NCT04920331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110889093|NCT04920331|Analgesics|analgesics|mesh-ancestor
110889094|NCT04920331|Sensory System Agents|sensory system agents|mesh-ancestor
110889095|NCT04920331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110889096|NCT04920331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110889098|NCT02745080|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110889099|NCT02745080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110889100|NCT02745080|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110889101|NCT01346137|Meloxicam|meloxicam|mesh-list
110889102|NCT01346137|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110889103|NCT01346137|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110889104|NCT01346137|Analgesics|analgesics|mesh-ancestor
110889105|NCT01346137|Sensory System Agents|sensory system agents|mesh-ancestor
110889106|NCT01346137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110889107|NCT01346137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110889108|NCT01346137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110889109|NCT01346137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110889110|NCT01346137|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110889111|NCT01346137|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110889112|NCT01346137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110889113|NCT01346137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110889114|NCT00521599|Mometasone Furoate|mometasone furoate|mesh-list
110889115|NCT00521599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110889116|NCT00521599|Dermatologic Agents|dermatologic agents|mesh-ancestor
110889117|NCT00521599|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110889118|NCT00442897|Atorvastatin|atorvastatin|mesh-list
110889119|NCT00442897|Simvastatin|simvastatin|mesh-list
110889120|NCT00442897|Ezetimibe|ezetimibe|mesh-list
110889121|NCT00442897|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110889122|NCT00442897|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110889123|NCT00442897|Antimetabolites|antimetabolites|mesh-ancestor
110200094|NCT00133354|Anastrozole|anastrozole|mesh-list
110889124|NCT00442897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110889125|NCT00442897|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110889126|NCT00442897|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110889127|NCT00442897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110889129|NCT01346215|Calcium heparin|calcium heparin|mesh-list
110889130|NCT01346215|Anticoagulants|anticoagulants|mesh-ancestor
110889131|NCT01346215|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110889132|NCT01346215|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110889133|NCT01346215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110889134|NCT02834390|Cytarabine|cytarabine|mesh-list
110889135|NCT02834390|Daunorubicin|daunorubicin|mesh-list
110889137|NCT02834390|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110889138|NCT02834390|Antimetabolites|antimetabolites|mesh-ancestor
110889139|NCT02834390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110889140|NCT02834390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110889141|NCT02834390|Antiviral Agents|antiviral agents|mesh-ancestor
110889142|NCT02834390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110889143|NCT02834390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110889144|NCT02834390|Immunologic Factors|immunologic factors|mesh-ancestor
110889145|NCT02834390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110220868|NCT00418171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110220869|NCT00418171|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110220870|NCT00418171|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110220871|NCT00418171|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110220872|NCT00418171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110220873|NCT00418171|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110220874|NCT00418171|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110220875|NCT00418171|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110889146|NCT02834390|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110889147|NCT02834390|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110889148|NCT02834390|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110889149|NCT02834390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110889150|NCT01317433|Doxycycline|doxycycline|mesh-list
110889151|NCT01317433|Cetuximab|cetuximab|mesh-list
110889152|NCT01317433|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110889153|NCT01317433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110889154|NCT01317433|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110889155|NCT01317433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110889157|NCT01317433|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110889158|NCT01317433|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110889159|NCT01317511|Caseins|caseins|mesh-list
110889160|NCT01317511|Chelating Agents|chelating agents|mesh-ancestor
110889161|NCT01317511|Sequestering Agents|sequestering agents|mesh-ancestor
110889162|NCT01317511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110889163|NCT01356602|Triamcinolone|triamcinolone|mesh-list
110889164|NCT01356602|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110889165|NCT01356602|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110889166|NCT01356602|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110889167|NCT01356602|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110889168|NCT01356602|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110889169|NCT01356602|Glucocorticoids|glucocorticoids|mesh-ancestor
110889170|NCT01356602|Hormones|hormones|mesh-ancestor
110889171|NCT01356602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110889172|NCT01356602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110889173|NCT01356602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110889174|NCT01356602|Immunologic Factors|immunologic factors|mesh-ancestor
110889175|NCT01356602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110889176|NCT01356602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110889177|NCT01347853|Ketorolac|ketorolac|mesh-list
110889178|NCT01347853|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
110889179|NCT01347853|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110889180|NCT01347853|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110889181|NCT01347853|Analgesics|analgesics|mesh-ancestor
110889182|NCT01347853|Sensory System Agents|sensory system agents|mesh-ancestor
110889183|NCT01347853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110889184|NCT01347853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110889185|NCT01347853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110889186|NCT01347853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110889187|NCT01347853|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110889188|NCT01347853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110889189|NCT01347853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110889190|NCT01346917|Lidocaine|lidocaine|mesh-list
110889191|NCT01346917|Anesthetics, Local|anesthetics, local|mesh-ancestor
110889192|NCT01346917|Anesthetics|anesthetics|mesh-ancestor
110889193|NCT01346917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110889194|NCT01346917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110889195|NCT01346917|Sensory System Agents|sensory system agents|mesh-ancestor
110889196|NCT01346917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110889197|NCT01346917|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110889198|NCT01346917|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110889200|NCT01346917|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110889201|NCT01346917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110889202|NCT01348009|Cisplatin|cisplatin|mesh-list
110889203|NCT01348009|Capecitabine|capecitabine|mesh-list
110889204|NCT01348009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110889205|NCT01348009|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110889206|NCT01348009|Antimetabolites|antimetabolites|mesh-ancestor
110889207|NCT01348009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110221230|NCT00086775|Rituximab|rituximab|mesh-list
110889208|NCT01343173|Imatinib Mesylate|imatinib mesylate|mesh-list
110889209|NCT01343173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110889210|NCT01343173|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110889211|NCT01343173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110889212|NCT01343173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110889213|NCT01348243|Clodronic Acid|clodronic acid|mesh-list
110889214|NCT01348243|Lidocaine|lidocaine|mesh-list
110889215|NCT01348243|Anesthetics, Local|anesthetics, local|mesh-ancestor
110889216|NCT01348243|Anesthetics|anesthetics|mesh-ancestor
110889217|NCT01348243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110889218|NCT01348243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110889219|NCT01348243|Sensory System Agents|sensory system agents|mesh-ancestor
110921741|NCT05298085|Oxytocin|oxytocin|mesh-list
110889221|NCT01348243|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110889222|NCT01348243|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110889223|NCT01348243|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110889224|NCT01348243|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110221357|NCT00120120|Growth Substances|growth substances|mesh-ancestor
110889225|NCT01348243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110889227|NCT01348321|Levamisole|levamisole|mesh-list
110889228|NCT01348321|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110889229|NCT01348321|Immunologic Factors|immunologic factors|mesh-ancestor
110889230|NCT01348321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110889231|NCT01348321|Antinematodal Agents|antinematodal agents|mesh-ancestor
110889232|NCT01348321|Anthelmintics|anthelmintics|mesh-ancestor
110889233|NCT01348321|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110889234|NCT01348321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110889235|NCT01348321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110889236|NCT03772951|Clozapine|clozapine|mesh-list
110889237|NCT03772951|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110889238|NCT03772951|Serotonin Agents|serotonin agents|mesh-ancestor
110889239|NCT03772951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110889240|NCT03772951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110889241|NCT03772951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110889242|NCT03772951|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110889243|NCT03772951|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110889244|NCT03772951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110889245|NCT03772951|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110889246|NCT03772951|GABA Antagonists|gaba antagonists|mesh-ancestor
110889247|NCT03772951|GABA Agents|gaba agents|mesh-ancestor
110889248|NCT01343329|Propranolol|propranolol|mesh-list
110889250|NCT01343329|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110889252|NCT01343329|Adrenergic Agents|adrenergic agents|mesh-ancestor
110889253|NCT01343329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110889254|NCT01343329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110889255|NCT01343329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110889256|NCT01343329|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110889257|NCT01343329|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110889258|NCT01343329|Vasodilator Agents|vasodilator agents|mesh-ancestor
110889259|NCT01343329|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110889260|NCT01317589|Fentanyl|fentanyl|mesh-list
110889261|NCT01317589|Methadone|methadone|mesh-list
110889262|NCT01317589|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110889263|NCT01317589|Narcotics|narcotics|mesh-ancestor
110889264|NCT01317589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110889265|NCT01317589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110221559|NCT00120198|Rituximab|rituximab|mesh-list
110889266|NCT01317589|Analgesics|analgesics|mesh-ancestor
110889267|NCT01317589|Sensory System Agents|sensory system agents|mesh-ancestor
110889268|NCT01317589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110889269|NCT01317589|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110889270|NCT01317589|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110889271|NCT01317589|Anesthetics, General|anesthetics, general|mesh-ancestor
110889272|NCT01317589|Anesthetics|anesthetics|mesh-ancestor
110889273|NCT01317589|Antitussive Agents|antitussive agents|mesh-ancestor
110889274|NCT01317589|Respiratory System Agents|respiratory system agents|mesh-ancestor
110889275|NCT02825420|Trabectedin|trabectedin|mesh-list
110889276|NCT02825420|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110889277|NCT02825420|Alkylating Agents|alkylating agents|mesh-ancestor
110889278|NCT02825420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110889279|NCT02825420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110889280|NCT02829944|Ketorolac|ketorolac|mesh-list
110889281|NCT02829944|Ropivacaine|ropivacaine|mesh-list
110889282|NCT02829944|Anesthetics, Local|anesthetics, local|mesh-ancestor
110889283|NCT02829944|Anesthetics|anesthetics|mesh-ancestor
110889284|NCT02829944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110889285|NCT02829944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110889286|NCT02829944|Sensory System Agents|sensory system agents|mesh-ancestor
110889287|NCT02829944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110921759|NCT05288153|Metformin|metformin|mesh-list
110889288|NCT02829944|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110889289|NCT02829944|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110889290|NCT02829944|Analgesics|analgesics|mesh-ancestor
110889291|NCT02829944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110889292|NCT02829944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110889293|NCT02829944|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110889294|NCT02829944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110889295|NCT02829944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110889296|NCT04014530|Pembrolizumab|pembrolizumab|mesh-list
110889297|NCT04014530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110889298|NCT04014530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110889299|NCT04014530|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110889300|NCT04014530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110889302|NCT03563534|Cariostatic Agents|cariostatic agents|mesh-ancestor
110889303|NCT03563534|Protective Agents|protective agents|mesh-ancestor
110889304|NCT03563534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110889305|NCT03563144|Leucovorin|leucovorin|mesh-list
110889306|NCT03563144|Paclitaxel|paclitaxel|mesh-list
110889307|NCT03563144|Cyclophosphamide|cyclophosphamide|mesh-list
110889308|NCT03563144|Bevacizumab|bevacizumab|mesh-list
110889309|NCT03563144|Gemcitabine|gemcitabine|mesh-list
110889310|NCT03563144|Fluorouracil|fluorouracil|mesh-list
110889311|NCT03563144|Capecitabine|capecitabine|mesh-list
110889312|NCT03563144|Oxaliplatin|oxaliplatin|mesh-list
110889313|NCT03563144|Avelumab|avelumab|mesh-list
110889314|NCT03563144|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110889315|NCT03563144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110889316|NCT03563144|Tubulin Modulators|tubulin modulators|mesh-ancestor
110889317|NCT03563144|Antimitotic Agents|antimitotic agents|mesh-ancestor
110889318|NCT03563144|Mitosis Modulators|mitosis modulators|mesh-ancestor
110889319|NCT03563144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110889320|NCT03563144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110889321|NCT03563144|Immunologic Factors|immunologic factors|mesh-ancestor
110889322|NCT03563144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110889323|NCT03563144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110889324|NCT03563144|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110889325|NCT03563144|Alkylating Agents|alkylating agents|mesh-ancestor
110889326|NCT03563144|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110889327|NCT03563144|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110221857|NCT00081848|Metronidazole|metronidazole|mesh-list
110889329|NCT03563144|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110889330|NCT03563144|Growth Substances|growth substances|mesh-ancestor
110889331|NCT03563144|Growth Inhibitors|growth inhibitors|mesh-ancestor
110889332|NCT03563144|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110889333|NCT03563144|Antimetabolites|antimetabolites|mesh-ancestor
110889334|NCT03563144|Antidotes|antidotes|mesh-ancestor
110889335|NCT03563144|Protective Agents|protective agents|mesh-ancestor
110889336|NCT03563144|Vitamin B Complex|vitamin b complex|mesh-ancestor
110889337|NCT03563144|Vitamins|vitamins|mesh-ancestor
110889338|NCT03563144|Micronutrients|micronutrients|mesh-ancestor
110889339|NCT01338818|Methylphenidate|methylphenidate|mesh-list
110889340|NCT01338818|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110889341|NCT01338818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110889342|NCT01338818|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110889343|NCT01338818|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110221925|NCT00304018|Prednisone|prednisone|mesh-list
110889344|NCT01338818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110889345|NCT01338818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110889346|NCT01338818|Dopamine Agents|dopamine agents|mesh-ancestor
110606869|NCT00833079|Tacrolimus|tacrolimus|mesh-list
110889347|NCT01338818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110889348|NCT05310110|Lidocaine|lidocaine|mesh-list
110889349|NCT05310110|Propofol|propofol|mesh-list
110889350|NCT05310110|Cisatracurium|cisatracurium|mesh-list
110889351|NCT05310110|Atracurium|atracurium|mesh-list
110889352|NCT05310110|Anesthetics, Local|anesthetics, local|mesh-ancestor
110063518|NCT02639065|Durvalumab|durvalumab|mesh-list
110889353|NCT05310110|Anesthetics|anesthetics|mesh-ancestor
110889354|NCT05310110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110889355|NCT05310110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110889356|NCT05310110|Sensory System Agents|sensory system agents|mesh-ancestor
110889357|NCT05310110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110889358|NCT05310110|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110889359|NCT05310110|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110889360|NCT05310110|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110889361|NCT05310110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110889362|NCT05310110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110889363|NCT05310110|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110889364|NCT05310110|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110889365|NCT05310110|Anesthetics, General|anesthetics, general|mesh-ancestor
110889366|NCT05310110|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110889367|NCT05310110|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110889368|NCT05310110|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110889369|NCT05310110|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
110889370|NCT05310110|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110889371|NCT05310110|Cholinergic Agents|cholinergic agents|mesh-ancestor
110889372|NCT05310110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110889373|NCT02823470|Ivacaftor|ivacaftor|mesh-list
110889374|NCT02823470|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
110889375|NCT02823470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110222042|NCT00304681|Dopamine Agents|dopamine agents|mesh-ancestor
110889376|NCT02823470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110889377|NCT03562754|Heparin|heparin|mesh-list
110889378|NCT03562754|Anticoagulants|anticoagulants|mesh-ancestor
110889379|NCT03562754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110889380|NCT03562754|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110889381|NCT03562754|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110889382|NCT02259920|p-Hydroxyamphetamine|p-hydroxyamphetamine|mesh-list
110889383|NCT02259920|Mydriatics|mydriatics|mesh-ancestor
110889384|NCT02259920|Autonomic Agents|autonomic agents|mesh-ancestor
110889385|NCT02259920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110889386|NCT02259920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110889387|NCT02259920|Sympathomimetics|sympathomimetics|mesh-ancestor
110889388|NCT01371656|Levofloxacin|levofloxacin|mesh-list
110889389|NCT01371656|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110889390|NCT01371656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110889391|NCT01371656|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110889392|NCT01371656|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110889393|NCT01371656|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110889394|NCT01371656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110921781|NCT05190432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110889395|NCT01371656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110889396|NCT01371656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110889397|NCT01371656|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110889398|NCT01371656|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110889399|NCT04541888|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110889400|NCT04541888|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110889401|NCT01354964|Vitamin D|vitamin d|mesh-list
110889402|NCT01354964|Ergocalciferols|ergocalciferols|mesh-list
110889403|NCT01354964|Cholecalciferol|cholecalciferol|mesh-list
110889404|NCT01354964|Vitamins|vitamins|mesh-list
110889405|NCT01354964|Micronutrients|micronutrients|mesh-ancestor
110222149|NCT00305422|Dopamine Agents|dopamine agents|mesh-ancestor
110889406|NCT01354964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110889407|NCT01354964|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110200181|NCT00133744|Folic Acid|folic acid|mesh-list
110889408|NCT01354964|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110889409|NCT02259998|Dipyridamole|dipyridamole|mesh-list
110889410|NCT02259998|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110889411|NCT02259998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110889412|NCT02259998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110889413|NCT02259998|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110889414|NCT02259998|Vasodilator Agents|vasodilator agents|mesh-ancestor
110889415|NCT02035904|Morphine|morphine|mesh-list
110889416|NCT02035904|Levobupivacaine|levobupivacaine|mesh-list
110889417|NCT02035904|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110889418|NCT02035904|Narcotics|narcotics|mesh-ancestor
110889419|NCT02035904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110889420|NCT02035904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110889421|NCT02035904|Analgesics|analgesics|mesh-ancestor
110889422|NCT02035904|Sensory System Agents|sensory system agents|mesh-ancestor
110889423|NCT02035904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110889424|NCT02035904|Anesthetics, Local|anesthetics, local|mesh-ancestor
110889425|NCT02035904|Anesthetics|anesthetics|mesh-ancestor
110889426|NCT04110080|Anesthetics|anesthetics|mesh-list
110222282|NCT00087945|Lamivudine|lamivudine|mesh-list
110889427|NCT04110080|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110889428|NCT04110080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110889429|NCT02035982|Rivastigmine|rivastigmine|mesh-list
110889430|NCT02035982|Donepezil|donepezil|mesh-list
110889431|NCT02035982|Galantamine|galantamine|mesh-list
110889432|NCT02035982|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
110889433|NCT02035982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110889434|NCT02035982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110222352|NCT00083057|Paclitaxel|paclitaxel|mesh-list
110889435|NCT02035982|Cholinergic Agents|cholinergic agents|mesh-ancestor
110889436|NCT02035982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110889437|NCT02035982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110889438|NCT02035982|Nootropic Agents|nootropic agents|mesh-ancestor
110889439|NCT02035982|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110889440|NCT02035982|Autonomic Agents|autonomic agents|mesh-ancestor
110889441|NCT02035982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110889442|NCT02035982|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110889443|NCT02035982|Protective Agents|protective agents|mesh-ancestor
110889444|NCT05707832|Amphotericin B|amphotericin b|mesh-list
110889445|NCT05707832|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
110889446|NCT05707832|Cholesteryl sulfate|cholesteryl sulfate|mesh-list
110889447|NCT05707832|Amebicides|amebicides|mesh-ancestor
110889448|NCT05707832|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110889449|NCT05707832|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110889450|NCT05707832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110889451|NCT05707832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110889452|NCT05707832|Antifungal Agents|antifungal agents|mesh-ancestor
110889453|NCT05707832|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110889454|NCT05707832|Protease Inhibitors|protease inhibitors|mesh-ancestor
110889455|NCT05707832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110889456|NCT05707832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110889457|NCT05707832|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110889458|NCT05707832|Protective Agents|protective agents|mesh-ancestor
110889459|NCT05707832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110889460|NCT05707832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110889461|NCT02822222|Magnesium citrate|magnesium citrate|mesh-list
110889462|NCT02822222|Cathartics|cathartics|mesh-ancestor
110889463|NCT02822222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110889465|NCT02821910|Empagliflozin|empagliflozin|mesh-list
110889466|NCT02821910|Linagliptin|linagliptin|mesh-list
110889467|NCT02821910|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110889468|NCT02821910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110889469|NCT02821910|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110889470|NCT02821910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110889471|NCT02821910|Incretins|incretins|mesh-ancestor
110889472|NCT02821910|Hormones|hormones|mesh-ancestor
110889473|NCT02821910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110889474|NCT02821910|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110222536|NCT00308425|Mycophenolic Acid|mycophenolic acid|mesh-list
110889475|NCT02821910|Protease Inhibitors|protease inhibitors|mesh-ancestor
110889476|NCT02821910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110889477|NCT03819452|Vitamin D|vitamin d|mesh-list
110889478|NCT03819452|Vitamins|vitamins|mesh-ancestor
110889479|NCT03819452|Micronutrients|micronutrients|mesh-ancestor
110889480|NCT03819452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110889481|NCT03819452|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110889482|NCT03138655|Vedolizumab|vedolizumab|mesh-list
110889483|NCT03138655|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110889484|NCT05707520|Mycophenolic Acid|mycophenolic acid|mesh-list
110889485|NCT05707520|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110889486|NCT05707520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110889487|NCT05707520|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110889488|NCT05707520|Antitubercular Agents|antitubercular agents|mesh-ancestor
110889489|NCT05707520|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110889490|NCT05707520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110889491|NCT05707520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110889492|NCT05707520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110889493|NCT04412785|Cyclosporine|cyclosporine|mesh-list
110889494|NCT04412785|Cyclosporins|cyclosporins|mesh-list
110889495|NCT04412785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110889496|NCT04412785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110889497|NCT04412785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110889498|NCT04412785|Immunologic Factors|immunologic factors|mesh-ancestor
110889499|NCT04412785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110889500|NCT04412785|Antifungal Agents|antifungal agents|mesh-ancestor
110889501|NCT04412785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110889502|NCT04412785|Dermatologic Agents|dermatologic agents|mesh-ancestor
110889503|NCT04412785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110889504|NCT04412785|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110889505|NCT01352611|Baclofen|baclofen|mesh-list
110222657|NCT04727502|Analgesics|analgesics|mesh-ancestor
110889506|NCT01352611|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110889507|NCT01352611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110889508|NCT01352611|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110889509|NCT01352611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110889510|NCT01352611|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
110889511|NCT01352611|GABA Agonists|gaba agonists|mesh-ancestor
110889512|NCT01352611|GABA Agents|gaba agents|mesh-ancestor
110889513|NCT01352611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110889514|NCT01352611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110889515|NCT02819804|Nivolumab|nivolumab|mesh-list
110889516|NCT02819804|Dasatinib|dasatinib|mesh-list
110889517|NCT02819804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110222721|NCT00309556|Docetaxel|docetaxel|mesh-list
110889518|NCT02819804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110889519|NCT02819804|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110889520|NCT02819804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110889521|NCT02819804|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110889522|NCT02819804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110889523|NCT02819726|Rituximab|rituximab|mesh-list
110889524|NCT02819726|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110889525|NCT02819726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110889526|NCT02819726|Immunologic Factors|immunologic factors|mesh-ancestor
110889527|NCT02819726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110889528|NCT02819726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110889529|NCT02816138|Nicotine|nicotine|mesh-list
110889530|NCT02816138|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110889531|NCT02816138|Autonomic Agents|autonomic agents|mesh-ancestor
110889532|NCT02816138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110889533|NCT02816138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110889534|NCT02816138|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110889535|NCT02816138|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110889536|NCT02816138|Cholinergic Agents|cholinergic agents|mesh-ancestor
110889537|NCT02816138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110889538|NCT02816138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110889539|NCT02036060|Prednisone|prednisone|mesh-list
110889540|NCT02036060|Docetaxel|docetaxel|mesh-list
110889541|NCT02036060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110889542|NCT02036060|Tubulin Modulators|tubulin modulators|mesh-ancestor
110889543|NCT02036060|Antimitotic Agents|antimitotic agents|mesh-ancestor
110889544|NCT02036060|Mitosis Modulators|mitosis modulators|mesh-ancestor
110889545|NCT02036060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110889546|NCT02036060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110889547|NCT02036060|Glucocorticoids|glucocorticoids|mesh-ancestor
110889549|NCT02036060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110889550|NCT02036060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110889551|NCT02036060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110889552|NCT02036528|Doxycycline|doxycycline|mesh-list
110889553|NCT02036528|Ciprofloxacin|ciprofloxacin|mesh-list
110889554|NCT02036528|Gentamicins|gentamicins|mesh-list
110889555|NCT02036528|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110889556|NCT02036528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110889557|NCT02036528|Antimalarials|antimalarials|mesh-ancestor
110889558|NCT02036528|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110889559|NCT02036528|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110889560|NCT02036528|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110889561|NCT02036528|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110889562|NCT02036528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110889563|NCT02036528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110889564|NCT02036528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110889565|NCT02036528|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110889566|NCT02036528|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110889567|NCT02036528|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110889568|NCT02880865|Vaccines|vaccines|mesh-list
110889569|NCT02880865|Immunologic Factors|immunologic factors|mesh-ancestor
110889570|NCT02880865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110889571|NCT03635125|Metoprolol|metoprolol|mesh-list
110889572|NCT03635125|Nebivolol|nebivolol|mesh-list
110889573|NCT03635125|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110889574|NCT03635125|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110889575|NCT03635125|Sympatholytics|sympatholytics|mesh-ancestor
110889576|NCT03635125|Autonomic Agents|autonomic agents|mesh-ancestor
110223035|NCT00088998|Growth Substances|growth substances|mesh-ancestor
110889577|NCT03635125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110889578|NCT03635125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110889579|NCT03635125|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110889580|NCT03635125|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110889581|NCT03635125|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110889582|NCT03635125|Adrenergic Agents|adrenergic agents|mesh-ancestor
110889583|NCT03635125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110889584|NCT03635125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110889585|NCT03635125|Vasodilator Agents|vasodilator agents|mesh-ancestor
110200219|NCT00047099|Tubulin Modulators|tubulin modulators|mesh-ancestor
110889586|NCT03635125|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
110889587|NCT03635125|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110889588|NCT03635125|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110889590|NCT01854385|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110889591|NCT01854385|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110889592|NCT01854385|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110889593|NCT01854385|Serotonin Agents|serotonin agents|mesh-ancestor
110889594|NCT01854385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110889595|NCT01854385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110889596|NCT01854385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110889597|NCT02047838|Hormones|hormones|mesh-list
110889598|NCT02047838|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
110889599|NCT02047838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110223160|NCT00312130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110889600|NCT02047838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110889602|NCT01318681|Xhance|xhance|mesh-list
110889603|NCT01318681|Cetirizine|cetirizine|mesh-list
110889604|NCT01318681|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110889605|NCT01318681|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110889606|NCT01318681|Autonomic Agents|autonomic agents|mesh-ancestor
110889607|NCT01318681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110889608|NCT01318681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110889609|NCT01318681|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110889610|NCT01318681|Respiratory System Agents|respiratory system agents|mesh-ancestor
110889611|NCT01318681|Dermatologic Agents|dermatologic agents|mesh-ancestor
110889612|NCT01318681|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110889613|NCT01318681|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110889614|NCT01318681|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110889615|NCT01318681|Histamine Antagonists|histamine antagonists|mesh-ancestor
110889616|NCT01318681|Histamine Agents|histamine agents|mesh-ancestor
110889617|NCT01318681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110889618|NCT01318681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110889619|NCT03604159|Buprenorphine|buprenorphine|mesh-list
110889620|NCT03604159|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
110889621|NCT03604159|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110889622|NCT03604159|Narcotics|narcotics|mesh-ancestor
110889623|NCT03604159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110889624|NCT03604159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110889625|NCT03604159|Analgesics|analgesics|mesh-ancestor
110889626|NCT03604159|Sensory System Agents|sensory system agents|mesh-ancestor
110223287|NCT00293332|Bevacizumab|bevacizumab|mesh-list
110889627|NCT03604159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110889628|NCT03604159|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110889629|NCT03686930|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110889630|NCT01353235|Prednisolone|prednisolone|mesh-list
110889631|NCT01353235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110889632|NCT01353235|Glucocorticoids|glucocorticoids|mesh-ancestor
110889633|NCT01353235|Hormones|hormones|mesh-ancestor
110889634|NCT01353235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110889635|NCT01353235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110889636|NCT01353235|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110889637|NCT01353235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110889638|NCT02048228|Clopidogrel|clopidogrel|mesh-list
110889639|NCT02048228|Ticagrelor|ticagrelor|mesh-list
110889640|NCT02048228|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110889641|NCT02048228|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110889642|NCT02048228|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110889643|NCT02048228|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110889644|NCT02048228|Purinergic Agents|purinergic agents|mesh-ancestor
110889645|NCT02048228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110889646|NCT02048228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110889647|NCT02048228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110889648|NCT03046927|Vitamin D|vitamin d|mesh-list
110607171|NCT00830505|Hormones|hormones|mesh-ancestor
110889649|NCT03046927|Ergocalciferols|ergocalciferols|mesh-list
110889650|NCT03046927|Vitamins|vitamins|mesh-ancestor
110889651|NCT03046927|Micronutrients|micronutrients|mesh-ancestor
110889652|NCT03046927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110889653|NCT03046927|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110889654|NCT03046927|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110889655|NCT01349257|Formoterol Fumarate|formoterol fumarate|mesh-list
110889656|NCT01349257|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110889657|NCT01349257|Autonomic Agents|autonomic agents|mesh-ancestor
110889658|NCT01349257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110889659|NCT01349257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110889660|NCT01349257|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110889661|NCT01349257|Respiratory System Agents|respiratory system agents|mesh-ancestor
110889662|NCT01349257|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110889663|NCT01349257|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110889664|NCT01349257|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110889665|NCT01349257|Adrenergic Agents|adrenergic agents|mesh-ancestor
110889666|NCT01349257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110889667|NCT01349257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110889668|NCT03589105|Ocrelizumab|ocrelizumab|mesh-list
110889669|NCT03589105|Immunologic Factors|immunologic factors|mesh-ancestor
110889670|NCT03589105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110889671|NCT02048384|Metformin|metformin|mesh-list
110889672|NCT02048384|Sirolimus|sirolimus|mesh-list
110889673|NCT02048384|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110889674|NCT02048384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110889675|NCT02048384|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110889676|NCT02048384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110889677|NCT02048384|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110889678|NCT02048384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110889679|NCT02048384|Antifungal Agents|antifungal agents|mesh-ancestor
110889680|NCT02048384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110889681|NCT02048384|Immunologic Factors|immunologic factors|mesh-ancestor
110889682|NCT01353391|Metformin|metformin|mesh-list
110889683|NCT01353391|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110889684|NCT01353391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110889685|NCT01349335|Tolvaptan|tolvaptan|mesh-list
110889686|NCT01349335|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
110889687|NCT01349335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110889688|NCT01349335|Natriuretic Agents|natriuretic agents|mesh-ancestor
110889689|NCT01349335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110889690|NCT03009487|Amlodipine|amlodipine|mesh-list
110889691|NCT03009487|Olmesartan|olmesartan|mesh-list
110889692|NCT03009487|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
110889693|NCT03009487|Amlodipine Besylate, Olmesartan Medoxomil Drug Combination|amlodipine besylate, olmesartan medoxomil drug combination|mesh-list
110889694|NCT03009487|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110889695|NCT03009487|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110889696|NCT03009487|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110889697|NCT03009487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110889698|NCT03009487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110889699|NCT03009487|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110889700|NCT03009487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110889701|NCT03009487|Vasodilator Agents|vasodilator agents|mesh-ancestor
110889702|NCT03009487|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110889703|NCT03009487|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110889704|NCT03009487|Antimetabolites|antimetabolites|mesh-ancestor
110889705|NCT03009487|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110889706|NCT03009487|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110889707|NCT03009487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110889708|NCT03009487|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110889709|NCT03009487|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110889710|NCT02048540|Bevacizumab|bevacizumab|mesh-list
110889711|NCT02048540|Docetaxel|docetaxel|mesh-list
110889712|NCT02048540|Oxaliplatin|oxaliplatin|mesh-list
110921842|NCT05065866|Azacitidine|azacitidine|mesh-list
110889713|NCT02048540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110889714|NCT02048540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110889715|NCT02048540|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110889716|NCT02048540|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110889717|NCT02048540|Growth Substances|growth substances|mesh-ancestor
110889718|NCT02048540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110889719|NCT02048540|Growth Inhibitors|growth inhibitors|mesh-ancestor
110889720|NCT02048540|Tubulin Modulators|tubulin modulators|mesh-ancestor
110889721|NCT02048540|Antimitotic Agents|antimitotic agents|mesh-ancestor
110889722|NCT02048540|Mitosis Modulators|mitosis modulators|mesh-ancestor
110889723|NCT02048540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110889724|NCT01353469|Insulin|insulin|mesh-list
110889725|NCT01353469|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110889726|NCT01353469|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110889727|NCT01353469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110889728|NCT03562130|Teduglutide|teduglutide|mesh-list
110889729|NCT03562130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110889730|NCT03562130|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110889731|NCT03562130|Protective Agents|protective agents|mesh-ancestor
110889732|NCT03562130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110889733|NCT02050178|Paclitaxel|paclitaxel|mesh-list
110889734|NCT02050178|Gemcitabine|gemcitabine|mesh-list
110889735|NCT02050178|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110889736|NCT02050178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110889737|NCT02050178|Tubulin Modulators|tubulin modulators|mesh-ancestor
110889738|NCT02050178|Antimitotic Agents|antimitotic agents|mesh-ancestor
110889739|NCT02050178|Mitosis Modulators|mitosis modulators|mesh-ancestor
110889740|NCT02050178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110889741|NCT02050178|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110889742|NCT02050178|Antimetabolites|antimetabolites|mesh-ancestor
110889743|NCT02048852|Menthol|menthol|mesh-list
110889744|NCT02048852|Nicotine|nicotine|mesh-list
110889745|NCT02048852|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110889746|NCT02048852|Autonomic Agents|autonomic agents|mesh-ancestor
110889747|NCT02048852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110889748|NCT02048852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110889749|NCT02048852|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110889750|NCT02048852|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110889751|NCT02048852|Cholinergic Agents|cholinergic agents|mesh-ancestor
110889752|NCT02048852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110889753|NCT02048852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110889754|NCT02048852|Antipruritics|antipruritics|mesh-ancestor
110889755|NCT02048852|Dermatologic Agents|dermatologic agents|mesh-ancestor
110889756|NCT02048930|Budesonide|budesonide|mesh-list
110889757|NCT02048930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110889758|NCT02048930|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110889759|NCT02048930|Autonomic Agents|autonomic agents|mesh-ancestor
110889760|NCT02048930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110889761|NCT02048930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110889762|NCT02048930|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110889763|NCT02048930|Respiratory System Agents|respiratory system agents|mesh-ancestor
110889764|NCT02048930|Glucocorticoids|glucocorticoids|mesh-ancestor
110889765|NCT02048930|Hormones|hormones|mesh-ancestor
110889766|NCT02048930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110889767|NCT02049320|Remifentanil|remifentanil|mesh-list
110889768|NCT02049320|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110889769|NCT02049320|Narcotics|narcotics|mesh-ancestor
110889770|NCT02049320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110889771|NCT02049320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110889772|NCT02049320|Analgesics|analgesics|mesh-ancestor
110889773|NCT02049320|Sensory System Agents|sensory system agents|mesh-ancestor
110889774|NCT02049320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110921860|NCT05024045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110889775|NCT02050724|Technetium Tc 99m Aggregated Albumin|technetium tc 99m aggregated albumin|mesh-list
110889776|NCT02050724|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110889777|NCT02050724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110889778|NCT02050802|Moxifloxacin|moxifloxacin|mesh-list
110889779|NCT02050802|Macitentan|macitentan|mesh-list
110889780|NCT02050802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110889781|NCT02050802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110889782|NCT02050802|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110889783|NCT02050802|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110889784|NCT02050802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110889785|NCT02050802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110889786|NCT02050802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110889787|NCT02050802|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
110889788|NCT02050802|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
110889789|NCT02050802|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
110889790|NCT02051738|Mebendazole|mebendazole|mesh-list
110889791|NCT02051738|Piperazine|piperazine|mesh-list
110889792|NCT02051738|Piperazine citrate|piperazine citrate|mesh-list
110889793|NCT02051738|DMP 777|dmp 777|mesh-list
110889794|NCT02051738|Antinematodal Agents|antinematodal agents|mesh-ancestor
110889795|NCT02051738|Anthelmintics|anthelmintics|mesh-ancestor
110889796|NCT02051738|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110889797|NCT02051738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110889798|NCT02051738|Tubulin Modulators|tubulin modulators|mesh-ancestor
110889799|NCT02051738|Antimitotic Agents|antimitotic agents|mesh-ancestor
110889800|NCT02051738|Mitosis Modulators|mitosis modulators|mesh-ancestor
110889801|NCT02051738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110889802|NCT02051738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110889803|NCT02051738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110889804|NCT02050958|Ibuprofen|ibuprofen|mesh-list
110889805|NCT02050958|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110889806|NCT02050958|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110223389|NCT00293839|Oxybutynin|oxybutynin|mesh-list
110889807|NCT02050958|Analgesics|analgesics|mesh-ancestor
110889808|NCT02050958|Sensory System Agents|sensory system agents|mesh-ancestor
110889809|NCT02050958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110889810|NCT02050958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110889811|NCT02050958|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110889812|NCT02050958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110889813|NCT02050958|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110889814|NCT02050958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110889815|NCT02050958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110889816|NCT02037464|Capsaicin|capsaicin|mesh-list
110889817|NCT02037464|Antipruritics|antipruritics|mesh-ancestor
110889818|NCT02037464|Dermatologic Agents|dermatologic agents|mesh-ancestor
110889819|NCT02037464|Sensory System Agents|sensory system agents|mesh-ancestor
110889820|NCT02037464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110889821|NCT02037464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110889822|NCT01357603|Insulin Glargine|insulin glargine|mesh-list
110889823|NCT01357603|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110889824|NCT01357603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110889825|NCT02051894|Dobutamine|dobutamine|mesh-list
110889826|NCT02051894|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110889827|NCT02051894|Sympathomimetics|sympathomimetics|mesh-ancestor
110889828|NCT02051894|Autonomic Agents|autonomic agents|mesh-ancestor
110889829|NCT02051894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110889830|NCT02051894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110889831|NCT02051894|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
110889832|NCT02051894|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110889833|NCT02051894|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110889834|NCT02051894|Adrenergic Agents|adrenergic agents|mesh-ancestor
110889835|NCT02051894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110889836|NCT02051894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110889837|NCT02051894|Protective Agents|protective agents|mesh-ancestor
110889838|NCT01357681|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
110889840|NCT01357681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110889841|NCT01357681|Protective Agents|protective agents|mesh-ancestor
110889842|NCT01357681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110889843|NCT01357681|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
110889844|NCT01357681|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110889845|NCT01357681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110889846|NCT01357681|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110889847|NCT01543633|Propofol|propofol|mesh-list
110889848|NCT01543633|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110889849|NCT01543633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110889850|NCT01543633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110889851|NCT01543633|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110889852|NCT01543633|Anesthetics, General|anesthetics, general|mesh-ancestor
110889853|NCT01543633|Anesthetics|anesthetics|mesh-ancestor
110889854|NCT03561740|Capecitabine|capecitabine|mesh-list
110889855|NCT03561740|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110889856|NCT03561740|Antimetabolites|antimetabolites|mesh-ancestor
110889857|NCT03561740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110889858|NCT03561740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110889859|NCT01357759|Gimsilumab|gimsilumab|mesh-list
110889860|NCT01357759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110889861|NCT01357759|Antiviral Agents|antiviral agents|mesh-ancestor
110889862|NCT01357759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110889863|NCT02052128|Onapristone|onapristone|mesh-list
110889864|NCT02052128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110889865|NCT02052128|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110889866|NCT02052128|Fertility Agents|fertility agents|mesh-ancestor
110889867|NCT02052128|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110889868|NCT02052128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110889869|NCT02052128|Hormone Antagonists|hormone antagonists|mesh-ancestor
110889870|NCT02052128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110889871|NCT01349413|Esomeprazole|esomeprazole|mesh-list
110607394|NCT00844233|Irinotecan|irinotecan|mesh-list
110889872|NCT01349413|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110889873|NCT01349413|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110889874|NCT01349413|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110889875|NCT01349413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110889876|NCT01349413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110889877|NCT01349647|Vaccines|vaccines|mesh-list
110889878|NCT01349647|Immunologic Factors|immunologic factors|mesh-ancestor
110889879|NCT01349647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110889880|NCT02806232|Praziquantel|praziquantel|mesh-list
110889881|NCT02806232|Anthelmintics|anthelmintics|mesh-ancestor
110889882|NCT02806232|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110889883|NCT02806232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110889884|NCT02908087|Liraglutide|liraglutide|mesh-list
110889885|NCT02908087|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110889886|NCT02908087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110889887|NCT02908087|Incretins|incretins|mesh-ancestor
110889888|NCT02908087|Hormones|hormones|mesh-ancestor
110889889|NCT02908087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110889890|NCT02053766|Dexmedetomidine|dexmedetomidine|mesh-list
110889891|NCT02053766|Propofol|propofol|mesh-list
110889892|NCT02053766|Sevoflurane|sevoflurane|mesh-list
110889893|NCT02053766|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110889894|NCT02053766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110889895|NCT02053766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110889896|NCT02053766|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110889898|NCT02053766|Sensory System Agents|sensory system agents|mesh-ancestor
110889899|NCT02053766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110889900|NCT02053766|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110889901|NCT02053766|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110889902|NCT02053766|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110889903|NCT02053766|Adrenergic Agents|adrenergic agents|mesh-ancestor
110889904|NCT02053766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110889905|NCT02053766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110889906|NCT02053766|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110889907|NCT02053766|Anesthetics, General|anesthetics, general|mesh-ancestor
110889908|NCT02053766|Anesthetics|anesthetics|mesh-ancestor
110889909|NCT02053766|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110889910|NCT02053766|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110889911|NCT02053922|Misoprostol|misoprostol|mesh-list
110889912|NCT02053922|Oxytocin|oxytocin|mesh-list
110889913|NCT02053922|Carbetocin|carbetocin|mesh-list
110889914|NCT02053922|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110889915|NCT02053922|Abortifacient Agents|abortifacient agents|mesh-ancestor
110889916|NCT02053922|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110889917|NCT02053922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110889918|NCT02053922|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110889919|NCT02053922|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110889920|NCT02053922|Oxytocics|oxytocics|mesh-ancestor
110889921|NCT02054000|Tirofiban|tirofiban|mesh-list
110889922|NCT02054000|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110889923|NCT02054000|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110889924|NCT02054000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110889925|NCT02054000|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110889926|NCT02054078|Bevacizumab|bevacizumab|mesh-list
110889927|NCT02054078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110889928|NCT02054078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110889929|NCT02054078|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110889930|NCT02054078|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110889931|NCT02054078|Growth Substances|growth substances|mesh-ancestor
110889932|NCT02054078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110921917|NCT04745026|Cannabidiol|cannabidiol|mesh-list
110889933|NCT02054078|Growth Inhibitors|growth inhibitors|mesh-ancestor
110889934|NCT00392327|Vitamin A|vitamin a|mesh-list
110889935|NCT00392327|Cyclophosphamide|cyclophosphamide|mesh-list
110889936|NCT00392327|Cisplatin|cisplatin|mesh-list
110889937|NCT00392327|Carboplatin|carboplatin|mesh-list
110889938|NCT00392327|Vincristine|vincristine|mesh-list
110889939|NCT00392327|Tretinoin|tretinoin|mesh-list
110889940|NCT00392327|Isotretinoin|isotretinoin|mesh-list
110889941|NCT00392327|Lenograstim|lenograstim|mesh-list
110889942|NCT00392327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110889943|NCT00392327|Immunologic Factors|immunologic factors|mesh-ancestor
110889944|NCT00392327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110889945|NCT00392327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110889946|NCT00392327|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110889947|NCT00392327|Alkylating Agents|alkylating agents|mesh-ancestor
110889948|NCT00392327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110889949|NCT00392327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110889950|NCT00392327|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110889951|NCT00392327|Vitamins|vitamins|mesh-ancestor
110889952|NCT00392327|Micronutrients|micronutrients|mesh-ancestor
110889953|NCT00392327|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110889954|NCT00392327|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110889955|NCT00392327|Tubulin Modulators|tubulin modulators|mesh-ancestor
110889956|NCT00392327|Antimitotic Agents|antimitotic agents|mesh-ancestor
110889957|NCT00392327|Mitosis Modulators|mitosis modulators|mesh-ancestor
110889958|NCT00392327|Keratolytic Agents|keratolytic agents|mesh-ancestor
110889959|NCT00392327|Dermatologic Agents|dermatologic agents|mesh-ancestor
110889960|NCT01336439|Botulinum Toxins|botulinum toxins|mesh-list
110889961|NCT01336439|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110889962|NCT01336439|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110889963|NCT01336439|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110889964|NCT01336439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110889965|NCT01336439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110889966|NCT01336439|Cholinergic Agents|cholinergic agents|mesh-ancestor
110889967|NCT01336439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110889968|NCT01336439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110889969|NCT01336439|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110889970|NCT01336439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110889971|NCT01336595|Cobalt|cobalt|mesh-list
110889972|NCT01336595|Triamcinolone|triamcinolone|mesh-list
110889973|NCT01336595|Trace Elements|trace elements|mesh-ancestor
110889974|NCT01336595|Micronutrients|micronutrients|mesh-ancestor
110889975|NCT01336595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110889976|NCT01336595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110889977|NCT01336595|Glucocorticoids|glucocorticoids|mesh-ancestor
110889978|NCT01336595|Hormones|hormones|mesh-ancestor
110889979|NCT01336595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110889980|NCT01336751|Insulin|insulin|mesh-list
110889981|NCT01336751|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110889982|NCT01336751|Insulin Glargine|insulin glargine|mesh-list
110889983|NCT01336751|Insulin Lispro|insulin lispro|mesh-list
110889984|NCT01336751|Protamines|protamines|mesh-list
110889985|NCT01336751|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110889986|NCT01336751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110889987|NCT01336751|Heparin Antagonists|heparin antagonists|mesh-ancestor
110921943|NCT04504331|Tamoxifen|tamoxifen|mesh-list
110889988|NCT01336751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110889989|NCT01336751|Coagulants|coagulants|mesh-ancestor
110889990|NCT01336829|Rilpivirine|rilpivirine|mesh-list
110889991|NCT01336829|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110889992|NCT01336829|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110889993|NCT01336829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110889994|NCT01336829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110889995|NCT01336829|Antiviral Agents|antiviral agents|mesh-ancestor
110889996|NCT01336829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110200337|NCT00080886|Cytarabine|cytarabine|mesh-list
110889997|NCT01336829|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110889998|NCT01336829|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110889999|NCT02960490|Quetmolimab|quetmolimab|mesh-list
110890000|NCT02960490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110890001|NCT05184179|Olmesartan|olmesartan|mesh-list
110890002|NCT05184179|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
110890003|NCT05184179|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110890004|NCT05184179|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110890005|NCT05184179|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110890006|NCT05184179|Antimetabolites|antimetabolites|mesh-ancestor
110890007|NCT05184179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110890008|NCT05184179|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110890009|NCT05184179|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110890010|NCT05184179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110890011|NCT05184179|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110890012|NCT05184179|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110890013|NCT05184179|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110890014|NCT05163834|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110890015|NCT05163834|Immunologic Factors|immunologic factors|mesh-ancestor
110890016|NCT05163834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110890017|NCT01065012|Udenafil|udenafil|mesh-list
110223401|NCT00293917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110890018|NCT01065012|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110890019|NCT01065012|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110890020|NCT01065012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110890021|NCT01065012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110890022|NCT01315691|Amikacin|amikacin|mesh-list
110890023|NCT01315691|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110890024|NCT01315691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110890025|NCT05654090|Sulbactam|sulbactam|mesh-list
110890027|NCT05654090|Sulperazone|sulperazone|mesh-list
110890028|NCT05654090|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110890029|NCT05654090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110890030|NCT05654090|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110890031|NCT05654090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110890032|NCT05654090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110890033|NCT05654090|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110890034|NCT02054468|Remifentanil|remifentanil|mesh-list
110890035|NCT02054468|Propofol|propofol|mesh-list
110890036|NCT02054468|Rocuronium|rocuronium|mesh-list
110890037|NCT02054468|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110890038|NCT02054468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110890039|NCT02054468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110890040|NCT02054468|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110890041|NCT02054468|Anesthetics, General|anesthetics, general|mesh-ancestor
110890042|NCT02054468|Anesthetics|anesthetics|mesh-ancestor
110890043|NCT02054468|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110890044|NCT02054468|Narcotics|narcotics|mesh-ancestor
110890045|NCT02054468|Analgesics|analgesics|mesh-ancestor
110890046|NCT02054468|Sensory System Agents|sensory system agents|mesh-ancestor
110890047|NCT02054468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110890048|NCT02054468|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110890049|NCT02054468|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110890050|NCT02054468|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110890051|NCT03640650|Triamcinolone|triamcinolone|mesh-list
110890052|NCT03640650|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110890053|NCT03640650|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110890054|NCT03640650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
110890055|NCT03640650|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110890056|NCT03640650|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110890057|NCT03640650|Glucocorticoids|glucocorticoids|mesh-ancestor
110890058|NCT03640650|Hormones|hormones|mesh-ancestor
110890059|NCT03640650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110890060|NCT03640650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110890061|NCT03640650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110890062|NCT03640650|Immunologic Factors|immunologic factors|mesh-ancestor
110890063|NCT03640650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110890064|NCT03640650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110890065|NCT03640650|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110890066|NCT05183555|Edotreotide|edotreotide|mesh-list
110890067|NCT05183555|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110890068|NCT05183555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110890069|NCT02052908|Naproxen|naproxen|mesh-list
110890070|NCT02052908|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110890071|NCT02052908|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110890072|NCT02052908|Analgesics|analgesics|mesh-ancestor
110890073|NCT02052908|Sensory System Agents|sensory system agents|mesh-ancestor
110890074|NCT02052908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110890075|NCT02052908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110890076|NCT02052908|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110890077|NCT02052908|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110890078|NCT02052908|Gout Suppressants|gout suppressants|mesh-ancestor
110890079|NCT02052908|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110890080|NCT02052908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110890081|NCT02052908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110890082|NCT01336985|Irinotecan|irinotecan|mesh-list
110890083|NCT01336985|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110890084|NCT01336985|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110890085|NCT01336985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110890086|NCT01336985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110890087|NCT01336985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110890088|NCT01337375|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110890090|NCT01337375|Antiviral Agents|antiviral agents|mesh-ancestor
110890091|NCT01337375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110890092|NCT01337375|Immunologic Factors|immunologic factors|mesh-ancestor
110890093|NCT01337375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110890094|NCT03635411|Niacinamide|niacinamide|mesh-list
110890095|NCT03635411|Niacin|niacin|mesh-list
110890096|NCT03635411|Nicotinic Acids|nicotinic acids|mesh-list
110890097|NCT03635411|Vitamin B Complex|vitamin b complex|mesh-ancestor
110890098|NCT03635411|Vitamins|vitamins|mesh-ancestor
110890099|NCT03635411|Micronutrients|micronutrients|mesh-ancestor
110607604|NCT04013386|Serotonin Agents|serotonin agents|mesh-ancestor
110890100|NCT03635411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110890101|NCT03635411|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110890102|NCT03635411|Antimetabolites|antimetabolites|mesh-ancestor
110890103|NCT03635411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110890104|NCT03635411|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110890105|NCT03635411|Vasodilator Agents|vasodilator agents|mesh-ancestor
110890106|NCT02748512|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
110890107|NCT02748512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110890108|NCT02748512|Glucocorticoids|glucocorticoids|mesh-ancestor
110890109|NCT02748512|Hormones|hormones|mesh-ancestor
110890110|NCT02748512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110890111|NCT02748512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110890112|NCT01341041|Chlorine dioxide|chlorine dioxide|mesh-list
110890113|NCT01341041|Dental Disinfectants|dental disinfectants|mesh-ancestor
110890114|NCT01341041|Disinfectants|disinfectants|mesh-ancestor
110890115|NCT01341041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110890116|NCT02053142|Acyclovir|acyclovir|mesh-list
110890117|NCT02053142|Antiviral Agents|antiviral agents|mesh-ancestor
110890118|NCT02053142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110890119|NCT01316549|Fludarabine|fludarabine|mesh-list
110890120|NCT01316549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110890121|NCT03439657|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110890122|NCT03439657|Immunologic Factors|immunologic factors|mesh-ancestor
110890123|NCT03439657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110890124|NCT01341743|Entecavir|entecavir|mesh-list
110890125|NCT01341743|Adefovir|adefovir|mesh-list
110890126|NCT01341743|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
110890127|NCT01341743|Antiviral Agents|antiviral agents|mesh-ancestor
110890128|NCT01341743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110890129|NCT01341743|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110890130|NCT01341743|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110890131|NCT01341743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110890132|NCT01341743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110890133|NCT01341275|Vaccines|vaccines|mesh-list
110890134|NCT01341275|Immunologic Factors|immunologic factors|mesh-ancestor
110890135|NCT01341275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110890136|NCT01353937|Plerixafor|plerixafor|mesh-list
110890137|NCT01353937|Becaplermin|becaplermin|mesh-list
110890138|NCT01353937|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110890139|NCT01353937|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110890140|NCT01353937|Antiviral Agents|antiviral agents|mesh-ancestor
110890141|NCT01353937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110890142|NCT01353937|Anticoagulants|anticoagulants|mesh-ancestor
110890143|NCT01353937|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
110890144|NCT01353937|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110890145|NCT01353937|Growth Substances|growth substances|mesh-ancestor
110890146|NCT01353937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110890147|NCT04705883|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
110890148|NCT04705883|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110890149|NCT04705883|Immunologic Factors|immunologic factors|mesh-ancestor
110890150|NCT04705883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110890151|NCT02053298|Timolol|timolol|mesh-list
110890152|NCT02053298|Dorzolamide|dorzolamide|mesh-list
110890153|NCT02053298|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110890154|NCT02053298|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110890155|NCT02053298|Adrenergic Agents|adrenergic agents|mesh-ancestor
110890156|NCT02053298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110890157|NCT02053298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110890158|NCT02053298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110890159|NCT02053298|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110890160|NCT02053298|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110890161|NCT02053298|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110890162|NCT02053298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110890163|NCT02054936|Warfarin|warfarin|mesh-list
110890164|NCT02054936|Rivaroxaban|rivaroxaban|mesh-list
110890165|NCT02054936|Anticoagulants|anticoagulants|mesh-ancestor
110890166|NCT02054936|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110890167|NCT02054936|Antithrombins|antithrombins|mesh-ancestor
110890168|NCT02054936|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110890169|NCT02054936|Protease Inhibitors|protease inhibitors|mesh-ancestor
110890170|NCT02054936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110890171|NCT02054936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110890172|NCT04782791|Nivolumab|nivolumab|mesh-list
110890173|NCT04782791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110890174|NCT04782791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110890175|NCT04782791|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110890176|NCT04782791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110890177|NCT01341353|Amiodarone|amiodarone|mesh-list
110890178|NCT01341353|Calcium Channel Blockers|calcium channel blockers|mesh-list
110890179|NCT01341353|Calcium|calcium|mesh-list
110890180|NCT01341353|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110890181|NCT01341353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110890182|NCT01341353|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110921987|NCT04123873|Hormones|hormones|mesh-ancestor
110890183|NCT01341353|Vasodilator Agents|vasodilator agents|mesh-ancestor
110890184|NCT01341353|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
110890185|NCT01341353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110890186|NCT01341353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110890187|NCT01341353|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110890188|NCT01341353|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110890189|NCT01341353|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110890190|NCT01341353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110890191|NCT01341353|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110890192|NCT01341353|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110890193|NCT01341353|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110890194|NCT02056106|Antidepressive Agents|antidepressive agents|mesh-list
110890195|NCT02056106|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110890196|NCT02056184|Adalimumab|adalimumab|mesh-list
110890197|NCT02056184|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110890198|NCT02056184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110890199|NCT02056184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110890200|NCT02800928|Aticaprant|aticaprant|mesh-list
110890201|NCT02800928|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110890202|NCT02800928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110890203|NCT02800928|Sensory System Agents|sensory system agents|mesh-ancestor
110890204|NCT02800928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110890205|NCT02056418|Prednisone|prednisone|mesh-list
110890206|NCT02056418|Hydrocortisone|hydrocortisone|mesh-list
110890207|NCT02056418|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110890208|NCT02056418|Glucocorticoids|glucocorticoids|mesh-ancestor
110890209|NCT02056418|Hormones|hormones|mesh-ancestor
110890210|NCT02056418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110890211|NCT02056418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110890212|NCT02056418|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110890213|NCT02056418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110890214|NCT02055014|Liraglutide|liraglutide|mesh-list
110890215|NCT02055014|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110890216|NCT02055014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110890217|NCT02055014|Incretins|incretins|mesh-ancestor
110890218|NCT02055014|Hormones|hormones|mesh-ancestor
110890219|NCT02055014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110890220|NCT02055170|Finasteride|finasteride|mesh-list
110890221|NCT02055170|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
110890222|NCT02055170|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110890223|NCT02055170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110890224|NCT02055170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110890225|NCT02055170|Hormone Antagonists|hormone antagonists|mesh-ancestor
110200399|NCT00080925|Immunologic Factors|immunologic factors|mesh-ancestor
110890226|NCT02055170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110890227|NCT02055170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110890228|NCT02055170|Urological Agents|urological agents|mesh-ancestor
110890229|NCT04490993|Epirubicin|epirubicin|mesh-list
110890230|NCT04490993|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110890231|NCT04490993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110890232|NCT04490993|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110890233|NCT04490993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110890234|NCT04490993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110890235|NCT04490993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110890236|NCT02055482|Darbepoetin alfa|darbepoetin alfa|mesh-list
110890237|NCT02055482|Hematinics|hematinics|mesh-ancestor
110890238|NCT02059460|Terlipressin|terlipressin|mesh-list
110890239|NCT02059460|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110890240|NCT02059460|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110890241|NCT02055716|Sulforaphane|sulforaphane|mesh-list
110890242|NCT02055716|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110890243|NCT02055716|Protective Agents|protective agents|mesh-ancestor
110890244|NCT02055716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110890245|NCT02055716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110890246|NCT04739735|Anesthetics|anesthetics|mesh-list
110890247|NCT04739735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110890248|NCT04739735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110890249|NCT02059616|Amlodipine|amlodipine|mesh-list
110890250|NCT02059616|Candesartan|candesartan|mesh-list
110890251|NCT02059616|Candesartan cilexetil|candesartan cilexetil|mesh-list
110890252|NCT02059616|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110890253|NCT02059616|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110890254|NCT02059616|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110890255|NCT02059616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110890256|NCT02059616|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110890257|NCT02059616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110890258|NCT02059616|Vasodilator Agents|vasodilator agents|mesh-ancestor
110890259|NCT02059616|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110890260|NCT02059616|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110890261|NCT02059694|Lidocaine|lidocaine|mesh-list
110890262|NCT02059694|Epinephrine|epinephrine|mesh-list
110890263|NCT02059694|Racepinephrine|racepinephrine|mesh-list
110890264|NCT02059694|Epinephryl borate|epinephryl borate|mesh-list
110890265|NCT02059694|Anesthetics, Local|anesthetics, local|mesh-ancestor
110890266|NCT02059694|Anesthetics|anesthetics|mesh-ancestor
110890267|NCT02059694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110890268|NCT02059694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110890269|NCT02059694|Sensory System Agents|sensory system agents|mesh-ancestor
110890270|NCT02059694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110200418|NCT00080925|Antimetabolites|antimetabolites|mesh-ancestor
110890271|NCT02059694|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110890272|NCT02059694|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110890273|NCT02059694|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110890274|NCT02059694|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110890275|NCT02059694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110890276|NCT02059694|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110890277|NCT02059694|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110890278|NCT02059694|Adrenergic Agents|adrenergic agents|mesh-ancestor
110890279|NCT02059694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110890280|NCT02059694|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110890281|NCT02059694|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110890282|NCT02059694|Autonomic Agents|autonomic agents|mesh-ancestor
110890283|NCT02059694|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110890284|NCT02059694|Respiratory System Agents|respiratory system agents|mesh-ancestor
110890285|NCT02059694|Mydriatics|mydriatics|mesh-ancestor
110890286|NCT02059694|Sympathomimetics|sympathomimetics|mesh-ancestor
110890287|NCT02059694|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110890288|NCT03146741|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
110890289|NCT03146741|Antiviral Agents|antiviral agents|mesh-ancestor
110890290|NCT03146741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110890291|NCT02056730|Calcium|calcium|mesh-list
110890292|NCT02056730|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110890293|NCT02056730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110890294|NCT05162573|177Lu-PSMA-617|177lu-psma-617|mesh-list
110922006|NCT04106362|Antibodies|antibodies|mesh-list
110890296|NCT05162573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110890297|NCT01337219|Tobramycin|tobramycin|mesh-list
110890298|NCT01337219|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110890299|NCT01337219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110890300|NCT03560804|Olmesartan|olmesartan|mesh-list
110890301|NCT03560804|Chlorthalidone|chlorthalidone|mesh-list
110890302|NCT03560804|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110890303|NCT03560804|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110890304|NCT03560804|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110890305|NCT03560804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110890306|NCT03560804|Diuretics|diuretics|mesh-ancestor
110890307|NCT03560804|Natriuretic Agents|natriuretic agents|mesh-ancestor
110890308|NCT03560804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110890309|NCT03560804|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110890310|NCT03560804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110890311|NCT03150719|Ivacaftor|ivacaftor|mesh-list
110890312|NCT03150719|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
110890313|NCT03150719|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110890314|NCT03150719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110890315|NCT02059772|Ranibizumab|ranibizumab|mesh-list
110890316|NCT02059772|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110890317|NCT02059772|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110890318|NCT02059772|Growth Substances|growth substances|mesh-ancestor
110890319|NCT02059772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110890320|NCT02059772|Growth Inhibitors|growth inhibitors|mesh-ancestor
110890321|NCT02059772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110890322|NCT01344083|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
110890323|NCT01344083|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110607822|NCT00563368|Appetite Depressants|appetite depressants|mesh-ancestor
110890324|NCT01344083|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110890325|NCT01344083|Analgesics|analgesics|mesh-ancestor
110890326|NCT01344083|Sensory System Agents|sensory system agents|mesh-ancestor
110890327|NCT01344083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110890328|NCT01344083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110890329|NCT01344083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110890330|NCT01344083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110890331|NCT01344083|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110890332|NCT01344083|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110890333|NCT01344083|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110890334|NCT01344083|Histamine Antagonists|histamine antagonists|mesh-ancestor
110890335|NCT01344083|Histamine Agents|histamine agents|mesh-ancestor
110890336|NCT01344083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110890337|NCT01344083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110890338|NCT02059850|Cyclophosphamide|cyclophosphamide|mesh-list
110890339|NCT02059850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110890340|NCT02059850|Immunologic Factors|immunologic factors|mesh-ancestor
110890341|NCT02059850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110890342|NCT02059850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110890343|NCT02059850|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110890344|NCT02059850|Alkylating Agents|alkylating agents|mesh-ancestor
110890345|NCT02059850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110890346|NCT02059850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110890347|NCT02059850|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110890348|NCT00982111|Pemetrexed|pemetrexed|mesh-list
110890349|NCT00982111|Necitumumab|necitumumab|mesh-list
110890350|NCT00982111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110890351|NCT00982111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110890352|NCT00982111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110890353|NCT00982111|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110890354|NCT00982111|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110922035|NCT04060030|Vitamins|vitamins|mesh-ancestor
110890355|NCT00982111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110890356|NCT02957682|Alirocumab|alirocumab|mesh-list
110890357|NCT02957682|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
110890358|NCT02957682|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110890359|NCT02957682|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110890360|NCT02957682|Antimetabolites|antimetabolites|mesh-ancestor
110890361|NCT02957682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110890362|NCT02957682|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110890363|NCT02957682|Protease Inhibitors|protease inhibitors|mesh-ancestor
110890364|NCT02957682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110890365|NCT02957682|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110890366|NCT03057951|Empagliflozin|empagliflozin|mesh-list
110890367|NCT03057951|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110890368|NCT03057951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110890369|NCT03057951|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110890370|NCT03057951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110890371|NCT02060318|Infliximab|infliximab|mesh-list
110890372|NCT02060318|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110890373|NCT02060318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110890374|NCT02060318|Dermatologic Agents|dermatologic agents|mesh-ancestor
110890376|NCT02060318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110890377|NCT01318837|Solifenacin Succinate|solifenacin succinate|mesh-list
110890378|NCT01318837|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110890379|NCT01318837|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110890380|NCT01318837|Cholinergic Agents|cholinergic agents|mesh-ancestor
110890381|NCT01318837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110890382|NCT01318837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110890383|NCT01318837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110890384|NCT01318837|Urological Agents|urological agents|mesh-ancestor
110890385|NCT01350037|Remifentanil|remifentanil|mesh-list
110890386|NCT01350037|Alfentanil|alfentanil|mesh-list
110890387|NCT01350037|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110890388|NCT01350037|Narcotics|narcotics|mesh-ancestor
110890389|NCT01350037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110890390|NCT01350037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110890391|NCT01350037|Analgesics|analgesics|mesh-ancestor
110890392|NCT01350037|Sensory System Agents|sensory system agents|mesh-ancestor
110890393|NCT01350037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110890394|NCT01350037|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110890395|NCT01350037|Anesthetics, General|anesthetics, general|mesh-ancestor
110890396|NCT01350037|Anesthetics|anesthetics|mesh-ancestor
110890397|NCT02060006|Meloxicam|meloxicam|mesh-list
110890398|NCT02060006|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
110890399|NCT02060006|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110890400|NCT02060006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110890402|NCT02060006|Sensory System Agents|sensory system agents|mesh-ancestor
110890403|NCT02060006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110890404|NCT02060006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110890405|NCT02060006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110890406|NCT02060006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110890407|NCT02060006|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110890408|NCT02060006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110890409|NCT02060006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110890410|NCT03620435|Atezolizumab|atezolizumab|mesh-list
110890411|NCT03620435|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110890412|NCT03620435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110890413|NCT03620435|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110890414|NCT03620435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110890415|NCT01317017|Interferon-gamma|interferon-gamma|mesh-list
110890416|NCT01317017|Antiviral Agents|antiviral agents|mesh-ancestor
110890417|NCT01317017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110890418|NCT04686773|Vaccines|vaccines|mesh-list
110890419|NCT04686773|Immunologic Factors|immunologic factors|mesh-ancestor
110890420|NCT04686773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110890421|NCT02956278|Allopurinol|allopurinol|mesh-list
110890422|NCT02956278|Antimetabolites|antimetabolites|mesh-ancestor
110890423|NCT02956278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110890424|NCT02956278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110890425|NCT02956278|Gout Suppressants|gout suppressants|mesh-ancestor
110890426|NCT02956278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110890427|NCT02956278|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110890428|NCT02956278|Antioxidants|antioxidants|mesh-ancestor
110890429|NCT02956278|Protective Agents|protective agents|mesh-ancestor
110890430|NCT02956278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110890431|NCT02060396|Aspirin|aspirin|mesh-list
110890432|NCT02060396|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110890433|NCT02060396|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110890434|NCT02060396|Analgesics|analgesics|mesh-ancestor
110890435|NCT02060396|Sensory System Agents|sensory system agents|mesh-ancestor
110890436|NCT02060396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110890437|NCT02060396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110890438|NCT02060396|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110890439|NCT02060396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110890440|NCT02060396|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110890441|NCT02060396|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110890442|NCT02060396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110890443|NCT02060396|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110890444|NCT02060396|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110890446|NCT02060396|Antipyretics|antipyretics|mesh-ancestor
110890447|NCT01358071|Doxorubicin|doxorubicin|mesh-list
110890448|NCT01358071|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110890449|NCT01358071|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110890450|NCT01358071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110890451|NCT01358071|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110890452|NCT01358071|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110890453|NCT01358071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110890454|NCT01358071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110890456|NCT02058212|Selenium|selenium|mesh-list
110890457|NCT02058212|Vitamins|vitamins|mesh-ancestor
110890458|NCT02058212|Micronutrients|micronutrients|mesh-ancestor
110890459|NCT02058212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110890460|NCT02058212|Antioxidants|antioxidants|mesh-ancestor
110890461|NCT02058212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110890462|NCT02058212|Protective Agents|protective agents|mesh-ancestor
110890463|NCT02058212|Trace Elements|trace elements|mesh-ancestor
110890464|NCT02058446|Amlodipine|amlodipine|mesh-list
110890465|NCT02058446|Valsartan|valsartan|mesh-list
110890466|NCT02058446|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
110890467|NCT02058446|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110890468|NCT02058446|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110890469|NCT02058446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110890470|NCT02058446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110890471|NCT02058446|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110890472|NCT02058446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110890473|NCT02058446|Vasodilator Agents|vasodilator agents|mesh-ancestor
110890474|NCT02058446|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110890475|NCT02058446|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110890476|NCT01354405|Lanreotide|lanreotide|mesh-list
110890477|NCT01354405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110890478|NCT03363035|Enoxaparin|enoxaparin|mesh-list
110890479|NCT03363035|Rivaroxaban|rivaroxaban|mesh-list
110890480|NCT03363035|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110890481|NCT03363035|Antithrombins|antithrombins|mesh-ancestor
110890482|NCT03363035|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110890483|NCT03363035|Protease Inhibitors|protease inhibitors|mesh-ancestor
110890484|NCT03363035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110890485|NCT03363035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110890486|NCT03363035|Anticoagulants|anticoagulants|mesh-ancestor
110890487|NCT03363035|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110890488|NCT03363035|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110890489|NCT02060552|Diacerein|diacerein|mesh-list
110890490|NCT02060552|Colchicine|colchicine|mesh-list
110890491|NCT02060552|Febuxostat|febuxostat|mesh-list
110890492|NCT02060552|Gout Suppressants|gout suppressants|mesh-ancestor
110890493|NCT02060552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110890494|NCT02060552|Tubulin Modulators|tubulin modulators|mesh-ancestor
110890495|NCT02060552|Antimitotic Agents|antimitotic agents|mesh-ancestor
110890496|NCT02060552|Mitosis Modulators|mitosis modulators|mesh-ancestor
110890497|NCT02060552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110890498|NCT02060552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110890499|NCT02060552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110890500|NCT05384574|Cholecalciferol|cholecalciferol|mesh-list
110890501|NCT05384574|Vitamin D|vitamin d|mesh-list
110890502|NCT05384574|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110890503|NCT05384574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110890504|NCT05384574|Vitamins|vitamins|mesh-ancestor
110890505|NCT05384574|Micronutrients|micronutrients|mesh-ancestor
110890506|NCT05384574|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110890507|NCT04355585|Colchicine|colchicine|mesh-list
110890508|NCT04355585|Gout Suppressants|gout suppressants|mesh-ancestor
110890509|NCT04355585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110890510|NCT04355585|Tubulin Modulators|tubulin modulators|mesh-ancestor
110890511|NCT04355585|Antimitotic Agents|antimitotic agents|mesh-ancestor
110890512|NCT04355585|Mitosis Modulators|mitosis modulators|mesh-ancestor
110890513|NCT04355585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110890514|NCT04355585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110890515|NCT02031744|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110890516|NCT02031744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110890517|NCT02031744|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110890518|NCT02031744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110890519|NCT02031744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110890520|NCT04653389|Immunomodulating Agents|immunomodulating agents|mesh-list
110890521|NCT04653389|Immunologic Factors|immunologic factors|mesh-ancestor
110890522|NCT04653389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110890523|NCT01344395|Ketorolac|ketorolac|mesh-list
110890524|NCT01344395|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
110890525|NCT01344395|Ropivacaine|ropivacaine|mesh-list
110890526|NCT01344395|Anesthetics, Local|anesthetics, local|mesh-ancestor
110890527|NCT01344395|Anesthetics|anesthetics|mesh-ancestor
110890528|NCT01344395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110890529|NCT01344395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110890530|NCT01344395|Sensory System Agents|sensory system agents|mesh-ancestor
110890531|NCT01344395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110890532|NCT01344395|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110890533|NCT01344395|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110890534|NCT01344395|Analgesics|analgesics|mesh-ancestor
110890535|NCT01344395|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110890536|NCT01344395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110890537|NCT01344395|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110890538|NCT01344395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110890539|NCT01344395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110890540|NCT02291445|Peppermint oil|peppermint oil|mesh-list
110890541|NCT02291445|Antiemetics|antiemetics|mesh-ancestor
110890542|NCT02291445|Autonomic Agents|autonomic agents|mesh-ancestor
110890543|NCT02291445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110890544|NCT02291445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110890545|NCT02291445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110608071|NCT05602064|Ibuprofen|ibuprofen|mesh-list
110890546|NCT02291445|Parasympatholytics|parasympatholytics|mesh-ancestor
110890547|NCT02062112|Laxatives|laxatives|mesh-list
110890548|NCT02062112|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110890549|NCT01342289|Mycophenolic Acid|mycophenolic acid|mesh-list
110890550|NCT01342289|Cyclophosphamide|cyclophosphamide|mesh-list
110890551|NCT01342289|Fludarabine|fludarabine|mesh-list
110890552|NCT01342289|Tacrolimus|tacrolimus|mesh-list
110890553|NCT01342289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110890554|NCT01342289|Immunologic Factors|immunologic factors|mesh-ancestor
110890555|NCT01342289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110890556|NCT01342289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110890557|NCT01342289|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110890558|NCT01342289|Alkylating Agents|alkylating agents|mesh-ancestor
110890559|NCT01342289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110890560|NCT01342289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110890561|NCT01342289|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110890562|NCT01342289|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110890563|NCT01342289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110890564|NCT01342289|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110890565|NCT01342289|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110890566|NCT01342289|Antitubercular Agents|antitubercular agents|mesh-ancestor
110890567|NCT01342289|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110890568|NCT01342289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110890569|NCT02062190|Resveratrol|resveratrol|mesh-list
110890570|NCT02062190|Antioxidants|antioxidants|mesh-ancestor
110890571|NCT02062190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110890572|NCT02062190|Protective Agents|protective agents|mesh-ancestor
110890573|NCT02062190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110890574|NCT02062190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110890575|NCT02062190|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110890576|NCT01354483|Methylprednisolone|methylprednisolone|mesh-list
110890577|NCT01354483|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110890578|NCT01354483|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110890579|NCT01354483|Prednisolone|prednisolone|mesh-list
110890580|NCT01354483|Prednisolone acetate|prednisolone acetate|mesh-list
110890581|NCT01354483|Lithium Carbonate|lithium carbonate|mesh-list
110890582|NCT01354483|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110890583|NCT01354483|Prednisolone phosphate|prednisolone phosphate|mesh-list
110890584|NCT01354483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110890585|NCT01354483|Antiemetics|antiemetics|mesh-ancestor
110890586|NCT01354483|Autonomic Agents|autonomic agents|mesh-ancestor
110890587|NCT01354483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110890588|NCT01354483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110890589|NCT01354483|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110890590|NCT01354483|Glucocorticoids|glucocorticoids|mesh-ancestor
110890591|NCT01354483|Hormones|hormones|mesh-ancestor
110890592|NCT01354483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110890593|NCT01354483|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110890594|NCT01354483|Protective Agents|protective agents|mesh-ancestor
110890595|NCT01354483|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110890596|NCT01354483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110890597|NCT01354483|Antidepressive Agents|antidepressive agents|mesh-ancestor
110890598|NCT01354483|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110890599|NCT01354483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110890600|NCT01354483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110890601|NCT01354483|Antimanic Agents|antimanic agents|mesh-ancestor
110890602|NCT01354483|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110922092|NCT03519906|Metoprolol|metoprolol|mesh-list
110890603|NCT01354483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110890604|NCT03618264|Dexamethasone|dexamethasone|mesh-list
110890605|NCT03618264|Ropivacaine|ropivacaine|mesh-list
110890606|NCT03618264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110890607|NCT03618264|Antiemetics|antiemetics|mesh-ancestor
110890608|NCT03618264|Autonomic Agents|autonomic agents|mesh-ancestor
110890609|NCT03618264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110890610|NCT03618264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110890611|NCT03618264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110890612|NCT03618264|Glucocorticoids|glucocorticoids|mesh-ancestor
110890613|NCT03618264|Hormones|hormones|mesh-ancestor
110890614|NCT03618264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110890615|NCT03618264|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110890616|NCT03618264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110890617|NCT03618264|Anesthetics, Local|anesthetics, local|mesh-ancestor
110890618|NCT03618264|Anesthetics|anesthetics|mesh-ancestor
110890619|NCT03618264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110890620|NCT03618264|Sensory System Agents|sensory system agents|mesh-ancestor
110890621|NCT03617016|Domperidone|domperidone|mesh-list
110890622|NCT03617016|Antiemetics|antiemetics|mesh-ancestor
110890623|NCT03617016|Autonomic Agents|autonomic agents|mesh-ancestor
110890624|NCT03617016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110890625|NCT03617016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110890626|NCT03617016|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110890627|NCT03617016|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110890628|NCT03617016|Dopamine Agents|dopamine agents|mesh-ancestor
110890629|NCT03617016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110890630|NCT03617016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110890631|NCT02060786|Clopidogrel|clopidogrel|mesh-list
110890632|NCT02060786|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110890633|NCT02060786|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110890634|NCT02060786|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110890635|NCT02060786|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110890636|NCT02060786|Purinergic Agents|purinergic agents|mesh-ancestor
110890637|NCT02060786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110890638|NCT02060786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110890639|NCT02060786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110890640|NCT03153137|Macitentan|macitentan|mesh-list
110890641|NCT03153137|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
110890642|NCT03153137|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
110890643|NCT03153137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110890644|NCT03153137|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
110890645|NCT03617484|Bortezomib|bortezomib|mesh-list
110890646|NCT03617484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110890647|NCT01344473|Caseins|caseins|mesh-list
110890648|NCT01344473|Chelating Agents|chelating agents|mesh-ancestor
110890649|NCT01344473|Sequestering Agents|sequestering agents|mesh-ancestor
110890650|NCT01344473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110890651|NCT03618108|Azithromycin|azithromycin|mesh-list
110890652|NCT03618108|Doxycycline|doxycycline|mesh-list
110890653|NCT03618108|Rifabutin|rifabutin|mesh-list
110890654|NCT03618108|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110890655|NCT03618108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110922105|NCT03519893|Losartan|losartan|mesh-list
110890656|NCT03618108|Antimalarials|antimalarials|mesh-ancestor
110890657|NCT03618108|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110890658|NCT03618108|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110890659|NCT03618108|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110890660|NCT03618108|Antitubercular Agents|antitubercular agents|mesh-ancestor
110890661|NCT01342601|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110890662|NCT01342601|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110890663|NCT02236728|Pramipexole|pramipexole|mesh-list
110890664|NCT02236728|Antioxidants|antioxidants|mesh-ancestor
110890665|NCT02236728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110890666|NCT02236728|Protective Agents|protective agents|mesh-ancestor
110890667|NCT02236728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110890668|NCT02236728|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110890669|NCT02236728|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110890670|NCT02236728|Dopamine Agonists|dopamine agonists|mesh-ancestor
110890671|NCT02236728|Dopamine Agents|dopamine agents|mesh-ancestor
110890672|NCT02236728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110890673|NCT03136861|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110890674|NCT03136861|Immunologic Factors|immunologic factors|mesh-ancestor
110890675|NCT03136861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110890676|NCT01342679|Dasatinib|dasatinib|mesh-list
110890677|NCT01342679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110890678|NCT01342679|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110890679|NCT01342679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110890680|NCT01342679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110890681|NCT01342835|Propofol|propofol|mesh-list
110890682|NCT01342835|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110890683|NCT01342835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110890684|NCT01342835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110890685|NCT01342835|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110890686|NCT01342835|Anesthetics, General|anesthetics, general|mesh-ancestor
110890687|NCT01342835|Anesthetics|anesthetics|mesh-ancestor
110890688|NCT01344863|Trastuzumab|trastuzumab|mesh-list
110890689|NCT01344863|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110890690|NCT01344863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110890691|NCT03139279|Dexmedetomidine|dexmedetomidine|mesh-list
110890692|NCT03139279|Propofol|propofol|mesh-list
110890693|NCT03139279|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110890694|NCT03139279|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110890695|NCT03139279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110890696|NCT03139279|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110890697|NCT03139279|Analgesics|analgesics|mesh-ancestor
110890699|NCT03139279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110890700|NCT03139279|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110890701|NCT03139279|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110890702|NCT03139279|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110890703|NCT03139279|Adrenergic Agents|adrenergic agents|mesh-ancestor
110890704|NCT03139279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110890705|NCT03139279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110890706|NCT03139279|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110890707|NCT03139279|Anesthetics, General|anesthetics, general|mesh-ancestor
110890708|NCT03139279|Anesthetics|anesthetics|mesh-ancestor
110890709|NCT02562599|Raltitrexed|raltitrexed|mesh-list
110890710|NCT02562599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110890711|NCT02562599|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110890712|NCT02562599|Antimetabolites|antimetabolites|mesh-ancestor
110890713|NCT02562599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110890714|NCT02562599|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110890715|NCT02562599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110890716|NCT03311958|Nivolumab|nivolumab|mesh-list
110890717|NCT03311958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110890718|NCT03311958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110890719|NCT03311958|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110890720|NCT03311958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110890721|NCT01370642|Ribavirin|ribavirin|mesh-list
110890722|NCT01370642|Antimetabolites|antimetabolites|mesh-ancestor
110890723|NCT01370642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110890724|NCT01370642|Antiviral Agents|antiviral agents|mesh-ancestor
110890725|NCT01370642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110890726|NCT03138967|Glycopyrrolate|glycopyrrolate|mesh-list
110890727|NCT03138967|Bromides|bromides|mesh-list
110890728|NCT03138967|Rocuronium|rocuronium|mesh-list
110890729|NCT03138967|Neostigmine|neostigmine|mesh-list
110890730|NCT03138967|Anticonvulsants|anticonvulsants|mesh-ancestor
110890731|NCT03138967|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110890732|NCT03138967|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110890733|NCT03138967|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110890734|NCT03138967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110890735|NCT03138967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110890736|NCT03138967|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110890737|NCT03138967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110890738|NCT03138967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110890739|NCT03138967|Cholinergic Agents|cholinergic agents|mesh-ancestor
110890740|NCT03138967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110890741|NCT03138967|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110890742|NCT03138967|Autonomic Agents|autonomic agents|mesh-ancestor
110890743|NCT03138967|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110890744|NCT03138967|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110890745|NCT03138967|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110890746|NCT01547117|Carbon Monoxide|carbon monoxide|mesh-list
110890747|NCT01547117|Antimetabolites|antimetabolites|mesh-ancestor
110890748|NCT01547117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110890749|NCT01547117|Gasotransmitters|gasotransmitters|mesh-ancestor
110890750|NCT01547117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110890751|NCT01547117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110890752|NCT01358383|Naproxen|naproxen|mesh-list
110890753|NCT01358383|Esomeprazole|esomeprazole|mesh-list
110890754|NCT01358383|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110890755|NCT01358383|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110890756|NCT01358383|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110890757|NCT01358383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110890758|NCT01358383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110890759|NCT01358383|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110890760|NCT01358383|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110890761|NCT01358383|Analgesics|analgesics|mesh-ancestor
110890762|NCT01358383|Sensory System Agents|sensory system agents|mesh-ancestor
110890763|NCT01358383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110922140|NCT02999230|Listerine|listerine|mesh-list
110890764|NCT01358383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110890765|NCT01358383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110890766|NCT01358383|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110890767|NCT01358383|Gout Suppressants|gout suppressants|mesh-ancestor
110890768|NCT01358383|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110890769|NCT03560336|Liraglutide|liraglutide|mesh-list
110890770|NCT03560336|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110890771|NCT03560336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110890772|NCT03560336|Incretins|incretins|mesh-ancestor
110890773|NCT03560336|Hormones|hormones|mesh-ancestor
110890774|NCT03560336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110890775|NCT03136159|Anti-Infective Agents|anti-infective agents|mesh-list
110890776|NCT03136159|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110890778|NCT03615768|Clindamycin palmitate|clindamycin palmitate|mesh-list
110890779|NCT03615768|Clindamycin phosphate|clindamycin phosphate|mesh-list
110890780|NCT03615768|Adapalene|adapalene|mesh-list
110890781|NCT03615768|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110890782|NCT03615768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110890783|NCT03615768|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110890784|NCT03615768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110890785|NCT03615768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110890786|NCT03615768|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110890787|NCT03615768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110890788|NCT03615768|Analgesics|analgesics|mesh-ancestor
110890789|NCT03615768|Sensory System Agents|sensory system agents|mesh-ancestor
110890790|NCT03615768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110890791|NCT03615768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110890792|NCT03615768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110890793|NCT03615768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110890794|NCT03615768|Dermatologic Agents|dermatologic agents|mesh-ancestor
110890795|NCT02061644|Anesthetics|anesthetics|mesh-list
110890796|NCT02061644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110890797|NCT02061644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110890798|NCT03793400|Bevacizumab|bevacizumab|mesh-list
110890799|NCT03793400|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110890800|NCT03793400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110890801|NCT03793400|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110890802|NCT03793400|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110890803|NCT03793400|Growth Substances|growth substances|mesh-ancestor
110890804|NCT03793400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110890805|NCT03793400|Growth Inhibitors|growth inhibitors|mesh-ancestor
110890806|NCT01318369|Diazepam|diazepam|mesh-list
110890807|NCT01318369|Dronabinol|dronabinol|mesh-list
110890808|NCT01318369|Hallucinogens|hallucinogens|mesh-ancestor
110890809|NCT01318369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110890810|NCT01318369|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110890811|NCT01318369|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110890812|NCT01318369|Analgesics|analgesics|mesh-ancestor
110890813|NCT01318369|Sensory System Agents|sensory system agents|mesh-ancestor
110890814|NCT01318369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110890815|NCT01318369|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
110890816|NCT01318369|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110890817|NCT01318369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110890818|NCT01318369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110890819|NCT01318369|Hormones|hormones|mesh-ancestor
110890820|NCT01318369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110890821|NCT01318369|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110890823|NCT01318369|Antiemetics|antiemetics|mesh-ancestor
110890824|NCT01318369|Autonomic Agents|autonomic agents|mesh-ancestor
110890825|NCT01318369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110890826|NCT01318369|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110890827|NCT01318369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110890828|NCT01318369|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110890829|NCT01318369|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110890830|NCT01318369|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110890831|NCT01318369|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110890832|NCT01318369|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110890833|NCT01318369|Anesthetics, General|anesthetics, general|mesh-ancestor
110890834|NCT01318369|Anesthetics|anesthetics|mesh-ancestor
110890835|NCT01318369|GABA Modulators|gaba modulators|mesh-ancestor
110890836|NCT01318369|GABA Agents|gaba agents|mesh-ancestor
110890837|NCT03479684|Warfarin|warfarin|mesh-list
110890838|NCT03479684|Anticoagulants|anticoagulants|mesh-ancestor
110890840|NCT03614052|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110890841|NCT03614052|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110890842|NCT03614052|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110890843|NCT03614052|Adrenergic Agents|adrenergic agents|mesh-ancestor
110890844|NCT03614052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110890845|NCT03614052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110890846|NCT03614052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110890847|NCT03614052|Urological Agents|urological agents|mesh-ancestor
110890848|NCT02062892|Sirolimus|sirolimus|mesh-list
110890849|NCT02062892|Everolimus|everolimus|mesh-list
110890850|NCT02062892|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110890851|NCT02062892|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110890852|NCT02062892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110890853|NCT02062892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110890854|NCT02062892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110890855|NCT02062892|Immunologic Factors|immunologic factors|mesh-ancestor
110890856|NCT02062892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110890857|NCT02062892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110890858|NCT02062892|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110890859|NCT02062892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110890860|NCT02062892|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110890861|NCT02062892|Antifungal Agents|antifungal agents|mesh-ancestor
110890862|NCT02063360|Ritonavir|ritonavir|mesh-list
110890863|NCT02063360|Darunavir|darunavir|mesh-list
110890864|NCT02063360|Fostemsavir|fostemsavir|mesh-list
110890865|NCT02063360|Etravirine|etravirine|mesh-list
110890866|NCT02063360|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110890867|NCT02063360|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110890868|NCT02063360|Protease Inhibitors|protease inhibitors|mesh-ancestor
110890869|NCT02063360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110890870|NCT02063360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110890871|NCT02063360|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110890872|NCT02063360|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110890873|NCT02063360|Antiviral Agents|antiviral agents|mesh-ancestor
110890874|NCT02063360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110890875|NCT02063360|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110890876|NCT02063360|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110890877|NCT02063360|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110890878|NCT02063360|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110890879|NCT02063360|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110890880|NCT02063360|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110890881|NCT03614832|Clopidogrel|clopidogrel|mesh-list
110890882|NCT03614832|Ticagrelor|ticagrelor|mesh-list
110890883|NCT03614832|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110922177|NCT02918721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110890884|NCT03614832|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110890885|NCT03614832|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110890886|NCT03614832|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110890887|NCT03614832|Purinergic Agents|purinergic agents|mesh-ancestor
110890888|NCT03614832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110890889|NCT03614832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110890890|NCT03614832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110890891|NCT05210595|Clopidogrel|clopidogrel|mesh-list
110890892|NCT05210595|Ticagrelor|ticagrelor|mesh-list
110890893|NCT05210595|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110890894|NCT05210595|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110890895|NCT05210595|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110890896|NCT05210595|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110890897|NCT05210595|Purinergic Agents|purinergic agents|mesh-ancestor
110890898|NCT05210595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110890899|NCT05210595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110890900|NCT05210595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110890901|NCT02061800|Methylprednisolone|methylprednisolone|mesh-list
110890902|NCT02061800|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110890903|NCT02061800|Cyclophosphamide|cyclophosphamide|mesh-list
110890904|NCT02061800|Melphalan|melphalan|mesh-list
110890905|NCT02061800|Busulfan|busulfan|mesh-list
110890906|NCT02061800|Thiotepa|thiotepa|mesh-list
110890907|NCT02061800|Fludarabine|fludarabine|mesh-list
110890908|NCT02061800|Alemtuzumab|alemtuzumab|mesh-list
110890909|NCT02061800|Tacrolimus|tacrolimus|mesh-list
110890910|NCT02061800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110890912|NCT02061800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110890913|NCT02061800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110890914|NCT02061800|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110890915|NCT02061800|Alkylating Agents|alkylating agents|mesh-ancestor
110890916|NCT02061800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110890917|NCT02061800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110890918|NCT02061800|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110890919|NCT02061800|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110890920|NCT02061800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110890921|NCT02061800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110890922|NCT02061800|Antiemetics|antiemetics|mesh-ancestor
110890923|NCT02061800|Autonomic Agents|autonomic agents|mesh-ancestor
110890924|NCT02061800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110890925|NCT02061800|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110608422|NCT00688740|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110890926|NCT02061800|Glucocorticoids|glucocorticoids|mesh-ancestor
110890927|NCT02061800|Hormones|hormones|mesh-ancestor
110890928|NCT02061800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110890929|NCT02061800|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110890930|NCT02061800|Protective Agents|protective agents|mesh-ancestor
110890931|NCT02061800|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110890932|NCT02061800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110890933|NCT01350817|Docetaxel|docetaxel|mesh-list
110890934|NCT01350817|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110890935|NCT01350817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110890936|NCT01350817|Tubulin Modulators|tubulin modulators|mesh-ancestor
110890937|NCT01350817|Antimitotic Agents|antimitotic agents|mesh-ancestor
110890938|NCT01350817|Mitosis Modulators|mitosis modulators|mesh-ancestor
110890939|NCT01350817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110890940|NCT01350817|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110890941|NCT01350817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110890942|NCT01986075|Amphetamine|amphetamine|mesh-list
110890943|NCT01986075|Adderall|adderall|mesh-list
110890944|NCT01986075|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110890945|NCT01986075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110890946|NCT01986075|Sympathomimetics|sympathomimetics|mesh-ancestor
110890947|NCT01986075|Autonomic Agents|autonomic agents|mesh-ancestor
110890948|NCT01986075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110890949|NCT01986075|Dopamine Agents|dopamine agents|mesh-ancestor
110890950|NCT01986075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110890951|NCT01986075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110890952|NCT01986075|Adrenergic Agents|adrenergic agents|mesh-ancestor
110890953|NCT01986075|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110890954|NCT01986075|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110890955|NCT01986075|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110890956|NCT01986075|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110890957|NCT02061878|Bexarotene|bexarotene|mesh-list
110890958|NCT02061878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110890959|NCT00394355|Fluticasone|fluticasone|mesh-list
110890960|NCT00394355|Xhance|xhance|mesh-list
110890961|NCT00394355|Mometasone Furoate|mometasone furoate|mesh-list
110890962|NCT00394355|Montelukast|montelukast|mesh-list
110890963|NCT00394355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110890964|NCT00394355|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110890965|NCT00394355|Autonomic Agents|autonomic agents|mesh-ancestor
110890966|NCT00394355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110890967|NCT00394355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110890968|NCT00394355|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110890969|NCT00394355|Respiratory System Agents|respiratory system agents|mesh-ancestor
110890970|NCT00394355|Dermatologic Agents|dermatologic agents|mesh-ancestor
110890971|NCT00394355|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110890972|NCT00394355|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110890973|NCT00394355|Hormone Antagonists|hormone antagonists|mesh-ancestor
110890974|NCT00394355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110890975|NCT00394355|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110890976|NCT00394355|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110890977|NCT00394355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110890978|NCT02797808|Sertraline|sertraline|mesh-list
110890979|NCT02797808|Antidepressive Agents|antidepressive agents|mesh-ancestor
110890980|NCT02797808|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110890981|NCT02797808|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110890982|NCT02797808|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110890983|NCT02797808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110890984|NCT02797808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110890985|NCT02797808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110890986|NCT02797808|Serotonin Agents|serotonin agents|mesh-ancestor
110890987|NCT02797808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110890988|NCT02796560|Travoprost|travoprost|mesh-list
110890989|NCT02796560|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110890990|NCT01316081|Vitamins|vitamins|mesh-list
110890991|NCT01316081|Ascorbic Acid|ascorbic acid|mesh-list
110890992|NCT01316081|Vitamin E|vitamin e|mesh-list
110890993|NCT01316081|Tocopherols|tocopherols|mesh-list
110890994|NCT01316081|Tocotrienols|tocotrienols|mesh-list
110890995|NCT01316081|alpha-Tocopherol|alpha-tocopherol|mesh-list
110890996|NCT01316081|Micronutrients|micronutrients|mesh-ancestor
110890997|NCT01316081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110890998|NCT01316081|Antioxidants|antioxidants|mesh-ancestor
110890999|NCT01316081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110891000|NCT01316081|Protective Agents|protective agents|mesh-ancestor
110891020|NCT02062034|Vitamins|vitamins|mesh-list
110891021|NCT02062034|Vitamin E|vitamin e|mesh-list
110891022|NCT02062034|Coenzyme Q10|coenzyme q10|mesh-list
110891023|NCT02062034|Ubiquinone|ubiquinone|mesh-list
110891024|NCT02062034|Antioxidants|antioxidants|mesh-list
110891025|NCT02062034|Micronutrients|micronutrients|mesh-ancestor
110891026|NCT02062034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110891027|NCT02062034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110891028|NCT02062034|Protective Agents|protective agents|mesh-ancestor
110891029|NCT00344487|Ritonavir|ritonavir|mesh-list
110891030|NCT00344487|Lopinavir|lopinavir|mesh-list
110891031|NCT00344487|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110891032|NCT00344487|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110891033|NCT00344487|Protease Inhibitors|protease inhibitors|mesh-ancestor
110891034|NCT00344487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110891035|NCT00344487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110891036|NCT00344487|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110891037|NCT00344487|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110891038|NCT00344487|Antiviral Agents|antiviral agents|mesh-ancestor
110891039|NCT00344487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110891040|NCT00344487|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110891041|NCT00344487|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110891042|NCT03789968|Tenofovir|tenofovir|mesh-list
110891043|NCT03789968|Emtricitabine|emtricitabine|mesh-list
110891044|NCT03789968|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
110891045|NCT03789968|Antiviral Agents|antiviral agents|mesh-ancestor
110891046|NCT03789968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110200664|NCT00081276|Cisplatin|cisplatin|mesh-list
110891047|NCT03789968|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110891048|NCT03789968|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110891049|NCT03789968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110891050|NCT03789968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110891051|NCT03789968|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110891052|NCT03789968|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110891053|NCT05089643|Capecitabine|capecitabine|mesh-list
110891054|NCT05089643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110891056|NCT05089643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110891057|NCT05089643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110891059|NCT02871492|Pritelivir|pritelivir|mesh-list
110891060|NCT02871492|Antiviral Agents|antiviral agents|mesh-ancestor
110891061|NCT02871492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110891062|NCT02871492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110891063|NCT02871492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110891064|NCT03613974|Lidocaine|lidocaine|mesh-list
110891065|NCT03613974|Anesthetics, Local|anesthetics, local|mesh-ancestor
110891066|NCT03613974|Anesthetics|anesthetics|mesh-ancestor
110891067|NCT03613974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110891068|NCT03613974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110891069|NCT03613974|Sensory System Agents|sensory system agents|mesh-ancestor
110891070|NCT03613974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110891071|NCT03613974|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110891072|NCT03613974|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110891073|NCT03613974|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110891074|NCT03613974|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110891075|NCT03613974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110891076|NCT01343225|Ritonavir|ritonavir|mesh-list
110891077|NCT01343225|Darunavir|darunavir|mesh-list
110891078|NCT01343225|Raltegravir Potassium|raltegravir potassium|mesh-list
110891079|NCT01343225|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110891081|NCT01343225|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110891082|NCT01343225|Protease Inhibitors|protease inhibitors|mesh-ancestor
110891083|NCT01343225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110891084|NCT01343225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110891085|NCT01343225|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110891086|NCT01343225|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110891087|NCT01343225|Antiviral Agents|antiviral agents|mesh-ancestor
110891088|NCT01343225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110891089|NCT01343225|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110891090|NCT01343225|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110891091|NCT01343225|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110891092|NCT01343225|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110891093|NCT01343225|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110891094|NCT01343225|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110891095|NCT04739865|Psilocybin|psilocybin|mesh-list
110891096|NCT04739865|Hallucinogens|hallucinogens|mesh-ancestor
110891097|NCT04739865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110891098|NCT04739865|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110891099|NCT01370408|Dexamethasone|dexamethasone|mesh-list
110891100|NCT01370408|Ondansetron|ondansetron|mesh-list
110891101|NCT01370408|Palonosetron|palonosetron|mesh-list
110891102|NCT01370408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110891103|NCT01370408|Antiemetics|antiemetics|mesh-ancestor
110891104|NCT01370408|Autonomic Agents|autonomic agents|mesh-ancestor
110891105|NCT01370408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110891106|NCT01370408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110891107|NCT01370408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110891108|NCT01370408|Glucocorticoids|glucocorticoids|mesh-ancestor
110891109|NCT01370408|Hormones|hormones|mesh-ancestor
110891110|NCT01370408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110891111|NCT01370408|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110891112|NCT01370408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110891113|NCT01370408|Antipruritics|antipruritics|mesh-ancestor
110891114|NCT01370408|Dermatologic Agents|dermatologic agents|mesh-ancestor
110891115|NCT01370408|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110891116|NCT01370408|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110891117|NCT01370408|Serotonin Agents|serotonin agents|mesh-ancestor
110891118|NCT01370408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110891119|NCT01370408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110891120|NCT04769388|Carboplatin|carboplatin|mesh-list
110891121|NCT04769388|Pemetrexed|pemetrexed|mesh-list
110891122|NCT04769388|Osimertinib|osimertinib|mesh-list
110891123|NCT04769388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110891124|NCT04769388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110891125|NCT04769388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110891126|NCT04769388|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110891127|NCT04769388|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110891128|NCT04769388|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110891129|NCT03294109|Bupivacaine|bupivacaine|mesh-list
110891130|NCT03294109|Anesthetics, Local|anesthetics, local|mesh-ancestor
110891132|NCT03294109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110891133|NCT03294109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110891134|NCT03294109|Sensory System Agents|sensory system agents|mesh-ancestor
110891135|NCT03294109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110891136|NCT01345643|Chrysarobin|chrysarobin|mesh-list
110891137|NCT01345643|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110891138|NCT01345643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110891139|NCT01345643|Analgesics|analgesics|mesh-ancestor
110891140|NCT01345643|Sensory System Agents|sensory system agents|mesh-ancestor
110891141|NCT01345643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110891142|NCT01345643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110891143|NCT01345643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110891144|NCT01345643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110891145|NCT02065466|Paclitaxel|paclitaxel|mesh-list
110891146|NCT02065466|Bevacizumab|bevacizumab|mesh-list
110891147|NCT02065466|Temozolomide|temozolomide|mesh-list
110891148|NCT02065466|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110891149|NCT02065466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110891150|NCT02065466|Tubulin Modulators|tubulin modulators|mesh-ancestor
110891151|NCT02065466|Antimitotic Agents|antimitotic agents|mesh-ancestor
110891152|NCT02065466|Mitosis Modulators|mitosis modulators|mesh-ancestor
110891153|NCT02065466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110891154|NCT02065466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110891155|NCT02065466|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110891156|NCT02065466|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110891157|NCT02065466|Growth Substances|growth substances|mesh-ancestor
110891158|NCT02065466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110891159|NCT02065466|Growth Inhibitors|growth inhibitors|mesh-ancestor
110891160|NCT02065466|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110891161|NCT02065466|Alkylating Agents|alkylating agents|mesh-ancestor
110891163|NCT05208801|Bupivacaine|bupivacaine|mesh-list
110891164|NCT05208801|Anesthetics, Local|anesthetics, local|mesh-ancestor
110891165|NCT05208801|Anesthetics|anesthetics|mesh-ancestor
110891166|NCT05208801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110891167|NCT05208801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110891168|NCT05208801|Sensory System Agents|sensory system agents|mesh-ancestor
110891169|NCT05208801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110891170|NCT05208801|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110891171|NCT05208801|Narcotics|narcotics|mesh-ancestor
110891172|NCT05208801|Analgesics|analgesics|mesh-ancestor
110891173|NCT02064140|Rocuronium|rocuronium|mesh-list
110891174|NCT02064140|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110891175|NCT02064140|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110891176|NCT02064140|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110891177|NCT02064140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110891178|NCT02064140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110891179|NCT05190627|Loratadine|loratadine|mesh-list
110891180|NCT05190627|Sirolimus|sirolimus|mesh-list
110891181|NCT05190627|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110891182|NCT05190627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110891183|NCT05190627|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110891184|NCT05190627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110891185|NCT05190627|Antifungal Agents|antifungal agents|mesh-ancestor
110891186|NCT05190627|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110891187|NCT05190627|Immunologic Factors|immunologic factors|mesh-ancestor
110891188|NCT05190627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110891189|NCT05190627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110891190|NCT05190627|Antipruritics|antipruritics|mesh-ancestor
110891191|NCT05190627|Dermatologic Agents|dermatologic agents|mesh-ancestor
110891192|NCT05190627|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110891193|NCT05190627|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110891194|NCT05190627|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110891195|NCT05190627|Histamine Antagonists|histamine antagonists|mesh-ancestor
110891196|NCT05190627|Histamine Agents|histamine agents|mesh-ancestor
110891197|NCT05190627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110891198|NCT02064218|Antihypertensive Agents|antihypertensive agents|mesh-list
110891199|NCT01343303|Naproxen|naproxen|mesh-list
110891200|NCT01343303|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110891201|NCT01343303|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110891202|NCT01343303|Analgesics|analgesics|mesh-ancestor
110891203|NCT01343303|Sensory System Agents|sensory system agents|mesh-ancestor
110891204|NCT01343303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110891205|NCT01343303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110891206|NCT01343303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110891207|NCT01343303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110891208|NCT01343303|Gout Suppressants|gout suppressants|mesh-ancestor
110891209|NCT01343303|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110891210|NCT01343303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110891211|NCT01343303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110891212|NCT01343381|Heparin|heparin|mesh-list
110891213|NCT01343381|Calcium heparin|calcium heparin|mesh-list
110891214|NCT01343381|Anticoagulants|anticoagulants|mesh-ancestor
110891215|NCT01343381|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110891216|NCT01343381|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110200700|NCT00145522|Dydrogesterone|dydrogesterone|mesh-list
110891217|NCT01343381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110891218|NCT03620149|Denosumab|denosumab|mesh-list
110891219|NCT03620149|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110891220|NCT03620149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110891221|NCT02064374|Metformin|metformin|mesh-list
110891222|NCT02064374|Dolutegravir|dolutegravir|mesh-list
110891223|NCT02064374|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110891224|NCT02064374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110891225|NCT02064374|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110891226|NCT02064374|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110891227|NCT02064374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110891228|NCT02064374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110891229|NCT02064374|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110891230|NCT02064374|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110891231|NCT02064374|Antiviral Agents|antiviral agents|mesh-ancestor
110891232|NCT02064374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110891233|NCT01355263|Vitamin A|vitamin a|mesh-list
110891234|NCT01355263|Vitamins|vitamins|mesh-ancestor
110891235|NCT01355263|Micronutrients|micronutrients|mesh-ancestor
110891236|NCT01355263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110891237|NCT03613428|Prednisone|prednisone|mesh-list
110891238|NCT03613428|Vincristine|vincristine|mesh-list
110891239|NCT03613428|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110891240|NCT03613428|Glucocorticoids|glucocorticoids|mesh-ancestor
110891241|NCT03613428|Hormones|hormones|mesh-ancestor
110891242|NCT03613428|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110891243|NCT03613428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110891244|NCT03613428|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110891245|NCT03613428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110891246|NCT03613428|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110891247|NCT03613428|Tubulin Modulators|tubulin modulators|mesh-ancestor
110891248|NCT03613428|Antimitotic Agents|antimitotic agents|mesh-ancestor
110891249|NCT03613428|Mitosis Modulators|mitosis modulators|mesh-ancestor
110891250|NCT03613428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110891251|NCT02064530|Dexmedetomidine|dexmedetomidine|mesh-list
110891252|NCT02064530|Bupivacaine|bupivacaine|mesh-list
110891253|NCT02064530|Anesthetics, Local|anesthetics, local|mesh-ancestor
110891254|NCT02064530|Anesthetics|anesthetics|mesh-ancestor
110891255|NCT02064530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110891256|NCT02064530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110891257|NCT02064530|Sensory System Agents|sensory system agents|mesh-ancestor
110891258|NCT02064530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110891259|NCT02064530|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110891260|NCT02064530|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110891261|NCT02064530|Analgesics|analgesics|mesh-ancestor
110891262|NCT02064530|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110891263|NCT02064530|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110891264|NCT02064530|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110891265|NCT02064530|Adrenergic Agents|adrenergic agents|mesh-ancestor
110891266|NCT02064530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110223573|NCT00294892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110891267|NCT02064530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110891268|NCT04519437|Casirivimab and imdevimab drug combination|casirivimab and imdevimab drug combination|mesh-list
110891269|NCT04519437|Antiviral Agents|antiviral agents|mesh-ancestor
110891270|NCT04519437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110891271|NCT01359085|Pregabalin|pregabalin|mesh-list
110891272|NCT01359085|Analgesics|analgesics|mesh-ancestor
110891273|NCT01359085|Sensory System Agents|sensory system agents|mesh-ancestor
110891274|NCT01359085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110891275|NCT01359085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110891276|NCT01359085|Anticonvulsants|anticonvulsants|mesh-ancestor
110891277|NCT01359085|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110891278|NCT01359085|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110891279|NCT01359085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110891280|NCT01359085|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110891281|NCT01359085|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110891282|NCT01359085|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110891283|NCT01359085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110891284|NCT01359085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110891285|NCT04322357|Prednisone|prednisone|mesh-list
110891286|NCT04322357|Glucocorticoids|glucocorticoids|mesh-list
110891287|NCT04322357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110891288|NCT04322357|Hormones|hormones|mesh-ancestor
110891289|NCT04322357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110891290|NCT04322357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110891291|NCT04322357|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110891292|NCT04322357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110891293|NCT01351285|Remifentanil|remifentanil|mesh-list
110891294|NCT01351285|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110891295|NCT01351285|Narcotics|narcotics|mesh-ancestor
110891296|NCT01351285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110891297|NCT01351285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110891298|NCT01351285|Analgesics|analgesics|mesh-ancestor
110891299|NCT01351285|Sensory System Agents|sensory system agents|mesh-ancestor
110891300|NCT01351285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110608800|NCT00943930|Sensory System Agents|sensory system agents|mesh-ancestor
110891301|NCT02032290|Clopidogrel|clopidogrel|mesh-list
110891302|NCT02032290|Ticagrelor|ticagrelor|mesh-list
110891303|NCT02032290|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110891304|NCT02032290|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110891305|NCT02032290|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110891306|NCT02032290|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110891307|NCT02032290|Purinergic Agents|purinergic agents|mesh-ancestor
110891308|NCT02032290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110891309|NCT02032290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110891310|NCT02032290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110891311|NCT03379428|Trastuzumab|trastuzumab|mesh-list
110891312|NCT03379428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110891313|NCT03379428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110891314|NCT03628131|Carboplatin|carboplatin|mesh-list
110891315|NCT03628131|Etoposide|etoposide|mesh-list
110891316|NCT03628131|Ifosfamide|ifosfamide|mesh-list
110891317|NCT03628131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110891318|NCT03628131|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110891319|NCT03628131|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110891320|NCT03628131|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110891321|NCT03628131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110200752|NCT00145990|Miotics|miotics|mesh-ancestor
110891322|NCT03628131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110891323|NCT03628131|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110891324|NCT03628131|Alkylating Agents|alkylating agents|mesh-ancestor
110891325|NCT03560024|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
110891326|NCT03560024|Growth Substances|growth substances|mesh-ancestor
110891327|NCT03560024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110891328|NCT03560024|Vasodilator Agents|vasodilator agents|mesh-ancestor
110891329|NCT03560024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110891330|NCT03560024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110891331|NCT01351519|Aminolevulinic Acid|aminolevulinic acid|mesh-list
110891332|NCT01351519|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110891333|NCT01351519|Dermatologic Agents|dermatologic agents|mesh-ancestor
110891334|NCT03612492|Lidocaine|lidocaine|mesh-list
110891335|NCT03612492|Anesthetics, Local|anesthetics, local|mesh-list
110891336|NCT03612492|Anesthetics|anesthetics|mesh-list
110891337|NCT03612492|Esmolol|esmolol|mesh-list
110891338|NCT03612492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110891339|NCT03612492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110891340|NCT03612492|Sensory System Agents|sensory system agents|mesh-ancestor
110891341|NCT03612492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110891342|NCT03612492|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110891343|NCT03612492|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110891344|NCT03612492|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110891345|NCT03612492|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110891346|NCT03612492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110891347|NCT03612492|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110891348|NCT03612492|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110891349|NCT03612492|Adrenergic Agents|adrenergic agents|mesh-ancestor
110891350|NCT03612492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110891351|NCT03612492|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110891352|NCT01359163|Ethynodiol Diacetate|ethynodiol diacetate|mesh-list
110891353|NCT01359163|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110891354|NCT01359163|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110891355|NCT01359163|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110891356|NCT01359163|Contraceptive Agents|contraceptive agents|mesh-ancestor
110891357|NCT01359163|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110891358|NCT01359163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110891359|NCT01359163|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110891360|NCT01359163|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110891361|NCT03730337|Nivolumab|nivolumab|mesh-list
110891362|NCT03730337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110891363|NCT03730337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110891364|NCT03730337|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110891365|NCT03730337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110891366|NCT01351597|Docetaxel|docetaxel|mesh-list
110891367|NCT01351597|Oxaliplatin|oxaliplatin|mesh-list
110891368|NCT01351597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110891369|NCT01351597|Tubulin Modulators|tubulin modulators|mesh-ancestor
110891370|NCT01351597|Antimitotic Agents|antimitotic agents|mesh-ancestor
110891371|NCT01351597|Mitosis Modulators|mitosis modulators|mesh-ancestor
110891372|NCT01351597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110891373|NCT02793128|Mitomycins|mitomycins|mesh-list
110891374|NCT02793128|Mitomycin|mitomycin|mesh-list
110891375|NCT02793128|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110891376|NCT02793128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110891377|NCT02793128|Alkylating Agents|alkylating agents|mesh-ancestor
110891378|NCT02793128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110891379|NCT02793128|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110891380|NCT02793128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110891382|NCT03612180|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110891383|NCT03612180|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110891384|NCT03612180|Sympatholytics|sympatholytics|mesh-ancestor
110891385|NCT03612180|Autonomic Agents|autonomic agents|mesh-ancestor
110891386|NCT03612180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110891387|NCT03612180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110891388|NCT03612180|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110891389|NCT03612180|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110891390|NCT03612180|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110891391|NCT03612180|Adrenergic Agents|adrenergic agents|mesh-ancestor
110891392|NCT03612180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110891393|NCT03612180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110891394|NCT04400799|Enoxaparin|enoxaparin|mesh-list
110891395|NCT04400799|Anticoagulants|anticoagulants|mesh-ancestor
110891396|NCT04400799|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110891397|NCT04400799|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110891398|NCT04400799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110891399|NCT01359241|Insulin|insulin|mesh-list
110891400|NCT01359241|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110891401|NCT01359241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110891402|NCT02068196|Ipilimumab|ipilimumab|mesh-list
110891403|NCT02068196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110891404|NCT02068196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110891405|NCT02068196|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110891406|NCT02068196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110891407|NCT03142451|Minocycline|minocycline|mesh-list
110891408|NCT03142451|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110891409|NCT03142451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110891410|NCT04065789|Dexamethasone|dexamethasone|mesh-list
110891411|NCT04065789|Lenalidomide|lenalidomide|mesh-list
110891412|NCT04065789|Daratumumab|daratumumab|mesh-list
110891413|NCT04065789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110891414|NCT04065789|Antiemetics|antiemetics|mesh-ancestor
110891415|NCT04065789|Autonomic Agents|autonomic agents|mesh-ancestor
110891416|NCT04065789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110891417|NCT04065789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110891418|NCT04065789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110891419|NCT04065789|Glucocorticoids|glucocorticoids|mesh-ancestor
110891421|NCT04065789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110891422|NCT04065789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110891423|NCT04065789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110891424|NCT04065789|Immunologic Factors|immunologic factors|mesh-ancestor
110891425|NCT04065789|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110891426|NCT04065789|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110891427|NCT04065789|Growth Substances|growth substances|mesh-ancestor
110891428|NCT04065789|Growth Inhibitors|growth inhibitors|mesh-ancestor
110891429|NCT02066558|Carbon Monoxide|carbon monoxide|mesh-list
110891430|NCT02066558|Antimetabolites|antimetabolites|mesh-ancestor
110891431|NCT02066558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110891432|NCT02066558|Gasotransmitters|gasotransmitters|mesh-ancestor
110891433|NCT02066558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110891434|NCT02066558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110891435|NCT02064842|Ritonavir|ritonavir|mesh-list
110891436|NCT02064842|Simeprevir|simeprevir|mesh-list
110891437|NCT02064842|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110891438|NCT02064842|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110891439|NCT02064842|Protease Inhibitors|protease inhibitors|mesh-ancestor
110891440|NCT02064842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110891441|NCT02064842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110891442|NCT02064842|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110891443|NCT02064842|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110891444|NCT02064842|Antiviral Agents|antiviral agents|mesh-ancestor
110891445|NCT02064842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110891446|NCT02064842|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110891447|NCT02064842|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110608952|NCT00865059|Gabapentin|gabapentin|mesh-list
110891448|NCT04192266|Estradiol|estradiol|mesh-list
110891450|NCT04192266|Hormones|hormones|mesh-ancestor
110891451|NCT04192266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110891452|NCT04192266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110891453|NCT01370018|Protease Inhibitors|protease inhibitors|mesh-list
110891454|NCT01370018|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
110891455|NCT01370018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110891456|NCT01370018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110891457|NCT01370018|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
110891458|NCT01370018|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110891459|NCT01359397|Bevacizumab|bevacizumab|mesh-list
110891460|NCT01359397|Trastuzumab|trastuzumab|mesh-list
110891461|NCT01359397|Docetaxel|docetaxel|mesh-list
110891462|NCT01359397|Oxaliplatin|oxaliplatin|mesh-list
110891463|NCT01359397|Capecitabine|capecitabine|mesh-list
110891464|NCT01359397|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110891465|NCT01359397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110891466|NCT01359397|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110891467|NCT01359397|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110891468|NCT01359397|Growth Substances|growth substances|mesh-ancestor
110891469|NCT01359397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110891470|NCT01359397|Growth Inhibitors|growth inhibitors|mesh-ancestor
110891471|NCT01359397|Tubulin Modulators|tubulin modulators|mesh-ancestor
110891472|NCT01359397|Antimitotic Agents|antimitotic agents|mesh-ancestor
110891473|NCT01359397|Mitosis Modulators|mitosis modulators|mesh-ancestor
110891474|NCT01359397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110891475|NCT01359397|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110891476|NCT01359397|Antimetabolites|antimetabolites|mesh-ancestor
110891477|NCT05250245|Tolterodine Tartrate|tolterodine tartrate|mesh-list
110891478|NCT05250245|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110891479|NCT05250245|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110891480|NCT05250245|Cholinergic Agents|cholinergic agents|mesh-ancestor
110891481|NCT05250245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110891482|NCT05250245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110891483|NCT05250245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110891484|NCT05250245|Urological Agents|urological agents|mesh-ancestor
110891485|NCT01347983|Methotrexate|methotrexate|mesh-list
110891486|NCT01347983|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110891487|NCT01347983|Abortifacient Agents|abortifacient agents|mesh-ancestor
110891488|NCT01347983|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110891489|NCT01347983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110891490|NCT01347983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110891491|NCT01347983|Antimetabolites|antimetabolites|mesh-ancestor
110891492|NCT01347983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110891493|NCT01347983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110891494|NCT01347983|Dermatologic Agents|dermatologic agents|mesh-ancestor
110891495|NCT01347983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110891496|NCT01347983|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110891497|NCT01347983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110891498|NCT01347983|Immunologic Factors|immunologic factors|mesh-ancestor
110891499|NCT01347983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110891500|NCT01347983|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110891501|NCT05249933|Benzocaine|benzocaine|mesh-list
110891502|NCT05249933|Anesthetics, Local|anesthetics, local|mesh-ancestor
110891503|NCT05249933|Anesthetics|anesthetics|mesh-ancestor
110891504|NCT05249933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110891505|NCT05249933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110891506|NCT05249933|Sensory System Agents|sensory system agents|mesh-ancestor
110891507|NCT05249933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110891508|NCT02032836|Iloprost|iloprost|mesh-list
110891509|NCT02032836|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110891510|NCT02032836|Vasodilator Agents|vasodilator agents|mesh-ancestor
110891511|NCT02065076|Polystyrene sulfonic acid|polystyrene sulfonic acid|mesh-list
110891512|NCT02065076|Chelating Agents|chelating agents|mesh-ancestor
110891513|NCT02065076|Sequestering Agents|sequestering agents|mesh-ancestor
110891514|NCT02065076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110891515|NCT02465593|Fluorouracil|fluorouracil|mesh-list
110891516|NCT02465593|Capecitabine|capecitabine|mesh-list
110891517|NCT02465593|Antimetabolites|antimetabolites|mesh-ancestor
110891518|NCT02465593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110891519|NCT02465593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110891520|NCT02465593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110891521|NCT02465593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110891522|NCT02465593|Immunologic Factors|immunologic factors|mesh-ancestor
110891523|NCT02465593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110891524|NCT02424019|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
110891525|NCT02424019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110891526|NCT02424019|Glucocorticoids|glucocorticoids|mesh-ancestor
110891527|NCT02424019|Hormones|hormones|mesh-ancestor
110891528|NCT02424019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110891529|NCT02424019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110891530|NCT02066870|Arsenic Trioxide|arsenic trioxide|mesh-list
110891531|NCT02066870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110891532|NCT03611244|Benzocaine|benzocaine|mesh-list
110891533|NCT03611244|Anesthetics, Local|anesthetics, local|mesh-ancestor
110891534|NCT03611244|Anesthetics|anesthetics|mesh-ancestor
110891535|NCT03611244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110891536|NCT03611244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110891537|NCT03611244|Sensory System Agents|sensory system agents|mesh-ancestor
110891538|NCT03611244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110891539|NCT01359709|Nicotine|nicotine|mesh-list
110891540|NCT01359709|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110891541|NCT01359709|Autonomic Agents|autonomic agents|mesh-ancestor
110891542|NCT01359709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110891543|NCT01359709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110891544|NCT01359709|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110891545|NCT01359709|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110891546|NCT01359709|Cholinergic Agents|cholinergic agents|mesh-ancestor
110891547|NCT01359709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110891548|NCT01359709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110891549|NCT02826486|Leucovorin|leucovorin|mesh-list
110891550|NCT02826486|Pembrolizumab|pembrolizumab|mesh-list
110891551|NCT02826486|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110891552|NCT02826486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110891553|NCT02826486|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110891554|NCT02826486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110891555|NCT02826486|Antidotes|antidotes|mesh-ancestor
110891556|NCT02826486|Protective Agents|protective agents|mesh-ancestor
110891557|NCT02826486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110891558|NCT02826486|Vitamin B Complex|vitamin b complex|mesh-ancestor
110891559|NCT02826486|Vitamins|vitamins|mesh-ancestor
110891560|NCT02826486|Micronutrients|micronutrients|mesh-ancestor
110891561|NCT02825940|Gemcitabine|gemcitabine|mesh-list
110891562|NCT02825940|Atezolizumab|atezolizumab|mesh-list
110891563|NCT02825940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110891564|NCT02825940|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110891565|NCT02825940|Antimetabolites|antimetabolites|mesh-ancestor
110891566|NCT02825940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110891567|NCT02825940|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110891568|NCT02825940|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110891569|NCT02304991|Glycerol|glycerol|mesh-list
110891570|NCT02304991|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
110891571|NCT02304991|Protective Agents|protective agents|mesh-ancestor
110891572|NCT02304991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110891573|NCT02069132|Warfarin|warfarin|mesh-list
110891574|NCT02069132|Anticoagulants|anticoagulants|mesh-ancestor
110891575|NCT01352065|Bosentan|bosentan|mesh-list
110891576|NCT01352065|Ambrisentan|ambrisentan|mesh-list
110891577|NCT01352065|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110891578|NCT01352065|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
110891579|NCT01352065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110891581|NCT01356043|Amlodipine|amlodipine|mesh-list
110891582|NCT01356043|Telmisartan|telmisartan|mesh-list
110891583|NCT01356043|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110891584|NCT01356043|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110891585|NCT01356043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110891586|NCT01356043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110891587|NCT01356043|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110891588|NCT01356043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110891589|NCT01356043|Vasodilator Agents|vasodilator agents|mesh-ancestor
110891590|NCT01356043|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110891591|NCT01356043|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110891592|NCT01356043|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110891593|NCT01356043|Antimetabolites|antimetabolites|mesh-ancestor
110891594|NCT01356043|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110891595|NCT01356043|Vitamin B Complex|vitamin b complex|mesh-ancestor
110891596|NCT01356043|Vitamins|vitamins|mesh-ancestor
110891597|NCT01356043|Micronutrients|micronutrients|mesh-ancestor
110891598|NCT02065388|Warfarin|warfarin|mesh-list
110891599|NCT02065388|Anticoagulants|anticoagulants|mesh-ancestor
110891600|NCT01317563|Vitamin A|vitamin a|mesh-list
110891601|NCT01317563|Selenium|selenium|mesh-list
110891602|NCT01317563|Vitamins|vitamins|mesh-ancestor
110891603|NCT01317563|Micronutrients|micronutrients|mesh-ancestor
110891604|NCT01317563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110891605|NCT01317563|Antioxidants|antioxidants|mesh-ancestor
110891606|NCT01317563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110891607|NCT01317563|Protective Agents|protective agents|mesh-ancestor
110891608|NCT01317563|Trace Elements|trace elements|mesh-ancestor
110891609|NCT02067338|Morphine|morphine|mesh-list
110891610|NCT02067338|Cellulose, Oxidized|cellulose, oxidized|mesh-list
110891611|NCT02067338|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110891612|NCT02067338|Narcotics|narcotics|mesh-ancestor
110891613|NCT02067338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110891614|NCT02067338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110891615|NCT02067338|Analgesics|analgesics|mesh-ancestor
110891616|NCT02067338|Sensory System Agents|sensory system agents|mesh-ancestor
110891617|NCT02067338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110891618|NCT02067338|Hemostatics|hemostatics|mesh-ancestor
110891619|NCT02067338|Coagulants|coagulants|mesh-ancestor
110891620|NCT01352143|Thrombin|thrombin|mesh-list
110891621|NCT01352143|Hemostatics|hemostatics|mesh-ancestor
110891622|NCT01352143|Coagulants|coagulants|mesh-ancestor
110891623|NCT01352299|Pyrithione zinc|pyrithione zinc|mesh-list
110891624|NCT01352299|Keratolytic Agents|keratolytic agents|mesh-ancestor
110891625|NCT01352299|Dermatologic Agents|dermatologic agents|mesh-ancestor
110891626|NCT05188495|Trastuzumab|trastuzumab|mesh-list
110891627|NCT05188495|Pertuzumab|pertuzumab|mesh-list
110891628|NCT05188495|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110891629|NCT05188495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110891630|NCT02069288|Fludrocortisone|fludrocortisone|mesh-list
110891631|NCT02069288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110891632|NCT01356121|Midazolam|midazolam|mesh-list
110891633|NCT01356121|Propofol|propofol|mesh-list
110891634|NCT01356121|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110891635|NCT01356121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110891636|NCT01356121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110891637|NCT01356121|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110891638|NCT01356121|Anesthetics, General|anesthetics, general|mesh-ancestor
110891639|NCT01356121|Anesthetics|anesthetics|mesh-ancestor
110891640|NCT01356121|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110891641|NCT01356121|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110891642|NCT01356121|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110891643|NCT01356121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110891644|NCT01356121|GABA Modulators|gaba modulators|mesh-ancestor
110891645|NCT01356121|GABA Agents|gaba agents|mesh-ancestor
110891646|NCT01356121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110891647|NCT01356121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110891649|NCT01336608|Xhance|xhance|mesh-list
110891650|NCT01336608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110891651|NCT01336608|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110891652|NCT01336608|Autonomic Agents|autonomic agents|mesh-ancestor
110891653|NCT01336608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110891654|NCT01336608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110891655|NCT01336608|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110891656|NCT01336608|Respiratory System Agents|respiratory system agents|mesh-ancestor
110891657|NCT01336608|Dermatologic Agents|dermatologic agents|mesh-ancestor
110891658|NCT01336608|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110891659|NCT03628521|Carboplatin|carboplatin|mesh-list
110891660|NCT03628521|Gemcitabine|gemcitabine|mesh-list
110891661|NCT03628521|Pemetrexed|pemetrexed|mesh-list
110891662|NCT03628521|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110891663|NCT03628521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110891664|NCT03628521|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110891665|NCT03628521|Antimetabolites|antimetabolites|mesh-ancestor
110891666|NCT03628521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110891667|NCT03628521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110891668|NCT03628521|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110891669|NCT03628521|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110891670|NCT03628521|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110891671|NCT05697003|Fluticasone|fluticasone|mesh-list
110891672|NCT05697003|Xhance|xhance|mesh-list
110891673|NCT05697003|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110891674|NCT05697003|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
110891675|NCT05697003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110891676|NCT05697003|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110891677|NCT05697003|Autonomic Agents|autonomic agents|mesh-ancestor
110891678|NCT05697003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110891679|NCT05697003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110891680|NCT05697003|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110891681|NCT05697003|Respiratory System Agents|respiratory system agents|mesh-ancestor
110891682|NCT05697003|Dermatologic Agents|dermatologic agents|mesh-ancestor
110891683|NCT05697003|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110891684|NCT05697003|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110891685|NCT05697003|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110891686|NCT05697003|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110891687|NCT05697003|Adrenergic Agents|adrenergic agents|mesh-ancestor
110891688|NCT05697003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110891689|NCT05697003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110891690|NCT05697003|Glucocorticoids|glucocorticoids|mesh-ancestor
110891692|NCT05697003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110891693|NCT05697003|Sympathomimetics|sympathomimetics|mesh-ancestor
110891694|NCT02069522|Carotenoids|carotenoids|mesh-list
110891695|NCT02069522|Antioxidants|antioxidants|mesh-ancestor
110891696|NCT02069522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110891697|NCT02069522|Protective Agents|protective agents|mesh-ancestor
110891698|NCT02069522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110891699|NCT01361425|Methyldopa|methyldopa|mesh-list
110891700|NCT01361425|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110891701|NCT01361425|Sympatholytics|sympatholytics|mesh-ancestor
110891702|NCT01361425|Autonomic Agents|autonomic agents|mesh-ancestor
110891703|NCT01361425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110891704|NCT01361425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110891705|NCT01361425|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110891706|NCT01361425|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110891707|NCT01361425|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110891708|NCT01361425|Adrenergic Agents|adrenergic agents|mesh-ancestor
110891709|NCT01361425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110891710|NCT01361425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110891711|NCT01356355|Tolterodine Tartrate|tolterodine tartrate|mesh-list
110891712|NCT01356355|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110891713|NCT01356355|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110891714|NCT01356355|Cholinergic Agents|cholinergic agents|mesh-ancestor
110891715|NCT01356355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110922429|NCT03104140|Anesthetics|anesthetics|mesh-ancestor
110891716|NCT01356355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110891717|NCT01356355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110891718|NCT01356355|Urological Agents|urological agents|mesh-ancestor
110891719|NCT01356433|Vitamins|vitamins|mesh-list
110891720|NCT01356433|Ascorbic Acid|ascorbic acid|mesh-list
110891721|NCT01356433|Micronutrients|micronutrients|mesh-ancestor
110891722|NCT01356433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110891723|NCT01356433|Antioxidants|antioxidants|mesh-ancestor
110891724|NCT01356433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110891725|NCT01356433|Protective Agents|protective agents|mesh-ancestor
110891726|NCT03691727|Tirofiban|tirofiban|mesh-list
110891727|NCT03691727|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110891728|NCT03691727|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110891729|NCT03691727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110063733|NCT01303341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110891730|NCT03691727|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110891731|NCT01346371|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110891732|NCT01346371|Lubricant Eye Drops|lubricant eye drops|mesh-list
110891733|NCT01346371|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110891734|NCT01356511|Dexamethasone|dexamethasone|mesh-list
110891735|NCT01356511|Prednisone|prednisone|mesh-list
110891736|NCT01356511|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110891737|NCT01356511|Antiemetics|antiemetics|mesh-ancestor
110891738|NCT01356511|Autonomic Agents|autonomic agents|mesh-ancestor
110891739|NCT01356511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110891740|NCT01356511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110891741|NCT01356511|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110891742|NCT01356511|Glucocorticoids|glucocorticoids|mesh-ancestor
110891743|NCT01356511|Hormones|hormones|mesh-ancestor
110891744|NCT01356511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110891745|NCT01356511|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110891746|NCT01356511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110891747|NCT02069990|Cholecalciferol|cholecalciferol|mesh-list
110891748|NCT02069990|Vitamin D|vitamin d|mesh-list
110891749|NCT02069990|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110891750|NCT02069990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110891751|NCT02069990|Vitamins|vitamins|mesh-ancestor
110891752|NCT02069990|Micronutrients|micronutrients|mesh-ancestor
110609258|NCT00948220|Ribavirin|ribavirin|mesh-list
110891753|NCT02069990|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110891754|NCT05076409|Fluconazole|fluconazole|mesh-list
110891755|NCT05076409|BI 425809|bi 425809|mesh-list
110891756|NCT05076409|Antifungal Agents|antifungal agents|mesh-ancestor
110891757|NCT05076409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110891758|NCT05076409|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110891759|NCT05076409|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110891760|NCT05076409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110891761|NCT05076409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110891762|NCT05076409|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110891763|NCT05076409|Hormone Antagonists|hormone antagonists|mesh-ancestor
110891764|NCT05076409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110891765|NCT05076409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110891766|NCT05076409|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110891767|NCT05076409|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110891768|NCT05076409|Nootropic Agents|nootropic agents|mesh-ancestor
110891769|NCT02076386|Dolutegravir|dolutegravir|mesh-list
110891770|NCT02076386|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110891771|NCT02076386|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110891772|NCT02076386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110891773|NCT02076386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110891774|NCT02076386|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110891775|NCT02076386|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110891776|NCT02076386|Antiviral Agents|antiviral agents|mesh-ancestor
110891777|NCT02076386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110891778|NCT01347593|Ceftizoxime|ceftizoxime|mesh-list
110891779|NCT01347593|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110891780|NCT01347593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110891782|NCT02072330|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110891783|NCT02072330|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
110891784|NCT02072330|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110891785|NCT02072330|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110891787|NCT02072330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110891788|NCT02072330|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110891789|NCT02072330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110891790|NCT02072330|Vasodilator Agents|vasodilator agents|mesh-ancestor
110891791|NCT02072330|Diuretics|diuretics|mesh-ancestor
110891792|NCT02072330|Natriuretic Agents|natriuretic agents|mesh-ancestor
110891793|NCT02072330|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110891794|NCT02072330|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110891795|NCT02072330|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110891796|NCT02072408|Aflibercept|aflibercept|mesh-list
110891797|NCT02072408|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110891798|NCT02072408|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110891799|NCT02072408|Growth Substances|growth substances|mesh-ancestor
110891800|NCT02072408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110891801|NCT02072408|Growth Inhibitors|growth inhibitors|mesh-ancestor
110891802|NCT02072408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110891803|NCT02070458|Cytarabine|cytarabine|mesh-list
110891804|NCT02070458|Etoposide|etoposide|mesh-list
110891805|NCT02070458|Mitoxantrone|mitoxantrone|mesh-list
110891806|NCT02070458|Etoposide phosphate|etoposide phosphate|mesh-list
110891807|NCT02070458|Ixazomib|ixazomib|mesh-list
110891808|NCT02070458|Glycine|glycine|mesh-list
110891809|NCT02070458|Proteasome Inhibitors|proteasome inhibitors|mesh-list
110891810|NCT02070458|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110891811|NCT02070458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110891812|NCT02070458|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110891813|NCT02070458|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110891814|NCT02070458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110891815|NCT02070458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110891816|NCT02070458|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110891817|NCT02070458|Antimetabolites|antimetabolites|mesh-ancestor
110891818|NCT02070458|Antiviral Agents|antiviral agents|mesh-ancestor
110891819|NCT02070458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110223615|NCT00089622|Levodopa|levodopa|mesh-list
110891820|NCT02070458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110891821|NCT02070458|Immunologic Factors|immunologic factors|mesh-ancestor
110891822|NCT02070458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110891823|NCT02070458|Analgesics|analgesics|mesh-ancestor
110891824|NCT02070458|Sensory System Agents|sensory system agents|mesh-ancestor
110891825|NCT02070458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110891826|NCT02070458|Protease Inhibitors|protease inhibitors|mesh-ancestor
110891827|NCT02070458|Glycine Agents|glycine agents|mesh-ancestor
110891828|NCT02070458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110891830|NCT03131479|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110891831|NCT03131479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110891832|NCT03131479|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110891833|NCT03131479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110891834|NCT02077010|Milrinone|milrinone|mesh-list
110891835|NCT02077010|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110891836|NCT02077010|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110891837|NCT02077010|Vasodilator Agents|vasodilator agents|mesh-ancestor
110891838|NCT02077010|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110891839|NCT02077010|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110891840|NCT02077010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110891841|NCT02077010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110891842|NCT02077010|Protective Agents|protective agents|mesh-ancestor
110891843|NCT02077010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110891844|NCT01319461|Hyaluronic Acid|hyaluronic acid|mesh-list
110891845|NCT01319461|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110891846|NCT01319461|Immunologic Factors|immunologic factors|mesh-ancestor
110891847|NCT01319461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110891848|NCT01319461|Viscosupplements|viscosupplements|mesh-ancestor
110891849|NCT01319461|Protective Agents|protective agents|mesh-ancestor
110891850|NCT02072720|Bevacizumab|bevacizumab|mesh-list
110891851|NCT02072720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110891852|NCT02072720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110891853|NCT02072720|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110891854|NCT02072720|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110891855|NCT02072720|Growth Substances|growth substances|mesh-ancestor
110891856|NCT02072720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110891857|NCT02072720|Growth Inhibitors|growth inhibitors|mesh-ancestor
110891858|NCT01356745|Nitrous Oxide|nitrous oxide|mesh-list
110891859|NCT01356745|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110891860|NCT01356745|Anesthetics, General|anesthetics, general|mesh-ancestor
110891861|NCT01356745|Anesthetics|anesthetics|mesh-ancestor
110891862|NCT01356745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110891863|NCT01356745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110891864|NCT01356745|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110891865|NCT01356745|Analgesics|analgesics|mesh-ancestor
110891866|NCT01356745|Sensory System Agents|sensory system agents|mesh-ancestor
110891867|NCT01356745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110891868|NCT02072798|Cefuroxime|cefuroxime|mesh-list
110891869|NCT02072798|Cefuroxime axetil|cefuroxime axetil|mesh-list
110891870|NCT02072798|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110891871|NCT02072798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110891872|NCT04943549|Bupivacaine|bupivacaine|mesh-list
110891873|NCT04943549|Anesthetics, Local|anesthetics, local|mesh-ancestor
110891874|NCT04943549|Anesthetics|anesthetics|mesh-ancestor
110891875|NCT04943549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110891876|NCT04943549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110891877|NCT04943549|Sensory System Agents|sensory system agents|mesh-ancestor
110891878|NCT04943549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110891879|NCT04252105|Antioxidants|antioxidants|mesh-list
110891880|NCT04252105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110891881|NCT04252105|Protective Agents|protective agents|mesh-ancestor
110891882|NCT04252105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110891883|NCT02077322|Polyvinyl alcohol formaldehyde foam|polyvinyl alcohol formaldehyde foam|mesh-list
110891884|NCT02077322|Hemostatics|hemostatics|mesh-ancestor
110891885|NCT02077322|Coagulants|coagulants|mesh-ancestor
110891886|NCT02077400|Cefazolin|cefazolin|mesh-list
110891887|NCT02077400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110891888|NCT02077400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110891889|NCT02077478|Remifentanil|remifentanil|mesh-list
110891890|NCT02077478|Propofol|propofol|mesh-list
110891891|NCT02077478|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110891892|NCT02077478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110200928|NCT00405730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110891893|NCT02077478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110891894|NCT02077478|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110891895|NCT02077478|Anesthetics, General|anesthetics, general|mesh-ancestor
110891896|NCT02077478|Anesthetics|anesthetics|mesh-ancestor
110891897|NCT02077478|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110891898|NCT02077478|Narcotics|narcotics|mesh-ancestor
110891899|NCT02077478|Analgesics|analgesics|mesh-ancestor
110891900|NCT02077478|Sensory System Agents|sensory system agents|mesh-ancestor
110891901|NCT02077478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110891902|NCT02077556|Mycophenolic Acid|mycophenolic acid|mesh-list
110891903|NCT02077556|Methylprednisolone|methylprednisolone|mesh-list
110891904|NCT02077556|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110891905|NCT02077556|Prednisolone|prednisolone|mesh-list
110891907|NCT02077556|Tacrolimus|tacrolimus|mesh-list
110891908|NCT02077556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110891909|NCT02077556|Immunologic Factors|immunologic factors|mesh-ancestor
110891910|NCT02077556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110891911|NCT02077556|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110891912|NCT02077556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110891913|NCT02077556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110891914|NCT02077556|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110891915|NCT02077556|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110891916|NCT02077556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110891917|NCT02077556|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110891918|NCT02077556|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110891919|NCT02077556|Antitubercular Agents|antitubercular agents|mesh-ancestor
110891920|NCT02077556|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110891921|NCT02077556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110922446|NCT00102648|Lonafarnib|lonafarnib|mesh-list
110891922|NCT02077556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110891923|NCT02077556|Antiemetics|antiemetics|mesh-ancestor
110891924|NCT02077556|Autonomic Agents|autonomic agents|mesh-ancestor
110891925|NCT02077556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110891926|NCT02077556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110891927|NCT02077556|Glucocorticoids|glucocorticoids|mesh-ancestor
110891928|NCT02077556|Hormones|hormones|mesh-ancestor
110891929|NCT02077556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110891930|NCT02077556|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110891931|NCT02077556|Protective Agents|protective agents|mesh-ancestor
110891932|NCT02077556|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110891933|NCT02930941|Tranexamic Acid|tranexamic acid|mesh-list
110891934|NCT02930941|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110891935|NCT02930941|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110891936|NCT02930941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110891937|NCT02930941|Hemostatics|hemostatics|mesh-ancestor
110891938|NCT02930941|Coagulants|coagulants|mesh-ancestor
110891939|NCT02077634|Prednisone|prednisone|mesh-list
110891940|NCT02077634|Abiraterone Acetate|abiraterone acetate|mesh-list
110891941|NCT02077634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110891942|NCT02077634|Glucocorticoids|glucocorticoids|mesh-ancestor
110891943|NCT02077634|Hormones|hormones|mesh-ancestor
110891944|NCT02077634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110891945|NCT02077634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110891946|NCT02077634|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110891947|NCT02077634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110891948|NCT02077634|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110891949|NCT02077634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110891950|NCT02077634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110891951|NCT02077634|Hormone Antagonists|hormone antagonists|mesh-ancestor
110891952|NCT02077634|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110891953|NCT01365403|Carbamazepine|carbamazepine|mesh-list
110891954|NCT01365403|Anticonvulsants|anticonvulsants|mesh-ancestor
110891955|NCT01365403|Antimanic Agents|antimanic agents|mesh-ancestor
110891956|NCT01365403|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110891957|NCT01365403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110891958|NCT01365403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110891959|NCT01365403|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110891960|NCT01365403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110891961|NCT01365403|Analgesics|analgesics|mesh-ancestor
110891962|NCT01365403|Sensory System Agents|sensory system agents|mesh-ancestor
110891963|NCT01365403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110891964|NCT01365403|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110891965|NCT01365403|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110223627|NCT00295555|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110891966|NCT01365403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110891967|NCT01365403|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110891968|NCT01365403|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110891969|NCT01352663|Insulin|insulin|mesh-list
110891970|NCT01352663|Insulin Glargine|insulin glargine|mesh-list
110891971|NCT01352663|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110891972|NCT01352663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110891973|NCT01362361|Nintedanib|nintedanib|mesh-list
110891974|NCT01362361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110891975|NCT01362361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110891976|NCT01362361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110891977|NCT01362361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110891978|NCT02077712|Dexmedetomidine|dexmedetomidine|mesh-list
110891979|NCT02077712|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110891980|NCT02077712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110891981|NCT02077712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110922452|NCT03290287|Bromides|bromides|mesh-list
110891982|NCT02077712|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110891983|NCT02077712|Analgesics|analgesics|mesh-ancestor
110891984|NCT02077712|Sensory System Agents|sensory system agents|mesh-ancestor
110891985|NCT02077712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110891986|NCT02077712|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110891987|NCT02077712|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110891988|NCT02077712|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110891989|NCT02077712|Adrenergic Agents|adrenergic agents|mesh-ancestor
110891990|NCT02077712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110891991|NCT02077712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110891992|NCT02073734|Dexamethasone|dexamethasone|mesh-list
110891993|NCT02073734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110891994|NCT02073734|Antiemetics|antiemetics|mesh-ancestor
110891995|NCT02073734|Autonomic Agents|autonomic agents|mesh-ancestor
110891996|NCT02073734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110891997|NCT02073734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110891998|NCT02073734|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110891999|NCT02073734|Glucocorticoids|glucocorticoids|mesh-ancestor
110892000|NCT02073734|Hormones|hormones|mesh-ancestor
110892001|NCT02073734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110892002|NCT02073734|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110892003|NCT02073734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110892004|NCT02071004|Aspirin|aspirin|mesh-list
110892005|NCT02071004|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110892006|NCT02071004|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110892007|NCT02071004|Analgesics|analgesics|mesh-ancestor
110892008|NCT02071004|Sensory System Agents|sensory system agents|mesh-ancestor
110892009|NCT02071004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110892010|NCT02071004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110892011|NCT02071004|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110892012|NCT02071004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110892013|NCT02071004|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110892014|NCT02071004|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110892015|NCT02071004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110892016|NCT02071004|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110892017|NCT02071004|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110892018|NCT02071004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110892019|NCT02071004|Antipyretics|antipyretics|mesh-ancestor
110892020|NCT02071160|Melatonin|melatonin|mesh-list
110892021|NCT02071160|Antioxidants|antioxidants|mesh-ancestor
110892022|NCT02071160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110892023|NCT02071160|Protective Agents|protective agents|mesh-ancestor
110892024|NCT02071160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110892025|NCT02071160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110892026|NCT03131713|Acetaminophen|acetaminophen|mesh-list
110892027|NCT03131713|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110892028|NCT03131713|Analgesics|analgesics|mesh-ancestor
110892029|NCT03131713|Sensory System Agents|sensory system agents|mesh-ancestor
110892030|NCT03131713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110892031|NCT03131713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110892032|NCT03131713|Antipyretics|antipyretics|mesh-ancestor
110892033|NCT03514121|Pembrolizumab|pembrolizumab|mesh-list
110892034|NCT03514121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110892035|NCT03514121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110892036|NCT03514121|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110892037|NCT03514121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110892038|NCT02930005|Meclofenamic Acid|meclofenamic acid|mesh-list
110892039|NCT02930005|Pentosan Sulfuric Polyester|pentosan sulfuric polyester|mesh-list
110892040|NCT02930005|Anticoagulants|anticoagulants|mesh-ancestor
110892041|NCT02930005|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110892044|NCT02930005|Sensory System Agents|sensory system agents|mesh-ancestor
110892045|NCT02930005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110892046|NCT02930005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110892047|NCT02930005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110892048|NCT02930005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110892049|NCT02930005|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110892050|NCT02930005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110892051|NCT02930005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110892052|NCT01349387|Metformin|metformin|mesh-list
110892053|NCT01349387|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110892054|NCT01349387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110892055|NCT04905173|Amyl Nitrite|amyl nitrite|mesh-list
110892056|NCT04905173|Vasodilator Agents|vasodilator agents|mesh-ancestor
110892057|NCT01361269|Clindamycin|clindamycin|mesh-list
110892058|NCT01361269|Clindamycin palmitate|clindamycin palmitate|mesh-list
110892059|NCT01361269|Clindamycin phosphate|clindamycin phosphate|mesh-list
110892060|NCT01361269|Fosmidomycin|fosmidomycin|mesh-list
110892061|NCT01361269|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110892062|NCT01361269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110892063|NCT01361269|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110892064|NCT01361269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110200985|NCT00146926|Analgesics|analgesics|mesh-ancestor
110892065|NCT01361269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110892066|NCT01353209|Letrozole|letrozole|mesh-list
110892067|NCT01353209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110892068|NCT01353209|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110892069|NCT01353209|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110892070|NCT01353209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110892071|NCT01353209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110892072|NCT01353209|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110892073|NCT01353209|Hormone Antagonists|hormone antagonists|mesh-ancestor
110892074|NCT01353209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110892075|NCT01353209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110892076|NCT03637491|Avelumab|avelumab|mesh-list
110892077|NCT03637491|Talazoparib|talazoparib|mesh-list
110892078|NCT03637491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110892079|NCT03637491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110892080|NCT03637491|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110892081|NCT03637491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110892082|NCT03637491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110892083|NCT01363063|Ketorolac|ketorolac|mesh-list
110892084|NCT01363063|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
110892085|NCT01363063|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110892086|NCT01363063|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110892087|NCT01363063|Analgesics|analgesics|mesh-ancestor
110892088|NCT01363063|Sensory System Agents|sensory system agents|mesh-ancestor
110892089|NCT01363063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110892090|NCT01363063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110892091|NCT01363063|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110892092|NCT01363063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110892093|NCT01363063|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110892094|NCT01363063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110892095|NCT01363063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110892096|NCT04550455|Cladribine|cladribine|mesh-list
110892097|NCT04550455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110892098|NCT04550455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110892099|NCT04550455|Immunologic Factors|immunologic factors|mesh-ancestor
110223642|NCT00121875|Hormones|hormones|mesh-list
110892100|NCT04550455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110922485|NCT05524038|Hormones|hormones|mesh-ancestor
110892101|NCT01349699|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
110892102|NCT01349699|Deferasirox|deferasirox|mesh-list
110892103|NCT01349699|Hematinics|hematinics|mesh-ancestor
110892104|NCT01349699|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110892105|NCT01349699|Chelating Agents|chelating agents|mesh-ancestor
110892106|NCT01349699|Sequestering Agents|sequestering agents|mesh-ancestor
110892107|NCT01349699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110892108|NCT01370161|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
110892109|NCT01370161|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110892110|NCT01370161|Adrenergic Agents|adrenergic agents|mesh-ancestor
110892111|NCT01370161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110892112|NCT01370161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110892113|NCT01370161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110892115|NCT03628443|Mitosis Modulators|mitosis modulators|mesh-ancestor
110892116|NCT03628443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110892117|NCT01365871|Anesthetics|anesthetics|mesh-list
110892118|NCT01365871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110892119|NCT01365871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110892120|NCT01349777|Clopidogrel|clopidogrel|mesh-list
110892121|NCT01349777|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110892122|NCT01349777|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110892123|NCT01349777|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110892124|NCT01349777|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110892125|NCT01349777|Purinergic Agents|purinergic agents|mesh-ancestor
110892126|NCT01349777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110892127|NCT01349777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110892128|NCT01349777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110892129|NCT03446157|Cetuximab|cetuximab|mesh-list
110892130|NCT03446157|Palbociclib|palbociclib|mesh-list
110892131|NCT03446157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110892132|NCT03446157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110892133|NCT03446157|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110892134|NCT03446157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110892135|NCT03446157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110892136|NCT04700007|Diphenhydramine|diphenhydramine|mesh-list
110892137|NCT04700007|Promethazine|promethazine|mesh-list
110892138|NCT04700007|Morphine|morphine|mesh-list
110892139|NCT04700007|Capsaicin|capsaicin|mesh-list
110892140|NCT04700007|Histamine|histamine|mesh-list
110892141|NCT04700007|Histamine Antagonists|histamine antagonists|mesh-list
110892142|NCT04700007|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110892143|NCT04700007|Narcotics|narcotics|mesh-ancestor
110892144|NCT04700007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110892145|NCT04700007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110892146|NCT04700007|Analgesics|analgesics|mesh-ancestor
110892147|NCT04700007|Sensory System Agents|sensory system agents|mesh-ancestor
110892148|NCT04700007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110892149|NCT04700007|Antipruritics|antipruritics|mesh-ancestor
110892150|NCT04700007|Dermatologic Agents|dermatologic agents|mesh-ancestor
110892151|NCT04700007|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110892152|NCT04700007|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110892153|NCT04700007|Anesthetics, Local|anesthetics, local|mesh-ancestor
110892154|NCT04700007|Anesthetics|anesthetics|mesh-ancestor
110892155|NCT04700007|Antiemetics|antiemetics|mesh-ancestor
110892156|NCT04700007|Autonomic Agents|autonomic agents|mesh-ancestor
110892157|NCT04700007|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110892158|NCT04700007|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110892159|NCT04700007|Histamine Agents|histamine agents|mesh-ancestor
110892160|NCT04700007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110892161|NCT04700007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110892162|NCT04700007|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110892163|NCT04700007|Histamine Agonists|histamine agonists|mesh-ancestor
110892164|NCT01349855|Insulin Glargine|insulin glargine|mesh-list
110892165|NCT01349855|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110892166|NCT01349855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110892167|NCT01318655|Naloxegol|naloxegol|mesh-list
110892168|NCT01318655|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110892169|NCT01318655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110892170|NCT01318655|Sensory System Agents|sensory system agents|mesh-ancestor
110892171|NCT01318655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110892172|NCT01353599|Mometasone Furoate|mometasone furoate|mesh-list
110892173|NCT01353599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110892174|NCT01353599|Dermatologic Agents|dermatologic agents|mesh-ancestor
110892175|NCT01353599|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110892176|NCT02961881|Blinatumomab|blinatumomab|mesh-list
110892177|NCT02961881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110892178|NCT03334539|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110892179|NCT03334539|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110892180|NCT01350089|Ethanol|ethanol|mesh-list
110892181|NCT01350089|Caffeine|caffeine|mesh-list
110892182|NCT01350089|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110892183|NCT01350089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110892184|NCT01350089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110892185|NCT01350089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110892186|NCT01350089|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110892187|NCT01350089|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110892188|NCT01350089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110892189|NCT01350089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110892190|NCT01350089|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110892191|NCT01350089|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110892192|NCT01350089|Purinergic Agents|purinergic agents|mesh-ancestor
110892193|NCT01350089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110892194|NCT03137303|Albuterol|albuterol|mesh-list
110892195|NCT03137303|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110892196|NCT03137303|Autonomic Agents|autonomic agents|mesh-ancestor
110892197|NCT03137303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110892198|NCT03137303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110892199|NCT03137303|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110892200|NCT03137303|Respiratory System Agents|respiratory system agents|mesh-ancestor
110892201|NCT03137303|Tocolytic Agents|tocolytic agents|mesh-ancestor
110892202|NCT03137303|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110892203|NCT03137303|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110892204|NCT03137303|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110892205|NCT03137303|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110892206|NCT03137303|Adrenergic Agents|adrenergic agents|mesh-ancestor
110892207|NCT03137303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110892208|NCT03137303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110892209|NCT03296553|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
110892210|NCT03296553|Valganciclovir|valganciclovir|mesh-list
110892211|NCT03296553|Antiviral Agents|antiviral agents|mesh-ancestor
110892212|NCT03296553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110892213|NCT01363375|Carbon Fiber|carbon fiber|mesh-list
110892214|NCT01363375|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110892215|NCT01363375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110892217|NCT01370707|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110892218|NCT01370707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110892219|NCT01363531|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110892220|NCT01363531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110892221|NCT01363609|Insulin Glargine|insulin glargine|mesh-list
110892222|NCT01363609|Liraglutide|liraglutide|mesh-list
110892224|NCT01363609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110892225|NCT01363609|Incretins|incretins|mesh-ancestor
110892226|NCT01363609|Hormones|hormones|mesh-ancestor
110892227|NCT01363609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110892228|NCT03060447|Vesatolimod|vesatolimod|mesh-list
110892229|NCT03060447|Antiviral Agents|antiviral agents|mesh-ancestor
110892230|NCT03060447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110892231|NCT04623567|Metformin|metformin|mesh-list
110892232|NCT04623567|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110892233|NCT04623567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110892234|NCT01712789|Dexamethasone|dexamethasone|mesh-list
110892235|NCT01712789|Pomalidomide|pomalidomide|mesh-list
110892236|NCT01712789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110892237|NCT01712789|Antiemetics|antiemetics|mesh-ancestor
110892238|NCT01712789|Autonomic Agents|autonomic agents|mesh-ancestor
110892239|NCT01712789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110892240|NCT01712789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110892241|NCT01712789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110892242|NCT01712789|Glucocorticoids|glucocorticoids|mesh-ancestor
110892243|NCT01712789|Hormones|hormones|mesh-ancestor
110892244|NCT01712789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110892245|NCT01712789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110892246|NCT01712789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110892247|NCT01712789|Immunologic Factors|immunologic factors|mesh-ancestor
110892248|NCT01712789|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110892249|NCT01712789|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110892250|NCT01712789|Growth Substances|growth substances|mesh-ancestor
110892251|NCT01712789|Growth Inhibitors|growth inhibitors|mesh-ancestor
110892252|NCT01350323|Bevacizumab|bevacizumab|mesh-list
110892253|NCT01350323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110892254|NCT01350323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110892255|NCT01350323|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110892256|NCT01350323|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110892257|NCT01350323|Growth Substances|growth substances|mesh-ancestor
110892258|NCT01350323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110892259|NCT01350323|Growth Inhibitors|growth inhibitors|mesh-ancestor
110892260|NCT03074318|Avelumab|avelumab|mesh-list
110892261|NCT03074318|Trabectedin|trabectedin|mesh-list
110892262|NCT03074318|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110892263|NCT03074318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110892264|NCT03074318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110892265|NCT03074318|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110892266|NCT03074318|Alkylating Agents|alkylating agents|mesh-ancestor
110892267|NCT03074318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110892268|NCT03074318|Immunologic Factors|immunologic factors|mesh-ancestor
110892269|NCT03074318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110892270|NCT02071316|Esomeprazole|esomeprazole|mesh-list
110892271|NCT02071316|Tranexamic Acid|tranexamic acid|mesh-list
110892272|NCT02071316|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110892273|NCT02071316|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110892274|NCT02071316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110892275|NCT02071316|Hemostatics|hemostatics|mesh-ancestor
110892276|NCT02071316|Coagulants|coagulants|mesh-ancestor
110892277|NCT02071316|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110609781|NCT00862875|Insulin|insulin|mesh-list
110892278|NCT02071316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110892279|NCT02071316|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110892280|NCT02071316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110892281|NCT02074202|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110892282|NCT02074202|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110892283|NCT02074202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110892284|NCT02074280|Rifaximin|rifaximin|mesh-list
110892285|NCT02074280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110892286|NCT02074280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110892287|NCT02074280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110892288|NCT02077946|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110892289|NCT02077946|Liraglutide|liraglutide|mesh-list
110892290|NCT02077946|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110892291|NCT02077946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110892292|NCT02077946|Incretins|incretins|mesh-ancestor
110892294|NCT02077946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110892295|NCT02077946|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110892296|NCT02077946|Protease Inhibitors|protease inhibitors|mesh-ancestor
110892297|NCT02077946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110892298|NCT02077946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110892299|NCT03559790|Tenofovir|tenofovir|mesh-list
110892300|NCT03559790|Antiviral Agents|antiviral agents|mesh-ancestor
110892301|NCT03559790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110892302|NCT03559790|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110892303|NCT03559790|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110892304|NCT03559790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110892305|NCT03559790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110201030|NCT00147355|Acetaminophen|acetaminophen|mesh-list
110892306|NCT03559790|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110892307|NCT03559790|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110892308|NCT02079974|Pravastatin|pravastatin|mesh-list
110892309|NCT02079974|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110892310|NCT02079974|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110892311|NCT02079974|Antimetabolites|antimetabolites|mesh-ancestor
110892312|NCT02079974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110892313|NCT02079974|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110892314|NCT02079974|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110892315|NCT02079974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110892316|NCT01353755|Immunomodulating Agents|immunomodulating agents|mesh-list
110892317|NCT01353755|Immunologic Factors|immunologic factors|mesh-ancestor
110892318|NCT01353755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110892319|NCT01317953|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
110892320|NCT01317953|Antioxidants|antioxidants|mesh-ancestor
110892321|NCT01317953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110892322|NCT01317953|Protective Agents|protective agents|mesh-ancestor
110892323|NCT01317953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110892324|NCT01317953|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
110892325|NCT01317953|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110892326|NCT01317953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110892327|NCT01317953|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110892328|NCT02078336|Atropine|atropine|mesh-list
110892329|NCT02078336|Midazolam|midazolam|mesh-list
110892330|NCT02078336|Droperidol|droperidol|mesh-list
110892331|NCT02078336|Lorazepam|lorazepam|mesh-list
110892332|NCT02078336|Biperiden|biperiden|mesh-list
110892333|NCT02078336|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110892334|NCT02078336|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110892335|NCT02078336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110892336|NCT02078336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110892337|NCT02078336|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110892338|NCT02078336|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110892339|NCT02078336|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110892340|NCT02078336|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110892341|NCT02078336|Anesthetics, General|anesthetics, general|mesh-ancestor
110892342|NCT02078336|Anesthetics|anesthetics|mesh-ancestor
110892343|NCT02078336|GABA Modulators|gaba modulators|mesh-ancestor
110892344|NCT02078336|GABA Agents|gaba agents|mesh-ancestor
110892345|NCT02078336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110892346|NCT02078336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110892347|NCT02078336|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110892348|NCT02078336|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110892349|NCT02078336|Autonomic Agents|autonomic agents|mesh-ancestor
110892350|NCT02078336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110892351|NCT02078336|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110892352|NCT02078336|Respiratory System Agents|respiratory system agents|mesh-ancestor
110892353|NCT02078336|Mydriatics|mydriatics|mesh-ancestor
110892354|NCT02078336|Parasympatholytics|parasympatholytics|mesh-ancestor
110892355|NCT02078336|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110892356|NCT02078336|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110892357|NCT02078336|Cholinergic Agents|cholinergic agents|mesh-ancestor
110892358|NCT02078336|Anticonvulsants|anticonvulsants|mesh-ancestor
110892359|NCT02078336|Antiemetics|antiemetics|mesh-ancestor
110892360|NCT02078336|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110892361|NCT02078336|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110892362|NCT02078336|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110892363|NCT02078336|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110892364|NCT02078336|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110892365|NCT02078336|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110892366|NCT02078336|Dopamine Agents|dopamine agents|mesh-ancestor
110892367|NCT01353833|Aldesleukin|aldesleukin|mesh-list
110892368|NCT01353833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110892369|NCT01353833|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110892370|NCT01353833|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110892371|NCT01353833|Antiviral Agents|antiviral agents|mesh-ancestor
110892372|NCT01353833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110892373|NCT03353675|Nivolumab|nivolumab|mesh-list
110892374|NCT03353675|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110892375|NCT03353675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110892376|NCT03353675|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110892377|NCT03353675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110892378|NCT01350713|Povidone-Iodine|povidone-iodine|mesh-list
110892379|NCT01350713|Povidone|povidone|mesh-list
110892380|NCT01350713|Plasma Substitutes|plasma substitutes|mesh-ancestor
110892381|NCT01350713|Blood Substitutes|blood substitutes|mesh-ancestor
110892382|NCT01350713|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110892383|NCT01350713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110892384|NCT02075294|Entecavir|entecavir|mesh-list
110892385|NCT02075294|Adefovir|adefovir|mesh-list
110892386|NCT02075294|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
110892387|NCT02075294|Antiviral Agents|antiviral agents|mesh-ancestor
110892388|NCT02075294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110892389|NCT02075294|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110892390|NCT02075294|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110892391|NCT02075294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110892392|NCT02075294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110892393|NCT01357967|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110892394|NCT01357967|Antidepressive Agents|antidepressive agents|mesh-ancestor
110892395|NCT01357967|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110892396|NCT01357967|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110892397|NCT01357967|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110892398|NCT01357967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110892399|NCT01357967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110892400|NCT02075528|Paliperidone Palmitate|paliperidone palmitate|mesh-list
110892401|NCT02075528|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110892402|NCT02075528|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110892403|NCT02075528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110892404|NCT02075528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110892405|NCT02075528|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110892406|NCT02075528|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110892407|NCT02075528|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110892408|NCT02075528|Serotonin Agents|serotonin agents|mesh-ancestor
110892409|NCT02075528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110922545|NCT02963493|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110892410|NCT02075528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110892411|NCT02075528|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110892412|NCT02075528|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110892413|NCT02075528|Dopamine Agents|dopamine agents|mesh-ancestor
110892415|NCT02078648|Bevacizumab|bevacizumab|mesh-list
110892416|NCT02078648|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
110892417|NCT02078648|Poly ICLC|poly iclc|mesh-list
110892418|NCT02078648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110892419|NCT02078648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110892420|NCT02078648|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110892421|NCT02078648|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110892422|NCT02078648|Growth Substances|growth substances|mesh-ancestor
110892423|NCT02078648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110892424|NCT02078648|Growth Inhibitors|growth inhibitors|mesh-ancestor
110892425|NCT02078648|Interferon Inducers|interferon inducers|mesh-ancestor
110892426|NCT02078648|Immunologic Factors|immunologic factors|mesh-ancestor
110892427|NCT02078648|Antiviral Agents|antiviral agents|mesh-ancestor
110892428|NCT02078648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110892429|NCT02078648|Laxatives|laxatives|mesh-ancestor
110892430|NCT02078648|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110892431|NCT01358045|Calcitriol|calcitriol|mesh-list
110892432|NCT01358045|Diclofenac|diclofenac|mesh-list
110892433|NCT01358045|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110892434|NCT01358045|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110892435|NCT01358045|Analgesics|analgesics|mesh-ancestor
110892436|NCT01358045|Sensory System Agents|sensory system agents|mesh-ancestor
110892437|NCT01358045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110892438|NCT01358045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110892439|NCT01358045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110892440|NCT01358045|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110892441|NCT01358045|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110892442|NCT01358045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110892443|NCT01358045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110892444|NCT01358045|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110892445|NCT01358045|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
110892446|NCT01358045|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110892447|NCT01358045|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110892448|NCT01358045|Vitamins|vitamins|mesh-ancestor
110892449|NCT01358045|Micronutrients|micronutrients|mesh-ancestor
110892450|NCT01358045|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110892451|NCT02076230|Phosphoramide Mustards|phosphoramide mustards|mesh-list
110892452|NCT02076230|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110892453|NCT02076230|Alkylating Agents|alkylating agents|mesh-ancestor
110892454|NCT02076230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110892455|NCT02076230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110892456|NCT01357811|Digoxin|digoxin|mesh-list
110892457|NCT01357811|Eliglustat|eliglustat|mesh-list
110892458|NCT01357811|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110892459|NCT01357811|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110892460|NCT01357811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110892461|NCT01357811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110892462|NCT01357811|Protective Agents|protective agents|mesh-ancestor
110892463|NCT01357811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110892464|NCT04300985|Magnesium Sulfate|magnesium sulfate|mesh-list
110892465|NCT04300985|Dexmedetomidine|dexmedetomidine|mesh-list
110892466|NCT04300985|Anesthetics|anesthetics|mesh-list
110892467|NCT04300985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110922564|NCT03519776|Hormones|hormones|mesh-ancestor
110892468|NCT04300985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110892469|NCT04300985|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110892470|NCT04300985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110892471|NCT04300985|Analgesics|analgesics|mesh-ancestor
110892472|NCT04300985|Sensory System Agents|sensory system agents|mesh-ancestor
110892473|NCT04300985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110892474|NCT04300985|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110892475|NCT04300985|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110892476|NCT04300985|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110892477|NCT04300985|Adrenergic Agents|adrenergic agents|mesh-ancestor
110892478|NCT04300985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110892479|NCT04300985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110892480|NCT04300985|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110892481|NCT04300985|Anticonvulsants|anticonvulsants|mesh-ancestor
110892482|NCT04300985|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110892483|NCT04300985|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110892484|NCT04300985|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110892485|NCT04300985|Tocolytic Agents|tocolytic agents|mesh-ancestor
110892486|NCT04300985|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110892487|NCT02079194|Aspirin|aspirin|mesh-list
110892488|NCT02079194|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110892489|NCT02079194|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110892490|NCT02079194|Analgesics|analgesics|mesh-ancestor
110892491|NCT02079194|Sensory System Agents|sensory system agents|mesh-ancestor
110892492|NCT02079194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110892493|NCT02079194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110892494|NCT02079194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110892495|NCT02079194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110892496|NCT02079194|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110892497|NCT02079194|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110892498|NCT02079194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110892499|NCT02079194|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110892500|NCT02079194|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110892501|NCT02079194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110892502|NCT02079194|Antipyretics|antipyretics|mesh-ancestor
110892503|NCT01351493|Nitric Oxide|nitric oxide|mesh-list
110892504|NCT01351493|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110610003|NCT00698204|Celecoxib|celecoxib|mesh-list
110892505|NCT01351493|Autonomic Agents|autonomic agents|mesh-ancestor
110892506|NCT01351493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110892507|NCT01351493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110892508|NCT01351493|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110892509|NCT01351493|Respiratory System Agents|respiratory system agents|mesh-ancestor
110892510|NCT01351493|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110892511|NCT01351493|Antioxidants|antioxidants|mesh-ancestor
110892512|NCT01351493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110892513|NCT01351493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110892514|NCT01351493|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
110892515|NCT01351493|Vasodilator Agents|vasodilator agents|mesh-ancestor
110892516|NCT01351493|Gasotransmitters|gasotransmitters|mesh-ancestor
110892517|NCT01351493|Protective Agents|protective agents|mesh-ancestor
110892518|NCT01318187|Acetaminophen|acetaminophen|mesh-list
110892519|NCT01318187|Morphine|morphine|mesh-list
110892520|NCT01318187|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110892521|NCT01318187|Narcotics|narcotics|mesh-ancestor
110892522|NCT01318187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110892523|NCT01318187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110892524|NCT01318187|Analgesics|analgesics|mesh-ancestor
110892525|NCT01318187|Sensory System Agents|sensory system agents|mesh-ancestor
110892526|NCT01318187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110892527|NCT01318187|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110892528|NCT01318187|Antipyretics|antipyretics|mesh-ancestor
110892529|NCT01358435|Insulin|insulin|mesh-list
110892530|NCT01358435|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110892531|NCT01358435|Insulin, Isophane|insulin, isophane|mesh-list
110892532|NCT01358435|Isophane Insulin, Human|isophane insulin, human|mesh-list
110892533|NCT01358435|Isophane insulin, beef|isophane insulin, beef|mesh-list
110892534|NCT01358435|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110892535|NCT01358435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110892536|NCT01318265|Ketoconazole|ketoconazole|mesh-list
110892537|NCT01318265|Antifungal Agents|antifungal agents|mesh-ancestor
110892538|NCT01318265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110892539|NCT01318265|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110892540|NCT01318265|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110892541|NCT01318265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110892542|NCT01318265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110892543|NCT01318265|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110892544|NCT01318265|Hormone Antagonists|hormone antagonists|mesh-ancestor
110892545|NCT01318265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110201089|NCT00147394|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110892546|NCT01318265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110892547|NCT01318265|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110892548|NCT01354457|Epratuzumab|epratuzumab|mesh-list
110892549|NCT01354457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110892550|NCT01354457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110892552|NCT02079350|Plasma Substitutes|plasma substitutes|mesh-ancestor
110892553|NCT02079350|Blood Substitutes|blood substitutes|mesh-ancestor
110892554|NCT03062540|Cyclobenzaprine|cyclobenzaprine|mesh-list
110892555|NCT03062540|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110892556|NCT03062540|Antidepressive Agents|antidepressive agents|mesh-ancestor
110892557|NCT03062540|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110892558|NCT03062540|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110892559|NCT03062540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110892560|NCT03062540|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110892561|NCT03062540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110892562|NCT03062540|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110892563|NCT03062540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110892564|NCT03060980|Empagliflozin|empagliflozin|mesh-list
110892565|NCT03060980|Glimepiride|glimepiride|mesh-list
110892566|NCT03060980|Exenatide|exenatide|mesh-list
110892567|NCT03060980|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110892568|NCT03060980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110892569|NCT03060980|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110892570|NCT03060980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110892571|NCT03060980|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110892572|NCT03060980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110892573|NCT03060980|Immunologic Factors|immunologic factors|mesh-ancestor
110892574|NCT03060980|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110892575|NCT03060980|Incretins|incretins|mesh-ancestor
110892576|NCT03060980|Hormones|hormones|mesh-ancestor
110892577|NCT03060980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110892578|NCT01358591|Calcium Carbonate|calcium carbonate|mesh-list
110892579|NCT01358591|Calcium|calcium|mesh-list
110892580|NCT01358591|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110892581|NCT01358591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110892582|NCT01358591|Antacids|antacids|mesh-ancestor
110892583|NCT01358591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110892584|NCT01358591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110892585|NCT02081144|Nicotine|nicotine|mesh-list
110892586|NCT02081144|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110892587|NCT02081144|Autonomic Agents|autonomic agents|mesh-ancestor
110892588|NCT02081144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110892589|NCT02081144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110892590|NCT02081144|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110892591|NCT02081144|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110892592|NCT02081144|Cholinergic Agents|cholinergic agents|mesh-ancestor
110892593|NCT02081144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110892594|NCT02081144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110892595|NCT02083328|Mannitol|mannitol|mesh-list
110892596|NCT02083328|Caffeine|caffeine|mesh-list
110892597|NCT02083328|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110892598|NCT02083328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110892599|NCT02083328|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110892600|NCT02083328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110892601|NCT02083328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110892602|NCT02083328|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110892603|NCT02083328|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110892604|NCT02083328|Purinergic Agents|purinergic agents|mesh-ancestor
110892605|NCT02083328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110892606|NCT02083328|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110892607|NCT02083328|Diuretics|diuretics|mesh-ancestor
110892608|NCT02083328|Natriuretic Agents|natriuretic agents|mesh-ancestor
110892609|NCT02079506|Candesartan|candesartan|mesh-list
110201113|NCT00048230|Bortezomib|bortezomib|mesh-list
110892610|NCT02079506|Candesartan cilexetil|candesartan cilexetil|mesh-list
110892611|NCT02079506|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110892612|NCT02079506|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110892613|NCT02079506|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110892614|NCT02079506|Antimetabolites|antimetabolites|mesh-ancestor
110892615|NCT02079506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110892616|NCT02079506|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110892617|NCT02079506|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110892618|NCT02079506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110892619|NCT02079506|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110892620|NCT02079506|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110892621|NCT02079506|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110892622|NCT02940548|Amlodipine|amlodipine|mesh-list
110892623|NCT02940548|Nifedipine|nifedipine|mesh-list
110892624|NCT02940548|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110892625|NCT02940548|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110892626|NCT02940548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110892627|NCT02940548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110892628|NCT02940548|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110892629|NCT02940548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110892630|NCT02940548|Vasodilator Agents|vasodilator agents|mesh-ancestor
110892631|NCT02940548|Tocolytic Agents|tocolytic agents|mesh-ancestor
110892632|NCT02940548|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110892633|NCT01366183|Paclitaxel|paclitaxel|mesh-list
110892635|NCT01366183|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110892636|NCT01366183|Lenograstim|lenograstim|mesh-list
110892637|NCT01366183|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110892638|NCT01366183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110892639|NCT01366183|Tubulin Modulators|tubulin modulators|mesh-ancestor
110892640|NCT01366183|Antimitotic Agents|antimitotic agents|mesh-ancestor
110892641|NCT01366183|Mitosis Modulators|mitosis modulators|mesh-ancestor
110892642|NCT01366183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110892643|NCT01366183|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110892644|NCT01366183|Immunologic Factors|immunologic factors|mesh-ancestor
110892645|NCT01366183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110892646|NCT03134183|Misoprostol|misoprostol|mesh-list
110892647|NCT03134183|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110892648|NCT03134183|Abortifacient Agents|abortifacient agents|mesh-ancestor
110892649|NCT03134183|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110892650|NCT03134183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110892651|NCT03134183|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110892652|NCT03134183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110610160|NCT00863577|Bemiparin|bemiparin|mesh-list
110892653|NCT03134183|Oxytocics|oxytocics|mesh-ancestor
110892654|NCT02083484|Pembrolizumab|pembrolizumab|mesh-list
110892655|NCT02083484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110892656|NCT02083484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110892657|NCT02083484|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110892658|NCT02083484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110892659|NCT01354613|Amlodipine|amlodipine|mesh-list
110892660|NCT01354613|Dobutamine|dobutamine|mesh-list
110892661|NCT01354613|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110892662|NCT01354613|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110892663|NCT01354613|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110892664|NCT01354613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110892665|NCT01354613|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110201124|NCT00397332|Alefacept|alefacept|mesh-list
110892666|NCT01354613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110892667|NCT01354613|Vasodilator Agents|vasodilator agents|mesh-ancestor
110223751|NCT00296062|Antimetabolites|antimetabolites|mesh-ancestor
110892668|NCT01354613|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110892669|NCT01354613|Sympathomimetics|sympathomimetics|mesh-ancestor
110892670|NCT01354613|Autonomic Agents|autonomic agents|mesh-ancestor
110892671|NCT01354613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110892672|NCT01354613|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
110892673|NCT01354613|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110892674|NCT01354613|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110892675|NCT01354613|Adrenergic Agents|adrenergic agents|mesh-ancestor
110892676|NCT01354613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110892677|NCT01354613|Protective Agents|protective agents|mesh-ancestor
110892678|NCT02083640|Palbociclib|palbociclib|mesh-list
110892679|NCT02083640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110892680|NCT02083640|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110892681|NCT02083640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110892682|NCT02083640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110892683|NCT01352039|Heparin|heparin|mesh-list
110892684|NCT01352039|Calcium heparin|calcium heparin|mesh-list
110892685|NCT01352039|Anticoagulants|anticoagulants|mesh-ancestor
110892686|NCT01352039|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110892687|NCT01352039|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110892688|NCT01352039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110892689|NCT04419337|Metformin|metformin|mesh-list
110892690|NCT04419337|Pioglitazone|pioglitazone|mesh-list
110892691|NCT04419337|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
110892692|NCT04419337|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110892693|NCT04419337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110892694|NCT04419337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110892695|NCT01359059|Pregabalin|pregabalin|mesh-list
110892696|NCT01359059|Analgesics|analgesics|mesh-ancestor
110892697|NCT01359059|Sensory System Agents|sensory system agents|mesh-ancestor
110892698|NCT01359059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110892699|NCT01359059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110892700|NCT01359059|Anticonvulsants|anticonvulsants|mesh-ancestor
110892701|NCT01359059|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110892702|NCT01359059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110892703|NCT01359059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110892704|NCT01359059|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110892705|NCT01359059|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110892706|NCT01359059|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110892707|NCT01359059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110892708|NCT01359059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110892709|NCT05189093|Antibodies|antibodies|mesh-list
110892710|NCT05189093|Antibodies, Bispecific|antibodies, bispecific|mesh-list
110892711|NCT05189093|Immunologic Factors|immunologic factors|mesh-ancestor
110892712|NCT05189093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110892713|NCT01371331|Tacrolimus|tacrolimus|mesh-list
110892714|NCT01371331|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110892715|NCT01371331|Immunologic Factors|immunologic factors|mesh-ancestor
110892716|NCT01371331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110892717|NCT01371331|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110892718|NCT01371331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110892719|NCT01371331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110892720|NCT01366339|Methylnaltrexone|methylnaltrexone|mesh-list
110892721|NCT01366339|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110892722|NCT01366339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110892723|NCT01366339|Sensory System Agents|sensory system agents|mesh-ancestor
110892724|NCT01366339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110892725|NCT03133793|Coenzyme Q10|coenzyme q10|mesh-list
110892726|NCT03133793|Vitamins|vitamins|mesh-ancestor
110892727|NCT03133793|Micronutrients|micronutrients|mesh-ancestor
110892728|NCT03133793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110892729|NCT03133481|Ropivacaine|ropivacaine|mesh-list
110892730|NCT03133481|Anesthetics, Local|anesthetics, local|mesh-ancestor
110892731|NCT03133481|Anesthetics|anesthetics|mesh-ancestor
110892732|NCT03133481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110892733|NCT03133481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110892734|NCT03133481|Sensory System Agents|sensory system agents|mesh-ancestor
110892735|NCT03133481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110892736|NCT01366651|Doripenem|doripenem|mesh-list
110892737|NCT01366651|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110892738|NCT01366651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110892739|NCT05124509|Vaccines|vaccines|mesh-list
110892740|NCT05124509|Immunologic Factors|immunologic factors|mesh-ancestor
110892741|NCT05124509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110892742|NCT02864316|Nivolumab|nivolumab|mesh-list
110892743|NCT02864316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110892744|NCT02864316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110892745|NCT02864316|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110892746|NCT02864316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110892747|NCT03941509|Anti-Infective Agents|anti-infective agents|mesh-list
110892748|NCT03941509|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110892749|NCT01361399|Aspirin|aspirin|mesh-list
110892750|NCT01361399|Lidocaine|lidocaine|mesh-list
110892751|NCT01361399|Anesthetics, Local|anesthetics, local|mesh-ancestor
110892752|NCT01361399|Anesthetics|anesthetics|mesh-ancestor
110892753|NCT01361399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110892754|NCT01361399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110892755|NCT01361399|Sensory System Agents|sensory system agents|mesh-ancestor
110892756|NCT01361399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110892757|NCT01361399|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110892758|NCT01361399|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110922651|NCT03512990|Bupivacaine|bupivacaine|mesh-list
110892759|NCT01361399|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110892760|NCT01361399|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110892761|NCT01361399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110892762|NCT01361399|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110892763|NCT01361399|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110892764|NCT01361399|Analgesics|analgesics|mesh-ancestor
110892765|NCT01361399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110892766|NCT01361399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110892767|NCT01361399|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110892768|NCT01361399|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110892769|NCT01361399|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110892770|NCT01361399|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110892771|NCT01361399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110892772|NCT01361399|Antipyretics|antipyretics|mesh-ancestor
110892773|NCT02862600|Perhexiline|perhexiline|mesh-list
110892774|NCT02862600|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110892775|NCT02862600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110892776|NCT02862600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110892777|NCT02862600|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110892778|NCT02862600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110892779|NCT02862600|Vasodilator Agents|vasodilator agents|mesh-ancestor
110892780|NCT01354925|Insulin|insulin|mesh-list
110892781|NCT01354925|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110892782|NCT01354925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110892783|NCT03556345|Trastuzumab|trastuzumab|mesh-list
110892784|NCT03556345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110892785|NCT03556345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110892786|NCT03610230|Iron|iron|mesh-list
110892787|NCT03610230|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
110892788|NCT03610230|Ferric Compounds|ferric compounds|mesh-list
110892789|NCT03610230|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
110892790|NCT03610230|Trace Elements|trace elements|mesh-ancestor
110892791|NCT03610230|Micronutrients|micronutrients|mesh-ancestor
110892792|NCT03610230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110892793|NCT03610230|Hematinics|hematinics|mesh-ancestor
110892794|NCT01359605|Varespladib methyl|varespladib methyl|mesh-list
110892795|NCT01359605|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
110892796|NCT01359605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110892797|NCT01359605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110892799|NCT05188859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110892800|NCT05188859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110892801|NCT05188859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110892802|NCT05188859|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110892803|NCT05188859|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110892804|NCT02033538|Paclitaxel|paclitaxel|mesh-list
110892805|NCT02033538|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110892806|NCT02033538|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110892807|NCT02033538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110892808|NCT02033538|Tubulin Modulators|tubulin modulators|mesh-ancestor
110892809|NCT02033538|Antimitotic Agents|antimitotic agents|mesh-ancestor
110892810|NCT02033538|Mitosis Modulators|mitosis modulators|mesh-ancestor
110892811|NCT02033538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110892812|NCT02792192|Atezolizumab|atezolizumab|mesh-list
110892813|NCT02792192|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110892814|NCT02792192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110892815|NCT02792192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110892816|NCT02792192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110892817|NCT03609996|Ranibizumab|ranibizumab|mesh-list
110892818|NCT03609996|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110892819|NCT03609996|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110892820|NCT03609996|Growth Substances|growth substances|mesh-ancestor
110892821|NCT03609996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110892822|NCT03609996|Growth Inhibitors|growth inhibitors|mesh-ancestor
110892823|NCT03609996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110892824|NCT02088008|Valsartan|valsartan|mesh-list
110892825|NCT02088008|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110892826|NCT02088008|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110892827|NCT02088008|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110892828|NCT02088008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110892829|NCT01361789|Dexamethasone|dexamethasone|mesh-list
110892830|NCT01361789|Dexamethasone acetate|dexamethasone acetate|mesh-list
110892831|NCT01361789|Etoricoxib|etoricoxib|mesh-list
110892832|NCT01361789|Parecoxib|parecoxib|mesh-list
110892833|NCT01361789|Valdecoxib|valdecoxib|mesh-list
110892834|NCT01361789|BB 1101|bb 1101|mesh-list
110892835|NCT01361789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110892836|NCT01361789|Antiemetics|antiemetics|mesh-ancestor
110892837|NCT01361789|Autonomic Agents|autonomic agents|mesh-ancestor
110892838|NCT01361789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110892839|NCT01361789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110892840|NCT01361789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110892841|NCT01361789|Glucocorticoids|glucocorticoids|mesh-ancestor
110892842|NCT01361789|Hormones|hormones|mesh-ancestor
110892843|NCT01361789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110892844|NCT01361789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110892845|NCT01361789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110892846|NCT01361789|Protease Inhibitors|protease inhibitors|mesh-ancestor
110892847|NCT01361789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110223789|NCT00296530|Xhance|xhance|mesh-list
110892848|NCT01361789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110892849|NCT01361789|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110892850|NCT01361789|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110892851|NCT01361789|Analgesics|analgesics|mesh-ancestor
110892852|NCT01361789|Sensory System Agents|sensory system agents|mesh-ancestor
110892853|NCT01361789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110892854|NCT01361789|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110892855|NCT01361789|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110892856|NCT02964507|Fulvestrant|fulvestrant|mesh-list
110892857|NCT02964507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110892858|NCT02964507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110892859|NCT02964507|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110892860|NCT02964507|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110892861|NCT02964507|Hormone Antagonists|hormone antagonists|mesh-ancestor
110892862|NCT02964507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110892863|NCT02964507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110892864|NCT02083874|Cannabidiol|cannabidiol|mesh-list
110892865|NCT02083874|Anticonvulsants|anticonvulsants|mesh-ancestor
110892866|NCT05188781|Pembrolizumab|pembrolizumab|mesh-list
110892867|NCT05188781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110892868|NCT05188781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110892869|NCT05188781|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110892870|NCT05188781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110892871|NCT03634735|Thiamine|thiamine|mesh-list
110892872|NCT03634735|Vitamins|vitamins|mesh-ancestor
110892873|NCT03634735|Micronutrients|micronutrients|mesh-ancestor
110892874|NCT03634735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110892875|NCT03634735|Vitamin B Complex|vitamin b complex|mesh-ancestor
110892876|NCT02084342|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
110610383|NCT00864357|Narcotics|narcotics|mesh-ancestor
110892877|NCT02084342|Tranexamic Acid|tranexamic acid|mesh-list
110892878|NCT02084342|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110892879|NCT02084342|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110892880|NCT02084342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110892882|NCT02084342|Coagulants|coagulants|mesh-ancestor
110892883|NCT02084342|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
110892884|NCT02084342|Natriuretic Agents|natriuretic agents|mesh-ancestor
110892885|NCT02084342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110892886|NCT01371487|Trametinib|trametinib|mesh-list
110892887|NCT01371487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110892888|NCT01371487|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110892889|NCT01371487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110892890|NCT01371487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110892891|NCT02084420|Pantoprazole|pantoprazole|mesh-list
110892892|NCT02084420|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110892893|NCT02084420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110892894|NCT02084420|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110892895|NCT02084420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110892896|NCT02084420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110892897|NCT01367431|Xanthohumol|xanthohumol|mesh-list
110892898|NCT01367431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110892899|NCT01367431|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110892900|NCT01367431|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110892901|NCT01367431|Growth Substances|growth substances|mesh-ancestor
110892902|NCT01367431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110892903|NCT01367431|Growth Inhibitors|growth inhibitors|mesh-ancestor
110892904|NCT01367509|Methylnaltrexone|methylnaltrexone|mesh-list
110892905|NCT01367509|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110892906|NCT01367509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110892907|NCT01367509|Sensory System Agents|sensory system agents|mesh-ancestor
110892908|NCT01367509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110892909|NCT01364701|Sildenafil Citrate|sildenafil citrate|mesh-list
110892910|NCT01364701|Tadalafil|tadalafil|mesh-list
110892911|NCT01364701|Vasodilator Agents|vasodilator agents|mesh-ancestor
110892912|NCT01364701|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110892913|NCT01364701|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110892914|NCT01364701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110223797|NCT00296530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110892915|NCT01364701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110892917|NCT02440464|Fludarabine|fludarabine|mesh-list
110892918|NCT02440464|Bortezomib|bortezomib|mesh-list
110892919|NCT02440464|Melphalan|melphalan|mesh-list
110892920|NCT02440464|Ixazomib|ixazomib|mesh-list
110892921|NCT02440464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110892922|NCT02440464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110892923|NCT02440464|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110892924|NCT02440464|Immunologic Factors|immunologic factors|mesh-ancestor
110892925|NCT02440464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110892926|NCT02440464|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110892927|NCT02440464|Alkylating Agents|alkylating agents|mesh-ancestor
110892928|NCT02440464|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110892929|NCT02440464|Protease Inhibitors|protease inhibitors|mesh-ancestor
110892930|NCT02440464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110892931|NCT01367587|Methylnaltrexone|methylnaltrexone|mesh-list
110892932|NCT01367587|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110892933|NCT01367587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110892934|NCT01367587|Sensory System Agents|sensory system agents|mesh-ancestor
110892935|NCT01367587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110892936|NCT02088398|Ricolinostat|ricolinostat|mesh-list
110892937|NCT02088398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110892938|NCT02088398|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110892939|NCT02088398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110892940|NCT02088398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110892941|NCT02084576|Ketorolac|ketorolac|mesh-list
110892942|NCT02084576|Nepafenac|nepafenac|mesh-list
110892943|NCT02084576|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110892944|NCT02084576|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110892945|NCT02084576|Analgesics|analgesics|mesh-ancestor
110892946|NCT02084576|Sensory System Agents|sensory system agents|mesh-ancestor
110892947|NCT02084576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110892948|NCT02084576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110892949|NCT02084576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110892950|NCT02084576|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110892951|NCT02084576|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110892952|NCT02084576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110892953|NCT02084576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110892954|NCT03131453|Umibecestat|umibecestat|mesh-list
110892955|NCT03131453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110892956|NCT03131453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110892957|NCT02084654|Exenatide|exenatide|mesh-list
110892958|NCT02084654|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110892959|NCT02084654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110892960|NCT02084654|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110892961|NCT02084654|Incretins|incretins|mesh-ancestor
110892962|NCT02084654|Hormones|hormones|mesh-ancestor
110892963|NCT02084654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110892964|NCT01367743|Epinephrine|epinephrine|mesh-list
110892965|NCT01367743|Norepinephrine|norepinephrine|mesh-list
110892966|NCT01367743|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
110892967|NCT01367743|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110892968|NCT01367743|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110892969|NCT01367743|Adrenergic Agents|adrenergic agents|mesh-ancestor
110892970|NCT01367743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110892971|NCT01367743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110892972|NCT01367743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110892973|NCT01367743|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110892974|NCT01367743|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110892975|NCT01367743|Autonomic Agents|autonomic agents|mesh-ancestor
110892976|NCT01367743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110892977|NCT01367743|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110892978|NCT01367743|Respiratory System Agents|respiratory system agents|mesh-ancestor
110892979|NCT01367743|Mydriatics|mydriatics|mesh-ancestor
110892980|NCT01367743|Sympathomimetics|sympathomimetics|mesh-ancestor
110892981|NCT02084732|Sorafenib|sorafenib|mesh-list
110892982|NCT02084732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110892983|NCT02084732|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110892984|NCT02084732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110892985|NCT02084732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110892986|NCT02780401|Vaccines|vaccines|mesh-list
110892987|NCT02780401|Sargramostim|sargramostim|mesh-list
110892988|NCT02780401|Immunologic Factors|immunologic factors|mesh-ancestor
110892989|NCT02780401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110892991|NCT02533232|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110892992|NCT02533232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110892993|NCT02673151|Edetic Acid|edetic acid|mesh-list
110892994|NCT02673151|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
110892995|NCT02673151|Chelating Agents|chelating agents|mesh-ancestor
110892996|NCT02673151|Sequestering Agents|sequestering agents|mesh-ancestor
110892997|NCT02673151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110892998|NCT02673151|Anticoagulants|anticoagulants|mesh-ancestor
110892999|NCT02673151|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110893000|NCT02673151|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110893001|NCT02942277|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
110893002|NCT02942277|Antimalarials|antimalarials|mesh-ancestor
110893003|NCT02942277|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110893004|NCT02942277|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110893005|NCT02942277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110893006|NCT05042947|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
110893007|NCT05042947|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
110893009|NCT05042947|Hormones|hormones|mesh-ancestor
110893010|NCT05042947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110893011|NCT05042947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110893012|NCT05042947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110893013|NCT05042947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110893014|NCT02082236|Sufentanil|sufentanil|mesh-list
110893015|NCT02082236|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110893016|NCT02082236|Narcotics|narcotics|mesh-ancestor
110893017|NCT02082236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110893018|NCT02082236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110893019|NCT02082236|Analgesics|analgesics|mesh-ancestor
110893020|NCT02082236|Sensory System Agents|sensory system agents|mesh-ancestor
110893021|NCT02082236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110893022|NCT02082236|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110893023|NCT02082236|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110893024|NCT02082236|Anesthetics, General|anesthetics, general|mesh-ancestor
110893025|NCT02082236|Anesthetics|anesthetics|mesh-ancestor
110893026|NCT03557996|Listerine|listerine|mesh-list
110893027|NCT03557996|Fluorides|fluorides|mesh-list
110893028|NCT03557996|Sodium Fluoride|sodium fluoride|mesh-list
110893029|NCT03557996|Fluorides, Topical|fluorides, topical|mesh-list
110893030|NCT03557996|Cariostatic Agents|cariostatic agents|mesh-ancestor
110893031|NCT03557996|Protective Agents|protective agents|mesh-ancestor
110893032|NCT03557996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110893033|NCT03557996|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110893034|NCT03557996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110893036|NCT02296801|Palbociclib|palbociclib|mesh-list
110893037|NCT02296801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110893038|NCT02296801|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110893039|NCT02296801|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110893040|NCT02296801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110893041|NCT02296801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110893042|NCT02296801|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110893043|NCT02296801|Hormone Antagonists|hormone antagonists|mesh-ancestor
110893044|NCT02296801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110893045|NCT02296801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110893046|NCT02296801|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110893047|NCT02859324|Nivolumab|nivolumab|mesh-list
110893048|NCT02859324|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110893049|NCT02859324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110893050|NCT02859324|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110893051|NCT02859324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110893052|NCT02085590|Vaccines|vaccines|mesh-list
110893054|NCT02085590|Immunologic Factors|immunologic factors|mesh-ancestor
110893055|NCT02085590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110893056|NCT02085590|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110893057|NCT02143063|Cocaine|cocaine|mesh-list
110893058|NCT02143063|Anesthetics, Local|anesthetics, local|mesh-ancestor
110893059|NCT02143063|Anesthetics|anesthetics|mesh-ancestor
110893060|NCT02143063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110893061|NCT02143063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110893062|NCT02143063|Sensory System Agents|sensory system agents|mesh-ancestor
110893063|NCT02143063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110893064|NCT02143063|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110893065|NCT02143063|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110893066|NCT02143063|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110893067|NCT02143063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110893068|NCT02143063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110893069|NCT02143063|Dopamine Agents|dopamine agents|mesh-ancestor
110201240|NCT00399711|Rosiglitazone|rosiglitazone|mesh-list
110893070|NCT02143063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110893071|NCT02088866|Lidocaine|lidocaine|mesh-list
110893072|NCT02088866|Anesthetics, Local|anesthetics, local|mesh-ancestor
110893073|NCT02088866|Anesthetics|anesthetics|mesh-ancestor
110893074|NCT02088866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110893075|NCT02088866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110893076|NCT02088866|Sensory System Agents|sensory system agents|mesh-ancestor
110893077|NCT02088866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110893078|NCT02088866|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110893079|NCT02088866|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110893080|NCT02088866|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110893081|NCT02088866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110893082|NCT02088866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110893083|NCT02859246|Guaifenesin|guaifenesin|mesh-list
110893084|NCT02859246|Expectorants|expectorants|mesh-ancestor
110893085|NCT02859246|Respiratory System Agents|respiratory system agents|mesh-ancestor
110893086|NCT02088944|Infliximab|infliximab|mesh-list
110893087|NCT02088944|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110893088|NCT02088944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110893089|NCT02088944|Dermatologic Agents|dermatologic agents|mesh-ancestor
110893090|NCT02088944|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110893091|NCT02088944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110893092|NCT02073097|Acyclovir|acyclovir|mesh-list
110893093|NCT02073097|Prednisone|prednisone|mesh-list
110893094|NCT02073097|Cyclophosphamide|cyclophosphamide|mesh-list
110893095|NCT02073097|Rituximab|rituximab|mesh-list
110893096|NCT02073097|Doxorubicin|doxorubicin|mesh-list
110893097|NCT02073097|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110893098|NCT02073097|Vincristine|vincristine|mesh-list
110893099|NCT02073097|Lenograstim|lenograstim|mesh-list
110893100|NCT02073097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110893101|NCT02073097|Immunologic Factors|immunologic factors|mesh-ancestor
110893102|NCT02073097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110893103|NCT02073097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110893104|NCT02073097|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110893106|NCT02073097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110893107|NCT02073097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110893108|NCT02073097|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110893109|NCT02073097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110893110|NCT02073097|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110893111|NCT02073097|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110893112|NCT02073097|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110893113|NCT02073097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110893114|NCT02073097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110893115|NCT02073097|Glucocorticoids|glucocorticoids|mesh-ancestor
110893116|NCT02073097|Hormones|hormones|mesh-ancestor
110893117|NCT02073097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110893118|NCT02073097|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110893119|NCT02073097|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110893120|NCT02073097|Tubulin Modulators|tubulin modulators|mesh-ancestor
110201253|NCT00148291|Docetaxel|docetaxel|mesh-list
110893121|NCT02073097|Antimitotic Agents|antimitotic agents|mesh-ancestor
110893122|NCT02073097|Mitosis Modulators|mitosis modulators|mesh-ancestor
110893123|NCT02073097|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110893124|NCT02073097|Antiviral Agents|antiviral agents|mesh-ancestor
110893125|NCT02073097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110893126|NCT02921997|Vaccines|vaccines|mesh-list
110893127|NCT02921997|Immunologic Factors|immunologic factors|mesh-ancestor
110893128|NCT02921997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110893129|NCT02791490|Metformin|metformin|mesh-list
110893130|NCT02791490|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110893131|NCT02791490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110893132|NCT02791490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110893133|NCT02791490|Incretins|incretins|mesh-ancestor
110893134|NCT02791490|Hormones|hormones|mesh-ancestor
110893135|NCT02791490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110893136|NCT02791490|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110893137|NCT02791490|Protease Inhibitors|protease inhibitors|mesh-ancestor
110893138|NCT02791490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110922721|NCT02293694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110893139|NCT02791490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110893140|NCT04635631|Talazoparib|talazoparib|mesh-list
110893141|NCT04635631|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110893142|NCT04635631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110893143|NCT04635631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110893144|NCT04635631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110893145|NCT02085824|Enoxaparin|enoxaparin|mesh-list
110893146|NCT02085824|Rivaroxaban|rivaroxaban|mesh-list
110893147|NCT02085824|Dabigatran|dabigatran|mesh-list
110893148|NCT02085824|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110893149|NCT02085824|Antithrombins|antithrombins|mesh-ancestor
110893150|NCT02085824|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110893151|NCT02085824|Protease Inhibitors|protease inhibitors|mesh-ancestor
110893152|NCT02085824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110893153|NCT02085824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110893154|NCT02085824|Anticoagulants|anticoagulants|mesh-ancestor
110893155|NCT02085824|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110893156|NCT02085824|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110893157|NCT01368445|Azelastine|azelastine|mesh-list
110893158|NCT01368445|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110893159|NCT01368445|Autonomic Agents|autonomic agents|mesh-ancestor
110893160|NCT01368445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110893161|NCT01368445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110893162|NCT01368445|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110893163|NCT01368445|Respiratory System Agents|respiratory system agents|mesh-ancestor
110893164|NCT01368445|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
110893165|NCT01368445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110893166|NCT01368445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110893167|NCT01368445|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110893168|NCT01368445|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110893169|NCT01368445|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110893170|NCT01368445|Histamine Antagonists|histamine antagonists|mesh-ancestor
110893171|NCT01368445|Histamine Agents|histamine agents|mesh-ancestor
110893172|NCT01368445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110893173|NCT02085902|Ropivacaine|ropivacaine|mesh-list
110893174|NCT02085902|Anesthetics, Local|anesthetics, local|mesh-ancestor
110893175|NCT02085902|Anesthetics|anesthetics|mesh-ancestor
110893176|NCT02085902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110893177|NCT02085902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110201263|NCT00148330|Glucocorticoids|glucocorticoids|mesh-ancestor
110893178|NCT02085902|Sensory System Agents|sensory system agents|mesh-ancestor
110893179|NCT02085902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110893180|NCT01368757|Lenalidomide|lenalidomide|mesh-list
110893181|NCT01368757|Immunologic Factors|immunologic factors|mesh-ancestor
110893182|NCT01368757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110893183|NCT01368757|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110893184|NCT01368757|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110893185|NCT01368757|Growth Substances|growth substances|mesh-ancestor
110893186|NCT01368757|Growth Inhibitors|growth inhibitors|mesh-ancestor
110893187|NCT01368757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110893188|NCT02086292|Lidocaine|lidocaine|mesh-list
110893190|NCT02086292|Anesthetics|anesthetics|mesh-ancestor
110893191|NCT02086292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110893192|NCT02086292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110893193|NCT02086292|Sensory System Agents|sensory system agents|mesh-ancestor
110893194|NCT02086292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110893195|NCT02086292|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110893196|NCT02086292|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110893197|NCT02086292|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110893198|NCT02086292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110893199|NCT02086292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110893200|NCT02425644|Teriflunomide|teriflunomide|mesh-list
110893201|NCT02425644|Ponesimod|ponesimod|mesh-list
110893202|NCT02425644|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110893203|NCT02425644|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110893204|NCT02425644|Analgesics|analgesics|mesh-ancestor
110893205|NCT02425644|Sensory System Agents|sensory system agents|mesh-ancestor
110893206|NCT02425644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110893207|NCT02425644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110893208|NCT02425644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110893209|NCT02425644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110893210|NCT02425644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110893211|NCT02425644|Immunologic Factors|immunologic factors|mesh-ancestor
110893212|NCT02425644|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
110893213|NCT02425644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110893214|NCT02184741|Immunoglobulins|immunoglobulins|mesh-list
110893215|NCT02184741|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110893216|NCT02184741|gamma-Globulins|gamma-globulins|mesh-list
110893217|NCT02184741|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110893218|NCT02184741|Immunologic Factors|immunologic factors|mesh-ancestor
110893219|NCT02184741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110893220|NCT02086526|Metformin|metformin|mesh-list
110893221|NCT02086526|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110893222|NCT02086526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110893223|NCT04180995|Axitinib|axitinib|mesh-list
110893224|NCT04180995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110893225|NCT04180995|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110893226|NCT04180995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110201279|NCT00405847|Dexmedetomidine|dexmedetomidine|mesh-list
110893227|NCT04180995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110893228|NCT02089178|Remifentanil|remifentanil|mesh-list
110893229|NCT02089178|Anesthetics|anesthetics|mesh-list
110893230|NCT02089178|Propofol|propofol|mesh-list
110893231|NCT02089178|Sevoflurane|sevoflurane|mesh-list
110893232|NCT02089178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110893233|NCT02089178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110893234|NCT02089178|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110893235|NCT02089178|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110893236|NCT02089178|Anesthetics, General|anesthetics, general|mesh-ancestor
110893237|NCT02089178|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110893238|NCT02089178|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110893239|NCT02089178|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110893240|NCT02089178|Narcotics|narcotics|mesh-ancestor
110893241|NCT02089178|Analgesics|analgesics|mesh-ancestor
110893242|NCT02089178|Sensory System Agents|sensory system agents|mesh-ancestor
110893243|NCT02089178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110893244|NCT02089256|Liraglutide|liraglutide|mesh-list
110893245|NCT02089256|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110893246|NCT02089256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110893247|NCT02089256|Incretins|incretins|mesh-ancestor
110893248|NCT02089256|Hormones|hormones|mesh-ancestor
110893249|NCT02089256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110893250|NCT02861664|Fluorides|fluorides|mesh-list
110893251|NCT02861664|Tin Fluorides|tin fluorides|mesh-list
110893252|NCT02861664|Fluorophosphate|fluorophosphate|mesh-list
110893253|NCT02861664|Cariostatic Agents|cariostatic agents|mesh-ancestor
110893254|NCT02861664|Protective Agents|protective agents|mesh-ancestor
110893255|NCT02861664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110893256|NCT02086838|Dextrans|dextrans|mesh-list
110893257|NCT02086838|Iron-Dextran Complex|iron-dextran complex|mesh-list
110893258|NCT02086838|Hematinics|hematinics|mesh-list
110893259|NCT02086838|Anticoagulants|anticoagulants|mesh-ancestor
110223834|NCT00296608|Leucovorin|leucovorin|mesh-list
110893261|NCT02086838|Blood Substitutes|blood substitutes|mesh-ancestor
110893262|NCT02236962|Pioglitazone|pioglitazone|mesh-list
110893263|NCT02236962|Ephedrine|ephedrine|mesh-list
110893264|NCT02236962|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110893265|NCT02236962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110893266|NCT02236962|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110893267|NCT02236962|Sympathomimetics|sympathomimetics|mesh-ancestor
110893268|NCT02236962|Autonomic Agents|autonomic agents|mesh-ancestor
110893269|NCT02236962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110893270|NCT02236962|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110893271|NCT02236962|Adrenergic Agents|adrenergic agents|mesh-ancestor
110893272|NCT02236962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110893273|NCT02236962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110893274|NCT04431375|Tenofovir|tenofovir|mesh-list
110893275|NCT04431375|Antiviral Agents|antiviral agents|mesh-ancestor
110893276|NCT04431375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110893277|NCT04431375|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110893278|NCT04431375|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110893279|NCT04431375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110893280|NCT04431375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110893281|NCT04431375|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110893282|NCT04431375|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110893283|NCT02086994|Misoprostol|misoprostol|mesh-list
110893284|NCT02086994|Carbetocin|carbetocin|mesh-list
110893285|NCT02086994|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110893286|NCT02086994|Abortifacient Agents|abortifacient agents|mesh-ancestor
110893287|NCT02086994|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110893288|NCT02086994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110893289|NCT02086994|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110893290|NCT02086994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110893291|NCT02086994|Oxytocics|oxytocics|mesh-ancestor
110893292|NCT05664711|Bupivacaine|bupivacaine|mesh-list
110893293|NCT05664711|Anesthetics, Local|anesthetics, local|mesh-ancestor
110893294|NCT05664711|Anesthetics|anesthetics|mesh-ancestor
110893295|NCT05664711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110893296|NCT05664711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110893297|NCT05664711|Sensory System Agents|sensory system agents|mesh-ancestor
110893298|NCT05664711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110893299|NCT02089568|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
110893300|NCT02089568|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110893301|NCT02089568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110893302|NCT02089568|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110893303|NCT02089568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110893304|NCT02089568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110893305|NCT03284853|Latanoprost|latanoprost|mesh-list
110893306|NCT03284853|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110893307|NCT03284853|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110893308|NCT02087384|Vaccines|vaccines|mesh-list
110893309|NCT02087384|Immunologic Factors|immunologic factors|mesh-ancestor
110893310|NCT02087384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110893311|NCT02087462|Vitamins|vitamins|mesh-list
110893312|NCT02087462|Thiamine|thiamine|mesh-list
110893313|NCT02087462|Vitamin B Complex|vitamin b complex|mesh-list
110893314|NCT02087462|Diclofenac|diclofenac|mesh-list
110893315|NCT02087462|Micronutrients|micronutrients|mesh-ancestor
110893316|NCT02087462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110893317|NCT02087462|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110893318|NCT02087462|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110893319|NCT02087462|Analgesics|analgesics|mesh-ancestor
110893320|NCT02087462|Sensory System Agents|sensory system agents|mesh-ancestor
110893321|NCT02087462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110893322|NCT02087462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110893323|NCT02087462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110893324|NCT02087462|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110893325|NCT02087462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110893326|NCT02087462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110893327|NCT02087540|Telmisartan|telmisartan|mesh-list
110893328|NCT02087540|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110893329|NCT02087540|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110893330|NCT02087540|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110610830|NCT00873483|Gestodene|gestodene|mesh-list
110893332|NCT02087540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110893333|NCT02087540|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110893334|NCT02087540|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110893335|NCT02087540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110893336|NCT02087540|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110893337|NCT02087540|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110893338|NCT02087540|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110893339|NCT03055221|Treprostinil|treprostinil|mesh-list
110893340|NCT03055221|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110893341|NCT03206463|Dronabinol|dronabinol|mesh-list
110893342|NCT03206463|Hallucinogens|hallucinogens|mesh-ancestor
110893343|NCT03206463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110893344|NCT03206463|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110893345|NCT03206463|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110893346|NCT03206463|Analgesics|analgesics|mesh-ancestor
110893347|NCT03206463|Sensory System Agents|sensory system agents|mesh-ancestor
110893348|NCT03206463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110893349|NCT03206463|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
110893350|NCT03206463|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110201315|NCT00043134|Antimetabolites|antimetabolites|mesh-ancestor
110893351|NCT03206463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110893352|NCT03206463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110893353|NCT03206463|Hormones|hormones|mesh-ancestor
110893354|NCT03206463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110893355|NCT02091674|Hyaluronic Acid|hyaluronic acid|mesh-list
110893356|NCT02091674|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110893357|NCT02091674|Immunologic Factors|immunologic factors|mesh-ancestor
110893358|NCT02091674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110893359|NCT02091674|Viscosupplements|viscosupplements|mesh-ancestor
110893360|NCT02091674|Protective Agents|protective agents|mesh-ancestor
110893361|NCT01218555|Lenalidomide|lenalidomide|mesh-list
110893362|NCT01218555|Everolimus|everolimus|mesh-list
110893363|NCT01218555|Immunologic Factors|immunologic factors|mesh-ancestor
110893364|NCT01218555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110893365|NCT01218555|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110893366|NCT01218555|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110893367|NCT01218555|Growth Substances|growth substances|mesh-ancestor
110893368|NCT01218555|Growth Inhibitors|growth inhibitors|mesh-ancestor
110893369|NCT01218555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110893370|NCT01218555|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110893371|NCT01218555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110893372|NCT01218555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110893373|NCT01218555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110893374|NCT01218555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110893375|NCT02091830|Acetaminophen|acetaminophen|mesh-list
110893376|NCT02091830|Cortisone|cortisone|mesh-list
110893377|NCT02091830|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
110893378|NCT02091830|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
110893379|NCT02091830|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110893380|NCT02091830|Analgesics|analgesics|mesh-ancestor
110893381|NCT02091830|Sensory System Agents|sensory system agents|mesh-ancestor
110893382|NCT02091830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110893383|NCT02091830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110893384|NCT02091830|Antipyretics|antipyretics|mesh-ancestor
110893385|NCT02091830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110893386|NCT01111305|Diethylcarbamazine|diethylcarbamazine|mesh-list
110893387|NCT01111305|Reslizumab|reslizumab|mesh-list
110893388|NCT01111305|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110893389|NCT01111305|Respiratory System Agents|respiratory system agents|mesh-ancestor
110893390|NCT01111305|Filaricides|filaricides|mesh-ancestor
110893391|NCT01111305|Antinematodal Agents|antinematodal agents|mesh-ancestor
110893392|NCT01111305|Anthelmintics|anthelmintics|mesh-ancestor
110893393|NCT01111305|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110893394|NCT01111305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110893395|NCT01111305|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
110893396|NCT01111305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110893397|NCT01111305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110893399|NCT03752307|Methylprednisolone|methylprednisolone|mesh-list
110893400|NCT03752307|Isoxsuprine|isoxsuprine|mesh-list
110893401|NCT03752307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110893402|NCT03752307|Glucocorticoids|glucocorticoids|mesh-ancestor
110893403|NCT03752307|Hormones|hormones|mesh-ancestor
110893404|NCT03752307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110893405|NCT03752307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110893406|NCT03752307|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110893407|NCT03752307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110893408|NCT03752307|Antiemetics|antiemetics|mesh-ancestor
110893409|NCT03752307|Autonomic Agents|autonomic agents|mesh-ancestor
110893410|NCT03752307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110893411|NCT03752307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110893412|NCT03752307|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110893413|NCT03752307|Protective Agents|protective agents|mesh-ancestor
110893414|NCT03752307|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110893415|NCT03752307|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110893416|NCT03752307|Adrenergic Agents|adrenergic agents|mesh-ancestor
110893417|NCT03752307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110893418|NCT03752307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110893419|NCT03752307|Sympathomimetics|sympathomimetics|mesh-ancestor
110893420|NCT03752307|Vasodilator Agents|vasodilator agents|mesh-ancestor
110893421|NCT03752307|Tocolytic Agents|tocolytic agents|mesh-ancestor
110223859|NCT00296686|Dopamine Agents|dopamine agents|mesh-ancestor
110893422|NCT03752307|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110893423|NCT00792831|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
110893424|NCT00792831|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110893425|NCT00792831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110893426|NCT00792831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110893427|NCT00496431|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
110893428|NCT00496431|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
110893429|NCT00496431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110893430|NCT00496431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110893432|NCT02091908|Vaccines|vaccines|mesh-list
110893433|NCT02091908|Immunologic Factors|immunologic factors|mesh-ancestor
110893434|NCT02091908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110893435|NCT02091908|Cathartics|cathartics|mesh-ancestor
110893436|NCT02091908|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110893437|NCT03627897|Bupivacaine|bupivacaine|mesh-list
110893438|NCT03627897|Anesthetics, Local|anesthetics, local|mesh-ancestor
110893439|NCT03627897|Anesthetics|anesthetics|mesh-ancestor
110893440|NCT03627897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110893441|NCT03627897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110893442|NCT03627897|Sensory System Agents|sensory system agents|mesh-ancestor
110893443|NCT03627897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110893444|NCT01372111|Cisplatin|cisplatin|mesh-list
110893445|NCT01372111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110893446|NCT03125941|Dexamethasone|dexamethasone|mesh-list
110893447|NCT03125941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110893448|NCT03125941|Antiemetics|antiemetics|mesh-ancestor
110893449|NCT03125941|Autonomic Agents|autonomic agents|mesh-ancestor
110893450|NCT03125941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110893451|NCT03125941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110893452|NCT03125941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110922780|NCT02300948|Folic Acid|folic acid|mesh-list
110893454|NCT03125941|Hormones|hormones|mesh-ancestor
110893455|NCT03125941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110893456|NCT03125941|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110893457|NCT03125941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110893458|NCT02092142|Vaccines|vaccines|mesh-list
110893459|NCT02092142|Immunologic Factors|immunologic factors|mesh-ancestor
110893460|NCT02092142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110893461|NCT02095886|BMS-955176|bms-955176|mesh-list
110893462|NCT02095886|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110893463|NCT02095886|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110893464|NCT02095886|Antiviral Agents|antiviral agents|mesh-ancestor
110893465|NCT02095886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110893466|NCT01372579|Carboplatin|carboplatin|mesh-list
110893467|NCT01372579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110893468|NCT02090036|Lumefantrine|lumefantrine|mesh-list
110893469|NCT02090036|Artemether|artemether|mesh-list
110893470|NCT02090036|Primaquine|primaquine|mesh-list
110893471|NCT02090036|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
110893472|NCT02090036|Antimalarials|antimalarials|mesh-ancestor
110893473|NCT02090036|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110893474|NCT02090036|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110893475|NCT02090036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110893476|NCT03125629|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110893477|NCT03125629|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110893478|NCT03125629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110610974|NCT00873795|Aripiprazole|aripiprazole|mesh-list
110893479|NCT02092376|Cholecalciferol|cholecalciferol|mesh-list
110893480|NCT02092376|Vitamin D|vitamin d|mesh-list
110893481|NCT02092376|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110893482|NCT02092376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110893484|NCT02092376|Micronutrients|micronutrients|mesh-ancestor
110893485|NCT02092376|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110893486|NCT05452928|Valacyclovir|valacyclovir|mesh-list
110893487|NCT05452928|Acyclovir|acyclovir|mesh-list
110893488|NCT05452928|Antiviral Agents|antiviral agents|mesh-ancestor
110893489|NCT05452928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110893490|NCT03125395|Ivacaftor|ivacaftor|mesh-list
110893491|NCT03125395|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
110893492|NCT03125395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110893493|NCT03125395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110893494|NCT01369303|Tenofovir|tenofovir|mesh-list
110893495|NCT01369303|Antiviral Agents|antiviral agents|mesh-ancestor
110893496|NCT01369303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110893497|NCT01369303|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110893498|NCT01369303|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110893499|NCT01369303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110893500|NCT01369303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110893501|NCT01369303|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110922797|NCT02297594|Ziresovir|ziresovir|mesh-list
110893502|NCT01369303|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110893504|NCT02092532|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110893505|NCT02092532|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110893506|NCT02092532|Growth Substances|growth substances|mesh-ancestor
110893507|NCT02092532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110893508|NCT02092532|Growth Inhibitors|growth inhibitors|mesh-ancestor
110893509|NCT02092532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110893510|NCT02092766|Artesunate|artesunate|mesh-list
110893511|NCT02092766|Quinine|quinine|mesh-list
110893512|NCT02092766|Antimalarials|antimalarials|mesh-ancestor
110893513|NCT02092766|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110893514|NCT02092766|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110893515|NCT02092766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110893516|NCT02092766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110893517|NCT02092766|Antiviral Agents|antiviral agents|mesh-ancestor
110893518|NCT02092766|Schistosomicides|schistosomicides|mesh-ancestor
110893519|NCT02092766|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110893520|NCT02092766|Anthelmintics|anthelmintics|mesh-ancestor
110893521|NCT02092766|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110893522|NCT02092766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110893523|NCT02092766|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110893524|NCT02092766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110893525|NCT02092766|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110893526|NCT02092766|Analgesics|analgesics|mesh-ancestor
110893527|NCT02092766|Sensory System Agents|sensory system agents|mesh-ancestor
110893528|NCT02090348|Dimethyl Fumarate|dimethyl fumarate|mesh-list
110893529|NCT02090348|Dermatologic Agents|dermatologic agents|mesh-ancestor
110893530|NCT02090348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110893531|NCT02090348|Immunologic Factors|immunologic factors|mesh-ancestor
110201361|NCT00148681|Mitosis Modulators|mitosis modulators|mesh-ancestor
110893532|NCT02090348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110893533|NCT02721069|Diazepam|diazepam|mesh-list
110893534|NCT02721069|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110893535|NCT02721069|Anticonvulsants|anticonvulsants|mesh-ancestor
110893536|NCT02721069|Antiemetics|antiemetics|mesh-ancestor
110893537|NCT02721069|Autonomic Agents|autonomic agents|mesh-ancestor
110893538|NCT02721069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110893539|NCT02721069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110893540|NCT02721069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110893541|NCT02721069|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110893542|NCT02721069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110893543|NCT02721069|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110893544|NCT02721069|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110893545|NCT02721069|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110893546|NCT02721069|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110893547|NCT02721069|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110893548|NCT02721069|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110893549|NCT02721069|Anesthetics, General|anesthetics, general|mesh-ancestor
110893550|NCT02721069|Anesthetics|anesthetics|mesh-ancestor
110893551|NCT02721069|GABA Modulators|gaba modulators|mesh-ancestor
110893552|NCT02721069|GABA Agents|gaba agents|mesh-ancestor
110893553|NCT02721069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110893554|NCT02721069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110893555|NCT02093000|Bevacizumab|bevacizumab|mesh-list
110893556|NCT02093000|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110893557|NCT02093000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110893558|NCT02093000|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110893560|NCT02093000|Growth Substances|growth substances|mesh-ancestor
110893561|NCT02093000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110893562|NCT02093000|Growth Inhibitors|growth inhibitors|mesh-ancestor
110893563|NCT00261807|Daptomycin|daptomycin|mesh-list
110893564|NCT00261807|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110893565|NCT00261807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110893566|NCT02090504|Sodium Oxybate|sodium oxybate|mesh-list
110893567|NCT02090504|Oxazepam|oxazepam|mesh-list
110893568|NCT02090504|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110893569|NCT02090504|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110893570|NCT02090504|Anesthetics, General|anesthetics, general|mesh-ancestor
110893571|NCT02090504|Anesthetics|anesthetics|mesh-ancestor
110893572|NCT02090504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110893573|NCT02090504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110893574|NCT02090504|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110893575|NCT02090504|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110893576|NCT02090504|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110893577|NCT02090504|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110893578|NCT02090504|GABA Modulators|gaba modulators|mesh-ancestor
110893579|NCT02090504|GABA Agents|gaba agents|mesh-ancestor
110893580|NCT02090504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110893581|NCT02090504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110893582|NCT01567059|Cytarabine|cytarabine|mesh-list
110893583|NCT01567059|Decitabine|decitabine|mesh-list
110893584|NCT01567059|Azacitidine|azacitidine|mesh-list
110893585|NCT01567059|Tosedostat|tosedostat|mesh-list
110893586|NCT01567059|Glycine|glycine|mesh-list
110893587|NCT01567059|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110893588|NCT01567059|Antimetabolites|antimetabolites|mesh-ancestor
110893589|NCT01567059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110893590|NCT01567059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110893591|NCT01567059|Antiviral Agents|antiviral agents|mesh-ancestor
110893592|NCT01567059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110893593|NCT01567059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110893594|NCT01567059|Immunologic Factors|immunologic factors|mesh-ancestor
110893595|NCT01567059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110893596|NCT01567059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110893597|NCT01567059|Glycine Agents|glycine agents|mesh-ancestor
110893598|NCT01567059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110893599|NCT02090738|Amoxicillin|amoxicillin|mesh-list
110893600|NCT02090738|Clarithromycin|clarithromycin|mesh-list
110893601|NCT02090738|Acetazolamide|acetazolamide|mesh-list
110893602|NCT02090738|Esomeprazole|esomeprazole|mesh-list
110893603|NCT02090738|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110893604|NCT02090738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110893605|NCT02090738|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110893606|NCT02090738|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110893607|NCT02090738|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110893608|NCT02090738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110893609|NCT02090738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110893610|NCT02090738|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110893611|NCT02090738|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110893612|NCT02090738|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110893613|NCT02090738|Anticonvulsants|anticonvulsants|mesh-ancestor
110893614|NCT02090738|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110893615|NCT02090738|Diuretics|diuretics|mesh-ancestor
110893616|NCT02090738|Natriuretic Agents|natriuretic agents|mesh-ancestor
110893617|NCT02090738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110893618|NCT02096510|Hydrocortisone|hydrocortisone|mesh-list
110893619|NCT02096510|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
110893620|NCT02096510|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
110893621|NCT02096510|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
110893622|NCT02096510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110893623|NCT03441555|Venetoclax|venetoclax|mesh-list
110893624|NCT03441555|Alvocidib|alvocidib|mesh-list
110893625|NCT03441555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110893626|NCT03441555|Growth Inhibitors|growth inhibitors|mesh-ancestor
110893627|NCT03441555|Growth Substances|growth substances|mesh-ancestor
110893628|NCT03441555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110893629|NCT03441555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110893630|NCT03441555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110893631|NCT03441555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110893632|NCT02093780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
110893633|NCT03346239|Escitalopram|escitalopram|mesh-list
110611128|NCT00880815|Tacrolimus|tacrolimus|mesh-list
110893634|NCT03346239|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110893635|NCT03346239|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110893636|NCT03346239|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110223903|NCT00297388|Risperidone|risperidone|mesh-list
110893637|NCT03346239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110893638|NCT03346239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110893639|NCT03346239|Serotonin Agents|serotonin agents|mesh-ancestor
110893640|NCT03346239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110893641|NCT05218161|Dexmedetomidine|dexmedetomidine|mesh-list
110893642|NCT05218161|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110893643|NCT05218161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110893644|NCT05218161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110893645|NCT05218161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110893646|NCT05218161|Analgesics|analgesics|mesh-ancestor
110893647|NCT05218161|Sensory System Agents|sensory system agents|mesh-ancestor
110893648|NCT05218161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110893649|NCT05218161|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110893650|NCT05218161|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110893651|NCT05218161|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110893652|NCT05218161|Adrenergic Agents|adrenergic agents|mesh-ancestor
110893653|NCT05218161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110924813|NCT03098680|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110893654|NCT05218161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110893655|NCT02861586|Vaccines|vaccines|mesh-list
110893656|NCT02861586|Immunologic Factors|immunologic factors|mesh-ancestor
110893657|NCT02861586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110893658|NCT02099240|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110893659|NCT02099240|Amoxicillin|amoxicillin|mesh-list
110893660|NCT02099240|Azithromycin|azithromycin|mesh-list
110893661|NCT02099240|Moxifloxacin|moxifloxacin|mesh-list
110893662|NCT02099240|Vancomycin|vancomycin|mesh-list
110893663|NCT02099240|Clarithromycin|clarithromycin|mesh-list
110893664|NCT02099240|Doxycycline|doxycycline|mesh-list
110893665|NCT02099240|Ciprofloxacin|ciprofloxacin|mesh-list
110893666|NCT02099240|Levofloxacin|levofloxacin|mesh-list
110893667|NCT02099240|Ofloxacin|ofloxacin|mesh-list
110893668|NCT02099240|Minocycline|minocycline|mesh-list
110893669|NCT02099240|Rifampin|rifampin|mesh-list
110893670|NCT02099240|Clindamycin|clindamycin|mesh-list
110893671|NCT02099240|Clindamycin palmitate|clindamycin palmitate|mesh-list
110893672|NCT02099240|Clindamycin phosphate|clindamycin phosphate|mesh-list
110893673|NCT02099240|Gentamicins|gentamicins|mesh-list
110893674|NCT02099240|Isoniazid|isoniazid|mesh-list
110893675|NCT02099240|Meropenem|meropenem|mesh-list
110893676|NCT02099240|Ceftriaxone|ceftriaxone|mesh-list
110893677|NCT02099240|Tazobactam|tazobactam|mesh-list
110893678|NCT02099240|Linezolid|linezolid|mesh-list
110893679|NCT02099240|Cycloserine|cycloserine|mesh-list
110893680|NCT02099240|Piperacillin|piperacillin|mesh-list
110893681|NCT02099240|Metronidazole|metronidazole|mesh-list
110893682|NCT02099240|Penicillins|penicillins|mesh-list
110893683|NCT02099240|Imipenem|imipenem|mesh-list
110893684|NCT02099240|Amikacin|amikacin|mesh-list
110893685|NCT02099240|Pyrazinamide|pyrazinamide|mesh-list
110893686|NCT02099240|Erythromycin|erythromycin|mesh-list
110893687|NCT02099240|Erythromycin Estolate|erythromycin estolate|mesh-list
110893688|NCT02099240|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
110893689|NCT02099240|Erythromycin stearate|erythromycin stearate|mesh-list
110893690|NCT02099240|Colistin|colistin|mesh-list
110893691|NCT02099240|Ceftazidime|ceftazidime|mesh-list
110893692|NCT02099240|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
110893693|NCT02099240|Ampicillin|ampicillin|mesh-list
110893694|NCT02099240|Clavulanic Acids|clavulanic acids|mesh-list
110893695|NCT02099240|Clavulanic Acid|clavulanic acid|mesh-list
110893696|NCT02099240|Mupirocin|mupirocin|mesh-list
110893697|NCT02099240|Rifabutin|rifabutin|mesh-list
110893698|NCT02099240|Rifapentine|rifapentine|mesh-list
110893699|NCT02099240|Cefepime|cefepime|mesh-list
110893700|NCT02099240|Fosfomycin|fosfomycin|mesh-list
110893701|NCT02099240|Cefuroxime|cefuroxime|mesh-list
110893702|NCT02099240|Cefuroxime axetil|cefuroxime axetil|mesh-list
110922845|NCT02254044|Immunotoxins|immunotoxins|mesh-ancestor
110893703|NCT02099240|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
110893704|NCT02099240|Paromomycin|paromomycin|mesh-list
110893705|NCT02099240|Nitrofurantoin|nitrofurantoin|mesh-list
110893706|NCT02099240|Aztreonam|aztreonam|mesh-list
110893707|NCT02099240|Polymyxins|polymyxins|mesh-list
110893708|NCT02099240|Neomycin|neomycin|mesh-list
110893709|NCT02099240|Sulbactam|sulbactam|mesh-list
110893710|NCT02099240|Bacitracin|bacitracin|mesh-list
110893711|NCT02099240|Cefotaxime|cefotaxime|mesh-list
110893712|NCT02099240|Cefoxitin|cefoxitin|mesh-list
110893713|NCT02099240|Gatifloxacin|gatifloxacin|mesh-list
110893714|NCT02099240|Sulfadiazine|sulfadiazine|mesh-list
110893715|NCT02099240|Cefixime|cefixime|mesh-list
110893716|NCT02099240|Polymyxin B|polymyxin b|mesh-list
110893717|NCT02099240|Cefdinir|cefdinir|mesh-list
110893718|NCT02099240|Penicillin G|penicillin g|mesh-list
110893719|NCT02099240|Penicillin G Benzathine|penicillin g benzathine|mesh-list
110893720|NCT02099240|Penicillin G Procaine|penicillin g procaine|mesh-list
110893721|NCT02099240|Norfloxacin|norfloxacin|mesh-list
110893722|NCT02099240|Cloxacillin|cloxacillin|mesh-list
110893724|NCT02099240|Cephalosporins|cephalosporins|mesh-list
110893725|NCT02099240|Oxacillin|oxacillin|mesh-list
110893726|NCT02099240|Nafcillin|nafcillin|mesh-list
110893727|NCT02099240|Streptomycin|streptomycin|mesh-list
110893728|NCT02099240|Ticarcillin|ticarcillin|mesh-list
110893729|NCT02099240|Methenamine hippurate|methenamine hippurate|mesh-list
110893730|NCT02099240|Methenamine mandelate|methenamine mandelate|mesh-list
110893731|NCT02099240|Dicloxacillin|dicloxacillin|mesh-list
110893732|NCT02099240|Sultamicillin|sultamicillin|mesh-list
110893733|NCT02099240|Cefpodoxime|cefpodoxime|mesh-list
110893734|NCT02099240|Cefpodoxime proxetil|cefpodoxime proxetil|mesh-list
110893735|NCT02099240|Ceftizoxime|ceftizoxime|mesh-list
110893736|NCT02099240|Ethionamide|ethionamide|mesh-list
110893737|NCT02099240|Cefoperazone|cefoperazone|mesh-list
110893738|NCT02099240|Kanamycin|kanamycin|mesh-list
110893739|NCT02099240|Penicillin V|penicillin v|mesh-list
110893740|NCT02099240|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
110893741|NCT02099240|Ceftibuten|ceftibuten|mesh-list
110893742|NCT02099240|Lincomycin|lincomycin|mesh-list
110893743|NCT02099240|Dirithromycin|dirithromycin|mesh-list
110893744|NCT02099240|Cefotetan|cefotetan|mesh-list
110893745|NCT02099240|Demeclocycline|demeclocycline|mesh-list
110893746|NCT02099240|Cefaclor|cefaclor|mesh-list
110893747|NCT02099240|Tobramycin|tobramycin|mesh-list
110893748|NCT02099240|Mafenide|mafenide|mesh-list
110893749|NCT02099240|Capreomycin|capreomycin|mesh-list
110893750|NCT02099240|Chloramphenicol|chloramphenicol|mesh-list
110893751|NCT02099240|Chloramphenicol succinate|chloramphenicol succinate|mesh-list
110893752|NCT02099240|Ticarcillin-clavulanic acid|ticarcillin-clavulanic acid|mesh-list
110893753|NCT02099240|Oxytetracycline|oxytetracycline|mesh-list
110893754|NCT02099240|Netilmicin|netilmicin|mesh-list
110893755|NCT02099240|Enoxacin|enoxacin|mesh-list
110893756|NCT02099240|Novobiocin|novobiocin|mesh-list
110893757|NCT02099240|Quinupristin-dalfopristin|quinupristin-dalfopristin|mesh-list
110893758|NCT02099240|Virginiamycin|virginiamycin|mesh-list
110893759|NCT02099240|Methicillin|methicillin|mesh-list
110893760|NCT02099240|Sulfacetamide|sulfacetamide|mesh-list
110893761|NCT02099240|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
110893762|NCT02099240|Spectinomycin|spectinomycin|mesh-list
110893763|NCT02099240|Dalfopristin|dalfopristin|mesh-list
110893764|NCT02099240|Chlortetracycline|chlortetracycline|mesh-list
110893765|NCT02099240|Tetracycline|tetracycline|mesh-list
110893766|NCT02099240|Methacycline|methacycline|mesh-list
110893767|NCT02099240|Sparfloxacin|sparfloxacin|mesh-list
110893768|NCT02099240|Fluoroquinolones|fluoroquinolones|mesh-list
110893769|NCT02099240|Nalidixic Acid|nalidixic acid|mesh-list
110893770|NCT02099240|Lomefloxacin|lomefloxacin|mesh-list
110893771|NCT02099240|Grepafloxacin|grepafloxacin|mesh-list
110893772|NCT02099240|Loracarbef|loracarbef|mesh-list
110893773|NCT02099240|Cefmetazole|cefmetazole|mesh-list
110893775|NCT02099240|Cefamandole nafate|cefamandole nafate|mesh-list
110893776|NCT02099240|Cefamandole|cefamandole|mesh-list
110893777|NCT02099240|Benzathine benzylpenicillin, procaine benzylpenicillin, drug combination|benzathine benzylpenicillin, procaine benzylpenicillin, drug combination|mesh-list
110893778|NCT02099240|Mezlocillin|mezlocillin|mesh-list
110893779|NCT02099240|Carbenicillin indanyl|carbenicillin indanyl|mesh-list
110893780|NCT02099240|Carbenicillin|carbenicillin|mesh-list
110893781|NCT02099240|Bacampicillin|bacampicillin|mesh-list
110893782|NCT02099240|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
110893783|NCT02099240|Sulfamethoxazole|sulfamethoxazole|mesh-list
110893784|NCT02099240|Sulfasalazine|sulfasalazine|mesh-list
110893785|NCT02099240|Silver Sulfadiazine|silver sulfadiazine|mesh-list
110893786|NCT02099240|Methenamine|methenamine|mesh-list
110893787|NCT02099240|Sulperazone|sulperazone|mesh-list
110893788|NCT02099240|Sulfisoxazole|sulfisoxazole|mesh-list
110893789|NCT02099240|Cinoxacin|cinoxacin|mesh-list
110893790|NCT02099240|Nitrofurazone|nitrofurazone|mesh-list
110893791|NCT02099240|Trimethoprim|trimethoprim|mesh-list
110893792|NCT02099240|Sulfamethizole|sulfamethizole|mesh-list
110893793|NCT02099240|Procaine|procaine|mesh-list
110893794|NCT02099240|Benzoyl Peroxide|benzoyl peroxide|mesh-list
110893795|NCT02099240|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
110893796|NCT02099240|Cilastatin|cilastatin|mesh-list
110893797|NCT02099240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110893798|NCT02099240|Antitubercular Agents|antitubercular agents|mesh-ancestor
110893799|NCT02099240|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110893800|NCT02099240|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110893801|NCT02099240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110893802|NCT02099240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110893803|NCT02099240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110893804|NCT02099240|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110893806|NCT02099240|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110893807|NCT02099240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110893808|NCT02099240|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110893809|NCT02099240|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110893810|NCT02099240|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110893811|NCT02099240|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110893812|NCT02099240|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110893813|NCT02099240|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110893814|NCT02099240|Antimalarials|antimalarials|mesh-ancestor
110893815|NCT02099240|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110893816|NCT02099240|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110893817|NCT02099240|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110893818|NCT02099240|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110893819|NCT02099240|Leprostatic Agents|leprostatic agents|mesh-ancestor
110893820|NCT02099240|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110893821|NCT02099240|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110893822|NCT02099240|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110893823|NCT02099240|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110893824|NCT02099240|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110893825|NCT02099240|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110893826|NCT02099240|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110893827|NCT02099240|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
110893828|NCT02099240|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110893829|NCT02099240|Antimetabolites|antimetabolites|mesh-ancestor
110893830|NCT02099240|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110893831|NCT02099240|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110893832|NCT02099240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110893833|NCT02099240|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110893834|NCT02099240|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110893835|NCT02099240|Analgesics|analgesics|mesh-ancestor
110893836|NCT02099240|Sensory System Agents|sensory system agents|mesh-ancestor
110922878|NCT03511820|Antifungal Agents|antifungal agents|mesh-ancestor
110893837|NCT02099240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110893838|NCT02099240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110893839|NCT02099240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110893840|NCT02099240|Protease Inhibitors|protease inhibitors|mesh-ancestor
110893841|NCT02099240|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110893842|NCT02099240|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110893843|NCT02099240|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110893844|NCT02099240|Coccidiostats|coccidiostats|mesh-ancestor
110893845|NCT02099240|Anesthetics, Local|anesthetics, local|mesh-ancestor
110893846|NCT02099240|Anesthetics|anesthetics|mesh-ancestor
110893847|NCT02099240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110893848|NCT02099240|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110893849|NCT02099240|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110893850|NCT02099240|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110893851|NCT02099240|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
110893852|NCT02099240|Dermatologic Agents|dermatologic agents|mesh-ancestor
110893853|NCT02245230|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
110893854|NCT02245230|Trimethaphan|trimethaphan|mesh-list
110893855|NCT02245230|Phenylephrine|phenylephrine|mesh-list
110893856|NCT02245230|Oxymetazoline|oxymetazoline|mesh-list
110893857|NCT02245230|Trimethaphan camsylate|trimethaphan camsylate|mesh-list
110893858|NCT02245230|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110893859|NCT02245230|Mydriatics|mydriatics|mesh-ancestor
110893860|NCT02245230|Autonomic Agents|autonomic agents|mesh-ancestor
110201432|NCT00048776|Autonomic Agents|autonomic agents|mesh-ancestor
110893861|NCT02245230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110893862|NCT02245230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110893863|NCT02245230|Sympathomimetics|sympathomimetics|mesh-ancestor
110893864|NCT02245230|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110893865|NCT02245230|Nasal Decongestants|nasal decongestants|mesh-ancestor
110893866|NCT02245230|Respiratory System Agents|respiratory system agents|mesh-ancestor
110893867|NCT02245230|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110893868|NCT02245230|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110893869|NCT02245230|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110893870|NCT02245230|Adrenergic Agents|adrenergic agents|mesh-ancestor
110893871|NCT02245230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110893872|NCT02245230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110893873|NCT02245230|Protective Agents|protective agents|mesh-ancestor
110893874|NCT02245230|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110893875|NCT02245230|Vasodilator Agents|vasodilator agents|mesh-ancestor
110893876|NCT02245230|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110893877|NCT02245230|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
110893878|NCT02245230|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
110893879|NCT02245230|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110893880|NCT02245230|Cholinergic Agents|cholinergic agents|mesh-ancestor
110893881|NCT05215743|Acetylcysteine|acetylcysteine|mesh-list
110893882|NCT05215743|Antioxidants|antioxidants|mesh-list
110893883|NCT05215743|Deferoxamine|deferoxamine|mesh-list
110893884|NCT05215743|Antiviral Agents|antiviral agents|mesh-ancestor
110893885|NCT05215743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110893886|NCT05215743|Expectorants|expectorants|mesh-ancestor
110893887|NCT05215743|Respiratory System Agents|respiratory system agents|mesh-ancestor
110893888|NCT05215743|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110893889|NCT05215743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110893890|NCT05215743|Protective Agents|protective agents|mesh-ancestor
110893891|NCT05215743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110893892|NCT05215743|Siderophores|siderophores|mesh-ancestor
110893893|NCT05215743|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110893894|NCT05215743|Chelating Agents|chelating agents|mesh-ancestor
110893895|NCT05215743|Sequestering Agents|sequestering agents|mesh-ancestor
110893896|NCT02099396|Gemcitabine|gemcitabine|mesh-list
110893897|NCT02099396|Docetaxel|docetaxel|mesh-list
110893898|NCT02099396|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110893899|NCT02099396|Antimetabolites|antimetabolites|mesh-ancestor
110893900|NCT02099396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110893901|NCT02099396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110893902|NCT02099396|Tubulin Modulators|tubulin modulators|mesh-ancestor
110893903|NCT02099396|Antimitotic Agents|antimitotic agents|mesh-ancestor
110893904|NCT02099396|Mitosis Modulators|mitosis modulators|mesh-ancestor
110893905|NCT05215665|Lenvatinib|lenvatinib|mesh-list
110893906|NCT05215665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110893907|NCT05215665|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110893908|NCT05215665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110922891|NCT02298062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110893909|NCT05215665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110893910|NCT02099474|Raltegravir Potassium|raltegravir potassium|mesh-list
110893911|NCT02099474|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110893912|NCT02099474|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110893913|NCT02099474|Antiviral Agents|antiviral agents|mesh-ancestor
110893914|NCT02099474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110893915|NCT02099474|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110893916|NCT02099474|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110893917|NCT02099474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110893918|NCT02099474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110893919|NCT05217069|Leucovorin|leucovorin|mesh-list
110893920|NCT05217069|Folic Acid|folic acid|mesh-list
110893921|NCT05217069|Irinotecan|irinotecan|mesh-list
110893922|NCT05217069|Cetuximab|cetuximab|mesh-list
110893923|NCT05217069|Avelumab|avelumab|mesh-list
110893924|NCT05217069|Levoleucovorin|levoleucovorin|mesh-list
110893925|NCT05217069|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110893926|NCT05217069|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110893927|NCT05217069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110893928|NCT05217069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110893929|NCT05217069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110893930|NCT05217069|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110893931|NCT05217069|Antidotes|antidotes|mesh-ancestor
110893932|NCT05217069|Protective Agents|protective agents|mesh-ancestor
110893933|NCT05217069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110893934|NCT05217069|Vitamin B Complex|vitamin b complex|mesh-ancestor
110893935|NCT05217069|Vitamins|vitamins|mesh-ancestor
110893936|NCT05217069|Micronutrients|micronutrients|mesh-ancestor
110893937|NCT05217069|Hematinics|hematinics|mesh-ancestor
110893938|NCT02065635|Propofol|propofol|mesh-list
110893939|NCT02065635|Sevoflurane|sevoflurane|mesh-list
110893940|NCT02065635|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110893941|NCT02065635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110893942|NCT02065635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110223925|NCT00297505|Citalopram|citalopram|mesh-list
110893944|NCT02065635|Anesthetics, General|anesthetics, general|mesh-ancestor
110893945|NCT02065635|Anesthetics|anesthetics|mesh-ancestor
110893946|NCT02065635|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110893947|NCT02065635|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110893948|NCT03628053|Blinatumomab|blinatumomab|mesh-list
110893949|NCT03628053|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
110893950|NCT03628053|Tisagenlecleucel|tisagenlecleucel|mesh-list
110893951|NCT03628053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110893952|NCT03628053|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110893953|NCT03628053|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110893954|NCT03628053|Immunotoxins|immunotoxins|mesh-ancestor
110893955|NCT03628053|Immunoconjugates|immunoconjugates|mesh-ancestor
110893956|NCT03628053|Immunologic Factors|immunologic factors|mesh-ancestor
110893957|NCT03628053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110893958|NCT02100176|Dopamine|dopamine|mesh-list
110893959|NCT02100176|Rotigotine|rotigotine|mesh-list
110893960|NCT02100176|Dopamine Agonists|dopamine agonists|mesh-list
110893961|NCT02100176|Dopamine Agents|dopamine agents|mesh-ancestor
110893962|NCT02100176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110893963|NCT02100176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110893964|NCT02100176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110893965|NCT02100176|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110893966|NCT02100176|Sympathomimetics|sympathomimetics|mesh-ancestor
110893967|NCT02100176|Autonomic Agents|autonomic agents|mesh-ancestor
110893968|NCT02100176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110893969|NCT02100176|Protective Agents|protective agents|mesh-ancestor
110893970|NCT02250482|Factor VIII|factor viii|mesh-list
110893971|NCT02250482|Coagulants|coagulants|mesh-ancestor
110893972|NCT05189145|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110922895|NCT03515018|Imatinib Mesylate|imatinib mesylate|mesh-list
110893974|NCT05189145|Hormones|hormones|mesh-list
110893975|NCT05189145|Estradiol|estradiol|mesh-list
110893976|NCT05189145|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110893977|NCT05189145|Progesterone|progesterone|mesh-list
110893978|NCT05189145|Dydrogesterone|dydrogesterone|mesh-list
110893979|NCT05189145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110893980|NCT05189145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110893981|NCT05189145|Estrogens|estrogens|mesh-ancestor
110893982|NCT05189145|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110893983|NCT05189145|Contraceptive Agents|contraceptive agents|mesh-ancestor
110893984|NCT05189145|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110893985|NCT05189145|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110893986|NCT05189145|Progestins|progestins|mesh-ancestor
110893987|NCT04967079|Trametinib|trametinib|mesh-list
110893988|NCT04967079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110893989|NCT04967079|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110893990|NCT04967079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110893991|NCT04967079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110893992|NCT03556592|Metoprolol|metoprolol|mesh-list
110893993|NCT03556592|Midazolam|midazolam|mesh-list
110893994|NCT03556592|Caffeine|caffeine|mesh-list
110893995|NCT03556592|Omeprazole|omeprazole|mesh-list
110893996|NCT03556592|Warfarin|warfarin|mesh-list
110893997|NCT03556592|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110893998|NCT03556592|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110893999|NCT03556592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110894000|NCT03556592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110894001|NCT03556592|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110894002|NCT03556592|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110894003|NCT03556592|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110894004|NCT03556592|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110894005|NCT03556592|Anesthetics, General|anesthetics, general|mesh-ancestor
110894006|NCT03556592|Anesthetics|anesthetics|mesh-ancestor
110894007|NCT03556592|GABA Modulators|gaba modulators|mesh-ancestor
110894008|NCT03556592|GABA Agents|gaba agents|mesh-ancestor
110894009|NCT03556592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110894010|NCT03556592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110894011|NCT03556592|Anticoagulants|anticoagulants|mesh-ancestor
110894012|NCT03556592|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110894013|NCT03556592|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110894014|NCT03556592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110894015|NCT03556592|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110894016|NCT03556592|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110894017|NCT03556592|Purinergic Agents|purinergic agents|mesh-ancestor
110894018|NCT03556592|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110894019|NCT03556592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110894020|NCT03556592|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110894021|NCT03556592|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110894022|NCT03556592|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110894023|NCT03556592|Sympatholytics|sympatholytics|mesh-ancestor
110894024|NCT03556592|Autonomic Agents|autonomic agents|mesh-ancestor
110894025|NCT03556592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110894026|NCT03556592|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110922910|NCT03748966|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110894027|NCT03556592|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110894028|NCT03556592|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110894029|NCT03556592|Adrenergic Agents|adrenergic agents|mesh-ancestor
110894030|NCT04964193|Cyproterone Acetate|cyproterone acetate|mesh-list
110894031|NCT04964193|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110894033|NCT04964193|Cyproterone acetate, ethinyl estradiol drug combination|cyproterone acetate, ethinyl estradiol drug combination|mesh-list
110894034|NCT04964193|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110894035|NCT04964193|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110894036|NCT04964193|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110894037|NCT04964193|Contraceptive Agents|contraceptive agents|mesh-ancestor
110611505|NCT00963664|Interferons|interferons|mesh-list
110894038|NCT04964193|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110894039|NCT04964193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110894040|NCT04964193|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110894041|NCT04964193|Estrogens|estrogens|mesh-ancestor
110894042|NCT04964193|Hormones|hormones|mesh-ancestor
110894043|NCT04964193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110894044|NCT04964193|Androgen Antagonists|androgen antagonists|mesh-ancestor
110894045|NCT04964193|Hormone Antagonists|hormone antagonists|mesh-ancestor
110894046|NCT04964193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110894047|NCT04964193|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110894048|NCT02100488|Insulin|insulin|mesh-list
110894049|NCT02100488|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110894050|NCT02100488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110894051|NCT02100488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110894052|NCT02095418|Mycophenolic Acid|mycophenolic acid|mesh-list
110894053|NCT02095418|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110894054|NCT02095418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110894055|NCT02095418|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110894056|NCT02095418|Antitubercular Agents|antitubercular agents|mesh-ancestor
110894057|NCT02095418|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110894058|NCT02095418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110894059|NCT02095418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110894060|NCT02095418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110894061|NCT04865497|Vaccines|vaccines|mesh-list
110894062|NCT04865497|Immunologic Factors|immunologic factors|mesh-ancestor
110894063|NCT04865497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110894065|NCT05665725|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110894066|NCT05665725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110894067|NCT05665725|Immunologic Factors|immunologic factors|mesh-ancestor
110894068|NCT05665725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110894069|NCT02098148|Xenon|xenon|mesh-list
110894070|NCT02098148|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110894071|NCT02098148|Anesthetics, General|anesthetics, general|mesh-ancestor
110894072|NCT02098148|Anesthetics|anesthetics|mesh-ancestor
110894073|NCT02098148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110894074|NCT02098148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110894075|NCT05168527|Paclitaxel|paclitaxel|mesh-list
110894076|NCT05168527|Gemcitabine|gemcitabine|mesh-list
110894077|NCT05168527|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110894078|NCT05168527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110894079|NCT05168527|Tubulin Modulators|tubulin modulators|mesh-ancestor
110894080|NCT05168527|Antimitotic Agents|antimitotic agents|mesh-ancestor
110894081|NCT05168527|Mitosis Modulators|mitosis modulators|mesh-ancestor
110894082|NCT05168527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110894083|NCT05168527|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110894084|NCT05168527|Antimetabolites|antimetabolites|mesh-ancestor
110894085|NCT02098460|Cilostazol|cilostazol|mesh-list
110894086|NCT02098460|Atorvastatin|atorvastatin|mesh-list
110894087|NCT02098460|Probucol|probucol|mesh-list
110894088|NCT02098460|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110894089|NCT02098460|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110894090|NCT02098460|Antimetabolites|antimetabolites|mesh-ancestor
110894091|NCT02098460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110894092|NCT02098460|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110894093|NCT02098460|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110894094|NCT02098460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110894095|NCT02098460|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110894096|NCT02098460|Autonomic Agents|autonomic agents|mesh-ancestor
110894097|NCT02098460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110894098|NCT02098460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110894099|NCT02098460|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110894100|NCT02098460|Respiratory System Agents|respiratory system agents|mesh-ancestor
110894101|NCT02098460|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110894102|NCT02098460|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110894103|NCT02098460|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110894104|NCT02098460|Vasodilator Agents|vasodilator agents|mesh-ancestor
110894105|NCT02098460|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110894106|NCT02098460|Protective Agents|protective agents|mesh-ancestor
110894107|NCT02098460|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110894108|NCT02098460|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110894109|NCT02098460|Antioxidants|antioxidants|mesh-ancestor
110894110|NCT02095574|Venetoclax|venetoclax|mesh-list
110894111|NCT02095574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110894112|NCT02095730|Vitamins|vitamins|mesh-list
110894113|NCT02095730|Riboflavin|riboflavin|mesh-list
110894114|NCT02095730|Vitamin B Complex|vitamin b complex|mesh-list
110894115|NCT02095730|Micronutrients|micronutrients|mesh-ancestor
110894116|NCT02095730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110894117|NCT02095730|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110894118|NCT02095730|Dermatologic Agents|dermatologic agents|mesh-ancestor
110894119|NCT02102438|Paclitaxel|paclitaxel|mesh-list
110894120|NCT02102438|Carboplatin|carboplatin|mesh-list
110894121|NCT02102438|Trastuzumab|trastuzumab|mesh-list
110894122|NCT02102438|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110894123|NCT02102438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110894124|NCT02102438|Tubulin Modulators|tubulin modulators|mesh-ancestor
110894125|NCT02102438|Antimitotic Agents|antimitotic agents|mesh-ancestor
110894126|NCT02102438|Mitosis Modulators|mitosis modulators|mesh-ancestor
110894127|NCT02102438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110894128|NCT02102438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110894129|NCT02098616|Asunaprevir|asunaprevir|mesh-list
110894130|NCT02098616|Protease Inhibitors|protease inhibitors|mesh-ancestor
110894131|NCT02098616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110894132|NCT02098616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110894133|NCT02102516|Ketorolac|ketorolac|mesh-list
110894134|NCT02102516|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
110894135|NCT02102516|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110894136|NCT02102516|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110894137|NCT02102516|Analgesics|analgesics|mesh-ancestor
110894138|NCT02102516|Sensory System Agents|sensory system agents|mesh-ancestor
110894139|NCT02102516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110894140|NCT02102516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110894141|NCT02102516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110894142|NCT02102516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110894143|NCT02102516|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110894144|NCT02102516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110894145|NCT02102516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110894146|NCT02106182|Silodosin|silodosin|mesh-list
110894147|NCT02106182|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110894148|NCT02106182|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110894149|NCT02106182|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110894150|NCT02106182|Adrenergic Agents|adrenergic agents|mesh-ancestor
110894151|NCT02106182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110894152|NCT02106182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110894153|NCT02106182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110894154|NCT02106182|Urological Agents|urological agents|mesh-ancestor
110894155|NCT01369693|Lobeline|lobeline|mesh-list
110894156|NCT01369693|Nicotine|nicotine|mesh-list
110894157|NCT01369693|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110894158|NCT01369693|Autonomic Agents|autonomic agents|mesh-ancestor
110894159|NCT01369693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110894160|NCT01369693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110894161|NCT01369693|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110894162|NCT01369693|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110894163|NCT01369693|Cholinergic Agents|cholinergic agents|mesh-ancestor
110894164|NCT01369693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110894165|NCT01369693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110894166|NCT01369693|Respiratory System Agents|respiratory system agents|mesh-ancestor
110894167|NCT02102594|Bortezomib|bortezomib|mesh-list
110894168|NCT02102594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110894169|NCT02102672|Trimetazidine|trimetazidine|mesh-list
110894170|NCT02102672|Vasodilator Agents|vasodilator agents|mesh-ancestor
110894171|NCT02106338|REP 3123|rep 3123|mesh-list
110894172|NCT02106338|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110894173|NCT02106338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110894174|NCT03121261|Clonidine|clonidine|mesh-list
110894175|NCT03121261|Levobupivacaine|levobupivacaine|mesh-list
110894176|NCT03121261|Analgesics|analgesics|mesh-ancestor
110894177|NCT03121261|Sensory System Agents|sensory system agents|mesh-ancestor
110894178|NCT03121261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110894179|NCT03121261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110894180|NCT03121261|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110894181|NCT03121261|Sympatholytics|sympatholytics|mesh-ancestor
110894182|NCT03121261|Autonomic Agents|autonomic agents|mesh-ancestor
110894183|NCT03121261|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110894184|NCT03121261|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110894185|NCT03121261|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110894186|NCT03121261|Adrenergic Agents|adrenergic agents|mesh-ancestor
110894187|NCT03121261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110894188|NCT03121261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110894189|NCT03121261|Anesthetics, Local|anesthetics, local|mesh-ancestor
110894190|NCT03121261|Anesthetics|anesthetics|mesh-ancestor
110611652|NCT02543697|Autonomic Agents|autonomic agents|mesh-ancestor
110894191|NCT03121261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110894192|NCT04249323|Prednisone|prednisone|mesh-list
110894193|NCT04249323|Cortisone|cortisone|mesh-list
110894194|NCT04249323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110894195|NCT04249323|Glucocorticoids|glucocorticoids|mesh-ancestor
110894196|NCT04249323|Hormones|hormones|mesh-ancestor
110894197|NCT04249323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110894198|NCT04249323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110894199|NCT04249323|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110894200|NCT04249323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110894201|NCT04227327|Aromatase Inhibitors|aromatase inhibitors|mesh-list
110894202|NCT04227327|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110894203|NCT04227327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110894204|NCT04227327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110894205|NCT04227327|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110894206|NCT04227327|Hormone Antagonists|hormone antagonists|mesh-ancestor
110894207|NCT04227327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110894208|NCT04227327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110894209|NCT02102828|Aspirin|aspirin|mesh-list
110894210|NCT02102828|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110894211|NCT02102828|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110894212|NCT02102828|Analgesics|analgesics|mesh-ancestor
110894213|NCT02102828|Sensory System Agents|sensory system agents|mesh-ancestor
110894214|NCT02102828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110894215|NCT02102828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110894216|NCT02102828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110894217|NCT02102828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110894218|NCT02102828|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110894219|NCT02102828|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110894220|NCT02102828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110894221|NCT02102828|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110894222|NCT02102828|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110894223|NCT02102828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110894224|NCT02102828|Antipyretics|antipyretics|mesh-ancestor
110894225|NCT01372423|Lubiprostone|lubiprostone|mesh-list
110894226|NCT01372423|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
110894227|NCT01372423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110894228|NCT01372423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110894229|NCT02106650|Leucovorin|leucovorin|mesh-list
110894230|NCT02106650|Folic Acid|folic acid|mesh-list
110894231|NCT02106650|Vitamin B 12|vitamin b 12|mesh-list
110894232|NCT02106650|Hydroxocobalamin|hydroxocobalamin|mesh-list
110894233|NCT02106650|Vitamins|vitamins|mesh-ancestor
110894234|NCT02106650|Micronutrients|micronutrients|mesh-ancestor
110894235|NCT02106650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110894236|NCT02106650|Antidotes|antidotes|mesh-ancestor
110894237|NCT02106650|Protective Agents|protective agents|mesh-ancestor
110894238|NCT02106650|Vitamin B Complex|vitamin b complex|mesh-ancestor
110894239|NCT02106650|Hematinics|hematinics|mesh-ancestor
110894240|NCT05221437|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110894241|NCT05221437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110894242|NCT01376011|Quercetin|quercetin|mesh-list
110894243|NCT01376011|Antioxidants|antioxidants|mesh-ancestor
110894244|NCT01376011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110894245|NCT01376011|Protective Agents|protective agents|mesh-ancestor
110894246|NCT01376011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110894256|NCT02106806|Zinc|zinc|mesh-list
110894257|NCT02106806|Zinc Sulfate|zinc sulfate|mesh-list
110894258|NCT02106806|Trace Elements|trace elements|mesh-ancestor
110894259|NCT02106806|Micronutrients|micronutrients|mesh-ancestor
110894260|NCT02106806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110894261|NCT02106806|Astringents|astringents|mesh-ancestor
110894262|NCT02106806|Dermatologic Agents|dermatologic agents|mesh-ancestor
110894263|NCT02966119|Aspirin|aspirin|mesh-list
110611722|NCT02543229|Growth Inhibitors|growth inhibitors|mesh-ancestor
110894264|NCT02966119|Clopidogrel|clopidogrel|mesh-list
110894265|NCT02966119|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110894266|NCT02966119|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110894267|NCT02966119|Analgesics|analgesics|mesh-ancestor
110894268|NCT02966119|Sensory System Agents|sensory system agents|mesh-ancestor
110894269|NCT02966119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110894270|NCT02966119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110894271|NCT02966119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110894272|NCT02966119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110894273|NCT02966119|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110922977|NCT05890768|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110894274|NCT02966119|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110894275|NCT02966119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110894276|NCT02966119|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110894277|NCT02966119|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110894278|NCT02966119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110894279|NCT02966119|Antipyretics|antipyretics|mesh-ancestor
110894280|NCT02966119|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110894281|NCT02966119|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110894282|NCT02966119|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110894283|NCT02966119|Purinergic Agents|purinergic agents|mesh-ancestor
110894284|NCT02966119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110894285|NCT02101892|Amitriptyline|amitriptyline|mesh-list
110894286|NCT02101892|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110894287|NCT02101892|Antidepressive Agents|antidepressive agents|mesh-ancestor
110894288|NCT02101892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110894289|NCT02101892|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110894290|NCT02101892|Analgesics|analgesics|mesh-ancestor
110894291|NCT02101892|Sensory System Agents|sensory system agents|mesh-ancestor
110201537|NCT00049088|Bevacizumab|bevacizumab|mesh-list
110894292|NCT02101892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110894293|NCT02101892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110894294|NCT02101892|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110894295|NCT02101892|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110894296|NCT02101892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110894297|NCT02101892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110894298|NCT02101892|Adrenergic Agents|adrenergic agents|mesh-ancestor
110894299|NCT02101892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110894300|NCT03634111|Morphine|morphine|mesh-list
110894301|NCT03634111|Ropivacaine|ropivacaine|mesh-list
110894302|NCT03634111|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110894303|NCT03634111|Narcotics|narcotics|mesh-ancestor
110894304|NCT03634111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110894305|NCT03634111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110894306|NCT03634111|Analgesics|analgesics|mesh-ancestor
110894307|NCT03634111|Sensory System Agents|sensory system agents|mesh-ancestor
110894308|NCT03634111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110894309|NCT03634111|Anesthetics, Local|anesthetics, local|mesh-ancestor
110894310|NCT03634111|Anesthetics|anesthetics|mesh-ancestor
110894311|NCT02102048|Atazanavir Sulfate|atazanavir sulfate|mesh-list
110894312|NCT02102048|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110894313|NCT02102048|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110894314|NCT02102048|Protease Inhibitors|protease inhibitors|mesh-ancestor
110894315|NCT02102048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110894316|NCT02102048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110894317|NCT02102048|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110894318|NCT02102048|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110894319|NCT02102048|Antiviral Agents|antiviral agents|mesh-ancestor
110223987|NCT00297739|Dopamine Agents|dopamine agents|mesh-ancestor
110894320|NCT02102048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110894321|NCT03118297|Ulipristal acetate|ulipristal acetate|mesh-list
110894322|NCT03118297|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110894323|NCT03118297|Contraceptive Agents|contraceptive agents|mesh-ancestor
110894324|NCT03118297|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110894325|NCT03118297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110894326|NCT03118297|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110894327|NCT02250794|Insulin|insulin|mesh-list
110894328|NCT02250794|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110894329|NCT02250794|Metformin|metformin|mesh-list
110894330|NCT02250794|Insulin Glargine|insulin glargine|mesh-list
110894331|NCT02250794|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110894332|NCT02250794|Insulin Lispro|insulin lispro|mesh-list
110894333|NCT02250794|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110894334|NCT02250794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110894335|NCT02250794|Incretins|incretins|mesh-ancestor
110894336|NCT02250794|Hormones|hormones|mesh-ancestor
110894337|NCT02250794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110894338|NCT02250794|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110894339|NCT02250794|Protease Inhibitors|protease inhibitors|mesh-ancestor
110894340|NCT02250794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110922996|NCT05890664|Colchicine|colchicine|mesh-list
110894341|NCT02250794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110894342|NCT02103374|Terbutaline|terbutaline|mesh-list
110894343|NCT02103374|Ipratropium|ipratropium|mesh-list
110894344|NCT02103374|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110894345|NCT02103374|Autonomic Agents|autonomic agents|mesh-ancestor
110894346|NCT02103374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110894347|NCT02103374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110894348|NCT02103374|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110894349|NCT02103374|Respiratory System Agents|respiratory system agents|mesh-ancestor
110894350|NCT02103374|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110894351|NCT02103374|Cholinergic Agents|cholinergic agents|mesh-ancestor
110894352|NCT02103374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110201539|NCT00049088|Docetaxel|docetaxel|mesh-list
110894353|NCT02103374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110894354|NCT02103374|Sympathomimetics|sympathomimetics|mesh-ancestor
110894355|NCT02103374|Tocolytic Agents|tocolytic agents|mesh-ancestor
110894356|NCT02103374|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110894357|NCT02103374|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110894358|NCT02103374|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110894359|NCT02103374|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110894360|NCT02103374|Adrenergic Agents|adrenergic agents|mesh-ancestor
110894361|NCT05707221|Chlorhexidine|chlorhexidine|mesh-list
110894362|NCT05707221|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110894363|NCT05707221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110894364|NCT05707221|Disinfectants|disinfectants|mesh-ancestor
110894365|NCT03117361|Dexamethasone|dexamethasone|mesh-list
110894366|NCT03117361|Bortezomib|bortezomib|mesh-list
110894367|NCT03117361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110894368|NCT03117361|Antiemetics|antiemetics|mesh-ancestor
110894369|NCT03117361|Autonomic Agents|autonomic agents|mesh-ancestor
110894370|NCT03117361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110894371|NCT03117361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110894372|NCT03117361|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110894373|NCT03117361|Glucocorticoids|glucocorticoids|mesh-ancestor
110894374|NCT03117361|Hormones|hormones|mesh-ancestor
110894375|NCT03117361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110894376|NCT03117361|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110894377|NCT03117361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110894378|NCT03053427|Gabapentin|gabapentin|mesh-list
110894379|NCT03053427|Analgesics|analgesics|mesh-ancestor
110894380|NCT03053427|Sensory System Agents|sensory system agents|mesh-ancestor
110894381|NCT03053427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110894382|NCT03053427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110894383|NCT03053427|Anticonvulsants|anticonvulsants|mesh-ancestor
110894384|NCT03053427|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110894385|NCT03053427|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110894386|NCT03053427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110894387|NCT03053427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110894388|NCT03053427|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110894389|NCT03053427|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110894390|NCT03053427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110894391|NCT03053427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110894392|NCT03053427|Antimanic Agents|antimanic agents|mesh-ancestor
110894393|NCT02107118|Complement Factor H|complement factor h|mesh-list
110894394|NCT02107118|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
110894395|NCT02107118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110894396|NCT02107118|Immunologic Factors|immunologic factors|mesh-ancestor
110894397|NCT02107118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110894398|NCT05081089|Lumefantrine|lumefantrine|mesh-list
110894399|NCT05081089|Artemether|artemether|mesh-list
110894400|NCT05081089|Pyrimethamine|pyrimethamine|mesh-list
110894401|NCT05081089|Primaquine|primaquine|mesh-list
110894402|NCT05081089|Sulfadoxine|sulfadoxine|mesh-list
110894403|NCT05081089|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
110894404|NCT05081089|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
110894405|NCT05081089|Amodiaquine|amodiaquine|mesh-list
110894406|NCT05081089|Tafenoquine|tafenoquine|mesh-list
110894407|NCT05081089|Antimalarials|antimalarials|mesh-ancestor
110894408|NCT05081089|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110894409|NCT05081089|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110894410|NCT05081089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110894411|NCT05081089|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110894412|NCT05081089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110894413|NCT05081089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110894414|NCT05081089|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110894415|NCT03555032|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
110894416|NCT03555032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110894417|NCT03555032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110894418|NCT03554408|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110894419|NCT03554408|Antibodies|antibodies|mesh-list
110894420|NCT03554408|Immunoglobulins|immunoglobulins|mesh-list
110894421|NCT03554408|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110894422|NCT03554408|Immunologic Factors|immunologic factors|mesh-ancestor
110894423|NCT03554408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110894424|NCT03554408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110894425|NCT02103686|Pregabalin|pregabalin|mesh-list
110894426|NCT02103686|Analgesics|analgesics|mesh-ancestor
110894427|NCT02103686|Sensory System Agents|sensory system agents|mesh-ancestor
110894428|NCT02103686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110894429|NCT02103686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110894430|NCT02103686|Anticonvulsants|anticonvulsants|mesh-ancestor
110894431|NCT02103686|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110894432|NCT02103686|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110894433|NCT02103686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110894434|NCT02103686|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110894435|NCT02103686|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110894436|NCT02103686|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110894437|NCT02103686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110894438|NCT02103686|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110894439|NCT02110082|Cetuximab|cetuximab|mesh-list
110894440|NCT02110082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110894441|NCT02110082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110894442|NCT02103764|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
110894443|NCT02103764|Medroxyprogesterone|medroxyprogesterone|mesh-list
110894444|NCT02103764|Desogestrel|desogestrel|mesh-list
110894445|NCT02103764|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110894446|NCT02103764|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110894447|NCT02103764|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110894448|NCT02103764|Contraceptive Agents|contraceptive agents|mesh-ancestor
110894449|NCT02103764|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110894450|NCT02103764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110894451|NCT02103764|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110894452|NCT02103764|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110894453|NCT02103764|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110224013|NCT00122226|Ritonavir|ritonavir|mesh-list
110894454|NCT02103764|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110894455|NCT02103764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110894456|NCT02103764|Progestins|progestins|mesh-ancestor
110894457|NCT02103764|Hormones|hormones|mesh-ancestor
110894458|NCT02103764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110894459|NCT02110316|Voriconazole|voriconazole|mesh-list
110894460|NCT02110316|Antifungal Agents|antifungal agents|mesh-ancestor
110894461|NCT02110316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110894462|NCT02110316|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110894463|NCT02110316|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110894464|NCT02110316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110923012|NCT05890495|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110894465|NCT02110316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110894466|NCT02110316|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110894467|NCT02110316|Hormone Antagonists|hormone antagonists|mesh-ancestor
110894468|NCT02110316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110894469|NCT02110316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110894470|NCT02110316|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110894471|NCT02110394|Rituximab|rituximab|mesh-list
110894472|NCT02110394|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110894473|NCT02110394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110894474|NCT02110394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110894475|NCT02110394|Immunologic Factors|immunologic factors|mesh-ancestor
110894476|NCT02110394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110894477|NCT02110394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110894478|NCT02110394|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110894479|NCT02110394|Alkylating Agents|alkylating agents|mesh-ancestor
110894480|NCT02110394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110894481|NCT02373241|Losartan|losartan|mesh-list
110894482|NCT02373241|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110894483|NCT02373241|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110894484|NCT02373241|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110894485|NCT02373241|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110894486|NCT02373241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110894487|NCT05656131|Fluzoparib|fluzoparib|mesh-list
110894488|NCT05656131|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110894489|NCT05656131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110894490|NCT05656131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110894491|NCT05656131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110894492|NCT02103998|Iodine|iodine|mesh-list
110894493|NCT02103998|Hormones|hormones|mesh-list
110894494|NCT02103998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110894495|NCT02103998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110894496|NCT02103998|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110894497|NCT02103998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110894498|NCT02103998|Trace Elements|trace elements|mesh-ancestor
110894499|NCT02103998|Micronutrients|micronutrients|mesh-ancestor
110894500|NCT01941589|Methylprednisolone|methylprednisolone|mesh-list
110894501|NCT01941589|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110894502|NCT01941589|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110894503|NCT01941589|Prednisolone|prednisolone|mesh-list
110894504|NCT01941589|Prednisolone acetate|prednisolone acetate|mesh-list
110894505|NCT01941589|Hydrocortisone|hydrocortisone|mesh-list
110894506|NCT01941589|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
110894507|NCT01941589|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
110894508|NCT01941589|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
110894509|NCT01941589|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110894510|NCT01941589|Prednisolone phosphate|prednisolone phosphate|mesh-list
110894511|NCT01941589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110894512|NCT01941589|Antiemetics|antiemetics|mesh-ancestor
110894513|NCT01941589|Autonomic Agents|autonomic agents|mesh-ancestor
110894514|NCT01941589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110894515|NCT01941589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110894516|NCT01941589|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110894518|NCT01941589|Hormones|hormones|mesh-ancestor
110894519|NCT01941589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110894520|NCT01941589|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110894521|NCT01941589|Protective Agents|protective agents|mesh-ancestor
110201594|NCT00049166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110894522|NCT01941589|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110894523|NCT01941589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110894524|NCT01845649|Estradiol|estradiol|mesh-list
110894525|NCT01845649|Estrogens|estrogens|mesh-ancestor
110894526|NCT01845649|Hormones|hormones|mesh-ancestor
110894527|NCT01845649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110894528|NCT01845649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110894530|NCT01345929|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110894531|NCT01345929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110894532|NCT01345929|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110894533|NCT01345929|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110894534|NCT01345929|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110894535|NCT01345929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110894536|NCT01345929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110894537|NCT01345929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110894538|NCT01345929|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110894539|NCT01345929|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110894540|NCT02107742|Lidocaine|lidocaine|mesh-list
110894541|NCT02107742|Anesthetics, Local|anesthetics, local|mesh-ancestor
110894542|NCT02107742|Anesthetics|anesthetics|mesh-ancestor
110894543|NCT02107742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110894544|NCT02107742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110894545|NCT02107742|Sensory System Agents|sensory system agents|mesh-ancestor
110894546|NCT02107742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110894547|NCT02107742|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110894548|NCT02107742|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110894549|NCT02107742|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110894550|NCT02107742|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110894551|NCT02107742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110894552|NCT02250872|Cisplatin|cisplatin|mesh-list
110894553|NCT02250872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110894554|NCT02110784|Piperaquine|piperaquine|mesh-list
110894555|NCT02110784|Artenimol|artenimol|mesh-list
110894556|NCT02110784|Antimalarials|antimalarials|mesh-ancestor
110894557|NCT02110784|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110894558|NCT02110784|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110894559|NCT02110784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110894560|NCT04988425|Methylprednisolone|methylprednisolone|mesh-list
110894561|NCT04988425|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110894562|NCT04988425|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110894563|NCT04988425|Prednisolone|prednisolone|mesh-list
110894564|NCT04988425|Prednisolone acetate|prednisolone acetate|mesh-list
110894565|NCT04988425|Antibodies|antibodies|mesh-list
110894566|NCT04988425|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110894567|NCT04988425|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110894568|NCT04988425|Prednisolone phosphate|prednisolone phosphate|mesh-list
110894569|NCT04988425|Immunologic Factors|immunologic factors|mesh-ancestor
110894570|NCT04988425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110894571|NCT04988425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110894573|NCT04988425|Autonomic Agents|autonomic agents|mesh-ancestor
110894574|NCT04988425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110894575|NCT04988425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110894576|NCT04988425|Glucocorticoids|glucocorticoids|mesh-ancestor
110894577|NCT04988425|Hormones|hormones|mesh-ancestor
110894578|NCT04988425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110894579|NCT04988425|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110894580|NCT04988425|Protective Agents|protective agents|mesh-ancestor
110894581|NCT04988425|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110894582|NCT04988425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110894583|NCT01343901|Bevacizumab|bevacizumab|mesh-list
110894584|NCT01343901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110894585|NCT01343901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110923035|NCT05890235|Tamsulosin|tamsulosin|mesh-list
110894586|NCT01343901|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110894587|NCT01343901|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110894589|NCT01343901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110894590|NCT01343901|Growth Inhibitors|growth inhibitors|mesh-ancestor
110894591|NCT05617521|Caffeine|caffeine|mesh-list
110894592|NCT05617521|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110894593|NCT05617521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110894594|NCT05617521|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110894595|NCT05617521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110894596|NCT05617521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110894597|NCT05617521|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110894598|NCT05617521|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110894599|NCT05617521|Purinergic Agents|purinergic agents|mesh-ancestor
110894600|NCT05617521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110894601|NCT02108210|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
110894602|NCT02108210|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110894603|NCT02104700|Tenofovir|tenofovir|mesh-list
110894604|NCT02104700|Emtricitabine|emtricitabine|mesh-list
110894605|NCT02104700|Rilpivirine|rilpivirine|mesh-list
110894606|NCT02104700|Antiviral Agents|antiviral agents|mesh-ancestor
110894607|NCT02104700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110894608|NCT02104700|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110894609|NCT02104700|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110894610|NCT02104700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110894611|NCT02104700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110894612|NCT02104700|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110894613|NCT02104700|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110894614|NCT02104778|Dexamethasone|dexamethasone|mesh-list
110894615|NCT02104778|Epinephrine|epinephrine|mesh-list
110894616|NCT02104778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110894617|NCT02104778|Antiemetics|antiemetics|mesh-ancestor
110894618|NCT02104778|Autonomic Agents|autonomic agents|mesh-ancestor
110894619|NCT02104778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110894620|NCT02104778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110894621|NCT02104778|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110894622|NCT02104778|Glucocorticoids|glucocorticoids|mesh-ancestor
110894623|NCT02104778|Hormones|hormones|mesh-ancestor
110894624|NCT02104778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110894625|NCT02104778|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110894626|NCT02104778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110894627|NCT02104778|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110894628|NCT02104778|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110894629|NCT02104778|Adrenergic Agents|adrenergic agents|mesh-ancestor
110894630|NCT02104778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110894631|NCT02104778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110894632|NCT02104778|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110894633|NCT02104778|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110894634|NCT02104778|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110894635|NCT02104778|Respiratory System Agents|respiratory system agents|mesh-ancestor
110894636|NCT02104778|Mydriatics|mydriatics|mesh-ancestor
110894637|NCT02104778|Sympathomimetics|sympathomimetics|mesh-ancestor
110894638|NCT02104778|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110894639|NCT02108366|Oseltamivir|oseltamivir|mesh-list
110894640|NCT02108366|Celecoxib|celecoxib|mesh-list
110612105|NCT05794659|Paclitaxel|paclitaxel|mesh-list
110894641|NCT02108366|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110894642|NCT02108366|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110894643|NCT02108366|Analgesics|analgesics|mesh-ancestor
110201617|NCT00150085|Cyclosporine|cyclosporine|mesh-list
110894644|NCT02108366|Sensory System Agents|sensory system agents|mesh-ancestor
110894645|NCT02108366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110894646|NCT02108366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110894647|NCT02108366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110894648|NCT02108366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110894649|NCT02108366|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110894650|NCT02108366|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110894652|NCT02108366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110894653|NCT02108366|Antiviral Agents|antiviral agents|mesh-ancestor
110894654|NCT02108366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110894655|NCT05706207|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110894656|NCT05706207|Antibodies|antibodies|mesh-list
110894657|NCT05706207|Immunoglobulins|immunoglobulins|mesh-list
110894658|NCT05706207|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110894659|NCT05706207|Immunologic Factors|immunologic factors|mesh-ancestor
110894660|NCT05706207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110894661|NCT05706207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110894662|NCT02105090|Anesthetics|anesthetics|mesh-list
110894663|NCT02105090|Anesthetics, Local|anesthetics, local|mesh-list
110894664|NCT02105090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110894665|NCT02105090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110894666|NCT02105090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110894667|NCT02105090|Sensory System Agents|sensory system agents|mesh-ancestor
110894668|NCT03553628|Chlorhexidine|chlorhexidine|mesh-list
110894669|NCT03553628|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110894670|NCT03553628|Propolis|propolis|mesh-list
110894671|NCT03553628|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110894672|NCT03553628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110894673|NCT03553628|Disinfectants|disinfectants|mesh-ancestor
110894674|NCT03553628|Dermatologic Agents|dermatologic agents|mesh-ancestor
110894675|NCT02112032|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110894676|NCT02112032|Pembrolizumab|pembrolizumab|mesh-list
110894677|NCT02112032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110894678|NCT02112032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110894679|NCT02112032|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110894680|NCT02112032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110894681|NCT02112032|Antiviral Agents|antiviral agents|mesh-ancestor
110894682|NCT02112032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110894683|NCT01343823|Ecallantide|ecallantide|mesh-list
110894684|NCT01343823|Analgesics|analgesics|mesh-ancestor
110894685|NCT01343823|Sensory System Agents|sensory system agents|mesh-ancestor
110894686|NCT01343823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110894687|NCT01343823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110894688|NCT01343823|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110894689|NCT01343823|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110894690|NCT01343823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110923072|NCT05826912|Calcium|calcium|mesh-list
110894691|NCT01343823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110894692|NCT02251184|Aspirin|aspirin|mesh-list
110894693|NCT02251184|Dipyridamole|dipyridamole|mesh-list
110894694|NCT02251184|Lansoprazole|lansoprazole|mesh-list
110894695|NCT02251184|Dexlansoprazole|dexlansoprazole|mesh-list
110894696|NCT02251184|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
110894697|NCT02251184|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110894698|NCT02251184|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110894699|NCT02251184|Analgesics|analgesics|mesh-ancestor
110894700|NCT02251184|Sensory System Agents|sensory system agents|mesh-ancestor
110894701|NCT02251184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110894702|NCT02251184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110894703|NCT02251184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110894704|NCT02251184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110894705|NCT02251184|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110894706|NCT02251184|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110894707|NCT02251184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110894708|NCT02251184|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110894709|NCT02251184|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110894710|NCT02251184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110894711|NCT02251184|Antipyretics|antipyretics|mesh-ancestor
110894712|NCT02251184|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110894713|NCT02251184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110894714|NCT02251184|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110894715|NCT02251184|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110894717|NCT02108756|Pantoprazole|pantoprazole|mesh-list
110894718|NCT02108756|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110894719|NCT02108756|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110894720|NCT02108756|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110894721|NCT02108756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110224045|NCT00298012|Antimetabolites|antimetabolites|mesh-ancestor
110894722|NCT02108756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110894723|NCT05547399|Zanubrutinib|zanubrutinib|mesh-list
110894724|NCT05547399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110894725|NCT05547399|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110894726|NCT05547399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110894727|NCT05547399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110894728|NCT01318083|Glimepiride|glimepiride|mesh-list
110894730|NCT01318083|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110894731|NCT01318083|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110894732|NCT01318083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110894733|NCT01318083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110894734|NCT01318083|Immunologic Factors|immunologic factors|mesh-ancestor
110894735|NCT01318083|Incretins|incretins|mesh-ancestor
110894736|NCT01318083|Hormones|hormones|mesh-ancestor
110894737|NCT01318083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110894738|NCT01318083|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110894739|NCT01318083|Protease Inhibitors|protease inhibitors|mesh-ancestor
110894740|NCT01318083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110894741|NCT01318083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110894742|NCT05545137|Fosfomycin|fosfomycin|mesh-list
110894743|NCT05545137|Amdinocillin Pivoxil|amdinocillin pivoxil|mesh-list
110894744|NCT05545137|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110894745|NCT05545137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110894746|NCT05545137|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110894747|NCT02105714|Formaldehyde|formaldehyde|mesh-list
110894748|NCT02105714|Disinfectants|disinfectants|mesh-ancestor
110894749|NCT02105714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110894750|NCT02105792|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
110894751|NCT02105792|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
110894752|NCT02105792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110894753|NCT02105792|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110894754|NCT02105792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110894755|NCT02105792|Protease Inhibitors|protease inhibitors|mesh-ancestor
110894756|NCT02105792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110894758|NCT03817515|Temsirolimus|temsirolimus|mesh-list
110894759|NCT03817515|MTOR Inhibitors|mtor inhibitors|mesh-list
110894760|NCT03817515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110894761|NCT03817515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110894762|NCT03817515|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110894763|NCT03817515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110894764|NCT03817515|Antifungal Agents|antifungal agents|mesh-ancestor
110894765|NCT03817515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110894766|NCT03817515|Immunologic Factors|immunologic factors|mesh-ancestor
110894767|NCT03817515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110894768|NCT03817515|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110894769|NCT03817515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110894770|NCT03817515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110894771|NCT02105870|Abciximab|abciximab|mesh-list
110894772|NCT02105870|Anticoagulants|anticoagulants|mesh-ancestor
110894773|NCT02105870|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110894774|NCT02112422|Dexamethasone|dexamethasone|mesh-list
110894775|NCT02112422|Dexamethasone acetate|dexamethasone acetate|mesh-list
110894776|NCT02112422|BB 1101|bb 1101|mesh-list
110894777|NCT02112422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110894778|NCT02112422|Antiemetics|antiemetics|mesh-ancestor
110894779|NCT02112422|Autonomic Agents|autonomic agents|mesh-ancestor
110894780|NCT02112422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110894781|NCT02112422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110894782|NCT02112422|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110894783|NCT02112422|Glucocorticoids|glucocorticoids|mesh-ancestor
110894784|NCT02112422|Hormones|hormones|mesh-ancestor
110894785|NCT02112422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110894786|NCT02112422|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110894787|NCT02112422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110894788|NCT02112422|Protease Inhibitors|protease inhibitors|mesh-ancestor
110894789|NCT02112422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110612248|NCT05473273|Estradiol|estradiol|mesh-list
110894790|NCT02112422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110243345|NCT00350077|Vitamins|vitamins|mesh-list
110894792|NCT02109614|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110894793|NCT02109614|Antimetabolites|antimetabolites|mesh-ancestor
110894794|NCT02109614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110894795|NCT02109614|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110894796|NCT02109614|Vasodilator Agents|vasodilator agents|mesh-ancestor
110894797|NCT02109614|Vitamin B Complex|vitamin b complex|mesh-ancestor
110894798|NCT02109614|Vitamins|vitamins|mesh-ancestor
110894799|NCT02109614|Micronutrients|micronutrients|mesh-ancestor
110894800|NCT02109614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110894801|NCT02106104|Glimepiride|glimepiride|mesh-list
110894802|NCT02106104|Linagliptin|linagliptin|mesh-list
110894803|NCT02106104|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110894804|NCT02106104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110894805|NCT02106104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110894806|NCT02106104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110894807|NCT02106104|Immunologic Factors|immunologic factors|mesh-ancestor
110894808|NCT02106104|Incretins|incretins|mesh-ancestor
110894809|NCT02106104|Hormones|hormones|mesh-ancestor
110894810|NCT02106104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110894811|NCT02106104|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110894812|NCT02106104|Protease Inhibitors|protease inhibitors|mesh-ancestor
110894813|NCT02106104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110894814|NCT02106104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110894815|NCT01376323|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110894816|NCT01376323|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110894817|NCT01376323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110894818|NCT01376323|Incretins|incretins|mesh-ancestor
110894819|NCT01376323|Hormones|hormones|mesh-ancestor
110894820|NCT01376323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110894821|NCT01376323|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110894823|NCT01376323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110894824|NCT01376323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110894825|NCT02113904|Adalimumab|adalimumab|mesh-list
110894826|NCT02113904|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110894827|NCT02113904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110894828|NCT02113904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110894829|NCT05432115|Amoxicillin|amoxicillin|mesh-list
110894830|NCT05432115|Tetracycline|tetracycline|mesh-list
110894831|NCT05432115|Esomeprazole|esomeprazole|mesh-list
110894832|NCT05432115|Bismuth|bismuth|mesh-list
110894833|NCT05432115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110894834|NCT05432115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110894835|NCT05432115|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110894836|NCT05432115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110894837|NCT05432115|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110894838|NCT05432115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110894839|NCT05432115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110894840|NCT05432115|Antacids|antacids|mesh-ancestor
110894841|NCT05432115|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110894842|NCT02114528|Amiodarone|amiodarone|mesh-list
110894843|NCT02114528|Sotalol|sotalol|mesh-list
110894844|NCT02114528|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
110894845|NCT02114528|Mexiletine|mexiletine|mesh-list
110894846|NCT02114528|Procainamide|procainamide|mesh-list
110894847|NCT02114528|Vasodilator Agents|vasodilator agents|mesh-ancestor
110894848|NCT02114528|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
110894849|NCT02114528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110894850|NCT02114528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110894851|NCT02114528|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110894852|NCT02114528|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110894853|NCT02114528|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110894854|NCT02114528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110894855|NCT02114528|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110894857|NCT02114528|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110894858|NCT02114528|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110894859|NCT02114528|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110894860|NCT02114528|Adrenergic Agents|adrenergic agents|mesh-ancestor
110894861|NCT02114528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110894862|NCT02114528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110894863|NCT02114528|Sympatholytics|sympatholytics|mesh-ancestor
110894864|NCT02114528|Autonomic Agents|autonomic agents|mesh-ancestor
110894865|NCT02114528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110894866|NCT02114528|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110894867|NCT02113202|Bevacizumab|bevacizumab|mesh-list
110894868|NCT02113202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110894869|NCT02113202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110894870|NCT02113202|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110894871|NCT02113202|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110894872|NCT02113202|Growth Substances|growth substances|mesh-ancestor
110894873|NCT02113202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110894874|NCT02113202|Growth Inhibitors|growth inhibitors|mesh-ancestor
110894875|NCT01376401|Prednisone|prednisone|mesh-list
110894876|NCT01376401|Bortezomib|bortezomib|mesh-list
110894877|NCT01376401|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110894878|NCT01376401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110894879|NCT01376401|Glucocorticoids|glucocorticoids|mesh-ancestor
110894880|NCT01376401|Hormones|hormones|mesh-ancestor
110894881|NCT01376401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110894882|NCT01376401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110894883|NCT01376401|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110894884|NCT01376401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110894885|NCT01376401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110894886|NCT01376401|Alkylating Agents|alkylating agents|mesh-ancestor
110894887|NCT01376401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110894888|NCT02119520|Atorvastatin|atorvastatin|mesh-list
110894889|NCT02119520|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110894890|NCT02119520|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110894891|NCT02119520|Antimetabolites|antimetabolites|mesh-ancestor
110894892|NCT02119520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110894893|NCT02119520|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110894894|NCT02119520|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110894895|NCT02119520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110894896|NCT03961789|Analgesics, Opioid|analgesics, opioid|mesh-list
110894897|NCT03961789|Narcotics|narcotics|mesh-ancestor
110894898|NCT03961789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110894899|NCT03961789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110894900|NCT03961789|Analgesics|analgesics|mesh-ancestor
110894901|NCT03961789|Sensory System Agents|sensory system agents|mesh-ancestor
110894902|NCT03961789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110894903|NCT04854343|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
110894904|NCT04854343|Protease Inhibitors|protease inhibitors|mesh-list
110894905|NCT04854343|Secretory Leukocyte Peptidase Inhibitor|secretory leukocyte peptidase inhibitor|mesh-list
110894906|NCT04854343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110894907|NCT04854343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110894908|NCT04854343|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110894909|NCT04854343|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110894910|NCT04854343|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110894911|NCT04854343|Antiviral Agents|antiviral agents|mesh-ancestor
110894912|NCT04854343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110894913|NCT04854343|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110894914|NCT01376713|Dacarbazine|dacarbazine|mesh-list
110894916|NCT01376713|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110894917|NCT01376713|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110894918|NCT01376713|Alkylating Agents|alkylating agents|mesh-ancestor
110894919|NCT01376713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110894920|NCT01376713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110894921|NCT01376713|Immunologic Factors|immunologic factors|mesh-ancestor
110894922|NCT01376713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110894923|NCT03728179|Aspirin|aspirin|mesh-list
110894924|NCT03728179|Celecoxib|celecoxib|mesh-list
110894925|NCT03728179|Cyclophosphamide|cyclophosphamide|mesh-list
110894926|NCT03728179|Nivolumab|nivolumab|mesh-list
110894927|NCT03728179|Ipilimumab|ipilimumab|mesh-list
110894928|NCT03728179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110894929|NCT03728179|Immunologic Factors|immunologic factors|mesh-ancestor
110894930|NCT03728179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110894931|NCT03728179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110894932|NCT03728179|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110894933|NCT03728179|Alkylating Agents|alkylating agents|mesh-ancestor
110894934|NCT03728179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110894935|NCT03728179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110894936|NCT03728179|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110894937|NCT03728179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110894938|NCT03728179|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110894939|NCT03728179|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110894940|NCT03728179|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110894941|NCT03728179|Analgesics|analgesics|mesh-ancestor
110923132|NCT05723874|Bosentan|bosentan|mesh-list
110894942|NCT03728179|Sensory System Agents|sensory system agents|mesh-ancestor
110894943|NCT03728179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110894944|NCT03728179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110894945|NCT03728179|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110894946|NCT03728179|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110894947|NCT03728179|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110894948|NCT03728179|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110894949|NCT03728179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110894950|NCT03728179|Antipyretics|antipyretics|mesh-ancestor
110894951|NCT03728179|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110894952|NCT01368536|Amlodipine|amlodipine|mesh-list
110894953|NCT01368536|Chlorthalidone|chlorthalidone|mesh-list
110894954|NCT01368536|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110894955|NCT01368536|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110894956|NCT01368536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110894957|NCT01368536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110894958|NCT01368536|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110894959|NCT01368536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110894960|NCT01368536|Vasodilator Agents|vasodilator agents|mesh-ancestor
110894961|NCT01368536|Diuretics|diuretics|mesh-ancestor
110894962|NCT01368536|Natriuretic Agents|natriuretic agents|mesh-ancestor
110894963|NCT01368536|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110201690|NCT00049361|Thalidomide|thalidomide|mesh-list
110894964|NCT05103735|Dexmedetomidine|dexmedetomidine|mesh-list
110894965|NCT05103735|Remifentanil|remifentanil|mesh-list
110894966|NCT05103735|Propofol|propofol|mesh-list
110894967|NCT05103735|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110894968|NCT05103735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110894969|NCT05103735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110894970|NCT05103735|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110894971|NCT05103735|Analgesics|analgesics|mesh-ancestor
110894972|NCT05103735|Sensory System Agents|sensory system agents|mesh-ancestor
110894973|NCT05103735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110894974|NCT05103735|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110894975|NCT05103735|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110894976|NCT05103735|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110894977|NCT05103735|Adrenergic Agents|adrenergic agents|mesh-ancestor
110894978|NCT05103735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110894979|NCT05103735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110894980|NCT05103735|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110894981|NCT05103735|Anesthetics, General|anesthetics, general|mesh-ancestor
110894982|NCT05103735|Anesthetics|anesthetics|mesh-ancestor
110894983|NCT05103735|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110894984|NCT05103735|Narcotics|narcotics|mesh-ancestor
110894985|NCT01319929|CB2 receptor agonist LY2828360|cb2 receptor agonist ly2828360|mesh-list
110894986|NCT01319929|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
110894987|NCT01319929|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110894988|NCT01319929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110894989|NCT01319929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110894990|NCT01319929|Hormones|hormones|mesh-ancestor
110894991|NCT01319929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110894992|NCT01319929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110894993|NCT03633565|Prednisolone|prednisolone|mesh-list
110894994|NCT03633565|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110894995|NCT03633565|Methylprednisolone|methylprednisolone|mesh-list
110894996|NCT03633565|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110894997|NCT03633565|Prednisolone acetate|prednisolone acetate|mesh-list
110894998|NCT03633565|Sildenafil Citrate|sildenafil citrate|mesh-list
110894999|NCT03633565|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110895000|NCT03633565|Prednisolone phosphate|prednisolone phosphate|mesh-list
110895001|NCT03633565|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-list
110895002|NCT03633565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110895003|NCT03633565|Glucocorticoids|glucocorticoids|mesh-ancestor
110895004|NCT03633565|Hormones|hormones|mesh-ancestor
110923141|NCT05650164|Avelumab|avelumab|mesh-list
110895005|NCT03633565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110895006|NCT03633565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110895007|NCT03633565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110895008|NCT03633565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110895009|NCT03633565|Antiemetics|antiemetics|mesh-ancestor
110895010|NCT03633565|Autonomic Agents|autonomic agents|mesh-ancestor
110895011|NCT03633565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110220897|NCT00079820|Vaccines|vaccines|mesh-list
110895012|NCT03633565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110895013|NCT03633565|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110895014|NCT03633565|Protective Agents|protective agents|mesh-ancestor
110895015|NCT03633565|Vasodilator Agents|vasodilator agents|mesh-ancestor
110895016|NCT03633565|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110895017|NCT03633565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110895018|NCT03633565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110895019|NCT03633565|Urological Agents|urological agents|mesh-ancestor
110895021|NCT02120066|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
110895022|NCT02120066|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110895023|NCT02120066|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110895024|NCT02120066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110895025|NCT01373359|Misoprostol|misoprostol|mesh-list
110895026|NCT01373359|Oxytocin|oxytocin|mesh-list
110895027|NCT01373359|Oxytocics|oxytocics|mesh-ancestor
110895028|NCT01373359|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110895029|NCT01373359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110895030|NCT01373359|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110895031|NCT01373359|Abortifacient Agents|abortifacient agents|mesh-ancestor
110895032|NCT01373359|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110895033|NCT01373359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110895034|NCT02123264|Zoledronic Acid|zoledronic acid|mesh-list
110895035|NCT02123264|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110895036|NCT02123264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110895037|NCT02251964|Rituximab|rituximab|mesh-list
110895038|NCT02251964|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110895039|NCT02251964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110895040|NCT02251964|Immunologic Factors|immunologic factors|mesh-ancestor
110895041|NCT02251964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110895042|NCT02251964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110895043|NCT04739995|Naltrexone|naltrexone|mesh-list
110895044|NCT04739995|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110895045|NCT04739995|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110895046|NCT04739995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110895047|NCT04739995|Sensory System Agents|sensory system agents|mesh-ancestor
110895048|NCT04739995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110895049|NCT02120612|Naloxone|naloxone|mesh-list
110895050|NCT02120612|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110895051|NCT02120612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110895052|NCT02120612|Sensory System Agents|sensory system agents|mesh-ancestor
110895053|NCT02120612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110895054|NCT02115152|Cyclophosphamide|cyclophosphamide|mesh-list
110895055|NCT02115152|Fluorouracil|fluorouracil|mesh-list
110895056|NCT02115152|Capecitabine|capecitabine|mesh-list
110895057|NCT02115152|Epirubicin|epirubicin|mesh-list
110895058|NCT02115152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110895059|NCT02115152|Immunologic Factors|immunologic factors|mesh-ancestor
110895060|NCT02115152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110895061|NCT02115152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110895062|NCT02115152|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110895063|NCT02115152|Alkylating Agents|alkylating agents|mesh-ancestor
110895064|NCT02115152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110895065|NCT02115152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110895066|NCT02115152|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110895067|NCT02115152|Antimetabolites|antimetabolites|mesh-ancestor
110895068|NCT02115152|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110895069|NCT02115152|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110923159|NCT05608837|Hormones|hormones|mesh-ancestor
110895070|NCT02115152|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110895071|NCT02115152|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110895072|NCT02115152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110895073|NCT02115464|Metformin|metformin|mesh-list
110895074|NCT02115464|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110895075|NCT02115464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110895076|NCT02858076|Aflibercept|aflibercept|mesh-list
110895077|NCT02858076|Endothelial Growth Factors|endothelial growth factors|mesh-list
110895078|NCT02858076|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110895079|NCT02858076|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110895080|NCT02858076|Growth Substances|growth substances|mesh-ancestor
110895081|NCT02858076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110895082|NCT02858076|Growth Inhibitors|growth inhibitors|mesh-ancestor
110895083|NCT02858076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110895084|NCT01319695|Hormones|hormones|mesh-list
110895085|NCT01319695|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
110895086|NCT01319695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110612548|NCT04861051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110895087|NCT01319695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110895088|NCT04594759|Isotretinoin|isotretinoin|mesh-list
110895089|NCT04594759|Dermatologic Agents|dermatologic agents|mesh-ancestor
110895090|NCT02123498|Omeprazole|omeprazole|mesh-list
110895091|NCT02123498|Pantoprazole|pantoprazole|mesh-list
110895092|NCT02123498|Ranitidine|ranitidine|mesh-list
110895093|NCT02123498|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
110895094|NCT02123498|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110895095|NCT02123498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110895096|NCT02123498|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110895097|NCT02123498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110895098|NCT02123498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110895099|NCT02123498|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110895100|NCT02123498|Histamine Antagonists|histamine antagonists|mesh-ancestor
110895101|NCT02123498|Histamine Agents|histamine agents|mesh-ancestor
110895102|NCT02123498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110895103|NCT02123498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110895104|NCT02115776|Amoxicillin|amoxicillin|mesh-list
110895105|NCT02115776|Clavulanic Acid|clavulanic acid|mesh-list
110895106|NCT02115776|Clavulanic Acids|clavulanic acids|mesh-list
110895107|NCT02115776|Chlorhexidine|chlorhexidine|mesh-list
110895108|NCT02115776|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110895109|NCT02115776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110895110|NCT02115776|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110895111|NCT02115776|Disinfectants|disinfectants|mesh-ancestor
110895112|NCT02115776|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110895113|NCT02115776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110895114|NCT02115776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110895115|NCT02123654|Asunaprevir|asunaprevir|mesh-list
110895116|NCT02123654|Protease Inhibitors|protease inhibitors|mesh-ancestor
110895117|NCT02123654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110895118|NCT02123654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110895119|NCT02116010|Sulfadiazine|sulfadiazine|mesh-list
110895120|NCT02116010|Silver Sulfadiazine|silver sulfadiazine|mesh-list
110895121|NCT02116010|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110895122|NCT02116010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110895123|NCT02116010|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110895124|NCT02116010|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110895125|NCT02116010|Coccidiostats|coccidiostats|mesh-ancestor
110895126|NCT02116010|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110895127|NCT03609294|Linagliptin|linagliptin|mesh-list
110895128|NCT03609294|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110895129|NCT03609294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110895130|NCT03609294|Incretins|incretins|mesh-ancestor
110895131|NCT03609294|Hormones|hormones|mesh-ancestor
110895132|NCT03609294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110895133|NCT03609294|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110895134|NCT03609294|Protease Inhibitors|protease inhibitors|mesh-ancestor
110895135|NCT03609294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110895136|NCT03609294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110895137|NCT01917552|Capecitabine|capecitabine|mesh-list
110923162|NCT05608837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110895138|NCT01917552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110895139|NCT01917552|Antimetabolites|antimetabolites|mesh-ancestor
110895140|NCT01917552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110895141|NCT01917552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110895142|NCT01261728|Gemcitabine|gemcitabine|mesh-list
110895143|NCT01261728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110895144|NCT01261728|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110895145|NCT01261728|Antimetabolites|antimetabolites|mesh-ancestor
110895146|NCT01261728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110895147|NCT02116400|Lithium Carbonate|lithium carbonate|mesh-list
110895148|NCT02116400|Antidepressive Agents|antidepressive agents|mesh-ancestor
110895149|NCT02116400|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110895150|NCT02116400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110895151|NCT02116400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110895152|NCT02116400|Antimanic Agents|antimanic agents|mesh-ancestor
110895153|NCT02116400|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110895154|NCT02116400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110895155|NCT02116400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110895156|NCT03119701|Interferons|interferons|mesh-list
110895157|NCT03119701|Interferon-beta|interferon-beta|mesh-list
110895158|NCT03119701|Interferon beta-1a|interferon beta-1a|mesh-list
110895159|NCT03119701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110895160|NCT03119701|Antiviral Agents|antiviral agents|mesh-ancestor
110895161|NCT03119701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110895162|NCT03119701|Immunologic Factors|immunologic factors|mesh-ancestor
110895163|NCT03119701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110895164|NCT03119701|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110895165|NCT03717129|Tenofovir|tenofovir|mesh-list
110895166|NCT03717129|Emtricitabine|emtricitabine|mesh-list
110895167|NCT03717129|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110895168|NCT03717129|Cobicistat|cobicistat|mesh-list
110895169|NCT03717129|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
110895170|NCT03717129|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110895172|NCT03717129|Antiviral Agents|antiviral agents|mesh-ancestor
110895173|NCT03717129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110895174|NCT03717129|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110895175|NCT03717129|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110895176|NCT03717129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110895177|NCT03717129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110895178|NCT03717129|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110895179|NCT03717129|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110895180|NCT03717129|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110895181|NCT03717129|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110895182|NCT03717129|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110895183|NCT03627039|Metformin|metformin|mesh-list
110895184|NCT03627039|Dapagliflozin|dapagliflozin|mesh-list
110895185|NCT03627039|Empagliflozin|empagliflozin|mesh-list
110895186|NCT03627039|Canagliflozin|canagliflozin|mesh-list
110895187|NCT03627039|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110895188|NCT03627039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110895189|NCT03627039|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110895190|NCT03627039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110923169|NCT05555706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110923173|NCT05489887|Ceritinib|ceritinib|mesh-list
110923185|NCT05354102|Nivolumab|nivolumab|mesh-list
110895191|NCT01374373|Epoetin Alfa|epoetin alfa|mesh-list
110895192|NCT01374373|Hematinics|hematinics|mesh-ancestor
110895193|NCT02116556|Rifaximin|rifaximin|mesh-list
110895194|NCT02116556|Prednisone|prednisone|mesh-list
110895195|NCT02116556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110895196|NCT02116556|Glucocorticoids|glucocorticoids|mesh-ancestor
110895197|NCT02116556|Hormones|hormones|mesh-ancestor
110895198|NCT02116556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110895199|NCT02116556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110895200|NCT02116556|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110895201|NCT02116556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110895202|NCT02116556|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110895203|NCT02116556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110895204|NCT02116556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110895205|NCT03634345|Fluconazole|fluconazole|mesh-list
110895206|NCT03634345|Fluvoxamine|fluvoxamine|mesh-list
110895207|NCT03634345|Abrocitinib|abrocitinib|mesh-list
110895208|NCT03634345|Antifungal Agents|antifungal agents|mesh-ancestor
110895209|NCT03634345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110895210|NCT03634345|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110895211|NCT03634345|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110895212|NCT03634345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110895213|NCT03634345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110895214|NCT03634345|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110895215|NCT03634345|Hormone Antagonists|hormone antagonists|mesh-ancestor
110895216|NCT03634345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110895217|NCT03634345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110895218|NCT03634345|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110895219|NCT03634345|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110895220|NCT03634345|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110895221|NCT03634345|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110895222|NCT03634345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110895223|NCT03634345|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110895224|NCT03634345|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110895225|NCT03634345|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110895226|NCT03634345|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110895227|NCT03634345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110895228|NCT03634345|Serotonin Agents|serotonin agents|mesh-ancestor
110895229|NCT03634345|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110895230|NCT03634345|Antidepressive Agents|antidepressive agents|mesh-ancestor
110895231|NCT03634345|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110895232|NCT03634345|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110895233|NCT03553238|Cytarabine|cytarabine|mesh-list
110895234|NCT03553238|Dexamethasone|dexamethasone|mesh-list
110895235|NCT03553238|Cyclophosphamide|cyclophosphamide|mesh-list
110895236|NCT03553238|Methotrexate|methotrexate|mesh-list
110895237|NCT03553238|Etoposide|etoposide|mesh-list
110895238|NCT03553238|Vincristine|vincristine|mesh-list
110895239|NCT03553238|Doxorubicin|doxorubicin|mesh-list
110895240|NCT03553238|Mercaptopurine|mercaptopurine|mesh-list
110895242|NCT03553238|Pegaspargase|pegaspargase|mesh-list
110895243|NCT03553238|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110895244|NCT03553238|Immunologic Factors|immunologic factors|mesh-ancestor
110895245|NCT03553238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110895246|NCT03553238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110895247|NCT03553238|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110895248|NCT03553238|Alkylating Agents|alkylating agents|mesh-ancestor
110895249|NCT03553238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110895250|NCT03553238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110895251|NCT03553238|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110895252|NCT03553238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110895253|NCT03553238|Antiemetics|antiemetics|mesh-ancestor
110895254|NCT03553238|Autonomic Agents|autonomic agents|mesh-ancestor
110895255|NCT03553238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110895256|NCT03553238|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110895257|NCT03553238|Glucocorticoids|glucocorticoids|mesh-ancestor
110895258|NCT03553238|Hormones|hormones|mesh-ancestor
110895259|NCT03553238|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110895260|NCT03553238|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110895261|NCT03553238|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110895262|NCT03553238|Abortifacient Agents|abortifacient agents|mesh-ancestor
110895263|NCT03553238|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110895264|NCT03553238|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110895265|NCT03553238|Antimetabolites|antimetabolites|mesh-ancestor
110895266|NCT03553238|Dermatologic Agents|dermatologic agents|mesh-ancestor
110895267|NCT03553238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110895268|NCT03553238|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110895269|NCT03553238|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110895270|NCT03553238|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110895271|NCT03553238|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110895272|NCT03553238|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110895273|NCT03553238|Antiviral Agents|antiviral agents|mesh-ancestor
110895274|NCT03553238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110895275|NCT03553238|Tubulin Modulators|tubulin modulators|mesh-ancestor
110895276|NCT03553238|Antimitotic Agents|antimitotic agents|mesh-ancestor
110895277|NCT03553238|Mitosis Modulators|mitosis modulators|mesh-ancestor
110895278|NCT03553238|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110895279|NCT04980027|Insulin Glargine|insulin glargine|mesh-list
110895280|NCT04980027|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110895281|NCT04980027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110895282|NCT01373593|Lidocaine|lidocaine|mesh-list
110895283|NCT01373593|Anesthetics, Local|anesthetics, local|mesh-ancestor
110895284|NCT01373593|Anesthetics|anesthetics|mesh-ancestor
110895285|NCT01373593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110895286|NCT01373593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110895287|NCT01373593|Sensory System Agents|sensory system agents|mesh-ancestor
110895288|NCT01373593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110895289|NCT01373593|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110895290|NCT01373593|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110895291|NCT01373593|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110895292|NCT01373593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110895293|NCT01373593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110895294|NCT02116712|Saracatinib|saracatinib|mesh-list
110895295|NCT02116712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110895296|NCT02116712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110895297|NCT02116712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110895298|NCT02116790|Naproxen|naproxen|mesh-list
110895299|NCT02116790|Levodopa|levodopa|mesh-list
110895300|NCT02116790|Carbidopa|carbidopa|mesh-list
110895301|NCT02116790|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
110895302|NCT02116790|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110895303|NCT02116790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110895304|NCT02116790|Analgesics|analgesics|mesh-ancestor
110895305|NCT02116790|Sensory System Agents|sensory system agents|mesh-ancestor
110895306|NCT02116790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110895307|NCT02116790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110895308|NCT02116790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110895309|NCT02116790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110895310|NCT02116790|Gout Suppressants|gout suppressants|mesh-ancestor
110895311|NCT02116790|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110895312|NCT02116790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110895313|NCT02116790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110895314|NCT02116790|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110895315|NCT02116790|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110895316|NCT02116790|Dopamine Agents|dopamine agents|mesh-ancestor
110895317|NCT02116790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110895318|NCT02116790|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
110895319|NCT02116790|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110895320|NCT02116790|Immunologic Factors|immunologic factors|mesh-ancestor
110895321|NCT02116790|Dopamine Agonists|dopamine agonists|mesh-ancestor
110895322|NCT02859961|Leronlimab|leronlimab|mesh-list
110895323|NCT02859961|HIV Antibodies|hiv antibodies|mesh-list
110895324|NCT02859961|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110895325|NCT02859961|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110895326|NCT02859961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110895327|NCT02859961|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110895328|NCT02859961|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110895329|NCT02859961|Antiviral Agents|antiviral agents|mesh-ancestor
110895330|NCT02859961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110895331|NCT02859961|Immunologic Factors|immunologic factors|mesh-ancestor
110895332|NCT02859961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110895333|NCT02124200|Nicotine|nicotine|mesh-list
110895334|NCT02124200|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110895335|NCT02124200|Autonomic Agents|autonomic agents|mesh-ancestor
110895336|NCT02124200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110895337|NCT02124200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110895338|NCT02124200|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110895339|NCT02124200|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110895340|NCT02124200|Cholinergic Agents|cholinergic agents|mesh-ancestor
110895341|NCT02124200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110895342|NCT02124200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110895343|NCT02124278|Pam2CSK4 acetate and ODN M362 combination|pam2csk4 acetate and odn m362 combination|mesh-list
110895344|NCT02124278|Respiratory System Agents|respiratory system agents|mesh-ancestor
110895345|NCT04503993|Antibodies|antibodies|mesh-list
110895346|NCT04503993|Immunoglobulins|immunoglobulins|mesh-list
110895347|NCT04503993|Immunologic Factors|immunologic factors|mesh-ancestor
110895348|NCT04503993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110895349|NCT02116868|Antihypertensive Agents|antihypertensive agents|mesh-list
110895350|NCT02116868|Nicardipine|nicardipine|mesh-list
110895351|NCT02116868|Urapidil|urapidil|mesh-list
110895352|NCT02116868|Remifentanil|remifentanil|mesh-list
110895353|NCT02116868|Esmolol|esmolol|mesh-list
110895354|NCT02116868|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110895355|NCT02116868|Narcotics|narcotics|mesh-ancestor
110895356|NCT02116868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110895357|NCT02116868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110895358|NCT02116868|Analgesics|analgesics|mesh-ancestor
110895359|NCT02116868|Sensory System Agents|sensory system agents|mesh-ancestor
110895360|NCT02116868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110895361|NCT02116868|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110895362|NCT02116868|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110895363|NCT02116868|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110895364|NCT02116868|Adrenergic Agents|adrenergic agents|mesh-ancestor
110895365|NCT02116868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110895366|NCT02116868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110895367|NCT02116868|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110895368|NCT02116868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110895369|NCT02116868|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110895370|NCT02116868|Vasodilator Agents|vasodilator agents|mesh-ancestor
110895371|NCT02116868|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110895372|NCT02116868|Serotonin Agents|serotonin agents|mesh-ancestor
110895373|NCT02116868|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110895374|NCT02116868|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110895375|NCT02679781|Midazolam|midazolam|mesh-list
110895376|NCT02679781|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110895377|NCT02679781|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110895378|NCT02679781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110895379|NCT02679781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110895380|NCT02679781|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110895381|NCT02679781|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110895382|NCT02679781|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110895383|NCT02679781|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110895384|NCT02679781|Anesthetics, General|anesthetics, general|mesh-ancestor
110895385|NCT02679781|Anesthetics|anesthetics|mesh-ancestor
110895386|NCT02679781|GABA Modulators|gaba modulators|mesh-ancestor
110895387|NCT02679781|GABA Agents|gaba agents|mesh-ancestor
110895388|NCT02679781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110895389|NCT02679781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110895390|NCT04373031|Pembrolizumab|pembrolizumab|mesh-list
110895391|NCT04373031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110895392|NCT04373031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110895393|NCT04373031|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110895394|NCT04373031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110895395|NCT02624869|Evolocumab|evolocumab|mesh-list
110895396|NCT02624869|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
110895397|NCT02624869|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110895398|NCT02624869|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110895399|NCT02624869|Antimetabolites|antimetabolites|mesh-ancestor
110895400|NCT02624869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110895401|NCT02624869|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110895402|NCT02624869|Protease Inhibitors|protease inhibitors|mesh-ancestor
110895403|NCT02624869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110895404|NCT02624869|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110895405|NCT02121782|Vaccines|vaccines|mesh-list
110895406|NCT02121782|Immunologic Factors|immunologic factors|mesh-ancestor
110895407|NCT02121782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110895408|NCT03553082|Propofol|propofol|mesh-list
110895409|NCT03553082|Sevoflurane|sevoflurane|mesh-list
110895410|NCT03553082|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110201821|NCT00151060|Paclitaxel|paclitaxel|mesh-list
110895411|NCT03553082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110895412|NCT03553082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110895413|NCT03553082|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110895414|NCT03553082|Anesthetics, General|anesthetics, general|mesh-ancestor
110895415|NCT03553082|Anesthetics|anesthetics|mesh-ancestor
110895416|NCT03553082|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110895417|NCT03553082|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110895418|NCT03318393|Heparin|heparin|mesh-list
110895419|NCT03318393|Calcium heparin|calcium heparin|mesh-list
110895420|NCT03318393|Bivalirudin|bivalirudin|mesh-list
110895421|NCT03318393|Anticoagulants|anticoagulants|mesh-ancestor
110895422|NCT03318393|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110895423|NCT03318393|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110895424|NCT03318393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110895425|NCT03318393|Antithrombins|antithrombins|mesh-ancestor
110895426|NCT03318393|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110895427|NCT03318393|Protease Inhibitors|protease inhibitors|mesh-ancestor
110895428|NCT03318393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110895429|NCT03110029|Efinaconazole|efinaconazole|mesh-list
110895430|NCT03110029|Antifungal Agents|antifungal agents|mesh-ancestor
110895431|NCT03110029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110895432|NCT03552146|Dexmedetomidine|dexmedetomidine|mesh-list
110895433|NCT03552146|Propofol|propofol|mesh-list
110895434|NCT03552146|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110895435|NCT03552146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110895436|NCT03552146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110895437|NCT03552146|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110895438|NCT03552146|Analgesics|analgesics|mesh-ancestor
110895439|NCT03552146|Sensory System Agents|sensory system agents|mesh-ancestor
110895440|NCT03552146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110895441|NCT03552146|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110895442|NCT03552146|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110895443|NCT03552146|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110895444|NCT03552146|Adrenergic Agents|adrenergic agents|mesh-ancestor
110895445|NCT03552146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110895446|NCT03552146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110895447|NCT03552146|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110895448|NCT03552146|Anesthetics, General|anesthetics, general|mesh-ancestor
110895449|NCT03552146|Anesthetics|anesthetics|mesh-ancestor
110895450|NCT01374763|Oxycodone|oxycodone|mesh-list
110895451|NCT01374763|Naloxone|naloxone|mesh-list
110895452|NCT01374763|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110895453|NCT01374763|Narcotics|narcotics|mesh-ancestor
110895454|NCT01374763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110895455|NCT01374763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110895456|NCT01374763|Analgesics|analgesics|mesh-ancestor
110895457|NCT01374763|Sensory System Agents|sensory system agents|mesh-ancestor
110895458|NCT01374763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110895459|NCT01374763|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110612927|NCT03593408|Adrenergic Agents|adrenergic agents|mesh-ancestor
110895461|NCT04454515|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110895462|NCT04454515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110895463|NCT04454515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110895464|NCT04454515|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110895465|NCT04454515|Analgesics|analgesics|mesh-ancestor
110895466|NCT04454515|Sensory System Agents|sensory system agents|mesh-ancestor
110895467|NCT04454515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110895468|NCT04454515|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110895469|NCT04454515|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110895470|NCT04454515|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110895471|NCT04454515|Adrenergic Agents|adrenergic agents|mesh-ancestor
110895472|NCT04454515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110895473|NCT04454515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110895474|NCT03608514|Terlipressin|terlipressin|mesh-list
110895475|NCT03608514|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110895476|NCT03608514|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110895477|NCT02117726|Midazolam|midazolam|mesh-list
110895478|NCT02117726|Dexmedetomidine|dexmedetomidine|mesh-list
110895479|NCT02117726|Propofol|propofol|mesh-list
110895480|NCT02117726|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110895481|NCT02117726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110895482|NCT02117726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110895483|NCT02117726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110895484|NCT02117726|Analgesics|analgesics|mesh-ancestor
110895485|NCT02117726|Sensory System Agents|sensory system agents|mesh-ancestor
110895486|NCT02117726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110895487|NCT02117726|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110895488|NCT02117726|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110895489|NCT02117726|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110895490|NCT02117726|Adrenergic Agents|adrenergic agents|mesh-ancestor
110895491|NCT02117726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110895492|NCT02117726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110895493|NCT02117726|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110895494|NCT02117726|Anesthetics, General|anesthetics, general|mesh-ancestor
110895495|NCT02117726|Anesthetics|anesthetics|mesh-ancestor
110895496|NCT02117726|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110895497|NCT02117726|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110895498|NCT02117726|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110895499|NCT02117726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110895500|NCT02117726|GABA Modulators|gaba modulators|mesh-ancestor
110895501|NCT02117726|GABA Agents|gaba agents|mesh-ancestor
110895502|NCT02733432|Fluconazole|fluconazole|mesh-list
110895503|NCT02733432|Rezafungin|rezafungin|mesh-list
110895504|NCT02733432|Antifungal Agents|antifungal agents|mesh-ancestor
110895505|NCT02733432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110895506|NCT02733432|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110895507|NCT02733432|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110895508|NCT02733432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110895509|NCT02733432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110895510|NCT02733432|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110895511|NCT02733432|Hormone Antagonists|hormone antagonists|mesh-ancestor
110895512|NCT02733432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110895513|NCT02733432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110895514|NCT02733432|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110895515|NCT02733432|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110895516|NCT03634189|Cannabidiol|cannabidiol|mesh-list
110895517|NCT03634189|Anticonvulsants|anticonvulsants|mesh-ancestor
110895518|NCT03608046|Irinotecan|irinotecan|mesh-list
110895519|NCT03608046|Cetuximab|cetuximab|mesh-list
110895520|NCT03608046|Avelumab|avelumab|mesh-list
110895521|NCT03608046|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110895522|NCT03608046|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110201855|NCT00082485|Baclofen|baclofen|mesh-list
110895523|NCT03608046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110895524|NCT03608046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110895525|NCT03608046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110895526|NCT03608046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110895527|NCT02122484|Colchicine|colchicine|mesh-list
110895529|NCT02122484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110895530|NCT02122484|Tubulin Modulators|tubulin modulators|mesh-ancestor
110895531|NCT02122484|Antimitotic Agents|antimitotic agents|mesh-ancestor
110895532|NCT02122484|Mitosis Modulators|mitosis modulators|mesh-ancestor
110895533|NCT02122484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110895534|NCT02122484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110895535|NCT03606018|Insulin|insulin|mesh-list
110895536|NCT03606018|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110895538|NCT03606018|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110895539|NCT03606018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110895540|NCT01373749|Sildenafil Citrate|sildenafil citrate|mesh-list
110895541|NCT01373749|Vasodilator Agents|vasodilator agents|mesh-ancestor
110895542|NCT01373749|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110895543|NCT01373749|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110895544|NCT01373749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110895545|NCT01373749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110895546|NCT01373749|Urological Agents|urological agents|mesh-ancestor
110895547|NCT04045795|Dexamethasone|dexamethasone|mesh-list
110895548|NCT04045795|Pomalidomide|pomalidomide|mesh-list
110895549|NCT04045795|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110895550|NCT04045795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110895551|NCT04045795|Antiemetics|antiemetics|mesh-ancestor
110895552|NCT04045795|Autonomic Agents|autonomic agents|mesh-ancestor
110895553|NCT04045795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110895554|NCT04045795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110895555|NCT04045795|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110895556|NCT04045795|Glucocorticoids|glucocorticoids|mesh-ancestor
110895557|NCT04045795|Hormones|hormones|mesh-ancestor
110895558|NCT04045795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110895559|NCT04045795|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110895560|NCT04045795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110895561|NCT04045795|Immunologic Factors|immunologic factors|mesh-ancestor
110895562|NCT04045795|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110895563|NCT04045795|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110895564|NCT04045795|Growth Substances|growth substances|mesh-ancestor
110895565|NCT04045795|Growth Inhibitors|growth inhibitors|mesh-ancestor
110895566|NCT03605940|Methoxsalen|methoxsalen|mesh-list
110895567|NCT03605940|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110895568|NCT03605940|Dermatologic Agents|dermatologic agents|mesh-ancestor
110895569|NCT03607734|Amoxicillin|amoxicillin|mesh-list
110895570|NCT03607734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110895571|NCT03607734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110895572|NCT02035488|Tobramycin|tobramycin|mesh-list
110895573|NCT02035488|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110895574|NCT02035488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110895575|NCT03602430|Vitamin D|vitamin d|mesh-list
110895576|NCT03602430|Cholecalciferol|cholecalciferol|mesh-list
110895577|NCT03602430|Vitamins|vitamins|mesh-ancestor
110895578|NCT03602430|Micronutrients|micronutrients|mesh-ancestor
110895579|NCT03602430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110895580|NCT03602430|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110895581|NCT03602430|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110895582|NCT02260544|Doxorubicin|doxorubicin|mesh-list
110895583|NCT02260544|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110895584|NCT02260544|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110895585|NCT02260544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110895586|NCT02260544|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110895587|NCT02260544|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110895588|NCT02260544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110895589|NCT02260544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110895590|NCT05470647|Interleukin-4|interleukin-4|mesh-list
110895591|NCT05470647|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110895592|NCT05470647|Immunologic Factors|immunologic factors|mesh-ancestor
110895593|NCT05470647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110895594|NCT05470647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110895595|NCT05470647|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110895596|NCT04409665|Ketamine|ketamine|mesh-list
110895597|NCT04409665|Analgesics|analgesics|mesh-ancestor
110895598|NCT04409665|Sensory System Agents|sensory system agents|mesh-ancestor
110895599|NCT04409665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110895600|NCT04409665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110895601|NCT04409665|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110895602|NCT04409665|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110895603|NCT04409665|Anesthetics, General|anesthetics, general|mesh-ancestor
110895604|NCT04409665|Anesthetics|anesthetics|mesh-ancestor
110895605|NCT04409665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110895606|NCT04409665|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110895607|NCT04409665|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110895608|NCT04409665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110895609|NCT04409665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110895610|NCT02854800|Varenicline|varenicline|mesh-list
110895611|NCT02854800|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110613078|NCT02942355|Palbociclib|palbociclib|mesh-list
110895612|NCT02854800|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110895613|NCT02854800|Cholinergic Agents|cholinergic agents|mesh-ancestor
110895614|NCT02854800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110895615|NCT02854800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110895616|NCT02854800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110895618|NCT03552770|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110895619|NCT03552770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110895620|NCT03552770|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110895621|NCT03552770|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110895622|NCT03552770|Growth Substances|growth substances|mesh-ancestor
110895623|NCT03552770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110895624|NCT03552770|Growth Inhibitors|growth inhibitors|mesh-ancestor
110895625|NCT02127164|Sodium Hypochlorite|sodium hypochlorite|mesh-list
110895627|NCT02127164|Disinfectants|disinfectants|mesh-ancestor
110895628|NCT02127164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110895629|NCT02931539|Valganciclovir|valganciclovir|mesh-list
110895630|NCT02931539|Ganciclovir|ganciclovir|mesh-list
110895631|NCT02931539|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
110895632|NCT02931539|Cidofovir|cidofovir|mesh-list
110895633|NCT02931539|Foscarnet|foscarnet|mesh-list
110895634|NCT02931539|Maribavir|maribavir|mesh-list
110895635|NCT02931539|Antiviral Agents|antiviral agents|mesh-ancestor
110895636|NCT02931539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110895637|NCT02931539|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110895638|NCT02931539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110895639|NCT02931539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110895640|NCT02931539|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110895641|NCT03602118|Phenobarbital|phenobarbital|mesh-list
110895642|NCT03602118|Anticonvulsants|anticonvulsants|mesh-ancestor
110895643|NCT03602118|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110923263|NCT05156710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110895644|NCT03602118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110201887|NCT00049751|Adalimumab|adalimumab|mesh-list
110895645|NCT03602118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110895646|NCT03602118|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110895647|NCT03602118|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110895648|NCT03602118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110895649|NCT03602118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110895650|NCT03602118|GABA Modulators|gaba modulators|mesh-ancestor
110895651|NCT03602118|GABA Agents|gaba agents|mesh-ancestor
110895652|NCT03602118|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110895653|NCT03602118|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110895654|NCT03602118|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110895655|NCT02125682|Atorvastatin|atorvastatin|mesh-list
110895656|NCT02125682|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110895657|NCT02125682|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110895658|NCT02125682|Antimetabolites|antimetabolites|mesh-ancestor
110895659|NCT02125682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110895660|NCT02125682|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110895661|NCT02125682|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110895662|NCT02125682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110895663|NCT02546999|Botulinum Toxins|botulinum toxins|mesh-list
110895664|NCT02546999|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110224146|NCT00322660|Mydriatics|mydriatics|mesh-ancestor
110895665|NCT02546999|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110895666|NCT02546999|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110895667|NCT02546999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110895668|NCT02546999|Cholinergic Agents|cholinergic agents|mesh-ancestor
110895669|NCT02546999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110895670|NCT02546999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110895671|NCT02546999|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110895672|NCT02546999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110895673|NCT02131220|Tirofiban|tirofiban|mesh-list
110895674|NCT02131220|Saruplase|saruplase|mesh-list
110895675|NCT02131220|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110895676|NCT02131220|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110895677|NCT02131220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110895678|NCT02131220|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110895679|NCT04042077|Vancomycin|vancomycin|mesh-list
110895680|NCT04042077|Tazobactam|tazobactam|mesh-list
110895681|NCT04042077|Linezolid|linezolid|mesh-list
110895682|NCT04042077|Piperacillin|piperacillin|mesh-list
110895683|NCT04042077|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
110895684|NCT04042077|Tigecycline|tigecycline|mesh-list
110895685|NCT04042077|Delafloxacin|delafloxacin|mesh-list
110895686|NCT04042077|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110895687|NCT04042077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110895688|NCT04042077|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110895689|NCT04042077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110895690|NCT04042077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110895691|NCT04042077|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110895692|NCT03557359|Nivolumab|nivolumab|mesh-list
110895693|NCT03557359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110895694|NCT03557359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110895695|NCT03557359|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110895696|NCT03557359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110895697|NCT02127320|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110895698|NCT02127320|Ezetimibe|ezetimibe|mesh-list
110895699|NCT02127320|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110895700|NCT02127320|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110895701|NCT02127320|Antimetabolites|antimetabolites|mesh-ancestor
110895702|NCT02127320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110895703|NCT02127320|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110923268|NCT05110482|Oxytocin|oxytocin|mesh-list
110895704|NCT02127320|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110895705|NCT02127320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110895706|NCT03522415|Methotrexate|methotrexate|mesh-list
110895707|NCT03522415|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110895708|NCT03522415|Abortifacient Agents|abortifacient agents|mesh-ancestor
110895709|NCT03522415|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110895710|NCT03522415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110895711|NCT03522415|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110895712|NCT03522415|Antimetabolites|antimetabolites|mesh-ancestor
110895713|NCT03522415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110895714|NCT03522415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110895715|NCT03522415|Dermatologic Agents|dermatologic agents|mesh-ancestor
110895716|NCT03522415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110895717|NCT03522415|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110895718|NCT03522415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110895719|NCT03522415|Immunologic Factors|immunologic factors|mesh-ancestor
110895720|NCT03522415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110895721|NCT03522415|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110895722|NCT04226833|Entrectinib|entrectinib|mesh-list
110895723|NCT04226833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110895724|NCT04226833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110895725|NCT04226833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110895726|NCT02131298|Itraconazole|itraconazole|mesh-list
110895727|NCT02131298|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
110895728|NCT02131298|Palbociclib|palbociclib|mesh-list
110895729|NCT02131298|Antifungal Agents|antifungal agents|mesh-ancestor
110895730|NCT02131298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110895731|NCT02131298|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110895732|NCT02131298|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110895733|NCT02131298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110895734|NCT02131298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110895735|NCT02131298|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110895736|NCT02131298|Hormone Antagonists|hormone antagonists|mesh-ancestor
110895737|NCT02131298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110895738|NCT02131298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110895739|NCT02131298|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110895740|NCT02131298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110895741|NCT02131298|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110895742|NCT01375387|Lacosamide|lacosamide|mesh-list
110895743|NCT01375387|Anticonvulsants|anticonvulsants|mesh-ancestor
110895744|NCT01375387|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110895745|NCT01375387|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110895746|NCT01375387|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110895747|NCT01375387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110923281|NCT05005000|Triamcinolone|triamcinolone|mesh-list
110895749|NCT02853318|Bevacizumab|bevacizumab|mesh-list
110895750|NCT02853318|Pembrolizumab|pembrolizumab|mesh-list
110895751|NCT02853318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110895752|NCT02853318|Antibodies|antibodies|mesh-list
110895753|NCT02853318|Immunoglobulins|immunoglobulins|mesh-list
110895754|NCT02853318|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110895755|NCT02853318|Immunoglobulin G|immunoglobulin g|mesh-list
110895756|NCT02853318|Endothelial Growth Factors|endothelial growth factors|mesh-list
110895757|NCT02853318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110895758|NCT02853318|Immunologic Factors|immunologic factors|mesh-ancestor
110895759|NCT02853318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110895760|NCT02853318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110895761|NCT02853318|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110895762|NCT02853318|Alkylating Agents|alkylating agents|mesh-ancestor
110895763|NCT02853318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110895764|NCT02853318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110895765|NCT02853318|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110895766|NCT02853318|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110895767|NCT02853318|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110895768|NCT02853318|Growth Substances|growth substances|mesh-ancestor
110895769|NCT02853318|Growth Inhibitors|growth inhibitors|mesh-ancestor
110895770|NCT02853318|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110895771|NCT03626727|Sodium Oxybate|sodium oxybate|mesh-list
110895772|NCT03626727|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110895773|NCT03626727|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110895774|NCT03626727|Anesthetics, General|anesthetics, general|mesh-ancestor
110895775|NCT03626727|Anesthetics|anesthetics|mesh-ancestor
110895776|NCT03626727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110895777|NCT03626727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110895778|NCT03604224|Canagliflozin|canagliflozin|mesh-list
110895779|NCT03604224|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110895780|NCT03604224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110895781|NCT03604224|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110895782|NCT03604224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110895783|NCT02126384|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110895784|NCT02126384|Immunologic Factors|immunologic factors|mesh-ancestor
110895785|NCT02126384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110895786|NCT02035410|Hydrogen Peroxide|hydrogen peroxide|mesh-list
110895787|NCT02035410|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110895788|NCT02035410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110895789|NCT02404155|Clozapine|clozapine|mesh-list
110895790|NCT02404155|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110895791|NCT02404155|Serotonin Agents|serotonin agents|mesh-ancestor
110895792|NCT02404155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110895793|NCT02404155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110895794|NCT02404155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110895795|NCT02404155|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110895796|NCT02404155|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110895797|NCT02404155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110895798|NCT02404155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110201946|NCT00049790|Paclitaxel|paclitaxel|mesh-list
110895799|NCT02404155|GABA Antagonists|gaba antagonists|mesh-ancestor
110895800|NCT02404155|GABA Agents|gaba agents|mesh-ancestor
110895801|NCT02127788|Micafungin|micafungin|mesh-list
110895802|NCT02127788|Antifungal Agents|antifungal agents|mesh-ancestor
110895803|NCT02127788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110895804|NCT02131688|Mitoxantrone|mitoxantrone|mesh-list
110895805|NCT02131688|Analgesics|analgesics|mesh-ancestor
110895806|NCT02131688|Sensory System Agents|sensory system agents|mesh-ancestor
110895807|NCT02131688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110895808|NCT02131688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110895809|NCT02131688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110895810|NCT02131688|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110895811|NCT02131688|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110895812|NCT02131688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110895813|NCT02131688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110895814|NCT02126462|Aluminum Hydroxide|aluminum hydroxide|mesh-list
110895815|NCT02126462|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110895816|NCT02126462|Immunologic Factors|immunologic factors|mesh-ancestor
110895817|NCT02126462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110895819|NCT02126462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110895820|NCT02126462|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110895821|NCT03113071|Decitabine|decitabine|mesh-list
110895822|NCT03113071|Digoxin|digoxin|mesh-list
110895823|NCT03113071|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110895824|NCT03113071|Antimetabolites|antimetabolites|mesh-ancestor
110895825|NCT03113071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110895826|NCT03113071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110895827|NCT03113071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110895828|NCT03113071|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110895829|NCT03113071|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110895830|NCT03113071|Protective Agents|protective agents|mesh-ancestor
110895831|NCT03113071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110895832|NCT03050307|Lansoprazole|lansoprazole|mesh-list
110895833|NCT03050307|Dexlansoprazole|dexlansoprazole|mesh-list
110895834|NCT03050307|Bismuth|bismuth|mesh-list
110895835|NCT03050307|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110895836|NCT03050307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110895837|NCT03050307|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110895838|NCT03050307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110895839|NCT03050307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110895840|NCT03050307|Antacids|antacids|mesh-ancestor
110895841|NCT02127866|Beclomethasone|beclomethasone|mesh-list
110895842|NCT02127866|Glycopyrrolate|glycopyrrolate|mesh-list
110895843|NCT02127866|Formoterol Fumarate|formoterol fumarate|mesh-list
110895844|NCT02127866|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110895845|NCT02127866|Autonomic Agents|autonomic agents|mesh-ancestor
110895846|NCT02127866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110895847|NCT02127866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110895848|NCT02127866|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110895849|NCT02127866|Respiratory System Agents|respiratory system agents|mesh-ancestor
110895850|NCT02127866|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110895851|NCT02127866|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110895852|NCT02127866|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110895853|NCT02127866|Adrenergic Agents|adrenergic agents|mesh-ancestor
110895854|NCT02127866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110895855|NCT02127866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110895856|NCT02127866|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110895857|NCT02127866|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110895858|NCT02127866|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110895859|NCT02127866|Cholinergic Agents|cholinergic agents|mesh-ancestor
110895860|NCT02127866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110895861|NCT02127866|Glucocorticoids|glucocorticoids|mesh-ancestor
110895862|NCT02127866|Hormones|hormones|mesh-ancestor
110895863|NCT02127866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110895864|NCT03550508|Antibodies|antibodies|mesh-list
110895865|NCT03550508|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110895866|NCT03550508|Immunologic Factors|immunologic factors|mesh-ancestor
110895867|NCT03550508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110895868|NCT03607578|Sunscreening Agents|sunscreening agents|mesh-list
110895869|NCT03607578|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110895870|NCT03607578|Protective Agents|protective agents|mesh-ancestor
110895871|NCT03607578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110895872|NCT03607578|Dermatologic Agents|dermatologic agents|mesh-ancestor
110895873|NCT05760079|Lactoferrin|lactoferrin|mesh-list
110895874|NCT05760079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110895875|NCT03603834|Leucovorin|leucovorin|mesh-list
110895876|NCT03603834|Fluorouracil|fluorouracil|mesh-list
110895877|NCT03603834|Oxaliplatin|oxaliplatin|mesh-list
110895878|NCT03603834|Irinotecan|irinotecan|mesh-list
110895879|NCT03603834|Antimetabolites|antimetabolites|mesh-ancestor
110895880|NCT03603834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110923318|NCT04891770|Tenofovir|tenofovir|mesh-list
110895881|NCT03603834|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110895882|NCT03603834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110895883|NCT03603834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110895884|NCT03603834|Immunologic Factors|immunologic factors|mesh-ancestor
110895885|NCT03603834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110895886|NCT03603834|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110895887|NCT03603834|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110895888|NCT03603834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110895889|NCT03603834|Antidotes|antidotes|mesh-ancestor
110895890|NCT03603834|Protective Agents|protective agents|mesh-ancestor
110895891|NCT03603834|Vitamin B Complex|vitamin b complex|mesh-ancestor
110895892|NCT03603834|Vitamins|vitamins|mesh-ancestor
110895893|NCT03603834|Micronutrients|micronutrients|mesh-ancestor
110895894|NCT03601338|Bemiparin|bemiparin|mesh-list
110895895|NCT03601338|Anticoagulants|anticoagulants|mesh-ancestor
110895896|NCT02128022|Glyburide|glyburide|mesh-list
110895897|NCT02128022|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110895898|NCT02128022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110895899|NCT03256045|Dexamethasone|dexamethasone|mesh-list
110895900|NCT03256045|Dexamethasone acetate|dexamethasone acetate|mesh-list
110895901|NCT03256045|Panobinostat|panobinostat|mesh-list
110895902|NCT03256045|Ichthammol|ichthammol|mesh-list
110895903|NCT03256045|BB 1101|bb 1101|mesh-list
110895904|NCT03256045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110895905|NCT03256045|Antiemetics|antiemetics|mesh-ancestor
110895906|NCT03256045|Autonomic Agents|autonomic agents|mesh-ancestor
110895907|NCT03256045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110895908|NCT03256045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110895909|NCT03256045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110895910|NCT03256045|Glucocorticoids|glucocorticoids|mesh-ancestor
110895911|NCT03256045|Hormones|hormones|mesh-ancestor
110895912|NCT03256045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110895913|NCT03256045|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110895914|NCT03256045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110895916|NCT03256045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110895917|NCT03256045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110895918|NCT03256045|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110895919|NCT03256045|Dermatologic Agents|dermatologic agents|mesh-ancestor
110895920|NCT03603756|Paclitaxel|paclitaxel|mesh-list
110895921|NCT03603756|Irinotecan|irinotecan|mesh-list
110895922|NCT03603756|Apatinib|apatinib|mesh-list
110895923|NCT03603756|Nedaplatin|nedaplatin|mesh-list
110895924|NCT03603756|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110895925|NCT03603756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110895926|NCT03603756|Tubulin Modulators|tubulin modulators|mesh-ancestor
110895927|NCT03603756|Antimitotic Agents|antimitotic agents|mesh-ancestor
110895928|NCT03603756|Mitosis Modulators|mitosis modulators|mesh-ancestor
110895929|NCT03603756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110895930|NCT03603756|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110895931|NCT03603756|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110895932|NCT03603756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110895933|NCT03603756|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110895934|NCT02372409|Doxorubicin|doxorubicin|mesh-list
110895935|NCT02372409|Etoposide|etoposide|mesh-list
110895936|NCT02372409|Etoposide phosphate|etoposide phosphate|mesh-list
110895937|NCT02372409|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110895938|NCT02372409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110895939|NCT02372409|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110895940|NCT02372409|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110895941|NCT02372409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110895942|NCT02372409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110895943|NCT02372409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110895944|NCT03626259|Losartan|losartan|mesh-list
110895945|NCT03626259|Amlodipine|amlodipine|mesh-list
110895946|NCT03626259|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110895947|NCT03626259|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110895948|NCT03626259|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110895949|NCT03626259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110895950|NCT03626259|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110895951|NCT03626259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110895952|NCT03626259|Vasodilator Agents|vasodilator agents|mesh-ancestor
110895953|NCT03626259|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110895954|NCT03626259|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110895955|NCT03626259|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110895956|NCT03601260|Allopurinol|allopurinol|mesh-list
110895957|NCT03601260|Antimetabolites|antimetabolites|mesh-ancestor
110202036|NCT00397787|Sunitinib|sunitinib|mesh-list
110895958|NCT03601260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110895959|NCT03601260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110895960|NCT03601260|Gout Suppressants|gout suppressants|mesh-ancestor
110895961|NCT03601260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110895962|NCT03601260|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110895963|NCT03601260|Antioxidants|antioxidants|mesh-ancestor
110895964|NCT03601260|Protective Agents|protective agents|mesh-ancestor
110895965|NCT03601260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110895966|NCT05193253|Liver Extracts|liver extracts|mesh-list
110895967|NCT05193253|Hematinics|hematinics|mesh-ancestor
110895968|NCT02131922|Chlorhexidine|chlorhexidine|mesh-list
110895969|NCT02131922|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110895970|NCT02131922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110895971|NCT02131922|Disinfectants|disinfectants|mesh-ancestor
110895972|NCT03600948|Sirolimus|sirolimus|mesh-list
110895973|NCT03600948|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110895974|NCT03600948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110895975|NCT03600948|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110895976|NCT03600948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110895977|NCT03600948|Antifungal Agents|antifungal agents|mesh-ancestor
110895978|NCT03600948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110895979|NCT03600948|Immunologic Factors|immunologic factors|mesh-ancestor
110895980|NCT03600948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110895981|NCT02132000|Tamoxifen|tamoxifen|mesh-list
110895982|NCT02132000|Toremifene|toremifene|mesh-list
110895983|NCT02132000|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110895984|NCT02132000|Hormone Antagonists|hormone antagonists|mesh-ancestor
110895985|NCT02132000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110895986|NCT02132000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110895987|NCT02132000|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110895988|NCT02132000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110895989|NCT02132000|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110895990|NCT02132000|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110895991|NCT02132000|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110895993|NCT03118765|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110895994|NCT03118765|Tiotropium Bromide|tiotropium bromide|mesh-list
110895995|NCT03118765|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110895996|NCT03118765|Autonomic Agents|autonomic agents|mesh-ancestor
110895997|NCT03118765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110895998|NCT03118765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110895999|NCT03118765|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110896000|NCT03118765|Respiratory System Agents|respiratory system agents|mesh-ancestor
110896001|NCT03118765|Parasympatholytics|parasympatholytics|mesh-ancestor
110896002|NCT03118765|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110896003|NCT03118765|Cholinergic Agents|cholinergic agents|mesh-ancestor
110896004|NCT03118765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110896005|NCT03118765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110896006|NCT03118765|Anticonvulsants|anticonvulsants|mesh-ancestor
110896007|NCT02128100|Leucovorin|leucovorin|mesh-list
110896008|NCT02128100|Fluorouracil|fluorouracil|mesh-list
110896009|NCT02128100|Oxaliplatin|oxaliplatin|mesh-list
110896010|NCT02128100|Irinotecan|irinotecan|mesh-list
110896011|NCT02128100|Folfirinox|folfirinox|mesh-list
110896012|NCT02128100|Antimetabolites|antimetabolites|mesh-ancestor
110896013|NCT02128100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110923337|NCT04870125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110896014|NCT02128100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110896015|NCT02128100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110896016|NCT02128100|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110896017|NCT02128100|Immunologic Factors|immunologic factors|mesh-ancestor
110896018|NCT02128100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110896019|NCT02128100|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110896020|NCT02128100|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110896021|NCT02128100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110896022|NCT02128100|Antidotes|antidotes|mesh-ancestor
110896023|NCT02128100|Protective Agents|protective agents|mesh-ancestor
110896024|NCT02128100|Vitamin B Complex|vitamin b complex|mesh-ancestor
110896025|NCT02128100|Vitamins|vitamins|mesh-ancestor
110896026|NCT02128100|Micronutrients|micronutrients|mesh-ancestor
110896027|NCT03603366|Aspirin|aspirin|mesh-list
110896028|NCT03603366|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110896029|NCT03603366|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110896030|NCT03603366|Analgesics|analgesics|mesh-ancestor
110896031|NCT03603366|Sensory System Agents|sensory system agents|mesh-ancestor
110896032|NCT03603366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110896033|NCT03603366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110896034|NCT03603366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110896035|NCT03603366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110896036|NCT03603366|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110896037|NCT03603366|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110896038|NCT03603366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110896039|NCT03603366|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110896040|NCT03603366|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110896041|NCT03603366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110896042|NCT03603366|Antipyretics|antipyretics|mesh-ancestor
110896043|NCT02128178|Enoxaparin|enoxaparin|mesh-list
110896044|NCT02128178|Enoxaparin sodium|enoxaparin sodium|mesh-list
110896045|NCT02128178|Anticoagulants|anticoagulants|mesh-ancestor
110896046|NCT02128178|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110896047|NCT02128178|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110896048|NCT02128178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110896049|NCT03600870|Midodrine|midodrine|mesh-list
110896050|NCT03600870|Sympathomimetics|sympathomimetics|mesh-ancestor
110896051|NCT03600870|Autonomic Agents|autonomic agents|mesh-ancestor
110896052|NCT03600870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110896053|NCT03600870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110896054|NCT03600870|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110896055|NCT03600870|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110896056|NCT03600870|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110896057|NCT03600870|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110896058|NCT03600870|Adrenergic Agents|adrenergic agents|mesh-ancestor
110896059|NCT03600870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110896060|NCT03600870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110896061|NCT02128334|Leuprolide|leuprolide|mesh-list
110896062|NCT02128334|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110896063|NCT02128334|Fertility Agents|fertility agents|mesh-ancestor
110896064|NCT02128334|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110896065|NCT02128334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110896066|NCT02128334|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110896067|NCT02128334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110896068|NCT01375699|Doxorubicin|doxorubicin|mesh-list
110896069|NCT01375699|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110896070|NCT01375699|Sildenafil Citrate|sildenafil citrate|mesh-list
110896071|NCT01375699|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110896072|NCT01375699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110896073|NCT01375699|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110896074|NCT01375699|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110896075|NCT01375699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110896076|NCT01375699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110896077|NCT01375699|Vasodilator Agents|vasodilator agents|mesh-ancestor
110896078|NCT01375699|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110896079|NCT01375699|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110896080|NCT01375699|Urological Agents|urological agents|mesh-ancestor
110896081|NCT01373983|Ziconotide|ziconotide|mesh-list
110896082|NCT01373983|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110896083|NCT01373983|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110896084|NCT01373983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110896085|NCT01373983|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110896086|NCT01373983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110896087|NCT01373983|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110896088|NCT01373983|Protective Agents|protective agents|mesh-ancestor
110896089|NCT01373983|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110896090|NCT01373983|Analgesics|analgesics|mesh-ancestor
110896091|NCT01373983|Sensory System Agents|sensory system agents|mesh-ancestor
110896092|NCT01373983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110896093|NCT05173597|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
110896094|NCT05173597|Hormones|hormones|mesh-ancestor
110896095|NCT05173597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110896096|NCT05173597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110896097|NCT05812612|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
110896098|NCT05812612|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
110896099|NCT05812612|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110896100|NCT05812521|Methylene Blue|methylene blue|mesh-list
110896101|NCT05812521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110896102|NCT05812521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110896103|NCT05812430|Paclitaxel|paclitaxel|mesh-list
110896104|NCT05812430|Cisplatin|cisplatin|mesh-list
110896105|NCT05812430|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110896106|NCT05812430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110896107|NCT05812430|Tubulin Modulators|tubulin modulators|mesh-ancestor
110896108|NCT05812430|Antimitotic Agents|antimitotic agents|mesh-ancestor
110896109|NCT05812430|Mitosis Modulators|mitosis modulators|mesh-ancestor
110896110|NCT05812430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110896111|NCT05812404|Fexuprazan|fexuprazan|mesh-list
110896112|NCT05812404|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110896113|NCT03607110|Fentanyl|fentanyl|mesh-list
110896114|NCT03607110|Ketamine|ketamine|mesh-list
110896115|NCT03607110|Analgesics|analgesics|mesh-ancestor
110896116|NCT03607110|Sensory System Agents|sensory system agents|mesh-ancestor
110896117|NCT03607110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110896118|NCT03607110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110896119|NCT03607110|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110896120|NCT03607110|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110896121|NCT03607110|Anesthetics, General|anesthetics, general|mesh-ancestor
110896122|NCT03607110|Anesthetics|anesthetics|mesh-ancestor
110896123|NCT03607110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110896124|NCT03607110|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110896125|NCT03607110|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110896126|NCT03607110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110896127|NCT03607110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110896128|NCT03607110|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110896129|NCT03607110|Narcotics|narcotics|mesh-ancestor
110202074|NCT00151684|Diazoxide|diazoxide|mesh-list
110896130|NCT03607110|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110896131|NCT05811793|Bevacizumab|bevacizumab|mesh-list
110896132|NCT05811793|Tislelizumab|tislelizumab|mesh-list
110896133|NCT05811793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110896134|NCT05811793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110896135|NCT05811793|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110896136|NCT05811793|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110896137|NCT05811793|Growth Substances|growth substances|mesh-ancestor
110896138|NCT05811793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110896139|NCT05811793|Growth Inhibitors|growth inhibitors|mesh-ancestor
110896140|NCT05811507|Testosterone|testosterone|mesh-list
110896141|NCT05811507|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
110896142|NCT05811507|Androgens|androgens|mesh-ancestor
110896143|NCT05811507|Hormones|hormones|mesh-ancestor
110896144|NCT05811507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110896145|NCT05811507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110896146|NCT05811507|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110896147|NCT05811507|Immunologic Factors|immunologic factors|mesh-ancestor
110896148|NCT05811221|Anesthetics|anesthetics|mesh-list
110896149|NCT05811221|Esketamine|esketamine|mesh-list
110896150|NCT05811221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110896151|NCT05811221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110896152|NCT05811221|Antidepressive Agents|antidepressive agents|mesh-ancestor
110896153|NCT05811221|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110896154|NCT05811000|Donepezil|donepezil|mesh-list
110896155|NCT05811000|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110896156|NCT05811000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110896157|NCT05811000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110896158|NCT05811000|Cholinergic Agents|cholinergic agents|mesh-ancestor
110896159|NCT05811000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110896160|NCT05811000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110896161|NCT05811000|Nootropic Agents|nootropic agents|mesh-ancestor
110896162|NCT05810909|Calcium Carbonate|calcium carbonate|mesh-list
110896163|NCT05810909|Calcium|calcium|mesh-list
110896164|NCT05810909|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110896165|NCT05810909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110896166|NCT05810909|Antacids|antacids|mesh-ancestor
110896167|NCT05810909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110896168|NCT05810909|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110896169|NCT05810350|Pemetrexed|pemetrexed|mesh-list
110896170|NCT05810350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110896171|NCT05810350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110896172|NCT05810350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110896173|NCT05810350|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110896174|NCT05810350|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110896175|NCT05807360|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110896176|NCT05807360|Hyaluronic Acid|hyaluronic acid|mesh-list
110896177|NCT05807360|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110896178|NCT05807360|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110896179|NCT05807360|Immunologic Factors|immunologic factors|mesh-ancestor
110896180|NCT05807360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110896181|NCT05807360|Viscosupplements|viscosupplements|mesh-ancestor
110896182|NCT05807360|Protective Agents|protective agents|mesh-ancestor
110896183|NCT05803655|Oxymetazoline|oxymetazoline|mesh-list
110896184|NCT05803655|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110896185|NCT05803655|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110896186|NCT05803655|Adrenergic Agents|adrenergic agents|mesh-ancestor
110896187|NCT05803655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110896188|NCT05803655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110896189|NCT05803655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110896190|NCT05803655|Sympathomimetics|sympathomimetics|mesh-ancestor
110896191|NCT05803655|Autonomic Agents|autonomic agents|mesh-ancestor
110896192|NCT05803655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110896193|NCT05803655|Nasal Decongestants|nasal decongestants|mesh-ancestor
110896194|NCT05803655|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110896195|NCT05803655|Respiratory System Agents|respiratory system agents|mesh-ancestor
110896196|NCT05801224|Nitric Oxide|nitric oxide|mesh-list
110896197|NCT05801224|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110896198|NCT05801224|Autonomic Agents|autonomic agents|mesh-ancestor
110896199|NCT05801224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110896200|NCT05801224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110896201|NCT05801224|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110896202|NCT05801224|Respiratory System Agents|respiratory system agents|mesh-ancestor
110896203|NCT05801224|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110896205|NCT05801224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110896206|NCT05801224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110896207|NCT05801224|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
110896208|NCT05801224|Vasodilator Agents|vasodilator agents|mesh-ancestor
110896209|NCT05801224|Gasotransmitters|gasotransmitters|mesh-ancestor
110896210|NCT05801224|Protective Agents|protective agents|mesh-ancestor
110896211|NCT05793489|Silybin|silybin|mesh-list
110896212|NCT05793489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110896213|NCT05793489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110896214|NCT05793489|Protective Agents|protective agents|mesh-ancestor
110896215|NCT05793489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110896216|NCT05754853|Paclitaxel|paclitaxel|mesh-list
110896217|NCT05754853|Docetaxel|docetaxel|mesh-list
110896218|NCT05754853|Gemcitabine|gemcitabine|mesh-list
110896219|NCT05754853|Pemetrexed|pemetrexed|mesh-list
110896220|NCT05754853|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110896221|NCT05754853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110896222|NCT05754853|Tubulin Modulators|tubulin modulators|mesh-ancestor
110896223|NCT05754853|Antimitotic Agents|antimitotic agents|mesh-ancestor
110896224|NCT05754853|Mitosis Modulators|mitosis modulators|mesh-ancestor
110896225|NCT05754853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110896226|NCT05754853|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110896227|NCT05754853|Antimetabolites|antimetabolites|mesh-ancestor
110896228|NCT05754853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110896229|NCT05754853|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110896230|NCT05754853|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110896231|NCT05747625|Panitumumab|panitumumab|mesh-list
110896232|NCT05747625|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110896233|NCT05747625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110896234|NCT05742347|Protective Agents|protective agents|mesh-list
110896235|NCT05742347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110896236|NCT05729932|Analgesics, Opioid|analgesics, opioid|mesh-list
110896237|NCT05729932|Narcotics|narcotics|mesh-ancestor
110896238|NCT05729932|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110896239|NCT05729932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110896240|NCT05729932|Analgesics|analgesics|mesh-ancestor
110896241|NCT05729932|Sensory System Agents|sensory system agents|mesh-ancestor
110896242|NCT05729932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110896243|NCT05705427|Tenofovir|tenofovir|mesh-list
110896244|NCT05705427|Vaccines|vaccines|mesh-list
110896245|NCT05705427|Immunologic Factors|immunologic factors|mesh-ancestor
110896246|NCT05705427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110896247|NCT05705427|Antiviral Agents|antiviral agents|mesh-ancestor
110896248|NCT05705427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110896249|NCT05705427|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110896250|NCT05705427|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110896251|NCT05705427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110896252|NCT05705427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110896253|NCT05705427|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110896254|NCT05705427|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110896255|NCT05692869|Propranolol|propranolol|mesh-list
110896256|NCT05692869|Pseudoephedrine|pseudoephedrine|mesh-list
110896257|NCT05692869|Ephedrine|ephedrine|mesh-list
110896258|NCT05692869|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110896259|NCT05692869|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110896260|NCT05692869|Adrenergic Agents|adrenergic agents|mesh-ancestor
110896261|NCT05692869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110896262|NCT05692869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110896263|NCT05692869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110896264|NCT05692869|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110896265|NCT05692869|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110896266|NCT05692869|Vasodilator Agents|vasodilator agents|mesh-ancestor
110896267|NCT05692869|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110896268|NCT05692869|Autonomic Agents|autonomic agents|mesh-ancestor
110896269|NCT05692869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110896270|NCT05692869|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110896271|NCT05692869|Respiratory System Agents|respiratory system agents|mesh-ancestor
110896272|NCT05692869|Nasal Decongestants|nasal decongestants|mesh-ancestor
110896273|NCT05692869|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110896274|NCT05692869|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110896275|NCT05692869|Sympathomimetics|sympathomimetics|mesh-ancestor
110896276|NCT05655468|Dronedarone|dronedarone|mesh-list
110896277|NCT05655468|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110896278|NCT05644353|Mirikizumab|mirikizumab|mesh-list
110896279|NCT05644353|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110896280|NCT05644353|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110896281|NCT05644353|Analgesics|analgesics|mesh-ancestor
110896282|NCT05644353|Sensory System Agents|sensory system agents|mesh-ancestor
110896283|NCT05644353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110896284|NCT05644353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110896285|NCT05644353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110896286|NCT05644353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110896287|NCT05644353|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110896288|NCT05644353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110896289|NCT05563389|Atorvastatin|atorvastatin|mesh-list
110896290|NCT05563389|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110896291|NCT05563389|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110896292|NCT05563389|Antimetabolites|antimetabolites|mesh-ancestor
110896293|NCT05563389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110896294|NCT05563389|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110896295|NCT05563389|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110896296|NCT05563389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110896298|NCT05548660|Sensory System Agents|sensory system agents|mesh-ancestor
110896299|NCT05548660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110896300|NCT05548660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110896301|NCT05539963|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110896302|NCT05539963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110896303|NCT05525273|Trametinib|trametinib|mesh-list
110896304|NCT05525273|Dabrafenib|dabrafenib|mesh-list
110896305|NCT05525273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110896306|NCT05525273|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110896307|NCT05525273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110896308|NCT05525273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110896309|NCT05511766|Allopurinol|allopurinol|mesh-list
110896310|NCT05511766|Atorvastatin|atorvastatin|mesh-list
110896311|NCT05511766|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110896312|NCT05511766|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110896313|NCT05511766|Antimetabolites|antimetabolites|mesh-ancestor
110896314|NCT05511766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110896315|NCT05511766|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110896316|NCT05511766|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110896317|NCT05511766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110896318|NCT05511766|Gout Suppressants|gout suppressants|mesh-ancestor
110896319|NCT05511766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110896320|NCT05511766|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110896321|NCT05511766|Antioxidants|antioxidants|mesh-ancestor
110896322|NCT05511766|Protective Agents|protective agents|mesh-ancestor
110896323|NCT05511766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110896324|NCT05476796|Trifluridine|trifluridine|mesh-list
110896325|NCT05476796|Oxaliplatin|oxaliplatin|mesh-list
110896326|NCT05476796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110896327|NCT05476796|Antimetabolites|antimetabolites|mesh-ancestor
110896328|NCT05476796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110896329|NCT05476796|Antiviral Agents|antiviral agents|mesh-ancestor
110896330|NCT05476796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110896331|NCT05466734|Cilostazol|cilostazol|mesh-list
110896332|NCT05466734|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110896333|NCT05466734|Autonomic Agents|autonomic agents|mesh-ancestor
110896334|NCT05466734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110896335|NCT05466734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110896336|NCT05466734|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110896337|NCT05466734|Respiratory System Agents|respiratory system agents|mesh-ancestor
110896338|NCT05466734|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110896339|NCT05466734|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110896340|NCT05466734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110896341|NCT05466734|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110896342|NCT05466734|Vasodilator Agents|vasodilator agents|mesh-ancestor
110896343|NCT05466734|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110896344|NCT05466734|Protective Agents|protective agents|mesh-ancestor
110896345|NCT05466734|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110896346|NCT05466734|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110896347|NCT05466734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110896349|NCT05420402|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110896350|NCT05420402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110896351|NCT05420402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110896352|NCT05420402|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110896353|NCT05420402|Anesthetics, General|anesthetics, general|mesh-ancestor
110896354|NCT05420402|Anesthetics|anesthetics|mesh-ancestor
110896355|NCT05417087|Vortioxetine|vortioxetine|mesh-list
110896356|NCT05417087|Antidepressive Agents|antidepressive agents|mesh-ancestor
110896357|NCT05417087|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110896358|NCT05417087|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110896359|NCT05417087|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110896360|NCT05417087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110896361|NCT05417087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110896362|NCT05417087|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110896363|NCT05417087|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110896365|NCT05417087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110896366|NCT05417087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110896367|NCT05417087|Serotonin Agents|serotonin agents|mesh-ancestor
110896368|NCT05417087|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110896369|NCT05417087|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110896370|NCT05417087|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110896371|NCT05417087|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110896372|NCT05416957|Vortioxetine|vortioxetine|mesh-list
110896373|NCT05416957|Antidepressive Agents|antidepressive agents|mesh-ancestor
110896374|NCT05416957|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110896375|NCT05416957|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110896376|NCT05416957|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110896377|NCT05416957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110896378|NCT05416957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110896379|NCT05416957|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110896380|NCT05416957|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110202202|NCT00082836|Rituximab|rituximab|mesh-list
110896381|NCT05416957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110896382|NCT05416957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110896383|NCT05416957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110896384|NCT05416957|Serotonin Agents|serotonin agents|mesh-ancestor
110896385|NCT05416957|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110896386|NCT05416957|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110896387|NCT05416957|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110896388|NCT05416957|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110896389|NCT05416762|Vortioxetine|vortioxetine|mesh-list
110896390|NCT05416762|Antidepressive Agents|antidepressive agents|mesh-ancestor
110896391|NCT05416762|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110896392|NCT05416762|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110896393|NCT05416762|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110896394|NCT05416762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110896395|NCT05416762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110896396|NCT05416762|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110896397|NCT05416762|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110896398|NCT05416762|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110896399|NCT05416762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110896400|NCT05416762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110896401|NCT05416762|Serotonin Agents|serotonin agents|mesh-ancestor
110896402|NCT05416762|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110896403|NCT05416762|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110896404|NCT05416762|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110896405|NCT05416762|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110896406|NCT05383742|Rifampin|rifampin|mesh-list
110896407|NCT05383742|Isoniazid|isoniazid|mesh-list
110896408|NCT05383742|Linezolid|linezolid|mesh-list
110896409|NCT05383742|Pyrazinamide|pyrazinamide|mesh-list
110896410|NCT05383742|Ethambutol|ethambutol|mesh-list
110896411|NCT05383742|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110896412|NCT05383742|Antitubercular Agents|antitubercular agents|mesh-ancestor
110896413|NCT05383742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110896414|NCT05383742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110896415|NCT05383742|Leprostatic Agents|leprostatic agents|mesh-ancestor
110896416|NCT05383742|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110896417|NCT05383742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110896418|NCT05383742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110896419|NCT05383742|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110896420|NCT05383742|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110896421|NCT05383742|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110896422|NCT05383742|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110896423|NCT05383742|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110896424|NCT05383742|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110896425|NCT05383742|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
110896426|NCT05383742|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110896427|NCT05383742|Antimetabolites|antimetabolites|mesh-ancestor
110896428|NCT05383742|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110896429|NCT05383742|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110896430|NCT05365802|FAPI-46|fapi-46|mesh-list
110896431|NCT05365802|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110896432|NCT05365802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110896433|NCT05358639|Olaparib|olaparib|mesh-list
110896434|NCT05358639|Navitoclax|navitoclax|mesh-list
110896435|NCT05358639|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110896437|NCT05358639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110896438|NCT05358639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110896439|NCT05330871|Vaccines|vaccines|mesh-list
110896440|NCT05330871|Immunologic Factors|immunologic factors|mesh-ancestor
110896441|NCT05330871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110896442|NCT05327595|Midazolam|midazolam|mesh-list
110896443|NCT05327595|Atorvastatin|atorvastatin|mesh-list
110896444|NCT05327595|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110896445|NCT05327595|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110896446|NCT05327595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110896447|NCT05327595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110896448|NCT05327595|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110896449|NCT05327595|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110896450|NCT05327595|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110896451|NCT05327595|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110896452|NCT05327595|Anesthetics, General|anesthetics, general|mesh-ancestor
110896453|NCT05327595|Anesthetics|anesthetics|mesh-ancestor
110896454|NCT05327595|GABA Modulators|gaba modulators|mesh-ancestor
110896455|NCT05327595|GABA Agents|gaba agents|mesh-ancestor
110896456|NCT05327595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110896457|NCT05327595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110896458|NCT05327595|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110896459|NCT05327595|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110896460|NCT05327595|Antimetabolites|antimetabolites|mesh-ancestor
110896461|NCT05327595|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110896462|NCT05327595|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110896463|NCT05327595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110896464|NCT05314153|Brexanolone|brexanolone|mesh-list
110896465|NCT05314153|Neurosteroids|neurosteroids|mesh-ancestor
110896466|NCT05314153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110896467|NCT05314153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110896468|NCT05314153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110896469|NCT05314153|GABA Modulators|gaba modulators|mesh-ancestor
110896470|NCT05314153|GABA Agents|gaba agents|mesh-ancestor
110896471|NCT05283408|Dexmedetomidine|dexmedetomidine|mesh-list
110896473|NCT05283408|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110896474|NCT05283408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110896475|NCT05283408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110896476|NCT05283408|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110896477|NCT05283408|Analgesics|analgesics|mesh-ancestor
110896478|NCT05283408|Sensory System Agents|sensory system agents|mesh-ancestor
110896479|NCT05283408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110896480|NCT05283408|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110896481|NCT05283408|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110896482|NCT05283408|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110896483|NCT05283408|Adrenergic Agents|adrenergic agents|mesh-ancestor
110896484|NCT05283408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110896485|NCT05283408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110896486|NCT05283408|Antidepressive Agents|antidepressive agents|mesh-ancestor
110896487|NCT05283408|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110896488|NCT05275400|Insulin|insulin|mesh-list
110896489|NCT05275400|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110896490|NCT05275400|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110896491|NCT05275400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110896492|NCT05240755|Cannabidiol|cannabidiol|mesh-list
110896493|NCT05240755|Anticonvulsants|anticonvulsants|mesh-ancestor
110896494|NCT05229315|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
110896495|NCT05229315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110896496|NCT05229315|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110896497|NCT05229315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110896498|NCT05213143|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
110896499|NCT05213143|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110896500|NCT05213143|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110896501|NCT05213143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110896502|NCT05213143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110896503|NCT05213143|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110896504|NCT05213143|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
110896505|NCT05213143|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110896506|NCT05213143|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110896507|NCT05213143|Adrenergic Agents|adrenergic agents|mesh-ancestor
110613976|NCT00890253|Glucocorticoids|glucocorticoids|mesh-ancestor
110896508|NCT05213143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110896509|NCT05213143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110896510|NCT05213143|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110896511|NCT05213143|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110896512|NCT05213143|Serotonin Agents|serotonin agents|mesh-ancestor
110896513|NCT05213143|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110896514|NCT05213143|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110896515|NCT05213143|Dopamine Agents|dopamine agents|mesh-ancestor
110896516|NCT05208931|Mitogens|mitogens|mesh-list
110896517|NCT05208931|Endothelial Growth Factors|endothelial growth factors|mesh-list
110896518|NCT05208931|Mitosis Modulators|mitosis modulators|mesh-ancestor
110896519|NCT05208931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110896520|NCT05208931|Growth Substances|growth substances|mesh-ancestor
110896521|NCT05208931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110896522|NCT05191862|Cilostazol|cilostazol|mesh-list
110896523|NCT05191862|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110896524|NCT05191862|Autonomic Agents|autonomic agents|mesh-ancestor
110896525|NCT05191862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110896526|NCT05191862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110896527|NCT05191862|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110896528|NCT05191862|Respiratory System Agents|respiratory system agents|mesh-ancestor
110896529|NCT05191862|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110896530|NCT05191862|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110896531|NCT05191862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110896532|NCT05191862|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110896533|NCT05191862|Vasodilator Agents|vasodilator agents|mesh-ancestor
110896534|NCT05191862|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110896535|NCT05191862|Protective Agents|protective agents|mesh-ancestor
110896536|NCT05191862|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110896537|NCT05191862|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110896538|NCT05191862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110896539|NCT05189704|Analgesics, Opioid|analgesics, opioid|mesh-list
110896540|NCT05189704|Narcotics|narcotics|mesh-ancestor
110896541|NCT05189704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110896542|NCT05189704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110896543|NCT05189704|Analgesics|analgesics|mesh-ancestor
110896544|NCT05189704|Sensory System Agents|sensory system agents|mesh-ancestor
110896545|NCT05189704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110896546|NCT05179421|Oxytocin|oxytocin|mesh-list
110896547|NCT05179421|Oxytocics|oxytocics|mesh-ancestor
110896548|NCT05179421|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110896549|NCT05179421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110896550|NCT05100160|Gabapentin|gabapentin|mesh-list
110896551|NCT05100160|Analgesics|analgesics|mesh-ancestor
110896552|NCT05100160|Sensory System Agents|sensory system agents|mesh-ancestor
110896553|NCT05100160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110896554|NCT05100160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110896555|NCT05100160|Anticonvulsants|anticonvulsants|mesh-ancestor
110896556|NCT05100160|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110896557|NCT05100160|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110896558|NCT05100160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110896559|NCT05100160|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110896560|NCT05100160|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110896561|NCT05100160|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110896562|NCT05100160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110896563|NCT05100160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110896564|NCT05100160|Antimanic Agents|antimanic agents|mesh-ancestor
110896565|NCT05052931|Paclitaxel|paclitaxel|mesh-list
110896566|NCT05052931|Oxaliplatin|oxaliplatin|mesh-list
110896567|NCT05052931|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110896568|NCT05052931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110896569|NCT05052931|Tubulin Modulators|tubulin modulators|mesh-ancestor
110896570|NCT05052931|Antimitotic Agents|antimitotic agents|mesh-ancestor
110896571|NCT05052931|Mitosis Modulators|mitosis modulators|mesh-ancestor
110896572|NCT05052931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110896573|NCT05052229|Nitric Oxide|nitric oxide|mesh-list
110896574|NCT05052229|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110896575|NCT05052229|Autonomic Agents|autonomic agents|mesh-ancestor
110896576|NCT05052229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110896577|NCT05052229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110896578|NCT05052229|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110896579|NCT05052229|Respiratory System Agents|respiratory system agents|mesh-ancestor
110896580|NCT05052229|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110896581|NCT05052229|Antioxidants|antioxidants|mesh-ancestor
110614052|NCT00966706|Antimetabolites|antimetabolites|mesh-ancestor
110896582|NCT05052229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110896583|NCT05052229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110896584|NCT05052229|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
110896585|NCT05052229|Vasodilator Agents|vasodilator agents|mesh-ancestor
110896586|NCT05052229|Gasotransmitters|gasotransmitters|mesh-ancestor
110896587|NCT05052229|Protective Agents|protective agents|mesh-ancestor
110896588|NCT05048212|Nivolumab|nivolumab|mesh-list
110896589|NCT05048212|Ipilimumab|ipilimumab|mesh-list
110896590|NCT05048212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110896591|NCT05048212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110896592|NCT05048212|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110896593|NCT05048212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110896594|NCT05037500|Decitabine|decitabine|mesh-list
110896595|NCT05037500|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
110896596|NCT05037500|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110896597|NCT05037500|Antimetabolites|antimetabolites|mesh-ancestor
110896598|NCT05037500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110896599|NCT05037500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110896600|NCT05037500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110896601|NCT05020769|Osimertinib|osimertinib|mesh-list
110896602|NCT05020769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110896603|NCT05020769|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110896604|NCT05020769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110896605|NCT05020769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110896606|NCT05002738|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110896607|NCT05002738|Desogestrel|desogestrel|mesh-list
110896608|NCT05002738|Estradiol|estradiol|mesh-list
110896609|NCT05002738|Estrogens|estrogens|mesh-ancestor
110896610|NCT05002738|Hormones|hormones|mesh-ancestor
110896611|NCT05002738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110896612|NCT05002738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110896613|NCT05002738|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110896614|NCT05002738|Contraceptive Agents|contraceptive agents|mesh-ancestor
110896615|NCT05002738|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110896616|NCT05002738|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110896617|NCT05002738|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110896618|NCT05002738|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110896619|NCT05002738|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110896620|NCT05002738|Progestins|progestins|mesh-ancestor
110896621|NCT04990284|Levodopa|levodopa|mesh-list
110896622|NCT04990284|Opicapone|opicapone|mesh-list
110896623|NCT04990284|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110896624|NCT04990284|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110896625|NCT04990284|Dopamine Agents|dopamine agents|mesh-ancestor
110896626|NCT04990284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110896627|NCT04990284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110896628|NCT04990284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110896629|NCT04990284|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
110896630|NCT04990284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110896631|NCT04955158|Dexmedetomidine|dexmedetomidine|mesh-list
110896632|NCT04955158|Ketamine|ketamine|mesh-list
110261042|NCT00147563|Eplerenone|eplerenone|mesh-list
110896633|NCT04955158|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110896634|NCT04955158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110896635|NCT04955158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110896636|NCT04955158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110896637|NCT04955158|Analgesics|analgesics|mesh-ancestor
110896638|NCT04955158|Sensory System Agents|sensory system agents|mesh-ancestor
110896639|NCT04955158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110896640|NCT04955158|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110896641|NCT04955158|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110896642|NCT04955158|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110896643|NCT04955158|Adrenergic Agents|adrenergic agents|mesh-ancestor
110896644|NCT04955158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110896645|NCT04955158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110896646|NCT04955158|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110896647|NCT04955158|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110896648|NCT04955158|Anesthetics, General|anesthetics, general|mesh-ancestor
110896649|NCT04955158|Anesthetics|anesthetics|mesh-ancestor
110896650|NCT04955158|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110896651|NCT04955158|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110896652|NCT04928391|Dexmedetomidine|dexmedetomidine|mesh-list
110896654|NCT04928391|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110896655|NCT04928391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110896656|NCT04928391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110896657|NCT04928391|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110896658|NCT04928391|Analgesics|analgesics|mesh-ancestor
110896659|NCT04928391|Sensory System Agents|sensory system agents|mesh-ancestor
110896660|NCT04928391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110896661|NCT04928391|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110896662|NCT04928391|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110896663|NCT04928391|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110896664|NCT04928391|Adrenergic Agents|adrenergic agents|mesh-ancestor
110896665|NCT04928391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110896666|NCT04928391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110896667|NCT04928391|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110896668|NCT04928391|Narcotics|narcotics|mesh-ancestor
110896669|NCT04928352|Bupivacaine|bupivacaine|mesh-list
110896670|NCT04928352|Anesthetics, Local|anesthetics, local|mesh-ancestor
110896671|NCT04928352|Anesthetics|anesthetics|mesh-ancestor
110896672|NCT04928352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110896673|NCT04928352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110896674|NCT04928352|Sensory System Agents|sensory system agents|mesh-ancestor
110896675|NCT04928352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110896676|NCT04928300|Dexmedetomidine|dexmedetomidine|mesh-list
110896677|NCT04928300|Ketamine|ketamine|mesh-list
110896678|NCT04928300|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110896679|NCT04928300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110896680|NCT04928300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110896681|NCT04928300|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110896682|NCT04928300|Analgesics|analgesics|mesh-ancestor
110896683|NCT04928300|Sensory System Agents|sensory system agents|mesh-ancestor
110896684|NCT04928300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110896685|NCT04928300|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110896686|NCT04928300|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110896687|NCT04928300|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110896688|NCT04928300|Adrenergic Agents|adrenergic agents|mesh-ancestor
110896689|NCT04928300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110896690|NCT04928300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110896691|NCT04928300|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110923473|NCT04500847|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110896692|NCT04928300|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110896693|NCT04928300|Anesthetics, General|anesthetics, general|mesh-ancestor
110896694|NCT04928300|Anesthetics|anesthetics|mesh-ancestor
110896695|NCT04928300|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110896696|NCT04928300|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110896697|NCT04910464|Tranexamic Acid|tranexamic acid|mesh-list
110896698|NCT04910464|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110896699|NCT04910464|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110896700|NCT04910464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110896701|NCT04910464|Hemostatics|hemostatics|mesh-ancestor
110896702|NCT04910464|Coagulants|coagulants|mesh-ancestor
110896703|NCT04905901|Tranexamic Acid|tranexamic acid|mesh-list
110896704|NCT04905901|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110896705|NCT04905901|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110896706|NCT04905901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110896707|NCT04905901|Hemostatics|hemostatics|mesh-ancestor
110896708|NCT04905901|Coagulants|coagulants|mesh-ancestor
110896709|NCT04901988|Nivolumab|nivolumab|mesh-list
110896710|NCT04901988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110896711|NCT04901988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110896712|NCT04901988|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110896713|NCT04901988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110896714|NCT04899687|Dextromethorphan|dextromethorphan|mesh-list
110896715|NCT04899687|Fluoxetine|fluoxetine|mesh-list
110896716|NCT04899687|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110896717|NCT04899687|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110896718|NCT04899687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110896719|NCT04899687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110896720|NCT04899687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110896721|NCT04899687|Serotonin Agents|serotonin agents|mesh-ancestor
110896722|NCT04899687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110924814|NCT03098680|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110896723|NCT04899687|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110896724|NCT04899687|Antidepressive Agents|antidepressive agents|mesh-ancestor
110896725|NCT04899687|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110896726|NCT04899687|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110896727|NCT04899687|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110896728|NCT04899687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110896729|NCT04899687|Antitussive Agents|antitussive agents|mesh-ancestor
110896730|NCT04899687|Respiratory System Agents|respiratory system agents|mesh-ancestor
110896731|NCT04899687|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110896732|NCT04899687|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110896733|NCT04823845|Adapalene|adapalene|mesh-list
110896734|NCT04823845|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110896735|NCT04823845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110896736|NCT04823845|Analgesics|analgesics|mesh-ancestor
110896737|NCT04823845|Sensory System Agents|sensory system agents|mesh-ancestor
110896738|NCT04823845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110896739|NCT04823845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110896740|NCT04823845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110896741|NCT04823845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110896742|NCT04823845|Dermatologic Agents|dermatologic agents|mesh-ancestor
110896743|NCT04792749|Metformin|metformin|mesh-list
110896744|NCT04792749|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110896745|NCT04792749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110896746|NCT04789070|Sirolimus|sirolimus|mesh-list
110896747|NCT04789070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110896748|NCT04789070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110923488|NCT04447989|Sildenafil Citrate|sildenafil citrate|mesh-list
110896749|NCT04789070|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110896750|NCT04789070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110896751|NCT04789070|Antifungal Agents|antifungal agents|mesh-ancestor
110896752|NCT04789070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110896753|NCT04789070|Immunologic Factors|immunologic factors|mesh-ancestor
110896754|NCT04789070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110896755|NCT04756427|Citric Acid|citric acid|mesh-list
110896756|NCT04756427|Sodium Citrate|sodium citrate|mesh-list
110896757|NCT04756427|Anticoagulants|anticoagulants|mesh-list
110896758|NCT04756427|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110896759|NCT04756427|Chelating Agents|chelating agents|mesh-ancestor
110896760|NCT04756427|Sequestering Agents|sequestering agents|mesh-ancestor
110896761|NCT04756427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110896762|NCT04722601|Azacitidine|azacitidine|mesh-list
110896763|NCT04722601|Venetoclax|venetoclax|mesh-list
110896764|NCT04722601|Obinutuzumab|obinutuzumab|mesh-list
110896766|NCT04722601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110896767|NCT04722601|Antimetabolites|antimetabolites|mesh-ancestor
110896768|NCT04722601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110896769|NCT04722601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110896770|NCT04722601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110896771|NCT04722601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110896772|NCT04692844|Propranolol|propranolol|mesh-list
110896773|NCT04692844|Primidone|primidone|mesh-list
110896774|NCT04692844|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110896775|NCT04692844|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110896776|NCT04692844|Adrenergic Agents|adrenergic agents|mesh-ancestor
110896777|NCT04692844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110896778|NCT04692844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110896779|NCT04692844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110896780|NCT04692844|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110896781|NCT04692844|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110896782|NCT04692844|Vasodilator Agents|vasodilator agents|mesh-ancestor
110896783|NCT04692844|Anticonvulsants|anticonvulsants|mesh-ancestor
110896784|NCT04692844|GABA Modulators|gaba modulators|mesh-ancestor
110896785|NCT04692844|GABA Agents|gaba agents|mesh-ancestor
110896786|NCT04657003|Tirzepatide|tirzepatide|mesh-list
110896787|NCT04657003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110896788|NCT04657003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110896789|NCT04657003|Incretins|incretins|mesh-ancestor
110896790|NCT04657003|Hormones|hormones|mesh-ancestor
110896791|NCT04657003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110896792|NCT04624906|Rituximab|rituximab|mesh-list
110224375|NCT06002854|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110896793|NCT04624906|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110896795|NCT04624906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110896796|NCT04624906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110896797|NCT04624906|Immunologic Factors|immunologic factors|mesh-ancestor
110896798|NCT04624906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110896799|NCT04624906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110896800|NCT04624906|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110896801|NCT04624906|Alkylating Agents|alkylating agents|mesh-ancestor
110896802|NCT04624906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110614277|NCT05208190|Clozapine|clozapine|mesh-list
110896803|NCT04610320|Daratumumab|daratumumab|mesh-list
110896804|NCT04610320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110896805|NCT04546399|Calcium, Dietary|calcium, dietary|mesh-list
110896806|NCT04546399|Leucovorin|leucovorin|mesh-list
110896807|NCT04546399|Folic Acid|folic acid|mesh-list
110896808|NCT04546399|Cytarabine|cytarabine|mesh-list
110896809|NCT04546399|Dexamethasone|dexamethasone|mesh-list
110896810|NCT04546399|Dexamethasone acetate|dexamethasone acetate|mesh-list
110896811|NCT04546399|Hydrocortisone|hydrocortisone|mesh-list
110896812|NCT04546399|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
110896813|NCT04546399|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
110224381|NCT06002659|Immunologic Factors|immunologic factors|mesh-ancestor
110896814|NCT04546399|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
110896815|NCT04546399|Cyclophosphamide|cyclophosphamide|mesh-list
110896816|NCT04546399|Nivolumab|nivolumab|mesh-list
110896817|NCT04546399|Methotrexate|methotrexate|mesh-list
110896818|NCT04546399|Etoposide|etoposide|mesh-list
110896819|NCT04546399|Vincristine|vincristine|mesh-list
110896820|NCT04546399|Etoposide phosphate|etoposide phosphate|mesh-list
110896821|NCT04546399|Asparaginase|asparaginase|mesh-list
110896822|NCT04546399|Mercaptopurine|mercaptopurine|mesh-list
110896823|NCT04546399|Podophyllotoxin|podophyllotoxin|mesh-list
110896824|NCT04546399|Pegaspargase|pegaspargase|mesh-list
110896825|NCT04546399|Thioguanine|thioguanine|mesh-list
110896826|NCT04546399|Blinatumomab|blinatumomab|mesh-list
110924815|NCT03098368|Rotigotine|rotigotine|mesh-list
110896827|NCT04546399|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110896828|NCT04546399|Muromonab-CD3|muromonab-cd3|mesh-list
110896829|NCT04546399|Antibodies|antibodies|mesh-list
110896830|NCT04546399|Immunoglobulins|immunoglobulins|mesh-list
110896831|NCT04546399|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110896832|NCT04546399|Antibodies, Bispecific|antibodies, bispecific|mesh-list
110896833|NCT04546399|BB 1101|bb 1101|mesh-list
110896834|NCT04546399|Calcium|calcium|mesh-list
110896835|NCT04546399|2-Aminopurine|2-aminopurine|mesh-list
110896836|NCT04546399|Levoleucovorin|levoleucovorin|mesh-list
110896837|NCT04546399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110896838|NCT04546399|Immunologic Factors|immunologic factors|mesh-ancestor
110896839|NCT04546399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110896840|NCT04546399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110896841|NCT04546399|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110896842|NCT04546399|Alkylating Agents|alkylating agents|mesh-ancestor
110896843|NCT04546399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110896844|NCT04546399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110896845|NCT04546399|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110896846|NCT04546399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110896847|NCT04546399|Antiemetics|antiemetics|mesh-ancestor
110896848|NCT04546399|Autonomic Agents|autonomic agents|mesh-ancestor
110896849|NCT04546399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110896850|NCT04546399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110896851|NCT04546399|Glucocorticoids|glucocorticoids|mesh-ancestor
110896852|NCT04546399|Hormones|hormones|mesh-ancestor
110896853|NCT04546399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110896854|NCT04546399|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110896855|NCT04546399|Protease Inhibitors|protease inhibitors|mesh-ancestor
110896856|NCT04546399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110896857|NCT04546399|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110896858|NCT04546399|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110896859|NCT04546399|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110896860|NCT04546399|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110896861|NCT04546399|Abortifacient Agents|abortifacient agents|mesh-ancestor
110896862|NCT04546399|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110896863|NCT04546399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110896864|NCT04546399|Antimetabolites|antimetabolites|mesh-ancestor
110896865|NCT04546399|Dermatologic Agents|dermatologic agents|mesh-ancestor
110896866|NCT04546399|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110896867|NCT04546399|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110896868|NCT04546399|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110896869|NCT04546399|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110896870|NCT04546399|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110896871|NCT04546399|Antiviral Agents|antiviral agents|mesh-ancestor
110896872|NCT04546399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110896873|NCT04546399|Antidotes|antidotes|mesh-ancestor
110896874|NCT04546399|Protective Agents|protective agents|mesh-ancestor
110923514|NCT04336189|Artenimol|artenimol|mesh-list
110896875|NCT04546399|Vitamin B Complex|vitamin b complex|mesh-ancestor
110896877|NCT04546399|Micronutrients|micronutrients|mesh-ancestor
110896878|NCT04546399|Tubulin Modulators|tubulin modulators|mesh-ancestor
110614351|NCT00975052|Metformin|metformin|mesh-list
110896879|NCT04546399|Antimitotic Agents|antimitotic agents|mesh-ancestor
110896880|NCT04546399|Mitosis Modulators|mitosis modulators|mesh-ancestor
110896881|NCT04546399|Hematinics|hematinics|mesh-ancestor
110896882|NCT04546399|Keratolytic Agents|keratolytic agents|mesh-ancestor
110896883|NCT04540120|Dapansutrile|dapansutrile|mesh-list
110896884|NCT04540120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110896885|NCT04480086|Navitoclax|navitoclax|mesh-list
110896886|NCT04480086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110896887|NCT04476212|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110896888|NCT04476212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110896889|NCT04432688|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
110896890|NCT04432688|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110896891|NCT04432688|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110896892|NCT04432688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110896893|NCT04432688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110896894|NCT04432688|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110896895|NCT04432688|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
110896896|NCT04432688|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110896897|NCT04432688|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110896898|NCT04432688|Adrenergic Agents|adrenergic agents|mesh-ancestor
110896899|NCT04432688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110896900|NCT04432688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110896901|NCT04432688|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110896902|NCT04432688|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110896903|NCT04432688|Serotonin Agents|serotonin agents|mesh-ancestor
110896904|NCT04432688|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110896905|NCT04432688|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110896906|NCT04432688|Dopamine Agents|dopamine agents|mesh-ancestor
110896907|NCT04426825|Bevacizumab|bevacizumab|mesh-list
110896908|NCT04426825|Atezolizumab|atezolizumab|mesh-list
110896909|NCT04426825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110896910|NCT04426825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110896911|NCT04426825|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110896912|NCT04426825|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110224483|NCT06001619|Tamsulosin|tamsulosin|mesh-list
110896913|NCT04426825|Growth Substances|growth substances|mesh-ancestor
110896914|NCT04426825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110896915|NCT04426825|Growth Inhibitors|growth inhibitors|mesh-ancestor
110896916|NCT04426825|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110896917|NCT04426825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110896918|NCT04418479|Aspirin|aspirin|mesh-list
110896919|NCT04418479|Clopidogrel|clopidogrel|mesh-list
110896920|NCT04418479|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110896921|NCT04418479|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110896922|NCT04418479|Analgesics|analgesics|mesh-ancestor
110896923|NCT04418479|Sensory System Agents|sensory system agents|mesh-ancestor
110896924|NCT04418479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110896925|NCT04418479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110896926|NCT04418479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110896927|NCT04418479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110896928|NCT04418479|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110896930|NCT04418479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110896931|NCT04418479|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110896932|NCT04418479|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110896933|NCT04418479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110896934|NCT04418479|Antipyretics|antipyretics|mesh-ancestor
110896935|NCT04418479|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110896936|NCT04418479|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110896937|NCT04418479|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110896938|NCT04418479|Purinergic Agents|purinergic agents|mesh-ancestor
110896939|NCT04418479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110896940|NCT04417998|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110896941|NCT04417998|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110896942|NCT04417998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110896943|NCT04408508|Amoxicillin|amoxicillin|mesh-list
110896944|NCT04408508|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110896945|NCT04408508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110896946|NCT04262206|Atorvastatin|atorvastatin|mesh-list
110896947|NCT04262206|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110896948|NCT04262206|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110896949|NCT04262206|Antimetabolites|antimetabolites|mesh-ancestor
110896950|NCT04262206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110896951|NCT04262206|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110896952|NCT04262206|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110896953|NCT04262206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110896954|NCT04181515|Hydrocortisone|hydrocortisone|mesh-list
110896955|NCT04181515|Yohimbine|yohimbine|mesh-list
110896956|NCT04181515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110896957|NCT04181515|Mydriatics|mydriatics|mesh-ancestor
110896958|NCT04181515|Autonomic Agents|autonomic agents|mesh-ancestor
110896959|NCT04181515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110896960|NCT04181515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110896961|NCT04181515|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
110896962|NCT04181515|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110896963|NCT04181515|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110896964|NCT04181515|Adrenergic Agents|adrenergic agents|mesh-ancestor
110896965|NCT04181515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110896966|NCT04181515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110896967|NCT04181515|Urological Agents|urological agents|mesh-ancestor
110896968|NCT04180969|Hydrocortisone|hydrocortisone|mesh-list
110896969|NCT04180969|Yohimbine|yohimbine|mesh-list
110896970|NCT04180969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110896971|NCT04180969|Mydriatics|mydriatics|mesh-ancestor
110896972|NCT04180969|Autonomic Agents|autonomic agents|mesh-ancestor
110896973|NCT04180969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110896974|NCT04180969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110896975|NCT04180969|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
110896976|NCT04180969|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110896977|NCT04180969|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110896978|NCT04180969|Adrenergic Agents|adrenergic agents|mesh-ancestor
110896979|NCT04180969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110896980|NCT04180969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110896981|NCT04180969|Urological Agents|urological agents|mesh-ancestor
110896982|NCT04123470|Atezolizumab|atezolizumab|mesh-list
110896983|NCT04123470|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110896984|NCT04123470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110896985|NCT04123470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110896986|NCT04123470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110896987|NCT04083495|Cyclophosphamide|cyclophosphamide|mesh-list
110896988|NCT04083495|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110896989|NCT04083495|Fludarabine|fludarabine|mesh-list
110896990|NCT04083495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110896991|NCT04083495|Immunologic Factors|immunologic factors|mesh-ancestor
110896992|NCT04083495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110896993|NCT04083495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110896994|NCT04083495|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110896995|NCT04083495|Alkylating Agents|alkylating agents|mesh-ancestor
110896996|NCT04083495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110896997|NCT04083495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110896998|NCT04083495|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110897000|NCT04082442|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
110897001|NCT04082442|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110897002|NCT04082442|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110897003|NCT04082442|Antimetabolites|antimetabolites|mesh-ancestor
110897004|NCT04082442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110897005|NCT04082442|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110897006|NCT04082442|Protease Inhibitors|protease inhibitors|mesh-ancestor
110897007|NCT04082442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110897008|NCT04082442|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110897009|NCT04080518|Dapagliflozin|dapagliflozin|mesh-list
110897010|NCT04080518|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110897011|NCT04080518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110897012|NCT04080518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110897013|NCT04080518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110897014|NCT04060108|Methamphetamine|methamphetamine|mesh-list
110897015|NCT04060108|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110897016|NCT04060108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110897017|NCT04060108|Sympathomimetics|sympathomimetics|mesh-ancestor
110897018|NCT04060108|Autonomic Agents|autonomic agents|mesh-ancestor
110897019|NCT04060108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110897020|NCT04060108|Dopamine Agents|dopamine agents|mesh-ancestor
110897021|NCT04060108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110897022|NCT04060108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110897023|NCT04060108|Adrenergic Agents|adrenergic agents|mesh-ancestor
110897024|NCT04060108|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110897025|NCT04060108|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110897026|NCT04060108|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110897027|NCT04060108|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110897028|NCT04017598|Iron|iron|mesh-list
110897029|NCT04017598|Trace Elements|trace elements|mesh-ancestor
110897030|NCT04017598|Micronutrients|micronutrients|mesh-ancestor
110614507|NCT04008316|Colchicine|colchicine|mesh-list
110897031|NCT04017598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110897033|NCT04014803|Clopidogrel|clopidogrel|mesh-list
110897034|NCT04014803|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
110897035|NCT04014803|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110897036|NCT04014803|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110897037|NCT04014803|Analgesics|analgesics|mesh-ancestor
110897038|NCT04014803|Sensory System Agents|sensory system agents|mesh-ancestor
110897039|NCT04014803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110897040|NCT04014803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110897041|NCT04014803|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110897042|NCT04014803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110897043|NCT04014803|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110897044|NCT04014803|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110897045|NCT04014803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110897046|NCT04014803|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110897047|NCT04014803|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110923561|NCT04231877|Tubulin Modulators|tubulin modulators|mesh-ancestor
110897048|NCT04014803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110897050|NCT04014803|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110897051|NCT04014803|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110897052|NCT04014803|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110897053|NCT04014803|Purinergic Agents|purinergic agents|mesh-ancestor
110897054|NCT04014803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110897055|NCT03980184|Guanfacine|guanfacine|mesh-list
110897056|NCT03980184|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110897057|NCT03980184|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110897058|NCT03980184|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110897059|NCT03980184|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110897060|NCT03980184|Adrenergic Agents|adrenergic agents|mesh-ancestor
110897061|NCT03980184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110897062|NCT03980184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110897063|NCT03980184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110897064|NCT03945903|Golimumab|golimumab|mesh-list
110897065|NCT03945903|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110897066|NCT03945903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110897067|NCT03945903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110897068|NCT03945903|Immunologic Factors|immunologic factors|mesh-ancestor
110897069|NCT03945903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110897081|NCT03943589|Immunoglobulins|immunoglobulins|mesh-list
110897082|NCT03943589|Immunoglobulin G|immunoglobulin g|mesh-list
110897083|NCT03943589|Immunologic Factors|immunologic factors|mesh-ancestor
110897084|NCT03943589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110897085|NCT03937219|Nivolumab|nivolumab|mesh-list
110897086|NCT03937219|Ipilimumab|ipilimumab|mesh-list
110897087|NCT03937219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110897088|NCT03937219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110897089|NCT03937219|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110897090|NCT03937219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110897091|NCT03934684|Dexamethasone|dexamethasone|mesh-list
110897092|NCT03934684|Dexamethasone acetate|dexamethasone acetate|mesh-list
110897093|NCT03934684|Lenalidomide|lenalidomide|mesh-list
110897094|NCT03934684|BB 1101|bb 1101|mesh-list
110897095|NCT03934684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110897096|NCT03934684|Antiemetics|antiemetics|mesh-ancestor
110897097|NCT03934684|Autonomic Agents|autonomic agents|mesh-ancestor
110897098|NCT03934684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110897099|NCT03934684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110897100|NCT03934684|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110897101|NCT03934684|Glucocorticoids|glucocorticoids|mesh-ancestor
110897102|NCT03934684|Hormones|hormones|mesh-ancestor
110897103|NCT03934684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110897104|NCT03934684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110897105|NCT03934684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110897106|NCT03934684|Protease Inhibitors|protease inhibitors|mesh-ancestor
110897107|NCT03934684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110897108|NCT03934684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110897109|NCT03934684|Immunologic Factors|immunologic factors|mesh-ancestor
110897110|NCT03934684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110897111|NCT03934684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110897112|NCT03934684|Growth Substances|growth substances|mesh-ancestor
110897113|NCT03934684|Growth Inhibitors|growth inhibitors|mesh-ancestor
110897114|NCT03873805|Vidarabine|vidarabine|mesh-list
110897115|NCT03873805|Cyclophosphamide|cyclophosphamide|mesh-list
110897116|NCT03873805|Fludarabine|fludarabine|mesh-list
110897117|NCT03873805|Fludarabine phosphate|fludarabine phosphate|mesh-list
110897118|NCT03873805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110897119|NCT03873805|Immunologic Factors|immunologic factors|mesh-ancestor
110897120|NCT03873805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110897121|NCT03873805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110897122|NCT03873805|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110897123|NCT03873805|Alkylating Agents|alkylating agents|mesh-ancestor
110897124|NCT03873805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110897125|NCT03873805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110897126|NCT03873805|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110897127|NCT03873805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110897128|NCT03873805|Antimetabolites|antimetabolites|mesh-ancestor
110897129|NCT03873805|Antiviral Agents|antiviral agents|mesh-ancestor
110897130|NCT03873805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110897132|NCT03869268|Ticagrelor|ticagrelor|mesh-list
110897133|NCT03869268|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110897134|NCT03869268|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110897135|NCT03869268|Analgesics|analgesics|mesh-ancestor
110897136|NCT03869268|Sensory System Agents|sensory system agents|mesh-ancestor
110897137|NCT03869268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110897138|NCT03869268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110897139|NCT03869268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110897140|NCT03869268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110897141|NCT03869268|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110897142|NCT03869268|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110897143|NCT03869268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110897144|NCT03869268|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110897145|NCT03869268|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110897146|NCT03869268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110897147|NCT03869268|Antipyretics|antipyretics|mesh-ancestor
110897148|NCT03869268|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110897149|NCT03869268|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110897150|NCT03869268|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110897151|NCT03869268|Purinergic Agents|purinergic agents|mesh-ancestor
110897152|NCT03869268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110897153|NCT03843463|Dexetimide|dexetimide|mesh-list
110897154|NCT03843463|Citalopram|citalopram|mesh-list
110897155|NCT03843463|Escitalopram|escitalopram|mesh-list
110897156|NCT03843463|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110897157|NCT03843463|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110897158|NCT03843463|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110897159|NCT03843463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110897160|NCT03843463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110897161|NCT03843463|Serotonin Agents|serotonin agents|mesh-ancestor
110897162|NCT03843463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110897163|NCT03843463|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110897164|NCT03843463|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110897165|NCT03843463|Parasympatholytics|parasympatholytics|mesh-ancestor
110897166|NCT03843463|Autonomic Agents|autonomic agents|mesh-ancestor
110897167|NCT03843463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110897168|NCT03843463|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110897169|NCT03843463|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110897170|NCT03843463|Cholinergic Agents|cholinergic agents|mesh-ancestor
110897171|NCT03843463|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110897172|NCT03843463|Antidepressive Agents|antidepressive agents|mesh-ancestor
110897173|NCT03843463|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110897174|NCT03660930|Sirolimus|sirolimus|mesh-list
110897175|NCT03660930|Temsirolimus|temsirolimus|mesh-list
110897176|NCT03660930|MTOR Inhibitors|mtor inhibitors|mesh-list
110897177|NCT03660930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110897178|NCT03660930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110202484|NCT00050531|Antiviral Agents|antiviral agents|mesh-ancestor
110897179|NCT03660930|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110897181|NCT03660930|Antifungal Agents|antifungal agents|mesh-ancestor
110897182|NCT03660930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110897183|NCT03660930|Immunologic Factors|immunologic factors|mesh-ancestor
110897184|NCT03660930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110224506|NCT06001385|Mycophenolic Acid|mycophenolic acid|mesh-list
110897185|NCT03660930|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110897186|NCT03660930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110897187|NCT03660930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110897188|NCT03643796|Dexmedetomidine|dexmedetomidine|mesh-list
110897189|NCT03643796|Ketamine|ketamine|mesh-list
110897190|NCT03643796|Remifentanil|remifentanil|mesh-list
110897191|NCT03643796|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110897192|NCT03643796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110897193|NCT03643796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110897194|NCT03643796|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110897195|NCT03643796|Analgesics|analgesics|mesh-ancestor
110897196|NCT03643796|Sensory System Agents|sensory system agents|mesh-ancestor
110897197|NCT03643796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110897198|NCT03643796|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110897199|NCT03643796|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110897200|NCT03643796|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110897201|NCT03643796|Adrenergic Agents|adrenergic agents|mesh-ancestor
110897202|NCT03643796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110897203|NCT03643796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110897204|NCT03643796|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110897205|NCT03643796|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110897206|NCT03643796|Anesthetics, General|anesthetics, general|mesh-ancestor
110897207|NCT03643796|Anesthetics|anesthetics|mesh-ancestor
110897208|NCT03643796|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110897209|NCT03643796|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110897210|NCT03643796|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110897211|NCT03643796|Narcotics|narcotics|mesh-ancestor
110897212|NCT03623854|Nivolumab|nivolumab|mesh-list
110897213|NCT03623854|Relatlimab|relatlimab|mesh-list
110897214|NCT03623854|Immunoglobulins|immunoglobulins|mesh-list
110897215|NCT03623854|Immunoglobulin G|immunoglobulin g|mesh-list
110897216|NCT03623854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110897217|NCT03623854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110897218|NCT03623854|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110897219|NCT03623854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110897220|NCT03623854|Immunologic Factors|immunologic factors|mesh-ancestor
110897221|NCT03623854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110897222|NCT03584334|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110897223|NCT03584334|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110897224|NCT03584334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110897225|NCT03530215|Antineoplastic Agents|antineoplastic agents|mesh-list
110897226|NCT03530215|Immunomodulating Agents|immunomodulating agents|mesh-list
110897227|NCT03530215|Immunologic Factors|immunologic factors|mesh-ancestor
110897228|NCT03530215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110897229|NCT03475277|Ketamine|ketamine|mesh-list
110897230|NCT03475277|Analgesics|analgesics|mesh-ancestor
110897231|NCT03475277|Sensory System Agents|sensory system agents|mesh-ancestor
110202500|NCT00153517|Metronidazole|metronidazole|mesh-list
110897232|NCT03475277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110897233|NCT03475277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110897234|NCT03475277|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110897235|NCT03475277|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110897237|NCT03475277|Anesthetics|anesthetics|mesh-ancestor
110897238|NCT03475277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110897239|NCT03475277|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110897240|NCT03475277|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110897241|NCT03475277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110897242|NCT03475277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110897243|NCT03472274|Durvalumab|durvalumab|mesh-list
110897244|NCT03472274|Tremelimumab|tremelimumab|mesh-list
110897245|NCT03472274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110897246|NCT03472274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110897247|NCT03436433|Lacosamide|lacosamide|mesh-list
110897248|NCT03436433|Levetiracetam|levetiracetam|mesh-list
110897249|NCT03436433|Anticonvulsants|anticonvulsants|mesh-ancestor
110897250|NCT03436433|Nootropic Agents|nootropic agents|mesh-ancestor
110897251|NCT03436433|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110897252|NCT03436433|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110897253|NCT03436433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110224513|NCT06001385|Immunologic Factors|immunologic factors|mesh-ancestor
110897254|NCT03436433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110897256|NCT03415854|Cisplatin|cisplatin|mesh-list
110897257|NCT03415854|Gemcitabine|gemcitabine|mesh-list
110897258|NCT03415854|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110897259|NCT03415854|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110897260|NCT03415854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110897261|NCT03415854|Tubulin Modulators|tubulin modulators|mesh-ancestor
110897262|NCT03415854|Antimitotic Agents|antimitotic agents|mesh-ancestor
110897263|NCT03415854|Mitosis Modulators|mitosis modulators|mesh-ancestor
110897264|NCT03415854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110897265|NCT03415854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110897266|NCT03415854|Antimetabolites|antimetabolites|mesh-ancestor
110897267|NCT03405090|Fentanyl|fentanyl|mesh-list
110897268|NCT03405090|Bronchodilator Agents|bronchodilator agents|mesh-list
110897269|NCT03405090|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110897270|NCT03405090|Narcotics|narcotics|mesh-ancestor
110897271|NCT03405090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110897272|NCT03405090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110897273|NCT03405090|Analgesics|analgesics|mesh-ancestor
110897274|NCT03405090|Sensory System Agents|sensory system agents|mesh-ancestor
110897275|NCT03405090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110897276|NCT03405090|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110897277|NCT03405090|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110897278|NCT03405090|Anesthetics, General|anesthetics, general|mesh-ancestor
110897279|NCT03405090|Anesthetics|anesthetics|mesh-ancestor
110897280|NCT03405090|Autonomic Agents|autonomic agents|mesh-ancestor
110897281|NCT03405090|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110897282|NCT03405090|Respiratory System Agents|respiratory system agents|mesh-ancestor
110897283|NCT03284307|Midazolam|midazolam|mesh-list
110897284|NCT03284307|Dexmedetomidine|dexmedetomidine|mesh-list
110897285|NCT03284307|Ketamine|ketamine|mesh-list
110897286|NCT03284307|Propofol|propofol|mesh-list
110897287|NCT03284307|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110897288|NCT03284307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110897289|NCT03284307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110897290|NCT03284307|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110897291|NCT03284307|Analgesics|analgesics|mesh-ancestor
110897292|NCT03284307|Sensory System Agents|sensory system agents|mesh-ancestor
110897293|NCT03284307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110897294|NCT03284307|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110897295|NCT03284307|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110897296|NCT03284307|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110897297|NCT03284307|Adrenergic Agents|adrenergic agents|mesh-ancestor
110897298|NCT03284307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110897299|NCT03284307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110897300|NCT03284307|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110897301|NCT03284307|Anesthetics, General|anesthetics, general|mesh-ancestor
110897303|NCT03284307|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110897304|NCT03284307|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110897305|NCT03284307|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110897306|NCT03284307|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110897307|NCT03284307|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110897308|NCT03284307|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110897309|NCT03284307|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110897310|NCT03284307|GABA Modulators|gaba modulators|mesh-ancestor
110897311|NCT03284307|GABA Agents|gaba agents|mesh-ancestor
110897312|NCT03279289|Leucovorin|leucovorin|mesh-list
110897313|NCT03279289|Folic Acid|folic acid|mesh-list
110897314|NCT03279289|Fluorouracil|fluorouracil|mesh-list
110897315|NCT03279289|Irinotecan|irinotecan|mesh-list
110897316|NCT03279289|Aflibercept|aflibercept|mesh-list
110897317|NCT03279289|Levoleucovorin|levoleucovorin|mesh-list
110897318|NCT03279289|Antimetabolites|antimetabolites|mesh-ancestor
110897319|NCT03279289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110897320|NCT03279289|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110897321|NCT03279289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110897322|NCT03279289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110897323|NCT03279289|Immunologic Factors|immunologic factors|mesh-ancestor
110897324|NCT03279289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110897325|NCT03279289|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110897326|NCT03279289|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110897327|NCT03279289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110897328|NCT03279289|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110614796|NCT00378079|Antitussive Agents|antitussive agents|mesh-ancestor
110897329|NCT03279289|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110897330|NCT03279289|Growth Substances|growth substances|mesh-ancestor
110897331|NCT03279289|Growth Inhibitors|growth inhibitors|mesh-ancestor
110897333|NCT03279289|Protective Agents|protective agents|mesh-ancestor
110897334|NCT03279289|Vitamin B Complex|vitamin b complex|mesh-ancestor
110897335|NCT03279289|Vitamins|vitamins|mesh-ancestor
110897336|NCT03279289|Micronutrients|micronutrients|mesh-ancestor
110897337|NCT03279289|Hematinics|hematinics|mesh-ancestor
110897338|NCT03207867|Spartalizumab|spartalizumab|mesh-list
110897339|NCT03207867|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110897340|NCT03207867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110897341|NCT03207867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110897342|NCT03207867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110897343|NCT03186456|Aspirin|aspirin|mesh-list
110897344|NCT03186456|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110897345|NCT03186456|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110897346|NCT03186456|Analgesics|analgesics|mesh-ancestor
110897347|NCT03186456|Sensory System Agents|sensory system agents|mesh-ancestor
110897348|NCT03186456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110897349|NCT03186456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110202543|NCT00153673|Celecoxib|celecoxib|mesh-list
110897350|NCT03186456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110897351|NCT03186456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110897352|NCT03186456|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110897353|NCT03186456|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110897354|NCT03186456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110897355|NCT03186456|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110897356|NCT03186456|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110897357|NCT03186456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110897358|NCT03186456|Antipyretics|antipyretics|mesh-ancestor
110897359|NCT03184935|Decitabine|decitabine|mesh-list
110897360|NCT03184935|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110897361|NCT03184935|Antimetabolites|antimetabolites|mesh-ancestor
110897362|NCT03184935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110897363|NCT03184935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110897364|NCT03184935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110897365|NCT03176498|Aspirin|aspirin|mesh-list
110897366|NCT03176498|Atorvastatin|atorvastatin|mesh-list
110897367|NCT03176498|Calcium|calcium|mesh-list
110897368|NCT03176498|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110897369|NCT03176498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110897370|NCT03176498|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110897371|NCT03176498|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110897372|NCT03176498|Analgesics|analgesics|mesh-ancestor
110897373|NCT03176498|Sensory System Agents|sensory system agents|mesh-ancestor
110897374|NCT03176498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110897375|NCT03176498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110897376|NCT03176498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110897377|NCT03176498|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110897378|NCT03176498|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110897379|NCT03176498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110897380|NCT03176498|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110897381|NCT03176498|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110897382|NCT03176498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110897383|NCT03176498|Antipyretics|antipyretics|mesh-ancestor
110897384|NCT03176498|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110897385|NCT03176498|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110897386|NCT03176498|Antimetabolites|antimetabolites|mesh-ancestor
110897387|NCT03176498|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110897388|NCT03176498|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110897389|NCT03126591|Pembrolizumab|pembrolizumab|mesh-list
110897390|NCT03126591|Olaratumab|olaratumab|mesh-list
110897391|NCT03126591|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110897392|NCT03126591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110897393|NCT03126591|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110897394|NCT03126591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110897395|NCT03122197|Letrozole|letrozole|mesh-list
110897396|NCT03122197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110897397|NCT03122197|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110897398|NCT03122197|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110897399|NCT03122197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110897400|NCT03122197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110897401|NCT03122197|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110897402|NCT03122197|Hormone Antagonists|hormone antagonists|mesh-ancestor
110897403|NCT03122197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110614933|NCT00971074|Hylan|hylan|mesh-list
110897404|NCT03122197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110897405|NCT03085004|Ethanol|ethanol|mesh-list
110897406|NCT03085004|Paclitaxel|paclitaxel|mesh-list
110897407|NCT03085004|Gemcitabine|gemcitabine|mesh-list
110897408|NCT03085004|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110897409|NCT03085004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110897410|NCT03085004|Tubulin Modulators|tubulin modulators|mesh-ancestor
110897411|NCT03085004|Antimitotic Agents|antimitotic agents|mesh-ancestor
110897412|NCT03085004|Mitosis Modulators|mitosis modulators|mesh-ancestor
110897413|NCT03085004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110897414|NCT03085004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110897415|NCT03085004|Antimetabolites|antimetabolites|mesh-ancestor
110897416|NCT03085004|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110897417|NCT03085004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110897418|NCT03085004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110897419|NCT03085004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110897420|NCT03059862|Tryptophan|tryptophan|mesh-list
110897421|NCT03059862|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110897422|NCT03059862|Antidepressive Agents|antidepressive agents|mesh-ancestor
110897423|NCT03059862|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110897424|NCT03015844|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
110897425|NCT03015844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110897426|NCT03015844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110897427|NCT03015844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110897428|NCT03015844|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110897429|NCT02916862|Calcium, Dietary|calcium, dietary|mesh-list
110897430|NCT02916862|Calcium|calcium|mesh-list
110897431|NCT02916862|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110897432|NCT02916862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110897433|NCT02916862|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110897434|NCT02891447|Cisplatin|cisplatin|mesh-list
110897435|NCT02891447|Mitomycins|mitomycins|mesh-list
110897436|NCT02891447|Mitomycin|mitomycin|mesh-list
110897437|NCT02891447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110897438|NCT02891447|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110897439|NCT02891447|Alkylating Agents|alkylating agents|mesh-ancestor
110897440|NCT02891447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110897441|NCT02891447|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110897442|NCT02891447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110897443|NCT02867761|Glycopyrrolate|glycopyrrolate|mesh-list
110897444|NCT02867761|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110897445|NCT02867761|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110897446|NCT02867761|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110897447|NCT02867761|Cholinergic Agents|cholinergic agents|mesh-ancestor
110897448|NCT02867761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110897449|NCT02867761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110897450|NCT02867761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110897451|NCT02680626|Magnesium Sulfate|magnesium sulfate|mesh-list
110897452|NCT02680626|Ropivacaine|ropivacaine|mesh-list
110897453|NCT02680626|Anesthetics, Local|anesthetics, local|mesh-ancestor
110897454|NCT02680626|Anesthetics|anesthetics|mesh-ancestor
110897455|NCT02680626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110897456|NCT02680626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110897457|NCT02680626|Sensory System Agents|sensory system agents|mesh-ancestor
110897458|NCT02680626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110897459|NCT02680626|Analgesics|analgesics|mesh-ancestor
110897460|NCT02680626|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110897461|NCT02680626|Anticonvulsants|anticonvulsants|mesh-ancestor
110897462|NCT02680626|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110897463|NCT02680626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110897464|NCT02680626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110897465|NCT02680626|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110897466|NCT02680626|Tocolytic Agents|tocolytic agents|mesh-ancestor
110897467|NCT02680626|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110897468|NCT02494583|Pembrolizumab|pembrolizumab|mesh-list
110897469|NCT02494583|Capecitabine|capecitabine|mesh-list
110897470|NCT02494583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110897471|NCT02494583|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110224522|NCT06001385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110897472|NCT02494583|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110897473|NCT02494583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110897474|NCT02494583|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110897475|NCT02494583|Antimetabolites|antimetabolites|mesh-ancestor
110897476|NCT02473042|Promethazine|promethazine|mesh-list
110897477|NCT02473042|Dexamethasone|dexamethasone|mesh-list
110897478|NCT02473042|Ondansetron|ondansetron|mesh-list
110897479|NCT02473042|Famotidine|famotidine|mesh-list
110897480|NCT02473042|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110897481|NCT02473042|Antiemetics|antiemetics|mesh-ancestor
110897482|NCT02473042|Autonomic Agents|autonomic agents|mesh-ancestor
110897483|NCT02473042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110897484|NCT02473042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110897485|NCT02473042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110897486|NCT02473042|Glucocorticoids|glucocorticoids|mesh-ancestor
110897488|NCT02473042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110897489|NCT02473042|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110897490|NCT02473042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110897491|NCT02473042|Antipruritics|antipruritics|mesh-ancestor
110897492|NCT02473042|Dermatologic Agents|dermatologic agents|mesh-ancestor
110897493|NCT02473042|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110897494|NCT02473042|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110897495|NCT02473042|Serotonin Agents|serotonin agents|mesh-ancestor
110897496|NCT02473042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110897497|NCT02473042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110897498|NCT02473042|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110897499|NCT02473042|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110897500|NCT02473042|Histamine Antagonists|histamine antagonists|mesh-ancestor
110897501|NCT02473042|Histamine Agents|histamine agents|mesh-ancestor
110897502|NCT02473042|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110897503|NCT02473042|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110897504|NCT02359331|Amoxicillin|amoxicillin|mesh-list
110897505|NCT02359331|Moxifloxacin|moxifloxacin|mesh-list
110897506|NCT02359331|Metronidazole|metronidazole|mesh-list
110897507|NCT02359331|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110897508|NCT02359331|Tetracycline|tetracycline|mesh-list
110897509|NCT02359331|Anti-Infective Agents|anti-infective agents|mesh-list
110897510|NCT02359331|Bismuth|bismuth|mesh-list
110897511|NCT02359331|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
110897512|NCT02359331|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110897513|NCT02359331|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110897514|NCT02359331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110897515|NCT02359331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110897516|NCT02359331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110897517|NCT02359331|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110897518|NCT02359331|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110897519|NCT02359331|Antacids|antacids|mesh-ancestor
110897520|NCT02359331|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110897521|NCT02359331|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110897522|NCT02322814|Paclitaxel|paclitaxel|mesh-list
110897523|NCT02322814|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110897524|NCT02322814|Atezolizumab|atezolizumab|mesh-list
110897525|NCT02322814|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110897526|NCT02322814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110897527|NCT02322814|Tubulin Modulators|tubulin modulators|mesh-ancestor
110897528|NCT02322814|Antimitotic Agents|antimitotic agents|mesh-ancestor
110897529|NCT02322814|Mitosis Modulators|mitosis modulators|mesh-ancestor
110897530|NCT02322814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110897531|NCT02322814|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110897532|NCT02322814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110897533|NCT02057133|Tamoxifen|tamoxifen|mesh-list
110897534|NCT02057133|Trastuzumab|trastuzumab|mesh-list
110897535|NCT02057133|Pertuzumab|pertuzumab|mesh-list
110897536|NCT02057133|Everolimus|everolimus|mesh-list
110897537|NCT02057133|Letrozole|letrozole|mesh-list
110897538|NCT02057133|Fulvestrant|fulvestrant|mesh-list
110897539|NCT02057133|Anastrozole|anastrozole|mesh-list
110897540|NCT02057133|Exemestane|exemestane|mesh-list
110897541|NCT02057133|Loperamide|loperamide|mesh-list
110897542|NCT02057133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110897543|NCT02057133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110897544|NCT02057133|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110897545|NCT02057133|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110897546|NCT02057133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110224524|NCT06001385|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110897547|NCT02057133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110897548|NCT02057133|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110897549|NCT02057133|Immunologic Factors|immunologic factors|mesh-ancestor
110897550|NCT02057133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110897551|NCT02057133|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110615025|NCT04008784|Triamcinolone|triamcinolone|mesh-list
110897552|NCT02057133|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110897553|NCT02057133|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110897554|NCT02057133|Hormone Antagonists|hormone antagonists|mesh-ancestor
110897555|NCT02057133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110897556|NCT02057133|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110897557|NCT02057133|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110897558|NCT02057133|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110897559|NCT02057133|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110897560|NCT02057133|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110897561|NCT02057133|Antidiarrheals|antidiarrheals|mesh-ancestor
110897562|NCT02057133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110897563|NCT01837862|Mebendazole|mebendazole|mesh-list
110897564|NCT01837862|Piperazine|piperazine|mesh-list
110897565|NCT01837862|Piperazine citrate|piperazine citrate|mesh-list
110897566|NCT01837862|Bevacizumab|bevacizumab|mesh-list
110897567|NCT01837862|Carboplatin|carboplatin|mesh-list
110897568|NCT01837862|Irinotecan|irinotecan|mesh-list
110897569|NCT01837862|Vincristine|vincristine|mesh-list
110897570|NCT01837862|Temozolomide|temozolomide|mesh-list
110897571|NCT01837862|DMP 777|dmp 777|mesh-list
110897572|NCT01837862|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110897573|NCT01837862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110897574|NCT01837862|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110897575|NCT01837862|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110897576|NCT01837862|Growth Substances|growth substances|mesh-ancestor
110897577|NCT01837862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110897578|NCT01837862|Growth Inhibitors|growth inhibitors|mesh-ancestor
110897579|NCT01837862|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110897580|NCT01837862|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110897581|NCT01837862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110897582|NCT01837862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110897583|NCT01837862|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110897584|NCT01837862|Tubulin Modulators|tubulin modulators|mesh-ancestor
110897585|NCT01837862|Antimitotic Agents|antimitotic agents|mesh-ancestor
110897586|NCT01837862|Mitosis Modulators|mitosis modulators|mesh-ancestor
110897587|NCT01837862|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110897588|NCT01837862|Alkylating Agents|alkylating agents|mesh-ancestor
110897589|NCT01837862|Antinematodal Agents|antinematodal agents|mesh-ancestor
110897590|NCT01837862|Anthelmintics|anthelmintics|mesh-ancestor
110897591|NCT01837862|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110897592|NCT01837862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110897593|NCT01675219|Mitomycins|mitomycins|mesh-list
110897594|NCT01675219|Mitomycin|mitomycin|mesh-list
110897595|NCT01675219|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110897596|NCT01675219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110897597|NCT01675219|Alkylating Agents|alkylating agents|mesh-ancestor
110897598|NCT01675219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110897599|NCT01675219|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110897600|NCT01675219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110897601|NCT01590069|Aldesleukin|aldesleukin|mesh-list
110897602|NCT01590069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110897603|NCT01590069|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110897604|NCT01590069|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110897605|NCT01590069|Antiviral Agents|antiviral agents|mesh-ancestor
110897606|NCT01590069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110897607|NCT01529593|Metformin|metformin|mesh-list
110897608|NCT01529593|Sirolimus|sirolimus|mesh-list
110897609|NCT01529593|Temsirolimus|temsirolimus|mesh-list
110897610|NCT01529593|MTOR Inhibitors|mtor inhibitors|mesh-list
110897611|NCT01529593|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110897612|NCT01529593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110897613|NCT01529593|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110897614|NCT01529593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110897615|NCT01529593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110897616|NCT01529593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110897617|NCT01529593|Immunologic Factors|immunologic factors|mesh-ancestor
110897618|NCT01529593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110897619|NCT01529593|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110897620|NCT01529593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110897621|NCT01529593|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110897622|NCT01529593|Antifungal Agents|antifungal agents|mesh-ancestor
110897624|NCT01446133|Lenalidomide|lenalidomide|mesh-list
110897625|NCT01446133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110897626|NCT01446133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110897627|NCT01446133|Immunologic Factors|immunologic factors|mesh-ancestor
110897628|NCT01446133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110615095|NCT03472365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110897629|NCT01446133|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110897630|NCT01446133|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110897631|NCT01446133|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110897632|NCT01446133|Growth Substances|growth substances|mesh-ancestor
110897633|NCT01446133|Growth Inhibitors|growth inhibitors|mesh-ancestor
110897634|NCT01333033|Leucovorin|leucovorin|mesh-list
110897635|NCT01333033|Paclitaxel|paclitaxel|mesh-list
110897636|NCT01333033|Carboplatin|carboplatin|mesh-list
110897637|NCT01333033|Fluorouracil|fluorouracil|mesh-list
110897638|NCT01333033|Oxaliplatin|oxaliplatin|mesh-list
110897639|NCT01333033|Calcium|calcium|mesh-list
110897640|NCT01333033|Levoleucovorin|levoleucovorin|mesh-list
110897641|NCT01333033|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110897642|NCT01333033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110897643|NCT01333033|Tubulin Modulators|tubulin modulators|mesh-ancestor
110897644|NCT01333033|Antimitotic Agents|antimitotic agents|mesh-ancestor
110897645|NCT01333033|Mitosis Modulators|mitosis modulators|mesh-ancestor
110897646|NCT01333033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110897647|NCT01333033|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110897648|NCT01333033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110897649|NCT01333033|Antimetabolites|antimetabolites|mesh-ancestor
110897650|NCT01333033|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110897651|NCT01333033|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110897652|NCT01333033|Immunologic Factors|immunologic factors|mesh-ancestor
110897653|NCT01333033|Antidotes|antidotes|mesh-ancestor
110897654|NCT01333033|Protective Agents|protective agents|mesh-ancestor
110897655|NCT01333033|Vitamin B Complex|vitamin b complex|mesh-ancestor
110897656|NCT01333033|Vitamins|vitamins|mesh-ancestor
110897657|NCT01333033|Micronutrients|micronutrients|mesh-ancestor
110897658|NCT01187199|Sirolimus|sirolimus|mesh-list
110897659|NCT01187199|Paclitaxel|paclitaxel|mesh-list
110897660|NCT01187199|Bevacizumab|bevacizumab|mesh-list
110897661|NCT01187199|Carboplatin|carboplatin|mesh-list
110897662|NCT01187199|Sorafenib|sorafenib|mesh-list
110897663|NCT01187199|Temsirolimus|temsirolimus|mesh-list
110897664|NCT01187199|MTOR Inhibitors|mtor inhibitors|mesh-list
110897665|NCT01187199|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110897666|NCT01187199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110897667|NCT01187199|Tubulin Modulators|tubulin modulators|mesh-ancestor
110897668|NCT01187199|Antimitotic Agents|antimitotic agents|mesh-ancestor
110897669|NCT01187199|Mitosis Modulators|mitosis modulators|mesh-ancestor
110897670|NCT01187199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110897671|NCT01187199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110897673|NCT01187199|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110897674|NCT01187199|Growth Substances|growth substances|mesh-ancestor
110897675|NCT01187199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110897676|NCT01187199|Growth Inhibitors|growth inhibitors|mesh-ancestor
110897677|NCT01187199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110897678|NCT01187199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110897679|NCT01187199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110897680|NCT01187199|Immunologic Factors|immunologic factors|mesh-ancestor
110897681|NCT01187199|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110897682|NCT01187199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110897683|NCT01187199|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110897684|NCT01187199|Antifungal Agents|antifungal agents|mesh-ancestor
110897685|NCT00778063|Dexmedetomidine|dexmedetomidine|mesh-list
110897686|NCT00778063|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110897687|NCT00778063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110897688|NCT00778063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110897689|NCT00778063|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110897690|NCT00778063|Analgesics|analgesics|mesh-ancestor
110897691|NCT00778063|Sensory System Agents|sensory system agents|mesh-ancestor
110923695|NCT03319537|Pevonedistat|pevonedistat|mesh-list
110897692|NCT00778063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110897693|NCT00778063|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110897694|NCT00778063|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110897695|NCT00778063|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110897696|NCT00778063|Adrenergic Agents|adrenergic agents|mesh-ancestor
110897697|NCT00778063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110897698|NCT00778063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110897699|NCT00547196|Cyclosporine|cyclosporine|mesh-list
110897700|NCT00547196|Mycophenolic Acid|mycophenolic acid|mesh-list
110897701|NCT00547196|Cyclophosphamide|cyclophosphamide|mesh-list
110897702|NCT00547196|Melphalan|melphalan|mesh-list
110897703|NCT00547196|Busulfan|busulfan|mesh-list
110897704|NCT00547196|Fludarabine|fludarabine|mesh-list
110897705|NCT00547196|Fludarabine phosphate|fludarabine phosphate|mesh-list
110897706|NCT00547196|Cyclosporins|cyclosporins|mesh-list
110202650|NCT00154258|Clozapine|clozapine|mesh-list
110897707|NCT00547196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110897708|NCT00547196|Immunologic Factors|immunologic factors|mesh-ancestor
110897709|NCT00547196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110897710|NCT00547196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110897711|NCT00547196|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110897712|NCT00547196|Alkylating Agents|alkylating agents|mesh-ancestor
110897713|NCT00547196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110897714|NCT00547196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110897715|NCT00547196|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110897716|NCT00547196|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110897717|NCT00547196|Antimetabolites|antimetabolites|mesh-ancestor
110897718|NCT00547196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110897719|NCT00547196|Antifungal Agents|antifungal agents|mesh-ancestor
110897720|NCT00547196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110897721|NCT00547196|Dermatologic Agents|dermatologic agents|mesh-ancestor
110897722|NCT00547196|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110897723|NCT00547196|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110897724|NCT00547196|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110897725|NCT00547196|Antitubercular Agents|antitubercular agents|mesh-ancestor
110897726|NCT00547196|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110897727|NCT00330941|Lidocaine|lidocaine|mesh-list
110897728|NCT00330941|Anesthetics, Local|anesthetics, local|mesh-ancestor
110897729|NCT00330941|Anesthetics|anesthetics|mesh-ancestor
110897730|NCT00330941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110897731|NCT00330941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110897732|NCT00330941|Sensory System Agents|sensory system agents|mesh-ancestor
110897733|NCT00330941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110897734|NCT00330941|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110897735|NCT00330941|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110897736|NCT00330941|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110897737|NCT00330941|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110897738|NCT00330941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110897739|NCT03149107|Acetylcysteine|acetylcysteine|mesh-list
110897740|NCT03149107|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110897741|NCT03149107|Antiviral Agents|antiviral agents|mesh-ancestor
110897742|NCT03149107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110897743|NCT03149107|Expectorants|expectorants|mesh-ancestor
110897744|NCT03149107|Respiratory System Agents|respiratory system agents|mesh-ancestor
110897745|NCT03149107|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110897746|NCT03149107|Antioxidants|antioxidants|mesh-ancestor
110897747|NCT03149107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110897748|NCT03149107|Protective Agents|protective agents|mesh-ancestor
110897749|NCT03149107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110897750|NCT03149107|Antidotes|antidotes|mesh-ancestor
110897751|NCT03135301|Metformin|metformin|mesh-list
110897752|NCT03135301|Letrozole|letrozole|mesh-list
110897753|NCT03135301|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110897754|NCT03135301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110897755|NCT03135301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110897756|NCT03135301|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110897757|NCT03135301|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110897758|NCT03135301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110897759|NCT03135301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110897760|NCT03135301|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110897761|NCT03135301|Hormone Antagonists|hormone antagonists|mesh-ancestor
110897762|NCT03135301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110897763|NCT03602898|Cyclosporine|cyclosporine|mesh-list
110897764|NCT03602898|Cyclophosphamide|cyclophosphamide|mesh-list
110897765|NCT03602898|Busulfan|busulfan|mesh-list
110897766|NCT03602898|Methotrexate|methotrexate|mesh-list
110897767|NCT03602898|Fludarabine|fludarabine|mesh-list
110897768|NCT03602898|Fludarabine phosphate|fludarabine phosphate|mesh-list
110897769|NCT03602898|Tacrolimus|tacrolimus|mesh-list
110897770|NCT03602898|Cyclosporins|cyclosporins|mesh-list
110897771|NCT03602898|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110897772|NCT03602898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110897773|NCT03602898|Immunologic Factors|immunologic factors|mesh-ancestor
110897774|NCT03602898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110897775|NCT03602898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110897776|NCT03602898|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110897777|NCT03602898|Alkylating Agents|alkylating agents|mesh-ancestor
110897778|NCT03602898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110897779|NCT03602898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110897780|NCT03602898|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110897781|NCT03602898|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110897782|NCT03602898|Abortifacient Agents|abortifacient agents|mesh-ancestor
110897783|NCT03602898|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110897784|NCT03602898|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110615245|NCT00544882|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110897786|NCT03602898|Dermatologic Agents|dermatologic agents|mesh-ancestor
110897787|NCT03602898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110897788|NCT03602898|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110897789|NCT03602898|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110897790|NCT03602898|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110897791|NCT03602898|Antifungal Agents|antifungal agents|mesh-ancestor
110897792|NCT03602898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110897793|NCT02983747|Loxoprofen|loxoprofen|mesh-list
110897794|NCT02983747|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110897795|NCT02983747|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110897796|NCT02983747|Analgesics|analgesics|mesh-ancestor
110897797|NCT02983747|Sensory System Agents|sensory system agents|mesh-ancestor
110897798|NCT02983747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110897799|NCT02983747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110897800|NCT02983747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110897801|NCT02983747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110897802|NCT05759845|Topiramate|topiramate|mesh-list
110897803|NCT05759845|Amitriptyline|amitriptyline|mesh-list
110897804|NCT05759845|Anticonvulsants|anticonvulsants|mesh-ancestor
110897805|NCT05759845|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110897806|NCT05759845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110897807|NCT05759845|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110897808|NCT05759845|Antidepressive Agents|antidepressive agents|mesh-ancestor
110897809|NCT05759845|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110897810|NCT05759845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110897811|NCT05759845|Analgesics|analgesics|mesh-ancestor
110897812|NCT05759845|Sensory System Agents|sensory system agents|mesh-ancestor
110897813|NCT05759845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110897814|NCT05759845|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110897815|NCT05759845|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110897816|NCT05759845|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110897817|NCT05759845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110202690|NCT00043914|Lamotrigine|lamotrigine|mesh-list
110897819|NCT05759845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110897820|NCT03931291|Azacitidine|azacitidine|mesh-list
110897821|NCT03931291|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110897822|NCT03931291|Antimetabolites|antimetabolites|mesh-ancestor
110897823|NCT03931291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110897824|NCT03931291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110897825|NCT03931291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110897826|NCT00799110|Imiquimod|imiquimod|mesh-list
110897827|NCT00799110|Vaccines|vaccines|mesh-list
110897828|NCT00799110|Immunologic Factors|immunologic factors|mesh-ancestor
110897829|NCT00799110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110897830|NCT00799110|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110897831|NCT00799110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110897832|NCT00799110|Interferon Inducers|interferon inducers|mesh-ancestor
110897833|NCT05199727|Tadalafil|tadalafil|mesh-list
110897834|NCT05199727|Vasodilator Agents|vasodilator agents|mesh-ancestor
110897835|NCT05199727|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110897836|NCT05199727|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110897837|NCT05199727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110897838|NCT05199727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110897839|NCT05199727|Urological Agents|urological agents|mesh-ancestor
110897840|NCT02132234|Adalimumab|adalimumab|mesh-list
110897841|NCT02132234|Infliximab|infliximab|mesh-list
110897842|NCT02132234|Certolizumab Pegol|certolizumab pegol|mesh-list
110897843|NCT02132234|Etanercept|etanercept|mesh-list
110897844|NCT02132234|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110897845|NCT02132234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110897846|NCT02132234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110897847|NCT02132234|Dermatologic Agents|dermatologic agents|mesh-ancestor
110897848|NCT02132234|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110897849|NCT02132234|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110897850|NCT02132234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110897851|NCT02132234|Analgesics|analgesics|mesh-ancestor
110897852|NCT02132234|Sensory System Agents|sensory system agents|mesh-ancestor
110897853|NCT02132234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110897854|NCT02132234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110897855|NCT02132234|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110897856|NCT02132234|Immunologic Factors|immunologic factors|mesh-ancestor
110897857|NCT02132390|Toremifene|toremifene|mesh-list
110897858|NCT02132390|Goserelin|goserelin|mesh-list
110897859|NCT02132390|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110897860|NCT02132390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110897861|NCT02132390|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110897862|NCT02132390|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110897863|NCT02132390|Hormone Antagonists|hormone antagonists|mesh-ancestor
110897864|NCT02132390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110897865|NCT02132390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110897866|NCT02132390|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110897868|NCT02128646|Bupivacaine|bupivacaine|mesh-list
110897869|NCT02128646|Anesthetics, Local|anesthetics, local|mesh-ancestor
110897870|NCT02128646|Anesthetics|anesthetics|mesh-ancestor
110897871|NCT02128646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110897872|NCT02128646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110897873|NCT02128646|Sensory System Agents|sensory system agents|mesh-ancestor
110897874|NCT02128646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110897875|NCT02128646|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110897876|NCT02128646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110897877|NCT02128646|Analgesics|analgesics|mesh-ancestor
110202702|NCT04705987|Colchicine|colchicine|mesh-list
110897878|NCT02128646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110897879|NCT02128646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110897880|NCT02128646|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110897881|NCT02128646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110897882|NCT02128646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110897883|NCT05199103|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110897884|NCT05199103|Thymoglobulin|thymoglobulin|mesh-list
110897885|NCT05199103|Immunologic Factors|immunologic factors|mesh-ancestor
110897886|NCT05199103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110897887|NCT05199103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110897888|NCT02132546|Chlorhexidine|chlorhexidine|mesh-list
110897889|NCT02132546|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110897890|NCT02132546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110897891|NCT02132546|Disinfectants|disinfectants|mesh-ancestor
110897892|NCT05198947|Ivermectin|ivermectin|mesh-list
110897893|NCT05198947|Permethrin|permethrin|mesh-list
110897894|NCT05198947|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110897895|NCT05198947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110897896|NCT05198947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110897897|NCT05198947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110897898|NCT01367834|Hormones|hormones|mesh-list
110897899|NCT01367834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110897900|NCT01367834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110897901|NCT03106753|Bupivacaine|bupivacaine|mesh-list
110897902|NCT03106753|Terbutaline|terbutaline|mesh-list
110897903|NCT03106753|Anesthetics, Local|anesthetics, local|mesh-ancestor
110897904|NCT03106753|Anesthetics|anesthetics|mesh-ancestor
110897905|NCT03106753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110897906|NCT03106753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110897907|NCT03106753|Sensory System Agents|sensory system agents|mesh-ancestor
110897908|NCT03106753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110897909|NCT03106753|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110897910|NCT03106753|Autonomic Agents|autonomic agents|mesh-ancestor
110897911|NCT03106753|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110897912|NCT03106753|Respiratory System Agents|respiratory system agents|mesh-ancestor
110897913|NCT03106753|Sympathomimetics|sympathomimetics|mesh-ancestor
110897914|NCT03106753|Tocolytic Agents|tocolytic agents|mesh-ancestor
110897915|NCT03106753|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110897916|NCT03106753|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110897917|NCT03106753|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110897918|NCT03106753|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110897919|NCT03106753|Adrenergic Agents|adrenergic agents|mesh-ancestor
110897920|NCT03106753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110897921|NCT03106753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110897922|NCT02133014|Fluorouracil|fluorouracil|mesh-list
110897923|NCT02133014|Antimetabolites|antimetabolites|mesh-ancestor
110897924|NCT02133014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110897925|NCT02133014|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110897926|NCT02133014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110897927|NCT02133014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110897928|NCT02133014|Immunologic Factors|immunologic factors|mesh-ancestor
110897929|NCT02133014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110897930|NCT05759455|Vitamin D|vitamin d|mesh-list
110897931|NCT05759455|Vitamins|vitamins|mesh-ancestor
110897932|NCT05759455|Micronutrients|micronutrients|mesh-ancestor
110897933|NCT05759455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110897934|NCT05759455|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110897935|NCT02129114|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110897936|NCT02129114|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110897937|NCT02129114|Estradiol|estradiol|mesh-list
110897938|NCT02129114|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110897939|NCT02129114|Estrogens|estrogens|mesh-ancestor
110897940|NCT02129114|Hormones|hormones|mesh-ancestor
110897941|NCT02129114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110897942|NCT02129114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110897943|NCT02129114|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110897944|NCT02129114|Contraceptive Agents|contraceptive agents|mesh-ancestor
110897945|NCT02129114|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110897946|NCT02129114|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110897947|NCT02136992|Pirfenidone|pirfenidone|mesh-list
110897948|NCT02136992|Analgesics|analgesics|mesh-ancestor
110897949|NCT02136992|Sensory System Agents|sensory system agents|mesh-ancestor
110897950|NCT02136992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110897951|NCT02136992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110897952|NCT02136992|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110897953|NCT02136992|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110897954|NCT02136992|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110897955|NCT02136992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110897956|NCT02136992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110897957|NCT02252978|Ciprofloxacin|ciprofloxacin|mesh-list
110897958|NCT02252978|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110897959|NCT02252978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110897960|NCT02252978|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110897961|NCT02252978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110897962|NCT02252978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110897963|NCT02252978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110897964|NCT02252978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110897965|NCT02252978|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110897966|NCT02252978|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110897967|NCT02129270|Lidocaine|lidocaine|mesh-list
110897968|NCT02129270|Anesthetics, Local|anesthetics, local|mesh-ancestor
110897969|NCT02129270|Anesthetics|anesthetics|mesh-ancestor
110897970|NCT02129270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110897971|NCT02129270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110897972|NCT02129270|Sensory System Agents|sensory system agents|mesh-ancestor
110897973|NCT02129270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110897974|NCT02129270|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110897975|NCT02129270|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110897976|NCT02129270|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110897977|NCT02129270|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110897978|NCT02129270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110897979|NCT05370547|Cyclophosphamide|cyclophosphamide|mesh-list
110897980|NCT05370547|Fludarabine|fludarabine|mesh-list
110897981|NCT05370547|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110897982|NCT05370547|Immunologic Factors|immunologic factors|mesh-ancestor
110897983|NCT05370547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110897984|NCT05370547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110897985|NCT05370547|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110897986|NCT05370547|Alkylating Agents|alkylating agents|mesh-ancestor
110897987|NCT05370547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110897988|NCT05370547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110897989|NCT05370547|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110897990|NCT02133326|Acetaminophen|acetaminophen|mesh-list
110897991|NCT02133326|Ibuprofen|ibuprofen|mesh-list
110897992|NCT02133326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110897993|NCT02133326|Analgesics|analgesics|mesh-ancestor
110897994|NCT02133326|Sensory System Agents|sensory system agents|mesh-ancestor
110897995|NCT02133326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110897996|NCT02133326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110897997|NCT02133326|Antipyretics|antipyretics|mesh-ancestor
110897998|NCT02133326|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110897999|NCT02133326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110898000|NCT02133326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110202738|NCT00406432|Paroxetine|paroxetine|mesh-list
110898001|NCT02133326|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110898002|NCT02133326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110898003|NCT02133326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110898004|NCT02137616|Olanzapine|olanzapine|mesh-list
110898005|NCT02137616|Risperidone|risperidone|mesh-list
110898006|NCT02137616|Aripiprazole|aripiprazole|mesh-list
110898007|NCT02137616|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110898008|NCT02137616|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110898009|NCT02137616|Serotonin Agents|serotonin agents|mesh-ancestor
110898010|NCT02137616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110898011|NCT02137616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110898012|NCT02137616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110898013|NCT02137616|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110898014|NCT02137616|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110898015|NCT02137616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110898016|NCT02137616|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110898017|NCT02137616|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110898018|NCT02137616|Dopamine Agents|dopamine agents|mesh-ancestor
110898019|NCT02137616|Antiemetics|antiemetics|mesh-ancestor
110898020|NCT02137616|Autonomic Agents|autonomic agents|mesh-ancestor
110898021|NCT02137616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110898022|NCT02137616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110898023|NCT02137616|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110898024|NCT02137616|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110898025|NCT02137616|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110898026|NCT02137616|Antidepressive Agents|antidepressive agents|mesh-ancestor
110898027|NCT02137616|Dopamine Agonists|dopamine agonists|mesh-ancestor
110898028|NCT02137616|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110898029|NCT02137616|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110898030|NCT02137616|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110898031|NCT02137616|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110898032|NCT02133638|Propofol|propofol|mesh-list
110898033|NCT02133638|Sevoflurane|sevoflurane|mesh-list
110898034|NCT02133638|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110898035|NCT02133638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110898036|NCT02133638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110898037|NCT02133638|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110898038|NCT02133638|Anesthetics, General|anesthetics, general|mesh-ancestor
110898039|NCT02133638|Anesthetics|anesthetics|mesh-ancestor
110898040|NCT02133638|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110898041|NCT02133638|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110898042|NCT02545283|Cytarabine|cytarabine|mesh-list
110898043|NCT02545283|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110898044|NCT02545283|Antimetabolites|antimetabolites|mesh-ancestor
110898045|NCT02545283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110898046|NCT02545283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110898047|NCT02545283|Antiviral Agents|antiviral agents|mesh-ancestor
110898048|NCT02545283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110898049|NCT02545283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110898050|NCT02545283|Immunologic Factors|immunologic factors|mesh-ancestor
110898051|NCT02545283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110898052|NCT02137928|Carboplatin|carboplatin|mesh-list
110898053|NCT02137928|Etoposide|etoposide|mesh-list
110898054|NCT02137928|Etoposide phosphate|etoposide phosphate|mesh-list
110898055|NCT02137928|Vincristine|vincristine|mesh-list
110898056|NCT02137928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110898057|NCT02137928|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110898058|NCT02137928|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110898059|NCT02137928|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110202744|NCT00406432|Serotonin Agents|serotonin agents|mesh-ancestor
110898060|NCT02137928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110898061|NCT02137928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110898062|NCT02137928|Tubulin Modulators|tubulin modulators|mesh-ancestor
110898063|NCT02137928|Antimitotic Agents|antimitotic agents|mesh-ancestor
110898064|NCT02137928|Mitosis Modulators|mitosis modulators|mesh-ancestor
110898065|NCT02138084|Ritonavir|ritonavir|mesh-list
110898066|NCT02138084|Fostemsavir|fostemsavir|mesh-list
110898067|NCT02138084|Rifabutin|rifabutin|mesh-list
110898068|NCT02138084|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110898069|NCT02138084|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110898070|NCT02138084|Protease Inhibitors|protease inhibitors|mesh-ancestor
110898071|NCT02138084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110898072|NCT02138084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110898073|NCT02138084|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110898074|NCT02138084|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110898075|NCT02138084|Antiviral Agents|antiviral agents|mesh-ancestor
110898076|NCT02138084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110898077|NCT02138084|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110898078|NCT02138084|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110898079|NCT02138084|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110898080|NCT02138084|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110898081|NCT02138084|Antitubercular Agents|antitubercular agents|mesh-ancestor
110898082|NCT02138084|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110898083|NCT02138084|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110898084|NCT02129582|Methotrexate|methotrexate|mesh-list
110898085|NCT02129582|Fludarabine phosphate|fludarabine phosphate|mesh-list
110898086|NCT02129582|Fludarabine|fludarabine|mesh-list
110898087|NCT02129582|Busulfan|busulfan|mesh-list
110898088|NCT02129582|Tacrolimus|tacrolimus|mesh-list
110898089|NCT02129582|Thymoglobulin|thymoglobulin|mesh-list
110898090|NCT02129582|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110898091|NCT02129582|Immunoglobulins|immunoglobulins|mesh-list
110898092|NCT02129582|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110898093|NCT02129582|Abortifacient Agents|abortifacient agents|mesh-ancestor
110898094|NCT02129582|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110898095|NCT02129582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110898096|NCT02129582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110898097|NCT02129582|Antimetabolites|antimetabolites|mesh-ancestor
110898098|NCT02129582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110898099|NCT02129582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110898100|NCT02129582|Dermatologic Agents|dermatologic agents|mesh-ancestor
110898101|NCT02129582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110898102|NCT02129582|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110898103|NCT02129582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110898104|NCT02129582|Immunologic Factors|immunologic factors|mesh-ancestor
110898105|NCT02129582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110898106|NCT02129582|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110898107|NCT02129582|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110898108|NCT02129582|Alkylating Agents|alkylating agents|mesh-ancestor
110898109|NCT02129582|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110898110|NCT02129582|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110898111|NCT02138396|Fentanyl|fentanyl|mesh-list
110898112|NCT02138396|Naltrexone|naltrexone|mesh-list
110898113|NCT02138396|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110898114|NCT02138396|Narcotics|narcotics|mesh-ancestor
110898115|NCT02138396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110898116|NCT02138396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110898117|NCT02138396|Analgesics|analgesics|mesh-ancestor
110898118|NCT02138396|Sensory System Agents|sensory system agents|mesh-ancestor
110898119|NCT02138396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110898120|NCT02138396|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110923791|NCT02740179|Diuretics|diuretics|mesh-ancestor
110898121|NCT02138396|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110898122|NCT02138396|Anesthetics, General|anesthetics, general|mesh-ancestor
110898123|NCT02138396|Anesthetics|anesthetics|mesh-ancestor
110898124|NCT02138396|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110898125|NCT02138396|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110898126|NCT04560881|Vaccines|vaccines|mesh-list
110898127|NCT04560881|Immunologic Factors|immunologic factors|mesh-ancestor
110898128|NCT04560881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110898129|NCT02875613|Avelumab|avelumab|mesh-list
110898130|NCT02875613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110898131|NCT02875613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110898132|NCT02815267|Minocycline|minocycline|mesh-list
110898133|NCT02815267|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110898134|NCT02815267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110898135|NCT02130440|Resveratrol|resveratrol|mesh-list
110898136|NCT02130440|Antioxidants|antioxidants|mesh-ancestor
110898137|NCT02130440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110898138|NCT02130440|Protective Agents|protective agents|mesh-ancestor
110898139|NCT02130440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110898140|NCT02130440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110898141|NCT02130440|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110898142|NCT02138552|Octenidine|octenidine|mesh-list
110898143|NCT02138552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110898144|NCT02138552|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110898145|NCT02930837|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
110898146|NCT02930837|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110898147|NCT02930837|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110898148|NCT02930837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110898149|NCT02138708|Adenosine|adenosine|mesh-list
110898150|NCT02138708|Acetylcholine|acetylcholine|mesh-list
110898151|NCT02138708|Analgesics|analgesics|mesh-ancestor
110898152|NCT02138708|Sensory System Agents|sensory system agents|mesh-ancestor
110898153|NCT02138708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110898154|NCT02138708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110898155|NCT02138708|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110615617|NCT00902811|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110898156|NCT02138708|Vasodilator Agents|vasodilator agents|mesh-ancestor
110898157|NCT02138708|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
110898158|NCT02138708|Purinergic Agonists|purinergic agonists|mesh-ancestor
110898159|NCT02138708|Purinergic Agents|purinergic agents|mesh-ancestor
110898160|NCT02138708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110898161|NCT02138708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110898162|NCT02138708|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110898163|NCT02138708|Cholinergic Agents|cholinergic agents|mesh-ancestor
110898165|NCT03633175|Progestins|progestins|mesh-ancestor
110898166|NCT03633175|Hormones|hormones|mesh-ancestor
110898167|NCT03633175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110898168|NCT03633175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110898169|NCT02539693|Lidocaine|lidocaine|mesh-list
110898170|NCT02539693|Clonidine|clonidine|mesh-list
110898171|NCT02539693|Anesthetics, Local|anesthetics, local|mesh-ancestor
110898172|NCT02539693|Anesthetics|anesthetics|mesh-ancestor
110898173|NCT02539693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110898174|NCT02539693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110898175|NCT02539693|Sensory System Agents|sensory system agents|mesh-ancestor
110898176|NCT02539693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110898177|NCT02539693|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110898178|NCT02539693|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110898179|NCT02539693|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110898180|NCT02539693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110898181|NCT02539693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110898182|NCT02539693|Analgesics|analgesics|mesh-ancestor
110898183|NCT02539693|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110898184|NCT02539693|Sympatholytics|sympatholytics|mesh-ancestor
110898185|NCT02539693|Autonomic Agents|autonomic agents|mesh-ancestor
110898186|NCT02539693|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110898187|NCT02539693|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110898188|NCT02539693|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110898189|NCT02539693|Adrenergic Agents|adrenergic agents|mesh-ancestor
110898190|NCT02539693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110898191|NCT05062135|Progesterone|progesterone|mesh-list
110898192|NCT05062135|Progestins|progestins|mesh-ancestor
110898193|NCT05062135|Hormones|hormones|mesh-ancestor
110898194|NCT05062135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110898195|NCT05062135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110898196|NCT02130518|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110898197|NCT02134106|Polymyxins|polymyxins|mesh-list
110898198|NCT02134106|Doripenem|doripenem|mesh-list
110898199|NCT02134106|Polymyxin B|polymyxin b|mesh-list
110898200|NCT02134106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110898201|NCT02134106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110898202|NCT01354301|Mycophenolic Acid|mycophenolic acid|mesh-list
110898203|NCT01354301|Everolimus|everolimus|mesh-list
110898204|NCT01354301|Tacrolimus|tacrolimus|mesh-list
110898205|NCT01354301|Thymoglobulin|thymoglobulin|mesh-list
110898206|NCT01354301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110898207|NCT01354301|Immunologic Factors|immunologic factors|mesh-ancestor
110898208|NCT01354301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110898209|NCT01354301|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110898210|NCT01354301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110898211|NCT01354301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110898212|NCT01354301|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110898213|NCT01354301|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110898214|NCT01354301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110898215|NCT01354301|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110898216|NCT01354301|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110898217|NCT01354301|Antitubercular Agents|antitubercular agents|mesh-ancestor
110898218|NCT01354301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110898219|NCT01354301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110898220|NCT02134262|Cyclophosphamide|cyclophosphamide|mesh-list
110898221|NCT02134262|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110898222|NCT02134262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110898223|NCT02134262|Immunologic Factors|immunologic factors|mesh-ancestor
110898224|NCT02134262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110898225|NCT02134262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110898226|NCT02134262|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110898227|NCT02134262|Alkylating Agents|alkylating agents|mesh-ancestor
110898228|NCT02134262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110898229|NCT02134262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110898230|NCT02134262|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110898231|NCT01343277|Dacarbazine|dacarbazine|mesh-list
110898232|NCT01343277|Trabectedin|trabectedin|mesh-list
110898233|NCT01343277|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110898234|NCT01343277|Alkylating Agents|alkylating agents|mesh-ancestor
110898235|NCT01343277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110898236|NCT01343277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110898237|NCT04856293|Crizotinib|crizotinib|mesh-list
110898238|NCT04856293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110898239|NCT04856293|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110898240|NCT04856293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110898241|NCT04856293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110898242|NCT02253212|Carboplatin|carboplatin|mesh-list
110898243|NCT02253212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110898244|NCT01355939|Zinc Oxide|zinc oxide|mesh-list
110898245|NCT01355939|Dermatologic Agents|dermatologic agents|mesh-ancestor
110898246|NCT01355939|Sunscreening Agents|sunscreening agents|mesh-ancestor
110898247|NCT01355939|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110898248|NCT01355939|Protective Agents|protective agents|mesh-ancestor
110898249|NCT01355939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110898250|NCT01356017|Amlodipine|amlodipine|mesh-list
110898251|NCT01356017|Telmisartan|telmisartan|mesh-list
110898252|NCT01356017|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110898253|NCT01356017|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110898254|NCT01356017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110898255|NCT01356017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110923806|NCT02650986|Immunologic Factors|immunologic factors|mesh-ancestor
110898256|NCT01356017|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110898257|NCT01356017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110898259|NCT01356017|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110898260|NCT01356017|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110898261|NCT02139098|Amitriptyline|amitriptyline|mesh-list
110898262|NCT02139098|Zolpidem|zolpidem|mesh-list
110898263|NCT02139098|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110898264|NCT02139098|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110898265|NCT02139098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110898266|NCT02139098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110898267|NCT02139098|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
110898268|NCT02139098|GABA Agonists|gaba agonists|mesh-ancestor
110898269|NCT02139098|GABA Agents|gaba agents|mesh-ancestor
110898270|NCT02139098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110898271|NCT02139098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110898272|NCT02139098|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110898273|NCT02139098|Antidepressive Agents|antidepressive agents|mesh-ancestor
110898274|NCT02139098|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110898275|NCT02139098|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110898276|NCT02139098|Analgesics|analgesics|mesh-ancestor
110898277|NCT02139098|Sensory System Agents|sensory system agents|mesh-ancestor
110898278|NCT02139098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110898279|NCT02139098|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110898280|NCT02139098|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110898281|NCT02139098|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110898282|NCT02139098|Adrenergic Agents|adrenergic agents|mesh-ancestor
110898283|NCT04498715|Zoledronic Acid|zoledronic acid|mesh-list
110898284|NCT04498715|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110898285|NCT04498715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110898286|NCT02487979|Glembatumumab vedotin|glembatumumab vedotin|mesh-list
110898287|NCT02487979|Immunoconjugates|immunoconjugates|mesh-list
110898288|NCT02487979|Immunotoxins|immunotoxins|mesh-list
110898289|NCT02487979|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110898290|NCT02487979|Immunologic Factors|immunologic factors|mesh-ancestor
110898291|NCT02487979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110898292|NCT02487979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110898293|NCT02487979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110898294|NCT02130830|Lidocaine|lidocaine|mesh-list
110898295|NCT02130830|Prilocaine|prilocaine|mesh-list
110898296|NCT02130830|Anesthetics, Local|anesthetics, local|mesh-ancestor
110898297|NCT02130830|Anesthetics|anesthetics|mesh-ancestor
110898298|NCT02130830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110898299|NCT02130830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110898300|NCT02130830|Sensory System Agents|sensory system agents|mesh-ancestor
110898301|NCT02130830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110898302|NCT02130830|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110898303|NCT02130830|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110898304|NCT02130830|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110898305|NCT02130830|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110898306|NCT02130830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110898307|NCT04471727|Atezolizumab|atezolizumab|mesh-list
110898308|NCT04471727|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110898309|NCT04471727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110898310|NCT04471727|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110898311|NCT04471727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110898312|NCT01360151|Ranibizumab|ranibizumab|mesh-list
110898314|NCT01360151|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110898315|NCT01360151|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110898316|NCT01360151|Growth Substances|growth substances|mesh-ancestor
110898317|NCT01360151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110898318|NCT01360151|Growth Inhibitors|growth inhibitors|mesh-ancestor
110923815|NCT02650986|Antimetabolites|antimetabolites|mesh-ancestor
110898319|NCT01360151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110898320|NCT01360151|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110898321|NCT01360151|Dermatologic Agents|dermatologic agents|mesh-ancestor
110898323|NCT01363037|Dapivirine|dapivirine|mesh-list
110898324|NCT01363037|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110898325|NCT01363037|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110898326|NCT01363037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110898327|NCT01363037|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110898328|NCT01363037|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110898329|NCT01363037|Antiviral Agents|antiviral agents|mesh-ancestor
110898330|NCT01363037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110898331|NCT01363037|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
110898332|NCT01363115|Vitamin D|vitamin d|mesh-list
110898333|NCT01363115|Calcium|calcium|mesh-list
110898334|NCT01363115|Vitamins|vitamins|mesh-ancestor
110898335|NCT01363115|Micronutrients|micronutrients|mesh-ancestor
110898336|NCT01363115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110898337|NCT01363115|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110898338|NCT01363115|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110898339|NCT01356329|Heparin|heparin|mesh-list
110898340|NCT01356329|Enoxaparin|enoxaparin|mesh-list
110898341|NCT01356329|Anticoagulants|anticoagulants|mesh-ancestor
110898342|NCT01356329|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110898343|NCT01356329|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110898344|NCT01356329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110898345|NCT05579522|Hyaluronic Acid|hyaluronic acid|mesh-list
110898346|NCT05579522|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110898347|NCT05579522|Immunologic Factors|immunologic factors|mesh-ancestor
110898348|NCT05579522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110898349|NCT05579522|Viscosupplements|viscosupplements|mesh-ancestor
110898350|NCT05579522|Protective Agents|protective agents|mesh-ancestor
110898351|NCT01356485|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110898352|NCT01363193|Heparin|heparin|mesh-list
110898353|NCT01363193|Calcium heparin|calcium heparin|mesh-list
110898354|NCT01363193|Anticoagulants|anticoagulants|mesh-ancestor
110898355|NCT01363193|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110898356|NCT01363193|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110898357|NCT01363193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110898358|NCT01319279|Hydrocodone|hydrocodone|mesh-list
110898359|NCT01319279|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110898360|NCT01319279|Narcotics|narcotics|mesh-ancestor
110898361|NCT01319279|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110898362|NCT01319279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110898363|NCT01319279|Analgesics|analgesics|mesh-ancestor
110898364|NCT01319279|Sensory System Agents|sensory system agents|mesh-ancestor
110898365|NCT01319279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110898366|NCT01319279|Antitussive Agents|antitussive agents|mesh-ancestor
110898367|NCT01319279|Respiratory System Agents|respiratory system agents|mesh-ancestor
110898368|NCT01363271|Vancomycin|vancomycin|mesh-list
110898369|NCT01363271|Linezolid|linezolid|mesh-list
110898370|NCT01363271|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110898371|NCT01363271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110898372|NCT01363271|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110898373|NCT01363271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110898374|NCT01363271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110898375|NCT02134886|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110898376|NCT02134886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110898377|NCT02134886|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110898378|NCT02134886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110224592|NCT06000917|Paclitaxel|paclitaxel|mesh-list
110898379|NCT02134886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110898381|NCT01360463|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110898382|NCT01360463|Narcotics|narcotics|mesh-ancestor
110898383|NCT01360463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110898384|NCT01360463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110898385|NCT01360463|Analgesics|analgesics|mesh-ancestor
110898386|NCT01360463|Sensory System Agents|sensory system agents|mesh-ancestor
110898387|NCT01360463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110898388|NCT01360463|Antitussive Agents|antitussive agents|mesh-ancestor
110898389|NCT01360463|Respiratory System Agents|respiratory system agents|mesh-ancestor
110898390|NCT01356641|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110898391|NCT01356641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110923824|NCT02606045|Tranexamic Acid|tranexamic acid|mesh-list
110898392|NCT03103087|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110898393|NCT03103087|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110898395|NCT03103087|Norethindrone Acetate|norethindrone acetate|mesh-list
110898396|NCT03103087|Estradiol|estradiol|mesh-list
110898397|NCT03103087|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110898398|NCT03103087|Relugolix|relugolix|mesh-list
110898399|NCT03103087|Estrogens|estrogens|mesh-ancestor
110898400|NCT03103087|Hormones|hormones|mesh-ancestor
110898401|NCT03103087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110898402|NCT03103087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110898403|NCT03103087|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110898404|NCT03103087|Contraceptive Agents|contraceptive agents|mesh-ancestor
110898405|NCT03103087|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110898406|NCT03103087|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110898407|NCT03103087|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110898408|NCT03103087|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110898409|NCT03103087|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110898410|NCT03103087|Androgen Antagonists|androgen antagonists|mesh-ancestor
110898411|NCT03103087|Hormone Antagonists|hormone antagonists|mesh-ancestor
110898412|NCT05579288|Nitrous Oxide|nitrous oxide|mesh-list
110898413|NCT05579288|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110898414|NCT05579288|Anesthetics, General|anesthetics, general|mesh-ancestor
110898415|NCT05579288|Anesthetics|anesthetics|mesh-ancestor
110898416|NCT05579288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110898417|NCT05579288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110898418|NCT05579288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110898419|NCT05579288|Analgesics|analgesics|mesh-ancestor
110898420|NCT05579288|Sensory System Agents|sensory system agents|mesh-ancestor
110898421|NCT05579288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110898422|NCT02134964|Dapansutrile|dapansutrile|mesh-list
110898423|NCT02134964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110898424|NCT01363583|Epoprostenol|epoprostenol|mesh-list
110898425|NCT01363583|Tezosentan|tezosentan|mesh-list
110898426|NCT01363583|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110898427|NCT01363583|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110898428|NCT01363583|Vasodilator Agents|vasodilator agents|mesh-ancestor
110898429|NCT02135120|Morphine|morphine|mesh-list
110898430|NCT02135120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110898431|NCT02135120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110898432|NCT02135120|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110898433|NCT02135120|Narcotics|narcotics|mesh-ancestor
110898434|NCT02135120|Analgesics|analgesics|mesh-ancestor
110898435|NCT02135120|Sensory System Agents|sensory system agents|mesh-ancestor
110898436|NCT02135120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110898437|NCT03131999|Imatinib Mesylate|imatinib mesylate|mesh-list
110898438|NCT03131999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110898439|NCT03131999|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110898440|NCT03131999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110898441|NCT03131999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110898442|NCT01319357|Saxagliptin|saxagliptin|mesh-list
110898443|NCT01319357|Incretins|incretins|mesh-ancestor
110898444|NCT01319357|Hormones|hormones|mesh-ancestor
110898445|NCT01319357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110898446|NCT01319357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110898447|NCT01319357|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110898448|NCT01319357|Protease Inhibitors|protease inhibitors|mesh-ancestor
110898449|NCT01319357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110898450|NCT01319357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110246996|NCT00481975|Hormones|hormones|mesh-ancestor
110898451|NCT01319357|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110898453|NCT02135354|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110898454|NCT02135354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110898455|NCT02055053|Bupivacaine|bupivacaine|mesh-list
110898456|NCT02055053|Anesthetics, Local|anesthetics, local|mesh-ancestor
110898457|NCT02055053|Anesthetics|anesthetics|mesh-ancestor
110898458|NCT02055053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110898459|NCT02055053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110898460|NCT02055053|Sensory System Agents|sensory system agents|mesh-ancestor
110898461|NCT02055053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110615912|NCT00336583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110898463|NCT02303431|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110898464|NCT02303431|Antithrombins|antithrombins|mesh-ancestor
110898465|NCT02303431|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110898466|NCT02303431|Protease Inhibitors|protease inhibitors|mesh-ancestor
110898467|NCT02303431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110898468|NCT02303431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110898469|NCT02303431|Anticoagulants|anticoagulants|mesh-ancestor
110898470|NCT02135510|Metoclopramide|metoclopramide|mesh-list
110898471|NCT02135510|Palonosetron|palonosetron|mesh-list
110898472|NCT02135510|Antiemetics|antiemetics|mesh-ancestor
110898473|NCT02135510|Autonomic Agents|autonomic agents|mesh-ancestor
110898474|NCT02135510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110898475|NCT02135510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110898476|NCT02135510|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110898477|NCT02135510|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110898478|NCT02135510|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110898479|NCT02135510|Dopamine Agents|dopamine agents|mesh-ancestor
110898480|NCT02135510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110898481|NCT02135510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110898482|NCT02135510|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110898483|NCT02135510|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110898484|NCT02135510|Serotonin Agents|serotonin agents|mesh-ancestor
110898485|NCT02004275|Dexamethasone|dexamethasone|mesh-list
110898486|NCT02004275|Pomalidomide|pomalidomide|mesh-list
110898487|NCT02004275|Ixazomib|ixazomib|mesh-list
110898488|NCT02004275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110898489|NCT02004275|Antiemetics|antiemetics|mesh-ancestor
110898490|NCT02004275|Autonomic Agents|autonomic agents|mesh-ancestor
110898491|NCT02004275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110898492|NCT02004275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110898493|NCT02004275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110898494|NCT02004275|Glucocorticoids|glucocorticoids|mesh-ancestor
110898495|NCT02004275|Hormones|hormones|mesh-ancestor
110898496|NCT02004275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110898497|NCT02004275|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110898498|NCT02004275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110898499|NCT02004275|Immunologic Factors|immunologic factors|mesh-ancestor
110898500|NCT02004275|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110898501|NCT02004275|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110898502|NCT02004275|Growth Substances|growth substances|mesh-ancestor
110898503|NCT02004275|Growth Inhibitors|growth inhibitors|mesh-ancestor
110898504|NCT02004275|Protease Inhibitors|protease inhibitors|mesh-ancestor
110898505|NCT02004275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110923845|NCT02559778|Vorinostat|vorinostat|mesh-list
110898506|NCT02004275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110898507|NCT03548714|Ethanol|ethanol|mesh-list
110898508|NCT03548714|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110224607|NCT06000709|Phenol|phenol|mesh-list
110224608|NCT06000709|Methylprednisolone|methylprednisolone|mesh-list
110224609|NCT06000709|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110224610|NCT06000709|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110898510|NCT03548714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110898511|NCT03548714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110898512|NCT02135588|Plasminogen|plasminogen|mesh-list
110898513|NCT02135588|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
110898514|NCT02135588|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110898515|NCT02135588|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110898516|NCT02135588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110898517|NCT01491763|Imatinib Mesylate|imatinib mesylate|mesh-list
110898518|NCT01491763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110898519|NCT01491763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110898520|NCT01491763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110898521|NCT01491763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110898522|NCT01363817|Dexamethasone|dexamethasone|mesh-list
110898523|NCT01363817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110898524|NCT01363817|Antiemetics|antiemetics|mesh-ancestor
110898525|NCT01363817|Autonomic Agents|autonomic agents|mesh-ancestor
110898526|NCT01363817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110898527|NCT01363817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110898528|NCT01363817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110898529|NCT01363817|Glucocorticoids|glucocorticoids|mesh-ancestor
110898530|NCT01363817|Hormones|hormones|mesh-ancestor
110898531|NCT01363817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110898532|NCT01363817|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110898533|NCT01363817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110898534|NCT02140268|Midazolam|midazolam|mesh-list
110898535|NCT02140268|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110898536|NCT02140268|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110898537|NCT02140268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110898538|NCT02140268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110898539|NCT02140268|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110898540|NCT02140268|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110898541|NCT02140268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110898542|NCT02140268|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110898543|NCT02140268|Anesthetics, General|anesthetics, general|mesh-ancestor
110898545|NCT02140268|GABA Modulators|gaba modulators|mesh-ancestor
110898546|NCT02140268|GABA Agents|gaba agents|mesh-ancestor
110898547|NCT02140268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110898548|NCT02140268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110898549|NCT05578352|Insulin|insulin|mesh-list
110898550|NCT05578352|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110898551|NCT05578352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110898552|NCT03602508|Solifenacin Succinate|solifenacin succinate|mesh-list
110898553|NCT03602508|Mirabegron|mirabegron|mesh-list
110898554|NCT03602508|Tolterodine Tartrate|tolterodine tartrate|mesh-list
110898555|NCT03602508|Fesoterodine|fesoterodine|mesh-list
110898556|NCT03602508|Oxybutynin|oxybutynin|mesh-list
110898557|NCT03602508|Darifenacin|darifenacin|mesh-list
110898558|NCT03602508|Propiverine|propiverine|mesh-list
110898559|NCT03602508|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110898560|NCT03602508|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110898561|NCT03602508|Cholinergic Agents|cholinergic agents|mesh-ancestor
110898562|NCT03602508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110898563|NCT03602508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110898564|NCT03602508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110898565|NCT03602508|Urological Agents|urological agents|mesh-ancestor
110898566|NCT03602508|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
110898567|NCT03602508|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110898568|NCT03602508|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110898569|NCT03602508|Adrenergic Agents|adrenergic agents|mesh-ancestor
110898570|NCT03602508|Parasympatholytics|parasympatholytics|mesh-ancestor
110898571|NCT03602508|Autonomic Agents|autonomic agents|mesh-ancestor
110898572|NCT03602508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110898574|NCT03549728|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110898575|NCT03549728|Immunologic Factors|immunologic factors|mesh-ancestor
110924816|NCT03098368|Dopamine Agonists|dopamine agonists|mesh-ancestor
110898576|NCT03549728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110898577|NCT01356797|Fentanyl|fentanyl|mesh-list
110898578|NCT01356797|Bupivacaine|bupivacaine|mesh-list
110898579|NCT01356797|Levobupivacaine|levobupivacaine|mesh-list
110898580|NCT01356797|Anesthetics, Local|anesthetics, local|mesh-ancestor
110898581|NCT01356797|Anesthetics|anesthetics|mesh-ancestor
110898582|NCT01356797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110898583|NCT01356797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110898584|NCT01356797|Sensory System Agents|sensory system agents|mesh-ancestor
110898585|NCT01356797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110898586|NCT01356797|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110898587|NCT01356797|Narcotics|narcotics|mesh-ancestor
110898588|NCT01356797|Analgesics|analgesics|mesh-ancestor
110898589|NCT01356797|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110898590|NCT01356797|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110898591|NCT01356797|Anesthetics, General|anesthetics, general|mesh-ancestor
110898592|NCT02238132|Ipratropium|ipratropium|mesh-list
110898593|NCT02238132|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110898594|NCT02238132|Autonomic Agents|autonomic agents|mesh-ancestor
110898595|NCT02238132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110898596|NCT02238132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110898597|NCT02238132|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110898598|NCT02238132|Respiratory System Agents|respiratory system agents|mesh-ancestor
110898599|NCT02238132|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110898600|NCT02238132|Cholinergic Agents|cholinergic agents|mesh-ancestor
110898601|NCT02238132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110898602|NCT02238132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110898603|NCT05200429|Ivacaftor|ivacaftor|mesh-list
110898604|NCT05200429|Elexacaftor|elexacaftor|mesh-list
110898605|NCT05200429|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
110898606|NCT05200429|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110898607|NCT05200429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110898608|NCT05578196|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110898609|NCT02135822|Paclitaxel|paclitaxel|mesh-list
110898610|NCT02135822|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110898611|NCT02135822|Gemcitabine|gemcitabine|mesh-list
110898612|NCT02135822|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110898613|NCT02135822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110898614|NCT02135822|Tubulin Modulators|tubulin modulators|mesh-ancestor
110898615|NCT02135822|Antimitotic Agents|antimitotic agents|mesh-ancestor
110898616|NCT02135822|Mitosis Modulators|mitosis modulators|mesh-ancestor
110898617|NCT02135822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110898618|NCT02135822|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110898619|NCT02135822|Antimetabolites|antimetabolites|mesh-ancestor
110898620|NCT02238210|Ipratropium|ipratropium|mesh-list
110898621|NCT02238210|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110898622|NCT02238210|Autonomic Agents|autonomic agents|mesh-ancestor
110898623|NCT02238210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110898624|NCT02238210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110898625|NCT02238210|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110898626|NCT02238210|Respiratory System Agents|respiratory system agents|mesh-ancestor
110898627|NCT02238210|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110923883|NCT02395666|Eflornithine|eflornithine|mesh-list
110898629|NCT02238210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110898630|NCT02238210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110898631|NCT05739955|Disinfectants|disinfectants|mesh-list
110898632|NCT05739955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110898633|NCT02978456|Sirolimus|sirolimus|mesh-list
110898634|NCT02978456|Temsirolimus|temsirolimus|mesh-list
110898635|NCT02978456|MTOR Inhibitors|mtor inhibitors|mesh-list
110898636|NCT02978456|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110898637|NCT02978456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110898638|NCT02978456|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110898639|NCT02978456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110898640|NCT02978456|Antifungal Agents|antifungal agents|mesh-ancestor
110898641|NCT02978456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110898642|NCT02978456|Immunologic Factors|immunologic factors|mesh-ancestor
110898643|NCT02978456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110898644|NCT02978456|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110898645|NCT02978456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110898646|NCT02978456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110898647|NCT05736913|Vaccines|vaccines|mesh-list
110898648|NCT05736913|Immunologic Factors|immunologic factors|mesh-ancestor
110898649|NCT05736913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110898650|NCT03598452|Ganciclovir|ganciclovir|mesh-list
110898651|NCT03598452|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
110898652|NCT03598452|Antiviral Agents|antiviral agents|mesh-ancestor
110898653|NCT03598452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110898654|NCT03598452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110898655|NCT03598452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110898656|NCT03598452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110898657|NCT03549026|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110898658|NCT03549026|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110898659|NCT03549026|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110898660|NCT03549026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110898661|NCT03549026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110898662|NCT03549026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110898663|NCT03549026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110898664|NCT03549026|Analgesics|analgesics|mesh-ancestor
110898665|NCT03549026|Sensory System Agents|sensory system agents|mesh-ancestor
110898666|NCT03549026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110898667|NCT03549026|Antidepressive Agents|antidepressive agents|mesh-ancestor
110898668|NCT03549026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110898669|NCT03549026|Dopamine Agents|dopamine agents|mesh-ancestor
110898670|NCT03101371|Iodine|iodine|mesh-list
110898671|NCT03101371|Povidone-Iodine|povidone-iodine|mesh-list
110898672|NCT03101371|Povidone|povidone|mesh-list
110898673|NCT03101371|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110898674|NCT03101371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110898675|NCT03101371|Trace Elements|trace elements|mesh-ancestor
110898676|NCT03101371|Micronutrients|micronutrients|mesh-ancestor
110898677|NCT03101371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110898678|NCT03101371|Plasma Substitutes|plasma substitutes|mesh-ancestor
110898679|NCT03101371|Blood Substitutes|blood substitutes|mesh-ancestor
110898680|NCT03588078|Azacitidine|azacitidine|mesh-list
110898681|NCT03588078|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110898682|NCT03588078|Antimetabolites|antimetabolites|mesh-ancestor
110898683|NCT03588078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110898684|NCT03588078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110898685|NCT03588078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110898686|NCT02238366|Triptorelin Pamoate|triptorelin pamoate|mesh-list
110898687|NCT02238366|Luteolytic Agents|luteolytic agents|mesh-ancestor
110898688|NCT02238366|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110898689|NCT02238366|Contraceptive Agents|contraceptive agents|mesh-ancestor
110898690|NCT02238366|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110898691|NCT02238366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110898692|NCT02238366|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110898693|NCT02238366|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110898694|NCT02238366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110898695|NCT05494190|Docetaxel|docetaxel|mesh-list
110898696|NCT05494190|Capecitabine|capecitabine|mesh-list
110898697|NCT05494190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110898698|NCT05494190|Tubulin Modulators|tubulin modulators|mesh-ancestor
110898699|NCT05494190|Antimitotic Agents|antimitotic agents|mesh-ancestor
110898700|NCT05494190|Mitosis Modulators|mitosis modulators|mesh-ancestor
110898701|NCT05494190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110898702|NCT05494190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110898703|NCT05494190|Antimetabolites|antimetabolites|mesh-ancestor
110898704|NCT02850276|Bromides|bromides|mesh-list
110898705|NCT02850276|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
110898706|NCT02850276|Anticonvulsants|anticonvulsants|mesh-ancestor
110898707|NCT02850276|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110898708|NCT02850276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110898709|NCT02850276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110898710|NCT02850276|Cholinergic Agents|cholinergic agents|mesh-ancestor
110898711|NCT02850276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110898712|NCT02850276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110898713|NCT04961593|Caspofungin|caspofungin|mesh-list
110898714|NCT04961593|Antifungal Agents|antifungal agents|mesh-ancestor
110898715|NCT04961593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110898716|NCT04961593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110898717|NCT04961593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110898718|NCT03862170|Ciprofloxacin|ciprofloxacin|mesh-list
110898719|NCT03862170|Cefazolin|cefazolin|mesh-list
110898720|NCT03862170|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110898721|NCT03862170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110224634|NCT06000657|Antiviral Agents|antiviral agents|mesh-ancestor
110898723|NCT03862170|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110898724|NCT03862170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110898725|NCT03862170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110898726|NCT03862170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110898727|NCT03862170|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110898728|NCT03862170|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110898729|NCT02140580|Pulmonary Surfactants|pulmonary surfactants|mesh-list
110898730|NCT02140580|Respiratory System Agents|respiratory system agents|mesh-ancestor
110898731|NCT05577806|Dydrogesterone|dydrogesterone|mesh-list
110898732|NCT05577806|Progestins|progestins|mesh-ancestor
110898733|NCT05577806|Hormones|hormones|mesh-ancestor
110898734|NCT05577806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110898735|NCT05577806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110898736|NCT03591276|Antineoplastic Agents|antineoplastic agents|mesh-list
110898737|NCT05465876|Cilgavimab and tixagevimab drug combination|cilgavimab and tixagevimab drug combination|mesh-list
110898738|NCT05465876|Antiviral Agents|antiviral agents|mesh-ancestor
110898739|NCT05465876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110898740|NCT03548948|Iron|iron|mesh-list
110898741|NCT03548948|Trace Elements|trace elements|mesh-ancestor
110898742|NCT03548948|Micronutrients|micronutrients|mesh-ancestor
110898743|NCT03548948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110898744|NCT02238444|Aspirin|aspirin|mesh-list
110898745|NCT02238444|Heparin|heparin|mesh-list
110898746|NCT02238444|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
110898747|NCT02238444|Tinzaparin|tinzaparin|mesh-list
110898748|NCT02238444|Dalteparin|dalteparin|mesh-list
110898749|NCT02238444|Dipyridamole|dipyridamole|mesh-list
110898750|NCT02238444|Warfarin|warfarin|mesh-list
110898751|NCT02238444|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110898752|NCT02238444|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110898753|NCT02238444|Analgesics|analgesics|mesh-ancestor
110898754|NCT02238444|Sensory System Agents|sensory system agents|mesh-ancestor
110898755|NCT02238444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110924817|NCT03098368|Dopamine Agents|dopamine agents|mesh-ancestor
110898756|NCT02238444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110898757|NCT02238444|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110898758|NCT02238444|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110898759|NCT02238444|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110898760|NCT02238444|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110898761|NCT02238444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110898762|NCT02238444|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110898763|NCT02238444|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110898764|NCT02238444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110898765|NCT02238444|Antipyretics|antipyretics|mesh-ancestor
110898766|NCT02238444|Anticoagulants|anticoagulants|mesh-ancestor
110898767|NCT02238444|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110898768|NCT02238444|Vasodilator Agents|vasodilator agents|mesh-ancestor
110898769|NCT03131687|Dulaglutide|dulaglutide|mesh-list
110898770|NCT03131687|Tirzepatide|tirzepatide|mesh-list
110898771|NCT03131687|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110898772|NCT03131687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110898773|NCT03131687|Incretins|incretins|mesh-ancestor
110898774|NCT03131687|Hormones|hormones|mesh-ancestor
110898775|NCT03131687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110898776|NCT03579888|Cyclophosphamide|cyclophosphamide|mesh-list
110898777|NCT03579888|Fludarabine|fludarabine|mesh-list
110898778|NCT03579888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110898779|NCT03579888|Immunologic Factors|immunologic factors|mesh-ancestor
110898780|NCT03579888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110898781|NCT03579888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110898782|NCT03579888|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110898783|NCT03579888|Alkylating Agents|alkylating agents|mesh-ancestor
110898784|NCT03579888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110898785|NCT03579888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110898786|NCT03579888|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110898787|NCT05344027|Mitotane|mitotane|mesh-list
110898788|NCT05344027|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110898789|NCT05344027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110898790|NCT05430698|Antibodies|antibodies|mesh-list
110898791|NCT05430698|Immunologic Factors|immunologic factors|mesh-ancestor
110898792|NCT05430698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110898793|NCT03585894|Ketorolac|ketorolac|mesh-list
110898794|NCT03585894|Sumatriptan|sumatriptan|mesh-list
110898795|NCT03585894|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110898796|NCT03585894|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110898797|NCT03585894|Analgesics|analgesics|mesh-ancestor
110898798|NCT03585894|Sensory System Agents|sensory system agents|mesh-ancestor
110898799|NCT03585894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110898800|NCT03585894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110898801|NCT03585894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110898802|NCT03585894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110898803|NCT03585894|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110898804|NCT03585894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110898805|NCT03585894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110898806|NCT03585894|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110898807|NCT03585894|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110898808|NCT03585894|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110898809|NCT03585894|Serotonin Agents|serotonin agents|mesh-ancestor
110898810|NCT03585894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110898811|NCT04912921|Palmidrol|palmidrol|mesh-list
110898812|NCT04912921|Curcumin|curcumin|mesh-list
110898813|NCT04912921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110898814|NCT04912921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110898815|NCT04912921|Analgesics|analgesics|mesh-ancestor
110898816|NCT04912921|Sensory System Agents|sensory system agents|mesh-ancestor
110898817|NCT04912921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110202974|NCT00399750|Bevacizumab|bevacizumab|mesh-list
110898818|NCT04912921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110898819|NCT04912921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110898820|NCT04912921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110898821|NCT04912921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110898822|NCT04912921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110898823|NCT04912921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110898824|NCT04912921|Antiviral Agents|antiviral agents|mesh-ancestor
110898825|NCT04912921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110898826|NCT04912921|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
110898827|NCT04912921|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110898828|NCT04912921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110898829|NCT04912921|Hormones|hormones|mesh-ancestor
110898830|NCT04912921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110898831|NCT05420324|Paclitaxel|paclitaxel|mesh-list
110898832|NCT05420324|Pembrolizumab|pembrolizumab|mesh-list
110898833|NCT05420324|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110898834|NCT05420324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110898835|NCT05420324|Tubulin Modulators|tubulin modulators|mesh-ancestor
110898836|NCT05420324|Antimitotic Agents|antimitotic agents|mesh-ancestor
110898837|NCT05420324|Mitosis Modulators|mitosis modulators|mesh-ancestor
110898838|NCT05420324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110898839|NCT05420324|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110898840|NCT05420324|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110898841|NCT02238288|Acetaminophen|acetaminophen|mesh-list
110898843|NCT02238288|Epinephrine|epinephrine|mesh-list
110898844|NCT02238288|Aminocaproic Acid|aminocaproic acid|mesh-list
110898845|NCT02238288|Anesthetics, Local|anesthetics, local|mesh-ancestor
110898846|NCT02238288|Anesthetics|anesthetics|mesh-ancestor
110898847|NCT02238288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110898848|NCT02238288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110898849|NCT02238288|Sensory System Agents|sensory system agents|mesh-ancestor
110898850|NCT02238288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110898851|NCT02238288|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110898852|NCT02238288|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110898853|NCT02238288|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110898854|NCT02238288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110898855|NCT02238288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110898856|NCT02238288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110898857|NCT02238288|Analgesics|analgesics|mesh-ancestor
110898858|NCT02238288|Antipyretics|antipyretics|mesh-ancestor
110898859|NCT02238288|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110898860|NCT02238288|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110898861|NCT02238288|Adrenergic Agents|adrenergic agents|mesh-ancestor
110898862|NCT02238288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110247402|NCT01241383|Bosentan|bosentan|mesh-list
110898863|NCT02238288|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110898864|NCT02238288|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110898865|NCT02238288|Autonomic Agents|autonomic agents|mesh-ancestor
110898866|NCT02238288|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110898867|NCT02238288|Respiratory System Agents|respiratory system agents|mesh-ancestor
110898868|NCT02238288|Mydriatics|mydriatics|mesh-ancestor
110898869|NCT02238288|Sympathomimetics|sympathomimetics|mesh-ancestor
110898870|NCT02238288|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110898871|NCT02238288|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110898872|NCT02238288|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110898873|NCT02238288|Hemostatics|hemostatics|mesh-ancestor
110898874|NCT02238288|Coagulants|coagulants|mesh-ancestor
110898875|NCT01561040|Vitamin D|vitamin d|mesh-list
110898876|NCT01561040|Vitamin A|vitamin a|mesh-list
110898877|NCT01561040|Vitamins|vitamins|mesh-ancestor
110898878|NCT01561040|Micronutrients|micronutrients|mesh-ancestor
110898879|NCT01561040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110898880|NCT01561040|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110898881|NCT03590496|Calcium|calcium|mesh-list
110898882|NCT03590496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110898883|NCT03590496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110898884|NCT05577260|Dexmedetomidine|dexmedetomidine|mesh-list
110898885|NCT05577260|Bupivacaine|bupivacaine|mesh-list
110898886|NCT05577260|Anesthetics, Local|anesthetics, local|mesh-ancestor
110898887|NCT05577260|Anesthetics|anesthetics|mesh-ancestor
110898888|NCT05577260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110898889|NCT05577260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110898890|NCT05577260|Sensory System Agents|sensory system agents|mesh-ancestor
110898891|NCT05577260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110898892|NCT05577260|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110898893|NCT05577260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110898894|NCT05577260|Analgesics|analgesics|mesh-ancestor
110898895|NCT05577260|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110898896|NCT05577260|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110898897|NCT05577260|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110898898|NCT05577260|Adrenergic Agents|adrenergic agents|mesh-ancestor
110898899|NCT05577260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110898900|NCT05577260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110898901|NCT03760562|Glucocorticoids|glucocorticoids|mesh-list
110898902|NCT03760562|Hormones|hormones|mesh-ancestor
110898903|NCT03760562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110898904|NCT03760562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110898905|NCT01357031|Amitriptyline|amitriptyline|mesh-list
110898906|NCT01357031|Melatonin|melatonin|mesh-list
110898907|NCT01357031|Antioxidants|antioxidants|mesh-ancestor
110898908|NCT01357031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110898909|NCT01357031|Protective Agents|protective agents|mesh-ancestor
110898910|NCT01357031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110898911|NCT01357031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110898912|NCT01357031|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110898913|NCT01357031|Antidepressive Agents|antidepressive agents|mesh-ancestor
110898914|NCT01357031|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110898915|NCT01357031|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110898916|NCT01357031|Analgesics|analgesics|mesh-ancestor
110898917|NCT01357031|Sensory System Agents|sensory system agents|mesh-ancestor
110898918|NCT01357031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110898919|NCT01357031|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110898920|NCT01357031|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110898921|NCT01357031|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110898922|NCT01357031|Adrenergic Agents|adrenergic agents|mesh-ancestor
110898923|NCT01357031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110898924|NCT01357109|Bosentan|bosentan|mesh-list
110898925|NCT01357109|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110898926|NCT01357109|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
110898927|NCT01357109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110898928|NCT02253446|Diclofenac|diclofenac|mesh-list
110898929|NCT02253446|Piroxicam|piroxicam|mesh-list
110898930|NCT02253446|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110224647|NCT06000137|Flurbiprofen|flurbiprofen|mesh-list
110898931|NCT02253446|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110898932|NCT02253446|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110898934|NCT02253446|Sensory System Agents|sensory system agents|mesh-ancestor
110898935|NCT02253446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110898936|NCT02253446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110898937|NCT02253446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110898938|NCT02253446|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110898939|NCT02253446|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110898940|NCT02253446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110898941|NCT02253446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110898942|NCT05417893|Sirolimus|sirolimus|mesh-list
110898943|NCT05417893|Everolimus|everolimus|mesh-list
110923940|NCT05015608|Carboplatin|carboplatin|mesh-list
110898945|NCT05417893|Temsirolimus|temsirolimus|mesh-list
110898946|NCT05417893|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110898947|NCT05417893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110898948|NCT05417893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110898949|NCT05417893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110898950|NCT05417893|Immunologic Factors|immunologic factors|mesh-ancestor
110898951|NCT05417893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110898952|NCT05417893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110898953|NCT05417893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110898954|NCT05417893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110898955|NCT05417893|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110898956|NCT05417893|Antifungal Agents|antifungal agents|mesh-ancestor
110898957|NCT03585348|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
110898958|NCT03585348|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110898959|NCT03585348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110898960|NCT03585348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110898961|NCT05384678|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
110898962|NCT05384678|Hallucinogens|hallucinogens|mesh-ancestor
110898963|NCT05384678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110898964|NCT05384678|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110898965|NCT05384678|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110898966|NCT05384678|Serotonin Agents|serotonin agents|mesh-ancestor
110898967|NCT05384678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110898968|NCT05384678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110898969|NCT05384678|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110898970|NCT01563224|Baclofen|baclofen|mesh-list
110898971|NCT01563224|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110898972|NCT01563224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110898973|NCT01563224|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110898974|NCT01563224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110898975|NCT01563224|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
110898976|NCT01563224|GABA Agonists|gaba agonists|mesh-ancestor
110898977|NCT01563224|GABA Agents|gaba agents|mesh-ancestor
110898978|NCT01563224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110898979|NCT01563224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110898980|NCT01369979|Imidacloprid|imidacloprid|mesh-list
110898981|NCT01369979|Cholinergic Agents|cholinergic agents|mesh-ancestor
110898982|NCT01369979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110898983|NCT01369979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110898984|NCT01369979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110898985|NCT03577860|Bupivacaine|bupivacaine|mesh-list
110898986|NCT03577860|Anesthetics, Local|anesthetics, local|mesh-ancestor
110898987|NCT03577860|Anesthetics|anesthetics|mesh-ancestor
110898988|NCT03577860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110898989|NCT03577860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110898991|NCT03577860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110898992|NCT03577782|Vedolizumab|vedolizumab|mesh-list
110898993|NCT03577782|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110898994|NCT03432065|Buspirone|buspirone|mesh-list
110898995|NCT03432065|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110898996|NCT03432065|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110898997|NCT03432065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110898998|NCT03432065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110898999|NCT03432065|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110899000|NCT03432065|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110899001|NCT03432065|Serotonin Agents|serotonin agents|mesh-ancestor
110224656|NCT06000137|Analgesics|analgesics|mesh-ancestor
110899003|NCT03432065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110899004|NCT03577626|Hemay005|hemay005|mesh-list
110899005|NCT03577626|Dermatologic Agents|dermatologic agents|mesh-ancestor
110899006|NCT03577626|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
110899007|NCT03577626|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110899008|NCT03577626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110899009|NCT03577626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110899011|NCT03412799|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110899012|NCT03412799|Gemcitabine|gemcitabine|mesh-list
110899013|NCT03412799|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110899014|NCT03412799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110899015|NCT03412799|Tubulin Modulators|tubulin modulators|mesh-ancestor
110899016|NCT03412799|Antimitotic Agents|antimitotic agents|mesh-ancestor
110899017|NCT03412799|Mitosis Modulators|mitosis modulators|mesh-ancestor
110899018|NCT03412799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110899019|NCT03412799|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110899020|NCT03412799|Antimetabolites|antimetabolites|mesh-ancestor
110899021|NCT03579732|Aspirin|aspirin|mesh-list
110899022|NCT03579732|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110899023|NCT03579732|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110899024|NCT03579732|Analgesics|analgesics|mesh-ancestor
110899025|NCT03579732|Sensory System Agents|sensory system agents|mesh-ancestor
110899026|NCT03579732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110899027|NCT03579732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110899028|NCT03579732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110899029|NCT03579732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110899030|NCT03579732|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110899031|NCT03579732|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110899032|NCT03579732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110899033|NCT03579732|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110899034|NCT03579732|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110899035|NCT03579732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110899036|NCT03579732|Antipyretics|antipyretics|mesh-ancestor
110899037|NCT02259816|Amlodipine|amlodipine|mesh-list
110899038|NCT02259816|Telmisartan|telmisartan|mesh-list
110899039|NCT02259816|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110899040|NCT02259816|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110899041|NCT02259816|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110899042|NCT02259816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110899043|NCT02259816|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110899044|NCT02259816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110899045|NCT02259816|Vasodilator Agents|vasodilator agents|mesh-ancestor
110899046|NCT02259816|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110899047|NCT02259816|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110899048|NCT01567735|Simeprevir|simeprevir|mesh-list
110899049|NCT01567735|Antiviral Agents|antiviral agents|mesh-ancestor
110899050|NCT01567735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110899051|NCT01567735|Protease Inhibitors|protease inhibitors|mesh-ancestor
110899052|NCT01567735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110899053|NCT01567735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110899054|NCT04631471|Ibudilast|ibudilast|mesh-list
110899055|NCT04631471|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110899056|NCT04631471|Autonomic Agents|autonomic agents|mesh-ancestor
110899057|NCT04631471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110899058|NCT04631471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110899059|NCT04631471|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110899060|NCT04631471|Respiratory System Agents|respiratory system agents|mesh-ancestor
110899061|NCT04631471|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110899062|NCT04631471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110899063|NCT04631471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110923961|NCT02646124|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110203025|NCT00044187|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110899064|NCT04631471|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110899066|NCT03577392|Capecitabine|capecitabine|mesh-list
110899067|NCT03577392|Oxaliplatin|oxaliplatin|mesh-list
110899068|NCT03577392|Endostatins|endostatins|mesh-list
110899069|NCT03577392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110899070|NCT03577392|Antimetabolites|antimetabolites|mesh-ancestor
110899071|NCT03577392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110899072|NCT03577392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110899073|NCT03577392|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110899074|NCT03577392|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110899075|NCT03577392|Growth Substances|growth substances|mesh-ancestor
110899076|NCT03577392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110899077|NCT03577392|Growth Inhibitors|growth inhibitors|mesh-ancestor
110899078|NCT03579576|Ribavirin|ribavirin|mesh-list
110899079|NCT03579576|Sofosbuvir|sofosbuvir|mesh-list
110899080|NCT03579576|Velpatasvir|velpatasvir|mesh-list
110899081|NCT03579576|Antimetabolites|antimetabolites|mesh-ancestor
110899082|NCT03579576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110899083|NCT03579576|Antiviral Agents|antiviral agents|mesh-ancestor
110899084|NCT03579576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110899085|NCT01364519|Fluticasone|fluticasone|mesh-list
110899086|NCT01364519|Xhance|xhance|mesh-list
110899087|NCT01364519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110899088|NCT01364519|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110899089|NCT01364519|Autonomic Agents|autonomic agents|mesh-ancestor
110899090|NCT01364519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110899091|NCT01364519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110899092|NCT01364519|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110899093|NCT01364519|Respiratory System Agents|respiratory system agents|mesh-ancestor
110899094|NCT01364519|Dermatologic Agents|dermatologic agents|mesh-ancestor
110899095|NCT01364519|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110899096|NCT03577158|Insulin|insulin|mesh-list
110899097|NCT03577158|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110899098|NCT03577158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110899099|NCT02253914|Ritonavir|ritonavir|mesh-list
110899100|NCT02253914|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110899101|NCT02253914|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110899102|NCT02253914|Protease Inhibitors|protease inhibitors|mesh-ancestor
110899103|NCT02253914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110899104|NCT02253914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110899105|NCT02253914|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110899106|NCT02253914|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110899107|NCT02253914|Antiviral Agents|antiviral agents|mesh-ancestor
110899108|NCT02253914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110899109|NCT02253914|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110899110|NCT02253914|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110899111|NCT01364675|Metformin|metformin|mesh-list
110899112|NCT01364675|Enalapril|enalapril|mesh-list
110899113|NCT01364675|Simvastatin|simvastatin|mesh-list
110899114|NCT01364675|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110899115|NCT01364675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110899116|NCT01364675|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110899117|NCT01364675|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110899118|NCT01364675|Antimetabolites|antimetabolites|mesh-ancestor
110899119|NCT01364675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110899120|NCT01364675|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110899121|NCT01364675|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110899122|NCT01364675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110899123|NCT01364675|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110899124|NCT01364675|Protease Inhibitors|protease inhibitors|mesh-ancestor
110899125|NCT01364675|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110899126|NCT02253758|Propofol|propofol|mesh-list
110899127|NCT02253758|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110899128|NCT02253758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110899129|NCT02253758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110899130|NCT02253758|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110899131|NCT02253758|Anesthetics, General|anesthetics, general|mesh-ancestor
110899132|NCT02253758|Anesthetics|anesthetics|mesh-ancestor
110899133|NCT03547232|Indomethacin|indomethacin|mesh-list
110899134|NCT03547232|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110899135|NCT03547232|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110899136|NCT03547232|Analgesics|analgesics|mesh-ancestor
110899137|NCT03547232|Sensory System Agents|sensory system agents|mesh-ancestor
110899138|NCT03547232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110899139|NCT03547232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110899140|NCT03547232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110899141|NCT03547232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110899142|NCT03547232|Gout Suppressants|gout suppressants|mesh-ancestor
110899143|NCT03547232|Tocolytic Agents|tocolytic agents|mesh-ancestor
110899144|NCT03547232|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110899145|NCT03547232|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110899146|NCT03547232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110899147|NCT03547232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110899149|NCT02250534|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110899150|NCT02250534|Autonomic Agents|autonomic agents|mesh-ancestor
110899151|NCT02250534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110899152|NCT02250534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110899153|NCT02250534|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110899154|NCT02250534|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110899155|NCT02250534|Cholinergic Agents|cholinergic agents|mesh-ancestor
110899156|NCT02250534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110899157|NCT02250534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110899158|NCT01370135|Ranibizumab|ranibizumab|mesh-list
110899159|NCT01370135|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110899160|NCT01370135|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110899161|NCT01370135|Growth Substances|growth substances|mesh-ancestor
110899162|NCT01370135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110899163|NCT01370135|Growth Inhibitors|growth inhibitors|mesh-ancestor
110899164|NCT01370135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110899165|NCT05266586|Ezetimibe|ezetimibe|mesh-list
110899166|NCT05266586|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110899167|NCT05266586|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110899168|NCT05266586|Antimetabolites|antimetabolites|mesh-ancestor
110899169|NCT05266586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110899170|NCT05266586|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110899171|NCT01370291|Risperidone|risperidone|mesh-list
110899172|NCT01370291|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110899173|NCT01370291|Serotonin Agents|serotonin agents|mesh-ancestor
110899174|NCT01370291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110899175|NCT01370291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110899176|NCT01370291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110899177|NCT01370291|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110899178|NCT01370291|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110899179|NCT01370291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110899180|NCT01370291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110899181|NCT01370291|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110899182|NCT01370291|Dopamine Agents|dopamine agents|mesh-ancestor
110899183|NCT05575544|Morphine|morphine|mesh-list
110899184|NCT05575544|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110899185|NCT05575544|Narcotics|narcotics|mesh-ancestor
110899186|NCT05575544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110899187|NCT05575544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110899188|NCT05575544|Analgesics|analgesics|mesh-ancestor
110899189|NCT05575544|Sensory System Agents|sensory system agents|mesh-ancestor
110899190|NCT05575544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110899191|NCT05179772|Olanzapine|olanzapine|mesh-list
110899192|NCT05179772|Antiemetics|antiemetics|mesh-ancestor
110899193|NCT05179772|Autonomic Agents|autonomic agents|mesh-ancestor
110923983|NCT02646124|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110899194|NCT05179772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110899195|NCT05179772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110899196|NCT05179772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110899197|NCT05179772|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110899198|NCT05179772|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110899199|NCT05179772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110899200|NCT05179772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110899201|NCT05179772|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110899202|NCT05179772|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110899203|NCT05179772|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110899204|NCT05179772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110899205|NCT05179772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110899206|NCT05179772|Serotonin Agents|serotonin agents|mesh-ancestor
110899207|NCT01364987|Mycophenolic Acid|mycophenolic acid|mesh-list
110899208|NCT01364987|Peficitinib|peficitinib|mesh-list
110899209|NCT01364987|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110899210|NCT01364987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110899211|NCT01364987|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110899212|NCT01364987|Antitubercular Agents|antitubercular agents|mesh-ancestor
110616672|NCT00927693|Calcium|calcium|mesh-list
110899214|NCT01364987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110899215|NCT01364987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110899216|NCT01364987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110899217|NCT01364987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110899218|NCT01364987|Immunologic Factors|immunologic factors|mesh-ancestor
110899219|NCT01364987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110899220|NCT01365923|Dexmedetomidine|dexmedetomidine|mesh-list
110899221|NCT01365923|Remifentanil|remifentanil|mesh-list
110899222|NCT01365923|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110899223|NCT01365923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110899224|NCT01365923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110899225|NCT01365923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110899226|NCT01365923|Analgesics|analgesics|mesh-ancestor
110899227|NCT01365923|Sensory System Agents|sensory system agents|mesh-ancestor
110899228|NCT01365923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110899229|NCT01365923|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110899230|NCT01365923|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110899231|NCT01365923|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110899232|NCT01365923|Adrenergic Agents|adrenergic agents|mesh-ancestor
110899233|NCT01365923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110899234|NCT01365923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110899235|NCT01365923|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110899236|NCT01365923|Narcotics|narcotics|mesh-ancestor
110899237|NCT01370915|Vitamins|vitamins|mesh-list
110899238|NCT01370915|Pregabalin|pregabalin|mesh-list
110899239|NCT01370915|Micronutrients|micronutrients|mesh-ancestor
110899240|NCT01370915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110899241|NCT01370915|Analgesics|analgesics|mesh-ancestor
110899242|NCT01370915|Sensory System Agents|sensory system agents|mesh-ancestor
110899243|NCT01370915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110899244|NCT01370915|Anticonvulsants|anticonvulsants|mesh-ancestor
110899245|NCT01370915|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110899246|NCT01370915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110899247|NCT01370915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110899248|NCT01370915|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110899249|NCT01370915|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110899250|NCT01370915|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110899251|NCT01370915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110899252|NCT01370915|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110899253|NCT05574998|Paclitaxel|paclitaxel|mesh-list
110899254|NCT05574998|Cisplatin|cisplatin|mesh-list
110899255|NCT05574998|Carboplatin|carboplatin|mesh-list
110899256|NCT05574998|Pemetrexed|pemetrexed|mesh-list
110899257|NCT05574998|Endostar protein|endostar protein|mesh-list
110899258|NCT05574998|Endostatins|endostatins|mesh-list
110899259|NCT05574998|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110899260|NCT05574998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110899261|NCT05574998|Tubulin Modulators|tubulin modulators|mesh-ancestor
110899262|NCT05574998|Antimitotic Agents|antimitotic agents|mesh-ancestor
110899263|NCT05574998|Mitosis Modulators|mitosis modulators|mesh-ancestor
110899264|NCT05574998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110899265|NCT05574998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110899266|NCT05574998|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110899267|NCT05574998|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110899268|NCT05574998|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110899269|NCT05574998|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110899270|NCT05574998|Growth Substances|growth substances|mesh-ancestor
110899271|NCT05574998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110899272|NCT05574998|Growth Inhibitors|growth inhibitors|mesh-ancestor
110899273|NCT03547778|Misoprostol|misoprostol|mesh-list
110899274|NCT03547778|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110899275|NCT03547778|Abortifacient Agents|abortifacient agents|mesh-ancestor
110899276|NCT03547778|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110899277|NCT03547778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110899278|NCT03547778|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110899279|NCT03547778|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110899280|NCT03547778|Oxytocics|oxytocics|mesh-ancestor
110899281|NCT03547700|Ixazomib|ixazomib|mesh-list
110899282|NCT03547700|Romidepsin|romidepsin|mesh-list
110899283|NCT03547700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110899284|NCT03547700|Protease Inhibitors|protease inhibitors|mesh-ancestor
110899285|NCT03547700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110899286|NCT03547700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110899287|NCT03547700|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110899288|NCT03547700|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110899290|NCT02239458|Incretins|incretins|mesh-ancestor
110899291|NCT02239458|Hormones|hormones|mesh-ancestor
110899292|NCT02239458|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110899293|NCT02239458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110899294|NCT02239458|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110899295|NCT02239458|Protease Inhibitors|protease inhibitors|mesh-ancestor
110899296|NCT02239458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110899297|NCT02239458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110899298|NCT02239458|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110899299|NCT03578874|Capecitabine|capecitabine|mesh-list
110899300|NCT03578874|Oxaliplatin|oxaliplatin|mesh-list
110899301|NCT03578874|Sorafenib|sorafenib|mesh-list
110899302|NCT03578874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110899303|NCT03578874|Antimetabolites|antimetabolites|mesh-ancestor
110899304|NCT03578874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110899305|NCT03578874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110899306|NCT03578874|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110899307|NCT03578874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110899308|NCT01366001|Buprenorphine|buprenorphine|mesh-list
110899309|NCT01366001|ALKS-33|alks-33|mesh-list
110899310|NCT01366001|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110899311|NCT01366001|Narcotics|narcotics|mesh-ancestor
110899312|NCT01366001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110899313|NCT01366001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110899314|NCT01366001|Analgesics|analgesics|mesh-ancestor
110899315|NCT01366001|Sensory System Agents|sensory system agents|mesh-ancestor
110899316|NCT01366001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110924025|NCT03507842|Cytarabine|cytarabine|mesh-list
110899317|NCT01366001|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110899318|NCT01365065|Vorinostat|vorinostat|mesh-list
110899319|NCT01365065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110899320|NCT01365065|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110899321|NCT01365065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110899322|NCT01365065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110899323|NCT03576456|Alprazolam|alprazolam|mesh-list
110899324|NCT03576456|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110899325|NCT03576456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110899326|NCT03576456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110899327|NCT03576456|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110899328|NCT03576456|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110899329|NCT03576456|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110899330|NCT03576456|GABA Modulators|gaba modulators|mesh-ancestor
110899331|NCT03576456|GABA Agents|gaba agents|mesh-ancestor
110899332|NCT03576456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110899333|NCT03576456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110899334|NCT03576378|Prednisone|prednisone|mesh-list
110899335|NCT03576378|Cyclophosphamide|cyclophosphamide|mesh-list
110899336|NCT03576378|Etoposide|etoposide|mesh-list
110899337|NCT03576378|Mitoxantrone|mitoxantrone|mesh-list
110899338|NCT03576378|Procarbazine|procarbazine|mesh-list
110899339|NCT03576378|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110899340|NCT03576378|Immunologic Factors|immunologic factors|mesh-ancestor
110899341|NCT03576378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110899342|NCT03576378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110899343|NCT03576378|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110899344|NCT03576378|Alkylating Agents|alkylating agents|mesh-ancestor
110899345|NCT03576378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110899346|NCT03576378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110899347|NCT03576378|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110899348|NCT03576378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110899349|NCT03576378|Glucocorticoids|glucocorticoids|mesh-ancestor
110899350|NCT03576378|Hormones|hormones|mesh-ancestor
110899351|NCT03576378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110899352|NCT03576378|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110899353|NCT03576378|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110899354|NCT03576378|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110899355|NCT03576378|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110899356|NCT03576378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110899357|NCT03576378|Analgesics|analgesics|mesh-ancestor
110899358|NCT03576378|Sensory System Agents|sensory system agents|mesh-ancestor
110899359|NCT03576378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110899360|NCT05572190|Hydrocodone|hydrocodone|mesh-list
110899361|NCT05572190|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110899362|NCT05572190|Narcotics|narcotics|mesh-ancestor
110899363|NCT05572190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110899364|NCT05572190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110899365|NCT05572190|Analgesics|analgesics|mesh-ancestor
110899366|NCT05572190|Sensory System Agents|sensory system agents|mesh-ancestor
110899367|NCT05572190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110899368|NCT05572190|Antitussive Agents|antitussive agents|mesh-ancestor
110899369|NCT05572190|Respiratory System Agents|respiratory system agents|mesh-ancestor
110899370|NCT01365221|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
110899371|NCT01365221|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110899372|NCT05567588|Pembrolizumab|pembrolizumab|mesh-list
110899373|NCT05567588|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110899374|NCT05567588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110899375|NCT05567588|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110899376|NCT05567588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110899377|NCT03124199|Rifaximin|rifaximin|mesh-list
110899378|NCT03124199|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110899379|NCT03124199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110899380|NCT03124199|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110899381|NCT03578640|Grazoprevir|grazoprevir|mesh-list
110899382|NCT03578640|Antiviral Agents|antiviral agents|mesh-ancestor
110899383|NCT03578640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110899385|NCT04465916|Entecavir|entecavir|mesh-list
110899386|NCT04465916|Antiviral Agents|antiviral agents|mesh-ancestor
110899387|NCT04465916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110899388|NCT04465916|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110899389|NCT04465916|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110899390|NCT04465916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110899391|NCT04465916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110899392|NCT04465916|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110899393|NCT04465916|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110899394|NCT01366235|Chloroquine|chloroquine|mesh-list
110899395|NCT01366235|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
110899396|NCT01366235|Amebicides|amebicides|mesh-ancestor
110899397|NCT01366235|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110899398|NCT01366235|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110899399|NCT01366235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110899400|NCT01366235|Antimalarials|antimalarials|mesh-ancestor
110899401|NCT01366235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110899402|NCT01366235|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110899403|NCT01366235|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110899404|NCT01366235|Analgesics|analgesics|mesh-ancestor
110899405|NCT01366235|Sensory System Agents|sensory system agents|mesh-ancestor
110899406|NCT01366235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110899407|NCT01366235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110899408|NCT01366235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110899409|NCT01366235|Filaricides|filaricides|mesh-ancestor
110899410|NCT01366235|Antinematodal Agents|antinematodal agents|mesh-ancestor
110899411|NCT01366235|Anthelmintics|anthelmintics|mesh-ancestor
110899412|NCT04871165|Immunoglobulins|immunoglobulins|mesh-list
110899413|NCT04871165|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110899414|NCT04871165|Antibodies|antibodies|mesh-list
110899415|NCT04871165|Immunologic Factors|immunologic factors|mesh-ancestor
110899416|NCT04871165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110899417|NCT04465760|Antibodies|antibodies|mesh-list
110899418|NCT04465760|Immunoglobulins|immunoglobulins|mesh-list
110899419|NCT04465760|Immunologic Factors|immunologic factors|mesh-ancestor
110899420|NCT04465760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110899421|NCT04249739|Pembrolizumab|pembrolizumab|mesh-list
110899422|NCT04249739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110899423|NCT04249739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110899424|NCT04249739|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110899425|NCT04249739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110899426|NCT01366313|Acetaminophen|acetaminophen|mesh-list
110899427|NCT01366313|Morphine|morphine|mesh-list
110899428|NCT01366313|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110899429|NCT01366313|Narcotics|narcotics|mesh-ancestor
110899430|NCT01366313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110899431|NCT01366313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110899432|NCT01366313|Analgesics|analgesics|mesh-ancestor
110899433|NCT01366313|Sensory System Agents|sensory system agents|mesh-ancestor
110899434|NCT01366313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110899435|NCT01366313|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110899436|NCT01366313|Antipyretics|antipyretics|mesh-ancestor
110899437|NCT02253524|Metoclopramide|metoclopramide|mesh-list
110899438|NCT02253524|Dimenhydrinate|dimenhydrinate|mesh-list
110899439|NCT02253524|Antiemetics|antiemetics|mesh-ancestor
110899440|NCT02253524|Autonomic Agents|autonomic agents|mesh-ancestor
110899441|NCT02253524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110899442|NCT02253524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110899443|NCT02253524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110899444|NCT02253524|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110899445|NCT02253524|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110899446|NCT02253524|Dopamine Agents|dopamine agents|mesh-ancestor
110899447|NCT02253524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110899448|NCT02253524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110899449|NCT02253524|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110899450|NCT02253524|Histamine Antagonists|histamine antagonists|mesh-ancestor
110899451|NCT02253524|Histamine Agents|histamine agents|mesh-ancestor
110899452|NCT02253602|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
110899454|NCT02253602|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
110899455|NCT02253602|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110899456|NCT03575520|Cyclophosphamide|cyclophosphamide|mesh-list
110899457|NCT03575520|Doxorubicin|doxorubicin|mesh-list
110899458|NCT03575520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110899459|NCT03575520|Immunologic Factors|immunologic factors|mesh-ancestor
110899460|NCT03575520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110899461|NCT03575520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110899462|NCT03575520|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110899463|NCT03575520|Alkylating Agents|alkylating agents|mesh-ancestor
110899464|NCT03575520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110899465|NCT03575520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110899466|NCT03575520|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110899467|NCT03575520|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110899468|NCT03575520|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110899469|NCT03575520|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110899470|NCT03575520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110899471|NCT01366391|Metformin|metformin|mesh-list
110899472|NCT01366391|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110899473|NCT01366391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110899474|NCT04408586|Topiramate|topiramate|mesh-list
110899475|NCT04408586|Phentermine|phentermine|mesh-list
110899476|NCT04408586|Anticonvulsants|anticonvulsants|mesh-ancestor
110899477|NCT04408586|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110899478|NCT04408586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110899479|NCT04408586|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110899480|NCT04408586|Appetite Depressants|appetite depressants|mesh-ancestor
110899481|NCT04408586|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110899482|NCT04408586|Sympathomimetics|sympathomimetics|mesh-ancestor
110899483|NCT04408586|Autonomic Agents|autonomic agents|mesh-ancestor
110899484|NCT04408586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110899485|NCT04408586|Adrenergic Agents|adrenergic agents|mesh-ancestor
110899486|NCT04408586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110899487|NCT04408586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110899488|NCT02239614|Aluminum Hydroxide|aluminum hydroxide|mesh-list
110899489|NCT02239614|Aluminum sulfate|aluminum sulfate|mesh-list
110899490|NCT02239614|Immunologic Factors|immunologic factors|mesh-ancestor
110899491|NCT02239614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110899492|NCT02239614|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110899493|NCT02239614|Antacids|antacids|mesh-ancestor
110899494|NCT02239614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110899495|NCT02239614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110899496|NCT03572400|Gemcitabine|gemcitabine|mesh-list
110899497|NCT03572400|Durvalumab|durvalumab|mesh-list
110899498|NCT03572400|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110899499|NCT03572400|Antimetabolites|antimetabolites|mesh-ancestor
110899500|NCT03572400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110899501|NCT03572400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110899502|NCT03572400|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110899503|NCT02253836|Ritonavir|ritonavir|mesh-list
110899504|NCT02253836|Atazanavir Sulfate|atazanavir sulfate|mesh-list
110899505|NCT02253836|Tipranavir|tipranavir|mesh-list
110899506|NCT02253836|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110899507|NCT02253836|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110899508|NCT02253836|Protease Inhibitors|protease inhibitors|mesh-ancestor
110899509|NCT02253836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110899510|NCT02253836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110899511|NCT02253836|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110899512|NCT02253836|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110899513|NCT02253836|Antiviral Agents|antiviral agents|mesh-ancestor
110899514|NCT02253836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110899515|NCT02253836|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110899516|NCT02253836|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110899517|NCT03575130|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110899518|NCT03575130|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110899520|NCT02241018|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110899521|NCT02241018|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
110899522|NCT02241018|Immunologic Factors|immunologic factors|mesh-ancestor
110899523|NCT02241018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110899524|NCT02241018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110899525|NCT02241018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110899526|NCT04039022|Dextromethorphan|dextromethorphan|mesh-list
110899527|NCT04039022|Bupropion|bupropion|mesh-list
110899528|NCT04039022|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110899529|NCT04039022|Antidepressive Agents|antidepressive agents|mesh-ancestor
110899530|NCT04039022|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110899531|NCT04039022|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110899532|NCT04039022|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110899533|NCT04039022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110899534|NCT04039022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110899535|NCT04039022|Dopamine Agents|dopamine agents|mesh-ancestor
110899536|NCT04039022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110899537|NCT04039022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110899538|NCT04039022|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110899539|NCT04039022|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110899540|NCT04039022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110899541|NCT04039022|Antitussive Agents|antitussive agents|mesh-ancestor
110899542|NCT04039022|Respiratory System Agents|respiratory system agents|mesh-ancestor
110899543|NCT04039022|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110899544|NCT04039022|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110899545|NCT00109772|Lenalidomide|lenalidomide|mesh-list
110899546|NCT00109772|Immunologic Factors|immunologic factors|mesh-ancestor
110899547|NCT00109772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110899548|NCT00109772|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110899549|NCT00109772|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110899550|NCT00109772|Growth Substances|growth substances|mesh-ancestor
110899551|NCT00109772|Growth Inhibitors|growth inhibitors|mesh-ancestor
110899552|NCT00109772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110899553|NCT03572010|Fesoterodine|fesoterodine|mesh-list
110899554|NCT03572010|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110899555|NCT03572010|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110899556|NCT03572010|Cholinergic Agents|cholinergic agents|mesh-ancestor
110899557|NCT03572010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110899558|NCT03572010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110899559|NCT03572010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110899560|NCT03572010|Urological Agents|urological agents|mesh-ancestor
110899561|NCT01560104|Paclitaxel|paclitaxel|mesh-list
110899562|NCT01560104|Carboplatin|carboplatin|mesh-list
110899563|NCT01560104|Veliparib|veliparib|mesh-list
110899564|NCT01560104|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110899565|NCT01560104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110899566|NCT01560104|Tubulin Modulators|tubulin modulators|mesh-ancestor
110899567|NCT01560104|Antimitotic Agents|antimitotic agents|mesh-ancestor
110899568|NCT01560104|Mitosis Modulators|mitosis modulators|mesh-ancestor
110203146|NCT00044343|Lapatinib|lapatinib|mesh-list
110899569|NCT01560104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110899570|NCT01560104|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110899571|NCT01560104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110899572|NCT00101972|Antibodies|antibodies|mesh-list
110899573|NCT00101972|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110899574|NCT00101972|Immunologic Factors|immunologic factors|mesh-ancestor
110899575|NCT00101972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110899576|NCT02245932|Resveratrol|resveratrol|mesh-list
110899578|NCT02245932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110899579|NCT02245932|Protective Agents|protective agents|mesh-ancestor
110899580|NCT02245932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110899581|NCT02245932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110899582|NCT02245932|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110899583|NCT03573102|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
110899584|NCT03573102|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
110899585|NCT03573102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110899586|NCT03573102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110899587|NCT03573102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110899588|NCT03573102|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110899589|NCT03573102|Protease Inhibitors|protease inhibitors|mesh-ancestor
110899590|NCT03865706|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110899591|NCT03865706|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
110899592|NCT03865706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110899593|NCT03865706|Antitubercular Agents|antitubercular agents|mesh-ancestor
110899594|NCT04944368|Myeloma Proteins|myeloma proteins|mesh-list
110899595|NCT04944368|Paraproteins|paraproteins|mesh-list
110899596|NCT04944368|Immunologic Factors|immunologic factors|mesh-ancestor
110899597|NCT04944368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110899598|NCT04260464|PF-06700841|pf-06700841|mesh-list
110899599|NCT04260464|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110899600|NCT04260464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110899601|NCT04260464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110899602|NCT03651518|Rituximab|rituximab|mesh-list
110899603|NCT03651518|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
110899604|NCT03651518|Ustekinumab|ustekinumab|mesh-list
110899605|NCT03651518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110899606|NCT03651518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110899607|NCT03651518|Immunologic Factors|immunologic factors|mesh-ancestor
110899608|NCT03651518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110899609|NCT03651518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110899610|NCT03651518|Dermatologic Agents|dermatologic agents|mesh-ancestor
110899611|NCT03546530|Interferons|interferons|mesh-list
110899612|NCT03546530|Resveratrol|resveratrol|mesh-list
110899613|NCT03546530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110899614|NCT03546530|Antiviral Agents|antiviral agents|mesh-ancestor
110899615|NCT03546530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110899616|NCT03546530|Antioxidants|antioxidants|mesh-ancestor
110899617|NCT03546530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110899618|NCT03546530|Protective Agents|protective agents|mesh-ancestor
110899619|NCT03546530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110899620|NCT03546530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110899621|NCT03546530|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110899622|NCT03568994|Cytarabine|cytarabine|mesh-list
110899623|NCT03568994|Atovaquone|atovaquone|mesh-list
110899624|NCT03568994|Etoposide|etoposide|mesh-list
110899625|NCT03568994|Daunorubicin|daunorubicin|mesh-list
110899626|NCT03568994|Gemtuzumab|gemtuzumab|mesh-list
110899627|NCT03568994|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110899628|NCT03568994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110899629|NCT03568994|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110899630|NCT03568994|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110899631|NCT03568994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110899632|NCT03568994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110224699|NCT05999994|Tubulin Modulators|tubulin modulators|mesh-ancestor
110248160|NCT00122603|Saquinavir|saquinavir|mesh-list
110899633|NCT03568994|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110899634|NCT03568994|Antimetabolites|antimetabolites|mesh-ancestor
110899635|NCT03568994|Antiviral Agents|antiviral agents|mesh-ancestor
110899637|NCT03568994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110899638|NCT03568994|Immunologic Factors|immunologic factors|mesh-ancestor
110899639|NCT03568994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110899640|NCT03568994|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110899641|NCT03568994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110899642|NCT03568994|Immunotoxins|immunotoxins|mesh-ancestor
110899643|NCT03568994|Immunoconjugates|immunoconjugates|mesh-ancestor
110899644|NCT03568994|Antimalarials|antimalarials|mesh-ancestor
110899645|NCT03568994|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110899646|NCT03568994|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110899647|NCT04203056|Aripiprazole|aripiprazole|mesh-list
110899648|NCT04203056|Aripiprazole lauroxil|aripiprazole lauroxil|mesh-list
110899649|NCT04203056|Antidepressive Agents|antidepressive agents|mesh-ancestor
110899650|NCT04203056|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110899651|NCT04203056|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110899652|NCT04203056|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110899653|NCT04203056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110899654|NCT04203056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110899655|NCT04203056|Dopamine Agonists|dopamine agonists|mesh-ancestor
110899656|NCT04203056|Dopamine Agents|dopamine agents|mesh-ancestor
110899657|NCT04203056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110899658|NCT04203056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110899659|NCT04203056|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110899660|NCT04203056|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110899661|NCT04203056|Serotonin Agents|serotonin agents|mesh-ancestor
110899662|NCT04203056|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110899663|NCT04203056|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110899664|NCT04203056|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110899665|NCT04203056|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110899667|NCT04894994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110899668|NCT04894994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110899669|NCT04894994|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110899670|NCT04894994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110899671|NCT01366547|Lamivudine|lamivudine|mesh-list
110899672|NCT01366547|Abacavir|abacavir|mesh-list
110899673|NCT01366547|Dideoxynucleosides|dideoxynucleosides|mesh-list
110899674|NCT01366547|Dolutegravir|dolutegravir|mesh-list
110899675|NCT01366547|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110899676|NCT01366547|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110899677|NCT01366547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110899678|NCT01366547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110899679|NCT01366547|Antiviral Agents|antiviral agents|mesh-ancestor
110899680|NCT01366547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110899681|NCT01366547|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110899682|NCT01366547|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110899683|NCT01366547|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110899684|NCT01366547|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110899685|NCT01366547|Antimetabolites|antimetabolites|mesh-ancestor
110899686|NCT05190341|Ibuprofen|ibuprofen|mesh-list
110899687|NCT05190341|Ketorolac|ketorolac|mesh-list
110899688|NCT05190341|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110899689|NCT05190341|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110899690|NCT05190341|Analgesics|analgesics|mesh-ancestor
110899691|NCT05190341|Sensory System Agents|sensory system agents|mesh-ancestor
110899692|NCT05190341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110899693|NCT05190341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110899694|NCT05190341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110899695|NCT05190341|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110248226|NCT00492466|Antiviral Agents|antiviral agents|mesh-ancestor
110899696|NCT05190341|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110899697|NCT05190341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110899698|NCT05190341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110899699|NCT04347239|Leronlimab|leronlimab|mesh-list
110899700|NCT04347239|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110899701|NCT04347239|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110899702|NCT04347239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110899703|NCT04347239|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110899704|NCT04347239|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110899705|NCT04347239|Antiviral Agents|antiviral agents|mesh-ancestor
110899706|NCT04347239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110899707|NCT00109928|Methylprednisolone|methylprednisolone|mesh-list
110899708|NCT00109928|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110899709|NCT00109928|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110899710|NCT00109928|Prednisolone|prednisolone|mesh-list
110899711|NCT00109928|Prednisolone acetate|prednisolone acetate|mesh-list
110899712|NCT00109928|Gemcitabine|gemcitabine|mesh-list
110899714|NCT00109928|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110899715|NCT00109928|Prednisolone phosphate|prednisolone phosphate|mesh-list
110899716|NCT00109928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110899717|NCT00109928|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110899718|NCT00109928|Antimetabolites|antimetabolites|mesh-ancestor
110899719|NCT00109928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110899720|NCT00109928|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110899721|NCT00109928|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110899722|NCT00109928|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110899723|NCT00109928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110899724|NCT00109928|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110899725|NCT00109928|Antiemetics|antiemetics|mesh-ancestor
110899726|NCT00109928|Autonomic Agents|autonomic agents|mesh-ancestor
110899727|NCT00109928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110899728|NCT00109928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110899729|NCT00109928|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110899730|NCT00109928|Glucocorticoids|glucocorticoids|mesh-ancestor
110899731|NCT00109928|Hormones|hormones|mesh-ancestor
110899732|NCT00109928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110899733|NCT00109928|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110899734|NCT00109928|Protective Agents|protective agents|mesh-ancestor
110899735|NCT00109928|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110899736|NCT02104310|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
110899737|NCT02104310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110899738|NCT02104310|Dopamine Agents|dopamine agents|mesh-ancestor
110899739|NCT02104310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110899740|NCT02104310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110899741|NCT00109850|Irinotecan|irinotecan|mesh-list
110899742|NCT00109850|Cetuximab|cetuximab|mesh-list
110899743|NCT00109850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110899744|NCT00109850|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110899745|NCT00109850|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110899746|NCT00109850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110899747|NCT00109850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110899748|NCT00109850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110899749|NCT03318770|Dasatinib|dasatinib|mesh-list
110899750|NCT03318770|Blinatumomab|blinatumomab|mesh-list
110899751|NCT03318770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110899752|NCT03318770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110224724|NCT05999942|Amikacin|amikacin|mesh-list
110224725|NCT05999942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110224726|NCT05999942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110224727|NCT05999890|Tapentadol|tapentadol|mesh-list
110224728|NCT05999890|Analgesics|analgesics|mesh-ancestor
110224729|NCT05999890|Sensory System Agents|sensory system agents|mesh-ancestor
110899754|NCT03318770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110899755|NCT01065519|Umirolimus|umirolimus|mesh-list
110899756|NCT01065519|Everolimus|everolimus|mesh-list
110899757|NCT01065519|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110899758|NCT01065519|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110924092|NCT02301806|Hormones|hormones|mesh-ancestor
110899760|NCT01065519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110899761|NCT01065519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110899762|NCT01065519|Immunologic Factors|immunologic factors|mesh-ancestor
110899763|NCT01065519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110899764|NCT01065519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110899765|NCT01065519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110899766|NCT05493111|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110899767|NCT05493111|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110899768|NCT01810016|Poly I-C|poly i-c|mesh-list
110899769|NCT01810016|Ipilimumab|ipilimumab|mesh-list
110899770|NCT01810016|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
110899771|NCT01810016|Vaccines|vaccines|mesh-list
110899772|NCT01810016|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
110899773|NCT01810016|Poly ICLC|poly iclc|mesh-list
110899774|NCT01810016|Immunologic Factors|immunologic factors|mesh-ancestor
110899775|NCT01810016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110899776|NCT01810016|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110899777|NCT01810016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110899778|NCT01810016|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110899779|NCT01810016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110899780|NCT01810016|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110899781|NCT01810016|Interferon Inducers|interferon inducers|mesh-ancestor
110899782|NCT01810016|Laxatives|laxatives|mesh-ancestor
110899783|NCT01810016|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110899784|NCT01810016|Antiviral Agents|antiviral agents|mesh-ancestor
110899785|NCT01810016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110899786|NCT01722266|Liraglutide|liraglutide|mesh-list
110899787|NCT01722266|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110899788|NCT01722266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110899789|NCT01722266|Incretins|incretins|mesh-ancestor
110899790|NCT01722266|Hormones|hormones|mesh-ancestor
110899791|NCT01722266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110899792|NCT02254148|Metoprolol|metoprolol|mesh-list
110899793|NCT02254148|Digoxin|digoxin|mesh-list
110899794|NCT02254148|Midazolam|midazolam|mesh-list
110899795|NCT02254148|Caffeine|caffeine|mesh-list
110899796|NCT02254148|Omeprazole|omeprazole|mesh-list
110899797|NCT02254148|Warfarin|warfarin|mesh-list
110899798|NCT02254148|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110899799|NCT02254148|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110899800|NCT02254148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110899801|NCT02254148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110899802|NCT02254148|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110899803|NCT02254148|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110899804|NCT02254148|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110899805|NCT02254148|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110899806|NCT02254148|Anesthetics, General|anesthetics, general|mesh-ancestor
110899807|NCT02254148|Anesthetics|anesthetics|mesh-ancestor
110899808|NCT02254148|GABA Modulators|gaba modulators|mesh-ancestor
110899809|NCT02254148|GABA Agents|gaba agents|mesh-ancestor
110899810|NCT02254148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110899811|NCT02254148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110899812|NCT02254148|Anticoagulants|anticoagulants|mesh-ancestor
110899813|NCT02254148|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110899814|NCT02254148|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110899815|NCT02254148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110899816|NCT02254148|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110899817|NCT02254148|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110899818|NCT02254148|Purinergic Agents|purinergic agents|mesh-ancestor
110899819|NCT02254148|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110899820|NCT02254148|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110899821|NCT02254148|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110899822|NCT02254148|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110899823|NCT02254148|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110899824|NCT02254148|Sympatholytics|sympatholytics|mesh-ancestor
110899825|NCT02254148|Autonomic Agents|autonomic agents|mesh-ancestor
110224739|NCT05999890|Adrenergic Agents|adrenergic agents|mesh-ancestor
110899826|NCT02254148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110899827|NCT02254148|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110899828|NCT02254148|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110899829|NCT02254148|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110899830|NCT02254148|Adrenergic Agents|adrenergic agents|mesh-ancestor
110899831|NCT02254148|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110899832|NCT02254148|Protective Agents|protective agents|mesh-ancestor
110899833|NCT02842866|Vaccines|vaccines|mesh-list
110899834|NCT02842866|Immunologic Factors|immunologic factors|mesh-ancestor
110899835|NCT02842866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110899836|NCT01316913|Bromides|bromides|mesh-list
110899837|NCT01316913|Tiotropium Bromide|tiotropium bromide|mesh-list
110899838|NCT01316913|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110899839|NCT01316913|Autonomic Agents|autonomic agents|mesh-ancestor
110899840|NCT01316913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110899841|NCT01316913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110899842|NCT01316913|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110899843|NCT01316913|Respiratory System Agents|respiratory system agents|mesh-ancestor
110899844|NCT01316913|Parasympatholytics|parasympatholytics|mesh-ancestor
110899845|NCT01316913|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110899846|NCT01316913|Cholinergic Agents|cholinergic agents|mesh-ancestor
110899847|NCT01316913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110899848|NCT01316913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110899849|NCT01316913|Anticonvulsants|anticonvulsants|mesh-ancestor
110899850|NCT02875067|Pembrolizumab|pembrolizumab|mesh-list
110899851|NCT02875067|Lenalidomide|lenalidomide|mesh-list
110899852|NCT02875067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110899853|NCT02875067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110899854|NCT02875067|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110899855|NCT02875067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110899856|NCT02875067|Immunologic Factors|immunologic factors|mesh-ancestor
110899857|NCT02875067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110899858|NCT02875067|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110899859|NCT02875067|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110899860|NCT02875067|Growth Substances|growth substances|mesh-ancestor
110899861|NCT02875067|Growth Inhibitors|growth inhibitors|mesh-ancestor
110899862|NCT03570294|Atosiban|atosiban|mesh-list
110899863|NCT03570294|Hormone Antagonists|hormone antagonists|mesh-ancestor
110899864|NCT03570294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110899865|NCT03570294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110899866|NCT03570294|Tocolytic Agents|tocolytic agents|mesh-ancestor
110899867|NCT03570294|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110899868|NCT02143622|Cetuximab|cetuximab|mesh-list
110899869|NCT02143622|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110899870|NCT02143622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110899871|NCT02781506|Nivolumab|nivolumab|mesh-list
110899872|NCT02781506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110899873|NCT02781506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110899874|NCT02781506|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110203211|NCT00158158|Nicotine|nicotine|mesh-list
110899875|NCT02781506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110899876|NCT03571230|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110899877|NCT03571230|Amoxicillin|amoxicillin|mesh-list
110899878|NCT03571230|Metronidazole|metronidazole|mesh-list
110899879|NCT03571230|Clarithromycin|clarithromycin|mesh-list
110899880|NCT03571230|Levofloxacin|levofloxacin|mesh-list
110899881|NCT03571230|Tetracycline|tetracycline|mesh-list
110899882|NCT03571230|Tinidazole|tinidazole|mesh-list
110899883|NCT03571230|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
110899884|NCT03571230|Furazolidone|furazolidone|mesh-list
110899885|NCT03571230|Bismuth|bismuth|mesh-list
110899886|NCT03571230|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
110899887|NCT03571230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110899888|NCT03571230|Antitubercular Agents|antitubercular agents|mesh-ancestor
110899889|NCT03571230|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110899890|NCT03571230|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110899891|NCT03571230|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110899892|NCT03571230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110899893|NCT03571230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110899894|NCT03571230|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110899895|NCT03571230|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110899896|NCT03571230|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110899897|NCT03571230|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110899898|NCT03571230|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110899899|NCT03571230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110899900|NCT03571230|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110899902|NCT03571230|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110899903|NCT03571230|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110899904|NCT03571230|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
110899905|NCT03571230|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
110899906|NCT03571230|Alkylating Agents|alkylating agents|mesh-ancestor
110899907|NCT03368963|Trifluridine|trifluridine|mesh-list
110899908|NCT03368963|Irinotecan|irinotecan|mesh-list
110899909|NCT03368963|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110899910|NCT03368963|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110899911|NCT03368963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110899912|NCT03368963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110899913|NCT03368963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110899914|NCT03368963|Antimetabolites|antimetabolites|mesh-ancestor
110899915|NCT03368963|Antiviral Agents|antiviral agents|mesh-ancestor
110899916|NCT03368963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110899917|NCT05489211|Leucovorin|leucovorin|mesh-list
110899918|NCT05489211|Prednisone|prednisone|mesh-list
110899919|NCT05489211|Prednisolone|prednisolone|mesh-list
110899920|NCT05489211|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110899921|NCT05489211|Methylprednisolone|methylprednisolone|mesh-list
110899922|NCT05489211|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110899923|NCT05489211|Prednisolone acetate|prednisolone acetate|mesh-list
110899924|NCT05489211|Bevacizumab|bevacizumab|mesh-list
110899925|NCT05489211|Durvalumab|durvalumab|mesh-list
110899926|NCT05489211|Carboplatin|carboplatin|mesh-list
110899927|NCT05489211|Fluorouracil|fluorouracil|mesh-list
110899928|NCT05489211|Capecitabine|capecitabine|mesh-list
110899929|NCT05489211|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110899930|NCT05489211|Prednisolone phosphate|prednisolone phosphate|mesh-list
110899931|NCT05489211|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110899932|NCT05489211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110899933|NCT05489211|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110899934|NCT05489211|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110899935|NCT05489211|Growth Substances|growth substances|mesh-ancestor
110924153|NCT03581734|Vaccines|vaccines|mesh-list
110899936|NCT05489211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110899937|NCT05489211|Growth Inhibitors|growth inhibitors|mesh-ancestor
110899938|NCT05489211|Antimetabolites|antimetabolites|mesh-ancestor
110899939|NCT05489211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110899940|NCT05489211|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110899941|NCT05489211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110899942|NCT05489211|Immunologic Factors|immunologic factors|mesh-ancestor
110899943|NCT05489211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110899944|NCT05489211|Glucocorticoids|glucocorticoids|mesh-ancestor
110899945|NCT05489211|Hormones|hormones|mesh-ancestor
110899946|NCT05489211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110899947|NCT05489211|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110899948|NCT05489211|Antidotes|antidotes|mesh-ancestor
110899949|NCT05489211|Protective Agents|protective agents|mesh-ancestor
110899950|NCT05489211|Vitamin B Complex|vitamin b complex|mesh-ancestor
110899951|NCT05489211|Vitamins|vitamins|mesh-ancestor
110899952|NCT05489211|Micronutrients|micronutrients|mesh-ancestor
110899953|NCT05489211|Antiemetics|antiemetics|mesh-ancestor
110899954|NCT05489211|Autonomic Agents|autonomic agents|mesh-ancestor
110899955|NCT05489211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110899956|NCT05489211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110899957|NCT05489211|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110899958|NCT02254226|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110899959|NCT02254226|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110899960|NCT02254226|Autonomic Agents|autonomic agents|mesh-ancestor
110899961|NCT02254226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110899962|NCT02254226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110899963|NCT02254226|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110899964|NCT02254226|Respiratory System Agents|respiratory system agents|mesh-ancestor
110899965|NCT02254226|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110899966|NCT02254226|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110899967|NCT02254226|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110899968|NCT02254226|Adrenergic Agents|adrenergic agents|mesh-ancestor
110617427|NCT00772902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110899969|NCT02254226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110899970|NCT02254226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110899971|NCT02143934|Chloroquine|chloroquine|mesh-list
110899972|NCT02143934|Lumefantrine|lumefantrine|mesh-list
110899974|NCT02143934|Primaquine|primaquine|mesh-list
110899975|NCT02143934|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
110899976|NCT02143934|Amebicides|amebicides|mesh-ancestor
110899977|NCT02143934|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110899978|NCT02143934|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110899979|NCT02143934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110899980|NCT02143934|Antimalarials|antimalarials|mesh-ancestor
110899981|NCT02143934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110899982|NCT03096847|Letrozole|letrozole|mesh-list
110899983|NCT03096847|Goserelin|goserelin|mesh-list
110899984|NCT03096847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110899985|NCT03096847|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110899986|NCT03096847|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110899987|NCT03096847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110899988|NCT03096847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110899989|NCT03096847|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110899990|NCT03096847|Hormone Antagonists|hormone antagonists|mesh-ancestor
110899991|NCT03096847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110899992|NCT03096847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110899993|NCT03096847|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110899994|NCT03545516|Dexmedetomidine|dexmedetomidine|mesh-list
110899995|NCT03545516|Bupivacaine|bupivacaine|mesh-list
110899996|NCT03545516|Anesthetics, Local|anesthetics, local|mesh-ancestor
110899997|NCT03545516|Anesthetics|anesthetics|mesh-ancestor
110899998|NCT03545516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110899999|NCT03545516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110924164|NCT02306798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110900001|NCT03545516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110900002|NCT03545516|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110900003|NCT03545516|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110900004|NCT03545516|Analgesics|analgesics|mesh-ancestor
110900005|NCT03545516|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110900006|NCT03545516|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110900007|NCT03545516|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110900008|NCT03545516|Adrenergic Agents|adrenergic agents|mesh-ancestor
110900009|NCT03545516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110900010|NCT03545516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110900011|NCT02846532|Aspirin|aspirin|mesh-list
110900012|NCT02846532|Rivaroxaban|rivaroxaban|mesh-list
110900013|NCT02846532|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110900014|NCT02846532|Antithrombins|antithrombins|mesh-ancestor
110900015|NCT02846532|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110900016|NCT02846532|Protease Inhibitors|protease inhibitors|mesh-ancestor
110900017|NCT02846532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110900018|NCT02846532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110900019|NCT02846532|Anticoagulants|anticoagulants|mesh-ancestor
110900020|NCT02846532|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110900021|NCT02846532|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110900022|NCT02846532|Analgesics|analgesics|mesh-ancestor
110900023|NCT02846532|Sensory System Agents|sensory system agents|mesh-ancestor
110900024|NCT02846532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110900025|NCT02846532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110900026|NCT02846532|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110900027|NCT02846532|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110900028|NCT02846532|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110900029|NCT02846532|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110224753|NCT05999812|Keratolytic Agents|keratolytic agents|mesh-ancestor
110900030|NCT02846532|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110900032|NCT02846532|Antipyretics|antipyretics|mesh-ancestor
110900033|NCT01371461|Paroxetine|paroxetine|mesh-list
110900034|NCT01371461|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110900035|NCT01371461|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110900036|NCT01371461|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110900037|NCT01371461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110900038|NCT01371461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110900039|NCT01371461|Serotonin Agents|serotonin agents|mesh-ancestor
110900040|NCT01371461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110900041|NCT01371461|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110900042|NCT01371461|Antidepressive Agents|antidepressive agents|mesh-ancestor
110900043|NCT01371461|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110900044|NCT01371461|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110900045|NCT01371461|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110900046|NCT01371461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110900048|NCT05324423|Febuxostat|febuxostat|mesh-list
110900049|NCT05324423|Gout Suppressants|gout suppressants|mesh-ancestor
110900050|NCT05324423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110900051|NCT05324423|Tubulin Modulators|tubulin modulators|mesh-ancestor
110900052|NCT05324423|Antimitotic Agents|antimitotic agents|mesh-ancestor
110900053|NCT05324423|Mitosis Modulators|mitosis modulators|mesh-ancestor
110900054|NCT05324423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110900055|NCT05324423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110900056|NCT04704219|Pembrolizumab|pembrolizumab|mesh-list
110900057|NCT04704219|Lenvatinib|lenvatinib|mesh-list
110900058|NCT04704219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110900059|NCT04704219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110900060|NCT04704219|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110900061|NCT04704219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110900062|NCT04704219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110900063|NCT04704219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110900064|NCT00842348|Lanreotide|lanreotide|mesh-list
110900065|NCT00842348|Somatostatin|somatostatin|mesh-list
110900066|NCT00842348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110900067|NCT00842348|Hormones|hormones|mesh-ancestor
110900068|NCT00842348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110900069|NCT00842348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110900070|NCT02144246|Moxifloxacin|moxifloxacin|mesh-list
110900071|NCT02144246|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110900072|NCT02144246|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110900073|NCT02144246|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110900074|NCT02144246|Norgestimate|norgestimate|mesh-list
110900075|NCT02144246|Norgestrel|norgestrel|mesh-list
110900076|NCT02144246|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
110900077|NCT02144246|Estradiol|estradiol|mesh-list
110900078|NCT02144246|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110900079|NCT02144246|Estrogens|estrogens|mesh-ancestor
110900080|NCT02144246|Hormones|hormones|mesh-ancestor
110900081|NCT02144246|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110900082|NCT02144246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110900083|NCT02144246|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110900084|NCT02144246|Contraceptive Agents|contraceptive agents|mesh-ancestor
110900085|NCT02144246|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110900086|NCT02144246|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110900087|NCT02144246|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110900088|NCT02144246|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110900089|NCT02144246|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110900090|NCT02144246|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110900091|NCT02144246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110900092|NCT02144246|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110900093|NCT02144246|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110900094|NCT02144246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110900095|NCT02144246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110900096|NCT02144246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110900097|NCT02144246|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110900099|NCT03095521|Antipruritics|antipruritics|mesh-ancestor
110900100|NCT03095521|Dermatologic Agents|dermatologic agents|mesh-ancestor
110900101|NCT01372865|Mometasone Furoate|mometasone furoate|mesh-list
110900102|NCT01372865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110900103|NCT01372865|Dermatologic Agents|dermatologic agents|mesh-ancestor
110900104|NCT01372865|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110900105|NCT03569046|Antihypertensive Agents|antihypertensive agents|mesh-list
110900106|NCT03569046|Bupivacaine|bupivacaine|mesh-list
110900107|NCT03569046|Anesthetics, Local|anesthetics, local|mesh-list
110900108|NCT03569046|Anesthetics|anesthetics|mesh-list
110900109|NCT03569046|Anesthetics, General|anesthetics, general|mesh-list
110900110|NCT03569046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110900111|NCT03569046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110900112|NCT03569046|Sensory System Agents|sensory system agents|mesh-ancestor
110900113|NCT03569046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110900114|NCT02935595|Ketamine|ketamine|mesh-list
110900115|NCT02935595|Analgesics|analgesics|mesh-ancestor
110900116|NCT02935595|Sensory System Agents|sensory system agents|mesh-ancestor
110900117|NCT02935595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110900118|NCT02935595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110900119|NCT02935595|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110900120|NCT02935595|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110900121|NCT02935595|Anesthetics, General|anesthetics, general|mesh-ancestor
110900122|NCT02935595|Anesthetics|anesthetics|mesh-ancestor
110900123|NCT02935595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110900124|NCT02935595|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110900125|NCT02935595|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110900126|NCT02935595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110900127|NCT02935595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110900128|NCT02649673|Topotecan|topotecan|mesh-list
110900129|NCT02649673|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110900130|NCT02649673|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110900131|NCT02649673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110924181|NCT02302274|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110900132|NCT02649673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110900133|NCT02649673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110900134|NCT02817347|Tazobactam|tazobactam|mesh-list
110900135|NCT02817347|Piperacillin|piperacillin|mesh-list
110900136|NCT02817347|Dexamethasone|dexamethasone|mesh-list
110900137|NCT02817347|Dexamethasone acetate|dexamethasone acetate|mesh-list
110900138|NCT02817347|BB 1101|bb 1101|mesh-list
110900139|NCT02817347|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110900140|NCT02817347|Antiemetics|antiemetics|mesh-ancestor
110900141|NCT02817347|Autonomic Agents|autonomic agents|mesh-ancestor
110900142|NCT02817347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110900143|NCT02817347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110900144|NCT02817347|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110900145|NCT02817347|Glucocorticoids|glucocorticoids|mesh-ancestor
110900146|NCT02817347|Hormones|hormones|mesh-ancestor
110900147|NCT02817347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110900148|NCT02817347|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110900149|NCT02817347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110900150|NCT02817347|Protease Inhibitors|protease inhibitors|mesh-ancestor
110900151|NCT02817347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110900152|NCT02817347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110900153|NCT02817347|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110900154|NCT02817347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110900155|NCT02817347|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110900156|NCT01373021|Fentanyl|fentanyl|mesh-list
110900157|NCT01373021|Dexmedetomidine|dexmedetomidine|mesh-list
110900158|NCT01373021|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110900159|NCT01373021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110900160|NCT01373021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110900161|NCT01373021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110900162|NCT01373021|Analgesics|analgesics|mesh-ancestor
110900163|NCT01373021|Sensory System Agents|sensory system agents|mesh-ancestor
110900164|NCT01373021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110900165|NCT01373021|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110224772|NCT05999708|Tocolytic Agents|tocolytic agents|mesh-ancestor
110900166|NCT01373021|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110900167|NCT01373021|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110900168|NCT01373021|Adrenergic Agents|adrenergic agents|mesh-ancestor
110900169|NCT01373021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110900170|NCT01373021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110900171|NCT01373021|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110900172|NCT01373021|Narcotics|narcotics|mesh-ancestor
110900173|NCT01373021|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110900174|NCT01373021|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110900175|NCT01373021|Anesthetics, General|anesthetics, general|mesh-ancestor
110900176|NCT01373021|Anesthetics|anesthetics|mesh-ancestor
110900177|NCT03568578|Entecavir|entecavir|mesh-list
110900178|NCT03568578|Antiviral Agents|antiviral agents|mesh-ancestor
110900179|NCT03568578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110900180|NCT01367483|Methylnaltrexone|methylnaltrexone|mesh-list
110900181|NCT01367483|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110900182|NCT01367483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110900183|NCT01367483|Sensory System Agents|sensory system agents|mesh-ancestor
110900184|NCT01367483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110900185|NCT02140736|Epoetin Alfa|epoetin alfa|mesh-list
110900186|NCT02140736|Hematinics|hematinics|mesh-ancestor
110900187|NCT05417035|Testosterone undecanoate|testosterone undecanoate|mesh-list
110900188|NCT05417035|Androgens|androgens|mesh-ancestor
110900189|NCT05417035|Hormones|hormones|mesh-ancestor
110900190|NCT05417035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110900191|NCT05417035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110900192|NCT05708742|Bupivacaine|bupivacaine|mesh-list
110900193|NCT05708742|Anesthetics, Local|anesthetics, local|mesh-list
110900194|NCT05708742|Anesthetics|anesthetics|mesh-list
110900195|NCT05708742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110900196|NCT05708742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110900197|NCT05708742|Sensory System Agents|sensory system agents|mesh-ancestor
110900198|NCT05708742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110900199|NCT03095287|Factor VIII|factor viii|mesh-list
110900200|NCT03095287|Coagulants|coagulants|mesh-ancestor
110900201|NCT01335581|Tretinoin|tretinoin|mesh-list
110900202|NCT01335581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110900203|NCT01335581|Keratolytic Agents|keratolytic agents|mesh-ancestor
110900204|NCT01335581|Dermatologic Agents|dermatologic agents|mesh-ancestor
110900205|NCT05204563|Imipenem|imipenem|mesh-list
110900206|NCT05204563|Relebactam|relebactam|mesh-list
110900207|NCT05204563|Cilastatin|cilastatin|mesh-list
110900208|NCT05204563|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110900209|NCT05204563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110900210|NCT05204563|Protease Inhibitors|protease inhibitors|mesh-ancestor
110900211|NCT05204563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110900212|NCT05204563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110900213|NCT05204563|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110900214|NCT02140814|Niacinamide|niacinamide|mesh-list
110900215|NCT02140814|Niacin|niacin|mesh-list
110900216|NCT02140814|Nicotinic Acids|nicotinic acids|mesh-list
110900217|NCT02140814|Vitamins|vitamins|mesh-ancestor
110900218|NCT02140814|Micronutrients|micronutrients|mesh-ancestor
110900219|NCT02140814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110900220|NCT02140814|Vitamin B Complex|vitamin b complex|mesh-ancestor
110900221|NCT02140814|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110900222|NCT02140814|Antimetabolites|antimetabolites|mesh-ancestor
110900223|NCT02140814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110900224|NCT02140814|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110900225|NCT02140814|Vasodilator Agents|vasodilator agents|mesh-ancestor
110900226|NCT03015090|Theophylline|theophylline|mesh-list
110900227|NCT03015090|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110900228|NCT03015090|Autonomic Agents|autonomic agents|mesh-ancestor
110900229|NCT03015090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110900230|NCT03015090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110900231|NCT03015090|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110900232|NCT03015090|Respiratory System Agents|respiratory system agents|mesh-ancestor
110900233|NCT03015090|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110900234|NCT03015090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110900235|NCT03015090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110900236|NCT03015090|Vasodilator Agents|vasodilator agents|mesh-ancestor
110900237|NCT03015090|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110900238|NCT03015090|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110900239|NCT03015090|Purinergic Agents|purinergic agents|mesh-ancestor
110203299|NCT00158821|Tenofovir|tenofovir|mesh-list
110900240|NCT03015090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110900241|NCT02620748|Tranexamic Acid|tranexamic acid|mesh-list
110900242|NCT02620748|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110900243|NCT02620748|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110900244|NCT02620748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110900245|NCT02620748|Hemostatics|hemostatics|mesh-ancestor
110900246|NCT02620748|Coagulants|coagulants|mesh-ancestor
110900247|NCT02144792|Verapamil|verapamil|mesh-list
110900248|NCT02144792|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110900249|NCT02144792|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110900250|NCT02144792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110900251|NCT02144792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110900252|NCT02144792|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110900253|NCT02144792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110900254|NCT02144792|Vasodilator Agents|vasodilator agents|mesh-ancestor
110900255|NCT03566394|Gabapentin|gabapentin|mesh-list
110900256|NCT03566394|Analgesics|analgesics|mesh-ancestor
110900257|NCT03566394|Sensory System Agents|sensory system agents|mesh-ancestor
110900258|NCT03566394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110900259|NCT03566394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110900260|NCT03566394|Anticonvulsants|anticonvulsants|mesh-ancestor
110900261|NCT03566394|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110900262|NCT03566394|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110900263|NCT03566394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110900264|NCT03566394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110924201|NCT04463342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110900265|NCT03566394|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110900266|NCT03566394|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110900267|NCT03566394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110900268|NCT03566394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110900269|NCT03566394|Antimanic Agents|antimanic agents|mesh-ancestor
110900270|NCT00033293|Prednisone|prednisone|mesh-list
110900271|NCT00033293|Cortisone|cortisone|mesh-list
110900272|NCT00033293|Cyclophosphamide|cyclophosphamide|mesh-list
110900273|NCT00033293|Immunoglobulins|immunoglobulins|mesh-list
110900274|NCT00033293|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110900275|NCT00033293|Antibodies|antibodies|mesh-list
110900276|NCT00033293|gamma-Globulins|gamma-globulins|mesh-list
110900277|NCT00033293|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110900278|NCT00033293|Immunoglobulin G|immunoglobulin g|mesh-list
110900279|NCT00033293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110900280|NCT00033293|Immunologic Factors|immunologic factors|mesh-ancestor
110900281|NCT00033293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110900282|NCT00033293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110900283|NCT00033293|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110900284|NCT00033293|Alkylating Agents|alkylating agents|mesh-ancestor
110900285|NCT00033293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110900286|NCT00033293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110900287|NCT00033293|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110900288|NCT00033293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110900289|NCT00033293|Glucocorticoids|glucocorticoids|mesh-ancestor
110900290|NCT00033293|Hormones|hormones|mesh-ancestor
110900291|NCT00033293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110900292|NCT00033293|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110900293|NCT03566316|Amlodipine|amlodipine|mesh-list
110900294|NCT03566316|Telmisartan|telmisartan|mesh-list
110900295|NCT03566316|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
110900296|NCT03566316|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110900297|NCT03566316|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110900298|NCT03566316|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110900299|NCT03566316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110224781|NCT05999487|Autonomic Agents|autonomic agents|mesh-ancestor
110900300|NCT03566316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110900301|NCT03566316|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110900302|NCT03566316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110900303|NCT03566316|Vasodilator Agents|vasodilator agents|mesh-ancestor
110900304|NCT03566316|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110900305|NCT03566316|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110900306|NCT03566316|Antimetabolites|antimetabolites|mesh-ancestor
110900307|NCT03566316|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110900308|NCT03566316|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110900309|NCT03566316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110900310|NCT03566316|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110900311|NCT03566316|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110900312|NCT02145104|Valsartan|valsartan|mesh-list
110900313|NCT02145104|Cilnidipine|cilnidipine|mesh-list
110900314|NCT02145104|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110900315|NCT02145104|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110900316|NCT02145104|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110900317|NCT02145104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110900318|NCT02145104|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110900319|NCT02145104|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110900320|NCT02145104|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110900321|NCT02145104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110900322|NCT02145338|Trimethoprim|trimethoprim|mesh-list
110900323|NCT02145338|Nitrofurantoin|nitrofurantoin|mesh-list
110900324|NCT02145338|Cephalexin|cephalexin|mesh-list
110900325|NCT02145338|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110924208|NCT02303912|Carboplatin|carboplatin|mesh-list
110900326|NCT02145338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110900327|NCT02145338|Antimalarials|antimalarials|mesh-ancestor
110900328|NCT02145338|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110900329|NCT02145338|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110900330|NCT02145338|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110900331|NCT02145338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110900332|NCT02145338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110900333|NCT02145338|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110900334|NCT02145338|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
110900335|NCT02145338|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110900336|NCT02145338|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110900337|NCT03565536|Sorafenib|sorafenib|mesh-list
110900338|NCT03565536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110900339|NCT03565536|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110900340|NCT03565536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110900341|NCT03565536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110900342|NCT03565458|Dapagliflozin|dapagliflozin|mesh-list
110900343|NCT03565458|Empagliflozin|empagliflozin|mesh-list
110900344|NCT03565458|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110900345|NCT03565458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110900346|NCT03565458|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110617802|NCT00567879|Panobinostat|panobinostat|mesh-list
110900347|NCT03565458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110900348|NCT03565302|Terbutaline|terbutaline|mesh-list
110900349|NCT03565302|Formoterol Fumarate|formoterol fumarate|mesh-list
110900350|NCT03565302|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110900351|NCT03565302|Autonomic Agents|autonomic agents|mesh-ancestor
110900352|NCT03565302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110900353|NCT03565302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110900354|NCT03565302|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110900355|NCT03565302|Respiratory System Agents|respiratory system agents|mesh-ancestor
110900356|NCT03565302|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110900357|NCT03565302|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110900358|NCT03565302|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110900359|NCT03565302|Adrenergic Agents|adrenergic agents|mesh-ancestor
110900360|NCT03565302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110900361|NCT03565302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110900362|NCT03565302|Sympathomimetics|sympathomimetics|mesh-ancestor
110900363|NCT03565302|Tocolytic Agents|tocolytic agents|mesh-ancestor
110900364|NCT03565302|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110900365|NCT05193227|Lidocaine|lidocaine|mesh-list
110900366|NCT05193227|Bupivacaine|bupivacaine|mesh-list
110900367|NCT05193227|Anesthetics, Local|anesthetics, local|mesh-ancestor
110900368|NCT05193227|Anesthetics|anesthetics|mesh-ancestor
110248888|NCT00497614|Adalimumab|adalimumab|mesh-list
110900369|NCT05193227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110900370|NCT05193227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110900371|NCT05193227|Sensory System Agents|sensory system agents|mesh-ancestor
110900372|NCT05193227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110900373|NCT05193227|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110900374|NCT05193227|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110900375|NCT05193227|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110900376|NCT05193227|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110900377|NCT05193227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110900378|NCT01372007|Lanreotide|lanreotide|mesh-list
110900379|NCT01372007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110900380|NCT01373411|Ticagrelor|ticagrelor|mesh-list
110900381|NCT01373411|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110900382|NCT01373411|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110900383|NCT01373411|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110900384|NCT01373411|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110900385|NCT01373411|Purinergic Agents|purinergic agents|mesh-ancestor
110900386|NCT01373411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110924219|NCT00109590|Zidovudine|zidovudine|mesh-list
110900387|NCT01373411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110900388|NCT01373411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110900390|NCT03567408|Antithrombins|antithrombins|mesh-ancestor
110900391|NCT03567408|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110900392|NCT03567408|Protease Inhibitors|protease inhibitors|mesh-ancestor
110900393|NCT03567408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110900394|NCT03567408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110900395|NCT03567408|Anticoagulants|anticoagulants|mesh-ancestor
110900396|NCT05354076|Doxorubicin|doxorubicin|mesh-list
110900397|NCT05354076|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110900398|NCT05354076|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110900399|NCT05354076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110900400|NCT05354076|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110900401|NCT05354076|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110900402|NCT05354076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110900403|NCT05354076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110900404|NCT05192681|Docetaxel|docetaxel|mesh-list
110900405|NCT05192681|Tislelizumab|tislelizumab|mesh-list
110900406|NCT05192681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110900407|NCT05192681|Tubulin Modulators|tubulin modulators|mesh-ancestor
110900408|NCT05192681|Antimitotic Agents|antimitotic agents|mesh-ancestor
110900409|NCT05192681|Mitosis Modulators|mitosis modulators|mesh-ancestor
110900410|NCT05192681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110900411|NCT05192681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110900412|NCT05192213|Thiamine|thiamine|mesh-list
110900413|NCT05192213|Hydrocortisone|hydrocortisone|mesh-list
110900414|NCT05192213|Vitamins|vitamins|mesh-ancestor
110900415|NCT05192213|Micronutrients|micronutrients|mesh-ancestor
110900416|NCT05192213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110900417|NCT05192213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110900418|NCT05192213|Vitamin B Complex|vitamin b complex|mesh-ancestor
110900419|NCT02039674|Paclitaxel|paclitaxel|mesh-list
110900420|NCT02039674|Bevacizumab|bevacizumab|mesh-list
110617878|NCT02538237|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110900421|NCT02039674|Carboplatin|carboplatin|mesh-list
110900422|NCT02039674|Pembrolizumab|pembrolizumab|mesh-list
110900423|NCT02039674|Pemetrexed|pemetrexed|mesh-list
110900424|NCT02039674|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110900425|NCT02039674|Ipilimumab|ipilimumab|mesh-list
110900426|NCT02039674|Gefitinib|gefitinib|mesh-list
110900427|NCT02039674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110900428|NCT02039674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110900429|NCT02039674|Tubulin Modulators|tubulin modulators|mesh-ancestor
110900430|NCT02039674|Antimitotic Agents|antimitotic agents|mesh-ancestor
110900431|NCT02039674|Mitosis Modulators|mitosis modulators|mesh-ancestor
110900432|NCT02039674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110900433|NCT02039674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110900434|NCT02039674|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110900435|NCT02039674|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110900436|NCT02039674|Growth Substances|growth substances|mesh-ancestor
110900437|NCT02039674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110900438|NCT02039674|Growth Inhibitors|growth inhibitors|mesh-ancestor
110900439|NCT02039674|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110900440|NCT02039674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110900441|NCT02039674|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110900442|NCT02039674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110900443|NCT02039674|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110900444|NCT03099187|Pirfenidone|pirfenidone|mesh-list
110900445|NCT03099187|Analgesics|analgesics|mesh-ancestor
110900446|NCT03099187|Sensory System Agents|sensory system agents|mesh-ancestor
110900447|NCT03099187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110900448|NCT03099187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110900449|NCT03099187|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110900450|NCT03099187|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110900451|NCT03099187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110900452|NCT03099187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110900453|NCT03099187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110900454|NCT04162756|Cyclophosphamide|cyclophosphamide|mesh-list
110900455|NCT04162756|Fludarabine|fludarabine|mesh-list
110900456|NCT04162756|Brexucabtagene autoleucel|brexucabtagene autoleucel|mesh-list
110900457|NCT04162756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110900458|NCT04162756|Immunologic Factors|immunologic factors|mesh-ancestor
110900459|NCT04162756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110900460|NCT04162756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110900461|NCT04162756|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110900462|NCT04162756|Alkylating Agents|alkylating agents|mesh-ancestor
110900463|NCT04162756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110900464|NCT04162756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110900465|NCT04162756|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110900466|NCT04162756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110900467|NCT04544267|Vaccines|vaccines|mesh-list
110900468|NCT04544267|Immunologic Factors|immunologic factors|mesh-ancestor
110900469|NCT04544267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110900470|NCT04895488|Vortioxetine|vortioxetine|mesh-list
110900471|NCT04895488|Antipsychotic Agents|antipsychotic agents|mesh-list
110900472|NCT04895488|Antidepressive Agents|antidepressive agents|mesh-ancestor
110900473|NCT04895488|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110900474|NCT04895488|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110900475|NCT04895488|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110900476|NCT04895488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110900477|NCT04895488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110900478|NCT04895488|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110900479|NCT04895488|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110900480|NCT04895488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110900481|NCT04895488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110900482|NCT04895488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110900483|NCT04895488|Serotonin Agents|serotonin agents|mesh-ancestor
110900484|NCT04895488|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110900485|NCT04895488|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110900486|NCT04895488|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110900487|NCT04895488|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110900488|NCT04342715|Paromomycin|paromomycin|mesh-list
110900489|NCT04342715|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
110900490|NCT04342715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110900491|NCT04342715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110900492|NCT04342715|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110900493|NCT04342715|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110617951|NCT00929799|Hormones|hormones|mesh-list
110900494|NCT04342715|Schistosomicides|schistosomicides|mesh-ancestor
110900495|NCT04342715|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110900496|NCT04342715|Anthelmintics|anthelmintics|mesh-ancestor
110900497|NCT01373333|Amifampridine|amifampridine|mesh-list
110900498|NCT01373333|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110900499|NCT01373333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110900500|NCT01373333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110900501|NCT01373333|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
110900502|NCT01373333|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110900503|NCT01373333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110900504|NCT01368341|Amoxicillin|amoxicillin|mesh-list
110900505|NCT01368341|Doxycycline|doxycycline|mesh-list
110900506|NCT01368341|Penicillin V|penicillin v|mesh-list
110900507|NCT01368341|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110900508|NCT01368341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110900509|NCT01368341|Antimalarials|antimalarials|mesh-ancestor
110900510|NCT01368341|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110900511|NCT01368341|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110900512|NCT01368419|Endostar protein|endostar protein|mesh-list
110900513|NCT01368419|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110900514|NCT01368419|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110900515|NCT01368419|Growth Substances|growth substances|mesh-ancestor
110900516|NCT01368419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110900517|NCT01368419|Growth Inhibitors|growth inhibitors|mesh-ancestor
110900518|NCT01368419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110900519|NCT04639219|Trastuzumab|trastuzumab|mesh-list
110900520|NCT04639219|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
110900521|NCT04639219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110900522|NCT04639219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110900523|NCT04639219|Immunoconjugates|immunoconjugates|mesh-ancestor
110900524|NCT04639219|Immunologic Factors|immunologic factors|mesh-ancestor
110900525|NCT04639219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110900526|NCT04455100|Itraconazole|itraconazole|mesh-list
110900527|NCT04455100|Antifungal Agents|antifungal agents|mesh-ancestor
110900528|NCT04455100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110900529|NCT04455100|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110900530|NCT04455100|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110900531|NCT04455100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110900532|NCT04455100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110900533|NCT04455100|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110900534|NCT04455100|Hormone Antagonists|hormone antagonists|mesh-ancestor
110900535|NCT04455100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110900536|NCT04455100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110900537|NCT04455100|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110900538|NCT04439578|Rifampin|rifampin|mesh-list
110900539|NCT04439578|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110900540|NCT04439578|Antitubercular Agents|antitubercular agents|mesh-ancestor
110900541|NCT04439578|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110900542|NCT04439578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110900543|NCT04439578|Leprostatic Agents|leprostatic agents|mesh-ancestor
110900544|NCT04439578|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110900545|NCT04439578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110900546|NCT04439578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110900547|NCT04439578|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110900548|NCT04439578|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110900549|NCT04439578|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110900550|NCT04439578|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110900551|NCT04439578|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110900552|NCT04439578|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110900553|NCT03110848|Methylprednisolone|methylprednisolone|mesh-list
110900554|NCT03110848|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110900555|NCT03110848|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110900556|NCT03110848|Prednisolone|prednisolone|mesh-list
110900557|NCT03110848|Prednisolone acetate|prednisolone acetate|mesh-list
110900558|NCT03110848|Atorvastatin|atorvastatin|mesh-list
110900559|NCT03110848|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110900560|NCT03110848|Prednisolone phosphate|prednisolone phosphate|mesh-list
110900561|NCT03110848|Glucocorticoids|glucocorticoids|mesh-list
110900562|NCT03110848|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110900563|NCT03110848|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110900564|NCT03110848|Antimetabolites|antimetabolites|mesh-ancestor
110900565|NCT03110848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110900566|NCT03110848|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110900567|NCT03110848|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110900568|NCT03110848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110900569|NCT03110848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110900571|NCT03110848|Autonomic Agents|autonomic agents|mesh-ancestor
110900572|NCT03110848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110900573|NCT03110848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110900574|NCT03110848|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110900575|NCT03110848|Hormones|hormones|mesh-ancestor
110224804|NCT05999474|Hormone Antagonists|hormone antagonists|mesh-ancestor
110900576|NCT03110848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110900578|NCT03110848|Protective Agents|protective agents|mesh-ancestor
110900579|NCT03110848|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110900580|NCT03110848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110900581|NCT03139474|Hormones|hormones|mesh-list
110900582|NCT03139474|Hormone Antagonists|hormone antagonists|mesh-list
110900583|NCT03139474|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110900584|NCT03139474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110900585|NCT01368887|Niacinamide|niacinamide|mesh-list
110900586|NCT01368887|Niacin|niacin|mesh-list
110900587|NCT01368887|Nicotinic Acids|nicotinic acids|mesh-list
110900588|NCT01368887|Calcipotriene|calcipotriene|mesh-list
110900589|NCT01368887|Vitamin B Complex|vitamin b complex|mesh-ancestor
110900590|NCT01368887|Vitamins|vitamins|mesh-ancestor
110900591|NCT01368887|Micronutrients|micronutrients|mesh-ancestor
110900592|NCT01368887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110900593|NCT01368887|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110900594|NCT01368887|Antimetabolites|antimetabolites|mesh-ancestor
110900595|NCT01368887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110900596|NCT01368887|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110900597|NCT01368887|Vasodilator Agents|vasodilator agents|mesh-ancestor
110900598|NCT01368887|Dermatologic Agents|dermatologic agents|mesh-ancestor
110900599|NCT01369043|Vitamins|vitamins|mesh-list
110900600|NCT01369043|Vitamin E|vitamin e|mesh-list
110900601|NCT01369043|Micronutrients|micronutrients|mesh-ancestor
110900602|NCT01369043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110900603|NCT01369043|Antioxidants|antioxidants|mesh-ancestor
110900604|NCT01369043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110900605|NCT01369043|Protective Agents|protective agents|mesh-ancestor
110900606|NCT04477096|Emtricitabine|emtricitabine|mesh-list
110900607|NCT04477096|Antiviral Agents|antiviral agents|mesh-ancestor
110900608|NCT04477096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110900609|NCT04477096|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110900610|NCT04477096|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110900611|NCT04477096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110900612|NCT04477096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110900613|NCT04477096|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110900614|NCT04477096|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110900615|NCT01369121|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
110900616|NCT01369121|Hormones|hormones|mesh-ancestor
110900617|NCT01369121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110900618|NCT01369121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110900619|NCT03868150|Amiodarone|amiodarone|mesh-list
110900620|NCT03868150|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110900621|NCT03868150|Vasodilator Agents|vasodilator agents|mesh-ancestor
110900622|NCT03868150|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
110900623|NCT03868150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110900624|NCT03868150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110900625|NCT03868150|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110900626|NCT03868150|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110900627|NCT03868150|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110900628|NCT03868150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110900629|NCT03868150|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110900630|NCT03868150|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110900631|NCT03868150|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110900632|NCT03521687|Apremilast|apremilast|mesh-list
110900633|NCT03521687|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110900634|NCT03521687|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110900635|NCT03521687|Analgesics|analgesics|mesh-ancestor
110900636|NCT03521687|Sensory System Agents|sensory system agents|mesh-ancestor
110900637|NCT03521687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110900638|NCT03521687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110900639|NCT03521687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110900640|NCT03521687|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110618101|NCT00667446|Leuprolide|leuprolide|mesh-list
110900641|NCT03521687|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
110900642|NCT03521687|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110900643|NCT03521687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110900644|NCT03521687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110900645|NCT03141658|Ketamine|ketamine|mesh-list
110900646|NCT03141658|Analgesics|analgesics|mesh-ancestor
110900647|NCT03141658|Sensory System Agents|sensory system agents|mesh-ancestor
110900648|NCT03141658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110900649|NCT03141658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110900650|NCT03141658|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110900651|NCT03141658|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110900652|NCT03141658|Anesthetics, General|anesthetics, general|mesh-ancestor
110900653|NCT03141658|Anesthetics|anesthetics|mesh-ancestor
110900654|NCT03141658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110900655|NCT03141658|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110900656|NCT03141658|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110900657|NCT03141658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110900658|NCT03141658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110900659|NCT03498131|Melatonin|melatonin|mesh-list
110900660|NCT03498131|Antioxidants|antioxidants|mesh-ancestor
110900661|NCT03498131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110900662|NCT03498131|Protective Agents|protective agents|mesh-ancestor
110900663|NCT03498131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110900664|NCT03498131|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110900665|NCT01319825|Milnacipran|milnacipran|mesh-list
110900666|NCT01319825|Levomilnacipran|levomilnacipran|mesh-list
110900667|NCT01319825|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110900668|NCT01319825|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110900669|NCT01319825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110900670|NCT01319825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110900671|NCT01319825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110900672|NCT01319825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110900673|NCT01319825|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110900674|NCT01319825|Analgesics|analgesics|mesh-ancestor
110900675|NCT01319825|Sensory System Agents|sensory system agents|mesh-ancestor
110900676|NCT01319825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110900677|NCT01319825|Antidepressive Agents|antidepressive agents|mesh-ancestor
110900678|NCT01319825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110900679|NCT01369277|Nicotinic Acids|nicotinic acids|mesh-list
110900680|NCT01369277|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1h-imidazol-1-yl)propanamido)nicotinic acid|mesh-list
110900681|NCT01369277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110900682|NCT01369277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110900683|NCT01369277|Vitamin B Complex|vitamin b complex|mesh-ancestor
110900684|NCT01369277|Vitamins|vitamins|mesh-ancestor
110900685|NCT01369277|Micronutrients|micronutrients|mesh-ancestor
110900686|NCT01369277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110900687|NCT02983006|Nivolumab|nivolumab|mesh-list
110900688|NCT02983006|DS-8273a|ds-8273a|mesh-list
110900689|NCT02983006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110900690|NCT02983006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110900691|NCT02983006|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110900692|NCT02983006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110900693|NCT03811756|Coenzyme Q10|coenzyme q10|mesh-list
110900694|NCT03811756|Vitamins|vitamins|mesh-ancestor
110900695|NCT03811756|Micronutrients|micronutrients|mesh-ancestor
110203437|NCT00159718|Amlodipine|amlodipine|mesh-list
110900696|NCT03811756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110900697|NCT03141268|Lactulose|lactulose|mesh-list
110900698|NCT03141268|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110900699|NCT03316781|Adalimumab|adalimumab|mesh-list
110900700|NCT03316781|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110900701|NCT03316781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110900702|NCT03316781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110900703|NCT01319903|Antibodies|antibodies|mesh-list
110900704|NCT01319903|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110900705|NCT01319903|Immunologic Factors|immunologic factors|mesh-ancestor
110900706|NCT01319903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110900707|NCT02839200|Zolpidem|zolpidem|mesh-list
110900708|NCT02839200|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110900709|NCT02839200|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110900710|NCT02839200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110900711|NCT02839200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110900712|NCT02839200|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
110900713|NCT02839200|GABA Agonists|gaba agonists|mesh-ancestor
110900714|NCT02839200|GABA Agents|gaba agents|mesh-ancestor
110900715|NCT02839200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110900716|NCT02839200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110900718|NCT01369667|Cholecalciferol|cholecalciferol|mesh-list
110900719|NCT01369667|Vitamins|vitamins|mesh-ancestor
110900720|NCT01369667|Micronutrients|micronutrients|mesh-ancestor
110900721|NCT01369667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110900722|NCT01369667|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110900723|NCT01369667|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110900724|NCT03564912|Capecitabine|capecitabine|mesh-list
110900725|NCT03564912|Oxaliplatin|oxaliplatin|mesh-list
110900726|NCT03564912|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110900727|NCT03564912|Antimetabolites|antimetabolites|mesh-ancestor
110900728|NCT03564912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110900729|NCT03564912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110900730|NCT03551626|Trametinib|trametinib|mesh-list
110900731|NCT03551626|Dabrafenib|dabrafenib|mesh-list
110900732|NCT03551626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110900733|NCT03551626|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110900734|NCT03551626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110900735|NCT03551626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110900736|NCT05760053|Cisplatin|cisplatin|mesh-list
110900737|NCT05760053|Carboplatin|carboplatin|mesh-list
110900738|NCT05760053|Etoposide|etoposide|mesh-list
110900739|NCT05760053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110900740|NCT05760053|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110900741|NCT05760053|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110900742|NCT05760053|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110900743|NCT05760053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110900744|NCT05760053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110900745|NCT03118739|Febuxostat|febuxostat|mesh-list
110900746|NCT03118739|Verinurad|verinurad|mesh-list
110900747|NCT03118739|Gout Suppressants|gout suppressants|mesh-ancestor
110900748|NCT03118739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110900749|NCT03181126|Venetoclax|venetoclax|mesh-list
110900750|NCT03181126|Navitoclax|navitoclax|mesh-list
110900751|NCT03181126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110900752|NCT05139875|Triamcinolone|triamcinolone|mesh-list
110900753|NCT05139875|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110203452|NCT00159757|Ziprasidone|ziprasidone|mesh-list
110900754|NCT05139875|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110900755|NCT05139875|Betamethasone|betamethasone|mesh-list
110900756|NCT05139875|Betamethasone Valerate|betamethasone valerate|mesh-list
110900757|NCT05139875|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
110900758|NCT05139875|Betamethasone benzoate|betamethasone benzoate|mesh-list
110900759|NCT05139875|Betamethasone dipropionate, betamethasone sodium phosphate drug combination|betamethasone dipropionate, betamethasone sodium phosphate drug combination|mesh-list
110900760|NCT05139875|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
110900761|NCT05139875|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110900762|NCT05139875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110900763|NCT05139875|Glucocorticoids|glucocorticoids|mesh-ancestor
110900764|NCT05139875|Hormones|hormones|mesh-ancestor
110900765|NCT05139875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110900766|NCT05139875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110900767|NCT05139875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110900768|NCT05139875|Immunologic Factors|immunologic factors|mesh-ancestor
110900769|NCT05139875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110900770|NCT05139875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110900771|NCT05139875|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110900772|NCT05139875|Respiratory System Agents|respiratory system agents|mesh-ancestor
110900773|NCT03140410|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110900774|NCT03140410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110900775|NCT04799548|Tislelizumab|tislelizumab|mesh-list
110900776|NCT04799548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110900777|NCT04799548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110900778|NCT01375985|Radavirsen|radavirsen|mesh-list
110900779|NCT01375985|Antiviral Agents|antiviral agents|mesh-ancestor
110900780|NCT01375985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110900781|NCT05384821|Irinotecan|irinotecan|mesh-list
110900782|NCT05384821|Etoposide|etoposide|mesh-list
110900783|NCT05384821|Vincristine|vincristine|mesh-list
110900784|NCT05384821|Temozolomide|temozolomide|mesh-list
110900785|NCT05384821|Tretinoin|tretinoin|mesh-list
110900786|NCT05384821|Isotretinoin|isotretinoin|mesh-list
110900787|NCT05384821|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110900788|NCT05384821|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110900789|NCT05384821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110900790|NCT05384821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110900791|NCT05384821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110900792|NCT05384821|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110900793|NCT05384821|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110900794|NCT05384821|Tubulin Modulators|tubulin modulators|mesh-ancestor
110900795|NCT05384821|Antimitotic Agents|antimitotic agents|mesh-ancestor
110900796|NCT05384821|Mitosis Modulators|mitosis modulators|mesh-ancestor
110900797|NCT05384821|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110900798|NCT05384821|Alkylating Agents|alkylating agents|mesh-ancestor
110900799|NCT05384821|Keratolytic Agents|keratolytic agents|mesh-ancestor
110900800|NCT05384821|Dermatologic Agents|dermatologic agents|mesh-ancestor
110900801|NCT02654080|Vaccines|vaccines|mesh-list
110900802|NCT02654080|Immunologic Factors|immunologic factors|mesh-ancestor
110900803|NCT02654080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110900804|NCT05375305|Morphine|morphine|mesh-list
110900805|NCT05375305|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110900806|NCT05375305|Narcotics|narcotics|mesh-ancestor
110900807|NCT05375305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110900808|NCT05375305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110900809|NCT05375305|Analgesics|analgesics|mesh-ancestor
110900810|NCT05375305|Sensory System Agents|sensory system agents|mesh-ancestor
110900811|NCT05375305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110900812|NCT03140332|Sorafenib|sorafenib|mesh-list
110900813|NCT03140332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110900814|NCT03140332|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110900815|NCT03140332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110900816|NCT03140332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110900818|NCT02835690|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110900819|NCT02835690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110900820|NCT02835690|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110900821|NCT02835690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110900822|NCT02832167|Nivolumab|nivolumab|mesh-list
110900823|NCT02832167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110900824|NCT02832167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110900825|NCT02832167|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110900826|NCT02832167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110900827|NCT04941040|Analgesics, Opioid|analgesics, opioid|mesh-list
110900828|NCT04941040|Anesthetics|anesthetics|mesh-list
110900829|NCT04941040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110900830|NCT04941040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110900831|NCT04941040|Narcotics|narcotics|mesh-ancestor
110900832|NCT04941040|Analgesics|analgesics|mesh-ancestor
110900833|NCT04941040|Sensory System Agents|sensory system agents|mesh-ancestor
110900834|NCT04941040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110900835|NCT00913705|Carboplatin|carboplatin|mesh-list
110900836|NCT00913705|Paclitaxel|paclitaxel|mesh-list
110900837|NCT00913705|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110900838|NCT00913705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110900839|NCT00913705|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110900840|NCT00913705|Tubulin Modulators|tubulin modulators|mesh-ancestor
110900841|NCT00913705|Antimitotic Agents|antimitotic agents|mesh-ancestor
110900842|NCT00913705|Mitosis Modulators|mitosis modulators|mesh-ancestor
110900843|NCT00913705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110900844|NCT04934410|Midazolam|midazolam|mesh-list
110900845|NCT04934410|Etomidate|etomidate|mesh-list
110900846|NCT04934410|Sevoflurane|sevoflurane|mesh-list
110900847|NCT04934410|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110900848|NCT04934410|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110900849|NCT04934410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110900850|NCT04934410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110900851|NCT04934410|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110900852|NCT04934410|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110900853|NCT04934410|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110900854|NCT04934410|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110900855|NCT04934410|Anesthetics, General|anesthetics, general|mesh-ancestor
110900856|NCT04934410|Anesthetics|anesthetics|mesh-ancestor
110900857|NCT04934410|GABA Modulators|gaba modulators|mesh-ancestor
110900858|NCT04934410|GABA Agents|gaba agents|mesh-ancestor
110900859|NCT04934410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110900860|NCT04934410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110900861|NCT04934410|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110900862|NCT04934410|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110618325|NCT00926835|Histamine Agents|histamine agents|mesh-ancestor
110900863|NCT02787239|Rituximab|rituximab|mesh-list
110900864|NCT02787239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110900865|NCT02787239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110900867|NCT02787239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110900868|NCT02787239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110900869|NCT03140956|Levodopa|levodopa|mesh-list
110900870|NCT03140956|Carbidopa|carbidopa|mesh-list
110900871|NCT03140956|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110900872|NCT03140956|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110900873|NCT03140956|Dopamine Agents|dopamine agents|mesh-ancestor
110900874|NCT03140956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110900875|NCT03140956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110900876|NCT03140956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110900877|NCT03140956|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
110900878|NCT03140956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110900879|NCT02681237|Olaparib|olaparib|mesh-list
110900880|NCT02681237|Cediranib|cediranib|mesh-list
110900881|NCT02681237|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110900882|NCT02681237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110900883|NCT02681237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110900884|NCT02681237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110900885|NCT02681237|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110900886|NCT00089245|Iodine|iodine|mesh-list
110900887|NCT00089245|Cadexomer iodine|cadexomer iodine|mesh-list
110900888|NCT00089245|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110900889|NCT00089245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110900890|NCT00089245|Trace Elements|trace elements|mesh-ancestor
110900891|NCT00089245|Micronutrients|micronutrients|mesh-ancestor
110900892|NCT00089245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110900893|NCT02674529|Escitalopram|escitalopram|mesh-list
110900894|NCT02674529|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110900895|NCT02674529|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110900896|NCT02674529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110900897|NCT02674529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110900898|NCT02674529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110900899|NCT02674529|Serotonin Agents|serotonin agents|mesh-ancestor
110900900|NCT02674529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110900901|NCT05418907|Exenatide|exenatide|mesh-list
110900902|NCT05418907|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110900903|NCT05418907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110900904|NCT05418907|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110900906|NCT05418907|Hormones|hormones|mesh-ancestor
110900907|NCT05418907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110900908|NCT02666599|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110900909|NCT02666599|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110900910|NCT02666599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110900911|NCT03632317|Everolimus|everolimus|mesh-list
110900912|NCT03632317|Panobinostat|panobinostat|mesh-list
110900913|NCT03632317|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110900914|NCT03632317|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110900915|NCT03632317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110900916|NCT03632317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110900917|NCT03632317|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110900918|NCT03632317|Immunologic Factors|immunologic factors|mesh-ancestor
110900919|NCT03632317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110900920|NCT03632317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110900921|NCT03632317|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110900922|NCT02591784|Nimotuzumab|nimotuzumab|mesh-list
110900923|NCT02591784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110900924|NCT02591784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110900925|NCT02653963|Triamcinolone|triamcinolone|mesh-list
110900926|NCT02653963|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110900927|NCT02653963|Glucocorticoids|glucocorticoids|mesh-ancestor
110900928|NCT02653963|Hormones|hormones|mesh-ancestor
110900929|NCT02653963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110900930|NCT02653963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110900931|NCT03097861|Lubiprostone|lubiprostone|mesh-list
110900932|NCT03097861|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
110900933|NCT03097861|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110900934|NCT03097861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110900935|NCT03910673|Fosfomycin|fosfomycin|mesh-list
110900936|NCT03910673|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110900937|NCT03910673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110900938|NCT01376141|Sumatriptan|sumatriptan|mesh-list
110900939|NCT01376141|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110900940|NCT01376141|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110900941|NCT01376141|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110900942|NCT01376141|Serotonin Agents|serotonin agents|mesh-ancestor
110900943|NCT01376141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110900944|NCT01376141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110900945|NCT01376141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110900946|NCT01816139|Estradiol|estradiol|mesh-list
110900947|NCT01816139|Estrogens|estrogens|mesh-ancestor
110900948|NCT01816139|Hormones|hormones|mesh-ancestor
110900949|NCT01816139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110900950|NCT01816139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110900951|NCT04052776|Levodopa|levodopa|mesh-list
110900952|NCT04052776|Carbidopa|carbidopa|mesh-list
110900953|NCT04052776|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
110900954|NCT04052776|Buspirone|buspirone|mesh-list
110900955|NCT04052776|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110900956|NCT04052776|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110900957|NCT04052776|Dopamine Agents|dopamine agents|mesh-ancestor
110900958|NCT04052776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110900959|NCT04052776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110900960|NCT04052776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110900961|NCT04052776|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
110900962|NCT04052776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110900963|NCT04052776|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110900964|NCT04052776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110900965|NCT04052776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110900966|NCT04052776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110900967|NCT04052776|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110900968|NCT04052776|Serotonin Agents|serotonin agents|mesh-ancestor
110900969|NCT04052776|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110900970|NCT04052776|Immunologic Factors|immunologic factors|mesh-ancestor
110900971|NCT04052776|Dopamine Agonists|dopamine agonists|mesh-ancestor
110900972|NCT01374191|Botulinum Toxins|botulinum toxins|mesh-list
110900973|NCT01374191|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110900974|NCT01374191|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110900975|NCT01374191|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110900976|NCT01374191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110900977|NCT01374191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110900978|NCT01374191|Cholinergic Agents|cholinergic agents|mesh-ancestor
110900979|NCT01374191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110900980|NCT01374191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110900981|NCT01374191|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110900982|NCT01374191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110900983|NCT03764735|Benzalkonium Compounds|benzalkonium compounds|mesh-list
110900984|NCT03764735|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110900985|NCT03764735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110900986|NCT05041673|Metformin|metformin|mesh-list
110900987|NCT05041673|Liraglutide|liraglutide|mesh-list
110900988|NCT05041673|Empagliflozin|empagliflozin|mesh-list
110900989|NCT05041673|Vildagliptin|vildagliptin|mesh-list
110900990|NCT05041673|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110900991|NCT05041673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110900992|NCT05041673|Incretins|incretins|mesh-ancestor
110900993|NCT05041673|Hormones|hormones|mesh-ancestor
110900994|NCT05041673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110900995|NCT05041673|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110900996|NCT05041673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110900997|NCT05041673|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110900998|NCT05041673|Protease Inhibitors|protease inhibitors|mesh-ancestor
110900999|NCT05041673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110901000|NCT03907540|Belumosudil|belumosudil|mesh-list
110901001|NCT03907540|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110901002|NCT03907540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110901003|NCT03907540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110901004|NCT05759429|Melatonin|melatonin|mesh-list
110901005|NCT05759429|Antioxidants|antioxidants|mesh-ancestor
110901006|NCT05759429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110901007|NCT05759429|Protective Agents|protective agents|mesh-ancestor
110901008|NCT05759429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110901009|NCT05759429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110901010|NCT04005209|Ketamine|ketamine|mesh-list
110901011|NCT04005209|Analgesics|analgesics|mesh-ancestor
110901012|NCT04005209|Sensory System Agents|sensory system agents|mesh-ancestor
110901013|NCT04005209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110901014|NCT04005209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110901015|NCT04005209|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110901016|NCT04005209|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110901017|NCT04005209|Anesthetics, General|anesthetics, general|mesh-ancestor
110901018|NCT04005209|Anesthetics|anesthetics|mesh-ancestor
110901019|NCT04005209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110901020|NCT04005209|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110901021|NCT04005209|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110901022|NCT04005209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110901023|NCT04005209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110901024|NCT03904108|Ramucirumab|ramucirumab|mesh-list
110901025|NCT03904108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110901026|NCT02833350|Folic Acid|folic acid|mesh-list
110901027|NCT02833350|Adalimumab|adalimumab|mesh-list
110901028|NCT02833350|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110901029|NCT02833350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110901030|NCT02833350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110901031|NCT02833350|Hematinics|hematinics|mesh-ancestor
110901032|NCT02833350|Vitamin B Complex|vitamin b complex|mesh-ancestor
110901033|NCT02833350|Vitamins|vitamins|mesh-ancestor
110901034|NCT02833350|Micronutrients|micronutrients|mesh-ancestor
110901035|NCT02833350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110901036|NCT03137134|Crizotinib|crizotinib|mesh-list
110901037|NCT03137134|Esomeprazole|esomeprazole|mesh-list
110901038|NCT03137134|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110901039|NCT03137134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110901040|NCT03137134|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110901041|NCT03137134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110901042|NCT03137134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110901043|NCT03137134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110901044|NCT03137134|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110901045|NCT03137368|Tamoxifen|tamoxifen|mesh-list
110901046|NCT03137368|Exemestane|exemestane|mesh-list
110901047|NCT03137368|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110901048|NCT03137368|Hormone Antagonists|hormone antagonists|mesh-ancestor
110901049|NCT03137368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110901050|NCT03137368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110901051|NCT03137368|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110901052|NCT03137368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110924372|NCT02311946|Palbociclib|palbociclib|mesh-list
110901053|NCT03137368|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110901054|NCT03137368|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110901055|NCT03137368|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110901056|NCT03137368|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110901057|NCT03137368|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110901058|NCT03137368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110901059|NCT03137368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110901060|NCT03138616|Vitamin D|vitamin d|mesh-list
110901061|NCT03138616|Vitamins|vitamins|mesh-ancestor
110901062|NCT03138616|Micronutrients|micronutrients|mesh-ancestor
110901063|NCT03138616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110203589|NCT00160537|Levocetirizine|levocetirizine|mesh-list
110901064|NCT03138616|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110901065|NCT03137290|Neostigmine|neostigmine|mesh-list
110901066|NCT03137290|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110901067|NCT03137290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110901068|NCT03137290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110901069|NCT03137290|Cholinergic Agents|cholinergic agents|mesh-ancestor
110901070|NCT03137290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110901071|NCT03137290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110901072|NCT03137290|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110901073|NCT03137290|Autonomic Agents|autonomic agents|mesh-ancestor
110901074|NCT03137290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110901075|NCT03782818|Olaparib|olaparib|mesh-list
110901076|NCT03782818|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110901077|NCT03782818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110901078|NCT03782818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110901079|NCT03782818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110901080|NCT05391724|Brincidofovir|brincidofovir|mesh-list
110901081|NCT05391724|Antiviral Agents|antiviral agents|mesh-ancestor
110901082|NCT05391724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110901083|NCT03355534|Dexmedetomidine|dexmedetomidine|mesh-list
110901084|NCT03355534|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110901085|NCT03355534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110901086|NCT03355534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110901087|NCT03355534|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110901088|NCT03355534|Analgesics|analgesics|mesh-ancestor
110901089|NCT03355534|Sensory System Agents|sensory system agents|mesh-ancestor
110901090|NCT03355534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110901091|NCT03355534|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110901092|NCT03355534|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110901093|NCT03355534|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110901094|NCT03355534|Adrenergic Agents|adrenergic agents|mesh-ancestor
110901095|NCT03355534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110901096|NCT03355534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110901098|NCT05385562|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110901099|NCT05385562|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110901100|NCT05385562|Hyaluronic Acid|hyaluronic acid|mesh-list
110901101|NCT05385562|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110901102|NCT05385562|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110901103|NCT05385562|Glucocorticoids|glucocorticoids|mesh-ancestor
110901104|NCT05385562|Hormones|hormones|mesh-ancestor
110901105|NCT05385562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110901106|NCT05385562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110901107|NCT05385562|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110901108|NCT05385562|Immunologic Factors|immunologic factors|mesh-ancestor
110901109|NCT05385562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110901110|NCT05385562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110901111|NCT05385562|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110901112|NCT05385562|Viscosupplements|viscosupplements|mesh-ancestor
110901113|NCT05385562|Protective Agents|protective agents|mesh-ancestor
110901114|NCT01343043|Cyclophosphamide|cyclophosphamide|mesh-list
110901115|NCT01343043|Fludarabine|fludarabine|mesh-list
110901116|NCT01343043|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110901117|NCT01343043|Immunologic Factors|immunologic factors|mesh-ancestor
110901118|NCT01343043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110901119|NCT01343043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110901120|NCT01343043|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110901121|NCT01343043|Alkylating Agents|alkylating agents|mesh-ancestor
110901122|NCT01343043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110901123|NCT01343043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110901124|NCT01343043|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110901125|NCT03139708|Brimonidine Tartrate|brimonidine tartrate|mesh-list
110901126|NCT03139708|Phenylephrine|phenylephrine|mesh-list
110901127|NCT03139708|Oxymetazoline|oxymetazoline|mesh-list
110901128|NCT03139708|Tropicamide|tropicamide|mesh-list
110901129|NCT03139708|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110901130|NCT03139708|Mydriatics|mydriatics|mesh-ancestor
110901131|NCT03139708|Autonomic Agents|autonomic agents|mesh-ancestor
110901132|NCT03139708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110901133|NCT03139708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110901134|NCT03139708|Sympathomimetics|sympathomimetics|mesh-ancestor
110901135|NCT03139708|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110901136|NCT03139708|Nasal Decongestants|nasal decongestants|mesh-ancestor
110901137|NCT03139708|Respiratory System Agents|respiratory system agents|mesh-ancestor
110901138|NCT03139708|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110901139|NCT03139708|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110901140|NCT03139708|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110901141|NCT03139708|Adrenergic Agents|adrenergic agents|mesh-ancestor
110901142|NCT03139708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110901143|NCT03139708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110901144|NCT03139708|Protective Agents|protective agents|mesh-ancestor
110901145|NCT03139708|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110901146|NCT03139708|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110901147|NCT03139708|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110901148|NCT03139708|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110901149|NCT03139708|Cholinergic Agents|cholinergic agents|mesh-ancestor
110901150|NCT01358760|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
110901151|NCT01358760|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110901152|NCT01358760|Immunologic Factors|immunologic factors|mesh-ancestor
110901153|NCT01358760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110901154|NCT05330364|Cladribine|cladribine|mesh-list
110901155|NCT05330364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110901156|NCT05330364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110901157|NCT05330364|Immunologic Factors|immunologic factors|mesh-ancestor
110901158|NCT05330364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110901159|NCT05087368|Vaccines|vaccines|mesh-list
110901160|NCT05087368|Immunologic Factors|immunologic factors|mesh-ancestor
110901161|NCT05087368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110901162|NCT01341990|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110901163|NCT05087134|Choline|choline|mesh-list
110901165|NCT05087134|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110901166|NCT05087134|Antimetabolites|antimetabolites|mesh-ancestor
110901167|NCT05087134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110901168|NCT05087134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110901169|NCT05087134|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110901170|NCT05087134|Nootropic Agents|nootropic agents|mesh-ancestor
110901171|NCT03048747|Tolvaptan|tolvaptan|mesh-list
110901172|NCT03048747|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
110901173|NCT03048747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110901174|NCT03048747|Natriuretic Agents|natriuretic agents|mesh-ancestor
110901175|NCT03048747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110901176|NCT05086822|Irinotecan|irinotecan|mesh-list
110901177|NCT05086822|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110901178|NCT05086822|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110901179|NCT05086822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110901180|NCT05086822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110901181|NCT05086822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110901182|NCT05354128|Fibrinolytic Agents|fibrinolytic agents|mesh-list
110901183|NCT05354128|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110901184|NCT05354128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110901185|NCT04051827|Midazolam|midazolam|mesh-list
110901186|NCT04051827|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110901187|NCT04051827|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110901188|NCT04051827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110901189|NCT04051827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110901190|NCT04051827|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110901191|NCT04051827|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110901192|NCT04051827|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110901193|NCT04051827|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110901194|NCT04051827|Anesthetics, General|anesthetics, general|mesh-ancestor
110901195|NCT04051827|Anesthetics|anesthetics|mesh-ancestor
110901196|NCT04051827|GABA Modulators|gaba modulators|mesh-ancestor
110901197|NCT04051827|GABA Agents|gaba agents|mesh-ancestor
110901198|NCT04051827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110901199|NCT04051827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110901200|NCT05346874|Oxaliplatin|oxaliplatin|mesh-list
110901201|NCT05346874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110901202|NCT02123823|Everolimus|everolimus|mesh-list
110901203|NCT02123823|Exemestane|exemestane|mesh-list
110901204|NCT02123823|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110901205|NCT02123823|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110901206|NCT02123823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110901207|NCT02123823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110901208|NCT02123823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110901209|NCT02123823|Immunologic Factors|immunologic factors|mesh-ancestor
110901210|NCT02123823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110901211|NCT02123823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110901212|NCT02123823|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110901213|NCT02123823|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110901214|NCT02123823|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110901215|NCT02123823|Hormone Antagonists|hormone antagonists|mesh-ancestor
110901216|NCT02123823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110901217|NCT05085652|Anesthetics|anesthetics|mesh-list
110901218|NCT05085652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110901219|NCT05085652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110901220|NCT03136510|Apixaban|apixaban|mesh-list
110901221|NCT03136510|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110901222|NCT03136510|Antithrombins|antithrombins|mesh-ancestor
110901223|NCT03136510|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110901224|NCT03136510|Protease Inhibitors|protease inhibitors|mesh-ancestor
110901225|NCT03136510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110901226|NCT03136510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110901227|NCT03136510|Anticoagulants|anticoagulants|mesh-ancestor
110901228|NCT05692245|Dexamethasone|dexamethasone|mesh-list
110901229|NCT05692245|Ondansetron|ondansetron|mesh-list
110901230|NCT05692245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110901231|NCT05692245|Antiemetics|antiemetics|mesh-ancestor
110901232|NCT05692245|Autonomic Agents|autonomic agents|mesh-ancestor
110901233|NCT05692245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110901234|NCT05692245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110901235|NCT05692245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110901236|NCT05692245|Glucocorticoids|glucocorticoids|mesh-ancestor
110901237|NCT05692245|Hormones|hormones|mesh-ancestor
110618699|NCT00565773|Alemtuzumab|alemtuzumab|mesh-list
110901238|NCT05692245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110901239|NCT05692245|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110901241|NCT05692245|Antipruritics|antipruritics|mesh-ancestor
110901242|NCT05692245|Dermatologic Agents|dermatologic agents|mesh-ancestor
110901243|NCT05692245|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110901244|NCT05692245|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110901245|NCT05692245|Serotonin Agents|serotonin agents|mesh-ancestor
110901246|NCT05692245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110924403|NCT02312180|Plasminogen|plasminogen|mesh-list
110901247|NCT05692245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110901248|NCT05085106|Biphenylylacetic acid|biphenylylacetic acid|mesh-list
110901249|NCT05085106|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110901250|NCT05085106|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110901251|NCT05085106|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110901252|NCT05085106|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110901253|NCT05085106|Analgesics|analgesics|mesh-ancestor
110901254|NCT05085106|Sensory System Agents|sensory system agents|mesh-ancestor
110901255|NCT05085106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110901256|NCT05085106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110901257|NCT05085106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110901258|NCT05085106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110901259|NCT05084872|Hydroxychloroquine|hydroxychloroquine|mesh-list
110901260|NCT05084872|Antimalarials|antimalarials|mesh-ancestor
110901261|NCT05084872|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110901262|NCT05084872|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110901263|NCT05084872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110901264|NCT05084872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110901265|NCT05084872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110901266|NCT05084872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110901267|NCT00159796|Olanzapine|olanzapine|mesh-list
110901268|NCT00159796|Asenapine|asenapine|mesh-list
110901269|NCT00159796|Antiemetics|antiemetics|mesh-ancestor
110901270|NCT00159796|Autonomic Agents|autonomic agents|mesh-ancestor
110901271|NCT00159796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110901272|NCT00159796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110901273|NCT00159796|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110901274|NCT00159796|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110901275|NCT00159796|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110901276|NCT00159796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110901277|NCT00159796|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110901278|NCT00159796|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110901279|NCT00159796|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110901280|NCT00159796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110901281|NCT00159796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110901282|NCT00159796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110901283|NCT00159796|Serotonin Agents|serotonin agents|mesh-ancestor
110901284|NCT03626571|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110901285|NCT03626571|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110901286|NCT03626571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110901287|NCT03327844|Calcium, Dietary|calcium, dietary|mesh-list
110901288|NCT03327844|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110901289|NCT03327844|Metronidazole|metronidazole|mesh-list
110901290|NCT03327844|Ciprofloxacin|ciprofloxacin|mesh-list
110901291|NCT03327844|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
110901292|NCT03327844|Calcium|calcium|mesh-list
110901293|NCT03327844|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110901294|NCT03327844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110901295|NCT03327844|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110901296|NCT03327844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110901297|NCT03327844|Antitubercular Agents|antitubercular agents|mesh-ancestor
110901298|NCT03327844|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110901299|NCT03327844|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110901300|NCT03327844|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110901301|NCT03327844|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110901302|NCT03327844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110901303|NCT03327844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110901304|NCT03327844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110901305|NCT03327844|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110901306|NCT03327844|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110901307|NCT05008510|Camptothecin|camptothecin|mesh-list
110901308|NCT05008510|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
110901309|NCT05008510|Immunoconjugates|immunoconjugates|mesh-list
110901310|NCT05008510|Immunologic Factors|immunologic factors|mesh-ancestor
110901311|NCT05008510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110901312|NCT05008510|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110901313|NCT05008510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110901314|NCT05008510|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110901315|NCT05008510|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110901316|NCT05008510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110901317|NCT05008510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110901318|NCT05194995|Cetuximab|cetuximab|mesh-list
110901319|NCT05194995|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110901320|NCT05194995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110901321|NCT05187039|Anesthetics|anesthetics|mesh-list
110224878|NCT05998876|Antitussive Agents|antitussive agents|mesh-ancestor
110901322|NCT05187039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110901323|NCT05187039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110901325|NCT03136666|Candesartan cilexetil|candesartan cilexetil|mesh-list
110901326|NCT03136666|Nifedipine|nifedipine|mesh-list
110901327|NCT03136666|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110901328|NCT03136666|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110901329|NCT03136666|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110901330|NCT03136666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110901331|NCT03136666|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110901332|NCT03136666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110901333|NCT03136666|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110901334|NCT03136666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110901335|NCT03136666|Vasodilator Agents|vasodilator agents|mesh-ancestor
110901336|NCT03136666|Tocolytic Agents|tocolytic agents|mesh-ancestor
110901337|NCT03136666|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110203704|NCT00161239|Prednisone|prednisone|mesh-list
110901338|NCT03255083|Osimertinib|osimertinib|mesh-list
110901339|NCT03255083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110901340|NCT03255083|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110901341|NCT03255083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110901342|NCT03255083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110901343|NCT04861558|Fluorouracil|fluorouracil|mesh-list
110901344|NCT04861558|Oxaliplatin|oxaliplatin|mesh-list
110901345|NCT04861558|Irinotecan|irinotecan|mesh-list
110901346|NCT04861558|Antimetabolites|antimetabolites|mesh-ancestor
110901347|NCT04861558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110901348|NCT04861558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110901349|NCT04861558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110901350|NCT04861558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110901351|NCT04861558|Immunologic Factors|immunologic factors|mesh-ancestor
110901352|NCT04861558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110901353|NCT04861558|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110901354|NCT04861558|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110924431|NCT05070520|Artemether|artemether|mesh-list
110901355|NCT04861558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110901356|NCT03735537|Zoledronic Acid|zoledronic acid|mesh-list
110901357|NCT03735537|Teriparatide|teriparatide|mesh-list
110901358|NCT03735537|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110901359|NCT03735537|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110901360|NCT03735537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110901361|NCT03735537|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110901362|NCT04531059|Metronidazole|metronidazole|mesh-list
110901363|NCT04531059|Minocycline|minocycline|mesh-list
110901364|NCT04531059|Tetracycline|tetracycline|mesh-list
110901365|NCT04531059|Potassium Citrate|potassium citrate|mesh-list
110901366|NCT04531059|Esomeprazole|esomeprazole|mesh-list
110901367|NCT04531059|Bismuth|bismuth|mesh-list
110901368|NCT04531059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110901369|NCT04531059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110901370|NCT04531059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110901371|NCT04531059|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110901372|NCT04531059|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110901373|NCT04531059|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110901374|NCT04531059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110901375|NCT04531059|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110901376|NCT04531059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110901377|NCT04531059|Antacids|antacids|mesh-ancestor
110901378|NCT04531059|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110901379|NCT04531059|Diuretics|diuretics|mesh-ancestor
110901380|NCT04531059|Natriuretic Agents|natriuretic agents|mesh-ancestor
110901381|NCT04531059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110901383|NCT04531059|Respiratory System Agents|respiratory system agents|mesh-ancestor
110901384|NCT05090176|Povidone|povidone|mesh-list
110901385|NCT05090176|Plasma Substitutes|plasma substitutes|mesh-ancestor
110618849|NCT00749450|Fluorouracil|fluorouracil|mesh-list
110901386|NCT05090176|Blood Substitutes|blood substitutes|mesh-ancestor
110901387|NCT01316055|4-Aminopyridine|4-aminopyridine|mesh-list
110901388|NCT01316055|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
110901389|NCT01316055|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110901390|NCT01316055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110901392|NCT05659563|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110901393|NCT05659563|Hormone Antagonists|hormone antagonists|mesh-ancestor
110901394|NCT05659563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110901395|NCT05659563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110901396|NCT05659563|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110901397|NCT05659563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110901398|NCT05659563|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110901399|NCT05659563|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110901400|NCT05659563|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110901401|NCT04558294|Ketanserin|ketanserin|mesh-list
110901402|NCT04558294|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
110901403|NCT04558294|Hallucinogens|hallucinogens|mesh-ancestor
110901404|NCT04558294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110901405|NCT04558294|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110901406|NCT04558294|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110901407|NCT04558294|Serotonin Agents|serotonin agents|mesh-ancestor
110901408|NCT04558294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110901409|NCT04558294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110901410|NCT04558294|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110901411|NCT04558294|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110901412|NCT04558294|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110901413|NCT05626257|Omalizumab|omalizumab|mesh-list
110901414|NCT05626257|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110901415|NCT05626257|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110924455|NCT03884452|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110901416|NCT05626257|Respiratory System Agents|respiratory system agents|mesh-ancestor
110901417|NCT04396821|Paclitaxel|paclitaxel|mesh-list
110901418|NCT04396821|Gemcitabine|gemcitabine|mesh-list
110901419|NCT04396821|Nivolumab|nivolumab|mesh-list
110901420|NCT04396821|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110901421|NCT04396821|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110901422|NCT04396821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110901423|NCT04396821|Tubulin Modulators|tubulin modulators|mesh-ancestor
110901424|NCT04396821|Antimitotic Agents|antimitotic agents|mesh-ancestor
110901425|NCT04396821|Mitosis Modulators|mitosis modulators|mesh-ancestor
110901426|NCT04396821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110901427|NCT04396821|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110901428|NCT04396821|Antimetabolites|antimetabolites|mesh-ancestor
110901429|NCT04396821|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110901430|NCT04396821|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110901431|NCT03378466|Heparin|heparin|mesh-list
110901432|NCT03378466|Calcium heparin|calcium heparin|mesh-list
110901433|NCT03378466|Anticoagulants|anticoagulants|mesh-ancestor
110901434|NCT03378466|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110901435|NCT03378466|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110901436|NCT03378466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110901437|NCT05077540|Misoprostol|misoprostol|mesh-list
110901438|NCT05077540|Oxytocin|oxytocin|mesh-list
110901439|NCT05077540|Oxytocics|oxytocics|mesh-ancestor
110901440|NCT05077540|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110901441|NCT05077540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110901442|NCT05077540|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110901443|NCT05077540|Abortifacient Agents|abortifacient agents|mesh-ancestor
110901444|NCT05077540|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110901445|NCT05077540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110901446|NCT04977375|Pembrolizumab|pembrolizumab|mesh-list
110901447|NCT04977375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110901448|NCT04977375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110901449|NCT04977375|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110901450|NCT04977375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110901451|NCT03097315|Triamcinolone|triamcinolone|mesh-list
110901452|NCT03097315|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110901453|NCT03097315|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110901454|NCT03097315|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110901455|NCT03097315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110901457|NCT03097315|Hormones|hormones|mesh-ancestor
110901458|NCT03097315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110618930|NCT03989557|Antipyretics|antipyretics|mesh-ancestor
110901459|NCT03097315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110901460|NCT03097315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110901461|NCT03097315|Immunologic Factors|immunologic factors|mesh-ancestor
110901462|NCT03097315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110901463|NCT03097315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110901464|NCT05530707|Niacinamide|niacinamide|mesh-list
110901465|NCT05530707|Niacin|niacin|mesh-list
110901466|NCT05530707|Nicotinic Acids|nicotinic acids|mesh-list
110901467|NCT05530707|Vitamin B Complex|vitamin b complex|mesh-ancestor
110901468|NCT05530707|Vitamins|vitamins|mesh-ancestor
110901469|NCT05530707|Micronutrients|micronutrients|mesh-ancestor
110901470|NCT05530707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110901471|NCT05530707|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110901472|NCT05530707|Antimetabolites|antimetabolites|mesh-ancestor
110901473|NCT05530707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110901474|NCT05530707|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110901475|NCT05530707|Vasodilator Agents|vasodilator agents|mesh-ancestor
110901476|NCT02833974|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110901477|NCT03093415|Grazoprevir|grazoprevir|mesh-list
110901478|NCT03093415|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
110901479|NCT03093415|Antiviral Agents|antiviral agents|mesh-ancestor
110901480|NCT03093415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110901481|NCT01358526|Oxycodone|oxycodone|mesh-list
110901482|NCT01358526|Naloxone|naloxone|mesh-list
110901483|NCT01358526|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110901484|NCT01358526|Narcotics|narcotics|mesh-ancestor
110901485|NCT01358526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110901486|NCT01358526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110901487|NCT01358526|Analgesics|analgesics|mesh-ancestor
110901488|NCT01358526|Sensory System Agents|sensory system agents|mesh-ancestor
110901489|NCT01358526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110901490|NCT01358526|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110901491|NCT01310010|Dasatinib|dasatinib|mesh-list
110901492|NCT01310010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110901493|NCT01310010|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110901494|NCT01310010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110901495|NCT01310010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110901496|NCT02830776|Bimatoprost|bimatoprost|mesh-list
110901497|NCT02830776|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110901498|NCT02830776|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110901499|NCT02830776|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110901500|NCT03563664|Danazol|danazol|mesh-list
110901501|NCT03563664|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110901502|NCT03563664|Hormone Antagonists|hormone antagonists|mesh-ancestor
110901503|NCT03563664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110901504|NCT03563664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110901505|NCT01904136|Mycophenolic Acid|mycophenolic acid|mesh-list
110901506|NCT01904136|Cyclophosphamide|cyclophosphamide|mesh-list
110901507|NCT01904136|Melphalan|melphalan|mesh-list
110901508|NCT01904136|Mechlorethamine|mechlorethamine|mesh-list
110901509|NCT01904136|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
110901510|NCT01904136|Fludarabine|fludarabine|mesh-list
110901511|NCT01904136|Tacrolimus|tacrolimus|mesh-list
110901512|NCT01904136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110901513|NCT01904136|Immunologic Factors|immunologic factors|mesh-ancestor
110901514|NCT01904136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110901515|NCT01904136|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110901516|NCT01904136|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110901517|NCT01904136|Alkylating Agents|alkylating agents|mesh-ancestor
110901518|NCT01904136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110901519|NCT01904136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110901520|NCT01904136|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110901521|NCT01904136|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110901522|NCT01904136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110901523|NCT01904136|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110901524|NCT01904136|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110901525|NCT01904136|Antitubercular Agents|antitubercular agents|mesh-ancestor
110901526|NCT01904136|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110901527|NCT01904136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110901528|NCT03041181|Gemcitabine|gemcitabine|mesh-list
110901529|NCT03041181|Docetaxel|docetaxel|mesh-list
110901530|NCT03041181|Nivolumab|nivolumab|mesh-list
110901531|NCT03041181|Pemetrexed|pemetrexed|mesh-list
110901532|NCT03041181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110901533|NCT03041181|Antimetabolites|antimetabolites|mesh-ancestor
110901534|NCT03041181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110901535|NCT03041181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110901536|NCT03041181|Tubulin Modulators|tubulin modulators|mesh-ancestor
110901538|NCT03041181|Mitosis Modulators|mitosis modulators|mesh-ancestor
110901539|NCT03041181|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110901540|NCT03041181|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110901541|NCT03041181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110901542|NCT03041181|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110901543|NCT03041181|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110901544|NCT05351229|Morphine|morphine|mesh-list
110901545|NCT05351229|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110901546|NCT05351229|Narcotics|narcotics|mesh-ancestor
110901547|NCT05351229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110901548|NCT05351229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110901549|NCT05351229|Analgesics|analgesics|mesh-ancestor
110901550|NCT05351229|Sensory System Agents|sensory system agents|mesh-ancestor
110901551|NCT05351229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110901552|NCT05121909|Listerine|listerine|mesh-list
110901553|NCT05121909|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
110901554|NCT05121909|Sodium Fluoride|sodium fluoride|mesh-list
110901555|NCT05121909|Cariostatic Agents|cariostatic agents|mesh-ancestor
110901556|NCT05121909|Protective Agents|protective agents|mesh-ancestor
110901557|NCT05121909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110901558|NCT05121909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110901559|NCT02828124|Nivolumab|nivolumab|mesh-list
110901560|NCT02828124|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110901561|NCT02828124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110901562|NCT02828124|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110901563|NCT02828124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110901564|NCT04761393|Xenon|xenon|mesh-list
110901565|NCT04761393|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110901566|NCT04761393|Anesthetics, General|anesthetics, general|mesh-ancestor
110901567|NCT04761393|Anesthetics|anesthetics|mesh-ancestor
110901568|NCT04761393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110901569|NCT04761393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110901570|NCT02829996|Latanoprost|latanoprost|mesh-list
110901571|NCT02829996|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110901572|NCT02829996|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110901573|NCT05385549|Imatinib Mesylate|imatinib mesylate|mesh-list
110901574|NCT05385549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110901575|NCT05385549|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110901576|NCT05385549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110901577|NCT05385549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110901578|NCT03563586|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110901579|NCT03563586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110901580|NCT05197062|Aticaprant|aticaprant|mesh-list
110901581|NCT05197062|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110901582|NCT05197062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110901583|NCT05197062|Sensory System Agents|sensory system agents|mesh-ancestor
110901584|NCT05197062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110901585|NCT05000736|Fulvestrant|fulvestrant|mesh-list
110901586|NCT05000736|Palbociclib|palbociclib|mesh-list
110901587|NCT05000736|Aromatase Inhibitors|aromatase inhibitors|mesh-list
110901588|NCT05000736|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110901589|NCT05000736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110901590|NCT05000736|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110901591|NCT05000736|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110901592|NCT05000736|Hormone Antagonists|hormone antagonists|mesh-ancestor
110224906|NCT05998551|Fentanyl|fentanyl|mesh-list
110901593|NCT05000736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110901594|NCT05000736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110901595|NCT05000736|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110924498|NCT02305550|Antioxidants|antioxidants|mesh-ancestor
110901596|NCT05000736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110901597|NCT05000736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110901598|NCT05000736|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110901599|NCT03828162|Anticoagulants|anticoagulants|mesh-list
110901600|NCT03563040|Methoxsalen|methoxsalen|mesh-list
110901601|NCT03563040|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110901602|NCT03563040|Dermatologic Agents|dermatologic agents|mesh-ancestor
110901603|NCT03094416|Esomeprazole|esomeprazole|mesh-list
110901605|NCT03094416|Rabeprazole|rabeprazole|mesh-list
110901606|NCT03094416|Pantoprazole|pantoprazole|mesh-list
110901607|NCT03094416|Lansoprazole|lansoprazole|mesh-list
110901608|NCT03094416|Dexlansoprazole|dexlansoprazole|mesh-list
110901609|NCT03094416|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
110901610|NCT03094416|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110901611|NCT03094416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110901612|NCT03094416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110901613|NCT03094416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110901621|NCT01338870|Nicotinic Acids|nicotinic acids|mesh-list
110901622|NCT01338870|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110901623|NCT01338870|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1h-imidazol-1-yl)propanamido)nicotinic acid|mesh-list
110901624|NCT01338870|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110901625|NCT01338870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110901626|NCT01338870|Incretins|incretins|mesh-ancestor
110901627|NCT01338870|Hormones|hormones|mesh-ancestor
110901628|NCT01338870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110901629|NCT01338870|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110901630|NCT01338870|Protease Inhibitors|protease inhibitors|mesh-ancestor
110901631|NCT01338870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110901632|NCT01338870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110901633|NCT01338870|Vitamin B Complex|vitamin b complex|mesh-ancestor
110901634|NCT01338870|Vitamins|vitamins|mesh-ancestor
110901635|NCT01338870|Micronutrients|micronutrients|mesh-ancestor
110901636|NCT02824224|Tamoxifen|tamoxifen|mesh-list
110901637|NCT02824224|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110901638|NCT02824224|Hormone Antagonists|hormone antagonists|mesh-ancestor
110901639|NCT02824224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110901640|NCT02824224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110901641|NCT02824224|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110901642|NCT02824224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110901643|NCT02824224|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110901644|NCT02824224|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110901645|NCT02824224|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110901646|NCT01338792|Oxaliplatin|oxaliplatin|mesh-list
110901647|NCT01338792|Pemetrexed|pemetrexed|mesh-list
110901648|NCT01338792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110901649|NCT01338792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110901650|NCT01338792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110901651|NCT01338792|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110901652|NCT01338792|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110901653|NCT01314105|Carboplatin|carboplatin|mesh-list
110901654|NCT01314105|Nintedanib|nintedanib|mesh-list
110901655|NCT01314105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110901656|NCT01314105|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110901657|NCT01314105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110901658|NCT01314105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110901659|NCT01966471|Maytansine|maytansine|mesh-list
110901660|NCT01966471|Docetaxel|docetaxel|mesh-list
110901661|NCT01966471|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
110901662|NCT01966471|Cyclophosphamide|cyclophosphamide|mesh-list
110901663|NCT01966471|Doxorubicin|doxorubicin|mesh-list
110901664|NCT01966471|Fluorouracil|fluorouracil|mesh-list
110901665|NCT01966471|Trastuzumab|trastuzumab|mesh-list
110901666|NCT01966471|Epirubicin|epirubicin|mesh-list
110901667|NCT01966471|Pertuzumab|pertuzumab|mesh-list
110901668|NCT01966471|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110901669|NCT01966471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110901670|NCT01966471|Tubulin Modulators|tubulin modulators|mesh-ancestor
110901671|NCT01966471|Antimitotic Agents|antimitotic agents|mesh-ancestor
110901672|NCT01966471|Mitosis Modulators|mitosis modulators|mesh-ancestor
110901673|NCT01966471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110901674|NCT01966471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110901675|NCT01966471|Immunologic Factors|immunologic factors|mesh-ancestor
110901676|NCT01966471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110901677|NCT01966471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110901678|NCT01966471|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110901679|NCT01966471|Alkylating Agents|alkylating agents|mesh-ancestor
110901680|NCT01966471|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110901681|NCT01966471|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110901682|NCT01966471|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110901683|NCT01966471|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110901684|NCT01966471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110901685|NCT01966471|Antimetabolites|antimetabolites|mesh-ancestor
110619159|NCT00791544|Sorafenib|sorafenib|mesh-list
110901686|NCT01966471|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110901687|NCT01966471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110901688|NCT01966471|Immunotoxins|immunotoxins|mesh-ancestor
110901689|NCT01966471|Immunoconjugates|immunoconjugates|mesh-ancestor
110901690|NCT04188847|Apatinib|apatinib|mesh-list
110901691|NCT04188847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110901692|NCT04188847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110901693|NCT04188847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110901694|NCT04188847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110901695|NCT05255107|Riboflavin|riboflavin|mesh-list
110901696|NCT05255107|Lubricant Eye Drops|lubricant eye drops|mesh-list
110901697|NCT05255107|Vitamin B Complex|vitamin b complex|mesh-ancestor
110901698|NCT05255107|Vitamins|vitamins|mesh-ancestor
110901699|NCT05255107|Micronutrients|micronutrients|mesh-ancestor
110901700|NCT05255107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110901701|NCT05255107|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110901702|NCT05255107|Dermatologic Agents|dermatologic agents|mesh-ancestor
110901703|NCT05255107|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110901704|NCT05255107|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110901705|NCT03227471|Ivacaftor|ivacaftor|mesh-list
110901706|NCT03227471|Elexacaftor|elexacaftor|mesh-list
110901707|NCT03227471|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
110901708|NCT03227471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110901709|NCT03227471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110901710|NCT01354314|Fluconazole|fluconazole|mesh-list
110901711|NCT01354314|Paroxetine|paroxetine|mesh-list
110901712|NCT01354314|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110901713|NCT01354314|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110901714|NCT01354314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110901715|NCT01354314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110901716|NCT01354314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110901717|NCT01354314|Serotonin Agents|serotonin agents|mesh-ancestor
110901718|NCT01354314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110901719|NCT01354314|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110901720|NCT01354314|Antidepressive Agents|antidepressive agents|mesh-ancestor
110901721|NCT01354314|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110901722|NCT01354314|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110901723|NCT01354314|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110901724|NCT01354314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110901725|NCT01354314|Antifungal Agents|antifungal agents|mesh-ancestor
110901726|NCT01354314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110901727|NCT01354314|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110901728|NCT01354314|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110901729|NCT01354314|Hormone Antagonists|hormone antagonists|mesh-ancestor
110901730|NCT01354314|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110901731|NCT01354314|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110901732|NCT01354314|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110901733|NCT04509336|Orphenadrine|orphenadrine|mesh-list
110901734|NCT04509336|Baclofen|baclofen|mesh-list
110901735|NCT04509336|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110901736|NCT04509336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110901737|NCT04509336|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110901738|NCT04509336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110901739|NCT04509336|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
110901740|NCT04509336|GABA Agonists|gaba agonists|mesh-ancestor
110901741|NCT04509336|GABA Agents|gaba agents|mesh-ancestor
110901742|NCT04509336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110901743|NCT04509336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110901744|NCT04509336|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110901745|NCT04509336|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110901746|NCT04509336|Parasympatholytics|parasympatholytics|mesh-ancestor
110901747|NCT04509336|Autonomic Agents|autonomic agents|mesh-ancestor
110901748|NCT04509336|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110901749|NCT04509336|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110901750|NCT04509336|Cholinergic Agents|cholinergic agents|mesh-ancestor
110901751|NCT04509336|Cytochrome P-450 CYP2B6 Inhibitors|cytochrome p-450 cyp2b6 inhibitors|mesh-ancestor
110901752|NCT04509336|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110901753|NCT04509336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110901754|NCT03194321|Tacrolimus|tacrolimus|mesh-list
110901755|NCT03194321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110901756|NCT03194321|Immunologic Factors|immunologic factors|mesh-ancestor
110901757|NCT03194321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110901758|NCT03194321|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110901759|NCT03194321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110901760|NCT03194321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110901762|NCT05231460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110901763|NCT05231460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110901764|NCT05231460|Analgesics|analgesics|mesh-ancestor
110901765|NCT05231460|Sensory System Agents|sensory system agents|mesh-ancestor
110901766|NCT05231460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110901767|NCT01374581|Artesunate|artesunate|mesh-list
110901768|NCT01374581|Lumefantrine|lumefantrine|mesh-list
110901769|NCT01374581|Artemether|artemether|mesh-list
110901770|NCT01374581|Amodiaquine|amodiaquine|mesh-list
110901771|NCT01374581|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
110901772|NCT01374581|Quinine|quinine|mesh-list
110901773|NCT01374581|Clindamycin|clindamycin|mesh-list
110901774|NCT01374581|Clindamycin palmitate|clindamycin palmitate|mesh-list
110901775|NCT01374581|Clindamycin phosphate|clindamycin phosphate|mesh-list
110901776|NCT01374581|Antimalarials|antimalarials|mesh-ancestor
110901777|NCT01374581|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110901778|NCT01374581|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110901779|NCT01374581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110901780|NCT01374581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110901781|NCT01374581|Antiviral Agents|antiviral agents|mesh-ancestor
110901782|NCT01374581|Schistosomicides|schistosomicides|mesh-ancestor
110901783|NCT01374581|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110901784|NCT01374581|Anthelmintics|anthelmintics|mesh-ancestor
110901785|NCT01374581|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110901786|NCT01374581|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110924542|NCT03503786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110901787|NCT01374581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110901788|NCT01374581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110901789|NCT01374581|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110901790|NCT01374581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110901791|NCT01374581|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110901792|NCT01374581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110901793|NCT01374581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110901794|NCT01374581|Analgesics|analgesics|mesh-ancestor
110901795|NCT01374581|Sensory System Agents|sensory system agents|mesh-ancestor
110901796|NCT01354938|Clarithromycin|clarithromycin|mesh-list
110901797|NCT01354938|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110901798|NCT01354938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110901799|NCT01354938|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110901800|NCT01354938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110901801|NCT01354938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110901802|NCT01354938|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110901803|NCT01354938|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110901804|NCT03065556|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110901806|NCT01374737|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110901807|NCT01374737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110901808|NCT01374737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110901809|NCT01374737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110901810|NCT01374737|Analgesics|analgesics|mesh-ancestor
110901811|NCT01374737|Sensory System Agents|sensory system agents|mesh-ancestor
110901812|NCT01374737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110901813|NCT01374737|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110901814|NCT01374737|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110901815|NCT01374737|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110901816|NCT01374737|Adrenergic Agents|adrenergic agents|mesh-ancestor
110901817|NCT01374737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110901818|NCT01374737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110901819|NCT03631615|Antibodies|antibodies|mesh-list
110901820|NCT03631615|Immunologic Factors|immunologic factors|mesh-ancestor
110901821|NCT03631615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110901822|NCT01376453|Fluorouracil|fluorouracil|mesh-list
110901823|NCT01376453|Sorafenib|sorafenib|mesh-list
110901824|NCT01376453|Antimetabolites|antimetabolites|mesh-ancestor
110901825|NCT01376453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110901826|NCT01376453|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110901827|NCT01376453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110901828|NCT01376453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110901829|NCT01376453|Immunologic Factors|immunologic factors|mesh-ancestor
110901830|NCT01376453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110901831|NCT01376453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110901832|NCT01376453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110901833|NCT05107219|Linaclotide|linaclotide|mesh-list
110901834|NCT05107219|Plecanatide|plecanatide|mesh-list
110901835|NCT05107219|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
110901836|NCT05107219|Enzyme Activators|enzyme activators|mesh-ancestor
110901837|NCT05107219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110901838|NCT05107219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110901839|NCT01568125|Hypoglycemic Agents|hypoglycemic agents|mesh-list
110901840|NCT01568125|Incretins|incretins|mesh-list
110901841|NCT01568125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110901842|NCT01568125|Hormones|hormones|mesh-ancestor
110901843|NCT01568125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110901844|NCT02288897|Temozolomide|temozolomide|mesh-list
110901845|NCT02288897|Dacarbazine|dacarbazine|mesh-list
110901846|NCT02288897|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
110901847|NCT02288897|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110901848|NCT02288897|Alkylating Agents|alkylating agents|mesh-ancestor
110924558|NCT02178436|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110901849|NCT02288897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110901850|NCT02288897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110901851|NCT02288897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110901852|NCT05707572|Methylprednisolone|methylprednisolone|mesh-list
110901853|NCT05707572|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110901854|NCT05707572|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110901855|NCT05707572|Prednisolone|prednisolone|mesh-list
110901856|NCT05707572|Prednisolone acetate|prednisolone acetate|mesh-list
110901857|NCT05707572|Lidocaine|lidocaine|mesh-list
110901858|NCT05707572|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110901859|NCT05707572|Prednisolone phosphate|prednisolone phosphate|mesh-list
110901860|NCT05707572|Anesthetics, Local|anesthetics, local|mesh-ancestor
110901861|NCT05707572|Anesthetics|anesthetics|mesh-ancestor
110901862|NCT05707572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110901863|NCT05707572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110901864|NCT05707572|Sensory System Agents|sensory system agents|mesh-ancestor
110901865|NCT05707572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110901866|NCT05707572|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110901867|NCT05707572|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110901868|NCT05707572|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110901869|NCT05707572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110901870|NCT05707572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110901871|NCT05707572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110901872|NCT05707572|Antiemetics|antiemetics|mesh-ancestor
110901873|NCT05707572|Autonomic Agents|autonomic agents|mesh-ancestor
110901874|NCT05707572|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110901875|NCT05707572|Glucocorticoids|glucocorticoids|mesh-ancestor
110901876|NCT05707572|Hormones|hormones|mesh-ancestor
110901877|NCT05707572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110901878|NCT05707572|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110901879|NCT05707572|Protective Agents|protective agents|mesh-ancestor
110901880|NCT05707572|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110901881|NCT05707572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110901882|NCT02035800|Adalimumab|adalimumab|mesh-list
110901883|NCT02035800|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110901884|NCT02035800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110901885|NCT02035800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110901886|NCT03993912|Dexamethasone|dexamethasone|mesh-list
110901887|NCT03993912|Lenalidomide|lenalidomide|mesh-list
110901888|NCT03993912|Daratumumab|daratumumab|mesh-list
110901889|NCT03993912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110901890|NCT03993912|Antiemetics|antiemetics|mesh-ancestor
110901891|NCT03993912|Autonomic Agents|autonomic agents|mesh-ancestor
110901892|NCT03993912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110901893|NCT03993912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110901894|NCT03993912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110901895|NCT03993912|Glucocorticoids|glucocorticoids|mesh-ancestor
110901896|NCT03993912|Hormones|hormones|mesh-ancestor
110901897|NCT03993912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110901898|NCT03993912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110901899|NCT03993912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110901900|NCT03993912|Immunologic Factors|immunologic factors|mesh-ancestor
110901901|NCT03993912|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110901902|NCT03993912|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110901903|NCT03993912|Growth Substances|growth substances|mesh-ancestor
110901904|NCT03993912|Growth Inhibitors|growth inhibitors|mesh-ancestor
110901905|NCT01568749|Acetaminophen|acetaminophen|mesh-list
110901906|NCT01568749|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110901907|NCT01568749|Analgesics|analgesics|mesh-ancestor
110901908|NCT01568749|Sensory System Agents|sensory system agents|mesh-ancestor
110901909|NCT01568749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110901910|NCT01568749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110901911|NCT01568749|Antipyretics|antipyretics|mesh-ancestor
110924577|NCT02305862|Antimetabolites|antimetabolites|mesh-ancestor
110901913|NCT02819310|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110901914|NCT03633773|Immunomodulating Agents|immunomodulating agents|mesh-list
110901915|NCT03633773|Immunologic Factors|immunologic factors|mesh-ancestor
110901916|NCT03633773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110901917|NCT01375361|Albuterol|albuterol|mesh-list
110901918|NCT01375361|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110901919|NCT01375361|Autonomic Agents|autonomic agents|mesh-ancestor
110901920|NCT01375361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110203863|NCT00053105|Prednisolone|prednisolone|mesh-list
110901921|NCT01375361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110901922|NCT01375361|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110901923|NCT01375361|Respiratory System Agents|respiratory system agents|mesh-ancestor
110901924|NCT01375361|Tocolytic Agents|tocolytic agents|mesh-ancestor
110901925|NCT01375361|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110901926|NCT01375361|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110901927|NCT01375361|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110901928|NCT01375361|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110901929|NCT01375361|Adrenergic Agents|adrenergic agents|mesh-ancestor
110901930|NCT01375361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110901931|NCT01375361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110901932|NCT01376765|Aluminum Hydroxide|aluminum hydroxide|mesh-list
110901933|NCT01376765|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110901934|NCT01376765|Immunologic Factors|immunologic factors|mesh-ancestor
110901935|NCT01376765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110901936|NCT01376765|Antacids|antacids|mesh-ancestor
110901937|NCT01376765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110901938|NCT01376765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110901939|NCT03278509|Metoprolol|metoprolol|mesh-list
110901940|NCT03278509|Bisoprolol|bisoprolol|mesh-list
110901941|NCT03278509|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110901942|NCT03278509|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110901943|NCT03278509|Sympatholytics|sympatholytics|mesh-ancestor
110901944|NCT03278509|Autonomic Agents|autonomic agents|mesh-ancestor
110901945|NCT03278509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110901946|NCT03278509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110250505|NCT00131300|Hylan|hylan|mesh-list
110901947|NCT03278509|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110901948|NCT03278509|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110901949|NCT03278509|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110901950|NCT03278509|Adrenergic Agents|adrenergic agents|mesh-ancestor
110901951|NCT03278509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110901952|NCT03278509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110901953|NCT05754593|Hormones|hormones|mesh-list
110901954|NCT05754593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110901955|NCT05754593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110901956|NCT04788563|Antihypertensive Agents|antihypertensive agents|mesh-list
110901957|NCT05196347|Dapagliflozin|dapagliflozin|mesh-list
110901958|NCT05196347|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110901959|NCT05196347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110901960|NCT05196347|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110901961|NCT05196347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110901962|NCT01358201|Cytarabine|cytarabine|mesh-list
110901963|NCT01358201|Dexamethasone|dexamethasone|mesh-list
110901964|NCT01358201|Methotrexate|methotrexate|mesh-list
110901965|NCT01358201|Vincristine|vincristine|mesh-list
110901966|NCT01358201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110901967|NCT01358201|Antiemetics|antiemetics|mesh-ancestor
110901968|NCT01358201|Autonomic Agents|autonomic agents|mesh-ancestor
110901969|NCT01358201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110901970|NCT01358201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110901971|NCT01358201|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110901972|NCT01358201|Glucocorticoids|glucocorticoids|mesh-ancestor
110901973|NCT01358201|Hormones|hormones|mesh-ancestor
110901974|NCT01358201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110901975|NCT01358201|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110901976|NCT01358201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110901977|NCT01358201|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110901978|NCT01358201|Abortifacient Agents|abortifacient agents|mesh-ancestor
110901979|NCT01358201|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110901980|NCT01358201|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110901981|NCT01358201|Antimetabolites|antimetabolites|mesh-ancestor
110901982|NCT01358201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110901983|NCT01358201|Dermatologic Agents|dermatologic agents|mesh-ancestor
110901984|NCT01358201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110901985|NCT01358201|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110901986|NCT01358201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110901987|NCT01358201|Immunologic Factors|immunologic factors|mesh-ancestor
110901988|NCT01358201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110901989|NCT01358201|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110901990|NCT01358201|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110901991|NCT01358201|Tubulin Modulators|tubulin modulators|mesh-ancestor
110901992|NCT01358201|Antimitotic Agents|antimitotic agents|mesh-ancestor
110901993|NCT01358201|Mitosis Modulators|mitosis modulators|mesh-ancestor
110901994|NCT01358201|Antiviral Agents|antiviral agents|mesh-ancestor
110901995|NCT01358201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110901996|NCT02969083|Cisplatin|cisplatin|mesh-list
110901997|NCT02969083|Gemcitabine|gemcitabine|mesh-list
110901998|NCT02969083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110901999|NCT02969083|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110902000|NCT02969083|Antimetabolites|antimetabolites|mesh-ancestor
110902001|NCT02969083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110902002|NCT04726475|Cannabidiol|cannabidiol|mesh-list
110902003|NCT04726475|Anticonvulsants|anticonvulsants|mesh-ancestor
110902004|NCT02951767|Atezolizumab|atezolizumab|mesh-list
110902005|NCT02951767|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110902006|NCT02951767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110902007|NCT02951767|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110902008|NCT02951767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110902009|NCT05170763|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110902010|NCT03091777|Metronidazole|metronidazole|mesh-list
110902011|NCT03091777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110902012|NCT03091777|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110902013|NCT03091777|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110902014|NCT03091777|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110902015|NCT05603741|Lidocaine|lidocaine|mesh-list
110902016|NCT05603741|Anesthetics, Local|anesthetics, local|mesh-ancestor
110902017|NCT05603741|Anesthetics|anesthetics|mesh-ancestor
110902018|NCT05603741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110902019|NCT05603741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110902020|NCT05603741|Sensory System Agents|sensory system agents|mesh-ancestor
110902021|NCT05603741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110902022|NCT05603741|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110902023|NCT05603741|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110902024|NCT05603741|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110902025|NCT05603741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110902026|NCT05603741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110902027|NCT05392361|Gabapentin|gabapentin|mesh-list
110902028|NCT05392361|Baclofen|baclofen|mesh-list
110902029|NCT05392361|Analgesics|analgesics|mesh-ancestor
110902030|NCT05392361|Sensory System Agents|sensory system agents|mesh-ancestor
110924595|NCT02312804|Mitosis Modulators|mitosis modulators|mesh-ancestor
110902031|NCT05392361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110902032|NCT05392361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110902033|NCT05392361|Anticonvulsants|anticonvulsants|mesh-ancestor
110902034|NCT05392361|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110902035|NCT05392361|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110203914|NCT00162487|Albuterol|albuterol|mesh-list
110902036|NCT05392361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110902037|NCT05392361|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110902038|NCT05392361|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110902039|NCT05392361|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110902040|NCT05392361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110902041|NCT05392361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110902042|NCT05392361|Antimanic Agents|antimanic agents|mesh-ancestor
110902043|NCT05392361|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110902044|NCT05392361|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110902045|NCT05392361|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
110902046|NCT05392361|GABA Agonists|gaba agonists|mesh-ancestor
110902047|NCT05392361|GABA Agents|gaba agents|mesh-ancestor
110902048|NCT05338541|Etoposide|etoposide|mesh-list
110902049|NCT05338541|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110902050|NCT05338541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110902051|NCT05338541|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110902052|NCT05338541|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110902053|NCT05338541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110902054|NCT05338541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110902055|NCT05335655|Dexmedetomidine|dexmedetomidine|mesh-list
110902056|NCT05335655|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110902057|NCT05335655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110902058|NCT05335655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110902060|NCT05335655|Analgesics|analgesics|mesh-ancestor
110902061|NCT05335655|Sensory System Agents|sensory system agents|mesh-ancestor
110902062|NCT05335655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110902063|NCT05335655|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110902064|NCT05335655|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110902065|NCT05335655|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110902066|NCT05335655|Adrenergic Agents|adrenergic agents|mesh-ancestor
110902067|NCT05335655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110902068|NCT05335655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110902069|NCT04589351|Ezetimibe|ezetimibe|mesh-list
110902070|NCT04589351|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110902071|NCT04589351|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110902072|NCT04589351|Antimetabolites|antimetabolites|mesh-ancestor
110902073|NCT04589351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110902074|NCT04589351|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110902075|NCT02818998|Aflibercept|aflibercept|mesh-list
110902076|NCT02818998|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110902077|NCT02818998|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110902078|NCT02818998|Growth Substances|growth substances|mesh-ancestor
110902079|NCT02818998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110902080|NCT02818998|Growth Inhibitors|growth inhibitors|mesh-ancestor
110902081|NCT02818998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110902082|NCT02821416|Benralizumab|benralizumab|mesh-list
110902083|NCT02821416|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110902084|NCT02821416|Respiratory System Agents|respiratory system agents|mesh-ancestor
110902085|NCT03108521|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110902086|NCT03108521|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110902087|NCT03108521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110902088|NCT03108521|Incretins|incretins|mesh-ancestor
110902089|NCT03108521|Hormones|hormones|mesh-ancestor
110902090|NCT03108521|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110902092|NCT03108521|Protease Inhibitors|protease inhibitors|mesh-ancestor
110902093|NCT03108521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110902094|NCT03108521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110902095|NCT04500509|Diclofenac|diclofenac|mesh-list
110902096|NCT04500509|Dinoprostone|dinoprostone|mesh-list
110902097|NCT04500509|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110203929|NCT00162526|Tocopherols|tocopherols|mesh-list
110902098|NCT04500509|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110902099|NCT04500509|Analgesics|analgesics|mesh-ancestor
110902100|NCT04500509|Sensory System Agents|sensory system agents|mesh-ancestor
110902101|NCT04500509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110902102|NCT04500509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110902103|NCT04500509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110902104|NCT04500509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110902105|NCT04500509|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110902106|NCT04500509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110902107|NCT04500509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110902108|NCT04500509|Oxytocics|oxytocics|mesh-ancestor
110902109|NCT04500509|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110902110|NCT05760599|Bevacizumab|bevacizumab|mesh-list
110902111|NCT05760599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110902112|NCT05760599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110902113|NCT05760599|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110902114|NCT05760599|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110902115|NCT05760599|Growth Substances|growth substances|mesh-ancestor
110902116|NCT05760599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110902117|NCT05760599|Growth Inhibitors|growth inhibitors|mesh-ancestor
110902118|NCT04441073|Lidocaine|lidocaine|mesh-list
110902119|NCT04441073|Anesthetics, Local|anesthetics, local|mesh-ancestor
110902120|NCT04441073|Anesthetics|anesthetics|mesh-ancestor
110902121|NCT04441073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110902122|NCT04441073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110902123|NCT04441073|Sensory System Agents|sensory system agents|mesh-ancestor
110902124|NCT04441073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110902125|NCT04441073|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110902126|NCT04441073|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110902127|NCT04441073|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110902128|NCT04441073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110902129|NCT04441073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110902130|NCT02817828|Drospirenone|drospirenone|mesh-list
110619595|NCT00326599|Gemcitabine|gemcitabine|mesh-list
110902131|NCT02817828|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110902132|NCT02817828|Hormone Antagonists|hormone antagonists|mesh-ancestor
110902133|NCT02817828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110902134|NCT02817828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110902135|NCT02817828|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110902136|NCT02817828|Diuretics|diuretics|mesh-ancestor
110902137|NCT02817828|Natriuretic Agents|natriuretic agents|mesh-ancestor
110902138|NCT03632681|Insulin|insulin|mesh-list
110902139|NCT03632681|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110902140|NCT03632681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110902141|NCT03632681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110902142|NCT05597995|Sodium Tetradecyl Sulfate|sodium tetradecyl sulfate|mesh-list
110902143|NCT05597995|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
110902144|NCT05597995|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110902145|NCT05597917|Trabectedin|trabectedin|mesh-list
110902146|NCT05597917|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110902147|NCT05597917|Alkylating Agents|alkylating agents|mesh-ancestor
110902148|NCT05597917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110902149|NCT05597917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110902150|NCT03796650|Vancomycin|vancomycin|mesh-list
110902151|NCT03796650|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110902152|NCT03796650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110902154|NCT05597527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110924628|NCT04475224|Mitogens|mitogens|mesh-list
110902155|NCT05597527|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110902156|NCT05597527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110902157|NCT05597527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110902159|NCT05198141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110902160|NCT05198141|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110902161|NCT05198141|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110902162|NCT05198141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110902163|NCT05198141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110902164|NCT05198141|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110902165|NCT05198141|Hormone Antagonists|hormone antagonists|mesh-ancestor
110902166|NCT05198141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110902167|NCT05198141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110902168|NCT02813694|Moxifloxacin|moxifloxacin|mesh-list
110902169|NCT02813694|Lefamulin|lefamulin|mesh-list
110902170|NCT02813694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110902171|NCT02813694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110902172|NCT02813694|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110902173|NCT02813694|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110902174|NCT02813694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110902175|NCT02813694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110902176|NCT02813694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110902177|NCT03632161|Dexmedetomidine|dexmedetomidine|mesh-list
110902178|NCT03632161|Bupivacaine|bupivacaine|mesh-list
110902179|NCT03632161|Anesthetics, Local|anesthetics, local|mesh-ancestor
110902180|NCT03632161|Anesthetics|anesthetics|mesh-ancestor
110902181|NCT03632161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110902182|NCT03632161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110902183|NCT03632161|Sensory System Agents|sensory system agents|mesh-ancestor
110902184|NCT03632161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110902185|NCT03632161|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110902186|NCT03632161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110902187|NCT03632161|Analgesics|analgesics|mesh-ancestor
110902188|NCT03632161|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110902189|NCT03632161|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110902190|NCT03632161|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110902191|NCT03632161|Adrenergic Agents|adrenergic agents|mesh-ancestor
110902192|NCT03632161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110902193|NCT03632161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110902194|NCT03103919|Rotigotine|rotigotine|mesh-list
110902195|NCT03103919|Dopamine Agonists|dopamine agonists|mesh-ancestor
110902196|NCT03103919|Dopamine Agents|dopamine agents|mesh-ancestor
110902197|NCT03103919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110902198|NCT03103919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110902199|NCT03103919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110902200|NCT04173325|Nivolumab|nivolumab|mesh-list
110902201|NCT04173325|Irinotecan|irinotecan|mesh-list
110902202|NCT04173325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110902203|NCT04173325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110902204|NCT04173325|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110902205|NCT04173325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110902206|NCT04173325|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110902207|NCT04173325|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110902208|NCT04173325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110902209|NCT02810964|Sulforaphane|sulforaphane|mesh-list
110902210|NCT02810964|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110902211|NCT02810964|Protective Agents|protective agents|mesh-ancestor
110902212|NCT02810964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110902213|NCT02810964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110902214|NCT04073147|Venetoclax|venetoclax|mesh-list
110902215|NCT04073147|Obinutuzumab|obinutuzumab|mesh-list
110902216|NCT04073147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110902217|NCT04073147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110902218|NCT02707159|Paclitaxel|paclitaxel|mesh-list
110902219|NCT02707159|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110902220|NCT02707159|Gemcitabine|gemcitabine|mesh-list
110902221|NCT02707159|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110902222|NCT02707159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110902223|NCT02707159|Tubulin Modulators|tubulin modulators|mesh-ancestor
110902224|NCT02707159|Antimitotic Agents|antimitotic agents|mesh-ancestor
110902225|NCT02707159|Mitosis Modulators|mitosis modulators|mesh-ancestor
110902226|NCT02707159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110902227|NCT02707159|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110902228|NCT02707159|Antimetabolites|antimetabolites|mesh-ancestor
110902229|NCT04113187|Propranolol|propranolol|mesh-list
110902230|NCT04113187|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110902231|NCT04113187|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110902232|NCT04113187|Adrenergic Agents|adrenergic agents|mesh-ancestor
110902233|NCT04113187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110902234|NCT04113187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110902235|NCT04113187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110902236|NCT04113187|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110902237|NCT04113187|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110902238|NCT04113187|Vasodilator Agents|vasodilator agents|mesh-ancestor
110902239|NCT03103763|Warfarin|warfarin|mesh-list
110902240|NCT03103763|Anticoagulants|anticoagulants|mesh-ancestor
110902241|NCT05197517|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110902242|NCT05197517|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110902243|NCT05197517|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110902244|NCT05197517|Antimetabolites|antimetabolites|mesh-ancestor
110902245|NCT05197517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110902246|NCT05197517|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110902247|NCT05197517|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110902248|NCT05197517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110902249|NCT04011475|Tiotropium Bromide|tiotropium bromide|mesh-list
110902250|NCT04011475|Olodaterol|olodaterol|mesh-list
110902251|NCT04011475|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110902252|NCT04011475|Autonomic Agents|autonomic agents|mesh-ancestor
110902253|NCT04011475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110902254|NCT04011475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110902255|NCT04011475|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110902256|NCT04011475|Respiratory System Agents|respiratory system agents|mesh-ancestor
110902257|NCT04011475|Parasympatholytics|parasympatholytics|mesh-ancestor
110902258|NCT04011475|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110902259|NCT04011475|Cholinergic Agents|cholinergic agents|mesh-ancestor
110902260|NCT04011475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110902261|NCT04011475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110902262|NCT03663335|Tacrolimus|tacrolimus|mesh-list
110203986|NCT00162721|Doxorubicin|doxorubicin|mesh-list
110902263|NCT03663335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110902264|NCT03663335|Immunologic Factors|immunologic factors|mesh-ancestor
110902265|NCT03663335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110902266|NCT03663335|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110902267|NCT03663335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110902268|NCT03663335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110902269|NCT03632915|Lacosamide|lacosamide|mesh-list
110902270|NCT03632915|Phenytoin|phenytoin|mesh-list
110902271|NCT03632915|Ketamine|ketamine|mesh-list
110902272|NCT03632915|Levetiracetam|levetiracetam|mesh-list
110902273|NCT03632915|Valproic Acid|valproic acid|mesh-list
110902274|NCT03632915|Phenobarbital|phenobarbital|mesh-list
110902275|NCT03632915|Analgesics|analgesics|mesh-ancestor
110902276|NCT03632915|Sensory System Agents|sensory system agents|mesh-ancestor
110902277|NCT03632915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110902278|NCT03632915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110902279|NCT03632915|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110902280|NCT03632915|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110902282|NCT03632915|Anesthetics|anesthetics|mesh-ancestor
110902283|NCT03632915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110902284|NCT03632915|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110902285|NCT03632915|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110902286|NCT03632915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110902287|NCT03632915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110902288|NCT03632915|Anticonvulsants|anticonvulsants|mesh-ancestor
110902289|NCT03632915|Nootropic Agents|nootropic agents|mesh-ancestor
110902290|NCT03632915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110902291|NCT03632915|GABA Agents|gaba agents|mesh-ancestor
110902292|NCT03632915|Antimanic Agents|antimanic agents|mesh-ancestor
110902293|NCT03632915|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110902294|NCT03632915|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110902295|NCT03632915|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110902296|NCT03632915|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110902297|NCT03632915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110902298|NCT03632915|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110902299|NCT03632915|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110902300|NCT03632915|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110902301|NCT03632915|GABA Modulators|gaba modulators|mesh-ancestor
110902302|NCT03632915|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110902303|NCT03632915|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110902304|NCT05649605|Methyltestosterone|methyltestosterone|mesh-list
110902305|NCT05649605|Testosterone|testosterone|mesh-list
110902306|NCT05649605|Testosterone undecanoate|testosterone undecanoate|mesh-list
110902307|NCT05649605|Testosterone enanthate|testosterone enanthate|mesh-list
110902308|NCT05649605|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
110902309|NCT05649605|Androgens|androgens|mesh-ancestor
110902310|NCT05649605|Hormones|hormones|mesh-ancestor
110902311|NCT05649605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110902312|NCT05649605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110902313|NCT05649605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110902314|NCT05649605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110902315|NCT05649605|Anabolic Agents|anabolic agents|mesh-ancestor
110902316|NCT05640479|Pregabalin|pregabalin|mesh-list
110902317|NCT05640479|Dexmedetomidine|dexmedetomidine|mesh-list
110902318|NCT05640479|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110902319|NCT05640479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110902320|NCT05640479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110902321|NCT05640479|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110902322|NCT05640479|Analgesics|analgesics|mesh-ancestor
110902323|NCT05640479|Sensory System Agents|sensory system agents|mesh-ancestor
110902324|NCT05640479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110902325|NCT05640479|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110902326|NCT05640479|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110902327|NCT05640479|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110902328|NCT05640479|Adrenergic Agents|adrenergic agents|mesh-ancestor
110902329|NCT05640479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110902330|NCT05640479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110902331|NCT05640479|Anticonvulsants|anticonvulsants|mesh-ancestor
110902332|NCT05640479|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110902333|NCT05640479|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110902334|NCT05640479|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110902335|NCT05640479|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110902336|NCT05640479|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110902337|NCT05640479|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110902338|NCT05309525|Tranexamic Acid|tranexamic acid|mesh-list
110902339|NCT05309525|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110902340|NCT05309525|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110902341|NCT05309525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110902342|NCT05309525|Hemostatics|hemostatics|mesh-ancestor
110902343|NCT05309525|Coagulants|coagulants|mesh-ancestor
110902344|NCT04905563|Acetaminophen|acetaminophen|mesh-list
110902345|NCT04905563|Ibuprofen|ibuprofen|mesh-list
110902346|NCT04905563|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
110902347|NCT04905563|Hydrocodone|hydrocodone|mesh-list
110902348|NCT04905563|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110902349|NCT04905563|Analgesics|analgesics|mesh-ancestor
110902350|NCT04905563|Sensory System Agents|sensory system agents|mesh-ancestor
110902351|NCT04905563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110902352|NCT04905563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110902353|NCT04905563|Antipyretics|antipyretics|mesh-ancestor
110902354|NCT04905563|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110902355|NCT04905563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110902357|NCT04905563|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110902358|NCT04905563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110902359|NCT04905563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110902360|NCT04905563|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110902361|NCT04905563|Narcotics|narcotics|mesh-ancestor
110902362|NCT04905563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110902363|NCT04905563|Antitussive Agents|antitussive agents|mesh-ancestor
110902364|NCT04905563|Respiratory System Agents|respiratory system agents|mesh-ancestor
110902365|NCT02810418|Paclitaxel|paclitaxel|mesh-list
110902366|NCT02810418|LMB-100|lmb-100|mesh-list
110902367|NCT02810418|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110902368|NCT02810418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110902369|NCT02810418|Tubulin Modulators|tubulin modulators|mesh-ancestor
110902370|NCT02810418|Antimitotic Agents|antimitotic agents|mesh-ancestor
110902371|NCT02810418|Mitosis Modulators|mitosis modulators|mesh-ancestor
110902372|NCT02810418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110902373|NCT02810418|Immunoconjugates|immunoconjugates|mesh-ancestor
110902374|NCT02810418|Immunologic Factors|immunologic factors|mesh-ancestor
110902375|NCT02810418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110902376|NCT02959541|Leucovorin|leucovorin|mesh-list
110902377|NCT02959541|Levoleucovorin|levoleucovorin|mesh-list
110902378|NCT02959541|Antidotes|antidotes|mesh-ancestor
110902379|NCT02959541|Protective Agents|protective agents|mesh-ancestor
110902380|NCT02959541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110902381|NCT02959541|Vitamin B Complex|vitamin b complex|mesh-ancestor
110902382|NCT02959541|Vitamins|vitamins|mesh-ancestor
110902383|NCT02959541|Micronutrients|micronutrients|mesh-ancestor
110902384|NCT05705700|Dutasteride|dutasteride|mesh-list
110902385|NCT05705700|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
110902386|NCT05705700|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110902387|NCT05705700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110902388|NCT05705700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110902389|NCT05705700|Hormone Antagonists|hormone antagonists|mesh-ancestor
110902390|NCT05705700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110902391|NCT05705700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110902392|NCT02498951|Obinutuzumab|obinutuzumab|mesh-list
110902393|NCT02498951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110902394|NCT02498951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110902396|NCT02260050|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110902397|NCT02260050|Histamine Antagonists|histamine antagonists|mesh-ancestor
110902398|NCT02260050|Histamine Agents|histamine agents|mesh-ancestor
110902399|NCT02260050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110902400|NCT02260050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110902401|NCT02260050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110902402|NCT02036736|Propofol|propofol|mesh-list
110902403|NCT02036736|Anesthetics|anesthetics|mesh-list
110902404|NCT02036736|Desflurane|desflurane|mesh-list
110902405|NCT02036736|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110902406|NCT02036736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110902407|NCT02036736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110902408|NCT02036736|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110902409|NCT02036736|Anesthetics, General|anesthetics, general|mesh-ancestor
110902410|NCT02036736|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110902411|NCT05693688|Atosiban|atosiban|mesh-list
110902412|NCT05693688|Hormone Antagonists|hormone antagonists|mesh-ancestor
110902413|NCT05693688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110902414|NCT05693688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110902415|NCT05693688|Tocolytic Agents|tocolytic agents|mesh-ancestor
110902416|NCT05693688|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110902417|NCT02047422|Metolazone|metolazone|mesh-list
110902418|NCT02047422|Furosemide|furosemide|mesh-list
110902419|NCT02047422|Spironolactone|spironolactone|mesh-list
110902420|NCT02047422|Diuretics|diuretics|mesh-ancestor
110902421|NCT02047422|Natriuretic Agents|natriuretic agents|mesh-ancestor
110902422|NCT02047422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110902423|NCT02047422|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110902424|NCT02047422|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110224969|NCT05998187|Botulinum Toxins|botulinum toxins|mesh-list
110902425|NCT02047422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110902426|NCT02047422|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110902428|NCT02047422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110619903|NCT00756860|Sevelamer|sevelamer|mesh-list
110902429|NCT02047422|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110902430|NCT02047422|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110902431|NCT02047422|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110902432|NCT02048358|Methylprednisolone|methylprednisolone|mesh-list
110902433|NCT02048358|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110902434|NCT02048358|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110902435|NCT02048358|Prednisolone|prednisolone|mesh-list
110902436|NCT02048358|Prednisolone acetate|prednisolone acetate|mesh-list
110902437|NCT02048358|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110902438|NCT02048358|Prednisolone phosphate|prednisolone phosphate|mesh-list
110902439|NCT02048358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110902440|NCT02048358|Antiemetics|antiemetics|mesh-ancestor
110902441|NCT02048358|Autonomic Agents|autonomic agents|mesh-ancestor
110902442|NCT02048358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110902443|NCT02048358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110902444|NCT02048358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110902445|NCT02048358|Glucocorticoids|glucocorticoids|mesh-ancestor
110902446|NCT02048358|Hormones|hormones|mesh-ancestor
110902447|NCT02048358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110902448|NCT02048358|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110902449|NCT02048358|Protective Agents|protective agents|mesh-ancestor
110902450|NCT02048358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110902451|NCT02048358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110902452|NCT02928029|Dexamethasone|dexamethasone|mesh-list
110902453|NCT02928029|Bortezomib|bortezomib|mesh-list
110902454|NCT02928029|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
110902455|NCT02928029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110902456|NCT02928029|Antiemetics|antiemetics|mesh-ancestor
110902457|NCT02928029|Autonomic Agents|autonomic agents|mesh-ancestor
110902458|NCT02928029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110902459|NCT02928029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110902460|NCT02928029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110902461|NCT02928029|Glucocorticoids|glucocorticoids|mesh-ancestor
110902462|NCT02928029|Hormones|hormones|mesh-ancestor
110902463|NCT02928029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110902464|NCT02928029|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110902465|NCT02928029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110902466|NCT02050074|Metformin|metformin|mesh-list
110902467|NCT02050074|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
110902468|NCT02050074|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110902469|NCT02050074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110902470|NCT02050074|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110902471|NCT02050074|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110902472|NCT02050074|Antimetabolites|antimetabolites|mesh-ancestor
110902473|NCT02050074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110902474|NCT02050074|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110902475|NCT02050152|Nitrous Oxide|nitrous oxide|mesh-list
110902476|NCT02050152|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110902477|NCT02050152|Anesthetics, General|anesthetics, general|mesh-ancestor
110902478|NCT02050152|Anesthetics|anesthetics|mesh-ancestor
110204071|NCT00163150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110902479|NCT02050152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110902480|NCT02050152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110902481|NCT02050152|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110902482|NCT02050152|Analgesics|analgesics|mesh-ancestor
110902483|NCT02050152|Sensory System Agents|sensory system agents|mesh-ancestor
110902484|NCT02050152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110902485|NCT02806986|Immunoglobulins|immunoglobulins|mesh-list
110902486|NCT02806986|gamma-Globulins|gamma-globulins|mesh-list
110902487|NCT02806986|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110902488|NCT02806986|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110902489|NCT02806986|Immunologic Factors|immunologic factors|mesh-ancestor
110902490|NCT02806986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110902491|NCT03095651|Insulin Glargine|insulin glargine|mesh-list
110902492|NCT03095651|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110902493|NCT03095651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110224976|NCT05998135|Atovaquone|atovaquone|mesh-list
110902494|NCT04717193|Epinephrine|epinephrine|mesh-list
110902495|NCT04717193|Racepinephrine|racepinephrine|mesh-list
110902496|NCT04717193|Bupivacaine|bupivacaine|mesh-list
110902497|NCT04717193|Anesthetics, Local|anesthetics, local|mesh-list
110902498|NCT04717193|Anesthetics|anesthetics|mesh-list
110902499|NCT04717193|Epinephryl borate|epinephryl borate|mesh-list
110902500|NCT04717193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110902501|NCT04717193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110902502|NCT04717193|Sensory System Agents|sensory system agents|mesh-ancestor
110902503|NCT04717193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110902504|NCT04717193|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110902505|NCT04717193|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110902506|NCT04717193|Adrenergic Agents|adrenergic agents|mesh-ancestor
110902507|NCT04717193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110902508|NCT04717193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110902509|NCT04717193|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110902510|NCT04717193|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110902511|NCT04717193|Autonomic Agents|autonomic agents|mesh-ancestor
110902512|NCT04717193|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110902513|NCT04717193|Respiratory System Agents|respiratory system agents|mesh-ancestor
110902514|NCT04717193|Mydriatics|mydriatics|mesh-ancestor
110902515|NCT04717193|Sympathomimetics|sympathomimetics|mesh-ancestor
110902516|NCT04717193|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110902517|NCT05212025|Gemcitabine|gemcitabine|mesh-list
110902518|NCT05212025|Adavosertib|adavosertib|mesh-list
110902519|NCT05212025|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110902520|NCT05212025|Antimetabolites|antimetabolites|mesh-ancestor
110902521|NCT05212025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110902522|NCT05212025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110902523|NCT05212025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110902524|NCT02051868|Paclitaxel|paclitaxel|mesh-list
110902525|NCT02051868|Carboplatin|carboplatin|mesh-list
110902526|NCT02051868|Fluorouracil|fluorouracil|mesh-list
110902527|NCT02051868|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110902528|NCT02051868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110902529|NCT02051868|Tubulin Modulators|tubulin modulators|mesh-ancestor
110902530|NCT02051868|Antimitotic Agents|antimitotic agents|mesh-ancestor
110902531|NCT02051868|Mitosis Modulators|mitosis modulators|mesh-ancestor
110902532|NCT02051868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110902533|NCT02051868|Antimetabolites|antimetabolites|mesh-ancestor
110902534|NCT02051868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110902535|NCT02051868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110902536|NCT02051868|Immunologic Factors|immunologic factors|mesh-ancestor
110902537|NCT02051868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110902538|NCT04696757|Capecitabine|capecitabine|mesh-list
110902539|NCT04696757|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110902540|NCT04696757|Antimetabolites|antimetabolites|mesh-ancestor
110902541|NCT04696757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110902542|NCT04696757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110902543|NCT02049294|Omalizumab|omalizumab|mesh-list
110902544|NCT02049294|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110902545|NCT02049294|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110902546|NCT02049294|Respiratory System Agents|respiratory system agents|mesh-ancestor
110902547|NCT02051946|Ethacrynic Acid|ethacrynic acid|mesh-list
110902548|NCT02051946|Diuretics|diuretics|mesh-ancestor
110902549|NCT02051946|Natriuretic Agents|natriuretic agents|mesh-ancestor
110902550|NCT02051946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110902551|NCT02051946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110902552|NCT02051946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110902553|NCT02049606|Nabumetone|nabumetone|mesh-list
110902554|NCT02049606|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110902555|NCT02049606|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110902556|NCT02049606|Analgesics|analgesics|mesh-ancestor
110902557|NCT02049606|Sensory System Agents|sensory system agents|mesh-ancestor
110902558|NCT02049606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110902559|NCT02049606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110902560|NCT02049606|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110902561|NCT02049606|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110902562|NCT02049606|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110902563|NCT02049606|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110902564|NCT02049606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110902565|NCT02049606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110902566|NCT05071703|Carboplatin|carboplatin|mesh-list
110902567|NCT05071703|Etoposide|etoposide|mesh-list
110902568|NCT05071703|Topotecan|topotecan|mesh-list
110902569|NCT05071703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110902570|NCT05071703|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110902571|NCT05071703|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110902572|NCT05071703|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110902573|NCT05071703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110902574|NCT05071703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110902575|NCT05071703|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110902576|NCT02037516|Neostigmine|neostigmine|mesh-list
110902577|NCT02037516|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110902578|NCT02037516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110902579|NCT02037516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110902580|NCT02037516|Cholinergic Agents|cholinergic agents|mesh-ancestor
110902581|NCT02037516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110902582|NCT02037516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110902583|NCT02037516|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110902584|NCT02037516|Autonomic Agents|autonomic agents|mesh-ancestor
110902585|NCT02037516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110902586|NCT02052024|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
110902587|NCT02052024|Botulinum Toxins|botulinum toxins|mesh-list
110902588|NCT02052024|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110902589|NCT02052024|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110902590|NCT02052024|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110902591|NCT02052024|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110902592|NCT02052024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110902593|NCT02052024|Cholinergic Agents|cholinergic agents|mesh-ancestor
110902594|NCT02052024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110902595|NCT02052024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110902596|NCT02052024|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110902597|NCT02052024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110902598|NCT02052024|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110902599|NCT02037672|Metformin|metformin|mesh-list
110902600|NCT02037672|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110902601|NCT02037672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110902602|NCT02049762|Aspirin|aspirin|mesh-list
110902603|NCT02049762|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110902604|NCT02049762|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110902605|NCT02049762|Analgesics|analgesics|mesh-ancestor
110902606|NCT02049762|Sensory System Agents|sensory system agents|mesh-ancestor
110902607|NCT02049762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110902608|NCT02049762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110902609|NCT02049762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110902610|NCT02049762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110902611|NCT02049762|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110902612|NCT02049762|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110902613|NCT02049762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110902614|NCT02049762|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110902615|NCT02049762|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110902616|NCT02049762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110902618|NCT03561558|Ibuprofen|ibuprofen|mesh-list
110902619|NCT03561558|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110902620|NCT03561558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110902621|NCT03561558|Analgesics|analgesics|mesh-ancestor
110902622|NCT03561558|Sensory System Agents|sensory system agents|mesh-ancestor
110902623|NCT03561558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110902624|NCT03561558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110902625|NCT03561558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110902626|NCT03561558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110902627|NCT03561558|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110902628|NCT03561558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110902629|NCT03561558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110902630|NCT03099161|Pembrolizumab|pembrolizumab|mesh-list
110902631|NCT03099161|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110902632|NCT03099161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110902633|NCT03099161|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110902634|NCT03099161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110902635|NCT04639115|Ozanimod|ozanimod|mesh-list
110902636|NCT04639115|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
110902637|NCT04639115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110902638|NCT04639115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110902639|NCT04639115|Immunologic Factors|immunologic factors|mesh-ancestor
110902640|NCT04639115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110902641|NCT04260659|Lidocaine|lidocaine|mesh-list
110902642|NCT04260659|Magnesium Sulfate|magnesium sulfate|mesh-list
110902643|NCT04260659|Fentanyl|fentanyl|mesh-list
110902644|NCT04260659|Dexmedetomidine|dexmedetomidine|mesh-list
110902645|NCT04260659|Ketamine|ketamine|mesh-list
110902646|NCT04260659|Remifentanil|remifentanil|mesh-list
110902647|NCT04260659|Anesthetics, Local|anesthetics, local|mesh-ancestor
110902648|NCT04260659|Anesthetics|anesthetics|mesh-ancestor
110902649|NCT04260659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110902650|NCT04260659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110902651|NCT04260659|Sensory System Agents|sensory system agents|mesh-ancestor
110902652|NCT04260659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110902653|NCT04260659|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110620122|NCT00660816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110902654|NCT04260659|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110902655|NCT04260659|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110902656|NCT04260659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110902657|NCT04260659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110902658|NCT04260659|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110902659|NCT04260659|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110902660|NCT04260659|Analgesics|analgesics|mesh-ancestor
110902661|NCT04260659|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110902662|NCT04260659|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110902663|NCT04260659|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110902664|NCT04260659|Adrenergic Agents|adrenergic agents|mesh-ancestor
110902665|NCT04260659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110902666|NCT04260659|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110902667|NCT04260659|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110902668|NCT04260659|Anesthetics, General|anesthetics, general|mesh-ancestor
110902669|NCT04260659|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110902670|NCT04260659|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110902671|NCT04260659|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110902672|NCT04260659|Narcotics|narcotics|mesh-ancestor
110902673|NCT04260659|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110902674|NCT04260659|Anticonvulsants|anticonvulsants|mesh-ancestor
110902675|NCT04260659|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110902676|NCT04260659|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110225014|NCT05997784|Antioxidants|antioxidants|mesh-ancestor
110902677|NCT04260659|Tocolytic Agents|tocolytic agents|mesh-ancestor
110902678|NCT04260659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110902679|NCT05068661|Fentanyl|fentanyl|mesh-list
110902680|NCT05068661|Bupivacaine|bupivacaine|mesh-list
110902681|NCT05068661|Ropivacaine|ropivacaine|mesh-list
110902682|NCT05068661|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110902683|NCT05068661|Anesthetics, Local|anesthetics, local|mesh-ancestor
110902684|NCT05068661|Anesthetics|anesthetics|mesh-ancestor
110902685|NCT05068661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110902686|NCT05068661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110902687|NCT05068661|Sensory System Agents|sensory system agents|mesh-ancestor
110902688|NCT05068661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110902689|NCT05068661|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110902690|NCT05068661|Narcotics|narcotics|mesh-ancestor
110902691|NCT05068661|Analgesics|analgesics|mesh-ancestor
110902692|NCT05068661|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110902693|NCT05068661|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110902694|NCT05068661|Anesthetics, General|anesthetics, general|mesh-ancestor
110902695|NCT04455815|Gabexate|gabexate|mesh-list
110902696|NCT04455815|Camostat|camostat|mesh-list
110902697|NCT04455815|Protease Inhibitors|protease inhibitors|mesh-ancestor
110902698|NCT04455815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110902699|NCT04455815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110902700|NCT04455815|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
110902701|NCT04455815|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110902702|NCT04455815|Anticoagulants|anticoagulants|mesh-ancestor
110902703|NCT04303403|Trametinib|trametinib|mesh-list
110902704|NCT04303403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110902705|NCT04303403|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110902706|NCT04303403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110902707|NCT04303403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110902708|NCT04148495|Acetaminophen|acetaminophen|mesh-list
110902709|NCT04148495|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110902710|NCT04148495|Analgesics|analgesics|mesh-ancestor
110902711|NCT04148495|Sensory System Agents|sensory system agents|mesh-ancestor
110902712|NCT04148495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110902713|NCT04148495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110902714|NCT04148495|Antipyretics|antipyretics|mesh-ancestor
110902715|NCT05060003|Atezolizumab|atezolizumab|mesh-list
110902716|NCT05060003|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110902717|NCT05060003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110902718|NCT05060003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110902719|NCT05060003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110902720|NCT04203641|Doxorubicin|doxorubicin|mesh-list
110902721|NCT04203641|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110902722|NCT04203641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110902723|NCT04203641|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110902724|NCT04203641|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110902725|NCT04203641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110902726|NCT04203641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110902727|NCT05051189|Fentanyl|fentanyl|mesh-list
110222989|NCT00311116|Vitamin E|vitamin e|mesh-list
110902728|NCT05051189|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110902729|NCT05051189|Narcotics|narcotics|mesh-ancestor
110902730|NCT05051189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110902731|NCT05051189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110902732|NCT05051189|Analgesics|analgesics|mesh-ancestor
110902733|NCT05051189|Sensory System Agents|sensory system agents|mesh-ancestor
110902734|NCT05051189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110902735|NCT05051189|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110902736|NCT05051189|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110902737|NCT05051189|Anesthetics, General|anesthetics, general|mesh-ancestor
110902738|NCT05051189|Anesthetics|anesthetics|mesh-ancestor
110902739|NCT04521647|Nicotine|nicotine|mesh-list
110902740|NCT04521647|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110902741|NCT04521647|Autonomic Agents|autonomic agents|mesh-ancestor
110902742|NCT04521647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110902743|NCT04521647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110902744|NCT04521647|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110902745|NCT04521647|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110902746|NCT04521647|Cholinergic Agents|cholinergic agents|mesh-ancestor
110902747|NCT04521647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110902748|NCT04521647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110902749|NCT04172597|Loperamide|loperamide|mesh-list
110902750|NCT04172597|Antidiarrheals|antidiarrheals|mesh-list
110902751|NCT04172597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110902752|NCT00446225|Carboplatin|carboplatin|mesh-list
110902753|NCT00446225|Docetaxel|docetaxel|mesh-list
110902754|NCT00446225|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110902755|NCT00446225|Gemcitabine|gemcitabine|mesh-list
110902756|NCT00446225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110902757|NCT00446225|Tubulin Modulators|tubulin modulators|mesh-ancestor
110902758|NCT00446225|Antimitotic Agents|antimitotic agents|mesh-ancestor
110902759|NCT00446225|Mitosis Modulators|mitosis modulators|mesh-ancestor
110902760|NCT00446225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110902761|NCT00446225|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110902762|NCT00446225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110902763|NCT00446225|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110902764|NCT00446225|Antimetabolites|antimetabolites|mesh-ancestor
110902765|NCT03080935|Evolocumab|evolocumab|mesh-list
110902766|NCT03080935|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
110902767|NCT03080935|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110902768|NCT03080935|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110902769|NCT03080935|Antimetabolites|antimetabolites|mesh-ancestor
110902770|NCT03080935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110902771|NCT03080935|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110902772|NCT03080935|Protease Inhibitors|protease inhibitors|mesh-ancestor
110902773|NCT03080935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110902774|NCT03080935|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110902775|NCT04479449|Otaplimastat|otaplimastat|mesh-list
110902776|NCT04479449|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110902777|NCT04479449|Protective Agents|protective agents|mesh-ancestor
110902778|NCT04479449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110902779|NCT03674567|Pembrolizumab|pembrolizumab|mesh-list
110902780|NCT03674567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110902781|NCT03674567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110902782|NCT03674567|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110902783|NCT03674567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110902784|NCT04986605|Methoxsalen|methoxsalen|mesh-list
110902785|NCT04986605|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110902786|NCT04986605|Dermatologic Agents|dermatologic agents|mesh-ancestor
110902787|NCT04390399|Leucovorin|leucovorin|mesh-list
110902788|NCT04390399|Paclitaxel|paclitaxel|mesh-list
110902789|NCT04390399|Cyclophosphamide|cyclophosphamide|mesh-list
110902790|NCT04390399|Gemcitabine|gemcitabine|mesh-list
110902791|NCT04390399|Fluorouracil|fluorouracil|mesh-list
110902792|NCT04390399|Irinotecan|irinotecan|mesh-list
110902793|NCT04390399|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110902794|NCT04390399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110902795|NCT04390399|Tubulin Modulators|tubulin modulators|mesh-ancestor
110902796|NCT04390399|Antimitotic Agents|antimitotic agents|mesh-ancestor
110902797|NCT04390399|Mitosis Modulators|mitosis modulators|mesh-ancestor
110902798|NCT04390399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110902799|NCT04390399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110902800|NCT04390399|Immunologic Factors|immunologic factors|mesh-ancestor
110902801|NCT04390399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110902802|NCT04390399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110902803|NCT04390399|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110902804|NCT04390399|Alkylating Agents|alkylating agents|mesh-ancestor
110902805|NCT04390399|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110902806|NCT04390399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110902807|NCT04390399|Antimetabolites|antimetabolites|mesh-ancestor
110902808|NCT04390399|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110902809|NCT04390399|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110902810|NCT04390399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110902812|NCT04390399|Protective Agents|protective agents|mesh-ancestor
110902813|NCT04390399|Vitamin B Complex|vitamin b complex|mesh-ancestor
110902814|NCT04390399|Vitamins|vitamins|mesh-ancestor
110902815|NCT04390399|Micronutrients|micronutrients|mesh-ancestor
110902816|NCT01383655|Magnesium Sulfate|magnesium sulfate|mesh-list
110902817|NCT01383655|Analgesics|analgesics|mesh-ancestor
110902818|NCT01383655|Sensory System Agents|sensory system agents|mesh-ancestor
110902819|NCT01383655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110902820|NCT01383655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110902821|NCT01383655|Anesthetics|anesthetics|mesh-ancestor
110902822|NCT01383655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110902823|NCT01383655|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110902824|NCT01383655|Anticonvulsants|anticonvulsants|mesh-ancestor
110902825|NCT01383655|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110902826|NCT01383655|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110902827|NCT01383655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110902828|NCT01383655|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110902829|NCT01383655|Tocolytic Agents|tocolytic agents|mesh-ancestor
110902830|NCT01383655|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110902831|NCT01568281|Anastrozole|anastrozole|mesh-list
110902832|NCT01568281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110902833|NCT01568281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110902834|NCT01568281|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110902835|NCT01568281|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110902836|NCT01568281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110902837|NCT01568281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110902838|NCT01568281|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110902839|NCT01568281|Hormone Antagonists|hormone antagonists|mesh-ancestor
110902840|NCT01568281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110902841|NCT01568281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110902842|NCT02921789|Mycophenolic Acid|mycophenolic acid|mesh-list
110902843|NCT02921789|Prednisone|prednisone|mesh-list
110902844|NCT02921789|Tacrolimus|tacrolimus|mesh-list
110902845|NCT02921789|Basiliximab|basiliximab|mesh-list
110902846|NCT02921789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110902847|NCT02921789|Glucocorticoids|glucocorticoids|mesh-ancestor
110902848|NCT02921789|Hormones|hormones|mesh-ancestor
110902849|NCT02921789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110902850|NCT02921789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110902851|NCT02921789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110902852|NCT02921789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110902853|NCT02921789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110902854|NCT02921789|Immunologic Factors|immunologic factors|mesh-ancestor
110902855|NCT02921789|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110902856|NCT02921789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110902857|NCT02921789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110902858|NCT02921789|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110902859|NCT02921789|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110902860|NCT02921789|Antitubercular Agents|antitubercular agents|mesh-ancestor
110902861|NCT02921789|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110902862|NCT02921789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110902863|NCT01568333|Decitabine|decitabine|mesh-list
110902864|NCT01568333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110902865|NCT01568333|Antimetabolites|antimetabolites|mesh-ancestor
110902866|NCT01568333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110902867|NCT01568333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110902868|NCT01568333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110902869|NCT03437005|Ketoconazole|ketoconazole|mesh-list
110902870|NCT03437005|Desonide|desonide|mesh-list
110902871|NCT03437005|Antifungal Agents|antifungal agents|mesh-ancestor
110902872|NCT03437005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110902873|NCT03437005|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110902874|NCT03437005|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110902875|NCT03437005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110902876|NCT03437005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110902877|NCT03437005|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110902878|NCT03437005|Hormone Antagonists|hormone antagonists|mesh-ancestor
110902879|NCT03437005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110902880|NCT03437005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110902881|NCT03437005|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110902882|NCT03437005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110902883|NCT03943823|Estrogens|estrogens|mesh-list
110902884|NCT03943823|Hormones|hormones|mesh-ancestor
110902885|NCT03943823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110902886|NCT03943823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110902887|NCT02535338|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110902888|NCT02535338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110902889|NCT02535338|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110902890|NCT02535338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110902891|NCT02535338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110902892|NCT02419742|Paclitaxel|paclitaxel|mesh-list
110902893|NCT02419742|Docetaxel|docetaxel|mesh-list
110902894|NCT02419742|Cyclophosphamide|cyclophosphamide|mesh-list
110902895|NCT02419742|Carboplatin|carboplatin|mesh-list
110902896|NCT02419742|Doxorubicin|doxorubicin|mesh-list
110902897|NCT02419742|Trastuzumab|trastuzumab|mesh-list
110902898|NCT02419742|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110902899|NCT02419742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110902900|NCT02419742|Tubulin Modulators|tubulin modulators|mesh-ancestor
110902901|NCT02419742|Antimitotic Agents|antimitotic agents|mesh-ancestor
110902902|NCT02419742|Mitosis Modulators|mitosis modulators|mesh-ancestor
110902903|NCT02419742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110902904|NCT02419742|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110902905|NCT02419742|Immunologic Factors|immunologic factors|mesh-ancestor
110902906|NCT02419742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110902907|NCT02419742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110902908|NCT02419742|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110204163|NCT02970383|Narcotics|narcotics|mesh-list
110902909|NCT02419742|Alkylating Agents|alkylating agents|mesh-ancestor
110902910|NCT02419742|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110902911|NCT02419742|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110902912|NCT02419742|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110902913|NCT02419742|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110902914|NCT02419742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110902915|NCT02419742|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110902916|NCT02409290|Moxifloxacin|moxifloxacin|mesh-list
110902917|NCT02409290|Levofloxacin|levofloxacin|mesh-list
110902918|NCT02409290|Isoniazid|isoniazid|mesh-list
110902919|NCT02409290|Pyrazinamide|pyrazinamide|mesh-list
110902920|NCT02409290|Ethambutol|ethambutol|mesh-list
110902921|NCT02409290|Bedaquiline|bedaquiline|mesh-list
110902922|NCT02409290|Clofazimine|clofazimine|mesh-list
110902923|NCT02409290|Kanamycin|kanamycin|mesh-list
110902924|NCT02409290|Prothionamide|prothionamide|mesh-list
110902925|NCT02409290|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110902926|NCT02409290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110902927|NCT02409290|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110902928|NCT02409290|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110902929|NCT02409290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110902930|NCT02409290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110902931|NCT02409290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110902932|NCT02409290|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110902933|NCT02409290|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110902934|NCT02409290|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110902935|NCT02409290|Antitubercular Agents|antitubercular agents|mesh-ancestor
110902936|NCT02409290|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
110902937|NCT02409290|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110902938|NCT02409290|Antimetabolites|antimetabolites|mesh-ancestor
110902939|NCT02409290|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110902940|NCT02409290|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110902941|NCT02409290|Leprostatic Agents|leprostatic agents|mesh-ancestor
110902942|NCT02409290|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110902943|NCT02898077|Paclitaxel|paclitaxel|mesh-list
110902944|NCT02898077|Ramucirumab|ramucirumab|mesh-list
110902945|NCT02898077|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110902946|NCT02898077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110902947|NCT02898077|Tubulin Modulators|tubulin modulators|mesh-ancestor
110902948|NCT02898077|Antimitotic Agents|antimitotic agents|mesh-ancestor
110902949|NCT02898077|Mitosis Modulators|mitosis modulators|mesh-ancestor
110902950|NCT02898077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110902951|NCT02145884|Timolol|timolol|mesh-list
110902952|NCT02145884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110902953|NCT02145884|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110902954|NCT02145884|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110902955|NCT02145884|Adrenergic Agents|adrenergic agents|mesh-ancestor
110902956|NCT02145884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110902957|NCT02145884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110902958|NCT02145884|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110902959|NCT02145884|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110902961|NCT03544814|Pemetrexed|pemetrexed|mesh-list
110902962|NCT03544814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110902963|NCT03544814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110902964|NCT03544814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110902965|NCT03544814|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110902966|NCT03544814|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110902967|NCT03097133|Esketamine|esketamine|mesh-list
110902968|NCT03097133|Antidepressive Agents|antidepressive agents|mesh-ancestor
110902969|NCT03097133|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110902970|NCT02148380|Carboplatin|carboplatin|mesh-list
110902971|NCT02148380|Pemetrexed|pemetrexed|mesh-list
110902972|NCT02148380|Gefitinib|gefitinib|mesh-list
110902973|NCT02148380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110902974|NCT02148380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110902975|NCT02148380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110902976|NCT02148380|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110902977|NCT02148380|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110902978|NCT02148380|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110902979|NCT02146118|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110902980|NCT02146118|Silybin|silybin|mesh-list
110902981|NCT02146118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110902982|NCT02146118|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110902983|NCT02146118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110924841|NCT04474600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110902984|NCT02146118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110902985|NCT02146118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110902986|NCT02146118|Protective Agents|protective agents|mesh-ancestor
110902987|NCT02146118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110902988|NCT02142140|Methylphenidate|methylphenidate|mesh-list
110902989|NCT02142140|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
110902990|NCT02142140|Adderall|adderall|mesh-list
110902991|NCT02142140|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
110902992|NCT02142140|Dextroamphetamine|dextroamphetamine|mesh-list
110902993|NCT02142140|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
110902994|NCT02142140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110902995|NCT02142140|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110902996|NCT02142140|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110902997|NCT02142140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110902998|NCT02142140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110902999|NCT02142140|Dopamine Agents|dopamine agents|mesh-ancestor
110903000|NCT02142140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110903001|NCT02142140|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110903002|NCT02142140|Adrenergic Agents|adrenergic agents|mesh-ancestor
110903003|NCT02142218|Nivolumab|nivolumab|mesh-list
110903004|NCT02142218|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110903005|NCT02142218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110903006|NCT02142218|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110903007|NCT02142218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110903008|NCT02142296|Aflibercept|aflibercept|mesh-list
110903009|NCT02142296|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110903010|NCT02142296|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110903011|NCT02142296|Growth Substances|growth substances|mesh-ancestor
110903012|NCT02142296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110903013|NCT02142296|Growth Inhibitors|growth inhibitors|mesh-ancestor
110903014|NCT02142296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110903015|NCT02142530|Belinostat|belinostat|mesh-list
110903016|NCT02142530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110903017|NCT02142530|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110903018|NCT02142530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110903019|NCT02142530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110903020|NCT01383343|Calcium, Dietary|calcium, dietary|mesh-list
110903021|NCT01383343|Leucovorin|leucovorin|mesh-list
110903022|NCT01383343|Folic Acid|folic acid|mesh-list
110903023|NCT01383343|Bevacizumab|bevacizumab|mesh-list
110903024|NCT01383343|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110903025|NCT01383343|Fluorouracil|fluorouracil|mesh-list
110903026|NCT01383343|Irinotecan|irinotecan|mesh-list
110903027|NCT01383343|Sorafenib|sorafenib|mesh-list
110903028|NCT01383343|Camptothecin|camptothecin|mesh-list
110924863|NCT03100318|Dotinurad|dotinurad|mesh-list
110903029|NCT01383343|Endothelial Growth Factors|endothelial growth factors|mesh-list
110903030|NCT01383343|Antibodies|antibodies|mesh-list
110903031|NCT01383343|Immunoglobulins|immunoglobulins|mesh-list
110903032|NCT01383343|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110903033|NCT01383343|Immunoglobulin G|immunoglobulin g|mesh-list
110903034|NCT01383343|Calcium|calcium|mesh-list
110903035|NCT01383343|Levoleucovorin|levoleucovorin|mesh-list
110903036|NCT01383343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110903037|NCT01383343|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110903038|NCT01383343|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110903039|NCT01383343|Growth Substances|growth substances|mesh-ancestor
110903040|NCT01383343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110903041|NCT01383343|Growth Inhibitors|growth inhibitors|mesh-ancestor
110903042|NCT01383343|Immunologic Factors|immunologic factors|mesh-ancestor
110903043|NCT01383343|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110903044|NCT01383343|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110903045|NCT01383343|Antimetabolites|antimetabolites|mesh-ancestor
110903046|NCT01383343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110903047|NCT01383343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110903048|NCT01383343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110903049|NCT01383343|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110903050|NCT01383343|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110903051|NCT01383343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110903052|NCT01383343|Antidotes|antidotes|mesh-ancestor
110903053|NCT01383343|Protective Agents|protective agents|mesh-ancestor
110903054|NCT01383343|Vitamin B Complex|vitamin b complex|mesh-ancestor
110903055|NCT01383343|Vitamins|vitamins|mesh-ancestor
110903056|NCT01383343|Micronutrients|micronutrients|mesh-ancestor
110903057|NCT01383343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110903058|NCT01383343|Hematinics|hematinics|mesh-ancestor
110903059|NCT01383343|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110903060|NCT03631147|Rifaximin|rifaximin|mesh-list
110903061|NCT03631147|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110903062|NCT03631147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110903063|NCT03631147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110903064|NCT02148848|Risedronic Acid|risedronic acid|mesh-list
110903065|NCT02148848|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110903066|NCT02148848|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110903067|NCT02148848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110903068|NCT02148848|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110903069|NCT02148848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110903070|NCT02148848|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110903071|NCT03265145|Cholinergic Agents|cholinergic agents|mesh-list
110903072|NCT03265145|Muscarinic Antagonists|muscarinic antagonists|mesh-list
110903073|NCT03265145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110903074|NCT03265145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110903075|NCT03265145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110903076|NCT03265145|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110903077|NCT05344495|Midazolam|midazolam|mesh-list
110903078|NCT05344495|Bupivacaine|bupivacaine|mesh-list
110903079|NCT05344495|Anesthetics, Local|anesthetics, local|mesh-ancestor
110903080|NCT05344495|Anesthetics|anesthetics|mesh-ancestor
110903081|NCT05344495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110903082|NCT05344495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110903083|NCT05344495|Sensory System Agents|sensory system agents|mesh-ancestor
110903084|NCT05344495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110903085|NCT05344495|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110903086|NCT05344495|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110903087|NCT05344495|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110903088|NCT05344495|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110903089|NCT05344495|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110903090|NCT05344495|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110903091|NCT05344495|Anesthetics, General|anesthetics, general|mesh-ancestor
110903092|NCT05344495|GABA Modulators|gaba modulators|mesh-ancestor
110903093|NCT05344495|GABA Agents|gaba agents|mesh-ancestor
110903094|NCT05344495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110903095|NCT05344495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110903097|NCT01593241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110903098|NCT05960565|Glucagon|glucagon|mesh-list
110903099|NCT05960565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110903100|NCT05960565|Hormones|hormones|mesh-ancestor
110903101|NCT05960565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110903102|NCT05960565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110903103|NCT05960227|Dextrans|dextrans|mesh-list
110903104|NCT05960227|Iron-Dextran Complex|iron-dextran complex|mesh-list
110903105|NCT05960227|Anticoagulants|anticoagulants|mesh-ancestor
110903106|NCT05960227|Plasma Substitutes|plasma substitutes|mesh-ancestor
110903107|NCT05960227|Blood Substitutes|blood substitutes|mesh-ancestor
110903108|NCT05960227|Hematinics|hematinics|mesh-ancestor
110903110|NCT05960110|Fluorides, Topical|fluorides, topical|mesh-list
110903111|NCT05960110|Cariostatic Agents|cariostatic agents|mesh-ancestor
110903112|NCT05960110|Protective Agents|protective agents|mesh-ancestor
110903113|NCT05960110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110903114|NCT05959889|Montelukast|montelukast|mesh-list
110903115|NCT05959889|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110903116|NCT05959889|Respiratory System Agents|respiratory system agents|mesh-ancestor
110903117|NCT05959889|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110903118|NCT05959889|Hormone Antagonists|hormone antagonists|mesh-ancestor
110903119|NCT05959889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110903120|NCT05959889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110903121|NCT05959889|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110903122|NCT05959889|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110903123|NCT05959889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110903124|NCT05959863|Captopril|captopril|mesh-list
110903125|NCT05959863|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110903126|NCT05959863|Protease Inhibitors|protease inhibitors|mesh-ancestor
110903127|NCT05959863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110903128|NCT05959863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110903129|NCT05959863|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110903130|NCT05959759|Dimethyl Fumarate|dimethyl fumarate|mesh-list
110903131|NCT05959759|Dermatologic Agents|dermatologic agents|mesh-ancestor
110903132|NCT05959759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110903133|NCT05959759|Immunologic Factors|immunologic factors|mesh-ancestor
110903134|NCT05959759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110903135|NCT05959616|Ciprofloxacin|ciprofloxacin|mesh-list
110903136|NCT05959616|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110903137|NCT05959616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110903138|NCT05959616|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110903139|NCT05959616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110903140|NCT05959616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110903141|NCT05959616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110903142|NCT05959616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110903143|NCT05959616|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110903144|NCT05959616|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110903145|NCT05959603|Vancomycin|vancomycin|mesh-list
110903146|NCT05959603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110903147|NCT05959603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110903148|NCT05959447|Dabigatran|dabigatran|mesh-list
110903149|NCT05959447|Gemfibrozil|gemfibrozil|mesh-list
110903150|NCT05959447|Antithrombins|antithrombins|mesh-ancestor
110903151|NCT05959447|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110903152|NCT05959447|Protease Inhibitors|protease inhibitors|mesh-ancestor
110903153|NCT05959447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110903154|NCT05959447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110903155|NCT05959447|Anticoagulants|anticoagulants|mesh-ancestor
110903156|NCT05959447|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110903157|NCT05959447|Antimetabolites|antimetabolites|mesh-ancestor
110903158|NCT05959447|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110903159|NCT05959447|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
110903160|NCT05959447|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110903161|NCT05958914|Calcitonin|calcitonin|mesh-list
110903162|NCT05958914|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
110903163|NCT05958914|Katacalcin|katacalcin|mesh-list
110903164|NCT05958914|Enkephalins|enkephalins|mesh-list
110903165|NCT05958914|Vasodilator Agents|vasodilator agents|mesh-ancestor
110903166|NCT05958914|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110903167|NCT05958914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110903168|NCT05958914|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110903169|NCT05958914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110903170|NCT05958914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110903171|NCT05958810|Lumefantrine|lumefantrine|mesh-list
110903172|NCT05958810|Artemether|artemether|mesh-list
110903173|NCT05958810|Primaquine|primaquine|mesh-list
110903174|NCT05958810|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
110903175|NCT05958810|Antimalarials|antimalarials|mesh-ancestor
110903176|NCT05958810|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110903177|NCT05958810|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110903178|NCT05958810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110903179|NCT05958797|Chloroquine|chloroquine|mesh-list
110903180|NCT05958797|Primaquine|primaquine|mesh-list
110903181|NCT05958797|Amebicides|amebicides|mesh-ancestor
110903182|NCT05958797|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110903183|NCT05958797|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110903184|NCT05958797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110903185|NCT05958797|Antimalarials|antimalarials|mesh-ancestor
110903186|NCT05958797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110903187|NCT05958758|Psilocybin|psilocybin|mesh-list
110903188|NCT05958758|Hallucinogens|hallucinogens|mesh-ancestor
110903189|NCT05958758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110903190|NCT05958758|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110903191|NCT05958719|Azacitidine|azacitidine|mesh-list
110903192|NCT05958719|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110903193|NCT05958719|Antimetabolites|antimetabolites|mesh-ancestor
110903194|NCT05958719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110903195|NCT05958719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110903196|NCT05958719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110903197|NCT05958290|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110903198|NCT05958290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110903199|NCT05955885|Flurbiprofen|flurbiprofen|mesh-list
110903200|NCT05955885|Benzydamine|benzydamine|mesh-list
110903201|NCT05955885|Analgesics|analgesics|mesh-ancestor
110903202|NCT05955885|Sensory System Agents|sensory system agents|mesh-ancestor
110903203|NCT05955885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110903204|NCT05955885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110903205|NCT05955885|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110903206|NCT05955885|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110903207|NCT05955885|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110903208|NCT05955885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110924925|NCT03501056|Antibodies|antibodies|mesh-list
110903210|NCT05955885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110903211|NCT05955885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110903212|NCT05952752|Dexamethasone|dexamethasone|mesh-list
110903213|NCT05952752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110903214|NCT05952752|Antiemetics|antiemetics|mesh-ancestor
110903215|NCT05952752|Autonomic Agents|autonomic agents|mesh-ancestor
110903216|NCT05952752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110903217|NCT05952752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110903218|NCT05952752|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110903219|NCT05952752|Glucocorticoids|glucocorticoids|mesh-ancestor
110903220|NCT05952752|Hormones|hormones|mesh-ancestor
110903221|NCT05952752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110903222|NCT05952752|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110903223|NCT05952752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110903224|NCT05949125|Cyclophosphamide|cyclophosphamide|mesh-list
110903225|NCT05949125|Fludarabine|fludarabine|mesh-list
110903226|NCT05949125|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110903227|NCT05949125|Immunologic Factors|immunologic factors|mesh-ancestor
110903228|NCT05949125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110903229|NCT05949125|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110903230|NCT05949125|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110903231|NCT05949125|Alkylating Agents|alkylating agents|mesh-ancestor
110903232|NCT05949125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110903233|NCT05949125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110903234|NCT05949125|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110903235|NCT05923060|Aminolevulinic Acid|aminolevulinic acid|mesh-list
110903236|NCT05923060|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110903237|NCT05923060|Dermatologic Agents|dermatologic agents|mesh-ancestor
110903238|NCT05914857|Dapagliflozin|dapagliflozin|mesh-list
110903239|NCT05914857|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110903240|NCT05914857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110903241|NCT05914857|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110903242|NCT05914857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110903244|NCT05909696|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110903245|NCT05909696|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110903246|NCT05909696|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110903247|NCT05909696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110903248|NCT05909696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110903249|NCT05908331|Sirolimus|sirolimus|mesh-list
110903250|NCT05908331|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110903251|NCT05908331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110903252|NCT05908331|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110903253|NCT05908331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110903254|NCT05908331|Antifungal Agents|antifungal agents|mesh-ancestor
110903255|NCT05908331|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110903256|NCT05908331|Immunologic Factors|immunologic factors|mesh-ancestor
110903257|NCT05908331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110903258|NCT05907811|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
110903259|NCT05907811|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110903260|NCT05907811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110903261|NCT05907811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110903262|NCT05903352|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110903263|NCT05903352|Anti-Infective Agents|anti-infective agents|mesh-list
110903264|NCT05902780|Dexmedetomidine|dexmedetomidine|mesh-list
110903265|NCT05902780|Bupivacaine|bupivacaine|mesh-list
110903266|NCT05902780|Anesthetics, Local|anesthetics, local|mesh-ancestor
110903267|NCT05902780|Anesthetics|anesthetics|mesh-ancestor
110903268|NCT05902780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110903269|NCT05902780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110903270|NCT05902780|Sensory System Agents|sensory system agents|mesh-ancestor
110903271|NCT05902780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110903272|NCT05902780|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110903273|NCT05902780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110903274|NCT05902780|Analgesics|analgesics|mesh-ancestor
110903275|NCT05902780|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110903276|NCT05902780|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110903277|NCT05902780|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110903278|NCT05902780|Adrenergic Agents|adrenergic agents|mesh-ancestor
110903279|NCT05902780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110903280|NCT05902780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110903281|NCT05901350|Levodopa|levodopa|mesh-list
110903282|NCT05901350|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110903283|NCT05901350|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110903284|NCT05901350|Dopamine Agents|dopamine agents|mesh-ancestor
110903285|NCT05901350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110903286|NCT05901350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110903287|NCT05901350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110903288|NCT05894018|Fluzoparib|fluzoparib|mesh-list
110903289|NCT05894018|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110903290|NCT05894018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110903291|NCT05894018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110903292|NCT05894018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110903293|NCT05892276|Cannabidiol|cannabidiol|mesh-list
110903294|NCT05892276|Anticonvulsants|anticonvulsants|mesh-ancestor
110903295|NCT05822440|Itraconazole|itraconazole|mesh-list
110903296|NCT05822440|Antifungal Agents|antifungal agents|mesh-ancestor
110903297|NCT05822440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110225061|NCT05997433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110903298|NCT05822440|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110903299|NCT05822440|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110903300|NCT05822440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110903301|NCT05822440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110903302|NCT05822440|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110903303|NCT05822440|Hormone Antagonists|hormone antagonists|mesh-ancestor
110903304|NCT05822440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110903305|NCT05822440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110903306|NCT05822440|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110903307|NCT05805839|Corticosterone|corticosterone|mesh-list
110903308|NCT05805839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110903309|NCT05790252|Buprenorphine|buprenorphine|mesh-list
110903310|NCT05790252|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110903311|NCT05790252|Narcotics|narcotics|mesh-ancestor
110903312|NCT05790252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110903313|NCT05790252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110903314|NCT05790252|Analgesics|analgesics|mesh-ancestor
110903315|NCT05790252|Sensory System Agents|sensory system agents|mesh-ancestor
110903316|NCT05790252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110903317|NCT05790252|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110903318|NCT05789173|Efavirenz|efavirenz|mesh-list
110903319|NCT05789173|Clonidine|clonidine|mesh-list
110903320|NCT05789173|Methadone|methadone|mesh-list
110903321|NCT05789173|Tizanidine|tizanidine|mesh-list
110903322|NCT05789173|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110903323|NCT05789173|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110903324|NCT05789173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110903325|NCT05789173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110903326|NCT05789173|Antiviral Agents|antiviral agents|mesh-ancestor
110903327|NCT05789173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110903328|NCT05789173|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110903329|NCT05789173|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110903330|NCT05789173|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110903331|NCT05789173|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110903332|NCT05789173|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110903333|NCT05789173|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110903334|NCT05789173|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110903336|NCT05789173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110903337|NCT05789173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110903338|NCT05789173|Analgesics|analgesics|mesh-ancestor
110903339|NCT05789173|Sensory System Agents|sensory system agents|mesh-ancestor
110903340|NCT05789173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110903341|NCT05789173|Antitussive Agents|antitussive agents|mesh-ancestor
110903342|NCT05789173|Respiratory System Agents|respiratory system agents|mesh-ancestor
110903343|NCT05789173|Anticonvulsants|anticonvulsants|mesh-ancestor
110903344|NCT05789173|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110903345|NCT05789173|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110903346|NCT05789173|Parasympatholytics|parasympatholytics|mesh-ancestor
110903347|NCT05789173|Autonomic Agents|autonomic agents|mesh-ancestor
110903348|NCT05789173|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110903349|NCT05789173|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110903350|NCT05789173|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110903351|NCT05789173|Adrenergic Agents|adrenergic agents|mesh-ancestor
110903352|NCT05789173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110903353|NCT05789173|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110903354|NCT05789173|Sympatholytics|sympatholytics|mesh-ancestor
110903355|NCT05778760|Vitamin A|vitamin a|mesh-list
110903356|NCT05778760|Vitamins|vitamins|mesh-ancestor
110903357|NCT05778760|Micronutrients|micronutrients|mesh-ancestor
110903358|NCT05778760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110903359|NCT05757999|Magnesium Sulfate|magnesium sulfate|mesh-list
110903360|NCT05757999|Analgesics|analgesics|mesh-ancestor
110903361|NCT05757999|Sensory System Agents|sensory system agents|mesh-ancestor
110903362|NCT05757999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110903363|NCT05757999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110903364|NCT05757999|Anesthetics|anesthetics|mesh-ancestor
110903365|NCT05757999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110903366|NCT05757999|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110903367|NCT05757999|Anticonvulsants|anticonvulsants|mesh-ancestor
110903368|NCT05757999|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110903369|NCT05757999|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110903370|NCT05757999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110903371|NCT05757999|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110903372|NCT05757999|Tocolytic Agents|tocolytic agents|mesh-ancestor
110903373|NCT05757999|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110903374|NCT05750264|Ibuprofen|ibuprofen|mesh-list
110903375|NCT05750264|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110903376|NCT05750264|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110903377|NCT05750264|Analgesics|analgesics|mesh-ancestor
110903378|NCT05750264|Sensory System Agents|sensory system agents|mesh-ancestor
110903379|NCT05750264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110903380|NCT05750264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110903381|NCT05750264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110903382|NCT05750264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110204307|NCT00164749|Analgesics|analgesics|mesh-ancestor
110903383|NCT05750264|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110903384|NCT05750264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110903385|NCT05750264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110903386|NCT05729646|Oxaliplatin|oxaliplatin|mesh-list
110903387|NCT05729646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110903388|NCT05689359|Hydroxychloroquine|hydroxychloroquine|mesh-list
110903389|NCT05689359|Antimalarials|antimalarials|mesh-ancestor
110903390|NCT05689359|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110924967|NCT03500900|Vildagliptin|vildagliptin|mesh-list
110903391|NCT05689359|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110903392|NCT05689359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110903393|NCT05689359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110903394|NCT05689359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110903395|NCT05689359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110903396|NCT05660395|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
110903397|NCT05660395|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110903398|NCT05660395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110903399|NCT05557136|Ether|ether|mesh-list
110903400|NCT05557136|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110903401|NCT05557136|Anesthetics, General|anesthetics, general|mesh-ancestor
110903402|NCT05557136|Anesthetics|anesthetics|mesh-ancestor
110903403|NCT05557136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110903404|NCT05557136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110903405|NCT05534243|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
110903406|NCT05534243|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110903407|NCT05534243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110903408|NCT05534243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110903409|NCT05502081|Remdesivir|remdesivir|mesh-list
110903410|NCT05502081|Favipiravir|favipiravir|mesh-list
110903411|NCT05502081|Casirivimab and imdevimab drug combination|casirivimab and imdevimab drug combination|mesh-list
110903412|NCT05502081|Antimetabolites|antimetabolites|mesh-ancestor
110903413|NCT05502081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110903414|NCT05502081|Antiviral Agents|antiviral agents|mesh-ancestor
110903415|NCT05502081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110903416|NCT05494385|Gabapentin|gabapentin|mesh-list
110903417|NCT05494385|Analgesics|analgesics|mesh-ancestor
110903418|NCT05494385|Sensory System Agents|sensory system agents|mesh-ancestor
110903419|NCT05494385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110903420|NCT05494385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110903421|NCT05494385|Anticonvulsants|anticonvulsants|mesh-ancestor
110903422|NCT05494385|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110903423|NCT05494385|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110903424|NCT05494385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110903425|NCT05494385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110903426|NCT05494385|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110903427|NCT05494385|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110903428|NCT05494385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110903429|NCT05494385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110903431|NCT05455294|Decitabine|decitabine|mesh-list
110903432|NCT05455294|Venetoclax|venetoclax|mesh-list
110903433|NCT05455294|Navitoclax|navitoclax|mesh-list
110903434|NCT05455294|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110903435|NCT05455294|Antimetabolites|antimetabolites|mesh-ancestor
110903436|NCT05455294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110903437|NCT05455294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110903438|NCT05455294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110903439|NCT05437796|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
110903440|NCT05437796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110903441|NCT05437796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110903442|NCT05396014|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110924818|NCT03098368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110903443|NCT05396014|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110903444|NCT05396014|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110903445|NCT05396014|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110903446|NCT05396014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110903447|NCT05396014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110903448|NCT05396014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110903449|NCT05396014|Analgesics|analgesics|mesh-ancestor
110903450|NCT05396014|Sensory System Agents|sensory system agents|mesh-ancestor
110903451|NCT05396014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110903452|NCT05396014|Antidepressive Agents|antidepressive agents|mesh-ancestor
110903453|NCT05396014|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110903454|NCT05396014|Dopamine Agents|dopamine agents|mesh-ancestor
110903455|NCT05357989|Phenserine|phenserine|mesh-list
110903456|NCT05357989|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110903457|NCT05357989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110903458|NCT05357989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110903459|NCT05357989|Cholinergic Agents|cholinergic agents|mesh-ancestor
110903460|NCT05357989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110903461|NCT05357989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110903462|NCT05304455|Heparin|heparin|mesh-list
110903463|NCT05304455|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
110903464|NCT05304455|Tinzaparin|tinzaparin|mesh-list
110903465|NCT05304455|Dalteparin|dalteparin|mesh-list
110903466|NCT05304455|Dipyridamole|dipyridamole|mesh-list
110903467|NCT05304455|Apixaban|apixaban|mesh-list
110903468|NCT05304455|Anticoagulants|anticoagulants|mesh-ancestor
110903469|NCT05304455|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110903470|NCT05304455|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110903471|NCT05304455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110903472|NCT05304455|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110903473|NCT05304455|Antithrombins|antithrombins|mesh-ancestor
110903474|NCT05304455|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110903475|NCT05304455|Protease Inhibitors|protease inhibitors|mesh-ancestor
110903476|NCT05304455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110903477|NCT05304455|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110903478|NCT05304455|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110903479|NCT05304455|Vasodilator Agents|vasodilator agents|mesh-ancestor
110903480|NCT05263557|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
110903481|NCT05263557|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110903482|NCT05263557|Immunologic Factors|immunologic factors|mesh-ancestor
110903483|NCT05263557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110903484|NCT05232825|Diphenhydramine|diphenhydramine|mesh-list
110903485|NCT05232825|Promethazine|promethazine|mesh-list
110903486|NCT05232825|Dexamethasone|dexamethasone|mesh-list
110903487|NCT05232825|Methylprednisolone|methylprednisolone|mesh-list
110903488|NCT05232825|Desloratadine|desloratadine|mesh-list
110903489|NCT05232825|Ocrelizumab|ocrelizumab|mesh-list
110903490|NCT05232825|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110903491|NCT05232825|Antiemetics|antiemetics|mesh-ancestor
110903492|NCT05232825|Autonomic Agents|autonomic agents|mesh-ancestor
110903493|NCT05232825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110903494|NCT05232825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110903495|NCT05232825|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110903496|NCT05232825|Glucocorticoids|glucocorticoids|mesh-ancestor
110903497|NCT05232825|Hormones|hormones|mesh-ancestor
110903498|NCT05232825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110903499|NCT05232825|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110903500|NCT05232825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110903501|NCT05232825|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110903502|NCT05232825|Protective Agents|protective agents|mesh-ancestor
110903503|NCT05232825|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110903504|NCT05232825|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110903505|NCT05232825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110903506|NCT05232825|Anesthetics, Local|anesthetics, local|mesh-ancestor
110903508|NCT05232825|Sensory System Agents|sensory system agents|mesh-ancestor
110224778|NCT05999487|Milrinone|milrinone|mesh-list
110903509|NCT05232825|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110903510|NCT05232825|Histamine Antagonists|histamine antagonists|mesh-ancestor
110903511|NCT05232825|Histamine Agents|histamine agents|mesh-ancestor
110903512|NCT05232825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110903513|NCT05232825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110903514|NCT05232825|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110903515|NCT05232825|Antipruritics|antipruritics|mesh-ancestor
110903516|NCT05232825|Dermatologic Agents|dermatologic agents|mesh-ancestor
110903517|NCT05232825|Immunologic Factors|immunologic factors|mesh-ancestor
110903518|NCT05232825|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110903519|NCT05232825|Cholinergic Agents|cholinergic agents|mesh-ancestor
110903520|NCT05232825|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110903521|NCT05231122|Bevacizumab|bevacizumab|mesh-list
110903522|NCT05231122|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110903523|NCT05231122|Pembrolizumab|pembrolizumab|mesh-list
110903524|NCT05231122|Endothelial Growth Factors|endothelial growth factors|mesh-list
110903525|NCT05231122|Antibodies|antibodies|mesh-list
110903526|NCT05231122|Immunoglobulins|immunoglobulins|mesh-list
110903527|NCT05231122|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110903528|NCT05231122|Immunoglobulin G|immunoglobulin g|mesh-list
110903529|NCT05231122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110903530|NCT05231122|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110903531|NCT05231122|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110903532|NCT05231122|Growth Substances|growth substances|mesh-ancestor
110903533|NCT05231122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110903534|NCT05231122|Growth Inhibitors|growth inhibitors|mesh-ancestor
110903535|NCT05231122|Immunologic Factors|immunologic factors|mesh-ancestor
110903536|NCT05231122|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110903537|NCT05231122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110903538|NCT05219110|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110903539|NCT05201300|Propofol|propofol|mesh-list
110903540|NCT05201300|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110903541|NCT05201300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110903542|NCT05201300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110903543|NCT05201300|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110903544|NCT05201300|Anesthetics, General|anesthetics, general|mesh-ancestor
110903545|NCT05201300|Anesthetics|anesthetics|mesh-ancestor
110903546|NCT05200208|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
110903547|NCT05200208|Nootropic Agents|nootropic agents|mesh-ancestor
110903548|NCT05182840|Empagliflozin|empagliflozin|mesh-list
110903549|NCT05182840|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110903550|NCT05182840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110903551|NCT05182840|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110903552|NCT05182840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110903553|NCT05119439|Misoprostol|misoprostol|mesh-list
110903554|NCT05119439|Mifepristone|mifepristone|mesh-list
110903555|NCT05119439|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110903556|NCT05119439|Abortifacient Agents|abortifacient agents|mesh-ancestor
110903557|NCT05119439|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110903558|NCT05119439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110903559|NCT05119439|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110903560|NCT05119439|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110903561|NCT05119439|Oxytocics|oxytocics|mesh-ancestor
110903562|NCT05119439|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
110903563|NCT05119439|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110903564|NCT05119439|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110903565|NCT05119439|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110903566|NCT05119439|Contraceptive Agents|contraceptive agents|mesh-ancestor
110903567|NCT05119439|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
110925022|NCT04462250|Narcotics|narcotics|mesh-ancestor
110903568|NCT05119439|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
110903569|NCT05119439|Hormone Antagonists|hormone antagonists|mesh-ancestor
110903570|NCT05119439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110903571|NCT05119439|Luteolytic Agents|luteolytic agents|mesh-ancestor
110903572|NCT05119439|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110903573|NCT05119439|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
110903574|NCT05065021|Paclitaxel|paclitaxel|mesh-list
110903575|NCT05065021|Bevacizumab|bevacizumab|mesh-list
110903576|NCT05065021|Niraparib|niraparib|mesh-list
110903577|NCT05065021|Dostarlimab|dostarlimab|mesh-list
110903578|NCT05065021|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110903579|NCT05065021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110903580|NCT05065021|Tubulin Modulators|tubulin modulators|mesh-ancestor
110903581|NCT05065021|Antimitotic Agents|antimitotic agents|mesh-ancestor
110903582|NCT05065021|Mitosis Modulators|mitosis modulators|mesh-ancestor
110903583|NCT05065021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110903584|NCT05065021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110903585|NCT05065021|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110903586|NCT05065021|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110903587|NCT05065021|Growth Substances|growth substances|mesh-ancestor
110903588|NCT05065021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110903589|NCT05065021|Growth Inhibitors|growth inhibitors|mesh-ancestor
110903590|NCT05065021|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110903591|NCT05065021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110903592|NCT05020392|Vidarabine|vidarabine|mesh-list
110903593|NCT05020392|Fludarabine|fludarabine|mesh-list
110903594|NCT05020392|Fludarabine phosphate|fludarabine phosphate|mesh-list
110903595|NCT05020392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110903596|NCT05020392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110903597|NCT05020392|Antimetabolites|antimetabolites|mesh-ancestor
110903598|NCT05020392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110903599|NCT05020392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110903600|NCT05020392|Immunologic Factors|immunologic factors|mesh-ancestor
110903601|NCT05020392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110903602|NCT05020392|Antiviral Agents|antiviral agents|mesh-ancestor
110903603|NCT05020392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110903604|NCT04992468|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
110903605|NCT04992468|Hormones|hormones|mesh-ancestor
110903606|NCT04992468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110903607|NCT04992468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110903608|NCT04975100|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
110903609|NCT04975100|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110903610|NCT04975100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110903611|NCT04975100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110903612|NCT04975100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110903613|NCT04975100|Serotonin Agents|serotonin agents|mesh-ancestor
110903614|NCT04975100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110903615|NCT04970342|Alprazolam|alprazolam|mesh-list
110903616|NCT04970342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110903617|NCT04970342|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110903618|NCT04970342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110903619|NCT04970342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110903620|NCT04970342|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110903621|NCT04970342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110903622|NCT04970342|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110903623|NCT04970342|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110903624|NCT04970342|GABA Modulators|gaba modulators|mesh-ancestor
110903625|NCT04970342|GABA Agents|gaba agents|mesh-ancestor
110903626|NCT04959981|Osimertinib|osimertinib|mesh-list
110903627|NCT04959981|Sotorasib|sotorasib|mesh-list
110903628|NCT04959981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110903629|NCT04959981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110903630|NCT04959981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110621095|NCT05589454|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110903631|NCT04959981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110903632|NCT04959981|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110903633|NCT04959981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110903635|NCT04901377|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110903636|NCT04901377|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110903637|NCT04901377|Estradiol|estradiol|mesh-list
110903638|NCT04901377|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110903639|NCT04901377|Estrogens|estrogens|mesh-ancestor
110903640|NCT04901377|Hormones|hormones|mesh-ancestor
110903641|NCT04901377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110903642|NCT04901377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110903643|NCT04901377|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110903644|NCT04901377|Contraceptive Agents|contraceptive agents|mesh-ancestor
110903645|NCT04901377|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110903646|NCT04901377|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110903647|NCT04901377|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110903648|NCT04901377|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110903649|NCT04901377|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110903650|NCT04901377|Hormone Antagonists|hormone antagonists|mesh-ancestor
110903651|NCT04901377|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110903652|NCT04901377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110903653|NCT04847557|Tirzepatide|tirzepatide|mesh-list
110903654|NCT04847557|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110903655|NCT04847557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110903656|NCT04847557|Incretins|incretins|mesh-ancestor
110903657|NCT04847557|Hormones|hormones|mesh-ancestor
110903658|NCT04847557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110903659|NCT04795245|Afatinib|afatinib|mesh-list
110903660|NCT04795245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110903661|NCT04795245|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110903662|NCT04795245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110903663|NCT04795245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110903664|NCT04742101|Azacitidine|azacitidine|mesh-list
110903665|NCT04742101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110903666|NCT04742101|Antimetabolites|antimetabolites|mesh-ancestor
110903667|NCT04742101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110903668|NCT04742101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110903669|NCT04742101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110903670|NCT04738422|Glycine|glycine|mesh-list
110903671|NCT04738422|Glycine Agents|glycine agents|mesh-ancestor
110903672|NCT04738422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110903673|NCT04738422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110903674|NCT04738422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110903675|NCT04729114|Dexamethasone|dexamethasone|mesh-list
110903676|NCT04729114|Prednisone|prednisone|mesh-list
110903677|NCT04729114|Docetaxel|docetaxel|mesh-list
110903678|NCT04729114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110903679|NCT04729114|Antiemetics|antiemetics|mesh-ancestor
110903680|NCT04729114|Autonomic Agents|autonomic agents|mesh-ancestor
110903681|NCT04729114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110903682|NCT04729114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110903683|NCT04729114|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110903684|NCT04729114|Glucocorticoids|glucocorticoids|mesh-ancestor
110903685|NCT04729114|Hormones|hormones|mesh-ancestor
110903686|NCT04729114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110903687|NCT04729114|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110903688|NCT04729114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110925051|NCT02261064|Amlodipine|amlodipine|mesh-list
110903689|NCT04729114|Tubulin Modulators|tubulin modulators|mesh-ancestor
110903690|NCT04729114|Antimitotic Agents|antimitotic agents|mesh-ancestor
110903691|NCT04729114|Mitosis Modulators|mitosis modulators|mesh-ancestor
110903692|NCT04729114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110903693|NCT04704999|Chloroquine|chloroquine|mesh-list
110903694|NCT04704999|Lumefantrine|lumefantrine|mesh-list
110903696|NCT04704999|Tafenoquine|tafenoquine|mesh-list
110903697|NCT04704999|Amebicides|amebicides|mesh-ancestor
110903698|NCT04704999|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110903699|NCT04704999|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110903700|NCT04704999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110903701|NCT04704999|Antimalarials|antimalarials|mesh-ancestor
110903702|NCT04704999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110903703|NCT04679402|Carbon Monoxide|carbon monoxide|mesh-list
110903704|NCT04679402|Antimetabolites|antimetabolites|mesh-ancestor
110903705|NCT04679402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110903706|NCT04679402|Gasotransmitters|gasotransmitters|mesh-ancestor
110903707|NCT04679402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110903708|NCT04679402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110903710|NCT04654507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110903711|NCT04654507|Antiemetics|antiemetics|mesh-ancestor
110903712|NCT04654507|Autonomic Agents|autonomic agents|mesh-ancestor
110903713|NCT04654507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110903714|NCT04654507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110903715|NCT04654507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110903716|NCT04654507|Glucocorticoids|glucocorticoids|mesh-ancestor
110903717|NCT04654507|Hormones|hormones|mesh-ancestor
110903718|NCT04654507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110903719|NCT04654507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110903720|NCT04654507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110903721|NCT04646655|Enoxaparin|enoxaparin|mesh-list
110903722|NCT04646655|Anticoagulants|anticoagulants|mesh-ancestor
110903723|NCT04646655|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110903724|NCT04646655|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110903725|NCT04646655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110903726|NCT04645550|Aspirin|aspirin|mesh-list
110903727|NCT04645550|Heparin|heparin|mesh-list
110903728|NCT04645550|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
110903729|NCT04645550|Tinzaparin|tinzaparin|mesh-list
110903730|NCT04645550|Dalteparin|dalteparin|mesh-list
110903731|NCT04645550|Dipyridamole|dipyridamole|mesh-list
110903732|NCT04645550|Warfarin|warfarin|mesh-list
110903733|NCT04645550|Apixaban|apixaban|mesh-list
110903734|NCT04645550|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110903735|NCT04645550|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110903736|NCT04645550|Analgesics|analgesics|mesh-ancestor
110903737|NCT04645550|Sensory System Agents|sensory system agents|mesh-ancestor
110903738|NCT04645550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110903739|NCT04645550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110903740|NCT04645550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110903741|NCT04645550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110903742|NCT04645550|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110903743|NCT04645550|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110903744|NCT04645550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110903745|NCT04645550|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110903746|NCT04645550|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110903747|NCT04645550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110903748|NCT04645550|Antipyretics|antipyretics|mesh-ancestor
110903749|NCT04645550|Anticoagulants|anticoagulants|mesh-ancestor
110903750|NCT04645550|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110903751|NCT04645550|Antithrombins|antithrombins|mesh-ancestor
110903752|NCT04645550|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110903753|NCT04645550|Protease Inhibitors|protease inhibitors|mesh-ancestor
110903754|NCT04645550|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110903755|NCT04645550|Vasodilator Agents|vasodilator agents|mesh-ancestor
110903756|NCT04629443|Azacitidine|azacitidine|mesh-list
110903757|NCT04629443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110903758|NCT04629443|Antimetabolites|antimetabolites|mesh-ancestor
110903759|NCT04629443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110903760|NCT04629443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110903761|NCT04629443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110903762|NCT04627922|Acetylcysteine|acetylcysteine|mesh-list
110225123|NCT05997043|Botulinum Toxins|botulinum toxins|mesh-list
110903763|NCT04627922|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110903764|NCT04627922|Antiviral Agents|antiviral agents|mesh-ancestor
110903765|NCT04627922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110903766|NCT04627922|Expectorants|expectorants|mesh-ancestor
110903767|NCT04627922|Respiratory System Agents|respiratory system agents|mesh-ancestor
110903768|NCT04627922|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110903769|NCT04627922|Antioxidants|antioxidants|mesh-ancestor
110903770|NCT04627922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110903771|NCT04627922|Protective Agents|protective agents|mesh-ancestor
110903772|NCT04627922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110903773|NCT04627922|Antidotes|antidotes|mesh-ancestor
110903775|NCT04596657|Vitamins|vitamins|mesh-ancestor
110903776|NCT04596657|Micronutrients|micronutrients|mesh-ancestor
110903777|NCT04596657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110903778|NCT04596657|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110903779|NCT04577716|Listerine|listerine|mesh-list
110903780|NCT04577716|Fluorides|fluorides|mesh-list
110903781|NCT04577716|Sodium Fluoride|sodium fluoride|mesh-list
110903782|NCT04577716|Cariostatic Agents|cariostatic agents|mesh-ancestor
110903783|NCT04577716|Protective Agents|protective agents|mesh-ancestor
110903784|NCT04577716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110903785|NCT04577716|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110903786|NCT04577716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110903788|NCT04540705|Axitinib|axitinib|mesh-list
110903789|NCT04540705|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110903790|NCT04540705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110903791|NCT04540705|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110903792|NCT04540705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110903793|NCT04540705|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110903794|NCT04540705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110903795|NCT04521413|Pembrolizumab|pembrolizumab|mesh-list
110903796|NCT04521413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110903797|NCT04521413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110903798|NCT04521413|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110903799|NCT04521413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110903800|NCT04516057|Nabilone|nabilone|mesh-list
110903801|NCT04516057|Antiemetics|antiemetics|mesh-ancestor
110903802|NCT04516057|Autonomic Agents|autonomic agents|mesh-ancestor
110903803|NCT04516057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110903804|NCT04516057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110903805|NCT04516057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110903806|NCT04516057|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110903807|NCT04516057|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110903808|NCT04516057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110903809|NCT04516057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110903810|NCT04475276|Thioctic Acid|thioctic acid|mesh-list
110903811|NCT04475276|Antioxidants|antioxidants|mesh-ancestor
110903812|NCT04475276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110903813|NCT04475276|Protective Agents|protective agents|mesh-ancestor
110903814|NCT04475276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110903815|NCT04475276|Vitamin B Complex|vitamin b complex|mesh-ancestor
110903816|NCT04475276|Vitamins|vitamins|mesh-ancestor
110903817|NCT04475276|Micronutrients|micronutrients|mesh-ancestor
110903818|NCT04424641|Antibodies|antibodies|mesh-list
110903819|NCT04424641|Immunoglobulins|immunoglobulins|mesh-list
110903820|NCT04424641|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110903821|NCT04424641|Immunoglobulin G|immunoglobulin g|mesh-list
110903822|NCT04424641|Antibodies, Bispecific|antibodies, bispecific|mesh-list
110903823|NCT04424641|Immunologic Factors|immunologic factors|mesh-ancestor
110903824|NCT04424641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110903825|NCT04393103|Atropine|atropine|mesh-list
110903826|NCT04393103|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
110903827|NCT04393103|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110903828|NCT04393103|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110903829|NCT04393103|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110903830|NCT04393103|Autonomic Agents|autonomic agents|mesh-ancestor
110903831|NCT04393103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110903832|NCT04393103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110903833|NCT04393103|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110903834|NCT04393103|Respiratory System Agents|respiratory system agents|mesh-ancestor
110903835|NCT04393103|Mydriatics|mydriatics|mesh-ancestor
110903836|NCT04393103|Parasympatholytics|parasympatholytics|mesh-ancestor
110903837|NCT04393103|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110903839|NCT04393103|Cholinergic Agents|cholinergic agents|mesh-ancestor
110903840|NCT04393103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110903841|NCT04393103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110903842|NCT04393103|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
110903843|NCT04393103|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
110903844|NCT04393103|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110903845|NCT04334629|Ibuprofen|ibuprofen|mesh-list
110903846|NCT04334629|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110903847|NCT04334629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110903848|NCT04334629|Analgesics|analgesics|mesh-ancestor
110903849|NCT04334629|Sensory System Agents|sensory system agents|mesh-ancestor
110903850|NCT04334629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110903851|NCT04334629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110903852|NCT04334629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110903853|NCT04334629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110903854|NCT04334629|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110903855|NCT04334629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110903856|NCT04334629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110903857|NCT04329975|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
110903858|NCT04329975|Hemostatics|hemostatics|mesh-ancestor
110903859|NCT04329975|Coagulants|coagulants|mesh-ancestor
110903860|NCT04329975|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
110903861|NCT04329975|Natriuretic Agents|natriuretic agents|mesh-ancestor
110903862|NCT04329975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110903863|NCT04300647|Atezolizumab|atezolizumab|mesh-list
110903864|NCT04300647|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110903865|NCT04300647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110903866|NCT04300647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110903867|NCT04300647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110903868|NCT04296890|Maytansine|maytansine|mesh-list
110903869|NCT04296890|Mirvetuximab soravtansine|mirvetuximab soravtansine|mesh-list
110903870|NCT04296890|Immunoconjugates|immunoconjugates|mesh-ancestor
110903871|NCT04296890|Immunologic Factors|immunologic factors|mesh-ancestor
110903872|NCT04296890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110903873|NCT04296890|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110903874|NCT04296890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110903875|NCT04296890|Tubulin Modulators|tubulin modulators|mesh-ancestor
110903876|NCT04296890|Antimitotic Agents|antimitotic agents|mesh-ancestor
110903877|NCT04296890|Mitosis Modulators|mitosis modulators|mesh-ancestor
110903878|NCT04296890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110903879|NCT04276090|Dexamethasone|dexamethasone|mesh-list
110204405|NCT00165178|Leucovorin|leucovorin|mesh-list
110903880|NCT04276090|Floxuridine|floxuridine|mesh-list
110903881|NCT04276090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110903882|NCT04276090|Antiemetics|antiemetics|mesh-ancestor
110903883|NCT04276090|Autonomic Agents|autonomic agents|mesh-ancestor
110903884|NCT04276090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110903885|NCT04276090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110903886|NCT04276090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110903887|NCT04276090|Glucocorticoids|glucocorticoids|mesh-ancestor
110903888|NCT04276090|Hormones|hormones|mesh-ancestor
110903889|NCT04276090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110903890|NCT04276090|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110903891|NCT04276090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110903892|NCT04276090|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110903893|NCT04276090|Antimetabolites|antimetabolites|mesh-ancestor
110903894|NCT04276090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110903895|NCT04273139|Venetoclax|venetoclax|mesh-list
110903896|NCT04273139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110903897|NCT04081688|Atezolizumab|atezolizumab|mesh-list
110903898|NCT04081688|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110903899|NCT04081688|Immunoglobulins|immunoglobulins|mesh-list
110903900|NCT04081688|Immunoglobulin G|immunoglobulin g|mesh-list
110903901|NCT04081688|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110903902|NCT04081688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110903903|NCT04081688|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110903904|NCT04081688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110903905|NCT04081688|Immunologic Factors|immunologic factors|mesh-ancestor
110903906|NCT04081688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110903907|NCT04064814|Thioctic Acid|thioctic acid|mesh-list
110903908|NCT04064814|Flunarizine|flunarizine|mesh-list
110903909|NCT04064814|Antioxidants|antioxidants|mesh-ancestor
110903910|NCT04064814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110903911|NCT04064814|Protective Agents|protective agents|mesh-ancestor
110903912|NCT04064814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110903913|NCT04064814|Vitamin B Complex|vitamin b complex|mesh-ancestor
110903914|NCT04064814|Vitamins|vitamins|mesh-ancestor
110903915|NCT04064814|Micronutrients|micronutrients|mesh-ancestor
110903916|NCT04064814|Anticonvulsants|anticonvulsants|mesh-ancestor
110903917|NCT04064814|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110903918|NCT04064814|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110903919|NCT04064814|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110903920|NCT04064814|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110903921|NCT04064814|Histamine Antagonists|histamine antagonists|mesh-ancestor
110903922|NCT04064814|Histamine Agents|histamine agents|mesh-ancestor
110903923|NCT04064814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110903924|NCT04064814|Vasodilator Agents|vasodilator agents|mesh-ancestor
110903925|NCT03972306|Ocrelizumab|ocrelizumab|mesh-list
110903926|NCT03972306|Immunologic Factors|immunologic factors|mesh-ancestor
110903927|NCT03972306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110903928|NCT03924414|Zoledronic Acid|zoledronic acid|mesh-list
110903929|NCT03924414|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110903930|NCT03924414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110903931|NCT03910452|Sirolimus|sirolimus|mesh-list
110903932|NCT03910452|Cyclophosphamide|cyclophosphamide|mesh-list
110903933|NCT03910452|Busulfan|busulfan|mesh-list
110903934|NCT03910452|Alemtuzumab|alemtuzumab|mesh-list
110621393|NCT02559440|Sympathomimetics|sympathomimetics|mesh-ancestor
110903936|NCT03910452|Immunologic Factors|immunologic factors|mesh-ancestor
110903937|NCT03910452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110903938|NCT03910452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110903939|NCT03910452|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110903940|NCT03910452|Alkylating Agents|alkylating agents|mesh-ancestor
110903941|NCT03910452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110903942|NCT03910452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110903943|NCT03910452|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110903944|NCT03910452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110903945|NCT03910452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110903946|NCT03910452|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110903947|NCT03910452|Antifungal Agents|antifungal agents|mesh-ancestor
110903948|NCT03910452|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110903949|NCT03846388|Hormones|hormones|mesh-list
110903950|NCT03846388|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
110903951|NCT03846388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110903952|NCT03846388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110903953|NCT03845166|Atezolizumab|atezolizumab|mesh-list
110903954|NCT03845166|Avelumab|avelumab|mesh-list
110903955|NCT03845166|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110903956|NCT03845166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110903957|NCT03845166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110903958|NCT03845166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110903959|NCT03714828|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
110903960|NCT03714828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110903961|NCT03714828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110903962|NCT03675815|Ritonavir|ritonavir|mesh-list
110903963|NCT03675815|Darunavir|darunavir|mesh-list
110903964|NCT03675815|Tenofovir|tenofovir|mesh-list
110903965|NCT03675815|Lamivudine|lamivudine|mesh-list
110903966|NCT03675815|Emtricitabine|emtricitabine|mesh-list
110903967|NCT03675815|Dolutegravir|dolutegravir|mesh-list
110903968|NCT03675815|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
110903969|NCT03675815|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110903970|NCT03675815|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110903971|NCT03675815|Protease Inhibitors|protease inhibitors|mesh-ancestor
110903972|NCT03675815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110903973|NCT03675815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110903974|NCT03675815|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110903975|NCT03675815|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110903976|NCT03675815|Antiviral Agents|antiviral agents|mesh-ancestor
110903977|NCT03675815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110903978|NCT03675815|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110225142|NCT05996588|Sevoflurane|sevoflurane|mesh-list
110903979|NCT03675815|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110903980|NCT03675815|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110903981|NCT03675815|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110903982|NCT03675815|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110903983|NCT03672695|Venetoclax|venetoclax|mesh-list
110903984|NCT03672695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110903985|NCT03669133|Vitamin E|vitamin e|mesh-list
110903986|NCT03669133|Vitamins|vitamins|mesh-ancestor
110903987|NCT03669133|Micronutrients|micronutrients|mesh-ancestor
110903988|NCT03669133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110903989|NCT03669133|Antioxidants|antioxidants|mesh-ancestor
110903990|NCT03669133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110903991|NCT03669133|Protective Agents|protective agents|mesh-ancestor
110903992|NCT03647969|Nivolumab|nivolumab|mesh-list
110903993|NCT03647969|Ipilimumab|ipilimumab|mesh-list
110903994|NCT03647969|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110903995|NCT03647969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110903996|NCT03647969|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110903997|NCT03647969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110903998|NCT03644186|Paclitaxel|paclitaxel|mesh-list
110903999|NCT03644186|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110904000|NCT03644186|Trastuzumab|trastuzumab|mesh-list
110904001|NCT03644186|Letrozole|letrozole|mesh-list
110904002|NCT03644186|Palbociclib|palbociclib|mesh-list
110904003|NCT03644186|Pertuzumab|pertuzumab|mesh-list
110904004|NCT03644186|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110904005|NCT03644186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110904006|NCT03644186|Tubulin Modulators|tubulin modulators|mesh-ancestor
110904007|NCT03644186|Antimitotic Agents|antimitotic agents|mesh-ancestor
110904008|NCT03644186|Mitosis Modulators|mitosis modulators|mesh-ancestor
110904009|NCT03644186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110904010|NCT03644186|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110904011|NCT03644186|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110904012|NCT03644186|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110904013|NCT03644186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110904014|NCT03644186|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110904015|NCT03644186|Hormone Antagonists|hormone antagonists|mesh-ancestor
110904016|NCT03644186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110904017|NCT03644186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110904018|NCT03644186|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110904019|NCT03593759|Prednisone|prednisone|mesh-list
110904020|NCT03593759|Prednisolone|prednisolone|mesh-list
110904021|NCT03593759|Methotrexate|methotrexate|mesh-list
110904022|NCT03593759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110904023|NCT03593759|Glucocorticoids|glucocorticoids|mesh-ancestor
110904024|NCT03593759|Hormones|hormones|mesh-ancestor
110904025|NCT03593759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110904026|NCT03593759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110904027|NCT03593759|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110904028|NCT03593759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110904029|NCT03593759|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110904030|NCT03593759|Abortifacient Agents|abortifacient agents|mesh-ancestor
110904031|NCT03593759|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110904032|NCT03593759|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110904033|NCT03593759|Antimetabolites|antimetabolites|mesh-ancestor
110904034|NCT03593759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110904035|NCT03593759|Dermatologic Agents|dermatologic agents|mesh-ancestor
110904036|NCT03593759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110904037|NCT03593759|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110904038|NCT03593759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110904039|NCT03593759|Immunologic Factors|immunologic factors|mesh-ancestor
110904040|NCT03593759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110904041|NCT03593759|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110904042|NCT03567577|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110904043|NCT03548155|Antipsychotic Agents|antipsychotic agents|mesh-list
110904044|NCT03548155|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110904046|NCT03548155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110904047|NCT03548155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110904048|NCT03457701|Iron|iron|mesh-list
110904049|NCT03457701|Trace Elements|trace elements|mesh-ancestor
110904050|NCT03457701|Micronutrients|micronutrients|mesh-ancestor
110904051|NCT03457701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110904052|NCT03347292|Pembrolizumab|pembrolizumab|mesh-list
110204477|NCT00053885|Vatalanib|vatalanib|mesh-list
110904053|NCT03347292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110904054|NCT03347292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110904055|NCT03347292|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110904056|NCT03347292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110904057|NCT03198650|Obinutuzumab|obinutuzumab|mesh-list
110904058|NCT03198650|Acalabrutinib|acalabrutinib|mesh-list
110904059|NCT03198650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110904060|NCT03198650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110904061|NCT03182426|Liraglutide|liraglutide|mesh-list
110904062|NCT03182426|Plerixafor|plerixafor|mesh-list
110904063|NCT03182426|Etanercept|etanercept|mesh-list
110904064|NCT03182426|Alemtuzumab|alemtuzumab|mesh-list
110904065|NCT03182426|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
110904066|NCT03182426|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110904067|NCT03182426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110904068|NCT03182426|Incretins|incretins|mesh-ancestor
110904069|NCT03182426|Hormones|hormones|mesh-ancestor
110904070|NCT03182426|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110904071|NCT03182426|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110904072|NCT03182426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110904073|NCT03182426|Analgesics|analgesics|mesh-ancestor
110904074|NCT03182426|Sensory System Agents|sensory system agents|mesh-ancestor
110904075|NCT03182426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110904076|NCT03182426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110904077|NCT03182426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110904078|NCT03182426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110904079|NCT03182426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110904080|NCT03182426|Immunologic Factors|immunologic factors|mesh-ancestor
110904081|NCT03182426|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110904082|NCT03182426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110904083|NCT03182426|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110904084|NCT03182426|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110904086|NCT03182426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110904087|NCT03141359|Paclitaxel|paclitaxel|mesh-list
110904088|NCT03141359|Etoposide|etoposide|mesh-list
110904089|NCT03141359|Carboplatin|carboplatin|mesh-list
110904090|NCT03141359|Durvalumab|durvalumab|mesh-list
110904091|NCT03141359|Cisplatin|cisplatin|mesh-list
110904092|NCT03141359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110904093|NCT03141359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110904094|NCT03141359|Tubulin Modulators|tubulin modulators|mesh-ancestor
110904095|NCT03141359|Antimitotic Agents|antimitotic agents|mesh-ancestor
110904096|NCT03141359|Mitosis Modulators|mitosis modulators|mesh-ancestor
110904097|NCT03141359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110904098|NCT03141359|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110904099|NCT03141359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110904100|NCT03141359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110904101|NCT03141359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110904102|NCT03078946|Midazolam|midazolam|mesh-list
110904103|NCT03078946|Dexmedetomidine|dexmedetomidine|mesh-list
110904104|NCT03078946|Morphine|morphine|mesh-list
110904105|NCT03078946|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110904106|NCT03078946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110904107|NCT03078946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110904108|NCT03078946|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110904109|NCT03078946|Analgesics|analgesics|mesh-ancestor
110904110|NCT03078946|Sensory System Agents|sensory system agents|mesh-ancestor
110904111|NCT03078946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110904112|NCT03078946|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110904113|NCT03078946|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110904114|NCT03078946|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110904115|NCT03078946|Adrenergic Agents|adrenergic agents|mesh-ancestor
110904116|NCT03078946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110204486|NCT00165334|Tubulin Modulators|tubulin modulators|mesh-ancestor
110904117|NCT03078946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110904118|NCT03078946|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110904119|NCT03078946|Narcotics|narcotics|mesh-ancestor
110904120|NCT03078946|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110904121|NCT03078946|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110904122|NCT03078946|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110904123|NCT03078946|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110904124|NCT03078946|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110904125|NCT03078946|Anesthetics, General|anesthetics, general|mesh-ancestor
110904126|NCT03078946|Anesthetics|anesthetics|mesh-ancestor
110904127|NCT03078946|GABA Modulators|gaba modulators|mesh-ancestor
110904128|NCT03078946|GABA Agents|gaba agents|mesh-ancestor
110904129|NCT03071861|Darbepoetin alfa|darbepoetin alfa|mesh-list
110904130|NCT03071861|Hematinics|hematinics|mesh-ancestor
110904131|NCT02974621|Bevacizumab|bevacizumab|mesh-list
110904132|NCT02974621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110904134|NCT02974621|Cediranib|cediranib|mesh-list
110904135|NCT02974621|Endothelial Growth Factors|endothelial growth factors|mesh-list
110904136|NCT02974621|Antibodies|antibodies|mesh-list
110904137|NCT02974621|Immunoglobulins|immunoglobulins|mesh-list
110904138|NCT02974621|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110904139|NCT02974621|Immunoglobulin G|immunoglobulin g|mesh-list
110904140|NCT02974621|Maleic acid|maleic acid|mesh-list
110904141|NCT02974621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110904142|NCT02974621|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110904143|NCT02974621|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110904144|NCT02974621|Growth Substances|growth substances|mesh-ancestor
110904145|NCT02974621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110904146|NCT02974621|Growth Inhibitors|growth inhibitors|mesh-ancestor
110904147|NCT02974621|Immunologic Factors|immunologic factors|mesh-ancestor
110904148|NCT02974621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110904149|NCT02974621|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110904150|NCT02974621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110904151|NCT02974621|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110904152|NCT02970448|Temozolomide|temozolomide|mesh-list
110904153|NCT02970448|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110904154|NCT02970448|Alkylating Agents|alkylating agents|mesh-ancestor
110904155|NCT02970448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110904156|NCT02970448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110904157|NCT02875223|Itraconazole|itraconazole|mesh-list
110904158|NCT02875223|Rifampin|rifampin|mesh-list
110904159|NCT02875223|Pulrodemstat besilate|pulrodemstat besilate|mesh-list
110621622|NCT00945789|Vasodilator Agents|vasodilator agents|mesh-ancestor
110904160|NCT02875223|Antifungal Agents|antifungal agents|mesh-ancestor
110904161|NCT02875223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110904162|NCT02875223|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110904163|NCT02875223|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110904164|NCT02875223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110904165|NCT02875223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110904166|NCT02875223|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110904167|NCT02875223|Hormone Antagonists|hormone antagonists|mesh-ancestor
110904168|NCT02875223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110904169|NCT02875223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110904170|NCT02875223|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110904171|NCT02875223|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110904172|NCT02875223|Antitubercular Agents|antitubercular agents|mesh-ancestor
110904173|NCT02875223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110904174|NCT02875223|Leprostatic Agents|leprostatic agents|mesh-ancestor
110904175|NCT02875223|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110904176|NCT02875223|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110904177|NCT02875223|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110904178|NCT02875223|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110904179|NCT02875223|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110904180|NCT02875223|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110904181|NCT02875223|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110225166|NCT05996406|Dexamethasone|dexamethasone|mesh-list
110904182|NCT02875223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110904183|NCT02759835|Osimertinib|osimertinib|mesh-list
110904184|NCT02759835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110904185|NCT02759835|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110904186|NCT02759835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110904187|NCT02759835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110904188|NCT02743741|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
110904189|NCT02743741|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110904190|NCT02743741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110904191|NCT02694978|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
110904192|NCT02694978|Hematinics|hematinics|mesh-ancestor
110904193|NCT02694978|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
110904194|NCT02694978|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110904195|NCT02663518|Rituximab|rituximab|mesh-list
110904196|NCT02663518|Nivolumab|nivolumab|mesh-list
110904197|NCT02663518|Immunoglobulin G|immunoglobulin g|mesh-list
110904198|NCT02663518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110904199|NCT02663518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110904200|NCT02663518|Immunologic Factors|immunologic factors|mesh-ancestor
110904201|NCT02663518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110904202|NCT02663518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110904203|NCT02663518|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110904204|NCT02663518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110904205|NCT02563002|Bevacizumab|bevacizumab|mesh-list
110904206|NCT02563002|Pembrolizumab|pembrolizumab|mesh-list
110904207|NCT02563002|Cetuximab|cetuximab|mesh-list
110904208|NCT02563002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110904209|NCT02563002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110904210|NCT02563002|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110904211|NCT02563002|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110904212|NCT02563002|Growth Substances|growth substances|mesh-ancestor
110904213|NCT02563002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110904214|NCT02563002|Growth Inhibitors|growth inhibitors|mesh-ancestor
110904215|NCT02563002|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110904216|NCT02563002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110904217|NCT02454933|Durvalumab|durvalumab|mesh-list
110904218|NCT02454933|Osimertinib|osimertinib|mesh-list
110904219|NCT02454933|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110904220|NCT02454933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110904221|NCT02454933|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110904222|NCT02454933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110904223|NCT02454933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110904224|NCT02430480|Goserelin|goserelin|mesh-list
110904225|NCT02430480|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110904226|NCT02430480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110904227|NCT02207439|Nelfinavir|nelfinavir|mesh-list
110904228|NCT02207439|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110904229|NCT02207439|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110904230|NCT02207439|Protease Inhibitors|protease inhibitors|mesh-ancestor
110904231|NCT02207439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110904232|NCT02207439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110904233|NCT02207439|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110904234|NCT02207439|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110904235|NCT02207439|Antiviral Agents|antiviral agents|mesh-ancestor
110904236|NCT02207439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110904237|NCT01983241|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
110904238|NCT01983241|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
110904239|NCT01983241|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110904240|NCT01983241|Protease Inhibitors|protease inhibitors|mesh-ancestor
110904241|NCT01983241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110904242|NCT01983241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110904243|NCT01864018|Dexamethasone|dexamethasone|mesh-list
110904244|NCT01864018|Dexamethasone acetate|dexamethasone acetate|mesh-list
110904245|NCT01864018|Cyclophosphamide|cyclophosphamide|mesh-list
110904246|NCT01864018|Ixazomib|ixazomib|mesh-list
110904247|NCT01864018|Ichthammol|ichthammol|mesh-list
110904248|NCT01864018|BB 1101|bb 1101|mesh-list
110904249|NCT01864018|Glycine|glycine|mesh-list
110904250|NCT01864018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110904251|NCT01864018|Immunologic Factors|immunologic factors|mesh-ancestor
110904252|NCT01864018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110904253|NCT01864018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110904254|NCT01864018|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110904255|NCT01864018|Alkylating Agents|alkylating agents|mesh-ancestor
110904256|NCT01864018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110904257|NCT01864018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110904258|NCT01864018|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110904259|NCT01864018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110904260|NCT01864018|Antiemetics|antiemetics|mesh-ancestor
110904261|NCT01864018|Autonomic Agents|autonomic agents|mesh-ancestor
110904262|NCT01864018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110904263|NCT01864018|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110904264|NCT01864018|Glucocorticoids|glucocorticoids|mesh-ancestor
110904265|NCT01864018|Hormones|hormones|mesh-ancestor
110904266|NCT01864018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110904267|NCT01864018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110904268|NCT01864018|Protease Inhibitors|protease inhibitors|mesh-ancestor
110904269|NCT01864018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110904270|NCT01864018|Dermatologic Agents|dermatologic agents|mesh-ancestor
110904271|NCT01864018|Glycine Agents|glycine agents|mesh-ancestor
110904272|NCT01864018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110904273|NCT01796197|Paclitaxel|paclitaxel|mesh-list
110904274|NCT01796197|Cyclophosphamide|cyclophosphamide|mesh-list
110904275|NCT01796197|Doxorubicin|doxorubicin|mesh-list
110904276|NCT01796197|Trastuzumab|trastuzumab|mesh-list
110904277|NCT01796197|Pertuzumab|pertuzumab|mesh-list
110904278|NCT01796197|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110904279|NCT01796197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110904280|NCT01796197|Tubulin Modulators|tubulin modulators|mesh-ancestor
110904281|NCT01796197|Antimitotic Agents|antimitotic agents|mesh-ancestor
110904282|NCT01796197|Mitosis Modulators|mitosis modulators|mesh-ancestor
110904283|NCT01796197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110904284|NCT01796197|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110904285|NCT01796197|Immunologic Factors|immunologic factors|mesh-ancestor
110904286|NCT01796197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110904287|NCT01796197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110904288|NCT01796197|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110226076|NCT05688098|Irbesartan|irbesartan|mesh-list
110904289|NCT01796197|Alkylating Agents|alkylating agents|mesh-ancestor
110904290|NCT01796197|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110904291|NCT01796197|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110904292|NCT01796197|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110904293|NCT01796197|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110904294|NCT01796197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110904295|NCT01796197|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110904296|NCT01689766|Technetium Tc 99m-ethylenedicysteine|technetium tc 99m-ethylenedicysteine|mesh-list
110904297|NCT01689766|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110225177|NCT05996406|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110904298|NCT01689766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110904299|NCT01205048|Lidocaine|lidocaine|mesh-list
110904300|NCT01205048|Anesthetics, Local|anesthetics, local|mesh-ancestor
110904301|NCT01205048|Anesthetics|anesthetics|mesh-ancestor
110904302|NCT01205048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110904303|NCT01205048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110925183|NCT03497702|Docetaxel|docetaxel|mesh-list
110904304|NCT01205048|Sensory System Agents|sensory system agents|mesh-ancestor
110904305|NCT01205048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110904306|NCT01205048|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110904307|NCT01205048|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110904308|NCT01205048|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110621780|NCT00762944|Cimetidine|cimetidine|mesh-list
110904309|NCT01205048|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110904310|NCT01205048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110904311|NCT01052779|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
110904312|NCT01052779|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
110904313|NCT01052779|Hematinics|hematinics|mesh-ancestor
110904314|NCT01052779|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
110904315|NCT01052779|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110904316|NCT00785525|Lenograstim|lenograstim|mesh-list
110904317|NCT00785525|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110904318|NCT00785525|Immunologic Factors|immunologic factors|mesh-ancestor
110904319|NCT00785525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110904320|NCT00591370|Temozolomide|temozolomide|mesh-list
110904321|NCT00591370|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110904322|NCT00591370|Alkylating Agents|alkylating agents|mesh-ancestor
110904323|NCT00591370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110904324|NCT00591370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110904325|NCT00389610|Pancrelipase|pancrelipase|mesh-list
110904326|NCT00389610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110904327|NCT03064763|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
110904328|NCT03064763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110904329|NCT03064763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110904330|NCT02782676|Hyaluronic Acid|hyaluronic acid|mesh-list
110904331|NCT02782676|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110904332|NCT02782676|Immunologic Factors|immunologic factors|mesh-ancestor
110904333|NCT02782676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110904334|NCT02782676|Viscosupplements|viscosupplements|mesh-ancestor
110904335|NCT02782676|Protective Agents|protective agents|mesh-ancestor
110904336|NCT03033095|Etanercept|etanercept|mesh-list
110904337|NCT03033095|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110904338|NCT03033095|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110904339|NCT03033095|Analgesics|analgesics|mesh-ancestor
110904340|NCT03033095|Sensory System Agents|sensory system agents|mesh-ancestor
110904341|NCT03033095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110904342|NCT03033095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110904343|NCT03033095|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110904344|NCT03033095|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110904345|NCT03033095|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110904346|NCT03033095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110904347|NCT03033095|Immunologic Factors|immunologic factors|mesh-ancestor
110904348|NCT02142920|Gedatolisib|gedatolisib|mesh-list
110904349|NCT02142920|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110904350|NCT02142920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110904351|NCT02142920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110904352|NCT01383785|Abciximab|abciximab|mesh-list
110904353|NCT01383785|Anticoagulants|anticoagulants|mesh-ancestor
110904354|NCT01383785|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110904355|NCT02923739|Paclitaxel|paclitaxel|mesh-list
110904356|NCT02923739|Bevacizumab|bevacizumab|mesh-list
110904357|NCT02923739|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110904358|NCT02923739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110904359|NCT02923739|Endothelial Growth Factors|endothelial growth factors|mesh-list
110904360|NCT02923739|Antibodies|antibodies|mesh-list
110904361|NCT02923739|Immunoglobulins|immunoglobulins|mesh-list
110904362|NCT02923739|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110904363|NCT02923739|Immunoglobulin G|immunoglobulin g|mesh-list
110904364|NCT02923739|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110904365|NCT02923739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110904366|NCT02923739|Tubulin Modulators|tubulin modulators|mesh-ancestor
110904367|NCT02923739|Antimitotic Agents|antimitotic agents|mesh-ancestor
110904368|NCT02923739|Mitosis Modulators|mitosis modulators|mesh-ancestor
110904369|NCT02923739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110904370|NCT02923739|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110904371|NCT02923739|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110904372|NCT02923739|Growth Substances|growth substances|mesh-ancestor
110904373|NCT02923739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110904374|NCT02923739|Growth Inhibitors|growth inhibitors|mesh-ancestor
110904375|NCT02923739|Immunologic Factors|immunologic factors|mesh-ancestor
110904377|NCT02146976|Sevoflurane|sevoflurane|mesh-list
110904378|NCT02146976|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110904379|NCT02146976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110904380|NCT02146976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110904381|NCT02146976|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110621848|NCT02558270|Dapagliflozin|dapagliflozin|mesh-list
110904382|NCT02146976|Anesthetics, General|anesthetics, general|mesh-ancestor
110904383|NCT02146976|Anesthetics|anesthetics|mesh-ancestor
110904384|NCT02146976|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110904385|NCT02146976|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110904386|NCT02147054|Rocuronium|rocuronium|mesh-list
110904387|NCT02147054|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110904388|NCT02147054|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110904389|NCT02147054|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110904390|NCT02147054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110904391|NCT02147054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110904392|NCT00107978|Vancomycin|vancomycin|mesh-list
110904393|NCT00107978|Telavancin|telavancin|mesh-list
110904394|NCT00107978|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110904395|NCT00107978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110904396|NCT02781818|Triamcinolone|triamcinolone|mesh-list
110904397|NCT02781818|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110904398|NCT02781818|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110904399|NCT02781818|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110904400|NCT02781818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110904401|NCT02781818|Glucocorticoids|glucocorticoids|mesh-ancestor
110904402|NCT02781818|Hormones|hormones|mesh-ancestor
110904403|NCT02781818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110904404|NCT02781818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110904405|NCT02781818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110904406|NCT02781818|Immunologic Factors|immunologic factors|mesh-ancestor
110904407|NCT02781818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110904408|NCT02781818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110904409|NCT02149628|Propofol|propofol|mesh-list
110904410|NCT02149628|Desflurane|desflurane|mesh-list
110904411|NCT02149628|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110904412|NCT02149628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110904413|NCT02149628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110904414|NCT02149628|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110904415|NCT02149628|Anesthetics, General|anesthetics, general|mesh-ancestor
110904416|NCT02149628|Anesthetics|anesthetics|mesh-ancestor
110904417|NCT02149628|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110904418|NCT02927873|Vaccines|vaccines|mesh-list
110904419|NCT02927873|Immunologic Factors|immunologic factors|mesh-ancestor
110904420|NCT02927873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110904421|NCT02460419|Capecitabine|capecitabine|mesh-list
110904422|NCT02460419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110904423|NCT02460419|Antimetabolites|antimetabolites|mesh-ancestor
110904424|NCT02460419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110904425|NCT02460419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110904426|NCT01568411|Itraconazole|itraconazole|mesh-list
110904427|NCT01568411|Antifungal Agents|antifungal agents|mesh-ancestor
110904428|NCT01568411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110925206|NCT03497702|Hormone Antagonists|hormone antagonists|mesh-ancestor
110904430|NCT01568411|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110904431|NCT01568411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110904432|NCT01568411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110904433|NCT01568411|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110904434|NCT01568411|Hormone Antagonists|hormone antagonists|mesh-ancestor
110904435|NCT01568411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110904436|NCT01568411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110904437|NCT01568411|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110904438|NCT00142415|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
110904439|NCT00142415|Chelating Agents|chelating agents|mesh-ancestor
110904440|NCT00142415|Sequestering Agents|sequestering agents|mesh-ancestor
110904441|NCT00142415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110904442|NCT03631901|Diazepam|diazepam|mesh-list
110904443|NCT03631901|Melatonin|melatonin|mesh-list
110904444|NCT03631901|Antioxidants|antioxidants|mesh-ancestor
110904445|NCT03631901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110904446|NCT03631901|Protective Agents|protective agents|mesh-ancestor
110904447|NCT03631901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110904448|NCT03631901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110904449|NCT03631901|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110904450|NCT03631901|Anticonvulsants|anticonvulsants|mesh-ancestor
110904451|NCT03631901|Antiemetics|antiemetics|mesh-ancestor
110904452|NCT03631901|Autonomic Agents|autonomic agents|mesh-ancestor
110904453|NCT03631901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110904454|NCT03631901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110904455|NCT03631901|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110904456|NCT03631901|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110904457|NCT03631901|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110904458|NCT03631901|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110904459|NCT03631901|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110904460|NCT03631901|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110904461|NCT03631901|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110904462|NCT03631901|Anesthetics, General|anesthetics, general|mesh-ancestor
110904463|NCT03631901|Anesthetics|anesthetics|mesh-ancestor
110904464|NCT03631901|GABA Modulators|gaba modulators|mesh-ancestor
110904465|NCT03631901|GABA Agents|gaba agents|mesh-ancestor
110904466|NCT03631901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110904467|NCT01383395|Cilostazol|cilostazol|mesh-list
110904468|NCT01383395|Simvastatin|simvastatin|mesh-list
110904469|NCT01383395|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110904470|NCT01383395|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110904471|NCT01383395|Antimetabolites|antimetabolites|mesh-ancestor
110904472|NCT01383395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110904473|NCT01383395|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110904474|NCT01383395|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110904475|NCT01383395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110904476|NCT01383395|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110904477|NCT01383395|Autonomic Agents|autonomic agents|mesh-ancestor
110904478|NCT01383395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110904479|NCT01383395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110904480|NCT01383395|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110904481|NCT01383395|Respiratory System Agents|respiratory system agents|mesh-ancestor
110904482|NCT01383395|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110904483|NCT01383395|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110904484|NCT01383395|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110904485|NCT01383395|Vasodilator Agents|vasodilator agents|mesh-ancestor
110904486|NCT01383395|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110904487|NCT01383395|Protective Agents|protective agents|mesh-ancestor
110904489|NCT01383395|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110904490|NCT05084651|Itraconazole|itraconazole|mesh-list
110904491|NCT05084651|Lumefantrine|lumefantrine|mesh-list
110904492|NCT05084651|Antifungal Agents|antifungal agents|mesh-ancestor
110904493|NCT05084651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110904494|NCT05084651|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110904495|NCT05084651|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110904496|NCT05084651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110904497|NCT05084651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110904498|NCT05084651|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110904499|NCT05084651|Hormone Antagonists|hormone antagonists|mesh-ancestor
110904500|NCT05084651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110904501|NCT05084651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110904502|NCT05084651|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110904503|NCT05084651|Antimalarials|antimalarials|mesh-ancestor
110904504|NCT05084651|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110904505|NCT05084651|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110904506|NCT02781584|Firsocostat|firsocostat|mesh-list
110904507|NCT02781584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110904508|NCT02781584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110904509|NCT02149706|Freund's Adjuvant|freund's adjuvant|mesh-list
110904510|NCT02149706|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110904511|NCT02149706|Immunologic Factors|immunologic factors|mesh-ancestor
110904512|NCT02149706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110904513|NCT02147678|Remifentanil|remifentanil|mesh-list
110904514|NCT02147678|Propofol|propofol|mesh-list
110904515|NCT02147678|Etomidate|etomidate|mesh-list
110904516|NCT02147678|Anesthetics|anesthetics|mesh-ancestor
110904517|NCT02147678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110904518|NCT02147678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110904519|NCT02147678|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110904520|NCT02147678|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110904521|NCT02147678|Anesthetics, General|anesthetics, general|mesh-ancestor
110904522|NCT02147678|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110904523|NCT02147678|Narcotics|narcotics|mesh-ancestor
110904524|NCT02147678|Analgesics|analgesics|mesh-ancestor
110904525|NCT02147678|Sensory System Agents|sensory system agents|mesh-ancestor
110904526|NCT02147678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110904527|NCT02151344|Vaccines|vaccines|mesh-list
110904528|NCT02151344|Immunologic Factors|immunologic factors|mesh-ancestor
110904529|NCT02151344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110904530|NCT02155634|Lenalidomide|lenalidomide|mesh-list
110904531|NCT02155634|Immunologic Factors|immunologic factors|mesh-ancestor
110904532|NCT02155634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110904533|NCT02155634|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110904534|NCT02155634|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110904535|NCT02155634|Growth Substances|growth substances|mesh-ancestor
110904536|NCT02155634|Growth Inhibitors|growth inhibitors|mesh-ancestor
110904537|NCT02155634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110904538|NCT02151812|Paclitaxel|paclitaxel|mesh-list
110904539|NCT02151812|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110904540|NCT02151812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110904541|NCT02151812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110904542|NCT02151812|Tubulin Modulators|tubulin modulators|mesh-ancestor
110904543|NCT02151812|Antimitotic Agents|antimitotic agents|mesh-ancestor
110904544|NCT02151812|Mitosis Modulators|mitosis modulators|mesh-ancestor
110904545|NCT02151812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110904546|NCT02151968|Anesthetics|anesthetics|mesh-list
110904547|NCT02151968|Anesthetics, Local|anesthetics, local|mesh-list
110904548|NCT02151968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110904549|NCT02151968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110904550|NCT02151968|Sensory System Agents|sensory system agents|mesh-ancestor
110904551|NCT02151968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110904552|NCT02776670|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110904553|NCT02776670|Lubricant Eye Drops|lubricant eye drops|mesh-list
110904554|NCT02776670|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110904555|NCT02255084|Menthol|menthol|mesh-list
110904556|NCT02255084|Antipruritics|antipruritics|mesh-ancestor
110904557|NCT02255084|Dermatologic Agents|dermatologic agents|mesh-ancestor
110904558|NCT02150330|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
110904559|NCT02150330|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110904560|NCT02150330|Immunologic Factors|immunologic factors|mesh-ancestor
110904561|NCT02150330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110904562|NCT02255162|Cytarabine|cytarabine|mesh-list
110904563|NCT02255162|Lenalidomide|lenalidomide|mesh-list
110904564|NCT02255162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110904565|NCT02255162|Antimetabolites|antimetabolites|mesh-ancestor
110225224|NCT05996185|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110904566|NCT02255162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110904567|NCT02255162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110904568|NCT02255162|Antiviral Agents|antiviral agents|mesh-ancestor
110904569|NCT02255162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110904570|NCT02255162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110904571|NCT02255162|Immunologic Factors|immunologic factors|mesh-ancestor
110904572|NCT02255162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110904573|NCT02255162|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110904574|NCT02255162|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110904575|NCT02255162|Growth Substances|growth substances|mesh-ancestor
110904576|NCT02255162|Growth Inhibitors|growth inhibitors|mesh-ancestor
110904577|NCT02152514|Sufentanil|sufentanil|mesh-list
110904578|NCT02152514|Morphine|morphine|mesh-list
110904579|NCT02152514|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110904580|NCT02152514|Narcotics|narcotics|mesh-ancestor
110904581|NCT02152514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110904582|NCT02152514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110904583|NCT02152514|Analgesics|analgesics|mesh-ancestor
110904584|NCT02152514|Sensory System Agents|sensory system agents|mesh-ancestor
110904585|NCT02152514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110904586|NCT02152514|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110904587|NCT02152514|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110904588|NCT02152514|Anesthetics, General|anesthetics, general|mesh-ancestor
110904589|NCT02152514|Anesthetics|anesthetics|mesh-ancestor
110904590|NCT02261090|Pramipexole|pramipexole|mesh-list
110904591|NCT02261090|Antioxidants|antioxidants|mesh-ancestor
110904592|NCT02261090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110904593|NCT02261090|Protective Agents|protective agents|mesh-ancestor
110904594|NCT02261090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110904595|NCT02261090|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110904596|NCT02261090|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110904597|NCT02261090|Dopamine Agonists|dopamine agonists|mesh-ancestor
110904598|NCT02261090|Dopamine Agents|dopamine agents|mesh-ancestor
110904599|NCT02261090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110904600|NCT01307423|Thalidomide|thalidomide|mesh-list
110904601|NCT01307423|Apremilast|apremilast|mesh-list
110904602|NCT01307423|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110904603|NCT01307423|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110904604|NCT01307423|Analgesics|analgesics|mesh-ancestor
110904605|NCT01307423|Sensory System Agents|sensory system agents|mesh-ancestor
110904606|NCT01307423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110904607|NCT01307423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110904608|NCT01307423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110904609|NCT01307423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110904610|NCT01307423|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
110904611|NCT01307423|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110904612|NCT01307423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110904613|NCT01307423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110904614|NCT01307423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110904615|NCT01307423|Immunologic Factors|immunologic factors|mesh-ancestor
110904616|NCT01307423|Leprostatic Agents|leprostatic agents|mesh-ancestor
110904617|NCT01307423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110904618|NCT01307423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110904619|NCT01307423|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110904620|NCT01307423|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110904621|NCT01307423|Growth Substances|growth substances|mesh-ancestor
110904622|NCT01307423|Growth Inhibitors|growth inhibitors|mesh-ancestor
110904623|NCT01307423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110904624|NCT03543254|Botulinum Toxins|botulinum toxins|mesh-list
110904625|NCT03543254|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110904626|NCT03543254|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110904627|NCT03543254|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110904628|NCT03543254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110904629|NCT03543254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110904630|NCT03543254|Cholinergic Agents|cholinergic agents|mesh-ancestor
110904631|NCT03543254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110904632|NCT03543254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110904633|NCT03543254|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110904634|NCT03543254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110904635|NCT02156336|Ranolazine|ranolazine|mesh-list
110904636|NCT02156336|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110904637|NCT02156336|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110904638|NCT02156336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110904639|NCT03542240|Curcumin|curcumin|mesh-list
110904640|NCT03542240|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110904641|NCT03542240|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110904642|NCT03542240|Analgesics|analgesics|mesh-ancestor
110904643|NCT03542240|Sensory System Agents|sensory system agents|mesh-ancestor
110904644|NCT03542240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110904645|NCT03542240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110904646|NCT03542240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110904647|NCT03542240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110904648|NCT03542240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110904649|NCT03542240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110904650|NCT03542240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110904651|NCT00911183|Prednisone|prednisone|mesh-list
110904652|NCT00911183|Cyclophosphamide|cyclophosphamide|mesh-list
110904653|NCT00911183|Rituximab|rituximab|mesh-list
110904654|NCT00911183|Doxorubicin|doxorubicin|mesh-list
110904655|NCT00911183|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110904656|NCT00911183|Vincristine|vincristine|mesh-list
110904657|NCT00911183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110904658|NCT00911183|Immunologic Factors|immunologic factors|mesh-ancestor
110904659|NCT00911183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110904660|NCT00911183|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110904661|NCT00911183|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110904662|NCT00911183|Alkylating Agents|alkylating agents|mesh-ancestor
110904663|NCT00911183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110904664|NCT00911183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110904665|NCT00911183|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110904666|NCT00911183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110904667|NCT00911183|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110904668|NCT00911183|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110904669|NCT00911183|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110904670|NCT00911183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110904671|NCT00911183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110904672|NCT00911183|Glucocorticoids|glucocorticoids|mesh-ancestor
110904673|NCT00911183|Hormones|hormones|mesh-ancestor
110904674|NCT00911183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110904675|NCT00911183|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110904676|NCT00911183|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110904677|NCT00911183|Tubulin Modulators|tubulin modulators|mesh-ancestor
110904678|NCT00911183|Antimitotic Agents|antimitotic agents|mesh-ancestor
110904679|NCT00911183|Mitosis Modulators|mitosis modulators|mesh-ancestor
110904680|NCT03631121|Insulin Glargine|insulin glargine|mesh-list
110904681|NCT03631121|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110904682|NCT03631121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110904683|NCT05420441|Chitosan|chitosan|mesh-list
110904684|NCT05420441|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110904685|NCT05420441|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110904686|NCT05420441|Antimetabolites|antimetabolites|mesh-ancestor
110904687|NCT05420441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110904688|NCT05420441|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110904689|NCT05420441|Chelating Agents|chelating agents|mesh-ancestor
110904690|NCT05420441|Sequestering Agents|sequestering agents|mesh-ancestor
110904691|NCT05420441|Hemostatics|hemostatics|mesh-ancestor
110904692|NCT05420441|Coagulants|coagulants|mesh-ancestor
110904693|NCT05598593|Cytarabine|cytarabine|mesh-list
110904694|NCT05598593|Fludarabine|fludarabine|mesh-list
110904695|NCT05598593|Busulfan|busulfan|mesh-list
110904696|NCT05598593|Thiotepa|thiotepa|mesh-list
110904697|NCT05598593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110904698|NCT05598593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110904699|NCT05598593|Antimetabolites|antimetabolites|mesh-ancestor
110904700|NCT05598593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110904701|NCT05598593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110904702|NCT05598593|Immunologic Factors|immunologic factors|mesh-ancestor
110904703|NCT05598593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110904704|NCT05598593|Antiviral Agents|antiviral agents|mesh-ancestor
110904705|NCT05598593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110904706|NCT05598593|Alkylating Agents|alkylating agents|mesh-ancestor
110904707|NCT05598593|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110904708|NCT05598593|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110904709|NCT05337449|Fluorides|fluorides|mesh-list
110904710|NCT05337449|Cariostatic Agents|cariostatic agents|mesh-ancestor
110904711|NCT05337449|Protective Agents|protective agents|mesh-ancestor
110904712|NCT05337449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110904713|NCT02150720|Tranexamic Acid|tranexamic acid|mesh-list
110904714|NCT02150720|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
110904715|NCT02150720|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110904716|NCT02150720|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110904717|NCT02150720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110904718|NCT02150720|Hemostatics|hemostatics|mesh-ancestor
110904719|NCT02150720|Coagulants|coagulants|mesh-ancestor
110904720|NCT02153060|Dexamethasone|dexamethasone|mesh-list
110204643|NCT00166465|Vitamins|vitamins|mesh-ancestor
110904721|NCT02153060|Dexamethasone acetate|dexamethasone acetate|mesh-list
110904722|NCT02153060|BB 1101|bb 1101|mesh-list
110904723|NCT02153060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110904724|NCT02153060|Antiemetics|antiemetics|mesh-ancestor
110904725|NCT02153060|Autonomic Agents|autonomic agents|mesh-ancestor
110904726|NCT02153060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110904727|NCT02153060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110904728|NCT02153060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110904729|NCT02153060|Glucocorticoids|glucocorticoids|mesh-ancestor
110904730|NCT02153060|Hormones|hormones|mesh-ancestor
110904731|NCT02153060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110904732|NCT02153060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110904733|NCT02153060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110904734|NCT02153060|Protease Inhibitors|protease inhibitors|mesh-ancestor
110904735|NCT02153060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110904736|NCT02153060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110904737|NCT02156570|Ribavirin|ribavirin|mesh-list
110904738|NCT02156570|Sofosbuvir|sofosbuvir|mesh-list
110904739|NCT02156570|Antimetabolites|antimetabolites|mesh-ancestor
110904740|NCT02156570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110904741|NCT02156570|Antiviral Agents|antiviral agents|mesh-ancestor
110904742|NCT02156570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110904743|NCT03087851|Zoledronic Acid|zoledronic acid|mesh-list
110904744|NCT03087851|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110904745|NCT03087851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110904746|NCT02156726|Cyclophosphamide|cyclophosphamide|mesh-list
110904747|NCT02156726|Fludarabine|fludarabine|mesh-list
110904748|NCT02156726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110904749|NCT02156726|Immunologic Factors|immunologic factors|mesh-ancestor
110904750|NCT02156726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110904751|NCT02156726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110904752|NCT02156726|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110904753|NCT02156726|Alkylating Agents|alkylating agents|mesh-ancestor
110904754|NCT02156726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110904755|NCT02156726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110904756|NCT02156726|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110904757|NCT02153450|Metformin|metformin|mesh-list
110904758|NCT02153450|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110622216|NCT04048226|Dexmedetomidine|dexmedetomidine|mesh-list
110904759|NCT02153450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110904760|NCT05598281|Sotorasib|sotorasib|mesh-list
110904761|NCT05598281|Digoxin|digoxin|mesh-list
110904762|NCT05598281|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110904763|NCT05598281|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110904764|NCT05598281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110904765|NCT05598281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110904766|NCT05598281|Protective Agents|protective agents|mesh-ancestor
110904767|NCT05598281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110904768|NCT05598281|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110904769|NCT05598281|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110904770|NCT05598281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110904772|NCT03092375|Antimetabolites|antimetabolites|mesh-ancestor
110904773|NCT03092375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110904774|NCT03092375|Antiviral Agents|antiviral agents|mesh-ancestor
110904775|NCT03092375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110904776|NCT01995513|Prednisone|prednisone|mesh-list
110904777|NCT01995513|Prednisolone|prednisolone|mesh-list
110904778|NCT01995513|Abiraterone Acetate|abiraterone acetate|mesh-list
110904779|NCT01995513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110904780|NCT01995513|Glucocorticoids|glucocorticoids|mesh-ancestor
110904781|NCT01995513|Hormones|hormones|mesh-ancestor
110204655|NCT00054236|Methylprednisolone|methylprednisolone|mesh-list
110904782|NCT01995513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110904783|NCT01995513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110904784|NCT01995513|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110904785|NCT01995513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110904786|NCT01995513|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110904787|NCT01995513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110904788|NCT01995513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110904789|NCT01995513|Hormone Antagonists|hormone antagonists|mesh-ancestor
110904790|NCT01995513|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110904791|NCT03180359|Vaccines|vaccines|mesh-list
110904792|NCT03180359|Immunologic Factors|immunologic factors|mesh-ancestor
110904793|NCT03180359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110904795|NCT01304511|Hormone Antagonists|hormone antagonists|mesh-ancestor
110904796|NCT01304511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110904797|NCT01304511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110904798|NCT04808973|Lamivudine|lamivudine|mesh-list
110904799|NCT04808973|Dolutegravir|dolutegravir|mesh-list
110904800|NCT04808973|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110904801|NCT04808973|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110904802|NCT04808973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110904803|NCT04808973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110904804|NCT04808973|Antiviral Agents|antiviral agents|mesh-ancestor
110904805|NCT04808973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110904806|NCT04808973|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110904807|NCT04808973|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110904808|NCT04808973|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110904809|NCT04808973|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110904810|NCT00103610|Plerixafor|plerixafor|mesh-list
110904811|NCT00103610|Lenograstim|lenograstim|mesh-list
110904812|NCT00103610|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110904813|NCT00103610|Immunologic Factors|immunologic factors|mesh-ancestor
110904814|NCT00103610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110904815|NCT00103610|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110904816|NCT00103610|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110904817|NCT00103610|Antiviral Agents|antiviral agents|mesh-ancestor
110904818|NCT00103610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110904819|NCT04871321|Paclitaxel|paclitaxel|mesh-list
110904820|NCT04871321|Gemcitabine|gemcitabine|mesh-list
110904821|NCT04871321|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110225267|NCT05995314|Caffeine|caffeine|mesh-list
110904822|NCT04871321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110904823|NCT04871321|Tubulin Modulators|tubulin modulators|mesh-ancestor
110904824|NCT04871321|Antimitotic Agents|antimitotic agents|mesh-ancestor
110904825|NCT04871321|Mitosis Modulators|mitosis modulators|mesh-ancestor
110904826|NCT04871321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110904827|NCT04871321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110904828|NCT04871321|Antimetabolites|antimetabolites|mesh-ancestor
110904829|NCT02156960|Denosumab|denosumab|mesh-list
110904830|NCT02156960|Teriparatide|teriparatide|mesh-list
110904831|NCT02156960|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110904832|NCT02156960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110904833|NCT02156960|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110904834|NCT02153606|Glycerol|glycerol|mesh-list
110904835|NCT02153606|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
110904836|NCT02153606|Protective Agents|protective agents|mesh-ancestor
110904837|NCT02153606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110904839|NCT02153762|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
110904840|NCT02153762|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
110904841|NCT02153762|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
110904842|NCT02153762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110904843|NCT04687631|Bevacizumab|bevacizumab|mesh-list
110904844|NCT04687631|Cetuximab|cetuximab|mesh-list
110904845|NCT04687631|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110904846|NCT04687631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110904847|NCT04687631|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110904848|NCT04687631|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110904849|NCT04687631|Growth Substances|growth substances|mesh-ancestor
110904850|NCT04687631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110904851|NCT04687631|Growth Inhibitors|growth inhibitors|mesh-ancestor
110904852|NCT04833023|Olanzapine|olanzapine|mesh-list
110904853|NCT04833023|Antiemetics|antiemetics|mesh-ancestor
110904854|NCT04833023|Autonomic Agents|autonomic agents|mesh-ancestor
110904855|NCT04833023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110925298|NCT03039673|Protective Agents|protective agents|mesh-ancestor
110925299|NCT02145624|Vaccines|vaccines|mesh-list
110904856|NCT04833023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110904857|NCT04833023|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110904859|NCT04833023|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110904860|NCT04833023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110904861|NCT04833023|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110904862|NCT04833023|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110904863|NCT04833023|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110904864|NCT04833023|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110904865|NCT04833023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110904866|NCT04833023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110904867|NCT04833023|Serotonin Agents|serotonin agents|mesh-ancestor
110904868|NCT03091439|Dalbavancin|dalbavancin|mesh-list
110904869|NCT03091439|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110904870|NCT03091439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110904871|NCT03631823|Temozolomide|temozolomide|mesh-list
110904872|NCT03631823|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110904873|NCT03631823|Alkylating Agents|alkylating agents|mesh-ancestor
110904874|NCT03631823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110904875|NCT03631823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110904876|NCT02157272|Rivaroxaban|rivaroxaban|mesh-list
110904877|NCT02157272|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110904878|NCT02157272|Antithrombins|antithrombins|mesh-ancestor
110904879|NCT02157272|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110904880|NCT02157272|Protease Inhibitors|protease inhibitors|mesh-ancestor
110904881|NCT02157272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110904882|NCT02157272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110904883|NCT02157272|Anticoagulants|anticoagulants|mesh-ancestor
110904884|NCT02154074|Dexmedetomidine|dexmedetomidine|mesh-list
110904885|NCT02154074|Isoflurane|isoflurane|mesh-list
110904886|NCT02154074|Anesthetics|anesthetics|mesh-ancestor
110904887|NCT02154074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110904888|NCT02154074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110904890|NCT02154074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110904891|NCT02154074|Analgesics|analgesics|mesh-ancestor
110904892|NCT02154074|Sensory System Agents|sensory system agents|mesh-ancestor
110904893|NCT02154074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110904894|NCT02154074|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110904895|NCT02154074|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110904896|NCT02154074|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110904897|NCT02154074|Adrenergic Agents|adrenergic agents|mesh-ancestor
110904898|NCT02154074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110904899|NCT02154074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110904900|NCT02154074|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110904901|NCT02154074|Anesthetics, General|anesthetics, general|mesh-ancestor
110904902|NCT05460455|Antibodies|antibodies|mesh-list
110904903|NCT05460455|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110904904|NCT05460455|Immunologic Factors|immunologic factors|mesh-ancestor
110904905|NCT05460455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110904906|NCT03104413|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110904907|NCT03104413|Immunologic Factors|immunologic factors|mesh-ancestor
110904908|NCT03104413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110904909|NCT01382147|Daunorubicin|daunorubicin|mesh-list
110904910|NCT01382147|Mitoxantrone|mitoxantrone|mesh-list
110622361|NCT00654732|Rituximab|rituximab|mesh-list
110904911|NCT01382147|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110904912|NCT01382147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110904913|NCT01382147|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110904914|NCT01382147|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110904915|NCT01382147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110904916|NCT01382147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110904917|NCT01382147|Analgesics|analgesics|mesh-ancestor
110904918|NCT01382147|Sensory System Agents|sensory system agents|mesh-ancestor
110904919|NCT01382147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110904920|NCT01382147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110904921|NCT01381835|Simeprevir|simeprevir|mesh-list
110904922|NCT01381835|Antiviral Agents|antiviral agents|mesh-ancestor
110904923|NCT01381835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110904924|NCT01381835|Protease Inhibitors|protease inhibitors|mesh-ancestor
110904925|NCT01381835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110904926|NCT01381835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110904927|NCT04429685|Ketamine|ketamine|mesh-list
110904928|NCT04429685|Analgesics|analgesics|mesh-ancestor
110904929|NCT04429685|Sensory System Agents|sensory system agents|mesh-ancestor
110904930|NCT04429685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110904931|NCT04429685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110904932|NCT04429685|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110904933|NCT04429685|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110904934|NCT04429685|Anesthetics, General|anesthetics, general|mesh-ancestor
110904935|NCT04429685|Anesthetics|anesthetics|mesh-ancestor
110904936|NCT04429685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110904937|NCT04429685|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110904938|NCT04429685|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110904939|NCT04429685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110904940|NCT04429685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110904941|NCT01384279|Metformin|metformin|mesh-list
110904942|NCT01384279|Topiramate|topiramate|mesh-list
110904943|NCT01384279|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110904944|NCT01384279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110904946|NCT01381601|Bevacizumab|bevacizumab|mesh-list
110904947|NCT01381601|Sunitinib|sunitinib|mesh-list
110904948|NCT01381601|Sorafenib|sorafenib|mesh-list
110904949|NCT01381601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110904950|NCT01381601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110904951|NCT01381601|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110904952|NCT01381601|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110904953|NCT01381601|Growth Substances|growth substances|mesh-ancestor
110904954|NCT01381601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110904955|NCT01381601|Growth Inhibitors|growth inhibitors|mesh-ancestor
110904956|NCT01381601|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110904957|NCT01381601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110904958|NCT01381601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110904959|NCT02823353|Fenofibrate|fenofibrate|mesh-list
110904960|NCT02823353|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110904961|NCT02823353|Antimetabolites|antimetabolites|mesh-ancestor
110904962|NCT02823353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110904963|NCT02823353|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110904964|NCT04509193|Warfarin|warfarin|mesh-list
110904965|NCT04509193|Rivaroxaban|rivaroxaban|mesh-list
110904966|NCT04509193|Anticoagulants|anticoagulants|mesh-ancestor
110904967|NCT04509193|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110904968|NCT04509193|Antithrombins|antithrombins|mesh-ancestor
110904969|NCT04509193|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110904970|NCT04509193|Protease Inhibitors|protease inhibitors|mesh-ancestor
110904971|NCT04509193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110904972|NCT04509193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110904973|NCT02697383|Dexamethasone|dexamethasone|mesh-list
110904974|NCT02697383|Ixazomib|ixazomib|mesh-list
110904975|NCT02697383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110904976|NCT02697383|Antiemetics|antiemetics|mesh-ancestor
110904977|NCT02697383|Autonomic Agents|autonomic agents|mesh-ancestor
110904978|NCT02697383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110904979|NCT02697383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110904980|NCT02697383|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110904981|NCT02697383|Glucocorticoids|glucocorticoids|mesh-ancestor
110904982|NCT02697383|Hormones|hormones|mesh-ancestor
110904983|NCT02697383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110904984|NCT02697383|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110904985|NCT02697383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110904986|NCT02697383|Protease Inhibitors|protease inhibitors|mesh-ancestor
110904987|NCT02697383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110904988|NCT02697383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110904989|NCT04173949|Ramipril|ramipril|mesh-list
110904990|NCT04173949|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110904991|NCT04173949|Protease Inhibitors|protease inhibitors|mesh-ancestor
110904992|NCT04173949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110904993|NCT04173949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110904994|NCT04173949|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110904995|NCT01382017|Lacosamide|lacosamide|mesh-list
110904997|NCT01382017|Anticonvulsants|anticonvulsants|mesh-ancestor
110904998|NCT01382017|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110904999|NCT01382017|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110905000|NCT01382017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110905001|NCT01382017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110905002|NCT01382017|Antimanic Agents|antimanic agents|mesh-ancestor
110905003|NCT01382017|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110905004|NCT01382017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110905005|NCT01382017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110905006|NCT01382017|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110905007|NCT01382017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110905008|NCT01382017|Analgesics|analgesics|mesh-ancestor
110905009|NCT01382017|Sensory System Agents|sensory system agents|mesh-ancestor
110905010|NCT01382017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110905011|NCT01382017|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110905012|NCT01382017|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110905013|NCT01381523|Naproxen|naproxen|mesh-list
110905014|NCT01381523|Sumatriptan|sumatriptan|mesh-list
110204722|NCT00054431|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110905015|NCT01381523|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110905016|NCT01381523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110905017|NCT01381523|Analgesics|analgesics|mesh-ancestor
110905018|NCT01381523|Sensory System Agents|sensory system agents|mesh-ancestor
110905019|NCT01381523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110905020|NCT01381523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110905021|NCT01381523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110905022|NCT01381523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110905023|NCT01381523|Gout Suppressants|gout suppressants|mesh-ancestor
110905024|NCT01381523|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110905025|NCT01381523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110905026|NCT01381523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110905027|NCT01381523|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110905028|NCT01381523|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110905029|NCT01381523|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110905030|NCT01381523|Serotonin Agents|serotonin agents|mesh-ancestor
110905031|NCT01381523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110905032|NCT04233047|Fostemsavir|fostemsavir|mesh-list
110905033|NCT04233047|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110905034|NCT04233047|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110905035|NCT04233047|Antiviral Agents|antiviral agents|mesh-ancestor
110905036|NCT04233047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110905037|NCT04233047|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110905038|NCT04233047|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110905039|NCT04233047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110905040|NCT01381445|Clobetasol|clobetasol|mesh-list
110905041|NCT01381445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110905042|NCT01381445|Glucocorticoids|glucocorticoids|mesh-ancestor
110905043|NCT01381445|Hormones|hormones|mesh-ancestor
110905044|NCT01381445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110905045|NCT01381445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110905046|NCT03083639|Esomeprazole|esomeprazole|mesh-list
110905047|NCT03083639|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110905048|NCT03083639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110905049|NCT03083639|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110905050|NCT03083639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110905051|NCT03083639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110905052|NCT02927431|Oseltamivir|oseltamivir|mesh-list
110905053|NCT02927431|Antiviral Agents|antiviral agents|mesh-ancestor
110905054|NCT02927431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110905055|NCT02927431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110905056|NCT02927431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110905057|NCT05027893|Moxifloxacin|moxifloxacin|mesh-list
110905058|NCT05027893|Cefixime|cefixime|mesh-list
110905059|NCT05027893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110905060|NCT05027893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110905061|NCT05027893|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110905062|NCT05027893|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110905063|NCT05027893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110905064|NCT05027893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110905065|NCT05027893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110905066|NCT04113083|Dehydrocholesterols|dehydrocholesterols|mesh-list
110905069|NCT04113083|Micronutrients|micronutrients|mesh-ancestor
110905070|NCT04113083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110905071|NCT01381367|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110905072|NCT01381367|Immunologic Factors|immunologic factors|mesh-ancestor
110905073|NCT01381367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110905074|NCT04989361|Hyaluronic Acid|hyaluronic acid|mesh-list
110905075|NCT04989361|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110905076|NCT04989361|Immunologic Factors|immunologic factors|mesh-ancestor
110905077|NCT04989361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110905078|NCT04989361|Viscosupplements|viscosupplements|mesh-ancestor
110905079|NCT04989361|Protective Agents|protective agents|mesh-ancestor
110905080|NCT01381289|Ivacaftor|ivacaftor|mesh-list
110905081|NCT01381289|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
110905082|NCT01381289|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110905083|NCT01381289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110905084|NCT04899193|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
110905085|NCT04899193|Hormones|hormones|mesh-ancestor
110905086|NCT04899193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110905087|NCT04899193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110905088|NCT01381705|Rituximab|rituximab|mesh-list
110905089|NCT01381705|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110905090|NCT01381705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110905091|NCT01381705|Immunologic Factors|immunologic factors|mesh-ancestor
110905092|NCT01381705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110905093|NCT01381705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110905094|NCT04401709|Gemcitabine|gemcitabine|mesh-list
110905095|NCT04401709|Capecitabine|capecitabine|mesh-list
110905096|NCT04401709|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110905097|NCT04401709|Antimetabolites|antimetabolites|mesh-ancestor
110905098|NCT04401709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110905099|NCT04401709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110905101|NCT04497987|Antiviral Agents|antiviral agents|mesh-ancestor
110905102|NCT04497987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110905103|NCT01381627|Dexmedetomidine|dexmedetomidine|mesh-list
110905104|NCT01381627|Remifentanil|remifentanil|mesh-list
110905105|NCT01381627|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110905106|NCT01381627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110905107|NCT01381627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110905108|NCT01381627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110905109|NCT01381627|Analgesics|analgesics|mesh-ancestor
110905110|NCT01381627|Sensory System Agents|sensory system agents|mesh-ancestor
110905111|NCT01381627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110905112|NCT01381627|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110905113|NCT01381627|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110905114|NCT01381627|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110905115|NCT01381627|Adrenergic Agents|adrenergic agents|mesh-ancestor
110905116|NCT01381627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110905117|NCT01381627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110905118|NCT01381627|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110905119|NCT01381627|Narcotics|narcotics|mesh-ancestor
110905120|NCT00974571|Cetirizine|cetirizine|mesh-list
110905121|NCT00974571|Montelukast|montelukast|mesh-list
110905122|NCT00974571|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110905123|NCT00974571|Respiratory System Agents|respiratory system agents|mesh-ancestor
110905124|NCT00974571|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110905125|NCT00974571|Hormone Antagonists|hormone antagonists|mesh-ancestor
110905126|NCT00974571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110905127|NCT00974571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110905128|NCT00974571|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110905129|NCT00974571|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110905130|NCT00974571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110905131|NCT00974571|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110225341|NCT05990985|Analgesics|analgesics|mesh-ancestor
110905132|NCT00974571|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110905134|NCT00974571|Histamine Antagonists|histamine antagonists|mesh-ancestor
110905135|NCT00974571|Histamine Agents|histamine agents|mesh-ancestor
110905136|NCT00974571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110905137|NCT02766608|Budesonide|budesonide|mesh-list
110905138|NCT02766608|Formoterol Fumarate|formoterol fumarate|mesh-list
110905139|NCT02766608|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
110905140|NCT02766608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110905141|NCT02766608|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110905142|NCT02766608|Autonomic Agents|autonomic agents|mesh-ancestor
110905143|NCT02766608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110905144|NCT02766608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110905145|NCT02766608|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110905146|NCT02766608|Respiratory System Agents|respiratory system agents|mesh-ancestor
110905147|NCT02766608|Glucocorticoids|glucocorticoids|mesh-ancestor
110905148|NCT02766608|Hormones|hormones|mesh-ancestor
110905149|NCT02766608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110905150|NCT02766608|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110905151|NCT02766608|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110905152|NCT02766608|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110905153|NCT02766608|Adrenergic Agents|adrenergic agents|mesh-ancestor
110905154|NCT02766608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110905155|NCT02766608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110905156|NCT01382407|Cetuximab|cetuximab|mesh-list
110905157|NCT01382407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110905158|NCT01382407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110905159|NCT02235857|Dextrans|dextrans|mesh-list
110905160|NCT02235857|Anticoagulants|anticoagulants|mesh-ancestor
110905161|NCT02235857|Plasma Substitutes|plasma substitutes|mesh-ancestor
110905162|NCT02235857|Blood Substitutes|blood substitutes|mesh-ancestor
110905163|NCT05082285|Vaccines|vaccines|mesh-list
110905164|NCT05082285|Immunologic Factors|immunologic factors|mesh-ancestor
110905165|NCT05082285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110905166|NCT03317119|Trifluridine|trifluridine|mesh-list
110905167|NCT03317119|Trametinib|trametinib|mesh-list
110905168|NCT03317119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110905169|NCT03317119|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110905170|NCT03317119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110905171|NCT03317119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110905172|NCT03317119|Antimetabolites|antimetabolites|mesh-ancestor
110905173|NCT03317119|Antiviral Agents|antiviral agents|mesh-ancestor
110905174|NCT03317119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110905175|NCT04356495|Ciclesonide|ciclesonide|mesh-list
110905176|NCT04356495|Interferons|interferons|mesh-list
110905177|NCT04356495|Interferon-beta|interferon-beta|mesh-list
110905178|NCT04356495|Telmisartan|telmisartan|mesh-list
110905179|NCT04356495|Interferon beta-1b|interferon beta-1b|mesh-list
110905180|NCT04356495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110905181|NCT04356495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110905182|NCT04356495|Antiviral Agents|antiviral agents|mesh-ancestor
110905183|NCT04356495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110905184|NCT04356495|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110905185|NCT04356495|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110905186|NCT04356495|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110905187|NCT04356495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110905188|NCT04356495|Glucocorticoids|glucocorticoids|mesh-ancestor
110905189|NCT04356495|Hormones|hormones|mesh-ancestor
110905190|NCT04356495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110905191|NCT04356495|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110905192|NCT04356495|Immunologic Factors|immunologic factors|mesh-ancestor
110905193|NCT04356495|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110905194|NCT05345249|Ropivacaine|ropivacaine|mesh-list
110905195|NCT05345249|Anesthetics, Local|anesthetics, local|mesh-ancestor
110905196|NCT05345249|Anesthetics|anesthetics|mesh-ancestor
110905197|NCT05345249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110905198|NCT05345249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110905199|NCT05345249|Sensory System Agents|sensory system agents|mesh-ancestor
110905200|NCT05345249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110905201|NCT02154230|Calcium|calcium|mesh-list
110905202|NCT02154230|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110225345|NCT05990985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110905203|NCT02154230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110905205|NCT04200963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110905206|NCT04200963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110905207|NCT04200963|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110905208|NCT04200963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110905209|NCT02157428|Flumazenil|flumazenil|mesh-list
110905210|NCT02157428|Antidotes|antidotes|mesh-ancestor
110905211|NCT02157428|Protective Agents|protective agents|mesh-ancestor
110905212|NCT02157428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110905213|NCT02157428|GABA Modulators|gaba modulators|mesh-ancestor
110905214|NCT02157428|GABA Agents|gaba agents|mesh-ancestor
110905215|NCT02157428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110905216|NCT02157428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110905217|NCT00960141|Loratadine|loratadine|mesh-list
110905218|NCT00960141|Montelukast|montelukast|mesh-list
110905219|NCT00960141|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110905220|NCT00960141|Respiratory System Agents|respiratory system agents|mesh-ancestor
110905221|NCT00960141|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110905222|NCT00960141|Hormone Antagonists|hormone antagonists|mesh-ancestor
110905223|NCT00960141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110905224|NCT00960141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110925391|NCT05053594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110905225|NCT00960141|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110905226|NCT00960141|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110905227|NCT00960141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110905228|NCT00960141|Antipruritics|antipruritics|mesh-ancestor
110905229|NCT00960141|Dermatologic Agents|dermatologic agents|mesh-ancestor
110905230|NCT00960141|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110905231|NCT00960141|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110905232|NCT00960141|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110905233|NCT00960141|Histamine Antagonists|histamine antagonists|mesh-ancestor
110905234|NCT00960141|Histamine Agents|histamine agents|mesh-ancestor
110905235|NCT00960141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110905236|NCT00759655|Factor VIII|factor viii|mesh-list
110905237|NCT00759655|Coagulants|coagulants|mesh-ancestor
110905238|NCT02255006|Glyburide|glyburide|mesh-list
110905239|NCT02255006|Celecoxib|celecoxib|mesh-list
110905240|NCT02255006|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110905241|NCT02255006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110905242|NCT02255006|Analgesics|analgesics|mesh-ancestor
110905243|NCT02255006|Sensory System Agents|sensory system agents|mesh-ancestor
110905244|NCT02255006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110905245|NCT02255006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110905246|NCT02255006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110905247|NCT02255006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110905248|NCT02255006|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110905249|NCT02255006|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110905250|NCT02255006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110905251|NCT02255006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110905252|NCT02255006|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110905253|NCT03396471|Pembrolizumab|pembrolizumab|mesh-list
110905254|NCT03396471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110905255|NCT03396471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110905256|NCT03396471|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110905257|NCT03396471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110905258|NCT00103142|Sargramostim|sargramostim|mesh-list
110905259|NCT00103142|Immunologic Factors|immunologic factors|mesh-ancestor
110905260|NCT00103142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110905261|NCT00943683|Montelukast|montelukast|mesh-list
110905262|NCT00943683|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110905263|NCT00943683|Respiratory System Agents|respiratory system agents|mesh-ancestor
110905264|NCT00943683|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110905265|NCT00943683|Hormone Antagonists|hormone antagonists|mesh-ancestor
110905266|NCT00943683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110905267|NCT00943683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110905268|NCT00943683|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110905269|NCT00943683|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110905270|NCT00943683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110905271|NCT03542006|Brinzolamide|brinzolamide|mesh-list
110905272|NCT03542006|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110905273|NCT03542006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110905274|NCT03542006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110905275|NCT02154464|Acetaminophen|acetaminophen|mesh-list
110905276|NCT02154464|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110905277|NCT02154464|Analgesics|analgesics|mesh-ancestor
110905278|NCT02154464|Sensory System Agents|sensory system agents|mesh-ancestor
110905279|NCT02154464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110905280|NCT02154464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110905281|NCT02154464|Antipyretics|antipyretics|mesh-ancestor
110905282|NCT00911547|Beclomethasone|beclomethasone|mesh-list
110905283|NCT00911547|Montelukast|montelukast|mesh-list
110905284|NCT00911547|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110905285|NCT00911547|Respiratory System Agents|respiratory system agents|mesh-ancestor
110905286|NCT00911547|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110905287|NCT00911547|Hormone Antagonists|hormone antagonists|mesh-ancestor
110905288|NCT00911547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110905289|NCT00911547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110905290|NCT00911547|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110905291|NCT00911547|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110905292|NCT00911547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110905293|NCT00911547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110905294|NCT00911547|Glucocorticoids|glucocorticoids|mesh-ancestor
110905295|NCT00911547|Hormones|hormones|mesh-ancestor
110905296|NCT02159690|Prednisone|prednisone|mesh-list
110905297|NCT02159690|Abiraterone Acetate|abiraterone acetate|mesh-list
110905298|NCT02159690|Dutasteride|dutasteride|mesh-list
110905299|NCT02159690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110905300|NCT02159690|Glucocorticoids|glucocorticoids|mesh-ancestor
110905301|NCT02159690|Hormones|hormones|mesh-ancestor
110905302|NCT02159690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110905303|NCT02159690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110905304|NCT02159690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110905305|NCT02159690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110905306|NCT02159690|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110905307|NCT02159690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110905308|NCT02159690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110905309|NCT02159690|Hormone Antagonists|hormone antagonists|mesh-ancestor
110905310|NCT02159690|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110905311|NCT02159690|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
110905312|NCT02157818|Midazolam|midazolam|mesh-list
110905313|NCT02157818|Dexmedetomidine|dexmedetomidine|mesh-list
110905314|NCT02157818|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110905315|NCT02157818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110905316|NCT02157818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110905317|NCT02157818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110905318|NCT02157818|Analgesics|analgesics|mesh-ancestor
110905319|NCT02157818|Sensory System Agents|sensory system agents|mesh-ancestor
110905320|NCT02157818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110905321|NCT02157818|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110905322|NCT02157818|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110905323|NCT02157818|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110905324|NCT02157818|Adrenergic Agents|adrenergic agents|mesh-ancestor
110905325|NCT02157818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110905326|NCT02157818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110905327|NCT02157818|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110905328|NCT02157818|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110905329|NCT02157818|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110905330|NCT02157818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110905331|NCT02157818|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110905332|NCT02157818|Anesthetics, General|anesthetics, general|mesh-ancestor
110905333|NCT02157818|Anesthetics|anesthetics|mesh-ancestor
110905334|NCT02157818|GABA Modulators|gaba modulators|mesh-ancestor
110905335|NCT02157818|GABA Agents|gaba agents|mesh-ancestor
110905336|NCT00899379|Rizatriptan|rizatriptan|mesh-list
110905337|NCT00899379|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110905338|NCT00899379|Serotonin Agents|serotonin agents|mesh-ancestor
110905339|NCT00899379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110905340|NCT00899379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110905341|NCT00899379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110905342|NCT04326439|Cytarabine|cytarabine|mesh-list
110905343|NCT04326439|Etoposide|etoposide|mesh-list
110905344|NCT04326439|Daunorubicin|daunorubicin|mesh-list
110905345|NCT04326439|Sorafenib|sorafenib|mesh-list
110905346|NCT04326439|Asparaginase|asparaginase|mesh-list
110905347|NCT04326439|Gemtuzumab|gemtuzumab|mesh-list
110905348|NCT04326439|Calicheamicins|calicheamicins|mesh-list
110905349|NCT04326439|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110905350|NCT04326439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110905351|NCT04326439|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110905352|NCT04326439|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110905353|NCT04326439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110905354|NCT04326439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110622817|NCT00773084|Lisinopril|lisinopril|mesh-list
110905355|NCT04326439|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110905357|NCT04326439|Antiviral Agents|antiviral agents|mesh-ancestor
110905358|NCT04326439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110905359|NCT04326439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110905360|NCT04326439|Immunologic Factors|immunologic factors|mesh-ancestor
110905361|NCT04326439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110905362|NCT04326439|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110905363|NCT04326439|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110227741|NCT04416984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110905364|NCT04326439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110905365|NCT04326439|Immunotoxins|immunotoxins|mesh-ancestor
110905366|NCT04326439|Immunoconjugates|immunoconjugates|mesh-ancestor
110905367|NCT03541928|Valacyclovir|valacyclovir|mesh-list
110905368|NCT03541928|Leuprolide|leuprolide|mesh-list
110905369|NCT03541928|Bicalutamide|bicalutamide|mesh-list
110905370|NCT03541928|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110905371|NCT03541928|Fertility Agents|fertility agents|mesh-ancestor
110905372|NCT03541928|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110905373|NCT03541928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110905374|NCT03541928|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110905375|NCT03541928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110905376|NCT03541928|Androgen Antagonists|androgen antagonists|mesh-ancestor
110905377|NCT03541928|Hormone Antagonists|hormone antagonists|mesh-ancestor
110905378|NCT03541928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110905379|NCT03541928|Antiviral Agents|antiviral agents|mesh-ancestor
110905380|NCT03541928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110905381|NCT00145795|Ritonavir|ritonavir|mesh-list
110905382|NCT00145795|Lopinavir|lopinavir|mesh-list
110905383|NCT00145795|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110905384|NCT00145795|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110905385|NCT00145795|Protease Inhibitors|protease inhibitors|mesh-ancestor
110905386|NCT00145795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110905387|NCT00145795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110905388|NCT00145795|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110905389|NCT00145795|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110905390|NCT00145795|Antiviral Agents|antiviral agents|mesh-ancestor
110905391|NCT00145795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110905392|NCT00145795|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110905393|NCT00145795|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110905394|NCT02771210|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110905395|NCT02771210|Immunologic Factors|immunologic factors|mesh-ancestor
110905396|NCT02771210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110905397|NCT00898677|Sumatriptan|sumatriptan|mesh-list
110905398|NCT00898677|Rizatriptan|rizatriptan|mesh-list
110905399|NCT00898677|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110905400|NCT00898677|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110905401|NCT00898677|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110905402|NCT00898677|Serotonin Agents|serotonin agents|mesh-ancestor
110905403|NCT00898677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110905404|NCT00898677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110905405|NCT00898677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110905406|NCT01381393|Ibandronic Acid|ibandronic acid|mesh-list
110905407|NCT01381393|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110905408|NCT01381393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110905410|NCT02154776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110905411|NCT02154776|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110905412|NCT02154776|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110905413|NCT02154776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110225353|NCT05989503|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110905414|NCT02154776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110905415|NCT02154776|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110905416|NCT02154776|Hormone Antagonists|hormone antagonists|mesh-ancestor
110905417|NCT02154776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110204839|NCT00045591|Celecoxib|celecoxib|mesh-list
110905418|NCT02154776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110905419|NCT04967157|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
110905420|NCT04967157|Nootropic Agents|nootropic agents|mesh-ancestor
110905422|NCT03388749|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110905423|NCT03388749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110905424|NCT02770820|Aldesleukin|aldesleukin|mesh-list
110905425|NCT02770820|Interleukin-2|interleukin-2|mesh-list
110905426|NCT02770820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110905427|NCT02770820|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110905428|NCT02770820|Analgesics|analgesics|mesh-ancestor
110905429|NCT02770820|Sensory System Agents|sensory system agents|mesh-ancestor
110622891|NCT02556866|Glucocorticoids|glucocorticoids|mesh-ancestor
110905430|NCT02770820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110905431|NCT02770820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110905433|NCT02770820|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110905434|NCT02770820|Antiviral Agents|antiviral agents|mesh-ancestor
110905435|NCT02770820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110905436|NCT02154854|Tacrolimus|tacrolimus|mesh-list
110905437|NCT02154854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110905438|NCT02154854|Immunologic Factors|immunologic factors|mesh-ancestor
110905439|NCT02154854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110905440|NCT02154854|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110905441|NCT02154854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110905442|NCT02154854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110905443|NCT02160080|Interferons|interferons|mesh-list
110905444|NCT02160080|Ribavirin|ribavirin|mesh-list
110905445|NCT02160080|Interferon-alpha|interferon-alpha|mesh-list
110905446|NCT02160080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110905447|NCT02160080|Antiviral Agents|antiviral agents|mesh-ancestor
110905448|NCT02160080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110905449|NCT02160080|Antimetabolites|antimetabolites|mesh-ancestor
110905450|NCT02160080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110905451|NCT02160080|Immunologic Factors|immunologic factors|mesh-ancestor
110905452|NCT02160080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110905453|NCT05422183|Lenvatinib|lenvatinib|mesh-list
110905454|NCT05422183|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
110905455|NCT05422183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110905456|NCT05422183|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110905457|NCT05422183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110905458|NCT05422183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110905459|NCT02160158|Fesoterodine|fesoterodine|mesh-list
110905460|NCT02160158|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110905461|NCT02160158|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110905462|NCT02160158|Cholinergic Agents|cholinergic agents|mesh-ancestor
110905463|NCT02160158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110905464|NCT02160158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110905465|NCT02160158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110925440|NCT00108732|Goserelin|goserelin|mesh-list
110905466|NCT02160158|Urological Agents|urological agents|mesh-ancestor
110905467|NCT02160236|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
110905469|NCT02160236|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110905470|NCT02160236|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110905471|NCT02160236|Analgesics|analgesics|mesh-ancestor
110905472|NCT02160236|Sensory System Agents|sensory system agents|mesh-ancestor
110905473|NCT02160236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110905474|NCT02160236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110905475|NCT02160236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110905476|NCT02160236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110905477|NCT02160236|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110905478|NCT02160236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110905479|NCT02160236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110905480|NCT02154932|Misoprostol|misoprostol|mesh-list
110905481|NCT02154932|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110905482|NCT02154932|Abortifacient Agents|abortifacient agents|mesh-ancestor
110905483|NCT02154932|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110253985|NCT00506623|Irinotecan|irinotecan|mesh-list
110905485|NCT02154932|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110905486|NCT02154932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110905487|NCT02154932|Oxytocics|oxytocics|mesh-ancestor
110905488|NCT02158286|Acetaminophen|acetaminophen|mesh-list
110905489|NCT02158286|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110905490|NCT02158286|Analgesics|analgesics|mesh-ancestor
110905491|NCT02158286|Sensory System Agents|sensory system agents|mesh-ancestor
110905492|NCT02158286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110905493|NCT02158286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110905494|NCT02158286|Antipyretics|antipyretics|mesh-ancestor
110905495|NCT01377415|Bupivacaine|bupivacaine|mesh-list
110905496|NCT01377415|Anesthetics, Local|anesthetics, local|mesh-ancestor
110905497|NCT01377415|Anesthetics|anesthetics|mesh-ancestor
110905498|NCT01377415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110905499|NCT01377415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110905500|NCT01377415|Sensory System Agents|sensory system agents|mesh-ancestor
110905501|NCT01377415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110905502|NCT02155088|Paclitaxel|paclitaxel|mesh-list
110905503|NCT02155088|Gemcitabine|gemcitabine|mesh-list
110622962|NCT00307801|Contraceptive Agents|contraceptive agents|mesh-ancestor
110905504|NCT02155088|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110905505|NCT02155088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110905506|NCT02155088|Tubulin Modulators|tubulin modulators|mesh-ancestor
110905507|NCT02155088|Antimitotic Agents|antimitotic agents|mesh-ancestor
110905508|NCT02155088|Mitosis Modulators|mitosis modulators|mesh-ancestor
110905509|NCT02155088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110905510|NCT02155088|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110905511|NCT02155088|Antimetabolites|antimetabolites|mesh-ancestor
110905512|NCT02160548|Atropine|atropine|mesh-list
110905513|NCT02160548|Albuterol|albuterol|mesh-list
110905514|NCT02160548|Pralidoxime|pralidoxime|mesh-list
110905515|NCT02160548|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110905516|NCT02160548|Autonomic Agents|autonomic agents|mesh-ancestor
110905517|NCT02160548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110905518|NCT02160548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110905519|NCT02160548|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110905520|NCT02160548|Respiratory System Agents|respiratory system agents|mesh-ancestor
110905521|NCT02160548|Tocolytic Agents|tocolytic agents|mesh-ancestor
110905522|NCT02160548|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110905523|NCT02160548|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110905524|NCT02160548|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110905525|NCT02160548|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110905526|NCT02160548|Adrenergic Agents|adrenergic agents|mesh-ancestor
110905527|NCT02160548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110905528|NCT02160548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110905529|NCT02160548|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110925455|NCT02319200|Metformin|metformin|mesh-list
110905530|NCT02160548|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110905531|NCT02160548|Mydriatics|mydriatics|mesh-ancestor
110905532|NCT02160548|Parasympatholytics|parasympatholytics|mesh-ancestor
110905533|NCT02160548|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110905534|NCT02160548|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110905535|NCT02160548|Cholinergic Agents|cholinergic agents|mesh-ancestor
110905536|NCT02160548|Antidotes|antidotes|mesh-ancestor
110905537|NCT02160548|Protective Agents|protective agents|mesh-ancestor
110905538|NCT02160548|Cholinesterase Reactivators|cholinesterase reactivators|mesh-ancestor
110905539|NCT02160548|Enzyme Reactivators|enzyme reactivators|mesh-ancestor
110905540|NCT02158598|Vitamin D|vitamin d|mesh-list
110905541|NCT02158598|Ergocalciferols|ergocalciferols|mesh-list
110905542|NCT02158598|Cholecalciferol|cholecalciferol|mesh-list
110905543|NCT02158598|Vitamins|vitamins|mesh-list
110905544|NCT02158598|Micronutrients|micronutrients|mesh-ancestor
110905545|NCT02158598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110905546|NCT02158598|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110905547|NCT02158598|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110905548|NCT03082729|Apremilast|apremilast|mesh-list
110905549|NCT03082729|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110905550|NCT03082729|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110905551|NCT03082729|Analgesics|analgesics|mesh-ancestor
110905552|NCT03082729|Sensory System Agents|sensory system agents|mesh-ancestor
110905553|NCT03082729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110905554|NCT03082729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110905555|NCT03082729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110905556|NCT03082729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110905557|NCT03082729|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
110905558|NCT03082729|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110905559|NCT03082729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110905560|NCT03082729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110905561|NCT02160704|Enclomiphene|enclomiphene|mesh-list
110905563|NCT02160704|Zuclomiphene|zuclomiphene|mesh-list
110905564|NCT02160704|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110905565|NCT02160704|Hormone Antagonists|hormone antagonists|mesh-ancestor
110905566|NCT02160704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110905567|NCT02160704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110905568|NCT02160704|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110905569|NCT02160704|Fertility Agents|fertility agents|mesh-ancestor
110905570|NCT02160704|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110905571|NCT02160704|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110905572|NCT02160704|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110905573|NCT03542552|Magnesium Sulfate|magnesium sulfate|mesh-list
110905574|NCT03542552|Nifedipine|nifedipine|mesh-list
110905575|NCT03542552|Analgesics|analgesics|mesh-ancestor
110905576|NCT03542552|Sensory System Agents|sensory system agents|mesh-ancestor
110905577|NCT03542552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110623036|NCT00773630|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110905578|NCT03542552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110905579|NCT03542552|Anesthetics|anesthetics|mesh-ancestor
110905580|NCT03542552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110905581|NCT03542552|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110905582|NCT03542552|Anticonvulsants|anticonvulsants|mesh-ancestor
110905583|NCT03542552|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110905584|NCT03542552|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110905585|NCT03542552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110905586|NCT03542552|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110905587|NCT03542552|Tocolytic Agents|tocolytic agents|mesh-ancestor
110905588|NCT03542552|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110905589|NCT03542552|Vasodilator Agents|vasodilator agents|mesh-ancestor
110905590|NCT02155166|Ibuprofen|ibuprofen|mesh-list
110905591|NCT02155166|Lidocaine|lidocaine|mesh-list
110905592|NCT02155166|Anesthetics, Local|anesthetics, local|mesh-ancestor
110905593|NCT02155166|Anesthetics|anesthetics|mesh-ancestor
110925469|NCT02321852|Mannitol|mannitol|mesh-list
110905594|NCT02155166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110905595|NCT02155166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110905596|NCT02155166|Sensory System Agents|sensory system agents|mesh-ancestor
110905597|NCT02155166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110905598|NCT02155166|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110905599|NCT02155166|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110905600|NCT02155166|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110905601|NCT02155166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110905602|NCT02155166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110905603|NCT02155166|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110905604|NCT02155166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110905605|NCT02155166|Analgesics|analgesics|mesh-ancestor
110905606|NCT02155166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110905607|NCT02155166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110905608|NCT02155166|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110905609|NCT02155166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110905610|NCT00398931|Alendronate|alendronate|mesh-list
110905611|NCT00398931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110905612|NCT00398931|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110905613|NCT00920361|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
110905614|NCT00920361|Hormones|hormones|mesh-ancestor
110905615|NCT00920361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110905616|NCT00920361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110905618|NCT00651807|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110905619|NCT00651807|Contraceptive Agents|contraceptive agents|mesh-ancestor
110905620|NCT00651807|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110905621|NCT00651807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110905622|NCT00651807|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110905623|NCT03246529|Lenograstim|lenograstim|mesh-list
110905624|NCT03246529|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110905625|NCT03246529|Immunologic Factors|immunologic factors|mesh-ancestor
110905626|NCT03246529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110905627|NCT02158910|Donepezil|donepezil|mesh-list
110905628|NCT02158910|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110905629|NCT02158910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110905630|NCT02158910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110905631|NCT02158910|Cholinergic Agents|cholinergic agents|mesh-ancestor
110905632|NCT02158910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110905633|NCT02158910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110905634|NCT02158910|Nootropic Agents|nootropic agents|mesh-ancestor
110905635|NCT03077659|Paclitaxel|paclitaxel|mesh-list
110905636|NCT03077659|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110905637|NCT03077659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110905638|NCT03077659|Tubulin Modulators|tubulin modulators|mesh-ancestor
110905639|NCT03077659|Antimitotic Agents|antimitotic agents|mesh-ancestor
110905640|NCT03077659|Mitosis Modulators|mitosis modulators|mesh-ancestor
110905641|NCT03077659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110905642|NCT05052723|Pembrolizumab|pembrolizumab|mesh-list
110905643|NCT05052723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110905644|NCT05052723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110905645|NCT05052723|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110905646|NCT05052723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110905647|NCT02807883|Blinatumomab|blinatumomab|mesh-list
110905648|NCT02807883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110905649|NCT04051047|Gemcitabine|gemcitabine|mesh-list
110905650|NCT04051047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110905651|NCT04051047|Antimetabolites|antimetabolites|mesh-ancestor
110905652|NCT04051047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110905653|NCT04051047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110905655|NCT00102440|Febuxostat|febuxostat|mesh-list
110905656|NCT00102440|Antimetabolites|antimetabolites|mesh-ancestor
110905657|NCT00102440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110905658|NCT00102440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110905659|NCT00102440|Gout Suppressants|gout suppressants|mesh-ancestor
110905660|NCT00102440|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110905661|NCT00102440|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110905662|NCT00102440|Antioxidants|antioxidants|mesh-ancestor
110905663|NCT00102440|Protective Agents|protective agents|mesh-ancestor
110905664|NCT00102440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110905665|NCT05224167|Melatonin|melatonin|mesh-list
110905666|NCT05224167|Hydroxyzine|hydroxyzine|mesh-list
110905667|NCT05224167|Antioxidants|antioxidants|mesh-ancestor
110905668|NCT05224167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110905669|NCT05224167|Protective Agents|protective agents|mesh-ancestor
110905670|NCT05224167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110905671|NCT05224167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110905672|NCT05224167|Antipruritics|antipruritics|mesh-ancestor
110905673|NCT05224167|Dermatologic Agents|dermatologic agents|mesh-ancestor
110905674|NCT05224167|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110905675|NCT05224167|Histamine Antagonists|histamine antagonists|mesh-ancestor
110905676|NCT05224167|Histamine Agents|histamine agents|mesh-ancestor
110905677|NCT05224167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110905679|NCT01377259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110905680|NCT01377259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110905681|NCT04994535|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110905682|NCT04994535|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110905683|NCT04994535|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110905684|NCT04994535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110905685|NCT04994535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110905686|NCT04994535|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110905687|NCT04994535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110905688|NCT04994535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110905689|NCT04994535|Cholinergic Agents|cholinergic agents|mesh-ancestor
110905690|NCT04994535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110905691|NCT03909607|Ketamine|ketamine|mesh-list
110905692|NCT03909607|Analgesics|analgesics|mesh-ancestor
110905693|NCT03909607|Sensory System Agents|sensory system agents|mesh-ancestor
110905694|NCT03909607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110905695|NCT03909607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110905696|NCT03909607|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110905697|NCT03909607|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110905698|NCT03909607|Anesthetics, General|anesthetics, general|mesh-ancestor
110905699|NCT03909607|Anesthetics|anesthetics|mesh-ancestor
110905700|NCT03909607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110905701|NCT03909607|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110905702|NCT03909607|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110905703|NCT03909607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110905704|NCT03909607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110905705|NCT03902509|Pirfenidone|pirfenidone|mesh-list
110905706|NCT03902509|Analgesics|analgesics|mesh-ancestor
110905707|NCT03902509|Sensory System Agents|sensory system agents|mesh-ancestor
110905708|NCT03902509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110905709|NCT03902509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110905710|NCT03902509|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110905711|NCT03902509|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110905712|NCT03902509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110905713|NCT03902509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110905714|NCT03902509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110905716|NCT02166632|Anesthetics, Local|anesthetics, local|mesh-ancestor
110905717|NCT02166632|Anesthetics|anesthetics|mesh-ancestor
110905718|NCT02166632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110905719|NCT02166632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110905720|NCT02166632|Sensory System Agents|sensory system agents|mesh-ancestor
110905721|NCT02166632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110905722|NCT02161952|Pirfenidone|pirfenidone|mesh-list
110905723|NCT02161952|Analgesics|analgesics|mesh-ancestor
110905724|NCT02161952|Sensory System Agents|sensory system agents|mesh-ancestor
110905725|NCT02161952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110905726|NCT02161952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110905727|NCT02161952|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110905728|NCT02161952|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110905729|NCT02161952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110905730|NCT02161952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110905731|NCT02161952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110905732|NCT04993677|Carboplatin|carboplatin|mesh-list
110905733|NCT04993677|Pembrolizumab|pembrolizumab|mesh-list
110905734|NCT04993677|Pemetrexed|pemetrexed|mesh-list
110905735|NCT04993677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110905736|NCT04993677|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110905737|NCT04993677|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110905738|NCT04993677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110905739|NCT04993677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110905740|NCT04993677|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110905741|NCT04993677|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110905742|NCT05047731|Antihypertensive Agents|antihypertensive agents|mesh-list
110905743|NCT04795869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110905744|NCT04795869|Pembrolizumab|pembrolizumab|mesh-list
110905745|NCT04795869|Brentuximab Vedotin|brentuximab vedotin|mesh-list
110905746|NCT04795869|Antibodies|antibodies|mesh-list
110905748|NCT04795869|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110905749|NCT04795869|Immunoconjugates|immunoconjugates|mesh-list
110905750|NCT04795869|Immunologic Factors|immunologic factors|mesh-ancestor
110905751|NCT04795869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110905752|NCT04795869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110905753|NCT04795869|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110905754|NCT04795869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110905755|NCT04795869|Immunotoxins|immunotoxins|mesh-ancestor
110905756|NCT04050735|Ethanol|ethanol|mesh-list
110905757|NCT04050735|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110905758|NCT04050735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110905759|NCT04050735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110905760|NCT04050735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110905761|NCT04784559|Remdesivir|remdesivir|mesh-list
110905762|NCT04784559|Favipiravir|favipiravir|mesh-list
110905763|NCT04784559|Dexamethasone|dexamethasone|mesh-list
110905764|NCT04784559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110905765|NCT04784559|Antiemetics|antiemetics|mesh-ancestor
110905766|NCT04784559|Autonomic Agents|autonomic agents|mesh-ancestor
110905767|NCT04784559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110905768|NCT04784559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110905769|NCT04784559|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110905770|NCT04784559|Glucocorticoids|glucocorticoids|mesh-ancestor
110905771|NCT04784559|Hormones|hormones|mesh-ancestor
110905772|NCT04784559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110905773|NCT04784559|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110905774|NCT04784559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110905775|NCT04784559|Antimetabolites|antimetabolites|mesh-ancestor
110905776|NCT04784559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110905777|NCT04784559|Antiviral Agents|antiviral agents|mesh-ancestor
110905778|NCT04784559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110905780|NCT03704181|Gout Suppressants|gout suppressants|mesh-ancestor
110905781|NCT03704181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110905782|NCT03704181|Tubulin Modulators|tubulin modulators|mesh-ancestor
110905783|NCT03704181|Antimitotic Agents|antimitotic agents|mesh-ancestor
110905784|NCT03704181|Mitosis Modulators|mitosis modulators|mesh-ancestor
110905785|NCT03704181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110905786|NCT03704181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110905787|NCT03625011|Gabapentin|gabapentin|mesh-list
110905788|NCT03625011|Analgesics|analgesics|mesh-ancestor
110905789|NCT03625011|Sensory System Agents|sensory system agents|mesh-ancestor
110905790|NCT03625011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110905791|NCT03625011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110905792|NCT03625011|Anticonvulsants|anticonvulsants|mesh-ancestor
110905793|NCT03625011|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110905794|NCT03625011|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110905795|NCT03625011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110905796|NCT03625011|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110905797|NCT03625011|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110905798|NCT03625011|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110905799|NCT03625011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110905800|NCT03625011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110905801|NCT03625011|Antimanic Agents|antimanic agents|mesh-ancestor
110905802|NCT03625167|Petrolatum|petrolatum|mesh-list
110905803|NCT03625167|Emollients|emollients|mesh-ancestor
110905804|NCT03625167|Dermatologic Agents|dermatologic agents|mesh-ancestor
110905805|NCT04718727|Olanzapine|olanzapine|mesh-list
110905806|NCT04718727|Antiemetics|antiemetics|mesh-ancestor
110905807|NCT04718727|Autonomic Agents|autonomic agents|mesh-ancestor
110905808|NCT04718727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110905809|NCT04718727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110905810|NCT04718727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110905811|NCT04718727|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110905812|NCT04718727|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110905813|NCT04718727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110905814|NCT04718727|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110905815|NCT04718727|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110905816|NCT04718727|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110905817|NCT04718727|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110905818|NCT04718727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110905819|NCT04718727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110905820|NCT04718727|Serotonin Agents|serotonin agents|mesh-ancestor
110905821|NCT03701529|Anesthetics|anesthetics|mesh-list
110905822|NCT03701529|Propofol|propofol|mesh-list
110905823|NCT03701529|Sevoflurane|sevoflurane|mesh-list
110905824|NCT03701529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110905825|NCT03701529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110905826|NCT03701529|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110905827|NCT03701529|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110905828|NCT03701529|Anesthetics, General|anesthetics, general|mesh-ancestor
110905829|NCT03701529|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110905830|NCT03701529|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110905831|NCT04535271|Gemcitabine|gemcitabine|mesh-list
110905832|NCT04535271|Dacarbazine|dacarbazine|mesh-list
110905833|NCT04535271|Trabectedin|trabectedin|mesh-list
110905834|NCT04535271|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110905835|NCT04535271|Antimetabolites|antimetabolites|mesh-ancestor
110905836|NCT04535271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110905837|NCT04535271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110905838|NCT04535271|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110905839|NCT04535271|Alkylating Agents|alkylating agents|mesh-ancestor
110905840|NCT04553133|Letrozole|letrozole|mesh-list
110905841|NCT04553133|Fulvestrant|fulvestrant|mesh-list
110905842|NCT04553133|Palbociclib|palbociclib|mesh-list
110905843|NCT04553133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110905844|NCT04553133|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110905845|NCT04553133|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110905846|NCT04553133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110905847|NCT04553133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110905848|NCT04553133|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110905849|NCT04553133|Hormone Antagonists|hormone antagonists|mesh-ancestor
110905850|NCT04553133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110905851|NCT04553133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110905852|NCT04553133|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110905853|NCT04553133|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110905854|NCT04553133|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110905855|NCT03701451|Decitabine|decitabine|mesh-list
110905856|NCT03701451|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110905857|NCT03701451|Antimetabolites|antimetabolites|mesh-ancestor
110905858|NCT03701451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110905859|NCT03701451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110905860|NCT03701451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110905861|NCT03703089|Paclitaxel|paclitaxel|mesh-list
110905862|NCT03703089|Gemcitabine|gemcitabine|mesh-list
110905863|NCT03703089|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110905864|NCT03703089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110905865|NCT03703089|Tubulin Modulators|tubulin modulators|mesh-ancestor
110905866|NCT03703089|Antimitotic Agents|antimitotic agents|mesh-ancestor
110905867|NCT03703089|Mitosis Modulators|mitosis modulators|mesh-ancestor
110905868|NCT03703089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110905869|NCT03703089|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110905870|NCT03703089|Antimetabolites|antimetabolites|mesh-ancestor
110905871|NCT02807844|Spartalizumab|spartalizumab|mesh-list
110905872|NCT02807844|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110905873|NCT02807844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110905874|NCT02807844|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110905875|NCT02807844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110905876|NCT03702855|Tetrabenazine|tetrabenazine|mesh-list
110225399|NCT05975463|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110225400|NCT05975463|Growth Substances|growth substances|mesh-ancestor
110225401|NCT05975463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110225402|NCT05975463|Growth Inhibitors|growth inhibitors|mesh-ancestor
110225403|NCT05972993|Vaccines|vaccines|mesh-list
110225404|NCT05972993|Immunologic Factors|immunologic factors|mesh-ancestor
110225405|NCT05972993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110905877|NCT03702855|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110905878|NCT03702855|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110905879|NCT03702855|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110905880|NCT03702855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110905881|NCT03702855|Adrenergic Agents|adrenergic agents|mesh-ancestor
110905882|NCT03702855|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110925538|NCT03499730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110905883|NCT03702855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110905884|NCT02052180|Bupivacaine|bupivacaine|mesh-list
110905885|NCT02052180|Anesthetics, Local|anesthetics, local|mesh-ancestor
110905886|NCT02052180|Anesthetics|anesthetics|mesh-ancestor
110905887|NCT02052180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110905888|NCT02052180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110905889|NCT02052180|Sensory System Agents|sensory system agents|mesh-ancestor
110905890|NCT02052180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110905891|NCT03561402|Teriflunomide|teriflunomide|mesh-list
110905892|NCT03561402|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110905893|NCT03561402|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110905894|NCT03561402|Analgesics|analgesics|mesh-ancestor
110905895|NCT03561402|Sensory System Agents|sensory system agents|mesh-ancestor
110905896|NCT03561402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110905897|NCT03561402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110905898|NCT03561402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110905899|NCT03561402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110905900|NCT03561402|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110905901|NCT03561402|Immunologic Factors|immunologic factors|mesh-ancestor
110905902|NCT04542135|Sulindac|sulindac|mesh-list
110905903|NCT04542135|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110905904|NCT04542135|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110905905|NCT04542135|Analgesics|analgesics|mesh-ancestor
110905906|NCT04542135|Sensory System Agents|sensory system agents|mesh-ancestor
110905907|NCT04542135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110905908|NCT04542135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110905909|NCT04542135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110905910|NCT04542135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110905911|NCT04542135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110905912|NCT04542135|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110905913|NCT04542135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110905914|NCT04542135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110905915|NCT04694781|Pembrolizumab|pembrolizumab|mesh-list
110905916|NCT04694781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110905917|NCT04694781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110905918|NCT04694781|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110905919|NCT04694781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110905920|NCT02805972|Naloxone|naloxone|mesh-list
110905921|NCT02805972|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110905922|NCT02805972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110905923|NCT02805972|Sensory System Agents|sensory system agents|mesh-ancestor
110905924|NCT02805972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110905925|NCT02052258|Oxytocin|oxytocin|mesh-list
110905926|NCT02052258|Oxytocics|oxytocics|mesh-ancestor
110905927|NCT02052258|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110905928|NCT02052258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110905929|NCT02053818|Sufentanil|sufentanil|mesh-list
110905930|NCT02053818|Remifentanil|remifentanil|mesh-list
110905931|NCT02053818|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110905932|NCT02053818|Narcotics|narcotics|mesh-ancestor
110905933|NCT02053818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110905934|NCT02053818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110905935|NCT02053818|Analgesics|analgesics|mesh-ancestor
110905936|NCT02053818|Sensory System Agents|sensory system agents|mesh-ancestor
110905937|NCT02053818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110905938|NCT02053818|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110905939|NCT02053818|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110905940|NCT02053818|Anesthetics, General|anesthetics, general|mesh-ancestor
110905941|NCT02053818|Anesthetics|anesthetics|mesh-ancestor
110905942|NCT03702387|Anesthetics|anesthetics|mesh-list
110905943|NCT03702387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110905944|NCT03702387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110905945|NCT03031899|Tolonium Chloride|tolonium chloride|mesh-list
110905946|NCT03031899|Hemostatics|hemostatics|mesh-ancestor
110905947|NCT03031899|Coagulants|coagulants|mesh-ancestor
110905948|NCT03031899|Heparin Antagonists|heparin antagonists|mesh-ancestor
110905949|NCT03031899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110623409|NCT00814866|Adalimumab|adalimumab|mesh-list
110905950|NCT03700905|Nivolumab|nivolumab|mesh-list
110905951|NCT03700905|Ipilimumab|ipilimumab|mesh-list
110905952|NCT03700905|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110905953|NCT03700905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110905954|NCT03700905|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110905955|NCT03700905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110905957|NCT03700749|Chlorhexidine|chlorhexidine|mesh-list
110905958|NCT03700749|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110905959|NCT03700749|Cadexomer iodine|cadexomer iodine|mesh-list
110905960|NCT03700749|Povidone-Iodine|povidone-iodine|mesh-list
110905961|NCT03700749|Povidone|povidone|mesh-list
110905962|NCT03700749|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110905963|NCT03700749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110905964|NCT03700749|Disinfectants|disinfectants|mesh-ancestor
110905965|NCT03700749|Dermatologic Agents|dermatologic agents|mesh-ancestor
110905966|NCT03700749|Trace Elements|trace elements|mesh-ancestor
110905967|NCT03700749|Micronutrients|micronutrients|mesh-ancestor
110905968|NCT03700749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110905969|NCT03700749|Plasma Substitutes|plasma substitutes|mesh-ancestor
110905970|NCT03700749|Blood Substitutes|blood substitutes|mesh-ancestor
110905971|NCT03086369|Paclitaxel|paclitaxel|mesh-list
110905972|NCT03086369|Gemcitabine|gemcitabine|mesh-list
110905973|NCT03086369|Olaratumab|olaratumab|mesh-list
110905974|NCT03086369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110905975|NCT03086369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110905976|NCT03086369|Tubulin Modulators|tubulin modulators|mesh-ancestor
110905977|NCT03086369|Antimitotic Agents|antimitotic agents|mesh-ancestor
110905978|NCT03086369|Mitosis Modulators|mitosis modulators|mesh-ancestor
110905979|NCT03086369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110905980|NCT03086369|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110905981|NCT03086369|Antimetabolites|antimetabolites|mesh-ancestor
110905982|NCT00101582|Cisplatin|cisplatin|mesh-list
110905983|NCT00101582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110905984|NCT05326373|Fluorides|fluorides|mesh-list
110905985|NCT05326373|Tin Fluorides|tin fluorides|mesh-list
110905986|NCT05326373|Cariostatic Agents|cariostatic agents|mesh-ancestor
110905987|NCT05326373|Protective Agents|protective agents|mesh-ancestor
110905988|NCT05326373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110905989|NCT02166944|Tamoxifen|tamoxifen|mesh-list
110905990|NCT02166944|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110905991|NCT02166944|Hormone Antagonists|hormone antagonists|mesh-ancestor
110905992|NCT02166944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110905993|NCT02166944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110905994|NCT02166944|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110905995|NCT02166944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110905996|NCT02166944|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110905997|NCT02166944|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110905998|NCT02166944|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110905999|NCT03540836|Cortisone|cortisone|mesh-list
110906000|NCT03540836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110906001|NCT04211675|Irinotecan|irinotecan|mesh-list
110906002|NCT04211675|Temozolomide|temozolomide|mesh-list
110906003|NCT04211675|Dinutuximab|dinutuximab|mesh-list
110906004|NCT04211675|Sargramostim|sargramostim|mesh-list
110906005|NCT04211675|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110906006|NCT04211675|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110906007|NCT04211675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110906008|NCT04211675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110906009|NCT04211675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110906010|NCT04211675|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110906011|NCT04211675|Alkylating Agents|alkylating agents|mesh-ancestor
110906012|NCT04211675|Immunologic Factors|immunologic factors|mesh-ancestor
110906013|NCT04211675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110906015|NCT02162264|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110906016|NCT02162264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110906017|NCT02162264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110906018|NCT02162264|Cholinergic Agents|cholinergic agents|mesh-ancestor
110906019|NCT02162264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110906020|NCT02162264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110906021|NCT02162264|Nootropic Agents|nootropic agents|mesh-ancestor
110906022|NCT03700515|Epoetin Alfa|epoetin alfa|mesh-list
110906023|NCT03700515|Hematinics|hematinics|mesh-ancestor
110906024|NCT04740008|Nicotine|nicotine|mesh-list
110906025|NCT04740008|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110906026|NCT04740008|Autonomic Agents|autonomic agents|mesh-ancestor
110906027|NCT04740008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110906029|NCT04740008|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110906030|NCT04740008|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110906031|NCT04740008|Cholinergic Agents|cholinergic agents|mesh-ancestor
110906032|NCT04740008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110906033|NCT04740008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110906034|NCT03700359|Etoposide|etoposide|mesh-list
110906035|NCT03700359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110906036|NCT03700359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110906037|NCT03700359|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110906038|NCT03700359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110906039|NCT03700359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110906040|NCT03700359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110906041|NCT02167178|Polygeline|polygeline|mesh-list
110906042|NCT02167178|Plasma Substitutes|plasma substitutes|mesh-ancestor
110906043|NCT02167178|Blood Substitutes|blood substitutes|mesh-ancestor
110906044|NCT03625089|Atorvastatin|atorvastatin|mesh-list
110906045|NCT03625089|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110906046|NCT03625089|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110906047|NCT03625089|Antimetabolites|antimetabolites|mesh-ancestor
110906048|NCT03625089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110906049|NCT03625089|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110906050|NCT03625089|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110906051|NCT03625089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110906052|NCT01378949|Morphine|morphine|mesh-list
110906053|NCT01378949|Bupivacaine|bupivacaine|mesh-list
110906054|NCT01378949|Anesthetics, Local|anesthetics, local|mesh-ancestor
110906055|NCT01378949|Anesthetics|anesthetics|mesh-ancestor
110906056|NCT01378949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110906057|NCT01378949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110906058|NCT01378949|Sensory System Agents|sensory system agents|mesh-ancestor
110906059|NCT01378949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110906060|NCT01378949|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110906061|NCT01378949|Narcotics|narcotics|mesh-ancestor
110906062|NCT01378949|Analgesics|analgesics|mesh-ancestor
110906063|NCT01381055|Pentoxifylline|pentoxifylline|mesh-list
110906064|NCT01381055|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110906065|NCT01381055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110906066|NCT01381055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110906067|NCT01381055|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110906068|NCT01381055|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110906069|NCT01381055|Protective Agents|protective agents|mesh-ancestor
110906070|NCT01381055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110906071|NCT01381055|Vasodilator Agents|vasodilator agents|mesh-ancestor
110906072|NCT01381055|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110906073|NCT01381055|Antioxidants|antioxidants|mesh-ancestor
110906075|NCT04649229|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
110906076|NCT04649229|Antiemetics|antiemetics|mesh-ancestor
110906077|NCT04649229|Autonomic Agents|autonomic agents|mesh-ancestor
110906078|NCT04649229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110906079|NCT04649229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110906080|NCT04649229|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110906081|NCT04649229|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110906082|NCT04649229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110906083|NCT04649229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110906084|NCT04649229|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110906085|NCT03122613|Curcumin|curcumin|mesh-list
110906086|NCT03122613|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110906087|NCT03122613|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110906088|NCT03122613|Analgesics|analgesics|mesh-ancestor
110906089|NCT03122613|Sensory System Agents|sensory system agents|mesh-ancestor
110906090|NCT03122613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110906091|NCT03122613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110906092|NCT03122613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110906093|NCT03122613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110906094|NCT03122613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110906095|NCT03122613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110906096|NCT03122613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110906097|NCT03540368|Tranexamic Acid|tranexamic acid|mesh-list
110906098|NCT03540368|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110906099|NCT03540368|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110623560|NCT00779792|Emollients|emollients|mesh-ancestor
110906100|NCT03540368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110906102|NCT03540368|Coagulants|coagulants|mesh-ancestor
110906103|NCT02255396|Estradiol|estradiol|mesh-list
110906104|NCT02255396|Estrogens|estrogens|mesh-ancestor
110906105|NCT02255396|Hormones|hormones|mesh-ancestor
110906106|NCT02255396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110205094|NCT00169156|Prednisone|prednisone|mesh-list
110906107|NCT02255396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110906108|NCT02163980|Dexmedetomidine|dexmedetomidine|mesh-list
110906109|NCT02163980|Ropivacaine|ropivacaine|mesh-list
110906110|NCT02163980|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110906111|NCT02163980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110906112|NCT02163980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110906113|NCT02163980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110906114|NCT02163980|Analgesics|analgesics|mesh-ancestor
110906115|NCT02163980|Sensory System Agents|sensory system agents|mesh-ancestor
110906116|NCT02163980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110906117|NCT02163980|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110906118|NCT02163980|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110906119|NCT02163980|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110906120|NCT02163980|Adrenergic Agents|adrenergic agents|mesh-ancestor
110906121|NCT02163980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110906122|NCT02163980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110906123|NCT02163980|Anesthetics, Local|anesthetics, local|mesh-ancestor
110906124|NCT02163980|Anesthetics|anesthetics|mesh-ancestor
110906125|NCT02162888|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110906126|NCT02162888|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110906127|NCT02162888|Alkylating Agents|alkylating agents|mesh-ancestor
110906128|NCT02162888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110906129|NCT02162888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110906130|NCT01569035|Warfarin|warfarin|mesh-list
110906131|NCT01569035|Anticoagulants|anticoagulants|mesh-ancestor
110906132|NCT03841565|Dexamethasone|dexamethasone|mesh-list
110906133|NCT03841565|Dexamethasone acetate|dexamethasone acetate|mesh-list
110906134|NCT03841565|Daratumumab|daratumumab|mesh-list
110906135|NCT03841565|Pomalidomide|pomalidomide|mesh-list
110906136|NCT03841565|Ichthammol|ichthammol|mesh-list
110906137|NCT03841565|BB 1101|bb 1101|mesh-list
110906138|NCT03841565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110906139|NCT03841565|Antiemetics|antiemetics|mesh-ancestor
110906140|NCT03841565|Autonomic Agents|autonomic agents|mesh-ancestor
110906141|NCT03841565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110906142|NCT03841565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110906143|NCT03841565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110906144|NCT03841565|Glucocorticoids|glucocorticoids|mesh-ancestor
110906145|NCT03841565|Hormones|hormones|mesh-ancestor
110906146|NCT03841565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110906147|NCT03841565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110906148|NCT03841565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110205206|NCT00170053|Sirolimus|sirolimus|mesh-list
110906149|NCT03841565|Protease Inhibitors|protease inhibitors|mesh-ancestor
110906150|NCT03841565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110906151|NCT03841565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110906152|NCT03841565|Immunologic Factors|immunologic factors|mesh-ancestor
110906153|NCT03841565|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110906154|NCT03841565|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110906155|NCT03841565|Growth Substances|growth substances|mesh-ancestor
110906156|NCT03841565|Growth Inhibitors|growth inhibitors|mesh-ancestor
110906157|NCT03841565|Dermatologic Agents|dermatologic agents|mesh-ancestor
110906158|NCT02162966|Colistin|colistin|mesh-list
110906159|NCT02162966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110906160|NCT02162966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110906161|NCT01595321|Leucovorin|leucovorin|mesh-list
110906162|NCT01595321|Cyclophosphamide|cyclophosphamide|mesh-list
110906163|NCT01595321|Fluorouracil|fluorouracil|mesh-list
110906164|NCT01595321|Oxaliplatin|oxaliplatin|mesh-list
110906165|NCT01595321|Irinotecan|irinotecan|mesh-list
110906166|NCT01595321|Folfirinox|folfirinox|mesh-list
110906167|NCT01595321|Vaccines|vaccines|mesh-list
110906168|NCT01595321|Immunologic Factors|immunologic factors|mesh-ancestor
110906169|NCT01595321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110906170|NCT01595321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110906171|NCT01595321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110906172|NCT01595321|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110906173|NCT01595321|Alkylating Agents|alkylating agents|mesh-ancestor
110906174|NCT01595321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110906175|NCT01595321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110906176|NCT01595321|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110906177|NCT01595321|Antimetabolites|antimetabolites|mesh-ancestor
110906178|NCT01595321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110906179|NCT01595321|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110906180|NCT01595321|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110906181|NCT01595321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110906182|NCT01595321|Antidotes|antidotes|mesh-ancestor
110906183|NCT01595321|Protective Agents|protective agents|mesh-ancestor
110906184|NCT01595321|Vitamin B Complex|vitamin b complex|mesh-ancestor
110906185|NCT01595321|Vitamins|vitamins|mesh-ancestor
110906186|NCT01595321|Micronutrients|micronutrients|mesh-ancestor
110906187|NCT02164214|Etanercept|etanercept|mesh-list
110906188|NCT02164214|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110906189|NCT02164214|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110906190|NCT02164214|Analgesics|analgesics|mesh-ancestor
110906191|NCT02164214|Sensory System Agents|sensory system agents|mesh-ancestor
110906192|NCT02164214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110906193|NCT02164214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110906194|NCT02164214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110906195|NCT02164214|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110906196|NCT02164214|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110906197|NCT02164214|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110906198|NCT02164214|Immunologic Factors|immunologic factors|mesh-ancestor
110906199|NCT03722849|Adenosine|adenosine|mesh-list
110906200|NCT03722849|Capsaicin|capsaicin|mesh-list
110906201|NCT03722849|Antipruritics|antipruritics|mesh-ancestor
110906202|NCT03722849|Dermatologic Agents|dermatologic agents|mesh-ancestor
110906203|NCT03722849|Sensory System Agents|sensory system agents|mesh-ancestor
110906204|NCT03722849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110906205|NCT03722849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110906206|NCT03722849|Analgesics|analgesics|mesh-ancestor
110906207|NCT03722849|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110906208|NCT03722849|Vasodilator Agents|vasodilator agents|mesh-ancestor
110906209|NCT03722849|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
110906210|NCT03722849|Purinergic Agonists|purinergic agonists|mesh-ancestor
110906211|NCT03722849|Purinergic Agents|purinergic agents|mesh-ancestor
110906212|NCT03722849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110906213|NCT03722849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110906215|NCT02170844|Antithrombins|antithrombins|mesh-ancestor
110906216|NCT02170844|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110906217|NCT02170844|Protease Inhibitors|protease inhibitors|mesh-ancestor
110906218|NCT02170844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110906219|NCT02170844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110906220|NCT02170844|Anticoagulants|anticoagulants|mesh-ancestor
110906221|NCT02170922|Dabigatran|dabigatran|mesh-list
110906222|NCT02170922|Antithrombins|antithrombins|mesh-ancestor
110906223|NCT02170922|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110906224|NCT02170922|Protease Inhibitors|protease inhibitors|mesh-ancestor
110906225|NCT02170922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110906226|NCT02170922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110906227|NCT02170922|Anticoagulants|anticoagulants|mesh-ancestor
110906228|NCT02167958|Cyclophosphamide|cyclophosphamide|mesh-list
110906229|NCT02167958|Fludarabine|fludarabine|mesh-list
110906230|NCT02167958|Tacrolimus|tacrolimus|mesh-list
110906231|NCT02167958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110906232|NCT02167958|Immunologic Factors|immunologic factors|mesh-ancestor
110906233|NCT02167958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110906234|NCT02167958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110906235|NCT02167958|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110906236|NCT02167958|Alkylating Agents|alkylating agents|mesh-ancestor
110906237|NCT02167958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110906238|NCT02167958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110906239|NCT02167958|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110906240|NCT02167958|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110906241|NCT02167958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110906242|NCT01384331|NuvaRing|nuvaring|mesh-list
110906243|NCT01384331|Desogestrel|desogestrel|mesh-list
110906244|NCT01384331|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110906245|NCT01384331|Contraceptive Agents|contraceptive agents|mesh-ancestor
110906246|NCT01384331|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110906247|NCT01384331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110906248|NCT01384331|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110906249|NCT01384331|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110906250|NCT01384331|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110906251|NCT01384331|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110906252|NCT01384331|Progestins|progestins|mesh-ancestor
110623713|NCT00784472|Morphine|morphine|mesh-list
110906253|NCT01384331|Hormones|hormones|mesh-ancestor
110906254|NCT01384331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110906255|NCT03699423|Atropine|atropine|mesh-list
110906256|NCT03699423|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110906257|NCT03699423|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110906258|NCT03699423|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110906259|NCT03699423|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110906260|NCT03699423|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110906261|NCT03699423|Autonomic Agents|autonomic agents|mesh-ancestor
110906262|NCT03699423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110906263|NCT03699423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110906264|NCT03699423|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110906265|NCT03699423|Respiratory System Agents|respiratory system agents|mesh-ancestor
110906266|NCT03699423|Mydriatics|mydriatics|mesh-ancestor
110906267|NCT03699423|Parasympatholytics|parasympatholytics|mesh-ancestor
110906268|NCT03699423|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110906269|NCT03699423|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110906270|NCT03699423|Cholinergic Agents|cholinergic agents|mesh-ancestor
110906271|NCT03699423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110906272|NCT03699423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110906273|NCT02164448|Dexmedetomidine|dexmedetomidine|mesh-list
110906274|NCT02164448|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110906275|NCT02164448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110906276|NCT02164448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110906277|NCT02164448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110906278|NCT02164448|Analgesics|analgesics|mesh-ancestor
110225466|NCT05959356|Antidotes|antidotes|mesh-ancestor
110906279|NCT02164448|Sensory System Agents|sensory system agents|mesh-ancestor
110906280|NCT02164448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110906281|NCT02164448|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110906282|NCT02164448|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110906283|NCT02164448|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110906284|NCT02164448|Adrenergic Agents|adrenergic agents|mesh-ancestor
110906285|NCT02164448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110906286|NCT02164448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110906288|NCT03612713|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110906289|NCT03612713|Narcotics|narcotics|mesh-ancestor
110906290|NCT03612713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110906291|NCT03612713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110906292|NCT03612713|Analgesics|analgesics|mesh-ancestor
110906293|NCT03612713|Sensory System Agents|sensory system agents|mesh-ancestor
110906294|NCT03612713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110906295|NCT01380509|Metronidazole|metronidazole|mesh-list
110906296|NCT01380509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110906297|NCT01380509|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110906298|NCT01380509|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110906299|NCT01380509|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110906300|NCT01378715|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110906301|NCT01378715|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110906302|NCT01378715|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110906303|NCT01378715|Antimetabolites|antimetabolites|mesh-ancestor
110906304|NCT01378715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110906305|NCT01378715|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110906306|NCT01378715|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110906307|NCT01378715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110906308|NCT00976131|Ubiquinone|ubiquinone|mesh-list
110906309|NCT00976131|Coenzyme Q10|coenzyme q10|mesh-list
110906310|NCT00976131|Cyclophosphamide|cyclophosphamide|mesh-list
110906311|NCT00976131|Doxorubicin|doxorubicin|mesh-list
110906312|NCT00976131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110906313|NCT00976131|Immunologic Factors|immunologic factors|mesh-ancestor
110906314|NCT00976131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110906315|NCT00976131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110906316|NCT00976131|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110906317|NCT00976131|Alkylating Agents|alkylating agents|mesh-ancestor
110906318|NCT00976131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110906319|NCT00976131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110906320|NCT00976131|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110906321|NCT00976131|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110205791|NCT00174655|Doxorubicin|doxorubicin|mesh-list
110906322|NCT00976131|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110906323|NCT00976131|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110906324|NCT00976131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110906325|NCT00976131|Micronutrients|micronutrients|mesh-ancestor
110906326|NCT00976131|Vitamins|vitamins|mesh-ancestor
110906327|NCT01384253|Trastuzumab|trastuzumab|mesh-list
110906328|NCT01384253|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110906330|NCT03631277|Calcium|calcium|mesh-list
110906331|NCT03631277|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110906332|NCT03631277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110906333|NCT02171000|Dabigatran|dabigatran|mesh-list
110906334|NCT02171000|Antithrombins|antithrombins|mesh-ancestor
110906335|NCT02171000|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110906336|NCT02171000|Protease Inhibitors|protease inhibitors|mesh-ancestor
110906337|NCT02171000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110906338|NCT02171000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110906339|NCT02171000|Anticoagulants|anticoagulants|mesh-ancestor
110906340|NCT04841265|Vitamin D|vitamin d|mesh-list
110906341|NCT04841265|Cholecalciferol|cholecalciferol|mesh-list
110906342|NCT04841265|Vitamins|vitamins|mesh-ancestor
110906343|NCT04841265|Micronutrients|micronutrients|mesh-ancestor
110906344|NCT04841265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110906345|NCT04841265|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110906346|NCT04841265|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110906347|NCT02164604|Ranibizumab|ranibizumab|mesh-list
110906348|NCT02164604|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110906349|NCT02164604|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110906350|NCT02164604|Growth Substances|growth substances|mesh-ancestor
110906351|NCT02164604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110906352|NCT02164604|Growth Inhibitors|growth inhibitors|mesh-ancestor
110906353|NCT02164604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110906354|NCT04380831|Cyclophosphamide|cyclophosphamide|mesh-list
110906355|NCT04380831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110906356|NCT04380831|Immunologic Factors|immunologic factors|mesh-ancestor
110906357|NCT04380831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110906358|NCT04380831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110205856|NCT00046176|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110906359|NCT04380831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110906360|NCT04380831|Alkylating Agents|alkylating agents|mesh-ancestor
110906361|NCT04380831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110906362|NCT04380831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110906363|NCT04380831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110906364|NCT04571645|Heparin|heparin|mesh-list
110906365|NCT04571645|Anticoagulants|anticoagulants|mesh-ancestor
110906366|NCT04571645|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110906367|NCT04571645|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110906368|NCT04571645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110906369|NCT04050267|Nitrous Oxide|nitrous oxide|mesh-list
110906370|NCT04050267|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110906371|NCT04050267|Anesthetics, General|anesthetics, general|mesh-ancestor
110906372|NCT04050267|Anesthetics|anesthetics|mesh-ancestor
110906373|NCT04050267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110906374|NCT04050267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110906375|NCT04050267|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110906376|NCT04050267|Analgesics|analgesics|mesh-ancestor
110906377|NCT04050267|Sensory System Agents|sensory system agents|mesh-ancestor
110906378|NCT04050267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110906379|NCT02759120|Doxycycline|doxycycline|mesh-list
110906380|NCT02759120|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110906381|NCT02759120|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
110906382|NCT02759120|Anti-Infective Agents|anti-infective agents|mesh-list
110906383|NCT02759120|Antimalarials|antimalarials|mesh-ancestor
110906384|NCT02759120|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110906385|NCT02759120|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110906386|NCT02759120|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110906387|NCT01569113|Levonorgestrel|levonorgestrel|mesh-list
110906388|NCT01569113|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110906389|NCT01569113|Ulipristal acetate|ulipristal acetate|mesh-list
110906390|NCT01569113|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
110906391|NCT01569113|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
110906392|NCT01569113|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110906393|NCT01569113|Contraceptive Agents|contraceptive agents|mesh-ancestor
110906394|NCT01569113|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110906395|NCT01569113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110906396|NCT01569113|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110906397|NCT01569113|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110906398|NCT01569113|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110906399|NCT01569113|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110906400|NCT01569113|Estrogens|estrogens|mesh-ancestor
110906401|NCT01569113|Hormones|hormones|mesh-ancestor
110906402|NCT01569113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110906403|NCT01569113|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110906404|NCT01569113|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
110906405|NCT01569113|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
110906406|NCT01569113|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
110906407|NCT03699033|Paclitaxel|paclitaxel|mesh-list
110906408|NCT03699033|Carboplatin|carboplatin|mesh-list
110906409|NCT03699033|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110906410|NCT03699033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110906411|NCT03699033|Tubulin Modulators|tubulin modulators|mesh-ancestor
110906412|NCT03699033|Antimitotic Agents|antimitotic agents|mesh-ancestor
110906413|NCT03699033|Mitosis Modulators|mitosis modulators|mesh-ancestor
110906414|NCT03699033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110906415|NCT03697239|Ascorbic Acid|ascorbic acid|mesh-list
110906416|NCT03697239|Paclitaxel|paclitaxel|mesh-list
110906417|NCT03697239|Gemcitabine|gemcitabine|mesh-list
110906418|NCT03697239|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110906419|NCT03697239|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110906420|NCT03697239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110906421|NCT03697239|Tubulin Modulators|tubulin modulators|mesh-ancestor
110906422|NCT03697239|Antimitotic Agents|antimitotic agents|mesh-ancestor
110906423|NCT03697239|Mitosis Modulators|mitosis modulators|mesh-ancestor
110906424|NCT03697239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110906425|NCT03697239|Vitamins|vitamins|mesh-ancestor
110906426|NCT03697239|Micronutrients|micronutrients|mesh-ancestor
110906427|NCT03697239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110906428|NCT03697239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110906429|NCT03697239|Antimetabolites|antimetabolites|mesh-ancestor
110906430|NCT03697239|Antioxidants|antioxidants|mesh-ancestor
110906431|NCT03697239|Protective Agents|protective agents|mesh-ancestor
110906432|NCT01380431|Lisinopril|lisinopril|mesh-list
110906433|NCT01380431|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110906434|NCT01380431|Protease Inhibitors|protease inhibitors|mesh-ancestor
110906435|NCT01380431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110906436|NCT01380431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110906437|NCT01380431|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110906438|NCT01380431|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110906439|NCT01380431|Protective Agents|protective agents|mesh-ancestor
110906440|NCT01380431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110906441|NCT03697161|Gaboxadol|gaboxadol|mesh-list
110906442|NCT03697161|Analgesics|analgesics|mesh-ancestor
110906443|NCT03697161|Sensory System Agents|sensory system agents|mesh-ancestor
110205997|NCT00175903|Analgesics|analgesics|mesh-ancestor
110906444|NCT03697161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110906445|NCT03697161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110906446|NCT03697161|Anticonvulsants|anticonvulsants|mesh-ancestor
110906447|NCT03697161|GABA Agonists|gaba agonists|mesh-ancestor
110906448|NCT03697161|GABA Agents|gaba agents|mesh-ancestor
110906449|NCT03697161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110906450|NCT03697161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110906451|NCT03164993|Cyclophosphamide|cyclophosphamide|mesh-list
110906452|NCT03164993|Doxorubicin|doxorubicin|mesh-list
110906453|NCT03164993|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110906454|NCT03164993|Atezolizumab|atezolizumab|mesh-list
110906455|NCT03164993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110906456|NCT03164993|Immunologic Factors|immunologic factors|mesh-ancestor
110906457|NCT03164993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110906458|NCT03164993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110906459|NCT03164993|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110906460|NCT03164993|Alkylating Agents|alkylating agents|mesh-ancestor
110906461|NCT03164993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110906462|NCT03164993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110906463|NCT03164993|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110906464|NCT03164993|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110906465|NCT03164993|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110906466|NCT03164993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110906467|NCT03164993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110906468|NCT03164993|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110906469|NCT03164993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110906470|NCT02171156|Nintedanib|nintedanib|mesh-list
110906471|NCT02171156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110906472|NCT02171156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110906473|NCT02171156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110225500|NCT05952713|Dopamine Agents|dopamine agents|mesh-ancestor
110906474|NCT02171156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110906475|NCT01380353|Diclofenac|diclofenac|mesh-list
110206101|NCT00176449|Bupropion|bupropion|mesh-list
110906476|NCT01380353|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
110906477|NCT01380353|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110906478|NCT01380353|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110906479|NCT01380353|Analgesics|analgesics|mesh-ancestor
110906480|NCT01380353|Sensory System Agents|sensory system agents|mesh-ancestor
110906481|NCT01380353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110906482|NCT01380353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110906483|NCT01380353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110906484|NCT01380353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110906485|NCT01380353|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110906486|NCT01380353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110906487|NCT01380353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110906488|NCT02168426|Hyaluronic Acid|hyaluronic acid|mesh-list
110906489|NCT02168426|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110906490|NCT02168426|Immunologic Factors|immunologic factors|mesh-ancestor
110906491|NCT02168426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110906492|NCT02168426|Viscosupplements|viscosupplements|mesh-ancestor
110906493|NCT02168426|Protective Agents|protective agents|mesh-ancestor
110906494|NCT01380275|Docetaxel|docetaxel|mesh-list
110906495|NCT01380275|Irinotecan|irinotecan|mesh-list
110906496|NCT01380275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110906497|NCT01380275|Tubulin Modulators|tubulin modulators|mesh-ancestor
110906498|NCT01380275|Antimitotic Agents|antimitotic agents|mesh-ancestor
110906499|NCT01380275|Mitosis Modulators|mitosis modulators|mesh-ancestor
110906500|NCT01380275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110906501|NCT01380275|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110906502|NCT01380275|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110906503|NCT01380275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110906504|NCT02171390|Methyltestosterone|methyltestosterone|mesh-list
110906506|NCT02171390|Testosterone undecanoate|testosterone undecanoate|mesh-list
110906507|NCT02171390|Testosterone enanthate|testosterone enanthate|mesh-list
110906508|NCT02171390|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
110906509|NCT02171390|Androgens|androgens|mesh-ancestor
110906510|NCT02171390|Hormones|hormones|mesh-ancestor
110906511|NCT02171390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110906512|NCT02171390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110906513|NCT02171390|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110906514|NCT02171390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110906515|NCT02171390|Anabolic Agents|anabolic agents|mesh-ancestor
110906516|NCT01378481|Vorinostat|vorinostat|mesh-list
110906517|NCT01378481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110906518|NCT01378481|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110906519|NCT01378481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110906520|NCT01378481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110906521|NCT02171468|Dabigatran|dabigatran|mesh-list
110906522|NCT02171468|Antithrombins|antithrombins|mesh-ancestor
110906523|NCT02171468|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110906524|NCT02171468|Protease Inhibitors|protease inhibitors|mesh-ancestor
110906525|NCT02171468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110906526|NCT02171468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110906527|NCT02171468|Anticoagulants|anticoagulants|mesh-ancestor
110906528|NCT03502031|Losartan|losartan|mesh-list
110906529|NCT03502031|Valsartan|valsartan|mesh-list
110906530|NCT03502031|Enalapril|enalapril|mesh-list
110906531|NCT03502031|Enalaprilat|enalaprilat|mesh-list
110906532|NCT03502031|Lisinopril|lisinopril|mesh-list
110906533|NCT03502031|Perindopril|perindopril|mesh-list
110906534|NCT03502031|Spironolactone|spironolactone|mesh-list
110906535|NCT03502031|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110906536|NCT03502031|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110906537|NCT03502031|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110206278|NCT00056966|Fludarabine|fludarabine|mesh-list
110906538|NCT03502031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110906539|NCT03502031|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110906540|NCT03502031|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110906541|NCT03502031|Hormone Antagonists|hormone antagonists|mesh-ancestor
110906542|NCT03502031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110906543|NCT03502031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110906544|NCT03502031|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110906546|NCT03502031|Natriuretic Agents|natriuretic agents|mesh-ancestor
110906547|NCT03502031|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110906548|NCT03502031|Protease Inhibitors|protease inhibitors|mesh-ancestor
110906549|NCT03502031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110906550|NCT03502031|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110906551|NCT03502031|Protective Agents|protective agents|mesh-ancestor
110906552|NCT02171546|Fexofenadine|fexofenadine|mesh-list
110906553|NCT02171546|Quinidine|quinidine|mesh-list
110624075|NCT00998920|Equol|equol|mesh-list
110906554|NCT02171546|Quinidine gluconate|quinidine gluconate|mesh-list
110906556|NCT02171546|Antithrombins|antithrombins|mesh-ancestor
110906557|NCT02171546|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110906558|NCT02171546|Protease Inhibitors|protease inhibitors|mesh-ancestor
110906559|NCT02171546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110906560|NCT02171546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110906561|NCT02171546|Anticoagulants|anticoagulants|mesh-ancestor
110906562|NCT02171546|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110906563|NCT02171546|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110906564|NCT02171546|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110906565|NCT02171546|Histamine Antagonists|histamine antagonists|mesh-ancestor
110925685|NCT02147964|Hormones|hormones|mesh-ancestor
110906566|NCT02171546|Histamine Agents|histamine agents|mesh-ancestor
110906567|NCT02171546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110906568|NCT02171546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110906569|NCT02171546|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110906570|NCT02171546|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110906571|NCT02171546|Adrenergic Agents|adrenergic agents|mesh-ancestor
110906572|NCT02171546|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110906573|NCT02171546|Antimalarials|antimalarials|mesh-ancestor
110906574|NCT02171546|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110906575|NCT02171546|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110906576|NCT02171546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110906577|NCT02171546|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110906578|NCT02171546|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110906579|NCT02171546|Cholinergic Agents|cholinergic agents|mesh-ancestor
110906580|NCT02171546|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110906581|NCT02171546|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110906582|NCT02171546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110906583|NCT02171546|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110906584|NCT02171546|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110906585|NCT02171624|Quinidine|quinidine|mesh-list
110906586|NCT02171624|Dabigatran|dabigatran|mesh-list
110906587|NCT02171624|Antithrombins|antithrombins|mesh-ancestor
110906588|NCT02171624|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110906589|NCT02171624|Protease Inhibitors|protease inhibitors|mesh-ancestor
110906590|NCT02171624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110906591|NCT02171624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110906592|NCT02171624|Anticoagulants|anticoagulants|mesh-ancestor
110906593|NCT02171624|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110206551|NCT00057278|Gabapentin|gabapentin|mesh-list
110906594|NCT02171624|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110906595|NCT02171624|Adrenergic Agents|adrenergic agents|mesh-ancestor
110906596|NCT02171624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110906597|NCT02171624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110906598|NCT02171624|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110906599|NCT02171624|Antimalarials|antimalarials|mesh-ancestor
110906600|NCT02171624|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110906601|NCT02171624|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110906602|NCT02171624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110906603|NCT02171624|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110906604|NCT02171624|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110206608|NCT00057356|Conivaptan|conivaptan|mesh-list
110906605|NCT02171624|Cholinergic Agents|cholinergic agents|mesh-ancestor
110906606|NCT02171624|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110906607|NCT02171624|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110906608|NCT02171624|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110906609|NCT02171624|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110906610|NCT02171624|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110906611|NCT03705351|Temozolomide|temozolomide|mesh-list
110906612|NCT03705351|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110906613|NCT03705351|Alkylating Agents|alkylating agents|mesh-ancestor
110906614|NCT03705351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110906615|NCT03705351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110906616|NCT03705195|Gliclazide|gliclazide|mesh-list
110906617|NCT03705195|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110906618|NCT03705195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110906619|NCT00101192|Cetuximab|cetuximab|mesh-list
110906620|NCT00101192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110906621|NCT00101192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110906622|NCT03688269|Dexamethasone|dexamethasone|mesh-list
110906623|NCT03688269|Ropivacaine|ropivacaine|mesh-list
110906624|NCT03688269|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110906625|NCT03688269|Antiemetics|antiemetics|mesh-ancestor
110906626|NCT03688269|Autonomic Agents|autonomic agents|mesh-ancestor
110206742|NCT00408655|Antimitotic Agents|antimitotic agents|mesh-ancestor
110906627|NCT03688269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110624087|NCT00641706|Bortezomib|bortezomib|mesh-list
110906628|NCT03688269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110906629|NCT03688269|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110906630|NCT03688269|Glucocorticoids|glucocorticoids|mesh-ancestor
110906631|NCT03688269|Hormones|hormones|mesh-ancestor
110906632|NCT03688269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110906633|NCT03688269|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110906634|NCT03688269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110906635|NCT03688269|Anesthetics, Local|anesthetics, local|mesh-ancestor
110906636|NCT03688269|Anesthetics|anesthetics|mesh-ancestor
110906637|NCT03688269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110906638|NCT03688269|Sensory System Agents|sensory system agents|mesh-ancestor
110906639|NCT03688191|Sirolimus|sirolimus|mesh-list
110906640|NCT03688191|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110906641|NCT03688191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110906642|NCT03688191|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110906643|NCT03688191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110906644|NCT03688191|Antifungal Agents|antifungal agents|mesh-ancestor
110906645|NCT03688191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110906646|NCT03688191|Immunologic Factors|immunologic factors|mesh-ancestor
110906647|NCT03688191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110906648|NCT02164838|Axitinib|axitinib|mesh-list
110906649|NCT02164838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110206879|NCT00057512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110906650|NCT02164838|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110906651|NCT02164838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110906652|NCT02164838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110906653|NCT02171702|Afatinib|afatinib|mesh-list
110906654|NCT02171702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110906655|NCT02171702|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110906656|NCT02171702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110906657|NCT02171702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110906658|NCT02171780|Olodaterol|olodaterol|mesh-list
110906659|NCT02171780|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110906660|NCT02171780|Autonomic Agents|autonomic agents|mesh-ancestor
110906661|NCT02171780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110906662|NCT02171780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110906663|NCT02171780|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110206946|NCT00183937|Docetaxel|docetaxel|mesh-list
110906664|NCT02171780|Respiratory System Agents|respiratory system agents|mesh-ancestor
110906665|NCT02172014|Fentanyl|fentanyl|mesh-list
110906666|NCT02172014|Midazolam|midazolam|mesh-list
110906667|NCT02172014|Citric Acid|citric acid|mesh-list
110906668|NCT02172014|Sodium Citrate|sodium citrate|mesh-list
110906669|NCT02172014|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110906670|NCT02172014|Narcotics|narcotics|mesh-ancestor
110906671|NCT02172014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110207006|NCT00184171|Antacids|antacids|mesh-ancestor
110906672|NCT02172014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110906673|NCT02172014|Analgesics|analgesics|mesh-ancestor
110906674|NCT02172014|Sensory System Agents|sensory system agents|mesh-ancestor
110906675|NCT02172014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110906676|NCT02172014|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110906677|NCT02172014|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110906678|NCT02172014|Anesthetics, General|anesthetics, general|mesh-ancestor
110906679|NCT02172014|Anesthetics|anesthetics|mesh-ancestor
110906680|NCT02172014|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110207074|NCT00058292|Antimetabolites|antimetabolites|mesh-ancestor
110906681|NCT02172014|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110906682|NCT02172014|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110906683|NCT02172014|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110906684|NCT02172014|GABA Modulators|gaba modulators|mesh-ancestor
110906685|NCT02172014|GABA Agents|gaba agents|mesh-ancestor
110906686|NCT02172014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110906687|NCT02172014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110906688|NCT02172014|Anticoagulants|anticoagulants|mesh-ancestor
110906689|NCT02172014|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110906690|NCT02172014|Chelating Agents|chelating agents|mesh-ancestor
110906691|NCT02172014|Sequestering Agents|sequestering agents|mesh-ancestor
110906692|NCT02172170|Empagliflozin|empagliflozin|mesh-list
110906693|NCT02172170|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110925710|NCT02147262|Doxycycline|doxycycline|mesh-list
110906694|NCT02172170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110906695|NCT02172170|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110906696|NCT02172170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110906698|NCT02255942|Iron|iron|mesh-list
110906699|NCT02255942|Zinc Sulfate|zinc sulfate|mesh-list
110906700|NCT02255942|Zinc Oxide|zinc oxide|mesh-list
110906701|NCT02255942|Trace Elements|trace elements|mesh-ancestor
110906702|NCT02255942|Micronutrients|micronutrients|mesh-ancestor
110906703|NCT02255942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110906704|NCT02255942|Astringents|astringents|mesh-ancestor
110906705|NCT02255942|Dermatologic Agents|dermatologic agents|mesh-ancestor
110906706|NCT02255942|Sunscreening Agents|sunscreening agents|mesh-ancestor
110906707|NCT02255942|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110906708|NCT02255942|Protective Agents|protective agents|mesh-ancestor
110906709|NCT03029247|Epoetin Alfa|epoetin alfa|mesh-list
110906710|NCT03029247|Hematinics|hematinics|mesh-ancestor
110906711|NCT03696459|Moxifloxacin|moxifloxacin|mesh-list
110906712|NCT03696459|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
110906713|NCT03696459|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110906714|NCT03696459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110906715|NCT03696459|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110906716|NCT03696459|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110906717|NCT03696459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110906718|NCT03696459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110906719|NCT03696459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110906720|NCT03696459|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110906721|NCT03696459|Contraceptive Agents|contraceptive agents|mesh-ancestor
110906722|NCT03696459|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110906723|NCT03696459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110906724|NCT03696459|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110906725|NCT03696459|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110906726|NCT03696459|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110906727|NCT03624309|Docetaxel|docetaxel|mesh-list
110906728|NCT03624309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110906729|NCT03624309|Tubulin Modulators|tubulin modulators|mesh-ancestor
110906730|NCT03624309|Antimitotic Agents|antimitotic agents|mesh-ancestor
110906731|NCT03624309|Mitosis Modulators|mitosis modulators|mesh-ancestor
110906732|NCT03624309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110906733|NCT04327791|Baloxavir|baloxavir|mesh-list
110906734|NCT04327791|Antiviral Agents|antiviral agents|mesh-ancestor
110906735|NCT04327791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110906736|NCT04327791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110906737|NCT04327791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110906738|NCT03692013|Losartan|losartan|mesh-list
110906739|NCT03692013|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110906740|NCT03692013|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110906741|NCT03692013|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110906742|NCT03692013|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110207324|NCT00186745|Tinzaparin|tinzaparin|mesh-list
110906743|NCT03692013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110906744|NCT03695835|Immunomodulating Agents|immunomodulating agents|mesh-list
110906745|NCT03695835|Immunologic Factors|immunologic factors|mesh-ancestor
110906746|NCT03695835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110906747|NCT03687255|Tazobactam|tazobactam|mesh-list
110906748|NCT03687255|Piperacillin|piperacillin|mesh-list
110906749|NCT03687255|Cefepime|cefepime|mesh-list
110906750|NCT03687255|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
110906751|NCT03687255|Enmetazobactam|enmetazobactam|mesh-list
110906752|NCT03687255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110906753|NCT03687255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110906754|NCT03687255|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110906755|NCT03687255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110906756|NCT03687255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110906757|NCT03691467|Hyaluronic Acid|hyaluronic acid|mesh-list
110906758|NCT03691467|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110906759|NCT03691467|Immunologic Factors|immunologic factors|mesh-ancestor
110906760|NCT03691467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110906761|NCT03691467|Viscosupplements|viscosupplements|mesh-ancestor
110906762|NCT03691467|Protective Agents|protective agents|mesh-ancestor
110906763|NCT02165774|Neurotransmitter Agents|neurotransmitter agents|mesh-list
110906764|NCT02165774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110906765|NCT02165774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110906766|NCT02165930|Naltrexone|naltrexone|mesh-list
110906767|NCT02165930|Oxycodone|oxycodone|mesh-list
110906768|NCT02165930|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110906769|NCT02165930|Narcotics|narcotics|mesh-ancestor
110906770|NCT02165930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110906771|NCT02165930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110906772|NCT02165930|Analgesics|analgesics|mesh-ancestor
110906773|NCT02165930|Sensory System Agents|sensory system agents|mesh-ancestor
110906774|NCT02165930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110207469|NCT00187525|Memantine|memantine|mesh-list
110906775|NCT02165930|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110906776|NCT02165930|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110906777|NCT03694977|Spartalizumab|spartalizumab|mesh-list
110906778|NCT03694977|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110906779|NCT03694977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110624247|NCT00995800|Xhance|xhance|mesh-list
110906780|NCT03694977|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110906781|NCT03694977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110906783|NCT02172248|Empagliflozin|empagliflozin|mesh-list
110906784|NCT02172248|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110906785|NCT02172248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110906786|NCT02172248|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110906787|NCT02172248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110906788|NCT02172326|Tiotropium Bromide|tiotropium bromide|mesh-list
110906789|NCT02172326|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110906790|NCT02172326|Autonomic Agents|autonomic agents|mesh-ancestor
110906791|NCT02172326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110906792|NCT02172326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110906793|NCT02172326|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110906794|NCT02172326|Respiratory System Agents|respiratory system agents|mesh-ancestor
110906795|NCT02172326|Parasympatholytics|parasympatholytics|mesh-ancestor
110906796|NCT02172326|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110906797|NCT02172326|Cholinergic Agents|cholinergic agents|mesh-ancestor
110906798|NCT02172326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110906799|NCT02172326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110906800|NCT02169596|Ticagrelor|ticagrelor|mesh-list
110906801|NCT02169596|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110906802|NCT02169596|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110906803|NCT02169596|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110906804|NCT02169596|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110906805|NCT02169596|Purinergic Agents|purinergic agents|mesh-ancestor
110906806|NCT02169596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110207646|NCT00409318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110906807|NCT02169596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110906808|NCT02169596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110906809|NCT02169752|Ambrisentan|ambrisentan|mesh-list
110906810|NCT02169752|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110906811|NCT02172404|Ipratropium|ipratropium|mesh-list
110906812|NCT02172404|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110906813|NCT02172404|Autonomic Agents|autonomic agents|mesh-ancestor
110906814|NCT02172404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110906815|NCT02172404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110906816|NCT02172404|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110906817|NCT02172404|Respiratory System Agents|respiratory system agents|mesh-ancestor
110906818|NCT02172404|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110906819|NCT02172404|Cholinergic Agents|cholinergic agents|mesh-ancestor
110906820|NCT02172404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110906821|NCT02172404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110906822|NCT00109538|Lonafarnib|lonafarnib|mesh-list
110906823|NCT00109538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110906824|NCT00109538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110906825|NCT02172482|Bromides|bromides|mesh-list
110906826|NCT02172482|Tiotropium Bromide|tiotropium bromide|mesh-list
110906827|NCT02172482|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110906828|NCT02172482|Autonomic Agents|autonomic agents|mesh-ancestor
110906829|NCT02172482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110906830|NCT02172482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110906831|NCT02172482|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110906832|NCT02172482|Respiratory System Agents|respiratory system agents|mesh-ancestor
110906833|NCT02172482|Parasympatholytics|parasympatholytics|mesh-ancestor
110906834|NCT02172482|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110906835|NCT02172482|Cholinergic Agents|cholinergic agents|mesh-ancestor
110906836|NCT02172482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110207777|NCT00189358|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110906837|NCT02172482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110906838|NCT02172482|Anticonvulsants|anticonvulsants|mesh-ancestor
110906839|NCT02172560|Tiotropium Bromide|tiotropium bromide|mesh-list
110906840|NCT02172560|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110906841|NCT02172560|Autonomic Agents|autonomic agents|mesh-ancestor
110906842|NCT02172560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110906843|NCT02172560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110906844|NCT02172560|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110906845|NCT02172560|Respiratory System Agents|respiratory system agents|mesh-ancestor
110906846|NCT02172560|Parasympatholytics|parasympatholytics|mesh-ancestor
110906847|NCT02172560|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110906848|NCT02172560|Cholinergic Agents|cholinergic agents|mesh-ancestor
110906849|NCT02172560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110906850|NCT02172560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110906851|NCT00106808|Pioglitazone|pioglitazone|mesh-list
110906852|NCT00106808|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110906853|NCT00106808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110906854|NCT02166554|Hyaluronic Acid|hyaluronic acid|mesh-list
110906855|NCT02166554|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110906856|NCT02166554|Immunologic Factors|immunologic factors|mesh-ancestor
110906857|NCT02166554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110906858|NCT02166554|Viscosupplements|viscosupplements|mesh-ancestor
110906859|NCT02166554|Protective Agents|protective agents|mesh-ancestor
110906860|NCT02174666|Vitamin D|vitamin d|mesh-list
110906861|NCT02174666|Ergocalciferols|ergocalciferols|mesh-list
110906862|NCT02174666|Cholecalciferol|cholecalciferol|mesh-list
110906863|NCT02174666|Vitamins|vitamins|mesh-list
110906864|NCT02174666|Genistein|genistein|mesh-list
110906865|NCT02174666|Biochanin A|biochanin a|mesh-list
110906866|NCT02174666|Daidzein|daidzein|mesh-list
110906867|NCT02174666|Formononetin|formononetin|mesh-list
110906868|NCT02174666|Micronutrients|micronutrients|mesh-ancestor
110906869|NCT02174666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110906870|NCT02174666|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110906871|NCT02174666|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110906872|NCT02174666|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110906873|NCT02174666|Protective Agents|protective agents|mesh-ancestor
110906874|NCT02174666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110906875|NCT02174666|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110906876|NCT02174666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110906877|NCT02174666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110906878|NCT02174666|Phytoestrogens|phytoestrogens|mesh-ancestor
110906879|NCT02174666|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
110906880|NCT02174666|Estrogens|estrogens|mesh-ancestor
110906881|NCT02174666|Hormones|hormones|mesh-ancestor
110906882|NCT02174666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110906883|NCT03687021|Progesterone|progesterone|mesh-list
110906884|NCT03687021|Progestins|progestins|mesh-ancestor
110906885|NCT03687021|Hormones|hormones|mesh-ancestor
110906886|NCT03687021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110906887|NCT03687021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110906888|NCT02172794|Tiotropium Bromide|tiotropium bromide|mesh-list
110925744|NCT04537910|Bamlanivimab|bamlanivimab|mesh-list
110906889|NCT02172794|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110906890|NCT02172794|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110906891|NCT02172794|Autonomic Agents|autonomic agents|mesh-ancestor
110225528|NCT05943795|Docetaxel|docetaxel|mesh-list
110906892|NCT02172794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110906893|NCT02172794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110906894|NCT02172794|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110906895|NCT02172794|Respiratory System Agents|respiratory system agents|mesh-ancestor
110906896|NCT02172794|Parasympatholytics|parasympatholytics|mesh-ancestor
110906897|NCT02172794|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110906898|NCT02172794|Cholinergic Agents|cholinergic agents|mesh-ancestor
110906899|NCT02172794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110906900|NCT02172794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110906901|NCT02172794|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110906902|NCT02172794|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110906903|NCT02172794|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110906904|NCT02172794|Adrenergic Agents|adrenergic agents|mesh-ancestor
110906905|NCT02174900|Lumefantrine|lumefantrine|mesh-list
110906906|NCT02174900|Artemether|artemether|mesh-list
110906907|NCT02174900|Primaquine|primaquine|mesh-list
110906908|NCT02174900|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
110906909|NCT02174900|Antimalarials|antimalarials|mesh-ancestor
110906910|NCT02174900|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110906911|NCT02174900|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110906912|NCT02174900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110906913|NCT02170610|Pantoprazole|pantoprazole|mesh-list
110906914|NCT02170610|Dabigatran|dabigatran|mesh-list
110906915|NCT02170610|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110906916|NCT02170610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110906917|NCT02170610|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110906918|NCT02170610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110906919|NCT02170610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110906920|NCT02170610|Antithrombins|antithrombins|mesh-ancestor
110906921|NCT02170610|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110906922|NCT02170610|Protease Inhibitors|protease inhibitors|mesh-ancestor
110906923|NCT02170610|Anticoagulants|anticoagulants|mesh-ancestor
110906924|NCT02173106|Cyclosporine|cyclosporine|mesh-list
110906925|NCT02173106|Cyclosporins|cyclosporins|mesh-list
110906926|NCT02173106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110624384|NCT00996190|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110906927|NCT02173106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110906928|NCT02173106|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110906929|NCT02173106|Immunologic Factors|immunologic factors|mesh-ancestor
110906930|NCT02173106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110906931|NCT02173106|Antifungal Agents|antifungal agents|mesh-ancestor
110906932|NCT02173106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110906933|NCT02173106|Dermatologic Agents|dermatologic agents|mesh-ancestor
110906934|NCT02173106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110906935|NCT02173106|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110906936|NCT03932721|Evolocumab|evolocumab|mesh-list
110906937|NCT03932721|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
110906938|NCT03932721|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110906939|NCT03932721|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110906940|NCT03932721|Antimetabolites|antimetabolites|mesh-ancestor
110906941|NCT03932721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110906942|NCT03932721|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110906943|NCT03932721|Protease Inhibitors|protease inhibitors|mesh-ancestor
110906944|NCT03932721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110906945|NCT03932721|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110906946|NCT00106340|Metformin|metformin|mesh-list
110906947|NCT00106340|Glimepiride|glimepiride|mesh-list
110906948|NCT00106340|Vildagliptin|vildagliptin|mesh-list
110906949|NCT00106340|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110906950|NCT00106340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110906951|NCT00106340|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110906952|NCT00106340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110906953|NCT00106340|Immunologic Factors|immunologic factors|mesh-ancestor
110906954|NCT00106340|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110906955|NCT00106340|Protease Inhibitors|protease inhibitors|mesh-ancestor
110906956|NCT00106340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110906957|NCT00106340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110906958|NCT03538496|Bupivacaine|bupivacaine|mesh-list
110906959|NCT03538496|Anesthetics, Local|anesthetics, local|mesh-ancestor
110906960|NCT03538496|Anesthetics|anesthetics|mesh-ancestor
110906961|NCT03538496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110906962|NCT03538496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110906963|NCT03538496|Sensory System Agents|sensory system agents|mesh-ancestor
110906964|NCT03538496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110906965|NCT03686787|Tranexamic Acid|tranexamic acid|mesh-list
110906966|NCT03686787|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110906967|NCT03686787|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110906968|NCT03686787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110906969|NCT03686787|Hemostatics|hemostatics|mesh-ancestor
110906970|NCT03686787|Coagulants|coagulants|mesh-ancestor
110906972|NCT03694587|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110906973|NCT03694587|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110906974|NCT03694587|Analgesics|analgesics|mesh-ancestor
110906975|NCT03694587|Sensory System Agents|sensory system agents|mesh-ancestor
110906976|NCT03694587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110906977|NCT03694587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110906978|NCT03694587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110906979|NCT03694587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110906980|NCT03694587|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110906981|NCT03694587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110234780|NCT04793906|Iron|iron|mesh-list
110906982|NCT03694587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110906983|NCT02175056|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
110906984|NCT02175056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110906985|NCT02170766|Pantoprazole|pantoprazole|mesh-list
110906986|NCT02170766|Dabigatran|dabigatran|mesh-list
110208432|NCT00193570|Topotecan|topotecan|mesh-list
110906987|NCT02170766|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110906988|NCT02170766|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110906989|NCT02170766|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110906990|NCT02170766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110906991|NCT02170766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110906992|NCT02170766|Antithrombins|antithrombins|mesh-ancestor
110906993|NCT02170766|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110906994|NCT02170766|Protease Inhibitors|protease inhibitors|mesh-ancestor
110234801|NCT04696042|Lanreotide|lanreotide|mesh-list
110906995|NCT02170766|Anticoagulants|anticoagulants|mesh-ancestor
110906996|NCT04156659|Tisagenlecleucel|tisagenlecleucel|mesh-list
110906997|NCT04156659|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110906998|NCT04156659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110906999|NCT03694119|Phenelzine|phenelzine|mesh-list
110907000|NCT03694119|Ozanimod|ozanimod|mesh-list
110907001|NCT03694119|Tyramine|tyramine|mesh-list
110907002|NCT03694119|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
110208571|NCT00398528|(T,G)-A-L|(t,g)-a-l|mesh-list
110907003|NCT03694119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110907004|NCT03694119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110624465|NCT00318643|Mitomycins|mitomycins|mesh-list
110907005|NCT03694119|Immunologic Factors|immunologic factors|mesh-ancestor
110907006|NCT03694119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110907007|NCT03694119|Antidepressive Agents|antidepressive agents|mesh-ancestor
110907008|NCT03694119|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110208637|NCT00194974|Tocolytic Agents|tocolytic agents|mesh-ancestor
110907009|NCT03694119|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
110907010|NCT03694119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110907011|NCT03694119|Sympathomimetics|sympathomimetics|mesh-ancestor
110907012|NCT03694119|Autonomic Agents|autonomic agents|mesh-ancestor
110907013|NCT03694119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110907014|NCT03694119|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110907015|NCT03694119|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110907016|NCT03694119|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110907017|NCT03694119|Adrenergic Agents|adrenergic agents|mesh-ancestor
110907018|NCT03694119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110907019|NCT02178254|Fosfomycin|fosfomycin|mesh-list
110925765|NCT04223024|Nimotuzumab|nimotuzumab|mesh-list
110907020|NCT02178254|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110907021|NCT02178254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110907022|NCT02173262|Ciprofloxacin|ciprofloxacin|mesh-list
110907023|NCT02173262|Lenograstim|lenograstim|mesh-list
110907024|NCT02173262|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110907025|NCT02173262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110907026|NCT02173262|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110907027|NCT02173262|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110907028|NCT02173262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110907029|NCT02173262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110907030|NCT02173262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110208772|NCT00195793|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110907031|NCT02173262|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110907032|NCT02173262|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110907033|NCT02173262|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110907034|NCT02173262|Immunologic Factors|immunologic factors|mesh-ancestor
110907035|NCT02173262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110907036|NCT02173418|Ropivacaine|ropivacaine|mesh-list
110907037|NCT02173418|Anesthetics, Local|anesthetics, local|mesh-ancestor
110907038|NCT02173418|Anesthetics|anesthetics|mesh-ancestor
110208845|NCT00060476|Analgesics|analgesics|mesh-ancestor
110907039|NCT02173418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110907040|NCT02173418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110907041|NCT02173418|Sensory System Agents|sensory system agents|mesh-ancestor
110907042|NCT02173418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110907043|NCT03932331|Acalabrutinib|acalabrutinib|mesh-list
110907044|NCT03932331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110907045|NCT02178488|Cholecalciferol|cholecalciferol|mesh-list
110907047|NCT02178488|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110907048|NCT02178488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110907049|NCT02178488|Vitamins|vitamins|mesh-ancestor
110907050|NCT02178488|Micronutrients|micronutrients|mesh-ancestor
110907051|NCT02178488|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110907052|NCT02173652|Linagliptin|linagliptin|mesh-list
110907053|NCT02173652|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110907054|NCT02173652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110907055|NCT02173652|Incretins|incretins|mesh-ancestor
110907056|NCT02173652|Hormones|hormones|mesh-ancestor
110907057|NCT02173652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110907058|NCT02173652|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110907059|NCT02173652|Protease Inhibitors|protease inhibitors|mesh-ancestor
110208909|NCT00196612|Emtricitabine|emtricitabine|mesh-list
110907060|NCT02173652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110907061|NCT02173652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110907062|NCT02173730|Pantoprazole|pantoprazole|mesh-list
110907063|NCT02173730|Dabigatran|dabigatran|mesh-list
110907064|NCT02173730|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110907065|NCT02173730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110907066|NCT02173730|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110907067|NCT02173730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110907068|NCT02173730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110907069|NCT02173730|Antithrombins|antithrombins|mesh-ancestor
110907070|NCT02173730|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110907071|NCT02173730|Protease Inhibitors|protease inhibitors|mesh-ancestor
110907072|NCT02173730|Anticoagulants|anticoagulants|mesh-ancestor
110907073|NCT02175446|Bevacizumab|bevacizumab|mesh-list
110907074|NCT02175446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110907075|NCT02175446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110907076|NCT02175446|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110907077|NCT02175446|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110907078|NCT02175446|Growth Substances|growth substances|mesh-ancestor
110907079|NCT02175446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110907080|NCT02175446|Growth Inhibitors|growth inhibitors|mesh-ancestor
110907081|NCT02178644|Capecitabine|capecitabine|mesh-list
110907082|NCT02178644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110925780|NCT03492710|Antibodies|antibodies|mesh-list
110907084|NCT02178644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110907085|NCT02178644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110907086|NCT03686163|Mitogens|mitogens|mesh-list
110907087|NCT03686163|Mitosis Modulators|mitosis modulators|mesh-ancestor
110209019|NCT00084435|Docetaxel|docetaxel|mesh-list
110907088|NCT03686163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110907089|NCT02173808|Levonorgestrel|levonorgestrel|mesh-list
110907090|NCT02173808|Levonorgestrel butanoate|levonorgestrel butanoate|mesh-list
110907091|NCT02173808|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110907092|NCT02173808|Contraceptive Agents|contraceptive agents|mesh-ancestor
110907093|NCT02173808|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110907094|NCT02173808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110907095|NCT02173808|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110907096|NCT02173808|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110907097|NCT02173808|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110907098|NCT02173808|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110907099|NCT02173886|Bupropion|bupropion|mesh-list
110907100|NCT02173886|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110907101|NCT02173886|Antidepressive Agents|antidepressive agents|mesh-ancestor
110225543|NCT05908786|Bevacizumab|bevacizumab|mesh-list
110907102|NCT02173886|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110907103|NCT02173886|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110907104|NCT02173886|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110907105|NCT02173886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110907106|NCT02173886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110907107|NCT02173886|Dopamine Agents|dopamine agents|mesh-ancestor
110907108|NCT02173886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110907109|NCT02173886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110907110|NCT02173886|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110209211|NCT00198367|Carboplatin|carboplatin|mesh-list
110907111|NCT02173886|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110907112|NCT02173886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110907113|NCT02173964|Pinaverium|pinaverium|mesh-list
110907114|NCT02173964|Bromides|bromides|mesh-list
110907115|NCT02173964|Anticonvulsants|anticonvulsants|mesh-ancestor
110907116|NCT02173964|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110907117|NCT02173964|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110907118|NCT02173964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110907119|NCT02173964|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110907120|NCT02173964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110907121|NCT02173964|Parasympatholytics|parasympatholytics|mesh-ancestor
110907122|NCT02173964|Autonomic Agents|autonomic agents|mesh-ancestor
110907123|NCT02173964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110907124|NCT02175602|Sertraline|sertraline|mesh-list
110907125|NCT02175602|Escitalopram|escitalopram|mesh-list
110907126|NCT02175602|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110907127|NCT02175602|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110907128|NCT02175602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110907129|NCT02175602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110907130|NCT02175602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110907131|NCT02175602|Serotonin Agents|serotonin agents|mesh-ancestor
110907132|NCT02175602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110907133|NCT02175602|Antidepressive Agents|antidepressive agents|mesh-ancestor
110907134|NCT02175602|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110907135|NCT03686085|Dinoprostone|dinoprostone|mesh-list
110907136|NCT03686085|Oxytocics|oxytocics|mesh-ancestor
110907137|NCT03686085|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110907138|NCT03686085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110907139|NCT03693885|Oxytocin|oxytocin|mesh-list
110907140|NCT03693885|Oxytocics|oxytocics|mesh-ancestor
110907141|NCT03693885|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110907142|NCT03693885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110907143|NCT02174120|Propofol|propofol|mesh-list
110907144|NCT02174120|Etomidate|etomidate|mesh-list
110907145|NCT02174120|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110907146|NCT02174120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110907147|NCT02174120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110907148|NCT02174120|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110907149|NCT02174120|Anesthetics, General|anesthetics, general|mesh-ancestor
110907150|NCT02174120|Anesthetics|anesthetics|mesh-ancestor
110907151|NCT02175914|Erythromycin|erythromycin|mesh-list
110907152|NCT02175914|Erythromycin Estolate|erythromycin estolate|mesh-list
110907153|NCT02175914|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
110907154|NCT02175914|Erythromycin stearate|erythromycin stearate|mesh-list
110907155|NCT02175914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110907156|NCT02175914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110907157|NCT02175914|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110907158|NCT02175914|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110907159|NCT02175914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110907160|NCT02175914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110907161|NCT02753816|Tranexamic Acid|tranexamic acid|mesh-list
110907162|NCT02753816|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110907163|NCT02753816|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110907164|NCT02753816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110907165|NCT02753816|Hemostatics|hemostatics|mesh-ancestor
110907166|NCT02753816|Coagulants|coagulants|mesh-ancestor
110907167|NCT02179034|Menthol|menthol|mesh-list
110907168|NCT02179034|Nicotine|nicotine|mesh-list
110907169|NCT02179034|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110907170|NCT02179034|Autonomic Agents|autonomic agents|mesh-ancestor
110907171|NCT02179034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110225546|NCT05908786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110907172|NCT02179034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110907173|NCT02179034|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110907174|NCT02179034|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110907175|NCT02179034|Cholinergic Agents|cholinergic agents|mesh-ancestor
110907176|NCT02179034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110907177|NCT02179034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110907178|NCT02179034|Antipruritics|antipruritics|mesh-ancestor
110907179|NCT02179034|Dermatologic Agents|dermatologic agents|mesh-ancestor
110907181|NCT02174588|Propofol|propofol|mesh-list
110907182|NCT02174588|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110907183|NCT02174588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110907184|NCT02174588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110907185|NCT02174588|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110907186|NCT02174588|Anesthetics, General|anesthetics, general|mesh-ancestor
110907187|NCT02174588|Anesthetics|anesthetics|mesh-ancestor
110907188|NCT02174588|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110907189|NCT02174588|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110907190|NCT02174588|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110907191|NCT02174588|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110907192|NCT02174588|GABA Modulators|gaba modulators|mesh-ancestor
110907193|NCT02174588|GABA Agents|gaba agents|mesh-ancestor
110907194|NCT02174588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110907195|NCT02174588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110907196|NCT03693573|Bevacizumab|bevacizumab|mesh-list
110907197|NCT03693573|Atezolizumab|atezolizumab|mesh-list
110907198|NCT03693573|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110907199|NCT03693573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110907200|NCT03693573|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110907201|NCT03693573|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110907202|NCT03693573|Growth Substances|growth substances|mesh-ancestor
110907203|NCT03693573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110907204|NCT03693573|Growth Inhibitors|growth inhibitors|mesh-ancestor
110907205|NCT03693573|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110907206|NCT03693573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110907207|NCT02176304|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110907208|NCT02176304|Methylprednisolone|methylprednisolone|mesh-list
110907209|NCT02176304|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110907210|NCT02176304|Prednisolone|prednisolone|mesh-list
110907211|NCT02176304|Prednisolone acetate|prednisolone acetate|mesh-list
110907212|NCT02176304|Lidocaine|lidocaine|mesh-list
110907213|NCT02176304|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110907214|NCT02176304|Prednisolone phosphate|prednisolone phosphate|mesh-list
110907215|NCT02176304|Anesthetics, Local|anesthetics, local|mesh-ancestor
110907216|NCT02176304|Anesthetics|anesthetics|mesh-ancestor
110907217|NCT02176304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110907218|NCT02176304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110907219|NCT02176304|Sensory System Agents|sensory system agents|mesh-ancestor
110907220|NCT02176304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110907221|NCT02176304|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110907222|NCT02176304|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110907223|NCT02176304|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110907224|NCT02176304|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110209787|NCT00048828|Serotonin Agents|serotonin agents|mesh-ancestor
110907225|NCT02176304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110907226|NCT02176304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110907227|NCT02176304|Antiemetics|antiemetics|mesh-ancestor
110907228|NCT02176304|Autonomic Agents|autonomic agents|mesh-ancestor
110907229|NCT02176304|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110907230|NCT02176304|Glucocorticoids|glucocorticoids|mesh-ancestor
110907231|NCT02176304|Hormones|hormones|mesh-ancestor
110907232|NCT02176304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110225554|NCT05905419|Analgesics, Opioid|analgesics, opioid|mesh-list
110907233|NCT02176304|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110907234|NCT02176304|Protective Agents|protective agents|mesh-ancestor
110209849|NCT00222235|Cycloserine|cycloserine|mesh-list
110907235|NCT02176304|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110907236|NCT02176304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110907237|NCT02176460|Colchicine|colchicine|mesh-list
110907238|NCT02176460|Gout Suppressants|gout suppressants|mesh-ancestor
110907239|NCT02176460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110907240|NCT02176460|Tubulin Modulators|tubulin modulators|mesh-ancestor
110907241|NCT02176460|Antimitotic Agents|antimitotic agents|mesh-ancestor
110907242|NCT02176460|Mitosis Modulators|mitosis modulators|mesh-ancestor
110907243|NCT02176460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110907244|NCT02176460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110907245|NCT02256254|Simvastatin|simvastatin|mesh-list
110209919|NCT00085332|Docetaxel|docetaxel|mesh-list
110907246|NCT02256254|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110907247|NCT02256254|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110907248|NCT02256254|Antimetabolites|antimetabolites|mesh-ancestor
110907249|NCT02256254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110907250|NCT02256254|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110907251|NCT02256254|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110907252|NCT02256254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110907253|NCT02182076|Nintedanib|nintedanib|mesh-list
110907254|NCT02182076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110907255|NCT02182076|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110907256|NCT02182076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110907257|NCT02182076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110907258|NCT02179268|Sertraline|sertraline|mesh-list
110907259|NCT02179268|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
110907260|NCT02179268|Citalopram|citalopram|mesh-list
110907261|NCT02179268|Reboxetine|reboxetine|mesh-list
110907262|NCT02179268|Antidepressive Agents|antidepressive agents|mesh-ancestor
110907263|NCT02179268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110907264|NCT02179268|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110907265|NCT02179268|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110907266|NCT02179268|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110907267|NCT02179268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110907269|NCT02179268|Serotonin Agents|serotonin agents|mesh-ancestor
110907270|NCT02179268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110907271|NCT02179268|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110907272|NCT02179268|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110210107|NCT00223717|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110907273|NCT02179268|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110907274|NCT02179268|Adrenergic Agents|adrenergic agents|mesh-ancestor
110907275|NCT02182154|Nintedanib|nintedanib|mesh-list
110907276|NCT02182154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110907277|NCT02182154|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110907278|NCT02182154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110907279|NCT02182154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110907280|NCT02182232|Paclitaxel|paclitaxel|mesh-list
110907281|NCT02182232|Carboplatin|carboplatin|mesh-list
110907282|NCT02182232|Nintedanib|nintedanib|mesh-list
110907283|NCT02182232|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110907284|NCT02182232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110907285|NCT02182232|Tubulin Modulators|tubulin modulators|mesh-ancestor
110907286|NCT02182232|Antimitotic Agents|antimitotic agents|mesh-ancestor
110907287|NCT02182232|Mitosis Modulators|mitosis modulators|mesh-ancestor
110907288|NCT02182232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110907289|NCT02182232|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110907290|NCT02182232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110907291|NCT02182310|Moxifloxacin|moxifloxacin|mesh-list
110907292|NCT02182310|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110907293|NCT02182310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110907294|NCT02182310|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110907295|NCT02182310|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110907296|NCT02182310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110907297|NCT02182310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110907298|NCT02182310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110907299|NCT02176850|Telmisartan|telmisartan|mesh-list
110210246|NCT00224458|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110907300|NCT02176850|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110907301|NCT02176850|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110907302|NCT02176850|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110624761|NCT01007500|Antipruritics|antipruritics|mesh-ancestor
110907303|NCT02176850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110907304|NCT03537326|Budesonide|budesonide|mesh-list
110907305|NCT03537326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110907306|NCT03537326|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110907307|NCT03537326|Autonomic Agents|autonomic agents|mesh-ancestor
110907308|NCT03537326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110907309|NCT03537326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110907310|NCT03537326|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110907311|NCT03537326|Respiratory System Agents|respiratory system agents|mesh-ancestor
110907312|NCT03537326|Glucocorticoids|glucocorticoids|mesh-ancestor
110907313|NCT03537326|Hormones|hormones|mesh-ancestor
110907314|NCT03537326|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110907315|NCT02182544|Ketotifen|ketotifen|mesh-list
110907316|NCT02182544|Epinastine|epinastine|mesh-list
110907317|NCT02182544|Antipruritics|antipruritics|mesh-ancestor
110907318|NCT02182544|Dermatologic Agents|dermatologic agents|mesh-ancestor
110907319|NCT02182544|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110907320|NCT02182544|Histamine Antagonists|histamine antagonists|mesh-ancestor
110907321|NCT02182544|Histamine Agents|histamine agents|mesh-ancestor
110907322|NCT02182544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110907323|NCT02182544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110907324|NCT02182544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110907325|NCT02182544|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110907326|NCT02179658|Vancomycin|vancomycin|mesh-list
110907327|NCT02179658|Fidaxomicin|fidaxomicin|mesh-list
110907328|NCT02179658|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110907329|NCT02179658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110907330|NCT02177318|Bromides|bromides|mesh-list
110907331|NCT02177318|Tiotropium Bromide|tiotropium bromide|mesh-list
110907332|NCT02177318|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110907333|NCT02177318|Autonomic Agents|autonomic agents|mesh-ancestor
110907334|NCT02177318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110907335|NCT02177318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110907336|NCT02177318|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110907337|NCT02177318|Respiratory System Agents|respiratory system agents|mesh-ancestor
110210508|NCT00095511|Aripiprazole|aripiprazole|mesh-list
110907338|NCT02177318|Parasympatholytics|parasympatholytics|mesh-ancestor
110907339|NCT02177318|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110907340|NCT02177318|Cholinergic Agents|cholinergic agents|mesh-ancestor
110907341|NCT02177318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110907342|NCT02177318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110907343|NCT02177318|Anticonvulsants|anticonvulsants|mesh-ancestor
110907344|NCT02177396|Valsartan|valsartan|mesh-list
110907345|NCT02177396|Telmisartan|telmisartan|mesh-list
110907346|NCT02177396|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110907347|NCT02177396|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110907348|NCT02177396|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110907349|NCT02177396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110907350|NCT02030054|Atorvastatin|atorvastatin|mesh-list
110907351|NCT02030054|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110907352|NCT02030054|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110907353|NCT02030054|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110907354|NCT02030054|Antimetabolites|antimetabolites|mesh-ancestor
110907355|NCT02030054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110907356|NCT02030054|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110907357|NCT02030054|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110907358|NCT02030054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110907359|NCT02182622|Prednisone|prednisone|mesh-list
110907360|NCT02182622|Docetaxel|docetaxel|mesh-list
110907361|NCT02182622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110907362|NCT02182622|Tubulin Modulators|tubulin modulators|mesh-ancestor
110907363|NCT02182622|Antimitotic Agents|antimitotic agents|mesh-ancestor
110907364|NCT02182622|Mitosis Modulators|mitosis modulators|mesh-ancestor
110907365|NCT02182622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110907366|NCT02182622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110907368|NCT02182622|Hormones|hormones|mesh-ancestor
110907369|NCT02182622|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110907370|NCT02182622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110907371|NCT02182622|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110907372|NCT02182700|Bromides|bromides|mesh-list
110907373|NCT02182700|Albuterol|albuterol|mesh-list
110907374|NCT02182700|Ipratropium|ipratropium|mesh-list
110907375|NCT02182700|Anticonvulsants|anticonvulsants|mesh-ancestor
110907376|NCT02182700|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110907377|NCT02182700|Autonomic Agents|autonomic agents|mesh-ancestor
110907378|NCT02182700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110907379|NCT02182700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110907380|NCT02182700|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110907381|NCT02182700|Respiratory System Agents|respiratory system agents|mesh-ancestor
110907382|NCT02182700|Tocolytic Agents|tocolytic agents|mesh-ancestor
110907383|NCT02182700|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110907384|NCT02182700|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110907385|NCT02182700|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110907386|NCT02182700|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110907387|NCT02182700|Adrenergic Agents|adrenergic agents|mesh-ancestor
110907388|NCT02182700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110907389|NCT02182700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110907390|NCT02182700|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110907391|NCT02182700|Cholinergic Agents|cholinergic agents|mesh-ancestor
110907392|NCT02182778|Cisplatin|cisplatin|mesh-list
110907393|NCT02182778|Gemcitabine|gemcitabine|mesh-list
110210749|NCT00226564|Narcotics|narcotics|mesh-ancestor
110907394|NCT02182778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110907395|NCT02182778|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110907396|NCT02182778|Antimetabolites|antimetabolites|mesh-ancestor
110907397|NCT02182778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110907398|NCT03688971|Ketoconazole|ketoconazole|mesh-list
110907399|NCT03688971|Antifungal Agents|antifungal agents|mesh-ancestor
110907400|NCT03688971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110907401|NCT03688971|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110210817|NCT00227032|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110907402|NCT03688971|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110907403|NCT03688971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110907404|NCT03688971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110907405|NCT03688971|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110907406|NCT03688971|Hormone Antagonists|hormone antagonists|mesh-ancestor
110907407|NCT03688971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110907408|NCT03688971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110907409|NCT03688971|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110907410|NCT02179814|Diphenhydramine|diphenhydramine|mesh-list
110907411|NCT02179814|Promethazine|promethazine|mesh-list
110907412|NCT02179814|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110907413|NCT02179814|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110907414|NCT02179814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110907415|NCT02179814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110907416|NCT02179814|Anesthetics, Local|anesthetics, local|mesh-ancestor
110907417|NCT02179814|Anesthetics|anesthetics|mesh-ancestor
110907418|NCT02179814|Sensory System Agents|sensory system agents|mesh-ancestor
110907419|NCT02179814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110907420|NCT02179814|Antiemetics|antiemetics|mesh-ancestor
110907421|NCT02179814|Autonomic Agents|autonomic agents|mesh-ancestor
110907422|NCT02179814|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110907423|NCT02179814|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110225578|NCT05896228|Acetaminophen|acetaminophen|mesh-list
110907424|NCT02179814|Histamine Antagonists|histamine antagonists|mesh-ancestor
110907425|NCT02179814|Histamine Agents|histamine agents|mesh-ancestor
110907426|NCT02179814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110907427|NCT02179814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110907428|NCT02179814|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110907429|NCT02179814|Antipruritics|antipruritics|mesh-ancestor
110907430|NCT02179814|Dermatologic Agents|dermatologic agents|mesh-ancestor
110907431|NCT02179970|Plerixafor|plerixafor|mesh-list
110907432|NCT02179970|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110907433|NCT02179970|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110907434|NCT02179970|Antiviral Agents|antiviral agents|mesh-ancestor
110907435|NCT02179970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110907436|NCT03537950|Cannabidiol|cannabidiol|mesh-list
110907437|NCT03537950|Anticonvulsants|anticonvulsants|mesh-ancestor
110907438|NCT02182856|Bromides|bromides|mesh-list
110907439|NCT02182856|Albuterol|albuterol|mesh-list
110907440|NCT02182856|Ipratropium|ipratropium|mesh-list
110907441|NCT02182856|Anticonvulsants|anticonvulsants|mesh-ancestor
110907442|NCT02182856|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110907443|NCT02182856|Autonomic Agents|autonomic agents|mesh-ancestor
110907444|NCT02182856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110907445|NCT02182856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110907446|NCT02182856|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110907447|NCT02182856|Respiratory System Agents|respiratory system agents|mesh-ancestor
110907448|NCT02182856|Tocolytic Agents|tocolytic agents|mesh-ancestor
110907449|NCT02182856|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110907450|NCT02182856|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110907451|NCT02182856|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110624911|NCT01008592|Levocetirizine|levocetirizine|mesh-list
110907452|NCT02182856|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110211082|NCT00228358|Analgesics|analgesics|mesh-ancestor
110907453|NCT02182856|Adrenergic Agents|adrenergic agents|mesh-ancestor
110907455|NCT02182856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110907456|NCT02182856|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110907457|NCT02182856|Cholinergic Agents|cholinergic agents|mesh-ancestor
110907459|NCT02183012|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110907460|NCT02183012|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110907461|NCT02183012|Analgesics|analgesics|mesh-ancestor
110907462|NCT02183012|Sensory System Agents|sensory system agents|mesh-ancestor
110907463|NCT02183012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110907464|NCT02183012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110907465|NCT02183012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110907466|NCT02183012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110907467|NCT02183012|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110907468|NCT02183012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110907469|NCT02183012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110907470|NCT02180048|Caffeine|caffeine|mesh-list
110907471|NCT02180048|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110907472|NCT02180048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110907473|NCT02180048|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110907474|NCT02180048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110907475|NCT02180048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110907476|NCT02180048|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110907477|NCT02180048|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110907478|NCT02180048|Purinergic Agents|purinergic agents|mesh-ancestor
110907479|NCT02180048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110907480|NCT03688659|Vancomycin|vancomycin|mesh-list
110907481|NCT03688659|Gentamicins|gentamicins|mesh-list
110907482|NCT03688659|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110907483|NCT03688659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110907484|NCT03688659|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110907485|NCT03688659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110907486|NCT03688659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110907487|NCT03683043|Leuprolide|leuprolide|mesh-list
110907488|NCT03683043|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110907489|NCT03683043|Fertility Agents|fertility agents|mesh-ancestor
110907490|NCT03683043|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110907491|NCT03683043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110907492|NCT03683043|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110907493|NCT03683043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110907494|NCT02180204|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
110907495|NCT02180204|Tenecteplase|tenecteplase|mesh-list
110907496|NCT02180204|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110907497|NCT02180204|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110907498|NCT02180204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110907499|NCT02183090|Meloxicam|meloxicam|mesh-list
110907500|NCT02183090|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110907501|NCT02183090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110907502|NCT02183090|Analgesics|analgesics|mesh-ancestor
110907503|NCT02183090|Sensory System Agents|sensory system agents|mesh-ancestor
110907504|NCT02183090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110907505|NCT02183090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110907506|NCT02183090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110907507|NCT02183090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110907508|NCT02183090|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110907509|NCT02183090|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110907510|NCT02183090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110907511|NCT02183090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110907512|NCT02177552|Carboplatin|carboplatin|mesh-list
110907513|NCT02177552|Docetaxel|docetaxel|mesh-list
110907514|NCT02177552|Capecitabine|capecitabine|mesh-list
110907515|NCT02177552|Oxaliplatin|oxaliplatin|mesh-list
110907516|NCT02177552|Epirubicin|epirubicin|mesh-list
110907517|NCT02177552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110907518|NCT02177552|Tubulin Modulators|tubulin modulators|mesh-ancestor
110907519|NCT02177552|Antimitotic Agents|antimitotic agents|mesh-ancestor
110907520|NCT02177552|Mitosis Modulators|mitosis modulators|mesh-ancestor
110907521|NCT02177552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110907522|NCT02177552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110907523|NCT02177552|Antimetabolites|antimetabolites|mesh-ancestor
110907524|NCT02177552|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110907525|NCT02177552|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110907526|NCT02177552|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110907527|NCT02177552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110235428|NCT00087854|Amonafide|amonafide|mesh-list
110907528|NCT03682653|Azithromycin|azithromycin|mesh-list
110907529|NCT03682653|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110907530|NCT03682653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110907531|NCT03684993|Chlorhexidine|chlorhexidine|mesh-list
110907532|NCT03684993|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110907533|NCT03684993|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110907534|NCT03684993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110907535|NCT03684993|Disinfectants|disinfectants|mesh-ancestor
110907536|NCT03684993|Dermatologic Agents|dermatologic agents|mesh-ancestor
110907537|NCT04062279|Autoantibodies|autoantibodies|mesh-list
110907538|NCT04062279|Immunologic Factors|immunologic factors|mesh-ancestor
110907539|NCT04062279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110907540|NCT02183168|Indomethacin|indomethacin|mesh-list
110907541|NCT02183168|Meloxicam|meloxicam|mesh-list
110907542|NCT02183168|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110907543|NCT02183168|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110907544|NCT02183168|Analgesics|analgesics|mesh-ancestor
110907545|NCT02183168|Sensory System Agents|sensory system agents|mesh-ancestor
110907546|NCT02183168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110907547|NCT02183168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110907548|NCT02183168|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110907549|NCT02183168|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110907550|NCT02183168|Gout Suppressants|gout suppressants|mesh-ancestor
110907551|NCT02183168|Tocolytic Agents|tocolytic agents|mesh-ancestor
110907552|NCT02183168|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110907553|NCT02183168|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110907554|NCT02183168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110211591|NCT00231829|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110907555|NCT02183168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110907556|NCT02183168|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110907557|NCT02183246|Porfiromycin|porfiromycin|mesh-list
110907558|NCT02183246|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110907559|NCT02183246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110907560|NCT02183324|Linagliptin|linagliptin|mesh-list
110907561|NCT02183324|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110907562|NCT02183324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110907563|NCT02183324|Incretins|incretins|mesh-ancestor
110907564|NCT02183324|Hormones|hormones|mesh-ancestor
110907565|NCT02183324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110907566|NCT02183324|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110907567|NCT02183324|Protease Inhibitors|protease inhibitors|mesh-ancestor
110907568|NCT02183324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110907569|NCT02183324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110907570|NCT02183402|Linagliptin|linagliptin|mesh-list
110907571|NCT02183402|Digoxin|digoxin|mesh-list
110907572|NCT02183402|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110925871|NCT03350984|Insulin|insulin|mesh-list
110907574|NCT02183402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110907575|NCT02183402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110907576|NCT02183402|Protective Agents|protective agents|mesh-ancestor
110907577|NCT02183402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110907578|NCT02183402|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110907579|NCT02183402|Incretins|incretins|mesh-ancestor
110907580|NCT02183402|Hormones|hormones|mesh-ancestor
110907581|NCT02183402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110907582|NCT02183402|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110907583|NCT02183402|Protease Inhibitors|protease inhibitors|mesh-ancestor
110907584|NCT02183480|Linagliptin|linagliptin|mesh-list
110907585|NCT02183480|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110907586|NCT02183480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110907587|NCT02183480|Incretins|incretins|mesh-ancestor
110907588|NCT02183480|Hormones|hormones|mesh-ancestor
110907589|NCT02183480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110907590|NCT02183480|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110907591|NCT02183480|Protease Inhibitors|protease inhibitors|mesh-ancestor
110211854|NCT00097344|Estrogens|estrogens|mesh-list
110907592|NCT02183480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110907593|NCT02183480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110907594|NCT05141864|Lidocaine|lidocaine|mesh-list
110907595|NCT05141864|Anesthetics, Local|anesthetics, local|mesh-ancestor
110907596|NCT05141864|Anesthetics|anesthetics|mesh-ancestor
110907597|NCT05141864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110907598|NCT05141864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110907599|NCT05141864|Sensory System Agents|sensory system agents|mesh-ancestor
110211917|NCT00064142|Halofuginone|halofuginone|mesh-list
110907600|NCT05141864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110907601|NCT05141864|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110907602|NCT05141864|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110907603|NCT05141864|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110907604|NCT05141864|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110907605|NCT05141864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110907608|NCT02180516|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
110907609|NCT02180516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
110907610|NCT02180516|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110907611|NCT02180516|Analgesics|analgesics|mesh-ancestor
110907612|NCT02180516|Sensory System Agents|sensory system agents|mesh-ancestor
110907613|NCT02180516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110907614|NCT02180516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110907615|NCT02180516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110907616|NCT02180516|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110907617|NCT02180516|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110907618|NCT02180516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110907619|NCT02180516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110907620|NCT02183636|Pioglitazone|pioglitazone|mesh-list
110907621|NCT02183636|Linagliptin|linagliptin|mesh-list
110907622|NCT02183636|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110907623|NCT02183636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110907624|NCT02183636|Incretins|incretins|mesh-ancestor
110907625|NCT02183636|Hormones|hormones|mesh-ancestor
110907626|NCT02183636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110907627|NCT02183636|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110907628|NCT02183636|Protease Inhibitors|protease inhibitors|mesh-ancestor
110907629|NCT02183636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110907630|NCT02183636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110907631|NCT02183948|Oxytocin|oxytocin|mesh-list
110907632|NCT02183948|Oxytocics|oxytocics|mesh-ancestor
110907633|NCT02183948|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110907634|NCT02183948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110907635|NCT02184104|Caffeine|caffeine|mesh-list
110907636|NCT02184104|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110907637|NCT02184104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110907638|NCT02184104|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110907639|NCT02184104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110907640|NCT02184104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110907641|NCT02184104|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110907642|NCT02184104|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110907643|NCT02184104|Purinergic Agents|purinergic agents|mesh-ancestor
110907644|NCT02184104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110907645|NCT02184260|Dipyrone|dipyrone|mesh-list
110212094|NCT00076284|Aplaviroc|aplaviroc|mesh-list
110907646|NCT02184260|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110907647|NCT02184260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110907648|NCT02184260|Analgesics|analgesics|mesh-ancestor
110907649|NCT02184260|Sensory System Agents|sensory system agents|mesh-ancestor
110907650|NCT02184260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110907651|NCT02184260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110907652|NCT02184260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110212161|NCT00234676|Hormones|hormones|mesh-ancestor
110907653|NCT02184260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110907654|NCT02184260|Antipyretics|antipyretics|mesh-ancestor
110907655|NCT03813147|Cytarabine|cytarabine|mesh-list
110907656|NCT03813147|Hydrocortisone|hydrocortisone|mesh-list
110907657|NCT03813147|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
110907658|NCT03813147|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
110907659|NCT03813147|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
110907660|NCT03813147|Methotrexate|methotrexate|mesh-list
110907661|NCT03813147|Fludarabine phosphate|fludarabine phosphate|mesh-list
110907662|NCT03813147|Azacitidine|azacitidine|mesh-list
110907663|NCT03813147|Fludarabine|fludarabine|mesh-list
110907664|NCT03813147|Enzyme Inhibitors|enzyme inhibitors|mesh-list
110907665|NCT03813147|Pevonedistat|pevonedistat|mesh-list
110907666|NCT03813147|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110907667|NCT03813147|Abortifacient Agents|abortifacient agents|mesh-ancestor
110907668|NCT03813147|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110907669|NCT03813147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110907670|NCT03813147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110907671|NCT03813147|Antimetabolites|antimetabolites|mesh-ancestor
110907672|NCT03813147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110907673|NCT03813147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110907674|NCT03813147|Dermatologic Agents|dermatologic agents|mesh-ancestor
110907675|NCT03813147|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110907676|NCT03813147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110907677|NCT03813147|Immunologic Factors|immunologic factors|mesh-ancestor
110907678|NCT03813147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110907679|NCT03813147|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110907680|NCT03813147|Antiviral Agents|antiviral agents|mesh-ancestor
110907681|NCT03813147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110907682|NCT03813147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110907684|NCT03684837|Vitamins|vitamins|mesh-ancestor
110907685|NCT03684837|Micronutrients|micronutrients|mesh-ancestor
110907686|NCT03684837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110907687|NCT03684837|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110907688|NCT03810417|Digoxin|digoxin|mesh-list
110907689|NCT03810417|Antibodies|antibodies|mesh-list
110907690|NCT03810417|Immunoglobulin Fab Fragments|immunoglobulin fab fragments|mesh-list
110907691|NCT03810417|Immunologic Factors|immunologic factors|mesh-ancestor
110907692|NCT03810417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110907693|NCT03810417|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110907694|NCT03810417|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110907695|NCT03810417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110907696|NCT03810417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110907697|NCT03810417|Protective Agents|protective agents|mesh-ancestor
110907698|NCT03808155|Tamsulosin|tamsulosin|mesh-list
110907699|NCT03808155|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110907700|NCT03808155|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110907701|NCT03808155|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110907702|NCT03808155|Adrenergic Agents|adrenergic agents|mesh-ancestor
110907703|NCT03808155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110907704|NCT03808155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110907705|NCT03808155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110907706|NCT03808155|Urological Agents|urological agents|mesh-ancestor
110907707|NCT02752958|Fluorides|fluorides|mesh-list
110907708|NCT02752958|Tin Fluorides|tin fluorides|mesh-list
110907709|NCT02752958|Cariostatic Agents|cariostatic agents|mesh-ancestor
110907710|NCT02752958|Protective Agents|protective agents|mesh-ancestor
110907711|NCT02752958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110907712|NCT02181218|Dexamethasone|dexamethasone|mesh-list
110907713|NCT02181218|Dexamethasone acetate|dexamethasone acetate|mesh-list
110907714|NCT02181218|Gemcitabine|gemcitabine|mesh-list
110907715|NCT02181218|Oxaliplatin|oxaliplatin|mesh-list
110907716|NCT02181218|Romidepsin|romidepsin|mesh-list
110907717|NCT02181218|BB 1101|bb 1101|mesh-list
110907718|NCT02181218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110907719|NCT02181218|Antiemetics|antiemetics|mesh-ancestor
110907720|NCT02181218|Autonomic Agents|autonomic agents|mesh-ancestor
110907721|NCT02181218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110907722|NCT02181218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110907724|NCT02181218|Glucocorticoids|glucocorticoids|mesh-ancestor
110907725|NCT02181218|Hormones|hormones|mesh-ancestor
110907726|NCT02181218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110907727|NCT02181218|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110907728|NCT02181218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110907729|NCT02181218|Protease Inhibitors|protease inhibitors|mesh-ancestor
110907730|NCT02181218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110907731|NCT02181218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110907732|NCT02181218|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110907733|NCT02181218|Antimetabolites|antimetabolites|mesh-ancestor
110907734|NCT02181218|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110907735|NCT02181218|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110907736|NCT03536234|Triptorelin Pamoate|triptorelin pamoate|mesh-list
110907737|NCT03536234|Luteolytic Agents|luteolytic agents|mesh-ancestor
110907738|NCT03536234|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110907739|NCT03536234|Contraceptive Agents|contraceptive agents|mesh-ancestor
110907740|NCT03536234|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110907741|NCT03536234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110907742|NCT03536234|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110907743|NCT03536234|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110907744|NCT03536234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110907745|NCT03682497|Spironolactone|spironolactone|mesh-list
110907746|NCT03682497|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110907747|NCT03682497|Hormone Antagonists|hormone antagonists|mesh-ancestor
110907748|NCT03682497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110907749|NCT03682497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110907750|NCT03682497|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110907751|NCT03682497|Diuretics|diuretics|mesh-ancestor
110907752|NCT03682497|Natriuretic Agents|natriuretic agents|mesh-ancestor
110907753|NCT02185898|Menthol|menthol|mesh-list
110907754|NCT02185898|Nicotine|nicotine|mesh-list
110907755|NCT02185898|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110907756|NCT02185898|Autonomic Agents|autonomic agents|mesh-ancestor
110907757|NCT02185898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110212607|NCT00237484|Interferons|interferons|mesh-list
110907758|NCT02185898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110907759|NCT02185898|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110907760|NCT02185898|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110907761|NCT02185898|Cholinergic Agents|cholinergic agents|mesh-ancestor
110907762|NCT02185898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110907763|NCT02185898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110907764|NCT02185898|Antipruritics|antipruritics|mesh-ancestor
110907765|NCT02185898|Dermatologic Agents|dermatologic agents|mesh-ancestor
110907766|NCT02805660|Durvalumab|durvalumab|mesh-list
110907767|NCT02805660|Mocetinostat|mocetinostat|mesh-list
110907768|NCT02805660|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110907769|NCT02805660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110225674|NCT05868122|Acetaminophen|acetaminophen|mesh-list
110907770|NCT02805660|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110907771|NCT02805660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110907772|NCT02805660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110907773|NCT02186132|Atropine|atropine|mesh-list
110907774|NCT02186132|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110907775|NCT02186132|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110907776|NCT02186132|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110907777|NCT02186132|Autonomic Agents|autonomic agents|mesh-ancestor
110907778|NCT02186132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110907779|NCT02186132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110907780|NCT02186132|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110907781|NCT02186132|Respiratory System Agents|respiratory system agents|mesh-ancestor
110907782|NCT02186132|Mydriatics|mydriatics|mesh-ancestor
110907783|NCT02186132|Parasympatholytics|parasympatholytics|mesh-ancestor
110907784|NCT02186132|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110907785|NCT02186132|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110907786|NCT02186132|Cholinergic Agents|cholinergic agents|mesh-ancestor
110907787|NCT02186132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110907788|NCT02186132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110907789|NCT03536780|Gemcitabine|gemcitabine|mesh-list
110907790|NCT03536780|Avelumab|avelumab|mesh-list
110907791|NCT03536780|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110907792|NCT03536780|Antimetabolites|antimetabolites|mesh-ancestor
110907793|NCT03536780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110907794|NCT03536780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110907795|NCT03536780|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110907796|NCT02052336|Clarithromycin|clarithromycin|mesh-list
110907797|NCT02052336|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110907798|NCT02052336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110907799|NCT02052336|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110907800|NCT02052336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110907801|NCT02052336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110907802|NCT02052336|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110907803|NCT02052336|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110907804|NCT02181920|Dipyrone|dipyrone|mesh-list
110907805|NCT02181920|Diclofenac|diclofenac|mesh-list
110907806|NCT02181920|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110907807|NCT02181920|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110212887|NCT00098358|Zileuton|zileuton|mesh-list
110907808|NCT02181920|Analgesics|analgesics|mesh-ancestor
110907809|NCT02181920|Sensory System Agents|sensory system agents|mesh-ancestor
110907810|NCT02181920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110907811|NCT02181920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110907812|NCT02181920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110907813|NCT02181920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110907814|NCT02181920|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110907815|NCT02181920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110907816|NCT02181920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110907817|NCT02181920|Antipyretics|antipyretics|mesh-ancestor
110907818|NCT02185118|Sevoflurane|sevoflurane|mesh-list
110907819|NCT02185118|Isoflurane|isoflurane|mesh-list
110907820|NCT02185118|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110907821|NCT02185118|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110907822|NCT02185118|Anesthetics, General|anesthetics, general|mesh-ancestor
110625290|NCT05438888|Warfarin|warfarin|mesh-list
110907823|NCT02185118|Anesthetics|anesthetics|mesh-ancestor
110925929|NCT02770248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110212985|NCT00239278|Adrenergic Agents|adrenergic agents|mesh-ancestor
110907824|NCT02185118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110907825|NCT02185118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110907826|NCT02186366|Buspirone|buspirone|mesh-list
110907827|NCT02186366|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110907828|NCT02186366|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110907829|NCT02186366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110907830|NCT02186366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110907831|NCT02186366|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110907832|NCT02186366|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110907833|NCT02186366|Serotonin Agents|serotonin agents|mesh-ancestor
110907834|NCT02186366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110907835|NCT02186366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110907836|NCT02053974|Spironolactone|spironolactone|mesh-list
110907837|NCT02053974|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110907838|NCT02053974|Hormone Antagonists|hormone antagonists|mesh-ancestor
110907839|NCT02053974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110907840|NCT02053974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110213110|NCT00239980|Tinzaparin|tinzaparin|mesh-list
110907841|NCT02053974|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110907842|NCT02053974|Diuretics|diuretics|mesh-ancestor
110907843|NCT02053974|Natriuretic Agents|natriuretic agents|mesh-ancestor
110907844|NCT02185196|Vitamin D|vitamin d|mesh-list
110907845|NCT02185196|Cholecalciferol|cholecalciferol|mesh-list
110907846|NCT02185196|Vitamins|vitamins|mesh-ancestor
110907847|NCT02185196|Micronutrients|micronutrients|mesh-ancestor
110213209|NCT00098631|Lapatinib|lapatinib|mesh-list
110907848|NCT02185196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110907849|NCT02185196|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110907850|NCT02185196|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110907851|NCT02052492|Vitamin D|vitamin d|mesh-list
110907852|NCT02052492|Vitamins|vitamins|mesh-ancestor
110907853|NCT02052492|Micronutrients|micronutrients|mesh-ancestor
110907854|NCT02052492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110907855|NCT02052492|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110907856|NCT02181998|Heparin|heparin|mesh-list
110907857|NCT02181998|Enoxaparin|enoxaparin|mesh-list
110907858|NCT02181998|Tenecteplase|tenecteplase|mesh-list
110907859|NCT02181998|Anticoagulants|anticoagulants|mesh-ancestor
110907860|NCT02181998|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110907861|NCT02181998|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110907862|NCT02181998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110907863|NCT02054052|Bevacizumab|bevacizumab|mesh-list
110907864|NCT02054052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110213334|NCT00241189|Sirolimus|sirolimus|mesh-list
110907865|NCT02054052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110907866|NCT02054052|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110907867|NCT02054052|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110907868|NCT02054052|Growth Substances|growth substances|mesh-ancestor
110213381|NCT00076986|Carmustine|carmustine|mesh-list
110907869|NCT02054052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110907870|NCT02054052|Growth Inhibitors|growth inhibitors|mesh-ancestor
110907871|NCT02185352|Cisplatin|cisplatin|mesh-list
110907872|NCT02185352|Etoposide|etoposide|mesh-list
110907873|NCT02185352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110907874|NCT02185352|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110907875|NCT02185352|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110907876|NCT02185352|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110907877|NCT02185352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110907878|NCT02185352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110907880|NCT02186600|Cholecalciferol|cholecalciferol|mesh-list
110907881|NCT02186600|Risedronic Acid|risedronic acid|mesh-list
110907882|NCT02186600|Calcium Carbonate|calcium carbonate|mesh-list
110907883|NCT02186600|Calcium|calcium|mesh-list
110907884|NCT02186600|Vitamins|vitamins|mesh-ancestor
110907885|NCT02186600|Micronutrients|micronutrients|mesh-ancestor
110907886|NCT02186600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110907887|NCT02186600|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110907888|NCT02186600|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110907889|NCT02186600|Antacids|antacids|mesh-ancestor
110907890|NCT02186600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110907891|NCT02186600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110907892|NCT02186600|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110907893|NCT02186600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110907894|NCT02052726|Vaccines|vaccines|mesh-list
110907895|NCT02052726|Immunologic Factors|immunologic factors|mesh-ancestor
110907896|NCT02052726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110907897|NCT02185430|Dexmedetomidine|dexmedetomidine|mesh-list
110907898|NCT02185430|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110907899|NCT02185430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110907900|NCT02185430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110907901|NCT02185430|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110907902|NCT02185430|Analgesics|analgesics|mesh-ancestor
110907903|NCT02185430|Sensory System Agents|sensory system agents|mesh-ancestor
110907904|NCT02185430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110907905|NCT02185430|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110907906|NCT02185430|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110907907|NCT02185430|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110907908|NCT02185430|Adrenergic Agents|adrenergic agents|mesh-ancestor
110907909|NCT02185430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110907910|NCT02185430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110907911|NCT03536390|Methylphenidate|methylphenidate|mesh-list
110907912|NCT03536390|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110907913|NCT03536390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110907914|NCT03536390|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110907915|NCT03536390|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110907916|NCT03536390|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110907917|NCT03536390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110907918|NCT03536390|Dopamine Agents|dopamine agents|mesh-ancestor
110907919|NCT03536390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110925958|NCT01344369|Norethindrone Acetate|norethindrone acetate|mesh-list
110925959|NCT01344369|Estradiol|estradiol|mesh-list
110213795|NCT00398957|Narcotics|narcotics|mesh-ancestor
110907921|NCT03561870|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110907922|NCT03561870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110907923|NCT03561870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110907924|NCT03561870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110907925|NCT02186990|Propofol|propofol|mesh-list
110907926|NCT02186990|Etomidate|etomidate|mesh-list
110907927|NCT02186990|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110907928|NCT02186990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110907929|NCT02186990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110907930|NCT02186990|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110907931|NCT02186990|Anesthetics, General|anesthetics, general|mesh-ancestor
110907932|NCT02186990|Anesthetics|anesthetics|mesh-ancestor
110907933|NCT05657028|Lidocaine|lidocaine|mesh-list
110907934|NCT05657028|Dexmedetomidine|dexmedetomidine|mesh-list
110907935|NCT05657028|Anesthetics, Local|anesthetics, local|mesh-ancestor
110907936|NCT05657028|Anesthetics|anesthetics|mesh-ancestor
110907937|NCT05657028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110907938|NCT05657028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110907939|NCT05657028|Sensory System Agents|sensory system agents|mesh-ancestor
110907940|NCT05657028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110907941|NCT05657028|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110907942|NCT05657028|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110907943|NCT05657028|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110907944|NCT05657028|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110907945|NCT05657028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110907946|NCT05657028|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110907947|NCT05657028|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110907948|NCT05657028|Analgesics|analgesics|mesh-ancestor
110907949|NCT05657028|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110907950|NCT05657028|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110907951|NCT05657028|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110907952|NCT05657028|Adrenergic Agents|adrenergic agents|mesh-ancestor
110907953|NCT05657028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110907954|NCT02187068|Dexmedetomidine|dexmedetomidine|mesh-list
110907955|NCT02187068|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110214068|NCT00067535|Anesthetics|anesthetics|mesh-ancestor
110907956|NCT02187068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110907957|NCT02187068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110907958|NCT02187068|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110907959|NCT02187068|Analgesics|analgesics|mesh-ancestor
110907960|NCT02187068|Sensory System Agents|sensory system agents|mesh-ancestor
110907961|NCT02187068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110925983|NCT03491072|Anesthetics|anesthetics|mesh-ancestor
110907962|NCT02187068|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110907963|NCT02187068|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110907964|NCT02187068|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110907965|NCT02187068|Adrenergic Agents|adrenergic agents|mesh-ancestor
110907966|NCT02187068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110907967|NCT02187068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110907968|NCT02054442|Methotrexate|methotrexate|mesh-list
110907969|NCT02054442|Cetuximab|cetuximab|mesh-list
110907970|NCT02054442|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110907971|NCT02054442|Abortifacient Agents|abortifacient agents|mesh-ancestor
110907972|NCT02054442|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110907973|NCT02054442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110907974|NCT02054442|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110907975|NCT02054442|Antimetabolites|antimetabolites|mesh-ancestor
110214263|NCT00247741|Lidocaine|lidocaine|mesh-list
110907976|NCT02054442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110907977|NCT02054442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110907978|NCT02054442|Dermatologic Agents|dermatologic agents|mesh-ancestor
110907979|NCT02054442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110907980|NCT02054442|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110907981|NCT02054442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110907982|NCT02054442|Immunologic Factors|immunologic factors|mesh-ancestor
110907983|NCT02054442|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110214331|NCT00248443|Dimercaprol|dimercaprol|mesh-list
110907984|NCT02054442|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110907985|NCT02054442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110907987|NCT02054676|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110907988|NCT02054676|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110907989|NCT02054676|Analgesics|analgesics|mesh-ancestor
110907990|NCT02054676|Sensory System Agents|sensory system agents|mesh-ancestor
110907991|NCT02054676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110907992|NCT02054676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110907993|NCT02054676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110907994|NCT02054676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110907995|NCT02054676|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110907996|NCT02054676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110907997|NCT02054676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110907998|NCT02256956|Amitriptyline|amitriptyline|mesh-list
110907999|NCT02256956|Tolterodine Tartrate|tolterodine tartrate|mesh-list
110908000|NCT02256956|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110908001|NCT02256956|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110908002|NCT02256956|Cholinergic Agents|cholinergic agents|mesh-ancestor
110908003|NCT02256956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110908004|NCT02256956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110908005|NCT02256956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110908006|NCT02256956|Urological Agents|urological agents|mesh-ancestor
110908007|NCT02256956|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110908008|NCT02256956|Antidepressive Agents|antidepressive agents|mesh-ancestor
110908009|NCT02256956|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110908010|NCT02256956|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110908011|NCT02256956|Analgesics|analgesics|mesh-ancestor
110908012|NCT02256956|Sensory System Agents|sensory system agents|mesh-ancestor
110908013|NCT02256956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110908014|NCT02256956|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110908015|NCT02256956|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110908016|NCT02256956|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110908017|NCT02256956|Adrenergic Agents|adrenergic agents|mesh-ancestor
110908018|NCT02187536|Telmisartan|telmisartan|mesh-list
110908019|NCT02187536|Simvastatin|simvastatin|mesh-list
110908020|NCT02187536|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110908021|NCT02187536|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110908022|NCT02187536|Antimetabolites|antimetabolites|mesh-ancestor
110908023|NCT02187536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110908024|NCT02187536|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110908025|NCT02187536|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110908026|NCT02187536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110908027|NCT02187536|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110908028|NCT02187536|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110908029|NCT02187536|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110908030|NCT02256722|Propranolol|propranolol|mesh-list
110908031|NCT02256722|Bisoprolol|bisoprolol|mesh-list
110908032|NCT02256722|Acipimox|acipimox|mesh-list
110908033|NCT02256722|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110908034|NCT02256722|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110908035|NCT02256722|Autonomic Agents|autonomic agents|mesh-ancestor
110908036|NCT02256722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110908037|NCT02256722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110908038|NCT02256722|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110908039|NCT02256722|Respiratory System Agents|respiratory system agents|mesh-ancestor
110908040|NCT02256722|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110214803|NCT00251524|Pemetrexed|pemetrexed|mesh-list
110908041|NCT02256722|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110908042|NCT02256722|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110908043|NCT02256722|Adrenergic Agents|adrenergic agents|mesh-ancestor
110908044|NCT02256722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110908045|NCT02256722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110908046|NCT02256722|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110908047|NCT02256722|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110908048|NCT02256722|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110908049|NCT02256722|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110908050|NCT02256722|Vasodilator Agents|vasodilator agents|mesh-ancestor
110908051|NCT02256722|Sympatholytics|sympatholytics|mesh-ancestor
110908052|NCT02256722|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110908053|NCT02256722|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110908054|NCT02256722|Antimetabolites|antimetabolites|mesh-ancestor
110908055|NCT02256722|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110908056|NCT02193620|Nalbuphine|nalbuphine|mesh-list
110908057|NCT02193620|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110908058|NCT02193620|Narcotics|narcotics|mesh-ancestor
110908059|NCT02193620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110214933|NCT00103935|Incretins|incretins|mesh-ancestor
110908060|NCT02193620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110908061|NCT02193620|Analgesics|analgesics|mesh-ancestor
110908062|NCT02193620|Sensory System Agents|sensory system agents|mesh-ancestor
110926028|NCT00002601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110908063|NCT02193620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110908064|NCT02187614|Acetaminophen|acetaminophen|mesh-list
110908065|NCT02187614|Diclofenac|diclofenac|mesh-list
110908066|NCT02187614|Morphine|morphine|mesh-list
110908067|NCT02187614|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110908068|NCT02187614|Narcotics|narcotics|mesh-ancestor
110908069|NCT02187614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110908071|NCT02187614|Analgesics|analgesics|mesh-ancestor
110908072|NCT02187614|Sensory System Agents|sensory system agents|mesh-ancestor
110908073|NCT02187614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110908074|NCT02187614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110908075|NCT02187614|Antipyretics|antipyretics|mesh-ancestor
110908076|NCT02187614|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110908077|NCT02187614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110908078|NCT02187614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110908079|NCT02187614|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110908080|NCT02187614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110908081|NCT02187614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110908082|NCT02030678|Irinotecan|irinotecan|mesh-list
110908083|NCT02030678|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110908084|NCT02030678|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110908085|NCT02030678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110908086|NCT02030678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110908087|NCT02030678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110908088|NCT02054988|Caffeine|caffeine|mesh-list
110908089|NCT02054988|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110908090|NCT02054988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110908091|NCT02054988|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110908092|NCT02054988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110908093|NCT02054988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110908094|NCT02054988|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110908095|NCT02054988|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110908096|NCT02054988|Purinergic Agents|purinergic agents|mesh-ancestor
110908097|NCT02054988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110908098|NCT02191124|Mirtazapine|mirtazapine|mesh-list
110908099|NCT02191124|Paroxetine|paroxetine|mesh-list
110908100|NCT02191124|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110908101|NCT02191124|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110908102|NCT02191124|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110908103|NCT02191124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110908104|NCT02191124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110908105|NCT02191124|Serotonin Agents|serotonin agents|mesh-ancestor
110908106|NCT02191124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110908107|NCT02191124|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110908108|NCT02191124|Antidepressive Agents|antidepressive agents|mesh-ancestor
110908109|NCT02191124|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110908110|NCT02191124|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110908111|NCT02191124|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110908112|NCT02191124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110908113|NCT02191124|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110908114|NCT02191124|Histamine Antagonists|histamine antagonists|mesh-ancestor
110908115|NCT02191124|Histamine Agents|histamine agents|mesh-ancestor
110908116|NCT02191124|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110908117|NCT02191124|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110908118|NCT02191124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110908119|NCT02191124|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
110908120|NCT02191124|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110625585|NCT04618913|Anticoagulants|anticoagulants|mesh-ancestor
110908121|NCT02191124|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110908122|NCT02191124|Adrenergic Agents|adrenergic agents|mesh-ancestor
110908123|NCT02191124|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110908124|NCT02191124|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110908125|NCT02191124|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110908126|NCT02193698|Dexamethasone|dexamethasone|mesh-list
110908127|NCT02193698|Lenalidomide|lenalidomide|mesh-list
110908128|NCT02193698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110908129|NCT02193698|Antiemetics|antiemetics|mesh-ancestor
110908130|NCT02193698|Autonomic Agents|autonomic agents|mesh-ancestor
110215405|NCT00070148|Androgens|androgens|mesh-ancestor
110908131|NCT02193698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110908132|NCT02193698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110908133|NCT02193698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110908134|NCT02193698|Glucocorticoids|glucocorticoids|mesh-ancestor
110908135|NCT02193698|Hormones|hormones|mesh-ancestor
110225771|NCT05826964|Anastrozole|anastrozole|mesh-list
110908136|NCT02193698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110908137|NCT02193698|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110908138|NCT02193698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110908139|NCT02193698|Immunologic Factors|immunologic factors|mesh-ancestor
110908140|NCT02193698|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110908141|NCT02193698|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110908142|NCT02193698|Growth Substances|growth substances|mesh-ancestor
110908143|NCT02193698|Growth Inhibitors|growth inhibitors|mesh-ancestor
110908144|NCT02191202|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
110908145|NCT02191202|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110908146|NCT02191202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110908147|NCT02191202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110908148|NCT02191202|Antiviral Agents|antiviral agents|mesh-ancestor
110908149|NCT02191202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110908150|NCT02055300|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
110908151|NCT02055300|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110908152|NCT02055300|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110908153|NCT02055300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110215456|NCT00070187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110908154|NCT02055300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110908155|NCT02055300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110908156|NCT02055300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110908157|NCT02055300|Antidepressive Agents|antidepressive agents|mesh-ancestor
110908158|NCT02055300|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110908159|NCT02191280|Quercetin|quercetin|mesh-list
110908160|NCT02191280|Antioxidants|antioxidants|mesh-ancestor
110908161|NCT02191280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110908162|NCT02191280|Protective Agents|protective agents|mesh-ancestor
110908163|NCT02191280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110908164|NCT02055378|Atropine|atropine|mesh-list
110908165|NCT02055378|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110908166|NCT02055378|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110908167|NCT02055378|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110908168|NCT02055378|Autonomic Agents|autonomic agents|mesh-ancestor
110908169|NCT02055378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110908170|NCT02055378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110908171|NCT02055378|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110908172|NCT02055378|Respiratory System Agents|respiratory system agents|mesh-ancestor
110908173|NCT02055378|Mydriatics|mydriatics|mesh-ancestor
110908174|NCT02055378|Parasympatholytics|parasympatholytics|mesh-ancestor
110908175|NCT02055378|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110908176|NCT02055378|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110908177|NCT02055378|Cholinergic Agents|cholinergic agents|mesh-ancestor
110908178|NCT02055378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110908179|NCT02055378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110908180|NCT04558190|Ubiquinone|ubiquinone|mesh-list
110908181|NCT04558190|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
110908182|NCT04558190|Albuterol|albuterol|mesh-list
110908183|NCT04558190|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110908184|NCT04558190|Autonomic Agents|autonomic agents|mesh-ancestor
110908185|NCT04558190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110908186|NCT04558190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110908187|NCT04558190|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110908188|NCT04558190|Respiratory System Agents|respiratory system agents|mesh-ancestor
110225779|NCT05826964|Estrogens|estrogens|mesh-list
110908189|NCT04558190|Tocolytic Agents|tocolytic agents|mesh-ancestor
110908190|NCT04558190|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110908191|NCT04558190|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110908192|NCT04558190|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110625660|NCT04194359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110908193|NCT04558190|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110908194|NCT04558190|Adrenergic Agents|adrenergic agents|mesh-ancestor
110908195|NCT04558190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110908196|NCT04558190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110908197|NCT04558190|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
110908198|NCT04558190|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
110908199|NCT04558190|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110908200|NCT04558190|Micronutrients|micronutrients|mesh-ancestor
110908201|NCT03676959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110908202|NCT03676959|Antibodies|antibodies|mesh-list
110908203|NCT03676959|Immunoglobulins|immunoglobulins|mesh-list
110908204|NCT03676959|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110908205|NCT03676959|Immunologic Factors|immunologic factors|mesh-ancestor
110908206|NCT03676959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110908207|NCT03676959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110215845|NCT00100971|Vaccines|vaccines|mesh-list
110908208|NCT03755973|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
110908209|NCT03755973|Hormones|hormones|mesh-ancestor
110908210|NCT03755973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110908211|NCT03755973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110908212|NCT02056938|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110908213|NCT02056938|Basiliximab|basiliximab|mesh-list
110908214|NCT02056938|Immunologic Factors|immunologic factors|mesh-ancestor
110908215|NCT02056938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110908216|NCT02056938|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110908217|NCT02191670|Tenecteplase|tenecteplase|mesh-list
110908218|NCT02191670|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110908219|NCT02191670|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110908220|NCT02191670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110908221|NCT02057094|Caseins|caseins|mesh-list
110908222|NCT02057094|Chelating Agents|chelating agents|mesh-ancestor
110225804|NCT05826964|Hormones|hormones|mesh-ancestor
110908224|NCT02057094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110908225|NCT02917941|Dexamethasone|dexamethasone|mesh-list
110908226|NCT02917941|Lenalidomide|lenalidomide|mesh-list
110908227|NCT02917941|Ixazomib|ixazomib|mesh-list
110908228|NCT02917941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110908229|NCT02917941|Antiemetics|antiemetics|mesh-ancestor
110908230|NCT02917941|Autonomic Agents|autonomic agents|mesh-ancestor
110908231|NCT02917941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110908232|NCT02917941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110908233|NCT02917941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110908234|NCT02917941|Glucocorticoids|glucocorticoids|mesh-ancestor
110908235|NCT02917941|Hormones|hormones|mesh-ancestor
110216041|NCT00105105|Luteolytic Agents|luteolytic agents|mesh-ancestor
110908236|NCT02917941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110908237|NCT02917941|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110908238|NCT02917941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110908239|NCT02917941|Immunologic Factors|immunologic factors|mesh-ancestor
110908240|NCT02917941|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110908241|NCT02917941|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110908242|NCT02917941|Growth Substances|growth substances|mesh-ancestor
110908243|NCT02917941|Growth Inhibitors|growth inhibitors|mesh-ancestor
110908244|NCT02917941|Protease Inhibitors|protease inhibitors|mesh-ancestor
110908245|NCT02917941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110216106|NCT00260026|Mitosis Modulators|mitosis modulators|mesh-ancestor
110908246|NCT02917941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110908248|NCT02055690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110908249|NCT02055690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110908250|NCT02191748|Triamcinolone|triamcinolone|mesh-list
110908251|NCT02191748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110908252|NCT02191748|Glucocorticoids|glucocorticoids|mesh-ancestor
110908253|NCT02191748|Hormones|hormones|mesh-ancestor
110908254|NCT02191748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110216176|NCT00071747|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110908255|NCT02191748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110908256|NCT02191826|Tolcapone|tolcapone|mesh-list
110908257|NCT02191826|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110908258|NCT02191826|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110908259|NCT02191826|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
110908260|NCT02191826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110908261|NCT02191826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110908262|NCT01333956|Pregabalin|pregabalin|mesh-list
110908263|NCT01333956|Analgesics|analgesics|mesh-ancestor
110908264|NCT01333956|Sensory System Agents|sensory system agents|mesh-ancestor
110225834|NCT05798663|Atezolizumab|atezolizumab|mesh-list
110908265|NCT01333956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110908266|NCT01333956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110908267|NCT01333956|Anticonvulsants|anticonvulsants|mesh-ancestor
110908268|NCT01333956|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110908269|NCT01333956|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110908270|NCT01333956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110908271|NCT01333956|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110908272|NCT01333956|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110908273|NCT01333956|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110908274|NCT01333956|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110908275|NCT01333956|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110908276|NCT02057328|Telmisartan|telmisartan|mesh-list
110908277|NCT02057328|Nebivolol|nebivolol|mesh-list
110908278|NCT02057328|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110908279|NCT02057328|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110908280|NCT02057328|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110908281|NCT02057328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110908282|NCT02057328|Vasodilator Agents|vasodilator agents|mesh-ancestor
110908283|NCT02057328|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
110908284|NCT02057328|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110908285|NCT02057328|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110908286|NCT02057328|Adrenergic Agents|adrenergic agents|mesh-ancestor
110908287|NCT02057328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110908288|NCT02057328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110908289|NCT02057484|Tacrolimus|tacrolimus|mesh-list
110908290|NCT02057484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110908291|NCT02057484|Immunologic Factors|immunologic factors|mesh-ancestor
110908292|NCT02057484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110908293|NCT02057484|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110908294|NCT02057484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110908295|NCT02057484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110908296|NCT02192060|Triclosan|triclosan|mesh-list
110908297|NCT02192060|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110908298|NCT02192060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110908299|NCT02192060|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
110908300|NCT02192060|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110908301|NCT02192060|Antimetabolites|antimetabolites|mesh-ancestor
110908302|NCT02192060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110926087|NCT03543774|Ezetimibe|ezetimibe|mesh-list
110908304|NCT02188394|Bupivacaine|bupivacaine|mesh-list
110908305|NCT02188394|Anesthetics|anesthetics|mesh-list
110908306|NCT02188394|Anesthetics, Local|anesthetics, local|mesh-ancestor
110908307|NCT02188394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110908308|NCT02188394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110908309|NCT02188394|Sensory System Agents|sensory system agents|mesh-ancestor
110908310|NCT02188394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110908311|NCT01333722|Acetaminophen|acetaminophen|mesh-list
110908312|NCT01333722|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
110908313|NCT01333722|Hydrocodone|hydrocodone|mesh-list
110908314|NCT01333722|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110908315|NCT01333722|Analgesics|analgesics|mesh-ancestor
110908316|NCT01333722|Sensory System Agents|sensory system agents|mesh-ancestor
110908317|NCT01333722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110908318|NCT01333722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110908319|NCT01333722|Antipyretics|antipyretics|mesh-ancestor
110908320|NCT01333722|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110908321|NCT01333722|Narcotics|narcotics|mesh-ancestor
110908322|NCT01333722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110908323|NCT01333722|Antitussive Agents|antitussive agents|mesh-ancestor
110908324|NCT01333722|Respiratory System Agents|respiratory system agents|mesh-ancestor
110225870|NCT05776056|Dopamine Agents|dopamine agents|mesh-ancestor
110908325|NCT01333722|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110908326|NCT01333722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110908327|NCT01333722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110908328|NCT02188472|Trimethoprim|trimethoprim|mesh-list
110908329|NCT02188472|Penicillins|penicillins|mesh-list
110908330|NCT02188472|Penicillin V|penicillin v|mesh-list
110908331|NCT02188472|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110908332|NCT02188472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110908333|NCT02188472|Antimalarials|antimalarials|mesh-ancestor
110908334|NCT02188472|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110908335|NCT02188472|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110908336|NCT02188472|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110908337|NCT02188472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110908338|NCT02188472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110908339|NCT02188472|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110908340|NCT02188472|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
110908341|NCT02188472|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110908342|NCT02188472|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110908343|NCT02188550|Everolimus|everolimus|mesh-list
110908344|NCT02188550|Letrozole|letrozole|mesh-list
110908345|NCT02188550|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110908346|NCT02188550|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110908347|NCT02188550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110908348|NCT02188550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110908349|NCT02188550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110908350|NCT02188550|Immunologic Factors|immunologic factors|mesh-ancestor
110908351|NCT02188550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110908352|NCT02188550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110908353|NCT02188550|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110908354|NCT02188550|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110908355|NCT02188550|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110908356|NCT02188550|Hormone Antagonists|hormone antagonists|mesh-ancestor
110908357|NCT02188550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110908358|NCT02059590|Isavuconazole|isavuconazole|mesh-list
110908359|NCT02059590|Antifungal Agents|antifungal agents|mesh-ancestor
110908360|NCT02059590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110908361|NCT02057796|Efavirenz|efavirenz|mesh-list
110908362|NCT02057796|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110908363|NCT02057796|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110216918|NCT00106548|Dermatologic Agents|dermatologic agents|mesh-ancestor
110908364|NCT02057796|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
110908365|NCT02057796|Rifampin|rifampin|mesh-list
110908366|NCT02057796|Isoniazid|isoniazid|mesh-list
110908367|NCT02057796|Pyrazinamide|pyrazinamide|mesh-list
110908368|NCT02057796|Ethambutol|ethambutol|mesh-list
110908369|NCT02057796|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110908370|NCT02057796|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110908371|NCT02057796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110908372|NCT02057796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110908373|NCT02057796|Antiviral Agents|antiviral agents|mesh-ancestor
110908374|NCT02057796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110908375|NCT02057796|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110216994|NCT00268216|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110908376|NCT02057796|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110908377|NCT02057796|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110908378|NCT02057796|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110908379|NCT02057796|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110217097|NCT00073736|Cytarabine|cytarabine|mesh-list
110908380|NCT02057796|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110908381|NCT02057796|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110908382|NCT02057796|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110908383|NCT02057796|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110908384|NCT02057796|Antitubercular Agents|antitubercular agents|mesh-ancestor
110908385|NCT02057796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110908386|NCT02057796|Leprostatic Agents|leprostatic agents|mesh-ancestor
110908387|NCT02057796|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110908388|NCT02057796|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110217132|NCT00268528|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110908389|NCT02057796|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110908390|NCT02057796|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
110908391|NCT02057796|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110908393|NCT02057796|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110908394|NCT02192450|Insulin|insulin|mesh-list
110908395|NCT02192450|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110908396|NCT02192450|Insulin Aspart|insulin aspart|mesh-list
110908397|NCT02192450|Insulin, Long-Acting|insulin, long-acting|mesh-list
110908398|NCT02192450|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
110908399|NCT02192450|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110908400|NCT02192450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110908401|NCT03560856|Fulvestrant|fulvestrant|mesh-list
110908402|NCT03560856|Palbociclib|palbociclib|mesh-list
110908403|NCT03560856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110908404|NCT03560856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110217274|NCT00269035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110908405|NCT03560856|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110908406|NCT03560856|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110908407|NCT03560856|Hormone Antagonists|hormone antagonists|mesh-ancestor
110908408|NCT03560856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110926125|NCT03488810|Androgens|androgens|mesh-list
110908409|NCT03560856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110908410|NCT03560856|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110908411|NCT03560856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110217347|NCT00416221|Antidepressive Agents|antidepressive agents|mesh-list
110908412|NCT03560856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110908414|NCT03676413|Xhance|xhance|mesh-list
110908415|NCT03676413|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110908416|NCT03676413|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
110908417|NCT03676413|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110908418|NCT03676413|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110908419|NCT03676413|Autonomic Agents|autonomic agents|mesh-ancestor
110217418|NCT00102609|Autonomic Agents|autonomic agents|mesh-ancestor
110908420|NCT03676413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110908421|NCT03676413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110908422|NCT03676413|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110908423|NCT03676413|Respiratory System Agents|respiratory system agents|mesh-ancestor
110908424|NCT03676413|Dermatologic Agents|dermatologic agents|mesh-ancestor
110908425|NCT03676413|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110908426|NCT03676413|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110908427|NCT03676413|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110908428|NCT03676413|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110908429|NCT03676413|Adrenergic Agents|adrenergic agents|mesh-ancestor
110908430|NCT03676413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110908431|NCT03676413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110908432|NCT03676413|Glucocorticoids|glucocorticoids|mesh-ancestor
110908433|NCT03676413|Hormones|hormones|mesh-ancestor
110908434|NCT03676413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110908435|NCT03676413|Sympathomimetics|sympathomimetics|mesh-ancestor
110908436|NCT03676335|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110908437|NCT03676335|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110908438|NCT01370694|Prednisolone|prednisolone|mesh-list
110908439|NCT01370694|Cyclophosphamide|cyclophosphamide|mesh-list
110908440|NCT01370694|Vincristine|vincristine|mesh-list
110908441|NCT01370694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110908442|NCT01370694|Immunologic Factors|immunologic factors|mesh-ancestor
110908443|NCT01370694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110908444|NCT01370694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110217558|NCT00270829|Natriuretic Agents|natriuretic agents|mesh-ancestor
110908445|NCT01370694|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110908446|NCT01370694|Alkylating Agents|alkylating agents|mesh-ancestor
110908447|NCT01370694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110908448|NCT01370694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110908449|NCT01370694|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110908450|NCT01370694|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110908451|NCT01370694|Tubulin Modulators|tubulin modulators|mesh-ancestor
110908452|NCT01370694|Antimitotic Agents|antimitotic agents|mesh-ancestor
110908453|NCT01370694|Mitosis Modulators|mitosis modulators|mesh-ancestor
110908454|NCT01370694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110908455|NCT01370694|Glucocorticoids|glucocorticoids|mesh-ancestor
110908456|NCT01370694|Hormones|hormones|mesh-ancestor
110908457|NCT01370694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110908458|NCT01370694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110908459|NCT02256878|Amitriptyline|amitriptyline|mesh-list
110908460|NCT02256878|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110908461|NCT02256878|Antidepressive Agents|antidepressive agents|mesh-ancestor
110908462|NCT02256878|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110908463|NCT02256878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110908464|NCT02256878|Analgesics|analgesics|mesh-ancestor
110908465|NCT02256878|Sensory System Agents|sensory system agents|mesh-ancestor
110908466|NCT02256878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110908467|NCT02256878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110908468|NCT02256878|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110908469|NCT02256878|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110908470|NCT02256878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110908471|NCT02256878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110908472|NCT02256878|Adrenergic Agents|adrenergic agents|mesh-ancestor
110908473|NCT02256878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110908474|NCT02058186|Vitamin D|vitamin d|mesh-list
110908475|NCT02058186|Vitamins|vitamins|mesh-ancestor
110908476|NCT02058186|Micronutrients|micronutrients|mesh-ancestor
110908477|NCT02058186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110908478|NCT02058186|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110908479|NCT03676023|Tranexamic Acid|tranexamic acid|mesh-list
110908480|NCT03676023|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110908481|NCT03676023|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110908482|NCT03676023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110908483|NCT03676023|Hemostatics|hemostatics|mesh-ancestor
110908484|NCT03676023|Coagulants|coagulants|mesh-ancestor
110908485|NCT02260206|Colchicine|colchicine|mesh-list
110908486|NCT02260206|Gout Suppressants|gout suppressants|mesh-ancestor
110908487|NCT02260206|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110908488|NCT02260206|Tubulin Modulators|tubulin modulators|mesh-ancestor
110908489|NCT02260206|Antimitotic Agents|antimitotic agents|mesh-ancestor
110908490|NCT02260206|Mitosis Modulators|mitosis modulators|mesh-ancestor
110908491|NCT02260206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110908492|NCT02260206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110908493|NCT02058576|Tamsulosin|tamsulosin|mesh-list
110908494|NCT02058576|Dutasteride|dutasteride|mesh-list
110908495|NCT02058576|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110908496|NCT02058576|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110908497|NCT02058576|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110908498|NCT02058576|Adrenergic Agents|adrenergic agents|mesh-ancestor
110908499|NCT02058576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110926161|NCT01673386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110217806|NCT00107835|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110908500|NCT02058576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110908501|NCT02058576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110908502|NCT02058576|Urological Agents|urological agents|mesh-ancestor
110908503|NCT02058576|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
110908504|NCT02058576|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110908505|NCT02058576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110908506|NCT02058576|Hormone Antagonists|hormone antagonists|mesh-ancestor
110908507|NCT02058576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110908508|NCT03535220|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
110908509|NCT03535220|Protease Inhibitors|protease inhibitors|mesh-list
110908510|NCT03535220|Proteasome Inhibitors|proteasome inhibitors|mesh-list
110908511|NCT03535220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110908512|NCT03535220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110908513|NCT03535220|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110908514|NCT03535220|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110908515|NCT03535220|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110908516|NCT03535220|Antiviral Agents|antiviral agents|mesh-ancestor
110908517|NCT03535220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110908518|NCT03675555|Dexamethasone|dexamethasone|mesh-list
110908519|NCT03675555|Mirtazapine|mirtazapine|mesh-list
110908520|NCT03675555|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
110908521|NCT03675555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110908522|NCT03675555|Antiemetics|antiemetics|mesh-ancestor
110908523|NCT03675555|Autonomic Agents|autonomic agents|mesh-ancestor
110908524|NCT03675555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110908525|NCT03675555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110908526|NCT03675555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110908527|NCT03675555|Glucocorticoids|glucocorticoids|mesh-ancestor
110908528|NCT03675555|Hormones|hormones|mesh-ancestor
110908529|NCT03675555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110908530|NCT03675555|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110908531|NCT03675555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110908532|NCT03675555|Antidepressive Agents|antidepressive agents|mesh-ancestor
110908533|NCT03675555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110908534|NCT03675555|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110908535|NCT03675555|Histamine Antagonists|histamine antagonists|mesh-ancestor
110908536|NCT03675555|Histamine Agents|histamine agents|mesh-ancestor
110908537|NCT03675555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110908538|NCT03675555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110908539|NCT03675555|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110908540|NCT03675555|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110908541|NCT03675555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110217998|NCT00274495|Rosiglitazone|rosiglitazone|mesh-list
110908542|NCT03675555|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
110908543|NCT03675555|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110908544|NCT03675555|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110908545|NCT03675555|Adrenergic Agents|adrenergic agents|mesh-ancestor
110908546|NCT03675555|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110908547|NCT03675555|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110908548|NCT03675555|Serotonin Agents|serotonin agents|mesh-ancestor
110908549|NCT03675555|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110908550|NCT02194166|Paclitaxel|paclitaxel|mesh-list
110908551|NCT02194166|Docetaxel|docetaxel|mesh-list
110908552|NCT02194166|Trastuzumab|trastuzumab|mesh-list
110908553|NCT02194166|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110908554|NCT02194166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110908555|NCT02194166|Tubulin Modulators|tubulin modulators|mesh-ancestor
110908556|NCT02194166|Antimitotic Agents|antimitotic agents|mesh-ancestor
110908557|NCT02194166|Mitosis Modulators|mitosis modulators|mesh-ancestor
110908558|NCT02194166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110908559|NCT02194166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110908560|NCT02194322|Olcegepant|olcegepant|mesh-list
110908561|NCT02194322|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
110225931|NCT05742607|Antimitotic Agents|antimitotic agents|mesh-ancestor
110908562|NCT02194322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110908563|NCT02194322|Analgesics|analgesics|mesh-ancestor
110908564|NCT02194322|Sensory System Agents|sensory system agents|mesh-ancestor
110908565|NCT02194322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110908566|NCT02194322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110908567|NCT02193308|Amlodipine|amlodipine|mesh-list
110908568|NCT02193308|Telmisartan|telmisartan|mesh-list
110908569|NCT02193308|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
110908570|NCT02193308|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110908571|NCT02193308|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110908572|NCT02193308|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110908573|NCT02193308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110908574|NCT02193308|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110908575|NCT02193308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110908576|NCT02193308|Vasodilator Agents|vasodilator agents|mesh-ancestor
110908577|NCT02193308|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110908578|NCT02193308|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110908579|NCT02060604|Ketorolac|ketorolac|mesh-list
110908580|NCT02060604|Ranibizumab|ranibizumab|mesh-list
110908581|NCT02060604|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110908582|NCT02060604|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110908583|NCT02060604|Growth Substances|growth substances|mesh-ancestor
110908584|NCT02060604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110908585|NCT02060604|Growth Inhibitors|growth inhibitors|mesh-ancestor
110908586|NCT02060604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110218260|NCT00278278|Abortifacient Agents|abortifacient agents|mesh-ancestor
110908587|NCT02060604|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110908588|NCT02060604|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110908589|NCT02060604|Analgesics|analgesics|mesh-ancestor
110908590|NCT02060604|Sensory System Agents|sensory system agents|mesh-ancestor
110908591|NCT02060604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110908592|NCT02060604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110908593|NCT02060604|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110908594|NCT02060604|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110908595|NCT02060604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110908596|NCT02060604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110908597|NCT03679455|Obinutuzumab|obinutuzumab|mesh-list
110908598|NCT03679455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110908599|NCT03679455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110908600|NCT03315143|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
110908601|NCT03315143|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110908602|NCT03315143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110908603|NCT03315143|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110218418|NCT00279565|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110908604|NCT03315143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110908605|NCT02194556|Gemcitabine|gemcitabine|mesh-list
110908606|NCT02194556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110908607|NCT02194556|Antimetabolites|antimetabolites|mesh-ancestor
110908608|NCT02194556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110908609|NCT02194556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110908610|NCT02030912|Amoxicillin|amoxicillin|mesh-list
110908611|NCT02030912|Minocycline|minocycline|mesh-list
110908612|NCT02030912|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110908613|NCT02030912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110908615|NCT02060916|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110908616|NCT02060916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110908617|NCT02797080|Interferons|interferons|mesh-list
110908618|NCT02797080|Interferon-gamma|interferon-gamma|mesh-list
110926201|NCT02152332|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110908619|NCT02797080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110908620|NCT02797080|Antiviral Agents|antiviral agents|mesh-ancestor
110908621|NCT02797080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110908622|NCT02196194|Tiotropium Bromide|tiotropium bromide|mesh-list
110908623|NCT02196194|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110908624|NCT02196194|Autonomic Agents|autonomic agents|mesh-ancestor
110908625|NCT02196194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110908626|NCT02196194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110908627|NCT02196194|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110908628|NCT02196194|Respiratory System Agents|respiratory system agents|mesh-ancestor
110908629|NCT02196194|Parasympatholytics|parasympatholytics|mesh-ancestor
110908630|NCT02196194|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110908631|NCT02196194|Cholinergic Agents|cholinergic agents|mesh-ancestor
110908632|NCT02196194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110908633|NCT02196194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110626107|NCT00602459|Antibodies|antibodies|mesh-list
110908635|NCT02915835|Enzyme Activators|enzyme activators|mesh-ancestor
110908636|NCT02915835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110908637|NCT01370616|Amoxicillin|amoxicillin|mesh-list
110908638|NCT01370616|Tazobactam|tazobactam|mesh-list
110908639|NCT01370616|Piperacillin|piperacillin|mesh-list
110908640|NCT01370616|Ertapenem|ertapenem|mesh-list
110908641|NCT01370616|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
110908642|NCT01370616|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110908643|NCT01370616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110908644|NCT01370616|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110908645|NCT01370616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110218771|NCT00281710|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110908646|NCT01370616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110908647|NCT02688881|Sirolimus|sirolimus|mesh-list
110908648|NCT02688881|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110908649|NCT02688881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110908650|NCT02688881|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110908651|NCT02688881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110908652|NCT02688881|Antifungal Agents|antifungal agents|mesh-ancestor
110908653|NCT02688881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110908654|NCT02688881|Immunologic Factors|immunologic factors|mesh-ancestor
110908655|NCT02688881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110908656|NCT03560310|Ticagrelor|ticagrelor|mesh-list
110218841|NCT00110058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110908657|NCT03560310|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110908658|NCT03560310|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110908659|NCT03560310|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110908660|NCT03560310|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110908661|NCT03560310|Purinergic Agents|purinergic agents|mesh-ancestor
110908662|NCT03560310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110908663|NCT03560310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110908664|NCT03560310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110908665|NCT02197286|Vitamin D|vitamin d|mesh-list
110908666|NCT02197286|Ergocalciferols|ergocalciferols|mesh-list
110908667|NCT02197286|Cholecalciferol|cholecalciferol|mesh-list
110908668|NCT02197286|Vitamins|vitamins|mesh-list
110908669|NCT02197286|Micronutrients|micronutrients|mesh-ancestor
110908670|NCT02197286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110908671|NCT02197286|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110908672|NCT02197286|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110908673|NCT02197442|Valsartan|valsartan|mesh-list
110908674|NCT02197442|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110225952|NCT05733351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110908675|NCT02197442|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110908676|NCT02197442|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110908677|NCT02197442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110908678|NCT03534674|Vitamin D|vitamin d|mesh-list
110908679|NCT03534674|Cholecalciferol|cholecalciferol|mesh-list
110908680|NCT03534674|Vitamins|vitamins|mesh-ancestor
110908681|NCT03534674|Micronutrients|micronutrients|mesh-ancestor
110908682|NCT03534674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110908683|NCT03534674|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110908684|NCT03534674|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110908685|NCT02063334|Vitamin D|vitamin d|mesh-list
110908686|NCT02063334|Cholecalciferol|cholecalciferol|mesh-list
110908687|NCT02063334|Vitamins|vitamins|mesh-ancestor
110908688|NCT02063334|Micronutrients|micronutrients|mesh-ancestor
110908689|NCT02063334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110908690|NCT02063334|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110908691|NCT02063334|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110908693|NCT02916927|Analgesics|analgesics|mesh-ancestor
110908694|NCT02916927|Sensory System Agents|sensory system agents|mesh-ancestor
110908695|NCT02916927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110908696|NCT02916927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110908697|NCT02916927|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110908698|NCT02916927|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110908699|NCT02916927|Anesthetics, General|anesthetics, general|mesh-ancestor
110908700|NCT02916927|Anesthetics|anesthetics|mesh-ancestor
110908701|NCT02916927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110908702|NCT02916927|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110908703|NCT02916927|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110908704|NCT02916927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110908705|NCT02916927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110908706|NCT02197598|Nalmefene|nalmefene|mesh-list
110908707|NCT02197598|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110908708|NCT02197598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110908709|NCT02197598|Sensory System Agents|sensory system agents|mesh-ancestor
110908710|NCT02197598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110908711|NCT02196662|Mesalamine|mesalamine|mesh-list
110908712|NCT02196662|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110908713|NCT02196662|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110908714|NCT02196662|Analgesics|analgesics|mesh-ancestor
110908715|NCT02196662|Sensory System Agents|sensory system agents|mesh-ancestor
110908716|NCT02196662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110908717|NCT02196662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110908718|NCT02196662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110908719|NCT02196662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110908720|NCT02195180|Leucovorin|leucovorin|mesh-list
110908721|NCT02195180|Gemcitabine|gemcitabine|mesh-list
110908722|NCT02195180|Fluorouracil|fluorouracil|mesh-list
110908723|NCT02195180|Oxaliplatin|oxaliplatin|mesh-list
110908724|NCT02195180|Asparaginase|asparaginase|mesh-list
110908725|NCT02195180|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110908726|NCT02195180|Antimetabolites|antimetabolites|mesh-ancestor
110908727|NCT02195180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110908728|NCT02195180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110908729|NCT02195180|Antidotes|antidotes|mesh-ancestor
110908730|NCT02195180|Protective Agents|protective agents|mesh-ancestor
110908731|NCT02195180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110908732|NCT02195180|Vitamin B Complex|vitamin b complex|mesh-ancestor
110908733|NCT02195180|Vitamins|vitamins|mesh-ancestor
110908734|NCT02195180|Micronutrients|micronutrients|mesh-ancestor
110908735|NCT02195180|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110908736|NCT02195180|Immunologic Factors|immunologic factors|mesh-ancestor
110908737|NCT03623529|Angiotensin II|angiotensin ii|mesh-list
110908738|NCT03623529|Giapreza|giapreza|mesh-list
110908739|NCT03623529|Angiotensinogen|angiotensinogen|mesh-list
110908740|NCT03623529|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110908741|NCT03623529|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110908742|NCT03623529|Protease Inhibitors|protease inhibitors|mesh-ancestor
110908743|NCT03623529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110926226|NCT02152410|Sensory System Agents|sensory system agents|mesh-ancestor
110908744|NCT03623529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110908745|NCT02197676|Guadecitabine|guadecitabine|mesh-list
110908746|NCT02197676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110908747|NCT02916693|Mirabegron|mirabegron|mesh-list
110908748|NCT02916693|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
110908749|NCT02916693|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110908750|NCT02916693|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110908751|NCT02916693|Adrenergic Agents|adrenergic agents|mesh-ancestor
110908752|NCT02916693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110908753|NCT02916693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110908754|NCT02916693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110908755|NCT02916693|Urological Agents|urological agents|mesh-ancestor
110908756|NCT02195336|Paclitaxel|paclitaxel|mesh-list
110908757|NCT02195336|Bevacizumab|bevacizumab|mesh-list
110908758|NCT02195336|Carboplatin|carboplatin|mesh-list
110908759|NCT02195336|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110908760|NCT02195336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110908761|NCT02195336|Tubulin Modulators|tubulin modulators|mesh-ancestor
110908762|NCT02195336|Antimitotic Agents|antimitotic agents|mesh-ancestor
110626261|NCT01065259|Adrenergic Agents|adrenergic agents|mesh-ancestor
110908763|NCT02195336|Mitosis Modulators|mitosis modulators|mesh-ancestor
110908764|NCT02195336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110908765|NCT02195336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110908766|NCT02195336|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110908767|NCT02195336|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110908768|NCT02195336|Growth Substances|growth substances|mesh-ancestor
110908769|NCT02195336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110908770|NCT02195336|Growth Inhibitors|growth inhibitors|mesh-ancestor
110908771|NCT03679065|Acetaminophen|acetaminophen|mesh-list
110908772|NCT03679065|Dexamethasone|dexamethasone|mesh-list
110908773|NCT03679065|Dexamethasone acetate|dexamethasone acetate|mesh-list
110908774|NCT03679065|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
110908775|NCT03679065|BB 1101|bb 1101|mesh-list
110908776|NCT03679065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110908777|NCT03679065|Antiemetics|antiemetics|mesh-ancestor
110908778|NCT03679065|Autonomic Agents|autonomic agents|mesh-ancestor
110908779|NCT03679065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110908780|NCT03679065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110908781|NCT03679065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110908782|NCT03679065|Glucocorticoids|glucocorticoids|mesh-ancestor
110908783|NCT03679065|Hormones|hormones|mesh-ancestor
110908784|NCT03679065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110908785|NCT03679065|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110908786|NCT03679065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110908787|NCT03679065|Protease Inhibitors|protease inhibitors|mesh-ancestor
110908788|NCT03679065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110908789|NCT03679065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110908790|NCT03679065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110908791|NCT03679065|Analgesics|analgesics|mesh-ancestor
110908792|NCT03679065|Sensory System Agents|sensory system agents|mesh-ancestor
110908793|NCT03679065|Antipyretics|antipyretics|mesh-ancestor
110908794|NCT02196740|Metronidazole|metronidazole|mesh-list
110908795|NCT02196740|Ciprofloxacin|ciprofloxacin|mesh-list
110908796|NCT02196740|Clindamycin|clindamycin|mesh-list
110219737|NCT00287911|Topotecan|topotecan|mesh-list
110908797|NCT02196740|Clindamycin palmitate|clindamycin palmitate|mesh-list
110908798|NCT02196740|Clindamycin phosphate|clindamycin phosphate|mesh-list
110908799|NCT02196740|Gatifloxacin|gatifloxacin|mesh-list
110908800|NCT02196740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110908801|NCT02196740|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110908802|NCT02196740|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110908803|NCT02196740|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110908804|NCT02196740|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110908805|NCT02196740|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110908806|NCT02196740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110908807|NCT02196740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110908808|NCT02196740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110908809|NCT02196740|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110908810|NCT02196740|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110908811|NCT02196740|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110908812|NCT02196740|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110219871|NCT00289042|Enoxaparin|enoxaparin|mesh-list
110908813|NCT02196740|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110908814|NCT02195492|Hylan|hylan|mesh-list
110908815|NCT02195492|Viscosupplements|viscosupplements|mesh-ancestor
110908816|NCT02195492|Protective Agents|protective agents|mesh-ancestor
110908817|NCT02195492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110908818|NCT03678987|Mycophenolic Acid|mycophenolic acid|mesh-list
110908819|NCT03678987|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110908820|NCT03678987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110908821|NCT03678987|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110908822|NCT03678987|Antitubercular Agents|antitubercular agents|mesh-ancestor
110908823|NCT03678987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110219932|NCT00289861|Dopamine Agents|dopamine agents|mesh-ancestor
110908824|NCT03678987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110908825|NCT03678987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110908826|NCT03678987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110908827|NCT02919345|Dapagliflozin|dapagliflozin|mesh-list
110908828|NCT02919345|Glyburide|glyburide|mesh-list
110908829|NCT02919345|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110908830|NCT02919345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110908831|NCT02919345|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110908832|NCT02919345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110908833|NCT02195804|Ranitidine|ranitidine|mesh-list
110908834|NCT02195804|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
110908835|NCT02195804|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110908836|NCT02195804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110908837|NCT02195804|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110908838|NCT02195804|Histamine Antagonists|histamine antagonists|mesh-ancestor
110908839|NCT02195804|Histamine Agents|histamine agents|mesh-ancestor
110908840|NCT02195804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110908841|NCT02195804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110908842|NCT02195804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110908843|NCT03672435|Proxymetacaine|proxymetacaine|mesh-list
110908844|NCT03672435|Anesthetics, Local|anesthetics, local|mesh-ancestor
110908845|NCT03672435|Anesthetics|anesthetics|mesh-ancestor
110908846|NCT03672435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110908847|NCT03672435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110908848|NCT03672435|Sensory System Agents|sensory system agents|mesh-ancestor
110908849|NCT03672435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110908850|NCT03674463|Immunomodulating Agents|immunomodulating agents|mesh-list
110908851|NCT03674463|Immunologic Factors|immunologic factors|mesh-ancestor
110908852|NCT03674463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110908853|NCT03674385|Vitamin E|vitamin e|mesh-list
110908854|NCT03674385|Metformin|metformin|mesh-list
110908855|NCT03674385|Clomiphene|clomiphene|mesh-list
110908856|NCT03674385|Enclomiphene|enclomiphene|mesh-list
110908857|NCT03674385|Zuclomiphene|zuclomiphene|mesh-list
110908858|NCT03674385|Vitamins|vitamins|mesh-ancestor
110908859|NCT03674385|Micronutrients|micronutrients|mesh-ancestor
110908860|NCT03674385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110908861|NCT03674385|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110908862|NCT03674385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110908863|NCT03674385|Antioxidants|antioxidants|mesh-ancestor
110908864|NCT03674385|Protective Agents|protective agents|mesh-ancestor
110908865|NCT03674385|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110908866|NCT03674385|Hormone Antagonists|hormone antagonists|mesh-ancestor
110908867|NCT03674385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110908868|NCT03674385|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110908869|NCT03674385|Fertility Agents|fertility agents|mesh-ancestor
110908870|NCT03674385|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110908871|NCT03674385|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110908872|NCT03674385|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110908873|NCT02574455|Gemcitabine|gemcitabine|mesh-list
110908874|NCT02574455|Capecitabine|capecitabine|mesh-list
110908875|NCT02574455|Vinorelbine|vinorelbine|mesh-list
110908876|NCT02574455|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
110220131|NCT00291382|Dermatologic Agents|dermatologic agents|mesh-ancestor
110908877|NCT02574455|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110908878|NCT02574455|Antimetabolites|antimetabolites|mesh-ancestor
110908879|NCT02574455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110908880|NCT02574455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110908881|NCT02574455|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110908882|NCT02574455|Tubulin Modulators|tubulin modulators|mesh-ancestor
110908883|NCT02574455|Antimitotic Agents|antimitotic agents|mesh-ancestor
110908884|NCT02574455|Mitosis Modulators|mitosis modulators|mesh-ancestor
110908885|NCT02574455|Immunoconjugates|immunoconjugates|mesh-ancestor
110908886|NCT02574455|Immunologic Factors|immunologic factors|mesh-ancestor
110908887|NCT02574455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110908889|NCT02197988|Bupivacaine|bupivacaine|mesh-list
110908890|NCT02197988|Anesthetics, Local|anesthetics, local|mesh-ancestor
110908891|NCT02197988|Anesthetics|anesthetics|mesh-ancestor
110908892|NCT02197988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110908893|NCT02197988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110908894|NCT02197988|Sensory System Agents|sensory system agents|mesh-ancestor
110908895|NCT02197988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110908896|NCT02197988|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110908897|NCT02197988|Narcotics|narcotics|mesh-ancestor
110908898|NCT02197988|Analgesics|analgesics|mesh-ancestor
110908899|NCT02197988|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110908900|NCT02197988|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110908901|NCT02197988|Anesthetics, General|anesthetics, general|mesh-ancestor
110908902|NCT03672357|Liver Extracts|liver extracts|mesh-list
110908903|NCT03672357|Hematinics|hematinics|mesh-ancestor
110908904|NCT02201030|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110908905|NCT02201030|Immunologic Factors|immunologic factors|mesh-ancestor
110908906|NCT02201030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110908907|NCT03674073|Vaccines|vaccines|mesh-list
110908908|NCT03674073|Immunologic Factors|immunologic factors|mesh-ancestor
110908909|NCT03674073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110908910|NCT03673995|Inositol|inositol|mesh-list
110908911|NCT03673995|Vitamin B Complex|vitamin b complex|mesh-ancestor
110908912|NCT03673995|Vitamins|vitamins|mesh-ancestor
110908913|NCT03673995|Micronutrients|micronutrients|mesh-ancestor
110908914|NCT03673995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110908915|NCT01378091|Prednisone|prednisone|mesh-list
110908916|NCT01378091|Docetaxel|docetaxel|mesh-list
110908917|NCT01378091|Lenalidomide|lenalidomide|mesh-list
110908918|NCT01378091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110908919|NCT01378091|Tubulin Modulators|tubulin modulators|mesh-ancestor
110908920|NCT01378091|Antimitotic Agents|antimitotic agents|mesh-ancestor
110908921|NCT01378091|Mitosis Modulators|mitosis modulators|mesh-ancestor
110908922|NCT01378091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110908923|NCT01378091|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110908924|NCT01378091|Glucocorticoids|glucocorticoids|mesh-ancestor
110908925|NCT01378091|Hormones|hormones|mesh-ancestor
110226008|NCT05706753|Drospirenone|drospirenone|mesh-list
110908926|NCT01378091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110908927|NCT01378091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110908928|NCT01378091|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110908929|NCT01378091|Immunologic Factors|immunologic factors|mesh-ancestor
110908930|NCT01378091|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110926265|NCT03614403|Vitamin D|vitamin d|mesh-list
110908931|NCT01378091|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110908933|NCT01378091|Growth Inhibitors|growth inhibitors|mesh-ancestor
110908934|NCT02794974|Anesthetics|anesthetics|mesh-list
110908935|NCT02794974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110908936|NCT02794974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110908937|NCT02063568|Oxytocin|oxytocin|mesh-list
110908938|NCT02063568|Oxytocics|oxytocics|mesh-ancestor
110908939|NCT02063568|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110220480|NCT00079157|Sargramostim|sargramostim|mesh-list
110908940|NCT02063568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110908941|NCT02257502|Aflibercept|aflibercept|mesh-list
110908942|NCT02257502|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110908943|NCT02257502|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110908944|NCT02257502|Growth Substances|growth substances|mesh-ancestor
110908945|NCT02257502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110908946|NCT02257502|Growth Inhibitors|growth inhibitors|mesh-ancestor
110908947|NCT02257502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110908948|NCT02907099|Pembrolizumab|pembrolizumab|mesh-list
110908949|NCT02907099|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110908950|NCT02907099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110908951|NCT02907099|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110908952|NCT02907099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110908953|NCT02450123|Sunitinib|sunitinib|mesh-list
110908954|NCT02450123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110908955|NCT02450123|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110908956|NCT02450123|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110908957|NCT02450123|Growth Substances|growth substances|mesh-ancestor
110908958|NCT02450123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110908959|NCT02450123|Growth Inhibitors|growth inhibitors|mesh-ancestor
110908960|NCT02450123|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110908961|NCT02450123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110908962|NCT02450123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110908963|NCT02063802|Metformin|metformin|mesh-list
110908964|NCT02063802|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110908965|NCT02063802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110908966|NCT03672045|Carbetocin|carbetocin|mesh-list
110908967|NCT03672045|Oxytocics|oxytocics|mesh-ancestor
110908968|NCT03672045|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110908969|NCT03672045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110908970|NCT02198300|Clopidogrel|clopidogrel|mesh-list
110908971|NCT02198300|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110908972|NCT02198300|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110908973|NCT02198300|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110908974|NCT02198300|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110908975|NCT02198300|Purinergic Agents|purinergic agents|mesh-ancestor
110908976|NCT02198300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110908977|NCT02198300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110908978|NCT02198300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110908979|NCT03560232|Clindamycin|clindamycin|mesh-list
110908980|NCT03560232|Gentamicins|gentamicins|mesh-list
110908981|NCT03560232|Cefazolin|cefazolin|mesh-list
110908982|NCT03560232|Ceftriaxone|ceftriaxone|mesh-list
110908983|NCT03560232|Tazobactam|tazobactam|mesh-list
110908984|NCT03560232|Piperacillin|piperacillin|mesh-list
110908985|NCT03560232|Ampicillin|ampicillin|mesh-list
110908986|NCT03560232|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
110908987|NCT03560232|Sulbactam|sulbactam|mesh-list
110908988|NCT03560232|Sultamicillin|sultamicillin|mesh-list
110908989|NCT03560232|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110908990|NCT03560232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110908991|NCT03560232|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110908992|NCT03560232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110220821|NCT00299884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110908993|NCT03560232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110908994|NCT03560232|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110908995|NCT02201342|Udenafil|udenafil|mesh-list
110626486|NCT02600741|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110908996|NCT02201342|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110908997|NCT02201342|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110908998|NCT02201342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110908999|NCT02201342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110909000|NCT02201576|Bortezomib|bortezomib|mesh-list
110909001|NCT02201576|Immunoglobulins|immunoglobulins|mesh-list
110909002|NCT02201576|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110909003|NCT02201576|Antibodies|antibodies|mesh-list
110220904|NCT00300118|Budesonide|budesonide|mesh-list
110909004|NCT02201576|gamma-Globulins|gamma-globulins|mesh-list
110909005|NCT02201576|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110909006|NCT02201576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110909007|NCT02201576|Immunologic Factors|immunologic factors|mesh-ancestor
110909008|NCT02201576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110909009|NCT02198378|Acetaminophen|acetaminophen|mesh-list
110909010|NCT02198378|Morphine|morphine|mesh-list
110909011|NCT02198378|Entonox|entonox|mesh-list
110909012|NCT02198378|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110909013|NCT02198378|Narcotics|narcotics|mesh-ancestor
110909014|NCT02198378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110909015|NCT02198378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110909016|NCT02198378|Analgesics|analgesics|mesh-ancestor
110909017|NCT02198378|Sensory System Agents|sensory system agents|mesh-ancestor
110909018|NCT02198378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110909019|NCT02198378|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110909020|NCT02198378|Antipyretics|antipyretics|mesh-ancestor
110909021|NCT02198378|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
110909022|NCT02198378|Anesthetics|anesthetics|mesh-ancestor
110909023|NCT02063100|Losartan|losartan|mesh-list
110909024|NCT02063100|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110909025|NCT02063100|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110909026|NCT02063100|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110909027|NCT02063100|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110909028|NCT02063100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110909029|NCT02198846|Insulin|insulin|mesh-list
110909030|NCT02198846|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110909031|NCT02198846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110909032|NCT02198924|Celecoxib|celecoxib|mesh-list
110909033|NCT02198924|Parecoxib|parecoxib|mesh-list
110909034|NCT02198924|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110909035|NCT02198924|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110909036|NCT02198924|Analgesics|analgesics|mesh-ancestor
110909037|NCT02198924|Sensory System Agents|sensory system agents|mesh-ancestor
110909038|NCT02198924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110909039|NCT02198924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110909040|NCT02198924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110909041|NCT02198924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110909042|NCT02198924|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110909043|NCT02198924|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110909044|NCT02198924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110909045|NCT02198924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110909046|NCT05462093|Liver Extracts|liver extracts|mesh-list
110909047|NCT05462093|Hematinics|hematinics|mesh-ancestor
110909048|NCT02064348|Moxifloxacin|moxifloxacin|mesh-list
110909049|NCT02064348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110909050|NCT02064348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110909051|NCT02064348|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110909052|NCT02064348|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110909053|NCT02064348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110909054|NCT02064348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110909055|NCT02064348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110909056|NCT02202200|Palbociclib|palbociclib|mesh-list
110909057|NCT02202200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110909058|NCT02202200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110909059|NCT02202200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110909060|NCT02202200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110909063|NCT02064504|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110909064|NCT02064504|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110909065|NCT02064504|Autonomic Agents|autonomic agents|mesh-ancestor
110909066|NCT02064504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110909067|NCT02064504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110909068|NCT02064504|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110909069|NCT02064504|Respiratory System Agents|respiratory system agents|mesh-ancestor
110909070|NCT02064504|Dermatologic Agents|dermatologic agents|mesh-ancestor
110909071|NCT02064504|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110909072|NCT02067936|Remifentanil|remifentanil|mesh-list
110909073|NCT02067936|Propofol|propofol|mesh-list
110909074|NCT02067936|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110909075|NCT02067936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110909076|NCT02067936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110909077|NCT02067936|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110909078|NCT02067936|Anesthetics, General|anesthetics, general|mesh-ancestor
110909079|NCT02067936|Anesthetics|anesthetics|mesh-ancestor
110909080|NCT02067936|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110909081|NCT02067936|Narcotics|narcotics|mesh-ancestor
110909082|NCT02067936|Analgesics|analgesics|mesh-ancestor
110909083|NCT02067936|Sensory System Agents|sensory system agents|mesh-ancestor
110909084|NCT02067936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110909085|NCT01377545|Anesthetics|anesthetics|mesh-list
110909086|NCT01377545|Anesthetics, Local|anesthetics, local|mesh-list
110909087|NCT01377545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110909088|NCT01377545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110909089|NCT01377545|Sensory System Agents|sensory system agents|mesh-ancestor
110909090|NCT01377545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110909091|NCT01379807|Docetaxel|docetaxel|mesh-list
110909092|NCT01379807|Panitumumab|panitumumab|mesh-list
110909093|NCT01379807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110909094|NCT01379807|Tubulin Modulators|tubulin modulators|mesh-ancestor
110909095|NCT01379807|Antimitotic Agents|antimitotic agents|mesh-ancestor
110909096|NCT01379807|Mitosis Modulators|mitosis modulators|mesh-ancestor
110909097|NCT01379807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110909098|NCT01379807|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110909099|NCT02202512|Naproxen|naproxen|mesh-list
110909100|NCT02202512|Cimetidine|cimetidine|mesh-list
110909101|NCT02202512|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110909102|NCT02202512|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110909103|NCT02202512|Analgesics|analgesics|mesh-ancestor
110909104|NCT02202512|Sensory System Agents|sensory system agents|mesh-ancestor
110909105|NCT02202512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110909106|NCT02202512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110909107|NCT02202512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110909108|NCT02202512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110909109|NCT02202512|Gout Suppressants|gout suppressants|mesh-ancestor
110909110|NCT02202512|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110909111|NCT02202512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110909112|NCT02202512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110909113|NCT02202512|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110909114|NCT02202512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110909115|NCT02202512|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110909116|NCT02202512|Histamine Antagonists|histamine antagonists|mesh-ancestor
110909117|NCT02202512|Histamine Agents|histamine agents|mesh-ancestor
110909118|NCT02202512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110909119|NCT02202512|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110909120|NCT02202512|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110909121|NCT02065752|Metformin|metformin|mesh-list
110909122|NCT02065752|Canagliflozin|canagliflozin|mesh-list
110909123|NCT02065752|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110909124|NCT02065752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110909125|NCT02065752|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110909126|NCT02065752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110909127|NCT02206490|Naltrexone|naltrexone|mesh-list
110909128|NCT02206490|Dextromethorphan|dextromethorphan|mesh-list
110909129|NCT02206490|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110909130|NCT02206490|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110909131|NCT02206490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110909132|NCT02206490|Sensory System Agents|sensory system agents|mesh-ancestor
110909133|NCT02206490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110909134|NCT02206490|Antitussive Agents|antitussive agents|mesh-ancestor
110909135|NCT02206490|Respiratory System Agents|respiratory system agents|mesh-ancestor
110909136|NCT02206490|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110909137|NCT02206490|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110909138|NCT02206490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110909139|NCT02206490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110909140|NCT02068170|Azithromycin|azithromycin|mesh-list
110909141|NCT02068170|Moxifloxacin|moxifloxacin|mesh-list
110909142|NCT02068170|Clarithromycin|clarithromycin|mesh-list
110909143|NCT02068170|Levofloxacin|levofloxacin|mesh-list
110909144|NCT02068170|Erythromycin|erythromycin|mesh-list
110909145|NCT02068170|Erythromycin Estolate|erythromycin estolate|mesh-list
110626634|NCT00631410|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110909146|NCT02068170|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
110909147|NCT02068170|Erythromycin stearate|erythromycin stearate|mesh-list
110909148|NCT02068170|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
110909149|NCT02068170|Itraconazole|itraconazole|mesh-list
110909150|NCT02068170|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
110909151|NCT02068170|Fluconazole|fluconazole|mesh-list
110909152|NCT02068170|Ketoconazole|ketoconazole|mesh-list
110909153|NCT02068170|Voriconazole|voriconazole|mesh-list
110909155|NCT02068170|Methadone|methadone|mesh-list
110909156|NCT02068170|Haloperidol|haloperidol|mesh-list
110909157|NCT02068170|Haloperidol decanoate|haloperidol decanoate|mesh-list
110909158|NCT02068170|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
110909159|NCT02068170|Tacrolimus|tacrolimus|mesh-list
110909160|NCT02068170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110909161|NCT02068170|Immunologic Factors|immunologic factors|mesh-ancestor
110909162|NCT02068170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110909163|NCT02068170|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110909164|NCT02068170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110909165|NCT02068170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110909166|NCT02068170|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110909167|NCT02068170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110909168|NCT02068170|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110909169|NCT02068170|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110909170|NCT02068170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110909171|NCT02068170|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110909172|NCT02068170|Contraceptive Agents|contraceptive agents|mesh-ancestor
110909173|NCT02068170|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110909174|NCT02068170|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110909175|NCT02068170|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110909176|NCT02068170|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110909177|NCT02068170|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110909178|NCT02068170|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110909179|NCT02068170|Growth Substances|growth substances|mesh-ancestor
110909180|NCT02068170|Growth Inhibitors|growth inhibitors|mesh-ancestor
110909181|NCT02068170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110909182|NCT02068170|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110909183|NCT02068170|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110909184|NCT02068170|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110909185|NCT02068170|Antifungal Agents|antifungal agents|mesh-ancestor
110909186|NCT02068170|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110909187|NCT02068170|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110221525|NCT00301951|Busulfan|busulfan|mesh-list
110909188|NCT02068170|Hormone Antagonists|hormone antagonists|mesh-ancestor
110909189|NCT02068170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110909190|NCT02068170|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110909191|NCT02068170|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110909192|NCT02068170|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110909193|NCT02068170|Narcotics|narcotics|mesh-ancestor
110909194|NCT02068170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110909195|NCT02068170|Analgesics|analgesics|mesh-ancestor
110909196|NCT02068170|Sensory System Agents|sensory system agents|mesh-ancestor
110909197|NCT02068170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110909198|NCT02068170|Antitussive Agents|antitussive agents|mesh-ancestor
110909199|NCT02068170|Respiratory System Agents|respiratory system agents|mesh-ancestor
110909200|NCT02068170|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110909201|NCT02068170|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110909203|NCT02068170|Autonomic Agents|autonomic agents|mesh-ancestor
110909204|NCT02068170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110909205|NCT02068170|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110909206|NCT02068170|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110909207|NCT02068170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110909208|NCT02068170|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110909209|NCT02068170|Dopamine Agents|dopamine agents|mesh-ancestor
110909210|NCT02068170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110909211|NCT02068170|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110909212|NCT02068170|Antimalarials|antimalarials|mesh-ancestor
110909213|NCT02068170|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110909214|NCT02068170|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110909215|NCT05545020|Chromium|chromium|mesh-list
110909216|NCT05545020|Trace Elements|trace elements|mesh-ancestor
110909217|NCT05545020|Micronutrients|micronutrients|mesh-ancestor
110909218|NCT05545020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110909219|NCT02206568|Insulin Lispro|insulin lispro|mesh-list
110909220|NCT02206568|Insulin, Short-Acting|insulin, short-acting|mesh-list
110909221|NCT02206568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110909222|NCT02206568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110626719|NCT00527332|Fentanyl|fentanyl|mesh-list
110909223|NCT02206646|Tenecteplase|tenecteplase|mesh-list
110909224|NCT02206646|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110909225|NCT02206646|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110909226|NCT02206646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110909227|NCT02419417|Nivolumab|nivolumab|mesh-list
110909228|NCT02419417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110909229|NCT02419417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110909230|NCT02419417|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110909231|NCT02419417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110909232|NCT02068404|Nifedipine|nifedipine|mesh-list
110909233|NCT02068404|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110909234|NCT02068404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110221772|NCT00081575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110909235|NCT02068404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110909236|NCT02068404|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110909237|NCT02068404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110909238|NCT02068404|Vasodilator Agents|vasodilator agents|mesh-ancestor
110909239|NCT02068404|Tocolytic Agents|tocolytic agents|mesh-ancestor
110909240|NCT02068404|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110909241|NCT02068482|Rifaximin|rifaximin|mesh-list
110909242|NCT02068482|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110909243|NCT02068482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110909244|NCT02068482|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110909245|NCT02206802|Minoxidil|minoxidil|mesh-list
110909246|NCT02206802|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110909247|NCT02206802|Vasodilator Agents|vasodilator agents|mesh-ancestor
110909248|NCT02065986|Tenofovir|tenofovir|mesh-list
110909249|NCT02065986|Emtricitabine|emtricitabine|mesh-list
110909250|NCT02065986|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110909251|NCT02065986|Antiviral Agents|antiviral agents|mesh-ancestor
110909252|NCT02065986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110909253|NCT02065986|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110909254|NCT02065986|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110909255|NCT02065986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110909256|NCT02065986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110909257|NCT02065986|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110909258|NCT02065986|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110909259|NCT02068560|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
110909260|NCT02068560|Hemostatics|hemostatics|mesh-ancestor
110909261|NCT02068560|Coagulants|coagulants|mesh-ancestor
110909262|NCT02068560|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
110909263|NCT02068560|Natriuretic Agents|natriuretic agents|mesh-ancestor
110909264|NCT02068560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110909265|NCT01377103|Testosterone|testosterone|mesh-list
110909266|NCT01377103|Androgens|androgens|mesh-ancestor
110909267|NCT01377103|Hormones|hormones|mesh-ancestor
110909268|NCT01377103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110909269|NCT01377103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110909270|NCT01377025|Sorafenib|sorafenib|mesh-list
110909271|NCT01377025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110909272|NCT01377025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110909273|NCT01377025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110909274|NCT01377025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110909275|NCT02342275|Propranolol|propranolol|mesh-list
110909276|NCT02342275|Atenolol|atenolol|mesh-list
110909277|NCT02342275|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110909278|NCT02342275|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110909279|NCT02342275|Adrenergic Agents|adrenergic agents|mesh-ancestor
110909280|NCT02342275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110909281|NCT02342275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110909282|NCT02342275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110909283|NCT02342275|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110909284|NCT02342275|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110909285|NCT02342275|Vasodilator Agents|vasodilator agents|mesh-ancestor
110909286|NCT02342275|Sympatholytics|sympatholytics|mesh-ancestor
110909287|NCT02342275|Autonomic Agents|autonomic agents|mesh-ancestor
110909288|NCT02342275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110222038|NCT00304681|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110909289|NCT02342275|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110909290|NCT01827553|Gemcitabine|gemcitabine|mesh-list
110909291|NCT01827553|Folfirinox|folfirinox|mesh-list
110909292|NCT01827553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110909293|NCT01827553|Antimetabolites|antimetabolites|mesh-ancestor
110909294|NCT01827553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110909295|NCT01827553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110909296|NCT02207348|Liraglutide|liraglutide|mesh-list
110626788|NCT00755183|Hormones|hormones|mesh-ancestor
110909297|NCT02207348|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110909298|NCT02207348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110909299|NCT02207348|Incretins|incretins|mesh-ancestor
110909300|NCT02207348|Hormones|hormones|mesh-ancestor
110909301|NCT02207348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110909302|NCT02066454|Apixaban|apixaban|mesh-list
110909303|NCT02066454|Anticoagulants|anticoagulants|mesh-list
110909304|NCT02066454|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110909305|NCT02066454|Antithrombins|antithrombins|mesh-ancestor
110909306|NCT02066454|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110909307|NCT02066454|Protease Inhibitors|protease inhibitors|mesh-ancestor
110909308|NCT02066454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110909309|NCT02066454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110909310|NCT02207426|Tobramycin|tobramycin|mesh-list
110909311|NCT02207426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110909312|NCT02207426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110909313|NCT00777491|Cisplatin|cisplatin|mesh-list
110909314|NCT00777491|Gemcitabine|gemcitabine|mesh-list
110909315|NCT00777491|Fluorouracil|fluorouracil|mesh-list
110909316|NCT00777491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110909317|NCT00777491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110909318|NCT00777491|Antimetabolites|antimetabolites|mesh-ancestor
110909319|NCT00777491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110909320|NCT00777491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110909321|NCT00777491|Immunologic Factors|immunologic factors|mesh-ancestor
110909322|NCT00777491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110909324|NCT02199392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110909325|NCT02199392|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110909326|NCT02199392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110909327|NCT02199392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110909328|NCT05320627|Edoxaban|edoxaban|mesh-list
110909329|NCT05320627|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110909330|NCT05320627|Antithrombins|antithrombins|mesh-ancestor
110909331|NCT05320627|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110909332|NCT05320627|Protease Inhibitors|protease inhibitors|mesh-ancestor
110909333|NCT05320627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110909334|NCT05320627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110909335|NCT05320627|Anticoagulants|anticoagulants|mesh-ancestor
110909336|NCT03559920|Propofol|propofol|mesh-list
110909337|NCT03559920|Anesthetics|anesthetics|mesh-list
110909338|NCT03559920|Sevoflurane|sevoflurane|mesh-list
110909339|NCT03559920|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110909340|NCT03559920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110909341|NCT03559920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110909342|NCT03559920|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110909343|NCT03559920|Anesthetics, General|anesthetics, general|mesh-ancestor
110909344|NCT03559920|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110909345|NCT03559920|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110909346|NCT02203760|Gemcitabine|gemcitabine|mesh-list
110909347|NCT02203760|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110909348|NCT02203760|Antimetabolites|antimetabolites|mesh-ancestor
110909349|NCT02203760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110909350|NCT02203760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110909351|NCT03703271|Methotrexate|methotrexate|mesh-list
110909352|NCT03703271|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110909353|NCT03703271|Abortifacient Agents|abortifacient agents|mesh-ancestor
110909354|NCT03703271|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110909355|NCT03703271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110909356|NCT03703271|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110909357|NCT03703271|Antimetabolites|antimetabolites|mesh-ancestor
110909358|NCT03703271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110909359|NCT03703271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110909360|NCT03703271|Dermatologic Agents|dermatologic agents|mesh-ancestor
110909361|NCT03703271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110909362|NCT03703271|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110909363|NCT03703271|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110909364|NCT03703271|Immunologic Factors|immunologic factors|mesh-ancestor
110909365|NCT03703271|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110909366|NCT03703271|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110909367|NCT03532802|Metoprolol|metoprolol|mesh-list
110909368|NCT03532802|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110909369|NCT03532802|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110909370|NCT03532802|Sympatholytics|sympatholytics|mesh-ancestor
110909371|NCT03532802|Autonomic Agents|autonomic agents|mesh-ancestor
110909372|NCT03532802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110909373|NCT03532802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110909374|NCT03532802|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110909375|NCT03532802|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110222189|NCT00082472|Docetaxel|docetaxel|mesh-list
110909376|NCT03532802|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110909377|NCT03532802|Adrenergic Agents|adrenergic agents|mesh-ancestor
110682922|NCT00903851|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110682923|NCT00903851|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110682924|NCT00903851|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110682925|NCT00903851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110682926|NCT00900887|Ketorolac|ketorolac|mesh-list
110682927|NCT00900887|Nepafenac|nepafenac|mesh-list
110682928|NCT00900887|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110682929|NCT00900887|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110682930|NCT00900887|Analgesics|analgesics|mesh-ancestor
110682931|NCT00900887|Sensory System Agents|sensory system agents|mesh-ancestor
110682932|NCT00900887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110682933|NCT00900887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110682934|NCT00900887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110682935|NCT00900887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110682936|NCT00900887|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110682937|NCT00900887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110682938|NCT00900887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110682939|NCT00904085|Oxymorphone|oxymorphone|mesh-list
110682940|NCT00904085|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110682941|NCT00904085|Narcotics|narcotics|mesh-ancestor
110682942|NCT00904085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110682943|NCT00904085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110682944|NCT00904085|Analgesics|analgesics|mesh-ancestor
110682945|NCT00904085|Sensory System Agents|sensory system agents|mesh-ancestor
110682946|NCT00904085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110682947|NCT00904085|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110682948|NCT00908453|Fosphenytoin|fosphenytoin|mesh-list
110682949|NCT00908453|Anticonvulsants|anticonvulsants|mesh-ancestor
110682950|NCT00908453|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110222230|NCT00313924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110682951|NCT00908453|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110682952|NCT00908453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110682953|NCT00908531|Letrozole|letrozole|mesh-list
110682954|NCT00908531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110682955|NCT00908531|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110682956|NCT00908531|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110682957|NCT00908531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110682958|NCT00908531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110682959|NCT00908531|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110682960|NCT00908531|Hormone Antagonists|hormone antagonists|mesh-ancestor
110682961|NCT00908531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110682962|NCT00908531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110682963|NCT00904397|Celecoxib|celecoxib|mesh-list
110682964|NCT00904397|Lidocaine|lidocaine|mesh-list
110682965|NCT00904397|Anesthetics, Local|anesthetics, local|mesh-ancestor
110682966|NCT00904397|Anesthetics|anesthetics|mesh-ancestor
110682967|NCT00904397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110682968|NCT00904397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110682969|NCT00904397|Sensory System Agents|sensory system agents|mesh-ancestor
110682970|NCT00904397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110682971|NCT00904397|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110682972|NCT00904397|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110682973|NCT00904397|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110682974|NCT00904397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110682975|NCT00904397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110682976|NCT00904397|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110682977|NCT00904397|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110330019|NCT01243827|Carvedilol|carvedilol|mesh-list
110682979|NCT00904397|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110682980|NCT00904397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110682981|NCT00904397|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110682982|NCT00904397|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110682983|NCT00904397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110682984|NCT00904475|Lidocaine|lidocaine|mesh-list
110682985|NCT00904475|Anesthetics, Local|anesthetics, local|mesh-ancestor
110682986|NCT00904475|Anesthetics|anesthetics|mesh-ancestor
110682987|NCT00904475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110682988|NCT00904475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110682989|NCT00904475|Sensory System Agents|sensory system agents|mesh-ancestor
110909378|NCT03532802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110909379|NCT03532802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110909380|NCT03430531|Lidocaine|lidocaine|mesh-list
110909381|NCT03430531|Anesthetics, Local|anesthetics, local|mesh-ancestor
110909382|NCT03430531|Anesthetics|anesthetics|mesh-ancestor
110909383|NCT03430531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110909384|NCT03430531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110909385|NCT03430531|Sensory System Agents|sensory system agents|mesh-ancestor
110909386|NCT03430531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110909387|NCT03430531|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110909388|NCT03430531|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110909389|NCT03430531|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110909390|NCT03430531|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110909391|NCT03430531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110909393|NCT02066532|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110909394|NCT02066532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110909395|NCT05763329|Lemborexant|lemborexant|mesh-list
110909396|NCT05763329|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
110909397|NCT05763329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110909398|NCT05763329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110909399|NCT05763329|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110909400|NCT05763329|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110909401|NCT05763329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110909402|NCT05763329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110909403|NCT04088513|Aspirin|aspirin|mesh-list
110909404|NCT04088513|Clopidogrel|clopidogrel|mesh-list
110909405|NCT04088513|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110909406|NCT04088513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110909407|NCT04088513|Analgesics|analgesics|mesh-ancestor
110909408|NCT04088513|Sensory System Agents|sensory system agents|mesh-ancestor
110909409|NCT04088513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110909410|NCT04088513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110909411|NCT04088513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110909412|NCT04088513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110909413|NCT04088513|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110909414|NCT04088513|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110909415|NCT04088513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110909416|NCT04088513|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110909417|NCT04088513|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110909418|NCT04088513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110909419|NCT04088513|Antipyretics|antipyretics|mesh-ancestor
110909420|NCT04088513|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110909421|NCT04088513|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110909422|NCT04088513|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110909423|NCT04088513|Purinergic Agents|purinergic agents|mesh-ancestor
110909424|NCT04088513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110909425|NCT02207660|Fluorouracil|fluorouracil|mesh-list
110909426|NCT02207660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110909427|NCT02207660|Antimetabolites|antimetabolites|mesh-ancestor
110909428|NCT02207660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110926364|NCT03613545|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110909429|NCT02207660|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110909430|NCT02207660|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110909431|NCT02207660|Immunologic Factors|immunologic factors|mesh-ancestor
110909432|NCT02207660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110909433|NCT02069340|Zoledronic Acid|zoledronic acid|mesh-list
110909434|NCT02069340|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110909435|NCT02069340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110909436|NCT02069418|Alovudine|alovudine|mesh-list
110909437|NCT02069418|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110909438|NCT02069418|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110909439|NCT02069418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110909440|NCT02069418|Antiviral Agents|antiviral agents|mesh-ancestor
110909441|NCT02069418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110909442|NCT02208128|Bevacizumab|bevacizumab|mesh-list
110909443|NCT02208128|Sunitinib|sunitinib|mesh-list
110909444|NCT02208128|Everolimus|everolimus|mesh-list
110909445|NCT02208128|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110909446|NCT02208128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110909447|NCT02208128|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110909448|NCT02208128|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110909449|NCT02208128|Growth Substances|growth substances|mesh-ancestor
110909450|NCT02208128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110909451|NCT02208128|Growth Inhibitors|growth inhibitors|mesh-ancestor
110909452|NCT02208128|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110909453|NCT02208128|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110909454|NCT02208128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110909455|NCT02208128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110909456|NCT02208128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110909457|NCT02208128|Immunologic Factors|immunologic factors|mesh-ancestor
110909458|NCT02066610|Selenium|selenium|mesh-list
110909459|NCT02066610|Selenious Acid|selenious acid|mesh-list
110909460|NCT02066610|Sodium Selenite|sodium selenite|mesh-list
110909461|NCT02066610|Selenic Acid|selenic acid|mesh-list
110909462|NCT02066610|Antioxidants|antioxidants|mesh-ancestor
110909463|NCT02066610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110909464|NCT02066610|Protective Agents|protective agents|mesh-ancestor
110909465|NCT02066610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110909466|NCT02066610|Trace Elements|trace elements|mesh-ancestor
110909467|NCT02066610|Micronutrients|micronutrients|mesh-ancestor
110909468|NCT03077711|Trimethoprim|trimethoprim|mesh-list
110909469|NCT03077711|Methenamine|methenamine|mesh-list
110909470|NCT03077711|Methenamine hippurate|methenamine hippurate|mesh-list
110909471|NCT03077711|Methenamine mandelate|methenamine mandelate|mesh-list
110909472|NCT03077711|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110909473|NCT03077711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110909474|NCT03077711|Antimalarials|antimalarials|mesh-ancestor
110909475|NCT03077711|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110909476|NCT03077711|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110909477|NCT03077711|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110909478|NCT03077711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110909479|NCT03077711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110909480|NCT03077711|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110909481|NCT03077711|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
110909482|NCT03077711|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110909483|NCT03077711|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110909484|NCT04374019|Artesunate|artesunate|mesh-list
110909485|NCT04374019|Ivermectin|ivermectin|mesh-list
110909486|NCT04374019|Camostat|camostat|mesh-list
110909487|NCT04374019|Antimalarials|antimalarials|mesh-ancestor
110909488|NCT04374019|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110909489|NCT04374019|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110909490|NCT04374019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110909491|NCT04374019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110909492|NCT04374019|Antiviral Agents|antiviral agents|mesh-ancestor
110909493|NCT04374019|Schistosomicides|schistosomicides|mesh-ancestor
110909494|NCT04374019|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110909495|NCT04374019|Anthelmintics|anthelmintics|mesh-ancestor
110909496|NCT04374019|Protease Inhibitors|protease inhibitors|mesh-ancestor
110909497|NCT04374019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110909498|NCT04374019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110909499|NCT04374019|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
110909500|NCT04374019|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110909501|NCT02069808|Leuprolide|leuprolide|mesh-list
110909503|NCT02069808|Ganirelix|ganirelix|mesh-list
110909504|NCT02069808|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110909505|NCT02069808|Fertility Agents|fertility agents|mesh-ancestor
110909506|NCT02069808|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110909507|NCT02069808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110909508|NCT02069808|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110909509|NCT02069808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110909510|NCT02069808|Hormone Antagonists|hormone antagonists|mesh-ancestor
110909511|NCT02069808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110909512|NCT03673605|Warfarin|warfarin|mesh-list
110909513|NCT03673605|Rivaroxaban|rivaroxaban|mesh-list
110909514|NCT03673605|Anticoagulants|anticoagulants|mesh-ancestor
110909515|NCT03673605|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110909516|NCT03673605|Antithrombins|antithrombins|mesh-ancestor
110909517|NCT03673605|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110909518|NCT03673605|Protease Inhibitors|protease inhibitors|mesh-ancestor
110222809|NCT00088686|Capsaicin|capsaicin|mesh-list
110909519|NCT03673605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110909520|NCT03673605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110909521|NCT02069886|Deferasirox|deferasirox|mesh-list
110909522|NCT02069886|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110627033|NCT01068067|Tacrolimus|tacrolimus|mesh-list
110909523|NCT02069886|Chelating Agents|chelating agents|mesh-ancestor
110909524|NCT02069886|Sequestering Agents|sequestering agents|mesh-ancestor
110909525|NCT02069886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110909526|NCT04311463|Paroxetine|paroxetine|mesh-list
110909527|NCT04311463|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110222865|NCT00310336|Interferon-alpha|interferon-alpha|mesh-list
110909528|NCT04311463|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110909529|NCT04311463|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110909530|NCT04311463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110909531|NCT04311463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110909532|NCT04311463|Serotonin Agents|serotonin agents|mesh-ancestor
110909533|NCT04311463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110909534|NCT04311463|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110909535|NCT04311463|Antidepressive Agents|antidepressive agents|mesh-ancestor
110909536|NCT04311463|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110909537|NCT04311463|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110909538|NCT04311463|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110909539|NCT04311463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110909540|NCT02065128|Capsaicin|capsaicin|mesh-list
110909541|NCT02065128|Antipruritics|antipruritics|mesh-ancestor
110909542|NCT02065128|Dermatologic Agents|dermatologic agents|mesh-ancestor
110909543|NCT02065128|Sensory System Agents|sensory system agents|mesh-ancestor
110909544|NCT02065128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110909545|NCT02065128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110909546|NCT03677895|Hyaluronic Acid|hyaluronic acid|mesh-list
110909547|NCT03677895|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110909548|NCT03677895|Immunologic Factors|immunologic factors|mesh-ancestor
110909549|NCT03677895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110909550|NCT03677895|Viscosupplements|viscosupplements|mesh-ancestor
110909551|NCT03677895|Protective Agents|protective agents|mesh-ancestor
110909552|NCT04295005|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110909553|NCT04295005|Empagliflozin|empagliflozin|mesh-list
110909554|NCT04295005|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110909555|NCT04295005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110909556|NCT04295005|Incretins|incretins|mesh-ancestor
110909557|NCT04295005|Hormones|hormones|mesh-ancestor
110909558|NCT04295005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110909559|NCT04295005|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110909560|NCT04295005|Protease Inhibitors|protease inhibitors|mesh-ancestor
110909561|NCT04295005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110909562|NCT04295005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110226125|NCT05665699|Allopurinol|allopurinol|mesh-list
110909563|NCT04295005|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110909564|NCT03174353|Lanreotide|lanreotide|mesh-list
110909565|NCT03174353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110909566|NCT05214235|Hypoglycemic Agents|hypoglycemic agents|mesh-list
110909567|NCT05214235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110909568|NCT03054363|Letrozole|letrozole|mesh-list
110909569|NCT03054363|Palbociclib|palbociclib|mesh-list
110909570|NCT03054363|Tucatinib|tucatinib|mesh-list
110909571|NCT03054363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110909572|NCT03054363|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110909573|NCT03054363|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110909574|NCT03054363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110909575|NCT03054363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110909576|NCT03054363|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110909577|NCT03054363|Hormone Antagonists|hormone antagonists|mesh-ancestor
110909578|NCT03054363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110909579|NCT03054363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110909580|NCT03054363|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110909581|NCT04080947|Montelukast|montelukast|mesh-list
110909582|NCT04080947|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110909583|NCT04080947|Respiratory System Agents|respiratory system agents|mesh-ancestor
110909584|NCT04080947|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110909585|NCT04080947|Hormone Antagonists|hormone antagonists|mesh-ancestor
110909586|NCT04080947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110909587|NCT04080947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110909588|NCT04080947|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110909589|NCT04080947|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110909590|NCT04080947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110909591|NCT02066688|Calcium, Dietary|calcium, dietary|mesh-list
110909592|NCT02066688|Vitamin D|vitamin d|mesh-list
110909593|NCT02066688|Folic Acid|folic acid|mesh-list
110909594|NCT02066688|Vitamin B Complex|vitamin b complex|mesh-list
110909595|NCT02066688|Calcium|calcium|mesh-list
110909596|NCT02066688|Vitamins|vitamins|mesh-ancestor
110909597|NCT02066688|Micronutrients|micronutrients|mesh-ancestor
110909598|NCT02066688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110909599|NCT02066688|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110909600|NCT02066688|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110909601|NCT02066688|Hematinics|hematinics|mesh-ancestor
110909602|NCT03671733|Liraglutide|liraglutide|mesh-list
110909603|NCT03671733|Exenatide|exenatide|mesh-list
110909604|NCT03671733|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110909605|NCT03671733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110909606|NCT03671733|Incretins|incretins|mesh-ancestor
110909607|NCT03671733|Hormones|hormones|mesh-ancestor
110909608|NCT03671733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110909609|NCT03671733|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110909610|NCT03119363|Methamphetamine|methamphetamine|mesh-list
110909611|NCT03119363|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110909612|NCT03119363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110909613|NCT03119363|Sympathomimetics|sympathomimetics|mesh-ancestor
110909614|NCT03119363|Autonomic Agents|autonomic agents|mesh-ancestor
110909615|NCT03119363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110909616|NCT03119363|Dopamine Agents|dopamine agents|mesh-ancestor
110909617|NCT03119363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110909618|NCT03119363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110909619|NCT03119363|Adrenergic Agents|adrenergic agents|mesh-ancestor
110909620|NCT03119363|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110909621|NCT03119363|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110909622|NCT03119363|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110909623|NCT03119363|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110909624|NCT04059081|Obinutuzumab|obinutuzumab|mesh-list
110909625|NCT04059081|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110909626|NCT04059081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110909627|NCT03671655|Paclitaxel|paclitaxel|mesh-list
110909628|NCT03671655|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110909629|NCT03671655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110909630|NCT03671655|Tubulin Modulators|tubulin modulators|mesh-ancestor
110909631|NCT03671655|Antimitotic Agents|antimitotic agents|mesh-ancestor
110909632|NCT03671655|Mitosis Modulators|mitosis modulators|mesh-ancestor
110909633|NCT03671655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110909634|NCT02200094|Telmisartan|telmisartan|mesh-list
110909635|NCT02200094|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110909636|NCT02200094|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110909637|NCT02200094|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110909638|NCT02200094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110909639|NCT01370538|Esomeprazole|esomeprazole|mesh-list
110909640|NCT01370538|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110909641|NCT01370538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110909642|NCT01370538|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110909643|NCT01370538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110909644|NCT01370538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110909645|NCT03248297|Amoxicillin|amoxicillin|mesh-list
110909646|NCT03248297|Azithromycin|azithromycin|mesh-list
110909647|NCT03248297|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110909648|NCT03248297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110909649|NCT02208596|Pentazocine|pentazocine|mesh-list
110909650|NCT02208596|Propofol|propofol|mesh-list
110909651|NCT02208596|Etomidate|etomidate|mesh-list
110909652|NCT02208596|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110909653|NCT02208596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110223591|NCT00294931|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110909654|NCT02208596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110909655|NCT02208596|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110909656|NCT02208596|Anesthetics, General|anesthetics, general|mesh-ancestor
110909657|NCT02208596|Anesthetics|anesthetics|mesh-ancestor
110909658|NCT02208596|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110909659|NCT02208596|Narcotics|narcotics|mesh-ancestor
110909660|NCT02208596|Analgesics|analgesics|mesh-ancestor
110909661|NCT02208596|Sensory System Agents|sensory system agents|mesh-ancestor
110909662|NCT02208596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110909663|NCT02208596|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110909664|NCT02208596|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110909665|NCT02070120|Mitomycins|mitomycins|mesh-list
110909666|NCT02070120|Mitomycin|mitomycin|mesh-list
110909667|NCT02070120|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110909668|NCT02070120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110909669|NCT02070120|Alkylating Agents|alkylating agents|mesh-ancestor
110909670|NCT02070120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110909671|NCT02070120|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110909672|NCT02070120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110909673|NCT02200172|Melatonin|melatonin|mesh-list
110909674|NCT02200172|Antioxidants|antioxidants|mesh-ancestor
110223735|NCT00296023|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110909675|NCT02200172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110909676|NCT02200172|Protective Agents|protective agents|mesh-ancestor
110909677|NCT02200172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110909678|NCT02200172|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110909679|NCT03673137|Gemcitabine|gemcitabine|mesh-list
110909680|NCT03673137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110909681|NCT03673137|Antimetabolites|antimetabolites|mesh-ancestor
110909682|NCT03673137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110909683|NCT03673137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110909684|NCT02066844|Betamethasone|betamethasone|mesh-list
110909685|NCT02066844|Betamethasone Valerate|betamethasone valerate|mesh-list
110909686|NCT02066844|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
110909687|NCT02066844|Betamethasone benzoate|betamethasone benzoate|mesh-list
110909688|NCT02066844|Lidocaine|lidocaine|mesh-list
110909689|NCT02066844|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
110909690|NCT02066844|Anesthetics, Local|anesthetics, local|mesh-ancestor
110909691|NCT02066844|Anesthetics|anesthetics|mesh-ancestor
110909692|NCT02066844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110909693|NCT02066844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110909694|NCT02066844|Sensory System Agents|sensory system agents|mesh-ancestor
110909695|NCT02066844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110909696|NCT02066844|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110223868|NCT00122070|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110909697|NCT02066844|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110909698|NCT02066844|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110909699|NCT02066844|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110909700|NCT02066844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110909701|NCT02066844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110909702|NCT02066844|Glucocorticoids|glucocorticoids|mesh-ancestor
110909703|NCT02066844|Hormones|hormones|mesh-ancestor
110909704|NCT02066844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110909705|NCT02066844|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110909706|NCT02066844|Respiratory System Agents|respiratory system agents|mesh-ancestor
110909707|NCT03669783|Dactinomycin|dactinomycin|mesh-list
110909708|NCT03669783|Carboplatin|carboplatin|mesh-list
110909709|NCT03669783|Doxorubicin|doxorubicin|mesh-list
110909710|NCT03669783|Etoposide|etoposide|mesh-list
110909711|NCT03669783|Vincristine|vincristine|mesh-list
110909712|NCT03669783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110909713|NCT03669783|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110909714|NCT03669783|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110909715|NCT03669783|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110909716|NCT03669783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110909717|NCT03669783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110909718|NCT03669783|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110909719|NCT03669783|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110909720|NCT03669783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110909721|NCT03669783|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110909722|NCT03669783|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110909723|NCT03669783|Tubulin Modulators|tubulin modulators|mesh-ancestor
110224003|NCT00297817|Vaccines|vaccines|mesh-list
110909724|NCT03669783|Antimitotic Agents|antimitotic agents|mesh-ancestor
110909725|NCT03669783|Mitosis Modulators|mitosis modulators|mesh-ancestor
110909726|NCT02067078|Dexamethasone|dexamethasone|mesh-list
110909727|NCT02067078|Dexamethasone acetate|dexamethasone acetate|mesh-list
110909728|NCT02067078|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
110909729|NCT02067078|Clonidine|clonidine|mesh-list
110909730|NCT02067078|Epinephrine|epinephrine|mesh-list
110909731|NCT02067078|Racepinephrine|racepinephrine|mesh-list
110909732|NCT02067078|Ropivacaine|ropivacaine|mesh-list
110909733|NCT02067078|Bupivacaine|bupivacaine|mesh-list
110909734|NCT02067078|Epinephryl borate|epinephryl borate|mesh-list
110909735|NCT02067078|BB 1101|bb 1101|mesh-list
110909736|NCT02067078|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110909737|NCT02067078|Antiemetics|antiemetics|mesh-ancestor
110909738|NCT02067078|Autonomic Agents|autonomic agents|mesh-ancestor
110909739|NCT02067078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110909740|NCT02067078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110909741|NCT02067078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110909742|NCT02067078|Glucocorticoids|glucocorticoids|mesh-ancestor
110909743|NCT02067078|Hormones|hormones|mesh-ancestor
110909744|NCT02067078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110909745|NCT02067078|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110909746|NCT02067078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110224201|NCT04717531|Docetaxel|docetaxel|mesh-list
110909747|NCT02067078|Protease Inhibitors|protease inhibitors|mesh-ancestor
110909748|NCT02067078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110909749|NCT02067078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110909750|NCT02067078|Anesthetics, Local|anesthetics, local|mesh-ancestor
110909751|NCT02067078|Anesthetics|anesthetics|mesh-ancestor
110909752|NCT02067078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110627233|NCT02598791|Hormones|hormones|mesh-ancestor
110909753|NCT02067078|Sensory System Agents|sensory system agents|mesh-ancestor
110909755|NCT02067078|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110909756|NCT02067078|Sympatholytics|sympatholytics|mesh-ancestor
110909757|NCT02067078|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110244786|NCT00449137|Antimetabolites|antimetabolites|mesh-ancestor
110909758|NCT02067078|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110909759|NCT02067078|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110909760|NCT02067078|Adrenergic Agents|adrenergic agents|mesh-ancestor
110909761|NCT02067078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110909762|NCT02067078|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110909763|NCT02067078|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110909764|NCT02067078|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110909765|NCT02067078|Respiratory System Agents|respiratory system agents|mesh-ancestor
110909766|NCT02067078|Mydriatics|mydriatics|mesh-ancestor
110909767|NCT02067078|Sympathomimetics|sympathomimetics|mesh-ancestor
110909768|NCT02067078|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110909769|NCT02067078|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110909770|NCT02067078|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110909771|NCT02067078|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110909772|NCT02067078|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110909773|NCT05461235|Pembrolizumab|pembrolizumab|mesh-list
110909774|NCT05461235|Nivolumab|nivolumab|mesh-list
110909775|NCT05461235|Tislelizumab|tislelizumab|mesh-list
110909776|NCT05461235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110909777|NCT05461235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110909778|NCT05461235|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110909779|NCT05461235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110909780|NCT02070198|Triptorelin Pamoate|triptorelin pamoate|mesh-list
110909781|NCT02070198|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
110909782|NCT02070198|Hormones|hormones|mesh-ancestor
110224474|NCT06001749|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110909783|NCT02070198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110909784|NCT02070198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110909785|NCT02070198|Luteolytic Agents|luteolytic agents|mesh-ancestor
110909786|NCT02070198|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110909787|NCT02070198|Contraceptive Agents|contraceptive agents|mesh-ancestor
110909788|NCT02070198|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110909789|NCT02070198|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110909790|NCT02070198|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110909791|NCT02070198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110909792|NCT02918201|Tranexamic Acid|tranexamic acid|mesh-list
110909793|NCT02918201|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110909794|NCT02918201|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110909795|NCT02918201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110909796|NCT02918201|Hemostatics|hemostatics|mesh-ancestor
110909797|NCT02918201|Coagulants|coagulants|mesh-ancestor
110909798|NCT02200406|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
110909799|NCT02200406|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110909800|NCT02200406|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110909801|NCT02200406|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110909802|NCT02200406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110909803|NCT02200406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110909804|NCT02200406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110909805|NCT02200406|Antidepressive Agents|antidepressive agents|mesh-ancestor
110909806|NCT02200406|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110909807|NCT02204852|Iloprost|iloprost|mesh-list
110909808|NCT02204852|Eptifibatide|eptifibatide|mesh-list
110909809|NCT02204852|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110224687|NCT05999994|Ramucirumab|ramucirumab|mesh-list
110909810|NCT02204852|Vasodilator Agents|vasodilator agents|mesh-ancestor
110909811|NCT02070510|Lisinopril|lisinopril|mesh-list
110909812|NCT02070510|Warfarin|warfarin|mesh-list
110909813|NCT02070510|Anticoagulants|anticoagulants|mesh-ancestor
110909814|NCT02070510|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110909815|NCT02070510|Protease Inhibitors|protease inhibitors|mesh-ancestor
110909816|NCT02070510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110909817|NCT02070510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110909818|NCT02070510|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110909819|NCT02070510|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110909820|NCT02070510|Protective Agents|protective agents|mesh-ancestor
110909821|NCT02070510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110909822|NCT02200562|Ipilimumab|ipilimumab|mesh-list
110909823|NCT02200562|Dabrafenib|dabrafenib|mesh-list
110909824|NCT02200562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110627306|NCT04094909|Pembrolizumab|pembrolizumab|mesh-list
110226153|NCT05660538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110226154|NCT05660538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110226156|NCT05660538|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110909825|NCT02200562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110909826|NCT02200562|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110909827|NCT02200562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110909828|NCT02200562|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110909829|NCT02200562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110909830|NCT02200640|Losartan|losartan|mesh-list
110909831|NCT02200640|Telmisartan|telmisartan|mesh-list
110909832|NCT02200640|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110909833|NCT02200640|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110909834|NCT02200640|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110909835|NCT02200640|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110909836|NCT02200640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110909837|NCT02200718|Freund's Adjuvant|freund's adjuvant|mesh-list
110909838|NCT02200718|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110909839|NCT02200718|Immunologic Factors|immunologic factors|mesh-ancestor
110909840|NCT02200718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110909841|NCT02208986|Triptorelin Pamoate|triptorelin pamoate|mesh-list
110909842|NCT02208986|Luteolytic Agents|luteolytic agents|mesh-ancestor
110249982|NCT04054830|Diclofenac|diclofenac|mesh-list
110909843|NCT02208986|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110909844|NCT02208986|Contraceptive Agents|contraceptive agents|mesh-ancestor
110926467|NCT03611985|Taxane|taxane|mesh-list
110909845|NCT02208986|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110909846|NCT02208986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110909847|NCT02208986|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110909848|NCT02208986|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110909850|NCT02067780|Levofloxacin|levofloxacin|mesh-list
110909851|NCT02067780|Ofloxacin|ofloxacin|mesh-list
110909852|NCT02067780|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110909853|NCT02067780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110909854|NCT02067780|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110909855|NCT02067780|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110909856|NCT02067780|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110909857|NCT02067780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110909858|NCT02067780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110909859|NCT02067780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110909860|NCT02067780|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110909861|NCT02067780|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110909862|NCT02205164|Aprepitant|aprepitant|mesh-list
110909863|NCT02205164|Palonosetron|palonosetron|mesh-list
110909864|NCT02205164|Antiemetics|antiemetics|mesh-ancestor
110909865|NCT02205164|Autonomic Agents|autonomic agents|mesh-ancestor
110909866|NCT02205164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110909867|NCT02205164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110909868|NCT02205164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110909869|NCT02205164|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110909870|NCT02205164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110909871|NCT02205164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110909872|NCT02205164|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110909873|NCT02205164|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110909874|NCT02205164|Serotonin Agents|serotonin agents|mesh-ancestor
110909875|NCT02071212|Ticagrelor|ticagrelor|mesh-list
110225093|NCT05997238|Triamcinolone|triamcinolone|mesh-list
110909876|NCT02071212|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110909877|NCT02071212|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110909878|NCT02071212|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110909879|NCT02071212|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110909880|NCT02071212|Purinergic Agents|purinergic agents|mesh-ancestor
110909881|NCT02071212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110909882|NCT02071212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110909883|NCT02071212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110909884|NCT02072382|Metformin|metformin|mesh-list
110909885|NCT02072382|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110909886|NCT02072382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110909887|NCT02205242|Azithromycin|azithromycin|mesh-list
110909888|NCT02205242|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110225235|NCT05995535|Analgesics|analgesics|mesh-ancestor
110909889|NCT02205242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110909890|NCT02071368|Metformin|metformin|mesh-list
110909891|NCT02071368|Canagliflozin|canagliflozin|mesh-list
110909892|NCT02071368|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110909893|NCT02071368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110909894|NCT02071368|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110926480|NCT00104676|Paclitaxel|paclitaxel|mesh-list
110926481|NCT00104676|Etoposide|etoposide|mesh-list
110926482|NCT00104676|Oxaliplatin|oxaliplatin|mesh-list
110909895|NCT02071368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110225318|NCT05990985|Rituximab|rituximab|mesh-list
110909897|NCT03402841|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110909898|NCT03402841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110909899|NCT03402841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110909900|NCT03402841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110909902|NCT02205398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110909903|NCT02205398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110909904|NCT04130659|Omeprazole|omeprazole|mesh-list
110909905|NCT04130659|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110909906|NCT04130659|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110909907|NCT04130659|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110909908|NCT04130659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110909909|NCT04130659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110909910|NCT02220608|Bortezomib|bortezomib|mesh-list
110909911|NCT02220608|Lenograstim|lenograstim|mesh-list
110909912|NCT02220608|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110343875|NCT06016452|Chlorophyllin|chlorophyllin|mesh-list
110909913|NCT02220608|Immunologic Factors|immunologic factors|mesh-ancestor
110909914|NCT02220608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110909915|NCT02220608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110909916|NCT03630367|Dexamethasone|dexamethasone|mesh-list
110909917|NCT03630367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110909918|NCT03630367|Antiemetics|antiemetics|mesh-ancestor
110909919|NCT03630367|Autonomic Agents|autonomic agents|mesh-ancestor
110909920|NCT03630367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110909921|NCT03630367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110909922|NCT03630367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110909923|NCT03630367|Glucocorticoids|glucocorticoids|mesh-ancestor
110909924|NCT03630367|Hormones|hormones|mesh-ancestor
110909925|NCT03630367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110909926|NCT03630367|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110909927|NCT03630367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110909928|NCT02258282|Etanercept|etanercept|mesh-list
110909929|NCT02258282|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110909930|NCT02258282|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110909931|NCT02258282|Analgesics|analgesics|mesh-ancestor
110909932|NCT02258282|Sensory System Agents|sensory system agents|mesh-ancestor
110909933|NCT02258282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110909934|NCT02258282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110909935|NCT02258282|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110909936|NCT02258282|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110909937|NCT02258282|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110909938|NCT02258282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110909939|NCT02258282|Immunologic Factors|immunologic factors|mesh-ancestor
110909940|NCT02076594|Docetaxel|docetaxel|mesh-list
110909941|NCT02076594|Capecitabine|capecitabine|mesh-list
110909942|NCT02076594|Oxaliplatin|oxaliplatin|mesh-list
110909943|NCT02076594|Epirubicin|epirubicin|mesh-list
110909944|NCT02076594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110909945|NCT02076594|Tubulin Modulators|tubulin modulators|mesh-ancestor
110909946|NCT02076594|Antimitotic Agents|antimitotic agents|mesh-ancestor
110909947|NCT02076594|Mitosis Modulators|mitosis modulators|mesh-ancestor
110909948|NCT02076594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110909949|NCT02076594|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110909950|NCT02076594|Antimetabolites|antimetabolites|mesh-ancestor
110909951|NCT02076594|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110909952|NCT02076594|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110909953|NCT02076594|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110909954|NCT02076594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110909955|NCT04175509|Acetaminophen|acetaminophen|mesh-list
110909956|NCT04175509|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110909957|NCT04175509|Analgesics|analgesics|mesh-ancestor
110909958|NCT04175509|Sensory System Agents|sensory system agents|mesh-ancestor
110909959|NCT04175509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110909960|NCT04175509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110909961|NCT04175509|Antipyretics|antipyretics|mesh-ancestor
110909962|NCT02220842|Atezolizumab|atezolizumab|mesh-list
110909963|NCT02220842|Obinutuzumab|obinutuzumab|mesh-list
110909964|NCT02220842|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110909965|NCT02220842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110909966|NCT02220842|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110909967|NCT02220842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110909969|NCT02205554|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110909970|NCT02205554|Narcotics|narcotics|mesh-ancestor
110909971|NCT02205554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110909972|NCT02205554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110909973|NCT02205554|Analgesics|analgesics|mesh-ancestor
110627462|NCT01564810|Cetuximab|cetuximab|mesh-list
110909974|NCT02205554|Sensory System Agents|sensory system agents|mesh-ancestor
110909975|NCT02205554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110909976|NCT02076750|Vitamin D|vitamin d|mesh-list
110909977|NCT02076750|Cholecalciferol|cholecalciferol|mesh-list
110909978|NCT02076750|Vitamins|vitamins|mesh-ancestor
110909979|NCT02076750|Micronutrients|micronutrients|mesh-ancestor
110909980|NCT02076750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110909981|NCT02076750|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110909982|NCT02076750|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110909983|NCT05262608|Olaparib|olaparib|mesh-list
110909984|NCT05262608|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110909985|NCT05262608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110909986|NCT05262608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110909987|NCT05262608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110909988|NCT01380457|Dronabinol|dronabinol|mesh-list
110909989|NCT01380457|Hallucinogens|hallucinogens|mesh-ancestor
110909990|NCT01380457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110909991|NCT01380457|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110909992|NCT01380457|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110909993|NCT01380457|Analgesics|analgesics|mesh-ancestor
110909994|NCT01380457|Sensory System Agents|sensory system agents|mesh-ancestor
110909995|NCT01380457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110909996|NCT01380457|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
110909997|NCT01380457|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110909998|NCT01380457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110909999|NCT01380457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110910000|NCT01380457|Hormones|hormones|mesh-ancestor
110910001|NCT01380457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110910002|NCT02071680|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
110910003|NCT02071680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110910004|NCT02071680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110910005|NCT02071680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110910006|NCT02071680|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110910007|NCT01380301|Miltefosine|miltefosine|mesh-list
110910008|NCT01380301|Antifungal Agents|antifungal agents|mesh-ancestor
110910009|NCT01380301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110910010|NCT01380301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110910011|NCT01380301|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110910012|NCT01380301|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110910013|NCT02076828|Zinc|zinc|mesh-list
110910014|NCT02076828|Glycine|glycine|mesh-list
110910015|NCT02076828|Trace Elements|trace elements|mesh-ancestor
110910016|NCT02076828|Micronutrients|micronutrients|mesh-ancestor
110910017|NCT02076828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110910018|NCT02076828|Glycine Agents|glycine agents|mesh-ancestor
110910019|NCT02076828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110910020|NCT02076828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110910021|NCT02221154|Folic Acid|folic acid|mesh-list
110910022|NCT02221154|Hematinics|hematinics|mesh-ancestor
110910023|NCT02221154|Vitamin B Complex|vitamin b complex|mesh-ancestor
110910024|NCT02221154|Vitamins|vitamins|mesh-ancestor
110910025|NCT02221154|Micronutrients|micronutrients|mesh-ancestor
110910026|NCT02221154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110910027|NCT02073084|Moxifloxacin|moxifloxacin|mesh-list
110910028|NCT02073084|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110910029|NCT02073084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110910030|NCT02073084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110910031|NCT02073084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110910032|NCT02073084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110910033|NCT02073084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110910034|NCT02073084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110910035|NCT03787849|Anesthetics|anesthetics|mesh-list
110910036|NCT03787849|Propofol|propofol|mesh-list
110910037|NCT03787849|Sevoflurane|sevoflurane|mesh-list
110910038|NCT03787849|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110910039|NCT03787849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110910040|NCT03787849|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110910041|NCT03787849|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110910042|NCT03787849|Anesthetics, General|anesthetics, general|mesh-ancestor
110910043|NCT03787849|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110910044|NCT03787849|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110910046|NCT03777319|Spironolactone|spironolactone|mesh-list
110910047|NCT03777319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110910048|NCT03777319|Glucocorticoids|glucocorticoids|mesh-ancestor
110910049|NCT03777319|Hormones|hormones|mesh-ancestor
110910050|NCT03777319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110910051|NCT03777319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110910052|NCT03777319|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110910053|NCT03777319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110910054|NCT03777319|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110910055|NCT03777319|Hormone Antagonists|hormone antagonists|mesh-ancestor
110910056|NCT03777319|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110910057|NCT03777319|Diuretics|diuretics|mesh-ancestor
110910058|NCT03777319|Natriuretic Agents|natriuretic agents|mesh-ancestor
110910059|NCT03671265|Apatinib|apatinib|mesh-list
110910060|NCT03671265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110910061|NCT03671265|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110910062|NCT03671265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110910063|NCT03671265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110910064|NCT02881957|Vitamin D|vitamin d|mesh-list
110910065|NCT02881957|Cholecalciferol|cholecalciferol|mesh-list
110910066|NCT02881957|Vitamins|vitamins|mesh-ancestor
110910067|NCT02881957|Micronutrients|micronutrients|mesh-ancestor
110910068|NCT02881957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110344739|NCT05644665|Ozanimod|ozanimod|mesh-list
110910069|NCT02881957|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110910070|NCT02881957|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110910071|NCT02206022|Remifentanil|remifentanil|mesh-list
110910072|NCT02206022|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110910073|NCT02206022|Narcotics|narcotics|mesh-ancestor
110910074|NCT02206022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110910075|NCT02206022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110910076|NCT02206022|Analgesics|analgesics|mesh-ancestor
110910077|NCT02206022|Sensory System Agents|sensory system agents|mesh-ancestor
110910078|NCT02206022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110910079|NCT02073552|Ascorbic Acid|ascorbic acid|mesh-list
110910080|NCT02073552|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
110910081|NCT02073552|Antioxidants|antioxidants|mesh-ancestor
110910082|NCT02073552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110910083|NCT02073552|Protective Agents|protective agents|mesh-ancestor
110910084|NCT02073552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110910085|NCT02073552|Vitamins|vitamins|mesh-ancestor
110910086|NCT02073552|Micronutrients|micronutrients|mesh-ancestor
110910087|NCT02073552|Laxatives|laxatives|mesh-ancestor
110910088|NCT02073552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110910089|NCT02210156|Micronutrients|micronutrients|mesh-list
110910090|NCT02210156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110910091|NCT02080026|Chloroquine|chloroquine|mesh-list
110910092|NCT02080026|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
110910093|NCT02080026|Atovaquone|atovaquone|mesh-list
110910094|NCT02080026|Proguanil|proguanil|mesh-list
110910095|NCT02080026|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
110910096|NCT02080026|Amebicides|amebicides|mesh-ancestor
110910097|NCT02080026|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110910098|NCT02080026|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110910099|NCT02080026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110910100|NCT02080026|Antimalarials|antimalarials|mesh-ancestor
110910101|NCT02080026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110910102|NCT02080026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110910103|NCT02080026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110910104|NCT02080026|Analgesics|analgesics|mesh-ancestor
110910105|NCT02080026|Sensory System Agents|sensory system agents|mesh-ancestor
110910106|NCT02080026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110910107|NCT02080026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110910108|NCT02080026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110910109|NCT02080026|Filaricides|filaricides|mesh-ancestor
110910110|NCT02080026|Antinematodal Agents|antinematodal agents|mesh-ancestor
110910111|NCT02080026|Anthelmintics|anthelmintics|mesh-ancestor
110910112|NCT02080026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110910113|NCT02080026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110910114|NCT02080026|Antimetabolites|antimetabolites|mesh-ancestor
110910115|NCT02206178|Acetaminophen|acetaminophen|mesh-list
110910116|NCT02206178|Acetylcysteine|acetylcysteine|mesh-list
110910117|NCT02206178|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110910118|NCT02206178|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110910119|NCT02206178|Analgesics|analgesics|mesh-ancestor
110910120|NCT02206178|Sensory System Agents|sensory system agents|mesh-ancestor
110910121|NCT02206178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110910122|NCT02206178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110910123|NCT02206178|Antipyretics|antipyretics|mesh-ancestor
110910124|NCT02206178|Antiviral Agents|antiviral agents|mesh-ancestor
110910125|NCT02206178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110910126|NCT02206178|Expectorants|expectorants|mesh-ancestor
110910127|NCT02206178|Respiratory System Agents|respiratory system agents|mesh-ancestor
110910128|NCT02206178|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110910129|NCT02206178|Antioxidants|antioxidants|mesh-ancestor
110910130|NCT02206178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110910131|NCT02206178|Protective Agents|protective agents|mesh-ancestor
110910132|NCT02206178|Antidotes|antidotes|mesh-ancestor
110910133|NCT02080104|Oxytocin|oxytocin|mesh-list
110910134|NCT02080104|Oxytocics|oxytocics|mesh-ancestor
110910135|NCT02080104|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110910136|NCT02080104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110910137|NCT02211326|Warfarin|warfarin|mesh-list
110345190|NCT05304273|Oxytocics|oxytocics|mesh-ancestor
110910138|NCT02211326|Anticoagulants|anticoagulants|mesh-ancestor
110910139|NCT02691793|Sunitinib|sunitinib|mesh-list
110910140|NCT02691793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110910141|NCT02691793|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110910142|NCT02691793|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110910143|NCT02691793|Growth Substances|growth substances|mesh-ancestor
110910144|NCT02691793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110910145|NCT02691793|Growth Inhibitors|growth inhibitors|mesh-ancestor
110910146|NCT02691793|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110910147|NCT02691793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110910148|NCT02691793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110910149|NCT02221622|Pregnanolone|pregnanolone|mesh-list
110910150|NCT02221622|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110910151|NCT02221622|Anesthetics|anesthetics|mesh-ancestor
110910152|NCT02221622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110910153|NCT02221622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110910154|NCT02080182|Acetylcysteine|acetylcysteine|mesh-list
110910155|NCT02080182|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110910156|NCT02080182|Antiviral Agents|antiviral agents|mesh-ancestor
110910157|NCT02080182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110910158|NCT02080182|Expectorants|expectorants|mesh-ancestor
110910159|NCT02080182|Respiratory System Agents|respiratory system agents|mesh-ancestor
110910160|NCT02080182|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110910161|NCT02080182|Antioxidants|antioxidants|mesh-ancestor
110910162|NCT02080182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110910163|NCT02080182|Protective Agents|protective agents|mesh-ancestor
110910164|NCT02080182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110910165|NCT02080182|Antidotes|antidotes|mesh-ancestor
110910166|NCT02750930|rGLP-1 protein|rglp-1 protein|mesh-list
110910167|NCT02750930|Incretins|incretins|mesh-ancestor
110910168|NCT02750930|Hormones|hormones|mesh-ancestor
110910169|NCT02750930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110910170|NCT02750930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110910171|NCT02080416|Nelfinavir|nelfinavir|mesh-list
110910172|NCT02080416|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110910173|NCT02080416|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110910174|NCT02080416|Protease Inhibitors|protease inhibitors|mesh-ancestor
110910175|NCT02080416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110910176|NCT02080416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110910177|NCT02080416|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110910178|NCT02080416|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110910179|NCT02080416|Antiviral Agents|antiviral agents|mesh-ancestor
110910180|NCT02080416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110910181|NCT02080494|Tranexamic Acid|tranexamic acid|mesh-list
110910182|NCT02080494|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110910183|NCT02080494|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110910184|NCT02080494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110910185|NCT02080494|Hemostatics|hemostatics|mesh-ancestor
110910186|NCT02080494|Coagulants|coagulants|mesh-ancestor
110926563|NCT03542214|Calcium|calcium|mesh-list
110910188|NCT02213744|Capecitabine|capecitabine|mesh-list
110910189|NCT02213744|Trastuzumab|trastuzumab|mesh-list
110910190|NCT02213744|Vinorelbine|vinorelbine|mesh-list
110910191|NCT02213744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110910192|NCT02213744|Antimetabolites|antimetabolites|mesh-ancestor
110910193|NCT02213744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110910194|NCT02213744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110910195|NCT02213744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110910196|NCT02213744|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110910197|NCT02213744|Tubulin Modulators|tubulin modulators|mesh-ancestor
110910198|NCT02213744|Antimitotic Agents|antimitotic agents|mesh-ancestor
110910199|NCT02213744|Mitosis Modulators|mitosis modulators|mesh-ancestor
110910200|NCT01378741|Dexmedetomidine|dexmedetomidine|mesh-list
110910201|NCT01378741|Propofol|propofol|mesh-list
110910202|NCT01378741|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110627680|NCT01068847|Naloxone|naloxone|mesh-list
110345597|NCT05041907|Serotonin Agents|serotonin agents|mesh-ancestor
110910203|NCT01378741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110910204|NCT01378741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110910205|NCT01378741|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110910206|NCT01378741|Analgesics|analgesics|mesh-ancestor
110910207|NCT01378741|Sensory System Agents|sensory system agents|mesh-ancestor
110910208|NCT01378741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110910209|NCT01378741|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110910210|NCT01378741|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110910211|NCT01378741|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110910212|NCT01378741|Adrenergic Agents|adrenergic agents|mesh-ancestor
110910213|NCT01378741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110910214|NCT01378741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110345739|NCT04988945|Durvalumab|durvalumab|mesh-list
110910215|NCT01378741|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110910216|NCT01378741|Anesthetics, General|anesthetics, general|mesh-ancestor
110910217|NCT01378741|Anesthetics|anesthetics|mesh-ancestor
110910218|NCT02461849|Imatinib Mesylate|imatinib mesylate|mesh-list
110910219|NCT02461849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110910220|NCT02461849|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110910221|NCT02461849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110910222|NCT02461849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110910223|NCT02225054|Dexmedetomidine|dexmedetomidine|mesh-list
110910224|NCT02225054|Ropivacaine|ropivacaine|mesh-list
110910225|NCT02225054|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110910226|NCT02225054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110910227|NCT02225054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110910228|NCT02225054|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110910229|NCT02225054|Analgesics|analgesics|mesh-ancestor
110910230|NCT02225054|Sensory System Agents|sensory system agents|mesh-ancestor
110910231|NCT02225054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110910232|NCT02225054|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110910233|NCT02225054|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110910234|NCT02225054|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110910235|NCT02225054|Adrenergic Agents|adrenergic agents|mesh-ancestor
110910236|NCT02225054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110910237|NCT02225054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110926589|NCT03096184|Antimetabolites|antimetabolites|mesh-ancestor
110910238|NCT02225054|Anesthetics, Local|anesthetics, local|mesh-ancestor
110910239|NCT02225054|Anesthetics|anesthetics|mesh-ancestor
110910240|NCT02080728|Ropivacaine|ropivacaine|mesh-list
110910241|NCT02080728|Anesthetics, Local|anesthetics, local|mesh-ancestor
110910242|NCT02080728|Anesthetics|anesthetics|mesh-ancestor
110910243|NCT02080728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110910244|NCT02080728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110910245|NCT02080728|Sensory System Agents|sensory system agents|mesh-ancestor
110910246|NCT02080728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110910247|NCT03078907|Selexipag|selexipag|mesh-list
110910248|NCT03078907|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110910249|NCT02225210|Fentanyl|fentanyl|mesh-list
110910250|NCT02225210|Midazolam|midazolam|mesh-list
110910251|NCT02225210|Dexmedetomidine|dexmedetomidine|mesh-list
110910252|NCT02225210|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110346070|NCT04790903|Immunoconjugates|immunoconjugates|mesh-ancestor
110910253|NCT02225210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110910254|NCT02225210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110910255|NCT02225210|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110910256|NCT02225210|Analgesics|analgesics|mesh-ancestor
110910257|NCT02225210|Sensory System Agents|sensory system agents|mesh-ancestor
110910258|NCT02225210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110910259|NCT02225210|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110910260|NCT02225210|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110910261|NCT02225210|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110910262|NCT02225210|Adrenergic Agents|adrenergic agents|mesh-ancestor
110910263|NCT02225210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110910264|NCT02225210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110910265|NCT02225210|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110910266|NCT02225210|Narcotics|narcotics|mesh-ancestor
110910267|NCT02225210|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110910268|NCT02225210|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110910269|NCT02225210|Anesthetics, General|anesthetics, general|mesh-ancestor
110910270|NCT02225210|Anesthetics|anesthetics|mesh-ancestor
110910271|NCT02225210|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110910272|NCT02225210|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110910273|NCT02225210|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110910274|NCT02225210|GABA Modulators|gaba modulators|mesh-ancestor
110910275|NCT02225210|GABA Agents|gaba agents|mesh-ancestor
110910276|NCT02217020|Oxaliplatin|oxaliplatin|mesh-list
110910277|NCT02217020|Irinotecan|irinotecan|mesh-list
110910278|NCT02217020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110910279|NCT02217020|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110910280|NCT02217020|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110910281|NCT02217020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110910282|NCT02217020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110910283|NCT03249714|Ofatumumab|ofatumumab|mesh-list
110910284|NCT03249714|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110910285|NCT03249714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110910286|NCT03249714|Immunologic Factors|immunologic factors|mesh-ancestor
110910287|NCT03249714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110910288|NCT02222168|BI 409306|bi 409306|mesh-list
110910289|NCT02222168|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110910290|NCT02222168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110910291|NCT02222168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110910292|NCT02925117|Upadacitinib|upadacitinib|mesh-list
110910293|NCT02925117|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
110910294|NCT02925117|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110910295|NCT02925117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110910296|NCT02925117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110910297|NCT02925117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110910298|NCT02077920|Chlorhexidine|chlorhexidine|mesh-list
110910299|NCT02077920|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110910300|NCT02077920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110910301|NCT02077920|Disinfectants|disinfectants|mesh-ancestor
110910302|NCT02225756|Cyclosporine|cyclosporine|mesh-list
110910303|NCT02225756|Cyclosporins|cyclosporins|mesh-list
110910304|NCT02225756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110910305|NCT02225756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110910306|NCT02225756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110910307|NCT02225756|Immunologic Factors|immunologic factors|mesh-ancestor
110910308|NCT02225756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110910309|NCT02225756|Antifungal Agents|antifungal agents|mesh-ancestor
110910310|NCT02225756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110910311|NCT02225756|Dermatologic Agents|dermatologic agents|mesh-ancestor
110910312|NCT02225756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110910313|NCT02225756|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110910314|NCT02225834|Atorvastatin|atorvastatin|mesh-list
110910315|NCT02225834|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110910316|NCT02225834|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110910317|NCT02225834|Antimetabolites|antimetabolites|mesh-ancestor
110910318|NCT02225834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110910319|NCT02225834|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110910320|NCT02225834|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110910321|NCT02225834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110910322|NCT02077998|Oxaliplatin|oxaliplatin|mesh-list
110910323|NCT02077998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110910324|NCT02222324|Moxifloxacin|moxifloxacin|mesh-list
110910325|NCT02222324|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110910326|NCT02222324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110910327|NCT02222324|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110910328|NCT02222324|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110910329|NCT02222324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110910330|NCT02222324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110910331|NCT02222324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110910332|NCT02074800|Siltuximab|siltuximab|mesh-list
110910333|NCT02074800|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110910334|NCT02074800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110910335|NCT02074800|Immunologic Factors|immunologic factors|mesh-ancestor
110910336|NCT02074800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110910337|NCT04504045|Metformin|metformin|mesh-list
110910338|NCT04504045|Efavirenz|efavirenz|mesh-list
110910339|NCT04504045|Losartan|losartan|mesh-list
110910340|NCT04504045|Metoprolol|metoprolol|mesh-list
110910341|NCT04504045|Midazolam|midazolam|mesh-list
110910342|NCT04504045|Caffeine|caffeine|mesh-list
110910343|NCT04504045|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110910344|NCT04504045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110910345|NCT04504045|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110910346|NCT04504045|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110910347|NCT04504045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110910348|NCT04504045|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110910349|NCT04504045|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110910350|NCT04504045|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110910351|NCT04504045|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110910352|NCT04504045|Anesthetics, General|anesthetics, general|mesh-ancestor
110910353|NCT04504045|Anesthetics|anesthetics|mesh-ancestor
110910354|NCT04504045|GABA Modulators|gaba modulators|mesh-ancestor
110910355|NCT04504045|GABA Agents|gaba agents|mesh-ancestor
110910356|NCT04504045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110910357|NCT04504045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110910358|NCT04504045|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110910359|NCT04504045|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110910360|NCT04504045|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110910361|NCT04504045|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110910362|NCT04504045|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110910363|NCT04504045|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110910364|NCT04504045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110910365|NCT04504045|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110910366|NCT04504045|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110910367|NCT04504045|Purinergic Agents|purinergic agents|mesh-ancestor
110175114|NCT04730596|Ketamine|ketamine|mesh-list
110910368|NCT04504045|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110910369|NCT04504045|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110910370|NCT04504045|Antiviral Agents|antiviral agents|mesh-ancestor
110910371|NCT04504045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110910372|NCT04504045|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110910373|NCT04504045|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110910374|NCT04504045|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110910375|NCT04504045|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110910376|NCT04504045|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110910377|NCT04504045|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110910378|NCT04504045|Sympatholytics|sympatholytics|mesh-ancestor
110226205|NCT05609968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110226206|NCT05609968|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110226207|NCT05609968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110226208|NCT05609968|Immunoconjugates|immunoconjugates|mesh-ancestor
110226209|NCT05609968|Immunologic Factors|immunologic factors|mesh-ancestor
110226210|NCT05609968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110910379|NCT04504045|Autonomic Agents|autonomic agents|mesh-ancestor
110910380|NCT04504045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110910381|NCT04504045|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110910382|NCT04504045|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110910383|NCT04504045|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110910384|NCT04504045|Adrenergic Agents|adrenergic agents|mesh-ancestor
110910385|NCT03283488|Megestrol|megestrol|mesh-list
110910386|NCT03283488|Megestrol Acetate|megestrol acetate|mesh-list
110346987|NCT04231448|Hormones|hormones|mesh-ancestor
110910387|NCT03283488|Mirtazapine|mirtazapine|mesh-list
110910388|NCT03283488|Antidepressive Agents|antidepressive agents|mesh-ancestor
110910389|NCT03283488|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110910390|NCT03283488|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110910391|NCT03283488|Histamine Antagonists|histamine antagonists|mesh-ancestor
110910392|NCT03283488|Histamine Agents|histamine agents|mesh-ancestor
110910393|NCT03283488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110910394|NCT03283488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110910395|NCT03283488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110910396|NCT03283488|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110910397|NCT03283488|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110910398|NCT03283488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110347110|NCT04166435|Temozolomide|temozolomide|mesh-list
110910399|NCT03283488|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
110910400|NCT03283488|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110910401|NCT03283488|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110910402|NCT03283488|Adrenergic Agents|adrenergic agents|mesh-ancestor
110910403|NCT03283488|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110910404|NCT03283488|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110910405|NCT03283488|Serotonin Agents|serotonin agents|mesh-ancestor
110910406|NCT03283488|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110910407|NCT03283488|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110910408|NCT03283488|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110910409|NCT03283488|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110910410|NCT03283488|Contraceptive Agents|contraceptive agents|mesh-ancestor
110910411|NCT03283488|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110926643|NCT04434430|Sensory System Agents|sensory system agents|mesh-ancestor
110910412|NCT03283488|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110347247|NCT04078152|Durvalumab|durvalumab|mesh-list
110910413|NCT03283488|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110910414|NCT03283488|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110910415|NCT03283488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110910416|NCT03283488|Appetite Stimulants|appetite stimulants|mesh-ancestor
110910417|NCT03283488|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110910418|NCT02258204|Ketamine|ketamine|mesh-list
110910419|NCT02258204|Analgesics|analgesics|mesh-ancestor
110910420|NCT02258204|Sensory System Agents|sensory system agents|mesh-ancestor
110910421|NCT02258204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110910422|NCT02258204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110910423|NCT02258204|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110910424|NCT02258204|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110910425|NCT02258204|Anesthetics, General|anesthetics, general|mesh-ancestor
110910426|NCT02258204|Anesthetics|anesthetics|mesh-ancestor
110910427|NCT02258204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110910428|NCT02258204|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110910429|NCT02258204|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110910430|NCT02258204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110910431|NCT02258204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110910432|NCT02226068|Cyclosporine|cyclosporine|mesh-list
110910433|NCT02226068|Cyclosporins|cyclosporins|mesh-list
110910434|NCT02226068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110910435|NCT02226068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110910436|NCT02226068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110910437|NCT02226068|Immunologic Factors|immunologic factors|mesh-ancestor
110910438|NCT02226068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110910439|NCT02226068|Antifungal Agents|antifungal agents|mesh-ancestor
110910440|NCT02226068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110910441|NCT02226068|Dermatologic Agents|dermatologic agents|mesh-ancestor
110910442|NCT02226068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110226222|NCT05604560|Tislelizumab|tislelizumab|mesh-list
110226223|NCT05604560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110226224|NCT05604560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110226225|NCT05597878|Acetaminophen|acetaminophen|mesh-list
110226226|NCT05597878|Ketorolac|ketorolac|mesh-list
110910443|NCT02226068|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110910445|NCT02220218|Canagliflozin|canagliflozin|mesh-list
110910446|NCT02220218|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110910447|NCT02220218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110910448|NCT02220218|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110910449|NCT02220218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110910450|NCT02222480|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110910451|NCT02222480|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110910452|NCT02222480|Diuretics|diuretics|mesh-ancestor
110910453|NCT02222480|Natriuretic Agents|natriuretic agents|mesh-ancestor
110910454|NCT02222480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110910455|NCT02222480|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110910456|NCT02222480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110910457|NCT02222480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110910458|NCT03670875|Curcumin|curcumin|mesh-list
110910459|NCT03670875|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110910460|NCT03670875|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110910461|NCT03670875|Analgesics|analgesics|mesh-ancestor
110910462|NCT03670875|Sensory System Agents|sensory system agents|mesh-ancestor
110910463|NCT03670875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110347777|NCT03586999|Glucocorticoids|glucocorticoids|mesh-ancestor
110910464|NCT03670875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110910465|NCT03670875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110910466|NCT03670875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110910467|NCT03670875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110910468|NCT03670875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110910469|NCT03670875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110910470|NCT01379677|Sodium Pertechnetate Tc 99m|sodium pertechnetate tc 99m|mesh-list
110910471|NCT01379677|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110910472|NCT01379677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110910473|NCT02220296|Insulin|insulin|mesh-list
110910474|NCT02220296|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110910475|NCT02220296|Insulin Glargine|insulin glargine|mesh-list
110910476|NCT02220296|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110347826|NCT03533283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110910477|NCT02220296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110910478|NCT02074878|Sunitinib|sunitinib|mesh-list
110910479|NCT02074878|Crizotinib|crizotinib|mesh-list
110910480|NCT02074878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110910481|NCT02074878|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110910482|NCT02074878|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110910483|NCT02074878|Growth Substances|growth substances|mesh-ancestor
110910484|NCT02074878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110910485|NCT02074878|Growth Inhibitors|growth inhibitors|mesh-ancestor
110910486|NCT02074878|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110910487|NCT02074878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110910488|NCT02074878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110910489|NCT03075163|Ondansetron|ondansetron|mesh-list
110910490|NCT03075163|Antiemetics|antiemetics|mesh-ancestor
110910491|NCT03075163|Autonomic Agents|autonomic agents|mesh-ancestor
110910492|NCT03075163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110910493|NCT03075163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110910494|NCT03075163|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110910495|NCT03075163|Antipruritics|antipruritics|mesh-ancestor
110910496|NCT03075163|Dermatologic Agents|dermatologic agents|mesh-ancestor
110910497|NCT03075163|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110910498|NCT03075163|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110910499|NCT03075163|Serotonin Agents|serotonin agents|mesh-ancestor
110910500|NCT03075163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110910501|NCT03075163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110910502|NCT02628405|Rituximab|rituximab|mesh-list
110627991|NCT00954135|Sorafenib|sorafenib|mesh-list
110910503|NCT02628405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110910504|NCT02628405|Carboplatin|carboplatin|mesh-list
110910505|NCT02628405|Etoposide|etoposide|mesh-list
110910506|NCT02628405|Lenalidomide|lenalidomide|mesh-list
110910507|NCT02628405|Etoposide phosphate|etoposide phosphate|mesh-list
110910508|NCT02628405|Ifosfamide|ifosfamide|mesh-list
110910509|NCT02628405|Isophosphamide mustard|isophosphamide mustard|mesh-list
110910510|NCT02628405|Podophyllotoxin|podophyllotoxin|mesh-list
110910511|NCT02628405|Antibodies|antibodies|mesh-list
110910512|NCT02628405|Immunoglobulins|immunoglobulins|mesh-list
110910513|NCT02628405|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110910514|NCT02628405|Immunologic Factors|immunologic factors|mesh-ancestor
110910515|NCT02628405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110910516|NCT02628405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110910517|NCT02628405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110910518|NCT02628405|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110910519|NCT02628405|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110910520|NCT02628405|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110910521|NCT02628405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110910522|NCT02628405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110910523|NCT02628405|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110910524|NCT02628405|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110910525|NCT02628405|Growth Substances|growth substances|mesh-ancestor
110910526|NCT02628405|Growth Inhibitors|growth inhibitors|mesh-ancestor
110910527|NCT02628405|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110910528|NCT02628405|Alkylating Agents|alkylating agents|mesh-ancestor
110910529|NCT02628405|Keratolytic Agents|keratolytic agents|mesh-ancestor
110910530|NCT02628405|Dermatologic Agents|dermatologic agents|mesh-ancestor
110910531|NCT02628405|Tubulin Modulators|tubulin modulators|mesh-ancestor
110910532|NCT02628405|Antimitotic Agents|antimitotic agents|mesh-ancestor
110910533|NCT02628405|Mitosis Modulators|mitosis modulators|mesh-ancestor
110910534|NCT02220530|Fentanyl|fentanyl|mesh-list
110910535|NCT02220530|Midazolam|midazolam|mesh-list
110910536|NCT02220530|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110910537|NCT02220530|Narcotics|narcotics|mesh-ancestor
110910538|NCT02220530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110910539|NCT02220530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110910540|NCT02220530|Analgesics|analgesics|mesh-ancestor
110910541|NCT02220530|Sensory System Agents|sensory system agents|mesh-ancestor
110347998|NCT03360721|Prednisone|prednisone|mesh-list
110910542|NCT02220530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110910543|NCT02220530|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110910544|NCT02220530|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110910545|NCT02220530|Anesthetics, General|anesthetics, general|mesh-ancestor
110910546|NCT02220530|Anesthetics|anesthetics|mesh-ancestor
110910547|NCT02220530|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110910548|NCT02220530|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110910549|NCT02220530|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110910550|NCT02220530|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110910551|NCT02220530|GABA Modulators|gaba modulators|mesh-ancestor
110910552|NCT02220530|GABA Agents|gaba agents|mesh-ancestor
110910553|NCT02220530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110910554|NCT02220530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110910555|NCT02078232|Pancrelipase|pancrelipase|mesh-list
110910556|NCT02078232|Pancreatin|pancreatin|mesh-list
110910557|NCT02078232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110910558|NCT02075034|ON 01910|on 01910|mesh-list
110910559|NCT02075034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110910560|NCT02075034|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110910561|NCT02075034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110910562|NCT02075034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110910563|NCT02567175|Domperidone|domperidone|mesh-list
110910564|NCT02567175|Antiemetics|antiemetics|mesh-ancestor
110910565|NCT02567175|Autonomic Agents|autonomic agents|mesh-ancestor
110910566|NCT02567175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110910567|NCT02567175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110910568|NCT02567175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110910569|NCT02567175|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110910570|NCT02567175|Dopamine Agents|dopamine agents|mesh-ancestor
110910571|NCT02567175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110910572|NCT02567175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110910573|NCT02078388|Doxorubicin|doxorubicin|mesh-list
110910574|NCT02078388|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110910575|NCT02078388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110910576|NCT02078388|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110910577|NCT02078388|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110910578|NCT02078388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110910579|NCT02078388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110910580|NCT02222636|Fentanyl|fentanyl|mesh-list
110910581|NCT02222636|Dexmedetomidine|dexmedetomidine|mesh-list
110910582|NCT02222636|Anesthetics|anesthetics|mesh-list
110910583|NCT02222636|Sevoflurane|sevoflurane|mesh-list
110910584|NCT02222636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110910585|NCT02222636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110910586|NCT02222636|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110910587|NCT02222636|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110910589|NCT02222636|Sensory System Agents|sensory system agents|mesh-ancestor
110910590|NCT02222636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110910591|NCT02222636|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110348166|NCT03210688|Prednisone|prednisone|mesh-list
110910592|NCT02222636|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110910593|NCT02222636|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110910594|NCT02222636|Adrenergic Agents|adrenergic agents|mesh-ancestor
110910595|NCT02222636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110910596|NCT02222636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110910597|NCT02222636|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110910598|NCT02222636|Narcotics|narcotics|mesh-ancestor
110910599|NCT02222636|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110910600|NCT02222636|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110910601|NCT02222636|Anesthetics, General|anesthetics, general|mesh-ancestor
110348301|NCT02980510|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110910602|NCT02222636|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110910603|NCT02222636|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110910604|NCT04058145|Plerixafor|plerixafor|mesh-list
110910605|NCT04058145|Pembrolizumab|pembrolizumab|mesh-list
110910606|NCT04058145|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110910607|NCT04058145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110910608|NCT04058145|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110910609|NCT04058145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110348378|NCT02880293|Melphalan|melphalan|mesh-list
110910610|NCT04058145|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110910611|NCT04058145|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110910612|NCT04058145|Antiviral Agents|antiviral agents|mesh-ancestor
110910613|NCT04058145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110910614|NCT02230982|Nintedanib|nintedanib|mesh-list
110910615|NCT02230982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110910616|NCT02230982|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110910617|NCT02230982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110910618|NCT02230982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110910619|NCT02075112|Genistein|genistein|mesh-list
110910620|NCT02075112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110910621|NCT02075112|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110910622|NCT02075112|Protective Agents|protective agents|mesh-ancestor
110910623|NCT02075112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110348444|NCT02845882|Alkylating Agents|alkylating agents|mesh-ancestor
110910624|NCT02075112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110910625|NCT02075112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110910626|NCT02075112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110910627|NCT02075112|Phytoestrogens|phytoestrogens|mesh-ancestor
110910628|NCT02075112|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
110910629|NCT02075112|Estrogens|estrogens|mesh-ancestor
110348526|NCT02719314|Hormones|hormones|mesh-ancestor
110910631|NCT02075112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110910632|NCT02223026|Metformin|metformin|mesh-list
110910633|NCT02223026|Linagliptin|linagliptin|mesh-list
110910634|NCT02223026|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110910635|NCT02223026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110910636|NCT02223026|Incretins|incretins|mesh-ancestor
110910637|NCT02223026|Hormones|hormones|mesh-ancestor
110910638|NCT02223026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110910639|NCT02223026|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110910640|NCT02223026|Protease Inhibitors|protease inhibitors|mesh-ancestor
110910641|NCT02223026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110910642|NCT02223026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110910643|NCT02075268|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
110910644|NCT02075268|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110348573|NCT02584465|Tamoxifen|tamoxifen|mesh-list
110910645|NCT02477384|Propranolol|propranolol|mesh-list
110926699|NCT02032797|Progesterone|progesterone|mesh-list
110910646|NCT02477384|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110910647|NCT02477384|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110910648|NCT02477384|Adrenergic Agents|adrenergic agents|mesh-ancestor
110910649|NCT02477384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110910650|NCT02477384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110910651|NCT02477384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110910652|NCT02477384|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110628129|NCT02548806|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110910653|NCT02477384|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110910654|NCT02477384|Vasodilator Agents|vasodilator agents|mesh-ancestor
110910655|NCT02231294|Pramipexole|pramipexole|mesh-list
110910656|NCT02231294|Antioxidants|antioxidants|mesh-ancestor
110910657|NCT02231294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110910658|NCT02231294|Protective Agents|protective agents|mesh-ancestor
110910659|NCT02231294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110910660|NCT02231294|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110910661|NCT02231294|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110910662|NCT02231294|Dopamine Agonists|dopamine agonists|mesh-ancestor
110910663|NCT02231294|Dopamine Agents|dopamine agents|mesh-ancestor
110910664|NCT02231294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110910665|NCT02223416|Teriparatide|teriparatide|mesh-list
110910666|NCT02223416|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110910667|NCT02223416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110910668|NCT02223416|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110910669|NCT02082054|Chlorpheniramine|chlorpheniramine|mesh-list
110910670|NCT02082054|Atropine|atropine|mesh-list
110910671|NCT02082054|Pseudoephedrine|pseudoephedrine|mesh-list
110910672|NCT02082054|Ephedrine|ephedrine|mesh-list
110910673|NCT02082054|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110910674|NCT02082054|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110910675|NCT02082054|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110910676|NCT02082054|Autonomic Agents|autonomic agents|mesh-ancestor
110910677|NCT02082054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110910678|NCT02082054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110226279|NCT05576662|Ritonavir|ritonavir|mesh-list
110910679|NCT02082054|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110910680|NCT02082054|Respiratory System Agents|respiratory system agents|mesh-ancestor
110910681|NCT02082054|Mydriatics|mydriatics|mesh-ancestor
110910682|NCT02082054|Parasympatholytics|parasympatholytics|mesh-ancestor
110910683|NCT02082054|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110910684|NCT02082054|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110910685|NCT02082054|Cholinergic Agents|cholinergic agents|mesh-ancestor
110910686|NCT02082054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110910687|NCT02082054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110910688|NCT02082054|Nasal Decongestants|nasal decongestants|mesh-ancestor
110910689|NCT02082054|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110910690|NCT02082054|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110910691|NCT02082054|Sympathomimetics|sympathomimetics|mesh-ancestor
110910692|NCT02082054|Adrenergic Agents|adrenergic agents|mesh-ancestor
110910693|NCT02082054|Antipruritics|antipruritics|mesh-ancestor
110910694|NCT02082054|Dermatologic Agents|dermatologic agents|mesh-ancestor
110910695|NCT02082054|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110910696|NCT02082054|Histamine Antagonists|histamine antagonists|mesh-ancestor
110910697|NCT02082054|Histamine Agents|histamine agents|mesh-ancestor
110910698|NCT02082054|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110910699|NCT02231372|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
110910700|NCT02231372|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110910701|NCT02231372|Autonomic Agents|autonomic agents|mesh-ancestor
110910702|NCT02231372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110910703|NCT02231372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110910704|NCT02231372|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110910705|NCT02231372|Respiratory System Agents|respiratory system agents|mesh-ancestor
110910706|NCT02884544|Dextroamphetamine|dextroamphetamine|mesh-list
110910707|NCT02884544|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110910708|NCT02884544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110910709|NCT02884544|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110910710|NCT02884544|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110349138|NCT01424982|Doxorubicin|doxorubicin|mesh-list
110910711|NCT02884544|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110910712|NCT02884544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110910713|NCT02884544|Dopamine Agents|dopamine agents|mesh-ancestor
110910714|NCT02884544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110910715|NCT02226926|Aspirin|aspirin|mesh-list
110910716|NCT02226926|Dipyridamole|dipyridamole|mesh-list
110910717|NCT02226926|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
110910718|NCT02226926|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110910719|NCT02226926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110910720|NCT02226926|Analgesics|analgesics|mesh-ancestor
110910721|NCT02226926|Sensory System Agents|sensory system agents|mesh-ancestor
110910722|NCT02226926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110910723|NCT02226926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110910724|NCT02226926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110910725|NCT02226926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110910726|NCT02226926|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110910727|NCT02226926|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110628205|NCT00998608|Dopamine Agents|dopamine agents|mesh-ancestor
110910728|NCT02226926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110910730|NCT02226926|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110910731|NCT02226926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110910732|NCT02226926|Antipyretics|antipyretics|mesh-ancestor
110910733|NCT02226926|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110910734|NCT02226926|Vasodilator Agents|vasodilator agents|mesh-ancestor
110910735|NCT02924883|Trastuzumab|trastuzumab|mesh-list
110910736|NCT02924883|Atezolizumab|atezolizumab|mesh-list
110910737|NCT02924883|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
110910738|NCT02924883|Maytansine|maytansine|mesh-list
110910739|NCT02924883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110910740|NCT02924883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110910741|NCT02924883|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110910742|NCT02924883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110910743|NCT02924883|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110910744|NCT02924883|Tubulin Modulators|tubulin modulators|mesh-ancestor
110910745|NCT02924883|Antimitotic Agents|antimitotic agents|mesh-ancestor
110910746|NCT02924883|Mitosis Modulators|mitosis modulators|mesh-ancestor
110910747|NCT02924883|Immunotoxins|immunotoxins|mesh-ancestor
110910748|NCT02924883|Immunoconjugates|immunoconjugates|mesh-ancestor
110910749|NCT02924883|Immunologic Factors|immunologic factors|mesh-ancestor
110910750|NCT02924883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110910752|NCT02075970|Hematinics|hematinics|mesh-ancestor
110910753|NCT02231450|(2-(6-fluoro-1H-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|(2-(6-fluoro-1h-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|mesh-list
110910754|NCT02231450|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110910755|NCT02231450|Serotonin Agents|serotonin agents|mesh-ancestor
110910756|NCT02231450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110910757|NCT02231450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110910758|NCT02231450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110910759|NCT02227082|Olaparib|olaparib|mesh-list
110910760|NCT02227082|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110910761|NCT02227082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110910762|NCT02227082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110910763|NCT02227082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110910764|NCT01369680|Ketamine|ketamine|mesh-list
110910765|NCT01369680|Analgesics|analgesics|mesh-ancestor
110910766|NCT01369680|Sensory System Agents|sensory system agents|mesh-ancestor
110910767|NCT01369680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110910768|NCT01369680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110910769|NCT01369680|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110910770|NCT01369680|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110910771|NCT01369680|Anesthetics, General|anesthetics, general|mesh-ancestor
110910772|NCT01369680|Anesthetics|anesthetics|mesh-ancestor
110910773|NCT01369680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110910774|NCT01369680|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110910775|NCT01369680|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110910776|NCT01369680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110910777|NCT01369680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110910778|NCT04780321|Antibodies|antibodies|mesh-list
110349388|NCT00557193|Calcium, Dietary|calcium, dietary|mesh-list
110910779|NCT04780321|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110910780|NCT04780321|Immunologic Factors|immunologic factors|mesh-ancestor
110910781|NCT04780321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110910782|NCT03670095|Memantine|memantine|mesh-list
110910783|NCT03670095|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110910784|NCT03670095|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110910785|NCT03670095|Dopamine Agents|dopamine agents|mesh-ancestor
110349467|NCT00557193|Hematinics|hematinics|mesh-ancestor
110910786|NCT03670095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110910787|NCT03670095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110910788|NCT03670095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110910789|NCT03670095|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110910790|NCT03670095|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110910791|NCT01378039|Budesonide|budesonide|mesh-list
110910792|NCT01378039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110910793|NCT01378039|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110910794|NCT01378039|Autonomic Agents|autonomic agents|mesh-ancestor
110910795|NCT01378039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110910796|NCT01378039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110910797|NCT01378039|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110910798|NCT01378039|Respiratory System Agents|respiratory system agents|mesh-ancestor
110910799|NCT01378039|Glucocorticoids|glucocorticoids|mesh-ancestor
110910800|NCT01378039|Hormones|hormones|mesh-ancestor
110910801|NCT01378039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110910803|NCT01377961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110910804|NCT01377961|Antioxidants|antioxidants|mesh-ancestor
110910805|NCT01377961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110910806|NCT01377961|Protective Agents|protective agents|mesh-ancestor
110910807|NCT01377961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110910808|NCT01377961|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110910809|NCT01377961|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110910810|NCT01377961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110910811|NCT03558750|Rituximab|rituximab|mesh-list
110910812|NCT03558750|Nivolumab|nivolumab|mesh-list
110910813|NCT03558750|Lenalidomide|lenalidomide|mesh-list
110910814|NCT03558750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110910815|NCT03558750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110910816|NCT03558750|Immunologic Factors|immunologic factors|mesh-ancestor
110910817|NCT03558750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110349740|NCT04817033|Midazolam|midazolam|mesh-list
110910818|NCT03558750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110910819|NCT03558750|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110910820|NCT03558750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110910821|NCT03558750|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110349809|NCT05600179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110910822|NCT03558750|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110910823|NCT03558750|Growth Substances|growth substances|mesh-ancestor
110910824|NCT03558750|Growth Inhibitors|growth inhibitors|mesh-ancestor
110910825|NCT03559140|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110910827|NCT02751320|Sodium Citrate|sodium citrate|mesh-list
110910828|NCT02751320|Anticoagulants|anticoagulants|mesh-ancestor
110910829|NCT02751320|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110910830|NCT02751320|Chelating Agents|chelating agents|mesh-ancestor
110910831|NCT02751320|Sequestering Agents|sequestering agents|mesh-ancestor
110910832|NCT02751320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110910833|NCT03559764|Idecabtagene vicleucel|idecabtagene vicleucel|mesh-list
110910834|NCT03559764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110910835|NCT03559764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110910836|NCT04931641|Ferrous fumarate|ferrous fumarate|mesh-list
110910837|NCT04931641|Trace Elements|trace elements|mesh-ancestor
110910838|NCT04931641|Micronutrients|micronutrients|mesh-ancestor
110910839|NCT04931641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110910840|NCT02083536|Docetaxel|docetaxel|mesh-list
110910841|NCT02083536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110910842|NCT02083536|Tubulin Modulators|tubulin modulators|mesh-ancestor
110910843|NCT02083536|Antimitotic Agents|antimitotic agents|mesh-ancestor
110910844|NCT02083536|Mitosis Modulators|mitosis modulators|mesh-ancestor
110910845|NCT02083536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110910846|NCT02231606|Methamphetamine|methamphetamine|mesh-list
110910847|NCT02231606|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110910848|NCT02231606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110910849|NCT02231606|Sympathomimetics|sympathomimetics|mesh-ancestor
110910850|NCT02231606|Autonomic Agents|autonomic agents|mesh-ancestor
110910851|NCT02231606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110910852|NCT02231606|Dopamine Agents|dopamine agents|mesh-ancestor
110910853|NCT02231606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110910854|NCT02231606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110910855|NCT02231606|Adrenergic Agents|adrenergic agents|mesh-ancestor
110910856|NCT02231606|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110910857|NCT02231606|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110910858|NCT02231606|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110910859|NCT02231606|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110910860|NCT02083692|Metformin|metformin|mesh-list
110910861|NCT02083692|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110910862|NCT02083692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110910863|NCT02227550|Vitamin K|vitamin k|mesh-list
110910864|NCT02227550|Warfarin|warfarin|mesh-list
110910865|NCT02227550|Apixaban|apixaban|mesh-list
110910866|NCT02227550|Phenprocoumon|phenprocoumon|mesh-list
110910867|NCT02227550|Fluindione|fluindione|mesh-list
110910868|NCT02227550|Vitamins|vitamins|mesh-ancestor
110910869|NCT02227550|Micronutrients|micronutrients|mesh-ancestor
110910870|NCT02227550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110910871|NCT02227550|Anticoagulants|anticoagulants|mesh-ancestor
110910872|NCT02227550|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110910873|NCT02227550|Antithrombins|antithrombins|mesh-ancestor
110910874|NCT02227550|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110910875|NCT02227550|Protease Inhibitors|protease inhibitors|mesh-ancestor
110910876|NCT02227550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110910877|NCT02227550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110926782|NCT03543306|Trametinib|trametinib|mesh-list
110910879|NCT02227550|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110910880|NCT02227550|Hemostatics|hemostatics|mesh-ancestor
110910881|NCT02227550|Coagulants|coagulants|mesh-ancestor
110910882|NCT02206035|Methotrexate|methotrexate|mesh-list
110910883|NCT02206035|Tacrolimus|tacrolimus|mesh-list
110910884|NCT02206035|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110910885|NCT02206035|Abortifacient Agents|abortifacient agents|mesh-ancestor
110910886|NCT02206035|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110910887|NCT02206035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110910888|NCT02206035|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110910889|NCT02206035|Antimetabolites|antimetabolites|mesh-ancestor
110226302|NCT05564650|Azacitidine|azacitidine|mesh-list
110910890|NCT02206035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110910891|NCT02206035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110910892|NCT02206035|Dermatologic Agents|dermatologic agents|mesh-ancestor
110910893|NCT02206035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110910894|NCT02206035|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110910895|NCT02206035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110910896|NCT02206035|Immunologic Factors|immunologic factors|mesh-ancestor
110910897|NCT02206035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110910898|NCT02206035|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110910899|NCT02206035|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110910900|NCT02258828|Memantine|memantine|mesh-list
110910901|NCT02258828|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110910902|NCT02258828|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110910903|NCT02258828|Dopamine Agents|dopamine agents|mesh-ancestor
110910904|NCT02258828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110910905|NCT02258828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110910906|NCT02258828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110910907|NCT02258828|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110910908|NCT02258828|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110910909|NCT02083068|Vaccines|vaccines|mesh-list
110910910|NCT02083068|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
110910911|NCT02083068|Immunologic Factors|immunologic factors|mesh-ancestor
110910912|NCT02083068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110910913|NCT02083068|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110910914|NCT02228252|Caseins|caseins|mesh-list
110910915|NCT02228252|Chelating Agents|chelating agents|mesh-ancestor
110910916|NCT02228252|Sequestering Agents|sequestering agents|mesh-ancestor
110910917|NCT02228252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110910918|NCT02070549|Trametinib|trametinib|mesh-list
110910919|NCT02070549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110910920|NCT02070549|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110910921|NCT02070549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110910922|NCT02070549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110910923|NCT02591953|Methylprednisolone|methylprednisolone|mesh-list
110910924|NCT02591953|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110350582|NCT02924285|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110910925|NCT02591953|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110910926|NCT02591953|Prednisolone|prednisolone|mesh-list
110910927|NCT02591953|Prednisolone acetate|prednisolone acetate|mesh-list
110910928|NCT02591953|Lidocaine|lidocaine|mesh-list
110910929|NCT02591953|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110910930|NCT02591953|Prednisolone phosphate|prednisolone phosphate|mesh-list
110910931|NCT02591953|Anesthetics, Local|anesthetics, local|mesh-ancestor
110910932|NCT02591953|Anesthetics|anesthetics|mesh-ancestor
110910933|NCT02591953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110910934|NCT02591953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110910935|NCT02591953|Sensory System Agents|sensory system agents|mesh-ancestor
110910936|NCT02591953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110910937|NCT02591953|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110910938|NCT02591953|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110910939|NCT02591953|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110910940|NCT02591953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110910941|NCT02591953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110910942|NCT02591953|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110910944|NCT02591953|Autonomic Agents|autonomic agents|mesh-ancestor
110910945|NCT02591953|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110910946|NCT02591953|Glucocorticoids|glucocorticoids|mesh-ancestor
110910947|NCT02591953|Hormones|hormones|mesh-ancestor
110350694|NCT05590936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110910948|NCT02591953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110910949|NCT02591953|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110910950|NCT02591953|Protective Agents|protective agents|mesh-ancestor
110910951|NCT02591953|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110910952|NCT02591953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110226307|NCT05564650|Antimetabolites|antimetabolites|mesh-ancestor
110226308|NCT05564650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110226309|NCT05564650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110350763|NCT02933853|Insulin Aspart|insulin aspart|mesh-list
110226310|NCT05564650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110910954|NCT02223884|Docetaxel|docetaxel|mesh-list
110910955|NCT02223884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110910956|NCT02223884|Tubulin Modulators|tubulin modulators|mesh-ancestor
110910957|NCT02223884|Antimitotic Agents|antimitotic agents|mesh-ancestor
110910958|NCT02223884|Mitosis Modulators|mitosis modulators|mesh-ancestor
110910959|NCT02223884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110910960|NCT02079480|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
110910961|NCT02079480|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110910962|NCT02079480|Immunologic Factors|immunologic factors|mesh-ancestor
110910963|NCT02079480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110910964|NCT02569489|Paclitaxel|paclitaxel|mesh-list
110910965|NCT02569489|Trastuzumab|trastuzumab|mesh-list
110910966|NCT02569489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110910967|NCT02569489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110910968|NCT02569489|Tubulin Modulators|tubulin modulators|mesh-ancestor
110910969|NCT02569489|Antimitotic Agents|antimitotic agents|mesh-ancestor
110910970|NCT02569489|Mitosis Modulators|mitosis modulators|mesh-ancestor
110910971|NCT02569489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110910972|NCT02569489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110910973|NCT02079558|Oxytocin|oxytocin|mesh-list
110910974|NCT02079558|Carbetocin|carbetocin|mesh-list
110910975|NCT02079558|Oxytocics|oxytocics|mesh-ancestor
110910976|NCT02079558|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110910977|NCT02079558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110910978|NCT04057755|Botulinum Toxins|botulinum toxins|mesh-list
110910979|NCT04057755|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110910980|NCT04057755|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110910981|NCT04057755|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110910982|NCT04057755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110910983|NCT04057755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110910984|NCT04057755|Cholinergic Agents|cholinergic agents|mesh-ancestor
110910985|NCT04057755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110910986|NCT04057755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110910987|NCT04057755|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110351044|NCT02932566|Analgesics|analgesics|mesh-ancestor
110910988|NCT04057755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110910989|NCT03669003|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
110910990|NCT03669003|Hemostatics|hemostatics|mesh-ancestor
110910991|NCT03669003|Coagulants|coagulants|mesh-ancestor
110910992|NCT04313959|Dexamethasone|dexamethasone|mesh-list
110910993|NCT04313959|Ropivacaine|ropivacaine|mesh-list
110910994|NCT04313959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110910995|NCT04313959|Antiemetics|antiemetics|mesh-ancestor
110910996|NCT04313959|Autonomic Agents|autonomic agents|mesh-ancestor
110910997|NCT04313959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110910998|NCT04313959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110910999|NCT04313959|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110911000|NCT04313959|Glucocorticoids|glucocorticoids|mesh-ancestor
110911001|NCT04313959|Hormones|hormones|mesh-ancestor
110351170|NCT02932020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110911002|NCT04313959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110911003|NCT04313959|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110911004|NCT04313959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110911005|NCT04313959|Anesthetics, Local|anesthetics, local|mesh-ancestor
110911006|NCT04313959|Anesthetics|anesthetics|mesh-ancestor
110911007|NCT04313959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110911008|NCT04313959|Sensory System Agents|sensory system agents|mesh-ancestor
110911009|NCT03073213|Ixekizumab|ixekizumab|mesh-list
110911010|NCT03073213|Dermatologic Agents|dermatologic agents|mesh-ancestor
110911011|NCT03070483|Vitamin D|vitamin d|mesh-list
110911012|NCT03070483|Cholecalciferol|cholecalciferol|mesh-list
110911013|NCT03070483|Vitamins|vitamins|mesh-ancestor
110911014|NCT03070483|Micronutrients|micronutrients|mesh-ancestor
110911015|NCT03070483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110911016|NCT03070483|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110226322|NCT05562063|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
110226323|NCT05562063|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110226324|NCT05562063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110911017|NCT03070483|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110911018|NCT05763667|Bupivacaine|bupivacaine|mesh-list
110911019|NCT05763667|Anesthetics, Local|anesthetics, local|mesh-ancestor
110911020|NCT05763667|Anesthetics|anesthetics|mesh-ancestor
110911021|NCT05763667|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110911022|NCT05763667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110911023|NCT05763667|Sensory System Agents|sensory system agents|mesh-ancestor
110911024|NCT05763667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110911025|NCT04107727|Cytarabine|cytarabine|mesh-list
110911026|NCT04107727|Idarubicin|idarubicin|mesh-list
110911027|NCT04107727|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110351456|NCT05356104|Hormones|hormones|mesh-ancestor
110911028|NCT04107727|Antimetabolites|antimetabolites|mesh-ancestor
110911029|NCT04107727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110911030|NCT04107727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110911031|NCT04107727|Antiviral Agents|antiviral agents|mesh-ancestor
110911032|NCT04107727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110911033|NCT04107727|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110926815|NCT05164549|Methadone|methadone|mesh-list
110911034|NCT04107727|Immunologic Factors|immunologic factors|mesh-ancestor
110351520|NCT05467436|Anesthetics|anesthetics|mesh-list
110911035|NCT04107727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110911036|NCT04107727|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110911037|NCT04107727|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110911038|NCT04107727|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110911039|NCT04107727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110911040|NCT01074151|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110911041|NCT01074151|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110911042|NCT01074151|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110911043|NCT01074151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110911044|NCT01074151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110911045|NCT01074151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110911046|NCT01074151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110911047|NCT01074151|Analgesics|analgesics|mesh-ancestor
110911048|NCT01074151|Sensory System Agents|sensory system agents|mesh-ancestor
110911049|NCT01074151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110911050|NCT01074151|Antidepressive Agents|antidepressive agents|mesh-ancestor
110911051|NCT01074151|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110911052|NCT01074151|Dopamine Agents|dopamine agents|mesh-ancestor
110911053|NCT02786329|Lidocaine|lidocaine|mesh-list
110911054|NCT02786329|Sevoflurane|sevoflurane|mesh-list
110911055|NCT02786329|Anesthetics, Local|anesthetics, local|mesh-ancestor
110911056|NCT02786329|Anesthetics|anesthetics|mesh-ancestor
110911057|NCT02786329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110911058|NCT02786329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110911059|NCT02786329|Sensory System Agents|sensory system agents|mesh-ancestor
110911060|NCT02786329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110911061|NCT02786329|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110911062|NCT02786329|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110911063|NCT02786329|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110911064|NCT02786329|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110911065|NCT02786329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110911066|NCT02786329|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110911067|NCT02786329|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110911068|NCT02786329|Anesthetics, General|anesthetics, general|mesh-ancestor
110911069|NCT05761327|Curcumin|curcumin|mesh-list
110911070|NCT05761327|Resveratrol|resveratrol|mesh-list
110911071|NCT05761327|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110911072|NCT05761327|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110911073|NCT05761327|Analgesics|analgesics|mesh-ancestor
110911074|NCT05761327|Sensory System Agents|sensory system agents|mesh-ancestor
110911075|NCT05761327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110911076|NCT05761327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110911077|NCT05761327|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110911078|NCT05761327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110911079|NCT05761327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110911080|NCT05761327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110911081|NCT05761327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110911082|NCT05761327|Antioxidants|antioxidants|mesh-ancestor
110911083|NCT05761327|Protective Agents|protective agents|mesh-ancestor
110911084|NCT05761327|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110911085|NCT02231762|Temozolomide|temozolomide|mesh-list
110911086|NCT02231762|Lanreotide|lanreotide|mesh-list
110911087|NCT02231762|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110911088|NCT02231762|Alkylating Agents|alkylating agents|mesh-ancestor
110351914|NCT05080959|Anesthetics|anesthetics|mesh-ancestor
110911089|NCT02231762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110911090|NCT02231762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110911091|NCT01191957|Cyclophosphamide|cyclophosphamide|mesh-list
110911092|NCT01191957|Busulfan|busulfan|mesh-list
110911093|NCT01191957|Fludarabine|fludarabine|mesh-list
110911094|NCT01191957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110911095|NCT01191957|Immunologic Factors|immunologic factors|mesh-ancestor
110351982|NCT01269385|Alemtuzumab|alemtuzumab|mesh-list
110911096|NCT01191957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110911097|NCT01191957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110911098|NCT01191957|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110911099|NCT01191957|Alkylating Agents|alkylating agents|mesh-ancestor
110911100|NCT01191957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110911101|NCT01191957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110911102|NCT01191957|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110911103|NCT01050855|Busulfan|busulfan|mesh-list
110911104|NCT01050855|Alemtuzumab|alemtuzumab|mesh-list
110911105|NCT01050855|Alkylating Agents|alkylating agents|mesh-ancestor
110911106|NCT01050855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110352124|NCT00536003|Hormones|hormones|mesh-ancestor
110911107|NCT01050855|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110911108|NCT01050855|Immunologic Factors|immunologic factors|mesh-ancestor
110911109|NCT01050855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110911110|NCT01050855|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110911111|NCT01050855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110911112|NCT01050855|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110911113|NCT01050855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110911114|NCT04459286|Ritonavir|ritonavir|mesh-list
110911115|NCT04459286|Atazanavir Sulfate|atazanavir sulfate|mesh-list
110911116|NCT04459286|Nitazoxanide|nitazoxanide|mesh-list
110911117|NCT04459286|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110911118|NCT04459286|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110911119|NCT04459286|Protease Inhibitors|protease inhibitors|mesh-ancestor
110911120|NCT04459286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110911121|NCT04459286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110911122|NCT04459286|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110911123|NCT04459286|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110911124|NCT04459286|Antiviral Agents|antiviral agents|mesh-ancestor
110911125|NCT04459286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110911126|NCT04459286|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110911127|NCT04459286|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110911128|NCT04459286|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110911129|NCT00744081|Topotecan|topotecan|mesh-list
110911130|NCT00744081|Mitoxantrone|mitoxantrone|mesh-list
110911131|NCT00744081|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110911132|NCT00744081|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110911133|NCT00744081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110911134|NCT00744081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110911135|NCT00744081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110911136|NCT00744081|Analgesics|analgesics|mesh-ancestor
110911137|NCT00744081|Sensory System Agents|sensory system agents|mesh-ancestor
110911138|NCT00744081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110911139|NCT00744081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110911140|NCT00744081|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110911141|NCT02229266|Cytarabine|cytarabine|mesh-list
110352317|NCT05469347|Alirocumab|alirocumab|mesh-list
110911142|NCT02229266|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110911143|NCT02229266|Antimetabolites|antimetabolites|mesh-ancestor
110911144|NCT02229266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110911145|NCT02229266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110911146|NCT02229266|Antiviral Agents|antiviral agents|mesh-ancestor
110911147|NCT02229266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110911148|NCT02229266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110911149|NCT02229266|Immunologic Factors|immunologic factors|mesh-ancestor
110911150|NCT02229266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110911151|NCT02224040|Azithromycin|azithromycin|mesh-list
110911152|NCT02224040|Ceftriaxone|ceftriaxone|mesh-list
110911153|NCT02224040|Cefixime|cefixime|mesh-list
110911154|NCT02224040|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110911155|NCT02224040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110911156|NCT04448834|Vincristine|vincristine|mesh-list
110911157|NCT04448834|Blinatumomab|blinatumomab|mesh-list
110911158|NCT04448834|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110911159|NCT04448834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110911160|NCT04448834|Tubulin Modulators|tubulin modulators|mesh-ancestor
110911161|NCT04448834|Antimitotic Agents|antimitotic agents|mesh-ancestor
110911162|NCT04448834|Mitosis Modulators|mitosis modulators|mesh-ancestor
110352457|NCT00596050|Ketamine|ketamine|mesh-list
110911163|NCT04448834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110911165|NCT02232308|Nizatidine|nizatidine|mesh-list
110911166|NCT02232308|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110911167|NCT02232308|Protease Inhibitors|protease inhibitors|mesh-ancestor
110911168|NCT02232308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110911169|NCT02232308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110911170|NCT02232308|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110911171|NCT02232308|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110911172|NCT02232308|Protective Agents|protective agents|mesh-ancestor
110911173|NCT02232308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110911174|NCT02232308|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110911175|NCT02232308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110911176|NCT02232308|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110911177|NCT02232308|Histamine Antagonists|histamine antagonists|mesh-ancestor
110911178|NCT02232308|Histamine Agents|histamine agents|mesh-ancestor
110911179|NCT02232308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110911180|NCT02232386|Rituximab|rituximab|mesh-list
110911181|NCT02232386|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110911182|NCT02232386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110911183|NCT02232386|Immunologic Factors|immunologic factors|mesh-ancestor
110911184|NCT02232386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110911185|NCT02232386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110911186|NCT02229734|Androgens|androgens|mesh-list
110911187|NCT02229734|Hormones|hormones|mesh-ancestor
110911188|NCT02229734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110911189|NCT02229734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110911190|NCT04333160|Hylan|hylan|mesh-list
110911191|NCT04333160|Viscosupplements|viscosupplements|mesh-ancestor
110911192|NCT04333160|Protective Agents|protective agents|mesh-ancestor
110911193|NCT04333160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110911194|NCT02258906|Urinastatin|urinastatin|mesh-list
110911195|NCT02258906|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
110911196|NCT02258906|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110911197|NCT02258906|Protease Inhibitors|protease inhibitors|mesh-ancestor
110911198|NCT02258906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110352798|NCT02909478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110911199|NCT02258906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110911200|NCT02229812|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
110911201|NCT02229812|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110911202|NCT02229812|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110911203|NCT02229812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110911204|NCT04222712|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110911205|NCT04222712|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110911206|NCT02229890|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
110911207|NCT02229890|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110911208|NCT02229890|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110911209|NCT02229890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110352868|NCT05312346|Vitamin B 12|vitamin b 12|mesh-list
110911210|NCT02230046|Abiraterone Acetate|abiraterone acetate|mesh-list
110911211|NCT02230046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110911212|NCT02230046|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110911213|NCT02230046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110911214|NCT02230046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110911215|NCT02230046|Hormone Antagonists|hormone antagonists|mesh-ancestor
110911216|NCT02230046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110911217|NCT02230046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110911218|NCT02230046|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110911220|NCT03068455|Ipilimumab|ipilimumab|mesh-list
110911221|NCT03068455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110911222|NCT03068455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110911223|NCT03068455|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110911224|NCT03068455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110911225|NCT03646994|Crizotinib|crizotinib|mesh-list
110911226|NCT03646994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110911227|NCT03646994|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110911228|NCT03646994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110911229|NCT03646994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110911230|NCT04207736|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110911231|NCT04207736|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110911232|NCT02232932|Capecitabine|capecitabine|mesh-list
110911233|NCT02232932|Liver Extracts|liver extracts|mesh-list
110911234|NCT02232932|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110911235|NCT02232932|Antimetabolites|antimetabolites|mesh-ancestor
110911236|NCT02232932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110911237|NCT02232932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110911238|NCT02232932|Hematinics|hematinics|mesh-ancestor
110911239|NCT02230358|Anesthetics|anesthetics|mesh-list
110911240|NCT02230358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110911241|NCT02230358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110911242|NCT03494504|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110911243|NCT03494504|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110911244|NCT04049864|Lenalidomide|lenalidomide|mesh-list
110911245|NCT04049864|Vaccines|vaccines|mesh-list
110911246|NCT04049864|Immunologic Factors|immunologic factors|mesh-ancestor
110911247|NCT04049864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110911248|NCT04049864|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110911249|NCT04049864|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110911250|NCT04049864|Growth Substances|growth substances|mesh-ancestor
110911251|NCT04049864|Growth Inhibitors|growth inhibitors|mesh-ancestor
110911252|NCT04049864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110911253|NCT03475706|Solabegron|solabegron|mesh-list
110911254|NCT03475706|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
110911255|NCT03475706|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110911256|NCT03475706|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110911257|NCT03475706|Adrenergic Agents|adrenergic agents|mesh-ancestor
110911258|NCT03475706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110911259|NCT03475706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110911260|NCT03475706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110911261|NCT02234492|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110911262|NCT02234492|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110911263|NCT02234492|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110911264|NCT02234492|Antimetabolites|antimetabolites|mesh-ancestor
110911265|NCT02234492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110911266|NCT02234492|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110353345|NCT05478720|Antimetabolites|antimetabolites|mesh-ancestor
110926888|NCT03092206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110911267|NCT02234492|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110911268|NCT02234492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110911269|NCT03928184|Lorecivivint|lorecivivint|mesh-list
110911270|NCT03928184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110911271|NCT02259374|Ropivacaine|ropivacaine|mesh-list
110911272|NCT02259374|Anesthetics, Local|anesthetics, local|mesh-ancestor
110911273|NCT02259374|Anesthetics|anesthetics|mesh-ancestor
110911274|NCT02259374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110911275|NCT02259374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110911276|NCT02259374|Sensory System Agents|sensory system agents|mesh-ancestor
110911277|NCT02259374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110353500|NCT04683458|Paclitaxel|paclitaxel|mesh-list
110911278|NCT04921982|Propranolol|propranolol|mesh-list
110911279|NCT04921982|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110911280|NCT04921982|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110911281|NCT04921982|Adrenergic Agents|adrenergic agents|mesh-ancestor
110911282|NCT04921982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110911283|NCT04921982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110911284|NCT04921982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110911285|NCT04921982|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110911286|NCT04921982|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110911287|NCT04921982|Vasodilator Agents|vasodilator agents|mesh-ancestor
110911288|NCT04874324|Levonadifloxacin|levonadifloxacin|mesh-list
110911289|NCT04874324|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110911290|NCT04874324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110911291|NCT04874324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110911292|NCT04874324|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110911293|NCT04874324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110911294|NCT04866056|Azacitidine|azacitidine|mesh-list
110911295|NCT04866056|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110911296|NCT04866056|Antimetabolites|antimetabolites|mesh-ancestor
110911297|NCT04866056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110911298|NCT04866056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110911299|NCT04866056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110911300|NCT03911102|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110911301|NCT03911102|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110911302|NCT03911102|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110911303|NCT03911102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110911304|NCT03911102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110911305|NCT03911102|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110911306|NCT03911102|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110911307|NCT03911102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110911308|NCT03911102|Cholinergic Agents|cholinergic agents|mesh-ancestor
110911309|NCT03911102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110911310|NCT04789148|Oxytocin|oxytocin|mesh-list
110911311|NCT04789148|Oxytocics|oxytocics|mesh-ancestor
110911312|NCT04789148|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110911313|NCT04789148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110911314|NCT03172910|Rivaroxaban|rivaroxaban|mesh-list
110911315|NCT03172910|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110911316|NCT03172910|Antithrombins|antithrombins|mesh-ancestor
110911317|NCT03172910|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110911318|NCT03172910|Protease Inhibitors|protease inhibitors|mesh-ancestor
110911319|NCT03172910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110911320|NCT03172910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110911321|NCT03172910|Anticoagulants|anticoagulants|mesh-ancestor
110911322|NCT03881852|Reboxetine|reboxetine|mesh-list
110911323|NCT03881852|Antidepressive Agents|antidepressive agents|mesh-ancestor
110911324|NCT03881852|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110911325|NCT03881852|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110911326|NCT03881852|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110911327|NCT03881852|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110911328|NCT03881852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110911329|NCT03881852|Adrenergic Agents|adrenergic agents|mesh-ancestor
110911330|NCT03881852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110911331|NCT03881852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110911332|NCT03818828|Iodine|iodine|mesh-list
110911333|NCT03818828|Cadexomer iodine|cadexomer iodine|mesh-list
110911334|NCT03818828|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110911335|NCT03818828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110911336|NCT03818828|Trace Elements|trace elements|mesh-ancestor
110911337|NCT03818828|Micronutrients|micronutrients|mesh-ancestor
110911338|NCT03818828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110911339|NCT02804282|Furosemide|furosemide|mesh-list
110911340|NCT02804282|Diuretics|diuretics|mesh-ancestor
110911341|NCT02804282|Natriuretic Agents|natriuretic agents|mesh-ancestor
110911342|NCT02804282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110911343|NCT02804282|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110911344|NCT02804282|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110353945|NCT01267201|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110911345|NCT02804282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110911346|NCT02233244|Midazolam|midazolam|mesh-list
110911347|NCT02233244|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110911348|NCT02233244|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110911349|NCT02233244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110911350|NCT02233244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110911352|NCT02233244|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110354009|NCT00537966|Tenofovir|tenofovir|mesh-list
110911353|NCT02233244|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110911354|NCT02233244|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110911355|NCT02233244|Anesthetics, General|anesthetics, general|mesh-ancestor
110911356|NCT02233244|Anesthetics|anesthetics|mesh-ancestor
110911357|NCT02233244|GABA Modulators|gaba modulators|mesh-ancestor
110911358|NCT02233244|GABA Agents|gaba agents|mesh-ancestor
110911359|NCT02233244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110354078|NCT00545493|Immunologic Factors|immunologic factors|mesh-ancestor
110911360|NCT02233244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110911361|NCT02259530|Psychotropic Drugs|psychotropic drugs|mesh-list
110911362|NCT02234882|Fostemsavir|fostemsavir|mesh-list
110911363|NCT02234882|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110911364|NCT02234882|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110911365|NCT02234882|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110911366|NCT02234882|Antimetabolites|antimetabolites|mesh-ancestor
110911367|NCT02234882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110911368|NCT02234882|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110911369|NCT02234882|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110911370|NCT02234882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110911371|NCT02234882|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110911372|NCT02234882|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110911373|NCT02234882|Antiviral Agents|antiviral agents|mesh-ancestor
110911374|NCT02234882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110911375|NCT02234882|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110911376|NCT02234882|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110911377|NCT03727022|Lorecivivint|lorecivivint|mesh-list
110911378|NCT03727022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110911379|NCT02233322|Ferrous gluconate|ferrous gluconate|mesh-list
110911380|NCT02233322|Hematinics|hematinics|mesh-ancestor
110911381|NCT02233400|Acetaminophen|acetaminophen|mesh-list
110911382|NCT02233400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110911383|NCT02233400|Analgesics|analgesics|mesh-ancestor
110911384|NCT02233400|Sensory System Agents|sensory system agents|mesh-ancestor
110911385|NCT02233400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110911386|NCT02233400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110911387|NCT02233400|Antipyretics|antipyretics|mesh-ancestor
110911388|NCT03067441|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
110911389|NCT03067441|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110911390|NCT03067441|Antimetabolites|antimetabolites|mesh-ancestor
110911391|NCT03067441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110911392|NCT03067441|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110911393|NCT03067441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110911394|NCT03067441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110911395|NCT03067441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110911397|NCT02235194|Picolinic acid|picolinic acid|mesh-list
110911398|NCT02235194|Trace Elements|trace elements|mesh-ancestor
110911399|NCT02235194|Micronutrients|micronutrients|mesh-ancestor
110628879|NCT00967629|Calcium|calcium|mesh-list
110911400|NCT02235194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110911401|NCT02235194|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110911402|NCT02235194|Chelating Agents|chelating agents|mesh-ancestor
110911403|NCT02235194|Sequestering Agents|sequestering agents|mesh-ancestor
110911404|NCT02235194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110911405|NCT03684278|Infliximab|infliximab|mesh-list
110911406|NCT03684278|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110911407|NCT03684278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110911408|NCT03684278|Dermatologic Agents|dermatologic agents|mesh-ancestor
110911409|NCT03684278|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110911410|NCT03684278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110911411|NCT02726659|Celecoxib|celecoxib|mesh-list
110911412|NCT02726659|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110911413|NCT02726659|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110911414|NCT02726659|Analgesics|analgesics|mesh-ancestor
110911415|NCT02726659|Sensory System Agents|sensory system agents|mesh-ancestor
110911416|NCT02726659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110911417|NCT02726659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110911418|NCT02726659|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110911419|NCT02726659|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110911420|NCT02726659|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110911421|NCT02726659|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110911422|NCT02726659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110911423|NCT02726659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110911424|NCT03660878|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110911425|NCT03660878|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110911426|NCT04446962|Lenalidomide|lenalidomide|mesh-list
110911427|NCT04446962|Immunologic Factors|immunologic factors|mesh-ancestor
110911428|NCT04446962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110911429|NCT04446962|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110911430|NCT04446962|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110911431|NCT04446962|Growth Substances|growth substances|mesh-ancestor
110911432|NCT04446962|Growth Inhibitors|growth inhibitors|mesh-ancestor
110911433|NCT04446962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110911434|NCT03951961|Midostaurin|midostaurin|mesh-list
110911435|NCT03951961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110911436|NCT03951961|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110911437|NCT03951961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110911438|NCT03951961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110911439|NCT02232542|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110911440|NCT02232542|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110911441|NCT02232542|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110911442|NCT02232542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110911443|NCT02232542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110911444|NCT02232542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110911445|NCT02232542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110911446|NCT02232542|Analgesics|analgesics|mesh-ancestor
110911447|NCT02232542|Sensory System Agents|sensory system agents|mesh-ancestor
110911448|NCT02232542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110911449|NCT02232542|Antidepressive Agents|antidepressive agents|mesh-ancestor
110911450|NCT02232542|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110911451|NCT02232542|Dopamine Agents|dopamine agents|mesh-ancestor
110911452|NCT02600923|Letrozole|letrozole|mesh-list
110354623|NCT00547287|Tadalafil|tadalafil|mesh-list
110911453|NCT02600923|Palbociclib|palbociclib|mesh-list
110911454|NCT02600923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110911455|NCT02600923|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110911456|NCT02600923|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110911457|NCT02600923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110911458|NCT02600923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110911459|NCT02600923|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110926920|NCT02033187|Chlorhexidine|chlorhexidine|mesh-list
110354664|NCT00547560|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
110911461|NCT02600923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110911462|NCT02600923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110911463|NCT02600923|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110911464|NCT02232776|Losartan|losartan|mesh-list
110911465|NCT02232776|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110911466|NCT02232776|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110911467|NCT02232776|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110911468|NCT02232776|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110911469|NCT02232776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110911470|NCT03847519|Pembrolizumab|pembrolizumab|mesh-list
110911471|NCT03847519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110628981|NCT00267865|Leucovorin|leucovorin|mesh-list
110911472|NCT03847519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110911473|NCT03847519|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110354733|NCT03809442|GABA Agents|gaba agents|mesh-ancestor
110911474|NCT03847519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110911475|NCT02235428|Bromides|bromides|mesh-list
110911476|NCT02235428|Albuterol|albuterol|mesh-list
110911477|NCT02235428|Ipratropium|ipratropium|mesh-list
110911478|NCT02235428|Anticonvulsants|anticonvulsants|mesh-ancestor
110911479|NCT02235428|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110911480|NCT02235428|Autonomic Agents|autonomic agents|mesh-ancestor
110911481|NCT02235428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110911482|NCT02235428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110911483|NCT02235428|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110911484|NCT02235428|Respiratory System Agents|respiratory system agents|mesh-ancestor
110911485|NCT02235428|Tocolytic Agents|tocolytic agents|mesh-ancestor
110911486|NCT02235428|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110911487|NCT02235428|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110354792|NCT02907749|Diuretics|diuretics|mesh-ancestor
110911488|NCT02235428|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110911489|NCT02235428|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110911490|NCT02235428|Adrenergic Agents|adrenergic agents|mesh-ancestor
110911491|NCT02235428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110911492|NCT02235428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110911493|NCT02235428|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110911494|NCT02235428|Cholinergic Agents|cholinergic agents|mesh-ancestor
110911495|NCT03070171|Dabigatran|dabigatran|mesh-list
110911496|NCT03070171|Antithrombins|antithrombins|mesh-ancestor
110911497|NCT03070171|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110911498|NCT03070171|Protease Inhibitors|protease inhibitors|mesh-ancestor
110911499|NCT03070171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110911500|NCT03070171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110911501|NCT03070171|Anticoagulants|anticoagulants|mesh-ancestor
110911502|NCT02262572|Telmisartan|telmisartan|mesh-list
110911503|NCT02262572|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110911504|NCT02262572|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110911505|NCT02262572|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110911506|NCT02262572|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110911507|NCT02262572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110911508|NCT02262572|Diuretics|diuretics|mesh-ancestor
110911509|NCT02262572|Natriuretic Agents|natriuretic agents|mesh-ancestor
110911510|NCT02262572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110911511|NCT02262572|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110911512|NCT02262572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110911513|NCT02235584|Dexamethasone|dexamethasone|mesh-list
110911514|NCT02235584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110911515|NCT02235584|Antiemetics|antiemetics|mesh-ancestor
110911516|NCT02235584|Autonomic Agents|autonomic agents|mesh-ancestor
110911517|NCT02235584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110911518|NCT02235584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110911519|NCT02235584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110911520|NCT02235584|Glucocorticoids|glucocorticoids|mesh-ancestor
110911521|NCT02235584|Hormones|hormones|mesh-ancestor
110911522|NCT02235584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110911523|NCT02235584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110911524|NCT02235584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110911525|NCT02235662|Tenofovir|tenofovir|mesh-list
110911526|NCT02235662|Levonorgestrel|levonorgestrel|mesh-list
110911527|NCT02235662|Antiviral Agents|antiviral agents|mesh-ancestor
110911528|NCT02235662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110911529|NCT02235662|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110911530|NCT02235662|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110911531|NCT02235662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110911532|NCT02235662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110911533|NCT02235662|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110911534|NCT02235662|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110911535|NCT02235662|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110911536|NCT02235662|Contraceptive Agents|contraceptive agents|mesh-ancestor
110911537|NCT02235662|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110911538|NCT02235662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110911539|NCT02235662|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110911540|NCT02235662|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110911541|NCT02235662|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110911542|NCT02262650|Telmisartan|telmisartan|mesh-list
110911543|NCT02262650|Clopidogrel|clopidogrel|mesh-list
110911544|NCT02262650|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110911545|NCT02262650|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110911546|NCT02262650|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110911547|NCT02262650|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110911548|NCT02262650|Purinergic Agents|purinergic agents|mesh-ancestor
110911549|NCT02262650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110911550|NCT02262650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110911551|NCT02262650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110911552|NCT02262650|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110911553|NCT02262650|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110911554|NCT02262650|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110911555|NCT02784002|Fidaxomicin|fidaxomicin|mesh-list
110911556|NCT02784002|Ridinilazole|ridinilazole|mesh-list
110355091|NCT00548964|Antimanic Agents|antimanic agents|mesh-ancestor
110911557|NCT02784002|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110911558|NCT02784002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110911559|NCT02233556|Memantine|memantine|mesh-list
110911560|NCT02233556|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110911561|NCT02233556|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110911562|NCT02233556|Dopamine Agents|dopamine agents|mesh-ancestor
110911563|NCT02233556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110911564|NCT02233556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110911565|NCT02233556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110911566|NCT02233556|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110911567|NCT02233556|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110911568|NCT04240288|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110911569|NCT04240288|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
110911570|NCT04240288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110911571|NCT04240288|Antitubercular Agents|antitubercular agents|mesh-ancestor
110911572|NCT02236052|Vaccines|vaccines|mesh-list
110911573|NCT02236052|Immunologic Factors|immunologic factors|mesh-ancestor
110911574|NCT02236052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110911575|NCT04908592|Dexamethasone|dexamethasone|mesh-list
110911576|NCT04908592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110911577|NCT04908592|Antiemetics|antiemetics|mesh-ancestor
110911578|NCT04908592|Autonomic Agents|autonomic agents|mesh-ancestor
110911579|NCT04908592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110911580|NCT04908592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110911581|NCT04908592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110911582|NCT04908592|Glucocorticoids|glucocorticoids|mesh-ancestor
110911583|NCT04908592|Hormones|hormones|mesh-ancestor
110911584|NCT04908592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110911585|NCT04908592|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110911586|NCT04908592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110911587|NCT04759768|Naltrexone|naltrexone|mesh-list
110911588|NCT04759768|Nalmefene|nalmefene|mesh-list
110911589|NCT04759768|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110911590|NCT04759768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110911591|NCT04759768|Sensory System Agents|sensory system agents|mesh-ancestor
110911592|NCT04759768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110911593|NCT04759768|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110911594|NCT02564744|Rituximab|rituximab|mesh-list
110911595|NCT02564744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110911596|NCT02564744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110911597|NCT02564744|Immunologic Factors|immunologic factors|mesh-ancestor
110911598|NCT02564744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110911599|NCT02564744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110911600|NCT05759767|Tamsulosin|tamsulosin|mesh-list
110911601|NCT05759767|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110911602|NCT05759767|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110911603|NCT05759767|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110911604|NCT05759767|Adrenergic Agents|adrenergic agents|mesh-ancestor
110911605|NCT05759767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110911606|NCT05759767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110911607|NCT05759767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110911608|NCT05759767|Urological Agents|urological agents|mesh-ancestor
110911609|NCT02750306|Suvorexant|suvorexant|mesh-list
110911610|NCT02750306|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110911611|NCT02750306|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110911612|NCT02750306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110911613|NCT02750306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110911614|NCT02750306|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
110911615|NCT02750306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110911616|NCT02750306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110911617|NCT03845140|Praziquantel|praziquantel|mesh-list
110911618|NCT03845140|Anthelmintics|anthelmintics|mesh-ancestor
110911619|NCT03845140|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110911620|NCT03845140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110911621|NCT01816165|Acipimox|acipimox|mesh-list
110911622|NCT01816165|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110911623|NCT01816165|Antimetabolites|antimetabolites|mesh-ancestor
110911624|NCT01816165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110355472|NCT02895659|Racepinephrine|racepinephrine|mesh-list
110911625|NCT01816165|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110911626|NCT04476680|Vitamin D|vitamin d|mesh-list
110911627|NCT04476680|Vitamins|vitamins|mesh-ancestor
110911628|NCT04476680|Micronutrients|micronutrients|mesh-ancestor
110911629|NCT04476680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110911630|NCT04476680|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110911631|NCT04952350|Atorvastatin|atorvastatin|mesh-list
110911632|NCT04952350|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110911633|NCT04952350|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110911634|NCT04952350|Antimetabolites|antimetabolites|mesh-ancestor
110355540|NCT02895113|Aspirin|aspirin|mesh-list
110911635|NCT04952350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110911636|NCT04952350|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110911637|NCT04952350|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110911638|NCT04952350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110911639|NCT05376202|Cetuximab|cetuximab|mesh-list
110911640|NCT05376202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110911641|NCT05376202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110355626|NCT00550992|Vitamins|vitamins|mesh-ancestor
110911642|NCT04812808|Bazedoxifene|bazedoxifene|mesh-list
110911643|NCT04812808|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110911644|NCT04812808|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110911645|NCT04812808|Hormone Antagonists|hormone antagonists|mesh-ancestor
110911646|NCT04812808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110911647|NCT04812808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110355677|NCT00551343|Exenatide|exenatide|mesh-list
110911648|NCT04812808|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110911649|NCT04788550|Listerine|listerine|mesh-list
110911650|NCT04788550|Fluorides|fluorides|mesh-list
110911651|NCT04788550|Sodium Fluoride|sodium fluoride|mesh-list
110911652|NCT04788550|Fluorides, Topical|fluorides, topical|mesh-list
110911653|NCT04788550|Cariostatic Agents|cariostatic agents|mesh-ancestor
110911654|NCT04788550|Protective Agents|protective agents|mesh-ancestor
110911655|NCT04788550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110911656|NCT04788550|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110911657|NCT04788550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110911658|NCT01677988|Folfirinox|folfirinox|mesh-list
110911659|NCT01677988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110911660|NCT02233790|Clopidogrel|clopidogrel|mesh-list
110911661|NCT02233790|Ticagrelor|ticagrelor|mesh-list
110911662|NCT02233790|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110911663|NCT02233790|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110911664|NCT02233790|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110911665|NCT02233790|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110911666|NCT02233790|Purinergic Agents|purinergic agents|mesh-ancestor
110911667|NCT02233790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110355813|NCT05426798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110911668|NCT02233790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110911669|NCT02233790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110911670|NCT02547818|Ibuprofen|ibuprofen|mesh-list
110911671|NCT02547818|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110911672|NCT02547818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110911673|NCT02547818|Analgesics|analgesics|mesh-ancestor
110911674|NCT02547818|Sensory System Agents|sensory system agents|mesh-ancestor
110911675|NCT02547818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110911676|NCT02547818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110911677|NCT02547818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110911678|NCT02547818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110911679|NCT02547818|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110911680|NCT02547818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110911681|NCT02547818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110911682|NCT04539808|Calcium, Dietary|calcium, dietary|mesh-list
110911683|NCT04539808|Leucovorin|leucovorin|mesh-list
110911684|NCT04539808|Folic Acid|folic acid|mesh-list
110911685|NCT04539808|Fluorouracil|fluorouracil|mesh-list
110911686|NCT04539808|Capecitabine|capecitabine|mesh-list
110911687|NCT04539808|Oxaliplatin|oxaliplatin|mesh-list
110911688|NCT04539808|Irinotecan|irinotecan|mesh-list
110911689|NCT04539808|Camptothecin|camptothecin|mesh-list
110911690|NCT04539808|Losartan|losartan|mesh-list
110911691|NCT04539808|Calcium|calcium|mesh-list
110911692|NCT04539808|Levoleucovorin|levoleucovorin|mesh-list
110911693|NCT04539808|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110226389|NCT05536154|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110355949|NCT04041011|Fluzoparib|fluzoparib|mesh-list
110911694|NCT04539808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110926969|NCT03610893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110911695|NCT04539808|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110911696|NCT04539808|Antimetabolites|antimetabolites|mesh-ancestor
110911697|NCT04539808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110911698|NCT04539808|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110911699|NCT04539808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110911700|NCT04539808|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110911701|NCT04539808|Immunologic Factors|immunologic factors|mesh-ancestor
110356005|NCT03911336|Acetaminophen|acetaminophen|mesh-list
110911702|NCT04539808|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110911703|NCT04539808|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110911704|NCT04539808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110911706|NCT04539808|Protective Agents|protective agents|mesh-ancestor
110911707|NCT04539808|Vitamin B Complex|vitamin b complex|mesh-ancestor
110911709|NCT04539808|Micronutrients|micronutrients|mesh-ancestor
110911710|NCT04539808|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110911711|NCT04539808|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110911712|NCT04539808|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110911713|NCT04539808|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110911715|NCT04539808|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110911716|NCT02520076|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
110911717|NCT02520076|Protein C Inhibitor|protein c inhibitor|mesh-list
110911718|NCT02520076|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
110911719|NCT02520076|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110911720|NCT02520076|Protease Inhibitors|protease inhibitors|mesh-ancestor
110911721|NCT02520076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110911722|NCT02520076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110911723|NCT03752918|Niacin|niacin|mesh-list
110911724|NCT03752918|Nicotinic Acids|nicotinic acids|mesh-list
110911725|NCT03752918|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
110911726|NCT03752918|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110911727|NCT03752918|Antimetabolites|antimetabolites|mesh-ancestor
110356134|NCT02964884|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110911728|NCT03752918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110911729|NCT03752918|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110911730|NCT03752918|Vasodilator Agents|vasodilator agents|mesh-ancestor
110911731|NCT03752918|Vitamin B Complex|vitamin b complex|mesh-ancestor
110911732|NCT03752918|Vitamins|vitamins|mesh-ancestor
110911733|NCT03752918|Micronutrients|micronutrients|mesh-ancestor
110911734|NCT03752918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110911735|NCT03752918|Hallucinogens|hallucinogens|mesh-ancestor
110911736|NCT03752918|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110911737|NCT03752918|Serotonin Agents|serotonin agents|mesh-ancestor
110911738|NCT03752918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110911739|NCT03752918|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110911740|NCT03752918|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110911741|NCT03752918|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110911742|NCT03752918|Adrenergic Agents|adrenergic agents|mesh-ancestor
110911743|NCT04259320|Propolis|propolis|mesh-list
110911744|NCT04259320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110911745|NCT04058158|Eculizumab|eculizumab|mesh-list
110911746|NCT04058158|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
110911747|NCT04058158|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110911748|NCT04058158|Immunologic Factors|immunologic factors|mesh-ancestor
110911749|NCT04058158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110911750|NCT02263196|Ethanol|ethanol|mesh-list
110911751|NCT02263196|Povidone-Iodine|povidone-iodine|mesh-list
110911752|NCT02263196|Povidone|povidone|mesh-list
110911753|NCT02263196|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110911754|NCT02263196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110911755|NCT02263196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110911756|NCT02263196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110911757|NCT02263196|Plasma Substitutes|plasma substitutes|mesh-ancestor
110911758|NCT02263196|Blood Substitutes|blood substitutes|mesh-ancestor
110911759|NCT05160506|Hydrocortisone|hydrocortisone|mesh-list
110911760|NCT05160506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110911761|NCT02926573|Gabapentin|gabapentin|mesh-list
110911762|NCT02926573|Analgesics|analgesics|mesh-ancestor
110911763|NCT02926573|Sensory System Agents|sensory system agents|mesh-ancestor
110911764|NCT02926573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110911765|NCT02926573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110911766|NCT02926573|Anticonvulsants|anticonvulsants|mesh-ancestor
110911767|NCT02926573|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110911768|NCT02926573|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110911769|NCT02926573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110682990|NCT00904475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110911770|NCT02926573|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110911771|NCT02926573|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110911772|NCT02926573|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110911773|NCT02926573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110911774|NCT02926573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110911775|NCT02926573|Antimanic Agents|antimanic agents|mesh-ancestor
110911777|NCT04477018|Chelating Agents|chelating agents|mesh-list
110911778|NCT04477018|Micronutrients|micronutrients|mesh-ancestor
110911779|NCT04477018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110911780|NCT04477018|Trace Elements|trace elements|mesh-ancestor
110911781|NCT04477018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110911782|NCT04477018|Sequestering Agents|sequestering agents|mesh-ancestor
110911783|NCT00158860|Valacyclovir|valacyclovir|mesh-list
110911784|NCT00158860|Antiviral Agents|antiviral agents|mesh-ancestor
110911785|NCT00158860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110911786|NCT02490488|Gemcitabine|gemcitabine|mesh-list
110911787|NCT02490488|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110911788|NCT02490488|Antimetabolites|antimetabolites|mesh-ancestor
110911789|NCT02490488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110911790|NCT02490488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110911791|NCT02471222|Amantadine|amantadine|mesh-list
110911792|NCT02471222|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110911793|NCT02471222|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110911794|NCT02471222|Antiviral Agents|antiviral agents|mesh-ancestor
110911795|NCT02471222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110911796|NCT02471222|Dopamine Agents|dopamine agents|mesh-ancestor
110911797|NCT02471222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110911798|NCT02471222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110911799|NCT02471222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110911800|NCT02471222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110911801|NCT02471222|Analgesics|analgesics|mesh-ancestor
110911802|NCT02471222|Sensory System Agents|sensory system agents|mesh-ancestor
110911803|NCT02471222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110911804|NCT03136120|Bromides|bromides|mesh-list
110911805|NCT03136120|Ipratropium|ipratropium|mesh-list
110911806|NCT03136120|Anticonvulsants|anticonvulsants|mesh-ancestor
110356523|NCT02529852|Hormones|hormones|mesh-ancestor
110911807|NCT03136120|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110911808|NCT03136120|Autonomic Agents|autonomic agents|mesh-ancestor
110911809|NCT03136120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110911810|NCT03136120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110911811|NCT03136120|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110911812|NCT03136120|Respiratory System Agents|respiratory system agents|mesh-ancestor
110911813|NCT03136120|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110911814|NCT03136120|Cholinergic Agents|cholinergic agents|mesh-ancestor
110911815|NCT03136120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110911816|NCT03136120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110911817|NCT01625234|Ensartinib|ensartinib|mesh-list
110911818|NCT01625234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110911819|NCT01625234|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110911820|NCT01625234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110911821|NCT01625234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110911822|NCT02264834|Sufentanil|sufentanil|mesh-list
110911823|NCT02264834|Dsuvia|dsuvia|mesh-list
110911824|NCT02264834|Levobupivacaine|levobupivacaine|mesh-list
110911825|NCT02264834|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110911826|NCT02264834|Narcotics|narcotics|mesh-ancestor
110911827|NCT02264834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110911828|NCT02264834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110911829|NCT02264834|Analgesics|analgesics|mesh-ancestor
110911830|NCT02264834|Sensory System Agents|sensory system agents|mesh-ancestor
110911831|NCT02264834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110911832|NCT02264834|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110911833|NCT02264834|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110911834|NCT02264834|Anesthetics, General|anesthetics, general|mesh-ancestor
110911835|NCT02264834|Anesthetics|anesthetics|mesh-ancestor
110911836|NCT02264834|Anesthetics, Local|anesthetics, local|mesh-ancestor
110911837|NCT05762419|Etoposide|etoposide|mesh-list
110911838|NCT05762419|Etoposide phosphate|etoposide phosphate|mesh-list
110911839|NCT05762419|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110911840|NCT05762419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110911841|NCT05762419|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110911842|NCT05762419|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110911843|NCT05762419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110911844|NCT05762419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110911845|NCT02264912|Clopidogrel|clopidogrel|mesh-list
110911846|NCT02264912|Ticagrelor|ticagrelor|mesh-list
110911847|NCT02264912|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
110911848|NCT02264912|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
110911849|NCT02264912|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110911850|NCT02264912|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110911851|NCT02264912|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110911852|NCT02264912|Purinergic Agents|purinergic agents|mesh-ancestor
110911853|NCT02264912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110911854|NCT02264912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110911855|NCT02264912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110911856|NCT02263352|Carotenoids|carotenoids|mesh-list
110911857|NCT02263352|Antioxidants|antioxidants|mesh-ancestor
110911858|NCT02263352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110911859|NCT02263352|Protective Agents|protective agents|mesh-ancestor
110356846|NCT04665284|Empagliflozin|empagliflozin|mesh-list
110911860|NCT02263352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110911861|NCT01435226|Ribavirin|ribavirin|mesh-list
110911862|NCT01435226|Ledipasvir|ledipasvir|mesh-list
110911863|NCT01435226|Antimetabolites|antimetabolites|mesh-ancestor
110911864|NCT01435226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110911865|NCT01435226|Antiviral Agents|antiviral agents|mesh-ancestor
110911866|NCT01435226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110911867|NCT01679002|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
110911868|NCT01679002|Oxcarbazepine|oxcarbazepine|mesh-list
110911869|NCT01679002|Anticonvulsants|anticonvulsants|mesh-ancestor
110911870|NCT01679002|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110911871|NCT01679002|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110927019|NCT02520921|Antipyretics|antipyretics|mesh-ancestor
110911872|NCT01679002|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110911873|NCT01679002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110911874|NCT01679002|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110911875|NCT01679002|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110356978|NCT03918252|Nivolumab|nivolumab|mesh-list
110911877|NCT04409509|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110911878|NCT04409509|Immunologic Factors|immunologic factors|mesh-ancestor
110911879|NCT04409509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110911880|NCT04401865|Riboflavin|riboflavin|mesh-list
110911881|NCT04401865|Vitamin B Complex|vitamin b complex|mesh-ancestor
110911882|NCT04401865|Vitamins|vitamins|mesh-ancestor
110911883|NCT04401865|Micronutrients|micronutrients|mesh-ancestor
110911884|NCT04401865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110911885|NCT04401865|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110911886|NCT04401865|Dermatologic Agents|dermatologic agents|mesh-ancestor
110911887|NCT02609048|Seladelpar|seladelpar|mesh-list
110911888|NCT02609048|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110911889|NCT02609048|Antimetabolites|antimetabolites|mesh-ancestor
110911890|NCT02609048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110911891|NCT02609048|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110911892|NCT02265068|Ticagrelor|ticagrelor|mesh-list
110911893|NCT02265068|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110911894|NCT02265068|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110911895|NCT02265068|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110911896|NCT02265068|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110911897|NCT02265068|Purinergic Agents|purinergic agents|mesh-ancestor
110911898|NCT02265068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110911899|NCT02265068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110911900|NCT02265068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110911901|NCT02262416|Leuprolide|leuprolide|mesh-list
110911902|NCT02262416|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110911903|NCT02262416|Fertility Agents|fertility agents|mesh-ancestor
110357110|NCT01208038|Androgens|androgens|mesh-ancestor
110911904|NCT02262416|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110911905|NCT02262416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110911906|NCT02262416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110911907|NCT02262416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110911908|NCT01577654|Folic Acid|folic acid|mesh-list
110911909|NCT01577654|Docetaxel|docetaxel|mesh-list
110911910|NCT01577654|Vinca Alkaloids|vinca alkaloids|mesh-list
110911911|NCT01577654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110357170|NCT04659551|Cyclophosphamide|cyclophosphamide|mesh-list
110911912|NCT01577654|Tubulin Modulators|tubulin modulators|mesh-ancestor
110911913|NCT01577654|Antimitotic Agents|antimitotic agents|mesh-ancestor
110911914|NCT01577654|Mitosis Modulators|mitosis modulators|mesh-ancestor
110911915|NCT01577654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110911916|NCT01577654|Hematinics|hematinics|mesh-ancestor
110911917|NCT01577654|Vitamin B Complex|vitamin b complex|mesh-ancestor
110911918|NCT01577654|Vitamins|vitamins|mesh-ancestor
110911919|NCT01577654|Micronutrients|micronutrients|mesh-ancestor
110911920|NCT01577654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110911921|NCT01423058|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
110911922|NCT01423058|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110911923|NCT01423058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110911924|NCT01423058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110911925|NCT04413292|BIRC5 protein, human|birc5 protein, human|mesh-list
110911926|NCT04413292|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
110911927|NCT04413292|Protease Inhibitors|protease inhibitors|mesh-ancestor
110911928|NCT04413292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110911929|NCT04413292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110911931|NCT01418222|Bevacizumab|bevacizumab|mesh-list
110911932|NCT01418222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110911933|NCT01418222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110911934|NCT01418222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110911935|NCT01418222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110911936|NCT01418222|Growth Substances|growth substances|mesh-ancestor
110911937|NCT01418222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110911938|NCT01418222|Growth Inhibitors|growth inhibitors|mesh-ancestor
110911940|NCT01418222|Protective Agents|protective agents|mesh-ancestor
110911941|NCT01418222|Vitamin B Complex|vitamin b complex|mesh-ancestor
110911942|NCT01418222|Vitamins|vitamins|mesh-ancestor
110911943|NCT01418222|Micronutrients|micronutrients|mesh-ancestor
110911944|NCT01256762|Paclitaxel|paclitaxel|mesh-list
110911945|NCT01256762|Bevacizumab|bevacizumab|mesh-list
110911946|NCT01256762|Imetelstat|imetelstat|mesh-list
110911947|NCT01256762|Motesanib diphosphate|motesanib diphosphate|mesh-list
110911948|NCT01256762|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110357292|NCT04658225|Disinfectants|disinfectants|mesh-ancestor
110911949|NCT01256762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110911950|NCT01256762|Tubulin Modulators|tubulin modulators|mesh-ancestor
110911951|NCT01256762|Antimitotic Agents|antimitotic agents|mesh-ancestor
110911952|NCT01256762|Mitosis Modulators|mitosis modulators|mesh-ancestor
110911953|NCT01256762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110911954|NCT01256762|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110911955|NCT01256762|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110911956|NCT01256762|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110911957|NCT01256762|Growth Substances|growth substances|mesh-ancestor
110911958|NCT01256762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110911959|NCT01256762|Growth Inhibitors|growth inhibitors|mesh-ancestor
110911960|NCT01256762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110911961|NCT01256762|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110911962|NCT01252628|Cetuximab|cetuximab|mesh-list
110911963|NCT01252628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110911964|NCT01252628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110911965|NCT01236638|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
110911966|NCT01236638|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110911967|NCT01236638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110911968|NCT01236638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110911969|NCT04349371|Chloroquine|chloroquine|mesh-list
110911970|NCT04349371|Amebicides|amebicides|mesh-ancestor
110911971|NCT04349371|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110911972|NCT04349371|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110911973|NCT04349371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110911974|NCT04349371|Antimalarials|antimalarials|mesh-ancestor
110911975|NCT04349371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110911976|NCT01410188|Latanoprost|latanoprost|mesh-list
110911977|NCT01410188|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110911978|NCT01410188|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110911979|NCT01408082|Azithromycin|azithromycin|mesh-list
110911980|NCT01408082|Dexamethasone|dexamethasone|mesh-list
110911981|NCT01408082|Dexamethasone acetate|dexamethasone acetate|mesh-list
110911982|NCT01408082|BB 1101|bb 1101|mesh-list
110911983|NCT01408082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110911984|NCT01408082|Antiemetics|antiemetics|mesh-ancestor
110911985|NCT01408082|Autonomic Agents|autonomic agents|mesh-ancestor
110911986|NCT01408082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110911987|NCT01408082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110911988|NCT01408082|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110911989|NCT01408082|Glucocorticoids|glucocorticoids|mesh-ancestor
110911991|NCT01408082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110911992|NCT01408082|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110911993|NCT01408082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110911994|NCT01408082|Protease Inhibitors|protease inhibitors|mesh-ancestor
110911995|NCT01408082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110357473|NCT04655417|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110911996|NCT01408082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110911997|NCT01408082|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110911998|NCT01408082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110911999|NCT03071263|Spironolactone|spironolactone|mesh-list
110912000|NCT03071263|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110912001|NCT03071263|Hormone Antagonists|hormone antagonists|mesh-ancestor
110912002|NCT03071263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110912003|NCT03071263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110912004|NCT03071263|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110912005|NCT03071263|Diuretics|diuretics|mesh-ancestor
110912006|NCT03071263|Natriuretic Agents|natriuretic agents|mesh-ancestor
110912007|NCT05200663|Tamoxifen|tamoxifen|mesh-list
110912008|NCT05200663|Vitamin E|vitamin e|mesh-list
110912009|NCT05200663|Vitamins|vitamins|mesh-ancestor
110912010|NCT05200663|Micronutrients|micronutrients|mesh-ancestor
110912011|NCT05200663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110912012|NCT05200663|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110912013|NCT05200663|Hormone Antagonists|hormone antagonists|mesh-ancestor
110912014|NCT05200663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110912015|NCT05200663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110912016|NCT05200663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110912017|NCT05200663|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110912018|NCT05200663|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110912019|NCT05200663|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110912020|NCT05200663|Antioxidants|antioxidants|mesh-ancestor
110912021|NCT05200663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110912022|NCT05200663|Protective Agents|protective agents|mesh-ancestor
110912023|NCT02268422|Buprenorphine|buprenorphine|mesh-list
110912024|NCT02268422|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110912025|NCT02268422|Narcotics|narcotics|mesh-ancestor
110912026|NCT02268422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110912027|NCT02268422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110912028|NCT02268422|Analgesics|analgesics|mesh-ancestor
110912029|NCT02268422|Sensory System Agents|sensory system agents|mesh-ancestor
110912030|NCT02268422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110912031|NCT02268422|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110912032|NCT01522196|Varespladib methyl|varespladib methyl|mesh-list
110912033|NCT01522196|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
110912034|NCT01522196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110912035|NCT01522196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110912036|NCT05049343|Ketamine|ketamine|mesh-list
110912037|NCT05049343|Analgesics|analgesics|mesh-ancestor
110912038|NCT05049343|Sensory System Agents|sensory system agents|mesh-ancestor
110912039|NCT05049343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110912040|NCT05049343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110912041|NCT05049343|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110912042|NCT05049343|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110912043|NCT05049343|Anesthetics, General|anesthetics, general|mesh-ancestor
110912044|NCT05049343|Anesthetics|anesthetics|mesh-ancestor
110912045|NCT05049343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110912046|NCT05049343|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110912047|NCT05049343|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110912048|NCT05049343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110912049|NCT05049343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110912050|NCT01569919|Folic Acid|folic acid|mesh-list
110912051|NCT01569919|Vitamin B 12|vitamin b 12|mesh-list
110912052|NCT01569919|Dexamethasone|dexamethasone|mesh-list
110912053|NCT01569919|Pemetrexed|pemetrexed|mesh-list
110912054|NCT01569919|Vitamins|vitamins|mesh-ancestor
110912056|NCT01569919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110912057|NCT01569919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110912058|NCT01569919|Antiemetics|antiemetics|mesh-ancestor
110912059|NCT01569919|Autonomic Agents|autonomic agents|mesh-ancestor
110912060|NCT01569919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110912061|NCT01569919|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110912062|NCT01569919|Glucocorticoids|glucocorticoids|mesh-ancestor
110912063|NCT01569919|Hormones|hormones|mesh-ancestor
110912064|NCT01569919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110912065|NCT01569919|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110912066|NCT01569919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110912067|NCT01569919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110912068|NCT01569919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110912069|NCT01569919|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110912070|NCT01569919|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110912071|NCT01569919|Hematinics|hematinics|mesh-ancestor
110357780|NCT04651205|Thiamine|thiamine|mesh-list
110912072|NCT01569919|Vitamin B Complex|vitamin b complex|mesh-ancestor
110682991|NCT00904475|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110912073|NCT01399580|Atrasentan|atrasentan|mesh-list
110912074|NCT01399580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110912075|NCT01399580|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
110912076|NCT01399580|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
110912077|NCT01399580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110912079|NCT04069585|Anesthetics|anesthetics|mesh-list
110912080|NCT04069585|Anesthetics, Local|anesthetics, local|mesh-ancestor
110912081|NCT04069585|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110912082|NCT04069585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110912083|NCT04069585|Sensory System Agents|sensory system agents|mesh-ancestor
110912084|NCT04069585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110912085|NCT04069585|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110912086|NCT04069585|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110912087|NCT04069585|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110912088|NCT04069585|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110912089|NCT04069585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110912090|NCT00157196|Cyclophosphamide|cyclophosphamide|mesh-list
110912091|NCT00157196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110912092|NCT00157196|Immunologic Factors|immunologic factors|mesh-ancestor
110912093|NCT00157196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110912094|NCT00157196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110912095|NCT00157196|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110912096|NCT00157196|Alkylating Agents|alkylating agents|mesh-ancestor
110912097|NCT00157196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110912098|NCT00157196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110912099|NCT00157196|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110912100|NCT03066193|Palmidrol|palmidrol|mesh-list
110912101|NCT03066193|Dronabinol|dronabinol|mesh-list
110912102|NCT03066193|Hallucinogens|hallucinogens|mesh-ancestor
110912103|NCT03066193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110912104|NCT03066193|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110912105|NCT03066193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110912106|NCT03066193|Analgesics|analgesics|mesh-ancestor
110912107|NCT03066193|Sensory System Agents|sensory system agents|mesh-ancestor
110912108|NCT03066193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110912109|NCT03066193|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
110912110|NCT03066193|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110912111|NCT03066193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110912112|NCT03066193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110912113|NCT03066193|Hormones|hormones|mesh-ancestor
110912114|NCT03066193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110912115|NCT03066193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110912116|NCT03066193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110357959|NCT02909088|Ecopipam|ecopipam|mesh-list
110912117|NCT03066193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110912118|NCT03066193|Antiviral Agents|antiviral agents|mesh-ancestor
110912119|NCT03066193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110912120|NCT02263976|Bromides|bromides|mesh-list
110912121|NCT02263976|Tiotropium Bromide|tiotropium bromide|mesh-list
110912122|NCT02263976|Methacholine Chloride|methacholine chloride|mesh-list
110912123|NCT02263976|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110912124|NCT02263976|Autonomic Agents|autonomic agents|mesh-ancestor
110912125|NCT02263976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110912126|NCT02263976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110912127|NCT02263976|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110358023|NCT01239472|Everolimus|everolimus|mesh-list
110912128|NCT02263976|Respiratory System Agents|respiratory system agents|mesh-ancestor
110912129|NCT02263976|Parasympatholytics|parasympatholytics|mesh-ancestor
110912130|NCT02263976|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110912131|NCT02263976|Cholinergic Agents|cholinergic agents|mesh-ancestor
110912132|NCT02263976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110912133|NCT02263976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110912134|NCT02263976|Anticonvulsants|anticonvulsants|mesh-ancestor
110912135|NCT02263976|Miotics|miotics|mesh-ancestor
110912136|NCT02263976|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110912137|NCT02263976|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
110912138|NCT02263976|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
110912139|NCT02263976|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110912140|NCT01382654|Azelastine|azelastine|mesh-list
110912141|NCT01382654|Epinastine|epinastine|mesh-list
110912142|NCT01382654|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110912143|NCT01382654|Autonomic Agents|autonomic agents|mesh-ancestor
110912144|NCT01382654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110912145|NCT01382654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110912146|NCT01382654|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110912147|NCT01382654|Respiratory System Agents|respiratory system agents|mesh-ancestor
110912148|NCT01382654|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
110912149|NCT01382654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110912150|NCT01382654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110912151|NCT01382654|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110912152|NCT01382654|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110912153|NCT01382654|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110912154|NCT01382654|Histamine Antagonists|histamine antagonists|mesh-ancestor
110912155|NCT01382654|Histamine Agents|histamine agents|mesh-ancestor
110912156|NCT01382654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110912157|NCT01378676|Riluzole|riluzole|mesh-list
110912158|NCT01378676|Anticonvulsants|anticonvulsants|mesh-ancestor
110912159|NCT01378676|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110912160|NCT01378676|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110912161|NCT01378676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110912162|NCT01378676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110912163|NCT01378676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110912164|NCT01378676|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110912165|NCT01378676|Protective Agents|protective agents|mesh-ancestor
110912166|NCT01377662|Methylphenidate|methylphenidate|mesh-list
110912167|NCT01377662|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110912168|NCT01377662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110912169|NCT01377662|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110912170|NCT01377662|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110912171|NCT01377662|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110358228|NCT06021210|Letermovir|letermovir|mesh-list
110912172|NCT01377662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110912173|NCT01377662|Dopamine Agents|dopamine agents|mesh-ancestor
110912174|NCT01377662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110912175|NCT01371578|Ribavirin|ribavirin|mesh-list
110912176|NCT01371578|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110912177|NCT01371578|Ledipasvir|ledipasvir|mesh-list
110912178|NCT01371578|Antimetabolites|antimetabolites|mesh-ancestor
110912179|NCT01371578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110912180|NCT01371578|Antiviral Agents|antiviral agents|mesh-ancestor
110358284|NCT06020833|Tretinoin|tretinoin|mesh-list
110912181|NCT01371578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110912182|NCT01225640|Oxazolidinones|oxazolidinones|mesh-list
110912183|NCT01225640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110912184|NCT01225640|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110912185|NCT01225640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110912186|NCT01225640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110912187|NCT01498328|Bevacizumab|bevacizumab|mesh-list
110912188|NCT01498328|Rindopepimut|rindopepimut|mesh-list
110912189|NCT01498328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110912190|NCT01498328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110912191|NCT01498328|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110912192|NCT01498328|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110912193|NCT01498328|Growth Substances|growth substances|mesh-ancestor
110912194|NCT01498328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110912195|NCT01498328|Growth Inhibitors|growth inhibitors|mesh-ancestor
110912196|NCT01497704|Apatinib|apatinib|mesh-list
110912197|NCT01497704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110912198|NCT01497704|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110912199|NCT01497704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110912200|NCT01497704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110912201|NCT02266160|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
110912202|NCT02266160|Anesthetics, Local|anesthetics, local|mesh-ancestor
110912203|NCT02266160|Anesthetics|anesthetics|mesh-ancestor
110226471|NCT05480865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110912204|NCT02266160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110912205|NCT02266160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110912206|NCT02266160|Sensory System Agents|sensory system agents|mesh-ancestor
110912207|NCT02266160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110912208|NCT02266160|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
110912209|NCT03911713|Ivacaftor|ivacaftor|mesh-list
110912210|NCT03911713|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
110912211|NCT03911713|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110912212|NCT03911713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110912213|NCT02264132|Pramipexole|pramipexole|mesh-list
110912214|NCT02264132|Antioxidants|antioxidants|mesh-ancestor
110912215|NCT02264132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110912216|NCT02264132|Protective Agents|protective agents|mesh-ancestor
110912217|NCT02264132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110912218|NCT02264132|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110912219|NCT02264132|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110912220|NCT02264132|Dopamine Agonists|dopamine agonists|mesh-ancestor
110912221|NCT02264132|Dopamine Agents|dopamine agents|mesh-ancestor
110912222|NCT02264132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110912223|NCT01192880|Antipsychotic Agents|antipsychotic agents|mesh-list
110912224|NCT01192880|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110912225|NCT01192880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110912226|NCT01192880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110912227|NCT01192880|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110912228|NCT04540744|Tadalafil|tadalafil|mesh-list
110912229|NCT04540744|Macitentan|macitentan|mesh-list
110912230|NCT04540744|Vasodilator Agents|vasodilator agents|mesh-ancestor
110912231|NCT04540744|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110912232|NCT04540744|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110912233|NCT04540744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110912234|NCT04540744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110912235|NCT04540744|Urological Agents|urological agents|mesh-ancestor
110912236|NCT04540744|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
110912237|NCT04540744|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
110912238|NCT04540744|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
110912240|NCT05375734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110912241|NCT05375734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110912242|NCT01489046|Tenofovir|tenofovir|mesh-list
110912243|NCT01489046|Lamivudine|lamivudine|mesh-list
110912244|NCT01489046|Efavirenz|efavirenz|mesh-list
110912245|NCT01489046|Antiviral Agents|antiviral agents|mesh-ancestor
110912246|NCT01489046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110912247|NCT01489046|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110912248|NCT01489046|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110912249|NCT01489046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110912250|NCT01489046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110912251|NCT01489046|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110912252|NCT01489046|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110912253|NCT01489046|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110912254|NCT01489046|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110912255|NCT01489046|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110912256|NCT01489046|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110912257|NCT01489046|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110912258|NCT01489046|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110912259|NCT01180634|Levofloxacin|levofloxacin|mesh-list
110358589|NCT05661149|Insulin|insulin|mesh-list
110912260|NCT01180634|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110912261|NCT01180634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110912262|NCT01180634|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110912263|NCT01180634|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110912264|NCT01180634|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110912265|NCT01180634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110912266|NCT01180634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110912267|NCT01180634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110912268|NCT01180634|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110358654|NCT05591755|Histamine Antagonists|histamine antagonists|mesh-ancestor
110912269|NCT01180634|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110912271|NCT02268890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110912272|NCT02268968|Lidocaine|lidocaine|mesh-list
110912273|NCT02268968|Anesthetics, Local|anesthetics, local|mesh-ancestor
110912274|NCT02268968|Anesthetics|anesthetics|mesh-ancestor
110912275|NCT02268968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110912276|NCT02268968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110912277|NCT02268968|Sensory System Agents|sensory system agents|mesh-ancestor
110912278|NCT02268968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110912279|NCT02268968|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110358734|NCT05473715|Aflibercept|aflibercept|mesh-list
110912280|NCT02268968|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110912281|NCT02268968|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110912282|NCT02268968|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110912283|NCT02268968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110912284|NCT01359566|Arbaclofen placarbil|arbaclofen placarbil|mesh-list
110912285|NCT01359566|Baclofen|baclofen|mesh-list
110912286|NCT01359566|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110912287|NCT01359566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110912288|NCT01359566|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110912289|NCT01359566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110912290|NCT01359566|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
110912291|NCT01359566|GABA Agonists|gaba agonists|mesh-ancestor
110629783|NCT00857142|Sensory System Agents|sensory system agents|mesh-ancestor
110912292|NCT01359566|GABA Agents|gaba agents|mesh-ancestor
110927111|NCT03659461|Protease Inhibitors|protease inhibitors|mesh-ancestor
110912293|NCT01359566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110912294|NCT01359566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110912295|NCT04885816|Sirolimus|sirolimus|mesh-list
110912296|NCT04885816|Everolimus|everolimus|mesh-list
110912297|NCT04885816|MTOR Inhibitors|mtor inhibitors|mesh-list
110912298|NCT04885816|Temsirolimus|temsirolimus|mesh-list
110912299|NCT04885816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110912300|NCT04885816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110912301|NCT04885816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110912302|NCT04885816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110912303|NCT04885816|Immunologic Factors|immunologic factors|mesh-ancestor
110912304|NCT04885816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110912305|NCT04885816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110358917|NCT04995484|Belzutifan|belzutifan|mesh-list
110912306|NCT04885816|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110912307|NCT04885816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110912308|NCT04885816|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110912309|NCT04885816|Antifungal Agents|antifungal agents|mesh-ancestor
110912310|NCT04865614|Sevoflurane|sevoflurane|mesh-list
110912311|NCT04865614|Etomidate|etomidate|mesh-list
110912312|NCT04865614|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110912313|NCT04865614|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110912314|NCT04865614|Anesthetics, General|anesthetics, general|mesh-ancestor
110912315|NCT04865614|Anesthetics|anesthetics|mesh-ancestor
110912316|NCT04865614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110912317|NCT04865614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110912318|NCT04865614|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110912319|NCT04865614|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110912320|NCT02269046|Simvastatin|simvastatin|mesh-list
110912321|NCT02269046|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110912322|NCT02269046|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110912323|NCT02269046|Antimetabolites|antimetabolites|mesh-ancestor
110912324|NCT02269046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110912325|NCT02269046|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110912326|NCT02269046|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110912327|NCT02269046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110912328|NCT01483742|Ritonavir|ritonavir|mesh-list
110912329|NCT01483742|Ribavirin|ribavirin|mesh-list
110912330|NCT01483742|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110912331|NCT01483742|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110912332|NCT01483742|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110912333|NCT01483742|Protease Inhibitors|protease inhibitors|mesh-ancestor
110912334|NCT01483742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110912335|NCT01483742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110912336|NCT01483742|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110912337|NCT01483742|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110912338|NCT01483742|Antiviral Agents|antiviral agents|mesh-ancestor
110912339|NCT01483742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110912340|NCT01483742|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110912341|NCT01483742|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110912342|NCT01483742|Antimetabolites|antimetabolites|mesh-ancestor
110912343|NCT04691128|Anesthetics|anesthetics|mesh-list
110912345|NCT04691128|Desflurane|desflurane|mesh-list
110912346|NCT04691128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110912347|NCT04691128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110912348|NCT04691128|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110912349|NCT04691128|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110912350|NCT04691128|Anesthetics, General|anesthetics, general|mesh-ancestor
110912351|NCT04691128|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110912352|NCT04207918|Nimotuzumab|nimotuzumab|mesh-list
110912353|NCT04207918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110912354|NCT04207918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110912355|NCT02269202|Midazolam|midazolam|mesh-list
110912356|NCT02269202|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110912357|NCT02269202|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110912358|NCT02269202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110912359|NCT02269202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110912360|NCT02269202|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110912361|NCT02269202|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110912362|NCT02269202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110912363|NCT02269202|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110912364|NCT02269202|Anesthetics, General|anesthetics, general|mesh-ancestor
110629859|NCT00959517|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110912365|NCT02269202|Anesthetics|anesthetics|mesh-ancestor
110912366|NCT02269202|GABA Modulators|gaba modulators|mesh-ancestor
110912367|NCT02269202|GABA Agents|gaba agents|mesh-ancestor
110912368|NCT02269202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110912369|NCT02269202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110912370|NCT03614923|Mometasone Furoate|mometasone furoate|mesh-list
110912371|NCT03614923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110912372|NCT03614923|Dermatologic Agents|dermatologic agents|mesh-ancestor
110912373|NCT03614923|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110912375|NCT01353248|Ledipasvir|ledipasvir|mesh-list
110912376|NCT01353248|Antimetabolites|antimetabolites|mesh-ancestor
110912377|NCT01353248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110912378|NCT01353248|Antiviral Agents|antiviral agents|mesh-ancestor
110359146|NCT04324307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110912379|NCT01353248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110912380|NCT05095636|Apatinib|apatinib|mesh-list
110912381|NCT05095636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110912382|NCT05095636|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110912383|NCT05095636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110912384|NCT05095636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110912385|NCT01343966|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110912386|NCT01343966|Immunologic Factors|immunologic factors|mesh-ancestor
110912387|NCT01343966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110912388|NCT05095480|Red yeast rice|red yeast rice|mesh-list
110912389|NCT05095480|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110912390|NCT05095480|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110912391|NCT05095480|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110912392|NCT05095480|Antimetabolites|antimetabolites|mesh-ancestor
110912393|NCT05095480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110912394|NCT05095480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110912395|NCT05095480|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110912396|NCT02915016|Vaccines|vaccines|mesh-list
110912397|NCT02915016|MF59 oil emulsion|mf59 oil emulsion|mesh-list
110912398|NCT02915016|Immunologic Factors|immunologic factors|mesh-ancestor
110912399|NCT02915016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110912400|NCT02915016|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110912401|NCT01170650|Doxorubicin|doxorubicin|mesh-list
110912402|NCT01170650|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110912403|NCT01170650|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110912404|NCT01170650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110912405|NCT01170650|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110912406|NCT01170650|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110912407|NCT01170650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110912408|NCT01170650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110912409|NCT04533646|Insulin|insulin|mesh-list
110912410|NCT04533646|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110912411|NCT04533646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110912412|NCT01168310|Fluticasone|fluticasone|mesh-list
110912413|NCT01168310|Xhance|xhance|mesh-list
110912414|NCT01168310|Formoterol Fumarate|formoterol fumarate|mesh-list
110359277|NCT04124614|Dopamine Agonists|dopamine agonists|mesh-ancestor
110912415|NCT01168310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110912416|NCT01168310|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110912417|NCT01168310|Autonomic Agents|autonomic agents|mesh-ancestor
110912418|NCT01168310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110912419|NCT01168310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110912420|NCT01168310|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110912421|NCT01168310|Respiratory System Agents|respiratory system agents|mesh-ancestor
110912422|NCT01168310|Dermatologic Agents|dermatologic agents|mesh-ancestor
110912423|NCT01168310|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110912424|NCT01168310|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110912425|NCT01168310|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110912426|NCT01168310|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110912427|NCT01168310|Adrenergic Agents|adrenergic agents|mesh-ancestor
110912428|NCT01168310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110912429|NCT01168310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110912430|NCT01472198|Gemcitabine|gemcitabine|mesh-list
110912431|NCT01472198|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110912432|NCT01472198|Antimetabolites|antimetabolites|mesh-ancestor
110912433|NCT01472198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110912434|NCT01472198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110912435|NCT02269358|Methotrexate|methotrexate|mesh-list
110912436|NCT02269358|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110912437|NCT02269358|Abortifacient Agents|abortifacient agents|mesh-ancestor
110912438|NCT02269358|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110912439|NCT02269358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110912440|NCT02269358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110912441|NCT02269358|Antimetabolites|antimetabolites|mesh-ancestor
110912442|NCT02269358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110912443|NCT02269358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110912444|NCT02269358|Dermatologic Agents|dermatologic agents|mesh-ancestor
110912445|NCT02269358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110912446|NCT02269358|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110912447|NCT02269358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110912448|NCT02269358|Immunologic Factors|immunologic factors|mesh-ancestor
110912449|NCT02269358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110912450|NCT02269358|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110912451|NCT04504240|Famotidine|famotidine|mesh-list
110912452|NCT04504240|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110912453|NCT04504240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110912454|NCT04504240|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110912455|NCT04504240|Histamine Antagonists|histamine antagonists|mesh-ancestor
110912456|NCT04504240|Histamine Agents|histamine agents|mesh-ancestor
110912457|NCT04504240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110912458|NCT04504240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110912459|NCT04504240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110912460|NCT02088060|Cannabidiol|cannabidiol|mesh-list
110912461|NCT02088060|Olanzapine|olanzapine|mesh-list
110912462|NCT02088060|Antiemetics|antiemetics|mesh-ancestor
110912463|NCT02088060|Autonomic Agents|autonomic agents|mesh-ancestor
110912464|NCT02088060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110912465|NCT02088060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110912466|NCT02088060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110912467|NCT02088060|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110912468|NCT02088060|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110912469|NCT02088060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110912470|NCT02088060|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110912471|NCT02088060|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110912472|NCT02088060|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110912473|NCT02088060|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110912474|NCT02088060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110912475|NCT02088060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110912476|NCT02088060|Serotonin Agents|serotonin agents|mesh-ancestor
110912477|NCT02088060|Anticonvulsants|anticonvulsants|mesh-ancestor
110912478|NCT02264522|Dialysis Solutions|dialysis solutions|mesh-list
110912479|NCT02264522|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110912480|NCT02269514|Nicotine|nicotine|mesh-list
110912481|NCT02269514|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110912482|NCT02269514|Autonomic Agents|autonomic agents|mesh-ancestor
110912483|NCT02269514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110912484|NCT02269514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110359606|NCT03190941|Aldesleukin|aldesleukin|mesh-list
110912485|NCT02269514|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110912486|NCT02269514|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110912487|NCT02269514|Cholinergic Agents|cholinergic agents|mesh-ancestor
110912488|NCT02269514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110912489|NCT02269514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110912490|NCT01332812|Dexamethasone|dexamethasone|mesh-list
110912491|NCT01332812|Dexamethasone acetate|dexamethasone acetate|mesh-list
110912492|NCT01332812|BB 1101|bb 1101|mesh-list
110912493|NCT01332812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110912494|NCT01332812|Antiemetics|antiemetics|mesh-ancestor
110912495|NCT01332812|Autonomic Agents|autonomic agents|mesh-ancestor
110912496|NCT01332812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110912497|NCT01332812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110912498|NCT01332812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110912499|NCT01332812|Glucocorticoids|glucocorticoids|mesh-ancestor
110912500|NCT01332812|Hormones|hormones|mesh-ancestor
110912501|NCT01332812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110912502|NCT01332812|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110912503|NCT01332812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110912504|NCT01332812|Protease Inhibitors|protease inhibitors|mesh-ancestor
110912505|NCT01332812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110912506|NCT01332812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110912507|NCT03408652|Zoledronic Acid|zoledronic acid|mesh-list
110912508|NCT03408652|Denosumab|denosumab|mesh-list
110912509|NCT03408652|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110912510|NCT03408652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110912511|NCT01332656|Paclitaxel|paclitaxel|mesh-list
110912512|NCT01332656|Carboplatin|carboplatin|mesh-list
110912513|NCT01332656|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110359696|NCT02485418|Propofol|propofol|mesh-list
110912514|NCT01332656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110912515|NCT01332656|Tubulin Modulators|tubulin modulators|mesh-ancestor
110912516|NCT01332656|Antimitotic Agents|antimitotic agents|mesh-ancestor
110912517|NCT01332656|Mitosis Modulators|mitosis modulators|mesh-ancestor
110912518|NCT01332656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110912519|NCT02084472|Petrolatum|petrolatum|mesh-list
110912520|NCT02084472|Glycerol|glycerol|mesh-list
110912521|NCT02084472|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
110912522|NCT02084472|Protective Agents|protective agents|mesh-ancestor
110912523|NCT02084472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110912524|NCT02084472|Emollients|emollients|mesh-ancestor
110912525|NCT02084472|Dermatologic Agents|dermatologic agents|mesh-ancestor
110912526|NCT02266784|Nicotine|nicotine|mesh-list
110912527|NCT02266784|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110912528|NCT02266784|Autonomic Agents|autonomic agents|mesh-ancestor
110912529|NCT02266784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110912530|NCT02266784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110912531|NCT02266784|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110912532|NCT02266784|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110912533|NCT02266784|Cholinergic Agents|cholinergic agents|mesh-ancestor
110912534|NCT02266784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110912535|NCT02266784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110912536|NCT02090790|Dexamethasone|dexamethasone|mesh-list
110912537|NCT02090790|Dexamethasone acetate|dexamethasone acetate|mesh-list
110912538|NCT02090790|BB 1101|bb 1101|mesh-list
110912539|NCT02090790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110912540|NCT02090790|Antiemetics|antiemetics|mesh-ancestor
110912541|NCT02090790|Autonomic Agents|autonomic agents|mesh-ancestor
110912542|NCT02090790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110912543|NCT02090790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110912544|NCT02090790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110912546|NCT02090790|Hormones|hormones|mesh-ancestor
110912547|NCT02090790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110359814|NCT01496976|Ofatumumab|ofatumumab|mesh-list
110912548|NCT02090790|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110912549|NCT02090790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110912550|NCT02090790|Protease Inhibitors|protease inhibitors|mesh-ancestor
110912551|NCT02090790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110912552|NCT02090790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110912553|NCT02084550|Amino-acid, glucose, and electrolyte solution|amino-acid, glucose, and electrolyte solution|mesh-list
110912554|NCT02084550|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
110912555|NCT02084550|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110912556|NCT01443728|Vitamin D|vitamin d|mesh-list
110912557|NCT01443728|Ergocalciferols|ergocalciferols|mesh-list
110912558|NCT01443728|Cholecalciferol|cholecalciferol|mesh-list
110912559|NCT01443728|Vitamins|vitamins|mesh-list
110912560|NCT01443728|Micronutrients|micronutrients|mesh-ancestor
110912561|NCT01443728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110912562|NCT01443728|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110912563|NCT01443728|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110912564|NCT01324466|5-((2-(6-Amino-9H-purin-9-yl) ethyl) amino)-1-pentanol|5-((2-(6-amino-9h-purin-9-yl) ethyl) amino)-1-pentanol|mesh-list
110912565|NCT01324466|Adenylyl Cyclase Inhibitors|adenylyl cyclase inhibitors|mesh-ancestor
110912566|NCT01324466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110912567|NCT01324466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110912568|NCT01312454|Travoprost|travoprost|mesh-list
110912569|NCT01312454|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110912570|NCT01312454|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110912571|NCT02084784|Methylene Blue|methylene blue|mesh-list
110912572|NCT02084784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110912573|NCT02084784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110912574|NCT02091180|Mannitol|mannitol|mesh-list
110359916|NCT01239394|Ofatumumab|ofatumumab|mesh-list
110912575|NCT02091180|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110912576|NCT02091180|Diuretics|diuretics|mesh-ancestor
110912577|NCT02091180|Natriuretic Agents|natriuretic agents|mesh-ancestor
110912578|NCT02091180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110912579|NCT02269748|Analgesics|analgesics|mesh-list
110912580|NCT02269748|Sensory System Agents|sensory system agents|mesh-ancestor
110912581|NCT02269748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110912582|NCT02269748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110912583|NCT02269904|Fluorouracil|fluorouracil|mesh-list
110912584|NCT02269904|Antimetabolites|antimetabolites|mesh-ancestor
110359981|NCT00544596|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
110912585|NCT02269904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110912586|NCT02269904|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110912587|NCT02269904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110912588|NCT02269904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110912589|NCT02269904|Immunologic Factors|immunologic factors|mesh-ancestor
110912590|NCT02269904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110912591|NCT03557112|Nimotuzumab|nimotuzumab|mesh-list
110912592|NCT03557112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110912593|NCT03557112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110912594|NCT01300208|CC-11050|cc-11050|mesh-list
110912595|NCT01300208|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
110912596|NCT01300208|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110912597|NCT01300208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110226528|NCT05460533|Tisagenlecleucel|tisagenlecleucel|mesh-list
110261191|NCT00147875|Prednisone|prednisone|mesh-list
110912598|NCT01300208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110912600|NCT02085018|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110912601|NCT02085018|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110912602|NCT02085018|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110912603|NCT02085018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110912604|NCT02085018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110912605|NCT02091336|Metformin|metformin|mesh-list
110912606|NCT02091336|Glyburide|glyburide|mesh-list
110912607|NCT02091336|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110912608|NCT02091336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110912609|NCT01442090|Everolimus|everolimus|mesh-list
110912610|NCT01442090|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110912611|NCT01442090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110912612|NCT01442090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110912613|NCT01442090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110912614|NCT01442090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110912615|NCT01442090|Immunologic Factors|immunologic factors|mesh-ancestor
110912616|NCT01442090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110912617|NCT01442090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110912618|NCT04475042|Dapagliflozin|dapagliflozin|mesh-list
110912619|NCT04475042|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110360054|NCT01237327|Megestrol|megestrol|mesh-list
110912620|NCT04475042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110912621|NCT04475042|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110912622|NCT04475042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110912623|NCT02088450|Nitrendipine|nitrendipine|mesh-list
110912624|NCT02088450|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110912625|NCT02088450|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110912626|NCT02088450|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110912627|NCT02088450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110360084|NCT04647695|Interferons|interferons|mesh-list
110912628|NCT02088450|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110912629|NCT02088450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110912630|NCT02088450|Vasodilator Agents|vasodilator agents|mesh-ancestor
110912631|NCT03688828|Amoxicillin|amoxicillin|mesh-list
110912632|NCT03688828|Clarithromycin|clarithromycin|mesh-list
110912633|NCT03688828|Potassium Citrate|potassium citrate|mesh-list
110912634|NCT03688828|Esomeprazole|esomeprazole|mesh-list
110912635|NCT03688828|Bismuth|bismuth|mesh-list
110912636|NCT03688828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110912637|NCT03688828|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110912638|NCT03688828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110912639|NCT03688828|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110912640|NCT03688828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110912641|NCT03688828|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110912642|NCT03688828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110912643|NCT03688828|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110912644|NCT03688828|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110360216|NCT00558623|Antacids|antacids|mesh-ancestor
110912645|NCT03688828|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110912646|NCT03688828|Antacids|antacids|mesh-ancestor
110912647|NCT03688828|Diuretics|diuretics|mesh-ancestor
110912648|NCT03688828|Natriuretic Agents|natriuretic agents|mesh-ancestor
110912649|NCT03688828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110912650|NCT03688828|Expectorants|expectorants|mesh-ancestor
110912651|NCT03688828|Respiratory System Agents|respiratory system agents|mesh-ancestor
110912652|NCT02091492|Teriparatide|teriparatide|mesh-list
110912653|NCT02091492|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110912654|NCT02091492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110912655|NCT02091492|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110912656|NCT02266940|DS-1971a|ds-1971a|mesh-list
110912657|NCT02266940|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110360287|NCT02905734|Nicotine|nicotine|mesh-list
110912658|NCT02266940|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110912659|NCT02266940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110912660|NCT02266940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110912661|NCT03981952|Vaccines|vaccines|mesh-list
110912662|NCT03981952|Immunologic Factors|immunologic factors|mesh-ancestor
110912663|NCT03981952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110912665|NCT04475120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110912666|NCT02088528|Mitomycins|mitomycins|mesh-list
110912667|NCT02088528|Mitomycin|mitomycin|mesh-list
110912668|NCT02088528|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110912669|NCT02088528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110912670|NCT02088528|Alkylating Agents|alkylating agents|mesh-ancestor
110912671|NCT02088528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110912672|NCT02088528|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110912673|NCT02088528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110912674|NCT03634150|Doxorubicin|doxorubicin|mesh-list
110912675|NCT03634150|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110912676|NCT03634150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110912677|NCT03634150|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110360416|NCT04642001|Cariostatic Agents|cariostatic agents|mesh-ancestor
110912678|NCT03634150|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110912679|NCT03634150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110912680|NCT03634150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110912681|NCT02092038|Temozolomide|temozolomide|mesh-list
110912682|NCT02092038|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110912683|NCT02092038|Alkylating Agents|alkylating agents|mesh-ancestor
110912684|NCT02092038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110912685|NCT02092038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110912686|NCT02272166|Propofol|propofol|mesh-list
110912687|NCT02272166|Sevoflurane|sevoflurane|mesh-list
110912688|NCT02272166|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110912689|NCT02272166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110912690|NCT02272166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110912691|NCT02272166|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110912692|NCT02272166|Anesthetics, General|anesthetics, general|mesh-ancestor
110912693|NCT02272166|Anesthetics|anesthetics|mesh-ancestor
110360467|NCT04640324|Silybin|silybin|mesh-list
110912694|NCT02272166|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110912695|NCT02272166|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110912696|NCT02088684|Fulvestrant|fulvestrant|mesh-list
110912697|NCT02088684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110912698|NCT02088684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110912699|NCT02088684|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110912700|NCT02088684|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110912701|NCT02088684|Hormone Antagonists|hormone antagonists|mesh-ancestor
110912702|NCT02088684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110912703|NCT02088684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110912704|NCT01137968|Bevacizumab|bevacizumab|mesh-list
110912705|NCT01137968|Imetelstat|imetelstat|mesh-list
110912706|NCT01137968|Motesanib diphosphate|motesanib diphosphate|mesh-list
110912707|NCT01137968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110912708|NCT01137968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110912709|NCT01137968|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110912710|NCT01137968|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110912711|NCT01137968|Growth Substances|growth substances|mesh-ancestor
110912712|NCT01137968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110912713|NCT01137968|Growth Inhibitors|growth inhibitors|mesh-ancestor
110912714|NCT01137968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110912715|NCT01137968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110912716|NCT01137968|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110912717|NCT01133990|Leucovorin|leucovorin|mesh-list
110912718|NCT01133990|Bevacizumab|bevacizumab|mesh-list
110912719|NCT01133990|Fluorouracil|fluorouracil|mesh-list
110912720|NCT01133990|Irinotecan|irinotecan|mesh-list
110912721|NCT01133990|Calcium|calcium|mesh-list
110912722|NCT01133990|Levoleucovorin|levoleucovorin|mesh-list
110912723|NCT01133990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110912724|NCT01133990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110912725|NCT01133990|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110912726|NCT01133990|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110927193|NCT02159196|Albuterol|albuterol|mesh-list
110912727|NCT01133990|Growth Substances|growth substances|mesh-ancestor
110912728|NCT01133990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110912729|NCT01133990|Growth Inhibitors|growth inhibitors|mesh-ancestor
110912730|NCT01133990|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110912731|NCT01133990|Antimetabolites|antimetabolites|mesh-ancestor
110912732|NCT01133990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110912733|NCT01133990|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110912734|NCT01133990|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110912735|NCT01133990|Immunologic Factors|immunologic factors|mesh-ancestor
110912736|NCT01133990|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110360723|NCT00553683|Alkylating Agents|alkylating agents|mesh-ancestor
110912737|NCT01133990|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110912738|NCT01133990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110912739|NCT01133990|Antidotes|antidotes|mesh-ancestor
110912740|NCT01133990|Protective Agents|protective agents|mesh-ancestor
110912741|NCT01133990|Vitamin B Complex|vitamin b complex|mesh-ancestor
110912743|NCT01133990|Micronutrients|micronutrients|mesh-ancestor
110912744|NCT02249910|Metformin|metformin|mesh-list
110912745|NCT02249910|Digoxin|digoxin|mesh-list
110912746|NCT02249910|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110912747|NCT02249910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110912748|NCT02249910|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110912749|NCT02249910|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110912750|NCT02249910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110912751|NCT02249910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110912752|NCT02249910|Protective Agents|protective agents|mesh-ancestor
110912753|NCT02936596|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
110912754|NCT02936596|Immunosuppressive Agents|immunosuppressive agents|mesh-list
110912755|NCT02936596|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
110912756|NCT02936596|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110912757|NCT02936596|Immunologic Factors|immunologic factors|mesh-ancestor
110912758|NCT02936596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110912759|NCT02398396|Lactitol|lactitol|mesh-list
110912760|NCT02398396|Cathartics|cathartics|mesh-ancestor
110912761|NCT02398396|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110912762|NCT05628584|Metformin|metformin|mesh-list
110912763|NCT05628584|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110912764|NCT05628584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110912765|NCT02088918|Metformin|metformin|mesh-list
110912766|NCT02088918|Nateglinide|nateglinide|mesh-list
110360845|NCT04637360|Calcitriol|calcitriol|mesh-list
110912767|NCT02088918|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110912768|NCT02088918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110912769|NCT02419378|Alemtuzumab|alemtuzumab|mesh-list
110912770|NCT02419378|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110912771|NCT02419378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110912772|NCT02092428|Adenosine|adenosine|mesh-list
110912773|NCT02092428|Regadenoson|regadenoson|mesh-list
110912774|NCT02092428|Analgesics|analgesics|mesh-ancestor
110912775|NCT02092428|Sensory System Agents|sensory system agents|mesh-ancestor
110912776|NCT02092428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110912777|NCT02092428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110912778|NCT02092428|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110912779|NCT02092428|Vasodilator Agents|vasodilator agents|mesh-ancestor
110912780|NCT02092428|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
110912781|NCT02092428|Purinergic Agonists|purinergic agonists|mesh-ancestor
110912782|NCT02092428|Purinergic Agents|purinergic agents|mesh-ancestor
110360909|NCT02895321|Listerine|listerine|mesh-list
110912783|NCT02092428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110912784|NCT02092428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110912785|NCT02092428|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
110912786|NCT02783404|Amoxicillin|amoxicillin|mesh-list
110912787|NCT02783404|Clavulanic Acid|clavulanic acid|mesh-list
110912788|NCT02783404|Clavulanic Acids|clavulanic acids|mesh-list
110912789|NCT02783404|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110912790|NCT02783404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110912791|NCT02783404|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110912792|NCT02783404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110927205|NCT02159196|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110912793|NCT02783404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110912794|NCT01097018|Capecitabine|capecitabine|mesh-list
110912795|NCT01097018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110912796|NCT01097018|Antimetabolites|antimetabolites|mesh-ancestor
110912797|NCT01097018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110912798|NCT01097018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110912799|NCT01096862|Peficitinib|peficitinib|mesh-list
110912800|NCT01096862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110912801|NCT01096862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110912802|NCT01096862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110912803|NCT01096862|Immunologic Factors|immunologic factors|mesh-ancestor
110912804|NCT01096862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110226545|NCT05424445|Misoprostol|misoprostol|mesh-list
110261399|NCT02929576|Paclitaxel|paclitaxel|mesh-list
110912806|NCT02092506|Metronidazole|metronidazole|mesh-list
110912807|NCT02092506|Clarithromycin|clarithromycin|mesh-list
110912808|NCT02092506|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
110912809|NCT02092506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110912810|NCT02092506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110912811|NCT02092506|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110912812|NCT02092506|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110912813|NCT02092506|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110912814|NCT02092506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110912815|NCT02092506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110912816|NCT02092506|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110912817|NCT02092506|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110912818|NCT01092104|Cenicriviroc|cenicriviroc|mesh-list
110912819|NCT01092104|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
110912820|NCT01092104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110912821|NCT01092104|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110912822|NCT01092104|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110912823|NCT01092104|Antiviral Agents|antiviral agents|mesh-ancestor
110912824|NCT01092104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110912825|NCT01128530|Linezolid|linezolid|mesh-list
110912826|NCT01128530|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110912827|NCT01128530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110912828|NCT01128530|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110912829|NCT01128530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110912830|NCT01128530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110912831|NCT02086032|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110912832|NCT02086032|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110912833|NCT02086032|Estradiol|estradiol|mesh-list
110912834|NCT02086032|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110912835|NCT02086032|Estrogens|estrogens|mesh-list
110912836|NCT02086032|Progesterone|progesterone|mesh-list
110912837|NCT02086032|Dydrogesterone|dydrogesterone|mesh-list
110912838|NCT02086032|Hormones|hormones|mesh-ancestor
110912839|NCT02086032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110912840|NCT02086032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110912841|NCT02086032|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110912842|NCT02086032|Contraceptive Agents|contraceptive agents|mesh-ancestor
110912843|NCT02086032|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110912844|NCT02086032|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110912845|NCT02086032|Progestins|progestins|mesh-ancestor
110912846|NCT02092818|Riociguat|riociguat|mesh-list
110912847|NCT02092818|Enzyme Activators|enzyme activators|mesh-ancestor
110912848|NCT02092818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110912849|NCT02086188|Mirabegron|mirabegron|mesh-list
110912850|NCT02086188|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
110912851|NCT02086188|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110912852|NCT02086188|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110912853|NCT02086188|Adrenergic Agents|adrenergic agents|mesh-ancestor
110912854|NCT02086188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110912855|NCT02086188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110912856|NCT02086188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110912857|NCT02086188|Urological Agents|urological agents|mesh-ancestor
110912858|NCT02267408|Warfarin|warfarin|mesh-list
110912859|NCT02267408|Anticoagulants|anticoagulants|mesh-ancestor
110912860|NCT02092896|Liraglutide|liraglutide|mesh-list
110912861|NCT02092896|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110912862|NCT02092896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110912863|NCT02092896|Incretins|incretins|mesh-ancestor
110912864|NCT02092896|Hormones|hormones|mesh-ancestor
110912865|NCT02092896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110912866|NCT02092974|Citalopram|citalopram|mesh-list
110912867|NCT02092974|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110912868|NCT02092974|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110912869|NCT02092974|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110912870|NCT02092974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110912871|NCT02092974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110361426|NCT00447239|Insulin|insulin|mesh-list
110912872|NCT02092974|Serotonin Agents|serotonin agents|mesh-ancestor
110912873|NCT02092974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110912874|NCT02092974|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110912875|NCT02092974|Antidepressive Agents|antidepressive agents|mesh-ancestor
110912876|NCT02092974|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110912877|NCT05097508|Bromides|bromides|mesh-list
110912878|NCT05097508|Rocuronium|rocuronium|mesh-list
110912879|NCT05097508|Atracurium|atracurium|mesh-list
110912880|NCT05097508|Anticonvulsants|anticonvulsants|mesh-ancestor
110912881|NCT05097508|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110361497|NCT00447863|Contraceptive Agents|contraceptive agents|mesh-ancestor
110912882|NCT05097508|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110912883|NCT05097508|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110912884|NCT05097508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110912885|NCT05097508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110912886|NCT05097508|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
110912887|NCT05097508|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110912888|NCT05097508|Cholinergic Agents|cholinergic agents|mesh-ancestor
110912889|NCT05097508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110912890|NCT05097508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110912891|NCT02089308|Nicotine|nicotine|mesh-list
110912892|NCT02089308|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110912893|NCT02089308|Autonomic Agents|autonomic agents|mesh-ancestor
110912894|NCT02089308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110912895|NCT02089308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110912896|NCT02089308|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110912897|NCT02089308|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110912898|NCT02089308|Cholinergic Agents|cholinergic agents|mesh-ancestor
110912899|NCT02089308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110912900|NCT02089308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110912901|NCT00153920|Bortezomib|bortezomib|mesh-list
110912902|NCT00153920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110912903|NCT05095714|Liver Extracts|liver extracts|mesh-list
110912904|NCT05095714|Hematinics|hematinics|mesh-ancestor
110912905|NCT02660242|Glucagon|glucagon|mesh-list
110912906|NCT02660242|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
110912907|NCT02660242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110912908|NCT02660242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110912909|NCT02660242|Hormones|hormones|mesh-ancestor
110912910|NCT02660242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110912911|NCT02660242|Incretins|incretins|mesh-ancestor
110912912|NCT02089386|Tamoxifen|tamoxifen|mesh-list
110912913|NCT02089386|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110912914|NCT02089386|Hormone Antagonists|hormone antagonists|mesh-ancestor
110361686|NCT05368441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110912915|NCT02089386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110912916|NCT02089386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110912917|NCT02089386|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110912918|NCT02089386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110912919|NCT02089386|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110912920|NCT02089386|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110912921|NCT02089386|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110912922|NCT03557580|Isosorbide|isosorbide|mesh-list
110912923|NCT03557580|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
110912924|NCT03557580|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
110912925|NCT03557580|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110912926|NCT03557580|Diuretics|diuretics|mesh-ancestor
110912927|NCT03557580|Natriuretic Agents|natriuretic agents|mesh-ancestor
110912928|NCT03557580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110912929|NCT03557580|Vasodilator Agents|vasodilator agents|mesh-ancestor
110912930|NCT03557580|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
110912931|NCT03557580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110912932|NCT02089542|Methylene Blue|methylene blue|mesh-list
110912933|NCT02089542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110361819|NCT04318444|Antimalarials|antimalarials|mesh-ancestor
110912934|NCT02089542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110912935|NCT01295060|Octreotide|octreotide|mesh-list
110912936|NCT01295060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110912937|NCT01295060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110912938|NCT01295060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110912939|NCT02086656|Bevacizumab|bevacizumab|mesh-list
110912940|NCT02086656|Capecitabine|capecitabine|mesh-list
110912941|NCT02086656|Oxaliplatin|oxaliplatin|mesh-list
110912942|NCT02086656|Irinotecan|irinotecan|mesh-list
110912943|NCT02086656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110912944|NCT02086656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110912945|NCT02086656|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110912946|NCT02086656|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110226552|NCT05424445|Oxytocics|oxytocics|mesh-ancestor
110912947|NCT02086656|Growth Substances|growth substances|mesh-ancestor
110912948|NCT02086656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110912949|NCT02086656|Growth Inhibitors|growth inhibitors|mesh-ancestor
110912950|NCT02086656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110912951|NCT02086656|Antimetabolites|antimetabolites|mesh-ancestor
110912952|NCT02086656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110912953|NCT02086656|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110912954|NCT02086656|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110912955|NCT02086656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110912956|NCT01294202|Imatinib Mesylate|imatinib mesylate|mesh-list
110912957|NCT01294202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110912958|NCT01294202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110912959|NCT01294202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110912960|NCT01294202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110912961|NCT01071902|Moxifloxacin|moxifloxacin|mesh-list
110912962|NCT01071902|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110912963|NCT01071902|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110912964|NCT01071902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110912965|NCT01071902|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110912966|NCT01071902|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110912967|NCT01071902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110630461|NCT04091009|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110912968|NCT01071902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110912969|NCT01071902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110912970|NCT01126970|Orlistat|orlistat|mesh-list
110361950|NCT00450164|Sympatholytics|sympatholytics|mesh-ancestor
110912971|NCT01126970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110912972|NCT01126970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110912973|NCT01126970|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110912974|NCT01126970|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110912975|NCT03557424|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
110912976|NCT03557424|Cathartics|cathartics|mesh-ancestor
110912977|NCT03557424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110912978|NCT05057572|Carvedilol|carvedilol|mesh-list
110912979|NCT05057572|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110912980|NCT05057572|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110912981|NCT05057572|Adrenergic Agents|adrenergic agents|mesh-ancestor
110912982|NCT05057572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110912983|NCT05057572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110912984|NCT05057572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110912985|NCT05057572|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110912986|NCT05057572|Antioxidants|antioxidants|mesh-ancestor
110912987|NCT05057572|Protective Agents|protective agents|mesh-ancestor
110912988|NCT05057572|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110927230|NCT02762370|Hormones|hormones|mesh-ancestor
110912989|NCT05057572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110912990|NCT05057572|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110912991|NCT05057572|Vasodilator Agents|vasodilator agents|mesh-ancestor
110912992|NCT05057572|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110912993|NCT05057572|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110912995|NCT02093598|Temsirolimus|temsirolimus|mesh-list
110912996|NCT02093598|MTOR Inhibitors|mtor inhibitors|mesh-list
110912997|NCT02093598|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110912998|NCT02093598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110912999|NCT02093598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110913000|NCT02093598|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110913001|NCT02093598|Immunologic Factors|immunologic factors|mesh-ancestor
110913002|NCT02093598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110913003|NCT02093598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110913004|NCT02093598|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110913005|NCT02093598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110913006|NCT02093598|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110913007|NCT02093598|Antifungal Agents|antifungal agents|mesh-ancestor
110913008|NCT01124552|Botulinum Toxins|botulinum toxins|mesh-list
110913009|NCT01124552|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110913010|NCT01124552|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110913011|NCT01124552|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110913012|NCT01124552|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110913013|NCT01124552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110913014|NCT01124552|Cholinergic Agents|cholinergic agents|mesh-ancestor
110913015|NCT01124552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110913016|NCT01124552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110913017|NCT01124552|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110913018|NCT01124552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110913019|NCT02087202|Magnesium Sulfate|magnesium sulfate|mesh-list
110913020|NCT02087202|Ketamine|ketamine|mesh-list
110913021|NCT02087202|Analgesics|analgesics|mesh-ancestor
110913022|NCT02087202|Sensory System Agents|sensory system agents|mesh-ancestor
110913023|NCT02087202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110913024|NCT02087202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110913025|NCT02087202|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110913026|NCT02087202|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110913027|NCT02087202|Anesthetics, General|anesthetics, general|mesh-ancestor
110913028|NCT02087202|Anesthetics|anesthetics|mesh-ancestor
110913029|NCT02087202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110913030|NCT02087202|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110913031|NCT02087202|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110913032|NCT02087202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110362172|NCT02929901|Caffeine|caffeine|mesh-list
110913033|NCT02087202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110913034|NCT02087202|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110913035|NCT02087202|Anticonvulsants|anticonvulsants|mesh-ancestor
110913036|NCT02087202|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110913037|NCT02087202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110913038|NCT02087202|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110913039|NCT02087202|Tocolytic Agents|tocolytic agents|mesh-ancestor
110913040|NCT02087202|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110913041|NCT01283594|Levodopa|levodopa|mesh-list
110913042|NCT01283594|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110913043|NCT01283594|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110913044|NCT01283594|Dopamine Agents|dopamine agents|mesh-ancestor
110913045|NCT01283594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110913046|NCT01283594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110913047|NCT01283594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110913048|NCT01281254|Trebananib|trebananib|mesh-list
110913049|NCT01281254|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110913050|NCT01281254|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110913051|NCT01281254|Growth Substances|growth substances|mesh-ancestor
110913052|NCT01281254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110913053|NCT01281254|Growth Inhibitors|growth inhibitors|mesh-ancestor
110913054|NCT01281254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110913055|NCT05104138|Eplerenone|eplerenone|mesh-list
110913056|NCT05104138|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110913057|NCT05104138|Hormone Antagonists|hormone antagonists|mesh-ancestor
110913058|NCT05104138|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110913059|NCT05104138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110913060|NCT05104138|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110913061|NCT05104138|Diuretics|diuretics|mesh-ancestor
110913062|NCT05104138|Natriuretic Agents|natriuretic agents|mesh-ancestor
110913063|NCT05104138|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110913064|NCT03072043|Azacitidine|azacitidine|mesh-list
110913065|NCT03072043|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110913066|NCT03072043|Antimetabolites|antimetabolites|mesh-ancestor
110913067|NCT03072043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110913068|NCT03072043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110913069|NCT03072043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110913070|NCT05626010|Acetaminophen|acetaminophen|mesh-list
110913071|NCT05626010|Ibuprofen|ibuprofen|mesh-list
110913072|NCT05626010|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110913073|NCT05626010|Analgesics|analgesics|mesh-ancestor
110913074|NCT05626010|Sensory System Agents|sensory system agents|mesh-ancestor
110913075|NCT05626010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110913076|NCT05626010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110913077|NCT05626010|Antipyretics|antipyretics|mesh-ancestor
110913078|NCT05626010|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110913079|NCT05626010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110913080|NCT05626010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110913081|NCT05626010|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110913082|NCT05626010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110913083|NCT05626010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110913084|NCT02089854|Toremifene|toremifene|mesh-list
110913085|NCT02089854|Anastrozole|anastrozole|mesh-list
110913086|NCT02089854|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110913087|NCT02089854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110913088|NCT02089854|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110913089|NCT02089854|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110913090|NCT02089854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110913091|NCT02089854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110913092|NCT02089854|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110913093|NCT02089854|Hormone Antagonists|hormone antagonists|mesh-ancestor
110913094|NCT02089854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110913095|NCT02089854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110913096|NCT02089854|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110913097|NCT02089854|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110913098|NCT02089854|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110913099|NCT05624840|Ritonavir|ritonavir|mesh-list
110913100|NCT05624840|Nirmatrelvir|nirmatrelvir|mesh-list
110913101|NCT05624840|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
110913102|NCT05624840|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110913103|NCT05624840|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110913104|NCT05624840|Protease Inhibitors|protease inhibitors|mesh-ancestor
110913105|NCT05624840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110913106|NCT05624840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110913107|NCT05624840|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110913108|NCT05624840|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110913109|NCT05624840|Antiviral Agents|antiviral agents|mesh-ancestor
110913110|NCT05624840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110362619|NCT01709214|Narcotics|narcotics|mesh-ancestor
110913111|NCT05624840|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110913112|NCT05624840|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110630611|NCT00262951|Interferon-alpha|interferon-alpha|mesh-list
110913113|NCT02093910|Dexamethasone|dexamethasone|mesh-list
110913114|NCT02093910|Bortezomib|bortezomib|mesh-list
110913115|NCT02093910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110913116|NCT02093910|Antiemetics|antiemetics|mesh-ancestor
110913117|NCT02093910|Autonomic Agents|autonomic agents|mesh-ancestor
110913118|NCT02093910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110913119|NCT02093910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110913120|NCT02093910|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110913121|NCT02093910|Glucocorticoids|glucocorticoids|mesh-ancestor
110913122|NCT02093910|Hormones|hormones|mesh-ancestor
110913123|NCT02093910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110362693|NCT04688723|Antithrombins|antithrombins|mesh-ancestor
110913124|NCT02093910|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110913125|NCT02093910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110913126|NCT04437160|Cyclophosphamide|cyclophosphamide|mesh-list
110913127|NCT04437160|Epirubicin|epirubicin|mesh-list
110913128|NCT04437160|Pirarubicin|pirarubicin|mesh-list
110913129|NCT04437160|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110913130|NCT04437160|Immunologic Factors|immunologic factors|mesh-ancestor
110913131|NCT04437160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110913132|NCT04437160|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110913133|NCT04437160|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110913134|NCT04437160|Alkylating Agents|alkylating agents|mesh-ancestor
110913135|NCT04437160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110913136|NCT04437160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110362752|NCT01666977|Growth Substances|growth substances|mesh-ancestor
110913137|NCT04437160|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110913138|NCT04437160|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110913139|NCT04437160|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110913140|NCT04437160|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110913141|NCT04437160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110913142|NCT02089932|Dexmedetomidine|dexmedetomidine|mesh-list
110913143|NCT02089932|Bupivacaine|bupivacaine|mesh-list
110913144|NCT02089932|Anesthetics, Local|anesthetics, local|mesh-ancestor
110913145|NCT02089932|Anesthetics|anesthetics|mesh-ancestor
110913146|NCT02089932|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110913147|NCT02089932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110913148|NCT02089932|Sensory System Agents|sensory system agents|mesh-ancestor
110913149|NCT02089932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110913150|NCT02089932|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110913151|NCT02089932|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110913152|NCT02089932|Analgesics|analgesics|mesh-ancestor
110913153|NCT02089932|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110913154|NCT02089932|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110913155|NCT02089932|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110913156|NCT02089932|Adrenergic Agents|adrenergic agents|mesh-ancestor
110913157|NCT02089932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110913158|NCT02089932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110913159|NCT01037036|Latanoprost|latanoprost|mesh-list
110913160|NCT01037036|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110913161|NCT01037036|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110913162|NCT05204641|Rifaximin|rifaximin|mesh-list
110913163|NCT05204641|Levodopa|levodopa|mesh-list
110913164|NCT05204641|Benserazide|benserazide|mesh-list
110913165|NCT05204641|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110913166|NCT05204641|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110913167|NCT05204641|Dopamine Agents|dopamine agents|mesh-ancestor
110913168|NCT05204641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110913169|NCT05204641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110913170|NCT05204641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110913171|NCT05204641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110913172|NCT05204641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110913173|NCT05204641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110362947|NCT02063685|Glucocorticoids|glucocorticoids|mesh-ancestor
110913174|NCT05204641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110913175|NCT03069313|Vitamin B 12|vitamin b 12|mesh-list
110913176|NCT03069313|Hydroxocobalamin|hydroxocobalamin|mesh-list
110913177|NCT03069313|Vitamins|vitamins|mesh-ancestor
110913178|NCT03069313|Micronutrients|micronutrients|mesh-ancestor
110913179|NCT03069313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110913180|NCT03069313|Vitamin B Complex|vitamin b complex|mesh-ancestor
110913181|NCT03069313|Hematinics|hematinics|mesh-ancestor
110913182|NCT02094066|Tranexamic Acid|tranexamic acid|mesh-list
110913183|NCT02094066|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110913184|NCT02094066|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110913185|NCT02094066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110913186|NCT02094066|Hemostatics|hemostatics|mesh-ancestor
110913187|NCT02094066|Coagulants|coagulants|mesh-ancestor
110913188|NCT01033292|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
110630692|NCT05147493|Antiemetics|antiemetics|mesh-ancestor
110913189|NCT01033292|Iniparib|iniparib|mesh-list
110913190|NCT01033292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110913191|NCT01033292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110913192|NCT01033292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110913193|NCT03068767|Vitamin D|vitamin d|mesh-list
110913194|NCT03068767|Vitamins|vitamins|mesh-ancestor
110913195|NCT03068767|Micronutrients|micronutrients|mesh-ancestor
110913196|NCT03068767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110913197|NCT03068767|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110913198|NCT02267720|Salicylic Acid|salicylic acid|mesh-list
110913199|NCT02267720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110913200|NCT02267720|Antifungal Agents|antifungal agents|mesh-ancestor
110913201|NCT02267720|Keratolytic Agents|keratolytic agents|mesh-ancestor
110913202|NCT02267720|Dermatologic Agents|dermatologic agents|mesh-ancestor
110913203|NCT05204329|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110913204|NCT05204329|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110913205|NCT01110902|Agomelatine|agomelatine|mesh-list
110913206|NCT01110902|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110913207|NCT01110902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110913208|NCT01110902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110913209|NCT05204173|Paclitaxel|paclitaxel|mesh-list
110363059|NCT02912702|Hormones|hormones|mesh-ancestor
110913210|NCT05204173|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110913211|NCT05204173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110913212|NCT05204173|Tubulin Modulators|tubulin modulators|mesh-ancestor
110913213|NCT05204173|Antimitotic Agents|antimitotic agents|mesh-ancestor
110913214|NCT05204173|Mitosis Modulators|mitosis modulators|mesh-ancestor
110913215|NCT05204173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110913216|NCT01025648|Epinephrine|epinephrine|mesh-list
110913217|NCT01025648|Racepinephrine|racepinephrine|mesh-list
110913218|NCT01025648|Epinephryl borate|epinephryl borate|mesh-list
110913219|NCT01025648|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110363121|NCT04676139|Fluoxetine|fluoxetine|mesh-list
110913220|NCT01025648|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110913221|NCT01025648|Adrenergic Agents|adrenergic agents|mesh-ancestor
110913222|NCT01025648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110927273|NCT03091894|Propofol|propofol|mesh-list
110913223|NCT01025648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110913224|NCT01025648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110913225|NCT01025648|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110913226|NCT01025648|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110913227|NCT01025648|Autonomic Agents|autonomic agents|mesh-ancestor
110913228|NCT01025648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110913229|NCT01025648|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110913230|NCT01025648|Respiratory System Agents|respiratory system agents|mesh-ancestor
110913231|NCT01025648|Mydriatics|mydriatics|mesh-ancestor
110913232|NCT01025648|Sympathomimetics|sympathomimetics|mesh-ancestor
110913233|NCT01025648|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110913234|NCT01110746|Insulin|insulin|mesh-list
110913235|NCT01110746|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110913236|NCT01110746|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110913237|NCT01110746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110913238|NCT05622968|Dinoprostone|dinoprostone|mesh-list
110913239|NCT05622968|Oxytocics|oxytocics|mesh-ancestor
110913240|NCT05622968|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110913241|NCT05622968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110913242|NCT02268032|Androgens|androgens|mesh-list
110913243|NCT02268032|Hormones|hormones|mesh-ancestor
110913244|NCT02268032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110913245|NCT02268032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110913246|NCT03019965|Meropenem|meropenem|mesh-list
110913247|NCT03019965|Tazobactam|tazobactam|mesh-list
110913248|NCT03019965|Piperacillin|piperacillin|mesh-list
110913249|NCT03019965|Imipenem|imipenem|mesh-list
110913250|NCT03019965|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
110913251|NCT03019965|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110913252|NCT03019965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110913253|NCT03019965|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110913254|NCT03019965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110913255|NCT03019965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110913256|NCT01468831|Minocycline|minocycline|mesh-list
110913257|NCT01468831|Bevacizumab|bevacizumab|mesh-list
110363253|NCT01217437|Irinotecan|irinotecan|mesh-list
110913258|NCT01468831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110913259|NCT01468831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110913260|NCT01468831|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110913261|NCT01468831|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110630764|NCT00867672|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110913262|NCT01468831|Growth Substances|growth substances|mesh-ancestor
110913263|NCT01468831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110913264|NCT01468831|Growth Inhibitors|growth inhibitors|mesh-ancestor
110913265|NCT01468831|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110913266|NCT01468831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110913267|NCT05627414|Paclitaxel|paclitaxel|mesh-list
110913268|NCT05627414|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110913269|NCT05627414|Tegafur|tegafur|mesh-list
110913270|NCT05627414|Disitamab vedotin|disitamab vedotin|mesh-list
110913271|NCT05627414|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110927296|NCT02761980|Ibuprofen|ibuprofen|mesh-list
110913272|NCT05627414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110913273|NCT05627414|Tubulin Modulators|tubulin modulators|mesh-ancestor
110913274|NCT05627414|Antimitotic Agents|antimitotic agents|mesh-ancestor
110913275|NCT05627414|Mitosis Modulators|mitosis modulators|mesh-ancestor
110913276|NCT05627414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110913277|NCT05627414|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110913279|NCT05627414|Immunoconjugates|immunoconjugates|mesh-ancestor
110913280|NCT05627414|Immunologic Factors|immunologic factors|mesh-ancestor
110913281|NCT05627414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110913282|NCT05617508|Niacinamide|niacinamide|mesh-list
110913284|NCT05617508|Nicotinic Acids|nicotinic acids|mesh-list
110913285|NCT05617508|Vitamin B Complex|vitamin b complex|mesh-ancestor
110913286|NCT05617508|Vitamins|vitamins|mesh-ancestor
110913287|NCT05617508|Micronutrients|micronutrients|mesh-ancestor
110913288|NCT05617508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110913289|NCT05617508|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110913290|NCT05617508|Antimetabolites|antimetabolites|mesh-ancestor
110913291|NCT05617508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110913292|NCT05617508|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110913293|NCT05617508|Vasodilator Agents|vasodilator agents|mesh-ancestor
110913294|NCT03018249|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
110913295|NCT03018249|Entinostat|entinostat|mesh-list
110913296|NCT03018249|Medroxyprogesterone|medroxyprogesterone|mesh-list
110913297|NCT03018249|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
110913298|NCT03018249|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110913299|NCT03018249|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110913300|NCT03018249|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110913301|NCT03018249|Contraceptive Agents|contraceptive agents|mesh-ancestor
110913302|NCT03018249|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110913303|NCT03018249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110913304|NCT03018249|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110913305|NCT03018249|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110913306|NCT03018249|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110927330|NCT02163174|Antioxidants|antioxidants|mesh-ancestor
110913307|NCT03018249|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110913308|NCT03018249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110913309|NCT03018249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110913310|NCT03018249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110913311|NCT05380154|Botulinum Toxins|botulinum toxins|mesh-list
110363416|NCT02910245|Analgesics|analgesics|mesh-ancestor
110913312|NCT05380154|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110913313|NCT05380154|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110913314|NCT05380154|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110913315|NCT05380154|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110913316|NCT05380154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110913317|NCT05380154|Cholinergic Agents|cholinergic agents|mesh-ancestor
110913318|NCT05380154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110913319|NCT05380154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110913320|NCT05380154|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110913321|NCT05380154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110913322|NCT05374252|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
110913323|NCT05374252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110913324|NCT05374252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110913325|NCT05374252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110913326|NCT04602975|Aluminum Hydroxide|aluminum hydroxide|mesh-list
110913327|NCT04602975|Vaccines|vaccines|mesh-list
110913328|NCT04602975|Immunologic Factors|immunologic factors|mesh-ancestor
110913329|NCT04602975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110913330|NCT04602975|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110913331|NCT04602975|Antacids|antacids|mesh-ancestor
110913332|NCT04602975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110913333|NCT04602975|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110913334|NCT00905606|Topiramate|topiramate|mesh-list
110913335|NCT00905606|Anticonvulsants|anticonvulsants|mesh-ancestor
110913336|NCT00905606|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110913337|NCT00905606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110913338|NCT03017235|Picosulfate sodium|picosulfate sodium|mesh-list
110630839|NCT02596763|Baclofen|baclofen|mesh-list
110913339|NCT03017235|Magnesium Oxide|magnesium oxide|mesh-list
110913340|NCT03017235|Sodium Citrate|sodium citrate|mesh-list
110913341|NCT03017235|Citric Acid|citric acid|mesh-list
110913342|NCT03017235|Anticoagulants|anticoagulants|mesh-ancestor
110913343|NCT03017235|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110913344|NCT03017235|Chelating Agents|chelating agents|mesh-ancestor
110913345|NCT03017235|Sequestering Agents|sequestering agents|mesh-ancestor
110913346|NCT03017235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110913347|NCT03017235|Cathartics|cathartics|mesh-ancestor
110913348|NCT03017235|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110913349|NCT03017235|Antacids|antacids|mesh-ancestor
110913350|NCT05048134|Trametinib|trametinib|mesh-list
110913351|NCT05048134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110913352|NCT05048134|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110913353|NCT05048134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110913354|NCT05048134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110913355|NCT04438928|Micronutrients|micronutrients|mesh-list
110913356|NCT04438928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110913357|NCT03667677|Amlodipine|amlodipine|mesh-list
110913359|NCT03667677|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110913360|NCT03667677|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110913361|NCT03667677|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110913362|NCT03667677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110913363|NCT03667677|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110913364|NCT03667677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110913365|NCT03667677|Vasodilator Agents|vasodilator agents|mesh-ancestor
110913366|NCT03667677|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110913367|NCT03667677|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110913368|NCT03667677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110913369|NCT03667677|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110913370|NCT03667677|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110913371|NCT03667677|Serotonin Agents|serotonin agents|mesh-ancestor
110913372|NCT03667677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110913373|NCT04176718|Dexamethasone|dexamethasone|mesh-list
110913374|NCT04176718|Daratumumab|daratumumab|mesh-list
110913375|NCT04176718|Pomalidomide|pomalidomide|mesh-list
110913376|NCT04176718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110913377|NCT04176718|Antiemetics|antiemetics|mesh-ancestor
110913378|NCT04176718|Autonomic Agents|autonomic agents|mesh-ancestor
110913379|NCT04176718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110913380|NCT04176718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110913381|NCT04176718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110913382|NCT04176718|Glucocorticoids|glucocorticoids|mesh-ancestor
110913383|NCT04176718|Hormones|hormones|mesh-ancestor
110913384|NCT04176718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110913385|NCT04176718|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110913386|NCT04176718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110913387|NCT04176718|Immunologic Factors|immunologic factors|mesh-ancestor
110913388|NCT04176718|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110913389|NCT04176718|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110913390|NCT04176718|Growth Substances|growth substances|mesh-ancestor
110913391|NCT04176718|Growth Inhibitors|growth inhibitors|mesh-ancestor
110913392|NCT02880371|Pembrolizumab|pembrolizumab|mesh-list
110913393|NCT02880371|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110913394|NCT02880371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110913395|NCT02880371|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110913396|NCT02880371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110913397|NCT00813956|Carboplatin|carboplatin|mesh-list
110913398|NCT00813956|Gemcitabine|gemcitabine|mesh-list
110913399|NCT00813956|Iniparib|iniparib|mesh-list
110913400|NCT00813956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110913401|NCT00813956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110913402|NCT00813956|Antimetabolites|antimetabolites|mesh-ancestor
110913403|NCT00813956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110913404|NCT00813956|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110913405|NCT00813956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110913406|NCT01002248|Dexamethasone|dexamethasone|mesh-list
110913407|NCT01002248|Bortezomib|bortezomib|mesh-list
110913408|NCT01002248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110913409|NCT01002248|Antiemetics|antiemetics|mesh-ancestor
110630914|NCT00979563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110913410|NCT01002248|Autonomic Agents|autonomic agents|mesh-ancestor
110913411|NCT01002248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110913412|NCT01002248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110913413|NCT01002248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110913414|NCT01002248|Glucocorticoids|glucocorticoids|mesh-ancestor
110913415|NCT01002248|Hormones|hormones|mesh-ancestor
110913416|NCT01002248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110913417|NCT01002248|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110913418|NCT01002248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110913419|NCT02837029|Nivolumab|nivolumab|mesh-list
110913420|NCT02837029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110913421|NCT02837029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110913422|NCT02837029|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110913423|NCT02837029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110913424|NCT03667131|Enalapril|enalapril|mesh-list
110913425|NCT03667131|Enalaprilat|enalaprilat|mesh-list
110913426|NCT03667131|Enzyme Inhibitors|enzyme inhibitors|mesh-list
110913427|NCT03667131|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
110913428|NCT03667131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110913429|NCT03667131|Protease Inhibitors|protease inhibitors|mesh-ancestor
110913430|NCT03667131|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110913431|NCT04532710|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110913432|NCT04532710|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110913433|NCT01377155|Insulin Detemir|insulin detemir|mesh-list
110913434|NCT01377155|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110913435|NCT01377155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110913436|NCT04976374|Dexmedetomidine|dexmedetomidine|mesh-list
110913437|NCT04976374|Gabapentin|gabapentin|mesh-list
110913438|NCT04976374|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110913439|NCT04976374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110913440|NCT04976374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110913441|NCT04976374|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110913442|NCT04976374|Analgesics|analgesics|mesh-ancestor
110913443|NCT04976374|Sensory System Agents|sensory system agents|mesh-ancestor
110913444|NCT04976374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110913445|NCT04976374|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110913446|NCT04976374|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110913447|NCT04976374|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110913448|NCT04976374|Adrenergic Agents|adrenergic agents|mesh-ancestor
110913449|NCT04976374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110913450|NCT04976374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110913451|NCT04976374|Anticonvulsants|anticonvulsants|mesh-ancestor
110913452|NCT04976374|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110913453|NCT04976374|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110913454|NCT04976374|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110913455|NCT04976374|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110913456|NCT04976374|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110913457|NCT04976374|Antimanic Agents|antimanic agents|mesh-ancestor
110913458|NCT00894530|Azithromycin|azithromycin|mesh-list
110913459|NCT00894530|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110913460|NCT00894530|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110913461|NCT00894530|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110913462|NCT00894530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110913463|NCT01376999|Hormones|hormones|mesh-list
110913464|NCT01376999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110913465|NCT01376999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110913466|NCT00892970|Azithromycin|azithromycin|mesh-list
110913467|NCT00892970|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110913468|NCT00892970|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110913469|NCT00892970|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110913470|NCT00892970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110913471|NCT05340257|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
110913472|NCT05340257|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110913473|NCT05340257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110363521|NCT04674423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110913474|NCT05340257|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110913475|NCT05340257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110913476|NCT05340257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110913477|NCT02201381|Metformin|metformin|mesh-list
110913478|NCT02201381|Doxycycline|doxycycline|mesh-list
110913479|NCT02201381|Mebendazole|mebendazole|mesh-list
110913480|NCT02201381|Atorvastatin|atorvastatin|mesh-list
110913481|NCT02201381|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110913482|NCT02201381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110913483|NCT02201381|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110913484|NCT02201381|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110913485|NCT02201381|Antimetabolites|antimetabolites|mesh-ancestor
110913486|NCT02201381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110913487|NCT02201381|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110913488|NCT02201381|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110913489|NCT02201381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110913490|NCT02201381|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110913491|NCT02201381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110913492|NCT02201381|Antimalarials|antimalarials|mesh-ancestor
110913493|NCT02201381|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110913494|NCT02201381|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110913495|NCT02201381|Antinematodal Agents|antinematodal agents|mesh-ancestor
110913496|NCT02201381|Anthelmintics|anthelmintics|mesh-ancestor
110913497|NCT02201381|Tubulin Modulators|tubulin modulators|mesh-ancestor
110913498|NCT02201381|Antimitotic Agents|antimitotic agents|mesh-ancestor
110913499|NCT02201381|Mitosis Modulators|mitosis modulators|mesh-ancestor
110913500|NCT02201381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110913501|NCT00803114|Morphine|morphine|mesh-list
110913502|NCT00803114|Narcotics|narcotics|mesh-list
110913503|NCT00803114|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110913504|NCT00803114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110913505|NCT00803114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110913506|NCT00803114|Analgesics|analgesics|mesh-ancestor
110913507|NCT00803114|Sensory System Agents|sensory system agents|mesh-ancestor
110913508|NCT00803114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110913509|NCT05519384|Cyclophosphamide|cyclophosphamide|mesh-list
110913510|NCT05519384|Fludarabine|fludarabine|mesh-list
110913511|NCT05519384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110913512|NCT05519384|Immunologic Factors|immunologic factors|mesh-ancestor
110913513|NCT05519384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110913514|NCT05519384|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110913515|NCT05519384|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110913516|NCT05519384|Alkylating Agents|alkylating agents|mesh-ancestor
110913517|NCT05519384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110913518|NCT05519384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110913519|NCT05519384|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110913520|NCT00799292|Vasopressins|vasopressins|mesh-list
110913521|NCT00799292|Arginine Vasopressin|arginine vasopressin|mesh-list
110913522|NCT00799292|Hemostatics|hemostatics|mesh-ancestor
110913523|NCT00799292|Coagulants|coagulants|mesh-ancestor
110913524|NCT00799292|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110913525|NCT00799292|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
110913526|NCT00799292|Natriuretic Agents|natriuretic agents|mesh-ancestor
110913527|NCT00799292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110913528|NCT02162849|Nicotine|nicotine|mesh-list
110913529|NCT02162849|Varenicline|varenicline|mesh-list
110913530|NCT02162849|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110913531|NCT02162849|Autonomic Agents|autonomic agents|mesh-ancestor
110913532|NCT02162849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110913533|NCT02162849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110913534|NCT02162849|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110913535|NCT02162849|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110913536|NCT02162849|Cholinergic Agents|cholinergic agents|mesh-ancestor
110913537|NCT02162849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110913538|NCT02162849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110913539|NCT02914275|Vaccines|vaccines|mesh-list
110913540|NCT02914275|Immunologic Factors|immunologic factors|mesh-ancestor
110226607|NCT05400109|Fludarabine|fludarabine|mesh-list
110913541|NCT02914275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110913543|NCT01941875|Progestins|progestins|mesh-ancestor
110913544|NCT01941875|Hormones|hormones|mesh-ancestor
110913545|NCT01941875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110913546|NCT01941875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110913547|NCT05508074|Riluzole|riluzole|mesh-list
110913548|NCT05508074|Anticonvulsants|anticonvulsants|mesh-ancestor
110913549|NCT05508074|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110913550|NCT05508074|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110913551|NCT05508074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110913552|NCT05508074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110913553|NCT05508074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110913554|NCT05508074|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110913555|NCT05508074|Protective Agents|protective agents|mesh-ancestor
110913556|NCT01814657|Lidocaine|lidocaine|mesh-list
110913557|NCT01814657|Anesthetics, Local|anesthetics, local|mesh-ancestor
110913558|NCT01814657|Anesthetics|anesthetics|mesh-ancestor
110913559|NCT01814657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110913560|NCT01814657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110913561|NCT01814657|Sensory System Agents|sensory system agents|mesh-ancestor
110913562|NCT01814657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110913563|NCT01814657|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110913564|NCT01814657|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110913565|NCT01814657|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110913566|NCT01814657|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110913567|NCT01814657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110913568|NCT01773395|Methotrexate|methotrexate|mesh-list
110913569|NCT01773395|Fludarabine|fludarabine|mesh-list
110913570|NCT01773395|Busulfan|busulfan|mesh-list
110913571|NCT01773395|Tacrolimus|tacrolimus|mesh-list
110913572|NCT01773395|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110913573|NCT01773395|Abortifacient Agents|abortifacient agents|mesh-ancestor
110913574|NCT01773395|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110913575|NCT01773395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110913576|NCT01773395|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110913577|NCT01773395|Antimetabolites|antimetabolites|mesh-ancestor
110913578|NCT01773395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110913579|NCT01773395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110913580|NCT01773395|Dermatologic Agents|dermatologic agents|mesh-ancestor
110913581|NCT01773395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110913582|NCT01773395|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110913583|NCT01773395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110913584|NCT01773395|Immunologic Factors|immunologic factors|mesh-ancestor
110913585|NCT01773395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110913586|NCT01773395|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110913587|NCT01773395|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110913588|NCT01773395|Alkylating Agents|alkylating agents|mesh-ancestor
110913589|NCT01773395|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110913590|NCT01773395|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110913591|NCT01000922|Insulin|insulin|mesh-list
110913592|NCT01000922|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110913593|NCT01000922|Insulin Glargine|insulin glargine|mesh-list
110913594|NCT01000922|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110913595|NCT01000922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110913596|NCT04559217|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
110363546|NCT00555984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110913597|NCT04559217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110913598|NCT03666195|Titanium dioxide|titanium dioxide|mesh-list
110913599|NCT03666195|Sunscreening Agents|sunscreening agents|mesh-ancestor
110913600|NCT03666195|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110913601|NCT03666195|Protective Agents|protective agents|mesh-ancestor
110913602|NCT03666195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110913603|NCT03666195|Dermatologic Agents|dermatologic agents|mesh-ancestor
110913604|NCT03666195|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110913605|NCT00889382|Paclitaxel|paclitaxel|mesh-list
110913606|NCT00889382|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110913607|NCT00889382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110913608|NCT00889382|Tubulin Modulators|tubulin modulators|mesh-ancestor
110913609|NCT00889382|Antimitotic Agents|antimitotic agents|mesh-ancestor
110913610|NCT00889382|Mitosis Modulators|mitosis modulators|mesh-ancestor
110913611|NCT00889382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110913612|NCT04059003|Taxane|taxane|mesh-list
110226630|NCT05384496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110913613|NCT04059003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110913614|NCT05375188|Dexmedetomidine|dexmedetomidine|mesh-list
110913615|NCT05375188|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110913616|NCT05375188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110913617|NCT05375188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110913618|NCT05375188|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110913619|NCT05375188|Analgesics|analgesics|mesh-ancestor
110913620|NCT05375188|Sensory System Agents|sensory system agents|mesh-ancestor
110913621|NCT05375188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110913622|NCT05375188|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110913623|NCT05375188|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110913624|NCT05375188|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110913625|NCT05375188|Adrenergic Agents|adrenergic agents|mesh-ancestor
110913626|NCT05375188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110913627|NCT05375188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110913628|NCT00994292|Darexaban|darexaban|mesh-list
110913629|NCT00994292|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110913630|NCT00994292|Antithrombins|antithrombins|mesh-ancestor
110913631|NCT00994292|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110913632|NCT00994292|Protease Inhibitors|protease inhibitors|mesh-ancestor
110913633|NCT00994292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110913634|NCT00994292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110913635|NCT00994292|Anticoagulants|anticoagulants|mesh-ancestor
110913636|NCT02604433|Luspatercept|luspatercept|mesh-list
110913637|NCT02604433|Hematinics|hematinics|mesh-ancestor
110913638|NCT04437004|Fenfluramine|fenfluramine|mesh-list
110913639|NCT04437004|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110913640|NCT04437004|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110913641|NCT04437004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110913642|NCT04437004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110913643|NCT04437004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110913644|NCT04437004|Serotonin Agents|serotonin agents|mesh-ancestor
110913645|NCT04437004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110913647|NCT00992732|Ganciclovir|ganciclovir|mesh-list
110913648|NCT00992732|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
110913649|NCT00992732|Arginine butyrate|arginine butyrate|mesh-list
110913650|NCT00992732|Antiviral Agents|antiviral agents|mesh-ancestor
110913651|NCT00992732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110913652|NCT00992732|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110913653|NCT00992732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110913654|NCT00992732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110913655|NCT00992732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110913657|NCT00884234|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110913658|NCT00884234|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110913659|NCT00884234|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110913660|NCT00884234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110913661|NCT00884234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110913662|NCT00884234|Cholinergic Agents|cholinergic agents|mesh-ancestor
110913663|NCT00884234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110913664|NCT00884234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110913665|NCT00884234|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110913666|NCT00884234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110913667|NCT03006393|Infliximab|infliximab|mesh-list
110913668|NCT03006393|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110913669|NCT03006393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110913670|NCT03006393|Dermatologic Agents|dermatologic agents|mesh-ancestor
110913671|NCT03006393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110913672|NCT03006393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110913673|NCT00991172|Fasinumab|fasinumab|mesh-list
110913674|NCT00991172|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110913675|NCT00991172|Analgesics|analgesics|mesh-ancestor
110913676|NCT00991172|Sensory System Agents|sensory system agents|mesh-ancestor
110913677|NCT00991172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110913678|NCT00991172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110913679|NCT01383109|Pyronaridine|pyronaridine|mesh-list
110913680|NCT01383109|Antimalarials|antimalarials|mesh-ancestor
110913681|NCT01383109|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110913682|NCT01383109|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110913683|NCT01383109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110913684|NCT00882440|Losartan|losartan|mesh-list
110913685|NCT00882440|Enalapril|enalapril|mesh-list
110913686|NCT00882440|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110913687|NCT00882440|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110913688|NCT00882440|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110913689|NCT00882440|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110913690|NCT00882440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110913691|NCT00882440|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110913692|NCT00882440|Protease Inhibitors|protease inhibitors|mesh-ancestor
110913693|NCT00882440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110913694|NCT05214391|Zanubrutinib|zanubrutinib|mesh-list
110913695|NCT05214391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110913696|NCT05214391|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110913697|NCT05214391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110913698|NCT05214391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110913699|NCT00880490|Formoterol Fumarate|formoterol fumarate|mesh-list
110913700|NCT00880490|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110913701|NCT00880490|Autonomic Agents|autonomic agents|mesh-ancestor
110913702|NCT00880490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110913703|NCT00880490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110913704|NCT00880490|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110913705|NCT00880490|Respiratory System Agents|respiratory system agents|mesh-ancestor
110913706|NCT00880490|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110913707|NCT00880490|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110913708|NCT00880490|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110913709|NCT00880490|Adrenergic Agents|adrenergic agents|mesh-ancestor
110913710|NCT00880490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110913711|NCT00880490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110913712|NCT05214157|Bupivacaine|bupivacaine|mesh-list
110913713|NCT05214157|Anesthetics, Local|anesthetics, local|mesh-ancestor
110913714|NCT05214157|Anesthetics|anesthetics|mesh-ancestor
110913715|NCT05214157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110913716|NCT05214157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110913717|NCT05214157|Sensory System Agents|sensory system agents|mesh-ancestor
110913718|NCT05214157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110913719|NCT04549467|Tenofovir|tenofovir|mesh-list
110913720|NCT04549467|Lamivudine|lamivudine|mesh-list
110913721|NCT04549467|Emtricitabine|emtricitabine|mesh-list
110913722|NCT04549467|Dolutegravir|dolutegravir|mesh-list
110913723|NCT04549467|Antiviral Agents|antiviral agents|mesh-ancestor
110913724|NCT04549467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110913725|NCT04549467|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110913726|NCT04549467|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110913727|NCT04549467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110913728|NCT04549467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110913729|NCT04549467|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110913730|NCT04549467|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110913731|NCT04549467|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110913732|NCT04549467|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110913733|NCT03630341|Clomiphene|clomiphene|mesh-list
110913734|NCT03630341|Enclomiphene|enclomiphene|mesh-list
110913735|NCT03630341|Zuclomiphene|zuclomiphene|mesh-list
110913736|NCT03630341|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110913737|NCT03630341|Hormone Antagonists|hormone antagonists|mesh-ancestor
110913738|NCT03630341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110913739|NCT03630341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110913740|NCT03630341|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110913741|NCT03630341|Fertility Agents|fertility agents|mesh-ancestor
110913742|NCT03630341|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110913743|NCT03630341|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110913744|NCT03630341|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110913745|NCT02632396|Rituximab|rituximab|mesh-list
110913746|NCT02632396|Ixazomib|ixazomib|mesh-list
110913747|NCT02632396|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110913748|NCT02632396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110913749|NCT02632396|Immunologic Factors|immunologic factors|mesh-ancestor
110262341|NCT04838808|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110913750|NCT02632396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110913751|NCT02632396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110913752|NCT02632396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110913753|NCT02632396|Protease Inhibitors|protease inhibitors|mesh-ancestor
110913754|NCT02632396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110913755|NCT05102422|Propofol|propofol|mesh-list
110913756|NCT05102422|Sevoflurane|sevoflurane|mesh-list
110913757|NCT05102422|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110913758|NCT05102422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110913759|NCT05102422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110927478|NCT00102960|Antimetabolites|antimetabolites|mesh-ancestor
110913760|NCT05102422|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110913761|NCT05102422|Anesthetics, General|anesthetics, general|mesh-ancestor
110913762|NCT05102422|Anesthetics|anesthetics|mesh-ancestor
110913763|NCT05102422|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110913764|NCT05102422|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110913765|NCT01088789|Cyclophosphamide|cyclophosphamide|mesh-list
110913766|NCT01088789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110363600|NCT05189717|Everolimus|everolimus|mesh-list
110913767|NCT01088789|Immunologic Factors|immunologic factors|mesh-ancestor
110913768|NCT01088789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110913769|NCT01088789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110913770|NCT01088789|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110913771|NCT01088789|Alkylating Agents|alkylating agents|mesh-ancestor
110913772|NCT01088789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110913773|NCT01088789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110913774|NCT01088789|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110913775|NCT03665181|Bismuth|bismuth|mesh-list
110913776|NCT03665181|Antacids|antacids|mesh-ancestor
110913777|NCT03665181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110913778|NCT03665181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110913779|NCT05326906|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
110913780|NCT05326906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110913781|NCT05326906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110913782|NCT05326906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110913783|NCT05101954|Mitogens|mitogens|mesh-list
110913784|NCT05101954|Mitosis Modulators|mitosis modulators|mesh-ancestor
110913785|NCT05101954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110913786|NCT00875108|Insulin|insulin|mesh-list
110913787|NCT00875108|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110913788|NCT00875108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110913789|NCT00875108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110913790|NCT04044209|Nivolumab|nivolumab|mesh-list
110913791|NCT04044209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110913792|NCT04044209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110913793|NCT04044209|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110913794|NCT04044209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110913795|NCT03817463|Empagliflozin|empagliflozin|mesh-list
110913796|NCT03817463|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
110913797|NCT03817463|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110913798|NCT03817463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110913799|NCT03817463|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110913800|NCT03817463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110913801|NCT03817463|Protease Inhibitors|protease inhibitors|mesh-ancestor
110913802|NCT03817463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110913803|NCT05207683|Antibodies|antibodies|mesh-list
110913804|NCT05207683|Antibodies, Antinuclear|antibodies, antinuclear|mesh-list
110913805|NCT05207683|Immunologic Factors|immunologic factors|mesh-ancestor
110913806|NCT05207683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110913807|NCT03000075|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110913808|NCT03000075|Immunologic Factors|immunologic factors|mesh-ancestor
110913809|NCT03000075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110913810|NCT05213065|Bupivacaine|bupivacaine|mesh-list
110913811|NCT05213065|Anesthetics, Local|anesthetics, local|mesh-ancestor
110913812|NCT05213065|Anesthetics|anesthetics|mesh-ancestor
110913813|NCT05213065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110913814|NCT05213065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110913815|NCT05213065|Sensory System Agents|sensory system agents|mesh-ancestor
110913816|NCT05213065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110913817|NCT04578938|Ketamine|ketamine|mesh-list
110913818|NCT04578938|Analgesics|analgesics|mesh-ancestor
110913819|NCT04578938|Sensory System Agents|sensory system agents|mesh-ancestor
110913820|NCT04578938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110913821|NCT04578938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110913822|NCT04578938|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110927497|NCT02160054|Tacrolimus|tacrolimus|mesh-list
110913823|NCT04578938|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110913824|NCT04578938|Anesthetics, General|anesthetics, general|mesh-ancestor
110913825|NCT04578938|Anesthetics|anesthetics|mesh-ancestor
110913826|NCT04578938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110913827|NCT04578938|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110913828|NCT04578938|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110913829|NCT04578938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110913830|NCT04578938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110913831|NCT00969722|Tretinoin|tretinoin|mesh-list
110913832|NCT00969722|Molgramostim|molgramostim|mesh-list
110913833|NCT00969722|Isotretinoin|isotretinoin|mesh-list
110913834|NCT00969722|Sargramostim|sargramostim|mesh-list
110913835|NCT00969722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110913836|NCT00969722|Keratolytic Agents|keratolytic agents|mesh-ancestor
110913837|NCT00969722|Dermatologic Agents|dermatologic agents|mesh-ancestor
110913838|NCT00969722|Immunologic Factors|immunologic factors|mesh-ancestor
110913839|NCT00969722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110913840|NCT05099614|Naloxone|naloxone|mesh-list
110913841|NCT05099614|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110913842|NCT05099614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110913843|NCT05099614|Sensory System Agents|sensory system agents|mesh-ancestor
110913844|NCT05099614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110913845|NCT00968942|Botulinum Toxins|botulinum toxins|mesh-list
110913846|NCT00968942|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110913847|NCT00968942|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110913848|NCT00968942|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110913849|NCT00968942|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110913850|NCT00968942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110913851|NCT00968942|Cholinergic Agents|cholinergic agents|mesh-ancestor
110913852|NCT00968942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110913853|NCT00968942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110913854|NCT00968942|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110913855|NCT00968942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110913856|NCT05283382|Cannabidiol|cannabidiol|mesh-list
110913857|NCT05283382|Anticonvulsants|anticonvulsants|mesh-ancestor
110913858|NCT00869336|Luliconazole|luliconazole|mesh-list
110913859|NCT00869336|Antifungal Agents|antifungal agents|mesh-ancestor
110913860|NCT00869336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110913861|NCT02371889|Topiramate|topiramate|mesh-list
110913862|NCT02371889|Anticonvulsants|anticonvulsants|mesh-ancestor
110913863|NCT02371889|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110913864|NCT02371889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110913865|NCT00860288|Metformin|metformin|mesh-list
110913866|NCT00860288|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110913867|NCT00860288|Vildagliptin|vildagliptin|mesh-list
110913868|NCT00860288|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110913869|NCT00860288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110913870|NCT00860288|Incretins|incretins|mesh-ancestor
110913872|NCT00860288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110913873|NCT00860288|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110913874|NCT00860288|Protease Inhibitors|protease inhibitors|mesh-ancestor
110913875|NCT00860288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110913876|NCT00860288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110913877|NCT03630029|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
110913878|NCT03630029|Hematinics|hematinics|mesh-ancestor
110913879|NCT05763953|Etripamil|etripamil|mesh-list
110913880|NCT05763953|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110913881|NCT05763953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110913882|NCT05763953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110913883|NCT05763953|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110913884|NCT05763953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110913885|NCT05212597|Losartan|losartan|mesh-list
110226657|NCT05382650|Immunoglobulins|immunoglobulins|mesh-list
110226658|NCT05382650|Antibodies|antibodies|mesh-list
110226659|NCT05382650|gamma-Globulins|gamma-globulins|mesh-list
110913887|NCT05212597|Valsartan|valsartan|mesh-list
110913888|NCT05212597|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
110913889|NCT05212597|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110913890|NCT05212597|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110913891|NCT05212597|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110913892|NCT05212597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110913893|NCT05212597|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110913894|NCT05212597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110913895|NCT05212597|Vasodilator Agents|vasodilator agents|mesh-ancestor
110913896|NCT05212597|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110913897|NCT05212597|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110913898|NCT05212597|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110913899|NCT02450812|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
110913900|NCT02450812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110913901|NCT03629717|Vitamin D|vitamin d|mesh-list
110913902|NCT03629717|Denosumab|denosumab|mesh-list
110913903|NCT03629717|Calcium|calcium|mesh-list
110913904|NCT03629717|Vitamins|vitamins|mesh-ancestor
110913905|NCT03629717|Micronutrients|micronutrients|mesh-ancestor
110913906|NCT03629717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110913907|NCT03629717|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110913908|NCT03629717|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110913909|NCT05108350|Metformin|metformin|mesh-list
110913910|NCT05108350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110913911|NCT05108350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110913912|NCT00859430|Levetiracetam|levetiracetam|mesh-list
110913913|NCT00859430|Anticonvulsants|anticonvulsants|mesh-ancestor
110913914|NCT00859430|Nootropic Agents|nootropic agents|mesh-ancestor
110913915|NCT00855764|Paclitaxel|paclitaxel|mesh-list
110913916|NCT00855764|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110913917|NCT00855764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110913918|NCT00855764|Tubulin Modulators|tubulin modulators|mesh-ancestor
110913919|NCT00855764|Antimitotic Agents|antimitotic agents|mesh-ancestor
110913920|NCT00855764|Mitosis Modulators|mitosis modulators|mesh-ancestor
110913921|NCT00855764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110913922|NCT00959036|Methotrexate|methotrexate|mesh-list
110913923|NCT00959036|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110913924|NCT00959036|Abortifacient Agents|abortifacient agents|mesh-ancestor
110913925|NCT00959036|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110913926|NCT00959036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110913927|NCT00959036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110913928|NCT00959036|Antimetabolites|antimetabolites|mesh-ancestor
110913929|NCT00959036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110913930|NCT00959036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110913931|NCT00959036|Dermatologic Agents|dermatologic agents|mesh-ancestor
110913932|NCT00959036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110913933|NCT00959036|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110913934|NCT00959036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110913935|NCT00959036|Immunologic Factors|immunologic factors|mesh-ancestor
110913936|NCT00959036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110913937|NCT00959036|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110913938|NCT04129723|Tin Fluorides|tin fluorides|mesh-list
110913939|NCT04129723|Cariostatic Agents|cariostatic agents|mesh-ancestor
110913940|NCT04129723|Protective Agents|protective agents|mesh-ancestor
110913941|NCT04129723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110913942|NCT04474262|Midodrine|midodrine|mesh-list
110913943|NCT04474262|Sympathomimetics|sympathomimetics|mesh-ancestor
110913944|NCT04474262|Autonomic Agents|autonomic agents|mesh-ancestor
110913945|NCT04474262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110913946|NCT04474262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110913947|NCT04474262|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110913948|NCT04474262|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110913949|NCT04474262|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110913950|NCT04474262|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110913951|NCT04474262|Adrenergic Agents|adrenergic agents|mesh-ancestor
110913952|NCT04474262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110913953|NCT04474262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110913954|NCT05211583|Progesterone|progesterone|mesh-list
110913955|NCT05211583|Progestins|progestins|mesh-ancestor
110913956|NCT05211583|Hormones|hormones|mesh-ancestor
110226660|NCT05382650|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110913957|NCT05211583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110913959|NCT04031599|Hormones|hormones|mesh-list
110913960|NCT04031599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110913961|NCT04031599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110913962|NCT04724759|Lidocaine|lidocaine|mesh-list
110913963|NCT04724759|Dexmedetomidine|dexmedetomidine|mesh-list
110913964|NCT04724759|Ketamine|ketamine|mesh-list
110913965|NCT04724759|Anesthetics, Local|anesthetics, local|mesh-ancestor
110913966|NCT04724759|Anesthetics|anesthetics|mesh-ancestor
110913967|NCT04724759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110913968|NCT04724759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110913969|NCT04724759|Sensory System Agents|sensory system agents|mesh-ancestor
110913970|NCT04724759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110913971|NCT04724759|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110913972|NCT04724759|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110913973|NCT04724759|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110913974|NCT04724759|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110913975|NCT04724759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110913976|NCT04724759|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110913977|NCT04724759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110913978|NCT04724759|Analgesics|analgesics|mesh-ancestor
110913979|NCT04724759|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110913980|NCT04724759|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110913981|NCT04724759|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110913982|NCT04724759|Adrenergic Agents|adrenergic agents|mesh-ancestor
110913983|NCT04724759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110913984|NCT04724759|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110913985|NCT04724759|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110913986|NCT04724759|Anesthetics, General|anesthetics, general|mesh-ancestor
110913987|NCT04724759|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110913988|NCT04724759|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110913989|NCT04019821|Insulin|insulin|mesh-list
110913990|NCT04019821|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110913991|NCT04019821|Insulin Aspart|insulin aspart|mesh-list
110913992|NCT04019821|Insulin Lispro|insulin lispro|mesh-list
110913993|NCT04019821|Insulin glulisine|insulin glulisine|mesh-list
110913994|NCT04019821|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110913995|NCT04019821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110913996|NCT05186467|Magnesium Sulfate|magnesium sulfate|mesh-list
110913997|NCT05186467|Analgesics|analgesics|mesh-ancestor
110913998|NCT05186467|Sensory System Agents|sensory system agents|mesh-ancestor
110913999|NCT05186467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110914000|NCT05186467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110914001|NCT05186467|Anesthetics|anesthetics|mesh-ancestor
110914002|NCT05186467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110914003|NCT05186467|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110914004|NCT05186467|Anticonvulsants|anticonvulsants|mesh-ancestor
110914005|NCT05186467|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110914006|NCT05186467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110914007|NCT05186467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110914008|NCT05186467|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110914009|NCT05186467|Tocolytic Agents|tocolytic agents|mesh-ancestor
110914010|NCT05186467|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110914011|NCT00771134|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110914012|NCT00771134|Antidepressive Agents|antidepressive agents|mesh-ancestor
110914013|NCT00771134|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110914015|NCT00771134|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110914016|NCT00771134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110914017|NCT00771134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110914018|NCT00768482|Buprenorphine|buprenorphine|mesh-list
110914019|NCT00768482|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110914020|NCT00768482|Narcotics|narcotics|mesh-ancestor
110914021|NCT00768482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110914022|NCT00768482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110914023|NCT00768482|Analgesics|analgesics|mesh-ancestor
110914024|NCT00768482|Sensory System Agents|sensory system agents|mesh-ancestor
110914025|NCT00768482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110914026|NCT00768482|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110914027|NCT00840866|Cefprozil|cefprozil|mesh-list
110914028|NCT00840866|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110914029|NCT00840866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110914030|NCT05043116|Vitamin D|vitamin d|mesh-list
110914031|NCT05043116|Cholecalciferol|cholecalciferol|mesh-list
110914032|NCT05043116|Vitamins|vitamins|mesh-ancestor
110914033|NCT05043116|Micronutrients|micronutrients|mesh-ancestor
110914034|NCT05043116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110914035|NCT05043116|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110914036|NCT05043116|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110914037|NCT00840632|Trandolapril|trandolapril|mesh-list
110914038|NCT00840632|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110914039|NCT00840632|Protease Inhibitors|protease inhibitors|mesh-ancestor
110914040|NCT00840632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110914041|NCT00840632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110914042|NCT00840632|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110914043|NCT00840476|Meloxicam|meloxicam|mesh-list
110914044|NCT00840476|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110914045|NCT00840476|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110914046|NCT00840476|Analgesics|analgesics|mesh-ancestor
110914047|NCT00840476|Sensory System Agents|sensory system agents|mesh-ancestor
110914048|NCT00840476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110914049|NCT00840476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110914050|NCT00840476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110914051|NCT00840476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110914052|NCT00840476|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110914053|NCT00840476|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110914054|NCT00840476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110914055|NCT00840476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110914056|NCT00765830|Vildagliptin|vildagliptin|mesh-list
110914057|NCT00765830|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110914058|NCT00765830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110914059|NCT00765830|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110914060|NCT00765830|Protease Inhibitors|protease inhibitors|mesh-ancestor
110914061|NCT00765830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110914062|NCT00765830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110914063|NCT03664869|Mitomycins|mitomycins|mesh-list
110914064|NCT03664869|Mitomycin|mitomycin|mesh-list
110914065|NCT03664869|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110914066|NCT03664869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110914067|NCT03664869|Alkylating Agents|alkylating agents|mesh-ancestor
110914068|NCT03664869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110914069|NCT03664869|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110927548|NCT02160132|Hormones|hormones|mesh-ancestor
110914070|NCT03664869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110914071|NCT00953420|Dexamethasone|dexamethasone|mesh-list
110914072|NCT00953420|Carboplatin|carboplatin|mesh-list
110914073|NCT00953420|Docetaxel|docetaxel|mesh-list
110914074|NCT00953420|Lenograstim|lenograstim|mesh-list
110914075|NCT00953420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110914076|NCT00953420|Antiemetics|antiemetics|mesh-ancestor
110914077|NCT00953420|Autonomic Agents|autonomic agents|mesh-ancestor
110914078|NCT00953420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110914079|NCT00953420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110914080|NCT00953420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110914081|NCT00953420|Glucocorticoids|glucocorticoids|mesh-ancestor
110914082|NCT00953420|Hormones|hormones|mesh-ancestor
110914083|NCT00953420|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110914084|NCT00953420|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110914085|NCT00953420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110914086|NCT00953420|Tubulin Modulators|tubulin modulators|mesh-ancestor
110914087|NCT00953420|Antimitotic Agents|antimitotic agents|mesh-ancestor
110914088|NCT00953420|Mitosis Modulators|mitosis modulators|mesh-ancestor
110914089|NCT00953420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110914090|NCT00953420|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110914091|NCT00953420|Immunologic Factors|immunologic factors|mesh-ancestor
110914092|NCT01602562|Valacyclovir|valacyclovir|mesh-list
110914093|NCT01602562|Antiviral Agents|antiviral agents|mesh-ancestor
110914094|NCT01602562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110914095|NCT01945775|Talazoparib|talazoparib|mesh-list
110914096|NCT01945775|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110914097|NCT01945775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110914098|NCT01945775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110914099|NCT01945775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110914100|NCT00839930|Cilostazol|cilostazol|mesh-list
110914101|NCT00839930|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110914102|NCT00839930|Autonomic Agents|autonomic agents|mesh-ancestor
110914103|NCT00839930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110914104|NCT00839930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110914105|NCT00839930|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110914106|NCT00839930|Respiratory System Agents|respiratory system agents|mesh-ancestor
110914107|NCT00839930|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110914108|NCT00839930|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110914109|NCT00839930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110914110|NCT00839930|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110914111|NCT00839930|Vasodilator Agents|vasodilator agents|mesh-ancestor
110914112|NCT00839930|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110914113|NCT00839930|Protective Agents|protective agents|mesh-ancestor
110914114|NCT00839930|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110914115|NCT00839930|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110914116|NCT00839930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110914117|NCT00838136|Lamotrigine|lamotrigine|mesh-list
110914118|NCT00838136|Anticonvulsants|anticonvulsants|mesh-ancestor
110914119|NCT00838136|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110914120|NCT00838136|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110914121|NCT00838136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110914122|NCT00838136|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110914123|NCT00838136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110927566|NCT02858037|Dapivirine|dapivirine|mesh-list
110914124|NCT00838136|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110914125|NCT00838136|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110914126|NCT00838136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110914127|NCT00838136|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110914128|NCT00838136|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110914129|NCT00944294|Adenosine|adenosine|mesh-list
110914130|NCT00944294|Binodenoson|binodenoson|mesh-list
110914131|NCT00944294|Analgesics|analgesics|mesh-ancestor
110914132|NCT00944294|Sensory System Agents|sensory system agents|mesh-ancestor
110914133|NCT00944294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110914134|NCT00944294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110914135|NCT00944294|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110914136|NCT00944294|Vasodilator Agents|vasodilator agents|mesh-ancestor
110914137|NCT00944294|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
110914138|NCT00944294|Purinergic Agonists|purinergic agonists|mesh-ancestor
110914139|NCT00944294|Purinergic Agents|purinergic agents|mesh-ancestor
110914140|NCT00944294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110914141|NCT00944294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110914142|NCT00758966|Naltrexone|naltrexone|mesh-list
110914143|NCT00758966|Fluoxetine|fluoxetine|mesh-list
110914144|NCT00758966|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110914145|NCT00758966|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110914146|NCT00758966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110914147|NCT00758966|Sensory System Agents|sensory system agents|mesh-ancestor
110914148|NCT00758966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110914149|NCT00758966|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110914150|NCT00758966|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110914151|NCT00758966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110914152|NCT00758966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110914153|NCT00758966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110914154|NCT00758966|Serotonin Agents|serotonin agents|mesh-ancestor
110914155|NCT00758966|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110914156|NCT00758966|Antidepressive Agents|antidepressive agents|mesh-ancestor
110914157|NCT00758966|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110914158|NCT00758966|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110914159|NCT00758966|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110914160|NCT00758966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110914161|NCT03072719|Fluorides|fluorides|mesh-list
110914163|NCT03072719|Fluorophosphate|fluorophosphate|mesh-list
110914164|NCT03072719|Cariostatic Agents|cariostatic agents|mesh-ancestor
110914165|NCT03072719|Protective Agents|protective agents|mesh-ancestor
110914166|NCT03072719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110914167|NCT05106400|Lidocaine|lidocaine|mesh-list
110914168|NCT05106400|Menthol|menthol|mesh-list
110914169|NCT05106400|Anesthetics, Local|anesthetics, local|mesh-ancestor
110914170|NCT05106400|Anesthetics|anesthetics|mesh-ancestor
110914171|NCT05106400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110914172|NCT05106400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110914173|NCT05106400|Sensory System Agents|sensory system agents|mesh-ancestor
110914174|NCT05106400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110914175|NCT05106400|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110914176|NCT05106400|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110914177|NCT05106400|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110914178|NCT05106400|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110914179|NCT05106400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110914180|NCT05106400|Antipruritics|antipruritics|mesh-ancestor
110914181|NCT05106400|Dermatologic Agents|dermatologic agents|mesh-ancestor
110914182|NCT00754988|Metformin|metformin|mesh-list
110914183|NCT00754988|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110914184|NCT00754988|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
110914185|NCT00754988|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110914186|NCT00754988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110914187|NCT00754988|Incretins|incretins|mesh-ancestor
110914188|NCT00754988|Hormones|hormones|mesh-ancestor
110914189|NCT00754988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110914190|NCT00754988|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110914191|NCT00754988|Protease Inhibitors|protease inhibitors|mesh-ancestor
110914192|NCT00754988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110914193|NCT00754988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110914194|NCT01416935|Amiodarone|amiodarone|mesh-list
110914195|NCT01416935|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110914196|NCT01416935|Vasodilator Agents|vasodilator agents|mesh-ancestor
110914197|NCT01416935|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
110914198|NCT01416935|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110914199|NCT01416935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110914200|NCT01416935|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110914201|NCT01416935|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110914202|NCT01416935|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110914203|NCT01416935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110914204|NCT01416935|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110914205|NCT01416935|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110914206|NCT01416935|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110914207|NCT05012566|Botulinum Toxins|botulinum toxins|mesh-list
110914208|NCT05012566|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110914209|NCT05012566|Hyaluronic Acid|hyaluronic acid|mesh-list
110914210|NCT05012566|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110914211|NCT05012566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110914212|NCT05012566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110914213|NCT05012566|Cholinergic Agents|cholinergic agents|mesh-ancestor
110914214|NCT05012566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110914215|NCT05012566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110914216|NCT05012566|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110914217|NCT05012566|Immunologic Factors|immunologic factors|mesh-ancestor
110914218|NCT05012566|Viscosupplements|viscosupplements|mesh-ancestor
110914219|NCT05012566|Protective Agents|protective agents|mesh-ancestor
110914220|NCT05012566|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110914221|NCT05012566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110914222|NCT05202665|Fluorides|fluorides|mesh-list
110914223|NCT05202665|Fluorides, Topical|fluorides, topical|mesh-list
110914224|NCT05202665|Cariostatic Agents|cariostatic agents|mesh-ancestor
110914225|NCT05202665|Protective Agents|protective agents|mesh-ancestor
110914226|NCT05202665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110914227|NCT04438772|Anesthetics|anesthetics|mesh-list
110914228|NCT04438772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110914229|NCT04438772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110914230|NCT04560634|Norepinephrine|norepinephrine|mesh-list
110914231|NCT04560634|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110914232|NCT04560634|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110914233|NCT04560634|Adrenergic Agents|adrenergic agents|mesh-ancestor
110914234|NCT04560634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110914235|NCT04560634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110914236|NCT04560634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110914237|NCT04560634|Sympathomimetics|sympathomimetics|mesh-ancestor
110914238|NCT04560634|Autonomic Agents|autonomic agents|mesh-ancestor
110914239|NCT04560634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110914240|NCT04560634|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110914242|NCT00927914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110914243|NCT00927914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110914244|NCT05261464|Metoprolol|metoprolol|mesh-list
110914245|NCT05261464|Diltiazem|diltiazem|mesh-list
110914246|NCT05261464|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110914247|NCT05261464|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110914248|NCT05261464|Sympatholytics|sympatholytics|mesh-ancestor
110914249|NCT05261464|Autonomic Agents|autonomic agents|mesh-ancestor
110914250|NCT05261464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110363790|NCT01782729|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110914251|NCT05261464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110914252|NCT05261464|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110914253|NCT05261464|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110914254|NCT05261464|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110914255|NCT05261464|Adrenergic Agents|adrenergic agents|mesh-ancestor
110914256|NCT05261464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110914257|NCT05261464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110914258|NCT05261464|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110914259|NCT05261464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110914260|NCT05261464|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110914261|NCT05261464|Vasodilator Agents|vasodilator agents|mesh-ancestor
110914262|NCT00835796|Finasteride|finasteride|mesh-list
110914263|NCT00835796|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
110914264|NCT00835796|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110914265|NCT00835796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110914266|NCT00835796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110914267|NCT00835796|Hormone Antagonists|hormone antagonists|mesh-ancestor
110914268|NCT00835796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110914269|NCT00835796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110914270|NCT00835796|Urological Agents|urological agents|mesh-ancestor
110914271|NCT05106712|Vitamin D|vitamin d|mesh-list
110914272|NCT05106712|Cholecalciferol|cholecalciferol|mesh-list
110914273|NCT05106712|Letrozole|letrozole|mesh-list
110914274|NCT05106712|Clomiphene|clomiphene|mesh-list
110914275|NCT05106712|Enclomiphene|enclomiphene|mesh-list
110914276|NCT05106712|Zuclomiphene|zuclomiphene|mesh-list
110914277|NCT05106712|Vitamins|vitamins|mesh-ancestor
110914278|NCT05106712|Micronutrients|micronutrients|mesh-ancestor
110914279|NCT05106712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110914280|NCT05106712|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110914281|NCT05106712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110914282|NCT05106712|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110914283|NCT05106712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110914284|NCT05106712|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110914285|NCT05106712|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110914286|NCT05106712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110914287|NCT05106712|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110914288|NCT05106712|Hormone Antagonists|hormone antagonists|mesh-ancestor
110914289|NCT05106712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110914290|NCT05106712|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110914291|NCT05106712|Fertility Agents|fertility agents|mesh-ancestor
110914292|NCT05106712|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110914293|NCT05106712|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110914294|NCT05106712|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110914295|NCT05105698|Dapagliflozin|dapagliflozin|mesh-list
110914296|NCT05105698|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
110914297|NCT05105698|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
110914298|NCT05105698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110914299|NCT05105698|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110914300|NCT05105698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110914301|NCT05105698|Protease Inhibitors|protease inhibitors|mesh-ancestor
110914302|NCT05105698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110914303|NCT00835640|Fexofenadine|fexofenadine|mesh-list
110914304|NCT00835640|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110914305|NCT00835640|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110914306|NCT00835640|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110631823|NCT00802958|Clobetasol|clobetasol|mesh-list
110914307|NCT00835640|Histamine Antagonists|histamine antagonists|mesh-ancestor
110914308|NCT00835640|Histamine Agents|histamine agents|mesh-ancestor
110914309|NCT00835640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110914310|NCT00835640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110914311|NCT00835640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110914312|NCT00752570|Trebananib|trebananib|mesh-list
110914313|NCT00752570|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110914314|NCT00752570|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110914315|NCT00752570|Growth Substances|growth substances|mesh-ancestor
110914316|NCT00752570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110914317|NCT00752570|Growth Inhibitors|growth inhibitors|mesh-ancestor
110914318|NCT00752570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110914319|NCT05083000|Topotecan|topotecan|mesh-list
110914320|NCT05083000|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110914321|NCT05083000|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110914322|NCT05083000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110914323|NCT05083000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110914324|NCT05083000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110914325|NCT00752258|Botulinum Toxins|botulinum toxins|mesh-list
110914326|NCT00752258|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110914327|NCT00752258|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110914328|NCT00752258|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110914329|NCT00752258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110914330|NCT00752258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110914331|NCT00752258|Cholinergic Agents|cholinergic agents|mesh-ancestor
110914332|NCT00752258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110914333|NCT00752258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110914334|NCT00752258|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110914335|NCT00752258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110914336|NCT02942017|Brexanolone|brexanolone|mesh-list
110914337|NCT02942017|Neurosteroids|neurosteroids|mesh-ancestor
110914338|NCT02942017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110914339|NCT02942017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110914340|NCT02942017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110914341|NCT02942017|GABA Modulators|gaba modulators|mesh-ancestor
110914342|NCT02942017|GABA Agents|gaba agents|mesh-ancestor
110914343|NCT04447781|Citric Acid|citric acid|mesh-list
110914344|NCT04447781|Sodium Citrate|sodium citrate|mesh-list
110914345|NCT04447781|Anticoagulants|anticoagulants|mesh-ancestor
110914346|NCT04447781|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110914347|NCT04447781|Chelating Agents|chelating agents|mesh-ancestor
110914348|NCT04447781|Sequestering Agents|sequestering agents|mesh-ancestor
110914349|NCT04447781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110914353|NCT00835484|Cefdinir|cefdinir|mesh-list
110914354|NCT00835484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110914355|NCT00835484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110914356|NCT00835406|Alendronate|alendronate|mesh-list
110914357|NCT00835406|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110914358|NCT00835406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110914359|NCT05202275|Olanzapine|olanzapine|mesh-list
110914360|NCT05202275|Aprepitant|aprepitant|mesh-list
110914361|NCT05202275|Palonosetron|palonosetron|mesh-list
110914362|NCT05202275|Antiemetics|antiemetics|mesh-ancestor
110914363|NCT05202275|Autonomic Agents|autonomic agents|mesh-ancestor
110914364|NCT05202275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110226699|NCT05370885|Vancomycin|vancomycin|mesh-list
110914365|NCT05202275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110914366|NCT05202275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110914368|NCT05202275|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110914369|NCT05202275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110914370|NCT05202275|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110914371|NCT05202275|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110914372|NCT05202275|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110914373|NCT05202275|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110914374|NCT05202275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110914375|NCT05202275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110914376|NCT05202275|Serotonin Agents|serotonin agents|mesh-ancestor
110914377|NCT05202275|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110914378|NCT05202275|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110914379|NCT05202275|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110914380|NCT00744926|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
110914381|NCT00744926|Incretins|incretins|mesh-ancestor
110914382|NCT00744926|Hormones|hormones|mesh-ancestor
110914383|NCT00744926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110914384|NCT00744926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110914385|NCT03838744|Olaparib|olaparib|mesh-list
110914386|NCT03838744|Trabectedin|trabectedin|mesh-list
110914387|NCT03838744|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110914388|NCT03838744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110914389|NCT03838744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110914390|NCT03838744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110914391|NCT03838744|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110914392|NCT03838744|Alkylating Agents|alkylating agents|mesh-ancestor
110914393|NCT05327348|Ascorbic Acid|ascorbic acid|mesh-list
110914394|NCT05327348|Antioxidants|antioxidants|mesh-ancestor
110914395|NCT05327348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110914396|NCT05327348|Protective Agents|protective agents|mesh-ancestor
110914397|NCT05327348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110914398|NCT05327348|Vitamins|vitamins|mesh-ancestor
110914399|NCT05327348|Micronutrients|micronutrients|mesh-ancestor
110914400|NCT04695106|Aspirin|aspirin|mesh-list
110914401|NCT04695106|Dabigatran|dabigatran|mesh-list
110914402|NCT04695106|Clopidogrel|clopidogrel|mesh-list
110914403|NCT04695106|Ticagrelor|ticagrelor|mesh-list
110914404|NCT04695106|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110914405|NCT04695106|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110914406|NCT04695106|Analgesics|analgesics|mesh-ancestor
110914407|NCT04695106|Sensory System Agents|sensory system agents|mesh-ancestor
110914408|NCT04695106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110914409|NCT04695106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110914410|NCT04695106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110914411|NCT04695106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110914412|NCT04695106|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110914413|NCT04695106|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110914414|NCT04695106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110914415|NCT04695106|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110914416|NCT04695106|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110914417|NCT04695106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110914418|NCT04695106|Antipyretics|antipyretics|mesh-ancestor
110927628|NCT01242267|Thalidomide|thalidomide|mesh-list
110914419|NCT04695106|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110914420|NCT04695106|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110914421|NCT04695106|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110914423|NCT04695106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110914424|NCT04695106|Antithrombins|antithrombins|mesh-ancestor
110914425|NCT04695106|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110914426|NCT04695106|Protease Inhibitors|protease inhibitors|mesh-ancestor
110914427|NCT04695106|Anticoagulants|anticoagulants|mesh-ancestor
110914428|NCT04032665|Rivaroxaban|rivaroxaban|mesh-list
110914429|NCT04032665|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110914430|NCT04032665|Antithrombins|antithrombins|mesh-ancestor
110914431|NCT04032665|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110914432|NCT04032665|Protease Inhibitors|protease inhibitors|mesh-ancestor
110914433|NCT04032665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110914434|NCT04032665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110914435|NCT04032665|Anticoagulants|anticoagulants|mesh-ancestor
110914437|NCT03629639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110914438|NCT03629639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110914439|NCT00835172|Glimepiride|glimepiride|mesh-list
110914440|NCT00835172|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110914441|NCT00835172|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110914442|NCT00835172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110914443|NCT00835172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110914444|NCT00835172|Immunologic Factors|immunologic factors|mesh-ancestor
110914445|NCT04941755|Famotidine|famotidine|mesh-list
110914446|NCT04941755|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110914447|NCT04941755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110914448|NCT04941755|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110914449|NCT04941755|Histamine Antagonists|histamine antagonists|mesh-ancestor
110914450|NCT04941755|Histamine Agents|histamine agents|mesh-ancestor
110914451|NCT04941755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110914452|NCT04941755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110914453|NCT04941755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110914454|NCT04921735|Cisatracurium|cisatracurium|mesh-list
110914455|NCT04921735|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110914456|NCT04921735|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110914457|NCT04921735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110914458|NCT04921735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110914459|NCT01676116|Liraglutide|liraglutide|mesh-list
110914460|NCT01676116|Exenatide|exenatide|mesh-list
110914461|NCT01676116|Xultophy|xultophy|mesh-list
110914462|NCT01676116|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110914463|NCT01676116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110914464|NCT01676116|Incretins|incretins|mesh-ancestor
110914465|NCT01676116|Hormones|hormones|mesh-ancestor
110914466|NCT01676116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110914467|NCT01676116|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110914468|NCT05200793|Metformin|metformin|mesh-list
110914469|NCT05200793|Empagliflozin|empagliflozin|mesh-list
110914470|NCT05200793|Linagliptin|linagliptin|mesh-list
110914471|NCT05200793|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110914472|NCT05200793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110914473|NCT05200793|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110914474|NCT05200793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110914475|NCT05200793|Incretins|incretins|mesh-ancestor
110914476|NCT05200793|Hormones|hormones|mesh-ancestor
110927644|NCT01242267|Growth Substances|growth substances|mesh-ancestor
110914477|NCT05200793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110914478|NCT05200793|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110914480|NCT05200793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110914481|NCT03383224|Nicotine|nicotine|mesh-list
110914482|NCT03383224|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110363860|NCT01776606|Cholinergic Agents|cholinergic agents|mesh-ancestor
110914484|NCT03383224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110914485|NCT03383224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110914486|NCT03383224|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110914487|NCT03383224|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110914488|NCT03383224|Cholinergic Agents|cholinergic agents|mesh-ancestor
110914489|NCT03383224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110914490|NCT03383224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110914491|NCT04699357|Atropine|atropine|mesh-list
110914492|NCT04699357|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110914493|NCT04699357|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110914494|NCT04699357|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110914495|NCT04699357|Autonomic Agents|autonomic agents|mesh-ancestor
110914496|NCT04699357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110914497|NCT04699357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110914498|NCT04699357|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110914499|NCT04699357|Respiratory System Agents|respiratory system agents|mesh-ancestor
110914500|NCT04699357|Mydriatics|mydriatics|mesh-ancestor
110914501|NCT04699357|Parasympatholytics|parasympatholytics|mesh-ancestor
110914502|NCT04699357|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110914503|NCT04699357|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110914504|NCT04699357|Cholinergic Agents|cholinergic agents|mesh-ancestor
110914505|NCT04699357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110914506|NCT04699357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110914507|NCT03030118|Hydroxychloroquine|hydroxychloroquine|mesh-list
110914508|NCT03030118|Antimalarials|antimalarials|mesh-ancestor
110914509|NCT03030118|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110914510|NCT03030118|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110914511|NCT03030118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110914512|NCT03030118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110914513|NCT03030118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110914514|NCT03030118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110914515|NCT05198531|Gemcitabine|gemcitabine|mesh-list
110914516|NCT05198531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110914517|NCT05198531|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110914518|NCT05198531|Antimetabolites|antimetabolites|mesh-ancestor
110914519|NCT05198531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110914520|NCT01869829|Antifungal Agents|antifungal agents|mesh-list
110914521|NCT01869829|Clotrimazole|clotrimazole|mesh-list
110914522|NCT01869829|Miconazole|miconazole|mesh-list
110914523|NCT01869829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110914524|NCT01869829|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110914525|NCT01869829|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110914526|NCT01869829|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110914527|NCT01869829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110914528|NCT01869829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110914529|NCT01869829|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110914530|NCT01869829|Hormone Antagonists|hormone antagonists|mesh-ancestor
110914531|NCT01869829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110914532|NCT01869829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110914533|NCT01869829|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110914534|NCT01869829|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110914535|NCT02683018|Dronabinol|dronabinol|mesh-list
110914536|NCT02683018|Hallucinogens|hallucinogens|mesh-ancestor
110914537|NCT02683018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110914538|NCT02683018|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110914539|NCT02683018|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110914540|NCT02683018|Analgesics|analgesics|mesh-ancestor
110914541|NCT02683018|Sensory System Agents|sensory system agents|mesh-ancestor
110914542|NCT02683018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110914543|NCT02683018|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
110914544|NCT02683018|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110226734|NCT05356741|Pembrolizumab|pembrolizumab|mesh-list
110914545|NCT02683018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110914546|NCT02683018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110914547|NCT02683018|Hormones|hormones|mesh-ancestor
110914548|NCT02683018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110914549|NCT03982576|Nicotine|nicotine|mesh-list
110914550|NCT03982576|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110914551|NCT03982576|Autonomic Agents|autonomic agents|mesh-ancestor
110914552|NCT03982576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110914553|NCT03982576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110914554|NCT03982576|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110914555|NCT03982576|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110914556|NCT03982576|Cholinergic Agents|cholinergic agents|mesh-ancestor
110914557|NCT03982576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110914558|NCT03982576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110914559|NCT02675842|Dronabinol|dronabinol|mesh-list
110914560|NCT02675842|Hallucinogens|hallucinogens|mesh-ancestor
110914561|NCT02675842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110914562|NCT02675842|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110914563|NCT02675842|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110914564|NCT02675842|Analgesics|analgesics|mesh-ancestor
110914565|NCT02675842|Sensory System Agents|sensory system agents|mesh-ancestor
110914566|NCT02675842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110914567|NCT02675842|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
110914568|NCT02675842|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110914569|NCT02675842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110914570|NCT02675842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110914572|NCT02675842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110914573|NCT04528108|Hemostatics|hemostatics|mesh-list
110914574|NCT04528108|Coagulants|coagulants|mesh-ancestor
110914575|NCT04251689|Mannitol|mannitol|mesh-list
110914576|NCT04251689|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110914577|NCT04251689|Diuretics|diuretics|mesh-ancestor
110914578|NCT04251689|Natriuretic Agents|natriuretic agents|mesh-ancestor
110914579|NCT04251689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110914580|NCT04232423|Olanzapine|olanzapine|mesh-list
110914581|NCT04232423|Antiemetics|antiemetics|mesh-ancestor
110914582|NCT04232423|Autonomic Agents|autonomic agents|mesh-ancestor
110226797|NCT05331664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110914583|NCT04232423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110914584|NCT04232423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110914585|NCT04232423|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110914586|NCT04232423|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110914587|NCT04232423|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110914588|NCT04232423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110914589|NCT04232423|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110914590|NCT04232423|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110914591|NCT04232423|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110914592|NCT04232423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110914593|NCT04232423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110914594|NCT04232423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110914595|NCT04232423|Serotonin Agents|serotonin agents|mesh-ancestor
110914596|NCT04178993|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110914597|NCT04178993|Methylphenidate|methylphenidate|mesh-list
110914598|NCT04178993|Methamphetamine|methamphetamine|mesh-list
110914599|NCT04178993|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110914600|NCT04178993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110914601|NCT04178993|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110914602|NCT04178993|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110914603|NCT04178993|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110914604|NCT04178993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110914605|NCT04178993|Dopamine Agents|dopamine agents|mesh-ancestor
110914606|NCT04178993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110914607|NCT04178993|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110914608|NCT04178993|Analgesics|analgesics|mesh-ancestor
110914609|NCT04178993|Sensory System Agents|sensory system agents|mesh-ancestor
110914610|NCT04178993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110914611|NCT04178993|Antidepressive Agents|antidepressive agents|mesh-ancestor
110914612|NCT04178993|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110914613|NCT04178993|Sympathomimetics|sympathomimetics|mesh-ancestor
110914614|NCT04178993|Autonomic Agents|autonomic agents|mesh-ancestor
110914615|NCT04178993|Adrenergic Agents|adrenergic agents|mesh-ancestor
110914616|NCT04178993|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110914617|NCT04436536|Methamphetamine|methamphetamine|mesh-list
110914618|NCT04436536|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110914619|NCT04436536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110914620|NCT04436536|Sympathomimetics|sympathomimetics|mesh-ancestor
110914621|NCT04436536|Autonomic Agents|autonomic agents|mesh-ancestor
110914622|NCT04436536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110914623|NCT04436536|Dopamine Agents|dopamine agents|mesh-ancestor
110226905|NCT05260008|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110226906|NCT05260008|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110226907|NCT05260008|Autonomic Agents|autonomic agents|mesh-ancestor
110914625|NCT04436536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110914626|NCT04436536|Adrenergic Agents|adrenergic agents|mesh-ancestor
110914627|NCT04436536|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110914628|NCT04436536|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110914629|NCT04436536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110914630|NCT04436536|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110914631|NCT05762003|Interferons|interferons|mesh-list
110914632|NCT05762003|Teriflunomide|teriflunomide|mesh-list
110914633|NCT05762003|Rituximab|rituximab|mesh-list
110914634|NCT05762003|Alemtuzumab|alemtuzumab|mesh-list
110914635|NCT05762003|Ofatumumab|ofatumumab|mesh-list
110914636|NCT05762003|Cladribine|cladribine|mesh-list
110914637|NCT05762003|Glatiramer Acetate|glatiramer acetate|mesh-list
110914638|NCT05762003|Dimethyl Fumarate|dimethyl fumarate|mesh-list
110914639|NCT05762003|Ocrelizumab|ocrelizumab|mesh-list
110914640|NCT05762003|Natalizumab|natalizumab|mesh-list
110914641|NCT05762003|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
110914642|NCT05762003|(T,G)-A-L|(t,g)-a-l|mesh-list
110914643|NCT05762003|Ponesimod|ponesimod|mesh-list
110914644|NCT05762003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110914645|NCT05762003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110914646|NCT05762003|Immunologic Factors|immunologic factors|mesh-ancestor
110914647|NCT05762003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110914648|NCT05762003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110914649|NCT05762003|Antiviral Agents|antiviral agents|mesh-ancestor
110914650|NCT05762003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110914651|NCT05762003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110914652|NCT05762003|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
110914653|NCT05762003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110914654|NCT05762003|Dermatologic Agents|dermatologic agents|mesh-ancestor
110914655|NCT05762003|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110914656|NCT05762003|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110914657|NCT05762003|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110914658|NCT05762003|Analgesics|analgesics|mesh-ancestor
110914659|NCT05762003|Sensory System Agents|sensory system agents|mesh-ancestor
110914660|NCT05762003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110914661|NCT05762003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110914662|NCT04094012|Isoniazid|isoniazid|mesh-list
110914663|NCT04094012|Rifapentine|rifapentine|mesh-list
110914664|NCT04094012|Antitubercular Agents|antitubercular agents|mesh-ancestor
110914665|NCT04094012|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110914666|NCT04094012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110914667|NCT04094012|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
110227021|NCT05065424|Narcotics|narcotics|mesh-ancestor
110914669|NCT04094012|Antimetabolites|antimetabolites|mesh-ancestor
110914670|NCT04094012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110914671|NCT04094012|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110914672|NCT04094012|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110914673|NCT04094012|Leprostatic Agents|leprostatic agents|mesh-ancestor
110914674|NCT03679676|Omalizumab|omalizumab|mesh-list
110914675|NCT03679676|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110914676|NCT03679676|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110914677|NCT03679676|Respiratory System Agents|respiratory system agents|mesh-ancestor
110914678|NCT03001557|Lemborexant|lemborexant|mesh-list
110914679|NCT03001557|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
110914680|NCT03001557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110914681|NCT03001557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110914682|NCT03001557|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110914683|NCT03001557|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110227075|NCT05050916|Vitamin D|vitamin d|mesh-list
110914684|NCT03001557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110914685|NCT03001557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110914687|NCT03134612|Ondansetron|ondansetron|mesh-list
110914688|NCT03134612|Anesthetics, Local|anesthetics, local|mesh-ancestor
110914689|NCT03134612|Anesthetics|anesthetics|mesh-ancestor
110914690|NCT03134612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110914691|NCT03134612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110914692|NCT03134612|Sensory System Agents|sensory system agents|mesh-ancestor
110914693|NCT03134612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110914694|NCT03134612|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110914695|NCT03134612|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110914696|NCT03134612|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110914697|NCT03134612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110914698|NCT03134612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110914699|NCT03134612|Antiemetics|antiemetics|mesh-ancestor
110914700|NCT03134612|Autonomic Agents|autonomic agents|mesh-ancestor
110914701|NCT03134612|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110914702|NCT03134612|Antipruritics|antipruritics|mesh-ancestor
110914703|NCT03134612|Dermatologic Agents|dermatologic agents|mesh-ancestor
110914704|NCT03134612|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110914705|NCT03134612|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110914706|NCT03134612|Serotonin Agents|serotonin agents|mesh-ancestor
110914707|NCT03134612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110914708|NCT00831662|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110914709|NCT00831662|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110914711|NCT04365985|Ketamine|ketamine|mesh-list
110914712|NCT04365985|Analgesics|analgesics|mesh-ancestor
110914713|NCT04365985|Sensory System Agents|sensory system agents|mesh-ancestor
110914714|NCT04365985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110914715|NCT04365985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110914716|NCT04365985|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110914717|NCT04365985|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110914718|NCT04365985|Anesthetics, General|anesthetics, general|mesh-ancestor
110914719|NCT04365985|Anesthetics|anesthetics|mesh-ancestor
110914720|NCT04365985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110363928|NCT04259138|Vedolizumab|vedolizumab|mesh-list
110914721|NCT04365985|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110914722|NCT04365985|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110914723|NCT04365985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110914724|NCT04365985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110914725|NCT04365985|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110914726|NCT04365985|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110914727|NCT05111860|Bevacizumab|bevacizumab|mesh-list
110914728|NCT05111860|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110914729|NCT05111860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110914730|NCT05111860|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110914731|NCT05111860|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110914732|NCT05111860|Growth Substances|growth substances|mesh-ancestor
110914733|NCT05111860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110914734|NCT05111860|Growth Inhibitors|growth inhibitors|mesh-ancestor
110914735|NCT00830336|Azithromycin|azithromycin|mesh-list
110914736|NCT00830336|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110914737|NCT00830336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110914738|NCT00830258|Pravastatin|pravastatin|mesh-list
110914739|NCT00830258|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110914740|NCT00830258|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110914741|NCT00830258|Antimetabolites|antimetabolites|mesh-ancestor
110914742|NCT00830258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110914743|NCT00830258|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110914744|NCT00830258|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110914745|NCT00830258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110914746|NCT00830102|Fluticasone|fluticasone|mesh-list
110914747|NCT00830102|Xhance|xhance|mesh-list
110914748|NCT00830102|Formoterol Fumarate|formoterol fumarate|mesh-list
110914749|NCT00830102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110914750|NCT00830102|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110914751|NCT00830102|Autonomic Agents|autonomic agents|mesh-ancestor
110914752|NCT00830102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110914753|NCT00830102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110914754|NCT00830102|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110914755|NCT00830102|Respiratory System Agents|respiratory system agents|mesh-ancestor
110914756|NCT00830102|Dermatologic Agents|dermatologic agents|mesh-ancestor
110914757|NCT00830102|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110914758|NCT00830102|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110914759|NCT00830102|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110914760|NCT00830102|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110914761|NCT00830102|Adrenergic Agents|adrenergic agents|mesh-ancestor
110914762|NCT00830102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110914763|NCT00830102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110914764|NCT03349775|Metformin|metformin|mesh-list
110914765|NCT03349775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110914766|NCT03349775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110914767|NCT00830024|Alprazolam|alprazolam|mesh-list
110914768|NCT00830024|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110914769|NCT00830024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110914770|NCT00830024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110914771|NCT00830024|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110914772|NCT00830024|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110914773|NCT00830024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110914774|NCT00830024|GABA Modulators|gaba modulators|mesh-ancestor
110914775|NCT00830024|GABA Agents|gaba agents|mesh-ancestor
110914776|NCT00830024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110914777|NCT00830024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110914778|NCT00829868|Zaleplon|zaleplon|mesh-list
110914779|NCT00829868|Anticonvulsants|anticonvulsants|mesh-ancestor
110914780|NCT00829868|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110914781|NCT00829868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110914782|NCT00829868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110914784|NCT00829868|GABA Agents|gaba agents|mesh-ancestor
110914785|NCT00829868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110914786|NCT00829868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110914787|NCT00721760|Enoxaparin|enoxaparin|mesh-list
110914788|NCT00721760|Semuloparin|semuloparin|mesh-list
110914789|NCT00721760|Enoxaparin sodium|enoxaparin sodium|mesh-list
110914790|NCT00721760|Anticoagulants|anticoagulants|mesh-ancestor
110914791|NCT00721760|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110914792|NCT00721760|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110914793|NCT00721760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110914794|NCT04491370|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
110914795|NCT04491370|Immunoconjugates|immunoconjugates|mesh-ancestor
110914796|NCT04491370|Immunologic Factors|immunologic factors|mesh-ancestor
110914797|NCT04491370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110914798|NCT00829790|Doxycycline|doxycycline|mesh-list
110914799|NCT00829790|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110914800|NCT00829790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110914801|NCT00829790|Antimalarials|antimalarials|mesh-ancestor
110914802|NCT00829790|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110914803|NCT00829790|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110914804|NCT03207815|Prednisone|prednisone|mesh-list
110914805|NCT03207815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110914806|NCT03207815|Glucocorticoids|glucocorticoids|mesh-ancestor
110914807|NCT03207815|Hormones|hormones|mesh-ancestor
110914808|NCT03207815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110914809|NCT03207815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110914810|NCT03207815|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110914811|NCT03207815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110914812|NCT02911935|Azithromycin|azithromycin|mesh-list
110914813|NCT02911935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110914814|NCT02911935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110914815|NCT05193487|Anesthetics|anesthetics|mesh-list
110914816|NCT05193487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110914817|NCT05193487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110914818|NCT03479762|Liraglutide|liraglutide|mesh-list
110914819|NCT03479762|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110914820|NCT03479762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110914821|NCT03479762|Incretins|incretins|mesh-ancestor
110914822|NCT03479762|Hormones|hormones|mesh-ancestor
110914823|NCT03479762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110914824|NCT00829712|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
110914825|NCT00829712|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110914826|NCT00829712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110914827|NCT00829712|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110914828|NCT00829712|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110632335|NCT00803972|Insulin|insulin|mesh-list
110914829|NCT00829712|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110914830|NCT00829712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110914831|NCT00829712|Dopamine Agents|dopamine agents|mesh-ancestor
110914832|NCT00829712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110914833|NCT05079802|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110914834|NCT05079802|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
110914835|NCT05079802|Chitosan|chitosan|mesh-list
110914836|NCT05079802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110914837|NCT05079802|Antitubercular Agents|antitubercular agents|mesh-ancestor
110914838|NCT05079802|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110914839|NCT05079802|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110914840|NCT05079802|Antimetabolites|antimetabolites|mesh-ancestor
110914841|NCT05079802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110914842|NCT05079802|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110914843|NCT05079802|Chelating Agents|chelating agents|mesh-ancestor
110914844|NCT05079802|Sequestering Agents|sequestering agents|mesh-ancestor
110914845|NCT05079802|Hemostatics|hemostatics|mesh-ancestor
110914846|NCT05079802|Coagulants|coagulants|mesh-ancestor
110914847|NCT05203055|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110914848|NCT05203055|Interferon-alpha|interferon-alpha|mesh-list
110914849|NCT05203055|Antiviral Agents|antiviral agents|mesh-ancestor
110914850|NCT05203055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110914851|NCT05203055|Immunologic Factors|immunologic factors|mesh-ancestor
110914852|NCT05203055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110914853|NCT03899636|Folfirinox|folfirinox|mesh-list
110914854|NCT03899636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110914855|NCT03386942|Farletuzumab|farletuzumab|mesh-list
110227507|NCT04630002|Ritonavir|ritonavir|mesh-list
110914856|NCT03386942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110914857|NCT04910230|Niacinamide|niacinamide|mesh-list
110914858|NCT04910230|Niacin|niacin|mesh-list
110914859|NCT04910230|Nicotinic Acids|nicotinic acids|mesh-list
110914860|NCT04910230|Vitamin B Complex|vitamin b complex|mesh-ancestor
110914861|NCT04910230|Vitamins|vitamins|mesh-ancestor
110914862|NCT04910230|Micronutrients|micronutrients|mesh-ancestor
110914863|NCT04910230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110914864|NCT04910230|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110914865|NCT04910230|Antimetabolites|antimetabolites|mesh-ancestor
110914866|NCT04910230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110914867|NCT04910230|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110227638|NCT04526197|Celecoxib|celecoxib|mesh-list
110914868|NCT04910230|Vasodilator Agents|vasodilator agents|mesh-ancestor
110914869|NCT04995094|Pembrolizumab|pembrolizumab|mesh-list
110914870|NCT04995094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110914871|NCT04995094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110914872|NCT04995094|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110914873|NCT04995094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110914874|NCT05202821|Fluorides|fluorides|mesh-list
110914875|NCT05202821|Fluorides, Topical|fluorides, topical|mesh-list
110914876|NCT05202821|Cariostatic Agents|cariostatic agents|mesh-ancestor
110914877|NCT05202821|Protective Agents|protective agents|mesh-ancestor
110914878|NCT05202821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110914879|NCT02560805|Losartan|losartan|mesh-list
110914880|NCT02560805|Atenolol|atenolol|mesh-list
110914881|NCT02560805|Nitroprusside|nitroprusside|mesh-list
110914882|NCT02560805|Phenylephrine|phenylephrine|mesh-list
110914883|NCT02560805|Oxymetazoline|oxymetazoline|mesh-list
110914884|NCT02560805|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110914885|NCT02560805|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110914886|NCT02560805|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110914887|NCT02560805|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110914888|NCT02560805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110914889|NCT02560805|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110914890|NCT02560805|Mydriatics|mydriatics|mesh-ancestor
110914891|NCT02560805|Autonomic Agents|autonomic agents|mesh-ancestor
110914892|NCT02560805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110914893|NCT02560805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110914894|NCT02560805|Sympathomimetics|sympathomimetics|mesh-ancestor
110914895|NCT02560805|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110227701|NCT04447027|Antimetabolites|antimetabolites|mesh-ancestor
110914896|NCT02560805|Nasal Decongestants|nasal decongestants|mesh-ancestor
110914897|NCT02560805|Respiratory System Agents|respiratory system agents|mesh-ancestor
110914898|NCT02560805|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110914899|NCT02560805|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110914900|NCT02560805|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110914901|NCT02560805|Adrenergic Agents|adrenergic agents|mesh-ancestor
110276176|NCT04111315|Dipyrone|dipyrone|mesh-list
110914902|NCT02560805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110914903|NCT02560805|Protective Agents|protective agents|mesh-ancestor
110914904|NCT02560805|Sympatholytics|sympatholytics|mesh-ancestor
110914905|NCT02560805|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110914906|NCT02560805|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110914907|NCT02560805|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110363967|NCT01712451|Fluticasone|fluticasone|mesh-list
110914908|NCT02560805|Vasodilator Agents|vasodilator agents|mesh-ancestor
110914909|NCT02560805|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
110914910|NCT04615936|Methylene Blue|methylene blue|mesh-list
110914911|NCT04615936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110914912|NCT04615936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110914913|NCT03797222|Vitamin E|vitamin e|mesh-list
110914914|NCT03797222|Tocopherols|tocopherols|mesh-list
110914915|NCT03797222|alpha-Tocopherol|alpha-tocopherol|mesh-list
110914916|NCT03797222|Vitamins|vitamins|mesh-ancestor
110914917|NCT03797222|Micronutrients|micronutrients|mesh-ancestor
110914918|NCT03797222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110914919|NCT03797222|Antioxidants|antioxidants|mesh-ancestor
110914920|NCT03797222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110914921|NCT03797222|Protective Agents|protective agents|mesh-ancestor
110914922|NCT04471675|Docetaxel|docetaxel|mesh-list
110914923|NCT04471675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110914924|NCT04471675|Tubulin Modulators|tubulin modulators|mesh-ancestor
110914925|NCT04471675|Antimitotic Agents|antimitotic agents|mesh-ancestor
110914926|NCT04471675|Mitosis Modulators|mitosis modulators|mesh-ancestor
110914927|NCT04471675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110914928|NCT04461028|Dexamethasone|dexamethasone|mesh-list
110914929|NCT04461028|Bupivacaine|bupivacaine|mesh-list
110914930|NCT04461028|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110914931|NCT04461028|Antiemetics|antiemetics|mesh-ancestor
110914932|NCT04461028|Autonomic Agents|autonomic agents|mesh-ancestor
110227807|NCT04288778|Metformin|metformin|mesh-list
110914933|NCT04461028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110914934|NCT04461028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110914935|NCT04461028|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110914936|NCT04461028|Glucocorticoids|glucocorticoids|mesh-ancestor
110914937|NCT04461028|Hormones|hormones|mesh-ancestor
110914938|NCT04461028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110914939|NCT04461028|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110914940|NCT04461028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110914941|NCT04461028|Anesthetics, Local|anesthetics, local|mesh-ancestor
110914942|NCT04461028|Anesthetics|anesthetics|mesh-ancestor
110914943|NCT04461028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110914944|NCT04461028|Sensory System Agents|sensory system agents|mesh-ancestor
110914945|NCT00716534|Paclitaxel|paclitaxel|mesh-list
110914946|NCT00716534|Carboplatin|carboplatin|mesh-list
110914947|NCT00716534|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110914948|NCT00716534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110914949|NCT00716534|Tubulin Modulators|tubulin modulators|mesh-ancestor
110914950|NCT00716534|Antimitotic Agents|antimitotic agents|mesh-ancestor
110914951|NCT00716534|Mitosis Modulators|mitosis modulators|mesh-ancestor
110227923|NCT04230265|Alkylating Agents|alkylating agents|mesh-ancestor
110914952|NCT00716534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110914953|NCT02283476|Gemcitabine|gemcitabine|mesh-list
110914954|NCT02283476|Endostar protein|endostar protein|mesh-list
110914955|NCT02283476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110914956|NCT02283476|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110914957|NCT02283476|Antimetabolites|antimetabolites|mesh-ancestor
110914958|NCT02283476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110914959|NCT02283476|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110914960|NCT02283476|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110227989|NCT04177004|Sirolimus|sirolimus|mesh-list
110914961|NCT02283476|Growth Substances|growth substances|mesh-ancestor
110914962|NCT02283476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110914963|NCT02283476|Growth Inhibitors|growth inhibitors|mesh-ancestor
110914965|NCT05156879|Drospirenone|drospirenone|mesh-list
110914966|NCT05156879|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110914967|NCT05156879|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
110914968|NCT05156879|Estradiol|estradiol|mesh-list
110914969|NCT05156879|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110914970|NCT05156879|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110914971|NCT05156879|Analgesics|analgesics|mesh-ancestor
110914972|NCT05156879|Sensory System Agents|sensory system agents|mesh-ancestor
110914973|NCT05156879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110914974|NCT05156879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110914975|NCT05156879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110914976|NCT05156879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110914977|NCT05156879|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110914978|NCT05156879|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110914979|NCT05156879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110914980|NCT05156879|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110914981|NCT05156879|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110632485|NCT00659438|Bicalutamide|bicalutamide|mesh-list
110914982|NCT05156879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110914983|NCT05156879|Antipyretics|antipyretics|mesh-ancestor
110914984|NCT05156879|Estrogens|estrogens|mesh-ancestor
110914986|NCT05156879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110914987|NCT05156879|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110914988|NCT05156879|Contraceptive Agents|contraceptive agents|mesh-ancestor
110914989|NCT05156879|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110914990|NCT05156879|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110914991|NCT05156879|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110914992|NCT05156879|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110914993|NCT05156879|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110914994|NCT05156879|Hormone Antagonists|hormone antagonists|mesh-ancestor
110228057|NCT04164069|Micronutrients|micronutrients|mesh-ancestor
110914996|NCT05156879|Diuretics|diuretics|mesh-ancestor
110914997|NCT05156879|Natriuretic Agents|natriuretic agents|mesh-ancestor
110914998|NCT02283554|Metformin|metformin|mesh-list
110914999|NCT02283554|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110915000|NCT02283554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110915001|NCT00641732|Enoxaparin|enoxaparin|mesh-list
110915002|NCT00641732|1-(1-(3-((6-chloronaphthalen-2-yl)sulfonyl)-2-hydroxypropanoyl)piperidin-4-yl)tetrahydropyrimidin-2(1H)-one|1-(1-(3-((6-chloronaphthalen-2-yl)sulfonyl)-2-hydroxypropanoyl)piperidin-4-yl)tetrahydropyrimidin-2(1h)-one|mesh-list
110915003|NCT00641732|Anticoagulants|anticoagulants|mesh-ancestor
110915004|NCT00641732|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110915005|NCT00641732|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110915006|NCT00641732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110915007|NCT00641732|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110915008|NCT00641732|Antithrombins|antithrombins|mesh-ancestor
110915009|NCT00641732|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110915010|NCT00641732|Protease Inhibitors|protease inhibitors|mesh-ancestor
110915011|NCT00641732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110915012|NCT00790829|Nicotine|nicotine|mesh-list
110915013|NCT00790829|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110915014|NCT00790829|Autonomic Agents|autonomic agents|mesh-ancestor
110915015|NCT00790829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110915016|NCT00790829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110915017|NCT00790829|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110915018|NCT00790829|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110915019|NCT00790829|Cholinergic Agents|cholinergic agents|mesh-ancestor
110915020|NCT00790829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110915021|NCT00790829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110915022|NCT00640484|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110915023|NCT00640484|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110915024|NCT00640484|Autonomic Agents|autonomic agents|mesh-ancestor
110915025|NCT00640484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110915026|NCT00640484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110915027|NCT00640484|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110915028|NCT00640484|Respiratory System Agents|respiratory system agents|mesh-ancestor
110915029|NCT00640484|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110915030|NCT00640484|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110915031|NCT00640484|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110915032|NCT00640484|Adrenergic Agents|adrenergic agents|mesh-ancestor
110915033|NCT00640484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110915034|NCT00640484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110915036|NCT03065933|Analgesics|analgesics|mesh-ancestor
110915037|NCT03065933|Sensory System Agents|sensory system agents|mesh-ancestor
110915038|NCT03065933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110915039|NCT03065933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110915040|NCT03065933|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110915041|NCT03065933|Sympatholytics|sympatholytics|mesh-ancestor
110915042|NCT03065933|Autonomic Agents|autonomic agents|mesh-ancestor
110915043|NCT03065933|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110915044|NCT03065933|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110915045|NCT03065933|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110915046|NCT03065933|Adrenergic Agents|adrenergic agents|mesh-ancestor
110915047|NCT03065933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110915048|NCT03065933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110915049|NCT00630656|Talactoferrin alfa|talactoferrin alfa|mesh-list
110915050|NCT00630656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110915051|NCT04256629|Allopurinol|allopurinol|mesh-list
110915052|NCT04256629|Verinurad|verinurad|mesh-list
110915053|NCT04256629|Antimetabolites|antimetabolites|mesh-ancestor
110915054|NCT04256629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110915055|NCT04256629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110915056|NCT04256629|Gout Suppressants|gout suppressants|mesh-ancestor
110915057|NCT04256629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110915058|NCT04256629|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110915059|NCT04256629|Antioxidants|antioxidants|mesh-ancestor
110915060|NCT04256629|Protective Agents|protective agents|mesh-ancestor
110915061|NCT04256629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110915062|NCT05206721|Chlorhexidine|chlorhexidine|mesh-list
110915063|NCT05206721|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110915064|NCT05206721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110915065|NCT05206721|Disinfectants|disinfectants|mesh-ancestor
110915066|NCT00696332|alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid|alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid|mesh-list
110915067|NCT00696332|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
110915068|NCT00696332|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110915069|NCT00696332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110915070|NCT00696332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110915071|NCT00696332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110915073|NCT05125523|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110915074|NCT05125523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110915075|NCT05125523|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110915076|NCT05125523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110915077|NCT05125523|Antifungal Agents|antifungal agents|mesh-ancestor
110915078|NCT05125523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110915079|NCT05125523|Immunologic Factors|immunologic factors|mesh-ancestor
110915080|NCT05125523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110915081|NCT00625664|Gemcitabine|gemcitabine|mesh-list
110915082|NCT00625664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110915083|NCT00625664|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110915084|NCT00625664|Antimetabolites|antimetabolites|mesh-ancestor
110915085|NCT00625664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110915086|NCT02947165|Spartalizumab|spartalizumab|mesh-list
110364001|NCT04669821|Anesthetics|anesthetics|mesh-ancestor
110915087|NCT02947165|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110915088|NCT02947165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110915089|NCT02947165|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110915090|NCT02947165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110915091|NCT03629093|Anesthetics|anesthetics|mesh-list
110915092|NCT03629093|Anesthetics, General|anesthetics, general|mesh-list
110915093|NCT03629093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110915094|NCT03629093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110915095|NCT02283710|Pentoxifylline|pentoxifylline|mesh-list
110915096|NCT02283710|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110915097|NCT02283710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110915098|NCT02283710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110915099|NCT02283710|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110915100|NCT02283710|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110915101|NCT02283710|Protective Agents|protective agents|mesh-ancestor
110915102|NCT02283710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110915103|NCT02283710|Vasodilator Agents|vasodilator agents|mesh-ancestor
110915104|NCT02283710|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110915105|NCT02283710|Antioxidants|antioxidants|mesh-ancestor
110915106|NCT05055947|Atezolizumab|atezolizumab|mesh-list
110915107|NCT05055947|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110228365|NCT03726268|Fentanyl|fentanyl|mesh-list
110915108|NCT05055947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110915109|NCT05055947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110915110|NCT05055947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110915112|NCT03943342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110915113|NCT00357565|Cyclosporine|cyclosporine|mesh-list
110915114|NCT00357565|Mycophenolic Acid|mycophenolic acid|mesh-list
110915115|NCT00357565|Fludarabine|fludarabine|mesh-list
110915116|NCT00357565|Fludarabine phosphate|fludarabine phosphate|mesh-list
110915117|NCT00357565|Melphalan|melphalan|mesh-list
110915118|NCT00357565|Busulfan|busulfan|mesh-list
110915119|NCT00357565|Cyclosporins|cyclosporins|mesh-list
110915120|NCT00357565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110915121|NCT00357565|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110915122|NCT00357565|Antimetabolites|antimetabolites|mesh-ancestor
110915123|NCT00357565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110915124|NCT00357565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110915125|NCT00357565|Immunologic Factors|immunologic factors|mesh-ancestor
110915126|NCT00357565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110915127|NCT00357565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110915128|NCT00357565|Antifungal Agents|antifungal agents|mesh-ancestor
110915129|NCT00357565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110915130|NCT00357565|Dermatologic Agents|dermatologic agents|mesh-ancestor
110915131|NCT00357565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110915132|NCT00357565|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110915133|NCT00357565|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110915134|NCT00357565|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110915135|NCT00357565|Antitubercular Agents|antitubercular agents|mesh-ancestor
110915136|NCT00357565|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110915137|NCT00357565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110915138|NCT00357565|Alkylating Agents|alkylating agents|mesh-ancestor
110915139|NCT00357565|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110915140|NCT00694928|Clindamycin|clindamycin|mesh-list
110915141|NCT00694928|Clindamycin palmitate|clindamycin palmitate|mesh-list
110915142|NCT00694928|Clindamycin phosphate|clindamycin phosphate|mesh-list
110915143|NCT00694928|Butoconazole|butoconazole|mesh-list
110915144|NCT00694928|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110915145|NCT00694928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110915146|NCT00694928|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110915148|NCT00694928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110915149|NCT00694928|Antifungal Agents|antifungal agents|mesh-ancestor
110915150|NCT00694382|Semuloparin|semuloparin|mesh-list
110364022|NCT00533312|Antimetabolites|antimetabolites|mesh-ancestor
110915151|NCT00694382|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
110915152|NCT00694382|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110915153|NCT00694382|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110915154|NCT00694382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110915155|NCT00694382|Anticoagulants|anticoagulants|mesh-ancestor
110915156|NCT05116228|Rituximab|rituximab|mesh-list
110915157|NCT05116228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110915158|NCT05116228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110915159|NCT05116228|Immunologic Factors|immunologic factors|mesh-ancestor
110915160|NCT05116228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110915161|NCT05116228|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110915162|NCT05116150|Grape Seed Extract|grape seed extract|mesh-list
110228543|NCT03463057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110915163|NCT05116150|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110915164|NCT05116150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110915165|NCT05116150|Antioxidants|antioxidants|mesh-ancestor
110915166|NCT05116150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110915167|NCT05116150|Protective Agents|protective agents|mesh-ancestor
110915168|NCT05116150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110915169|NCT00136903|Cyclosporine|cyclosporine|mesh-list
110915170|NCT00136903|Mycophenolic Acid|mycophenolic acid|mesh-list
110915171|NCT00136903|Remestemcel-l|remestemcel-l|mesh-list
110915173|NCT00136903|Methylprednisolone|methylprednisolone|mesh-list
110915174|NCT00136903|Tacrolimus|tacrolimus|mesh-list
110915175|NCT00136903|Cyclosporins|cyclosporins|mesh-list
110915176|NCT00136903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110915177|NCT00136903|Glucocorticoids|glucocorticoids|mesh-ancestor
110915178|NCT00136903|Hormones|hormones|mesh-ancestor
110915179|NCT00136903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110915180|NCT00136903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110915181|NCT00136903|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110915182|NCT00136903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110915183|NCT00136903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110915184|NCT00136903|Immunologic Factors|immunologic factors|mesh-ancestor
110915185|NCT00136903|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110915186|NCT00136903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110915187|NCT00136903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110915188|NCT00136903|Antifungal Agents|antifungal agents|mesh-ancestor
110915189|NCT00136903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110915190|NCT00136903|Dermatologic Agents|dermatologic agents|mesh-ancestor
110915191|NCT00136903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110915192|NCT00136903|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110915193|NCT00136903|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110915194|NCT00136903|Antitubercular Agents|antitubercular agents|mesh-ancestor
110915195|NCT00136903|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110915196|NCT00136903|Antiemetics|antiemetics|mesh-ancestor
110915197|NCT00136903|Autonomic Agents|autonomic agents|mesh-ancestor
110228604|NCT03399981|Natalizumab|natalizumab|mesh-list
110915198|NCT00136903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110915199|NCT00136903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110915200|NCT00136903|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110915201|NCT00136903|Protective Agents|protective agents|mesh-ancestor
110915202|NCT00136903|Antiviral Agents|antiviral agents|mesh-ancestor
110632708|NCT00655928|Acetylcysteine|acetylcysteine|mesh-list
110915203|NCT04917029|Dexmedetomidine|dexmedetomidine|mesh-list
110915204|NCT04917029|Bupivacaine|bupivacaine|mesh-list
110915205|NCT04917029|Anesthetics, Local|anesthetics, local|mesh-ancestor
110915206|NCT04917029|Anesthetics|anesthetics|mesh-ancestor
110915207|NCT04917029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110915208|NCT04917029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110915209|NCT04917029|Sensory System Agents|sensory system agents|mesh-ancestor
110915210|NCT04917029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110915211|NCT04917029|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110927797|NCT05003596|Analgesics|analgesics|mesh-ancestor
110915212|NCT04917029|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110915214|NCT04917029|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110915215|NCT04917029|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110915216|NCT04917029|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110915217|NCT04917029|Adrenergic Agents|adrenergic agents|mesh-ancestor
110915218|NCT04917029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110915219|NCT04917029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110915221|NCT04189510|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110915222|NCT03632759|Liraglutide|liraglutide|mesh-list
110915223|NCT03632759|Golimumab|golimumab|mesh-list
110915224|NCT03632759|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110915225|NCT03632759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110915226|NCT03632759|Incretins|incretins|mesh-ancestor
110915227|NCT03632759|Hormones|hormones|mesh-ancestor
110915228|NCT03632759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110915229|NCT03632759|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110915230|NCT03632759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110915231|NCT03632759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110915232|NCT03632759|Immunologic Factors|immunologic factors|mesh-ancestor
110915233|NCT02953093|Acarbose|acarbose|mesh-list
110915234|NCT02953093|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
110915235|NCT02953093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110915236|NCT02953093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110915237|NCT02953093|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110915238|NCT02953093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110915239|NCT04518280|Capecitabine|capecitabine|mesh-list
110915240|NCT04518280|Oxaliplatin|oxaliplatin|mesh-list
110915241|NCT04518280|Antibodies|antibodies|mesh-list
110915242|NCT04518280|Immunologic Factors|immunologic factors|mesh-ancestor
110915243|NCT04518280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110915244|NCT04518280|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110915245|NCT04518280|Antimetabolites|antimetabolites|mesh-ancestor
110915246|NCT04518280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110915247|NCT04518280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110915248|NCT00498836|Sorafenib|sorafenib|mesh-list
110915249|NCT00498836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110915250|NCT00498836|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110915251|NCT00498836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110915252|NCT00498836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110915253|NCT02283866|Desflurane|desflurane|mesh-list
110915254|NCT02283866|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110915255|NCT02283866|Anesthetics, General|anesthetics, general|mesh-ancestor
110915256|NCT02283866|Anesthetics|anesthetics|mesh-ancestor
110915257|NCT02283866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110915258|NCT02283866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110915259|NCT04517110|Pregabalin|pregabalin|mesh-list
110915260|NCT04517110|Analgesics|analgesics|mesh-ancestor
110915261|NCT04517110|Sensory System Agents|sensory system agents|mesh-ancestor
110915262|NCT04517110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110915263|NCT04517110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110915264|NCT04517110|Anticonvulsants|anticonvulsants|mesh-ancestor
110915265|NCT04517110|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110915266|NCT04517110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110915267|NCT04517110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110915268|NCT04517110|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110915269|NCT04517110|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110915270|NCT04517110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110915271|NCT04517110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110915272|NCT04517110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110915273|NCT00498212|1018 oligonucleotide|1018 oligonucleotide|mesh-list
110915274|NCT00498212|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110915275|NCT00498212|Immunologic Factors|immunologic factors|mesh-ancestor
110915276|NCT00498212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110915278|NCT02281058|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110915279|NCT02281058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110915280|NCT02281058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110915281|NCT02281058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110915282|NCT02281058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110228789|NCT03216967|Everolimus|everolimus|mesh-list
110915284|NCT02281058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110915285|NCT02281058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110915286|NCT02784262|Botulinum Toxins|botulinum toxins|mesh-list
110915287|NCT02784262|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110915288|NCT02784262|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110915289|NCT02784262|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110915290|NCT02784262|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110915291|NCT02784262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110915292|NCT02784262|Cholinergic Agents|cholinergic agents|mesh-ancestor
110915293|NCT02784262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110915294|NCT02784262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110915295|NCT02784262|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110915296|NCT02784262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110915297|NCT05205317|Metformin|metformin|mesh-list
110915298|NCT05205317|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110915299|NCT05205317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110915300|NCT00691964|Etanercept|etanercept|mesh-list
110915301|NCT00691964|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110915302|NCT00691964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110915303|NCT00691964|Analgesics|analgesics|mesh-ancestor
110915304|NCT00691964|Sensory System Agents|sensory system agents|mesh-ancestor
110915305|NCT00691964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110915306|NCT00691964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110915307|NCT00691964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110915308|NCT00691964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110915309|NCT00691964|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110915310|NCT00691964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110915311|NCT00691964|Immunologic Factors|immunologic factors|mesh-ancestor
110915312|NCT04470908|Rifabutin|rifabutin|mesh-list
110915313|NCT04470908|Zanubrutinib|zanubrutinib|mesh-list
110915314|NCT04470908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110915315|NCT04470908|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110915316|NCT04470908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110915317|NCT04470908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110915318|NCT04470908|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110915319|NCT04470908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110915320|NCT04470908|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110915321|NCT04470908|Antitubercular Agents|antitubercular agents|mesh-ancestor
110915322|NCT02281292|Ranibizumab|ranibizumab|mesh-list
110915323|NCT02281292|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110915324|NCT02281292|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110915325|NCT02281292|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110915326|NCT02281292|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110915327|NCT02281292|Growth Substances|growth substances|mesh-ancestor
110915328|NCT02281292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110915329|NCT02281292|Growth Inhibitors|growth inhibitors|mesh-ancestor
110915330|NCT02281292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110915331|NCT03723772|Insulin|insulin|mesh-list
110915332|NCT03723772|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110915333|NCT03723772|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110915334|NCT03723772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110915335|NCT02660827|Insulin|insulin|mesh-list
110915336|NCT02660827|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110915337|NCT02660827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110915338|NCT00491738|Bevacizumab|bevacizumab|mesh-list
110915339|NCT00491738|Sunitinib|sunitinib|mesh-list
110915340|NCT00491738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110915341|NCT00491738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110915342|NCT00491738|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110915343|NCT00491738|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110915344|NCT00491738|Growth Substances|growth substances|mesh-ancestor
110915345|NCT00491738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110915346|NCT00491738|Growth Inhibitors|growth inhibitors|mesh-ancestor
110915347|NCT00491738|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110915348|NCT00491738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110915349|NCT00491738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110915350|NCT02281370|Cyclosporine|cyclosporine|mesh-list
110915351|NCT02281370|Cyclosporins|cyclosporins|mesh-list
110229100|NCT02355379|Capecitabine|capecitabine|mesh-list
110915352|NCT02281370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110915353|NCT02281370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110915354|NCT02281370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110915355|NCT02281370|Immunologic Factors|immunologic factors|mesh-ancestor
110915356|NCT02281370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110229158|NCT02046395|Amlodipine|amlodipine|mesh-list
110915358|NCT02281370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110915359|NCT02281370|Dermatologic Agents|dermatologic agents|mesh-ancestor
110915360|NCT02281370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110915361|NCT02281370|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110915363|NCT00680342|Antioxidants|antioxidants|mesh-ancestor
110915364|NCT00680342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110915365|NCT00680342|Protective Agents|protective agents|mesh-ancestor
110915366|NCT00680342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110915367|NCT04057365|Nivolumab|nivolumab|mesh-list
110915368|NCT04057365|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110915369|NCT04057365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110915370|NCT04057365|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110915371|NCT04057365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110915372|NCT00616148|Cenobamate|cenobamate|mesh-list
110915373|NCT00616148|Anticonvulsants|anticonvulsants|mesh-ancestor
110915374|NCT03622827|Endostar protein|endostar protein|mesh-list
110915375|NCT03622827|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110915376|NCT03622827|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110915377|NCT03622827|Growth Substances|growth substances|mesh-ancestor
110915378|NCT03622827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110915379|NCT03622827|Growth Inhibitors|growth inhibitors|mesh-ancestor
110915380|NCT03622827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110915381|NCT00486512|Aspirin|aspirin|mesh-list
110915382|NCT00486512|Calcium, Dietary|calcium, dietary|mesh-list
110915383|NCT00486512|Calcitriol|calcitriol|mesh-list
110915384|NCT00486512|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
110915385|NCT00486512|Calcium Carbonate|calcium carbonate|mesh-list
110915386|NCT00486512|Calcium|calcium|mesh-list
110915387|NCT00486512|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110915388|NCT00486512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110915389|NCT00486512|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110915390|NCT00486512|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110915391|NCT00486512|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110915392|NCT00486512|Analgesics|analgesics|mesh-ancestor
110915393|NCT00486512|Sensory System Agents|sensory system agents|mesh-ancestor
110915394|NCT00486512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110915395|NCT00486512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110915396|NCT00486512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110915397|NCT00486512|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110915398|NCT00486512|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110915399|NCT00486512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110915400|NCT00486512|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110915401|NCT00486512|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110915402|NCT00486512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110915404|NCT00486512|Antacids|antacids|mesh-ancestor
110915405|NCT00486512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110915406|NCT00486512|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
110915407|NCT00486512|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110915408|NCT00486512|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110915409|NCT00486512|Vitamins|vitamins|mesh-ancestor
110915410|NCT00486512|Micronutrients|micronutrients|mesh-ancestor
110915411|NCT04057989|Ketamine|ketamine|mesh-list
110915412|NCT04057989|Analgesics|analgesics|mesh-ancestor
110915413|NCT04057989|Sensory System Agents|sensory system agents|mesh-ancestor
110915414|NCT04057989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110915415|NCT04057989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110915416|NCT04057989|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110915417|NCT04057989|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110915418|NCT04057989|Anesthetics, General|anesthetics, general|mesh-ancestor
110915419|NCT04057989|Anesthetics|anesthetics|mesh-ancestor
110915420|NCT04057989|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110915421|NCT04057989|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110915422|NCT04057989|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110915423|NCT04057989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110915424|NCT04057989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110915425|NCT00486200|Valacyclovir|valacyclovir|mesh-list
110915426|NCT00486200|Antiviral Agents|antiviral agents|mesh-ancestor
110915427|NCT00486200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110915428|NCT00479258|Insulin|insulin|mesh-list
110915429|NCT00479258|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110364121|NCT00533585|Sorafenib|sorafenib|mesh-list
110915431|NCT00479258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110915432|NCT00612170|Reboxetine|reboxetine|mesh-list
110915433|NCT00612170|Antidepressive Agents|antidepressive agents|mesh-ancestor
110915434|NCT00612170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110915435|NCT00612170|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110915436|NCT00612170|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110915437|NCT00612170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110915438|NCT00612170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110915439|NCT00612170|Adrenergic Agents|adrenergic agents|mesh-ancestor
110915440|NCT00612170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110915441|NCT00612170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110915442|NCT05068336|Anesthetics|anesthetics|mesh-list
110915443|NCT05068336|Sevoflurane|sevoflurane|mesh-list
110915444|NCT05068336|Desflurane|desflurane|mesh-list
110915445|NCT05068336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110915446|NCT05068336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110915447|NCT05068336|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110915448|NCT05068336|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110915449|NCT05068336|Anesthetics, General|anesthetics, general|mesh-ancestor
110915451|NCT00607256|Antidepressive Agents|antidepressive agents|mesh-ancestor
110915452|NCT00607256|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110915453|NCT00607256|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110915454|NCT00607256|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110915455|NCT00607256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110915456|NCT00607256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110915457|NCT00607256|Adrenergic Agents|adrenergic agents|mesh-ancestor
110915458|NCT00607256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110915459|NCT00607256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110915460|NCT02774590|Timolol|timolol|mesh-list
110915461|NCT02774590|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110915462|NCT02774590|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110915463|NCT02774590|Adrenergic Agents|adrenergic agents|mesh-ancestor
110915464|NCT02774590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110229515|NCT00122577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110915465|NCT02774590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110927846|NCT03608241|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110915468|NCT02774590|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110915469|NCT01069341|Ranibizumab|ranibizumab|mesh-list
110915470|NCT01069341|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110915471|NCT01069341|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110915472|NCT01069341|Growth Substances|growth substances|mesh-ancestor
110915473|NCT01069341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110915474|NCT01069341|Growth Inhibitors|growth inhibitors|mesh-ancestor
110915475|NCT01069341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110915476|NCT00676832|Prednisolone|prednisolone|mesh-list
110915477|NCT00676832|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110915478|NCT00676832|Methylprednisolone|methylprednisolone|mesh-list
110915479|NCT00676832|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110915480|NCT00676832|Prednisolone acetate|prednisolone acetate|mesh-list
110915481|NCT00676832|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110915482|NCT00676832|Prednisolone phosphate|prednisolone phosphate|mesh-list
110915483|NCT00676832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110915484|NCT00676832|Glucocorticoids|glucocorticoids|mesh-ancestor
110915485|NCT00676832|Hormones|hormones|mesh-ancestor
110915486|NCT00676832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110915487|NCT00676832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110915488|NCT00676832|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110915489|NCT00676832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110915490|NCT00676832|Antiemetics|antiemetics|mesh-ancestor
110915491|NCT00676832|Autonomic Agents|autonomic agents|mesh-ancestor
110915492|NCT00676832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110915493|NCT00676832|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110915494|NCT00676832|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110364145|NCT04659057|Lidocaine|lidocaine|mesh-list
110915495|NCT00676832|Protective Agents|protective agents|mesh-ancestor
110915496|NCT01909414|Vaccines|vaccines|mesh-list
110915497|NCT01909414|Immunologic Factors|immunologic factors|mesh-ancestor
110915498|NCT01909414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110915499|NCT00467402|Agomelatine|agomelatine|mesh-list
110915500|NCT00467402|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110915501|NCT00467402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110915502|NCT00467402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110915503|NCT02996097|Triamcinolone|triamcinolone|mesh-list
110915504|NCT02996097|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110915505|NCT02996097|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110915506|NCT02996097|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110915507|NCT02996097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110915508|NCT02996097|Glucocorticoids|glucocorticoids|mesh-ancestor
110915510|NCT02996097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110915511|NCT02996097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110915512|NCT02996097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110915513|NCT02996097|Immunologic Factors|immunologic factors|mesh-ancestor
110915514|NCT02996097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110915515|NCT02996097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110915516|NCT04054713|Acetic Acid|acetic acid|mesh-list
110915517|NCT04054713|Retinol acetate|retinol acetate|mesh-list
110915518|NCT04054713|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110915519|NCT04054713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110915520|NCT04054713|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110915521|NCT04054713|Immunologic Factors|immunologic factors|mesh-ancestor
110915522|NCT04054713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110915523|NCT04054713|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110915524|NCT04054713|Protective Agents|protective agents|mesh-ancestor
110915525|NCT04054713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110915527|NCT03314181|Bortezomib|bortezomib|mesh-list
110915528|NCT03314181|Venetoclax|venetoclax|mesh-list
110915529|NCT03314181|Daratumumab|daratumumab|mesh-list
110915530|NCT03314181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110915531|NCT03314181|Antiemetics|antiemetics|mesh-ancestor
110915532|NCT03314181|Autonomic Agents|autonomic agents|mesh-ancestor
110915533|NCT03314181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110915534|NCT03314181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110915535|NCT03314181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110915536|NCT03314181|Glucocorticoids|glucocorticoids|mesh-ancestor
110915538|NCT03314181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110915539|NCT03314181|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110915540|NCT03314181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110915541|NCT03133832|Praziquantel|praziquantel|mesh-list
110915542|NCT03133832|Anthelmintics|anthelmintics|mesh-ancestor
110915543|NCT03133832|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110229683|NCT00090909|Hormones|hormones|mesh-ancestor
110915544|NCT03133832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110915545|NCT03663465|Antipsychotic Agents|antipsychotic agents|mesh-list
110915546|NCT03663465|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110915547|NCT03663465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110915548|NCT03663465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110915549|NCT03663465|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110915550|NCT04161430|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110915551|NCT04161430|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110915552|NCT04161430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110915553|NCT04161430|Incretins|incretins|mesh-ancestor
110915554|NCT04161430|Hormones|hormones|mesh-ancestor
110229726|NCT00314743|Serotonin Agents|serotonin agents|mesh-ancestor
110915555|NCT04161430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110915556|NCT04161430|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110915557|NCT04161430|Protease Inhibitors|protease inhibitors|mesh-ancestor
110915558|NCT04161430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110915559|NCT04161430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110915560|NCT00673478|Tiotropium Bromide|tiotropium bromide|mesh-list
110915561|NCT00673478|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110915562|NCT00673478|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110915563|NCT00673478|Autonomic Agents|autonomic agents|mesh-ancestor
110915564|NCT00673478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110915565|NCT00673478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110915566|NCT00673478|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110915567|NCT00673478|Respiratory System Agents|respiratory system agents|mesh-ancestor
110915569|NCT00673478|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110915570|NCT00673478|Cholinergic Agents|cholinergic agents|mesh-ancestor
110915571|NCT00673478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110915572|NCT00673478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110915573|NCT00673478|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110915574|NCT00673478|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110915576|NCT00673478|Adrenergic Agents|adrenergic agents|mesh-ancestor
110915577|NCT02203474|Tiotropium Bromide|tiotropium bromide|mesh-list
110915578|NCT02203474|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110915579|NCT02203474|Autonomic Agents|autonomic agents|mesh-ancestor
110915580|NCT02203474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110915581|NCT02203474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110915582|NCT02203474|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110915583|NCT02203474|Respiratory System Agents|respiratory system agents|mesh-ancestor
110915584|NCT02203474|Parasympatholytics|parasympatholytics|mesh-ancestor
110915585|NCT02203474|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110915586|NCT02203474|Cholinergic Agents|cholinergic agents|mesh-ancestor
110915587|NCT02203474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110915588|NCT02203474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110915589|NCT04053699|Factor VIII|factor viii|mesh-list
110915590|NCT04053699|Coagulants|coagulants|mesh-ancestor
110915591|NCT04303000|Analgesics, Opioid|analgesics, opioid|mesh-list
110915592|NCT04303000|Naloxone|naloxone|mesh-list
110915593|NCT04303000|Narcotics|narcotics|mesh-ancestor
110645386|NCT05271162|Empagliflozin|empagliflozin|mesh-list
110915594|NCT04303000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110915595|NCT04303000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110915596|NCT04303000|Analgesics|analgesics|mesh-ancestor
110915597|NCT04303000|Sensory System Agents|sensory system agents|mesh-ancestor
110915598|NCT04303000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110915599|NCT04303000|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110915600|NCT00672386|Metformin|metformin|mesh-list
110915601|NCT00672386|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110915602|NCT00672386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110915603|NCT04056897|Teriflunomide|teriflunomide|mesh-list
110915604|NCT04056897|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110915605|NCT04056897|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110915606|NCT04056897|Analgesics|analgesics|mesh-ancestor
110915607|NCT04056897|Sensory System Agents|sensory system agents|mesh-ancestor
110915608|NCT04056897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110915609|NCT04056897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110915610|NCT04056897|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110915611|NCT04056897|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110915612|NCT04056897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110915613|NCT04056897|Immunologic Factors|immunologic factors|mesh-ancestor
110915614|NCT02281682|Fluorouracil|fluorouracil|mesh-list
110915615|NCT02281682|Imiquimod|imiquimod|mesh-list
110915616|NCT02281682|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
110915617|NCT02281682|Antimetabolites|antimetabolites|mesh-ancestor
110915618|NCT02281682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110915619|NCT02281682|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110915620|NCT02281682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110915621|NCT02281682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110915622|NCT02281682|Immunologic Factors|immunologic factors|mesh-ancestor
110915623|NCT02281682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110915624|NCT02281682|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110915625|NCT02281682|Interferon Inducers|interferon inducers|mesh-ancestor
110915626|NCT02281682|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110915627|NCT02281682|Dermatologic Agents|dermatologic agents|mesh-ancestor
110915628|NCT04057053|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110915629|NCT04057053|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110915630|NCT04056975|Antibodies|antibodies|mesh-list
110915631|NCT04056975|Immunologic Factors|immunologic factors|mesh-ancestor
110915632|NCT04056975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110915633|NCT02281916|Immunomodulating Agents|immunomodulating agents|mesh-list
110915634|NCT02281916|Immunologic Factors|immunologic factors|mesh-ancestor
110915635|NCT02281916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110915636|NCT03662763|Guanfacine|guanfacine|mesh-list
110915637|NCT03662763|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110915638|NCT03662763|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110915639|NCT03662763|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110915640|NCT03662763|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110915641|NCT03662763|Adrenergic Agents|adrenergic agents|mesh-ancestor
110915642|NCT03662763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110915643|NCT03662763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110915644|NCT03662763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110915645|NCT00458978|Cediranib|cediranib|mesh-list
110915646|NCT00458978|Maleic acid|maleic acid|mesh-list
110915647|NCT00458978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110915648|NCT00458978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110915649|NCT00458978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110915650|NCT00458978|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110915651|NCT00458276|Tezosentan|tezosentan|mesh-list
110915652|NCT00458276|Vasodilator Agents|vasodilator agents|mesh-ancestor
110915653|NCT04520074|Cyclophosphamide|cyclophosphamide|mesh-list
110915654|NCT04520074|Carboplatin|carboplatin|mesh-list
110915655|NCT04520074|Etoposide|etoposide|mesh-list
110915657|NCT04520074|Immunologic Factors|immunologic factors|mesh-ancestor
110915658|NCT04520074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110915659|NCT04520074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110915660|NCT04520074|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110915661|NCT04520074|Alkylating Agents|alkylating agents|mesh-ancestor
110915662|NCT04520074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110915663|NCT04520074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110915664|NCT04520074|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110915665|NCT04520074|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110915666|NCT04520074|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110915667|NCT04520074|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110915668|NCT04520074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110915669|NCT00455156|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110915670|NCT00455156|ST 1435|st 1435|mesh-list
110915671|NCT00455156|Estradiol|estradiol|mesh-list
110915672|NCT00455156|Estrogens|estrogens|mesh-ancestor
110915673|NCT00455156|Hormones|hormones|mesh-ancestor
110915674|NCT00455156|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110915675|NCT00455156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110915676|NCT00455156|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110915677|NCT00455156|Contraceptive Agents|contraceptive agents|mesh-ancestor
110915678|NCT00455156|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110915679|NCT00455156|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110915680|NCT00455156|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110915681|NCT00455156|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110915682|NCT03661515|Cytarabine|cytarabine|mesh-list
110915683|NCT03661515|Fludarabine|fludarabine|mesh-list
110915684|NCT03661515|Idarubicin|idarubicin|mesh-list
110915685|NCT03661515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110915686|NCT03661515|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110915687|NCT03661515|Antimetabolites|antimetabolites|mesh-ancestor
110364172|NCT00533741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110915688|NCT03661515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110915689|NCT03661515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110915690|NCT03661515|Immunologic Factors|immunologic factors|mesh-ancestor
110230111|NCT00091650|Olanzapine|olanzapine|mesh-list
110915691|NCT03661515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110915692|NCT03661515|Antiviral Agents|antiviral agents|mesh-ancestor
110915693|NCT03661515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110915694|NCT03661515|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110915695|NCT03661515|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110915696|NCT03661515|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110915697|NCT03661515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110915698|NCT01624480|Modafinil|modafinil|mesh-list
110915699|NCT01624480|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110915700|NCT01624480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110915701|NCT01624480|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
110915702|NCT01624480|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110915703|NCT01624480|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110915704|NCT01624480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110915705|NCT00448058|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
110915706|NCT00448058|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110915707|NCT00448058|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110915708|NCT00448058|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110915709|NCT00448058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110915710|NCT00448058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110915711|NCT00448058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110915712|NCT00448058|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110915713|NCT00448058|Antidepressive Agents|antidepressive agents|mesh-ancestor
110915714|NCT00448058|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110915715|NCT02284412|Neostigmine|neostigmine|mesh-list
110915716|NCT02284412|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110915717|NCT02284412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110230225|NCT00327769|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110927889|NCT03607149|Pemetrexed|pemetrexed|mesh-list
110915718|NCT02284412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110915719|NCT02284412|Cholinergic Agents|cholinergic agents|mesh-ancestor
110915720|NCT02284412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110915721|NCT02284412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110915722|NCT02284412|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110915723|NCT02284412|Autonomic Agents|autonomic agents|mesh-ancestor
110915724|NCT02284412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110915725|NCT02284490|Pemetrexed|pemetrexed|mesh-list
110915726|NCT02284490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110915727|NCT02284490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110915728|NCT02284490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110915729|NCT02284490|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110915730|NCT02284490|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110915731|NCT02273570|Vitamin D|vitamin d|mesh-list
110915732|NCT02273570|Calcium|calcium|mesh-list
110915733|NCT02273570|Vitamins|vitamins|mesh-ancestor
110915734|NCT02273570|Micronutrients|micronutrients|mesh-ancestor
110915735|NCT02273570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110915736|NCT02273570|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110915737|NCT02273570|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110915738|NCT02282150|Hydrocortisone|hydrocortisone|mesh-list
110915739|NCT02282150|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
110364194|NCT00533936|Paclitaxel|paclitaxel|mesh-list
110915740|NCT02282150|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
110915741|NCT02282150|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
110915742|NCT02282150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110915743|NCT00579020|Moxifloxacin|moxifloxacin|mesh-list
110915744|NCT00579020|Dexamethasone|dexamethasone|mesh-list
110915745|NCT00579020|Dexamethasone acetate|dexamethasone acetate|mesh-list
110915746|NCT00579020|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110915747|NCT00579020|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110915748|NCT00579020|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
110915749|NCT00579020|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
110915750|NCT00579020|BB 1101|bb 1101|mesh-list
110915751|NCT00579020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110915752|NCT00579020|Antiemetics|antiemetics|mesh-ancestor
110915753|NCT00579020|Autonomic Agents|autonomic agents|mesh-ancestor
110915754|NCT00579020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110915755|NCT00579020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110915756|NCT00579020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110915757|NCT00579020|Glucocorticoids|glucocorticoids|mesh-ancestor
110915758|NCT00579020|Hormones|hormones|mesh-ancestor
110915759|NCT00579020|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110915760|NCT00579020|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110915761|NCT00579020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110915762|NCT00579020|Protease Inhibitors|protease inhibitors|mesh-ancestor
110915763|NCT00579020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110230404|NCT00123552|Artemether|artemether|mesh-list
110915764|NCT00579020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110915765|NCT00579020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110915766|NCT00579020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110915767|NCT00579020|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110915768|NCT00579020|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110915769|NCT00579020|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110915770|NCT00579020|Contraceptive Agents|contraceptive agents|mesh-ancestor
110915771|NCT00579020|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110915772|NCT00579020|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110915773|NCT00579020|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110915774|NCT00579020|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110915775|NCT04530604|Defibrotide|defibrotide|mesh-list
110915776|NCT04530604|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110915777|NCT04530604|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110927896|NCT04998838|Immunoglobulins|immunoglobulins|mesh-list
110915778|NCT04530604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110915779|NCT04530604|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110915780|NCT04169698|Denosumab|denosumab|mesh-list
110915781|NCT04169698|Alendronate|alendronate|mesh-list
110915782|NCT04169698|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110915783|NCT04169698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110915784|NCT04470752|Capsaicin|capsaicin|mesh-list
110915785|NCT04470752|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110915786|NCT04470752|Antipruritics|antipruritics|mesh-ancestor
110915787|NCT04470752|Dermatologic Agents|dermatologic agents|mesh-ancestor
110915788|NCT04470752|Sensory System Agents|sensory system agents|mesh-ancestor
110915789|NCT04470752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110230538|NCT00316927|Fosfestrol|fosfestrol|mesh-list
110915790|NCT04470752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110915791|NCT02273804|Topiramate|topiramate|mesh-list
110915792|NCT02273804|Anticonvulsants|anticonvulsants|mesh-ancestor
110915793|NCT02273804|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110915794|NCT02273804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110915795|NCT00578474|Ofloxacin|ofloxacin|mesh-list
110915796|NCT00578474|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110915797|NCT00578474|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110915798|NCT00578474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110915799|NCT00578474|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110915800|NCT00578474|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110915801|NCT00578474|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110915802|NCT00578474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110915803|NCT00578474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110915804|NCT00578474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110915805|NCT00578474|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110915806|NCT00578474|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110915807|NCT00577148|Rimonabant|rimonabant|mesh-list
110915808|NCT00577148|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110915809|NCT00577148|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
110915810|NCT00577148|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110915811|NCT00577148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110915812|NCT00577148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110915813|NCT00577148|Hormones|hormones|mesh-ancestor
110915814|NCT00577148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110915815|NCT00577148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110915816|NCT03673228|Nicotine|nicotine|mesh-list
110915817|NCT03673228|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110915818|NCT03673228|Autonomic Agents|autonomic agents|mesh-ancestor
110915819|NCT03673228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110915820|NCT03673228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110915821|NCT03673228|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110915822|NCT03673228|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110915823|NCT03673228|Cholinergic Agents|cholinergic agents|mesh-ancestor
110915824|NCT03673228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110915825|NCT03673228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110915826|NCT05116462|Paclitaxel|paclitaxel|mesh-list
110915827|NCT05116462|Docetaxel|docetaxel|mesh-list
110915828|NCT05116462|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110915829|NCT05116462|Carboplatin|carboplatin|mesh-list
110915830|NCT05116462|Gemcitabine|gemcitabine|mesh-list
110915831|NCT05116462|Pemetrexed|pemetrexed|mesh-list
110915832|NCT05116462|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110915833|NCT05116462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110915834|NCT05116462|Tubulin Modulators|tubulin modulators|mesh-ancestor
110915835|NCT05116462|Antimitotic Agents|antimitotic agents|mesh-ancestor
110915836|NCT05116462|Mitosis Modulators|mitosis modulators|mesh-ancestor
110915837|NCT05116462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110915838|NCT05116462|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110230645|NCT00092508|Analgesics|analgesics|mesh-ancestor
110915839|NCT05116462|Antimetabolites|antimetabolites|mesh-ancestor
110915840|NCT05116462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110915841|NCT05116462|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110915842|NCT05116462|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110915843|NCT05116306|Hyaluronic Acid|hyaluronic acid|mesh-list
110915844|NCT05116306|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110915845|NCT05116306|Immunologic Factors|immunologic factors|mesh-ancestor
110915846|NCT05116306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110915847|NCT05116306|Viscosupplements|viscosupplements|mesh-ancestor
110915848|NCT05116306|Protective Agents|protective agents|mesh-ancestor
110915849|NCT00570986|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110915850|NCT00570986|Immunologic Factors|immunologic factors|mesh-ancestor
110915851|NCT00570986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110915852|NCT00570752|Atorvastatin|atorvastatin|mesh-list
110915853|NCT00570752|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110915854|NCT00570752|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110915855|NCT00570752|Antimetabolites|antimetabolites|mesh-ancestor
110915856|NCT00570752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110364229|NCT00557544|Dopamine Agents|dopamine agents|mesh-ancestor
110915857|NCT00570752|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110230696|NCT00328939|Enoxaparin|enoxaparin|mesh-list
110915858|NCT00570752|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110915859|NCT00570752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110915861|NCT02282384|Calcium Carbonate|calcium carbonate|mesh-list
110915862|NCT02282384|Antiviral Agents|antiviral agents|mesh-ancestor
110915863|NCT02282384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110915864|NCT02282384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110915865|NCT02282384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110915866|NCT02282384|Antacids|antacids|mesh-ancestor
110915867|NCT02282384|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110915868|NCT02989389|Itraconazole|itraconazole|mesh-list
110915869|NCT02989389|Antifungal Agents|antifungal agents|mesh-ancestor
110915870|NCT02989389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110915871|NCT02989389|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110915872|NCT02989389|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110915873|NCT02989389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110915874|NCT02989389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110915875|NCT02989389|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110633392|NCT00737477|Epoetin Alfa|epoetin alfa|mesh-list
110915876|NCT02989389|Hormone Antagonists|hormone antagonists|mesh-ancestor
110915877|NCT02989389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110915878|NCT02989389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110915879|NCT02989389|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110915880|NCT02653300|Insulin|insulin|mesh-list
110915881|NCT02653300|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110915882|NCT02653300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110915883|NCT00436670|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110915884|NCT00436670|Immunologic Factors|immunologic factors|mesh-ancestor
110915885|NCT00436670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110915886|NCT03187509|Torsemide|torsemide|mesh-list
110915887|NCT03187509|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110915888|NCT03187509|Diuretics|diuretics|mesh-ancestor
110915889|NCT03187509|Natriuretic Agents|natriuretic agents|mesh-ancestor
110915890|NCT03187509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110915891|NCT03187509|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110915892|NCT03187509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110915893|NCT03187509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110915894|NCT00430508|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110915895|NCT00430508|Olmesartan|olmesartan|mesh-list
110915896|NCT00430508|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
110915897|NCT00430508|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110915898|NCT00430508|Diuretics|diuretics|mesh-ancestor
110915899|NCT00430508|Natriuretic Agents|natriuretic agents|mesh-ancestor
110915900|NCT00430508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110915901|NCT00430508|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110915902|NCT00430508|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110915903|NCT00430508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110915904|NCT00430508|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110915905|NCT00430508|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110915906|NCT04221880|Lidocaine|lidocaine|mesh-list
110915907|NCT04221880|Bupivacaine|bupivacaine|mesh-list
110915908|NCT04221880|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110915909|NCT04221880|Anesthetics, Local|anesthetics, local|mesh-ancestor
110915910|NCT04221880|Anesthetics|anesthetics|mesh-ancestor
110915911|NCT04221880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110915912|NCT04221880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110915913|NCT04221880|Sensory System Agents|sensory system agents|mesh-ancestor
110915914|NCT04221880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110915915|NCT04221880|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110915916|NCT04221880|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110915917|NCT04221880|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110915918|NCT04221880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110915919|NCT04221880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110915920|NCT04055415|Bronchodilator Agents|bronchodilator agents|mesh-list
110915921|NCT04055415|Expectorants|expectorants|mesh-list
110915922|NCT04055415|Autonomic Agents|autonomic agents|mesh-ancestor
110915923|NCT04055415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110915924|NCT04055415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110915925|NCT04055415|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110915926|NCT04055415|Respiratory System Agents|respiratory system agents|mesh-ancestor
110915927|NCT00427856|Rituximab|rituximab|mesh-list
110915928|NCT00427856|Obatoclax|obatoclax|mesh-list
110915929|NCT00427856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110915930|NCT00427856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110915931|NCT00427856|Immunologic Factors|immunologic factors|mesh-ancestor
110915932|NCT00427856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110915933|NCT00427856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110915934|NCT00427856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110915935|NCT00427856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110915936|NCT00427154|Insulin|insulin|mesh-list
110915937|NCT00427154|Metformin|metformin|mesh-list
110915938|NCT00427154|Glimepiride|glimepiride|mesh-list
110915939|NCT00427154|Rosiglitazone|rosiglitazone|mesh-list
110915940|NCT00427154|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110915941|NCT00427154|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110915942|NCT00427154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110915943|NCT00427154|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110915944|NCT00427154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110915945|NCT00427154|Immunologic Factors|immunologic factors|mesh-ancestor
110915946|NCT02988219|Epinephrine|epinephrine|mesh-list
110915947|NCT02988219|Fentanyl|fentanyl|mesh-list
110915948|NCT02988219|Bupivacaine|bupivacaine|mesh-list
110915949|NCT02988219|Anesthetics|anesthetics|mesh-list
110915950|NCT02988219|Anesthetics, Local|anesthetics, local|mesh-ancestor
110915951|NCT02988219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110915952|NCT02988219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110230838|NCT00329680|Protective Agents|protective agents|mesh-ancestor
110927935|NCT03074968|Benzydamine|benzydamine|mesh-list
110915953|NCT02988219|Sensory System Agents|sensory system agents|mesh-ancestor
110915954|NCT02988219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110915955|NCT02988219|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110915956|NCT02988219|Narcotics|narcotics|mesh-ancestor
110915957|NCT02988219|Analgesics|analgesics|mesh-ancestor
110915958|NCT02988219|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110915959|NCT02988219|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110915960|NCT02988219|Anesthetics, General|anesthetics, general|mesh-ancestor
110915961|NCT02988219|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110915962|NCT02988219|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110915963|NCT02988219|Adrenergic Agents|adrenergic agents|mesh-ancestor
110915964|NCT02988219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110915965|NCT02988219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110915966|NCT02988219|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110915967|NCT02988219|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110915968|NCT02988219|Autonomic Agents|autonomic agents|mesh-ancestor
110915969|NCT02988219|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110915970|NCT02988219|Respiratory System Agents|respiratory system agents|mesh-ancestor
110915971|NCT02988219|Mydriatics|mydriatics|mesh-ancestor
110915972|NCT02988219|Sympathomimetics|sympathomimetics|mesh-ancestor
110915973|NCT02988219|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110915974|NCT01346059|Vancomycin|vancomycin|mesh-list
110915975|NCT01346059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110915976|NCT01346059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110915977|NCT05204069|Cyclopentolate|cyclopentolate|mesh-list
110915978|NCT05204069|Mydriatics|mydriatics|mesh-ancestor
110915979|NCT05204069|Autonomic Agents|autonomic agents|mesh-ancestor
110915980|NCT05204069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110230888|NCT00093093|Interferons|interferons|mesh-list
110915982|NCT05204069|Parasympatholytics|parasympatholytics|mesh-ancestor
110915983|NCT05204069|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110915984|NCT05204069|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110915985|NCT05204069|Cholinergic Agents|cholinergic agents|mesh-ancestor
110915986|NCT05204069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110915987|NCT05204069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110915988|NCT04548973|Esketamine|esketamine|mesh-list
110915989|NCT04548973|Antidepressive Agents|antidepressive agents|mesh-ancestor
110915990|NCT04548973|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110915991|NCT02277938|Amantadine|amantadine|mesh-list
110915992|NCT02277938|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110915993|NCT02277938|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110915994|NCT02277938|Antiviral Agents|antiviral agents|mesh-ancestor
110915995|NCT02277938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110915996|NCT02277938|Dopamine Agents|dopamine agents|mesh-ancestor
110915997|NCT02277938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110915998|NCT02277938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110915999|NCT02277938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110916000|NCT02277938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110916001|NCT02277938|Analgesics|analgesics|mesh-ancestor
110916002|NCT02277938|Sensory System Agents|sensory system agents|mesh-ancestor
110916003|NCT02277938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110916004|NCT00415142|Escitalopram|escitalopram|mesh-list
110230937|NCT00083993|Sirolimus|sirolimus|mesh-list
110916005|NCT00415142|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110916006|NCT00415142|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110916007|NCT00415142|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110916008|NCT00415142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110916009|NCT00415142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110916010|NCT00415142|Serotonin Agents|serotonin agents|mesh-ancestor
110916011|NCT00415142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110916012|NCT03661125|Saracatinib|saracatinib|mesh-list
110916013|NCT03661125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110916014|NCT03661125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110916015|NCT03661125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110916016|NCT00413114|Obatoclax|obatoclax|mesh-list
110916017|NCT00413114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110927953|NCT04991584|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110916018|NCT00413114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110916019|NCT01318915|Mycophenolic Acid|mycophenolic acid|mesh-list
110916020|NCT01318915|Sirolimus|sirolimus|mesh-list
110916021|NCT01318915|Rituximab|rituximab|mesh-list
110916022|NCT01318915|Tacrolimus|tacrolimus|mesh-list
110916023|NCT01318915|Thymoglobulin|thymoglobulin|mesh-list
110916024|NCT01318915|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110916025|NCT01318915|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110916026|NCT01318915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110916027|NCT01318915|Immunologic Factors|immunologic factors|mesh-ancestor
110916028|NCT01318915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110916029|NCT01318915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110916030|NCT01318915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110916031|NCT01318915|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110916033|NCT01318915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110916034|NCT01318915|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110916035|NCT01318915|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110916036|NCT01318915|Antitubercular Agents|antitubercular agents|mesh-ancestor
110916037|NCT01318915|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110916038|NCT01318915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110916039|NCT01318915|Antifungal Agents|antifungal agents|mesh-ancestor
110916040|NCT04688177|Nicotine|nicotine|mesh-list
110916041|NCT04688177|Carbon Monoxide|carbon monoxide|mesh-list
110916042|NCT04688177|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110916043|NCT04688177|Autonomic Agents|autonomic agents|mesh-ancestor
110916044|NCT04688177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110916045|NCT04688177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110916046|NCT04688177|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110916047|NCT04688177|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110916048|NCT04688177|Cholinergic Agents|cholinergic agents|mesh-ancestor
110916049|NCT04688177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110916050|NCT04688177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110916051|NCT04688177|Antimetabolites|antimetabolites|mesh-ancestor
110916052|NCT04688177|Gasotransmitters|gasotransmitters|mesh-ancestor
110916053|NCT04675294|Pembrolizumab|pembrolizumab|mesh-list
110916054|NCT04675294|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110916055|NCT04675294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110916056|NCT04675294|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110916057|NCT04675294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110916058|NCT00411242|Agomelatine|agomelatine|mesh-list
110916059|NCT00411242|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110916060|NCT00411242|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110916061|NCT00411242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110916062|NCT05203913|Paclitaxel|paclitaxel|mesh-list
110916063|NCT05203913|Nivolumab|nivolumab|mesh-list
110916064|NCT05203913|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110916065|NCT05203913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110916066|NCT05203913|Tubulin Modulators|tubulin modulators|mesh-ancestor
110916067|NCT05203913|Antimitotic Agents|antimitotic agents|mesh-ancestor
110916068|NCT05203913|Mitosis Modulators|mitosis modulators|mesh-ancestor
110916069|NCT05203913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110916070|NCT05203913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110916071|NCT05203913|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110916072|NCT00402428|Interferons|interferons|mesh-list
110916074|NCT00402428|Interferon-alpha|interferon-alpha|mesh-list
110916075|NCT00402428|Interferon alpha-2|interferon alpha-2|mesh-list
110916076|NCT00402428|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110916077|NCT00402428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110916078|NCT00402428|Antiviral Agents|antiviral agents|mesh-ancestor
110916079|NCT00402428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110916080|NCT00402428|Antimetabolites|antimetabolites|mesh-ancestor
110916081|NCT00402428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110916082|NCT00402428|Immunologic Factors|immunologic factors|mesh-ancestor
110927962|NCT05001412|Etoposide|etoposide|mesh-list
110916083|NCT00402428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110916084|NCT05120206|Chlorhexidine|chlorhexidine|mesh-list
110916085|NCT05120206|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110916086|NCT05120206|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110916087|NCT05120206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110916088|NCT05120206|Disinfectants|disinfectants|mesh-ancestor
110916089|NCT05120206|Dermatologic Agents|dermatologic agents|mesh-ancestor
110916090|NCT03660267|Caffeine|caffeine|mesh-list
110916091|NCT03660267|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110916092|NCT03660267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110916093|NCT03660267|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110916094|NCT03660267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110916095|NCT03660267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110916096|NCT03660267|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110916097|NCT03660267|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110916098|NCT03660267|Purinergic Agents|purinergic agents|mesh-ancestor
110916099|NCT03660267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110916100|NCT03950245|Glucagon|glucagon|mesh-list
110916101|NCT03950245|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
110916102|NCT03950245|Incretins|incretins|mesh-ancestor
110916103|NCT03950245|Hormones|hormones|mesh-ancestor
110916104|NCT03950245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110916105|NCT03950245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110231068|NCT00084227|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110916106|NCT03950245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110916107|NCT00401570|Gemcitabine|gemcitabine|mesh-list
110916108|NCT00401570|Volociximab|volociximab|mesh-list
110916109|NCT00401570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110916110|NCT00401570|Antimetabolites|antimetabolites|mesh-ancestor
110916111|NCT00401570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110916112|NCT00401570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110916113|NCT00401570|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110916114|NCT00401570|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110916115|NCT00401570|Growth Substances|growth substances|mesh-ancestor
110916116|NCT00401570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110916117|NCT00401570|Growth Inhibitors|growth inhibitors|mesh-ancestor
110916118|NCT04056741|Pulmonary Surfactants|pulmonary surfactants|mesh-list
110916119|NCT04056741|Respiratory System Agents|respiratory system agents|mesh-ancestor
110916120|NCT05193565|Mycophenolic Acid|mycophenolic acid|mesh-list
110916121|NCT05193565|Sirolimus|sirolimus|mesh-list
110916122|NCT05193565|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110916123|NCT05193565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110916124|NCT05193565|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110916125|NCT05193565|Antitubercular Agents|antitubercular agents|mesh-ancestor
110916126|NCT05193565|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110916127|NCT05193565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110916128|NCT05193565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110916129|NCT05193565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110916130|NCT05193565|Antifungal Agents|antifungal agents|mesh-ancestor
110916131|NCT05193565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110916132|NCT05193565|Immunologic Factors|immunologic factors|mesh-ancestor
110916133|NCT05193565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110916134|NCT04471922|Rabeprazole|rabeprazole|mesh-list
110916135|NCT04471922|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110916136|NCT04471922|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110916137|NCT04471922|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110916138|NCT04471922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110916139|NCT04471922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110916140|NCT04368364|Morphine|morphine|mesh-list
110916141|NCT04368364|Bupivacaine|bupivacaine|mesh-list
110916142|NCT04368364|Ropivacaine|ropivacaine|mesh-list
110916143|NCT04368364|Anesthetics, Local|anesthetics, local|mesh-ancestor
110916144|NCT04368364|Anesthetics|anesthetics|mesh-ancestor
110927974|NCT04991896|Bisoprolol|bisoprolol|mesh-list
110916145|NCT04368364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110916147|NCT04368364|Sensory System Agents|sensory system agents|mesh-ancestor
110916148|NCT04368364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110916149|NCT04368364|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110916150|NCT04368364|Narcotics|narcotics|mesh-ancestor
110916151|NCT04368364|Analgesics|analgesics|mesh-ancestor
110916152|NCT02285036|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110916153|NCT02285036|Immunologic Factors|immunologic factors|mesh-ancestor
110916154|NCT02285036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110916155|NCT00543374|Remestemcel-l|remestemcel-l|mesh-list
110916156|NCT00543374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110916157|NCT00543374|Antiviral Agents|antiviral agents|mesh-ancestor
110916158|NCT00543374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110916159|NCT02926937|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
110916160|NCT02926937|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110916161|NCT02926937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110916162|NCT02926937|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110916163|NCT02926937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110916164|NCT05229796|Empagliflozin|empagliflozin|mesh-list
110916165|NCT05229796|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110916166|NCT05229796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110916167|NCT05229796|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110916168|NCT05229796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110916169|NCT04189588|Diphenhydramine|diphenhydramine|mesh-list
110916170|NCT04189588|Promethazine|promethazine|mesh-list
110916171|NCT04189588|Cetirizine|cetirizine|mesh-list
110916172|NCT04189588|Paclitaxel|paclitaxel|mesh-list
110916173|NCT04189588|Rituximab|rituximab|mesh-list
110916174|NCT04189588|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110916175|NCT04189588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110916176|NCT04189588|Tubulin Modulators|tubulin modulators|mesh-ancestor
110916177|NCT04189588|Antimitotic Agents|antimitotic agents|mesh-ancestor
110916178|NCT04189588|Mitosis Modulators|mitosis modulators|mesh-ancestor
110916179|NCT04189588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110916180|NCT04189588|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110916181|NCT04189588|Immunologic Factors|immunologic factors|mesh-ancestor
110916182|NCT04189588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110916183|NCT04189588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110916184|NCT04189588|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110916185|NCT04189588|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110916186|NCT04189588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110916187|NCT04189588|Anesthetics, Local|anesthetics, local|mesh-ancestor
110916188|NCT04189588|Anesthetics|anesthetics|mesh-ancestor
110916189|NCT04189588|Sensory System Agents|sensory system agents|mesh-ancestor
110916190|NCT04189588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110916191|NCT04189588|Antiemetics|antiemetics|mesh-ancestor
110916192|NCT04189588|Autonomic Agents|autonomic agents|mesh-ancestor
110916193|NCT04189588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110916194|NCT04189588|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110916195|NCT04189588|Histamine Antagonists|histamine antagonists|mesh-ancestor
110916196|NCT04189588|Histamine Agents|histamine agents|mesh-ancestor
110364325|NCT01184326|Everolimus|everolimus|mesh-list
110916197|NCT04189588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110916198|NCT04189588|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110916199|NCT04189588|Antipruritics|antipruritics|mesh-ancestor
110916200|NCT04189588|Dermatologic Agents|dermatologic agents|mesh-ancestor
110916201|NCT04189588|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110916203|NCT00151892|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110916204|NCT00151892|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110916205|NCT00151892|Analgesics|analgesics|mesh-ancestor
110916206|NCT00151892|Sensory System Agents|sensory system agents|mesh-ancestor
110916207|NCT00151892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110916208|NCT00151892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110916209|NCT00151892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110916210|NCT00151892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110916211|NCT02740127|Dexamethasone|dexamethasone|mesh-list
110916213|NCT02740127|Epinephrine|epinephrine|mesh-list
110916214|NCT02740127|Propofol|propofol|mesh-list
110916215|NCT02740127|Ropivacaine|ropivacaine|mesh-list
110916216|NCT02740127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110916217|NCT02740127|Antiemetics|antiemetics|mesh-ancestor
110916218|NCT02740127|Autonomic Agents|autonomic agents|mesh-ancestor
110916219|NCT02740127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110916220|NCT02740127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110916221|NCT02740127|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110916222|NCT02740127|Glucocorticoids|glucocorticoids|mesh-ancestor
110916223|NCT02740127|Hormones|hormones|mesh-ancestor
110916224|NCT02740127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110916225|NCT02740127|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110916226|NCT02740127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110916227|NCT02740127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110916228|NCT02740127|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110916229|NCT02740127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110916230|NCT02740127|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110916231|NCT02740127|Anesthetics, General|anesthetics, general|mesh-ancestor
110916232|NCT02740127|Anesthetics|anesthetics|mesh-ancestor
110916233|NCT02740127|Anesthetics, Local|anesthetics, local|mesh-ancestor
110916234|NCT02740127|Sensory System Agents|sensory system agents|mesh-ancestor
110916235|NCT02740127|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110916236|NCT02740127|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110916237|NCT02740127|Adrenergic Agents|adrenergic agents|mesh-ancestor
110916238|NCT02740127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110916239|NCT02740127|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110916240|NCT02740127|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110916241|NCT02740127|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110916242|NCT02740127|Respiratory System Agents|respiratory system agents|mesh-ancestor
110916243|NCT02740127|Mydriatics|mydriatics|mesh-ancestor
110916244|NCT02740127|Sympathomimetics|sympathomimetics|mesh-ancestor
110916245|NCT02740127|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110916246|NCT02740127|Analgesics|analgesics|mesh-ancestor
110916247|NCT02740127|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110916248|NCT02740127|Sympatholytics|sympatholytics|mesh-ancestor
110916249|NCT02740127|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110916250|NCT05008783|Capecitabine|capecitabine|mesh-list
110916251|NCT05008783|Oxaliplatin|oxaliplatin|mesh-list
110916252|NCT05008783|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110916253|NCT05008783|Antimetabolites|antimetabolites|mesh-ancestor
110928007|NCT03072082|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
110916254|NCT05008783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110916255|NCT05008783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110916257|NCT04450498|Immunologic Factors|immunologic factors|mesh-ancestor
110916258|NCT04450498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110916259|NCT00654992|Epoetin Alfa|epoetin alfa|mesh-list
110916260|NCT00654992|Hematinics|hematinics|mesh-ancestor
110916261|NCT02921919|Talazoparib|talazoparib|mesh-list
110916262|NCT02921919|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110916263|NCT02921919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110916264|NCT02921919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110916265|NCT02921919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110916266|NCT00393068|Paclitaxel|paclitaxel|mesh-list
110916267|NCT00393068|Bevacizumab|bevacizumab|mesh-list
110916268|NCT00393068|Carboplatin|carboplatin|mesh-list
110916269|NCT00393068|Fluorouracil|fluorouracil|mesh-list
110916270|NCT00393068|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110916271|NCT00393068|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110916272|NCT00393068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110916273|NCT00393068|Tubulin Modulators|tubulin modulators|mesh-ancestor
110916274|NCT00393068|Antimitotic Agents|antimitotic agents|mesh-ancestor
110916275|NCT00393068|Mitosis Modulators|mitosis modulators|mesh-ancestor
110916276|NCT00393068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110916277|NCT00393068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110916278|NCT00393068|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110916279|NCT00393068|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110916280|NCT00393068|Growth Substances|growth substances|mesh-ancestor
110916281|NCT00393068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110916282|NCT00393068|Growth Inhibitors|growth inhibitors|mesh-ancestor
110916283|NCT00393068|Antimetabolites|antimetabolites|mesh-ancestor
110916284|NCT00393068|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110916285|NCT00393068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110916286|NCT00393068|Immunologic Factors|immunologic factors|mesh-ancestor
110916287|NCT00393068|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110916288|NCT00393068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110916289|NCT02280278|Immunomodulating Agents|immunomodulating agents|mesh-list
110916290|NCT02280278|Immunologic Factors|immunologic factors|mesh-ancestor
110916291|NCT02280278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110916292|NCT04769401|Progesterone|progesterone|mesh-list
110916293|NCT04769401|Progestins|progestins|mesh-ancestor
110916294|NCT04769401|Hormones|hormones|mesh-ancestor
110916295|NCT04769401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110916296|NCT04769401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110916297|NCT02094222|Glycerol|glycerol|mesh-list
110916298|NCT02094222|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
110916299|NCT02094222|Protective Agents|protective agents|mesh-ancestor
110916300|NCT02094222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110916301|NCT02280590|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110916302|NCT02280590|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110916303|NCT02280590|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110916304|NCT02280590|Antimetabolites|antimetabolites|mesh-ancestor
110916305|NCT02280590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110916306|NCT02280590|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110916307|NCT02280590|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110916308|NCT02280590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110916309|NCT02090244|Teriparatide|teriparatide|mesh-list
110916310|NCT02090244|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110916311|NCT02090244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110916312|NCT02090244|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110916313|NCT02282774|Lidocaine|lidocaine|mesh-list
110916314|NCT02282774|Bupivacaine|bupivacaine|mesh-list
110916315|NCT02282774|Anesthetics, Local|anesthetics, local|mesh-ancestor
110916317|NCT02282774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110916318|NCT02282774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110916319|NCT02282774|Sensory System Agents|sensory system agents|mesh-ancestor
110364371|NCT05449522|Vitamin D|vitamin d|mesh-list
110916320|NCT02282774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110916321|NCT02282774|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110916322|NCT02282774|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110231242|NCT00318448|Zolpidem|zolpidem|mesh-list
110916323|NCT02282774|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110916324|NCT02282774|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110633842|NCT00612534|Anesthetics, General|anesthetics, general|mesh-ancestor
110916325|NCT02282774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110916327|NCT02090322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110916328|NCT02090322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110916329|NCT02090322|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110916330|NCT02090322|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110916331|NCT02090322|Growth Substances|growth substances|mesh-ancestor
110916332|NCT02090322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110916333|NCT02090322|Growth Inhibitors|growth inhibitors|mesh-ancestor
110916334|NCT03658785|Aldesleukin|aldesleukin|mesh-list
110916335|NCT03658785|Cyclophosphamide|cyclophosphamide|mesh-list
110916336|NCT03658785|Fludarabine|fludarabine|mesh-list
110916337|NCT03658785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110916338|NCT03658785|Immunologic Factors|immunologic factors|mesh-ancestor
110916339|NCT03658785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110916340|NCT03658785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110916341|NCT03658785|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110916342|NCT03658785|Alkylating Agents|alkylating agents|mesh-ancestor
110916343|NCT03658785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110916344|NCT03658785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110916345|NCT03658785|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110916346|NCT03658785|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110916347|NCT03658785|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110916348|NCT03658785|Antiviral Agents|antiviral agents|mesh-ancestor
110916349|NCT03658785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110916350|NCT02095782|Paclitaxel|paclitaxel|mesh-list
110916352|NCT02095782|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110916353|NCT02095782|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110916354|NCT02095782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110916355|NCT02095782|Tubulin Modulators|tubulin modulators|mesh-ancestor
110916356|NCT02095782|Antimitotic Agents|antimitotic agents|mesh-ancestor
110916357|NCT02095782|Mitosis Modulators|mitosis modulators|mesh-ancestor
110916358|NCT02095782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110916359|NCT02095782|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110916360|NCT02095782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110916361|NCT02094378|Esketamine|esketamine|mesh-list
110916362|NCT02094378|Antidepressive Agents|antidepressive agents|mesh-ancestor
110916364|NCT02285738|Aspirin|aspirin|mesh-list
110916365|NCT02285738|Simvastatin|simvastatin|mesh-list
110916366|NCT02285738|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110916367|NCT02285738|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110916368|NCT02285738|Analgesics|analgesics|mesh-ancestor
110916369|NCT02285738|Sensory System Agents|sensory system agents|mesh-ancestor
110916370|NCT02285738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110916371|NCT02285738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110916372|NCT02285738|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110916373|NCT02285738|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110916374|NCT02285738|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110916376|NCT02285738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110916377|NCT02285738|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110916378|NCT02285738|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110916379|NCT02285738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110916380|NCT02285738|Antipyretics|antipyretics|mesh-ancestor
110916381|NCT02285738|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110916382|NCT02285738|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110916383|NCT02285738|Antimetabolites|antimetabolites|mesh-ancestor
110916384|NCT02285738|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110916385|NCT02285738|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110916386|NCT00650702|Latanoprost|latanoprost|mesh-list
110916387|NCT00650702|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110916388|NCT00650702|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110916389|NCT02090400|Bazedoxifene|bazedoxifene|mesh-list
110916390|NCT02090400|Calcium|calcium|mesh-list
110916391|NCT02090400|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110916392|NCT02090400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110916393|NCT02090400|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110916394|NCT02090400|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110916395|NCT02090400|Hormone Antagonists|hormone antagonists|mesh-ancestor
110916396|NCT02090400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110916397|NCT02090400|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110916398|NCT03134846|Cetuximab|cetuximab|mesh-list
110916399|NCT03134846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110916400|NCT03134846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110916401|NCT01068717|Metformin|metformin|mesh-list
110916402|NCT01068717|Saxagliptin|saxagliptin|mesh-list
110916403|NCT01068717|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110916404|NCT01068717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110916405|NCT01068717|Incretins|incretins|mesh-ancestor
110916406|NCT01068717|Hormones|hormones|mesh-ancestor
110916407|NCT01068717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110916408|NCT01068717|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110916409|NCT01068717|Protease Inhibitors|protease inhibitors|mesh-ancestor
110916410|NCT01068717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110916411|NCT01068717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110916412|NCT02095938|Amisulpride|amisulpride|mesh-list
110916413|NCT02095938|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110916414|NCT02095938|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110916415|NCT02095938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110916416|NCT02095938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110916417|NCT02095938|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110916418|NCT02095938|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110916419|NCT02095938|Dopamine Agents|dopamine agents|mesh-ancestor
110916420|NCT02095938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110916421|NCT02095938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110916422|NCT02095938|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110916423|NCT02095938|Antidepressive Agents|antidepressive agents|mesh-ancestor
110916424|NCT02285972|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
110916425|NCT02285972|Tenoxicam|tenoxicam|mesh-list
110916426|NCT02285972|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110916427|NCT02285972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110916428|NCT02285972|Analgesics|analgesics|mesh-ancestor
110916429|NCT02285972|Sensory System Agents|sensory system agents|mesh-ancestor
110916430|NCT02285972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110916431|NCT02285972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110916432|NCT02285972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110916433|NCT02285972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110916434|NCT02285972|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110916435|NCT02285972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110916436|NCT02285972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110916437|NCT02096094|Chlorhexidine|chlorhexidine|mesh-list
110916438|NCT02096094|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110916439|NCT02096094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110916440|NCT02096094|Disinfectants|disinfectants|mesh-ancestor
110916441|NCT02921763|Dydrogesterone|dydrogesterone|mesh-list
110916442|NCT02921763|Progestins|progestins|mesh-ancestor
110916443|NCT02921763|Hormones|hormones|mesh-ancestor
110916444|NCT02921763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110916445|NCT02921763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110916446|NCT03658473|Naproxen|naproxen|mesh-list
110916447|NCT03658473|Rabeprazole|rabeprazole|mesh-list
110916448|NCT03658473|Rebamipide|rebamipide|mesh-list
110916449|NCT03658473|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110916450|NCT03658473|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110916451|NCT03658473|Analgesics|analgesics|mesh-ancestor
110916452|NCT03658473|Sensory System Agents|sensory system agents|mesh-ancestor
110916453|NCT03658473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110916454|NCT03658473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110916455|NCT03658473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110916456|NCT03658473|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110916457|NCT03658473|Gout Suppressants|gout suppressants|mesh-ancestor
110916458|NCT03658473|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110916459|NCT03658473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110916460|NCT03658473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110916461|NCT03658473|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110916462|NCT03658473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110916463|NCT03658473|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110916464|NCT03658473|Antioxidants|antioxidants|mesh-ancestor
110916465|NCT03658473|Protective Agents|protective agents|mesh-ancestor
110916466|NCT02096250|Ferrous fumarate|ferrous fumarate|mesh-list
110916467|NCT02096250|Edetic Acid|edetic acid|mesh-list
110916468|NCT02096250|Ferric Compounds|ferric compounds|mesh-list
110916469|NCT02096250|Fe(III)-EDTA|fe(iii)-edta|mesh-list
110916470|NCT02096250|Trace Elements|trace elements|mesh-ancestor
110916471|NCT02096250|Micronutrients|micronutrients|mesh-ancestor
110916472|NCT02096250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110916473|NCT02096250|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110916474|NCT02096250|Chelating Agents|chelating agents|mesh-ancestor
110916475|NCT02096250|Sequestering Agents|sequestering agents|mesh-ancestor
110916476|NCT02096250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110916477|NCT02096250|Anticoagulants|anticoagulants|mesh-ancestor
110916478|NCT02096250|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110916479|NCT02096250|Hematinics|hematinics|mesh-ancestor
110916480|NCT02096328|Murepavadin|murepavadin|mesh-list
110916481|NCT02096328|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110916482|NCT02096328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110916483|NCT01318135|Metformin|metformin|mesh-list
110916484|NCT01318135|Glimepiride|glimepiride|mesh-list
110916485|NCT01318135|Alogliptin|alogliptin|mesh-list
110916486|NCT01318135|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110916487|NCT01318135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110916488|NCT01318135|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110916489|NCT01318135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110916490|NCT01318135|Immunologic Factors|immunologic factors|mesh-ancestor
110916491|NCT01318135|Incretins|incretins|mesh-ancestor
110916492|NCT01318135|Hormones|hormones|mesh-ancestor
110916493|NCT01318135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110916494|NCT01318135|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110916495|NCT01318135|Protease Inhibitors|protease inhibitors|mesh-ancestor
110916496|NCT01318135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110916497|NCT01318135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110916498|NCT02094924|Candesartan|candesartan|mesh-list
110916499|NCT02094924|Candesartan cilexetil|candesartan cilexetil|mesh-list
110364414|NCT05335915|Nicotine|nicotine|mesh-list
110916500|NCT02094924|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110916501|NCT02094924|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110916502|NCT02094924|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110916503|NCT02094924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110916504|NCT02286206|Clozapine|clozapine|mesh-list
110916505|NCT02286206|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110916506|NCT02286206|Serotonin Agents|serotonin agents|mesh-ancestor
110916507|NCT02286206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110916508|NCT02286206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110916509|NCT02286206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110916510|NCT02286206|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110916511|NCT02286206|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110916512|NCT02286206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110916513|NCT02286206|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110916514|NCT02286206|GABA Antagonists|gaba antagonists|mesh-ancestor
110916515|NCT02286206|GABA Agents|gaba agents|mesh-ancestor
110916516|NCT03104283|Apatinib|apatinib|mesh-list
110916517|NCT03104283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110916518|NCT03104283|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110916519|NCT03104283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110916520|NCT03104283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110916521|NCT00529178|Pravastatin|pravastatin|mesh-list
110916522|NCT00529178|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110916523|NCT00529178|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110916524|NCT00529178|Antimetabolites|antimetabolites|mesh-ancestor
110916525|NCT00529178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110916526|NCT00529178|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110916527|NCT00529178|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110916528|NCT00529178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110916529|NCT00382460|Pravastatin|pravastatin|mesh-list
110916530|NCT00382460|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110916531|NCT00382460|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110916532|NCT00382460|Antimetabolites|antimetabolites|mesh-ancestor
110916533|NCT00382460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110916534|NCT00382460|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110916535|NCT00382460|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110916536|NCT00382460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110916537|NCT00523250|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110916538|NCT00523250|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110916539|NCT02286596|Heparin|heparin|mesh-list
110916540|NCT02286596|Dextrans|dextrans|mesh-list
110916541|NCT02286596|Anticoagulants|anticoagulants|mesh-ancestor
110916542|NCT02286596|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110916543|NCT02286596|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110916544|NCT02286596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110916545|NCT02286596|Plasma Substitutes|plasma substitutes|mesh-ancestor
110916546|NCT02286596|Blood Substitutes|blood substitutes|mesh-ancestor
110916547|NCT02098824|Methylphenidate|methylphenidate|mesh-list
110916548|NCT02098824|Galantamine|galantamine|mesh-list
110916549|NCT02098824|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110916550|NCT02098824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110916551|NCT02098824|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110916552|NCT02098824|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110916553|NCT02098824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110916554|NCT02098824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110916555|NCT02098824|Dopamine Agents|dopamine agents|mesh-ancestor
110916556|NCT02098824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110916557|NCT02098824|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110916558|NCT02098824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110916559|NCT02098824|Cholinergic Agents|cholinergic agents|mesh-ancestor
110231795|NCT00320359|Cisplatin|cisplatin|mesh-list
110916560|NCT02098824|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110916561|NCT02098824|Autonomic Agents|autonomic agents|mesh-ancestor
110916562|NCT02098824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110916563|NCT02098824|Nootropic Agents|nootropic agents|mesh-ancestor
110916565|NCT03658317|Antioxidants|antioxidants|mesh-ancestor
110916566|NCT03658317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110916567|NCT03658317|Protective Agents|protective agents|mesh-ancestor
110916568|NCT03658317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110916569|NCT02286752|Neostigmine|neostigmine|mesh-list
110916570|NCT02286752|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110916571|NCT02286752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110916572|NCT02286752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110916573|NCT02286752|Cholinergic Agents|cholinergic agents|mesh-ancestor
110916574|NCT02286752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110916575|NCT02286752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110916576|NCT02286752|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110916577|NCT02286752|Autonomic Agents|autonomic agents|mesh-ancestor
110916578|NCT02286752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110916579|NCT04470050|Dexmedetomidine|dexmedetomidine|mesh-list
110916580|NCT04470050|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110916581|NCT04470050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110916582|NCT04470050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110916583|NCT04470050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110916584|NCT04470050|Analgesics|analgesics|mesh-ancestor
110916585|NCT04470050|Sensory System Agents|sensory system agents|mesh-ancestor
110916586|NCT04470050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110916587|NCT04470050|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110916588|NCT04470050|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110916589|NCT04470050|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110916590|NCT04470050|Adrenergic Agents|adrenergic agents|mesh-ancestor
110916591|NCT04470050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110916592|NCT04470050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110916593|NCT02095314|Vaccines|vaccines|mesh-list
110916594|NCT02095314|Immunologic Factors|immunologic factors|mesh-ancestor
110916595|NCT02095314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110916596|NCT02098980|Vitamin D|vitamin d|mesh-list
110916597|NCT02098980|Vitamins|vitamins|mesh-ancestor
110916598|NCT02098980|Micronutrients|micronutrients|mesh-ancestor
110916599|NCT02098980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110916600|NCT02098980|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110916601|NCT00372944|Capecitabine|capecitabine|mesh-list
110916602|NCT00372944|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110916603|NCT00372944|Antimetabolites|antimetabolites|mesh-ancestor
110916604|NCT00372944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110916605|NCT00372944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110916606|NCT02099136|Celecoxib|celecoxib|mesh-list
110916607|NCT02099136|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110916608|NCT02099136|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110916609|NCT02099136|Analgesics|analgesics|mesh-ancestor
110916610|NCT02099136|Sensory System Agents|sensory system agents|mesh-ancestor
110916611|NCT02099136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110916612|NCT02099136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110916613|NCT02099136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110916614|NCT02099136|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110916615|NCT02099136|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110916616|NCT02099136|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110916617|NCT02099136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110916618|NCT02099136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110916619|NCT00117650|Etoposide|etoposide|mesh-list
110916620|NCT00117650|Etoposide phosphate|etoposide phosphate|mesh-list
110916621|NCT00117650|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110916622|NCT00117650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110634140|NCT00807872|Immunologic Factors|immunologic factors|mesh-ancestor
110916623|NCT00117650|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110916624|NCT00117650|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110916625|NCT00117650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110916626|NCT00117650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110916627|NCT02095548|Lorecivivint|lorecivivint|mesh-list
110916628|NCT02095548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110916629|NCT00113438|Paclitaxel|paclitaxel|mesh-list
110916630|NCT00113438|Fosbretabulin|fosbretabulin|mesh-list
110916631|NCT00113438|Combretastatin|combretastatin|mesh-list
110916632|NCT00113438|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110916633|NCT00113438|Carboplatin|carboplatin|mesh-list
110916634|NCT00113438|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110231889|NCT00327418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110916635|NCT00113438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110916636|NCT00113438|Tubulin Modulators|tubulin modulators|mesh-ancestor
110916637|NCT00113438|Antimitotic Agents|antimitotic agents|mesh-ancestor
110916638|NCT00113438|Mitosis Modulators|mitosis modulators|mesh-ancestor
110916639|NCT00113438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110916641|NCT04087408|Progesterone|progesterone|mesh-list
110916642|NCT04087408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110916643|NCT04087408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110916644|NCT04087408|Progestins|progestins|mesh-ancestor
110916645|NCT02099292|Rituximab|rituximab|mesh-list
110916646|NCT02099292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110916647|NCT02099292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110916648|NCT02099292|Immunologic Factors|immunologic factors|mesh-ancestor
110916649|NCT02099292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110916650|NCT02099292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110231916|NCT00320827|Antibodies|antibodies|mesh-list
110916651|NCT02283242|Galantamine|galantamine|mesh-list
110916652|NCT02283242|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110916653|NCT02283242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110916654|NCT02283242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110916655|NCT02283242|Cholinergic Agents|cholinergic agents|mesh-ancestor
110916656|NCT02283242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110916657|NCT02283242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110916658|NCT02283242|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110916659|NCT02283242|Autonomic Agents|autonomic agents|mesh-ancestor
110916660|NCT02283242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110916661|NCT02283242|Nootropic Agents|nootropic agents|mesh-ancestor
110916662|NCT02283320|Docetaxel|docetaxel|mesh-list
110916663|NCT02283320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110916664|NCT02283320|Tubulin Modulators|tubulin modulators|mesh-ancestor
110916665|NCT02283320|Antimitotic Agents|antimitotic agents|mesh-ancestor
110916666|NCT02283320|Mitosis Modulators|mitosis modulators|mesh-ancestor
110916667|NCT02283320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110916668|NCT03556098|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
110916670|NCT03556098|Incretins|incretins|mesh-list
110916671|NCT03556098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110916672|NCT03556098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110916673|NCT03556098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110916674|NCT02286986|Cannabidiol|cannabidiol|mesh-list
110916675|NCT02286986|Anticonvulsants|anticonvulsants|mesh-ancestor
110916676|NCT04995874|Micronutrients|micronutrients|mesh-list
110916677|NCT04995874|Trace Elements|trace elements|mesh-list
110916678|NCT04995874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110916679|NCT02287064|Immunoglobulins|immunoglobulins|mesh-list
110916680|NCT02287064|Antibodies|antibodies|mesh-list
110916681|NCT02287064|gamma-Globulins|gamma-globulins|mesh-list
110916682|NCT02287064|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110916683|NCT02287064|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110916684|NCT02287064|Immunologic Factors|immunologic factors|mesh-ancestor
110916685|NCT02287064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110916686|NCT02095704|Acetaminophen|acetaminophen|mesh-list
110916687|NCT02095704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110916688|NCT02095704|Analgesics|analgesics|mesh-ancestor
110916689|NCT02095704|Sensory System Agents|sensory system agents|mesh-ancestor
110916690|NCT02095704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110916691|NCT02095704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110916692|NCT02095704|Antipyretics|antipyretics|mesh-ancestor
110916693|NCT02099604|Vitamin D|vitamin d|mesh-list
110916694|NCT02099604|Interferons|interferons|mesh-list
110916695|NCT02099604|Ribavirin|ribavirin|mesh-list
110916696|NCT02099604|Interferon-alpha|interferon-alpha|mesh-list
110916697|NCT02099604|Interferon alpha-2|interferon alpha-2|mesh-list
110916698|NCT02099604|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110634225|NCT00654368|Analgesics|analgesics|mesh-ancestor
110916699|NCT02099604|Vitamins|vitamins|mesh-ancestor
110916700|NCT02099604|Micronutrients|micronutrients|mesh-ancestor
110916701|NCT02099604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110916702|NCT02099604|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110916703|NCT02099604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110916704|NCT02099604|Antiviral Agents|antiviral agents|mesh-ancestor
110916705|NCT02099604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110916706|NCT02099604|Antimetabolites|antimetabolites|mesh-ancestor
110916707|NCT02099604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110916708|NCT02099604|Immunologic Factors|immunologic factors|mesh-ancestor
110916709|NCT02099916|Menotropins|menotropins|mesh-list
110916710|NCT02099916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110916711|NCT02099916|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110916712|NCT02099916|Fertility Agents|fertility agents|mesh-ancestor
110916713|NCT02099916|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110916714|NCT02102646|Triptorelin Pamoate|triptorelin pamoate|mesh-list
110916715|NCT02102646|Luteolytic Agents|luteolytic agents|mesh-ancestor
110916716|NCT02102646|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110916717|NCT02102646|Contraceptive Agents|contraceptive agents|mesh-ancestor
110916718|NCT02102646|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110916719|NCT02102646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110916720|NCT02102646|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110916721|NCT02102646|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110916722|NCT02102646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110916723|NCT00366704|Risperidone|risperidone|mesh-list
110916724|NCT00366704|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110916725|NCT00366704|Serotonin Agents|serotonin agents|mesh-ancestor
110928132|NCT03069820|Tubulin Modulators|tubulin modulators|mesh-ancestor
110916726|NCT00366704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110916727|NCT00366704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110916728|NCT00366704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110916729|NCT00366704|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110916730|NCT00366704|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110916731|NCT00366704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110916732|NCT00366704|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110916733|NCT00366704|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110916734|NCT00366704|Dopamine Agents|dopamine agents|mesh-ancestor
110916736|NCT02097264|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110916737|NCT02097264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110916738|NCT02097264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110916739|NCT02097342|Linagliptin|linagliptin|mesh-list
110916740|NCT02097342|Voglibose|voglibose|mesh-list
110916741|NCT02097342|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110916742|NCT02097342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110916743|NCT02097342|Incretins|incretins|mesh-ancestor
110916744|NCT02097342|Hormones|hormones|mesh-ancestor
110916745|NCT02097342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110916746|NCT02097342|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110916747|NCT02097342|Protease Inhibitors|protease inhibitors|mesh-ancestor
110916748|NCT02097342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110232176|NCT00124605|Pamidronate|pamidronate|mesh-list
110916749|NCT02097342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110916750|NCT02097342|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
110916752|NCT04294498|Durvalumab|durvalumab|mesh-list
110916753|NCT04294498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110916754|NCT04294498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110916755|NCT04294498|Antiviral Agents|antiviral agents|mesh-ancestor
110916756|NCT04294498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110916757|NCT04059172|Ibuprofen|ibuprofen|mesh-list
110916758|NCT04059172|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110916759|NCT04059172|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110916760|NCT04059172|Analgesics|analgesics|mesh-ancestor
110916761|NCT04059172|Sensory System Agents|sensory system agents|mesh-ancestor
110916762|NCT04059172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110916763|NCT04059172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110916764|NCT04059172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110916765|NCT04059172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110916766|NCT04059172|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110916767|NCT04059172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110916768|NCT04059172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110916770|NCT00359450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110916771|NCT03530462|Methylprednisolone|methylprednisolone|mesh-list
110916772|NCT03530462|Cyclophosphamide|cyclophosphamide|mesh-list
110916773|NCT03530462|Rituximab|rituximab|mesh-list
110916774|NCT03530462|Immunoglobulins|immunoglobulins|mesh-list
110916775|NCT03530462|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110634290|NCT00813332|Mitosis Modulators|mitosis modulators|mesh-ancestor
110916776|NCT03530462|Antibodies|antibodies|mesh-list
110916777|NCT03530462|gamma-Globulins|gamma-globulins|mesh-list
110916778|NCT03530462|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110916779|NCT03530462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110916780|NCT03530462|Immunologic Factors|immunologic factors|mesh-ancestor
110916781|NCT03530462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110916782|NCT03530462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110916783|NCT03530462|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110916784|NCT03530462|Alkylating Agents|alkylating agents|mesh-ancestor
110916785|NCT03530462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110916786|NCT03530462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110916787|NCT03530462|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110916788|NCT03530462|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110916789|NCT03530462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110916790|NCT03530462|Antiemetics|antiemetics|mesh-ancestor
110916791|NCT03530462|Autonomic Agents|autonomic agents|mesh-ancestor
110916792|NCT03530462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110916793|NCT03530462|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110916794|NCT03530462|Glucocorticoids|glucocorticoids|mesh-ancestor
110916795|NCT03530462|Hormones|hormones|mesh-ancestor
110916796|NCT03530462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110916797|NCT03530462|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110916798|NCT03530462|Protective Agents|protective agents|mesh-ancestor
110916799|NCT02103192|Antioxidants|antioxidants|mesh-list
110916800|NCT02103192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110916801|NCT02103192|Protective Agents|protective agents|mesh-ancestor
110916802|NCT02103192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110916803|NCT02097810|Entrectinib|entrectinib|mesh-list
110916804|NCT02097810|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110916805|NCT02097810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110916806|NCT02097810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110916807|NCT02100462|Aspirin|aspirin|mesh-list
110916808|NCT02100462|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110916809|NCT02100462|Chlorthalidone|chlorthalidone|mesh-list
110916810|NCT02100462|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110916811|NCT02100462|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110916812|NCT02100462|Analgesics|analgesics|mesh-ancestor
110232275|NCT00124722|Bromides|bromides|mesh-list
110916813|NCT02100462|Sensory System Agents|sensory system agents|mesh-ancestor
110916814|NCT02100462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110916815|NCT02100462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110916816|NCT02100462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110916817|NCT02100462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110916818|NCT02100462|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110916819|NCT02100462|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110916820|NCT02100462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110916821|NCT02100462|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110916822|NCT02100462|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110916823|NCT02100462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110916824|NCT02100462|Antipyretics|antipyretics|mesh-ancestor
110916825|NCT02100462|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110916826|NCT02100462|Diuretics|diuretics|mesh-ancestor
110916827|NCT02100462|Natriuretic Agents|natriuretic agents|mesh-ancestor
110916828|NCT02100462|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110916829|NCT02100462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110916830|NCT04507126|BCG Vaccine|bcg vaccine|mesh-list
110916831|NCT04507126|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110916832|NCT04507126|Immunologic Factors|immunologic factors|mesh-ancestor
110916833|NCT04507126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110916834|NCT00150176|Asenapine|asenapine|mesh-list
110916835|NCT00150176|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110916836|NCT00150176|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110916837|NCT00150176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110232322|NCT00322075|Insulin Glargine|insulin glargine|mesh-list
110916838|NCT00150176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110916840|NCT00961792|Diphenhydramine|diphenhydramine|mesh-list
110916841|NCT00961792|Promethazine|promethazine|mesh-list
110916842|NCT00961792|Ethanol|ethanol|mesh-list
110916843|NCT00961792|Caffeine|caffeine|mesh-list
110916844|NCT00961792|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110916845|NCT00961792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110916846|NCT00961792|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110916847|NCT00961792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110916848|NCT00961792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110916849|NCT00961792|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110634368|NCT00814268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110916850|NCT00961792|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110916851|NCT00961792|Purinergic Agents|purinergic agents|mesh-ancestor
110916852|NCT00961792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110916853|NCT00961792|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110916854|NCT00961792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110916855|NCT00961792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110916856|NCT00961792|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110916857|NCT00961792|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110916858|NCT00961792|Anesthetics, Local|anesthetics, local|mesh-ancestor
110916859|NCT00961792|Anesthetics|anesthetics|mesh-ancestor
110916860|NCT00961792|Sensory System Agents|sensory system agents|mesh-ancestor
110916861|NCT00961792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110916862|NCT00961792|Antiemetics|antiemetics|mesh-ancestor
110916863|NCT00961792|Autonomic Agents|autonomic agents|mesh-ancestor
110916864|NCT00961792|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110916865|NCT00961792|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110916866|NCT00961792|Histamine Antagonists|histamine antagonists|mesh-ancestor
110916867|NCT00961792|Histamine Agents|histamine agents|mesh-ancestor
110916868|NCT00961792|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110916869|NCT00961792|Antipruritics|antipruritics|mesh-ancestor
110916870|NCT00961792|Dermatologic Agents|dermatologic agents|mesh-ancestor
110916871|NCT04435912|Hydrocortisone|hydrocortisone|mesh-list
110916872|NCT04435912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110916873|NCT02100852|Obinutuzumab|obinutuzumab|mesh-list
110916874|NCT02100852|Chlorambucil|chlorambucil|mesh-list
110916875|NCT02100852|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110916876|NCT02100852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110916877|NCT02100852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110916878|NCT02100852|Alkylating Agents|alkylating agents|mesh-ancestor
110916879|NCT02100852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110916881|NCT00057980|Epirubicin|epirubicin|mesh-list
110916882|NCT00057980|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110232424|NCT00087269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110232425|NCT00087269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110916883|NCT00057980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110916884|NCT00057980|Analgesics|analgesics|mesh-ancestor
110916885|NCT00057980|Sensory System Agents|sensory system agents|mesh-ancestor
110916886|NCT00057980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110916887|NCT00057980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110916888|NCT00057980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110916889|NCT00057980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110916890|NCT00057980|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110916891|NCT00057980|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110916892|NCT00057980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110916893|NCT00057980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110916894|NCT00057980|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110916895|NCT00057980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110916896|NCT00057980|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110916897|NCT00057980|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110916898|NCT02985879|Tilavonemab|tilavonemab|mesh-list
110916899|NCT02985879|Nootropic Agents|nootropic agents|mesh-ancestor
110916900|NCT02097966|Ribavirin|ribavirin|mesh-list
110916901|NCT02097966|Sofosbuvir|sofosbuvir|mesh-list
110916902|NCT02097966|Antimetabolites|antimetabolites|mesh-ancestor
110916903|NCT02097966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110916904|NCT02097966|Antiviral Agents|antiviral agents|mesh-ancestor
110232486|NCT00330772|Aspirin|aspirin|mesh-list
110916905|NCT02097966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110916906|NCT00052598|Aldesleukin|aldesleukin|mesh-list
110916907|NCT00052598|Interleukin-2|interleukin-2|mesh-list
110916908|NCT00052598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110916909|NCT00052598|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110916910|NCT00052598|Analgesics|analgesics|mesh-ancestor
110916911|NCT00052598|Sensory System Agents|sensory system agents|mesh-ancestor
110916912|NCT00052598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110916913|NCT00052598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110916914|NCT00052598|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110916915|NCT00052598|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110916916|NCT00052598|Antiviral Agents|antiviral agents|mesh-ancestor
110916917|NCT00052598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110916919|NCT05037994|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110916920|NCT05037994|Methylprednisolone|methylprednisolone|mesh-list
110916921|NCT05037994|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110232533|NCT00331045|Alvimopan|alvimopan|mesh-list
110916922|NCT05037994|Prednisolone acetate|prednisolone acetate|mesh-list
110916924|NCT05037994|Bupivacaine|bupivacaine|mesh-list
110916925|NCT05037994|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110916926|NCT05037994|Prednisolone phosphate|prednisolone phosphate|mesh-list
110916927|NCT05037994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110916928|NCT05037994|Glucocorticoids|glucocorticoids|mesh-ancestor
110916929|NCT05037994|Hormones|hormones|mesh-ancestor
110916930|NCT05037994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110916931|NCT05037994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110916932|NCT05037994|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110916933|NCT05037994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110916934|NCT05037994|Antiemetics|antiemetics|mesh-ancestor
110916935|NCT05037994|Autonomic Agents|autonomic agents|mesh-ancestor
110916936|NCT05037994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110916937|NCT05037994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110916938|NCT05037994|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110916939|NCT05037994|Protective Agents|protective agents|mesh-ancestor
110916940|NCT05037994|Analgesics|analgesics|mesh-ancestor
110916941|NCT05037994|Sensory System Agents|sensory system agents|mesh-ancestor
110916942|NCT05037994|Anticonvulsants|anticonvulsants|mesh-ancestor
110916943|NCT05037994|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110916944|NCT05037994|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110916945|NCT05037994|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110916946|NCT05037994|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110916947|NCT05037994|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110232596|NCT00331240|Timolol|timolol|mesh-list
110916948|NCT05037994|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110916949|NCT05037994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110916950|NCT05037994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110916951|NCT05037994|Antimanic Agents|antimanic agents|mesh-ancestor
110916952|NCT05037994|Anesthetics, Local|anesthetics, local|mesh-ancestor
110916953|NCT05037994|Anesthetics|anesthetics|mesh-ancestor
110916954|NCT00052520|Aldesleukin|aldesleukin|mesh-list
110916955|NCT00052520|Interleukin-2|interleukin-2|mesh-list
110916956|NCT00052520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110916957|NCT00052520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110916958|NCT00052520|Analgesics|analgesics|mesh-ancestor
110916959|NCT00052520|Sensory System Agents|sensory system agents|mesh-ancestor
110916960|NCT00052520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110916961|NCT00052520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110916962|NCT00052520|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110916963|NCT00052520|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110916964|NCT00052520|Antiviral Agents|antiviral agents|mesh-ancestor
110916965|NCT00052520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110916966|NCT05036434|Pembrolizumab|pembrolizumab|mesh-list
110916967|NCT05036434|Lenvatinib|lenvatinib|mesh-list
110916968|NCT05036434|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110916969|NCT05036434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110916970|NCT05036434|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110916971|NCT05036434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110916972|NCT05036434|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110916973|NCT05036434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110916974|NCT00051038|Entecavir|entecavir|mesh-list
110916975|NCT00051038|Antiviral Agents|antiviral agents|mesh-ancestor
110916976|NCT00051038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110916977|NCT05035186|Amoxicillin|amoxicillin|mesh-list
110916978|NCT05035186|Clarithromycin|clarithromycin|mesh-list
110916979|NCT05035186|Levofloxacin|levofloxacin|mesh-list
110232640|NCT00331513|Vorinostat|vorinostat|mesh-list
110916980|NCT05035186|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110916981|NCT05035186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110916982|NCT05035186|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110916983|NCT05035186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110916984|NCT05035186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110916985|NCT05035186|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110916986|NCT05035186|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110916987|NCT05035186|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110916988|NCT05035186|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110916989|NCT05035186|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110916990|NCT05035186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110916991|NCT05035186|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110916992|NCT01067469|Bevacizumab|bevacizumab|mesh-list
110916993|NCT01067469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110916994|NCT01067469|Lomustine|lomustine|mesh-list
110916995|NCT01067469|Antibodies|antibodies|mesh-list
110916996|NCT01067469|Immunoglobulins|immunoglobulins|mesh-list
110916997|NCT01067469|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110916998|NCT01067469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110916999|NCT01067469|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110917000|NCT01067469|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110917001|NCT01067469|Growth Substances|growth substances|mesh-ancestor
110917002|NCT01067469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110634517|NCT02551796|Dipivefrin|dipivefrin|mesh-list
110917003|NCT01067469|Growth Inhibitors|growth inhibitors|mesh-ancestor
110917004|NCT01067469|Immunologic Factors|immunologic factors|mesh-ancestor
110917005|NCT01067469|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110917006|NCT01067469|Alkylating Agents|alkylating agents|mesh-ancestor
110917007|NCT01067469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110917008|NCT00050102|Ipilimumab|ipilimumab|mesh-list
110917009|NCT00050102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110917010|NCT00050102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110917011|NCT00050102|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110917012|NCT00050102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110917013|NCT02103660|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
110917014|NCT02103660|Contraceptive Agents|contraceptive agents|mesh-list
110917015|NCT02103660|Medroxyprogesterone|medroxyprogesterone|mesh-list
110917016|NCT02103660|Progestins|progestins|mesh-list
110917017|NCT02103660|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110917018|NCT02103660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110917019|NCT02103660|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110917020|NCT02103660|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110917021|NCT02103660|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110917022|NCT02103660|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110917023|NCT02103660|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110917024|NCT02103660|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110917025|NCT02103660|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110917026|NCT02103660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110917027|NCT02103660|Hormones|hormones|mesh-ancestor
110917028|NCT02103660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110917029|NCT00358982|Mocetinostat|mocetinostat|mesh-list
110917030|NCT00358982|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110917031|NCT00358982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110917032|NCT00358982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110917033|NCT02101164|Denosumab|denosumab|mesh-list
110917034|NCT02101164|Pamidronate|pamidronate|mesh-list
110917035|NCT02101164|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110917036|NCT02101164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110917037|NCT00036608|Entecavir|entecavir|mesh-list
110917038|NCT00036608|Antiviral Agents|antiviral agents|mesh-ancestor
110917039|NCT00036608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110917040|NCT02103738|Ranibizumab|ranibizumab|mesh-list
110917041|NCT02103738|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110917042|NCT02103738|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110917043|NCT02103738|Growth Substances|growth substances|mesh-ancestor
110917044|NCT02103738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110917045|NCT02103738|Growth Inhibitors|growth inhibitors|mesh-ancestor
110917046|NCT02103738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110928185|NCT02635204|Clobetasol|clobetasol|mesh-list
110917047|NCT02985021|Carboplatin|carboplatin|mesh-list
110917048|NCT02985021|Docetaxel|docetaxel|mesh-list
110917049|NCT02985021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110917050|NCT02985021|Tubulin Modulators|tubulin modulators|mesh-ancestor
110917051|NCT02985021|Antimitotic Agents|antimitotic agents|mesh-ancestor
110917052|NCT02985021|Mitosis Modulators|mitosis modulators|mesh-ancestor
110917053|NCT02985021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110917054|NCT05714540|Magnesium Sulfate|magnesium sulfate|mesh-list
110917055|NCT05714540|Ketamine|ketamine|mesh-list
110917056|NCT05714540|Analgesics|analgesics|mesh-ancestor
110917057|NCT05714540|Sensory System Agents|sensory system agents|mesh-ancestor
110917058|NCT05714540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110917059|NCT05714540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110917060|NCT05714540|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110917061|NCT05714540|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110917062|NCT05714540|Anesthetics, General|anesthetics, general|mesh-ancestor
110917063|NCT05714540|Anesthetics|anesthetics|mesh-ancestor
110917064|NCT05714540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110917065|NCT05714540|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110917066|NCT05714540|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110917067|NCT05714540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110917068|NCT05714540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110917069|NCT05714540|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110917070|NCT05714540|Anticonvulsants|anticonvulsants|mesh-ancestor
110917071|NCT05714540|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110917072|NCT05714540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110917073|NCT05714540|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110917074|NCT05714540|Tocolytic Agents|tocolytic agents|mesh-ancestor
110917075|NCT05714540|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110917076|NCT04385667|Levonorgestrel|levonorgestrel|mesh-list
110917077|NCT04385667|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110917078|NCT04385667|Contraceptive Agents|contraceptive agents|mesh-ancestor
110917079|NCT04385667|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110917080|NCT04385667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110917081|NCT04385667|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110917082|NCT04385667|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110917083|NCT04385667|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110917085|NCT04441424|Hydroxychloroquine|hydroxychloroquine|mesh-list
110917086|NCT04441424|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110917087|NCT04441424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110917088|NCT04441424|Antimalarials|antimalarials|mesh-ancestor
110917089|NCT04441424|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110917090|NCT04441424|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110917091|NCT04441424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110917092|NCT04441424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110917093|NCT04441424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110917094|NCT03530228|Esomeprazole|esomeprazole|mesh-list
110917095|NCT03530228|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110917096|NCT03530228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110917097|NCT03530228|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110917098|NCT03530228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110917099|NCT03530228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110917101|NCT01066923|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110917102|NCT01066923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110917103|NCT01066923|Analgesics|analgesics|mesh-ancestor
110364563|NCT00535418|Letrozole|letrozole|mesh-list
110917104|NCT01066923|Sensory System Agents|sensory system agents|mesh-ancestor
110917105|NCT01066923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110917106|NCT01066923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110917107|NCT01066923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110917108|NCT01066923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110917109|NCT01066923|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110917110|NCT01066923|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110917111|NCT01066923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110917112|NCT01066923|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110917113|NCT01066923|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110917114|NCT01066923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110917115|NCT01066923|Antipyretics|antipyretics|mesh-ancestor
110917116|NCT03530150|Pirfenidone|pirfenidone|mesh-list
110917117|NCT03530150|Analgesics|analgesics|mesh-ancestor
110917118|NCT03530150|Sensory System Agents|sensory system agents|mesh-ancestor
110917119|NCT03530150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110917120|NCT03530150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110917121|NCT03530150|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110917122|NCT03530150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110232977|NCT05830071|Hormones|hormones|mesh-ancestor
110917133|NCT02098590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110917134|NCT02098590|Antimalarials|antimalarials|mesh-ancestor
110917135|NCT02098590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110917136|NCT02098590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110917137|NCT02098590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110917138|NCT02098590|Antimetabolites|antimetabolites|mesh-ancestor
110917139|NCT03657381|Antibodies|antibodies|mesh-list
110917140|NCT03657381|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110917141|NCT03657381|Immunologic Factors|immunologic factors|mesh-ancestor
110917142|NCT03657381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110917143|NCT00005918|Lamivudine|lamivudine|mesh-list
110917144|NCT00005918|Efavirenz|efavirenz|mesh-list
110917145|NCT00005918|Stavudine|stavudine|mesh-list
110917146|NCT00005918|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110917147|NCT00005918|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110232983|NCT05820997|Anesthetics, Local|anesthetics, local|mesh-ancestor
110232984|NCT05820997|Anesthetics|anesthetics|mesh-ancestor
110232985|NCT05820997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110232986|NCT05820997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110232987|NCT05820997|Sensory System Agents|sensory system agents|mesh-ancestor
110232988|NCT05820997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110233005|NCT05776017|Antacids|antacids|mesh-ancestor
110917148|NCT00005918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110917149|NCT00005918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110917150|NCT00005918|Antiviral Agents|antiviral agents|mesh-ancestor
110917151|NCT00005918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110917152|NCT00005918|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110917153|NCT00005918|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110917154|NCT00005918|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110917155|NCT00005918|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110917156|NCT00005918|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110917157|NCT00005918|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110917158|NCT00005918|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110917159|NCT00005918|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110917161|NCT02656797|Amphotericin B|amphotericin b|mesh-list
110917162|NCT02656797|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
110917163|NCT02656797|Amebicides|amebicides|mesh-ancestor
110917164|NCT02656797|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110917165|NCT02656797|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110917166|NCT02656797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110917167|NCT02656797|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110917168|NCT02656797|Antifungal Agents|antifungal agents|mesh-ancestor
110917169|NCT04443244|Botulinum Toxins|botulinum toxins|mesh-list
110917170|NCT04443244|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110233038|NCT05665270|Hormones|hormones|mesh-ancestor
110364573|NCT04679064|Paclitaxel|paclitaxel|mesh-list
110917171|NCT04443244|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110917172|NCT04443244|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110917173|NCT04443244|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110917174|NCT04443244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110917175|NCT04443244|Cholinergic Agents|cholinergic agents|mesh-ancestor
110917176|NCT04443244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110917177|NCT04443244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110917178|NCT04443244|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110917179|NCT04443244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110917180|NCT02101476|Acetaminophen|acetaminophen|mesh-list
110917181|NCT02101476|Oxycodone|oxycodone|mesh-list
110917182|NCT02101476|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110917183|NCT02101476|Analgesics|analgesics|mesh-ancestor
110917184|NCT02101476|Sensory System Agents|sensory system agents|mesh-ancestor
110917185|NCT02101476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110917186|NCT02101476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110917187|NCT02101476|Antipyretics|antipyretics|mesh-ancestor
110917188|NCT02101476|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110917189|NCT02101476|Narcotics|narcotics|mesh-ancestor
110917190|NCT02101476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110917191|NCT02104128|Bupropion|bupropion|mesh-list
110917192|NCT02104128|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110917193|NCT02104128|Antidepressive Agents|antidepressive agents|mesh-ancestor
110917194|NCT02104128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110917195|NCT02104128|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110917196|NCT02104128|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110917197|NCT02104128|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110917198|NCT02104128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110917199|NCT02104128|Dopamine Agents|dopamine agents|mesh-ancestor
110917200|NCT02104128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110917201|NCT02104128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110917202|NCT02104128|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110917203|NCT02104128|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110917204|NCT02104128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110917205|NCT00004916|Paclitaxel|paclitaxel|mesh-list
110917206|NCT00004916|Ifosfamide|ifosfamide|mesh-list
110917207|NCT00004916|Teniposide|teniposide|mesh-list
110917208|NCT00004916|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110917209|NCT00004916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110917210|NCT00004916|Tubulin Modulators|tubulin modulators|mesh-ancestor
110917211|NCT00004916|Antimitotic Agents|antimitotic agents|mesh-ancestor
110917212|NCT00004916|Mitosis Modulators|mitosis modulators|mesh-ancestor
110917213|NCT00004916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110917214|NCT00004916|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110364601|NCT01183780|Leucovorin|leucovorin|mesh-list
110917215|NCT00004916|Alkylating Agents|alkylating agents|mesh-ancestor
110917216|NCT00004916|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110917217|NCT00004916|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110917218|NCT00004916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110917219|NCT02101632|Petrolatum|petrolatum|mesh-list
110917220|NCT02101632|Emollients|emollients|mesh-ancestor
110917221|NCT02101632|Dermatologic Agents|dermatologic agents|mesh-ancestor
110917222|NCT02101710|Isosorbide|isosorbide|mesh-list
110917223|NCT02101710|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
110917224|NCT02101710|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
110917225|NCT02101710|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110917226|NCT02101710|Diuretics|diuretics|mesh-ancestor
110917227|NCT02101710|Natriuretic Agents|natriuretic agents|mesh-ancestor
110917228|NCT02101710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110917229|NCT02101710|Vasodilator Agents|vasodilator agents|mesh-ancestor
110917230|NCT02101710|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
110917231|NCT02101710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110917233|NCT03878368|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110917234|NCT03878368|Protective Agents|protective agents|mesh-ancestor
110917235|NCT03878368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110917236|NCT03878368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110917237|NCT02910063|Blinatumomab|blinatumomab|mesh-list
110917238|NCT02910063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110917239|NCT04441762|Ketorolac|ketorolac|mesh-list
110917240|NCT04441762|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
110917241|NCT04441762|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110917242|NCT04441762|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110917243|NCT04441762|Analgesics|analgesics|mesh-ancestor
110917244|NCT04441762|Sensory System Agents|sensory system agents|mesh-ancestor
110917245|NCT04441762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110917246|NCT04441762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110917247|NCT04441762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110917248|NCT04441762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110917249|NCT04441762|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110917250|NCT04441762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110917251|NCT04441762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110917252|NCT02104284|Mannitol|mannitol|mesh-list
110917253|NCT02104284|Methacholine Chloride|methacholine chloride|mesh-list
110917254|NCT02104284|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110917255|NCT02104284|Diuretics|diuretics|mesh-ancestor
110917256|NCT02104284|Natriuretic Agents|natriuretic agents|mesh-ancestor
110917257|NCT02104284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110917258|NCT02104284|Miotics|miotics|mesh-ancestor
110917259|NCT02104284|Autonomic Agents|autonomic agents|mesh-ancestor
110917260|NCT02104284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110917261|NCT02104284|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110917262|NCT02104284|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
110917263|NCT02104284|Respiratory System Agents|respiratory system agents|mesh-ancestor
110917264|NCT02104284|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
110917265|NCT02104284|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110917266|NCT02104284|Cholinergic Agents|cholinergic agents|mesh-ancestor
110917267|NCT02104284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110917268|NCT02104284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110917269|NCT00337532|Paclitaxel|paclitaxel|mesh-list
110917270|NCT00337532|Cisplatin|cisplatin|mesh-list
110917271|NCT00337532|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110917272|NCT00337532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110917273|NCT00337532|Tubulin Modulators|tubulin modulators|mesh-ancestor
110917274|NCT00337532|Antimitotic Agents|antimitotic agents|mesh-ancestor
110917275|NCT00337532|Mitosis Modulators|mitosis modulators|mesh-ancestor
110917276|NCT00337532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110917277|NCT02625441|Trastuzumab|trastuzumab|mesh-list
110917278|NCT02625441|Pertuzumab|pertuzumab|mesh-list
110917279|NCT02625441|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110917280|NCT02625441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110917281|NCT04209868|Bupivacaine|bupivacaine|mesh-list
110917282|NCT04209868|Levobupivacaine|levobupivacaine|mesh-list
110917283|NCT04209868|Anesthetics, Local|anesthetics, local|mesh-ancestor
110917284|NCT04209868|Anesthetics|anesthetics|mesh-ancestor
110917285|NCT04209868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110917286|NCT04209868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110917287|NCT04209868|Sensory System Agents|sensory system agents|mesh-ancestor
110917288|NCT04209868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110917289|NCT02361801|Dobutamine|dobutamine|mesh-list
110233230|NCT05097261|Ketamine|ketamine|mesh-list
110917291|NCT02361801|Sympathomimetics|sympathomimetics|mesh-ancestor
110917292|NCT02361801|Autonomic Agents|autonomic agents|mesh-ancestor
110917293|NCT02361801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110917294|NCT02361801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110917295|NCT02361801|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
110917296|NCT02361801|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110917297|NCT02361801|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110917298|NCT02361801|Adrenergic Agents|adrenergic agents|mesh-ancestor
110917299|NCT02361801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110917300|NCT02361801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110917301|NCT02361801|Protective Agents|protective agents|mesh-ancestor
110917302|NCT03965728|Methotrexate|methotrexate|mesh-list
110917303|NCT03965728|Midazolam|midazolam|mesh-list
110917304|NCT03965728|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110917305|NCT03965728|Abortifacient Agents|abortifacient agents|mesh-ancestor
110917306|NCT03965728|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110917307|NCT03965728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110917308|NCT03965728|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110917309|NCT03965728|Antimetabolites|antimetabolites|mesh-ancestor
110233271|NCT04800393|Anesthetics, General|anesthetics, general|mesh-ancestor
110917310|NCT03965728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110917311|NCT03965728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110917312|NCT03965728|Dermatologic Agents|dermatologic agents|mesh-ancestor
110917313|NCT03965728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110917314|NCT03965728|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110917315|NCT03965728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110917316|NCT03965728|Immunologic Factors|immunologic factors|mesh-ancestor
110917317|NCT03965728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110917318|NCT03965728|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110917319|NCT03965728|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110917320|NCT03965728|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110917321|NCT03965728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110917322|NCT03965728|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110917323|NCT03965728|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110917324|NCT03965728|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110917325|NCT03965728|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110917326|NCT03965728|Anesthetics, General|anesthetics, general|mesh-ancestor
110917328|NCT03965728|GABA Modulators|gaba modulators|mesh-ancestor
110917329|NCT03965728|GABA Agents|gaba agents|mesh-ancestor
110917330|NCT03965728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110917331|NCT00337454|Dasatinib|dasatinib|mesh-list
110917332|NCT00337454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110917333|NCT00337454|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110917334|NCT00337454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110917335|NCT00337454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110917336|NCT02909907|Botulinum Toxins|botulinum toxins|mesh-list
110917337|NCT02909907|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110917338|NCT02909907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110917339|NCT02909907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110917340|NCT02909907|Cholinergic Agents|cholinergic agents|mesh-ancestor
110917341|NCT02909907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110917342|NCT02909907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110917343|NCT00004898|Cyclophosphamide|cyclophosphamide|mesh-list
110917344|NCT00004898|Etoposide|etoposide|mesh-list
110917345|NCT00004898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110917346|NCT00004898|Immunologic Factors|immunologic factors|mesh-ancestor
110917347|NCT00004898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110917348|NCT00004898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110917349|NCT00004898|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110917350|NCT00004898|Alkylating Agents|alkylating agents|mesh-ancestor
110917351|NCT00004898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110917352|NCT00004898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110917353|NCT00004898|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110917354|NCT00004898|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110917355|NCT00004898|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110917356|NCT00004898|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110917357|NCT00004898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110917358|NCT02106468|Prednisone|prednisone|mesh-list
110917359|NCT02106468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110917360|NCT02106468|Glucocorticoids|glucocorticoids|mesh-ancestor
110917361|NCT02106468|Hormones|hormones|mesh-ancestor
110917362|NCT02106468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110917363|NCT02106468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110917364|NCT02106468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110917366|NCT03956446|Doxycycline|doxycycline|mesh-list
110917367|NCT03956446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110917368|NCT03956446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110917369|NCT03956446|Antimalarials|antimalarials|mesh-ancestor
110917370|NCT03956446|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110917371|NCT03956446|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110917372|NCT00325364|Insulin|insulin|mesh-list
110917373|NCT00325364|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110917374|NCT00325364|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110917375|NCT00325364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110917376|NCT02104674|Montelukast|montelukast|mesh-list
110917377|NCT02104674|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110917378|NCT02104674|Respiratory System Agents|respiratory system agents|mesh-ancestor
110917379|NCT02104674|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110917380|NCT02104674|Hormone Antagonists|hormone antagonists|mesh-ancestor
110917381|NCT02104674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110917382|NCT02104674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110233369|NCT04302870|Antiviral Agents|antiviral agents|mesh-ancestor
110917383|NCT02104674|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110917384|NCT02104674|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110917385|NCT02104674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110917386|NCT01903330|Cyclophosphamide|cyclophosphamide|mesh-list
110917387|NCT01903330|Bevacizumab|bevacizumab|mesh-list
110917388|NCT01903330|Sargramostim|sargramostim|mesh-list
110917389|NCT01903330|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110917390|NCT01903330|Immunologic Factors|immunologic factors|mesh-ancestor
110917391|NCT01903330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110917392|NCT01903330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110917393|NCT01903330|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110917394|NCT01903330|Alkylating Agents|alkylating agents|mesh-ancestor
110917395|NCT01903330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110917396|NCT01903330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110917397|NCT01903330|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110364645|NCT03245021|Rituximab|rituximab|mesh-list
110917398|NCT01903330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110917399|NCT01903330|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110917400|NCT01903330|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110917401|NCT01903330|Growth Substances|growth substances|mesh-ancestor
110233401|NCT04229095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110233402|NCT04229095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110233403|NCT04229095|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
110233404|NCT04229095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110233406|NCT04088604|Fluorouracil|fluorouracil|mesh-list
110917402|NCT01903330|Growth Inhibitors|growth inhibitors|mesh-ancestor
110917403|NCT02907177|Ponesimod|ponesimod|mesh-list
110917404|NCT02907177|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
110917405|NCT02907177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110917406|NCT02907177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110917407|NCT02907177|Immunologic Factors|immunologic factors|mesh-ancestor
110917408|NCT02907177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110917409|NCT00004172|Cyclophosphamide|cyclophosphamide|mesh-list
110917410|NCT00004172|Ifosfamide|ifosfamide|mesh-list
110917411|NCT00004172|Thiotepa|thiotepa|mesh-list
110917412|NCT00004172|Carboplatin|carboplatin|mesh-list
110917413|NCT00004172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110917414|NCT00004172|Immunologic Factors|immunologic factors|mesh-ancestor
110917415|NCT00004172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110917416|NCT00004172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110917417|NCT00004172|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110917418|NCT00004172|Alkylating Agents|alkylating agents|mesh-ancestor
110917419|NCT00004172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110917420|NCT00004172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110917421|NCT00004172|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110917422|NCT04353310|Curcumin|curcumin|mesh-list
110917423|NCT04353310|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110917424|NCT04353310|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110917425|NCT04353310|Analgesics|analgesics|mesh-ancestor
110917426|NCT04353310|Sensory System Agents|sensory system agents|mesh-ancestor
110917427|NCT04353310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110917428|NCT04353310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110917429|NCT04353310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110917430|NCT04353310|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110917431|NCT04353310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110917432|NCT04353310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110917433|NCT04353310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110917434|NCT00004166|Amifostine|amifostine|mesh-list
110917435|NCT00004166|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110917436|NCT00004166|Protective Agents|protective agents|mesh-ancestor
110917437|NCT00004166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110917438|NCT00004106|Temozolomide|temozolomide|mesh-list
110917439|NCT00004106|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110917440|NCT00004106|Alkylating Agents|alkylating agents|mesh-ancestor
110917441|NCT00004106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110917442|NCT00004106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110917443|NCT00002246|Stavudine|stavudine|mesh-list
110917444|NCT00002246|Antimetabolites|antimetabolites|mesh-ancestor
110917445|NCT00002246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110917446|NCT00002246|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110917447|NCT00002246|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110917448|NCT00002246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110917449|NCT00002246|Antiviral Agents|antiviral agents|mesh-ancestor
110917450|NCT00002246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110917451|NCT00002246|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110917452|NCT00002246|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110917453|NCT00002240|Atazanavir Sulfate|atazanavir sulfate|mesh-list
110917454|NCT00002240|Nelfinavir|nelfinavir|mesh-list
110917455|NCT00002240|Stavudine|stavudine|mesh-list
110917456|NCT00002240|Didanosine|didanosine|mesh-list
110917457|NCT00002240|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110917458|NCT00002240|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110917459|NCT00002240|Protease Inhibitors|protease inhibitors|mesh-ancestor
110917460|NCT00002240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110917461|NCT00002240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110917462|NCT00002240|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110917463|NCT00002240|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110917464|NCT00002240|Antiviral Agents|antiviral agents|mesh-ancestor
110917465|NCT00002240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110917466|NCT00002240|Antimetabolites|antimetabolites|mesh-ancestor
110917467|NCT00002240|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110917468|NCT00002240|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110917470|NCT02250924|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110917471|NCT02250924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110917472|NCT02250924|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110917473|NCT02250924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110917474|NCT02250924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110917475|NCT02250924|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110917476|NCT02250924|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110917477|NCT02250924|Purinergic Agents|purinergic agents|mesh-ancestor
110917478|NCT02250924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110917479|NCT03645148|Molgramostim|molgramostim|mesh-list
110917480|NCT03645148|Sargramostim|sargramostim|mesh-list
110917481|NCT03645148|Immunologic Factors|immunologic factors|mesh-ancestor
110917482|NCT03645148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110917483|NCT03645148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110917484|NCT04082728|Dipyrone|dipyrone|mesh-list
110917485|NCT04082728|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110917486|NCT04082728|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110917487|NCT04082728|Analgesics|analgesics|mesh-ancestor
110917488|NCT04082728|Sensory System Agents|sensory system agents|mesh-ancestor
110917489|NCT04082728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110917490|NCT04082728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110917491|NCT04082728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110917492|NCT04082728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110917493|NCT04082728|Antipyretics|antipyretics|mesh-ancestor
110917494|NCT02906709|Insulin|insulin|mesh-list
110917495|NCT02906709|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110917496|NCT02906709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110917497|NCT00321308|Pemetrexed|pemetrexed|mesh-list
110917498|NCT00321308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110917499|NCT00321308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110917500|NCT00321308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110917501|NCT00321308|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110917502|NCT00321308|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110917503|NCT02110134|Hydroquinone|hydroquinone|mesh-list
110917504|NCT02110134|Antioxidants|antioxidants|mesh-ancestor
110917505|NCT02110134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110917506|NCT02110134|Protective Agents|protective agents|mesh-ancestor
110917507|NCT02110134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110917508|NCT02110134|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110917509|NCT00318656|Metformin|metformin|mesh-list
110917510|NCT00318656|Glimepiride|glimepiride|mesh-list
110917511|NCT00318656|Rosiglitazone|rosiglitazone|mesh-list
110917512|NCT00318656|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110917513|NCT00318656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110917514|NCT00318656|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110917515|NCT00318656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110917516|NCT00318656|Immunologic Factors|immunologic factors|mesh-ancestor
110917517|NCT02110524|Paclitaxel|paclitaxel|mesh-list
110364669|NCT02887807|Cyclosporine|cyclosporine|mesh-list
110917518|NCT02110524|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110917519|NCT02110524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110917520|NCT02110524|Tubulin Modulators|tubulin modulators|mesh-ancestor
110917521|NCT02110524|Antimitotic Agents|antimitotic agents|mesh-ancestor
110917522|NCT02110524|Mitosis Modulators|mitosis modulators|mesh-ancestor
110917523|NCT02110524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110917524|NCT00317486|Bosentan|bosentan|mesh-list
110917525|NCT00317486|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110917526|NCT00317486|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
110233721|NCT02807805|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110917527|NCT00317486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110928285|NCT03485456|Tobramycin|tobramycin|mesh-list
110917528|NCT02107170|Remifentanil|remifentanil|mesh-list
110917530|NCT02107170|Sevoflurane|sevoflurane|mesh-list
110917531|NCT02107170|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110917532|NCT02107170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110917533|NCT02107170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110917534|NCT02107170|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110917535|NCT02107170|Anesthetics, General|anesthetics, general|mesh-ancestor
110917536|NCT02107170|Anesthetics|anesthetics|mesh-ancestor
110917537|NCT02107170|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110917538|NCT02107170|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110917539|NCT02107170|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110917540|NCT02107170|Narcotics|narcotics|mesh-ancestor
110917541|NCT02107170|Analgesics|analgesics|mesh-ancestor
110917542|NCT02107170|Sensory System Agents|sensory system agents|mesh-ancestor
110917543|NCT02107170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110917544|NCT00313196|Bosentan|bosentan|mesh-list
110917545|NCT00313196|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110917546|NCT00313196|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
110917547|NCT00313196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110917548|NCT03656679|Iodine|iodine|mesh-list
110917549|NCT03656679|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110917550|NCT03656679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110917551|NCT03656679|Trace Elements|trace elements|mesh-ancestor
110917552|NCT03656679|Micronutrients|micronutrients|mesh-ancestor
110917553|NCT03656679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110917554|NCT03663166|Nivolumab|nivolumab|mesh-list
110917555|NCT03663166|Ipilimumab|ipilimumab|mesh-list
110917556|NCT03663166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110917557|NCT03663166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110917558|NCT03663166|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110917559|NCT03663166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110917560|NCT03554304|Moxifloxacin|moxifloxacin|mesh-list
110917561|NCT03554304|Cefepime-zidebactam|cefepime-zidebactam|mesh-list
110917562|NCT03554304|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
110917563|NCT03554304|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110917564|NCT03554304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110917565|NCT03554304|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110917566|NCT03554304|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110917567|NCT03554304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110917568|NCT03554304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110917569|NCT03554304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110917570|NCT03554304|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110917571|NCT03554304|Contraceptive Agents|contraceptive agents|mesh-ancestor
110917572|NCT03554304|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110917573|NCT03554304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110917574|NCT03554304|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110917575|NCT03554304|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110917576|NCT03554304|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110917578|NCT02107716|Anesthetics, Local|anesthetics, local|mesh-ancestor
110917579|NCT02107716|Anesthetics|anesthetics|mesh-ancestor
110917580|NCT02107716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110917581|NCT02107716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110917582|NCT02107716|Sensory System Agents|sensory system agents|mesh-ancestor
110364684|NCT03098589|Lenalidomide|lenalidomide|mesh-list
110917583|NCT02107716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110917584|NCT02107716|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110917585|NCT02107716|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110917586|NCT02107716|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110917587|NCT02107716|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110917588|NCT02107716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110917589|NCT02110992|Docetaxel|docetaxel|mesh-list
110917590|NCT02110992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110917591|NCT02110992|Tubulin Modulators|tubulin modulators|mesh-ancestor
110917592|NCT02110992|Antimitotic Agents|antimitotic agents|mesh-ancestor
110917593|NCT02110992|Mitosis Modulators|mitosis modulators|mesh-ancestor
110917594|NCT02110992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110917595|NCT03306394|Trifluridine|trifluridine|mesh-list
110917596|NCT03306394|Antimetabolites|antimetabolites|mesh-ancestor
110928304|NCT02167620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110917597|NCT03306394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110917598|NCT03306394|Antiviral Agents|antiviral agents|mesh-ancestor
110917599|NCT03306394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110635117|NCT00608244|Immunologic Factors|immunologic factors|mesh-ancestor
110917600|NCT00311090|Idraparinux|idraparinux|mesh-list
110917601|NCT00311090|Idrabiotaparinux|idrabiotaparinux|mesh-list
110917602|NCT00311090|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110917603|NCT00311090|Antithrombins|antithrombins|mesh-ancestor
110917604|NCT00311090|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110917605|NCT00311090|Protease Inhibitors|protease inhibitors|mesh-ancestor
110917606|NCT00311090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110917607|NCT00311090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110917608|NCT00311090|Anticoagulants|anticoagulants|mesh-ancestor
110917609|NCT02105610|Anesthetics|anesthetics|mesh-list
110917610|NCT02105610|Sevoflurane|sevoflurane|mesh-list
110917611|NCT02105610|Desflurane|desflurane|mesh-list
110917612|NCT02105610|Isoflurane|isoflurane|mesh-list
110917613|NCT02105610|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
110917614|NCT02105610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110917615|NCT02105610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110917616|NCT02105610|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110917617|NCT02105610|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110233958|NCT05953142|Dobutamine|dobutamine|mesh-list
110917619|NCT00301262|Sildenafil Citrate|sildenafil citrate|mesh-list
110917620|NCT00301262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110917621|NCT00301262|Vasodilator Agents|vasodilator agents|mesh-ancestor
110917622|NCT00301262|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110917623|NCT00301262|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110917624|NCT00301262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110917625|NCT00301262|Urological Agents|urological agents|mesh-ancestor
110917626|NCT02254941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110917627|NCT02254941|Antibodies|antibodies|mesh-list
110917628|NCT02254941|Immunoglobulins|immunoglobulins|mesh-list
110917629|NCT02254941|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110917630|NCT02254941|Immunologic Factors|immunologic factors|mesh-ancestor
110917631|NCT02254941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110917632|NCT02254941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110917633|NCT03598270|Paclitaxel|paclitaxel|mesh-list
110917634|NCT03598270|Carboplatin|carboplatin|mesh-list
110917635|NCT03598270|Gemcitabine|gemcitabine|mesh-list
110917636|NCT03598270|Doxorubicin|doxorubicin|mesh-list
110917637|NCT03598270|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110917638|NCT03598270|Atezolizumab|atezolizumab|mesh-list
110917639|NCT03598270|Niraparib|niraparib|mesh-list
110917640|NCT03598270|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110917641|NCT03598270|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110917642|NCT03598270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110917643|NCT03598270|Tubulin Modulators|tubulin modulators|mesh-ancestor
110917644|NCT03598270|Antimitotic Agents|antimitotic agents|mesh-ancestor
110917645|NCT03598270|Mitosis Modulators|mitosis modulators|mesh-ancestor
110917646|NCT03598270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110917647|NCT03598270|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110917648|NCT03598270|Antimetabolites|antimetabolites|mesh-ancestor
110917649|NCT03598270|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110917650|NCT03598270|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110917651|NCT03598270|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110917652|NCT03598270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110917653|NCT03598270|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110917654|NCT03598270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110917655|NCT03598270|Immunologic Factors|immunologic factors|mesh-ancestor
110917656|NCT03598270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110917657|NCT03598270|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110917659|NCT03077620|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110917660|NCT03077620|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110917661|NCT03077620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110917662|NCT03077620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110917663|NCT03077620|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
110917664|NCT03077620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110917665|NCT03077620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110917666|NCT03656445|Tranexamic Acid|tranexamic acid|mesh-list
110917667|NCT03656445|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110917668|NCT03656445|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110917669|NCT03656445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110917670|NCT03656445|Hemostatics|hemostatics|mesh-ancestor
110917671|NCT03656445|Coagulants|coagulants|mesh-ancestor
110917672|NCT01903486|Prednisone|prednisone|mesh-list
110917673|NCT01903486|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110917674|NCT01903486|Glucocorticoids|glucocorticoids|mesh-ancestor
110917675|NCT01903486|Hormones|hormones|mesh-ancestor
110917676|NCT01903486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110917677|NCT01903486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110917678|NCT01903486|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110917679|NCT01903486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110917680|NCT03656289|Etonogestrel|etonogestrel|mesh-list
110917681|NCT03656289|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110917682|NCT03656289|Contraceptive Agents|contraceptive agents|mesh-ancestor
110234107|NCT05951465|Anesthetics|anesthetics|mesh-ancestor
110917683|NCT03656289|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110917684|NCT03656289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110917685|NCT03656289|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110917686|NCT00599170|Rituximab|rituximab|mesh-list
110917687|NCT00599170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110917688|NCT00599170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110917689|NCT00599170|Immunologic Factors|immunologic factors|mesh-ancestor
110917690|NCT00599170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110917691|NCT00599170|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110917692|NCT04256434|Nalbuphine|nalbuphine|mesh-list
110917693|NCT04256434|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110917694|NCT04256434|Narcotics|narcotics|mesh-ancestor
110917695|NCT04256434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110917696|NCT04256434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110917697|NCT04256434|Analgesics|analgesics|mesh-ancestor
110917698|NCT04256434|Sensory System Agents|sensory system agents|mesh-ancestor
110917699|NCT04256434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110917700|NCT02588326|Mometasone Furoate|mometasone furoate|mesh-list
110917701|NCT02588326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110917702|NCT02588326|Dermatologic Agents|dermatologic agents|mesh-ancestor
110917703|NCT02588326|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110917704|NCT02107950|Carboplatin|carboplatin|mesh-list
110917705|NCT02107950|Gemcitabine|gemcitabine|mesh-list
110917706|NCT02107950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110917707|NCT02107950|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110917708|NCT02107950|Antimetabolites|antimetabolites|mesh-ancestor
110917709|NCT02107950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110917710|NCT02108106|Mitapivat|mitapivat|mesh-list
110917711|NCT02108106|Enzyme Activators|enzyme activators|mesh-ancestor
110288524|NCT00245427|Lactams|lactams|mesh-list
110234208|NCT05925179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110234209|NCT05925179|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110234210|NCT05925179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110234211|NCT05925179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110917712|NCT02108106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110917714|NCT02113800|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110917715|NCT02113800|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110917716|NCT02113800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110917717|NCT02113800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110917718|NCT02113800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110917719|NCT02113800|Immunologic Factors|immunologic factors|mesh-ancestor
110917720|NCT02113800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110917721|NCT02113800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110234286|NCT05860933|Analgesics|analgesics|mesh-ancestor
110917722|NCT01066143|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110917723|NCT01066143|Antidepressive Agents|antidepressive agents|mesh-ancestor
110917724|NCT01066143|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110917725|NCT01066143|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110917726|NCT01066143|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110917727|NCT01066143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110917728|NCT01066143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110917729|NCT02111928|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110234335|NCT05794997|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110234336|NCT05794997|Sympatholytics|sympatholytics|mesh-ancestor
110234337|NCT05794997|Autonomic Agents|autonomic agents|mesh-ancestor
110917730|NCT02111928|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110917731|NCT02112006|Bupivacaine|bupivacaine|mesh-list
110917732|NCT02112006|Anesthetics, Local|anesthetics, local|mesh-ancestor
110917733|NCT02112006|Anesthetics|anesthetics|mesh-ancestor
110917734|NCT02112006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110917735|NCT02112006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110917736|NCT02112006|Sensory System Agents|sensory system agents|mesh-ancestor
110917737|NCT02112006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110917738|NCT02251158|Ritonavir|ritonavir|mesh-list
110917739|NCT02251158|Tipranavir|tipranavir|mesh-list
110917740|NCT02251158|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110917741|NCT02251158|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110917742|NCT02251158|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110917743|NCT02251158|Protease Inhibitors|protease inhibitors|mesh-ancestor
110917744|NCT02251158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110917745|NCT02251158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110917746|NCT02251158|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110917747|NCT02251158|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110917748|NCT02251158|Antiviral Agents|antiviral agents|mesh-ancestor
110917749|NCT02251158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110917750|NCT02251158|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110917751|NCT02251158|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110917752|NCT02652130|Remestemcel-l|remestemcel-l|mesh-list
110917753|NCT02652130|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110917754|NCT02652130|Antiviral Agents|antiviral agents|mesh-ancestor
110917755|NCT02652130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110917756|NCT05404516|Cytarabine|cytarabine|mesh-list
110917757|NCT05404516|Sorafenib|sorafenib|mesh-list
110917758|NCT05404516|Idarubicin|idarubicin|mesh-list
110917759|NCT05404516|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110917760|NCT05404516|Antimetabolites|antimetabolites|mesh-ancestor
110917761|NCT05404516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110917762|NCT05404516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110917763|NCT05404516|Antiviral Agents|antiviral agents|mesh-ancestor
110917764|NCT05404516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110917765|NCT05404516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110917766|NCT05404516|Immunologic Factors|immunologic factors|mesh-ancestor
110917767|NCT05404516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110917768|NCT05404516|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110917769|NCT05404516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110917770|NCT05404516|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110917771|NCT05404516|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110917772|NCT05404516|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110917773|NCT02114346|Atorvastatin|atorvastatin|mesh-list
110917774|NCT02114346|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110917775|NCT02114346|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110917776|NCT02114346|Antimetabolites|antimetabolites|mesh-ancestor
110917777|NCT02114346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110234600|NCT05322902|Propofol|propofol|mesh-list
110917778|NCT02114346|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110917779|NCT02114346|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110917780|NCT02114346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110917781|NCT02112162|Deoxyglucose|deoxyglucose|mesh-list
110917782|NCT02112162|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110917783|NCT02112162|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110917784|NCT02112162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110917785|NCT02112162|Antimetabolites|antimetabolites|mesh-ancestor
110917786|NCT02112162|Antiviral Agents|antiviral agents|mesh-ancestor
110917787|NCT02112162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110917788|NCT02108808|Clopidogrel|clopidogrel|mesh-list
110917789|NCT02108808|Ticagrelor|ticagrelor|mesh-list
110917790|NCT02108808|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
110917791|NCT02108808|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110917792|NCT02108808|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110917793|NCT02108808|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110917794|NCT02108808|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110917795|NCT02108808|Purinergic Agents|purinergic agents|mesh-ancestor
110917796|NCT02108808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110917797|NCT02108808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110234717|NCT05049902|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110917798|NCT02108808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110917800|NCT02108886|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110917801|NCT02108886|Respiratory System Agents|respiratory system agents|mesh-ancestor
110917802|NCT02108886|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110917803|NCT02108886|Hormone Antagonists|hormone antagonists|mesh-ancestor
110917804|NCT02108886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110917805|NCT02108886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110917806|NCT02108886|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110917807|NCT02108886|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110917808|NCT02108886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110917809|NCT02114502|Pyridoxine|pyridoxine|mesh-list
110234793|NCT04716413|Dsuvia|dsuvia|mesh-list
110917810|NCT02114502|Dexamethasone|dexamethasone|mesh-list
110917811|NCT02114502|Gemcitabine|gemcitabine|mesh-list
110917812|NCT02114502|Melphalan|melphalan|mesh-list
110917813|NCT02114502|Busulfan|busulfan|mesh-list
110917814|NCT02114502|Vorinostat|vorinostat|mesh-list
110917815|NCT02114502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110917816|NCT02114502|Antiemetics|antiemetics|mesh-ancestor
110917817|NCT02114502|Autonomic Agents|autonomic agents|mesh-ancestor
110917818|NCT02114502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110917819|NCT02114502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110917820|NCT02114502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110917821|NCT02114502|Glucocorticoids|glucocorticoids|mesh-ancestor
110917822|NCT02114502|Hormones|hormones|mesh-ancestor
110917823|NCT02114502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110917824|NCT02114502|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110917825|NCT02114502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110917826|NCT02114502|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110917827|NCT02114502|Antimetabolites|antimetabolites|mesh-ancestor
110917828|NCT02114502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110917829|NCT02114502|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110917830|NCT02114502|Alkylating Agents|alkylating agents|mesh-ancestor
110917831|NCT02114502|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110917832|NCT02114502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110917833|NCT02114502|Immunologic Factors|immunologic factors|mesh-ancestor
110917834|NCT02114502|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110917835|NCT02114502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110917836|NCT02114502|Vitamin B Complex|vitamin b complex|mesh-ancestor
110917837|NCT02114502|Vitamins|vitamins|mesh-ancestor
110917838|NCT02114502|Micronutrients|micronutrients|mesh-ancestor
110917839|NCT03654027|Docetaxel|docetaxel|mesh-list
110917840|NCT03654027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110917841|NCT03654027|Tubulin Modulators|tubulin modulators|mesh-ancestor
110917842|NCT03654027|Antimitotic Agents|antimitotic agents|mesh-ancestor
110917843|NCT03654027|Mitosis Modulators|mitosis modulators|mesh-ancestor
110917844|NCT03654027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110235047|NCT03774810|GABA Agonists|gaba agonists|mesh-ancestor
110917846|NCT02114658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110917847|NCT02114658|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110917848|NCT02114658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110917849|NCT02114658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110917850|NCT05126602|Vitamin D|vitamin d|mesh-list
110917851|NCT05126602|Ergocalciferols|ergocalciferols|mesh-list
110917852|NCT05126602|Cholecalciferol|cholecalciferol|mesh-list
110917853|NCT05126602|Vitamins|vitamins|mesh-list
110917854|NCT05126602|Micronutrients|micronutrients|mesh-ancestor
110917855|NCT05126602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110917856|NCT05126602|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110917857|NCT05126602|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110917858|NCT02114736|Botulinum Toxins|botulinum toxins|mesh-list
110917859|NCT02114736|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110917860|NCT02114736|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110917861|NCT02114736|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110917862|NCT02114736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110917863|NCT02114736|Cholinergic Agents|cholinergic agents|mesh-ancestor
110917865|NCT02114736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110917866|NCT02114736|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110364756|NCT00538109|Imatinib Mesylate|imatinib mesylate|mesh-list
110917867|NCT02114736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110917868|NCT02112552|Paclitaxel|paclitaxel|mesh-list
110917869|NCT02112552|Carboplatin|carboplatin|mesh-list
110917870|NCT02112552|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110917871|NCT02112552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110917872|NCT02112552|Tubulin Modulators|tubulin modulators|mesh-ancestor
110917873|NCT02112552|Antimitotic Agents|antimitotic agents|mesh-ancestor
110917874|NCT02112552|Mitosis Modulators|mitosis modulators|mesh-ancestor
110917875|NCT02112552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110917877|NCT02109354|Immunologic Factors|immunologic factors|mesh-ancestor
110917878|NCT02109354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110917879|NCT03165136|Hydroxychloroquine|hydroxychloroquine|mesh-list
110917880|NCT03165136|Antimalarials|antimalarials|mesh-ancestor
110917881|NCT03165136|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110917882|NCT03165136|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110917883|NCT03165136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110917884|NCT03165136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110917885|NCT03165136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110917886|NCT03165136|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110917887|NCT02109510|Lidocaine|lidocaine|mesh-list
110917888|NCT02109510|Dexmedetomidine|dexmedetomidine|mesh-list
110917889|NCT02109510|Ketamine|ketamine|mesh-list
110917890|NCT02109510|Anesthetics|anesthetics|mesh-list
110917891|NCT02109510|Propofol|propofol|mesh-list
110917892|NCT02109510|Sevoflurane|sevoflurane|mesh-list
110917893|NCT02109510|Rocuronium|rocuronium|mesh-list
110917894|NCT02109510|Anesthetics, Local|anesthetics, local|mesh-ancestor
110917895|NCT02109510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110235303|NCT01423812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110917896|NCT02109510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110917897|NCT02109510|Sensory System Agents|sensory system agents|mesh-ancestor
110917898|NCT02109510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110917899|NCT02109510|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110917900|NCT02109510|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110917901|NCT02109510|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110917902|NCT02109510|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110917903|NCT02109510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110917904|NCT02109510|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110917905|NCT02109510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110917906|NCT02109510|Analgesics|analgesics|mesh-ancestor
110917907|NCT02109510|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110235360|NCT00099086|Docetaxel|docetaxel|mesh-list
110917908|NCT02109510|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110917909|NCT02109510|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110917910|NCT02109510|Adrenergic Agents|adrenergic agents|mesh-ancestor
110917911|NCT02109510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110917912|NCT02109510|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110917913|NCT02109510|Anesthetics, General|anesthetics, general|mesh-ancestor
110917914|NCT02109510|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110917915|NCT02109510|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110917916|NCT02109510|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110917917|NCT02109510|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110917918|NCT02109510|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110917919|NCT02109510|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110917920|NCT02109510|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110917921|NCT02109510|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110917922|NCT02109666|Abatacept|abatacept|mesh-list
110917923|NCT02109666|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110917924|NCT02109666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110917925|NCT02109666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110917926|NCT02109666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110917927|NCT02109666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110917928|NCT02109666|Immunologic Factors|immunologic factors|mesh-ancestor
110917929|NCT02109666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110917930|NCT02109666|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110917931|NCT02865928|Bupivacaine|bupivacaine|mesh-list
110917932|NCT02865928|Anesthetics, Local|anesthetics, local|mesh-ancestor
110917933|NCT02865928|Anesthetics|anesthetics|mesh-ancestor
110917934|NCT02865928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110917935|NCT02865928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110917936|NCT02865928|Sensory System Agents|sensory system agents|mesh-ancestor
110917937|NCT02865928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110917939|NCT02109900|Progestins|progestins|mesh-ancestor
110917940|NCT02109900|Hormones|hormones|mesh-ancestor
110917941|NCT02109900|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110917942|NCT02109900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110917943|NCT02112630|Interferons|interferons|mesh-list
110917944|NCT02112630|Ribavirin|ribavirin|mesh-list
110917945|NCT02112630|Interferon-alpha|interferon-alpha|mesh-list
110917946|NCT02112630|Interferon alpha-2|interferon alpha-2|mesh-list
110917947|NCT02112630|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110917948|NCT02112630|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
110917949|NCT02112630|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110917950|NCT02112630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110917951|NCT02112630|Antiviral Agents|antiviral agents|mesh-ancestor
110917952|NCT02112630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110917953|NCT02112630|Antimetabolites|antimetabolites|mesh-ancestor
110917954|NCT02112630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110917955|NCT02112630|Immunologic Factors|immunologic factors|mesh-ancestor
110917956|NCT02112630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110917957|NCT04873375|Cemiplimab|cemiplimab|mesh-list
110917958|NCT04873375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110917959|NCT04873375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110917960|NCT05125588|Meloxicam|meloxicam|mesh-list
110917961|NCT05125588|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110917962|NCT05125588|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110917963|NCT05125588|Analgesics|analgesics|mesh-ancestor
110917964|NCT05125588|Sensory System Agents|sensory system agents|mesh-ancestor
110917965|NCT05125588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110917966|NCT05125588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110917967|NCT05125588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110917968|NCT05125588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110917969|NCT05125588|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110917970|NCT05125588|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110917971|NCT05125588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110917972|NCT05125588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110917973|NCT02115204|Cyclophosphamide|cyclophosphamide|mesh-list
110917974|NCT02115204|Docetaxel|docetaxel|mesh-list
110917975|NCT02115204|Fluorouracil|fluorouracil|mesh-list
110917976|NCT02115204|Methotrexate|methotrexate|mesh-list
110917977|NCT02115204|Epirubicin|epirubicin|mesh-list
110917978|NCT02115204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110917979|NCT02115204|Immunologic Factors|immunologic factors|mesh-ancestor
110917980|NCT02115204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110917981|NCT02115204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110917982|NCT02115204|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110917983|NCT02115204|Alkylating Agents|alkylating agents|mesh-ancestor
110917984|NCT02115204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110917985|NCT02115204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110917986|NCT02115204|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110917987|NCT02115204|Tubulin Modulators|tubulin modulators|mesh-ancestor
110917988|NCT02115204|Antimitotic Agents|antimitotic agents|mesh-ancestor
110917989|NCT02115204|Mitosis Modulators|mitosis modulators|mesh-ancestor
110917991|NCT02115204|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110917992|NCT02115204|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110917993|NCT02115204|Abortifacient Agents|abortifacient agents|mesh-ancestor
110917994|NCT02115204|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110917995|NCT02115204|Dermatologic Agents|dermatologic agents|mesh-ancestor
110917996|NCT02115204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110917997|NCT02115204|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110917998|NCT02115204|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110917999|NCT02115204|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110918000|NCT02115204|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110918002|NCT02115360|Calcitonin|calcitonin|mesh-list
110918003|NCT02115360|Salmon calcitonin|salmon calcitonin|mesh-list
110918004|NCT02115360|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
110918005|NCT02115360|Fentanyl|fentanyl|mesh-list
110918007|NCT02115360|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110918008|NCT02115360|Narcotics|narcotics|mesh-ancestor
110918009|NCT02115360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110918010|NCT02115360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110918011|NCT02115360|Analgesics|analgesics|mesh-ancestor
110918012|NCT02115360|Sensory System Agents|sensory system agents|mesh-ancestor
110918013|NCT02115360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110918014|NCT02115360|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110918015|NCT02115360|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110918016|NCT02115360|Anesthetics, General|anesthetics, general|mesh-ancestor
110918017|NCT02115360|Anesthetics|anesthetics|mesh-ancestor
110918018|NCT02115360|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110918019|NCT02115360|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110918020|NCT02115360|Vasodilator Agents|vasodilator agents|mesh-ancestor
110918022|NCT02432404|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110918023|NCT02432404|Contraceptive Agents|contraceptive agents|mesh-ancestor
110918024|NCT02432404|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110918025|NCT02432404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110918026|NCT02113176|Minocycline|minocycline|mesh-list
110918027|NCT02113176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110918028|NCT02113176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110918029|NCT02118870|Aspirin|aspirin|mesh-list
110918030|NCT02118870|Clopidogrel|clopidogrel|mesh-list
110918031|NCT02118870|Ticagrelor|ticagrelor|mesh-list
110918032|NCT02118870|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
110918033|NCT02118870|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110918034|NCT02118870|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110918035|NCT02118870|Analgesics|analgesics|mesh-ancestor
110918036|NCT02118870|Sensory System Agents|sensory system agents|mesh-ancestor
110918037|NCT02118870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110918038|NCT02118870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110918039|NCT02118870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110918040|NCT02118870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110918041|NCT02118870|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110918042|NCT02118870|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110918043|NCT02118870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110918044|NCT02118870|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110918045|NCT02118870|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110918046|NCT02118870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110918047|NCT02118870|Antipyretics|antipyretics|mesh-ancestor
110918048|NCT02118870|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110918049|NCT02118870|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110918050|NCT02118870|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110918051|NCT02118870|Purinergic Agents|purinergic agents|mesh-ancestor
110918052|NCT02118870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110918053|NCT03552666|Vitamin D|vitamin d|mesh-list
110918054|NCT03552666|Cholecalciferol|cholecalciferol|mesh-list
110918055|NCT03552666|Vitamins|vitamins|mesh-ancestor
110918056|NCT03552666|Micronutrients|micronutrients|mesh-ancestor
110918057|NCT03552666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110918058|NCT03552666|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110918059|NCT03552666|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110918061|NCT02115594|Entinostat|entinostat|mesh-list
110918062|NCT02115594|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110918063|NCT02115594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110918064|NCT02115594|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110918065|NCT02115594|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110918066|NCT02115594|Hormone Antagonists|hormone antagonists|mesh-ancestor
110918067|NCT02115594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110918068|NCT02115594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110918069|NCT02115594|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110918070|NCT02115594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110928411|NCT03893318|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110918071|NCT02115594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110918072|NCT05125042|Amiodarone|amiodarone|mesh-list
110918073|NCT05125042|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110918074|NCT05125042|Vasodilator Agents|vasodilator agents|mesh-ancestor
110918075|NCT05125042|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
110918076|NCT05125042|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110918077|NCT05125042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110918078|NCT05125042|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110918079|NCT05125042|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110918080|NCT05125042|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110918081|NCT05125042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110918082|NCT05125042|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110918083|NCT05125042|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110918084|NCT05125042|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110918085|NCT02113332|Liraglutide|liraglutide|mesh-list
110918086|NCT02113332|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110918087|NCT02113332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110918088|NCT02113332|Incretins|incretins|mesh-ancestor
110918089|NCT02113332|Hormones|hormones|mesh-ancestor
110235984|NCT00089726|Immunologic Factors|immunologic factors|mesh-ancestor
110918090|NCT02113332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110918091|NCT02119338|Aminolevulinic Acid|aminolevulinic acid|mesh-list
110918092|NCT02119338|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110918093|NCT02119338|Dermatologic Agents|dermatologic agents|mesh-ancestor
110918094|NCT02918877|Propofol|propofol|mesh-list
110918095|NCT02918877|Sevoflurane|sevoflurane|mesh-list
110918096|NCT02918877|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110918097|NCT02918877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110918098|NCT02918877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110918099|NCT02918877|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110918100|NCT02918877|Anesthetics, General|anesthetics, general|mesh-ancestor
110918101|NCT02918877|Anesthetics|anesthetics|mesh-ancestor
110918102|NCT02918877|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110918103|NCT02918877|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110918104|NCT03652857|Apatinib|apatinib|mesh-list
110918105|NCT03652857|Vinorelbine|vinorelbine|mesh-list
110918106|NCT03652857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110918107|NCT03652857|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110918108|NCT03652857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110918109|NCT03652857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110918110|NCT03652857|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110918111|NCT03652857|Tubulin Modulators|tubulin modulators|mesh-ancestor
110918112|NCT03652857|Antimitotic Agents|antimitotic agents|mesh-ancestor
110236064|NCT00343369|Hormones|hormones|mesh-ancestor
110918113|NCT03652857|Mitosis Modulators|mitosis modulators|mesh-ancestor
110918114|NCT05129410|Mycophenolic Acid|mycophenolic acid|mesh-list
110918115|NCT05129410|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110918116|NCT05129410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110918117|NCT05129410|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110918118|NCT05129410|Antitubercular Agents|antitubercular agents|mesh-ancestor
110918119|NCT05129410|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110918120|NCT05129410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110918121|NCT05129410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110918122|NCT05129410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110918123|NCT04221555|Docetaxel|docetaxel|mesh-list
110918124|NCT04221555|Oxaliplatin|oxaliplatin|mesh-list
110918125|NCT04221555|Durvalumab|durvalumab|mesh-list
110918126|NCT04221555|Tremelimumab|tremelimumab|mesh-list
110918127|NCT04221555|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110918128|NCT04221555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110918129|NCT04221555|Tubulin Modulators|tubulin modulators|mesh-ancestor
110918130|NCT04221555|Antimitotic Agents|antimitotic agents|mesh-ancestor
110918131|NCT04221555|Mitosis Modulators|mitosis modulators|mesh-ancestor
110918132|NCT04221555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110918133|NCT04221555|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110918134|NCT04221555|Immunologic Factors|immunologic factors|mesh-ancestor
110918135|NCT04221555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110918136|NCT02113566|Acetaminophen|acetaminophen|mesh-list
110918137|NCT02113566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110918138|NCT02113566|Analgesics|analgesics|mesh-ancestor
110918139|NCT02113566|Sensory System Agents|sensory system agents|mesh-ancestor
110918140|NCT02113566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110918141|NCT02113566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110918142|NCT02113566|Antipyretics|antipyretics|mesh-ancestor
110918143|NCT05124730|Metformin|metformin|mesh-list
110918144|NCT05124730|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110918145|NCT05124730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110918146|NCT02251626|Ubiquinone|ubiquinone|mesh-list
110918147|NCT02251626|Coenzyme Q10|coenzyme q10|mesh-list
110918148|NCT02251626|Micronutrients|micronutrients|mesh-ancestor
110918149|NCT02251626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110918150|NCT02251626|Vitamins|vitamins|mesh-ancestor
110918151|NCT02123004|Clopidogrel|clopidogrel|mesh-list
110918152|NCT02123004|Ticagrelor|ticagrelor|mesh-list
110918153|NCT02123004|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110918154|NCT02123004|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110918155|NCT02123004|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110236228|NCT00344422|Dexamethasone|dexamethasone|mesh-list
110918156|NCT02123004|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110918157|NCT02123004|Purinergic Agents|purinergic agents|mesh-ancestor
110918158|NCT02123004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110918159|NCT02123004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110918160|NCT02123004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110918161|NCT01674712|Simvastatin|simvastatin|mesh-list
110918162|NCT01674712|Fenofibrate|fenofibrate|mesh-list
110918163|NCT01674712|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110918164|NCT01674712|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110918165|NCT01674712|Antimetabolites|antimetabolites|mesh-ancestor
110918166|NCT01674712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110918167|NCT01674712|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110918168|NCT01674712|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110918169|NCT01674712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110918170|NCT01368432|Escitalopram|escitalopram|mesh-list
110918171|NCT01368432|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110918172|NCT01368432|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110918173|NCT01368432|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110918174|NCT01368432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110918175|NCT01368432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110918176|NCT01368432|Serotonin Agents|serotonin agents|mesh-ancestor
110918177|NCT01368432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110918178|NCT05122780|Acetylcholine|acetylcholine|mesh-list
110918180|NCT05122780|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
110918181|NCT05122780|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
110918182|NCT05122780|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110918183|NCT05122780|Adrenergic Agents|adrenergic agents|mesh-ancestor
110918184|NCT05122780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110918185|NCT05122780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110918186|NCT05122780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110918187|NCT05122780|Vasodilator Agents|vasodilator agents|mesh-ancestor
110918188|NCT05122780|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110918189|NCT05122780|Cholinergic Agents|cholinergic agents|mesh-ancestor
110918190|NCT02119806|Fentanyl|fentanyl|mesh-list
110918191|NCT02119806|Midazolam|midazolam|mesh-list
110918192|NCT02119806|Propofol|propofol|mesh-list
110918193|NCT02119806|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110918194|NCT02119806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110918195|NCT02119806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110918196|NCT02119806|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110918197|NCT02119806|Anesthetics, General|anesthetics, general|mesh-ancestor
110918198|NCT02119806|Anesthetics|anesthetics|mesh-ancestor
110918199|NCT02119806|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110918200|NCT02119806|Narcotics|narcotics|mesh-ancestor
110918201|NCT02119806|Analgesics|analgesics|mesh-ancestor
110918202|NCT02119806|Sensory System Agents|sensory system agents|mesh-ancestor
110918203|NCT02119806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110918204|NCT02119806|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110918205|NCT02119806|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110918206|NCT02119806|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110918207|NCT02119806|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110918208|NCT02119806|GABA Modulators|gaba modulators|mesh-ancestor
110918209|NCT02119806|GABA Agents|gaba agents|mesh-ancestor
110918210|NCT02119806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110918211|NCT02119806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110918212|NCT02119884|Octreotide|octreotide|mesh-list
110918213|NCT02119884|Terlipressin|terlipressin|mesh-list
110918214|NCT02119884|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110918215|NCT02119884|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110918217|NCT02119884|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110918218|NCT02119884|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110918219|NCT05104918|Vortioxetine|vortioxetine|mesh-list
110918220|NCT05104918|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
110918221|NCT05104918|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110918222|NCT05104918|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110918223|NCT05104918|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110918224|NCT05104918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110918225|NCT05104918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110918226|NCT05104918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110918227|NCT05104918|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110918228|NCT05104918|Antidepressive Agents|antidepressive agents|mesh-ancestor
110918229|NCT05104918|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110918230|NCT05104918|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110918231|NCT05104918|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110918232|NCT05104918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110918233|NCT05104918|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110918234|NCT05104918|Serotonin Agents|serotonin agents|mesh-ancestor
110918235|NCT05104918|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110918236|NCT05104918|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110918237|NCT05104918|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110918238|NCT05104918|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110918239|NCT05089942|Insulin|insulin|mesh-list
110918240|NCT05089942|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110918241|NCT05089942|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110236608|NCT00346567|Antiviral Agents|antiviral agents|mesh-ancestor
110918242|NCT05089942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110918243|NCT04941508|Dexmedetomidine|dexmedetomidine|mesh-list
110918244|NCT04941508|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110918245|NCT04941508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110918246|NCT04941508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110918247|NCT04941508|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110918248|NCT04941508|Analgesics|analgesics|mesh-ancestor
110918249|NCT04941508|Sensory System Agents|sensory system agents|mesh-ancestor
110918250|NCT04941508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110918251|NCT04941508|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110918252|NCT04941508|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110918253|NCT04941508|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110918254|NCT04941508|Adrenergic Agents|adrenergic agents|mesh-ancestor
110918255|NCT04941508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110918256|NCT04941508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110918257|NCT01062555|Cyclosporine|cyclosporine|mesh-list
110918258|NCT01062555|Sirolimus|sirolimus|mesh-list
110918259|NCT01062555|Mycophenolic Acid|mycophenolic acid|mesh-list
110918260|NCT01062555|Tacrolimus|tacrolimus|mesh-list
110918261|NCT01062555|Cyclosporins|cyclosporins|mesh-list
110918262|NCT01062555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110918263|NCT01062555|Immunologic Factors|immunologic factors|mesh-ancestor
110918264|NCT01062555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110918265|NCT01062555|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110918266|NCT01062555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110918267|NCT01062555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110918268|NCT01062555|Antifungal Agents|antifungal agents|mesh-ancestor
110918269|NCT01062555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110918270|NCT01062555|Dermatologic Agents|dermatologic agents|mesh-ancestor
110918271|NCT01062555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110918272|NCT01062555|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110918273|NCT01062555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110918274|NCT01062555|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110918275|NCT01062555|Antitubercular Agents|antitubercular agents|mesh-ancestor
110918276|NCT01062555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110918277|NCT03622047|Sufentanil|sufentanil|mesh-list
110918278|NCT03622047|Dexmedetomidine|dexmedetomidine|mesh-list
110918279|NCT03622047|Ropivacaine|ropivacaine|mesh-list
110918280|NCT03622047|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110918281|NCT03622047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110236842|NCT00347425|Antiemetics|antiemetics|mesh-ancestor
110918285|NCT03622047|Sensory System Agents|sensory system agents|mesh-ancestor
110918286|NCT03622047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110918287|NCT03622047|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110918288|NCT03622047|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110918289|NCT03622047|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110918290|NCT03622047|Adrenergic Agents|adrenergic agents|mesh-ancestor
110918291|NCT03622047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110918292|NCT03622047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110918293|NCT03622047|Anesthetics, Local|anesthetics, local|mesh-ancestor
110918294|NCT03622047|Anesthetics|anesthetics|mesh-ancestor
110918295|NCT03622047|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110918296|NCT03622047|Narcotics|narcotics|mesh-ancestor
110918297|NCT03622047|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110918298|NCT03622047|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110918299|NCT03622047|Anesthetics, General|anesthetics, general|mesh-ancestor
110918303|NCT05073562|Folic Acid|folic acid|mesh-list
110918304|NCT05073562|Mebendazole|mebendazole|mesh-list
110918305|NCT05073562|Piperazine|piperazine|mesh-list
110918306|NCT05073562|Piperazine citrate|piperazine citrate|mesh-list
110918307|NCT05073562|DMP 777|dmp 777|mesh-list
110918308|NCT05073562|Hematinics|hematinics|mesh-ancestor
110918309|NCT05073562|Vitamin B Complex|vitamin b complex|mesh-ancestor
110918310|NCT05073562|Vitamins|vitamins|mesh-ancestor
110918311|NCT05073562|Micronutrients|micronutrients|mesh-ancestor
110918312|NCT05073562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110918313|NCT05073562|Antinematodal Agents|antinematodal agents|mesh-ancestor
110918314|NCT05073562|Anthelmintics|anthelmintics|mesh-ancestor
110918315|NCT05073562|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110918316|NCT05073562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110918317|NCT05073562|Tubulin Modulators|tubulin modulators|mesh-ancestor
110918318|NCT05073562|Antimitotic Agents|antimitotic agents|mesh-ancestor
110918319|NCT05073562|Mitosis Modulators|mitosis modulators|mesh-ancestor
110918320|NCT05073562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110918321|NCT05073562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110918322|NCT05073562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110918323|NCT01368276|Molgramostim|molgramostim|mesh-list
110918324|NCT01368276|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
110918325|NCT01368276|Sargramostim|sargramostim|mesh-list
110918326|NCT01368276|Immunologic Factors|immunologic factors|mesh-ancestor
110918327|NCT01368276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110237025|NCT01058863|Albuterol|albuterol|mesh-list
110918328|NCT01368276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110918329|NCT01368276|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110918330|NCT02116842|Fentanyl|fentanyl|mesh-list
110918331|NCT02116842|Bupivacaine|bupivacaine|mesh-list
110918332|NCT02116842|Anesthetics, Local|anesthetics, local|mesh-ancestor
110918333|NCT02116842|Anesthetics|anesthetics|mesh-ancestor
110918334|NCT02116842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110918335|NCT02116842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110918336|NCT02116842|Sensory System Agents|sensory system agents|mesh-ancestor
110918337|NCT02116842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110918338|NCT02116842|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110918339|NCT02116842|Narcotics|narcotics|mesh-ancestor
110918340|NCT02116842|Analgesics|analgesics|mesh-ancestor
110918341|NCT02116842|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110918342|NCT02116842|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110918343|NCT02116842|Anesthetics, General|anesthetics, general|mesh-ancestor
110918344|NCT02120118|Docetaxel|docetaxel|mesh-list
110918345|NCT02120118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110918346|NCT02120118|Tubulin Modulators|tubulin modulators|mesh-ancestor
110918347|NCT02120118|Antimitotic Agents|antimitotic agents|mesh-ancestor
110918348|NCT02120118|Mitosis Modulators|mitosis modulators|mesh-ancestor
110918349|NCT02120118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110918350|NCT04054089|Tenofovir|tenofovir|mesh-list
110918351|NCT04054089|Lamivudine|lamivudine|mesh-list
110918352|NCT04054089|Emtricitabine|emtricitabine|mesh-list
110918353|NCT04054089|Dolutegravir|dolutegravir|mesh-list
110237092|NCT00091559|Vorinostat|vorinostat|mesh-list
110918355|NCT04054089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110918356|NCT04054089|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110918357|NCT04054089|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110918358|NCT04054089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110918359|NCT04054089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110918360|NCT04054089|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110918361|NCT04054089|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110237136|NCT00427414|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110918363|NCT04054089|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110918364|NCT02120196|Rifaximin|rifaximin|mesh-list
110918365|NCT02120196|Norfloxacin|norfloxacin|mesh-list
110918366|NCT02120196|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110918367|NCT02120196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110918368|NCT02120196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110918369|NCT02120196|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110918370|NCT02120196|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110918371|NCT02120196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110918372|NCT02120196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110918373|NCT02120196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110918374|NCT02120196|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110237196|NCT00427882|Urological Agents|urological agents|mesh-ancestor
110918375|NCT02120196|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110918376|NCT05001802|Ropivacaine|ropivacaine|mesh-list
110918377|NCT05001802|Anesthetics, Local|anesthetics, local|mesh-ancestor
110918378|NCT05001802|Anesthetics|anesthetics|mesh-ancestor
110918379|NCT05001802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110918380|NCT05001802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110918381|NCT05001802|Sensory System Agents|sensory system agents|mesh-ancestor
110918382|NCT05001802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110918384|NCT02120274|Vitamins|vitamins|mesh-list
110918385|NCT02120274|Vitamin B 12|vitamin b 12|mesh-list
110918386|NCT02120274|Hydroxocobalamin|hydroxocobalamin|mesh-list
110928475|NCT03071068|Antibodies|antibodies|mesh-list
110918387|NCT02120274|Micronutrients|micronutrients|mesh-ancestor
110918388|NCT02120274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110918389|NCT02120274|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110918390|NCT02120274|Vitamin B Complex|vitamin b complex|mesh-ancestor
110918391|NCT02120274|Hematinics|hematinics|mesh-ancestor
110918392|NCT02402842|Docetaxel|docetaxel|mesh-list
110918393|NCT02402842|Fluorouracil|fluorouracil|mesh-list
110918394|NCT02402842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110918395|NCT02402842|Tubulin Modulators|tubulin modulators|mesh-ancestor
110918396|NCT02402842|Antimitotic Agents|antimitotic agents|mesh-ancestor
110918397|NCT02402842|Mitosis Modulators|mitosis modulators|mesh-ancestor
110918398|NCT02402842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110918399|NCT02402842|Antimetabolites|antimetabolites|mesh-ancestor
110918400|NCT02402842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110918401|NCT02402842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110918402|NCT02402842|Immunologic Factors|immunologic factors|mesh-ancestor
110364915|NCT00538499|Narcotics|narcotics|mesh-ancestor
110918403|NCT02402842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110918404|NCT01061775|Exenatide|exenatide|mesh-list
110918405|NCT01061775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110918406|NCT01061775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110918407|NCT01061775|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110918409|NCT01061775|Hormones|hormones|mesh-ancestor
110918410|NCT01061775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110918411|NCT02123628|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110918412|NCT02123628|Doxycycline|doxycycline|mesh-list
110918413|NCT02123628|Ciprofloxacin|ciprofloxacin|mesh-list
110918414|NCT02123628|Levofloxacin|levofloxacin|mesh-list
110918415|NCT02123628|Rifampin|rifampin|mesh-list
110918416|NCT02123628|Ceftriaxone|ceftriaxone|mesh-list
110918417|NCT02123628|Linezolid|linezolid|mesh-list
110918418|NCT02123628|Cefepime|cefepime|mesh-list
110918419|NCT02123628|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
110918420|NCT02123628|Cefotaxime|cefotaxime|mesh-list
110918421|NCT02123628|Fusidic Acid|fusidic acid|mesh-list
110918422|NCT02123628|Trimethoprim|trimethoprim|mesh-list
110918423|NCT02123628|Sulfamethoxazole|sulfamethoxazole|mesh-list
110918424|NCT02123628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110918425|NCT02123628|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110918426|NCT02123628|Antitubercular Agents|antitubercular agents|mesh-ancestor
110918427|NCT02123628|Antimalarials|antimalarials|mesh-ancestor
110918428|NCT02123628|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110237517|NCT05543109|Analgesics|analgesics|mesh-ancestor
110918429|NCT02123628|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110918430|NCT02123628|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110918431|NCT02123628|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110918432|NCT02123628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110918433|NCT02123628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110918434|NCT02123628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110918435|NCT02123628|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110918436|NCT02123628|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110918437|NCT02123628|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110918438|NCT02123628|Leprostatic Agents|leprostatic agents|mesh-ancestor
110918439|NCT02123628|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110918440|NCT02123628|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110918441|NCT02123628|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110918442|NCT02123628|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110918443|NCT02123628|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110237583|NCT00093743|Cyclosporins|cyclosporins|mesh-list
110918444|NCT02123628|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110918445|NCT02123628|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110918446|NCT02123628|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110918447|NCT02123628|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110918448|NCT02123628|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110918449|NCT02123628|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
110918450|NCT02651116|Dextromethorphan|dextromethorphan|mesh-list
110918451|NCT02651116|Antitussive Agents|antitussive agents|mesh-ancestor
110918452|NCT02651116|Respiratory System Agents|respiratory system agents|mesh-ancestor
110237642|NCT00094406|Sequestering Agents|sequestering agents|mesh-ancestor
110918453|NCT02651116|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110918455|NCT02651116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110928484|NCT03487172|Natriuretic Agents|natriuretic agents|mesh-ancestor
110918456|NCT02651116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110918457|NCT02651116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110918458|NCT03652467|Chlorotrianisene|chlorotrianisene|mesh-list
110918459|NCT03652467|Deferoxamine|deferoxamine|mesh-list
110918460|NCT03652467|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
110918461|NCT03652467|Estrogens|estrogens|mesh-ancestor
110918462|NCT03652467|Hormones|hormones|mesh-ancestor
110918463|NCT03652467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110918464|NCT03652467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110918465|NCT03652467|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110918466|NCT03652467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110918467|NCT03652467|Siderophores|siderophores|mesh-ancestor
110918468|NCT03652467|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110918469|NCT03652467|Chelating Agents|chelating agents|mesh-ancestor
110918470|NCT03652467|Sequestering Agents|sequestering agents|mesh-ancestor
110918471|NCT03652467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110918472|NCT03528824|Diclofenac|diclofenac|mesh-list
110918473|NCT03528824|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110918474|NCT03528824|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110918475|NCT03528824|Analgesics|analgesics|mesh-ancestor
110918476|NCT03528824|Sensory System Agents|sensory system agents|mesh-ancestor
110918477|NCT03528824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110918478|NCT03528824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110918479|NCT03528824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110918480|NCT03528824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110918481|NCT03528824|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110918482|NCT03528824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110918483|NCT03528824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110918484|NCT00289640|Ipilimumab|ipilimumab|mesh-list
110918485|NCT00289640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110918486|NCT00289640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110918487|NCT00289640|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110918488|NCT00289640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110918489|NCT05039086|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
110918490|NCT05039086|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-list
110918491|NCT05039086|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110918492|NCT05039086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110918493|NCT05039086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110918495|NCT03552432|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
110918496|NCT03552432|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110918497|NCT03552432|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110918498|NCT03552432|Antimetabolites|antimetabolites|mesh-ancestor
110237886|NCT00095888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110918499|NCT03552432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110918500|NCT03552432|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110918502|NCT03552432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110918503|NCT03552432|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110918504|NCT03765632|Busulfan|busulfan|mesh-list
110918505|NCT03765632|Alkylating Agents|alkylating agents|mesh-ancestor
110918506|NCT03765632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110918507|NCT03765632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110918508|NCT03765632|Immunologic Factors|immunologic factors|mesh-ancestor
110918509|NCT03765632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110918510|NCT03765632|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110918511|NCT03765632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110918512|NCT03765632|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110918513|NCT02973477|Dapagliflozin|dapagliflozin|mesh-list
110918514|NCT02973477|Glimepiride|glimepiride|mesh-list
110918515|NCT02973477|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110918516|NCT02973477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110918517|NCT02973477|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110918518|NCT02973477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110237976|NCT01803594|Niacin|niacin|mesh-list
110918519|NCT02973477|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110918520|NCT02973477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110918521|NCT02973477|Immunologic Factors|immunologic factors|mesh-ancestor
110918522|NCT03552354|Argatroban|argatroban|mesh-list
110918523|NCT03552354|Antithrombins|antithrombins|mesh-ancestor
110918524|NCT03552354|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110918525|NCT03552354|Protease Inhibitors|protease inhibitors|mesh-ancestor
110918526|NCT03552354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110918527|NCT03552354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110918528|NCT03552354|Anticoagulants|anticoagulants|mesh-ancestor
110918529|NCT03552354|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110918530|NCT02288000|Memantine|memantine|mesh-list
110918531|NCT02288000|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110918532|NCT02288000|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110918533|NCT02288000|Dopamine Agents|dopamine agents|mesh-ancestor
110918534|NCT02288000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110238077|NCT00096434|Sorafenib|sorafenib|mesh-list
110918535|NCT02288000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110918536|NCT02288000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110918537|NCT02288000|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110918538|NCT02288000|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110918540|NCT02788656|Angiotensin II|angiotensin ii|mesh-list
110918541|NCT02788656|Giapreza|giapreza|mesh-list
110918542|NCT02788656|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-list
110918543|NCT02788656|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
110918544|NCT02788656|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
110918545|NCT02788656|Enzyme Inhibitors|enzyme inhibitors|mesh-list
110918546|NCT02788656|Angiotensinogen|angiotensinogen|mesh-list
110918547|NCT02788656|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
110918548|NCT02788656|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110918549|NCT02788656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110918550|NCT02788656|Protease Inhibitors|protease inhibitors|mesh-ancestor
110918551|NCT02788656|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110918552|NCT02788656|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110918554|NCT05258110|BI 425809|bi 425809|mesh-list
110918555|NCT05258110|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110918556|NCT05258110|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110918557|NCT05258110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110918558|NCT05258110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110918559|NCT05258110|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110918560|NCT05258110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110918561|NCT05258110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110918562|NCT05258110|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110918563|NCT05258110|Anesthetics, General|anesthetics, general|mesh-ancestor
110918564|NCT05258110|Anesthetics|anesthetics|mesh-ancestor
110918565|NCT05258110|GABA Modulators|gaba modulators|mesh-ancestor
110918566|NCT05258110|GABA Agents|gaba agents|mesh-ancestor
110918567|NCT05258110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110918568|NCT05258110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110918569|NCT05258110|Nootropic Agents|nootropic agents|mesh-ancestor
110918571|NCT03652233|Afatinib|afatinib|mesh-list
110918572|NCT03652233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110918573|NCT03652233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110918574|NCT03652233|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110918575|NCT03652233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110918576|NCT03652233|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110918577|NCT03652233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110918579|NCT02117466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110918580|NCT02117466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110918581|NCT02117622|Insulin|insulin|mesh-list
110918582|NCT02117622|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110636092|NCT05498259|Rituximab|rituximab|mesh-list
110918583|NCT02117622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110918584|NCT04529902|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
110918585|NCT04529902|Abatacept|abatacept|mesh-list
110918586|NCT04529902|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110918587|NCT04529902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110918588|NCT04529902|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110918589|NCT04529902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110918590|NCT04529902|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110918591|NCT04529902|Immunologic Factors|immunologic factors|mesh-ancestor
110918592|NCT04529902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110918593|NCT04529902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110918594|NCT04529902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110918595|NCT04693468|Palbociclib|palbociclib|mesh-list
110918596|NCT04693468|Axitinib|axitinib|mesh-list
110918597|NCT04693468|Crizotinib|crizotinib|mesh-list
110918598|NCT04693468|Talazoparib|talazoparib|mesh-list
110918599|NCT04693468|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
110918600|NCT04693468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110238384|NCT05049057|Analgesics|analgesics|mesh-ancestor
110918601|NCT04693468|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110918602|NCT04693468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110918603|NCT04693468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110918604|NCT04693468|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110918605|NCT02288078|Dexamethasone|dexamethasone|mesh-list
110918606|NCT02288078|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
110918607|NCT02288078|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110918608|NCT02288078|Antiemetics|antiemetics|mesh-ancestor
110918609|NCT02288078|Autonomic Agents|autonomic agents|mesh-ancestor
110918610|NCT02288078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110918611|NCT02288078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110918612|NCT02288078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110918613|NCT02288078|Glucocorticoids|glucocorticoids|mesh-ancestor
110918614|NCT02288078|Hormones|hormones|mesh-ancestor
110918615|NCT02288078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110918616|NCT02288078|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110918617|NCT02288078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110918618|NCT02288078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110918619|NCT02288078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110918620|NCT02288234|Telavancin|telavancin|mesh-list
110918621|NCT02288234|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110918622|NCT02288234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110918623|NCT04654312|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110918624|NCT04654312|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110928530|NCT04994626|Rituximab|rituximab|mesh-list
110918626|NCT04654312|Natriuretic Agents|natriuretic agents|mesh-ancestor
110918627|NCT04654312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110918628|NCT04654312|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110918629|NCT04654312|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110918630|NCT04654312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110918631|NCT02973087|Factor VIII|factor viii|mesh-list
110918632|NCT02973087|Coagulants|coagulants|mesh-ancestor
110918634|NCT05284656|Vitamin B Complex|vitamin b complex|mesh-list
110918635|NCT05284656|Pentoxifylline|pentoxifylline|mesh-list
110918636|NCT05284656|Hematinics|hematinics|mesh-ancestor
110918637|NCT05284656|Vitamins|vitamins|mesh-ancestor
110918638|NCT05284656|Micronutrients|micronutrients|mesh-ancestor
110918639|NCT05284656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110918640|NCT05284656|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110918641|NCT05284656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110918642|NCT05284656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110918643|NCT05284656|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110918644|NCT05284656|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110918645|NCT05284656|Protective Agents|protective agents|mesh-ancestor
110918646|NCT05284656|Vasodilator Agents|vasodilator agents|mesh-ancestor
110918647|NCT05284656|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110918648|NCT05284656|Antioxidants|antioxidants|mesh-ancestor
110918649|NCT02124174|Azacitidine|azacitidine|mesh-list
110918650|NCT02124174|Valproic Acid|valproic acid|mesh-list
110238635|NCT04702906|Vasodilator Agents|vasodilator agents|mesh-ancestor
110238637|NCT00131313|Rituximab|rituximab|mesh-list
110918651|NCT02124174|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110918652|NCT02124174|Antimetabolites|antimetabolites|mesh-ancestor
110918653|NCT02124174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110918654|NCT02124174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110918655|NCT02124174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110918656|NCT02124174|Anticonvulsants|anticonvulsants|mesh-ancestor
110918657|NCT02124174|GABA Agents|gaba agents|mesh-ancestor
110918658|NCT02124174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110918659|NCT02124174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110918660|NCT02124174|Antimanic Agents|antimanic agents|mesh-ancestor
110918661|NCT02124174|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110918662|NCT02124174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110918663|NCT02124174|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110918664|NCT03956368|Atorvastatin|atorvastatin|mesh-list
110238701|NCT00131391|Hormones|hormones|mesh-ancestor
110918665|NCT03956368|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110918666|NCT03956368|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110918667|NCT03956368|Antimetabolites|antimetabolites|mesh-ancestor
110364960|NCT00538811|Interferons|interferons|mesh-list
110918668|NCT03956368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110918669|NCT03956368|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110918670|NCT03956368|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110918671|NCT03956368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110918672|NCT02124330|Bentonite|bentonite|mesh-list
110918673|NCT02124330|Antidotes|antidotes|mesh-ancestor
110238754|NCT00098384|Rifaximin|rifaximin|mesh-list
110918674|NCT02124330|Protective Agents|protective agents|mesh-ancestor
110918675|NCT02124330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110918676|NCT02118090|Chloroquine|chloroquine|mesh-list
110918677|NCT02118090|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
110918678|NCT02118090|Amebicides|amebicides|mesh-ancestor
110918679|NCT02118090|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110918680|NCT02118090|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110918681|NCT02118090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110918682|NCT02118090|Antimalarials|antimalarials|mesh-ancestor
110918683|NCT02118090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110918684|NCT02118090|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110918685|NCT02118090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110918686|NCT02118090|Analgesics|analgesics|mesh-ancestor
110918687|NCT02118090|Sensory System Agents|sensory system agents|mesh-ancestor
110928544|NCT04994314|Fluorides|fluorides|mesh-list
110918688|NCT02118090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110918689|NCT02118090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110918690|NCT02118090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110918691|NCT02118090|Filaricides|filaricides|mesh-ancestor
110918692|NCT02118090|Antinematodal Agents|antinematodal agents|mesh-ancestor
110918693|NCT02118090|Anthelmintics|anthelmintics|mesh-ancestor
110918694|NCT04235114|Nimotuzumab|nimotuzumab|mesh-list
110918695|NCT04235114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110918696|NCT04235114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110918697|NCT03551808|Ketorolac|ketorolac|mesh-list
110918698|NCT03551808|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
110918699|NCT03551808|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110918700|NCT03551808|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110918701|NCT03551808|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110918702|NCT03551808|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110918703|NCT03551808|Analgesics|analgesics|mesh-ancestor
110918704|NCT03551808|Sensory System Agents|sensory system agents|mesh-ancestor
110918705|NCT03551808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110918706|NCT03551808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110918707|NCT03551808|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110918708|NCT03551808|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110918709|NCT03551808|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110918710|NCT03551808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110918711|NCT03551808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110918712|NCT04053543|CXA-10|cxa-10|mesh-list
110918713|NCT04053543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110918714|NCT04202458|Tenecteplase|tenecteplase|mesh-list
110918715|NCT04202458|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110918716|NCT04202458|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110918717|NCT04202458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110918718|NCT00273650|Vitamin B 12|vitamin b 12|mesh-list
110918719|NCT00273650|Vitamins|vitamins|mesh-ancestor
110918720|NCT00273650|Micronutrients|micronutrients|mesh-ancestor
110918721|NCT00273650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110918722|NCT00273650|Vitamin B Complex|vitamin b complex|mesh-ancestor
110918723|NCT02121288|Clopidogrel|clopidogrel|mesh-list
110918724|NCT02121288|Ticagrelor|ticagrelor|mesh-list
110364965|NCT00538811|Amantadine|amantadine|mesh-list
110918725|NCT02121288|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110918726|NCT02121288|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110918727|NCT02121288|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110918728|NCT02121288|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110918729|NCT02121288|Purinergic Agents|purinergic agents|mesh-ancestor
110918730|NCT02121288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110918731|NCT02121288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110918732|NCT02121288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110918734|NCT01525329|Antimetabolites|antimetabolites|mesh-ancestor
110636276|NCT00987441|Dsuvia|dsuvia|mesh-list
110239074|NCT00403728|Cyclosporine|cyclosporine|mesh-list
110918735|NCT01525329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110918736|NCT01525329|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110918737|NCT01525329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110918738|NCT01525329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110918739|NCT01525329|Immunologic Factors|immunologic factors|mesh-ancestor
110918740|NCT01525329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110918741|NCT02121366|Ethanol|ethanol|mesh-list
110918742|NCT02121366|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110918744|NCT02121366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110918745|NCT02121366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110918746|NCT02121444|Interferons|interferons|mesh-list
110918747|NCT02121444|Interferon-beta|interferon-beta|mesh-list
110918748|NCT02121444|Interferon beta-1b|interferon beta-1b|mesh-list
110918749|NCT02121444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110918750|NCT02121444|Antiviral Agents|antiviral agents|mesh-ancestor
110918751|NCT02121444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110918752|NCT02121444|Immunologic Factors|immunologic factors|mesh-ancestor
110918753|NCT02121444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110239204|NCT00100139|Paclitaxel|paclitaxel|mesh-list
110918754|NCT02121444|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110918755|NCT04413526|Chlorotrianisene|chlorotrianisene|mesh-list
110918756|NCT04413526|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
110918757|NCT04413526|Estrogens|estrogens|mesh-ancestor
110918758|NCT04413526|Hormones|hormones|mesh-ancestor
110918759|NCT04413526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110918760|NCT04413526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110918761|NCT04413526|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110918762|NCT04413526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110918763|NCT03665506|Trifluridine|trifluridine|mesh-list
110918764|NCT03665506|Antimetabolites|antimetabolites|mesh-ancestor
110918765|NCT03665506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110918766|NCT03665506|Antiviral Agents|antiviral agents|mesh-ancestor
110918767|NCT03665506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110918768|NCT03318874|Hyaluronic Acid|hyaluronic acid|mesh-list
110918769|NCT03318874|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110918770|NCT03318874|Immunologic Factors|immunologic factors|mesh-ancestor
110918771|NCT03318874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110918772|NCT03318874|Viscosupplements|viscosupplements|mesh-ancestor
110918773|NCT03318874|Protective Agents|protective agents|mesh-ancestor
110918774|NCT03551652|Rocuronium|rocuronium|mesh-list
110918775|NCT03551652|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110918776|NCT03551652|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110918777|NCT03551652|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110918778|NCT03551652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110918779|NCT03551652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110918780|NCT00263042|Rimonabant|rimonabant|mesh-list
110918781|NCT00263042|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110918782|NCT00263042|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
110918783|NCT00263042|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110918784|NCT00263042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110918785|NCT00263042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110918786|NCT00263042|Hormones|hormones|mesh-ancestor
110918787|NCT00263042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110928568|NCT02746575|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110918788|NCT00263042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110918789|NCT05002192|Eucalyptol|eucalyptol|mesh-list
110918790|NCT05002192|Ambroxol|ambroxol|mesh-list
110918791|NCT05002192|Expectorants|expectorants|mesh-list
110918792|NCT05002192|Respiratory System Agents|respiratory system agents|mesh-ancestor
110918793|NCT05002192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110918794|NCT05002192|Antitussive Agents|antitussive agents|mesh-ancestor
110918795|NCT05002192|Insect Repellents|insect repellents|mesh-ancestor
110918796|NCT05002192|Protective Agents|protective agents|mesh-ancestor
110918797|NCT05002192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110918798|NCT04973020|Efavirenz|efavirenz|mesh-list
110918799|NCT04973020|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110918800|NCT04973020|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110918801|NCT04973020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110918802|NCT04973020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110918803|NCT04973020|Antiviral Agents|antiviral agents|mesh-ancestor
110918804|NCT04973020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110918805|NCT04973020|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110918806|NCT04973020|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110918807|NCT04973020|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110918808|NCT04973020|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110918809|NCT04973020|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110918810|NCT04973020|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110918811|NCT05724446|Prednisolone|prednisolone|mesh-list
110918812|NCT05724446|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110918813|NCT05724446|Methylprednisolone|methylprednisolone|mesh-list
110918814|NCT05724446|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110918815|NCT05724446|Prednisolone acetate|prednisolone acetate|mesh-list
110918817|NCT05724446|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110918818|NCT05724446|Prednisolone phosphate|prednisolone phosphate|mesh-list
110918819|NCT05724446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110918820|NCT05724446|Glucocorticoids|glucocorticoids|mesh-ancestor
110918821|NCT05724446|Hormones|hormones|mesh-ancestor
110918822|NCT05724446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110918823|NCT05724446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110918824|NCT05724446|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110239512|NCT00133224|Prednisone|prednisone|mesh-list
110918825|NCT05724446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110918826|NCT05724446|Antiemetics|antiemetics|mesh-ancestor
110918827|NCT05724446|Autonomic Agents|autonomic agents|mesh-ancestor
110918828|NCT05724446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110918829|NCT05724446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110918830|NCT05724446|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110918831|NCT05724446|Protective Agents|protective agents|mesh-ancestor
110918832|NCT02124642|Folic Acid|folic acid|mesh-list
110918833|NCT02124642|Vitamin B Complex|vitamin b complex|mesh-list
110918834|NCT02124642|Hematinics|hematinics|mesh-ancestor
110918835|NCT02124642|Vitamins|vitamins|mesh-ancestor
110918836|NCT02124642|Micronutrients|micronutrients|mesh-ancestor
110928594|NCT04988932|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110918837|NCT02124642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110918838|NCT03094234|Propranolol|propranolol|mesh-list
110918839|NCT03094234|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110918840|NCT03094234|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110918841|NCT03094234|Adrenergic Agents|adrenergic agents|mesh-ancestor
110918842|NCT03094234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110918843|NCT03094234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110918844|NCT03094234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110918845|NCT03094234|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110918846|NCT03094234|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110918847|NCT03094234|Vasodilator Agents|vasodilator agents|mesh-ancestor
110918848|NCT00260156|Vildagliptin|vildagliptin|mesh-list
110918849|NCT00260156|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110918850|NCT00260156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110918851|NCT00260156|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110918852|NCT00260156|Protease Inhibitors|protease inhibitors|mesh-ancestor
110918853|NCT00260156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110364983|NCT04660773|Sensory System Agents|sensory system agents|mesh-ancestor
110918854|NCT00260156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110918855|NCT04367103|Phenylephrine|phenylephrine|mesh-list
110918856|NCT04367103|Oxymetazoline|oxymetazoline|mesh-list
110918857|NCT04367103|Norepinephrine|norepinephrine|mesh-list
110918858|NCT04367103|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110918859|NCT04367103|Mydriatics|mydriatics|mesh-ancestor
110918860|NCT04367103|Autonomic Agents|autonomic agents|mesh-ancestor
110239627|NCT00102206|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110918861|NCT04367103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110918862|NCT04367103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110918863|NCT04367103|Sympathomimetics|sympathomimetics|mesh-ancestor
110918864|NCT04367103|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110918865|NCT04367103|Nasal Decongestants|nasal decongestants|mesh-ancestor
110918866|NCT04367103|Respiratory System Agents|respiratory system agents|mesh-ancestor
110918867|NCT04367103|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110918868|NCT04367103|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110918869|NCT04367103|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110918870|NCT04367103|Adrenergic Agents|adrenergic agents|mesh-ancestor
110918871|NCT04367103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110918872|NCT04367103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110918873|NCT04367103|Protective Agents|protective agents|mesh-ancestor
110918874|NCT00260078|Ritonavir|ritonavir|mesh-list
110918875|NCT00260078|Atazanavir Sulfate|atazanavir sulfate|mesh-list
110918876|NCT00260078|Darunavir|darunavir|mesh-list
110918877|NCT00260078|Tenofovir|tenofovir|mesh-list
110918878|NCT00260078|Nevirapine|nevirapine|mesh-list
110918879|NCT00260078|Efavirenz|efavirenz|mesh-list
110918880|NCT00260078|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110636394|NCT04085627|Amlodipine|amlodipine|mesh-list
110918881|NCT00260078|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110918882|NCT00260078|Protease Inhibitors|protease inhibitors|mesh-ancestor
110918883|NCT00260078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110918884|NCT00260078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110918885|NCT00260078|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110918886|NCT00260078|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110918887|NCT00260078|Antiviral Agents|antiviral agents|mesh-ancestor
110918888|NCT00260078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110918889|NCT00260078|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110918890|NCT00260078|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110918891|NCT00260078|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110918892|NCT00260078|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110918893|NCT00260078|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110239813|NCT00102869|Levodopa|levodopa|mesh-list
110918895|NCT00260078|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110918896|NCT00260078|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110918897|NCT00260078|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110918898|NCT03034564|Droxidopa|droxidopa|mesh-list
110918899|NCT03034564|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110918900|NCT03034564|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110918901|NCT05342532|Amoxicillin|amoxicillin|mesh-list
110918902|NCT05342532|Clarithromycin|clarithromycin|mesh-list
110918903|NCT05342532|Omeprazole|omeprazole|mesh-list
110918904|NCT05342532|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110918905|NCT05342532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110918906|NCT05342532|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110918907|NCT05342532|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110918908|NCT05342532|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110918909|NCT05342532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110918910|NCT05342532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110918911|NCT05342532|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110918912|NCT05342532|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110918913|NCT05342532|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110918915|NCT04469114|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
110918916|NCT04469114|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110918917|NCT04469114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110918918|NCT04469114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110918919|NCT02400567|Cyclophosphamide|cyclophosphamide|mesh-list
110918920|NCT02400567|Letrozole|letrozole|mesh-list
110918921|NCT02400567|Epirubicin|epirubicin|mesh-list
110918922|NCT02400567|Palbociclib|palbociclib|mesh-list
110918923|NCT02400567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110918924|NCT02400567|Immunologic Factors|immunologic factors|mesh-ancestor
110918925|NCT02400567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110918926|NCT02400567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110918927|NCT02400567|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110918928|NCT02400567|Alkylating Agents|alkylating agents|mesh-ancestor
110918929|NCT02400567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110918930|NCT02400567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110918931|NCT02400567|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110918932|NCT02400567|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110918933|NCT02400567|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110918934|NCT02400567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110918935|NCT02400567|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110918936|NCT02400567|Hormone Antagonists|hormone antagonists|mesh-ancestor
110918937|NCT02400567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110918938|NCT02400567|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110918939|NCT02400567|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110918940|NCT02400567|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110918941|NCT02400567|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110918942|NCT00228176|Rimonabant|rimonabant|mesh-list
110918943|NCT00228176|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110918944|NCT00228176|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
110918945|NCT00228176|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110918946|NCT00228176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110918947|NCT00228176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110918948|NCT00228176|Hormones|hormones|mesh-ancestor
110918949|NCT00228176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110918950|NCT00228176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110918951|NCT05131984|Ocrelizumab|ocrelizumab|mesh-list
110918952|NCT05131984|Immunologic Factors|immunologic factors|mesh-ancestor
110918953|NCT05131984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110918954|NCT01308190|Capecitabine|capecitabine|mesh-list
110918955|NCT01308190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110918956|NCT01308190|Antimetabolites|antimetabolites|mesh-ancestor
110918957|NCT01308190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110918958|NCT01308190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110918959|NCT01210768|Cyclophosphamide|cyclophosphamide|mesh-list
110918960|NCT01210768|Doxorubicin|doxorubicin|mesh-list
110918961|NCT01210768|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110918962|NCT01210768|Epirubicin|epirubicin|mesh-list
110918963|NCT01210768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110918964|NCT01210768|Immunologic Factors|immunologic factors|mesh-ancestor
110240135|NCT00136773|Amlodipine|amlodipine|mesh-list
110918965|NCT01210768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110918966|NCT01210768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110918967|NCT01210768|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110918968|NCT01210768|Alkylating Agents|alkylating agents|mesh-ancestor
110918969|NCT01210768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110918970|NCT01210768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110918971|NCT01210768|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110918972|NCT01210768|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110918973|NCT01210768|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110918974|NCT01210768|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110918975|NCT01210768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110918977|NCT02971605|Hallucinogens|hallucinogens|mesh-ancestor
110918978|NCT02971605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110918979|NCT02971605|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110918980|NCT04410874|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
110918981|NCT04410874|Vaccines|vaccines|mesh-list
110918982|NCT04410874|Immunologic Factors|immunologic factors|mesh-ancestor
110918983|NCT04410874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110918984|NCT04410874|Antiviral Agents|antiviral agents|mesh-ancestor
110918985|NCT04410874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110918986|NCT02124954|Digoxin|digoxin|mesh-list
110918987|NCT02124954|Midazolam|midazolam|mesh-list
110918988|NCT02124954|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110918989|NCT02124954|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110240235|NCT00134394|Etanercept|etanercept|mesh-list
110918990|NCT02124954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110918991|NCT02124954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110918992|NCT02124954|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110918993|NCT02124954|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110918994|NCT02124954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110918995|NCT02124954|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110918996|NCT02124954|Anesthetics, General|anesthetics, general|mesh-ancestor
110918997|NCT02124954|Anesthetics|anesthetics|mesh-ancestor
110918998|NCT02124954|GABA Modulators|gaba modulators|mesh-ancestor
110918999|NCT02124954|GABA Agents|gaba agents|mesh-ancestor
110919000|NCT02124954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110240300|NCT00134550|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110919001|NCT02124954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110919002|NCT02124954|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110919003|NCT02124954|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110919004|NCT02124954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110919005|NCT02124954|Protective Agents|protective agents|mesh-ancestor
110919006|NCT04441112|Triamcinolone|triamcinolone|mesh-list
110919008|NCT04441112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110919009|NCT04441112|Glucocorticoids|glucocorticoids|mesh-ancestor
110919011|NCT04441112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110919012|NCT04441112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110919013|NCT04441112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110240435|NCT00105326|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110919014|NCT04441112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110919015|NCT04441112|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110919016|NCT04441112|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110919017|NCT04441112|Analgesics|analgesics|mesh-ancestor
110919018|NCT04441112|Sensory System Agents|sensory system agents|mesh-ancestor
110919019|NCT04441112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110919020|NCT04441112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110919021|NCT04441112|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110919022|NCT02121990|Paclitaxel|paclitaxel|mesh-list
110919023|NCT02121990|Bevacizumab|bevacizumab|mesh-list
110919024|NCT02121990|Olaparib|olaparib|mesh-list
110919025|NCT02121990|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110919027|NCT02121990|Tubulin Modulators|tubulin modulators|mesh-ancestor
110919028|NCT02121990|Antimitotic Agents|antimitotic agents|mesh-ancestor
110919029|NCT02121990|Mitosis Modulators|mitosis modulators|mesh-ancestor
110365021|NCT00538967|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110919030|NCT02121990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110919031|NCT02121990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110919032|NCT02121990|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110919033|NCT02121990|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110636550|NCT05313477|Vitamin D|vitamin d|mesh-list
110919034|NCT02121990|Growth Substances|growth substances|mesh-ancestor
110919035|NCT02121990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110919036|NCT02121990|Growth Inhibitors|growth inhibitors|mesh-ancestor
110919037|NCT02121990|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110919038|NCT02121990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110919039|NCT05724056|Hyaluronic Acid|hyaluronic acid|mesh-list
110919040|NCT05724056|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110919041|NCT05724056|Immunologic Factors|immunologic factors|mesh-ancestor
110919042|NCT05724056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110919043|NCT05724056|Viscosupplements|viscosupplements|mesh-ancestor
110919044|NCT05724056|Protective Agents|protective agents|mesh-ancestor
110919045|NCT02609737|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
110919046|NCT02609737|Chelating Agents|chelating agents|mesh-ancestor
110919047|NCT02609737|Sequestering Agents|sequestering agents|mesh-ancestor
110919048|NCT02609737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110919050|NCT01060059|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110919051|NCT01060059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110919052|NCT01060059|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110919053|NCT01060059|Incretins|incretins|mesh-ancestor
110919055|NCT01060059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110919056|NCT04318015|Hydroxychloroquine|hydroxychloroquine|mesh-list
110919057|NCT04318015|Antimalarials|antimalarials|mesh-ancestor
110919058|NCT04318015|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110919059|NCT04318015|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110919060|NCT04318015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110919061|NCT04318015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110919062|NCT04318015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110919063|NCT04318015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110919064|NCT04307797|Exenatide|exenatide|mesh-list
110919065|NCT04307797|Glucagon|glucagon|mesh-list
110919066|NCT04307797|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
110919067|NCT04307797|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110919068|NCT04307797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110919069|NCT04307797|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110919070|NCT04307797|Incretins|incretins|mesh-ancestor
110919071|NCT04307797|Hormones|hormones|mesh-ancestor
110919072|NCT04307797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110919073|NCT04307797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110919074|NCT02125188|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
110919075|NCT02125188|Hemostatics|hemostatics|mesh-ancestor
110919076|NCT02125188|Coagulants|coagulants|mesh-ancestor
110919077|NCT02125188|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
110919078|NCT02125188|Natriuretic Agents|natriuretic agents|mesh-ancestor
110919079|NCT02125188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110919080|NCT02125344|Paclitaxel|paclitaxel|mesh-list
110240828|NCT00138099|Dalteparin|dalteparin|mesh-list
110919081|NCT02125344|Cyclophosphamide|cyclophosphamide|mesh-list
110919082|NCT02125344|Carboplatin|carboplatin|mesh-list
110919083|NCT02125344|Doxorubicin|doxorubicin|mesh-list
110919084|NCT02125344|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110919085|NCT02125344|Trastuzumab|trastuzumab|mesh-list
110919086|NCT02125344|Epirubicin|epirubicin|mesh-list
110919087|NCT02125344|Pertuzumab|pertuzumab|mesh-list
110919088|NCT02125344|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110919089|NCT02125344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110919090|NCT02125344|Tubulin Modulators|tubulin modulators|mesh-ancestor
110919091|NCT02125344|Antimitotic Agents|antimitotic agents|mesh-ancestor
110919092|NCT02125344|Mitosis Modulators|mitosis modulators|mesh-ancestor
110240882|NCT00437320|Dermatologic Agents|dermatologic agents|mesh-ancestor
110919093|NCT02125344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110919094|NCT02125344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110919095|NCT02125344|Immunologic Factors|immunologic factors|mesh-ancestor
110919096|NCT02125344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110919097|NCT02125344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110919098|NCT02125344|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110919099|NCT02125344|Alkylating Agents|alkylating agents|mesh-ancestor
110919100|NCT02125344|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110919101|NCT02125344|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110919102|NCT02125344|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110919103|NCT02125344|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110919104|NCT02125344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110919105|NCT02125344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110919106|NCT05468840|Ketamine|ketamine|mesh-list
110919107|NCT05468840|Analgesics|analgesics|mesh-ancestor
110919108|NCT05468840|Sensory System Agents|sensory system agents|mesh-ancestor
110919109|NCT05468840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110919110|NCT05468840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110919111|NCT05468840|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110919112|NCT05468840|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110919113|NCT05468840|Anesthetics, General|anesthetics, general|mesh-ancestor
110919114|NCT05468840|Anesthetics|anesthetics|mesh-ancestor
110919115|NCT05468840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110928694|NCT02634346|Antiemetics|antiemetics|mesh-ancestor
110919116|NCT05468840|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110919117|NCT05468840|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110919118|NCT05468840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110919119|NCT05468840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110919121|NCT05723900|Cathartics|cathartics|mesh-ancestor
110919122|NCT05723900|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110919123|NCT02127138|Sirolimus|sirolimus|mesh-list
110919124|NCT02127138|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110919125|NCT02127138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110919126|NCT02127138|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110919127|NCT02127138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110919128|NCT02127138|Antifungal Agents|antifungal agents|mesh-ancestor
110241149|NCT00439699|Memantine|memantine|mesh-list
110919129|NCT02127138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110919130|NCT02127138|Immunologic Factors|immunologic factors|mesh-ancestor
110919131|NCT02127138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110919133|NCT03651531|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110919134|NCT03651531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110919135|NCT02903511|Metformin|metformin|mesh-list
110919136|NCT02903511|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110919137|NCT02903511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110919138|NCT05325528|Oxaliplatin|oxaliplatin|mesh-list
110919139|NCT05325528|Tislelizumab|tislelizumab|mesh-list
110919140|NCT05325528|Tegafur|tegafur|mesh-list
110919141|NCT05325528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110919142|NCT05325528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110919143|NCT05325528|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110919144|NCT05325528|Antimetabolites|antimetabolites|mesh-ancestor
110919145|NCT05325528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110919146|NCT02125500|Sofosbuvir|sofosbuvir|mesh-list
110919147|NCT02125500|Ledipasvir|ledipasvir|mesh-list
110919148|NCT02125500|Antiviral Agents|antiviral agents|mesh-ancestor
110919149|NCT02125500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110919150|NCT02125578|Interferons|interferons|mesh-list
110919151|NCT02125578|Interferon-beta|interferon-beta|mesh-list
110919152|NCT02125578|Interferon beta-1a|interferon beta-1a|mesh-list
110919153|NCT02125578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110919154|NCT02125578|Antiviral Agents|antiviral agents|mesh-ancestor
110919155|NCT02125578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110919156|NCT02125578|Immunologic Factors|immunologic factors|mesh-ancestor
110919157|NCT02125578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110919158|NCT02125578|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110919159|NCT02122536|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110919160|NCT02122536|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
110919161|NCT02122536|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110919162|NCT02122536|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110919163|NCT02122536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110919164|NCT02122536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110919165|NCT02122536|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110241408|NCT00440713|Serotonin Agents|serotonin agents|mesh-ancestor
110919166|NCT02122536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110919167|NCT02122536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110919168|NCT02122536|Cholinergic Agents|cholinergic agents|mesh-ancestor
110919169|NCT02122536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110919170|NCT05606965|Vaccines|vaccines|mesh-list
110919171|NCT05606965|Immunologic Factors|immunologic factors|mesh-ancestor
110919172|NCT05606965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110919173|NCT03830359|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110241472|NCT00441649|Methylphenidate|methylphenidate|mesh-list
110919174|NCT03830359|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110919175|NCT00141284|Lamivudine|lamivudine|mesh-list
110919176|NCT00141284|Zidovudine|zidovudine|mesh-list
110919177|NCT00141284|Nelfinavir|nelfinavir|mesh-list
110919178|NCT00141284|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110919179|NCT00141284|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110919180|NCT00141284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110919181|NCT00141284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110919182|NCT00141284|Antiviral Agents|antiviral agents|mesh-ancestor
110919183|NCT00141284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110919184|NCT00141284|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110919185|NCT00141284|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110919186|NCT00141284|Antimetabolites|antimetabolites|mesh-ancestor
110919187|NCT00141284|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110919188|NCT00141284|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110919189|NCT00141284|Protease Inhibitors|protease inhibitors|mesh-ancestor
110919191|NCT04328506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110919192|NCT04328506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110919193|NCT04328506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110919195|NCT02125812|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110919196|NCT02125812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110919197|NCT02125812|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110919198|NCT02125812|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110919199|NCT02125812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110919200|NCT02125812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110919201|NCT02125812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110919202|NCT02125890|Tranexamic Acid|tranexamic acid|mesh-list
110919203|NCT02125890|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110919204|NCT02125890|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110919205|NCT02125890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110919206|NCT02125890|Hemostatics|hemostatics|mesh-ancestor
110919207|NCT02125890|Coagulants|coagulants|mesh-ancestor
110919208|NCT05287984|Cyclophosphamide|cyclophosphamide|mesh-list
110919209|NCT05287984|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110919211|NCT05287984|Fludarabine|fludarabine|mesh-list
110241741|NCT00108446|Anesthetics|anesthetics|mesh-ancestor
110919212|NCT05287984|Zanubrutinib|zanubrutinib|mesh-list
110919213|NCT05287984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110919214|NCT05287984|Immunologic Factors|immunologic factors|mesh-ancestor
110919215|NCT05287984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110919216|NCT05287984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110919217|NCT05287984|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110919218|NCT05287984|Alkylating Agents|alkylating agents|mesh-ancestor
110919219|NCT05287984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110919220|NCT05287984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110919221|NCT05287984|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110919222|NCT05287984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110919223|NCT05287984|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110919224|NCT05287984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110919225|NCT00134264|Atorvastatin|atorvastatin|mesh-list
110919226|NCT00134264|Torcetrapib|torcetrapib|mesh-list
110919227|NCT00134264|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110919228|NCT00134264|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110919229|NCT00134264|Antimetabolites|antimetabolites|mesh-ancestor
110919230|NCT00134264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110919231|NCT00134264|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110928729|NCT02165046|Respiratory System Agents|respiratory system agents|mesh-ancestor
110919232|NCT00134264|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110919233|NCT00134264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110919234|NCT05285800|Bupivacaine|bupivacaine|mesh-list
110919235|NCT05285800|Anesthetics, Local|anesthetics, local|mesh-ancestor
110919236|NCT05285800|Anesthetics|anesthetics|mesh-ancestor
110919237|NCT05285800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110919238|NCT05285800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110919239|NCT05285800|Sensory System Agents|sensory system agents|mesh-ancestor
110919240|NCT05285800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110919241|NCT02122692|Itraconazole|itraconazole|mesh-list
110919242|NCT02122692|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
110919243|NCT02122692|(2-(6-fluoro-1H-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|(2-(6-fluoro-1h-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|mesh-list
110919244|NCT02122692|Antifungal Agents|antifungal agents|mesh-ancestor
110919245|NCT02122692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110919246|NCT02122692|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110919247|NCT02122692|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110919248|NCT02122692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110241966|NCT00139035|Dermatologic Agents|dermatologic agents|mesh-ancestor
110919249|NCT02122692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110919250|NCT02122692|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110919251|NCT02122692|Hormone Antagonists|hormone antagonists|mesh-ancestor
110919252|NCT02122692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110919253|NCT02122692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110919254|NCT02122692|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110919255|NCT02122692|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110242035|NCT00451984|Interleukin-2|interleukin-2|mesh-list
110919256|NCT02122692|Serotonin Agents|serotonin agents|mesh-ancestor
110919257|NCT02122692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110919258|NCT00131924|Estrogens|estrogens|mesh-list
110919259|NCT00131924|Estrogens, Esterified (USP)|estrogens, esterified (usp)|mesh-list
110919260|NCT00131924|Hormones|hormones|mesh-ancestor
110919261|NCT00131924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110919262|NCT00131924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110919263|NCT05284474|Mitogens|mitogens|mesh-list
110919264|NCT05284474|Mitosis Modulators|mitosis modulators|mesh-ancestor
110919265|NCT05284474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110919266|NCT05609695|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
110919267|NCT05609695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110242100|NCT00143169|Analgesics|analgesics|mesh-ancestor
110919268|NCT05609695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110919269|NCT05609695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110919270|NCT04246060|Cysteamine|cysteamine|mesh-list
110919271|NCT04246060|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
110919272|NCT04246060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110919273|NCT05129176|Metronidazole|metronidazole|mesh-list
110919274|NCT05129176|Levofloxacin|levofloxacin|mesh-list
110919275|NCT05129176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110919276|NCT05129176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110919277|NCT05129176|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110919278|NCT05129176|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110919279|NCT05129176|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110919280|NCT05129176|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110919281|NCT05129176|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110919282|NCT05129176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110919283|NCT05129176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110919284|NCT05129176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110919285|NCT05129176|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110919286|NCT05129176|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110919287|NCT02127684|Ranibizumab|ranibizumab|mesh-list
110919288|NCT02127684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110919289|NCT02127684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110919290|NCT02127684|Growth Substances|growth substances|mesh-ancestor
110919291|NCT02127684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110919292|NCT02127684|Growth Inhibitors|growth inhibitors|mesh-ancestor
110919293|NCT02127684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110919294|NCT02126358|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110919295|NCT02126358|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110919296|NCT02126358|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110919297|NCT02126358|Antimetabolites|antimetabolites|mesh-ancestor
110919298|NCT02126358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110919299|NCT02126358|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110919300|NCT02126358|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110919301|NCT02126358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110919302|NCT02127840|Epinephrine|epinephrine|mesh-list
110919303|NCT02127840|Racepinephrine|racepinephrine|mesh-list
110919304|NCT02127840|Epinephryl borate|epinephryl borate|mesh-list
110919305|NCT02127840|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110919306|NCT02127840|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110919307|NCT02127840|Adrenergic Agents|adrenergic agents|mesh-ancestor
110919308|NCT02127840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110919309|NCT02127840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110919310|NCT02127840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110919311|NCT02127840|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110919312|NCT02127840|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110919313|NCT02127840|Autonomic Agents|autonomic agents|mesh-ancestor
110919314|NCT02127840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110919315|NCT02127840|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110919316|NCT02127840|Respiratory System Agents|respiratory system agents|mesh-ancestor
110919317|NCT02127840|Mydriatics|mydriatics|mesh-ancestor
110919318|NCT02127840|Sympathomimetics|sympathomimetics|mesh-ancestor
110919319|NCT02127840|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110919320|NCT05031442|Zinc Oxide|zinc oxide|mesh-list
110919321|NCT05031442|Dermatologic Agents|dermatologic agents|mesh-ancestor
110919322|NCT05031442|Sunscreening Agents|sunscreening agents|mesh-ancestor
110919323|NCT05031442|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110919324|NCT05031442|Protective Agents|protective agents|mesh-ancestor
110919325|NCT05031442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110919326|NCT02127918|Clobazam|clobazam|mesh-list
110919327|NCT02127918|Anticonvulsants|anticonvulsants|mesh-ancestor
110919328|NCT02127918|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110919329|NCT02127918|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110919330|NCT02127918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110919331|NCT02127918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110919332|NCT02127918|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110919333|NCT02127918|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
110919334|NCT02127918|GABA Agonists|gaba agonists|mesh-ancestor
110919335|NCT02127918|GABA Agents|gaba agents|mesh-ancestor
110919336|NCT02127918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110919337|NCT02127918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110919338|NCT00127634|Insulin|insulin|mesh-list
110919339|NCT00127634|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110919340|NCT00127634|Insulin Glargine|insulin glargine|mesh-list
110919341|NCT00127634|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110919342|NCT00127634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110919343|NCT02127996|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
110919344|NCT02127996|Incretins|incretins|mesh-ancestor
110919345|NCT02127996|Hormones|hormones|mesh-ancestor
110919346|NCT02127996|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110919347|NCT02127996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110919348|NCT02131350|Ranibizumab|ranibizumab|mesh-list
110242383|NCT00454480|Immunotoxins|immunotoxins|mesh-ancestor
110928744|NCT03070678|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110919350|NCT02131350|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110919351|NCT02131350|Growth Substances|growth substances|mesh-ancestor
110919352|NCT02131350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110919353|NCT02131350|Growth Inhibitors|growth inhibitors|mesh-ancestor
110919354|NCT02131350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110919357|NCT02128308|Ofloxacin|ofloxacin|mesh-list
110919358|NCT02128308|Cycloserine|cycloserine|mesh-list
110919359|NCT02128308|Pyrazinamide|pyrazinamide|mesh-list
110919360|NCT02128308|Aminosalicylic Acid|aminosalicylic acid|mesh-list
110919361|NCT02128308|Streptomycin|streptomycin|mesh-list
110919362|NCT02128308|Kanamycin|kanamycin|mesh-list
110919363|NCT02128308|Prothionamide|prothionamide|mesh-list
110919364|NCT02128308|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
110919365|NCT02128308|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110919366|NCT02128308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110919367|NCT02128308|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110919368|NCT02128308|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110919369|NCT02128308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110919370|NCT02128308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110919371|NCT02128308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110919372|NCT02128308|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110919373|NCT02128308|Contraceptive Agents|contraceptive agents|mesh-ancestor
110919374|NCT02128308|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110919375|NCT02128308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110919376|NCT02128308|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110919377|NCT02128308|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110919378|NCT02128308|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110919379|NCT02128308|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110919380|NCT02128308|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110919381|NCT02128308|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110919382|NCT02128308|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110919383|NCT02128308|Antitubercular Agents|antitubercular agents|mesh-ancestor
110919384|NCT02128308|Antimetabolites|antimetabolites|mesh-ancestor
110919385|NCT02128308|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110919386|NCT02131506|Lapatinib|lapatinib|mesh-list
110919387|NCT02131506|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110919388|NCT02131506|Doxorubicin|doxorubicin|mesh-list
110919389|NCT02131506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110919390|NCT02131506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110919391|NCT02131506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110919392|NCT02131506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110919393|NCT02131506|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110919395|NCT02131506|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110919396|NCT01674010|Inositol|inositol|mesh-list
110919397|NCT01674010|Lamotrigine|lamotrigine|mesh-list
110919398|NCT01674010|Valproic Acid|valproic acid|mesh-list
110919399|NCT01674010|Anticonvulsants|anticonvulsants|mesh-ancestor
110919400|NCT01674010|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110919401|NCT01674010|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110919402|NCT01674010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110919403|NCT01674010|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110919404|NCT01674010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110919405|NCT01674010|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110919406|NCT01674010|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110919407|NCT01674010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110919409|NCT01674010|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110919410|NCT01674010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110919411|NCT01674010|GABA Agents|gaba agents|mesh-ancestor
110919412|NCT01674010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110919413|NCT01674010|Antimanic Agents|antimanic agents|mesh-ancestor
110919414|NCT01674010|Vitamin B Complex|vitamin b complex|mesh-ancestor
110919416|NCT01674010|Micronutrients|micronutrients|mesh-ancestor
110919417|NCT02252328|Simvastatin|simvastatin|mesh-list
110919418|NCT02252328|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110919419|NCT02252328|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110919420|NCT02252328|Antimetabolites|antimetabolites|mesh-ancestor
110242767|NCT00456976|Selegiline|selegiline|mesh-list
110919421|NCT02252328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110919422|NCT02252328|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110919423|NCT02252328|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110919424|NCT02252328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110919425|NCT04656964|Midazolam|midazolam|mesh-list
110919426|NCT04656964|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110919427|NCT04656964|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110919428|NCT04656964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110919429|NCT04656964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110919430|NCT04656964|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110919431|NCT04656964|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110919432|NCT04656964|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110919433|NCT04656964|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110919434|NCT04656964|Anesthetics, General|anesthetics, general|mesh-ancestor
110919435|NCT04656964|Anesthetics|anesthetics|mesh-ancestor
110919436|NCT04656964|GABA Modulators|gaba modulators|mesh-ancestor
110919437|NCT04656964|GABA Agents|gaba agents|mesh-ancestor
110919438|NCT04656964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110919439|NCT04656964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110919440|NCT02136030|Amphotericin B|amphotericin b|mesh-list
110919441|NCT02136030|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
110919442|NCT02136030|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
110919443|NCT02136030|Deoxycholic Acid|deoxycholic acid|mesh-list
110919444|NCT02136030|Amebicides|amebicides|mesh-ancestor
110919445|NCT02136030|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110919446|NCT02136030|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110919447|NCT02136030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110919448|NCT02136030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110919449|NCT02136030|Antifungal Agents|antifungal agents|mesh-ancestor
110919450|NCT02136030|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
110919452|NCT02131818|Amoxicillin|amoxicillin|mesh-list
110919453|NCT02131818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110919454|NCT02131818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110919455|NCT04605796|Bevacizumab|bevacizumab|mesh-list
110919456|NCT04605796|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110919457|NCT04605796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110919458|NCT04605796|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110919459|NCT04605796|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110919460|NCT04605796|Growth Substances|growth substances|mesh-ancestor
110919461|NCT04605796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110919462|NCT04605796|Growth Inhibitors|growth inhibitors|mesh-ancestor
110919463|NCT01345669|Afatinib|afatinib|mesh-list
110919464|NCT01345669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110919465|NCT01345669|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110919466|NCT01345669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110919467|NCT01345669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110919468|NCT04313608|Gemcitabine|gemcitabine|mesh-list
110919469|NCT04313608|Oxaliplatin|oxaliplatin|mesh-list
110919470|NCT04313608|Obinutuzumab|obinutuzumab|mesh-list
110919471|NCT04313608|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110919472|NCT04313608|Antimetabolites|antimetabolites|mesh-ancestor
110919473|NCT04313608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110919474|NCT04313608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110919475|NCT04313608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110919476|NCT04502264|Botulinum Toxins|botulinum toxins|mesh-list
110919477|NCT04502264|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110928776|NCT03601611|Hormones|hormones|mesh-ancestor
110919478|NCT04502264|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110919479|NCT04502264|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110919480|NCT04502264|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110919481|NCT04502264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110919482|NCT04502264|Cholinergic Agents|cholinergic agents|mesh-ancestor
110919483|NCT04502264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110636991|NCT00827684|Antifungal Agents|antifungal agents|mesh-ancestor
110919484|NCT04502264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110919485|NCT04502264|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110919486|NCT04502264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110919487|NCT03527732|Ivermectin|ivermectin|mesh-list
110919488|NCT03527732|Albendazole|albendazole|mesh-list
110919489|NCT03527732|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110919490|NCT03527732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110919491|NCT03527732|Anthelmintics|anthelmintics|mesh-ancestor
110919492|NCT03527732|Anticestodal Agents|anticestodal agents|mesh-ancestor
110919493|NCT03527732|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110919494|NCT03527732|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110919495|NCT03527732|Tubulin Modulators|tubulin modulators|mesh-ancestor
110919496|NCT03527732|Antimitotic Agents|antimitotic agents|mesh-ancestor
110919497|NCT03527732|Mitosis Modulators|mitosis modulators|mesh-ancestor
110919498|NCT03527732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110919499|NCT03527732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110919500|NCT01673854|Ipilimumab|ipilimumab|mesh-list
110919501|NCT01673854|Vemurafenib|vemurafenib|mesh-list
110919502|NCT01673854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110919503|NCT01673854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110919504|NCT01673854|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110919505|NCT01673854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110919506|NCT01673854|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110919507|NCT01673854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110919508|NCT03549702|Povidone-Iodine|povidone-iodine|mesh-list
110919509|NCT03549702|Povidone|povidone|mesh-list
110919510|NCT03549702|Plasma Substitutes|plasma substitutes|mesh-ancestor
110919511|NCT03549702|Blood Substitutes|blood substitutes|mesh-ancestor
110919512|NCT03549702|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110919513|NCT03549702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110919514|NCT02529904|Vaccines|vaccines|mesh-list
110919515|NCT02529904|Immunologic Factors|immunologic factors|mesh-ancestor
110919516|NCT02529904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110919517|NCT01367886|Fesoterodine|fesoterodine|mesh-list
110919518|NCT01367886|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110919519|NCT01367886|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110243264|NCT00111449|Etanercept|etanercept|mesh-list
110919520|NCT01367886|Cholinergic Agents|cholinergic agents|mesh-ancestor
110919521|NCT01367886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110919522|NCT01367886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110919523|NCT01367886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110919524|NCT01367886|Urological Agents|urological agents|mesh-ancestor
110919525|NCT05706337|Propofol|propofol|mesh-list
110919526|NCT05706337|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110919527|NCT05706337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110919528|NCT05706337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110919529|NCT05706337|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110919530|NCT05706337|Anesthetics, General|anesthetics, general|mesh-ancestor
110919531|NCT05706337|Anesthetics|anesthetics|mesh-ancestor
110919532|NCT05222113|Remdesivir|remdesivir|mesh-list
110919533|NCT05222113|Favipiravir|favipiravir|mesh-list
110919534|NCT05222113|Antimetabolites|antimetabolites|mesh-ancestor
110919535|NCT05222113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110919536|NCT05222113|Antiviral Agents|antiviral agents|mesh-ancestor
110919537|NCT05222113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110919538|NCT03854578|Citalopram|citalopram|mesh-list
110919539|NCT03854578|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110919540|NCT03854578|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110919541|NCT03854578|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110919542|NCT03854578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110919543|NCT03854578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110919544|NCT03854578|Serotonin Agents|serotonin agents|mesh-ancestor
110919545|NCT03854578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110919546|NCT03854578|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110919547|NCT03854578|Antidepressive Agents|antidepressive agents|mesh-ancestor
110919548|NCT03854578|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110919550|NCT03038594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110243394|NCT00404781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110919551|NCT03038594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110919553|NCT02136888|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
110919554|NCT02136888|Ponesimod|ponesimod|mesh-list
110919555|NCT02136888|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110919556|NCT02136888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110919557|NCT02136888|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110919558|NCT02136888|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110637063|NCT00828230|Glucocorticoids|glucocorticoids|mesh-ancestor
110919559|NCT02136888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110919560|NCT02136888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110919561|NCT02136888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110919562|NCT02136888|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110919563|NCT02136888|Contraceptive Agents|contraceptive agents|mesh-ancestor
110919564|NCT02136888|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110919565|NCT02136888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110919566|NCT02136888|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110919567|NCT02136888|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110919568|NCT02136888|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110243510|NCT00114270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110919569|NCT02136888|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
110919570|NCT02136888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110919571|NCT02136888|Immunologic Factors|immunologic factors|mesh-ancestor
110919572|NCT02132286|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110919573|NCT02132286|Antidepressive Agents|antidepressive agents|mesh-ancestor
110919574|NCT02132286|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110919575|NCT02132286|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110919576|NCT02132286|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110919577|NCT02132286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110919578|NCT02132286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110919579|NCT05252754|Indomethacin|indomethacin|mesh-list
110919580|NCT05252754|Tacrolimus|tacrolimus|mesh-list
110919581|NCT05252754|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110919582|NCT05252754|Immunologic Factors|immunologic factors|mesh-ancestor
110919583|NCT05252754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110919584|NCT05252754|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110919585|NCT05252754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110919586|NCT05252754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110919587|NCT05252754|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110919588|NCT05252754|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110919589|NCT05252754|Analgesics|analgesics|mesh-ancestor
110243640|NCT00351403|Ribavirin|ribavirin|mesh-list
110919590|NCT05252754|Sensory System Agents|sensory system agents|mesh-ancestor
110919591|NCT05252754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110919592|NCT05252754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110919593|NCT05252754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110919594|NCT05252754|Gout Suppressants|gout suppressants|mesh-ancestor
110919595|NCT05252754|Tocolytic Agents|tocolytic agents|mesh-ancestor
110919596|NCT05252754|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110919597|NCT05252754|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110919598|NCT03548246|Hydrocortisone|hydrocortisone|mesh-list
110919599|NCT03548246|Fludrocortisone|fludrocortisone|mesh-list
110919600|NCT03548246|Abiraterone Acetate|abiraterone acetate|mesh-list
110919601|NCT03548246|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110919602|NCT03548246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110919603|NCT03548246|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110919604|NCT03548246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110919605|NCT03548246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110919606|NCT03548246|Hormone Antagonists|hormone antagonists|mesh-ancestor
110365103|NCT00540098|Serotonin Agents|serotonin agents|mesh-ancestor
110919607|NCT03548246|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110919608|NCT03548246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110919609|NCT03548246|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110919611|NCT02132442|Ergocalciferols|ergocalciferols|mesh-list
110919612|NCT02132442|Vitamins|vitamins|mesh-ancestor
110919613|NCT02132442|Micronutrients|micronutrients|mesh-ancestor
110919614|NCT02132442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110919615|NCT02132442|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110919616|NCT02132442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110919617|NCT05010148|Lidocaine|lidocaine|mesh-list
110919618|NCT05010148|Anesthetics, Local|anesthetics, local|mesh-ancestor
110919619|NCT05010148|Anesthetics|anesthetics|mesh-ancestor
110919620|NCT05010148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110919621|NCT05010148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110919622|NCT05010148|Sensory System Agents|sensory system agents|mesh-ancestor
110919623|NCT05010148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110919624|NCT05010148|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110919625|NCT05010148|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110919626|NCT05010148|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110919627|NCT05010148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110243825|NCT00352495|Vinblastine|vinblastine|mesh-list
110919628|NCT05010148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110919629|NCT05138146|Doxorubicin|doxorubicin|mesh-list
110919630|NCT05138146|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110919631|NCT05138146|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110919632|NCT05138146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110919633|NCT05138146|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110919634|NCT05138146|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110919635|NCT05138146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110919636|NCT05138146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110919637|NCT05221879|Enoxaparin|enoxaparin|mesh-list
110919638|NCT05221879|Anticoagulants|anticoagulants|mesh-ancestor
110919639|NCT05221879|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110919640|NCT05221879|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110243889|NCT00352768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110919641|NCT05221879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110919642|NCT03450772|Pancrelipase|pancrelipase|mesh-list
110919643|NCT03450772|Pancreatin|pancreatin|mesh-list
110919644|NCT03450772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110919645|NCT02129088|Esketamine|esketamine|mesh-list
110919646|NCT02129088|Antidepressive Agents|antidepressive agents|mesh-ancestor
110919647|NCT02129088|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110919648|NCT05137522|Methylprednisolone|methylprednisolone|mesh-list
110919649|NCT05137522|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110919650|NCT05137522|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110919651|NCT05137522|Prednisolone|prednisolone|mesh-list
110919652|NCT05137522|Prednisolone acetate|prednisolone acetate|mesh-list
110919653|NCT05137522|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110919654|NCT05137522|Prednisolone phosphate|prednisolone phosphate|mesh-list
110919655|NCT05137522|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110919656|NCT05137522|Antiemetics|antiemetics|mesh-ancestor
110919657|NCT05137522|Autonomic Agents|autonomic agents|mesh-ancestor
110919658|NCT05137522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110919659|NCT05137522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110919660|NCT05137522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110919661|NCT05137522|Glucocorticoids|glucocorticoids|mesh-ancestor
110919662|NCT05137522|Hormones|hormones|mesh-ancestor
110919663|NCT05137522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110919664|NCT05137522|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110919665|NCT05137522|Protective Agents|protective agents|mesh-ancestor
110919666|NCT05137522|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110919667|NCT05137522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110919668|NCT02129166|Imatinib Mesylate|imatinib mesylate|mesh-list
110919669|NCT02129166|Dasatinib|dasatinib|mesh-list
110919670|NCT02129166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110919671|NCT02129166|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110919672|NCT02129166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110919673|NCT02129166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110919674|NCT02137278|Antihypertensive Agents|antihypertensive agents|mesh-list
110919675|NCT02137278|Levodopa|levodopa|mesh-list
110919676|NCT02137278|Antipsychotic Agents|antipsychotic agents|mesh-list
110919677|NCT02137278|Antidepressive Agents|antidepressive agents|mesh-list
110919678|NCT02137278|Diuretics|diuretics|mesh-list
110244144|NCT01059526|Ecallantide|ecallantide|mesh-list
110919679|NCT02137278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110919680|NCT02137278|Natriuretic Agents|natriuretic agents|mesh-ancestor
110919681|NCT02137278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110919682|NCT02137278|Dopamine Agents|dopamine agents|mesh-ancestor
110919683|NCT02137278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110919684|NCT02137278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110919685|NCT02137278|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110919686|NCT02137278|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110919687|NCT02137278|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110919688|NCT02137278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110919689|NCT05705635|Docetaxel|docetaxel|mesh-list
110919690|NCT05705635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110919691|NCT05705635|Tubulin Modulators|tubulin modulators|mesh-ancestor
110919692|NCT05705635|Antimitotic Agents|antimitotic agents|mesh-ancestor
110919693|NCT05705635|Mitosis Modulators|mitosis modulators|mesh-ancestor
110919694|NCT05705635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110919695|NCT05204550|Heparin|heparin|mesh-list
110244274|NCT00445081|Hormones|hormones|mesh-ancestor
110919696|NCT05204550|Calcium heparin|calcium heparin|mesh-list
110919697|NCT05204550|Anticoagulants|anticoagulants|mesh-ancestor
110919698|NCT05204550|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110919699|NCT05204550|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110919700|NCT05204550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110919701|NCT00085774|Albuterol|albuterol|mesh-list
110919702|NCT00085774|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110919703|NCT00085774|Autonomic Agents|autonomic agents|mesh-ancestor
110919704|NCT00085774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110919705|NCT00085774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110919706|NCT00085774|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110919707|NCT00085774|Respiratory System Agents|respiratory system agents|mesh-ancestor
110244337|NCT00445900|Prednisone|prednisone|mesh-list
110919708|NCT00085774|Tocolytic Agents|tocolytic agents|mesh-ancestor
110919709|NCT00085774|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110919710|NCT00085774|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110919711|NCT00085774|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110919712|NCT00085774|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110244407|NCT00446212|Propofol|propofol|mesh-list
110919713|NCT00085774|Adrenergic Agents|adrenergic agents|mesh-ancestor
110919714|NCT00085774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110919715|NCT00085774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110919716|NCT04491682|Megestrol|megestrol|mesh-list
110919717|NCT04491682|Megestrol Acetate|megestrol acetate|mesh-list
110919718|NCT04491682|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110919719|NCT04491682|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110919720|NCT04491682|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110919721|NCT04491682|Antimetabolites|antimetabolites|mesh-ancestor
110244470|NCT00114179|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110919722|NCT04491682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110919723|NCT04491682|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110919724|NCT04491682|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110919725|NCT04491682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110919726|NCT04491682|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110919727|NCT04491682|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110919728|NCT04491682|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110919729|NCT04491682|Contraceptive Agents|contraceptive agents|mesh-ancestor
110919730|NCT04491682|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110919731|NCT04491682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110919732|NCT04491682|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110919733|NCT04491682|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110919734|NCT04491682|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110919736|NCT04491682|Appetite Stimulants|appetite stimulants|mesh-ancestor
110919737|NCT04491682|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110919738|NCT05193968|Nitroprusside|nitroprusside|mesh-list
110919739|NCT05193968|Norepinephrine|norepinephrine|mesh-list
110919740|NCT05193968|Acetylcholine|acetylcholine|mesh-list
110919741|NCT05193968|Terbutaline|terbutaline|mesh-list
110919742|NCT05193968|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110919743|NCT05193968|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110919744|NCT05193968|Adrenergic Agents|adrenergic agents|mesh-ancestor
110919745|NCT05193968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110919746|NCT05193968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110919747|NCT05193968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110919748|NCT05193968|Sympathomimetics|sympathomimetics|mesh-ancestor
110919750|NCT05193968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110919751|NCT05193968|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110919752|NCT05193968|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110919753|NCT05193968|Vasodilator Agents|vasodilator agents|mesh-ancestor
110919754|NCT05193968|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
110919755|NCT05193968|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110919756|NCT05193968|Cholinergic Agents|cholinergic agents|mesh-ancestor
110919757|NCT05193968|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110919758|NCT05193968|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110919759|NCT05193968|Respiratory System Agents|respiratory system agents|mesh-ancestor
110919760|NCT05193968|Tocolytic Agents|tocolytic agents|mesh-ancestor
110919761|NCT05193968|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110919762|NCT05193968|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110919763|NCT05193968|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110919764|NCT02137356|Capecitabine|capecitabine|mesh-list
110919765|NCT02137356|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110919766|NCT02137356|Antimetabolites|antimetabolites|mesh-ancestor
110919767|NCT02137356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110919768|NCT02137356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110919769|NCT05137288|Atropine|atropine|mesh-list
110919770|NCT05137288|Ondansetron|ondansetron|mesh-list
110919771|NCT05137288|Bupivacaine|bupivacaine|mesh-list
110919772|NCT05137288|Anesthetics, Local|anesthetics, local|mesh-ancestor
110919773|NCT05137288|Anesthetics|anesthetics|mesh-ancestor
110919774|NCT05137288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110919775|NCT05137288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110919776|NCT05137288|Sensory System Agents|sensory system agents|mesh-ancestor
110919777|NCT05137288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110919779|NCT05137288|Autonomic Agents|autonomic agents|mesh-ancestor
110919780|NCT05137288|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110919781|NCT05137288|Antipruritics|antipruritics|mesh-ancestor
110919782|NCT05137288|Dermatologic Agents|dermatologic agents|mesh-ancestor
110919783|NCT05137288|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110244866|NCT00449527|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110919784|NCT05137288|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110919785|NCT05137288|Serotonin Agents|serotonin agents|mesh-ancestor
110919786|NCT05137288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110919787|NCT05137288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110919788|NCT05137288|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110919789|NCT05137288|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110919790|NCT05137288|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110919791|NCT05137288|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110919792|NCT05137288|Respiratory System Agents|respiratory system agents|mesh-ancestor
110919793|NCT05137288|Mydriatics|mydriatics|mesh-ancestor
110919794|NCT05137288|Parasympatholytics|parasympatholytics|mesh-ancestor
110244934|NCT05536362|Clonidine|clonidine|mesh-list
110919795|NCT05137288|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110919796|NCT05137288|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110919797|NCT05137288|Cholinergic Agents|cholinergic agents|mesh-ancestor
110919798|NCT05135182|Metronidazole|metronidazole|mesh-list
110919799|NCT05135182|Furazolidone|furazolidone|mesh-list
110919800|NCT05135182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110919801|NCT05135182|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110919802|NCT05135182|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110919803|NCT05135182|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110919804|NCT05135182|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110919805|NCT05135182|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110244992|NCT00458185|Etanercept|etanercept|mesh-list
110919806|NCT05135182|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
110919807|NCT05135182|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
110919808|NCT05135182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110919809|NCT05135182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110919810|NCT02137434|Calcium, Dietary|calcium, dietary|mesh-list
110919812|NCT02137434|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110245057|NCT03274024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110919817|NCT02137668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110919830|NCT03522428|Vitamins|vitamins|mesh-ancestor
110919831|NCT03522428|Micronutrients|micronutrients|mesh-ancestor
110919832|NCT03522428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110919833|NCT03522428|Vitamin B Complex|vitamin b complex|mesh-ancestor
110919834|NCT03522428|Hematinics|hematinics|mesh-ancestor
110919835|NCT05575999|Ketorolac|ketorolac|mesh-list
110919836|NCT05575999|Ketamine|ketamine|mesh-list
110919837|NCT05575999|Bupivacaine|bupivacaine|mesh-list
110919838|NCT05575999|Anesthetics, Local|anesthetics, local|mesh-ancestor
110919839|NCT05575999|Anesthetics|anesthetics|mesh-ancestor
110919840|NCT05575999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110919841|NCT05575999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110919842|NCT05575999|Sensory System Agents|sensory system agents|mesh-ancestor
110919843|NCT05575999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110919844|NCT05575999|Analgesics|analgesics|mesh-ancestor
110919845|NCT05575999|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110245257|NCT00461266|Enfuvirtide|enfuvirtide|mesh-list
110919846|NCT05575999|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110919847|NCT05575999|Anesthetics, General|anesthetics, general|mesh-ancestor
110919848|NCT05575999|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110919849|NCT05575999|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110919850|NCT05575999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110919851|NCT05575999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110919852|NCT05575999|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110919853|NCT05575999|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110919854|NCT05575999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110919855|NCT05575999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110919856|NCT05575999|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110919857|NCT05575999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110919858|NCT01062399|Everolimus|everolimus|mesh-list
110919859|NCT01062399|Temozolomide|temozolomide|mesh-list
110919861|NCT01062399|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110919862|NCT01062399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110919863|NCT01062399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110919864|NCT01062399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110919865|NCT01062399|Immunologic Factors|immunologic factors|mesh-ancestor
110919866|NCT01062399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110919867|NCT01062399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110919868|NCT01062399|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110919869|NCT01062399|Alkylating Agents|alkylating agents|mesh-ancestor
110919870|NCT05136508|Propofol|propofol|mesh-list
110919871|NCT05136508|Sevoflurane|sevoflurane|mesh-list
110928838|NCT05153486|Ethanol|ethanol|mesh-list
110919872|NCT05136508|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110919873|NCT05136508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110919874|NCT05136508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110919875|NCT05136508|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110919876|NCT05136508|Anesthetics, General|anesthetics, general|mesh-ancestor
110919878|NCT05136508|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110919879|NCT05136508|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110919880|NCT02129322|Oxaliplatin|oxaliplatin|mesh-list
110919882|NCT02129322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110919883|NCT02129322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110245445|NCT00462553|Gemcitabine|gemcitabine|mesh-list
110919884|NCT02129322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110919885|NCT02129322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110919886|NCT03767712|Antibodies|antibodies|mesh-list
110919887|NCT03767712|Antibodies, Antinuclear|antibodies, antinuclear|mesh-list
110919888|NCT03767712|Immunologic Factors|immunologic factors|mesh-ancestor
110919889|NCT03767712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110919890|NCT05221411|Mycophenolic Acid|mycophenolic acid|mesh-list
110919891|NCT05221411|Tacrolimus|tacrolimus|mesh-list
110919892|NCT05221411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110919893|NCT05221411|Immunologic Factors|immunologic factors|mesh-ancestor
110919894|NCT05221411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110919895|NCT05221411|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110919896|NCT05221411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110919897|NCT05221411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110919899|NCT05221411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110919900|NCT05221411|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110919901|NCT05221411|Antitubercular Agents|antitubercular agents|mesh-ancestor
110919902|NCT05221411|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110919903|NCT05221411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110919904|NCT05306002|Antioxidants|antioxidants|mesh-list
110919905|NCT05306002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110919906|NCT05306002|Protective Agents|protective agents|mesh-ancestor
110245569|NCT00463762|Sulbactam|sulbactam|mesh-list
110919907|NCT05306002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110919908|NCT04346914|Carboplatin|carboplatin|mesh-list
110919909|NCT04346914|Etoposide|etoposide|mesh-list
110919910|NCT04346914|Antibodies|antibodies|mesh-list
110919911|NCT04346914|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110919912|NCT04346914|Immunologic Factors|immunologic factors|mesh-ancestor
110919913|NCT04346914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110919914|NCT04346914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110919915|NCT04346914|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110919916|NCT04346914|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110919917|NCT04346914|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110919918|NCT04346914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110919919|NCT04346914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110919920|NCT02129400|Anesthetics|anesthetics|mesh-list
110919921|NCT02129400|Xenon|xenon|mesh-list
110919922|NCT02129400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110919923|NCT02129400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110919924|NCT02129400|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110919925|NCT02129400|Anesthetics, General|anesthetics, general|mesh-ancestor
110919926|NCT05305768|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
110919927|NCT05305768|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110919928|NCT05305768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110919929|NCT05305768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110919930|NCT05305768|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110919931|NCT05305768|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110919932|NCT05305768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110919933|NCT05305768|Cholinergic Agents|cholinergic agents|mesh-ancestor
110919934|NCT05305768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110919935|NCT02133378|Hemostatics|hemostatics|mesh-list
110919936|NCT02133378|Coagulants|coagulants|mesh-ancestor
110919937|NCT04171622|Pembrolizumab|pembrolizumab|mesh-list
110919938|NCT04171622|Lenvatinib|lenvatinib|mesh-list
110919939|NCT04171622|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110919940|NCT04171622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110919941|NCT04171622|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110919942|NCT04171622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110919943|NCT04171622|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110919944|NCT04171622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110919945|NCT05234580|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110919946|NCT02138058|Topiramate|topiramate|mesh-list
110919947|NCT02138058|Anticonvulsants|anticonvulsants|mesh-ancestor
110919948|NCT02138058|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110919949|NCT02138058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110919950|NCT02129634|Paclitaxel|paclitaxel|mesh-list
110919951|NCT02129634|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110919952|NCT02129634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110919953|NCT02129634|Tubulin Modulators|tubulin modulators|mesh-ancestor
110919954|NCT02129634|Antimitotic Agents|antimitotic agents|mesh-ancestor
110919955|NCT02129634|Mitosis Modulators|mitosis modulators|mesh-ancestor
110919956|NCT02129634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110919957|NCT05174455|Niraparib|niraparib|mesh-list
110919958|NCT05174455|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110365156|NCT00540605|Tenofovir|tenofovir|mesh-list
110919959|NCT05174455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110919960|NCT05174455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110919961|NCT05174455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110919962|NCT05162053|Clopidogrel|clopidogrel|mesh-list
110919963|NCT05162053|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110919964|NCT05162053|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110919965|NCT05162053|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110919966|NCT05162053|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110919967|NCT05162053|Purinergic Agents|purinergic agents|mesh-ancestor
110919968|NCT05162053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110919969|NCT05162053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110919970|NCT05162053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110919971|NCT02138292|Trametinib|trametinib|mesh-list
110919972|NCT02138292|Digoxin|digoxin|mesh-list
110919973|NCT02138292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110919974|NCT02138292|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110919975|NCT02138292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110919976|NCT02138292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110919977|NCT02138292|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110919978|NCT02138292|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110919979|NCT02138292|Protective Agents|protective agents|mesh-ancestor
110919980|NCT02138292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110919981|NCT02133612|Paclitaxel|paclitaxel|mesh-list
110919982|NCT02133612|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110919983|NCT02133612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110919984|NCT02133612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110919985|NCT02133612|Tubulin Modulators|tubulin modulators|mesh-ancestor
110919986|NCT02133612|Antimitotic Agents|antimitotic agents|mesh-ancestor
110919987|NCT02133612|Mitosis Modulators|mitosis modulators|mesh-ancestor
110919988|NCT02133612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110919989|NCT03522194|Propofol|propofol|mesh-list
110919990|NCT03522194|Sevoflurane|sevoflurane|mesh-list
110919991|NCT03522194|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110919992|NCT03522194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110919993|NCT03522194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110919994|NCT03522194|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110919995|NCT03522194|Anesthetics, General|anesthetics, general|mesh-ancestor
110919996|NCT03522194|Anesthetics|anesthetics|mesh-ancestor
110919997|NCT03522194|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110919998|NCT03522194|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110919999|NCT04820686|Tenofovir|tenofovir|mesh-list
110920000|NCT04820686|Entecavir|entecavir|mesh-list
110920001|NCT04820686|Antiviral Agents|antiviral agents|mesh-ancestor
110920002|NCT04820686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110920003|NCT04820686|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110920004|NCT04820686|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110920005|NCT04820686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110920006|NCT04820686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110245863|NCT00474019|Esomeprazole|esomeprazole|mesh-list
110920007|NCT04820686|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110920008|NCT04820686|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110920010|NCT02260908|Anticoagulants|anticoagulants|mesh-ancestor
110920011|NCT02260908|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110920012|NCT02260908|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110920013|NCT02260908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110920014|NCT02969655|Darbepoetin alfa|darbepoetin alfa|mesh-list
110920015|NCT02969655|Glycine|glycine|mesh-list
110920016|NCT02969655|Hematinics|hematinics|mesh-ancestor
110920017|NCT02969655|Glycine Agents|glycine agents|mesh-ancestor
110920018|NCT02969655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110920019|NCT02969655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110920020|NCT02969655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110920021|NCT04488874|Mannitol|mannitol|mesh-list
110920022|NCT04488874|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110920024|NCT04488874|Natriuretic Agents|natriuretic agents|mesh-ancestor
110920025|NCT04488874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110920026|NCT03651219|Irinotecan|irinotecan|mesh-list
110920027|NCT03651219|Apatinib|apatinib|mesh-list
110920028|NCT03651219|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110920029|NCT03651219|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110920030|NCT03651219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110920031|NCT03651219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110920032|NCT03651219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110920033|NCT03651219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110920034|NCT02648698|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110920035|NCT02648698|Levofloxacin|levofloxacin|mesh-list
110920036|NCT02648698|Tinidazole|tinidazole|mesh-list
110920037|NCT02648698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110920038|NCT02648698|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110920039|NCT02648698|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110920040|NCT02648698|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110920041|NCT02648698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110920042|NCT02648698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110920043|NCT02648698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110920044|NCT02648698|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110920045|NCT02648698|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110920046|NCT02648698|Alkylating Agents|alkylating agents|mesh-ancestor
110920047|NCT02648698|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
110920048|NCT02648698|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110920049|NCT02648698|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110920050|NCT04059458|Calcium, Dietary|calcium, dietary|mesh-list
110920051|NCT04059458|Calcium|calcium|mesh-list
110920052|NCT04059458|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110920053|NCT04059458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110920054|NCT04059458|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110246038|NCT00117377|Analgesics|analgesics|mesh-ancestor
110920055|NCT05304598|Dexmedetomidine|dexmedetomidine|mesh-list
110920056|NCT05304598|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110920057|NCT05304598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110920058|NCT05304598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110920059|NCT05304598|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110920061|NCT05304598|Sensory System Agents|sensory system agents|mesh-ancestor
110920062|NCT05304598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110920063|NCT05304598|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110920064|NCT05304598|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110920065|NCT05304598|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110246099|NCT00475813|Xhance|xhance|mesh-list
110920066|NCT05304598|Adrenergic Agents|adrenergic agents|mesh-ancestor
110920067|NCT05304598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110920068|NCT05304598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110920069|NCT03524846|Vitamins|vitamins|mesh-list
110920070|NCT03524846|Ascorbic Acid|ascorbic acid|mesh-list
110920071|NCT03524846|Micronutrients|micronutrients|mesh-ancestor
110920072|NCT03524846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110920073|NCT03524846|Antioxidants|antioxidants|mesh-ancestor
110920074|NCT03524846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110920075|NCT03524846|Protective Agents|protective agents|mesh-ancestor
110920077|NCT05134558|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110920078|NCT05134558|Anesthetics, General|anesthetics, general|mesh-ancestor
110920079|NCT05134558|Anesthetics|anesthetics|mesh-ancestor
110920080|NCT05134558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110920081|NCT05134558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110920082|NCT02970669|Valsartan|valsartan|mesh-list
110920083|NCT02970669|Enalapril|enalapril|mesh-list
110920084|NCT02970669|Enalaprilat|enalaprilat|mesh-list
110920085|NCT02970669|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
110920086|NCT02970669|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110920087|NCT02970669|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110920088|NCT02970669|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110920089|NCT02970669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110920090|NCT02970669|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110920091|NCT02970669|Protease Inhibitors|protease inhibitors|mesh-ancestor
110920092|NCT02970669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110920094|NCT02134002|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110920095|NCT02134002|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
110920096|NCT02134002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110920097|NCT02134002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110920098|NCT03650361|Adapalene|adapalene|mesh-list
110920099|NCT03650361|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110920100|NCT03650361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110920101|NCT03650361|Analgesics|analgesics|mesh-ancestor
110920102|NCT03650361|Sensory System Agents|sensory system agents|mesh-ancestor
110920103|NCT03650361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110920104|NCT03650361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110920105|NCT03650361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110920106|NCT03650361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110920107|NCT03650361|Dermatologic Agents|dermatologic agents|mesh-ancestor
110920108|NCT02138994|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110920109|NCT02138994|Bacitracin zinc, neomycin sulfate, polymyxin B, drug combination|bacitracin zinc, neomycin sulfate, polymyxin b, drug combination|mesh-list
110920110|NCT02138994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110920111|NCT02138994|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110920112|NCT05303818|Rivaroxaban|rivaroxaban|mesh-list
110920113|NCT05303818|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110920114|NCT05303818|Antithrombins|antithrombins|mesh-ancestor
110920115|NCT05303818|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110920116|NCT05303818|Protease Inhibitors|protease inhibitors|mesh-ancestor
110920117|NCT05303818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110920118|NCT05303818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110920119|NCT05303818|Anticoagulants|anticoagulants|mesh-ancestor
110920120|NCT02902965|Dexamethasone|dexamethasone|mesh-list
110920121|NCT02902965|Bortezomib|bortezomib|mesh-list
110920122|NCT02902965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110920123|NCT02902965|Antiemetics|antiemetics|mesh-ancestor
110920124|NCT02902965|Autonomic Agents|autonomic agents|mesh-ancestor
110920125|NCT02902965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110920126|NCT02902965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110920127|NCT02902965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110920128|NCT02902965|Glucocorticoids|glucocorticoids|mesh-ancestor
110920129|NCT02902965|Hormones|hormones|mesh-ancestor
110920130|NCT02902965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110920131|NCT02902965|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110920133|NCT02130414|Cyclosporine|cyclosporine|mesh-list
110920134|NCT02130414|Cyclosporins|cyclosporins|mesh-list
110920135|NCT02130414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110920136|NCT02130414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110920137|NCT02130414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110920138|NCT02130414|Immunologic Factors|immunologic factors|mesh-ancestor
110246397|NCT00477061|Morphine|morphine|mesh-list
110920139|NCT02130414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110920140|NCT02130414|Antifungal Agents|antifungal agents|mesh-ancestor
110920141|NCT02130414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110920142|NCT02130414|Dermatologic Agents|dermatologic agents|mesh-ancestor
110920143|NCT02130414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110920144|NCT02130414|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110920145|NCT02902809|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110920146|NCT02902809|Immunologic Factors|immunologic factors|mesh-ancestor
110920147|NCT02902809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110920148|NCT02134470|Testosterone|testosterone|mesh-list
110920149|NCT02134470|Androgens|androgens|mesh-ancestor
110920150|NCT02134470|Hormones|hormones|mesh-ancestor
110920151|NCT02134470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110920152|NCT02134470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110920153|NCT02134626|Simvastatin|simvastatin|mesh-list
110920154|NCT02134626|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110920155|NCT02134626|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110920156|NCT02134626|Antimetabolites|antimetabolites|mesh-ancestor
110920157|NCT02134626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110920159|NCT02134626|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110920160|NCT02134626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110920161|NCT02969187|Bupivacaine|bupivacaine|mesh-list
110920162|NCT02969187|Anesthetics, Local|anesthetics, local|mesh-ancestor
110920163|NCT02969187|Anesthetics|anesthetics|mesh-ancestor
110920164|NCT02969187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110920165|NCT02969187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110920166|NCT02969187|Sensory System Agents|sensory system agents|mesh-ancestor
110920167|NCT02969187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110920168|NCT02139618|Aminolevulinic Acid|aminolevulinic acid|mesh-list
110920169|NCT02139618|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
110920170|NCT02139618|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110920171|NCT02139618|Dermatologic Agents|dermatologic agents|mesh-ancestor
110920172|NCT05285085|Atorvastatin|atorvastatin|mesh-list
110920173|NCT05285085|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110920174|NCT05285085|Simvastatin|simvastatin|mesh-list
110920175|NCT05285085|Pravastatin|pravastatin|mesh-list
110920176|NCT05285085|Pitavastatin|pitavastatin|mesh-list
110920177|NCT05285085|Lovastatin|lovastatin|mesh-list
110920178|NCT05285085|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110920179|NCT05285085|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110920180|NCT05285085|Antimetabolites|antimetabolites|mesh-ancestor
110920181|NCT05285085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110920182|NCT05285085|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110246640|NCT00119249|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110920183|NCT05285085|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110920184|NCT05285085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110920185|NCT02139930|Nicotine|nicotine|mesh-list
110920186|NCT02139930|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110920187|NCT02139930|Autonomic Agents|autonomic agents|mesh-ancestor
110920188|NCT02139930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110920189|NCT02139930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110920190|NCT02139930|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110246714|NCT00480298|Hormones|hormones|mesh-ancestor
110920191|NCT02139930|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110920192|NCT02139930|Cholinergic Agents|cholinergic agents|mesh-ancestor
110920193|NCT02139930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110920194|NCT02139930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110920195|NCT02130804|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
110920196|NCT02130804|Salicylates|salicylates|mesh-list
110920197|NCT02130804|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110920198|NCT02130804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110246789|NCT00480844|Risperidone|risperidone|mesh-list
110920199|NCT02130804|Analgesics|analgesics|mesh-ancestor
110920200|NCT02130804|Sensory System Agents|sensory system agents|mesh-ancestor
110920201|NCT02130804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110920202|NCT02130804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110920203|NCT02130804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110920204|NCT02130804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110920205|NCT02130804|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110920206|NCT02130804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110920207|NCT02130804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110920208|NCT05303272|Mycophenolic Acid|mycophenolic acid|mesh-list
110920209|NCT05303272|Abatacept|abatacept|mesh-list
110920210|NCT05303272|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110920211|NCT05303272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110920212|NCT05303272|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110920213|NCT05303272|Antitubercular Agents|antitubercular agents|mesh-ancestor
110920214|NCT05303272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110920215|NCT05303272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110920216|NCT05303272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110920217|NCT05303272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110920218|NCT05303272|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110920219|NCT05303272|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110920220|NCT05303272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110920221|NCT05303272|Immunologic Factors|immunologic factors|mesh-ancestor
110920222|NCT05303272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110920223|NCT05303272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110920224|NCT03549312|Tenofovir|tenofovir|mesh-list
110920225|NCT03549312|Emtricitabine|emtricitabine|mesh-list
110920226|NCT03549312|Sofosbuvir|sofosbuvir|mesh-list
110920227|NCT03549312|Cobicistat|cobicistat|mesh-list
110920228|NCT03549312|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
110920230|NCT03549312|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
110920231|NCT03549312|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110920232|NCT03549312|Elvitegravir|elvitegravir|mesh-list
110920233|NCT03549312|Antiviral Agents|antiviral agents|mesh-ancestor
110920234|NCT03549312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110920235|NCT03549312|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110920236|NCT03549312|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110920237|NCT03549312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110920238|NCT03549312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110920239|NCT03549312|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110920240|NCT03549312|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110920241|NCT03549312|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110920242|NCT03549312|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110920243|NCT03549312|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110920244|NCT03649269|Bezafibrate|bezafibrate|mesh-list
110920245|NCT03649269|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110920246|NCT03649269|Antimetabolites|antimetabolites|mesh-ancestor
110920247|NCT03649269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110920248|NCT03649269|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110246957|NCT00481819|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110920249|NCT02134938|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
110920250|NCT02134938|Cathartics|cathartics|mesh-ancestor
110920251|NCT02134938|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110920252|NCT05373446|Ritonavir|ritonavir|mesh-list
110920253|NCT05373446|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110920254|NCT05373446|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110920255|NCT05373446|Protease Inhibitors|protease inhibitors|mesh-ancestor
110920256|NCT05373446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110920257|NCT05373446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110920258|NCT05373446|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110920259|NCT05373446|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110920260|NCT05373446|Antiviral Agents|antiviral agents|mesh-ancestor
110920261|NCT05373446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110920262|NCT05373446|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110920263|NCT05373446|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110920264|NCT04734028|Clopidogrel|clopidogrel|mesh-list
110920265|NCT04734028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110920266|NCT04734028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110920267|NCT04734028|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110920268|NCT04734028|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110920269|NCT04734028|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110920270|NCT04734028|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110920271|NCT04734028|Purinergic Agents|purinergic agents|mesh-ancestor
110920272|NCT04734028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110920273|NCT05285397|Liraglutide|liraglutide|mesh-list
110247075|NCT00482716|Hematinics|hematinics|mesh-ancestor
110920275|NCT05285397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110920276|NCT05285397|Incretins|incretins|mesh-ancestor
110920277|NCT05285397|Hormones|hormones|mesh-ancestor
110920278|NCT05285397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110920279|NCT03050359|Lansoprazole|lansoprazole|mesh-list
110920280|NCT03050359|Dexlansoprazole|dexlansoprazole|mesh-list
110920281|NCT03050359|Bismuth|bismuth|mesh-list
110920282|NCT03050359|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110920283|NCT03050359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110920284|NCT03050359|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110920285|NCT03050359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110920286|NCT03050359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110920287|NCT03050359|Antacids|antacids|mesh-ancestor
110920288|NCT05302726|Estrogens|estrogens|mesh-list
110920289|NCT05302726|Hormones|hormones|mesh-ancestor
110920290|NCT05302726|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110920291|NCT05302726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110920292|NCT02253264|Rituximab|rituximab|mesh-list
110920293|NCT02253264|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110920294|NCT02253264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110920295|NCT02253264|Immunologic Factors|immunologic factors|mesh-ancestor
110920296|NCT02253264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110920297|NCT02253264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110920299|NCT03648333|Amlodipine|amlodipine|mesh-list
110920300|NCT03648333|Valsartan|valsartan|mesh-list
110920301|NCT03648333|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
110920302|NCT03648333|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110177774|NCT00404404|Paclitaxel|paclitaxel|mesh-list
110920303|NCT03648333|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110920304|NCT03648333|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110920305|NCT03648333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110920306|NCT03648333|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110920307|NCT03648333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110920308|NCT03648333|Vasodilator Agents|vasodilator agents|mesh-ancestor
110920309|NCT03648333|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110920310|NCT03648333|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110920311|NCT03648333|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110920312|NCT03648333|Antimetabolites|antimetabolites|mesh-ancestor
110920313|NCT03648333|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110920314|NCT03648333|Vitamin B Complex|vitamin b complex|mesh-ancestor
110920316|NCT03648333|Micronutrients|micronutrients|mesh-ancestor
110920317|NCT02252796|Paclitaxel|paclitaxel|mesh-list
110920318|NCT02252796|Carboplatin|carboplatin|mesh-list
110920319|NCT02252796|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110920321|NCT02252796|Tubulin Modulators|tubulin modulators|mesh-ancestor
110920322|NCT02252796|Antimitotic Agents|antimitotic agents|mesh-ancestor
110920323|NCT02252796|Mitosis Modulators|mitosis modulators|mesh-ancestor
110920324|NCT02252796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110920325|NCT02785770|Moxifloxacin|moxifloxacin|mesh-list
110920326|NCT02785770|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110920327|NCT02785770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110920328|NCT02785770|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110920329|NCT02785770|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110920330|NCT02785770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110920331|NCT02785770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110920332|NCT02785770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110920333|NCT04166474|Dolutegravir|dolutegravir|mesh-list
110920334|NCT04166474|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110920335|NCT04166474|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110920337|NCT04166474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110920338|NCT04166474|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110920339|NCT04166474|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110920340|NCT04166474|Antiviral Agents|antiviral agents|mesh-ancestor
110920341|NCT04166474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110920342|NCT04660123|Bismuth|bismuth|mesh-list
110920343|NCT04660123|Antacids|antacids|mesh-ancestor
110920344|NCT04660123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110920345|NCT04660123|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110920346|NCT04530136|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
110920347|NCT04530136|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
110920348|NCT04530136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110247602|NCT00486421|Prednisone|prednisone|mesh-list
110920349|NCT04530136|Immunologic Factors|immunologic factors|mesh-ancestor
110920350|NCT04530136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110920351|NCT02965833|Hydrogen Peroxide|hydrogen peroxide|mesh-list
110920352|NCT02965833|Contact Lens Solutions|contact lens solutions|mesh-list
110920353|NCT02965833|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110920354|NCT02965833|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110920355|NCT02965833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110920356|NCT02965833|Disinfectants|disinfectants|mesh-ancestor
110920358|NCT05579418|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
110920359|NCT05579418|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110920360|NCT05579418|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110920361|NCT05579418|Antimetabolites|antimetabolites|mesh-ancestor
110928942|NCT03066466|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110920362|NCT05579418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110920363|NCT05579418|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110920364|NCT05579418|Protease Inhibitors|protease inhibitors|mesh-ancestor
110920365|NCT05579418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110920366|NCT05579418|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110920367|NCT02968173|Palivizumab|palivizumab|mesh-list
110920368|NCT02968173|Antiviral Agents|antiviral agents|mesh-ancestor
110920369|NCT02968173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110920370|NCT02135640|Denosumab|denosumab|mesh-list
110920371|NCT02135640|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110920372|NCT02135640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110920373|NCT02784834|Dimethyl Fumarate|dimethyl fumarate|mesh-list
110920374|NCT02784834|Dermatologic Agents|dermatologic agents|mesh-ancestor
110920375|NCT02784834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110920376|NCT02784834|Immunologic Factors|immunologic factors|mesh-ancestor
110920377|NCT02784834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110920378|NCT02253342|Levonadifloxacin|levonadifloxacin|mesh-list
110920379|NCT02253342|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110920380|NCT02253342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110920381|NCT02253342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110920382|NCT02253342|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110920383|NCT02253342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110920385|NCT00495508|Artemether|artemether|mesh-list
110920386|NCT00495508|Quinine|quinine|mesh-list
110920387|NCT00495508|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
110920388|NCT00495508|Antimalarials|antimalarials|mesh-ancestor
110920389|NCT00495508|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110920390|NCT00495508|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110920391|NCT00495508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110920392|NCT00495508|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110920393|NCT00495508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110920394|NCT00495508|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110920395|NCT00495508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110920396|NCT00495508|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110920397|NCT00495508|Analgesics|analgesics|mesh-ancestor
110920398|NCT00495508|Sensory System Agents|sensory system agents|mesh-ancestor
110920399|NCT01554046|Methylphenidate|methylphenidate|mesh-list
110920400|NCT01554046|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110920401|NCT01554046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110920402|NCT01554046|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110920403|NCT01554046|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110920404|NCT01554046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110247910|NCT01242826|Insulin Aspart|insulin aspart|mesh-list
110920405|NCT01554046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110920406|NCT01554046|Dopamine Agents|dopamine agents|mesh-ancestor
110920407|NCT01554046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110920408|NCT05284851|Vaccines|vaccines|mesh-list
110920409|NCT05284851|Immunologic Factors|immunologic factors|mesh-ancestor
110920410|NCT05284851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110920411|NCT03049735|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110920412|NCT03049735|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110920413|NCT03049735|Norethindrone|norethindrone|mesh-list
110920414|NCT03049735|Norethindrone Acetate|norethindrone acetate|mesh-list
110920415|NCT03049735|Estradiol|estradiol|mesh-list
110920416|NCT03049735|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110920417|NCT03049735|Relugolix|relugolix|mesh-list
110920418|NCT03049735|Estrogens|estrogens|mesh-ancestor
110920419|NCT03049735|Hormones|hormones|mesh-ancestor
110920420|NCT03049735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110920421|NCT03049735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110920422|NCT03049735|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110920423|NCT03049735|Contraceptive Agents|contraceptive agents|mesh-ancestor
110920424|NCT03049735|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110920425|NCT03049735|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110920426|NCT03049735|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110920428|NCT03049735|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110920429|NCT03049735|Androgen Antagonists|androgen antagonists|mesh-ancestor
110920430|NCT03049735|Hormone Antagonists|hormone antagonists|mesh-ancestor
110920431|NCT04785638|Bupivacaine|bupivacaine|mesh-list
110920432|NCT04785638|Anesthetics, Local|anesthetics, local|mesh-ancestor
110920433|NCT04785638|Anesthetics|anesthetics|mesh-ancestor
110920434|NCT04785638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110920435|NCT04785638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110920436|NCT04785638|Sensory System Agents|sensory system agents|mesh-ancestor
110920437|NCT04785638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110920438|NCT04762472|Montelukast|montelukast|mesh-list
110920439|NCT04762472|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110920440|NCT04762472|Respiratory System Agents|respiratory system agents|mesh-ancestor
110920441|NCT04762472|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110920442|NCT04762472|Hormone Antagonists|hormone antagonists|mesh-ancestor
110920443|NCT04762472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110920444|NCT04762472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110920445|NCT04762472|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110920446|NCT04762472|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110920447|NCT04762472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110920448|NCT01295944|Bevacizumab|bevacizumab|mesh-list
110920449|NCT01295944|Carboplatin|carboplatin|mesh-list
110920450|NCT01295944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110920451|NCT01295944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110920452|NCT01295944|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110920453|NCT01295944|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110920454|NCT01295944|Growth Substances|growth substances|mesh-ancestor
110920455|NCT01295944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110920456|NCT01295944|Growth Inhibitors|growth inhibitors|mesh-ancestor
110637955|NCT05407233|Insulin|insulin|mesh-list
110920457|NCT04742348|Levodopa|levodopa|mesh-list
110920458|NCT04742348|Carbidopa|carbidopa|mesh-list
110920459|NCT04742348|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
110920460|NCT04742348|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110920461|NCT04742348|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110920462|NCT04742348|Dopamine Agents|dopamine agents|mesh-ancestor
110920463|NCT04742348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110248224|NCT00492466|Methylprednisolone|methylprednisolone|mesh-list
110920464|NCT04742348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110920465|NCT04742348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110920466|NCT04742348|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
110920468|NCT04742348|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110920469|NCT04742348|Immunologic Factors|immunologic factors|mesh-ancestor
110920470|NCT04742348|Dopamine Agonists|dopamine agonists|mesh-ancestor
110920471|NCT02140632|Methylprednisolone|methylprednisolone|mesh-list
110920472|NCT02140632|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110920473|NCT02140632|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110248290|NCT04760730|Vaccines|vaccines|mesh-list
110920474|NCT02140632|Prednisolone|prednisolone|mesh-list
110920475|NCT02140632|Prednisolone acetate|prednisolone acetate|mesh-list
110920476|NCT02140632|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110920477|NCT02140632|Prednisolone phosphate|prednisolone phosphate|mesh-list
110920478|NCT02140632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110920479|NCT02140632|Antiemetics|antiemetics|mesh-ancestor
110920480|NCT02140632|Autonomic Agents|autonomic agents|mesh-ancestor
110920481|NCT02140632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110920482|NCT02140632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110920483|NCT02140632|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110920484|NCT02140632|Glucocorticoids|glucocorticoids|mesh-ancestor
110920485|NCT02140632|Hormones|hormones|mesh-ancestor
110920486|NCT02140632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110920487|NCT02140632|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110920488|NCT02140632|Protective Agents|protective agents|mesh-ancestor
110920489|NCT02140632|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110920490|NCT02140632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110920491|NCT05578404|Cholecalciferol|cholecalciferol|mesh-list
110920492|NCT05578404|Vitamin D|vitamin d|mesh-list
110920493|NCT05578404|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110920494|NCT05578404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110920495|NCT05578404|Vitamins|vitamins|mesh-ancestor
110920496|NCT05578404|Micronutrients|micronutrients|mesh-ancestor
110920497|NCT05578404|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110920498|NCT04848584|Vaccines|vaccines|mesh-list
110920499|NCT04848584|Immunologic Factors|immunologic factors|mesh-ancestor
110920500|NCT04848584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110920501|NCT03521960|Buspirone|buspirone|mesh-list
110920502|NCT03521960|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110920503|NCT03521960|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110920504|NCT03521960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110920505|NCT03521960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110920506|NCT03521960|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110920507|NCT03521960|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110920508|NCT03521960|Serotonin Agents|serotonin agents|mesh-ancestor
110920509|NCT03521960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110920510|NCT03521960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110920512|NCT05479578|Dexamethasone acetate|dexamethasone acetate|mesh-list
110920513|NCT05479578|Cyclophosphamide|cyclophosphamide|mesh-list
110920514|NCT05479578|Ichthammol|ichthammol|mesh-list
110920515|NCT05479578|BB 1101|bb 1101|mesh-list
110920516|NCT05479578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110920517|NCT05479578|Immunologic Factors|immunologic factors|mesh-ancestor
110920518|NCT05479578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110248471|NCT00405366|Sorafenib|sorafenib|mesh-list
110920519|NCT05479578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110920520|NCT05479578|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110920521|NCT05479578|Alkylating Agents|alkylating agents|mesh-ancestor
110920522|NCT05479578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110920523|NCT05479578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110920524|NCT05479578|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110920525|NCT05479578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110920526|NCT05479578|Antiemetics|antiemetics|mesh-ancestor
110920527|NCT05479578|Autonomic Agents|autonomic agents|mesh-ancestor
110920528|NCT05479578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110920529|NCT05479578|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110920530|NCT05479578|Glucocorticoids|glucocorticoids|mesh-ancestor
110920531|NCT05479578|Hormones|hormones|mesh-ancestor
110920532|NCT05479578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110920533|NCT05479578|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110920534|NCT05479578|Protease Inhibitors|protease inhibitors|mesh-ancestor
110920535|NCT05479578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110920536|NCT05479578|Dermatologic Agents|dermatologic agents|mesh-ancestor
110920537|NCT02899377|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
110920538|NCT02899377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110920539|NCT02899377|Chelating Agents|chelating agents|mesh-ancestor
110920540|NCT02899377|Sequestering Agents|sequestering agents|mesh-ancestor
110928980|NCT02162550|Incretins|incretins|mesh-ancestor
110920541|NCT05363462|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110920542|NCT05363462|Vancomycin|vancomycin|mesh-list
110920543|NCT05363462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110920544|NCT04853628|Ethanol|ethanol|mesh-list
110920545|NCT04853628|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110920546|NCT04853628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110920547|NCT04853628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110920548|NCT04853628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110920549|NCT03521726|Amoxicillin|amoxicillin|mesh-list
110920550|NCT03521726|Rabeprazole|rabeprazole|mesh-list
110248655|NCT00405405|Cisplatin|cisplatin|mesh-list
110920551|NCT03521726|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110920552|NCT03521726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110920553|NCT03521726|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110920554|NCT03521726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110920555|NCT03521726|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110920556|NCT03521726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110920557|NCT03521726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110920558|NCT03546426|Pembrolizumab|pembrolizumab|mesh-list
110920559|NCT03546426|Interleukin-2|interleukin-2|mesh-list
110920560|NCT03546426|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110920561|NCT03546426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110920562|NCT03546426|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110920563|NCT03546426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110920564|NCT03546426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110920565|NCT03546426|Analgesics|analgesics|mesh-ancestor
110920566|NCT03546426|Sensory System Agents|sensory system agents|mesh-ancestor
110920567|NCT03546426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110920568|NCT03546426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110920569|NCT02897349|Linagliptin|linagliptin|mesh-list
110920570|NCT02897349|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110920571|NCT02897349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110920572|NCT02897349|Incretins|incretins|mesh-ancestor
110920573|NCT02897349|Hormones|hormones|mesh-ancestor
110920574|NCT02897349|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110920575|NCT02897349|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110920576|NCT02897349|Protease Inhibitors|protease inhibitors|mesh-ancestor
110920577|NCT02897349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110920578|NCT02897349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110920579|NCT03134378|Amoxicillin|amoxicillin|mesh-list
110920580|NCT03134378|Clarithromycin|clarithromycin|mesh-list
110920581|NCT03134378|Rabeprazole|rabeprazole|mesh-list
110920582|NCT03134378|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110920583|NCT03134378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110920584|NCT03134378|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110920585|NCT03134378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110920586|NCT03134378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110920587|NCT03134378|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110920588|NCT03134378|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110920589|NCT03134378|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110920590|NCT03134378|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110920591|NCT03134378|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110920592|NCT05434104|Metronidazole|metronidazole|mesh-list
110920593|NCT05434104|Fluconazole|fluconazole|mesh-list
110920594|NCT05434104|Lactoferrin|lactoferrin|mesh-list
110920595|NCT05434104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110920596|NCT05434104|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110920597|NCT05434104|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110920598|NCT05434104|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110920599|NCT05434104|Antifungal Agents|antifungal agents|mesh-ancestor
110920600|NCT05434104|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110928989|NCT02852265|Contraceptive Agents|contraceptive agents|mesh-list
110920601|NCT05434104|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110920602|NCT05434104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110920603|NCT05434104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110920604|NCT05434104|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110920605|NCT05434104|Hormone Antagonists|hormone antagonists|mesh-ancestor
110920606|NCT05434104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110920607|NCT05434104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110920608|NCT05434104|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110920609|NCT05434104|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110920610|NCT00488072|Mirtazapine|mirtazapine|mesh-list
110920611|NCT00488072|Antidepressive Agents|antidepressive agents|mesh-ancestor
110920612|NCT00488072|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110248907|NCT00127907|Mydriatics|mydriatics|mesh-ancestor
110920613|NCT00488072|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110920614|NCT00488072|Histamine Antagonists|histamine antagonists|mesh-ancestor
110920615|NCT00488072|Histamine Agents|histamine agents|mesh-ancestor
110920616|NCT00488072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110920617|NCT00488072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110920618|NCT00488072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110920619|NCT00488072|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110920620|NCT00488072|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110920621|NCT00488072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110920622|NCT00488072|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
110920623|NCT00488072|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110920624|NCT00488072|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110920625|NCT00488072|Adrenergic Agents|adrenergic agents|mesh-ancestor
110920626|NCT00488072|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110920627|NCT00488072|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110920628|NCT00488072|Serotonin Agents|serotonin agents|mesh-ancestor
110920629|NCT00488072|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110920630|NCT03525704|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110920631|NCT03523832|Celecoxib|celecoxib|mesh-list
110920632|NCT03523832|Pregabalin|pregabalin|mesh-list
110920633|NCT03523832|Analgesics|analgesics|mesh-ancestor
110920634|NCT03523832|Sensory System Agents|sensory system agents|mesh-ancestor
110365207|NCT00540956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110920635|NCT03523832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110920636|NCT03523832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110920637|NCT03523832|Anticonvulsants|anticonvulsants|mesh-ancestor
110920638|NCT03523832|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110920639|NCT03523832|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110920640|NCT03523832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110920641|NCT03523832|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110920642|NCT03523832|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110920643|NCT03523832|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110249090|NCT01245244|Analgesics|analgesics|mesh-ancestor
110920644|NCT03523832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110920645|NCT03523832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110920646|NCT03523832|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110920647|NCT03523832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110920648|NCT03523832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110920649|NCT03523832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110920650|NCT03523832|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110920651|NCT03523832|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110920652|NCT03523832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110920653|NCT05577624|Rifampin|rifampin|mesh-list
110920654|NCT05577624|Sotorasib|sotorasib|mesh-list
110920655|NCT05577624|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110920656|NCT05577624|Antitubercular Agents|antitubercular agents|mesh-ancestor
110920657|NCT05577624|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110920658|NCT05577624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110920659|NCT05577624|Leprostatic Agents|leprostatic agents|mesh-ancestor
110920660|NCT05577624|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110920661|NCT05577624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110920662|NCT05577624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110920663|NCT05577624|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110920664|NCT05577624|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110920665|NCT05577624|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110249216|NCT00499525|Paclitaxel|paclitaxel|mesh-list
110920666|NCT05577624|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110920667|NCT05577624|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110920668|NCT05577624|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110920669|NCT05577624|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110920670|NCT05577624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110920671|NCT05577624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110920672|NCT03294694|Fulvestrant|fulvestrant|mesh-list
110920673|NCT03294694|Spartalizumab|spartalizumab|mesh-list
110920674|NCT03294694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110920675|NCT03294694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110920676|NCT03294694|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110920677|NCT03294694|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110920678|NCT03294694|Hormone Antagonists|hormone antagonists|mesh-ancestor
110920679|NCT03294694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110920680|NCT03294694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110920681|NCT03294694|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110920682|NCT03294694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110920683|NCT03294694|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110920684|NCT03523754|Isosorbide|isosorbide|mesh-list
110920685|NCT03523754|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
110920686|NCT03523754|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
110920687|NCT03523754|Misoprostol|misoprostol|mesh-list
110920688|NCT03523754|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110920689|NCT03523754|Abortifacient Agents|abortifacient agents|mesh-ancestor
110920690|NCT03523754|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110920691|NCT03523754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110920692|NCT03523754|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110920693|NCT03523754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110920694|NCT03523754|Oxytocics|oxytocics|mesh-ancestor
110920695|NCT03523754|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110920696|NCT03523754|Diuretics|diuretics|mesh-ancestor
110920697|NCT03523754|Natriuretic Agents|natriuretic agents|mesh-ancestor
110920698|NCT03523754|Vasodilator Agents|vasodilator agents|mesh-ancestor
110920699|NCT03523754|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
110920700|NCT03523754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110920701|NCT04727034|Propofol|propofol|mesh-list
110920702|NCT04727034|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110920703|NCT04727034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110920704|NCT04727034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110920705|NCT04727034|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110920706|NCT04727034|Anesthetics, General|anesthetics, general|mesh-ancestor
110920707|NCT04727034|Anesthetics|anesthetics|mesh-ancestor
110920708|NCT03644511|Sorafenib|sorafenib|mesh-list
110249407|NCT00147186|Hylan|hylan|mesh-list
110920709|NCT03644511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110920710|NCT03644511|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110920711|NCT03644511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110920712|NCT03644511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110920713|NCT03290560|Kallikreins|kallikreins|mesh-list
110920714|NCT03290560|Coagulants|coagulants|mesh-ancestor
110920715|NCT03290560|Fertility Agents, Male|fertility agents, male|mesh-ancestor
110920716|NCT03290560|Fertility Agents|fertility agents|mesh-ancestor
110920717|NCT03290560|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110920718|NCT03290560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110920719|NCT01316419|Amlodipine|amlodipine|mesh-list
110920721|NCT01316419|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110920722|NCT01316419|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110920723|NCT01316419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110920724|NCT01316419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110920725|NCT01316419|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110920726|NCT01316419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110920727|NCT01316419|Vasodilator Agents|vasodilator agents|mesh-ancestor
110920728|NCT01316419|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110920729|NCT01316419|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110920731|NCT03547362|Chelating Agents|chelating agents|mesh-ancestor
110920732|NCT03547362|Sequestering Agents|sequestering agents|mesh-ancestor
110249521|NCT00502567|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110920733|NCT03547362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110920734|NCT04258150|Nivolumab|nivolumab|mesh-list
110920735|NCT04258150|Ipilimumab|ipilimumab|mesh-list
110920736|NCT04258150|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110920737|NCT04258150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110920738|NCT04258150|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110920739|NCT04258150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110920740|NCT02854696|Insulin|insulin|mesh-list
110920741|NCT02854696|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110920742|NCT02854696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110920743|NCT02289248|Ketamine|ketamine|mesh-list
110920744|NCT02289248|Analgesics|analgesics|mesh-ancestor
110920745|NCT02289248|Sensory System Agents|sensory system agents|mesh-ancestor
110920746|NCT02289248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110920747|NCT02289248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110920748|NCT02289248|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110249726|NCT01247077|Selenium|selenium|mesh-list
110920749|NCT02289248|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110920750|NCT02289248|Anesthetics, General|anesthetics, general|mesh-ancestor
110920751|NCT02289248|Anesthetics|anesthetics|mesh-ancestor
110920752|NCT02289248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110920753|NCT02289248|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110365230|NCT00541112|Cetuximab|cetuximab|mesh-list
110920754|NCT02289248|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110920755|NCT02289248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110920756|NCT02289248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110920757|NCT02782468|Azacitidine|azacitidine|mesh-list
110920758|NCT02782468|Pevonedistat|pevonedistat|mesh-list
110920759|NCT02782468|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110920760|NCT02782468|Antimetabolites|antimetabolites|mesh-ancestor
110920761|NCT02782468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110920762|NCT02782468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110920763|NCT02782468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110920764|NCT02253420|Itraconazole|itraconazole|mesh-list
110920766|NCT02253420|Antifungal Agents|antifungal agents|mesh-ancestor
110920767|NCT02253420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110920768|NCT02253420|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110920769|NCT02253420|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110920770|NCT02253420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110920771|NCT02253420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110249863|NCT00504127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110920772|NCT02253420|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110920773|NCT02253420|Hormone Antagonists|hormone antagonists|mesh-ancestor
110920774|NCT02253420|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110920775|NCT02253420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110920776|NCT02253420|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110920777|NCT02253420|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110920778|NCT02253420|Antitubercular Agents|antitubercular agents|mesh-ancestor
110920779|NCT02253420|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110920780|NCT02253420|Leprostatic Agents|leprostatic agents|mesh-ancestor
110920781|NCT02253420|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110920782|NCT02253420|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110920783|NCT02253420|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110920784|NCT02253420|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110920785|NCT02253420|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110920786|NCT02253420|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110920787|NCT02253420|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110920788|NCT02028364|Everolimus|everolimus|mesh-list
110920789|NCT02028364|Exemestane|exemestane|mesh-list
110920790|NCT02028364|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110920791|NCT02028364|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110920792|NCT02028364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110920793|NCT02028364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110920794|NCT02028364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110920795|NCT02028364|Immunologic Factors|immunologic factors|mesh-ancestor
110920796|NCT02028364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110920797|NCT02028364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110920798|NCT02028364|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110920799|NCT02028364|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110920800|NCT02028364|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110920801|NCT02028364|Hormone Antagonists|hormone antagonists|mesh-ancestor
110920802|NCT02028364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110920803|NCT02897115|Adalimumab|adalimumab|mesh-list
110920804|NCT02897115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
110920805|NCT02897115|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
110920806|NCT02897115|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110920807|NCT02897115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110920808|NCT02897115|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110920809|NCT02897115|Analgesics|analgesics|mesh-ancestor
110920810|NCT02897115|Sensory System Agents|sensory system agents|mesh-ancestor
110920811|NCT02897115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110920812|NCT02897115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110920813|NCT02289482|Ritonavir|ritonavir|mesh-list
110920814|NCT02289482|GSK-2838232|gsk-2838232|mesh-list
110920815|NCT02289482|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110920816|NCT02289482|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110920817|NCT02289482|Protease Inhibitors|protease inhibitors|mesh-ancestor
110920818|NCT02289482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110920819|NCT02289482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110920820|NCT02289482|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110920821|NCT02289482|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110920822|NCT02289482|Antiviral Agents|antiviral agents|mesh-ancestor
110638338|NCT00842114|Glucocorticoids|glucocorticoids|mesh-ancestor
110920823|NCT02289482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110920824|NCT02289482|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110920825|NCT02289482|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110250175|NCT00139230|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110250176|NCT00139230|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110250183|NCT00139269|Docetaxel|docetaxel|mesh-list
110250184|NCT00139269|Fluorouracil|fluorouracil|mesh-list
110250185|NCT00139269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110250186|NCT00139269|Tubulin Modulators|tubulin modulators|mesh-ancestor
110920826|NCT05277636|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
110920827|NCT05277636|Hallucinogens|hallucinogens|mesh-ancestor
110920828|NCT05277636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110920829|NCT05277636|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110920830|NCT05277636|Serotonin Agents|serotonin agents|mesh-ancestor
110920831|NCT05277636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110920832|NCT05277636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110920833|NCT05277636|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110920834|NCT05277636|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110920835|NCT05277636|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110920836|NCT05277636|Adrenergic Agents|adrenergic agents|mesh-ancestor
110250238|NCT00139386|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110920837|NCT04030195|Cyclophosphamide|cyclophosphamide|mesh-list
110920838|NCT04030195|Fludarabine|fludarabine|mesh-list
110920839|NCT04030195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110920840|NCT04030195|Immunologic Factors|immunologic factors|mesh-ancestor
110920841|NCT04030195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110920842|NCT04030195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110920843|NCT04030195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110920844|NCT04030195|Alkylating Agents|alkylating agents|mesh-ancestor
110920845|NCT04030195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110920846|NCT04030195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110920847|NCT04030195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110920848|NCT02253966|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110250301|NCT00139581|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110920849|NCT02253966|Methylprednisolone|methylprednisolone|mesh-list
110920850|NCT02253966|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110920851|NCT02253966|Prednisolone|prednisolone|mesh-list
110920852|NCT02253966|Prednisolone acetate|prednisolone acetate|mesh-list
110920853|NCT02253966|Lidocaine|lidocaine|mesh-list
110920854|NCT02253966|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110920855|NCT02253966|Prednisolone phosphate|prednisolone phosphate|mesh-list
110920856|NCT02253966|Anesthetics, Local|anesthetics, local|mesh-ancestor
110920857|NCT02253966|Anesthetics|anesthetics|mesh-ancestor
110920858|NCT02253966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110920859|NCT02253966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110920860|NCT02253966|Sensory System Agents|sensory system agents|mesh-ancestor
110920861|NCT02253966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110920862|NCT02253966|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110250359|NCT00130754|Immunologic Factors|immunologic factors|mesh-ancestor
110920863|NCT02253966|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110920864|NCT02253966|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110920865|NCT02253966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110920866|NCT02253966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110920867|NCT02253966|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110920868|NCT02253966|Antiemetics|antiemetics|mesh-ancestor
110920869|NCT02253966|Autonomic Agents|autonomic agents|mesh-ancestor
110920870|NCT02253966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110920871|NCT02253966|Glucocorticoids|glucocorticoids|mesh-ancestor
110920872|NCT02253966|Hormones|hormones|mesh-ancestor
110920873|NCT02253966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110920874|NCT02253966|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110920875|NCT02253966|Protective Agents|protective agents|mesh-ancestor
110920876|NCT02253966|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110920877|NCT02253966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110920878|NCT01673620|Loratadine|loratadine|mesh-list
110920879|NCT01673620|Montelukast|montelukast|mesh-list
110920880|NCT01673620|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110920881|NCT01673620|Respiratory System Agents|respiratory system agents|mesh-ancestor
110250489|NCT00131261|Dexamethasone|dexamethasone|mesh-list
110920882|NCT01673620|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110920883|NCT01673620|Hormone Antagonists|hormone antagonists|mesh-ancestor
110920884|NCT01673620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110920885|NCT01673620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110920886|NCT01673620|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110920887|NCT01673620|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110929063|NCT02170896|Pantoprazole|pantoprazole|mesh-list
110920888|NCT01673620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110920889|NCT01673620|Antipruritics|antipruritics|mesh-ancestor
110920890|NCT01673620|Dermatologic Agents|dermatologic agents|mesh-ancestor
110920891|NCT01673620|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110920892|NCT01673620|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110920893|NCT01673620|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110920894|NCT01673620|Histamine Antagonists|histamine antagonists|mesh-ancestor
110920895|NCT01673620|Histamine Agents|histamine agents|mesh-ancestor
110920896|NCT01673620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110920898|NCT04671355|Xhance|xhance|mesh-list
110920899|NCT04671355|Beclomethasone|beclomethasone|mesh-list
110920900|NCT04671355|Glycopyrrolate|glycopyrrolate|mesh-list
110920901|NCT04671355|Formoterol Fumarate|formoterol fumarate|mesh-list
110920902|NCT04671355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110920903|NCT04671355|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110920904|NCT04671355|Autonomic Agents|autonomic agents|mesh-ancestor
110920905|NCT04671355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110920906|NCT04671355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110920907|NCT04671355|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110920908|NCT04671355|Respiratory System Agents|respiratory system agents|mesh-ancestor
110920909|NCT04671355|Dermatologic Agents|dermatologic agents|mesh-ancestor
110920910|NCT04671355|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110920911|NCT04671355|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110920912|NCT04671355|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110920913|NCT04671355|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110920914|NCT04671355|Adrenergic Agents|adrenergic agents|mesh-ancestor
110920915|NCT04671355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110920916|NCT04671355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110920917|NCT04671355|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110920918|NCT04671355|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110920919|NCT04671355|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110920920|NCT04671355|Cholinergic Agents|cholinergic agents|mesh-ancestor
110920921|NCT04671355|Glucocorticoids|glucocorticoids|mesh-ancestor
110920922|NCT04671355|Hormones|hormones|mesh-ancestor
110920923|NCT04671355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110920924|NCT03521492|Vitamin D|vitamin d|mesh-list
110920925|NCT03521492|Calcium|calcium|mesh-list
110920926|NCT03521492|Parathyroid Hormone|parathyroid hormone|mesh-list
110920927|NCT03521492|Hormones|hormones|mesh-list
110920928|NCT03521492|Vitamins|vitamins|mesh-ancestor
110920929|NCT03521492|Micronutrients|micronutrients|mesh-ancestor
110920930|NCT03521492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110920931|NCT03521492|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110920932|NCT03521492|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110920933|NCT03521492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110920934|NCT03521414|Sevoflurane|sevoflurane|mesh-list
110920935|NCT03521414|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110920936|NCT03521414|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110920937|NCT03521414|Anesthetics, General|anesthetics, general|mesh-ancestor
110920938|NCT03521414|Anesthetics|anesthetics|mesh-ancestor
110920939|NCT03521414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110920940|NCT03521414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110920941|NCT00432094|Paclitaxel|paclitaxel|mesh-list
110920942|NCT00432094|Etoposide|etoposide|mesh-list
110920943|NCT00432094|Carboplatin|carboplatin|mesh-list
110920944|NCT00432094|Ifosfamide|ifosfamide|mesh-list
110920945|NCT00432094|Thiotepa|thiotepa|mesh-list
110920946|NCT00432094|Mesna|mesna|mesh-list
110920947|NCT00432094|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110920948|NCT00432094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110920949|NCT00432094|Tubulin Modulators|tubulin modulators|mesh-ancestor
110920950|NCT00432094|Antimitotic Agents|antimitotic agents|mesh-ancestor
110920951|NCT00432094|Mitosis Modulators|mitosis modulators|mesh-ancestor
110920952|NCT00432094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110920953|NCT00432094|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110920954|NCT00432094|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110920955|NCT00432094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110920956|NCT00432094|Immunologic Factors|immunologic factors|mesh-ancestor
110920957|NCT00432094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110920958|NCT00432094|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110920959|NCT00432094|Alkylating Agents|alkylating agents|mesh-ancestor
110920960|NCT00432094|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110920961|NCT00432094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110920962|NCT00432094|Protective Agents|protective agents|mesh-ancestor
110920963|NCT04562779|Naltrexone|naltrexone|mesh-list
110920964|NCT04562779|Ketamine|ketamine|mesh-list
110920965|NCT04562779|Analgesics|analgesics|mesh-ancestor
110920966|NCT04562779|Sensory System Agents|sensory system agents|mesh-ancestor
110920967|NCT04562779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110920968|NCT04562779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110920969|NCT04562779|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110920970|NCT04562779|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110920971|NCT04562779|Anesthetics, General|anesthetics, general|mesh-ancestor
110920972|NCT04562779|Anesthetics|anesthetics|mesh-ancestor
110920973|NCT04562779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110920974|NCT04562779|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110920975|NCT04562779|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110250929|NCT01154439|Antimetabolites|antimetabolites|mesh-ancestor
110920976|NCT04562779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110365283|NCT02324985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110920977|NCT04562779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110920979|NCT04562779|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110920980|NCT03751761|Paclitaxel|paclitaxel|mesh-list
110920981|NCT03751761|Durvalumab|durvalumab|mesh-list
110920982|NCT03751761|Tremelimumab|tremelimumab|mesh-list
110920983|NCT03751761|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110920984|NCT03751761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110920985|NCT03751761|Tubulin Modulators|tubulin modulators|mesh-ancestor
110920986|NCT03751761|Antimitotic Agents|antimitotic agents|mesh-ancestor
110920987|NCT03751761|Mitosis Modulators|mitosis modulators|mesh-ancestor
110920988|NCT03751761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110920989|NCT03751761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110920990|NCT03644823|Atezolizumab|atezolizumab|mesh-list
110920991|NCT03644823|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110920992|NCT03644823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110920993|NCT03644823|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110920994|NCT03644823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110920995|NCT00072358|Carbamide Peroxide|carbamide peroxide|mesh-list
110920996|NCT00072358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110920997|NCT00072358|Irinotecan|irinotecan|mesh-list
110920998|NCT00072358|Temozolomide|temozolomide|mesh-list
110920999|NCT00072358|Molgramostim|molgramostim|mesh-list
110921000|NCT00072358|Isotretinoin|isotretinoin|mesh-list
110921001|NCT00072358|Antibodies|antibodies|mesh-list
110921002|NCT00072358|Immunoglobulins|immunoglobulins|mesh-list
110921003|NCT00072358|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110921004|NCT00072358|Sargramostim|sargramostim|mesh-list
110921005|NCT00072358|Immunoglobulin G|immunoglobulin g|mesh-list
110921006|NCT00072358|Immunologic Factors|immunologic factors|mesh-ancestor
110921007|NCT00072358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110921008|NCT00072358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110921009|NCT00072358|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110921010|NCT00072358|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110921011|NCT00072358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110921012|NCT00072358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110921013|NCT00072358|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110921014|NCT00072358|Alkylating Agents|alkylating agents|mesh-ancestor
110921015|NCT00072358|Dermatologic Agents|dermatologic agents|mesh-ancestor
110921016|NCT00072358|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110921017|NCT00072358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110921018|NCT03104998|Ubiquinone|ubiquinone|mesh-list
110921019|NCT03104998|Coenzyme Q10|coenzyme q10|mesh-list
110921020|NCT03104998|Micronutrients|micronutrients|mesh-ancestor
110921021|NCT03104998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110921022|NCT03104998|Vitamins|vitamins|mesh-ancestor
110921023|NCT03990766|Theophylline|theophylline|mesh-list
110921024|NCT03990766|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110921025|NCT03990766|Autonomic Agents|autonomic agents|mesh-ancestor
110921026|NCT03990766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110921027|NCT03990766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110921028|NCT03990766|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110921029|NCT03990766|Respiratory System Agents|respiratory system agents|mesh-ancestor
110921030|NCT03990766|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110921031|NCT03990766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110921032|NCT03990766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110921033|NCT03990766|Vasodilator Agents|vasodilator agents|mesh-ancestor
110921034|NCT03990766|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110921035|NCT03990766|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110921036|NCT03990766|Purinergic Agents|purinergic agents|mesh-ancestor
110921037|NCT03990766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110921038|NCT02294162|Ketamine|ketamine|mesh-list
110921039|NCT02294162|Analgesics|analgesics|mesh-ancestor
110921040|NCT02294162|Sensory System Agents|sensory system agents|mesh-ancestor
110921041|NCT02294162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110921042|NCT02294162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110921043|NCT02294162|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110921044|NCT02294162|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110921045|NCT02294162|Anesthetics, General|anesthetics, general|mesh-ancestor
110921046|NCT02294162|Anesthetics|anesthetics|mesh-ancestor
110921047|NCT02294162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110921048|NCT02294162|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110921049|NCT02294162|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110921050|NCT02294162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110921051|NCT02294162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110921052|NCT05176158|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
110921053|NCT05176158|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110921054|NCT05176158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110921055|NCT05176158|Analgesics|analgesics|mesh-ancestor
110921056|NCT05176158|Sensory System Agents|sensory system agents|mesh-ancestor
110921057|NCT05176158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110921058|NCT05176158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110921059|NCT05176158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110251303|NCT00141882|Memantine|memantine|mesh-list
110921060|NCT05176158|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110921061|NCT02294240|Folic Acid|folic acid|mesh-list
110921062|NCT02294240|Hematinics|hematinics|mesh-ancestor
110921063|NCT02294240|Vitamin B Complex|vitamin b complex|mesh-ancestor
110921064|NCT02294240|Vitamins|vitamins|mesh-ancestor
110921065|NCT02294240|Micronutrients|micronutrients|mesh-ancestor
110921066|NCT02294240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110921067|NCT04481724|Evening primrose oil|evening primrose oil|mesh-list
110921068|NCT04481724|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110251354|NCT00152412|Levocetirizine|levocetirizine|mesh-list
110921069|NCT04481724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110921071|NCT04481724|Sensory System Agents|sensory system agents|mesh-ancestor
110921072|NCT04481724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110921073|NCT04481724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110921074|NCT04481724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110921075|NCT04481724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110921076|NCT04481724|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110921077|NCT04481724|Antimetabolites|antimetabolites|mesh-ancestor
110921078|NCT04481724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110921079|NCT04481724|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110921080|NCT04481724|Dermatologic Agents|dermatologic agents|mesh-ancestor
110921081|NCT02298218|Meloxicam|meloxicam|mesh-list
110921082|NCT02298218|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110921083|NCT02298218|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110921084|NCT02298218|Analgesics|analgesics|mesh-ancestor
110921085|NCT02298218|Sensory System Agents|sensory system agents|mesh-ancestor
110921086|NCT02298218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110921087|NCT02298218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110921088|NCT02298218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110921089|NCT02298218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110921090|NCT02298218|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110921091|NCT02298218|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110921092|NCT02298218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110251482|NCT00142350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110921093|NCT02298218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110921094|NCT03547830|Plerixafor|plerixafor|mesh-list
110921095|NCT03547830|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110921096|NCT03547830|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110921097|NCT03547830|Antiviral Agents|antiviral agents|mesh-ancestor
110921098|NCT03547830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110921099|NCT04390945|Capecitabine|capecitabine|mesh-list
110921100|NCT04390945|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110921101|NCT04390945|Antimetabolites|antimetabolites|mesh-ancestor
110921102|NCT04390945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110921103|NCT04390945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110251579|NCT00152802|Vaccines|vaccines|mesh-list
110921104|NCT03734809|Pembrolizumab|pembrolizumab|mesh-list
110921105|NCT03734809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110921106|NCT03734809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110921107|NCT03734809|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110921108|NCT03734809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110921109|NCT02291666|Tolbutamide|tolbutamide|mesh-list
110921110|NCT02291666|Midazolam|midazolam|mesh-list
110921111|NCT02291666|Dextromethorphan|dextromethorphan|mesh-list
110921112|NCT02291666|Caffeine|caffeine|mesh-list
110921113|NCT02291666|Chlorzoxazone|chlorzoxazone|mesh-list
110921114|NCT02291666|Bupropion|bupropion|mesh-list
110921115|NCT02291666|Omeprazole|omeprazole|mesh-list
110921116|NCT02291666|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110921117|NCT02291666|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110921118|NCT02291666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110921119|NCT02291666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110921120|NCT02291666|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110921121|NCT02291666|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110921122|NCT02291666|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110921123|NCT02291666|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110921124|NCT02291666|Anesthetics, General|anesthetics, general|mesh-ancestor
110921125|NCT02291666|Anesthetics|anesthetics|mesh-ancestor
110921126|NCT02291666|GABA Modulators|gaba modulators|mesh-ancestor
110921127|NCT02291666|GABA Agents|gaba agents|mesh-ancestor
110921128|NCT02291666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110921129|NCT02291666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110921130|NCT02291666|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110921131|NCT02291666|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110921132|NCT02291666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110921133|NCT02291666|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110921134|NCT02291666|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110921135|NCT02291666|Purinergic Agents|purinergic agents|mesh-ancestor
110921136|NCT02291666|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110921137|NCT02291666|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110921138|NCT02291666|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110921139|NCT02291666|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110921140|NCT02291666|Antidepressive Agents|antidepressive agents|mesh-ancestor
110921141|NCT02291666|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110921142|NCT02291666|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110921143|NCT02291666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110921144|NCT02291666|Dopamine Agents|dopamine agents|mesh-ancestor
110921145|NCT02291666|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110921146|NCT02291666|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110921147|NCT02291666|Antitussive Agents|antitussive agents|mesh-ancestor
110921148|NCT02291666|Respiratory System Agents|respiratory system agents|mesh-ancestor
110921149|NCT02291666|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110921150|NCT02291666|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110921151|NCT02291666|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110921152|NCT02291666|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110921153|NCT02291666|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110921154|NCT02291666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110921156|NCT03102658|Antifungal Agents|antifungal agents|mesh-ancestor
110921157|NCT03102658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110921158|NCT02646748|Pembrolizumab|pembrolizumab|mesh-list
110921159|NCT02646748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110921160|NCT02646748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110921161|NCT02646748|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110921162|NCT02646748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110921163|NCT03624985|Lidocaine|lidocaine|mesh-list
110921164|NCT03624985|Anesthetics, Local|anesthetics, local|mesh-ancestor
110921165|NCT03624985|Anesthetics|anesthetics|mesh-ancestor
110921166|NCT03624985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110921167|NCT03624985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110921168|NCT03624985|Sensory System Agents|sensory system agents|mesh-ancestor
110365316|NCT00541814|Cyclosporine|cyclosporine|mesh-list
110921169|NCT03624985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110921170|NCT03624985|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110921171|NCT03624985|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110921172|NCT03624985|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110251673|NCT00135941|Insulin glulisine|insulin glulisine|mesh-list
110921173|NCT03624985|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110929136|NCT02169882|Hormones|hormones|mesh-ancestor
110921174|NCT03624985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110921175|NCT03521024|Lithium Carbonate|lithium carbonate|mesh-list
110921177|NCT03521024|Antidepressive Agents|antidepressive agents|mesh-ancestor
110921178|NCT03521024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110921179|NCT03521024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110921180|NCT03521024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110921181|NCT03521024|Antimanic Agents|antimanic agents|mesh-ancestor
110921182|NCT03521024|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110921183|NCT03521024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110921184|NCT03521024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110921185|NCT03521024|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110921186|NCT03521024|Anesthetics, General|anesthetics, general|mesh-ancestor
110921187|NCT03521024|Anesthetics|anesthetics|mesh-ancestor
110921188|NCT02294552|Mycophenolic Acid|mycophenolic acid|mesh-list
110921189|NCT02294552|Cyclophosphamide|cyclophosphamide|mesh-list
110921190|NCT02294552|Busulfan|busulfan|mesh-list
110921191|NCT02294552|Fludarabine|fludarabine|mesh-list
110921192|NCT02294552|Fludarabine phosphate|fludarabine phosphate|mesh-list
110921193|NCT02294552|Tacrolimus|tacrolimus|mesh-list
110921194|NCT02294552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110921195|NCT02294552|Immunologic Factors|immunologic factors|mesh-ancestor
110921196|NCT02294552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110921197|NCT02294552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110921198|NCT02294552|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110921199|NCT02294552|Alkylating Agents|alkylating agents|mesh-ancestor
110921200|NCT02294552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110921201|NCT02294552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110921202|NCT02294552|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110921203|NCT02294552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110921204|NCT02294552|Antimetabolites|antimetabolites|mesh-ancestor
110921205|NCT02294552|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110921206|NCT02294552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110921207|NCT02294552|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110921208|NCT02294552|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110921209|NCT02294552|Antitubercular Agents|antitubercular agents|mesh-ancestor
110921210|NCT02294552|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110921211|NCT02294552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110921212|NCT05574036|Vitamin E|vitamin e|mesh-list
110921213|NCT05574036|Febuxostat|febuxostat|mesh-list
110921214|NCT05574036|Vitamins|vitamins|mesh-ancestor
110921215|NCT05574036|Micronutrients|micronutrients|mesh-ancestor
110921216|NCT05574036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110921217|NCT05574036|Antioxidants|antioxidants|mesh-ancestor
110921218|NCT05574036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110921219|NCT05574036|Protective Agents|protective agents|mesh-ancestor
110921220|NCT05574036|Gout Suppressants|gout suppressants|mesh-ancestor
110921221|NCT05574036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110921222|NCT03517982|Mycophenolic Acid|mycophenolic acid|mesh-list
110921223|NCT03517982|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110921224|NCT03517982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110921225|NCT03517982|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110921226|NCT03517982|Antitubercular Agents|antitubercular agents|mesh-ancestor
110921227|NCT03517982|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110921228|NCT03517982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110251871|NCT00136565|Bortezomib|bortezomib|mesh-list
110921230|NCT03517982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110921231|NCT03869944|Lamivudine|lamivudine|mesh-list
110921232|NCT03869944|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110921233|NCT03869944|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110921234|NCT03869944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110921235|NCT03869944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110921281|NCT05573802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110921282|NCT05573802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110921283|NCT05573802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110921285|NCT05573802|Hormones|hormones|mesh-ancestor
110921286|NCT05573802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110921287|NCT05573802|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110921288|NCT05573802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110921289|NCT05573802|Immunologic Factors|immunologic factors|mesh-ancestor
110921290|NCT05573802|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110921291|NCT05573802|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110921292|NCT05573802|Growth Substances|growth substances|mesh-ancestor
110921293|NCT05573802|Growth Inhibitors|growth inhibitors|mesh-ancestor
110921294|NCT05573802|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
110921295|NCT05573802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110921296|NCT05573802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110921298|NCT04435522|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110921299|NCT04435522|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110921300|NCT04435522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110921301|NCT04435522|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110921302|NCT04435522|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110921303|NCT04435522|Antiviral Agents|antiviral agents|mesh-ancestor
110921304|NCT04435522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110921305|NCT04435522|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
110921306|NCT03575325|Cytarabine|cytarabine|mesh-list
110921307|NCT03575325|Daunorubicin|daunorubicin|mesh-list
110921308|NCT03575325|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110921309|NCT03575325|Antimetabolites|antimetabolites|mesh-ancestor
110921310|NCT03575325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110921311|NCT03575325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110921312|NCT03575325|Antiviral Agents|antiviral agents|mesh-ancestor
110921313|NCT03575325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110921314|NCT03575325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110921315|NCT03575325|Immunologic Factors|immunologic factors|mesh-ancestor
110921316|NCT03575325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110921317|NCT03575325|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110921318|NCT03575325|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110921319|NCT03575325|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110921320|NCT03575325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110921321|NCT03843970|Bupivacaine|bupivacaine|mesh-list
110921322|NCT03843970|Levobupivacaine|levobupivacaine|mesh-list
110921323|NCT03843970|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110921324|NCT03843970|Anesthetics, Local|anesthetics, local|mesh-ancestor
110921325|NCT03843970|Anesthetics|anesthetics|mesh-ancestor
110921326|NCT03843970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110921327|NCT03843970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110921328|NCT03843970|Sensory System Agents|sensory system agents|mesh-ancestor
110921329|NCT03843970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110921330|NCT03043651|Treprostinil|treprostinil|mesh-list
110921331|NCT03043651|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110921332|NCT04353024|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
110921333|NCT04353024|Hallucinogens|hallucinogens|mesh-ancestor
110921334|NCT04353024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110921335|NCT04353024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110921336|NCT04353024|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110921337|NCT04353024|Serotonin Agents|serotonin agents|mesh-ancestor
110921338|NCT04353024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110921339|NCT04353024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110921340|NCT04353024|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110921341|NCT04465292|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110921342|NCT04465292|Immunologic Factors|immunologic factors|mesh-ancestor
110921343|NCT04465292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110921345|NCT02298530|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110921346|NCT02298530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110921347|NCT02298530|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110921348|NCT02298530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110921349|NCT02298530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110921350|NCT02298530|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110921351|NCT02298530|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110921352|NCT02298530|Purinergic Agents|purinergic agents|mesh-ancestor
110921353|NCT02298530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110921354|NCT05051436|Tadalafil|tadalafil|mesh-list
110921355|NCT05051436|Mirabegron|mirabegron|mesh-list
110921356|NCT05051436|Vasodilator Agents|vasodilator agents|mesh-ancestor
110921357|NCT05051436|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110921358|NCT05051436|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110921359|NCT05051436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110921360|NCT05051436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110921361|NCT05051436|Urological Agents|urological agents|mesh-ancestor
110921362|NCT05051436|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
110921363|NCT05051436|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110921364|NCT05051436|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110921365|NCT05051436|Adrenergic Agents|adrenergic agents|mesh-ancestor
110921366|NCT05051436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110921367|NCT05051436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110921368|NCT03644589|Pembrolizumab|pembrolizumab|mesh-list
110921369|NCT03644589|Immunoglobulins|immunoglobulins|mesh-list
110921370|NCT03644589|Immunoglobulin G|immunoglobulin g|mesh-list
110921371|NCT03644589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110921372|NCT03644589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110921373|NCT03644589|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110921374|NCT03644589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110252361|NCT00161070|Analgesics|analgesics|mesh-ancestor
110921375|NCT03644589|Immunologic Factors|immunologic factors|mesh-ancestor
110921376|NCT03644589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110921377|NCT03514550|Propofol|propofol|mesh-list
110921378|NCT03514550|Sevoflurane|sevoflurane|mesh-list
110921379|NCT03514550|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110921380|NCT03514550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110921381|NCT03514550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110921382|NCT03514550|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110921383|NCT03514550|Anesthetics, General|anesthetics, general|mesh-ancestor
110921384|NCT03514550|Anesthetics|anesthetics|mesh-ancestor
110921385|NCT03514550|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110921386|NCT03514550|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110921387|NCT04173988|Cyclophosphamide|cyclophosphamide|mesh-list
110921388|NCT04173988|Fludarabine|fludarabine|mesh-list
110921389|NCT04173988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110252378|NCT00138983|Alfacalcidol|alfacalcidol|mesh-list
110921390|NCT04173988|Immunologic Factors|immunologic factors|mesh-ancestor
110921391|NCT04173988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110921392|NCT04173988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110921393|NCT04173988|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110921394|NCT04173988|Alkylating Agents|alkylating agents|mesh-ancestor
110921395|NCT04173988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110921396|NCT04173988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110921397|NCT04173988|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110921398|NCT01344759|Dexmedetomidine|dexmedetomidine|mesh-list
110921399|NCT01344759|Propofol|propofol|mesh-list
110921400|NCT01344759|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110921401|NCT01344759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110921402|NCT01344759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110921403|NCT01344759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110921404|NCT01344759|Analgesics|analgesics|mesh-ancestor
110921405|NCT01344759|Sensory System Agents|sensory system agents|mesh-ancestor
110921406|NCT01344759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110921407|NCT01344759|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110921408|NCT01344759|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110921409|NCT01344759|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110921410|NCT01344759|Adrenergic Agents|adrenergic agents|mesh-ancestor
110921411|NCT01344759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110921412|NCT01344759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110921413|NCT01344759|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110921414|NCT01344759|Anesthetics, General|anesthetics, general|mesh-ancestor
110921416|NCT05885386|Temozolomide|temozolomide|mesh-list
110921417|NCT05885386|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110921419|NCT05885386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110921420|NCT05885386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110921421|NCT05885360|Istradefylline|istradefylline|mesh-list
110921422|NCT05885360|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
110638943|NCT00845546|Loratadine|loratadine|mesh-list
110921423|NCT05885360|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110921424|NCT05885360|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110921425|NCT05885360|Purinergic Agents|purinergic agents|mesh-ancestor
110921426|NCT05885360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110921427|NCT05885360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110921428|NCT05885360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110921429|NCT05885269|Clobetasol|clobetasol|mesh-list
110921430|NCT05885269|Tacrolimus|tacrolimus|mesh-list
110921431|NCT05885269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110921432|NCT05885269|Immunologic Factors|immunologic factors|mesh-ancestor
110921433|NCT05885269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110921434|NCT05885269|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110921435|NCT05885269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110921436|NCT05885269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110921437|NCT05885269|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110921438|NCT05885269|Glucocorticoids|glucocorticoids|mesh-ancestor
110921439|NCT05885269|Hormones|hormones|mesh-ancestor
110921440|NCT05885269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110921441|NCT05885035|Calcium|calcium|mesh-list
110921442|NCT05885035|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110921443|NCT05885035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110921444|NCT05884983|Vaccines|vaccines|mesh-list
110921445|NCT05884983|Immunologic Factors|immunologic factors|mesh-ancestor
110921446|NCT05884983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110921447|NCT05884970|Albuterol|albuterol|mesh-list
110921448|NCT05884970|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110921449|NCT05884970|Autonomic Agents|autonomic agents|mesh-ancestor
110921450|NCT05884970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110921451|NCT05884970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110921453|NCT05884970|Respiratory System Agents|respiratory system agents|mesh-ancestor
110921454|NCT05884970|Tocolytic Agents|tocolytic agents|mesh-ancestor
110921455|NCT05884970|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110921456|NCT05884970|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110921457|NCT05884970|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110921458|NCT05884970|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110921459|NCT05884970|Adrenergic Agents|adrenergic agents|mesh-ancestor
110921460|NCT05884970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110921461|NCT05884970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110921462|NCT05884957|Nitric Oxide|nitric oxide|mesh-list
110921463|NCT05884957|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110921464|NCT05884957|Autonomic Agents|autonomic agents|mesh-ancestor
110921465|NCT05884957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110921466|NCT05884957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110921467|NCT05884957|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110921468|NCT05884957|Respiratory System Agents|respiratory system agents|mesh-ancestor
110921469|NCT05884957|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110921470|NCT05884957|Antioxidants|antioxidants|mesh-ancestor
110921471|NCT05884957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110921472|NCT05884957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110921473|NCT05884957|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
110921474|NCT05884957|Vasodilator Agents|vasodilator agents|mesh-ancestor
110921475|NCT05884957|Gasotransmitters|gasotransmitters|mesh-ancestor
110921476|NCT05884957|Protective Agents|protective agents|mesh-ancestor
110921477|NCT05884866|Dapagliflozin|dapagliflozin|mesh-list
110929179|NCT02170038|Contraceptive Agents|contraceptive agents|mesh-ancestor
110921478|NCT05884866|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110921479|NCT05884866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110921481|NCT05884866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110921482|NCT05884502|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110921483|NCT05884502|Ezetimibe|ezetimibe|mesh-list
110921484|NCT05884502|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110921485|NCT05884502|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110921486|NCT05884502|Antimetabolites|antimetabolites|mesh-ancestor
110921487|NCT05884502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110921488|NCT05884502|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110921489|NCT05884502|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110921490|NCT05884502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110921491|NCT05884463|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110921493|NCT05884463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110921494|NCT05884268|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
110639005|NCT00719537|Antipyretics|antipyretics|mesh-ancestor
110921495|NCT05884268|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110921496|NCT05884268|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110921497|NCT05884268|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110921498|NCT05884268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110921499|NCT05884268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110921500|NCT05884268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110921501|NCT05884268|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110921502|NCT05884268|Antidepressive Agents|antidepressive agents|mesh-ancestor
110921503|NCT05884268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110921504|NCT05884255|Octreotide|octreotide|mesh-list
110921505|NCT05884255|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
110921506|NCT05884255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110921507|NCT05884255|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110921508|NCT05884255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110921509|NCT05884255|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110921510|NCT05884255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110921511|NCT05884151|Tranexamic Acid|tranexamic acid|mesh-list
110252916|NCT04515628|Antimetabolites|antimetabolites|mesh-ancestor
110921512|NCT05884151|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110921513|NCT05884151|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110921514|NCT05884151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110921516|NCT05884151|Coagulants|coagulants|mesh-ancestor
110921517|NCT05883956|Azacitidine|azacitidine|mesh-list
110921518|NCT05883956|Decitabine|decitabine|mesh-list
110921519|NCT05883956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110921520|NCT05883956|Antimetabolites|antimetabolites|mesh-ancestor
110921521|NCT05883956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110921522|NCT05883956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110921523|NCT05883956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110921524|NCT05883891|Thrombin|thrombin|mesh-list
110921525|NCT05883891|Hemostatics|hemostatics|mesh-ancestor
110921526|NCT05883891|Coagulants|coagulants|mesh-ancestor
110921527|NCT05883865|Fenofibrate|fenofibrate|mesh-list
110921528|NCT05883865|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110921529|NCT05883865|Antimetabolites|antimetabolites|mesh-ancestor
110921530|NCT05883865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110921531|NCT05883865|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110921532|NCT05883709|Lenalidomide|lenalidomide|mesh-list
110921533|NCT05883709|Immunologic Factors|immunologic factors|mesh-ancestor
110921534|NCT05883709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110921535|NCT05883709|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110921536|NCT05883709|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110921537|NCT05883709|Growth Substances|growth substances|mesh-ancestor
110921538|NCT05883709|Growth Inhibitors|growth inhibitors|mesh-ancestor
110921539|NCT05883709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110921540|NCT05883449|Cyclophosphamide|cyclophosphamide|mesh-list
110921541|NCT05883449|Fludarabine|fludarabine|mesh-list
110921542|NCT05883449|Interleukin-2|interleukin-2|mesh-list
110921543|NCT05883449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110921544|NCT05883449|Immunologic Factors|immunologic factors|mesh-ancestor
110921545|NCT05883449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110921546|NCT05883449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110921547|NCT05883449|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110921548|NCT05883449|Alkylating Agents|alkylating agents|mesh-ancestor
110921549|NCT05883449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110921550|NCT05883449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110921551|NCT05883449|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110921552|NCT05883449|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110921553|NCT05883449|Analgesics|analgesics|mesh-ancestor
110921554|NCT05883449|Sensory System Agents|sensory system agents|mesh-ancestor
110921555|NCT05883449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110921556|NCT05881720|Valsartan|valsartan|mesh-list
110921557|NCT05881720|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
110253097|NCT00162318|Cetuximab|cetuximab|mesh-list
110921558|NCT05881720|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110921559|NCT05881720|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110921560|NCT05881720|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110921561|NCT05881720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110921562|NCT05873725|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
110921563|NCT05873725|Hormones|hormones|mesh-ancestor
110253153|NCT00162396|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110921564|NCT05873725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110921565|NCT05873725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110921566|NCT05860530|Olaparib|olaparib|mesh-list
110921567|NCT05860530|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110921568|NCT05860530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110921569|NCT05860530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110921570|NCT05860530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110921571|NCT05833126|Bevacizumab|bevacizumab|mesh-list
110921572|NCT05833126|Atezolizumab|atezolizumab|mesh-list
110921573|NCT05833126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110921574|NCT05833126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110921575|NCT05833126|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110921576|NCT05833126|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110921577|NCT05833126|Growth Substances|growth substances|mesh-ancestor
110921578|NCT05833126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110921579|NCT05833126|Growth Inhibitors|growth inhibitors|mesh-ancestor
110921580|NCT05833126|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110921581|NCT05833126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110921582|NCT05830799|Tolbutamide|tolbutamide|mesh-list
110921583|NCT05830799|Nintedanib|nintedanib|mesh-list
110921584|NCT05830799|Midazolam|midazolam|mesh-list
110921585|NCT05830799|Caffeine|caffeine|mesh-list
110921586|NCT05830799|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110921587|NCT05830799|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110253285|NCT04518163|Tranexamic Acid|tranexamic acid|mesh-list
110921588|NCT05830799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110921589|NCT05830799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110921590|NCT05830799|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110921591|NCT05830799|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110921592|NCT05830799|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110921593|NCT05830799|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110921594|NCT05830799|Anesthetics, General|anesthetics, general|mesh-ancestor
110921595|NCT05830799|Anesthetics|anesthetics|mesh-ancestor
110921596|NCT05830799|GABA Modulators|gaba modulators|mesh-ancestor
110921597|NCT05830799|GABA Agents|gaba agents|mesh-ancestor
110921598|NCT05830799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110253343|NCT00141791|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110921599|NCT05830799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110929205|NCT03591549|Fulvestrant|fulvestrant|mesh-list
110921600|NCT05830799|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110921601|NCT05830799|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110921603|NCT05830799|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110921604|NCT05830799|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110921605|NCT05830799|Purinergic Agents|purinergic agents|mesh-ancestor
110921606|NCT05830799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110921607|NCT05830799|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110921608|NCT05830799|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110921609|NCT05827523|Cisplatin|cisplatin|mesh-list
110921610|NCT05827523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110921611|NCT05798156|Rituximab|rituximab|mesh-list
110921612|NCT05798156|Obinutuzumab|obinutuzumab|mesh-list
110921613|NCT05798156|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
110921614|NCT05798156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110921615|NCT05798156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110921616|NCT05798156|Immunologic Factors|immunologic factors|mesh-ancestor
110921617|NCT05798156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110921618|NCT05798156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110921619|NCT05798156|Immunoconjugates|immunoconjugates|mesh-ancestor
110921620|NCT05731843|Ruzasvir|ruzasvir|mesh-list
110921621|NCT05731843|Antiviral Agents|antiviral agents|mesh-ancestor
110921622|NCT05731843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110921623|NCT05720949|Dexamethasone|dexamethasone|mesh-list
110921624|NCT05720949|Bupivacaine|bupivacaine|mesh-list
110921625|NCT05720949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110921626|NCT05720949|Antiemetics|antiemetics|mesh-ancestor
110921627|NCT05720949|Autonomic Agents|autonomic agents|mesh-ancestor
110921628|NCT05720949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110921629|NCT05720949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110921630|NCT05720949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110921631|NCT05720949|Glucocorticoids|glucocorticoids|mesh-ancestor
110921632|NCT05720949|Hormones|hormones|mesh-ancestor
110921633|NCT05720949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110921634|NCT05720949|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110921635|NCT05720949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110921636|NCT05720949|Anesthetics, Local|anesthetics, local|mesh-ancestor
110921637|NCT05720949|Anesthetics|anesthetics|mesh-ancestor
110921638|NCT05720949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110921639|NCT05720949|Sensory System Agents|sensory system agents|mesh-ancestor
110921640|NCT05714631|Lidocaine|lidocaine|mesh-list
110921641|NCT05714631|Anesthetics, Local|anesthetics, local|mesh-ancestor
110921642|NCT05714631|Anesthetics|anesthetics|mesh-ancestor
110921643|NCT05714631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110921644|NCT05714631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110921645|NCT05714631|Sensory System Agents|sensory system agents|mesh-ancestor
110921646|NCT05714631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110921647|NCT05714631|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110921648|NCT05714631|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110921649|NCT05714631|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110921650|NCT05714631|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110921651|NCT05714631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110921652|NCT05676411|Benzoyl Peroxide|benzoyl peroxide|mesh-list
110253468|NCT04514731|Analgesics|analgesics|mesh-ancestor
110921653|NCT05676411|Dermatologic Agents|dermatologic agents|mesh-ancestor
110921654|NCT05633563|Trimetazidine|trimetazidine|mesh-list
110921655|NCT05633563|Vasodilator Agents|vasodilator agents|mesh-ancestor
110921656|NCT05627271|Ofatumumab|ofatumumab|mesh-list
110921657|NCT05627271|Ocrelizumab|ocrelizumab|mesh-list
110921658|NCT05627271|Natalizumab|natalizumab|mesh-list
110921659|NCT05627271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110921660|NCT05627271|Immunologic Factors|immunologic factors|mesh-ancestor
110921661|NCT05627271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110921662|NCT05610735|Doxorubicin|doxorubicin|mesh-list
110921663|NCT05610735|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110921664|NCT05610735|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110921665|NCT05610735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110929210|NCT03591549|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110921666|NCT05610735|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110921667|NCT05610735|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110921668|NCT05610735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110921669|NCT05610735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110921671|NCT05593458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110921672|NCT05571514|Calcium Carbonate|calcium carbonate|mesh-list
110921673|NCT05571514|Calcium|calcium|mesh-list
110921674|NCT05571514|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110253513|NCT00162786|Hydroxyzine|hydroxyzine|mesh-list
110921675|NCT05571514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110921676|NCT05571514|Antacids|antacids|mesh-ancestor
110921677|NCT05571514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110921678|NCT05571514|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110921679|NCT05556720|Vaccines|vaccines|mesh-list
110921680|NCT05556720|Immunologic Factors|immunologic factors|mesh-ancestor
110921681|NCT05556720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110921682|NCT05513391|Vaccines|vaccines|mesh-list
110921683|NCT05513391|Immunologic Factors|immunologic factors|mesh-ancestor
110921684|NCT05513391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110921685|NCT05498766|Capecitabine|capecitabine|mesh-list
110921686|NCT05498766|Tegafur|tegafur|mesh-list
110921687|NCT05498766|Oxaliplatin|oxaliplatin|mesh-list
110921688|NCT05498766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110921689|NCT05498766|Antimetabolites|antimetabolites|mesh-ancestor
110921690|NCT05498766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110921691|NCT05498766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110921692|NCT05498389|Osimertinib|osimertinib|mesh-list
110921693|NCT05498389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110921694|NCT05498389|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110921695|NCT05498389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110921696|NCT05498389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110921697|NCT05351541|Zolpidem|zolpidem|mesh-list
110921698|NCT05351541|Modafinil|modafinil|mesh-list
110921699|NCT05351541|Psilocybin|psilocybin|mesh-list
110921700|NCT05351541|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
110921701|NCT05351541|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110921702|NCT05351541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110921703|NCT05351541|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
110921704|NCT05351541|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110921705|NCT05351541|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110921706|NCT05351541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110921707|NCT05351541|Hallucinogens|hallucinogens|mesh-ancestor
110921708|NCT05351541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110921709|NCT05351541|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110921710|NCT05351541|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110921711|NCT05351541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110921712|NCT05351541|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
110921713|NCT05351541|GABA Agonists|gaba agonists|mesh-ancestor
110921714|NCT05351541|GABA Agents|gaba agents|mesh-ancestor
110921715|NCT05351541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110921716|NCT05351541|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110921717|NCT05351541|Serotonin Agents|serotonin agents|mesh-ancestor
110921718|NCT05351541|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110921719|NCT05334056|Cocaine|cocaine|mesh-list
110921720|NCT05334056|Anesthetics, Local|anesthetics, local|mesh-ancestor
110921721|NCT05334056|Anesthetics|anesthetics|mesh-ancestor
110921722|NCT05334056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110921723|NCT05334056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110921724|NCT05334056|Sensory System Agents|sensory system agents|mesh-ancestor
110921725|NCT05334056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110921726|NCT05334056|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110921727|NCT05334056|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110921728|NCT05334056|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110921729|NCT05334056|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110921730|NCT05334056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110921731|NCT05334056|Dopamine Agents|dopamine agents|mesh-ancestor
110921732|NCT05334056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110921733|NCT05328414|Prednisolone|prednisolone|mesh-list
110921734|NCT05328414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110921735|NCT05328414|Glucocorticoids|glucocorticoids|mesh-ancestor
110921736|NCT05328414|Hormones|hormones|mesh-ancestor
110921737|NCT05328414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110921738|NCT05328414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110921739|NCT05328414|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110921740|NCT05328414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110921742|NCT05298085|Oxytocics|oxytocics|mesh-ancestor
110921743|NCT05298085|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110921744|NCT05298085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110921745|NCT05291598|Ketorolac|ketorolac|mesh-list
110921746|NCT05291598|Meloxicam|meloxicam|mesh-list
110921747|NCT05291598|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110921748|NCT05291598|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110921749|NCT05291598|Analgesics|analgesics|mesh-ancestor
110921750|NCT05291598|Sensory System Agents|sensory system agents|mesh-ancestor
110921751|NCT05291598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110921752|NCT05291598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110921753|NCT05291598|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110921754|NCT05291598|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110921755|NCT05291598|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110921756|NCT05291598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110921757|NCT05291598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110921758|NCT05291598|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110921760|NCT05288153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110921761|NCT05288153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110921762|NCT05255003|Enoxaparin|enoxaparin|mesh-list
110921763|NCT05255003|Dalteparin|dalteparin|mesh-list
110921764|NCT05255003|Tinzaparin|tinzaparin|mesh-list
110253773|NCT04514029|Hormones|hormones|mesh-ancestor
110921765|NCT05255003|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
110921766|NCT05255003|Anticoagulants|anticoagulants|mesh-ancestor
110921767|NCT05255003|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110921768|NCT05255003|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110921769|NCT05255003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110921770|NCT05190432|Taxifolin|taxifolin|mesh-list
110921771|NCT05190432|Ergothioneine|ergothioneine|mesh-list
110921772|NCT05190432|Antioxidants|antioxidants|mesh-ancestor
110921773|NCT05190432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110921774|NCT05190432|Protective Agents|protective agents|mesh-ancestor
110921775|NCT05190432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110921776|NCT05190432|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110921777|NCT05190432|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110921778|NCT05190432|Analgesics|analgesics|mesh-ancestor
110921779|NCT05190432|Sensory System Agents|sensory system agents|mesh-ancestor
110921780|NCT05190432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110921782|NCT05190432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110921783|NCT05171166|Leucovorin|leucovorin|mesh-list
110921784|NCT05171166|Fluorouracil|fluorouracil|mesh-list
110921785|NCT05171166|Oxaliplatin|oxaliplatin|mesh-list
110921786|NCT05171166|Chlorotrianisene|chlorotrianisene|mesh-list
110921787|NCT05171166|Antimetabolites|antimetabolites|mesh-ancestor
110921788|NCT05171166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110921789|NCT05171166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110921790|NCT05171166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110921791|NCT05171166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110921792|NCT05171166|Immunologic Factors|immunologic factors|mesh-ancestor
110921793|NCT05171166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110921794|NCT05171166|Antidotes|antidotes|mesh-ancestor
110921795|NCT05171166|Protective Agents|protective agents|mesh-ancestor
110921796|NCT05171166|Vitamin B Complex|vitamin b complex|mesh-ancestor
110921797|NCT05171166|Vitamins|vitamins|mesh-ancestor
110921798|NCT05171166|Micronutrients|micronutrients|mesh-ancestor
110921799|NCT05171166|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
110921800|NCT05171166|Estrogens|estrogens|mesh-ancestor
110921801|NCT05171166|Hormones|hormones|mesh-ancestor
110921802|NCT05171166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110921803|NCT05171166|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110921804|NCT05123131|Dexamethasone|dexamethasone|mesh-list
110921805|NCT05123131|Lenalidomide|lenalidomide|mesh-list
110921806|NCT05123131|Bortezomib|bortezomib|mesh-list
110253904|NCT02598895|Docetaxel|docetaxel|mesh-list
110921807|NCT05123131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110921808|NCT05123131|Antiemetics|antiemetics|mesh-ancestor
110921809|NCT05123131|Autonomic Agents|autonomic agents|mesh-ancestor
110921810|NCT05123131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110921811|NCT05123131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110921812|NCT05123131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110921813|NCT05123131|Glucocorticoids|glucocorticoids|mesh-ancestor
110921814|NCT05123131|Hormones|hormones|mesh-ancestor
110921815|NCT05123131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110921816|NCT05123131|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110921817|NCT05123131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110921818|NCT05123131|Immunologic Factors|immunologic factors|mesh-ancestor
110921819|NCT05123131|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110921820|NCT05123131|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110921821|NCT05123131|Growth Substances|growth substances|mesh-ancestor
110921822|NCT05123131|Growth Inhibitors|growth inhibitors|mesh-ancestor
110921823|NCT05102162|Meropenem|meropenem|mesh-list
110921824|NCT05102162|Tazobactam|tazobactam|mesh-list
110921825|NCT05102162|Piperacillin|piperacillin|mesh-list
110921826|NCT05102162|Cefepime|cefepime|mesh-list
110921827|NCT05102162|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
110921828|NCT05102162|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110921829|NCT05102162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110921830|NCT05102162|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110921831|NCT05102162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110921832|NCT05102162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110921833|NCT05101187|Amphotericin B|amphotericin b|mesh-list
110921834|NCT05101187|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
110921835|NCT05101187|Olorofim|olorofim|mesh-list
110921836|NCT05101187|Amebicides|amebicides|mesh-ancestor
110921837|NCT05101187|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110921838|NCT05101187|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110921839|NCT05101187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110921840|NCT05101187|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110921841|NCT05101187|Antifungal Agents|antifungal agents|mesh-ancestor
110921843|NCT05065866|Cc-486|cc-486|mesh-list
110921844|NCT05065866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110921845|NCT05065866|Antimetabolites|antimetabolites|mesh-ancestor
110921846|NCT05065866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110921847|NCT05065866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110921848|NCT05065866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110921849|NCT05024513|Fluorouracil|fluorouracil|mesh-list
110921850|NCT05024513|Oxaliplatin|oxaliplatin|mesh-list
110921851|NCT05024513|Antimetabolites|antimetabolites|mesh-ancestor
110921852|NCT05024513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110921853|NCT05024513|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110921854|NCT05024513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110921855|NCT05024513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110921856|NCT05024513|Immunologic Factors|immunologic factors|mesh-ancestor
110921857|NCT05024513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110929247|NCT02170116|Dabigatran|dabigatran|mesh-list
110921858|NCT05024045|Pirtobrutinib|pirtobrutinib|mesh-list
110921859|NCT05024045|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110921861|NCT05024045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110921862|NCT05000047|Silicon|silicon|mesh-list
110921863|NCT05000047|Trace Elements|trace elements|mesh-ancestor
110921864|NCT05000047|Micronutrients|micronutrients|mesh-ancestor
110921865|NCT05000047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110921866|NCT04982445|Cabotegravir, rilpivirine drug combination|cabotegravir, rilpivirine drug combination|mesh-list
110921867|NCT04982445|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110921868|NCT04982445|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110921869|NCT04982445|Antiviral Agents|antiviral agents|mesh-ancestor
110921870|NCT04982445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110921871|NCT04974047|Tislelizumab|tislelizumab|mesh-list
110921872|NCT04974047|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110921873|NCT04974047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110921874|NCT04934800|Cladribine|cladribine|mesh-list
110921875|NCT04934800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110921876|NCT04934800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110921877|NCT04934800|Immunologic Factors|immunologic factors|mesh-ancestor
110921878|NCT04934800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110921879|NCT04920942|Ivermectin|ivermectin|mesh-list
110921880|NCT04920942|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110921881|NCT04920942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110921882|NCT04918186|Durvalumab|durvalumab|mesh-list
110921883|NCT04918186|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110921884|NCT04918186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110921885|NCT04821687|Opicapone|opicapone|mesh-list
110921886|NCT04821687|Benserazide, levodopa drug combination|benserazide, levodopa drug combination|mesh-list
110921887|NCT04821687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110921888|NCT04821687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110921889|NCT04821687|Dopamine Agents|dopamine agents|mesh-ancestor
110921890|NCT04821687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110921891|NCT04821687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110921892|NCT04821687|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
110921893|NCT04821687|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110921894|NCT04821687|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110921895|NCT04764344|Haloperidol|haloperidol|mesh-list
110921896|NCT04764344|Ondansetron|ondansetron|mesh-list
110921897|NCT04764344|Haloperidol decanoate|haloperidol decanoate|mesh-list
110921898|NCT04764344|Antiemetics|antiemetics|mesh-ancestor
110921899|NCT04764344|Autonomic Agents|autonomic agents|mesh-ancestor
110921900|NCT04764344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110921901|NCT04764344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110921902|NCT04764344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110921903|NCT04764344|Antipruritics|antipruritics|mesh-ancestor
110921904|NCT04764344|Dermatologic Agents|dermatologic agents|mesh-ancestor
110921905|NCT04764344|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110921906|NCT04764344|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110921907|NCT04764344|Serotonin Agents|serotonin agents|mesh-ancestor
110921908|NCT04764344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110921909|NCT04764344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110921910|NCT04764344|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110921911|NCT04764344|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110921912|NCT04764344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110921913|NCT04764344|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110921914|NCT04764344|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110921915|NCT04764344|Dopamine Agents|dopamine agents|mesh-ancestor
110921916|NCT04764344|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110921918|NCT04745026|Anticonvulsants|anticonvulsants|mesh-ancestor
110921919|NCT04738981|Basiliximab|basiliximab|mesh-list
110921920|NCT04738981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110921921|NCT04738981|Immunologic Factors|immunologic factors|mesh-ancestor
110921922|NCT04738981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110921923|NCT04709185|Dexamethasone|dexamethasone|mesh-list
110921924|NCT04709185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110921925|NCT04709185|Antiemetics|antiemetics|mesh-ancestor
110921926|NCT04709185|Autonomic Agents|autonomic agents|mesh-ancestor
110921927|NCT04709185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110921928|NCT04709185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110921929|NCT04709185|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110921930|NCT04709185|Glucocorticoids|glucocorticoids|mesh-ancestor
110921931|NCT04709185|Hormones|hormones|mesh-ancestor
110921932|NCT04709185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110921933|NCT04709185|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110921934|NCT04709185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110921935|NCT04693156|Bupivacaine|bupivacaine|mesh-list
110921936|NCT04693156|Prilocaine|prilocaine|mesh-list
110921937|NCT04693156|Anesthetics, Local|anesthetics, local|mesh-ancestor
110921938|NCT04693156|Anesthetics|anesthetics|mesh-ancestor
110921939|NCT04693156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110921940|NCT04693156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110921941|NCT04693156|Sensory System Agents|sensory system agents|mesh-ancestor
110921942|NCT04693156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110921944|NCT04504331|Infigratinib|infigratinib|mesh-list
110921945|NCT04504331|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
110921946|NCT04504331|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110921947|NCT04504331|Hormone Antagonists|hormone antagonists|mesh-ancestor
110921948|NCT04504331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110921949|NCT04504331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110639452|NCT00619892|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110921950|NCT04504331|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110921951|NCT04504331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110921952|NCT04504331|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110921953|NCT04504331|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110921954|NCT04504331|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110921955|NCT04504331|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110921956|NCT04504331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110921957|NCT04504331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110921958|NCT04447911|Empagliflozin|empagliflozin|mesh-list
110921959|NCT04447911|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110921960|NCT04447911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110921961|NCT04447911|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110921962|NCT04447911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110921963|NCT04420195|Tacrolimus|tacrolimus|mesh-list
110921964|NCT04420195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110921965|NCT04420195|Immunologic Factors|immunologic factors|mesh-ancestor
110921966|NCT04420195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110921967|NCT04420195|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110921968|NCT04420195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110921969|NCT04420195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110921970|NCT04313985|Immunologic Factors|immunologic factors|mesh-list
110921971|NCT04313985|Immunomodulating Agents|immunomodulating agents|mesh-list
110921972|NCT04313985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110921973|NCT04283578|Oxytocin|oxytocin|mesh-list
110921974|NCT04283578|Oxytocics|oxytocics|mesh-ancestor
110921975|NCT04283578|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110921976|NCT04283578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110921977|NCT04123873|Acetaminophen|acetaminophen|mesh-list
110921978|NCT04123873|Dexamethasone|dexamethasone|mesh-list
110921979|NCT04123873|Ibuprofen|ibuprofen|mesh-list
110921980|NCT04123873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110921981|NCT04123873|Antiemetics|antiemetics|mesh-ancestor
110921982|NCT04123873|Autonomic Agents|autonomic agents|mesh-ancestor
110921983|NCT04123873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110921984|NCT04123873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110921985|NCT04123873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110921986|NCT04123873|Glucocorticoids|glucocorticoids|mesh-ancestor
110921988|NCT04123873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110921989|NCT04123873|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110921990|NCT04123873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110921991|NCT04123873|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110254683|NCT00157326|Tadalafil|tadalafil|mesh-list
110921993|NCT04123873|Sensory System Agents|sensory system agents|mesh-ancestor
110921994|NCT04123873|Antipyretics|antipyretics|mesh-ancestor
110921995|NCT04123873|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110921996|NCT04123873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110921997|NCT04123873|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110921998|NCT04123873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110921999|NCT04123873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110922000|NCT04116203|Metformin|metformin|mesh-list
110922001|NCT04116203|Hypoglycemic Agents|hypoglycemic agents|mesh-list
110922002|NCT04116203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110922003|NCT04106362|Cisplatin|cisplatin|mesh-list
110922004|NCT04106362|Cetuximab|cetuximab|mesh-list
110922005|NCT04106362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110922007|NCT04106362|Immunoglobulins|immunoglobulins|mesh-list
110922008|NCT04106362|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110922009|NCT04106362|Immunologic Factors|immunologic factors|mesh-ancestor
110922010|NCT04106362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110922011|NCT04106362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110922012|NCT04079088|Interferons|interferons|mesh-list
110922013|NCT04079088|Interferon-beta|interferon-beta|mesh-list
110922014|NCT04079088|Glatiramer Acetate|glatiramer acetate|mesh-list
110922015|NCT04079088|(T,G)-A-L|(t,g)-a-l|mesh-list
110922016|NCT04079088|Interferon beta-1b|interferon beta-1b|mesh-list
110922017|NCT04079088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110922018|NCT04079088|Antiviral Agents|antiviral agents|mesh-ancestor
110922019|NCT04079088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110922020|NCT04079088|Immunologic Factors|immunologic factors|mesh-ancestor
110922021|NCT04079088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110922022|NCT04079088|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110922023|NCT04079088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110922024|NCT04079088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110922025|NCT04060030|Calcium, Dietary|calcium, dietary|mesh-list
110922026|NCT04060030|Leucovorin|leucovorin|mesh-list
110922027|NCT04060030|Calcium|calcium|mesh-list
110922028|NCT04060030|Levoleucovorin|levoleucovorin|mesh-list
110922029|NCT04060030|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110254809|NCT00467662|Antiviral Agents|antiviral agents|mesh-ancestor
110922030|NCT04060030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110922031|NCT04060030|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110922032|NCT04060030|Antidotes|antidotes|mesh-ancestor
110922033|NCT04060030|Protective Agents|protective agents|mesh-ancestor
110922034|NCT04060030|Vitamin B Complex|vitamin b complex|mesh-ancestor
110922036|NCT04060030|Micronutrients|micronutrients|mesh-ancestor
110922037|NCT04005352|Aflibercept|aflibercept|mesh-list
110922038|NCT04005352|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110922039|NCT04005352|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110922040|NCT04005352|Growth Substances|growth substances|mesh-ancestor
110922041|NCT04005352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110922042|NCT04005352|Growth Inhibitors|growth inhibitors|mesh-ancestor
110922043|NCT04005352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110922044|NCT03913819|Cholinergic Antagonists|cholinergic antagonists|mesh-list
110922045|NCT03913819|Cholinergic Agents|cholinergic agents|mesh-ancestor
110922046|NCT03913819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110922047|NCT03913819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110922048|NCT03913819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110922049|NCT03819465|Paclitaxel|paclitaxel|mesh-list
110922050|NCT03819465|Carboplatin|carboplatin|mesh-list
110922051|NCT03819465|Gemcitabine|gemcitabine|mesh-list
110922052|NCT03819465|Pemetrexed|pemetrexed|mesh-list
110922053|NCT03819465|Durvalumab|durvalumab|mesh-list
110922054|NCT03819465|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110922055|NCT03819465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110922056|NCT03819465|Tubulin Modulators|tubulin modulators|mesh-ancestor
110922057|NCT03819465|Antimitotic Agents|antimitotic agents|mesh-ancestor
110922058|NCT03819465|Mitosis Modulators|mitosis modulators|mesh-ancestor
110922059|NCT03819465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110922060|NCT03819465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110922061|NCT03819465|Antimetabolites|antimetabolites|mesh-ancestor
110922062|NCT03819465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110922063|NCT03819465|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110922064|NCT03819465|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110922065|NCT03819465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110922066|NCT03713424|Clavulanic Acids|clavulanic acids|mesh-list
110922067|NCT03713424|Clavulanic Acid|clavulanic acid|mesh-list
110922068|NCT03713424|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110922069|NCT03713424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110922070|NCT03713424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110922071|NCT03713424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110922072|NCT03713424|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110922073|NCT03637803|Pembrolizumab|pembrolizumab|mesh-list
110922074|NCT03637803|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110922075|NCT03637803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110922076|NCT03637803|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110922077|NCT03637803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110922078|NCT03567720|Paclitaxel|paclitaxel|mesh-list
110922079|NCT03567720|Carboplatin|carboplatin|mesh-list
110922080|NCT03567720|Gemcitabine|gemcitabine|mesh-list
110922081|NCT03567720|Pembrolizumab|pembrolizumab|mesh-list
110922082|NCT03567720|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110922083|NCT03567720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110922084|NCT03567720|Tubulin Modulators|tubulin modulators|mesh-ancestor
110922085|NCT03567720|Antimitotic Agents|antimitotic agents|mesh-ancestor
110922086|NCT03567720|Mitosis Modulators|mitosis modulators|mesh-ancestor
110922087|NCT03567720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110922088|NCT03567720|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110922089|NCT03567720|Antimetabolites|antimetabolites|mesh-ancestor
110922090|NCT03567720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110922091|NCT03567720|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110922093|NCT03519906|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110922094|NCT03519906|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110922095|NCT03519906|Sympatholytics|sympatholytics|mesh-ancestor
110922096|NCT03519906|Autonomic Agents|autonomic agents|mesh-ancestor
110922097|NCT03519906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110255118|NCT05350592|Dobutamine|dobutamine|mesh-list
110922098|NCT03519906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110922099|NCT03519906|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110922100|NCT03519906|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110922101|NCT03519906|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110922102|NCT03519906|Adrenergic Agents|adrenergic agents|mesh-ancestor
110922103|NCT03519906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110922104|NCT03519906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110922106|NCT03519893|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110922107|NCT03519893|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110922108|NCT03519893|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110929286|NCT00394069|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110922109|NCT03519893|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110922110|NCT03519893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110922111|NCT03519256|Nivolumab|nivolumab|mesh-list
110922112|NCT03519256|Linrodostat|linrodostat|mesh-list
110922113|NCT03519256|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110922114|NCT03519256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110922115|NCT03519256|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110922116|NCT03519256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110255178|NCT00336154|Tetracycline|tetracycline|mesh-list
110922117|NCT03519256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110922118|NCT03507608|Flutamide|flutamide|mesh-list
110922119|NCT03507608|Androgen Antagonists|androgen antagonists|mesh-ancestor
110922120|NCT03507608|Hormone Antagonists|hormone antagonists|mesh-ancestor
110922121|NCT03507608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110922122|NCT03507608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110922123|NCT03507608|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110922124|NCT03507608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110922125|NCT03465579|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
110922126|NCT03465579|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110922127|NCT03465579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110922128|NCT03453528|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
110922129|NCT03453528|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110922130|NCT03453528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110922131|NCT03215927|Abatacept|abatacept|mesh-list
110922132|NCT03215927|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110922133|NCT03215927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110922134|NCT03215927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110922135|NCT03215927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110922136|NCT03215927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110922137|NCT03215927|Immunologic Factors|immunologic factors|mesh-ancestor
110922138|NCT03215927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110922139|NCT03215927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110922141|NCT02999230|Fluorides|fluorides|mesh-list
110922142|NCT02999230|Sodium Fluoride|sodium fluoride|mesh-list
110922143|NCT02999230|Cariostatic Agents|cariostatic agents|mesh-ancestor
110922144|NCT02999230|Protective Agents|protective agents|mesh-ancestor
110922145|NCT02999230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110922146|NCT02999230|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110922147|NCT02999230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110922148|NCT02941315|Captopril|captopril|mesh-list
110922149|NCT02941315|Spironolactone|spironolactone|mesh-list
110922150|NCT02941315|Furosemide|furosemide|mesh-list
110922151|NCT02941315|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
110922152|NCT02941315|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110922153|NCT02941315|Hormone Antagonists|hormone antagonists|mesh-ancestor
110922154|NCT02941315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110922155|NCT02941315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110922156|NCT02941315|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110922157|NCT02941315|Diuretics|diuretics|mesh-ancestor
110922158|NCT02941315|Natriuretic Agents|natriuretic agents|mesh-ancestor
110922159|NCT02941315|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110922160|NCT02941315|Adrenergic Agents|adrenergic agents|mesh-ancestor
110922161|NCT02941315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110365552|NCT04647669|Immunologic Factors|immunologic factors|mesh-ancestor
110922162|NCT02941315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110922163|NCT02941315|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110922164|NCT02941315|Protease Inhibitors|protease inhibitors|mesh-ancestor
110922165|NCT02941315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110922166|NCT02941315|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110922167|NCT02941315|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110922168|NCT02941315|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110922169|NCT02920229|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
110922170|NCT02920229|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110922171|NCT02920229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110922172|NCT02918721|Lidocaine|lidocaine|mesh-list
110922173|NCT02918721|Hyaluronic Acid|hyaluronic acid|mesh-list
110922174|NCT02918721|Anesthetics, Local|anesthetics, local|mesh-ancestor
110922175|NCT02918721|Anesthetics|anesthetics|mesh-ancestor
110255332|NCT00336739|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
110922176|NCT02918721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110922178|NCT02918721|Sensory System Agents|sensory system agents|mesh-ancestor
110922179|NCT02918721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110922180|NCT02918721|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110922181|NCT02918721|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110922182|NCT02918721|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110922183|NCT02918721|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110922184|NCT02918721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110922185|NCT02918721|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110922186|NCT02918721|Immunologic Factors|immunologic factors|mesh-ancestor
110922187|NCT02918721|Viscosupplements|viscosupplements|mesh-ancestor
110922188|NCT02918721|Protective Agents|protective agents|mesh-ancestor
110922189|NCT02884180|Dexamethasone|dexamethasone|mesh-list
110922190|NCT02884180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110922191|NCT02884180|Antiemetics|antiemetics|mesh-ancestor
110922192|NCT02884180|Autonomic Agents|autonomic agents|mesh-ancestor
110922193|NCT02884180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110922194|NCT02884180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110922195|NCT02884180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110922196|NCT02884180|Glucocorticoids|glucocorticoids|mesh-ancestor
110922197|NCT02884180|Hormones|hormones|mesh-ancestor
110922198|NCT02884180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110922199|NCT02884180|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110922200|NCT02884180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110922201|NCT02799602|Docetaxel|docetaxel|mesh-list
110922202|NCT02799602|Androgens|androgens|mesh-list
110922203|NCT02799602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110922204|NCT02799602|Tubulin Modulators|tubulin modulators|mesh-ancestor
110922205|NCT02799602|Antimitotic Agents|antimitotic agents|mesh-ancestor
110922206|NCT02799602|Mitosis Modulators|mitosis modulators|mesh-ancestor
110922207|NCT02799602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110922208|NCT02799602|Hormones|hormones|mesh-ancestor
110922209|NCT02799602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110922210|NCT02799602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110922211|NCT02770040|Infliximab|infliximab|mesh-list
110922212|NCT02770040|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110922213|NCT02770040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110922214|NCT02770040|Dermatologic Agents|dermatologic agents|mesh-ancestor
110922215|NCT02770040|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110922216|NCT02770040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110922217|NCT02754297|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
110922218|NCT02754297|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110922219|NCT02754297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110922220|NCT02291705|Tramadol|tramadol|mesh-list
110922221|NCT02291705|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110922222|NCT02291705|Narcotics|narcotics|mesh-ancestor
110922223|NCT02291705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110922224|NCT02291705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110922225|NCT02291705|Analgesics|analgesics|mesh-ancestor
110922226|NCT02291705|Sensory System Agents|sensory system agents|mesh-ancestor
110922227|NCT02291705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110922228|NCT02243709|Mifepristone|mifepristone|mesh-list
110922229|NCT02243709|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
110922230|NCT02243709|Abortifacient Agents|abortifacient agents|mesh-ancestor
110922231|NCT02243709|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110922232|NCT02243709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110922233|NCT02243709|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110922235|NCT02243709|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110922236|NCT02243709|Contraceptive Agents|contraceptive agents|mesh-ancestor
110922237|NCT02243709|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
110922238|NCT02243709|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
110922239|NCT02243709|Hormone Antagonists|hormone antagonists|mesh-ancestor
110922240|NCT02243709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110922241|NCT02243709|Luteolytic Agents|luteolytic agents|mesh-ancestor
110922242|NCT02243709|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110922243|NCT02243709|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
110922244|NCT02027935|Aldesleukin|aldesleukin|mesh-list
110922245|NCT02027935|Cyclophosphamide|cyclophosphamide|mesh-list
110922246|NCT02027935|Ipilimumab|ipilimumab|mesh-list
110922247|NCT02027935|Interleukin-2|interleukin-2|mesh-list
110922248|NCT02027935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110922249|NCT02027935|Immunologic Factors|immunologic factors|mesh-ancestor
110922250|NCT02027935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110922251|NCT02027935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110922252|NCT02027935|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110922253|NCT02027935|Alkylating Agents|alkylating agents|mesh-ancestor
110922254|NCT02027935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110922255|NCT02027935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110922256|NCT02027935|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110922257|NCT02027935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110922258|NCT02027935|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110922259|NCT02027935|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110922261|NCT02027935|Sensory System Agents|sensory system agents|mesh-ancestor
110922262|NCT02027935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110922263|NCT02027935|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110922264|NCT02027935|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110922265|NCT02027935|Antiviral Agents|antiviral agents|mesh-ancestor
110922266|NCT02027935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110922267|NCT01896011|Teriparatide|teriparatide|mesh-list
110922268|NCT01896011|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110922269|NCT01896011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110922270|NCT01896011|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110922271|NCT01891396|Hyaluronic Acid|hyaluronic acid|mesh-list
110922272|NCT01891396|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110922273|NCT01891396|Immunologic Factors|immunologic factors|mesh-ancestor
110922274|NCT01891396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110922275|NCT01891396|Viscosupplements|viscosupplements|mesh-ancestor
110922276|NCT01891396|Protective Agents|protective agents|mesh-ancestor
110922277|NCT01746225|Paclitaxel|paclitaxel|mesh-list
110922278|NCT01746225|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110922279|NCT01746225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110922280|NCT01746225|Tubulin Modulators|tubulin modulators|mesh-ancestor
110922281|NCT01746225|Antimitotic Agents|antimitotic agents|mesh-ancestor
110922282|NCT01746225|Mitosis Modulators|mitosis modulators|mesh-ancestor
110922283|NCT01746225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110922284|NCT01716806|Nivolumab|nivolumab|mesh-list
110922285|NCT01716806|Brentuximab Vedotin|brentuximab vedotin|mesh-list
110922286|NCT01716806|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110922287|NCT01716806|Dacarbazine|dacarbazine|mesh-list
110922288|NCT01716806|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110922289|NCT01716806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110922290|NCT01716806|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110922291|NCT01716806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110922292|NCT01716806|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110922293|NCT01716806|Alkylating Agents|alkylating agents|mesh-ancestor
110922294|NCT01716806|Immunotoxins|immunotoxins|mesh-ancestor
110922295|NCT01716806|Immunoconjugates|immunoconjugates|mesh-ancestor
110922296|NCT01716806|Immunologic Factors|immunologic factors|mesh-ancestor
110922297|NCT01716806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110922298|NCT01650545|Cyclosporine|cyclosporine|mesh-list
110922299|NCT01650545|Sirolimus|sirolimus|mesh-list
110922300|NCT01650545|Tacrolimus|tacrolimus|mesh-list
110922301|NCT01650545|Cyclosporins|cyclosporins|mesh-list
110922302|NCT01650545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110922303|NCT01650545|Immunologic Factors|immunologic factors|mesh-ancestor
110922304|NCT01650545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110922305|NCT01650545|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110922306|NCT01650545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110922307|NCT01650545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110922308|NCT01650545|Antifungal Agents|antifungal agents|mesh-ancestor
110922309|NCT01650545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110255734|NCT02953210|Histamine Agents|histamine agents|mesh-ancestor
110922310|NCT01650545|Dermatologic Agents|dermatologic agents|mesh-ancestor
110922311|NCT01650545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110922312|NCT01650545|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110922313|NCT01650545|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110922314|NCT01650545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110922315|NCT01191008|Timolol|timolol|mesh-list
110922316|NCT01191008|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110922317|NCT01191008|Latanoprost|latanoprost|mesh-list
110922318|NCT01191008|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110922319|NCT01191008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110922320|NCT01191008|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110922321|NCT01191008|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110922322|NCT01191008|Adrenergic Agents|adrenergic agents|mesh-ancestor
110922323|NCT01191008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110922324|NCT01191008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110922325|NCT01191008|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110922326|NCT01191008|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110922327|NCT01155232|Teriparatide|teriparatide|mesh-list
110255793|NCT00338221|Glycine|glycine|mesh-list
110922328|NCT01155232|Parathyroid Hormone|parathyroid hormone|mesh-list
110922329|NCT01155232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110922330|NCT01155232|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110922331|NCT01155232|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110922332|NCT00821587|Cyclosporine|cyclosporine|mesh-list
110922333|NCT00821587|Tacrolimus|tacrolimus|mesh-list
110922334|NCT00821587|Cyclosporins|cyclosporins|mesh-list
110922335|NCT00821587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110922336|NCT00821587|Immunologic Factors|immunologic factors|mesh-ancestor
110922337|NCT00821587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110922338|NCT00821587|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110922339|NCT00821587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110922340|NCT00821587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110922341|NCT00821587|Antifungal Agents|antifungal agents|mesh-ancestor
110922342|NCT00821587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110922343|NCT00821587|Dermatologic Agents|dermatologic agents|mesh-ancestor
110922344|NCT00821587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110922345|NCT00751829|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110922346|NCT00751829|Olmesartan|olmesartan|mesh-list
110922347|NCT00751829|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
110922348|NCT00751829|Nitrendipine|nitrendipine|mesh-list
110922349|NCT00751829|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110922350|NCT00751829|Diuretics|diuretics|mesh-ancestor
110922351|NCT00751829|Natriuretic Agents|natriuretic agents|mesh-ancestor
110922352|NCT00751829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110922353|NCT00751829|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110922354|NCT00751829|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110922355|NCT00751829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110922356|NCT00751829|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110922357|NCT00751829|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110922358|NCT00751829|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110929336|NCT03579927|Etoposide phosphate|etoposide phosphate|mesh-list
110922359|NCT00751829|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110922361|NCT00645801|Lubiprostone|lubiprostone|mesh-list
110922362|NCT00645801|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
110922363|NCT00645801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110255969|NCT00510211|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110922364|NCT00645801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110922365|NCT00424099|Methylphenidate|methylphenidate|mesh-list
110922366|NCT00424099|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110922367|NCT00424099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110922368|NCT00424099|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110922369|NCT00424099|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110922370|NCT00424099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110922371|NCT00424099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110922372|NCT00424099|Dopamine Agents|dopamine agents|mesh-ancestor
110922373|NCT00424099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110922374|NCT00382213|Olmesartan|olmesartan|mesh-list
110922375|NCT00382213|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
110922376|NCT00382213|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110922377|NCT00382213|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110922378|NCT00382213|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110922379|NCT00382213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110922380|NCT00176267|Paclitaxel|paclitaxel|mesh-list
110922381|NCT00176267|Carboplatin|carboplatin|mesh-list
110922382|NCT00176267|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110922383|NCT00176267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110922384|NCT00176267|Tubulin Modulators|tubulin modulators|mesh-ancestor
110922385|NCT00176267|Antimitotic Agents|antimitotic agents|mesh-ancestor
110922386|NCT00176267|Mitosis Modulators|mitosis modulators|mesh-ancestor
110922387|NCT00176267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110922388|NCT02298764|Psychotropic Drugs|psychotropic drugs|mesh-list
110922389|NCT02298920|Zoliflodacin|zoliflodacin|mesh-list
110922390|NCT02298920|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110922391|NCT02298920|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110922392|NCT02298920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110922393|NCT02298920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110922394|NCT02298920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110922395|NCT03517748|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110639910|NCT00615992|Tiotropium Bromide|tiotropium bromide|mesh-list
110922397|NCT03517670|Milrinone|milrinone|mesh-list
110922398|NCT03517670|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110922399|NCT03517670|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110922400|NCT03517670|Vasodilator Agents|vasodilator agents|mesh-ancestor
110922401|NCT03517670|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110922402|NCT03517670|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110922403|NCT03517670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110922404|NCT03517670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110922405|NCT03517670|Protective Agents|protective agents|mesh-ancestor
110922406|NCT03517670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110922407|NCT03316573|Pembrolizumab|pembrolizumab|mesh-list
110922408|NCT03316573|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110922409|NCT03316573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110922410|NCT03316573|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110365590|NCT04638816|Hyaluronic Acid|hyaluronic acid|mesh-list
110922411|NCT03316573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110922412|NCT00109668|Beclomethasone|beclomethasone|mesh-list
110922413|NCT00109668|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110922414|NCT00109668|Glucocorticoids|glucocorticoids|mesh-ancestor
110922415|NCT00109668|Hormones|hormones|mesh-ancestor
110922416|NCT00109668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110922417|NCT00109668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110922418|NCT00109668|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110922419|NCT00109668|Respiratory System Agents|respiratory system agents|mesh-ancestor
110922420|NCT03104140|Ketamine|ketamine|mesh-list
110922421|NCT03104140|Thiopental|thiopental|mesh-list
110922422|NCT03104140|Analgesics|analgesics|mesh-ancestor
110922423|NCT03104140|Sensory System Agents|sensory system agents|mesh-ancestor
110922424|NCT03104140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110256129|NCT00150657|Antimetabolites|antimetabolites|mesh-ancestor
110922425|NCT03104140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110922426|NCT03104140|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110922427|NCT03104140|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110922428|NCT03104140|Anesthetics, General|anesthetics, general|mesh-ancestor
110922430|NCT03104140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110922431|NCT03104140|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110922432|NCT03104140|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110922433|NCT03104140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110922434|NCT03104140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110922435|NCT03104140|Anticonvulsants|anticonvulsants|mesh-ancestor
110922436|NCT03104140|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110922437|NCT03104140|GABA Modulators|gaba modulators|mesh-ancestor
110922438|NCT03104140|GABA Agents|gaba agents|mesh-ancestor
110922439|NCT03520478|Bicalutamide|bicalutamide|mesh-list
110922440|NCT03520478|Androgen Antagonists|androgen antagonists|mesh-ancestor
110922441|NCT03520478|Hormone Antagonists|hormone antagonists|mesh-ancestor
110922442|NCT03520478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110922443|NCT03520478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110922444|NCT03520478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110922445|NCT00102648|Temozolomide|temozolomide|mesh-list
110922447|NCT00102648|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110922448|NCT00102648|Alkylating Agents|alkylating agents|mesh-ancestor
110922449|NCT00102648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110922450|NCT00102648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110922451|NCT00102648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110922453|NCT03290287|Anticonvulsants|anticonvulsants|mesh-ancestor
110922454|NCT02253888|Ritonavir|ritonavir|mesh-list
110922455|NCT02253888|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110922456|NCT02253888|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110922457|NCT02253888|Protease Inhibitors|protease inhibitors|mesh-ancestor
110922458|NCT02253888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110922459|NCT02253888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110922460|NCT02253888|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110922461|NCT02253888|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110922462|NCT02253888|Antiviral Agents|antiviral agents|mesh-ancestor
110922463|NCT02253888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110922464|NCT02253888|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110922465|NCT02253888|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110922466|NCT05430802|Pemetrexed|pemetrexed|mesh-list
110922467|NCT05430802|Aflutinib|aflutinib|mesh-list
110922468|NCT05430802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110922469|NCT05430802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110922470|NCT05430802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110922472|NCT05430802|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110922473|NCT05430802|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110922474|NCT05524038|Dexamethasone|dexamethasone|mesh-list
110922475|NCT05524038|Dexamethasone acetate|dexamethasone acetate|mesh-list
110922476|NCT05524038|Bupivacaine|bupivacaine|mesh-list
110922477|NCT05524038|BB 1101|bb 1101|mesh-list
110922478|NCT05524038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110922479|NCT05524038|Antiemetics|antiemetics|mesh-ancestor
110922480|NCT05524038|Autonomic Agents|autonomic agents|mesh-ancestor
110922481|NCT05524038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110922482|NCT05524038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110365604|NCT04638816|Viscosupplements|viscosupplements|mesh-ancestor
110922483|NCT05524038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110922484|NCT05524038|Glucocorticoids|glucocorticoids|mesh-ancestor
110922486|NCT05524038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110922487|NCT05524038|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110922488|NCT05524038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110922489|NCT05524038|Protease Inhibitors|protease inhibitors|mesh-ancestor
110922490|NCT05524038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110922491|NCT05524038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110922492|NCT05524038|Anesthetics, Local|anesthetics, local|mesh-ancestor
110922493|NCT05524038|Anesthetics|anesthetics|mesh-ancestor
110922494|NCT05524038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110922495|NCT05524038|Sensory System Agents|sensory system agents|mesh-ancestor
110922496|NCT03240835|Docetaxel|docetaxel|mesh-list
110922497|NCT03240835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110922498|NCT03240835|Tubulin Modulators|tubulin modulators|mesh-ancestor
110922499|NCT03240835|Antimitotic Agents|antimitotic agents|mesh-ancestor
110922500|NCT03240835|Mitosis Modulators|mitosis modulators|mesh-ancestor
110922501|NCT03240835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110922502|NCT04118868|Pembrolizumab|pembrolizumab|mesh-list
110922503|NCT04118868|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110922504|NCT04118868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110922505|NCT04118868|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110922506|NCT04118868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110922507|NCT04900350|Azacitidine|azacitidine|mesh-list
110922508|NCT04900350|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110922509|NCT04900350|Antimetabolites|antimetabolites|mesh-ancestor
110922510|NCT04900350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110922511|NCT04900350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110922512|NCT04900350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110922513|NCT02292290|Pioglitazone|pioglitazone|mesh-list
110922514|NCT02292290|Liraglutide|liraglutide|mesh-list
110922515|NCT02292290|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110922516|NCT02292290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110922517|NCT02292290|Incretins|incretins|mesh-ancestor
110922518|NCT02292290|Hormones|hormones|mesh-ancestor
110922519|NCT02292290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110922520|NCT02299232|Dexmedetomidine|dexmedetomidine|mesh-list
110922521|NCT02299232|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110922522|NCT02299232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110922523|NCT02299232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110922524|NCT02299232|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110922525|NCT02299232|Analgesics|analgesics|mesh-ancestor
110922526|NCT02299232|Sensory System Agents|sensory system agents|mesh-ancestor
110922527|NCT02299232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110922528|NCT02299232|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110922529|NCT02299232|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110922530|NCT02299232|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110922531|NCT02299232|Adrenergic Agents|adrenergic agents|mesh-ancestor
110922532|NCT02299232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110922533|NCT02299232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110922534|NCT02963493|Dexamethasone|dexamethasone|mesh-list
110922535|NCT02963493|Melphalan|melphalan|mesh-list
110922536|NCT02963493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110922537|NCT02963493|Antiemetics|antiemetics|mesh-ancestor
110922538|NCT02963493|Autonomic Agents|autonomic agents|mesh-ancestor
110922539|NCT02963493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110922540|NCT02963493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110922541|NCT02963493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110922542|NCT02963493|Glucocorticoids|glucocorticoids|mesh-ancestor
110922543|NCT02963493|Hormones|hormones|mesh-ancestor
110922544|NCT02963493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110922546|NCT02963493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110922547|NCT02963493|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110922548|NCT02963493|Alkylating Agents|alkylating agents|mesh-ancestor
110922549|NCT02963493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110922550|NCT02963493|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110922551|NCT02963493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110922552|NCT02963493|Immunologic Factors|immunologic factors|mesh-ancestor
110922554|NCT02299310|Perindopril|perindopril|mesh-list
110922555|NCT02299310|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110922556|NCT02299310|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110922557|NCT02299310|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110922558|NCT02299310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110922559|NCT02299310|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110922560|NCT02299310|Protease Inhibitors|protease inhibitors|mesh-ancestor
110922561|NCT02299310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110922562|NCT03519776|Progesterone|progesterone|mesh-list
110922563|NCT03519776|Progestins|progestins|mesh-ancestor
110922565|NCT03519776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110922566|NCT03519776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110922567|NCT02295566|Nitric Oxide|nitric oxide|mesh-list
110922568|NCT02295566|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110922569|NCT02295566|Autonomic Agents|autonomic agents|mesh-ancestor
110922570|NCT02295566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110922571|NCT02295566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110922572|NCT02295566|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110922573|NCT02295566|Respiratory System Agents|respiratory system agents|mesh-ancestor
110922574|NCT02295566|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110922575|NCT02295566|Antioxidants|antioxidants|mesh-ancestor
110922576|NCT02295566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110922577|NCT02295566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110922578|NCT02295566|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
110922579|NCT02295566|Vasodilator Agents|vasodilator agents|mesh-ancestor
110922580|NCT02295566|Gasotransmitters|gasotransmitters|mesh-ancestor
110922581|NCT02295566|Protective Agents|protective agents|mesh-ancestor
110922582|NCT05283681|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110922583|NCT05283681|Immunologic Factors|immunologic factors|mesh-ancestor
110922584|NCT05283681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110922585|NCT03513458|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
110922586|NCT03513458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110922587|NCT03738397|Upadacitinib|upadacitinib|mesh-list
110922588|NCT03738397|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110922589|NCT03738397|Immunologic Factors|immunologic factors|mesh-ancestor
110922590|NCT03738397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110922591|NCT03738397|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
110922592|NCT03738397|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110922593|NCT03738397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110922594|NCT03738397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110922595|NCT03738397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110922596|NCT03643497|Meropenem|meropenem|mesh-list
110922597|NCT03643497|Linezolid|linezolid|mesh-list
110922598|NCT03643497|Anti-Infective Agents|anti-infective agents|mesh-list
110922599|NCT03643497|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110922600|NCT03643497|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110922601|NCT03643497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110922602|NCT03643497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110922603|NCT03519542|Sunitinib|sunitinib|mesh-list
110922604|NCT03519542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110922605|NCT03519542|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110922606|NCT03519542|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110922607|NCT03519542|Growth Substances|growth substances|mesh-ancestor
110922608|NCT03519542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110922609|NCT03519542|Growth Inhibitors|growth inhibitors|mesh-ancestor
110277851|NCT00575848|Glycine|glycine|mesh-list
110922610|NCT03519542|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110922611|NCT03519542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110922612|NCT03519542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110922613|NCT03516500|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
110922614|NCT03516500|Hematinics|hematinics|mesh-ancestor
110922615|NCT02293148|Moxifloxacin|moxifloxacin|mesh-list
110640135|NCT00872378|Incretins|incretins|mesh-ancestor
110922616|NCT02293148|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
110922618|NCT02293148|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110922619|NCT02293148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110922620|NCT02293148|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110922621|NCT02293148|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110922622|NCT02293148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110922623|NCT02293148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110922624|NCT02293148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110922625|NCT02293148|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110922626|NCT02293148|Contraceptive Agents|contraceptive agents|mesh-ancestor
110922627|NCT02293148|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110922628|NCT02293148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110922629|NCT02293148|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110922630|NCT02293148|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110922631|NCT02293148|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110922632|NCT02293148|Glycine Agents|glycine agents|mesh-ancestor
110922633|NCT02293148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110922634|NCT03519152|Diclofenac|diclofenac|mesh-list
110922635|NCT03519152|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110922636|NCT03519152|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110257145|NCT05501665|Paclitaxel|paclitaxel|mesh-list
110922637|NCT03519152|Analgesics|analgesics|mesh-ancestor
110922638|NCT03519152|Sensory System Agents|sensory system agents|mesh-ancestor
110922639|NCT03519152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110922640|NCT03519152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110922641|NCT03519152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110922642|NCT03519152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110922643|NCT03519152|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110922644|NCT03519152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110922645|NCT03519152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110922646|NCT02959983|Eluxadoline|eluxadoline|mesh-list
110922647|NCT02959983|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110922648|NCT03516188|Antacids|antacids|mesh-list
110922649|NCT03516188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110922650|NCT03516188|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110922652|NCT03512990|Anesthetics, Local|anesthetics, local|mesh-ancestor
110922653|NCT03512990|Anesthetics|anesthetics|mesh-ancestor
110922654|NCT03512990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110922655|NCT03512990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110922656|NCT03512990|Sensory System Agents|sensory system agents|mesh-ancestor
110922657|NCT03512990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110922658|NCT03512834|Paclitaxel|paclitaxel|mesh-list
110922659|NCT03512834|Avelumab|avelumab|mesh-list
110922660|NCT03512834|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110922661|NCT03512834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110922662|NCT03512834|Tubulin Modulators|tubulin modulators|mesh-ancestor
110922663|NCT03512834|Antimitotic Agents|antimitotic agents|mesh-ancestor
110922664|NCT03512834|Mitosis Modulators|mitosis modulators|mesh-ancestor
110922665|NCT03512834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110922666|NCT03512834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110922667|NCT03640221|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
110922668|NCT03640221|Ertugliflozin|ertugliflozin|mesh-list
110922669|NCT03640221|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110922670|NCT03640221|Antihypertensive Agents|antihypertensive agents|mesh-list
110922671|NCT03640221|Diuretics|diuretics|mesh-ancestor
110922672|NCT03640221|Natriuretic Agents|natriuretic agents|mesh-ancestor
110922673|NCT03640221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110922674|NCT03640221|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110922675|NCT03640221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110922676|NCT03640221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110922677|NCT03640221|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110922678|NCT03518528|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110922679|NCT03518528|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110922680|NCT03518528|Estradiol|estradiol|mesh-list
110922681|NCT03518528|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110922682|NCT03518528|Estrogens|estrogens|mesh-ancestor
110922683|NCT03518528|Hormones|hormones|mesh-ancestor
110922684|NCT03518528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110922685|NCT03518528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110922686|NCT03518528|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110922687|NCT03518528|Contraceptive Agents|contraceptive agents|mesh-ancestor
110640212|NCT00994383|Analgesics|analgesics|mesh-ancestor
110922688|NCT03518528|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110922689|NCT03518528|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110922690|NCT03515798|Paclitaxel|paclitaxel|mesh-list
110922691|NCT03515798|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110922692|NCT03515798|Cyclophosphamide|cyclophosphamide|mesh-list
110922693|NCT03515798|Pembrolizumab|pembrolizumab|mesh-list
110922694|NCT03515798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110922695|NCT03515798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110922696|NCT03515798|Tubulin Modulators|tubulin modulators|mesh-ancestor
110922697|NCT03515798|Antimitotic Agents|antimitotic agents|mesh-ancestor
110922698|NCT03515798|Mitosis Modulators|mitosis modulators|mesh-ancestor
110922699|NCT03515798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110922700|NCT03515798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110922701|NCT03515798|Immunologic Factors|immunologic factors|mesh-ancestor
110922702|NCT03515798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110922703|NCT03515798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110922704|NCT03515798|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110922705|NCT03515798|Alkylating Agents|alkylating agents|mesh-ancestor
110922706|NCT03515798|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110922707|NCT03515798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110922708|NCT03515798|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110922709|NCT03041701|Dasatinib|dasatinib|mesh-list
110922710|NCT03041701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110922711|NCT03041701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110922712|NCT03041701|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110922713|NCT03041701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110922714|NCT02293694|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
110922715|NCT02293694|Medroxyprogesterone|medroxyprogesterone|mesh-list
110922716|NCT02293694|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110922717|NCT02293694|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110922718|NCT02293694|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110922719|NCT02293694|Contraceptive Agents|contraceptive agents|mesh-ancestor
110922720|NCT02293694|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110922722|NCT02293694|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110922723|NCT02293694|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110922724|NCT02293694|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110922725|NCT02293694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110922726|NCT02293694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110922727|NCT02956629|Ribavirin|ribavirin|mesh-list
110922728|NCT02956629|Ruzasvir|ruzasvir|mesh-list
110922729|NCT02956629|Uprifosbuvir|uprifosbuvir|mesh-list
110922730|NCT02956629|Antimetabolites|antimetabolites|mesh-ancestor
110929404|NCT03539328|Paclitaxel|paclitaxel|mesh-list
110922731|NCT02956629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110922732|NCT02956629|Antiviral Agents|antiviral agents|mesh-ancestor
110922733|NCT02956629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110922734|NCT02297204|Aflibercept|aflibercept|mesh-list
110922735|NCT02297204|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110922736|NCT02297204|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110922737|NCT02297204|Growth Substances|growth substances|mesh-ancestor
110922738|NCT02297204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110922739|NCT02297204|Growth Inhibitors|growth inhibitors|mesh-ancestor
110922740|NCT02297204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110922741|NCT02294006|Metformin|metformin|mesh-list
110922742|NCT02294006|Everolimus|everolimus|mesh-list
110922743|NCT02294006|Octreotide|octreotide|mesh-list
110922744|NCT02294006|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110922745|NCT02294006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110922746|NCT02294006|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110922747|NCT02294006|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110922748|NCT02294006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110922749|NCT02294006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110922750|NCT02294006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110922751|NCT02294006|Immunologic Factors|immunologic factors|mesh-ancestor
110922752|NCT02294006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110922753|NCT02294006|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110922754|NCT02294006|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110922755|NCT02294084|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110257755|NCT03896880|Miconazole|miconazole|mesh-list
110922756|NCT02294084|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110922757|NCT02294084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110922758|NCT02294084|Incretins|incretins|mesh-ancestor
110922759|NCT02294084|Hormones|hormones|mesh-ancestor
110922760|NCT02294084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110922761|NCT02294084|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110922762|NCT02294084|Protease Inhibitors|protease inhibitors|mesh-ancestor
110922763|NCT02294084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110922764|NCT02294084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110922766|NCT01597258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110922767|NCT01597258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110922768|NCT01597258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110922769|NCT01597258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110922770|NCT02958267|Hyaluronic Acid|hyaluronic acid|mesh-list
110922771|NCT02958267|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110922772|NCT02958267|Immunologic Factors|immunologic factors|mesh-ancestor
110922773|NCT02958267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110922774|NCT02958267|Viscosupplements|viscosupplements|mesh-ancestor
110922775|NCT02958267|Protective Agents|protective agents|mesh-ancestor
110922776|NCT02302430|Oxytocin|oxytocin|mesh-list
110922777|NCT02302430|Oxytocics|oxytocics|mesh-ancestor
110922778|NCT02302430|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110922779|NCT02302430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110922781|NCT02300948|Vitamin B Complex|vitamin b complex|mesh-list
110922782|NCT02300948|Hematinics|hematinics|mesh-ancestor
110922783|NCT02300948|Vitamins|vitamins|mesh-ancestor
110922784|NCT02300948|Micronutrients|micronutrients|mesh-ancestor
110922785|NCT02300948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110922786|NCT02302508|Clopidogrel|clopidogrel|mesh-list
110922787|NCT02302508|Ticagrelor|ticagrelor|mesh-list
110922788|NCT02302508|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
110922789|NCT02302508|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110922790|NCT02302508|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110922791|NCT02302508|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110922792|NCT02302508|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110922793|NCT02302508|Purinergic Agents|purinergic agents|mesh-ancestor
110922794|NCT02302508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110922795|NCT02302508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110257929|NCT02811523|Doxorubicin|doxorubicin|mesh-list
110922796|NCT02302508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110922798|NCT02297594|Antiviral Agents|antiviral agents|mesh-ancestor
110922799|NCT02297594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110922800|NCT02301026|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
110922801|NCT02301026|Hematinics|hematinics|mesh-ancestor
110922802|NCT01952574|Erenumab|erenumab|mesh-list
110922803|NCT01952574|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110365652|NCT00544232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110922804|NCT01952574|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
110922805|NCT01952574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110922806|NCT01952574|Analgesics|analgesics|mesh-ancestor
110922807|NCT01952574|Sensory System Agents|sensory system agents|mesh-ancestor
110922808|NCT01952574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110922809|NCT01952574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110922810|NCT01952574|Immunologic Factors|immunologic factors|mesh-ancestor
110922811|NCT02302586|Morphine|morphine|mesh-list
110922812|NCT02302586|Bupivacaine|bupivacaine|mesh-list
110922813|NCT02302586|Anesthetics, Local|anesthetics, local|mesh-ancestor
110922814|NCT02302586|Anesthetics|anesthetics|mesh-ancestor
110922815|NCT02302586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110922816|NCT02302586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110922817|NCT02302586|Sensory System Agents|sensory system agents|mesh-ancestor
110922818|NCT02302586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110922819|NCT02302586|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110922820|NCT02302586|Narcotics|narcotics|mesh-ancestor
110922821|NCT02302586|Analgesics|analgesics|mesh-ancestor
110922822|NCT04484272|Analgesics, Opioid|analgesics, opioid|mesh-list
110922823|NCT04484272|Narcotics|narcotics|mesh-ancestor
110257988|NCT02144857|Etanercept|etanercept|mesh-list
110922824|NCT04484272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110922825|NCT04484272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110922826|NCT04484272|Analgesics|analgesics|mesh-ancestor
110922827|NCT04484272|Sensory System Agents|sensory system agents|mesh-ancestor
110922828|NCT04484272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110922829|NCT01551472|Vitamin E|vitamin e|mesh-list
110922830|NCT01551472|Vitamins|vitamins|mesh-ancestor
110922831|NCT01551472|Micronutrients|micronutrients|mesh-ancestor
110922832|NCT01551472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110922833|NCT01551472|Antioxidants|antioxidants|mesh-ancestor
110258035|NCT00937131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110922834|NCT01551472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110922835|NCT01551472|Protective Agents|protective agents|mesh-ancestor
110922836|NCT02254044|Maytansine|maytansine|mesh-list
110922837|NCT02254044|Bivatuzumab mertansine|bivatuzumab mertansine|mesh-list
110922838|NCT02254044|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110922839|NCT02254044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110922840|NCT02254044|Tubulin Modulators|tubulin modulators|mesh-ancestor
110922841|NCT02254044|Antimitotic Agents|antimitotic agents|mesh-ancestor
110922842|NCT02254044|Mitosis Modulators|mitosis modulators|mesh-ancestor
110258102|NCT00516958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110922843|NCT02254044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110922844|NCT02254044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110922846|NCT02254044|Immunoconjugates|immunoconjugates|mesh-ancestor
110922847|NCT02254044|Immunologic Factors|immunologic factors|mesh-ancestor
110922848|NCT02254044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110922849|NCT02959437|Pembrolizumab|pembrolizumab|mesh-list
110922850|NCT02959437|Azacitidine|azacitidine|mesh-list
110922851|NCT02959437|INCB057643|incb057643|mesh-list
110922852|NCT02959437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110922853|NCT02959437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110922854|NCT02959437|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110922855|NCT02959437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110922856|NCT02959437|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110922858|NCT02959437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110922859|NCT02297906|Ketorolac|ketorolac|mesh-list
110922860|NCT02297906|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110922861|NCT02297906|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110922862|NCT02297906|Analgesics|analgesics|mesh-ancestor
110922863|NCT02297906|Sensory System Agents|sensory system agents|mesh-ancestor
110922864|NCT02297906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110922865|NCT02297906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110922866|NCT02297906|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110922867|NCT02297906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110922868|NCT02297906|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110922869|NCT02297906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110922870|NCT02297906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110922871|NCT03511820|Amphotericin B|amphotericin b|mesh-list
110922872|NCT03511820|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
110922873|NCT03511820|Amebicides|amebicides|mesh-ancestor
110922874|NCT03511820|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110922875|NCT03511820|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110922876|NCT03511820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110922877|NCT03511820|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110922879|NCT02957331|Propranolol|propranolol|mesh-list
110922880|NCT02957331|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110922881|NCT02957331|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110922882|NCT02957331|Adrenergic Agents|adrenergic agents|mesh-ancestor
110922883|NCT02957331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110922884|NCT02957331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110922885|NCT02957331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110922886|NCT02957331|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110922887|NCT02957331|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110922888|NCT02957331|Vasodilator Agents|vasodilator agents|mesh-ancestor
110922889|NCT02298062|Infliximab|infliximab|mesh-list
110258282|NCT02949466|Hormones|hormones|mesh-ancestor
110922890|NCT02298062|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110922892|NCT02298062|Dermatologic Agents|dermatologic agents|mesh-ancestor
110922893|NCT02298062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110258355|NCT02949193|Hormones|hormones|mesh-ancestor
110922894|NCT02298062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110922896|NCT03515018|Hydroxyurea|hydroxyurea|mesh-list
110922897|NCT03515018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110922898|NCT03515018|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110922899|NCT03515018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110922900|NCT03515018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110922901|NCT03515018|Antisickling Agents|antisickling agents|mesh-ancestor
110922902|NCT03515018|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110922903|NCT03748966|Calcitriol|calcitriol|mesh-list
110922904|NCT03748966|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
110922905|NCT03748966|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110922906|NCT03748966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110922907|NCT03748966|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
110922908|NCT03748966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110922909|NCT03748966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110922911|NCT03748966|Vitamins|vitamins|mesh-ancestor
110922912|NCT03748966|Micronutrients|micronutrients|mesh-ancestor
110922913|NCT03748966|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110922914|NCT05891145|Midazolam|midazolam|mesh-list
110922915|NCT05891145|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110922916|NCT05891145|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110922917|NCT05891145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110922918|NCT05891145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110922919|NCT05891145|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110922920|NCT05891145|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110922921|NCT05891145|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110922922|NCT05891145|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110922923|NCT05891145|Anesthetics, General|anesthetics, general|mesh-ancestor
110922925|NCT05891145|GABA Modulators|gaba modulators|mesh-ancestor
110922926|NCT05891145|GABA Agents|gaba agents|mesh-ancestor
110922927|NCT05891145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110922928|NCT05891145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110922929|NCT05891093|Tamoxifen|tamoxifen|mesh-list
110922930|NCT05891093|Toremifene|toremifene|mesh-list
110922931|NCT05891093|Letrozole|letrozole|mesh-list
110922932|NCT05891093|Anastrozole|anastrozole|mesh-list
110922933|NCT05891093|Exemestane|exemestane|mesh-list
110922934|NCT05891093|Fluzoparib|fluzoparib|mesh-list
110922935|NCT05891093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110922936|NCT05891093|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110922937|NCT05891093|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110922938|NCT05891093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110922939|NCT05891093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110922940|NCT05891093|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110922941|NCT05891093|Hormone Antagonists|hormone antagonists|mesh-ancestor
110258524|NCT00151983|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110922942|NCT05891093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110922943|NCT05891093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110922944|NCT05891093|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110922945|NCT05891093|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110922946|NCT05891093|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110922947|NCT05891093|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110922948|NCT05891093|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110922949|NCT05891080|Paclitaxel|paclitaxel|mesh-list
110922950|NCT05891080|Carboplatin|carboplatin|mesh-list
110922951|NCT05891080|Pemetrexed|pemetrexed|mesh-list
110922952|NCT05891080|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110922953|NCT05891080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110922954|NCT05891080|Tubulin Modulators|tubulin modulators|mesh-ancestor
110922955|NCT05891080|Antimitotic Agents|antimitotic agents|mesh-ancestor
110922956|NCT05891080|Mitosis Modulators|mitosis modulators|mesh-ancestor
110922957|NCT05891080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110922958|NCT05891080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110922959|NCT05891080|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110922960|NCT05891080|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110922961|NCT05890911|Dopamine|dopamine|mesh-list
110922962|NCT05890911|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110922963|NCT05890911|Sympathomimetics|sympathomimetics|mesh-ancestor
110922964|NCT05890911|Autonomic Agents|autonomic agents|mesh-ancestor
110922965|NCT05890911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110922966|NCT05890911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110922967|NCT05890911|Dopamine Agents|dopamine agents|mesh-ancestor
110922968|NCT05890911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110922969|NCT05890911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110922970|NCT05890911|Protective Agents|protective agents|mesh-ancestor
110922971|NCT05890768|Risperidone|risperidone|mesh-list
110922972|NCT05890768|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110922973|NCT05890768|Serotonin Agents|serotonin agents|mesh-ancestor
110922974|NCT05890768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110922975|NCT05890768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110922976|NCT05890768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110922978|NCT05890768|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110922979|NCT05890768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110922981|NCT05890768|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110922982|NCT05890768|Dopamine Agents|dopamine agents|mesh-ancestor
110922983|NCT05890703|Lidocaine|lidocaine|mesh-list
110922984|NCT05890703|Tetracaine|tetracaine|mesh-list
110922985|NCT05890703|Anesthetics, Local|anesthetics, local|mesh-ancestor
110922986|NCT05890703|Anesthetics|anesthetics|mesh-ancestor
110922987|NCT05890703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110922988|NCT05890703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110922989|NCT05890703|Sensory System Agents|sensory system agents|mesh-ancestor
110922990|NCT05890703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110922991|NCT05890703|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110922992|NCT05890703|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110258702|NCT04083560|Hydroxocobalamin|hydroxocobalamin|mesh-list
110922993|NCT05890703|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110922994|NCT05890703|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110922995|NCT05890703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110922997|NCT05890664|Gout Suppressants|gout suppressants|mesh-ancestor
110922998|NCT05890664|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110258757|NCT00523159|Sargramostim|sargramostim|mesh-list
110922999|NCT05890664|Tubulin Modulators|tubulin modulators|mesh-ancestor
110923000|NCT05890664|Antimitotic Agents|antimitotic agents|mesh-ancestor
110923001|NCT05890664|Mitosis Modulators|mitosis modulators|mesh-ancestor
110923002|NCT05890664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110923003|NCT05890664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110923004|NCT05890495|Lidocaine|lidocaine|mesh-list
110923005|NCT05890495|Anesthetics, Local|anesthetics, local|mesh-ancestor
110923006|NCT05890495|Anesthetics|anesthetics|mesh-ancestor
110923007|NCT05890495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110923008|NCT05890495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110923009|NCT05890495|Sensory System Agents|sensory system agents|mesh-ancestor
110923010|NCT05890495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110923011|NCT05890495|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110923013|NCT05890495|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110923014|NCT05890495|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110923015|NCT05890495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110923016|NCT05890287|Tamoxifen|tamoxifen|mesh-list
110923017|NCT05890287|Letrozole|letrozole|mesh-list
110923018|NCT05890287|Fulvestrant|fulvestrant|mesh-list
110923019|NCT05890287|Anastrozole|anastrozole|mesh-list
110923020|NCT05890287|Exemestane|exemestane|mesh-list
110923021|NCT05890287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110923022|NCT05890287|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110258950|NCT04696120|Apixaban|apixaban|mesh-list
110923023|NCT05890287|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110923024|NCT05890287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110923025|NCT05890287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110923026|NCT05890287|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110923027|NCT05890287|Hormone Antagonists|hormone antagonists|mesh-ancestor
110923028|NCT05890287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110923029|NCT05890287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110923030|NCT05890287|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110258953|NCT04696120|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110923031|NCT05890287|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110923032|NCT05890287|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110923033|NCT05890287|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110923034|NCT05890287|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110923036|NCT05890235|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110923037|NCT05890235|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110923038|NCT05890235|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110923039|NCT05890235|Adrenergic Agents|adrenergic agents|mesh-ancestor
110923040|NCT05890235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110923041|NCT05890235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110923042|NCT05890235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110923043|NCT05890235|Urological Agents|urological agents|mesh-ancestor
110923044|NCT05887505|Vitamin D|vitamin d|mesh-list
110923045|NCT05887505|Vitamins|vitamins|mesh-ancestor
110923046|NCT05887505|Micronutrients|micronutrients|mesh-ancestor
110923047|NCT05887505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110923048|NCT05887505|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110923049|NCT05882162|Calcium|calcium|mesh-list
110923050|NCT05882162|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110923051|NCT05882162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110923052|NCT05881486|Ondansetron|ondansetron|mesh-list
110923053|NCT05881486|Fosaprepitant|fosaprepitant|mesh-list
110923054|NCT05881486|Aprepitant|aprepitant|mesh-list
110923055|NCT05881486|Antiemetics|antiemetics|mesh-ancestor
110923056|NCT05881486|Autonomic Agents|autonomic agents|mesh-ancestor
110923057|NCT05881486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110923058|NCT05881486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110923059|NCT05881486|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110259084|NCT03879122|Hormones|hormones|mesh-ancestor
110923060|NCT05881486|Antipruritics|antipruritics|mesh-ancestor
110923061|NCT05881486|Dermatologic Agents|dermatologic agents|mesh-ancestor
110923062|NCT05881486|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110640581|NCT05653661|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110923063|NCT05881486|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110923064|NCT05881486|Serotonin Agents|serotonin agents|mesh-ancestor
110923065|NCT05881486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110923066|NCT05881486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110923067|NCT05881486|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110923068|NCT05826912|Minocycline|minocycline|mesh-list
110923069|NCT05826912|Candesartan|candesartan|mesh-list
110923070|NCT05826912|Candesartan cilexetil|candesartan cilexetil|mesh-list
110923071|NCT05826912|Atorvastatin|atorvastatin|mesh-list
110923073|NCT05826912|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110923074|NCT05826912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110923075|NCT05826912|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110923076|NCT05826912|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110923077|NCT05826912|Antimetabolites|antimetabolites|mesh-ancestor
110923078|NCT05826912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110923079|NCT05826912|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110923080|NCT05826912|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110923081|NCT05826912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110923082|NCT05826912|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110923083|NCT05826912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110923084|NCT05826912|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110923085|NCT05826912|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110923086|NCT05826912|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110923087|NCT05806060|Paclitaxel|paclitaxel|mesh-list
110923088|NCT05806060|Vinorelbine|vinorelbine|mesh-list
110923089|NCT05806060|Carboplatin|carboplatin|mesh-list
110923090|NCT05806060|Capecitabine|capecitabine|mesh-list
110259137|NCT00525967|Acetaminophen|acetaminophen|mesh-list
110923091|NCT05806060|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110923092|NCT05806060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110923093|NCT05806060|Tubulin Modulators|tubulin modulators|mesh-ancestor
110923094|NCT05806060|Antimitotic Agents|antimitotic agents|mesh-ancestor
110923095|NCT05806060|Mitosis Modulators|mitosis modulators|mesh-ancestor
110923096|NCT05806060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110923097|NCT05806060|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110923098|NCT05806060|Antimetabolites|antimetabolites|mesh-ancestor
110923099|NCT05770297|Propolis|propolis|mesh-list
110923100|NCT05770297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110923101|NCT05760378|Carboplatin|carboplatin|mesh-list
110923102|NCT05760378|Capecitabine|capecitabine|mesh-list
110923103|NCT05760378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110923104|NCT05760378|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110923105|NCT05760378|Antimetabolites|antimetabolites|mesh-ancestor
110923106|NCT05760378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110923107|NCT05744635|Tacrolimus|tacrolimus|mesh-list
110923108|NCT05744635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110923109|NCT05744635|Immunologic Factors|immunologic factors|mesh-ancestor
110923110|NCT05744635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110923111|NCT05744635|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110923112|NCT05744635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110923113|NCT05744635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110923114|NCT05733689|Paclitaxel|paclitaxel|mesh-list
110923115|NCT05733689|Docetaxel|docetaxel|mesh-list
110923116|NCT05733689|Carboplatin|carboplatin|mesh-list
110923117|NCT05733689|Pembrolizumab|pembrolizumab|mesh-list
110923118|NCT05733689|Nivolumab|nivolumab|mesh-list
110923119|NCT05733689|Irinotecan|irinotecan|mesh-list
110923120|NCT05733689|Folfirinox|folfirinox|mesh-list
110923121|NCT05733689|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110923122|NCT05733689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110923123|NCT05733689|Tubulin Modulators|tubulin modulators|mesh-ancestor
110923124|NCT05733689|Antimitotic Agents|antimitotic agents|mesh-ancestor
110923125|NCT05733689|Mitosis Modulators|mitosis modulators|mesh-ancestor
110259312|NCT04693312|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110923126|NCT05733689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110923127|NCT05733689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110923128|NCT05733689|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110923129|NCT05733689|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110923130|NCT05733689|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110923131|NCT05733689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110923133|NCT05723874|BI 425809|bi 425809|mesh-list
110923134|NCT05723874|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110923135|NCT05723874|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
110923136|NCT05723874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110923137|NCT05723874|Nootropic Agents|nootropic agents|mesh-ancestor
110923138|NCT05663957|Cilgavimab and tixagevimab drug combination|cilgavimab and tixagevimab drug combination|mesh-list
110923139|NCT05663957|Antiviral Agents|antiviral agents|mesh-ancestor
110923140|NCT05663957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110923142|NCT05650164|Axitinib|axitinib|mesh-list
110923143|NCT05650164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110923144|NCT05650164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110923145|NCT05650164|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110923146|NCT05650164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110923147|NCT05650164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110923148|NCT05610826|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
110923149|NCT05610826|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110923150|NCT05610826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110923151|NCT05608837|Dexamethasone|dexamethasone|mesh-list
110923152|NCT05608837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110923153|NCT05608837|Antiemetics|antiemetics|mesh-ancestor
110923154|NCT05608837|Autonomic Agents|autonomic agents|mesh-ancestor
110923155|NCT05608837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110923156|NCT05608837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110923157|NCT05608837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110923158|NCT05608837|Glucocorticoids|glucocorticoids|mesh-ancestor
110923160|NCT05608837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110923161|NCT05608837|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110923163|NCT05555706|Paclitaxel|paclitaxel|mesh-list
110923164|NCT05555706|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110923165|NCT05555706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110923166|NCT05555706|Tubulin Modulators|tubulin modulators|mesh-ancestor
110923167|NCT05555706|Antimitotic Agents|antimitotic agents|mesh-ancestor
110923168|NCT05555706|Mitosis Modulators|mitosis modulators|mesh-ancestor
110923174|NCT05489887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110923175|NCT05489887|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110923176|NCT05489887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110923177|NCT05489887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110923178|NCT05446727|Ropivacaine|ropivacaine|mesh-list
110923180|NCT05446727|Anesthetics|anesthetics|mesh-ancestor
110923181|NCT05446727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110923182|NCT05446727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110923183|NCT05446727|Sensory System Agents|sensory system agents|mesh-ancestor
110923184|NCT05446727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110923186|NCT05354102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110923187|NCT05354102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110923188|NCT05354102|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110259628|NCT02945527|Diuretics|diuretics|mesh-ancestor
110923189|NCT05354102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110923190|NCT05349890|Pembrolizumab|pembrolizumab|mesh-list
110923191|NCT05349890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110923192|NCT05349890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110923193|NCT05349890|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110923194|NCT05349890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110923195|NCT05301517|Epoetin Alfa|epoetin alfa|mesh-list
110923196|NCT05301517|Hematinics|hematinics|mesh-ancestor
110923197|NCT05296304|Bexarotene|bexarotene|mesh-list
110923198|NCT05296304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110923199|NCT05271448|Losartan|losartan|mesh-list
110923200|NCT05271448|Valsartan|valsartan|mesh-list
110923201|NCT05271448|Candesartan|candesartan|mesh-list
110923202|NCT05271448|Candesartan cilexetil|candesartan cilexetil|mesh-list
110923203|NCT05271448|Ramipril|ramipril|mesh-list
110923204|NCT05271448|Enalapril|enalapril|mesh-list
110923205|NCT05271448|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
110923206|NCT05271448|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110923207|NCT05271448|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110923208|NCT05271448|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110923209|NCT05271448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110923210|NCT05271448|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110923211|NCT05271448|Protease Inhibitors|protease inhibitors|mesh-ancestor
110923212|NCT05271448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110923213|NCT05254405|Brexanolone|brexanolone|mesh-list
110640731|NCT00920153|Alkylating Agents|alkylating agents|mesh-ancestor
110923214|NCT05254405|Neurosteroids|neurosteroids|mesh-ancestor
110923215|NCT05254405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110259813|NCT00144677|Immunologic Factors|immunologic factors|mesh-ancestor
110923216|NCT05254405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110923217|NCT05254405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110923218|NCT05254405|GABA Modulators|gaba modulators|mesh-ancestor
110923219|NCT05254405|GABA Agents|gaba agents|mesh-ancestor
110923220|NCT05223231|Antibodies|antibodies|mesh-list
110923221|NCT05223231|Immunoglobulins|immunoglobulins|mesh-list
110923222|NCT05223231|Immunologic Factors|immunologic factors|mesh-ancestor
110923223|NCT05223231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110923224|NCT05215106|Durvalumab|durvalumab|mesh-list
110923225|NCT05215106|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110923226|NCT05215106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110923227|NCT05187182|Pembrolizumab|pembrolizumab|mesh-list
110923228|NCT05187182|Nivolumab|nivolumab|mesh-list
110923229|NCT05187182|Trastuzumab|trastuzumab|mesh-list
110923230|NCT05187182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110923231|NCT05187182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110923232|NCT05187182|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110923233|NCT05187182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110923234|NCT05177731|Cytarabine|cytarabine|mesh-list
110923235|NCT05177731|Decitabine|decitabine|mesh-list
110923236|NCT05177731|Venetoclax|venetoclax|mesh-list
110923237|NCT05177731|Idarubicin|idarubicin|mesh-list
110923238|NCT05177731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110923239|NCT05177731|Antimetabolites|antimetabolites|mesh-ancestor
110923240|NCT05177731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110929498|NCT03577899|Aflibercept|aflibercept|mesh-list
110923241|NCT05177731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110923242|NCT05177731|Antiviral Agents|antiviral agents|mesh-ancestor
110923243|NCT05177731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110923244|NCT05177731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110923245|NCT05177731|Immunologic Factors|immunologic factors|mesh-ancestor
110923246|NCT05177731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110923247|NCT05177731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110923248|NCT05177731|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110923249|NCT05177731|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110923250|NCT05177731|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110923252|NCT05156710|Tacrolimus|tacrolimus|mesh-list
110923253|NCT05156710|Immunoglobulins|immunoglobulins|mesh-list
110923254|NCT05156710|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110923255|NCT05156710|Antibodies|antibodies|mesh-list
110923256|NCT05156710|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110923257|NCT05156710|gamma-Globulins|gamma-globulins|mesh-list
110923258|NCT05156710|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110923259|NCT05156710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110923260|NCT05156710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110923261|NCT05156710|Immunologic Factors|immunologic factors|mesh-ancestor
110923262|NCT05156710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110923264|NCT05156710|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110923265|NCT05156710|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110923266|NCT05156710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110923267|NCT05156710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110923269|NCT05110482|Carbetocin|carbetocin|mesh-list
110923270|NCT05110482|Oxytocics|oxytocics|mesh-ancestor
110923271|NCT05110482|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110923272|NCT05110482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110923273|NCT05054348|Pembrolizumab|pembrolizumab|mesh-list
110923274|NCT05054348|Cemiplimab|cemiplimab|mesh-list
110923275|NCT05054348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110923276|NCT05054348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110923277|NCT05054348|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110923278|NCT05054348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110923279|NCT05029960|Brivaracetam|brivaracetam|mesh-list
110923280|NCT05029960|Anticonvulsants|anticonvulsants|mesh-ancestor
110923282|NCT05005000|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110923283|NCT05005000|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110923284|NCT05005000|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110923285|NCT05005000|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110923286|NCT05005000|Glucocorticoids|glucocorticoids|mesh-ancestor
110923287|NCT05005000|Hormones|hormones|mesh-ancestor
110923288|NCT05005000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110923289|NCT05005000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110923290|NCT05005000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110923291|NCT05005000|Immunologic Factors|immunologic factors|mesh-ancestor
110923292|NCT05005000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110923293|NCT05005000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110923294|NCT04989946|Nivolumab|nivolumab|mesh-list
110923295|NCT04989946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110923296|NCT04989946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110923297|NCT04989946|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110923298|NCT04989946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110923299|NCT04987996|Pembrolizumab|pembrolizumab|mesh-list
110923300|NCT04987996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110923301|NCT04987996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110923302|NCT04987996|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110923303|NCT04987996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110923304|NCT04916509|Fulvestrant|fulvestrant|mesh-list
110923305|NCT04916509|Palbociclib|palbociclib|mesh-list
110923306|NCT04916509|Aromatase Inhibitors|aromatase inhibitors|mesh-list
110923307|NCT04916509|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110923308|NCT04916509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110923309|NCT04916509|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110923310|NCT04916509|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110923311|NCT04916509|Hormone Antagonists|hormone antagonists|mesh-ancestor
110923312|NCT04916509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110923313|NCT04916509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110923314|NCT04916509|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110923315|NCT04916509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110923316|NCT04916509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110923317|NCT04916509|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110923319|NCT04891770|Nivolumab|nivolumab|mesh-list
110923320|NCT04891770|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110923321|NCT04891770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110923322|NCT04891770|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110923323|NCT04891770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110923324|NCT04891770|Antiviral Agents|antiviral agents|mesh-ancestor
110260297|NCT05319340|Anticoagulants|anticoagulants|mesh-list
110923325|NCT04891770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110923326|NCT04891770|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110923327|NCT04891770|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110923328|NCT04891770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110923329|NCT04891770|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110923330|NCT04891770|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110923331|NCT04882774|Treprostinil|treprostinil|mesh-list
110923332|NCT04882774|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110923333|NCT04870125|Carbon Monoxide|carbon monoxide|mesh-list
110923334|NCT04870125|Antimetabolites|antimetabolites|mesh-ancestor
110923335|NCT04870125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110923336|NCT04870125|Gasotransmitters|gasotransmitters|mesh-ancestor
110923338|NCT04870125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110923339|NCT04846920|Belzutifan|belzutifan|mesh-list
110923340|NCT04846920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110923341|NCT04774406|Olaparib|olaparib|mesh-list
110923342|NCT04774406|Niraparib|niraparib|mesh-list
110923343|NCT04774406|Talazoparib|talazoparib|mesh-list
110923344|NCT04774406|Veliparib|veliparib|mesh-list
110923345|NCT04774406|Fluzoparib|fluzoparib|mesh-list
110923346|NCT04774406|Rucaparib|rucaparib|mesh-list
110923347|NCT04774406|Pamiparib|pamiparib|mesh-list
110260437|NCT02942563|Irinotecan|irinotecan|mesh-list
110923348|NCT04774406|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110923349|NCT04774406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110923350|NCT04774406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110923351|NCT04774406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110923352|NCT04759833|Prucalopride|prucalopride|mesh-list
110923353|NCT04759833|Laxatives|laxatives|mesh-ancestor
110923354|NCT04759833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110923355|NCT04759833|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
110923356|NCT04759833|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110923357|NCT04759833|Serotonin Agents|serotonin agents|mesh-ancestor
110923358|NCT04759833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110923359|NCT04759833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110923360|NCT04759833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110923361|NCT04752813|Vitamin K|vitamin k|mesh-list
110923362|NCT04752813|Vitamin K 1|vitamin k 1|mesh-list
110923363|NCT04752813|Temozolomide|temozolomide|mesh-list
110923364|NCT04752813|Vitamins|vitamins|mesh-ancestor
110923365|NCT04752813|Micronutrients|micronutrients|mesh-ancestor
110923366|NCT04752813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110923367|NCT04752813|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110929527|NCT00101010|Prednisone|prednisone|mesh-list
110923368|NCT04752813|Alkylating Agents|alkylating agents|mesh-ancestor
110923369|NCT04752813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110923370|NCT04752813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110923371|NCT04752813|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110923372|NCT04752813|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110923374|NCT04752813|Coagulants|coagulants|mesh-ancestor
110923375|NCT04735367|Letrozole|letrozole|mesh-list
110923376|NCT04735367|Palbociclib|palbociclib|mesh-list
110923377|NCT04735367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110923378|NCT04735367|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110923379|NCT04735367|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110923380|NCT04735367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110260544|NCT02942212|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110923381|NCT04735367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110923382|NCT04735367|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110923383|NCT04735367|Hormone Antagonists|hormone antagonists|mesh-ancestor
110923384|NCT04735367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110923385|NCT04735367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110923386|NCT04735367|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110923387|NCT04715113|Sildenafil Citrate|sildenafil citrate|mesh-list
110260611|NCT02277067|Carbetocin|carbetocin|mesh-list
110923388|NCT04715113|Vasodilator Agents|vasodilator agents|mesh-ancestor
110923389|NCT04715113|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110923390|NCT04715113|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110923391|NCT04715113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110923392|NCT04715113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110923393|NCT04715113|Urological Agents|urological agents|mesh-ancestor
110923394|NCT04713657|Propranolol|propranolol|mesh-list
110923395|NCT04713657|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110923396|NCT04713657|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110923397|NCT04713657|Adrenergic Agents|adrenergic agents|mesh-ancestor
110923398|NCT04713657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110923399|NCT04713657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110923400|NCT04713657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110923401|NCT04713657|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110923402|NCT04713657|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110923403|NCT04713657|Vasodilator Agents|vasodilator agents|mesh-ancestor
110923404|NCT04706546|Sildenafil Citrate|sildenafil citrate|mesh-list
110923405|NCT04706546|Vasodilator Agents|vasodilator agents|mesh-ancestor
110923406|NCT04706546|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110923407|NCT04706546|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110923408|NCT04706546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110260808|NCT02944045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110923409|NCT04706546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110923410|NCT04706546|Urological Agents|urological agents|mesh-ancestor
110923411|NCT04704440|Sildenafil Citrate|sildenafil citrate|mesh-list
110923412|NCT04704440|Vasodilator Agents|vasodilator agents|mesh-ancestor
110923413|NCT04704440|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110923414|NCT04704440|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110923415|NCT04704440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110923416|NCT04704440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110923417|NCT04704440|Urological Agents|urological agents|mesh-ancestor
110923418|NCT04697862|Sildenafil Citrate|sildenafil citrate|mesh-list
110923419|NCT04697862|Vasodilator Agents|vasodilator agents|mesh-ancestor
110923421|NCT04697862|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110923422|NCT04697862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110923423|NCT04697862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110260889|NCT02943655|Hormones|hormones|mesh-ancestor
110923424|NCT04697862|Urological Agents|urological agents|mesh-ancestor
110923425|NCT04696029|Eflornithine|eflornithine|mesh-list
110923426|NCT04696029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110923427|NCT04696029|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
110923428|NCT04696029|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110923429|NCT04696029|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110923430|NCT04696029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110923431|NCT04696029|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
110923432|NCT04696029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110923433|NCT04696029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110923434|NCT04666610|Brivaracetam|brivaracetam|mesh-list
110923435|NCT04666610|Anticonvulsants|anticonvulsants|mesh-ancestor
110923436|NCT04652544|Vitamin D|vitamin d|mesh-list
110923437|NCT04652544|Cholecalciferol|cholecalciferol|mesh-list
110923438|NCT04652544|Vitamins|vitamins|mesh-ancestor
110923439|NCT04652544|Micronutrients|micronutrients|mesh-ancestor
110923440|NCT04652544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110640962|NCT05371223|Gemcitabine|gemcitabine|mesh-list
110923441|NCT04652544|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110923442|NCT04652544|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110923444|NCT04640545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110260935|NCT00175266|Infliximab|infliximab|mesh-list
110923445|NCT04640545|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110923446|NCT04640545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110923447|NCT04640545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110923448|NCT04625699|Durvalumab|durvalumab|mesh-list
110923449|NCT04625699|Tremelimumab|tremelimumab|mesh-list
110923450|NCT04625699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110923451|NCT04625699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110923452|NCT04562467|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
110923453|NCT04562467|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110923454|NCT04562467|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110923455|NCT04510584|Bevacizumab|bevacizumab|mesh-list
110923456|NCT04510584|Atezolizumab|atezolizumab|mesh-list
110923457|NCT04510584|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110923458|NCT04510584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110923459|NCT04510584|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110923460|NCT04510584|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110923461|NCT04510584|Growth Substances|growth substances|mesh-ancestor
110923462|NCT04510584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110923463|NCT04510584|Growth Inhibitors|growth inhibitors|mesh-ancestor
110923464|NCT04510584|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110923465|NCT04510584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110923466|NCT04500847|Emtricitabine|emtricitabine|mesh-list
110923467|NCT04500847|Antiviral Agents|antiviral agents|mesh-ancestor
110923468|NCT04500847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110923469|NCT04500847|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110923470|NCT04500847|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110923471|NCT04500847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110923472|NCT04500847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110923474|NCT04500847|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110923475|NCT04484532|Vaccines|vaccines|mesh-list
110923476|NCT04484532|Immunologic Factors|immunologic factors|mesh-ancestor
110923477|NCT04484532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110923478|NCT04483583|Clopidogrel|clopidogrel|mesh-list
110923479|NCT04483583|Ticagrelor|ticagrelor|mesh-list
110923480|NCT04483583|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110923481|NCT04483583|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110929553|NCT00101010|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110923482|NCT04483583|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110923483|NCT04483583|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110923484|NCT04483583|Purinergic Agents|purinergic agents|mesh-ancestor
110923485|NCT04483583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110261118|NCT02941198|Copper|copper|mesh-list
110923486|NCT04483583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110923487|NCT04483583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110923489|NCT04447989|Vasodilator Agents|vasodilator agents|mesh-ancestor
110923490|NCT04447989|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110923491|NCT04447989|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110923492|NCT04447989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110923493|NCT04447989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110923494|NCT04447989|Urological Agents|urological agents|mesh-ancestor
110923495|NCT04416750|Imatinib Mesylate|imatinib mesylate|mesh-list
110923496|NCT04416750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110923497|NCT04416750|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110923498|NCT04416750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110923499|NCT04416750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110923500|NCT04382898|Cemiplimab|cemiplimab|mesh-list
110261166|NCT00169845|Vitamins|vitamins|mesh-ancestor
110923501|NCT04382898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110923502|NCT04382898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110923503|NCT04375527|Nivolumab|nivolumab|mesh-list
110923504|NCT04375527|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110923505|NCT04375527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110923506|NCT04375527|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110923507|NCT04375527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110923508|NCT04362488|Benzoyl Peroxide|benzoyl peroxide|mesh-list
110923509|NCT04362488|Dermatologic Agents|dermatologic agents|mesh-ancestor
110923510|NCT04336189|Pyrimethamine|pyrimethamine|mesh-list
110923511|NCT04336189|Piperaquine|piperaquine|mesh-list
110923512|NCT04336189|Sulfadoxine|sulfadoxine|mesh-list
110261227|NCT00147953|Rituximab|rituximab|mesh-list
110641031|NCT05304533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110923513|NCT04336189|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
110923515|NCT04336189|Antimalarials|antimalarials|mesh-ancestor
110923516|NCT04336189|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110923517|NCT04336189|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110923518|NCT04336189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110923519|NCT04336189|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110923520|NCT04336189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110923521|NCT04336189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110923522|NCT04336189|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110923523|NCT04231877|Prednisone|prednisone|mesh-list
110923524|NCT04231877|Cortisone|cortisone|mesh-list
110923525|NCT04231877|Cyclophosphamide|cyclophosphamide|mesh-list
110923526|NCT04231877|Rituximab|rituximab|mesh-list
110923527|NCT04231877|Doxorubicin|doxorubicin|mesh-list
110923528|NCT04231877|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110923529|NCT04231877|Etoposide|etoposide|mesh-list
110923530|NCT04231877|Daunorubicin|daunorubicin|mesh-list
110923531|NCT04231877|Podophyllotoxin|podophyllotoxin|mesh-list
110923532|NCT04231877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110923533|NCT04231877|Antibodies|antibodies|mesh-list
110923534|NCT04231877|Immunoglobulins|immunoglobulins|mesh-list
110923535|NCT04231877|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110923536|NCT04231877|Lenograstim|lenograstim|mesh-list
110923537|NCT04231877|Immunoconjugates|immunoconjugates|mesh-list
110923538|NCT04231877|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
110923539|NCT04231877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110923540|NCT04231877|Immunologic Factors|immunologic factors|mesh-ancestor
110923541|NCT04231877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110923542|NCT04231877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110923543|NCT04231877|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110929564|NCT03209401|Niraparib|niraparib|mesh-list
110923544|NCT04231877|Alkylating Agents|alkylating agents|mesh-ancestor
110923545|NCT04231877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110923546|NCT04231877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110923547|NCT04231877|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110923548|NCT04231877|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110261347|NCT00175734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110923549|NCT04231877|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110923550|NCT04231877|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110923551|NCT04231877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110923552|NCT04231877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110923553|NCT04231877|Glucocorticoids|glucocorticoids|mesh-ancestor
110923554|NCT04231877|Hormones|hormones|mesh-ancestor
110923555|NCT04231877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110923556|NCT04231877|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110923557|NCT04231877|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110923558|NCT04231877|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110923559|NCT04231877|Keratolytic Agents|keratolytic agents|mesh-ancestor
110923560|NCT04231877|Dermatologic Agents|dermatologic agents|mesh-ancestor
110261406|NCT00175812|Tretinoin|tretinoin|mesh-list
110923562|NCT04231877|Antimitotic Agents|antimitotic agents|mesh-ancestor
110923563|NCT04231877|Mitosis Modulators|mitosis modulators|mesh-ancestor
110923564|NCT04218799|Chlorhexidine|chlorhexidine|mesh-list
110923565|NCT04218799|Mupirocin|mupirocin|mesh-list
110923566|NCT04218799|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110923567|NCT04218799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110923568|NCT04218799|Disinfectants|disinfectants|mesh-ancestor
110923569|NCT04218799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110923570|NCT04218799|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110923571|NCT04218799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110923572|NCT04218799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110923573|NCT04189445|Futibatinib|futibatinib|mesh-list
110923574|NCT04189445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110923575|NCT04179032|Belimumab|belimumab|mesh-list
110923576|NCT04179032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110923577|NCT04179032|Immunologic Factors|immunologic factors|mesh-ancestor
110923578|NCT04179032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110923579|NCT04143594|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
110923580|NCT04143594|Antiviral Agents|antiviral agents|mesh-ancestor
110923581|NCT04143594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110923582|NCT04143594|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110923583|NCT04143594|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110923584|NCT04143594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110923585|NCT04143594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110923586|NCT04143594|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110923587|NCT04143594|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110923588|NCT04026776|Allopurinol|allopurinol|mesh-list
110923589|NCT04026776|Antimetabolites|antimetabolites|mesh-ancestor
110923590|NCT04026776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110923591|NCT04026776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110923592|NCT04026776|Gout Suppressants|gout suppressants|mesh-ancestor
110923593|NCT04026776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110923594|NCT04026776|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110923595|NCT04026776|Antioxidants|antioxidants|mesh-ancestor
110923596|NCT04026776|Protective Agents|protective agents|mesh-ancestor
110923597|NCT04026776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110923598|NCT03871348|Cemiplimab|cemiplimab|mesh-list
110923599|NCT03871348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110923600|NCT03871348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110923601|NCT03846427|Zanubrutinib|zanubrutinib|mesh-list
110923602|NCT03846427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110923603|NCT03846427|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110923604|NCT03846427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110923605|NCT03846427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110923607|NCT03831113|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110923608|NCT03831113|Narcotics|narcotics|mesh-ancestor
110923609|NCT03831113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110923610|NCT03831113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110923611|NCT03831113|Analgesics|analgesics|mesh-ancestor
110923612|NCT03831113|Sensory System Agents|sensory system agents|mesh-ancestor
110923613|NCT03831113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110923614|NCT03831113|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110923615|NCT03824561|Vedolizumab|vedolizumab|mesh-list
110923616|NCT03824561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110923617|NCT03821857|Corticosterone|corticosterone|mesh-list
110923618|NCT03821857|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110923619|NCT04305236|Fulvestrant|fulvestrant|mesh-list
110365814|NCT05822713|Amisulpride|amisulpride|mesh-list
110923620|NCT04305236|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110923621|NCT04305236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110923622|NCT04305236|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110923623|NCT04305236|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110923624|NCT04305236|Hormone Antagonists|hormone antagonists|mesh-ancestor
110923625|NCT04305236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110923626|NCT04305236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110923627|NCT03774472|Hydroxychloroquine|hydroxychloroquine|mesh-list
110923628|NCT03774472|Letrozole|letrozole|mesh-list
110923629|NCT03774472|Palbociclib|palbociclib|mesh-list
110923630|NCT03774472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110923631|NCT03774472|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110923632|NCT03774472|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110923633|NCT03774472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110923634|NCT03774472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110923635|NCT03774472|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110923636|NCT03774472|Hormone Antagonists|hormone antagonists|mesh-ancestor
110923637|NCT03774472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110923638|NCT03774472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110923639|NCT03774472|Antimalarials|antimalarials|mesh-ancestor
110923640|NCT03774472|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110923641|NCT03774472|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110923642|NCT03774472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110923643|NCT03774472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110923644|NCT03774472|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110923645|NCT03727061|Carboplatin|carboplatin|mesh-list
110923646|NCT03727061|Pembrolizumab|pembrolizumab|mesh-list
110923647|NCT03727061|Fluorouracil|fluorouracil|mesh-list
110923648|NCT03727061|Nivolumab|nivolumab|mesh-list
110923649|NCT03727061|Cetuximab|cetuximab|mesh-list
110923650|NCT03727061|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
110923651|NCT03727061|Hematoporphyrin Derivative|hematoporphyrin derivative|mesh-list
110923652|NCT03727061|Trioxsalen|trioxsalen|mesh-list
110923653|NCT03727061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110923654|NCT03727061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110923655|NCT03727061|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110923656|NCT03727061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110923657|NCT03727061|Antimetabolites|antimetabolites|mesh-ancestor
110923658|NCT03727061|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110923659|NCT03727061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110923660|NCT03727061|Immunologic Factors|immunologic factors|mesh-ancestor
110923661|NCT03727061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110923662|NCT03727061|Dermatologic Agents|dermatologic agents|mesh-ancestor
110923663|NCT03727061|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110923664|NCT03668340|Adavosertib|adavosertib|mesh-list
110923665|NCT03668340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110923666|NCT03668340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110923668|NCT03657160|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110923669|NCT03508726|Ascorbic Acid|ascorbic acid|mesh-list
110923670|NCT03508726|Vitamins|vitamins|mesh-ancestor
110923671|NCT03508726|Micronutrients|micronutrients|mesh-ancestor
110923672|NCT03508726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110923673|NCT03508726|Antioxidants|antioxidants|mesh-ancestor
110923674|NCT03508726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110923675|NCT03508726|Protective Agents|protective agents|mesh-ancestor
110923676|NCT03404661|Secretin|secretin|mesh-list
110923677|NCT03404661|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110923678|NCT03404661|Hormones|hormones|mesh-ancestor
110923679|NCT03404661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110923680|NCT03404661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110923681|NCT03370172|Factor VIII|factor viii|mesh-list
110923682|NCT03370172|Coagulants|coagulants|mesh-ancestor
110923683|NCT03342196|Fludarabine|fludarabine|mesh-list
110923684|NCT03342196|Melphalan|melphalan|mesh-list
110923685|NCT03342196|Thiotepa|thiotepa|mesh-list
110923686|NCT03342196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110365830|NCT05822674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110923687|NCT03342196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110261948|NCT05785585|Vitamins|vitamins|mesh-ancestor
110923688|NCT03342196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110923689|NCT03342196|Immunologic Factors|immunologic factors|mesh-ancestor
110923690|NCT03342196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110923691|NCT03342196|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110923692|NCT03342196|Alkylating Agents|alkylating agents|mesh-ancestor
110923693|NCT03342196|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110923694|NCT03319537|Pemetrexed|pemetrexed|mesh-list
110923696|NCT03319537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110923697|NCT03319537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110923698|NCT03319537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110923699|NCT03319537|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110923700|NCT03319537|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110923701|NCT03279692|Pembrolizumab|pembrolizumab|mesh-list
110923702|NCT03279692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110262082|NCT05780437|Antiviral Agents|antiviral agents|mesh-ancestor
110923703|NCT03279692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110923704|NCT03279692|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110923705|NCT03279692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110923706|NCT03100786|Dexamethasone|dexamethasone|mesh-list
110923707|NCT03100786|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110923708|NCT03100786|Antiemetics|antiemetics|mesh-ancestor
110923709|NCT03100786|Autonomic Agents|autonomic agents|mesh-ancestor
110923710|NCT03100786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110923711|NCT03100786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110923712|NCT03100786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110923713|NCT03100786|Glucocorticoids|glucocorticoids|mesh-ancestor
110923714|NCT03100786|Hormones|hormones|mesh-ancestor
110923715|NCT03100786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110923716|NCT03100786|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110262148|NCT05611034|Oxaliplatin|oxaliplatin|mesh-list
110923717|NCT03100786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110923718|NCT03043053|Oxytocin|oxytocin|mesh-list
110923719|NCT03043053|Oxytocics|oxytocics|mesh-ancestor
110923720|NCT03043053|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110923721|NCT03043053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110923722|NCT03025035|Pembrolizumab|pembrolizumab|mesh-list
110923723|NCT03025035|Olaparib|olaparib|mesh-list
110923724|NCT03025035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110923725|NCT03025035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110923726|NCT03025035|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110923727|NCT03025035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110923728|NCT03025035|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110923729|NCT03025035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110923730|NCT03001882|Nivolumab|nivolumab|mesh-list
110923731|NCT03001882|Ipilimumab|ipilimumab|mesh-list
110923732|NCT03001882|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110923733|NCT03001882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110923734|NCT03001882|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110923735|NCT03001882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110923736|NCT02981966|Dapagliflozin|dapagliflozin|mesh-list
110923737|NCT02981966|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110262209|NCT05292339|Immunologic Factors|immunologic factors|mesh-ancestor
110923738|NCT02981966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110923739|NCT02981966|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110923740|NCT02981966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110923741|NCT02932956|Cyclophosphamide|cyclophosphamide|mesh-list
110923742|NCT02932956|Fludarabine|fludarabine|mesh-list
110923743|NCT02932956|Fludarabine phosphate|fludarabine phosphate|mesh-list
110365840|NCT05817474|Lidocaine|lidocaine|mesh-list
110923744|NCT02932956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110923745|NCT02932956|Immunologic Factors|immunologic factors|mesh-ancestor
110923746|NCT02932956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110923747|NCT02932956|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110923748|NCT02932956|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110923749|NCT02932956|Alkylating Agents|alkylating agents|mesh-ancestor
110923750|NCT02932956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110923751|NCT02932956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110923752|NCT02932956|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110923753|NCT02932956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110923754|NCT02932956|Antimetabolites|antimetabolites|mesh-ancestor
110923755|NCT02843165|Immunomodulating Agents|immunomodulating agents|mesh-list
110923756|NCT02843165|Immunologic Factors|immunologic factors|mesh-list
110923757|NCT02843165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110923758|NCT02807467|Dexmedetomidine|dexmedetomidine|mesh-list
110923759|NCT02807467|Propofol|propofol|mesh-list
110923760|NCT02807467|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110923761|NCT02807467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110923762|NCT02807467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110923763|NCT02807467|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110923764|NCT02807467|Analgesics|analgesics|mesh-ancestor
110923765|NCT02807467|Sensory System Agents|sensory system agents|mesh-ancestor
110923766|NCT02807467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110923767|NCT02807467|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110923768|NCT02807467|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110923769|NCT02807467|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110923770|NCT02807467|Adrenergic Agents|adrenergic agents|mesh-ancestor
110923771|NCT02807467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110923772|NCT02807467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110923773|NCT02807467|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110923774|NCT02807467|Anesthetics, General|anesthetics, general|mesh-ancestor
110923775|NCT02807467|Anesthetics|anesthetics|mesh-ancestor
110923776|NCT02794428|Eflornithine|eflornithine|mesh-list
110923777|NCT02794428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110923778|NCT02794428|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
110923779|NCT02794428|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110923780|NCT02794428|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110923781|NCT02794428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110923782|NCT02794428|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
110923783|NCT02794428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110923784|NCT02794428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110923785|NCT02740179|Eplerenone|eplerenone|mesh-list
110923786|NCT02740179|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110923787|NCT02740179|Hormone Antagonists|hormone antagonists|mesh-ancestor
110923788|NCT02740179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110923789|NCT02740179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110262444|NCT04511247|Immunologic Factors|immunologic factors|mesh-ancestor
110923790|NCT02740179|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110923792|NCT02740179|Natriuretic Agents|natriuretic agents|mesh-ancestor
110923793|NCT02740179|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110923794|NCT02679144|Eflornithine|eflornithine|mesh-list
110923795|NCT02679144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110923796|NCT02679144|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
110923797|NCT02679144|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110923798|NCT02679144|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110923799|NCT02679144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110923800|NCT02679144|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
110923801|NCT02679144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110923802|NCT02679144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110923803|NCT02650986|Cyclophosphamide|cyclophosphamide|mesh-list
110923804|NCT02650986|Decitabine|decitabine|mesh-list
110923805|NCT02650986|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110923807|NCT02650986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110923808|NCT02650986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110923809|NCT02650986|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110923810|NCT02650986|Alkylating Agents|alkylating agents|mesh-ancestor
110923811|NCT02650986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110923812|NCT02650986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110923813|NCT02650986|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110923814|NCT02650986|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110923816|NCT02650986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110923817|NCT02619409|Bupivacaine|bupivacaine|mesh-list
110923818|NCT02619409|Anesthetics, Local|anesthetics, local|mesh-ancestor
110923819|NCT02619409|Anesthetics|anesthetics|mesh-ancestor
110923820|NCT02619409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110923821|NCT02619409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110923822|NCT02619409|Sensory System Agents|sensory system agents|mesh-ancestor
110923823|NCT02619409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110262722|NCT03440879|Goserelin|goserelin|mesh-list
110923825|NCT02606045|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110923826|NCT02606045|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110923827|NCT02606045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110923828|NCT02606045|Hemostatics|hemostatics|mesh-ancestor
110923829|NCT02606045|Coagulants|coagulants|mesh-ancestor
110923830|NCT02603432|Avelumab|avelumab|mesh-list
110923831|NCT02603432|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110923832|NCT02603432|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110923833|NCT02603432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110923834|NCT02603432|Immunologic Factors|immunologic factors|mesh-ancestor
110923835|NCT02603432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110923836|NCT02582866|Lacosamide|lacosamide|mesh-list
110923837|NCT02582866|Anticonvulsants|anticonvulsants|mesh-ancestor
110923838|NCT02582866|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110923839|NCT02582866|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110923840|NCT02582866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110923841|NCT02582866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110923842|NCT02559778|Eflornithine|eflornithine|mesh-list
110923843|NCT02559778|Sorafenib|sorafenib|mesh-list
110923844|NCT02559778|Dasatinib|dasatinib|mesh-list
110923846|NCT02559778|Ceritinib|ceritinib|mesh-list
110923847|NCT02559778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110923848|NCT02559778|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110923849|NCT02559778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110923850|NCT02559778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110923851|NCT02559778|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110923852|NCT02559778|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
110923853|NCT02559778|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110923854|NCT02559778|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110929626|NCT02171676|Docetaxel|docetaxel|mesh-list
110923855|NCT02559778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110262909|NCT01064648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110262910|NCT01064648|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110262911|NCT01064648|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110262912|NCT01064648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110262913|NCT00635700|Ziprasidone|ziprasidone|mesh-list
110262914|NCT00635700|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110262915|NCT00635700|Serotonin Agents|serotonin agents|mesh-ancestor
110262916|NCT00635700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110923856|NCT02559778|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
110923857|NCT02465307|Hydrocortisone|hydrocortisone|mesh-list
110923858|NCT02465307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110923859|NCT02453373|Magnesium Sulfate|magnesium sulfate|mesh-list
110923860|NCT02453373|Plasminogen|plasminogen|mesh-list
110923861|NCT02453373|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
110923862|NCT02453373|Propofol|propofol|mesh-list
110923863|NCT02453373|Etomidate|etomidate|mesh-list
110923864|NCT02453373|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110923865|NCT02453373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110923866|NCT02453373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110923867|NCT02453373|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110923868|NCT02453373|Anesthetics, General|anesthetics, general|mesh-ancestor
110923869|NCT02453373|Anesthetics|anesthetics|mesh-ancestor
110923870|NCT02453373|Analgesics|analgesics|mesh-ancestor
110923871|NCT02453373|Sensory System Agents|sensory system agents|mesh-ancestor
110923872|NCT02453373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110923873|NCT02453373|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110923874|NCT02453373|Anticonvulsants|anticonvulsants|mesh-ancestor
110923875|NCT02453373|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110923876|NCT02453373|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110923877|NCT02453373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110923878|NCT02453373|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110923879|NCT02453373|Tocolytic Agents|tocolytic agents|mesh-ancestor
110923880|NCT02453373|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110923881|NCT02453373|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110923882|NCT02453373|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110923884|NCT02395666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110923885|NCT02395666|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
110923886|NCT02395666|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110923887|NCT02395666|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110923888|NCT02395666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110923889|NCT02395666|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
110923890|NCT02395666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110923891|NCT02395666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110923892|NCT01734928|Thalidomide|thalidomide|mesh-list
110923893|NCT01734928|Dexamethasone|dexamethasone|mesh-list
110923895|NCT01734928|Pomalidomide|pomalidomide|mesh-list
110923896|NCT01734928|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110923897|NCT01734928|Antiemetics|antiemetics|mesh-ancestor
110923898|NCT01734928|Autonomic Agents|autonomic agents|mesh-ancestor
110923899|NCT01734928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110923900|NCT01734928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110923901|NCT01734928|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110923902|NCT01734928|Glucocorticoids|glucocorticoids|mesh-ancestor
110923903|NCT01734928|Hormones|hormones|mesh-ancestor
110923904|NCT01734928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110923905|NCT01734928|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110923906|NCT01734928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110923907|NCT01734928|Immunologic Factors|immunologic factors|mesh-ancestor
110923908|NCT01734928|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110923909|NCT01734928|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110923910|NCT01734928|Growth Substances|growth substances|mesh-ancestor
110923911|NCT01734928|Growth Inhibitors|growth inhibitors|mesh-ancestor
110923912|NCT01734928|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110923913|NCT01734928|Leprostatic Agents|leprostatic agents|mesh-ancestor
110923914|NCT01734928|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110923915|NCT01734928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110923916|NCT01682616|Rituximab|rituximab|mesh-list
110923917|NCT01682616|Venetoclax|venetoclax|mesh-list
110923918|NCT01682616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110923919|NCT01682616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110923920|NCT01682616|Immunologic Factors|immunologic factors|mesh-ancestor
110923921|NCT01682616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110923922|NCT01682616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110923923|NCT01430572|Everolimus|everolimus|mesh-list
110923924|NCT01430572|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110923925|NCT01430572|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110923926|NCT01430572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110923927|NCT01430572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110263206|NCT00150293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110923928|NCT01430572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110923929|NCT01430572|Immunologic Factors|immunologic factors|mesh-ancestor
110923930|NCT01430572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110923931|NCT01430572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110923932|NCT00950430|Corticosterone|corticosterone|mesh-list
110923933|NCT00950430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110923934|NCT00909051|Acarbose|acarbose|mesh-list
110263275|NCT02912182|Antiemetics|antiemetics|mesh-ancestor
110923935|NCT00909051|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
110923936|NCT00909051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110923937|NCT00909051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110923938|NCT00909051|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110923939|NCT00909051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110923941|NCT05015608|Pemetrexed|pemetrexed|mesh-list
110923942|NCT05015608|Osimertinib|osimertinib|mesh-list
110923943|NCT05015608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110923944|NCT05015608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110923945|NCT05015608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110923946|NCT05015608|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110923947|NCT05015608|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110923948|NCT05015608|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110923949|NCT03510416|Apatinib|apatinib|mesh-list
110923950|NCT03510416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110923951|NCT03510416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110923952|NCT03510416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110923953|NCT03510416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110923954|NCT03510962|Chlorhexidine|chlorhexidine|mesh-list
110923955|NCT03510962|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110923956|NCT03510962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110923957|NCT03510962|Disinfectants|disinfectants|mesh-ancestor
110923958|NCT02646124|Naproxen|naproxen|mesh-list
110923959|NCT02646124|Diazepam|diazepam|mesh-list
110923960|NCT02646124|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110923962|NCT02646124|Analgesics|analgesics|mesh-ancestor
110923963|NCT02646124|Sensory System Agents|sensory system agents|mesh-ancestor
110923964|NCT02646124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110923965|NCT02646124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110923966|NCT02646124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110923967|NCT02646124|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110923968|NCT02646124|Gout Suppressants|gout suppressants|mesh-ancestor
110923969|NCT02646124|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110923970|NCT02646124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110923971|NCT02646124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110923972|NCT02646124|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110923973|NCT02646124|Anticonvulsants|anticonvulsants|mesh-ancestor
110923974|NCT02646124|Antiemetics|antiemetics|mesh-ancestor
110923975|NCT02646124|Autonomic Agents|autonomic agents|mesh-ancestor
110923976|NCT02646124|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110923977|NCT02646124|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110923978|NCT02646124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110923979|NCT02646124|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110923980|NCT02646124|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110923981|NCT02646124|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110923982|NCT02646124|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110923984|NCT02646124|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110923985|NCT02646124|Anesthetics, General|anesthetics, general|mesh-ancestor
110923987|NCT02646124|GABA Modulators|gaba modulators|mesh-ancestor
110923988|NCT02646124|GABA Agents|gaba agents|mesh-ancestor
110923989|NCT02646124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110923990|NCT02306564|Cabergoline|cabergoline|mesh-list
110923991|NCT02306564|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110923992|NCT02306564|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110923993|NCT02306564|Dopamine Agonists|dopamine agonists|mesh-ancestor
110923994|NCT02306564|Dopamine Agents|dopamine agents|mesh-ancestor
110923995|NCT02306564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110923996|NCT02306564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110923997|NCT02306564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110923998|NCT02301494|Fluocinonide|fluocinonide|mesh-list
110923999|NCT02301494|Imiquimod|imiquimod|mesh-list
110924000|NCT02301494|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110924001|NCT02301494|Immunologic Factors|immunologic factors|mesh-ancestor
110924002|NCT02301494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110924003|NCT02301494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110924004|NCT02301494|Interferon Inducers|interferon inducers|mesh-ancestor
110924005|NCT02301494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110924006|NCT02301494|Glucocorticoids|glucocorticoids|mesh-ancestor
110924007|NCT02301494|Hormones|hormones|mesh-ancestor
110924008|NCT02301494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110924009|NCT02301494|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110924010|NCT03101800|Azathioprine|azathioprine|mesh-list
110924011|NCT03101800|Allopurinol|allopurinol|mesh-list
110924012|NCT03101800|Antimetabolites|antimetabolites|mesh-ancestor
110924013|NCT03101800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110924014|NCT03101800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110924015|NCT03101800|Gout Suppressants|gout suppressants|mesh-ancestor
110924016|NCT03101800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110924017|NCT03101800|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110924018|NCT03101800|Antioxidants|antioxidants|mesh-ancestor
110924019|NCT03101800|Protective Agents|protective agents|mesh-ancestor
110924020|NCT03101800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110924021|NCT03101800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110924022|NCT03101800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110924023|NCT03101800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110924024|NCT03101800|Immunologic Factors|immunologic factors|mesh-ancestor
110924026|NCT03507842|Daunorubicin|daunorubicin|mesh-list
110924027|NCT03507842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110924028|NCT03507842|Antimetabolites|antimetabolites|mesh-ancestor
110924029|NCT03507842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110924030|NCT03507842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110924031|NCT03507842|Antiviral Agents|antiviral agents|mesh-ancestor
110924032|NCT03507842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110924033|NCT03507842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110924034|NCT03507842|Immunologic Factors|immunologic factors|mesh-ancestor
110924035|NCT03507842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110924036|NCT03507842|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110924037|NCT03507842|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110924038|NCT03507842|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110924039|NCT03507842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110924040|NCT03132584|Cyclophosphamide|cyclophosphamide|mesh-list
110924041|NCT03132584|Alemtuzumab|alemtuzumab|mesh-list
110924042|NCT03132584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110641549|NCT01000857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110924043|NCT03132584|Immunologic Factors|immunologic factors|mesh-ancestor
110924044|NCT03132584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110924045|NCT03132584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110924046|NCT03132584|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110924047|NCT03132584|Alkylating Agents|alkylating agents|mesh-ancestor
110924048|NCT03132584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110924049|NCT03132584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110924050|NCT03132584|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110294087|NCT00199277|Iron|iron|mesh-list
110924051|NCT03132584|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110924053|NCT03656926|Cyclosporins|cyclosporins|mesh-list
110924054|NCT03656926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110365907|NCT05728294|Ropivacaine|ropivacaine|mesh-list
110924055|NCT03656926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110924056|NCT03656926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110924057|NCT03656926|Immunologic Factors|immunologic factors|mesh-ancestor
110924058|NCT03656926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110924059|NCT03656926|Antifungal Agents|antifungal agents|mesh-ancestor
110924060|NCT03656926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110924061|NCT03656926|Dermatologic Agents|dermatologic agents|mesh-ancestor
110924062|NCT03656926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110924063|NCT03656926|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110924064|NCT02301650|Tenofovir|tenofovir|mesh-list
110924065|NCT02301650|Lamivudine|lamivudine|mesh-list
110924066|NCT02301650|Telbivudine|telbivudine|mesh-list
110924067|NCT02301650|Antiviral Agents|antiviral agents|mesh-ancestor
110924068|NCT02301650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110924069|NCT02301650|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110924070|NCT02301650|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110924071|NCT02301650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110924072|NCT02301650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110924073|NCT02301650|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110924074|NCT02301650|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110924075|NCT03510338|Sildenafil Citrate|sildenafil citrate|mesh-list
110924076|NCT03510338|Vasodilator Agents|vasodilator agents|mesh-ancestor
110924077|NCT03510338|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110924078|NCT03510338|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110924079|NCT03510338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110924080|NCT03510338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110924081|NCT03510338|Urological Agents|urological agents|mesh-ancestor
110924082|NCT02303366|Pembrolizumab|pembrolizumab|mesh-list
110924083|NCT02303366|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110924084|NCT02303366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110924085|NCT02303366|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110924086|NCT02303366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110924087|NCT02301806|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110924088|NCT02301806|Glimepiride|glimepiride|mesh-list
110924089|NCT02301806|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110924090|NCT02301806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110924091|NCT02301806|Incretins|incretins|mesh-ancestor
110924093|NCT02301806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110924094|NCT02301806|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110924095|NCT02301806|Protease Inhibitors|protease inhibitors|mesh-ancestor
110924096|NCT02301806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110924097|NCT02301806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110924098|NCT02301806|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110924099|NCT02301806|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110924100|NCT02301806|Immunologic Factors|immunologic factors|mesh-ancestor
110924101|NCT03103204|Chlorhexidine|chlorhexidine|mesh-list
110924102|NCT03103204|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110924103|NCT03103204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110924104|NCT03103204|Disinfectants|disinfectants|mesh-ancestor
110924105|NCT02301962|Panitumumab|panitumumab|mesh-list
110264141|NCT02937844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110924106|NCT02301962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110924107|NCT02301962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110924108|NCT03507374|Alirocumab|alirocumab|mesh-list
110924109|NCT03507374|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
110924110|NCT03507374|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110924111|NCT03507374|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110924112|NCT03507374|Antimetabolites|antimetabolites|mesh-ancestor
110924113|NCT03507374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110924114|NCT03507374|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110924115|NCT03507374|Protease Inhibitors|protease inhibitors|mesh-ancestor
110924116|NCT03507374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110924119|NCT02639650|Paclitaxel|paclitaxel|mesh-list
110924120|NCT02639650|Etoposide|etoposide|mesh-list
110924121|NCT02639650|Vincristine|vincristine|mesh-list
110924122|NCT02639650|Cyclophosphamide|cyclophosphamide|mesh-list
110924123|NCT02639650|Carboplatin|carboplatin|mesh-list
110924124|NCT02639650|Methotrexate|methotrexate|mesh-list
110924125|NCT02639650|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110924126|NCT02639650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110924127|NCT02639650|Tubulin Modulators|tubulin modulators|mesh-ancestor
110924128|NCT02639650|Antimitotic Agents|antimitotic agents|mesh-ancestor
110924129|NCT02639650|Mitosis Modulators|mitosis modulators|mesh-ancestor
110924130|NCT02639650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110924131|NCT02639650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110924132|NCT02639650|Immunologic Factors|immunologic factors|mesh-ancestor
110924133|NCT02639650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110924134|NCT02639650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110924135|NCT02639650|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110924136|NCT02639650|Alkylating Agents|alkylating agents|mesh-ancestor
110924137|NCT02639650|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110924138|NCT02639650|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110924139|NCT02639650|Abortifacient Agents|abortifacient agents|mesh-ancestor
110924140|NCT02639650|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110924141|NCT02639650|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110924142|NCT02639650|Antimetabolites|antimetabolites|mesh-ancestor
110924143|NCT02639650|Dermatologic Agents|dermatologic agents|mesh-ancestor
110924144|NCT02639650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110924145|NCT02639650|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110924146|NCT02639650|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110924147|NCT02639650|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110924148|NCT02639650|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110924149|NCT02639650|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110924150|NCT02639650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110924151|NCT02639650|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110924152|NCT02639650|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110924154|NCT03581734|Immunologic Factors|immunologic factors|mesh-ancestor
110924155|NCT03581734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110924156|NCT02306798|Mesalamine|mesalamine|mesh-list
110924157|NCT02306798|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110924158|NCT02306798|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110924159|NCT02306798|Analgesics|analgesics|mesh-ancestor
110924160|NCT02306798|Sensory System Agents|sensory system agents|mesh-ancestor
110924161|NCT02306798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110924162|NCT02306798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110924163|NCT02306798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110924165|NCT02306954|Aldesleukin|aldesleukin|mesh-list
110924166|NCT02306954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110924167|NCT02306954|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110924168|NCT02306954|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110924169|NCT02306954|Antiviral Agents|antiviral agents|mesh-ancestor
110924170|NCT02306954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110924171|NCT03509714|Ascorbic Acid|ascorbic acid|mesh-list
110924172|NCT03509714|Antioxidants|antioxidants|mesh-ancestor
110264374|NCT02935972|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110924173|NCT03509714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110924174|NCT03509714|Protective Agents|protective agents|mesh-ancestor
110924175|NCT03509714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110924176|NCT03509714|Vitamins|vitamins|mesh-ancestor
110924177|NCT03509714|Micronutrients|micronutrients|mesh-ancestor
110924178|NCT02302274|Flecainide|flecainide|mesh-list
110924179|NCT02302274|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110924180|NCT02302274|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110924182|NCT02302274|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110924183|NCT02302274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110924184|NCT02303600|Montelukast|montelukast|mesh-list
110924185|NCT02303600|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110924186|NCT02303600|Respiratory System Agents|respiratory system agents|mesh-ancestor
110924187|NCT02303600|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110924188|NCT02303600|Hormone Antagonists|hormone antagonists|mesh-ancestor
110365927|NCT05681572|Dexmedetomidine|dexmedetomidine|mesh-list
110924189|NCT02303600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110924190|NCT02303600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110924191|NCT02303600|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110924192|NCT02303600|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110924193|NCT02303600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110924194|NCT04463342|Methamphetamine|methamphetamine|mesh-list
110924195|NCT04463342|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110924196|NCT04463342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110924197|NCT04463342|Sympathomimetics|sympathomimetics|mesh-ancestor
110924198|NCT04463342|Autonomic Agents|autonomic agents|mesh-ancestor
110924199|NCT04463342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110924200|NCT04463342|Dopamine Agents|dopamine agents|mesh-ancestor
110264574|NCT02934217|Cyclosporine|cyclosporine|mesh-list
110924202|NCT04463342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110924203|NCT04463342|Adrenergic Agents|adrenergic agents|mesh-ancestor
110924204|NCT04463342|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110924205|NCT04463342|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110924206|NCT04463342|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110924207|NCT04463342|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110924209|NCT02303912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110924211|NCT01597492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110924212|NCT01597492|Immunologic Factors|immunologic factors|mesh-ancestor
110924213|NCT01597492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110924214|NCT04569994|Insulin|insulin|mesh-list
110924215|NCT04569994|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110924216|NCT04569994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110924217|NCT00109590|Ritonavir|ritonavir|mesh-list
110924218|NCT00109590|Lopinavir|lopinavir|mesh-list
110924220|NCT00109590|Nevirapine|nevirapine|mesh-list
110924221|NCT00109590|Didanosine|didanosine|mesh-list
110924222|NCT00109590|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110924223|NCT00109590|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110924224|NCT00109590|Protease Inhibitors|protease inhibitors|mesh-ancestor
110924225|NCT00109590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110924226|NCT00109590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110924227|NCT00109590|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110924228|NCT00109590|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110924229|NCT00109590|Antiviral Agents|antiviral agents|mesh-ancestor
110924230|NCT00109590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110924231|NCT00109590|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110924232|NCT00109590|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110924233|NCT00109590|Antimetabolites|antimetabolites|mesh-ancestor
110924234|NCT00109590|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110924235|NCT00109590|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110924236|NCT00109590|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110924237|NCT00109590|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110924238|NCT05243446|Losartan|losartan|mesh-list
110924239|NCT05243446|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110924240|NCT05243446|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110924241|NCT05243446|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110924242|NCT05243446|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110924243|NCT05243446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110924244|NCT02143362|Remifentanil|remifentanil|mesh-list
110924245|NCT02143362|Anesthetics|anesthetics|mesh-list
110924246|NCT02143362|Propofol|propofol|mesh-list
110924247|NCT02143362|Cisatracurium|cisatracurium|mesh-list
110924248|NCT02143362|Atracurium|atracurium|mesh-list
110924249|NCT02143362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110924250|NCT02143362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110924251|NCT02143362|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110924252|NCT02143362|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110924253|NCT02143362|Anesthetics, General|anesthetics, general|mesh-ancestor
110924254|NCT02143362|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110924256|NCT02143362|Analgesics|analgesics|mesh-ancestor
110924257|NCT02143362|Sensory System Agents|sensory system agents|mesh-ancestor
110924258|NCT02143362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110924259|NCT02143362|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110924260|NCT02143362|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110924261|NCT02143362|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110924262|NCT02143362|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
110924263|NCT02143362|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110924264|NCT02143362|Cholinergic Agents|cholinergic agents|mesh-ancestor
110924265|NCT02143362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110924266|NCT02143362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110924267|NCT03509324|Insulin Lispro|insulin lispro|mesh-list
110924268|NCT03509324|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110924269|NCT03509324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110924270|NCT02143440|Insulin|insulin|mesh-list
110924271|NCT02143440|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110924272|NCT02143440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110924273|NCT02143518|Aluminum Hydroxide|aluminum hydroxide|mesh-list
110924274|NCT02143518|CPG-oligonucleotide|cpg-oligonucleotide|mesh-list
110924275|NCT02143518|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110924276|NCT02143518|Immunologic Factors|immunologic factors|mesh-ancestor
110924277|NCT02143518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110924278|NCT02143518|Antacids|antacids|mesh-ancestor
110924279|NCT02143518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110924280|NCT02143518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110924281|NCT03682770|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110924282|NCT03682770|Immunologic Factors|immunologic factors|mesh-ancestor
110265010|NCT02923336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110924283|NCT03682770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110924284|NCT03506828|Phenol|phenol|mesh-list
110924285|NCT03506828|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110924286|NCT03506828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110924287|NCT03506828|Disinfectants|disinfectants|mesh-ancestor
110924288|NCT03506828|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
110924289|NCT03506828|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110924290|NCT00054964|Albuterol|albuterol|mesh-list
110924291|NCT00054964|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110924292|NCT00054964|Autonomic Agents|autonomic agents|mesh-ancestor
110924293|NCT00054964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110265075|NCT02921659|Micronutrients|micronutrients|mesh-ancestor
110924294|NCT00054964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110924295|NCT00054964|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110924296|NCT00054964|Respiratory System Agents|respiratory system agents|mesh-ancestor
110924297|NCT00054964|Tocolytic Agents|tocolytic agents|mesh-ancestor
110924298|NCT00054964|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110929692|NCT00778999|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110924299|NCT00054964|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110924300|NCT00054964|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110924301|NCT00054964|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110924302|NCT00054964|Adrenergic Agents|adrenergic agents|mesh-ancestor
110924303|NCT00054964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110265141|NCT02920801|Incretins|incretins|mesh-ancestor
110924304|NCT00054964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110924305|NCT02781558|Sofosbuvir|sofosbuvir|mesh-list
110924306|NCT02781558|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
110924307|NCT02781558|Velpatasvir|velpatasvir|mesh-list
110924308|NCT02781558|Antiviral Agents|antiviral agents|mesh-ancestor
110924309|NCT02781558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110924310|NCT05073640|Pentoxifylline|pentoxifylline|mesh-list
110924311|NCT05073640|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110924312|NCT05073640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110924313|NCT05073640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110924314|NCT05073640|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110924315|NCT05073640|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110924316|NCT05073640|Protective Agents|protective agents|mesh-ancestor
110924317|NCT05073640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110924318|NCT05073640|Vasodilator Agents|vasodilator agents|mesh-ancestor
110924319|NCT05073640|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110924320|NCT05073640|Antioxidants|antioxidants|mesh-ancestor
110924321|NCT05073094|Esmolol|esmolol|mesh-list
110265210|NCT00154661|Antioxidants|antioxidants|mesh-ancestor
110924322|NCT05073094|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110924323|NCT05073094|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110924324|NCT05073094|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110924325|NCT05073094|Adrenergic Agents|adrenergic agents|mesh-ancestor
110924326|NCT05073094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110924327|NCT05073094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110924328|NCT05073094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110924329|NCT03509246|Doxorubicin|doxorubicin|mesh-list
110924330|NCT03509246|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110924331|NCT03509246|Bortezomib|bortezomib|mesh-list
110924332|NCT03509246|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110924333|NCT03509246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110924334|NCT03509246|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110924335|NCT03509246|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110924336|NCT03509246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110924337|NCT03509246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110924338|NCT03509168|Misoprostol|misoprostol|mesh-list
110924339|NCT03509168|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110641854|NCT00868634|Capecitabine|capecitabine|mesh-list
110924341|NCT03509168|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110924342|NCT03509168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110924343|NCT03509168|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110924344|NCT03509168|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110924345|NCT03509168|Oxytocics|oxytocics|mesh-ancestor
110924346|NCT05072938|Nizatidine|nizatidine|mesh-list
110924347|NCT05072938|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110924348|NCT05072938|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110924349|NCT05072938|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110924350|NCT05072938|Histamine Antagonists|histamine antagonists|mesh-ancestor
110924351|NCT05072938|Histamine Agents|histamine agents|mesh-ancestor
110924352|NCT05072938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110924353|NCT05072938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110929722|NCT00725413|Etonogestrel|etonogestrel|mesh-list
110924354|NCT05072938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110924355|NCT03041311|Carboplatin|carboplatin|mesh-list
110924356|NCT03041311|Etoposide|etoposide|mesh-list
110924357|NCT03041311|Atezolizumab|atezolizumab|mesh-list
110924358|NCT03041311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110924359|NCT03041311|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110924360|NCT03041311|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110924361|NCT03041311|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110924362|NCT03041311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110924363|NCT03041311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110924364|NCT03041311|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110924365|NCT03041311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110924366|NCT05072860|Tranexamic Acid|tranexamic acid|mesh-list
110924367|NCT05072860|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110924368|NCT05072860|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110924369|NCT05072860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110924370|NCT05072860|Hemostatics|hemostatics|mesh-ancestor
110924371|NCT05072860|Coagulants|coagulants|mesh-ancestor
110924373|NCT02311946|Rabeprazole|rabeprazole|mesh-list
110924374|NCT02311946|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
110924375|NCT02311946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110924376|NCT02311946|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110924377|NCT02311946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110924378|NCT02311946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110924379|NCT02311946|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110924380|NCT02311946|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110924381|NCT04302766|Remdesivir|remdesivir|mesh-list
110924382|NCT04302766|Antimetabolites|antimetabolites|mesh-ancestor
110265446|NCT00155558|Leucovorin|leucovorin|mesh-list
110924383|NCT04302766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110924384|NCT04302766|Antiviral Agents|antiviral agents|mesh-ancestor
110924385|NCT04302766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110924386|NCT02312102|Lenalidomide|lenalidomide|mesh-list
110924387|NCT02312102|Bortezomib|bortezomib|mesh-list
110924388|NCT02312102|Immunologic Factors|immunologic factors|mesh-ancestor
110924389|NCT02312102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110924390|NCT02312102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110265513|NCT00181779|Aripiprazole|aripiprazole|mesh-list
110924391|NCT02312102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110924392|NCT02312102|Growth Substances|growth substances|mesh-ancestor
110924393|NCT02312102|Growth Inhibitors|growth inhibitors|mesh-ancestor
110924394|NCT02312102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110924395|NCT05408221|Lenvatinib|lenvatinib|mesh-list
110924396|NCT05408221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110924397|NCT05408221|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110924398|NCT05408221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110924399|NCT05408221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110924400|NCT02307968|Insulin|insulin|mesh-list
110924401|NCT02307968|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110924402|NCT02307968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110924404|NCT02312180|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110924405|NCT02312180|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110924406|NCT02312180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110924407|NCT03504566|Empagliflozin|empagliflozin|mesh-list
110924408|NCT03504566|Linagliptin|linagliptin|mesh-list
110924409|NCT03504566|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
110924410|NCT03504566|Telmisartan|telmisartan|mesh-list
110924411|NCT03504566|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110924412|NCT03504566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110924413|NCT03504566|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110924414|NCT03504566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110924415|NCT03504566|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110924416|NCT03504566|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110924417|NCT03504566|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110924419|NCT03504566|Hormones|hormones|mesh-ancestor
110924420|NCT03504566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110924421|NCT03504566|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110924422|NCT03504566|Protease Inhibitors|protease inhibitors|mesh-ancestor
110924423|NCT03504566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110924424|NCT03504566|Anticoagulants|anticoagulants|mesh-ancestor
110924425|NCT03504566|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110924426|NCT03504566|Antimetabolites|antimetabolites|mesh-ancestor
110924427|NCT03504566|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110924428|NCT03504566|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110924429|NCT03504566|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110924430|NCT05070520|Lumefantrine|lumefantrine|mesh-list
110924432|NCT05070520|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
110924433|NCT05070520|Antimalarials|antimalarials|mesh-ancestor
110924434|NCT05070520|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110924435|NCT05070520|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110924436|NCT05070520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110924437|NCT05070598|Paclitaxel|paclitaxel|mesh-list
110924438|NCT05070598|Tegafur|tegafur|mesh-list
110924439|NCT05070598|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110924440|NCT05070598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110924441|NCT05070598|Tubulin Modulators|tubulin modulators|mesh-ancestor
110924442|NCT05070598|Antimitotic Agents|antimitotic agents|mesh-ancestor
110924443|NCT05070598|Mitosis Modulators|mitosis modulators|mesh-ancestor
110924444|NCT05070598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110924445|NCT05070598|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110924446|NCT05070598|Antimetabolites|antimetabolites|mesh-ancestor
110924447|NCT03884452|Atorvastatin|atorvastatin|mesh-list
110924448|NCT03884452|Simvastatin|simvastatin|mesh-list
110924449|NCT03884452|Ezetimibe|ezetimibe|mesh-list
110924450|NCT03884452|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110924451|NCT03884452|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110924452|NCT03884452|Antimetabolites|antimetabolites|mesh-ancestor
110924453|NCT03884452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110924454|NCT03884452|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110924456|NCT03884452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110924457|NCT03882892|Ezetimibe|ezetimibe|mesh-list
110924458|NCT03882892|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110924459|NCT03882892|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110924460|NCT03882892|Antimetabolites|antimetabolites|mesh-ancestor
110924461|NCT03882892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110924462|NCT03882892|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110924463|NCT02305160|Poractant alfa|poractant alfa|mesh-list
110924464|NCT02305160|Beractant|beractant|mesh-list
110924465|NCT02305160|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
110924466|NCT02305160|Respiratory System Agents|respiratory system agents|mesh-ancestor
110924467|NCT02305394|Ketamine|ketamine|mesh-list
110924468|NCT02305394|Propofol|propofol|mesh-list
110924469|NCT02305394|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110924470|NCT02305394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110924471|NCT02305394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110924472|NCT02305394|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110924473|NCT02305394|Anesthetics, General|anesthetics, general|mesh-ancestor
110924474|NCT02305394|Anesthetics|anesthetics|mesh-ancestor
110924475|NCT02305394|Analgesics|analgesics|mesh-ancestor
110924476|NCT02305394|Sensory System Agents|sensory system agents|mesh-ancestor
110924477|NCT02305394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110924478|NCT02305394|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110924479|NCT02305394|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110924480|NCT02305394|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110924481|NCT02305394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110924482|NCT02305394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110924483|NCT05068960|Bupivacaine|bupivacaine|mesh-list
110924484|NCT05068960|Anesthetics, Local|anesthetics, local|mesh-ancestor
110924485|NCT05068960|Anesthetics|anesthetics|mesh-ancestor
110924486|NCT05068960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110924487|NCT05068960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110924488|NCT05068960|Sensory System Agents|sensory system agents|mesh-ancestor
110924489|NCT05068960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110924490|NCT02305550|Nitric Oxide|nitric oxide|mesh-list
110924491|NCT02305550|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110924492|NCT02305550|Autonomic Agents|autonomic agents|mesh-ancestor
110924493|NCT02305550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110924494|NCT02305550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110924495|NCT02305550|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110265926|NCT00156650|Androgens|androgens|mesh-ancestor
110924496|NCT02305550|Respiratory System Agents|respiratory system agents|mesh-ancestor
110924497|NCT02305550|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110924499|NCT02305550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110924500|NCT02305550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110924501|NCT02305550|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
110924502|NCT02305550|Vasodilator Agents|vasodilator agents|mesh-ancestor
110924503|NCT02305550|Gasotransmitters|gasotransmitters|mesh-ancestor
110924504|NCT02305550|Protective Agents|protective agents|mesh-ancestor
110924505|NCT03506516|Ethanol|ethanol|mesh-list
110924506|NCT03506516|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110924507|NCT03506516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110924508|NCT03506516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110924509|NCT03506516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110924510|NCT02312492|Palmitic Acid|palmitic acid|mesh-list
110924511|NCT02312492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110924512|NCT02312492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110924513|NCT02643394|Acetaminophen|acetaminophen|mesh-list
110924514|NCT02643394|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110924515|NCT02643394|Analgesics|analgesics|mesh-ancestor
110924516|NCT02643394|Sensory System Agents|sensory system agents|mesh-ancestor
110924517|NCT02643394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110924518|NCT02643394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110924519|NCT02643394|Antipyretics|antipyretics|mesh-ancestor
110924520|NCT03101644|Darunavir|darunavir|mesh-list
110924521|NCT03101644|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110924522|NCT03101644|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110924523|NCT03101644|Protease Inhibitors|protease inhibitors|mesh-ancestor
110924524|NCT03101644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110924525|NCT03101644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110924526|NCT03101644|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110924527|NCT03101644|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110924528|NCT03101644|Antiviral Agents|antiviral agents|mesh-ancestor
110924529|NCT03101644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110924530|NCT03132272|Autoantibodies|autoantibodies|mesh-list
110924531|NCT03132272|Immunologic Factors|immunologic factors|mesh-ancestor
110924532|NCT03132272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110924533|NCT03503786|Paclitaxel|paclitaxel|mesh-list
110924534|NCT03503786|Carboplatin|carboplatin|mesh-list
110924535|NCT03503786|Avelumab|avelumab|mesh-list
110929764|NCT04887064|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110924536|NCT03503786|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110924537|NCT03503786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110924538|NCT03503786|Tubulin Modulators|tubulin modulators|mesh-ancestor
110924539|NCT03503786|Antimitotic Agents|antimitotic agents|mesh-ancestor
110924540|NCT03503786|Mitosis Modulators|mitosis modulators|mesh-ancestor
110924541|NCT03503786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110266112|NCT00189384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110924543|NCT02308982|Immunoglobulins|immunoglobulins|mesh-list
110924544|NCT02308982|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110924545|NCT02308982|Antibodies|antibodies|mesh-list
110924546|NCT02308982|gamma-Globulins|gamma-globulins|mesh-list
110924547|NCT02308982|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110924548|NCT02308982|Immunologic Factors|immunologic factors|mesh-ancestor
110924549|NCT02308982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110924550|NCT05515627|Atezolizumab|atezolizumab|mesh-list
110924551|NCT05515627|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110924552|NCT05515627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110924553|NCT05515627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110924554|NCT05515627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110924555|NCT02178436|Paclitaxel|paclitaxel|mesh-list
110924556|NCT02178436|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110924557|NCT02178436|Gemcitabine|gemcitabine|mesh-list
110924559|NCT02178436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110924560|NCT02178436|Tubulin Modulators|tubulin modulators|mesh-ancestor
110924561|NCT02178436|Antimitotic Agents|antimitotic agents|mesh-ancestor
110924562|NCT02178436|Mitosis Modulators|mitosis modulators|mesh-ancestor
110924563|NCT02178436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110924564|NCT02178436|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110924565|NCT02178436|Antimetabolites|antimetabolites|mesh-ancestor
110924566|NCT02144064|Heparin|heparin|mesh-list
110924567|NCT02144064|Calcium heparin|calcium heparin|mesh-list
110924568|NCT02144064|Anticoagulants|anticoagulants|mesh-ancestor
110924569|NCT02144064|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110924570|NCT02144064|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110924571|NCT02144064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110924572|NCT02144142|Anti-Infective Agents|anti-infective agents|mesh-list
110924573|NCT02144142|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110924574|NCT02305862|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110924575|NCT02305862|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110924576|NCT02305862|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110924578|NCT02305862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110924579|NCT02305862|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110924580|NCT02305862|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110924581|NCT02305862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110924582|NCT02305940|Doxycycline|doxycycline|mesh-list
110924583|NCT02305940|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110924584|NCT02305940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110924585|NCT02305940|Antimalarials|antimalarials|mesh-ancestor
110924586|NCT02305940|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110924587|NCT02305940|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110924588|NCT02312804|Paclitaxel|paclitaxel|mesh-list
110924589|NCT02312804|Carboplatin|carboplatin|mesh-list
110924590|NCT02312804|Infigratinib|infigratinib|mesh-list
110924591|NCT02312804|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110924592|NCT02312804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110924593|NCT02312804|Tubulin Modulators|tubulin modulators|mesh-ancestor
110924594|NCT02312804|Antimitotic Agents|antimitotic agents|mesh-ancestor
110924596|NCT02312804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110924597|NCT03099616|Propofol|propofol|mesh-list
110924598|NCT03099616|Desflurane|desflurane|mesh-list
110924599|NCT03099616|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110924600|NCT03099616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110924601|NCT03099616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110924602|NCT03099616|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110924603|NCT03099616|Anesthetics, General|anesthetics, general|mesh-ancestor
110924604|NCT03099616|Anesthetics|anesthetics|mesh-ancestor
110924605|NCT03099616|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110924606|NCT04463966|Tranexamic Acid|tranexamic acid|mesh-list
110924607|NCT04463966|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110924608|NCT04463966|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110924609|NCT04463966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110924610|NCT04463966|Hemostatics|hemostatics|mesh-ancestor
110924611|NCT04463966|Coagulants|coagulants|mesh-ancestor
110924612|NCT00794248|Fexofenadine|fexofenadine|mesh-list
110924613|NCT00794248|Desloratadine|desloratadine|mesh-list
110924614|NCT00794248|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110924615|NCT00794248|Cholinergic Agents|cholinergic agents|mesh-ancestor
110924616|NCT00794248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110924617|NCT00794248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110924618|NCT00794248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110924619|NCT00794248|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110924620|NCT00794248|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110924621|NCT00794248|Histamine Antagonists|histamine antagonists|mesh-ancestor
110924622|NCT00794248|Histamine Agents|histamine agents|mesh-ancestor
110924623|NCT00794248|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110924624|NCT02309450|Asunaprevir|asunaprevir|mesh-list
110924625|NCT02309450|Protease Inhibitors|protease inhibitors|mesh-ancestor
110924626|NCT02309450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110924627|NCT02309450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110924629|NCT04475224|Mitosis Modulators|mitosis modulators|mesh-ancestor
110924630|NCT04475224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110924631|NCT00353496|Lanreotide|lanreotide|mesh-list
110924632|NCT00353496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110924633|NCT00389896|Oxymetazoline|oxymetazoline|mesh-list
110924634|NCT00389896|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110924635|NCT00389896|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110924636|NCT00389896|Adrenergic Agents|adrenergic agents|mesh-ancestor
110924637|NCT00389896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110924638|NCT00389896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110924639|NCT00389896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110924640|NCT00389896|Sympathomimetics|sympathomimetics|mesh-ancestor
110924641|NCT00389896|Autonomic Agents|autonomic agents|mesh-ancestor
110924642|NCT00389896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110924644|NCT00389896|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110924645|NCT00389896|Respiratory System Agents|respiratory system agents|mesh-ancestor
110924646|NCT03388190|Leucovorin|leucovorin|mesh-list
110924647|NCT03388190|Fluorouracil|fluorouracil|mesh-list
110924648|NCT03388190|Oxaliplatin|oxaliplatin|mesh-list
110924649|NCT03388190|Nivolumab|nivolumab|mesh-list
110924650|NCT03388190|Levoleucovorin|levoleucovorin|mesh-list
110924651|NCT03388190|Antimetabolites|antimetabolites|mesh-ancestor
110924652|NCT03388190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110924653|NCT03388190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110924654|NCT03388190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110924655|NCT03388190|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110924656|NCT03388190|Immunologic Factors|immunologic factors|mesh-ancestor
110924657|NCT03388190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110924658|NCT03388190|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110924659|NCT03388190|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110924660|NCT03388190|Antidotes|antidotes|mesh-ancestor
110924661|NCT03388190|Protective Agents|protective agents|mesh-ancestor
110924662|NCT03388190|Vitamin B Complex|vitamin b complex|mesh-ancestor
110924663|NCT03388190|Vitamins|vitamins|mesh-ancestor
110924664|NCT03388190|Micronutrients|micronutrients|mesh-ancestor
110924665|NCT02313272|Bevacizumab|bevacizumab|mesh-list
110924666|NCT02313272|Pembrolizumab|pembrolizumab|mesh-list
110266650|NCT00158561|Dapsone|dapsone|mesh-list
110924667|NCT02313272|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110924668|NCT02313272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110924669|NCT02313272|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110924670|NCT02313272|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110924671|NCT02313272|Growth Substances|growth substances|mesh-ancestor
110924672|NCT02313272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110924673|NCT02313272|Growth Inhibitors|growth inhibitors|mesh-ancestor
110924674|NCT02313272|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110929787|NCT02176200|Respiratory System Agents|respiratory system agents|mesh-ancestor
110924675|NCT02313272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110924676|NCT03473977|Benralizumab|benralizumab|mesh-list
110924677|NCT03473977|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110924678|NCT03473977|Respiratory System Agents|respiratory system agents|mesh-ancestor
110924679|NCT01361464|Tipifarnib|tipifarnib|mesh-list
110924680|NCT01361464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110924681|NCT04051255|Metronidazole|metronidazole|mesh-list
110924682|NCT04051255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110924683|NCT04051255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110924684|NCT04051255|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110924685|NCT04051255|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110924686|NCT03505736|Adenosine|adenosine|mesh-list
110924687|NCT03505736|Regadenoson|regadenoson|mesh-list
110924688|NCT03505736|Analgesics|analgesics|mesh-ancestor
110924689|NCT03505736|Sensory System Agents|sensory system agents|mesh-ancestor
110924690|NCT03505736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110924691|NCT03505736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110924692|NCT03505736|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110924693|NCT03505736|Vasodilator Agents|vasodilator agents|mesh-ancestor
110924694|NCT03505736|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
110924695|NCT03505736|Purinergic Agonists|purinergic agonists|mesh-ancestor
110924696|NCT03505736|Purinergic Agents|purinergic agents|mesh-ancestor
110924697|NCT03505736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110924698|NCT03505736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110924699|NCT03505736|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
110924700|NCT02316626|Progesterone|progesterone|mesh-list
110924701|NCT02316626|Progestins|progestins|mesh-ancestor
110924702|NCT02316626|Hormones|hormones|mesh-ancestor
110924703|NCT02316626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110924704|NCT02316626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110924705|NCT03505502|Tranexamic Acid|tranexamic acid|mesh-list
110924706|NCT03505502|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110924707|NCT03505502|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110924708|NCT03505502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110924709|NCT03505502|Hemostatics|hemostatics|mesh-ancestor
110924710|NCT03505502|Coagulants|coagulants|mesh-ancestor
110924711|NCT03977896|Carbon-11 methionine|carbon-11 methionine|mesh-list
110924712|NCT03977896|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110924713|NCT03977896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110924714|NCT02316704|Tacrine|tacrine|mesh-list
110924715|NCT02316704|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110924716|NCT02316704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110924717|NCT02316704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110924718|NCT02316704|Cholinergic Agents|cholinergic agents|mesh-ancestor
110924719|NCT02316704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110924720|NCT02316704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110924721|NCT02316704|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110924722|NCT02316704|Autonomic Agents|autonomic agents|mesh-ancestor
110924723|NCT02316704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110924724|NCT02316704|Nootropic Agents|nootropic agents|mesh-ancestor
110924726|NCT03501680|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110924727|NCT03501680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110924728|NCT02310074|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
110924729|NCT02310074|Hormones|hormones|mesh-list
110924730|NCT02310074|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
110924731|NCT02310074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110924732|NCT02310074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110924733|NCT02310074|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110924734|NCT02313584|Dabigatran|dabigatran|mesh-list
110924735|NCT02313584|Antithrombins|antithrombins|mesh-ancestor
110924736|NCT02313584|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110924737|NCT02313584|Protease Inhibitors|protease inhibitors|mesh-ancestor
110924738|NCT02313584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110924739|NCT02313584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110924740|NCT02313584|Anticoagulants|anticoagulants|mesh-ancestor
110924742|NCT05063578|Anesthetics, Local|anesthetics, local|mesh-ancestor
110924743|NCT05063578|Anesthetics|anesthetics|mesh-ancestor
110924744|NCT05063578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110924745|NCT05063578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110924746|NCT05063578|Sensory System Agents|sensory system agents|mesh-ancestor
110924747|NCT05063578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110267012|NCT00539968|Docetaxel|docetaxel|mesh-list
110924748|NCT05063578|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110924749|NCT05063578|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110924750|NCT05063578|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110924751|NCT05063578|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110924752|NCT05063578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110924753|NCT05063422|Trimethoprim|trimethoprim|mesh-list
110924754|NCT05063422|Polymyxins|polymyxins|mesh-list
110924755|NCT05063422|Polymyxin B|polymyxin b|mesh-list
110924756|NCT05063422|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
110924757|NCT05063422|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110924758|NCT05063422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110924759|NCT05063422|Antimalarials|antimalarials|mesh-ancestor
110924760|NCT05063422|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110924761|NCT05063422|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110924762|NCT05063422|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110924763|NCT05063422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110924764|NCT05063422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110924765|NCT05063422|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110924766|NCT05063422|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
110924767|NCT05063422|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110924768|NCT05063422|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110924769|NCT05063422|Laxatives|laxatives|mesh-ancestor
110924770|NCT05063422|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110924771|NCT03782350|Tranexamic Acid|tranexamic acid|mesh-list
110924772|NCT03782350|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110924773|NCT03782350|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110924774|NCT03782350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110924775|NCT03782350|Hemostatics|hemostatics|mesh-ancestor
110924776|NCT03782350|Coagulants|coagulants|mesh-ancestor
110924777|NCT03098680|Verapamil|verapamil|mesh-list
110924778|NCT03098680|Nicardipine|nicardipine|mesh-list
110924779|NCT03098680|Phentolamine|phentolamine|mesh-list
110924780|NCT03098680|Phenylephrine|phenylephrine|mesh-list
110924781|NCT03098680|Dobutamine|dobutamine|mesh-list
110924782|NCT03098680|Oxymetazoline|oxymetazoline|mesh-list
110924783|NCT03098680|Albuterol|albuterol|mesh-list
110924784|NCT03098680|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110924785|NCT03098680|Autonomic Agents|autonomic agents|mesh-ancestor
110924786|NCT03098680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110924787|NCT03098680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110924788|NCT03098680|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110924789|NCT03098680|Respiratory System Agents|respiratory system agents|mesh-ancestor
110924790|NCT03098680|Tocolytic Agents|tocolytic agents|mesh-ancestor
110924791|NCT03098680|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110924819|NCT03098368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110924820|NCT03098368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110924821|NCT05062486|Curcumin|curcumin|mesh-list
110924822|NCT05062486|Resveratrol|resveratrol|mesh-list
110924823|NCT05062486|Quercetin|quercetin|mesh-list
110924824|NCT05062486|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110924825|NCT05062486|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110924826|NCT05062486|Analgesics|analgesics|mesh-ancestor
110924827|NCT05062486|Sensory System Agents|sensory system agents|mesh-ancestor
110924828|NCT05062486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110924829|NCT05062486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110924830|NCT05062486|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110924831|NCT05062486|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110924832|NCT05062486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110924833|NCT05062486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110924834|NCT05062486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110924835|NCT05062486|Antioxidants|antioxidants|mesh-ancestor
110924836|NCT05062486|Protective Agents|protective agents|mesh-ancestor
110924837|NCT05062486|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110924838|NCT04474600|Propofol|propofol|mesh-list
110924839|NCT04474600|Desflurane|desflurane|mesh-list
110924840|NCT04474600|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110267279|NCT00541567|Ibipinabant|ibipinabant|mesh-list
110924842|NCT04474600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110924843|NCT04474600|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110924844|NCT04474600|Anesthetics, General|anesthetics, general|mesh-ancestor
110924845|NCT04474600|Anesthetics|anesthetics|mesh-ancestor
110924846|NCT04474600|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110924847|NCT02314208|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
110924848|NCT02314208|Resveratrol|resveratrol|mesh-list
110924849|NCT02314208|Atorvastatin|atorvastatin|mesh-list
110924850|NCT02314208|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110924851|NCT02314208|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110924852|NCT02314208|Antimetabolites|antimetabolites|mesh-ancestor
110924853|NCT02314208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110924854|NCT02314208|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110924855|NCT02314208|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110924856|NCT02314208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110924857|NCT02314208|Antioxidants|antioxidants|mesh-ancestor
110924858|NCT02314208|Protective Agents|protective agents|mesh-ancestor
110924859|NCT02314208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110924860|NCT02314208|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110924861|NCT02314208|Cathartics|cathartics|mesh-ancestor
110924862|NCT02314208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110924864|NCT03100318|Benzbromarone|benzbromarone|mesh-list
110924865|NCT03100318|Uricosuric Agents|uricosuric agents|mesh-ancestor
110924866|NCT03100318|Gout Suppressants|gout suppressants|mesh-ancestor
110924867|NCT03100318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110924868|NCT02311010|Tacrolimus|tacrolimus|mesh-list
110924869|NCT02311010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110924870|NCT02311010|Immunologic Factors|immunologic factors|mesh-ancestor
110924871|NCT02311010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110924872|NCT02311010|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110924873|NCT02311010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110924874|NCT02311010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110924875|NCT02314286|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110924876|NCT02314286|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110924877|NCT02314286|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110924878|NCT02314286|Antimetabolites|antimetabolites|mesh-ancestor
110924879|NCT02314286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110924880|NCT02314286|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110924881|NCT02314286|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110924882|NCT02314286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110924883|NCT03132194|Dapsone|dapsone|mesh-list
110924884|NCT03132194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110924885|NCT03132194|Antimalarials|antimalarials|mesh-ancestor
110924886|NCT03132194|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110924887|NCT03132194|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110924888|NCT03132194|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110924889|NCT03132194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110924890|NCT03132194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110924891|NCT03132194|Leprostatic Agents|leprostatic agents|mesh-ancestor
110924892|NCT03132194|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110924893|NCT02311088|Caffeine|caffeine|mesh-list
110924894|NCT02311088|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110924895|NCT02311088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110924896|NCT02311088|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110924897|NCT02311088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110924898|NCT02311088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110924899|NCT02311088|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110924900|NCT02311088|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110924901|NCT02311088|Purinergic Agents|purinergic agents|mesh-ancestor
110924902|NCT02311088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110924903|NCT03501212|Anesthetics|anesthetics|mesh-list
110924904|NCT03501212|Anesthetics, Local|anesthetics, local|mesh-list
110924905|NCT03501212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110924906|NCT03501212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110924907|NCT03501212|Sensory System Agents|sensory system agents|mesh-ancestor
110924908|NCT03501212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110924909|NCT02317484|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
110924910|NCT02317484|Ipragliflozin|ipragliflozin|mesh-list
110924911|NCT02317484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110924912|NCT02317484|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110924913|NCT02317484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110924914|NCT04435210|Hydralazine|hydralazine|mesh-list
110924915|NCT04435210|Nifedipine|nifedipine|mesh-list
110924916|NCT04435210|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110924917|NCT04435210|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110924918|NCT04435210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110924919|NCT04435210|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110924920|NCT04435210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110924921|NCT04435210|Vasodilator Agents|vasodilator agents|mesh-ancestor
110924922|NCT04435210|Tocolytic Agents|tocolytic agents|mesh-ancestor
110924923|NCT04435210|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110924924|NCT04435210|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110924926|NCT03501056|Antibodies, Bispecific|antibodies, bispecific|mesh-list
110924927|NCT03501056|Immunologic Factors|immunologic factors|mesh-ancestor
110924928|NCT03501056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110924930|NCT03292146|Alendronate|alendronate|mesh-list
110924931|NCT03292146|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110924932|NCT03292146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110924933|NCT02144376|Psyllium|psyllium|mesh-list
110924934|NCT02144376|Cathartics|cathartics|mesh-ancestor
110924935|NCT02144376|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110924936|NCT02314754|Misoprostol|misoprostol|mesh-list
110924937|NCT02314754|Mifepristone|mifepristone|mesh-list
110924938|NCT02314754|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110924939|NCT02314754|Abortifacient Agents|abortifacient agents|mesh-ancestor
110924940|NCT02314754|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110924941|NCT02314754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110924942|NCT02314754|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110924943|NCT02314754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110924945|NCT02314754|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
110924946|NCT02314754|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110924947|NCT02314754|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110924948|NCT02314754|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110924949|NCT02314754|Contraceptive Agents|contraceptive agents|mesh-ancestor
110924950|NCT02314754|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
110924951|NCT02314754|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
110924952|NCT02314754|Hormone Antagonists|hormone antagonists|mesh-ancestor
110924953|NCT02314754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110924954|NCT02314754|Luteolytic Agents|luteolytic agents|mesh-ancestor
110924955|NCT02314754|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110924956|NCT02314754|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
110924957|NCT02317640|Testosterone|testosterone|mesh-list
110924958|NCT02317640|Androgens|androgens|mesh-ancestor
110924960|NCT02317640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110924961|NCT02317640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110924962|NCT02716948|Nivolumab|nivolumab|mesh-list
110924963|NCT02716948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110924964|NCT02716948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110924965|NCT02716948|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110924966|NCT02716948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110924968|NCT03500900|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110924969|NCT03500900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110924970|NCT03500900|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110924971|NCT03500900|Protease Inhibitors|protease inhibitors|mesh-ancestor
110924972|NCT03500900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110924973|NCT03500900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110924974|NCT02144688|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
110924975|NCT02144688|Antiviral Agents|antiviral agents|mesh-ancestor
110924976|NCT02144688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110924977|NCT02141100|Thioguanine|thioguanine|mesh-list
110924978|NCT02141100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110924979|NCT02141100|Antimetabolites|antimetabolites|mesh-ancestor
110924980|NCT02141100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110924981|NCT02141100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110924982|NCT02141178|Bupivacaine|bupivacaine|mesh-list
110924983|NCT02141178|Anesthetics, Local|anesthetics, local|mesh-ancestor
110924984|NCT02141178|Anesthetics|anesthetics|mesh-ancestor
110655652|NCT00973050|Hormone Antagonists|hormone antagonists|mesh-ancestor
110924985|NCT02141178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110924986|NCT02141178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110924987|NCT02141178|Sensory System Agents|sensory system agents|mesh-ancestor
110924988|NCT02141178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110924989|NCT02141412|Dexmedetomidine|dexmedetomidine|mesh-list
110924990|NCT02141412|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110924991|NCT02141412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110924992|NCT02141412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110924993|NCT02141412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110924994|NCT02141412|Analgesics|analgesics|mesh-ancestor
110924995|NCT02141412|Sensory System Agents|sensory system agents|mesh-ancestor
110924996|NCT02141412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110924997|NCT02141412|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110924998|NCT02141412|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110924999|NCT02141412|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110925000|NCT02141412|Adrenergic Agents|adrenergic agents|mesh-ancestor
110925001|NCT02141412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110925002|NCT02141412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110925004|NCT04463264|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110925005|NCT04463264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110925006|NCT03210558|Testosterone|testosterone|mesh-list
110925007|NCT03210558|Androgens|androgens|mesh-ancestor
110925008|NCT03210558|Hormones|hormones|mesh-ancestor
110925009|NCT03210558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110925010|NCT03210558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110925011|NCT05046262|Calcium|calcium|mesh-list
110925012|NCT05046262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110925013|NCT05046262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110925014|NCT05036824|Tinzaparin|tinzaparin|mesh-list
110925015|NCT05036824|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
110925016|NCT05036824|Dalteparin|dalteparin|mesh-list
110925017|NCT05036824|Anticoagulants|anticoagulants|mesh-ancestor
110925018|NCT05036824|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110925019|NCT05036824|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110925020|NCT05036824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110925021|NCT04462250|Analgesics, Opioid|analgesics, opioid|mesh-list
110925023|NCT04462250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110925024|NCT04462250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110925025|NCT04462250|Analgesics|analgesics|mesh-ancestor
110925026|NCT04462250|Sensory System Agents|sensory system agents|mesh-ancestor
110925027|NCT04462250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110925028|NCT02144766|Ropivacaine|ropivacaine|mesh-list
110925029|NCT02144766|Anesthetics, Local|anesthetics, local|mesh-ancestor
110925030|NCT02144766|Anesthetics|anesthetics|mesh-ancestor
110925031|NCT02144766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110925032|NCT02144766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110925033|NCT02144766|Sensory System Agents|sensory system agents|mesh-ancestor
110925034|NCT02144766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110925035|NCT05045248|Apraclonidine|apraclonidine|mesh-list
110925036|NCT05045248|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110925037|NCT05045248|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110925038|NCT05045248|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110925039|NCT05045248|Adrenergic Agents|adrenergic agents|mesh-ancestor
110925040|NCT05045248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110267955|NCT00546130|Immunologic Factors|immunologic factors|mesh-ancestor
110925041|NCT05045248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110925042|NCT05045248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110925043|NCT02144922|Pitavastatin|pitavastatin|mesh-list
110925044|NCT02144922|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110925045|NCT02144922|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110925046|NCT02144922|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110925047|NCT02144922|Antimetabolites|antimetabolites|mesh-ancestor
110925048|NCT02144922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110925049|NCT02144922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110925050|NCT02144922|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110925052|NCT02261064|Telmisartan|telmisartan|mesh-list
110925053|NCT02261064|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
110268022|NCT00546520|Ciclesonide|ciclesonide|mesh-list
110925054|NCT02261064|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110925055|NCT02261064|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110925056|NCT02261064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110925057|NCT02261064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110925058|NCT02261064|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110925059|NCT02261064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110925060|NCT02261064|Vasodilator Agents|vasodilator agents|mesh-ancestor
110925061|NCT02261064|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110925062|NCT02261064|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110925063|NCT02955966|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110925064|NCT02955966|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110925065|NCT02955966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110925066|NCT05035498|Phenylephrine|phenylephrine|mesh-list
110925067|NCT05035498|Oxymetazoline|oxymetazoline|mesh-list
110925068|NCT05035498|Norepinephrine|norepinephrine|mesh-list
110925069|NCT05035498|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
110925070|NCT05035498|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110925071|NCT05035498|Mydriatics|mydriatics|mesh-ancestor
110925072|NCT05035498|Autonomic Agents|autonomic agents|mesh-ancestor
110925073|NCT05035498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110925074|NCT05035498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110925075|NCT05035498|Sympathomimetics|sympathomimetics|mesh-ancestor
110925076|NCT05035498|Nasal Decongestants|nasal decongestants|mesh-ancestor
110925077|NCT05035498|Respiratory System Agents|respiratory system agents|mesh-ancestor
110925078|NCT05035498|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110925079|NCT05035498|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110925080|NCT05035498|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110925081|NCT05035498|Adrenergic Agents|adrenergic agents|mesh-ancestor
110925082|NCT05035498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110925083|NCT05035498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110925084|NCT05035498|Protective Agents|protective agents|mesh-ancestor
110925085|NCT03498326|Celecoxib|celecoxib|mesh-list
110925086|NCT03498326|Gemcitabine|gemcitabine|mesh-list
110925087|NCT03498326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110925088|NCT03498326|Antimetabolites|antimetabolites|mesh-ancestor
110925089|NCT03498326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110642611|NCT00201643|Dexamethasone|dexamethasone|mesh-list
110925090|NCT03498326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110925091|NCT03498326|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110925092|NCT03498326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110925093|NCT03498326|Analgesics|analgesics|mesh-ancestor
110925094|NCT03498326|Sensory System Agents|sensory system agents|mesh-ancestor
110925095|NCT03498326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110925096|NCT03498326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110925097|NCT03498326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110925098|NCT03498326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110925099|NCT03498326|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110925100|NCT03498326|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110925101|NCT03498326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110925102|NCT03498248|Lenograstim|lenograstim|mesh-list
110925103|NCT03498248|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110925104|NCT03498248|Immunologic Factors|immunologic factors|mesh-ancestor
110925105|NCT03498248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110925106|NCT01360996|Contraceptive Agents|contraceptive agents|mesh-list
110925107|NCT01360996|Contraceptives, Oral|contraceptives, oral|mesh-list
110925108|NCT01360996|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110925109|NCT01360996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110925110|NCT01360996|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110925111|NCT03498170|Itraconazole|itraconazole|mesh-list
110925112|NCT03498170|Acumapimod|acumapimod|mesh-list
110925113|NCT03498170|Antifungal Agents|antifungal agents|mesh-ancestor
110925114|NCT03498170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110925115|NCT03498170|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110925116|NCT03498170|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110925117|NCT03498170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110925118|NCT03498170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110925119|NCT03498170|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110925120|NCT03498170|Hormone Antagonists|hormone antagonists|mesh-ancestor
110925121|NCT03498170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110925122|NCT03498170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110925123|NCT03498170|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110925124|NCT03498170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110925125|NCT05055544|Fosfomycin|fosfomycin|mesh-list
110925126|NCT05055544|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110925127|NCT05055544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110925128|NCT03498092|Dexmedetomidine|dexmedetomidine|mesh-list
110925129|NCT03498092|Bupivacaine|bupivacaine|mesh-list
110925130|NCT03498092|Anesthetics, Local|anesthetics, local|mesh-ancestor
110925131|NCT03498092|Anesthetics|anesthetics|mesh-ancestor
110925132|NCT03498092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110925133|NCT03498092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110925134|NCT03498092|Sensory System Agents|sensory system agents|mesh-ancestor
110925135|NCT03498092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110925136|NCT03498092|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110925137|NCT03498092|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110925138|NCT03498092|Analgesics|analgesics|mesh-ancestor
110925139|NCT03498092|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110925140|NCT03498092|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110925141|NCT03498092|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110925142|NCT03498092|Adrenergic Agents|adrenergic agents|mesh-ancestor
110925143|NCT03498092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110655622|NCT04008966|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
110925144|NCT03498092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110925145|NCT03500432|Lidocaine|lidocaine|mesh-list
110925146|NCT03500432|Anesthetics, Local|anesthetics, local|mesh-ancestor
110925147|NCT03500432|Anesthetics|anesthetics|mesh-ancestor
110925148|NCT03500432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110925149|NCT03500432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110925150|NCT03500432|Sensory System Agents|sensory system agents|mesh-ancestor
110925151|NCT03500432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110925152|NCT03500432|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110925153|NCT03500432|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110655623|NCT04008966|Progestins|progestins|mesh-ancestor
110655624|NCT04008966|Hormones|hormones|mesh-ancestor
110925154|NCT03500432|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110268437|NCT00191685|Analgesics|analgesics|mesh-ancestor
110302849|NCT00252434|Adrenergic Agents|adrenergic agents|mesh-ancestor
110925155|NCT03500432|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110925156|NCT03500432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110925157|NCT02315690|Piperaquine|piperaquine|mesh-list
110925158|NCT02315690|Artenimol|artenimol|mesh-list
110925159|NCT02315690|Antimalarials|antimalarials|mesh-ancestor
110925160|NCT02315690|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110925161|NCT02315690|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110925162|NCT02315690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110925163|NCT02639338|Sofosbuvir|sofosbuvir|mesh-list
110925165|NCT02639338|Antiviral Agents|antiviral agents|mesh-ancestor
110925166|NCT02639338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110925167|NCT01754857|Rituximab|rituximab|mesh-list
110925168|NCT01754857|Lenalidomide|lenalidomide|mesh-list
110925169|NCT01754857|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110925170|NCT01754857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110568102|NCT02977468|Pembrolizumab|pembrolizumab|mesh-list
110925171|NCT01754857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110929963|NCT00431431|Tibolone|tibolone|mesh-list
110925172|NCT01754857|Immunologic Factors|immunologic factors|mesh-ancestor
110925173|NCT01754857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110925174|NCT01754857|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110925175|NCT01754857|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110925176|NCT01754857|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110925177|NCT01754857|Growth Substances|growth substances|mesh-ancestor
110925178|NCT01754857|Growth Inhibitors|growth inhibitors|mesh-ancestor
110925179|NCT01754857|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110925180|NCT01754857|Alkylating Agents|alkylating agents|mesh-ancestor
110268559|NCT00550810|Sunitinib|sunitinib|mesh-list
110925181|NCT01754857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110925182|NCT03497702|Cyclophosphamide|cyclophosphamide|mesh-list
110925184|NCT03497702|Doxorubicin|doxorubicin|mesh-list
110925185|NCT03497702|Letrozole|letrozole|mesh-list
110925186|NCT03497702|Leuprolide|leuprolide|mesh-list
110925187|NCT03497702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110925188|NCT03497702|Immunologic Factors|immunologic factors|mesh-ancestor
110925189|NCT03497702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110925190|NCT03497702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110925191|NCT03497702|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110925192|NCT03497702|Alkylating Agents|alkylating agents|mesh-ancestor
110925193|NCT03497702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110268612|NCT00551005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110925194|NCT03497702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110925195|NCT03497702|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110925196|NCT03497702|Tubulin Modulators|tubulin modulators|mesh-ancestor
110925197|NCT03497702|Antimitotic Agents|antimitotic agents|mesh-ancestor
110925198|NCT03497702|Mitosis Modulators|mitosis modulators|mesh-ancestor
110925199|NCT03497702|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110568362|NCT00757198|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110925200|NCT03497702|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110925201|NCT03497702|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110925202|NCT03497702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110925203|NCT03497702|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110925204|NCT03497702|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110925205|NCT03497702|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110268675|NCT02963337|Remifentanil|remifentanil|mesh-list
110568433|NCT00682786|Fluorouracil|fluorouracil|mesh-list
110925207|NCT03497702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110925208|NCT03497702|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110925209|NCT03497702|Fertility Agents|fertility agents|mesh-ancestor
110925210|NCT03497702|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110925211|NCT03497702|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110925212|NCT02900352|Zonisamide|zonisamide|mesh-list
110925213|NCT02900352|Anticonvulsants|anticonvulsants|mesh-ancestor
110925214|NCT02900352|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110925215|NCT02900352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110268725|NCT00185172|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110925216|NCT02900352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110568576|NCT05435560|Dexmedetomidine|dexmedetomidine|mesh-list
110925217|NCT02900352|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110925218|NCT02900352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110925219|NCT05034406|Lidocaine|lidocaine|mesh-list
110925220|NCT05034406|Levobupivacaine|levobupivacaine|mesh-list
110925221|NCT05034406|Anesthetics, Local|anesthetics, local|mesh-ancestor
110925222|NCT05034406|Anesthetics|anesthetics|mesh-ancestor
110925223|NCT05034406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110925224|NCT05034406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110925225|NCT05034406|Sensory System Agents|sensory system agents|mesh-ancestor
110925226|NCT05034406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110925227|NCT05034406|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110568713|NCT02607657|Hormone Antagonists|hormone antagonists|mesh-ancestor
110925228|NCT05034406|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110568784|NCT00761332|Diphosphonates|diphosphonates|mesh-list
110925229|NCT05034406|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110925230|NCT05034406|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110925231|NCT05034406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110925232|NCT02254668|Mycophenolic Acid|mycophenolic acid|mesh-list
110925234|NCT02254668|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110925235|NCT02254668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110568859|NCT00762190|Insulin|insulin|mesh-list
110925236|NCT02254668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110925237|NCT02254668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110568922|NCT00673894|Incretins|incretins|mesh-ancestor
110925238|NCT02254668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110925239|NCT02254668|Immunologic Factors|immunologic factors|mesh-ancestor
110925240|NCT02254668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110925241|NCT02254668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110925242|NCT02254668|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110268861|NCT00409071|Sinomenine|sinomenine|mesh-list
110925243|NCT02254668|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110925244|NCT02254668|Antitubercular Agents|antitubercular agents|mesh-ancestor
110925245|NCT02254668|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110925246|NCT02254668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110925247|NCT03095404|Lidocaine|lidocaine|mesh-list
110925248|NCT03095404|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110925249|NCT03095404|Anesthetics, Local|anesthetics, local|mesh-ancestor
110925250|NCT03095404|Anesthetics|anesthetics|mesh-ancestor
110569212|NCT00709254|Analgesics|analgesics|mesh-ancestor
110925251|NCT03095404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110925252|NCT03095404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110925253|NCT03095404|Sensory System Agents|sensory system agents|mesh-ancestor
110925254|NCT03095404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110925255|NCT03095404|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110925256|NCT03095404|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110925257|NCT03095404|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110925258|NCT03095404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110925259|NCT03095404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110925260|NCT02145546|Amiodarone|amiodarone|mesh-list
110925261|NCT02145546|Sotalol|sotalol|mesh-list
110925262|NCT02145546|Propafenone|propafenone|mesh-list
110925263|NCT02145546|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110925264|NCT02145546|Vasodilator Agents|vasodilator agents|mesh-ancestor
110925265|NCT02145546|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
110925266|NCT02145546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110925267|NCT02145546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110925268|NCT02145546|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110925269|NCT02145546|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110925270|NCT02145546|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110925271|NCT02145546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110925272|NCT02145546|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110925273|NCT02145546|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110925274|NCT02145546|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110925275|NCT02145546|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110925276|NCT02145546|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110925277|NCT02145546|Adrenergic Agents|adrenergic agents|mesh-ancestor
110925278|NCT02145546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110925279|NCT02145546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110925280|NCT02145546|Sympatholytics|sympatholytics|mesh-ancestor
110925281|NCT02145546|Autonomic Agents|autonomic agents|mesh-ancestor
110569708|NCT02556970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110925282|NCT02145546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110925283|NCT02145546|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110925284|NCT03039673|Interleukin-2|interleukin-2|mesh-list
110925285|NCT03039673|Riluzole|riluzole|mesh-list
110925286|NCT03039673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110569853|NCT00820170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110925287|NCT03039673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110925288|NCT03039673|Analgesics|analgesics|mesh-ancestor
110925289|NCT03039673|Sensory System Agents|sensory system agents|mesh-ancestor
110929979|NCT02172222|Hormones|hormones|mesh-ancestor
110925290|NCT03039673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110925291|NCT03039673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110569944|NCT05758662|Listerine|listerine|mesh-list
110925292|NCT03039673|Anticonvulsants|anticonvulsants|mesh-ancestor
110925293|NCT03039673|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110925294|NCT03039673|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110570031|NCT00685607|Loperamide|loperamide|mesh-list
110925295|NCT03039673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110925296|NCT03039673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110925297|NCT03039673|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110925300|NCT02145624|Immunologic Factors|immunologic factors|mesh-ancestor
110925301|NCT02145624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110925302|NCT02321384|Ritonavir|ritonavir|mesh-list
110925303|NCT02321384|Midazolam|midazolam|mesh-list
110925304|NCT02321384|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110925305|NCT02321384|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110925306|NCT02321384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110925307|NCT02321384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110925308|NCT02321384|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110925309|NCT02321384|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110925310|NCT02321384|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110925311|NCT02321384|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110925312|NCT02321384|Anesthetics, General|anesthetics, general|mesh-ancestor
110925313|NCT02321384|Anesthetics|anesthetics|mesh-ancestor
110925314|NCT02321384|GABA Modulators|gaba modulators|mesh-ancestor
110925315|NCT02321384|GABA Agents|gaba agents|mesh-ancestor
110925316|NCT02321384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110925317|NCT02321384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110925318|NCT02321384|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110925319|NCT02321384|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110570284|NCT02556658|Anesthetics|anesthetics|mesh-list
110925320|NCT02321384|Protease Inhibitors|protease inhibitors|mesh-ancestor
110925321|NCT02321384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110570358|NCT00683189|Warfarin|warfarin|mesh-list
110925322|NCT02321384|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110925323|NCT02321384|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110925324|NCT02321384|Antiviral Agents|antiviral agents|mesh-ancestor
110570431|NCT00666718|Coagulants|coagulants|mesh-ancestor
110925325|NCT02321384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110925326|NCT02321384|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110925327|NCT02321384|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110925328|NCT03095326|Zinc|zinc|mesh-list
110925329|NCT03095326|Zinc Sulfate|zinc sulfate|mesh-list
110925330|NCT03095326|Vaccines|vaccines|mesh-list
110925331|NCT03095326|Immunologic Factors|immunologic factors|mesh-ancestor
110925332|NCT03095326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110925333|NCT03095326|Trace Elements|trace elements|mesh-ancestor
110925334|NCT03095326|Micronutrients|micronutrients|mesh-ancestor
110570599|NCT00778180|Furosemide|furosemide|mesh-list
110925335|NCT03095326|Astringents|astringents|mesh-ancestor
110925336|NCT03095326|Dermatologic Agents|dermatologic agents|mesh-ancestor
110925337|NCT02318810|Rocuronium|rocuronium|mesh-list
110925338|NCT02318810|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110570638|NCT00853580|Antimetabolites|antimetabolites|mesh-ancestor
110925339|NCT02318810|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110925340|NCT02318810|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110925341|NCT02318810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110925342|NCT02318810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110925343|NCT03500120|Fludrocortisone|fludrocortisone|mesh-list
110925344|NCT03500120|Captopril|captopril|mesh-list
110570707|NCT02613026|Cyclophosphamide|cyclophosphamide|mesh-list
110929994|NCT03065842|Contraceptive Agents|contraceptive agents|mesh-list
110925345|NCT03500120|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110925346|NCT03500120|Protease Inhibitors|protease inhibitors|mesh-ancestor
110925347|NCT03500120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110925348|NCT03500120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110925349|NCT03500120|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110570776|NCT00865280|Linezolid|linezolid|mesh-list
110925350|NCT03500120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110925351|NCT02141958|Fenretinide|fenretinide|mesh-list
110925352|NCT02141958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110925353|NCT02141958|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110925354|NCT02141958|Protective Agents|protective agents|mesh-ancestor
110925355|NCT02141958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110925356|NCT02142036|Trastuzumab|trastuzumab|mesh-list
110925357|NCT02142036|Cetuximab|cetuximab|mesh-list
110925358|NCT02142036|Panitumumab|panitumumab|mesh-list
110925359|NCT02142036|Everolimus|everolimus|mesh-list
110925360|NCT02142036|Sunitinib|sunitinib|mesh-list
110925361|NCT02142036|Dasatinib|dasatinib|mesh-list
110925362|NCT02142036|Lapatinib|lapatinib|mesh-list
110925363|NCT02142036|Gefitinib|gefitinib|mesh-list
110925364|NCT02142036|Temsirolimus|temsirolimus|mesh-list
110925365|NCT02142036|Afatinib|afatinib|mesh-list
110925366|NCT02142036|Vemurafenib|vemurafenib|mesh-list
110925367|NCT02142036|Dabrafenib|dabrafenib|mesh-list
110925368|NCT02142036|Crizotinib|crizotinib|mesh-list
110925369|NCT02142036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110925370|NCT02142036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110925371|NCT02142036|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110925372|NCT02142036|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110925373|NCT02142036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110925374|NCT02142036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110925375|NCT02142036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110925376|NCT02142036|Immunologic Factors|immunologic factors|mesh-ancestor
110925377|NCT02142036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110925378|NCT02142036|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110925379|NCT02142036|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110571045|NCT05298683|Antipruritics|antipruritics|mesh-ancestor
110925380|NCT02142036|Growth Substances|growth substances|mesh-ancestor
110925381|NCT02142036|Growth Inhibitors|growth inhibitors|mesh-ancestor
110925382|NCT05053594|Neostigmine|neostigmine|mesh-list
110925383|NCT05053594|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110925384|NCT05053594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110925385|NCT05053594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110925386|NCT05053594|Cholinergic Agents|cholinergic agents|mesh-ancestor
110925387|NCT05053594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110642909|NCT03712904|Aflibercept|aflibercept|mesh-list
110925388|NCT05053594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110925389|NCT05053594|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110925390|NCT05053594|Autonomic Agents|autonomic agents|mesh-ancestor
110925393|NCT02318888|Dialysis Solutions|dialysis solutions|mesh-ancestor
110925394|NCT02318888|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110925395|NCT02142192|Natalizumab|natalizumab|mesh-list
110925396|NCT02142192|Immunologic Factors|immunologic factors|mesh-ancestor
110925397|NCT02142192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110925398|NCT02324582|Pembrolizumab|pembrolizumab|mesh-list
110925399|NCT02324582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110925400|NCT02324582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110925401|NCT02324582|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110925402|NCT02324582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110925403|NCT01255891|Androgens|androgens|mesh-list
110925404|NCT01255891|Hormones|hormones|mesh-ancestor
110269552|NCT05674513|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110925405|NCT01255891|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110925406|NCT01255891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110925407|NCT02777190|Misoprostol|misoprostol|mesh-list
110925408|NCT02777190|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110925409|NCT02777190|Abortifacient Agents|abortifacient agents|mesh-ancestor
110925410|NCT02777190|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110925411|NCT02777190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110925412|NCT02777190|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110925413|NCT02777190|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110925414|NCT02777190|Oxytocics|oxytocics|mesh-ancestor
110925415|NCT03494426|Pregabalin|pregabalin|mesh-list
110925416|NCT03494426|Tramadol|tramadol|mesh-list
110925417|NCT03494426|Antidepressive Agents|antidepressive agents|mesh-list
110925418|NCT03494426|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-list
110925419|NCT03494426|Analgesics|analgesics|mesh-ancestor
110925420|NCT03494426|Sensory System Agents|sensory system agents|mesh-ancestor
110925421|NCT03494426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110925422|NCT03494426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110925423|NCT03494426|Anticonvulsants|anticonvulsants|mesh-ancestor
110925424|NCT03494426|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110269624|NCT05591105|Analgesics|analgesics|mesh-ancestor
110925425|NCT03494426|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110925426|NCT03494426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110925427|NCT03494426|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110925428|NCT03494426|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110925429|NCT03494426|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110169277|NCT00000941|Calcium|calcium|mesh-list
110925430|NCT03494426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110925431|NCT03494426|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110925432|NCT03494426|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110925433|NCT03494426|Narcotics|narcotics|mesh-ancestor
110925434|NCT02432209|Orlistat|orlistat|mesh-list
110925435|NCT02432209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110925436|NCT02432209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110925437|NCT02432209|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110925438|NCT02432209|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110925439|NCT00108732|Metronidazole|metronidazole|mesh-list
110925441|NCT00108732|Bicalutamide|bicalutamide|mesh-list
110925442|NCT00108732|Vaccines|vaccines|mesh-list
110925443|NCT00108732|Sargramostim|sargramostim|mesh-list
110925444|NCT00108732|Immunologic Factors|immunologic factors|mesh-ancestor
110925445|NCT00108732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110925446|NCT00108732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110925447|NCT00108732|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110925448|NCT00108732|Androgen Antagonists|androgen antagonists|mesh-ancestor
110925449|NCT00108732|Hormone Antagonists|hormone antagonists|mesh-ancestor
110925450|NCT00108732|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110925451|NCT00108732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110925452|NCT00108732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110925453|NCT00108732|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110269735|NCT04999644|Nicotine|nicotine|mesh-list
110925454|NCT00108732|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110925456|NCT02319200|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110925457|NCT02319200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110925458|NCT02319278|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
110925459|NCT02319278|Hematinics|hematinics|mesh-ancestor
110925460|NCT02319278|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
110925461|NCT02319278|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110925462|NCT02324738|Piperaquine|piperaquine|mesh-list
110925463|NCT02324738|Artenimol|artenimol|mesh-list
110925464|NCT02324738|Mefloquine|mefloquine|mesh-list
110925466|NCT02324738|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110925467|NCT02324738|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110925468|NCT02324738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110925470|NCT02321852|Triflusal|triflusal|mesh-list
110925471|NCT02321852|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110925472|NCT02321852|Diuretics|diuretics|mesh-ancestor
110925473|NCT02321852|Natriuretic Agents|natriuretic agents|mesh-ancestor
110925474|NCT02321852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110925475|NCT02321852|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110925476|NCT03499886|Ketamine|ketamine|mesh-list
110925477|NCT03499886|Analgesics|analgesics|mesh-ancestor
110925478|NCT03499886|Sensory System Agents|sensory system agents|mesh-ancestor
110925479|NCT03499886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110925480|NCT03499886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110925481|NCT03499886|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110925482|NCT03499886|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110925483|NCT03499886|Anesthetics, General|anesthetics, general|mesh-ancestor
110925484|NCT03499886|Anesthetics|anesthetics|mesh-ancestor
110925485|NCT03499886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110925486|NCT03499886|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110925487|NCT03499886|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110925488|NCT03499886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110925489|NCT03499886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110925490|NCT05084430|Pembrolizumab|pembrolizumab|mesh-list
110925491|NCT05084430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110925492|NCT05084430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110925493|NCT05084430|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110925494|NCT05084430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110925495|NCT02716038|Paclitaxel|paclitaxel|mesh-list
110925496|NCT02716038|Carboplatin|carboplatin|mesh-list
110925497|NCT02716038|Atezolizumab|atezolizumab|mesh-list
110925498|NCT02716038|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110925499|NCT02716038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110925500|NCT02716038|Tubulin Modulators|tubulin modulators|mesh-ancestor
110925501|NCT02716038|Antimitotic Agents|antimitotic agents|mesh-ancestor
110925502|NCT02716038|Mitosis Modulators|mitosis modulators|mesh-ancestor
110925503|NCT02716038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110925504|NCT02716038|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110925505|NCT02716038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110925506|NCT02325050|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
110925507|NCT02325050|Antiviral Agents|antiviral agents|mesh-ancestor
110925508|NCT02325050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110269986|NCT03406299|Leucovorin|leucovorin|mesh-list
110925509|NCT03544710|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
110925510|NCT03544710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110925511|NCT02322008|Adalimumab|adalimumab|mesh-list
110925512|NCT02322008|Infliximab|infliximab|mesh-list
110925513|NCT02322008|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110925514|NCT02322008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110925515|NCT02322008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110925516|NCT02322008|Dermatologic Agents|dermatologic agents|mesh-ancestor
110925517|NCT02322008|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110925518|NCT02647554|Urinastatin|urinastatin|mesh-list
110925519|NCT02647554|Trypsin Inhibitors|trypsin inhibitors|mesh-list
110925520|NCT02647554|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110925521|NCT02647554|Protease Inhibitors|protease inhibitors|mesh-ancestor
110925522|NCT02647554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110925523|NCT02647554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110925524|NCT03499730|Midazolam|midazolam|mesh-list
110925525|NCT03499730|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110925526|NCT03499730|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110925527|NCT03499730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110925528|NCT03499730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110925529|NCT03499730|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110925530|NCT03499730|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110925531|NCT03499730|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110925532|NCT03499730|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110925533|NCT03499730|Anesthetics, General|anesthetics, general|mesh-ancestor
110925534|NCT03499730|Anesthetics|anesthetics|mesh-ancestor
110925535|NCT03499730|GABA Modulators|gaba modulators|mesh-ancestor
110925536|NCT03499730|GABA Agents|gaba agents|mesh-ancestor
110925537|NCT03499730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110270097|NCT03162627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110925539|NCT02143050|Metformin|metformin|mesh-list
110925540|NCT02143050|Trametinib|trametinib|mesh-list
110925541|NCT02143050|Dabrafenib|dabrafenib|mesh-list
110925542|NCT02143050|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110925543|NCT02143050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110925544|NCT02143050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110925545|NCT02143050|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110925546|NCT02143050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110169781|NCT00015951|Sensory System Agents|sensory system agents|mesh-ancestor
110925547|NCT02143050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110925548|NCT02325206|Dapagliflozin|dapagliflozin|mesh-list
110169854|NCT00016107|Growth Inhibitors|growth inhibitors|mesh-ancestor
110925549|NCT02325206|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110925550|NCT02325206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110270161|NCT02427620|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110270162|NCT02427620|Protease Inhibitors|protease inhibitors|mesh-ancestor
110270163|NCT02427620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110925551|NCT02325206|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110925552|NCT02325206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110925553|NCT02325362|Miglustat|miglustat|mesh-list
110925554|NCT02325362|1-Deoxynojirimycin|1-deoxynojirimycin|mesh-list
110925555|NCT02325362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110925556|NCT02325362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110925557|NCT02325362|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110925558|NCT02325362|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110925559|NCT02325362|Antiviral Agents|antiviral agents|mesh-ancestor
110925560|NCT02325362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110925561|NCT02325362|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
110925562|NCT02325362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110925563|NCT02325362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110925564|NCT04462094|Ketamine|ketamine|mesh-list
110925565|NCT04462094|Anesthetics|anesthetics|mesh-ancestor
110925566|NCT04462094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110925567|NCT04462094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110925568|NCT04462094|Analgesics|analgesics|mesh-ancestor
110925569|NCT04462094|Sensory System Agents|sensory system agents|mesh-ancestor
110925570|NCT04462094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110925571|NCT04462094|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110270225|NCT01527149|Cytarabine|cytarabine|mesh-list
110925572|NCT04462094|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110925573|NCT04462094|Anesthetics, General|anesthetics, general|mesh-ancestor
110925574|NCT04462094|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110925575|NCT04462094|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110925576|NCT04462094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110925577|NCT04462094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110925578|NCT02325440|Natalizumab|natalizumab|mesh-list
110925579|NCT02325440|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
110925580|NCT02325440|Immunologic Factors|immunologic factors|mesh-ancestor
110925581|NCT02325440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110925582|NCT02325440|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
110925583|NCT02325440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110925584|NCT02325440|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110925585|NCT03499184|Metronidazole|metronidazole|mesh-list
110925586|NCT03499184|Amoxicillin|amoxicillin|mesh-list
110925587|NCT03499184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110925588|NCT03499184|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110925589|NCT03499184|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110925590|NCT03499184|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110925591|NCT00107952|Vancomycin|vancomycin|mesh-list
110925592|NCT00107952|Telavancin|telavancin|mesh-list
110925593|NCT00107952|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110925594|NCT00107952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110925595|NCT03499106|Itraconazole|itraconazole|mesh-list
110925596|NCT03499106|Praliciguat|praliciguat|mesh-list
110925597|NCT03499106|Antifungal Agents|antifungal agents|mesh-ancestor
110270336|NCT00775749|Nicotine|nicotine|mesh-list
110925598|NCT03499106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110925599|NCT03499106|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110169963|NCT00016302|Micronutrients|micronutrients|mesh-ancestor
110925600|NCT03499106|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110925601|NCT03499106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110925602|NCT03499106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110925603|NCT03499106|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110925604|NCT03499106|Hormone Antagonists|hormone antagonists|mesh-ancestor
110170032|NCT00001202|Testolactone|testolactone|mesh-list
110925605|NCT03499106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110925606|NCT03499106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110925607|NCT03499106|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110925608|NCT03499106|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
110925609|NCT03499106|Enzyme Activators|enzyme activators|mesh-ancestor
110925610|NCT03499106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110925611|NCT02146638|Fentanyl|fentanyl|mesh-list
110925612|NCT02146638|Morphine|morphine|mesh-list
110925613|NCT02146638|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110925614|NCT02146638|Narcotics|narcotics|mesh-ancestor
110925615|NCT02146638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110925616|NCT02146638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110925617|NCT02146638|Analgesics|analgesics|mesh-ancestor
110925619|NCT02146638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110925620|NCT02146638|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110925621|NCT02146638|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110925622|NCT02146638|Anesthetics, General|anesthetics, general|mesh-ancestor
110925623|NCT02146638|Anesthetics|anesthetics|mesh-ancestor
110925624|NCT02320448|Cisplatin|cisplatin|mesh-list
110925625|NCT02320448|Doxorubicin|doxorubicin|mesh-list
110925626|NCT02320448|Oxaliplatin|oxaliplatin|mesh-list
110925627|NCT02320448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110925628|NCT02320448|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110925629|NCT02320448|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110925630|NCT02320448|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110925631|NCT02320448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110170316|NCT00039364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110925632|NCT02320448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110925633|NCT02320604|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
110925634|NCT02320604|Antifungal Agents|antifungal agents|mesh-ancestor
110925635|NCT02320604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110925636|NCT02320604|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110925637|NCT02320604|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110925638|NCT03493568|Dolutegravir|dolutegravir|mesh-list
110925639|NCT03493568|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110925640|NCT03493568|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110925641|NCT03493568|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110925642|NCT03493568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110925643|NCT03493568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110925644|NCT03493568|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110925645|NCT03493568|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110925646|NCT03493568|Antiviral Agents|antiviral agents|mesh-ancestor
110270585|NCT00164411|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110270586|NCT00164411|Immunologic Factors|immunologic factors|mesh-ancestor
110270587|NCT00164411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110270588|NCT00193635|Mycophenolic Acid|mycophenolic acid|mesh-list
110925647|NCT03493568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110925648|NCT01366638|Ribavirin|ribavirin|mesh-list
110925649|NCT01366638|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110925650|NCT01366638|Simeprevir|simeprevir|mesh-list
110925651|NCT01366638|Antimetabolites|antimetabolites|mesh-ancestor
110925652|NCT01366638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110925653|NCT01366638|Antiviral Agents|antiviral agents|mesh-ancestor
110925654|NCT01366638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110925655|NCT01366638|Protease Inhibitors|protease inhibitors|mesh-ancestor
110925656|NCT01366638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110925657|NCT02147808|Midazolam|midazolam|mesh-list
110925658|NCT02147808|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110925659|NCT02147808|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110925660|NCT02147808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110925661|NCT02147808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110925662|NCT02147808|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110925663|NCT02147808|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110925664|NCT02147808|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110925665|NCT02147808|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110925666|NCT02147808|Anesthetics, General|anesthetics, general|mesh-ancestor
110925667|NCT02147808|Anesthetics|anesthetics|mesh-ancestor
110925668|NCT02147808|GABA Modulators|gaba modulators|mesh-ancestor
110925669|NCT02147808|GABA Agents|gaba agents|mesh-ancestor
110925670|NCT02147808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110925671|NCT02147808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110925672|NCT03543072|Diphosphonates|diphosphonates|mesh-list
110270709|NCT04635007|Hemostatics|hemostatics|mesh-ancestor
110925673|NCT03543072|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110925674|NCT03543072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110925675|NCT02147964|Ketoconazole|ketoconazole|mesh-list
110925676|NCT02147964|Methyltestosterone|methyltestosterone|mesh-list
110925677|NCT02147964|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
110925678|NCT02147964|Testosterone|testosterone|mesh-list
110925679|NCT02147964|Testosterone undecanoate|testosterone undecanoate|mesh-list
110925680|NCT02147964|Testosterone enanthate|testosterone enanthate|mesh-list
110925681|NCT02147964|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
110925682|NCT02147964|Dutasteride|dutasteride|mesh-list
110925683|NCT02147964|Acyline|acyline|mesh-list
110925684|NCT02147964|Androgens|androgens|mesh-ancestor
110925686|NCT02147964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110925687|NCT02147964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110170648|NCT00397072|Sagopilone|sagopilone|mesh-list
110925688|NCT02147964|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110925689|NCT02147964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110925690|NCT02147964|Anabolic Agents|anabolic agents|mesh-ancestor
110925691|NCT02147964|Antifungal Agents|antifungal agents|mesh-ancestor
110925692|NCT02147964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110925693|NCT02147964|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110925694|NCT02147964|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110925695|NCT02147964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110925696|NCT02147964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110170799|NCT00042367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110925697|NCT02147964|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110925698|NCT02147964|Hormone Antagonists|hormone antagonists|mesh-ancestor
110925699|NCT02147964|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110925700|NCT02147964|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
110925701|NCT02147964|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110925703|NCT02780700|Nintedanib|nintedanib|mesh-list
110925704|NCT02780700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110925705|NCT02780700|Antimetabolites|antimetabolites|mesh-ancestor
110925706|NCT02780700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110925707|NCT02780700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110925708|NCT02780700|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110925709|NCT02780700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110925711|NCT02147262|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110925712|NCT02147262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110925713|NCT02147262|Antimalarials|antimalarials|mesh-ancestor
110925714|NCT02147262|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110925715|NCT02147262|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110925716|NCT02447276|Fasinumab|fasinumab|mesh-list
110925717|NCT02447276|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110171020|NCT00017940|Mitogens|mitogens|mesh-list
110925718|NCT02447276|Analgesics|analgesics|mesh-ancestor
110925719|NCT02447276|Sensory System Agents|sensory system agents|mesh-ancestor
110925720|NCT02447276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110925721|NCT02447276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110925722|NCT05079620|Amoxicillin|amoxicillin|mesh-list
110925723|NCT05079620|Vancomycin|vancomycin|mesh-list
110925724|NCT05079620|Levofloxacin|levofloxacin|mesh-list
110925725|NCT05079620|Ceftriaxone|ceftriaxone|mesh-list
110925726|NCT05079620|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
110925727|NCT05079620|Clavulanic Acids|clavulanic acids|mesh-list
110925728|NCT05079620|Clavulanic Acid|clavulanic acid|mesh-list
110925729|NCT05079620|Cefepime|cefepime|mesh-list
110925730|NCT05079620|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110925731|NCT05079620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110925732|NCT05079620|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110925733|NCT05079620|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110925734|NCT05079620|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110925735|NCT05079620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110925736|NCT05079620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110925737|NCT05079620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110925738|NCT05079620|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110925739|NCT05079620|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110925740|NCT05079620|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110925741|NCT02323412|Amoxicillin|amoxicillin|mesh-list
110925742|NCT02323412|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110925743|NCT02323412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110925745|NCT04537910|Antiviral Agents|antiviral agents|mesh-ancestor
110925746|NCT04537910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110925747|NCT03109730|Tenofovir|tenofovir|mesh-list
110925748|NCT03109730|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110925749|NCT03109730|Entecavir|entecavir|mesh-list
110171299|NCT00397501|Antidotes|antidotes|mesh-ancestor
110925750|NCT03109730|Antiviral Agents|antiviral agents|mesh-ancestor
110925751|NCT03109730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110271139|NCT00166478|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110925752|NCT03109730|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110925753|NCT03109730|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110925754|NCT03109730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110171362|NCT00044785|Vitamins|vitamins|mesh-ancestor
110925755|NCT03109730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110925756|NCT03109730|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110925757|NCT03109730|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110925758|NCT03495206|Edaravone|edaravone|mesh-list
110925759|NCT03495206|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110171438|NCT00045292|Acyclovir|acyclovir|mesh-list
110925760|NCT03495206|Antioxidants|antioxidants|mesh-ancestor
110925761|NCT03495206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110925762|NCT03495206|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110925763|NCT03495206|Protective Agents|protective agents|mesh-ancestor
110925764|NCT03495206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110925766|NCT04223024|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110925767|NCT04223024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110925768|NCT03491696|Metyrapone|metyrapone|mesh-list
110925769|NCT03491696|Antimetabolites|antimetabolites|mesh-ancestor
110271267|NCT00194961|Hormones|hormones|mesh-list
110925770|NCT03491696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110171576|NCT00045799|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110925771|NCT03491696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110925773|NCT03492866|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110925774|NCT03492866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110925775|NCT03492866|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110925776|NCT03492866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110925777|NCT03492866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110925779|NCT03492710|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110171643|NCT00046033|Ritonavir|ritonavir|mesh-list
110925781|NCT03492710|Immunologic Factors|immunologic factors|mesh-ancestor
110925782|NCT03492710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110925783|NCT03954938|Cocaine|cocaine|mesh-list
110925784|NCT03954938|Anesthetics, Local|anesthetics, local|mesh-ancestor
110925785|NCT03954938|Anesthetics|anesthetics|mesh-ancestor
110925786|NCT03954938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110925787|NCT03954938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110171713|NCT00397657|Niacin|niacin|mesh-list
110925788|NCT03954938|Sensory System Agents|sensory system agents|mesh-ancestor
110925789|NCT03954938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110925790|NCT03954938|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110925791|NCT03954938|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110925792|NCT03954938|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110925793|NCT03954938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110925794|NCT03954938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110925795|NCT03954938|Dopamine Agents|dopamine agents|mesh-ancestor
110925796|NCT03954938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110925797|NCT02148120|Beclomethasone|beclomethasone|mesh-list
110925798|NCT02148120|Formoterol Fumarate|formoterol fumarate|mesh-list
110925799|NCT02148120|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110925800|NCT02148120|Autonomic Agents|autonomic agents|mesh-ancestor
110925801|NCT02148120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110925802|NCT02148120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110925803|NCT02148120|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110171923|NCT00047281|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110925804|NCT02148120|Respiratory System Agents|respiratory system agents|mesh-ancestor
110925805|NCT02148120|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110925806|NCT02148120|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110925807|NCT02148120|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110925808|NCT02148120|Adrenergic Agents|adrenergic agents|mesh-ancestor
110271455|NCT04299880|Antidotes|antidotes|mesh-ancestor
110925809|NCT02148120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110925810|NCT02148120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110925811|NCT02148120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110925812|NCT02148120|Glucocorticoids|glucocorticoids|mesh-ancestor
110925813|NCT02148120|Hormones|hormones|mesh-ancestor
110925814|NCT02148120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110925815|NCT03492632|Hormones|hormones|mesh-list
110925816|NCT03492632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110925817|NCT03492632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110925818|NCT02147574|Antidiarrheals|antidiarrheals|mesh-list
110925819|NCT02147574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110925820|NCT02147730|Anesthetics|anesthetics|mesh-list
110925821|NCT02147730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110925822|NCT02147730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110925823|NCT02151630|Salicylic Acid|salicylic acid|mesh-list
110925824|NCT02151630|Salicylates|salicylates|mesh-list
110925825|NCT02151630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110925826|NCT02151630|Antifungal Agents|antifungal agents|mesh-ancestor
110925827|NCT02151630|Keratolytic Agents|keratolytic agents|mesh-ancestor
110925828|NCT02151630|Dermatologic Agents|dermatologic agents|mesh-ancestor
110925829|NCT02151630|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110925830|NCT02151630|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110925831|NCT02151630|Analgesics|analgesics|mesh-ancestor
110925832|NCT02151630|Sensory System Agents|sensory system agents|mesh-ancestor
110271582|NCT02906176|Voriconazole|voriconazole|mesh-list
110172273|NCT00049972|Serotonin Agents|serotonin agents|mesh-ancestor
110925833|NCT02151630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110925834|NCT02151630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110925835|NCT02151630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110925836|NCT02151630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110925837|NCT02151630|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110925838|NCT02151630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110925839|NCT02151630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110925840|NCT03494972|Tetracycline|tetracycline|mesh-list
110925841|NCT03494972|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110643358|NCT02542748|Sympathomimetics|sympathomimetics|mesh-ancestor
110925842|NCT03494972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110925843|NCT03494972|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110925844|NCT03494972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110172406|NCT00051103|Antineoplastic Agents|antineoplastic agents|mesh-list
110925845|NCT03494972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110925847|NCT02224573|Anticonvulsants|anticonvulsants|mesh-ancestor
110172468|NCT00398008|Sensory System Agents|sensory system agents|mesh-ancestor
110925848|NCT03490058|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110925849|NCT03490058|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110925850|NCT03490058|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110925851|NCT03490058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110172544|NCT00052117|Capravirine|capravirine|mesh-list
110925852|NCT03490058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110925853|NCT03490058|Antiviral Agents|antiviral agents|mesh-ancestor
110925854|NCT03490058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110925855|NCT03490058|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110925856|NCT03490058|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110925857|NCT02148432|Dexmedetomidine|dexmedetomidine|mesh-list
110925858|NCT02148432|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110271713|NCT00178035|Serotonin Agents|serotonin agents|mesh-ancestor
110925859|NCT02148432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110925860|NCT02148432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110925861|NCT02148432|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110925862|NCT02148432|Analgesics|analgesics|mesh-ancestor
110925863|NCT02148432|Sensory System Agents|sensory system agents|mesh-ancestor
110925864|NCT02148432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110925865|NCT02148432|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110925866|NCT02148432|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110925867|NCT02148432|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110925868|NCT02148432|Adrenergic Agents|adrenergic agents|mesh-ancestor
110172703|NCT00053131|Cytarabine|cytarabine|mesh-list
110925869|NCT02148432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110925870|NCT02148432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110925872|NCT03350984|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110925873|NCT03350984|Insulin Glargine|insulin glargine|mesh-list
110925874|NCT03350984|Insulin Lispro|insulin lispro|mesh-list
110925875|NCT03350984|Insulin, Isophane|insulin, isophane|mesh-list
110925876|NCT03350984|Isophane Insulin, Human|isophane insulin, human|mesh-list
110925877|NCT03350984|Isophane insulin, beef|isophane insulin, beef|mesh-list
110925878|NCT03350984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110925879|NCT03350984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110925880|NCT05033314|Rivaroxaban|rivaroxaban|mesh-list
110925881|NCT05033314|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110925882|NCT05033314|Antithrombins|antithrombins|mesh-ancestor
110925883|NCT05033314|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110925884|NCT05033314|Protease Inhibitors|protease inhibitors|mesh-ancestor
110925885|NCT05033314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110925886|NCT05033314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110925887|NCT05033314|Anticoagulants|anticoagulants|mesh-ancestor
110925888|NCT03504423|Leucovorin|leucovorin|mesh-list
110925889|NCT03504423|Folic Acid|folic acid|mesh-list
110925890|NCT03504423|Oxaliplatin|oxaliplatin|mesh-list
110925891|NCT03504423|Irinotecan|irinotecan|mesh-list
110925892|NCT03504423|Folfirinox|folfirinox|mesh-list
110925893|NCT03504423|Levoleucovorin|levoleucovorin|mesh-list
110925894|NCT03504423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110172964|NCT02970097|Anesthetics, General|anesthetics, general|mesh-ancestor
110925895|NCT03504423|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110925896|NCT03504423|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110925897|NCT03504423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110925898|NCT03504423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110925899|NCT03504423|Antidotes|antidotes|mesh-ancestor
110925900|NCT03504423|Protective Agents|protective agents|mesh-ancestor
110925901|NCT03504423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110925902|NCT03504423|Vitamin B Complex|vitamin b complex|mesh-ancestor
110925903|NCT03504423|Vitamins|vitamins|mesh-ancestor
110925904|NCT03504423|Micronutrients|micronutrients|mesh-ancestor
110925905|NCT03504423|Hematinics|hematinics|mesh-ancestor
110925906|NCT03097198|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110925907|NCT03097198|Tropicamide|tropicamide|mesh-list
110925908|NCT03097198|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110925909|NCT03097198|Mydriatics|mydriatics|mesh-ancestor
110271969|NCT05994742|Pyridoxine|pyridoxine|mesh-list
110925910|NCT03097198|Autonomic Agents|autonomic agents|mesh-ancestor
110925911|NCT03097198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110925912|NCT03097198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110925913|NCT03097198|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110925914|NCT03097198|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110925915|NCT03097198|Cholinergic Agents|cholinergic agents|mesh-ancestor
110925916|NCT03097198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110925917|NCT03097198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110925918|NCT02770248|Brimonidine Tartrate|brimonidine tartrate|mesh-list
110925919|NCT02770248|Brinzolamide|brinzolamide|mesh-list
110925920|NCT02770248|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110925921|NCT02770248|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110925922|NCT02770248|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110925923|NCT02770248|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110027431|NCT01834170|Gemcitabine|gemcitabine|mesh-list
110925924|NCT02770248|Adrenergic Agents|adrenergic agents|mesh-ancestor
110925925|NCT02770248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110925926|NCT02770248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110925927|NCT02770248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110925928|NCT02770248|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110925930|NCT03619005|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
110925931|NCT03619005|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110925932|NCT03619005|Immunologic Factors|immunologic factors|mesh-ancestor
110925933|NCT03619005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110925934|NCT02686346|Etoposide|etoposide|mesh-list
110925935|NCT02686346|Ifosfamide|ifosfamide|mesh-list
110925936|NCT02686346|Brentuximab Vedotin|brentuximab vedotin|mesh-list
110925937|NCT02686346|Carboplatin|carboplatin|mesh-list
110173450|NCT00058357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110925938|NCT02686346|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110925939|NCT02686346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110925940|NCT02686346|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110925941|NCT02686346|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110925942|NCT02686346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110173519|NCT02969278|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110925943|NCT02686346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110925944|NCT02686346|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110925945|NCT02686346|Alkylating Agents|alkylating agents|mesh-ancestor
110925946|NCT02686346|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110925947|NCT02686346|Immunotoxins|immunotoxins|mesh-ancestor
110925948|NCT02686346|Immunoconjugates|immunoconjugates|mesh-ancestor
110925949|NCT02686346|Immunologic Factors|immunologic factors|mesh-ancestor
110925950|NCT02686346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110925951|NCT03489044|Levetiracetam|levetiracetam|mesh-list
110925952|NCT03489044|Anticonvulsants|anticonvulsants|mesh-ancestor
110925953|NCT03489044|Nootropic Agents|nootropic agents|mesh-ancestor
110925954|NCT01344369|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110173657|NCT05105685|Hormones|hormones|mesh-list
110925955|NCT01344369|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110925956|NCT01344369|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110925957|NCT01344369|Norethindrone|norethindrone|mesh-list
110925960|NCT01344369|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110925961|NCT01344369|Estrogens|estrogens|mesh-ancestor
110925962|NCT01344369|Hormones|hormones|mesh-ancestor
110925963|NCT01344369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110173727|NCT05312372|Paclitaxel|paclitaxel|mesh-list
110925964|NCT01344369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110925965|NCT01344369|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110925966|NCT01344369|Contraceptive Agents|contraceptive agents|mesh-ancestor
110925967|NCT01344369|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110173820|NCT00061360|Sirolimus|sirolimus|mesh-list
110925968|NCT01344369|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110925969|NCT01344369|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110925970|NCT01344369|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110925971|NCT01344369|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110925972|NCT03491072|Fentanyl|fentanyl|mesh-list
110925973|NCT03491072|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110925974|NCT03491072|Narcotics|narcotics|mesh-ancestor
110925975|NCT03491072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110925976|NCT03491072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110925977|NCT03491072|Analgesics|analgesics|mesh-ancestor
110272197|NCT05763121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110272198|NCT05763121|Protective Agents|protective agents|mesh-ancestor
110272199|NCT05763121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110272200|NCT05763121|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110272201|NCT05763121|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110272202|NCT05763121|Dopamine Agonists|dopamine agonists|mesh-ancestor
110272203|NCT05763121|Dopamine Agents|dopamine agents|mesh-ancestor
110272204|NCT05763121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110272205|NCT05755048|Trastuzumab|trastuzumab|mesh-list
110173932|NCT00398554|Hormones|hormones|mesh-ancestor
110272206|NCT05755048|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
110925978|NCT03491072|Sensory System Agents|sensory system agents|mesh-ancestor
110925979|NCT03491072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110925980|NCT03491072|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110925981|NCT03491072|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110925982|NCT03491072|Anesthetics, General|anesthetics, general|mesh-ancestor
110925984|NCT03503409|Ivosidenib|ivosidenib|mesh-list
110925985|NCT03503409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110925986|NCT03503409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110930165|NCT05588284|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110174064|NCT00062296|Rituximab|rituximab|mesh-list
110925987|NCT03503409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110925988|NCT03490994|Warfarin|warfarin|mesh-list
110925989|NCT03490994|Rivaroxaban|rivaroxaban|mesh-list
110925990|NCT03490994|Anticoagulants|anticoagulants|mesh-ancestor
110925991|NCT03490994|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110925992|NCT03490994|Antithrombins|antithrombins|mesh-ancestor
110925993|NCT03490994|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110925994|NCT03490994|Protease Inhibitors|protease inhibitors|mesh-ancestor
110925995|NCT03490994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110925996|NCT03490994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110925997|NCT01360762|Pentamidine|pentamidine|mesh-list
110925998|NCT01360762|Antifungal Agents|antifungal agents|mesh-ancestor
110925999|NCT01360762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110926000|NCT01360762|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110926001|NCT01360762|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110926002|NCT01360762|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
110926003|NCT04382924|Ifenprodil|ifenprodil|mesh-list
110926004|NCT04382924|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110926005|NCT04382924|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110926006|NCT04382924|Adrenergic Agents|adrenergic agents|mesh-ancestor
110926007|NCT04382924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110926008|NCT04382924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110926009|NCT04382924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110926010|NCT04382924|Vasodilator Agents|vasodilator agents|mesh-ancestor
110272263|NCT05676112|Nintedanib|nintedanib|mesh-list
110926011|NCT04382924|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110926012|NCT04382924|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110926013|NCT00002601|Doxorubicin|doxorubicin|mesh-list
110926014|NCT00002601|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110926015|NCT00002601|Melphalan|melphalan|mesh-list
110926016|NCT00002601|Ifosfamide|ifosfamide|mesh-list
110926017|NCT00002601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110926018|NCT00002601|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110926019|NCT00002601|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110926020|NCT00002601|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110926021|NCT00002601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110926022|NCT00002601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110926023|NCT00002601|Immunologic Factors|immunologic factors|mesh-ancestor
110926024|NCT00002601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110926025|NCT00002601|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110926026|NCT00002601|Alkylating Agents|alkylating agents|mesh-ancestor
110926027|NCT00002601|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110272295|NCT05663866|Antiemetics|antiemetics|mesh-ancestor
110926029|NCT05033704|Plasma protein fraction|plasma protein fraction|mesh-list
110926030|NCT05033704|Plasma Substitutes|plasma substitutes|mesh-ancestor
110926031|NCT05033704|Blood Substitutes|blood substitutes|mesh-ancestor
110926032|NCT02031861|Nifedipine|nifedipine|mesh-list
110926033|NCT02031861|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110926034|NCT02031861|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110926035|NCT02031861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110926036|NCT02031861|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110926037|NCT02031861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110926038|NCT02031861|Vasodilator Agents|vasodilator agents|mesh-ancestor
110926039|NCT02031861|Tocolytic Agents|tocolytic agents|mesh-ancestor
110926040|NCT02031861|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110926041|NCT03455439|Rivaroxaban|rivaroxaban|mesh-list
110926042|NCT03455439|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110926043|NCT03455439|Antithrombins|antithrombins|mesh-ancestor
110926044|NCT03455439|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110926045|NCT03455439|Protease Inhibitors|protease inhibitors|mesh-ancestor
110926046|NCT03455439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110272349|NCT05583708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110272350|NCT05583708|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110272351|NCT05583708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110272352|NCT05583708|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110272353|NCT05525078|Nicotine|nicotine|mesh-list
110272354|NCT05525078|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110272355|NCT05525078|Autonomic Agents|autonomic agents|mesh-ancestor
110272356|NCT05525078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110272357|NCT05525078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110272358|NCT05525078|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110926047|NCT03455439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110926048|NCT03455439|Anticoagulants|anticoagulants|mesh-ancestor
110926049|NCT02645474|Ropivacaine|ropivacaine|mesh-list
110375926|NCT00586430|GABA Agents|gaba agents|mesh-ancestor
110926050|NCT02645474|Anesthetics, Local|anesthetics, local|mesh-ancestor
110926051|NCT02645474|Anesthetics|anesthetics|mesh-ancestor
110926052|NCT02645474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110926053|NCT02645474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110926054|NCT02645474|Sensory System Agents|sensory system agents|mesh-ancestor
110926055|NCT02645474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110926056|NCT05052814|Chlorhexidine|chlorhexidine|mesh-list
110375999|NCT04568772|Proguanil|proguanil|mesh-list
110926057|NCT05052814|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110926058|NCT05052814|Root Canal Irrigants|root canal irrigants|mesh-list
110926059|NCT05052814|Calcium|calcium|mesh-list
110926060|NCT05052814|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110926061|NCT05052814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110926062|NCT05052814|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110926063|NCT05052814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110926064|NCT05052814|Disinfectants|disinfectants|mesh-ancestor
110926065|NCT05052814|Dermatologic Agents|dermatologic agents|mesh-ancestor
110926066|NCT05052814|Dental Disinfectants|dental disinfectants|mesh-ancestor
110926067|NCT03615417|Anesthetics|anesthetics|mesh-list
110926068|NCT03615417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110643585|NCT00886574|Respiratory System Agents|respiratory system agents|mesh-ancestor
110926069|NCT03615417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110926071|NCT02155530|Pravastatin|pravastatin|mesh-list
110926072|NCT02155530|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110926073|NCT02155530|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110926074|NCT02155530|Antimetabolites|antimetabolites|mesh-ancestor
110926075|NCT02155530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110926076|NCT02155530|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110926077|NCT02155530|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110926078|NCT02155530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110926079|NCT05051956|Palbociclib|palbociclib|mesh-list
110926080|NCT05051956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110926081|NCT05051956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110926082|NCT05051956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110926083|NCT05051956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110926084|NCT02769624|Treprostinil|treprostinil|mesh-list
110926085|NCT02769624|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110926086|NCT03543774|Simvastatin|simvastatin|mesh-list
110926088|NCT03543774|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
110926089|NCT03543774|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110926090|NCT03543774|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110926091|NCT03543774|Antimetabolites|antimetabolites|mesh-ancestor
110926092|NCT03543774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110926093|NCT03543774|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110926094|NCT03543774|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110926095|NCT03543774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110926096|NCT02152176|Morphine|morphine|mesh-list
110272589|NCT05073679|Naltrexone|naltrexone|mesh-list
110926097|NCT02152176|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110926098|NCT02152176|Narcotics|narcotics|mesh-ancestor
110926099|NCT02152176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110926100|NCT02152176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110926101|NCT02152176|Analgesics|analgesics|mesh-ancestor
110926102|NCT02152176|Sensory System Agents|sensory system agents|mesh-ancestor
110926103|NCT02152176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110926104|NCT03617055|Cystatins|cystatins|mesh-list
110926105|NCT03617055|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
110926106|NCT03617055|Protease Inhibitors|protease inhibitors|mesh-ancestor
110926107|NCT03617055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110926108|NCT03617055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110926109|NCT03488888|Bupivacaine|bupivacaine|mesh-list
110926110|NCT03488888|Anesthetics, Local|anesthetics, local|mesh-ancestor
110926111|NCT03488888|Anesthetics|anesthetics|mesh-ancestor
110926112|NCT03488888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110926113|NCT03488888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110926114|NCT03488888|Sensory System Agents|sensory system agents|mesh-ancestor
110926115|NCT03488888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110926116|NCT05031676|Analgesics, Opioid|analgesics, opioid|mesh-list
110926117|NCT05031676|Anesthetics|anesthetics|mesh-list
110376326|NCT00590603|Protective Agents|protective agents|mesh-ancestor
110926118|NCT05031676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110926119|NCT05031676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110926120|NCT05031676|Narcotics|narcotics|mesh-ancestor
110926121|NCT05031676|Analgesics|analgesics|mesh-ancestor
110926122|NCT05031676|Sensory System Agents|sensory system agents|mesh-ancestor
110376395|NCT01083615|Hormones|hormones|mesh-ancestor
110926123|NCT05031676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110926124|NCT03488810|Hormones|hormones|mesh-list
110926126|NCT03488810|Androgen Antagonists|androgen antagonists|mesh-list
110926127|NCT03488810|Nonsteroidal Anti-Androgens|nonsteroidal anti-androgens|mesh-list
110926128|NCT03488810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110926129|NCT03488810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110926130|NCT03488810|Hormone Antagonists|hormone antagonists|mesh-ancestor
110926131|NCT03492242|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
110926132|NCT03492242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110926133|NCT03492242|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110376542|NCT03450317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110926134|NCT03492242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110926135|NCT03572283|Bethanechol|bethanechol|mesh-list
110926136|NCT03572283|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110926137|NCT03572283|Autonomic Agents|autonomic agents|mesh-ancestor
110926138|NCT03572283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110926139|NCT03572283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110926140|NCT03572283|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
110926141|NCT03572283|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110643660|NCT00892190|Keratolytic Agents|keratolytic agents|mesh-ancestor
110926142|NCT03572283|Cholinergic Agents|cholinergic agents|mesh-ancestor
110926143|NCT03572283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110926144|NCT03572283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110926145|NCT02254824|Atorvastatin|atorvastatin|mesh-list
110926146|NCT02254824|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110926147|NCT02254824|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110926148|NCT02254824|Antimetabolites|antimetabolites|mesh-ancestor
110926149|NCT02254824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110926150|NCT02254824|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110926151|NCT02254824|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110926152|NCT02254824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110926153|NCT01525316|Lactoferrin|lactoferrin|mesh-list
110926154|NCT01525316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110926155|NCT01673386|Sunitinib|sunitinib|mesh-list
110926156|NCT01673386|Tivozanib|tivozanib|mesh-list
110926157|NCT01673386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110926158|NCT01673386|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110926159|NCT01673386|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110926160|NCT01673386|Growth Substances|growth substances|mesh-ancestor
110926162|NCT01673386|Growth Inhibitors|growth inhibitors|mesh-ancestor
110926163|NCT01673386|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110926164|NCT01673386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110926165|NCT01673386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110926166|NCT00103740|Vitamin D|vitamin d|mesh-list
110926167|NCT00103740|Zoledronic Acid|zoledronic acid|mesh-list
110926168|NCT00103740|Risedronic Acid|risedronic acid|mesh-list
110926169|NCT00103740|Etidronic Acid|etidronic acid|mesh-list
110926170|NCT00103740|Calcium|calcium|mesh-list
110926171|NCT00103740|Vitamins|vitamins|mesh-ancestor
110926172|NCT00103740|Micronutrients|micronutrients|mesh-ancestor
110926173|NCT00103740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110376822|NCT00194675|Hormone Antagonists|hormone antagonists|mesh-ancestor
110926174|NCT00103740|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110926175|NCT00103740|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110926176|NCT00103740|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110926177|NCT00103740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110926178|NCT00103740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110926179|NCT03616509|Hormones|hormones|mesh-list
110926180|NCT03616509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110926181|NCT03616509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110926182|NCT02869893|Secretin|secretin|mesh-list
110926183|NCT02869893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110926184|NCT02869893|Hormones|hormones|mesh-ancestor
110376954|NCT00179660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110926185|NCT02869893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110926186|NCT02869893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110926187|NCT02152332|Moxifloxacin|moxifloxacin|mesh-list
110926188|NCT02152332|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
110926189|NCT02152332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110926190|NCT02152332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110926191|NCT02152332|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110926192|NCT02152332|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110272815|NCT04435782|Selexipag|selexipag|mesh-list
110926193|NCT02152332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110926194|NCT02152332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110926195|NCT02152332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110926196|NCT02152332|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110926197|NCT02152332|Contraceptive Agents|contraceptive agents|mesh-ancestor
110926198|NCT02152332|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110926199|NCT02152332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110926200|NCT02152332|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110926202|NCT02152332|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110926203|NCT05118308|Liver Extracts|liver extracts|mesh-list
110926204|NCT05118308|Hematinics|hematinics|mesh-ancestor
110926205|NCT03617289|Magnesium Sulfate|magnesium sulfate|mesh-list
110926206|NCT03617289|Analgesics|analgesics|mesh-ancestor
110926207|NCT03617289|Sensory System Agents|sensory system agents|mesh-ancestor
110926208|NCT03617289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110926209|NCT03617289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110926210|NCT03617289|Anesthetics|anesthetics|mesh-ancestor
110926211|NCT03617289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110926212|NCT03617289|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110926213|NCT03617289|Anticonvulsants|anticonvulsants|mesh-ancestor
110643734|NCT00191113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110926214|NCT03617289|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110272921|NCT04082533|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110926215|NCT03617289|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110926216|NCT03617289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110377051|NCT00176462|Hormones|hormones|mesh-ancestor
110926217|NCT03617289|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110926218|NCT03617289|Tocolytic Agents|tocolytic agents|mesh-ancestor
110926219|NCT03617289|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110926220|NCT02152410|Morphine|morphine|mesh-list
110926221|NCT02152410|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110926222|NCT02152410|Narcotics|narcotics|mesh-ancestor
110926223|NCT02152410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110926224|NCT02152410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110926225|NCT02152410|Analgesics|analgesics|mesh-ancestor
110926227|NCT02152410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110926228|NCT05043688|Paclitaxel|paclitaxel|mesh-list
110926229|NCT05043688|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110926230|NCT05043688|Carboplatin|carboplatin|mesh-list
110926231|NCT05043688|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110926232|NCT05043688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110926233|NCT05043688|Tubulin Modulators|tubulin modulators|mesh-ancestor
110926234|NCT05043688|Antimitotic Agents|antimitotic agents|mesh-ancestor
110926235|NCT05043688|Mitosis Modulators|mitosis modulators|mesh-ancestor
110926236|NCT05043688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110926237|NCT03614715|Interferons|interferons|mesh-list
110926238|NCT03614715|Interferon-beta|interferon-beta|mesh-list
110926239|NCT03614715|Interferon beta-1a|interferon beta-1a|mesh-list
110926240|NCT03614715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110926241|NCT03614715|Antiviral Agents|antiviral agents|mesh-ancestor
110926242|NCT03614715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110926243|NCT03614715|Immunologic Factors|immunologic factors|mesh-ancestor
110926244|NCT03614715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110926245|NCT03614715|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110926246|NCT00363038|Vitamins|vitamins|mesh-list
110926247|NCT00363038|Vitamin K|vitamin k|mesh-list
110926248|NCT00363038|Vitamin A|vitamin a|mesh-list
110926249|NCT00363038|Petrolatum|petrolatum|mesh-list
110926250|NCT00363038|Micronutrients|micronutrients|mesh-ancestor
110926251|NCT00363038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110926252|NCT00363038|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110926253|NCT00363038|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110273116|NCT03159702|Melphalan|melphalan|mesh-list
110926254|NCT00363038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110926255|NCT00363038|Hemostatics|hemostatics|mesh-ancestor
110926256|NCT00363038|Coagulants|coagulants|mesh-ancestor
110926257|NCT00363038|Emollients|emollients|mesh-ancestor
110926258|NCT00363038|Dermatologic Agents|dermatologic agents|mesh-ancestor
110926259|NCT03489668|Metformin|metformin|mesh-list
110926260|NCT03489668|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110926261|NCT03489668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110926262|NCT02872311|Vaccines|vaccines|mesh-list
110273175|NCT02365597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110273176|NCT02365597|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110273177|NCT02365597|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110273178|NCT02365597|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110273179|NCT02365597|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110273180|NCT02365597|Anesthetics, General|anesthetics, general|mesh-ancestor
110273181|NCT02365597|Anesthetics|anesthetics|mesh-ancestor
110273182|NCT02365597|GABA Modulators|gaba modulators|mesh-ancestor
110273183|NCT02365597|GABA Agents|gaba agents|mesh-ancestor
110273195|NCT02222155|Cyclophosphamide|cyclophosphamide|mesh-list
110926263|NCT02872311|Immunologic Factors|immunologic factors|mesh-ancestor
110926264|NCT02872311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110926266|NCT03614403|Cholecalciferol|cholecalciferol|mesh-list
110926267|NCT03614403|Vitamins|vitamins|mesh-ancestor
110926268|NCT03614403|Micronutrients|micronutrients|mesh-ancestor
110926269|NCT03614403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110926270|NCT03614403|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110377570|NCT01088048|Everolimus|everolimus|mesh-list
110926271|NCT03614403|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110926272|NCT03488186|Lansoprazole|lansoprazole|mesh-list
110926273|NCT03488186|Dexlansoprazole|dexlansoprazole|mesh-list
110926274|NCT03488186|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110926275|NCT03488186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110926276|NCT03488186|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110926277|NCT03488186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110926278|NCT03488186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110926279|NCT05103644|Atorvastatin|atorvastatin|mesh-list
110926280|NCT05103644|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110926281|NCT05103644|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110926282|NCT05103644|Antimetabolites|antimetabolites|mesh-ancestor
110926283|NCT05103644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110926284|NCT05103644|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110926285|NCT05103644|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110926286|NCT05103644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110926287|NCT03887624|Ethosuximide|ethosuximide|mesh-list
110926288|NCT03887624|Escitalopram|escitalopram|mesh-list
110377866|NCT00556088|Paclitaxel|paclitaxel|mesh-list
110926289|NCT03887624|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110926290|NCT03887624|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110926291|NCT03887624|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110273399|NCT00168584|Vitamin A|vitamin a|mesh-list
110926292|NCT03887624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110926293|NCT03887624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110926294|NCT03887624|Serotonin Agents|serotonin agents|mesh-ancestor
110926295|NCT03887624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110926296|NCT03887624|Anticonvulsants|anticonvulsants|mesh-ancestor
110926297|NCT02446028|Insulin Lispro|insulin lispro|mesh-list
110926298|NCT02446028|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110926299|NCT02446028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110926300|NCT03485846|Ritonavir|ritonavir|mesh-list
110926301|NCT03485846|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110926302|NCT03485846|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110926303|NCT03485846|Protease Inhibitors|protease inhibitors|mesh-ancestor
110926304|NCT03485846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110926305|NCT03485846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110926306|NCT03485846|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110926307|NCT03485846|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110926308|NCT03485846|Antiviral Agents|antiviral agents|mesh-ancestor
110926309|NCT03485846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110926310|NCT03485846|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110926311|NCT03485846|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110926312|NCT02032095|Immunoglobulins|immunoglobulins|mesh-list
110926313|NCT02032095|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110926314|NCT02032095|gamma-Globulins|gamma-globulins|mesh-list
110926315|NCT02032095|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110926316|NCT02032095|Immunologic Factors|immunologic factors|mesh-ancestor
110273506|NCT02901106|Dermatologic Agents|dermatologic agents|mesh-ancestor
110926317|NCT02032095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110926319|NCT03613857|Ticagrelor|ticagrelor|mesh-list
110926320|NCT03613857|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110926321|NCT03613857|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110926322|NCT03613857|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110926323|NCT03613857|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110926324|NCT03613857|Purinergic Agents|purinergic agents|mesh-ancestor
110926325|NCT03613857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110926326|NCT03613857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110926327|NCT03613857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110926328|NCT03613389|Vitamin E|vitamin e|mesh-list
110926329|NCT03613389|Vitamins|vitamins|mesh-ancestor
110926330|NCT03613389|Micronutrients|micronutrients|mesh-ancestor
110926331|NCT03613389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110926332|NCT03613389|Antioxidants|antioxidants|mesh-ancestor
110926333|NCT03613389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110926334|NCT03613389|Protective Agents|protective agents|mesh-ancestor
110926335|NCT03614013|Immunomodulating Agents|immunomodulating agents|mesh-list
110926336|NCT03614013|Immunologic Factors|immunologic factors|mesh-ancestor
110926337|NCT03614013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110926338|NCT02259777|Amlodipine|amlodipine|mesh-list
110926339|NCT02259777|Telmisartan|telmisartan|mesh-list
110926340|NCT02259777|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
110926341|NCT02259777|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110926342|NCT02259777|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110926343|NCT02259777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110926344|NCT02259777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110926345|NCT02259777|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110926346|NCT02259777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110926347|NCT02259777|Vasodilator Agents|vasodilator agents|mesh-ancestor
110378514|NCT05135104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110926348|NCT02259777|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110926349|NCT02259777|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110926350|NCT03261375|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110926351|NCT03261375|Antihypertensive Agents|antihypertensive agents|mesh-list
110926352|NCT03261375|Nifedipine|nifedipine|mesh-list
110926353|NCT03261375|Diuretics|diuretics|mesh-ancestor
110926354|NCT03261375|Natriuretic Agents|natriuretic agents|mesh-ancestor
110926355|NCT03261375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110926356|NCT03261375|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110926357|NCT03261375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110926358|NCT03261375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110926359|NCT03261375|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110926360|NCT03261375|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110926361|NCT03261375|Vasodilator Agents|vasodilator agents|mesh-ancestor
110926362|NCT03261375|Tocolytic Agents|tocolytic agents|mesh-ancestor
110926363|NCT03261375|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110273753|NCT02897830|Lenalidomide|lenalidomide|mesh-list
110273754|NCT02897830|Ixazomib|ixazomib|mesh-list
110643905|NCT00944814|Zinc|zinc|mesh-list
110926365|NCT03613545|Rifaximin|rifaximin|mesh-list
110926366|NCT03613545|Antidepressive Agents|antidepressive agents|mesh-list
110926367|NCT03613545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110926368|NCT03613545|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110926369|NCT03613545|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110926370|NCT01361308|Paroxetine|paroxetine|mesh-list
110926371|NCT01361308|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110926372|NCT01361308|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110926373|NCT01361308|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110926374|NCT01361308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110926376|NCT01361308|Serotonin Agents|serotonin agents|mesh-ancestor
110926377|NCT01361308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110926378|NCT01361308|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110926379|NCT01361308|Antidepressive Agents|antidepressive agents|mesh-ancestor
110926380|NCT01361308|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110926381|NCT01361308|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110378799|NCT02882581|Metformin|metformin|mesh-list
110926382|NCT01361308|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110926383|NCT01361308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110926384|NCT05043142|Antibodies|antibodies|mesh-list
110926385|NCT05043142|Immunologic Factors|immunologic factors|mesh-ancestor
110926386|NCT05043142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110926387|NCT03612297|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110926388|NCT03612297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110926389|NCT02872935|Glycopyrrolate|glycopyrrolate|mesh-list
110926390|NCT02872935|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110926391|NCT02872935|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110378860|NCT04558268|Progestins|progestins|mesh-ancestor
110926392|NCT02872935|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110926393|NCT02872935|Cholinergic Agents|cholinergic agents|mesh-ancestor
110926394|NCT02872935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110926395|NCT02872935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110926396|NCT02872935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110926397|NCT00103662|Plerixafor|plerixafor|mesh-list
110926398|NCT00103662|Lenograstim|lenograstim|mesh-list
110926399|NCT00103662|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110926400|NCT00103662|Immunologic Factors|immunologic factors|mesh-ancestor
110926401|NCT00103662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110926402|NCT00103662|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110926403|NCT00103662|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110926404|NCT00103662|Antiviral Agents|antiviral agents|mesh-ancestor
110926405|NCT00103662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110926406|NCT03612219|Apatinib|apatinib|mesh-list
110926407|NCT03612219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110926408|NCT03612219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110926409|NCT03612219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110926410|NCT03612219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110926411|NCT05030116|Domperidone|domperidone|mesh-list
110926412|NCT05030116|Antiemetics|antiemetics|mesh-ancestor
110926413|NCT05030116|Autonomic Agents|autonomic agents|mesh-ancestor
110926414|NCT05030116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110926415|NCT05030116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110926416|NCT05030116|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110926417|NCT05030116|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110926418|NCT05030116|Dopamine Agents|dopamine agents|mesh-ancestor
110926419|NCT05030116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110926420|NCT05030116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110926421|NCT03015129|Durvalumab|durvalumab|mesh-list
110926422|NCT03015129|Tremelimumab|tremelimumab|mesh-list
110926423|NCT03015129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110926424|NCT03015129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110926425|NCT02148978|Saxagliptin|saxagliptin|mesh-list
110926426|NCT02148978|Incretins|incretins|mesh-ancestor
110926427|NCT02148978|Hormones|hormones|mesh-ancestor
110379287|NCT02214966|Ramipril|ramipril|mesh-list
110926428|NCT02148978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110926429|NCT02148978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110926430|NCT02148978|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110926431|NCT02148978|Protease Inhibitors|protease inhibitors|mesh-ancestor
110926432|NCT02148978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110274057|NCT00179244|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110926433|NCT02148978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110926434|NCT02148978|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110926435|NCT05048914|Acetaminophen|acetaminophen|mesh-list
110926436|NCT05048914|Dipyrone|dipyrone|mesh-list
110926437|NCT05048914|Ibuprofen|ibuprofen|mesh-list
110926438|NCT05048914|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110926439|NCT05048914|Analgesics|analgesics|mesh-ancestor
110926440|NCT05048914|Sensory System Agents|sensory system agents|mesh-ancestor
110926441|NCT05048914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110926442|NCT05048914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110926443|NCT05048914|Antipyretics|antipyretics|mesh-ancestor
110379427|NCT04542252|Cyclosporins|cyclosporins|mesh-list
110926444|NCT05048914|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110926445|NCT05048914|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110926446|NCT05048914|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110926447|NCT05048914|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110926448|NCT05048914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110926449|NCT05048914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110926451|NCT03046017|Anesthetics, Local|anesthetics, local|mesh-ancestor
110926452|NCT03046017|Anesthetics|anesthetics|mesh-ancestor
110926453|NCT03046017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110926454|NCT03046017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110926455|NCT03046017|Sensory System Agents|sensory system agents|mesh-ancestor
110926456|NCT03046017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110926457|NCT03046017|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110926458|NCT03046017|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110926459|NCT03046017|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110926460|NCT03046017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110926461|NCT03046017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110926462|NCT02149212|Aminaftone|aminaftone|mesh-list
110926463|NCT02149212|Hemostatics|hemostatics|mesh-ancestor
110926464|NCT02149212|Coagulants|coagulants|mesh-ancestor
110926465|NCT04667013|Tetramethylpyrazine|tetramethylpyrazine|mesh-list
110926466|NCT04667013|Vasodilator Agents|vasodilator agents|mesh-ancestor
110926468|NCT03611985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110926469|NCT03097900|Caffeine|caffeine|mesh-list
110926470|NCT03097900|Caffeine citrate|caffeine citrate|mesh-list
110926471|NCT03097900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110926472|NCT03097900|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110379638|NCT04530864|Dexamethasone|dexamethasone|mesh-list
110926473|NCT03097900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110926474|NCT03097900|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110926475|NCT03097900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110926476|NCT03097900|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110926477|NCT03097900|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110926478|NCT03097900|Purinergic Agents|purinergic agents|mesh-ancestor
110926479|NCT03097900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110926483|NCT00104676|Ifosfamide|ifosfamide|mesh-list
110926484|NCT00104676|Bleomycin|bleomycin|mesh-list
110926485|NCT00104676|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110926486|NCT00104676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110926487|NCT00104676|Tubulin Modulators|tubulin modulators|mesh-ancestor
110926488|NCT00104676|Antimitotic Agents|antimitotic agents|mesh-ancestor
110926489|NCT00104676|Mitosis Modulators|mitosis modulators|mesh-ancestor
110926490|NCT00104676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110926491|NCT00104676|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110926492|NCT00104676|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110926493|NCT00104676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110926494|NCT00104676|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110926495|NCT00104676|Alkylating Agents|alkylating agents|mesh-ancestor
110926496|NCT00104676|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110926498|NCT00354835|Cactinomycin|cactinomycin|mesh-list
110274290|NCT05392699|Interleukin-12|interleukin-12|mesh-list
110274291|NCT05392699|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110274292|NCT05392699|Immunologic Factors|immunologic factors|mesh-ancestor
110274293|NCT05392699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110926499|NCT00354835|Cyclophosphamide|cyclophosphamide|mesh-list
110926500|NCT00354835|Irinotecan|irinotecan|mesh-list
110926501|NCT00354835|Vincristine|vincristine|mesh-list
110926502|NCT00354835|Camptothecin|camptothecin|mesh-list
110926503|NCT00354835|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110926504|NCT00354835|Immunologic Factors|immunologic factors|mesh-ancestor
110926505|NCT00354835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110926506|NCT00354835|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110926507|NCT00354835|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110926508|NCT00354835|Alkylating Agents|alkylating agents|mesh-ancestor
110926509|NCT00354835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110926510|NCT00354835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110926511|NCT00354835|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110926512|NCT00354835|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110926513|NCT00354835|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110274344|NCT05349448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110644035|NCT00186121|Hormone Antagonists|hormone antagonists|mesh-ancestor
110926514|NCT00354835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110926515|NCT00354835|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110926516|NCT00354835|Tubulin Modulators|tubulin modulators|mesh-ancestor
110926517|NCT00354835|Antimitotic Agents|antimitotic agents|mesh-ancestor
110926518|NCT00354835|Mitosis Modulators|mitosis modulators|mesh-ancestor
110926519|NCT00354835|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110926520|NCT00354835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110926521|NCT00354835|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110926522|NCT00354835|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110926523|NCT00354835|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110926524|NCT02768298|Enalapril|enalapril|mesh-list
110926525|NCT02768298|Enalaprilat|enalaprilat|mesh-list
110926526|NCT02768298|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
110926527|NCT02768298|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110274411|NCT00179712|Topotecan|topotecan|mesh-list
110926528|NCT02768298|Protease Inhibitors|protease inhibitors|mesh-ancestor
110926529|NCT02768298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110926530|NCT02768298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110926531|NCT02768298|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110926532|NCT02768298|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110926533|NCT05028322|Imiquimod|imiquimod|mesh-list
110926534|NCT05028322|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110926535|NCT05028322|Immunologic Factors|immunologic factors|mesh-ancestor
110926536|NCT05028322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110926537|NCT05028322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110926538|NCT05028322|Interferon Inducers|interferon inducers|mesh-ancestor
110926539|NCT03096340|10-hydroxycamptothecin|10-hydroxycamptothecin|mesh-list
110926540|NCT03096340|Irinotecan|irinotecan|mesh-list
110926541|NCT03096340|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110926542|NCT03096340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110926543|NCT03096340|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110274463|NCT00171665|Diclofenac|diclofenac|mesh-list
110380173|NCT04553510|Bevacizumab|bevacizumab|mesh-list
110926544|NCT03096340|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110926545|NCT03096340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110926546|NCT03096340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110926547|NCT02152800|Valacyclovir|valacyclovir|mesh-list
110926548|NCT02152800|Antiviral Agents|antiviral agents|mesh-ancestor
110926549|NCT02152800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110926550|NCT02149758|Etoricoxib|etoricoxib|mesh-list
110926551|NCT02149758|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110926552|NCT02149758|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110926553|NCT02149758|Analgesics|analgesics|mesh-ancestor
110926554|NCT02149758|Sensory System Agents|sensory system agents|mesh-ancestor
110926555|NCT02149758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110926556|NCT02149758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110926557|NCT02149758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110926558|NCT02149758|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110926559|NCT02149758|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110926560|NCT02149758|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110926561|NCT02149758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110926562|NCT02149758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110926564|NCT03542214|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110926565|NCT03542214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110926566|NCT03094468|Terbinafine|terbinafine|mesh-list
110926567|NCT03094468|Antifungal Agents|antifungal agents|mesh-ancestor
110926568|NCT03094468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110926569|NCT03094468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110926570|NCT03094468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110926571|NCT03744546|Tilavonemab|tilavonemab|mesh-list
110926572|NCT03744546|Nootropic Agents|nootropic agents|mesh-ancestor
110380367|NCT04551248|Vaccines|vaccines|mesh-list
110926573|NCT02775864|Antipsychotic Agents|antipsychotic agents|mesh-list
110926574|NCT02775864|Antidepressive Agents|antidepressive agents|mesh-list
110926575|NCT02775864|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110926576|NCT02775864|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110926577|NCT02775864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110926578|NCT02775864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110926579|NCT03095872|Petrolatum|petrolatum|mesh-list
110926580|NCT03095872|Emollients|emollients|mesh-ancestor
110926581|NCT03095872|Dermatologic Agents|dermatologic agents|mesh-ancestor
110926582|NCT03096184|Apatinib|apatinib|mesh-list
110926583|NCT03096184|Tegafur|tegafur|mesh-list
110926584|NCT03096184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110926585|NCT03096184|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110274623|NCT04958122|Cefixime|cefixime|mesh-list
110926586|NCT03096184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110926587|NCT03096184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110926588|NCT03096184|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110926590|NCT02157012|Tofacitinib|tofacitinib|mesh-list
110926591|NCT02157012|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
110926592|NCT02157012|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110926593|NCT02157012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110926594|NCT02157012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110926595|NCT03096028|Vitamin B 12|vitamin b 12|mesh-list
110926596|NCT03096028|Hydroxocobalamin|hydroxocobalamin|mesh-list
110926597|NCT03096028|Vitamins|vitamins|mesh-ancestor
110926598|NCT03096028|Micronutrients|micronutrients|mesh-ancestor
110926599|NCT03096028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110926600|NCT03096028|Vitamin B Complex|vitamin b complex|mesh-ancestor
110380728|NCT01641666|Ribavirin|ribavirin|mesh-list
110926601|NCT03096028|Hematinics|hematinics|mesh-ancestor
110926602|NCT02149914|Rabeprazole|rabeprazole|mesh-list
110926603|NCT02149914|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
110926604|NCT02149914|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110926605|NCT02149914|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110926606|NCT02149914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110930336|NCT02174094|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110380821|NCT04546256|Xhance|xhance|mesh-list
110926607|NCT02149914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110926608|NCT02149992|Inositol|inositol|mesh-list
110926609|NCT02149992|Vitamin B Complex|vitamin b complex|mesh-ancestor
110926610|NCT02149992|Vitamins|vitamins|mesh-ancestor
110926611|NCT02149992|Micronutrients|micronutrients|mesh-ancestor
110926612|NCT02149992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110926613|NCT04833582|Gemcitabine|gemcitabine|mesh-list
110926614|NCT04833582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110926615|NCT04833582|Antimetabolites|antimetabolites|mesh-ancestor
110926616|NCT04833582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110926617|NCT04833582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110926618|NCT05041582|Citalopram|citalopram|mesh-list
110926619|NCT05041582|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110926620|NCT05041582|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110380928|NCT04544969|Gemcitabine|gemcitabine|mesh-list
110926621|NCT05041582|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110926622|NCT05041582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110926623|NCT05041582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110926624|NCT05041582|Serotonin Agents|serotonin agents|mesh-ancestor
110926625|NCT05041582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110926626|NCT05041582|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110926627|NCT05041582|Antidepressive Agents|antidepressive agents|mesh-ancestor
110926628|NCT05041582|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110926629|NCT02150070|ASP2408|asp2408|mesh-list
110926630|NCT02150070|Immunoconjugates|immunoconjugates|mesh-ancestor
110926631|NCT02150070|Immunologic Factors|immunologic factors|mesh-ancestor
110926632|NCT02150070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110926633|NCT02153424|Apixaban|apixaban|mesh-list
110926634|NCT02153424|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110926635|NCT02153424|Antithrombins|antithrombins|mesh-ancestor
110926636|NCT02153424|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110926637|NCT02153424|Protease Inhibitors|protease inhibitors|mesh-ancestor
110926638|NCT02153424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110926639|NCT02153424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110926640|NCT02153424|Anticoagulants|anticoagulants|mesh-ancestor
110926641|NCT04434430|Gabapentin|gabapentin|mesh-list
110926642|NCT04434430|Analgesics|analgesics|mesh-ancestor
110926644|NCT04434430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110926645|NCT04434430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110926646|NCT04434430|Anticonvulsants|anticonvulsants|mesh-ancestor
110926647|NCT04434430|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110926648|NCT04434430|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110926649|NCT04434430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110926650|NCT04434430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110926651|NCT04434430|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110926652|NCT04434430|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110274802|NCT02907307|Miconazole|miconazole|mesh-list
110274804|NCT02907307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110381286|NCT01682499|Calcium|calcium|mesh-list
110926653|NCT04434430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110926654|NCT04434430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110926655|NCT04434430|Antimanic Agents|antimanic agents|mesh-ancestor
110926656|NCT03094156|Resveratrol|resveratrol|mesh-list
110926657|NCT03094156|Benserazide, levodopa drug combination|benserazide, levodopa drug combination|mesh-list
110926658|NCT03094156|Antioxidants|antioxidants|mesh-ancestor
110926659|NCT03094156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110926660|NCT03094156|Protective Agents|protective agents|mesh-ancestor
110926661|NCT03094156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110926662|NCT03094156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110926663|NCT03094156|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110926664|NCT03094156|Dopamine Agents|dopamine agents|mesh-ancestor
110926665|NCT03094156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110926666|NCT02964273|Tolvaptan|tolvaptan|mesh-list
110926667|NCT02964273|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
110926668|NCT02964273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110926669|NCT02964273|Natriuretic Agents|natriuretic agents|mesh-ancestor
110274862|NCT00198237|Antimetabolites|antimetabolites|mesh-ancestor
110926670|NCT02964273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110926671|NCT05040724|Ivermectin|ivermectin|mesh-list
110926672|NCT05040724|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110930350|NCT02174172|Bevacizumab|bevacizumab|mesh-list
110926673|NCT05040724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110926674|NCT03542058|Carvedilol|carvedilol|mesh-list
110381559|NCT01179334|Vasodilator Agents|vasodilator agents|mesh-ancestor
110926675|NCT03542058|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110926676|NCT03542058|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110926677|NCT03542058|Adrenergic Agents|adrenergic agents|mesh-ancestor
110926678|NCT03542058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110926679|NCT03542058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110926680|NCT03542058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110926681|NCT03542058|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110926682|NCT03542058|Antioxidants|antioxidants|mesh-ancestor
110926683|NCT03542058|Protective Agents|protective agents|mesh-ancestor
110926684|NCT03542058|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110274921|NCT00198393|Gemcitabine|gemcitabine|mesh-list
110926685|NCT03542058|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110926686|NCT03542058|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110926687|NCT03542058|Vasodilator Agents|vasodilator agents|mesh-ancestor
110926688|NCT03542058|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110926689|NCT03542058|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110926690|NCT03321513|Bevacizumab|bevacizumab|mesh-list
110926691|NCT03321513|Aflibercept|aflibercept|mesh-list
110926692|NCT03321513|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110926693|NCT03321513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110926694|NCT03321513|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110926695|NCT03321513|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110926696|NCT03321513|Growth Substances|growth substances|mesh-ancestor
110274978|NCT00198432|Tubulin Modulators|tubulin modulators|mesh-ancestor
110926697|NCT03321513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110926698|NCT03321513|Growth Inhibitors|growth inhibitors|mesh-ancestor
110926700|NCT02032797|Progestins|progestins|mesh-ancestor
110926701|NCT02032797|Hormones|hormones|mesh-ancestor
110926702|NCT02032797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110926703|NCT02032797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110926704|NCT05024266|Paclitaxel|paclitaxel|mesh-list
110926705|NCT05024266|Carboplatin|carboplatin|mesh-list
110926706|NCT05024266|Tislelizumab|tislelizumab|mesh-list
110926707|NCT05024266|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110381833|NCT04530578|Heparin|heparin|mesh-list
110926708|NCT05024266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110926709|NCT05024266|Tubulin Modulators|tubulin modulators|mesh-ancestor
110926710|NCT05024266|Antimitotic Agents|antimitotic agents|mesh-ancestor
110926711|NCT05024266|Mitosis Modulators|mitosis modulators|mesh-ancestor
110926712|NCT05024266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110926713|NCT05024266|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110926714|NCT02773368|Insulin|insulin|mesh-list
110926715|NCT02773368|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110926716|NCT02773368|Insulin Glargine|insulin glargine|mesh-list
110926717|NCT02773368|Liraglutide|liraglutide|mesh-list
110926718|NCT02773368|Xultophy|xultophy|mesh-list
110926719|NCT02773368|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110926720|NCT02773368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110926721|NCT02773368|Incretins|incretins|mesh-ancestor
110926722|NCT02773368|Hormones|hormones|mesh-ancestor
110926723|NCT02773368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110926724|NCT02153658|Chlorhexidine|chlorhexidine|mesh-list
110926725|NCT02153658|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110926726|NCT02153658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110926727|NCT02153658|Disinfectants|disinfectants|mesh-ancestor
110926728|NCT02157558|Fexofenadine|fexofenadine|mesh-list
110382046|NCT04530227|Paclitaxel|paclitaxel|mesh-list
110926729|NCT02157558|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110926730|NCT02157558|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110926731|NCT02157558|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110926732|NCT02157558|Histamine Antagonists|histamine antagonists|mesh-ancestor
110926733|NCT02157558|Histamine Agents|histamine agents|mesh-ancestor
110926734|NCT02157558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110926735|NCT02157558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110382117|NCT05126121|Clarithromycin|clarithromycin|mesh-list
110926736|NCT02157558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110926737|NCT05018182|Leucovorin|leucovorin|mesh-list
110926738|NCT05018182|Folic Acid|folic acid|mesh-list
110926739|NCT05018182|Fluorouracil|fluorouracil|mesh-list
110926740|NCT05018182|Capecitabine|capecitabine|mesh-list
110926741|NCT05018182|Oxaliplatin|oxaliplatin|mesh-list
110926742|NCT05018182|Irinotecan|irinotecan|mesh-list
110926743|NCT05018182|Levoleucovorin|levoleucovorin|mesh-list
110926744|NCT05018182|Antimetabolites|antimetabolites|mesh-ancestor
110926745|NCT05018182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110926746|NCT05018182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110382348|NCT02219789|Fulvestrant|fulvestrant|mesh-list
110926747|NCT05018182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110926748|NCT05018182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110926749|NCT05018182|Immunologic Factors|immunologic factors|mesh-ancestor
110926750|NCT05018182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110926751|NCT05018182|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110926752|NCT05018182|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110926753|NCT05018182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110926754|NCT05018182|Antidotes|antidotes|mesh-ancestor
110926755|NCT05018182|Protective Agents|protective agents|mesh-ancestor
110926756|NCT05018182|Vitamin B Complex|vitamin b complex|mesh-ancestor
110926757|NCT05018182|Vitamins|vitamins|mesh-ancestor
110926758|NCT05018182|Micronutrients|micronutrients|mesh-ancestor
110926759|NCT05018182|Hematinics|hematinics|mesh-ancestor
110926760|NCT01336569|Timolol|timolol|mesh-list
110926761|NCT01336569|Travoprost|travoprost|mesh-list
110926762|NCT01336569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110926763|NCT01336569|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110926764|NCT01336569|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110926765|NCT01336569|Adrenergic Agents|adrenergic agents|mesh-ancestor
110926766|NCT01336569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110926767|NCT01336569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110926768|NCT01336569|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110926769|NCT01336569|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110926770|NCT03092986|Paclitaxel|paclitaxel|mesh-list
110926771|NCT03092986|Vinblastine|vinblastine|mesh-list
110926772|NCT03092986|Carboplatin|carboplatin|mesh-list
110926773|NCT03092986|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110926774|NCT03092986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110382547|NCT02279186|Hemostatics|hemostatics|mesh-ancestor
110926775|NCT03092986|Tubulin Modulators|tubulin modulators|mesh-ancestor
110926776|NCT03092986|Antimitotic Agents|antimitotic agents|mesh-ancestor
110926777|NCT03092986|Mitosis Modulators|mitosis modulators|mesh-ancestor
110926778|NCT03092986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110926779|NCT03092908|Acetic Acid|acetic acid|mesh-list
110926780|NCT03092908|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110926781|NCT03092908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110926783|NCT03543306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110926784|NCT03543306|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110926785|NCT03543306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110926786|NCT03543306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110926787|NCT02157792|Carboplatin|carboplatin|mesh-list
110926788|NCT02157792|Gemcitabine|gemcitabine|mesh-list
110926789|NCT02157792|Irinotecan|irinotecan|mesh-list
110926790|NCT02157792|Etoposide|etoposide|mesh-list
110930377|NCT02180334|Incretins|incretins|mesh-ancestor
110926791|NCT02157792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110926792|NCT02157792|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110926793|NCT02157792|Antimetabolites|antimetabolites|mesh-ancestor
110926794|NCT02157792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110275267|NCT01862224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110275268|NCT01862224|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110275269|NCT01862224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110275270|NCT01862224|Immunologic Factors|immunologic factors|mesh-ancestor
110275271|NCT01862224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110275272|NCT01862224|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110275273|NCT01859962|Ribavirin|ribavirin|mesh-list
110275274|NCT01859962|Antimetabolites|antimetabolites|mesh-ancestor
110926795|NCT02157792|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110926796|NCT02157792|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110926797|NCT02157792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110382888|NCT06048367|Iron|iron|mesh-list
110926798|NCT02157792|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110926799|NCT02157792|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110926800|NCT05023408|Bleomycin|bleomycin|mesh-list
110926801|NCT05023408|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110926802|NCT05023408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110926803|NCT02772978|Tolcapone|tolcapone|mesh-list
110926804|NCT02772978|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110926805|NCT02772978|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110926806|NCT02772978|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
110926807|NCT02772978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110926808|NCT02772978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110926809|NCT03090490|Antipsychotic Agents|antipsychotic agents|mesh-list
110926810|NCT03090490|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110926811|NCT03090490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110926812|NCT03090490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110926813|NCT03090490|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110926814|NCT05164549|Buprenorphine|buprenorphine|mesh-list
110275279|NCT00173888|Gemcitabine|gemcitabine|mesh-list
110275280|NCT00173888|Docetaxel|docetaxel|mesh-list
110926816|NCT05164549|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110644338|NCT00134563|Teriflunomide|teriflunomide|mesh-list
110926817|NCT05164549|Narcotics|narcotics|mesh-ancestor
110926818|NCT05164549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110926819|NCT05164549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110926820|NCT05164549|Analgesics|analgesics|mesh-ancestor
110926821|NCT05164549|Sensory System Agents|sensory system agents|mesh-ancestor
110926822|NCT05164549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110926823|NCT05164549|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110926824|NCT05164549|Antitussive Agents|antitussive agents|mesh-ancestor
110926825|NCT05164549|Respiratory System Agents|respiratory system agents|mesh-ancestor
110926826|NCT00104052|Ribavirin|ribavirin|mesh-list
110926827|NCT00104052|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110926828|NCT00104052|Interferon-alpha|interferon-alpha|mesh-list
110926829|NCT00104052|Antimetabolites|antimetabolites|mesh-ancestor
110926830|NCT00104052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110926831|NCT00104052|Antiviral Agents|antiviral agents|mesh-ancestor
110926832|NCT00104052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110926833|NCT00104052|Immunologic Factors|immunologic factors|mesh-ancestor
110926834|NCT00104052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110926835|NCT05038072|Triamcinolone|triamcinolone|mesh-list
110383188|NCT06046274|Pembrolizumab|pembrolizumab|mesh-list
110926836|NCT05038072|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110926837|NCT05038072|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110926838|NCT05038072|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110926839|NCT05038072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110926841|NCT05038072|Hormones|hormones|mesh-ancestor
110275320|NCT00555100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110926842|NCT05038072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110926843|NCT05038072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110926844|NCT05038072|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110926845|NCT05038072|Immunologic Factors|immunologic factors|mesh-ancestor
110926846|NCT05038072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110383261|NCT06045754|Ustekinumab|ustekinumab|mesh-list
110926847|NCT05038072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110926848|NCT02777970|Acetaminophen|acetaminophen|mesh-list
110926849|NCT02777970|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
110926850|NCT02777970|Tramadol|tramadol|mesh-list
110926851|NCT02777970|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110926852|NCT02777970|Analgesics|analgesics|mesh-ancestor
110926853|NCT02777970|Sensory System Agents|sensory system agents|mesh-ancestor
110926854|NCT02777970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110926855|NCT02777970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110926856|NCT02777970|Antipyretics|antipyretics|mesh-ancestor
110926857|NCT02777970|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110926858|NCT02777970|Narcotics|narcotics|mesh-ancestor
110926859|NCT02777970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110926860|NCT02777970|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110926861|NCT02777970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110926862|NCT02777970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110926863|NCT02150616|Sevoflurane|sevoflurane|mesh-list
110926864|NCT02150616|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110926865|NCT02150616|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110926866|NCT02150616|Anesthetics, General|anesthetics, general|mesh-ancestor
110926867|NCT02150616|Anesthetics|anesthetics|mesh-ancestor
110926868|NCT02150616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110926869|NCT02150616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110926870|NCT01336023|Insulin|insulin|mesh-list
110926871|NCT01336023|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110926872|NCT01336023|Liraglutide|liraglutide|mesh-list
110926873|NCT01336023|Insulin, Long-Acting|insulin, long-acting|mesh-list
110926874|NCT01336023|Xultophy|xultophy|mesh-list
110926875|NCT01336023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110926876|NCT01336023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110926877|NCT01336023|Incretins|incretins|mesh-ancestor
110926878|NCT01336023|Hormones|hormones|mesh-ancestor
110383618|NCT06043336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110926879|NCT01336023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110926880|NCT02255292|Cannabidiol|cannabidiol|mesh-list
110926881|NCT02255292|Anticonvulsants|anticonvulsants|mesh-ancestor
110926882|NCT03092206|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
110926883|NCT03092206|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110926885|NCT03092206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110926886|NCT03092206|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110926887|NCT03092206|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110926889|NCT03092206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110926890|NCT03092206|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110926891|NCT03092206|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110926892|NCT02254980|Vitamin E|vitamin e|mesh-list
110926893|NCT02254980|Vitamins|vitamins|mesh-ancestor
110926894|NCT02254980|Micronutrients|micronutrients|mesh-ancestor
110926895|NCT02254980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110926896|NCT02254980|Antioxidants|antioxidants|mesh-ancestor
110926897|NCT02254980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110926898|NCT02254980|Protective Agents|protective agents|mesh-ancestor
110926899|NCT05281003|Paclitaxel|paclitaxel|mesh-list
110926900|NCT05281003|Pembrolizumab|pembrolizumab|mesh-list
110383779|NCT06037980|Tubulin Modulators|tubulin modulators|mesh-ancestor
110926901|NCT05281003|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110926902|NCT05281003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110926903|NCT05281003|Tubulin Modulators|tubulin modulators|mesh-ancestor
110926904|NCT05281003|Antimitotic Agents|antimitotic agents|mesh-ancestor
110926905|NCT05281003|Mitosis Modulators|mitosis modulators|mesh-ancestor
110926906|NCT05281003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110926907|NCT05281003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110926908|NCT05281003|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110926909|NCT02158182|Rifaximin|rifaximin|mesh-list
110926910|NCT02158182|Lactulose|lactulose|mesh-list
110926911|NCT02158182|N-Methylaspartate|n-methylaspartate|mesh-list
110926912|NCT02158182|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110926913|NCT02158182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110926914|NCT02158182|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110926915|NCT02158182|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
110926916|NCT02158182|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110275396|NCT00203580|Tinzaparin|tinzaparin|mesh-list
110926917|NCT02158182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110383970|NCT05976464|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110926918|NCT02158182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110926919|NCT02158182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110926921|NCT02033187|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110926922|NCT02033187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110926923|NCT02033187|Disinfectants|disinfectants|mesh-ancestor
110926924|NCT02154360|Aprepitant|aprepitant|mesh-list
110926925|NCT02154360|Antiemetics|antiemetics|mesh-ancestor
110926926|NCT02154360|Autonomic Agents|autonomic agents|mesh-ancestor
110926927|NCT02154360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110926928|NCT02154360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110926929|NCT02154360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110926930|NCT02154360|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110926931|NCT02154360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110275413|NCT01768975|Dapansutrile|dapansutrile|mesh-list
110384103|NCT05927649|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110926932|NCT02154360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110926933|NCT02033031|Bevacizumab|bevacizumab|mesh-list
110926934|NCT02033031|Ranibizumab|ranibizumab|mesh-list
110926935|NCT02033031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110926936|NCT02033031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110926937|NCT02033031|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110926938|NCT02033031|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110926939|NCT02033031|Growth Substances|growth substances|mesh-ancestor
110926940|NCT02033031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110926941|NCT02033031|Growth Inhibitors|growth inhibitors|mesh-ancestor
110926942|NCT05034367|Mannitol|mannitol|mesh-list
110926943|NCT05034367|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110926944|NCT05034367|Diuretics|diuretics|mesh-ancestor
110926945|NCT05034367|Natriuretic Agents|natriuretic agents|mesh-ancestor
110926946|NCT05034367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110926947|NCT02150928|Asparaginase|asparaginase|mesh-list
110926948|NCT02150928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110275421|NCT01756924|Ceftriaxone|ceftriaxone|mesh-list
110926949|NCT03611049|Vitamin D|vitamin d|mesh-list
110926950|NCT03611049|Ergocalciferols|ergocalciferols|mesh-list
110926951|NCT03611049|Cholecalciferol|cholecalciferol|mesh-list
110926952|NCT03611049|Vitamins|vitamins|mesh-list
110926953|NCT03611049|Micronutrients|micronutrients|mesh-ancestor
110926954|NCT03611049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110926955|NCT03611049|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110926956|NCT03611049|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110926957|NCT03610893|Dexamethasone|dexamethasone|mesh-list
110926958|NCT03610893|Dexmedetomidine|dexmedetomidine|mesh-list
110926959|NCT03610893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110926960|NCT03610893|Antiemetics|antiemetics|mesh-ancestor
110926961|NCT03610893|Autonomic Agents|autonomic agents|mesh-ancestor
110926962|NCT03610893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110926963|NCT03610893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110926964|NCT03610893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110926965|NCT03610893|Glucocorticoids|glucocorticoids|mesh-ancestor
110926966|NCT03610893|Hormones|hormones|mesh-ancestor
110926967|NCT03610893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110926968|NCT03610893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110926970|NCT03610893|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110926971|NCT03610893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110926972|NCT03610893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110926973|NCT03610893|Analgesics|analgesics|mesh-ancestor
110926974|NCT03610893|Sensory System Agents|sensory system agents|mesh-ancestor
110926975|NCT03610893|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110926976|NCT03610893|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110926977|NCT03610893|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110926978|NCT03610893|Adrenergic Agents|adrenergic agents|mesh-ancestor
110926979|NCT03610893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110926980|NCT03610893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110926981|NCT04737109|Ipatasertib|ipatasertib|mesh-list
110926983|NCT04737109|Hormones|hormones|mesh-ancestor
110275465|NCT00174200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110926984|NCT04737109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110926985|NCT04737109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110926986|NCT04737109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110926987|NCT04737109|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110926988|NCT04737109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110926989|NCT04737109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110926990|NCT02154438|Ketamine|ketamine|mesh-list
110926991|NCT02154438|Analgesics|analgesics|mesh-ancestor
110926992|NCT02154438|Sensory System Agents|sensory system agents|mesh-ancestor
110278925|NCT04575103|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110926993|NCT02154438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110926994|NCT02154438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110926995|NCT02154438|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110926996|NCT02154438|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110926997|NCT02154438|Anesthetics, General|anesthetics, general|mesh-ancestor
110926998|NCT02154438|Anesthetics|anesthetics|mesh-ancestor
110384717|NCT05653401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110926999|NCT02154438|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110927000|NCT02154438|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110927001|NCT02154438|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110927002|NCT02154438|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110927003|NCT02154438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110927004|NCT02520921|Aspirin|aspirin|mesh-list
110927005|NCT02520921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110927006|NCT02520921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110927007|NCT02520921|Analgesics|analgesics|mesh-ancestor
110927008|NCT02520921|Sensory System Agents|sensory system agents|mesh-ancestor
110927009|NCT02520921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110927010|NCT02520921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110927011|NCT02520921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110927012|NCT02520921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110927013|NCT02520921|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110384874|NCT05589220|Nicotine|nicotine|mesh-list
110927014|NCT02520921|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110927015|NCT02520921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110927016|NCT02520921|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110275491|NCT00203697|Minocycline|minocycline|mesh-list
110927017|NCT02520921|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110927018|NCT02520921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110927020|NCT02154594|Chlorhexidine|chlorhexidine|mesh-list
110927021|NCT02154594|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110927022|NCT02154594|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110927023|NCT02154594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110927024|NCT02154594|Disinfectants|disinfectants|mesh-ancestor
110927025|NCT02154594|Dermatologic Agents|dermatologic agents|mesh-ancestor
110927026|NCT03610347|Paclitaxel|paclitaxel|mesh-list
110927027|NCT03610347|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110927028|NCT03610347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110927029|NCT03610347|Tubulin Modulators|tubulin modulators|mesh-ancestor
110927030|NCT03610347|Antimitotic Agents|antimitotic agents|mesh-ancestor
110927031|NCT03610347|Mitosis Modulators|mitosis modulators|mesh-ancestor
110927032|NCT03610347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110927033|NCT01518517|Asparaginase|asparaginase|mesh-list
110927034|NCT01518517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110927035|NCT02863575|Ibuprofen|ibuprofen|mesh-list
110927036|NCT02863575|Caffeine|caffeine|mesh-list
110927037|NCT02863575|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110927038|NCT02863575|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110927039|NCT02863575|Analgesics|analgesics|mesh-ancestor
110927040|NCT02863575|Sensory System Agents|sensory system agents|mesh-ancestor
110930468|NCT04411030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110927041|NCT02863575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110927042|NCT02863575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110927043|NCT02863575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110927044|NCT02863575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110927045|NCT02863575|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110927046|NCT02863575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110275510|NCT01737892|Epinephryl borate|epinephryl borate|mesh-list
110927047|NCT02863575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110927048|NCT02863575|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110927049|NCT02863575|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110927050|NCT02863575|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110927051|NCT02863575|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110927052|NCT02863575|Purinergic Agents|purinergic agents|mesh-ancestor
110927053|NCT02863575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110927054|NCT05021770|Thiotepa|thiotepa|mesh-list
110927055|NCT05021770|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110385146|NCT05490381|Ethiodized Oil|ethiodized oil|mesh-list
110927056|NCT05021770|Alkylating Agents|alkylating agents|mesh-ancestor
110927057|NCT05021770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110927058|NCT05021770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110927059|NCT05021770|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110927060|NCT05021770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110275543|NCT01719016|Adenosine|adenosine|mesh-list
110927061|NCT05021770|Immunologic Factors|immunologic factors|mesh-ancestor
110927062|NCT05021770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110927063|NCT05230303|Caffeine|caffeine|mesh-list
110927064|NCT05230303|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110927065|NCT05230303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110927066|NCT05230303|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110927067|NCT05230303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110927068|NCT05230303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110927069|NCT05230303|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110927070|NCT05230303|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110927071|NCT05230303|Purinergic Agents|purinergic agents|mesh-ancestor
110927072|NCT05230303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110927073|NCT04287790|Naltrexone|naltrexone|mesh-list
110927074|NCT04287790|Disulfiram|disulfiram|mesh-list
110927075|NCT04287790|Acamprosate|acamprosate|mesh-list
110927076|NCT04287790|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110927077|NCT04287790|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110927078|NCT04287790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110927079|NCT04287790|Sensory System Agents|sensory system agents|mesh-ancestor
110927080|NCT04287790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110927081|NCT04287790|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
110927082|NCT04287790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110927083|NCT04287790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110927084|NCT03723967|Paclitaxel|paclitaxel|mesh-list
110927085|NCT03723967|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110927086|NCT03723967|Carboplatin|carboplatin|mesh-list
110927087|NCT03723967|Durvalumab|durvalumab|mesh-list
110927088|NCT03723967|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110275555|NCT00174356|Paclitaxel|paclitaxel|mesh-list
110927089|NCT03723967|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110927090|NCT03723967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110927091|NCT03723967|Tubulin Modulators|tubulin modulators|mesh-ancestor
110927092|NCT03723967|Antimitotic Agents|antimitotic agents|mesh-ancestor
110927093|NCT03723967|Mitosis Modulators|mitosis modulators|mesh-ancestor
110927094|NCT03723967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110927095|NCT03723967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110927096|NCT03723967|Immunologic Factors|immunologic factors|mesh-ancestor
110927097|NCT03723967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110927098|NCT05008666|Azacitidine|azacitidine|mesh-list
110275569|NCT00174395|Eletriptan|eletriptan|mesh-list
110385278|NCT05407662|Hormones|hormones|mesh-ancestor
110927099|NCT05008666|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110927100|NCT05008666|Antimetabolites|antimetabolites|mesh-ancestor
110927101|NCT05008666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110927102|NCT05008666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110927103|NCT05008666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110927104|NCT03659461|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110927105|NCT03659461|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110927106|NCT03659461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110927107|NCT03659461|Incretins|incretins|mesh-ancestor
110927108|NCT03659461|Hormones|hormones|mesh-ancestor
110534632|NCT05364996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110927109|NCT03659461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110927110|NCT03659461|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110927112|NCT03659461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110927113|NCT03659461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110927114|NCT01227187|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
110927115|NCT01227187|Protein C|protein c|mesh-list
110927116|NCT01227187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110927117|NCT01227187|Anticoagulants|anticoagulants|mesh-ancestor
110644636|NCT02390427|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
110927118|NCT01227187|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110927119|NCT01227187|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110927120|NCT01227187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110927122|NCT03088072|Warfarin|warfarin|mesh-list
110927123|NCT03088072|Edoxaban|edoxaban|mesh-list
110927124|NCT03088072|Clopidogrel|clopidogrel|mesh-list
110927125|NCT03088072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110927126|NCT03088072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110927127|NCT03088072|Analgesics|analgesics|mesh-ancestor
110927128|NCT03088072|Sensory System Agents|sensory system agents|mesh-ancestor
110927129|NCT03088072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110927130|NCT03088072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110927131|NCT03088072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110927132|NCT03088072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110927133|NCT03088072|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110927134|NCT03088072|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110927135|NCT03088072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110927136|NCT03088072|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110927137|NCT03088072|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110927138|NCT03088072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110927139|NCT03088072|Antipyretics|antipyretics|mesh-ancestor
110927140|NCT03088072|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110385449|NCT05352815|Insulin|insulin|mesh-list
110534633|NCT00643734|Azithromycin|azithromycin|mesh-list
110927141|NCT03088072|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110927142|NCT03088072|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110927143|NCT03088072|Purinergic Agents|purinergic agents|mesh-ancestor
110927144|NCT03088072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110930547|NCT04930783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110930548|NCT04930783|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110930549|NCT04930783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110930550|NCT05666206|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
110930551|NCT05666206|Hemostatics|hemostatics|mesh-ancestor
110930552|NCT05666206|Coagulants|coagulants|mesh-ancestor
110278987|NCT00588016|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110927145|NCT03088072|Anticoagulants|anticoagulants|mesh-ancestor
110927146|NCT03088072|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110927147|NCT03088072|Antithrombins|antithrombins|mesh-ancestor
110927148|NCT03088072|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110927149|NCT03088072|Protease Inhibitors|protease inhibitors|mesh-ancestor
110927151|NCT01077817|Risedronic Acid|risedronic acid|mesh-list
110927152|NCT01077817|Ibandronic Acid|ibandronic acid|mesh-list
110927153|NCT01077817|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
110927154|NCT01077817|Etidronic Acid|etidronic acid|mesh-list
110927155|NCT01077817|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110927156|NCT01077817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110385619|NCT05239624|Pembrolizumab|pembrolizumab|mesh-list
110927157|NCT01077817|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110927158|NCT01077817|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110927159|NCT01077817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110927160|NCT01077817|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110927161|NCT01077817|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110927162|NCT01077817|Hormone Antagonists|hormone antagonists|mesh-ancestor
110385702|NCT05198934|Antiviral Agents|antiviral agents|mesh-ancestor
110927163|NCT01077817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110927164|NCT01077817|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110927165|NCT01077817|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110927166|NCT02638012|Hemostatics|hemostatics|mesh-list
110927167|NCT02638012|Coagulants|coagulants|mesh-ancestor
110927168|NCT05014906|Minocycline|minocycline|mesh-list
110927169|NCT05014906|Azelaic acid|azelaic acid|mesh-list
110927170|NCT05014906|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110385776|NCT05171075|Dalteparin|dalteparin|mesh-list
110927171|NCT05014906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110927172|NCT05014906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110927173|NCT05014906|Dermatologic Agents|dermatologic agents|mesh-ancestor
110927175|NCT00103506|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110927176|NCT00103506|Bortezomib|bortezomib|mesh-list
110927177|NCT00103506|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110927178|NCT00103506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110927179|NCT00103506|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110927180|NCT00103506|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110927181|NCT00103506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110927182|NCT00103506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110927183|NCT02151240|Acyclovir|acyclovir|mesh-list
110927184|NCT02151240|Foscarnet|foscarnet|mesh-list
110927185|NCT02151240|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
110927186|NCT02151240|Antiviral Agents|antiviral agents|mesh-ancestor
110927187|NCT02151240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110927188|NCT02151240|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110927189|NCT02151240|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110927190|NCT02151240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110927191|NCT02151240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110644713|NCT06027723|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110927192|NCT02159196|Acetylcysteine|acetylcysteine|mesh-list
110927194|NCT02159196|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110927195|NCT02159196|Antiviral Agents|antiviral agents|mesh-ancestor
110927196|NCT02159196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110927197|NCT02159196|Expectorants|expectorants|mesh-ancestor
110927198|NCT02159196|Respiratory System Agents|respiratory system agents|mesh-ancestor
110927199|NCT02159196|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110927200|NCT02159196|Antioxidants|antioxidants|mesh-ancestor
110927201|NCT02159196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110927202|NCT02159196|Protective Agents|protective agents|mesh-ancestor
110927203|NCT02159196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110927204|NCT02159196|Antidotes|antidotes|mesh-ancestor
110275690|NCT00199017|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110927206|NCT02159196|Autonomic Agents|autonomic agents|mesh-ancestor
110927207|NCT02159196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110927208|NCT02159196|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110927209|NCT02159196|Tocolytic Agents|tocolytic agents|mesh-ancestor
110927210|NCT02159196|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110927211|NCT02159196|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110927212|NCT02159196|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110927213|NCT02159196|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110927214|NCT02159196|Adrenergic Agents|adrenergic agents|mesh-ancestor
110927215|NCT02159196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110927217|NCT02765490|Odalasvir|odalasvir|mesh-list
110927218|NCT02765490|Antiviral Agents|antiviral agents|mesh-ancestor
110927219|NCT02765490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110927220|NCT02765490|Protease Inhibitors|protease inhibitors|mesh-ancestor
110927221|NCT02765490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110927222|NCT02765490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110927223|NCT02762370|Triamcinolone|triamcinolone|mesh-list
110927224|NCT02762370|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110927225|NCT02762370|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110927226|NCT02762370|FX006|fx006|mesh-list
110927227|NCT02762370|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110275708|NCT01660633|Melphalan|melphalan|mesh-list
110927228|NCT02762370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110927229|NCT02762370|Glucocorticoids|glucocorticoids|mesh-ancestor
110927231|NCT02762370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110927232|NCT02762370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110927233|NCT02762370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110927234|NCT02762370|Immunologic Factors|immunologic factors|mesh-ancestor
110927235|NCT02762370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110927236|NCT02762370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110927237|NCT02639182|Axitinib|axitinib|mesh-list
110534634|NCT00643734|Levofloxacin|levofloxacin|mesh-list
110927238|NCT02639182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110927239|NCT02639182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110927240|NCT02639182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110927241|NCT02639182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110927242|NCT02863419|Liraglutide|liraglutide|mesh-list
110930675|NCT03943147|Dermatologic Agents|dermatologic agents|mesh-ancestor
110927243|NCT02863419|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110927244|NCT02863419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110927245|NCT02863419|Incretins|incretins|mesh-ancestor
110927246|NCT02863419|Hormones|hormones|mesh-ancestor
110927247|NCT02863419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110275723|NCT00174551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110927248|NCT03541668|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
110927249|NCT03541668|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110386239|NCT04947631|Urological Agents|urological agents|mesh-ancestor
110927250|NCT03541668|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110927251|NCT03541668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110927252|NCT04961632|Tamoxifen|tamoxifen|mesh-list
110927253|NCT04961632|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110927254|NCT04961632|Hormone Antagonists|hormone antagonists|mesh-ancestor
110927255|NCT04961632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110927256|NCT04961632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110275742|NCT01652482|Leucovorin|leucovorin|mesh-list
110386330|NCT04891757|Antimetabolites|antimetabolites|mesh-ancestor
110927257|NCT04961632|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110927258|NCT04961632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110927259|NCT04961632|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110927260|NCT04961632|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110927261|NCT04961632|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110927262|NCT02155374|Insulin|insulin|mesh-list
110927263|NCT02155374|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110927264|NCT02155374|Insulin, Short-Acting|insulin, short-acting|mesh-list
110927265|NCT02155374|Antineoplastic Agents|antineoplastic agents|mesh-list
110644787|NCT06026657|Antimetabolites|antimetabolites|mesh-ancestor
110927266|NCT02155374|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110927267|NCT02155374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110930714|NCT03576963|Antimetabolites|antimetabolites|mesh-ancestor
110927268|NCT04434118|Antirheumatic Agents|antirheumatic agents|mesh-list
110927269|NCT02765100|Minocycline|minocycline|mesh-list
110927270|NCT02765100|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110927271|NCT02765100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110927272|NCT03091894|Dexmedetomidine|dexmedetomidine|mesh-list
110927274|NCT03091894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110927275|NCT03091894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110927276|NCT03091894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110927277|NCT03091894|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110927278|NCT03091894|Analgesics|analgesics|mesh-ancestor
110927279|NCT03091894|Sensory System Agents|sensory system agents|mesh-ancestor
110927280|NCT03091894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110927281|NCT03091894|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110927282|NCT03091894|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110927283|NCT03091894|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110927284|NCT03091894|Adrenergic Agents|adrenergic agents|mesh-ancestor
110927285|NCT03091894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110927286|NCT03091894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110927287|NCT03091894|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110927288|NCT03091894|Anesthetics, General|anesthetics, general|mesh-ancestor
110927289|NCT03091894|Anesthetics|anesthetics|mesh-ancestor
110927290|NCT05014594|Dapagliflozin|dapagliflozin|mesh-list
110927291|NCT05014594|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110927292|NCT05014594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110927293|NCT05014594|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110386542|NCT04740697|Tamoxifen|tamoxifen|mesh-list
110927294|NCT05014594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110927295|NCT02761980|Acetaminophen|acetaminophen|mesh-list
110927297|NCT02761980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110927298|NCT02761980|Analgesics|analgesics|mesh-ancestor
110927299|NCT02761980|Sensory System Agents|sensory system agents|mesh-ancestor
110927300|NCT02761980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110927301|NCT02761980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110927302|NCT02761980|Antipyretics|antipyretics|mesh-ancestor
110927303|NCT02761980|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110927304|NCT02761980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110927305|NCT02761980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110927306|NCT02761980|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110927307|NCT02761980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110927308|NCT02761980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110927309|NCT05007340|Dimercaprol|dimercaprol|mesh-list
110927310|NCT05007340|Chelating Agents|chelating agents|mesh-ancestor
110927311|NCT05007340|Sequestering Agents|sequestering agents|mesh-ancestor
110930764|NCT03066544|Hormones|hormones|mesh-ancestor
110927312|NCT05007340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110927314|NCT05014048|Cholecalciferol|cholecalciferol|mesh-list
110927315|NCT05014048|Vitamins|vitamins|mesh-ancestor
110927316|NCT05014048|Micronutrients|micronutrients|mesh-ancestor
110927317|NCT05014048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110927318|NCT05014048|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110927319|NCT05014048|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110927320|NCT02163174|Pentoxifylline|pentoxifylline|mesh-list
110927321|NCT02163174|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110927322|NCT02163174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110275814|NCT00174707|Mitosis Modulators|mitosis modulators|mesh-ancestor
110927323|NCT02163174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110927324|NCT02163174|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110927325|NCT02163174|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110927326|NCT02163174|Protective Agents|protective agents|mesh-ancestor
110927327|NCT02163174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110927328|NCT02163174|Vasodilator Agents|vasodilator agents|mesh-ancestor
110927329|NCT02163174|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110927331|NCT01744912|Lenalidomide|lenalidomide|mesh-list
110927332|NCT01744912|Immunologic Factors|immunologic factors|mesh-ancestor
110927333|NCT01744912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110927334|NCT01744912|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110927335|NCT01744912|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110927336|NCT01744912|Growth Substances|growth substances|mesh-ancestor
110927337|NCT01744912|Growth Inhibitors|growth inhibitors|mesh-ancestor
110927338|NCT01744912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110927339|NCT03540810|Hydroxychloroquine|hydroxychloroquine|mesh-list
110927340|NCT03540810|Antimalarials|antimalarials|mesh-ancestor
110927341|NCT03540810|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110927342|NCT03540810|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110927343|NCT03540810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110927344|NCT03540810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110927345|NCT03540810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110927346|NCT03540810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110927347|NCT02159820|Paclitaxel|paclitaxel|mesh-list
110927348|NCT02159820|Carboplatin|carboplatin|mesh-list
110927349|NCT02159820|Decitabine|decitabine|mesh-list
110927350|NCT02159820|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110927351|NCT02159820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110927352|NCT02159820|Tubulin Modulators|tubulin modulators|mesh-ancestor
110927353|NCT02159820|Antimitotic Agents|antimitotic agents|mesh-ancestor
110927354|NCT02159820|Mitosis Modulators|mitosis modulators|mesh-ancestor
110930785|NCT03182179|Antiemetics|antiemetics|mesh-ancestor
110927355|NCT02159820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110927356|NCT02159820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110927358|NCT02159820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110927359|NCT02862171|Dapivirine|dapivirine|mesh-list
110275827|NCT00199134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110275828|NCT00199134|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110275829|NCT00199134|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110275830|NCT00199134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110275839|NCT00174863|SR 31747|sr 31747|mesh-list
110927360|NCT02862171|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110927361|NCT02862171|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110927362|NCT02862171|Antiviral Agents|antiviral agents|mesh-ancestor
110927363|NCT02862171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110927364|NCT05013112|Metformin|metformin|mesh-list
110927365|NCT05013112|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
110927366|NCT05013112|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110927367|NCT05013112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110927368|NCT05013112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110927369|NCT05013034|Basiliximab|basiliximab|mesh-list
110927370|NCT05013034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110927371|NCT05013034|Immunologic Factors|immunologic factors|mesh-ancestor
110927372|NCT05013034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110927373|NCT02638948|Methotrexate|methotrexate|mesh-list
110927374|NCT02638948|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110927375|NCT02638948|Abortifacient Agents|abortifacient agents|mesh-ancestor
110927376|NCT02638948|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110927377|NCT02638948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110927378|NCT02638948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110927379|NCT02638948|Antimetabolites|antimetabolites|mesh-ancestor
110927380|NCT02638948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110927381|NCT02638948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110927382|NCT02638948|Dermatologic Agents|dermatologic agents|mesh-ancestor
110927383|NCT02638948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110927384|NCT02638948|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110927385|NCT02638948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110927386|NCT02638948|Immunologic Factors|immunologic factors|mesh-ancestor
110927387|NCT02638948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110927388|NCT02638948|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110927389|NCT03091426|Antimicrobial Cationic Peptides|antimicrobial cationic peptides|mesh-list
110927390|NCT03091426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110927391|NCT04465864|Dexamethasone|dexamethasone|mesh-list
110927392|NCT04465864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110927393|NCT04465864|Antiemetics|antiemetics|mesh-ancestor
110927394|NCT04465864|Autonomic Agents|autonomic agents|mesh-ancestor
110927395|NCT04465864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110930816|NCT04116112|Autonomic Agents|autonomic agents|mesh-ancestor
110927396|NCT04465864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110927397|NCT04465864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110927398|NCT04465864|Glucocorticoids|glucocorticoids|mesh-ancestor
110927399|NCT04465864|Hormones|hormones|mesh-ancestor
110927400|NCT04465864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110927401|NCT04465864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110927402|NCT04465864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110927403|NCT03091504|Albuterol|albuterol|mesh-list
110927404|NCT03091504|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110927405|NCT03091504|Autonomic Agents|autonomic agents|mesh-ancestor
110927406|NCT03091504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110283546|NCT00203099|Antidotes|antidotes|mesh-ancestor
110275865|NCT00712582|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110927407|NCT03091504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110927408|NCT03091504|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110927409|NCT03091504|Respiratory System Agents|respiratory system agents|mesh-ancestor
110927410|NCT03091504|Tocolytic Agents|tocolytic agents|mesh-ancestor
110927411|NCT03091504|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110927412|NCT03091504|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110927413|NCT03091504|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110927414|NCT03091504|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110927415|NCT03091504|Adrenergic Agents|adrenergic agents|mesh-ancestor
110927416|NCT03091504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110387234|NCT04269213|Cytarabine|cytarabine|mesh-list
110927417|NCT03091504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110927418|NCT05019586|Amoxicillin|amoxicillin|mesh-list
110927419|NCT05019586|Clarithromycin|clarithromycin|mesh-list
110927420|NCT05019586|Levofloxacin|levofloxacin|mesh-list
110927421|NCT05019586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110927422|NCT05019586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110927423|NCT05019586|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110927424|NCT05019586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110927425|NCT05019586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110927426|NCT05019586|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110927427|NCT05019586|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110387294|NCT04235140|Ivacaftor|ivacaftor|mesh-list
110927428|NCT05019586|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110927429|NCT05019586|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110927430|NCT05019586|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110927431|NCT05019586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110927432|NCT05019586|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110927433|NCT03081676|Glimepiride|glimepiride|mesh-list
110927434|NCT03081676|Glucagon|glucagon|mesh-list
110927435|NCT03081676|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
110927436|NCT03081676|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
110927437|NCT03081676|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110275879|NCT00174902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110927438|NCT03081676|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110927439|NCT03081676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110927440|NCT03081676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110927441|NCT03081676|Immunologic Factors|immunologic factors|mesh-ancestor
110927442|NCT03081676|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110927443|NCT03081676|Hormones|hormones|mesh-ancestor
110927444|NCT03081676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110927445|NCT03081676|Incretins|incretins|mesh-ancestor
110927446|NCT05013268|Paclitaxel|paclitaxel|mesh-list
110927447|NCT05013268|Docetaxel|docetaxel|mesh-list
110927448|NCT05013268|Carboplatin|carboplatin|mesh-list
110927449|NCT05013268|Tislelizumab|tislelizumab|mesh-list
110927450|NCT05013268|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110927451|NCT05013268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110927452|NCT05013268|Tubulin Modulators|tubulin modulators|mesh-ancestor
110927453|NCT05013268|Antimitotic Agents|antimitotic agents|mesh-ancestor
110927454|NCT05013268|Mitosis Modulators|mitosis modulators|mesh-ancestor
110927455|NCT05013268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110927456|NCT05013268|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110927457|NCT00102960|Ritonavir|ritonavir|mesh-list
110927458|NCT00102960|Lopinavir|lopinavir|mesh-list
110927459|NCT00102960|Lamivudine|lamivudine|mesh-list
110927460|NCT00102960|Zidovudine|zidovudine|mesh-list
110927461|NCT00102960|Nevirapine|nevirapine|mesh-list
110927462|NCT00102960|Abacavir|abacavir|mesh-list
110927463|NCT00102960|Didanosine|didanosine|mesh-list
110927464|NCT00102960|Efavirenz|efavirenz|mesh-list
110927465|NCT00102960|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110927466|NCT00102960|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110927467|NCT00102960|Protease Inhibitors|protease inhibitors|mesh-ancestor
110927468|NCT00102960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110927469|NCT00102960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110927470|NCT00102960|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110927471|NCT00102960|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110927472|NCT00102960|Antiviral Agents|antiviral agents|mesh-ancestor
110927473|NCT00102960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110275909|NCT00555373|Sirolimus|sirolimus|mesh-list
110927474|NCT00102960|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110927475|NCT00102960|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110927476|NCT00102960|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110927477|NCT00102960|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110927479|NCT00102960|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110927480|NCT00102960|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110387563|NCT04017650|Nivolumab|nivolumab|mesh-list
110927481|NCT00102960|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110927482|NCT00102960|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110927483|NCT00102960|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110927484|NCT02858895|Interleukin-4|interleukin-4|mesh-list
110927485|NCT02858895|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110927486|NCT02858895|Immunologic Factors|immunologic factors|mesh-ancestor
110927487|NCT02858895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110927488|NCT02858895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110927489|NCT02858895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110927490|NCT05018962|Paclitaxel|paclitaxel|mesh-list
110927491|NCT05018962|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110645011|NCT05794503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110927492|NCT05018962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110927493|NCT05018962|Tubulin Modulators|tubulin modulators|mesh-ancestor
110927494|NCT05018962|Antimitotic Agents|antimitotic agents|mesh-ancestor
110927495|NCT05018962|Mitosis Modulators|mitosis modulators|mesh-ancestor
110927496|NCT05018962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110927498|NCT02160054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110927499|NCT02160054|Immunologic Factors|immunologic factors|mesh-ancestor
110927500|NCT02160054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110927501|NCT02160054|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110927502|NCT02160054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110927503|NCT02160054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110927504|NCT03609489|Capecitabine|capecitabine|mesh-list
110927505|NCT03609489|Apatinib|apatinib|mesh-list
110927506|NCT03609489|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110927507|NCT03609489|Antimetabolites|antimetabolites|mesh-ancestor
110927508|NCT03609489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110927509|NCT03609489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110275961|NCT00555607|Prednisolone|prednisolone|mesh-list
110927510|NCT03609489|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110927511|NCT03609489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110927512|NCT02033967|Milrinone|milrinone|mesh-list
110927513|NCT02033967|Vasodilator Agents|vasodilator agents|mesh-list
110927514|NCT02033967|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110927515|NCT02033967|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110927516|NCT02033967|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110927517|NCT02033967|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110930924|NCT03062800|Growth Inhibitors|growth inhibitors|mesh-ancestor
110930925|NCT05709015|Chlorhexidine|chlorhexidine|mesh-list
110930926|NCT05709015|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110930927|NCT05709015|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110930928|NCT05709015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110930929|NCT05709015|Disinfectants|disinfectants|mesh-ancestor
110930930|NCT05709015|Dermatologic Agents|dermatologic agents|mesh-ancestor
110927518|NCT02033967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110927519|NCT02033967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110927520|NCT02033967|Protective Agents|protective agents|mesh-ancestor
110927521|NCT02033967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110927522|NCT02163330|Acetazolamide|acetazolamide|mesh-list
110927523|NCT02163330|Anticonvulsants|anticonvulsants|mesh-ancestor
110927524|NCT02163330|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110927525|NCT02163330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110927526|NCT02163330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110927527|NCT02163330|Diuretics|diuretics|mesh-ancestor
110927528|NCT02163330|Natriuretic Agents|natriuretic agents|mesh-ancestor
110927529|NCT02163330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110927530|NCT03610035|Immunoglobulins|immunoglobulins|mesh-list
110927531|NCT03610035|Immunoglobulin G|immunoglobulin g|mesh-list
110927532|NCT03610035|Immunologic Factors|immunologic factors|mesh-ancestor
110927533|NCT03610035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110927534|NCT02160132|Methylprednisolone|methylprednisolone|mesh-list
110927535|NCT02160132|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110927536|NCT02160132|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110927537|NCT02160132|Prednisolone|prednisolone|mesh-list
110927538|NCT02160132|Prednisolone acetate|prednisolone acetate|mesh-list
110927539|NCT02160132|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110927540|NCT02160132|Prednisolone phosphate|prednisolone phosphate|mesh-list
110927541|NCT02160132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110927542|NCT02160132|Antiemetics|antiemetics|mesh-ancestor
110927543|NCT02160132|Autonomic Agents|autonomic agents|mesh-ancestor
110927544|NCT02160132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110927545|NCT02160132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110927546|NCT02160132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110927547|NCT02160132|Glucocorticoids|glucocorticoids|mesh-ancestor
110927549|NCT02160132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110276003|NCT04675372|Midazolam|midazolam|mesh-list
110276010|NCT04675372|Sensory System Agents|sensory system agents|mesh-ancestor
110927550|NCT02160132|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110927551|NCT02160132|Protective Agents|protective agents|mesh-ancestor
110927552|NCT02160132|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110927553|NCT02160132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110927554|NCT02034201|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
110387979|NCT03577431|Cyclophosphamide|cyclophosphamide|mesh-list
110927555|NCT02034201|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110927556|NCT02034201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110927557|NCT02034201|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110927558|NCT02034201|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110927559|NCT02034201|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110927560|NCT02034201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110927561|NCT02034201|Dopamine Agents|dopamine agents|mesh-ancestor
110927562|NCT02034201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110927563|NCT02637856|Ocrelizumab|ocrelizumab|mesh-list
110927564|NCT02637856|Immunologic Factors|immunologic factors|mesh-ancestor
110927565|NCT02637856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110927567|NCT02858037|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110276027|NCT04424602|Cyclophosphamide|cyclophosphamide|mesh-list
110927568|NCT02858037|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110927569|NCT02858037|Antiviral Agents|antiviral agents|mesh-ancestor
110927570|NCT02858037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110927571|NCT01755975|Lenalidomide|lenalidomide|mesh-list
110927572|NCT01755975|Romidepsin|romidepsin|mesh-list
110927573|NCT01755975|Immunologic Factors|immunologic factors|mesh-ancestor
110927574|NCT01755975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110927575|NCT01755975|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110927576|NCT01755975|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110930947|NCT03573063|Androgens|androgens|mesh-list
110930948|NCT03573063|Hormones|hormones|mesh-ancestor
110930949|NCT03573063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110930950|NCT03573063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110930951|NCT03572829|Dexamethasone|dexamethasone|mesh-list
110930952|NCT03572829|Ondansetron|ondansetron|mesh-list
110927577|NCT01755975|Growth Substances|growth substances|mesh-ancestor
110927578|NCT01755975|Growth Inhibitors|growth inhibitors|mesh-ancestor
110927579|NCT01755975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110927580|NCT01755975|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110927581|NCT01755975|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110927582|NCT01755975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110927583|NCT01755975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110927584|NCT01541709|Imatinib Mesylate|imatinib mesylate|mesh-list
110388140|NCT03456076|Antimetabolites|antimetabolites|mesh-ancestor
110927585|NCT01541709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110927586|NCT01541709|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110927587|NCT01541709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110927588|NCT01541709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110927589|NCT04266340|Midazolam|midazolam|mesh-list
110927590|NCT04266340|Dexmedetomidine|dexmedetomidine|mesh-list
110927591|NCT04266340|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110927592|NCT04266340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110927593|NCT04266340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110927594|NCT04266340|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110927595|NCT04266340|Analgesics|analgesics|mesh-ancestor
110927596|NCT04266340|Sensory System Agents|sensory system agents|mesh-ancestor
110927597|NCT04266340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110927598|NCT04266340|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110927599|NCT04266340|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110927600|NCT04266340|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110927601|NCT04266340|Adrenergic Agents|adrenergic agents|mesh-ancestor
110927602|NCT04266340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110927603|NCT04266340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110927604|NCT04266340|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110927605|NCT04266340|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110927606|NCT04266340|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110927607|NCT04266340|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110927608|NCT04266340|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110927609|NCT04266340|Anesthetics, General|anesthetics, general|mesh-ancestor
110927610|NCT04266340|Anesthetics|anesthetics|mesh-ancestor
110927611|NCT04266340|GABA Modulators|gaba modulators|mesh-ancestor
110927612|NCT04266340|GABA Agents|gaba agents|mesh-ancestor
110927613|NCT02856555|Firsocostat|firsocostat|mesh-list
110927614|NCT02856555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110927615|NCT02856555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110927616|NCT03609099|Moxifloxacin|moxifloxacin|mesh-list
110927617|NCT03609099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110927618|NCT03609099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110927619|NCT03609099|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110927620|NCT03609099|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110927621|NCT03609099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110927622|NCT03609099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110927623|NCT03609099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110927624|NCT05000086|Diphosphonates|diphosphonates|mesh-list
110927625|NCT05000086|Methylene diphosphonate|methylene diphosphonate|mesh-list
110927626|NCT05000086|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110927627|NCT05000086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110927629|NCT01242267|Bortezomib|bortezomib|mesh-list
110927630|NCT01242267|Melphalan|melphalan|mesh-list
110927631|NCT01242267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110927632|NCT01242267|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110927633|NCT01242267|Alkylating Agents|alkylating agents|mesh-ancestor
110927634|NCT01242267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110927635|NCT01242267|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110927636|NCT01242267|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110927637|NCT01242267|Immunologic Factors|immunologic factors|mesh-ancestor
110927638|NCT01242267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110927639|NCT01242267|Leprostatic Agents|leprostatic agents|mesh-ancestor
110930960|NCT03572829|Glucocorticoids|glucocorticoids|mesh-ancestor
110927640|NCT01242267|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110927641|NCT01242267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110927642|NCT01242267|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110927643|NCT01242267|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110927645|NCT01242267|Growth Inhibitors|growth inhibitors|mesh-ancestor
110927646|NCT02637232|Brimonidine Tartrate|brimonidine tartrate|mesh-list
110927647|NCT02637232|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110927648|NCT02637232|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110927649|NCT02637232|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110927650|NCT02637232|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110927651|NCT02637232|Adrenergic Agents|adrenergic agents|mesh-ancestor
110927652|NCT02637232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110927653|NCT02637232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110388443|NCT03164057|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110927654|NCT02637232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110927655|NCT02635984|Olanzapine|olanzapine|mesh-list
110927656|NCT02635984|Antiemetics|antiemetics|mesh-ancestor
110927657|NCT02635984|Autonomic Agents|autonomic agents|mesh-ancestor
110927658|NCT02635984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110927659|NCT02635984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110927660|NCT02635984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110927661|NCT02635984|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110927662|NCT02635984|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110927663|NCT02635984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110927664|NCT02635984|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110927665|NCT02635984|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110927666|NCT02635984|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110927667|NCT02635984|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110927668|NCT02635984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110927669|NCT02635984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110927670|NCT02635984|Serotonin Agents|serotonin agents|mesh-ancestor
110927671|NCT03073408|Propofol|propofol|mesh-list
110927672|NCT03073408|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110927673|NCT03073408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110927674|NCT03073408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110927675|NCT03073408|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110276118|NCT00175643|Imiquimod|imiquimod|mesh-list
110927676|NCT03073408|Anesthetics, General|anesthetics, general|mesh-ancestor
110927677|NCT03073408|Anesthetics|anesthetics|mesh-ancestor
110927678|NCT04993222|Amphotericin B|amphotericin b|mesh-list
110927679|NCT04993222|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
110927680|NCT04993222|Amebicides|amebicides|mesh-ancestor
110927681|NCT04993222|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110927682|NCT04993222|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110927683|NCT04993222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110927684|NCT04993222|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110927685|NCT04993222|Antifungal Agents|antifungal agents|mesh-ancestor
110927686|NCT03076762|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110927687|NCT03076762|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110927688|NCT03076762|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110927689|NCT03076762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110927690|NCT03076762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110388606|NCT02911142|Prednisone|prednisone|mesh-list
110927691|NCT03076762|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110927692|NCT03076762|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110927693|NCT03076762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110927694|NCT03076762|Cholinergic Agents|cholinergic agents|mesh-ancestor
110927695|NCT03076762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110927696|NCT02747043|Rituximab|rituximab|mesh-list
110927697|NCT02747043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110930974|NCT03575247|Hormones|hormones|mesh-ancestor
110927698|NCT02747043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110927699|NCT02747043|Immunologic Factors|immunologic factors|mesh-ancestor
110927700|NCT02747043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110276138|NCT00204438|Progestins|progestins|mesh-ancestor
110927701|NCT02747043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110927702|NCT05004142|Letrozole|letrozole|mesh-list
110927703|NCT05004142|Fulvestrant|fulvestrant|mesh-list
110927704|NCT05004142|Goserelin|goserelin|mesh-list
110927705|NCT05004142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110927706|NCT05004142|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110927707|NCT05004142|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110927708|NCT05004142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110927709|NCT05004142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110927710|NCT05004142|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110927711|NCT05004142|Hormone Antagonists|hormone antagonists|mesh-ancestor
110927712|NCT05004142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110927713|NCT05004142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110927714|NCT05004142|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110927715|NCT05004142|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110927716|NCT03076684|Allopurinol|allopurinol|mesh-list
110927717|NCT03076684|Antimetabolites|antimetabolites|mesh-ancestor
110927718|NCT03076684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110927719|NCT03076684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110927720|NCT03076684|Gout Suppressants|gout suppressants|mesh-ancestor
110927721|NCT03076684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110927722|NCT03076684|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110927723|NCT03076684|Antioxidants|antioxidants|mesh-ancestor
110927724|NCT03076684|Protective Agents|protective agents|mesh-ancestor
110927725|NCT03076684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110927726|NCT04999930|Tiotropium Bromide|tiotropium bromide|mesh-list
110927727|NCT04999930|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110927728|NCT04999930|Autonomic Agents|autonomic agents|mesh-ancestor
110927729|NCT04999930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110927730|NCT04999930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110927731|NCT04999930|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110927732|NCT04999930|Respiratory System Agents|respiratory system agents|mesh-ancestor
110927733|NCT04999930|Parasympatholytics|parasympatholytics|mesh-ancestor
110927734|NCT04999930|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110927735|NCT04999930|Cholinergic Agents|cholinergic agents|mesh-ancestor
110927736|NCT04999930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110927737|NCT04999930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110927738|NCT03607851|Lacosamide|lacosamide|mesh-list
110927739|NCT03607851|Anticonvulsants|anticonvulsants|mesh-ancestor
110927740|NCT03607851|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110927741|NCT03607851|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110927742|NCT03607851|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110927743|NCT03607851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110927744|NCT04999540|Fulvestrant|fulvestrant|mesh-list
110927745|NCT04999540|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110927746|NCT04999540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110927747|NCT04999540|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110927748|NCT04999540|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110927749|NCT04999540|Hormone Antagonists|hormone antagonists|mesh-ancestor
110930982|NCT03704623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110927750|NCT04999540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110927751|NCT04999540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110927752|NCT03608007|Ensartinib|ensartinib|mesh-list
110927753|NCT03608007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110927754|NCT03608007|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110927755|NCT03608007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110927756|NCT03608007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110927757|NCT02637076|Sodium Oxybate|sodium oxybate|mesh-list
110927758|NCT02637076|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110927759|NCT02637076|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110927760|NCT02637076|Anesthetics, General|anesthetics, general|mesh-ancestor
110927761|NCT02637076|Anesthetics|anesthetics|mesh-ancestor
110927762|NCT02637076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110927763|NCT02637076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110927764|NCT03075358|Lidocaine|lidocaine|mesh-list
110927765|NCT03075358|Anesthetics, Local|anesthetics, local|mesh-ancestor
110927766|NCT03075358|Anesthetics|anesthetics|mesh-ancestor
110927767|NCT03075358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110927768|NCT03075358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110927769|NCT03075358|Sensory System Agents|sensory system agents|mesh-ancestor
110927770|NCT03075358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110927771|NCT03075358|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110927772|NCT03075358|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110927773|NCT03075358|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110927774|NCT03075358|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110927775|NCT03075358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110276197|NCT04679506|Cytarabine|cytarabine|mesh-list
110927776|NCT05003596|Methylprednisolone|methylprednisolone|mesh-list
110927777|NCT05003596|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110927778|NCT05003596|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110927779|NCT05003596|Prednisolone|prednisolone|mesh-list
110927780|NCT05003596|Prednisolone acetate|prednisolone acetate|mesh-list
110927781|NCT05003596|Narcotics|narcotics|mesh-list
110927782|NCT05003596|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110927783|NCT05003596|Prednisolone phosphate|prednisolone phosphate|mesh-list
110927784|NCT05003596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110927785|NCT05003596|Antiemetics|antiemetics|mesh-ancestor
110927786|NCT05003596|Autonomic Agents|autonomic agents|mesh-ancestor
110276198|NCT04679506|Etoposide|etoposide|mesh-list
110276206|NCT04679506|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110927787|NCT05003596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110927788|NCT05003596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110927789|NCT05003596|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110927790|NCT05003596|Glucocorticoids|glucocorticoids|mesh-ancestor
110927791|NCT05003596|Hormones|hormones|mesh-ancestor
110927792|NCT05003596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110927793|NCT05003596|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110927794|NCT05003596|Protective Agents|protective agents|mesh-ancestor
110927795|NCT05003596|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110927796|NCT05003596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110927798|NCT05003596|Sensory System Agents|sensory system agents|mesh-ancestor
110927799|NCT05003596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110927800|NCT02854527|Metformin|metformin|mesh-list
110927801|NCT02854527|Digoxin|digoxin|mesh-list
110927802|NCT02854527|Furosemide|furosemide|mesh-list
110927803|NCT02854527|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110927804|NCT02854527|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110927805|NCT02854527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110927806|NCT02854527|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110927807|NCT02854527|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110927808|NCT02854527|Antimetabolites|antimetabolites|mesh-ancestor
110286291|NCT00210392|Bortezomib|bortezomib|mesh-list
110927809|NCT02854527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110927810|NCT02854527|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110927811|NCT02854527|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110927812|NCT02854527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110927814|NCT02854527|Natriuretic Agents|natriuretic agents|mesh-ancestor
110927815|NCT02854527|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110927816|NCT02854527|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110927817|NCT02854527|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110927818|NCT02854527|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110927819|NCT02854527|Protective Agents|protective agents|mesh-ancestor
110927820|NCT04433572|Sirolimus|sirolimus|mesh-list
110927821|NCT04433572|Temsirolimus|temsirolimus|mesh-list
110927822|NCT04433572|MTOR Inhibitors|mtor inhibitors|mesh-list
110927823|NCT04433572|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110927824|NCT04433572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110389216|NCT02403778|Ipilimumab|ipilimumab|mesh-list
110927825|NCT04433572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110927826|NCT04433572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110927827|NCT04433572|Immunologic Factors|immunologic factors|mesh-ancestor
110927828|NCT04433572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110927829|NCT04433572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110927830|NCT04433572|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110927831|NCT04433572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110927832|NCT04433572|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110927833|NCT04433572|Antifungal Agents|antifungal agents|mesh-ancestor
110927834|NCT03073018|Fosinopril|fosinopril|mesh-list
110927835|NCT03073018|Pravastatin|pravastatin|mesh-list
110927836|NCT03073018|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110927837|NCT03073018|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110927838|NCT03073018|Antimetabolites|antimetabolites|mesh-ancestor
110927839|NCT03073018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110927840|NCT03073018|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110927841|NCT03073018|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110927842|NCT03073018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110927843|NCT03073018|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110927844|NCT03073018|Protease Inhibitors|protease inhibitors|mesh-ancestor
110927845|NCT03073018|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110927847|NCT03608241|Contraceptive Agents|contraceptive agents|mesh-list
110927848|NCT03608241|Contraceptives, Oral|contraceptives, oral|mesh-list
110927849|NCT03608241|Estradiol|estradiol|mesh-list
110927850|NCT03608241|Estrogens|estrogens|mesh-ancestor
110927851|NCT03608241|Hormones|hormones|mesh-ancestor
110927852|NCT03608241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110927853|NCT03608241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110927854|NCT03608241|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110927855|NCT03608241|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110927856|NCT03608241|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110927857|NCT03608241|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110927858|NCT03606057|Moxifloxacin|moxifloxacin|mesh-list
110927859|NCT03606057|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
110927860|NCT03606057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110927861|NCT03606057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110927862|NCT03606057|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110276280|NCT03430882|Paclitaxel|paclitaxel|mesh-list
110927863|NCT03606057|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110927864|NCT03606057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110927865|NCT03606057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110927866|NCT03606057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110927867|NCT03606057|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110927868|NCT03606057|Contraceptive Agents|contraceptive agents|mesh-ancestor
110927869|NCT03606057|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110927870|NCT03606057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110927871|NCT03606057|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110927872|NCT03606057|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110927873|NCT03606057|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110927874|NCT03607383|Red yeast rice|red yeast rice|mesh-list
110276289|NCT00199758|Gemcitabine|gemcitabine|mesh-list
110927875|NCT03607383|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110927876|NCT03607383|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110927877|NCT03607383|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110927878|NCT03607383|Antimetabolites|antimetabolites|mesh-ancestor
110927879|NCT03607383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110927880|NCT03607383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110927881|NCT03607383|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110927882|NCT03607227|Levobupivacaine|levobupivacaine|mesh-list
110927883|NCT03607227|Anesthetics, Local|anesthetics, local|mesh-ancestor
110927884|NCT03607227|Anesthetics|anesthetics|mesh-ancestor
110927885|NCT03607227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110389528|NCT01619176|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110927886|NCT03607227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110276302|NCT03291886|Hormone Antagonists|hormone antagonists|mesh-ancestor
110927887|NCT03607227|Sensory System Agents|sensory system agents|mesh-ancestor
110927888|NCT03607227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110927890|NCT03607149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110927891|NCT03607149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110927892|NCT03607149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110927893|NCT03607149|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110927894|NCT03607149|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110927895|NCT04998838|Tenofovir|tenofovir|mesh-list
110927897|NCT04998838|Antibodies|antibodies|mesh-list
110927898|NCT04998838|gamma-Globulins|gamma-globulins|mesh-list
110389631|NCT01276704|Hormones|hormones|mesh-ancestor
110927899|NCT04998838|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110927900|NCT04998838|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110927901|NCT04998838|Antiviral Agents|antiviral agents|mesh-ancestor
110927902|NCT04998838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110927903|NCT04998838|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110927904|NCT04998838|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110927905|NCT04998838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110927906|NCT04998838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110927907|NCT04998838|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110927908|NCT04998838|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110927909|NCT04998838|Immunologic Factors|immunologic factors|mesh-ancestor
110927910|NCT04998838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110927911|NCT03607071|Prednisolone|prednisolone|mesh-list
110927912|NCT03607071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110927913|NCT03607071|Glucocorticoids|glucocorticoids|mesh-ancestor
110927914|NCT03607071|Hormones|hormones|mesh-ancestor
110927915|NCT03607071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110931027|NCT03940690|Bevacizumab|bevacizumab|mesh-list
110927916|NCT03607071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110927917|NCT03607071|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110927918|NCT03607071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110927919|NCT02035215|Atorvastatin|atorvastatin|mesh-list
110927920|NCT02035215|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110927921|NCT02035215|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110927922|NCT02035215|Antimetabolites|antimetabolites|mesh-ancestor
110927923|NCT02035215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110927924|NCT02035215|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110927925|NCT02035215|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110927926|NCT02035215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110927927|NCT03605589|Pembrolizumab|pembrolizumab|mesh-list
110927928|NCT03605589|Blinatumomab|blinatumomab|mesh-list
110927929|NCT03605589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110927930|NCT03605589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110927931|NCT03605589|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110927932|NCT03605589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110927933|NCT05002036|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110927934|NCT05002036|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110927936|NCT03074968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110927937|NCT04991584|Amoxicillin|amoxicillin|mesh-list
110927939|NCT04991584|Tetracycline|tetracycline|mesh-list
110927940|NCT04991584|Furazolidone|furazolidone|mesh-list
110927941|NCT04991584|Esomeprazole|esomeprazole|mesh-list
110927942|NCT04991584|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110927943|NCT04991584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110927944|NCT04991584|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110927945|NCT04991584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110927946|NCT04991584|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110927947|NCT04991584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110927948|NCT04991584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110927949|NCT04991584|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110927950|NCT04991584|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110927951|NCT04991584|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110927952|NCT04991584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110927954|NCT04991584|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110389921|NCT06031454|Antitubercular Agents|antitubercular agents|mesh-ancestor
110927955|NCT04991584|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110927956|NCT04991584|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110927957|NCT04991584|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
110927958|NCT04991584|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110927959|NCT04991584|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110927960|NCT04991584|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
110927961|NCT05001412|Carboplatin|carboplatin|mesh-list
110927963|NCT05001412|Apatinib|apatinib|mesh-list
110927964|NCT05001412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110927965|NCT05001412|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110927966|NCT05001412|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110927967|NCT05001412|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110927968|NCT05001412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110927969|NCT05001412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110927970|NCT05001412|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110927971|NCT04991896|Metoprolol|metoprolol|mesh-list
110927972|NCT04991896|Sotalol|sotalol|mesh-list
110927973|NCT04991896|Flecainide|flecainide|mesh-list
110927975|NCT04991896|Betaxolol|betaxolol|mesh-list
110927976|NCT04991896|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110927977|NCT04991896|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110927978|NCT04991896|Sympatholytics|sympatholytics|mesh-ancestor
110927979|NCT04991896|Autonomic Agents|autonomic agents|mesh-ancestor
110927980|NCT04991896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110927981|NCT04991896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110927982|NCT04991896|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110927983|NCT04991896|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110927984|NCT04991896|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110389981|NCT06031233|Nivolumab|nivolumab|mesh-list
110927985|NCT04991896|Adrenergic Agents|adrenergic agents|mesh-ancestor
110927986|NCT04991896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110927987|NCT04991896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110927988|NCT04991896|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110927989|NCT04991896|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110927990|NCT04991896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110927991|NCT03072394|Lidocaine|lidocaine|mesh-list
110927992|NCT03072394|Anesthetics, Local|anesthetics, local|mesh-list
110927993|NCT03072394|Anesthetics|anesthetics|mesh-list
110927994|NCT03072394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110927995|NCT03072394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110927996|NCT03072394|Sensory System Agents|sensory system agents|mesh-ancestor
110927997|NCT03072394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110927998|NCT03072394|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110390042|NCT06030934|Lenvatinib|lenvatinib|mesh-list
110927999|NCT03072394|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110928000|NCT03072394|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110928001|NCT03072394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110928002|NCT03072394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110928003|NCT03072082|Aspirin|aspirin|mesh-list
110928004|NCT03072082|Metoprolol|metoprolol|mesh-list
110928005|NCT03072082|Isosorbide|isosorbide|mesh-list
110928006|NCT03072082|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
110928008|NCT03072082|Trimetazidine|trimetazidine|mesh-list
110928009|NCT03072082|Clopidogrel|clopidogrel|mesh-list
110928010|NCT03072082|Atorvastatin|atorvastatin|mesh-list
110928011|NCT03072082|Calcium|calcium|mesh-list
110928012|NCT03072082|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110645549|NCT05031780|Mitapivat|mitapivat|mesh-list
110928013|NCT03072082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110928014|NCT03072082|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110928015|NCT03072082|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110928017|NCT03072082|Sensory System Agents|sensory system agents|mesh-ancestor
110928018|NCT03072082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110928019|NCT03072082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110928020|NCT03072082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110928021|NCT03072082|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110928022|NCT03072082|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110928023|NCT03072082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110928024|NCT03072082|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110928025|NCT03072082|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110928026|NCT03072082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110928027|NCT03072082|Antipyretics|antipyretics|mesh-ancestor
110928028|NCT03072082|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110928029|NCT03072082|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110928030|NCT03072082|Antimetabolites|antimetabolites|mesh-ancestor
110928031|NCT03072082|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110928032|NCT03072082|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110928033|NCT03072082|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110928034|NCT03072082|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110928035|NCT03072082|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110928036|NCT03072082|Purinergic Agents|purinergic agents|mesh-ancestor
110928037|NCT03072082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110928038|NCT03072082|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110928039|NCT03072082|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110928040|NCT03072082|Sympatholytics|sympatholytics|mesh-ancestor
110928041|NCT03072082|Autonomic Agents|autonomic agents|mesh-ancestor
110928042|NCT03072082|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110928043|NCT03072082|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110928044|NCT03072082|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110287348|NCT00212810|Topiramate|topiramate|mesh-list
110928045|NCT03072082|Adrenergic Agents|adrenergic agents|mesh-ancestor
110928046|NCT03072082|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110928047|NCT03072082|Diuretics|diuretics|mesh-ancestor
110928048|NCT03072082|Natriuretic Agents|natriuretic agents|mesh-ancestor
110928049|NCT03072082|Vasodilator Agents|vasodilator agents|mesh-ancestor
110928050|NCT03072082|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
110928051|NCT04934020|Metronidazole|metronidazole|mesh-list
110928052|NCT04934020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110928053|NCT04934020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110928054|NCT04934020|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110928055|NCT04934020|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110928056|NCT04904614|Letermovir|letermovir|mesh-list
110928057|NCT04904614|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110928058|NCT04904614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110928059|NCT04904614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110928060|NCT04904614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110928061|NCT04904614|Antiviral Agents|antiviral agents|mesh-ancestor
110928062|NCT04904614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110928063|NCT04987450|Prednisone|prednisone|mesh-list
110928064|NCT04987450|Methylprednisolone|methylprednisolone|mesh-list
110928065|NCT04987450|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110928066|NCT04987450|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110928067|NCT04987450|Prednisolone|prednisolone|mesh-list
110928068|NCT04987450|Prednisolone acetate|prednisolone acetate|mesh-list
110928069|NCT04987450|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110928070|NCT04987450|Prednisolone phosphate|prednisolone phosphate|mesh-list
110928071|NCT04987450|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110928072|NCT04987450|Glucocorticoids|glucocorticoids|mesh-ancestor
110928073|NCT04987450|Hormones|hormones|mesh-ancestor
110928074|NCT04987450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110276493|NCT00176774|Immunologic Factors|immunologic factors|mesh-ancestor
110928075|NCT04987450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110928076|NCT04987450|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110928077|NCT04987450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110928078|NCT04987450|Antiemetics|antiemetics|mesh-ancestor
110928079|NCT04987450|Autonomic Agents|autonomic agents|mesh-ancestor
110928080|NCT04987450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110928081|NCT04987450|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110928082|NCT04987450|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110928083|NCT04987450|Protective Agents|protective agents|mesh-ancestor
110928084|NCT03074578|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
110928085|NCT03074578|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
110928086|NCT03074578|beta-Endorphin|beta-endorphin|mesh-list
110928087|NCT03074578|Hormones|hormones|mesh-ancestor
110928088|NCT03074578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110928089|NCT03074578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110928090|NCT03074578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110928091|NCT03074578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110928092|NCT04991194|Zamicastat|zamicastat|mesh-list
110928093|NCT04991194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110928094|NCT04991194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110928095|NCT02853435|Gepotidacin|gepotidacin|mesh-list
110928096|NCT02853435|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110928097|NCT02853435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110534635|NCT00643734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110928098|NCT02853435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110928099|NCT02853435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110928100|NCT03071770|Ivosidenib|ivosidenib|mesh-list
110928101|NCT03071770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110928102|NCT03071770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110928103|NCT03071770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110928104|NCT04986982|Opicapone|opicapone|mesh-list
110928105|NCT04986982|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
110928106|NCT04986982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110928107|NCT04986982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110928108|NCT04986982|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110928109|NCT04986982|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110928110|NCT04996498|Oxytocin|oxytocin|mesh-list
110928111|NCT04996498|Oxytocics|oxytocics|mesh-ancestor
110928112|NCT04996498|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110928113|NCT04996498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110928114|NCT03074344|Hyaluronic Acid|hyaluronic acid|mesh-list
110928115|NCT03074344|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110928116|NCT03074344|Immunologic Factors|immunologic factors|mesh-ancestor
110928117|NCT03074344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110928118|NCT03074344|Viscosupplements|viscosupplements|mesh-ancestor
110928119|NCT03074344|Protective Agents|protective agents|mesh-ancestor
110928120|NCT03605511|Complement System Proteins|complement system proteins|mesh-list
110928121|NCT03605511|Immunologic Factors|immunologic factors|mesh-ancestor
110928122|NCT03605511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110928123|NCT02035371|Insulin|insulin|mesh-list
110928124|NCT02035371|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110928125|NCT02035371|Insulin Aspart|insulin aspart|mesh-list
110928126|NCT02035371|Insulin, Long-Acting|insulin, long-acting|mesh-list
110390343|NCT05842759|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110928127|NCT02035371|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
110928128|NCT02035371|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110928129|NCT02035371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110928130|NCT03069820|Docetaxel|docetaxel|mesh-list
110928131|NCT03069820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110928133|NCT03069820|Antimitotic Agents|antimitotic agents|mesh-ancestor
110928134|NCT03069820|Mitosis Modulators|mitosis modulators|mesh-ancestor
110928135|NCT03069820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110928136|NCT03605433|Rivaroxaban|rivaroxaban|mesh-list
110928137|NCT03605433|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110928138|NCT03605433|Antithrombins|antithrombins|mesh-ancestor
110928139|NCT03605433|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110928140|NCT03605433|Protease Inhibitors|protease inhibitors|mesh-ancestor
110928141|NCT03605433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110928142|NCT03605433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110928143|NCT03605433|Anticoagulants|anticoagulants|mesh-ancestor
110928144|NCT03071302|Tissue Inhibitor of Metalloproteinase-3|tissue inhibitor of metalloproteinase-3|mesh-list
110928145|NCT03071302|Matrix Metalloproteinase Inhibitors|matrix metalloproteinase inhibitors|mesh-ancestor
110928146|NCT03071302|Protease Inhibitors|protease inhibitors|mesh-ancestor
110928147|NCT03071302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110276568|NCT00554476|Hormones|hormones|mesh-ancestor
110928148|NCT03071302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110928149|NCT03270501|Golimumab|golimumab|mesh-list
110928150|NCT03270501|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110928151|NCT03270501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110928152|NCT03270501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110928153|NCT03270501|Immunologic Factors|immunologic factors|mesh-ancestor
110928154|NCT03270501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110928155|NCT03606681|Calcium, Dietary|calcium, dietary|mesh-list
110928156|NCT03606681|Calcium|calcium|mesh-list
110928157|NCT03606681|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110928158|NCT03606681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110928159|NCT03606681|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110928160|NCT03071380|Rivaroxaban|rivaroxaban|mesh-list
110928161|NCT03071380|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110928162|NCT03071380|Antithrombins|antithrombins|mesh-ancestor
110928163|NCT03071380|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110928164|NCT03071380|Protease Inhibitors|protease inhibitors|mesh-ancestor
110928165|NCT03071380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110928166|NCT03071380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110928167|NCT03071380|Anticoagulants|anticoagulants|mesh-ancestor
110928169|NCT03605199|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110928170|NCT03605199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110928171|NCT03606369|Ondansetron|ondansetron|mesh-list
110928172|NCT03606369|Palonosetron|palonosetron|mesh-list
110928173|NCT03606369|Antiemetics|antiemetics|mesh-ancestor
110928174|NCT03606369|Autonomic Agents|autonomic agents|mesh-ancestor
110928175|NCT03606369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110928176|NCT03606369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110276606|NCT00176813|Analgesics|analgesics|mesh-ancestor
110928177|NCT03606369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110928178|NCT03606369|Antipruritics|antipruritics|mesh-ancestor
110928179|NCT03606369|Dermatologic Agents|dermatologic agents|mesh-ancestor
110928180|NCT03606369|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110928181|NCT03606369|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110928182|NCT03606369|Serotonin Agents|serotonin agents|mesh-ancestor
110928183|NCT03606369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110928184|NCT03606369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110928186|NCT02635204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110928187|NCT02635204|Glucocorticoids|glucocorticoids|mesh-ancestor
110928188|NCT02635204|Hormones|hormones|mesh-ancestor
110928189|NCT02635204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110928190|NCT02635204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110928191|NCT00102804|Pemetrexed|pemetrexed|mesh-list
110928192|NCT00102804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110928193|NCT00102804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110928194|NCT00102804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110928195|NCT00102804|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110928196|NCT00102804|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110928197|NCT03038113|Immunomodulating Agents|immunomodulating agents|mesh-list
110928198|NCT03038113|Immunologic Factors|immunologic factors|mesh-ancestor
110928199|NCT03038113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110928200|NCT02163720|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110928201|NCT02163720|Doxorubicin|doxorubicin|mesh-list
110928202|NCT02163720|Trabectedin|trabectedin|mesh-list
110928203|NCT02163720|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110928204|NCT02163720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110928205|NCT02163720|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110928206|NCT02163720|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110276645|NCT02295865|Toreforant|toreforant|mesh-list
110928207|NCT02163720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110928208|NCT02163720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110928209|NCT02163720|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110928210|NCT02163720|Alkylating Agents|alkylating agents|mesh-ancestor
110928211|NCT03487874|Ropivacaine|ropivacaine|mesh-list
110928212|NCT03487874|Anesthetics, Local|anesthetics, local|mesh-ancestor
110928213|NCT03487874|Anesthetics|anesthetics|mesh-ancestor
110928214|NCT03487874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110928215|NCT03487874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110928216|NCT03487874|Sensory System Agents|sensory system agents|mesh-ancestor
110928217|NCT03487874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110928218|NCT04989400|Misoprostol|misoprostol|mesh-list
110928219|NCT04989400|Ulipristal acetate|ulipristal acetate|mesh-list
110928220|NCT04989400|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110928221|NCT04989400|Abortifacient Agents|abortifacient agents|mesh-ancestor
110928222|NCT04989400|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110928223|NCT04989400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110928224|NCT04989400|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110928225|NCT04989400|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110928226|NCT04989400|Oxytocics|oxytocics|mesh-ancestor
110928227|NCT04989400|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110928228|NCT04989400|Contraceptive Agents|contraceptive agents|mesh-ancestor
110928229|NCT04989400|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110390542|NCT05438602|Ritonavir|ritonavir|mesh-list
110928230|NCT02163954|Clopidogrel|clopidogrel|mesh-list
110928231|NCT02163954|Ticagrelor|ticagrelor|mesh-list
110928232|NCT02163954|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110928233|NCT02163954|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110928234|NCT02163954|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110928235|NCT02163954|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110928236|NCT02163954|Purinergic Agents|purinergic agents|mesh-ancestor
110928237|NCT02163954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110928238|NCT02163954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110276671|NCT00177008|Dopamine Agonists|dopamine agonists|mesh-ancestor
110928239|NCT02163954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110928240|NCT04985656|Decitabine|decitabine|mesh-list
110928241|NCT04985656|Pevonedistat|pevonedistat|mesh-list
110928242|NCT04985656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110928243|NCT04985656|Antimetabolites|antimetabolites|mesh-ancestor
110928244|NCT04985656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110928245|NCT04985656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110928246|NCT04985656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110928247|NCT02164032|Insulin|insulin|mesh-list
110928248|NCT02164032|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110928249|NCT02164032|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110928250|NCT02164032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110928251|NCT04682288|Levofloxacin|levofloxacin|mesh-list
110928252|NCT04682288|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110928253|NCT04682288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110928254|NCT04682288|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110928255|NCT04682288|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110928256|NCT04682288|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110390589|NCT05263908|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110928257|NCT04682288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110928258|NCT04682288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110928259|NCT04682288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110928260|NCT04682288|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110928261|NCT04682288|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110928262|NCT00968149|Montelukast|montelukast|mesh-list
110928263|NCT00968149|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110928264|NCT00968149|Respiratory System Agents|respiratory system agents|mesh-ancestor
110928265|NCT00968149|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110928266|NCT00968149|Hormone Antagonists|hormone antagonists|mesh-ancestor
110534636|NCT00643734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110928267|NCT00968149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110928268|NCT00968149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110928269|NCT00968149|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110931128|NCT03698227|Razoxane|razoxane|mesh-list
110928270|NCT00968149|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110928271|NCT00968149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110928272|NCT02164110|Vaccines|vaccines|mesh-list
110928273|NCT02164110|Immunologic Factors|immunologic factors|mesh-ancestor
110928274|NCT02164110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110928275|NCT02167464|Coal Tar|coal tar|mesh-list
110928276|NCT02167464|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
110928277|NCT02167464|Keratolytic Agents|keratolytic agents|mesh-ancestor
110928278|NCT02167464|Dermatologic Agents|dermatologic agents|mesh-ancestor
110928279|NCT02167464|Hormone Antagonists|hormone antagonists|mesh-ancestor
110928280|NCT02167464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110928281|NCT02167464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110928282|NCT02167464|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110928283|NCT02167464|Diuretics|diuretics|mesh-ancestor
110288329|NCT04662658|Xenon|xenon|mesh-list
110928284|NCT02167464|Natriuretic Agents|natriuretic agents|mesh-ancestor
110928286|NCT03485456|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110928287|NCT03485456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110928288|NCT03487562|Amoxicillin|amoxicillin|mesh-list
110928289|NCT03487562|Clarithromycin|clarithromycin|mesh-list
110928290|NCT03487562|Lansoprazole|lansoprazole|mesh-list
110928291|NCT03487562|Dexlansoprazole|dexlansoprazole|mesh-list
110928292|NCT03487562|Fexuprazan|fexuprazan|mesh-list
110928293|NCT03487562|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110928294|NCT03487562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110928295|NCT03487562|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110928296|NCT03487562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110928297|NCT03487562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110928298|NCT03487562|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110928299|NCT03487562|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110928300|NCT03487562|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110928301|NCT03487562|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110928302|NCT03487562|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110928303|NCT02167620|Metformin|metformin|mesh-list
110928305|NCT02167620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110928306|NCT03485300|Warfarin|warfarin|mesh-list
110928307|NCT03485300|Anticoagulants|anticoagulants|mesh-ancestor
110928308|NCT00963469|Loratadine|loratadine|mesh-list
110928309|NCT00963469|Montelukast|montelukast|mesh-list
110928310|NCT00963469|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110645858|NCT04675151|Miotics|miotics|mesh-ancestor
110928311|NCT00963469|Respiratory System Agents|respiratory system agents|mesh-ancestor
110928312|NCT00963469|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110928313|NCT00963469|Hormone Antagonists|hormone antagonists|mesh-ancestor
110928314|NCT00963469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110928315|NCT00963469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110928316|NCT00963469|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110928317|NCT00963469|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110928318|NCT00963469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110928319|NCT00963469|Antipruritics|antipruritics|mesh-ancestor
110928320|NCT00963469|Dermatologic Agents|dermatologic agents|mesh-ancestor
110928321|NCT00963469|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110928322|NCT00963469|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110928323|NCT00963469|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110928324|NCT00963469|Histamine Antagonists|histamine antagonists|mesh-ancestor
110928325|NCT00963469|Histamine Agents|histamine agents|mesh-ancestor
110928326|NCT00963469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110928327|NCT00897949|Rizatriptan|rizatriptan|mesh-list
110928328|NCT00897949|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110928329|NCT00897949|Serotonin Agents|serotonin agents|mesh-ancestor
110928330|NCT00897949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110931146|NCT02181348|Vitamin E|vitamin e|mesh-list
110928331|NCT00897949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110928332|NCT00897949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110928333|NCT05119855|Vaccines|vaccines|mesh-list
110928334|NCT05119855|Immunologic Factors|immunologic factors|mesh-ancestor
110928335|NCT05119855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110928336|NCT03487406|Aspirin|aspirin|mesh-list
110928337|NCT03487406|Ticagrelor|ticagrelor|mesh-list
110276772|NCT00177242|Gefitinib|gefitinib|mesh-list
110928338|NCT03487406|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110928339|NCT03487406|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110928340|NCT03487406|Analgesics|analgesics|mesh-ancestor
110928341|NCT03487406|Sensory System Agents|sensory system agents|mesh-ancestor
110928342|NCT03487406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110928343|NCT03487406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110928344|NCT03487406|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110928345|NCT03487406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110928346|NCT03487406|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110928347|NCT03487406|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110928348|NCT03487406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110928349|NCT03487406|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110928350|NCT03487406|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110928351|NCT03487406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110928352|NCT03487406|Antipyretics|antipyretics|mesh-ancestor
110928353|NCT03487406|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110928354|NCT03487406|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110928355|NCT03487406|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110390891|NCT04753749|Aspirin|aspirin|mesh-list
110928356|NCT03487406|Purinergic Agents|purinergic agents|mesh-ancestor
110928357|NCT03487406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110928358|NCT00725491|Triptorelin Pamoate|triptorelin pamoate|mesh-list
110928359|NCT00725491|Ganirelix|ganirelix|mesh-list
110928360|NCT00725491|Luteolytic Agents|luteolytic agents|mesh-ancestor
110276788|NCT04659070|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110928361|NCT00725491|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110928362|NCT00725491|Contraceptive Agents|contraceptive agents|mesh-ancestor
110928363|NCT00725491|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110928364|NCT00725491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110928365|NCT00725491|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110928366|NCT00725491|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110928367|NCT00725491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110928368|NCT00725491|Hormone Antagonists|hormone antagonists|mesh-ancestor
110928369|NCT00725491|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110928370|NCT00724789|Ganirelix|ganirelix|mesh-list
110928371|NCT00724789|Hormone Antagonists|hormone antagonists|mesh-ancestor
110928372|NCT00724789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110928373|NCT00724789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110928374|NCT00711607|Estradiol|estradiol|mesh-list
110928375|NCT00711607|Estrogens|estrogens|mesh-ancestor
110928376|NCT00711607|Hormones|hormones|mesh-ancestor
110534637|NCT00643734|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110928377|NCT00711607|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110928378|NCT00711607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110928379|NCT02164578|Aspirin|aspirin|mesh-list
110928380|NCT02164578|Rivaroxaban|rivaroxaban|mesh-list
110928381|NCT02164578|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110928383|NCT02164578|Analgesics|analgesics|mesh-ancestor
110928384|NCT02164578|Sensory System Agents|sensory system agents|mesh-ancestor
110928385|NCT02164578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110928386|NCT02164578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110928387|NCT02164578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110928388|NCT02164578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110928389|NCT02164578|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110928390|NCT02164578|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110928391|NCT02164578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110928392|NCT02164578|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110928393|NCT02164578|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110928394|NCT02164578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110928395|NCT02164578|Antipyretics|antipyretics|mesh-ancestor
110928396|NCT02164578|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110928397|NCT02164578|Antithrombins|antithrombins|mesh-ancestor
110928398|NCT02164578|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110928399|NCT02164578|Protease Inhibitors|protease inhibitors|mesh-ancestor
110928400|NCT02164578|Anticoagulants|anticoagulants|mesh-ancestor
110928401|NCT03893318|Lidocaine|lidocaine|mesh-list
110928402|NCT03893318|Anesthetics, Local|anesthetics, local|mesh-ancestor
110928403|NCT03893318|Anesthetics|anesthetics|mesh-ancestor
110928404|NCT03893318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110928405|NCT03893318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110928406|NCT03893318|Sensory System Agents|sensory system agents|mesh-ancestor
110928407|NCT03893318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110928408|NCT03893318|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110928409|NCT03893318|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110928410|NCT03893318|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110391086|NCT04458259|Axitinib|axitinib|mesh-list
110928412|NCT03893318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110928413|NCT03625531|Letrozole|letrozole|mesh-list
110928414|NCT03625531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110928415|NCT03625531|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110928416|NCT03625531|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110928417|NCT03625531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110928418|NCT03625531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110928419|NCT03625531|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110928420|NCT03625531|Hormone Antagonists|hormone antagonists|mesh-ancestor
110928421|NCT03625531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110928422|NCT03625531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110928423|NCT02167698|Methylprednisolone|methylprednisolone|mesh-list
110391156|NCT04311073|Hemostatics|hemostatics|mesh-ancestor
110928424|NCT02167698|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110928425|NCT02167698|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110928426|NCT02167698|Prednisolone|prednisolone|mesh-list
110928427|NCT02167698|Prednisolone acetate|prednisolone acetate|mesh-list
110928428|NCT02167698|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110928429|NCT02167698|Prednisolone phosphate|prednisolone phosphate|mesh-list
110928430|NCT02167698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110928431|NCT02167698|Antiemetics|antiemetics|mesh-ancestor
110928432|NCT02167698|Autonomic Agents|autonomic agents|mesh-ancestor
110928433|NCT02167698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110928434|NCT02167698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110928435|NCT02167698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110391242|NCT04172246|Zanubrutinib|zanubrutinib|mesh-list
110928436|NCT02167698|Glucocorticoids|glucocorticoids|mesh-ancestor
110928437|NCT02167698|Hormones|hormones|mesh-ancestor
110928438|NCT02167698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110928439|NCT02167698|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110928440|NCT02167698|Protective Agents|protective agents|mesh-ancestor
110928441|NCT02167698|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110928442|NCT02167698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110928443|NCT02634580|Ezetimibe|ezetimibe|mesh-list
110928444|NCT02634580|Evolocumab|evolocumab|mesh-list
110928445|NCT02634580|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110928446|NCT02634580|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110928447|NCT02634580|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110928448|NCT02634580|Antimetabolites|antimetabolites|mesh-ancestor
110391302|NCT04081389|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110928449|NCT02634580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110928450|NCT02634580|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110928451|NCT02634580|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
110928452|NCT02634580|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110928453|NCT02634580|Protease Inhibitors|protease inhibitors|mesh-ancestor
110928454|NCT02634580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110928455|NCT02634580|Immunologic Factors|immunologic factors|mesh-ancestor
110928456|NCT02634580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110928457|NCT00697255|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
110928458|NCT00697255|Hormones|hormones|mesh-list
110928459|NCT00697255|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
110928460|NCT00697255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110928461|NCT00697255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110928462|NCT00697255|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110928463|NCT00548912|Spironolactone|spironolactone|mesh-list
110928464|NCT00548912|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110928465|NCT00548912|Hormone Antagonists|hormone antagonists|mesh-ancestor
110928466|NCT00548912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110928467|NCT00548912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110928468|NCT00548912|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110928469|NCT00548912|Diuretics|diuretics|mesh-ancestor
110928470|NCT00548912|Natriuretic Agents|natriuretic agents|mesh-ancestor
110928471|NCT05002933|Insulin Glargine|insulin glargine|mesh-list
110276906|NCT00177749|Posaconazole|posaconazole|mesh-list
110928472|NCT05002933|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110928473|NCT05002933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110928474|NCT03071068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110928476|NCT03071068|Immunoglobulins|immunoglobulins|mesh-list
110928477|NCT03071068|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110928478|NCT03071068|Immunologic Factors|immunologic factors|mesh-ancestor
110928479|NCT03071068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110928480|NCT03071068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110928481|NCT03487172|Mannitol|mannitol|mesh-list
110928482|NCT03487172|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110928483|NCT03487172|Diuretics|diuretics|mesh-ancestor
110928485|NCT03487172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110928486|NCT04995016|Pembrolizumab|pembrolizumab|mesh-list
110928487|NCT04995016|Axitinib|axitinib|mesh-list
110928488|NCT04995016|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110276935|NCT04654741|Ganirelix|ganirelix|mesh-list
110928489|NCT04995016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110928490|NCT04995016|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110928491|NCT04995016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110928492|NCT04995016|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110928493|NCT04995016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110928494|NCT04994860|Sildenafil Citrate|sildenafil citrate|mesh-list
110928495|NCT04994860|Zamicastat|zamicastat|mesh-list
110928496|NCT04994860|Vasodilator Agents|vasodilator agents|mesh-ancestor
110928497|NCT04994860|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110928498|NCT04994860|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110928499|NCT04994860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110928500|NCT04994860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110928501|NCT04994860|Urological Agents|urological agents|mesh-ancestor
110928502|NCT03481400|Calcitonin|calcitonin|mesh-list
110928503|NCT03481400|Salmon calcitonin|salmon calcitonin|mesh-list
110928504|NCT03481400|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
110928505|NCT03481400|Katacalcin|katacalcin|mesh-list
110928506|NCT03481400|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110928507|NCT03481400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110928508|NCT03481400|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110928509|NCT03481400|Vasodilator Agents|vasodilator agents|mesh-ancestor
110928510|NCT02851407|Defibrotide|defibrotide|mesh-list
110928511|NCT02851407|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110928512|NCT02851407|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110928513|NCT02851407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110928514|NCT02851407|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110928515|NCT02167854|Trastuzumab|trastuzumab|mesh-list
110928516|NCT02167854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110928517|NCT02167854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110928518|NCT02161614|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110928519|NCT02161614|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110928520|NCT02161614|Estradiol|estradiol|mesh-list
110928521|NCT02161614|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110928522|NCT02161614|Estrogens|estrogens|mesh-ancestor
110928523|NCT02161614|Hormones|hormones|mesh-ancestor
110928524|NCT02161614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110928525|NCT02161614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110928526|NCT02161614|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110928527|NCT02161614|Contraceptive Agents|contraceptive agents|mesh-ancestor
110276966|NCT03454789|Lidocaine|lidocaine|mesh-list
110928528|NCT02161614|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110928529|NCT02161614|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110928531|NCT04994626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110682992|NCT00904475|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110928533|NCT04994626|Immunologic Factors|immunologic factors|mesh-ancestor
110928534|NCT04994626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110928535|NCT04994626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110928536|NCT02168010|Neurotropin|neurotropin|mesh-list
110928537|NCT02168010|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110276978|NCT00200655|Pravastatin|pravastatin|mesh-list
110928538|NCT02168010|Immunologic Factors|immunologic factors|mesh-ancestor
110928539|NCT02168010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110928540|NCT02168010|Analgesics|analgesics|mesh-ancestor
110928541|NCT02168010|Sensory System Agents|sensory system agents|mesh-ancestor
110928542|NCT02168010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110928543|NCT02168010|Anticonvulsants|anticonvulsants|mesh-ancestor
110928545|NCT04994314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110928546|NCT04994314|Cariostatic Agents|cariostatic agents|mesh-ancestor
110928547|NCT04994314|Protective Agents|protective agents|mesh-ancestor
110276987|NCT04653493|Fludarabine|fludarabine|mesh-list
110289397|NCT00220064|Irinotecan|irinotecan|mesh-list
110928548|NCT02161692|Cyclophosphamide|cyclophosphamide|mesh-list
110928549|NCT02161692|Carboplatin|carboplatin|mesh-list
110928550|NCT02161692|Etoposide|etoposide|mesh-list
110928551|NCT02161692|Bleomycin|bleomycin|mesh-list
110928552|NCT02161692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110928553|NCT02161692|Immunologic Factors|immunologic factors|mesh-ancestor
110928554|NCT02161692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110928555|NCT02161692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110928556|NCT02161692|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110928557|NCT02161692|Alkylating Agents|alkylating agents|mesh-ancestor
110928558|NCT02161692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110928559|NCT02161692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110928560|NCT02161692|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110928561|NCT02161692|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110928562|NCT02161692|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110928563|NCT02161692|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110928564|NCT02161692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110928565|NCT02161692|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110928567|NCT02746575|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110276998|NCT00200694|Ramipril|ramipril|mesh-list
110928569|NCT02746575|Sympatholytics|sympatholytics|mesh-ancestor
110928570|NCT02746575|Autonomic Agents|autonomic agents|mesh-ancestor
110928571|NCT02746575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110928572|NCT02746575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110928573|NCT02746575|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110928574|NCT02746575|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110928575|NCT02746575|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110928576|NCT02746575|Adrenergic Agents|adrenergic agents|mesh-ancestor
110928577|NCT02746575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110928578|NCT02746575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110928579|NCT02161770|Osimertinib|osimertinib|mesh-list
110928580|NCT02161770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110928581|NCT02161770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110928582|NCT02161770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110928583|NCT02161770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110928584|NCT03604575|Insulin|insulin|mesh-list
110928585|NCT03604575|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110928586|NCT03604575|Insulin Lispro|insulin lispro|mesh-list
110928587|NCT03604575|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110928588|NCT03604575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110928589|NCT04988932|Nitric Oxide|nitric oxide|mesh-list
110928590|NCT04988932|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110928591|NCT04988932|Autonomic Agents|autonomic agents|mesh-ancestor
110928592|NCT04988932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110277017|NCT00557713|Growth Substances|growth substances|mesh-ancestor
110928593|NCT04988932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110928595|NCT04988932|Respiratory System Agents|respiratory system agents|mesh-ancestor
110928596|NCT04988932|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110928597|NCT04988932|Antioxidants|antioxidants|mesh-ancestor
110928598|NCT04988932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110928599|NCT04988932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110928600|NCT04988932|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
110928601|NCT04988932|Vasodilator Agents|vasodilator agents|mesh-ancestor
110928602|NCT04988932|Gasotransmitters|gasotransmitters|mesh-ancestor
110928603|NCT04988932|Protective Agents|protective agents|mesh-ancestor
110928604|NCT03625466|Ivacaftor|ivacaftor|mesh-list
110928605|NCT03625466|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
110928606|NCT03625466|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110928607|NCT03625466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110928608|NCT03604419|Metformin|metformin|mesh-list
110928609|NCT03604419|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110928610|NCT03604419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110928611|NCT03484832|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
110928612|NCT03484832|Ethyl Chloride|ethyl chloride|mesh-list
110928613|NCT03484832|Anesthetics, Local|anesthetics, local|mesh-ancestor
110928614|NCT03484832|Anesthetics|anesthetics|mesh-ancestor
110928615|NCT03484832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110928616|NCT03484832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110277043|NCT04653415|Antiemetics|antiemetics|mesh-ancestor
110928617|NCT03484832|Sensory System Agents|sensory system agents|mesh-ancestor
110928618|NCT03484832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110928619|NCT03484832|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
110928620|NCT04985110|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
110928621|NCT04985110|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110928622|NCT04985110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110928623|NCT04985110|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110928624|NCT04985110|Antimalarials|antimalarials|mesh-ancestor
110928625|NCT04985110|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110928626|NCT04985110|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110928628|NCT02164812|Efavirenz|efavirenz|mesh-list
110928629|NCT02164812|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110928630|NCT02164812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110928631|NCT02164812|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110928632|NCT02164812|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110928633|NCT02164812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110928634|NCT02164812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110928635|NCT02164812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110928636|NCT02164812|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110928637|NCT02164812|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110928638|NCT02164812|Antiviral Agents|antiviral agents|mesh-ancestor
110928639|NCT02164812|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110928640|NCT02164812|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110928641|NCT02164812|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110928642|NCT02164812|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110928643|NCT02164812|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110928644|NCT02164812|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110928645|NCT04988776|Bupivacaine|bupivacaine|mesh-list
110928646|NCT04988776|Anesthetics, Local|anesthetics, local|mesh-ancestor
110928647|NCT04988776|Anesthetics|anesthetics|mesh-ancestor
110928648|NCT04988776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110928649|NCT04988776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110928650|NCT04988776|Sensory System Agents|sensory system agents|mesh-ancestor
110928651|NCT04988776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110928652|NCT02853123|Tiotropium Bromide|tiotropium bromide|mesh-list
110928653|NCT02853123|Olodaterol|olodaterol|mesh-list
110928654|NCT02853123|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110928655|NCT02853123|Autonomic Agents|autonomic agents|mesh-ancestor
110928656|NCT02853123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110928657|NCT02853123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110928658|NCT02853123|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110928659|NCT02853123|Respiratory System Agents|respiratory system agents|mesh-ancestor
110928660|NCT02853123|Parasympatholytics|parasympatholytics|mesh-ancestor
110928661|NCT02853123|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110928662|NCT02853123|Cholinergic Agents|cholinergic agents|mesh-ancestor
110928663|NCT02853123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110928664|NCT02853123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110928665|NCT02255370|Curcumin|curcumin|mesh-list
110928666|NCT02255370|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110928667|NCT02255370|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110928668|NCT02255370|Analgesics|analgesics|mesh-ancestor
110928669|NCT02255370|Sensory System Agents|sensory system agents|mesh-ancestor
110928670|NCT02255370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110928671|NCT02255370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110928672|NCT02255370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110928673|NCT02255370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110928674|NCT02255370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110928675|NCT02255370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110928676|NCT02255370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110928677|NCT04984408|Vaccines|vaccines|mesh-list
110928678|NCT04984408|Immunologic Factors|immunologic factors|mesh-ancestor
110928679|NCT04984408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110928680|NCT03484754|Botulinum Toxins|botulinum toxins|mesh-list
110928681|NCT03484754|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110928682|NCT03484754|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110928683|NCT03484754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110928684|NCT03484754|Cholinergic Agents|cholinergic agents|mesh-ancestor
110928685|NCT03484754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110928686|NCT03484754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110928687|NCT04459676|Mitogens|mitogens|mesh-list
110928688|NCT04459676|Mitosis Modulators|mitosis modulators|mesh-ancestor
110928689|NCT04459676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110928690|NCT02164890|Micafungin|micafungin|mesh-list
110928691|NCT02164890|Antifungal Agents|antifungal agents|mesh-ancestor
110928692|NCT02164890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110928693|NCT02634346|Olanzapine|olanzapine|mesh-list
110928695|NCT02634346|Autonomic Agents|autonomic agents|mesh-ancestor
110928696|NCT02634346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110928697|NCT02634346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110928698|NCT02634346|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110928699|NCT02634346|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110928700|NCT02634346|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110928701|NCT02634346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110928702|NCT02634346|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110928703|NCT02634346|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110928704|NCT02634346|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110277148|NCT00558142|Antioxidants|antioxidants|mesh-ancestor
110928705|NCT02634346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110928706|NCT02634346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110928707|NCT02634346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110928708|NCT02634346|Serotonin Agents|serotonin agents|mesh-ancestor
110928709|NCT02168634|Botulinum Toxins|botulinum toxins|mesh-list
110928710|NCT02168634|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110928711|NCT02168634|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110928712|NCT02168634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110928713|NCT02168634|Cholinergic Agents|cholinergic agents|mesh-ancestor
110928714|NCT02168634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110928715|NCT02168634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110928716|NCT00812240|Imatinib Mesylate|imatinib mesylate|mesh-list
110928717|NCT00812240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110928718|NCT00812240|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110928719|NCT00812240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110928720|NCT00812240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110928721|NCT02165046|Budesonide|budesonide|mesh-list
110928722|NCT02165046|Procaterol|procaterol|mesh-list
110928723|NCT02165046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110928724|NCT02165046|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110928725|NCT02165046|Autonomic Agents|autonomic agents|mesh-ancestor
110928726|NCT02165046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110928727|NCT02165046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110928728|NCT02165046|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110928730|NCT02165046|Glucocorticoids|glucocorticoids|mesh-ancestor
110928731|NCT02165046|Hormones|hormones|mesh-ancestor
110928732|NCT02165046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110928733|NCT02165046|Sympathomimetics|sympathomimetics|mesh-ancestor
110928734|NCT02165046|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110928735|NCT02165046|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110928736|NCT02165046|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110928737|NCT02165046|Adrenergic Agents|adrenergic agents|mesh-ancestor
110928738|NCT02165046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110928739|NCT02165046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110928740|NCT03070678|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
110928741|NCT03070678|Mefenamic Acid|mefenamic acid|mesh-list
110928742|NCT03070678|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110928743|NCT03070678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110277203|NCT00559741|Antidotes|antidotes|mesh-ancestor
110928745|NCT03070678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110928746|NCT03070678|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110928747|NCT03070678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110928748|NCT03070678|Analgesics|analgesics|mesh-ancestor
110928749|NCT03070678|Sensory System Agents|sensory system agents|mesh-ancestor
110646287|NCT03798626|Leucovorin|leucovorin|mesh-list
110931237|NCT02183220|Aspirin|aspirin|mesh-list
110928750|NCT03070678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110928751|NCT03070678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110928752|NCT03070678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110928753|NCT03070678|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110928754|NCT03070678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110928756|NCT00101166|Immunologic Factors|immunologic factors|mesh-ancestor
110928757|NCT00101166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110928758|NCT04994236|Leucovorin|leucovorin|mesh-list
110928759|NCT04994236|Fluorouracil|fluorouracil|mesh-list
110928760|NCT04994236|Oxaliplatin|oxaliplatin|mesh-list
110928761|NCT04994236|Antimetabolites|antimetabolites|mesh-ancestor
110928762|NCT04994236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110928763|NCT04994236|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110928764|NCT04994236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110928765|NCT04994236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110928766|NCT04994236|Immunologic Factors|immunologic factors|mesh-ancestor
110928767|NCT04994236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110928768|NCT04994236|Antidotes|antidotes|mesh-ancestor
110928769|NCT04994236|Protective Agents|protective agents|mesh-ancestor
110928770|NCT04994236|Vitamin B Complex|vitamin b complex|mesh-ancestor
110928771|NCT04994236|Vitamins|vitamins|mesh-ancestor
110928772|NCT04994236|Micronutrients|micronutrients|mesh-ancestor
110928773|NCT03601611|Prednisolone|prednisolone|mesh-list
110928774|NCT03601611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110928775|NCT03601611|Glucocorticoids|glucocorticoids|mesh-ancestor
110928777|NCT03601611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110928778|NCT03601611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110928779|NCT03601611|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110928780|NCT03601611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110928781|NCT03597945|Lidocaine|lidocaine|mesh-list
110928782|NCT03597945|Magnesium Sulfate|magnesium sulfate|mesh-list
110928783|NCT03597945|Epinephrine|epinephrine|mesh-list
110928784|NCT03597945|Anesthetics, Local|anesthetics, local|mesh-ancestor
110928785|NCT03597945|Anesthetics|anesthetics|mesh-ancestor
110928786|NCT03597945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110928787|NCT03597945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110928788|NCT03597945|Sensory System Agents|sensory system agents|mesh-ancestor
110928789|NCT03597945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110928790|NCT03597945|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110928791|NCT03597945|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110928792|NCT03597945|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110928793|NCT03597945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110928794|NCT03597945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110928795|NCT03597945|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110928796|NCT03597945|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110928797|NCT03597945|Adrenergic Agents|adrenergic agents|mesh-ancestor
110928798|NCT03597945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110928799|NCT03597945|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110928800|NCT03597945|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110928801|NCT03597945|Autonomic Agents|autonomic agents|mesh-ancestor
110928802|NCT03597945|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110928803|NCT03597945|Respiratory System Agents|respiratory system agents|mesh-ancestor
110928804|NCT03597945|Mydriatics|mydriatics|mesh-ancestor
110928805|NCT03597945|Sympathomimetics|sympathomimetics|mesh-ancestor
110928806|NCT03597945|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110928807|NCT03597945|Analgesics|analgesics|mesh-ancestor
110928808|NCT03597945|Anticonvulsants|anticonvulsants|mesh-ancestor
110928809|NCT03597945|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110928810|NCT03597945|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110928811|NCT03597945|Tocolytic Agents|tocolytic agents|mesh-ancestor
110928812|NCT03597945|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110928813|NCT03601533|Phenol|phenol|mesh-list
110928814|NCT03601533|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110928816|NCT03601533|Disinfectants|disinfectants|mesh-ancestor
110928817|NCT03601533|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
110928818|NCT03601533|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110928819|NCT03486626|Metformin|metformin|mesh-list
110928820|NCT03486626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110928821|NCT03486626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110928822|NCT04983550|Doxorubicin|doxorubicin|mesh-list
110928823|NCT04983550|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110928824|NCT04983550|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110646369|NCT03710161|Vitamin D|vitamin d|mesh-list
110928825|NCT04983550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110928826|NCT04983550|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110928827|NCT04983550|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110928828|NCT04983550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110928829|NCT04983550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110928830|NCT02255682|Simvastatin|simvastatin|mesh-list
110928831|NCT02255682|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110928832|NCT02255682|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110928833|NCT02255682|Antimetabolites|antimetabolites|mesh-ancestor
110928834|NCT02255682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110928835|NCT02255682|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110928836|NCT02255682|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110928837|NCT02255682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110928839|NCT05153486|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110928840|NCT05153486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110928841|NCT05153486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110928842|NCT05153486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110928843|NCT03136263|Oxytocin|oxytocin|mesh-list
110928844|NCT03136263|Oxytocics|oxytocics|mesh-ancestor
110928845|NCT03136263|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110928846|NCT03136263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110928847|NCT03486548|Dexamethasone|dexamethasone|mesh-list
110928848|NCT03486548|Lidocaine|lidocaine|mesh-list
110928849|NCT03486548|Bupivacaine|bupivacaine|mesh-list
110928850|NCT03486548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110928851|NCT03486548|Antiemetics|antiemetics|mesh-ancestor
110928852|NCT03486548|Autonomic Agents|autonomic agents|mesh-ancestor
110928853|NCT03486548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110928854|NCT03486548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110928855|NCT03486548|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110928856|NCT03486548|Glucocorticoids|glucocorticoids|mesh-ancestor
110928857|NCT03486548|Hormones|hormones|mesh-ancestor
110928858|NCT03486548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110928859|NCT03486548|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110928860|NCT03486548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110928861|NCT03486548|Anesthetics, Local|anesthetics, local|mesh-ancestor
110928862|NCT03486548|Anesthetics|anesthetics|mesh-ancestor
110928863|NCT03486548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110928864|NCT03486548|Sensory System Agents|sensory system agents|mesh-ancestor
110928865|NCT03486548|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110928866|NCT03486548|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110928867|NCT03486548|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110928868|NCT03486548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110928869|NCT03486548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110928870|NCT04983160|Allopurinol|allopurinol|mesh-list
110928871|NCT04983160|Antimetabolites|antimetabolites|mesh-ancestor
110928872|NCT04983160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110928873|NCT04983160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110928874|NCT04983160|Gout Suppressants|gout suppressants|mesh-ancestor
110928875|NCT04983160|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110277319|NCT04637152|Valsartan|valsartan|mesh-list
110928876|NCT04983160|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110928877|NCT04983160|Antioxidants|antioxidants|mesh-ancestor
110928878|NCT04983160|Protective Agents|protective agents|mesh-ancestor
110928879|NCT04983160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110928880|NCT02759016|BI 836826|bi 836826|mesh-list
110928881|NCT02759016|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110928882|NCT02759016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110928883|NCT02852967|Belumosudil|belumosudil|mesh-list
110928884|NCT02852967|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110928885|NCT02852967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110928886|NCT02852967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110928887|NCT03593044|Atropine|atropine|mesh-list
110928888|NCT03593044|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110928889|NCT03593044|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110928890|NCT03593044|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110928891|NCT03593044|Autonomic Agents|autonomic agents|mesh-ancestor
110928892|NCT03593044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110928893|NCT03593044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110928894|NCT03593044|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110928895|NCT03593044|Respiratory System Agents|respiratory system agents|mesh-ancestor
110928896|NCT03593044|Mydriatics|mydriatics|mesh-ancestor
110928897|NCT03593044|Parasympatholytics|parasympatholytics|mesh-ancestor
110928898|NCT03593044|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110928899|NCT03593044|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110928900|NCT03593044|Cholinergic Agents|cholinergic agents|mesh-ancestor
110928901|NCT03593044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110928902|NCT03593044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110928903|NCT03597087|Anesthetics|anesthetics|mesh-list
110928904|NCT03597087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110928905|NCT03597087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110928906|NCT03603327|Antiviral Agents|antiviral agents|mesh-list
110928907|NCT03603327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110928908|NCT03596775|Dexmedetomidine|dexmedetomidine|mesh-list
110928909|NCT03596775|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110928910|NCT03596775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110277354|NCT04636957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110277355|NCT04636957|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110277356|NCT04636957|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110277357|NCT04636957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110277358|NCT04636957|Glucocorticoids|glucocorticoids|mesh-ancestor
110277359|NCT04636957|Hormones|hormones|mesh-ancestor
110277362|NCT00560326|Tacrolimus|tacrolimus|mesh-list
110928911|NCT03596775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110928912|NCT03596775|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110928913|NCT03596775|Analgesics|analgesics|mesh-ancestor
110928914|NCT03596775|Sensory System Agents|sensory system agents|mesh-ancestor
110928915|NCT03596775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110928916|NCT03596775|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110928917|NCT03596775|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110928918|NCT03596775|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110928919|NCT03596775|Adrenergic Agents|adrenergic agents|mesh-ancestor
110928920|NCT03596775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110928921|NCT03596775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110928923|NCT03066466|Atorvastatin|atorvastatin|mesh-list
110928924|NCT03066466|Tacrolimus|tacrolimus|mesh-list
110928925|NCT03066466|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110928926|NCT03066466|Abortifacient Agents|abortifacient agents|mesh-ancestor
110928927|NCT03066466|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110928928|NCT03066466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110928929|NCT03066466|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110928930|NCT03066466|Antimetabolites|antimetabolites|mesh-ancestor
110928931|NCT03066466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110928932|NCT03066466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110928933|NCT03066466|Dermatologic Agents|dermatologic agents|mesh-ancestor
110928934|NCT03066466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110928935|NCT03066466|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110928936|NCT03066466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110928937|NCT03066466|Immunologic Factors|immunologic factors|mesh-ancestor
110928938|NCT03066466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110928939|NCT03066466|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110928940|NCT03066466|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110928941|NCT03066466|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110928943|NCT03066466|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110928944|NCT03066466|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110928945|NCT03603249|Trimetazidine|trimetazidine|mesh-list
110928946|NCT03603249|Vasodilator Agents|vasodilator agents|mesh-ancestor
110928947|NCT03068260|Acetaminophen|acetaminophen|mesh-list
110928948|NCT03068260|Ibuprofen|ibuprofen|mesh-list
110928949|NCT03068260|Morphine|morphine|mesh-list
110928950|NCT03068260|Ropivacaine|ropivacaine|mesh-list
110928951|NCT03068260|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110928952|NCT03068260|Narcotics|narcotics|mesh-ancestor
110928953|NCT03068260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110928954|NCT03068260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110928955|NCT03068260|Analgesics|analgesics|mesh-ancestor
110928956|NCT03068260|Sensory System Agents|sensory system agents|mesh-ancestor
110928957|NCT03068260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110928958|NCT03068260|Anesthetics, Local|anesthetics, local|mesh-ancestor
110928959|NCT03068260|Anesthetics|anesthetics|mesh-ancestor
110928960|NCT03068260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110928961|NCT03068260|Antipyretics|antipyretics|mesh-ancestor
110928962|NCT03068260|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110928963|NCT03068260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110928964|NCT03068260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110928965|NCT03068260|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110928966|NCT03068260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110928967|NCT03068260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110928968|NCT02237859|Vancomycin|vancomycin|mesh-list
110928969|NCT02237859|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110928970|NCT02237859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110928971|NCT03594825|Valsartan|valsartan|mesh-list
110928972|NCT03594825|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110928973|NCT03594825|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110928974|NCT03594825|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110931291|NCT02183376|Incretins|incretins|mesh-ancestor
110928975|NCT03594825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110928976|NCT02162550|Exenatide|exenatide|mesh-list
110928977|NCT02162550|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110928978|NCT02162550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110928979|NCT02162550|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110928981|NCT02162550|Hormones|hormones|mesh-ancestor
110928982|NCT02162550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110928983|NCT03600831|Docetaxel|docetaxel|mesh-list
110928984|NCT03600831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110928985|NCT03600831|Tubulin Modulators|tubulin modulators|mesh-ancestor
110928986|NCT03600831|Antimitotic Agents|antimitotic agents|mesh-ancestor
110928987|NCT03600831|Mitosis Modulators|mitosis modulators|mesh-ancestor
110928988|NCT03600831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110277440|NCT00201396|Leucovorin|leucovorin|mesh-list
110928990|NCT02852265|Etonogestrel|etonogestrel|mesh-list
110928991|NCT02852265|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110928992|NCT02852265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110928993|NCT02852265|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110928994|NCT02852265|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110928995|NCT02162784|Budesonide|budesonide|mesh-list
110928996|NCT02162784|Albuterol|albuterol|mesh-list
110928997|NCT02162784|Procaterol|procaterol|mesh-list
110928998|NCT02162784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110928999|NCT02162784|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110929000|NCT02162784|Autonomic Agents|autonomic agents|mesh-ancestor
110929001|NCT02162784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110929002|NCT02162784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110929003|NCT02162784|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110929004|NCT02162784|Respiratory System Agents|respiratory system agents|mesh-ancestor
110929005|NCT02162784|Glucocorticoids|glucocorticoids|mesh-ancestor
110929006|NCT02162784|Hormones|hormones|mesh-ancestor
110929007|NCT02162784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110929008|NCT02162784|Tocolytic Agents|tocolytic agents|mesh-ancestor
110929009|NCT02162784|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110929010|NCT02162784|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110929011|NCT02162784|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110929012|NCT02162784|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110929013|NCT02162784|Adrenergic Agents|adrenergic agents|mesh-ancestor
110929014|NCT02162784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110929015|NCT02162784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110929016|NCT02162784|Sympathomimetics|sympathomimetics|mesh-ancestor
110929017|NCT03539718|Taurolidine|taurolidine|mesh-list
110929018|NCT03539718|Heparin|heparin|mesh-list
110929019|NCT03539718|Calcium heparin|calcium heparin|mesh-list
110929020|NCT03539718|Anticoagulants|anticoagulants|mesh-ancestor
110929021|NCT03539718|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110929022|NCT03539718|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110929023|NCT03539718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110929024|NCT03539718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110929025|NCT03539718|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110929026|NCT03539718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110929027|NCT02166450|Nystatin|nystatin|mesh-list
110929028|NCT02166450|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110929029|NCT02166450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110929030|NCT02166450|Antifungal Agents|antifungal agents|mesh-ancestor
110929031|NCT02166450|Ionophores|ionophores|mesh-ancestor
110929032|NCT02166450|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110929033|NCT02166450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110929034|NCT03600363|Metformin|metformin|mesh-list
110929035|NCT03600363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110929036|NCT03600363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110929037|NCT03600129|Ropivacaine|ropivacaine|mesh-list
110929038|NCT03600129|Anesthetics, Local|anesthetics, local|mesh-ancestor
110929039|NCT03600129|Anesthetics|anesthetics|mesh-ancestor
110929040|NCT03600129|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110929041|NCT03600129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110929042|NCT03600129|Sensory System Agents|sensory system agents|mesh-ancestor
110929043|NCT03600129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110929044|NCT02169570|Calcium, Dietary|calcium, dietary|mesh-list
110929045|NCT02169570|Vitamin D|vitamin d|mesh-list
110929046|NCT02169570|Ergocalciferols|ergocalciferols|mesh-list
110929047|NCT02169570|Cholecalciferol|cholecalciferol|mesh-list
110929048|NCT02169570|Vitamins|vitamins|mesh-list
110929049|NCT02169570|Calcium|calcium|mesh-list
110929050|NCT02169570|Micronutrients|micronutrients|mesh-ancestor
110929051|NCT02169570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110929052|NCT02169570|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110929053|NCT02169570|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110929054|NCT02169648|Ranibizumab|ranibizumab|mesh-list
110929055|NCT02169648|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110929056|NCT02169648|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110929057|NCT02169648|Growth Substances|growth substances|mesh-ancestor
110929058|NCT02169648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110929059|NCT02169648|Growth Inhibitors|growth inhibitors|mesh-ancestor
110929060|NCT02169648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110929061|NCT03594591|Hypoglycemic Agents|hypoglycemic agents|mesh-list
110929062|NCT03594591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110929064|NCT02170896|Dabigatran|dabigatran|mesh-list
110929065|NCT02170896|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110929066|NCT02170896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110929067|NCT02170896|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110929068|NCT02170896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110929069|NCT02170896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110929070|NCT02170896|Antithrombins|antithrombins|mesh-ancestor
110929071|NCT02170896|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110929072|NCT02170896|Protease Inhibitors|protease inhibitors|mesh-ancestor
110929073|NCT02170896|Anticoagulants|anticoagulants|mesh-ancestor
110929074|NCT03594513|Dipyrone|dipyrone|mesh-list
110277526|NCT00179231|Olanzapine|olanzapine|mesh-list
110929075|NCT03594513|Chlorhexidine|chlorhexidine|mesh-list
110929076|NCT03594513|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110929077|NCT03594513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110929078|NCT03594513|Disinfectants|disinfectants|mesh-ancestor
110929079|NCT03594513|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110929080|NCT03594513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110929081|NCT03594513|Analgesics|analgesics|mesh-ancestor
110929082|NCT03594513|Sensory System Agents|sensory system agents|mesh-ancestor
110929083|NCT03594513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110929084|NCT03594513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110929085|NCT03594513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110929086|NCT03594513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110929087|NCT03594513|Antipyretics|antipyretics|mesh-ancestor
110929088|NCT02633800|Carboplatin|carboplatin|mesh-list
110929089|NCT02633800|Cetuximab|cetuximab|mesh-list
110929090|NCT02633800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110929091|NCT02633800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110929092|NCT02169804|Enclomiphene|enclomiphene|mesh-list
110929093|NCT02169804|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110929094|NCT02169804|Hormone Antagonists|hormone antagonists|mesh-ancestor
110929095|NCT02169804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110929096|NCT02169804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110929097|NCT02169804|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110929098|NCT02169804|Fertility Agents|fertility agents|mesh-ancestor
110929099|NCT02169804|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110929100|NCT02169804|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110929101|NCT02169804|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110929102|NCT02170974|Dabigatran|dabigatran|mesh-list
110929103|NCT02170974|Antithrombins|antithrombins|mesh-ancestor
110929104|NCT02170974|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110929105|NCT02170974|Protease Inhibitors|protease inhibitors|mesh-ancestor
110929106|NCT02170974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110929107|NCT02170974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110929108|NCT02170974|Anticoagulants|anticoagulants|mesh-ancestor
110929109|NCT02174718|Vitamin D|vitamin d|mesh-list
110929110|NCT02174718|Cholecalciferol|cholecalciferol|mesh-list
110929111|NCT02174718|Vitamins|vitamins|mesh-ancestor
110929112|NCT02174718|Micronutrients|micronutrients|mesh-ancestor
110929113|NCT02174718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110929114|NCT02174718|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110929115|NCT02174718|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110929116|NCT02238171|Ipratropium|ipratropium|mesh-list
110929117|NCT02238171|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110929118|NCT02238171|Autonomic Agents|autonomic agents|mesh-ancestor
110929119|NCT02238171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110929120|NCT02238171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110929121|NCT02238171|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110929122|NCT02238171|Respiratory System Agents|respiratory system agents|mesh-ancestor
110929123|NCT02238171|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110929124|NCT02238171|Cholinergic Agents|cholinergic agents|mesh-ancestor
110929125|NCT02238171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110929126|NCT02238171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110646664|NCT02863055|Nintedanib|nintedanib|mesh-list
110929127|NCT02169882|Rifampin|rifampin|mesh-list
110929128|NCT02169882|Dexamethasone|dexamethasone|mesh-list
110929129|NCT02169882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110929131|NCT02169882|Autonomic Agents|autonomic agents|mesh-ancestor
110929132|NCT02169882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110929133|NCT02169882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110929134|NCT02169882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110929135|NCT02169882|Glucocorticoids|glucocorticoids|mesh-ancestor
110929137|NCT02169882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110929138|NCT02169882|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110929139|NCT02169882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110929140|NCT02169882|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110929141|NCT02169882|Antitubercular Agents|antitubercular agents|mesh-ancestor
110929142|NCT02169882|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110929143|NCT02169882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110929144|NCT02169882|Leprostatic Agents|leprostatic agents|mesh-ancestor
110929145|NCT02169882|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110929146|NCT02169882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110929147|NCT02169882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110929148|NCT02169882|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110929149|NCT02169882|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110929150|NCT02169882|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110929151|NCT02169882|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110929152|NCT02169882|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110929153|NCT02169882|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110929154|NCT03602547|Vorolanib|vorolanib|mesh-list
110929155|NCT03602547|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110929156|NCT03602547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110929157|NCT03602547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110929158|NCT03602469|Bupivacaine|bupivacaine|mesh-list
110929159|NCT03602469|Propofol|propofol|mesh-list
110929160|NCT03602469|Sevoflurane|sevoflurane|mesh-list
110929161|NCT03602469|Rocuronium|rocuronium|mesh-list
110929162|NCT03602469|Anesthetics, Local|anesthetics, local|mesh-ancestor
110929164|NCT03602469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110929165|NCT03602469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110929166|NCT03602469|Sensory System Agents|sensory system agents|mesh-ancestor
110929167|NCT03602469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110929168|NCT03602469|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110929169|NCT03602469|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110929170|NCT03602469|Anesthetics, General|anesthetics, general|mesh-ancestor
110929171|NCT03602469|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110929172|NCT03602469|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110929173|NCT03602469|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110929174|NCT03602469|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110929175|NCT03602469|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110929176|NCT02170038|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
110929177|NCT02170038|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
110929178|NCT02170038|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110277631|NCT04630522|Vitamin D|vitamin d|mesh-list
110929180|NCT02170038|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110929181|NCT02170038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110929182|NCT02170038|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110929183|NCT02170038|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110929184|NCT02170038|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110929185|NCT02170038|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110929186|NCT02170038|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110929187|NCT02170038|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
110929188|NCT02170038|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
110929189|NCT02170038|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
110929190|NCT05001373|Vaccines|vaccines|mesh-list
110929191|NCT05001373|Immunologic Factors|immunologic factors|mesh-ancestor
110929192|NCT05001373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110929193|NCT02171052|Digoxin|digoxin|mesh-list
110929194|NCT02171052|Dabigatran|dabigatran|mesh-list
110929195|NCT02171052|Antithrombins|antithrombins|mesh-ancestor
110929196|NCT02171052|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110929197|NCT02171052|Protease Inhibitors|protease inhibitors|mesh-ancestor
110929198|NCT02171052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110929199|NCT02171052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110929200|NCT02171052|Anticoagulants|anticoagulants|mesh-ancestor
110929201|NCT02171052|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110929202|NCT02171052|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110929203|NCT02171052|Protective Agents|protective agents|mesh-ancestor
110929204|NCT02171052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110929206|NCT03591549|Goserelin|goserelin|mesh-list
110929207|NCT03591549|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110929208|NCT03591549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110929209|NCT03591549|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110929211|NCT03591549|Hormone Antagonists|hormone antagonists|mesh-ancestor
110929212|NCT03591549|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110929213|NCT03591549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110929214|NCT02261220|Durvalumab|durvalumab|mesh-list
110929215|NCT02261220|Tremelimumab|tremelimumab|mesh-list
110929216|NCT02261220|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110929217|NCT02261220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110929218|NCT02237937|Amitriptyline|amitriptyline|mesh-list
110929219|NCT02237937|Citalopram|citalopram|mesh-list
110929220|NCT02237937|Paroxetine|paroxetine|mesh-list
110929221|NCT02237937|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
110929222|NCT02237937|Sertraline|sertraline|mesh-list
110929223|NCT02237937|Nortriptyline|nortriptyline|mesh-list
110929224|NCT02237937|Trimipramine|trimipramine|mesh-list
110929225|NCT02237937|Escitalopram|escitalopram|mesh-list
110929226|NCT02237937|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110929227|NCT02237937|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110929228|NCT02237937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110929229|NCT02237937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110929230|NCT02237937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110929231|NCT02237937|Serotonin Agents|serotonin agents|mesh-ancestor
110929232|NCT02237937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110929233|NCT02237937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110929234|NCT02237937|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110929235|NCT02237937|Antidepressive Agents|antidepressive agents|mesh-ancestor
110929236|NCT02237937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110929237|NCT02237937|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110929238|NCT02237937|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110929239|NCT02237937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110929240|NCT02237937|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110929241|NCT02237937|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110929242|NCT02237937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110929243|NCT02237937|Analgesics|analgesics|mesh-ancestor
110929244|NCT02237937|Sensory System Agents|sensory system agents|mesh-ancestor
110929245|NCT02237937|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110929246|NCT02237937|Adrenergic Agents|adrenergic agents|mesh-ancestor
110929248|NCT02170116|Antithrombins|antithrombins|mesh-ancestor
110929249|NCT02170116|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110929250|NCT02170116|Protease Inhibitors|protease inhibitors|mesh-ancestor
110929251|NCT02170116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110929252|NCT02170116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110929253|NCT02170116|Anticoagulants|anticoagulants|mesh-ancestor
110929254|NCT03035227|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
110929255|NCT03539562|Promethazine|promethazine|mesh-list
110929256|NCT03539562|Diphenhydramine|diphenhydramine|mesh-list
110929257|NCT03539562|Morphine|morphine|mesh-list
110929258|NCT03539562|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110929259|NCT03539562|Narcotics|narcotics|mesh-ancestor
110929260|NCT03539562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110929261|NCT03539562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110929262|NCT03539562|Analgesics|analgesics|mesh-ancestor
110277713|NCT00561106|Antiviral Agents|antiviral agents|mesh-ancestor
110929263|NCT03539562|Sensory System Agents|sensory system agents|mesh-ancestor
110929264|NCT03539562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110929265|NCT03539562|Antipruritics|antipruritics|mesh-ancestor
110929266|NCT03539562|Dermatologic Agents|dermatologic agents|mesh-ancestor
110929267|NCT03539562|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110929268|NCT03539562|Histamine Antagonists|histamine antagonists|mesh-ancestor
110929269|NCT03539562|Histamine Agents|histamine agents|mesh-ancestor
110929270|NCT03539562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110929271|NCT03539562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110929272|NCT03539562|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110929273|NCT03539562|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110929274|NCT03539562|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110929275|NCT03539562|Anesthetics, Local|anesthetics, local|mesh-ancestor
110929276|NCT03539562|Anesthetics|anesthetics|mesh-ancestor
110929277|NCT03539562|Antiemetics|antiemetics|mesh-ancestor
110929278|NCT03539562|Autonomic Agents|autonomic agents|mesh-ancestor
110929279|NCT03539562|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110929281|NCT03590769|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110929282|NCT03590769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110929283|NCT00394069|Montelukast|montelukast|mesh-list
110929284|NCT00394069|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110929285|NCT00394069|Respiratory System Agents|respiratory system agents|mesh-ancestor
110277736|NCT00186849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110929287|NCT00394069|Hormone Antagonists|hormone antagonists|mesh-ancestor
110929288|NCT00394069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110929289|NCT00394069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110929290|NCT00394069|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110929291|NCT00394069|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110929292|NCT00394069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110929293|NCT03598959|Tofacitinib|tofacitinib|mesh-list
110929294|NCT03598959|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
110929295|NCT03598959|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110929296|NCT03598959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110929297|NCT03598959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110929298|NCT02238717|Pregabalin|pregabalin|mesh-list
110929299|NCT02238717|PF-06372865|pf-06372865|mesh-list
110929300|NCT02238717|Analgesics|analgesics|mesh-ancestor
110929301|NCT02238717|Sensory System Agents|sensory system agents|mesh-ancestor
110277747|NCT00561223|Iloprost|iloprost|mesh-list
110929302|NCT02238717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110929303|NCT02238717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110929304|NCT02238717|Anticonvulsants|anticonvulsants|mesh-ancestor
110929305|NCT02238717|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110929306|NCT02238717|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110929307|NCT02238717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110929308|NCT02238717|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110929309|NCT02238717|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110929310|NCT02238717|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110929311|NCT02238717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110929312|NCT02238717|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110929313|NCT02238717|GABA Modulators|gaba modulators|mesh-ancestor
110929314|NCT02238717|GABA Agents|gaba agents|mesh-ancestor
110929315|NCT02238717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110929316|NCT05266066|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110929317|NCT05266066|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
110929318|NCT05266066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110929319|NCT05266066|Antitubercular Agents|antitubercular agents|mesh-ancestor
110929320|NCT03470311|Benralizumab|benralizumab|mesh-list
110929321|NCT03470311|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110929322|NCT03470311|Respiratory System Agents|respiratory system agents|mesh-ancestor
110929323|NCT03580005|Methylphenidate|methylphenidate|mesh-list
110929324|NCT03580005|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110929325|NCT03580005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110929326|NCT03580005|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110929327|NCT03580005|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110929328|NCT03580005|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110929329|NCT03580005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110929330|NCT03580005|Dopamine Agents|dopamine agents|mesh-ancestor
110929331|NCT03580005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110929332|NCT03579927|Cytarabine|cytarabine|mesh-list
110929333|NCT03579927|Rituximab|rituximab|mesh-list
110929334|NCT03579927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110929335|NCT03579927|Etoposide|etoposide|mesh-list
110929337|NCT03579927|Melphalan|melphalan|mesh-list
110929338|NCT03579927|Mechlorethamine|mechlorethamine|mesh-list
110929339|NCT03579927|Carmustine|carmustine|mesh-list
110929340|NCT03579927|Podophyllotoxin|podophyllotoxin|mesh-list
110929341|NCT03579927|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
110929342|NCT03579927|Antibodies|antibodies|mesh-list
110929343|NCT03579927|Immunoglobulins|immunoglobulins|mesh-list
110931383|NCT02183532|Incretins|incretins|mesh-ancestor
110929344|NCT03579927|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110929345|NCT03579927|Lenograstim|lenograstim|mesh-list
110929346|NCT03579927|Immunologic Factors|immunologic factors|mesh-ancestor
110929347|NCT03579927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110929348|NCT03579927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110929349|NCT03579927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110929350|NCT03579927|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110929351|NCT03579927|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110929352|NCT03579927|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110929353|NCT03579927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110929354|NCT03579927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110929355|NCT03579927|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110929356|NCT03579927|Antimetabolites|antimetabolites|mesh-ancestor
110929357|NCT03579927|Antiviral Agents|antiviral agents|mesh-ancestor
110929358|NCT03579927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110929359|NCT03579927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110929360|NCT03579927|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110929361|NCT03579927|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110929362|NCT03579927|Alkylating Agents|alkylating agents|mesh-ancestor
110929363|NCT03579927|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110929364|NCT03579927|Keratolytic Agents|keratolytic agents|mesh-ancestor
110929365|NCT03579927|Dermatologic Agents|dermatologic agents|mesh-ancestor
110929366|NCT03579927|Tubulin Modulators|tubulin modulators|mesh-ancestor
110929367|NCT03579927|Antimitotic Agents|antimitotic agents|mesh-ancestor
110929368|NCT03579927|Mitosis Modulators|mitosis modulators|mesh-ancestor
110929369|NCT03587025|Amitriptyline|amitriptyline|mesh-list
110929370|NCT03587025|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110929371|NCT03587025|Antidepressive Agents|antidepressive agents|mesh-ancestor
110929372|NCT03587025|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110929373|NCT03587025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110929374|NCT03587025|Analgesics|analgesics|mesh-ancestor
110929375|NCT03587025|Sensory System Agents|sensory system agents|mesh-ancestor
110929376|NCT03587025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110929377|NCT03587025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110929378|NCT03587025|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110929379|NCT03587025|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110277838|NCT00180128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110929380|NCT03587025|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110929381|NCT03587025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110929382|NCT03587025|Adrenergic Agents|adrenergic agents|mesh-ancestor
110929383|NCT03587025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110929384|NCT02171208|Dimethyl Fumarate|dimethyl fumarate|mesh-list
110929385|NCT02171208|Dermatologic Agents|dermatologic agents|mesh-ancestor
110929386|NCT02171208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110929387|NCT02171208|Immunologic Factors|immunologic factors|mesh-ancestor
110929388|NCT02171208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110929389|NCT00140881|Montelukast|montelukast|mesh-list
110929390|NCT00140881|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110929391|NCT00140881|Respiratory System Agents|respiratory system agents|mesh-ancestor
110929392|NCT00140881|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110929393|NCT00140881|Hormone Antagonists|hormone antagonists|mesh-ancestor
110929394|NCT00140881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110929395|NCT00140881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110929396|NCT00140881|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110929397|NCT00140881|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110929398|NCT00140881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110929399|NCT02848833|Empagliflozin|empagliflozin|mesh-list
110929400|NCT02848833|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110929401|NCT02848833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110929402|NCT02848833|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110931395|NCT02629822|Tenofovir|tenofovir|mesh-list
110929403|NCT02848833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110929405|NCT03539328|Gemcitabine|gemcitabine|mesh-list
110929406|NCT03539328|Doxorubicin|doxorubicin|mesh-list
110929407|NCT03539328|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110929408|NCT03539328|Pembrolizumab|pembrolizumab|mesh-list
110929409|NCT03539328|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110929410|NCT03539328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110929411|NCT03539328|Tubulin Modulators|tubulin modulators|mesh-ancestor
110929412|NCT03539328|Antimitotic Agents|antimitotic agents|mesh-ancestor
110929413|NCT03539328|Mitosis Modulators|mitosis modulators|mesh-ancestor
110929414|NCT03539328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110929415|NCT03539328|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110929416|NCT03539328|Antimetabolites|antimetabolites|mesh-ancestor
110929417|NCT03539328|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110929418|NCT03539328|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110929419|NCT03539328|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110929420|NCT03539328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110929421|NCT03539328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110929422|NCT03539328|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110929423|NCT00111709|Rizatriptan|rizatriptan|mesh-list
110929424|NCT00111709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110929425|NCT00111709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110929426|NCT00111709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110929427|NCT00111709|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110929428|NCT00111709|Serotonin Agents|serotonin agents|mesh-ancestor
110929429|NCT02171442|Dabigatran|dabigatran|mesh-list
110929430|NCT02171442|Antithrombins|antithrombins|mesh-ancestor
110929431|NCT02171442|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110929432|NCT02171442|Protease Inhibitors|protease inhibitors|mesh-ancestor
110929433|NCT02171442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110929434|NCT02171442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110929435|NCT02171442|Anticoagulants|anticoagulants|mesh-ancestor
110929436|NCT02035527|Docetaxel|docetaxel|mesh-list
110929437|NCT02035527|Sorafenib|sorafenib|mesh-list
110929438|NCT02035527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110929439|NCT02035527|Tubulin Modulators|tubulin modulators|mesh-ancestor
110929440|NCT02035527|Antimitotic Agents|antimitotic agents|mesh-ancestor
110929441|NCT02035527|Mitosis Modulators|mitosis modulators|mesh-ancestor
110929442|NCT02035527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110929443|NCT02035527|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110929444|NCT02035527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110929445|NCT00092131|Montelukast|montelukast|mesh-list
110929446|NCT00092131|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110929447|NCT00092131|Respiratory System Agents|respiratory system agents|mesh-ancestor
110929448|NCT00092131|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110929449|NCT00092131|Hormone Antagonists|hormone antagonists|mesh-ancestor
110929450|NCT00092131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110929451|NCT00092131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110929452|NCT00092131|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110929453|NCT00092131|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110929454|NCT00092131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110929455|NCT02170584|Dabigatran|dabigatran|mesh-list
110929456|NCT02170584|Antithrombins|antithrombins|mesh-ancestor
110929457|NCT02170584|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110929458|NCT02170584|Protease Inhibitors|protease inhibitors|mesh-ancestor
110929459|NCT02170584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110929460|NCT02170584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110929461|NCT02170584|Anticoagulants|anticoagulants|mesh-ancestor
110929462|NCT03577977|Interferons|interferons|mesh-list
110929463|NCT03577977|Interferon-beta|interferon-beta|mesh-list
110929464|NCT03577977|Interferon beta-1b|interferon beta-1b|mesh-list
110929465|NCT03577977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110929466|NCT03577977|Antiviral Agents|antiviral agents|mesh-ancestor
110929467|NCT03577977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110277934|NCT00202020|Aspirin|aspirin|mesh-list
110929468|NCT03577977|Immunologic Factors|immunologic factors|mesh-ancestor
110929469|NCT03577977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110929470|NCT03577977|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110929471|NCT02668783|Ibuprofen|ibuprofen|mesh-list
110929472|NCT02668783|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110929473|NCT02668783|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110929474|NCT02668783|Etonogestrel|etonogestrel|mesh-list
110929475|NCT02668783|Estradiol|estradiol|mesh-list
110293156|NCT00235287|Enalapril|enalapril|mesh-list
110929476|NCT02668783|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110929477|NCT02668783|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110929478|NCT02668783|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110929479|NCT02668783|Analgesics|analgesics|mesh-ancestor
110929480|NCT02668783|Sensory System Agents|sensory system agents|mesh-ancestor
110929481|NCT02668783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110929482|NCT02668783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110929483|NCT02668783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110929484|NCT02668783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110929485|NCT02668783|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110929486|NCT02668783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110929487|NCT02668783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110293208|NCT04572724|Valsartan|valsartan|mesh-list
110929488|NCT02668783|Estrogens|estrogens|mesh-ancestor
110929489|NCT02668783|Hormones|hormones|mesh-ancestor
110929490|NCT02668783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110929491|NCT02668783|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110929492|NCT02668783|Contraceptive Agents|contraceptive agents|mesh-ancestor
110929493|NCT02668783|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110929494|NCT02668783|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110929495|NCT05010304|Amoxicillin|amoxicillin|mesh-list
110929496|NCT05010304|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110929497|NCT05010304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110929499|NCT03577899|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110929500|NCT03577899|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110929501|NCT03577899|Growth Substances|growth substances|mesh-ancestor
110929502|NCT03577899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110929503|NCT03577899|Growth Inhibitors|growth inhibitors|mesh-ancestor
110929504|NCT03577899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110929505|NCT02175342|Tiotropium Bromide|tiotropium bromide|mesh-list
110929506|NCT02175342|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110929507|NCT02175342|Autonomic Agents|autonomic agents|mesh-ancestor
110929508|NCT02175342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110929509|NCT02175342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110929510|NCT02175342|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110929511|NCT02175342|Respiratory System Agents|respiratory system agents|mesh-ancestor
110929512|NCT02175342|Parasympatholytics|parasympatholytics|mesh-ancestor
110929513|NCT02175342|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110929514|NCT02175342|Cholinergic Agents|cholinergic agents|mesh-ancestor
110929515|NCT02175342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110929516|NCT02175342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110929517|NCT02171520|Dabigatran|dabigatran|mesh-list
110929518|NCT02171520|Antithrombins|antithrombins|mesh-ancestor
110929519|NCT02171520|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110929520|NCT02171520|Protease Inhibitors|protease inhibitors|mesh-ancestor
110929521|NCT02171520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110929522|NCT02171520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110929523|NCT02171520|Anticoagulants|anticoagulants|mesh-ancestor
110929524|NCT00092053|Ibandronic Acid|ibandronic acid|mesh-list
110929525|NCT00092053|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110929526|NCT00092053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110929528|NCT00101010|Cyclophosphamide|cyclophosphamide|mesh-list
110929529|NCT00101010|Rituximab|rituximab|mesh-list
110929530|NCT00101010|Doxorubicin|doxorubicin|mesh-list
110929531|NCT00101010|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110929532|NCT00101010|Vincristine|vincristine|mesh-list
110929533|NCT00101010|Lenograstim|lenograstim|mesh-list
110929534|NCT00101010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110277994|NCT00187005|Idarubicin|idarubicin|mesh-list
110293454|NCT00255996|Linezolid|linezolid|mesh-list
110929535|NCT00101010|Immunologic Factors|immunologic factors|mesh-ancestor
110929536|NCT00101010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110929537|NCT00101010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110929538|NCT00101010|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110929539|NCT00101010|Alkylating Agents|alkylating agents|mesh-ancestor
110929540|NCT00101010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110929541|NCT00101010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110929542|NCT00101010|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110929543|NCT00101010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110929544|NCT00101010|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110929545|NCT00101010|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110929546|NCT00101010|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110929547|NCT00101010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110929548|NCT00101010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110929549|NCT00101010|Glucocorticoids|glucocorticoids|mesh-ancestor
110929550|NCT00101010|Hormones|hormones|mesh-ancestor
110929551|NCT00101010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110929552|NCT00101010|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110929554|NCT00101010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110929555|NCT00101010|Tubulin Modulators|tubulin modulators|mesh-ancestor
110929556|NCT00101010|Antimitotic Agents|antimitotic agents|mesh-ancestor
110929557|NCT00101010|Mitosis Modulators|mitosis modulators|mesh-ancestor
110929558|NCT03539172|Apatinib|apatinib|mesh-list
110929559|NCT03539172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110929560|NCT03539172|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110929561|NCT03539172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110929562|NCT03539172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110929563|NCT03209401|Carboplatin|carboplatin|mesh-list
110929565|NCT03209401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110929566|NCT03209401|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110929567|NCT03209401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110929568|NCT03209401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110929569|NCT02175420|BCG Vaccine|bcg vaccine|mesh-list
110929570|NCT02175420|Immunologic Factors|immunologic factors|mesh-ancestor
110929571|NCT02175420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110929572|NCT02175420|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110929573|NCT04859764|Betamethasone|betamethasone|mesh-list
110929574|NCT04859764|Bupivacaine|bupivacaine|mesh-list
110647123|NCT04187703|Decitabine|decitabine|mesh-list
110929575|NCT04859764|Anesthetics, Local|anesthetics, local|mesh-ancestor
110929576|NCT04859764|Anesthetics|anesthetics|mesh-ancestor
110929577|NCT04859764|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110929578|NCT04859764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110929579|NCT04859764|Sensory System Agents|sensory system agents|mesh-ancestor
110929580|NCT04859764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110929581|NCT04859764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110929582|NCT04859764|Glucocorticoids|glucocorticoids|mesh-ancestor
110929584|NCT04859764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110929585|NCT04859764|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110929586|NCT04859764|Respiratory System Agents|respiratory system agents|mesh-ancestor
110929587|NCT02170740|Pantoprazole|pantoprazole|mesh-list
110929588|NCT02170740|Dabigatran|dabigatran|mesh-list
110929589|NCT02170740|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110929590|NCT02170740|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110929591|NCT02170740|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110929592|NCT02170740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110929593|NCT02170740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110929594|NCT02170740|Antithrombins|antithrombins|mesh-ancestor
110929595|NCT02170740|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110929596|NCT02170740|Protease Inhibitors|protease inhibitors|mesh-ancestor
110929597|NCT02170740|Anticoagulants|anticoagulants|mesh-ancestor
110929598|NCT02848599|Morphine|morphine|mesh-list
110929599|NCT02848599|Levobupivacaine|levobupivacaine|mesh-list
110929600|NCT02848599|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110929601|NCT02848599|Narcotics|narcotics|mesh-ancestor
110929602|NCT02848599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110929603|NCT02848599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110929604|NCT02848599|Analgesics|analgesics|mesh-ancestor
110929605|NCT02848599|Sensory System Agents|sensory system agents|mesh-ancestor
110929606|NCT02848599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110929607|NCT02848599|Anesthetics, Local|anesthetics, local|mesh-ancestor
110929608|NCT02848599|Anesthetics|anesthetics|mesh-ancestor
110929609|NCT02171598|Dabigatran|dabigatran|mesh-list
110929610|NCT02171598|Clopidogrel|clopidogrel|mesh-list
110929611|NCT02171598|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110929612|NCT02171598|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110929613|NCT02171598|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110929614|NCT02171598|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110929615|NCT02171598|Purinergic Agents|purinergic agents|mesh-ancestor
110929616|NCT02171598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110929617|NCT02171598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110929618|NCT02171598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110929619|NCT02171598|Antithrombins|antithrombins|mesh-ancestor
110929620|NCT02171598|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110929621|NCT02171598|Protease Inhibitors|protease inhibitors|mesh-ancestor
110929622|NCT02171598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110929623|NCT02171598|Anticoagulants|anticoagulants|mesh-ancestor
110929624|NCT03068962|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
110929625|NCT03068962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110278096|NCT00577837|Etidronic Acid|etidronic acid|mesh-list
110929627|NCT02171676|Afatinib|afatinib|mesh-list
110929628|NCT02171676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110929629|NCT02171676|Tubulin Modulators|tubulin modulators|mesh-ancestor
110929630|NCT02171676|Antimitotic Agents|antimitotic agents|mesh-ancestor
110929631|NCT02171676|Mitosis Modulators|mitosis modulators|mesh-ancestor
110929632|NCT02171676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110929633|NCT02171676|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110929634|NCT02171676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110929635|NCT03577743|Bevacizumab|bevacizumab|mesh-list
110929636|NCT03577743|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110278103|NCT00578149|Paclitaxel|paclitaxel|mesh-list
110929637|NCT03577743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110929638|NCT03577743|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110929639|NCT03577743|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110929640|NCT03577743|Growth Substances|growth substances|mesh-ancestor
110929641|NCT03577743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110929642|NCT03577743|Growth Inhibitors|growth inhibitors|mesh-ancestor
110929643|NCT04794790|Buprenorphine|buprenorphine|mesh-list
110929644|NCT04794790|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
110929645|NCT04794790|Naloxone|naloxone|mesh-list
110929646|NCT04794790|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110929647|NCT04794790|Narcotics|narcotics|mesh-ancestor
110929648|NCT04794790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110929649|NCT04794790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110647195|NCT02576327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110929650|NCT04794790|Analgesics|analgesics|mesh-ancestor
110929651|NCT04794790|Sensory System Agents|sensory system agents|mesh-ancestor
110929652|NCT04794790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110929653|NCT04794790|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110929656|NCT02171754|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110929657|NCT02171754|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110929658|NCT02171754|Protease Inhibitors|protease inhibitors|mesh-ancestor
110929659|NCT02171754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110929660|NCT02171754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110929661|NCT02171754|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110929662|NCT02171754|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110929663|NCT02171754|Antiviral Agents|antiviral agents|mesh-ancestor
110929664|NCT02171754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110929665|NCT02171754|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110929666|NCT02171754|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110929667|NCT02171754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110929668|NCT02171754|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110929669|NCT02171832|Olodaterol|olodaterol|mesh-list
110929670|NCT02171832|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110929671|NCT02171832|Autonomic Agents|autonomic agents|mesh-ancestor
110929672|NCT02171832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110929673|NCT02171832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110929674|NCT02171832|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110929675|NCT02171832|Respiratory System Agents|respiratory system agents|mesh-ancestor
110929676|NCT02171910|Doxapram|doxapram|mesh-list
110929677|NCT02171910|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110929678|NCT02171910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110929679|NCT02171910|Respiratory System Agents|respiratory system agents|mesh-ancestor
110929680|NCT02178306|Telmisartan|telmisartan|mesh-list
110929681|NCT02178306|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110929682|NCT02178306|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110929683|NCT02178306|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110929684|NCT02178306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110929685|NCT05729386|Metformin|metformin|mesh-list
110929686|NCT05729386|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110929687|NCT05729386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110929688|NCT05729308|Anesthetics|anesthetics|mesh-list
110929689|NCT05729308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110929690|NCT05729308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110929691|NCT00778999|Desogestrel|desogestrel|mesh-list
110929693|NCT00778999|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110929694|NCT00778999|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110929695|NCT00778999|Contraceptive Agents|contraceptive agents|mesh-ancestor
110929696|NCT00778999|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110929697|NCT00778999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110931463|NCT03397654|Pembrolizumab|pembrolizumab|mesh-list
110929698|NCT00778999|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110929699|NCT00778999|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110929700|NCT00778999|Progestins|progestins|mesh-ancestor
110929701|NCT00778999|Hormones|hormones|mesh-ancestor
110929702|NCT00778999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110929703|NCT02171988|Propranolol|propranolol|mesh-list
110929704|NCT02171988|Bisoprolol|bisoprolol|mesh-list
110929705|NCT02171988|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
110929706|NCT02171988|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110929707|NCT02171988|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110929708|NCT02171988|Adrenergic Agents|adrenergic agents|mesh-ancestor
110929709|NCT02171988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110929710|NCT02171988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110929711|NCT02171988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110929712|NCT02171988|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110929713|NCT02171988|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110929714|NCT02171988|Vasodilator Agents|vasodilator agents|mesh-ancestor
110929715|NCT02171988|Sympatholytics|sympatholytics|mesh-ancestor
110929716|NCT02171988|Autonomic Agents|autonomic agents|mesh-ancestor
110929717|NCT02171988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110929718|NCT02171988|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110929719|NCT02171988|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110929720|NCT02171988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110929721|NCT02171988|Cholinergic Agents|cholinergic agents|mesh-ancestor
110929723|NCT00725413|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110929724|NCT00725413|Contraceptive Agents|contraceptive agents|mesh-ancestor
110929725|NCT00725413|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110929726|NCT00725413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110929727|NCT00725413|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110929728|NCT00103038|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
110929729|NCT00103038|Hematinics|hematinics|mesh-ancestor
110929730|NCT00103038|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
110929731|NCT00103038|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110929732|NCT00620035|Etonogestrel|etonogestrel|mesh-list
110929733|NCT00620035|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110929734|NCT00620035|Contraceptive Agents|contraceptive agents|mesh-ancestor
110929735|NCT00620035|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110929736|NCT00620035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110929737|NCT00620035|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110929739|NCT02175888|Trace Elements|trace elements|mesh-ancestor
110929740|NCT02175888|Micronutrients|micronutrients|mesh-ancestor
110929741|NCT02175888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110929742|NCT05577637|Tacrolimus|tacrolimus|mesh-list
110929743|NCT05577637|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110929744|NCT05577637|Immunologic Factors|immunologic factors|mesh-ancestor
110929745|NCT05577637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110929746|NCT05577637|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110929747|NCT05577637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110929748|NCT05577637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110929749|NCT02176044|Nitroprusside|nitroprusside|mesh-list
110929750|NCT02176044|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110929751|NCT02176044|Vasodilator Agents|vasodilator agents|mesh-ancestor
110929752|NCT02176044|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
110929753|NCT02176044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110929754|NCT02176122|Meropenem|meropenem|mesh-list
110929755|NCT02176122|Tazobactam|tazobactam|mesh-list
110929756|NCT02176122|Piperacillin|piperacillin|mesh-list
110929757|NCT02176122|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
110929758|NCT02176122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110929759|NCT02176122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110929760|NCT02176122|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110929761|NCT02176122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110929762|NCT02176122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110929763|NCT04887064|Sotorasib|sotorasib|mesh-list
110278225|NCT00187161|Antiviral Agents|antiviral agents|mesh-ancestor
110929765|NCT04887064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110929766|NCT04887064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110929767|NCT04887064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110929768|NCT02967757|Liraglutide|liraglutide|mesh-list
110929769|NCT02967757|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110929770|NCT02967757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110929771|NCT02967757|Incretins|incretins|mesh-ancestor
110929772|NCT02967757|Hormones|hormones|mesh-ancestor
110929773|NCT02967757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110929774|NCT02261298|Nivolumab|nivolumab|mesh-list
110929775|NCT02261298|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110929776|NCT02261298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110929777|NCT02261298|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110929778|NCT02261298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110929779|NCT02176200|Fenoterol|fenoterol|mesh-list
110929780|NCT02176200|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
110929781|NCT02176200|Ipratropium|ipratropium|mesh-list
110929782|NCT02176200|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110929783|NCT02176200|Autonomic Agents|autonomic agents|mesh-ancestor
110929784|NCT02176200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110929785|NCT02176200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110929786|NCT02176200|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110929788|NCT02176200|Sympathomimetics|sympathomimetics|mesh-ancestor
110929789|NCT02176200|Tocolytic Agents|tocolytic agents|mesh-ancestor
110929790|NCT02176200|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110929791|NCT02176200|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110929792|NCT02176200|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110929793|NCT02176200|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110929794|NCT02176200|Adrenergic Agents|adrenergic agents|mesh-ancestor
110929795|NCT02176200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110929796|NCT02176200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110929797|NCT02176200|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110929798|NCT02176200|Cholinergic Agents|cholinergic agents|mesh-ancestor
110929799|NCT03537612|Clonidine|clonidine|mesh-list
110929801|NCT03537612|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110929802|NCT03537612|Narcotics|narcotics|mesh-ancestor
110929803|NCT03537612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110929804|NCT03537612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110929805|NCT03537612|Analgesics|analgesics|mesh-ancestor
110929806|NCT03537612|Sensory System Agents|sensory system agents|mesh-ancestor
110929807|NCT03537612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110929808|NCT03537612|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110929809|NCT03537612|Sympatholytics|sympatholytics|mesh-ancestor
110929810|NCT03537612|Autonomic Agents|autonomic agents|mesh-ancestor
110929811|NCT03537612|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110929812|NCT03537612|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110929813|NCT03537612|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110929814|NCT03537612|Adrenergic Agents|adrenergic agents|mesh-ancestor
110929815|NCT03537612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110929816|NCT03537612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110929817|NCT02172144|Moxifloxacin|moxifloxacin|mesh-list
110929818|NCT02172144|Olodaterol|olodaterol|mesh-list
110929819|NCT02172144|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110929820|NCT02172144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110929821|NCT02172144|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110929822|NCT02172144|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110929823|NCT02172144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110929824|NCT02172144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110929825|NCT02172144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110929826|NCT02172144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110929827|NCT02172144|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110929828|NCT02172144|Autonomic Agents|autonomic agents|mesh-ancestor
110929829|NCT02172144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110929830|NCT02172144|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110929831|NCT02172144|Respiratory System Agents|respiratory system agents|mesh-ancestor
110929832|NCT05729074|Pimecrolimus|pimecrolimus|mesh-list
110929833|NCT05729074|Varespladib methyl|varespladib methyl|mesh-list
110929834|NCT05729074|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110929835|NCT05729074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110929836|NCT05729074|Analgesics|analgesics|mesh-ancestor
110929837|NCT05729074|Sensory System Agents|sensory system agents|mesh-ancestor
110929838|NCT05729074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110929839|NCT05729074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110929840|NCT05729074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110929841|NCT05729074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110929842|NCT05729074|Dermatologic Agents|dermatologic agents|mesh-ancestor
110929843|NCT05729074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110929844|NCT05729074|Immunologic Factors|immunologic factors|mesh-ancestor
110929845|NCT05729074|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110929846|NCT05729074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110929847|NCT05729074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110929848|NCT05729074|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
110929849|NCT02176512|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110929850|NCT02176512|Telmisartan|telmisartan|mesh-list
110929851|NCT02176512|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110929852|NCT02176512|Diuretics|diuretics|mesh-ancestor
110929853|NCT02176512|Natriuretic Agents|natriuretic agents|mesh-ancestor
110929854|NCT02176512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110929855|NCT02176512|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110929856|NCT02176512|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110929857|NCT02176512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110929858|NCT02176512|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110931528|NCT04432714|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110929859|NCT02176512|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110929860|NCT03537534|Lidocaine|lidocaine|mesh-list
110929861|NCT03537534|Anesthetics, Local|anesthetics, local|mesh-ancestor
110929862|NCT03537534|Anesthetics|anesthetics|mesh-ancestor
110929863|NCT03537534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110929864|NCT03537534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110929865|NCT03537534|Sensory System Agents|sensory system agents|mesh-ancestor
110929866|NCT03537534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110929867|NCT03537534|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110929868|NCT03537534|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110929869|NCT03537534|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110929870|NCT03537534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110929871|NCT03537534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110929872|NCT03068650|Rindopepimut|rindopepimut|mesh-list
110929873|NCT03068650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110929874|NCT03068650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110929875|NCT04646005|Cemiplimab|cemiplimab|mesh-list
110929876|NCT04646005|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110929877|NCT04646005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110929878|NCT02757768|Tamsulosin|tamsulosin|mesh-list
110929879|NCT02757768|Mirabegron|mirabegron|mesh-list
110929880|NCT02757768|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110929881|NCT02757768|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110929882|NCT02757768|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110929883|NCT02757768|Adrenergic Agents|adrenergic agents|mesh-ancestor
110929884|NCT02757768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110929885|NCT02757768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110929886|NCT02757768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110929887|NCT02757768|Urological Agents|urological agents|mesh-ancestor
110929888|NCT02757768|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
110929889|NCT02757768|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110929890|NCT02757768|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110929891|NCT03066076|Propylthiouracil|propylthiouracil|mesh-list
110929892|NCT03066076|Antithyroid Agents|antithyroid agents|mesh-list
110929893|NCT03066076|Antimetabolites|antimetabolites|mesh-ancestor
110929894|NCT03066076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110929895|NCT03066076|Hormone Antagonists|hormone antagonists|mesh-ancestor
110929896|NCT03066076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110929897|NCT03066076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110929898|NCT05225077|Dapagliflozin|dapagliflozin|mesh-list
110929899|NCT05225077|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110929900|NCT05225077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110929901|NCT05225077|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110929902|NCT05225077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110929903|NCT03067792|Leucovorin|leucovorin|mesh-list
110929904|NCT03067792|Docetaxel|docetaxel|mesh-list
110929905|NCT03067792|Fluorouracil|fluorouracil|mesh-list
110929907|NCT03067792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110929908|NCT03067792|Tubulin Modulators|tubulin modulators|mesh-ancestor
110929909|NCT03067792|Antimitotic Agents|antimitotic agents|mesh-ancestor
110929910|NCT03067792|Mitosis Modulators|mitosis modulators|mesh-ancestor
110929911|NCT03067792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110929912|NCT03067792|Antimetabolites|antimetabolites|mesh-ancestor
110929913|NCT03067792|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110929914|NCT03067792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110929915|NCT03067792|Immunologic Factors|immunologic factors|mesh-ancestor
110929916|NCT03067792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110929917|NCT03067792|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110929918|NCT03067792|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110929919|NCT03067792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110929920|NCT03067792|Antidotes|antidotes|mesh-ancestor
110929921|NCT03067792|Protective Agents|protective agents|mesh-ancestor
110929922|NCT03067792|Vitamin B Complex|vitamin b complex|mesh-ancestor
110929923|NCT03067792|Vitamins|vitamins|mesh-ancestor
110929924|NCT03067792|Micronutrients|micronutrients|mesh-ancestor
110929925|NCT05224999|Nivolumab|nivolumab|mesh-list
110929926|NCT05224999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110929927|NCT05224999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110929928|NCT05224999|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110929929|NCT05224999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110929930|NCT03066154|Ritonavir|ritonavir|mesh-list
110929931|NCT03066154|Docetaxel|docetaxel|mesh-list
110929932|NCT03066154|Androgens|androgens|mesh-list
110929933|NCT03066154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110278406|NCT00181025|Melphalan|melphalan|mesh-list
110929934|NCT03066154|Tubulin Modulators|tubulin modulators|mesh-ancestor
110929935|NCT03066154|Antimitotic Agents|antimitotic agents|mesh-ancestor
110929936|NCT03066154|Mitosis Modulators|mitosis modulators|mesh-ancestor
110929937|NCT03066154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110929938|NCT03066154|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110929939|NCT03066154|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110929940|NCT03066154|Protease Inhibitors|protease inhibitors|mesh-ancestor
110929941|NCT03066154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110929942|NCT03066154|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110929943|NCT03066154|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110929944|NCT03066154|Antiviral Agents|antiviral agents|mesh-ancestor
110929945|NCT03066154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110929946|NCT03066154|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110647503|NCT00581555|Etanercept|etanercept|mesh-list
110929947|NCT03066154|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110929948|NCT03066154|Hormones|hormones|mesh-ancestor
110929949|NCT03066154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110929950|NCT03066154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110929951|NCT05224687|Daptomycin|daptomycin|mesh-list
110929952|NCT05224687|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110929953|NCT05224687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110929954|NCT02753946|Tazobactam|tazobactam|mesh-list
110929955|NCT02753946|Piperacillin|piperacillin|mesh-list
110929956|NCT02753946|Fosfomycin|fosfomycin|mesh-list
110929957|NCT02753946|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
110929958|NCT02753946|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110929959|NCT02753946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110929960|NCT02753946|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110931570|NCT03063892|Tranexamic Acid|tranexamic acid|mesh-list
110929961|NCT02753946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110929962|NCT02753946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110929964|NCT00431431|Androgen Antagonists|androgen antagonists|mesh-ancestor
110929965|NCT00431431|Hormone Antagonists|hormone antagonists|mesh-ancestor
110929966|NCT00431431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110929967|NCT00431431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110929968|NCT00431431|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110929969|NCT00431431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110929970|NCT00431431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110929971|NCT00431431|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110929972|NCT00431431|Anabolic Agents|anabolic agents|mesh-ancestor
110929973|NCT00431431|Hormones|hormones|mesh-ancestor
110929974|NCT02172222|Linagliptin|linagliptin|mesh-list
110929975|NCT02172222|Empagliflozin|empagliflozin|mesh-list
110278450|NCT00181220|Valproic Acid|valproic acid|mesh-list
110929976|NCT02172222|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110929977|NCT02172222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110929978|NCT02172222|Incretins|incretins|mesh-ancestor
110929980|NCT02172222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110929981|NCT02172222|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110929982|NCT02172222|Protease Inhibitors|protease inhibitors|mesh-ancestor
110929983|NCT02172222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110929984|NCT02172222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110929985|NCT02172222|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110929986|NCT03625219|Prednisone|prednisone|mesh-list
110929987|NCT03625219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110929988|NCT03625219|Glucocorticoids|glucocorticoids|mesh-ancestor
110929989|NCT03625219|Hormones|hormones|mesh-ancestor
110929990|NCT03625219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110929991|NCT03625219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110929992|NCT03625219|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110929993|NCT03625219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110929995|NCT03065842|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110929996|NCT03065842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110929997|NCT02179008|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110929998|NCT02179008|Latanoprost|latanoprost|mesh-list
110929999|NCT02179008|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110930000|NCT02172300|Tiotropium Bromide|tiotropium bromide|mesh-list
110930001|NCT02172300|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110931597|NCT05353101|Tobramycin|tobramycin|mesh-list
110930002|NCT02172300|Autonomic Agents|autonomic agents|mesh-ancestor
110930003|NCT02172300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110930004|NCT02172300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110930005|NCT02172300|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110930006|NCT02172300|Respiratory System Agents|respiratory system agents|mesh-ancestor
110930007|NCT02172300|Parasympatholytics|parasympatholytics|mesh-ancestor
110930008|NCT02172300|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110930009|NCT02172300|Cholinergic Agents|cholinergic agents|mesh-ancestor
110278478|NCT00181298|Memantine|memantine|mesh-list
110930010|NCT02172300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110930011|NCT02172300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110930012|NCT05223907|Propofol|propofol|mesh-list
110930013|NCT05223907|Etomidate|etomidate|mesh-list
110930014|NCT05223907|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110930015|NCT05223907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110930016|NCT05223907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110930017|NCT05223907|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110930018|NCT05223907|Anesthetics, General|anesthetics, general|mesh-ancestor
110930019|NCT05223907|Anesthetics|anesthetics|mesh-ancestor
110930020|NCT03065998|Baclofen|baclofen|mesh-list
110930021|NCT03065998|Opipramol|opipramol|mesh-list
110930022|NCT03065998|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110930023|NCT03065998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110930024|NCT03065998|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110930025|NCT03065998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110930026|NCT03065998|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
110930027|NCT03065998|GABA Agonists|gaba agonists|mesh-ancestor
110930028|NCT03065998|GABA Agents|gaba agents|mesh-ancestor
110930029|NCT03065998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110930030|NCT03065998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110930031|NCT03065998|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110930032|NCT03065998|Antidepressive Agents|antidepressive agents|mesh-ancestor
110930033|NCT03065998|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110930034|NCT03065998|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110278493|NCT00583258|Alfuzosin|alfuzosin|mesh-list
110930035|NCT03065998|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110930036|NCT03065998|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110930037|NCT03065998|Adrenergic Agents|adrenergic agents|mesh-ancestor
110930038|NCT02172378|Tiotropium Bromide|tiotropium bromide|mesh-list
110930039|NCT02172378|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110930040|NCT02172378|Autonomic Agents|autonomic agents|mesh-ancestor
110930041|NCT02172378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110278517|NCT04576390|Antiemetics|antiemetics|mesh-ancestor
110930042|NCT02172378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110930043|NCT02172378|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110930044|NCT02172378|Respiratory System Agents|respiratory system agents|mesh-ancestor
110930045|NCT02172378|Parasympatholytics|parasympatholytics|mesh-ancestor
110930046|NCT02172378|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110930047|NCT02172378|Cholinergic Agents|cholinergic agents|mesh-ancestor
110930048|NCT02172378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110930049|NCT02172378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110930050|NCT05728528|Factor VIII|factor viii|mesh-list
110930051|NCT05728528|Coagulants|coagulants|mesh-ancestor
110930052|NCT02256228|Ropivacaine|ropivacaine|mesh-list
110930053|NCT02256228|Anesthetics, Local|anesthetics, local|mesh-ancestor
110930054|NCT02256228|Anesthetics|anesthetics|mesh-ancestor
110930055|NCT02256228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110930056|NCT02256228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110930057|NCT02256228|Sensory System Agents|sensory system agents|mesh-ancestor
110930058|NCT02256228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110930059|NCT03067168|Bupivacaine|bupivacaine|mesh-list
110930060|NCT03067168|Anesthetics, Local|anesthetics, local|mesh-ancestor
110930061|NCT03067168|Anesthetics|anesthetics|mesh-ancestor
110930062|NCT03067168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110930063|NCT03067168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110930064|NCT03067168|Sensory System Agents|sensory system agents|mesh-ancestor
110930065|NCT03067168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110930066|NCT04774237|Brimonidine Tartrate|brimonidine tartrate|mesh-list
110930067|NCT04774237|Carbachol|carbachol|mesh-list
110930068|NCT04774237|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110930069|NCT04774237|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110930070|NCT04774237|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110930071|NCT04774237|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110930072|NCT04774237|Adrenergic Agents|adrenergic agents|mesh-ancestor
110930073|NCT04774237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110930074|NCT04774237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110930075|NCT04774237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110930076|NCT04774237|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110930077|NCT04774237|Miotics|miotics|mesh-ancestor
110930078|NCT04774237|Autonomic Agents|autonomic agents|mesh-ancestor
110930079|NCT04774237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110930080|NCT04774237|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110930081|NCT04774237|Cholinergic Agents|cholinergic agents|mesh-ancestor
110930082|NCT04774237|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110930083|NCT04774237|Analgesics|analgesics|mesh-ancestor
110930084|NCT04774237|Sensory System Agents|sensory system agents|mesh-ancestor
110278561|NCT00181688|Anastrozole|anastrozole|mesh-list
110930085|NCT04774237|Protective Agents|protective agents|mesh-ancestor
110930086|NCT02172456|Tiotropium Bromide|tiotropium bromide|mesh-list
110930087|NCT02172456|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110930088|NCT02172456|Autonomic Agents|autonomic agents|mesh-ancestor
110930089|NCT02172456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110930090|NCT02172456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110930091|NCT02172456|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110930092|NCT02172456|Respiratory System Agents|respiratory system agents|mesh-ancestor
110930093|NCT02172456|Parasympatholytics|parasympatholytics|mesh-ancestor
110930094|NCT02172456|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110930095|NCT02172456|Cholinergic Agents|cholinergic agents|mesh-ancestor
110930096|NCT02172456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110930097|NCT02172456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110930098|NCT02172534|Bromides|bromides|mesh-list
110930099|NCT02172534|Tiotropium Bromide|tiotropium bromide|mesh-list
110278567|NCT00181688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110930100|NCT02172534|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110930101|NCT02172534|Autonomic Agents|autonomic agents|mesh-ancestor
110930102|NCT02172534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110930103|NCT02172534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110930104|NCT02172534|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110930105|NCT02172534|Respiratory System Agents|respiratory system agents|mesh-ancestor
110930106|NCT02172534|Parasympatholytics|parasympatholytics|mesh-ancestor
110930107|NCT02172534|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110930108|NCT02172534|Cholinergic Agents|cholinergic agents|mesh-ancestor
110930109|NCT02172534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110930110|NCT02172534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110930111|NCT02172534|Anticonvulsants|anticonvulsants|mesh-ancestor
110930112|NCT04713631|Artesunate|artesunate|mesh-list
110930113|NCT04713631|Curcumin|curcumin|mesh-list
110930114|NCT04713631|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110930115|NCT04713631|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110930116|NCT04713631|Analgesics|analgesics|mesh-ancestor
110930117|NCT04713631|Sensory System Agents|sensory system agents|mesh-ancestor
110930118|NCT04713631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110930119|NCT04713631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110930120|NCT04713631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110930121|NCT04713631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110930122|NCT04713631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110930123|NCT04713631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110930124|NCT04713631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110930125|NCT04713631|Antimalarials|antimalarials|mesh-ancestor
110930126|NCT04713631|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110930127|NCT04713631|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110930128|NCT04713631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110930129|NCT04713631|Antiviral Agents|antiviral agents|mesh-ancestor
110930130|NCT04713631|Schistosomicides|schistosomicides|mesh-ancestor
110930131|NCT04713631|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110930132|NCT04713631|Anthelmintics|anthelmintics|mesh-ancestor
110930133|NCT04459078|Apatinib|apatinib|mesh-list
110930134|NCT04459078|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
110930135|NCT04459078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110930136|NCT04459078|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110930137|NCT04459078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110930138|NCT04459078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110930139|NCT04459078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110930140|NCT02756832|Alogliptin|alogliptin|mesh-list
110930141|NCT02756832|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110930142|NCT02756832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110930143|NCT02756832|Incretins|incretins|mesh-ancestor
110930144|NCT02756832|Hormones|hormones|mesh-ancestor
110930145|NCT02756832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110930146|NCT02756832|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110930147|NCT02756832|Protease Inhibitors|protease inhibitors|mesh-ancestor
110930148|NCT02756832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110930149|NCT02756832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110930150|NCT00108810|Ketoprofen|ketoprofen|mesh-list
110930151|NCT00108810|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110930152|NCT00108810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110930154|NCT00108810|Sensory System Agents|sensory system agents|mesh-ancestor
110930155|NCT00108810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110930156|NCT00108810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110930157|NCT00108810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110930158|NCT00108810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110930159|NCT00108810|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110930160|NCT00108810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110930161|NCT00108810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110930162|NCT05588284|Rivaroxaban|rivaroxaban|mesh-list
110930163|NCT05588284|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110930164|NCT05588284|Antithrombins|antithrombins|mesh-ancestor
110278633|NCT00181922|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110930166|NCT05588284|Protease Inhibitors|protease inhibitors|mesh-ancestor
110930167|NCT05588284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110930168|NCT05588284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110930169|NCT05588284|Anticoagulants|anticoagulants|mesh-ancestor
110930170|NCT02256150|Mizoribine|mizoribine|mesh-list
110647722|NCT00128843|Anastrozole|anastrozole|mesh-list
110930171|NCT02256150|Cyclophosphamide|cyclophosphamide|mesh-list
110930172|NCT02256150|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110930173|NCT02256150|Immunologic Factors|immunologic factors|mesh-ancestor
110930174|NCT02256150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110930175|NCT02256150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110930176|NCT02256150|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110930177|NCT02256150|Alkylating Agents|alkylating agents|mesh-ancestor
110930178|NCT02256150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110930179|NCT02256150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110930180|NCT02256150|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110930181|NCT02256150|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110930182|NCT02256150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110930183|NCT02256150|Analgesics|analgesics|mesh-ancestor
110930184|NCT02256150|Sensory System Agents|sensory system agents|mesh-ancestor
110930185|NCT02256150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110930186|NCT02256150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110930187|NCT02256150|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110930188|NCT02256150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110930189|NCT02256150|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110930190|NCT02256150|Antimalarials|antimalarials|mesh-ancestor
110930191|NCT02256150|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110930192|NCT02256150|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110930193|NCT02256150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110930195|NCT02177370|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110930196|NCT02177370|Autonomic Agents|autonomic agents|mesh-ancestor
110930197|NCT02177370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110930198|NCT02177370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110930199|NCT02177370|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110930200|NCT02177370|Respiratory System Agents|respiratory system agents|mesh-ancestor
110930201|NCT02177370|Sympathomimetics|sympathomimetics|mesh-ancestor
110930202|NCT02177370|Tocolytic Agents|tocolytic agents|mesh-ancestor
110930203|NCT02177370|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110930204|NCT02177370|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110930205|NCT02177370|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110930206|NCT02177370|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110930207|NCT02177370|Adrenergic Agents|adrenergic agents|mesh-ancestor
110930208|NCT02177370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110930209|NCT02177370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110930210|NCT03538704|Metformin|metformin|mesh-list
110930211|NCT03538704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110930212|NCT03538704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110930213|NCT02172768|Micafungin|micafungin|mesh-list
110930214|NCT02172768|Antifungal Agents|antifungal agents|mesh-ancestor
110930215|NCT02172768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110930216|NCT02172846|Paclitaxel|paclitaxel|mesh-list
110930217|NCT02172846|Carboplatin|carboplatin|mesh-list
110930218|NCT02172846|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110278690|NCT00584779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110930219|NCT02172846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110930220|NCT02172846|Tubulin Modulators|tubulin modulators|mesh-ancestor
110930221|NCT02172846|Antimitotic Agents|antimitotic agents|mesh-ancestor
110930222|NCT02172846|Mitosis Modulators|mitosis modulators|mesh-ancestor
110930223|NCT02172846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110930224|NCT00106626|Pemetrexed|pemetrexed|mesh-list
110930225|NCT00106626|Vorinostat|vorinostat|mesh-list
110930226|NCT00106626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110930227|NCT00106626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110930228|NCT00106626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110930229|NCT00106626|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110930230|NCT00106626|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110930231|NCT00106626|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110930232|NCT02177448|Enalapril|enalapril|mesh-list
110930233|NCT02177448|Enalaprilat|enalaprilat|mesh-list
110930234|NCT02177448|Telmisartan|telmisartan|mesh-list
110930235|NCT02177448|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110930236|NCT02177448|Protease Inhibitors|protease inhibitors|mesh-ancestor
110930237|NCT02177448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110930238|NCT02177448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110930239|NCT02177448|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110930240|NCT02177448|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110930241|NCT02177448|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110930242|NCT03537144|Acetaminophen|acetaminophen|mesh-list
110930243|NCT03537144|Indomethacin|indomethacin|mesh-list
110930244|NCT03537144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110647799|NCT01037387|Autonomic Agents|autonomic agents|mesh-ancestor
110930245|NCT03537144|Analgesics|analgesics|mesh-ancestor
110930246|NCT03537144|Sensory System Agents|sensory system agents|mesh-ancestor
110930247|NCT03537144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110930248|NCT03537144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110930249|NCT03537144|Antipyretics|antipyretics|mesh-ancestor
110930250|NCT03537144|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110930251|NCT03537144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110930252|NCT03537144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110930253|NCT03537144|Gout Suppressants|gout suppressants|mesh-ancestor
110930255|NCT03537144|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110930256|NCT03537144|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110930257|NCT03537144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110930258|NCT03537144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110930259|NCT03065764|Pembrolizumab|pembrolizumab|mesh-list
110930260|NCT03065764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110278727|NCT00585442|Vitamin D|vitamin d|mesh-list
110930261|NCT03065764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110930262|NCT03065764|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110930263|NCT03065764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110930264|NCT02755818|Heparin|heparin|mesh-list
110930265|NCT02755818|Calcium heparin|calcium heparin|mesh-list
110930266|NCT02755818|Anticoagulants|anticoagulants|mesh-ancestor
110930267|NCT02755818|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110930268|NCT02755818|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110930269|NCT02755818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110930270|NCT02177760|Sirolimus|sirolimus|mesh-list
110930271|NCT02177760|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110930272|NCT02177760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110930273|NCT02177760|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110930274|NCT02177760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110930275|NCT02177760|Antifungal Agents|antifungal agents|mesh-ancestor
110930276|NCT02177760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110930277|NCT02177760|Immunologic Factors|immunologic factors|mesh-ancestor
110930278|NCT02177760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110930279|NCT02173782|Fenoterol|fenoterol|mesh-list
110930280|NCT02173782|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
110930281|NCT02173782|Ipratropium|ipratropium|mesh-list
110930282|NCT02173782|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110930283|NCT02173782|Autonomic Agents|autonomic agents|mesh-ancestor
110930284|NCT02173782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110930285|NCT02173782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110930286|NCT02173782|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110930287|NCT02173782|Respiratory System Agents|respiratory system agents|mesh-ancestor
110930288|NCT02173782|Sympathomimetics|sympathomimetics|mesh-ancestor
110930289|NCT02173782|Tocolytic Agents|tocolytic agents|mesh-ancestor
110930290|NCT02173782|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110930291|NCT02173782|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110930292|NCT02173782|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110930293|NCT02173782|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110930294|NCT02173782|Adrenergic Agents|adrenergic agents|mesh-ancestor
110930295|NCT02173782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110930296|NCT02173782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110930297|NCT02173782|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110930298|NCT02173782|Cholinergic Agents|cholinergic agents|mesh-ancestor
110930299|NCT05717374|Dexamethasone|dexamethasone|mesh-list
110930300|NCT05717374|Dexamethasone acetate|dexamethasone acetate|mesh-list
110930301|NCT05717374|Methylprednisolone|methylprednisolone|mesh-list
110930302|NCT05717374|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110930303|NCT05717374|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110930304|NCT05717374|Prednisolone|prednisolone|mesh-list
110930305|NCT05717374|Prednisolone acetate|prednisolone acetate|mesh-list
110930306|NCT05717374|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110930307|NCT05717374|Prednisolone phosphate|prednisolone phosphate|mesh-list
110930308|NCT05717374|BB 1101|bb 1101|mesh-list
110930309|NCT05717374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110930310|NCT05717374|Antiemetics|antiemetics|mesh-ancestor
110930311|NCT05717374|Autonomic Agents|autonomic agents|mesh-ancestor
110930312|NCT05717374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110930313|NCT05717374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110930314|NCT05717374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110930315|NCT05717374|Glucocorticoids|glucocorticoids|mesh-ancestor
110930316|NCT05717374|Hormones|hormones|mesh-ancestor
110930317|NCT05717374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110930318|NCT05717374|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110930319|NCT05717374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110930320|NCT05717374|Protease Inhibitors|protease inhibitors|mesh-ancestor
110930321|NCT05717374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110930322|NCT05717374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110930323|NCT05717374|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110930324|NCT05717374|Protective Agents|protective agents|mesh-ancestor
110930325|NCT03537768|Levonorgestrel|levonorgestrel|mesh-list
110930326|NCT03537768|Ulipristal acetate|ulipristal acetate|mesh-list
110930327|NCT03537768|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110930328|NCT03537768|Contraceptive Agents|contraceptive agents|mesh-ancestor
110930329|NCT03537768|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110930330|NCT03537768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110930331|NCT03537768|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110930332|NCT03537768|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110930333|NCT03537768|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110930335|NCT02174094|Anticonvulsants|anticonvulsants|mesh-ancestor
110278809|NCT04575415|Bevacizumab|bevacizumab|mesh-list
110930337|NCT02174094|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110930338|NCT02174094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110930339|NCT02174094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110930340|NCT02174094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110930341|NCT02174094|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
110930342|NCT02174094|GABA Agonists|gaba agonists|mesh-ancestor
110930343|NCT02174094|GABA Agents|gaba agents|mesh-ancestor
110930344|NCT02174094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110930345|NCT02174094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110930346|NCT02174172|Interferons|interferons|mesh-list
110930347|NCT02174172|Interferon-alpha|interferon-alpha|mesh-list
110930348|NCT02174172|Interferon alpha-2|interferon alpha-2|mesh-list
110930349|NCT02174172|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110930351|NCT02174172|Ipilimumab|ipilimumab|mesh-list
110930352|NCT02174172|Atezolizumab|atezolizumab|mesh-list
110930353|NCT02174172|Obinutuzumab|obinutuzumab|mesh-list
110930354|NCT02174172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110278840|NCT00209625|Vitamins|vitamins|mesh-ancestor
110930355|NCT02174172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110930356|NCT02174172|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110930357|NCT02174172|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110930358|NCT02174172|Growth Substances|growth substances|mesh-ancestor
110930359|NCT02174172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110930360|NCT02174172|Growth Inhibitors|growth inhibitors|mesh-ancestor
110930361|NCT02174172|Antiviral Agents|antiviral agents|mesh-ancestor
110930362|NCT02174172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110930363|NCT02174172|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110930364|NCT02174172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110930365|NCT02174172|Immunologic Factors|immunologic factors|mesh-ancestor
110930366|NCT02180334|Acetaminophen|acetaminophen|mesh-list
110930367|NCT02180334|Linagliptin|linagliptin|mesh-list
110930368|NCT02180334|Mosapride|mosapride|mesh-list
110930369|NCT02180334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110930370|NCT02180334|Analgesics|analgesics|mesh-ancestor
110930371|NCT02180334|Sensory System Agents|sensory system agents|mesh-ancestor
110930372|NCT02180334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110930373|NCT02180334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110930374|NCT02180334|Antipyretics|antipyretics|mesh-ancestor
110930375|NCT02180334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110930376|NCT02180334|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110930378|NCT02180334|Hormones|hormones|mesh-ancestor
110930379|NCT02180334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110930380|NCT02180334|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110930381|NCT02180334|Protease Inhibitors|protease inhibitors|mesh-ancestor
110930382|NCT02180334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110930383|NCT02180334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110930384|NCT02180334|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110930385|NCT02180334|Serotonin Agents|serotonin agents|mesh-ancestor
110930386|NCT02180334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110930387|NCT02174250|Rifampin|rifampin|mesh-list
110930388|NCT02174250|Istradefylline|istradefylline|mesh-list
110930389|NCT02174250|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110930390|NCT02174250|Antitubercular Agents|antitubercular agents|mesh-ancestor
110930391|NCT02174250|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110930392|NCT02174250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110930393|NCT02174250|Leprostatic Agents|leprostatic agents|mesh-ancestor
110930394|NCT02174250|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110930395|NCT02174250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110930396|NCT02174250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110930397|NCT02174250|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110930398|NCT02174250|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110930399|NCT02174250|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110930400|NCT02174250|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110930401|NCT02174250|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110930402|NCT02174250|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110930403|NCT02174250|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
110930404|NCT02174250|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110930405|NCT02174250|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110930406|NCT02174250|Purinergic Agents|purinergic agents|mesh-ancestor
110278881|NCT00587119|Budesonide|budesonide|mesh-list
110930407|NCT02174250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110930408|NCT02174250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110930410|NCT02174328|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110930411|NCT02174328|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110930412|NCT02174328|Analgesics|analgesics|mesh-ancestor
110930413|NCT02174328|Sensory System Agents|sensory system agents|mesh-ancestor
110930414|NCT02174328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110930415|NCT02174328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110930416|NCT02174328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110930418|NCT02174328|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110930419|NCT02174328|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110930420|NCT02174328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110930421|NCT02174328|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110930422|NCT02174328|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110930423|NCT02174328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110930424|NCT02174328|Antipyretics|antipyretics|mesh-ancestor
110930425|NCT02177994|Ceftriaxone|ceftriaxone|mesh-list
110930426|NCT02177994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110930427|NCT02177994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110930428|NCT02755116|Olanzapine|olanzapine|mesh-list
110930429|NCT02755116|Antiemetics|antiemetics|mesh-ancestor
110930430|NCT02755116|Autonomic Agents|autonomic agents|mesh-ancestor
110930431|NCT02755116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110930432|NCT02755116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110278900|NCT00182351|Hemostatics|hemostatics|mesh-ancestor
110930433|NCT02755116|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110930434|NCT02755116|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110930435|NCT02755116|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110930436|NCT02755116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110930437|NCT02755116|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110930438|NCT02755116|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110930439|NCT02755116|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110930440|NCT02755116|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110930441|NCT02755116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110930442|NCT02755116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110930443|NCT02755116|Serotonin Agents|serotonin agents|mesh-ancestor
110930444|NCT02178150|Magnesium Oxide|magnesium oxide|mesh-list
110930445|NCT02178150|Antacids|antacids|mesh-ancestor
110534638|NCT00643734|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110278926|NCT04575103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110278927|NCT04575103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110278928|NCT04575103|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110278929|NCT00587548|Diethylenetriamine|diethylenetriamine|mesh-list
110278930|NCT00587548|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
110930446|NCT02178150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110930447|NCT02178150|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110930448|NCT04411030|Itraconazole|itraconazole|mesh-list
110930449|NCT04411030|Midazolam|midazolam|mesh-list
110930450|NCT04411030|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110930451|NCT04411030|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110930452|NCT04411030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110930453|NCT04411030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110930454|NCT04411030|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110930455|NCT04411030|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110930456|NCT04411030|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110930457|NCT04411030|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110930458|NCT04411030|Anesthetics, General|anesthetics, general|mesh-ancestor
110930459|NCT04411030|Anesthetics|anesthetics|mesh-ancestor
110930460|NCT04411030|GABA Modulators|gaba modulators|mesh-ancestor
110930461|NCT04411030|GABA Agents|gaba agents|mesh-ancestor
110930462|NCT04411030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110930463|NCT04411030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110930464|NCT04411030|Antifungal Agents|antifungal agents|mesh-ancestor
110930465|NCT04411030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110930466|NCT04411030|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110930467|NCT04411030|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110930469|NCT04411030|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110930470|NCT04411030|Hormone Antagonists|hormone antagonists|mesh-ancestor
110930471|NCT04411030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110930472|NCT04411030|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110930474|NCT04437654|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110930475|NCT04437654|Antithrombins|antithrombins|mesh-ancestor
110930476|NCT04437654|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110930477|NCT04437654|Protease Inhibitors|protease inhibitors|mesh-ancestor
110930478|NCT04437654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110930479|NCT04437654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110930480|NCT04437654|Anticoagulants|anticoagulants|mesh-ancestor
110930481|NCT02185638|Appetite Depressants|appetite depressants|mesh-list
110930482|NCT02185638|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110930483|NCT02185716|Levobupivacaine|levobupivacaine|mesh-list
110930484|NCT02185716|Anesthetics, Local|anesthetics, local|mesh-ancestor
110930485|NCT02185716|Anesthetics|anesthetics|mesh-ancestor
110930486|NCT02185716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110930487|NCT02185716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110930488|NCT02185716|Sensory System Agents|sensory system agents|mesh-ancestor
110930489|NCT02185716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110930490|NCT02182050|Nintedanib|nintedanib|mesh-list
110930491|NCT02182050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110278957|NCT00182429|Antitubercular Agents|antitubercular agents|mesh-ancestor
110278958|NCT00182429|Leprostatic Agents|leprostatic agents|mesh-ancestor
110278959|NCT00182429|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110278960|NCT00182429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110278961|NCT00182429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110278962|NCT00182429|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110278963|NCT00182429|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110278964|NCT00182429|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110278968|NCT00216645|Doxorubicin|doxorubicin|mesh-list
110930492|NCT02182050|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110930493|NCT02182050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110930494|NCT02182050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110930495|NCT02182128|Nintedanib|nintedanib|mesh-list
110930496|NCT02182128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110930497|NCT02182128|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110930498|NCT02182128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110930499|NCT02182128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110930500|NCT02182206|Nintedanib|nintedanib|mesh-list
110930501|NCT02182206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110930502|NCT02182206|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110930503|NCT02182206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110930504|NCT02182206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110930505|NCT03963544|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
110930506|NCT03963544|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110930507|NCT03963544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110930508|NCT03963544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110930509|NCT02180568|Ethiodized Oil|ethiodized oil|mesh-list
110930510|NCT02180568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110930511|NCT02657889|Pembrolizumab|pembrolizumab|mesh-list
110930512|NCT02657889|Niraparib|niraparib|mesh-list
110930513|NCT02657889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110930514|NCT02657889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110930515|NCT02657889|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110931790|NCT02184078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110930516|NCT02657889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110930517|NCT02657889|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110930518|NCT02657889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110930519|NCT03536208|Warfarin|warfarin|mesh-list
110930520|NCT03536208|Anticoagulants|anticoagulants|mesh-ancestor
110930521|NCT03034915|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110930522|NCT03034915|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110930523|NCT03034915|Autonomic Agents|autonomic agents|mesh-ancestor
110930524|NCT03034915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110930525|NCT03034915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110930526|NCT03034915|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110930527|NCT03034915|Respiratory System Agents|respiratory system agents|mesh-ancestor
110930528|NCT03034915|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110930529|NCT03034915|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110930530|NCT03034915|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110930531|NCT03034915|Adrenergic Agents|adrenergic agents|mesh-ancestor
110930532|NCT03034915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110930533|NCT03034915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110930534|NCT02631538|Rituximab|rituximab|mesh-list
110930535|NCT02631538|Belimumab|belimumab|mesh-list
110930536|NCT02631538|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110930537|NCT02631538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110930538|NCT02631538|Immunologic Factors|immunologic factors|mesh-ancestor
110930539|NCT02631538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110930540|NCT02631538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110930541|NCT02631538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110930542|NCT03578679|Ivermectin|ivermectin|mesh-list
110930543|NCT03578679|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110930544|NCT03578679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110930545|NCT04930783|Nivolumab|nivolumab|mesh-list
110930546|NCT04930783|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110278988|NCT00216684|Fentanyl|fentanyl|mesh-list
110930560|NCT02256462|Adalimumab|adalimumab|mesh-list
110930561|NCT02256462|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110930562|NCT02256462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110930563|NCT02256462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110930564|NCT02631148|Melatonin|melatonin|mesh-list
110930565|NCT02631148|Antioxidants|antioxidants|mesh-ancestor
110930566|NCT02631148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110930567|NCT02631148|Protective Agents|protective agents|mesh-ancestor
110930568|NCT02631148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110930569|NCT02631148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110930570|NCT02239107|Acetylcysteine|acetylcysteine|mesh-list
110930571|NCT02239107|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110930572|NCT02239107|Antiviral Agents|antiviral agents|mesh-ancestor
110930573|NCT02239107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110930574|NCT02239107|Expectorants|expectorants|mesh-ancestor
110930575|NCT02239107|Respiratory System Agents|respiratory system agents|mesh-ancestor
110930576|NCT02239107|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110930577|NCT02239107|Antioxidants|antioxidants|mesh-ancestor
110930578|NCT02239107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110930579|NCT02239107|Protective Agents|protective agents|mesh-ancestor
110930580|NCT02239107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110930581|NCT02239107|Antidotes|antidotes|mesh-ancestor
110930582|NCT02182518|Pseudoephedrine|pseudoephedrine|mesh-list
110930583|NCT02182518|Ephedrine|ephedrine|mesh-list
110930584|NCT02182518|Epinastine|epinastine|mesh-list
110930585|NCT02182518|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110930586|NCT02182518|Autonomic Agents|autonomic agents|mesh-ancestor
110930587|NCT02182518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110930588|NCT02182518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110278989|NCT00216684|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110930589|NCT02182518|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110930590|NCT02182518|Respiratory System Agents|respiratory system agents|mesh-ancestor
110930591|NCT02182518|Nasal Decongestants|nasal decongestants|mesh-ancestor
110930592|NCT02182518|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110930593|NCT02182518|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110930594|NCT02182518|Sympathomimetics|sympathomimetics|mesh-ancestor
110930595|NCT02182518|Adrenergic Agents|adrenergic agents|mesh-ancestor
110930596|NCT02182518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110930597|NCT02182518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110930598|NCT02182518|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110930599|NCT02182518|Histamine Antagonists|histamine antagonists|mesh-ancestor
110930600|NCT02182518|Histamine Agents|histamine agents|mesh-ancestor
110930601|NCT03881488|Pembrolizumab|pembrolizumab|mesh-list
110930602|NCT03881488|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110279020|NCT00182507|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110930603|NCT03881488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110930604|NCT03881488|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110930605|NCT03881488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110930606|NCT05486182|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
110930607|NCT05486182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110930608|NCT03574857|Metolazone|metolazone|mesh-list
110930609|NCT03574857|Chlorothiazide|chlorothiazide|mesh-list
110930610|NCT03574857|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110930611|NCT03574857|Diuretics|diuretics|mesh-ancestor
110930612|NCT03574857|Natriuretic Agents|natriuretic agents|mesh-ancestor
110930613|NCT03574857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110930614|NCT03574857|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110930615|NCT03574857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110930616|NCT03574857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110930617|NCT02238639|Fibrin fragment D|fibrin fragment d|mesh-list
110930618|NCT02238639|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110930620|NCT02238639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110930621|NCT02238639|Hemostatics|hemostatics|mesh-ancestor
110930622|NCT02238639|Coagulants|coagulants|mesh-ancestor
110930623|NCT02186028|Vitamin D|vitamin d|mesh-list
110930624|NCT02186028|Vitamins|vitamins|mesh-ancestor
110930625|NCT02186028|Micronutrients|micronutrients|mesh-ancestor
110930626|NCT02186028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110930627|NCT02186028|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110930628|NCT02182596|Gemtuzumab|gemtuzumab|mesh-list
110930629|NCT02182596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110930630|NCT02182596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110930631|NCT02182596|Immunotoxins|immunotoxins|mesh-ancestor
110930632|NCT02182596|Immunoconjugates|immunoconjugates|mesh-ancestor
110930633|NCT02182596|Immunologic Factors|immunologic factors|mesh-ancestor
110930634|NCT02182596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110930635|NCT03574701|Vitamin A|vitamin a|mesh-list
110930636|NCT03574701|Vitamins|vitamins|mesh-ancestor
110930637|NCT03574701|Micronutrients|micronutrients|mesh-ancestor
110930638|NCT03574701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110930639|NCT02180880|Pregabalin|pregabalin|mesh-list
110930640|NCT02180880|Oxcarbazepine|oxcarbazepine|mesh-list
110930641|NCT02180880|Analgesics|analgesics|mesh-ancestor
110930642|NCT02180880|Sensory System Agents|sensory system agents|mesh-ancestor
110930643|NCT02180880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110930644|NCT02180880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110930645|NCT02180880|Anticonvulsants|anticonvulsants|mesh-ancestor
110930646|NCT02180880|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110930647|NCT02180880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110930648|NCT02180880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110930649|NCT02180880|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110930650|NCT02180880|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110930651|NCT02180880|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110930652|NCT02180880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110930653|NCT02180880|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110930654|NCT02180880|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110930655|NCT02180880|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110930656|NCT02180880|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110930657|NCT02180880|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110930658|NCT02186106|Cholecalciferol|cholecalciferol|mesh-list
110930659|NCT02186106|Vitamin D|vitamin d|mesh-list
110930660|NCT02186106|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110930661|NCT02186106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110930662|NCT02186106|Vitamins|vitamins|mesh-ancestor
110930663|NCT02186106|Micronutrients|micronutrients|mesh-ancestor
110930664|NCT02186106|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110930665|NCT03943147|Mycophenolic Acid|mycophenolic acid|mesh-list
110930666|NCT03943147|Deucravacitinib|deucravacitinib|mesh-list
110930667|NCT03943147|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110930668|NCT03943147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110930669|NCT03943147|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110930670|NCT03943147|Antitubercular Agents|antitubercular agents|mesh-ancestor
110930671|NCT03943147|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110930672|NCT03943147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110930673|NCT03943147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110279040|NCT00209742|Immunologic Factors|immunologic factors|mesh-ancestor
110930674|NCT03943147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110930676|NCT03943147|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110930677|NCT02182752|Tramadol|tramadol|mesh-list
110930678|NCT02182752|Ropivacaine|ropivacaine|mesh-list
110930679|NCT02182752|Anesthetics, Local|anesthetics, local|mesh-ancestor
110930680|NCT02182752|Anesthetics|anesthetics|mesh-ancestor
110931875|NCT02184312|Nevirapine|nevirapine|mesh-list
110930681|NCT02182752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110930682|NCT02182752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110930683|NCT02182752|Sensory System Agents|sensory system agents|mesh-ancestor
110930684|NCT02182752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110930685|NCT02182752|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110930686|NCT02182752|Narcotics|narcotics|mesh-ancestor
110930687|NCT02182752|Analgesics|analgesics|mesh-ancestor
110930688|NCT03536598|Amlodipine|amlodipine|mesh-list
110930689|NCT03536598|Valsartan|valsartan|mesh-list
110930690|NCT03536598|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110930691|NCT03536598|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110930692|NCT03536598|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110930693|NCT03536598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110930694|NCT03536598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110930695|NCT03536598|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110930696|NCT03536598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110930697|NCT03536598|Vasodilator Agents|vasodilator agents|mesh-ancestor
110930698|NCT03536598|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110930699|NCT03536598|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110930700|NCT03536598|Antimetabolites|antimetabolites|mesh-ancestor
110930701|NCT03536598|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110930702|NCT03536598|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110930703|NCT03536598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110930704|NCT03536598|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110930705|NCT03536598|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110930706|NCT03576963|Nivolumab|nivolumab|mesh-list
110930707|NCT03576963|Guadecitabine|guadecitabine|mesh-list
110930708|NCT03576963|Azacitidine|azacitidine|mesh-list
110930709|NCT03576963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110930710|NCT03576963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110930711|NCT03576963|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110930712|NCT03576963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110930713|NCT03576963|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110930715|NCT03576963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110930716|NCT02186496|Amlodipine|amlodipine|mesh-list
110930717|NCT02186496|Candesartan|candesartan|mesh-list
110930718|NCT02186496|Candesartan cilexetil|candesartan cilexetil|mesh-list
110930719|NCT02186496|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110930720|NCT02186496|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110930721|NCT02186496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110930722|NCT02186496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110930723|NCT02186496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110930724|NCT02186496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110930725|NCT02186496|Vasodilator Agents|vasodilator agents|mesh-ancestor
110930726|NCT02186496|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110930727|NCT02186496|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110930728|NCT05615194|Dexmedetomidine|dexmedetomidine|mesh-list
110930729|NCT05615194|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110930730|NCT05615194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110930731|NCT05615194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110930732|NCT05615194|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110930733|NCT05615194|Analgesics|analgesics|mesh-ancestor
110930734|NCT05615194|Sensory System Agents|sensory system agents|mesh-ancestor
110930735|NCT05615194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110930736|NCT05615194|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110930737|NCT05615194|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110930738|NCT05615194|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110930739|NCT05615194|Adrenergic Agents|adrenergic agents|mesh-ancestor
110930740|NCT05615194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110930741|NCT05615194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110930742|NCT02186574|Tenofovir|tenofovir|mesh-list
110930743|NCT02186574|Antiviral Agents|antiviral agents|mesh-ancestor
110930744|NCT02186574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110930745|NCT02186574|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110930746|NCT02186574|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110930747|NCT02186574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110930748|NCT02186574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110930749|NCT02186574|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110930750|NCT02186574|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110930751|NCT03066700|Hemostatics|hemostatics|mesh-list
110930752|NCT03066700|Coagulants|coagulants|mesh-ancestor
110930753|NCT03066544|Dexamethasone|dexamethasone|mesh-list
110930754|NCT03066544|Ketorolac|ketorolac|mesh-list
110930755|NCT03066544|Naratriptan|naratriptan|mesh-list
110930756|NCT03066544|Bupivacaine|bupivacaine|mesh-list
110930757|NCT03066544|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110930758|NCT03066544|Antiemetics|antiemetics|mesh-ancestor
110930759|NCT03066544|Autonomic Agents|autonomic agents|mesh-ancestor
110930760|NCT03066544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110930761|NCT03066544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110930762|NCT03066544|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110930763|NCT03066544|Glucocorticoids|glucocorticoids|mesh-ancestor
110930765|NCT03066544|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110930766|NCT03066544|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110930767|NCT03066544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110930768|NCT03066544|Anesthetics, Local|anesthetics, local|mesh-ancestor
110930769|NCT03066544|Anesthetics|anesthetics|mesh-ancestor
110930770|NCT03066544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110930771|NCT03066544|Sensory System Agents|sensory system agents|mesh-ancestor
110930772|NCT03066544|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110930773|NCT03066544|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110930774|NCT03066544|Analgesics|analgesics|mesh-ancestor
110930775|NCT03066544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110930776|NCT03066544|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110930777|NCT03066544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110930778|NCT03066544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110930779|NCT03066544|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110930780|NCT03066544|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110930781|NCT03066544|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110930782|NCT03066544|Serotonin Agents|serotonin agents|mesh-ancestor
110930783|NCT03066544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110930784|NCT03182179|Ondansetron|ondansetron|mesh-list
110279083|NCT00182663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110279084|NCT00182663|Glucocorticoids|glucocorticoids|mesh-ancestor
110930786|NCT03182179|Autonomic Agents|autonomic agents|mesh-ancestor
110930787|NCT03182179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110930788|NCT03182179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110930789|NCT03182179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110930790|NCT03182179|Antipruritics|antipruritics|mesh-ancestor
110930791|NCT03182179|Dermatologic Agents|dermatologic agents|mesh-ancestor
110930792|NCT03182179|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110930793|NCT03182179|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110930794|NCT03182179|Serotonin Agents|serotonin agents|mesh-ancestor
110930795|NCT03182179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110930796|NCT03182179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110930797|NCT03576651|Bevacizumab|bevacizumab|mesh-list
110930798|NCT03576651|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110930799|NCT03576651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110931894|NCT02191332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110930800|NCT03576651|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110930801|NCT03576651|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110930802|NCT03576651|Growth Substances|growth substances|mesh-ancestor
110930803|NCT03576651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110930804|NCT03576651|Growth Inhibitors|growth inhibitors|mesh-ancestor
110930806|NCT04116112|Hydralazine|hydralazine|mesh-list
110930807|NCT04116112|Nicardipine|nicardipine|mesh-list
110930808|NCT04116112|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110930809|NCT04116112|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110930810|NCT04116112|Adrenergic Agents|adrenergic agents|mesh-ancestor
110930811|NCT04116112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110930812|NCT04116112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110930813|NCT04116112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110930814|NCT04116112|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110930815|NCT04116112|Sympathomimetics|sympathomimetics|mesh-ancestor
110930817|NCT04116112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110930818|NCT04116112|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110930819|NCT04116112|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110930820|NCT04116112|Vasodilator Agents|vasodilator agents|mesh-ancestor
110930821|NCT04116112|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110930822|NCT04116112|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110930823|NCT04116112|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110930824|NCT03064906|Pancrelipase|pancrelipase|mesh-list
110930825|NCT03064906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110930826|NCT03034135|Copper|copper|mesh-list
110930827|NCT03034135|Temozolomide|temozolomide|mesh-list
110930828|NCT03034135|Disulfiram|disulfiram|mesh-list
110930829|NCT03034135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110930830|NCT03034135|Alkylating Agents|alkylating agents|mesh-ancestor
110930831|NCT03034135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110930832|NCT03034135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110930833|NCT03034135|Trace Elements|trace elements|mesh-ancestor
110930834|NCT03034135|Micronutrients|micronutrients|mesh-ancestor
110930835|NCT03034135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110930836|NCT03034135|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110930837|NCT03034135|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
110930838|NCT03034135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110930839|NCT02239731|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110930840|NCT02239731|Doxycycline|doxycycline|mesh-list
110930841|NCT02239731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110930842|NCT02239731|Antimalarials|antimalarials|mesh-ancestor
110930843|NCT02239731|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110930844|NCT02239731|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110930846|NCT03571815|Fluorides|fluorides|mesh-list
110930847|NCT03571815|Sodium Fluoride|sodium fluoride|mesh-list
110930848|NCT03571815|Fluorides, Topical|fluorides, topical|mesh-list
110930849|NCT03571815|Cariostatic Agents|cariostatic agents|mesh-ancestor
110930850|NCT03571815|Protective Agents|protective agents|mesh-ancestor
110930851|NCT03571815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110930852|NCT03571815|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110930853|NCT03571815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110930854|NCT03571737|Ibuprofen|ibuprofen|mesh-list
110930855|NCT03571737|Lidocaine|lidocaine|mesh-list
110930856|NCT03571737|Anesthetics, Local|anesthetics, local|mesh-ancestor
110930857|NCT03571737|Anesthetics|anesthetics|mesh-ancestor
110930858|NCT03571737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110930859|NCT03571737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110930860|NCT03571737|Sensory System Agents|sensory system agents|mesh-ancestor
110931917|NCT02189304|Budesonide|budesonide|mesh-list
110930861|NCT03571737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110930862|NCT03571737|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110930863|NCT03571737|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110930864|NCT03571737|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110930865|NCT03571737|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110930866|NCT03571737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110930867|NCT03571737|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110930868|NCT03571737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110930869|NCT03571737|Analgesics|analgesics|mesh-ancestor
110930870|NCT03571737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110930871|NCT03571737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110930872|NCT03571737|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110930873|NCT03571737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110930874|NCT03573999|Mannitol|mannitol|mesh-list
110930875|NCT03573999|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110930876|NCT03573999|Diuretics|diuretics|mesh-ancestor
110930877|NCT03573999|Natriuretic Agents|natriuretic agents|mesh-ancestor
110930878|NCT03573999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110930879|NCT03063190|Vitamin D|vitamin d|mesh-list
110930880|NCT03063190|Vitamins|vitamins|mesh-ancestor
110930881|NCT03063190|Micronutrients|micronutrients|mesh-ancestor
110930882|NCT03063190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110930883|NCT03063190|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110930884|NCT03573687|Caseins|caseins|mesh-list
110930885|NCT03573687|Chelating Agents|chelating agents|mesh-ancestor
110930886|NCT03573687|Sequestering Agents|sequestering agents|mesh-ancestor
110279129|NCT00588835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110930887|NCT03573687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110930888|NCT01671280|Azithromycin|azithromycin|mesh-list
110930889|NCT01671280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110930890|NCT01671280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110930891|NCT03575637|Olanzapine|olanzapine|mesh-list
110930892|NCT03575637|Antiemetics|antiemetics|mesh-ancestor
110930893|NCT03575637|Autonomic Agents|autonomic agents|mesh-ancestor
110930894|NCT03575637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110930895|NCT03575637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110930896|NCT03575637|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110930897|NCT03575637|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110930898|NCT03575637|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110930899|NCT03575637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110930900|NCT03575637|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110930901|NCT03575637|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110930902|NCT03575637|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110930903|NCT03575637|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110930904|NCT03575637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110930905|NCT03575637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110930906|NCT03575637|Serotonin Agents|serotonin agents|mesh-ancestor
110930907|NCT03062800|Thalidomide|thalidomide|mesh-list
110930908|NCT03062800|Carboplatin|carboplatin|mesh-list
110930909|NCT03062800|Pemetrexed|pemetrexed|mesh-list
110930911|NCT03062800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110930912|NCT03062800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110930913|NCT03062800|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110930914|NCT03062800|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110930915|NCT03062800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110930916|NCT03062800|Immunologic Factors|immunologic factors|mesh-ancestor
110930917|NCT03062800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110930918|NCT03062800|Leprostatic Agents|leprostatic agents|mesh-ancestor
110930919|NCT03062800|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110930921|NCT03062800|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110930922|NCT03062800|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110930923|NCT03062800|Growth Substances|growth substances|mesh-ancestor
110279162|NCT00209859|Hormones|hormones|mesh-ancestor
110930953|NCT03572829|Aprepitant|aprepitant|mesh-list
110930954|NCT03572829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110930955|NCT03572829|Antiemetics|antiemetics|mesh-ancestor
110930956|NCT03572829|Autonomic Agents|autonomic agents|mesh-ancestor
110930957|NCT03572829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110930958|NCT03572829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110930959|NCT03572829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110930961|NCT03572829|Hormones|hormones|mesh-ancestor
110930962|NCT03572829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110930963|NCT03572829|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110930964|NCT03572829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110930965|NCT03572829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110930966|NCT03572829|Antipruritics|antipruritics|mesh-ancestor
110930967|NCT03572829|Dermatologic Agents|dermatologic agents|mesh-ancestor
110930968|NCT03572829|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110930969|NCT03572829|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110930970|NCT03572829|Serotonin Agents|serotonin agents|mesh-ancestor
110930971|NCT03572829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110930972|NCT03572829|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110930973|NCT03575247|Glucocorticoids|glucocorticoids|mesh-list
110930975|NCT03575247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110930976|NCT03575247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110930977|NCT03704623|Acetaminophen|acetaminophen|mesh-list
110930978|NCT03704623|Parecoxib|parecoxib|mesh-list
110930979|NCT03704623|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110930980|NCT03704623|Analgesics|analgesics|mesh-ancestor
110930981|NCT03704623|Sensory System Agents|sensory system agents|mesh-ancestor
110279212|NCT00589264|Copper|copper|mesh-list
110930983|NCT03704623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110930984|NCT03704623|Antipyretics|antipyretics|mesh-ancestor
110930985|NCT03704623|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110930986|NCT03704623|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110930987|NCT03704623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110930988|NCT03704623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110930989|NCT03704623|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110930990|NCT03704623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110930991|NCT03704623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110930992|NCT03572595|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110930993|NCT03572595|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110930994|NCT03572595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110930996|NCT03572517|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110930997|NCT03572517|Narcotics|narcotics|mesh-ancestor
110930998|NCT03572517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110930999|NCT03572517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110931000|NCT03572517|Analgesics|analgesics|mesh-ancestor
110931001|NCT03572517|Sensory System Agents|sensory system agents|mesh-ancestor
110931002|NCT03572517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110931003|NCT03570645|Dexamethasone|dexamethasone|mesh-list
110931004|NCT03570645|Dexmedetomidine|dexmedetomidine|mesh-list
110931005|NCT03570645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110931006|NCT03570645|Antiemetics|antiemetics|mesh-ancestor
110931007|NCT03570645|Autonomic Agents|autonomic agents|mesh-ancestor
110931008|NCT03570645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110931009|NCT03570645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110931010|NCT03570645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110931011|NCT03570645|Glucocorticoids|glucocorticoids|mesh-ancestor
110931012|NCT03570645|Hormones|hormones|mesh-ancestor
110534639|NCT00643734|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110931013|NCT03570645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110931014|NCT03570645|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110931015|NCT03570645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110931016|NCT03570645|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110931017|NCT03570645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110931018|NCT03570645|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110931019|NCT03570645|Analgesics|analgesics|mesh-ancestor
110931020|NCT03570645|Sensory System Agents|sensory system agents|mesh-ancestor
110931021|NCT03570645|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110931022|NCT03570645|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110931023|NCT03570645|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110931024|NCT03570645|Adrenergic Agents|adrenergic agents|mesh-ancestor
110931025|NCT03570645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110931026|NCT03570645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110931028|NCT03940690|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110931029|NCT03940690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110931030|NCT03940690|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110931031|NCT03940690|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110931032|NCT03940690|Growth Substances|growth substances|mesh-ancestor
110931033|NCT03940690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110931034|NCT03940690|Growth Inhibitors|growth inhibitors|mesh-ancestor
110931035|NCT03567135|Temozolomide|temozolomide|mesh-list
110931036|NCT03567135|Apatinib|apatinib|mesh-list
110931037|NCT03567135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110931038|NCT03567135|Alkylating Agents|alkylating agents|mesh-ancestor
110931039|NCT03567135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110931040|NCT03567135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110931041|NCT03567135|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110931042|NCT03567135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110931043|NCT03698383|Trastuzumab|trastuzumab|mesh-list
110931044|NCT03698383|Gedatolisib|gedatolisib|mesh-list
110931045|NCT03698383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110931046|NCT03698383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110931047|NCT03698383|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110931048|NCT03698383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110931049|NCT03698383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110931050|NCT04760782|Abaloparatide|abaloparatide|mesh-list
110931051|NCT04760782|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110279276|NCT00209937|Gaboxadol|gaboxadol|mesh-list
110931052|NCT04760782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110931053|NCT04740580|Acetylcysteine|acetylcysteine|mesh-list
110931962|NCT03702205|Betaine|betaine|mesh-list
110931055|NCT04740580|Glycine|glycine|mesh-list
110931056|NCT04740580|Antiviral Agents|antiviral agents|mesh-ancestor
110931057|NCT04740580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110931058|NCT04740580|Expectorants|expectorants|mesh-ancestor
110931059|NCT04740580|Respiratory System Agents|respiratory system agents|mesh-ancestor
110931060|NCT04740580|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110931061|NCT04740580|Antioxidants|antioxidants|mesh-ancestor
110931062|NCT04740580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110931063|NCT04740580|Protective Agents|protective agents|mesh-ancestor
110931064|NCT04740580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110931065|NCT04740580|Antidotes|antidotes|mesh-ancestor
110931066|NCT04740580|Glycine Agents|glycine agents|mesh-ancestor
110931067|NCT04740580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110931068|NCT03064282|Papaverine|papaverine|mesh-list
110931069|NCT03064282|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110931070|NCT03064282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110931071|NCT03064282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110931072|NCT03064282|Vasodilator Agents|vasodilator agents|mesh-ancestor
110931073|NCT03064282|Urological Agents|urological agents|mesh-ancestor
110931074|NCT04679818|Fentanyl|fentanyl|mesh-list
110297245|NCT04541251|Paclitaxel|paclitaxel|mesh-list
110931075|NCT04679818|Analgesics, Opioid|analgesics, opioid|mesh-list
110931076|NCT04679818|Narcotics|narcotics|mesh-ancestor
110931077|NCT04679818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110931078|NCT04679818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110931079|NCT04679818|Analgesics|analgesics|mesh-ancestor
110931080|NCT04679818|Sensory System Agents|sensory system agents|mesh-ancestor
110931081|NCT04679818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110931082|NCT04679818|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110931083|NCT04679818|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110931084|NCT04679818|Anesthetics, General|anesthetics, general|mesh-ancestor
110931085|NCT04679818|Anesthetics|anesthetics|mesh-ancestor
110931086|NCT03027609|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110931087|NCT03027609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110931088|NCT03063112|Ethanol|ethanol|mesh-list
110931089|NCT03063112|Lidocaine|lidocaine|mesh-list
110279313|NCT04574791|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110931090|NCT03063112|Anesthetics, Local|anesthetics, local|mesh-ancestor
110931091|NCT03063112|Anesthetics|anesthetics|mesh-ancestor
110931092|NCT03063112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110931093|NCT03063112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110931094|NCT03063112|Sensory System Agents|sensory system agents|mesh-ancestor
110931095|NCT03063112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110931096|NCT03063112|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110931097|NCT03063112|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110931098|NCT03063112|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110931099|NCT03063112|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110931100|NCT03063112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110931101|NCT03063112|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110931102|NCT03063112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110931103|NCT04767217|Lumefantrine|lumefantrine|mesh-list
110931104|NCT04767217|Artemether|artemether|mesh-list
110931105|NCT04767217|Piperaquine|piperaquine|mesh-list
110931106|NCT04767217|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
110931107|NCT04767217|Artenimol|artenimol|mesh-list
110931108|NCT04767217|Antimalarials|antimalarials|mesh-ancestor
110931109|NCT04767217|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110931110|NCT04767217|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110931111|NCT04767217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110931112|NCT03701503|Hormones|hormones|mesh-list
110931113|NCT03701503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110931114|NCT03701503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110931115|NCT03704155|Botulinum Toxins|botulinum toxins|mesh-list
110931116|NCT03704155|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110931117|NCT03704155|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110931972|NCT03698851|Sympathomimetics|sympathomimetics|mesh-ancestor
110931118|NCT03704155|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110931119|NCT03704155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110931120|NCT03704155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110931121|NCT03704155|Cholinergic Agents|cholinergic agents|mesh-ancestor
110931122|NCT03704155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110931123|NCT03704155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110931124|NCT03704155|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110931125|NCT03704155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110931126|NCT03698227|Doxorubicin|doxorubicin|mesh-list
110931127|NCT03698227|Dexrazoxane|dexrazoxane|mesh-list
110931129|NCT03698227|Olaratumab|olaratumab|mesh-list
110931130|NCT03698227|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110931131|NCT03698227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110931132|NCT03698227|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110931133|NCT03698227|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110931134|NCT03698227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110931135|NCT03698227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110931136|NCT03698227|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110931137|NCT03698227|Protective Agents|protective agents|mesh-ancestor
110931138|NCT03698227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110931139|NCT03698227|Antimitotic Agents|antimitotic agents|mesh-ancestor
110931140|NCT03698227|Mitosis Modulators|mitosis modulators|mesh-ancestor
110931141|NCT01342965|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110931142|NCT01342965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110931143|NCT01342965|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110931144|NCT01342965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110931145|NCT01342965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110931147|NCT02181348|Vitamins|vitamins|mesh-ancestor
110931148|NCT02181348|Micronutrients|micronutrients|mesh-ancestor
110931149|NCT02181348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110931150|NCT02181348|Antioxidants|antioxidants|mesh-ancestor
110931151|NCT02181348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110931152|NCT02181348|Protective Agents|protective agents|mesh-ancestor
110931153|NCT02186886|Golimumab|golimumab|mesh-list
110931154|NCT02186886|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110931155|NCT02186886|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110931156|NCT02186886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110931157|NCT02186886|Immunologic Factors|immunologic factors|mesh-ancestor
110931158|NCT02186886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110931159|NCT03722680|Riluzole|riluzole|mesh-list
110931160|NCT03722680|Anticonvulsants|anticonvulsants|mesh-ancestor
110931161|NCT03722680|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110931162|NCT03722680|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110931163|NCT03722680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110931164|NCT03722680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110931165|NCT03722680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110931166|NCT03722680|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110931167|NCT03722680|Protective Agents|protective agents|mesh-ancestor
110931168|NCT02182986|Immunosuppressive Agents|immunosuppressive agents|mesh-list
110931169|NCT02182986|Immunologic Factors|immunologic factors|mesh-ancestor
110931170|NCT02182986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110931171|NCT03536910|Arginine Vasopressin|arginine vasopressin|mesh-list
110931172|NCT03536910|Hemostatics|hemostatics|mesh-ancestor
110931173|NCT03536910|Coagulants|coagulants|mesh-ancestor
110931174|NCT03536910|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110931175|NCT03536910|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
110931176|NCT03536910|Natriuretic Agents|natriuretic agents|mesh-ancestor
110931177|NCT03536910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110931178|NCT04308174|Durvalumab|durvalumab|mesh-list
110931179|NCT04308174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110931180|NCT04308174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110931181|NCT03697681|Tranexamic Acid|tranexamic acid|mesh-list
110931182|NCT03697681|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110931183|NCT03697681|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110931184|NCT03697681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110931185|NCT03697681|Hemostatics|hemostatics|mesh-ancestor
110931186|NCT03697681|Coagulants|coagulants|mesh-ancestor
110931187|NCT02187276|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
110931188|NCT02187276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110931189|NCT02187276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110931190|NCT02187276|Cholinergic Agents|cholinergic agents|mesh-ancestor
110931191|NCT02187276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110931192|NCT02187276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110931193|NCT02683239|Fasinumab|fasinumab|mesh-list
110931194|NCT02683239|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110931195|NCT02683239|Analgesics|analgesics|mesh-ancestor
110931196|NCT02683239|Sensory System Agents|sensory system agents|mesh-ancestor
110931197|NCT02683239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110931198|NCT02683239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110931199|NCT02183064|Meloxicam|meloxicam|mesh-list
110931200|NCT02183064|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110931201|NCT02183064|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110931202|NCT02183064|Analgesics|analgesics|mesh-ancestor
110931203|NCT02183064|Sensory System Agents|sensory system agents|mesh-ancestor
110931204|NCT02183064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110931205|NCT02183064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110931206|NCT02183064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110931207|NCT02183064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110931208|NCT02183064|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110931209|NCT02183064|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110931210|NCT02183064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110534640|NCT00643734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110279432|NCT00217152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110931211|NCT02183064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110931212|NCT03704077|Paclitaxel|paclitaxel|mesh-list
110931213|NCT03704077|Nivolumab|nivolumab|mesh-list
110931214|NCT03704077|Ramucirumab|ramucirumab|mesh-list
110931215|NCT03704077|Relatlimab|relatlimab|mesh-list
110931216|NCT03704077|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110931217|NCT03704077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110931218|NCT03704077|Tubulin Modulators|tubulin modulators|mesh-ancestor
110931219|NCT03704077|Antimitotic Agents|antimitotic agents|mesh-ancestor
110931220|NCT03704077|Mitosis Modulators|mitosis modulators|mesh-ancestor
110931221|NCT03704077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110931223|NCT03704077|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110931224|NCT02183142|Meloxicam|meloxicam|mesh-list
110932002|NCT02192424|Insulin|insulin|mesh-list
110931225|NCT02183142|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110931226|NCT02183142|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110931227|NCT02183142|Analgesics|analgesics|mesh-ancestor
110931228|NCT02183142|Sensory System Agents|sensory system agents|mesh-ancestor
110931229|NCT02183142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110931230|NCT02183142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110931231|NCT02183142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110931232|NCT02183142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110931233|NCT02183142|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110931234|NCT02183142|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110931235|NCT02183142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110931236|NCT02183142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110931238|NCT02183220|Dipyrone|dipyrone|mesh-list
110931239|NCT02183220|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110931240|NCT02183220|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110931241|NCT02183220|Analgesics|analgesics|mesh-ancestor
110931242|NCT02183220|Sensory System Agents|sensory system agents|mesh-ancestor
110931243|NCT02183220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110931244|NCT02183220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110931245|NCT02183220|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110279473|NCT00476008|Memantine|memantine|mesh-list
110931246|NCT02183220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110931247|NCT02183220|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110931248|NCT02183220|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110931249|NCT02183220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110931250|NCT02183220|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110931251|NCT02183220|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110931252|NCT02183220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110931253|NCT02183220|Antipyretics|antipyretics|mesh-ancestor
110931254|NCT02187588|Ibuprofen|ibuprofen|mesh-list
110931255|NCT02187588|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110931256|NCT02187588|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110931257|NCT02187588|Analgesics|analgesics|mesh-ancestor
110931258|NCT02187588|Sensory System Agents|sensory system agents|mesh-ancestor
110931259|NCT02187588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110931260|NCT02187588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110931261|NCT02187588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110931262|NCT02187588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110931263|NCT02187588|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110931264|NCT02187588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110931265|NCT02187588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110931266|NCT05364489|Bevacizumab|bevacizumab|mesh-list
110931267|NCT05364489|Oxaliplatin|oxaliplatin|mesh-list
110931268|NCT05364489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110931269|NCT05364489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110931270|NCT05364489|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110931271|NCT05364489|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110931272|NCT05364489|Growth Substances|growth substances|mesh-ancestor
110931273|NCT05364489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110931274|NCT05364489|Growth Inhibitors|growth inhibitors|mesh-ancestor
110931275|NCT02183298|Linagliptin|linagliptin|mesh-list
110931276|NCT02183298|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110931277|NCT02183298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110931278|NCT02183298|Incretins|incretins|mesh-ancestor
110931279|NCT02183298|Hormones|hormones|mesh-ancestor
110931280|NCT02183298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110931281|NCT02183298|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110931282|NCT02183298|Protease Inhibitors|protease inhibitors|mesh-ancestor
110931283|NCT02183298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110931284|NCT02183298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110931285|NCT03697057|Anesthetics|anesthetics|mesh-list
110931286|NCT03697057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110931287|NCT03697057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110931289|NCT02183376|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110279514|NCT00183911|Vitamins|vitamins|mesh-ancestor
110931290|NCT02183376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110931292|NCT02183376|Hormones|hormones|mesh-ancestor
110648848|NCT00606008|Sunitinib|sunitinib|mesh-list
110931293|NCT02183376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110931294|NCT02183376|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110931295|NCT02183376|Protease Inhibitors|protease inhibitors|mesh-ancestor
110931296|NCT02183376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110225496|NCT05952713|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110931297|NCT02183376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110931298|NCT02187822|Taxane|taxane|mesh-list
110931299|NCT02187822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110931300|NCT03696901|Dalbavancin|dalbavancin|mesh-list
110931301|NCT03696901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110931302|NCT03696901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110931303|NCT02187900|Mycophenolic Acid|mycophenolic acid|mesh-list
110931304|NCT02187900|Cardiac Glycosides|cardiac glycosides|mesh-list
110931305|NCT02187900|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110931306|NCT02187900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110931307|NCT02187900|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110931308|NCT02187900|Antitubercular Agents|antitubercular agents|mesh-ancestor
110931309|NCT02187900|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110225534|NCT05925023|Sirolimus|sirolimus|mesh-list
110931310|NCT02187900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110931311|NCT02187900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110931312|NCT02187900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110931313|NCT02187900|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110931314|NCT02187900|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110931315|NCT02187900|Protective Agents|protective agents|mesh-ancestor
110931316|NCT02187900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110931317|NCT03062644|Celecoxib|celecoxib|mesh-list
110931318|NCT03062644|Tramadol|tramadol|mesh-list
110931319|NCT03062644|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110225624|NCT05888493|Prednisone|prednisone|mesh-list
110931320|NCT03062644|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110931321|NCT03062644|Analgesics|analgesics|mesh-ancestor
110931322|NCT03062644|Sensory System Agents|sensory system agents|mesh-ancestor
110931323|NCT03062644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110931324|NCT03062644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110931325|NCT03062644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110931326|NCT03062644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110932035|NCT04412707|Dexamethasone|dexamethasone|mesh-list
110931327|NCT03062644|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110931328|NCT03062644|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110931329|NCT03062644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110931330|NCT03062644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110931331|NCT03062644|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110931332|NCT03062644|Narcotics|narcotics|mesh-ancestor
110931333|NCT03062644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110931334|NCT02190318|Losartan|losartan|mesh-list
110931335|NCT02190318|Spironolactone|spironolactone|mesh-list
110931336|NCT02190318|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110931337|NCT02190318|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110931338|NCT02190318|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110931339|NCT02190318|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110279564|NCT00183950|Noscapine|noscapine|mesh-list
110931340|NCT02190318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110931341|NCT02190318|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110931342|NCT02190318|Hormone Antagonists|hormone antagonists|mesh-ancestor
110931343|NCT02190318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110931344|NCT02190318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110931345|NCT02190318|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110931346|NCT02190318|Diuretics|diuretics|mesh-ancestor
110931347|NCT02190318|Natriuretic Agents|natriuretic agents|mesh-ancestor
110931348|NCT04743661|Antipyretics|antipyretics|mesh-list
110931349|NCT04743661|Dexamethasone|dexamethasone|mesh-list
110931350|NCT04743661|Bevacizumab|bevacizumab|mesh-list
110931351|NCT04743661|Irinotecan|irinotecan|mesh-list
110931352|NCT04743661|Temozolomide|temozolomide|mesh-list
110931353|NCT04743661|Antiemetics|antiemetics|mesh-list
110931354|NCT04743661|Emetics|emetics|mesh-list
110931355|NCT04743661|Histamine Antagonists|histamine antagonists|mesh-list
110931356|NCT04743661|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
110931357|NCT04743661|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110931358|NCT04743661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110931359|NCT04743661|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110931360|NCT04743661|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110931361|NCT04743661|Growth Substances|growth substances|mesh-ancestor
110931362|NCT04743661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110931363|NCT04743661|Growth Inhibitors|growth inhibitors|mesh-ancestor
110931364|NCT04743661|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110931365|NCT04743661|Autonomic Agents|autonomic agents|mesh-ancestor
110931366|NCT04743661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110931367|NCT04743661|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110931368|NCT04743661|Glucocorticoids|glucocorticoids|mesh-ancestor
110931369|NCT04743661|Hormones|hormones|mesh-ancestor
110298224|NCT04532671|Ether|ether|mesh-list
110226079|NCT05688098|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110931370|NCT04743661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110931371|NCT04743661|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110931372|NCT04743661|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110931373|NCT04743661|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110931374|NCT04743661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110931375|NCT04743661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110931376|NCT04743661|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110931377|NCT04743661|Alkylating Agents|alkylating agents|mesh-ancestor
110931378|NCT04743661|Histamine Agents|histamine agents|mesh-ancestor
110931379|NCT04743661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110931380|NCT02183532|Linagliptin|linagliptin|mesh-list
110931381|NCT02183532|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110931382|NCT02183532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110931384|NCT02183532|Hormones|hormones|mesh-ancestor
110931385|NCT02183532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110932073|NCT03698617|Propofol|propofol|mesh-list
110931386|NCT02183532|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110931387|NCT02183532|Protease Inhibitors|protease inhibitors|mesh-ancestor
110931388|NCT02183532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110931389|NCT02183532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110931390|NCT03569631|BPN14770|bpn14770|mesh-list
110279626|NCT00210444|Cholinergic Agents|cholinergic agents|mesh-ancestor
110931391|NCT03569631|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
110931392|NCT03569631|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110931393|NCT03569631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110931394|NCT03569631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110931396|NCT02629822|Lamivudine|lamivudine|mesh-list
110931397|NCT02629822|Antiviral Agents|antiviral agents|mesh-ancestor
110931398|NCT02629822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110931399|NCT02629822|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110931400|NCT02629822|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110931401|NCT02629822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110279633|NCT00475306|Metoclopramide|metoclopramide|mesh-list
110931402|NCT02629822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110931403|NCT02629822|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110931404|NCT02629822|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110931405|NCT03700801|Insulin|insulin|mesh-list
110931406|NCT03700801|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110931407|NCT03700801|Metformin|metformin|mesh-list
110931408|NCT03700801|Dapagliflozin|dapagliflozin|mesh-list
110931409|NCT03700801|Insulin Aspart|insulin aspart|mesh-list
110931410|NCT03700801|Saxagliptin|saxagliptin|mesh-list
110931411|NCT03700801|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110931412|NCT03700801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110931413|NCT03700801|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110931414|NCT03700801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110931415|NCT03700801|Incretins|incretins|mesh-ancestor
110931416|NCT03700801|Hormones|hormones|mesh-ancestor
110279645|NCT00475306|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110931417|NCT03700801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110931418|NCT03700801|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110931419|NCT03700801|Protease Inhibitors|protease inhibitors|mesh-ancestor
110931420|NCT03700801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110931421|NCT03700645|Allopurinol|allopurinol|mesh-list
110931422|NCT03700645|Antimetabolites|antimetabolites|mesh-ancestor
110931423|NCT03700645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110931424|NCT03700645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110931425|NCT03700645|Gout Suppressants|gout suppressants|mesh-ancestor
110931426|NCT03700645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110931427|NCT03700645|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110931428|NCT03700645|Antioxidants|antioxidants|mesh-ancestor
110931429|NCT03700645|Protective Agents|protective agents|mesh-ancestor
110279664|NCT00183989|Rituximab|rituximab|mesh-list
110931430|NCT03700645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110931431|NCT04499053|Durvalumab|durvalumab|mesh-list
110931432|NCT04499053|Tremelimumab|tremelimumab|mesh-list
110931433|NCT04499053|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110931434|NCT04499053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110931435|NCT03567681|Oxcarbazepine|oxcarbazepine|mesh-list
110931436|NCT03567681|Anticonvulsants|anticonvulsants|mesh-ancestor
110931437|NCT03567681|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110931438|NCT03567681|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110931439|NCT03567681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110931440|NCT03567681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110931441|NCT03567681|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110931442|NCT03567681|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110931443|NCT03567447|Droxidopa|droxidopa|mesh-list
110931444|NCT03567447|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110931445|NCT03567447|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110931446|NCT03567369|Dexamethasone|dexamethasone|mesh-list
110931447|NCT03567369|Dexamethasone acetate|dexamethasone acetate|mesh-list
110931448|NCT03567369|BB 1101|bb 1101|mesh-list
110931449|NCT03567369|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110931450|NCT03567369|Antiemetics|antiemetics|mesh-ancestor
110931451|NCT03567369|Autonomic Agents|autonomic agents|mesh-ancestor
110931452|NCT03567369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110931453|NCT03567369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110931454|NCT03567369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110931455|NCT03567369|Glucocorticoids|glucocorticoids|mesh-ancestor
110931456|NCT03567369|Hormones|hormones|mesh-ancestor
110931457|NCT03567369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110931458|NCT03567369|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110931459|NCT03567369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110931460|NCT03567369|Protease Inhibitors|protease inhibitors|mesh-ancestor
110931461|NCT03567369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110931462|NCT03567369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110931464|NCT03397654|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110931465|NCT03397654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110931466|NCT03397654|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110931467|NCT03397654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110931468|NCT03266146|Methylprednisolone|methylprednisolone|mesh-list
110931469|NCT03266146|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110931470|NCT03266146|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110931471|NCT03266146|Prednisolone|prednisolone|mesh-list
110931472|NCT03266146|Prednisolone acetate|prednisolone acetate|mesh-list
110931473|NCT03266146|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110931474|NCT03266146|Prednisolone phosphate|prednisolone phosphate|mesh-list
110931475|NCT03266146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110931476|NCT03266146|Antiemetics|antiemetics|mesh-ancestor
110931477|NCT03266146|Autonomic Agents|autonomic agents|mesh-ancestor
110931478|NCT03266146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110279704|NCT00210561|Tramadol|tramadol|mesh-list
110931479|NCT03266146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110931480|NCT03266146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110931481|NCT03266146|Glucocorticoids|glucocorticoids|mesh-ancestor
110931482|NCT03266146|Hormones|hormones|mesh-ancestor
110931483|NCT03266146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110931484|NCT03266146|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110931485|NCT03266146|Protective Agents|protective agents|mesh-ancestor
110931486|NCT03266146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110931487|NCT03266146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110931488|NCT03700489|Titanium dioxide|titanium dioxide|mesh-list
110931489|NCT03700489|Sunscreening Agents|sunscreening agents|mesh-ancestor
110931490|NCT03700489|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110931491|NCT03700489|Protective Agents|protective agents|mesh-ancestor
110931492|NCT03700489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110931493|NCT03700489|Dermatologic Agents|dermatologic agents|mesh-ancestor
110931494|NCT03700489|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110931495|NCT02800941|Warfarin|warfarin|mesh-list
110931496|NCT02800941|Anticoagulants|anticoagulants|mesh-list
110931497|NCT02800941|Acenocoumarol|acenocoumarol|mesh-list
110931498|NCT02800941|Fluindione|fluindione|mesh-list
110931499|NCT03695887|Nitrous Oxide|nitrous oxide|mesh-list
110931500|NCT03695887|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110931501|NCT03695887|Anesthetics, General|anesthetics, general|mesh-ancestor
110931502|NCT03695887|Anesthetics|anesthetics|mesh-ancestor
110931503|NCT03695887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110931504|NCT03695887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110931505|NCT03695887|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110931506|NCT03695887|Analgesics|analgesics|mesh-ancestor
110279725|NCT00217386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110931507|NCT03695887|Sensory System Agents|sensory system agents|mesh-ancestor
110931508|NCT03695887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110931509|NCT04432714|Prednisone|prednisone|mesh-list
110931510|NCT04432714|Cyclophosphamide|cyclophosphamide|mesh-list
110931511|NCT04432714|Rituximab|rituximab|mesh-list
110931512|NCT04432714|Doxorubicin|doxorubicin|mesh-list
110931513|NCT04432714|Etoposide|etoposide|mesh-list
110931514|NCT04432714|Vincristine|vincristine|mesh-list
110931515|NCT04432714|Lenalidomide|lenalidomide|mesh-list
110931516|NCT04432714|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110649068|NCT00722033|Sensory System Agents|sensory system agents|mesh-ancestor
110931517|NCT04432714|Immunologic Factors|immunologic factors|mesh-ancestor
110931518|NCT04432714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110931519|NCT04432714|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110931520|NCT04432714|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110931521|NCT04432714|Alkylating Agents|alkylating agents|mesh-ancestor
110931522|NCT04432714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110931523|NCT04432714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110931524|NCT04432714|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110931525|NCT04432714|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110931526|NCT04432714|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110931527|NCT04432714|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110931529|NCT04432714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110931530|NCT04432714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110931531|NCT04432714|Glucocorticoids|glucocorticoids|mesh-ancestor
110931532|NCT04432714|Hormones|hormones|mesh-ancestor
110931533|NCT04432714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110931534|NCT04432714|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110931535|NCT04432714|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110931536|NCT04432714|Tubulin Modulators|tubulin modulators|mesh-ancestor
110931537|NCT04432714|Antimitotic Agents|antimitotic agents|mesh-ancestor
110931538|NCT04432714|Mitosis Modulators|mitosis modulators|mesh-ancestor
110931539|NCT04432714|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110298811|NCT04177433|Hormones|hormones|mesh-ancestor
110931540|NCT04432714|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110931541|NCT04432714|Growth Substances|growth substances|mesh-ancestor
110931542|NCT04432714|Growth Inhibitors|growth inhibitors|mesh-ancestor
110931543|NCT02752074|Pembrolizumab|pembrolizumab|mesh-list
110931544|NCT02752074|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110931545|NCT02752074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110931546|NCT02752074|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110931547|NCT02752074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110931548|NCT03564795|Sulfadiazine|sulfadiazine|mesh-list
110931549|NCT03564795|Silver Sulfadiazine|silver sulfadiazine|mesh-list
110931550|NCT03564795|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110931551|NCT03564795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110931552|NCT03564795|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110931553|NCT03564795|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110931554|NCT03564795|Coccidiostats|coccidiostats|mesh-ancestor
110931555|NCT03564795|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110931556|NCT03624595|Dexmedetomidine|dexmedetomidine|mesh-list
110931557|NCT03624595|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110931558|NCT03624595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110931559|NCT03624595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110931560|NCT03624595|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110931561|NCT03624595|Analgesics|analgesics|mesh-ancestor
110931562|NCT03624595|Sensory System Agents|sensory system agents|mesh-ancestor
110931563|NCT03624595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110931564|NCT03624595|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110931565|NCT03624595|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110931566|NCT03624595|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110931567|NCT03624595|Adrenergic Agents|adrenergic agents|mesh-ancestor
110931568|NCT03624595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110931569|NCT03624595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110931571|NCT03063892|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110931572|NCT03063892|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110931573|NCT03063892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110931574|NCT03063892|Hemostatics|hemostatics|mesh-ancestor
110931575|NCT03063892|Coagulants|coagulants|mesh-ancestor
110226771|NCT05342519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110931576|NCT03063580|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
110931577|NCT03063580|Rifampin|rifampin|mesh-list
110931578|NCT03063580|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110931579|NCT03063580|Antitubercular Agents|antitubercular agents|mesh-ancestor
110931580|NCT03063580|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110279813|NCT00217659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110931581|NCT03063580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110931582|NCT03063580|Leprostatic Agents|leprostatic agents|mesh-ancestor
110931583|NCT03063580|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110931584|NCT03063580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110931585|NCT03063580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110931586|NCT03063580|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110931587|NCT03063580|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110931588|NCT03063580|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110931589|NCT03063580|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110226819|NCT05331664|Mydriatics|mydriatics|mesh-ancestor
110931590|NCT03063580|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110931591|NCT03063580|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110931592|NCT03063580|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110931593|NCT03063580|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110931594|NCT03063580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110931595|NCT05353101|Loteprednol Etabonate|loteprednol etabonate|mesh-list
110931596|NCT05353101|Cyclosporine|cyclosporine|mesh-list
110931598|NCT05353101|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110931599|NCT05353101|Cyclosporins|cyclosporins|mesh-list
110931600|NCT05353101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110931601|NCT05353101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110931602|NCT05353101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110931603|NCT05353101|Immunologic Factors|immunologic factors|mesh-ancestor
110931604|NCT05353101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110931605|NCT05353101|Antifungal Agents|antifungal agents|mesh-ancestor
110931606|NCT05353101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110931607|NCT05353101|Dermatologic Agents|dermatologic agents|mesh-ancestor
110931608|NCT05353101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110931609|NCT05353101|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110931610|NCT05353101|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110931611|NCT05353101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110931612|NCT05353101|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110931613|NCT03700333|Pemetrexed|pemetrexed|mesh-list
110931614|NCT03700333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110931615|NCT03700333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110931616|NCT03700333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110931617|NCT03700333|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110931618|NCT03700333|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110931619|NCT03700177|Dexamethasone|dexamethasone|mesh-list
110931620|NCT03700177|Ropivacaine|ropivacaine|mesh-list
110931621|NCT03700177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110931622|NCT03700177|Antiemetics|antiemetics|mesh-ancestor
110931623|NCT03700177|Autonomic Agents|autonomic agents|mesh-ancestor
110931624|NCT03700177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110931625|NCT03700177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110931626|NCT03700177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110931627|NCT03700177|Glucocorticoids|glucocorticoids|mesh-ancestor
110279867|NCT00184847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110279868|NCT00184847|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110279869|NCT00184847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110279870|NCT00184847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110227024|NCT05065424|Analgesics|analgesics|mesh-ancestor
110279871|NCT00184847|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110279872|NCT00184847|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110279873|NCT00184847|Purinergic Agents|purinergic agents|mesh-ancestor
110279874|NCT00184847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110931628|NCT03700177|Hormones|hormones|mesh-ancestor
110931629|NCT03700177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110931630|NCT03700177|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110931631|NCT03700177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110931632|NCT03700177|Anesthetics, Local|anesthetics, local|mesh-ancestor
110931633|NCT03700177|Anesthetics|anesthetics|mesh-ancestor
110931634|NCT03700177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110931635|NCT03700177|Sensory System Agents|sensory system agents|mesh-ancestor
110931636|NCT02183610|Linagliptin|linagliptin|mesh-list
110931637|NCT02183610|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110931638|NCT02183610|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110931639|NCT02183610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110931640|NCT02183610|Incretins|incretins|mesh-ancestor
110931641|NCT02183610|Hormones|hormones|mesh-ancestor
110931642|NCT02183610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110931643|NCT02183610|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110931644|NCT02183610|Protease Inhibitors|protease inhibitors|mesh-ancestor
110931645|NCT02183610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110931646|NCT02183610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110931647|NCT02183688|Acetaminophen|acetaminophen|mesh-list
110931648|NCT02183688|Caffeine|caffeine|mesh-list
110931649|NCT02183688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110931650|NCT02183688|Analgesics|analgesics|mesh-ancestor
110931651|NCT02183688|Sensory System Agents|sensory system agents|mesh-ancestor
110931652|NCT02183688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110931653|NCT02183688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110931654|NCT02183688|Antipyretics|antipyretics|mesh-ancestor
110931655|NCT02183688|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110931656|NCT02183688|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110931657|NCT02183688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110931658|NCT02183688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110931659|NCT02183688|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110931660|NCT02183688|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110931661|NCT02183688|Purinergic Agents|purinergic agents|mesh-ancestor
110931662|NCT02183688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110931663|NCT02190708|Midazolam|midazolam|mesh-list
110931664|NCT02190708|Omeprazole|omeprazole|mesh-list
110649236|NCT00722579|Cobalt|cobalt|mesh-list
110931665|NCT02190708|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
110931666|NCT02190708|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110931667|NCT02190708|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110931668|NCT02190708|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110279902|NCT00217932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110279903|NCT00217932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110931669|NCT02190708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110931670|NCT02190708|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110931671|NCT02190708|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110931672|NCT02190708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110931673|NCT02190708|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110931674|NCT02190708|Anesthetics, General|anesthetics, general|mesh-ancestor
110931675|NCT02190708|Anesthetics|anesthetics|mesh-ancestor
110931676|NCT02190708|GABA Modulators|gaba modulators|mesh-ancestor
110931677|NCT02190708|GABA Agents|gaba agents|mesh-ancestor
110931678|NCT02190708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110931679|NCT02190708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110931680|NCT02190708|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110931681|NCT02190708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110931682|NCT02190708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110931683|NCT05338983|Anesthetics|anesthetics|mesh-list
110931684|NCT05338983|Mepivacaine|mepivacaine|mesh-list
110931685|NCT05338983|Anesthetics, Local|anesthetics, local|mesh-list
110931686|NCT05338983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110931687|NCT05338983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110931688|NCT05338983|Sensory System Agents|sensory system agents|mesh-ancestor
110931689|NCT05338983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110931690|NCT03063658|Acetaminophen|acetaminophen|mesh-list
110931691|NCT03063658|Ibuprofen|ibuprofen|mesh-list
110931692|NCT03063658|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110931693|NCT03063658|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110931694|NCT03063658|Analgesics|analgesics|mesh-ancestor
110931695|NCT03063658|Sensory System Agents|sensory system agents|mesh-ancestor
110931696|NCT03063658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110931697|NCT03063658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110931698|NCT03063658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110931699|NCT03063658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110931700|NCT03063658|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110931701|NCT03063658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110931702|NCT03063658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110931703|NCT03063658|Antipyretics|antipyretics|mesh-ancestor
110931704|NCT03695107|Nifedipine|nifedipine|mesh-list
110931705|NCT03695107|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110931706|NCT03695107|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110931707|NCT03695107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110931708|NCT03695107|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110931709|NCT03695107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110931710|NCT03695107|Vasodilator Agents|vasodilator agents|mesh-ancestor
110931711|NCT03695107|Tocolytic Agents|tocolytic agents|mesh-ancestor
110931712|NCT03695107|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110931713|NCT02835339|Magnesium Sulfate|magnesium sulfate|mesh-list
110931714|NCT02835339|Analgesics|analgesics|mesh-ancestor
110931715|NCT02835339|Sensory System Agents|sensory system agents|mesh-ancestor
110931716|NCT02835339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110931717|NCT02835339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110931718|NCT02835339|Anesthetics|anesthetics|mesh-ancestor
110931719|NCT02835339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110227424|NCT04680052|Rituximab|rituximab|mesh-list
110931720|NCT02835339|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110931721|NCT02835339|Anticonvulsants|anticonvulsants|mesh-ancestor
110931722|NCT02835339|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110931723|NCT02835339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110931724|NCT02835339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110931725|NCT02835339|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110931726|NCT02835339|Tocolytic Agents|tocolytic agents|mesh-ancestor
110931727|NCT02835339|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110931728|NCT03695029|Tenofovir|tenofovir|mesh-list
110931729|NCT03695029|Antiviral Agents|antiviral agents|mesh-ancestor
110931730|NCT03695029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110931731|NCT03695029|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110931732|NCT03695029|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110931733|NCT03695029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110931734|NCT03695029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110931735|NCT03695029|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110931736|NCT03695029|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110931737|NCT02259855|Interferons|interferons|mesh-list
110931738|NCT02259855|Ritonavir|ritonavir|mesh-list
110931739|NCT02259855|Ribavirin|ribavirin|mesh-list
110931740|NCT02259855|Tipranavir|tipranavir|mesh-list
110227466|NCT04652700|Tenofovir|tenofovir|mesh-list
110931741|NCT02259855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110931742|NCT02259855|Antiviral Agents|antiviral agents|mesh-ancestor
110931743|NCT02259855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110931744|NCT02259855|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110931745|NCT02259855|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110931746|NCT02259855|Protease Inhibitors|protease inhibitors|mesh-ancestor
110931747|NCT02259855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110931748|NCT02259855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110931749|NCT02259855|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110931750|NCT02259855|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110931751|NCT02259855|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110931752|NCT02259855|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110931753|NCT02259855|Antimetabolites|antimetabolites|mesh-ancestor
110931754|NCT03703063|Leucovorin|leucovorin|mesh-list
110931755|NCT03703063|Paclitaxel|paclitaxel|mesh-list
110931756|NCT03703063|Gemcitabine|gemcitabine|mesh-list
110931757|NCT03703063|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110931758|NCT03703063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110931759|NCT03703063|Tubulin Modulators|tubulin modulators|mesh-ancestor
110931760|NCT03703063|Antimitotic Agents|antimitotic agents|mesh-ancestor
110931761|NCT03703063|Mitosis Modulators|mitosis modulators|mesh-ancestor
110931762|NCT03703063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110931763|NCT03703063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110931764|NCT03703063|Antimetabolites|antimetabolites|mesh-ancestor
110931765|NCT03703063|Antidotes|antidotes|mesh-ancestor
110931766|NCT03703063|Protective Agents|protective agents|mesh-ancestor
110931767|NCT03703063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110931768|NCT03703063|Vitamin B Complex|vitamin b complex|mesh-ancestor
110931769|NCT03703063|Vitamins|vitamins|mesh-ancestor
110931770|NCT03703063|Micronutrients|micronutrients|mesh-ancestor
110931771|NCT03702985|Capecitabine|capecitabine|mesh-list
110931772|NCT03702985|Irinotecan|irinotecan|mesh-list
110931773|NCT03702985|Amifostine|amifostine|mesh-list
110931774|NCT03702985|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110931775|NCT03702985|Antimetabolites|antimetabolites|mesh-ancestor
110280004|NCT00211146|Epoetin Alfa|epoetin alfa|mesh-list
110931776|NCT03702985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110931777|NCT03702985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110931778|NCT03702985|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110931779|NCT03702985|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110931780|NCT03702985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110931781|NCT03702985|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110931782|NCT03702985|Protective Agents|protective agents|mesh-ancestor
110931783|NCT03702985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110931784|NCT03064984|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110931785|NCT03064984|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110931786|NCT02184078|Nevirapine|nevirapine|mesh-list
110931787|NCT02184078|Rifabutin|rifabutin|mesh-list
110931788|NCT02184078|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110931789|NCT02184078|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110931791|NCT02184078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110931792|NCT02184078|Antiviral Agents|antiviral agents|mesh-ancestor
110931793|NCT02184078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110931794|NCT02184078|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110931795|NCT02184078|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110931796|NCT02184078|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110931797|NCT02184078|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110931798|NCT02184078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110931799|NCT02184078|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110931800|NCT02184078|Antitubercular Agents|antitubercular agents|mesh-ancestor
110931801|NCT04323436|Spartalizumab|spartalizumab|mesh-list
110931802|NCT04323436|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110931803|NCT04323436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110931804|NCT04323436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110931805|NCT04323436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110931806|NCT03694873|Celecoxib|celecoxib|mesh-list
110931807|NCT03694873|Tramadol|tramadol|mesh-list
110931808|NCT03694873|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110931809|NCT03694873|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110931810|NCT03694873|Analgesics|analgesics|mesh-ancestor
110931811|NCT03694873|Sensory System Agents|sensory system agents|mesh-ancestor
110931812|NCT03694873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110931813|NCT03694873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110931814|NCT03694873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110931815|NCT03694873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110931816|NCT03694873|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110280063|NCT00218244|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110931817|NCT03694873|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110931818|NCT03694873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110931819|NCT03694873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110931820|NCT03694873|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110931822|NCT03694873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110931823|NCT02191020|Acitretin|acitretin|mesh-list
110931824|NCT02191020|Keratolytic Agents|keratolytic agents|mesh-ancestor
110931825|NCT02191020|Dermatologic Agents|dermatologic agents|mesh-ancestor
110931826|NCT04476199|Decitabine|decitabine|mesh-list
110931827|NCT04476199|Venetoclax|venetoclax|mesh-list
110931828|NCT04476199|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110931829|NCT04476199|Antimetabolites|antimetabolites|mesh-ancestor
110931830|NCT04476199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110931831|NCT04476199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110931832|NCT04476199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110931833|NCT02188368|Clarithromycin|clarithromycin|mesh-list
110931834|NCT02188368|Dexamethasone|dexamethasone|mesh-list
110931835|NCT02188368|Prednisone|prednisone|mesh-list
110931836|NCT02188368|Cyclophosphamide|cyclophosphamide|mesh-list
110931837|NCT02188368|Bortezomib|bortezomib|mesh-list
110931838|NCT02188368|Pomalidomide|pomalidomide|mesh-list
110931839|NCT02188368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110931840|NCT02188368|Immunologic Factors|immunologic factors|mesh-ancestor
110931841|NCT02188368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110931842|NCT02188368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110931843|NCT02188368|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110931844|NCT02188368|Alkylating Agents|alkylating agents|mesh-ancestor
110931845|NCT02188368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110931846|NCT02188368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110931847|NCT02188368|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110931848|NCT02188368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110931849|NCT02188368|Antiemetics|antiemetics|mesh-ancestor
110931850|NCT02188368|Autonomic Agents|autonomic agents|mesh-ancestor
110227589|NCT04569747|Fertility Agents|fertility agents|mesh-ancestor
110931851|NCT02188368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110931852|NCT02188368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110931853|NCT02188368|Glucocorticoids|glucocorticoids|mesh-ancestor
110931854|NCT02188368|Hormones|hormones|mesh-ancestor
110280073|NCT00211302|Aripiprazole|aripiprazole|mesh-list
110931855|NCT02188368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110931856|NCT02188368|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110931857|NCT02188368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110931858|NCT02188368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110931859|NCT02188368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110931860|NCT02188368|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110931861|NCT02188368|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110931862|NCT02188368|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110931863|NCT02188368|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110931864|NCT02188368|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110931865|NCT02188368|Growth Substances|growth substances|mesh-ancestor
110931866|NCT02188368|Growth Inhibitors|growth inhibitors|mesh-ancestor
110931867|NCT02191176|Dextromethorphan|dextromethorphan|mesh-list
110931868|NCT02191176|Antitussive Agents|antitussive agents|mesh-ancestor
110931869|NCT02191176|Respiratory System Agents|respiratory system agents|mesh-ancestor
110931870|NCT02191176|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110931871|NCT02191176|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110931872|NCT02191176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110931873|NCT02191176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110931874|NCT02191176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110931876|NCT02184312|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110931877|NCT02184312|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110931878|NCT02184312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110931879|NCT02184312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110931880|NCT02184312|Antiviral Agents|antiviral agents|mesh-ancestor
110931881|NCT02184312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110931882|NCT02184312|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110931883|NCT02184312|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110931884|NCT02184312|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110931885|NCT02184312|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110931886|NCT04301011|Pembrolizumab|pembrolizumab|mesh-list
110227685|NCT04447027|Antiemetics|antiemetics|mesh-ancestor
110931887|NCT04301011|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110931888|NCT04301011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110931889|NCT04301011|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110280146|NCT00218361|Hydromorphone|hydromorphone|mesh-list
110931890|NCT04301011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110931892|NCT02191332|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110931893|NCT02191332|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110931895|NCT02191332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110931896|NCT02191332|Antiviral Agents|antiviral agents|mesh-ancestor
110931897|NCT02191332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110931898|NCT02191332|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110931899|NCT02191332|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110931900|NCT02191332|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110931901|NCT02191332|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110931902|NCT02256774|Ritonavir|ritonavir|mesh-list
110931903|NCT02256774|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
110227854|NCT04246697|Morphine|morphine|mesh-list
110931904|NCT02256774|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110931905|NCT02256774|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110931906|NCT02256774|Protease Inhibitors|protease inhibitors|mesh-ancestor
110931907|NCT02256774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110931908|NCT02256774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110931909|NCT02256774|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110931910|NCT02256774|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110931911|NCT02256774|Antiviral Agents|antiviral agents|mesh-ancestor
110931912|NCT02256774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110931913|NCT02256774|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110931914|NCT02256774|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110931915|NCT02256774|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110931916|NCT02256774|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110931918|NCT02189304|Glycopyrrolate|glycopyrrolate|mesh-list
110931919|NCT02189304|Formoterol Fumarate|formoterol fumarate|mesh-list
110931920|NCT02189304|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
110931921|NCT02189304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110931922|NCT02189304|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110931923|NCT02189304|Autonomic Agents|autonomic agents|mesh-ancestor
110931924|NCT02189304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110931925|NCT02189304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110931926|NCT02189304|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110931927|NCT02189304|Respiratory System Agents|respiratory system agents|mesh-ancestor
110931928|NCT02189304|Glucocorticoids|glucocorticoids|mesh-ancestor
110931929|NCT02189304|Hormones|hormones|mesh-ancestor
110931930|NCT02189304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110931931|NCT02189304|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110931932|NCT02189304|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110931933|NCT02189304|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110931934|NCT02189304|Adrenergic Agents|adrenergic agents|mesh-ancestor
110931935|NCT02189304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110931936|NCT02189304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110931937|NCT02189304|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110931938|NCT02189304|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110931939|NCT02189304|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110931940|NCT02189304|Cholinergic Agents|cholinergic agents|mesh-ancestor
110931941|NCT02184858|Lisinopril|lisinopril|mesh-list
110280178|NCT00211419|Growth Inhibitors|growth inhibitors|mesh-ancestor
110931942|NCT02184858|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
110931943|NCT02184858|Protease Inhibitors|protease inhibitors|mesh-ancestor
110931944|NCT02184858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110931945|NCT02184858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110931946|NCT02184858|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110931947|NCT02184858|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110931948|NCT02184858|Protective Agents|protective agents|mesh-ancestor
110931949|NCT02184858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110931950|NCT03535662|Itraconazole|itraconazole|mesh-list
110931951|NCT03535662|Antifungal Agents|antifungal agents|mesh-ancestor
110931952|NCT03535662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110931953|NCT03535662|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110932220|NCT02197182|Copper|copper|mesh-list
110931954|NCT03535662|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110931955|NCT03535662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110931956|NCT03535662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110931957|NCT03535662|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110931958|NCT03535662|Hormone Antagonists|hormone antagonists|mesh-ancestor
110931959|NCT03535662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110931960|NCT03535662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110280203|NCT00186797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110931961|NCT03535662|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110931963|NCT03702205|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110931964|NCT03702205|Lipotropic Agents|lipotropic agents|mesh-ancestor
110931965|NCT03702205|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110931966|NCT03702205|Antimetabolites|antimetabolites|mesh-ancestor
110931967|NCT03702205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110931968|NCT03702205|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110931969|NCT03698851|Methamphetamine|methamphetamine|mesh-list
110931970|NCT03698851|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110280217|NCT00211653|Respiratory System Agents|respiratory system agents|mesh-ancestor
110931971|NCT03698851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110931973|NCT03698851|Autonomic Agents|autonomic agents|mesh-ancestor
110931974|NCT03698851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110931975|NCT03698851|Dopamine Agents|dopamine agents|mesh-ancestor
110931976|NCT03698851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110931977|NCT03698851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110931978|NCT03698851|Adrenergic Agents|adrenergic agents|mesh-ancestor
110931979|NCT03698851|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110931980|NCT03698851|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110931981|NCT03698851|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110931982|NCT03698851|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110931984|NCT03125902|Atezolizumab|atezolizumab|mesh-list
110931985|NCT03125902|Antibodies|antibodies|mesh-list
110931986|NCT03125902|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110931987|NCT03125902|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110228295|NCT03774394|Clopidogrel|clopidogrel|mesh-list
110931988|NCT03125902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110931989|NCT03125902|Tubulin Modulators|tubulin modulators|mesh-ancestor
110931990|NCT03125902|Antimitotic Agents|antimitotic agents|mesh-ancestor
110931991|NCT03125902|Mitosis Modulators|mitosis modulators|mesh-ancestor
110931992|NCT03125902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110931993|NCT03125902|Immunologic Factors|immunologic factors|mesh-ancestor
110931994|NCT03125902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110931995|NCT03125902|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110931996|NCT03125902|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110931997|NCT02189694|Hormones|hormones|mesh-list
110228352|NCT03744793|Pemetrexed|pemetrexed|mesh-list
110931998|NCT02189694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110931999|NCT02189694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110932000|NCT02189772|Metadoxine|metadoxine|mesh-list
110932001|NCT02189772|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110228423|NCT03692403|Quinagolide|quinagolide|mesh-list
110932003|NCT02192424|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110932004|NCT02192424|Metformin|metformin|mesh-list
110932005|NCT02192424|Insulin Glargine|insulin glargine|mesh-list
110932006|NCT02192424|Insulin Lispro|insulin lispro|mesh-list
110932007|NCT02192424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110932008|NCT02192424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110932009|NCT04276597|Edotreotide lutetium LU-177|edotreotide lutetium lu-177|mesh-list
110932010|NCT04276597|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110932011|NCT04276597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110932012|NCT02257008|Ritonavir|ritonavir|mesh-list
110932013|NCT02257008|Atazanavir Sulfate|atazanavir sulfate|mesh-list
110932014|NCT02257008|Nelfinavir|nelfinavir|mesh-list
110932015|NCT02257008|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110932016|NCT02257008|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110932017|NCT02257008|Protease Inhibitors|protease inhibitors|mesh-ancestor
110932018|NCT02257008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110932236|NCT03687931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110932019|NCT02257008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110932020|NCT02257008|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110932021|NCT02257008|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110932022|NCT02257008|Antiviral Agents|antiviral agents|mesh-ancestor
110932023|NCT02257008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110932024|NCT02257008|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110932025|NCT02257008|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110932026|NCT03693391|Fluorides|fluorides|mesh-list
110932027|NCT03693391|Cariostatic Agents|cariostatic agents|mesh-ancestor
110932028|NCT03693391|Protective Agents|protective agents|mesh-ancestor
110932029|NCT03693391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110932030|NCT02193594|Oxaliplatin|oxaliplatin|mesh-list
110932031|NCT02193594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110932032|NCT02185326|Hormones|hormones|mesh-list
110932033|NCT02185326|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110932034|NCT02185326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110932036|NCT04412707|Melphalan|melphalan|mesh-list
110932037|NCT04412707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110932039|NCT04412707|Autonomic Agents|autonomic agents|mesh-ancestor
110932040|NCT04412707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110932041|NCT04412707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110228624|NCT03374085|Dexamethasone|dexamethasone|mesh-list
110932042|NCT04412707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110932043|NCT04412707|Glucocorticoids|glucocorticoids|mesh-ancestor
110932044|NCT04412707|Hormones|hormones|mesh-ancestor
110932045|NCT04412707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110932046|NCT04412707|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110932047|NCT04412707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110932048|NCT04412707|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110932049|NCT04412707|Alkylating Agents|alkylating agents|mesh-ancestor
110932050|NCT04412707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110932051|NCT04412707|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110932052|NCT04412707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110932053|NCT04412707|Immunologic Factors|immunologic factors|mesh-ancestor
110932054|NCT03698695|Mefloquine|mefloquine|mesh-list
110932055|NCT03698695|Donepezil|donepezil|mesh-list
110932056|NCT03698695|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110932057|NCT03698695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110932058|NCT03698695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110932059|NCT03698695|Cholinergic Agents|cholinergic agents|mesh-ancestor
110932060|NCT03698695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110932061|NCT03698695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110932062|NCT03698695|Nootropic Agents|nootropic agents|mesh-ancestor
110932063|NCT03698695|Antimalarials|antimalarials|mesh-ancestor
110932064|NCT03698695|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110932065|NCT03698695|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110932066|NCT03698695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110932067|NCT04729296|Golimumab|golimumab|mesh-list
110932068|NCT04729296|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110228746|NCT03260504|Analgesics|analgesics|mesh-ancestor
110932069|NCT04729296|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110932070|NCT04729296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110932071|NCT04729296|Immunologic Factors|immunologic factors|mesh-ancestor
110932072|NCT04729296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110932074|NCT03698617|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110932075|NCT03698617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110932076|NCT03698617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110932077|NCT03698617|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110932078|NCT03698617|Anesthetics, General|anesthetics, general|mesh-ancestor
110932079|NCT03698617|Anesthetics|anesthetics|mesh-ancestor
110932080|NCT02194374|Cyclophosphamide|cyclophosphamide|mesh-list
110932081|NCT02194374|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110932082|NCT02194374|Rituximab|rituximab|mesh-list
110932083|NCT02194374|Fludarabine|fludarabine|mesh-list
110932084|NCT02194374|Fludarabine phosphate|fludarabine phosphate|mesh-list
110932085|NCT02194374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110932086|NCT02194374|Immunologic Factors|immunologic factors|mesh-ancestor
110932087|NCT02194374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110932088|NCT02194374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110932089|NCT02194374|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110932090|NCT02194374|Alkylating Agents|alkylating agents|mesh-ancestor
110932091|NCT02194374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110932092|NCT02194374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110932093|NCT02194374|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110932094|NCT02194374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110932095|NCT02194374|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110932096|NCT02194374|Antimetabolites|antimetabolites|mesh-ancestor
110932097|NCT02194452|Octreotide|octreotide|mesh-list
110932098|NCT02194452|Edotreotide|edotreotide|mesh-list
110932099|NCT02194452|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110932100|NCT02194452|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110932101|NCT02194452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110932102|NCT02194452|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110932103|NCT02194452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110932104|NCT01358721|Nivolumab|nivolumab|mesh-list
110932105|NCT01358721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110932106|NCT01358721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110932107|NCT01358721|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110932108|NCT01358721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110932109|NCT02194686|Cilostazol|cilostazol|mesh-list
110932110|NCT02194686|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110649693|NCT00902954|Letrozole|letrozole|mesh-list
110932111|NCT02194686|Autonomic Agents|autonomic agents|mesh-ancestor
110932112|NCT02194686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110932113|NCT02194686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110280359|NCT00188045|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110932114|NCT02194686|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110229153|NCT02081378|Dasatinib|dasatinib|mesh-list
110932115|NCT02194686|Respiratory System Agents|respiratory system agents|mesh-ancestor
110932116|NCT02194686|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110932117|NCT02194686|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110932118|NCT02194686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110932119|NCT02194686|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110932120|NCT02194686|Vasodilator Agents|vasodilator agents|mesh-ancestor
110932121|NCT02194686|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110932122|NCT02194686|Protective Agents|protective agents|mesh-ancestor
110932123|NCT02194686|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110932124|NCT02194686|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110280382|NCT00219375|Sivelestat|sivelestat|mesh-list
110932125|NCT02194686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110932126|NCT04622995|Diazepam|diazepam|mesh-list
110932127|NCT04622995|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110932128|NCT04622995|Anticonvulsants|anticonvulsants|mesh-ancestor
110932129|NCT04622995|Antiemetics|antiemetics|mesh-ancestor
110932130|NCT04622995|Autonomic Agents|autonomic agents|mesh-ancestor
110932131|NCT04622995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110932132|NCT04622995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110932133|NCT04622995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110932134|NCT04622995|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110932135|NCT04622995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110932136|NCT04622995|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110932137|NCT04622995|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110932138|NCT04622995|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110932139|NCT04622995|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110932140|NCT04622995|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110932141|NCT04622995|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110932142|NCT04622995|Anesthetics, General|anesthetics, general|mesh-ancestor
110932143|NCT04622995|Anesthetics|anesthetics|mesh-ancestor
110932144|NCT04622995|GABA Modulators|gaba modulators|mesh-ancestor
110932145|NCT04622995|GABA Agents|gaba agents|mesh-ancestor
110932146|NCT04622995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110229420|NCT00085202|Alkylating Agents|alkylating agents|mesh-ancestor
110932147|NCT04622995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110932148|NCT01341639|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110932149|NCT01341639|Immunologic Factors|immunologic factors|mesh-ancestor
110280400|NCT00188396|Serotonin Agents|serotonin agents|mesh-ancestor
110932150|NCT01341639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110932152|NCT02194764|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110932153|NCT02194764|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110229490|NCT00039130|Micronutrients|micronutrients|mesh-ancestor
110932154|NCT02194764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110932155|NCT02194764|Sensory System Agents|sensory system agents|mesh-ancestor
110932156|NCT02194764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110932157|NCT02967640|Ketamine|ketamine|mesh-list
110932158|NCT02967640|Analgesics|analgesics|mesh-ancestor
110932159|NCT02967640|Sensory System Agents|sensory system agents|mesh-ancestor
110932160|NCT02967640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110932161|NCT02967640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110932162|NCT02967640|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110932163|NCT02967640|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110932164|NCT02967640|Anesthetics, General|anesthetics, general|mesh-ancestor
110932165|NCT02967640|Anesthetics|anesthetics|mesh-ancestor
110932166|NCT02967640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110932167|NCT02967640|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110932168|NCT02967640|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110932169|NCT02967640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110932170|NCT02967640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110932171|NCT02194920|Parathyroid Hormone|parathyroid hormone|mesh-list
110932172|NCT02194920|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110932173|NCT02194920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110932174|NCT00005584|Prednisone|prednisone|mesh-list
110932175|NCT00005584|Epirubicin|epirubicin|mesh-list
110932176|NCT00005584|Bleomycin|bleomycin|mesh-list
110932177|NCT00005584|Vinblastine|vinblastine|mesh-list
110932178|NCT00005584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110932179|NCT00005584|Glucocorticoids|glucocorticoids|mesh-ancestor
110932180|NCT00005584|Hormones|hormones|mesh-ancestor
110932181|NCT00005584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110932182|NCT00005584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110932183|NCT00005584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110649745|NCT01074853|Propranolol|propranolol|mesh-list
110932184|NCT00005584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110932185|NCT00005584|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110932186|NCT00005584|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110932187|NCT00005584|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110932188|NCT00005584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110280439|NCT00188630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110932189|NCT00005584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110932190|NCT00005584|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110932191|NCT00005584|Tubulin Modulators|tubulin modulators|mesh-ancestor
110932192|NCT00005584|Antimitotic Agents|antimitotic agents|mesh-ancestor
110932193|NCT00005584|Mitosis Modulators|mitosis modulators|mesh-ancestor
110932194|NCT02194218|Nevirapine|nevirapine|mesh-list
110932195|NCT02194218|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110932196|NCT02194218|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110932197|NCT02194218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110932198|NCT02194218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110932200|NCT02194218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110932201|NCT02194218|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110932202|NCT02194218|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110229986|NCT03690544|Apremilast|apremilast|mesh-list
110932203|NCT02194218|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110932204|NCT02194218|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110932205|NCT02194296|Ambroxol|ambroxol|mesh-list
110932206|NCT02194296|Expectorants|expectorants|mesh-ancestor
110932207|NCT02194296|Respiratory System Agents|respiratory system agents|mesh-ancestor
110932208|NCT02197026|Hylan|hylan|mesh-list
110932209|NCT02197026|Viscosupplements|viscosupplements|mesh-ancestor
110932210|NCT02197026|Protective Agents|protective agents|mesh-ancestor
110932211|NCT02197026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110932212|NCT02197104|Choline|choline|mesh-list
110932213|NCT02197104|Lipotropic Agents|lipotropic agents|mesh-ancestor
110932214|NCT02197104|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110932215|NCT02197104|Antimetabolites|antimetabolites|mesh-ancestor
110932216|NCT02197104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110932217|NCT02197104|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110932218|NCT02197104|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110932219|NCT02197104|Nootropic Agents|nootropic agents|mesh-ancestor
110932221|NCT02197182|Metronidazole|metronidazole|mesh-list
110932222|NCT02197182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110932223|NCT02197182|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110932224|NCT02197182|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110932225|NCT02197182|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110932226|NCT02197182|Trace Elements|trace elements|mesh-ancestor
110932227|NCT02197182|Micronutrients|micronutrients|mesh-ancestor
110932228|NCT02197182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110932229|NCT02197260|Amoxicillin|amoxicillin|mesh-list
110932230|NCT02197260|Metronidazole|metronidazole|mesh-list
110932231|NCT02197260|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110932232|NCT02197260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110932233|NCT02197260|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110932234|NCT02197260|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110932235|NCT03687931|Dexamethasone|dexamethasone|mesh-list
110280469|NCT02963051|Copper|copper|mesh-list
110932237|NCT03687931|Antiemetics|antiemetics|mesh-ancestor
110932238|NCT03687931|Autonomic Agents|autonomic agents|mesh-ancestor
110932239|NCT03687931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110932240|NCT03687931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110932241|NCT03687931|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110932242|NCT03687931|Glucocorticoids|glucocorticoids|mesh-ancestor
110932243|NCT03687931|Hormones|hormones|mesh-ancestor
110280486|NCT00409253|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110932244|NCT03687931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110932245|NCT03687931|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110932246|NCT03687931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110932247|NCT03534024|Curcumin|curcumin|mesh-list
110230489|NCT03272477|Tamoxifen|tamoxifen|mesh-list
110932248|NCT03534024|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110932249|NCT03534024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110932250|NCT03534024|Analgesics|analgesics|mesh-ancestor
110932251|NCT03534024|Sensory System Agents|sensory system agents|mesh-ancestor
110932252|NCT03534024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110932253|NCT03534024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110230553|NCT00316927|Analgesics|analgesics|mesh-ancestor
110932254|NCT03534024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110932255|NCT03534024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110280499|NCT00219765|Cytarabine|cytarabine|mesh-list
110932256|NCT03534024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110932257|NCT03534024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110932258|NCT03534024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110932259|NCT02753686|Tamoxifen|tamoxifen|mesh-list
110932260|NCT02753686|Everolimus|everolimus|mesh-list
110932261|NCT02753686|Letrozole|letrozole|mesh-list
110932262|NCT02753686|Fulvestrant|fulvestrant|mesh-list
110932263|NCT02753686|Anastrozole|anastrozole|mesh-list
110932264|NCT02753686|Exemestane|exemestane|mesh-list
110932265|NCT02753686|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110230629|NCT02571725|Olaparib|olaparib|mesh-list
110932266|NCT02753686|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110932267|NCT02753686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110932268|NCT02753686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110932269|NCT02753686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110932270|NCT02753686|Immunologic Factors|immunologic factors|mesh-ancestor
110932271|NCT02753686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110932272|NCT02753686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110932273|NCT02753686|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110932274|NCT02753686|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110230769|NCT00329368|Vitamins|vitamins|mesh-ancestor
110932275|NCT02753686|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110932276|NCT02753686|Hormone Antagonists|hormone antagonists|mesh-ancestor
110932277|NCT02753686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110932278|NCT02753686|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110932279|NCT02753686|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110932280|NCT02753686|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110280524|NCT00212589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110932281|NCT02753686|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110932282|NCT02753686|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110932283|NCT04216927|Nitric Oxide|nitric oxide|mesh-list
110932284|NCT04216927|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110932285|NCT04216927|Autonomic Agents|autonomic agents|mesh-ancestor
110932286|NCT04216927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110932287|NCT04216927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110932288|NCT04216927|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110932289|NCT04216927|Respiratory System Agents|respiratory system agents|mesh-ancestor
110932290|NCT04216927|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110932291|NCT04216927|Antioxidants|antioxidants|mesh-ancestor
110932292|NCT04216927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110932293|NCT04216927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110932294|NCT04216927|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
110932295|NCT04216927|Vasodilator Agents|vasodilator agents|mesh-ancestor
110932296|NCT04216927|Gasotransmitters|gasotransmitters|mesh-ancestor
110932297|NCT04216927|Protective Agents|protective agents|mesh-ancestor
110932298|NCT02329834|Furosemide|furosemide|mesh-list
110932299|NCT02329834|Diuretics|diuretics|mesh-ancestor
110932300|NCT02329834|Natriuretic Agents|natriuretic agents|mesh-ancestor
110932301|NCT02329834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110932302|NCT02329834|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110932303|NCT02329834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110932304|NCT02329834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110932305|NCT02195466|Ritonavir|ritonavir|mesh-list
110932306|NCT02195466|Tipranavir|tipranavir|mesh-list
110280554|NCT00188864|Hormones|hormones|mesh-ancestor
110932649|NCT03532854|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110231041|NCT00324298|Etoposide|etoposide|mesh-list
110932650|NCT03532854|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110932652|NCT03532854|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110932653|NCT03532854|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110932654|NCT03532854|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110932655|NCT02203500|Telmisartan|telmisartan|mesh-list
110932656|NCT02203500|Lacidipine|lacidipine|mesh-list
110932657|NCT02203500|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110932658|NCT02203500|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110932659|NCT02203500|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110932660|NCT02203500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110932661|NCT02203500|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110034922|NCT01402479|Ramipril|ramipril|mesh-list
110932307|NCT02195466|Fluconazole|fluconazole|mesh-list
110932308|NCT02195466|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110932309|NCT02195466|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110231138|NCT00324571|Calcium|calcium|mesh-list
110932310|NCT02195466|Protease Inhibitors|protease inhibitors|mesh-ancestor
110932311|NCT02195466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110932312|NCT02195466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110932313|NCT02195466|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110932314|NCT02195466|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110932315|NCT02195466|Antiviral Agents|antiviral agents|mesh-ancestor
110932316|NCT02195466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110932662|NCT02203500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110932663|NCT02203500|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110933165|NCT03563937|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110933166|NCT03563937|Antithrombins|antithrombins|mesh-ancestor
110933167|NCT03563937|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110933168|NCT03563937|Protease Inhibitors|protease inhibitors|mesh-ancestor
110933169|NCT03563937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110933170|NCT03563937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110933171|NCT03563937|Anticoagulants|anticoagulants|mesh-ancestor
110933172|NCT02231346|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
110933173|NCT02231346|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110933174|NCT02231346|Autonomic Agents|autonomic agents|mesh-ancestor
110933175|NCT02231346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110933176|NCT02231346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110933177|NCT02231346|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110933178|NCT02231346|Respiratory System Agents|respiratory system agents|mesh-ancestor
110933179|NCT02225418|Ropivacaine|ropivacaine|mesh-list
110933180|NCT02225418|Anesthetics, Local|anesthetics, local|mesh-ancestor
110933181|NCT02225418|Anesthetics|anesthetics|mesh-ancestor
110933182|NCT02225418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110933183|NCT02225418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110933184|NCT02225418|Sensory System Agents|sensory system agents|mesh-ancestor
110933185|NCT02225418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110933186|NCT02231424|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
110933187|NCT02231424|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110933188|NCT02231424|Autonomic Agents|autonomic agents|mesh-ancestor
110933189|NCT02231424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110933190|NCT02231424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110933191|NCT02231424|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110231443|NCT00318955|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110933192|NCT02231424|Respiratory System Agents|respiratory system agents|mesh-ancestor
110933193|NCT05057130|Cisplatin|cisplatin|mesh-list
110933194|NCT05057130|Doxorubicin|doxorubicin|mesh-list
110933195|NCT05057130|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110933196|NCT05057130|Methotrexate|methotrexate|mesh-list
110933197|NCT05057130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110933198|NCT05057130|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110933199|NCT05057130|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110933200|NCT05057130|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110933201|NCT05057130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110933202|NCT05057130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110933203|NCT05057130|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110933204|NCT05057130|Abortifacient Agents|abortifacient agents|mesh-ancestor
110231573|NCT00319189|Nateglinide|nateglinide|mesh-list
110933205|NCT05057130|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110933206|NCT05057130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110265094|NCT04689100|Antidotes|antidotes|mesh-ancestor
110933207|NCT05057130|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110933208|NCT05057130|Antimetabolites|antimetabolites|mesh-ancestor
110933209|NCT05057130|Dermatologic Agents|dermatologic agents|mesh-ancestor
110933210|NCT05057130|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110933211|NCT05057130|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110933212|NCT05057130|Immunologic Factors|immunologic factors|mesh-ancestor
110933213|NCT05057130|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110933214|NCT05057130|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110933215|NCT02222220|Metoclopramide|metoclopramide|mesh-list
110933216|NCT02222220|Antiemetics|antiemetics|mesh-ancestor
110932317|NCT02195466|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110932318|NCT02195466|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110932319|NCT02195466|Antifungal Agents|antifungal agents|mesh-ancestor
110932320|NCT02195466|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110932321|NCT02195466|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110932322|NCT02195466|Hormone Antagonists|hormone antagonists|mesh-ancestor
110932323|NCT02195466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110932324|NCT02195466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110932325|NCT02195466|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110933217|NCT02222220|Autonomic Agents|autonomic agents|mesh-ancestor
110933218|NCT02222220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110933219|NCT02222220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110933220|NCT02222220|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110933221|NCT02222220|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110933222|NCT02222220|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110933223|NCT02222220|Dopamine Agents|dopamine agents|mesh-ancestor
110933224|NCT02222220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110933225|NCT02222220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110933226|NCT03677323|Sufentanil|sufentanil|mesh-list
110933227|NCT03677323|Droperidol|droperidol|mesh-list
110933228|NCT03677323|Propofol|propofol|mesh-list
110933234|NCT03677323|Anesthetics|anesthetics|mesh-ancestor
110933235|NCT03677323|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110933236|NCT03677323|Narcotics|narcotics|mesh-ancestor
110933237|NCT03677323|Analgesics|analgesics|mesh-ancestor
110933238|NCT03677323|Sensory System Agents|sensory system agents|mesh-ancestor
110933239|NCT03677323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110933240|NCT03677323|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110933241|NCT03677323|Antiemetics|antiemetics|mesh-ancestor
110933242|NCT03677323|Autonomic Agents|autonomic agents|mesh-ancestor
110232147|NCT00086645|Dexetimide|dexetimide|mesh-list
110933243|NCT03677323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110933244|NCT03677323|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110933245|NCT03677323|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110933246|NCT03677323|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110933247|NCT03677323|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110933248|NCT03677323|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110933249|NCT03677323|Dopamine Agents|dopamine agents|mesh-ancestor
110933250|NCT03677323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110933251|NCT03677323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110933252|NCT02225652|Paclitaxel|paclitaxel|mesh-list
110933253|NCT02225652|Cyclophosphamide|cyclophosphamide|mesh-list
110933254|NCT02225652|Fluorouracil|fluorouracil|mesh-list
110933255|NCT02225652|Epirubicin|epirubicin|mesh-list
110933256|NCT02225652|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110933257|NCT02225652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110933258|NCT02225652|Tubulin Modulators|tubulin modulators|mesh-ancestor
110933259|NCT02225652|Antimitotic Agents|antimitotic agents|mesh-ancestor
110232210|NCT00124644|Cytarabine|cytarabine|mesh-list
110933260|NCT02225652|Mitosis Modulators|mitosis modulators|mesh-ancestor
110933261|NCT02225652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110933262|NCT02225652|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110933263|NCT02225652|Immunologic Factors|immunologic factors|mesh-ancestor
110933264|NCT02225652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110933265|NCT02225652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110933266|NCT02225652|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110933267|NCT02225652|Alkylating Agents|alkylating agents|mesh-ancestor
110933268|NCT02225652|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110933269|NCT02225652|Antimetabolites|antimetabolites|mesh-ancestor
110933270|NCT02225652|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110933271|NCT02225652|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110933272|NCT02225652|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110933273|NCT02225652|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110933274|NCT02225652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110933275|NCT02222376|Pirfenidone|pirfenidone|mesh-list
110933276|NCT02222376|Analgesics|analgesics|mesh-ancestor
110933277|NCT02222376|Sensory System Agents|sensory system agents|mesh-ancestor
110232332|NCT00322114|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110932326|NCT02195466|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110932327|NCT02195544|Hylan|hylan|mesh-list
110932328|NCT02195544|Viscosupplements|viscosupplements|mesh-ancestor
110932329|NCT02195544|Protective Agents|protective agents|mesh-ancestor
110932330|NCT02195544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110932331|NCT02197494|Valsartan|valsartan|mesh-list
110932332|NCT02197494|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110932333|NCT02197494|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110932334|NCT02197494|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110649897|NCT00908726|Anesthetics|anesthetics|mesh-ancestor
110932335|NCT02197494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110932336|NCT01340937|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110933278|NCT02222376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110933279|NCT02222376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110232543|NCT00331084|Autonomic Agents|autonomic agents|mesh-ancestor
110933280|NCT02222376|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110232616|NCT00087581|Cyclosporine|cyclosporine|mesh-list
110933281|NCT02222376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110933282|NCT02222376|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110933283|NCT02222376|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110933284|NCT02222376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110933285|NCT02231658|Liraglutide|liraglutide|mesh-list
110933286|NCT02231658|Lixisenatide|lixisenatide|mesh-list
110933287|NCT02231658|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110933288|NCT02231658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110933289|NCT02231658|Incretins|incretins|mesh-ancestor
110933290|NCT02231658|Hormones|hormones|mesh-ancestor
110232767|NCT00331981|Amisulpride|amisulpride|mesh-list
110933291|NCT02231658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110933292|NCT04542408|Heparin|heparin|mesh-list
110933293|NCT04542408|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
110933294|NCT04542408|Tinzaparin|tinzaparin|mesh-list
110933295|NCT04542408|Dalteparin|dalteparin|mesh-list
110933296|NCT04542408|Edoxaban|edoxaban|mesh-list
110933297|NCT04542408|Anticoagulants|anticoagulants|mesh-list
110933298|NCT04542408|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110933299|NCT04542408|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110933300|NCT04542408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110933308|NCT03059134|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110933309|NCT03059134|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110933310|NCT03059134|Adrenergic Agents|adrenergic agents|mesh-ancestor
110933311|NCT03059134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110933312|NCT03059134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110933313|NCT03059134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110933314|NCT03059134|Urological Agents|urological agents|mesh-ancestor
110933315|NCT02928991|Vidarabine|vidarabine|mesh-list
110933316|NCT02928991|Fludarabine|fludarabine|mesh-list
110933317|NCT02928991|Fludarabine phosphate|fludarabine phosphate|mesh-list
110933318|NCT02928991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110933319|NCT02928991|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110933320|NCT02928991|Antimetabolites|antimetabolites|mesh-ancestor
110933321|NCT02928991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110933322|NCT02928991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110933323|NCT02928991|Immunologic Factors|immunologic factors|mesh-ancestor
110933324|NCT02928991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110933325|NCT02928991|Antiviral Agents|antiviral agents|mesh-ancestor
110933326|NCT02928991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110933327|NCT03554317|Nivolumab|nivolumab|mesh-list
110933328|NCT03554317|Methyltestosterone|methyltestosterone|mesh-list
110933329|NCT03554317|Testosterone|testosterone|mesh-list
110233162|NCT05243940|Narcotics|narcotics|mesh-ancestor
110933330|NCT03554317|Testosterone undecanoate|testosterone undecanoate|mesh-list
110933331|NCT03554317|Testosterone enanthate|testosterone enanthate|mesh-list
110933332|NCT03554317|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
110933333|NCT03554317|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110933334|NCT03554317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110933335|NCT03554317|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110932337|NCT01340937|Immunologic Factors|immunologic factors|mesh-ancestor
110932338|NCT01340937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110932339|NCT03692299|Metronidazole|metronidazole|mesh-list
110932340|NCT03692299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110233302|NCT04481204|Antimitotic Agents|antimitotic agents|mesh-ancestor
110932341|NCT03692299|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110932342|NCT03692299|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110932343|NCT03692299|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110932344|NCT02197650|Asparaginase|asparaginase|mesh-list
110932345|NCT02197650|Eryaspase|eryaspase|mesh-list
110932346|NCT02197650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110233464|NCT03956680|Nivolumab|nivolumab|mesh-list
110932347|NCT02650648|Cyclophosphamide|cyclophosphamide|mesh-list
110932348|NCT02650648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110233594|NCT03191864|Xhance|xhance|mesh-list
110932349|NCT02650648|Immunologic Factors|immunologic factors|mesh-ancestor
110933336|NCT03554317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110933337|NCT03554317|Androgens|androgens|mesh-ancestor
110933338|NCT03554317|Hormones|hormones|mesh-ancestor
110933339|NCT03554317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110933340|NCT03554317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110933341|NCT03554317|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110933342|NCT03554317|Anabolic Agents|anabolic agents|mesh-ancestor
110933343|NCT03623425|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
110933344|NCT03623425|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110933345|NCT03623425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110933346|NCT04957420|Rotigotine|rotigotine|mesh-list
110933347|NCT04957420|Dopamine Agonists|dopamine agonists|mesh-ancestor
110933348|NCT04957420|Dopamine Agents|dopamine agents|mesh-ancestor
110933349|NCT04957420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110933350|NCT04957420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110933351|NCT04957420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110933352|NCT03350035|Ganaxolone|ganaxolone|mesh-list
110933353|NCT03350035|Neurosteroids|neurosteroids|mesh-ancestor
110933354|NCT03350035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110933355|NCT03350035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110933356|NCT03350035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110933357|NCT03350035|GABA Modulators|gaba modulators|mesh-ancestor
110933358|NCT03350035|GABA Agents|gaba agents|mesh-ancestor
110933359|NCT02905188|Cyclophosphamide|cyclophosphamide|mesh-list
110933360|NCT02905188|Fludarabine|fludarabine|mesh-list
110933361|NCT02905188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110933362|NCT02905188|Immunologic Factors|immunologic factors|mesh-ancestor
110933363|NCT02905188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110933364|NCT02905188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110933365|NCT02905188|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110933366|NCT02905188|Alkylating Agents|alkylating agents|mesh-ancestor
110933367|NCT02905188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110933368|NCT02905188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110933381|NCT03671941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110933382|NCT03671941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110933383|NCT03058900|Methotrexate|methotrexate|mesh-list
110933384|NCT03058900|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110933385|NCT03058900|Abortifacient Agents|abortifacient agents|mesh-ancestor
110933386|NCT03058900|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110933387|NCT03058900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110933388|NCT03058900|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110933389|NCT03058900|Antimetabolites|antimetabolites|mesh-ancestor
110933390|NCT03058900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110933391|NCT03058900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110933392|NCT03058900|Dermatologic Agents|dermatologic agents|mesh-ancestor
110933393|NCT03058900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110933394|NCT03058900|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110933395|NCT03058900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110933396|NCT03058900|Immunologic Factors|immunologic factors|mesh-ancestor
110932350|NCT02650648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110932351|NCT02650648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110932352|NCT02650648|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110932353|NCT02650648|Alkylating Agents|alkylating agents|mesh-ancestor
110932354|NCT02650648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110932355|NCT02650648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110932356|NCT02650648|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110932357|NCT03682939|Vaccines|vaccines|mesh-list
110932358|NCT03682939|Immunologic Factors|immunologic factors|mesh-ancestor
110933397|NCT03058900|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110933398|NCT03058900|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110933399|NCT02226510|Metformin|metformin|mesh-list
110933400|NCT02226510|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110933401|NCT02226510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110933402|NCT02225886|Ascorbic Acid|ascorbic acid|mesh-list
110933403|NCT02225886|Antioxidants|antioxidants|mesh-ancestor
110933404|NCT02225886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110933405|NCT02225886|Protective Agents|protective agents|mesh-ancestor
110933406|NCT02225886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110933407|NCT02225886|Vitamins|vitamins|mesh-ancestor
110933408|NCT02225886|Micronutrients|micronutrients|mesh-ancestor
110933409|NCT03671707|Nicotine|nicotine|mesh-list
110933410|NCT03671707|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110933411|NCT03671707|Autonomic Agents|autonomic agents|mesh-ancestor
110933412|NCT03671707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110933413|NCT03671707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110933414|NCT03671707|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110933415|NCT03671707|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110933416|NCT03671707|Cholinergic Agents|cholinergic agents|mesh-ancestor
110933417|NCT03671707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110933418|NCT03671707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110933419|NCT02226588|Misoprostol|misoprostol|mesh-list
110933420|NCT02226588|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110933421|NCT02226588|Abortifacient Agents|abortifacient agents|mesh-ancestor
110933422|NCT02226588|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110933423|NCT02226588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110933424|NCT02226588|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110933425|NCT02226588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110933426|NCT02226588|Oxytocics|oxytocics|mesh-ancestor
110933427|NCT03676621|Misoprostol|misoprostol|mesh-list
110933428|NCT03676621|Oxytocin|oxytocin|mesh-list
110933429|NCT03676621|Oxytocics|oxytocics|mesh-ancestor
110933430|NCT03676621|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110933431|NCT03676621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110933453|NCT02232360|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110933454|NCT02232360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110933456|NCT02226978|Tipranavir|tipranavir|mesh-list
110933457|NCT02226978|Valacyclovir|valacyclovir|mesh-list
110933458|NCT02226978|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110933459|NCT02226978|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110933460|NCT02226978|Protease Inhibitors|protease inhibitors|mesh-ancestor
110933461|NCT02226978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110933462|NCT02226978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110933463|NCT02226978|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110933464|NCT02226978|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110933465|NCT02226978|Antiviral Agents|antiviral agents|mesh-ancestor
110933466|NCT02226978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110933467|NCT02226978|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110933468|NCT02226978|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110933469|NCT02227056|Methylphenidate|methylphenidate|mesh-list
110933470|NCT02227056|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110933471|NCT02227056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110933472|NCT02227056|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110933473|NCT02227056|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110933474|NCT02227056|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110932359|NCT03682939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110932360|NCT02201992|Crizotinib|crizotinib|mesh-list
110932361|NCT02201992|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
110932362|NCT02201992|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110932363|NCT02201992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110932364|NCT02201992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110932365|NCT02201992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110932366|NCT03534492|Durvalumab|durvalumab|mesh-list
110932367|NCT03534492|Olaparib|olaparib|mesh-list
110932368|NCT03534492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110932369|NCT03534492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110932370|NCT03534492|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110234435|NCT05645718|Antiemetics|antiemetics|mesh-ancestor
110933475|NCT02227056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110933476|NCT02227056|Dopamine Agents|dopamine agents|mesh-ancestor
110933477|NCT02227056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110933478|NCT05708157|Histamine Antagonists|histamine antagonists|mesh-list
110933479|NCT05708157|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
110933480|NCT05708157|Histamine Agents|histamine agents|mesh-ancestor
110933481|NCT05708157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110281685|NCT04571437|Letrozole|letrozole|mesh-list
110933504|NCT03058666|Respiratory System Agents|respiratory system agents|mesh-ancestor
110933506|NCT02227212|Insulin Glargine|insulin glargine|mesh-list
110933507|NCT02227212|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110933508|NCT02227212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110933509|NCT00303849|Sodium thiosulfate|sodium thiosulfate|mesh-list
110933510|NCT00303849|Carboplatin|carboplatin|mesh-list
110933511|NCT00303849|Etoposide|etoposide|mesh-list
110933512|NCT00303849|Etoposide phosphate|etoposide phosphate|mesh-list
110933513|NCT00303849|Melphalan|melphalan|mesh-list
110933514|NCT00303849|Mechlorethamine|mechlorethamine|mesh-list
110933515|NCT00303849|Podophyllotoxin|podophyllotoxin|mesh-list
110933516|NCT00303849|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
110933517|NCT00303849|Mannitol|mannitol|mesh-list
110933518|NCT00303849|Antidotes|antidotes|mesh-list
110933519|NCT00303849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110933520|NCT00303849|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110933521|NCT00303849|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110933522|NCT00303849|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110933523|NCT00303849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110933524|NCT00303849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110933525|NCT00303849|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110933526|NCT00303849|Alkylating Agents|alkylating agents|mesh-ancestor
110933527|NCT00303849|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110933528|NCT00303849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110933529|NCT00303849|Immunologic Factors|immunologic factors|mesh-ancestor
110234856|NCT04528004|Niacin|niacin|mesh-list
110933530|NCT00303849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110933531|NCT00303849|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110933532|NCT00303849|Diuretics|diuretics|mesh-ancestor
110933533|NCT00303849|Natriuretic Agents|natriuretic agents|mesh-ancestor
110933534|NCT00303849|Keratolytic Agents|keratolytic agents|mesh-ancestor
110933535|NCT00303849|Dermatologic Agents|dermatologic agents|mesh-ancestor
110933552|NCT01355523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110933553|NCT01355523|Protective Agents|protective agents|mesh-ancestor
110933554|NCT01355523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110933555|NCT01355523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110933556|NCT02227914|Sorafenib|sorafenib|mesh-list
110933557|NCT02227914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110933558|NCT02227914|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110933559|NCT02227914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110933560|NCT02227914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110933561|NCT04161456|Apremilast|apremilast|mesh-list
110933562|NCT04161456|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110933563|NCT04161456|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110235056|NCT03678883|Paclitaxel|paclitaxel|mesh-list
110932371|NCT03534492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110932372|NCT03534492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110932373|NCT03624283|Betahistine|betahistine|mesh-list
110932374|NCT03624283|Vasodilator Agents|vasodilator agents|mesh-ancestor
110932375|NCT03624283|Histamine Agonists|histamine agonists|mesh-ancestor
110932376|NCT03624283|Histamine Agents|histamine agents|mesh-ancestor
110932377|NCT03624283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110932378|NCT03624283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110933564|NCT04161456|Analgesics|analgesics|mesh-ancestor
110933565|NCT04161456|Sensory System Agents|sensory system agents|mesh-ancestor
110933566|NCT04161456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110933567|NCT04161456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110933568|NCT04161456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110933569|NCT04161456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110933570|NCT04161456|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
110933571|NCT04161456|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110235112|NCT03464942|Atezolizumab|atezolizumab|mesh-list
110933572|NCT04161456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110933573|NCT04161456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110933574|NCT02224014|Brotizolam|brotizolam|mesh-list
110933575|NCT02224014|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110933576|NCT02224014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110933577|NCT02224014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110933578|NCT03671161|Insulin|insulin|mesh-list
110933579|NCT03671161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110933580|NCT03671161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110933581|NCT04950400|Apatinib|apatinib|mesh-list
110933582|NCT04950400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110933583|NCT04950400|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110933584|NCT04950400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110933585|NCT04950400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110933586|NCT04949932|Turmeric extract|turmeric extract|mesh-list
110933587|NCT04949932|Antioxidants|antioxidants|mesh-ancestor
110933588|NCT04949932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110933589|NCT04949932|Protective Agents|protective agents|mesh-ancestor
110933590|NCT04949932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110933591|NCT02826603|Ustekinumab|ustekinumab|mesh-list
110933592|NCT02826603|Dermatologic Agents|dermatologic agents|mesh-ancestor
110933593|NCT02224170|Dexamethasone|dexamethasone|mesh-list
110933594|NCT02224170|Lidocaine|lidocaine|mesh-list
110933595|NCT02224170|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110933596|NCT02224170|Antiemetics|antiemetics|mesh-ancestor
110933603|NCT02224170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110933604|NCT02224170|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110933605|NCT02224170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110933606|NCT02224170|Anesthetics, Local|anesthetics, local|mesh-ancestor
110933607|NCT02224170|Anesthetics|anesthetics|mesh-ancestor
110933608|NCT02224170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110933609|NCT02224170|Sensory System Agents|sensory system agents|mesh-ancestor
110235295|NCT01952782|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110933610|NCT02224170|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110933611|NCT02224170|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110933612|NCT02224170|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110933613|NCT02224170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110933614|NCT02224170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110235362|NCT00099086|Goserelin|goserelin|mesh-list
110933615|NCT05956769|Tranexamic Acid|tranexamic acid|mesh-list
110933616|NCT05956769|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110933617|NCT05956769|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110933618|NCT05956769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110933619|NCT05956769|Hemostatics|hemostatics|mesh-ancestor
110933620|NCT05956769|Coagulants|coagulants|mesh-ancestor
110933621|NCT05956639|Androgen Antagonists|androgen antagonists|mesh-list
110933622|NCT05956639|Hormone Antagonists|hormone antagonists|mesh-ancestor
110933623|NCT05956639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110235434|NCT04715620|Niraparib|niraparib|mesh-list
110933624|NCT05956639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110933625|NCT05956600|Amisulpride|amisulpride|mesh-list
110933626|NCT05956600|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110932379|NCT03624283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110932381|NCT03687463|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110932382|NCT03687463|Antimetabolites|antimetabolites|mesh-ancestor
110932383|NCT03687463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110932384|NCT03687463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110932385|NCT03687463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110932386|NCT03692143|Alendronate|alendronate|mesh-list
110932387|NCT03692143|Teriparatide|teriparatide|mesh-list
110932388|NCT03692143|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110933627|NCT05956600|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110933628|NCT05956600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110933629|NCT05956600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110933630|NCT05956600|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110933631|NCT05956600|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110933632|NCT05956600|Dopamine Agents|dopamine agents|mesh-ancestor
110933633|NCT05956600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110933634|NCT05956600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110933635|NCT05956600|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110933636|NCT05956600|Antidepressive Agents|antidepressive agents|mesh-ancestor
110933637|NCT05956561|Vitamin D|vitamin d|mesh-list
110933638|NCT05956561|Vitamins|vitamins|mesh-ancestor
110933639|NCT05956561|Micronutrients|micronutrients|mesh-ancestor
110235571|NCT00088556|Paclitaxel|paclitaxel|mesh-list
110933640|NCT05956561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110933641|NCT05956561|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110933642|NCT05956522|Empagliflozin|empagliflozin|mesh-list
110933643|NCT05956522|Linagliptin|linagliptin|mesh-list
110933644|NCT05956522|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110933645|NCT05956522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110933646|NCT05956522|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110933647|NCT05956522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110933648|NCT05956522|Incretins|incretins|mesh-ancestor
110933649|NCT05956522|Hormones|hormones|mesh-ancestor
110933650|NCT05956522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110933651|NCT05956522|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110933652|NCT05956522|Protease Inhibitors|protease inhibitors|mesh-ancestor
110933653|NCT05956522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110933654|NCT05956509|Botulinum Toxins|botulinum toxins|mesh-list
110933655|NCT05956509|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110933656|NCT05956509|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110235776|NCT00089258|Antibodies|antibodies|mesh-list
110933657|NCT05956509|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110933658|NCT05956509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110933659|NCT05956509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110933660|NCT05956509|Cholinergic Agents|cholinergic agents|mesh-ancestor
110933661|NCT05956509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110933662|NCT05956509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110281842|NCT00215514|Fluorouracil|fluorouracil|mesh-list
110933668|NCT05956431|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110933669|NCT05956431|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110933670|NCT05956431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110933671|NCT05956431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110933672|NCT05956431|Protective Agents|protective agents|mesh-ancestor
110933673|NCT05956431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110933674|NCT05956418|Citric Acid|citric acid|mesh-list
110933675|NCT05956418|Sodium Citrate|sodium citrate|mesh-list
110933676|NCT05956418|Anticoagulants|anticoagulants|mesh-ancestor
110933677|NCT05956418|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110933678|NCT05956418|Chelating Agents|chelating agents|mesh-ancestor
110933679|NCT05956418|Sequestering Agents|sequestering agents|mesh-ancestor
110933680|NCT05956418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110933681|NCT05956275|Tramadol|tramadol|mesh-list
110933682|NCT05956275|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110933683|NCT05956275|Narcotics|narcotics|mesh-ancestor
110933684|NCT05956275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110932389|NCT03692143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110932390|NCT03692143|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110655625|NCT04008966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110266744|NCT00538603|Paclitaxel|paclitaxel|mesh-list
110932391|NCT02201004|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3H),2'-(2H)pyran)-3',4',5'-triol|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3h),2'-(2h)pyran)-3',4',5'-triol|mesh-list
110932392|NCT02201004|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110932393|NCT02201004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110236289|NCT00127959|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110932394|NCT02201004|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110932395|NCT02201004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110932396|NCT02197884|Clarithromycin|clarithromycin|mesh-list
110932397|NCT02197884|Itraconazole|itraconazole|mesh-list
110932398|NCT02197884|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110932399|NCT02197884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110932400|NCT02197884|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110932401|NCT02197884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110932402|NCT02197884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110932403|NCT02197884|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110236435|NCT00345163|Growth Substances|growth substances|mesh-ancestor
110932404|NCT02197884|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110932405|NCT02197884|Antifungal Agents|antifungal agents|mesh-ancestor
110932406|NCT02197884|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110932407|NCT02197884|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110932408|NCT02197884|Hormone Antagonists|hormone antagonists|mesh-ancestor
110932409|NCT02197884|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110932410|NCT02197884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110932412|NCT02201082|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110932413|NCT02201082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110932414|NCT03687229|Insulin|insulin|mesh-list
110932415|NCT03687229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110932416|NCT03687229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110932417|NCT05085054|Osimertinib|osimertinib|mesh-list
110932418|NCT05085054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110932419|NCT05085054|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110932420|NCT05085054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110236689|NCT00346879|PENTA|penta|mesh-list
110933685|NCT05956275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110933686|NCT05956275|Analgesics|analgesics|mesh-ancestor
110933687|NCT05956275|Sensory System Agents|sensory system agents|mesh-ancestor
110933688|NCT05956275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110932421|NCT05085054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110932423|NCT03969121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110932424|NCT03969121|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110932425|NCT03969121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110932426|NCT03969121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110932427|NCT02201238|Diclofenac|diclofenac|mesh-list
110932428|NCT02201238|Menthol|menthol|mesh-list
110932429|NCT02201238|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110932430|NCT02201238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110932431|NCT02201238|Analgesics|analgesics|mesh-ancestor
110932432|NCT02201238|Sensory System Agents|sensory system agents|mesh-ancestor
110932433|NCT02201238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110932434|NCT02201238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110933689|NCT05956145|Colchicine|colchicine|mesh-list
110933690|NCT05956145|Gout Suppressants|gout suppressants|mesh-ancestor
110933691|NCT05956145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110933692|NCT05956145|Tubulin Modulators|tubulin modulators|mesh-ancestor
110933693|NCT05956145|Antimitotic Agents|antimitotic agents|mesh-ancestor
110933694|NCT05956145|Mitosis Modulators|mitosis modulators|mesh-ancestor
110933695|NCT05956145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110933696|NCT05956145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110933697|NCT05955833|Trastuzumab|trastuzumab|mesh-list
110933698|NCT05955833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110933699|NCT05955833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110933700|NCT05955677|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
110933701|NCT05955677|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110933702|NCT05955677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110933703|NCT05955313|Naltrexone|naltrexone|mesh-list
110933704|NCT05955313|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110933705|NCT05955313|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110933706|NCT05955313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110933707|NCT05955313|Sensory System Agents|sensory system agents|mesh-ancestor
110237105|NCT00426946|Reboxetine|reboxetine|mesh-list
110933708|NCT05955313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110933709|NCT05955209|Disitamab vedotin|disitamab vedotin|mesh-list
110933710|NCT05955209|Immunoconjugates|immunoconjugates|mesh-ancestor
110933711|NCT05955209|Immunologic Factors|immunologic factors|mesh-ancestor
110933712|NCT05955209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110933713|NCT05955170|Trastuzumab|trastuzumab|mesh-list
110933714|NCT05955170|Tucatinib|tucatinib|mesh-list
110933715|NCT05955170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110237250|NCT00428272|Interferons|interferons|mesh-list
110933716|NCT05955170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110933717|NCT05955170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110933718|NCT05955170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110933719|NCT05955170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110933720|NCT05955157|Tegafur|tegafur|mesh-list
110933721|NCT05955157|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110933722|NCT05955157|Antimetabolites|antimetabolites|mesh-ancestor
110237325|NCT00092339|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110933723|NCT05955157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110933724|NCT05955157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110933725|NCT05952349|Metformin|metformin|mesh-list
110933726|NCT05952349|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110933727|NCT05952349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110933728|NCT05952310|Immunomodulating Agents|immunomodulating agents|mesh-list
110933729|NCT05952310|Immunologic Factors|immunologic factors|mesh-ancestor
110933730|NCT05952310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110933731|NCT05951504|Methylprednisolone|methylprednisolone|mesh-list
110933732|NCT05951504|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110933733|NCT05951504|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110933737|NCT05951504|Prednisolone phosphate|prednisolone phosphate|mesh-list
110932435|NCT02201238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110932436|NCT02201238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110932437|NCT02201238|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110932438|NCT02201238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110932439|NCT02201238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110932440|NCT02201238|Antipruritics|antipruritics|mesh-ancestor
110932441|NCT02201238|Dermatologic Agents|dermatologic agents|mesh-ancestor
110932442|NCT02257398|Moxifloxacin|moxifloxacin|mesh-list
110932443|NCT02257398|Gepotidacin|gepotidacin|mesh-list
110932444|NCT02257398|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
110237629|NCT00094367|Lamivudine|lamivudine|mesh-list
110932445|NCT02257398|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110237701|NCT00094640|Serotonin Agents|serotonin agents|mesh-ancestor
110932446|NCT02257398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110932447|NCT02257398|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110932448|NCT02257398|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110280694|NCT00189683|Capecitabine|capecitabine|mesh-list
110933738|NCT05951504|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110933739|NCT05951504|Antiemetics|antiemetics|mesh-ancestor
110933740|NCT05951504|Autonomic Agents|autonomic agents|mesh-ancestor
110933741|NCT05951504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110933742|NCT05951504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110933743|NCT05951504|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110237856|NCT00095810|Aripiprazole|aripiprazole|mesh-list
110933744|NCT05951504|Glucocorticoids|glucocorticoids|mesh-ancestor
110933745|NCT05951504|Hormones|hormones|mesh-ancestor
110237923|NCT00429754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110933746|NCT05951504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110267111|NCT00540748|Oxytocin|oxytocin|mesh-list
110933747|NCT05951504|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110933748|NCT05951504|Protective Agents|protective agents|mesh-ancestor
110933749|NCT05951504|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110933750|NCT05951504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110933751|NCT05946200|Anesthetics|anesthetics|mesh-list
110933752|NCT05946200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110933753|NCT05946200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110933754|NCT05925166|Triamcinolone|triamcinolone|mesh-list
110933755|NCT05925166|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110933756|NCT05925166|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110933757|NCT05925166|Etanercept|etanercept|mesh-list
110933758|NCT05925166|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110933759|NCT05925166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110933760|NCT05925166|Glucocorticoids|glucocorticoids|mesh-ancestor
110933761|NCT05925166|Hormones|hormones|mesh-ancestor
110933762|NCT05925166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110933763|NCT05925166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110933764|NCT05925166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110933765|NCT05925166|Immunologic Factors|immunologic factors|mesh-ancestor
110238223|NCT00431080|Fluorouracil|fluorouracil|mesh-list
110933766|NCT05925166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110933767|NCT05925166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110933768|NCT05925166|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110933769|NCT05925166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110933770|NCT05925166|Analgesics|analgesics|mesh-ancestor
110238294|NCT00431236|Glucocorticoids|glucocorticoids|mesh-ancestor
110933771|NCT05925166|Sensory System Agents|sensory system agents|mesh-ancestor
110933772|NCT05925166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110238368|NCT01052662|Memantine|memantine|mesh-list
110933773|NCT05925166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110933774|NCT05925166|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110933775|NCT05914155|Rituximab|rituximab|mesh-list
110933776|NCT05914155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110933777|NCT05914155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110933778|NCT05914155|Immunologic Factors|immunologic factors|mesh-ancestor
110933779|NCT05914155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110933780|NCT05914155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110933781|NCT05896293|Hormones|hormones|mesh-list
110035404|NCT01404767|Autonomic Agents|autonomic agents|mesh-ancestor
110932449|NCT02257398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110932450|NCT02257398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110932451|NCT02257398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110932452|NCT02257398|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110932453|NCT02257398|Contraceptive Agents|contraceptive agents|mesh-ancestor
110932454|NCT02257398|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110932455|NCT02257398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110932456|NCT02257398|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110932457|NCT02257398|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110932458|NCT02257398|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110932459|NCT02201316|Mosapride|mosapride|mesh-list
110238508|NCT00432406|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110932460|NCT02201316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110933782|NCT05896293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110933783|NCT05896293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110933784|NCT05881928|Lamotrigine|lamotrigine|mesh-list
110933785|NCT05881928|Valproic Acid|valproic acid|mesh-list
110238569|NCT00097916|Memantine|memantine|mesh-list
110933786|NCT05881928|Anticonvulsants|anticonvulsants|mesh-ancestor
110933787|NCT05881928|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110933788|NCT05881928|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110933789|NCT05881928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110933790|NCT05881928|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110933791|NCT05881928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110238657|NCT00433225|Gatifloxacin|gatifloxacin|mesh-list
110933792|NCT05881928|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110933793|NCT05881928|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110933794|NCT05881928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110933795|NCT05881928|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110933796|NCT05881928|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110933797|NCT05881928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110933798|NCT05881928|GABA Agents|gaba agents|mesh-ancestor
110933799|NCT05881928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110933800|NCT05881928|Antimanic Agents|antimanic agents|mesh-ancestor
110933801|NCT05872893|Dexamethasone|dexamethasone|mesh-list
110933802|NCT05872893|Ondansetron|ondansetron|mesh-list
110933803|NCT05872893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110933804|NCT05872893|Antiemetics|antiemetics|mesh-ancestor
110933805|NCT05872893|Autonomic Agents|autonomic agents|mesh-ancestor
110933806|NCT05872893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110933816|NCT05872893|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110933817|NCT05872893|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110933818|NCT05872893|Serotonin Agents|serotonin agents|mesh-ancestor
110933819|NCT05872893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110933820|NCT05872893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110933821|NCT05853575|Adagrasib|adagrasib|mesh-list
110933822|NCT05853575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110933823|NCT05826275|Pembrolizumab|pembrolizumab|mesh-list
110933824|NCT05826275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110933825|NCT05826275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110933826|NCT05826275|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110933827|NCT05826275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110933828|NCT05774249|Bupivacaine|bupivacaine|mesh-list
110933829|NCT05774249|Anesthetics, Local|anesthetics, local|mesh-ancestor
110933830|NCT05774249|Anesthetics|anesthetics|mesh-ancestor
110239069|NCT00099320|Hormones|hormones|mesh-ancestor
110933831|NCT05774249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110933832|NCT05774249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110933833|NCT05774249|Sensory System Agents|sensory system agents|mesh-ancestor
110933834|NCT05774249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110933835|NCT05767398|Zanubrutinib|zanubrutinib|mesh-list
110933836|NCT05767398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110933837|NCT05767398|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110933838|NCT05767398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110932461|NCT02201316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110932462|NCT02201316|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110932464|NCT02201316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110932465|NCT02201316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110932466|NCT02198820|Anesthetics|anesthetics|mesh-list
110932467|NCT02198820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110932468|NCT02198820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110932469|NCT02257476|Dexamethasone|dexamethasone|mesh-list
110932470|NCT02257476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110932471|NCT02257476|Antiemetics|antiemetics|mesh-ancestor
110932472|NCT02257476|Autonomic Agents|autonomic agents|mesh-ancestor
110932473|NCT02257476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110932474|NCT02257476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110932475|NCT02257476|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110932476|NCT02257476|Glucocorticoids|glucocorticoids|mesh-ancestor
110932477|NCT02257476|Hormones|hormones|mesh-ancestor
110239281|NCT00132561|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110932478|NCT02257476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110932479|NCT02257476|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110933839|NCT05767398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110933840|NCT05742438|Lidocaine|lidocaine|mesh-list
110933841|NCT05742438|Dexmedetomidine|dexmedetomidine|mesh-list
110933842|NCT05742438|Morphine|morphine|mesh-list
110933843|NCT05742438|Anesthetics, Local|anesthetics, local|mesh-ancestor
110933844|NCT05742438|Anesthetics|anesthetics|mesh-ancestor
110933845|NCT05742438|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110933846|NCT05742438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110933847|NCT05742438|Sensory System Agents|sensory system agents|mesh-ancestor
110933848|NCT05742438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110933849|NCT05742438|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110933850|NCT05742438|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110933851|NCT05742438|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110933852|NCT05742438|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110933853|NCT05742438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110933854|NCT05742438|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110933855|NCT05742438|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110933856|NCT05742438|Analgesics|analgesics|mesh-ancestor
110933857|NCT05742438|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110933858|NCT05742438|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110933859|NCT05742438|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110933860|NCT05742438|Adrenergic Agents|adrenergic agents|mesh-ancestor
110933861|NCT05742438|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110933862|NCT05742438|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110933863|NCT05742438|Narcotics|narcotics|mesh-ancestor
110933864|NCT05732961|Luspatercept|luspatercept|mesh-list
110933865|NCT05732961|Hematinics|hematinics|mesh-ancestor
110933866|NCT05730751|Anesthetics|anesthetics|mesh-list
110933867|NCT05730751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110933868|NCT05730751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110933869|NCT05685225|Acetaminophen|acetaminophen|mesh-list
110933870|NCT05685225|Naltrexone|naltrexone|mesh-list
110933871|NCT05685225|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110933882|NCT05670743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110933883|NCT05662319|Antithrombins|antithrombins|mesh-list
110933884|NCT05662319|Antithrombin III|antithrombin iii|mesh-list
110035480|NCT01405131|Glucocorticoids|glucocorticoids|mesh-ancestor
110932480|NCT02257476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110932481|NCT03946111|Naltrexone|naltrexone|mesh-list
110932482|NCT03946111|Bupropion|bupropion|mesh-list
110239549|NCT00135720|Etanercept|etanercept|mesh-list
110932483|NCT03946111|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110932484|NCT03946111|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110932485|NCT03946111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110932486|NCT03946111|Sensory System Agents|sensory system agents|mesh-ancestor
110932487|NCT03946111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110932488|NCT03946111|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110932489|NCT03946111|Antidepressive Agents|antidepressive agents|mesh-ancestor
110932490|NCT03946111|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110933885|NCT05662319|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110933886|NCT05662319|Protease Inhibitors|protease inhibitors|mesh-ancestor
110933887|NCT05662319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110239610|NCT00135876|Anticoagulants|anticoagulants|mesh-ancestor
110933888|NCT05662319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110933889|NCT05662319|Anticoagulants|anticoagulants|mesh-ancestor
110933890|NCT05656248|Cytarabine|cytarabine|mesh-list
110933891|NCT05656248|Hydrocortisone|hydrocortisone|mesh-list
110933892|NCT05656248|Methotrexate|methotrexate|mesh-list
110933893|NCT05656248|Daunorubicin|daunorubicin|mesh-list
110933894|NCT05656248|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110933895|NCT05656248|Abortifacient Agents|abortifacient agents|mesh-ancestor
110933896|NCT05656248|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110933897|NCT05656248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110933898|NCT05656248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110933899|NCT05656248|Antimetabolites|antimetabolites|mesh-ancestor
110933900|NCT05656248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110933901|NCT05656248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110933902|NCT05656248|Dermatologic Agents|dermatologic agents|mesh-ancestor
110933903|NCT05656248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110933904|NCT05656248|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110933905|NCT05656248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110933906|NCT05656248|Immunologic Factors|immunologic factors|mesh-ancestor
110933907|NCT05656248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110239736|NCT00133419|Zinc|zinc|mesh-list
110933908|NCT05656248|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110933909|NCT05656248|Antiviral Agents|antiviral agents|mesh-ancestor
110933910|NCT05656248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110651468|NCT00566696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110933911|NCT05656248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110933912|NCT05656248|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110933913|NCT05656248|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110933914|NCT05656248|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110933915|NCT05650008|Anesthetics|anesthetics|mesh-list
110933916|NCT05650008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110933917|NCT05650008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110933918|NCT05634174|Mirabegron|mirabegron|mesh-list
110933919|NCT05634174|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
110933920|NCT05634174|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110933921|NCT05634174|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110933922|NCT05634174|Adrenergic Agents|adrenergic agents|mesh-ancestor
110933923|NCT05634174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110933924|NCT05634174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110239877|NCT00136383|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110933925|NCT05634174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110933926|NCT05634174|Urological Agents|urological agents|mesh-ancestor
110933927|NCT05619705|Benzocaine|benzocaine|mesh-list
110933928|NCT05619705|Anesthetics, Local|anesthetics, local|mesh-ancestor
110933929|NCT05619705|Anesthetics|anesthetics|mesh-ancestor
110933930|NCT05619705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110933931|NCT05619705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110933932|NCT05619705|Sensory System Agents|sensory system agents|mesh-ancestor
110933933|NCT05619705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110933934|NCT05609565|Bupivacaine|bupivacaine|mesh-list
110933935|NCT05609565|Prilocaine|prilocaine|mesh-list
110933936|NCT05609565|Anesthetics|anesthetics|mesh-list
110933937|NCT05609565|Anesthetics, Local|anesthetics, local|mesh-ancestor
110932491|NCT03946111|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110932492|NCT03946111|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110932493|NCT03946111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110932494|NCT03946111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110932495|NCT03946111|Dopamine Agents|dopamine agents|mesh-ancestor
110932496|NCT03946111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110932497|NCT03946111|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110932498|NCT03946111|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110932499|NCT03946111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110932500|NCT03943927|Metoprolol|metoprolol|mesh-list
110932501|NCT03943927|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110932502|NCT03943927|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110932503|NCT03943927|Sympatholytics|sympatholytics|mesh-ancestor
110932504|NCT03943927|Autonomic Agents|autonomic agents|mesh-ancestor
110932505|NCT03943927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110933943|NCT05604859|Heparin|heparin|mesh-list
110933944|NCT05604859|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
110933945|NCT05604859|Tinzaparin|tinzaparin|mesh-list
110933946|NCT05604859|Dalteparin|dalteparin|mesh-list
110933947|NCT05604859|Immunoglobulins|immunoglobulins|mesh-list
110933948|NCT05604859|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110933949|NCT05604859|gamma-Globulins|gamma-globulins|mesh-list
110239998|NCT00136539|Doxorubicin|doxorubicin|mesh-list
110933950|NCT05604859|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110933951|NCT05604859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110933952|NCT05604859|Antiemetics|antiemetics|mesh-ancestor
110933953|NCT05604859|Autonomic Agents|autonomic agents|mesh-ancestor
110933954|NCT05604859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110933955|NCT05604859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110933956|NCT05604859|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110933957|NCT05604859|Glucocorticoids|glucocorticoids|mesh-ancestor
110933958|NCT05604859|Hormones|hormones|mesh-ancestor
110933959|NCT05604859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110933960|NCT05604859|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110933961|NCT05604859|Protective Agents|protective agents|mesh-ancestor
110933962|NCT05604859|Anticoagulants|anticoagulants|mesh-ancestor
110240133|NCT00136734|Dopamine Agents|dopamine agents|mesh-ancestor
110933963|NCT05604859|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110933964|NCT05604859|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110933965|NCT05604859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110933966|NCT05604859|Immunologic Factors|immunologic factors|mesh-ancestor
110933967|NCT05590234|Dexmedetomidine|dexmedetomidine|mesh-list
110933968|NCT05590234|Bupivacaine|bupivacaine|mesh-list
110933969|NCT05590234|Anesthetics, Local|anesthetics, local|mesh-ancestor
110933970|NCT05590234|Anesthetics|anesthetics|mesh-ancestor
110933971|NCT05590234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110933972|NCT05590234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110933973|NCT05590234|Sensory System Agents|sensory system agents|mesh-ancestor
110933974|NCT05590234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110933975|NCT05590234|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110933976|NCT05590234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110933977|NCT05590234|Analgesics|analgesics|mesh-ancestor
110933978|NCT05590234|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110933979|NCT05590234|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110933980|NCT05590234|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110933981|NCT05590234|Adrenergic Agents|adrenergic agents|mesh-ancestor
110933982|NCT05590234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110933983|NCT05590234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110933984|NCT05572749|Metformin|metformin|mesh-list
110933985|NCT05572749|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110933986|NCT05572749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110933987|NCT05540223|Sirolimus|sirolimus|mesh-list
110932506|NCT03943927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110932507|NCT03943927|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110932508|NCT03943927|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110932509|NCT03943927|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110932510|NCT03943927|Adrenergic Agents|adrenergic agents|mesh-ancestor
110932511|NCT03943927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110932512|NCT03943927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110932513|NCT03533166|Chlorhexidine|chlorhexidine|mesh-list
110932514|NCT03533166|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110932515|NCT03533166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110932516|NCT03533166|Disinfectants|disinfectants|mesh-ancestor
110932517|NCT03687073|Silybin|silybin|mesh-list
110932518|NCT03687073|Indole-3-carbinol|indole-3-carbinol|mesh-list
110280767|NCT00189839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110933988|NCT05540223|Everolimus|everolimus|mesh-list
110933989|NCT05540223|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110933990|NCT05540223|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110240474|NCT00135018|Celecoxib|celecoxib|mesh-list
110933991|NCT05540223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110933992|NCT05540223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110933993|NCT05540223|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110933994|NCT05540223|Immunologic Factors|immunologic factors|mesh-ancestor
110933995|NCT05540223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110933996|NCT05540223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110240537|NCT04702048|Growth Substances|growth substances|mesh-ancestor
110933997|NCT05540223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110933998|NCT05540223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110933999|NCT05540223|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110934000|NCT05540223|Antifungal Agents|antifungal agents|mesh-ancestor
110934001|NCT05539027|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110934002|NCT05539027|N-Methylaspartate|n-methylaspartate|mesh-list
110240605|NCT00135096|Insulin|insulin|mesh-list
110934003|NCT05539027|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
110934004|NCT05539027|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110934005|NCT05539027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110934006|NCT05539027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110934007|NCT05539027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110934011|NCT05476172|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110934013|NCT05476172|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110934014|NCT05476172|Contraceptive Agents|contraceptive agents|mesh-ancestor
110934015|NCT05476172|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110934016|NCT05476172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110934017|NCT05476172|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110934018|NCT05476172|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110934019|NCT05476172|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110934020|NCT05476172|Hormone Antagonists|hormone antagonists|mesh-ancestor
110934021|NCT05476172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110934022|NCT05476172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110934023|NCT05476172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110934024|NCT05432518|Everolimus|everolimus|mesh-list
110934025|NCT05432518|Dasatinib|dasatinib|mesh-list
110934026|NCT05432518|Olaparib|olaparib|mesh-list
110934027|NCT05432518|Palbociclib|palbociclib|mesh-list
110934028|NCT05432518|Afatinib|afatinib|mesh-list
110934029|NCT05432518|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110934030|NCT05432518|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110934031|NCT05432518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110240888|NCT00106496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110934032|NCT05432518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110934033|NCT05432518|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110934034|NCT05432518|Immunologic Factors|immunologic factors|mesh-ancestor
110934035|NCT05432518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110934036|NCT05432518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110932519|NCT03687073|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110932520|NCT03687073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110932521|NCT03687073|Protective Agents|protective agents|mesh-ancestor
110932522|NCT03687073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110932523|NCT03687073|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110932524|NCT03682471|Deoxycholic Acid|deoxycholic acid|mesh-list
110932525|NCT03682471|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
110932526|NCT03682471|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110932528|NCT02198352|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
110934037|NCT05432518|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110934038|NCT05413096|Propolis|propolis|mesh-list
110934039|NCT05413096|Diclofenac|diclofenac|mesh-list
110934040|NCT05413096|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110934041|NCT05413096|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110934042|NCT05413096|Analgesics|analgesics|mesh-ancestor
110934043|NCT05413096|Sensory System Agents|sensory system agents|mesh-ancestor
110934044|NCT05413096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110934045|NCT05413096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110934046|NCT05413096|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110934047|NCT05413096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110934048|NCT05413096|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110934049|NCT05413096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110934050|NCT05413096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110934051|NCT05413096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110934052|NCT05393037|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110934053|NCT05393037|Immunologic Factors|immunologic factors|mesh-ancestor
110934054|NCT05393037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110934055|NCT05391061|Abrocitinib|abrocitinib|mesh-list
110934056|NCT05391061|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110934057|NCT05391061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110934058|NCT05391061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110934059|NCT05388006|Durvalumab|durvalumab|mesh-list
110934060|NCT05388006|Venetoclax|venetoclax|mesh-list
110934061|NCT05388006|Acalabrutinib|acalabrutinib|mesh-list
110934062|NCT05388006|Immunoglobulins|immunoglobulins|mesh-list
110934063|NCT05388006|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110241246|NCT00107432|Sorafenib|sorafenib|mesh-list
110934064|NCT05388006|Immunoglobulin G|immunoglobulin g|mesh-list
110934065|NCT05388006|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
110934066|NCT05388006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110934067|NCT05388006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110934068|NCT05388006|Immunologic Factors|immunologic factors|mesh-ancestor
110934069|NCT05388006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110934070|NCT05388006|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110934071|NCT05388006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110241301|NCT00404157|Rituximab|rituximab|mesh-list
110934072|NCT05388006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110934073|NCT05375994|Adagrasib|adagrasib|mesh-list
110934074|NCT05375994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110934075|NCT05338320|Fentanyl|fentanyl|mesh-list
110934076|NCT05338320|Morphine|morphine|mesh-list
110934077|NCT05338320|Anesthetics|anesthetics|mesh-ancestor
110934078|NCT05338320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110934079|NCT05338320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110934080|NCT05338320|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110934081|NCT05338320|Narcotics|narcotics|mesh-ancestor
110934086|NCT05338320|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110934087|NCT05338320|Anesthetics, General|anesthetics, general|mesh-ancestor
110934088|NCT05337540|Hylan|hylan|mesh-list
110934089|NCT05337540|Viscosupplements|viscosupplements|mesh-ancestor
110934090|NCT05337540|Protective Agents|protective agents|mesh-ancestor
110934091|NCT05337540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110934092|NCT05316129|Hormones|hormones|mesh-list
110934093|NCT05316129|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
110934094|NCT05316129|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110932529|NCT02198352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110932530|NCT02198352|Analgesics|analgesics|mesh-ancestor
110932531|NCT02198352|Sensory System Agents|sensory system agents|mesh-ancestor
110932532|NCT02198352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110932533|NCT02198352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110932534|NCT02202564|Ganciclovir|ganciclovir|mesh-list
110932535|NCT02202564|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
110932536|NCT02202564|Antiviral Agents|antiviral agents|mesh-ancestor
110932537|NCT02202564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110932538|NCT02202564|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110932539|NCT02202564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110934095|NCT05316129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110934096|NCT05303532|Durvalumab|durvalumab|mesh-list
110934097|NCT05303532|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110934098|NCT05303532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110934099|NCT05279937|Lidocaine|lidocaine|mesh-list
110934100|NCT05279937|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110934101|NCT05279937|Anesthetics, Local|anesthetics, local|mesh-ancestor
110934102|NCT05279937|Anesthetics|anesthetics|mesh-ancestor
110934103|NCT05279937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110934104|NCT05279937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110934105|NCT05279937|Sensory System Agents|sensory system agents|mesh-ancestor
110934106|NCT05279937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110934107|NCT05279937|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110934108|NCT05279937|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110934109|NCT05279937|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110934110|NCT05279937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110934111|NCT05279937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110934112|NCT05260073|Tirbanibulin|tirbanibulin|mesh-list
110241565|NCT00108095|Ondansetron|ondansetron|mesh-list
110934113|NCT05260073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110934114|NCT05260073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110934115|NCT05249959|Cytarabine|cytarabine|mesh-list
110934116|NCT05249959|Rituximab|rituximab|mesh-list
110934117|NCT05249959|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
110934118|NCT05249959|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110934119|NCT05249959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110934120|NCT05249959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110934121|NCT05249959|Immunologic Factors|immunologic factors|mesh-ancestor
110934122|NCT05249959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110934123|NCT05249959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110934124|NCT05249959|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110934125|NCT05249959|Antimetabolites|antimetabolites|mesh-ancestor
110934126|NCT05249959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110934127|NCT05249959|Antiviral Agents|antiviral agents|mesh-ancestor
110934128|NCT05249959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110934129|NCT05249959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110934130|NCT05249959|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110934131|NCT05249959|Alkylating Agents|alkylating agents|mesh-ancestor
110934132|NCT05242874|Dexamethasone|dexamethasone|mesh-list
110934133|NCT05242874|Dexamethasone acetate|dexamethasone acetate|mesh-list
110934134|NCT05242874|Olanzapine|olanzapine|mesh-list
110934135|NCT05242874|Fosaprepitant|fosaprepitant|mesh-list
110934136|NCT05242874|Aprepitant|aprepitant|mesh-list
110651700|NCT00446992|Olanzapine|olanzapine|mesh-list
110934137|NCT05242874|Antiemetics|antiemetics|mesh-list
110934138|NCT05242874|Tropisetron|tropisetron|mesh-list
110934139|NCT05242874|BB 1101|bb 1101|mesh-list
110934140|NCT05242874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110934141|NCT05242874|Autonomic Agents|autonomic agents|mesh-ancestor
110241625|NCT00442741|Epothilone B|epothilone b|mesh-list
110934142|NCT05242874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110934143|NCT05242874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110934144|NCT05242874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110934145|NCT05242874|Glucocorticoids|glucocorticoids|mesh-ancestor
110934146|NCT05242874|Hormones|hormones|mesh-ancestor
110035481|NCT01405131|Hormones|hormones|mesh-ancestor
110932540|NCT02202564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110932541|NCT02198508|Deferasirox|deferasirox|mesh-list
110932542|NCT02198508|Deferiprone|deferiprone|mesh-list
110932543|NCT02198508|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110932544|NCT02198508|Chelating Agents|chelating agents|mesh-ancestor
110932545|NCT02198508|Sequestering Agents|sequestering agents|mesh-ancestor
110932546|NCT02198508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110932547|NCT02202720|Sevoflurane|sevoflurane|mesh-list
110932548|NCT02202720|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110934147|NCT05242874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110934148|NCT05242874|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110934149|NCT05242874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110934150|NCT05242874|Protease Inhibitors|protease inhibitors|mesh-ancestor
110934151|NCT05242874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110282322|NCT00193739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110934160|NCT05242874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110934161|NCT05242874|Serotonin Agents|serotonin agents|mesh-ancestor
110934162|NCT05242874|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110934163|NCT05242874|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110934164|NCT05242874|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110934165|NCT05218733|Fentanyl|fentanyl|mesh-list
110934166|NCT05218733|Morphine|morphine|mesh-list
110934167|NCT05218733|Anesthetics|anesthetics|mesh-ancestor
110934168|NCT05218733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110934169|NCT05218733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110934170|NCT05218733|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110934171|NCT05218733|Narcotics|narcotics|mesh-ancestor
110934172|NCT05218733|Analgesics|analgesics|mesh-ancestor
110934173|NCT05218733|Sensory System Agents|sensory system agents|mesh-ancestor
110934174|NCT05218733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110934175|NCT05218733|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110934176|NCT05218733|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110934177|NCT05218733|Anesthetics, General|anesthetics, general|mesh-ancestor
110934179|NCT05214287|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110934180|NCT05214287|Protective Agents|protective agents|mesh-ancestor
110934181|NCT05214287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110934182|NCT05182931|Trametinib|trametinib|mesh-list
110934183|NCT05182931|Dabrafenib|dabrafenib|mesh-list
110934184|NCT05182931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110934185|NCT05182931|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110934186|NCT05182931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110267829|NCT03456466|Rituximab|rituximab|mesh-list
110934187|NCT05182931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110934188|NCT05154370|Immunoglobulins|immunoglobulins|mesh-list
110934189|NCT05154370|Immunologic Factors|immunologic factors|mesh-ancestor
110934190|NCT05154370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110934191|NCT05128734|Temozolomide|temozolomide|mesh-list
110934192|NCT05128734|Olaparib|olaparib|mesh-list
110934193|NCT05128734|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110934194|NCT05128734|Alkylating Agents|alkylating agents|mesh-ancestor
110934195|NCT05128734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110934196|NCT05128734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110934197|NCT05128734|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110934198|NCT05128734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110934199|NCT05126836|Cilostazol|cilostazol|mesh-list
110934200|NCT05126836|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110934201|NCT05126836|Autonomic Agents|autonomic agents|mesh-ancestor
110934202|NCT05126836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110934203|NCT05126836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110934204|NCT05126836|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110934205|NCT05126836|Respiratory System Agents|respiratory system agents|mesh-ancestor
110934206|NCT05126836|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110934207|NCT05126836|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110934208|NCT05126836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110934209|NCT05126836|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110932549|NCT02202720|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110932550|NCT02202720|Anesthetics, General|anesthetics, general|mesh-ancestor
110932551|NCT02202720|Anesthetics|anesthetics|mesh-ancestor
110242157|NCT00452569|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110932552|NCT02202720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110932553|NCT02202720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110932554|NCT02206308|Antibodies|antibodies|mesh-list
110932555|NCT02206308|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110932556|NCT02206308|Immunologic Factors|immunologic factors|mesh-ancestor
110932557|NCT02206308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110932558|NCT03028129|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110932559|NCT03028129|Isoniazid|isoniazid|mesh-list
110932560|NCT03028129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110932561|NCT03028129|Antitubercular Agents|antitubercular agents|mesh-ancestor
110280809|NCT00213252|Glucocorticoids|glucocorticoids|mesh-ancestor
110934210|NCT05126836|Vasodilator Agents|vasodilator agents|mesh-ancestor
110934211|NCT05126836|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110934212|NCT05126836|Protective Agents|protective agents|mesh-ancestor
110934213|NCT05126836|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110934214|NCT05126836|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110934215|NCT05126836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110934216|NCT05108688|Sumatriptan|sumatriptan|mesh-list
110934232|NCT05108688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110934233|NCT05108688|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
110934234|NCT05108688|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110934235|NCT05108688|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110934236|NCT05108688|Adrenergic Agents|adrenergic agents|mesh-ancestor
110242278|NCT00453232|Etoposide|etoposide|mesh-list
110934237|NCT05108688|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110934238|NCT05108688|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110934239|NCT05108688|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110934240|NCT05085002|Letrozole|letrozole|mesh-list
110934241|NCT05085002|Fulvestrant|fulvestrant|mesh-list
110934242|NCT05085002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110934243|NCT05085002|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110934244|NCT05085002|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110934245|NCT05085002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110934246|NCT05085002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110934247|NCT05085002|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110934248|NCT05085002|Hormone Antagonists|hormone antagonists|mesh-ancestor
110934249|NCT05085002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110934250|NCT05085002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110934251|NCT05085002|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110934252|NCT05085002|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110934264|NCT05050357|Norethindrone|norethindrone|mesh-list
110934265|NCT05050357|Norethindrone Acetate|norethindrone acetate|mesh-list
110934266|NCT05050357|Progestins|progestins|mesh-list
110934267|NCT05050357|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110934268|NCT05050357|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110934269|NCT05050357|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110934270|NCT05050357|Contraceptive Agents|contraceptive agents|mesh-ancestor
110934271|NCT05050357|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110934272|NCT05050357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110934273|NCT05050357|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110934274|NCT05050357|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110934278|NCT05017571|Gout Suppressants|gout suppressants|mesh-ancestor
110934279|NCT05017571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110934280|NCT05017571|Tubulin Modulators|tubulin modulators|mesh-ancestor
110934281|NCT05017571|Antimitotic Agents|antimitotic agents|mesh-ancestor
110934282|NCT05017571|Mitosis Modulators|mitosis modulators|mesh-ancestor
110934283|NCT05017571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110934284|NCT05017571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110934285|NCT05008809|Leucovorin|leucovorin|mesh-list
110932562|NCT03028129|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
110932563|NCT03028129|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110932564|NCT03028129|Antimetabolites|antimetabolites|mesh-ancestor
110932565|NCT03028129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110932566|NCT03028129|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110932567|NCT04059679|Aspirin|aspirin|mesh-list
110932568|NCT04059679|Rivaroxaban|rivaroxaban|mesh-list
110932569|NCT04059679|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110932570|NCT04059679|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110932571|NCT04059679|Analgesics|analgesics|mesh-ancestor
110932572|NCT04059679|Sensory System Agents|sensory system agents|mesh-ancestor
110932573|NCT04059679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110932574|NCT04059679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110934286|NCT05008809|Fluorouracil|fluorouracil|mesh-list
110651866|NCT04409795|Metformin|metformin|mesh-list
110934287|NCT05008809|Oxaliplatin|oxaliplatin|mesh-list
110934289|NCT05008809|Levoleucovorin|levoleucovorin|mesh-list
110934290|NCT05008809|Antimetabolites|antimetabolites|mesh-ancestor
110934291|NCT05008809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110934292|NCT05008809|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110934293|NCT05008809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110934294|NCT05008809|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110934295|NCT05008809|Immunologic Factors|immunologic factors|mesh-ancestor
110934296|NCT05008809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110934297|NCT05008809|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110934298|NCT05008809|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110934299|NCT05008809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110934300|NCT05008809|Antidotes|antidotes|mesh-ancestor
110934301|NCT05008809|Protective Agents|protective agents|mesh-ancestor
110934302|NCT05008809|Vitamin B Complex|vitamin b complex|mesh-ancestor
110934303|NCT05008809|Vitamins|vitamins|mesh-ancestor
110934304|NCT05008809|Micronutrients|micronutrients|mesh-ancestor
110934305|NCT04975334|Naloxone|naloxone|mesh-list
110934306|NCT04975334|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
110934307|NCT04975334|Hormones|hormones|mesh-ancestor
110934308|NCT04975334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110934309|NCT04975334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110934310|NCT04975334|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110934311|NCT04975334|Sensory System Agents|sensory system agents|mesh-ancestor
110242441|NCT00454714|Urological Agents|urological agents|mesh-ancestor
110934312|NCT04975334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110934313|NCT04964843|Acetylcysteine|acetylcysteine|mesh-list
110934314|NCT04964843|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110934315|NCT04964843|Antiviral Agents|antiviral agents|mesh-ancestor
110934316|NCT04964843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110934317|NCT04964843|Expectorants|expectorants|mesh-ancestor
110934318|NCT04964843|Respiratory System Agents|respiratory system agents|mesh-ancestor
110934319|NCT04964843|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110934320|NCT04964843|Antioxidants|antioxidants|mesh-ancestor
110934321|NCT04964843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110934322|NCT04964843|Protective Agents|protective agents|mesh-ancestor
110934323|NCT04964843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110934324|NCT04964843|Antidotes|antidotes|mesh-ancestor
110934325|NCT04946825|Nicotine|nicotine|mesh-list
110934326|NCT04946825|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110934327|NCT04946825|Autonomic Agents|autonomic agents|mesh-ancestor
110934328|NCT04946825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110934329|NCT04946825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110934330|NCT04946825|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110934331|NCT04946825|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110934332|NCT04946825|Cholinergic Agents|cholinergic agents|mesh-ancestor
110934333|NCT04946825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110934334|NCT04946825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110934335|NCT04908579|Ketamine|ketamine|mesh-list
110932576|NCT04059679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110932577|NCT04059679|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110932578|NCT04059679|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110932579|NCT04059679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110932580|NCT04059679|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110932581|NCT04059679|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110932582|NCT04059679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110932583|NCT04059679|Antipyretics|antipyretics|mesh-ancestor
110932584|NCT04059679|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110932585|NCT04059679|Antithrombins|antithrombins|mesh-ancestor
110932586|NCT04059679|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110932587|NCT04059679|Protease Inhibitors|protease inhibitors|mesh-ancestor
110934336|NCT04908579|Bupivacaine|bupivacaine|mesh-list
110934337|NCT04908579|Anesthetics, Local|anesthetics, local|mesh-ancestor
110934338|NCT04908579|Anesthetics|anesthetics|mesh-ancestor
110242558|NCT00401492|Gemcitabine|gemcitabine|mesh-list
110934339|NCT04908579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110934340|NCT04908579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110934341|NCT04908579|Sensory System Agents|sensory system agents|mesh-ancestor
110934342|NCT04908579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110934343|NCT04908579|Analgesics|analgesics|mesh-ancestor
110934344|NCT04908579|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110934345|NCT04908579|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110934346|NCT04908579|Anesthetics, General|anesthetics, general|mesh-ancestor
110934347|NCT04908579|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110934348|NCT04908579|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110934367|NCT04848753|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110934369|NCT04848753|Tubulin Modulators|tubulin modulators|mesh-ancestor
110934370|NCT04848753|Antimitotic Agents|antimitotic agents|mesh-ancestor
110934371|NCT04848753|Mitosis Modulators|mitosis modulators|mesh-ancestor
110934372|NCT04848753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110934373|NCT04823247|Interleukin-23|interleukin-23|mesh-list
110934374|NCT04823247|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110934375|NCT04823247|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110934376|NCT04823247|Growth Substances|growth substances|mesh-ancestor
110934377|NCT04823247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110934378|NCT04823247|Growth Inhibitors|growth inhibitors|mesh-ancestor
110934379|NCT04823247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110934380|NCT04777994|Mitogens|mitogens|mesh-list
110934381|NCT04777994|Endothelial Growth Factors|endothelial growth factors|mesh-list
110934382|NCT04777994|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
110934383|NCT04777994|Mitosis Modulators|mitosis modulators|mesh-ancestor
110655626|NCT04008966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110934384|NCT04777994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110934385|NCT04777994|Growth Substances|growth substances|mesh-ancestor
110934386|NCT04777994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110934387|NCT04777994|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110934388|NCT04777994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110934389|NCT04772222|Dexmedetomidine|dexmedetomidine|mesh-list
110934390|NCT04772222|Morphine|morphine|mesh-list
110934391|NCT04772222|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110934392|NCT04772222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110934393|NCT04772222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110934394|NCT04772222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110934395|NCT04772222|Analgesics|analgesics|mesh-ancestor
110934396|NCT04772222|Sensory System Agents|sensory system agents|mesh-ancestor
110934397|NCT04772222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110934398|NCT04772222|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110934399|NCT04772222|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110934400|NCT04772222|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110934401|NCT04772222|Adrenergic Agents|adrenergic agents|mesh-ancestor
110934402|NCT04772222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110932588|NCT04059679|Anticoagulants|anticoagulants|mesh-ancestor
110932589|NCT03533556|Caffeine|caffeine|mesh-list
110932590|NCT03533556|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110932591|NCT03533556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110932592|NCT03533556|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110932593|NCT03533556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110932594|NCT03533556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110932595|NCT03533556|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110932596|NCT03533556|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110932597|NCT03533556|Purinergic Agents|purinergic agents|mesh-ancestor
110932598|NCT03533556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110932599|NCT02206854|Flurbiprofen|flurbiprofen|mesh-list
110932600|NCT02206854|Tarenflurbil|tarenflurbil|mesh-list
110932601|NCT02206854|Analgesics|analgesics|mesh-ancestor
110932602|NCT02206854|Sensory System Agents|sensory system agents|mesh-ancestor
110932603|NCT02206854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110932604|NCT02206854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110932605|NCT02206854|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110280847|NCT00189995|GABA Antagonists|gaba antagonists|mesh-ancestor
110655627|NCT04008966|Luteolytic Agents|luteolytic agents|mesh-ancestor
110934403|NCT04772222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110934404|NCT04772222|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110934405|NCT04772222|Narcotics|narcotics|mesh-ancestor
110934406|NCT04766021|Mirabegron|mirabegron|mesh-list
110934407|NCT04766021|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
110282596|NCT00473512|Hormones|hormones|mesh-ancestor
110934417|NCT04677049|Niacin|niacin|mesh-list
110934418|NCT04677049|Nicotinic Acids|nicotinic acids|mesh-list
110934419|NCT04677049|Vitamins|vitamins|mesh-ancestor
110934420|NCT04677049|Micronutrients|micronutrients|mesh-ancestor
110934421|NCT04677049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110934422|NCT04677049|Vitamin B Complex|vitamin b complex|mesh-ancestor
110934423|NCT04677049|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110934424|NCT04677049|Antimetabolites|antimetabolites|mesh-ancestor
110934425|NCT04677049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110934426|NCT04677049|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110934427|NCT04677049|Vasodilator Agents|vasodilator agents|mesh-ancestor
110934428|NCT04648969|Hormones|hormones|mesh-list
110934429|NCT04648969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110934430|NCT04648969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110934431|NCT04562129|Aldesleukin|aldesleukin|mesh-list
110934432|NCT04562129|Nivolumab|nivolumab|mesh-list
110934433|NCT04562129|Ipilimumab|ipilimumab|mesh-list
110934434|NCT04562129|Interleukin-2|interleukin-2|mesh-list
110934435|NCT04562129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110934436|NCT04562129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110934437|NCT04562129|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110655628|NCT04008966|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110934438|NCT04562129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110934439|NCT04562129|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110934440|NCT04562129|Analgesics|analgesics|mesh-ancestor
110934441|NCT04562129|Sensory System Agents|sensory system agents|mesh-ancestor
110934442|NCT04562129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110934443|NCT04562129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110934444|NCT04562129|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110934445|NCT04562129|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110934446|NCT04562129|Antiviral Agents|antiviral agents|mesh-ancestor
110934447|NCT04562129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110932606|NCT02206854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110932607|NCT02206854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110932608|NCT02206854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110932609|NCT02206854|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110932610|NCT02206854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110932611|NCT02206854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110932612|NCT02206854|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
110932613|NCT03624205|Paclitaxel|paclitaxel|mesh-list
110932614|NCT03624205|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110932615|NCT03624205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110932616|NCT03624205|Tubulin Modulators|tubulin modulators|mesh-ancestor
110932617|NCT03624205|Antimitotic Agents|antimitotic agents|mesh-ancestor
110932618|NCT03624205|Mitosis Modulators|mitosis modulators|mesh-ancestor
110280872|NCT00412581|Lenalidomide|lenalidomide|mesh-list
110934448|NCT04545866|Budesonide|budesonide|mesh-list
110934449|NCT04545866|Poractant alfa|poractant alfa|mesh-list
110934450|NCT04545866|Pulmonary Surfactants|pulmonary surfactants|mesh-list
110934451|NCT04545866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110934452|NCT04545866|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110934453|NCT04545866|Autonomic Agents|autonomic agents|mesh-ancestor
110934454|NCT04545866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110934455|NCT04545866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110934456|NCT04545866|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110934457|NCT04545866|Respiratory System Agents|respiratory system agents|mesh-ancestor
110934458|NCT04545866|Glucocorticoids|glucocorticoids|mesh-ancestor
110934459|NCT04545866|Hormones|hormones|mesh-ancestor
110934460|NCT04545866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110934461|NCT04502849|Vitamin E|vitamin e|mesh-list
110934462|NCT04502849|Tocopherols|tocopherols|mesh-list
110934463|NCT04502849|alpha-Tocopherol|alpha-tocopherol|mesh-list
110934464|NCT04502849|Vitamins|vitamins|mesh-ancestor
110934465|NCT04502849|Micronutrients|micronutrients|mesh-ancestor
110934466|NCT04502849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110934467|NCT04502849|Antioxidants|antioxidants|mesh-ancestor
110934468|NCT04502849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110934469|NCT04502849|Protective Agents|protective agents|mesh-ancestor
110934470|NCT04417465|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
110934471|NCT04417465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110934472|NCT04417465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110934473|NCT04417465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110934474|NCT04407442|Dexamethasone|dexamethasone|mesh-list
110934488|NCT04407442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110934490|NCT04407442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110934491|NCT04407442|Protease Inhibitors|protease inhibitors|mesh-ancestor
110934492|NCT04407442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110934493|NCT04407442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110934494|NCT04407442|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110934495|NCT04407442|Antimetabolites|antimetabolites|mesh-ancestor
110934496|NCT04407442|Dermatologic Agents|dermatologic agents|mesh-ancestor
110934497|NCT04348448|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110934498|NCT04348448|Immunologic Factors|immunologic factors|mesh-ancestor
110934499|NCT04348448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110934500|NCT04345796|Empagliflozin|empagliflozin|mesh-list
110934501|NCT04345796|Carvedilol|carvedilol|mesh-list
110934502|NCT04345796|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110934503|NCT04345796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110934504|NCT04345796|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110934505|NCT04345796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110934506|NCT04345796|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110934507|NCT04345796|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110932619|NCT03624205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110932620|NCT02206932|Sofosbuvir|sofosbuvir|mesh-list
110932621|NCT02206932|Simeprevir|simeprevir|mesh-list
110932622|NCT02206932|Antiviral Agents|antiviral agents|mesh-ancestor
110932623|NCT02206932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110932624|NCT02206932|Protease Inhibitors|protease inhibitors|mesh-ancestor
110932625|NCT02206932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110932626|NCT02206932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110932627|NCT02207010|Adavosertib|adavosertib|mesh-list
110932629|NCT02207010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110932630|NCT02203422|Cyclosporine|cyclosporine|mesh-list
110932631|NCT02203422|Cyclosporins|cyclosporins|mesh-list
110932632|NCT02203422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110932633|NCT02203422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110932634|NCT02203422|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110932635|NCT02203422|Immunologic Factors|immunologic factors|mesh-ancestor
110932636|NCT02203422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110932637|NCT02203422|Antifungal Agents|antifungal agents|mesh-ancestor
110932638|NCT02203422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110932639|NCT02203422|Dermatologic Agents|dermatologic agents|mesh-ancestor
110932640|NCT02203422|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110932641|NCT02203422|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110932642|NCT03532854|Valsartan|valsartan|mesh-list
110932643|NCT03532854|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110932644|NCT03532854|Ezetimibe|ezetimibe|mesh-list
110932645|NCT03532854|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110932646|NCT03532854|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110932647|NCT03532854|Antimetabolites|antimetabolites|mesh-ancestor
110932648|NCT03532854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110932651|NCT03532854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110932665|NCT02203656|Methyltestosterone|methyltestosterone|mesh-list
110932666|NCT02203656|Testosterone|testosterone|mesh-list
110932667|NCT02203656|Testosterone undecanoate|testosterone undecanoate|mesh-list
110932668|NCT02203656|Testosterone enanthate|testosterone enanthate|mesh-list
110932669|NCT02203656|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
110932670|NCT02203656|Androgens|androgens|mesh-ancestor
110932671|NCT02203656|Hormones|hormones|mesh-ancestor
110932672|NCT02203656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110932673|NCT02203656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110932674|NCT02203656|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110932675|NCT02203656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110932676|NCT02203656|Anabolic Agents|anabolic agents|mesh-ancestor
110934508|NCT04345796|Adrenergic Agents|adrenergic agents|mesh-ancestor
110934509|NCT04345796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110934510|NCT04345796|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110934511|NCT04345796|Antioxidants|antioxidants|mesh-ancestor
110652063|NCT00939614|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110934512|NCT04345796|Protective Agents|protective agents|mesh-ancestor
110934513|NCT04345796|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110934514|NCT04345796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110934515|NCT04345796|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110934516|NCT04345796|Vasodilator Agents|vasodilator agents|mesh-ancestor
110934517|NCT04345796|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110934518|NCT04345796|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110934519|NCT04265612|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
110934520|NCT04265612|Laxatives|laxatives|mesh-ancestor
110934521|NCT04265612|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110934522|NCT04222088|Chloroquine|chloroquine|mesh-list
110934523|NCT04222088|Lumefantrine|lumefantrine|mesh-list
110934524|NCT04222088|Primaquine|primaquine|mesh-list
110934525|NCT04222088|Amebicides|amebicides|mesh-ancestor
110934526|NCT04222088|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110934527|NCT04222088|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110244068|NCT00425932|Rituximab|rituximab|mesh-list
110934528|NCT04222088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110934529|NCT04222088|Antimalarials|antimalarials|mesh-ancestor
110934530|NCT04222088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110934531|NCT04217694|Memantine|memantine|mesh-list
110934532|NCT04217694|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110934533|NCT04217694|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110934534|NCT04217694|Dopamine Agents|dopamine agents|mesh-ancestor
110934535|NCT04217694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110934536|NCT04217694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110934537|NCT04217694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110934545|NCT04198506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110934546|NCT04198506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110934548|NCT04192981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110655629|NCT04008966|Contraceptive Agents|contraceptive agents|mesh-ancestor
110934549|NCT04192981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110934550|NCT04026113|Linaclotide|linaclotide|mesh-list
110934551|NCT04026113|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
110934552|NCT04026113|Enzyme Activators|enzyme activators|mesh-ancestor
110244269|NCT00445081|Cyclosporine|cyclosporine|mesh-list
110934553|NCT04026113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110934554|NCT04026113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110934555|NCT04021043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110934556|NCT04021043|Nivolumab|nivolumab|mesh-list
110934557|NCT04021043|Ipilimumab|ipilimumab|mesh-list
110934558|NCT04021043|Antibodies|antibodies|mesh-list
110934559|NCT04021043|Immunoglobulins|immunoglobulins|mesh-list
110934560|NCT04021043|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110934561|NCT04021043|Immunologic Factors|immunologic factors|mesh-ancestor
110934562|NCT04021043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110934563|NCT04021043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110035874|NCT01407822|Gemcitabine|gemcitabine|mesh-list
110932677|NCT04431388|Levobupivacaine|levobupivacaine|mesh-list
110932678|NCT04431388|Anesthetics, Local|anesthetics, local|mesh-ancestor
110932679|NCT04431388|Anesthetics|anesthetics|mesh-ancestor
110932680|NCT04431388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110932681|NCT04431388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110932682|NCT04431388|Sensory System Agents|sensory system agents|mesh-ancestor
110932683|NCT04431388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110932684|NCT02199444|Sevelamer|sevelamer|mesh-list
110932685|NCT02199444|Chelating Agents|chelating agents|mesh-ancestor
110932686|NCT02199444|Sequestering Agents|sequestering agents|mesh-ancestor
110932687|NCT02199444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110932688|NCT02199522|Propofol|propofol|mesh-list
110932689|NCT02199522|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110932690|NCT02199522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110932691|NCT02199522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110932692|NCT02199522|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110934564|NCT04021043|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110934565|NCT04021043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110934566|NCT03981614|Trifluridine|trifluridine|mesh-list
110934567|NCT03981614|Palbociclib|palbociclib|mesh-list
110934568|NCT03981614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110934569|NCT03981614|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110934570|NCT03981614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110934571|NCT03981614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110934572|NCT03981614|Antimetabolites|antimetabolites|mesh-ancestor
110934573|NCT03981614|Antiviral Agents|antiviral agents|mesh-ancestor
110934574|NCT03981614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110934575|NCT03978520|Upadacitinib|upadacitinib|mesh-list
110934576|NCT03978520|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
110934577|NCT03978520|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110934578|NCT03978520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110934579|NCT03978520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110934580|NCT03978520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110934581|NCT03941743|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
110934582|NCT03941743|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
110934583|NCT03941743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110934584|NCT03941743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110934585|NCT03941743|Immunologic Factors|immunologic factors|mesh-ancestor
110934586|NCT03941743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110934587|NCT03896685|Linezolid|linezolid|mesh-list
110934588|NCT03896685|Bedaquiline|bedaquiline|mesh-list
110934589|NCT03896685|Clofazimine|clofazimine|mesh-list
110934590|NCT03896685|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110934591|NCT03896685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110934592|NCT03896685|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110934593|NCT03896685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110934594|NCT03896685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110934595|NCT03896685|Antitubercular Agents|antitubercular agents|mesh-ancestor
110934596|NCT03896685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110934597|NCT03896685|Leprostatic Agents|leprostatic agents|mesh-ancestor
110934598|NCT03874715|Insulin|insulin|mesh-list
110934599|NCT03874715|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110934600|NCT03874715|Insulin Glargine|insulin glargine|mesh-list
110934601|NCT03874715|Insulin Aspart|insulin aspart|mesh-list
110934602|NCT03874715|Insulin, Long-Acting|insulin, long-acting|mesh-list
110934603|NCT03874715|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
110934604|NCT03874715|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110934610|NCT03869996|Antimetabolites|antimetabolites|mesh-ancestor
110932693|NCT02199522|Anesthetics, General|anesthetics, general|mesh-ancestor
110932695|NCT03532698|Aspirin|aspirin|mesh-list
110932696|NCT03532698|Osimertinib|osimertinib|mesh-list
110655630|NCT04008966|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110932697|NCT03532698|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110932698|NCT03532698|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110932699|NCT03532698|Analgesics|analgesics|mesh-ancestor
110932700|NCT03532698|Sensory System Agents|sensory system agents|mesh-ancestor
110650276|NCT00729287|Selenium|selenium|mesh-list
110932701|NCT03532698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110932702|NCT03532698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110934611|NCT03869996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110934612|NCT03869996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110934613|NCT03869996|Antiviral Agents|antiviral agents|mesh-ancestor
110934614|NCT03869996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110934615|NCT03869996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110934616|NCT03869996|Immunologic Factors|immunologic factors|mesh-ancestor
110934617|NCT03869996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110934618|NCT03869996|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110934619|NCT03869996|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110934620|NCT03869996|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110934621|NCT03869996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110934622|NCT03869996|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110934623|NCT03869996|Abortifacient Agents|abortifacient agents|mesh-ancestor
110934624|NCT03869996|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110934625|NCT03869996|Dermatologic Agents|dermatologic agents|mesh-ancestor
110934626|NCT03869996|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110934627|NCT03869996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110245249|NCT00461149|Octreotide|octreotide|mesh-list
110934628|NCT03869996|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110934629|NCT03801863|Ropivacaine|ropivacaine|mesh-list
110934630|NCT03801863|Anesthetics, Local|anesthetics, local|mesh-ancestor
110934631|NCT03801863|Anesthetics|anesthetics|mesh-ancestor
110934632|NCT03801863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110934633|NCT03801863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110934634|NCT03801863|Sensory System Agents|sensory system agents|mesh-ancestor
110934635|NCT03801863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110934636|NCT03664037|Dexamethasone|dexamethasone|mesh-list
110934637|NCT03664037|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
110934638|NCT03664037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110934639|NCT03664037|Antiemetics|antiemetics|mesh-ancestor
110934640|NCT03664037|Autonomic Agents|autonomic agents|mesh-ancestor
110934641|NCT03664037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110934642|NCT03664037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110934643|NCT03664037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110934644|NCT03664037|Glucocorticoids|glucocorticoids|mesh-ancestor
110934645|NCT03664037|Hormones|hormones|mesh-ancestor
110934646|NCT03664037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110934647|NCT03664037|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110934648|NCT03664037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110934649|NCT03593473|Oxytocin|oxytocin|mesh-list
110934650|NCT03593473|Oxytocics|oxytocics|mesh-ancestor
110934651|NCT03593473|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110934652|NCT03593473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110934653|NCT03581487|Durvalumab|durvalumab|mesh-list
110934654|NCT03581487|Ipilimumab|ipilimumab|mesh-list
110934655|NCT03581487|Tremelimumab|tremelimumab|mesh-list
110934656|NCT03581487|Immunoglobulins|immunoglobulins|mesh-list
110934657|NCT03581487|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110934658|NCT03581487|Immunoglobulin G|immunoglobulin g|mesh-list
110934659|NCT03581487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110934660|NCT03581487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110934661|NCT03581487|Immunologic Factors|immunologic factors|mesh-ancestor
110934662|NCT03581487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110934663|NCT03581487|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110652220|NCT00940784|Aspirin|aspirin|mesh-list
110478547|NCT00628316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110932704|NCT03532698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110932705|NCT03532698|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110932706|NCT03532698|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110932707|NCT03532698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110932708|NCT03532698|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110932709|NCT03532698|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110245605|NCT00463957|Tadalafil|tadalafil|mesh-list
110932710|NCT03532698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110932712|NCT03532698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110932713|NCT03532698|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110932714|NCT03690739|Paclitaxel|paclitaxel|mesh-list
110932715|NCT03690739|Bevacizumab|bevacizumab|mesh-list
110932716|NCT03690739|Carboplatin|carboplatin|mesh-list
110932717|NCT03690739|Gemcitabine|gemcitabine|mesh-list
110932718|NCT03690739|Trabectedin|trabectedin|mesh-list
110932719|NCT03690739|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110280976|NCT00190580|Valsartan|valsartan|mesh-list
110934664|NCT03581487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110934665|NCT03576547|Dexamethasone|dexamethasone|mesh-list
110934666|NCT03576547|Dexamethasone acetate|dexamethasone acetate|mesh-list
110934667|NCT03576547|Rituximab|rituximab|mesh-list
110934668|NCT03576547|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110934669|NCT03576547|Venetoclax|venetoclax|mesh-list
110934670|NCT03576547|Ponatinib|ponatinib|mesh-list
110934671|NCT03576547|Antibodies|antibodies|mesh-list
110934672|NCT03576547|Immunoglobulins|immunoglobulins|mesh-list
110934673|NCT03576547|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110934674|NCT03576547|BB 1101|bb 1101|mesh-list
110934675|NCT03576547|Immunologic Factors|immunologic factors|mesh-ancestor
110934676|NCT03576547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110934682|NCT03576547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110934683|NCT03576547|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110934684|NCT03576547|Glucocorticoids|glucocorticoids|mesh-ancestor
110934685|NCT03576547|Hormones|hormones|mesh-ancestor
110934686|NCT03576547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110934687|NCT03576547|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110934688|NCT03576547|Protease Inhibitors|protease inhibitors|mesh-ancestor
110934689|NCT03576547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110934690|NCT03576547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110934691|NCT03576547|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110934692|NCT03538457|Acetaminophen|acetaminophen|mesh-list
110934693|NCT03538457|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110934694|NCT03538457|Analgesics|analgesics|mesh-ancestor
110934695|NCT03538457|Sensory System Agents|sensory system agents|mesh-ancestor
110934696|NCT03538457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110934697|NCT03538457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110934698|NCT03538457|Antipyretics|antipyretics|mesh-ancestor
110934699|NCT03535376|Valsartan|valsartan|mesh-list
110934700|NCT03535376|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110934701|NCT03535376|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110934702|NCT03535376|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110934703|NCT03535376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110934704|NCT03521154|Osimertinib|osimertinib|mesh-list
110934705|NCT03521154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110934706|NCT03521154|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110934707|NCT03521154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110934708|NCT03521154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110934709|NCT03485677|Eliglustat|eliglustat|mesh-list
110934710|NCT03485677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110932720|NCT03690739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110932721|NCT03690739|Tubulin Modulators|tubulin modulators|mesh-ancestor
110932722|NCT03690739|Antimitotic Agents|antimitotic agents|mesh-ancestor
110932723|NCT03690739|Mitosis Modulators|mitosis modulators|mesh-ancestor
110932724|NCT03690739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110932725|NCT03690739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110932726|NCT03690739|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110932727|NCT03690739|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110932728|NCT03690739|Growth Substances|growth substances|mesh-ancestor
110932729|NCT03690739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110932730|NCT03690739|Growth Inhibitors|growth inhibitors|mesh-ancestor
110932731|NCT03690739|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110932732|NCT03690739|Antimetabolites|antimetabolites|mesh-ancestor
110932733|NCT03690739|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110932734|NCT03690739|Alkylating Agents|alkylating agents|mesh-ancestor
110932735|NCT02199678|Ketamine|ketamine|mesh-list
110246201|NCT00117611|Omalizumab|omalizumab|mesh-list
110934711|NCT03485677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110934712|NCT03402945|Vancomycin|vancomycin|mesh-list
110934713|NCT03402945|Cefazolin|cefazolin|mesh-list
110934714|NCT03402945|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110934715|NCT03402945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110934716|NCT03381183|Durvalumab|durvalumab|mesh-list
110934717|NCT03381183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110934718|NCT03381183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110934719|NCT03361306|Elotuzumab|elotuzumab|mesh-list
110934720|NCT03361306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110934721|NCT03336242|Cannabidiol|cannabidiol|mesh-list
110934722|NCT03336242|Anticonvulsants|anticonvulsants|mesh-ancestor
110934723|NCT03333395|Heparin|heparin|mesh-list
110934724|NCT03333395|Albuterol|albuterol|mesh-list
110934725|NCT03333395|Anticoagulants|anticoagulants|mesh-ancestor
110934726|NCT03333395|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110934727|NCT03333395|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110934728|NCT03333395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110934729|NCT03333395|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110934730|NCT03333395|Autonomic Agents|autonomic agents|mesh-ancestor
110934731|NCT03333395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110934732|NCT03333395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110934733|NCT03333395|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110246412|NCT00477373|GABA Agents|gaba agents|mesh-ancestor
110934734|NCT03333395|Respiratory System Agents|respiratory system agents|mesh-ancestor
110934735|NCT03333395|Tocolytic Agents|tocolytic agents|mesh-ancestor
110934736|NCT03333395|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110246482|NCT00478504|Fertility Agents|fertility agents|mesh-ancestor
110934737|NCT03333395|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110934738|NCT03333395|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110934739|NCT03333395|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110934740|NCT03333395|Adrenergic Agents|adrenergic agents|mesh-ancestor
110246554|NCT00479206|Artesunate|artesunate|mesh-list
110934742|NCT03328104|Cyclophosphamide|cyclophosphamide|mesh-list
110934743|NCT03328104|Etoposide|etoposide|mesh-list
110934744|NCT03328104|Everolimus|everolimus|mesh-list
110934745|NCT03328104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110934746|NCT03328104|Immunologic Factors|immunologic factors|mesh-ancestor
110246626|NCT00119210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110934747|NCT03328104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110934748|NCT03328104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110934749|NCT03328104|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110934753|NCT03328104|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110934754|NCT03328104|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110934755|NCT03328104|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110934756|NCT03328104|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110934757|NCT03328104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110932736|NCT02199678|Analgesics|analgesics|mesh-ancestor
110932737|NCT02199678|Sensory System Agents|sensory system agents|mesh-ancestor
110932738|NCT02199678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110246699|NCT00480181|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110932739|NCT02199678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110932740|NCT02199678|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110932741|NCT02199678|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110932742|NCT02199678|Anesthetics, General|anesthetics, general|mesh-ancestor
110932743|NCT02199678|Anesthetics|anesthetics|mesh-ancestor
110932744|NCT02199678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110932745|NCT02199678|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110932746|NCT02199678|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110932747|NCT02199678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110932748|NCT02199678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110932749|NCT03681613|Pyrantel|pyrantel|mesh-list
110932750|NCT03681613|Pyrantel Pamoate|pyrantel pamoate|mesh-list
110932751|NCT03681613|Antinematodal Agents|antinematodal agents|mesh-ancestor
110932752|NCT03681613|Anthelmintics|anthelmintics|mesh-ancestor
110280995|NCT00190619|Analgesics|analgesics|mesh-ancestor
110934758|NCT03328104|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110934759|NCT03328104|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110934760|NCT03274258|Nivolumab|nivolumab|mesh-list
110934761|NCT03274258|Ipilimumab|ipilimumab|mesh-list
110934762|NCT03274258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110934763|NCT03274258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110934764|NCT03274258|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110934765|NCT03274258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110934766|NCT03179904|Paclitaxel|paclitaxel|mesh-list
110934767|NCT03179904|Trastuzumab|trastuzumab|mesh-list
110934768|NCT03179904|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110934769|NCT03179904|Letrozole|letrozole|mesh-list
110934770|NCT03179904|Fulvestrant|fulvestrant|mesh-list
110934771|NCT03179904|Anastrozole|anastrozole|mesh-list
110934772|NCT03179904|Exemestane|exemestane|mesh-list
110934773|NCT03179904|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
110934774|NCT03179904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110934775|NCT03179904|Antibodies|antibodies|mesh-list
110934776|NCT03179904|Immunoglobulins|immunoglobulins|mesh-list
110934777|NCT03179904|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110246977|NCT00481819|Antiemetics|antiemetics|mesh-ancestor
110934778|NCT03179904|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110934779|NCT03179904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110934780|NCT03179904|Tubulin Modulators|tubulin modulators|mesh-ancestor
110934781|NCT03179904|Antimitotic Agents|antimitotic agents|mesh-ancestor
110934782|NCT03179904|Mitosis Modulators|mitosis modulators|mesh-ancestor
110934783|NCT03179904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110934784|NCT03179904|Immunologic Factors|immunologic factors|mesh-ancestor
110934785|NCT03179904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110934786|NCT03179904|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110247036|NCT00117975|Galiximab|galiximab|mesh-list
110934787|NCT03179904|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110934788|NCT03179904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110934789|NCT03179904|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110934790|NCT03179904|Hormone Antagonists|hormone antagonists|mesh-ancestor
110934791|NCT03179904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110934792|NCT03179904|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110934793|NCT03179904|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110934794|NCT03137771|Gemcitabine|gemcitabine|mesh-list
110934795|NCT03137771|Docetaxel|docetaxel|mesh-list
110934796|NCT03137771|Pembrolizumab|pembrolizumab|mesh-list
110934797|NCT03137771|Pemetrexed|pemetrexed|mesh-list
110932753|NCT03681613|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110932754|NCT03681613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110932755|NCT03681613|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
110932756|NCT03681613|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110932757|NCT03681613|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110932758|NCT03681613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110932759|NCT03681613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110932761|NCT03690583|Zinc Sulfate|zinc sulfate|mesh-list
110932762|NCT03690583|Trace Elements|trace elements|mesh-ancestor
110932763|NCT03690583|Micronutrients|micronutrients|mesh-ancestor
110932764|NCT03690583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110932765|NCT03690583|Astringents|astringents|mesh-ancestor
110934798|NCT03137771|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110934799|NCT03137771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110934800|NCT03137771|Antimetabolites|antimetabolites|mesh-ancestor
110934801|NCT03137771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110934802|NCT03137771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110934803|NCT03137771|Tubulin Modulators|tubulin modulators|mesh-ancestor
110934804|NCT03137771|Antimitotic Agents|antimitotic agents|mesh-ancestor
110934805|NCT03137771|Mitosis Modulators|mitosis modulators|mesh-ancestor
110934806|NCT03137771|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110934807|NCT03137771|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110934808|NCT03137771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110934809|NCT03137771|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110934810|NCT03137771|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110934811|NCT03137771|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110934812|NCT02955758|Pembrolizumab|pembrolizumab|mesh-list
110934813|NCT02955758|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110934814|NCT02955758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110934815|NCT02955758|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110934816|NCT02955758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110934817|NCT02919449|Atezolizumab|atezolizumab|mesh-list
110934818|NCT02919449|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110934819|NCT02919449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110934820|NCT02919449|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110934829|NCT02904291|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110934830|NCT02904291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110934831|NCT02904291|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110934832|NCT02904291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110934833|NCT02904291|Vasodilator Agents|vasodilator agents|mesh-ancestor
110934834|NCT02891824|Bevacizumab|bevacizumab|mesh-list
110934835|NCT02891824|Atezolizumab|atezolizumab|mesh-list
110934836|NCT02891824|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110934837|NCT02891824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110934838|NCT02891824|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110934839|NCT02891824|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110934840|NCT02891824|Growth Substances|growth substances|mesh-ancestor
110934841|NCT02891824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110934842|NCT02891824|Growth Inhibitors|growth inhibitors|mesh-ancestor
110934843|NCT02891824|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110934844|NCT02891824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110934845|NCT02796859|Siltuximab|siltuximab|mesh-list
110934846|NCT02796859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110934847|NCT02769832|Paclitaxel|paclitaxel|mesh-list
110934848|NCT02769832|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110934849|NCT02769832|Gemcitabine|gemcitabine|mesh-list
110934850|NCT02769832|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110934851|NCT02769832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110934852|NCT02769832|Tubulin Modulators|tubulin modulators|mesh-ancestor
110932766|NCT03690583|Dermatologic Agents|dermatologic agents|mesh-ancestor
110932767|NCT01309672|Prednisone|prednisone|mesh-list
110932768|NCT01309672|Abiraterone Acetate|abiraterone acetate|mesh-list
110932769|NCT01309672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110932770|NCT01309672|Glucocorticoids|glucocorticoids|mesh-ancestor
110932771|NCT01309672|Hormones|hormones|mesh-ancestor
110932772|NCT01309672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110932773|NCT01309672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110932774|NCT01309672|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110932775|NCT01309672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110932776|NCT01309672|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110934853|NCT02769832|Antimitotic Agents|antimitotic agents|mesh-ancestor
110934854|NCT02769832|Mitosis Modulators|mitosis modulators|mesh-ancestor
110934855|NCT02769832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110934856|NCT02769832|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110934857|NCT02769832|Antimetabolites|antimetabolites|mesh-ancestor
110934858|NCT02723994|Leucovorin|leucovorin|mesh-list
110934859|NCT02723994|Cytarabine|cytarabine|mesh-list
110934860|NCT02723994|Dexamethasone|dexamethasone|mesh-list
110934861|NCT02723994|Prednisone|prednisone|mesh-list
110934862|NCT02723994|Cyclophosphamide|cyclophosphamide|mesh-list
110934863|NCT02723994|Doxorubicin|doxorubicin|mesh-list
110934864|NCT02723994|Methotrexate|methotrexate|mesh-list
110934865|NCT02723994|Vincristine|vincristine|mesh-list
110934866|NCT02723994|Asparaginase|asparaginase|mesh-list
110934867|NCT02723994|Mercaptopurine|mercaptopurine|mesh-list
110934868|NCT02723994|Pegaspargase|pegaspargase|mesh-list
110934869|NCT02723994|Thioguanine|thioguanine|mesh-list
110934870|NCT02723994|Levoleucovorin|levoleucovorin|mesh-list
110934871|NCT02723994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110934872|NCT02723994|Immunologic Factors|immunologic factors|mesh-ancestor
110934873|NCT02723994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110934874|NCT02723994|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110934875|NCT02723994|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110934876|NCT02723994|Alkylating Agents|alkylating agents|mesh-ancestor
110934877|NCT02723994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110934878|NCT02723994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110934879|NCT02723994|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110934880|NCT02723994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110934881|NCT02723994|Antiemetics|antiemetics|mesh-ancestor
110934882|NCT02723994|Autonomic Agents|autonomic agents|mesh-ancestor
110934883|NCT02723994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110934884|NCT02723994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110934885|NCT02723994|Glucocorticoids|glucocorticoids|mesh-ancestor
110934886|NCT02723994|Hormones|hormones|mesh-ancestor
110934887|NCT02723994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110934888|NCT02723994|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110934889|NCT02723994|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110934893|NCT02723994|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110934894|NCT02723994|Abortifacient Agents|abortifacient agents|mesh-ancestor
110934895|NCT02723994|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110934896|NCT02723994|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110934898|NCT02723994|Dermatologic Agents|dermatologic agents|mesh-ancestor
110934899|NCT02723994|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110934900|NCT02723994|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110934901|NCT02723994|Antiviral Agents|antiviral agents|mesh-ancestor
110934902|NCT02723994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110934903|NCT02723994|Antidotes|antidotes|mesh-ancestor
110934904|NCT02723994|Protective Agents|protective agents|mesh-ancestor
110934905|NCT02723994|Vitamin B Complex|vitamin b complex|mesh-ancestor
110934906|NCT02723994|Vitamins|vitamins|mesh-ancestor
110934907|NCT02723994|Micronutrients|micronutrients|mesh-ancestor
110934908|NCT02723994|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110934909|NCT02723994|Tubulin Modulators|tubulin modulators|mesh-ancestor
110934910|NCT02723994|Antimitotic Agents|antimitotic agents|mesh-ancestor
110934911|NCT02723994|Mitosis Modulators|mitosis modulators|mesh-ancestor
110932777|NCT01309672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110932778|NCT01309672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110932779|NCT01309672|Hormone Antagonists|hormone antagonists|mesh-ancestor
110932780|NCT01309672|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110932782|NCT03026257|Contact Lens Solutions|contact lens solutions|mesh-list
110932783|NCT03026257|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110932784|NCT03026257|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110932785|NCT03026257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110932786|NCT03026257|Disinfectants|disinfectants|mesh-ancestor
110932787|NCT02200146|Hydroxychloroquine|hydroxychloroquine|mesh-list
110932788|NCT02200146|Prednisone|prednisone|mesh-list
110281033|NCT00220584|Donepezil|donepezil|mesh-list
110934912|NCT02706704|Adalimumab|adalimumab|mesh-list
110934913|NCT02706704|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110934914|NCT02706704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110934915|NCT02706704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110934916|NCT02697227|Nicotine|nicotine|mesh-list
110934917|NCT02697227|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110934918|NCT02697227|Autonomic Agents|autonomic agents|mesh-ancestor
110934919|NCT02697227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110934920|NCT02697227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110934921|NCT02697227|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110934922|NCT02697227|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110934923|NCT02697227|Cholinergic Agents|cholinergic agents|mesh-ancestor
110934924|NCT02697227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110934925|NCT02697227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110934926|NCT02547662|Dexamethasone|dexamethasone|mesh-list
110934927|NCT02547662|Dexamethasone acetate|dexamethasone acetate|mesh-list
110934928|NCT02547662|Pomalidomide|pomalidomide|mesh-list
110934929|NCT02547662|Ixazomib|ixazomib|mesh-list
110934930|NCT02547662|Ichthammol|ichthammol|mesh-list
110934931|NCT02547662|BB 1101|bb 1101|mesh-list
110934932|NCT02547662|Glycine|glycine|mesh-list
110934933|NCT02547662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110934934|NCT02547662|Antiemetics|antiemetics|mesh-ancestor
110934935|NCT02547662|Autonomic Agents|autonomic agents|mesh-ancestor
110934936|NCT02547662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110934937|NCT02547662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110934938|NCT02547662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110934939|NCT02547662|Glucocorticoids|glucocorticoids|mesh-ancestor
110934940|NCT02547662|Hormones|hormones|mesh-ancestor
110934941|NCT02547662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110934942|NCT02547662|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110934943|NCT02547662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110934944|NCT02547662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110934945|NCT02547662|Protease Inhibitors|protease inhibitors|mesh-ancestor
110934946|NCT02547662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110934947|NCT02547662|Immunologic Factors|immunologic factors|mesh-ancestor
110934948|NCT02547662|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110934949|NCT02547662|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110934950|NCT02547662|Growth Substances|growth substances|mesh-ancestor
110247914|NCT01242904|Icodextrin|icodextrin|mesh-list
110934951|NCT02547662|Growth Inhibitors|growth inhibitors|mesh-ancestor
110934952|NCT02547662|Dermatologic Agents|dermatologic agents|mesh-ancestor
110934953|NCT02547662|Glycine Agents|glycine agents|mesh-ancestor
110934954|NCT02547662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110934955|NCT02326311|Imatinib Mesylate|imatinib mesylate|mesh-list
110934956|NCT02326311|Dasatinib|dasatinib|mesh-list
110934957|NCT02326311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110934958|NCT02326311|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110934959|NCT02326311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110934960|NCT02326311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110934961|NCT02324543|Gemcitabine|gemcitabine|mesh-list
110934965|NCT02324543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110934966|NCT02324543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110934967|NCT02324543|Antimetabolites|antimetabolites|mesh-ancestor
110932789|NCT02200146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110932790|NCT02200146|Glucocorticoids|glucocorticoids|mesh-ancestor
110932792|NCT02200146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110932793|NCT02200146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110932794|NCT02200146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110932795|NCT02200146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110932796|NCT02200146|Antimalarials|antimalarials|mesh-ancestor
110932797|NCT02200146|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110932798|NCT02200146|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110932799|NCT02200146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110932800|NCT02200146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110932801|NCT02200146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110932802|NCT02200146|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110932803|NCT02208492|Levetiracetam|levetiracetam|mesh-list
110932804|NCT02208492|Anticonvulsants|anticonvulsants|mesh-ancestor
110932805|NCT02208492|Nootropic Agents|nootropic agents|mesh-ancestor
110932806|NCT01933048|Vaccines|vaccines|mesh-list
110932807|NCT01933048|Immunologic Factors|immunologic factors|mesh-ancestor
110932808|NCT01933048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110934968|NCT02324543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110934969|NCT02324543|Tubulin Modulators|tubulin modulators|mesh-ancestor
110934970|NCT02324543|Antimitotic Agents|antimitotic agents|mesh-ancestor
110934971|NCT02324543|Mitosis Modulators|mitosis modulators|mesh-ancestor
110934972|NCT02324543|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110934973|NCT02324543|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110934974|NCT02324543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110934976|NCT02215265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110934978|NCT02055638|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
110934979|NCT02055638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110934980|NCT02055638|Natriuretic Agents|natriuretic agents|mesh-ancestor
110934981|NCT02055638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110934982|NCT02029443|Acalabrutinib|acalabrutinib|mesh-list
110934983|NCT02029443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110934984|NCT01850524|Dexamethasone|dexamethasone|mesh-list
110934985|NCT01850524|Lenalidomide|lenalidomide|mesh-list
110934986|NCT01850524|Ixazomib|ixazomib|mesh-list
110934987|NCT01850524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110934988|NCT01850524|Antiemetics|antiemetics|mesh-ancestor
110934989|NCT01850524|Autonomic Agents|autonomic agents|mesh-ancestor
110934990|NCT01850524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110934991|NCT01850524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110934992|NCT01850524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110934993|NCT01850524|Glucocorticoids|glucocorticoids|mesh-ancestor
110934994|NCT01850524|Hormones|hormones|mesh-ancestor
110934995|NCT01850524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110934996|NCT01850524|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110934997|NCT01850524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110934998|NCT01850524|Immunologic Factors|immunologic factors|mesh-ancestor
110934999|NCT01850524|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110935000|NCT01850524|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110935001|NCT01850524|Growth Substances|growth substances|mesh-ancestor
110935002|NCT01850524|Growth Inhibitors|growth inhibitors|mesh-ancestor
110935003|NCT01850524|Protease Inhibitors|protease inhibitors|mesh-ancestor
110935004|NCT01850524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110932809|NCT02208882|Midazolam|midazolam|mesh-list
110932810|NCT02208882|BMS-986120|bms-986120|mesh-list
110932811|NCT02208882|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110248167|NCT00122603|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110932812|NCT02208882|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110932813|NCT02208882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110932814|NCT02208882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110932815|NCT02208882|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110932816|NCT02208882|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110932817|NCT02208882|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110932818|NCT02208882|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110932819|NCT02208882|Anesthetics, General|anesthetics, general|mesh-ancestor
110932820|NCT02208882|Anesthetics|anesthetics|mesh-ancestor
110932821|NCT02208882|GABA Modulators|gaba modulators|mesh-ancestor
110932822|NCT02208882|GABA Agents|gaba agents|mesh-ancestor
110932823|NCT02208882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110248208|NCT00492388|Anesthetics|anesthetics|mesh-ancestor
110281061|NCT00220818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110935005|NCT01850524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110935006|NCT01664910|Rituximab|rituximab|mesh-list
110935007|NCT01664910|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110935008|NCT01664910|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
110935009|NCT01664910|Methotrexate|methotrexate|mesh-list
110935010|NCT01664910|Fludarabine|fludarabine|mesh-list
110935011|NCT01664910|Fludarabine phosphate|fludarabine phosphate|mesh-list
110935012|NCT01664910|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110935013|NCT01664910|Antibodies|antibodies|mesh-list
110935014|NCT01664910|Immunoglobulins|immunoglobulins|mesh-list
110935015|NCT01664910|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110935016|NCT01664910|Tacrolimus|tacrolimus|mesh-list
110935017|NCT01664910|Thymoglobulin|thymoglobulin|mesh-list
110935018|NCT01664910|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110935019|NCT01664910|Immunologic Factors|immunologic factors|mesh-ancestor
110935020|NCT01664910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110935021|NCT01664910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110935022|NCT01664910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110935023|NCT01664910|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110935024|NCT01664910|Abortifacient Agents|abortifacient agents|mesh-ancestor
110935025|NCT01664910|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110248267|NCT00402350|Narcotics|narcotics|mesh-ancestor
110935026|NCT01664910|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110935027|NCT01664910|Antimetabolites|antimetabolites|mesh-ancestor
110935028|NCT01664910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110935029|NCT01664910|Dermatologic Agents|dermatologic agents|mesh-ancestor
110935030|NCT01664910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110935031|NCT01664910|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110935032|NCT01664910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110935033|NCT01664910|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110935034|NCT01664910|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110935035|NCT01664910|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110935036|NCT01664910|Alkylating Agents|alkylating agents|mesh-ancestor
110935043|NCT01550003|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110935044|NCT01550003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110652596|NCT03817853|Prednisone|prednisone|mesh-list
110935045|NCT01550003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110935046|NCT01550003|Immunologic Factors|immunologic factors|mesh-ancestor
110935047|NCT01550003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110935048|NCT01550003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110935049|NCT00764595|Imatinib Mesylate|imatinib mesylate|mesh-list
110935050|NCT00764595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110935051|NCT00764595|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110935052|NCT00764595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110935053|NCT00764595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110935054|NCT00576979|Cyclophosphamide|cyclophosphamide|mesh-list
110935055|NCT00576979|Etoposide|etoposide|mesh-list
110932824|NCT02208882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110932825|NCT02208882|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110932827|NCT03690115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110932828|NCT03690115|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110932829|NCT03690115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110932830|NCT03690115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110932831|NCT02204202|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110932832|NCT02204202|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110932833|NCT02204202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110932834|NCT01886794|Estrogens|estrogens|mesh-list
110932835|NCT01886794|Hormones|hormones|mesh-ancestor
110932836|NCT01886794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110932837|NCT01886794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110932838|NCT02209350|Aspirin|aspirin|mesh-list
110932839|NCT02209350|Clopidogrel|clopidogrel|mesh-list
110932840|NCT02209350|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110932841|NCT02209350|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110935056|NCT00576979|Etoposide phosphate|etoposide phosphate|mesh-list
110935057|NCT00576979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110935058|NCT00576979|Immunologic Factors|immunologic factors|mesh-ancestor
110935059|NCT00576979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110935060|NCT00576979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110935061|NCT00576979|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110935062|NCT00576979|Alkylating Agents|alkylating agents|mesh-ancestor
110935063|NCT00576979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110935064|NCT00576979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110935065|NCT00576979|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110935066|NCT00576979|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110935067|NCT00576979|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110935068|NCT00576979|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110935069|NCT00576979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110935070|NCT00390793|Cytarabine|cytarabine|mesh-list
110935071|NCT00390793|Dexamethasone|dexamethasone|mesh-list
110935072|NCT00390793|Prednisone|prednisone|mesh-list
110935073|NCT00390793|Dexamethasone acetate|dexamethasone acetate|mesh-list
110935074|NCT00390793|Cortisone|cortisone|mesh-list
110935075|NCT00390793|Cyclophosphamide|cyclophosphamide|mesh-list
110935076|NCT00390793|Doxorubicin|doxorubicin|mesh-list
110935077|NCT00390793|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110935078|NCT00390793|Methotrexate|methotrexate|mesh-list
110935079|NCT00390793|Vincristine|vincristine|mesh-list
110935080|NCT00390793|Daunorubicin|daunorubicin|mesh-list
110935081|NCT00390793|Dasatinib|dasatinib|mesh-list
110935082|NCT00390793|BB 1101|bb 1101|mesh-list
110935083|NCT00390793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110935084|NCT00390793|Immunologic Factors|immunologic factors|mesh-ancestor
110935085|NCT00390793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110935086|NCT00390793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110935087|NCT00390793|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110935088|NCT00390793|Alkylating Agents|alkylating agents|mesh-ancestor
110935089|NCT00390793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110248432|NCT01244113|Propofol|propofol|mesh-list
110935090|NCT00390793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110935091|NCT00390793|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110935092|NCT00390793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110935093|NCT00390793|Antiemetics|antiemetics|mesh-ancestor
110932842|NCT02209350|Analgesics|analgesics|mesh-ancestor
110932843|NCT02209350|Sensory System Agents|sensory system agents|mesh-ancestor
110932844|NCT02209350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110932845|NCT02209350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110932846|NCT02209350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110932847|NCT02209350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110932848|NCT02209350|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110932849|NCT02209350|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110932850|NCT02209350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110932851|NCT02209350|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110932852|NCT02209350|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110932853|NCT02209350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110932854|NCT02209350|Antipyretics|antipyretics|mesh-ancestor
110932855|NCT02209350|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110932856|NCT02209350|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110932857|NCT02209350|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110281100|NCT00190892|Analgesics|analgesics|mesh-ancestor
110935094|NCT00390793|Autonomic Agents|autonomic agents|mesh-ancestor
110935095|NCT00390793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110935096|NCT00390793|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110935097|NCT00390793|Glucocorticoids|glucocorticoids|mesh-ancestor
110935098|NCT00390793|Hormones|hormones|mesh-ancestor
110935099|NCT00390793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110935100|NCT00390793|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110935101|NCT00390793|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110935102|NCT00390793|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110935103|NCT00390793|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110935104|NCT00390793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110935105|NCT00390793|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110935106|NCT00390793|Abortifacient Agents|abortifacient agents|mesh-ancestor
110935107|NCT00390793|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110935129|NCT03563235|Micronutrients|micronutrients|mesh-ancestor
110935130|NCT03563235|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110935131|NCT01329900|Etoposide|etoposide|mesh-list
110935132|NCT01329900|Ifosfamide|ifosfamide|mesh-list
110935133|NCT01329900|Ofatumumab|ofatumumab|mesh-list
110935134|NCT01329900|Lenograstim|lenograstim|mesh-list
110935135|NCT01329900|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110935136|NCT01329900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110935137|NCT01329900|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110935138|NCT01329900|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110935139|NCT01329900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110935140|NCT01329900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110935141|NCT01329900|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110935142|NCT01329900|Alkylating Agents|alkylating agents|mesh-ancestor
110935143|NCT01329900|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110935144|NCT01329900|Immunologic Factors|immunologic factors|mesh-ancestor
110935145|NCT01329900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110935146|NCT04948294|Pyrithione zinc|pyrithione zinc|mesh-list
110935147|NCT04948294|Keratolytic Agents|keratolytic agents|mesh-ancestor
110935148|NCT04948294|Dermatologic Agents|dermatologic agents|mesh-ancestor
110935149|NCT04948372|Terlipressin|terlipressin|mesh-list
110935150|NCT04948372|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110935151|NCT04948372|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110935152|NCT04947748|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110935153|NCT04947748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110935154|NCT04947826|Antibodies|antibodies|mesh-list
110932858|NCT02209350|Purinergic Agents|purinergic agents|mesh-ancestor
110932859|NCT02209350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110932860|NCT02209428|Temozolomide|temozolomide|mesh-list
110932861|NCT02209428|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110932862|NCT02209428|Alkylating Agents|alkylating agents|mesh-ancestor
110932863|NCT02209428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110932864|NCT02209428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110932865|NCT02200848|Rituximab|rituximab|mesh-list
110935155|NCT04947826|Immunoglobulins|immunoglobulins|mesh-list
110935156|NCT04947826|Immunologic Factors|immunologic factors|mesh-ancestor
110935157|NCT04947826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110935158|NCT05059977|Immunoglobulins|immunoglobulins|mesh-list
110935159|NCT05059977|gamma-Globulins|gamma-globulins|mesh-list
110935160|NCT05059977|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110935161|NCT05059977|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110935171|NCT02228616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110935172|NCT02228616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110935173|NCT02228616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110935175|NCT02228772|Cyclophosphamide|cyclophosphamide|mesh-list
110935176|NCT02228772|Doxorubicin|doxorubicin|mesh-list
110935177|NCT02228772|Methotrexate|methotrexate|mesh-list
110935178|NCT02228772|Vincristine|vincristine|mesh-list
110935179|NCT02228772|Mercaptopurine|mercaptopurine|mesh-list
110935180|NCT02228772|Ixazomib|ixazomib|mesh-list
110935181|NCT02228772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110935182|NCT02228772|Immunologic Factors|immunologic factors|mesh-ancestor
110935183|NCT02228772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110935184|NCT02228772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110935185|NCT02228772|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110935186|NCT02228772|Alkylating Agents|alkylating agents|mesh-ancestor
110935187|NCT02228772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110935188|NCT02228772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110935189|NCT02228772|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110935190|NCT02228772|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110935191|NCT02228772|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110935192|NCT02228772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110935193|NCT02228772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110935194|NCT02228772|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110935195|NCT02228772|Abortifacient Agents|abortifacient agents|mesh-ancestor
110935196|NCT02228772|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110935197|NCT02228772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110652744|NCT00950066|Amlodipine|amlodipine|mesh-list
110935198|NCT02228772|Antimetabolites|antimetabolites|mesh-ancestor
110935199|NCT02228772|Dermatologic Agents|dermatologic agents|mesh-ancestor
110935200|NCT02228772|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110935201|NCT02228772|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110935202|NCT02228772|Antiviral Agents|antiviral agents|mesh-ancestor
110935203|NCT02228772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110935204|NCT02228772|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110935205|NCT02228772|Tubulin Modulators|tubulin modulators|mesh-ancestor
110935206|NCT02228772|Antimitotic Agents|antimitotic agents|mesh-ancestor
110935207|NCT02228772|Mitosis Modulators|mitosis modulators|mesh-ancestor
110248746|NCT04665765|Rituximab|rituximab|mesh-list
110935208|NCT02228772|Protease Inhibitors|protease inhibitors|mesh-ancestor
110935209|NCT03646968|Docetaxel|docetaxel|mesh-list
110935210|NCT03646968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110935211|NCT03646968|Tubulin Modulators|tubulin modulators|mesh-ancestor
110935212|NCT03646968|Antimitotic Agents|antimitotic agents|mesh-ancestor
110935213|NCT03646968|Mitosis Modulators|mitosis modulators|mesh-ancestor
110935214|NCT03646968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110935215|NCT02228850|Alprostadil|alprostadil|mesh-list
110935216|NCT02228850|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110935217|NCT02228850|Vasodilator Agents|vasodilator agents|mesh-ancestor
110935218|NCT02228850|Urological Agents|urological agents|mesh-ancestor
110935219|NCT02822508|Laxatives|laxatives|mesh-list
110935220|NCT02822508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110935221|NCT03563001|Budesonide|budesonide|mesh-list
110935222|NCT03563001|Formoterol Fumarate|formoterol fumarate|mesh-list
110935223|NCT03563001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110478548|NCT01018862|Azelastine|azelastine|mesh-list
110932867|NCT02200848|Glutarimide|glutarimide|mesh-list
110932868|NCT02200848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110932869|NCT02200848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110932870|NCT02200848|Immunologic Factors|immunologic factors|mesh-ancestor
110932871|NCT02200848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110932872|NCT02200848|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110932873|NCT02200848|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110932874|NCT02200848|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110932875|NCT02200848|Growth Substances|growth substances|mesh-ancestor
110932876|NCT02200848|Growth Inhibitors|growth inhibitors|mesh-ancestor
110932877|NCT02200848|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110932878|NCT02200848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110932879|NCT02200848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110932880|NCT02751450|Fluorides|fluorides|mesh-list
110935224|NCT03563001|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110935225|NCT03563001|Autonomic Agents|autonomic agents|mesh-ancestor
110935226|NCT03563001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110935227|NCT03563001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110935228|NCT03563001|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110935243|NCT02228928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110935244|NCT02228928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110935245|NCT03888378|Minocycline|minocycline|mesh-list
110935246|NCT03888378|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110935247|NCT03888378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110935248|NCT03603288|Idebenone|idebenone|mesh-list
110935249|NCT03603288|Antioxidants|antioxidants|mesh-ancestor
110935250|NCT03603288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110935251|NCT03603288|Protective Agents|protective agents|mesh-ancestor
110935252|NCT03603288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110935253|NCT03857646|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
110935254|NCT03857646|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
110935255|NCT03857646|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
110935256|NCT03857646|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110935257|NCT03844074|Bevacizumab|bevacizumab|mesh-list
110935258|NCT03844074|Ranibizumab|ranibizumab|mesh-list
110935259|NCT03844074|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110935260|NCT03844074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110935261|NCT03844074|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110935262|NCT03844074|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110935263|NCT03844074|Growth Substances|growth substances|mesh-ancestor
110935264|NCT03844074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110935265|NCT03844074|Growth Inhibitors|growth inhibitors|mesh-ancestor
110935266|NCT02624986|Rituximab|rituximab|mesh-list
110935267|NCT02624986|Obinutuzumab|obinutuzumab|mesh-list
110935268|NCT02624986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110935269|NCT02624986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110935270|NCT02624986|Immunologic Factors|immunologic factors|mesh-ancestor
110935271|NCT02624986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110935272|NCT02624986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110935273|NCT04946734|Aspirin|aspirin|mesh-list
110935275|NCT04946734|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110935276|NCT04946734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110935277|NCT04946734|Analgesics|analgesics|mesh-ancestor
110935278|NCT04946734|Sensory System Agents|sensory system agents|mesh-ancestor
110935279|NCT04946734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110935280|NCT04946734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110935281|NCT04946734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110935282|NCT04946734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110935283|NCT04946734|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110932881|NCT02751450|Tin Fluorides|tin fluorides|mesh-list
110932882|NCT02751450|Fluorophosphate|fluorophosphate|mesh-list
110932883|NCT02751450|Cariostatic Agents|cariostatic agents|mesh-ancestor
110932884|NCT02751450|Protective Agents|protective agents|mesh-ancestor
110932885|NCT02751450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110932886|NCT02209740|Tenofovir|tenofovir|mesh-list
110932887|NCT02209740|Antiviral Agents|antiviral agents|mesh-ancestor
110932888|NCT02209740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110932889|NCT02209740|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110932890|NCT02209740|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110932891|NCT02209740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110281134|NCT00191009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110935284|NCT04946734|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110935285|NCT04946734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110935286|NCT04946734|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110935287|NCT04946734|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110935288|NCT04946734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110935289|NCT04946734|Antipyretics|antipyretics|mesh-ancestor
110935295|NCT04945954|Cyclophosphamide|cyclophosphamide|mesh-list
110935296|NCT04945954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110935297|NCT04945954|Immunologic Factors|immunologic factors|mesh-ancestor
110935298|NCT04945954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110935299|NCT04945954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110935300|NCT04945954|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110935301|NCT04945954|Alkylating Agents|alkylating agents|mesh-ancestor
110935302|NCT04945954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110935303|NCT04945954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110935304|NCT04945954|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110935306|NCT04945096|Acetylcysteine|acetylcysteine|mesh-list
110935307|NCT04945096|Cyclosporine|cyclosporine|mesh-list
110935308|NCT04945096|Cyclophosphamide|cyclophosphamide|mesh-list
110935309|NCT04945096|Busulfan|busulfan|mesh-list
110935310|NCT04945096|Semustine|semustine|mesh-list
110935311|NCT04945096|Decitabine|decitabine|mesh-list
110935312|NCT04945096|Cyclosporins|cyclosporins|mesh-list
110935313|NCT04945096|Thymoglobulin|thymoglobulin|mesh-list
110935314|NCT04945096|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110935315|NCT04945096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110935316|NCT04945096|Immunologic Factors|immunologic factors|mesh-ancestor
110935317|NCT04945096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110935318|NCT04945096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110935319|NCT04945096|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110935320|NCT04945096|Alkylating Agents|alkylating agents|mesh-ancestor
110935321|NCT04945096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110935322|NCT04945096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110935323|NCT04945096|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110935324|NCT04945096|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110935325|NCT04945096|Antimetabolites|antimetabolites|mesh-ancestor
110935326|NCT04945096|Antiviral Agents|antiviral agents|mesh-ancestor
110935327|NCT04945096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110935328|NCT04945096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110935329|NCT04945096|Antifungal Agents|antifungal agents|mesh-ancestor
110935330|NCT04945096|Dermatologic Agents|dermatologic agents|mesh-ancestor
110935331|NCT04945096|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110935332|NCT04945096|Expectorants|expectorants|mesh-ancestor
110935333|NCT04945096|Respiratory System Agents|respiratory system agents|mesh-ancestor
110935334|NCT04945096|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110935335|NCT04945096|Antioxidants|antioxidants|mesh-ancestor
110935336|NCT04945096|Protective Agents|protective agents|mesh-ancestor
110935337|NCT04944082|Ivermectin|ivermectin|mesh-list
110935338|NCT04944082|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110935339|NCT04944082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110935340|NCT04943692|Metformin|metformin|mesh-list
110935341|NCT04943692|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110932892|NCT02209740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110932893|NCT02209740|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110932894|NCT02209740|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110932895|NCT02257788|Leronlimab|leronlimab|mesh-list
110932896|NCT02257788|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110932897|NCT02257788|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110932898|NCT02257788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110932899|NCT02257788|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110932900|NCT02257788|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110932901|NCT02257788|Antiviral Agents|antiviral agents|mesh-ancestor
110932902|NCT02257788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110932903|NCT02220660|Olodaterol|olodaterol|mesh-list
110932904|NCT02220660|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110932905|NCT02220660|Autonomic Agents|autonomic agents|mesh-ancestor
110932906|NCT02220660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110932907|NCT02220660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110935342|NCT04943692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110935343|NCT02587598|Cytarabine|cytarabine|mesh-list
110935344|NCT02587598|Azacitidine|azacitidine|mesh-list
110935345|NCT02587598|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110935346|NCT02587598|Antimetabolites|antimetabolites|mesh-ancestor
110935347|NCT02587598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110935348|NCT02587598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110935349|NCT02587598|Antiviral Agents|antiviral agents|mesh-ancestor
110935350|NCT02587598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110935352|NCT02587598|Immunologic Factors|immunologic factors|mesh-ancestor
110935353|NCT02587598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110935354|NCT02587598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110935355|NCT04943536|Bicalutamide|bicalutamide|mesh-list
110935356|NCT04943536|Androgen Antagonists|androgen antagonists|mesh-ancestor
110935357|NCT04943536|Hormone Antagonists|hormone antagonists|mesh-ancestor
110935358|NCT04943536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110935359|NCT04943536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110935360|NCT04943536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110935361|NCT04943146|Aspirin|aspirin|mesh-list
110935362|NCT04943146|Prednisone|prednisone|mesh-list
110935368|NCT04943146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110935369|NCT04943146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110935370|NCT04943146|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110935371|NCT04943146|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110935372|NCT04943146|Analgesics|analgesics|mesh-ancestor
110935373|NCT04943146|Sensory System Agents|sensory system agents|mesh-ancestor
110935374|NCT04943146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110935375|NCT04943146|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110935376|NCT04943146|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110935377|NCT04943146|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110935378|NCT04943146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110935379|NCT04943146|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110935380|NCT04943146|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110935381|NCT04943146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110935382|NCT04943146|Antipyretics|antipyretics|mesh-ancestor
110935383|NCT02485574|Calcium|calcium|mesh-list
110935384|NCT02485574|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110935385|NCT02485574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110935386|NCT04942834|Amiodarone|amiodarone|mesh-list
110935387|NCT04942834|Sotalol|sotalol|mesh-list
110935388|NCT04942834|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
110935389|NCT04942834|Dronedarone|dronedarone|mesh-list
110932908|NCT02220660|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110932909|NCT02220660|Respiratory System Agents|respiratory system agents|mesh-ancestor
110932911|NCT01515748|Fluorouracil|fluorouracil|mesh-list
110932912|NCT01515748|Oxaliplatin|oxaliplatin|mesh-list
110932913|NCT01515748|Tegafur|tegafur|mesh-list
110932914|NCT01515748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110932915|NCT01515748|Tubulin Modulators|tubulin modulators|mesh-ancestor
110932916|NCT01515748|Antimitotic Agents|antimitotic agents|mesh-ancestor
110932917|NCT01515748|Mitosis Modulators|mitosis modulators|mesh-ancestor
110932918|NCT01515748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110932919|NCT01515748|Antimetabolites|antimetabolites|mesh-ancestor
110935390|NCT04942834|Propafenone|propafenone|mesh-list
110935391|NCT04942834|Vasodilator Agents|vasodilator agents|mesh-ancestor
110935392|NCT04942834|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
110935393|NCT04942834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110935394|NCT04942834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110935395|NCT04942834|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110935396|NCT04942834|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110935397|NCT04942834|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110935398|NCT04942834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110935399|NCT04942834|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110935400|NCT04942834|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110935401|NCT04942834|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110935402|NCT04942834|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110935403|NCT04942834|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110935404|NCT04942834|Adrenergic Agents|adrenergic agents|mesh-ancestor
110935405|NCT04942834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110935406|NCT04942834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110935407|NCT04942834|Sympatholytics|sympatholytics|mesh-ancestor
110935408|NCT04942834|Autonomic Agents|autonomic agents|mesh-ancestor
110935409|NCT04942834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110935410|NCT04942834|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110935411|NCT04941976|Benzydamine|benzydamine|mesh-list
110935412|NCT04941976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110935413|NCT01291004|Drospirenone|drospirenone|mesh-list
110935414|NCT01291004|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110935415|NCT01291004|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110935416|NCT01291004|Levonorgestrel|levonorgestrel|mesh-list
110935417|NCT01291004|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110935418|NCT01291004|Desogestrel|desogestrel|mesh-list
110935419|NCT01291004|Contraceptive Agents|contraceptive agents|mesh-list
110935420|NCT01291004|Contraceptives, Oral|contraceptives, oral|mesh-list
110935421|NCT01291004|Estradiol|estradiol|mesh-list
110935422|NCT01291004|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110935423|NCT01291004|Estrogens|estrogens|mesh-ancestor
110935424|NCT01291004|Hormones|hormones|mesh-ancestor
110652975|NCT00946166|Simvastatin|simvastatin|mesh-list
110935425|NCT01291004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110935426|NCT01291004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110935427|NCT01291004|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110935428|NCT01291004|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110935429|NCT01291004|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110283593|NCT00196586|Interferons|interferons|mesh-list
110935436|NCT01291004|Natriuretic Agents|natriuretic agents|mesh-ancestor
110935438|NCT04941118|Anesthetics|anesthetics|mesh-list
110935439|NCT04941118|Anesthetics, Local|anesthetics, local|mesh-list
110935440|NCT04941118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110935441|NCT04941118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110935442|NCT04941118|Sensory System Agents|sensory system agents|mesh-ancestor
110935443|NCT04941118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110935444|NCT03483818|Antiviral Agents|antiviral agents|mesh-list
110935445|NCT03483818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110935446|NCT00374660|Oxaliplatin|oxaliplatin|mesh-list
110935447|NCT00374660|Irofulven|irofulven|mesh-list
110932920|NCT01515748|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110932921|NCT01515748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110932922|NCT01515748|Immunologic Factors|immunologic factors|mesh-ancestor
110932923|NCT01515748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110932924|NCT04973722|Denosumab|denosumab|mesh-list
110932925|NCT04973722|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110932926|NCT04973722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110932927|NCT03284034|Deoxycholic Acid|deoxycholic acid|mesh-list
110932928|NCT03284034|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
110932929|NCT03284034|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110935448|NCT00374660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110935449|NCT00374660|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110935450|NCT00374660|Alkylating Agents|alkylating agents|mesh-ancestor
110935451|NCT00374660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110935452|NCT02624050|Propofol|propofol|mesh-list
110935453|NCT02624050|Methohexital|methohexital|mesh-list
110935454|NCT02624050|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110935455|NCT02624050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110935456|NCT02624050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110935457|NCT02624050|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110935458|NCT02624050|Anesthetics, General|anesthetics, general|mesh-ancestor
110935459|NCT02624050|Anesthetics|anesthetics|mesh-ancestor
110935460|NCT03131882|Triamcinolone|triamcinolone|mesh-list
110935461|NCT03131882|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110935462|NCT03131882|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110935463|NCT03131882|Hyaluronic Acid|hyaluronic acid|mesh-list
110935464|NCT03131882|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110935465|NCT03131882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110935466|NCT03131882|Glucocorticoids|glucocorticoids|mesh-ancestor
110935467|NCT03131882|Hormones|hormones|mesh-ancestor
110935468|NCT03131882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110935469|NCT03131882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110935470|NCT03131882|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110935471|NCT03131882|Immunologic Factors|immunologic factors|mesh-ancestor
110935472|NCT03131882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110935473|NCT03131882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110935474|NCT03131882|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110935475|NCT03131882|Viscosupplements|viscosupplements|mesh-ancestor
110935476|NCT03131882|Protective Agents|protective agents|mesh-ancestor
110935477|NCT03483350|Midazolam|midazolam|mesh-list
110935478|NCT03483350|Granisetron|granisetron|mesh-list
110935479|NCT03483350|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110935480|NCT03483350|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110935481|NCT03483350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110935482|NCT03483350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110935483|NCT03483350|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110935484|NCT03483350|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110935485|NCT03483350|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110935486|NCT03483350|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110935487|NCT03483350|Anesthetics, General|anesthetics, general|mesh-ancestor
110935488|NCT03483350|Anesthetics|anesthetics|mesh-ancestor
110935489|NCT03483350|GABA Modulators|gaba modulators|mesh-ancestor
110935490|NCT03483350|GABA Agents|gaba agents|mesh-ancestor
110935491|NCT03483350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110935492|NCT03483350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110935493|NCT03483350|Antiemetics|antiemetics|mesh-ancestor
110935494|NCT03483350|Autonomic Agents|autonomic agents|mesh-ancestor
110935495|NCT03483350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110935496|NCT03483350|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110935497|NCT03483350|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110935498|NCT03483350|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110653047|NCT00120289|Vitamins|vitamins|mesh-ancestor
110935499|NCT03483350|Serotonin Agents|serotonin agents|mesh-ancestor
110935504|NCT03480308|Antiemetics|antiemetics|mesh-ancestor
110935505|NCT03480308|Autonomic Agents|autonomic agents|mesh-ancestor
110935506|NCT03480308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110932930|NCT01358175|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110932931|NCT01358175|Immunologic Factors|immunologic factors|mesh-ancestor
110932932|NCT01358175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110932933|NCT02209974|Fluticasone|fluticasone|mesh-list
110932934|NCT02209974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110932935|NCT02209974|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110932936|NCT02209974|Autonomic Agents|autonomic agents|mesh-ancestor
110932937|NCT02209974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110932938|NCT02209974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110932939|NCT02209974|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110932940|NCT02209974|Respiratory System Agents|respiratory system agents|mesh-ancestor
110932941|NCT02209974|Dermatologic Agents|dermatologic agents|mesh-ancestor
110932942|NCT02209974|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110932943|NCT02212392|Meropenem|meropenem|mesh-list
110932944|NCT02212392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110932945|NCT02212392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110932946|NCT03679897|Ropivacaine|ropivacaine|mesh-list
110932947|NCT03679897|Levobupivacaine|levobupivacaine|mesh-list
110932948|NCT03679897|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110932949|NCT03679897|Anesthetics, Local|anesthetics, local|mesh-ancestor
110932950|NCT03679897|Anesthetics|anesthetics|mesh-ancestor
110932951|NCT03679897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110932952|NCT03679897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110932953|NCT03679897|Sensory System Agents|sensory system agents|mesh-ancestor
110932954|NCT03679897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110932955|NCT03060070|Dexmedetomidine|dexmedetomidine|mesh-list
110932956|NCT03060070|Ketamine|ketamine|mesh-list
110932957|NCT03060070|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110281183|NCT00191204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110935507|NCT03480308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110935508|NCT03480308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110935509|NCT03480308|Glucocorticoids|glucocorticoids|mesh-ancestor
110935510|NCT03480308|Hormones|hormones|mesh-ancestor
110655631|NCT04008966|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110935511|NCT03480308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110935512|NCT03480308|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110935513|NCT03480308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110935514|NCT03480308|Anesthetics, Local|anesthetics, local|mesh-ancestor
110935515|NCT03480308|Anesthetics|anesthetics|mesh-ancestor
110935516|NCT03480308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110935517|NCT03480308|Sensory System Agents|sensory system agents|mesh-ancestor
110935518|NCT03480308|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110935519|NCT03480308|Narcotics|narcotics|mesh-ancestor
110935520|NCT03480308|Analgesics|analgesics|mesh-ancestor
110935521|NCT03480308|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110935522|NCT03480308|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110935523|NCT03480308|Anesthetics, General|anesthetics, general|mesh-ancestor
110935524|NCT05151614|Colchicine|colchicine|mesh-list
110935525|NCT05151614|Gout Suppressants|gout suppressants|mesh-ancestor
110932958|NCT03060070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110932959|NCT03060070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110932960|NCT03060070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110932961|NCT03060070|Analgesics|analgesics|mesh-ancestor
110932962|NCT03060070|Sensory System Agents|sensory system agents|mesh-ancestor
110932963|NCT03060070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110932964|NCT03060070|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110932965|NCT03060070|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110935526|NCT05151614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110935527|NCT05151614|Tubulin Modulators|tubulin modulators|mesh-ancestor
110935528|NCT05151614|Antimitotic Agents|antimitotic agents|mesh-ancestor
110935529|NCT05151614|Mitosis Modulators|mitosis modulators|mesh-ancestor
110935530|NCT05151614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110935531|NCT05151614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110935532|NCT04937140|Antibodies|antibodies|mesh-list
110935533|NCT04937140|Immunologic Factors|immunologic factors|mesh-ancestor
110935534|NCT04937140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110935535|NCT03482960|Xenon|xenon|mesh-list
110935536|NCT03482960|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110935537|NCT03482960|Anesthetics, General|anesthetics, general|mesh-ancestor
110935538|NCT03482960|Anesthetics|anesthetics|mesh-ancestor
110935539|NCT03482960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110935540|NCT03482960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110935541|NCT03479996|Bupivacaine|bupivacaine|mesh-list
110935542|NCT03479996|Anesthetics, Local|anesthetics, local|mesh-ancestor
110935543|NCT03479996|Anesthetics|anesthetics|mesh-ancestor
110935544|NCT03479996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110935545|NCT03479996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110935546|NCT03479996|Sensory System Agents|sensory system agents|mesh-ancestor
110935547|NCT03479996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110935548|NCT04936282|Tacrolimus|tacrolimus|mesh-list
110935549|NCT04936282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110935550|NCT04936282|Immunologic Factors|immunologic factors|mesh-ancestor
110935551|NCT04936282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110935552|NCT04936282|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110935553|NCT04936282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110935554|NCT04936282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110935555|NCT02524184|Sildenafil Citrate|sildenafil citrate|mesh-list
110935556|NCT02524184|Vasodilator Agents|vasodilator agents|mesh-ancestor
110935557|NCT02524184|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110935558|NCT02524184|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110935559|NCT02524184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110935560|NCT02524184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110935561|NCT02524184|Urological Agents|urological agents|mesh-ancestor
110935562|NCT04936204|Hyaluronic Acid|hyaluronic acid|mesh-list
110935563|NCT04936204|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110935564|NCT04936204|Immunologic Factors|immunologic factors|mesh-ancestor
110935565|NCT04936204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110935566|NCT04936204|Viscosupplements|viscosupplements|mesh-ancestor
110935567|NCT04936204|Protective Agents|protective agents|mesh-ancestor
110935568|NCT03486236|Ivacaftor|ivacaftor|mesh-list
110935569|NCT03486236|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
110935570|NCT03486236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110935571|NCT03486236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110935572|NCT03479918|Prednisone|prednisone|mesh-list
110935573|NCT03479918|Cyclophosphamide|cyclophosphamide|mesh-list
110935579|NCT03479918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110935580|NCT03479918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110935581|NCT03479918|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110935582|NCT03479918|Alkylating Agents|alkylating agents|mesh-ancestor
110935583|NCT03479918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110935584|NCT03479918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110935585|NCT03479918|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110935586|NCT03479918|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110935587|NCT03479918|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110932966|NCT03060070|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110932967|NCT03060070|Adrenergic Agents|adrenergic agents|mesh-ancestor
110932968|NCT03060070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110932969|NCT03060070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110932970|NCT03060070|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110932971|NCT03060070|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110932972|NCT03060070|Anesthetics, General|anesthetics, general|mesh-ancestor
110932973|NCT03060070|Anesthetics|anesthetics|mesh-ancestor
110932974|NCT03060070|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110932975|NCT03060070|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110932976|NCT03683563|Citric Acid|citric acid|mesh-list
110932977|NCT03683563|Sodium Citrate|sodium citrate|mesh-list
110932978|NCT03683563|Anticoagulants|anticoagulants|mesh-ancestor
110932979|NCT03683563|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110932980|NCT03683563|Chelating Agents|chelating agents|mesh-ancestor
110932981|NCT03683563|Sequestering Agents|sequestering agents|mesh-ancestor
110932982|NCT03683563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110932983|NCT03563625|Bupivacaine|bupivacaine|mesh-list
110932984|NCT03563625|Anesthetics, Local|anesthetics, local|mesh-ancestor
110932985|NCT03563625|Anesthetics|anesthetics|mesh-ancestor
110932986|NCT03563625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110932987|NCT03563625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110281219|NCT00123305|Plasminogen|plasminogen|mesh-list
110935588|NCT03479918|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110935589|NCT03479918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110935590|NCT03479918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110935591|NCT03479918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110935593|NCT03479918|Hormones|hormones|mesh-ancestor
110935594|NCT03479918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110935595|NCT03479918|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110935596|NCT03479918|Tubulin Modulators|tubulin modulators|mesh-ancestor
110935597|NCT03479918|Antimitotic Agents|antimitotic agents|mesh-ancestor
110935598|NCT03479918|Mitosis Modulators|mitosis modulators|mesh-ancestor
110935599|NCT03486080|Lenograstim|lenograstim|mesh-list
110935600|NCT03486080|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110935601|NCT03486080|Immunologic Factors|immunologic factors|mesh-ancestor
110935602|NCT03486080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110935603|NCT03479450|Pulmonary Surfactants|pulmonary surfactants|mesh-list
110935604|NCT03479450|Respiratory System Agents|respiratory system agents|mesh-ancestor
110935605|NCT03477344|Dexmedetomidine|dexmedetomidine|mesh-list
110935606|NCT03477344|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110935607|NCT03477344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110935608|NCT03477344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110935609|NCT03477344|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110935610|NCT03477344|Analgesics|analgesics|mesh-ancestor
110935611|NCT03477344|Sensory System Agents|sensory system agents|mesh-ancestor
110935612|NCT03477344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110935613|NCT03477344|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110935614|NCT03477344|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110935615|NCT03477344|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110935616|NCT03477344|Adrenergic Agents|adrenergic agents|mesh-ancestor
110935617|NCT03477344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110932988|NCT03563625|Sensory System Agents|sensory system agents|mesh-ancestor
110932989|NCT03563625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110932990|NCT02832375|Fluorides|fluorides|mesh-list
110932991|NCT02832375|Tin Fluorides|tin fluorides|mesh-list
110932992|NCT02832375|Fluorophosphate|fluorophosphate|mesh-list
110932993|NCT02832375|Cariostatic Agents|cariostatic agents|mesh-ancestor
110932994|NCT02832375|Protective Agents|protective agents|mesh-ancestor
110935618|NCT03477344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110935619|NCT04933864|Methylene Blue|methylene blue|mesh-list
110935620|NCT04933864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110935621|NCT04933864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110935622|NCT03477266|Mosapride|mosapride|mesh-list
110935623|NCT03477266|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110935624|NCT03477266|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110935625|NCT03477266|Serotonin Agents|serotonin agents|mesh-ancestor
110935626|NCT03477266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110935627|NCT03477266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110935628|NCT03477266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110935629|NCT03479372|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110935630|NCT03479372|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110935631|NCT03131336|Fibrin Foam|fibrin foam|mesh-list
110935632|NCT03131336|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
110935633|NCT03131336|Hemostatics|hemostatics|mesh-ancestor
110935634|NCT03131336|Coagulants|coagulants|mesh-ancestor
110935635|NCT03482492|Acetaminophen|acetaminophen|mesh-list
110935636|NCT03482492|Tramadol|tramadol|mesh-list
110935637|NCT03482492|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110935638|NCT03482492|Analgesics|analgesics|mesh-ancestor
110935639|NCT03482492|Sensory System Agents|sensory system agents|mesh-ancestor
110935640|NCT03482492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110935641|NCT03482492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110935642|NCT03482492|Antipyretics|antipyretics|mesh-ancestor
110935643|NCT03482492|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110935644|NCT03482492|Narcotics|narcotics|mesh-ancestor
110935647|NCT03477110|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110935648|NCT03477110|Alkylating Agents|alkylating agents|mesh-ancestor
110935649|NCT03477110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110682994|NCT00904475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110935650|NCT03477110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110935652|NCT03874286|Hematinics|hematinics|mesh-ancestor
110935653|NCT05259098|Sufentanil|sufentanil|mesh-list
110935654|NCT05259098|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110935655|NCT05259098|Narcotics|narcotics|mesh-ancestor
110935656|NCT05259098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110935657|NCT05259098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110935658|NCT05259098|Analgesics|analgesics|mesh-ancestor
110935659|NCT05259098|Sensory System Agents|sensory system agents|mesh-ancestor
110935660|NCT05259098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110935661|NCT05259098|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110935662|NCT05259098|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110935663|NCT05259098|Anesthetics, General|anesthetics, general|mesh-ancestor
110935664|NCT05259098|Anesthetics|anesthetics|mesh-ancestor
110935665|NCT03482180|Atorvastatin|atorvastatin|mesh-list
110935666|NCT03482180|Calcium|calcium|mesh-list
110935667|NCT03482180|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110935668|NCT03482180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110935669|NCT03482180|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110935670|NCT03482180|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110935671|NCT03482180|Antimetabolites|antimetabolites|mesh-ancestor
110935672|NCT03482180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110935673|NCT03482180|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110935674|NCT03482180|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110935675|NCT03482180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110935676|NCT04390646|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
110935677|NCT04390646|Hormones|hormones|mesh-ancestor
110249251|NCT00499876|Mefloquine|mefloquine|mesh-list
110935678|NCT04390646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110935679|NCT04390646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110935680|NCT04294550|Naloxegol|naloxegol|mesh-list
110935681|NCT04294550|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110036034|NCT01408797|Bortezomib|bortezomib|mesh-list
110932995|NCT02832375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110932996|NCT03683329|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110932997|NCT03683329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110932998|NCT02218476|Coenzyme Q10|coenzyme q10|mesh-list
110650566|NCT00734123|Diuretics|diuretics|mesh-list
110932999|NCT02218476|Vitamins|vitamins|mesh-ancestor
110933000|NCT02218476|Micronutrients|micronutrients|mesh-ancestor
110933001|NCT02218476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110933002|NCT02205996|Insulin|insulin|mesh-list
110933003|NCT02205996|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110933004|NCT02205996|Hypoglycemic Agents|hypoglycemic agents|mesh-list
110933005|NCT02205996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110935682|NCT04294550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110935683|NCT04294550|Sensory System Agents|sensory system agents|mesh-ancestor
110935684|NCT04294550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110935685|NCT03476564|Pentoxifylline|pentoxifylline|mesh-list
110935686|NCT03476564|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110935687|NCT03476564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110935688|NCT03476564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110935689|NCT03476564|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110935690|NCT03476564|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110935691|NCT03476564|Protective Agents|protective agents|mesh-ancestor
110935692|NCT03476564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110935693|NCT03476564|Vasodilator Agents|vasodilator agents|mesh-ancestor
110935694|NCT03476564|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110935695|NCT03476564|Antioxidants|antioxidants|mesh-ancestor
110935696|NCT05258474|Niacinamide|niacinamide|mesh-list
110935698|NCT05258474|Nicotinic Acids|nicotinic acids|mesh-list
110935699|NCT05258474|Vitamin B Complex|vitamin b complex|mesh-ancestor
110935700|NCT05258474|Vitamins|vitamins|mesh-ancestor
110935701|NCT05258474|Micronutrients|micronutrients|mesh-ancestor
110935702|NCT05258474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110935703|NCT05258474|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110935704|NCT05258474|Antimetabolites|antimetabolites|mesh-ancestor
110935705|NCT05258474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110935706|NCT05258474|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110935707|NCT05258474|Vasodilator Agents|vasodilator agents|mesh-ancestor
110935708|NCT03478436|Doxycycline|doxycycline|mesh-list
110935709|NCT03478436|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110935710|NCT03478436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110935711|NCT03478436|Antimalarials|antimalarials|mesh-ancestor
110935712|NCT03478436|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110935713|NCT03478436|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110935714|NCT01338987|Alovudine|alovudine|mesh-list
110935715|NCT01338987|Cyclophosphamide|cyclophosphamide|mesh-list
110935716|NCT01338987|Busulfan|busulfan|mesh-list
110935717|NCT01338987|Methotrexate|methotrexate|mesh-list
110935723|NCT01338987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110935724|NCT01338987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110935725|NCT01338987|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110935726|NCT01338987|Alkylating Agents|alkylating agents|mesh-ancestor
110935727|NCT01338987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110935728|NCT01338987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110935729|NCT01338987|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110935730|NCT01338987|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110935731|NCT01338987|Abortifacient Agents|abortifacient agents|mesh-ancestor
110935732|NCT01338987|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110935733|NCT01338987|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110935734|NCT01338987|Antimetabolites|antimetabolites|mesh-ancestor
110935735|NCT01338987|Dermatologic Agents|dermatologic agents|mesh-ancestor
110935736|NCT01338987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110935737|NCT01338987|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110935738|NCT01338987|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110935739|NCT01338987|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110935740|NCT01338987|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110933006|NCT02220036|Magnesium Oxide|magnesium oxide|mesh-list
110933007|NCT02220036|Antacids|antacids|mesh-ancestor
110933008|NCT02220036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110933009|NCT02220036|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110933010|NCT02220114|Vigabatrin|vigabatrin|mesh-list
110933011|NCT02220114|Anticonvulsants|anticonvulsants|mesh-ancestor
110933012|NCT02220114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110933013|NCT02220114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110933014|NCT02220114|GABA Agents|gaba agents|mesh-ancestor
110281256|NCT00191438|Gemcitabine|gemcitabine|mesh-list
110935741|NCT01338987|Fertility Agents|fertility agents|mesh-ancestor
110935742|NCT01338987|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110935743|NCT01338987|Antiviral Agents|antiviral agents|mesh-ancestor
110935744|NCT01338987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110935745|NCT03478280|Brodalumab|brodalumab|mesh-list
110935746|NCT03478280|Dermatologic Agents|dermatologic agents|mesh-ancestor
110935747|NCT04856007|Metformin|metformin|mesh-list
110935748|NCT04856007|Dapagliflozin|dapagliflozin|mesh-list
110935749|NCT04856007|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110935750|NCT04856007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110935751|NCT04856007|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110935752|NCT04856007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110935753|NCT04736979|Amoxicillin|amoxicillin|mesh-list
110935754|NCT04736979|Clavulanic Acid|clavulanic acid|mesh-list
110935755|NCT04736979|Clavulanic Acids|clavulanic acids|mesh-list
110935756|NCT04736979|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
110935757|NCT04736979|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110935758|NCT04736979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110935759|NCT04736979|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110935760|NCT04736979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110935761|NCT04736979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110935762|NCT03562923|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
110935763|NCT03562923|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110935764|NCT03562923|Autonomic Agents|autonomic agents|mesh-ancestor
110935765|NCT03562923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110935766|NCT03562923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110935767|NCT03562923|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110935768|NCT03562923|Respiratory System Agents|respiratory system agents|mesh-ancestor
110935769|NCT03562923|Glucocorticoids|glucocorticoids|mesh-ancestor
110935770|NCT03562923|Hormones|hormones|mesh-ancestor
110935771|NCT03562923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110935772|NCT03562923|Sympathomimetics|sympathomimetics|mesh-ancestor
110935773|NCT03593252|Metronidazole|metronidazole|mesh-list
110935774|NCT03593252|Cefazolin|cefazolin|mesh-list
110935775|NCT03593252|Neomycin|neomycin|mesh-list
110935776|NCT03593252|Picosulfate sodium|picosulfate sodium|mesh-list
110935777|NCT03593252|Magnesium Oxide|magnesium oxide|mesh-list
110935778|NCT03593252|Citric Acid|citric acid|mesh-list
110935779|NCT03593252|Sodium Citrate|sodium citrate|mesh-list
110935780|NCT03593252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110935781|NCT03593252|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110935782|NCT03593252|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110935783|NCT03593252|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110935784|NCT03593252|Cathartics|cathartics|mesh-ancestor
110935785|NCT03593252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110935786|NCT03593252|Anticoagulants|anticoagulants|mesh-ancestor
110935787|NCT03593252|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110935788|NCT03593252|Chelating Agents|chelating agents|mesh-ancestor
110935789|NCT03593252|Sequestering Agents|sequestering agents|mesh-ancestor
110283944|NCT00203567|Sensory System Agents|sensory system agents|mesh-ancestor
110935794|NCT03476174|Pembrolizumab|pembrolizumab|mesh-list
110935795|NCT03476174|Interleukin-2|interleukin-2|mesh-list
110935796|NCT03476174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110935797|NCT03476174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110935798|NCT03476174|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110935799|NCT03476174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110935800|NCT03476174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110933016|NCT02220114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110933017|NCT02221596|Vitamin D|vitamin d|mesh-list
110933018|NCT02221596|Vitamins|vitamins|mesh-ancestor
110933019|NCT02221596|Micronutrients|micronutrients|mesh-ancestor
110933020|NCT02221596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110933021|NCT02221596|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110933022|NCT02221752|Folic Acid|folic acid|mesh-list
110933023|NCT02221752|Vitamin B Complex|vitamin b complex|mesh-list
110933024|NCT02221752|Hematinics|hematinics|mesh-ancestor
110933025|NCT02221752|Vitamins|vitamins|mesh-ancestor
110933026|NCT02221752|Micronutrients|micronutrients|mesh-ancestor
110933027|NCT02221752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110933028|NCT04971382|Curcumin|curcumin|mesh-list
110933029|NCT04971382|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110281264|NCT00191438|Antimitotic Agents|antimitotic agents|mesh-ancestor
110935801|NCT03476174|Analgesics|analgesics|mesh-ancestor
110935802|NCT03476174|Sensory System Agents|sensory system agents|mesh-ancestor
110935803|NCT03476174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110935804|NCT03476174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110935805|NCT02523638|Interferons|interferons|mesh-list
110935806|NCT02523638|Interferon-alpha|interferon-alpha|mesh-list
110935807|NCT02523638|Interferon alpha-2|interferon alpha-2|mesh-list
110935808|NCT02523638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110935809|NCT02523638|Antiviral Agents|antiviral agents|mesh-ancestor
110935810|NCT02523638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110935811|NCT02523638|Immunologic Factors|immunologic factors|mesh-ancestor
110935812|NCT02523638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110935814|NCT05257148|Zofenopril|zofenopril|mesh-list
110935815|NCT05257148|Captopril|captopril|mesh-list
110935816|NCT05257148|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110935817|NCT05257148|Vasodilator Agents|vasodilator agents|mesh-ancestor
110935818|NCT05257148|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
110935819|NCT05257148|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110935820|NCT05257148|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110935821|NCT05257148|Adrenergic Agents|adrenergic agents|mesh-ancestor
110935822|NCT05257148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110935823|NCT05257148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110935824|NCT05257148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110935825|NCT05257148|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110935826|NCT05257148|Protease Inhibitors|protease inhibitors|mesh-ancestor
110935827|NCT05257148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110935828|NCT03481790|Folic Acid|folic acid|mesh-list
110935829|NCT03481790|Lactoferrin|lactoferrin|mesh-list
110935830|NCT03481790|Vitamins|vitamins|mesh-ancestor
110935831|NCT03481790|Micronutrients|micronutrients|mesh-ancestor
110935832|NCT03481790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110935833|NCT03481790|Hematinics|hematinics|mesh-ancestor
110935834|NCT03481790|Vitamin B Complex|vitamin b complex|mesh-ancestor
110935835|NCT03481790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110935836|NCT03475862|Oxycodone|oxycodone|mesh-list
110935837|NCT03475862|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110935838|NCT03475862|Narcotics|narcotics|mesh-ancestor
110935839|NCT03475862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110935840|NCT03475862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110935841|NCT03475862|Analgesics|analgesics|mesh-ancestor
110935842|NCT03475862|Sensory System Agents|sensory system agents|mesh-ancestor
110935843|NCT03475862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110935844|NCT03368066|Cosyntropin|cosyntropin|mesh-list
110935845|NCT03368066|Hormones|hormones|mesh-ancestor
110935846|NCT03368066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110935847|NCT03368066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110935848|NCT03475628|Daratumumab|daratumumab|mesh-list
110933030|NCT04971382|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110933032|NCT04971382|Sensory System Agents|sensory system agents|mesh-ancestor
110933033|NCT04971382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110933034|NCT04971382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110933035|NCT04971382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110933036|NCT04971382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110933037|NCT04971382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110933038|NCT04971382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110933039|NCT04971382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110933040|NCT02220348|Linaclotide|linaclotide|mesh-list
110935849|NCT03475628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110935850|NCT05195450|Tenofovir|tenofovir|mesh-list
110935851|NCT05195450|Antiviral Agents|antiviral agents|mesh-ancestor
110935852|NCT05195450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110935853|NCT05195450|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110935854|NCT05195450|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110935855|NCT05195450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110935856|NCT05195450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110935857|NCT05195450|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110935858|NCT05195450|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110935859|NCT03477422|Meropenem|meropenem|mesh-list
110935860|NCT03477422|Ceftriaxone|ceftriaxone|mesh-list
110935861|NCT03477422|Sulbactam|sulbactam|mesh-list
110284019|NCT00203723|Dopamine Agents|dopamine agents|mesh-ancestor
110936212|NCT03056092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110936213|NCT03056092|Growth Inhibitors|growth inhibitors|mesh-ancestor
110936214|NCT03056092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110936215|NCT04921306|Clenbuterol|clenbuterol|mesh-list
110936216|NCT04921306|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110936217|NCT04921306|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110936218|NCT04921306|Adrenergic Agents|adrenergic agents|mesh-ancestor
110936219|NCT04921306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110936220|NCT04921306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110937077|NCT05363267|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110937078|NCT05363267|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110937079|NCT05363267|Analgesics|analgesics|mesh-ancestor
110937080|NCT05363267|Sensory System Agents|sensory system agents|mesh-ancestor
110937081|NCT05363267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110937082|NCT05363267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110937083|NCT05363267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110937084|NCT05363267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110937085|NCT05363267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110937086|NCT05363267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110937087|NCT05363267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110937088|NCT05360966|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110937089|NCT05360966|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110937090|NCT05353257|Carboplatin|carboplatin|mesh-list
110937091|NCT05353257|Etoposide|etoposide|mesh-list
110937092|NCT05353257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110937093|NCT05353257|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110937094|NCT05353257|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110937095|NCT05353257|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110937096|NCT05353257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110937097|NCT05353257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110937098|NCT05307705|Paclitaxel|paclitaxel|mesh-list
110937099|NCT05307705|Letrozole|letrozole|mesh-list
110937100|NCT05307705|Fulvestrant|fulvestrant|mesh-list
110937101|NCT05307705|Anastrozole|anastrozole|mesh-list
110937102|NCT05307705|Exemestane|exemestane|mesh-list
110937103|NCT05307705|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110937104|NCT05307705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110937105|NCT05307705|Tubulin Modulators|tubulin modulators|mesh-ancestor
110937106|NCT05307705|Antimitotic Agents|antimitotic agents|mesh-ancestor
110937107|NCT05307705|Mitosis Modulators|mitosis modulators|mesh-ancestor
110933041|NCT02220348|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
110933042|NCT02220348|Enzyme Activators|enzyme activators|mesh-ancestor
110933043|NCT02220348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110933044|NCT02220348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110933045|NCT04151680|Rivaroxaban|rivaroxaban|mesh-list
110933046|NCT04151680|Apixaban|apixaban|mesh-list
110937108|NCT05307705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110937109|NCT05307705|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110937110|NCT05307705|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110937111|NCT05307705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110937112|NCT05307705|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110937113|NCT05307705|Hormone Antagonists|hormone antagonists|mesh-ancestor
110937114|NCT05307705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110937115|NCT05307705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110937116|NCT05307705|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110937117|NCT05307705|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110937118|NCT05301842|Durvalumab|durvalumab|mesh-list
110937119|NCT05301842|Lenvatinib|lenvatinib|mesh-list
110937120|NCT05301842|Tremelimumab|tremelimumab|mesh-list
110937126|NCT05276492|Prednisone|prednisone|mesh-list
110937127|NCT05276492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110937128|NCT05276492|Glucocorticoids|glucocorticoids|mesh-ancestor
110937129|NCT05276492|Hormones|hormones|mesh-ancestor
110937130|NCT05276492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110937131|NCT05276492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110937132|NCT05276492|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110937133|NCT05276492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110937134|NCT05267626|Aldesleukin|aldesleukin|mesh-list
110937135|NCT05267626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110937136|NCT05267626|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110937137|NCT05267626|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110937138|NCT05267626|Antiviral Agents|antiviral agents|mesh-ancestor
110937139|NCT05267626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110937140|NCT05190315|Temozolomide|temozolomide|mesh-list
110937141|NCT05190315|Chlorpromazine|chlorpromazine|mesh-list
110937142|NCT05190315|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110937143|NCT05190315|Alkylating Agents|alkylating agents|mesh-ancestor
110937144|NCT05190315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110937145|NCT05190315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110937146|NCT05190315|Antiemetics|antiemetics|mesh-ancestor
110937147|NCT05190315|Autonomic Agents|autonomic agents|mesh-ancestor
110937148|NCT05190315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110937149|NCT05190315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110937150|NCT05190315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110937151|NCT05190315|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110937152|NCT05190315|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110937153|NCT05190315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110937154|NCT05190315|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110937155|NCT05190315|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110937156|NCT05190315|Dopamine Agents|dopamine agents|mesh-ancestor
110937157|NCT05190315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110937158|NCT05143840|Niacinamide|niacinamide|mesh-list
110937159|NCT05143840|Imatinib Mesylate|imatinib mesylate|mesh-list
110937161|NCT05143840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110937162|NCT05143840|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110937163|NCT05143840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110937164|NCT05143840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110937165|NCT05143840|Vitamin B Complex|vitamin b complex|mesh-ancestor
110937166|NCT05143840|Vitamins|vitamins|mesh-ancestor
110937167|NCT05143840|Micronutrients|micronutrients|mesh-ancestor
110937168|NCT05143840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110937169|NCT05134974|Phentolamine|phentolamine|mesh-list
110937170|NCT05134974|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110937171|NCT05134974|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110937172|NCT05134974|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110937173|NCT05134974|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110937174|NCT05134974|Adrenergic Agents|adrenergic agents|mesh-ancestor
110937175|NCT05134974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110937176|NCT05134974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110933048|NCT04151680|Dabigatran|dabigatran|mesh-list
110933049|NCT04151680|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110933050|NCT04151680|Antithrombins|antithrombins|mesh-ancestor
110933051|NCT04151680|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110933052|NCT04151680|Protease Inhibitors|protease inhibitors|mesh-ancestor
110933053|NCT04151680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110933054|NCT04151680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110933055|NCT04151680|Anticoagulants|anticoagulants|mesh-ancestor
110933056|NCT02221830|Oxytocin|oxytocin|mesh-list
110933057|NCT02221830|Oxytocics|oxytocics|mesh-ancestor
110249301|NCT01245868|Lidocaine|lidocaine|mesh-list
110933058|NCT02221830|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110933059|NCT02221830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110933060|NCT02224950|Emollients|emollients|mesh-list
110933061|NCT02224950|Chitosan|chitosan|mesh-list
110933062|NCT02224950|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110933063|NCT02224950|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110933064|NCT02224950|Antimetabolites|antimetabolites|mesh-ancestor
110933065|NCT02224950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110933066|NCT02224950|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110933067|NCT02224950|Chelating Agents|chelating agents|mesh-ancestor
110933068|NCT02224950|Sequestering Agents|sequestering agents|mesh-ancestor
110933069|NCT02224950|Hemostatics|hemostatics|mesh-ancestor
110933070|NCT02224950|Coagulants|coagulants|mesh-ancestor
110933071|NCT02224950|Dermatologic Agents|dermatologic agents|mesh-ancestor
110933072|NCT03039114|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110933073|NCT03039114|Obinutuzumab|obinutuzumab|mesh-list
110933074|NCT03039114|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110933075|NCT03039114|Alkylating Agents|alkylating agents|mesh-ancestor
110937177|NCT05134974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110937178|NCT05134974|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110937179|NCT05134922|Gedatolisib|gedatolisib|mesh-list
110937180|NCT05134922|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110937181|NCT05134922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110937182|NCT05134922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110937183|NCT05109442|Atezolizumab|atezolizumab|mesh-list
110937184|NCT05109442|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110937185|NCT05109442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110937186|NCT05109442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110937187|NCT05109442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110937188|NCT05108870|Paclitaxel|paclitaxel|mesh-list
110937189|NCT05108870|Carboplatin|carboplatin|mesh-list
110937190|NCT05108870|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110937210|NCT05070650|Oxymetazoline|oxymetazoline|mesh-list
110937211|NCT05070650|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110937212|NCT05070650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110937213|NCT05070650|Analgesics|analgesics|mesh-ancestor
110937214|NCT05070650|Sensory System Agents|sensory system agents|mesh-ancestor
110937215|NCT05070650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110933076|NCT03039114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110933077|NCT03039114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110933078|NCT03039114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110933079|NCT04970602|Methylene Blue|methylene blue|mesh-list
110933080|NCT04970602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110933081|NCT04970602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110933082|NCT04970446|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110933083|NCT04970446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110933085|NCT02831673|Lamivudine|lamivudine|mesh-list
110933086|NCT02831673|Emtricitabine|emtricitabine|mesh-list
110933087|NCT02831673|Dolutegravir|dolutegravir|mesh-list
110933088|NCT02831673|Antiviral Agents|antiviral agents|mesh-ancestor
110933089|NCT02831673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110933090|NCT02831673|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110933091|NCT02831673|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110933092|NCT02831673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110933093|NCT02831673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110933094|NCT02831673|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110933095|NCT02831673|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110933096|NCT02831673|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110281325|NCT00191555|Olanzapine|olanzapine|mesh-list
110937216|NCT05070650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110937217|NCT05070650|Antipyretics|antipyretics|mesh-ancestor
110937218|NCT05070650|Antiviral Agents|antiviral agents|mesh-ancestor
110937219|NCT05070650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110937220|NCT05070650|Expectorants|expectorants|mesh-ancestor
110937221|NCT05070650|Respiratory System Agents|respiratory system agents|mesh-ancestor
110937222|NCT05070650|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110937223|NCT05070650|Antioxidants|antioxidants|mesh-ancestor
110937224|NCT05070650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110937225|NCT05070650|Protective Agents|protective agents|mesh-ancestor
110937226|NCT05070650|Antidotes|antidotes|mesh-ancestor
110937228|NCT05070650|Mydriatics|mydriatics|mesh-ancestor
110937229|NCT05070650|Autonomic Agents|autonomic agents|mesh-ancestor
110937230|NCT05070650|Sympathomimetics|sympathomimetics|mesh-ancestor
110937231|NCT05070650|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110937232|NCT05070650|Nasal Decongestants|nasal decongestants|mesh-ancestor
110937233|NCT05070650|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110937234|NCT05070650|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110937235|NCT05070650|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110937236|NCT05070650|Adrenergic Agents|adrenergic agents|mesh-ancestor
110937237|NCT05070650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110937239|NCT05047211|Iron-Dextran Complex|iron-dextran complex|mesh-list
110937240|NCT05047211|Anticoagulants|anticoagulants|mesh-ancestor
110937241|NCT05047211|Plasma Substitutes|plasma substitutes|mesh-ancestor
110937242|NCT05047211|Blood Substitutes|blood substitutes|mesh-ancestor
110937243|NCT05047211|Hematinics|hematinics|mesh-ancestor
110937244|NCT04956432|Allopurinol|allopurinol|mesh-list
110937245|NCT04956432|Antimetabolites|antimetabolites|mesh-ancestor
110937246|NCT04956432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110937247|NCT04956432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110937248|NCT04956432|Gout Suppressants|gout suppressants|mesh-ancestor
110937249|NCT04956432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110937275|NCT04895202|Siponimod|siponimod|mesh-list
110937276|NCT04895202|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
110933097|NCT02831673|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110933098|NCT02220504|Antipsychotic Agents|antipsychotic agents|mesh-list
110933099|NCT02220504|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110933100|NCT02220504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110933101|NCT02220504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110933102|NCT02220504|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110933104|NCT04962958|Fluorouracil|fluorouracil|mesh-list
110933105|NCT04962958|Oxaliplatin|oxaliplatin|mesh-list
110933106|NCT04962958|Antimetabolites|antimetabolites|mesh-ancestor
110933107|NCT04962958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110933108|NCT04962958|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110933109|NCT04962958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110933110|NCT04962958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110933111|NCT04962958|Immunologic Factors|immunologic factors|mesh-ancestor
110933112|NCT04962958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110937277|NCT04895202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110937278|NCT04895202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110937279|NCT04895202|Immunologic Factors|immunologic factors|mesh-ancestor
110937280|NCT04895202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110937281|NCT04845399|Factor VIII|factor viii|mesh-list
110937282|NCT04845399|Coagulants|coagulants|mesh-ancestor
110937283|NCT04781322|Alirocumab|alirocumab|mesh-list
110937284|NCT04781322|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
110937285|NCT04781322|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110937286|NCT04781322|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110937287|NCT04781322|Antimetabolites|antimetabolites|mesh-ancestor
110937288|NCT04781322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110937289|NCT04781322|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110937290|NCT04781322|Protease Inhibitors|protease inhibitors|mesh-ancestor
110937291|NCT04781322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110937292|NCT04781322|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110937293|NCT04766853|Dexamethasone|dexamethasone|mesh-list
110937294|NCT04766853|Hyaluronic Acid|hyaluronic acid|mesh-list
110937295|NCT04766853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110937296|NCT04766853|Antiemetics|antiemetics|mesh-ancestor
110937297|NCT04766853|Autonomic Agents|autonomic agents|mesh-ancestor
110937298|NCT04766853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110937299|NCT04766853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110937300|NCT04766853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110937319|NCT04749628|Anticonvulsants|anticonvulsants|mesh-ancestor
110937320|NCT04732845|Cyclophosphamide|cyclophosphamide|mesh-list
110937321|NCT04732845|Fludarabine|fludarabine|mesh-list
110937322|NCT04732845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110937323|NCT04732845|Immunologic Factors|immunologic factors|mesh-ancestor
110937324|NCT04732845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110937325|NCT04732845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110937326|NCT04732845|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110937327|NCT04732845|Alkylating Agents|alkylating agents|mesh-ancestor
110937328|NCT04732845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110937329|NCT04732845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110937330|NCT04732845|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110937331|NCT04699188|Tislelizumab|tislelizumab|mesh-list
110937332|NCT04699188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110937333|NCT04699188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110937335|NCT04693715|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110937336|NCT04693715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110937337|NCT04693715|Analgesics|analgesics|mesh-ancestor
110937338|NCT04693715|Sensory System Agents|sensory system agents|mesh-ancestor
110933113|NCT04962958|Antidotes|antidotes|mesh-ancestor
110933114|NCT04962958|Protective Agents|protective agents|mesh-ancestor
110933115|NCT04962958|Vitamin B Complex|vitamin b complex|mesh-ancestor
110933116|NCT04962958|Vitamins|vitamins|mesh-ancestor
110933117|NCT04962958|Micronutrients|micronutrients|mesh-ancestor
110933118|NCT02031510|Dexmedetomidine|dexmedetomidine|mesh-list
110933119|NCT02031510|Bupivacaine|bupivacaine|mesh-list
110933120|NCT02031510|Anesthetics, Local|anesthetics, local|mesh-ancestor
110933121|NCT02031510|Anesthetics|anesthetics|mesh-ancestor
110933122|NCT02031510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110933123|NCT02031510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110933124|NCT02031510|Sensory System Agents|sensory system agents|mesh-ancestor
110937339|NCT04693715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110937340|NCT04693715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110937341|NCT04693715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110937342|NCT04693715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110937343|NCT04693715|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110937357|NCT04614610|Lidocaine|lidocaine|mesh-list
110937358|NCT04614610|Anesthetics, Local|anesthetics, local|mesh-ancestor
110937359|NCT04614610|Anesthetics|anesthetics|mesh-ancestor
110937374|NCT04613453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110937375|NCT04613453|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110937376|NCT04613453|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110937377|NCT04613453|Anesthetics, General|anesthetics, general|mesh-ancestor
110937378|NCT04613453|Anesthetics|anesthetics|mesh-ancestor
110937379|NCT04613453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110937380|NCT04613453|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110937381|NCT04613453|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110937382|NCT04613453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110937383|NCT04613453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110937384|NCT04613453|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110937385|NCT04613453|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110937386|NCT04613453|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110937387|NCT04613453|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110937388|NCT04613453|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110937389|NCT04613453|GABA Modulators|gaba modulators|mesh-ancestor
110937390|NCT04613453|GABA Agents|gaba agents|mesh-ancestor
110937394|NCT04511234|Sirolimus|sirolimus|mesh-list
110937395|NCT04511234|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110937396|NCT04511234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110937397|NCT04511234|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110937398|NCT04511234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110937399|NCT04511234|Antifungal Agents|antifungal agents|mesh-ancestor
110937400|NCT04511234|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110937401|NCT04511234|Immunologic Factors|immunologic factors|mesh-ancestor
110937402|NCT04511234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110937403|NCT04499924|Paclitaxel|paclitaxel|mesh-list
110937404|NCT04499924|Trastuzumab|trastuzumab|mesh-list
110937405|NCT04499924|Ramucirumab|ramucirumab|mesh-list
110937406|NCT04499924|Tucatinib|tucatinib|mesh-list
110937407|NCT04499924|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110937408|NCT04499924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110937409|NCT04499924|Tubulin Modulators|tubulin modulators|mesh-ancestor
110937410|NCT04499924|Antimitotic Agents|antimitotic agents|mesh-ancestor
110937411|NCT04499924|Mitosis Modulators|mitosis modulators|mesh-ancestor
110937412|NCT04499924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110937413|NCT04499924|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110937414|NCT04499924|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110937415|NCT04499924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110937416|NCT04481555|Azithromycin|azithromycin|mesh-list
110937417|NCT04481555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110937418|NCT04481555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110937419|NCT04468230|Nicotine|nicotine|mesh-list
110937430|NCT04456387|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
110937431|NCT04456387|Coagulants|coagulants|mesh-ancestor
110937432|NCT04456387|Immunologic Factors|immunologic factors|mesh-ancestor
110933125|NCT02031510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110933126|NCT02031510|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110933127|NCT02031510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110933128|NCT02031510|Analgesics|analgesics|mesh-ancestor
110933129|NCT02031510|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110933130|NCT02031510|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110933131|NCT02031510|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110933132|NCT02031510|Adrenergic Agents|adrenergic agents|mesh-ancestor
110933133|NCT02031510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110933134|NCT02031510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110933135|NCT04961788|Antibodies|antibodies|mesh-list
110933136|NCT04961788|Immunologic Factors|immunologic factors|mesh-ancestor
110933137|NCT04961788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110937433|NCT04456387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110937434|NCT04439357|Trametinib|trametinib|mesh-list
110937435|NCT04439357|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
110937436|NCT04439357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110937437|NCT04439357|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110937438|NCT04439357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110937439|NCT04439357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110937440|NCT04439357|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
110937441|NCT04439357|Protective Agents|protective agents|mesh-ancestor
110937442|NCT04439357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110937443|NCT04439357|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110937444|NCT04439357|Antioxidants|antioxidants|mesh-ancestor
110937445|NCT04390763|Paclitaxel|paclitaxel|mesh-list
110937446|NCT04390763|Gemcitabine|gemcitabine|mesh-list
110937447|NCT04390763|Spartalizumab|spartalizumab|mesh-list
110937448|NCT04390763|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110937449|NCT04390763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110937450|NCT04390763|Tubulin Modulators|tubulin modulators|mesh-ancestor
110937451|NCT04390763|Antimitotic Agents|antimitotic agents|mesh-ancestor
110937452|NCT04390763|Mitosis Modulators|mitosis modulators|mesh-ancestor
110937453|NCT04390763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110937454|NCT04390763|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110937455|NCT04390763|Antimetabolites|antimetabolites|mesh-ancestor
110937456|NCT04390763|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110937457|NCT04390763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110937458|NCT04388163|Gentian Violet|gentian violet|mesh-list
110937459|NCT04388163|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110937460|NCT04388163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110937461|NCT04377555|Ocrelizumab|ocrelizumab|mesh-list
110937462|NCT04377555|Immunologic Factors|immunologic factors|mesh-ancestor
110937463|NCT04377555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110937464|NCT04370587|Pembrolizumab|pembrolizumab|mesh-list
110937465|NCT04370587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110937466|NCT04370587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110937467|NCT04370587|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110937468|NCT04370587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110937469|NCT04354012|Gentian Violet|gentian violet|mesh-list
110937470|NCT04354012|Methylene Blue|methylene blue|mesh-list
110937471|NCT04354012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110937472|NCT04354012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110937473|NCT04354012|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110937474|NCT04354012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110937475|NCT04323956|Prednisone|prednisone|mesh-list
110937476|NCT04323956|Cortisone|cortisone|mesh-list
110937477|NCT04323956|Cyclophosphamide|cyclophosphamide|mesh-list
110937478|NCT04323956|Rituximab|rituximab|mesh-list
110937479|NCT04323956|Doxorubicin|doxorubicin|mesh-list
110937480|NCT04323956|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110937481|NCT04323956|Vincristine|vincristine|mesh-list
110933138|NCT02222142|Anesthetics|anesthetics|mesh-list
110933140|NCT02222142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110933141|NCT02222142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110933142|NCT02222142|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110933143|NCT02222142|Anesthetics, General|anesthetics, general|mesh-ancestor
110933144|NCT04426084|Antihypertensive Agents|antihypertensive agents|mesh-list
110933145|NCT04425382|Ritonavir|ritonavir|mesh-list
110933146|NCT04425382|Lopinavir|lopinavir|mesh-list
110933147|NCT04425382|Darunavir|darunavir|mesh-list
110933148|NCT04425382|Cobicistat|cobicistat|mesh-list
110933149|NCT04425382|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
110933150|NCT04425382|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110933151|NCT04425382|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110933152|NCT04425382|Protease Inhibitors|protease inhibitors|mesh-ancestor
110933153|NCT04425382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110933154|NCT04425382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110933155|NCT04425382|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110933156|NCT04425382|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110650718|NCT00112489|Paclitaxel|paclitaxel|mesh-list
110933157|NCT04425382|Antiviral Agents|antiviral agents|mesh-ancestor
110933158|NCT04425382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110281382|NCT00123578|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110937482|NCT04323956|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110937483|NCT04323956|Antibodies|antibodies|mesh-list
110937484|NCT04323956|Immunoglobulins|immunoglobulins|mesh-list
110937485|NCT04323956|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110937486|NCT04323956|Lenograstim|lenograstim|mesh-list
110937504|NCT04323956|Hormones|hormones|mesh-ancestor
110937505|NCT04323956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110937506|NCT04323956|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110937507|NCT04323956|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110937508|NCT04323956|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110937509|NCT04323956|Tubulin Modulators|tubulin modulators|mesh-ancestor
110937510|NCT04323956|Antimitotic Agents|antimitotic agents|mesh-ancestor
110937511|NCT04323956|Mitosis Modulators|mitosis modulators|mesh-ancestor
110937512|NCT04319198|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
110937513|NCT04319198|Immunoconjugates|immunoconjugates|mesh-ancestor
110937514|NCT04319198|Immunologic Factors|immunologic factors|mesh-ancestor
110937515|NCT04319198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110937516|NCT04318938|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
110937517|NCT04318938|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110937518|NCT04318938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110937519|NCT04318938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110937520|NCT04311723|Anesthetics|anesthetics|mesh-list
110937521|NCT04311723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110937522|NCT04311723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110937523|NCT04311632|Mycophenolic Acid|mycophenolic acid|mesh-list
110937524|NCT04311632|Tacrolimus|tacrolimus|mesh-list
110937525|NCT04311632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110937526|NCT04311632|Immunologic Factors|immunologic factors|mesh-ancestor
110937527|NCT04311632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110937528|NCT04311632|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110937529|NCT04311632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110933159|NCT04425382|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110933160|NCT04425382|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110933161|NCT03563937|Rivaroxaban|rivaroxaban|mesh-list
110933162|NCT03563937|Apixaban|apixaban|mesh-list
110933163|NCT03563937|Edoxaban|edoxaban|mesh-list
110933164|NCT03563937|Phenprocoumon|phenprocoumon|mesh-list
110933229|NCT03677323|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110933230|NCT03677323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110933231|NCT03677323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110933232|NCT03677323|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110933233|NCT03677323|Anesthetics, General|anesthetics, general|mesh-ancestor
110933302|NCT04542408|Antithrombins|antithrombins|mesh-ancestor
110933303|NCT04542408|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110933304|NCT04542408|Protease Inhibitors|protease inhibitors|mesh-ancestor
110933305|NCT04542408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110933306|NCT03059134|Mirabegron|mirabegron|mesh-list
110933307|NCT03059134|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
110933370|NCT03676933|Hydrocortisone|hydrocortisone|mesh-list
110933371|NCT03676933|Hydrocortisone-17-butyrate|hydrocortisone-17-butyrate|mesh-list
110933372|NCT03676933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110933373|NCT03676933|Dermatologic Agents|dermatologic agents|mesh-ancestor
110933374|NCT03671941|Ticagrelor|ticagrelor|mesh-list
110933375|NCT03671941|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110933376|NCT03671941|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110933377|NCT03671941|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110933378|NCT03671941|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110933379|NCT03671941|Purinergic Agents|purinergic agents|mesh-ancestor
110933380|NCT03671941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110933432|NCT03676621|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110933434|NCT03676621|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110933435|NCT03676621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110933436|NCT03678649|Capecitabine|capecitabine|mesh-list
110933437|NCT03678649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110933438|NCT03678649|Antimetabolites|antimetabolites|mesh-ancestor
110933439|NCT03678649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110933440|NCT03678649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110933441|NCT02845297|Pembrolizumab|pembrolizumab|mesh-list
110933442|NCT02845297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110933443|NCT02845297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110933444|NCT02845297|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110933445|NCT02845297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110933446|NCT02232360|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110933447|NCT02232360|Fenofibrate|fenofibrate|mesh-list
110933448|NCT02232360|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110933449|NCT02232360|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110933450|NCT02232360|Antimetabolites|antimetabolites|mesh-ancestor
110933451|NCT02232360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110933452|NCT02232360|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110933455|NCT02226978|Ritonavir|ritonavir|mesh-list
110933482|NCT05708157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110933483|NCT05708157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110933484|NCT03058744|Clobetasol|clobetasol|mesh-list
110933485|NCT03058744|Halobetasol|halobetasol|mesh-list
110933486|NCT03058744|Tazarotene|tazarotene|mesh-list
110933487|NCT03058744|Dermatologic Agents|dermatologic agents|mesh-ancestor
110933488|NCT03058744|Keratolytic Agents|keratolytic agents|mesh-ancestor
110933489|NCT03058744|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110933490|NCT03058744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110933491|NCT03058744|Glucocorticoids|glucocorticoids|mesh-ancestor
110933492|NCT03058744|Hormones|hormones|mesh-ancestor
110933493|NCT03058744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110933494|NCT03058744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110933495|NCT02734537|Cisplatin|cisplatin|mesh-list
110933496|NCT02734537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110933497|NCT03059056|Empagliflozin|empagliflozin|mesh-list
110933498|NCT03059056|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110933499|NCT03059056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110933500|NCT03059056|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110933501|NCT03059056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110933502|NCT03058666|Calfactant|calfactant|mesh-list
110933503|NCT03058666|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
110933505|NCT02227212|Insulin|insulin|mesh-list
110933536|NCT00303849|Tubulin Modulators|tubulin modulators|mesh-ancestor
110933537|NCT00303849|Antimitotic Agents|antimitotic agents|mesh-ancestor
110933538|NCT00303849|Mitosis Modulators|mitosis modulators|mesh-ancestor
110933539|NCT00303849|Protective Agents|protective agents|mesh-ancestor
110933540|NCT00303849|Antioxidants|antioxidants|mesh-ancestor
110933541|NCT00303849|Antitubercular Agents|antitubercular agents|mesh-ancestor
110933542|NCT00303849|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110933543|NCT00303849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110933544|NCT00303849|Chelating Agents|chelating agents|mesh-ancestor
110933545|NCT00303849|Sequestering Agents|sequestering agents|mesh-ancestor
110933546|NCT04952272|CPG-oligonucleotide|cpg-oligonucleotide|mesh-list
110933547|NCT04952272|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110933548|NCT04952272|Immunologic Factors|immunologic factors|mesh-ancestor
110933549|NCT04952272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110933550|NCT01355523|Melatonin|melatonin|mesh-list
110933551|NCT01355523|Antioxidants|antioxidants|mesh-ancestor
110933597|NCT02224170|Autonomic Agents|autonomic agents|mesh-ancestor
110933598|NCT02224170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110933599|NCT02224170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110933600|NCT02224170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110933601|NCT02224170|Glucocorticoids|glucocorticoids|mesh-ancestor
110933602|NCT02224170|Hormones|hormones|mesh-ancestor
110933663|NCT05956509|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110933664|NCT05956509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110933665|NCT05956431|Simendan|simendan|mesh-list
110933666|NCT05956431|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110933667|NCT05956431|Vasodilator Agents|vasodilator agents|mesh-ancestor
110933734|NCT05951504|Prednisolone|prednisolone|mesh-list
110933735|NCT05951504|Prednisolone acetate|prednisolone acetate|mesh-list
110933736|NCT05951504|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110933807|NCT05872893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110933808|NCT05872893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110933809|NCT05872893|Glucocorticoids|glucocorticoids|mesh-ancestor
110933811|NCT05872893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110933812|NCT05872893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110933813|NCT05872893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110933814|NCT05872893|Antipruritics|antipruritics|mesh-ancestor
110933815|NCT05872893|Dermatologic Agents|dermatologic agents|mesh-ancestor
110933872|NCT05685225|Analgesics|analgesics|mesh-ancestor
110933873|NCT05685225|Sensory System Agents|sensory system agents|mesh-ancestor
110933874|NCT05685225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110933875|NCT05685225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110933876|NCT05685225|Antipyretics|antipyretics|mesh-ancestor
110933877|NCT05685225|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110933878|NCT05685225|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110933879|NCT05670743|Fluorides|fluorides|mesh-list
110933880|NCT05670743|Cariostatic Agents|cariostatic agents|mesh-ancestor
110933881|NCT05670743|Protective Agents|protective agents|mesh-ancestor
110933938|NCT05609565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110933939|NCT05609565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110933940|NCT05609565|Sensory System Agents|sensory system agents|mesh-ancestor
110933941|NCT05609565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110933942|NCT05604859|Methylprednisolone|methylprednisolone|mesh-list
110934010|NCT05476172|Norethindrone Acetate|norethindrone acetate|mesh-list
110934012|NCT05476172|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110934082|NCT05338320|Analgesics|analgesics|mesh-ancestor
110934083|NCT05338320|Sensory System Agents|sensory system agents|mesh-ancestor
110934084|NCT05338320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110934085|NCT05338320|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110934152|NCT05242874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110934153|NCT05242874|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110934154|NCT05242874|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110934155|NCT05242874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110934156|NCT05242874|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110934157|NCT05242874|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110934158|NCT05242874|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110934159|NCT05242874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110934218|NCT05108688|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110934219|NCT05108688|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110934220|NCT05108688|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110934221|NCT05108688|Serotonin Agents|serotonin agents|mesh-ancestor
110934222|NCT05108688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110934223|NCT05108688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110934224|NCT05108688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110934225|NCT05108688|Antidepressive Agents|antidepressive agents|mesh-ancestor
110934226|NCT05108688|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110934227|NCT05108688|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110934228|NCT05108688|Histamine Antagonists|histamine antagonists|mesh-ancestor
110934229|NCT05108688|Histamine Agents|histamine agents|mesh-ancestor
110934230|NCT05108688|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110934231|NCT05108688|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110934275|NCT05050357|Hormones|hormones|mesh-ancestor
110934276|NCT05050357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110934277|NCT05017571|Colchicine|colchicine|mesh-list
110934349|NCT04908579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110934350|NCT04908579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110934352|NCT04898387|Bimatoprost|bimatoprost|mesh-list
110934353|NCT04898387|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110934354|NCT04898387|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110934355|NCT04898387|Adrenergic Agents|adrenergic agents|mesh-ancestor
110934356|NCT04898387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110934357|NCT04898387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110934358|NCT04898387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110934359|NCT04898387|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110934360|NCT04898387|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110934365|NCT04848753|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110934366|NCT04848753|Cisplatin|cisplatin|mesh-list
110934368|NCT04848753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110934408|NCT04766021|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110934409|NCT04766021|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110934410|NCT04766021|Adrenergic Agents|adrenergic agents|mesh-ancestor
110934411|NCT04766021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110934412|NCT04766021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110934413|NCT04766021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110934414|NCT04766021|Urological Agents|urological agents|mesh-ancestor
110934415|NCT04728360|Ustekinumab|ustekinumab|mesh-list
110934416|NCT04728360|Dermatologic Agents|dermatologic agents|mesh-ancestor
110934475|NCT04407442|Dexamethasone acetate|dexamethasone acetate|mesh-list
110934476|NCT04407442|Azacitidine|azacitidine|mesh-list
110934477|NCT04407442|Daratumumab|daratumumab|mesh-list
110934478|NCT04407442|Ichthammol|ichthammol|mesh-list
110934479|NCT04407442|BB 1101|bb 1101|mesh-list
110934480|NCT04407442|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110934481|NCT04407442|Antiemetics|antiemetics|mesh-ancestor
110934482|NCT04407442|Autonomic Agents|autonomic agents|mesh-ancestor
110934483|NCT04407442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110934484|NCT04407442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110934485|NCT04407442|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110934486|NCT04407442|Glucocorticoids|glucocorticoids|mesh-ancestor
110934487|NCT04407442|Hormones|hormones|mesh-ancestor
110934489|NCT04407442|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110934538|NCT04217694|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110934539|NCT04217694|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110934540|NCT04198506|Tacrolimus|tacrolimus|mesh-list
110934541|NCT04198506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110934542|NCT04198506|Immunologic Factors|immunologic factors|mesh-ancestor
110934543|NCT04198506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110249348|NCT00146913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110934544|NCT04198506|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110934547|NCT04192981|GDC-0084|gdc-0084|mesh-list
110934605|NCT03874715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110934607|NCT03869996|Methotrexate|methotrexate|mesh-list
110934608|NCT03869996|Etoposide|etoposide|mesh-list
110934609|NCT03869996|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110934677|NCT03576547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110934678|NCT03576547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110934679|NCT03576547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110934680|NCT03576547|Antiemetics|antiemetics|mesh-ancestor
110934681|NCT03576547|Autonomic Agents|autonomic agents|mesh-ancestor
110934750|NCT03328104|Alkylating Agents|alkylating agents|mesh-ancestor
110934751|NCT03328104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110934752|NCT03328104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110934821|NCT02919449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110934822|NCT02913482|Risdiplam|risdiplam|mesh-list
110934823|NCT02913482|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110934824|NCT02913482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110934825|NCT02913482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110934826|NCT02904291|Amlodipine|amlodipine|mesh-list
110934827|NCT02904291|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110934828|NCT02904291|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110934890|NCT02723994|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110682993|NCT00904475|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110934891|NCT02723994|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110934892|NCT02723994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110934897|NCT02723994|Antimetabolites|antimetabolites|mesh-ancestor
110934962|NCT02324543|Docetaxel|docetaxel|mesh-list
110934963|NCT02324543|Capecitabine|capecitabine|mesh-list
110934964|NCT02324543|Irinotecan|irinotecan|mesh-list
110934977|NCT02055638|SRX246|srx246|mesh-list
110935037|NCT01664910|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110935038|NCT01664910|Immunotoxins|immunotoxins|mesh-ancestor
110935039|NCT01664910|Immunoconjugates|immunoconjugates|mesh-ancestor
110935040|NCT01594580|Anti-Infective Agents|anti-infective agents|mesh-list
110935041|NCT01594580|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110935042|NCT01550003|Certolizumab Pegol|certolizumab pegol|mesh-list
110935108|NCT00390793|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110935109|NCT00390793|Antimetabolites|antimetabolites|mesh-ancestor
110935110|NCT00390793|Dermatologic Agents|dermatologic agents|mesh-ancestor
110935111|NCT00390793|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110935112|NCT00390793|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110935113|NCT00390793|Antiviral Agents|antiviral agents|mesh-ancestor
110935114|NCT00390793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110935115|NCT00390793|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110935116|NCT00390793|Tubulin Modulators|tubulin modulators|mesh-ancestor
110935117|NCT00390793|Antimitotic Agents|antimitotic agents|mesh-ancestor
110935118|NCT00390793|Mitosis Modulators|mitosis modulators|mesh-ancestor
110935119|NCT00390793|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110935120|NCT00390793|Protease Inhibitors|protease inhibitors|mesh-ancestor
110935121|NCT03563235|Calcitriol|calcitriol|mesh-list
110935122|NCT03563235|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110935123|NCT03563235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110935124|NCT03563235|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
110935125|NCT03563235|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110935126|NCT03563235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110935127|NCT03563235|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110935128|NCT03563235|Vitamins|vitamins|mesh-ancestor
110935162|NCT05059977|Immunologic Factors|immunologic factors|mesh-ancestor
110935163|NCT05059977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110935165|NCT02228616|Prucalopride|prucalopride|mesh-list
110935166|NCT02228616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110935167|NCT02228616|Laxatives|laxatives|mesh-ancestor
110935168|NCT02228616|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
110935169|NCT02228616|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110935170|NCT02228616|Serotonin Agents|serotonin agents|mesh-ancestor
110935174|NCT02228772|Cytarabine|cytarabine|mesh-list
110935229|NCT03563001|Respiratory System Agents|respiratory system agents|mesh-ancestor
110935230|NCT03563001|Glucocorticoids|glucocorticoids|mesh-ancestor
110935231|NCT03563001|Hormones|hormones|mesh-ancestor
110935232|NCT03563001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110935233|NCT03563001|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110935234|NCT03563001|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110935235|NCT03563001|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110935236|NCT03563001|Adrenergic Agents|adrenergic agents|mesh-ancestor
110935237|NCT03563001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110935238|NCT03563001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110935239|NCT02228928|Capsaicin|capsaicin|mesh-list
110935240|NCT02228928|Antipruritics|antipruritics|mesh-ancestor
110935241|NCT02228928|Dermatologic Agents|dermatologic agents|mesh-ancestor
110935242|NCT02228928|Sensory System Agents|sensory system agents|mesh-ancestor
110935290|NCT04946734|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110935291|NCT04946734|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110935292|NCT04946734|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110935293|NCT04946734|Purinergic Agents|purinergic agents|mesh-ancestor
110935294|NCT04946734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110935305|NCT04945096|Cytarabine|cytarabine|mesh-list
110935363|NCT04943146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110935364|NCT04943146|Glucocorticoids|glucocorticoids|mesh-ancestor
110935365|NCT04943146|Hormones|hormones|mesh-ancestor
110935366|NCT04943146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110935367|NCT04943146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110935430|NCT01291004|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110935431|NCT01291004|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110935432|NCT01291004|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110935433|NCT01291004|Hormone Antagonists|hormone antagonists|mesh-ancestor
110935434|NCT01291004|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110935437|NCT01291004|Progestins|progestins|mesh-ancestor
110935501|NCT03480308|Fentanyl|fentanyl|mesh-list
110935502|NCT03480308|Bupivacaine|bupivacaine|mesh-list
110935503|NCT03480308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110935574|NCT03479918|Doxorubicin|doxorubicin|mesh-list
110935575|NCT03479918|Etoposide|etoposide|mesh-list
110935576|NCT03479918|Vincristine|vincristine|mesh-list
110935577|NCT03479918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110935578|NCT03479918|Immunologic Factors|immunologic factors|mesh-ancestor
110935592|NCT03479918|Glucocorticoids|glucocorticoids|mesh-ancestor
110935645|NCT03482492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110935646|NCT03477110|Temozolomide|temozolomide|mesh-list
110935651|NCT03874286|Liver Extracts|liver extracts|mesh-list
110935718|NCT01338987|Fludarabine|fludarabine|mesh-list
110935719|NCT01338987|Leuprolide|leuprolide|mesh-list
110935720|NCT01338987|Tacrolimus|tacrolimus|mesh-list
110935721|NCT01338987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110935722|NCT01338987|Immunologic Factors|immunologic factors|mesh-ancestor
110935790|NCT03593252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110935791|NCT03593252|Antacids|antacids|mesh-ancestor
110935792|NCT03593252|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110935793|NCT03593252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110935813|NCT05257148|Nebivolol|nebivolol|mesh-list
110935862|NCT03477422|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110935863|NCT03477422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110935864|NCT03477422|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110935865|NCT03477422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110935866|NCT03477422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110935867|NCT01355289|Interferons|interferons|mesh-list
110935868|NCT01355289|Ribavirin|ribavirin|mesh-list
110935869|NCT01355289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110935870|NCT01355289|Antiviral Agents|antiviral agents|mesh-ancestor
110935871|NCT01355289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110935872|NCT01355289|Antimetabolites|antimetabolites|mesh-ancestor
110935873|NCT01355289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110935874|NCT03473210|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110935875|NCT03473210|Erythromycin|erythromycin|mesh-list
110935876|NCT03473210|Ampicillin|ampicillin|mesh-list
110653418|NCT00549848|Thioguanine|thioguanine|mesh-list
110935877|NCT03473210|Dexamethasone|dexamethasone|mesh-list
110937530|NCT04311632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110937531|NCT04311632|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110937532|NCT04311632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110937533|NCT04311632|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110937534|NCT04311632|Antitubercular Agents|antitubercular agents|mesh-ancestor
110937535|NCT04311632|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110937536|NCT04311632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110937559|NCT04208958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110937560|NCT04208958|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110937561|NCT04208958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110937562|NCT04208958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110937563|NCT04208958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110937564|NCT04154956|Docetaxel|docetaxel|mesh-list
110937565|NCT04154956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110937566|NCT04154956|Tubulin Modulators|tubulin modulators|mesh-ancestor
110937567|NCT04154956|Antimitotic Agents|antimitotic agents|mesh-ancestor
110937568|NCT04154956|Mitosis Modulators|mitosis modulators|mesh-ancestor
110937569|NCT04154956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110937570|NCT04144153|Analgesics, Opioid|analgesics, opioid|mesh-list
110937571|NCT04144153|Anesthetics|anesthetics|mesh-list
110937572|NCT04144153|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110937573|NCT04144153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110937574|NCT04144153|Narcotics|narcotics|mesh-ancestor
110937575|NCT04144153|Analgesics|analgesics|mesh-ancestor
110937576|NCT04144153|Sensory System Agents|sensory system agents|mesh-ancestor
110937577|NCT04144153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110937578|NCT04086745|Adalimumab|adalimumab|mesh-list
110937579|NCT04086745|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
110937580|NCT04086745|Etanercept|etanercept|mesh-list
110937581|NCT04086745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110937582|NCT04086745|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110937583|NCT04086745|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110937584|NCT04086745|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110937585|NCT04086745|Analgesics|analgesics|mesh-ancestor
110937586|NCT04086745|Sensory System Agents|sensory system agents|mesh-ancestor
110937587|NCT04086745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110937588|NCT04086745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110937589|NCT04086745|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110937590|NCT04086745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110937591|NCT04086745|Immunologic Factors|immunologic factors|mesh-ancestor
110937592|NCT03950739|Treprostinil|treprostinil|mesh-list
110937593|NCT03950739|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110935879|NCT03473210|Antiemetics|antiemetics|mesh-ancestor
110935880|NCT03473210|Autonomic Agents|autonomic agents|mesh-ancestor
110935881|NCT03473210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110935882|NCT03473210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110935883|NCT03473210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110935884|NCT03473210|Glucocorticoids|glucocorticoids|mesh-ancestor
110935886|NCT03473210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110935887|NCT03473210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110935888|NCT03473210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110935889|NCT03473210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110935890|NCT03473210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110937594|NCT03944772|Carboplatin|carboplatin|mesh-list
110937595|NCT03944772|Etoposide|etoposide|mesh-list
110937596|NCT03944772|Pemetrexed|pemetrexed|mesh-list
110937597|NCT03944772|Durvalumab|durvalumab|mesh-list
110937598|NCT03944772|Gefitinib|gefitinib|mesh-list
110937599|NCT03944772|Osimertinib|osimertinib|mesh-list
110937600|NCT03944772|Necitumumab|necitumumab|mesh-list
110937601|NCT03944772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110937602|NCT03944772|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110937603|NCT03944772|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110937604|NCT03944772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110937605|NCT03944772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110937606|NCT03944772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110937607|NCT03944772|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110937608|NCT03944772|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110937609|NCT03944772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110249402|NCT00501397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110937631|NCT03915769|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
110937632|NCT03915769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110937633|NCT03915769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110937634|NCT03915769|Immunologic Factors|immunologic factors|mesh-ancestor
110937635|NCT03915769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110937636|NCT03910387|Paclitaxel|paclitaxel|mesh-list
110937637|NCT03910387|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110937638|NCT03910387|Gemcitabine|gemcitabine|mesh-list
110937639|NCT03910387|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110937640|NCT03910387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110937641|NCT03910387|Tubulin Modulators|tubulin modulators|mesh-ancestor
110937642|NCT03910387|Antimitotic Agents|antimitotic agents|mesh-ancestor
110937643|NCT03910387|Mitosis Modulators|mitosis modulators|mesh-ancestor
110937644|NCT03910387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110937645|NCT03910387|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110937646|NCT03910387|Antimetabolites|antimetabolites|mesh-ancestor
110937647|NCT03850574|Venetoclax|venetoclax|mesh-list
110937648|NCT03850574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110937649|NCT03844815|Decitabine|decitabine|mesh-list
110937650|NCT03844815|Venetoclax|venetoclax|mesh-list
110937651|NCT03844815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110937652|NCT03844815|Antimetabolites|antimetabolites|mesh-ancestor
110937653|NCT03844815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110937654|NCT03844815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110937655|NCT03844815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110937656|NCT03837899|Durvalumab|durvalumab|mesh-list
110937657|NCT03837899|Tremelimumab|tremelimumab|mesh-list
110937658|NCT03837899|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110937659|NCT03837899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110937660|NCT03837899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110937661|NCT03837899|Immunologic Factors|immunologic factors|mesh-ancestor
110937662|NCT03837899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110937681|NCT03530189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110937682|NCT03507491|Paclitaxel|paclitaxel|mesh-list
110935892|NCT03473210|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110935893|NCT03473132|Thrombin|thrombin|mesh-list
110935894|NCT03473132|Hemostatics|hemostatics|mesh-ancestor
110935895|NCT03473132|Coagulants|coagulants|mesh-ancestor
110935896|NCT03475160|Sildenafil Citrate|sildenafil citrate|mesh-list
110935897|NCT03475160|Citric Acid|citric acid|mesh-list
110935898|NCT03475160|Sodium Citrate|sodium citrate|mesh-list
110935899|NCT03475160|Anticoagulants|anticoagulants|mesh-ancestor
110935900|NCT03475160|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110935901|NCT03475160|Chelating Agents|chelating agents|mesh-ancestor
110935902|NCT03475160|Sequestering Agents|sequestering agents|mesh-ancestor
110935903|NCT03475160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110935904|NCT03475160|Vasodilator Agents|vasodilator agents|mesh-ancestor
110935905|NCT03475160|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110935906|NCT03475160|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110935907|NCT03475160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110935908|NCT03475160|Urological Agents|urological agents|mesh-ancestor
110935909|NCT00308516|Leucovorin|leucovorin|mesh-list
110935910|NCT00308516|Bevacizumab|bevacizumab|mesh-list
110935911|NCT00308516|Fluorouracil|fluorouracil|mesh-list
110937683|NCT03507491|Gemcitabine|gemcitabine|mesh-list
110937684|NCT03507491|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110937685|NCT03507491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110937686|NCT03507491|Tubulin Modulators|tubulin modulators|mesh-ancestor
110937687|NCT03507491|Antimitotic Agents|antimitotic agents|mesh-ancestor
110937688|NCT03507491|Mitosis Modulators|mitosis modulators|mesh-ancestor
110937689|NCT03507491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110937690|NCT03507491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110937691|NCT03507491|Antimetabolites|antimetabolites|mesh-ancestor
110937692|NCT03478956|Etrolizumab|etrolizumab|mesh-list
110937693|NCT03478956|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110937694|NCT03478956|Immunologic Factors|immunologic factors|mesh-ancestor
110937695|NCT03478956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110937696|NCT03434769|Cyclophosphamide|cyclophosphamide|mesh-list
110937697|NCT03434769|Fludarabine|fludarabine|mesh-list
110937698|NCT03434769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110937699|NCT03434769|Immunologic Factors|immunologic factors|mesh-ancestor
110937700|NCT03434769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110937701|NCT03434769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110937702|NCT03434769|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110937703|NCT03434769|Alkylating Agents|alkylating agents|mesh-ancestor
110937704|NCT03434769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110937705|NCT03434769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110937706|NCT03434769|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110937707|NCT03331198|Venetoclax|venetoclax|mesh-list
110937708|NCT03331198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110937709|NCT03326310|Azacitidine|azacitidine|mesh-list
110937710|NCT03326310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110937711|NCT03326310|Antimetabolites|antimetabolites|mesh-ancestor
110937712|NCT03326310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110937713|NCT03326310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110937714|NCT03326310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110937715|NCT03317496|Cisplatin|cisplatin|mesh-list
110937716|NCT03317496|Carboplatin|carboplatin|mesh-list
110937717|NCT03317496|Gemcitabine|gemcitabine|mesh-list
110937718|NCT03317496|Pemetrexed|pemetrexed|mesh-list
110937719|NCT03317496|Avelumab|avelumab|mesh-list
110937720|NCT03317496|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110935912|NCT00308516|Oxaliplatin|oxaliplatin|mesh-list
110935913|NCT00308516|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110935914|NCT00308516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110935915|NCT00308516|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110935916|NCT00308516|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110935917|NCT00308516|Growth Substances|growth substances|mesh-ancestor
110935918|NCT00308516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110935919|NCT00308516|Growth Inhibitors|growth inhibitors|mesh-ancestor
110935920|NCT00308516|Antimetabolites|antimetabolites|mesh-ancestor
110935921|NCT00308516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110935922|NCT00308516|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110935923|NCT00308516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110935924|NCT00308516|Immunologic Factors|immunologic factors|mesh-ancestor
110937732|NCT03301506|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110937733|NCT03301506|Antimetabolites|antimetabolites|mesh-ancestor
110937734|NCT03301506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110937735|NCT03301506|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110937736|NCT03298945|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
110937737|NCT03298945|Laxatives|laxatives|mesh-ancestor
110937738|NCT03298945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110937739|NCT03274492|Prednisone|prednisone|mesh-list
110937740|NCT03274492|Cyclophosphamide|cyclophosphamide|mesh-list
110937741|NCT03274492|Rituximab|rituximab|mesh-list
110937742|NCT03274492|Doxorubicin|doxorubicin|mesh-list
110937743|NCT03274492|Vincristine|vincristine|mesh-list
110937744|NCT03274492|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110937745|NCT03274492|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
110937746|NCT03274492|Immunoconjugates|immunoconjugates|mesh-list
110937747|NCT03274492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110937748|NCT03274492|Immunologic Factors|immunologic factors|mesh-ancestor
110937749|NCT03274492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110937750|NCT03274492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110937751|NCT03274492|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110937752|NCT03274492|Alkylating Agents|alkylating agents|mesh-ancestor
110937753|NCT03274492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110937754|NCT03274492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110937755|NCT03274492|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110937756|NCT03274492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110937757|NCT03274492|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110937758|NCT03274492|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110937759|NCT03274492|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110937760|NCT03274492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110937761|NCT03274492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110937762|NCT03274492|Glucocorticoids|glucocorticoids|mesh-ancestor
110937763|NCT03274492|Hormones|hormones|mesh-ancestor
110937764|NCT03274492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110937765|NCT03274492|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110937766|NCT03274492|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110937767|NCT03274492|Tubulin Modulators|tubulin modulators|mesh-ancestor
110937768|NCT03274492|Antimitotic Agents|antimitotic agents|mesh-ancestor
110937769|NCT03274492|Mitosis Modulators|mitosis modulators|mesh-ancestor
110937770|NCT03269136|Thalidomide|thalidomide|mesh-list
110937771|NCT03269136|Dexamethasone|dexamethasone|mesh-list
110937772|NCT03269136|Dexamethasone acetate|dexamethasone acetate|mesh-list
110937773|NCT03269136|Lenalidomide|lenalidomide|mesh-list
110937774|NCT03269136|Pomalidomide|pomalidomide|mesh-list
110937775|NCT03269136|Antibodies|antibodies|mesh-list
110937776|NCT03269136|Immunoglobulins|immunoglobulins|mesh-list
110937777|NCT03269136|Antibodies, Bispecific|antibodies, bispecific|mesh-list
110937778|NCT03269136|BB 1101|bb 1101|mesh-list
110937779|NCT03269136|Immunologic Factors|immunologic factors|mesh-ancestor
110937780|NCT03269136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110937781|NCT03269136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110935926|NCT00308516|Protective Agents|protective agents|mesh-ancestor
110935927|NCT00308516|Vitamin B Complex|vitamin b complex|mesh-ancestor
110935928|NCT00308516|Vitamins|vitamins|mesh-ancestor
110935929|NCT00308516|Micronutrients|micronutrients|mesh-ancestor
110935930|NCT05155592|Adalimumab|adalimumab|mesh-list
110935931|NCT05155592|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110935932|NCT05155592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110935933|NCT05155592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110935934|NCT03474614|Propranolol|propranolol|mesh-list
110935935|NCT03474614|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110935936|NCT03474614|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110935937|NCT03474614|Adrenergic Agents|adrenergic agents|mesh-ancestor
110935938|NCT03474614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110284150|NCT00197561|Protective Agents|protective agents|mesh-ancestor
110937782|NCT03269136|Antiemetics|antiemetics|mesh-ancestor
110937783|NCT03269136|Autonomic Agents|autonomic agents|mesh-ancestor
110937784|NCT03269136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110937785|NCT03269136|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110937794|NCT03269136|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110937795|NCT03269136|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110937796|NCT03269136|Growth Substances|growth substances|mesh-ancestor
110937797|NCT03269136|Growth Inhibitors|growth inhibitors|mesh-ancestor
110937798|NCT03269136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110937799|NCT03269136|Leprostatic Agents|leprostatic agents|mesh-ancestor
110937800|NCT03269136|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110937801|NCT03269136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110937802|NCT03228667|Pembrolizumab|pembrolizumab|mesh-list
110937803|NCT03228667|Nivolumab|nivolumab|mesh-list
110937804|NCT03228667|Atezolizumab|atezolizumab|mesh-list
110937805|NCT03228667|Durvalumab|durvalumab|mesh-list
110937806|NCT03228667|Avelumab|avelumab|mesh-list
110937807|NCT03228667|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110937808|NCT03228667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110937809|NCT03228667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110937810|NCT03228667|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110937811|NCT03228667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110937812|NCT03228667|Immunologic Factors|immunologic factors|mesh-ancestor
110937813|NCT03228667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110937814|NCT03127215|Olaparib|olaparib|mesh-list
110937815|NCT03127215|Trabectedin|trabectedin|mesh-list
110937816|NCT03127215|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110937817|NCT03127215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110937818|NCT03127215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110937819|NCT03127215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110937820|NCT03127215|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110937821|NCT03127215|Alkylating Agents|alkylating agents|mesh-ancestor
110937822|NCT03125811|Ethanol|ethanol|mesh-list
110937823|NCT03125811|Ondansetron|ondansetron|mesh-list
110937824|NCT03125811|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110937825|NCT03125811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110937826|NCT03125811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110937827|NCT03125811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110937828|NCT03125811|Antiemetics|antiemetics|mesh-ancestor
110937829|NCT03125811|Autonomic Agents|autonomic agents|mesh-ancestor
110655388|NCT00964106|Analgesics|analgesics|mesh-ancestor
110937830|NCT03125811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110937831|NCT03125811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110937832|NCT03125811|Antipruritics|antipruritics|mesh-ancestor
110937833|NCT03125811|Dermatologic Agents|dermatologic agents|mesh-ancestor
110937834|NCT03125811|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110937835|NCT03125811|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110937836|NCT03125811|Serotonin Agents|serotonin agents|mesh-ancestor
110937837|NCT03125811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110935939|NCT03474614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110935940|NCT03474614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110935941|NCT03474614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110935942|NCT03474614|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110935944|NCT05155202|Antihypertensive Agents|antihypertensive agents|mesh-list
110935945|NCT02737358|Acetylcysteine|acetylcysteine|mesh-list
110935946|NCT02737358|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110935947|NCT02737358|Antiviral Agents|antiviral agents|mesh-ancestor
110935948|NCT02737358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110935949|NCT02737358|Expectorants|expectorants|mesh-ancestor
110935950|NCT02737358|Respiratory System Agents|respiratory system agents|mesh-ancestor
110937838|NCT03125811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110937839|NCT03096782|Mycophenolic Acid|mycophenolic acid|mesh-list
110937840|NCT03096782|Cyclophosphamide|cyclophosphamide|mesh-list
110937841|NCT03096782|Melphalan|melphalan|mesh-list
110937842|NCT03096782|Busulfan|busulfan|mesh-list
110937843|NCT03096782|Mechlorethamine|mechlorethamine|mesh-list
110937844|NCT03096782|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
110937845|NCT03096782|Rituximab|rituximab|mesh-list
110937846|NCT03096782|Fludarabine|fludarabine|mesh-list
110937847|NCT03096782|Clofarabine|clofarabine|mesh-list
110937848|NCT03096782|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110937849|NCT03096782|Tacrolimus|tacrolimus|mesh-list
110937850|NCT03096782|Thymoglobulin|thymoglobulin|mesh-list
110937851|NCT03096782|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110937852|NCT03096782|Antibodies|antibodies|mesh-list
110937853|NCT03096782|Immunoglobulins|immunoglobulins|mesh-list
110937864|NCT03096782|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110937865|NCT03096782|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110937866|NCT03096782|Antimetabolites|antimetabolites|mesh-ancestor
110937867|NCT03096782|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110937868|NCT03096782|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110937869|NCT03096782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110937870|NCT03096782|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110937871|NCT03096782|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110937872|NCT03096782|Antitubercular Agents|antitubercular agents|mesh-ancestor
110937873|NCT03096782|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110937874|NCT03096782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110937875|NCT02962401|Obinutuzumab|obinutuzumab|mesh-list
110937876|NCT02962401|Idelalisib|idelalisib|mesh-list
110937877|NCT02962401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110937878|NCT02962401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110937879|NCT02962401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110937880|NCT02962401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110937881|NCT02700841|Melphalan|melphalan|mesh-list
110937882|NCT02700841|Mechlorethamine|mechlorethamine|mesh-list
110937883|NCT02700841|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110937884|NCT02700841|Alkylating Agents|alkylating agents|mesh-ancestor
110937885|NCT02700841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110937886|NCT02700841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110937887|NCT02700841|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110937888|NCT02700841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110937889|NCT02700841|Immunologic Factors|immunologic factors|mesh-ancestor
110937890|NCT02700841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110937891|NCT02688985|Ocrelizumab|ocrelizumab|mesh-list
110937892|NCT02688985|Histamine Antagonists|histamine antagonists|mesh-list
110937893|NCT02688985|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
110937894|NCT02688985|Immunologic Factors|immunologic factors|mesh-ancestor
110937895|NCT02688985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110937896|NCT02688985|Histamine Agents|histamine agents|mesh-ancestor
110937897|NCT02688985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110937898|NCT02688985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110937899|NCT02669186|Fentanyl|fentanyl|mesh-list
110937900|NCT02669186|Bupivacaine|bupivacaine|mesh-list
110935951|NCT02737358|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110935952|NCT02737358|Antioxidants|antioxidants|mesh-ancestor
110935953|NCT02737358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110935954|NCT02737358|Protective Agents|protective agents|mesh-ancestor
110935955|NCT02737358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110935956|NCT02737358|Antidotes|antidotes|mesh-ancestor
110935957|NCT05052710|Midazolam|midazolam|mesh-list
110935958|NCT05052710|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110935959|NCT05052710|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110935960|NCT05052710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110935961|NCT05052710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110935962|NCT05052710|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110937901|NCT02669186|Anesthetics, Local|anesthetics, local|mesh-ancestor
110937902|NCT02669186|Anesthetics|anesthetics|mesh-ancestor
110937903|NCT02669186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110937904|NCT02669186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110937905|NCT02669186|Sensory System Agents|sensory system agents|mesh-ancestor
110937906|NCT02669186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110937907|NCT02669186|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110937908|NCT02669186|Narcotics|narcotics|mesh-ancestor
110937909|NCT02669186|Analgesics|analgesics|mesh-ancestor
110937910|NCT02669186|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110937911|NCT02669186|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110937912|NCT02669186|Anesthetics, General|anesthetics, general|mesh-ancestor
110937913|NCT02568566|Vaccines|vaccines|mesh-list
110937914|NCT02568566|Immunologic Factors|immunologic factors|mesh-ancestor
110937915|NCT02568566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110937916|NCT02536183|Doxorubicin|doxorubicin|mesh-list
110937917|NCT02536183|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110286036|NCT00234507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110937921|NCT02536183|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110937922|NCT02536183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110937923|NCT02536183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110937924|NCT02365766|Gemcitabine|gemcitabine|mesh-list
110937925|NCT02365766|Pembrolizumab|pembrolizumab|mesh-list
110937926|NCT02365766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110937927|NCT02365766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110937928|NCT02365766|Antimetabolites|antimetabolites|mesh-ancestor
110937929|NCT02365766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110937930|NCT02365766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110937931|NCT02365766|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110937932|NCT02317874|Paclitaxel|paclitaxel|mesh-list
110937933|NCT02317874|Carboplatin|carboplatin|mesh-list
110937934|NCT02317874|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110937935|NCT02317874|Talazoparib|talazoparib|mesh-list
110937936|NCT02317874|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110937937|NCT02317874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110937938|NCT02317874|Tubulin Modulators|tubulin modulators|mesh-ancestor
110937939|NCT02317874|Antimitotic Agents|antimitotic agents|mesh-ancestor
110937940|NCT02317874|Mitosis Modulators|mitosis modulators|mesh-ancestor
110937941|NCT02317874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110937942|NCT02317874|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110937943|NCT02317874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110937944|NCT02221999|Paclitaxel|paclitaxel|mesh-list
110937945|NCT02221999|Letrozole|letrozole|mesh-list
110937946|NCT02221999|Hormones|hormones|mesh-list
110937947|NCT02221999|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110937948|NCT02221999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110937949|NCT02221999|Tubulin Modulators|tubulin modulators|mesh-ancestor
110937950|NCT02221999|Antimitotic Agents|antimitotic agents|mesh-ancestor
110937951|NCT02221999|Mitosis Modulators|mitosis modulators|mesh-ancestor
110937952|NCT02221999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110478549|NCT01018862|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110935963|NCT05052710|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110935964|NCT05052710|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110935965|NCT05052710|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110935966|NCT05052710|Anesthetics, General|anesthetics, general|mesh-ancestor
110935968|NCT05052710|GABA Modulators|gaba modulators|mesh-ancestor
110935969|NCT05052710|GABA Agents|gaba agents|mesh-ancestor
110249440|NCT00502060|Cediranib|cediranib|mesh-list
110935970|NCT05052710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110935971|NCT05052710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110935972|NCT02866838|Tranexamic Acid|tranexamic acid|mesh-list
110284200|NCT00204191|Tacrolimus|tacrolimus|mesh-list
110937953|NCT02221999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110937954|NCT02221999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110937955|NCT02221999|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110937956|NCT02221999|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110937957|NCT02221999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110937958|NCT02221999|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110937959|NCT02221999|Hormone Antagonists|hormone antagonists|mesh-ancestor
110937960|NCT02143414|Prednisone|prednisone|mesh-list
110937961|NCT02143414|Cortisone|cortisone|mesh-list
110937962|NCT02143414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110937963|NCT02143414|Methotrexate|methotrexate|mesh-list
110937964|NCT02143414|Vincristine|vincristine|mesh-list
110937965|NCT02143414|Dasatinib|dasatinib|mesh-list
110937966|NCT02143414|Mercaptopurine|mercaptopurine|mesh-list
110937967|NCT02143414|Blinatumomab|blinatumomab|mesh-list
110937968|NCT02143414|Antibodies|antibodies|mesh-list
110937969|NCT02143414|Immunoglobulins|immunoglobulins|mesh-list
110937970|NCT02143414|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110937971|NCT02143414|Muromonab-CD3|muromonab-cd3|mesh-list
110937972|NCT02143414|Antibodies, Bispecific|antibodies, bispecific|mesh-list
110937973|NCT02143414|Immunologic Factors|immunologic factors|mesh-ancestor
110937974|NCT02143414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110937975|NCT02143414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110937976|NCT02143414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110937977|NCT02143414|Glucocorticoids|glucocorticoids|mesh-ancestor
110937978|NCT02143414|Hormones|hormones|mesh-ancestor
110937979|NCT02143414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110937980|NCT02143414|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110937981|NCT02143414|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110937982|NCT02143414|Abortifacient Agents|abortifacient agents|mesh-ancestor
110937983|NCT02143414|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110937984|NCT02143414|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110937985|NCT02143414|Antimetabolites|antimetabolites|mesh-ancestor
110937986|NCT02143414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110937987|NCT02143414|Dermatologic Agents|dermatologic agents|mesh-ancestor
110937988|NCT02143414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110937989|NCT02143414|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110937990|NCT02143414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110937996|NCT02143414|Mitosis Modulators|mitosis modulators|mesh-ancestor
110937997|NCT02143414|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110937998|NCT02112916|Calcium, Dietary|calcium, dietary|mesh-list
110937999|NCT02112916|Leucovorin|leucovorin|mesh-list
110938000|NCT02112916|Folic Acid|folic acid|mesh-list
110938001|NCT02112916|Cytarabine|cytarabine|mesh-list
110938002|NCT02112916|Dexamethasone|dexamethasone|mesh-list
110938003|NCT02112916|Dexamethasone acetate|dexamethasone acetate|mesh-list
110938004|NCT02112916|Hydrocortisone|hydrocortisone|mesh-list
110938005|NCT02112916|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
110938006|NCT02112916|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
110938007|NCT02112916|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
110938008|NCT02112916|Cyclophosphamide|cyclophosphamide|mesh-list
110938009|NCT02112916|Ifosfamide|ifosfamide|mesh-list
110938010|NCT02112916|Isophosphamide mustard|isophosphamide mustard|mesh-list
110938011|NCT02112916|Doxorubicin|doxorubicin|mesh-list
110938012|NCT02112916|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110938013|NCT02112916|Methotrexate|methotrexate|mesh-list
110938014|NCT02112916|Etoposide|etoposide|mesh-list
110938015|NCT02112916|Vincristine|vincristine|mesh-list
110935973|NCT02866838|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110935974|NCT02866838|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110935975|NCT02866838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110935976|NCT02866838|Hemostatics|hemostatics|mesh-ancestor
110935977|NCT02866838|Coagulants|coagulants|mesh-ancestor
110935978|NCT03474146|Chlorhexidine|chlorhexidine|mesh-list
110935979|NCT03474146|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110935980|NCT03474146|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110935981|NCT03474146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110935982|NCT03474146|Disinfectants|disinfectants|mesh-ancestor
110935983|NCT03474146|Dermatologic Agents|dermatologic agents|mesh-ancestor
110935984|NCT01090154|Certolizumab Pegol|certolizumab pegol|mesh-list
110935985|NCT01090154|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110935986|NCT01090154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110284207|NCT00204230|Mycophenolic Acid|mycophenolic acid|mesh-list
110938016|NCT02112916|Etoposide phosphate|etoposide phosphate|mesh-list
110938017|NCT02112916|Bortezomib|bortezomib|mesh-list
110938018|NCT02112916|Daunorubicin|daunorubicin|mesh-list
110938019|NCT02112916|Asparaginase|asparaginase|mesh-list
110938020|NCT02112916|Mercaptopurine|mercaptopurine|mesh-list
110938021|NCT02112916|Podophyllotoxin|podophyllotoxin|mesh-list
110938022|NCT02112916|Pegaspargase|pegaspargase|mesh-list
110938023|NCT02112916|Thioguanine|thioguanine|mesh-list
110938024|NCT02112916|BB 1101|bb 1101|mesh-list
110938025|NCT02112916|Calcium|calcium|mesh-list
110938026|NCT02112916|2-Aminopurine|2-aminopurine|mesh-list
110938027|NCT02112916|Levoleucovorin|levoleucovorin|mesh-list
110938028|NCT02112916|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110938029|NCT02112916|Immunologic Factors|immunologic factors|mesh-ancestor
110938030|NCT02112916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110938031|NCT02112916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110938032|NCT02112916|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110938033|NCT02112916|Alkylating Agents|alkylating agents|mesh-ancestor
110938034|NCT02112916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110938035|NCT02112916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110938036|NCT02112916|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110938037|NCT02112916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110938038|NCT02112916|Antiemetics|antiemetics|mesh-ancestor
110938039|NCT02112916|Autonomic Agents|autonomic agents|mesh-ancestor
110938040|NCT02112916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110938041|NCT02112916|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110938042|NCT02112916|Glucocorticoids|glucocorticoids|mesh-ancestor
110938043|NCT02112916|Hormones|hormones|mesh-ancestor
110938044|NCT02112916|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110938045|NCT02112916|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110938046|NCT02112916|Protease Inhibitors|protease inhibitors|mesh-ancestor
110938047|NCT02112916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110938048|NCT02112916|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110938049|NCT02112916|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110938050|NCT02112916|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110938051|NCT02112916|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110938052|NCT02112916|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110938053|NCT02112916|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110938054|NCT02112916|Abortifacient Agents|abortifacient agents|mesh-ancestor
110938055|NCT02112916|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110938056|NCT02112916|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110938057|NCT02112916|Antimetabolites|antimetabolites|mesh-ancestor
110938058|NCT02112916|Dermatologic Agents|dermatologic agents|mesh-ancestor
110938059|NCT02112916|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110938060|NCT02112916|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110938061|NCT02112916|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110938062|NCT02112916|Antiviral Agents|antiviral agents|mesh-ancestor
110935987|NCT01090154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110935988|NCT01090154|Immunologic Factors|immunologic factors|mesh-ancestor
110935989|NCT01090154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110935990|NCT01090154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110935991|NCT01354431|Nivolumab|nivolumab|mesh-list
110935992|NCT01354431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110935993|NCT01354431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110935994|NCT01354431|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110935995|NCT01354431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110938063|NCT02112916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110938064|NCT02112916|Antidotes|antidotes|mesh-ancestor
110938068|NCT02112916|Micronutrients|micronutrients|mesh-ancestor
110938069|NCT02112916|Tubulin Modulators|tubulin modulators|mesh-ancestor
110938070|NCT02112916|Antimitotic Agents|antimitotic agents|mesh-ancestor
110938071|NCT02112916|Mitosis Modulators|mitosis modulators|mesh-ancestor
110938073|NCT02112916|Keratolytic Agents|keratolytic agents|mesh-ancestor
110938074|NCT01849562|Ribavirin|ribavirin|mesh-list
110938075|NCT01849562|Odalasvir|odalasvir|mesh-list
110938076|NCT01849562|Antimetabolites|antimetabolites|mesh-ancestor
110938077|NCT01849562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110938078|NCT01849562|Antiviral Agents|antiviral agents|mesh-ancestor
110938079|NCT01849562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110938080|NCT01700179|Ribavirin|ribavirin|mesh-list
110938081|NCT01700179|Antimetabolites|antimetabolites|mesh-ancestor
110938082|NCT01700179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110938083|NCT01700179|Antiviral Agents|antiviral agents|mesh-ancestor
110938084|NCT01700179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110938085|NCT01659606|Cyclosporine|cyclosporine|mesh-list
110938086|NCT01659606|Mycophenolic Acid|mycophenolic acid|mesh-list
110938087|NCT01659606|Fludarabine|fludarabine|mesh-list
110938088|NCT01659606|Alemtuzumab|alemtuzumab|mesh-list
110938089|NCT01659606|Tacrolimus|tacrolimus|mesh-list
110938090|NCT01659606|Cyclosporins|cyclosporins|mesh-list
110938091|NCT01659606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110938092|NCT01659606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110938093|NCT01659606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110938094|NCT01659606|Immunologic Factors|immunologic factors|mesh-ancestor
110938095|NCT01659606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110938096|NCT01659606|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110938097|NCT01659606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110938098|NCT01659606|Antifungal Agents|antifungal agents|mesh-ancestor
110938099|NCT01659606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110938100|NCT01659606|Dermatologic Agents|dermatologic agents|mesh-ancestor
110938101|NCT01659606|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110938102|NCT01659606|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110938103|NCT01659606|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110938104|NCT01659606|Antitubercular Agents|antitubercular agents|mesh-ancestor
110938105|NCT01659606|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110938106|NCT01659606|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110938107|NCT01543763|Abexinostat|abexinostat|mesh-list
110938108|NCT01543763|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110938109|NCT01543763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110938110|NCT01543763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110938111|NCT01517100|Dronabinol|dronabinol|mesh-list
110938112|NCT01517100|Nabilone|nabilone|mesh-list
110938113|NCT01517100|Antiemetics|antiemetics|mesh-ancestor
110938114|NCT01517100|Autonomic Agents|autonomic agents|mesh-ancestor
110938115|NCT01517100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110938116|NCT01517100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110938117|NCT01517100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110938118|NCT01517100|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110938119|NCT01517100|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110938120|NCT01517100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110938121|NCT01517100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110938122|NCT01517100|Hallucinogens|hallucinogens|mesh-ancestor
110938123|NCT01517100|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110938124|NCT01517100|Analgesics|analgesics|mesh-ancestor
110938125|NCT01517100|Sensory System Agents|sensory system agents|mesh-ancestor
110935997|NCT02736578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110935998|NCT02736578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110935999|NCT05157542|Paclitaxel|paclitaxel|mesh-list
110936000|NCT05157542|Durvalumab|durvalumab|mesh-list
110936001|NCT05157542|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110936002|NCT05157542|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110936003|NCT05157542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110936004|NCT05157542|Tubulin Modulators|tubulin modulators|mesh-ancestor
110936005|NCT05157542|Antimitotic Agents|antimitotic agents|mesh-ancestor
110936006|NCT05157542|Mitosis Modulators|mitosis modulators|mesh-ancestor
110936007|NCT05157542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110936008|NCT05157542|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110936009|NCT03472976|Imiquimod|imiquimod|mesh-list
110936010|NCT03472976|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110936011|NCT03472976|Immunologic Factors|immunologic factors|mesh-ancestor
110936012|NCT03472976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110936013|NCT03472976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110936014|NCT03472976|Interferon Inducers|interferon inducers|mesh-ancestor
110936015|NCT03473600|Triamcinolone|triamcinolone|mesh-list
110936016|NCT03473600|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110938126|NCT01517100|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
110938127|NCT01517100|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110938128|NCT01517100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110938129|NCT01517100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110938130|NCT01517100|Hormones|hormones|mesh-ancestor
110938131|NCT01517100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110938132|NCT01474200|Furosemide|furosemide|mesh-list
110938133|NCT01474200|Diuretics|diuretics|mesh-list
110938134|NCT01474200|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
110938135|NCT01474200|Natriuretic Agents|natriuretic agents|mesh-ancestor
110938136|NCT01474200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110938137|NCT01474200|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110286242|NCT00210158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110938151|NCT01245179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110938152|NCT01245179|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110938153|NCT01245179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110938154|NCT01245179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110938155|NCT00500123|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
110938156|NCT00500123|Protein C Inhibitor|protein c inhibitor|mesh-list
110938157|NCT00500123|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
110938158|NCT00500123|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110938159|NCT00500123|Protease Inhibitors|protease inhibitors|mesh-ancestor
110938160|NCT00500123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110938161|NCT00500123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110938162|NCT03055234|Treprostinil|treprostinil|mesh-list
110938163|NCT03055234|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110938164|NCT03055312|Bicalutamide|bicalutamide|mesh-list
110938165|NCT03055312|Androgen Antagonists|androgen antagonists|mesh-ancestor
110938166|NCT03055312|Hormone Antagonists|hormone antagonists|mesh-ancestor
110938167|NCT03055312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110938168|NCT03055312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110936017|NCT03473600|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110936018|NCT03473600|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110936019|NCT03473600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110936021|NCT03473600|Hormones|hormones|mesh-ancestor
110936022|NCT03473600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110936023|NCT03473600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110936024|NCT03473600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110936025|NCT03473600|Immunologic Factors|immunologic factors|mesh-ancestor
110936026|NCT03473600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110936027|NCT03473600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110936028|NCT04457648|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110936029|NCT04457648|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110936030|NCT02622724|Interferons|interferons|mesh-list
110936031|NCT02622724|Interferon-beta|interferon-beta|mesh-list
110936032|NCT02622724|Interferon beta-1a|interferon beta-1a|mesh-list
110936033|NCT02622724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110284246|NCT00204308|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110938169|NCT03055312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110938170|NCT04977544|Sertraline|sertraline|mesh-list
110938171|NCT04977544|Antidepressive Agents|antidepressive agents|mesh-ancestor
110938172|NCT04977544|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110938173|NCT04977544|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110938174|NCT04977544|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110938175|NCT04977544|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110938176|NCT04977544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110938177|NCT04977544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110938178|NCT04977544|Serotonin Agents|serotonin agents|mesh-ancestor
110938179|NCT04977544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110938180|NCT02626000|Pembrolizumab|pembrolizumab|mesh-list
110938181|NCT02626000|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
110938182|NCT02626000|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110938183|NCT02626000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110938184|NCT02626000|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110938185|NCT02626000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110938186|NCT03769376|Salvin|salvin|mesh-list
110938187|NCT03769376|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110938188|NCT03769376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110938189|NCT03769376|Antioxidants|antioxidants|mesh-ancestor
110938190|NCT03769376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110938191|NCT03769376|Protective Agents|protective agents|mesh-ancestor
110938192|NCT03769376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110938193|NCT05156450|Prednisone|prednisone|mesh-list
110938194|NCT05156450|Abiraterone Acetate|abiraterone acetate|mesh-list
110938195|NCT05156450|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110938196|NCT05156450|Glucocorticoids|glucocorticoids|mesh-ancestor
110938197|NCT05156450|Hormones|hormones|mesh-ancestor
110938198|NCT05156450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110938199|NCT05156450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110938209|NCT03060304|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110938211|NCT03060304|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110938212|NCT03060304|Estrogens|estrogens|mesh-ancestor
110938213|NCT03060304|Hormones|hormones|mesh-ancestor
110938214|NCT03060304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110938215|NCT03060304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110936034|NCT02622724|Antiviral Agents|antiviral agents|mesh-ancestor
110936035|NCT02622724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110936036|NCT02622724|Immunologic Factors|immunologic factors|mesh-ancestor
110936037|NCT02622724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110936038|NCT02622724|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110936039|NCT01354353|Aripiprazole|aripiprazole|mesh-list
110936040|NCT01354353|Antidepressive Agents|antidepressive agents|mesh-ancestor
110936041|NCT01354353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110936042|NCT01354353|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110936043|NCT01354353|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110936044|NCT01354353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110936045|NCT01354353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110936046|NCT01354353|Dopamine Agonists|dopamine agonists|mesh-ancestor
110938216|NCT03060304|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110938217|NCT03060304|Contraceptive Agents|contraceptive agents|mesh-ancestor
110938218|NCT03060304|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110938219|NCT03060304|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110938220|NCT03060304|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110938221|NCT03060304|Hormone Antagonists|hormone antagonists|mesh-ancestor
110938222|NCT03060304|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110938223|NCT03060304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110938224|NCT03060304|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110938225|NCT03060304|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110938226|NCT03060304|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110938227|NCT04432402|Gemcitabine|gemcitabine|mesh-list
110938228|NCT04432402|Oxaliplatin|oxaliplatin|mesh-list
110938229|NCT04432402|Lenalidomide|lenalidomide|mesh-list
110938230|NCT04432402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110938231|NCT04432402|Immunologic Factors|immunologic factors|mesh-ancestor
110938232|NCT04432402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110938233|NCT04432402|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110938234|NCT04432402|Antimetabolites|antimetabolites|mesh-ancestor
110938235|NCT04432402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110938236|NCT04432402|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110938237|NCT04432402|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110938238|NCT04432402|Growth Substances|growth substances|mesh-ancestor
110938239|NCT04432402|Growth Inhibitors|growth inhibitors|mesh-ancestor
110938240|NCT04432324|Immunoglobulins|immunoglobulins|mesh-list
110938241|NCT04432324|Antibodies|antibodies|mesh-list
110938242|NCT04432324|gamma-Globulins|gamma-globulins|mesh-list
110938243|NCT04432324|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110938244|NCT04432324|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110938245|NCT04432324|Immunologic Factors|immunologic factors|mesh-ancestor
110938246|NCT04432324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110938247|NCT02736890|Botulinum Toxins|botulinum toxins|mesh-list
110938248|NCT02736890|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110938249|NCT02736890|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110938250|NCT02736890|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110938251|NCT02736890|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110938252|NCT02736890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110938253|NCT02736890|Cholinergic Agents|cholinergic agents|mesh-ancestor
110938254|NCT02736890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110938255|NCT02736890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110938256|NCT02736890|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110938257|NCT02736890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110938258|NCT04977388|Droxidopa|droxidopa|mesh-list
110938259|NCT04977388|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110938260|NCT04977388|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110938261|NCT03470480|Methamphetamine|methamphetamine|mesh-list
110938262|NCT03470480|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110938263|NCT03470480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110938275|NCT03469856|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
110936047|NCT01354353|Dopamine Agents|dopamine agents|mesh-ancestor
110936048|NCT01354353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110936049|NCT01354353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110936050|NCT01354353|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110936051|NCT01354353|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110936052|NCT01354353|Serotonin Agents|serotonin agents|mesh-ancestor
110936053|NCT01354353|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110936054|NCT01354353|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110936055|NCT01354353|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110936056|NCT01354353|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110936058|NCT04931524|Mitosis Modulators|mitosis modulators|mesh-ancestor
110936059|NCT04931524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110284276|NCT00227682|Immunologic Factors|immunologic factors|mesh-ancestor
110938276|NCT03469856|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110938277|NCT04917250|Dexamethasone|dexamethasone|mesh-list
110938278|NCT04917250|Gemcitabine|gemcitabine|mesh-list
110938279|NCT04917250|Etoposide|etoposide|mesh-list
110938280|NCT04917250|Pegaspargase|pegaspargase|mesh-list
110938281|NCT04917250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110938282|NCT04917250|Antiemetics|antiemetics|mesh-ancestor
110938283|NCT04917250|Autonomic Agents|autonomic agents|mesh-ancestor
110938284|NCT04917250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110938285|NCT04917250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110938286|NCT04917250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110938287|NCT04917250|Glucocorticoids|glucocorticoids|mesh-ancestor
110938288|NCT04917250|Hormones|hormones|mesh-ancestor
110938289|NCT04917250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110938290|NCT04917250|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110938291|NCT04917250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110655803|NCT00966966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110938292|NCT04917250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110938293|NCT04917250|Antimetabolites|antimetabolites|mesh-ancestor
110938294|NCT04917250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110938295|NCT04917250|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110938296|NCT04917250|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110938297|NCT04917250|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110938298|NCT04917250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110938299|NCT04859582|Pembrolizumab|pembrolizumab|mesh-list
110938300|NCT04859582|Fluorouracil|fluorouracil|mesh-list
110938301|NCT04859582|Capecitabine|capecitabine|mesh-list
110938302|NCT04859582|Oxaliplatin|oxaliplatin|mesh-list
110938303|NCT04859582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110938304|NCT04859582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110938305|NCT04859582|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110938306|NCT04859582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110938307|NCT04859582|Antimetabolites|antimetabolites|mesh-ancestor
110938308|NCT04859582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110938309|NCT04859582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110938310|NCT04859582|Immunologic Factors|immunologic factors|mesh-ancestor
110938311|NCT04859582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110938312|NCT03469700|Anesthetics|anesthetics|mesh-list
110938313|NCT03469700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110938314|NCT03469700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110938315|NCT04912726|Sildenafil Citrate|sildenafil citrate|mesh-list
110938316|NCT04912726|Vasodilator Agents|vasodilator agents|mesh-ancestor
110938317|NCT04912726|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110938318|NCT04912726|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110938319|NCT04912726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110938320|NCT04912726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110936060|NCT03562611|Flurbiprofen|flurbiprofen|mesh-list
110936061|NCT03562611|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
110936062|NCT03562611|Nalbuphine|nalbuphine|mesh-list
110936063|NCT03562611|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110936064|NCT03562611|Narcotics|narcotics|mesh-ancestor
110936065|NCT03562611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110936066|NCT03562611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110936067|NCT03562611|Analgesics|analgesics|mesh-ancestor
110938321|NCT04912726|Urological Agents|urological agents|mesh-ancestor
110938322|NCT02603900|Bupivacaine|bupivacaine|mesh-list
110938323|NCT02603900|Ropivacaine|ropivacaine|mesh-list
110938324|NCT02603900|Anesthetics, Local|anesthetics, local|mesh-ancestor
110938325|NCT02603900|Anesthetics|anesthetics|mesh-ancestor
110938349|NCT04458116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110938351|NCT03469544|Antibodies|antibodies|mesh-list
110938352|NCT03469544|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110938353|NCT03469544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110938354|NCT03469544|Immunologic Factors|immunologic factors|mesh-ancestor
110938355|NCT03062254|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
110938356|NCT03062254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110938357|NCT04912258|Irinotecan|irinotecan|mesh-list
110938358|NCT04912258|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110938359|NCT04912258|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110938360|NCT04912258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110938361|NCT04912258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110938362|NCT04912258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110938363|NCT01952288|Simvastatin|simvastatin|mesh-list
110938364|NCT01952288|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110938365|NCT01952288|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110938366|NCT01952288|Antimetabolites|antimetabolites|mesh-ancestor
110938367|NCT01952288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110938368|NCT01952288|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110938369|NCT01952288|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110938370|NCT01952288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110938371|NCT03054532|Durvalumab|durvalumab|mesh-list
110938372|NCT03054532|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110938373|NCT03054532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110938374|NCT04975360|Caffeine|caffeine|mesh-list
110286509|NCT00210860|Topiramate|topiramate|mesh-list
110938382|NCT04975360|Purinergic Agents|purinergic agents|mesh-ancestor
110938383|NCT04975360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110938384|NCT00563576|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
110938385|NCT00563576|Medroxyprogesterone|medroxyprogesterone|mesh-list
110938387|NCT00563576|Estrogens|estrogens|mesh-ancestor
110938388|NCT00563576|Hormones|hormones|mesh-ancestor
110938389|NCT00563576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110938390|NCT00563576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110938391|NCT00563576|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110938392|NCT00563576|Contraceptive Agents|contraceptive agents|mesh-ancestor
110938393|NCT00563576|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110938394|NCT00563576|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110938395|NCT00563576|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110938396|NCT00563576|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110938397|NCT00563576|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110938398|NCT00563576|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110938399|NCT00563576|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110938400|NCT00563576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110938401|NCT04915846|Tamoxifen|tamoxifen|mesh-list
110938402|NCT04915846|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110938403|NCT04915846|Hormone Antagonists|hormone antagonists|mesh-ancestor
110938404|NCT04915846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110938405|NCT04915846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110938406|NCT04915846|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110938407|NCT04915846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110938408|NCT04915846|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110938409|NCT04915846|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110938410|NCT04915846|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110936068|NCT03562611|Sensory System Agents|sensory system agents|mesh-ancestor
110936069|NCT03562611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110936070|NCT03562611|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110936071|NCT03562611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110936072|NCT03562611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110936073|NCT03562611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110936074|NCT03562611|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110936075|NCT03562611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110936076|NCT03562611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110938411|NCT03782636|Aldesleukin|aldesleukin|mesh-list
110938412|NCT03782636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110938413|NCT03782636|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110938414|NCT03782636|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110938415|NCT03782636|Antiviral Agents|antiviral agents|mesh-ancestor
110938416|NCT03782636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110938417|NCT04911244|Dimercaprol|dimercaprol|mesh-list
110938418|NCT04911244|Chelating Agents|chelating agents|mesh-ancestor
110938419|NCT04911244|Sequestering Agents|sequestering agents|mesh-ancestor
110938420|NCT04911244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110938421|NCT03761810|Tretinoin|tretinoin|mesh-list
110938422|NCT03761810|Benzoyl Peroxide|benzoyl peroxide|mesh-list
110938423|NCT03761810|Dermatologic Agents|dermatologic agents|mesh-ancestor
110938424|NCT03761810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110938425|NCT03761810|Keratolytic Agents|keratolytic agents|mesh-ancestor
110938426|NCT04915456|Prednisolone|prednisolone|mesh-list
110938427|NCT04915456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110938428|NCT04915456|Glucocorticoids|glucocorticoids|mesh-ancestor
110938429|NCT04915456|Hormones|hormones|mesh-ancestor
110938430|NCT04915456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110938431|NCT04915456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110938432|NCT04915456|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110938433|NCT04915456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110938434|NCT04841668|Metformin|metformin|mesh-list
110938435|NCT04841668|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110938436|NCT04841668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110938437|NCT03469310|Acetaminophen|acetaminophen|mesh-list
110938438|NCT03469310|Tramadol|tramadol|mesh-list
110938439|NCT03469310|Codeine|codeine|mesh-list
110938440|NCT03469310|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110938448|NCT03469310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110938450|NCT03469310|Respiratory System Agents|respiratory system agents|mesh-ancestor
110938451|NCT03527186|Risperidone|risperidone|mesh-list
110938452|NCT03527186|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110938453|NCT03527186|Serotonin Agents|serotonin agents|mesh-ancestor
110938454|NCT03527186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110938455|NCT03527186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110938456|NCT03527186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110938457|NCT03527186|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110938458|NCT03527186|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110938459|NCT03527186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110938460|NCT03527186|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110938461|NCT03527186|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110938462|NCT03527186|Dopamine Agents|dopamine agents|mesh-ancestor
110938463|NCT05159882|Dapagliflozin|dapagliflozin|mesh-list
110938464|NCT05159882|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110938465|NCT05159882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110938466|NCT05159882|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110938467|NCT05159882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110938468|NCT04910698|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110938469|NCT04910698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110938470|NCT04455464|Midodrine|midodrine|mesh-list
110938471|NCT04455464|Sympathomimetics|sympathomimetics|mesh-ancestor
110938472|NCT04455464|Autonomic Agents|autonomic agents|mesh-ancestor
110938473|NCT04455464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110938474|NCT04455464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110938475|NCT04455464|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110936077|NCT03057574|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
110936078|NCT03057574|Hormones|hormones|mesh-ancestor
110936079|NCT03057574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110936080|NCT03057574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110936081|NCT03057028|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
110936082|NCT03057028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110936083|NCT04929652|Irinotecan|irinotecan|mesh-list
110936084|NCT04929652|Molgramostim|molgramostim|mesh-list
110936085|NCT04929652|Sargramostim|sargramostim|mesh-list
110936086|NCT04929652|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110936087|NCT04929652|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110936088|NCT04929652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110936089|NCT04929652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110936090|NCT04929652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110936091|NCT04929652|Immunologic Factors|immunologic factors|mesh-ancestor
110936092|NCT04929652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110936093|NCT01353963|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
110936094|NCT01353963|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110936095|NCT01353963|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110936096|NCT01353963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110938476|NCT04455464|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110938477|NCT04455464|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110938478|NCT04455464|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110938479|NCT04455464|Adrenergic Agents|adrenergic agents|mesh-ancestor
110938480|NCT04455464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110938481|NCT04455464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110938482|NCT04914598|Cisplatin|cisplatin|mesh-list
110938483|NCT04914598|Endostar protein|endostar protein|mesh-list
110938484|NCT04914598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110938485|NCT04914598|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110938486|NCT04914598|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110938487|NCT04914598|Growth Substances|growth substances|mesh-ancestor
110938488|NCT04914598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110938489|NCT04914598|Growth Inhibitors|growth inhibitors|mesh-ancestor
110938490|NCT03054220|Tramadol|tramadol|mesh-list
110938491|NCT03054220|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110938492|NCT03054220|Dextromethorphan|dextromethorphan|mesh-list
110938493|NCT03054220|Paroxetine|paroxetine|mesh-list
110938494|NCT03054220|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110938495|NCT03054220|Narcotics|narcotics|mesh-ancestor
110938496|NCT03054220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110938497|NCT03054220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110938498|NCT03054220|Analgesics|analgesics|mesh-ancestor
110938499|NCT03054220|Sensory System Agents|sensory system agents|mesh-ancestor
110938500|NCT03054220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110938501|NCT03054220|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110938502|NCT03054220|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110938503|NCT03054220|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110938504|NCT03054220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110938505|NCT03054220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110938506|NCT03054220|Antidepressive Agents|antidepressive agents|mesh-ancestor
110936097|NCT01353963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110936098|NCT01353963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110936099|NCT01353963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110936100|NCT01353963|Antidepressive Agents|antidepressive agents|mesh-ancestor
110936101|NCT01353963|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110936102|NCT04927936|Vaccines|vaccines|mesh-list
110936103|NCT04927936|Immunologic Factors|immunologic factors|mesh-ancestor
110936104|NCT04927936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110936105|NCT04167813|Ondansetron|ondansetron|mesh-list
110936106|NCT04167813|Antiemetics|antiemetics|mesh-ancestor
110653640|NCT03954834|Tirzepatide|tirzepatide|mesh-list
110936107|NCT04167813|Autonomic Agents|autonomic agents|mesh-ancestor
110936108|NCT04167813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110936109|NCT04167813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110936110|NCT04167813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110936111|NCT04167813|Antipruritics|antipruritics|mesh-ancestor
110936112|NCT04167813|Dermatologic Agents|dermatologic agents|mesh-ancestor
110936113|NCT04167813|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110936114|NCT04167813|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110286628|NCT00211250|Antimanic Agents|antimanic agents|mesh-ancestor
110938511|NCT03054220|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110938512|NCT03054220|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110938513|NCT03054220|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110938514|NCT03054220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110938515|NCT03054220|Antitussive Agents|antitussive agents|mesh-ancestor
110938516|NCT03054220|Respiratory System Agents|respiratory system agents|mesh-ancestor
110938517|NCT03054220|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110938518|NCT03054220|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110938520|NCT05388188|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110938521|NCT05388188|Narcotics|narcotics|mesh-ancestor
110938522|NCT05388188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110938523|NCT05388188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110938524|NCT05388188|Analgesics|analgesics|mesh-ancestor
110938525|NCT05388188|Sensory System Agents|sensory system agents|mesh-ancestor
110249483|NCT00147381|Tacrolimus|tacrolimus|mesh-list
110938526|NCT05388188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110938527|NCT05388188|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110938528|NCT05388188|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110938529|NCT05388188|Anesthetics, General|anesthetics, general|mesh-ancestor
110938530|NCT05388188|Anesthetics|anesthetics|mesh-ancestor
110938531|NCT04118036|Pembrolizumab|pembrolizumab|mesh-list
110938532|NCT04118036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110938533|NCT04118036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110938534|NCT04118036|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110938535|NCT04118036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110938536|NCT04909918|Dexamethasone|dexamethasone|mesh-list
110938537|NCT04909918|Methylprednisolone|methylprednisolone|mesh-list
110938538|NCT04909918|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110938539|NCT04909918|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110938540|NCT04909918|Prednisolone|prednisolone|mesh-list
110938541|NCT04909918|Prednisolone acetate|prednisolone acetate|mesh-list
110938542|NCT04909918|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110938543|NCT04909918|Prednisolone phosphate|prednisolone phosphate|mesh-list
110938544|NCT04909918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110938545|NCT04909918|Antiemetics|antiemetics|mesh-ancestor
110938546|NCT04909918|Autonomic Agents|autonomic agents|mesh-ancestor
110938547|NCT04909918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110936115|NCT04167813|Serotonin Agents|serotonin agents|mesh-ancestor
110936116|NCT04167813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110936117|NCT04167813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110936119|NCT03562533|Carboplatin|carboplatin|mesh-list
110936120|NCT03562533|Doxorubicin|doxorubicin|mesh-list
110936121|NCT03562533|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110936122|NCT03562533|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110936123|NCT03562533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110936124|NCT03562533|Tubulin Modulators|tubulin modulators|mesh-ancestor
110936125|NCT03562533|Antimitotic Agents|antimitotic agents|mesh-ancestor
110936126|NCT03562533|Mitosis Modulators|mitosis modulators|mesh-ancestor
110938548|NCT04909918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110938549|NCT04909918|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110938550|NCT04909918|Glucocorticoids|glucocorticoids|mesh-ancestor
110938551|NCT04909918|Hormones|hormones|mesh-ancestor
110938552|NCT04909918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110938553|NCT04909918|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110938554|NCT04909918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110938555|NCT04909918|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110938556|NCT04909918|Protective Agents|protective agents|mesh-ancestor
110938557|NCT04903678|Melphalan|melphalan|mesh-list
110938558|NCT04903678|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110938559|NCT04903678|Alkylating Agents|alkylating agents|mesh-ancestor
110938560|NCT04903678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110938561|NCT04903678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110938562|NCT04903678|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110938563|NCT04903678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110938564|NCT04903678|Immunologic Factors|immunologic factors|mesh-ancestor
110938565|NCT04903678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110938566|NCT04903366|Timolol|timolol|mesh-list
110938567|NCT04903366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110938568|NCT04903366|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110938569|NCT04903366|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110938570|NCT04903366|Adrenergic Agents|adrenergic agents|mesh-ancestor
110938571|NCT04903366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110938572|NCT04903366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110938573|NCT04903366|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110938574|NCT04903366|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110938575|NCT03054610|Betamethasone|betamethasone|mesh-list
110938576|NCT03054610|Betamethasone Valerate|betamethasone valerate|mesh-list
110938577|NCT03054610|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
110938579|NCT03054610|Ropivacaine|ropivacaine|mesh-list
110938580|NCT03054610|Betamethasone acetate phosphate|betamethasone acetate phosphate|mesh-list
110938581|NCT03054610|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110938582|NCT03054610|Botulinum Toxins|botulinum toxins|mesh-list
110938583|NCT03054610|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110938584|NCT03054610|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
110938585|NCT03054610|Anesthetics, Local|anesthetics, local|mesh-ancestor
110938586|NCT03054610|Anesthetics|anesthetics|mesh-ancestor
110938587|NCT03054610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110656102|NCT00981708|Antiemetics|antiemetics|mesh-ancestor
110938588|NCT03054610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110938589|NCT03054610|Sensory System Agents|sensory system agents|mesh-ancestor
110938590|NCT03054610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110938591|NCT03054610|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110938592|NCT03054610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110938593|NCT03054610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110938594|NCT03054610|Cholinergic Agents|cholinergic agents|mesh-ancestor
110938595|NCT03054610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110938596|NCT03054610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110938597|NCT03054610|Glucocorticoids|glucocorticoids|mesh-ancestor
110478550|NCT01018862|Autonomic Agents|autonomic agents|mesh-ancestor
110936127|NCT03562533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110936128|NCT03562533|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110936129|NCT03562533|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110936130|NCT03562533|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110936131|NCT03562533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110936132|NCT04927858|Empagliflozin|empagliflozin|mesh-list
110936133|NCT04927858|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110936134|NCT04927858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110936135|NCT04927858|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110936136|NCT04927858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110936137|NCT04927000|Tofacitinib|tofacitinib|mesh-list
110936138|NCT04927000|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
110936139|NCT04927000|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110938599|NCT03054610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110938600|NCT03054610|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110938601|NCT03054610|Respiratory System Agents|respiratory system agents|mesh-ancestor
110938602|NCT03054610|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110938603|NCT03054610|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110938604|NCT03054610|Autonomic Agents|autonomic agents|mesh-ancestor
110938605|NCT03053830|Ketamine|ketamine|mesh-list
110938606|NCT03053830|Analgesics|analgesics|mesh-ancestor
110938607|NCT03053830|Sensory System Agents|sensory system agents|mesh-ancestor
110938608|NCT03053830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110938609|NCT03053830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110938610|NCT03053830|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110938611|NCT03053830|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110938612|NCT03053830|Anesthetics, General|anesthetics, general|mesh-ancestor
110938613|NCT03053830|Anesthetics|anesthetics|mesh-ancestor
110938614|NCT03053830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110938615|NCT03053830|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110938616|NCT03053830|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110938617|NCT03053830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110938618|NCT03053830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110938619|NCT04913896|Oxaliplatin|oxaliplatin|mesh-list
110938620|NCT04913896|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
110938621|NCT04913896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110938622|NCT04913896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110938623|NCT04913896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110938624|NCT03053284|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110938625|NCT03053284|Pasireotide|pasireotide|mesh-list
110938626|NCT03053284|Hormones|hormones|mesh-ancestor
110938627|NCT03053284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110938628|NCT03053284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110938629|NCT04901884|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110938630|NCT04901884|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110938631|NCT04901884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110938632|NCT04908982|Aspirin|aspirin|mesh-list
110938633|NCT04908982|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110938634|NCT04908982|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110938635|NCT04908982|Analgesics|analgesics|mesh-ancestor
110938636|NCT04908982|Sensory System Agents|sensory system agents|mesh-ancestor
110938637|NCT04908982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110938638|NCT04908982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110938639|NCT04908982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110938640|NCT04908982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110938641|NCT04908982|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110938642|NCT04908982|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110936140|NCT04927000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110936141|NCT04927000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110936142|NCT04926532|Sorafenib|sorafenib|mesh-list
110936143|NCT04926532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110936144|NCT04926532|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110936145|NCT04926532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110936146|NCT04926532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110936147|NCT03842709|Pramipexole|pramipexole|mesh-list
110936148|NCT03842709|Antioxidants|antioxidants|mesh-ancestor
110936149|NCT03842709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110936150|NCT03842709|Protective Agents|protective agents|mesh-ancestor
110936151|NCT03842709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110936152|NCT03842709|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110938643|NCT04908982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110938644|NCT04908982|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110938645|NCT04908982|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110938646|NCT04908982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110938647|NCT04908982|Antipyretics|antipyretics|mesh-ancestor
110286772|NCT00238407|Docetaxel|docetaxel|mesh-list
110938657|NCT04900948|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110938658|NCT04900948|Prednisolone|prednisolone|mesh-list
110938659|NCT04900948|Prednisolone acetate|prednisolone acetate|mesh-list
110938660|NCT04900948|Pimecrolimus|pimecrolimus|mesh-list
110938661|NCT04900948|Methylprednisolone aceponate|methylprednisolone aceponate|mesh-list
110938662|NCT04900948|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110938663|NCT04900948|Prednisolone phosphate|prednisolone phosphate|mesh-list
110938664|NCT04900948|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110938665|NCT04900948|Antiemetics|antiemetics|mesh-ancestor
110938666|NCT04900948|Autonomic Agents|autonomic agents|mesh-ancestor
110938667|NCT04900948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110938668|NCT04900948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110938669|NCT04900948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110938670|NCT04900948|Glucocorticoids|glucocorticoids|mesh-ancestor
110938671|NCT04900948|Hormones|hormones|mesh-ancestor
110938672|NCT04900948|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110938673|NCT04900948|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110938674|NCT04900948|Protective Agents|protective agents|mesh-ancestor
110938675|NCT04900948|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110938676|NCT04900948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110938677|NCT04900948|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110938678|NCT04900948|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110938679|NCT04900948|Analgesics|analgesics|mesh-ancestor
110938680|NCT04900948|Sensory System Agents|sensory system agents|mesh-ancestor
110938681|NCT04900948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110938682|NCT04900948|Dermatologic Agents|dermatologic agents|mesh-ancestor
110938683|NCT04900948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110938684|NCT04900948|Immunologic Factors|immunologic factors|mesh-ancestor
110938685|NCT04900948|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110938686|NCT04900948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110938687|NCT04900948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110938688|NCT04901104|Thymalfasin|thymalfasin|mesh-list
110938689|NCT04901104|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110938690|NCT04901104|Immunologic Factors|immunologic factors|mesh-ancestor
110938691|NCT04901104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110938692|NCT04907812|Tranexamic Acid|tranexamic acid|mesh-list
110938693|NCT04907812|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110938694|NCT04907812|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110938695|NCT04907812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110938696|NCT04907812|Hemostatics|hemostatics|mesh-ancestor
110938697|NCT04907812|Coagulants|coagulants|mesh-ancestor
110938698|NCT01889186|Venetoclax|venetoclax|mesh-list
110936153|NCT03842709|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110936154|NCT03842709|Dopamine Agonists|dopamine agonists|mesh-ancestor
110936155|NCT03842709|Dopamine Agents|dopamine agents|mesh-ancestor
110936156|NCT03842709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110936157|NCT05707533|Cefoxitin|cefoxitin|mesh-list
110936158|NCT05707533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110936159|NCT05707533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110936160|NCT03056482|Haloperidol|haloperidol|mesh-list
110936161|NCT03056482|Ondansetron|ondansetron|mesh-list
110936162|NCT03056482|Haloperidol decanoate|haloperidol decanoate|mesh-list
110936163|NCT03056482|Antiemetics|antiemetics|mesh-ancestor
110936164|NCT03056482|Autonomic Agents|autonomic agents|mesh-ancestor
110936165|NCT03056482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110936166|NCT03056482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110936167|NCT03056482|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110936168|NCT03056482|Antipruritics|antipruritics|mesh-ancestor
110936169|NCT03056482|Dermatologic Agents|dermatologic agents|mesh-ancestor
110936170|NCT03056482|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110936171|NCT03056482|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110936172|NCT03056482|Serotonin Agents|serotonin agents|mesh-ancestor
110936173|NCT03056482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110936174|NCT03056482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110936175|NCT03056482|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110936176|NCT03056482|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110936177|NCT03056482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110938699|NCT01889186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110938700|NCT04892212|Sirolimus|sirolimus|mesh-list
110938701|NCT04892212|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110938702|NCT04892212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110938703|NCT04892212|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110938704|NCT04892212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110938705|NCT04892212|Antifungal Agents|antifungal agents|mesh-ancestor
110938706|NCT04892212|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110938707|NCT04892212|Immunologic Factors|immunologic factors|mesh-ancestor
110938708|NCT04892212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110938709|NCT01510184|Rituximab|rituximab|mesh-list
110938710|NCT01510184|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110938711|NCT01510184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110938712|NCT01510184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110938713|NCT01510184|Immunologic Factors|immunologic factors|mesh-ancestor
110938714|NCT01510184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110938715|NCT01510184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110938728|NCT04906876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110938729|NCT04906876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110938730|NCT04906876|Tubulin Modulators|tubulin modulators|mesh-ancestor
110938731|NCT04906876|Antimitotic Agents|antimitotic agents|mesh-ancestor
110938732|NCT04906876|Mitosis Modulators|mitosis modulators|mesh-ancestor
110938733|NCT04891744|Thalidomide|thalidomide|mesh-list
110938734|NCT04891744|Dexamethasone|dexamethasone|mesh-list
110938735|NCT04891744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110938736|NCT04891744|Antiemetics|antiemetics|mesh-ancestor
110938737|NCT04891744|Autonomic Agents|autonomic agents|mesh-ancestor
110936178|NCT03056482|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110936179|NCT03056482|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110936180|NCT03056482|Dopamine Agents|dopamine agents|mesh-ancestor
110936181|NCT03056482|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110936182|NCT02817555|Epoetin Alfa|epoetin alfa|mesh-list
110936183|NCT02817555|Darbepoetin alfa|darbepoetin alfa|mesh-list
110936184|NCT02817555|Hematinics|hematinics|mesh-ancestor
110936185|NCT04924192|Irinotecan|irinotecan|mesh-list
110936186|NCT04924192|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110936187|NCT04924192|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110936188|NCT04924192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110936189|NCT04924192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110936190|NCT04924192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110936191|NCT02036073|Epoetin Alfa|epoetin alfa|mesh-list
110936192|NCT02036073|Hematinics|hematinics|mesh-ancestor
110936193|NCT02036229|Ivermectin|ivermectin|mesh-list
110936194|NCT02036229|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110936195|NCT02036229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110936196|NCT04922008|Capecitabine|capecitabine|mesh-list
110936197|NCT04922008|Trastuzumab|trastuzumab|mesh-list
110936198|NCT04922008|Vinorelbine|vinorelbine|mesh-list
110936199|NCT04922008|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110936200|NCT04922008|Antimetabolites|antimetabolites|mesh-ancestor
110936201|NCT04922008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110936202|NCT04922008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110936203|NCT04922008|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110936204|NCT04922008|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110936205|NCT04922008|Tubulin Modulators|tubulin modulators|mesh-ancestor
110936206|NCT04922008|Antimitotic Agents|antimitotic agents|mesh-ancestor
110936207|NCT04922008|Mitosis Modulators|mitosis modulators|mesh-ancestor
110936208|NCT03056092|Ranibizumab|ranibizumab|mesh-list
110936209|NCT03056092|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110936210|NCT03056092|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110936211|NCT03056092|Growth Substances|growth substances|mesh-ancestor
110936221|NCT04921306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110936222|NCT04921306|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110936223|NCT04921306|Autonomic Agents|autonomic agents|mesh-ancestor
110936224|NCT04921306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110936225|NCT04921306|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110936226|NCT04921306|Respiratory System Agents|respiratory system agents|mesh-ancestor
110936227|NCT04921306|Sympathomimetics|sympathomimetics|mesh-ancestor
110936228|NCT04920760|Vitamin A|vitamin a|mesh-list
110936229|NCT04920760|Vitamins|vitamins|mesh-ancestor
110936230|NCT04920760|Micronutrients|micronutrients|mesh-ancestor
110936231|NCT04920760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110936232|NCT03056248|Lithium Carbonate|lithium carbonate|mesh-list
110936233|NCT03056248|Antidepressive Agents|antidepressive agents|mesh-ancestor
110936234|NCT03056248|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110936235|NCT03056248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110936236|NCT03056248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110936237|NCT03056248|Antimanic Agents|antimanic agents|mesh-ancestor
110936238|NCT03056248|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110936239|NCT03056248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110936240|NCT03056248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110936241|NCT04920604|Anesthetics|anesthetics|mesh-list
110936242|NCT04920604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110936243|NCT04920604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110936244|NCT04920448|Acetylcysteine|acetylcysteine|mesh-list
110936245|NCT04920448|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110936246|NCT04920448|Antiviral Agents|antiviral agents|mesh-ancestor
110936247|NCT04920448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110936248|NCT04920448|Expectorants|expectorants|mesh-ancestor
110936249|NCT04920448|Respiratory System Agents|respiratory system agents|mesh-ancestor
110938738|NCT04891744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110938739|NCT04891744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110938740|NCT04891744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110938741|NCT04891744|Glucocorticoids|glucocorticoids|mesh-ancestor
110938742|NCT04891744|Hormones|hormones|mesh-ancestor
110938743|NCT04891744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110938744|NCT04891744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110938745|NCT04891744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110938746|NCT04891744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110938747|NCT04891744|Immunologic Factors|immunologic factors|mesh-ancestor
110938748|NCT04891744|Leprostatic Agents|leprostatic agents|mesh-ancestor
110938749|NCT04891744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110938750|NCT04891744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110938751|NCT04891744|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110938752|NCT04891744|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110938753|NCT04891744|Growth Substances|growth substances|mesh-ancestor
110938754|NCT04891744|Growth Inhibitors|growth inhibitors|mesh-ancestor
110936250|NCT04920448|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110936251|NCT04920448|Antioxidants|antioxidants|mesh-ancestor
110936252|NCT04920448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110936253|NCT04920448|Protective Agents|protective agents|mesh-ancestor
110936254|NCT04920448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110936255|NCT04920448|Antidotes|antidotes|mesh-ancestor
110936256|NCT04969354|Immunomodulating Agents|immunomodulating agents|mesh-list
110936257|NCT04969354|Immunologic Factors|immunologic factors|mesh-ancestor
110936258|NCT04969354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110936259|NCT03061006|Warfarin|warfarin|mesh-list
110936260|NCT03061006|Dabigatran|dabigatran|mesh-list
110936261|NCT03061006|Anticoagulants|anticoagulants|mesh-ancestor
110936262|NCT03061006|Antithrombins|antithrombins|mesh-ancestor
110936263|NCT03061006|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110936264|NCT03061006|Protease Inhibitors|protease inhibitors|mesh-ancestor
110938755|NCT04891900|Capecitabine|capecitabine|mesh-list
110938756|NCT04891900|Oxaliplatin|oxaliplatin|mesh-list
110249512|NCT00502567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110938757|NCT04891900|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
110938758|NCT04891900|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110938759|NCT04891900|Antimetabolites|antimetabolites|mesh-ancestor
110938760|NCT04891900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110938761|NCT04891900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110938762|NCT04891900|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110938763|NCT04891588|Timolol|timolol|mesh-list
110938764|NCT04891588|Latanoprost|latanoprost|mesh-list
110938765|NCT04891588|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110938766|NCT04891588|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110938767|NCT04891588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110938768|NCT04891588|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110938769|NCT04891588|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110938770|NCT04891588|Adrenergic Agents|adrenergic agents|mesh-ancestor
110938771|NCT04891588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110938772|NCT04891588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110938773|NCT04891588|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110938774|NCT04891588|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110938775|NCT03050866|Antiemetics|antiemetics|mesh-list
110938776|NCT03050866|Histamine|histamine|mesh-list
110938777|NCT03050866|Histamine Antagonists|histamine antagonists|mesh-list
110938778|NCT03050866|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
110938779|NCT03050866|Histamine Agonists|histamine agonists|mesh-ancestor
110938780|NCT03050866|Histamine Agents|histamine agents|mesh-ancestor
110938784|NCT03050866|Autonomic Agents|autonomic agents|mesh-ancestor
110938785|NCT03050866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110938786|NCT03050866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110938787|NCT03052660|Midazolam|midazolam|mesh-list
110938788|NCT03052660|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110938789|NCT03052660|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110938790|NCT03052660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110938791|NCT03052660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110938792|NCT03052660|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110938793|NCT03052660|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110938794|NCT03052660|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110938795|NCT03052660|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110938796|NCT03052660|Anesthetics, General|anesthetics, general|mesh-ancestor
110938797|NCT03052660|Anesthetics|anesthetics|mesh-ancestor
110938798|NCT03052660|GABA Modulators|gaba modulators|mesh-ancestor
110938799|NCT03052660|GABA Agents|gaba agents|mesh-ancestor
110938800|NCT03052660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110938801|NCT03052660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110938802|NCT05162456|Antibodies|antibodies|mesh-list
110938803|NCT05162456|Immunoglobulins|immunoglobulins|mesh-list
110938804|NCT05162456|Immunoglobulin G|immunoglobulin g|mesh-list
110938805|NCT05162456|Immunologic Factors|immunologic factors|mesh-ancestor
110936265|NCT03061006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110936266|NCT03061006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110936267|NCT03060850|Abivertinib|abivertinib|mesh-list
110936268|NCT03060850|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110936269|NCT03060850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110936270|NCT03060850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110936271|NCT04432558|Acetaminophen|acetaminophen|mesh-list
110936272|NCT04432558|Diclofenac|diclofenac|mesh-list
110936273|NCT04432558|Tramadol|tramadol|mesh-list
110936274|NCT04432558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110936275|NCT04432558|Analgesics|analgesics|mesh-ancestor
110936276|NCT04432558|Sensory System Agents|sensory system agents|mesh-ancestor
110936277|NCT04432558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110936278|NCT04432558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110936279|NCT04432558|Antipyretics|antipyretics|mesh-ancestor
110936280|NCT04432558|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110936281|NCT04432558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110936282|NCT04432558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110936283|NCT04432558|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110936284|NCT04432558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110936285|NCT04432558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110936286|NCT04432558|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110936287|NCT04432558|Narcotics|narcotics|mesh-ancestor
110936288|NCT04432558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110936289|NCT04979650|Methylprednisolone|methylprednisolone|mesh-list
110936290|NCT04979650|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110936291|NCT04979650|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110936292|NCT04979650|Prednisolone|prednisolone|mesh-list
110936293|NCT04979650|Prednisolone acetate|prednisolone acetate|mesh-list
110936294|NCT04979650|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110936295|NCT04979650|Prednisolone phosphate|prednisolone phosphate|mesh-list
110936296|NCT04979650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110284498|NCT00231348|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110938806|NCT05162456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110938807|NCT05137886|Decitabine|decitabine|mesh-list
110938808|NCT05137886|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
110938809|NCT05137886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110938810|NCT05137886|Antimetabolites|antimetabolites|mesh-ancestor
110938811|NCT05137886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110938812|NCT05137886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110938813|NCT05137886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110936297|NCT04979650|Antiemetics|antiemetics|mesh-ancestor
110936298|NCT04979650|Autonomic Agents|autonomic agents|mesh-ancestor
110936299|NCT04979650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110936300|NCT04979650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110936301|NCT04979650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110936302|NCT04979650|Glucocorticoids|glucocorticoids|mesh-ancestor
110936303|NCT04979650|Hormones|hormones|mesh-ancestor
110936304|NCT04979650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110936305|NCT04979650|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110936306|NCT04979650|Protective Agents|protective agents|mesh-ancestor
110936307|NCT04979650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110936308|NCT04979650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110936309|NCT04650152|Fenofibrate|fenofibrate|mesh-list
110936310|NCT04650152|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110936311|NCT04650152|Antimetabolites|antimetabolites|mesh-ancestor
110936312|NCT04650152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110936313|NCT04650152|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110936314|NCT04967950|Methotrexate|methotrexate|mesh-list
110936315|NCT04967950|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110936316|NCT04967950|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110936317|NCT04967950|Abortifacient Agents|abortifacient agents|mesh-ancestor
110936318|NCT04967950|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110936319|NCT04967950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110936320|NCT04967950|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110936321|NCT04967950|Antimetabolites|antimetabolites|mesh-ancestor
110936322|NCT04967950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110936323|NCT04967950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110936324|NCT04967950|Dermatologic Agents|dermatologic agents|mesh-ancestor
110936325|NCT04967950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110936326|NCT04967950|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110936327|NCT04967950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110936328|NCT04967950|Immunologic Factors|immunologic factors|mesh-ancestor
110936329|NCT04967950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110938814|NCT05137886|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110938815|NCT04890418|Ketamine|ketamine|mesh-list
110938816|NCT04890418|Analgesics|analgesics|mesh-ancestor
110938817|NCT04890418|Sensory System Agents|sensory system agents|mesh-ancestor
110938818|NCT04890418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110938819|NCT04890418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110938820|NCT04890418|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110936330|NCT04967950|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110936332|NCT04967326|Phenytoin|phenytoin|mesh-list
110936333|NCT04967326|Valproic Acid|valproic acid|mesh-list
110936334|NCT04967326|Anticonvulsants|anticonvulsants|mesh-list
110936335|NCT04967326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110936336|NCT04967326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110936338|NCT04967326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110936339|NCT04967326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110936340|NCT04967326|Antimanic Agents|antimanic agents|mesh-ancestor
110936341|NCT04967326|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110936342|NCT04967326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110936343|NCT04967326|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110936344|NCT04967326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110936345|NCT04967326|Analgesics|analgesics|mesh-ancestor
110936346|NCT04967326|Sensory System Agents|sensory system agents|mesh-ancestor
110936347|NCT04967326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110938821|NCT04890418|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110938822|NCT04890418|Anesthetics, General|anesthetics, general|mesh-ancestor
110938823|NCT04890418|Anesthetics|anesthetics|mesh-ancestor
110938824|NCT04890418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110938825|NCT04890418|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110938826|NCT04890418|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110938827|NCT04890418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110938828|NCT04890418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110938829|NCT04455932|Liver Extracts|liver extracts|mesh-list
110938830|NCT04455932|Hematinics|hematinics|mesh-ancestor
110938831|NCT03051022|Dexamethasone|dexamethasone|mesh-list
110938832|NCT03051022|Morphine|morphine|mesh-list
110938833|NCT03051022|Bupivacaine|bupivacaine|mesh-list
110938834|NCT03051022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110938835|NCT03051022|Antiemetics|antiemetics|mesh-ancestor
110938836|NCT03051022|Autonomic Agents|autonomic agents|mesh-ancestor
110938837|NCT03051022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110938838|NCT03051022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110938839|NCT03051022|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110938840|NCT03051022|Glucocorticoids|glucocorticoids|mesh-ancestor
110938841|NCT03051022|Hormones|hormones|mesh-ancestor
110938842|NCT03051022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110938843|NCT03051022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110938844|NCT03051022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110938845|NCT03051022|Anesthetics, Local|anesthetics, local|mesh-ancestor
110938846|NCT03051022|Anesthetics|anesthetics|mesh-ancestor
110938847|NCT03051022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110938848|NCT03051022|Sensory System Agents|sensory system agents|mesh-ancestor
110938849|NCT03051022|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110938850|NCT03051022|Narcotics|narcotics|mesh-ancestor
110938851|NCT03051022|Analgesics|analgesics|mesh-ancestor
110938852|NCT04648826|Azacitidine|azacitidine|mesh-list
110286970|NCT05425654|Antimetabolites|antimetabolites|mesh-ancestor
110938861|NCT03052348|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
110938862|NCT03052348|Betamethasone benzoate|betamethasone benzoate|mesh-list
110938863|NCT03052348|Ether|ether|mesh-list
110938864|NCT03052348|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
110938865|NCT03052348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110938866|NCT03052348|Glucocorticoids|glucocorticoids|mesh-ancestor
110938867|NCT03052348|Hormones|hormones|mesh-ancestor
110938868|NCT03052348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110938869|NCT03052348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110936348|NCT04967326|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110936349|NCT04967326|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110936350|NCT04967326|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110936351|NCT04967326|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110936352|NCT04967326|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110936353|NCT04967326|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110936354|NCT03062176|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
110936355|NCT03062176|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110936356|NCT02620384|Metolazone|metolazone|mesh-list
110936357|NCT02620384|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110936358|NCT02620384|Diuretics|diuretics|mesh-ancestor
110936359|NCT02620384|Natriuretic Agents|natriuretic agents|mesh-ancestor
110936360|NCT02620384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110936361|NCT02620384|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110936362|NCT02620384|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110936363|NCT02620384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110936364|NCT04918576|Tranexamic Acid|tranexamic acid|mesh-list
110938870|NCT03052348|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110938871|NCT03052348|Respiratory System Agents|respiratory system agents|mesh-ancestor
110938872|NCT03052348|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110938873|NCT03052348|Anesthetics, General|anesthetics, general|mesh-ancestor
110938874|NCT03052348|Anesthetics|anesthetics|mesh-ancestor
110938875|NCT03052348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110938876|NCT03052348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110938877|NCT03052348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110938878|NCT03052348|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110938879|NCT03052348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110938880|NCT03052348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110938881|NCT03963518|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
110938882|NCT03963518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110938883|NCT03963518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110938884|NCT03963518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110938885|NCT04101890|Zinc Oxide|zinc oxide|mesh-list
110938886|NCT04101890|Dermatologic Agents|dermatologic agents|mesh-ancestor
110938887|NCT04101890|Sunscreening Agents|sunscreening agents|mesh-ancestor
110938888|NCT04101890|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110938889|NCT04101890|Protective Agents|protective agents|mesh-ancestor
110938890|NCT04101890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110938891|NCT04456712|Ciprofloxacin|ciprofloxacin|mesh-list
110938893|NCT04456712|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110938894|NCT04456712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110938895|NCT04456712|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110938896|NCT04456712|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110938897|NCT04456712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110938898|NCT04456712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110938899|NCT04456712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110938900|NCT04456712|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110938901|NCT04456712|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110938902|NCT04456712|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110938903|NCT04884490|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
110938904|NCT04884490|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110938905|NCT04884490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110936365|NCT04918576|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110936366|NCT04918576|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110936367|NCT04918576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110936368|NCT04918576|Hemostatics|hemostatics|mesh-ancestor
110936369|NCT04918576|Coagulants|coagulants|mesh-ancestor
110936370|NCT03472508|Folic Acid|folic acid|mesh-list
110936371|NCT03472508|Vitamin B Complex|vitamin b complex|mesh-list
110936372|NCT03472508|Enalapril|enalapril|mesh-list
110936373|NCT03472508|Enalaprilat|enalaprilat|mesh-list
110936374|NCT03472508|Hematinics|hematinics|mesh-ancestor
110936375|NCT03472508|Vitamins|vitamins|mesh-ancestor
110936376|NCT03472508|Micronutrients|micronutrients|mesh-ancestor
110936377|NCT03472508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110936378|NCT03472508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110936379|NCT03472508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110936380|NCT03472508|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110936381|NCT03472508|Protease Inhibitors|protease inhibitors|mesh-ancestor
110936382|NCT03472508|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110936383|NCT04966234|Posaconazole|posaconazole|mesh-list
110936384|NCT04966234|Antifungal Agents|antifungal agents|mesh-ancestor
110936385|NCT04966234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110936386|NCT04966234|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
110936387|NCT04966234|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110936388|NCT04966234|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110936389|NCT04966234|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110938906|NCT04884490|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110938907|NCT04884490|Antimalarials|antimalarials|mesh-ancestor
110938908|NCT04884490|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110938909|NCT04884490|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110938910|NCT04854434|Trifluridine|trifluridine|mesh-list
110938911|NCT04854434|Pembrolizumab|pembrolizumab|mesh-list
110938912|NCT04854434|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110938913|NCT04854434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110938914|NCT04854434|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110938915|NCT04854434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110938916|NCT04854434|Antimetabolites|antimetabolites|mesh-ancestor
110938917|NCT04854434|Antiviral Agents|antiviral agents|mesh-ancestor
110938918|NCT04854434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110938932|NCT04456088|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
110938933|NCT04456088|Vasodilator Agents|vasodilator agents|mesh-ancestor
110938934|NCT04456088|Gasotransmitters|gasotransmitters|mesh-ancestor
110938935|NCT04456088|Protective Agents|protective agents|mesh-ancestor
110938936|NCT04454840|Riluzole|riluzole|mesh-list
110938937|NCT04454840|Anticonvulsants|anticonvulsants|mesh-ancestor
110938938|NCT04454840|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110938939|NCT04454840|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110938940|NCT04454840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110938941|NCT04454840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110938942|NCT04454840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110938943|NCT04454840|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110938944|NCT04454840|Protective Agents|protective agents|mesh-ancestor
110938945|NCT03050710|Lidocaine|lidocaine|mesh-list
110936390|NCT04966234|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110936392|NCT04966234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110936393|NCT04966234|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110936394|NCT04966234|Hormone Antagonists|hormone antagonists|mesh-ancestor
110936395|NCT04966234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110936396|NCT04966234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110936397|NCT03915860|Trifarotene|trifarotene|mesh-list
110936398|NCT03915860|Dermatologic Agents|dermatologic agents|mesh-ancestor
110936399|NCT04170998|Metformin|metformin|mesh-list
110936400|NCT04170998|Dapagliflozin|dapagliflozin|mesh-list
110936401|NCT04170998|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110936402|NCT04170998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110936403|NCT04170998|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110936404|NCT04170998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110936405|NCT04965532|Anesthetics|anesthetics|mesh-list
110936406|NCT04965532|Propofol|propofol|mesh-list
110938946|NCT03050710|Anesthetics, Local|anesthetics, local|mesh-ancestor
110938947|NCT03050710|Anesthetics|anesthetics|mesh-ancestor
110938948|NCT03050710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110938949|NCT03050710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110938950|NCT03050710|Sensory System Agents|sensory system agents|mesh-ancestor
110938951|NCT03050710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110938952|NCT03050710|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110938953|NCT03050710|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110938954|NCT03050710|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110938955|NCT03050710|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110938956|NCT03050710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110938957|NCT03051568|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110938958|NCT03051568|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110938959|NCT03051568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110938960|NCT03993314|Bupivacaine|bupivacaine|mesh-list
110938961|NCT03993314|Chloroprocaine|chloroprocaine|mesh-list
110938962|NCT03993314|Anesthetics, Local|anesthetics, local|mesh-ancestor
110938963|NCT03993314|Anesthetics|anesthetics|mesh-ancestor
110656482|NCT00429364|Losartan|losartan|mesh-list
110938964|NCT03993314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110938965|NCT03993314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110938966|NCT03993314|Sensory System Agents|sensory system agents|mesh-ancestor
110938967|NCT03993314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110938969|NCT04883164|Immunologic Factors|immunologic factors|mesh-ancestor
110938970|NCT04883164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110938971|NCT03161054|Prednisone|prednisone|mesh-list
110938972|NCT03161054|Cyclophosphamide|cyclophosphamide|mesh-list
110938973|NCT03161054|Rituximab|rituximab|mesh-list
110938974|NCT03161054|Etoposide|etoposide|mesh-list
110938975|NCT03161054|Vinorelbine|vinorelbine|mesh-list
110938976|NCT03161054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110938977|NCT03161054|Immunologic Factors|immunologic factors|mesh-ancestor
110938978|NCT03161054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110938979|NCT03161054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110287116|NCT00211952|Celecoxib|celecoxib|mesh-list
110938984|NCT03161054|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110938985|NCT03161054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110938986|NCT03161054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110938988|NCT03161054|Hormones|hormones|mesh-ancestor
110936407|NCT04965532|Sevoflurane|sevoflurane|mesh-list
110936408|NCT04965532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110653942|NCT03952650|Ibuprofen|ibuprofen|mesh-list
110936409|NCT04965532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110936410|NCT04965532|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110936411|NCT04965532|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110936412|NCT04965532|Anesthetics, General|anesthetics, general|mesh-ancestor
110936413|NCT04965532|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110936414|NCT04965532|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110936415|NCT03055546|Oxytocin|oxytocin|mesh-list
110936416|NCT03055546|Oxytocics|oxytocics|mesh-ancestor
110936417|NCT03055546|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110936418|NCT03055546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110936419|NCT04918264|Capecitabine|capecitabine|mesh-list
110936420|NCT04918264|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110936421|NCT04918264|Antimetabolites|antimetabolites|mesh-ancestor
110936422|NCT04918264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110936423|NCT04918264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110936424|NCT04917718|Tacrolimus|tacrolimus|mesh-list
110936425|NCT04917718|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110936426|NCT04917718|Immunologic Factors|immunologic factors|mesh-ancestor
110936427|NCT04917718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110284652|NCT00199004|Antiemetics|antiemetics|mesh-ancestor
110938989|NCT03161054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110938990|NCT03161054|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110938991|NCT03161054|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110938992|NCT03161054|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110938993|NCT03161054|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110938994|NCT03161054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110938995|NCT03161054|Tubulin Modulators|tubulin modulators|mesh-ancestor
110938996|NCT03161054|Antimitotic Agents|antimitotic agents|mesh-ancestor
110938997|NCT03161054|Mitosis Modulators|mitosis modulators|mesh-ancestor
110938998|NCT03050554|Avelumab|avelumab|mesh-list
110938999|NCT03050554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110939000|NCT03050554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110939001|NCT03050164|Gefitinib|gefitinib|mesh-list
110939002|NCT03050164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110939003|NCT03050164|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110939004|NCT03050164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110939005|NCT03050164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110939006|NCT03049930|Ketamine|ketamine|mesh-list
110939007|NCT03049930|Analgesics|analgesics|mesh-ancestor
110939008|NCT03049930|Sensory System Agents|sensory system agents|mesh-ancestor
110939009|NCT03049930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110939010|NCT03049930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110939011|NCT03049930|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110939012|NCT03049930|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110939013|NCT03049930|Anesthetics, General|anesthetics, general|mesh-ancestor
110939014|NCT03049930|Anesthetics|anesthetics|mesh-ancestor
110939015|NCT03049930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110939016|NCT03049930|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110939017|NCT03049930|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110936428|NCT04917718|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110936429|NCT04917718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110936430|NCT04917718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110936431|NCT06016556|Ritonavir|ritonavir|mesh-list
110936432|NCT06016556|Nirmatrelvir|nirmatrelvir|mesh-list
110936433|NCT06016556|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
110936434|NCT06016556|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110936435|NCT06016556|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110936436|NCT06016556|Protease Inhibitors|protease inhibitors|mesh-ancestor
110936437|NCT06016556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110284679|NCT00228852|Busulfan|busulfan|mesh-list
110939018|NCT03049930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110939019|NCT03049930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110939020|NCT02036463|Prednisone|prednisone|mesh-list
110939021|NCT02036463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110939022|NCT02036463|Glucocorticoids|glucocorticoids|mesh-ancestor
110939023|NCT02036463|Hormones|hormones|mesh-ancestor
110939024|NCT02036463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110939025|NCT02036463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110939026|NCT02036463|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110939027|NCT02036463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110939028|NCT04887844|Betamethasone dipropionate, betamethasone sodium phosphate drug combination|betamethasone dipropionate, betamethasone sodium phosphate drug combination|mesh-list
110939029|NCT04887844|Lidocaine|lidocaine|mesh-list
110939030|NCT04887844|Anesthetics, Local|anesthetics, local|mesh-ancestor
110939031|NCT04887844|Anesthetics|anesthetics|mesh-ancestor
110249540|NCT00502684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110939032|NCT04887844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110939033|NCT04887844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110939034|NCT04887844|Sensory System Agents|sensory system agents|mesh-ancestor
110939035|NCT04887844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110939036|NCT04887844|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110939037|NCT04887844|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110939038|NCT04887844|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110939039|NCT04887844|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110939040|NCT04887844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110939041|NCT04887844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110939043|NCT04887844|Hormones|hormones|mesh-ancestor
110939044|NCT04887844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110939045|NCT02595320|Capecitabine|capecitabine|mesh-list
110939046|NCT02595320|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110939052|NCT02809053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110939053|NCT02809053|Immunologic Factors|immunologic factors|mesh-ancestor
110939054|NCT02809053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110939055|NCT02809053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110939056|NCT04666688|Paclitaxel|paclitaxel|mesh-list
110939057|NCT04666688|Gemcitabine|gemcitabine|mesh-list
110939058|NCT04666688|Tislelizumab|tislelizumab|mesh-list
110939059|NCT04666688|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110939060|NCT04666688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110939061|NCT04666688|Tubulin Modulators|tubulin modulators|mesh-ancestor
110939062|NCT04666688|Antimitotic Agents|antimitotic agents|mesh-ancestor
110939063|NCT04666688|Mitosis Modulators|mitosis modulators|mesh-ancestor
110939064|NCT04666688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110939065|NCT04666688|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110939066|NCT04666688|Antimetabolites|antimetabolites|mesh-ancestor
110939067|NCT04666688|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110939068|NCT03462290|Botulinum Toxins|botulinum toxins|mesh-list
110939069|NCT03462290|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110939070|NCT03462290|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110939071|NCT03462290|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110939072|NCT03462290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110939073|NCT03462290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110936438|NCT06016556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110936439|NCT06016556|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110936440|NCT06016556|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110936441|NCT06016556|Antiviral Agents|antiviral agents|mesh-ancestor
110936442|NCT06016556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110936443|NCT06016556|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110936444|NCT06016556|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110936445|NCT06016530|Dexamethasone|dexamethasone|mesh-list
110936446|NCT06016530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110936447|NCT06016530|Antiemetics|antiemetics|mesh-ancestor
110936448|NCT06016530|Autonomic Agents|autonomic agents|mesh-ancestor
110936449|NCT06016530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110936450|NCT06016530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110939074|NCT03462290|Cholinergic Agents|cholinergic agents|mesh-ancestor
110939075|NCT03462290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110939076|NCT03462290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110939077|NCT03462290|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110939078|NCT03462290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110939079|NCT02047539|Aspirin|aspirin|mesh-list
110939080|NCT02047539|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110939081|NCT02047539|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110939082|NCT02047539|Analgesics|analgesics|mesh-ancestor
110939083|NCT02047539|Sensory System Agents|sensory system agents|mesh-ancestor
110939084|NCT02047539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110939085|NCT02047539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110939086|NCT02047539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110939087|NCT02047539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110939088|NCT02047539|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110249546|NCT00502762|Topotecan|topotecan|mesh-list
110939089|NCT02047539|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110939090|NCT02047539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110939091|NCT02047539|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110939092|NCT02047539|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110939093|NCT02047539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110939094|NCT02047539|Antipyretics|antipyretics|mesh-ancestor
110939095|NCT02522858|Atropine|atropine|mesh-list
110939096|NCT02522858|Ephedrine|ephedrine|mesh-list
110939097|NCT02522858|Dexmedetomidine|dexmedetomidine|mesh-list
110939098|NCT02522858|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110939099|NCT02522858|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110939100|NCT02522858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110939101|NCT02522858|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110939102|NCT02522858|Analgesics|analgesics|mesh-ancestor
110939103|NCT02522858|Sensory System Agents|sensory system agents|mesh-ancestor
110939104|NCT02522858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110939105|NCT02522858|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110939106|NCT02522858|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110939107|NCT02522858|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110939108|NCT02522858|Adrenergic Agents|adrenergic agents|mesh-ancestor
110939109|NCT02522858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110939110|NCT02522858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110939111|NCT02522858|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110939112|NCT02522858|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110939113|NCT02522858|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110939114|NCT02522858|Autonomic Agents|autonomic agents|mesh-ancestor
110939115|NCT02522858|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110939125|NCT02036697|Fentanyl|fentanyl|mesh-list
110939126|NCT02036697|Morphine|morphine|mesh-list
110939127|NCT02036697|Bupivacaine|bupivacaine|mesh-list
110939128|NCT02036697|Anesthetics, Local|anesthetics, local|mesh-ancestor
110939129|NCT02036697|Anesthetics|anesthetics|mesh-ancestor
110939130|NCT02036697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110936451|NCT06016530|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110936452|NCT06016530|Glucocorticoids|glucocorticoids|mesh-ancestor
110936453|NCT06016530|Hormones|hormones|mesh-ancestor
110936454|NCT06016530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110936455|NCT06016530|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110936456|NCT06016530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110936457|NCT06016517|Adalimumab|adalimumab|mesh-list
110936458|NCT06016517|Upadacitinib|upadacitinib|mesh-list
110936459|NCT06016517|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110936460|NCT06016517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110936461|NCT06016517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110936462|NCT06016517|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
110939131|NCT02036697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110939132|NCT02036697|Sensory System Agents|sensory system agents|mesh-ancestor
110939133|NCT02036697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110939134|NCT02036697|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110939135|NCT02036697|Narcotics|narcotics|mesh-ancestor
110939136|NCT02036697|Analgesics|analgesics|mesh-ancestor
110939137|NCT02036697|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110939138|NCT02036697|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110939139|NCT02036697|Anesthetics, General|anesthetics, general|mesh-ancestor
110939140|NCT04882462|Nimotuzumab|nimotuzumab|mesh-list
110939141|NCT04882462|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110939142|NCT04882462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110939143|NCT03106688|Carfentanil|carfentanil|mesh-list
110939144|NCT03106688|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110939145|NCT03106688|Narcotics|narcotics|mesh-ancestor
110939146|NCT03106688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110939147|NCT03106688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110939148|NCT03106688|Analgesics|analgesics|mesh-ancestor
110939149|NCT03106688|Sensory System Agents|sensory system agents|mesh-ancestor
110939150|NCT03106688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110939151|NCT02037009|Anesthetics|anesthetics|mesh-list
110939152|NCT02037009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110939153|NCT02037009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110939154|NCT02260011|Bromides|bromides|mesh-list
110939155|NCT02260011|Norflurane|norflurane|mesh-list
110939156|NCT02260011|Ipratropium|ipratropium|mesh-list
110939157|NCT02260011|Anticonvulsants|anticonvulsants|mesh-ancestor
110939158|NCT02260011|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110939159|NCT02260011|Autonomic Agents|autonomic agents|mesh-ancestor
110939160|NCT02260011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110939161|NCT02260011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110939162|NCT02260011|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110939163|NCT02260011|Respiratory System Agents|respiratory system agents|mesh-ancestor
110939164|NCT02260011|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110939165|NCT02260011|Cholinergic Agents|cholinergic agents|mesh-ancestor
110939166|NCT02260011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110939167|NCT02260011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110939168|NCT02260011|Anesthetics|anesthetics|mesh-ancestor
110939169|NCT02260011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110939170|NCT02047773|Meropenem|meropenem|mesh-list
110939171|NCT02047773|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110939172|NCT02047773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110939173|NCT04886752|Vitamins|vitamins|mesh-list
110939174|NCT04886752|Ascorbic Acid|ascorbic acid|mesh-list
110939175|NCT04886752|Vitamin B Complex|vitamin b complex|mesh-list
110939176|NCT04886752|Micronutrients|micronutrients|mesh-ancestor
110939177|NCT04886752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110939178|NCT04886752|Antioxidants|antioxidants|mesh-ancestor
110939179|NCT04886752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110939180|NCT04886752|Protective Agents|protective agents|mesh-ancestor
110939181|NCT04895800|Caffeine|caffeine|mesh-list
110939182|NCT04895800|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110936463|NCT06016517|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110936464|NCT06016517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110936465|NCT06016517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110936478|NCT06016413|Paclitaxel|paclitaxel|mesh-list
110936479|NCT06016413|Carboplatin|carboplatin|mesh-list
110936480|NCT06016413|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110939183|NCT04895800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110939184|NCT04895800|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110939191|NCT04886362|Ivermectin|ivermectin|mesh-list
110939192|NCT04886362|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110939193|NCT04886362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110939194|NCT02048007|Azithromycin|azithromycin|mesh-list
110939195|NCT02048007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110939196|NCT02048007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110939197|NCT02048085|Clopidogrel|clopidogrel|mesh-list
110939198|NCT02048085|Ticagrelor|ticagrelor|mesh-list
110939199|NCT02048085|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110939200|NCT02048085|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110939201|NCT02048085|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110939202|NCT02048085|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110939203|NCT02048085|Purinergic Agents|purinergic agents|mesh-ancestor
110939204|NCT02048085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110939205|NCT02048085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110939206|NCT02048085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110939207|NCT02808975|Adalimumab|adalimumab|mesh-list
110939208|NCT02808975|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110939209|NCT02808975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110939210|NCT02808975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110939211|NCT04885894|Ozanimod|ozanimod|mesh-list
110939212|NCT04885894|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
110939213|NCT04885894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110939214|NCT04885894|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110939215|NCT04885894|Immunologic Factors|immunologic factors|mesh-ancestor
110939216|NCT04885894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110939217|NCT04885660|Lisinopril|lisinopril|mesh-list
110939218|NCT04885660|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110939219|NCT04885660|Protease Inhibitors|protease inhibitors|mesh-ancestor
110939220|NCT04885660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110939221|NCT04885660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110939222|NCT04885660|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110939223|NCT04885660|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110939224|NCT04885660|Protective Agents|protective agents|mesh-ancestor
110939225|NCT04885660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110939226|NCT02037633|Fentanyl|fentanyl|mesh-list
110939227|NCT02037633|Ropivacaine|ropivacaine|mesh-list
110939228|NCT02037633|Anesthetics, Local|anesthetics, local|mesh-ancestor
110939229|NCT02037633|Anesthetics|anesthetics|mesh-ancestor
110939230|NCT02037633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110939231|NCT02037633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110939232|NCT02037633|Sensory System Agents|sensory system agents|mesh-ancestor
110939233|NCT02037633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110939234|NCT02037633|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110939235|NCT02037633|Narcotics|narcotics|mesh-ancestor
110939236|NCT02037633|Analgesics|analgesics|mesh-ancestor
110939237|NCT02037633|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110939238|NCT02037633|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110936481|NCT06016413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110936482|NCT06016413|Tubulin Modulators|tubulin modulators|mesh-ancestor
110654014|NCT00956150|Rifaximin|rifaximin|mesh-list
110936484|NCT06016413|Mitosis Modulators|mitosis modulators|mesh-ancestor
110936485|NCT06016413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110936486|NCT06016400|Alfacalcidol|alfacalcidol|mesh-list
110936487|NCT06016400|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
110936488|NCT06016400|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110936489|NCT06016400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110936490|NCT06016400|Vitamins|vitamins|mesh-ancestor
110936491|NCT06016400|Micronutrients|micronutrients|mesh-ancestor
110936492|NCT06016387|Capecitabine|capecitabine|mesh-list
110936493|NCT06016387|Trastuzumab|trastuzumab|mesh-list
110936494|NCT06016387|Tucatinib|tucatinib|mesh-list
110939239|NCT02037633|Anesthetics, General|anesthetics, general|mesh-ancestor
110939240|NCT05684211|Cetuximab|cetuximab|mesh-list
110939241|NCT05684211|Antibodies|antibodies|mesh-list
110939242|NCT05684211|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110939243|NCT05684211|Immunologic Factors|immunologic factors|mesh-ancestor
110939244|NCT05684211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110939245|NCT05684211|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110939246|NCT05684211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110939247|NCT03130634|Silymarin|silymarin|mesh-list
110939248|NCT03130634|Antioxidants|antioxidants|mesh-ancestor
110939249|NCT03130634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110939250|NCT03130634|Protective Agents|protective agents|mesh-ancestor
110939251|NCT03130634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110939252|NCT02124824|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
110939253|NCT02124824|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110939254|NCT02124824|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
110939267|NCT03050242|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110939268|NCT03050242|Cholinergic Agents|cholinergic agents|mesh-ancestor
110939269|NCT03050242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110939270|NCT03050242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110939271|NCT03050242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110939272|NCT04894630|Anti-Infective Agents|anti-infective agents|mesh-list
110939273|NCT04894630|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110939274|NCT04885270|Cisplatin|cisplatin|mesh-list
110939275|NCT04885270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110939276|NCT04885426|Metformin|metformin|mesh-list
110939277|NCT04885426|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110939278|NCT04885426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110939279|NCT02808819|Benralizumab|benralizumab|mesh-list
110939280|NCT02808819|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110939281|NCT02808819|Respiratory System Agents|respiratory system agents|mesh-ancestor
110939282|NCT04872244|Levonorgestrel|levonorgestrel|mesh-list
110939283|NCT04872244|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110939284|NCT04872244|Contraceptive Agents|contraceptive agents|mesh-ancestor
110939285|NCT04872244|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110939286|NCT04872244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110939287|NCT04872244|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110939288|NCT04872244|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110939289|NCT04872244|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110939290|NCT04872322|Ropivacaine|ropivacaine|mesh-list
110939291|NCT04872322|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110939292|NCT04872322|Anesthetics, Local|anesthetics, local|mesh-ancestor
110939293|NCT04872322|Anesthetics|anesthetics|mesh-ancestor
110939294|NCT04872322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110939295|NCT04872322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110939296|NCT04872322|Sensory System Agents|sensory system agents|mesh-ancestor
110939297|NCT04872322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110939298|NCT04879030|Moxifloxacin|moxifloxacin|mesh-list
110939299|NCT04879030|Ciprofloxacin|ciprofloxacin|mesh-list
110939300|NCT04879030|Levofloxacin|levofloxacin|mesh-list
110936495|NCT06016387|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110936496|NCT06016387|Antimetabolites|antimetabolites|mesh-ancestor
110936497|NCT06016387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110936498|NCT06016387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110936499|NCT06016387|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110936500|NCT06016387|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110936501|NCT06016387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110936502|NCT06016270|Paclitaxel|paclitaxel|mesh-list
110936503|NCT06016270|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110936504|NCT06016270|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110936505|NCT06016270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110936506|NCT06016270|Tubulin Modulators|tubulin modulators|mesh-ancestor
110936507|NCT06016270|Antimitotic Agents|antimitotic agents|mesh-ancestor
110936508|NCT06016270|Mitosis Modulators|mitosis modulators|mesh-ancestor
110936509|NCT06016270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110936510|NCT06016088|Tobramycin|tobramycin|mesh-list
110936511|NCT06016088|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110936512|NCT06016088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110936513|NCT06015828|Lactoferrin|lactoferrin|mesh-list
110936514|NCT06015828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110936515|NCT06015750|Folic Acid|folic acid|mesh-list
110936516|NCT06015750|Rituximab|rituximab|mesh-list
110936517|NCT06015750|Methotrexate|methotrexate|mesh-list
110936518|NCT06015750|Bortezomib|bortezomib|mesh-list
110936519|NCT06015750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110936520|NCT06015750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110936521|NCT06015750|Immunologic Factors|immunologic factors|mesh-ancestor
110936522|NCT06015750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110936523|NCT06015750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110936524|NCT06015750|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110936525|NCT06015750|Abortifacient Agents|abortifacient agents|mesh-ancestor
110936526|NCT06015750|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110284744|NCT00477412|Antiviral Agents|antiviral agents|mesh-ancestor
110939301|NCT04879030|Meropenem|meropenem|mesh-list
110939302|NCT04879030|Ceftriaxone|ceftriaxone|mesh-list
110939303|NCT04879030|Tazobactam|tazobactam|mesh-list
110939304|NCT04879030|Piperacillin|piperacillin|mesh-list
110939305|NCT04879030|Clavulanic Acid|clavulanic acid|mesh-list
110939306|NCT04879030|Imipenem|imipenem|mesh-list
110939307|NCT04879030|Ceftazidime|ceftazidime|mesh-list
110939308|NCT04879030|Ertapenem|ertapenem|mesh-list
110939309|NCT04879030|Lactams|lactams|mesh-list
110939310|NCT04879030|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
110939311|NCT04879030|Cefotaxime|cefotaxime|mesh-list
110939312|NCT04879030|Cefixime|cefixime|mesh-list
110936527|NCT06015750|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110936528|NCT06015750|Antimetabolites|antimetabolites|mesh-ancestor
110936529|NCT06015750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110936530|NCT06015750|Dermatologic Agents|dermatologic agents|mesh-ancestor
110936531|NCT06015750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110936532|NCT06015750|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110936533|NCT06015750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110936534|NCT06015750|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110936535|NCT06015750|Hematinics|hematinics|mesh-ancestor
110936536|NCT06015750|Vitamin B Complex|vitamin b complex|mesh-ancestor
110936537|NCT06015750|Vitamins|vitamins|mesh-ancestor
110939313|NCT04879030|beta-Lactams|beta-lactams|mesh-list
110939314|NCT04879030|Fluoroquinolones|fluoroquinolones|mesh-list
110939315|NCT04879030|Ticarcillin|ticarcillin|mesh-list
110939316|NCT04879030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110939317|NCT04879030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110939318|NCT04879030|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110939319|NCT04879030|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110939320|NCT04879030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110939321|NCT04879030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110939327|NCT04879030|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110939328|NCT04878718|Vancomycin|vancomycin|mesh-list
110939329|NCT04878718|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110939330|NCT04878718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110939331|NCT04878016|Carboplatin|carboplatin|mesh-list
110939332|NCT04878016|Etoposide|etoposide|mesh-list
110939333|NCT04878016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110939334|NCT04878016|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110939335|NCT04878016|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110939336|NCT04878016|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110939337|NCT04878016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110939338|NCT04878016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110939339|NCT04871152|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110939340|NCT04871152|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110939341|NCT04871152|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110939342|NCT04871152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110939343|NCT04871152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110939344|NCT04871152|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110939345|NCT04871152|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110939346|NCT04871152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110939347|NCT04871152|Cholinergic Agents|cholinergic agents|mesh-ancestor
110939348|NCT04871152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110939350|NCT04870372|Antidepressive Agents|antidepressive agents|mesh-ancestor
110939351|NCT04870372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110939352|NCT04870372|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110939353|NCT04870372|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110939354|NCT04870372|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
110939355|NCT04870372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110939356|NCT04870372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110939357|NCT04870372|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110939358|NCT04870372|Protective Agents|protective agents|mesh-ancestor
110939359|NCT04870372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110939360|NCT02048319|Ethanol|ethanol|mesh-list
110939361|NCT02048319|Pasireotide|pasireotide|mesh-list
110939362|NCT02048319|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110939363|NCT02048319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110939364|NCT02048319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110939365|NCT02048319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110939366|NCT02048319|Hormones|hormones|mesh-ancestor
110939367|NCT02048319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110939368|NCT01594762|Pexiganan|pexiganan|mesh-list
110939369|NCT01594762|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110939370|NCT01594762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110936538|NCT06015750|Micronutrients|micronutrients|mesh-ancestor
110936539|NCT06015659|Gemcitabine|gemcitabine|mesh-list
110936540|NCT06015659|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110936541|NCT06015659|Antimetabolites|antimetabolites|mesh-ancestor
110936542|NCT06015659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110936543|NCT06015659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110936544|NCT06015594|Metformin|metformin|mesh-list
110936545|NCT06015594|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110936546|NCT06015594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110936547|NCT06015516|Minoxidil|minoxidil|mesh-list
110936548|NCT06015516|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110936549|NCT06015516|Vasodilator Agents|vasodilator agents|mesh-ancestor
110936550|NCT06015477|Ticagrelor|ticagrelor|mesh-list
110284787|NCT00232011|Pimecrolimus|pimecrolimus|mesh-list
110939371|NCT02048475|Desflurane|desflurane|mesh-list
110939372|NCT02048475|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110939373|NCT02048475|Anesthetics, General|anesthetics, general|mesh-ancestor
110939374|NCT02048475|Anesthetics|anesthetics|mesh-ancestor
110939375|NCT02048475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110939376|NCT02048475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110939377|NCT03562143|Iron|iron|mesh-list
110939378|NCT03562143|Trace Elements|trace elements|mesh-ancestor
110939379|NCT03562143|Micronutrients|micronutrients|mesh-ancestor
110939380|NCT03562143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110939381|NCT02048865|Apixaban|apixaban|mesh-list
110939382|NCT02048865|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110939383|NCT02048865|Antithrombins|antithrombins|mesh-ancestor
110939384|NCT02048865|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110939385|NCT02048865|Protease Inhibitors|protease inhibitors|mesh-ancestor
110939386|NCT02048865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110939387|NCT02048865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110939388|NCT02048865|Anticoagulants|anticoagulants|mesh-ancestor
110939389|NCT02048943|Paclitaxel|paclitaxel|mesh-list
110939390|NCT02048943|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110939391|NCT02048943|Gemcitabine|gemcitabine|mesh-list
110939398|NCT02048943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110939399|NCT02048943|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110939401|NCT02048943|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110939402|NCT02048943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110939403|NCT02050893|Midazolam|midazolam|mesh-list
110939404|NCT02050893|Propofol|propofol|mesh-list
110939405|NCT02050893|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
110939406|NCT02050893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110939407|NCT02050893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110939408|NCT02050893|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110939409|NCT02050893|Anesthetics, General|anesthetics, general|mesh-ancestor
110939410|NCT02050893|Anesthetics|anesthetics|mesh-ancestor
110939411|NCT02050893|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110939412|NCT02050893|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110939413|NCT02050893|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110939414|NCT02050893|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110939415|NCT02050893|GABA Modulators|gaba modulators|mesh-ancestor
110939416|NCT02050893|GABA Agents|gaba agents|mesh-ancestor
110939417|NCT02050893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110939418|NCT02050893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110939419|NCT02806947|Sirolimus|sirolimus|mesh-list
110939420|NCT02806947|Prednisone|prednisone|mesh-list
110939421|NCT02806947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110939422|NCT02806947|Glucocorticoids|glucocorticoids|mesh-ancestor
110939423|NCT02806947|Hormones|hormones|mesh-ancestor
110939424|NCT02806947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110939425|NCT02806947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110939426|NCT02806947|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110939427|NCT02806947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110939428|NCT02806947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110936551|NCT06015477|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110936552|NCT06015477|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110936553|NCT06015477|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110936554|NCT06015477|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110936555|NCT06015477|Purinergic Agents|purinergic agents|mesh-ancestor
110936556|NCT06015477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110654127|NCT00744107|Cobalt|cobalt|mesh-list
110936557|NCT06015477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110936558|NCT06015477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110936559|NCT06015373|Carvedilol|carvedilol|mesh-list
110936560|NCT06015373|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110936561|NCT06015373|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110936562|NCT06015373|Adrenergic Agents|adrenergic agents|mesh-ancestor
110939429|NCT02806947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110939430|NCT02806947|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110939431|NCT02806947|Antifungal Agents|antifungal agents|mesh-ancestor
110939432|NCT02806947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110939433|NCT02806947|Immunologic Factors|immunologic factors|mesh-ancestor
110939434|NCT03442114|Hydroxyurea|hydroxyurea|mesh-list
110939435|NCT03442114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110939436|NCT03442114|Antisickling Agents|antisickling agents|mesh-ancestor
110939437|NCT03442114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110939438|NCT03442114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110939439|NCT03442114|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110939440|NCT02037399|Dexamethasone|dexamethasone|mesh-list
110939441|NCT02037399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110939442|NCT02037399|Antiemetics|antiemetics|mesh-ancestor
110939443|NCT02037399|Autonomic Agents|autonomic agents|mesh-ancestor
110939444|NCT02037399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110939445|NCT02037399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110249588|NCT00503503|Etanercept|etanercept|mesh-list
110939446|NCT02037399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110939447|NCT02037399|Glucocorticoids|glucocorticoids|mesh-ancestor
110939448|NCT02037399|Hormones|hormones|mesh-ancestor
110939449|NCT02037399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110939450|NCT02037399|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110939451|NCT02037399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110939452|NCT02260089|Telmisartan|telmisartan|mesh-list
110939453|NCT02260089|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110939454|NCT02260089|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110939455|NCT02260089|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110939456|NCT02260089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110939457|NCT02049255|Bupivacaine|bupivacaine|mesh-list
110939458|NCT02049255|Chloroprocaine|chloroprocaine|mesh-list
110939459|NCT02049255|Anesthetics, Local|anesthetics, local|mesh-ancestor
110939464|NCT02049255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110939466|NCT02037711|Anesthetics, Local|anesthetics, local|mesh-ancestor
110939467|NCT02037711|Anesthetics|anesthetics|mesh-ancestor
110939468|NCT02037711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110939469|NCT02037711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110939470|NCT02037711|Sensory System Agents|sensory system agents|mesh-ancestor
110939471|NCT02037711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110939472|NCT03561675|Acetazolamide|acetazolamide|mesh-list
110939473|NCT03561675|Anticonvulsants|anticonvulsants|mesh-ancestor
110939474|NCT03561675|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110939475|NCT03561675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110939476|NCT03561675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110939477|NCT03561675|Diuretics|diuretics|mesh-ancestor
110939478|NCT03561675|Natriuretic Agents|natriuretic agents|mesh-ancestor
110939479|NCT03561675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110939480|NCT02049411|Ketamine|ketamine|mesh-list
110936563|NCT06015373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110936564|NCT06015373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110936565|NCT06015373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110936566|NCT06015373|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110936567|NCT06015373|Antioxidants|antioxidants|mesh-ancestor
110936568|NCT06015373|Protective Agents|protective agents|mesh-ancestor
110936569|NCT06015373|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110936570|NCT06015373|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110936571|NCT06015373|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110936572|NCT06015373|Vasodilator Agents|vasodilator agents|mesh-ancestor
110936573|NCT06015373|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110936574|NCT06015373|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110936575|NCT06015269|Vaccines|vaccines|mesh-list
110936576|NCT06015269|Immunologic Factors|immunologic factors|mesh-ancestor
110936577|NCT06015269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110939481|NCT02049411|Analgesics|analgesics|mesh-ancestor
110939482|NCT02049411|Sensory System Agents|sensory system agents|mesh-ancestor
110939483|NCT02049411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110939484|NCT02049411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110939485|NCT02049411|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110939486|NCT02049411|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110939487|NCT02049411|Anesthetics, General|anesthetics, general|mesh-ancestor
110939488|NCT02049411|Anesthetics|anesthetics|mesh-ancestor
110939489|NCT02049411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110656998|NCT05918302|Everolimus|everolimus|mesh-list
110939490|NCT02049411|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110939491|NCT02049411|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110939493|NCT02049411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110939494|NCT02807493|Salicylic Acid|salicylic acid|mesh-list
110939495|NCT02807493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110939496|NCT02807493|Antifungal Agents|antifungal agents|mesh-ancestor
110939497|NCT02807493|Keratolytic Agents|keratolytic agents|mesh-ancestor
110939498|NCT02807493|Dermatologic Agents|dermatologic agents|mesh-ancestor
110939499|NCT02051751|Paclitaxel|paclitaxel|mesh-list
110939500|NCT02051751|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110939501|NCT02051751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110939502|NCT02051751|Tubulin Modulators|tubulin modulators|mesh-ancestor
110939503|NCT02051751|Antimitotic Agents|antimitotic agents|mesh-ancestor
110939504|NCT02051751|Mitosis Modulators|mitosis modulators|mesh-ancestor
110939505|NCT02051751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110939506|NCT02049801|Cytarabine|cytarabine|mesh-list
110939507|NCT02049801|Idarubicin|idarubicin|mesh-list
110939508|NCT02049801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110939509|NCT02049801|Antimetabolites|antimetabolites|mesh-ancestor
110939510|NCT02049801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110939511|NCT02049801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110939512|NCT02049801|Antiviral Agents|antiviral agents|mesh-ancestor
110939513|NCT02049801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110939514|NCT02049801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110939515|NCT02049801|Immunologic Factors|immunologic factors|mesh-ancestor
110939516|NCT02049801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110939517|NCT02049801|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110939518|NCT02049801|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110939519|NCT02049801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110939520|NCT02049801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110939521|NCT02802345|Nintedanib|nintedanib|mesh-list
110939522|NCT02802345|Sildenafil Citrate|sildenafil citrate|mesh-list
110939523|NCT02802345|Vasodilator Agents|vasodilator agents|mesh-ancestor
110936579|NCT06015152|Dermatologic Agents|dermatologic agents|mesh-ancestor
110936580|NCT06015152|Keratolytic Agents|keratolytic agents|mesh-ancestor
110936581|NCT06015126|Vinorelbine|vinorelbine|mesh-list
110936582|NCT06015126|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110936583|NCT06015126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110936584|NCT06015126|Tubulin Modulators|tubulin modulators|mesh-ancestor
110936585|NCT06015126|Antimitotic Agents|antimitotic agents|mesh-ancestor
110936586|NCT06015126|Mitosis Modulators|mitosis modulators|mesh-ancestor
110936587|NCT06015126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110936588|NCT06015113|Disitamab vedotin|disitamab vedotin|mesh-list
110936589|NCT06015113|Immunoconjugates|immunoconjugates|mesh-ancestor
110936590|NCT06015113|Immunologic Factors|immunologic factors|mesh-ancestor
110936591|NCT06015113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110936592|NCT06015100|Capecitabine|capecitabine|mesh-list
110936593|NCT06015100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110936594|NCT06015100|Antimetabolites|antimetabolites|mesh-ancestor
110936595|NCT06015100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110936596|NCT06015100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110936597|NCT06015074|Propofol|propofol|mesh-list
110936598|NCT06015074|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110936599|NCT06015074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110936600|NCT06015074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110936601|NCT06015074|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110936602|NCT06015074|Anesthetics, General|anesthetics, general|mesh-ancestor
110936603|NCT06015074|Anesthetics|anesthetics|mesh-ancestor
110936604|NCT06015022|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
110936605|NCT06015022|Antioxidants|antioxidants|mesh-ancestor
110936606|NCT06015022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110936607|NCT06015022|Protective Agents|protective agents|mesh-ancestor
110936608|NCT06015022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110284828|NCT00229125|Anticonvulsants|anticonvulsants|mesh-ancestor
110939524|NCT02802345|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110939525|NCT02802345|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110939526|NCT02802345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110939527|NCT02802345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110939528|NCT02802345|Urological Agents|urological agents|mesh-ancestor
110939529|NCT02802345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110939535|NCT02053779|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110939536|NCT02053779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110939537|NCT02053779|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110936609|NCT06015022|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
110936610|NCT06015022|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110936611|NCT06015022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110936612|NCT06015022|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110936614|NCT06012669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110936615|NCT06003348|Potassium Citrate|potassium citrate|mesh-list
110936616|NCT06003348|Diuretics|diuretics|mesh-ancestor
110936617|NCT06003348|Natriuretic Agents|natriuretic agents|mesh-ancestor
110936618|NCT06003348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110936619|NCT06003348|Expectorants|expectorants|mesh-ancestor
110936620|NCT06003348|Respiratory System Agents|respiratory system agents|mesh-ancestor
110249600|NCT00503542|Metronidazole|metronidazole|mesh-list
110284860|NCT00232167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110939538|NCT02053779|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110939539|NCT02053779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110939540|NCT02056041|Liver Extracts|liver extracts|mesh-list
110939541|NCT02056041|Hematinics|hematinics|mesh-ancestor
110939542|NCT02053857|Amoxicillin|amoxicillin|mesh-list
110939543|NCT02053857|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110939544|NCT02053857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110939545|NCT02053935|Dopamine|dopamine|mesh-list
110939546|NCT02053935|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110939547|NCT02053935|Sympathomimetics|sympathomimetics|mesh-ancestor
110939548|NCT02053935|Autonomic Agents|autonomic agents|mesh-ancestor
110939549|NCT02053935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110939550|NCT02053935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110939551|NCT02053935|Dopamine Agents|dopamine agents|mesh-ancestor
110939552|NCT02053935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110939553|NCT02053935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110939554|NCT02053935|Protective Agents|protective agents|mesh-ancestor
110939555|NCT02056353|Insulin|insulin|mesh-list
110939556|NCT02056353|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110939557|NCT02056353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110939558|NCT02056587|Everolimus|everolimus|mesh-list
110939559|NCT02056587|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110939560|NCT02056587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110939561|NCT02056587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110939562|NCT02056587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110939563|NCT02056587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110939564|NCT02056587|Immunologic Factors|immunologic factors|mesh-ancestor
110939565|NCT02056587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110939566|NCT02056587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110939567|NCT02038335|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
110939568|NCT02038335|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110939569|NCT02038335|Levonorgestrel|levonorgestrel|mesh-list
110939570|NCT02038335|Medroxyprogesterone|medroxyprogesterone|mesh-list
110939571|NCT02038335|Etonogestrel|etonogestrel|mesh-list
110939572|NCT02038335|Norethindrone|norethindrone|mesh-list
110939573|NCT02038335|Estradiol|estradiol|mesh-list
110939574|NCT02038335|Estrogens|estrogens|mesh-ancestor
110939575|NCT02038335|Hormones|hormones|mesh-ancestor
110939576|NCT02038335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110939577|NCT02038335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110939578|NCT02038335|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110939579|NCT02038335|Contraceptive Agents|contraceptive agents|mesh-ancestor
110939580|NCT02038335|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110939581|NCT02038335|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110939582|NCT02038335|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110939583|NCT02038335|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110939584|NCT02038335|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110939585|NCT02038335|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110939586|NCT02038335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110939587|NCT02038335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110939588|NCT02056665|Minocycline|minocycline|mesh-list
110936621|NCT05999773|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
110936622|NCT05999773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110936623|NCT05999773|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110936624|NCT05999773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110936625|NCT05996471|Cabotegravir|cabotegravir|mesh-list
110936626|NCT05996471|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110936627|NCT05996471|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110936628|NCT05996471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110936629|NCT05996471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110936630|NCT05996471|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110936631|NCT05996471|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110936632|NCT05996471|Antiviral Agents|antiviral agents|mesh-ancestor
110936633|NCT05996471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110936634|NCT05995444|Moxifloxacin|moxifloxacin|mesh-list
110936635|NCT05995444|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110936636|NCT05995444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110284873|NCT00205322|Antimetabolites|antimetabolites|mesh-ancestor
110939589|NCT02056665|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110249601|NCT00503542|Clindamycin|clindamycin|mesh-list
110939590|NCT02056665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110939591|NCT02056743|Fexofenadine|fexofenadine|mesh-list
110939592|NCT02056743|Losartan|losartan|mesh-list
110939593|NCT02056743|Midazolam|midazolam|mesh-list
110939594|NCT02056743|Dextromethorphan|dextromethorphan|mesh-list
110939595|NCT02056743|Caffeine|caffeine|mesh-list
110939596|NCT02056743|Omeprazole|omeprazole|mesh-list
110939597|NCT02056743|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110939598|NCT02056743|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110939599|NCT02056743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110939600|NCT02056743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110939601|NCT02056743|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110939616|NCT02056743|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110939618|NCT02056743|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110939619|NCT02056743|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110939620|NCT02056743|Purinergic Agents|purinergic agents|mesh-ancestor
110939621|NCT02056743|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110939622|NCT02056743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110939623|NCT02056743|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110939624|NCT02056743|Antitussive Agents|antitussive agents|mesh-ancestor
110939625|NCT02056743|Respiratory System Agents|respiratory system agents|mesh-ancestor
110939626|NCT02056743|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110939627|NCT02056743|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110939628|NCT02056743|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110939629|NCT02056743|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110939630|NCT02056743|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110939631|NCT02056743|Histamine Antagonists|histamine antagonists|mesh-ancestor
110939632|NCT02056743|Histamine Agents|histamine agents|mesh-ancestor
110939633|NCT02052375|ASP2408|asp2408|mesh-list
110939634|NCT02052375|Immunoconjugates|immunoconjugates|mesh-ancestor
110939635|NCT02052375|Immunologic Factors|immunologic factors|mesh-ancestor
110939636|NCT02052375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110939637|NCT02054637|Lanreotide|lanreotide|mesh-list
110939638|NCT02054637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110939639|NCT02054793|Itraconazole|itraconazole|mesh-list
110939640|NCT02054793|Antifungal Agents|antifungal agents|mesh-ancestor
110939641|NCT02054793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110939642|NCT02054793|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110939643|NCT02054793|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110939644|NCT02054793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110936638|NCT05995444|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110936639|NCT05995444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110936640|NCT05995444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110936641|NCT05995444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110936642|NCT05946941|Deucravacitinib|deucravacitinib|mesh-list
110936643|NCT05946941|Dermatologic Agents|dermatologic agents|mesh-ancestor
110936644|NCT05946941|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110936645|NCT05946941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110936646|NCT05946941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110936647|NCT05933395|Everolimus|everolimus|mesh-list
110936648|NCT05933395|Fulvestrant|fulvestrant|mesh-list
110936649|NCT05933395|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110936650|NCT05933395|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110936651|NCT05933395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110936652|NCT05933395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110936653|NCT05933395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110936654|NCT05933395|Immunologic Factors|immunologic factors|mesh-ancestor
110936655|NCT05933395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110936656|NCT05933395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110936657|NCT05933395|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110936658|NCT05933395|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110936659|NCT05933395|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110936660|NCT05933395|Hormone Antagonists|hormone antagonists|mesh-ancestor
110936661|NCT05933395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110936662|NCT05907980|Atezolizumab|atezolizumab|mesh-list
110936663|NCT05907980|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110936664|NCT05907980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110936665|NCT05907980|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110936666|NCT05907980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110249607|NCT00503542|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110936667|NCT05903820|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110936668|NCT05903820|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110936669|NCT05903820|Estradiol|estradiol|mesh-list
110936670|NCT05903820|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110936671|NCT05903820|Progesterone|progesterone|mesh-list
110936672|NCT05903820|Estrogens|estrogens|mesh-ancestor
110936673|NCT05903820|Hormones|hormones|mesh-ancestor
110936674|NCT05903820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110936675|NCT05903820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110936676|NCT05903820|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110936677|NCT05903820|Contraceptive Agents|contraceptive agents|mesh-ancestor
110936678|NCT05903820|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110936679|NCT05903820|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110936680|NCT05903820|Progestins|progestins|mesh-ancestor
110936681|NCT05888402|Immunomodulating Agents|immunomodulating agents|mesh-list
110936682|NCT05888402|Immunologic Factors|immunologic factors|mesh-ancestor
110936683|NCT05888402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110936684|NCT05888207|Fluvoxamine|fluvoxamine|mesh-list
110936685|NCT05888207|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110936686|NCT05888207|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110936687|NCT05888207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110936688|NCT05888207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110936689|NCT05888207|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110936690|NCT05888207|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110939645|NCT02054793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110939646|NCT02054793|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110939647|NCT02054793|Hormone Antagonists|hormone antagonists|mesh-ancestor
110939648|NCT02054793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110939649|NCT02054793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110939650|NCT02054793|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110939652|NCT02052687|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110939653|NCT02052687|Immunologic Factors|immunologic factors|mesh-ancestor
110939654|NCT02052687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110939655|NCT02052687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110939656|NCT02052687|Interferon Inducers|interferon inducers|mesh-ancestor
110939657|NCT02057289|Micafungin|micafungin|mesh-list
110939658|NCT02057289|Antifungal Agents|antifungal agents|mesh-ancestor
110939659|NCT02057289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110939660|NCT02057367|Bupivacaine|bupivacaine|mesh-list
110939661|NCT02057367|Anesthetics, Local|anesthetics, local|mesh-ancestor
110939665|NCT02057367|Sensory System Agents|sensory system agents|mesh-ancestor
110939666|NCT02057367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110939667|NCT02054949|Acetylcysteine|acetylcysteine|mesh-list
110939668|NCT02054949|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110939669|NCT02054949|Antiviral Agents|antiviral agents|mesh-ancestor
110939670|NCT02054949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110939671|NCT02054949|Expectorants|expectorants|mesh-ancestor
110939672|NCT02054949|Respiratory System Agents|respiratory system agents|mesh-ancestor
110939673|NCT02054949|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110939674|NCT02054949|Antioxidants|antioxidants|mesh-ancestor
110939675|NCT02054949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110939676|NCT02054949|Protective Agents|protective agents|mesh-ancestor
110939677|NCT02054949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110939678|NCT02054949|Antidotes|antidotes|mesh-ancestor
110939679|NCT02748057|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110939680|NCT02748057|Ezetimibe|ezetimibe|mesh-list
110939681|NCT02748057|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110939682|NCT02748057|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110939683|NCT02748057|Antimetabolites|antimetabolites|mesh-ancestor
110939684|NCT02748057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110939685|NCT02748057|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110936691|NCT05888207|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110936692|NCT05888207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110936693|NCT05888207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110936694|NCT05888207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110936695|NCT05888207|Serotonin Agents|serotonin agents|mesh-ancestor
110936696|NCT05888207|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110936697|NCT05888207|Antidepressive Agents|antidepressive agents|mesh-ancestor
110249612|NCT00503542|Antifungal Agents|antifungal agents|mesh-ancestor
110936698|NCT05888207|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110936699|NCT05888207|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110936700|NCT05888207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110936701|NCT05888207|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110936702|NCT05887843|Mometasone Furoate|mometasone furoate|mesh-list
110936703|NCT05887843|Azelastine|azelastine|mesh-list
110936704|NCT05887843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110654238|NCT00958100|Lamivudine|lamivudine|mesh-list
110936706|NCT05887843|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110936707|NCT05887843|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110936708|NCT05887843|Autonomic Agents|autonomic agents|mesh-ancestor
110936709|NCT05887843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110936710|NCT05887843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110936711|NCT05887843|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110936712|NCT05887843|Respiratory System Agents|respiratory system agents|mesh-ancestor
110936713|NCT05887843|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
110936714|NCT05887843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110936715|NCT05887843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110936716|NCT05887843|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110936717|NCT05887843|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110936718|NCT05887843|Histamine Antagonists|histamine antagonists|mesh-ancestor
110936719|NCT05887843|Histamine Agents|histamine agents|mesh-ancestor
110936720|NCT05887843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110936721|NCT05878405|Anti-Infective Agents|anti-infective agents|mesh-list
110939686|NCT02748057|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110939687|NCT02748057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110939688|NCT02057601|Levobupivacaine|levobupivacaine|mesh-list
110939689|NCT02057601|Anesthetics, Local|anesthetics, local|mesh-ancestor
110939690|NCT02057601|Anesthetics|anesthetics|mesh-ancestor
110939691|NCT02057601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110939692|NCT02057601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110939693|NCT02057601|Sensory System Agents|sensory system agents|mesh-ancestor
110939694|NCT02057601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110936722|NCT05878405|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110936723|NCT05878405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
110936724|NCT05878405|Analgesics|analgesics|mesh-list
110936725|NCT05878405|Methylene Blue|methylene blue|mesh-list
110936726|NCT05878405|Sensory System Agents|sensory system agents|mesh-ancestor
110936727|NCT05878405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110936728|NCT05878405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110936729|NCT05878405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110936730|NCT05878405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110936731|NCT05878093|Budesonide|budesonide|mesh-list
110936732|NCT05878093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110936733|NCT05878093|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110284977|NCT00229515|Immunologic Factors|immunologic factors|mesh-ancestor
110939695|NCT02057679|Amoxicillin|amoxicillin|mesh-list
110939696|NCT02057679|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110939697|NCT02057679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110939698|NCT02038491|Anesthetics|anesthetics|mesh-list
110939699|NCT02038491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110939700|NCT02038491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110939701|NCT02055183|Antitoxins|antitoxins|mesh-list
110939702|NCT02055183|Botulinum Antitoxin|botulinum antitoxin|mesh-list
110939703|NCT02055183|Immunologic Factors|immunologic factors|mesh-ancestor
110939704|NCT02055183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110939705|NCT02748213|Docetaxel|docetaxel|mesh-list
110939706|NCT02748213|Capecitabine|capecitabine|mesh-list
110939707|NCT02748213|Trastuzumab|trastuzumab|mesh-list
110939708|NCT02748213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110939709|NCT02748213|Tubulin Modulators|tubulin modulators|mesh-ancestor
110939710|NCT02748213|Antimitotic Agents|antimitotic agents|mesh-ancestor
110939711|NCT02748213|Mitosis Modulators|mitosis modulators|mesh-ancestor
110939712|NCT02748213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110939713|NCT02748213|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110939714|NCT02748213|Antimetabolites|antimetabolites|mesh-ancestor
110939715|NCT02748213|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110939716|NCT03804099|Aflibercept|aflibercept|mesh-list
110939717|NCT03804099|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110939718|NCT03804099|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110939719|NCT03804099|Growth Substances|growth substances|mesh-ancestor
110939720|NCT03804099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110939721|NCT03804099|Growth Inhibitors|growth inhibitors|mesh-ancestor
110939722|NCT03804099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110939723|NCT02058303|Bupivacaine|bupivacaine|mesh-list
110939724|NCT02058303|Anesthetics, Local|anesthetics, local|mesh-ancestor
110939725|NCT02058303|Anesthetics|anesthetics|mesh-ancestor
110939726|NCT02058303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110939727|NCT02058303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110939728|NCT02058303|Sensory System Agents|sensory system agents|mesh-ancestor
110939729|NCT02058303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110939730|NCT04870060|Curcumin|curcumin|mesh-list
110939731|NCT04870060|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110939732|NCT04870060|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110939733|NCT04870060|Analgesics|analgesics|mesh-ancestor
110939734|NCT04870060|Sensory System Agents|sensory system agents|mesh-ancestor
110939751|NCT02613910|Hormones|hormones|mesh-ancestor
110939752|NCT02613910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110939753|NCT02613910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110939754|NCT02613910|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110939755|NCT02613910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110939756|NCT02613910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110939757|NCT02613910|Analgesics|analgesics|mesh-ancestor
110939758|NCT02613910|Sensory System Agents|sensory system agents|mesh-ancestor
110939759|NCT02613910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110939760|NCT02613910|Antipyretics|antipyretics|mesh-ancestor
110936734|NCT05878093|Autonomic Agents|autonomic agents|mesh-ancestor
110936735|NCT05878093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110936736|NCT05878093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110936737|NCT05878093|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110936738|NCT05878093|Respiratory System Agents|respiratory system agents|mesh-ancestor
110936739|NCT05878093|Glucocorticoids|glucocorticoids|mesh-ancestor
110936740|NCT05878093|Hormones|hormones|mesh-ancestor
110936741|NCT05878093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110936742|NCT05866367|Insulin|insulin|mesh-list
110936743|NCT05866367|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110936744|NCT05866367|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110936745|NCT05866367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110936746|NCT05836272|Norepinephrine|norepinephrine|mesh-list
110936747|NCT05836272|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110936748|NCT05836272|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110936749|NCT05836272|Adrenergic Agents|adrenergic agents|mesh-ancestor
110936750|NCT05836272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110936751|NCT05836272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110936752|NCT05836272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110936753|NCT05836272|Sympathomimetics|sympathomimetics|mesh-ancestor
110936754|NCT05836272|Autonomic Agents|autonomic agents|mesh-ancestor
110936755|NCT05836272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110936756|NCT05836272|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110936757|NCT05822765|Epinephrine|epinephrine|mesh-list
110936758|NCT05822765|Racepinephrine|racepinephrine|mesh-list
110936759|NCT05822765|Epinephryl borate|epinephryl borate|mesh-list
110936760|NCT05822765|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110936761|NCT05822765|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110936762|NCT05822765|Adrenergic Agents|adrenergic agents|mesh-ancestor
110939761|NCT02613910|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110939762|NCT02613910|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110939763|NCT02613910|Histamine Agents|histamine agents|mesh-ancestor
110939764|NCT02613910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110939765|NCT02613910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110939766|NCT02802735|Apremilast|apremilast|mesh-list
110939767|NCT02802735|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110939768|NCT02802735|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110939769|NCT02802735|Analgesics|analgesics|mesh-ancestor
110939770|NCT02802735|Sensory System Agents|sensory system agents|mesh-ancestor
110939771|NCT02802735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110939772|NCT02802735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110939773|NCT02802735|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110939774|NCT02802735|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110939775|NCT02802735|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
110939776|NCT02802735|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110936763|NCT05822765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110936764|NCT05822765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110936765|NCT05822765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110936766|NCT05822765|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110936767|NCT05822765|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110936768|NCT05822765|Autonomic Agents|autonomic agents|mesh-ancestor
110936769|NCT05822765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110936770|NCT05822765|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110936771|NCT05822765|Respiratory System Agents|respiratory system agents|mesh-ancestor
110936772|NCT05822765|Mydriatics|mydriatics|mesh-ancestor
110936773|NCT05822765|Sympathomimetics|sympathomimetics|mesh-ancestor
110939777|NCT02802735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110939778|NCT02802735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110939779|NCT03048214|Anesthetics|anesthetics|mesh-list
110939780|NCT03048214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110939781|NCT03048214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110939782|NCT02060955|Bevacizumab|bevacizumab|mesh-list
110939783|NCT02060955|Irinotecan|irinotecan|mesh-list
110939784|NCT02060955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110939785|NCT02060955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110939786|NCT02060955|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110939787|NCT02060955|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110939788|NCT02060955|Growth Substances|growth substances|mesh-ancestor
110939789|NCT02060955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110939790|NCT02060955|Growth Inhibitors|growth inhibitors|mesh-ancestor
110657295|NCT05365893|Losartan|losartan|mesh-list
110939791|NCT02060955|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110939792|NCT02060955|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110287919|NCT04667299|Expectorants|expectorants|mesh-ancestor
110939797|NCT02273362|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110939798|NCT02273362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110939799|NCT02273362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110939800|NCT04877626|Artesunate|artesunate|mesh-list
110939801|NCT04877626|Antimalarials|antimalarials|mesh-ancestor
110939802|NCT04877626|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110939803|NCT04877626|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110939804|NCT04877626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110939805|NCT04877626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110939806|NCT04877626|Antiviral Agents|antiviral agents|mesh-ancestor
110939807|NCT04877626|Schistosomicides|schistosomicides|mesh-ancestor
110939808|NCT04877626|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110939809|NCT04877626|Anthelmintics|anthelmintics|mesh-ancestor
110939810|NCT05255848|Heparin|heparin|mesh-list
110939811|NCT05255848|Calcium heparin|calcium heparin|mesh-list
110939812|NCT05255848|Anticoagulants|anticoagulants|mesh-ancestor
110939813|NCT05255848|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110939814|NCT05255848|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110939815|NCT05255848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110939816|NCT04430062|Anesthetics|anesthetics|mesh-list
110939817|NCT04430062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110939818|NCT04430062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110939819|NCT02799381|Levodopa|levodopa|mesh-list
110939820|NCT02799381|Carbidopa|carbidopa|mesh-list
110939821|NCT02799381|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
110939822|NCT02799381|Antiparkinson Agents|antiparkinson agents|mesh-list
110939823|NCT02799381|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110939824|NCT02799381|Dopamine Agents|dopamine agents|mesh-ancestor
110939825|NCT02799381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110939826|NCT02799381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110939827|NCT02799381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110939828|NCT02799381|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
110939829|NCT02799381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110939830|NCT02799381|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110936774|NCT05822765|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110936775|NCT05795504|Vitamin D|vitamin d|mesh-list
110936776|NCT05795504|Calcium|calcium|mesh-list
110936777|NCT05795504|Vitamins|vitamins|mesh-ancestor
110936778|NCT05795504|Micronutrients|micronutrients|mesh-ancestor
110682995|NCT00904475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110936779|NCT05795504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110936780|NCT05795504|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110936781|NCT05795504|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110936782|NCT05782244|Sildenafil Citrate|sildenafil citrate|mesh-list
110936783|NCT05782244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110936784|NCT05782244|Vasodilator Agents|vasodilator agents|mesh-ancestor
110936785|NCT05782244|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110936786|NCT05782244|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110936787|NCT05782244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110936788|NCT05782244|Urological Agents|urological agents|mesh-ancestor
110936789|NCT05766514|Cytarabine|cytarabine|mesh-list
110936790|NCT05766514|Decitabine|decitabine|mesh-list
110939831|NCT02799381|Immunologic Factors|immunologic factors|mesh-ancestor
110939832|NCT02799381|Dopamine Agonists|dopamine agonists|mesh-ancestor
110939833|NCT04387942|Aldesleukin|aldesleukin|mesh-list
110939834|NCT04387942|Interleukin-2|interleukin-2|mesh-list
110939835|NCT04387942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110939836|NCT04387942|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110939837|NCT04387942|Analgesics|analgesics|mesh-ancestor
110939838|NCT04387942|Sensory System Agents|sensory system agents|mesh-ancestor
110939839|NCT04387942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110939840|NCT04387942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110939841|NCT04387942|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110939842|NCT04387942|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110939843|NCT04387942|Antiviral Agents|antiviral agents|mesh-ancestor
110939844|NCT04387942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110939845|NCT01333059|Fentanyl|fentanyl|mesh-list
110939846|NCT01333059|Midazolam|midazolam|mesh-list
110939847|NCT01333059|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110939848|NCT01333059|Narcotics|narcotics|mesh-ancestor
110939849|NCT01333059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110939850|NCT01333059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110939851|NCT01333059|Analgesics|analgesics|mesh-ancestor
110939852|NCT01333059|Sensory System Agents|sensory system agents|mesh-ancestor
110939853|NCT01333059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110939854|NCT01333059|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110939855|NCT01333059|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110939856|NCT01333059|Anesthetics, General|anesthetics, general|mesh-ancestor
110939857|NCT01333059|Anesthetics|anesthetics|mesh-ancestor
110939858|NCT01333059|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110939859|NCT01333059|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110939860|NCT01333059|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110939861|NCT01333059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110939862|NCT01333059|GABA Modulators|gaba modulators|mesh-ancestor
110939863|NCT01333059|GABA Agents|gaba agents|mesh-ancestor
110939864|NCT01333059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110287980|NCT00557011|Adrenergic Agents|adrenergic agents|mesh-ancestor
110939869|NCT02060253|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110939870|NCT02060253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110939871|NCT02060253|Tubulin Modulators|tubulin modulators|mesh-ancestor
110939872|NCT02060253|Antimitotic Agents|antimitotic agents|mesh-ancestor
110939873|NCT02060253|Mitosis Modulators|mitosis modulators|mesh-ancestor
110939874|NCT02060253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110936791|NCT05766514|Venetoclax|venetoclax|mesh-list
110936792|NCT05766514|Cladribine|cladribine|mesh-list
110936793|NCT05766514|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110936794|NCT05766514|Antimetabolites|antimetabolites|mesh-ancestor
110936795|NCT05766514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110936796|NCT05766514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110936797|NCT05766514|Antiviral Agents|antiviral agents|mesh-ancestor
110936798|NCT05766514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110936799|NCT05766514|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110936800|NCT05766514|Immunologic Factors|immunologic factors|mesh-ancestor
110936801|NCT05766514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110936802|NCT05766514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110936803|NCT05741658|Dapagliflozin|dapagliflozin|mesh-list
110936804|NCT05741658|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110936805|NCT05741658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110939875|NCT02060253|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110939876|NCT03560973|Gemcitabine|gemcitabine|mesh-list
110939877|NCT03560973|Ramucirumab|ramucirumab|mesh-list
110939878|NCT03560973|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110939879|NCT03560973|Antimetabolites|antimetabolites|mesh-ancestor
110939880|NCT03560973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110939881|NCT03560973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110939883|NCT04383574|Immunologic Factors|immunologic factors|mesh-ancestor
110939884|NCT04383574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110939885|NCT03046108|Triamcinolone|triamcinolone|mesh-list
110939886|NCT03046108|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110939887|NCT03046108|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110939888|NCT03046108|Mepivacaine|mepivacaine|mesh-list
110939889|NCT03046108|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110939890|NCT03046108|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110939891|NCT03046108|Glucocorticoids|glucocorticoids|mesh-ancestor
110939892|NCT03046108|Hormones|hormones|mesh-ancestor
110939893|NCT03046108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110939894|NCT03046108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110939895|NCT03046108|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110939896|NCT03046108|Immunologic Factors|immunologic factors|mesh-ancestor
110939897|NCT03046108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110939898|NCT03046108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110939899|NCT03046108|Anesthetics, Local|anesthetics, local|mesh-ancestor
110939900|NCT03046108|Anesthetics|anesthetics|mesh-ancestor
110939901|NCT03046108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110939902|NCT03046108|Sensory System Agents|sensory system agents|mesh-ancestor
110939903|NCT03046108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110939904|NCT02061267|Niacin|niacin|mesh-list
110939905|NCT02061267|Nicotinic Acids|nicotinic acids|mesh-list
110939906|NCT02061267|Vitamins|vitamins|mesh-ancestor
110939907|NCT02061267|Micronutrients|micronutrients|mesh-ancestor
110939908|NCT02061267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110939909|NCT02061267|Vitamin B Complex|vitamin b complex|mesh-ancestor
110939910|NCT02061267|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110939911|NCT02061267|Antimetabolites|antimetabolites|mesh-ancestor
110939912|NCT02061267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110939913|NCT02061267|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110939914|NCT02061267|Vasodilator Agents|vasodilator agents|mesh-ancestor
110939915|NCT01370655|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110939916|NCT01370655|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110939917|NCT01370655|Diuretics|diuretics|mesh-ancestor
110939918|NCT01370655|Natriuretic Agents|natriuretic agents|mesh-ancestor
110939919|NCT01370655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110936807|NCT05741658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110936808|NCT05738135|Aminophylline|aminophylline|mesh-list
110936809|NCT05738135|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110936810|NCT05738135|Autonomic Agents|autonomic agents|mesh-ancestor
110936811|NCT05738135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110936812|NCT05738135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110936813|NCT05738135|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110936814|NCT05738135|Respiratory System Agents|respiratory system agents|mesh-ancestor
110936815|NCT05738135|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110936816|NCT05738135|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110936817|NCT05738135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110936818|NCT05738135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110936819|NCT05738135|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110939920|NCT01370655|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110939921|NCT01370655|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110939922|NCT01370655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110939923|NCT02612194|Crizotinib|crizotinib|mesh-list
110939924|NCT02612194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110939925|NCT02612194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110939926|NCT02612194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110939927|NCT02612194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110939928|NCT03044626|Nivolumab|nivolumab|mesh-list
110939929|NCT03044626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110939930|NCT03044626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110939931|NCT03044626|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110939932|NCT03044626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110939933|NCT04865224|Chrysarobin|chrysarobin|mesh-list
110939934|NCT04865224|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110939935|NCT04865224|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110939936|NCT04865224|Analgesics|analgesics|mesh-ancestor
110939945|NCT04865380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110939947|NCT04865380|Coagulants|coagulants|mesh-ancestor
110939948|NCT04869046|Acetaminophen|acetaminophen|mesh-list
110939949|NCT04869046|Ibuprofen|ibuprofen|mesh-list
110939950|NCT04869046|Analgesics|analgesics|mesh-list
110939951|NCT04869046|Levobupivacaine|levobupivacaine|mesh-list
110939952|NCT04869046|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110939953|NCT04869046|Sensory System Agents|sensory system agents|mesh-ancestor
110939954|NCT04869046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110939955|NCT04869046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110939956|NCT04869046|Antipyretics|antipyretics|mesh-ancestor
110939957|NCT04869046|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110939958|NCT04869046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110939959|NCT04869046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110939960|NCT04869046|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110939961|NCT04869046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110939962|NCT04869046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110939963|NCT04869046|Anesthetics, Local|anesthetics, local|mesh-ancestor
110939964|NCT04869046|Anesthetics|anesthetics|mesh-ancestor
110939965|NCT04869046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110939966|NCT04385680|Chlorhexidine|chlorhexidine|mesh-list
110939967|NCT04385680|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110939968|NCT04385680|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110939969|NCT04385680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110939970|NCT04385680|Disinfectants|disinfectants|mesh-ancestor
110939971|NCT04385680|Dermatologic Agents|dermatologic agents|mesh-ancestor
110939972|NCT02798211|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110939973|NCT02798211|Immunologic Factors|immunologic factors|mesh-ancestor
110936820|NCT05738135|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110936821|NCT05738135|Purinergic Agents|purinergic agents|mesh-ancestor
110936822|NCT05738135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110936823|NCT05738135|Protective Agents|protective agents|mesh-ancestor
110936824|NCT05708625|Doxycycline|doxycycline|mesh-list
110936825|NCT05708625|Voriconazole|voriconazole|mesh-list
110936826|NCT05708625|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
110936827|NCT05708625|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110936828|NCT05708625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110936829|NCT05708625|Antimalarials|antimalarials|mesh-ancestor
110936830|NCT05708625|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110936831|NCT05708625|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110936832|NCT05708625|Antifungal Agents|antifungal agents|mesh-ancestor
110936833|NCT05708625|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110936834|NCT05708625|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110936835|NCT05708625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110936836|NCT05708625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110936837|NCT05708625|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110936838|NCT05708625|Hormone Antagonists|hormone antagonists|mesh-ancestor
110285078|NCT00411164|Analgesics|analgesics|mesh-ancestor
110939974|NCT02798211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110939975|NCT02060019|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
110939976|NCT02060019|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110939977|NCT02060019|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110939978|NCT02060019|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110939979|NCT02060019|Antimetabolites|antimetabolites|mesh-ancestor
110939980|NCT02060019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110939981|NCT02060019|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110939982|NCT02060019|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110939983|NCT02060019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110939984|NCT02060019|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110939985|NCT05654415|Melatonin|melatonin|mesh-list
110939986|NCT05654415|Antioxidants|antioxidants|mesh-ancestor
110939987|NCT05654415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110939988|NCT05654415|Protective Agents|protective agents|mesh-ancestor
110939989|NCT05654415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110939990|NCT05654415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110939991|NCT03044938|Albuterol|albuterol|mesh-list
110939992|NCT03044938|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110939993|NCT03044938|Autonomic Agents|autonomic agents|mesh-ancestor
110939994|NCT03044938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110939995|NCT03044938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110939996|NCT03044938|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110249641|NCT01246804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110939997|NCT03044938|Respiratory System Agents|respiratory system agents|mesh-ancestor
110939998|NCT03044938|Tocolytic Agents|tocolytic agents|mesh-ancestor
110939999|NCT03044938|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110940000|NCT03044938|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110940001|NCT03044938|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110940002|NCT03044938|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110940007|NCT03045484|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110940008|NCT03045484|Narcotics|narcotics|mesh-ancestor
110940009|NCT03045484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110940010|NCT03045484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110940011|NCT03045484|Analgesics|analgesics|mesh-ancestor
110936839|NCT05708625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110936840|NCT05708625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110936841|NCT05708625|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110936842|NCT05708625|Schistosomicides|schistosomicides|mesh-ancestor
110936843|NCT05708625|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110936844|NCT05708625|Anthelmintics|anthelmintics|mesh-ancestor
110936845|NCT05697276|Lidocaine|lidocaine|mesh-list
110936846|NCT05697276|Bupivacaine|bupivacaine|mesh-list
110936847|NCT05697276|Anesthetics, Local|anesthetics, local|mesh-ancestor
110936848|NCT05697276|Anesthetics|anesthetics|mesh-ancestor
110936849|NCT05697276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110936850|NCT05697276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110936851|NCT05697276|Sensory System Agents|sensory system agents|mesh-ancestor
110654388|NCT00094861|Paclitaxel|paclitaxel|mesh-list
110936852|NCT05697276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110936853|NCT05697276|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110936854|NCT05697276|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110936855|NCT05697276|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110936856|NCT05697276|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110936857|NCT05697276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110936858|NCT05690204|Colchicine|colchicine|mesh-list
110936859|NCT05690204|Gout Suppressants|gout suppressants|mesh-ancestor
110936860|NCT05690204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110936861|NCT05690204|Tubulin Modulators|tubulin modulators|mesh-ancestor
110936862|NCT05690204|Antimitotic Agents|antimitotic agents|mesh-ancestor
110936863|NCT05690204|Mitosis Modulators|mitosis modulators|mesh-ancestor
110285095|NCT00411281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110940012|NCT03045484|Sensory System Agents|sensory system agents|mesh-ancestor
110940013|NCT03045484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110940014|NCT04874506|TEMPO|tempo|mesh-list
110940015|NCT04874506|TEMPOL-H|tempol-h|mesh-list
110940016|NCT04874506|Antioxidants|antioxidants|mesh-ancestor
110940017|NCT04874506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110940018|NCT04874506|Protective Agents|protective agents|mesh-ancestor
110940019|NCT04874506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110940020|NCT04874506|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110940021|NCT04874428|Rivaroxaban|rivaroxaban|mesh-list
110940022|NCT04874428|Apixaban|apixaban|mesh-list
110940023|NCT04874428|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110940024|NCT04874428|Antithrombins|antithrombins|mesh-ancestor
110940025|NCT04874428|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110940026|NCT04874428|Protease Inhibitors|protease inhibitors|mesh-ancestor
110940027|NCT04874428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110940028|NCT04874428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110940029|NCT04874428|Anticoagulants|anticoagulants|mesh-ancestor
110940030|NCT04867720|Everolimus|everolimus|mesh-list
110940031|NCT04867720|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110936864|NCT05690204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110936865|NCT05690204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110936866|NCT05689151|Abrocitinib|abrocitinib|mesh-list
110936867|NCT05689151|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110936868|NCT05689151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110936869|NCT05689151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110936870|NCT05672784|Acetaminophen|acetaminophen|mesh-list
110936871|NCT05672784|Meloxicam|meloxicam|mesh-list
110936872|NCT05672784|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110936873|NCT05672784|Analgesics|analgesics|mesh-ancestor
110936874|NCT05672784|Sensory System Agents|sensory system agents|mesh-ancestor
110936875|NCT05672784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110936876|NCT05672784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110936877|NCT05672784|Antipyretics|antipyretics|mesh-ancestor
110936878|NCT05672784|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110936879|NCT05672784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110936880|NCT05672784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110940032|NCT04867720|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110940033|NCT04867720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110940034|NCT04867720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110940035|NCT04867720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110940036|NCT04867720|Immunologic Factors|immunologic factors|mesh-ancestor
110940037|NCT04867720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110940038|NCT04867720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110940039|NCT02799069|Aminolevulinic Acid|aminolevulinic acid|mesh-list
110940040|NCT02799069|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110940041|NCT02799069|Dermatologic Agents|dermatologic agents|mesh-ancestor
110940042|NCT02062047|Chlorhexidine|chlorhexidine|mesh-list
110940043|NCT02062047|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110940044|NCT02062047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110940045|NCT02062047|Disinfectants|disinfectants|mesh-ancestor
110940046|NCT03045406|Dalteparin|dalteparin|mesh-list
110940047|NCT03045406|Tinzaparin|tinzaparin|mesh-list
110940048|NCT03045406|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
110940049|NCT03045406|Apixaban|apixaban|mesh-list
110940050|NCT03045406|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110940051|NCT03045406|Antithrombins|antithrombins|mesh-ancestor
110940052|NCT03045406|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110940053|NCT03045406|Protease Inhibitors|protease inhibitors|mesh-ancestor
110940054|NCT03045406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110940055|NCT03045406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110940056|NCT03045406|Anticoagulants|anticoagulants|mesh-ancestor
110940057|NCT03045406|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110940058|NCT03045406|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110940059|NCT02798835|Dexamethasone|dexamethasone|mesh-list
110940060|NCT02798835|Dexamethasone acetate|dexamethasone acetate|mesh-list
110940061|NCT02798835|Fentanyl|fentanyl|mesh-list
110940062|NCT02798835|Bupivacaine|bupivacaine|mesh-list
110940063|NCT02798835|Ropivacaine|ropivacaine|mesh-list
110940064|NCT02798835|BB 1101|bb 1101|mesh-list
110940065|NCT02798835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110940066|NCT02798835|Antiemetics|antiemetics|mesh-ancestor
110940067|NCT02798835|Autonomic Agents|autonomic agents|mesh-ancestor
110940068|NCT02798835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110940069|NCT02798835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110940070|NCT02798835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110940071|NCT02798835|Glucocorticoids|glucocorticoids|mesh-ancestor
110940072|NCT02798835|Hormones|hormones|mesh-ancestor
110940073|NCT02798835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110936881|NCT05672784|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110936882|NCT05672784|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110936883|NCT05672784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110936884|NCT05672784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110936886|NCT05669352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110936887|NCT05669352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110936888|NCT05669352|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110936889|NCT05669352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110936890|NCT05661253|Bupivacaine|bupivacaine|mesh-list
110936891|NCT05661253|Anesthetics, Local|anesthetics, local|mesh-ancestor
110936892|NCT05661253|Anesthetics|anesthetics|mesh-ancestor
110936893|NCT05661253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110936894|NCT05661253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110936895|NCT05661253|Sensory System Agents|sensory system agents|mesh-ancestor
110936896|NCT05661253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110936897|NCT05624918|Paclitaxel|paclitaxel|mesh-list
110940074|NCT02798835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110940075|NCT02798835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110288190|NCT00216281|GABA Antagonists|gaba antagonists|mesh-ancestor
110940089|NCT02061657|Misoprostol|misoprostol|mesh-list
110940090|NCT02061657|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110940091|NCT02061657|Abortifacient Agents|abortifacient agents|mesh-ancestor
110940092|NCT02061657|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110940093|NCT02061657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110940094|NCT02061657|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110940095|NCT02061657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110940096|NCT02061657|Oxytocics|oxytocics|mesh-ancestor
110940097|NCT03048136|Nivolumab|nivolumab|mesh-list
110940098|NCT03048136|Ipilimumab|ipilimumab|mesh-list
110940099|NCT03048136|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110940100|NCT03048136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110940101|NCT03048136|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110940102|NCT03048136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110940103|NCT02062203|Moxifloxacin|moxifloxacin|mesh-list
110940104|NCT02062203|Glycine|glycine|mesh-list
110940105|NCT02062203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110940106|NCT02062203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110940107|NCT02062203|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110940108|NCT02062203|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110940109|NCT02062203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110940110|NCT02062203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110940111|NCT02062203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110940112|NCT02062203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110940113|NCT02062203|Glycine Agents|glycine agents|mesh-ancestor
110940114|NCT02062203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110940115|NCT04863742|Prednisolone|prednisolone|mesh-list
110940116|NCT04863742|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110940117|NCT04863742|Methylprednisolone|methylprednisolone|mesh-list
110940118|NCT04863742|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110940119|NCT04863742|Prednisolone acetate|prednisolone acetate|mesh-list
110940120|NCT04863742|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110940121|NCT04863742|Prednisolone phosphate|prednisolone phosphate|mesh-list
110940122|NCT04863742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110940123|NCT04863742|Glucocorticoids|glucocorticoids|mesh-ancestor
110940124|NCT04863742|Hormones|hormones|mesh-ancestor
110478551|NCT01018862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110936898|NCT05624918|Gemcitabine|gemcitabine|mesh-list
110936899|NCT05624918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110936900|NCT05624918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110936901|NCT05624918|Tubulin Modulators|tubulin modulators|mesh-ancestor
110936902|NCT05624918|Antimitotic Agents|antimitotic agents|mesh-ancestor
110936903|NCT05624918|Mitosis Modulators|mitosis modulators|mesh-ancestor
110936904|NCT05624918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110936905|NCT05624918|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110936906|NCT05624918|Antimetabolites|antimetabolites|mesh-ancestor
110936907|NCT05617885|Leuprolide|leuprolide|mesh-list
110936908|NCT05617885|Goserelin|goserelin|mesh-list
110936909|NCT05617885|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
110936910|NCT05617885|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110936911|NCT05617885|Fertility Agents|fertility agents|mesh-ancestor
110936912|NCT05617885|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110936913|NCT05617885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110936914|NCT05617885|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110936915|NCT05617885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110936916|NCT05617885|Hormones|hormones|mesh-ancestor
110936917|NCT05617885|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110936918|NCT05617313|Pembrolizumab|pembrolizumab|mesh-list
110936919|NCT05617313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110936920|NCT05617313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110936921|NCT05617313|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110936922|NCT05617313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110936923|NCT05615818|Gemcitabine|gemcitabine|mesh-list
110940125|NCT04863742|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110940126|NCT04863742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110940127|NCT04863742|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110940128|NCT04863742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110940129|NCT04863742|Antiemetics|antiemetics|mesh-ancestor
110940130|NCT04863742|Autonomic Agents|autonomic agents|mesh-ancestor
110940131|NCT04863742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110940132|NCT04863742|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110940133|NCT04863742|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110940134|NCT04863742|Protective Agents|protective agents|mesh-ancestor
110940135|NCT02611882|Edetic Acid|edetic acid|mesh-list
110940136|NCT02611882|N,N'-bis(2-hydroxybenzyl)ethylenediamine-N,N'-diacetic acid|n,n'-bis(2-hydroxybenzyl)ethylenediamine-n,n'-diacetic acid|mesh-list
110940137|NCT02611882|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
110288266|NCT00244998|Fulvestrant|fulvestrant|mesh-list
110940146|NCT02062281|Immunologic Factors|immunologic factors|mesh-ancestor
110940147|NCT02062281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110940148|NCT03560583|Metoclopramide|metoclopramide|mesh-list
110940149|NCT03560583|Antiemetics|antiemetics|mesh-ancestor
110940150|NCT03560583|Autonomic Agents|autonomic agents|mesh-ancestor
110940151|NCT03560583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110654463|NCT00969696|Autonomic Agents|autonomic agents|mesh-ancestor
110936924|NCT05615818|Trastuzumab|trastuzumab|mesh-list
110936925|NCT05615818|Niraparib|niraparib|mesh-list
110936926|NCT05615818|Ivosidenib|ivosidenib|mesh-list
110936927|NCT05615818|Futibatinib|futibatinib|mesh-list
110936928|NCT05615818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110936929|NCT05615818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110936930|NCT05615818|Antimetabolites|antimetabolites|mesh-ancestor
110936931|NCT05615818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110936932|NCT05615818|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110936933|NCT05615818|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110936934|NCT05615818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110936935|NCT05603832|Acetaminophen|acetaminophen|mesh-list
110936936|NCT05603832|Bupivacaine|bupivacaine|mesh-list
110936937|NCT05603832|Methocarbamol|methocarbamol|mesh-list
110936938|NCT05603832|Anesthetics, Local|anesthetics, local|mesh-ancestor
110936939|NCT05603832|Anesthetics|anesthetics|mesh-ancestor
110936940|NCT05603832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110936941|NCT05603832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110936942|NCT05603832|Sensory System Agents|sensory system agents|mesh-ancestor
110936943|NCT05603832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110936944|NCT05603832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110936945|NCT05603832|Analgesics|analgesics|mesh-ancestor
110936946|NCT05603832|Antipyretics|antipyretics|mesh-ancestor
110936947|NCT05603832|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110936948|NCT05603832|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110936949|NCT05601492|Thalidomide|thalidomide|mesh-list
110936950|NCT05601492|Apremilast|apremilast|mesh-list
110936951|NCT05601492|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110936952|NCT05601492|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110940152|NCT03560583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110940153|NCT03560583|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110940154|NCT03560583|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110940155|NCT03560583|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110940156|NCT03560583|Dopamine Agents|dopamine agents|mesh-ancestor
110940157|NCT03560583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110940158|NCT03560583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110940159|NCT03560427|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110940160|NCT03560427|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110940161|NCT03560427|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110940162|NCT03560427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110940163|NCT03560427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110940164|NCT03560427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110940165|NCT03560427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110940166|NCT03560427|Analgesics|analgesics|mesh-ancestor
110936953|NCT05601492|Analgesics|analgesics|mesh-ancestor
110936954|NCT05601492|Sensory System Agents|sensory system agents|mesh-ancestor
110936955|NCT05601492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110936956|NCT05601492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110936957|NCT05601492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110936958|NCT05601492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110936959|NCT05601492|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
110936960|NCT05601492|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110936961|NCT05601492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110940167|NCT03560427|Sensory System Agents|sensory system agents|mesh-ancestor
110940168|NCT03560427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110940169|NCT03560427|Antidepressive Agents|antidepressive agents|mesh-ancestor
110940170|NCT03560427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110940171|NCT03560427|Dopamine Agents|dopamine agents|mesh-ancestor
110940172|NCT03797547|Aflibercept|aflibercept|mesh-list
110940173|NCT03797547|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110940174|NCT03797547|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110940175|NCT03797547|Growth Substances|growth substances|mesh-ancestor
110940176|NCT03797547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110940177|NCT03797547|Growth Inhibitors|growth inhibitors|mesh-ancestor
110940178|NCT03797547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110940179|NCT04867252|Inositol|inositol|mesh-list
110940180|NCT04867252|Metformin|metformin|mesh-list
110940181|NCT04867252|Pioglitazone|pioglitazone|mesh-list
110940182|NCT04867252|Resveratrol|resveratrol|mesh-list
110940183|NCT04867252|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110940184|NCT04867252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110940185|NCT04867252|Antioxidants|antioxidants|mesh-ancestor
110940186|NCT04867252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110940187|NCT04867252|Protective Agents|protective agents|mesh-ancestor
110940188|NCT04867252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110940189|NCT04867252|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110940190|NCT04867252|Vitamin B Complex|vitamin b complex|mesh-ancestor
110940191|NCT04867252|Vitamins|vitamins|mesh-ancestor
110940192|NCT04867252|Micronutrients|micronutrients|mesh-ancestor
110940193|NCT04863274|Atorvastatin|atorvastatin|mesh-list
110940194|NCT04863274|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110940195|NCT04863274|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110940196|NCT04863274|Antimetabolites|antimetabolites|mesh-ancestor
110940197|NCT04863274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110940198|NCT04863274|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110940199|NCT04863274|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110940200|NCT04863274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110940201|NCT02063373|Hyaluronic Acid|hyaluronic acid|mesh-list
110940202|NCT02063373|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110940203|NCT02063373|Immunologic Factors|immunologic factors|mesh-ancestor
110288320|NCT00216632|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110940214|NCT02796651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110940215|NCT02796651|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110940216|NCT02796651|Respiratory System Agents|respiratory system agents|mesh-ancestor
110940217|NCT02796651|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110940218|NCT02796651|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110940220|NCT02796651|Adrenergic Agents|adrenergic agents|mesh-ancestor
110940221|NCT02796651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110940222|NCT02796651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110940223|NCT03044080|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110940224|NCT03044080|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
110940225|NCT03044080|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110940226|NCT03044080|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110940227|NCT03044080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110940228|NCT03044080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110940229|NCT03044080|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110940230|NCT03044080|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110940231|NCT03044080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110940232|NCT03044080|Cholinergic Agents|cholinergic agents|mesh-ancestor
110936962|NCT05601492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110936963|NCT05601492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110936964|NCT05601492|Immunologic Factors|immunologic factors|mesh-ancestor
110936965|NCT05601492|Leprostatic Agents|leprostatic agents|mesh-ancestor
110936966|NCT05601492|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110936967|NCT05601492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110936968|NCT05601492|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110936969|NCT05601492|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110936970|NCT05601492|Growth Substances|growth substances|mesh-ancestor
110936971|NCT05601492|Growth Inhibitors|growth inhibitors|mesh-ancestor
110936972|NCT05601492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110936973|NCT05601271|Allopurinol|allopurinol|mesh-list
110936974|NCT05601271|Antimetabolites|antimetabolites|mesh-ancestor
110936975|NCT05601271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110936976|NCT05601271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110936977|NCT05601271|Gout Suppressants|gout suppressants|mesh-ancestor
110936978|NCT05601271|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110936979|NCT05601271|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110936980|NCT05601271|Antioxidants|antioxidants|mesh-ancestor
110936981|NCT05601271|Protective Agents|protective agents|mesh-ancestor
110936982|NCT05601271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110936983|NCT05567835|Leucovorin|leucovorin|mesh-list
110936984|NCT05567835|Docetaxel|docetaxel|mesh-list
110936985|NCT05567835|Fluorouracil|fluorouracil|mesh-list
110936986|NCT05567835|Oxaliplatin|oxaliplatin|mesh-list
110936987|NCT05567835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110936988|NCT05567835|Tubulin Modulators|tubulin modulators|mesh-ancestor
110936989|NCT05567835|Antimitotic Agents|antimitotic agents|mesh-ancestor
110936990|NCT05567835|Mitosis Modulators|mitosis modulators|mesh-ancestor
110936991|NCT05567835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110936992|NCT05567835|Antimetabolites|antimetabolites|mesh-ancestor
110285222|NCT00207077|Cetuximab|cetuximab|mesh-list
110940233|NCT03044080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110940234|NCT04429282|Ibuprofen|ibuprofen|mesh-list
110940235|NCT04429282|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110940236|NCT04429282|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110940237|NCT04429282|Analgesics|analgesics|mesh-ancestor
110940238|NCT04429282|Sensory System Agents|sensory system agents|mesh-ancestor
110940239|NCT04429282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110940240|NCT04429282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110940241|NCT04429282|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110940242|NCT04429282|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110940243|NCT04429282|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110940244|NCT04429282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110936993|NCT05567835|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110936994|NCT05567835|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110936995|NCT05567835|Immunologic Factors|immunologic factors|mesh-ancestor
110936996|NCT05567835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110936997|NCT05567835|Antidotes|antidotes|mesh-ancestor
110936998|NCT05567835|Protective Agents|protective agents|mesh-ancestor
110936999|NCT05567835|Vitamin B Complex|vitamin b complex|mesh-ancestor
110937000|NCT05567835|Vitamins|vitamins|mesh-ancestor
110937001|NCT05567835|Micronutrients|micronutrients|mesh-ancestor
110937002|NCT05565495|Hydromorphone|hydromorphone|mesh-list
110937003|NCT05565495|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110937004|NCT05565495|Narcotics|narcotics|mesh-ancestor
110937005|NCT05565495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110937006|NCT05565495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110937007|NCT05565495|Analgesics|analgesics|mesh-ancestor
110937008|NCT05565495|Sensory System Agents|sensory system agents|mesh-ancestor
110285262|NCT00230217|Rasburicase|rasburicase|mesh-list
110940245|NCT04429282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110940246|NCT02063529|Leucovorin|leucovorin|mesh-list
110940247|NCT02063529|Fluorouracil|fluorouracil|mesh-list
110940248|NCT02063529|Oxaliplatin|oxaliplatin|mesh-list
110940249|NCT02063529|Irinotecan|irinotecan|mesh-list
110940250|NCT02063529|Cetuximab|cetuximab|mesh-list
110940251|NCT02063529|Levoleucovorin|levoleucovorin|mesh-list
110940252|NCT02063529|Antimetabolites|antimetabolites|mesh-ancestor
110940253|NCT02063529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110940254|NCT02063529|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110940255|NCT02063529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110940256|NCT02063529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110940257|NCT02063529|Immunologic Factors|immunologic factors|mesh-ancestor
110940258|NCT02063529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110940259|NCT02063529|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110940260|NCT02063529|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110940261|NCT02063529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110940262|NCT02063529|Antidotes|antidotes|mesh-ancestor
110940263|NCT02063529|Protective Agents|protective agents|mesh-ancestor
110940264|NCT02063529|Vitamin B Complex|vitamin b complex|mesh-ancestor
110940265|NCT02063529|Vitamins|vitamins|mesh-ancestor
110940266|NCT02063529|Micronutrients|micronutrients|mesh-ancestor
110940267|NCT02063529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110940268|NCT02062983|Trastuzumab|trastuzumab|mesh-list
110940295|NCT01668784|Everolimus|everolimus|mesh-list
110940296|NCT01668784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110940297|NCT01668784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110940298|NCT01668784|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110940299|NCT01668784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110940300|NCT01668784|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110940301|NCT01668784|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110940302|NCT01668784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110249676|NCT04696939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110940303|NCT01668784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110940304|NCT01668784|Immunologic Factors|immunologic factors|mesh-ancestor
110940305|NCT01668784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110940306|NCT02750514|Nivolumab|nivolumab|mesh-list
110940307|NCT02750514|Ipilimumab|ipilimumab|mesh-list
110940308|NCT02750514|Relatlimab|relatlimab|mesh-list
110940309|NCT02750514|Dasatinib|dasatinib|mesh-list
110940310|NCT02750514|Linrodostat|linrodostat|mesh-list
110940311|NCT02750514|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110940312|NCT02750514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110940313|NCT02750514|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110940314|NCT02750514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110940315|NCT02750514|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110937009|NCT05565495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110937011|NCT05542394|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110937012|NCT05542394|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110937013|NCT05542394|Analgesics|analgesics|mesh-ancestor
110937014|NCT05542394|Sensory System Agents|sensory system agents|mesh-ancestor
110937015|NCT05542394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110937016|NCT05542394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110937017|NCT05542394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110937018|NCT05542394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110937019|NCT05542394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110937020|NCT05542394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110940316|NCT02750514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110940317|NCT02229240|rGLP-1 protein|rglp-1 protein|mesh-list
110940335|NCT03738618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110940336|NCT03738618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110940337|NCT03412890|Norethindrone|norethindrone|mesh-list
110940338|NCT03412890|Norethindrone Acetate|norethindrone acetate|mesh-list
110940339|NCT03412890|Estradiol|estradiol|mesh-list
110940340|NCT03412890|Relugolix|relugolix|mesh-list
110940341|NCT03412890|Estrogens|estrogens|mesh-ancestor
110940342|NCT03412890|Hormones|hormones|mesh-ancestor
110940343|NCT03412890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110940344|NCT03412890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110940345|NCT03412890|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110940346|NCT03412890|Contraceptive Agents|contraceptive agents|mesh-ancestor
110940347|NCT03412890|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110940348|NCT03412890|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110940349|NCT03412890|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110940350|NCT03412890|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110940351|NCT03412890|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110940352|NCT03412890|Androgen Antagonists|androgen antagonists|mesh-ancestor
110940353|NCT03412890|Hormone Antagonists|hormone antagonists|mesh-ancestor
110940354|NCT03371082|Insulin Glargine|insulin glargine|mesh-list
110940355|NCT03371082|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110940356|NCT03371082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110940357|NCT03340974|Avasopasem manganese|avasopasem manganese|mesh-list
110940358|NCT03340974|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110940359|NCT03340974|Antioxidants|antioxidants|mesh-ancestor
110940360|NCT03340974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110940361|NCT03340974|Protective Agents|protective agents|mesh-ancestor
110940362|NCT03340974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110940363|NCT02229786|Acetaminophen|acetaminophen|mesh-list
110940364|NCT02229786|Scopolamine|scopolamine|mesh-list
110940365|NCT02229786|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
110940366|NCT02229786|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110940367|NCT02229786|Analgesics|analgesics|mesh-ancestor
110940368|NCT02229786|Sensory System Agents|sensory system agents|mesh-ancestor
110940369|NCT02229786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110940370|NCT02229786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110940371|NCT02229786|Antipyretics|antipyretics|mesh-ancestor
110940372|NCT02229786|Parasympatholytics|parasympatholytics|mesh-ancestor
110940373|NCT02229786|Autonomic Agents|autonomic agents|mesh-ancestor
110940374|NCT02229786|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110940375|NCT02229786|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110940376|NCT02229786|Cholinergic Agents|cholinergic agents|mesh-ancestor
110940377|NCT02229786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110288506|NCT00558181|Antiemetics|antiemetics|mesh-ancestor
110940381|NCT02229786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110940382|NCT02229786|Mydriatics|mydriatics|mesh-ancestor
110940383|NCT03287232|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
110940384|NCT03287232|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110940385|NCT03287232|Immunologic Factors|immunologic factors|mesh-ancestor
110940386|NCT03287232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110937021|NCT05542394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110937022|NCT05519579|Methotrexate|methotrexate|mesh-list
110937023|NCT05519579|Blinatumomab|blinatumomab|mesh-list
110937024|NCT05519579|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110937025|NCT05519579|Abortifacient Agents|abortifacient agents|mesh-ancestor
110937026|NCT05519579|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110937027|NCT05519579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110937028|NCT05519579|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110937029|NCT05519579|Antimetabolites|antimetabolites|mesh-ancestor
110937030|NCT05519579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110937031|NCT05519579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110937032|NCT05519579|Dermatologic Agents|dermatologic agents|mesh-ancestor
110937033|NCT05519579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110937034|NCT05519579|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110937035|NCT05519579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110937036|NCT05519579|Immunologic Factors|immunologic factors|mesh-ancestor
110937037|NCT05519579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110937038|NCT05519579|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110937039|NCT05470517|Ceftriaxone|ceftriaxone|mesh-list
110937040|NCT05470517|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110937041|NCT05470517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110368726|NCT04617015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110940387|NCT02229942|Rituximab|rituximab|mesh-list
110940388|NCT02229942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110940389|NCT02229942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110940390|NCT02229942|Immunologic Factors|immunologic factors|mesh-ancestor
110940391|NCT02229942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110940392|NCT02229942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110940393|NCT03047278|Cetirizine|cetirizine|mesh-list
110940394|NCT03047278|Gabapentin|gabapentin|mesh-list
110940395|NCT03047278|Analgesics|analgesics|mesh-ancestor
110940396|NCT03047278|Sensory System Agents|sensory system agents|mesh-ancestor
110940397|NCT03047278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110940398|NCT03047278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110940399|NCT03047278|Anticonvulsants|anticonvulsants|mesh-ancestor
110940400|NCT03047278|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110940401|NCT03047278|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110940402|NCT03047278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110940403|NCT03047278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110940404|NCT03047278|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110940405|NCT03047278|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110940406|NCT03047278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110940407|NCT03047278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110940408|NCT03047278|Antimanic Agents|antimanic agents|mesh-ancestor
110940409|NCT03047278|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110940410|NCT03047278|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110940411|NCT03047278|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110940412|NCT03047278|Histamine Antagonists|histamine antagonists|mesh-ancestor
110940413|NCT03047278|Histamine Agents|histamine agents|mesh-ancestor
110940414|NCT03045016|Prazosin|prazosin|mesh-list
110940415|NCT03045016|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110937060|NCT05442216|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110937061|NCT05442216|Antimetabolites|antimetabolites|mesh-ancestor
110940416|NCT03045016|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110940417|NCT03045016|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110940418|NCT03045016|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110940419|NCT03045016|Adrenergic Agents|adrenergic agents|mesh-ancestor
110940420|NCT03045016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110940421|NCT03045016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110940422|NCT03045016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110940423|NCT04849858|Bupivacaine|bupivacaine|mesh-list
110940424|NCT04849858|Anesthetics, Local|anesthetics, local|mesh-ancestor
110940425|NCT04849858|Anesthetics|anesthetics|mesh-ancestor
110249688|NCT05560919|Vitamins|vitamins|mesh-ancestor
110940426|NCT04849858|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110940427|NCT04849858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110940428|NCT04849858|Sensory System Agents|sensory system agents|mesh-ancestor
110940429|NCT04849858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110940430|NCT03043612|Doxazosin|doxazosin|mesh-list
110940431|NCT03043612|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110940432|NCT03043612|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110940433|NCT03043612|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110940434|NCT03043612|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110940435|NCT03043612|Adrenergic Agents|adrenergic agents|mesh-ancestor
110940436|NCT03043612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110940437|NCT03043612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110940438|NCT03043612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110940439|NCT02230176|Sunitinib|sunitinib|mesh-list
110940440|NCT02230176|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
110940441|NCT02230176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110940442|NCT02230176|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110940443|NCT02230176|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110940444|NCT02230176|Growth Substances|growth substances|mesh-ancestor
110940445|NCT02230176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110940446|NCT02230176|Growth Inhibitors|growth inhibitors|mesh-ancestor
110940447|NCT02230176|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110288567|NCT00241605|Metformin|metformin|mesh-list
110940462|NCT02232516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110940463|NCT02232516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110940464|NCT03647592|Bevacizumab|bevacizumab|mesh-list
110940465|NCT03647592|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110940466|NCT03647592|Gefitinib|gefitinib|mesh-list
110940467|NCT03647592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110940468|NCT03647592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110940469|NCT03647592|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110940470|NCT03647592|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110940471|NCT03647592|Growth Substances|growth substances|mesh-ancestor
110940472|NCT03647592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110940473|NCT03647592|Growth Inhibitors|growth inhibitors|mesh-ancestor
110940474|NCT03647592|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110940475|NCT03647592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110940476|NCT03647592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110940477|NCT02232594|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
110940478|NCT02232594|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110937062|NCT05442216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110937064|NCT05442216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110937065|NCT05417594|Temozolomide|temozolomide|mesh-list
110937066|NCT05417594|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110937067|NCT05417594|Alkylating Agents|alkylating agents|mesh-ancestor
110937068|NCT05417594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110937069|NCT05417594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110937070|NCT05390515|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110937071|NCT05390515|Immunologic Factors|immunologic factors|mesh-ancestor
110937072|NCT05390515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110937073|NCT05372588|Vaccines|vaccines|mesh-list
110937074|NCT05372588|Immunologic Factors|immunologic factors|mesh-ancestor
110937075|NCT05372588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110682996|NCT00908921|Glimepiride|glimepiride|mesh-list
110937121|NCT05301842|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110937122|NCT05301842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110937123|NCT05301842|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110937124|NCT05301842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110937125|NCT05301842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110937192|NCT05108870|Tubulin Modulators|tubulin modulators|mesh-ancestor
110937193|NCT05108870|Antimitotic Agents|antimitotic agents|mesh-ancestor
110937194|NCT05108870|Mitosis Modulators|mitosis modulators|mesh-ancestor
110937195|NCT05108870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110937196|NCT05099276|Tranexamic Acid|tranexamic acid|mesh-list
110937197|NCT05099276|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110937198|NCT05099276|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110937199|NCT05099276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110937200|NCT05099276|Hemostatics|hemostatics|mesh-ancestor
110937201|NCT05099276|Coagulants|coagulants|mesh-ancestor
110937202|NCT05096481|Temozolomide|temozolomide|mesh-list
110937203|NCT05096481|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110937204|NCT05096481|Alkylating Agents|alkylating agents|mesh-ancestor
110937205|NCT05096481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110937206|NCT05096481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110937207|NCT05070650|Acetaminophen|acetaminophen|mesh-list
110937208|NCT05070650|Acetylcysteine|acetylcysteine|mesh-list
110937209|NCT05070650|Phenylephrine|phenylephrine|mesh-list
110937238|NCT05047211|Dextrans|dextrans|mesh-list
110937250|NCT04956432|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110937252|NCT04956432|Protective Agents|protective agents|mesh-ancestor
110937253|NCT04956432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110937254|NCT04912492|Ethanol|ethanol|mesh-list
110937255|NCT04912492|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110937256|NCT04912492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110937257|NCT04912492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110937258|NCT04912492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110937259|NCT04906278|Oxytocin|oxytocin|mesh-list
110937260|NCT04906278|Oxytocics|oxytocics|mesh-ancestor
110937261|NCT04906278|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110937262|NCT04906278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110937263|NCT04900038|Lamivudine|lamivudine|mesh-list
110937264|NCT04900038|Dolutegravir|dolutegravir|mesh-list
110937265|NCT04900038|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110937266|NCT04900038|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110937267|NCT04900038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110937268|NCT04900038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110937269|NCT04900038|Antiviral Agents|antiviral agents|mesh-ancestor
110937270|NCT04900038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110937271|NCT04900038|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110937272|NCT04900038|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110937273|NCT04900038|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110937274|NCT04900038|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110937303|NCT04766853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110937304|NCT04766853|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110937305|NCT04766853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110937306|NCT04766853|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110937307|NCT04766853|Immunologic Factors|immunologic factors|mesh-ancestor
110937308|NCT04766853|Viscosupplements|viscosupplements|mesh-ancestor
110937309|NCT04766853|Protective Agents|protective agents|mesh-ancestor
110937311|NCT04755218|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110937312|NCT04755218|Abortifacient Agents|abortifacient agents|mesh-ancestor
110937313|NCT04755218|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110937314|NCT04755218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110937315|NCT04755218|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110937316|NCT04755218|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110937317|NCT04755218|Oxytocics|oxytocics|mesh-ancestor
110937318|NCT04749628|Cannabidiol|cannabidiol|mesh-list
110937334|NCT04693715|RNS60|rns60|mesh-list
110937360|NCT04614610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110937361|NCT04614610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110937362|NCT04614610|Sensory System Agents|sensory system agents|mesh-ancestor
110937363|NCT04614610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110937364|NCT04614610|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110937365|NCT04614610|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110937366|NCT04614610|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110937367|NCT04614610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110655632|NCT04008966|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110937368|NCT04614610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110937369|NCT04613453|Midazolam|midazolam|mesh-list
110937370|NCT04613453|Ketamine|ketamine|mesh-list
110937371|NCT04613453|Analgesics|analgesics|mesh-ancestor
110937372|NCT04613453|Sensory System Agents|sensory system agents|mesh-ancestor
110937373|NCT04613453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110937420|NCT04468230|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110937421|NCT04468230|Autonomic Agents|autonomic agents|mesh-ancestor
110937422|NCT04468230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110937423|NCT04468230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110937424|NCT04468230|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110937425|NCT04468230|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110937426|NCT04468230|Cholinergic Agents|cholinergic agents|mesh-ancestor
110937427|NCT04468230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110937428|NCT04468230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110937429|NCT04456387|Factor VIII|factor viii|mesh-list
110937487|NCT04323956|Immunoconjugates|immunoconjugates|mesh-list
110937488|NCT04323956|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
110937489|NCT04323956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110937490|NCT04323956|Immunologic Factors|immunologic factors|mesh-ancestor
110937491|NCT04323956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110937492|NCT04323956|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110937493|NCT04323956|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110937494|NCT04323956|Alkylating Agents|alkylating agents|mesh-ancestor
110937495|NCT04323956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110937496|NCT04323956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110937497|NCT04323956|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110937498|NCT04323956|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110937499|NCT04323956|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110937500|NCT04323956|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110937501|NCT04323956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110937502|NCT04323956|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110937503|NCT04323956|Glucocorticoids|glucocorticoids|mesh-ancestor
110937549|NCT04238754|Anticonvulsants|anticonvulsants|mesh-ancestor
110937550|NCT04232358|Anesthetics|anesthetics|mesh-list
110937551|NCT04232358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110937552|NCT04232358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110937553|NCT04223570|Protoporphyrin IX|protoporphyrin ix|mesh-list
110937554|NCT04223570|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110937555|NCT04223570|Dermatologic Agents|dermatologic agents|mesh-ancestor
110937556|NCT04208958|Vancomycin|vancomycin|mesh-list
110937557|NCT04208958|Nivolumab|nivolumab|mesh-list
110937558|NCT04208958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110937610|NCT03944772|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110937611|NCT03940703|Osimertinib|osimertinib|mesh-list
110937612|NCT03940703|Tepotinib|tepotinib|mesh-list
110937613|NCT03940703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110937614|NCT03940703|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110937615|NCT03940703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110937616|NCT03940703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110937617|NCT03921242|Metformin|metformin|mesh-list
110937618|NCT03921242|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
110937619|NCT03921242|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
110937620|NCT03921242|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110937621|NCT03921242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110937622|NCT03921242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110937623|NCT03921242|Protease Inhibitors|protease inhibitors|mesh-ancestor
110937624|NCT03921242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110937625|NCT03920293|Ravulizumab|ravulizumab|mesh-list
110937626|NCT03920293|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
110937627|NCT03920293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110937628|NCT03920293|Immunologic Factors|immunologic factors|mesh-ancestor
110937629|NCT03920293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110937630|NCT03915769|Ozanimod|ozanimod|mesh-list
110937663|NCT03820830|Palbociclib|palbociclib|mesh-list
110937664|NCT03820830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110937665|NCT03820830|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110937666|NCT03820830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110937667|NCT03820830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110937668|NCT03602586|Pembrolizumab|pembrolizumab|mesh-list
110937669|NCT03602586|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110937670|NCT03602586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110937671|NCT03602586|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110937672|NCT03602586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110937673|NCT03535272|Bismuth|bismuth|mesh-list
110937674|NCT03535272|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
110937675|NCT03535272|Antacids|antacids|mesh-ancestor
110937676|NCT03535272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110937677|NCT03535272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110937678|NCT03535272|Antidiarrheals|antidiarrheals|mesh-ancestor
110937679|NCT03530189|Insulin|insulin|mesh-list
110937680|NCT03530189|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110937721|NCT03317496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110937722|NCT03317496|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110937723|NCT03317496|Antimetabolites|antimetabolites|mesh-ancestor
110937724|NCT03317496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110937725|NCT03317496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110937726|NCT03317496|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110937727|NCT03317496|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110937728|NCT03317496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110937729|NCT03317496|Immunologic Factors|immunologic factors|mesh-ancestor
110937730|NCT03317496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110937731|NCT03301506|Seladelpar|seladelpar|mesh-list
110937786|NCT03269136|Glucocorticoids|glucocorticoids|mesh-ancestor
110937788|NCT03269136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110937789|NCT03269136|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110937790|NCT03269136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110937791|NCT03269136|Protease Inhibitors|protease inhibitors|mesh-ancestor
110937792|NCT03269136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110937793|NCT03269136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110937854|NCT03096782|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110937855|NCT03096782|Lenograstim|lenograstim|mesh-list
110937856|NCT03096782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110937857|NCT03096782|Immunologic Factors|immunologic factors|mesh-ancestor
110937858|NCT03096782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110937859|NCT03096782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110937860|NCT03096782|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110937861|NCT03096782|Alkylating Agents|alkylating agents|mesh-ancestor
110937862|NCT03096782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110937863|NCT03096782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110937918|NCT02536183|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110937919|NCT02536183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110937920|NCT02536183|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110937991|NCT02143414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110937992|NCT02143414|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110937993|NCT02143414|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110937994|NCT02143414|Tubulin Modulators|tubulin modulators|mesh-ancestor
110937995|NCT02143414|Antimitotic Agents|antimitotic agents|mesh-ancestor
110938065|NCT02112916|Protective Agents|protective agents|mesh-ancestor
110938066|NCT02112916|Vitamin B Complex|vitamin b complex|mesh-ancestor
110938067|NCT02112916|Vitamins|vitamins|mesh-ancestor
110938138|NCT01474200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110938139|NCT01407263|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110938140|NCT01407263|Hemostatics|hemostatics|mesh-list
110938141|NCT01407263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110938142|NCT01407263|Coagulants|coagulants|mesh-ancestor
110938143|NCT01351103|Spartalizumab|spartalizumab|mesh-list
110938144|NCT01351103|LGK974|lgk974|mesh-list
110938145|NCT01351103|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110938146|NCT01351103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110938147|NCT01351103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110938148|NCT01351103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110938149|NCT01351103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110938200|NCT05156450|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110938201|NCT05156450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110938202|NCT05156450|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110938203|NCT05156450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110938204|NCT05156450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110938205|NCT05156450|Hormone Antagonists|hormone antagonists|mesh-ancestor
110938206|NCT05156450|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110938207|NCT03060304|Tamoxifen|tamoxifen|mesh-list
110938208|NCT03060304|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110938210|NCT03060304|Estradiol|estradiol|mesh-list
110938264|NCT03470480|Sympathomimetics|sympathomimetics|mesh-ancestor
110938265|NCT03470480|Autonomic Agents|autonomic agents|mesh-ancestor
110938266|NCT03470480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110938267|NCT03470480|Dopamine Agents|dopamine agents|mesh-ancestor
110938268|NCT03470480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110938269|NCT03470480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110938270|NCT03470480|Adrenergic Agents|adrenergic agents|mesh-ancestor
110938271|NCT03470480|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110938272|NCT03470480|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110938273|NCT03470480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110938274|NCT03470480|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110938326|NCT02603900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110938327|NCT02603900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110938328|NCT02603900|Sensory System Agents|sensory system agents|mesh-ancestor
110938329|NCT02603900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110938330|NCT01669798|Nintedanib|nintedanib|mesh-list
110938331|NCT01669798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110938332|NCT01669798|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110938333|NCT01669798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110938334|NCT01669798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110938335|NCT02334722|Levetiracetam|levetiracetam|mesh-list
110938336|NCT02334722|Anticonvulsants|anticonvulsants|mesh-ancestor
110938337|NCT02334722|Nootropic Agents|nootropic agents|mesh-ancestor
110938338|NCT04458116|Curcumin|curcumin|mesh-list
110938339|NCT04458116|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110938340|NCT04458116|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110938341|NCT04458116|Analgesics|analgesics|mesh-ancestor
110938342|NCT04458116|Sensory System Agents|sensory system agents|mesh-ancestor
110938343|NCT04458116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110938344|NCT04458116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110938345|NCT04458116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110938346|NCT04458116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110938347|NCT04458116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110938348|NCT04458116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110938350|NCT03469544|Hormones|hormones|mesh-list
110938375|NCT04975360|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110938376|NCT04975360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110938377|NCT04975360|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110938378|NCT04975360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110938379|NCT04975360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110938380|NCT04975360|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110938381|NCT04975360|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110938386|NCT00563576|Estradiol|estradiol|mesh-list
110938441|NCT03469310|Analgesics|analgesics|mesh-ancestor
110938442|NCT03469310|Sensory System Agents|sensory system agents|mesh-ancestor
110938443|NCT03469310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110938444|NCT03469310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110938445|NCT03469310|Antipyretics|antipyretics|mesh-ancestor
110938446|NCT03469310|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110938447|NCT03469310|Narcotics|narcotics|mesh-ancestor
110938449|NCT03469310|Antitussive Agents|antitussive agents|mesh-ancestor
110938507|NCT03054220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110938508|NCT03054220|Dopamine Agents|dopamine agents|mesh-ancestor
110938509|NCT03054220|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110938510|NCT03054220|Serotonin Agents|serotonin agents|mesh-ancestor
110938578|NCT03054610|Betamethasone benzoate|betamethasone benzoate|mesh-list
110938598|NCT03054610|Hormones|hormones|mesh-ancestor
110938649|NCT04430998|Polaprezinc|polaprezinc|mesh-list
110938650|NCT04430998|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110938651|NCT04430998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110938652|NCT04430998|Disinfectants|disinfectants|mesh-ancestor
110938653|NCT04430998|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110249724|NCT00503815|Laxatives|laxatives|mesh-ancestor
110938654|NCT04430998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110938655|NCT04900948|Methylprednisolone|methylprednisolone|mesh-list
110938656|NCT04900948|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110938716|NCT04907344|Paclitaxel|paclitaxel|mesh-list
110938717|NCT04907344|Carboplatin|carboplatin|mesh-list
110938718|NCT04907344|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110938719|NCT04907344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110938720|NCT04907344|Tubulin Modulators|tubulin modulators|mesh-ancestor
110938721|NCT04907344|Antimitotic Agents|antimitotic agents|mesh-ancestor
110938722|NCT04907344|Mitosis Modulators|mitosis modulators|mesh-ancestor
110938723|NCT04907344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110938724|NCT04906876|Gemcitabine|gemcitabine|mesh-list
110938725|NCT04906876|Docetaxel|docetaxel|mesh-list
110938726|NCT04906876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110938727|NCT04906876|Antimetabolites|antimetabolites|mesh-ancestor
110938782|NCT03050866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110938783|NCT03050866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110938853|NCT04648826|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110938854|NCT04648826|Antimetabolites|antimetabolites|mesh-ancestor
110938855|NCT04648826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110938856|NCT04648826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110938857|NCT04648826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110938858|NCT03052348|Fusidic Acid|fusidic acid|mesh-list
110938859|NCT03052348|Betamethasone|betamethasone|mesh-list
110938860|NCT03052348|Betamethasone Valerate|betamethasone valerate|mesh-list
110938919|NCT04897984|Anti-Infective Agents|anti-infective agents|mesh-list
110938920|NCT04897984|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110938921|NCT04456088|Nitric Oxide|nitric oxide|mesh-list
110938922|NCT04456088|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110938923|NCT04456088|Autonomic Agents|autonomic agents|mesh-ancestor
110938924|NCT04456088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110938925|NCT04456088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110938926|NCT04456088|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110938927|NCT04456088|Respiratory System Agents|respiratory system agents|mesh-ancestor
110938928|NCT04456088|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110938929|NCT04456088|Antioxidants|antioxidants|mesh-ancestor
110938930|NCT04456088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110938931|NCT04456088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110938980|NCT03161054|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110938981|NCT03161054|Alkylating Agents|alkylating agents|mesh-ancestor
110938982|NCT03161054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110938983|NCT03161054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110938987|NCT03161054|Glucocorticoids|glucocorticoids|mesh-ancestor
110939047|NCT02595320|Antimetabolites|antimetabolites|mesh-ancestor
110939048|NCT02595320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110939049|NCT02595320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110939050|NCT02809053|Rituximab|rituximab|mesh-list
110939051|NCT02809053|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110939116|NCT02522858|Respiratory System Agents|respiratory system agents|mesh-ancestor
110939118|NCT02522858|Parasympatholytics|parasympatholytics|mesh-ancestor
110939119|NCT02522858|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110939120|NCT02522858|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110939121|NCT02522858|Cholinergic Agents|cholinergic agents|mesh-ancestor
110939122|NCT02522858|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110939123|NCT02522858|Sympathomimetics|sympathomimetics|mesh-ancestor
110939124|NCT02522858|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110939185|NCT04895800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110939186|NCT04895800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110939187|NCT04895800|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110939188|NCT04895800|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110939190|NCT04895800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110939255|NCT02124824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110939256|NCT04880746|Cladribine|cladribine|mesh-list
110939257|NCT04880746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110939258|NCT04880746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110939259|NCT04880746|Immunologic Factors|immunologic factors|mesh-ancestor
110939260|NCT04880746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110939261|NCT03050086|Minocycline|minocycline|mesh-list
110939262|NCT03050086|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110939263|NCT03050086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110939264|NCT03050242|Glycopyrrolate|glycopyrrolate|mesh-list
110939265|NCT03050242|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110939266|NCT03050242|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110939322|NCT04879030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110939323|NCT04879030|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110939324|NCT04879030|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110939325|NCT04879030|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110939326|NCT04879030|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110939392|NCT02048943|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
110939393|NCT02048943|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110939394|NCT02048943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110939396|NCT02048943|Antimitotic Agents|antimitotic agents|mesh-ancestor
110939397|NCT02048943|Mitosis Modulators|mitosis modulators|mesh-ancestor
110939400|NCT02048943|Antimetabolites|antimetabolites|mesh-ancestor
110939461|NCT02049255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110939462|NCT02049255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110939463|NCT02049255|Sensory System Agents|sensory system agents|mesh-ancestor
110939465|NCT02037711|Levobupivacaine|levobupivacaine|mesh-list
110939530|NCT02802345|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110939531|NCT02053779|Triptorelin Pamoate|triptorelin pamoate|mesh-list
110939532|NCT02053779|Luteolytic Agents|luteolytic agents|mesh-ancestor
110939533|NCT02053779|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110939534|NCT02053779|Contraceptive Agents|contraceptive agents|mesh-ancestor
110939602|NCT02056743|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110939603|NCT02056743|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110939604|NCT02056743|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110939605|NCT02056743|Anesthetics, General|anesthetics, general|mesh-ancestor
110939606|NCT02056743|Anesthetics|anesthetics|mesh-ancestor
110939607|NCT02056743|GABA Modulators|gaba modulators|mesh-ancestor
110939608|NCT02056743|GABA Agents|gaba agents|mesh-ancestor
110939609|NCT02056743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110939610|NCT02056743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110939611|NCT02056743|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110939612|NCT02056743|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110939613|NCT02056743|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110939614|NCT02056743|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110939615|NCT02056743|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110939617|NCT02056743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110939662|NCT02057367|Anesthetics|anesthetics|mesh-ancestor
110939663|NCT02057367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110939664|NCT02057367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110939735|NCT04870060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110939736|NCT04870060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110939737|NCT04870060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110939738|NCT04870060|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110939739|NCT04870060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110939740|NCT04870060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110939741|NCT04870060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110939742|NCT02613910|Acetaminophen|acetaminophen|mesh-list
110939743|NCT02613910|Cetirizine|cetirizine|mesh-list
110939744|NCT02613910|Prednisone|prednisone|mesh-list
110939745|NCT02613910|Prednisolone|prednisolone|mesh-list
110939746|NCT02613910|Ofatumumab|ofatumumab|mesh-list
110939747|NCT02613910|Histamine Antagonists|histamine antagonists|mesh-list
110939748|NCT02613910|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
110939749|NCT02613910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110939750|NCT02613910|Glucocorticoids|glucocorticoids|mesh-ancestor
110939793|NCT02060955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110939794|NCT02060955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110939795|NCT02273362|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110939796|NCT02273362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110939865|NCT01333059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110939866|NCT02060253|Paclitaxel|paclitaxel|mesh-list
110939867|NCT02060253|Trastuzumab|trastuzumab|mesh-list
110939868|NCT02060253|Pertuzumab|pertuzumab|mesh-list
110939937|NCT04865224|Sensory System Agents|sensory system agents|mesh-ancestor
110249732|NCT01247077|Micronutrients|micronutrients|mesh-ancestor
110939938|NCT04865224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110939939|NCT04865224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110939940|NCT04865224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110939941|NCT04865224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110657449|NCT04781088|Paclitaxel|paclitaxel|mesh-list
110939943|NCT04865380|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110939944|NCT04865380|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110939946|NCT04865380|Hemostatics|hemostatics|mesh-ancestor
110940003|NCT03044938|Adrenergic Agents|adrenergic agents|mesh-ancestor
110940004|NCT03044938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110940005|NCT03044938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110940006|NCT03045484|Oxycodone|oxycodone|mesh-list
110940077|NCT02798835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110940078|NCT02798835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110940079|NCT02798835|Anesthetics, Local|anesthetics, local|mesh-ancestor
110940080|NCT02798835|Anesthetics|anesthetics|mesh-ancestor
110940081|NCT02798835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110940082|NCT02798835|Sensory System Agents|sensory system agents|mesh-ancestor
110940083|NCT02798835|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110940084|NCT02798835|Narcotics|narcotics|mesh-ancestor
110940085|NCT02798835|Analgesics|analgesics|mesh-ancestor
110940086|NCT02798835|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110940087|NCT02798835|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110940088|NCT02798835|Anesthetics, General|anesthetics, general|mesh-ancestor
110940138|NCT02611882|Chelating Agents|chelating agents|mesh-ancestor
110940139|NCT02611882|Sequestering Agents|sequestering agents|mesh-ancestor
110940140|NCT02611882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110940141|NCT02611882|Anticoagulants|anticoagulants|mesh-ancestor
110940142|NCT02611882|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110940143|NCT02611882|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110940144|NCT02062281|Vaccines|vaccines|mesh-list
110940145|NCT02062281|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110940204|NCT02063373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110940205|NCT02063373|Viscosupplements|viscosupplements|mesh-ancestor
110940206|NCT02063373|Protective Agents|protective agents|mesh-ancestor
110940207|NCT02062749|Oxaliplatin|oxaliplatin|mesh-list
110940208|NCT02062749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110940209|NCT02796651|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110940210|NCT02796651|Formoterol Fumarate|formoterol fumarate|mesh-list
110940211|NCT02796651|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110940212|NCT02796651|Autonomic Agents|autonomic agents|mesh-ancestor
110940213|NCT02796651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110940219|NCT02796651|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110940269|NCT02062983|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110940270|NCT02062983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110940271|NCT02613208|Paclitaxel|paclitaxel|mesh-list
110940272|NCT02613208|Bevacizumab|bevacizumab|mesh-list
110940273|NCT02613208|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110940274|NCT02613208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110940275|NCT02613208|Tubulin Modulators|tubulin modulators|mesh-ancestor
110940276|NCT02613208|Antimitotic Agents|antimitotic agents|mesh-ancestor
110940277|NCT02613208|Mitosis Modulators|mitosis modulators|mesh-ancestor
110940278|NCT02613208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110940279|NCT02613208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110940280|NCT02613208|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110940281|NCT02613208|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110940282|NCT02613208|Growth Substances|growth substances|mesh-ancestor
110940283|NCT02613208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110940284|NCT02613208|Growth Inhibitors|growth inhibitors|mesh-ancestor
110940285|NCT02063841|Bismuth|bismuth|mesh-list
110940286|NCT02063841|Antacids|antacids|mesh-ancestor
110940287|NCT02063841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110940288|NCT02063841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110940289|NCT02064153|Dialysis Solutions|dialysis solutions|mesh-list
110940290|NCT02064153|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110940291|NCT04872634|Cetuximab|cetuximab|mesh-list
110940292|NCT04872634|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110940293|NCT04872634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110940294|NCT01668784|Nivolumab|nivolumab|mesh-list
110940318|NCT02229240|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
110940319|NCT02229240|Incretins|incretins|mesh-ancestor
110940320|NCT02229240|Hormones|hormones|mesh-ancestor
110940321|NCT02229240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110940322|NCT02229240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110940323|NCT02820714|Laxatives|laxatives|mesh-list
110940324|NCT02820714|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110940325|NCT02259426|Primaquine|primaquine|mesh-list
110940326|NCT02259426|Piperaquine|piperaquine|mesh-list
110940327|NCT02259426|Artenimol|artenimol|mesh-list
110940328|NCT02259426|Antimalarials|antimalarials|mesh-ancestor
110940329|NCT02259426|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110940330|NCT02259426|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110940331|NCT02259426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110940332|NCT03742518|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110940333|NCT03738618|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
110940334|NCT03738618|Hormones|hormones|mesh-ancestor
110940378|NCT02229786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110940379|NCT02229786|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110940380|NCT02229786|Antiemetics|antiemetics|mesh-ancestor
110940448|NCT02230176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110940449|NCT02230176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110940450|NCT02230176|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110940451|NCT02232516|Lenalidomide|lenalidomide|mesh-list
110940452|NCT02232516|Romidepsin|romidepsin|mesh-list
110940453|NCT02232516|Immunologic Factors|immunologic factors|mesh-ancestor
110940454|NCT02232516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110940455|NCT02232516|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110940456|NCT02232516|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110940457|NCT02232516|Growth Substances|growth substances|mesh-ancestor
110940458|NCT02232516|Growth Inhibitors|growth inhibitors|mesh-ancestor
110940459|NCT02232516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110940460|NCT02232516|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110940461|NCT02232516|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110940480|NCT02232594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110940481|NCT02232594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110940482|NCT02232594|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110940483|NCT02232594|Respiratory System Agents|respiratory system agents|mesh-ancestor
110940485|NCT04858516|Palbociclib|palbociclib|mesh-list
110940486|NCT04858516|Exemestane|exemestane|mesh-list
110940487|NCT04858516|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110940488|NCT04858516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110940489|NCT04858516|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110940490|NCT04858516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110940491|NCT04858516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110940492|NCT04858516|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110940493|NCT04858516|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110940494|NCT04858516|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110940495|NCT04858516|Hormone Antagonists|hormone antagonists|mesh-ancestor
110940496|NCT04858516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110940497|NCT04858516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110940498|NCT03148860|Methotrexate|methotrexate|mesh-list
110940499|NCT03148860|Ustekinumab|ustekinumab|mesh-list
110940500|NCT03148860|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110940501|NCT03148860|Abortifacient Agents|abortifacient agents|mesh-ancestor
110940502|NCT03148860|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110940503|NCT03148860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110940504|NCT03148860|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110940505|NCT03148860|Antimetabolites|antimetabolites|mesh-ancestor
110288637|NCT04646161|Abortifacient Agents|abortifacient agents|mesh-ancestor
110940506|NCT03148860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110940507|NCT03148860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110940726|NCT02233452|Ketamine|ketamine|mesh-list
110940508|NCT03148860|Dermatologic Agents|dermatologic agents|mesh-ancestor
110940509|NCT03148860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110940510|NCT03148860|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110940511|NCT03148860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110940512|NCT03148860|Immunologic Factors|immunologic factors|mesh-ancestor
110940513|NCT03148860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110940514|NCT03148860|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110940515|NCT03131154|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110940516|NCT03131154|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110940517|NCT02232672|Choline|choline|mesh-list
110940518|NCT02232672|Lipotropic Agents|lipotropic agents|mesh-ancestor
110940519|NCT02232672|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110940520|NCT02232672|Antimetabolites|antimetabolites|mesh-ancestor
110940521|NCT02232672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110940522|NCT02232672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110940523|NCT02232672|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110940524|NCT02232672|Nootropic Agents|nootropic agents|mesh-ancestor
110940525|NCT05072262|Dexamethasone|dexamethasone|mesh-list
110940526|NCT05072262|Nepafenac|nepafenac|mesh-list
110940527|NCT05072262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110940528|NCT05072262|Antiemetics|antiemetics|mesh-ancestor
110940529|NCT05072262|Autonomic Agents|autonomic agents|mesh-ancestor
110940530|NCT05072262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110940531|NCT05072262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110940532|NCT05072262|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110940533|NCT05072262|Glucocorticoids|glucocorticoids|mesh-ancestor
110940534|NCT05072262|Hormones|hormones|mesh-ancestor
110940535|NCT05072262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110940536|NCT05072262|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110940537|NCT05072262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110940538|NCT05072262|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110940539|NCT05072262|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110941064|NCT04838860|Siltuximab|siltuximab|mesh-list
110940540|NCT05072262|Analgesics|analgesics|mesh-ancestor
110940541|NCT05072262|Sensory System Agents|sensory system agents|mesh-ancestor
110940542|NCT05072262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110940543|NCT04858048|Anesthetics|anesthetics|mesh-list
110940544|NCT04858048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110940545|NCT04858048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110940547|NCT02234466|Ondansetron|ondansetron|mesh-list
110940548|NCT02234466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110940549|NCT02234466|Antiemetics|antiemetics|mesh-ancestor
110940550|NCT02234466|Autonomic Agents|autonomic agents|mesh-ancestor
110940551|NCT02234466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110940552|NCT02234466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110940553|NCT02234466|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110940554|NCT02234466|Glucocorticoids|glucocorticoids|mesh-ancestor
110940555|NCT02234466|Hormones|hormones|mesh-ancestor
110940556|NCT02234466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110940557|NCT02234466|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110940558|NCT02234466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110940559|NCT02234466|Antipruritics|antipruritics|mesh-ancestor
110940560|NCT02234466|Dermatologic Agents|dermatologic agents|mesh-ancestor
110940561|NCT02234466|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110940562|NCT02234466|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110940564|NCT02234466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110940565|NCT02234466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110940566|NCT02230800|Tocovid|tocovid|mesh-list
110940567|NCT02230800|Pentoxifylline|pentoxifylline|mesh-list
110940568|NCT02230800|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110940569|NCT02230800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110940570|NCT02230800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110940571|NCT02230800|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110940572|NCT02230800|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110940573|NCT02230800|Protective Agents|protective agents|mesh-ancestor
110940574|NCT02230800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110940575|NCT02230800|Vasodilator Agents|vasodilator agents|mesh-ancestor
110940576|NCT02230800|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110940577|NCT02230800|Antioxidants|antioxidants|mesh-ancestor
110940578|NCT02230800|Vitamins|vitamins|mesh-ancestor
110940579|NCT02230800|Micronutrients|micronutrients|mesh-ancestor
110940580|NCT02234544|Vitamin D|vitamin d|mesh-list
110941322|NCT06058585|Diuretics|diuretics|mesh-ancestor
110940581|NCT02234544|Cholecalciferol|cholecalciferol|mesh-list
110940582|NCT02234544|Ezetimibe|ezetimibe|mesh-list
110940583|NCT02234544|Vitamins|vitamins|mesh-ancestor
110940584|NCT02234544|Micronutrients|micronutrients|mesh-ancestor
110940585|NCT02234544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110940586|NCT02234544|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110940587|NCT02234544|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110940588|NCT02234544|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110940589|NCT02234544|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110940590|NCT02234544|Antimetabolites|antimetabolites|mesh-ancestor
110940591|NCT02234544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110940592|NCT02234544|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110940593|NCT03043066|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110940594|NCT03043066|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
110940595|NCT03043066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110940596|NCT03043066|Antitubercular Agents|antitubercular agents|mesh-ancestor
110940597|NCT04860076|Pembrolizumab|pembrolizumab|mesh-list
110940598|NCT04860076|Nivolumab|nivolumab|mesh-list
110940599|NCT04860076|Ipilimumab|ipilimumab|mesh-list
110940600|NCT04860076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110940601|NCT04860076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110940602|NCT04860076|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110940603|NCT04860076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110940604|NCT04856878|Vancomycin|vancomycin|mesh-list
110940605|NCT04856878|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110940606|NCT04856878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110940607|NCT04856644|Moxifloxacin|moxifloxacin|mesh-list
110940608|NCT04856644|Rifapentine|rifapentine|mesh-list
110940609|NCT04856644|Rifampin|rifampin|mesh-list
110940610|NCT04856644|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110940611|NCT04856644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110940612|NCT04856644|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110940613|NCT04856644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110940614|NCT04856644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110940615|NCT04856644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110940616|NCT04856644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110940617|NCT04856644|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110940618|NCT04856644|Antitubercular Agents|antitubercular agents|mesh-ancestor
110940619|NCT04856644|Leprostatic Agents|leprostatic agents|mesh-ancestor
110940620|NCT04856644|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110940621|NCT04856644|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110940622|NCT04856644|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110940623|NCT04856644|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110940624|NCT04856644|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110940625|NCT04856644|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110940626|NCT04856644|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110940628|NCT01329978|Antiviral Agents|antiviral agents|mesh-ancestor
110940629|NCT01329978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110940630|NCT04984278|Nabiximols|nabiximols|mesh-list
110940631|NCT04984278|Analgesics|analgesics|mesh-ancestor
110940632|NCT04984278|Sensory System Agents|sensory system agents|mesh-ancestor
110940633|NCT04984278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110940634|NCT04984278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110940635|NCT02233218|Amlodipine|amlodipine|mesh-list
110940636|NCT02233218|Telmisartan|telmisartan|mesh-list
110940637|NCT02233218|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110940638|NCT02233218|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110940639|NCT02233218|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110940640|NCT02233218|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110940641|NCT02233218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110940642|NCT02233218|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110940643|NCT02233218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110940644|NCT02233218|Vasodilator Agents|vasodilator agents|mesh-ancestor
110940645|NCT02233218|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110940646|NCT02233218|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110940647|NCT02233218|Antimetabolites|antimetabolites|mesh-ancestor
110940648|NCT02233218|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110940649|NCT02233218|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110940650|NCT02233218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110940651|NCT02233218|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110940652|NCT02233218|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110940653|NCT02262546|Moxifloxacin|moxifloxacin|mesh-list
110940654|NCT02262546|Pramipexole|pramipexole|mesh-list
110940655|NCT02262546|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
110940656|NCT02262546|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110940657|NCT02262546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110940658|NCT02262546|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110940659|NCT02262546|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110940660|NCT02262546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110940661|NCT02262546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110940662|NCT02262546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110940663|NCT02262546|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110940664|NCT02262546|Contraceptive Agents|contraceptive agents|mesh-ancestor
110940665|NCT02262546|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110940666|NCT02262546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110940667|NCT02262546|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110940668|NCT02262546|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110940669|NCT02262546|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110940670|NCT02262546|Antioxidants|antioxidants|mesh-ancestor
110940671|NCT02262546|Protective Agents|protective agents|mesh-ancestor
110940672|NCT02262546|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110940673|NCT02262546|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110940674|NCT02262546|Dopamine Agonists|dopamine agonists|mesh-ancestor
110940675|NCT02262546|Dopamine Agents|dopamine agents|mesh-ancestor
110940676|NCT02262546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110940677|NCT03042052|Botulinum Toxins|botulinum toxins|mesh-list
110940678|NCT03042052|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110940679|NCT03042052|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110940680|NCT03042052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110940681|NCT03042052|Cholinergic Agents|cholinergic agents|mesh-ancestor
110940682|NCT03042052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110940683|NCT03042052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110940684|NCT04856098|Glycopyrrolate|glycopyrrolate|mesh-list
110940685|NCT04856098|Bromides|bromides|mesh-list
110940686|NCT04856098|Maleic acid|maleic acid|mesh-list
110940687|NCT04856098|Charcoal|charcoal|mesh-list
110940688|NCT04856098|Anticonvulsants|anticonvulsants|mesh-ancestor
110940689|NCT04856098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110940690|NCT04856098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110940691|NCT04856098|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110940692|NCT04856098|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110940693|NCT04856098|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110940694|NCT04856098|Cholinergic Agents|cholinergic agents|mesh-ancestor
110940695|NCT04856098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110658209|NCT01081639|Hormones|hormones|mesh-ancestor
110940696|NCT04856098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110940697|NCT04856098|Antidotes|antidotes|mesh-ancestor
110940698|NCT04856098|Protective Agents|protective agents|mesh-ancestor
110940699|NCT04859452|Metformin|metformin|mesh-list
110940700|NCT04859452|Glyburide|glyburide|mesh-list
110940701|NCT04859452|Valsartan|valsartan|mesh-list
110940702|NCT04859452|Simvastatin|simvastatin|mesh-list
110940703|NCT04859452|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110288852|NCT00559312|Fluticasone|fluticasone|mesh-list
110940704|NCT04859452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110940705|NCT04859452|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110940706|NCT04859452|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110940707|NCT04859452|Antimetabolites|antimetabolites|mesh-ancestor
110940708|NCT04859452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110940709|NCT04859452|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110940710|NCT04859452|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110940711|NCT04859452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110940712|NCT04859452|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110940713|NCT04859452|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110940714|NCT04859452|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110940715|NCT02262624|Telmisartan|telmisartan|mesh-list
110940716|NCT02262624|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110940717|NCT02262624|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110940718|NCT02262624|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110940719|NCT02262624|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110940720|NCT02262624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110940721|NCT02262624|Diuretics|diuretics|mesh-ancestor
110940722|NCT02262624|Natriuretic Agents|natriuretic agents|mesh-ancestor
110940723|NCT02262624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110940724|NCT02262624|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110940725|NCT02262624|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110940728|NCT02233452|Analgesics|analgesics|mesh-ancestor
110940729|NCT02233452|Sensory System Agents|sensory system agents|mesh-ancestor
110941529|NCT06056687|Thioctic Acid|thioctic acid|mesh-list
110941530|NCT06056687|Antioxidants|antioxidants|mesh-ancestor
110941531|NCT06056687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110941532|NCT06056687|Protective Agents|protective agents|mesh-ancestor
110941533|NCT06056687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110941534|NCT06056687|Vitamin B Complex|vitamin b complex|mesh-ancestor
110941536|NCT06056687|Micronutrients|micronutrients|mesh-ancestor
110941580|NCT06056349|Midazolam|midazolam|mesh-list
110941581|NCT06056349|Clonazepam|clonazepam|mesh-list
110941582|NCT06056349|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110941583|NCT06056349|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110941584|NCT06056349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110941585|NCT06056349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110941586|NCT06056349|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110941587|NCT06056349|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110940730|NCT02233452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110940731|NCT02233452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110940732|NCT02233452|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110940733|NCT02233452|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110940734|NCT02233452|Anesthetics, General|anesthetics, general|mesh-ancestor
110940735|NCT02233452|Anesthetics|anesthetics|mesh-ancestor
110940736|NCT02233452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110940737|NCT02233452|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110940738|NCT02233452|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110940739|NCT02233452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110940740|NCT02233452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110940741|NCT02233452|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110940742|NCT02233452|Narcotics|narcotics|mesh-ancestor
110940743|NCT02233452|Antitussive Agents|antitussive agents|mesh-ancestor
110941588|NCT06056349|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110941589|NCT06056349|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110941590|NCT06056349|Anesthetics, General|anesthetics, general|mesh-ancestor
110941591|NCT06056349|Anesthetics|anesthetics|mesh-ancestor
110941592|NCT06056349|GABA Modulators|gaba modulators|mesh-ancestor
110941593|NCT06056349|GABA Agents|gaba agents|mesh-ancestor
110941594|NCT06056349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110941595|NCT06056349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110941596|NCT06056349|Anticonvulsants|anticonvulsants|mesh-ancestor
110940744|NCT02233452|Respiratory System Agents|respiratory system agents|mesh-ancestor
110940745|NCT02262702|Acetaminophen|acetaminophen|mesh-list
110940746|NCT02262702|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110940747|NCT02262702|Analgesics|analgesics|mesh-ancestor
110940748|NCT02262702|Sensory System Agents|sensory system agents|mesh-ancestor
110940749|NCT02262702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110940750|NCT02262702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110940751|NCT02262702|Antipyretics|antipyretics|mesh-ancestor
110940752|NCT04846894|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
110940753|NCT04846894|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110940754|NCT04846894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110940755|NCT04845880|Myeloma Proteins|myeloma proteins|mesh-list
110940756|NCT04845880|Paraproteins|paraproteins|mesh-list
110940757|NCT04845880|Immunologic Factors|immunologic factors|mesh-ancestor
110940758|NCT04845880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110940759|NCT04600752|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
110249781|NCT01248091|Vasodilator Agents|vasodilator agents|mesh-ancestor
110940760|NCT04600752|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110940761|NCT04600752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110940762|NCT04600752|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110940763|NCT04600752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110940764|NCT04600752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110940765|NCT03041506|Lidocaine|lidocaine|mesh-list
110940766|NCT03041506|Midazolam|midazolam|mesh-list
110940767|NCT03041506|Ketamine|ketamine|mesh-list
110940768|NCT03041506|Anesthetics, Local|anesthetics, local|mesh-ancestor
110940770|NCT03041506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110940771|NCT03041506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110940772|NCT03041506|Sensory System Agents|sensory system agents|mesh-ancestor
110940773|NCT03041506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110940774|NCT03041506|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110940775|NCT03041506|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110940776|NCT03041506|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110940777|NCT03041506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110941812|NCT06047366|Lidocaine|lidocaine|mesh-list
110941813|NCT06047366|Epinephrine|epinephrine|mesh-list
110941814|NCT06047366|Racepinephrine|racepinephrine|mesh-list
110941815|NCT06047366|Carticaine|carticaine|mesh-list
110941816|NCT06047366|Mepivacaine|mepivacaine|mesh-list
110941817|NCT06047366|Epinephryl borate|epinephryl borate|mesh-list
110941818|NCT06047366|Anesthetics, Local|anesthetics, local|mesh-ancestor
110941819|NCT06047366|Anesthetics|anesthetics|mesh-ancestor
110941820|NCT06047366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110941821|NCT06047366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110941822|NCT06047366|Sensory System Agents|sensory system agents|mesh-ancestor
110941823|NCT06047366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110941824|NCT06047366|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110941825|NCT06047366|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110941826|NCT06047366|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110941827|NCT06047366|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110941828|NCT06047366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110941829|NCT06047366|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110941830|NCT06047366|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110941831|NCT06047366|Adrenergic Agents|adrenergic agents|mesh-ancestor
110941832|NCT06047366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110941833|NCT06047366|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110941834|NCT06047366|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110941835|NCT06047366|Autonomic Agents|autonomic agents|mesh-ancestor
110941836|NCT06047366|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110941837|NCT06047366|Respiratory System Agents|respiratory system agents|mesh-ancestor
110941839|NCT06047366|Sympathomimetics|sympathomimetics|mesh-ancestor
110941840|NCT06047366|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110941841|NCT06047262|Dapansutrile|dapansutrile|mesh-list
110941842|NCT06047262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110940778|NCT03041506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110940780|NCT03041506|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110940781|NCT03041506|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110940782|NCT03041506|Anesthetics, General|anesthetics, general|mesh-ancestor
110940783|NCT03041506|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110940784|NCT03041506|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110940785|NCT03041506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110940786|NCT03041506|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110940787|NCT03041506|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110659401|NCT00419770|Amphotericin B|amphotericin b|mesh-list
110940788|NCT03041506|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110940789|NCT03041506|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110940790|NCT03041506|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110940791|NCT03041506|GABA Modulators|gaba modulators|mesh-ancestor
110940792|NCT03041506|GABA Agents|gaba agents|mesh-ancestor
110940793|NCT02580708|Trametinib|trametinib|mesh-list
110940794|NCT02580708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110940795|NCT02580708|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110940796|NCT02580708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110940797|NCT02580708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110940798|NCT02262780|Telmisartan|telmisartan|mesh-list
110940799|NCT02262780|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110940800|NCT02262780|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110940801|NCT02262780|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110940802|NCT02262780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110940803|NCT04845646|Itraconazole|itraconazole|mesh-list
110941986|NCT06027983|Trastuzumab|trastuzumab|mesh-list
110941987|NCT06027983|Fludarabine|fludarabine|mesh-list
110941988|NCT06027983|Epoetin Alfa|epoetin alfa|mesh-list
110941989|NCT06027983|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110941990|NCT06027983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110941991|NCT06027983|Hematinics|hematinics|mesh-ancestor
110941992|NCT06021860|Spironolactone|spironolactone|mesh-list
110941993|NCT06021860|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110941994|NCT06021860|Hormone Antagonists|hormone antagonists|mesh-ancestor
110941995|NCT06021860|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110941996|NCT06021860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110941997|NCT06021860|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110941998|NCT06021860|Diuretics|diuretics|mesh-ancestor
110941999|NCT06021860|Natriuretic Agents|natriuretic agents|mesh-ancestor
110942000|NCT06013345|Propofol|propofol|mesh-list
110942001|NCT06013345|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110940804|NCT04845646|Phenytoin|phenytoin|mesh-list
110940805|NCT04845646|Antifungal Agents|antifungal agents|mesh-ancestor
110940806|NCT04845646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110940807|NCT04845646|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110940808|NCT04845646|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110940809|NCT04845646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110940810|NCT04845646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110940811|NCT04845646|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110942002|NCT06013345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110942003|NCT06013345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110942004|NCT06013345|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110942005|NCT06013345|Anesthetics, General|anesthetics, general|mesh-ancestor
110942006|NCT06013345|Anesthetics|anesthetics|mesh-ancestor
110942018|NCT06000787|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
110942019|NCT06000787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110942020|NCT06000787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110942021|NCT06000787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110942022|NCT06000787|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110942047|NCT05994820|Immunologic Factors|immunologic factors|mesh-ancestor
110942048|NCT05994820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110942049|NCT05989165|Minoxidil|minoxidil|mesh-list
110942050|NCT05989165|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110942051|NCT05989165|Vasodilator Agents|vasodilator agents|mesh-ancestor
110940812|NCT04845646|Hormone Antagonists|hormone antagonists|mesh-ancestor
110940813|NCT04845646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110940814|NCT04845646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110940815|NCT04845646|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110940816|NCT04845646|Anticonvulsants|anticonvulsants|mesh-ancestor
110940817|NCT04845646|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110940818|NCT04845646|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110940819|NCT04845646|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110940820|NCT04845646|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110940821|NCT04845646|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110940822|NCT03038776|Hemagglutinins|hemagglutinins|mesh-list
110940823|NCT03038776|Agglutinins|agglutinins|mesh-ancestor
110940824|NCT03038776|Immunologic Factors|immunologic factors|mesh-ancestor
110940825|NCT03038776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110940826|NCT03038776|Coagulants|coagulants|mesh-ancestor
110940827|NCT02570490|Linezolid|linezolid|mesh-list
110940828|NCT02570490|Fusidic Acid|fusidic acid|mesh-list
110940829|NCT02570490|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110940830|NCT02570490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110940831|NCT02570490|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110940832|NCT02570490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110249798|NCT02275039|Gemcitabine|gemcitabine|mesh-list
110940833|NCT02570490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110940834|NCT02565732|Botulinum Toxins|botulinum toxins|mesh-list
110940835|NCT02565732|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110940836|NCT02565732|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110940837|NCT02565732|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110940838|NCT02565732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110940839|NCT02565732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110940840|NCT02565732|Cholinergic Agents|cholinergic agents|mesh-ancestor
110940841|NCT02565732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110940842|NCT02565732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110940843|NCT02565732|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110940844|NCT02565732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110940845|NCT02561442|Ceftriaxone|ceftriaxone|mesh-list
110940846|NCT02561442|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110940847|NCT02561442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110940848|NCT02262858|Telmisartan|telmisartan|mesh-list
110940849|NCT02262858|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110940850|NCT02262858|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110940851|NCT02262858|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110940852|NCT02262858|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110940853|NCT02262858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110940854|NCT02262858|Diuretics|diuretics|mesh-ancestor
110940855|NCT02262858|Natriuretic Agents|natriuretic agents|mesh-ancestor
110940856|NCT02262858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110940857|NCT02262858|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110940858|NCT02262858|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110940859|NCT02235012|Ketamine|ketamine|mesh-list
110940860|NCT02235012|Analgesics|analgesics|mesh-ancestor
110940861|NCT02235012|Sensory System Agents|sensory system agents|mesh-ancestor
110940862|NCT02235012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110940863|NCT02235012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110940864|NCT02235012|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110940865|NCT02235012|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110940866|NCT02235012|Anesthetics, General|anesthetics, general|mesh-ancestor
110940867|NCT02235012|Anesthetics|anesthetics|mesh-ancestor
110940868|NCT02235012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110940869|NCT02235012|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110940870|NCT02235012|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110940871|NCT02235012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110940872|NCT02235012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110940873|NCT02262936|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
110940874|NCT02262936|Fesoterodine|fesoterodine|mesh-list
110940875|NCT02262936|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110940876|NCT02262936|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110940877|NCT02262936|Cholinergic Agents|cholinergic agents|mesh-ancestor
110940878|NCT02262936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110940879|NCT02262936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110940880|NCT02262936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110940881|NCT02262936|Urological Agents|urological agents|mesh-ancestor
110940884|NCT02262936|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
110940885|NCT02262936|Natriuretic Agents|natriuretic agents|mesh-ancestor
110940886|NCT04838704|Mycophenolic Acid|mycophenolic acid|mesh-list
110940887|NCT04838704|Methotrexate|methotrexate|mesh-list
110940888|NCT04838704|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110940889|NCT04838704|Abortifacient Agents|abortifacient agents|mesh-ancestor
110940890|NCT04838704|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110940891|NCT04838704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110940892|NCT04838704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110940893|NCT04838704|Antimetabolites|antimetabolites|mesh-ancestor
110940894|NCT04838704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110940895|NCT04838704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110940896|NCT04838704|Dermatologic Agents|dermatologic agents|mesh-ancestor
110940897|NCT04838704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110940898|NCT04838704|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110249806|NCT01248403|Paclitaxel|paclitaxel|mesh-list
110940899|NCT04838704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110940900|NCT04838704|Immunologic Factors|immunologic factors|mesh-ancestor
110940901|NCT04838704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110940902|NCT04838704|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110940903|NCT04838704|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110940904|NCT04838704|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110940905|NCT04838704|Antitubercular Agents|antitubercular agents|mesh-ancestor
110940906|NCT04838704|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110940907|NCT04838704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110940908|NCT02259738|Kallikreins|kallikreins|mesh-list
110940909|NCT02259738|Coagulants|coagulants|mesh-ancestor
110940910|NCT02259738|Fertility Agents, Male|fertility agents, male|mesh-ancestor
110940911|NCT02259738|Fertility Agents|fertility agents|mesh-ancestor
110940912|NCT02259738|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110940913|NCT02259738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110940915|NCT04854460|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110940916|NCT04854460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110942166|NCT05947851|Rituximab|rituximab|mesh-list
110942167|NCT05947851|Venetoclax|venetoclax|mesh-list
110942168|NCT05947851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110942169|NCT05947851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110942170|NCT05947851|Immunologic Factors|immunologic factors|mesh-ancestor
110942171|NCT05947851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110942172|NCT05947851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110942209|NCT05915728|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
110942210|NCT05915728|Chelating Agents|chelating agents|mesh-ancestor
110942211|NCT05915728|Sequestering Agents|sequestering agents|mesh-ancestor
110942212|NCT05915728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110942213|NCT05915702|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
110942214|NCT05915702|Chelating Agents|chelating agents|mesh-ancestor
110942215|NCT05915702|Sequestering Agents|sequestering agents|mesh-ancestor
110942216|NCT05915702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110942217|NCT05913921|Amphotericin B|amphotericin b|mesh-list
110942218|NCT05913921|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
110942219|NCT05913921|Amebicides|amebicides|mesh-ancestor
110940917|NCT04854538|Budesonide|budesonide|mesh-list
110940918|NCT04854538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110940919|NCT04854538|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110940920|NCT04854538|Autonomic Agents|autonomic agents|mesh-ancestor
110940921|NCT04854538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110940922|NCT04854538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110940923|NCT04854538|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110940924|NCT04854538|Respiratory System Agents|respiratory system agents|mesh-ancestor
110940925|NCT04854538|Glucocorticoids|glucocorticoids|mesh-ancestor
110940927|NCT04854538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110940928|NCT05331690|Dexamethasone|dexamethasone|mesh-list
110940929|NCT05331690|Nepafenac|nepafenac|mesh-list
110940930|NCT05331690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110940931|NCT05331690|Antiemetics|antiemetics|mesh-ancestor
110942220|NCT05913921|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110942221|NCT05913921|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110942222|NCT05913921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110942223|NCT05913921|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110942224|NCT05913921|Antifungal Agents|antifungal agents|mesh-ancestor
110942257|NCT05903092|Carboplatin|carboplatin|mesh-list
110942258|NCT05903092|Etoposide|etoposide|mesh-list
110942259|NCT05903092|Durvalumab|durvalumab|mesh-list
110942260|NCT05903092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110942261|NCT05903092|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110942262|NCT05903092|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110942263|NCT05903092|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110942264|NCT05903092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110942265|NCT05903092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110942266|NCT05903092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110659765|NCT00539838|Ocrelizumab|ocrelizumab|mesh-list
110290409|NCT00222677|Antipyretics|antipyretics|mesh-ancestor
110940932|NCT05331690|Autonomic Agents|autonomic agents|mesh-ancestor
110940933|NCT05331690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110940934|NCT05331690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110940935|NCT05331690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110940936|NCT05331690|Glucocorticoids|glucocorticoids|mesh-ancestor
110940937|NCT05331690|Hormones|hormones|mesh-ancestor
110940938|NCT05331690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110940939|NCT05331690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110942330|NCT05864742|Rituximab|rituximab|mesh-list
110942331|NCT05864742|Venetoclax|venetoclax|mesh-list
110942332|NCT05864742|Navitoclax|navitoclax|mesh-list
110942333|NCT05864742|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110942334|NCT05864742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110942335|NCT05864742|Immunologic Factors|immunologic factors|mesh-ancestor
110942336|NCT05864742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110942337|NCT05864742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110940940|NCT05331690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110940941|NCT05331690|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110940942|NCT05331690|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110940943|NCT05331690|Analgesics|analgesics|mesh-ancestor
110940944|NCT05331690|Sensory System Agents|sensory system agents|mesh-ancestor
110940945|NCT05331690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110940946|NCT04373668|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
110940947|NCT04373668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110940948|NCT04373668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110940949|NCT02263170|Phenobarbital|phenobarbital|mesh-list
110940950|NCT02263170|Anticonvulsants|anticonvulsants|mesh-ancestor
110940951|NCT02263170|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110940952|NCT02263170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110940953|NCT02263170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110940954|NCT02263170|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110940955|NCT02263170|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110940956|NCT02263170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110940957|NCT02263170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110942352|NCT05848011|Docetaxel|docetaxel|mesh-list
110942353|NCT05848011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110942354|NCT05848011|Tubulin Modulators|tubulin modulators|mesh-ancestor
110942355|NCT05848011|Antimitotic Agents|antimitotic agents|mesh-ancestor
110942356|NCT05848011|Mitosis Modulators|mitosis modulators|mesh-ancestor
110942357|NCT05848011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110942358|NCT05848011|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110942359|NCT05848011|Glucocorticoids|glucocorticoids|mesh-ancestor
110942360|NCT05848011|Hormones|hormones|mesh-ancestor
110942361|NCT05848011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110942362|NCT05848011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110942363|NCT05848011|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110942364|NCT05845996|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
110942365|NCT05845996|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110942366|NCT05845996|Immunologic Factors|immunologic factors|mesh-ancestor
110942367|NCT05845996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110942380|NCT05843253|Everolimus|everolimus|mesh-list
110942381|NCT05843253|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110942382|NCT05843253|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110942383|NCT05843253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110942384|NCT05843253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110942385|NCT05843253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110942386|NCT05843253|Immunologic Factors|immunologic factors|mesh-ancestor
110942387|NCT05843253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110942388|NCT05843253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110942420|NCT05831176|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110942421|NCT05831176|Immunologic Factors|immunologic factors|mesh-ancestor
110940958|NCT02263170|GABA Modulators|gaba modulators|mesh-ancestor
110940959|NCT02263170|GABA Agents|gaba agents|mesh-ancestor
110940960|NCT02263170|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110940961|NCT02263170|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110940962|NCT02263170|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110940963|NCT02543268|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
110940964|NCT02543268|Antiviral Agents|antiviral agents|mesh-ancestor
110940965|NCT02543268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110940967|NCT05252988|Antidiarrheals|antidiarrheals|mesh-list
110940968|NCT05252988|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
110940969|NCT05252988|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110940970|NCT05252988|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110942422|NCT05831176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110942423|NCT05825235|Pramipexole|pramipexole|mesh-list
110942424|NCT05825235|Antioxidants|antioxidants|mesh-ancestor
110942425|NCT05825235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110942426|NCT05825235|Protective Agents|protective agents|mesh-ancestor
110942427|NCT05825235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110942428|NCT05825235|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110942429|NCT05825235|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110942430|NCT05825235|Dopamine Agonists|dopamine agonists|mesh-ancestor
110942431|NCT05825235|Dopamine Agents|dopamine agents|mesh-ancestor
110942432|NCT05825235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110942433|NCT05824806|Hyaluronic Acid|hyaluronic acid|mesh-list
110942434|NCT05824806|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110942435|NCT05824806|Immunologic Factors|immunologic factors|mesh-ancestor
110942436|NCT05824806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110942437|NCT05824806|Viscosupplements|viscosupplements|mesh-ancestor
110942438|NCT05824806|Protective Agents|protective agents|mesh-ancestor
110942439|NCT05815160|Carboplatin|carboplatin|mesh-list
110942440|NCT05815160|Etoposide|etoposide|mesh-list
110942441|NCT05815160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110942442|NCT05815160|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110942443|NCT05815160|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110942444|NCT05815160|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110942445|NCT05815160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110942446|NCT05815160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110940971|NCT05252988|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110940972|NCT05252988|Antimetabolites|antimetabolites|mesh-ancestor
110940973|NCT05252988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110940974|NCT05252988|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110940976|NCT03038230|Antibodies, Bispecific|antibodies, bispecific|mesh-list
110940977|NCT03038230|Immunologic Factors|immunologic factors|mesh-ancestor
110940978|NCT03038230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110940979|NCT04853758|Valsartan|valsartan|mesh-list
110940980|NCT04853758|Enalapril|enalapril|mesh-list
110940981|NCT04853758|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
110940982|NCT04853758|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
110940983|NCT04853758|Enzyme Inhibitors|enzyme inhibitors|mesh-list
110940984|NCT04853758|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110940985|NCT04853758|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110940986|NCT04853758|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110940987|NCT04853758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110940988|NCT04853758|Protease Inhibitors|protease inhibitors|mesh-ancestor
110940989|NCT02784288|Paclitaxel|paclitaxel|mesh-list
110940990|NCT02784288|Carboplatin|carboplatin|mesh-list
110940991|NCT02784288|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110940992|NCT02784288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110940993|NCT02784288|Tubulin Modulators|tubulin modulators|mesh-ancestor
110940994|NCT02784288|Antimitotic Agents|antimitotic agents|mesh-ancestor
110940995|NCT02784288|Mitosis Modulators|mitosis modulators|mesh-ancestor
110940996|NCT02784288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110940997|NCT03040180|Bleomycin|bleomycin|mesh-list
110940998|NCT03040180|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110940999|NCT03040180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110941000|NCT02235246|Magnesium Sulfate|magnesium sulfate|mesh-list
110941001|NCT02235246|Analgesics|analgesics|mesh-ancestor
110941002|NCT02235246|Sensory System Agents|sensory system agents|mesh-ancestor
110941003|NCT02235246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110941004|NCT02235246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110941005|NCT02235246|Anesthetics|anesthetics|mesh-ancestor
110941006|NCT02235246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110941007|NCT02235246|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110941008|NCT02235246|Anticonvulsants|anticonvulsants|mesh-ancestor
110941009|NCT02235246|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110941010|NCT02235246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110941011|NCT02235246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110941012|NCT02235246|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110941013|NCT02235246|Tocolytic Agents|tocolytic agents|mesh-ancestor
110941014|NCT02235246|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110941015|NCT02235324|Leucovorin|leucovorin|mesh-list
110941016|NCT02235324|Fluorouracil|fluorouracil|mesh-list
110941017|NCT02235324|Aflibercept|aflibercept|mesh-list
110941018|NCT02235324|Calcium|calcium|mesh-list
110941019|NCT02235324|Levoleucovorin|levoleucovorin|mesh-list
110941020|NCT02235324|Endothelial Growth Factors|endothelial growth factors|mesh-list
110941021|NCT02235324|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110941022|NCT02235324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110941023|NCT02235324|Antimetabolites|antimetabolites|mesh-ancestor
110941024|NCT02235324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110941025|NCT02235324|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110941026|NCT02235324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110941027|NCT02235324|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110941028|NCT02235324|Immunologic Factors|immunologic factors|mesh-ancestor
110941029|NCT02235324|Antidotes|antidotes|mesh-ancestor
110941030|NCT02235324|Protective Agents|protective agents|mesh-ancestor
110941031|NCT02235324|Vitamin B Complex|vitamin b complex|mesh-ancestor
110941032|NCT02235324|Vitamins|vitamins|mesh-ancestor
110941033|NCT02235324|Micronutrients|micronutrients|mesh-ancestor
110941034|NCT02235324|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110941035|NCT02235324|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110941036|NCT02235324|Growth Substances|growth substances|mesh-ancestor
110941037|NCT02235324|Growth Inhibitors|growth inhibitors|mesh-ancestor
110941038|NCT01230242|Levonorgestrel|levonorgestrel|mesh-list
110941039|NCT01230242|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110941040|NCT01230242|Contraceptive Agents|contraceptive agents|mesh-ancestor
110941041|NCT01230242|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110941042|NCT01230242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110941043|NCT01230242|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110941044|NCT01230242|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110941045|NCT01230242|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110941046|NCT02263248|Buprenorphine|buprenorphine|mesh-list
110941047|NCT02263248|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
110941048|NCT02263248|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110941049|NCT02263248|Narcotics|narcotics|mesh-ancestor
110941050|NCT02263248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110941051|NCT02263248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110941052|NCT02263248|Analgesics|analgesics|mesh-ancestor
110941053|NCT02263248|Sensory System Agents|sensory system agents|mesh-ancestor
110941054|NCT02263248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110289181|NCT00219479|Phenytoin|phenytoin|mesh-list
110941055|NCT02263248|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110941056|NCT02263248|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110941057|NCT02263248|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110941058|NCT02263248|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110941059|NCT02263248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110941060|NCT02263248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110941061|NCT02263248|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110941062|NCT02263248|Antidepressive Agents|antidepressive agents|mesh-ancestor
110941063|NCT02263248|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110658574|NCT01088035|Carboplatin|carboplatin|mesh-list
110941065|NCT04838860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110941066|NCT04853524|Tenofovir|tenofovir|mesh-list
110941067|NCT04853524|Emtricitabine|emtricitabine|mesh-list
110941068|NCT04853524|JNJ-56136379|jnj-56136379|mesh-list
110941069|NCT04853524|Antiviral Agents|antiviral agents|mesh-ancestor
110941070|NCT04853524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110941071|NCT04853524|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110941072|NCT04853524|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110941073|NCT04853524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110941074|NCT04853524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110941075|NCT04853524|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110941076|NCT04853524|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110941077|NCT04852510|Metformin|metformin|mesh-list
110941078|NCT04852510|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110941079|NCT04852510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110941080|NCT05163704|Dexmedetomidine|dexmedetomidine|mesh-list
110941081|NCT05163704|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110941082|NCT05163704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110941083|NCT05163704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110941084|NCT05163704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110941085|NCT05163704|Analgesics|analgesics|mesh-ancestor
110941086|NCT05163704|Sensory System Agents|sensory system agents|mesh-ancestor
110941087|NCT05163704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110941088|NCT05163704|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110941089|NCT05163704|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110941090|NCT05163704|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110942705|NCT05712941|Letrozole|letrozole|mesh-list
110942706|NCT05712941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110942707|NCT05712941|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110942708|NCT05712941|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110942709|NCT05712941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110942710|NCT05712941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110942711|NCT05712941|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110942712|NCT05712941|Hormone Antagonists|hormone antagonists|mesh-ancestor
110942713|NCT05712941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110098610|NCT01743235|Serotonin Agents|serotonin agents|mesh-ancestor
110941091|NCT05163704|Adrenergic Agents|adrenergic agents|mesh-ancestor
110941092|NCT05163704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110941093|NCT05163704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110941094|NCT03130556|Rabeprazole|rabeprazole|mesh-list
110941095|NCT03130556|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110941096|NCT03130556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110941097|NCT03130556|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110941098|NCT03130556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110941099|NCT03130556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110941100|NCT04838080|Vaccines|vaccines|mesh-list
110941101|NCT04838080|Immunologic Factors|immunologic factors|mesh-ancestor
110941102|NCT04838080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110941103|NCT04842838|Paclitaxel|paclitaxel|mesh-list
110941104|NCT04842838|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110941105|NCT04842838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110941106|NCT04842838|Tubulin Modulators|tubulin modulators|mesh-ancestor
110941107|NCT04842838|Antimitotic Agents|antimitotic agents|mesh-ancestor
110941108|NCT04842838|Mitosis Modulators|mitosis modulators|mesh-ancestor
110289261|NCT00242541|Octreotide|octreotide|mesh-list
110941109|NCT04842838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110941110|NCT03037606|Rabeprazole|rabeprazole|mesh-list
110941111|NCT03037606|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110941112|NCT03037606|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110941113|NCT03037606|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110122310|NCT01917617|Cisplatin|cisplatin|mesh-list
110941115|NCT03037606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110941116|NCT04842370|PHI-101|phi-101|mesh-list
110941117|NCT04842370|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110941118|NCT04842370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110941119|NCT04842370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110941120|NCT04842370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110941121|NCT03037372|Atorvastatin|atorvastatin|mesh-list
110941122|NCT03037372|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110941123|NCT03037372|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
110941124|NCT03037372|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110941125|NCT03037372|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110941126|NCT03037372|Antimetabolites|antimetabolites|mesh-ancestor
110941127|NCT03037372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110941128|NCT03037372|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110249845|NCT03809429|Cetrorelix|cetrorelix|mesh-list
110941129|NCT03037372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110941130|NCT04842526|Irinotecan|irinotecan|mesh-list
110941131|NCT04842526|Temozolomide|temozolomide|mesh-list
110446084|NCT04131283|Mydriatics|mydriatics|mesh-ancestor
110941132|NCT04842526|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110941133|NCT04842526|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110941134|NCT04842526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110941135|NCT04842526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110941136|NCT04842526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110941137|NCT04842526|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110941138|NCT04842526|Alkylating Agents|alkylating agents|mesh-ancestor
110941140|NCT04850950|Antiviral Agents|antiviral agents|mesh-ancestor
110941141|NCT04850950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110941142|NCT04850950|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110446207|NCT00869323|Rituximab|rituximab|mesh-list
110941143|NCT04850950|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110941145|NCT04850950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110941146|NCT04850950|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110941147|NCT04850950|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110941148|NCT05164952|Zoledronic Acid|zoledronic acid|mesh-list
110941149|NCT05164952|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110941150|NCT05164952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110941151|NCT04850560|Decitabine|decitabine|mesh-list
110941152|NCT04850560|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110941153|NCT04850560|Antimetabolites|antimetabolites|mesh-ancestor
110941154|NCT04850560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110941155|NCT04850560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110941156|NCT04850560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110941157|NCT04850404|Ropivacaine|ropivacaine|mesh-list
110941158|NCT04850404|Rocuronium|rocuronium|mesh-list
110941159|NCT04850404|Anesthetics, Local|anesthetics, local|mesh-ancestor
110941160|NCT04850404|Anesthetics|anesthetics|mesh-ancestor
110941161|NCT04850404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110941162|NCT04850404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110941163|NCT04850404|Sensory System Agents|sensory system agents|mesh-ancestor
110941164|NCT04850404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110941165|NCT04850404|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110446485|NCT00865189|Micronutrients|micronutrients|mesh-ancestor
110941166|NCT04850404|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110941167|NCT04850404|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110941168|NCT06059547|Nivolumab|nivolumab|mesh-list
110941169|NCT06059547|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110941170|NCT06059547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110941171|NCT06059547|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110941172|NCT06059547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110941173|NCT06059495|Dostarlimab|dostarlimab|mesh-list
110941174|NCT06059495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110941175|NCT06059469|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
110941176|NCT06059469|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110941177|NCT06059469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110941178|NCT06059456|Vaccines|vaccines|mesh-list
110941179|NCT06059456|Immunologic Factors|immunologic factors|mesh-ancestor
110941180|NCT06059456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110941181|NCT06059391|Vaccines|vaccines|mesh-list
110941182|NCT06059391|Lenograstim|lenograstim|mesh-list
110941183|NCT06059391|Immunologic Factors|immunologic factors|mesh-ancestor
110941184|NCT06059391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110941185|NCT06059391|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110941186|NCT06059339|Analgesics, Opioid|analgesics, opioid|mesh-list
110941187|NCT06059339|Narcotics|narcotics|mesh-ancestor
110941188|NCT06059339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110941189|NCT06059339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110941190|NCT06059339|Analgesics|analgesics|mesh-ancestor
110941191|NCT06059339|Sensory System Agents|sensory system agents|mesh-ancestor
110941192|NCT06059339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110941193|NCT06059287|Metformin|metformin|mesh-list
110941194|NCT06059287|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110941195|NCT06059287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110941196|NCT06059261|Endostatins|endostatins|mesh-list
110941197|NCT06059261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110941198|NCT06059261|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110941199|NCT06059261|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110941200|NCT06059261|Growth Substances|growth substances|mesh-ancestor
110941201|NCT06059261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110941202|NCT06059261|Growth Inhibitors|growth inhibitors|mesh-ancestor
110941203|NCT06059222|Zoledronic Acid|zoledronic acid|mesh-list
110941204|NCT06059222|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110941205|NCT06059222|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110446811|NCT01128569|Fluticasone|fluticasone|mesh-list
110941206|NCT06059222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110941207|NCT06059222|Immunologic Factors|immunologic factors|mesh-ancestor
110941208|NCT06059144|Norepinephrine|norepinephrine|mesh-list
110941209|NCT06059144|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110941210|NCT06059144|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110941211|NCT06059144|Adrenergic Agents|adrenergic agents|mesh-ancestor
110941212|NCT06059144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110941213|NCT06059144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110941214|NCT06059144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110941215|NCT06059144|Sympathomimetics|sympathomimetics|mesh-ancestor
110941216|NCT06059144|Autonomic Agents|autonomic agents|mesh-ancestor
110941217|NCT06059144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110941218|NCT06059144|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110941219|NCT06059118|Eflornithine|eflornithine|mesh-list
110941220|NCT06059118|Methyltestosterone|methyltestosterone|mesh-list
110941221|NCT06059118|Hormones|hormones|mesh-list
110941222|NCT06059118|Testosterone|testosterone|mesh-list
110941223|NCT06059118|Testosterone undecanoate|testosterone undecanoate|mesh-list
110941224|NCT06059118|Testosterone enanthate|testosterone enanthate|mesh-list
110941225|NCT06059118|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
110941226|NCT06059118|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
110941227|NCT06059118|Relugolix|relugolix|mesh-list
110941228|NCT06059118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110941229|NCT06059118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110941230|NCT06059118|Androgens|androgens|mesh-ancestor
110941231|NCT06059118|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110941232|NCT06059118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110941233|NCT06059118|Anabolic Agents|anabolic agents|mesh-ancestor
110447239|NCT02695654|Clonidine|clonidine|mesh-list
110941234|NCT06059118|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
110941235|NCT06059118|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110941236|NCT06059118|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110941237|NCT06059118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110941238|NCT06059118|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
110941240|NCT06059118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110941241|NCT06059118|Androgen Antagonists|androgen antagonists|mesh-ancestor
110941242|NCT06059118|Hormone Antagonists|hormone antagonists|mesh-ancestor
110941243|NCT06059014|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
110941244|NCT06059014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110941245|NCT06059001|Paclitaxel|paclitaxel|mesh-list
110941246|NCT06059001|Gemcitabine|gemcitabine|mesh-list
110941247|NCT06059001|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110941248|NCT06059001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110941249|NCT06059001|Tubulin Modulators|tubulin modulators|mesh-ancestor
110941250|NCT06059001|Antimitotic Agents|antimitotic agents|mesh-ancestor
110941251|NCT06059001|Mitosis Modulators|mitosis modulators|mesh-ancestor
110941252|NCT06059001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110447440|NCT04217668|Isosorbide|isosorbide|mesh-list
110941253|NCT06059001|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110941254|NCT06059001|Antimetabolites|antimetabolites|mesh-ancestor
110941255|NCT06058988|Trastuzumab|trastuzumab|mesh-list
110941256|NCT06058988|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
110941257|NCT06058988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110941258|NCT06058988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110941259|NCT06058988|Immunoconjugates|immunoconjugates|mesh-ancestor
110941260|NCT06058988|Immunologic Factors|immunologic factors|mesh-ancestor
110941261|NCT06058988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110941263|NCT06058962|Antinematodal Agents|antinematodal agents|mesh-ancestor
110941264|NCT06058962|Anthelmintics|anthelmintics|mesh-ancestor
110941265|NCT06058962|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110941266|NCT06058962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110941267|NCT06058962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110941268|NCT06058962|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
110941269|NCT06058962|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110941274|NCT06058702|Dronabinol|dronabinol|mesh-list
110941275|NCT06058702|Hallucinogens|hallucinogens|mesh-ancestor
110941276|NCT06058702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110941277|NCT06058702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110941278|NCT06058702|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110941279|NCT06058702|Analgesics|analgesics|mesh-ancestor
110941280|NCT06058702|Sensory System Agents|sensory system agents|mesh-ancestor
110941281|NCT06058702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110941282|NCT06058702|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
110941283|NCT06058702|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110941285|NCT06058702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110941286|NCT06058702|Hormones|hormones|mesh-ancestor
110941287|NCT06058702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110941288|NCT06058689|Thalidomide|thalidomide|mesh-list
110941289|NCT06058689|Pomalidomide|pomalidomide|mesh-list
110941290|NCT06058689|Immunologic Factors|immunologic factors|mesh-ancestor
110941291|NCT06058689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110941292|NCT06058689|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110941293|NCT06058689|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110941294|NCT06058689|Growth Substances|growth substances|mesh-ancestor
110941295|NCT06058689|Growth Inhibitors|growth inhibitors|mesh-ancestor
110941296|NCT06058689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110941297|NCT06058689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110941298|NCT06058689|Leprostatic Agents|leprostatic agents|mesh-ancestor
110941299|NCT06058689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110941300|NCT06058689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110941302|NCT06058663|Ipilimumab|ipilimumab|mesh-list
110941303|NCT06058663|Tremelimumab|tremelimumab|mesh-list
110941304|NCT06058663|Immunoglobulins|immunoglobulins|mesh-list
110941305|NCT06058663|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110941306|NCT06058663|Immunoglobulin G|immunoglobulin g|mesh-list
110941307|NCT06058663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110941308|NCT06058663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110941309|NCT06058663|Immunologic Factors|immunologic factors|mesh-ancestor
110941310|NCT06058663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110941311|NCT06058663|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110941312|NCT06058663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110941313|NCT06058650|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
110941314|NCT06058650|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110289443|NCT01580683|Antioxidants|antioxidants|mesh-ancestor
110941315|NCT06058650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110941316|NCT06058585|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
110941317|NCT06058585|Mineralocorticoids|mineralocorticoids|mesh-list
110941318|NCT06058585|Hormone Antagonists|hormone antagonists|mesh-ancestor
110941319|NCT06058585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110941320|NCT06058585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110941321|NCT06058585|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110941323|NCT06058585|Natriuretic Agents|natriuretic agents|mesh-ancestor
110941324|NCT06058585|Hormones|hormones|mesh-ancestor
110941325|NCT06058572|Rifaximin|rifaximin|mesh-list
110941326|NCT06058572|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110941327|NCT06058572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110941328|NCT06058572|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110941329|NCT06058377|Paclitaxel|paclitaxel|mesh-list
110941330|NCT06058377|Cyclophosphamide|cyclophosphamide|mesh-list
110941331|NCT06058377|Doxorubicin|doxorubicin|mesh-list
110941332|NCT06058377|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110447983|NCT00856375|Irinotecan|irinotecan|mesh-list
110941333|NCT06058377|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110941334|NCT06058377|Durvalumab|durvalumab|mesh-list
110941335|NCT06058377|Daunorubicin|daunorubicin|mesh-list
110941336|NCT06058377|Immunoglobulins|immunoglobulins|mesh-list
110941337|NCT06058377|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110941338|NCT06058377|Immunoglobulin G|immunoglobulin g|mesh-list
110941339|NCT06058377|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110941340|NCT06058377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110941341|NCT06058377|Tubulin Modulators|tubulin modulators|mesh-ancestor
110941342|NCT06058377|Antimitotic Agents|antimitotic agents|mesh-ancestor
110941343|NCT06058377|Mitosis Modulators|mitosis modulators|mesh-ancestor
110941344|NCT06058377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110941345|NCT06058377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110941346|NCT06058377|Immunologic Factors|immunologic factors|mesh-ancestor
110941347|NCT06058377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110941348|NCT06058377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110941349|NCT06058377|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110941350|NCT06058377|Alkylating Agents|alkylating agents|mesh-ancestor
110941351|NCT06058377|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110941352|NCT06058377|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110941353|NCT06058377|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110941354|NCT06058377|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110941355|NCT06058377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110941356|NCT06058377|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110941357|NCT06058299|Linezolid|linezolid|mesh-list
110941358|NCT06058299|Bedaquiline|bedaquiline|mesh-list
110941359|NCT06058299|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110941360|NCT06058299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110941361|NCT06058299|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110941362|NCT06058299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110941363|NCT06058299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110941364|NCT06058299|Antitubercular Agents|antitubercular agents|mesh-ancestor
110941366|NCT06058234|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110941367|NCT06058234|Immunologic Factors|immunologic factors|mesh-ancestor
110941368|NCT06058234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110941369|NCT06058130|Anticoagulants|anticoagulants|mesh-list
110941370|NCT06057935|Carboplatin|carboplatin|mesh-list
110941372|NCT06057935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110941373|NCT06057935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110941374|NCT06057935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110941375|NCT06057935|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110941376|NCT06057935|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110941387|NCT06057831|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110941388|NCT06057831|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110941389|NCT06057831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110941482|NCT06056895|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110941484|NCT06056895|Immunoglobulins|immunoglobulins|mesh-list
110941485|NCT06056895|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110941486|NCT06056895|Immunologic Factors|immunologic factors|mesh-ancestor
110941487|NCT06056895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110941488|NCT06056895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110942494|NCT05789069|Tislelizumab|tislelizumab|mesh-list
110942495|NCT05789069|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110942496|NCT05789069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110942497|NCT05785442|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
110659993|NCT00972218|Adalimumab|adalimumab|mesh-list
110942498|NCT05785442|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110942540|NCT05769309|Fentanyl|fentanyl|mesh-list
110942541|NCT05769309|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110942542|NCT05769309|Narcotics|narcotics|mesh-ancestor
110942543|NCT05769309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110942544|NCT05769309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110942545|NCT05769309|Analgesics|analgesics|mesh-ancestor
110942546|NCT05769309|Sensory System Agents|sensory system agents|mesh-ancestor
110942547|NCT05769309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110942548|NCT05769309|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110942549|NCT05769309|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110942550|NCT05769309|Anesthetics, General|anesthetics, general|mesh-ancestor
110942552|NCT05765812|Temozolomide|temozolomide|mesh-list
110942553|NCT05765812|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110942554|NCT05765812|Alkylating Agents|alkylating agents|mesh-ancestor
110942555|NCT05765812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110942556|NCT05765812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110942559|NCT05753059|Bendroflumethiazide|bendroflumethiazide|mesh-list
110942560|NCT05753059|Amiloride|amiloride|mesh-list
110942561|NCT05753059|Diuretics|diuretics|mesh-ancestor
110942562|NCT05753059|Natriuretic Agents|natriuretic agents|mesh-ancestor
110942563|NCT05753059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110942564|NCT05753059|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
110942565|NCT05753059|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110942566|NCT05753059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110448628|NCT00913315|Tolterodine Tartrate|tolterodine tartrate|mesh-list
110942567|NCT05753059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110942568|NCT05753059|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
110942569|NCT05753059|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110942570|NCT05753059|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110942571|NCT05753059|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110942572|NCT05752903|Dexmedetomidine|dexmedetomidine|mesh-list
110942573|NCT05752903|Ketamine|ketamine|mesh-list
110942574|NCT05752903|Propofol|propofol|mesh-list
110942575|NCT05752903|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110942576|NCT05752903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110942577|NCT05752903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110942578|NCT05752903|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110942579|NCT05752903|Analgesics|analgesics|mesh-ancestor
110942580|NCT05752903|Sensory System Agents|sensory system agents|mesh-ancestor
110942581|NCT05752903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110942582|NCT05752903|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110942583|NCT05752903|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110942584|NCT05752903|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110942585|NCT05752903|Adrenergic Agents|adrenergic agents|mesh-ancestor
110942586|NCT05752903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110942587|NCT05752903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110942588|NCT05752903|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110448840|NCT02719132|Metformin|metformin|mesh-list
110942589|NCT05752903|Anesthetics, General|anesthetics, general|mesh-ancestor
110942590|NCT05752903|Anesthetics|anesthetics|mesh-ancestor
110942591|NCT05752903|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110448900|NCT02717884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110942592|NCT05752903|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110942593|NCT05752903|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110942594|NCT05752201|Vaccines|vaccines|mesh-list
110942595|NCT05752201|Immunologic Factors|immunologic factors|mesh-ancestor
110942596|NCT05752201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110942602|NCT05740566|Topotecan|topotecan|mesh-list
110942603|NCT05740566|Amrubicin|amrubicin|mesh-list
110942604|NCT05740566|AMG 757|amg 757|mesh-list
110942605|NCT05740566|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110942606|NCT05740566|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110942607|NCT05740566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110942608|NCT05740566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110942609|NCT05740566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110942627|NCT05735353|Methamphetamine|methamphetamine|mesh-list
110942628|NCT05735353|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110942629|NCT05735353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110942630|NCT05735353|Sympathomimetics|sympathomimetics|mesh-ancestor
110942631|NCT05735353|Autonomic Agents|autonomic agents|mesh-ancestor
110942632|NCT05735353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110942633|NCT05735353|Dopamine Agents|dopamine agents|mesh-ancestor
110942634|NCT05735353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110249891|NCT01249690|Autonomic Agents|autonomic agents|mesh-ancestor
110290739|NCT04603729|Prednisolone acetate|prednisolone acetate|mesh-list
110942635|NCT05735353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110942636|NCT05735353|Adrenergic Agents|adrenergic agents|mesh-ancestor
110942637|NCT05735353|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110942638|NCT05735353|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110942639|NCT05735353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110942640|NCT05735353|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110942647|NCT05728619|Temozolomide|temozolomide|mesh-list
110942648|NCT05728619|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110942649|NCT05728619|Alkylating Agents|alkylating agents|mesh-ancestor
110942650|NCT05728619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110942651|NCT05728619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110942652|NCT05726032|Empagliflozin|empagliflozin|mesh-list
110942653|NCT05726032|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110942654|NCT05726032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110942655|NCT05726032|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110942656|NCT05726032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110942669|NCT05718843|BI 425809|bi 425809|mesh-list
110942670|NCT05718843|Nootropic Agents|nootropic agents|mesh-ancestor
110942671|NCT05717140|Nivolumab|nivolumab|mesh-list
110942672|NCT05717140|Sargramostim|sargramostim|mesh-list
110942673|NCT05717140|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110942674|NCT05717140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110942675|NCT05717140|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110942676|NCT05717140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110942677|NCT05717140|Immunologic Factors|immunologic factors|mesh-ancestor
110942678|NCT05717140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110942683|NCT05716009|Gemtuzumab|gemtuzumab|mesh-list
110942684|NCT05716009|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110942685|NCT05716009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110942686|NCT05716009|Immunotoxins|immunotoxins|mesh-ancestor
110942687|NCT05716009|Immunoconjugates|immunoconjugates|mesh-ancestor
110942688|NCT05716009|Immunologic Factors|immunologic factors|mesh-ancestor
110942689|NCT05716009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110942714|NCT05712941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110098677|NCT01743755|Antiemetics|antiemetics|mesh-ancestor
110445873|NCT02770378|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110098827|NCT01744444|Memantine|memantine|mesh-list
110449195|NCT02711176|Tinidazole|tinidazole|mesh-list
110098902|NCT01744964|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110445874|NCT02770378|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110445875|NCT02770378|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110445876|NCT02770378|Alkylating Agents|alkylating agents|mesh-ancestor
110445877|NCT02770378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110098976|NCT01745601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110445878|NCT02770378|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110445879|NCT02770378|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110445880|NCT02770378|Analgesics|analgesics|mesh-ancestor
110099426|NCT01748279|Atorvastatin|atorvastatin|mesh-list
110445881|NCT02770378|Sensory System Agents|sensory system agents|mesh-ancestor
110445882|NCT02770378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110445883|NCT02770378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110099798|NCT01750060|Fentanyl|fentanyl|mesh-list
110099873|NCT01750463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110445884|NCT02770378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110445885|NCT02770378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110100020|NCT01751321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110100320|NCT01754324|Analgesics|analgesics|mesh-ancestor
110100473|NCT01755403|Benzonidazole|benzonidazole|mesh-list
110445886|NCT02770378|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110100699|NCT01756443|Autonomic Agents|autonomic agents|mesh-ancestor
110100914|NCT01757587|Protease Inhibitors|protease inhibitors|mesh-ancestor
110101442|NCT01760226|Antimitotic Agents|antimitotic agents|mesh-ancestor
110101516|NCT01760642|Rifampin|rifampin|mesh-list
110445887|NCT02770378|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110445888|NCT02770378|Antifungal Agents|antifungal agents|mesh-ancestor
110449496|NCT00606411|Topiramate|topiramate|mesh-list
110445889|NCT02770378|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110101894|NCT01762475|Sildenafil Citrate|sildenafil citrate|mesh-list
110102040|NCT01762995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110445890|NCT02770378|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110102706|NCT01767363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110102858|NCT01768273|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110102932|NCT01768377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110560303|NCT02963831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110560304|NCT02963831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110103154|NCT01769651|Respiratory System Agents|respiratory system agents|mesh-ancestor
110103378|NCT01770470|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110103625|NCT01772381|Hormones|hormones|mesh-ancestor
110103680|NCT01772940|Antimetabolites|antimetabolites|mesh-ancestor
110103826|NCT01773798|Insulin, Long-Acting|insulin, long-acting|mesh-list
110103899|NCT01774474|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110560305|NCT02963831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110560306|NCT02963831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110560308|NCT00859898|Dapagliflozin|dapagliflozin|mesh-list
110560309|NCT00859898|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110104580|NCT01780519|Lorazepam|lorazepam|mesh-list
110560310|NCT00859898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110105643|NCT01788254|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110560311|NCT00859898|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110105946|NCT01792804|Vancomycin|vancomycin|mesh-list
110106245|NCT01800357|Antipyretics|antipyretics|mesh-ancestor
110560312|NCT00859898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110445892|NCT02770378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110445893|NCT02770378|Antidepressive Agents|antidepressive agents|mesh-ancestor
110445894|NCT02770378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110449690|NCT01123889|Anesthetics|anesthetics|mesh-ancestor
110445895|NCT02770378|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110445896|NCT02770378|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110449762|NCT00607035|Olmesartan|olmesartan|mesh-list
110445897|NCT02770378|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110445898|NCT02770378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110445899|NCT02770378|Serotonin Agents|serotonin agents|mesh-ancestor
110445900|NCT02770378|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110445901|NCT02770378|Antiemetics|antiemetics|mesh-ancestor
110445902|NCT02770378|Autonomic Agents|autonomic agents|mesh-ancestor
110445903|NCT02770378|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110445904|NCT02770378|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110445905|NCT02770378|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110445906|NCT02770378|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
110445907|NCT02770378|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110106748|NCT01804387|Adefovir|adefovir|mesh-list
110106982|NCT01808638|Gemcitabine|gemcitabine|mesh-list
110107057|NCT01809392|Decitabine|decitabine|mesh-list
110107125|NCT01809925|Cathartics|cathartics|mesh-ancestor
110445908|NCT02770378|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110445909|NCT02770222|Rifampin|rifampin|mesh-list
110445910|NCT02770222|Selexipag|selexipag|mesh-list
110107735|NCT01813955|Papaverine|papaverine|mesh-list
110445911|NCT02770222|Gemfibrozil|gemfibrozil|mesh-list
110560313|NCT02684123|Apremilast|apremilast|mesh-list
110445912|NCT02770222|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110108101|NCT01816035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110108251|NCT01817153|Hydrocortisone|hydrocortisone|mesh-list
110108915|NCT01821612|Leucovorin|leucovorin|mesh-list
110108995|NCT01822405|Tocopherols|tocopherols|mesh-list
110109077|NCT01822808|Isosorbide|isosorbide|mesh-list
110445914|NCT02770222|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110109211|NCT01823848|Emollients|emollients|mesh-ancestor
110445915|NCT02770222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110109435|NCT01825473|Phenobarbital|phenobarbital|mesh-list
110109665|NCT01827293|GABA Agents|gaba agents|mesh-ancestor
110445916|NCT02770222|Leprostatic Agents|leprostatic agents|mesh-ancestor
110445917|NCT02770222|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110109967|NCT01829802|Ritonavir|ritonavir|mesh-list
110110036|NCT01830530|Telmisartan|telmisartan|mesh-list
110445918|NCT02770222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110110406|NCT01841307|Immunologic Factors|immunologic factors|mesh-ancestor
110110943|NCT01844648|Tropicamide|tropicamide|mesh-list
110111019|NCT01845090|Calcium|calcium|mesh-list
110111094|NCT01845272|Candesartan cilexetil|candesartan cilexetil|mesh-list
110111167|NCT01845675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110111248|NCT01846559|Clopidogrel|clopidogrel|mesh-list
110111323|NCT01847235|Temozolomide|temozolomide|mesh-list
110111474|NCT01848197|Paclitaxel|paclitaxel|mesh-list
110111550|NCT01848743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110111620|NCT01849211|Rocuronium|rocuronium|mesh-list
110111769|NCT01850628|Pertuzumab|pertuzumab|mesh-list
110111919|NCT01851473|Analgesics|analgesics|mesh-ancestor
110112002|NCT01851980|Furosemide|furosemide|mesh-list
110112070|NCT01852539|Analgesics|analgesics|mesh-ancestor
110112150|NCT01853111|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110112221|NCT01853813|Growth Substances|growth substances|mesh-ancestor
110112526|NCT01855594|Antimanic Agents|antimanic agents|mesh-ancestor
110112753|NCT01856985|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110112979|NCT01857895|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110113132|NCT01858402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110113433|NCT01860300|Amoxicillin|amoxicillin|mesh-list
110113508|NCT01860716|Melatonin|melatonin|mesh-list
110445919|NCT02770222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110445920|NCT02770222|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110445921|NCT02770222|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110114129|NCT01865175|Iron|iron|mesh-list
110114262|NCT01866241|Misoprostol|misoprostol|mesh-list
110114327|NCT01866605|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110445922|NCT02770222|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110445923|NCT02770222|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110445924|NCT02770222|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110445925|NCT02770222|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110445926|NCT02770222|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110445927|NCT02770222|Antimetabolites|antimetabolites|mesh-ancestor
110445928|NCT02770222|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110445929|NCT02770222|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
110445930|NCT02770222|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110445931|NCT02770222|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110445932|NCT00943917|Exenatide|exenatide|mesh-list
110445933|NCT00943917|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110114557|NCT01868581|Insulin Aspart|insulin aspart|mesh-list
110115027|NCT01871480|Gefitinib|gefitinib|mesh-list
110115068|NCT01871662|Antioxidants|antioxidants|mesh-ancestor
110115143|NCT01871844|Octreotide|octreotide|mesh-list
110445934|NCT00943917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110445935|NCT00943917|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110445936|NCT00943917|Incretins|incretins|mesh-ancestor
110116149|NCT04893525|Naloxone|naloxone|mesh-list
110116300|NCT04648033|Vinorelbine|vinorelbine|mesh-list
110116540|NCT03721653|Antidotes|antidotes|mesh-ancestor
110116602|NCT03404596|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110445938|NCT00943917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110116754|NCT01185171|Gefitinib|gefitinib|mesh-list
110445939|NCT02876250|Cyclosporine|cyclosporine|mesh-list
110445940|NCT02876250|Cyclosporins|cyclosporins|mesh-list
110117360|NCT01876550|Mupirocin|mupirocin|mesh-list
110445942|NCT02876250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110445943|NCT02876250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110118144|NCT01883505|Levodopa|levodopa|mesh-list
110445944|NCT02876250|Immunologic Factors|immunologic factors|mesh-ancestor
110118190|NCT01884116|Capsaicin|capsaicin|mesh-list
110118263|NCT01884428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110118338|NCT01884636|Antimetabolites|antimetabolites|mesh-ancestor
110445945|NCT02876250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110450412|NCT02692534|Cocaine|cocaine|mesh-list
110118564|NCT01886209|Antiemetics|antiemetics|mesh-ancestor
110445946|NCT02876250|Antifungal Agents|antifungal agents|mesh-ancestor
110118789|NCT01887613|Gabapentin|gabapentin|mesh-list
110445947|NCT02876250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110450467|NCT03903016|Insulin Lispro|insulin lispro|mesh-list
110445948|NCT02876250|Dermatologic Agents|dermatologic agents|mesh-ancestor
110445949|NCT02876250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110445950|NCT02876250|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110119614|NCT01900509|Hormones|hormones|mesh-ancestor
110445951|NCT02769910|Capsaicin|capsaicin|mesh-list
110120060|NCT01903057|Anthelmintics|anthelmintics|mesh-ancestor
110445953|NCT02769910|Dermatologic Agents|dermatologic agents|mesh-ancestor
110120281|NCT01904643|Sensory System Agents|sensory system agents|mesh-ancestor
110450639|NCT01032018|Bupropion|bupropion|mesh-list
110120508|NCT01906450|Azithromycin|azithromycin|mesh-list
110445954|NCT02769910|Sensory System Agents|sensory system agents|mesh-ancestor
110445955|NCT02769910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110121115|NCT01910415|Moxifloxacin|moxifloxacin|mesh-list
110121183|NCT01910766|Hormone Antagonists|hormone antagonists|mesh-ancestor
110121258|NCT01911299|Lipotropic Agents|lipotropic agents|mesh-ancestor
110121334|NCT01911507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110121410|NCT01912053|Gemcitabine|gemcitabine|mesh-list
110121494|NCT01912677|Labetalol|labetalol|mesh-list
110445956|NCT02769910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110445957|NCT02876484|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
110445958|NCT02876484|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
110445959|NCT02876484|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110445960|NCT02876484|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110445961|NCT02876484|Antimetabolites|antimetabolites|mesh-ancestor
110121995|NCT01916187|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110122070|NCT01916447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110122366|NCT01918098|Narcotics|narcotics|mesh-ancestor
110445962|NCT02876484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110122670|NCT01919918|Adenosine|adenosine|mesh-list
110122897|NCT01930292|Antimitotic Agents|antimitotic agents|mesh-ancestor
110123125|NCT01931332|Narcotics|narcotics|mesh-ancestor
110123198|NCT01931787|Protective Agents|protective agents|mesh-ancestor
110445963|NCT02876484|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110445964|NCT02876484|Cathartics|cathartics|mesh-ancestor
110123423|NCT01933347|Gefitinib|gefitinib|mesh-list
110123496|NCT01933997|Micronutrients|micronutrients|mesh-ancestor
110123583|NCT01934569|Antimetabolites|antimetabolites|mesh-ancestor
110445965|NCT02876484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110445966|NCT02876094|Celecoxib|celecoxib|mesh-list
110445967|NCT02876094|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110445968|NCT02876094|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110445969|NCT02876094|Analgesics|analgesics|mesh-ancestor
110445970|NCT02876094|Sensory System Agents|sensory system agents|mesh-ancestor
110124549|NCT01939743|Analgesics|analgesics|mesh-ancestor
110450897|NCT01114373|Melatonin|melatonin|mesh-list
110445971|NCT02876094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110124774|NCT01941173|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110445972|NCT02876094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110125002|NCT01942343|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110125147|NCT01943487|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110445973|NCT02876094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110445974|NCT02876094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110445975|NCT02876094|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110445976|NCT02876094|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110445977|NCT02876094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110445978|NCT02876094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110445979|NCT00603135|Levetiracetam|levetiracetam|mesh-list
110445980|NCT00603135|Anticonvulsants|anticonvulsants|mesh-ancestor
110445981|NCT00603135|Nootropic Agents|nootropic agents|mesh-ancestor
110445982|NCT02769286|Osimertinib|osimertinib|mesh-list
110445983|NCT02769286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110445984|NCT02769286|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110125667|NCT04411940|Dopamine Agents|dopamine agents|mesh-ancestor
110445985|NCT02769286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110125882|NCT05411757|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110126266|NCT05414149|Ranibizumab|ranibizumab|mesh-list
110126566|NCT03578276|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110126639|NCT02518009|Estrogens|estrogens|mesh-list
110126790|NCT01946399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110127088|NCT01948336|Adrenergic Agents|adrenergic agents|mesh-ancestor
110127160|NCT01948895|Antidepressive Agents|antidepressive agents|mesh-ancestor
110127610|NCT01951560|Antimanic Agents|antimanic agents|mesh-ancestor
110127865|NCT05875519|Nordefrin|nordefrin|mesh-list
110445986|NCT02769286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110445987|NCT02855073|Hyaluronic Acid|hyaluronic acid|mesh-list
110128082|NCT05823675|Hormones|hormones|mesh-ancestor
110445988|NCT02855073|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110445989|NCT02855073|Immunologic Factors|immunologic factors|mesh-ancestor
110128375|NCT05027919|Adrenergic Agents|adrenergic agents|mesh-ancestor
110128451|NCT04756401|Glucocorticoids|glucocorticoids|mesh-ancestor
110128608|NCT04030026|Nalbuphine|nalbuphine|mesh-list
110128677|NCT03543969|Nivolumab|nivolumab|mesh-list
110445990|NCT02855073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110445991|NCT02855073|Viscosupplements|viscosupplements|mesh-ancestor
110445992|NCT02855073|Protective Agents|protective agents|mesh-ancestor
110445993|NCT02769130|Losartan|losartan|mesh-list
110129212|NCT01953536|Vitamins|vitamins|mesh-ancestor
110445994|NCT02769130|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110445995|NCT02769130|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110291078|NCT00565981|Alemtuzumab|alemtuzumab|mesh-list
110451163|NCT00610545|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110445996|NCT02769130|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110129585|NCT01955200|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110129658|NCT01955694|Diuretics|diuretics|mesh-ancestor
110129725|NCT01956201|Atorvastatin|atorvastatin|mesh-list
110445997|NCT02769130|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110451223|NCT02705950|Baclofen|baclofen|mesh-list
110445998|NCT02769130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110130094|NCT01959074|Naftopidil|naftopidil|mesh-list
110446000|NCT02768740|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
110446001|NCT02768740|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
110130242|NCT01960205|Incretins|incretins|mesh-ancestor
110446002|NCT02768740|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
110130395|NCT01961635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110451378|NCT02699710|Hematinics|hematinics|mesh-ancestor
110446003|NCT02768740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110130916|NCT01964846|Antioxidants|antioxidants|mesh-ancestor
110446004|NCT02851095|Metformin|metformin|mesh-list
110131063|NCT01966133|Doxorubicin|doxorubicin|mesh-list
110446005|NCT02851095|Canagliflozin|canagliflozin|mesh-list
110131363|NCT01967979|Fluoxetine|fluoxetine|mesh-list
110131594|NCT01969149|Insulin|insulin|mesh-list
110131665|NCT01969695|Venetoclax|venetoclax|mesh-list
110446006|NCT02851095|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110132117|NCT01973140|Tolvaptan|tolvaptan|mesh-list
110132638|NCT01976936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110132711|NCT01977859|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
110132787|NCT01978457|Vasodilator Agents|vasodilator agents|mesh-ancestor
110132789|NCT01978457|Anesthetics|anesthetics|mesh-ancestor
110132936|NCT01979679|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110446007|NCT02851095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110446008|NCT02851095|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110451505|NCT01015638|Dermatologic Agents|dermatologic agents|mesh-ancestor
110446009|NCT02851095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110446011|NCT00580047|Vitamin D|vitamin d|mesh-list
110133237|NCT01982396|Lamivudine|lamivudine|mesh-list
110446013|NCT00580047|Alendronate|alendronate|mesh-list
110446014|NCT00580047|Calcium Carbonate|calcium carbonate|mesh-list
110446016|NCT00580047|Vitamins|vitamins|mesh-ancestor
110446017|NCT00580047|Micronutrients|micronutrients|mesh-ancestor
110134297|NCT01989676|Paclitaxel|paclitaxel|mesh-list
110134365|NCT01990079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110134442|NCT01990781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110134682|NCT01992562|Ziconotide|ziconotide|mesh-list
110446018|NCT00580047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110134979|NCT01994967|Bupivacaine|bupivacaine|mesh-list
110135047|NCT01995188|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110135123|NCT01995734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110446019|NCT00580047|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110135648|NCT01998776|Oxytocics|oxytocics|mesh-ancestor
110135799|NCT02000336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110135946|NCT02001285|Remifentanil|remifentanil|mesh-list
110446020|NCT00580047|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110136102|NCT02002039|Epoetin Alfa|epoetin alfa|mesh-list
110136398|NCT02004067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110136549|NCT02005315|Paclitaxel|paclitaxel|mesh-list
110446021|NCT00580047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110446022|NCT00580047|Antacids|antacids|mesh-ancestor
110137150|NCT05944926|Serotonin Agents|serotonin agents|mesh-ancestor
110137224|NCT05917340|Antimetabolites|antimetabolites|mesh-ancestor
110137471|NCT05680805|Metformin|metformin|mesh-list
110137618|NCT05493371|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110446023|NCT00580047|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110446024|NCT01074450|Pramipexole|pramipexole|mesh-list
110446025|NCT01074450|Antioxidants|antioxidants|mesh-ancestor
110655633|NCT04008966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110446026|NCT01074450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110446027|NCT01074450|Protective Agents|protective agents|mesh-ancestor
110446028|NCT01074450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110446029|NCT01074450|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110446030|NCT01074450|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110291145|NCT00252798|Paclitaxel|paclitaxel|mesh-list
110446031|NCT01074450|Dopamine Agonists|dopamine agonists|mesh-ancestor
110446032|NCT01074450|Dopamine Agents|dopamine agents|mesh-ancestor
110139096|NCT03301857|Denosumab|denosumab|mesh-list
110139320|NCT02797470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110139772|NCT02007408|Lidocaine|lidocaine|mesh-list
110139918|NCT02008162|Autonomic Agents|autonomic agents|mesh-ancestor
110446033|NCT01074450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110140301|NCT05121168|Bupivacaine|bupivacaine|mesh-list
110446034|NCT02768116|Sirolimus|sirolimus|mesh-list
110140601|NCT03652753|Acetylcysteine|acetylcysteine|mesh-list
110446035|NCT02768116|Temsirolimus|temsirolimus|mesh-list
110140751|NCT02649998|Diuretics|diuretics|mesh-ancestor
110140824|NCT02038452|Antiemetics|antiemetics|mesh-ancestor
110141129|NCT02010970|Anesthetics|anesthetics|mesh-ancestor
110446036|NCT02768116|MTOR Inhibitors|mtor inhibitors|mesh-list
110446037|NCT02768116|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110446038|NCT02768116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110446039|NCT02768116|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110446040|NCT02768116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110446041|NCT02768116|Antifungal Agents|antifungal agents|mesh-ancestor
110446042|NCT02768116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110446043|NCT02768116|Immunologic Factors|immunologic factors|mesh-ancestor
110141354|NCT02012244|Fentanyl|fentanyl|mesh-list
110446044|NCT02768116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110141716|NCT02014558|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110446045|NCT02768116|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110446046|NCT02768116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110141951|NCT02016196|Rifaximin|rifaximin|mesh-list
110142016|NCT02016391|Adrenergic Agents|adrenergic agents|mesh-ancestor
110142401|NCT02019160|Fluorides|fluorides|mesh-list
110142473|NCT02019459|Nicotine|nicotine|mesh-list
110142619|NCT02020499|Lanreotide|lanreotide|mesh-list
110142694|NCT02021097|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110142767|NCT02021422|Antimetabolites|antimetabolites|mesh-ancestor
110142844|NCT02022241|Triptorelin Pamoate|triptorelin pamoate|mesh-list
110446047|NCT02768116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110143363|NCT02024984|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110143511|NCT02025855|Antitussive Agents|antitussive agents|mesh-ancestor
110446049|NCT00635284|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110446050|NCT00635284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110144079|NCT02029378|Eculizumab|eculizumab|mesh-list
110144188|NCT02029950|Podophyllotoxin|podophyllotoxin|mesh-list
110144491|NCT02040597|Hormones|hormones|mesh-ancestor
110144568|NCT02040883|Dopamine Agonists|dopamine agonists|mesh-ancestor
110446052|NCT00635284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110446053|NCT00635284|Antifungal Agents|antifungal agents|mesh-ancestor
110446054|NCT00635284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110446055|NCT00635284|Immunologic Factors|immunologic factors|mesh-ancestor
110144867|NCT02043886|Acarbose|acarbose|mesh-list
110446056|NCT00635284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110145164|NCT02045953|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110145383|NCT02047019|Vasodilator Agents|vasodilator agents|mesh-ancestor
110145457|NCT02047292|Cholinergic Agents|cholinergic agents|mesh-ancestor
110145607|NCT00005880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110145755|NCT00005940|Alkylating Agents|alkylating agents|mesh-ancestor
110146058|NCT00006009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110146136|NCT00006030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110146283|NCT05679336|Alkylating Agents|alkylating agents|mesh-ancestor
110146441|NCT03869736|Nitrous Oxide|nitrous oxide|mesh-list
110146656|NCT00006054|Antimetabolites|antimetabolites|mesh-ancestor
110146814|NCT00006129|Testosterone|testosterone|mesh-list
110147110|NCT00006270|Cosyntropin|cosyntropin|mesh-list
110452003|NCT02872818|Estradiol|estradiol|mesh-list
110147259|NCT00005851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110560314|NCT02684123|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110560315|NCT02684123|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110560316|NCT02684123|Analgesics|analgesics|mesh-ancestor
110560317|NCT02684123|Sensory System Agents|sensory system agents|mesh-ancestor
110147635|NCT00005968|Irofulven|irofulven|mesh-list
110147862|NCT00006022|Immunologic Factors|immunologic factors|mesh-ancestor
110147936|NCT00006040|Etoposide|etoposide|mesh-list
110560318|NCT02684123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110148237|NCT05247970|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110446057|NCT04131595|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
110446058|NCT04131595|Antiviral Agents|antiviral agents|mesh-ancestor
110446059|NCT04131595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110446060|NCT00699049|Solifenacin Succinate|solifenacin succinate|mesh-list
110446061|NCT00699049|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
110446062|NCT00699049|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110446063|NCT00699049|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110446064|NCT00699049|Cholinergic Agents|cholinergic agents|mesh-ancestor
110446065|NCT00699049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110446066|NCT00699049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110446067|NCT00699049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110446068|NCT00699049|Urological Agents|urological agents|mesh-ancestor
110446069|NCT00699049|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110446070|NCT00699049|Adrenergic Agents|adrenergic agents|mesh-ancestor
110446072|NCT04131283|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110446073|NCT04131283|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110446074|NCT04131283|Adrenergic Agents|adrenergic agents|mesh-ancestor
110446075|NCT04131283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110446076|NCT04131283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110446077|NCT04131283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110446078|NCT04131283|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110446079|NCT04131283|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110446080|NCT04131283|Autonomic Agents|autonomic agents|mesh-ancestor
110446081|NCT04131283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110446082|NCT04131283|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110446083|NCT04131283|Respiratory System Agents|respiratory system agents|mesh-ancestor
110446085|NCT04131283|Sympathomimetics|sympathomimetics|mesh-ancestor
110446086|NCT04131283|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110446087|NCT00943761|Interferons|interferons|mesh-list
110446088|NCT00943761|Ribavirin|ribavirin|mesh-list
110446089|NCT00943761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110446090|NCT00943761|Antiviral Agents|antiviral agents|mesh-ancestor
110446091|NCT00943761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110446092|NCT00943761|Antimetabolites|antimetabolites|mesh-ancestor
110446093|NCT00943761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110446094|NCT02617771|Vitamin D|vitamin d|mesh-list
110452401|NCT00831181|Leucovorin|leucovorin|mesh-list
110446095|NCT02617771|Cholecalciferol|cholecalciferol|mesh-list
110446096|NCT02617771|Vitamins|vitamins|mesh-ancestor
110446097|NCT02617771|Micronutrients|micronutrients|mesh-ancestor
110446098|NCT02617771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110446099|NCT02617771|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110446100|NCT02617771|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110446102|NCT02696590|Cholecalciferol|cholecalciferol|mesh-list
110446103|NCT02696590|Vitamins|vitamins|mesh-ancestor
110446104|NCT02696590|Micronutrients|micronutrients|mesh-ancestor
110446105|NCT02696590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110446106|NCT02696590|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110446107|NCT02696590|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110446108|NCT02617459|Betaxolol|betaxolol|mesh-list
110446109|NCT02617459|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110446110|NCT02617459|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110446111|NCT02617459|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110446112|NCT02617459|Sympatholytics|sympatholytics|mesh-ancestor
110446113|NCT02617459|Autonomic Agents|autonomic agents|mesh-ancestor
110446114|NCT02617459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110446115|NCT02617459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110446116|NCT02617459|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110446117|NCT02617459|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110446118|NCT02617459|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110446119|NCT02617459|Adrenergic Agents|adrenergic agents|mesh-ancestor
110446120|NCT02617459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110446121|NCT02617459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110446122|NCT02854995|Triamcinolone|triamcinolone|mesh-list
110446123|NCT02854995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110446124|NCT02854995|Glucocorticoids|glucocorticoids|mesh-ancestor
110446126|NCT02854995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110446127|NCT02854995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110446128|NCT02696512|Thioctic Acid|thioctic acid|mesh-list
110446129|NCT02696512|Minocycline|minocycline|mesh-list
110446130|NCT02696512|Lamotrigine|lamotrigine|mesh-list
110446131|NCT02696512|Flumazenil|flumazenil|mesh-list
110446132|NCT02696512|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110446133|NCT02696512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110446134|NCT02696512|Anticonvulsants|anticonvulsants|mesh-ancestor
110446135|NCT02696512|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110446136|NCT02696512|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110453038|NCT02299414|Vasodilator Agents|vasodilator agents|mesh-ancestor
110446137|NCT02696512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110446138|NCT02696512|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110446139|NCT02696512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110446140|NCT02696512|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110446141|NCT02696512|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110446142|NCT02696512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110446143|NCT02696512|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110446144|NCT02696512|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110446145|NCT02696512|Antioxidants|antioxidants|mesh-ancestor
110446146|NCT02696512|Protective Agents|protective agents|mesh-ancestor
110446147|NCT02696512|Vitamin B Complex|vitamin b complex|mesh-ancestor
110446148|NCT02696512|Vitamins|vitamins|mesh-ancestor
110446149|NCT02696512|Micronutrients|micronutrients|mesh-ancestor
110446150|NCT02696512|Antidotes|antidotes|mesh-ancestor
110446151|NCT02696512|GABA Modulators|gaba modulators|mesh-ancestor
110446152|NCT02696512|GABA Agents|gaba agents|mesh-ancestor
110446153|NCT02696512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110446154|NCT00949533|Oseltamivir|oseltamivir|mesh-list
110446155|NCT00949533|Antiviral Agents|antiviral agents|mesh-ancestor
110446156|NCT00949533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110446157|NCT00949533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110446158|NCT00949533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110446159|NCT02767258|Lubricant Eye Drops|lubricant eye drops|mesh-list
110446160|NCT02767258|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110446161|NCT02767258|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110446162|NCT02854761|Vitamin D|vitamin d|mesh-list
110446163|NCT02854761|Vitamins|vitamins|mesh-ancestor
110446164|NCT02854761|Micronutrients|micronutrients|mesh-ancestor
110446165|NCT02854761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110446166|NCT02854761|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110446167|NCT00866047|Brentuximab Vedotin|brentuximab vedotin|mesh-list
110453187|NCT01089725|Tanezumab|tanezumab|mesh-list
110446168|NCT00866047|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110446169|NCT00866047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110446170|NCT00866047|Immunotoxins|immunotoxins|mesh-ancestor
110446171|NCT00866047|Immunoconjugates|immunoconjugates|mesh-ancestor
110446172|NCT00866047|Immunologic Factors|immunologic factors|mesh-ancestor
110446173|NCT00866047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110446174|NCT01706692|Cyclosporine|cyclosporine|mesh-list
110446175|NCT01706692|Adalimumab|adalimumab|mesh-list
110446176|NCT01706692|Infliximab|infliximab|mesh-list
110446177|NCT01706692|Etanercept|etanercept|mesh-list
110446178|NCT01706692|Methotrexate|methotrexate|mesh-list
110446179|NCT01706692|Ustekinumab|ustekinumab|mesh-list
110446180|NCT01706692|Cyclosporins|cyclosporins|mesh-list
110446181|NCT01706692|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110446182|NCT01706692|Abortifacient Agents|abortifacient agents|mesh-ancestor
110446183|NCT01706692|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110446184|NCT01706692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110446185|NCT01706692|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110446186|NCT01706692|Antimetabolites|antimetabolites|mesh-ancestor
110446187|NCT01706692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110446188|NCT01706692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110446189|NCT01706692|Dermatologic Agents|dermatologic agents|mesh-ancestor
110446190|NCT01706692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110446191|NCT01706692|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110446192|NCT01706692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110249950|NCT00405444|Anesthetics|anesthetics|mesh-ancestor
110446193|NCT01706692|Immunologic Factors|immunologic factors|mesh-ancestor
110446194|NCT01706692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110446195|NCT01706692|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110453234|NCT01101191|Oxycodone|oxycodone|mesh-list
110446197|NCT01706692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110446198|NCT01706692|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110446199|NCT01706692|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110446200|NCT01706692|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110093223|NCT01701323|Cytarabine|cytarabine|mesh-list
110446201|NCT01706692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110446202|NCT01706692|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110446203|NCT01706692|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110446204|NCT01706692|Analgesics|analgesics|mesh-ancestor
110446205|NCT01706692|Sensory System Agents|sensory system agents|mesh-ancestor
110446206|NCT01706692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110446208|NCT00869323|Bortezomib|bortezomib|mesh-list
110446209|NCT00869323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110446210|NCT00869323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110446211|NCT00869323|Immunologic Factors|immunologic factors|mesh-ancestor
110446212|NCT00869323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110446213|NCT00869323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110446215|NCT02767102|Antioxidants|antioxidants|mesh-ancestor
110453347|NCT02697058|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110446216|NCT02767102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110446217|NCT02767102|Protective Agents|protective agents|mesh-ancestor
110446218|NCT02767102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110446219|NCT02767102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110446220|NCT02774902|Clarithromycin|clarithromycin|mesh-list
110446221|NCT02774902|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110446222|NCT02774902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110446223|NCT02774902|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110446224|NCT02774902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110446225|NCT02774902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110446226|NCT02774902|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110446227|NCT02774902|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110446228|NCT02767024|Nitroprusside|nitroprusside|mesh-list
110446229|NCT02767024|Dobutamine|dobutamine|mesh-list
110446230|NCT02767024|Furosemide|furosemide|mesh-list
110446231|NCT02767024|Diuretics|diuretics|mesh-ancestor
110446232|NCT02767024|Natriuretic Agents|natriuretic agents|mesh-ancestor
110446233|NCT02767024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110446234|NCT02767024|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110446235|NCT02767024|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110446236|NCT02767024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110446237|NCT02767024|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110446238|NCT02767024|Sympathomimetics|sympathomimetics|mesh-ancestor
110446239|NCT02767024|Autonomic Agents|autonomic agents|mesh-ancestor
110446240|NCT02767024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110446241|NCT02767024|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
110446242|NCT02767024|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110446243|NCT02767024|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110446245|NCT02767024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110446246|NCT02767024|Protective Agents|protective agents|mesh-ancestor
110446247|NCT02767024|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110446248|NCT02767024|Vasodilator Agents|vasodilator agents|mesh-ancestor
110446249|NCT02767024|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
110446250|NCT02774200|Apatinib|apatinib|mesh-list
110446251|NCT02774200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110446252|NCT02774200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110446253|NCT02774200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110446254|NCT02774200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110446255|NCT02766634|Lenograstim|lenograstim|mesh-list
110446256|NCT02766634|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110446257|NCT02766634|Immunologic Factors|immunologic factors|mesh-ancestor
110446258|NCT02766634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110446259|NCT02774044|Beractant|beractant|mesh-list
110446260|NCT02774044|Goat lung surfactant extract|goat lung surfactant extract|mesh-list
110446261|NCT02774044|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
110446262|NCT02774044|Respiratory System Agents|respiratory system agents|mesh-ancestor
110446263|NCT02766556|Dexmedetomidine|dexmedetomidine|mesh-list
110446264|NCT02766556|Ropivacaine|ropivacaine|mesh-list
110446265|NCT02766556|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110446266|NCT02766556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110446267|NCT02766556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110446268|NCT02766556|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110446269|NCT02766556|Analgesics|analgesics|mesh-ancestor
110446270|NCT02766556|Sensory System Agents|sensory system agents|mesh-ancestor
110446271|NCT02766556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110446272|NCT02766556|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110446273|NCT02766556|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110446274|NCT02766556|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110446275|NCT02766556|Adrenergic Agents|adrenergic agents|mesh-ancestor
110446276|NCT02766556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110453681|NCT04521946|Etoposide|etoposide|mesh-list
110446277|NCT02766556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110446278|NCT02766556|Anesthetics, Local|anesthetics, local|mesh-ancestor
110446279|NCT02766556|Anesthetics|anesthetics|mesh-ancestor
110446280|NCT01191944|Pramipexole|pramipexole|mesh-list
110446281|NCT01191944|Antioxidants|antioxidants|mesh-ancestor
110446282|NCT01191944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110446283|NCT01191944|Protective Agents|protective agents|mesh-ancestor
110446284|NCT01191944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110446285|NCT01191944|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110446286|NCT01191944|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110446287|NCT01191944|Dopamine Agonists|dopamine agonists|mesh-ancestor
110446288|NCT01191944|Dopamine Agents|dopamine agents|mesh-ancestor
110446289|NCT01191944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110446290|NCT00940875|Gemcitabine|gemcitabine|mesh-list
110446291|NCT00940875|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110446292|NCT00940875|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110446293|NCT00940875|Antimetabolites|antimetabolites|mesh-ancestor
110446294|NCT00940875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110446295|NCT00940875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110446296|NCT00940875|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110446297|NCT00940875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110446298|NCT02766322|Ethanol|ethanol|mesh-list
110446299|NCT02766322|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110446300|NCT02766322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110446301|NCT02766322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110446302|NCT02766322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110446303|NCT05655728|Metformin|metformin|mesh-list
110446304|NCT05655728|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110453802|NCT04186936|Loperamide|loperamide|mesh-list
110446305|NCT05655728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110446306|NCT00940485|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110446307|NCT00940485|Entecavir|entecavir|mesh-list
110446308|NCT00940485|Antiviral Agents|antiviral agents|mesh-ancestor
110446309|NCT00940485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110446310|NCT04317248|Cyclophosphamide|cyclophosphamide|mesh-list
110446311|NCT04317248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110446312|NCT04317248|Immunologic Factors|immunologic factors|mesh-ancestor
110446313|NCT04317248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110446314|NCT04317248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110446315|NCT04317248|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110446316|NCT04317248|Alkylating Agents|alkylating agents|mesh-ancestor
110446317|NCT04317248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110446318|NCT04317248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110446319|NCT04317248|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110446320|NCT05655338|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110453989|NCT02685670|Fludarabine|fludarabine|mesh-list
110453990|NCT02685670|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110453991|NCT02685670|Immunologic Factors|immunologic factors|mesh-ancestor
110453992|NCT02685670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110453993|NCT02685670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110453994|NCT02685670|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110453995|NCT02685670|Alkylating Agents|alkylating agents|mesh-ancestor
110453996|NCT02685670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110453999|NCT02687932|Valsartan|valsartan|mesh-list
110446321|NCT05655338|Amoxicillin|amoxicillin|mesh-list
110446322|NCT05655338|Metronidazole|metronidazole|mesh-list
110446323|NCT05655338|Anti-Infective Agents|anti-infective agents|mesh-list
110446324|NCT05655338|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110446325|NCT05655338|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110446326|NCT01132313|Ribavirin|ribavirin|mesh-list
110446327|NCT01132313|Antimetabolites|antimetabolites|mesh-ancestor
110446328|NCT01132313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110446329|NCT01132313|Antiviral Agents|antiviral agents|mesh-ancestor
110446330|NCT01132313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110446331|NCT00422565|Sirolimus|sirolimus|mesh-list
110446332|NCT00422565|Paclitaxel|paclitaxel|mesh-list
110446333|NCT00422565|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110446334|NCT00422565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110446335|NCT00422565|Tubulin Modulators|tubulin modulators|mesh-ancestor
110446336|NCT00422565|Antimitotic Agents|antimitotic agents|mesh-ancestor
110446337|NCT00422565|Mitosis Modulators|mitosis modulators|mesh-ancestor
110446338|NCT00422565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110446339|NCT00422565|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110454129|NCT00641680|Glucocorticoids|glucocorticoids|mesh-ancestor
110446340|NCT00422565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110446341|NCT00422565|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110446342|NCT00422565|Antifungal Agents|antifungal agents|mesh-ancestor
110446343|NCT00422565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110446344|NCT00422565|Immunologic Factors|immunologic factors|mesh-ancestor
110446345|NCT00422565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110446346|NCT04316936|Dexamethasone|dexamethasone|mesh-list
110446347|NCT04316936|Prednisolone|prednisolone|mesh-list
110446348|NCT04316936|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110446349|NCT04316936|Methylprednisolone|methylprednisolone|mesh-list
110446350|NCT04316936|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110446351|NCT04316936|Prednisolone acetate|prednisolone acetate|mesh-list
110446352|NCT04316936|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110446353|NCT04316936|Prednisolone phosphate|prednisolone phosphate|mesh-list
110446354|NCT04316936|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110446356|NCT04316936|Autonomic Agents|autonomic agents|mesh-ancestor
110446357|NCT04316936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110446358|NCT04316936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110446359|NCT04316936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110446360|NCT04316936|Glucocorticoids|glucocorticoids|mesh-ancestor
110446361|NCT04316936|Hormones|hormones|mesh-ancestor
110454328|NCT00640588|Adefovir|adefovir|mesh-list
110454337|NCT05663398|Ibuprofen|ibuprofen|mesh-list
110446362|NCT04316936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110446363|NCT04316936|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110446364|NCT04316936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110446365|NCT04316936|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110446366|NCT04316936|Protective Agents|protective agents|mesh-ancestor
110446367|NCT00861757|Tadalafil|tadalafil|mesh-list
110446368|NCT00861757|Tamsulosin|tamsulosin|mesh-list
110446369|NCT00861757|Vasodilator Agents|vasodilator agents|mesh-ancestor
110446370|NCT00861757|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110446371|NCT00861757|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110446372|NCT00861757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110446373|NCT00861757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110446374|NCT00861757|Urological Agents|urological agents|mesh-ancestor
110454460|NCT04180150|Antiviral Agents|antiviral agents|mesh-ancestor
110446375|NCT00861757|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110446376|NCT00861757|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110446377|NCT00861757|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110446378|NCT00861757|Adrenergic Agents|adrenergic agents|mesh-ancestor
110446379|NCT00861757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110446380|NCT00861757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110446381|NCT02762812|Infliximab|infliximab|mesh-list
110446382|NCT02762812|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110446383|NCT02762812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110446384|NCT02762812|Dermatologic Agents|dermatologic agents|mesh-ancestor
110446385|NCT02762812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110446386|NCT02762812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110446387|NCT02762890|Iodine|iodine|mesh-list
110446388|NCT02762890|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110446389|NCT02762890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110446390|NCT02762890|Trace Elements|trace elements|mesh-ancestor
110446391|NCT02762890|Micronutrients|micronutrients|mesh-ancestor
110446392|NCT02762890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110446393|NCT02613715|Ethanol|ethanol|mesh-list
110446394|NCT02613715|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110446395|NCT02613715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110446396|NCT02613715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110446397|NCT02613715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110446398|NCT02762656|Lidocaine|lidocaine|mesh-list
110446399|NCT02762656|Anesthetics, Local|anesthetics, local|mesh-ancestor
110446400|NCT02762656|Anesthetics|anesthetics|mesh-ancestor
110446401|NCT02762656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110446402|NCT02762656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110446403|NCT02762656|Sensory System Agents|sensory system agents|mesh-ancestor
110446404|NCT02762656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110446405|NCT02762656|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110446406|NCT02762656|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110446407|NCT02762656|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110446408|NCT02762656|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110446409|NCT02762656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110446410|NCT00637325|Trastuzumab|trastuzumab|mesh-list
110446411|NCT00637325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110446412|NCT00637325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110446413|NCT02762344|Heparin|heparin|mesh-list
110446414|NCT02762344|Anticoagulants|anticoagulants|mesh-ancestor
110446415|NCT02762344|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110446416|NCT02762344|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110446417|NCT02762344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110446418|NCT04663282|Insulin|insulin|mesh-list
110446419|NCT04663282|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110446420|NCT04663282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110446421|NCT01130597|Spironolactone|spironolactone|mesh-list
110446422|NCT01130597|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110446423|NCT01130597|Hormone Antagonists|hormone antagonists|mesh-ancestor
110446424|NCT01130597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110446425|NCT01130597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110093444|NCT01702636|Tranexamic Acid|tranexamic acid|mesh-list
110446426|NCT01130597|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110446427|NCT01130597|Diuretics|diuretics|mesh-ancestor
110446428|NCT01130597|Natriuretic Agents|natriuretic agents|mesh-ancestor
110446429|NCT00939003|Adalimumab|adalimumab|mesh-list
110446430|NCT00939003|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110446431|NCT00939003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110446432|NCT00939003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110446434|NCT01188668|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
110446435|NCT01188668|Antidepressive Agents|antidepressive agents|mesh-ancestor
110446436|NCT01188668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110446437|NCT01188668|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110446438|NCT01188668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110454845|NCT02671318|Sirolimus|sirolimus|mesh-list
110446439|NCT01188668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110446440|NCT01188668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110446441|NCT01188668|Dopamine Agonists|dopamine agonists|mesh-ancestor
110446442|NCT01188668|Dopamine Agents|dopamine agents|mesh-ancestor
110446443|NCT01188668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110446444|NCT01188668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110446445|NCT01188668|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110446446|NCT01188668|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110446447|NCT01188668|Serotonin Agents|serotonin agents|mesh-ancestor
110446448|NCT01188668|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110446449|NCT01188668|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110446450|NCT01188668|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110446451|NCT01188668|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110446452|NCT01188668|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110446453|NCT01188668|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110446454|NCT01188668|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110446455|NCT01130051|Colchicine|colchicine|mesh-list
110446456|NCT01130051|Gout Suppressants|gout suppressants|mesh-ancestor
110446457|NCT01130051|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110446458|NCT01130051|Tubulin Modulators|tubulin modulators|mesh-ancestor
110446459|NCT01130051|Antimitotic Agents|antimitotic agents|mesh-ancestor
110455074|NCT04173832|Amantadine|amantadine|mesh-list
110446460|NCT01130051|Mitosis Modulators|mitosis modulators|mesh-ancestor
110446461|NCT01130051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110446462|NCT01130051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110446463|NCT00865189|Leucovorin|leucovorin|mesh-list
110446464|NCT00865189|Folic Acid|folic acid|mesh-list
110446465|NCT00865189|Bevacizumab|bevacizumab|mesh-list
110446466|NCT00865189|Fluorouracil|fluorouracil|mesh-list
110446467|NCT00865189|Oxaliplatin|oxaliplatin|mesh-list
110446468|NCT00865189|Levoleucovorin|levoleucovorin|mesh-list
110446469|NCT00865189|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110446470|NCT00865189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110446471|NCT00865189|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110446472|NCT00865189|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110446473|NCT00865189|Growth Substances|growth substances|mesh-ancestor
110446474|NCT00865189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110446475|NCT00865189|Growth Inhibitors|growth inhibitors|mesh-ancestor
110446476|NCT00865189|Antimetabolites|antimetabolites|mesh-ancestor
110446477|NCT00865189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110446478|NCT00865189|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110446479|NCT00865189|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110446481|NCT00865189|Antidotes|antidotes|mesh-ancestor
110446482|NCT00865189|Protective Agents|protective agents|mesh-ancestor
110446483|NCT00865189|Vitamin B Complex|vitamin b complex|mesh-ancestor
110446484|NCT00865189|Vitamins|vitamins|mesh-ancestor
110291630|NCT04589494|Analgesics|analgesics|mesh-ancestor
110446486|NCT00865189|Hematinics|hematinics|mesh-ancestor
110446487|NCT05362292|Mirabegron|mirabegron|mesh-list
110446488|NCT05362292|Tolterodine Tartrate|tolterodine tartrate|mesh-list
110446489|NCT05362292|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
110446490|NCT05362292|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110446491|NCT05362292|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110446492|NCT05362292|Adrenergic Agents|adrenergic agents|mesh-ancestor
110446493|NCT05362292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110446494|NCT05362292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110446495|NCT05362292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110446496|NCT05362292|Urological Agents|urological agents|mesh-ancestor
110446497|NCT05362292|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110446498|NCT05362292|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110446499|NCT05362292|Cholinergic Agents|cholinergic agents|mesh-ancestor
110446500|NCT00698269|Insulin|insulin|mesh-list
110446501|NCT00698269|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110446502|NCT00698269|Insulin Aspart|insulin aspart|mesh-list
110446503|NCT00698269|Insulin, Long-Acting|insulin, long-acting|mesh-list
110446504|NCT00698269|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
110446506|NCT00698269|Biphasic Insulins|biphasic insulins|mesh-list
110446507|NCT00698269|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
110446508|NCT00698269|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110446509|NCT00698269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110446511|NCT01182194|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110446512|NCT01182194|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110446513|NCT01182194|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110446514|NCT01182194|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
110446515|NCT01182194|Estradiol|estradiol|mesh-list
110446516|NCT01182194|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110446517|NCT01182194|Estrogens|estrogens|mesh-ancestor
110446518|NCT01182194|Hormones|hormones|mesh-ancestor
110446519|NCT01182194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110446520|NCT01182194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110446521|NCT01182194|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110446522|NCT01182194|Contraceptive Agents|contraceptive agents|mesh-ancestor
110446523|NCT01182194|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110446524|NCT01182194|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110446525|NCT01182194|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110446526|NCT01182194|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110446527|NCT01182194|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110446528|NCT01182194|Hormone Antagonists|hormone antagonists|mesh-ancestor
110446529|NCT01182194|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110446530|NCT01182194|Diuretics|diuretics|mesh-ancestor
110446531|NCT01182194|Natriuretic Agents|natriuretic agents|mesh-ancestor
110446532|NCT01181726|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110446533|NCT01181726|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110446534|NCT01181726|Norethindrone|norethindrone|mesh-list
110446535|NCT01181726|Norethindrone Acetate|norethindrone acetate|mesh-list
110446536|NCT01181726|Estradiol|estradiol|mesh-list
110446537|NCT01181726|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110446538|NCT01181726|Estrogens|estrogens|mesh-ancestor
110446539|NCT01181726|Hormones|hormones|mesh-ancestor
110446540|NCT01181726|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110446541|NCT01181726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110446542|NCT01181726|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110446543|NCT01181726|Contraceptive Agents|contraceptive agents|mesh-ancestor
110455575|NCT00648856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110446544|NCT01181726|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110446545|NCT01181726|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110446546|NCT01181726|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110446547|NCT01181726|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110446548|NCT01181726|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110446549|NCT01137071|Antibodies|antibodies|mesh-list
110446550|NCT01137071|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110446551|NCT01137071|Immunologic Factors|immunologic factors|mesh-ancestor
110446552|NCT01137071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110446553|NCT00603759|Celecoxib|celecoxib|mesh-list
110446554|NCT00603759|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110446555|NCT00603759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110446556|NCT00603759|Analgesics|analgesics|mesh-ancestor
110446557|NCT00603759|Sensory System Agents|sensory system agents|mesh-ancestor
110446558|NCT00603759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110446559|NCT00603759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110446560|NCT00603759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110446562|NCT00603759|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110446563|NCT00603759|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110446564|NCT00603759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110446565|NCT00603759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110446566|NCT04130815|Furosemide|furosemide|mesh-list
110446567|NCT04130815|Diuretics|diuretics|mesh-ancestor
110446568|NCT04130815|Natriuretic Agents|natriuretic agents|mesh-ancestor
110446569|NCT04130815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110446570|NCT04130815|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110446571|NCT04130815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110446572|NCT04130815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110446573|NCT04256265|Risdiplam|risdiplam|mesh-list
110446574|NCT04256265|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110455907|NCT00992394|Etanercept|etanercept|mesh-list
110446575|NCT04256265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110446576|NCT04256265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110446577|NCT04312061|Tramadol|tramadol|mesh-list
110446578|NCT04312061|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110446579|NCT04312061|Narcotics|narcotics|mesh-ancestor
110446580|NCT04312061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110446581|NCT04312061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110446582|NCT04312061|Analgesics|analgesics|mesh-ancestor
110446583|NCT04312061|Sensory System Agents|sensory system agents|mesh-ancestor
110103121|NCT01769482|Udenafil|udenafil|mesh-list
110446584|NCT04312061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110446585|NCT00860743|Antioxidants|antioxidants|mesh-list
110446586|NCT00860743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110446587|NCT00860743|Protective Agents|protective agents|mesh-ancestor
110446588|NCT00860743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110446589|NCT01186796|Fulvestrant|fulvestrant|mesh-list
110446590|NCT01186796|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110446591|NCT01186796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110446592|NCT01186796|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110446593|NCT01186796|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110446594|NCT01186796|Hormone Antagonists|hormone antagonists|mesh-ancestor
110446595|NCT01186796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110456187|NCT00707083|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110446596|NCT01186796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110446597|NCT05383131|Pirfenidone|pirfenidone|mesh-list
110446598|NCT05383131|Nintedanib|nintedanib|mesh-list
110446599|NCT05383131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110446600|NCT05383131|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110446601|NCT05383131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110446602|NCT05383131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110446603|NCT05383131|Analgesics|analgesics|mesh-ancestor
110446604|NCT05383131|Sensory System Agents|sensory system agents|mesh-ancestor
110446605|NCT05383131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110446606|NCT05383131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110446607|NCT05383131|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110446608|NCT05383131|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110446609|NCT05383131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110446610|NCT05383131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110446611|NCT02761486|Aspirin|aspirin|mesh-list
110446612|NCT02761486|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110446613|NCT02761486|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110446614|NCT02761486|Analgesics|analgesics|mesh-ancestor
110446615|NCT02761486|Sensory System Agents|sensory system agents|mesh-ancestor
110446616|NCT02761486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110446617|NCT02761486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110446618|NCT02761486|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110446619|NCT02761486|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110446621|NCT02761486|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110446622|NCT02761486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110446623|NCT02761486|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110446624|NCT02761486|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110446625|NCT02761486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110446626|NCT02761486|Antipyretics|antipyretics|mesh-ancestor
110446627|NCT02882789|Delpazolid|delpazolid|mesh-list
110446628|NCT02882789|Oxazolidinones|oxazolidinones|mesh-list
110446629|NCT02882789|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110446630|NCT02882789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110446631|NCT02882789|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110446632|NCT02882789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110446633|NCT02882789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110446635|NCT00940017|Anidulafungin|anidulafungin|mesh-list
110446636|NCT00940017|Antifungal Agents|antifungal agents|mesh-ancestor
110446637|NCT00940017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110446638|NCT00940017|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110446639|NCT00940017|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110446640|NCT00940017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110446641|NCT00940017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110446642|NCT00940017|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110446643|NCT00940017|Hormone Antagonists|hormone antagonists|mesh-ancestor
110446644|NCT00940017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110446645|NCT00940017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110446646|NCT00940017|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110446648|NCT01129583|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110446650|NCT01129583|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110446651|NCT01129583|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110446652|NCT01129583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110446653|NCT01129583|Cholinergic Agents|cholinergic agents|mesh-ancestor
110446654|NCT01129583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110446655|NCT01129583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110446656|NCT01129583|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110249994|NCT03622775|Daratumumab|daratumumab|mesh-list
110446657|NCT01129583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110446658|NCT01186328|Cytarabine|cytarabine|mesh-list
110446659|NCT01186328|Prednisone|prednisone|mesh-list
110446660|NCT01186328|Hydrocortisone|hydrocortisone|mesh-list
110446661|NCT01186328|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
110446662|NCT01186328|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
110446663|NCT01186328|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
110446664|NCT01186328|Cortisone|cortisone|mesh-list
110446665|NCT01186328|Doxorubicin|doxorubicin|mesh-list
110446667|NCT01186328|Vincristine|vincristine|mesh-list
110446668|NCT01186328|Asparaginase|asparaginase|mesh-list
110446669|NCT01186328|Pegaspargase|pegaspargase|mesh-list
110446670|NCT01186328|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110446671|NCT01186328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110446672|NCT01186328|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110446673|NCT01186328|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110446674|NCT01186328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110446675|NCT01186328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110446676|NCT01186328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110446677|NCT01186328|Glucocorticoids|glucocorticoids|mesh-ancestor
110446678|NCT01186328|Hormones|hormones|mesh-ancestor
110446679|NCT01186328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110446680|NCT01186328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110446681|NCT01186328|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110446682|NCT01186328|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110446683|NCT01186328|Abortifacient Agents|abortifacient agents|mesh-ancestor
110446684|NCT01186328|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110446685|NCT01186328|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110446686|NCT01186328|Antimetabolites|antimetabolites|mesh-ancestor
110446687|NCT01186328|Dermatologic Agents|dermatologic agents|mesh-ancestor
110446688|NCT01186328|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110446689|NCT01186328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110446690|NCT01186328|Immunologic Factors|immunologic factors|mesh-ancestor
110446691|NCT01186328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110446692|NCT01186328|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110446693|NCT01186328|Antiviral Agents|antiviral agents|mesh-ancestor
110446694|NCT01186328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110456906|NCT02640976|Cetrorelix|cetrorelix|mesh-list
110446695|NCT01186328|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110446696|NCT01186328|Tubulin Modulators|tubulin modulators|mesh-ancestor
110446697|NCT01186328|Antimitotic Agents|antimitotic agents|mesh-ancestor
110446698|NCT01186328|Mitosis Modulators|mitosis modulators|mesh-ancestor
110446699|NCT00848497|Methyltestosterone|methyltestosterone|mesh-list
110446700|NCT00848497|Sildenafil Citrate|sildenafil citrate|mesh-list
110446701|NCT00848497|Testosterone|testosterone|mesh-list
110446702|NCT00848497|Testosterone undecanoate|testosterone undecanoate|mesh-list
110446703|NCT00848497|Testosterone enanthate|testosterone enanthate|mesh-list
110446704|NCT00848497|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
110446705|NCT00848497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110446706|NCT00848497|Androgens|androgens|mesh-ancestor
110446707|NCT00848497|Hormones|hormones|mesh-ancestor
110456975|NCT04166890|Carticaine|carticaine|mesh-list
110446708|NCT00848497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110446709|NCT00848497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110446710|NCT00848497|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110446711|NCT00848497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110446713|NCT00848497|Vasodilator Agents|vasodilator agents|mesh-ancestor
110446714|NCT00848497|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110446715|NCT00848497|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110446716|NCT00848497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110446717|NCT00848497|Urological Agents|urological agents|mesh-ancestor
110457129|NCT02613091|Clemastine|clemastine|mesh-list
110446719|NCT02763592|Anesthetics, Local|anesthetics, local|mesh-ancestor
110446721|NCT02763592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110457181|NCT00654160|Leucovorin|leucovorin|mesh-list
110446722|NCT02763592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110446723|NCT02763592|Sensory System Agents|sensory system agents|mesh-ancestor
110446724|NCT02763592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110446725|NCT02763592|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110250002|NCT03999723|Ascorbic Acid|ascorbic acid|mesh-list
110446726|NCT02763592|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110446727|NCT02763592|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110446728|NCT02763592|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110446729|NCT02763592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110446730|NCT01185782|Gonadotropins, Pituitary|gonadotropins, pituitary|mesh-list
110446732|NCT01185782|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
110446733|NCT01185782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110446734|NCT01185782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110446735|NCT01185782|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110446736|NCT01185782|Fertility Agents|fertility agents|mesh-ancestor
110446737|NCT01185782|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110446738|NCT01185782|Fertility Agents, Male|fertility agents, male|mesh-ancestor
110446739|NCT02761174|Brimonidine Tartrate|brimonidine tartrate|mesh-list
110446740|NCT02761174|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110446741|NCT02761174|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110446742|NCT02761174|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110446743|NCT02761174|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110446744|NCT02761174|Adrenergic Agents|adrenergic agents|mesh-ancestor
110446745|NCT02761174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110446746|NCT02761174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110446747|NCT02761174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110446749|NCT02882555|Antipruritics|antipruritics|mesh-ancestor
110446750|NCT02882555|Dermatologic Agents|dermatologic agents|mesh-ancestor
110446751|NCT02882555|Sensory System Agents|sensory system agents|mesh-ancestor
110446752|NCT02882555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110446753|NCT02882555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110446754|NCT00699361|Pantoprazole|pantoprazole|mesh-list
110446755|NCT00699361|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110446756|NCT00699361|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110446757|NCT00699361|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110446758|NCT00699361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110446759|NCT00699361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110446760|NCT01185704|Cetrorelix|cetrorelix|mesh-list
110446761|NCT01185704|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
110446762|NCT01185704|Hormones|hormones|mesh-list
110446763|NCT01185704|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
110446764|NCT01185704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110446765|NCT01185704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110446766|NCT01185704|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110446767|NCT01185704|Fertility Agents|fertility agents|mesh-ancestor
110446768|NCT01185704|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110446769|NCT01185704|Hormone Antagonists|hormone antagonists|mesh-ancestor
110446770|NCT01128959|Carbamazepine|carbamazepine|mesh-list
110446771|NCT01128959|Anticonvulsants|anticonvulsants|mesh-ancestor
110446772|NCT01128959|Antimanic Agents|antimanic agents|mesh-ancestor
110446773|NCT01128959|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110446774|NCT01128959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110446775|NCT01128959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110446776|NCT01128959|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110446777|NCT01128959|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110446778|NCT01128959|Analgesics|analgesics|mesh-ancestor
110446779|NCT01128959|Sensory System Agents|sensory system agents|mesh-ancestor
110446780|NCT01128959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110446781|NCT01128959|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110446782|NCT01128959|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110446783|NCT01128959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110446784|NCT01128959|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110446785|NCT01128959|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110446786|NCT04119739|Ibuprofen|ibuprofen|mesh-list
110446787|NCT04119739|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110446788|NCT04119739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110446789|NCT04119739|Analgesics|analgesics|mesh-ancestor
110446790|NCT04119739|Sensory System Agents|sensory system agents|mesh-ancestor
110446791|NCT04119739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110250010|NCT01249417|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110446792|NCT04119739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110446793|NCT04119739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110446794|NCT04119739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110446795|NCT04119739|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110093831|NCT01704872|Dinutuximab|dinutuximab|mesh-list
110446796|NCT04119739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110446797|NCT04119739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110446798|NCT00859573|Modafinil|modafinil|mesh-list
110446799|NCT00859573|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110446800|NCT00859573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110446801|NCT00859573|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
110446802|NCT00859573|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110446803|NCT00859573|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110446804|NCT00859573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110446805|NCT02758444|Micronutrients|micronutrients|mesh-list
110446806|NCT02758444|Trace Elements|trace elements|mesh-list
110446807|NCT02758444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110446808|NCT01185548|Tolbutamide|tolbutamide|mesh-list
110446809|NCT01185548|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110291964|NCT04584034|Autonomic Agents|autonomic agents|mesh-ancestor
110446810|NCT01185548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110446812|NCT01128569|Xhance|xhance|mesh-list
110446813|NCT01128569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110457418|NCT00598702|Acetaminophen|acetaminophen|mesh-list
110446814|NCT01128569|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110446815|NCT01128569|Autonomic Agents|autonomic agents|mesh-ancestor
110446816|NCT01128569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110446817|NCT01128569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110457446|NCT01164956|Dopamine Agents|dopamine agents|mesh-ancestor
110446818|NCT01128569|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110446819|NCT01128569|Respiratory System Agents|respiratory system agents|mesh-ancestor
110446820|NCT01128569|Dermatologic Agents|dermatologic agents|mesh-ancestor
110446821|NCT01128569|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110446822|NCT04582942|Lactulose|lactulose|mesh-list
110446823|NCT04582942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110446824|NCT02883179|Lidocaine|lidocaine|mesh-list
110446825|NCT02883179|Prilocaine|prilocaine|mesh-list
110446826|NCT02883179|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
110446827|NCT02883179|Anesthetics, Local|anesthetics, local|mesh-ancestor
110446828|NCT02883179|Anesthetics|anesthetics|mesh-ancestor
110446829|NCT02883179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110446830|NCT02883179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110446831|NCT02883179|Sensory System Agents|sensory system agents|mesh-ancestor
110446832|NCT02883179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110446833|NCT02883179|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110446834|NCT02883179|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110446835|NCT02883179|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110446836|NCT02883179|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110446837|NCT02883179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110446838|NCT02883179|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
110446839|NCT02758366|Doxorubicin|doxorubicin|mesh-list
110446840|NCT02758366|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110446841|NCT02758366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110446842|NCT02758366|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110446843|NCT02758366|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110446844|NCT02758366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110446845|NCT02758366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110446846|NCT00637403|Megestrol|megestrol|mesh-list
110446847|NCT00637403|Megestrol Acetate|megestrol acetate|mesh-list
110446848|NCT00637403|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110446849|NCT00637403|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110446850|NCT00637403|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110446851|NCT00637403|Contraceptive Agents|contraceptive agents|mesh-ancestor
110446852|NCT00637403|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110446853|NCT00637403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110446854|NCT00637403|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110446855|NCT00637403|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110446856|NCT00637403|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110446857|NCT00637403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110446858|NCT00637403|Appetite Stimulants|appetite stimulants|mesh-ancestor
110446859|NCT00637403|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110446860|NCT01185080|Adenosine|adenosine|mesh-list
110446861|NCT01185080|Analgesics|analgesics|mesh-ancestor
110446862|NCT01185080|Sensory System Agents|sensory system agents|mesh-ancestor
110446863|NCT01185080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110446864|NCT01185080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110446865|NCT01185080|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110446866|NCT01185080|Vasodilator Agents|vasodilator agents|mesh-ancestor
110446867|NCT01185080|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
110446868|NCT01185080|Purinergic Agonists|purinergic agonists|mesh-ancestor
110446869|NCT01185080|Purinergic Agents|purinergic agents|mesh-ancestor
110446870|NCT01185080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110446871|NCT01185080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110446872|NCT01181102|Enoxaparin|enoxaparin|mesh-list
110446873|NCT01181102|Enoxaparin sodium|enoxaparin sodium|mesh-list
110446874|NCT01181102|Edoxaban|edoxaban|mesh-list
110446875|NCT01181102|Anticoagulants|anticoagulants|mesh-ancestor
110446876|NCT01181102|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110446877|NCT01181102|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110446878|NCT01181102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110446879|NCT01181102|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110446880|NCT01181102|Antithrombins|antithrombins|mesh-ancestor
110446881|NCT01181102|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110446882|NCT01181102|Protease Inhibitors|protease inhibitors|mesh-ancestor
110446883|NCT01181102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110457660|NCT04290858|Antioxidants|antioxidants|mesh-ancestor
110446884|NCT00858637|Bile Acids and Salts|bile acids and salts|mesh-list
110446885|NCT00858637|Simvastatin|simvastatin|mesh-list
110446886|NCT00858637|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110446887|NCT00858637|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110446888|NCT00858637|Antimetabolites|antimetabolites|mesh-ancestor
110446889|NCT00858637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110446890|NCT00858637|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110446891|NCT00858637|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110446892|NCT00858637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110446893|NCT00858637|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110446894|NCT02760316|Prednisolone|prednisolone|mesh-list
110446895|NCT02760316|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110446896|NCT02760316|Methylprednisolone|methylprednisolone|mesh-list
110446897|NCT02760316|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110446898|NCT02760316|Prednisolone acetate|prednisolone acetate|mesh-list
110446899|NCT02760316|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110446900|NCT02760316|Prednisolone phosphate|prednisolone phosphate|mesh-list
110446901|NCT02760316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110446902|NCT02760316|Glucocorticoids|glucocorticoids|mesh-ancestor
110446903|NCT02760316|Hormones|hormones|mesh-ancestor
110457738|NCT00599326|Sequestering Agents|sequestering agents|mesh-ancestor
110446904|NCT02760316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110446905|NCT02760316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110446906|NCT02760316|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110457807|NCT00709189|Contraceptive Agents|contraceptive agents|mesh-ancestor
110446907|NCT02760316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110446908|NCT02760316|Antiemetics|antiemetics|mesh-ancestor
110446909|NCT02760316|Autonomic Agents|autonomic agents|mesh-ancestor
110446910|NCT02760316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110446911|NCT02760316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110446912|NCT02760316|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110446913|NCT02760316|Protective Agents|protective agents|mesh-ancestor
110446914|NCT00858403|Dasatinib|dasatinib|mesh-list
110446915|NCT00858403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110446916|NCT00858403|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110446917|NCT00858403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110446918|NCT00858403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110446919|NCT02760472|SMOFlipid|smoflipid|mesh-list
110250027|NCT04725747|Midazolam|midazolam|mesh-list
110446920|NCT02760472|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
110446921|NCT02760472|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
110446922|NCT02760472|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110446923|NCT00858247|Vitamin D|vitamin d|mesh-list
110446924|NCT00858247|Cholecalciferol|cholecalciferol|mesh-list
110446925|NCT00858247|Vitamins|vitamins|mesh-ancestor
110446926|NCT00858247|Micronutrients|micronutrients|mesh-ancestor
110446927|NCT00858247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110446928|NCT00858247|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110446929|NCT00858247|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110446930|NCT04222348|Metformin|metformin|mesh-list
110446931|NCT04222348|Insulin Detemir|insulin detemir|mesh-list
110446932|NCT04222348|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110446933|NCT04222348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110446934|NCT04222114|Catumaxomab|catumaxomab|mesh-list
110446935|NCT04222114|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110446936|NCT00838435|Verapamil|verapamil|mesh-list
110446937|NCT00838435|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110446938|NCT00838435|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110446939|NCT00838435|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110446940|NCT00838435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110446941|NCT00838435|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110446942|NCT00838435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110446943|NCT00838435|Vasodilator Agents|vasodilator agents|mesh-ancestor
110446944|NCT02757508|Vitamins|vitamins|mesh-list
110446945|NCT02757508|Micronutrients|micronutrients|mesh-ancestor
110446946|NCT02757508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110446948|NCT02757196|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110446949|NCT02757196|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110446950|NCT02757196|Prednisolone|prednisolone|mesh-list
110446951|NCT02757196|Prednisolone acetate|prednisolone acetate|mesh-list
110446952|NCT02757196|Rituximab|rituximab|mesh-list
110446953|NCT02757196|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110457929|NCT00655252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110446955|NCT02757196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110446956|NCT02757196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110446957|NCT02757196|Immunologic Factors|immunologic factors|mesh-ancestor
110446958|NCT02757196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110446959|NCT02757196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110446960|NCT02757196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110446961|NCT02757196|Antiemetics|antiemetics|mesh-ancestor
110446962|NCT02757196|Autonomic Agents|autonomic agents|mesh-ancestor
110446963|NCT02757196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110446964|NCT02757196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110446965|NCT02757196|Glucocorticoids|glucocorticoids|mesh-ancestor
110446966|NCT02757196|Hormones|hormones|mesh-ancestor
110446967|NCT02757196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110446968|NCT02757196|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110446969|NCT02757196|Protective Agents|protective agents|mesh-ancestor
110446970|NCT02757196|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110446971|NCT04403698|Alendronate|alendronate|mesh-list
110446972|NCT04403698|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110446973|NCT04403698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110446974|NCT02759926|Quinine|quinine|mesh-list
110446975|NCT02759926|Denatonium|denatonium|mesh-list
110446976|NCT02759926|Antimalarials|antimalarials|mesh-ancestor
110446977|NCT02759926|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110446978|NCT02759926|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110446979|NCT02759926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110446980|NCT02759926|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110446981|NCT02759926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110446982|NCT02759926|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110446983|NCT02759926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110446984|NCT02759926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110446986|NCT02759926|Sensory System Agents|sensory system agents|mesh-ancestor
110446987|NCT02759926|Aversive Agents|aversive agents|mesh-ancestor
110446988|NCT02759926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110446989|NCT02759926|Abuse-Deterrent Formulations|abuse-deterrent formulations|mesh-ancestor
110446990|NCT04221256|Escitalopram|escitalopram|mesh-list
110446991|NCT04221256|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110446992|NCT04221256|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110458105|NCT00656110|Ethanol|ethanol|mesh-list
110446993|NCT04221256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110446994|NCT04221256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110446995|NCT04221256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110446996|NCT04221256|Serotonin Agents|serotonin agents|mesh-ancestor
110446997|NCT04221256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110446998|NCT00838201|Denosumab|denosumab|mesh-list
110446999|NCT00838201|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110447000|NCT00838201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110447001|NCT00837967|Terbutaline|terbutaline|mesh-list
110447002|NCT00837967|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
110447003|NCT00837967|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110447004|NCT00837967|Respiratory System Agents|respiratory system agents|mesh-ancestor
110447005|NCT00837967|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110447006|NCT00837967|Autonomic Agents|autonomic agents|mesh-ancestor
110447007|NCT00837967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110447008|NCT00837967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110447009|NCT00837967|Sympathomimetics|sympathomimetics|mesh-ancestor
110447010|NCT00837967|Tocolytic Agents|tocolytic agents|mesh-ancestor
110447011|NCT00837967|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110447012|NCT00837967|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110447013|NCT00837967|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110447014|NCT00837967|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110447015|NCT00837967|Adrenergic Agents|adrenergic agents|mesh-ancestor
110447016|NCT00837967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110447017|NCT00837967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110447018|NCT02759614|Bevacizumab|bevacizumab|mesh-list
110447019|NCT02759614|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110447020|NCT02759614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110447021|NCT02759614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110447022|NCT02759614|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110447023|NCT02759614|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110447024|NCT02759614|Growth Substances|growth substances|mesh-ancestor
110447025|NCT02759614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110447026|NCT02759614|Growth Inhibitors|growth inhibitors|mesh-ancestor
110447027|NCT02759614|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110447028|NCT02759614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110447029|NCT02759614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110447030|NCT02757040|Arsenic Trioxide|arsenic trioxide|mesh-list
110447031|NCT02757040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110447032|NCT02759224|Irsogladine|irsogladine|mesh-list
110447034|NCT02759224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110447035|NCT02759224|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110447036|NCT02759224|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110447037|NCT02759224|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110447038|NCT02759224|Histamine Antagonists|histamine antagonists|mesh-ancestor
110447039|NCT02759224|Histamine Agents|histamine agents|mesh-ancestor
110447040|NCT02759224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110447041|NCT02759224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110447042|NCT02759224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110447043|NCT02759224|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110447044|NCT02759224|Protective Agents|protective agents|mesh-ancestor
110447045|NCT02759224|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110447046|NCT02756728|Melphalan|melphalan|mesh-list
110447047|NCT02756728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110447048|NCT02756728|Alkylating Agents|alkylating agents|mesh-ancestor
110447049|NCT02756728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110447050|NCT02756728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110447051|NCT02756728|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110447052|NCT02756728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110447053|NCT02756728|Immunologic Factors|immunologic factors|mesh-ancestor
110447054|NCT02756728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110447056|NCT04586920|Midazolam|midazolam|mesh-list
110447057|NCT04586920|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110447058|NCT04586920|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110447059|NCT04586920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110447060|NCT04586920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110447061|NCT04586920|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110447062|NCT04586920|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110447063|NCT04586920|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110447064|NCT04586920|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110447065|NCT04586920|Anesthetics, General|anesthetics, general|mesh-ancestor
110447066|NCT04586920|Anesthetics|anesthetics|mesh-ancestor
110447067|NCT04586920|GABA Modulators|gaba modulators|mesh-ancestor
110447068|NCT04586920|GABA Agents|gaba agents|mesh-ancestor
110447069|NCT04586920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110447070|NCT04586920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110447071|NCT04586920|Antifungal Agents|antifungal agents|mesh-ancestor
110447072|NCT04586920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110447073|NCT04586920|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110447074|NCT04586920|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110447075|NCT04586920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110447076|NCT04586920|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110447077|NCT04586920|Hormone Antagonists|hormone antagonists|mesh-ancestor
110447078|NCT04586920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110447079|NCT04586920|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110447080|NCT02758990|Vitamin D|vitamin d|mesh-list
110458328|NCT00597766|Anesthetics|anesthetics|mesh-ancestor
110447081|NCT02758990|Cholecalciferol|cholecalciferol|mesh-list
110447083|NCT02758990|Ascorbic Acid|ascorbic acid|mesh-list
110447084|NCT02758990|Vitamin E|vitamin e|mesh-list
110447085|NCT02758990|Tocopherols|tocopherols|mesh-list
110447086|NCT02758990|Vitamin A|vitamin a|mesh-list
110447087|NCT02758990|Niacinamide|niacinamide|mesh-list
110447088|NCT02758990|Niacin|niacin|mesh-list
110447089|NCT02758990|Nicotinic Acids|nicotinic acids|mesh-list
110447090|NCT02758990|Pyridoxine|pyridoxine|mesh-list
110447091|NCT02758990|Pyridoxal|pyridoxal|mesh-list
110447092|NCT02758990|Vitamin B 6|vitamin b 6|mesh-list
110094137|NCT01707251|Ibuprofen|ibuprofen|mesh-list
110447093|NCT02758990|Caffeine|caffeine|mesh-list
110447094|NCT02758990|Micronutrients|micronutrients|mesh-ancestor
110447095|NCT02758990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110447096|NCT02758990|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110447097|NCT02758990|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110447098|NCT02758990|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110447099|NCT02758990|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110447100|NCT02758990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110447101|NCT02758990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110447102|NCT02758990|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110447103|NCT02758990|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110447104|NCT02758990|Purinergic Agents|purinergic agents|mesh-ancestor
110447105|NCT02758990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110447107|NCT02758990|Protective Agents|protective agents|mesh-ancestor
110447108|NCT02758990|Vitamin B Complex|vitamin b complex|mesh-ancestor
110447110|NCT02758990|Antimetabolites|antimetabolites|mesh-ancestor
110447111|NCT02758990|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110447112|NCT02758990|Vasodilator Agents|vasodilator agents|mesh-ancestor
110447113|NCT02756104|Vitamin D|vitamin d|mesh-list
110447114|NCT02756104|Vitamins|vitamins|mesh-ancestor
110447115|NCT02756104|Micronutrients|micronutrients|mesh-ancestor
110447116|NCT02756104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110447117|NCT02756104|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110447118|NCT02756026|Micronutrients|micronutrients|mesh-list
110447119|NCT02756026|Trace Elements|trace elements|mesh-list
110447120|NCT02756026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110447121|NCT02755714|Bromides|bromides|mesh-list
110447122|NCT02755714|Ipratropium|ipratropium|mesh-list
110447123|NCT02755714|Anticonvulsants|anticonvulsants|mesh-ancestor
110447124|NCT02755714|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110447125|NCT02755714|Autonomic Agents|autonomic agents|mesh-ancestor
110447126|NCT02755714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110447127|NCT02755714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110447128|NCT02755714|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110447129|NCT02755714|Respiratory System Agents|respiratory system agents|mesh-ancestor
110447130|NCT02755714|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110447131|NCT02755714|Cholinergic Agents|cholinergic agents|mesh-ancestor
110447132|NCT02755714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110447133|NCT02755714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110447134|NCT02758522|Insulin|insulin|mesh-list
110447135|NCT02758522|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110447136|NCT02758522|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110447137|NCT02758522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110447138|NCT00942357|Paclitaxel|paclitaxel|mesh-list
110447139|NCT00942357|Cisplatin|cisplatin|mesh-list
110447140|NCT00942357|Carboplatin|carboplatin|mesh-list
110458501|NCT00913549|Clemastine|clemastine|mesh-list
110447141|NCT00942357|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110447142|NCT00942357|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110447143|NCT00942357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110447144|NCT00942357|Tubulin Modulators|tubulin modulators|mesh-ancestor
110447145|NCT00942357|Antimitotic Agents|antimitotic agents|mesh-ancestor
110447146|NCT00942357|Mitosis Modulators|mitosis modulators|mesh-ancestor
110447147|NCT00942357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110447149|NCT02752828|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110447150|NCT02752828|Insulin Glargine|insulin glargine|mesh-list
110447151|NCT02752828|Lixisenatide|lixisenatide|mesh-list
110447152|NCT02752828|Hypoglycemic Agents|hypoglycemic agents|mesh-list
110447153|NCT02752828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110447154|NCT02753062|Rituximab|rituximab|mesh-list
110447155|NCT02753062|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110447156|NCT02753062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110447157|NCT02753062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110447158|NCT02753062|Immunologic Factors|immunologic factors|mesh-ancestor
110458611|NCT00661336|Melphalan|melphalan|mesh-list
110447159|NCT02753062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110447161|NCT02753062|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110447162|NCT02753062|Alkylating Agents|alkylating agents|mesh-ancestor
110447163|NCT02753062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110447164|NCT02752204|Rituximab|rituximab|mesh-list
110447165|NCT02752204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110447166|NCT02752204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110447167|NCT02752204|Immunologic Factors|immunologic factors|mesh-ancestor
110447168|NCT02752204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110094211|NCT01707537|Vaccines|vaccines|mesh-list
110447169|NCT02752204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110447170|NCT04220398|Hormones|hormones|mesh-list
110447171|NCT04220398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110447172|NCT04220398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110447173|NCT04220632|Prednisone|prednisone|mesh-list
110447174|NCT04220632|Methylprednisolone|methylprednisolone|mesh-list
110447175|NCT04220632|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110447176|NCT04220632|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110447177|NCT04220632|Prednisolone|prednisolone|mesh-list
110447178|NCT04220632|Prednisolone acetate|prednisolone acetate|mesh-list
110447179|NCT04220632|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110447180|NCT04220632|Prednisolone phosphate|prednisolone phosphate|mesh-list
110447181|NCT04220632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110447182|NCT04220632|Glucocorticoids|glucocorticoids|mesh-ancestor
110447183|NCT04220632|Hormones|hormones|mesh-ancestor
110447184|NCT04220632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110447185|NCT04220632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110447186|NCT04220632|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110447187|NCT04220632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110447188|NCT04220632|Antiemetics|antiemetics|mesh-ancestor
110447189|NCT04220632|Autonomic Agents|autonomic agents|mesh-ancestor
110447190|NCT04220632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110447191|NCT04220632|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110447192|NCT04220632|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110447193|NCT04220632|Protective Agents|protective agents|mesh-ancestor
110447194|NCT00939627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110447195|NCT00939627|Cetuximab|cetuximab|mesh-list
110447196|NCT00939627|Sorafenib|sorafenib|mesh-list
110447197|NCT00939627|Antibodies|antibodies|mesh-list
110447198|NCT00939627|Immunoglobulins|immunoglobulins|mesh-list
110447199|NCT00939627|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110447200|NCT00939627|Immunologic Factors|immunologic factors|mesh-ancestor
110447201|NCT00939627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110447202|NCT00939627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110447203|NCT00939627|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110447204|NCT00939627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110447205|NCT00939627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110447206|NCT05382741|Durvalumab|durvalumab|mesh-list
110447207|NCT05382741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110447208|NCT05382741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110447209|NCT04220476|Letrozole|letrozole|mesh-list
110447210|NCT04220476|Palbociclib|palbociclib|mesh-list
110447211|NCT04220476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110447212|NCT04220476|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110447213|NCT04220476|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110447214|NCT04220476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110447215|NCT04220476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110447216|NCT04220476|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110447217|NCT04220476|Hormone Antagonists|hormone antagonists|mesh-ancestor
110447218|NCT04220476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110447219|NCT04220476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110447220|NCT04220476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110447221|NCT02695810|Metformin|metformin|mesh-list
110447222|NCT02695810|Dapagliflozin|dapagliflozin|mesh-list
110447223|NCT02695810|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110447224|NCT02695810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110447225|NCT02695810|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110447226|NCT02695810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110447227|NCT02753764|Prednisone|prednisone|mesh-list
110447228|NCT02753764|AZD7624|azd7624|mesh-list
110447229|NCT02753764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110447230|NCT02753764|Glucocorticoids|glucocorticoids|mesh-ancestor
110447231|NCT02753764|Hormones|hormones|mesh-ancestor
110447232|NCT02753764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110447233|NCT02753764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110447234|NCT02753764|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110447235|NCT02753764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110447236|NCT02753764|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110447237|NCT02753764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110447238|NCT02753764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110447240|NCT02695654|Levobupivacaine|levobupivacaine|mesh-list
110458729|NCT01077323|Exenatide|exenatide|mesh-list
110447241|NCT02695654|Analgesics|analgesics|mesh-ancestor
110447242|NCT02695654|Sensory System Agents|sensory system agents|mesh-ancestor
110447243|NCT02695654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110447244|NCT02695654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110094272|NCT01707953|Midodrine|midodrine|mesh-list
110447245|NCT02695654|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110447246|NCT02695654|Sympatholytics|sympatholytics|mesh-ancestor
110447247|NCT02695654|Autonomic Agents|autonomic agents|mesh-ancestor
110447248|NCT02695654|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110458739|NCT03870438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110447249|NCT02695654|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110447250|NCT02695654|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110447251|NCT02695654|Adrenergic Agents|adrenergic agents|mesh-ancestor
110447252|NCT02695654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110447253|NCT02695654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110447254|NCT02695654|Anesthetics, Local|anesthetics, local|mesh-ancestor
110447255|NCT02695654|Anesthetics|anesthetics|mesh-ancestor
110447256|NCT02695654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110447257|NCT02696122|Anesthetics|anesthetics|mesh-list
110447258|NCT02696122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110447259|NCT02696122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110447260|NCT01135511|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110447261|NCT01135511|Tofacitinib|tofacitinib|mesh-list
110447262|NCT01135511|Hyaluronic Acid|hyaluronic acid|mesh-list
110447263|NCT01135511|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110447264|NCT01135511|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
110447265|NCT01135511|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110447266|NCT01135511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110447267|NCT01135511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110447268|NCT01135511|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110447269|NCT01135511|Immunologic Factors|immunologic factors|mesh-ancestor
110447270|NCT01135511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110447271|NCT01135511|Viscosupplements|viscosupplements|mesh-ancestor
110447272|NCT01135511|Protective Agents|protective agents|mesh-ancestor
110447274|NCT02753140|Cetuximab|cetuximab|mesh-list
110447275|NCT02753140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110447276|NCT02753140|Tubulin Modulators|tubulin modulators|mesh-ancestor
110447277|NCT02753140|Antimitotic Agents|antimitotic agents|mesh-ancestor
110447278|NCT02753140|Mitosis Modulators|mitosis modulators|mesh-ancestor
110447279|NCT02753140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110447280|NCT02753140|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110447281|NCT02753218|Midazolam|midazolam|mesh-list
110447282|NCT02753218|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110447283|NCT02753218|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110447284|NCT02753218|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110447285|NCT02753218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110447286|NCT02753218|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110447287|NCT02753218|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110447288|NCT02753218|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110447289|NCT02753218|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110447290|NCT02753218|Anesthetics, General|anesthetics, general|mesh-ancestor
110447291|NCT02753218|Anesthetics|anesthetics|mesh-ancestor
110447292|NCT02753218|GABA Modulators|gaba modulators|mesh-ancestor
110447293|NCT02753218|GABA Agents|gaba agents|mesh-ancestor
110447294|NCT02753218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110447295|NCT02753218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110447296|NCT05429554|Vildagliptin|vildagliptin|mesh-list
110447297|NCT05429554|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110447298|NCT05429554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110447299|NCT05429554|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110447300|NCT05429554|Protease Inhibitors|protease inhibitors|mesh-ancestor
110447301|NCT05429554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110447302|NCT05429554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110447303|NCT05429086|Propofol|propofol|mesh-list
110447304|NCT05429086|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110447305|NCT05429086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110447306|NCT05429086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110447307|NCT05429086|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110447308|NCT05429086|Anesthetics, General|anesthetics, general|mesh-ancestor
110447309|NCT05429086|Anesthetics|anesthetics|mesh-ancestor
110447310|NCT00638248|Salivary plasminogen activator alpha 1, Desmodus rotundus|salivary plasminogen activator alpha 1, desmodus rotundus|mesh-list
110447311|NCT00638248|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110447312|NCT00638248|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110447313|NCT00638248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110447314|NCT05422144|Anti-Infective Agents|anti-infective agents|mesh-list
110447315|NCT05422144|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110447316|NCT01184846|Immunoglobulins|immunoglobulins|mesh-list
110447317|NCT01184846|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110447318|NCT01184846|Antibodies|antibodies|mesh-list
110447319|NCT01184846|Immunologic Factors|immunologic factors|mesh-ancestor
110447320|NCT01184846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110094346|NCT01708616|Risperidone|risperidone|mesh-list
110447322|NCT01191086|Anticonvulsants|anticonvulsants|mesh-ancestor
110447323|NCT01191086|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110447324|NCT01191086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110447325|NCT05318560|Lidocaine|lidocaine|mesh-list
110447326|NCT05318560|Anesthetics, Local|anesthetics, local|mesh-ancestor
110447327|NCT05318560|Anesthetics|anesthetics|mesh-ancestor
110447328|NCT05318560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110250078|NCT03890952|Bevacizumab|bevacizumab|mesh-list
110447329|NCT05318560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110447330|NCT05318560|Sensory System Agents|sensory system agents|mesh-ancestor
110447331|NCT05318560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110447332|NCT05318560|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110447333|NCT05318560|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110447334|NCT05318560|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110447335|NCT05318560|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110447336|NCT05318560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110447337|NCT04171258|Botulinum Toxins|botulinum toxins|mesh-list
110447338|NCT04171258|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110447339|NCT04171258|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110447340|NCT04171258|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110447341|NCT04171258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110447342|NCT04171258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110447343|NCT04171258|Cholinergic Agents|cholinergic agents|mesh-ancestor
110447344|NCT04171258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110447345|NCT04171258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110447346|NCT04171258|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110447347|NCT04171258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110447348|NCT01086384|Fluticasone|fluticasone|mesh-list
110447349|NCT01086384|Xhance|xhance|mesh-list
110447350|NCT01086384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110447351|NCT01086384|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110447352|NCT01086384|Autonomic Agents|autonomic agents|mesh-ancestor
110447353|NCT01086384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110447354|NCT01086384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110447355|NCT01086384|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110447356|NCT01086384|Respiratory System Agents|respiratory system agents|mesh-ancestor
110447357|NCT01086384|Dermatologic Agents|dermatologic agents|mesh-ancestor
110447358|NCT01086384|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110447359|NCT04115644|Triamcinolone|triamcinolone|mesh-list
110447360|NCT04115644|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110447361|NCT04115644|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110447362|NCT04115644|Ketorolac|ketorolac|mesh-list
110447363|NCT04115644|Bupivacaine|bupivacaine|mesh-list
110447364|NCT04115644|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110447365|NCT04115644|Anesthetics, Local|anesthetics, local|mesh-ancestor
110447366|NCT04115644|Anesthetics|anesthetics|mesh-ancestor
110447367|NCT04115644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110447368|NCT04115644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110447369|NCT04115644|Sensory System Agents|sensory system agents|mesh-ancestor
110447370|NCT04115644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110447371|NCT04115644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110447373|NCT04115644|Hormones|hormones|mesh-ancestor
110292525|NCT00254631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110447374|NCT04115644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110447375|NCT04115644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110447376|NCT04115644|Immunologic Factors|immunologic factors|mesh-ancestor
110447377|NCT04115644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110447378|NCT04115644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110447379|NCT04115644|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110447380|NCT04115644|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110447381|NCT04115644|Analgesics|analgesics|mesh-ancestor
110447382|NCT04115644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110447383|NCT04115644|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110447384|NCT00635986|Fentanyl|fentanyl|mesh-list
110447385|NCT00635986|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110447386|NCT00635986|Narcotics|narcotics|mesh-ancestor
110447387|NCT00635986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110447388|NCT00635986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110447389|NCT00635986|Analgesics|analgesics|mesh-ancestor
110447390|NCT00635986|Sensory System Agents|sensory system agents|mesh-ancestor
110447391|NCT00635986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110447392|NCT00635986|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110447393|NCT00635986|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110447394|NCT00635986|Anesthetics, General|anesthetics, general|mesh-ancestor
110447395|NCT00635986|Anesthetics|anesthetics|mesh-ancestor
110447396|NCT04799626|Levofloxacin|levofloxacin|mesh-list
110447397|NCT04799626|Meropenem|meropenem|mesh-list
110447398|NCT04799626|Tazobactam|tazobactam|mesh-list
110447399|NCT04799626|Piperacillin|piperacillin|mesh-list
110447400|NCT04799626|Tigecycline|tigecycline|mesh-list
110447401|NCT04799626|Biapenem|biapenem|mesh-list
110447402|NCT04799626|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110447403|NCT04799626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110447404|NCT04799626|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110447405|NCT04799626|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110447406|NCT04799626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110447407|NCT04799626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110459249|NCT05637060|Antimetabolites|antimetabolites|mesh-ancestor
110447408|NCT04799626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110447409|NCT04799626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110447410|NCT04799626|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110447411|NCT04799626|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110447412|NCT04799626|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110447413|NCT04799626|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110447414|NCT00636064|Parecoxib|parecoxib|mesh-list
110447415|NCT00636064|Valdecoxib|valdecoxib|mesh-list
110447416|NCT00636064|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110447417|NCT00636064|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110447418|NCT00636064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110447419|NCT00636064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110447420|NCT00636064|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110447421|NCT00636064|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110447422|NCT00636064|Analgesics|analgesics|mesh-ancestor
110447423|NCT00636064|Sensory System Agents|sensory system agents|mesh-ancestor
110447424|NCT00636064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110447425|NCT00636064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110447426|NCT00636064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110447427|NCT00636064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110447429|NCT02751034|Anesthetics, Local|anesthetics, local|mesh-ancestor
110447430|NCT02751034|Anesthetics|anesthetics|mesh-ancestor
110447431|NCT02751034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110447432|NCT02751034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110447433|NCT02751034|Sensory System Agents|sensory system agents|mesh-ancestor
110447434|NCT02751034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110447435|NCT02751034|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110447436|NCT02751034|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110447437|NCT02751034|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110447438|NCT02751034|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110447439|NCT02751034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110447441|NCT04217668|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
110447442|NCT04217668|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
110447443|NCT04217668|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110447444|NCT04217668|Diuretics|diuretics|mesh-ancestor
110447445|NCT04217668|Natriuretic Agents|natriuretic agents|mesh-ancestor
110447446|NCT04217668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110447447|NCT04217668|Vasodilator Agents|vasodilator agents|mesh-ancestor
110447448|NCT04217668|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
110447449|NCT04217668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110447450|NCT01127165|Zonisamide|zonisamide|mesh-list
110447451|NCT01127165|Anticonvulsants|anticonvulsants|mesh-ancestor
110447452|NCT01127165|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110447453|NCT01127165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110459430|NCT05108649|Nicotine|nicotine|mesh-list
110447454|NCT01127165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110447455|NCT01127165|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110447456|NCT01127165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110447457|NCT04335292|Pemetrexed|pemetrexed|mesh-list
110447458|NCT04335292|Osimertinib|osimertinib|mesh-list
110459496|NCT04901702|Irinotecan|irinotecan|mesh-list
110447459|NCT04335292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110447460|NCT04335292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110447461|NCT04335292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110447462|NCT04335292|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110447463|NCT04335292|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110447464|NCT04335292|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110447465|NCT04278508|Progesterone|progesterone|mesh-list
110447466|NCT04278508|Progestins|progestins|mesh-ancestor
110447467|NCT04278508|Hormones|hormones|mesh-ancestor
110447468|NCT04278508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110447469|NCT04278508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110447471|NCT05382351|Entecavir|entecavir|mesh-list
110459725|NCT03640026|Tacrolimus|tacrolimus|mesh-list
110447472|NCT05382351|Antiviral Agents|antiviral agents|mesh-ancestor
110447473|NCT05382351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110447474|NCT05382351|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110447475|NCT05382351|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110447476|NCT05382351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110447477|NCT05382351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110447478|NCT05382351|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110447479|NCT05382351|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110447480|NCT04218760|Isosorbide|isosorbide|mesh-list
110447481|NCT04218760|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
110447482|NCT04218760|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
110447483|NCT04218760|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110447484|NCT04218760|Diuretics|diuretics|mesh-ancestor
110447485|NCT04218760|Natriuretic Agents|natriuretic agents|mesh-ancestor
110447486|NCT04218760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110447487|NCT04218760|Vasodilator Agents|vasodilator agents|mesh-ancestor
110447488|NCT04218760|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
110447489|NCT04218760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110447490|NCT02750254|Plerixafor|plerixafor|mesh-list
110447491|NCT02750254|Cyclophosphamide|cyclophosphamide|mesh-list
110447492|NCT02750254|Melphalan|melphalan|mesh-list
110447493|NCT02750254|Busulfan|busulfan|mesh-list
110447494|NCT02750254|Fludarabine|fludarabine|mesh-list
110447495|NCT02750254|Fludarabine phosphate|fludarabine phosphate|mesh-list
110447496|NCT02750254|Azacitidine|azacitidine|mesh-list
110447497|NCT02750254|Lenograstim|lenograstim|mesh-list
110447498|NCT02750254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110447499|NCT02750254|Immunologic Factors|immunologic factors|mesh-ancestor
110447500|NCT02750254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110460005|NCT01144364|Rituximab|rituximab|mesh-list
110447501|NCT02750254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110447502|NCT02750254|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110447503|NCT02750254|Alkylating Agents|alkylating agents|mesh-ancestor
110447504|NCT02750254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110447505|NCT02750254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110460078|NCT02882984|Gefitinib|gefitinib|mesh-list
110447506|NCT02750254|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110447507|NCT02750254|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110447508|NCT02750254|Antimetabolites|antimetabolites|mesh-ancestor
110447509|NCT02750254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110447510|NCT02750254|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110447511|NCT02750254|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110460149|NCT01117766|Pregabalin|pregabalin|mesh-list
110447512|NCT02750254|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110447513|NCT02750254|Antiviral Agents|antiviral agents|mesh-ancestor
110447514|NCT02750254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110447515|NCT00941655|Leucovorin|leucovorin|mesh-list
110447516|NCT00941655|Fluorouracil|fluorouracil|mesh-list
110447517|NCT00941655|Oxaliplatin|oxaliplatin|mesh-list
110447518|NCT00941655|Irinotecan|irinotecan|mesh-list
110447519|NCT00941655|Antimetabolites|antimetabolites|mesh-ancestor
110447520|NCT00941655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110447521|NCT00941655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110447522|NCT00941655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110447523|NCT00941655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110447524|NCT00941655|Immunologic Factors|immunologic factors|mesh-ancestor
110460351|NCT00632073|Maleic acid|maleic acid|mesh-list
110447525|NCT00941655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110447526|NCT00941655|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110447527|NCT00941655|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110447528|NCT00941655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110447529|NCT00941655|Antidotes|antidotes|mesh-ancestor
110447530|NCT00941655|Protective Agents|protective agents|mesh-ancestor
110447531|NCT00941655|Vitamin B Complex|vitamin b complex|mesh-ancestor
110447532|NCT00941655|Vitamins|vitamins|mesh-ancestor
110447533|NCT00941655|Micronutrients|micronutrients|mesh-ancestor
110447534|NCT00605787|1-(carboxymethylthio)tetradecane|1-(carboxymethylthio)tetradecane|mesh-list
110447535|NCT00605787|Antioxidants|antioxidants|mesh-ancestor
110447536|NCT00605787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110250093|NCT03761511|Niacin|niacin|mesh-list
110447537|NCT00605787|Protective Agents|protective agents|mesh-ancestor
110447538|NCT00605787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110447539|NCT00605787|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110447540|NCT00936117|Posaconazole|posaconazole|mesh-list
110447541|NCT00936117|Antifungal Agents|antifungal agents|mesh-ancestor
110447542|NCT00936117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110447543|NCT00936117|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
110460489|NCT00961350|Antipyretics|antipyretics|mesh-ancestor
110447544|NCT00936117|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110447545|NCT00936117|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110447546|NCT00936117|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110447547|NCT00936117|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110447548|NCT00936117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110447549|NCT00936117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110447550|NCT00936117|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110447551|NCT00936117|Hormone Antagonists|hormone antagonists|mesh-ancestor
110460615|NCT00666796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110447552|NCT00936117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110447553|NCT00936117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110447554|NCT04267653|Lactoferrin|lactoferrin|mesh-list
110447555|NCT04267653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110447556|NCT04088500|Nivolumab|nivolumab|mesh-list
110447557|NCT04088500|Ipilimumab|ipilimumab|mesh-list
110447558|NCT04088500|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110447559|NCT04088500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110447560|NCT04088500|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110447561|NCT04088500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110447562|NCT01082874|Clonidine|clonidine|mesh-list
110447563|NCT01082874|Analgesics|analgesics|mesh-ancestor
110447564|NCT01082874|Sensory System Agents|sensory system agents|mesh-ancestor
110447565|NCT01082874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110447566|NCT01082874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110447567|NCT01082874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110447568|NCT01082874|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110447569|NCT01082874|Sympatholytics|sympatholytics|mesh-ancestor
110447570|NCT01082874|Autonomic Agents|autonomic agents|mesh-ancestor
110447571|NCT01082874|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110447572|NCT01082874|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110447573|NCT01082874|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110447574|NCT01082874|Adrenergic Agents|adrenergic agents|mesh-ancestor
110447575|NCT01082874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110447576|NCT00607503|Terbutaline|terbutaline|mesh-list
110447577|NCT00607503|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110447578|NCT00607503|Autonomic Agents|autonomic agents|mesh-ancestor
110447579|NCT00607503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110447580|NCT00607503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110447581|NCT00607503|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110447582|NCT00607503|Respiratory System Agents|respiratory system agents|mesh-ancestor
110447583|NCT00607503|Sympathomimetics|sympathomimetics|mesh-ancestor
110447584|NCT00607503|Tocolytic Agents|tocolytic agents|mesh-ancestor
110447585|NCT00607503|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110447586|NCT00607503|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110447587|NCT00607503|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110447588|NCT00607503|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110447589|NCT00607503|Adrenergic Agents|adrenergic agents|mesh-ancestor
110447590|NCT00607503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110447591|NCT00607503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110447593|NCT04217512|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110447594|NCT04217512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110447595|NCT04217512|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110447596|NCT04217512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110447597|NCT04217512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110447599|NCT01079988|Methotrexate|methotrexate|mesh-list
110447600|NCT01079988|Cyclosporins|cyclosporins|mesh-list
110461163|NCT02630290|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110447601|NCT01079988|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110250096|NCT03761511|Vitamins|vitamins|mesh-ancestor
110447602|NCT01079988|Abortifacient Agents|abortifacient agents|mesh-ancestor
110447603|NCT01079988|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110447604|NCT01079988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110447605|NCT01079988|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110447607|NCT01079988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110461329|NCT00669370|Docetaxel|docetaxel|mesh-list
110447608|NCT01079988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110447609|NCT01079988|Dermatologic Agents|dermatologic agents|mesh-ancestor
110447610|NCT01079988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110447611|NCT01079988|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110447612|NCT01079988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110447613|NCT01079988|Immunologic Factors|immunologic factors|mesh-ancestor
110447614|NCT01079988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110447615|NCT01079988|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110447616|NCT01079988|Antifungal Agents|antifungal agents|mesh-ancestor
110447617|NCT01079988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110447618|NCT01079988|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110447619|NCT02876718|Rivaroxaban|rivaroxaban|mesh-list
110447620|NCT02876718|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110094648|NCT01710488|Levofloxacin|levofloxacin|mesh-list
110447621|NCT02876718|Antithrombins|antithrombins|mesh-ancestor
110447622|NCT02876718|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110447623|NCT02876718|Protease Inhibitors|protease inhibitors|mesh-ancestor
110447624|NCT02876718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110447625|NCT02876718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110447626|NCT02876718|Anticoagulants|anticoagulants|mesh-ancestor
110447627|NCT01074216|Vitamin D|vitamin d|mesh-list
110447628|NCT01074216|Ergocalciferols|ergocalciferols|mesh-list
110447629|NCT01074216|Cholecalciferol|cholecalciferol|mesh-list
110447630|NCT01074216|Vitamins|vitamins|mesh-list
110447632|NCT01074216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110447633|NCT01074216|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110447634|NCT01074216|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110447636|NCT00636142|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110447637|NCT00636142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110447638|NCT00636142|Dermatologic Agents|dermatologic agents|mesh-ancestor
110447639|NCT00636142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110447640|NCT00636142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110447641|NCT02499562|Entecavir|entecavir|mesh-list
110447642|NCT02499562|Antiviral Agents|antiviral agents|mesh-ancestor
110447644|NCT04304430|Dapagliflozin|dapagliflozin|mesh-list
110447645|NCT04304430|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
110447646|NCT04304430|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110447647|NCT04304430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110447648|NCT04304430|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110461568|NCT00671320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110447649|NCT04304430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110447651|NCT04304430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110447652|NCT02875002|Belinostat|belinostat|mesh-list
110447653|NCT02875002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110447654|NCT02875002|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110447655|NCT02875002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110447656|NCT02875002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110447657|NCT02749396|Interferons|interferons|mesh-list
110447658|NCT02749396|Interferon-beta|interferon-beta|mesh-list
110447659|NCT02749396|Interferon beta-1a|interferon beta-1a|mesh-list
110447660|NCT02749396|Interferon beta-1b|interferon beta-1b|mesh-list
110447661|NCT02749396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110447662|NCT02749396|Antiviral Agents|antiviral agents|mesh-ancestor
110447663|NCT02749396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110447664|NCT02749396|Immunologic Factors|immunologic factors|mesh-ancestor
110447665|NCT02749396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110447666|NCT02749396|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110447667|NCT02749162|Acetaminophen|acetaminophen|mesh-list
110447668|NCT02749162|Dexamethasone|dexamethasone|mesh-list
110447669|NCT02749162|Lidocaine|lidocaine|mesh-list
110447670|NCT02749162|Morphine|morphine|mesh-list
110447671|NCT02749162|Ropivacaine|ropivacaine|mesh-list
110447672|NCT02749162|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
110461635|NCT00908583|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110461636|NCT05519241|Paclitaxel|paclitaxel|mesh-list
110447673|NCT02749162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110447675|NCT02749162|Autonomic Agents|autonomic agents|mesh-ancestor
110447676|NCT02749162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110447677|NCT02749162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110447678|NCT02749162|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110447679|NCT02749162|Glucocorticoids|glucocorticoids|mesh-ancestor
110447680|NCT02749162|Hormones|hormones|mesh-ancestor
110447681|NCT02749162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110447682|NCT02749162|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110447683|NCT02749162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110447684|NCT02749162|Anesthetics, Local|anesthetics, local|mesh-ancestor
110447685|NCT02749162|Anesthetics|anesthetics|mesh-ancestor
110447686|NCT02749162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110447687|NCT02749162|Sensory System Agents|sensory system agents|mesh-ancestor
110447688|NCT02749162|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110447689|NCT02749162|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110447690|NCT02749162|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110447691|NCT02749162|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110447692|NCT02749162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110447693|NCT02749162|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110447694|NCT02749162|Narcotics|narcotics|mesh-ancestor
110447695|NCT02749162|Analgesics|analgesics|mesh-ancestor
110447696|NCT02749162|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110447697|NCT02749162|Antipyretics|antipyretics|mesh-ancestor
110447698|NCT02041234|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110447699|NCT02041234|Liraglutide|liraglutide|mesh-list
110447700|NCT02041234|Empagliflozin|empagliflozin|mesh-list
110447701|NCT02041234|Linagliptin|linagliptin|mesh-list
110447702|NCT02041234|Canagliflozin|canagliflozin|mesh-list
110447703|NCT02041234|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
110447704|NCT02041234|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
110447706|NCT02041234|Incretins|incretins|mesh-list
110447707|NCT02041234|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110447708|NCT02041234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110447710|NCT02041234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110461808|NCT00808015|Varenicline|varenicline|mesh-list
110447711|NCT02041234|Protease Inhibitors|protease inhibitors|mesh-ancestor
110447712|NCT02041234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110447713|NCT02041234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110447714|NCT02041234|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110447715|NCT02041234|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110447716|NCT02695732|Carvedilol|carvedilol|mesh-list
110447717|NCT02695732|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110447718|NCT02695732|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110447719|NCT02695732|Adrenergic Agents|adrenergic agents|mesh-ancestor
110447720|NCT02695732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110447721|NCT02695732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110447722|NCT02695732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110447723|NCT02695732|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110447724|NCT02695732|Antioxidants|antioxidants|mesh-ancestor
110447725|NCT02695732|Protective Agents|protective agents|mesh-ancestor
110447726|NCT02695732|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110447727|NCT02695732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110447728|NCT02695732|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110447729|NCT02695732|Vasodilator Agents|vasodilator agents|mesh-ancestor
110447730|NCT02695732|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110447731|NCT02695732|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110447732|NCT02751268|Ropivacaine|ropivacaine|mesh-list
110447733|NCT02751268|Anesthetics, Local|anesthetics, local|mesh-ancestor
110447734|NCT02751268|Anesthetics|anesthetics|mesh-ancestor
110447735|NCT02751268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110447736|NCT02751268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110447737|NCT02751268|Sensory System Agents|sensory system agents|mesh-ancestor
110447738|NCT02751268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110447739|NCT02748772|Thalidomide|thalidomide|mesh-list
110447740|NCT02748772|Endostar protein|endostar protein|mesh-list
110447741|NCT02748772|Endostatins|endostatins|mesh-list
110447742|NCT02748772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110447743|NCT02748772|Immunologic Factors|immunologic factors|mesh-ancestor
110447744|NCT02748772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110447745|NCT02748772|Leprostatic Agents|leprostatic agents|mesh-ancestor
110447746|NCT02748772|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110447747|NCT02748772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110447748|NCT02748772|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110447749|NCT02748772|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110447750|NCT02748772|Growth Substances|growth substances|mesh-ancestor
110447751|NCT02748772|Growth Inhibitors|growth inhibitors|mesh-ancestor
110109279|NCT01824433|Fluoxetine|fluoxetine|mesh-list
110447752|NCT02748772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110447753|NCT04216888|Ketamine|ketamine|mesh-list
110447754|NCT04216888|Analgesics|analgesics|mesh-ancestor
110447755|NCT04216888|Sensory System Agents|sensory system agents|mesh-ancestor
110447756|NCT04216888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110447757|NCT04216888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110447758|NCT04216888|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110447759|NCT04216888|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110447760|NCT04216888|Anesthetics, General|anesthetics, general|mesh-ancestor
110447761|NCT04216888|Anesthetics|anesthetics|mesh-ancestor
110447762|NCT04216888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110447763|NCT04216888|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110447764|NCT04216888|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110447765|NCT04216888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110447766|NCT04216888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110447767|NCT02746744|Rituximab|rituximab|mesh-list
110447768|NCT02746744|Dimethyl Fumarate|dimethyl fumarate|mesh-list
110447769|NCT02746744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110447770|NCT02746744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110447771|NCT02746744|Immunologic Factors|immunologic factors|mesh-ancestor
110447772|NCT02746744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110447774|NCT02746744|Dermatologic Agents|dermatologic agents|mesh-ancestor
110447775|NCT02746744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110447776|NCT02748304|Aspirin|aspirin|mesh-list
110447777|NCT02748304|Sorafenib|sorafenib|mesh-list
110447778|NCT02748304|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110447779|NCT02748304|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110447780|NCT02748304|Analgesics|analgesics|mesh-ancestor
110447781|NCT02748304|Sensory System Agents|sensory system agents|mesh-ancestor
110447782|NCT02748304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110447783|NCT02748304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110447784|NCT02748304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110447786|NCT02748304|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110447787|NCT02748304|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110447788|NCT02748304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110447789|NCT02748304|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110447790|NCT02748304|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110447791|NCT02748304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110447792|NCT02748304|Antipyretics|antipyretics|mesh-ancestor
110447793|NCT02748304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110447794|NCT02748304|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110447795|NCT02746276|Metronidazole|metronidazole|mesh-list
110447796|NCT02746276|Ceftriaxone|ceftriaxone|mesh-list
110447797|NCT02746276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110447798|NCT02746276|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110447799|NCT02746276|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110447800|NCT02746276|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110447802|NCT02745886|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110462370|NCT02606383|Ketoconazole|ketoconazole|mesh-list
110447803|NCT02745886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110447804|NCT02742142|Fluorides|fluorides|mesh-list
110447805|NCT02742142|Cariostatic Agents|cariostatic agents|mesh-ancestor
110447806|NCT02742142|Protective Agents|protective agents|mesh-ancestor
110447807|NCT02742142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110447808|NCT00636298|Bevacizumab|bevacizumab|mesh-list
110447810|NCT00636298|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110447811|NCT00636298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110447812|NCT00636298|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110447813|NCT00636298|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110447814|NCT00636298|Growth Substances|growth substances|mesh-ancestor
110447815|NCT00636298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110447816|NCT00636298|Growth Inhibitors|growth inhibitors|mesh-ancestor
110447817|NCT02744716|Aspirin|aspirin|mesh-list
110447818|NCT02744716|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110447819|NCT02744716|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110447820|NCT02744716|Analgesics|analgesics|mesh-ancestor
110462496|NCT00800683|Incretins|incretins|mesh-ancestor
110447821|NCT02744716|Sensory System Agents|sensory system agents|mesh-ancestor
110447822|NCT02744716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110447823|NCT02744716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110447824|NCT02744716|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110447825|NCT02744716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110447826|NCT02744716|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110447827|NCT02744716|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110447828|NCT02744716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110447829|NCT02744716|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110447830|NCT02744716|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110447831|NCT02744716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110447832|NCT02744716|Antipyretics|antipyretics|mesh-ancestor
110447833|NCT02744872|Felodipine|felodipine|mesh-list
110447834|NCT02744872|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110447835|NCT02744872|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110447836|NCT02744872|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110447837|NCT02744872|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110447838|NCT02744872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110447839|NCT02744872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110447840|NCT02744872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110447841|NCT02744872|Vasodilator Agents|vasodilator agents|mesh-ancestor
110447842|NCT02744638|Metronidazole|metronidazole|mesh-list
110447843|NCT02744638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110462851|NCT00681928|Letrozole|letrozole|mesh-list
110447844|NCT02744638|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110447845|NCT02744638|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110447846|NCT02744638|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110094881|NCT01711528|Hormones|hormones|mesh-ancestor
110447847|NCT02740894|Gefitinib|gefitinib|mesh-list
110447848|NCT02740894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110447849|NCT02740894|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110447851|NCT02740894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110447852|NCT00857389|Cyclophosphamide|cyclophosphamide|mesh-list
110447853|NCT00857389|Busulfan|busulfan|mesh-list
110447854|NCT00857389|Thiotepa|thiotepa|mesh-list
110447855|NCT00857389|Methotrexate|methotrexate|mesh-list
110447856|NCT00857389|Clofarabine|clofarabine|mesh-list
110447857|NCT00857389|Tacrolimus|tacrolimus|mesh-list
110447858|NCT00857389|Thymoglobulin|thymoglobulin|mesh-list
110447859|NCT00857389|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110447860|NCT00857389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110447861|NCT00857389|Immunologic Factors|immunologic factors|mesh-ancestor
110447862|NCT00857389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110447863|NCT00857389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110462975|NCT01111292|Vitamins|vitamins|mesh-ancestor
110447864|NCT00857389|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110447865|NCT00857389|Alkylating Agents|alkylating agents|mesh-ancestor
110447866|NCT00857389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110447867|NCT00857389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110447868|NCT00857389|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110447869|NCT00857389|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110447870|NCT00857389|Abortifacient Agents|abortifacient agents|mesh-ancestor
110447871|NCT00857389|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110447872|NCT00857389|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110447873|NCT00857389|Antimetabolites|antimetabolites|mesh-ancestor
110447874|NCT00857389|Dermatologic Agents|dermatologic agents|mesh-ancestor
110447875|NCT00857389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110447876|NCT00857389|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110447877|NCT00857389|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110250125|NCT02824523|Antipyretics|antipyretics|mesh-ancestor
110447878|NCT00857389|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110447879|NCT02744482|Risedronic Acid|risedronic acid|mesh-list
110447880|NCT02744482|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110447881|NCT02744482|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110463173|NCT00904839|Growth Inhibitors|growth inhibitors|mesh-ancestor
110447882|NCT02744482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110447883|NCT02744482|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110447884|NCT02744482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110447885|NCT02744482|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110447886|NCT01071798|Rituximab|rituximab|mesh-list
110447887|NCT01071798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110447888|NCT01071798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110447889|NCT01071798|Immunologic Factors|immunologic factors|mesh-ancestor
110447890|NCT01071798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110447891|NCT01071798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110447892|NCT00857311|Vaccines|vaccines|mesh-list
110447893|NCT00857311|Immunologic Factors|immunologic factors|mesh-ancestor
110447894|NCT00857311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110447895|NCT02874768|Dexmedetomidine|dexmedetomidine|mesh-list
110447896|NCT02874768|Propofol|propofol|mesh-list
110447897|NCT02874768|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110447898|NCT02874768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110447899|NCT02874768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110447900|NCT02874768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110447901|NCT02874768|Analgesics|analgesics|mesh-ancestor
110447902|NCT02874768|Sensory System Agents|sensory system agents|mesh-ancestor
110447903|NCT02874768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110447904|NCT02874768|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110447905|NCT02874768|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110447906|NCT02874768|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110447907|NCT02874768|Adrenergic Agents|adrenergic agents|mesh-ancestor
110447908|NCT02874768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110447909|NCT02874768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110447910|NCT02874768|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110447911|NCT02874768|Anesthetics, General|anesthetics, general|mesh-ancestor
110447912|NCT02874768|Anesthetics|anesthetics|mesh-ancestor
110447913|NCT00857233|Memantine|memantine|mesh-list
110447914|NCT00857233|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110447915|NCT00857233|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110447916|NCT00857233|Dopamine Agents|dopamine agents|mesh-ancestor
110447917|NCT00857233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110447918|NCT00857233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110094948|NCT01711814|Immunologic Factors|immunologic factors|mesh-ancestor
110447919|NCT00857233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110447920|NCT00857233|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110447921|NCT00857233|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110447923|NCT02740426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110447924|NCT02743234|Vancomycin|vancomycin|mesh-list
110447925|NCT02743234|Fidaxomicin|fidaxomicin|mesh-list
110447926|NCT02743234|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110447927|NCT02743234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110447928|NCT02740270|Spartalizumab|spartalizumab|mesh-list
110447929|NCT02740270|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110447930|NCT02740270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110447931|NCT02740270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110447932|NCT02740270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110447933|NCT00856843|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
110447934|NCT00856843|Laxatives|laxatives|mesh-ancestor
110447935|NCT00856843|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110447936|NCT02740192|Bupivacaine|bupivacaine|mesh-list
110447937|NCT02740192|Ropivacaine|ropivacaine|mesh-list
110447938|NCT02740192|Anesthetics, Local|anesthetics, local|mesh-ancestor
110447939|NCT02740192|Anesthetics|anesthetics|mesh-ancestor
110447940|NCT02740192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110463425|NCT02853552|Abortifacient Agents|abortifacient agents|mesh-ancestor
110447941|NCT02740192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110447942|NCT02740192|Sensory System Agents|sensory system agents|mesh-ancestor
110447943|NCT02740192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110447944|NCT02743390|Infliximab|infliximab|mesh-list
110447945|NCT02743390|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110447946|NCT02743390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110447947|NCT02743390|Dermatologic Agents|dermatologic agents|mesh-ancestor
110447948|NCT02743390|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110447949|NCT02743390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110447950|NCT00856609|Exenatide|exenatide|mesh-list
110447951|NCT00856609|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110447952|NCT00856609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110447953|NCT00856609|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110447954|NCT00856609|Incretins|incretins|mesh-ancestor
110447955|NCT00856609|Hormones|hormones|mesh-ancestor
110463482|NCT00941304|Analgesics|analgesics|mesh-ancestor
110447956|NCT00856609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110447957|NCT02739958|Propofol|propofol|mesh-list
110447958|NCT02739958|Isoflurane|isoflurane|mesh-list
110447959|NCT02739958|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110447960|NCT02739958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110447961|NCT02739958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110447962|NCT02739958|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110447963|NCT02739958|Anesthetics, General|anesthetics, general|mesh-ancestor
110447964|NCT02739958|Anesthetics|anesthetics|mesh-ancestor
110447965|NCT02739958|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110447966|NCT02739880|Hyaluronic Acid|hyaluronic acid|mesh-list
110447967|NCT02739880|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110447968|NCT02739880|Immunologic Factors|immunologic factors|mesh-ancestor
110447969|NCT02739880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110447970|NCT02739880|Viscosupplements|viscosupplements|mesh-ancestor
110447971|NCT02739880|Protective Agents|protective agents|mesh-ancestor
110447972|NCT01071096|Botulinum Toxins|botulinum toxins|mesh-list
110447973|NCT01071096|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110447974|NCT01071096|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110447975|NCT01071096|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110447976|NCT01071096|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110447977|NCT01071096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110447978|NCT01071096|Cholinergic Agents|cholinergic agents|mesh-ancestor
110447979|NCT01071096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110447980|NCT01071096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110447981|NCT01071096|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110447982|NCT01071096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110447984|NCT00856375|Etirinotecan pegol|etirinotecan pegol|mesh-list
110447985|NCT00856375|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110447986|NCT00856375|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110447987|NCT00856375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110447988|NCT00856375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110463670|NCT05336721|Capecitabine|capecitabine|mesh-list
110463671|NCT05336721|Chiauranib|chiauranib|mesh-list
110447989|NCT00856375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110447990|NCT00856375|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110447992|NCT01070784|Formoterol Fumarate|formoterol fumarate|mesh-list
110447993|NCT01070784|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
110447994|NCT01070784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110095021|NCT01712295|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110447995|NCT01070784|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110447996|NCT01070784|Autonomic Agents|autonomic agents|mesh-ancestor
110447997|NCT01070784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110447998|NCT01070784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110447999|NCT01070784|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110448000|NCT01070784|Respiratory System Agents|respiratory system agents|mesh-ancestor
110448001|NCT01070784|Glucocorticoids|glucocorticoids|mesh-ancestor
110448002|NCT01070784|Hormones|hormones|mesh-ancestor
110448003|NCT01070784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110448004|NCT01070784|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110448005|NCT01070784|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110448006|NCT01070784|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110448007|NCT01070784|Adrenergic Agents|adrenergic agents|mesh-ancestor
110448008|NCT01070784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110448009|NCT01070784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110448010|NCT02694874|Rosiglitazone|rosiglitazone|mesh-list
110463812|NCT00140907|Losartan|losartan|mesh-list
110448012|NCT02694874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110448013|NCT00837577|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110448014|NCT00837577|Voglibose|voglibose|mesh-list
110448015|NCT00837577|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110448016|NCT00837577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110448017|NCT00837577|Incretins|incretins|mesh-ancestor
110448018|NCT00837577|Hormones|hormones|mesh-ancestor
110448019|NCT00837577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110448020|NCT00837577|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110448021|NCT00837577|Protease Inhibitors|protease inhibitors|mesh-ancestor
110448022|NCT00837577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110448023|NCT00837577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110448024|NCT00837577|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
110448025|NCT01070550|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110448026|NCT01070550|Antiviral Agents|antiviral agents|mesh-ancestor
110448027|NCT01070550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110448028|NCT04189900|Triptorelin Pamoate|triptorelin pamoate|mesh-list
110448029|NCT04189900|Luteolytic Agents|luteolytic agents|mesh-ancestor
110448030|NCT04189900|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110448031|NCT04189900|Contraceptive Agents|contraceptive agents|mesh-ancestor
110448032|NCT04189900|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110448033|NCT04189900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110448034|NCT04189900|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110448035|NCT04189900|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110448036|NCT04189900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110448037|NCT00848107|Treprostinil|treprostinil|mesh-list
110448038|NCT00848107|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110448039|NCT04030741|Metronidazole|metronidazole|mesh-list
110448040|NCT04030741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110448041|NCT04030741|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110448042|NCT04030741|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110448043|NCT04030741|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110448044|NCT02736760|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
110448045|NCT02736760|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110448046|NCT02736760|Dermatologic Agents|dermatologic agents|mesh-ancestor
110448047|NCT05620108|Rocuronium|rocuronium|mesh-list
110448048|NCT05620108|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110448049|NCT05620108|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110448050|NCT05620108|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110448051|NCT05620108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110448052|NCT05620108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110448053|NCT00856297|Vaccines|vaccines|mesh-list
110448054|NCT00856297|Immunologic Factors|immunologic factors|mesh-ancestor
110448055|NCT00856297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110448056|NCT02736604|Nitrous Oxide|nitrous oxide|mesh-list
110448057|NCT02736604|Anesthetics|anesthetics|mesh-list
110448058|NCT02736604|Sevoflurane|sevoflurane|mesh-list
110448059|NCT02736604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110448060|NCT02736604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110448061|NCT02736604|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110448062|NCT02736604|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110448063|NCT02736604|Anesthetics, General|anesthetics, general|mesh-ancestor
110448064|NCT02736604|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110448065|NCT02736604|Analgesics|analgesics|mesh-ancestor
110448066|NCT02736604|Sensory System Agents|sensory system agents|mesh-ancestor
110448067|NCT02736604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110448068|NCT02613013|Proxymetacaine|proxymetacaine|mesh-list
110448069|NCT02613013|Pilocarpine|pilocarpine|mesh-list
110448071|NCT02613013|Autonomic Agents|autonomic agents|mesh-ancestor
110448072|NCT02613013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110448073|NCT02613013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110448074|NCT02613013|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
110448075|NCT02613013|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110448076|NCT02613013|Cholinergic Agents|cholinergic agents|mesh-ancestor
110448077|NCT02613013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110448078|NCT02613013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110448079|NCT02613013|Anesthetics, Local|anesthetics, local|mesh-ancestor
110448081|NCT02613013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110448082|NCT02613013|Sensory System Agents|sensory system agents|mesh-ancestor
110448083|NCT04306510|Antibodies|antibodies|mesh-list
110448085|NCT04306510|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110448086|NCT04306510|Immunologic Factors|immunologic factors|mesh-ancestor
110448087|NCT04306510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110448088|NCT02611921|Ketamine|ketamine|mesh-list
110448089|NCT02611921|Analgesics|analgesics|mesh-ancestor
110448090|NCT02611921|Sensory System Agents|sensory system agents|mesh-ancestor
110448091|NCT02611921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110448092|NCT02611921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110448093|NCT02611921|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110448094|NCT02611921|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110448095|NCT02611921|Anesthetics, General|anesthetics, general|mesh-ancestor
110448096|NCT02611921|Anesthetics|anesthetics|mesh-ancestor
110448097|NCT02611921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110448098|NCT02611921|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110448099|NCT02611921|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110448100|NCT02611921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110448101|NCT02611921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110448102|NCT02736448|Capecitabine|capecitabine|mesh-list
110448103|NCT02736448|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110464373|NCT00939510|Lenalidomide|lenalidomide|mesh-list
110448104|NCT02736448|Antimetabolites|antimetabolites|mesh-ancestor
110448105|NCT02736448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110448106|NCT02736448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110448107|NCT00703651|Vaccines|vaccines|mesh-list
110448108|NCT00703651|Immunologic Factors|immunologic factors|mesh-ancestor
110448109|NCT00703651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110448110|NCT01046136|Phenylpropanolamine|phenylpropanolamine|mesh-list
110448111|NCT01046136|Guaifenesin|guaifenesin|mesh-list
110448112|NCT01046136|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
110448113|NCT01046136|Expectorants|expectorants|mesh-ancestor
110448114|NCT01046136|Respiratory System Agents|respiratory system agents|mesh-ancestor
110448115|NCT01046136|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110448116|NCT01046136|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110448117|NCT01046136|Adrenergic Agents|adrenergic agents|mesh-ancestor
110448118|NCT01046136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110448119|NCT01046136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110448120|NCT01046136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110448121|NCT01046136|Appetite Depressants|appetite depressants|mesh-ancestor
110448122|NCT01046136|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110448123|NCT01046136|Sympathomimetics|sympathomimetics|mesh-ancestor
110448124|NCT01046136|Autonomic Agents|autonomic agents|mesh-ancestor
110448125|NCT01046136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110448126|NCT01046136|Nasal Decongestants|nasal decongestants|mesh-ancestor
110448127|NCT01046136|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110448128|NCT02736682|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110448129|NCT02736682|Metronidazole|metronidazole|mesh-list
110448130|NCT02736682|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
110448132|NCT02736682|Antitubercular Agents|antitubercular agents|mesh-ancestor
110448133|NCT02736682|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110448134|NCT02736682|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110448135|NCT00701155|Insulin Detemir|insulin detemir|mesh-list
110448136|NCT00701155|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110448137|NCT00701155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110448138|NCT02874690|Methylphenidate|methylphenidate|mesh-list
110448139|NCT02874690|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110448140|NCT02874690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110448141|NCT02874690|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110448142|NCT02874690|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110448143|NCT02874690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110095174|NCT01713049|Alovudine|alovudine|mesh-list
110448144|NCT02874690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110448145|NCT02874690|Dopamine Agents|dopamine agents|mesh-ancestor
110448146|NCT02874690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110448148|NCT02738632|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110448149|NCT02738632|Telmisartan|telmisartan|mesh-list
110448150|NCT02738632|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
110448151|NCT02738632|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110448152|NCT02738632|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110448153|NCT02738632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110448154|NCT02738632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110448155|NCT02738632|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110464850|NCT00673504|Gemcitabine|gemcitabine|mesh-list
110448156|NCT02738632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110448157|NCT02738632|Vasodilator Agents|vasodilator agents|mesh-ancestor
110448158|NCT02738632|Diuretics|diuretics|mesh-ancestor
110448159|NCT02738632|Natriuretic Agents|natriuretic agents|mesh-ancestor
110448160|NCT02738632|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110448161|NCT02738632|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110448162|NCT02738632|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110448163|NCT01070394|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
110448164|NCT01070394|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110448165|NCT01070394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110448166|NCT01070394|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110448167|NCT01070394|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110448168|NCT01070394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110448169|NCT01070394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110448170|NCT01070394|Dopamine Agents|dopamine agents|mesh-ancestor
110448171|NCT01070394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110448172|NCT00703807|Everolimus|everolimus|mesh-list
110448173|NCT00703807|Topotecan|topotecan|mesh-list
110448174|NCT00703807|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110448175|NCT00703807|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110448176|NCT00703807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110448177|NCT00703807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110448178|NCT00703807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110448179|NCT00703807|Immunologic Factors|immunologic factors|mesh-ancestor
110448180|NCT00703807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110465043|NCT00607074|Anthelmintics|anthelmintics|mesh-list
110448181|NCT00703807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110448182|NCT00703807|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110448183|NCT00703807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110448184|NCT03649438|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
110448185|NCT03649438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110448186|NCT03649438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110448187|NCT03649438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110448188|NCT03649438|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110448189|NCT00701233|Botulinum Toxins|botulinum toxins|mesh-list
110465187|NCT02878772|Aspirin|aspirin|mesh-list
110448190|NCT00701233|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110448191|NCT00701233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110448192|NCT00701233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110448194|NCT00701233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110448195|NCT00701233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110448196|NCT03633058|Ketamine|ketamine|mesh-list
110448197|NCT03633058|Analgesics|analgesics|mesh-ancestor
110448198|NCT03633058|Sensory System Agents|sensory system agents|mesh-ancestor
110448199|NCT03633058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110448200|NCT03633058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110448201|NCT03633058|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110448202|NCT03633058|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110448203|NCT03633058|Anesthetics, General|anesthetics, general|mesh-ancestor
110448204|NCT03633058|Anesthetics|anesthetics|mesh-ancestor
110448205|NCT03633058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110448206|NCT03633058|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110448207|NCT03633058|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110448208|NCT03633058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110448209|NCT03633058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110448210|NCT01070316|Everolimus|everolimus|mesh-list
110448211|NCT01070316|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110448212|NCT01070316|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110448213|NCT01070316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110448214|NCT01070316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110095247|NCT01713426|Anticonvulsants|anticonvulsants|mesh-ancestor
110448215|NCT01070316|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110448216|NCT01070316|Immunologic Factors|immunologic factors|mesh-ancestor
110448217|NCT01070316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110448218|NCT01070316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110448219|NCT02737774|Carboplatin|carboplatin|mesh-list
110448220|NCT02737774|Pemetrexed|pemetrexed|mesh-list
110448221|NCT02737774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110448222|NCT02737774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110655634|NCT04008966|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110448223|NCT02737774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110448224|NCT02737774|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110293376|NCT00413504|PENTA|penta|mesh-list
110448225|NCT02737774|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110448226|NCT02735590|Isoniazid|isoniazid|mesh-list
110448227|NCT02735590|Rifapentine|rifapentine|mesh-list
110448228|NCT02735590|Antitubercular Agents|antitubercular agents|mesh-ancestor
110448229|NCT02735590|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110448230|NCT02735590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110448231|NCT02735590|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
110448232|NCT02735590|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110448233|NCT02735590|Antimetabolites|antimetabolites|mesh-ancestor
110448234|NCT02735590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110448235|NCT02735590|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110465614|NCT00696982|Glyburide|glyburide|mesh-list
110448236|NCT02735590|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110448237|NCT02735590|Leprostatic Agents|leprostatic agents|mesh-ancestor
110448238|NCT05626348|Hydroxychloroquine|hydroxychloroquine|mesh-list
110448239|NCT05626348|Adalimumab|adalimumab|mesh-list
110448240|NCT05626348|Methotrexate|methotrexate|mesh-list
110448241|NCT05626348|Leflunomide|leflunomide|mesh-list
110448242|NCT05626348|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110448243|NCT05626348|Abortifacient Agents|abortifacient agents|mesh-ancestor
110448244|NCT05626348|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110448245|NCT05626348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110448246|NCT05626348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110448247|NCT05626348|Antimetabolites|antimetabolites|mesh-ancestor
110448248|NCT05626348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110465661|NCT00931710|Vasodilator Agents|vasodilator agents|mesh-ancestor
110448249|NCT05626348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110448250|NCT05626348|Dermatologic Agents|dermatologic agents|mesh-ancestor
110465721|NCT00863746|Sorafenib|sorafenib|mesh-list
110448251|NCT05626348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110448252|NCT05626348|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110465793|NCT04263402|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110448253|NCT05626348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110448254|NCT05626348|Immunologic Factors|immunologic factors|mesh-ancestor
110448255|NCT05626348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110448256|NCT05626348|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110448257|NCT05626348|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110448258|NCT05626348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110448259|NCT05626348|Antimalarials|antimalarials|mesh-ancestor
110448260|NCT05626348|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110448261|NCT05626348|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110448262|NCT05626348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110448264|NCT02737696|Narcotics|narcotics|mesh-ancestor
110465859|NCT04122040|Roxithromycin|roxithromycin|mesh-list
110448265|NCT02737696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110448266|NCT02737696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110448267|NCT02737696|Analgesics|analgesics|mesh-ancestor
110448268|NCT02737696|Sensory System Agents|sensory system agents|mesh-ancestor
110465929|NCT00925704|Chelating Agents|chelating agents|mesh-ancestor
110448269|NCT02737696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110448270|NCT02737228|Gemcitabine|gemcitabine|mesh-list
110448271|NCT02737228|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110448272|NCT02737228|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110448273|NCT02737228|Antimetabolites|antimetabolites|mesh-ancestor
110466002|NCT00610038|Glyburide|glyburide|mesh-list
110448274|NCT02737228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110448275|NCT02737228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110448276|NCT02737228|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110448277|NCT02737228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110448278|NCT01126541|Rituximab|rituximab|mesh-list
110448279|NCT01126541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110448280|NCT01126541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110448281|NCT01126541|Immunologic Factors|immunologic factors|mesh-ancestor
110466071|NCT04132570|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110448282|NCT01126541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110448284|NCT02737150|Anesthetics|anesthetics|mesh-list
110448285|NCT02737150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110448286|NCT02737150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110448287|NCT02735356|Itraconazole|itraconazole|mesh-list
110448288|NCT02735356|Antifungal Agents|antifungal agents|mesh-ancestor
110448289|NCT02735356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110466136|NCT02878538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110095319|NCT01714011|Aripiprazole|aripiprazole|mesh-list
110448290|NCT02735356|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110448291|NCT02735356|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110448292|NCT02735356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110293434|NCT00226538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110448293|NCT02735356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110448294|NCT02735356|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110448295|NCT02735356|Hormone Antagonists|hormone antagonists|mesh-ancestor
110448296|NCT02735356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110448297|NCT02735356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110448298|NCT02735356|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110448301|NCT00625469|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
110448302|NCT00625469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110448303|NCT05577910|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110448304|NCT05577910|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110448306|NCT00637481|Calcium|calcium|mesh-list
110448307|NCT00637481|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110466409|NCT01070888|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110448308|NCT00637481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110448309|NCT00637481|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110448310|NCT00637481|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110448311|NCT00637481|Antimetabolites|antimetabolites|mesh-ancestor
110448312|NCT00637481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110448313|NCT00637481|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110448314|NCT00637481|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110448315|NCT00637481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110448316|NCT00637559|Esomeprazole|esomeprazole|mesh-list
110448317|NCT00637559|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110448318|NCT00637559|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110466482|NCT01074554|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110466483|NCT01074554|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110466484|NCT01074554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110466486|NCT01074554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110448319|NCT00637559|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110448320|NCT00637559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110448321|NCT00637559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110448322|NCT00836875|Voriconazole|voriconazole|mesh-list
110448323|NCT00836875|Antifungal Agents|antifungal agents|mesh-ancestor
110466549|NCT00699634|Nabilone|nabilone|mesh-list
110448324|NCT00836875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110448325|NCT00836875|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110448326|NCT00836875|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110448327|NCT00836875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110466608|NCT00914797|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110448328|NCT00836875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110448329|NCT00836875|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110448330|NCT00836875|Hormone Antagonists|hormone antagonists|mesh-ancestor
110448331|NCT00836875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110448332|NCT00836875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110448333|NCT00836875|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110448334|NCT02732314|Desonide|desonide|mesh-list
110448335|NCT02732314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110448336|NCT01125917|Buprenorphine|buprenorphine|mesh-list
110448337|NCT01125917|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110448338|NCT01125917|Narcotics|narcotics|mesh-ancestor
110448339|NCT01125917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110448340|NCT01125917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110448341|NCT01125917|Analgesics|analgesics|mesh-ancestor
110448342|NCT01125917|Sensory System Agents|sensory system agents|mesh-ancestor
110448343|NCT01125917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110448344|NCT01125917|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110448345|NCT02732236|Rituximab|rituximab|mesh-list
110448346|NCT02732236|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110448347|NCT02732236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110448348|NCT02732236|Immunologic Factors|immunologic factors|mesh-ancestor
110448349|NCT02732236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110448350|NCT02732236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110448351|NCT01121549|Exemestane|exemestane|mesh-list
110448352|NCT01121549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110448353|NCT01121549|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110448354|NCT01121549|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110448355|NCT01121549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110448356|NCT01121549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110448357|NCT01121549|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110448358|NCT01121549|Hormone Antagonists|hormone antagonists|mesh-ancestor
110448359|NCT01121549|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110448360|NCT01121549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110448361|NCT00847405|Sumatriptan|sumatriptan|mesh-list
110448362|NCT00847405|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110448363|NCT00847405|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110448364|NCT00847405|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110448365|NCT00847405|Serotonin Agents|serotonin agents|mesh-ancestor
110448366|NCT00847405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110448367|NCT00847405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110448368|NCT00847405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110448369|NCT02731846|Fluticasone|fluticasone|mesh-list
110448371|NCT02731846|Albuterol|albuterol|mesh-list
110448372|NCT02731846|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110448373|NCT02731846|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110448374|NCT02731846|Autonomic Agents|autonomic agents|mesh-ancestor
110448375|NCT02731846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110448376|NCT02731846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110448377|NCT02731846|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110448378|NCT02731846|Respiratory System Agents|respiratory system agents|mesh-ancestor
110448379|NCT02731846|Dermatologic Agents|dermatologic agents|mesh-ancestor
110448380|NCT02731846|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110448381|NCT02731846|Tocolytic Agents|tocolytic agents|mesh-ancestor
110448382|NCT02731846|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110448383|NCT02731846|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110448384|NCT02731846|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110448385|NCT02731846|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110448386|NCT02731846|Adrenergic Agents|adrenergic agents|mesh-ancestor
110448387|NCT02731846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110448388|NCT02731846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110448389|NCT04248712|Loratadine|loratadine|mesh-list
110448390|NCT04248712|Famotidine|famotidine|mesh-list
110448391|NCT04248712|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110448392|NCT04248712|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110448393|NCT04248712|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110448394|NCT04248712|Histamine Antagonists|histamine antagonists|mesh-ancestor
110448395|NCT04248712|Histamine Agents|histamine agents|mesh-ancestor
110466888|NCT02013141|Telavancin|telavancin|mesh-list
110448396|NCT04248712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110448397|NCT04248712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110448398|NCT04248712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110448399|NCT04248712|Antipruritics|antipruritics|mesh-ancestor
110448400|NCT04248712|Dermatologic Agents|dermatologic agents|mesh-ancestor
110448401|NCT04248712|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110448402|NCT04248712|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110448403|NCT04248712|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110448404|NCT02734732|Ciprofloxacin|ciprofloxacin|mesh-list
110448405|NCT02734732|Trimethoprim|trimethoprim|mesh-list
110448406|NCT02734732|Sulfamethoxazole|sulfamethoxazole|mesh-list
110448407|NCT02734732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110448408|NCT02734732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110448409|NCT02734732|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110448410|NCT02734732|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110448411|NCT02734732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110448412|NCT02734732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110448413|NCT02734732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110448414|NCT02734732|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110448415|NCT02734732|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110448416|NCT02734732|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110448417|NCT02734732|Antimalarials|antimalarials|mesh-ancestor
110448418|NCT02734732|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110448419|NCT02734732|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110448420|NCT02734732|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110448421|NCT02734732|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110448422|NCT02734732|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
110448424|NCT02731378|Dextrans|dextrans|mesh-list
110448425|NCT02731378|Epoetin Alfa|epoetin alfa|mesh-list
110448426|NCT02731378|Iron-Dextran Complex|iron-dextran complex|mesh-list
110448427|NCT02731378|Trace Elements|trace elements|mesh-ancestor
110448428|NCT02731378|Micronutrients|micronutrients|mesh-ancestor
110448429|NCT02731378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110448430|NCT02731378|Hematinics|hematinics|mesh-ancestor
110448431|NCT02731378|Anticoagulants|anticoagulants|mesh-ancestor
110448432|NCT02731378|Plasma Substitutes|plasma substitutes|mesh-ancestor
110448433|NCT02731378|Blood Substitutes|blood substitutes|mesh-ancestor
110095482|NCT01714427|Hormones|hormones|mesh-ancestor
110448434|NCT02731534|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
110448435|NCT02731534|Hematinics|hematinics|mesh-ancestor
110448436|NCT02734420|Tolonium Chloride|tolonium chloride|mesh-list
110448437|NCT02734420|Hemostatics|hemostatics|mesh-ancestor
110448438|NCT02734420|Coagulants|coagulants|mesh-ancestor
110448439|NCT02734420|Heparin Antagonists|heparin antagonists|mesh-ancestor
110448440|NCT02734420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110448441|NCT00704275|Cyclosporine|cyclosporine|mesh-list
110448442|NCT00704275|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110448443|NCT00704275|Cyclosporins|cyclosporins|mesh-list
110448444|NCT00704275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110448445|NCT00704275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110448446|NCT00704275|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110448447|NCT00704275|Immunologic Factors|immunologic factors|mesh-ancestor
110448448|NCT00704275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110448449|NCT00704275|Antifungal Agents|antifungal agents|mesh-ancestor
110448450|NCT00704275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110448451|NCT00704275|Dermatologic Agents|dermatologic agents|mesh-ancestor
110448452|NCT00704275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110448453|NCT00704275|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110448454|NCT00704275|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110448455|NCT00847015|Gemcitabine|gemcitabine|mesh-list
110448456|NCT00847015|Sunitinib|sunitinib|mesh-list
110448457|NCT00847015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110448458|NCT00847015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110448459|NCT00847015|Antimetabolites|antimetabolites|mesh-ancestor
110448460|NCT00847015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110448461|NCT00847015|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110448462|NCT00847015|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110448463|NCT00847015|Growth Substances|growth substances|mesh-ancestor
110448464|NCT00847015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110448465|NCT00847015|Growth Inhibitors|growth inhibitors|mesh-ancestor
110448466|NCT00847015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110448467|NCT00847015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110448469|NCT00627354|Etoposide|etoposide|mesh-list
110448470|NCT00627354|Vinorelbine|vinorelbine|mesh-list
110448471|NCT00627354|Mitoxantrone|mitoxantrone|mesh-list
110448472|NCT00627354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110448473|NCT00627354|Glucocorticoids|glucocorticoids|mesh-ancestor
110448474|NCT00627354|Hormones|hormones|mesh-ancestor
110448475|NCT00627354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110448476|NCT00627354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110448477|NCT00627354|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110448478|NCT00627354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110448479|NCT00627354|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110448480|NCT00627354|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110448481|NCT00627354|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110448482|NCT00627354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110448483|NCT00627354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110448484|NCT00627354|Tubulin Modulators|tubulin modulators|mesh-ancestor
110448485|NCT00627354|Antimitotic Agents|antimitotic agents|mesh-ancestor
110448486|NCT00627354|Mitosis Modulators|mitosis modulators|mesh-ancestor
110448487|NCT00627354|Analgesics|analgesics|mesh-ancestor
110448488|NCT00627354|Sensory System Agents|sensory system agents|mesh-ancestor
110448489|NCT00627354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110448490|NCT00704431|Darapladib|darapladib|mesh-list
110448491|NCT00704431|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
110448492|NCT00704431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110448493|NCT00704431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110448494|NCT02734186|Praziquantel|praziquantel|mesh-list
110448495|NCT02734186|Anthelmintics|anthelmintics|mesh-ancestor
110448496|NCT02734186|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110448497|NCT02734186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110448498|NCT00704509|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110448499|NCT00704509|Antidepressive Agents|antidepressive agents|mesh-ancestor
110448500|NCT00704509|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110448501|NCT00704509|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110448502|NCT00704509|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110448503|NCT00704509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110448504|NCT00704509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110448505|NCT02733952|Tranexamic Acid|tranexamic acid|mesh-list
110448506|NCT02733952|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110467645|NCT00892437|Atazanavir Sulfate|atazanavir sulfate|mesh-list
110448507|NCT02733952|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110448508|NCT02733952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110448509|NCT02733952|Hemostatics|hemostatics|mesh-ancestor
110448510|NCT02733952|Coagulants|coagulants|mesh-ancestor
110448511|NCT02733640|Pantoprazole|pantoprazole|mesh-list
110448512|NCT02733640|Ranitidine|ranitidine|mesh-list
110448513|NCT02733640|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
110448515|NCT02733640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110448516|NCT02733640|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110448517|NCT02733640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110448518|NCT02733640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110448519|NCT02733640|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110448521|NCT02733640|Histamine Agents|histamine agents|mesh-ancestor
110448522|NCT02733640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110448523|NCT02733640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110448525|NCT02730676|Antipruritics|antipruritics|mesh-ancestor
110448526|NCT02730676|Dermatologic Agents|dermatologic agents|mesh-ancestor
110448527|NCT00855595|Metronidazole|metronidazole|mesh-list
110448528|NCT00855595|Doxycycline|doxycycline|mesh-list
110448529|NCT00855595|Azelaic acid|azelaic acid|mesh-list
110448530|NCT00855595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110448531|NCT00855595|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110448532|NCT00855595|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110448533|NCT00855595|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110448534|NCT00855595|Antimalarials|antimalarials|mesh-ancestor
110448535|NCT00855595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110448536|NCT00855595|Dermatologic Agents|dermatologic agents|mesh-ancestor
110448537|NCT05433532|Azacitidine|azacitidine|mesh-list
110448539|NCT05433532|Flumatinib|flumatinib|mesh-list
110448540|NCT05433532|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110448541|NCT05433532|Antimetabolites|antimetabolites|mesh-ancestor
110448542|NCT05433532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110448543|NCT05433532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110468141|NCT00782275|Sirolimus|sirolimus|mesh-list
110448544|NCT05433532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110448545|NCT05433532|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110448546|NCT00855439|Exenatide|exenatide|mesh-list
110448547|NCT00855439|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110468207|NCT00919854|Ritonavir|ritonavir|mesh-list
110448548|NCT00855439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110448549|NCT00855439|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110448550|NCT00855439|Incretins|incretins|mesh-ancestor
110448551|NCT00855439|Hormones|hormones|mesh-ancestor
110448552|NCT00855439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110448553|NCT01064856|Adalimumab|adalimumab|mesh-list
110448554|NCT01064856|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110448555|NCT01064856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110448556|NCT01064856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110468292|NCT04675866|Paclitaxel|paclitaxel|mesh-list
110448557|NCT02730442|Fluconazole|fluconazole|mesh-list
110448558|NCT02730442|Antifungal Agents|antifungal agents|mesh-list
110448559|NCT02730442|Clotrimazole|clotrimazole|mesh-list
110448560|NCT02730442|Miconazole|miconazole|mesh-list
110448562|NCT02730442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110448563|NCT02730442|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110448564|NCT02730442|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110448565|NCT02730442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110448566|NCT02730442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110293713|NCT00236067|Anticonvulsants|anticonvulsants|mesh-ancestor
110448567|NCT02730442|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110448568|NCT02730442|Hormone Antagonists|hormone antagonists|mesh-ancestor
110448569|NCT02730442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110448570|NCT02730442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110448571|NCT02730442|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110448572|NCT02730442|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110448573|NCT02730442|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110448574|NCT02730442|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110448576|NCT02733874|Clobetasol|clobetasol|mesh-list
110448577|NCT02733874|Calcipotriene|calcipotriene|mesh-list
110448578|NCT02733874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110448579|NCT02733874|Glucocorticoids|glucocorticoids|mesh-ancestor
110448580|NCT02733874|Hormones|hormones|mesh-ancestor
110448581|NCT02733874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110468493|NCT00704392|XL647|xl647|mesh-list
110448582|NCT02733874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110448583|NCT02733874|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110448584|NCT02733874|Respiratory System Agents|respiratory system agents|mesh-ancestor
110448585|NCT02733874|Dermatologic Agents|dermatologic agents|mesh-ancestor
110448587|NCT02730364|Pheniramine|pheniramine|mesh-list
110448588|NCT02730364|Phenylephrine|phenylephrine|mesh-list
110448589|NCT02730364|Oxymetazoline|oxymetazoline|mesh-list
110095619|NCT01715311|Parasympatholytics|parasympatholytics|mesh-ancestor
110448590|NCT02730364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110448591|NCT02730364|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110448593|NCT02730364|Sensory System Agents|sensory system agents|mesh-ancestor
110448594|NCT02730364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110448595|NCT02730364|Antipyretics|antipyretics|mesh-ancestor
110115741|NCT05674656|Antiviral Agents|antiviral agents|mesh-ancestor
110448596|NCT02730364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110448597|NCT02730364|Protective Agents|protective agents|mesh-ancestor
110448598|NCT02730364|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110448599|NCT02730364|Mydriatics|mydriatics|mesh-ancestor
110448600|NCT02730364|Autonomic Agents|autonomic agents|mesh-ancestor
110448601|NCT02730364|Sympathomimetics|sympathomimetics|mesh-ancestor
110448602|NCT02730364|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110468680|NCT04244097|Bupivacaine|bupivacaine|mesh-list
110448603|NCT02730364|Nasal Decongestants|nasal decongestants|mesh-ancestor
110448604|NCT02730364|Respiratory System Agents|respiratory system agents|mesh-ancestor
110448605|NCT02730364|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110448606|NCT02730364|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110448608|NCT02730364|Adrenergic Agents|adrenergic agents|mesh-ancestor
110448609|NCT02730364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110448610|NCT02730364|Antipruritics|antipruritics|mesh-ancestor
110448611|NCT02730364|Dermatologic Agents|dermatologic agents|mesh-ancestor
110448612|NCT02730364|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110448613|NCT02730364|Histamine Antagonists|histamine antagonists|mesh-ancestor
110448614|NCT02730364|Histamine Agents|histamine agents|mesh-ancestor
110448615|NCT02730364|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110448616|NCT01042392|Ramipril|ramipril|mesh-list
110448617|NCT01042392|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110448618|NCT01042392|Protease Inhibitors|protease inhibitors|mesh-ancestor
110448619|NCT01042392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110655635|NCT04008966|Fertility Agents|fertility agents|mesh-ancestor
110448620|NCT01042392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110448621|NCT01042392|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110448622|NCT00704665|Methocarbamol|methocarbamol|mesh-list
110448623|NCT00704665|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110468811|NCT04834206|Tubulin Modulators|tubulin modulators|mesh-ancestor
110448624|NCT00704665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110448625|NCT00704665|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110448626|NCT00704665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110448627|NCT00913315|Tamsulosin|tamsulosin|mesh-list
110448629|NCT00913315|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110448630|NCT00913315|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110448631|NCT00913315|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110448632|NCT00913315|Adrenergic Agents|adrenergic agents|mesh-ancestor
110448633|NCT00913315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110448634|NCT00913315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110448635|NCT00913315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110448636|NCT00913315|Urological Agents|urological agents|mesh-ancestor
110468876|NCT00778921|Amlodipine|amlodipine|mesh-list
110448637|NCT00913315|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110448638|NCT00913315|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110448639|NCT00913315|Cholinergic Agents|cholinergic agents|mesh-ancestor
110448640|NCT00701857|Pemetrexed|pemetrexed|mesh-list
110448641|NCT00701857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110448642|NCT00701857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110448643|NCT00701857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110448644|NCT00701857|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110448645|NCT00701857|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110448646|NCT02729662|Tolvaptan|tolvaptan|mesh-list
110448647|NCT02729662|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
110468924|NCT00632268|Vitamins|vitamins|mesh-ancestor
110448648|NCT02729662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110448649|NCT02729662|Natriuretic Agents|natriuretic agents|mesh-ancestor
110448650|NCT02729662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110448651|NCT02733250|Paclitaxel|paclitaxel|mesh-list
110448652|NCT02733250|Pembrolizumab|pembrolizumab|mesh-list
110448653|NCT02733250|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110448654|NCT02733250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110448655|NCT02733250|Tubulin Modulators|tubulin modulators|mesh-ancestor
110448656|NCT02733250|Antimitotic Agents|antimitotic agents|mesh-ancestor
110448657|NCT02733250|Mitosis Modulators|mitosis modulators|mesh-ancestor
110448658|NCT02733250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110448659|NCT02733250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110448660|NCT02733250|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110448661|NCT03188068|Sirolimus|sirolimus|mesh-list
110448662|NCT03188068|Prednisolone|prednisolone|mesh-list
110448663|NCT03188068|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110448664|NCT03188068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110448665|NCT03188068|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110448666|NCT03188068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110448667|NCT03188068|Antifungal Agents|antifungal agents|mesh-ancestor
110448668|NCT03188068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110448669|NCT03188068|Immunologic Factors|immunologic factors|mesh-ancestor
110448670|NCT03188068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110448671|NCT03188068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110448672|NCT03188068|Glucocorticoids|glucocorticoids|mesh-ancestor
110448674|NCT03188068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110448675|NCT03188068|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110448676|NCT01064310|Sunitinib|sunitinib|mesh-list
110448677|NCT01064310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110448678|NCT01064310|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110448679|NCT01064310|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110448680|NCT01064310|Growth Substances|growth substances|mesh-ancestor
110448681|NCT01064310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110448682|NCT01064310|Growth Inhibitors|growth inhibitors|mesh-ancestor
110448683|NCT01064310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110468991|NCT04102267|Epinephrine|epinephrine|mesh-list
110448684|NCT01064310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110448685|NCT01064310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110448686|NCT02726854|Apatinib|apatinib|mesh-list
110448687|NCT02726854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110448688|NCT02726854|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110448689|NCT02726854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110448690|NCT02726854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110448691|NCT04724928|Immunomodulating Agents|immunomodulating agents|mesh-list
110448692|NCT04724928|Immunologic Factors|immunologic factors|mesh-ancestor
110448693|NCT04724928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110448694|NCT02728492|Paclitaxel|paclitaxel|mesh-list
110448695|NCT02728492|Carboplatin|carboplatin|mesh-list
110448696|NCT02728492|Gemcitabine|gemcitabine|mesh-list
110448697|NCT02728492|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110448698|NCT02728492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110448699|NCT02728492|Tubulin Modulators|tubulin modulators|mesh-ancestor
110448700|NCT02728492|Antimitotic Agents|antimitotic agents|mesh-ancestor
110448701|NCT02728492|Mitosis Modulators|mitosis modulators|mesh-ancestor
110448702|NCT02728492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110448703|NCT02728492|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110448704|NCT02728492|Antimetabolites|antimetabolites|mesh-ancestor
110448705|NCT02726308|Dexamethasone|dexamethasone|mesh-list
110448706|NCT02726308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110448707|NCT02726308|Antiemetics|antiemetics|mesh-ancestor
110448708|NCT02726308|Autonomic Agents|autonomic agents|mesh-ancestor
110448709|NCT02726308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110448710|NCT02726308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110448711|NCT02726308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110469158|NCT00833560|Antiemetics|antiemetics|mesh-ancestor
110448712|NCT02726308|Glucocorticoids|glucocorticoids|mesh-ancestor
110448713|NCT02726308|Hormones|hormones|mesh-ancestor
110448714|NCT02726308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110448715|NCT02726308|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110448716|NCT02726308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110448717|NCT01037244|Udenafil|udenafil|mesh-list
110448718|NCT01037244|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110448719|NCT01037244|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110448720|NCT01037244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110448721|NCT01037244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110448722|NCT00627432|Gemcitabine|gemcitabine|mesh-list
110448723|NCT00627432|Oxaliplatin|oxaliplatin|mesh-list
110448724|NCT00627432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110448725|NCT00627432|Antimetabolites|antimetabolites|mesh-ancestor
110448726|NCT00627432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110448727|NCT00627432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110448728|NCT02727712|Anesthetics|anesthetics|mesh-list
110448729|NCT02727712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110448730|NCT02727712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110448731|NCT01042236|Fesoterodine|fesoterodine|mesh-list
110448732|NCT01042236|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110448733|NCT01042236|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110448734|NCT01042236|Cholinergic Agents|cholinergic agents|mesh-ancestor
110448735|NCT01042236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110448736|NCT01042236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110448737|NCT01042236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110448738|NCT01042236|Urological Agents|urological agents|mesh-ancestor
110448739|NCT02725918|Pemetrexed|pemetrexed|mesh-list
110448740|NCT02725918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110448741|NCT02725918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110448742|NCT02725918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110448743|NCT02725918|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110448744|NCT02725918|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110448745|NCT00592501|Fluorouracil|fluorouracil|mesh-list
110448746|NCT00592501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110448747|NCT00592501|Antimetabolites|antimetabolites|mesh-ancestor
110469344|NCT04099771|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110448748|NCT00592501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110448749|NCT00592501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110448750|NCT00592501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110448751|NCT00592501|Immunologic Factors|immunologic factors|mesh-ancestor
110448752|NCT00592501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110448753|NCT01040832|Cetuximab|cetuximab|mesh-list
110448754|NCT01040832|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110448755|NCT01040832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110448756|NCT02721238|Plasma-lyte 148|plasma-lyte 148|mesh-list
110448757|NCT02721238|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110448758|NCT02721238|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110448760|NCT04304196|Antioxidants|antioxidants|mesh-ancestor
110448761|NCT04304196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110448762|NCT04304196|Protective Agents|protective agents|mesh-ancestor
110448763|NCT04304196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110448764|NCT02720770|Hormones|hormones|mesh-list
110448765|NCT02720770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110448766|NCT02720770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110448767|NCT02720926|Capecitabine|capecitabine|mesh-list
110448768|NCT02720926|Oxaliplatin|oxaliplatin|mesh-list
110448769|NCT02720926|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110448770|NCT02720926|Antimetabolites|antimetabolites|mesh-ancestor
110469416|NCT05037045|Hormones|hormones|mesh-ancestor
110448771|NCT02720926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110448772|NCT02720926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110448773|NCT00854581|Interferons|interferons|mesh-list
110448774|NCT00854581|Interferon-alpha|interferon-alpha|mesh-list
110448775|NCT00854581|Interferon alpha-2|interferon alpha-2|mesh-list
110448777|NCT00854581|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110448778|NCT00854581|Valproic Acid|valproic acid|mesh-list
110448779|NCT00854581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110448780|NCT00854581|Antiviral Agents|antiviral agents|mesh-ancestor
110448781|NCT00854581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110448782|NCT00854581|Immunologic Factors|immunologic factors|mesh-ancestor
110448783|NCT00854581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110448784|NCT00854581|Antimetabolites|antimetabolites|mesh-ancestor
110448785|NCT00854581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110448786|NCT00854581|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110448787|NCT00854581|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110448788|NCT00854581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110448789|NCT00854581|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110448790|NCT00854581|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110448791|NCT00854581|Anticonvulsants|anticonvulsants|mesh-ancestor
110448792|NCT00854581|GABA Agents|gaba agents|mesh-ancestor
110448793|NCT00854581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110448794|NCT00854581|Antimanic Agents|antimanic agents|mesh-ancestor
110448795|NCT00854581|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110448796|NCT00854581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110448797|NCT00854581|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110448798|NCT02720458|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
110448799|NCT02720458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110448800|NCT02720458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110448801|NCT00833911|Tramadol|tramadol|mesh-list
110448802|NCT00833911|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110448803|NCT00833911|Narcotics|narcotics|mesh-ancestor
110448804|NCT00833911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110448805|NCT00833911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110448806|NCT00833911|Analgesics|analgesics|mesh-ancestor
110448807|NCT00833911|Sensory System Agents|sensory system agents|mesh-ancestor
110448808|NCT00833911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110448809|NCT02719756|Metformin|metformin|mesh-list
110448810|NCT02719756|Dapagliflozin|dapagliflozin|mesh-list
110448811|NCT02719756|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110448812|NCT02719756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110448813|NCT02719756|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110448814|NCT02719756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110448815|NCT01125293|Rituximab|rituximab|mesh-list
110448816|NCT01125293|Everolimus|everolimus|mesh-list
110448817|NCT01125293|Bortezomib|bortezomib|mesh-list
110448818|NCT01125293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110448819|NCT01125293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110448820|NCT01125293|Immunologic Factors|immunologic factors|mesh-ancestor
110448821|NCT01125293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110448822|NCT01125293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110448823|NCT01125293|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110448824|NCT01125293|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110448825|NCT01125293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110448826|NCT01125293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110448827|NCT01125293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110448829|NCT02719834|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110448830|NCT02719834|Analgesics|analgesics|mesh-ancestor
110448831|NCT02719834|Sensory System Agents|sensory system agents|mesh-ancestor
110448832|NCT02719834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110448833|NCT02719834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110448834|NCT02719834|Antipyretics|antipyretics|mesh-ancestor
110448835|NCT02719210|Mannitol|mannitol|mesh-list
110448836|NCT02719210|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110448837|NCT02719210|Diuretics|diuretics|mesh-ancestor
110448838|NCT02719210|Natriuretic Agents|natriuretic agents|mesh-ancestor
110448839|NCT02719210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110448841|NCT02719132|Dapagliflozin|dapagliflozin|mesh-list
110448842|NCT02719132|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110448843|NCT02719132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110448844|NCT02719132|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110116947|NCT01873378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110448845|NCT02719132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110448846|NCT02718820|Docetaxel|docetaxel|mesh-list
110448847|NCT02718820|Pembrolizumab|pembrolizumab|mesh-list
110448848|NCT02718820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110448849|NCT02718820|Tubulin Modulators|tubulin modulators|mesh-ancestor
110448850|NCT02718820|Antimitotic Agents|antimitotic agents|mesh-ancestor
110448851|NCT02718820|Mitosis Modulators|mitosis modulators|mesh-ancestor
110448852|NCT02718820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110448853|NCT02718820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110469838|NCT04101019|Lidocaine|lidocaine|mesh-list
110448854|NCT02718820|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110448855|NCT02718976|Lidocaine|lidocaine|mesh-list
110448856|NCT02718976|Epinephrine|epinephrine|mesh-list
110448857|NCT02718976|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
110448858|NCT02718976|Anesthetics, Local|anesthetics, local|mesh-ancestor
110448859|NCT02718976|Anesthetics|anesthetics|mesh-ancestor
110448860|NCT02718976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110448861|NCT02718976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110448862|NCT02718976|Sensory System Agents|sensory system agents|mesh-ancestor
110448863|NCT02718976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110448864|NCT02718976|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110448865|NCT02718976|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110448866|NCT02718976|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110448867|NCT02718976|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110448868|NCT02718976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110448869|NCT02718976|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110448870|NCT02718976|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110448871|NCT02718976|Adrenergic Agents|adrenergic agents|mesh-ancestor
110448872|NCT02718976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110448873|NCT02718976|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110448874|NCT02718976|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110448875|NCT02718976|Autonomic Agents|autonomic agents|mesh-ancestor
110448876|NCT02718976|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110448877|NCT02718976|Respiratory System Agents|respiratory system agents|mesh-ancestor
110448878|NCT02718976|Mydriatics|mydriatics|mesh-ancestor
110448879|NCT02718976|Sympathomimetics|sympathomimetics|mesh-ancestor
110448880|NCT02718976|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110448881|NCT02718976|Chelating Agents|chelating agents|mesh-ancestor
110448882|NCT02718976|Sequestering Agents|sequestering agents|mesh-ancestor
110448883|NCT02718742|Paclitaxel|paclitaxel|mesh-list
110448884|NCT02718742|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110448885|NCT02718742|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110448886|NCT02718742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110448887|NCT02718742|Tubulin Modulators|tubulin modulators|mesh-ancestor
110448888|NCT02718742|Antimitotic Agents|antimitotic agents|mesh-ancestor
110448889|NCT02718742|Mitosis Modulators|mitosis modulators|mesh-ancestor
110448890|NCT02718742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110448891|NCT02717884|Cytarabine|cytarabine|mesh-list
110448892|NCT02717884|Tretinoin|tretinoin|mesh-list
110470096|NCT02811627|Memantine|memantine|mesh-list
110448893|NCT02717884|Tranylcypromine|tranylcypromine|mesh-list
110470160|NCT02808741|Olorofim|olorofim|mesh-list
110448894|NCT02717884|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110448896|NCT02717884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110448897|NCT02717884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110448898|NCT02717884|Antiviral Agents|antiviral agents|mesh-ancestor
110448899|NCT02717884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110448901|NCT02717884|Immunologic Factors|immunologic factors|mesh-ancestor
110448902|NCT02717884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110448903|NCT02717884|Keratolytic Agents|keratolytic agents|mesh-ancestor
110470234|NCT03893175|Antipyretics|antipyretics|mesh-ancestor
110448904|NCT02717884|Dermatologic Agents|dermatologic agents|mesh-ancestor
110448905|NCT02717884|Antidepressive Agents|antidepressive agents|mesh-ancestor
110448906|NCT02717884|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110448907|NCT02717884|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
110448908|NCT02717884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110448909|NCT02717884|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110448910|NCT02717884|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110448911|NCT02717884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110448912|NCT02717572|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110448913|NCT02717572|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110448914|NCT02717572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110448915|NCT01121393|Gemcitabine|gemcitabine|mesh-list
110448916|NCT01121393|Afatinib|afatinib|mesh-list
110448917|NCT01121393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110448918|NCT01121393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110448919|NCT01121393|Antimetabolites|antimetabolites|mesh-ancestor
110448920|NCT01121393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110448921|NCT01121393|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110448922|NCT01121393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110448923|NCT02882477|Metformin|metformin|mesh-list
110448924|NCT02882477|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110448925|NCT02882477|Acetylcysteine|acetylcysteine|mesh-list
110448926|NCT02882477|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110448927|NCT02882477|Deferiprone|deferiprone|mesh-list
110448928|NCT02882477|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110448929|NCT02882477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110448930|NCT02882477|Incretins|incretins|mesh-ancestor
110448931|NCT02882477|Hormones|hormones|mesh-ancestor
110448932|NCT02882477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110448933|NCT02882477|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110448934|NCT02882477|Protease Inhibitors|protease inhibitors|mesh-ancestor
110470367|NCT00841672|Amlodipine|amlodipine|mesh-list
110448935|NCT02882477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110448936|NCT02882477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110448937|NCT02882477|Antiviral Agents|antiviral agents|mesh-ancestor
110448938|NCT02882477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110448939|NCT02882477|Expectorants|expectorants|mesh-ancestor
110448940|NCT02882477|Respiratory System Agents|respiratory system agents|mesh-ancestor
110448941|NCT02882477|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110448942|NCT02882477|Antioxidants|antioxidants|mesh-ancestor
110448943|NCT02882477|Protective Agents|protective agents|mesh-ancestor
110448944|NCT02882477|Antidotes|antidotes|mesh-ancestor
110448945|NCT02882477|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110448946|NCT02882477|Chelating Agents|chelating agents|mesh-ancestor
110448947|NCT02882477|Sequestering Agents|sequestering agents|mesh-ancestor
110448948|NCT04163224|Imidacloprid|imidacloprid|mesh-list
110448949|NCT04163224|Cholinergic Agents|cholinergic agents|mesh-ancestor
110448950|NCT04163224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110448951|NCT04163224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110448952|NCT04163224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110448954|NCT02716792|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110448955|NCT02716792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110448956|NCT04964284|Hormones|hormones|mesh-list
110448957|NCT04964284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110448958|NCT04964284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110448959|NCT02716090|Adapalene|adapalene|mesh-list
110448960|NCT02716090|Benzoyl Peroxide|benzoyl peroxide|mesh-list
110448961|NCT02716090|Dermatologic Agents|dermatologic agents|mesh-ancestor
110448962|NCT02716090|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110448963|NCT02716090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110448965|NCT02716090|Sensory System Agents|sensory system agents|mesh-ancestor
110448966|NCT02716090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110448967|NCT02716090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110448968|NCT02716090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110448969|NCT02716090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110448970|NCT01227616|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
110448971|NCT01227616|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
110448972|NCT01227616|Hematinics|hematinics|mesh-ancestor
110448973|NCT01227616|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
110448974|NCT01227616|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110448975|NCT04189276|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110448976|NCT04189276|Antiviral Agents|antiviral agents|mesh-ancestor
110448977|NCT04189276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110448978|NCT02714998|Methotrexate|methotrexate|mesh-list
110448979|NCT02714998|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110448980|NCT02714998|Abortifacient Agents|abortifacient agents|mesh-ancestor
110448981|NCT02714998|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110448982|NCT02714998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110448983|NCT02714998|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110448985|NCT02714998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110448986|NCT02714998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110448987|NCT02714998|Dermatologic Agents|dermatologic agents|mesh-ancestor
110448988|NCT02714998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110448989|NCT02714998|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110448990|NCT02714998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110448991|NCT02714998|Immunologic Factors|immunologic factors|mesh-ancestor
110448992|NCT02714998|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110448993|NCT02714998|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110448995|NCT00765310|Antioxidants|antioxidants|mesh-ancestor
110448996|NCT00765310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110448997|NCT00765310|Protective Agents|protective agents|mesh-ancestor
110448998|NCT00765310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110448999|NCT00765310|Vitamin B Complex|vitamin b complex|mesh-ancestor
110449000|NCT00765310|Vitamins|vitamins|mesh-ancestor
110449001|NCT00765310|Micronutrients|micronutrients|mesh-ancestor
110449002|NCT02715154|Dexmedetomidine|dexmedetomidine|mesh-list
110449003|NCT02715154|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110449004|NCT02715154|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110449005|NCT02715154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110449006|NCT02715154|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110449007|NCT02715154|Analgesics|analgesics|mesh-ancestor
110449008|NCT02715154|Sensory System Agents|sensory system agents|mesh-ancestor
110449009|NCT02715154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110449010|NCT02715154|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110470870|NCT05803070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110449011|NCT02715154|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110449012|NCT02715154|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110449013|NCT02715154|Adrenergic Agents|adrenergic agents|mesh-ancestor
110449014|NCT02715154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110449015|NCT02715154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110449016|NCT02715232|Triptorelin Pamoate|triptorelin pamoate|mesh-list
110449017|NCT02715232|Cyproterone Acetate|cyproterone acetate|mesh-list
110449018|NCT02715232|Lynestrenol|lynestrenol|mesh-list
110449019|NCT02715232|Estradiol|estradiol|mesh-list
110449020|NCT02715232|Testosterone|testosterone|mesh-list
110449021|NCT02715232|Cyproterone|cyproterone|mesh-list
110449022|NCT02715232|Estrogens|estrogens|mesh-ancestor
110449023|NCT02715232|Hormones|hormones|mesh-ancestor
110449024|NCT02715232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110449025|NCT02715232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110449026|NCT02715232|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110449027|NCT02715232|Contraceptive Agents|contraceptive agents|mesh-ancestor
110449028|NCT02715232|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110449029|NCT02715232|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110449030|NCT02715232|Androgens|androgens|mesh-ancestor
110449031|NCT02715232|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110449032|NCT02715232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110449033|NCT02715232|Luteolytic Agents|luteolytic agents|mesh-ancestor
110449034|NCT02715232|Androgen Antagonists|androgen antagonists|mesh-ancestor
110449035|NCT02715232|Hormone Antagonists|hormone antagonists|mesh-ancestor
110449036|NCT02715232|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110449037|NCT02715232|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110449038|NCT02715232|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110449039|NCT02715232|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110449040|NCT02693860|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110449041|NCT02693860|Immunologic Factors|immunologic factors|mesh-ancestor
110449042|NCT02693860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110449043|NCT02714842|Diclofenac|diclofenac|mesh-list
110449044|NCT02714842|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110449045|NCT02714842|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110449046|NCT02714842|Analgesics|analgesics|mesh-ancestor
110449047|NCT02714842|Sensory System Agents|sensory system agents|mesh-ancestor
110449048|NCT02714842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110449049|NCT02714842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110449050|NCT02714842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110449051|NCT02714842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110449052|NCT02714842|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110471142|NCT05313308|Midazolam|midazolam|mesh-list
110449054|NCT02714842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110449055|NCT02714530|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110449056|NCT02714530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110449057|NCT02714530|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110449058|NCT02714530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110449059|NCT02714530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110449060|NCT02713750|Contraceptive Agents|contraceptive agents|mesh-list
110449061|NCT02713750|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110449062|NCT02713750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110449063|NCT04738162|Aminolevulinic Acid|aminolevulinic acid|mesh-list
110449064|NCT04738162|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110449065|NCT04738162|Dermatologic Agents|dermatologic agents|mesh-ancestor
110449067|NCT04000906|Cisplatin|cisplatin|mesh-list
110449068|NCT04000906|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110449069|NCT04000906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110449070|NCT04000906|Tubulin Modulators|tubulin modulators|mesh-ancestor
110449071|NCT04000906|Antimitotic Agents|antimitotic agents|mesh-ancestor
110449072|NCT04000906|Mitosis Modulators|mitosis modulators|mesh-ancestor
110449073|NCT04000906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110449074|NCT00636766|Metformin|metformin|mesh-list
110449075|NCT00636766|Rosiglitazone|rosiglitazone|mesh-list
110449076|NCT00636766|Rimonabant|rimonabant|mesh-list
110449077|NCT00636766|Atorvastatin|atorvastatin|mesh-list
110449078|NCT00636766|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110449079|NCT00636766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110471280|NCT04860804|Aspirin|aspirin|mesh-list
110449080|NCT00636766|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110449081|NCT00636766|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110449082|NCT00636766|Antimetabolites|antimetabolites|mesh-ancestor
110471430|NCT03990623|Liver Extracts|liver extracts|mesh-list
110449083|NCT00636766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110449084|NCT00636766|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110449085|NCT00636766|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110449086|NCT00636766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110449087|NCT00636766|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110449088|NCT00636766|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
110449089|NCT00636766|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110449090|NCT00636766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110449091|NCT00636766|Hormones|hormones|mesh-ancestor
110449092|NCT00636766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110449093|NCT03998176|Tenofovir|tenofovir|mesh-list
110294260|NCT04709172|Cefditoren|cefditoren|mesh-list
110449094|NCT03998176|Emtricitabine|emtricitabine|mesh-list
110471644|NCT02912572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110449095|NCT03998176|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
110449097|NCT03998176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110449098|NCT03998176|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110449099|NCT03998176|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110449100|NCT03998176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110449101|NCT03998176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110449102|NCT03998176|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110471789|NCT01712490|Tubulin Modulators|tubulin modulators|mesh-ancestor
110449103|NCT03998176|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110449104|NCT02713282|Paliperidone Palmitate|paliperidone palmitate|mesh-list
110449105|NCT02713282|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110449106|NCT02713282|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110449107|NCT02713282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110449108|NCT02713282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110449109|NCT02713282|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110449110|NCT02713282|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110449111|NCT02713282|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110096141|NCT01718496|Analgesics|analgesics|mesh-ancestor
110449112|NCT02713282|Serotonin Agents|serotonin agents|mesh-ancestor
110449113|NCT02713282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110471932|NCT02795949|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110449114|NCT02713282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110449115|NCT02713282|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110449116|NCT02713282|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110449117|NCT02713282|Dopamine Agents|dopamine agents|mesh-ancestor
110449118|NCT00611416|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
110449120|NCT00611416|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110449121|NCT00611416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110449122|NCT00611416|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110449123|NCT00611416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110449124|NCT00611416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110449125|NCT00611416|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110449126|NCT00611416|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110449127|NCT00611416|Purinergic Agents|purinergic agents|mesh-ancestor
110449128|NCT00611416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110449129|NCT00611416|Antioxidants|antioxidants|mesh-ancestor
110449130|NCT00611416|Protective Agents|protective agents|mesh-ancestor
110449131|NCT00611416|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
110449132|NCT00611416|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110449133|NCT00611416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110449134|NCT00611416|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110449136|NCT02712658|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110449137|NCT02712658|Autonomic Agents|autonomic agents|mesh-ancestor
110449138|NCT02712658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110449139|NCT02712658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110449140|NCT02712658|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110472357|NCT02611804|Diclofenac|diclofenac|mesh-list
110449141|NCT02712658|Respiratory System Agents|respiratory system agents|mesh-ancestor
110449143|NCT02712658|Tocolytic Agents|tocolytic agents|mesh-ancestor
110449144|NCT02712658|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110449145|NCT02712658|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110449146|NCT02712658|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110449147|NCT02712658|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110449148|NCT02712658|Adrenergic Agents|adrenergic agents|mesh-ancestor
110449149|NCT02712658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110449150|NCT02712658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110449151|NCT00611494|Mycophenolic Acid|mycophenolic acid|mesh-list
110449152|NCT00611494|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110449153|NCT00611494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110449154|NCT00611494|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110449155|NCT00611494|Antitubercular Agents|antitubercular agents|mesh-ancestor
110449156|NCT00611494|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110449157|NCT00611494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110449158|NCT00611494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110449159|NCT00611494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110449160|NCT02712502|Amoxicillin|amoxicillin|mesh-list
110449161|NCT02712502|Levofloxacin|levofloxacin|mesh-list
110449162|NCT02712502|Clavulanic Acid|clavulanic acid|mesh-list
110449163|NCT02712502|Clavulanic Acids|clavulanic acids|mesh-list
110449164|NCT02712502|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
110449165|NCT02712502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110449166|NCT02712502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110449167|NCT02712502|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110449168|NCT02712502|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110449169|NCT02712502|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110449170|NCT02712502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110449171|NCT02712502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110449172|NCT02712502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110449173|NCT02712502|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110472553|NCT04302116|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110449174|NCT02712502|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110449175|NCT02712502|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110449176|NCT02712346|Ambrisentan|ambrisentan|mesh-list
110449177|NCT02712346|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110449178|NCT04617028|Hydroxyurea|hydroxyurea|mesh-list
110449179|NCT04617028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110449180|NCT04617028|Antisickling Agents|antisickling agents|mesh-ancestor
110449181|NCT04617028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110449182|NCT04617028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110655636|NCT04008966|Hormone Antagonists|hormone antagonists|mesh-ancestor
110449183|NCT04617028|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110096223|NCT01718912|Metronidazole|metronidazole|mesh-list
110449184|NCT02711410|Clopidogrel|clopidogrel|mesh-list
110449185|NCT02711410|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110449186|NCT02711410|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110449187|NCT02711410|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110449188|NCT02711410|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110449189|NCT02711410|Purinergic Agents|purinergic agents|mesh-ancestor
110449190|NCT02711410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110449191|NCT02711410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110472836|NCT00839956|Bortezomib|bortezomib|mesh-list
110449192|NCT02711410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110449193|NCT02711176|Amoxicillin|amoxicillin|mesh-list
110449194|NCT02711176|Clarithromycin|clarithromycin|mesh-list
110449196|NCT02711176|Esomeprazole|esomeprazole|mesh-list
110449197|NCT02711176|Lansoprazole|lansoprazole|mesh-list
110449198|NCT02711176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110449199|NCT02711176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110449200|NCT02711176|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110449201|NCT02711176|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110449202|NCT02711176|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110449203|NCT02711176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110449204|NCT02711176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110449205|NCT02711176|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110449206|NCT02711176|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110449207|NCT02711176|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110449208|NCT02711176|Alkylating Agents|alkylating agents|mesh-ancestor
110449209|NCT02711176|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
110449210|NCT02711176|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110449211|NCT02711176|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110449212|NCT00611650|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
110449213|NCT00611650|Antioxidants|antioxidants|mesh-ancestor
110449214|NCT00611650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110449215|NCT00611650|Protective Agents|protective agents|mesh-ancestor
110449216|NCT00611650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110449217|NCT00611650|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
110449218|NCT00611650|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110449219|NCT00611650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110449220|NCT00611650|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110449221|NCT02710552|Amlodipine|amlodipine|mesh-list
110449222|NCT02710552|Antihypertensive Agents|antihypertensive agents|mesh-list
110449223|NCT02710552|Perindopril|perindopril|mesh-list
110449224|NCT02710552|Indapamide|indapamide|mesh-list
110449225|NCT02710552|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110449226|NCT02710552|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110449227|NCT02710552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110449228|NCT02710552|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110449229|NCT02710552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110449230|NCT02710552|Vasodilator Agents|vasodilator agents|mesh-ancestor
110449231|NCT02710552|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110449232|NCT02710552|Protease Inhibitors|protease inhibitors|mesh-ancestor
110449233|NCT02710552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110449234|NCT02710552|Diuretics|diuretics|mesh-ancestor
110449235|NCT02710552|Natriuretic Agents|natriuretic agents|mesh-ancestor
110449236|NCT02710552|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110449237|NCT02710396|Paclitaxel|paclitaxel|mesh-list
110449238|NCT02710396|Carboplatin|carboplatin|mesh-list
110449239|NCT02710396|Pembrolizumab|pembrolizumab|mesh-list
110449240|NCT02710396|Pemetrexed|pemetrexed|mesh-list
110449241|NCT02710396|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110449242|NCT02710396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110449243|NCT02710396|Tubulin Modulators|tubulin modulators|mesh-ancestor
110449244|NCT02710396|Antimitotic Agents|antimitotic agents|mesh-ancestor
110449245|NCT02710396|Mitosis Modulators|mitosis modulators|mesh-ancestor
110449246|NCT02710396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110449247|NCT02710396|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110449248|NCT02710396|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110449249|NCT02710396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110449250|NCT02710396|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110449251|NCT02710396|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110449252|NCT02710162|Capsaicin|capsaicin|mesh-list
110449253|NCT02710162|Antipruritics|antipruritics|mesh-ancestor
110449254|NCT02710162|Dermatologic Agents|dermatologic agents|mesh-ancestor
110473382|NCT05341401|Autonomic Agents|autonomic agents|mesh-ancestor
110449255|NCT02710162|Sensory System Agents|sensory system agents|mesh-ancestor
110449256|NCT02710162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110449257|NCT02710162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110449258|NCT00611728|Irinotecan|irinotecan|mesh-list
110449259|NCT00611728|Sunitinib|sunitinib|mesh-list
110449260|NCT00611728|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110449261|NCT00611728|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110449262|NCT00611728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110449263|NCT00611728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110449264|NCT00611728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110449265|NCT00611728|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110449266|NCT00611728|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110449267|NCT00611728|Growth Substances|growth substances|mesh-ancestor
110449268|NCT00611728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110449269|NCT00611728|Growth Inhibitors|growth inhibitors|mesh-ancestor
110449270|NCT00611728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110473590|NCT00751218|Histamine Agents|histamine agents|mesh-ancestor
110449272|NCT02709304|Anesthetics, Local|anesthetics, local|mesh-ancestor
110449274|NCT02709304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110449275|NCT02709304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110449276|NCT02709304|Sensory System Agents|sensory system agents|mesh-ancestor
110449277|NCT02709304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110449278|NCT02709304|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110449279|NCT02709304|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110449280|NCT02709304|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110449281|NCT02709304|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110449282|NCT02709304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110449283|NCT04189666|Melatonin|melatonin|mesh-list
110449284|NCT04189666|Rivastigmine|rivastigmine|mesh-list
110449285|NCT04189666|Antioxidants|antioxidants|mesh-ancestor
110473724|NCT00212784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110449286|NCT04189666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110449287|NCT04189666|Protective Agents|protective agents|mesh-ancestor
110449288|NCT04189666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110449289|NCT04189666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110449290|NCT04189666|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110449291|NCT04189666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110449292|NCT04189666|Cholinergic Agents|cholinergic agents|mesh-ancestor
110449293|NCT04189666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110449294|NCT04189666|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110449295|NCT00937521|Antipyretics|antipyretics|mesh-list
110449296|NCT00937521|Vaccines|vaccines|mesh-list
110449297|NCT00937521|Immunologic Factors|immunologic factors|mesh-ancestor
110449298|NCT00937521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110449299|NCT02709382|Tazobactam|tazobactam|mesh-list
110449300|NCT02709382|Cefepime|cefepime|mesh-list
110449301|NCT02709382|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110449302|NCT02709382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110449303|NCT02709382|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110449304|NCT02709382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110449305|NCT02709382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110449306|NCT02708992|Azithromycin|azithromycin|mesh-list
110449307|NCT02708992|Cefixime|cefixime|mesh-list
110449308|NCT02708992|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110449309|NCT02708992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110449310|NCT00611962|Paclitaxel|paclitaxel|mesh-list
110449311|NCT00611962|Oxaliplatin|oxaliplatin|mesh-list
110449312|NCT00611962|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110449313|NCT00611962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110449314|NCT00611962|Tubulin Modulators|tubulin modulators|mesh-ancestor
110449315|NCT00611962|Antimitotic Agents|antimitotic agents|mesh-ancestor
110449316|NCT00611962|Mitosis Modulators|mitosis modulators|mesh-ancestor
110449317|NCT00611962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110449318|NCT05380713|Cyclophosphamide|cyclophosphamide|mesh-list
110449319|NCT05380713|Durvalumab|durvalumab|mesh-list
110449320|NCT05380713|Tremelimumab|tremelimumab|mesh-list
110449321|NCT05380713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110449322|NCT05380713|Immunologic Factors|immunologic factors|mesh-ancestor
110449323|NCT05380713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110449324|NCT05380713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110449325|NCT05380713|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110449326|NCT05380713|Alkylating Agents|alkylating agents|mesh-ancestor
110449327|NCT05380713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110449328|NCT05380713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110449329|NCT05380713|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110449330|NCT05380713|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110449331|NCT00606099|Adefovir|adefovir|mesh-list
110449332|NCT00606099|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
110449333|NCT00606099|Telbivudine|telbivudine|mesh-list
110449334|NCT00606099|Antiviral Agents|antiviral agents|mesh-ancestor
110449335|NCT00606099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110449336|NCT00606099|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110449337|NCT00606099|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110449338|NCT00606099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110449339|NCT00606099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110449340|NCT00935883|Eculizumab|eculizumab|mesh-list
110449341|NCT00935883|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
110449342|NCT00935883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110449343|NCT00935883|Immunologic Factors|immunologic factors|mesh-ancestor
110449344|NCT00935883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110449345|NCT02708446|Misoprostol|misoprostol|mesh-list
110449346|NCT02708446|Mifepristone|mifepristone|mesh-list
110294492|NCT00176488|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110449347|NCT02708446|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110449348|NCT02708446|Abortifacient Agents|abortifacient agents|mesh-ancestor
110449349|NCT02708446|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110449350|NCT02708446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110449351|NCT02708446|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110449352|NCT02708446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110449354|NCT02708446|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
110449355|NCT02708446|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110449356|NCT02708446|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110449357|NCT02708446|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110449358|NCT02708446|Contraceptive Agents|contraceptive agents|mesh-ancestor
110449359|NCT02708446|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
110449360|NCT02708446|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
110449361|NCT02708446|Hormone Antagonists|hormone antagonists|mesh-ancestor
110449362|NCT02708446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110449363|NCT02708446|Luteolytic Agents|luteolytic agents|mesh-ancestor
110449364|NCT02708446|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110449365|NCT02708446|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
110449366|NCT05378919|Folic Acid|folic acid|mesh-list
110449367|NCT05378919|Leucovorin|leucovorin|mesh-list
110449368|NCT05378919|Fluorouracil|fluorouracil|mesh-list
110449369|NCT05378919|Oxaliplatin|oxaliplatin|mesh-list
110449370|NCT05378919|Levoleucovorin|levoleucovorin|mesh-list
110449371|NCT05378919|Antimetabolites|antimetabolites|mesh-ancestor
110473941|NCT01316250|Imatinib Mesylate|imatinib mesylate|mesh-list
110449372|NCT05378919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110449373|NCT05378919|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110449374|NCT05378919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110449375|NCT05378919|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110449376|NCT05378919|Immunologic Factors|immunologic factors|mesh-ancestor
110449377|NCT05378919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110449378|NCT05378919|Hematinics|hematinics|mesh-ancestor
110449379|NCT05378919|Vitamin B Complex|vitamin b complex|mesh-ancestor
110449380|NCT05378919|Vitamins|vitamins|mesh-ancestor
110449381|NCT05378919|Micronutrients|micronutrients|mesh-ancestor
110449382|NCT05378919|Antidotes|antidotes|mesh-ancestor
110449383|NCT05378919|Protective Agents|protective agents|mesh-ancestor
110449384|NCT00607581|Dexamethasone|dexamethasone|mesh-list
110449385|NCT00607581|Cyclophosphamide|cyclophosphamide|mesh-list
110449386|NCT00607581|Lenalidomide|lenalidomide|mesh-list
110449387|NCT00607581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110449388|NCT00607581|Immunologic Factors|immunologic factors|mesh-ancestor
110449389|NCT00607581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110449390|NCT00607581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110449391|NCT00607581|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110449392|NCT00607581|Alkylating Agents|alkylating agents|mesh-ancestor
110449393|NCT00607581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110449394|NCT00607581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110449395|NCT00607581|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110449396|NCT00607581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110449397|NCT00607581|Antiemetics|antiemetics|mesh-ancestor
110449398|NCT00607581|Autonomic Agents|autonomic agents|mesh-ancestor
110449399|NCT00607581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110449400|NCT00607581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110449402|NCT00607581|Hormones|hormones|mesh-ancestor
110449403|NCT00607581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110449404|NCT00607581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110449405|NCT00607581|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110474288|NCT02767479|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110449406|NCT00607581|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110449407|NCT00607581|Growth Substances|growth substances|mesh-ancestor
110449408|NCT00607581|Growth Inhibitors|growth inhibitors|mesh-ancestor
110449409|NCT02707900|Vorinostat|vorinostat|mesh-list
110449410|NCT02707900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110449412|NCT02707900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110449413|NCT02707900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110449414|NCT05380479|Megestrol|megestrol|mesh-list
110449415|NCT05380479|Megestrol Acetate|megestrol acetate|mesh-list
110449416|NCT05380479|Mirtazapine|mirtazapine|mesh-list
110449417|NCT05380479|Antidepressive Agents|antidepressive agents|mesh-ancestor
110449418|NCT05380479|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110449419|NCT05380479|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110449420|NCT05380479|Histamine Antagonists|histamine antagonists|mesh-ancestor
110449421|NCT05380479|Histamine Agents|histamine agents|mesh-ancestor
110449422|NCT05380479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110449423|NCT05380479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110449424|NCT05380479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110449425|NCT05380479|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110449426|NCT05380479|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110372146|NCT00568347|Xhance|xhance|mesh-list
110449427|NCT05380479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110449428|NCT05380479|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
110449429|NCT05380479|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110449430|NCT05380479|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110449431|NCT05380479|Adrenergic Agents|adrenergic agents|mesh-ancestor
110449432|NCT05380479|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110474596|NCT02760459|Hormones|hormones|mesh-ancestor
110449433|NCT05380479|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110449434|NCT05380479|Serotonin Agents|serotonin agents|mesh-ancestor
110449435|NCT05380479|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110449436|NCT05380479|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110449437|NCT05380479|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110449438|NCT05380479|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110449439|NCT05380479|Contraceptive Agents|contraceptive agents|mesh-ancestor
110449440|NCT05380479|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110449441|NCT05380479|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110449442|NCT05380479|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110449443|NCT05380479|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110449444|NCT05380479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110449445|NCT05380479|Appetite Stimulants|appetite stimulants|mesh-ancestor
110449446|NCT05380479|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110449447|NCT00936975|Listerine|listerine|mesh-list
110449448|NCT00936975|Fluorides|fluorides|mesh-list
110449449|NCT00936975|Sodium Fluoride|sodium fluoride|mesh-list
110449450|NCT00936975|Cariostatic Agents|cariostatic agents|mesh-ancestor
110449451|NCT00936975|Protective Agents|protective agents|mesh-ancestor
110449452|NCT00936975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110449453|NCT00936975|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110449454|NCT00936975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110449455|NCT02707120|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110449456|NCT02707120|Lubricant Eye Drops|lubricant eye drops|mesh-list
110449457|NCT02707120|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110449458|NCT02693470|Ustekinumab|ustekinumab|mesh-list
110449459|NCT02693470|Dermatologic Agents|dermatologic agents|mesh-ancestor
110449460|NCT00936897|Denosumab|denosumab|mesh-list
110449461|NCT00936897|Ibandronic Acid|ibandronic acid|mesh-list
110449462|NCT00936897|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110449463|NCT00936897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110449464|NCT05265676|Enoxaparin|enoxaparin|mesh-list
110449465|NCT05265676|Enoxaparin sodium|enoxaparin sodium|mesh-list
110449466|NCT05265676|Anticoagulants|anticoagulants|mesh-ancestor
110449467|NCT05265676|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110449468|NCT05265676|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110449469|NCT05265676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110449470|NCT00606333|Sirolimus|sirolimus|mesh-list
110449471|NCT00606333|Paclitaxel|paclitaxel|mesh-list
110449472|NCT00606333|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110449473|NCT00606333|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110449474|NCT00606333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110449475|NCT00606333|Tubulin Modulators|tubulin modulators|mesh-ancestor
110449476|NCT00606333|Antimitotic Agents|antimitotic agents|mesh-ancestor
110449477|NCT00606333|Mitosis Modulators|mitosis modulators|mesh-ancestor
110449478|NCT00606333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110449479|NCT00606333|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110449480|NCT00606333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110449481|NCT00606333|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110449482|NCT00606333|Antifungal Agents|antifungal agents|mesh-ancestor
110449483|NCT00606333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110449484|NCT00606333|Immunologic Factors|immunologic factors|mesh-ancestor
110449485|NCT00606333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110449487|NCT05265442|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110449488|NCT05265442|Narcotics|narcotics|mesh-ancestor
110449489|NCT05265442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110449490|NCT05265442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110449491|NCT05265442|Analgesics|analgesics|mesh-ancestor
110449492|NCT05265442|Sensory System Agents|sensory system agents|mesh-ancestor
110449493|NCT05265442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110449494|NCT05265442|Antitussive Agents|antitussive agents|mesh-ancestor
110449495|NCT05265442|Respiratory System Agents|respiratory system agents|mesh-ancestor
110449497|NCT00606411|Anticonvulsants|anticonvulsants|mesh-ancestor
110449498|NCT00606411|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110449499|NCT00606411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110449500|NCT00607737|Insulin Detemir|insulin detemir|mesh-list
110449501|NCT00607737|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110449502|NCT00607737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110449503|NCT01120691|Glycopyrrolate|glycopyrrolate|mesh-list
110449505|NCT01120691|Tiotropium Bromide|tiotropium bromide|mesh-list
110449506|NCT01120691|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110449507|NCT01120691|Autonomic Agents|autonomic agents|mesh-ancestor
110449508|NCT01120691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110449509|NCT01120691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110449510|NCT01120691|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110449511|NCT01120691|Respiratory System Agents|respiratory system agents|mesh-ancestor
110449512|NCT01120691|Parasympatholytics|parasympatholytics|mesh-ancestor
110449513|NCT01120691|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110449514|NCT01120691|Cholinergic Agents|cholinergic agents|mesh-ancestor
110449515|NCT01120691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110449516|NCT01120691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110449517|NCT01120691|Tocolytic Agents|tocolytic agents|mesh-ancestor
110449518|NCT01120691|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110449519|NCT01120691|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110449520|NCT01120691|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110449521|NCT01120691|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110449522|NCT01120691|Adrenergic Agents|adrenergic agents|mesh-ancestor
110449523|NCT01120691|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110449524|NCT01120691|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110449525|NCT00612274|Sirolimus|sirolimus|mesh-list
110449526|NCT00612274|Methotrexate|methotrexate|mesh-list
110449527|NCT00612274|Tacrolimus|tacrolimus|mesh-list
110449528|NCT00612274|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110449529|NCT00612274|Abortifacient Agents|abortifacient agents|mesh-ancestor
110449530|NCT00612274|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110449531|NCT00612274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110449532|NCT00612274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110449533|NCT00612274|Antimetabolites|antimetabolites|mesh-ancestor
110449534|NCT00612274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110449535|NCT00612274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110449536|NCT00612274|Dermatologic Agents|dermatologic agents|mesh-ancestor
110449537|NCT00612274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110449538|NCT00612274|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110449539|NCT00612274|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110449540|NCT00612274|Immunologic Factors|immunologic factors|mesh-ancestor
110449541|NCT00612274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110449542|NCT00612274|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110449543|NCT00612274|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110449544|NCT00612274|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110449545|NCT00612274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110449546|NCT00612274|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110449547|NCT00612274|Antifungal Agents|antifungal agents|mesh-ancestor
110449548|NCT05263882|Gemcitabine|gemcitabine|mesh-list
110449549|NCT05263882|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110449550|NCT05263882|Antimetabolites|antimetabolites|mesh-ancestor
110449551|NCT05263882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110449552|NCT05263882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110449553|NCT02724904|Methotrexate|methotrexate|mesh-list
110449554|NCT02724904|Fludarabine|fludarabine|mesh-list
110449555|NCT02724904|Thiotepa|thiotepa|mesh-list
110449556|NCT02724904|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110449557|NCT02724904|Abortifacient Agents|abortifacient agents|mesh-ancestor
110449558|NCT02724904|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110449559|NCT02724904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110449560|NCT02724904|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110449561|NCT02724904|Antimetabolites|antimetabolites|mesh-ancestor
110449562|NCT02724904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110449563|NCT02724904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110449564|NCT02724904|Dermatologic Agents|dermatologic agents|mesh-ancestor
110449565|NCT02724904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110449566|NCT02724904|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110449567|NCT02724904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110449568|NCT02724904|Immunologic Factors|immunologic factors|mesh-ancestor
110449569|NCT02724904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110449570|NCT02724904|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110449571|NCT02724904|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110449572|NCT02724904|Alkylating Agents|alkylating agents|mesh-ancestor
110449573|NCT02724904|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110449575|NCT00935493|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110449576|NCT00935493|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110449577|NCT00935493|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110449579|NCT00935493|Adrenergic Agents|adrenergic agents|mesh-ancestor
110449580|NCT00935493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110449581|NCT00935493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110449582|NCT00935493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110449583|NCT05380245|Clarithromycin|clarithromycin|mesh-list
110449584|NCT05380245|Voriconazole|voriconazole|mesh-list
110449585|NCT05380245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110449586|NCT05380245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110449587|NCT05380245|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110449588|NCT05380245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110475307|NCT02741427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110449589|NCT05380245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110449590|NCT05380245|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110449591|NCT05380245|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110449592|NCT05380245|Antifungal Agents|antifungal agents|mesh-ancestor
110449593|NCT05380245|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110449594|NCT05380245|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110449595|NCT05380245|Hormone Antagonists|hormone antagonists|mesh-ancestor
110449596|NCT05380245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110449597|NCT05380245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110449598|NCT00935259|Simvastatin|simvastatin|mesh-list
110449599|NCT00935259|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110449600|NCT00935259|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110449601|NCT00935259|Antimetabolites|antimetabolites|mesh-ancestor
110449602|NCT00935259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110449603|NCT00935259|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110449604|NCT00935259|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110449605|NCT00935259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110449606|NCT02937766|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
110449607|NCT02937766|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
110449608|NCT02937766|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110449609|NCT02937766|Hormone Antagonists|hormone antagonists|mesh-ancestor
110449610|NCT02937766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110449611|NCT02937766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110449612|NCT02937766|Progestins|progestins|mesh-ancestor
110449613|NCT02937766|Hormones|hormones|mesh-ancestor
110449614|NCT00607971|Renzapride|renzapride|mesh-list
110449615|NCT00607971|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110449616|NCT00607971|Serotonin Agents|serotonin agents|mesh-ancestor
110449617|NCT00607971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110449618|NCT00607971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110449619|NCT00607971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110475591|NCT02736123|Ipilimumab|ipilimumab|mesh-list
110449620|NCT02724358|Chlorotrianisene|chlorotrianisene|mesh-list
110449621|NCT02724358|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
110449622|NCT02724358|Estrogens|estrogens|mesh-ancestor
110449623|NCT02724358|Hormones|hormones|mesh-ancestor
110449624|NCT02724358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110449625|NCT02724358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110475715|NCT00734617|Nicotine|nicotine|mesh-list
110449626|NCT02724358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110449627|NCT02724358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110449629|NCT02724202|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110449630|NCT02724202|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110449631|NCT02724202|Analgesics|analgesics|mesh-ancestor
110449632|NCT02724202|Sensory System Agents|sensory system agents|mesh-ancestor
110449633|NCT02724202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110449634|NCT02724202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110449635|NCT02724202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110449636|NCT02724202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110449637|NCT02724202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110475782|NCT02737059|Narcotics|narcotics|mesh-ancestor
110449638|NCT02724202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110449639|NCT02724202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110449641|NCT00605397|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110449642|NCT00605397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110449643|NCT00625547|Levodopa|levodopa|mesh-list
110449644|NCT00625547|Cabergoline|cabergoline|mesh-list
110449645|NCT00625547|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110449646|NCT00625547|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110449647|NCT00625547|Dopamine Agents|dopamine agents|mesh-ancestor
110449648|NCT00625547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110560319|NCT02684123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110449649|NCT00625547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110449650|NCT00625547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110449652|NCT05241340|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
110449653|NCT05241340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110449654|NCT05241340|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110449655|NCT05241340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110449656|NCT02724046|Ciprofloxacin|ciprofloxacin|mesh-list
110449657|NCT02724046|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110449658|NCT02724046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110476047|NCT00636519|Antitoxins|antitoxins|mesh-list
110449659|NCT02724046|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110449660|NCT02724046|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110449661|NCT02724046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110449662|NCT02724046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110449663|NCT02724046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110449664|NCT02724046|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110449665|NCT02724046|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110449666|NCT01124045|Prednisolone|prednisolone|mesh-list
110449667|NCT01124045|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110449668|NCT01124045|Methylprednisolone|methylprednisolone|mesh-list
110449669|NCT01124045|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110449670|NCT01124045|Prednisolone acetate|prednisolone acetate|mesh-list
110449671|NCT01124045|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110449672|NCT01124045|Prednisolone phosphate|prednisolone phosphate|mesh-list
110449673|NCT01124045|Difluprednate|difluprednate|mesh-list
110449674|NCT01124045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110449675|NCT01124045|Glucocorticoids|glucocorticoids|mesh-ancestor
110449676|NCT01124045|Hormones|hormones|mesh-ancestor
110476332|NCT02727621|Anesthetics|anesthetics|mesh-ancestor
110449677|NCT01124045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110449678|NCT01124045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110449679|NCT01124045|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110449680|NCT01124045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110449681|NCT01124045|Antiemetics|antiemetics|mesh-ancestor
110449682|NCT01124045|Autonomic Agents|autonomic agents|mesh-ancestor
110449683|NCT01124045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110449684|NCT01124045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110449685|NCT01124045|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110449686|NCT01124045|Protective Agents|protective agents|mesh-ancestor
110449687|NCT01123889|Lidocaine|lidocaine|mesh-list
110449688|NCT01123889|Ropivacaine|ropivacaine|mesh-list
110449689|NCT01123889|Anesthetics, Local|anesthetics, local|mesh-ancestor
110449691|NCT01123889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110449692|NCT01123889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110449693|NCT01123889|Sensory System Agents|sensory system agents|mesh-ancestor
110449694|NCT01123889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110449695|NCT01123889|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110449696|NCT01123889|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110449697|NCT01123889|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110449698|NCT01123889|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110449699|NCT01123889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110449700|NCT02723968|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110449702|NCT00606957|Cholecalciferol|cholecalciferol|mesh-list
110449703|NCT00606957|Vitamins|vitamins|mesh-ancestor
110449704|NCT00606957|Micronutrients|micronutrients|mesh-ancestor
110449705|NCT00606957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110449706|NCT00606957|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110449707|NCT00606957|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110449708|NCT00934947|Propranolol|propranolol|mesh-list
110449709|NCT00934947|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110449710|NCT00934947|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110449711|NCT00934947|Adrenergic Agents|adrenergic agents|mesh-ancestor
110449712|NCT00934947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110123927|NCT01936090|Bortezomib|bortezomib|mesh-list
110449713|NCT00934947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110449714|NCT00934947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110449715|NCT00934947|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110449716|NCT00934947|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110449717|NCT00934947|Vasodilator Agents|vasodilator agents|mesh-ancestor
110449718|NCT02723578|Pemetrexed|pemetrexed|mesh-list
110449719|NCT02723578|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110449720|NCT02723578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110449721|NCT02723578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110449722|NCT02723578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110449723|NCT02723578|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110449724|NCT02723578|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110449725|NCT02723578|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110449726|NCT04189198|Bupivacaine|bupivacaine|mesh-list
110449727|NCT04189198|Carticaine|carticaine|mesh-list
110449728|NCT04189198|Anesthetics, Local|anesthetics, local|mesh-ancestor
110449729|NCT04189198|Anesthetics|anesthetics|mesh-ancestor
110449730|NCT04189198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110449731|NCT04189198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110449733|NCT04189198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110449734|NCT00608361|Dasatinib|dasatinib|mesh-list
110449735|NCT00608361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110449736|NCT00608361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110449737|NCT00608361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110477014|NCT02713191|Fentanyl|fentanyl|mesh-list
110449738|NCT00608361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110449740|NCT00934791|Sirolimus|sirolimus|mesh-list
110449743|NCT00934791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110449744|NCT00934791|Glucocorticoids|glucocorticoids|mesh-ancestor
110449745|NCT00934791|Hormones|hormones|mesh-ancestor
110449746|NCT00934791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110449747|NCT00934791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110449748|NCT00934791|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110477258|NCT02776527|Apatinib|apatinib|mesh-list
110449749|NCT00934791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110449750|NCT00934791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110449751|NCT00934791|Immunologic Factors|immunologic factors|mesh-ancestor
110449752|NCT00934791|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110449753|NCT00934791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110449754|NCT00934791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110449755|NCT00934791|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110449756|NCT00934791|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110449757|NCT00934791|Antitubercular Agents|antitubercular agents|mesh-ancestor
110449758|NCT00934791|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110449759|NCT00934791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110449760|NCT00934791|Antifungal Agents|antifungal agents|mesh-ancestor
110449761|NCT00607035|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110449763|NCT00607035|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
110449764|NCT00607035|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110449765|NCT00607035|Diuretics|diuretics|mesh-ancestor
110449766|NCT00607035|Natriuretic Agents|natriuretic agents|mesh-ancestor
110449767|NCT00607035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110449768|NCT00607035|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110449769|NCT00607035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110449770|NCT00607035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110449771|NCT00607035|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110449772|NCT00607035|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110449773|NCT02723266|Tin Fluorides|tin fluorides|mesh-list
110449774|NCT02723266|Cariostatic Agents|cariostatic agents|mesh-ancestor
110449775|NCT02723266|Protective Agents|protective agents|mesh-ancestor
110449776|NCT02723266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110449778|NCT02722954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110449779|NCT02722954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110449780|NCT02722954|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110449781|NCT02722954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110449782|NCT00625859|Bupropion|bupropion|mesh-list
110449783|NCT00625859|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110449784|NCT00625859|Antidepressive Agents|antidepressive agents|mesh-ancestor
110449785|NCT00625859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110449786|NCT00625859|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110449787|NCT00625859|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110449788|NCT00625859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110449789|NCT00625859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110449790|NCT00625859|Dopamine Agents|dopamine agents|mesh-ancestor
110449791|NCT00625859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110449792|NCT00625859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110449793|NCT00625859|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110449794|NCT00625859|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110449795|NCT00625859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110449796|NCT02691195|Ropivacaine|ropivacaine|mesh-list
110449797|NCT02691195|Anesthetics, Local|anesthetics, local|mesh-list
110449798|NCT02691195|Anesthetics|anesthetics|mesh-list
110449799|NCT02691195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110124839|NCT01941758|Vaccines|vaccines|mesh-list
110449800|NCT02691195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110449801|NCT02691195|Sensory System Agents|sensory system agents|mesh-ancestor
110449802|NCT02691195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110449803|NCT03808090|Calcium|calcium|mesh-list
110449804|NCT03808090|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110449805|NCT03808090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110449806|NCT01111019|Hormones|hormones|mesh-list
110477774|NCT02605720|Artenimol|artenimol|mesh-list
110449807|NCT01111019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110449808|NCT01111019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110449809|NCT02883400|Spironolactone|spironolactone|mesh-list
110449810|NCT02883400|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110449811|NCT02883400|Hormone Antagonists|hormone antagonists|mesh-ancestor
110449812|NCT02883400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110449813|NCT02883400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110449814|NCT02883400|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110449815|NCT02883400|Diuretics|diuretics|mesh-ancestor
110449816|NCT02883400|Natriuretic Agents|natriuretic agents|mesh-ancestor
110449817|NCT01119287|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
110449818|NCT01119287|Dexamethasone|dexamethasone|mesh-list
110449819|NCT01119287|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110449820|NCT01119287|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110449821|NCT01119287|Antiemetics|antiemetics|mesh-ancestor
110449822|NCT01119287|Autonomic Agents|autonomic agents|mesh-ancestor
110449823|NCT01119287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110449824|NCT01119287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110449825|NCT01119287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110449826|NCT01119287|Glucocorticoids|glucocorticoids|mesh-ancestor
110449827|NCT01119287|Hormones|hormones|mesh-ancestor
110477979|NCT04114630|Analgesics|analgesics|mesh-ancestor
110449828|NCT01119287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110449829|NCT01119287|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110449830|NCT01119287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110449831|NCT01119287|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110449832|NCT01119287|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110449833|NCT01119287|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110449834|NCT01119287|Analgesics|analgesics|mesh-ancestor
110449835|NCT01119287|Sensory System Agents|sensory system agents|mesh-ancestor
110449836|NCT01119287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110449837|NCT01119287|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110449838|NCT01119287|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110449839|NCT01119287|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110449840|NCT01119287|Histamine Antagonists|histamine antagonists|mesh-ancestor
110449841|NCT01119287|Histamine Agents|histamine agents|mesh-ancestor
110449842|NCT01119287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110449843|NCT01119287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110449844|NCT01110707|Hormones|hormones|mesh-list
110449845|NCT01110707|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
110449846|NCT01110707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110449847|NCT01110707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110449848|NCT04931368|Rituximab|rituximab|mesh-list
110449849|NCT04931368|Methotrexate|methotrexate|mesh-list
110449850|NCT04931368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110449851|NCT04931368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110449852|NCT04931368|Immunologic Factors|immunologic factors|mesh-ancestor
110449853|NCT04931368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110449854|NCT04931368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110449855|NCT04931368|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110449856|NCT04931368|Abortifacient Agents|abortifacient agents|mesh-ancestor
110449857|NCT04931368|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110449858|NCT04931368|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110449859|NCT04931368|Antimetabolites|antimetabolites|mesh-ancestor
110449860|NCT04931368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110449861|NCT04931368|Dermatologic Agents|dermatologic agents|mesh-ancestor
110449862|NCT04931368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110449863|NCT04931368|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110449864|NCT04931368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110449865|NCT04931368|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110449866|NCT01119131|Vitamin D|vitamin d|mesh-list
110449867|NCT01119131|Cholecalciferol|cholecalciferol|mesh-list
110449868|NCT01119131|Calcium|calcium|mesh-list
110449870|NCT01119131|Micronutrients|micronutrients|mesh-ancestor
110449871|NCT01119131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110449872|NCT01119131|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110449873|NCT01119131|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110449874|NCT00636922|Everolimus|everolimus|mesh-list
110449875|NCT00636922|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110449876|NCT00636922|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110449877|NCT00636922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110449878|NCT00636922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110449879|NCT00636922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110449880|NCT00636922|Immunologic Factors|immunologic factors|mesh-ancestor
110449881|NCT00636922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110449882|NCT00636922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110449883|NCT02722096|Lidocaine|lidocaine|mesh-list
110449884|NCT02722096|Ropivacaine|ropivacaine|mesh-list
110449885|NCT02722096|Anesthetics|anesthetics|mesh-list
110449886|NCT02722096|Anesthetics, Local|anesthetics, local|mesh-ancestor
110449887|NCT02722096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110449888|NCT02722096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110449889|NCT02722096|Sensory System Agents|sensory system agents|mesh-ancestor
110449890|NCT02722096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110449891|NCT02722096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110449892|NCT02722096|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110449893|NCT02722096|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110449894|NCT02722096|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110449895|NCT02722096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110449896|NCT04862962|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110449897|NCT04862962|Ezetimibe|ezetimibe|mesh-list
110449898|NCT04862962|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110449899|NCT04862962|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110449900|NCT04862962|Antimetabolites|antimetabolites|mesh-ancestor
110449901|NCT04862962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110449902|NCT04862962|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110449903|NCT04862962|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110449904|NCT04862962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110449905|NCT01118975|Lapatinib|lapatinib|mesh-list
110449906|NCT01118975|Vorinostat|vorinostat|mesh-list
110449907|NCT01118975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110449908|NCT01118975|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110449909|NCT01118975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110449910|NCT01118975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110449911|NCT01118975|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110449912|NCT02721940|Zoledronic Acid|zoledronic acid|mesh-list
110449913|NCT02721940|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110449914|NCT02721940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110449916|NCT04829422|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110449917|NCT04829422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110449918|NCT04829422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110449919|NCT02721862|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
110449920|NCT02721862|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
110449921|NCT02721862|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110449922|NCT00612898|Lamivudine|lamivudine|mesh-list
110478683|NCT02871986|Estrogens|estrogens|mesh-list
110449923|NCT00612898|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110449924|NCT00612898|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110096974|NCT01732224|Telbivudine|telbivudine|mesh-list
110449926|NCT00612898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110449927|NCT00612898|Antiviral Agents|antiviral agents|mesh-ancestor
110449928|NCT00612898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110449929|NCT00612898|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110449930|NCT00612898|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110449931|NCT01118663|Acetylcysteine|acetylcysteine|mesh-list
110449932|NCT01118663|Edetic Acid|edetic acid|mesh-list
110478756|NCT00588640|Methadone|methadone|mesh-list
110449933|NCT01118663|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110449935|NCT01118663|Antiviral Agents|antiviral agents|mesh-ancestor
110449937|NCT01118663|Expectorants|expectorants|mesh-ancestor
110449938|NCT01118663|Respiratory System Agents|respiratory system agents|mesh-ancestor
110449939|NCT01118663|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110449940|NCT01118663|Antioxidants|antioxidants|mesh-ancestor
110449941|NCT01118663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110449942|NCT01118663|Protective Agents|protective agents|mesh-ancestor
110449943|NCT01118663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110449944|NCT01118663|Antidotes|antidotes|mesh-ancestor
110449945|NCT01118663|Anticoagulants|anticoagulants|mesh-ancestor
110449946|NCT01118663|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110449947|NCT01118663|Chelating Agents|chelating agents|mesh-ancestor
110449948|NCT01118663|Sequestering Agents|sequestering agents|mesh-ancestor
110449949|NCT01118663|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110449951|NCT01118351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110449952|NCT01118351|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110449953|NCT01118351|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110449954|NCT01118351|Growth Substances|growth substances|mesh-ancestor
110479249|NCT04108468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110449955|NCT01118351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110449956|NCT01118351|Growth Inhibitors|growth inhibitors|mesh-ancestor
110449957|NCT01118351|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110449958|NCT01118351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110449959|NCT01118351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110449960|NCT01110005|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110449961|NCT02693392|Metformin|metformin|mesh-list
110449962|NCT02693392|Hypoglycemic Agents|hypoglycemic agents|mesh-list
110449963|NCT02693392|Fenugreek seed meal|fenugreek seed meal|mesh-list
110449964|NCT02693392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110449965|NCT04175626|Sirolimus|sirolimus|mesh-list
110449966|NCT04175626|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110449967|NCT04175626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110479401|NCT02588287|Tenofovir|tenofovir|mesh-list
110449968|NCT04175626|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110449969|NCT04175626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110449970|NCT04175626|Antifungal Agents|antifungal agents|mesh-ancestor
110449971|NCT04175626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110449972|NCT04175626|Immunologic Factors|immunologic factors|mesh-ancestor
110449973|NCT04175626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110449974|NCT00613054|Imatinib Mesylate|imatinib mesylate|mesh-list
110449975|NCT00613054|Hydroxyurea|hydroxyurea|mesh-list
110449976|NCT00613054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110449977|NCT00613054|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110449978|NCT00613054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110449979|NCT00613054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110449980|NCT00613054|Antisickling Agents|antisickling agents|mesh-ancestor
110449981|NCT00613054|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110449982|NCT00613132|Everolimus|everolimus|mesh-list
110449983|NCT00613132|Imatinib Mesylate|imatinib mesylate|mesh-list
110449984|NCT00613132|Hydroxyurea|hydroxyurea|mesh-list
110449985|NCT00613132|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110449986|NCT00613132|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110449987|NCT00613132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110449988|NCT00613132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110449989|NCT00613132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110449990|NCT00613132|Immunologic Factors|immunologic factors|mesh-ancestor
110449991|NCT00613132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110449992|NCT00613132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110449993|NCT00613132|Antisickling Agents|antisickling agents|mesh-ancestor
110449994|NCT00613132|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110449995|NCT04558216|Rifampin|rifampin|mesh-list
110449996|NCT04558216|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110449997|NCT04558216|Antitubercular Agents|antitubercular agents|mesh-ancestor
110449998|NCT04558216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110449999|NCT04558216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110450000|NCT04558216|Leprostatic Agents|leprostatic agents|mesh-ancestor
110450001|NCT04558216|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110450002|NCT04558216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110450003|NCT04558216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110450004|NCT04558216|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110450005|NCT04558216|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110450006|NCT04558216|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110450007|NCT04558216|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110450008|NCT04558216|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110450009|NCT04558216|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110450010|NCT04120870|Ketamine|ketamine|mesh-list
110450011|NCT04120870|Etomidate|etomidate|mesh-list
110450012|NCT04120870|Analgesics|analgesics|mesh-ancestor
110450013|NCT04120870|Sensory System Agents|sensory system agents|mesh-ancestor
110450014|NCT04120870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110450015|NCT04120870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110450016|NCT04120870|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110450017|NCT04120870|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110450018|NCT04120870|Anesthetics, General|anesthetics, general|mesh-ancestor
110450019|NCT04120870|Anesthetics|anesthetics|mesh-ancestor
110450020|NCT04120870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110450021|NCT04120870|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110450022|NCT04120870|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110450023|NCT04120870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110450024|NCT04120870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110450025|NCT04120870|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110450026|NCT03747562|Gabapentin|gabapentin|mesh-list
110450027|NCT03747562|Analgesics|analgesics|mesh-ancestor
110450028|NCT03747562|Sensory System Agents|sensory system agents|mesh-ancestor
110450029|NCT03747562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110450030|NCT03747562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110450031|NCT03747562|Anticonvulsants|anticonvulsants|mesh-ancestor
110450032|NCT03747562|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110450033|NCT03747562|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110450034|NCT03747562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110450035|NCT03747562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110450036|NCT03747562|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110450037|NCT03747562|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110450038|NCT03747562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110450039|NCT03747562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110450040|NCT03747562|Antimanic Agents|antimanic agents|mesh-ancestor
110450041|NCT01109849|Methylphenidate|methylphenidate|mesh-list
110450042|NCT01109849|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
110450043|NCT01109849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110450044|NCT01109849|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110450045|NCT01109849|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110450046|NCT01109849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110478552|NCT01018862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110450047|NCT01109849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110450048|NCT01109849|Dopamine Agents|dopamine agents|mesh-ancestor
110450049|NCT01109849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110450050|NCT01061736|Folic Acid|folic acid|mesh-list
110450051|NCT01061736|Methotrexate|methotrexate|mesh-list
110479679|NCT02702739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110450052|NCT01061736|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110450053|NCT01061736|Abortifacient Agents|abortifacient agents|mesh-ancestor
110450054|NCT01061736|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110450055|NCT01061736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110479788|NCT00915382|Cisplatin|cisplatin|mesh-list
110450056|NCT01061736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110450057|NCT01061736|Antimetabolites|antimetabolites|mesh-ancestor
110295235|NCT00266643|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110450058|NCT01061736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110450059|NCT01061736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110450060|NCT01061736|Dermatologic Agents|dermatologic agents|mesh-ancestor
110450061|NCT01061736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110450062|NCT01061736|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110450063|NCT01061736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110450064|NCT01061736|Immunologic Factors|immunologic factors|mesh-ancestor
110479825|NCT04766437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110450065|NCT01061736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110450066|NCT01061736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110450067|NCT01061736|Hematinics|hematinics|mesh-ancestor
110479897|NCT02960763|Serotonin Agents|serotonin agents|mesh-ancestor
110450068|NCT01061736|Vitamin B Complex|vitamin b complex|mesh-ancestor
110450069|NCT01061736|Vitamins|vitamins|mesh-ancestor
110450070|NCT01061736|Micronutrients|micronutrients|mesh-ancestor
110450071|NCT02874378|Dexmedetomidine|dexmedetomidine|mesh-list
110479986|NCT00775450|Vaccines|vaccines|mesh-list
110450072|NCT02874378|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110450073|NCT02874378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110450074|NCT02874378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110450075|NCT02874378|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110450076|NCT02874378|Analgesics|analgesics|mesh-ancestor
110480032|NCT03236805|Ketamine|ketamine|mesh-list
110450077|NCT02874378|Sensory System Agents|sensory system agents|mesh-ancestor
110450078|NCT02874378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110450079|NCT02874378|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110450080|NCT02874378|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110450081|NCT02874378|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110450082|NCT02874378|Adrenergic Agents|adrenergic agents|mesh-ancestor
110450083|NCT02874378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110450084|NCT02874378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110450085|NCT01117181|Methylphenidate|methylphenidate|mesh-list
110450086|NCT01117181|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110450087|NCT01117181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110450088|NCT01117181|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110450089|NCT01117181|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110250346|NCT00130676|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
110450090|NCT01117181|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110450091|NCT01117181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110450092|NCT01117181|Dopamine Agents|dopamine agents|mesh-ancestor
110480172|NCT00783796|Immunologic Factors|immunologic factors|mesh-ancestor
110450093|NCT01117181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110450095|NCT02881619|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110450096|NCT02881619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110450097|NCT02881619|Analgesics|analgesics|mesh-ancestor
110450098|NCT02881619|Sensory System Agents|sensory system agents|mesh-ancestor
110450099|NCT02881619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110450100|NCT02881619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110450101|NCT02881619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110450102|NCT02881619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110450103|NCT02881619|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110450104|NCT02881619|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110450105|NCT02881619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110450106|NCT02881619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110450107|NCT04303806|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110450108|NCT04303806|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110450110|NCT04303806|Antimetabolites|antimetabolites|mesh-ancestor
110450111|NCT04303806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110450112|NCT04303806|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110480533|NCT04426669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110450113|NCT04303806|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110450114|NCT04303806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110450115|NCT02882087|Methotrexate|methotrexate|mesh-list
110450116|NCT02882087|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110450117|NCT02882087|Abortifacient Agents|abortifacient agents|mesh-ancestor
110450118|NCT02882087|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110480604|NCT02583217|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110450119|NCT02882087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110450120|NCT02882087|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110450122|NCT02882087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110450123|NCT02882087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110450124|NCT02882087|Dermatologic Agents|dermatologic agents|mesh-ancestor
110450125|NCT02882087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110450126|NCT02882087|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110450127|NCT02882087|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110450128|NCT02882087|Immunologic Factors|immunologic factors|mesh-ancestor
110450129|NCT02882087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110450130|NCT02882087|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110450131|NCT04303884|Pembrolizumab|pembrolizumab|mesh-list
110450132|NCT04303884|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110450133|NCT04303884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110450134|NCT04303884|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110450135|NCT04303884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110450136|NCT01040130|Olodaterol|olodaterol|mesh-list
110450137|NCT01040130|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110450138|NCT01040130|Autonomic Agents|autonomic agents|mesh-ancestor
110450139|NCT01040130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110450140|NCT01040130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110450141|NCT01040130|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110450142|NCT01040130|Respiratory System Agents|respiratory system agents|mesh-ancestor
110450143|NCT00932451|Crizotinib|crizotinib|mesh-list
110450144|NCT00932451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110450145|NCT00932451|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110450146|NCT00932451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110450147|NCT00932451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110450148|NCT05297682|Propofol|propofol|mesh-list
110450149|NCT05297682|Anesthetics|anesthetics|mesh-ancestor
110450150|NCT05297682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110450151|NCT05297682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110450152|NCT05297682|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110450153|NCT05297682|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110450154|NCT05297682|Anesthetics, General|anesthetics, general|mesh-ancestor
110450155|NCT01108055|Paclitaxel|paclitaxel|mesh-list
110450156|NCT01108055|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110450157|NCT01108055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110450158|NCT01108055|Tubulin Modulators|tubulin modulators|mesh-ancestor
110450159|NCT01108055|Antimitotic Agents|antimitotic agents|mesh-ancestor
110450160|NCT01108055|Mitosis Modulators|mitosis modulators|mesh-ancestor
110450161|NCT01108055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110450162|NCT00609375|Cefepime|cefepime|mesh-list
110450163|NCT00609375|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110450164|NCT00609375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110450165|NCT01107899|Clopidogrel|clopidogrel|mesh-list
110450166|NCT01107899|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
110450167|NCT01107899|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110481015|NCT00618345|Everolimus|everolimus|mesh-list
110450168|NCT01107899|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110450169|NCT01107899|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110450170|NCT01107899|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110450171|NCT01107899|Purinergic Agents|purinergic agents|mesh-ancestor
110450172|NCT01107899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110450173|NCT01107899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110450174|NCT01107899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110450175|NCT01107743|Amlodipine|amlodipine|mesh-list
110450176|NCT01107743|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
110450177|NCT01107743|Atorvastatin|atorvastatin|mesh-list
110450178|NCT01107743|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110450179|NCT01107743|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110450180|NCT01107743|Antimetabolites|antimetabolites|mesh-ancestor
110450181|NCT01107743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110450182|NCT01107743|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110450183|NCT01107743|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110450184|NCT01107743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110450185|NCT01107743|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110450186|NCT01107743|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110450187|NCT01107743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110450188|NCT01107743|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110450189|NCT01107743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110450191|NCT01059864|Atorvastatin|atorvastatin|mesh-list
110450192|NCT01059864|Tofacitinib|tofacitinib|mesh-list
110450193|NCT01059864|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110450194|NCT01059864|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110450195|NCT01059864|Antimetabolites|antimetabolites|mesh-ancestor
110295347|NCT00231998|Pimecrolimus|pimecrolimus|mesh-list
110450196|NCT01059864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110450197|NCT01059864|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110450198|NCT01059864|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110450199|NCT01059864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110450200|NCT01059864|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
110450201|NCT01059864|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110478553|NCT01018862|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110478554|NCT01018862|Respiratory System Agents|respiratory system agents|mesh-ancestor
110450202|NCT01035138|N2-((2S)-2-(3,5-difluorophenyl)-2-hydroxyethanoyl)-N1-((7S)-5-methyl-6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-L-alaninamide|n2-((2s)-2-(3,5-difluorophenyl)-2-hydroxyethanoyl)-n1-((7s)-5-methyl-6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-l-alaninamide|mesh-list
110450203|NCT01035138|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
110450204|NCT01035138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110450205|NCT01035138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110450207|NCT03739840|Anticonvulsants|anticonvulsants|mesh-ancestor
110450208|NCT00613600|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
110450209|NCT00613600|Cathartics|cathartics|mesh-ancestor
110481407|NCT00766636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110450210|NCT00613600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110450211|NCT04302402|Rifaximin|rifaximin|mesh-list
110450212|NCT04302402|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110450213|NCT04302402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110450214|NCT04302402|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110450215|NCT03931408|Gentamicins|gentamicins|mesh-list
110450216|NCT03931408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110450217|NCT03931408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110450218|NCT03931408|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110450219|NCT03931408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110450220|NCT03931408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110450221|NCT03398824|Metformin|metformin|mesh-list
110450222|NCT03398824|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110450223|NCT03398824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110450224|NCT01033734|Oseltamivir|oseltamivir|mesh-list
110450225|NCT01033734|Antiviral Agents|antiviral agents|mesh-ancestor
110450226|NCT01033734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110450227|NCT01033734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110450228|NCT01033734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110450229|NCT03792256|Cytarabine|cytarabine|mesh-list
110450230|NCT03792256|Prednisone|prednisone|mesh-list
110450231|NCT03792256|Prednisolone|prednisolone|mesh-list
110450232|NCT03792256|Hydrocortisone|hydrocortisone|mesh-list
110450233|NCT03792256|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
110450234|NCT03792256|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
110450235|NCT03792256|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
110450236|NCT03792256|Doxorubicin|doxorubicin|mesh-list
110450237|NCT03792256|Methotrexate|methotrexate|mesh-list
110450238|NCT03792256|Vincristine|vincristine|mesh-list
110450239|NCT03792256|Palbociclib|palbociclib|mesh-list
110450241|NCT03792256|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110450242|NCT03792256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110450243|NCT03792256|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110450244|NCT03792256|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110450245|NCT03792256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110450246|NCT03792256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110450247|NCT03792256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110450248|NCT03792256|Glucocorticoids|glucocorticoids|mesh-ancestor
110450249|NCT03792256|Hormones|hormones|mesh-ancestor
110450250|NCT03792256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110450251|NCT03792256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110450252|NCT03792256|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110450253|NCT03792256|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110450254|NCT03792256|Abortifacient Agents|abortifacient agents|mesh-ancestor
110450255|NCT03792256|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110450256|NCT03792256|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110450257|NCT03792256|Antimetabolites|antimetabolites|mesh-ancestor
110450258|NCT03792256|Dermatologic Agents|dermatologic agents|mesh-ancestor
110450259|NCT03792256|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110450260|NCT03792256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110450261|NCT03792256|Immunologic Factors|immunologic factors|mesh-ancestor
110450262|NCT03792256|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110450263|NCT03792256|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110450264|NCT03792256|Antiviral Agents|antiviral agents|mesh-ancestor
110450265|NCT03792256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110450266|NCT03792256|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110450267|NCT03792256|Tubulin Modulators|tubulin modulators|mesh-ancestor
110450268|NCT03792256|Antimitotic Agents|antimitotic agents|mesh-ancestor
110450269|NCT03792256|Mitosis Modulators|mitosis modulators|mesh-ancestor
110450270|NCT03792256|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110450272|NCT00613288|Androgens|androgens|mesh-ancestor
110450273|NCT00613288|Hormones|hormones|mesh-ancestor
110450274|NCT00613288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110450275|NCT00613288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110450276|NCT03711838|Acetylcysteine|acetylcysteine|mesh-list
110450277|NCT03711838|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110450278|NCT03711838|Antiviral Agents|antiviral agents|mesh-ancestor
110450279|NCT03711838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110450280|NCT03711838|Expectorants|expectorants|mesh-ancestor
110450281|NCT03711838|Respiratory System Agents|respiratory system agents|mesh-ancestor
110450282|NCT03711838|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110450283|NCT03711838|Antioxidants|antioxidants|mesh-ancestor
110450284|NCT03711838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110450285|NCT03711838|Protective Agents|protective agents|mesh-ancestor
110450286|NCT03711838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110450287|NCT03711838|Antidotes|antidotes|mesh-ancestor
110450288|NCT04275778|Hydroxychloroquine|hydroxychloroquine|mesh-list
110450289|NCT04275778|Antimalarials|antimalarials|mesh-ancestor
110450290|NCT04275778|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110450291|NCT04275778|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110097354|NCT01735227|Omeprazole|omeprazole|mesh-list
110450292|NCT04275778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110450293|NCT04275778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110450294|NCT04275778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110450295|NCT04275778|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110450297|NCT01115855|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110450298|NCT01115855|Hormone Antagonists|hormone antagonists|mesh-ancestor
110450299|NCT01115855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110450300|NCT01115855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110450301|NCT01115855|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110450302|NCT01115855|Diuretics|diuretics|mesh-ancestor
110450303|NCT01115855|Natriuretic Agents|natriuretic agents|mesh-ancestor
110450304|NCT01115855|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110450305|NCT03615508|Phenylephrine|phenylephrine|mesh-list
110450306|NCT03615508|Oxymetazoline|oxymetazoline|mesh-list
110450307|NCT03615508|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110450309|NCT03615508|Autonomic Agents|autonomic agents|mesh-ancestor
110655637|NCT00425854|Afatinib|afatinib|mesh-list
110450310|NCT03615508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110450311|NCT03615508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110450312|NCT03615508|Sympathomimetics|sympathomimetics|mesh-ancestor
110481910|NCT02575885|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110450313|NCT03615508|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110450314|NCT03615508|Nasal Decongestants|nasal decongestants|mesh-ancestor
110450315|NCT03615508|Respiratory System Agents|respiratory system agents|mesh-ancestor
110450316|NCT03615508|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110450317|NCT03615508|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110450318|NCT03615508|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110450319|NCT03615508|Adrenergic Agents|adrenergic agents|mesh-ancestor
110450320|NCT03615508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110450321|NCT03615508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110450322|NCT03615508|Protective Agents|protective agents|mesh-ancestor
110450323|NCT02880995|Amisulpride|amisulpride|mesh-list
110450324|NCT02880995|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110450325|NCT02880995|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110450326|NCT02880995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110481977|NCT00581893|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110450327|NCT02880995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110450328|NCT02880995|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110450329|NCT02880995|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110450330|NCT02880995|Dopamine Agents|dopamine agents|mesh-ancestor
110482046|NCT00770146|Mipomersen|mipomersen|mesh-list
110450331|NCT02880995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110450332|NCT02880995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110450333|NCT02880995|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110450334|NCT02880995|Antidepressive Agents|antidepressive agents|mesh-ancestor
110450335|NCT03522064|Carboplatin|carboplatin|mesh-list
110450336|NCT03522064|Methyltestosterone|methyltestosterone|mesh-list
110450337|NCT03522064|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110450338|NCT03522064|Testosterone|testosterone|mesh-list
110450339|NCT03522064|Testosterone undecanoate|testosterone undecanoate|mesh-list
110450340|NCT03522064|Testosterone enanthate|testosterone enanthate|mesh-list
110450341|NCT03522064|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
110450342|NCT03522064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110450343|NCT03522064|Androgens|androgens|mesh-ancestor
110450344|NCT03522064|Hormones|hormones|mesh-ancestor
110450345|NCT03522064|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110450346|NCT03522064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110450347|NCT03522064|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110450348|NCT03522064|Anabolic Agents|anabolic agents|mesh-ancestor
110450349|NCT04310579|Midazolam|midazolam|mesh-list
110450350|NCT04310579|Oxycodone|oxycodone|mesh-list
110450351|NCT04310579|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110450352|NCT04310579|Paroxetine|paroxetine|mesh-list
110450353|NCT04310579|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110450354|NCT04310579|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110450355|NCT04310579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110450356|NCT04310579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110482310|NCT01207011|Amrubicin|amrubicin|mesh-list
110450357|NCT04310579|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110450358|NCT04310579|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110450359|NCT04310579|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110450360|NCT04310579|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110450361|NCT04310579|Anesthetics, General|anesthetics, general|mesh-ancestor
110450362|NCT04310579|Anesthetics|anesthetics|mesh-ancestor
110450363|NCT04310579|GABA Modulators|gaba modulators|mesh-ancestor
110450364|NCT04310579|GABA Agents|gaba agents|mesh-ancestor
110450365|NCT04310579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110450366|NCT04310579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110450367|NCT04310579|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110450368|NCT04310579|Narcotics|narcotics|mesh-ancestor
110450369|NCT04310579|Analgesics|analgesics|mesh-ancestor
110450370|NCT04310579|Sensory System Agents|sensory system agents|mesh-ancestor
110450371|NCT04310579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110450372|NCT04310579|Antidepressive Agents|antidepressive agents|mesh-ancestor
110450373|NCT04310579|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110450374|NCT04310579|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110450375|NCT04310579|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110482519|NCT00998738|Analgesics|analgesics|mesh-ancestor
110450377|NCT04310579|Serotonin Agents|serotonin agents|mesh-ancestor
110450378|NCT04310579|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110450379|NCT04310579|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110450380|NCT04310579|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110373084|NCT04590482|Letrozole|letrozole|mesh-list
110450381|NCT04310579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110450384|NCT05244538|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110450385|NCT05244538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110450386|NCT05244538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110450387|NCT05244538|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110450388|NCT05244538|Anesthetics, General|anesthetics, general|mesh-ancestor
110450389|NCT05244538|Anesthetics|anesthetics|mesh-ancestor
110450390|NCT05244538|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110450391|NCT05244538|Narcotics|narcotics|mesh-ancestor
110450392|NCT05244538|Analgesics|analgesics|mesh-ancestor
110450393|NCT05244538|Sensory System Agents|sensory system agents|mesh-ancestor
110450394|NCT05244538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110450395|NCT03638128|Denosumab|denosumab|mesh-list
110450396|NCT03638128|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110450397|NCT03638128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110450398|NCT03481660|Aflibercept|aflibercept|mesh-list
110450399|NCT03481660|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110450400|NCT03481660|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110450401|NCT03481660|Growth Substances|growth substances|mesh-ancestor
110450402|NCT03481660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110450403|NCT03481660|Growth Inhibitors|growth inhibitors|mesh-ancestor
110450404|NCT03481660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110450405|NCT05345236|Aflibercept|aflibercept|mesh-list
110450407|NCT05345236|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110450408|NCT05345236|Growth Substances|growth substances|mesh-ancestor
110450409|NCT05345236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110450410|NCT05345236|Growth Inhibitors|growth inhibitors|mesh-ancestor
110450411|NCT05345236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110450413|NCT02692534|Anesthetics, Local|anesthetics, local|mesh-ancestor
110450414|NCT02692534|Anesthetics|anesthetics|mesh-ancestor
110450415|NCT02692534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110450416|NCT02692534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110450417|NCT02692534|Sensory System Agents|sensory system agents|mesh-ancestor
110450418|NCT02692534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110450419|NCT02692534|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110450420|NCT02692534|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110450421|NCT02692534|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110450422|NCT02692534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110478555|NCT01018862|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
110450423|NCT02692534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110450424|NCT02692534|Dopamine Agents|dopamine agents|mesh-ancestor
110450425|NCT02692534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110450426|NCT00614536|Rabeprazole|rabeprazole|mesh-list
110250544|NCT03117309|Nivolumab|nivolumab|mesh-list
110450427|NCT00614536|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110450428|NCT00614536|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110450429|NCT00614536|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110450430|NCT00614536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110450431|NCT00614536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110482920|NCT01253161|Hormones|hormones|mesh-ancestor
110450432|NCT04333654|Hydroxychloroquine|hydroxychloroquine|mesh-list
110450433|NCT04333654|Antimalarials|antimalarials|mesh-ancestor
110450434|NCT04333654|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110450435|NCT04333654|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110450436|NCT04333654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110450437|NCT04333654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110450438|NCT04333654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110450439|NCT04333654|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110450440|NCT01059630|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110450442|NCT01059630|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110450443|NCT01059630|Alkylating Agents|alkylating agents|mesh-ancestor
110450444|NCT01059630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110097505|NCT01736150|Sevelamer|sevelamer|mesh-list
110450445|NCT01059630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110450446|NCT01059630|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110450447|NCT04142086|Vaccines|vaccines|mesh-list
110450448|NCT04142086|Immunologic Factors|immunologic factors|mesh-ancestor
110450449|NCT04142086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110450450|NCT03664882|Fexofenadine|fexofenadine|mesh-list
110450451|NCT03664882|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110450452|NCT03664882|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110450453|NCT03664882|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110450454|NCT03664882|Histamine Antagonists|histamine antagonists|mesh-ancestor
110450455|NCT03664882|Histamine Agents|histamine agents|mesh-ancestor
110450456|NCT03664882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110483257|NCT00715039|Autonomic Agents|autonomic agents|mesh-ancestor
110450457|NCT03664882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110450458|NCT03664882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110450459|NCT03951142|Losartan|losartan|mesh-list
110450460|NCT03951142|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110450461|NCT03951142|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110450462|NCT03951142|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110450463|NCT03951142|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110450464|NCT03951142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110450466|NCT03903016|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110483480|NCT04208061|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110450468|NCT03903016|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110450469|NCT03903016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110450470|NCT03514732|Melatonin|melatonin|mesh-list
110450471|NCT03514732|Antioxidants|antioxidants|mesh-ancestor
110450472|NCT03514732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110450473|NCT03514732|Protective Agents|protective agents|mesh-ancestor
110450474|NCT03514732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110450475|NCT03514732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110450476|NCT03800836|Paclitaxel|paclitaxel|mesh-list
110450477|NCT03800836|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110450478|NCT03800836|Atezolizumab|atezolizumab|mesh-list
110450479|NCT03800836|Ipatasertib|ipatasertib|mesh-list
110450480|NCT03800836|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110450481|NCT03800836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110450482|NCT03800836|Tubulin Modulators|tubulin modulators|mesh-ancestor
110450483|NCT03800836|Antimitotic Agents|antimitotic agents|mesh-ancestor
110450484|NCT03800836|Mitosis Modulators|mitosis modulators|mesh-ancestor
110450485|NCT03800836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110483553|NCT00639327|Irinotecan|irinotecan|mesh-list
110450486|NCT03800836|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110450487|NCT03800836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110450488|NCT03800836|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110450489|NCT03800836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110450490|NCT00932373|Trastuzumab|trastuzumab|mesh-list
110450491|NCT00932373|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
110450492|NCT00932373|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110450493|NCT00932373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110450494|NCT00932373|Immunotoxins|immunotoxins|mesh-ancestor
110450495|NCT00932373|Immunoconjugates|immunoconjugates|mesh-ancestor
110450496|NCT00932373|Immunologic Factors|immunologic factors|mesh-ancestor
110450497|NCT00932373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110450498|NCT00932373|Tubulin Modulators|tubulin modulators|mesh-ancestor
110450499|NCT00932373|Antimitotic Agents|antimitotic agents|mesh-ancestor
110450500|NCT00932373|Mitosis Modulators|mitosis modulators|mesh-ancestor
110450501|NCT00932373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110483693|NCT00719173|Aprepitant|aprepitant|mesh-list
110450503|NCT04265001|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110450504|NCT04265001|Immunologic Factors|immunologic factors|mesh-ancestor
110450505|NCT04265001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110450506|NCT04265001|Viscosupplements|viscosupplements|mesh-ancestor
110450507|NCT04265001|Protective Agents|protective agents|mesh-ancestor
110450508|NCT00608595|Celecoxib|celecoxib|mesh-list
110450509|NCT00608595|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110450510|NCT00608595|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110450511|NCT00608595|Analgesics|analgesics|mesh-ancestor
110450512|NCT00608595|Sensory System Agents|sensory system agents|mesh-ancestor
110450513|NCT00608595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110450514|NCT00608595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110450515|NCT00608595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110450516|NCT00608595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110483803|NCT00909831|Sirolimus|sirolimus|mesh-list
110450517|NCT00608595|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110450518|NCT00608595|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110450519|NCT00608595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110450520|NCT00608595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110450522|NCT03761134|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
110450523|NCT03761134|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110450524|NCT03761134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110450525|NCT03761134|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110450526|NCT03761134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110450527|NCT01055496|Dexamethasone|dexamethasone|mesh-list
110450528|NCT01055496|Prednisone|prednisone|mesh-list
110450529|NCT01055496|Cyclophosphamide|cyclophosphamide|mesh-list
110450541|NCT01055496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110450543|NCT01055496|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110450544|NCT01055496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110450545|NCT01055496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110450546|NCT01055496|Antiemetics|antiemetics|mesh-ancestor
110450547|NCT01055496|Autonomic Agents|autonomic agents|mesh-ancestor
110450548|NCT01055496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110450549|NCT01055496|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110450550|NCT01055496|Glucocorticoids|glucocorticoids|mesh-ancestor
110450551|NCT01055496|Hormones|hormones|mesh-ancestor
110450552|NCT01055496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110450553|NCT01055496|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110450554|NCT01055496|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110450555|NCT01055496|Antimetabolites|antimetabolites|mesh-ancestor
110450556|NCT01055496|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110450557|NCT01055496|Tubulin Modulators|tubulin modulators|mesh-ancestor
110450558|NCT01055496|Antimitotic Agents|antimitotic agents|mesh-ancestor
110450559|NCT01055496|Mitosis Modulators|mitosis modulators|mesh-ancestor
110450560|NCT01055496|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110450561|NCT01055496|Immunotoxins|immunotoxins|mesh-ancestor
110450562|NCT01055496|Immunoconjugates|immunoconjugates|mesh-ancestor
110450563|NCT03436498|Insulin|insulin|mesh-list
110450564|NCT03436498|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110450565|NCT03436498|Insulin Aspart|insulin aspart|mesh-list
110450566|NCT03436498|Insulin, Long-Acting|insulin, long-acting|mesh-list
110450567|NCT03436498|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
110450568|NCT03436498|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110450569|NCT03436498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110450581|NCT00609531|Citalopram|citalopram|mesh-list
110450582|NCT00609531|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110450583|NCT00609531|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110450584|NCT00609531|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110450585|NCT00609531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110450586|NCT00609531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110450587|NCT00609531|Serotonin Agents|serotonin agents|mesh-ancestor
110450588|NCT00609531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110450589|NCT00609531|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110484283|NCT00754936|Escitalopram|escitalopram|mesh-list
110450590|NCT00609531|Antidepressive Agents|antidepressive agents|mesh-ancestor
110450591|NCT00609531|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110097667|NCT01737294|Capsaicin|capsaicin|mesh-list
110450592|NCT03406000|Insulin Glargine|insulin glargine|mesh-list
110450593|NCT03406000|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110450594|NCT03406000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110450597|NCT01052844|Sensory System Agents|sensory system agents|mesh-ancestor
110450598|NCT01052844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110450599|NCT01052844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110450601|NCT01052844|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110450602|NCT01052844|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110450603|NCT01052844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110450604|NCT01052844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110450605|NCT01052844|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110450606|NCT01052844|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110450607|NCT01052844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110450608|NCT01052844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110450610|NCT01049412|Insulin Glargine|insulin glargine|mesh-list
110450611|NCT01049412|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110450612|NCT01049412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110450613|NCT02584426|Cefazolin|cefazolin|mesh-list
110450614|NCT02584426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110450615|NCT02584426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110450616|NCT00934089|Latanoprost|latanoprost|mesh-list
110450617|NCT00934089|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110450618|NCT00934089|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110450619|NCT01032174|Azithromycin|azithromycin|mesh-list
110450620|NCT01032174|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110450621|NCT01032174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110450622|NCT02704780|Misoprostol|misoprostol|mesh-list
110450623|NCT02704780|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110450624|NCT02704780|Abortifacient Agents|abortifacient agents|mesh-ancestor
110450625|NCT02704780|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110450626|NCT02704780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110450627|NCT02704780|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110450628|NCT02704780|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110450629|NCT02704780|Oxytocics|oxytocics|mesh-ancestor
110450631|NCT02704546|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110450632|NCT02704546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110450633|NCT02704546|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110450634|NCT02704546|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110450635|NCT02704546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110450636|NCT02704546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110450637|NCT02704546|Dopamine Agents|dopamine agents|mesh-ancestor
110450638|NCT02704546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110450640|NCT01032018|Citalopram|citalopram|mesh-list
110450641|NCT01032018|Sertraline|sertraline|mesh-list
110450642|NCT01032018|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110450643|NCT01032018|Antidepressive Agents|antidepressive agents|mesh-ancestor
110450644|NCT01032018|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110484830|NCT00640809|Analgesics|analgesics|mesh-ancestor
110450645|NCT01032018|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110450646|NCT01032018|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110450647|NCT01032018|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110450648|NCT01032018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110450649|NCT01032018|Dopamine Agents|dopamine agents|mesh-ancestor
110450650|NCT01032018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110450651|NCT01032018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110450652|NCT01032018|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110450653|NCT01032018|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110450654|NCT01032018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110450655|NCT01032018|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110450656|NCT01032018|Serotonin Agents|serotonin agents|mesh-ancestor
110450658|NCT00927069|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110450659|NCT00927069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110450660|NCT00927069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110450661|NCT01031628|Imatinib Mesylate|imatinib mesylate|mesh-list
110450662|NCT01031628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110450663|NCT01031628|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110450664|NCT01031628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110450665|NCT01031628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110450666|NCT00609843|Ethiodized Oil|ethiodized oil|mesh-list
110450667|NCT00609843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110450668|NCT00608673|Betamethasone|betamethasone|mesh-list
110450669|NCT00608673|Betamethasone Valerate|betamethasone valerate|mesh-list
110450670|NCT00608673|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
110450671|NCT00608673|Betamethasone benzoate|betamethasone benzoate|mesh-list
110450672|NCT00608673|Pimecrolimus|pimecrolimus|mesh-list
110450673|NCT00608673|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
110450674|NCT00608673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110450675|NCT00608673|Glucocorticoids|glucocorticoids|mesh-ancestor
110450676|NCT00608673|Hormones|hormones|mesh-ancestor
110450677|NCT00608673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110148314|NCT00388011|Morphine|morphine|mesh-list
110450678|NCT00608673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110450679|NCT00608673|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110450680|NCT00608673|Respiratory System Agents|respiratory system agents|mesh-ancestor
110450681|NCT00608673|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110450682|NCT00608673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110450683|NCT00608673|Analgesics|analgesics|mesh-ancestor
110450684|NCT00608673|Sensory System Agents|sensory system agents|mesh-ancestor
110450685|NCT00608673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110450686|NCT00608673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110450687|NCT00608673|Dermatologic Agents|dermatologic agents|mesh-ancestor
110450688|NCT00608673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110450689|NCT00608673|Immunologic Factors|immunologic factors|mesh-ancestor
110450690|NCT00608673|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110450691|NCT00608673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110450692|NCT00608673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110450694|NCT04263519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110450695|NCT04263519|Immunologic Factors|immunologic factors|mesh-ancestor
110450696|NCT04263519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110450697|NCT04263519|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110450698|NCT04263519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110450699|NCT04263519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110450700|NCT00637767|Melphalan|melphalan|mesh-list
110450701|NCT00637767|Antibodies|antibodies|mesh-list
110450702|NCT00637767|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110450703|NCT00637767|Immunologic Factors|immunologic factors|mesh-ancestor
110450704|NCT00637767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110450705|NCT00637767|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110450706|NCT00637767|Alkylating Agents|alkylating agents|mesh-ancestor
110450707|NCT00637767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110450708|NCT00637767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110450709|NCT00637767|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110450710|NCT00637767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110450711|NCT00609999|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110450712|NCT00609999|Dasatinib|dasatinib|mesh-list
110450713|NCT00609999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110450714|NCT00609999|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110450715|NCT00609999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110450716|NCT00609999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110450718|NCT00627250|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110450719|NCT00627250|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110450720|NCT00627250|Antiviral Agents|antiviral agents|mesh-ancestor
110450721|NCT00627250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110450722|NCT00627250|Dopamine Agents|dopamine agents|mesh-ancestor
110450723|NCT00627250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110450724|NCT00627250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110450725|NCT00627250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110450726|NCT00627250|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110450727|NCT00627250|Analgesics|analgesics|mesh-ancestor
110450728|NCT00627250|Sensory System Agents|sensory system agents|mesh-ancestor
110450729|NCT00627250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110450730|NCT04300374|Anesthetics|anesthetics|mesh-list
110450731|NCT04300374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110450732|NCT04300374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110450733|NCT02703376|Prednisone|prednisone|mesh-list
110450734|NCT02703376|Prednisolone|prednisolone|mesh-list
110450735|NCT02703376|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110450736|NCT02703376|Glucocorticoids|glucocorticoids|mesh-ancestor
110450737|NCT02703376|Hormones|hormones|mesh-ancestor
110450738|NCT02703376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110450739|NCT02703376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110450740|NCT02703376|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110450741|NCT02703376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110450742|NCT00610077|Letrozole|letrozole|mesh-list
110450743|NCT00610077|Clomiphene|clomiphene|mesh-list
110450744|NCT00610077|Enclomiphene|enclomiphene|mesh-list
110450745|NCT00610077|Zuclomiphene|zuclomiphene|mesh-list
110450746|NCT00610077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110450747|NCT00610077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110450748|NCT00610077|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110450749|NCT00610077|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110450750|NCT00610077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110450751|NCT00610077|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110450752|NCT00610077|Hormone Antagonists|hormone antagonists|mesh-ancestor
110450753|NCT00610077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110450754|NCT00610077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110450755|NCT00610077|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110450756|NCT00610077|Fertility Agents|fertility agents|mesh-ancestor
110450757|NCT00610077|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110450758|NCT00610077|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110450759|NCT00610077|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110450760|NCT00823576|Ropivacaine|ropivacaine|mesh-list
110450761|NCT00823576|Anesthetics, Local|anesthetics, local|mesh-ancestor
110450762|NCT00823576|Anesthetics|anesthetics|mesh-ancestor
110450763|NCT00823576|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110450764|NCT00823576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110450765|NCT00823576|Sensory System Agents|sensory system agents|mesh-ancestor
110450766|NCT00823576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110450767|NCT01028352|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110450768|NCT01028352|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110295905|NCT00267657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110450769|NCT01028352|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110450770|NCT01028352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110485720|NCT02674737|Tramadol|tramadol|mesh-list
110450771|NCT01028352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110450772|NCT01028352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110450773|NCT01028352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110450774|NCT01028352|Analgesics|analgesics|mesh-ancestor
110450775|NCT01028352|Sensory System Agents|sensory system agents|mesh-ancestor
110450776|NCT01028352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110450777|NCT01028352|Antidepressive Agents|antidepressive agents|mesh-ancestor
110450778|NCT01028352|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110450779|NCT01028352|Dopamine Agents|dopamine agents|mesh-ancestor
110450780|NCT03172780|Diclofenac|diclofenac|mesh-list
110450781|NCT03172780|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110450782|NCT03172780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110450783|NCT03172780|Analgesics|analgesics|mesh-ancestor
110450784|NCT03172780|Sensory System Agents|sensory system agents|mesh-ancestor
110450785|NCT03172780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110450786|NCT03172780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110450787|NCT03172780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110450788|NCT03172780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110450789|NCT03172780|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110450790|NCT03172780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110450791|NCT03172780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110450792|NCT05011617|Anesthetics|anesthetics|mesh-list
110450793|NCT05011617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110450794|NCT05011617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110450795|NCT03169972|Factor VIII|factor viii|mesh-list
110450796|NCT03169972|BAX 855|bax 855|mesh-list
110450797|NCT03169972|Coagulants|coagulants|mesh-ancestor
110450798|NCT00926367|Clindamycin|clindamycin|mesh-list
110450799|NCT00926367|Clindamycin palmitate|clindamycin palmitate|mesh-list
110450800|NCT00926367|Clindamycin phosphate|clindamycin phosphate|mesh-list
110450801|NCT00926367|Adapalene|adapalene|mesh-list
110450802|NCT00926367|Benzoyl Peroxide|benzoyl peroxide|mesh-list
110250718|NCT01246999|Vaccines|vaccines|mesh-list
110450803|NCT00926367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110450804|NCT00926367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110450805|NCT00926367|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110450806|NCT00926367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110450807|NCT00926367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110450808|NCT00926367|Dermatologic Agents|dermatologic agents|mesh-ancestor
110450809|NCT00926367|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110450810|NCT00926367|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110450811|NCT00926367|Analgesics|analgesics|mesh-ancestor
110450812|NCT00926367|Sensory System Agents|sensory system agents|mesh-ancestor
110486015|NCT00736801|Fluticasone|fluticasone|mesh-list
110450813|NCT00926367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110450814|NCT00926367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110450815|NCT00926367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110450816|NCT00926367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110450817|NCT04261023|Abatacept|abatacept|mesh-list
110450818|NCT04261023|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110450819|NCT04261023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110450820|NCT04261023|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110450821|NCT04261023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110450822|NCT04261023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110450823|NCT04261023|Immunologic Factors|immunologic factors|mesh-ancestor
110450824|NCT04261023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110450825|NCT04261023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110450827|NCT01114529|Everolimus|everolimus|mesh-list
110450828|NCT01114529|Tacrolimus|tacrolimus|mesh-list
110450829|NCT01114529|Cyclosporins|cyclosporins|mesh-list
110450830|NCT01114529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110450831|NCT01114529|Immunologic Factors|immunologic factors|mesh-ancestor
110450832|NCT01114529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110450833|NCT01114529|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110450834|NCT01114529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110450835|NCT01114529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110450836|NCT01114529|Antifungal Agents|antifungal agents|mesh-ancestor
110450837|NCT01114529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110450838|NCT01114529|Dermatologic Agents|dermatologic agents|mesh-ancestor
110450839|NCT01114529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110450840|NCT01114529|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110450841|NCT01114529|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110450843|NCT00926289|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110450844|NCT00926289|Telmisartan|telmisartan|mesh-list
110450845|NCT00926289|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110450847|NCT00926289|Natriuretic Agents|natriuretic agents|mesh-ancestor
110450848|NCT00926289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110450849|NCT00926289|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110450850|NCT00926289|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110450851|NCT00926289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110450852|NCT00926289|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110450853|NCT00926289|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110450854|NCT04309643|Levonorgestrel|levonorgestrel|mesh-list
110450855|NCT04309643|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110450856|NCT04309643|Contraceptive Agents|contraceptive agents|mesh-list
110450857|NCT04309643|Contraceptives, Oral|contraceptives, oral|mesh-list
110450858|NCT04309643|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
110450859|NCT04309643|Estradiol|estradiol|mesh-list
110450860|NCT04309643|Estrogens|estrogens|mesh-ancestor
110450861|NCT04309643|Hormones|hormones|mesh-ancestor
110478556|NCT01018862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110450862|NCT04309643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110450863|NCT04309643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110450864|NCT04309643|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110450865|NCT04309643|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110450866|NCT04309643|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110450867|NCT04309643|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110450868|NCT04309643|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110450869|NCT03188146|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
110450870|NCT03188146|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
110450871|NCT03188146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110450873|NCT04259073|Analgesics|analgesics|mesh-ancestor
110450875|NCT04259073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110450876|NCT04259073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110450877|NCT04259073|Anticonvulsants|anticonvulsants|mesh-ancestor
110450878|NCT04259073|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110450879|NCT04259073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110450880|NCT04259073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110450881|NCT04259073|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110450882|NCT04259073|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110450883|NCT04259073|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110486552|NCT00649935|Azithromycin|azithromycin|mesh-list
110450884|NCT04259073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110450885|NCT04259073|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110450886|NCT00609063|Atorvastatin|atorvastatin|mesh-list
110450887|NCT00609063|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110450888|NCT00609063|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110486616|NCT02536209|Oxycodone|oxycodone|mesh-list
110450889|NCT00609063|Antimetabolites|antimetabolites|mesh-ancestor
110450890|NCT00609063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110450891|NCT00609063|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110450892|NCT00609063|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110450893|NCT00609063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110450894|NCT02703064|Fenugreek seed meal|fenugreek seed meal|mesh-list
110450895|NCT02703064|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110450896|NCT02703064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110450898|NCT01114373|Antioxidants|antioxidants|mesh-ancestor
110450899|NCT01114373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110450901|NCT01114373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110450902|NCT01114373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110450904|NCT00925899|Antioxidants|antioxidants|mesh-ancestor
110450905|NCT00925899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110450906|NCT00925899|Protective Agents|protective agents|mesh-ancestor
110450907|NCT00925899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110450908|NCT00925899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110450909|NCT02601586|Oxycodone|oxycodone|mesh-list
110450910|NCT02601586|Levodopa|levodopa|mesh-list
110450911|NCT02601586|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110450912|NCT02601586|Narcotics|narcotics|mesh-ancestor
110450913|NCT02601586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110450914|NCT02601586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110450915|NCT02601586|Analgesics|analgesics|mesh-ancestor
110450916|NCT02601586|Sensory System Agents|sensory system agents|mesh-ancestor
110450917|NCT02601586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110450918|NCT02601586|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110450919|NCT02601586|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110450920|NCT02601586|Dopamine Agents|dopamine agents|mesh-ancestor
110450921|NCT02601586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110450922|NCT02601586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110450923|NCT00609141|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110450924|NCT00609141|Immunologic Factors|immunologic factors|mesh-ancestor
110450925|NCT00609141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110450926|NCT00610389|Immunomodulating Agents|immunomodulating agents|mesh-list
110450927|NCT00610389|Immunologic Factors|immunologic factors|mesh-ancestor
110450928|NCT00610389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110450929|NCT01114217|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
110450930|NCT01114217|Hematinics|hematinics|mesh-ancestor
110450931|NCT01114217|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
110450932|NCT01114217|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110450933|NCT01030536|Immunotoxin HA22|immunotoxin ha22|mesh-list
110450934|NCT01030536|Immunotoxins|immunotoxins|mesh-ancestor
110450935|NCT01030536|Immunoconjugates|immunoconjugates|mesh-ancestor
110450936|NCT01030536|Immunologic Factors|immunologic factors|mesh-ancestor
110450937|NCT01030536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110450938|NCT01030536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110450940|NCT01030458|Valsartan|valsartan|mesh-list
110450941|NCT01030458|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110450942|NCT01030458|Bisoprolol|bisoprolol|mesh-list
110450943|NCT01030458|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110450944|NCT01030458|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110450945|NCT01030458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110450946|NCT01030458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110487012|NCT00709111|Maraviroc|maraviroc|mesh-list
110450947|NCT01030458|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110450948|NCT01030458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110450949|NCT01030458|Vasodilator Agents|vasodilator agents|mesh-ancestor
110450950|NCT01030458|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110450951|NCT01030458|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110450952|NCT01030458|Diuretics|diuretics|mesh-ancestor
110450953|NCT01030458|Natriuretic Agents|natriuretic agents|mesh-ancestor
110450954|NCT01030458|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110450955|NCT01030458|Sympatholytics|sympatholytics|mesh-ancestor
110450956|NCT01030458|Autonomic Agents|autonomic agents|mesh-ancestor
110450957|NCT01030458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110450959|NCT01030458|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110450960|NCT01030458|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110450961|NCT01030458|Adrenergic Agents|adrenergic agents|mesh-ancestor
110450962|NCT01030458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110450963|NCT02702674|Propranolol|propranolol|mesh-list
110450964|NCT02702674|Oxytocin|oxytocin|mesh-list
110450965|NCT02702674|Oxytocics|oxytocics|mesh-ancestor
110450966|NCT02702674|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110450967|NCT02702674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110450968|NCT02702674|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110487364|NCT00654537|Atorvastatin|atorvastatin|mesh-list
110450969|NCT02702674|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110450970|NCT02702674|Adrenergic Agents|adrenergic agents|mesh-ancestor
110450971|NCT02702674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110487432|NCT00970502|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110450972|NCT02702674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110373664|NCT00568880|Bortezomib|bortezomib|mesh-list
110450974|NCT02702674|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110450975|NCT02702674|Vasodilator Agents|vasodilator agents|mesh-ancestor
110450976|NCT01114139|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
110250754|NCT00140712|Dopamine Agents|dopamine agents|mesh-ancestor
110450978|NCT01114139|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
110450979|NCT01114139|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110450980|NCT01027884|Idebenone|idebenone|mesh-list
110450981|NCT01027884|Antioxidants|antioxidants|mesh-ancestor
110450982|NCT01027884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110450983|NCT01027884|Protective Agents|protective agents|mesh-ancestor
110450984|NCT01027884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110450986|NCT02699008|Ticagrelor|ticagrelor|mesh-list
110450987|NCT02699008|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110450988|NCT02699008|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110450989|NCT02699008|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110450990|NCT02699008|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110450991|NCT02699008|Purinergic Agents|purinergic agents|mesh-ancestor
110450992|NCT02699008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110450993|NCT02699008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110450994|NCT02699008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110450995|NCT00627666|Leucovorin|leucovorin|mesh-list
110450996|NCT00627666|Methotrexate|methotrexate|mesh-list
110487724|NCT05973188|Warfarin|warfarin|mesh-list
110450997|NCT00627666|Fludarabine phosphate|fludarabine phosphate|mesh-list
110450998|NCT00627666|Fludarabine|fludarabine|mesh-list
110451000|NCT00627666|Calcium|calcium|mesh-list
110451001|NCT00627666|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110451002|NCT00627666|Levoleucovorin|levoleucovorin|mesh-list
110451003|NCT00627666|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110451004|NCT00627666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110451005|NCT00627666|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110451007|NCT00627666|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110451008|NCT00627666|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110451009|NCT00627666|Antimetabolites|antimetabolites|mesh-ancestor
110451010|NCT00627666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110487847|NCT05972434|Protective Agents|protective agents|mesh-ancestor
110451011|NCT00627666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110451012|NCT00627666|Dermatologic Agents|dermatologic agents|mesh-ancestor
110451013|NCT00627666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110451014|NCT00627666|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110451015|NCT00627666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110451016|NCT00627666|Immunologic Factors|immunologic factors|mesh-ancestor
110451017|NCT00627666|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110451018|NCT00627666|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110451020|NCT00627666|Protective Agents|protective agents|mesh-ancestor
110451021|NCT00627666|Vitamin B Complex|vitamin b complex|mesh-ancestor
110451022|NCT00627666|Vitamins|vitamins|mesh-ancestor
110451024|NCT00627666|Alkylating Agents|alkylating agents|mesh-ancestor
110451025|NCT00627666|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110451026|NCT00627666|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110451027|NCT01022580|Pulmonary Surfactants|pulmonary surfactants|mesh-list
110451028|NCT01022580|Calfactant|calfactant|mesh-list
110451029|NCT01022580|Respiratory System Agents|respiratory system agents|mesh-ancestor
110296177|NCT00234572|Lanreotide|lanreotide|mesh-list
110451030|NCT02698930|Dexmedetomidine|dexmedetomidine|mesh-list
110451031|NCT02698930|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110451032|NCT02698930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110451033|NCT02698930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110451034|NCT02698930|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110451035|NCT02698930|Analgesics|analgesics|mesh-ancestor
110451036|NCT02698930|Sensory System Agents|sensory system agents|mesh-ancestor
110451037|NCT02698930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110451038|NCT02698930|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110451040|NCT02698930|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110451041|NCT02698930|Adrenergic Agents|adrenergic agents|mesh-ancestor
110451042|NCT02698930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110451043|NCT02698930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110451045|NCT01107353|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110250783|NCT00140751|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110451046|NCT01107353|Antidepressive Agents|antidepressive agents|mesh-ancestor
110451047|NCT01107353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110451048|NCT01107353|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110451049|NCT01107353|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110451050|NCT01107353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110451051|NCT01107353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110451052|NCT01107353|Adrenergic Agents|adrenergic agents|mesh-ancestor
110451053|NCT01107353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110451054|NCT01107353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110451055|NCT02702206|Triamcinolone|triamcinolone|mesh-list
110451056|NCT02702206|Hyaluronic Acid|hyaluronic acid|mesh-list
110451057|NCT02702206|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110451058|NCT02702206|Glucocorticoids|glucocorticoids|mesh-ancestor
110451059|NCT02702206|Hormones|hormones|mesh-ancestor
110451060|NCT02702206|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110488325|NCT04909853|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110488326|NCT04909853|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110488340|NCT04733534|Dasatinib|dasatinib|mesh-list
110488341|NCT04733534|Quercetin|quercetin|mesh-list
110488342|NCT04733534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110488343|NCT04733534|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110488344|NCT04733534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110488345|NCT04733534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110488346|NCT04733534|Antioxidants|antioxidants|mesh-ancestor
110488347|NCT04733534|Protective Agents|protective agents|mesh-ancestor
110488349|NCT04727307|Bevacizumab|bevacizumab|mesh-list
110488350|NCT04727307|Atezolizumab|atezolizumab|mesh-list
110488351|NCT04727307|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110488362|NCT04683939|Paclitaxel|paclitaxel|mesh-list
110451061|NCT02702206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110451062|NCT02702206|Immunologic Factors|immunologic factors|mesh-ancestor
110451063|NCT02702206|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110451064|NCT02702206|Viscosupplements|viscosupplements|mesh-ancestor
110451065|NCT02702206|Protective Agents|protective agents|mesh-ancestor
110451066|NCT04216186|Ubiquinone|ubiquinone|mesh-list
110451067|NCT04216186|Coenzyme Q10|coenzyme q10|mesh-list
110451068|NCT04216186|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
110451069|NCT04216186|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110451070|NCT04216186|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110451071|NCT04216186|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110451072|NCT04216186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110451073|NCT04216186|Adrenergic Agents|adrenergic agents|mesh-ancestor
110451074|NCT04216186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110451075|NCT04216186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110451076|NCT04216186|Micronutrients|micronutrients|mesh-ancestor
110451077|NCT04216186|Vitamins|vitamins|mesh-ancestor
110451078|NCT01989598|Trametinib|trametinib|mesh-list
110451079|NCT01989598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110451080|NCT01989598|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110451081|NCT01989598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110451082|NCT01989598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110451083|NCT04214938|Lidocaine|lidocaine|mesh-list
110451084|NCT04214938|Xylometazoline|xylometazoline|mesh-list
110451085|NCT04214938|Anesthetics, Local|anesthetics, local|mesh-ancestor
110451086|NCT04214938|Anesthetics|anesthetics|mesh-ancestor
110451087|NCT04214938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110451088|NCT04214938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110451089|NCT04214938|Sensory System Agents|sensory system agents|mesh-ancestor
110488606|NCT03662074|Nivolumab|nivolumab|mesh-list
110451090|NCT04214938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110451091|NCT04214938|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110451092|NCT04214938|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110451093|NCT04214938|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110451094|NCT04214938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110488671|NCT03439046|Letrozole|letrozole|mesh-list
110451095|NCT04214938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110451096|NCT04214938|Nasal Decongestants|nasal decongestants|mesh-ancestor
110451097|NCT04214938|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110451098|NCT04214938|Respiratory System Agents|respiratory system agents|mesh-ancestor
110451099|NCT00615160|Dacarbazine|dacarbazine|mesh-list
110451100|NCT00615160|Vatalanib|vatalanib|mesh-list
110451101|NCT00615160|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110451102|NCT00615160|Alkylating Agents|alkylating agents|mesh-ancestor
110451103|NCT00615160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110451104|NCT00615160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110451105|NCT00615160|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110451106|NCT00615160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110451107|NCT01112267|Acetaminophen|acetaminophen|mesh-list
110451108|NCT01112267|Tramadol|tramadol|mesh-list
110451109|NCT01112267|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110451110|NCT01112267|Analgesics|analgesics|mesh-ancestor
110451111|NCT01112267|Sensory System Agents|sensory system agents|mesh-ancestor
110451112|NCT01112267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110451113|NCT01112267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110098172|NCT01741038|Cetuximab|cetuximab|mesh-list
110451115|NCT01112267|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110451116|NCT01112267|Narcotics|narcotics|mesh-ancestor
110451117|NCT01112267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110451118|NCT00925587|Darbepoetin alfa|darbepoetin alfa|mesh-list
110451119|NCT00925587|Hematinics|hematinics|mesh-ancestor
110451120|NCT02698306|Dexamethasone|dexamethasone|mesh-list
110451121|NCT02698306|Diclofenac|diclofenac|mesh-list
110451122|NCT02698306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110451123|NCT02698306|Antiemetics|antiemetics|mesh-ancestor
110451124|NCT02698306|Autonomic Agents|autonomic agents|mesh-ancestor
110451125|NCT02698306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110451126|NCT02698306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110451127|NCT02698306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110451129|NCT02698306|Hormones|hormones|mesh-ancestor
110451130|NCT02698306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110451131|NCT02698306|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110451132|NCT02698306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110451133|NCT02698306|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110451134|NCT02698306|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110451135|NCT02698306|Analgesics|analgesics|mesh-ancestor
110451136|NCT02698306|Sensory System Agents|sensory system agents|mesh-ancestor
110451137|NCT02698306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110451138|NCT02698306|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110488812|NCT02918370|Aripiprazole|aripiprazole|mesh-list
110451139|NCT02698306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110451140|NCT02698306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110451141|NCT02698228|Morphine|morphine|mesh-list
110451142|NCT02698228|Bupivacaine|bupivacaine|mesh-list
110451143|NCT02698228|Anesthetics, Local|anesthetics, local|mesh-ancestor
110451144|NCT02698228|Anesthetics|anesthetics|mesh-ancestor
110451145|NCT02698228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110451146|NCT02698228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110451147|NCT02698228|Sensory System Agents|sensory system agents|mesh-ancestor
110451148|NCT02698228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110451150|NCT02698228|Narcotics|narcotics|mesh-ancestor
110451151|NCT02698228|Analgesics|analgesics|mesh-ancestor
110451152|NCT02702128|Tranexamic Acid|tranexamic acid|mesh-list
110451153|NCT02702128|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110451154|NCT02702128|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110451155|NCT02702128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110451156|NCT02702128|Hemostatics|hemostatics|mesh-ancestor
110451157|NCT02702128|Coagulants|coagulants|mesh-ancestor
110451158|NCT00610545|Atorvastatin|atorvastatin|mesh-list
110451160|NCT00610545|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110451161|NCT00610545|Antimetabolites|antimetabolites|mesh-ancestor
110451162|NCT00610545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110296294|NCT02211625|Analgesics|analgesics|mesh-ancestor
110451164|NCT00610545|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110451165|NCT00610545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110451166|NCT00193414|Gemcitabine|gemcitabine|mesh-list
110451167|NCT00193414|Pemetrexed|pemetrexed|mesh-list
110451168|NCT00193414|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110451169|NCT00193414|Antimetabolites|antimetabolites|mesh-ancestor
110451170|NCT00193414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110451171|NCT00193414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110451172|NCT00193414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110451173|NCT00193414|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110451174|NCT00193414|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110451175|NCT04260711|Interferons|interferons|mesh-list
110451176|NCT04260711|Teriflunomide|teriflunomide|mesh-list
110451177|NCT04260711|Glatiramer Acetate|glatiramer acetate|mesh-list
110451178|NCT04260711|Dimethyl Fumarate|dimethyl fumarate|mesh-list
110451179|NCT04260711|(T,G)-A-L|(t,g)-a-l|mesh-list
110451180|NCT04260711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110451181|NCT04260711|Antiviral Agents|antiviral agents|mesh-ancestor
110451182|NCT04260711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110451183|NCT04260711|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110451184|NCT04260711|Immunologic Factors|immunologic factors|mesh-ancestor
110451185|NCT04260711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110451186|NCT04260711|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110451188|NCT04260711|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110451189|NCT04260711|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110451190|NCT04260711|Analgesics|analgesics|mesh-ancestor
110451191|NCT04260711|Sensory System Agents|sensory system agents|mesh-ancestor
110451192|NCT04260711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110451193|NCT04260711|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110451194|NCT04260711|Dermatologic Agents|dermatologic agents|mesh-ancestor
110451195|NCT00610623|Azithromycin|azithromycin|mesh-list
110451196|NCT00610623|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110451197|NCT00610623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110451198|NCT02697838|Paclitaxel|paclitaxel|mesh-list
110451199|NCT02697838|Apatinib|apatinib|mesh-list
110451200|NCT02697838|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110451201|NCT02697838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110451203|NCT02697838|Antimitotic Agents|antimitotic agents|mesh-ancestor
110451204|NCT02697838|Mitosis Modulators|mitosis modulators|mesh-ancestor
110451205|NCT02697838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110451206|NCT02697838|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110451207|NCT02697838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110451209|NCT00928707|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
110451210|NCT00928707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110451211|NCT00928707|Antisickling Agents|antisickling agents|mesh-ancestor
110451212|NCT00928707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110451213|NCT00928707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110489247|NCT02598310|Paclitaxel|paclitaxel|mesh-list
110451214|NCT00928707|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110451215|NCT00928707|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110451216|NCT04956705|Vitamin D|vitamin d|mesh-list
110451217|NCT04956705|Calcium|calcium|mesh-list
110451218|NCT04956705|Vitamins|vitamins|mesh-ancestor
110451219|NCT04956705|Micronutrients|micronutrients|mesh-ancestor
110451220|NCT04956705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110451221|NCT04956705|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110451222|NCT04956705|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110451224|NCT02705950|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110451225|NCT02705950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110451226|NCT02705950|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110451227|NCT02705950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110451228|NCT02705950|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
110451229|NCT02705950|GABA Agonists|gaba agonists|mesh-ancestor
110451230|NCT02705950|GABA Agents|gaba agents|mesh-ancestor
110451231|NCT02705950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110451232|NCT02705950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110451233|NCT04951323|Vaccines|vaccines|mesh-list
110451234|NCT04951323|Immunologic Factors|immunologic factors|mesh-ancestor
110451235|NCT04951323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110451238|NCT02705872|Levobupivacaine|levobupivacaine|mesh-list
110451239|NCT02705872|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110451240|NCT02705872|Narcotics|narcotics|mesh-ancestor
110451241|NCT02705872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110451242|NCT02705872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110451243|NCT02705872|Analgesics|analgesics|mesh-ancestor
110451244|NCT02705872|Sensory System Agents|sensory system agents|mesh-ancestor
110451245|NCT02705872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110451246|NCT02705872|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110451247|NCT02705872|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110451249|NCT02705872|Anesthetics|anesthetics|mesh-ancestor
110451250|NCT02705872|Anesthetics, Local|anesthetics, local|mesh-ancestor
110451251|NCT02701348|Letrozole|letrozole|mesh-list
110451252|NCT02701348|Aromatase Inhibitors|aromatase inhibitors|mesh-list
110451253|NCT02701348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110451254|NCT02701348|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110451255|NCT02701348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110451256|NCT02701348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110451257|NCT02701348|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110451258|NCT02701348|Hormone Antagonists|hormone antagonists|mesh-ancestor
110451259|NCT02701348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110451260|NCT02701348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110451262|NCT05324800|Antioxidants|antioxidants|mesh-ancestor
110451263|NCT05324800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110489572|NCT00962780|Vaccines|vaccines|mesh-list
110451264|NCT05324800|Protective Agents|protective agents|mesh-ancestor
110451265|NCT05324800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110451266|NCT04258371|Dapagliflozin|dapagliflozin|mesh-list
110489635|NCT04391569|GABA Agents|gaba agents|mesh-ancestor
110451267|NCT04258371|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110451268|NCT04258371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110451269|NCT04258371|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110451270|NCT04258371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110451272|NCT00930579|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110451273|NCT00930579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110451274|NCT02700568|Axitinib|axitinib|mesh-list
110451275|NCT02700568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110451276|NCT02700568|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110451277|NCT02700568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110451278|NCT02700568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110451279|NCT00925353|Lidocaine|lidocaine|mesh-list
110451280|NCT00925353|Anesthetics, Local|anesthetics, local|mesh-ancestor
110451281|NCT00925353|Anesthetics|anesthetics|mesh-ancestor
110451282|NCT00925353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110489776|NCT04284098|Adrenergic Agents|adrenergic agents|mesh-ancestor
110451283|NCT00925353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110451284|NCT00925353|Sensory System Agents|sensory system agents|mesh-ancestor
110451285|NCT00925353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110451286|NCT00925353|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110451287|NCT00925353|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110451288|NCT00925353|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110451289|NCT00925353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110451290|NCT00925353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110451291|NCT02705482|Durvalumab|durvalumab|mesh-list
110451292|NCT02705482|Tremelimumab|tremelimumab|mesh-list
110451293|NCT02705482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110451294|NCT02705482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110451295|NCT02705638|Rituximab|rituximab|mesh-list
110451296|NCT02705638|Lenalidomide|lenalidomide|mesh-list
110451297|NCT02705638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110451298|NCT02705638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110451299|NCT02705638|Immunologic Factors|immunologic factors|mesh-ancestor
110451300|NCT02705638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110451301|NCT02705638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110451302|NCT02705638|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110451303|NCT02705638|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110451304|NCT02705638|Growth Substances|growth substances|mesh-ancestor
110451305|NCT02705638|Growth Inhibitors|growth inhibitors|mesh-ancestor
110451306|NCT02691910|Chloroquine|chloroquine|mesh-list
110451307|NCT02691910|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
110451308|NCT02691910|Primaquine|primaquine|mesh-list
110451309|NCT02691910|Amebicides|amebicides|mesh-ancestor
110451310|NCT02691910|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110451311|NCT02691910|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110451312|NCT02691910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110451313|NCT02691910|Antimalarials|antimalarials|mesh-ancestor
110451314|NCT02691910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110451315|NCT02691910|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110451316|NCT02691910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110451318|NCT02691910|Sensory System Agents|sensory system agents|mesh-ancestor
110451319|NCT02691910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110451320|NCT02691910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110451321|NCT02691910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110451322|NCT02691910|Filaricides|filaricides|mesh-ancestor
110451323|NCT02691910|Antinematodal Agents|antinematodal agents|mesh-ancestor
110451324|NCT02691910|Anthelmintics|anthelmintics|mesh-ancestor
110451325|NCT02705014|Hormones|hormones|mesh-list
110489963|NCT00958724|Vinorelbine|vinorelbine|mesh-list
110451326|NCT02705014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110451327|NCT02705014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110451328|NCT02704624|Vitamin D|vitamin d|mesh-list
110451329|NCT02704624|Vitamins|vitamins|mesh-ancestor
110451330|NCT02704624|Micronutrients|micronutrients|mesh-ancestor
110451331|NCT02704624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110451332|NCT02704624|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110451333|NCT02700022|Prednisone|prednisone|mesh-list
110451334|NCT02700022|Cyclophosphamide|cyclophosphamide|mesh-list
110451335|NCT02700022|Doxorubicin|doxorubicin|mesh-list
110451336|NCT02700022|Etoposide|etoposide|mesh-list
110451337|NCT02700022|Vincristine|vincristine|mesh-list
110451338|NCT02700022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110451339|NCT02700022|Immunologic Factors|immunologic factors|mesh-ancestor
110451340|NCT02700022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110451341|NCT02700022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110451342|NCT02700022|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110451343|NCT02700022|Alkylating Agents|alkylating agents|mesh-ancestor
110451344|NCT02700022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110451345|NCT02700022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110451346|NCT02700022|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110451347|NCT02700022|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110451348|NCT02700022|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110451349|NCT02700022|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110451351|NCT02700022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110451352|NCT02700022|Glucocorticoids|glucocorticoids|mesh-ancestor
110374035|NCT00572663|Acetylcysteine|acetylcysteine|mesh-list
110490231|NCT02856932|Dopamine Agents|dopamine agents|mesh-ancestor
110490299|NCT01005329|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110451354|NCT02700022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110451355|NCT02700022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110451356|NCT02700022|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110451357|NCT02700022|Tubulin Modulators|tubulin modulators|mesh-ancestor
110451358|NCT02700022|Antimitotic Agents|antimitotic agents|mesh-ancestor
110451359|NCT02700022|Mitosis Modulators|mitosis modulators|mesh-ancestor
110451361|NCT02699710|Methotrexate|methotrexate|mesh-list
110451362|NCT02699710|Rabeprazole|rabeprazole|mesh-list
110451363|NCT02699710|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110451364|NCT02699710|Abortifacient Agents|abortifacient agents|mesh-ancestor
110451365|NCT02699710|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110451366|NCT02699710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110296491|NCT00268398|Immunologic Factors|immunologic factors|mesh-ancestor
110451367|NCT02699710|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110451368|NCT02699710|Antimetabolites|antimetabolites|mesh-ancestor
110451369|NCT02699710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110451370|NCT02699710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110451371|NCT02699710|Dermatologic Agents|dermatologic agents|mesh-ancestor
110451372|NCT02699710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110451373|NCT02699710|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110451374|NCT02699710|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110451375|NCT02699710|Immunologic Factors|immunologic factors|mesh-ancestor
110451376|NCT02699710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110451377|NCT02699710|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110451379|NCT02699710|Vitamin B Complex|vitamin b complex|mesh-ancestor
110451380|NCT02699710|Vitamins|vitamins|mesh-ancestor
110451381|NCT02699710|Micronutrients|micronutrients|mesh-ancestor
110451382|NCT02699710|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110451383|NCT02699710|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110451384|NCT02699710|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110451386|NCT03140488|Oxytocics|oxytocics|mesh-ancestor
110451387|NCT03140488|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110451388|NCT03140488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110451389|NCT00616408|Octreotide|octreotide|mesh-list
110451390|NCT00616408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110451392|NCT00616408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110451393|NCT02691754|Acetaminophen|acetaminophen|mesh-list
110451394|NCT02691754|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110451395|NCT02691754|Analgesics|analgesics|mesh-ancestor
110451396|NCT02691754|Sensory System Agents|sensory system agents|mesh-ancestor
110451397|NCT02691754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110451398|NCT02691754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110451399|NCT02691754|Antipyretics|antipyretics|mesh-ancestor
110451400|NCT02691676|Plasma-lyte 148|plasma-lyte 148|mesh-list
110451401|NCT02691676|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110451402|NCT02691676|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110451403|NCT05321602|Paliperidone Palmitate|paliperidone palmitate|mesh-list
110451404|NCT05321602|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110451405|NCT05321602|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110451406|NCT05321602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110451407|NCT05321602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110451408|NCT05321602|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110451409|NCT05321602|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110451410|NCT05321602|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110451411|NCT05321602|Serotonin Agents|serotonin agents|mesh-ancestor
110451412|NCT05321602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110451413|NCT05321602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110451414|NCT05321602|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110451415|NCT05321602|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110451416|NCT05321602|Dopamine Agents|dopamine agents|mesh-ancestor
110451417|NCT01106651|Canagliflozin|canagliflozin|mesh-list
110098474|NCT01742702|Bisoprolol|bisoprolol|mesh-list
110451418|NCT01106651|Hypoglycemic Agents|hypoglycemic agents|mesh-list
110451419|NCT01106651|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110451420|NCT01106651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110451421|NCT01106651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110451422|NCT00637078|Amlodipine|amlodipine|mesh-list
110451423|NCT00637078|Spironolactone|spironolactone|mesh-list
110451424|NCT00637078|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110451425|NCT00637078|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110490684|NCT02855294|Drospirenone|drospirenone|mesh-list
110451426|NCT00637078|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110451427|NCT00637078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110451428|NCT00637078|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110451429|NCT00637078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110451430|NCT00637078|Vasodilator Agents|vasodilator agents|mesh-ancestor
110490757|NCT00053677|Naltrexone|naltrexone|mesh-list
110250914|NCT01154439|Cytarabine|cytarabine|mesh-list
110451431|NCT00637078|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110451432|NCT00637078|Hormone Antagonists|hormone antagonists|mesh-ancestor
110451433|NCT00637078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110451434|NCT00637078|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110451435|NCT00637078|Diuretics|diuretics|mesh-ancestor
110451436|NCT00637078|Natriuretic Agents|natriuretic agents|mesh-ancestor
110451437|NCT00625781|Insulin|insulin|mesh-list
110451438|NCT00625781|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110451439|NCT00625781|Insulin Aspart|insulin aspart|mesh-list
110451440|NCT00625781|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110451441|NCT00625781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110451442|NCT01027650|Dexamethasone|dexamethasone|mesh-list
110451443|NCT01027650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110451444|NCT01027650|Antiemetics|antiemetics|mesh-ancestor
110451445|NCT01027650|Autonomic Agents|autonomic agents|mesh-ancestor
110451446|NCT01027650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110451447|NCT01027650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110451448|NCT01027650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110451449|NCT01027650|Glucocorticoids|glucocorticoids|mesh-ancestor
110451450|NCT01027650|Hormones|hormones|mesh-ancestor
110490894|NCT00730756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110451451|NCT01027650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110451452|NCT01027650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110451453|NCT01027650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110451454|NCT00616876|Lactulose|lactulose|mesh-list
110451455|NCT00616876|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110451456|NCT01106027|Eculizumab|eculizumab|mesh-list
110451457|NCT01106027|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
110451458|NCT01106027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110451459|NCT01106027|Immunologic Factors|immunologic factors|mesh-ancestor
110451460|NCT01106027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110451461|NCT01027416|Tamoxifen|tamoxifen|mesh-list
110451462|NCT01027416|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110451463|NCT01027416|Hormone Antagonists|hormone antagonists|mesh-ancestor
110451464|NCT01027416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110451465|NCT01027416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110451466|NCT01027416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110451467|NCT01027416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110451468|NCT01027416|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110451469|NCT01027416|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110451470|NCT01027416|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110451471|NCT02873520|Immunomodulating Agents|immunomodulating agents|mesh-list
110451472|NCT02873520|Immunologic Factors|immunologic factors|mesh-ancestor
110451473|NCT02873520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110451474|NCT05026203|Midazolam|midazolam|mesh-list
110451475|NCT05026203|Ketamine|ketamine|mesh-list
110451476|NCT05026203|Analgesics|analgesics|mesh-ancestor
110451477|NCT05026203|Sensory System Agents|sensory system agents|mesh-ancestor
110451478|NCT05026203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110451479|NCT05026203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110451480|NCT05026203|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110451481|NCT05026203|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110451482|NCT05026203|Anesthetics, General|anesthetics, general|mesh-ancestor
110451483|NCT05026203|Anesthetics|anesthetics|mesh-ancestor
110451484|NCT05026203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110451485|NCT05026203|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110451486|NCT05026203|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110491004|NCT00602342|Terbinafine|terbinafine|mesh-list
110451487|NCT05026203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110451488|NCT05026203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110451489|NCT05026203|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110451490|NCT05026203|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110451491|NCT05026203|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110451492|NCT05026203|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110451493|NCT05026203|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110451494|NCT05026203|GABA Modulators|gaba modulators|mesh-ancestor
110451495|NCT05026203|GABA Agents|gaba agents|mesh-ancestor
110451496|NCT01015638|Clindamycin|clindamycin|mesh-list
110451497|NCT01015638|Clindamycin palmitate|clindamycin palmitate|mesh-list
110451498|NCT01015638|Clindamycin phosphate|clindamycin phosphate|mesh-list
110451499|NCT01015638|Benzoyl Peroxide|benzoyl peroxide|mesh-list
110451500|NCT01015638|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110451501|NCT01015638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110451502|NCT01015638|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110451503|NCT01015638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110296636|NCT04555525|Sarecycline|sarecycline|mesh-list
110451504|NCT01015638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110451506|NCT00627744|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110451507|NCT00627744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110451508|NCT00627744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110451509|NCT00627744|Incretins|incretins|mesh-ancestor
110451510|NCT00627744|Hormones|hormones|mesh-ancestor
110451511|NCT00627744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110451512|NCT00627744|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110451513|NCT00627744|Protease Inhibitors|protease inhibitors|mesh-ancestor
110451514|NCT00627744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110451515|NCT00627744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110451516|NCT01105091|Epoprostenol|epoprostenol|mesh-list
110451517|NCT01105091|Tezosentan|tezosentan|mesh-list
110451518|NCT01105091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110491065|NCT01410344|Antimetabolites|antimetabolites|mesh-ancestor
110451519|NCT01105091|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110451520|NCT01105091|Vasodilator Agents|vasodilator agents|mesh-ancestor
110451522|NCT00628056|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110451523|NCT00628056|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110451524|NCT00628056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110451525|NCT00628056|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110451526|NCT00628056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110451527|NCT00628056|Vasodilator Agents|vasodilator agents|mesh-ancestor
110451528|NCT00924729|Moxifloxacin|moxifloxacin|mesh-list
110451529|NCT00924729|Besifloxacin|besifloxacin|mesh-list
110451530|NCT00924729|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110451531|NCT00924729|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110451532|NCT00924729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110451533|NCT00924729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110451534|NCT00924729|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110451535|NCT00924729|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110451536|NCT00924729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110451537|NCT00924729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110451538|NCT00924729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110451539|NCT01099709|Oxycodone|oxycodone|mesh-list
110451540|NCT01099709|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110451541|NCT01099709|Narcotics|narcotics|mesh-ancestor
110451542|NCT01099709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110451543|NCT01099709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110451544|NCT01099709|Analgesics|analgesics|mesh-ancestor
110451545|NCT01099709|Sensory System Agents|sensory system agents|mesh-ancestor
110451546|NCT01099709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110451547|NCT04907019|Rifampin|rifampin|mesh-list
110451548|NCT04907019|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110451549|NCT04907019|Antitubercular Agents|antitubercular agents|mesh-ancestor
110451550|NCT04907019|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110451551|NCT04907019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110451552|NCT04907019|Leprostatic Agents|leprostatic agents|mesh-ancestor
110451553|NCT04907019|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110451554|NCT04907019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110491294|NCT02563327|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110451555|NCT04907019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110451556|NCT04907019|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110451557|NCT04907019|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110250944|NCT00133172|Prednisone|prednisone|mesh-list
110451558|NCT04907019|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110451559|NCT04907019|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110451560|NCT04907019|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110451561|NCT04907019|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110451562|NCT01022424|Tolvaptan|tolvaptan|mesh-list
110451563|NCT01022424|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
110451564|NCT01022424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110451565|NCT01022424|Natriuretic Agents|natriuretic agents|mesh-ancestor
110451566|NCT01022424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110451567|NCT05329857|Metformin|metformin|mesh-list
110451568|NCT05329857|Vildagliptin|vildagliptin|mesh-list
110451569|NCT05329857|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110451570|NCT05329857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110451571|NCT05329857|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110451572|NCT05329857|Protease Inhibitors|protease inhibitors|mesh-ancestor
110451573|NCT05329857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110451574|NCT05329857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110451575|NCT01026948|Dinoprostone|dinoprostone|mesh-list
110451576|NCT01026948|Oxytocics|oxytocics|mesh-ancestor
110451577|NCT01026948|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110451578|NCT01026948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110451579|NCT01104779|Cariprazine|cariprazine|mesh-list
110451580|NCT01104779|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110451581|NCT01104779|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110451582|NCT01104779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110451583|NCT01104779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110451584|NCT01104779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110451585|NCT00918957|Tobramycin|tobramycin|mesh-list
110451586|NCT00918957|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110451587|NCT00918957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110451588|NCT04308161|Vitamin D|vitamin d|mesh-list
110451589|NCT04308161|Miconazole|miconazole|mesh-list
110451590|NCT04308161|Vitamins|vitamins|mesh-ancestor
110451591|NCT04308161|Micronutrients|micronutrients|mesh-ancestor
110451592|NCT04308161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110451593|NCT04308161|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110451594|NCT04308161|Antifungal Agents|antifungal agents|mesh-ancestor
110491760|NCT00747721|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110451595|NCT04308161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110451596|NCT04308161|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110451597|NCT04308161|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110451598|NCT04308161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110451599|NCT04308161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110451600|NCT04308161|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110451601|NCT04308161|Hormone Antagonists|hormone antagonists|mesh-ancestor
110451602|NCT04308161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110451603|NCT04308161|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110451604|NCT04308161|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110451605|NCT04939467|Pirfenidone|pirfenidone|mesh-list
110451606|NCT04939467|Nintedanib|nintedanib|mesh-list
110451607|NCT04939467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110451608|NCT04939467|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110451609|NCT04939467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110451610|NCT04939467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110451611|NCT04939467|Analgesics|analgesics|mesh-ancestor
110451612|NCT04939467|Sensory System Agents|sensory system agents|mesh-ancestor
110451613|NCT04939467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110491890|NCT00752479|Prednisolone|prednisolone|mesh-list
110451614|NCT04939467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110451615|NCT04939467|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110451616|NCT04939467|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110451617|NCT04939467|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110451618|NCT04939467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110451619|NCT01015560|Antibodies|antibodies|mesh-list
110451620|NCT01015560|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110451621|NCT01015560|Immunologic Factors|immunologic factors|mesh-ancestor
110492031|NCT04614545|Phentermine|phentermine|mesh-list
110451622|NCT01015560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110451623|NCT04253223|Volagidemab|volagidemab|mesh-list
110451624|NCT04253223|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110451625|NCT04253223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110451626|NCT00918879|Saxagliptin|saxagliptin|mesh-list
110451627|NCT00918879|Incretins|incretins|mesh-ancestor
110451628|NCT00918879|Hormones|hormones|mesh-ancestor
110451629|NCT00918879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110451630|NCT00918879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110492173|NCT02559973|Sensory System Agents|sensory system agents|mesh-ancestor
110451631|NCT00918879|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110451632|NCT00918879|Protease Inhibitors|protease inhibitors|mesh-ancestor
110451633|NCT00918879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110451634|NCT00918879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110451635|NCT00918879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110451636|NCT01026792|Sirolimus|sirolimus|mesh-list
110451637|NCT01026792|Temsirolimus|temsirolimus|mesh-list
110451638|NCT01026792|MTOR Inhibitors|mtor inhibitors|mesh-list
110451639|NCT01026792|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110451640|NCT01026792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110451641|NCT01026792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110451642|NCT01026792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110451643|NCT01026792|Immunologic Factors|immunologic factors|mesh-ancestor
110451644|NCT01026792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110451645|NCT01026792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110451646|NCT01026792|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110451647|NCT01026792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110451648|NCT01026792|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110451649|NCT01026792|Antifungal Agents|antifungal agents|mesh-ancestor
110451650|NCT01026324|Cyclin-Dependent Kinase Inhibitor Proteins|cyclin-dependent kinase inhibitor proteins|mesh-list
110451651|NCT01026324|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110451652|NCT01026324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110451653|NCT01026324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110451654|NCT04300686|Adalimumab|adalimumab|mesh-list
110451655|NCT04300686|Antibodies|antibodies|mesh-list
110451656|NCT04300686|Immunoglobulins|immunoglobulins|mesh-list
110451657|NCT04300686|Immunologic Factors|immunologic factors|mesh-ancestor
110451658|NCT04300686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110451659|NCT04300686|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110451660|NCT04300686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110451661|NCT04300686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110451662|NCT01098539|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110451663|NCT01098539|rGLP-1 protein|rglp-1 protein|mesh-list
110451664|NCT01098539|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110451665|NCT01098539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110451666|NCT01098539|Incretins|incretins|mesh-ancestor
110451667|NCT01098539|Hormones|hormones|mesh-ancestor
110451668|NCT01098539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110451669|NCT01098539|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110492512|NCT00741286|Analgesics|analgesics|mesh-ancestor
110451670|NCT01098539|Protease Inhibitors|protease inhibitors|mesh-ancestor
110451671|NCT01098539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110451672|NCT01098539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110451673|NCT04922723|Daratumumab|daratumumab|mesh-list
110451674|NCT04922723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110451675|NCT01098461|rGLP-1 protein|rglp-1 protein|mesh-list
110451676|NCT01098461|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
110451677|NCT01098461|Incretins|incretins|mesh-ancestor
110451678|NCT01098461|Hormones|hormones|mesh-ancestor
110451679|NCT01098461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110451680|NCT01098461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110451681|NCT01098305|Varenicline|varenicline|mesh-list
110451682|NCT01098305|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110451683|NCT01098305|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110451684|NCT01098305|Cholinergic Agents|cholinergic agents|mesh-ancestor
110451685|NCT01098305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110492653|NCT00679627|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110655638|NCT00425854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110451686|NCT01098305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110451687|NCT01098305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110451688|NCT00833833|Aspirin|aspirin|mesh-list
110451689|NCT00833833|Dexamethasone|dexamethasone|mesh-list
110451690|NCT00833833|Dexamethasone acetate|dexamethasone acetate|mesh-list
110451691|NCT00833833|Pomalidomide|pomalidomide|mesh-list
110451692|NCT00833833|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
110451693|NCT00833833|BB 1101|bb 1101|mesh-list
110451694|NCT00833833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110451695|NCT00833833|Antiemetics|antiemetics|mesh-ancestor
110451696|NCT00833833|Autonomic Agents|autonomic agents|mesh-ancestor
110451697|NCT00833833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110451698|NCT00833833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110451699|NCT00833833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110451700|NCT00833833|Glucocorticoids|glucocorticoids|mesh-ancestor
110451701|NCT00833833|Hormones|hormones|mesh-ancestor
110451702|NCT00833833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110451703|NCT00833833|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110451704|NCT00833833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110451705|NCT00833833|Protease Inhibitors|protease inhibitors|mesh-ancestor
110451706|NCT00833833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110451707|NCT00833833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110492731|NCT02589340|Buspirone|buspirone|mesh-list
110451708|NCT00833833|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110451709|NCT00833833|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110451710|NCT00833833|Analgesics|analgesics|mesh-ancestor
110451711|NCT00833833|Sensory System Agents|sensory system agents|mesh-ancestor
110451712|NCT00833833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110451713|NCT00833833|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110451714|NCT00833833|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110451715|NCT00833833|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110451716|NCT00833833|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110451718|NCT00833833|Immunologic Factors|immunologic factors|mesh-ancestor
110451719|NCT00833833|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110451720|NCT00833833|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110451721|NCT00833833|Growth Substances|growth substances|mesh-ancestor
110451722|NCT00833833|Growth Inhibitors|growth inhibitors|mesh-ancestor
110451723|NCT01098071|Mometasone Furoate|mometasone furoate|mesh-list
110451724|NCT01098071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110492948|NCT04968106|Ifosfamide|ifosfamide|mesh-list
110451725|NCT01098071|Dermatologic Agents|dermatologic agents|mesh-ancestor
110451726|NCT01098071|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110451727|NCT02612545|Piperaquine|piperaquine|mesh-list
110451729|NCT02612545|Mefloquine|mefloquine|mesh-list
110451730|NCT02612545|Antimalarials|antimalarials|mesh-ancestor
110451731|NCT02612545|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110451732|NCT02612545|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110451733|NCT02612545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110451735|NCT00704743|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
110451736|NCT00704743|Protease Inhibitors|protease inhibitors|mesh-ancestor
110451737|NCT00704743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110451738|NCT00704743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110451739|NCT01097057|Plerixafor|plerixafor|mesh-list
110451740|NCT01097057|Rituximab|rituximab|mesh-list
110451741|NCT01097057|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110451742|NCT01097057|Carboplatin|carboplatin|mesh-list
110451743|NCT01097057|Etoposide|etoposide|mesh-list
110451744|NCT01097057|Etoposide phosphate|etoposide phosphate|mesh-list
110451745|NCT01097057|Ifosfamide|ifosfamide|mesh-list
110451746|NCT01097057|Isophosphamide mustard|isophosphamide mustard|mesh-list
110451747|NCT01097057|Podophyllotoxin|podophyllotoxin|mesh-list
110451748|NCT01097057|Antibodies|antibodies|mesh-list
110451749|NCT01097057|Immunoglobulins|immunoglobulins|mesh-list
110451750|NCT01097057|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110451751|NCT01097057|Lenograstim|lenograstim|mesh-list
110451752|NCT01097057|Immunologic Factors|immunologic factors|mesh-ancestor
110451753|NCT01097057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110451754|NCT01097057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110451755|NCT01097057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110451756|NCT01097057|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110451757|NCT01097057|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110451758|NCT01097057|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110451759|NCT01097057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110451760|NCT01097057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110451761|NCT01097057|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110451762|NCT01097057|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110451763|NCT01097057|Alkylating Agents|alkylating agents|mesh-ancestor
110451764|NCT01097057|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110451765|NCT01097057|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110451766|NCT01097057|Antiviral Agents|antiviral agents|mesh-ancestor
110451767|NCT01097057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110451768|NCT01097057|Keratolytic Agents|keratolytic agents|mesh-ancestor
110451769|NCT01097057|Dermatologic Agents|dermatologic agents|mesh-ancestor
110451770|NCT01097057|Tubulin Modulators|tubulin modulators|mesh-ancestor
110451771|NCT01097057|Antimitotic Agents|antimitotic agents|mesh-ancestor
110451772|NCT01097057|Mitosis Modulators|mitosis modulators|mesh-ancestor
110451773|NCT02612701|Nicotine|nicotine|mesh-list
110451774|NCT02612701|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110451775|NCT02612701|Autonomic Agents|autonomic agents|mesh-ancestor
110451776|NCT02612701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110451777|NCT02612701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110451778|NCT02612701|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110451779|NCT02612701|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110451780|NCT02612701|Cholinergic Agents|cholinergic agents|mesh-ancestor
110451781|NCT02612701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110451782|NCT02612701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110451783|NCT01096667|Ertugliflozin|ertugliflozin|mesh-list
110451784|NCT01096667|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110451785|NCT01096667|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110451786|NCT01096667|Diuretics|diuretics|mesh-ancestor
110451787|NCT01096667|Natriuretic Agents|natriuretic agents|mesh-ancestor
110451788|NCT01096667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110493058|NCT00758407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110451789|NCT01096667|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110098853|NCT01744587|Antioxidants|antioxidants|mesh-ancestor
110451790|NCT01096667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110451791|NCT01096667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110451792|NCT01096667|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110451793|NCT01096667|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110451795|NCT01014624|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
110451796|NCT01014624|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110451797|NCT01014624|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110451798|NCT01014624|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110451799|NCT01014624|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110451800|NCT01014624|Purinergic Agents|purinergic agents|mesh-ancestor
110451801|NCT01014624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110451802|NCT01014624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110451803|NCT01014624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110451804|NCT01021878|Icodextrin|icodextrin|mesh-list
110493145|NCT00760279|Azithromycin|azithromycin|mesh-list
110451805|NCT01021878|Dialysis Solutions|dialysis solutions|mesh-ancestor
110451806|NCT01021878|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110451807|NCT02872428|Valproic Acid|valproic acid|mesh-list
110451808|NCT02872428|Anticonvulsants|anticonvulsants|mesh-ancestor
110451809|NCT02872428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110451810|NCT02872428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110451811|NCT02872428|GABA Agents|gaba agents|mesh-ancestor
110451812|NCT02872428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110451813|NCT02872428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110451814|NCT02872428|Antimanic Agents|antimanic agents|mesh-ancestor
110451815|NCT02872428|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110451816|NCT02872428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110451817|NCT02872428|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110451818|NCT02873364|Vitamin D|vitamin d|mesh-list
110451819|NCT02873364|Ergocalciferols|ergocalciferols|mesh-list
110451820|NCT02873364|Cholecalciferol|cholecalciferol|mesh-list
110451821|NCT02873364|Vitamins|vitamins|mesh-list
110451822|NCT02873364|Micronutrients|micronutrients|mesh-ancestor
110451823|NCT02873364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110493273|NCT04551040|Terazosin|terazosin|mesh-list
110451824|NCT02873364|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110451825|NCT02873364|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110451826|NCT00628290|Cannabidiol|cannabidiol|mesh-list
110451827|NCT00628290|Amisulpride|amisulpride|mesh-list
110451828|NCT00628290|Anticonvulsants|anticonvulsants|mesh-ancestor
110451829|NCT00628290|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110451830|NCT00628290|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110451831|NCT00628290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110451832|NCT00628290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110451833|NCT00628290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110493421|NCT02583958|Laxatives|laxatives|mesh-ancestor
110451835|NCT00628290|Dopamine Agents|dopamine agents|mesh-ancestor
110451836|NCT00628290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110451837|NCT00628290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110451838|NCT00628290|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110451840|NCT04559412|Etanercept|etanercept|mesh-list
110451841|NCT04559412|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110451842|NCT04559412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110451843|NCT04559412|Analgesics|analgesics|mesh-ancestor
110451844|NCT04559412|Sensory System Agents|sensory system agents|mesh-ancestor
110451845|NCT04559412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110451846|NCT04559412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110451847|NCT04559412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110451848|NCT04559412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110451849|NCT04559412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110451850|NCT04559412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110451851|NCT04559412|Immunologic Factors|immunologic factors|mesh-ancestor
110451852|NCT00854113|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
110451853|NCT00854113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110451854|NCT00854113|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110451855|NCT00854113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110451856|NCT02872584|Prednisone|prednisone|mesh-list
110451857|NCT02872584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110451858|NCT02872584|Glucocorticoids|glucocorticoids|mesh-ancestor
110451859|NCT02872584|Hormones|hormones|mesh-ancestor
110493688|NCT05844813|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110451860|NCT02872584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110451861|NCT02872584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110493762|NCT05678647|Iron|iron|mesh-list
110451862|NCT02872584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110451863|NCT02872584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110451864|NCT00704821|Docetaxel|docetaxel|mesh-list
110451865|NCT00704821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110451866|NCT00704821|Tubulin Modulators|tubulin modulators|mesh-ancestor
110451867|NCT00704821|Antimitotic Agents|antimitotic agents|mesh-ancestor
110451868|NCT00704821|Mitosis Modulators|mitosis modulators|mesh-ancestor
110451869|NCT00704821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110451871|NCT00704899|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110451872|NCT00704899|Antidepressive Agents|antidepressive agents|mesh-ancestor
110451873|NCT00704899|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110451874|NCT00704899|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110451876|NCT00704899|Sensory System Agents|sensory system agents|mesh-ancestor
110451877|NCT00704899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110451878|NCT00704899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110451879|NCT00704899|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110451880|NCT00704899|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110493972|NCT04983940|Hormones|hormones|mesh-ancestor
110451882|NCT00704899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110451883|NCT00704899|Adrenergic Agents|adrenergic agents|mesh-ancestor
110451884|NCT00704899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110451886|NCT01104701|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110451887|NCT01104701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110451888|NCT01104701|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110451889|NCT01104701|Incretins|incretins|mesh-ancestor
110451891|NCT01104701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110451892|NCT00833755|Ketamine|ketamine|mesh-list
110451893|NCT00833755|Analgesics|analgesics|mesh-ancestor
110451894|NCT00833755|Sensory System Agents|sensory system agents|mesh-ancestor
110451895|NCT00833755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110451896|NCT00833755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110451897|NCT00833755|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110451898|NCT00833755|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110451899|NCT00833755|Anesthetics, General|anesthetics, general|mesh-ancestor
110451900|NCT00833755|Anesthetics|anesthetics|mesh-ancestor
110451901|NCT00833755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110451902|NCT00833755|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110451903|NCT00833755|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110451904|NCT00833755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110451905|NCT00833755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110451906|NCT01021332|Tamsulosin|tamsulosin|mesh-list
110451907|NCT01021332|Solifenacin Succinate|solifenacin succinate|mesh-list
110451908|NCT01021332|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110451909|NCT01021332|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110451910|NCT01021332|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110451911|NCT01021332|Adrenergic Agents|adrenergic agents|mesh-ancestor
110451912|NCT01021332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110451913|NCT01021332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110451914|NCT01021332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110451915|NCT01021332|Urological Agents|urological agents|mesh-ancestor
110451916|NCT01021332|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110451917|NCT01021332|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110451918|NCT01021332|Cholinergic Agents|cholinergic agents|mesh-ancestor
110451919|NCT00923091|Amlodipine|amlodipine|mesh-list
110451920|NCT00923091|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110451921|NCT00923091|Olmesartan|olmesartan|mesh-list
110451922|NCT00923091|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
110451923|NCT00923091|Amlodipine Besylate, Olmesartan Medoxomil Drug Combination|amlodipine besylate, olmesartan medoxomil drug combination|mesh-list
110451924|NCT00923091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110451925|NCT00923091|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110451926|NCT00923091|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110451927|NCT00923091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110451928|NCT00923091|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110451929|NCT00923091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110451930|NCT00923091|Vasodilator Agents|vasodilator agents|mesh-ancestor
110451931|NCT00923091|Diuretics|diuretics|mesh-ancestor
110451932|NCT00923091|Natriuretic Agents|natriuretic agents|mesh-ancestor
110451933|NCT00923091|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110451934|NCT00923091|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110451935|NCT00923091|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110451936|NCT00853957|Amlodipine|amlodipine|mesh-list
110494440|NCT02706054|Meloxicam|meloxicam|mesh-list
110451937|NCT00853957|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110451938|NCT00853957|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110451939|NCT00853957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110451940|NCT00853957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110451941|NCT00853957|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110451942|NCT00853957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110451943|NCT00853957|Vasodilator Agents|vasodilator agents|mesh-ancestor
110451944|NCT01021020|Colchicine|colchicine|mesh-list
110451945|NCT01021020|Probenecid|probenecid|mesh-list
110451946|NCT01021020|Gout Suppressants|gout suppressants|mesh-ancestor
110494504|NCT02168140|Antioxidants|antioxidants|mesh-ancestor
110451947|NCT01021020|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110451948|NCT01021020|Tubulin Modulators|tubulin modulators|mesh-ancestor
110451949|NCT01021020|Antimitotic Agents|antimitotic agents|mesh-ancestor
110451950|NCT01021020|Mitosis Modulators|mitosis modulators|mesh-ancestor
110451951|NCT01021020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110451952|NCT01021020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110451954|NCT00833053|Infliximab|infliximab|mesh-list
110451955|NCT00833053|Methotrexate|methotrexate|mesh-list
110451956|NCT00833053|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110451957|NCT00833053|Abortifacient Agents|abortifacient agents|mesh-ancestor
110451958|NCT00833053|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110451959|NCT00833053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110451960|NCT00833053|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110451961|NCT00833053|Antimetabolites|antimetabolites|mesh-ancestor
110451962|NCT00833053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110451963|NCT00833053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110451964|NCT00833053|Dermatologic Agents|dermatologic agents|mesh-ancestor
110451965|NCT00833053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110451966|NCT00833053|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110451967|NCT00833053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110451968|NCT00833053|Immunologic Factors|immunologic factors|mesh-ancestor
110451969|NCT00833053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110451970|NCT00833053|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110451971|NCT00833053|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110451972|NCT00833053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110451973|NCT00833053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110451974|NCT01020786|Carboplatin|carboplatin|mesh-list
110451976|NCT01020786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110451977|NCT01020786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110494688|NCT00574951|Imetelstat|imetelstat|mesh-list
110451978|NCT01020786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110451979|NCT01020786|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110451980|NCT01020786|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110451981|NCT00918645|Calcium|calcium|mesh-list
110451982|NCT00918645|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110451983|NCT00918645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110451984|NCT01020474|Pregabalin|pregabalin|mesh-list
110451985|NCT01020474|Analgesics|analgesics|mesh-ancestor
110451986|NCT01020474|Sensory System Agents|sensory system agents|mesh-ancestor
110451987|NCT01020474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110451988|NCT01020474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110451989|NCT01020474|Anticonvulsants|anticonvulsants|mesh-ancestor
110451990|NCT01020474|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110451991|NCT01020474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110494902|NCT00770497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110451992|NCT01020474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110451993|NCT01020474|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110451994|NCT01020474|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110451995|NCT01020474|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110451996|NCT01020474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110451997|NCT01020474|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110451998|NCT02872818|Metformin|metformin|mesh-list
110451999|NCT02872818|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
110452000|NCT02872818|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110452001|NCT02872818|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110495043|NCT00668863|Antidotes|antidotes|mesh-ancestor
110452002|NCT02872818|Medroxyprogesterone|medroxyprogesterone|mesh-list
110452004|NCT02872818|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110452005|NCT02872818|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110495114|NCT00771199|Anesthetics, General|anesthetics, general|mesh-ancestor
110452006|NCT02872818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110452007|NCT02872818|Estrogens|estrogens|mesh-ancestor
110452008|NCT02872818|Hormones|hormones|mesh-ancestor
110452009|NCT02872818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110452010|NCT02872818|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110452011|NCT02872818|Contraceptive Agents|contraceptive agents|mesh-ancestor
110452012|NCT02872818|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110452013|NCT02872818|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110452014|NCT02872818|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110452015|NCT02872818|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110452016|NCT02872818|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110452017|NCT02872818|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110452018|NCT02872818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110452019|NCT02872818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110452020|NCT00922779|Ribavirin|ribavirin|mesh-list
110452021|NCT00922779|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110452022|NCT00922779|Antimetabolites|antimetabolites|mesh-ancestor
110452023|NCT00922779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110452024|NCT00922779|Antiviral Agents|antiviral agents|mesh-ancestor
110452025|NCT00922779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110452026|NCT04528680|Paclitaxel|paclitaxel|mesh-list
110452027|NCT04528680|Carboplatin|carboplatin|mesh-list
110452028|NCT04528680|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110452029|NCT04528680|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110452030|NCT04528680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110452031|NCT04528680|Tubulin Modulators|tubulin modulators|mesh-ancestor
110452032|NCT04528680|Antimitotic Agents|antimitotic agents|mesh-ancestor
110452033|NCT04528680|Mitosis Modulators|mitosis modulators|mesh-ancestor
110452034|NCT04528680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110452035|NCT04570410|Gemcitabine|gemcitabine|mesh-list
110452036|NCT04570410|Tislelizumab|tislelizumab|mesh-list
110452037|NCT04570410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110452038|NCT04570410|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110452039|NCT04570410|Antimetabolites|antimetabolites|mesh-ancestor
110452040|NCT04570410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110452041|NCT04570410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110452042|NCT04203771|Ibuprofen|ibuprofen|mesh-list
110452043|NCT04203771|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110452044|NCT04203771|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110452045|NCT04203771|Analgesics|analgesics|mesh-ancestor
110452046|NCT04203771|Sensory System Agents|sensory system agents|mesh-ancestor
110452047|NCT04203771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110452048|NCT04203771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110452049|NCT04203771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110452050|NCT04203771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110452051|NCT04203771|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110452052|NCT04203771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110452053|NCT04203771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110452054|NCT04256733|Capsaicin|capsaicin|mesh-list
110452055|NCT04256733|Antipruritics|antipruritics|mesh-ancestor
110452056|NCT04256733|Dermatologic Agents|dermatologic agents|mesh-ancestor
110452057|NCT04256733|Sensory System Agents|sensory system agents|mesh-ancestor
110452058|NCT04256733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110452059|NCT04256733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110452060|NCT01025232|Ranibizumab|ranibizumab|mesh-list
110452061|NCT01025232|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110452062|NCT01025232|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110452063|NCT01025232|Growth Substances|growth substances|mesh-ancestor
110452064|NCT01025232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110452065|NCT01025232|Growth Inhibitors|growth inhibitors|mesh-ancestor
110452066|NCT01025232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110452067|NCT05321199|Tranexamic Acid|tranexamic acid|mesh-list
110452068|NCT05321199|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110452069|NCT05321199|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110452070|NCT05321199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110495501|NCT00768157|Lamivudine|lamivudine|mesh-list
110452072|NCT05321199|Coagulants|coagulants|mesh-ancestor
110452073|NCT04300452|Carbetocin|carbetocin|mesh-list
110452074|NCT04300452|Ergonovine|ergonovine|mesh-list
110452075|NCT04300452|Oxytocics|oxytocics|mesh-ancestor
110452076|NCT04300452|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110452077|NCT04300452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110452078|NCT01025154|Cytarabine|cytarabine|mesh-list
110452079|NCT01025154|Clofarabine|clofarabine|mesh-list
110452080|NCT01025154|Idarubicin|idarubicin|mesh-list
110495568|NCT00669877|Hormones|hormones|mesh-ancestor
110452081|NCT01025154|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110452083|NCT01025154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110452084|NCT01025154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110452085|NCT01025154|Antiviral Agents|antiviral agents|mesh-ancestor
110452086|NCT01025154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110452087|NCT01025154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110452089|NCT01025154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110452090|NCT01025154|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110452091|NCT01025154|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110452092|NCT01025154|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110452093|NCT01025154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110452094|NCT04252365|Pembrolizumab|pembrolizumab|mesh-list
110452095|NCT04252365|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110452096|NCT04252365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110452097|NCT04252365|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110495775|NCT02579902|Vitamin D|vitamin d|mesh-list
110452098|NCT04252365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110452099|NCT04252443|Analgesics, Opioid|analgesics, opioid|mesh-list
110452100|NCT04252443|Analgesics|analgesics|mesh-list
110452101|NCT04252443|Narcotics|narcotics|mesh-ancestor
110452102|NCT04252443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110452103|NCT04252443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110452104|NCT04252443|Sensory System Agents|sensory system agents|mesh-ancestor
110452105|NCT04252443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110452106|NCT00832819|Paclitaxel|paclitaxel|mesh-list
110452107|NCT00832819|Carboplatin|carboplatin|mesh-list
110452108|NCT00832819|Lenvatinib|lenvatinib|mesh-list
110452109|NCT00832819|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110452110|NCT00832819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110452111|NCT00832819|Tubulin Modulators|tubulin modulators|mesh-ancestor
110452112|NCT00832819|Antimitotic Agents|antimitotic agents|mesh-ancestor
110452113|NCT00832819|Mitosis Modulators|mitosis modulators|mesh-ancestor
110452114|NCT00832819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110452115|NCT00832819|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110452116|NCT00832819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110452117|NCT04820361|Parasympatholytics|parasympatholytics|mesh-list
110452118|NCT04820361|Autonomic Agents|autonomic agents|mesh-ancestor
110452119|NCT04820361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110452120|NCT04820361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110452121|NCT00853723|Teriparatide|teriparatide|mesh-list
110452122|NCT00853723|Hormones|hormones|mesh-list
110452123|NCT00853723|Parathyroid Hormone|parathyroid hormone|mesh-list
110452124|NCT00853723|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
110452125|NCT00853723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110495986|NCT00934856|Mitosis Modulators|mitosis modulators|mesh-ancestor
110452126|NCT00853723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110452127|NCT00853723|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110452128|NCT00853723|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110496046|NCT00779389|Dasatinib|dasatinib|mesh-list
110452130|NCT00918255|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110452131|NCT00918255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110452132|NCT00918255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110452133|NCT01096589|Monensin|monensin|mesh-list
110452134|NCT01096589|Antifungal Agents|antifungal agents|mesh-ancestor
110452135|NCT01096589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110452136|NCT01096589|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110452137|NCT01096589|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110496115|NCT00780325|Diuretics|diuretics|mesh-ancestor
110452138|NCT01096589|Coccidiostats|coccidiostats|mesh-ancestor
110452139|NCT01096589|Proton Ionophores|proton ionophores|mesh-ancestor
110452140|NCT01096589|Uncoupling Agents|uncoupling agents|mesh-ancestor
110452141|NCT01096589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110452142|NCT01096589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110452143|NCT01096589|Ionophores|ionophores|mesh-ancestor
110452144|NCT01096589|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110452145|NCT01096589|Sodium Ionophores|sodium ionophores|mesh-ancestor
110452146|NCT04252521|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
110452147|NCT04252521|Ketoprofen|ketoprofen|mesh-list
110452148|NCT04252521|Metoclopramide|metoclopramide|mesh-list
110452149|NCT04252521|Antiemetics|antiemetics|mesh-ancestor
110452150|NCT04252521|Autonomic Agents|autonomic agents|mesh-ancestor
110452151|NCT04252521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110452152|NCT04252521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110452153|NCT04252521|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110452154|NCT04252521|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110452155|NCT04252521|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110452156|NCT04252521|Dopamine Agents|dopamine agents|mesh-ancestor
110496182|NCT04264988|Tin Fluorides|tin fluorides|mesh-list
110452157|NCT04252521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110452158|NCT04252521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110452159|NCT04252521|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110099223|NCT01747044|Milnacipran|milnacipran|mesh-list
110452161|NCT04252521|Analgesics|analgesics|mesh-ancestor
110452162|NCT04252521|Sensory System Agents|sensory system agents|mesh-ancestor
110452163|NCT04252521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110496307|NCT00790387|Enoxaparin|enoxaparin|mesh-list
110452164|NCT04252521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110452165|NCT04252521|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110452166|NCT04252521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110452168|NCT00845065|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110452169|NCT00845065|Antimetabolites|antimetabolites|mesh-ancestor
110452170|NCT00845065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110452171|NCT00845065|Antiviral Agents|antiviral agents|mesh-ancestor
110452172|NCT00845065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110452173|NCT04772001|Carboplatin|carboplatin|mesh-list
110452174|NCT04772001|Cisplatin|cisplatin|mesh-list
110496447|NCT00785473|Vitamins|vitamins|mesh-ancestor
110452175|NCT04772001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110452176|NCT00702091|Ramipril|ramipril|mesh-list
110452177|NCT00702091|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110452178|NCT00702091|Protease Inhibitors|protease inhibitors|mesh-ancestor
110452179|NCT00702091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110452180|NCT00702091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110297352|NCT00269568|Misoprostol|misoprostol|mesh-list
110452181|NCT00702091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110452182|NCT00832585|Alefacept|alefacept|mesh-list
110452183|NCT00832585|Dermatologic Agents|dermatologic agents|mesh-ancestor
110452184|NCT00832585|Immunologic Factors|immunologic factors|mesh-ancestor
110452185|NCT00832585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110496582|NCT04031859|Aspirin|aspirin|mesh-list
110452186|NCT00918567|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
110452187|NCT00918567|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110452188|NCT00918567|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110452189|NCT00918567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110452190|NCT00918567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110452191|NCT00918567|Adrenergic Agents|adrenergic agents|mesh-ancestor
110452192|NCT00918567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110452193|NCT00918567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110452194|NCT05252325|Lidocaine|lidocaine|mesh-list
110452195|NCT05252325|Hyaluronic Acid|hyaluronic acid|mesh-list
110452196|NCT05252325|Anesthetics, Local|anesthetics, local|mesh-ancestor
110452197|NCT05252325|Anesthetics|anesthetics|mesh-ancestor
110452198|NCT05252325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110452199|NCT05252325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110452200|NCT05252325|Sensory System Agents|sensory system agents|mesh-ancestor
110452201|NCT05252325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110452202|NCT05252325|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110452203|NCT05252325|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110452204|NCT05252325|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110452205|NCT05252325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110452206|NCT05252325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110452207|NCT05252325|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110452208|NCT05252325|Immunologic Factors|immunologic factors|mesh-ancestor
110452209|NCT05252325|Viscosupplements|viscosupplements|mesh-ancestor
110452210|NCT05252325|Protective Agents|protective agents|mesh-ancestor
110452211|NCT01024920|Sunitinib|sunitinib|mesh-list
110452212|NCT01024920|Nintedanib|nintedanib|mesh-list
110452213|NCT01024920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110452214|NCT01024920|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110452215|NCT01024920|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110452216|NCT01024920|Growth Substances|growth substances|mesh-ancestor
110452217|NCT01024920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110452218|NCT01024920|Growth Inhibitors|growth inhibitors|mesh-ancestor
110452219|NCT01024920|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110452220|NCT01024920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110452221|NCT01024920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110452222|NCT00832117|Cisplatin|cisplatin|mesh-list
110452223|NCT00832117|Epothilones|epothilones|mesh-list
110452224|NCT00832117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110452225|NCT00832117|Tubulin Modulators|tubulin modulators|mesh-ancestor
110452226|NCT00832117|Antimitotic Agents|antimitotic agents|mesh-ancestor
110452227|NCT00832117|Mitosis Modulators|mitosis modulators|mesh-ancestor
110452228|NCT00832117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110452229|NCT02872272|Amikacin|amikacin|mesh-list
110452230|NCT02872272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110452231|NCT02872272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110452232|NCT00831493|Vorinostat|vorinostat|mesh-list
110452233|NCT00831493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110452234|NCT00831493|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110452235|NCT00831493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110452236|NCT00831493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110452238|NCT00705445|Trace Elements|trace elements|mesh-list
110452239|NCT00705445|Micronutrients|micronutrients|mesh-list
110452240|NCT00705445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110452241|NCT02879981|Trimethoprim|trimethoprim|mesh-list
110452242|NCT02879981|Sulfamethoxazole|sulfamethoxazole|mesh-list
110452243|NCT02879981|Phenylpropanolamine|phenylpropanolamine|mesh-list
110452244|NCT02879981|Guaifenesin|guaifenesin|mesh-list
110452245|NCT02879981|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
110452246|NCT02879981|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110452247|NCT02879981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110452248|NCT02879981|Antimalarials|antimalarials|mesh-ancestor
110452249|NCT02879981|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110452250|NCT02879981|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110496738|NCT02869763|Ethanol|ethanol|mesh-list
110452251|NCT02879981|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110452252|NCT02879981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110297390|NCT00237224|Letrozole|letrozole|mesh-list
110452253|NCT02879981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110452254|NCT02879981|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110452255|NCT02879981|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
110452256|NCT02879981|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110452258|NCT02879981|Respiratory System Agents|respiratory system agents|mesh-ancestor
110452259|NCT02879981|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110452260|NCT02879981|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110452261|NCT02879981|Adrenergic Agents|adrenergic agents|mesh-ancestor
110452262|NCT02879981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110452263|NCT02879981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110452264|NCT02879981|Appetite Depressants|appetite depressants|mesh-ancestor
110452265|NCT02879981|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110452267|NCT02879981|Autonomic Agents|autonomic agents|mesh-ancestor
110452268|NCT02879981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110452269|NCT02879981|Nasal Decongestants|nasal decongestants|mesh-ancestor
110452270|NCT02879981|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110452271|NCT04307693|Ritonavir|ritonavir|mesh-list
110452272|NCT04307693|Lopinavir|lopinavir|mesh-list
110452273|NCT04307693|Hydroxychloroquine|hydroxychloroquine|mesh-list
110452274|NCT04307693|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110452275|NCT04307693|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110452276|NCT04307693|Protease Inhibitors|protease inhibitors|mesh-ancestor
110452277|NCT04307693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110452278|NCT04307693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110452279|NCT04307693|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110452280|NCT04307693|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110452281|NCT04307693|Antiviral Agents|antiviral agents|mesh-ancestor
110452282|NCT04307693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110452283|NCT04307693|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110452284|NCT04307693|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110452285|NCT04307693|Antimalarials|antimalarials|mesh-ancestor
110452286|NCT04307693|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110452287|NCT04307693|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110452288|NCT04307693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110452289|NCT02878421|Nicotine|nicotine|mesh-list
110452290|NCT02878421|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110452291|NCT02878421|Autonomic Agents|autonomic agents|mesh-ancestor
110452292|NCT02878421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110452293|NCT02878421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110452294|NCT02878421|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110452295|NCT02878421|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110452296|NCT02878421|Cholinergic Agents|cholinergic agents|mesh-ancestor
110452297|NCT02878421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110452298|NCT02878421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110452299|NCT01019694|Albuterol|albuterol|mesh-list
110452300|NCT01019694|Ipratropium|ipratropium|mesh-list
110452301|NCT01019694|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110452302|NCT01019694|Autonomic Agents|autonomic agents|mesh-ancestor
110452303|NCT01019694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110452304|NCT01019694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110452305|NCT01019694|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110452306|NCT01019694|Respiratory System Agents|respiratory system agents|mesh-ancestor
110452307|NCT01019694|Tocolytic Agents|tocolytic agents|mesh-ancestor
110099374|NCT01747746|Warfarin|warfarin|mesh-list
110452308|NCT01019694|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110452309|NCT01019694|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110452310|NCT01019694|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110452311|NCT01019694|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110452312|NCT01019694|Adrenergic Agents|adrenergic agents|mesh-ancestor
110452313|NCT01019694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110452314|NCT01019694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110452315|NCT01019694|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110452316|NCT01019694|Cholinergic Agents|cholinergic agents|mesh-ancestor
110452317|NCT00831415|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
110452318|NCT00831415|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110452319|NCT00831415|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110452320|NCT00831415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110452321|NCT00831415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110452322|NCT00831415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110452323|NCT00831415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110452324|NCT00831415|Antidepressive Agents|antidepressive agents|mesh-ancestor
110452325|NCT00831415|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110452328|NCT01095653|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110452329|NCT01095653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110452330|NCT01095653|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110452331|NCT01095653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110452332|NCT00920907|Ipilimumab|ipilimumab|mesh-list
110452333|NCT00920907|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110497355|NCT00996281|Olmesartan|olmesartan|mesh-list
110452334|NCT00920907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110452335|NCT00920907|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110452336|NCT00920907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110452338|NCT00700297|Gout Suppressants|gout suppressants|mesh-ancestor
110452339|NCT00700297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110452340|NCT00700297|Tubulin Modulators|tubulin modulators|mesh-ancestor
110452341|NCT00700297|Antimitotic Agents|antimitotic agents|mesh-ancestor
110452342|NCT00700297|Mitosis Modulators|mitosis modulators|mesh-ancestor
110452343|NCT00700297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110452344|NCT00700297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110452345|NCT04307147|Capecitabine|capecitabine|mesh-list
110452346|NCT04307147|Vinorelbine|vinorelbine|mesh-list
110452347|NCT04307147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110452348|NCT04307147|Antimetabolites|antimetabolites|mesh-ancestor
110452349|NCT04307147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110452350|NCT04307147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110452351|NCT04307147|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110452352|NCT04307147|Tubulin Modulators|tubulin modulators|mesh-ancestor
110452353|NCT04307147|Antimitotic Agents|antimitotic agents|mesh-ancestor
110452354|NCT04307147|Mitosis Modulators|mitosis modulators|mesh-ancestor
110452355|NCT00844831|Lubiprostone|lubiprostone|mesh-list
110452356|NCT00844831|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
110452357|NCT00844831|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110452358|NCT00844831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110452359|NCT00920829|Naltrexone|naltrexone|mesh-list
110497545|NCT05003102|Narcotics|narcotics|mesh-ancestor
110452360|NCT00920829|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110452361|NCT00920829|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110452362|NCT00920829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110452363|NCT00920829|Sensory System Agents|sensory system agents|mesh-ancestor
110452364|NCT00920829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110452365|NCT05010876|Icatibant|icatibant|mesh-list
110452366|NCT05010876|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
110452367|NCT05010876|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110452368|NCT05010876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110452369|NCT05010876|Analgesics|analgesics|mesh-ancestor
110452370|NCT05010876|Sensory System Agents|sensory system agents|mesh-ancestor
110452371|NCT05010876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110497674|NCT00877773|Sirolimus|sirolimus|mesh-list
110452372|NCT05010876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110452373|NCT05010876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110452374|NCT05010876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110452375|NCT05010876|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
110452376|NCT05010876|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
110452377|NCT05010876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110452378|NCT05010876|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
110452379|NCT05010876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110452380|NCT05010876|Immunologic Factors|immunologic factors|mesh-ancestor
110452381|NCT04307069|Oxytocin|oxytocin|mesh-list
110452382|NCT04307069|Oxytocics|oxytocics|mesh-ancestor
110452383|NCT04307069|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110452384|NCT04307069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110452386|NCT04251741|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110452387|NCT04251741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110452388|NCT04251741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110452389|NCT02878265|Vitamins|vitamins|mesh-list
110452390|NCT02878265|Vitamin A|vitamin a|mesh-list
110452392|NCT02878265|Retinol palmitate|retinol palmitate|mesh-list
110452393|NCT02878265|Micronutrients|micronutrients|mesh-ancestor
110452394|NCT02878265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110452395|NCT02878265|Trace Elements|trace elements|mesh-ancestor
110452396|NCT02878265|Antioxidants|antioxidants|mesh-ancestor
110452397|NCT02878265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110452398|NCT02878265|Protective Agents|protective agents|mesh-ancestor
110497869|NCT00929240|Antimetabolites|antimetabolites|mesh-ancestor
110452399|NCT02878265|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110452400|NCT02878265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110452402|NCT00831181|Fluorouracil|fluorouracil|mesh-list
110452403|NCT00831181|Oxaliplatin|oxaliplatin|mesh-list
110452404|NCT00831181|Antimetabolites|antimetabolites|mesh-ancestor
110497937|NCT00877071|Doxorubicin|doxorubicin|mesh-list
110452405|NCT00831181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110452406|NCT00831181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110452407|NCT00831181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110452408|NCT00831181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110452409|NCT00831181|Immunologic Factors|immunologic factors|mesh-ancestor
110251511|NCT00135473|Insulin|insulin|mesh-list
110452410|NCT00831181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110452411|NCT00831181|Antidotes|antidotes|mesh-ancestor
110452412|NCT00831181|Protective Agents|protective agents|mesh-ancestor
110452413|NCT00831181|Vitamin B Complex|vitamin b complex|mesh-ancestor
110452414|NCT00831181|Vitamins|vitamins|mesh-ancestor
110498077|NCT04046029|Bivalirudin|bivalirudin|mesh-list
110452415|NCT00831181|Micronutrients|micronutrients|mesh-ancestor
110452416|NCT01023672|Modafinil|modafinil|mesh-list
110452417|NCT01023672|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110498221|NCT00685191|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110452418|NCT01023672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110452419|NCT01023672|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
110452420|NCT01023672|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110452421|NCT01023672|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110452422|NCT01023672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110452423|NCT00705835|Aluminum Hydroxide|aluminum hydroxide|mesh-list
110452424|NCT00705835|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110452425|NCT00705835|Immunologic Factors|immunologic factors|mesh-ancestor
110452426|NCT00705835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110452427|NCT00705835|Antacids|antacids|mesh-ancestor
110452428|NCT00705835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110452429|NCT00705835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110452430|NCT00702637|Modafinil|modafinil|mesh-list
110452431|NCT00702637|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110452432|NCT00702637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110452433|NCT00702637|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
110452434|NCT00702637|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110452435|NCT00702637|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110452436|NCT00702637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110452437|NCT04786275|Fentanyl|fentanyl|mesh-list
110452438|NCT04786275|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110452439|NCT04786275|Narcotics|narcotics|mesh-ancestor
110452440|NCT04786275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110452441|NCT04786275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110452442|NCT04786275|Analgesics|analgesics|mesh-ancestor
110452443|NCT04786275|Sensory System Agents|sensory system agents|mesh-ancestor
110452444|NCT04786275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110452445|NCT04786275|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110452446|NCT04786275|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110452447|NCT04786275|Anesthetics, General|anesthetics, general|mesh-ancestor
110452448|NCT04786275|Anesthetics|anesthetics|mesh-ancestor
110452449|NCT00844753|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
110452450|NCT00844753|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110452451|NCT00844753|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110452452|NCT00844753|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110452453|NCT00844753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110452454|NCT00844753|Adrenergic Agents|adrenergic agents|mesh-ancestor
110452455|NCT00844753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110452456|NCT00844753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110452457|NCT05525611|Cabergoline|cabergoline|mesh-list
110452458|NCT05525611|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110498368|NCT00924950|Calcitriol|calcitriol|mesh-list
110452459|NCT05525611|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110452460|NCT05525611|Dopamine Agonists|dopamine agonists|mesh-ancestor
110452461|NCT05525611|Dopamine Agents|dopamine agents|mesh-ancestor
110452462|NCT05525611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110452463|NCT05525611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110452464|NCT05525611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110452465|NCT00917553|Doxycycline|doxycycline|mesh-list
110452466|NCT00917553|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110452467|NCT00917553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110452468|NCT00917553|Antimalarials|antimalarials|mesh-ancestor
110452469|NCT00917553|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110452470|NCT00917553|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110452471|NCT04255251|Fluorides|fluorides|mesh-list
110452472|NCT04255251|Fluorides, Topical|fluorides, topical|mesh-list
110452474|NCT04255251|Protective Agents|protective agents|mesh-ancestor
110452475|NCT04255251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110452476|NCT01018680|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110452477|NCT01018680|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110452478|NCT01018680|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110452479|NCT01018680|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110452480|NCT01018680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110452481|NCT01018680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110452482|NCT01018680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110452484|NCT01018680|Sensory System Agents|sensory system agents|mesh-ancestor
110452485|NCT01018680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110452486|NCT01018680|Antidepressive Agents|antidepressive agents|mesh-ancestor
110452487|NCT01018680|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110452488|NCT01018680|Dopamine Agents|dopamine agents|mesh-ancestor
110452489|NCT04255017|Ritonavir|ritonavir|mesh-list
110452490|NCT04255017|Lopinavir|lopinavir|mesh-list
110452491|NCT04255017|Oseltamivir|oseltamivir|mesh-list
110452492|NCT04255017|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110452493|NCT04255017|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110452494|NCT04255017|Protease Inhibitors|protease inhibitors|mesh-ancestor
110452495|NCT04255017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110452496|NCT04255017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110452497|NCT04255017|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110452498|NCT04255017|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110452499|NCT04255017|Antiviral Agents|antiviral agents|mesh-ancestor
110452500|NCT04255017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110452501|NCT04255017|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110452502|NCT04255017|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110452503|NCT04592991|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
110452504|NCT04592991|Chelating Agents|chelating agents|mesh-ancestor
110452505|NCT04592991|Sequestering Agents|sequestering agents|mesh-ancestor
110452506|NCT04592991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110452507|NCT01017120|Tazarotene|tazarotene|mesh-list
110498453|NCT00797485|Calcium|calcium|mesh-list
110452508|NCT01017120|Dermatologic Agents|dermatologic agents|mesh-ancestor
110452509|NCT01017120|Keratolytic Agents|keratolytic agents|mesh-ancestor
110452510|NCT02872038|Cefazolin|cefazolin|mesh-list
110452511|NCT02872038|Ceftazidime|ceftazidime|mesh-list
110452512|NCT02872038|Cefepime|cefepime|mesh-list
110452513|NCT02872038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110452514|NCT02872038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110452515|NCT00627900|Sirolimus|sirolimus|mesh-list
110452516|NCT00627900|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110452517|NCT00627900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110498502|NCT02625753|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110452518|NCT00627900|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110452519|NCT00627900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110452520|NCT00627900|Antifungal Agents|antifungal agents|mesh-ancestor
110452521|NCT00627900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110452522|NCT00627900|Immunologic Factors|immunologic factors|mesh-ancestor
110452523|NCT00627900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110452524|NCT02996110|Nivolumab|nivolumab|mesh-list
110452525|NCT02996110|Ipilimumab|ipilimumab|mesh-list
110452526|NCT02996110|Relatlimab|relatlimab|mesh-list
110452527|NCT02996110|Linrodostat|linrodostat|mesh-list
110452528|NCT02996110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110452529|NCT02996110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110452530|NCT02996110|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110498715|NCT00690105|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110452531|NCT02996110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110452532|NCT02996110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110452533|NCT01103063|Azithromycin|azithromycin|mesh-list
110452534|NCT01103063|Chloroquine|chloroquine|mesh-list
110452535|NCT01103063|Pyrimethamine|pyrimethamine|mesh-list
110452536|NCT01103063|Sulfadoxine|sulfadoxine|mesh-list
110452537|NCT01103063|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
110452538|NCT01103063|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110452539|NCT01103063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110452540|NCT01103063|Amebicides|amebicides|mesh-ancestor
110452541|NCT01103063|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110452542|NCT01103063|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110452543|NCT01103063|Antimalarials|antimalarials|mesh-ancestor
110452544|NCT01103063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110452545|NCT01103063|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110452546|NCT01103063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110452547|NCT01103063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110452548|NCT01103063|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110452549|NCT02987998|Pembrolizumab|pembrolizumab|mesh-list
110452550|NCT02987998|Etoposide|etoposide|mesh-list
110452551|NCT02987998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110452552|NCT02987998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110452553|NCT02987998|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110452554|NCT02987998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110452555|NCT02987998|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110452556|NCT02987998|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110452558|NCT02987998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110452559|NCT04213378|Paclitaxel|paclitaxel|mesh-list
110452560|NCT04213378|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110452561|NCT04213378|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110452562|NCT04213378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110452563|NCT04213378|Tubulin Modulators|tubulin modulators|mesh-ancestor
110452564|NCT04213378|Antimitotic Agents|antimitotic agents|mesh-ancestor
110452565|NCT04213378|Mitosis Modulators|mitosis modulators|mesh-ancestor
110452566|NCT04213378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110452567|NCT04213924|Ibuprofen|ibuprofen|mesh-list
110452568|NCT04213924|Lidocaine|lidocaine|mesh-list
110452569|NCT04213924|Bupivacaine|bupivacaine|mesh-list
110452570|NCT04213924|Anesthetics, Local|anesthetics, local|mesh-ancestor
110452571|NCT04213924|Anesthetics|anesthetics|mesh-ancestor
110452572|NCT04213924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110452573|NCT04213924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110452574|NCT04213924|Sensory System Agents|sensory system agents|mesh-ancestor
110452575|NCT04213924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110452576|NCT04213924|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110499197|NCT05485519|GABA Modulators|gaba modulators|mesh-ancestor
110452577|NCT04213924|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110452579|NCT04213924|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110452580|NCT04213924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110452581|NCT04213924|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110452582|NCT04213924|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110452583|NCT04213924|Analgesics|analgesics|mesh-ancestor
110452584|NCT04213924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110452585|NCT04213924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110452586|NCT04213924|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110452587|NCT04213924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110452588|NCT00616720|Interferons|interferons|mesh-list
110452589|NCT00616720|Aldesleukin|aldesleukin|mesh-list
110452590|NCT00616720|Interferon-gamma|interferon-gamma|mesh-list
110452591|NCT00616720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110452592|NCT00616720|Antiviral Agents|antiviral agents|mesh-ancestor
110452593|NCT00616720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110452594|NCT00616720|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110452595|NCT00616720|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110452596|NCT01091675|Etoricoxib|etoricoxib|mesh-list
110452597|NCT01091675|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110452598|NCT01091675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110452599|NCT01091675|Analgesics|analgesics|mesh-ancestor
110452600|NCT01091675|Sensory System Agents|sensory system agents|mesh-ancestor
110452601|NCT01091675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110452602|NCT01091675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110452603|NCT01091675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110452604|NCT01091675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110452605|NCT01091675|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110452606|NCT01091675|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110297748|NCT04542226|Bromides|bromides|mesh-list
110452607|NCT01091675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110452608|NCT01091675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110099675|NCT01749228|Etodolac|etodolac|mesh-list
110452609|NCT02739412|Aldesleukin|aldesleukin|mesh-list
110452610|NCT02739412|Interleukin-2|interleukin-2|mesh-list
110452611|NCT02739412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110452612|NCT02739412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110452613|NCT02739412|Analgesics|analgesics|mesh-ancestor
110452614|NCT02739412|Sensory System Agents|sensory system agents|mesh-ancestor
110452615|NCT02739412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110452616|NCT02739412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110452617|NCT02739412|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110452618|NCT02739412|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110452619|NCT02739412|Antiviral Agents|antiviral agents|mesh-ancestor
110452620|NCT02739412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110452621|NCT04213612|Cyclophosphamide|cyclophosphamide|mesh-list
110452622|NCT04213612|Doxorubicin|doxorubicin|mesh-list
110452623|NCT04213612|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110452624|NCT04213612|Vincristine|vincristine|mesh-list
110452625|NCT04213612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110452626|NCT04213612|Immunologic Factors|immunologic factors|mesh-ancestor
110452627|NCT04213612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110499419|NCT04004611|Mirikizumab|mirikizumab|mesh-list
110452628|NCT04213612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110452629|NCT04213612|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110452630|NCT04213612|Alkylating Agents|alkylating agents|mesh-ancestor
110452631|NCT04213612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110452632|NCT04213612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110452633|NCT04213612|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110452634|NCT04213612|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110452635|NCT04213612|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110452636|NCT04213612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110452637|NCT04213612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110452638|NCT04213612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110452639|NCT04213612|Tubulin Modulators|tubulin modulators|mesh-ancestor
110452640|NCT04213612|Antimitotic Agents|antimitotic agents|mesh-ancestor
110452641|NCT04213612|Mitosis Modulators|mitosis modulators|mesh-ancestor
110452643|NCT01091519|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110452644|NCT01091519|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110452645|NCT01091519|Cholinergic Agents|cholinergic agents|mesh-ancestor
110452646|NCT01091519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110452647|NCT01091519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110452648|NCT01091519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110452649|NCT01091519|Urological Agents|urological agents|mesh-ancestor
110452650|NCT02878031|Amoxicillin|amoxicillin|mesh-list
110452651|NCT02878031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110452652|NCT02878031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110452653|NCT02879669|Cyclophosphamide|cyclophosphamide|mesh-list
110452654|NCT02879669|Carboplatin|carboplatin|mesh-list
110452655|NCT02879669|Pemetrexed|pemetrexed|mesh-list
110452656|NCT02879669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110452657|NCT02879669|Immunologic Factors|immunologic factors|mesh-ancestor
110452658|NCT02879669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110452659|NCT02879669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110499601|NCT02658097|Pembrolizumab|pembrolizumab|mesh-list
110452660|NCT02879669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110452661|NCT02879669|Alkylating Agents|alkylating agents|mesh-ancestor
110452662|NCT02879669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110452663|NCT02879669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110452664|NCT02879669|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110452665|NCT02879669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110452666|NCT02879669|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110499714|NCT01838174|Hormones|hormones|mesh-ancestor
110452667|NCT02879669|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110452668|NCT04875533|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110452669|NCT04875533|Immunologic Factors|immunologic factors|mesh-ancestor
110452670|NCT04875533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110452671|NCT00918333|Everolimus|everolimus|mesh-list
110452672|NCT00918333|Panobinostat|panobinostat|mesh-list
110452673|NCT00918333|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
110452674|NCT00918333|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110452675|NCT00918333|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110452676|NCT00918333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110452677|NCT00918333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110452678|NCT00918333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110452679|NCT00918333|Immunologic Factors|immunologic factors|mesh-ancestor
110452680|NCT00918333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110452681|NCT00918333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110452682|NCT01090973|Panobinostat|panobinostat|mesh-list
110499927|NCT04001621|Capecitabine|capecitabine|mesh-list
110452683|NCT01090973|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
110099758|NCT01749475|Anesthetics|anesthetics|mesh-ancestor
110452684|NCT01090973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110452685|NCT01090973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110452686|NCT01090973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110452688|NCT02607904|Anticonvulsants|anticonvulsants|mesh-ancestor
110452690|NCT05295394|Dolutegravir|dolutegravir|mesh-list
110452691|NCT05295394|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110452692|NCT05295394|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110452693|NCT05295394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110452694|NCT05295394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110452695|NCT05295394|Antiviral Agents|antiviral agents|mesh-ancestor
110452696|NCT05295394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110452697|NCT05295394|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110452699|NCT05295394|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110500058|NCT02867345|Analgesics|analgesics|mesh-ancestor
110452700|NCT05295394|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110452701|NCT02871648|Fludrocortisone|fludrocortisone|mesh-list
110452702|NCT02871648|Eplerenone|eplerenone|mesh-list
110452703|NCT02871648|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110452705|NCT02871648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110452706|NCT02871648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110452707|NCT02871648|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110452708|NCT02871648|Diuretics|diuretics|mesh-ancestor
110452709|NCT02871648|Natriuretic Agents|natriuretic agents|mesh-ancestor
110452710|NCT02871648|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110452711|NCT02871648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110452712|NCT00637845|Esomeprazole|esomeprazole|mesh-list
110452713|NCT00637845|Lansoprazole|lansoprazole|mesh-list
110452714|NCT00637845|Dexlansoprazole|dexlansoprazole|mesh-list
110452715|NCT00637845|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110452716|NCT00637845|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110452717|NCT00637845|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110452718|NCT00637845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110452719|NCT00637845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110452720|NCT04738695|Antibodies|antibodies|mesh-list
110452721|NCT04738695|Immunologic Factors|immunologic factors|mesh-ancestor
110452722|NCT04738695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110452723|NCT02497300|Amiloride|amiloride|mesh-list
110452724|NCT02497300|Spironolactone|spironolactone|mesh-list
110452725|NCT02497300|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110452726|NCT02497300|Hormone Antagonists|hormone antagonists|mesh-ancestor
110452727|NCT02497300|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110452728|NCT02497300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110452729|NCT02497300|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110452730|NCT02497300|Diuretics|diuretics|mesh-ancestor
110452731|NCT02497300|Natriuretic Agents|natriuretic agents|mesh-ancestor
110452732|NCT02497300|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
110452733|NCT02497300|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110452734|NCT02497300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110452735|NCT02497300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110452736|NCT02497300|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
110452737|NCT04254471|Carboplatin|carboplatin|mesh-list
110452738|NCT04254471|Etoposide|etoposide|mesh-list
110452739|NCT04254471|Rabeprazole|rabeprazole|mesh-list
110452740|NCT04254471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110452741|NCT04254471|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110452742|NCT04254471|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110452743|NCT04254471|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110452744|NCT04254471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110452745|NCT04254471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110452746|NCT04254471|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110452747|NCT04254471|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110452748|NCT04254471|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110452749|NCT00631527|Sunitinib|sunitinib|mesh-list
110452750|NCT00631527|Leuprolide|leuprolide|mesh-list
110452751|NCT00631527|Goserelin|goserelin|mesh-list
110452752|NCT00631527|Bicalutamide|bicalutamide|mesh-list
110452753|NCT00631527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110452754|NCT00631527|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110500518|NCT04251962|Anesthetics, General|anesthetics, general|mesh-ancestor
110452755|NCT00631527|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110452756|NCT00631527|Growth Substances|growth substances|mesh-ancestor
110452757|NCT00631527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110452758|NCT00631527|Growth Inhibitors|growth inhibitors|mesh-ancestor
110452760|NCT00631527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110452761|NCT00631527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110452762|NCT00631527|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110452763|NCT00631527|Fertility Agents|fertility agents|mesh-ancestor
110452764|NCT00631527|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110452765|NCT00631527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110452766|NCT00631527|Androgen Antagonists|androgen antagonists|mesh-ancestor
110500675|NCT00804115|Miotics|miotics|mesh-ancestor
110452767|NCT00631527|Hormone Antagonists|hormone antagonists|mesh-ancestor
110452768|NCT00631527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110452769|NCT00620620|Zaleplon|zaleplon|mesh-list
110452770|NCT00620620|Anticonvulsants|anticonvulsants|mesh-ancestor
110452771|NCT00620620|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110452772|NCT00620620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110452773|NCT00620620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110452774|NCT00620620|GABA Modulators|gaba modulators|mesh-ancestor
110452775|NCT00620620|GABA Agents|gaba agents|mesh-ancestor
110452776|NCT00620620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110452777|NCT00620620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110452778|NCT00916383|Donepezil|donepezil|mesh-list
110452779|NCT00916383|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110452780|NCT00916383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110452781|NCT00916383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110452782|NCT00916383|Cholinergic Agents|cholinergic agents|mesh-ancestor
110452783|NCT00916383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110452784|NCT00916383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110452785|NCT00916383|Nootropic Agents|nootropic agents|mesh-ancestor
110452786|NCT00617500|Hormones|hormones|mesh-list
110452787|NCT00617500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110251570|NCT00152724|Vasodilator Agents|vasodilator agents|mesh-ancestor
110452788|NCT00617500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110452789|NCT04209478|Morphine|morphine|mesh-list
110452790|NCT04209478|Tramadol|tramadol|mesh-list
110452791|NCT04209478|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110452792|NCT04209478|Narcotics|narcotics|mesh-ancestor
110452793|NCT04209478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110452794|NCT04209478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110452795|NCT04209478|Analgesics|analgesics|mesh-ancestor
110452796|NCT04209478|Sensory System Agents|sensory system agents|mesh-ancestor
110452797|NCT04209478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110452798|NCT05252715|Vaccines|vaccines|mesh-list
110452799|NCT05252715|Immunologic Factors|immunologic factors|mesh-ancestor
110452800|NCT05252715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110452801|NCT04209166|Norepinephrine|norepinephrine|mesh-list
110452802|NCT04209166|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110452803|NCT04209166|Serotonin|serotonin|mesh-list
110452804|NCT04209166|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
110452805|NCT04209166|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-list
110452806|NCT04209166|Antidepressive Agents|antidepressive agents|mesh-ancestor
110452807|NCT04209166|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110452808|NCT04209166|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110452809|NCT04209166|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110452810|NCT04209166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110452811|NCT04209166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110452812|NCT04209166|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110452813|NCT04209166|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110452814|NCT04209166|Adrenergic Agents|adrenergic agents|mesh-ancestor
110452815|NCT04209166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110452816|NCT04209166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110452818|NCT04209166|Autonomic Agents|autonomic agents|mesh-ancestor
110452819|NCT04209166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110452820|NCT04209166|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110452821|NCT04209166|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110501191|NCT00807625|Copper|copper|mesh-list
110452822|NCT04209166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110452824|NCT04209166|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110452825|NCT04766008|Metformin|metformin|mesh-list
110501207|NCT02551549|Rezafungin|rezafungin|mesh-list
110452826|NCT04766008|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110501278|NCT00654355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110452827|NCT04766008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110452828|NCT00916149|Lamotrigine|lamotrigine|mesh-list
110452829|NCT00916149|Levetiracetam|levetiracetam|mesh-list
110452830|NCT00916149|Anticonvulsants|anticonvulsants|mesh-ancestor
110452831|NCT00916149|Nootropic Agents|nootropic agents|mesh-ancestor
110452832|NCT00916149|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110452833|NCT00916149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110452834|NCT00916149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110452835|NCT00916149|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110452836|NCT00916149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110452839|NCT00916149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110452840|NCT00916149|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110452841|NCT00916149|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110452842|NCT00617656|Cisplatin|cisplatin|mesh-list
110452843|NCT00617656|Gemcitabine|gemcitabine|mesh-list
110452844|NCT00617656|Docetaxel|docetaxel|mesh-list
110452845|NCT00617656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110452846|NCT00617656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110452847|NCT00617656|Antimetabolites|antimetabolites|mesh-ancestor
110452848|NCT00617656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110452849|NCT00617656|Tubulin Modulators|tubulin modulators|mesh-ancestor
110452850|NCT00617656|Antimitotic Agents|antimitotic agents|mesh-ancestor
110452851|NCT00617656|Mitosis Modulators|mitosis modulators|mesh-ancestor
110452852|NCT00175162|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
110452853|NCT00175162|Vasodilator Agents|vasodilator agents|mesh-ancestor
110452854|NCT00175162|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
110452855|NCT00175162|Protective Agents|protective agents|mesh-ancestor
110452856|NCT00175162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110452858|NCT04213222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110452859|NCT04213222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110452860|NCT04213222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110452861|NCT04213222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110452862|NCT04213222|Growth Substances|growth substances|mesh-ancestor
110501769|NCT00811759|Temozolomide|temozolomide|mesh-list
110452863|NCT04213222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110452865|NCT00621166|Ritonavir|ritonavir|mesh-list
110452866|NCT00621166|Lopinavir|lopinavir|mesh-list
110452867|NCT00621166|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110452868|NCT00621166|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110452869|NCT00621166|Protease Inhibitors|protease inhibitors|mesh-ancestor
110501840|NCT00811915|Sirolimus|sirolimus|mesh-list
110452870|NCT00621166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110452871|NCT00621166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110452872|NCT00621166|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110452873|NCT00621166|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110452874|NCT00621166|Antiviral Agents|antiviral agents|mesh-ancestor
110452875|NCT00621166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110452876|NCT00621166|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110452877|NCT00621166|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110452878|NCT04555798|Meropenem|meropenem|mesh-list
110452879|NCT04555798|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110452880|NCT04555798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110452881|NCT00617968|Docetaxel|docetaxel|mesh-list
110452882|NCT00617968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110452883|NCT00617968|Tubulin Modulators|tubulin modulators|mesh-ancestor
110452884|NCT00617968|Antimitotic Agents|antimitotic agents|mesh-ancestor
110452885|NCT00617968|Mitosis Modulators|mitosis modulators|mesh-ancestor
110501915|NCT04133948|Nivolumab|nivolumab|mesh-list
110452886|NCT00617968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110452887|NCT00621400|Dexamethasone|dexamethasone|mesh-list
110452889|NCT00621400|Melphalan|melphalan|mesh-list
110452890|NCT00621400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110452891|NCT00621400|Antiemetics|antiemetics|mesh-ancestor
110452892|NCT00621400|Autonomic Agents|autonomic agents|mesh-ancestor
110452893|NCT00621400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110452894|NCT00621400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110452895|NCT00621400|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110452896|NCT00621400|Glucocorticoids|glucocorticoids|mesh-ancestor
110452897|NCT00621400|Hormones|hormones|mesh-ancestor
110452898|NCT00621400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110452899|NCT00621400|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110452900|NCT00621400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110452901|NCT00621400|Immunologic Factors|immunologic factors|mesh-ancestor
110502182|NCT04084106|Amoxicillin|amoxicillin|mesh-list
110452902|NCT00621400|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110452903|NCT00621400|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110452904|NCT00621400|Growth Substances|growth substances|mesh-ancestor
110452905|NCT00621400|Growth Inhibitors|growth inhibitors|mesh-ancestor
110452906|NCT00621400|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110452907|NCT00621400|Alkylating Agents|alkylating agents|mesh-ancestor
110452908|NCT00621400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110452909|NCT00621400|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110452910|NCT00621400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110452912|NCT04208854|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110452913|NCT04208854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110452914|NCT04208854|Tubulin Modulators|tubulin modulators|mesh-ancestor
110452915|NCT04208854|Antimitotic Agents|antimitotic agents|mesh-ancestor
110452916|NCT04208854|Mitosis Modulators|mitosis modulators|mesh-ancestor
110452917|NCT04208854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110452918|NCT01090427|Ustekinumab|ustekinumab|mesh-list
110452919|NCT01090427|Dermatologic Agents|dermatologic agents|mesh-ancestor
110452920|NCT04208776|Propranolol|propranolol|mesh-list
110452922|NCT04208776|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110452923|NCT04208776|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110452924|NCT04208776|Adrenergic Agents|adrenergic agents|mesh-ancestor
110452925|NCT04208776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110452926|NCT04208776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110452927|NCT04208776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110452928|NCT04208776|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110452929|NCT04208776|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110452930|NCT04208776|Vasodilator Agents|vasodilator agents|mesh-ancestor
110452931|NCT04208776|Sympathomimetics|sympathomimetics|mesh-ancestor
110452932|NCT04208776|Autonomic Agents|autonomic agents|mesh-ancestor
110452933|NCT04208776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110452934|NCT04208776|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110452935|NCT04208776|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110452936|NCT04208776|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110452937|NCT04208776|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110452938|NCT02879435|Bupivacaine|bupivacaine|mesh-list
110452939|NCT02879435|Anesthetics, Local|anesthetics, local|mesh-ancestor
110452940|NCT02879435|Anesthetics|anesthetics|mesh-ancestor
110452941|NCT02879435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110452942|NCT02879435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110502623|NCT00826657|Vitamins|vitamins|mesh-ancestor
110452943|NCT02879435|Sensory System Agents|sensory system agents|mesh-ancestor
110452944|NCT02879435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110452945|NCT02879513|Paclitaxel|paclitaxel|mesh-list
110452946|NCT02879513|Cyclophosphamide|cyclophosphamide|mesh-list
110452947|NCT02879513|Epirubicin|epirubicin|mesh-list
110452948|NCT02879513|Fluorouracil|fluorouracil|mesh-list
110452949|NCT02879513|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110452950|NCT02879513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110452951|NCT02879513|Tubulin Modulators|tubulin modulators|mesh-ancestor
110452952|NCT02879513|Antimitotic Agents|antimitotic agents|mesh-ancestor
110452953|NCT02879513|Mitosis Modulators|mitosis modulators|mesh-ancestor
110452954|NCT02879513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110452955|NCT02879513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110452956|NCT02879513|Immunologic Factors|immunologic factors|mesh-ancestor
110452957|NCT02879513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110452958|NCT02879513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110452959|NCT02879513|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110452960|NCT02879513|Alkylating Agents|alkylating agents|mesh-ancestor
110452961|NCT02879513|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110452962|NCT02879513|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110452963|NCT02879513|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110452964|NCT02879513|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110452965|NCT02879513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110452966|NCT02879513|Antimetabolites|antimetabolites|mesh-ancestor
110502842|NCT03667313|Sirolimus|sirolimus|mesh-list
110452967|NCT02879513|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110452968|NCT00621478|Diazepam|diazepam|mesh-list
110452969|NCT00621478|Lorazepam|lorazepam|mesh-list
110452970|NCT00621478|Anticonvulsants|anticonvulsants|mesh-ancestor
110452971|NCT00621478|Antiemetics|antiemetics|mesh-ancestor
110452972|NCT00621478|Autonomic Agents|autonomic agents|mesh-ancestor
110452973|NCT00621478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110452974|NCT00621478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110452975|NCT00621478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110452976|NCT00621478|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110452977|NCT00621478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110452978|NCT00621478|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110452979|NCT00621478|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110452980|NCT00621478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110100060|NCT01751854|Escitalopram|escitalopram|mesh-list
110452981|NCT00621478|GABA Modulators|gaba modulators|mesh-ancestor
110452982|NCT00621478|GABA Agents|gaba agents|mesh-ancestor
110502861|NCT04925531|Ampicillin|ampicillin|mesh-list
110452983|NCT00621478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110452984|NCT00621478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110452985|NCT00621478|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110452986|NCT00621478|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110452987|NCT00621478|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110452988|NCT00621478|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110452989|NCT00621478|Anesthetics, General|anesthetics, general|mesh-ancestor
110452990|NCT00621478|Anesthetics|anesthetics|mesh-ancestor
110452991|NCT00621556|Secretin|secretin|mesh-list
110452992|NCT00621556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110452993|NCT00621556|Hormones|hormones|mesh-ancestor
110452994|NCT00621556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110452995|NCT00621556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110452996|NCT00618046|Oxcarbazepine|oxcarbazepine|mesh-list
110503067|NCT00903968|Hormones|hormones|mesh-ancestor
110452998|NCT00618046|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110452999|NCT00618046|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110453000|NCT00618046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110453001|NCT00618046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110453002|NCT00618046|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110453003|NCT00618046|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110453004|NCT04308551|Aspirin|aspirin|mesh-list
110453005|NCT04308551|Indobufen|indobufen|mesh-list
110453006|NCT04308551|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110453007|NCT04308551|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110453008|NCT04308551|Analgesics|analgesics|mesh-ancestor
110453009|NCT04308551|Sensory System Agents|sensory system agents|mesh-ancestor
110453010|NCT04308551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110503135|NCT02849132|Entecavir|entecavir|mesh-list
110453011|NCT04308551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110453012|NCT04308551|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110453013|NCT04308551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110453014|NCT04308551|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110453015|NCT04308551|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110453016|NCT04308551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110453017|NCT04308551|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110453018|NCT04308551|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110453019|NCT04308551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110453020|NCT04308551|Antipyretics|antipyretics|mesh-ancestor
110453021|NCT04306913|Cardioplegic Solutions|cardioplegic solutions|mesh-list
110453022|NCT04306913|Esmolol|esmolol|mesh-list
110453023|NCT04306913|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110453024|NCT04306913|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110453025|NCT04306913|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110453026|NCT04306913|Adrenergic Agents|adrenergic agents|mesh-ancestor
110453027|NCT04306913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110453028|NCT04306913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110453029|NCT04306913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110453030|NCT04306913|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110251637|NCT00159159|Cyclosporine|cyclosporine|mesh-list
110453031|NCT02299414|Antihypertensive Agents|antihypertensive agents|mesh-list
110453032|NCT02299414|Nifedipine|nifedipine|mesh-list
110453033|NCT02299414|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110453034|NCT02299414|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110453035|NCT02299414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110453036|NCT02299414|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110453037|NCT02299414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110453040|NCT02299414|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110453041|NCT01016262|Mesalamine|mesalamine|mesh-list
110453042|NCT01016262|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110453043|NCT01016262|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110453045|NCT01016262|Sensory System Agents|sensory system agents|mesh-ancestor
110453046|NCT01016262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110453047|NCT01016262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110453048|NCT01016262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110453049|NCT01016262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110453050|NCT00625937|Docetaxel|docetaxel|mesh-list
110453051|NCT00625937|Tegafur|tegafur|mesh-list
110453052|NCT00625937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110453053|NCT00625937|Tubulin Modulators|tubulin modulators|mesh-ancestor
110453054|NCT00625937|Antimitotic Agents|antimitotic agents|mesh-ancestor
110453055|NCT00625937|Mitosis Modulators|mitosis modulators|mesh-ancestor
110453056|NCT00625937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110453057|NCT00625937|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110453058|NCT00625937|Antimetabolites|antimetabolites|mesh-ancestor
110453059|NCT01001910|Carboplatin|carboplatin|mesh-list
110453060|NCT01001910|Pemetrexed|pemetrexed|mesh-list
110453061|NCT01001910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110453062|NCT01001910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110453063|NCT01001910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110453064|NCT01001910|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110453065|NCT01001910|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110453066|NCT04308317|Tetrandrine|tetrandrine|mesh-list
110453067|NCT04308317|Antimalarials|antimalarials|mesh-ancestor
110453068|NCT04308317|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110453069|NCT04308317|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110453070|NCT04308317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110453071|NCT04308317|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110453072|NCT04308317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110453073|NCT04308317|Antiviral Agents|antiviral agents|mesh-ancestor
110453074|NCT04308317|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110453075|NCT04308317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110453076|NCT04308317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110453077|NCT04308317|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110453078|NCT04308317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110453079|NCT04308317|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110453080|NCT04308317|Immunologic Factors|immunologic factors|mesh-ancestor
110453081|NCT01009554|Listerine|listerine|mesh-list
110453082|NCT01009554|Fluorides|fluorides|mesh-list
110453083|NCT01009554|Sodium Fluoride|sodium fluoride|mesh-list
110453084|NCT01009554|Cariostatic Agents|cariostatic agents|mesh-ancestor
110453085|NCT01009554|Protective Agents|protective agents|mesh-ancestor
110453086|NCT01009554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110453087|NCT01009554|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110453088|NCT01009554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110453089|NCT04211896|Nivolumab|nivolumab|mesh-list
110453090|NCT04211896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110453091|NCT04211896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110453092|NCT04211896|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110453093|NCT04211896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110453094|NCT04188184|Epinephrine|epinephrine|mesh-list
110453095|NCT04188184|Tranexamic Acid|tranexamic acid|mesh-list
110453096|NCT04188184|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110453097|NCT04188184|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110453098|NCT04188184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110453099|NCT04188184|Hemostatics|hemostatics|mesh-ancestor
110453100|NCT04188184|Coagulants|coagulants|mesh-ancestor
110453101|NCT04188184|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110453102|NCT04188184|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110453103|NCT04188184|Adrenergic Agents|adrenergic agents|mesh-ancestor
110453104|NCT04188184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110453105|NCT04188184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110453106|NCT04188184|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110453107|NCT04188184|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110453108|NCT04188184|Autonomic Agents|autonomic agents|mesh-ancestor
110453109|NCT04188184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110453110|NCT04188184|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110453111|NCT04188184|Respiratory System Agents|respiratory system agents|mesh-ancestor
110453112|NCT04188184|Mydriatics|mydriatics|mesh-ancestor
110453113|NCT04188184|Sympathomimetics|sympathomimetics|mesh-ancestor
110453114|NCT04188184|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110453115|NCT01006590|Metformin|metformin|mesh-list
110453116|NCT01006590|Saxagliptin|saxagliptin|mesh-list
110453117|NCT01006590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110453118|NCT01006590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110453119|NCT01006590|Incretins|incretins|mesh-ancestor
110453120|NCT01006590|Hormones|hormones|mesh-ancestor
110504003|NCT02836548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110453121|NCT01006590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110453122|NCT01006590|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110453123|NCT01006590|Protease Inhibitors|protease inhibitors|mesh-ancestor
110453124|NCT01006590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110453125|NCT01006590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110453126|NCT04212832|Bupivacaine|bupivacaine|mesh-list
110453127|NCT04212832|Anesthetics, Local|anesthetics, local|mesh-ancestor
110453128|NCT04212832|Anesthetics|anesthetics|mesh-ancestor
110453129|NCT04212832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110453130|NCT04212832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110453131|NCT04212832|Sensory System Agents|sensory system agents|mesh-ancestor
110453132|NCT04212832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110453134|NCT00621790|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110453135|NCT00621790|Vasodilator Agents|vasodilator agents|mesh-ancestor
110453136|NCT00621790|Dopamine Agonists|dopamine agonists|mesh-ancestor
110453137|NCT00621790|Dopamine Agents|dopamine agents|mesh-ancestor
110504159|NCT05877690|Prilocaine|prilocaine|mesh-list
110453138|NCT00621790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110453139|NCT00621790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110453140|NCT00621790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110453141|NCT00618124|Capecitabine|capecitabine|mesh-list
110453142|NCT00618124|Sunitinib|sunitinib|mesh-list
110453143|NCT00618124|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110453144|NCT00618124|Antimetabolites|antimetabolites|mesh-ancestor
110453145|NCT00618124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110453146|NCT00618124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110453147|NCT00618124|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110453148|NCT00618124|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110453149|NCT00618124|Growth Substances|growth substances|mesh-ancestor
110453150|NCT00618124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110453151|NCT00618124|Growth Inhibitors|growth inhibitors|mesh-ancestor
110251657|NCT00135863|Anticoagulants|anticoagulants|mesh-ancestor
110453152|NCT00618124|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110453153|NCT00618124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110453155|NCT00621868|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110453156|NCT00621868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110453157|NCT00621868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110453158|NCT00621868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110453159|NCT01882660|Decitabine|decitabine|mesh-list
110453160|NCT01882660|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110453161|NCT01882660|Antimetabolites|antimetabolites|mesh-ancestor
110453162|NCT01882660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110453163|NCT01882660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110453164|NCT01882660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110453165|NCT01001832|Abatacept|abatacept|mesh-list
110453166|NCT01001832|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110453167|NCT01001832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110453168|NCT01001832|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110504282|NCT05606263|Nimotuzumab|nimotuzumab|mesh-list
110453169|NCT01001832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110453170|NCT01001832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110453171|NCT01001832|Immunologic Factors|immunologic factors|mesh-ancestor
110453172|NCT01001832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110453173|NCT01001832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110453174|NCT01001598|Danazol|danazol|mesh-list
110453175|NCT01001598|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110453176|NCT01001598|Hormone Antagonists|hormone antagonists|mesh-ancestor
110453177|NCT01001598|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110453178|NCT01001598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110453179|NCT01006356|Hydromorphone|hydromorphone|mesh-list
110453180|NCT01006356|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110453181|NCT01006356|Narcotics|narcotics|mesh-ancestor
110453182|NCT01006356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110453183|NCT01006356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110453184|NCT01006356|Analgesics|analgesics|mesh-ancestor
110504548|NCT04532528|Anticoagulants|anticoagulants|mesh-ancestor
110617822|NCT00777504|Growth Substances|growth substances|mesh-ancestor
110617823|NCT00777504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110617824|NCT00777504|Growth Inhibitors|growth inhibitors|mesh-ancestor
110617825|NCT00777504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110617826|NCT00781482|Zolpidem|zolpidem|mesh-list
110617827|NCT00781482|Eszopiclone|eszopiclone|mesh-list
110617828|NCT00781482|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110617829|NCT00781482|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110617830|NCT00781482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110617831|NCT00781482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110617834|NCT00781482|GABA Agents|gaba agents|mesh-ancestor
110617886|NCT00691028|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110617887|NCT00691028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110617888|NCT00690794|Travoprost|travoprost|mesh-list
110617889|NCT00690794|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110617890|NCT00690794|Latanoprost|latanoprost|mesh-list
110617891|NCT00690794|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110617892|NCT00690794|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110617893|NCT00666276|Linezolid|linezolid|mesh-list
110617899|NCT00567255|Naltrexone|naltrexone|mesh-list
110617953|NCT00929799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110617954|NCT00777738|Bortezomib|bortezomib|mesh-list
110617955|NCT00777738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110617956|NCT00744770|Rilpivirine|rilpivirine|mesh-list
110617957|NCT00744770|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110617958|NCT00744770|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110617959|NCT00744770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110617960|NCT00744770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110617961|NCT00744770|Antiviral Agents|antiviral agents|mesh-ancestor
110617962|NCT00744770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110617963|NCT00744770|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110617964|NCT00744770|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110617965|NCT00784680|Tamoxifen|tamoxifen|mesh-list
110617966|NCT00784680|Anastrozole|anastrozole|mesh-list
110618013|NCT00931437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110618014|NCT00931437|Hemostatics|hemostatics|mesh-ancestor
110618015|NCT00931437|Coagulants|coagulants|mesh-ancestor
110618016|NCT00742040|Captopril|captopril|mesh-list
110618017|NCT00742040|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110618018|NCT00742040|Protease Inhibitors|protease inhibitors|mesh-ancestor
110618019|NCT00742040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110618020|NCT00742040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110618021|NCT00742040|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110618022|NCT00926757|Entecavir|entecavir|mesh-list
110618023|NCT00926757|Antiviral Agents|antiviral agents|mesh-ancestor
110618024|NCT00926757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110618025|NCT00782106|Immunoglobulins|immunoglobulins|mesh-list
110618026|NCT00782106|Antibodies|antibodies|mesh-list
110618076|NCT00745004|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110618077|NCT00745004|Serotonin Agents|serotonin agents|mesh-ancestor
110618078|NCT00745004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110618080|NCT05450978|Lamotrigine|lamotrigine|mesh-list
110618148|NCT00749138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110618149|NCT00749138|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110618150|NCT00749138|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110618151|NCT00749138|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110618152|NCT02563340|Rituximab|rituximab|mesh-list
110618153|NCT02563340|Bortezomib|bortezomib|mesh-list
110618219|NCT00567567|Immunologic Factors|immunologic factors|mesh-ancestor
110618220|NCT00567567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110618221|NCT00567567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110618222|NCT00567567|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110618223|NCT00567567|Alkylating Agents|alkylating agents|mesh-ancestor
110618224|NCT00567567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110618287|NCT00926835|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110618288|NCT00926835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110618289|NCT00926835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110618290|NCT00926835|Serotonin Agents|serotonin agents|mesh-ancestor
110618291|NCT00926835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110618292|NCT00926835|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110618293|NCT00926835|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110618294|NCT00926835|Parasympatholytics|parasympatholytics|mesh-ancestor
110265596|NCT00406679|Acetaminophen|acetaminophen|mesh-list
110618351|NCT00664560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110618352|NCT00664560|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110618353|NCT00664560|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110618354|NCT00664560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110618355|NCT00664560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110618356|NCT00664560|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110618357|NCT00783042|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110618358|NCT00783042|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110618359|NCT00783042|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110618360|NCT00783042|Antimetabolites|antimetabolites|mesh-ancestor
110618361|NCT00783042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110618362|NCT00783042|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110618363|NCT00783042|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110618364|NCT00783042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110618365|NCT00688688|Mirabegron|mirabegron|mesh-list
110618366|NCT00688688|Tolterodine Tartrate|tolterodine tartrate|mesh-list
110618367|NCT00688688|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
110618368|NCT00688688|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110618369|NCT00688688|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110618370|NCT00688688|Adrenergic Agents|adrenergic agents|mesh-ancestor
110618371|NCT00688688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110618372|NCT00688688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110618373|NCT00688688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110618374|NCT00688688|Urological Agents|urological agents|mesh-ancestor
110618375|NCT00688688|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110618399|NCT00931827|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110618400|NCT00931827|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110618401|NCT00931827|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110618402|NCT00778908|Cisplatin|cisplatin|mesh-list
110618403|NCT00778908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110618404|NCT02561468|Nefopam|nefopam|mesh-list
110618405|NCT02561468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110618406|NCT02561468|Analgesics|analgesics|mesh-ancestor
110618407|NCT02561468|Sensory System Agents|sensory system agents|mesh-ancestor
110618408|NCT02561468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110618409|NCT02561468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110618410|NCT02555748|Sunitinib|sunitinib|mesh-list
110618411|NCT02555748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110618412|NCT02555748|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110618413|NCT02555748|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110618414|NCT02555748|Growth Substances|growth substances|mesh-ancestor
110618415|NCT02555748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110618416|NCT02555748|Growth Inhibitors|growth inhibitors|mesh-ancestor
110618417|NCT02555748|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110618418|NCT02555748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110618419|NCT02555748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110618420|NCT00930345|Sunitinib|sunitinib|mesh-list
110618421|NCT00930345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110618422|NCT00930345|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110618423|NCT00930345|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110618449|NCT00686972|Hormones|hormones|mesh-ancestor
110618450|NCT00686972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110618451|NCT00686972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110618452|NCT00686972|Incretins|incretins|mesh-ancestor
110618453|NCT00665652|Lenalidomide|lenalidomide|mesh-list
110618454|NCT00665652|Immunologic Factors|immunologic factors|mesh-ancestor
110618458|NCT00665652|Growth Substances|growth substances|mesh-ancestor
110618519|NCT00932217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110618520|NCT00786318|Ziprasidone|ziprasidone|mesh-list
110618521|NCT00786318|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110618522|NCT00786318|Serotonin Agents|serotonin agents|mesh-ancestor
110618523|NCT00786318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110618524|NCT00786318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110618525|NCT00786318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110618526|NCT00786318|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110618527|NCT00786318|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110618528|NCT00786318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110618529|NCT00786318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110618530|NCT00786318|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110618531|NCT00786318|Dopamine Agents|dopamine agents|mesh-ancestor
110618532|NCT00566631|Paliperidone Palmitate|paliperidone palmitate|mesh-list
110618533|NCT00566631|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110618534|NCT00566631|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110618535|NCT00566631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110618536|NCT00566631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110618546|NCT00937911|Darexaban|darexaban|mesh-list
110618575|NCT00932529|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110618576|NCT00932529|Ziprasidone|ziprasidone|mesh-list
110618577|NCT00932529|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110618578|NCT00932529|Serotonin Agents|serotonin agents|mesh-ancestor
110618579|NCT00932529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110618580|NCT00932529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110618581|NCT00932529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110618582|NCT00932529|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110618583|NCT00932529|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110618584|NCT00932529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110618585|NCT00932529|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110618640|NCT00932763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110618641|NCT00932763|Vasodilator Agents|vasodilator agents|mesh-ancestor
110618642|NCT00786396|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
110618643|NCT00786396|Antiviral Agents|antiviral agents|mesh-ancestor
110618644|NCT00786396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110618645|NCT00783900|Metoprolol|metoprolol|mesh-list
110618646|NCT00783900|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110618647|NCT00783900|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110618648|NCT00783900|Sympatholytics|sympatholytics|mesh-ancestor
110618649|NCT00783900|Autonomic Agents|autonomic agents|mesh-ancestor
110618650|NCT00783900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110618651|NCT00783900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110618652|NCT00783900|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110618653|NCT00783900|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110618654|NCT00783900|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110618655|NCT00783900|Adrenergic Agents|adrenergic agents|mesh-ancestor
110618656|NCT00783900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110618657|NCT00783900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110618658|NCT00938613|Budesonide|budesonide|mesh-list
110618659|NCT00938613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110618660|NCT00938613|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110618661|NCT00938613|Autonomic Agents|autonomic agents|mesh-ancestor
110618662|NCT00938613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110618663|NCT00938613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110618664|NCT00938613|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110618665|NCT00938613|Respiratory System Agents|respiratory system agents|mesh-ancestor
110618666|NCT00938613|Glucocorticoids|glucocorticoids|mesh-ancestor
110618667|NCT00938613|Hormones|hormones|mesh-ancestor
110618687|NCT00931203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110618688|NCT00931203|Analgesics|analgesics|mesh-ancestor
110618698|NCT00565773|Sirolimus|sirolimus|mesh-list
110618763|NCT00933231|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110618764|NCT00933231|Protective Agents|protective agents|mesh-ancestor
110618765|NCT00933231|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110618766|NCT00933231|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110618767|NCT00933231|Antitubercular Agents|antitubercular agents|mesh-ancestor
110618768|NCT00933231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110618769|NCT00933231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110618770|NCT00933231|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110618771|NCT00933231|Protease Inhibitors|protease inhibitors|mesh-ancestor
110618772|NCT00933231|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110266061|NCT00536770|Calcitriol|calcitriol|mesh-list
110618773|NCT00933231|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110618774|NCT00933231|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110618775|NCT03489525|Antibodies|antibodies|mesh-list
110618824|NCT00663858|Hormone Antagonists|hormone antagonists|mesh-ancestor
110618825|NCT00663858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110618826|NCT05223400|Clindamycin|clindamycin|mesh-list
110618827|NCT05223400|Clindamycin palmitate|clindamycin palmitate|mesh-list
110618828|NCT05223400|Clindamycin phosphate|clindamycin phosphate|mesh-list
110266125|NCT00189501|Cinacalcet|cinacalcet|mesh-list
110618893|NCT01060735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110618894|NCT01060735|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110618895|NCT02555358|Docetaxel|docetaxel|mesh-list
110618896|NCT02555358|Capecitabine|capecitabine|mesh-list
110618897|NCT02555358|Oxaliplatin|oxaliplatin|mesh-list
110618898|NCT02555358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110618899|NCT02555358|Tubulin Modulators|tubulin modulators|mesh-ancestor
110618900|NCT02555358|Antimitotic Agents|antimitotic agents|mesh-ancestor
110618901|NCT02555358|Mitosis Modulators|mitosis modulators|mesh-ancestor
110618903|NCT02555358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110618961|NCT00540514|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110618962|NCT00540514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110618963|NCT00540514|Tubulin Modulators|tubulin modulators|mesh-ancestor
110618964|NCT00540514|Antimitotic Agents|antimitotic agents|mesh-ancestor
110618965|NCT00540514|Mitosis Modulators|mitosis modulators|mesh-ancestor
110618966|NCT00540514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110618967|NCT00663702|Abatacept|abatacept|mesh-list
110618968|NCT00663702|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110618969|NCT00663702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110618970|NCT00663702|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110618971|NCT00663702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110618972|NCT00663702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110618973|NCT00663702|Immunologic Factors|immunologic factors|mesh-ancestor
110618974|NCT00663702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110618975|NCT00663702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110618976|NCT02022592|Midazolam|midazolam|mesh-list
110618977|NCT02022592|Lormetazepam|lormetazepam|mesh-list
110618978|NCT02022592|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110618979|NCT02022592|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110618980|NCT02022592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110618981|NCT02022592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110618982|NCT02022592|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110619014|NCT00795678|Antimitotic Agents|antimitotic agents|mesh-ancestor
110619015|NCT00795678|Mitosis Modulators|mitosis modulators|mesh-ancestor
110619016|NCT00795678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110619017|NCT00795678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110619018|NCT00795678|Immunologic Factors|immunologic factors|mesh-ancestor
110619032|NCT00753038|Paclitaxel|paclitaxel|mesh-list
110619081|NCT01563952|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110619082|NCT01563952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110619083|NCT01563952|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110619084|NCT01563952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110619153|NCT04058132|Vasodilator Agents|vasodilator agents|mesh-ancestor
110619154|NCT04058132|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110619155|NCT04058132|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110619156|NCT04058132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110619224|NCT00326911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110619225|NCT00791622|Paliperidone Palmitate|paliperidone palmitate|mesh-list
110619226|NCT00791622|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110619227|NCT00791622|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110619228|NCT00791622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110619229|NCT00791622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110619239|NCT00747110|Budesonide|budesonide|mesh-list
110619290|NCT00788424|Antiviral Agents|antiviral agents|mesh-ancestor
110619291|NCT00788424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110619292|NCT00791856|Methyltestosterone|methyltestosterone|mesh-list
110619293|NCT00791856|Testosterone|testosterone|mesh-list
110266571|NCT00158171|Hematinics|hematinics|mesh-ancestor
110619294|NCT00791856|Testosterone undecanoate|testosterone undecanoate|mesh-list
110619295|NCT00791856|Testosterone enanthate|testosterone enanthate|mesh-list
110619296|NCT00791856|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
110619297|NCT00791856|Androgens|androgens|mesh-ancestor
110619298|NCT00791856|Hormones|hormones|mesh-ancestor
110619299|NCT00791856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110619300|NCT00791856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110619301|NCT00791856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110619302|NCT00791856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110619303|NCT00791856|Anabolic Agents|anabolic agents|mesh-ancestor
110619304|NCT00796692|Heparin|heparin|mesh-list
110619305|NCT00796692|Calcium heparin|calcium heparin|mesh-list
110619306|NCT00796692|Nadroparin|nadroparin|mesh-list
110619307|NCT00796692|Anticoagulants|anticoagulants|mesh-ancestor
110619308|NCT00796692|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110619309|NCT00796692|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110619310|NCT00796692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110619311|NCT00540436|Ambrisentan|ambrisentan|mesh-list
110619344|NCT02562950|Midazolam|midazolam|mesh-list
110619345|NCT02562950|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110619346|NCT02562950|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110619347|NCT02562950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110619348|NCT02562950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110619349|NCT02562950|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110619350|NCT02562950|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110619351|NCT02562950|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110619353|NCT02562950|Anesthetics, General|anesthetics, general|mesh-ancestor
110619408|NCT00754910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110619409|NCT00754910|Dermatologic Agents|dermatologic agents|mesh-ancestor
110619410|NCT00754910|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110619411|NCT00755066|Fluticasone|fluticasone|mesh-list
110619412|NCT00755066|Xhance|xhance|mesh-list
110619413|NCT00755066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110619414|NCT00755066|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110619415|NCT00755066|Autonomic Agents|autonomic agents|mesh-ancestor
110619416|NCT00755066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110619417|NCT00755066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110619418|NCT00755066|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110619419|NCT00755066|Respiratory System Agents|respiratory system agents|mesh-ancestor
110619420|NCT00755066|Dermatologic Agents|dermatologic agents|mesh-ancestor
110619421|NCT00755066|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110619422|NCT00990574|Anesthetics|anesthetics|mesh-list
110619423|NCT00990574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110619424|NCT00990574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110619425|NCT00659490|Naproxen|naproxen|mesh-list
110619464|NCT00539500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110619465|NCT00662532|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110619466|NCT00662532|Minocycline|minocycline|mesh-list
110619467|NCT00662532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110619468|NCT00792324|Efavirenz|efavirenz|mesh-list
110619469|NCT00792324|Etravirine|etravirine|mesh-list
110619470|NCT00792324|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110619471|NCT00792324|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110619472|NCT00792324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110619473|NCT00792324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110619474|NCT00792324|Antiviral Agents|antiviral agents|mesh-ancestor
110619475|NCT00792324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110619476|NCT00792324|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110619477|NCT00792324|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110619478|NCT00792324|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110619479|NCT00792324|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110619480|NCT00792324|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110619481|NCT00792324|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110619482|NCT00990808|Atorvastatin|atorvastatin|mesh-list
110619483|NCT00990808|Anacetrapib|anacetrapib|mesh-list
110619484|NCT00990808|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110619485|NCT00990808|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110619486|NCT00990808|Antimetabolites|antimetabolites|mesh-ancestor
110619487|NCT00990808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110619514|NCT00990886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110619515|NCT00990886|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110619516|NCT00990886|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110619518|NCT00990886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110619519|NCT00990886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110619520|NCT00990886|Urological Agents|urological agents|mesh-ancestor
110619521|NCT00797394|Saw palmetto extract|saw palmetto extract|mesh-list
110619522|NCT00797394|Urological Agents|urological agents|mesh-ancestor
110619523|NCT00681824|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
110619581|NCT00755456|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110619582|NCT00755534|Capecitabine|capecitabine|mesh-list
110619583|NCT00755534|Oxaliplatin|oxaliplatin|mesh-list
110619584|NCT00755534|Irinotecan|irinotecan|mesh-list
110619585|NCT00755534|Cetuximab|cetuximab|mesh-list
110619654|NCT00792714|Diuretics|diuretics|mesh-ancestor
110619655|NCT00792714|Natriuretic Agents|natriuretic agents|mesh-ancestor
110619656|NCT00792714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110619657|NCT04961554|Anesthetics|anesthetics|mesh-list
110619658|NCT04961554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110619659|NCT04961554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110619660|NCT00354601|Docetaxel|docetaxel|mesh-list
110619661|NCT00354601|Capecitabine|capecitabine|mesh-list
110619663|NCT00354601|Tubulin Modulators|tubulin modulators|mesh-ancestor
110619721|NCT00797784|Analgesics|analgesics|mesh-ancestor
110619722|NCT00797784|Sensory System Agents|sensory system agents|mesh-ancestor
110619723|NCT00797784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110619724|NCT00797784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110619725|NCT00797784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110619726|NCT00797784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110619791|NCT00537940|Antimanic Agents|antimanic agents|mesh-ancestor
110619792|NCT00661362|Metformin|metformin|mesh-list
110619793|NCT00661362|Saxagliptin|saxagliptin|mesh-list
110619794|NCT00661362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110619795|NCT00661362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110619796|NCT00661362|Incretins|incretins|mesh-ancestor
110619797|NCT00661362|Hormones|hormones|mesh-ancestor
110619798|NCT00661362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110619799|NCT00661362|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110619800|NCT00661362|Protease Inhibitors|protease inhibitors|mesh-ancestor
110619801|NCT00661362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110619802|NCT00661362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110619852|NCT02554344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110619853|NCT02554344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110619854|NCT02554344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110619855|NCT02554344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110619856|NCT02554344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110619857|NCT02554344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110619858|NCT01055041|Budesonide|budesonide|mesh-list
110619859|NCT01055041|Doxofylline|doxofylline|mesh-list
110619860|NCT01055041|Montelukast|montelukast|mesh-list
110619861|NCT01055041|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110619862|NCT01055041|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110619915|NCT00757016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110619916|NCT00757016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110619917|NCT00757016|Immunologic Factors|immunologic factors|mesh-ancestor
110619918|NCT00757016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110619919|NCT00757016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110619920|NCT00687362|Infliximab|infliximab|mesh-list
110619921|NCT00687362|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110619922|NCT00687362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110619923|NCT00687362|Dermatologic Agents|dermatologic agents|mesh-ancestor
110619924|NCT00687362|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110619925|NCT00687362|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110619926|NCT00757250|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
110619927|NCT00757250|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110619977|NCT00685334|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110619978|NCT00685334|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110619980|NCT00801294|Afatinib|afatinib|mesh-list
110619981|NCT00801294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110619982|NCT00801294|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110619983|NCT00801294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110619984|NCT00801294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110619985|NCT04013919|Insulin|insulin|mesh-list
110619986|NCT04013919|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110619987|NCT04013919|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110619988|NCT04013919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110619989|NCT00344461|Tenofovir|tenofovir|mesh-list
110619990|NCT00344461|Nevirapine|nevirapine|mesh-list
110619991|NCT00344461|Antiviral Agents|antiviral agents|mesh-ancestor
110619992|NCT00344461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110619993|NCT00344461|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110619994|NCT00344461|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110619995|NCT00344461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110620001|NCT00685178|Topiramate|topiramate|mesh-list
110620036|NCT00933309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110620037|NCT00933309|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110620038|NCT00933309|Hormone Antagonists|hormone antagonists|mesh-ancestor
110620039|NCT00933309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110620040|NCT00352885|Escitalopram|escitalopram|mesh-list
110251742|NCT00136292|Daptomycin|daptomycin|mesh-list
110620041|NCT00352885|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110620042|NCT00352885|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110620043|NCT00352885|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110620044|NCT00352885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110620045|NCT00352885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110620046|NCT00352885|Serotonin Agents|serotonin agents|mesh-ancestor
110620047|NCT00352885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110620048|NCT00933387|Paclitaxel|paclitaxel|mesh-list
110620049|NCT00933387|Cetuximab|cetuximab|mesh-list
110620050|NCT00933387|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110620051|NCT00933387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110620052|NCT00933387|Tubulin Modulators|tubulin modulators|mesh-ancestor
110620053|NCT00933387|Antimitotic Agents|antimitotic agents|mesh-ancestor
110620054|NCT00933387|Mitosis Modulators|mitosis modulators|mesh-ancestor
110620055|NCT00933387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110620056|NCT00933387|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110620087|NCT00757874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110620088|NCT00757874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110620089|NCT00757874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110620090|NCT00757874|Glucocorticoids|glucocorticoids|mesh-ancestor
110620091|NCT00757874|Hormones|hormones|mesh-ancestor
110620092|NCT00757874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110620093|NCT00344305|Vaccines|vaccines|mesh-list
110620094|NCT00344305|Immunologic Factors|immunologic factors|mesh-ancestor
110620095|NCT00344305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110620096|NCT00933777|Everolimus|everolimus|mesh-list
110620097|NCT00933777|Sorafenib|sorafenib|mesh-list
110620098|NCT00933777|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110620099|NCT00933777|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110620100|NCT00933777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110620102|NCT00933777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110620148|NCT01060891|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110620150|NCT04003402|Ethanol|ethanol|mesh-list
110620223|NCT00758030|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110620224|NCT00758030|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110620225|NCT00758030|Serotonin Agents|serotonin agents|mesh-ancestor
110620226|NCT00758030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110620227|NCT00758030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110620228|NCT00758030|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110620229|NCT00758030|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110620230|NCT00758030|Dopamine Agents|dopamine agents|mesh-ancestor
110620231|NCT00991822|Timolol|timolol|mesh-list
110620232|NCT00991822|Dorzolamide|dorzolamide|mesh-list
110620233|NCT00991822|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110620234|NCT00991822|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110620235|NCT00991822|Adrenergic Agents|adrenergic agents|mesh-ancestor
110620236|NCT00991822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110620237|NCT00991822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110620238|NCT00991822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110620239|NCT00991822|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110620240|NCT00991822|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110620241|NCT00991822|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110620242|NCT00991822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110620243|NCT00798954|Sirolimus|sirolimus|mesh-list
110620244|NCT00798954|Paclitaxel|paclitaxel|mesh-list
110620245|NCT00798954|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110620246|NCT00798954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110620247|NCT00798954|Tubulin Modulators|tubulin modulators|mesh-ancestor
110620248|NCT00798954|Antimitotic Agents|antimitotic agents|mesh-ancestor
110620249|NCT00798954|Mitosis Modulators|mitosis modulators|mesh-ancestor
110620250|NCT00798954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110620251|NCT00798954|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110620267|NCT00934167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110620272|NCT00934245|Vaccines|vaccines|mesh-list
110620342|NCT01564108|Ranibizumab|ranibizumab|mesh-list
110620343|NCT01564108|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110620344|NCT01564108|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110620345|NCT01564108|Growth Substances|growth substances|mesh-ancestor
110620346|NCT01564108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110620398|NCT05408104|Natriuretic Agents|natriuretic agents|mesh-ancestor
110620399|NCT05408104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110620400|NCT00343291|Paclitaxel|paclitaxel|mesh-list
110620401|NCT00343291|Bevacizumab|bevacizumab|mesh-list
110620402|NCT00343291|Carboplatin|carboplatin|mesh-list
110620403|NCT00343291|Cetuximab|cetuximab|mesh-list
110620404|NCT00343291|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110620405|NCT00343291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110620406|NCT00343291|Tubulin Modulators|tubulin modulators|mesh-ancestor
110620407|NCT00343291|Antimitotic Agents|antimitotic agents|mesh-ancestor
110620408|NCT00343291|Mitosis Modulators|mitosis modulators|mesh-ancestor
110620409|NCT00343291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110620410|NCT00343291|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110620411|NCT00343291|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110620412|NCT00343291|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110620413|NCT00343291|Growth Substances|growth substances|mesh-ancestor
110620414|NCT00343291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110620415|NCT00343291|Growth Inhibitors|growth inhibitors|mesh-ancestor
110620416|NCT05407870|Propofol|propofol|mesh-list
110620417|NCT05407870|Etomidate|etomidate|mesh-list
110620418|NCT05407870|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110620494|NCT00802308|Morphine|morphine|mesh-list
110267690|NCT00544219|Glucocorticoids|glucocorticoids|mesh-ancestor
110620419|NCT05407870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110620420|NCT05407870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110620421|NCT05407870|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110620422|NCT05407870|Anesthetics, General|anesthetics, general|mesh-ancestor
110620423|NCT05407870|Anesthetics|anesthetics|mesh-ancestor
110620424|NCT03988231|Enoxaparin|enoxaparin|mesh-list
110620425|NCT03988231|Anticoagulants|anticoagulants|mesh-ancestor
110620426|NCT03988231|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110620427|NCT03988231|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110620428|NCT03988231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110620429|NCT00658788|Calcitriol|calcitriol|mesh-list
110620430|NCT00658788|Clobetasol|clobetasol|mesh-list
110620431|NCT00658788|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110620432|NCT00658788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110620433|NCT00658788|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
110620434|NCT00658788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110620435|NCT00658788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110620436|NCT00658788|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110620437|NCT00658788|Vitamins|vitamins|mesh-ancestor
110620438|NCT00658788|Micronutrients|micronutrients|mesh-ancestor
110620439|NCT00658788|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110620440|NCT00658788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110620441|NCT00658788|Glucocorticoids|glucocorticoids|mesh-ancestor
110620442|NCT00658788|Hormones|hormones|mesh-ancestor
110620443|NCT00658788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110620444|NCT01060969|Acetazolamide|acetazolamide|mesh-list
110620445|NCT01060969|Tadalafil|tadalafil|mesh-list
110620446|NCT01060969|Vasodilator Agents|vasodilator agents|mesh-ancestor
110620447|NCT01060969|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110620448|NCT01060969|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110620449|NCT01060969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110620450|NCT01060969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110620451|NCT01060969|Urological Agents|urological agents|mesh-ancestor
110620452|NCT01060969|Anticonvulsants|anticonvulsants|mesh-ancestor
110620453|NCT01060969|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110620454|NCT01060969|Diuretics|diuretics|mesh-ancestor
110620455|NCT01060969|Natriuretic Agents|natriuretic agents|mesh-ancestor
110620456|NCT01060969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110620457|NCT05407246|Hemay005|hemay005|mesh-list
110620458|NCT05407246|Dermatologic Agents|dermatologic agents|mesh-ancestor
110620459|NCT05407246|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
110620460|NCT05407246|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110620461|NCT05407246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110620462|NCT05407246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110620464|NCT00799890|Antioxidants|antioxidants|mesh-ancestor
110620465|NCT00799890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110620466|NCT00799890|Protective Agents|protective agents|mesh-ancestor
110620467|NCT00799890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110620468|NCT00799890|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
110620469|NCT00799890|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110620470|NCT00799890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110620471|NCT00799890|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110620472|NCT00799968|Fibrinolytic Agents|fibrinolytic agents|mesh-list
110620473|NCT00799968|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110620474|NCT00799968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110620478|NCT00802230|Terbutaline|terbutaline|mesh-list
110620479|NCT00802230|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110620480|NCT00802230|Autonomic Agents|autonomic agents|mesh-ancestor
110620481|NCT00802230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110620482|NCT00802230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110620483|NCT00802230|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110620484|NCT00802230|Respiratory System Agents|respiratory system agents|mesh-ancestor
110620485|NCT00802230|Sympathomimetics|sympathomimetics|mesh-ancestor
110620486|NCT00802230|Tocolytic Agents|tocolytic agents|mesh-ancestor
110620487|NCT00802230|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110620488|NCT00802230|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110620489|NCT00802230|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110620490|NCT00802230|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110620491|NCT00802230|Adrenergic Agents|adrenergic agents|mesh-ancestor
110620492|NCT00802230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110620493|NCT00802230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110620495|NCT00802308|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110620496|NCT00802308|Narcotics|narcotics|mesh-ancestor
110620497|NCT00802308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110620498|NCT00802308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110620499|NCT00802308|Analgesics|analgesics|mesh-ancestor
110620500|NCT00802308|Sensory System Agents|sensory system agents|mesh-ancestor
110620501|NCT00802308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110620502|NCT00562965|Dexamethasone|dexamethasone|mesh-list
110620503|NCT00562965|Prednisone|prednisone|mesh-list
110620504|NCT00562965|Prednisolone|prednisolone|mesh-list
110620505|NCT00562965|Cyclophosphamide|cyclophosphamide|mesh-list
110620506|NCT00562965|Rituximab|rituximab|mesh-list
110620507|NCT00562965|Fludarabine|fludarabine|mesh-list
110620508|NCT00562965|Vincristine|vincristine|mesh-list
110620509|NCT00562965|Mitoxantrone|mitoxantrone|mesh-list
110620510|NCT00562965|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
110620511|NCT00562965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110620512|NCT00562965|Immunologic Factors|immunologic factors|mesh-ancestor
110620513|NCT00562965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110620514|NCT00562965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110620515|NCT00562965|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110620517|NCT00562965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110620518|NCT00562965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110620519|NCT00562965|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110620520|NCT00562965|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110620521|NCT00562965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110620522|NCT00562965|Antiemetics|antiemetics|mesh-ancestor
110620523|NCT00562965|Autonomic Agents|autonomic agents|mesh-ancestor
110620524|NCT00562965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110620525|NCT00562965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110620526|NCT00562965|Glucocorticoids|glucocorticoids|mesh-ancestor
110620527|NCT00562965|Hormones|hormones|mesh-ancestor
110620528|NCT00562965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110620529|NCT00562965|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110620530|NCT00562965|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110620531|NCT00562965|Tubulin Modulators|tubulin modulators|mesh-ancestor
110620532|NCT00562965|Antimitotic Agents|antimitotic agents|mesh-ancestor
110620533|NCT00562965|Mitosis Modulators|mitosis modulators|mesh-ancestor
110620534|NCT00562965|Analgesics|analgesics|mesh-ancestor
110620535|NCT00562965|Sensory System Agents|sensory system agents|mesh-ancestor
110620536|NCT00562965|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110620537|NCT00562965|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110620538|NCT00562965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110620539|NCT00562965|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110620540|NCT00562965|Immunotoxins|immunotoxins|mesh-ancestor
110620541|NCT00562965|Immunoconjugates|immunoconjugates|mesh-ancestor
110620542|NCT05406934|Infliximab|infliximab|mesh-list
110620543|NCT05406934|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110620544|NCT05406934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110620545|NCT05406934|Dermatologic Agents|dermatologic agents|mesh-ancestor
110620546|NCT05406934|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110620547|NCT05406934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110620548|NCT00794898|Infliximab|infliximab|mesh-list
110620549|NCT00794898|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110620550|NCT00794898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110620551|NCT00794898|Dermatologic Agents|dermatologic agents|mesh-ancestor
110620552|NCT00794898|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110620553|NCT00794898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110620554|NCT00800280|Cimetidine|cimetidine|mesh-list
110620555|NCT00800280|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110620556|NCT00800280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110620557|NCT00800280|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110620558|NCT00800280|Histamine Antagonists|histamine antagonists|mesh-ancestor
110620559|NCT00800280|Histamine Agents|histamine agents|mesh-ancestor
110620560|NCT00800280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110620561|NCT00800280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110620562|NCT00800280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110620563|NCT00800280|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110620564|NCT00800280|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110620565|NCT00800280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110620566|NCT00800358|Calcitriol|calcitriol|mesh-list
110620567|NCT00800358|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110620568|NCT00800358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110620569|NCT00800358|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
110620570|NCT00800358|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110620571|NCT00800358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110620572|NCT00800358|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110620573|NCT00800358|Vitamins|vitamins|mesh-ancestor
110620574|NCT00800358|Micronutrients|micronutrients|mesh-ancestor
110620575|NCT00800358|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110620576|NCT00934713|Montelukast|montelukast|mesh-list
110620577|NCT00934713|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110620578|NCT00934713|Respiratory System Agents|respiratory system agents|mesh-ancestor
110620579|NCT00934713|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110620580|NCT00934713|Hormone Antagonists|hormone antagonists|mesh-ancestor
110620581|NCT00934713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110620582|NCT00934713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110620583|NCT00934713|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110620584|NCT00934713|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110620585|NCT00934713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110620588|NCT01057849|Aripiprazole|aripiprazole|mesh-list
110620589|NCT01057849|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110620590|NCT01057849|Serotonin Agents|serotonin agents|mesh-ancestor
110620591|NCT01057849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110251785|NCT00159510|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110620592|NCT01057849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110620593|NCT01057849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110620594|NCT01057849|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110620595|NCT01057849|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110620596|NCT01057849|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110620597|NCT01057849|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110620598|NCT01057849|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110620599|NCT01057849|Dopamine Agents|dopamine agents|mesh-ancestor
110620600|NCT01057849|Antiemetics|antiemetics|mesh-ancestor
110251802|NCT00153114|Laxatives|laxatives|mesh-ancestor
110620601|NCT01057849|Autonomic Agents|autonomic agents|mesh-ancestor
110620602|NCT01057849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110620603|NCT01057849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110620604|NCT01057849|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110620605|NCT01057849|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110620606|NCT01057849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110620607|NCT01057849|Antidepressive Agents|antidepressive agents|mesh-ancestor
110620608|NCT01057849|Dopamine Agonists|dopamine agonists|mesh-ancestor
110620609|NCT01057849|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110620610|NCT01057849|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110620611|NCT01057849|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110620612|NCT01057849|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110620613|NCT00794976|Dexamethasone|dexamethasone|mesh-list
110620614|NCT00794976|Dexamethasone acetate|dexamethasone acetate|mesh-list
110620615|NCT00794976|BB 1101|bb 1101|mesh-list
110620616|NCT00794976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110620617|NCT00794976|Antiemetics|antiemetics|mesh-ancestor
110620618|NCT00794976|Autonomic Agents|autonomic agents|mesh-ancestor
110620619|NCT00794976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110620620|NCT00794976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110620621|NCT00794976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110620622|NCT00794976|Glucocorticoids|glucocorticoids|mesh-ancestor
110620623|NCT00794976|Hormones|hormones|mesh-ancestor
110620624|NCT00794976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110620625|NCT00794976|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110620626|NCT00794976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110620627|NCT00794976|Protease Inhibitors|protease inhibitors|mesh-ancestor
110620628|NCT00794976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110620629|NCT00794976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110620630|NCT00939939|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110620631|NCT00939939|Glimepiride|glimepiride|mesh-list
110620632|NCT00939939|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110620633|NCT00939939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110620634|NCT00939939|Incretins|incretins|mesh-ancestor
110620635|NCT00939939|Hormones|hormones|mesh-ancestor
110620636|NCT00939939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110620637|NCT00939939|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110620638|NCT00939939|Protease Inhibitors|protease inhibitors|mesh-ancestor
110620639|NCT00939939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110621120|NCT00676130|Antimalarials|antimalarials|mesh-ancestor
110620640|NCT00939939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110620641|NCT00939939|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110620642|NCT00939939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110620643|NCT00939939|Immunologic Factors|immunologic factors|mesh-ancestor
110620644|NCT00537082|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
110620645|NCT00537082|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
110620646|NCT00537082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110620647|NCT00537082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110620648|NCT00537082|Immunologic Factors|immunologic factors|mesh-ancestor
110620649|NCT00537082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110620650|NCT00805662|Oxytocin|oxytocin|mesh-list
110620651|NCT00805662|Oxytocics|oxytocics|mesh-ancestor
110620652|NCT00805662|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110620653|NCT00805662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110620655|NCT04978012|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110620656|NCT04978012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110620657|NCT04978012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110620658|NCT04978012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110620659|NCT00803166|Clobetasol|clobetasol|mesh-list
110620660|NCT00803166|Halobetasol|halobetasol|mesh-list
110620661|NCT00803166|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110620662|NCT00803166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110620663|NCT00803166|Glucocorticoids|glucocorticoids|mesh-ancestor
110620664|NCT00803166|Hormones|hormones|mesh-ancestor
110620665|NCT00803166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110620666|NCT00803166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110620667|NCT00324961|Adefovir|adefovir|mesh-list
110620668|NCT00324961|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
110620669|NCT00324961|Antiviral Agents|antiviral agents|mesh-ancestor
110620670|NCT00324961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110620671|NCT00324961|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110620672|NCT00324961|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110620673|NCT00324961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110620674|NCT00324961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110620675|NCT00935415|Montelukast|montelukast|mesh-list
110620676|NCT00935415|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110620677|NCT00935415|Respiratory System Agents|respiratory system agents|mesh-ancestor
110620678|NCT00935415|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110620679|NCT00935415|Hormone Antagonists|hormone antagonists|mesh-ancestor
110620680|NCT00935415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110620681|NCT00935415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110620682|NCT00935415|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110620683|NCT00935415|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110620684|NCT00935415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110620685|NCT00935571|Remifentanil|remifentanil|mesh-list
110620686|NCT00935571|Propofol|propofol|mesh-list
110620687|NCT00935571|Sevoflurane|sevoflurane|mesh-list
110620688|NCT00935571|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110620689|NCT00935571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110620690|NCT00935571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110620691|NCT00935571|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110620692|NCT00935571|Anesthetics, General|anesthetics, general|mesh-ancestor
110620693|NCT00935571|Anesthetics|anesthetics|mesh-ancestor
110620694|NCT00935571|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110620695|NCT00935571|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110620696|NCT00935571|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110620697|NCT00935571|Narcotics|narcotics|mesh-ancestor
110620698|NCT00935571|Analgesics|analgesics|mesh-ancestor
110620699|NCT00935571|Sensory System Agents|sensory system agents|mesh-ancestor
110620700|NCT00935571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110620701|NCT00324649|Lamivudine|lamivudine|mesh-list
110620702|NCT00324649|Zidovudine|zidovudine|mesh-list
110620703|NCT00324649|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110620704|NCT00324649|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110620705|NCT00324649|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110620706|NCT00324649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110620707|NCT00324649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110620708|NCT00324649|Antiviral Agents|antiviral agents|mesh-ancestor
110620709|NCT00324649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110620710|NCT00324649|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110620711|NCT00324649|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110620712|NCT00324649|Antimetabolites|antimetabolites|mesh-ancestor
110620713|NCT03743259|Charcoal|charcoal|mesh-list
110620714|NCT03743259|Antidotes|antidotes|mesh-ancestor
110620715|NCT03743259|Protective Agents|protective agents|mesh-ancestor
110620716|NCT03743259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110620717|NCT03983239|Efavirenz|efavirenz|mesh-list
110620718|NCT03983239|Rifampin|rifampin|mesh-list
110267992|NCT00546325|Rimonabant|rimonabant|mesh-list
110153873|NCT00005861|Doxorubicin|doxorubicin|mesh-list
110620719|NCT03983239|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110620720|NCT03983239|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110620721|NCT03983239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110620722|NCT03983239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110620723|NCT03983239|Antiviral Agents|antiviral agents|mesh-ancestor
110620724|NCT03983239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110620725|NCT03983239|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110620726|NCT03983239|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110620727|NCT03983239|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110620728|NCT03983239|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110620729|NCT03983239|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110620730|NCT03983239|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110620731|NCT03983239|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110620732|NCT03983239|Antitubercular Agents|antitubercular agents|mesh-ancestor
110620733|NCT03983239|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110620734|NCT03983239|Leprostatic Agents|leprostatic agents|mesh-ancestor
110620735|NCT03983239|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110620736|NCT03983239|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110620737|NCT03983239|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110620739|NCT00935805|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110620740|NCT00935805|Metformin|metformin|mesh-list
110620741|NCT00935805|Insulin, Isophane|insulin, isophane|mesh-list
110620742|NCT00935805|Isophane Insulin, Human|isophane insulin, human|mesh-list
110620743|NCT00935805|Isophane insulin, beef|isophane insulin, beef|mesh-list
110620744|NCT00935805|Glyburide|glyburide|mesh-list
110620745|NCT00935805|Propranolol|propranolol|mesh-list
110620746|NCT00935805|Amlodipine|amlodipine|mesh-list
110620747|NCT00935805|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110620748|NCT00935805|Captopril|captopril|mesh-list
110620749|NCT00935805|Diuretics|diuretics|mesh-list
110620750|NCT00935805|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110620751|NCT00935805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110620752|NCT00935805|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110620753|NCT00935805|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110620754|NCT00935805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110620755|NCT00935805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110620756|NCT00935805|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110620757|NCT00935805|Vasodilator Agents|vasodilator agents|mesh-ancestor
110620759|NCT00935805|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110620760|NCT00935805|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110620761|NCT00935805|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110620762|NCT00935805|Adrenergic Agents|adrenergic agents|mesh-ancestor
110620763|NCT00935805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110620764|NCT00935805|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110620765|NCT00935805|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110620766|NCT00935805|Protease Inhibitors|protease inhibitors|mesh-ancestor
110621478|NCT00561951|Fesoterodine|fesoterodine|mesh-list
110620767|NCT00935805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110620768|NCT00935961|Docetaxel|docetaxel|mesh-list
110620769|NCT00935961|Everolimus|everolimus|mesh-list
110620770|NCT00935961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110620771|NCT00935961|Tubulin Modulators|tubulin modulators|mesh-ancestor
110620772|NCT00935961|Antimitotic Agents|antimitotic agents|mesh-ancestor
110620773|NCT00935961|Mitosis Modulators|mitosis modulators|mesh-ancestor
110621541|NCT00941343|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110620774|NCT00935961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110620775|NCT00935961|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110620776|NCT00935961|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110620777|NCT00935961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110620778|NCT00935961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110620779|NCT00935961|Immunologic Factors|immunologic factors|mesh-ancestor
110620780|NCT00935961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110620782|NCT01055431|Trace Elements|trace elements|mesh-ancestor
110620783|NCT01055431|Micronutrients|micronutrients|mesh-ancestor
110620784|NCT01055431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110620785|NCT00803556|Paclitaxel|paclitaxel|mesh-list
110620786|NCT00803556|Trastuzumab|trastuzumab|mesh-list
110620787|NCT00803556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110620788|NCT00803556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110620789|NCT00803556|Tubulin Modulators|tubulin modulators|mesh-ancestor
110620790|NCT00803556|Antimitotic Agents|antimitotic agents|mesh-ancestor
110620791|NCT00803556|Mitosis Modulators|mitosis modulators|mesh-ancestor
110620792|NCT00803556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110620793|NCT00803556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110620794|NCT00936195|Ritonavir|ritonavir|mesh-list
110620795|NCT00936195|Lopinavir|lopinavir|mesh-list
110620796|NCT00936195|Tenofovir|tenofovir|mesh-list
110620797|NCT00936195|Lamivudine|lamivudine|mesh-list
110620798|NCT00936195|Emtricitabine|emtricitabine|mesh-list
110620799|NCT00936195|Zidovudine|zidovudine|mesh-list
110620800|NCT00936195|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
110620801|NCT00936195|Efavirenz|efavirenz|mesh-list
110620802|NCT00936195|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110620803|NCT00936195|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110620804|NCT00936195|Protease Inhibitors|protease inhibitors|mesh-ancestor
110620805|NCT00936195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110620806|NCT00936195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110620807|NCT00936195|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110620808|NCT00936195|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110620809|NCT00936195|Antiviral Agents|antiviral agents|mesh-ancestor
110620810|NCT00936195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110620811|NCT00936195|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110620812|NCT00936195|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110620813|NCT00936195|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110621803|NCT00763178|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110620814|NCT00936195|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110620815|NCT00936195|Antimetabolites|antimetabolites|mesh-ancestor
110620816|NCT00936195|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110620817|NCT00936195|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110620818|NCT00936195|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110620819|NCT00936195|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110620820|NCT00936195|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110620821|NCT00680186|Warfarin|warfarin|mesh-list
110620822|NCT00680186|Dabigatran|dabigatran|mesh-list
110620823|NCT00680186|Anticoagulants|anticoagulants|mesh-ancestor
110620824|NCT00680186|Antithrombins|antithrombins|mesh-ancestor
110620825|NCT00680186|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110620826|NCT00680186|Protease Inhibitors|protease inhibitors|mesh-ancestor
110620827|NCT00680186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110620828|NCT00680186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110620829|NCT00936429|Aluminum Hydroxide|aluminum hydroxide|mesh-list
110620830|NCT00936429|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110620831|NCT00936429|Immunologic Factors|immunologic factors|mesh-ancestor
110620832|NCT00936429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110620833|NCT00936429|Antacids|antacids|mesh-ancestor
110620834|NCT00936429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110620835|NCT00936429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110620836|NCT00656292|Simvastatin|simvastatin|mesh-list
110620837|NCT00656292|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110620838|NCT00656292|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110620839|NCT00656292|Antimetabolites|antimetabolites|mesh-ancestor
110620840|NCT00656292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110620841|NCT00656292|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110620842|NCT00656292|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110620843|NCT00656292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110620844|NCT00352417|Atreleuton|atreleuton|mesh-list
110620845|NCT00352417|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
110620846|NCT00352417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110620847|NCT00352417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110620848|NCT00944541|Maraviroc|maraviroc|mesh-list
110620849|NCT00944541|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110620850|NCT00944541|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110620851|NCT00944541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110620852|NCT00944541|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110620853|NCT00944541|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110620854|NCT00944541|Antiviral Agents|antiviral agents|mesh-ancestor
110620855|NCT00944541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110620856|NCT00944541|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
110620857|NCT00944619|Insulin|insulin|mesh-list
110620858|NCT00944619|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110620859|NCT00944619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110620861|NCT00323869|Carboplatin|carboplatin|mesh-list
110620862|NCT00323869|Gemcitabine|gemcitabine|mesh-list
110620863|NCT00323869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110620864|NCT00323869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110620865|NCT00323869|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110620866|NCT00323869|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110620867|NCT00323869|Growth Substances|growth substances|mesh-ancestor
110620868|NCT00323869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110620869|NCT00323869|Growth Inhibitors|growth inhibitors|mesh-ancestor
110620870|NCT00323869|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110620871|NCT00323869|Antimetabolites|antimetabolites|mesh-ancestor
110620872|NCT00323869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110620873|NCT00323557|Molgramostim|molgramostim|mesh-list
110620874|NCT00323557|Sargramostim|sargramostim|mesh-list
110620875|NCT00323557|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110620876|NCT00323557|Immunologic Factors|immunologic factors|mesh-ancestor
110621987|NCT00763646|Docetaxel|docetaxel|mesh-list
110620877|NCT00323557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110620878|NCT00323557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110620879|NCT00558363|Dutasteride|dutasteride|mesh-list
110620880|NCT00558363|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
110620881|NCT00558363|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110620882|NCT00558363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110620883|NCT00558363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110620884|NCT00558363|Hormone Antagonists|hormone antagonists|mesh-ancestor
110620885|NCT00558363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110620886|NCT00558363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110620887|NCT00323479|Anastrozole|anastrozole|mesh-list
110620888|NCT00323479|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110620889|NCT00323479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110620890|NCT00323479|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110620891|NCT00323479|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110620892|NCT00323479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110620893|NCT00323479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110620894|NCT00323479|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110620895|NCT00323479|Hormone Antagonists|hormone antagonists|mesh-ancestor
110620896|NCT00323479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110620897|NCT00323479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110620898|NCT00352105|Fluorouracil|fluorouracil|mesh-list
110620899|NCT00352105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110620900|NCT00352105|Antimetabolites|antimetabolites|mesh-ancestor
110620901|NCT00352105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110620902|NCT00352105|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110620903|NCT00352105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110620904|NCT00352105|Immunologic Factors|immunologic factors|mesh-ancestor
110620905|NCT00352105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110620906|NCT03988075|Acetaminophen|acetaminophen|mesh-list
110620909|NCT03988075|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110620910|NCT03988075|Analgesics|analgesics|mesh-ancestor
110620911|NCT03988075|Sensory System Agents|sensory system agents|mesh-ancestor
110620912|NCT03988075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110620913|NCT03988075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110620914|NCT03988075|Antipyretics|antipyretics|mesh-ancestor
110620915|NCT03988075|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110620916|NCT03988075|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110620917|NCT03988075|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110620918|NCT03988075|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110620919|NCT03988075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110620920|NCT03988075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110620921|NCT03988075|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110620922|NCT03988075|Narcotics|narcotics|mesh-ancestor
110620923|NCT03988075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110620924|NCT03988075|Antitussive Agents|antitussive agents|mesh-ancestor
110620925|NCT03988075|Respiratory System Agents|respiratory system agents|mesh-ancestor
110620926|NCT00944853|Zinc|zinc|mesh-list
110620927|NCT00944853|Trace Elements|trace elements|mesh-ancestor
110620928|NCT00944853|Micronutrients|micronutrients|mesh-ancestor
110620929|NCT00944853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110620930|NCT03985891|Antibodies|antibodies|mesh-list
110620931|NCT03985891|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110620932|NCT03985891|Immunologic Factors|immunologic factors|mesh-ancestor
110620933|NCT03985891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110620934|NCT00350779|Metformin|metformin|mesh-list
110620935|NCT00350779|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110620936|NCT00350779|Rosiglitazone|rosiglitazone|mesh-list
110620937|NCT00350779|Glipizide|glipizide|mesh-list
110620938|NCT00350779|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110620939|NCT00350779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110620940|NCT00350779|Incretins|incretins|mesh-ancestor
110620941|NCT00350779|Hormones|hormones|mesh-ancestor
110620942|NCT00350779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110622312|NCT00807534|Bromides|bromides|mesh-list
110620943|NCT00350779|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110620944|NCT00350779|Protease Inhibitors|protease inhibitors|mesh-ancestor
110620945|NCT00350779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110620946|NCT00350779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110620947|NCT00656136|Afatinib|afatinib|mesh-list
110620948|NCT00656136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110620949|NCT00656136|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110620950|NCT00656136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110620951|NCT00656136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110620952|NCT00676520|Everolimus|everolimus|mesh-list
110620953|NCT00676520|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110620954|NCT00676520|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110620955|NCT00676520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110622400|NCT00771368|Gasotransmitters|gasotransmitters|mesh-ancestor
110620956|NCT00676520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110620957|NCT00676520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110620958|NCT00676520|Immunologic Factors|immunologic factors|mesh-ancestor
110620959|NCT00676520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110620960|NCT00676520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110620961|NCT02559908|Hyaluronic Acid|hyaluronic acid|mesh-list
110620962|NCT02559908|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110620963|NCT02559908|Immunologic Factors|immunologic factors|mesh-ancestor
110620964|NCT02559908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110620965|NCT02559908|Viscosupplements|viscosupplements|mesh-ancestor
110620966|NCT02559908|Protective Agents|protective agents|mesh-ancestor
110620967|NCT00322621|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110620968|NCT00322621|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110620969|NCT00322621|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110620970|NCT00322621|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110655639|NCT00425854|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110620971|NCT00322621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110620972|NCT00322621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110620973|NCT00322621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110620974|NCT00322621|Analgesics|analgesics|mesh-ancestor
110620975|NCT00322621|Sensory System Agents|sensory system agents|mesh-ancestor
110620976|NCT00322621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110620977|NCT00322621|Antidepressive Agents|antidepressive agents|mesh-ancestor
110622541|NCT00942747|Sirolimus|sirolimus|mesh-list
110620978|NCT00322621|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110620979|NCT00322621|Dopamine Agents|dopamine agents|mesh-ancestor
110620980|NCT02558972|Droxidopa|droxidopa|mesh-list
110620981|NCT02558972|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110620982|NCT02558972|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110620983|NCT00809718|Raltegravir Potassium|raltegravir potassium|mesh-list
110620984|NCT00809718|Rifapentine|rifapentine|mesh-list
110620985|NCT00809718|Rifampin|rifampin|mesh-list
110620986|NCT00809718|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110620987|NCT00809718|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110620988|NCT00809718|Antiviral Agents|antiviral agents|mesh-ancestor
110620989|NCT00809718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110620990|NCT00809718|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110620991|NCT00809718|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110620992|NCT00809718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110620993|NCT00809718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110620994|NCT00809718|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110620995|NCT00809718|Antitubercular Agents|antitubercular agents|mesh-ancestor
110620996|NCT00809718|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110620997|NCT00809718|Leprostatic Agents|leprostatic agents|mesh-ancestor
110620998|NCT00809718|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110620999|NCT00809718|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110621000|NCT00809718|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110622739|NCT00952029|Vitamins|vitamins|mesh-ancestor
110621001|NCT00809718|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110621002|NCT00809718|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110621003|NCT00809718|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110621004|NCT00809718|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110621006|NCT05427266|Anesthetics, Local|anesthetics, local|mesh-ancestor
110621007|NCT05427266|Anesthetics|anesthetics|mesh-ancestor
110392231|NCT02484924|Clopidogrel|clopidogrel|mesh-list
110621008|NCT05427266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110621009|NCT05427266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110621010|NCT05427266|Sensory System Agents|sensory system agents|mesh-ancestor
110621011|NCT05427266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110621012|NCT00575042|Fenofibrate|fenofibrate|mesh-list
110621013|NCT00575042|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110621014|NCT00575042|Antimetabolites|antimetabolites|mesh-ancestor
110621015|NCT00575042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110621016|NCT00575042|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110621017|NCT00656058|Montelukast|montelukast|mesh-list
110621018|NCT00656058|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110621019|NCT00656058|Respiratory System Agents|respiratory system agents|mesh-ancestor
110621020|NCT00656058|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110621021|NCT00656058|Hormone Antagonists|hormone antagonists|mesh-ancestor
110621022|NCT00656058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110621023|NCT00656058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110251951|NCT00137033|Celecoxib|celecoxib|mesh-list
110621024|NCT00656058|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110621025|NCT00656058|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110621026|NCT00656058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110621027|NCT00537316|Infliximab|infliximab|mesh-list
110621028|NCT00537316|Azathioprine|azathioprine|mesh-list
110621029|NCT00537316|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110621030|NCT00537316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110621031|NCT00537316|Dermatologic Agents|dermatologic agents|mesh-ancestor
110621032|NCT00537316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110621033|NCT00537316|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110622861|NCT00776828|Cilostazol|cilostazol|mesh-list
110621034|NCT00537316|Antimetabolites|antimetabolites|mesh-ancestor
110621035|NCT00537316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110621036|NCT00537316|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110621037|NCT00537316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110621038|NCT00537316|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110621039|NCT00537316|Immunologic Factors|immunologic factors|mesh-ancestor
110621040|NCT00537316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110621041|NCT00803868|Varenicline|varenicline|mesh-list
110621042|NCT00803868|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110621043|NCT00803868|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110622913|NCT03982849|Silymarin|silymarin|mesh-list
110621045|NCT00803868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110621046|NCT00803868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110621047|NCT00803868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110621048|NCT00655980|Folic Acid|folic acid|mesh-list
110621049|NCT00655980|Vitamin B 12|vitamin b 12|mesh-list
110621050|NCT00655980|Hydroxocobalamin|hydroxocobalamin|mesh-list
110621051|NCT00655980|Nitrous Oxide|nitrous oxide|mesh-list
110621052|NCT00655980|Vitamins|vitamins|mesh-ancestor
110621053|NCT00655980|Micronutrients|micronutrients|mesh-ancestor
110622976|NCT00671060|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110621054|NCT00655980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110621055|NCT00655980|Hematinics|hematinics|mesh-ancestor
110621056|NCT00655980|Vitamin B Complex|vitamin b complex|mesh-ancestor
110621057|NCT00655980|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110621058|NCT00655980|Anesthetics, General|anesthetics, general|mesh-ancestor
110621059|NCT00655980|Anesthetics|anesthetics|mesh-ancestor
110621060|NCT00655980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110621061|NCT00655980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110621062|NCT00655980|Analgesics|analgesics|mesh-ancestor
110621063|NCT00655980|Sensory System Agents|sensory system agents|mesh-ancestor
110621064|NCT00655980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110621065|NCT01063621|Apomorphine|apomorphine|mesh-list
110621067|NCT01063621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110621068|NCT01063621|Autonomic Agents|autonomic agents|mesh-ancestor
110621069|NCT01063621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110621070|NCT01063621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110621072|NCT01063621|Dopamine Agents|dopamine agents|mesh-ancestor
110621073|NCT01063621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110621074|NCT01063621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110621075|NCT02533141|Simvastatin|simvastatin|mesh-list
110621076|NCT02533141|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110621077|NCT02533141|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110623112|NCT00762359|Gefarnate|gefarnate|mesh-list
110621078|NCT02533141|Antimetabolites|antimetabolites|mesh-ancestor
110621079|NCT02533141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110621080|NCT02533141|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110623169|NCT03979105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110621081|NCT02533141|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110621082|NCT02533141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110621083|NCT00809796|Pentamidine|pentamidine|mesh-list
110621084|NCT00809796|Antifungal Agents|antifungal agents|mesh-ancestor
110621085|NCT00809796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110621086|NCT00809796|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110621087|NCT00809796|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110621088|NCT00809796|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
110621089|NCT05589454|Calcium, Dietary|calcium, dietary|mesh-list
110621090|NCT05589454|Atorvastatin|atorvastatin|mesh-list
110621091|NCT05589454|Calcium|calcium|mesh-list
110621092|NCT05589454|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110621093|NCT05589454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110268363|NCT00191607|Doxorubicin|doxorubicin|mesh-list
110621094|NCT05589454|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110621096|NCT05589454|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110621097|NCT05589454|Antimetabolites|antimetabolites|mesh-ancestor
110621098|NCT05589454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110621099|NCT05589454|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110621100|NCT05589454|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110621101|NCT05589454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110621103|NCT00803946|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110621104|NCT00803946|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110621105|NCT00803946|Analgesics|analgesics|mesh-ancestor
110623308|NCT05123092|Morphine|morphine|mesh-list
110621106|NCT00803946|Sensory System Agents|sensory system agents|mesh-ancestor
110621107|NCT00803946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110621108|NCT00803946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110621109|NCT00803946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110621110|NCT00803946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110621111|NCT00803946|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110621112|NCT00803946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110621113|NCT00803946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110621114|NCT00676130|Trimethoprim|trimethoprim|mesh-list
110621115|NCT00676130|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
110621116|NCT00676130|Sulfamethoxazole|sulfamethoxazole|mesh-list
110392277|NCT01603758|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110621118|NCT00676130|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110621119|NCT00676130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110623365|NCT00778544|Amoxicillin|amoxicillin|mesh-list
110621121|NCT00676130|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110621122|NCT00676130|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110621123|NCT00676130|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110621124|NCT00676130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110621125|NCT00676130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110621126|NCT00676130|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110621127|NCT00676130|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
110621128|NCT00676130|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110621129|NCT00676130|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110621130|NCT00809874|Caseins|caseins|mesh-list
110621131|NCT00809874|Chelating Agents|chelating agents|mesh-ancestor
110621133|NCT00809874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110621134|NCT05436002|Hyaluronic Acid|hyaluronic acid|mesh-list
110621135|NCT05436002|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110621136|NCT05436002|Immunologic Factors|immunologic factors|mesh-ancestor
110621137|NCT05436002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110621138|NCT05436002|Viscosupplements|viscosupplements|mesh-ancestor
110621139|NCT05436002|Protective Agents|protective agents|mesh-ancestor
110621140|NCT02560376|Exenatide|exenatide|mesh-list
110621141|NCT02560376|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110621142|NCT02560376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110621144|NCT02560376|Incretins|incretins|mesh-ancestor
110621145|NCT02560376|Hormones|hormones|mesh-ancestor
110621146|NCT02560376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110621147|NCT00535288|Mirtazapine|mirtazapine|mesh-list
110621148|NCT00535288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110621149|NCT00535288|Antidepressive Agents|antidepressive agents|mesh-ancestor
110621150|NCT00535288|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110621151|NCT00535288|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110621152|NCT00535288|Histamine Antagonists|histamine antagonists|mesh-ancestor
110621153|NCT00535288|Histamine Agents|histamine agents|mesh-ancestor
110621154|NCT00535288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110621155|NCT00535288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110621156|NCT00535288|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110621157|NCT00535288|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110621158|NCT00535288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110621159|NCT00535288|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
110621160|NCT00535288|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110621161|NCT00535288|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110621162|NCT00535288|Adrenergic Agents|adrenergic agents|mesh-ancestor
110621163|NCT00535288|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110621164|NCT00535288|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110621165|NCT00535288|Serotonin Agents|serotonin agents|mesh-ancestor
110621166|NCT00535288|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110621167|NCT00921830|Ibuprofen|ibuprofen|mesh-list
110621168|NCT00921830|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110621169|NCT00921830|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110621170|NCT00921830|Analgesics|analgesics|mesh-ancestor
110621171|NCT00921830|Sensory System Agents|sensory system agents|mesh-ancestor
110621172|NCT00921830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110621173|NCT00921830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110621174|NCT00921830|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110621175|NCT00921830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110621176|NCT00921830|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110621177|NCT00921830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110621178|NCT00921830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110621179|NCT02560220|Mitomycins|mitomycins|mesh-list
110621180|NCT02560220|Mitomycin|mitomycin|mesh-list
110621181|NCT02560220|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110621182|NCT02560220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110621183|NCT02560220|Alkylating Agents|alkylating agents|mesh-ancestor
110621184|NCT02560220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110621185|NCT02560220|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110621186|NCT02560220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110621187|NCT05356078|Antidepressive Agents|antidepressive agents|mesh-list
110621188|NCT05356078|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110621189|NCT04836832|Acalabrutinib|acalabrutinib|mesh-list
110621190|NCT04836832|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
110621191|NCT04836832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110621193|NCT04836832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110621194|NCT04836832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110621195|NCT02783300|Pembrolizumab|pembrolizumab|mesh-list
110621196|NCT02783300|GSK-3326595|gsk-3326595|mesh-list
110621197|NCT02783300|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110621198|NCT02783300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110621199|NCT02783300|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110621200|NCT02783300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110621201|NCT02783300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110621203|NCT00675506|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
110621204|NCT00675506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110621205|NCT00675506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110621206|NCT05435378|Vitamins|vitamins|mesh-list
110621207|NCT05435378|Folic Acid|folic acid|mesh-list
110621208|NCT05435378|Niacinamide|niacinamide|mesh-list
110621209|NCT05435378|Vitamin B Complex|vitamin b complex|mesh-list
110621210|NCT05435378|Micronutrients|micronutrients|mesh-ancestor
110621211|NCT05435378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110621212|NCT05435378|Hematinics|hematinics|mesh-ancestor
110621213|NCT03895840|Triamcinolone|triamcinolone|mesh-list
110621214|NCT03895840|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110621215|NCT03895840|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110621216|NCT03895840|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110621217|NCT03895840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110621218|NCT03895840|Glucocorticoids|glucocorticoids|mesh-ancestor
110621219|NCT03895840|Hormones|hormones|mesh-ancestor
110621220|NCT03895840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110621221|NCT03895840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110621222|NCT03895840|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110621223|NCT03895840|Immunologic Factors|immunologic factors|mesh-ancestor
110621224|NCT03895840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110621225|NCT03895840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110621227|NCT00310375|Anticonvulsants|anticonvulsants|mesh-ancestor
110621228|NCT00310375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110621229|NCT00310375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110621231|NCT00309907|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110621232|NCT00309907|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110621233|NCT00309907|Prednisolone|prednisolone|mesh-list
110621234|NCT00309907|Prednisolone acetate|prednisolone acetate|mesh-list
110621235|NCT00309907|Etanercept|etanercept|mesh-list
110621236|NCT00309907|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110621237|NCT00309907|Prednisolone phosphate|prednisolone phosphate|mesh-list
110621238|NCT00309907|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110621239|NCT00309907|Antiemetics|antiemetics|mesh-ancestor
110621240|NCT00309907|Autonomic Agents|autonomic agents|mesh-ancestor
110621241|NCT00309907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110621242|NCT00309907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110621243|NCT00309907|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110621244|NCT00309907|Glucocorticoids|glucocorticoids|mesh-ancestor
110621245|NCT00309907|Hormones|hormones|mesh-ancestor
110621246|NCT00309907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110621247|NCT00309907|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110621248|NCT00309907|Protective Agents|protective agents|mesh-ancestor
110621249|NCT00309907|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110621250|NCT00309907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110621251|NCT00309907|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110621252|NCT00309907|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110621253|NCT00309907|Analgesics|analgesics|mesh-ancestor
110621254|NCT00309907|Sensory System Agents|sensory system agents|mesh-ancestor
110621255|NCT00309907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110621256|NCT00309907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110621257|NCT00309907|Immunologic Factors|immunologic factors|mesh-ancestor
110621259|NCT00655824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110621260|NCT03985969|Indomethacin|indomethacin|mesh-list
110621261|NCT03985969|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110621262|NCT03985969|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110621263|NCT03985969|Analgesics|analgesics|mesh-ancestor
110621264|NCT03985969|Sensory System Agents|sensory system agents|mesh-ancestor
110621265|NCT03985969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110621266|NCT03985969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110621267|NCT03985969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110621268|NCT03985969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110621269|NCT03985969|Gout Suppressants|gout suppressants|mesh-ancestor
110621270|NCT03985969|Tocolytic Agents|tocolytic agents|mesh-ancestor
110621271|NCT03985969|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110621272|NCT03985969|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110621273|NCT03985969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110621274|NCT03985969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110621275|NCT01061437|Lansoprazole|lansoprazole|mesh-list
110621276|NCT01061437|Dexlansoprazole|dexlansoprazole|mesh-list
110392346|NCT01607580|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110621278|NCT01061437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110621279|NCT01061437|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110621280|NCT01061437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110621281|NCT01061437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110621283|NCT00575588|Saxagliptin|saxagliptin|mesh-list
110621284|NCT00575588|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110621285|NCT00575588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110621286|NCT00575588|Incretins|incretins|mesh-ancestor
110621287|NCT00575588|Hormones|hormones|mesh-ancestor
110624764|NCT01007500|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110621288|NCT00575588|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110621289|NCT00575588|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110621290|NCT00575588|Protease Inhibitors|protease inhibitors|mesh-ancestor
110621291|NCT00575588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110621292|NCT00575588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110621294|NCT01058317|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110621295|NCT01058317|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110621296|NCT01058317|Adrenergic Agents|adrenergic agents|mesh-ancestor
110621297|NCT01058317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110621298|NCT01058317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110621299|NCT01058317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110621300|NCT01058317|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110621301|NCT01058317|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110621302|NCT01058317|Vasodilator Agents|vasodilator agents|mesh-ancestor
110621303|NCT00810030|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
110621304|NCT00810030|Hematinics|hematinics|mesh-ancestor
110621305|NCT00675428|Natalizumab|natalizumab|mesh-list
110621306|NCT00675428|Immunologic Factors|immunologic factors|mesh-ancestor
110621307|NCT00675428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110621308|NCT00760916|Treprostinil|treprostinil|mesh-list
110621309|NCT00760916|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110621310|NCT00761228|Apomorphine|apomorphine|mesh-list
110621312|NCT00761228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110621313|NCT00761228|Autonomic Agents|autonomic agents|mesh-ancestor
110621314|NCT00761228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110621315|NCT00761228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110268588|NCT00185133|Olmesartan|olmesartan|mesh-list
110621316|NCT00761228|Dopamine Agonists|dopamine agonists|mesh-ancestor
110621317|NCT00761228|Dopamine Agents|dopamine agents|mesh-ancestor
110621318|NCT00761228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110621319|NCT00761228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110621320|NCT00758732|Carboplatin|carboplatin|mesh-list
110621321|NCT00758732|Docetaxel|docetaxel|mesh-list
110621322|NCT00758732|Doxorubicin|doxorubicin|mesh-list
110621323|NCT00758732|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110621324|NCT00758732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110621325|NCT00758732|Tubulin Modulators|tubulin modulators|mesh-ancestor
110621326|NCT00758732|Antimitotic Agents|antimitotic agents|mesh-ancestor
110621327|NCT00758732|Mitosis Modulators|mitosis modulators|mesh-ancestor
110621328|NCT00758732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110621329|NCT00758732|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110621330|NCT00758732|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110621331|NCT00758732|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110621332|NCT00758732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110621333|NCT02559674|Paclitaxel|paclitaxel|mesh-list
110621334|NCT02559674|Gemcitabine|gemcitabine|mesh-list
110621335|NCT02559674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110621336|NCT02559674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110621337|NCT02559674|Tubulin Modulators|tubulin modulators|mesh-ancestor
110621338|NCT02559674|Antimitotic Agents|antimitotic agents|mesh-ancestor
110625246|NCT05476770|Cytarabine|cytarabine|mesh-list
110621339|NCT02559674|Mitosis Modulators|mitosis modulators|mesh-ancestor
110655640|NCT00425854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110621340|NCT02559674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110621341|NCT02559674|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110621342|NCT02559674|Antimetabolites|antimetabolites|mesh-ancestor
110621343|NCT00761540|Liraglutide|liraglutide|mesh-list
110621344|NCT00761540|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110621345|NCT00761540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110621346|NCT00761540|Incretins|incretins|mesh-ancestor
110621347|NCT00761540|Hormones|hormones|mesh-ancestor
110153916|NCT00001086|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110621348|NCT00761540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110621349|NCT00759122|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
110621350|NCT00759122|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110621351|NCT00759122|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110625380|NCT05227716|Anticonvulsants|anticonvulsants|mesh-ancestor
110621352|NCT00759122|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110621353|NCT00759122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110621354|NCT00759122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110621355|NCT00759122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110621356|NCT00759122|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110621357|NCT00759122|Antidepressive Agents|antidepressive agents|mesh-ancestor
110621358|NCT00759122|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110621359|NCT00759200|Interferons|interferons|mesh-list
110621360|NCT00759200|Interferon-alpha|interferon-alpha|mesh-list
110621361|NCT00759200|Interferon alpha-2|interferon alpha-2|mesh-list
110621362|NCT00759200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110621363|NCT00759200|Antiviral Agents|antiviral agents|mesh-ancestor
110625451|NCT04974216|Rituximab|rituximab|mesh-list
110621365|NCT00759200|Immunologic Factors|immunologic factors|mesh-ancestor
110621366|NCT00759200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110621367|NCT02558816|Obinutuzumab|obinutuzumab|mesh-list
110621368|NCT02558816|Venetoclax|venetoclax|mesh-list
110621369|NCT02558816|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110621370|NCT02558816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110621372|NCT01299753|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110621373|NCT01299753|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110621374|NCT01299753|Adrenergic Agents|adrenergic agents|mesh-ancestor
110621375|NCT01299753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110621376|NCT01299753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110621377|NCT01299753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110621378|NCT01299753|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110621379|NCT01299753|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110621380|NCT01299753|Vasodilator Agents|vasodilator agents|mesh-ancestor
110621381|NCT02559440|Mometasone Furoate|mometasone furoate|mesh-list
110621382|NCT02559440|Phenylephrine|phenylephrine|mesh-list
110621383|NCT02559440|Oxymetazoline|oxymetazoline|mesh-list
110621384|NCT02559440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110621385|NCT02559440|Dermatologic Agents|dermatologic agents|mesh-ancestor
110621386|NCT02559440|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110621387|NCT02559440|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110621388|NCT02559440|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110621389|NCT02559440|Adrenergic Agents|adrenergic agents|mesh-ancestor
110621390|NCT02559440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110621391|NCT02559440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110621392|NCT02559440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110621394|NCT02559440|Autonomic Agents|autonomic agents|mesh-ancestor
110625715|NCT03957590|Paclitaxel|paclitaxel|mesh-list
110621395|NCT02559440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110621396|NCT02559440|Nasal Decongestants|nasal decongestants|mesh-ancestor
110621397|NCT02559440|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110621398|NCT02559440|Respiratory System Agents|respiratory system agents|mesh-ancestor
110621399|NCT02559440|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110621400|NCT02559440|Mydriatics|mydriatics|mesh-ancestor
110621401|NCT02559440|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110621402|NCT02559440|Protective Agents|protective agents|mesh-ancestor
110621403|NCT00674570|Cycloserine|cycloserine|mesh-list
110621404|NCT00674570|Hydrocortisone|hydrocortisone|mesh-list
110621405|NCT00674570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110621406|NCT00674570|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110621407|NCT00674570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110621408|NCT00674570|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110621409|NCT00674570|Antitubercular Agents|antitubercular agents|mesh-ancestor
110621410|NCT00674570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110621411|NCT00674570|Antimetabolites|antimetabolites|mesh-ancestor
110621412|NCT00674570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110621413|NCT00940563|Imatinib Mesylate|imatinib mesylate|mesh-list
110621414|NCT00940563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110621415|NCT00940563|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110621416|NCT00940563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110621417|NCT00940563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110621418|NCT00761852|Ruboxistaurin|ruboxistaurin|mesh-list
110621419|NCT00761852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110621420|NCT00761852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110621421|NCT00940719|Vitamin D|vitamin d|mesh-list
110621422|NCT00940719|Cholecalciferol|cholecalciferol|mesh-list
110621423|NCT00940719|Vitamins|vitamins|mesh-ancestor
110621424|NCT00940719|Micronutrients|micronutrients|mesh-ancestor
110621425|NCT00940719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110621426|NCT00940719|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110621427|NCT00940719|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110621428|NCT00940953|Azelastine|azelastine|mesh-list
110621429|NCT00940953|Budesonide|budesonide|mesh-list
110392419|NCT01608360|Anesthetics, Local|anesthetics, local|mesh-ancestor
110621430|NCT00940953|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110621431|NCT00940953|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110621432|NCT00940953|Autonomic Agents|autonomic agents|mesh-ancestor
110621433|NCT00940953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110621434|NCT00940953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110621435|NCT00940953|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110154408|NCT00011128|Antiviral Agents|antiviral agents|mesh-ancestor
110621436|NCT00940953|Respiratory System Agents|respiratory system agents|mesh-ancestor
110621437|NCT00940953|Glucocorticoids|glucocorticoids|mesh-ancestor
110621438|NCT00940953|Hormones|hormones|mesh-ancestor
110621439|NCT00940953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110621440|NCT00940953|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
110621441|NCT00940953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110621442|NCT00940953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110621443|NCT00940953|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110621444|NCT00940953|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110621445|NCT00940953|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110621446|NCT00940953|Histamine Antagonists|histamine antagonists|mesh-ancestor
110621447|NCT00940953|Histamine Agents|histamine agents|mesh-ancestor
110621448|NCT00940953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110621449|NCT00759824|Cyclophosphamide|cyclophosphamide|mesh-list
110621450|NCT00759824|Doxorubicin|doxorubicin|mesh-list
110621451|NCT00759824|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110621452|NCT00759824|Vindesine|vindesine|mesh-list
110621453|NCT00759824|Valproic Acid|valproic acid|mesh-list
110621454|NCT00759824|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110621455|NCT00759824|Immunologic Factors|immunologic factors|mesh-ancestor
110621456|NCT00759824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110621457|NCT00759824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110621458|NCT00759824|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110621459|NCT00759824|Alkylating Agents|alkylating agents|mesh-ancestor
110621460|NCT00759824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110621461|NCT00759824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110625945|NCT03011268|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110621462|NCT00759824|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110621463|NCT00759824|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110252027|NCT00153660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110621464|NCT00759824|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110621465|NCT00759824|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110268745|NCT00551824|Mitomycins|mitomycins|mesh-list
110621466|NCT00759824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110621467|NCT00759824|Anticonvulsants|anticonvulsants|mesh-ancestor
110621468|NCT00759824|GABA Agents|gaba agents|mesh-ancestor
110621469|NCT00759824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110621470|NCT00759824|Antimanic Agents|antimanic agents|mesh-ancestor
110621471|NCT00759824|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110626014|NCT02374242|Nivolumab|nivolumab|mesh-list
110621472|NCT00759824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110621473|NCT00759824|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110392435|NCT01604811|Tamsulosin|tamsulosin|mesh-list
110621474|NCT00759824|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110621475|NCT00759824|Tubulin Modulators|tubulin modulators|mesh-ancestor
110621476|NCT00759824|Antimitotic Agents|antimitotic agents|mesh-ancestor
110621477|NCT00759824|Mitosis Modulators|mitosis modulators|mesh-ancestor
110621479|NCT00561951|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110621480|NCT00561951|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110621481|NCT00561951|Cholinergic Agents|cholinergic agents|mesh-ancestor
110621482|NCT00561951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110621483|NCT00561951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110621484|NCT00561951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110621485|NCT00561951|Urological Agents|urological agents|mesh-ancestor
110621486|NCT00762398|Chrysarobin|chrysarobin|mesh-list
110621487|NCT00762398|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110621488|NCT00762398|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110626101|NCT00602459|Cyclophosphamide|cyclophosphamide|mesh-list
110626102|NCT00602459|Rituximab|rituximab|mesh-list
110626103|NCT00602459|Fludarabine|fludarabine|mesh-list
110626104|NCT00602459|Fludarabine phosphate|fludarabine phosphate|mesh-list
110626105|NCT00602459|Lenalidomide|lenalidomide|mesh-list
110273396|NCT02902744|Hormones|hormones|mesh-ancestor
110626106|NCT00602459|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110626108|NCT00602459|Immunoglobulins|immunoglobulins|mesh-list
110626109|NCT00602459|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110626110|NCT00602459|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110626111|NCT00602459|Immunologic Factors|immunologic factors|mesh-ancestor
110626112|NCT00602459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110626113|NCT00602459|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110626114|NCT00602459|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110626115|NCT00602459|Alkylating Agents|alkylating agents|mesh-ancestor
110626116|NCT00602459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110626117|NCT00602459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110626118|NCT00602459|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110626119|NCT00602459|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110626120|NCT00602459|Antimetabolites|antimetabolites|mesh-ancestor
110626121|NCT00602459|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110626122|NCT00602459|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110626123|NCT00602459|Growth Substances|growth substances|mesh-ancestor
110626124|NCT00602459|Growth Inhibitors|growth inhibitors|mesh-ancestor
110626125|NCT00199069|Cytarabine|cytarabine|mesh-list
110626129|NCT00199069|Ifosfamide|ifosfamide|mesh-list
110621489|NCT00762398|Analgesics|analgesics|mesh-ancestor
110621490|NCT00762398|Sensory System Agents|sensory system agents|mesh-ancestor
110621491|NCT00762398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110621492|NCT00762398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110621493|NCT00762398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110621494|NCT00762398|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110621495|NCT04552886|Immunomodulating Agents|immunomodulating agents|mesh-list
110621496|NCT04552886|Immunologic Factors|immunologic factors|mesh-ancestor
110621497|NCT04552886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110621499|NCT00762632|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110621500|NCT00762632|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110621501|NCT00762632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110626218|NCT01067365|Citric Acid|citric acid|mesh-list
110621502|NCT00762632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110621503|NCT00762632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110621504|NCT00762632|Immunologic Factors|immunologic factors|mesh-ancestor
110621505|NCT00762632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110621506|NCT00762632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110621507|NCT00322387|Plerixafor|plerixafor|mesh-list
110621508|NCT00322387|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110621509|NCT00322387|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110621510|NCT00322387|Antiviral Agents|antiviral agents|mesh-ancestor
110621511|NCT00322387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110621513|NCT00561015|Interferon alpha-2|interferon alpha-2|mesh-list
110621514|NCT00561015|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110621515|NCT00561015|Antimetabolites|antimetabolites|mesh-ancestor
110621516|NCT00561015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110621517|NCT00561015|Antiviral Agents|antiviral agents|mesh-ancestor
110621518|NCT00561015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110621519|NCT00561015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110621520|NCT04012047|Cromakalim|cromakalim|mesh-list
110621521|NCT04012047|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110621522|NCT04012047|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110621523|NCT04012047|Autonomic Agents|autonomic agents|mesh-ancestor
110621524|NCT04012047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110621525|NCT04012047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110621526|NCT04012047|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110621527|NCT04012047|Respiratory System Agents|respiratory system agents|mesh-ancestor
110621528|NCT04012047|Parasympatholytics|parasympatholytics|mesh-ancestor
110621529|NCT04012047|Vasodilator Agents|vasodilator agents|mesh-ancestor
110621530|NCT00941265|Levodopa|levodopa|mesh-list
110621531|NCT00941265|Benserazide|benserazide|mesh-list
110621532|NCT00941265|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110621533|NCT00941265|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110621534|NCT00941265|Dopamine Agents|dopamine agents|mesh-ancestor
110621535|NCT00941265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110621536|NCT00941265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110626488|NCT02600741|GABA Agents|gaba agents|mesh-ancestor
110621537|NCT00941265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110621538|NCT00941265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110392467|NCT01683149|Sorafenib|sorafenib|mesh-list
110621540|NCT00941343|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110621542|NCT00941343|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110621543|NCT00941343|Adrenergic Agents|adrenergic agents|mesh-ancestor
110621544|NCT00941343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110621545|NCT00941343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110621546|NCT00941343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110621547|NCT00941343|Urological Agents|urological agents|mesh-ancestor
110621548|NCT00561795|Paclitaxel|paclitaxel|mesh-list
110621549|NCT00561795|Carboplatin|carboplatin|mesh-list
110621550|NCT00561795|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110626614|NCT00755807|Analgesics|analgesics|mesh-ancestor
110621551|NCT00561795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110621552|NCT00561795|Tubulin Modulators|tubulin modulators|mesh-ancestor
110621553|NCT00561795|Antimitotic Agents|antimitotic agents|mesh-ancestor
110621554|NCT00561795|Mitosis Modulators|mitosis modulators|mesh-ancestor
110621555|NCT00561795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110621556|NCT00652626|Azacitidine|azacitidine|mesh-list
110621557|NCT00652626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110621558|NCT00652626|Antimetabolites|antimetabolites|mesh-ancestor
110621559|NCT00652626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110621560|NCT00652626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110621561|NCT00652626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110621562|NCT00560703|Doxycycline|doxycycline|mesh-list
110621563|NCT00560703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110621564|NCT00560703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110621566|NCT00560703|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110621567|NCT00560703|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110621568|NCT00308737|Insulin|insulin|mesh-list
110621569|NCT00308737|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110621570|NCT00308737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110621571|NCT04711902|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110621572|NCT04711902|Immunologic Factors|immunologic factors|mesh-ancestor
110621573|NCT04711902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110621574|NCT00941499|Leucovorin|leucovorin|mesh-list
110621575|NCT00941499|Bevacizumab|bevacizumab|mesh-list
110621576|NCT00941499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110621577|NCT00941499|Cetuximab|cetuximab|mesh-list
110621578|NCT00941499|Fluorouracil|fluorouracil|mesh-list
110621579|NCT00941499|Oxaliplatin|oxaliplatin|mesh-list
110621580|NCT00941499|Antibodies|antibodies|mesh-list
110621581|NCT00941499|Immunoglobulins|immunoglobulins|mesh-list
110621582|NCT00941499|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110621583|NCT00941499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110621584|NCT00941499|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110621585|NCT00941499|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110621586|NCT00941499|Growth Substances|growth substances|mesh-ancestor
110621587|NCT00941499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110621588|NCT00941499|Growth Inhibitors|growth inhibitors|mesh-ancestor
110621589|NCT00941499|Immunologic Factors|immunologic factors|mesh-ancestor
110621591|NCT00941499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110621592|NCT00941499|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110621593|NCT00941499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110621594|NCT00941499|Antidotes|antidotes|mesh-ancestor
110621595|NCT00941499|Protective Agents|protective agents|mesh-ancestor
110621596|NCT00941499|Vitamin B Complex|vitamin b complex|mesh-ancestor
110621597|NCT00941499|Vitamins|vitamins|mesh-ancestor
110621598|NCT00941499|Micronutrients|micronutrients|mesh-ancestor
110621599|NCT04752384|Buprenorphine|buprenorphine|mesh-list
110621600|NCT04752384|Tramadol|tramadol|mesh-list
110621601|NCT04752384|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110621602|NCT04752384|Narcotics|narcotics|mesh-ancestor
110621603|NCT04752384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110621604|NCT04752384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110621605|NCT04752384|Analgesics|analgesics|mesh-ancestor
110621606|NCT04752384|Sensory System Agents|sensory system agents|mesh-ancestor
110621607|NCT04752384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110621608|NCT04752384|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110621609|NCT00945789|Nitric Oxide|nitric oxide|mesh-list
110621610|NCT00945789|Epoetin Alfa|epoetin alfa|mesh-list
110621611|NCT00945789|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110621612|NCT00945789|Autonomic Agents|autonomic agents|mesh-ancestor
110621613|NCT00945789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110621614|NCT00945789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110621615|NCT00945789|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110621616|NCT00945789|Respiratory System Agents|respiratory system agents|mesh-ancestor
110621617|NCT00945789|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110621619|NCT00945789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110621620|NCT00945789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110621621|NCT00945789|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
110621623|NCT00945789|Gasotransmitters|gasotransmitters|mesh-ancestor
110621624|NCT00945789|Protective Agents|protective agents|mesh-ancestor
110621625|NCT00945789|Hematinics|hematinics|mesh-ancestor
110621627|NCT00941811|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110621628|NCT00941811|Immunologic Factors|immunologic factors|mesh-ancestor
110621629|NCT00941811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110621630|NCT00941811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110621631|NCT00941811|Interferon Inducers|interferon inducers|mesh-ancestor
110621632|NCT02553018|Methotrexate|methotrexate|mesh-list
110621633|NCT02553018|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110621634|NCT02553018|Abortifacient Agents|abortifacient agents|mesh-ancestor
110621635|NCT02553018|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110621636|NCT02553018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110621637|NCT02553018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110621638|NCT02553018|Antimetabolites|antimetabolites|mesh-ancestor
110621639|NCT02553018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110621640|NCT02553018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110621641|NCT02553018|Dermatologic Agents|dermatologic agents|mesh-ancestor
110621642|NCT02553018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110621643|NCT02553018|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110621644|NCT02553018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110621645|NCT02553018|Immunologic Factors|immunologic factors|mesh-ancestor
110621646|NCT02553018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110621647|NCT02553018|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110621648|NCT00941967|Gemcitabine|gemcitabine|mesh-list
110621649|NCT00941967|Oxaliplatin|oxaliplatin|mesh-list
110621650|NCT00941967|Sorafenib|sorafenib|mesh-list
110621651|NCT00941967|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110621652|NCT00941967|Antimetabolites|antimetabolites|mesh-ancestor
110621653|NCT00941967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110627207|NCT03979625|Heparin|heparin|mesh-list
110621654|NCT00941967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110621655|NCT00941967|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110621656|NCT00941967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110621658|NCT00655746|Omeprazole|omeprazole|mesh-list
110621659|NCT00655746|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110621660|NCT00655746|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110621661|NCT00655746|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110621662|NCT00655746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110621663|NCT00655746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110621664|NCT00655746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110621665|NCT00655746|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110621667|NCT00338455|Milrinone|milrinone|mesh-list
110621668|NCT00338455|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
110621669|NCT00338455|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110621670|NCT00338455|Sympathomimetics|sympathomimetics|mesh-ancestor
110621671|NCT00338455|Autonomic Agents|autonomic agents|mesh-ancestor
110621672|NCT00338455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110392475|NCT01608555|Tobramycin|tobramycin|mesh-list
110621673|NCT00338455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110621674|NCT00338455|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
110621675|NCT00338455|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110621676|NCT00338455|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110621677|NCT00338455|Adrenergic Agents|adrenergic agents|mesh-ancestor
110621678|NCT00338455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110621679|NCT00338455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110621680|NCT00338455|Protective Agents|protective agents|mesh-ancestor
110621681|NCT00338455|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110621682|NCT00338455|Vasodilator Agents|vasodilator agents|mesh-ancestor
110621683|NCT00338455|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110621684|NCT00338455|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110621685|NCT00338455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110621686|NCT00338455|Natriuretic Agents|natriuretic agents|mesh-ancestor
110621687|NCT00678392|Sorafenib|sorafenib|mesh-list
110621688|NCT00678392|Axitinib|axitinib|mesh-list
110621689|NCT00678392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110252081|NCT00160329|Atazanavir Sulfate|atazanavir sulfate|mesh-list
110621690|NCT00678392|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110621691|NCT00678392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110621692|NCT00678392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110621693|NCT00950391|Tacrolimus|tacrolimus|mesh-list
110621694|NCT00950391|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110621695|NCT00950391|Immunologic Factors|immunologic factors|mesh-ancestor
110268958|NCT00185562|Adalimumab|adalimumab|mesh-list
110621696|NCT00950391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110627447|NCT01068301|Antiviral Agents|antiviral agents|mesh-ancestor
110621697|NCT00950391|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110621698|NCT00950391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110621699|NCT00950391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110621700|NCT00804336|Everolimus|everolimus|mesh-list
110621701|NCT00804336|Pasireotide|pasireotide|mesh-list
110621702|NCT00804336|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110621703|NCT00804336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110621704|NCT00804336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110621705|NCT00804336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110621706|NCT00804336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110621707|NCT00804336|Immunologic Factors|immunologic factors|mesh-ancestor
110621708|NCT00804336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110621709|NCT00804336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110621710|NCT00804336|Hormones|hormones|mesh-ancestor
110621711|NCT00804336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110621712|NCT00942201|Dexamethasone|dexamethasone|mesh-list
110621713|NCT00942201|Dexamethasone acetate|dexamethasone acetate|mesh-list
110621714|NCT00942201|BB 1101|bb 1101|mesh-list
110621715|NCT00942201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110621717|NCT00942201|Autonomic Agents|autonomic agents|mesh-ancestor
110621718|NCT00942201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110621719|NCT00942201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110621720|NCT00942201|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110621721|NCT00942201|Glucocorticoids|glucocorticoids|mesh-ancestor
110621722|NCT00942201|Hormones|hormones|mesh-ancestor
110621723|NCT00942201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110621724|NCT00942201|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110621725|NCT00942201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110621726|NCT00942201|Protease Inhibitors|protease inhibitors|mesh-ancestor
110621727|NCT00942201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110627719|NCT04043676|Ponatinib|ponatinib|mesh-list
110621728|NCT00942201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110621729|NCT00942435|Darexaban|darexaban|mesh-list
110621730|NCT00942435|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110621731|NCT00942435|Antithrombins|antithrombins|mesh-ancestor
110621732|NCT00942435|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110621733|NCT00942435|Protease Inhibitors|protease inhibitors|mesh-ancestor
110621734|NCT00942435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110621735|NCT00942435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110621736|NCT00942435|Anticoagulants|anticoagulants|mesh-ancestor
110621737|NCT00946179|Vaccines|vaccines|mesh-list
110621738|NCT00946179|Immunologic Factors|immunologic factors|mesh-ancestor
110621739|NCT00946179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110621740|NCT00950625|Lidocaine|lidocaine|mesh-list
110621741|NCT00950625|Anesthetics, Local|anesthetics, local|mesh-ancestor
110621742|NCT00950625|Anesthetics|anesthetics|mesh-ancestor
110621743|NCT00950625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110621744|NCT00950625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110621745|NCT00950625|Sensory System Agents|sensory system agents|mesh-ancestor
110621746|NCT00950625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110621747|NCT00950625|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110627847|NCT03865732|Pregnanolone|pregnanolone|mesh-list
110621748|NCT00950625|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110621749|NCT00950625|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110621750|NCT00950625|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110621751|NCT00950625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110627910|NCT00953589|Ribavirin|ribavirin|mesh-list
110621753|NCT00942591|Interferon-beta|interferon-beta|mesh-list
110621754|NCT00942591|Atorvastatin|atorvastatin|mesh-list
110621755|NCT00942591|Interferon beta-1b|interferon beta-1b|mesh-list
110621756|NCT00942591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110621757|NCT00942591|Antiviral Agents|antiviral agents|mesh-ancestor
110621758|NCT00942591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110621759|NCT00942591|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110621760|NCT00942591|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110621761|NCT00942591|Antimetabolites|antimetabolites|mesh-ancestor
110252161|NCT00404183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110621762|NCT00942591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110621763|NCT00942591|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110621764|NCT00942591|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110621765|NCT00942591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110621766|NCT00942591|Immunologic Factors|immunologic factors|mesh-ancestor
110621767|NCT00942591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110621768|NCT00942591|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110621769|NCT00946335|Temozolomide|temozolomide|mesh-list
110621771|NCT00946335|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110621772|NCT00946335|Alkylating Agents|alkylating agents|mesh-ancestor
110621773|NCT00946335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110621774|NCT00946335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110621775|NCT00946335|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110621776|NCT00946335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110621777|NCT00760370|Zoledronic Acid|zoledronic acid|mesh-list
110621778|NCT00760370|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110621779|NCT00760370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110621781|NCT00762944|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110621782|NCT00762944|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110621783|NCT00762944|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110621784|NCT00762944|Histamine Antagonists|histamine antagonists|mesh-ancestor
110621785|NCT00762944|Histamine Agents|histamine agents|mesh-ancestor
110621786|NCT00762944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110628110|NCT00954603|Antiemetics|antiemetics|mesh-ancestor
110621787|NCT00762944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110621788|NCT00762944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110628169|NCT00957879|Vitamins|vitamins|mesh-ancestor
110621789|NCT00762944|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110621790|NCT00762944|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110621791|NCT00762944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110621792|NCT00760448|Insulin|insulin|mesh-list
110621794|NCT00760448|Insulin Detemir|insulin detemir|mesh-list
110621795|NCT00760448|Isophane Insulin, Human|isophane insulin, human|mesh-list
110621796|NCT00760448|Insulin, Isophane|insulin, isophane|mesh-list
110621797|NCT00760448|Isophane insulin, beef|isophane insulin, beef|mesh-list
110621798|NCT00760448|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110621799|NCT00760448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110621800|NCT00763178|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110621801|NCT00763178|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110621802|NCT00763178|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110621804|NCT00763178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110621805|NCT00763178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110621806|NCT00763178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110621807|NCT00763178|Analgesics|analgesics|mesh-ancestor
110621808|NCT00763178|Sensory System Agents|sensory system agents|mesh-ancestor
110621809|NCT00763178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110621810|NCT00763178|Antidepressive Agents|antidepressive agents|mesh-ancestor
110621811|NCT00763178|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110621812|NCT00763178|Dopamine Agents|dopamine agents|mesh-ancestor
110628380|NCT00949299|Narcotics|narcotics|mesh-ancestor
110621814|NCT04391348|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110621815|NCT04391348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110621816|NCT00308581|Certolizumab Pegol|certolizumab pegol|mesh-list
110621817|NCT00308581|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110621818|NCT00308581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110621819|NCT00308581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110621820|NCT00308581|Immunologic Factors|immunologic factors|mesh-ancestor
110621821|NCT00308581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110621822|NCT00308581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110621823|NCT00678080|Metformin|metformin|mesh-list
110621824|NCT00678080|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110621825|NCT00678080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110628449|NCT00949455|Lapatinib|lapatinib|mesh-list
110621826|NCT00658320|Cyclosporine|cyclosporine|mesh-list
110621827|NCT00658320|Mycophenolic Acid|mycophenolic acid|mesh-list
110621828|NCT00658320|Everolimus|everolimus|mesh-list
110621829|NCT00658320|Cyclosporins|cyclosporins|mesh-list
110621831|NCT00658320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110621832|NCT00658320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110621833|NCT00658320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110621834|NCT00658320|Immunologic Factors|immunologic factors|mesh-ancestor
110621835|NCT00658320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110621836|NCT00658320|Antifungal Agents|antifungal agents|mesh-ancestor
110621837|NCT00658320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110621838|NCT00658320|Dermatologic Agents|dermatologic agents|mesh-ancestor
110621839|NCT00658320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110621840|NCT00658320|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110621841|NCT00658320|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110269103|NCT00185952|Vasodilator Agents|vasodilator agents|mesh-ancestor
110621842|NCT00658320|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110621843|NCT00658320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110621844|NCT00658320|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110628579|NCT00835848|Exenatide|exenatide|mesh-list
110621845|NCT00658320|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110621846|NCT00658320|Antitubercular Agents|antitubercular agents|mesh-ancestor
110621847|NCT00658320|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110621849|NCT02558270|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110621850|NCT02558270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110621851|NCT02558270|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110621852|NCT02558270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110621853|NCT00763568|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110621854|NCT00763568|Nitazoxanide|nitazoxanide|mesh-list
110621855|NCT00763568|Antiviral Agents|antiviral agents|mesh-ancestor
110621856|NCT00763568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110621857|NCT00763568|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110621858|NCT00806754|Ciclesonide|ciclesonide|mesh-list
110621859|NCT00806754|Azelastine|azelastine|mesh-list
110621860|NCT00806754|Glucocorticoids|glucocorticoids|mesh-ancestor
110621861|NCT00806754|Hormones|hormones|mesh-ancestor
110621862|NCT00806754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110621863|NCT00806754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110628637|NCT00836316|Anesthetics|anesthetics|mesh-ancestor
110621864|NCT00806754|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110621865|NCT00806754|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110621866|NCT00806754|Autonomic Agents|autonomic agents|mesh-ancestor
110621867|NCT00806754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110621868|NCT00806754|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110621869|NCT00806754|Respiratory System Agents|respiratory system agents|mesh-ancestor
110621870|NCT00806754|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
110621871|NCT00806754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110621872|NCT00806754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110621873|NCT00806754|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110621874|NCT00806754|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110621875|NCT00806754|Histamine Antagonists|histamine antagonists|mesh-ancestor
110621876|NCT00806754|Histamine Agents|histamine agents|mesh-ancestor
110621877|NCT00806754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110621878|NCT00764816|Caseins|caseins|mesh-list
110621879|NCT00764816|Chelating Agents|chelating agents|mesh-ancestor
110621880|NCT00764816|Sequestering Agents|sequestering agents|mesh-ancestor
110621881|NCT00764816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110621882|NCT00322153|Memantine|memantine|mesh-list
110621883|NCT00322153|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110621884|NCT00322153|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110621885|NCT00322153|Dopamine Agents|dopamine agents|mesh-ancestor
110621886|NCT00322153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110621887|NCT00322153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110621888|NCT00322153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110628822|NCT00844740|Cinacalcet|cinacalcet|mesh-list
110621889|NCT00322153|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110621890|NCT00322153|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110621891|NCT00806910|Conivaptan|conivaptan|mesh-list
110252186|NCT00404222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110621892|NCT00806910|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
110621893|NCT00806910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110621894|NCT00806910|Natriuretic Agents|natriuretic agents|mesh-ancestor
110621895|NCT00806910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110621896|NCT00807066|Gefitinib|gefitinib|mesh-list
110621897|NCT00807066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110621898|NCT00807066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110621899|NCT00807066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110621900|NCT00807066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110621901|NCT00804960|Letrozole|letrozole|mesh-list
110621902|NCT00804960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110621903|NCT00804960|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110621904|NCT00804960|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110621905|NCT00804960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110621906|NCT00804960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110621907|NCT00804960|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110621908|NCT00804960|Hormone Antagonists|hormone antagonists|mesh-ancestor
110621909|NCT00804960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110621910|NCT00804960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110621911|NCT00805116|Cod Liver Oil|cod liver oil|mesh-list
110621912|NCT00805116|Vitamins|vitamins|mesh-ancestor
110621913|NCT00805116|Micronutrients|micronutrients|mesh-ancestor
110621914|NCT00805116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110621915|NCT03985735|Anesthetics|anesthetics|mesh-list
110621916|NCT03985735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110621917|NCT03985735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110621918|NCT00807222|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
110621919|NCT00807222|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110621920|NCT00807222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110621921|NCT00807222|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110621922|NCT00807222|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110621923|NCT00807222|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110621924|NCT00807222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110621925|NCT00807222|Dopamine Agents|dopamine agents|mesh-ancestor
110621926|NCT00807222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110621927|NCT00657618|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
110621928|NCT00657618|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110621929|NCT00657618|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110621930|NCT00657618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110621931|NCT00657618|Schistosomicides|schistosomicides|mesh-ancestor
110621932|NCT00657618|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110621933|NCT00657618|Anthelmintics|anthelmintics|mesh-ancestor
110629161|NCT00841854|Antacids|antacids|mesh-ancestor
110621934|NCT00672620|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110621935|NCT00672620|Vortioxetine|vortioxetine|mesh-list
110621936|NCT00672620|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110621937|NCT00672620|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110621938|NCT00672620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110621939|NCT00672620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110621940|NCT00672620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110621941|NCT00672620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110621943|NCT00672620|Sensory System Agents|sensory system agents|mesh-ancestor
110621944|NCT00672620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110621945|NCT00672620|Antidepressive Agents|antidepressive agents|mesh-ancestor
110621946|NCT00672620|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110621947|NCT00672620|Dopamine Agents|dopamine agents|mesh-ancestor
110621948|NCT00672620|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110621949|NCT00672620|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110621950|NCT00672620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110621951|NCT00672620|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110621952|NCT00672620|Serotonin Agents|serotonin agents|mesh-ancestor
110621953|NCT00672620|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110621954|NCT00672620|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110629305|NCT00842556|Dapagliflozin|dapagliflozin|mesh-list
110621955|NCT00672620|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110621956|NCT00672620|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110621957|NCT00764972|Sorafenib|sorafenib|mesh-list
110621958|NCT00764972|Vinorelbine|vinorelbine|mesh-list
110621959|NCT00764972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110621960|NCT00764972|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110621961|NCT00764972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110621962|NCT00764972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110621963|NCT00764972|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110621964|NCT00764972|Tubulin Modulators|tubulin modulators|mesh-ancestor
110621965|NCT00764972|Antimitotic Agents|antimitotic agents|mesh-ancestor
110621966|NCT00764972|Mitosis Modulators|mitosis modulators|mesh-ancestor
110621967|NCT00673790|Losartan|losartan|mesh-list
110621968|NCT00673790|Lisinopril|lisinopril|mesh-list
110621969|NCT00673790|Nebivolol|nebivolol|mesh-list
110621970|NCT00673790|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110621971|NCT00673790|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110621972|NCT00673790|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110621973|NCT00673790|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110621974|NCT00673790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110629488|NCT00573768|Diclofenac|diclofenac|mesh-list
110621975|NCT00673790|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110392553|NCT01683656|Niacin|niacin|mesh-list
110621976|NCT00673790|Protease Inhibitors|protease inhibitors|mesh-ancestor
110621977|NCT00673790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110621978|NCT00673790|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110621979|NCT00673790|Protective Agents|protective agents|mesh-ancestor
110621980|NCT00673790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110621981|NCT00673790|Vasodilator Agents|vasodilator agents|mesh-ancestor
110621982|NCT00673790|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
110621983|NCT00673790|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110621984|NCT00673790|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110621985|NCT00673790|Adrenergic Agents|adrenergic agents|mesh-ancestor
110621986|NCT00673790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110621988|NCT00763646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110621989|NCT00763646|Tubulin Modulators|tubulin modulators|mesh-ancestor
110621990|NCT00763646|Antimitotic Agents|antimitotic agents|mesh-ancestor
110621991|NCT00763646|Mitosis Modulators|mitosis modulators|mesh-ancestor
110621992|NCT00763646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110621993|NCT00763880|Lidocaine|lidocaine|mesh-list
110621994|NCT00763880|Anesthetics, Local|anesthetics, local|mesh-ancestor
110621995|NCT00763880|Anesthetics|anesthetics|mesh-ancestor
110621996|NCT00763880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110621997|NCT00763880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110621998|NCT00763880|Sensory System Agents|sensory system agents|mesh-ancestor
110621999|NCT00763880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110629627|NCT00861510|ON 01910|on 01910|mesh-list
110622000|NCT00763880|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110622001|NCT00763880|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110622002|NCT00763880|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110622003|NCT00763880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110622004|NCT00763880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110622006|NCT00657150|Dabigatran|dabigatran|mesh-list
110622007|NCT00657150|Anticoagulants|anticoagulants|mesh-ancestor
110622008|NCT00657150|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110622009|NCT00657150|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110622010|NCT00657150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110622011|NCT00657150|Antithrombins|antithrombins|mesh-ancestor
110622012|NCT00657150|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110622013|NCT00657150|Protease Inhibitors|protease inhibitors|mesh-ancestor
110622014|NCT00657150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110622016|NCT00770354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110622017|NCT00770354|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110622018|NCT00770354|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110622019|NCT00770354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110622020|NCT00770354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110622021|NCT00770354|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110622022|NCT00770354|Hormone Antagonists|hormone antagonists|mesh-ancestor
110622023|NCT00770354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110622024|NCT00770354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110622025|NCT00670748|Aldesleukin|aldesleukin|mesh-list
110622026|NCT00670748|Cyclophosphamide|cyclophosphamide|mesh-list
110622027|NCT00670748|Fludarabine|fludarabine|mesh-list
110622028|NCT00670748|Fludarabine phosphate|fludarabine phosphate|mesh-list
110629745|NCT00970905|Antipruritics|antipruritics|mesh-ancestor
110622029|NCT00670748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110622030|NCT00670748|Immunologic Factors|immunologic factors|mesh-ancestor
110622031|NCT00670748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110622032|NCT00670748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110622033|NCT00670748|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110622034|NCT00670748|Alkylating Agents|alkylating agents|mesh-ancestor
110622035|NCT00670748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110622036|NCT00670748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110622037|NCT00670748|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110622038|NCT00670748|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110622039|NCT00670748|Antimetabolites|antimetabolites|mesh-ancestor
110622040|NCT00670748|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110622041|NCT00670748|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110622042|NCT00670748|Antiviral Agents|antiviral agents|mesh-ancestor
110622043|NCT00670748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110622044|NCT00646776|Ritonavir|ritonavir|mesh-list
110622045|NCT00646776|Atazanavir Sulfate|atazanavir sulfate|mesh-list
110622046|NCT00646776|Rifabutin|rifabutin|mesh-list
110629807|NCT00959439|Naproxen|naproxen|mesh-list
110622047|NCT00646776|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110622048|NCT00646776|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110622049|NCT00646776|Protease Inhibitors|protease inhibitors|mesh-ancestor
110622050|NCT00646776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110622051|NCT00646776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110622052|NCT00646776|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110622053|NCT00646776|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110622054|NCT00646776|Antiviral Agents|antiviral agents|mesh-ancestor
110622055|NCT00646776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110622056|NCT00646776|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110622057|NCT00646776|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110154020|NCT00008866|Didanosine|didanosine|mesh-list
110622058|NCT00646776|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110622059|NCT00646776|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110622060|NCT00646776|Antitubercular Agents|antitubercular agents|mesh-ancestor
110622061|NCT02558114|Ribavirin|ribavirin|mesh-list
110622062|NCT02558114|Antimetabolites|antimetabolites|mesh-ancestor
110622063|NCT02558114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110269328|NCT00066040|Fluorides|fluorides|mesh-list
110622064|NCT02558114|Antiviral Agents|antiviral agents|mesh-ancestor
110622065|NCT02558114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110622066|NCT00770666|Bupropion|bupropion|mesh-list
110622067|NCT00770666|Nicotine|nicotine|mesh-list
110622068|NCT00770666|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110622069|NCT00770666|Autonomic Agents|autonomic agents|mesh-ancestor
110622070|NCT00770666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110622071|NCT00770666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110622072|NCT00770666|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110622073|NCT00770666|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110622074|NCT00770666|Cholinergic Agents|cholinergic agents|mesh-ancestor
110622075|NCT00770666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110629992|NCT05179239|Tubulin Modulators|tubulin modulators|mesh-ancestor
110622076|NCT00770666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110622077|NCT00770666|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110622078|NCT00770666|Antidepressive Agents|antidepressive agents|mesh-ancestor
110622079|NCT00770666|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110622080|NCT00770666|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110622081|NCT00770666|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110622082|NCT00770666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110622083|NCT00770666|Dopamine Agents|dopamine agents|mesh-ancestor
110622084|NCT00770666|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110622085|NCT00770666|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110622086|NCT00770666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110622087|NCT00764036|Artesunate|artesunate|mesh-list
110622088|NCT00764036|Antimalarials|antimalarials|mesh-ancestor
110622089|NCT00764036|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110622090|NCT00764036|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110622091|NCT00764036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110622092|NCT00764036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110622093|NCT00764036|Antiviral Agents|antiviral agents|mesh-ancestor
110622094|NCT00764036|Schistosomicides|schistosomicides|mesh-ancestor
110622095|NCT00764036|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110622096|NCT00764036|Anthelmintics|anthelmintics|mesh-ancestor
110622097|NCT00764114|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110622098|NCT00764114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110622099|NCT00811200|Triamcinolone|triamcinolone|mesh-list
110622100|NCT00811200|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110622101|NCT00811200|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110622102|NCT00811200|Ranibizumab|ranibizumab|mesh-list
110622103|NCT00811200|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110622104|NCT00811200|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110622105|NCT00811200|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110622106|NCT00811200|Growth Substances|growth substances|mesh-ancestor
110622107|NCT00811200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110622108|NCT00811200|Growth Inhibitors|growth inhibitors|mesh-ancestor
110622109|NCT00811200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110622110|NCT00811200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110622111|NCT00811200|Glucocorticoids|glucocorticoids|mesh-ancestor
110622113|NCT00811200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110622114|NCT00811200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110622115|NCT00811200|Immunologic Factors|immunologic factors|mesh-ancestor
110622116|NCT00811200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110622117|NCT00811200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110622118|NCT00811356|Rosiglitazone|rosiglitazone|mesh-list
110622119|NCT00811356|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110154027|NCT00008866|Antimetabolites|antimetabolites|mesh-ancestor
110622120|NCT00811356|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110622121|NCT00811356|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110622122|NCT00811356|Antimetabolites|antimetabolites|mesh-ancestor
110622123|NCT00811356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110622124|NCT00811356|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110630160|NCT00791804|Fentanyl|fentanyl|mesh-list
110622125|NCT00811356|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110622126|NCT00811356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110622127|NCT00811356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110622128|NCT00811356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110622129|NCT00765986|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110622130|NCT00765986|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
110622131|NCT00765986|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110622132|NCT00765986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110622133|NCT00766064|Paliperidone Palmitate|paliperidone palmitate|mesh-list
110622134|NCT00766064|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110622135|NCT00766064|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110622136|NCT00766064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110622137|NCT00766064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110622138|NCT00766064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110392614|NCT01648595|Analgesics|analgesics|mesh-ancestor
110622139|NCT00766064|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110622140|NCT00766064|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110622141|NCT00766064|Serotonin Agents|serotonin agents|mesh-ancestor
110622142|NCT00766064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110622143|NCT00766064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110622144|NCT00766064|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110622145|NCT00766064|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110622146|NCT00766064|Dopamine Agents|dopamine agents|mesh-ancestor
110622148|NCT00770744|Antiemetics|antiemetics|mesh-ancestor
110622149|NCT00770744|Autonomic Agents|autonomic agents|mesh-ancestor
110622150|NCT00770744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110622151|NCT00770744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110622152|NCT00770744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110622153|NCT00770744|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110622154|NCT00770744|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110622155|NCT00770744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110622156|NCT00770744|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110622157|NCT00770744|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110622158|NCT00770744|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110622159|NCT00770744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110622160|NCT00770744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110622161|NCT00770744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110622162|NCT00770744|Serotonin Agents|serotonin agents|mesh-ancestor
110622163|NCT00655668|Lenalidomide|lenalidomide|mesh-list
110622164|NCT00655668|Immunologic Factors|immunologic factors|mesh-ancestor
110622165|NCT00655668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110622166|NCT00655668|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110622167|NCT00655668|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110622168|NCT00655668|Growth Substances|growth substances|mesh-ancestor
110622169|NCT00655668|Growth Inhibitors|growth inhibitors|mesh-ancestor
110622170|NCT00655668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110622171|NCT00770900|Montelukast|montelukast|mesh-list
110622172|NCT00770900|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110622173|NCT00770900|Respiratory System Agents|respiratory system agents|mesh-ancestor
110630516|NCT00748553|Paclitaxel|paclitaxel|mesh-list
110622174|NCT00770900|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110622175|NCT00770900|Hormone Antagonists|hormone antagonists|mesh-ancestor
110622176|NCT00770900|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110622177|NCT00770900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110622178|NCT00770900|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110630639|NCT00262873|Bortezomib|bortezomib|mesh-list
110622179|NCT00770900|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110622180|NCT00770900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110622181|NCT00766220|Irinotecan|irinotecan|mesh-list
110622182|NCT00766220|Cetuximab|cetuximab|mesh-list
110622183|NCT00766220|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110622184|NCT00766220|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110622185|NCT00766220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110154041|NCT00001119|Vaccines|vaccines|mesh-list
110622186|NCT00766220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110622187|NCT00766220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110622188|NCT00766220|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110622189|NCT00770978|Ceftobiprole|ceftobiprole|mesh-list
110622190|NCT00770978|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
110622191|NCT00770978|Cephalosporins|cephalosporins|mesh-list
110622192|NCT00770978|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110622193|NCT00770978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110622194|NCT00764426|Ethanol|ethanol|mesh-list
110622195|NCT00764426|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110622196|NCT00764426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110622197|NCT00764426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110622198|NCT00764426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110622199|NCT02558036|Pyrithione zinc|pyrithione zinc|mesh-list
110622200|NCT02558036|Keratolytic Agents|keratolytic agents|mesh-ancestor
110622201|NCT02558036|Dermatologic Agents|dermatologic agents|mesh-ancestor
110622202|NCT00764582|Moxifloxacin|moxifloxacin|mesh-list
110622203|NCT00764582|Levofloxacin|levofloxacin|mesh-list
110622204|NCT00764582|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110622205|NCT00764582|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110622206|NCT00764582|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110622207|NCT00764582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110622208|NCT00764582|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110622209|NCT00764582|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110622210|NCT00764582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110630917|NCT00745901|Drospirenone|drospirenone|mesh-list
110622211|NCT00764582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110622212|NCT00764582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110622213|NCT00764582|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110622214|NCT00764582|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110622215|NCT00764582|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110622218|NCT04048226|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110622219|NCT04048226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110622220|NCT04048226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110622221|NCT04048226|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110622222|NCT04048226|Analgesics|analgesics|mesh-ancestor
110622223|NCT04048226|Sensory System Agents|sensory system agents|mesh-ancestor
110622224|NCT04048226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110622225|NCT04048226|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110622226|NCT04048226|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110622227|NCT04048226|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110622228|NCT04048226|Adrenergic Agents|adrenergic agents|mesh-ancestor
110622229|NCT04048226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110622230|NCT04048226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110622231|NCT04048226|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110622232|NCT04048226|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110622233|NCT04048226|Anesthetics, General|anesthetics, general|mesh-ancestor
110622234|NCT04048226|Anesthetics|anesthetics|mesh-ancestor
110622235|NCT04048226|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110622236|NCT04048226|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110622237|NCT00811746|Eszopiclone|eszopiclone|mesh-list
110622238|NCT00811746|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110622239|NCT00811746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110622240|NCT00811746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110622241|NCT04048070|Flurbiprofen|flurbiprofen|mesh-list
110622242|NCT04048070|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
110622243|NCT04048070|Sufentanil|sufentanil|mesh-list
110622244|NCT04048070|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110622245|NCT04048070|Narcotics|narcotics|mesh-ancestor
110631111|NCT00864396|Lansoprazole|lansoprazole|mesh-list
110622246|NCT04048070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110622247|NCT04048070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110622248|NCT04048070|Analgesics|analgesics|mesh-ancestor
110622249|NCT04048070|Sensory System Agents|sensory system agents|mesh-ancestor
110622250|NCT04048070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110622251|NCT04048070|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110622252|NCT04048070|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110622253|NCT04048070|Anesthetics, General|anesthetics, general|mesh-ancestor
110622254|NCT04048070|Anesthetics|anesthetics|mesh-ancestor
110154046|NCT00001119|Protease Inhibitors|protease inhibitors|mesh-ancestor
110622255|NCT04048070|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110622256|NCT04048070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110622257|NCT04048070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110622258|NCT04048070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110622259|NCT04048070|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110622260|NCT04048070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110622261|NCT04048070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110622263|NCT00571064|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110622264|NCT00571064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110622265|NCT00571064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110622266|NCT00571064|Cholinergic Agents|cholinergic agents|mesh-ancestor
110622267|NCT00571064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110622268|NCT00571064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110622269|NCT00571064|Nootropic Agents|nootropic agents|mesh-ancestor
110622270|NCT00811980|Vancomycin|vancomycin|mesh-list
110622271|NCT00811980|Linezolid|linezolid|mesh-list
110622272|NCT00811980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110622273|NCT00811980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110622274|NCT00811980|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110622275|NCT00811980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110622276|NCT00811980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110622277|NCT00775034|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
110622279|NCT00775034|Coagulants|coagulants|mesh-ancestor
110622280|NCT00813696|Gemcitabine|gemcitabine|mesh-list
110622281|NCT00813696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110622282|NCT00813696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110622283|NCT00813696|Antimetabolites|antimetabolites|mesh-ancestor
110622284|NCT00813696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110622285|NCT00813774|Certolizumab Pegol|certolizumab pegol|mesh-list
110622286|NCT00813774|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110622287|NCT00813774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110622288|NCT00813774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110622289|NCT00813774|Immunologic Factors|immunologic factors|mesh-ancestor
110622290|NCT00813774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110622291|NCT00813774|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110622293|NCT02557490|Raltitrexed|raltitrexed|mesh-list
110622294|NCT02557490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110622295|NCT02557490|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110622296|NCT02557490|Antimetabolites|antimetabolites|mesh-ancestor
110622297|NCT02557490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110622298|NCT02557490|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110622299|NCT02557490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110622300|NCT02551848|Botulinum Toxins|botulinum toxins|mesh-list
110622301|NCT02551848|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110622302|NCT02551848|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110622303|NCT02551848|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
110622304|NCT02551848|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110622305|NCT02551848|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110622306|NCT02551848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110622307|NCT02551848|Cholinergic Agents|cholinergic agents|mesh-ancestor
110622308|NCT02551848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110622309|NCT02551848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110622310|NCT02551848|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110622311|NCT02551848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110622313|NCT00807534|Ipratropium|ipratropium|mesh-list
110622314|NCT00807534|Anticonvulsants|anticonvulsants|mesh-ancestor
110622315|NCT00807534|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110622316|NCT00807534|Autonomic Agents|autonomic agents|mesh-ancestor
110622317|NCT00807534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110622318|NCT00807534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110622319|NCT00807534|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110622320|NCT00807534|Respiratory System Agents|respiratory system agents|mesh-ancestor
110622321|NCT00807534|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110622322|NCT00807534|Cholinergic Agents|cholinergic agents|mesh-ancestor
110622323|NCT00807534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110622324|NCT00807534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110622325|NCT05589064|Vitamin D|vitamin d|mesh-list
110622326|NCT05589064|Cholecalciferol|cholecalciferol|mesh-list
110622327|NCT05589064|Vitamins|vitamins|mesh-ancestor
110622328|NCT05589064|Micronutrients|micronutrients|mesh-ancestor
110622329|NCT05589064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110622330|NCT05589064|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110622331|NCT05589064|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110622332|NCT00807690|Tacrolimus|tacrolimus|mesh-list
110622333|NCT00807690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110622334|NCT00807690|Immunologic Factors|immunologic factors|mesh-ancestor
110622335|NCT00807690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110622336|NCT00807690|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110622337|NCT00807690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110622338|NCT00807690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110622339|NCT05355844|Benzoyl Peroxide|benzoyl peroxide|mesh-list
110622340|NCT05355844|Dermatologic Agents|dermatologic agents|mesh-ancestor
110622341|NCT00814008|Insulin|insulin|mesh-list
110622342|NCT00814008|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110622343|NCT00814008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110622344|NCT00814086|Paclitaxel|paclitaxel|mesh-list
110622345|NCT00814086|Cisplatin|cisplatin|mesh-list
110622346|NCT00814086|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110622347|NCT00814086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110622348|NCT00814086|Tubulin Modulators|tubulin modulators|mesh-ancestor
110622349|NCT00814086|Antimitotic Agents|antimitotic agents|mesh-ancestor
110622350|NCT00814086|Mitosis Modulators|mitosis modulators|mesh-ancestor
110622351|NCT00814086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110622352|NCT00669110|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
110622353|NCT00669110|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110622354|NCT00669110|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110622355|NCT00669110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110622356|NCT00669110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110622357|NCT00669110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110622358|NCT00669110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110622359|NCT00669110|Antidepressive Agents|antidepressive agents|mesh-ancestor
110622360|NCT00669110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110622362|NCT00654732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110622363|NCT00654732|Doxorubicin|doxorubicin|mesh-list
110622364|NCT00654732|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110622365|NCT00654732|Dacarbazine|dacarbazine|mesh-list
110622366|NCT00654732|Bleomycin|bleomycin|mesh-list
110622367|NCT00654732|Vinblastine|vinblastine|mesh-list
110622368|NCT00654732|Antibodies|antibodies|mesh-list
110622369|NCT00654732|Immunoglobulins|immunoglobulins|mesh-list
110622370|NCT00654732|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110622371|NCT00654732|Imidazole|imidazole|mesh-list
110622372|NCT00654732|Immunologic Factors|immunologic factors|mesh-ancestor
110622373|NCT00654732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110622374|NCT00654732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110622375|NCT00654732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110622376|NCT00654732|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110622377|NCT00654732|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110622378|NCT00654732|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110622379|NCT00654732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110154062|NCT00001119|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110631640|NCT00870636|Bevacizumab|bevacizumab|mesh-list
110622380|NCT00654732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110622381|NCT00654732|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110622382|NCT00654732|Alkylating Agents|alkylating agents|mesh-ancestor
110622383|NCT00654732|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110622384|NCT00654732|Tubulin Modulators|tubulin modulators|mesh-ancestor
110622385|NCT00654732|Antimitotic Agents|antimitotic agents|mesh-ancestor
110622386|NCT00654732|Mitosis Modulators|mitosis modulators|mesh-ancestor
110622387|NCT00771368|Nitric Oxide|nitric oxide|mesh-list
110622388|NCT00771368|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110622389|NCT00771368|Autonomic Agents|autonomic agents|mesh-ancestor
110622390|NCT00771368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110622391|NCT00771368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110622392|NCT00771368|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110622393|NCT00771368|Respiratory System Agents|respiratory system agents|mesh-ancestor
110622394|NCT00771368|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110622395|NCT00771368|Antioxidants|antioxidants|mesh-ancestor
110631770|NCT00796796|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110622396|NCT00771368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110622397|NCT00771368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110622398|NCT00771368|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
110622401|NCT00771368|Protective Agents|protective agents|mesh-ancestor
110622402|NCT00771524|Ceftobiprole|ceftobiprole|mesh-list
110622403|NCT00771524|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
110622404|NCT00771524|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110622405|NCT00771524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110622407|NCT00771680|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110622408|NCT00771680|Insulin Aspart|insulin aspart|mesh-list
110622409|NCT00771680|Insulin, Long-Acting|insulin, long-acting|mesh-list
110622410|NCT00771680|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
110622411|NCT00771680|Insulin Detemir|insulin detemir|mesh-list
110622412|NCT00771680|Biphasic Insulins|biphasic insulins|mesh-list
110631901|NCT02595359|Moxifloxacin|moxifloxacin|mesh-list
110622413|NCT00771680|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
110622414|NCT00771680|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110622415|NCT00771680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110622417|NCT00767468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110622418|NCT00767468|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110622419|NCT00767468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110622420|NCT00767468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110622421|NCT00669032|Hyaluronic Acid|hyaluronic acid|mesh-list
110622422|NCT00669032|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110622423|NCT00669032|Immunologic Factors|immunologic factors|mesh-ancestor
110622424|NCT00669032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110622425|NCT00669032|Viscosupplements|viscosupplements|mesh-ancestor
110622426|NCT00669032|Protective Agents|protective agents|mesh-ancestor
110622428|NCT00775580|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110622429|NCT00775580|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110622430|NCT00775580|Sympatholytics|sympatholytics|mesh-ancestor
110622432|NCT00775580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110622433|NCT00775580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110622434|NCT00775580|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110622435|NCT00775580|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110622436|NCT00775580|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110622437|NCT00775580|Adrenergic Agents|adrenergic agents|mesh-ancestor
110622438|NCT00775580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110622439|NCT00775580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110622440|NCT00767546|Botulinum Toxins|botulinum toxins|mesh-list
110622441|NCT00767546|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110622442|NCT00767546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110622443|NCT00767546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110252222|NCT00154089|Analgesics|analgesics|mesh-ancestor
110622444|NCT00767546|Cholinergic Agents|cholinergic agents|mesh-ancestor
110622445|NCT00767546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110622446|NCT00767546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110622447|NCT00654498|Pramipexole|pramipexole|mesh-list
110622448|NCT00654498|Antioxidants|antioxidants|mesh-ancestor
110622449|NCT00654498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110622450|NCT00654498|Protective Agents|protective agents|mesh-ancestor
110622451|NCT00654498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110622452|NCT00654498|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110622453|NCT00654498|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110622454|NCT00654498|Dopamine Agonists|dopamine agonists|mesh-ancestor
110622455|NCT00654498|Dopamine Agents|dopamine agents|mesh-ancestor
110622456|NCT00654498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110622457|NCT00670046|Valproic Acid|valproic acid|mesh-list
110622458|NCT00670046|Anticonvulsants|anticonvulsants|mesh-ancestor
110622459|NCT00670046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110622460|NCT00670046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110622461|NCT00670046|GABA Agents|gaba agents|mesh-ancestor
110622462|NCT00670046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110622463|NCT00670046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110622464|NCT00670046|Antimanic Agents|antimanic agents|mesh-ancestor
110622465|NCT00670046|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110622466|NCT00670046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110622467|NCT00670046|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110622468|NCT00560391|Dexamethasone|dexamethasone|mesh-list
110622469|NCT00560391|Dexamethasone acetate|dexamethasone acetate|mesh-list
110622470|NCT00560391|Lenalidomide|lenalidomide|mesh-list
110622471|NCT00560391|Dasatinib|dasatinib|mesh-list
110622472|NCT00560391|BB 1101|bb 1101|mesh-list
110622473|NCT00560391|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110622474|NCT00560391|Antiemetics|antiemetics|mesh-ancestor
110622475|NCT00560391|Autonomic Agents|autonomic agents|mesh-ancestor
110622476|NCT00560391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110622477|NCT00560391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110622478|NCT00560391|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110622479|NCT00560391|Glucocorticoids|glucocorticoids|mesh-ancestor
110622480|NCT00560391|Hormones|hormones|mesh-ancestor
110622481|NCT00560391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110622482|NCT00560391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110622483|NCT00560391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110622484|NCT00560391|Protease Inhibitors|protease inhibitors|mesh-ancestor
110622485|NCT00560391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110622486|NCT00560391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110622487|NCT00560391|Immunologic Factors|immunologic factors|mesh-ancestor
110622488|NCT00560391|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110622489|NCT00560391|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110622490|NCT00560391|Growth Substances|growth substances|mesh-ancestor
110622491|NCT00560391|Growth Inhibitors|growth inhibitors|mesh-ancestor
110622492|NCT00560391|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110622493|NCT00775736|Insulin|insulin|mesh-list
110622494|NCT00775736|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110622495|NCT00775736|Insulin Aspart|insulin aspart|mesh-list
110622496|NCT00775736|Insulin, Long-Acting|insulin, long-acting|mesh-list
110622497|NCT00775736|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
110622498|NCT00775736|Biphasic Insulins|biphasic insulins|mesh-list
110622499|NCT00775736|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
110622500|NCT00775736|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110632267|NCT03970265|Meropenem|meropenem|mesh-list
110622501|NCT00775736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110622503|NCT00537238|Levetiracetam|levetiracetam|mesh-list
110622504|NCT00537238|Analgesics|analgesics|mesh-ancestor
110622505|NCT00537238|Sensory System Agents|sensory system agents|mesh-ancestor
110622506|NCT00537238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110622507|NCT00537238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110622508|NCT00537238|Anticonvulsants|anticonvulsants|mesh-ancestor
110622509|NCT00537238|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110622510|NCT00537238|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110269779|NCT04778618|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110252227|NCT00138359|Niclosamide|niclosamide|mesh-list
110622511|NCT00537238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110622512|NCT00537238|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110622513|NCT00537238|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110622514|NCT00537238|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110622515|NCT00537238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110622516|NCT00537238|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110622517|NCT00537238|Nootropic Agents|nootropic agents|mesh-ancestor
110622518|NCT03982771|Cyclophosphamide|cyclophosphamide|mesh-list
110622519|NCT03982771|Bortezomib|bortezomib|mesh-list
110622520|NCT03982771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110622521|NCT03982771|Immunologic Factors|immunologic factors|mesh-ancestor
110622522|NCT03982771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110622523|NCT03982771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110622524|NCT03982771|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110622525|NCT03982771|Alkylating Agents|alkylating agents|mesh-ancestor
110622526|NCT03982771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110622527|NCT03982771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110622528|NCT03982771|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110622529|NCT00775814|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110622530|NCT00775814|Candesartan|candesartan|mesh-list
110632340|NCT00880386|Losartan|losartan|mesh-list
110622531|NCT00775814|Candesartan cilexetil|candesartan cilexetil|mesh-list
110622532|NCT00775814|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110622533|NCT00775814|Diuretics|diuretics|mesh-ancestor
110622534|NCT00775814|Natriuretic Agents|natriuretic agents|mesh-ancestor
110392662|NCT01688583|Anesthetics|anesthetics|mesh-ancestor
110622535|NCT00775814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110622536|NCT00775814|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110622537|NCT00775814|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110622538|NCT00775814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110622539|NCT00775814|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110622540|NCT00775814|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110622542|NCT00942747|Temsirolimus|temsirolimus|mesh-list
110622543|NCT00942747|MTOR Inhibitors|mtor inhibitors|mesh-list
110622544|NCT00942747|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110622545|NCT00942747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110632374|NCT00978159|Histamine Agents|histamine agents|mesh-ancestor
110622546|NCT00942747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110622547|NCT00942747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110622548|NCT00942747|Immunologic Factors|immunologic factors|mesh-ancestor
110622549|NCT00942747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110622550|NCT00942747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110622551|NCT00942747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110622552|NCT00942747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110622553|NCT00942747|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110622554|NCT00942747|Antifungal Agents|antifungal agents|mesh-ancestor
110622555|NCT00946491|Haloperidol|haloperidol|mesh-list
110622556|NCT00946491|Haloperidol decanoate|haloperidol decanoate|mesh-list
110154090|NCT00009178|Fluoxetine|fluoxetine|mesh-list
110622557|NCT00946491|Antiemetics|antiemetics|mesh-ancestor
110622558|NCT00946491|Autonomic Agents|autonomic agents|mesh-ancestor
110622559|NCT00946491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110622560|NCT00946491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110622561|NCT00946491|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110622562|NCT00946491|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110622563|NCT00946491|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110622564|NCT00946491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110622565|NCT00946491|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110622566|NCT00946491|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110622567|NCT00946491|Dopamine Agents|dopamine agents|mesh-ancestor
110622568|NCT00946491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110622569|NCT00946491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110622570|NCT00946491|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110622571|NCT05355610|Gentamicins|gentamicins|mesh-list
110622572|NCT05355610|Dexamethasone|dexamethasone|mesh-list
110622573|NCT05355610|Dexamethasone acetate|dexamethasone acetate|mesh-list
110622574|NCT05355610|BB 1101|bb 1101|mesh-list
110622575|NCT05355610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110622576|NCT05355610|Antiemetics|antiemetics|mesh-ancestor
110622577|NCT05355610|Autonomic Agents|autonomic agents|mesh-ancestor
110622578|NCT05355610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110622579|NCT05355610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110622581|NCT05355610|Glucocorticoids|glucocorticoids|mesh-ancestor
110622582|NCT05355610|Hormones|hormones|mesh-ancestor
110622583|NCT05355610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110622584|NCT05355610|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110622585|NCT05355610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110622587|NCT05355610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110622588|NCT05355610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110622589|NCT05355610|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110622590|NCT05355610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110622591|NCT05355610|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110622592|NCT00552669|Sirolimus|sirolimus|mesh-list
110622593|NCT00552669|Paclitaxel|paclitaxel|mesh-list
110622594|NCT00552669|Temsirolimus|temsirolimus|mesh-list
110622595|NCT00552669|MTOR Inhibitors|mtor inhibitors|mesh-list
110622596|NCT00552669|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110622597|NCT00552669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110622598|NCT00552669|Tubulin Modulators|tubulin modulators|mesh-ancestor
110622599|NCT00552669|Antimitotic Agents|antimitotic agents|mesh-ancestor
110622600|NCT00552669|Mitosis Modulators|mitosis modulators|mesh-ancestor
110622601|NCT00552669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110622602|NCT00552669|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110622603|NCT00552669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110622604|NCT00552669|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110622605|NCT00552669|Antifungal Agents|antifungal agents|mesh-ancestor
110622606|NCT00552669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110622607|NCT00552669|Immunologic Factors|immunologic factors|mesh-ancestor
110622608|NCT00552669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110622609|NCT00552669|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110622610|NCT00552669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110622611|NCT00943059|Acipimox|acipimox|mesh-list
110622612|NCT00943059|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110622613|NCT00943059|Antimetabolites|antimetabolites|mesh-ancestor
110622614|NCT00943059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110622615|NCT00943059|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110622616|NCT00943137|Fluorouracil|fluorouracil|mesh-list
110622617|NCT00943137|Antimetabolites|antimetabolites|mesh-ancestor
110622618|NCT00943137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110622619|NCT00943137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110622620|NCT00943137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110622621|NCT00943137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110622622|NCT00943137|Immunologic Factors|immunologic factors|mesh-ancestor
110622623|NCT00943137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110622624|NCT00772616|Sufentanil|sufentanil|mesh-list
110622625|NCT00772616|Remifentanil|remifentanil|mesh-list
110622626|NCT00772616|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110622627|NCT00772616|Narcotics|narcotics|mesh-ancestor
110622628|NCT00772616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110622629|NCT00772616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110622631|NCT00772616|Sensory System Agents|sensory system agents|mesh-ancestor
110622632|NCT00772616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110622633|NCT00772616|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110622634|NCT00772616|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110622635|NCT00772616|Anesthetics, General|anesthetics, general|mesh-ancestor
110622636|NCT00772616|Anesthetics|anesthetics|mesh-ancestor
110622637|NCT00768404|Phentermine|phentermine|mesh-list
110622638|NCT00768404|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110622639|NCT00768404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110622640|NCT00768404|Appetite Depressants|appetite depressants|mesh-ancestor
110622641|NCT00768404|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110622642|NCT00768404|Sympathomimetics|sympathomimetics|mesh-ancestor
110622643|NCT00768404|Autonomic Agents|autonomic agents|mesh-ancestor
110632677|NCT00613938|Oxycodone|oxycodone|mesh-list
110622644|NCT00768404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110622645|NCT00768404|Adrenergic Agents|adrenergic agents|mesh-ancestor
110622646|NCT00768404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110622647|NCT00768404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110622648|NCT05406622|Sirolimus|sirolimus|mesh-list
110622649|NCT05406622|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110622650|NCT05406622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110622651|NCT05406622|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110622652|NCT05406622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110622653|NCT05406622|Antifungal Agents|antifungal agents|mesh-ancestor
110622654|NCT05406622|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110622655|NCT05406622|Immunologic Factors|immunologic factors|mesh-ancestor
110622656|NCT05406622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110622657|NCT00776282|Loratadine|loratadine|mesh-list
110622658|NCT00776282|Antipruritics|antipruritics|mesh-ancestor
110622659|NCT00776282|Dermatologic Agents|dermatologic agents|mesh-ancestor
110622660|NCT00776282|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110269932|NCT03729245|Nivolumab|nivolumab|mesh-list
110622661|NCT00776282|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110622662|NCT00776282|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110622663|NCT00776282|Histamine Antagonists|histamine antagonists|mesh-ancestor
110622665|NCT00776282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110622666|NCT00776282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110622667|NCT00776282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110622669|NCT00943293|Melphalan|melphalan|mesh-list
110622670|NCT00943293|Alemtuzumab|alemtuzumab|mesh-list
110622671|NCT00943293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110622672|NCT00943293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110622673|NCT00943293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110622674|NCT00943293|Immunologic Factors|immunologic factors|mesh-ancestor
110622675|NCT00943293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110622676|NCT00943293|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110622677|NCT00943293|Alkylating Agents|alkylating agents|mesh-ancestor
110622678|NCT00943293|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110622679|NCT00943293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110622680|NCT00776360|Oxytocin|oxytocin|mesh-list
110622681|NCT00776360|Oxytocics|oxytocics|mesh-ancestor
110622682|NCT00776360|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110622683|NCT00776360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110622684|NCT00946725|Atenolol|atenolol|mesh-list
110622685|NCT00946725|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110622686|NCT00946725|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110622687|NCT00946725|Sympatholytics|sympatholytics|mesh-ancestor
110622688|NCT00946725|Autonomic Agents|autonomic agents|mesh-ancestor
110632980|NCT02593643|Midazolam|midazolam|mesh-list
110622689|NCT00946725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110622690|NCT00946725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110622691|NCT00946725|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110622692|NCT00946725|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110622693|NCT00946725|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110622694|NCT00946725|Adrenergic Agents|adrenergic agents|mesh-ancestor
110622695|NCT00946725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110622696|NCT00946725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110622697|NCT03041740|Perflubron|perflubron|mesh-list
110622698|NCT03041740|Bromides|bromides|mesh-list
110622699|NCT03041740|Anticonvulsants|anticonvulsants|mesh-ancestor
110622700|NCT03041740|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110622701|NCT00772694|Sorafenib|sorafenib|mesh-list
110633043|NCT00881634|Autonomic Agents|autonomic agents|mesh-ancestor
110622702|NCT00772694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110622703|NCT00772694|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110622704|NCT00772694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110622705|NCT00772694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110622707|NCT00776438|Immunologic Factors|immunologic factors|mesh-ancestor
110622708|NCT00776438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110622709|NCT00943449|Sorafenib|sorafenib|mesh-list
110622710|NCT00943449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110622711|NCT00943449|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110622712|NCT00943449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110622713|NCT00943449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110622714|NCT00952029|Leucovorin|leucovorin|mesh-list
110622715|NCT00952029|Bevacizumab|bevacizumab|mesh-list
110622716|NCT00952029|Fluorouracil|fluorouracil|mesh-list
110622717|NCT00952029|Irinotecan|irinotecan|mesh-list
110622718|NCT00952029|Calcium|calcium|mesh-list
110622719|NCT00952029|Levoleucovorin|levoleucovorin|mesh-list
110622720|NCT00952029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110622721|NCT00952029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110622722|NCT00952029|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110622723|NCT00952029|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110622724|NCT00952029|Growth Substances|growth substances|mesh-ancestor
110622725|NCT00952029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110622726|NCT00952029|Growth Inhibitors|growth inhibitors|mesh-ancestor
110633237|NCT03829020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110622727|NCT00952029|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110622728|NCT00952029|Antimetabolites|antimetabolites|mesh-ancestor
110392700|NCT01688934|Naproxen|naproxen|mesh-list
110622729|NCT00952029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110622730|NCT00952029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110622731|NCT00952029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110622732|NCT00952029|Immunologic Factors|immunologic factors|mesh-ancestor
110622733|NCT00952029|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110622734|NCT00952029|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110622735|NCT00952029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110622736|NCT00952029|Antidotes|antidotes|mesh-ancestor
110622737|NCT00952029|Protective Agents|protective agents|mesh-ancestor
110622738|NCT00952029|Vitamin B Complex|vitamin b complex|mesh-ancestor
110622740|NCT00952029|Micronutrients|micronutrients|mesh-ancestor
110622741|NCT00667862|Panobinostat|panobinostat|mesh-list
110622742|NCT00667862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110622743|NCT00667862|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110622744|NCT00667862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110622745|NCT00667862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110622746|NCT00952185|Antibodies|antibodies|mesh-list
110622747|NCT00952185|Immunologic Factors|immunologic factors|mesh-ancestor
110622748|NCT00952185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110622749|NCT00776516|Rifampin|rifampin|mesh-list
110622750|NCT00776516|Mirabegron|mirabegron|mesh-list
110622751|NCT00776516|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110622752|NCT00776516|Antitubercular Agents|antitubercular agents|mesh-ancestor
110622753|NCT00776516|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110622754|NCT00776516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110622755|NCT00776516|Leprostatic Agents|leprostatic agents|mesh-ancestor
110622756|NCT00776516|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110622757|NCT00776516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110622758|NCT00776516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110622759|NCT00776516|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110622760|NCT00776516|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110622761|NCT00776516|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110622762|NCT00776516|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110622763|NCT00776516|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110622764|NCT00776516|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110622765|NCT00776516|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
110622766|NCT00776516|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110622767|NCT00776516|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110622768|NCT00776516|Adrenergic Agents|adrenergic agents|mesh-ancestor
110622769|NCT00776516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110622770|NCT00776516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110622771|NCT00776516|Urological Agents|urological agents|mesh-ancestor
110622772|NCT00768638|Atorvastatin|atorvastatin|mesh-list
110622773|NCT00768638|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110622774|NCT00768638|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110622775|NCT00768638|Antimetabolites|antimetabolites|mesh-ancestor
110622776|NCT00768638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110622777|NCT00768638|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110622778|NCT00768638|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110622779|NCT00768638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110622780|NCT02557958|Azithromycin|azithromycin|mesh-list
110622781|NCT02557958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110622782|NCT02557958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110622783|NCT00776672|Fosinopril|fosinopril|mesh-list
110622784|NCT00776672|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110622785|NCT00776672|Protease Inhibitors|protease inhibitors|mesh-ancestor
110622786|NCT00776672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110622787|NCT00776672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110622788|NCT00776672|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110622789|NCT00535132|Risperidone|risperidone|mesh-list
110622790|NCT00535132|Paliperidone Palmitate|paliperidone palmitate|mesh-list
110622791|NCT00535132|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110622792|NCT00535132|Serotonin Agents|serotonin agents|mesh-ancestor
110622793|NCT00535132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110622794|NCT00535132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110622795|NCT00535132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110622796|NCT00535132|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110622797|NCT00535132|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110392704|NCT01688934|Sensory System Agents|sensory system agents|mesh-ancestor
110622798|NCT00535132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110622799|NCT00535132|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110622800|NCT00535132|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110622801|NCT00535132|Dopamine Agents|dopamine agents|mesh-ancestor
110622802|NCT00535132|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110622803|NCT00535132|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110622805|NCT00570908|Sunitinib|sunitinib|mesh-list
110622806|NCT00570908|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110622807|NCT00570908|Antimetabolites|antimetabolites|mesh-ancestor
110622808|NCT00570908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110622809|NCT00570908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110622810|NCT00570908|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110622811|NCT00570908|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110622812|NCT00570908|Growth Substances|growth substances|mesh-ancestor
110622813|NCT00570908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110622814|NCT00570908|Growth Inhibitors|growth inhibitors|mesh-ancestor
110622815|NCT00570908|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110622816|NCT00570908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110633612|NCT00730925|Paclitaxel|paclitaxel|mesh-list
110622818|NCT00773084|Spironolactone|spironolactone|mesh-list
110622819|NCT00773084|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110622820|NCT00773084|Hormone Antagonists|hormone antagonists|mesh-ancestor
110622821|NCT00773084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110622822|NCT00773084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110622823|NCT00773084|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110622824|NCT00773084|Diuretics|diuretics|mesh-ancestor
110281021|NCT00122876|Talaporfin|talaporfin|mesh-list
110622825|NCT00773084|Natriuretic Agents|natriuretic agents|mesh-ancestor
110622826|NCT00773084|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110622827|NCT00773084|Protease Inhibitors|protease inhibitors|mesh-ancestor
110622828|NCT00773084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110622829|NCT00773084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110622830|NCT00773084|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110622831|NCT00773084|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110622832|NCT00773084|Protective Agents|protective agents|mesh-ancestor
110622833|NCT00321919|Epoetin Alfa|epoetin alfa|mesh-list
110622834|NCT00321919|Hematinics|hematinics|mesh-ancestor
110622835|NCT00781391|Warfarin|warfarin|mesh-list
110622836|NCT00781391|Edoxaban|edoxaban|mesh-list
110622837|NCT00781391|Anticoagulants|anticoagulants|mesh-ancestor
110622838|NCT00781391|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110622839|NCT00781391|Antithrombins|antithrombins|mesh-ancestor
110622840|NCT00781391|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110622841|NCT00781391|Protease Inhibitors|protease inhibitors|mesh-ancestor
110622842|NCT00781391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110633735|NCT03973411|Autonomic Agents|autonomic agents|mesh-ancestor
110622843|NCT00781391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110622844|NCT00534976|Montelukast|montelukast|mesh-list
110622845|NCT00534976|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110622846|NCT00534976|Respiratory System Agents|respiratory system agents|mesh-ancestor
110622847|NCT00534976|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110622848|NCT00534976|Hormone Antagonists|hormone antagonists|mesh-ancestor
110622849|NCT00534976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110622850|NCT00534976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110622851|NCT00534976|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110622852|NCT00534976|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110622853|NCT00534976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110622854|NCT00773162|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110622855|NCT00773162|Antidepressive Agents|antidepressive agents|mesh-ancestor
110622856|NCT00773162|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110622857|NCT00773162|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110622858|NCT00773162|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110622859|NCT00773162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110622860|NCT00773162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110622862|NCT00776828|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110622863|NCT00776828|Autonomic Agents|autonomic agents|mesh-ancestor
110622864|NCT00776828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110633857|NCT02542254|Adrenergic Agents|adrenergic agents|mesh-ancestor
110622865|NCT00776828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110622866|NCT00776828|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110622867|NCT00776828|Respiratory System Agents|respiratory system agents|mesh-ancestor
110622868|NCT00776828|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110622869|NCT00776828|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110622870|NCT00776828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110622871|NCT00776828|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110622872|NCT00776828|Vasodilator Agents|vasodilator agents|mesh-ancestor
110622873|NCT00776828|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110622874|NCT00776828|Protective Agents|protective agents|mesh-ancestor
110622875|NCT00776828|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110622876|NCT00776828|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110622877|NCT00776828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110622878|NCT01063933|Peramivir|peramivir|mesh-list
110622879|NCT01063933|Antiviral Agents|antiviral agents|mesh-ancestor
110622880|NCT01063933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110622881|NCT01063933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110622882|NCT01063933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110622883|NCT02556866|Prednisone|prednisone|mesh-list
110622884|NCT02556866|Rituximab|rituximab|mesh-list
110622885|NCT02556866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110622886|NCT02556866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110633980|NCT02543034|Petrolatum|petrolatum|mesh-list
110622887|NCT02556866|Immunologic Factors|immunologic factors|mesh-ancestor
110622888|NCT02556866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110622889|NCT02556866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110622890|NCT02556866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110622892|NCT02556866|Hormones|hormones|mesh-ancestor
110622893|NCT02556866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110622894|NCT02556866|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110622895|NCT00308113|Ubiquinone|ubiquinone|mesh-list
110622896|NCT00308113|Coenzyme Q10|coenzyme q10|mesh-list
110622897|NCT00308113|Prednisone|prednisone|mesh-list
110622898|NCT00308113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110622899|NCT00308113|Glucocorticoids|glucocorticoids|mesh-ancestor
110622900|NCT00308113|Hormones|hormones|mesh-ancestor
110622901|NCT00308113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110622902|NCT00308113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110622903|NCT00308113|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110622904|NCT00308113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110622905|NCT00308113|Micronutrients|micronutrients|mesh-ancestor
110622906|NCT00308113|Vitamins|vitamins|mesh-ancestor
110622907|NCT03903640|Nivolumab|nivolumab|mesh-list
110622908|NCT03903640|Ipilimumab|ipilimumab|mesh-list
110622909|NCT03903640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110622910|NCT03903640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110622911|NCT03903640|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110392730|NCT02279615|Adrenergic Agents|adrenergic agents|mesh-ancestor
110622912|NCT03903640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110622914|NCT03982849|Hydroquinone|hydroquinone|mesh-list
110622915|NCT03982849|Antioxidants|antioxidants|mesh-ancestor
110622916|NCT03982849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110622917|NCT03982849|Protective Agents|protective agents|mesh-ancestor
110622918|NCT03982849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110622919|NCT03982849|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110622920|NCT05357872|Anesthetics|anesthetics|mesh-list
110622921|NCT05357872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110622922|NCT05357872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110622924|NCT00777218|Propranolol|propranolol|mesh-list
110622925|NCT00777218|Zonisamide|zonisamide|mesh-list
110622926|NCT00777218|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110622927|NCT00777218|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110622928|NCT00777218|Adrenergic Agents|adrenergic agents|mesh-ancestor
110622929|NCT00777218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110154139|NCT00009646|Tocolytic Agents|tocolytic agents|mesh-ancestor
110252319|NCT00138866|Risedronic Acid|risedronic acid|mesh-list
110622930|NCT00777218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110622931|NCT00777218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110622932|NCT00777218|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110622933|NCT00777218|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110622934|NCT00777218|Vasodilator Agents|vasodilator agents|mesh-ancestor
110622936|NCT00777218|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110622937|NCT00777218|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110622938|NCT00777218|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110622939|NCT00777218|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110622940|NCT04047758|Letrozole|letrozole|mesh-list
110622941|NCT04047758|Palbociclib|palbociclib|mesh-list
110622942|NCT04047758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110622943|NCT04047758|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110622944|NCT04047758|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110622945|NCT04047758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110622946|NCT04047758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110622947|NCT04047758|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110622948|NCT04047758|Hormone Antagonists|hormone antagonists|mesh-ancestor
110622949|NCT04047758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110622950|NCT04047758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110622951|NCT04047758|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110622952|NCT00307801|Dienogest|dienogest|mesh-list
110622953|NCT00307801|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110622954|NCT00307801|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110622955|NCT00307801|Estradiol|estradiol|mesh-list
110622956|NCT00307801|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110622957|NCT00307801|Estrogens|estrogens|mesh-ancestor
110622958|NCT00307801|Hormones|hormones|mesh-ancestor
110622959|NCT00307801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110622960|NCT00307801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110622961|NCT00307801|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110622963|NCT00307801|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110622964|NCT00307801|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110622965|NCT00307801|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110622966|NCT00307801|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110622967|NCT00307801|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110622968|NCT00307801|Hormone Antagonists|hormone antagonists|mesh-ancestor
110622969|NCT00307801|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110622970|NCT00307801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110622971|NCT00671060|Misoprostol|misoprostol|mesh-list
110622972|NCT00671060|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110622973|NCT00671060|Abortifacient Agents|abortifacient agents|mesh-ancestor
110622974|NCT00671060|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110392744|NCT01689051|Incretins|incretins|mesh-ancestor
110622975|NCT00671060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110622977|NCT00671060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110622978|NCT00671060|Oxytocics|oxytocics|mesh-ancestor
110622979|NCT05354986|Povidone|povidone|mesh-list
110622980|NCT05354986|Plasma Substitutes|plasma substitutes|mesh-ancestor
110622981|NCT05354986|Blood Substitutes|blood substitutes|mesh-ancestor
110622982|NCT00773552|Solifenacin Succinate|solifenacin succinate|mesh-list
110622983|NCT00773552|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110622984|NCT00773552|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110622985|NCT00773552|Cholinergic Agents|cholinergic agents|mesh-ancestor
110622986|NCT00773552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110622987|NCT00773552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110622988|NCT00773552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110622989|NCT00773552|Urological Agents|urological agents|mesh-ancestor
110622990|NCT04002700|Haloperidol|haloperidol|mesh-list
110622991|NCT04002700|Haloperidol decanoate|haloperidol decanoate|mesh-list
110622992|NCT04002700|Antipsychotic Agents|antipsychotic agents|mesh-list
110622993|NCT04002700|Antiemetics|antiemetics|mesh-ancestor
110622994|NCT04002700|Autonomic Agents|autonomic agents|mesh-ancestor
110622995|NCT04002700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110252339|NCT00161031|Adrenergic Agents|adrenergic agents|mesh-ancestor
110622996|NCT04002700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110622997|NCT04002700|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110622998|NCT04002700|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110622999|NCT04002700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110623000|NCT04002700|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110623001|NCT04002700|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110623002|NCT04002700|Dopamine Agents|dopamine agents|mesh-ancestor
110623003|NCT04002700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110623004|NCT04002700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110623005|NCT04002700|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110623006|NCT04098653|Cyclophosphamide|cyclophosphamide|mesh-list
110623007|NCT04098653|Busulfan|busulfan|mesh-list
110623008|NCT04098653|Decitabine|decitabine|mesh-list
110623009|NCT04098653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110623010|NCT04098653|Immunologic Factors|immunologic factors|mesh-ancestor
110623011|NCT04098653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110623012|NCT04098653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110623013|NCT04098653|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110623014|NCT04098653|Alkylating Agents|alkylating agents|mesh-ancestor
110623015|NCT04098653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110623016|NCT04098653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110623017|NCT04098653|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110623018|NCT04098653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110623019|NCT04098653|Antimetabolites|antimetabolites|mesh-ancestor
110623020|NCT04098653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110623021|NCT05297123|Tretinoin|tretinoin|mesh-list
110623022|NCT05297123|Arsenic Trioxide|arsenic trioxide|mesh-list
110623023|NCT05297123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110623024|NCT05297123|Keratolytic Agents|keratolytic agents|mesh-ancestor
110623025|NCT05297123|Dermatologic Agents|dermatologic agents|mesh-ancestor
110623026|NCT00654420|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110623027|NCT00654420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110623028|NCT00654420|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110623029|NCT00654420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110623030|NCT00654420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110623031|NCT00773630|Cilostazol|cilostazol|mesh-list
110623032|NCT00773630|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110623033|NCT00773630|Autonomic Agents|autonomic agents|mesh-ancestor
110623034|NCT00773630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110623035|NCT00773630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110623037|NCT00773630|Respiratory System Agents|respiratory system agents|mesh-ancestor
110634664|NCT03974035|Ropivacaine|ropivacaine|mesh-list
110623038|NCT00773630|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110623039|NCT00773630|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110623040|NCT00773630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110392756|NCT01689090|Analgesics|analgesics|mesh-ancestor
110623041|NCT00773630|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110623042|NCT00773630|Vasodilator Agents|vasodilator agents|mesh-ancestor
110623043|NCT00773630|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110623044|NCT00773630|Protective Agents|protective agents|mesh-ancestor
110623045|NCT00773630|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110623046|NCT00773630|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110623047|NCT00773630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110623048|NCT04016922|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
110623049|NCT04016922|Hematinics|hematinics|mesh-ancestor
110623050|NCT03646474|Tranexamic Acid|tranexamic acid|mesh-list
110623051|NCT03646474|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110623052|NCT03646474|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110623053|NCT03646474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110623054|NCT03646474|Hemostatics|hemostatics|mesh-ancestor
110623055|NCT03646474|Coagulants|coagulants|mesh-ancestor
110623056|NCT00808002|Tenofovir|tenofovir|mesh-list
110623057|NCT00808002|Emtricitabine|emtricitabine|mesh-list
110623058|NCT00808002|Raltegravir Potassium|raltegravir potassium|mesh-list
110623059|NCT00808002|Maraviroc|maraviroc|mesh-list
110623060|NCT00808002|Antiviral Agents|antiviral agents|mesh-ancestor
110623061|NCT00808002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110623062|NCT00808002|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110623063|NCT00808002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110634802|NCT00884676|Sunitinib|sunitinib|mesh-list
110623064|NCT00808002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110623065|NCT00808002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110623066|NCT00808002|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110623067|NCT00808002|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110623068|NCT00808002|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110623069|NCT00808002|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110623070|NCT00808002|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110623071|NCT00808002|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110623072|NCT00808002|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
110623074|NCT00307489|Emtricitabine|emtricitabine|mesh-list
110623075|NCT00307489|Antiviral Agents|antiviral agents|mesh-ancestor
110623076|NCT00307489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110623077|NCT00307489|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110623078|NCT00307489|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110623079|NCT00307489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110623080|NCT00307489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110623081|NCT00307489|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110623082|NCT00307489|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110623083|NCT00812292|Rilpivirine|rilpivirine|mesh-list
110623084|NCT00812292|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110623085|NCT00812292|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110623086|NCT00812292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110634984|NCT02542098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110623087|NCT00812292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110623088|NCT00812292|Antiviral Agents|antiviral agents|mesh-ancestor
110623089|NCT00812292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110623090|NCT00812292|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110623091|NCT00812292|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110623092|NCT00812370|Bivalirudin|bivalirudin|mesh-list
110623093|NCT00812370|Antithrombins|antithrombins|mesh-ancestor
110623094|NCT00812370|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110623095|NCT00812370|Protease Inhibitors|protease inhibitors|mesh-ancestor
110623096|NCT00812370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110623097|NCT00812370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110623098|NCT00812370|Anticoagulants|anticoagulants|mesh-ancestor
110623099|NCT00645840|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
110623100|NCT00645840|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110635053|NCT02541786|Rabeprazole|rabeprazole|mesh-list
110623101|NCT00773708|Raltegravir Potassium|raltegravir potassium|mesh-list
110623102|NCT00773708|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110623103|NCT00773708|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110623104|NCT00773708|Antiviral Agents|antiviral agents|mesh-ancestor
110623105|NCT00773708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110623106|NCT00773708|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110623107|NCT00773708|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110623108|NCT00773708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110623109|NCT00773708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110392765|NCT01689129|Insulin Glargine|insulin glargine|mesh-list
110623110|NCT00762359|Lansoprazole|lansoprazole|mesh-list
110623111|NCT00762359|Dexlansoprazole|dexlansoprazole|mesh-list
110623113|NCT00762359|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110623114|NCT00762359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110623115|NCT00762359|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110623116|NCT00762359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110623117|NCT00762359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110623118|NCT04003090|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
110623119|NCT04003090|Nootropic Agents|nootropic agents|mesh-ancestor
110623120|NCT01061749|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110623121|NCT01061749|Immunologic Factors|immunologic factors|mesh-ancestor
110623122|NCT01061749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110623124|NCT00770042|Ketoconazole|ketoconazole|mesh-list
110623125|NCT00770042|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110623126|NCT00770042|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110623127|NCT00770042|Protease Inhibitors|protease inhibitors|mesh-ancestor
110623128|NCT00770042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110623129|NCT00770042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110623130|NCT00770042|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110623131|NCT00770042|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110623132|NCT00770042|Antiviral Agents|antiviral agents|mesh-ancestor
110623133|NCT00770042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110623134|NCT00770042|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110623135|NCT00770042|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110623136|NCT00770042|Antifungal Agents|antifungal agents|mesh-ancestor
110623137|NCT00770042|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110623138|NCT00770042|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110623139|NCT00770042|Hormone Antagonists|hormone antagonists|mesh-ancestor
110154176|NCT00009802|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
110623140|NCT00770042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110623141|NCT00770042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110623142|NCT00654186|Lenalidomide|lenalidomide|mesh-list
110623143|NCT00654186|Immunologic Factors|immunologic factors|mesh-ancestor
110623144|NCT00654186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110623145|NCT00654186|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110623146|NCT00654186|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110623147|NCT00654186|Growth Substances|growth substances|mesh-ancestor
110635375|NCT04035876|Apatinib|apatinib|mesh-list
110623148|NCT00654186|Growth Inhibitors|growth inhibitors|mesh-ancestor
110623149|NCT00654186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110623151|NCT03275818|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110623152|NCT03275818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110623153|NCT03275818|Tubulin Modulators|tubulin modulators|mesh-ancestor
110623154|NCT03275818|Antimitotic Agents|antimitotic agents|mesh-ancestor
110623156|NCT03275818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110623157|NCT03979105|Ketamine|ketamine|mesh-list
110623158|NCT03979105|Analgesics|analgesics|mesh-ancestor
110623159|NCT03979105|Sensory System Agents|sensory system agents|mesh-ancestor
110623160|NCT03979105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110623161|NCT03979105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110623162|NCT03979105|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110623163|NCT03979105|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110623164|NCT03979105|Anesthetics, General|anesthetics, general|mesh-ancestor
110623165|NCT03979105|Anesthetics|anesthetics|mesh-ancestor
110623166|NCT03979105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110623167|NCT03979105|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110623168|NCT03979105|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110623170|NCT03979105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110623171|NCT00774020|Zoledronic Acid|zoledronic acid|mesh-list
110623172|NCT00774020|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110623173|NCT00774020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110623174|NCT04100447|Tranexamic Acid|tranexamic acid|mesh-list
110623175|NCT04100447|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110623176|NCT04100447|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110623177|NCT04100447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110623178|NCT04100447|Hemostatics|hemostatics|mesh-ancestor
110623179|NCT04100447|Coagulants|coagulants|mesh-ancestor
110623180|NCT03274804|Maraviroc|maraviroc|mesh-list
110623181|NCT03274804|Pembrolizumab|pembrolizumab|mesh-list
110623182|NCT03274804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110623183|NCT03274804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110623185|NCT03274804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110623186|NCT03274804|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110623187|NCT03274804|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110623188|NCT03274804|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110623189|NCT03274804|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110623190|NCT03274804|Antiviral Agents|antiviral agents|mesh-ancestor
110623191|NCT03274804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110623192|NCT03274804|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
110623193|NCT00761891|Aspirin|aspirin|mesh-list
110623194|NCT00761891|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110623195|NCT00761891|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110623196|NCT00761891|Analgesics|analgesics|mesh-ancestor
110623197|NCT00761891|Sensory System Agents|sensory system agents|mesh-ancestor
110623198|NCT00761891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110623199|NCT00761891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110623200|NCT00761891|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110623201|NCT00761891|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110623202|NCT00761891|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110623203|NCT00761891|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110623204|NCT00761891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110623205|NCT00761891|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110154179|NCT00009802|Vitamins|vitamins|mesh-ancestor
110623206|NCT00761891|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110623207|NCT00761891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110623208|NCT00761891|Antipyretics|antipyretics|mesh-ancestor
110623209|NCT00321685|Calcium, Dietary|calcium, dietary|mesh-list
110623211|NCT00321685|Folic Acid|folic acid|mesh-list
110623212|NCT00321685|Bevacizumab|bevacizumab|mesh-list
110623213|NCT00321685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110623214|NCT00321685|Fluorouracil|fluorouracil|mesh-list
110623215|NCT00321685|Capecitabine|capecitabine|mesh-list
110623216|NCT00321685|Oxaliplatin|oxaliplatin|mesh-list
110623217|NCT00321685|Endothelial Growth Factors|endothelial growth factors|mesh-list
110623218|NCT00321685|Antibodies|antibodies|mesh-list
110623219|NCT00321685|Immunoglobulins|immunoglobulins|mesh-list
110635691|NCT00895128|Dasatinib|dasatinib|mesh-list
110623220|NCT00321685|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110623221|NCT00321685|Immunoglobulin G|immunoglobulin g|mesh-list
110623222|NCT00321685|Calcium|calcium|mesh-list
110623223|NCT00321685|Levoleucovorin|levoleucovorin|mesh-list
110623224|NCT00321685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110623225|NCT00321685|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110252454|NCT00139217|Antioxidants|antioxidants|mesh-ancestor
110623226|NCT00321685|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110623227|NCT00321685|Growth Substances|growth substances|mesh-ancestor
110623228|NCT00321685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110623229|NCT00321685|Growth Inhibitors|growth inhibitors|mesh-ancestor
110623230|NCT00321685|Immunologic Factors|immunologic factors|mesh-ancestor
110623231|NCT00321685|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110623232|NCT00321685|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110623233|NCT00321685|Antimetabolites|antimetabolites|mesh-ancestor
110623234|NCT00321685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110623235|NCT00321685|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110635742|NCT02540070|Ketorolac|ketorolac|mesh-list
110623236|NCT00321685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110623238|NCT00321685|Protective Agents|protective agents|mesh-ancestor
110623239|NCT00321685|Vitamin B Complex|vitamin b complex|mesh-ancestor
110623240|NCT00321685|Vitamins|vitamins|mesh-ancestor
110623241|NCT00321685|Micronutrients|micronutrients|mesh-ancestor
110623242|NCT00321685|Hematinics|hematinics|mesh-ancestor
110623243|NCT00777998|Ferrous fumarate|ferrous fumarate|mesh-list
110623244|NCT00777998|Thalidomide|thalidomide|mesh-list
110623245|NCT00777998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110623246|NCT00777998|Immunologic Factors|immunologic factors|mesh-ancestor
110623247|NCT00777998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110635797|NCT00160693|Certolizumab Pegol|certolizumab pegol|mesh-list
110623248|NCT00777998|Leprostatic Agents|leprostatic agents|mesh-ancestor
110623249|NCT00777998|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110623250|NCT00777998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110623251|NCT00777998|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110623252|NCT00777998|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110623253|NCT00777998|Growth Substances|growth substances|mesh-ancestor
110623254|NCT00777998|Growth Inhibitors|growth inhibitors|mesh-ancestor
110623255|NCT00777998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110623256|NCT00777998|Trace Elements|trace elements|mesh-ancestor
110623257|NCT00777998|Micronutrients|micronutrients|mesh-ancestor
110623258|NCT00778076|Hyaluronic Acid|hyaluronic acid|mesh-list
110270540|NCT00193557|Bortezomib|bortezomib|mesh-list
110623259|NCT00778076|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110623260|NCT00778076|Immunologic Factors|immunologic factors|mesh-ancestor
110623261|NCT00778076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110623262|NCT00778076|Viscosupplements|viscosupplements|mesh-ancestor
110623263|NCT00778076|Protective Agents|protective agents|mesh-ancestor
110623264|NCT00306787|Valacyclovir|valacyclovir|mesh-list
110623265|NCT00306787|Famciclovir|famciclovir|mesh-list
110623266|NCT00306787|Antiviral Agents|antiviral agents|mesh-ancestor
110623267|NCT00306787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110623268|NCT00306787|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110623269|NCT00306787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110623270|NCT00306787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110623271|NCT00778232|Gabapentin|gabapentin|mesh-list
110623272|NCT00778232|Analgesics|analgesics|mesh-ancestor
110623273|NCT00778232|Sensory System Agents|sensory system agents|mesh-ancestor
110623274|NCT00778232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110623275|NCT00778232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110623276|NCT00778232|Anticonvulsants|anticonvulsants|mesh-ancestor
110623277|NCT00778232|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110623278|NCT00778232|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110623279|NCT00778232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110154185|NCT00005891|Cyclophosphamide|cyclophosphamide|mesh-list
110623280|NCT00778232|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110623281|NCT00778232|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110623282|NCT00778232|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110623283|NCT00778232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110623284|NCT00778232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110623286|NCT00774488|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
110252492|NCT00139373|Donepezil|donepezil|mesh-list
110623287|NCT00774488|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110623288|NCT00774488|Incretins|incretins|mesh-ancestor
110623289|NCT00774488|Hormones|hormones|mesh-ancestor
110635981|NCT00819728|Irinotecan|irinotecan|mesh-list
110623290|NCT00774488|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110623291|NCT00774488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110623292|NCT01066195|Pemetrexed|pemetrexed|mesh-list
110623293|NCT01066195|Gefitinib|gefitinib|mesh-list
110623294|NCT01066195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110623295|NCT01066195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110636045|NCT00819962|Sensory System Agents|sensory system agents|mesh-ancestor
110623296|NCT01066195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110623297|NCT01066195|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110623298|NCT01066195|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110623299|NCT01066195|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110623300|NCT00774644|Clarithromycin|clarithromycin|mesh-list
110623301|NCT00774644|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110623302|NCT00774644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110392796|NCT02279966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110623303|NCT00774644|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110623304|NCT00774644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110623305|NCT00774644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110623306|NCT00774644|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110623307|NCT00774644|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110623309|NCT05123092|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110623310|NCT05123092|Narcotics|narcotics|mesh-ancestor
110623311|NCT05123092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110623312|NCT05123092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110623313|NCT05123092|Analgesics|analgesics|mesh-ancestor
110623314|NCT05123092|Sensory System Agents|sensory system agents|mesh-ancestor
110623315|NCT05123092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110623316|NCT04001530|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110623317|NCT00769067|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110623318|NCT00769067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110623319|NCT00769067|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110623320|NCT00769067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110636114|NCT00987207|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110252508|NCT00161421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110623321|NCT00769067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110623322|NCT04001608|Sofosbuvir|sofosbuvir|mesh-list
110623323|NCT04001608|Antiviral Agents|antiviral agents|mesh-ancestor
110623324|NCT04001608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110623325|NCT00667394|Bevacizumab|bevacizumab|mesh-list
110623326|NCT00667394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110623327|NCT00667394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110623328|NCT00667394|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110623329|NCT00667394|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110623330|NCT00667394|Growth Substances|growth substances|mesh-ancestor
110623331|NCT00667394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110623332|NCT00667394|Growth Inhibitors|growth inhibitors|mesh-ancestor
110623333|NCT05357326|Atropine|atropine|mesh-list
110623334|NCT05357326|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110623335|NCT05357326|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110623336|NCT05357326|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110623337|NCT05357326|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110623338|NCT05357326|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110636244|NCT04005417|Fluorides|fluorides|mesh-list
110623339|NCT05357326|Autonomic Agents|autonomic agents|mesh-ancestor
110623340|NCT05357326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110623341|NCT05357326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110623342|NCT05357326|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110623343|NCT05357326|Respiratory System Agents|respiratory system agents|mesh-ancestor
110623344|NCT05357326|Mydriatics|mydriatics|mesh-ancestor
110623345|NCT05357326|Parasympatholytics|parasympatholytics|mesh-ancestor
110623346|NCT05357326|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110623347|NCT05357326|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110623348|NCT05357326|Cholinergic Agents|cholinergic agents|mesh-ancestor
110623349|NCT05357326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110623350|NCT05357326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110623352|NCT00778466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110623353|NCT00778466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110623354|NCT00761735|Ribavirin|ribavirin|mesh-list
110636376|NCT04388319|Zonisamide|zonisamide|mesh-list
110623355|NCT00761735|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110623356|NCT00761735|Antimetabolites|antimetabolites|mesh-ancestor
110623357|NCT00761735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110623358|NCT00761735|Antiviral Agents|antiviral agents|mesh-ancestor
110623359|NCT00761735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110623360|NCT00569946|Axitinib|axitinib|mesh-list
110623361|NCT00569946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110623362|NCT00569946|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110623363|NCT00569946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110623364|NCT00569946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110623366|NCT00778544|Clavulanic Acids|clavulanic acids|mesh-list
110623367|NCT00778544|Clavulanic Acid|clavulanic acid|mesh-list
110623368|NCT00778544|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
110623369|NCT00778544|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110623370|NCT00778544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110623371|NCT00778544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110623372|NCT00778544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110623373|NCT00778544|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110623374|NCT04001374|Ticagrelor|ticagrelor|mesh-list
110623375|NCT04001374|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110623376|NCT04001374|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110623377|NCT04001374|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110623378|NCT04001374|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110623379|NCT04001374|Purinergic Agents|purinergic agents|mesh-ancestor
110623380|NCT04001374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110623381|NCT04001374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110623382|NCT04001374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110623383|NCT02556320|Anticonvulsants|anticonvulsants|mesh-list
110623384|NCT05265910|Loratadine|loratadine|mesh-list
110623385|NCT05265910|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
110623386|NCT05265910|Dextrans|dextrans|mesh-list
110623387|NCT05265910|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110623388|NCT05265910|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110623389|NCT05265910|Antipruritics|antipruritics|mesh-ancestor
110623390|NCT05265910|Dermatologic Agents|dermatologic agents|mesh-ancestor
110623391|NCT05265910|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110623392|NCT05265910|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110623393|NCT05265910|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110623394|NCT05265910|Histamine Antagonists|histamine antagonists|mesh-ancestor
110623395|NCT05265910|Histamine Agents|histamine agents|mesh-ancestor
110623396|NCT05265910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110623397|NCT05265910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110623398|NCT05265910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110623399|NCT05265910|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110623400|NCT05265910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110623401|NCT05265910|Analgesics|analgesics|mesh-ancestor
110623402|NCT05265910|Sensory System Agents|sensory system agents|mesh-ancestor
110623403|NCT05265910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110623404|NCT05265910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110623405|NCT05265910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110154195|NCT00009880|Paclitaxel|paclitaxel|mesh-list
110623406|NCT05265910|Anticoagulants|anticoagulants|mesh-ancestor
110623407|NCT05265910|Plasma Substitutes|plasma substitutes|mesh-ancestor
110623408|NCT05265910|Blood Substitutes|blood substitutes|mesh-ancestor
110623410|NCT00814866|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110623411|NCT00814866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110623412|NCT00814866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110636606|NCT00822380|Iron|iron|mesh-list
110623413|NCT00991978|Bevacizumab|bevacizumab|mesh-list
110623414|NCT00991978|89Zr-bevacizumab|89zr-bevacizumab|mesh-list
110623415|NCT00991978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110623416|NCT00991978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110623417|NCT00991978|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110623418|NCT00991978|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110623419|NCT00991978|Growth Substances|growth substances|mesh-ancestor
110392816|NCT01684787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110623420|NCT00991978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110623421|NCT00991978|Growth Inhibitors|growth inhibitors|mesh-ancestor
110623422|NCT00991978|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110623423|NCT00991978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110623424|NCT00645528|Insulin|insulin|mesh-list
110623425|NCT00645528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110623426|NCT00645528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110623427|NCT00812448|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
110623428|NCT00812448|Antioxidants|antioxidants|mesh-ancestor
110623429|NCT00812448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110623430|NCT00812448|Protective Agents|protective agents|mesh-ancestor
110623431|NCT00812448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110623432|NCT00812448|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
110623433|NCT00812448|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110623434|NCT00812448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110623435|NCT00812448|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110623436|NCT00295633|Metformin|metformin|mesh-list
110623438|NCT00295633|Rosiglitazone|rosiglitazone|mesh-list
110623439|NCT00295633|Saxagliptin|saxagliptin|mesh-list
110623440|NCT00295633|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110623441|NCT00295633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110623442|NCT00295633|Incretins|incretins|mesh-ancestor
110623443|NCT00295633|Hormones|hormones|mesh-ancestor
110623444|NCT00295633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110623445|NCT00295633|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110623446|NCT00295633|Protease Inhibitors|protease inhibitors|mesh-ancestor
110623447|NCT00295633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110636794|NCT00827138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110623448|NCT00295633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110623449|NCT00570674|Paclitaxel|paclitaxel|mesh-list
110623450|NCT00570674|Carboplatin|carboplatin|mesh-list
110623451|NCT00570674|Cetuximab|cetuximab|mesh-list
110623452|NCT00570674|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110623453|NCT00570674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110623454|NCT00570674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110623455|NCT00570674|Tubulin Modulators|tubulin modulators|mesh-ancestor
110623456|NCT00570674|Antimitotic Agents|antimitotic agents|mesh-ancestor
110623457|NCT00570674|Mitosis Modulators|mitosis modulators|mesh-ancestor
110623458|NCT00570674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110623459|NCT00570674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110623460|NCT00808314|Dipyridamole|dipyridamole|mesh-list
110623461|NCT00808314|Regadenoson|regadenoson|mesh-list
110623462|NCT00808314|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110623463|NCT00808314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110623464|NCT00808314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110623465|NCT00808314|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110623466|NCT00808314|Vasodilator Agents|vasodilator agents|mesh-ancestor
110623467|NCT00808314|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
110623468|NCT00808314|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
110623469|NCT00808314|Purinergic Agonists|purinergic agonists|mesh-ancestor
110623470|NCT00808314|Purinergic Agents|purinergic agents|mesh-ancestor
110623471|NCT00808314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110623472|NCT00808314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110623473|NCT04992052|Bone wax|bone wax|mesh-list
110623474|NCT04992052|Hemostatics|hemostatics|mesh-ancestor
110623475|NCT04992052|Coagulants|coagulants|mesh-ancestor
110623476|NCT00812682|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
110154211|NCT00009919|Growth Substances|growth substances|mesh-ancestor
110623477|NCT00812682|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110623478|NCT00812682|Respiratory System Agents|respiratory system agents|mesh-ancestor
110623479|NCT00768989|Ritonavir|ritonavir|mesh-list
110623480|NCT00768989|Atazanavir Sulfate|atazanavir sulfate|mesh-list
110623481|NCT00768989|Tenofovir|tenofovir|mesh-list
110270757|NCT04326673|Testosterone enanthate|testosterone enanthate|mesh-list
110623482|NCT00768989|Emtricitabine|emtricitabine|mesh-list
110623483|NCT00768989|Raltegravir Potassium|raltegravir potassium|mesh-list
110623484|NCT00768989|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110623485|NCT00768989|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110636916|NCT00823004|Fertility Agents|fertility agents|mesh-ancestor
110623486|NCT00768989|Protease Inhibitors|protease inhibitors|mesh-ancestor
110623487|NCT00768989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110623488|NCT00768989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110623489|NCT00768989|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110623490|NCT00768989|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110623491|NCT00768989|Antiviral Agents|antiviral agents|mesh-ancestor
110623492|NCT00768989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110623493|NCT00768989|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110623494|NCT00768989|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110623495|NCT00768989|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110623496|NCT00768989|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110623497|NCT00768989|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110623498|NCT00768989|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110623499|NCT00779714|Cytarabine|cytarabine|mesh-list
110623500|NCT00779714|Paclitaxel|paclitaxel|mesh-list
110623501|NCT00779714|Cisplatin|cisplatin|mesh-list
110623502|NCT00779714|Dacarbazine|dacarbazine|mesh-list
110623503|NCT00779714|Treosulfan|treosulfan|mesh-list
110623504|NCT00779714|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110623505|NCT00779714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110623506|NCT00779714|Tubulin Modulators|tubulin modulators|mesh-ancestor
110623507|NCT00779714|Antimitotic Agents|antimitotic agents|mesh-ancestor
110623508|NCT00779714|Mitosis Modulators|mitosis modulators|mesh-ancestor
110623509|NCT00779714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110623510|NCT00779714|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110623511|NCT00779714|Antimetabolites|antimetabolites|mesh-ancestor
110623512|NCT00779714|Antiviral Agents|antiviral agents|mesh-ancestor
110623513|NCT00779714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110623514|NCT00779714|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110623515|NCT00779714|Immunologic Factors|immunologic factors|mesh-ancestor
110623516|NCT00779714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110623517|NCT00779714|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110623518|NCT00779714|Alkylating Agents|alkylating agents|mesh-ancestor
110623519|NCT00812760|Levodopa|levodopa|mesh-list
110623520|NCT00812760|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110623521|NCT00812760|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110623522|NCT00812760|Dopamine Agents|dopamine agents|mesh-ancestor
110623523|NCT00812760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110623524|NCT00812760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110623525|NCT00812760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110623526|NCT00814944|Sirolimus|sirolimus|mesh-list
110623527|NCT00814944|Temsirolimus|temsirolimus|mesh-list
110623528|NCT00814944|MTOR Inhibitors|mtor inhibitors|mesh-list
110623529|NCT00814944|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110623530|NCT00814944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110623531|NCT00814944|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110623532|NCT00814944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110623533|NCT00814944|Antifungal Agents|antifungal agents|mesh-ancestor
110623534|NCT00814944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110623535|NCT00814944|Immunologic Factors|immunologic factors|mesh-ancestor
110623536|NCT00814944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110623537|NCT00814944|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110623538|NCT00814944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110623539|NCT00814944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110623540|NCT00779792|Triamcinolone|triamcinolone|mesh-list
110623541|NCT00779792|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110623542|NCT00779792|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110623543|NCT00779792|Clobetasol|clobetasol|mesh-list
110623544|NCT00779792|Mineral Oil|mineral oil|mesh-list
110623545|NCT00779792|Tacrolimus|tacrolimus|mesh-list
110623546|NCT00779792|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110623547|NCT00779792|Glycerol|glycerol|mesh-list
110623548|NCT00779792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110623549|NCT00779792|Immunologic Factors|immunologic factors|mesh-ancestor
110623550|NCT00779792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110623551|NCT00779792|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110623552|NCT00779792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110623553|NCT00779792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110623554|NCT00779792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110623555|NCT00779792|Glucocorticoids|glucocorticoids|mesh-ancestor
110623556|NCT00779792|Hormones|hormones|mesh-ancestor
110623557|NCT00779792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110623558|NCT00779792|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
110623561|NCT00779792|Dermatologic Agents|dermatologic agents|mesh-ancestor
110623562|NCT00992134|Cytarabine|cytarabine|mesh-list
110623563|NCT00992134|Rituximab|rituximab|mesh-list
110623564|NCT00992134|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110623565|NCT00992134|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110623566|NCT00992134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110623567|NCT00992134|Immunologic Factors|immunologic factors|mesh-ancestor
110623568|NCT00992134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110623569|NCT00992134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110623570|NCT00992134|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110623571|NCT00992134|Antimetabolites|antimetabolites|mesh-ancestor
110623572|NCT00992134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110623573|NCT00992134|Antiviral Agents|antiviral agents|mesh-ancestor
110623574|NCT00992134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110637191|NCT00938184|Paroxetine|paroxetine|mesh-list
110623575|NCT00992134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110623576|NCT00992134|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110623577|NCT00992134|Alkylating Agents|alkylating agents|mesh-ancestor
110623578|NCT02551536|Fexofenadine|fexofenadine|mesh-list
110623579|NCT02551536|Montelukast|montelukast|mesh-list
110623580|NCT02551536|Levocetirizine|levocetirizine|mesh-list
110623581|NCT02551536|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110623582|NCT02551536|Respiratory System Agents|respiratory system agents|mesh-ancestor
110623583|NCT02551536|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110623584|NCT02551536|Hormone Antagonists|hormone antagonists|mesh-ancestor
110637246|NCT04013958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110623585|NCT02551536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110623586|NCT02551536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110623587|NCT02551536|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110623588|NCT02551536|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110623589|NCT02551536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110623590|NCT02551536|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110623591|NCT02551536|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110623592|NCT02551536|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110623593|NCT02551536|Histamine Antagonists|histamine antagonists|mesh-ancestor
110623595|NCT02551536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110623596|NCT00815022|Fentanyl|fentanyl|mesh-list
110623597|NCT00815022|Morphine|morphine|mesh-list
110623598|NCT00815022|Bupivacaine|bupivacaine|mesh-list
110623599|NCT00815022|Anesthetics, Local|anesthetics, local|mesh-ancestor
110623600|NCT00815022|Anesthetics|anesthetics|mesh-ancestor
110623601|NCT00815022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110623602|NCT00815022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110623603|NCT00815022|Sensory System Agents|sensory system agents|mesh-ancestor
110623604|NCT00815022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110623605|NCT00815022|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110623606|NCT00815022|Narcotics|narcotics|mesh-ancestor
110623607|NCT00815022|Analgesics|analgesics|mesh-ancestor
110623608|NCT00815022|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110623609|NCT00815022|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110623610|NCT00815022|Anesthetics, General|anesthetics, general|mesh-ancestor
110623611|NCT00774722|Metronidazole|metronidazole|mesh-list
110623612|NCT00774722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110623613|NCT00774722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110623614|NCT00774722|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110623615|NCT00774722|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110623616|NCT00808392|Vaccines|vaccines|mesh-list
110623617|NCT00808392|Immunologic Factors|immunologic factors|mesh-ancestor
110623619|NCT04045548|Dinoprostone|dinoprostone|mesh-list
110623620|NCT04045548|Oxytocics|oxytocics|mesh-ancestor
110623621|NCT04045548|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110637441|NCT03823911|Antiviral Agents|antiviral agents|mesh-ancestor
110623622|NCT04045548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110623623|NCT00780104|Cytarabine|cytarabine|mesh-list
110623624|NCT00780104|Sirolimus|sirolimus|mesh-list
110623625|NCT00780104|Etoposide|etoposide|mesh-list
110623626|NCT00780104|Mitoxantrone|mitoxantrone|mesh-list
110623627|NCT00780104|Temsirolimus|temsirolimus|mesh-list
110623628|NCT00780104|MTOR Inhibitors|mtor inhibitors|mesh-list
110623629|NCT00780104|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110623630|NCT00780104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110623631|NCT00780104|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110623632|NCT00780104|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110623633|NCT00780104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110623634|NCT00780104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110623635|NCT00780104|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110623636|NCT00780104|Antimetabolites|antimetabolites|mesh-ancestor
110623637|NCT00780104|Antiviral Agents|antiviral agents|mesh-ancestor
110623638|NCT00780104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110623639|NCT00780104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110623640|NCT00780104|Immunologic Factors|immunologic factors|mesh-ancestor
110623641|NCT00780104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110623642|NCT00780104|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110623643|NCT00780104|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110623644|NCT00780104|Antifungal Agents|antifungal agents|mesh-ancestor
110623645|NCT00780104|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110623646|NCT00780104|Analgesics|analgesics|mesh-ancestor
110623647|NCT00780104|Sensory System Agents|sensory system agents|mesh-ancestor
110623648|NCT00780104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110623649|NCT04047680|Ritonavir|ritonavir|mesh-list
110623650|NCT04047680|Sofosbuvir|sofosbuvir|mesh-list
110623651|NCT04047680|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
110623652|NCT04047680|Grazoprevir|grazoprevir|mesh-list
110623653|NCT04047680|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
110623654|NCT04047680|Ledipasvir|ledipasvir|mesh-list
110623655|NCT04047680|Velpatasvir|velpatasvir|mesh-list
110623656|NCT04047680|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
110623657|NCT04047680|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110623658|NCT04047680|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110623659|NCT04047680|Protease Inhibitors|protease inhibitors|mesh-ancestor
110623660|NCT04047680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110623661|NCT04047680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110623662|NCT04047680|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110623663|NCT04047680|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110637553|NCT00830492|Clomiphene|clomiphene|mesh-list
110623664|NCT04047680|Antiviral Agents|antiviral agents|mesh-ancestor
110623665|NCT04047680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110623666|NCT04047680|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110623667|NCT04047680|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110623668|NCT00774878|Fulvestrant|fulvestrant|mesh-list
110623669|NCT00774878|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110623670|NCT00774878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110623671|NCT00774878|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110623672|NCT00774878|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110623673|NCT00774878|Hormone Antagonists|hormone antagonists|mesh-ancestor
110623674|NCT00774878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110623675|NCT00774878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110623677|NCT00815256|Vitamin B Complex|vitamin b complex|mesh-ancestor
110623678|NCT00815256|Vitamins|vitamins|mesh-ancestor
110623679|NCT00815256|Micronutrients|micronutrients|mesh-ancestor
110623680|NCT00815256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110623681|NCT00815256|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110623682|NCT00815256|Dermatologic Agents|dermatologic agents|mesh-ancestor
110623683|NCT00778778|Cefprozil|cefprozil|mesh-list
110623684|NCT00778778|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110623685|NCT00778778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110623686|NCT00305773|Vorinostat|vorinostat|mesh-list
110623687|NCT00305773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110623688|NCT00305773|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110623689|NCT00305773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110623690|NCT00305773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110623691|NCT00780182|Brincidofovir|brincidofovir|mesh-list
110623692|NCT00780182|Antiviral Agents|antiviral agents|mesh-ancestor
110623693|NCT00780182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110623694|NCT00812994|Escitalopram|escitalopram|mesh-list
110623695|NCT00812994|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110623696|NCT00812994|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110623697|NCT00812994|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110623698|NCT00812994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110623699|NCT00812994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110623700|NCT00812994|Serotonin Agents|serotonin agents|mesh-ancestor
110623701|NCT00812994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110623702|NCT00784394|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
110623703|NCT00784394|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110623704|NCT00784394|Protective Agents|protective agents|mesh-ancestor
110623705|NCT00784394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110623706|NCT00784394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110623707|NCT00305695|Zoledronic Acid|zoledronic acid|mesh-list
110623709|NCT00305695|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110623710|NCT00305695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110623711|NCT00305695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110623712|NCT00305695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110623714|NCT00784472|Oxycodone|oxycodone|mesh-list
110623715|NCT00784472|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110623716|NCT00784472|Narcotics|narcotics|mesh-ancestor
110623717|NCT00784472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110623718|NCT00784472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110623719|NCT00784472|Analgesics|analgesics|mesh-ancestor
110623720|NCT00784472|Sensory System Agents|sensory system agents|mesh-ancestor
110623721|NCT00784472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110623722|NCT00779012|Infliximab|infliximab|mesh-list
110252638|NCT00161655|Analgesics|analgesics|mesh-ancestor
110637794|NCT05590221|Immunologic Factors|immunologic factors|mesh-ancestor
110623723|NCT00779012|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110623724|NCT00779012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110623725|NCT00779012|Dermatologic Agents|dermatologic agents|mesh-ancestor
110637843|NCT01105767|Chlorhexidine|chlorhexidine|mesh-list
110623726|NCT00779012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110623727|NCT00779012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110623728|NCT00647556|Adapalene|adapalene|mesh-list
110623729|NCT00647556|Tretinoin|tretinoin|mesh-list
110623730|NCT00647556|Emollients|emollients|mesh-list
110623731|NCT00647556|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110623732|NCT00647556|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110623733|NCT00647556|Analgesics|analgesics|mesh-ancestor
110623734|NCT00647556|Sensory System Agents|sensory system agents|mesh-ancestor
110623735|NCT00647556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110623736|NCT00647556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110623737|NCT00647556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110623738|NCT00647556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110623739|NCT00647556|Dermatologic Agents|dermatologic agents|mesh-ancestor
110623740|NCT00647556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110623741|NCT00647556|Keratolytic Agents|keratolytic agents|mesh-ancestor
110623742|NCT03978559|Trimethoprim|trimethoprim|mesh-list
110623743|NCT03978559|Caspofungin|caspofungin|mesh-list
110623744|NCT03978559|Sulfisoxazole|sulfisoxazole|mesh-list
110623745|NCT03978559|Methylprednisolone|methylprednisolone|mesh-list
110623746|NCT03978559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110623747|NCT03978559|Antiemetics|antiemetics|mesh-ancestor
110623748|NCT03978559|Autonomic Agents|autonomic agents|mesh-ancestor
110623749|NCT03978559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110623750|NCT03978559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110623751|NCT03978559|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110623752|NCT03978559|Glucocorticoids|glucocorticoids|mesh-ancestor
110623753|NCT03978559|Hormones|hormones|mesh-ancestor
110623754|NCT03978559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110623755|NCT03978559|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110623756|NCT03978559|Protective Agents|protective agents|mesh-ancestor
110623757|NCT03978559|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110623758|NCT03978559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110623759|NCT03978559|Antimalarials|antimalarials|mesh-ancestor
110623760|NCT03978559|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110623761|NCT03978559|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110623762|NCT03978559|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110623763|NCT03978559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110623764|NCT03978559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110623765|NCT03978559|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110623766|NCT03978559|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
110623767|NCT03978559|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110623768|NCT03978559|Antifungal Agents|antifungal agents|mesh-ancestor
110623769|NCT00813072|Docetaxel|docetaxel|mesh-list
110623770|NCT00813072|Irinotecan|irinotecan|mesh-list
110623771|NCT00813072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110623772|NCT00813072|Tubulin Modulators|tubulin modulators|mesh-ancestor
110623773|NCT00813072|Antimitotic Agents|antimitotic agents|mesh-ancestor
110623774|NCT00813072|Mitosis Modulators|mitosis modulators|mesh-ancestor
110623775|NCT00813072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110623776|NCT00813072|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110623777|NCT00813072|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110623778|NCT00813072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110623779|NCT00813228|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110623780|NCT00813228|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110623781|NCT00813228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110623782|NCT00813228|Incretins|incretins|mesh-ancestor
110623783|NCT00813228|Hormones|hormones|mesh-ancestor
110623784|NCT00813228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110623785|NCT00813228|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110623786|NCT00813228|Protease Inhibitors|protease inhibitors|mesh-ancestor
110623787|NCT00813228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110623788|NCT00813228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110623789|NCT00808704|Epoetin Alfa|epoetin alfa|mesh-list
110623790|NCT00808704|Hematinics|hematinics|mesh-ancestor
110623791|NCT00320515|Pemetrexed|pemetrexed|mesh-list
110623792|NCT00320515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110623793|NCT00320515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110623794|NCT00320515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110623795|NCT00320515|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110623796|NCT00320515|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110623797|NCT00662012|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
110623798|NCT00662012|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110623799|NCT00662012|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110623800|NCT00662012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110623801|NCT00662012|Schistosomicides|schistosomicides|mesh-ancestor
110623802|NCT00662012|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110623803|NCT00662012|Anthelmintics|anthelmintics|mesh-ancestor
110623804|NCT00815568|Fludarabine|fludarabine|mesh-list
110623805|NCT00815568|Fludarabine phosphate|fludarabine phosphate|mesh-list
110623806|NCT00815568|Busulfan|busulfan|mesh-list
110392886|NCT01606878|Mitosis Modulators|mitosis modulators|mesh-ancestor
110623807|NCT00815568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110623808|NCT00815568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110623809|NCT00815568|Antimetabolites|antimetabolites|mesh-ancestor
110623810|NCT00815568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110623811|NCT00815568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110623812|NCT00815568|Immunologic Factors|immunologic factors|mesh-ancestor
110623813|NCT00815568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110638214|NCT00625586|Antimetabolites|antimetabolites|mesh-ancestor
110623815|NCT00815568|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110623816|NCT00815568|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110623817|NCT00815646|Sildenafil Citrate|sildenafil citrate|mesh-list
110623818|NCT00815646|Vasodilator Agents|vasodilator agents|mesh-ancestor
110623819|NCT00815646|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110623820|NCT00815646|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110623821|NCT00815646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110623822|NCT00815646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110623823|NCT00815646|Urological Agents|urological agents|mesh-ancestor
110623825|NCT01066351|Hematinics|hematinics|mesh-ancestor
110623826|NCT00809016|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110623827|NCT00809016|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110623828|NCT00809016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110623829|NCT00661778|Bevacizumab|bevacizumab|mesh-list
110623830|NCT00661778|Docetaxel|docetaxel|mesh-list
110623831|NCT00661778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110623832|NCT00661778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110623833|NCT00661778|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110623834|NCT00661778|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110623835|NCT00661778|Growth Substances|growth substances|mesh-ancestor
110623836|NCT00661778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110623837|NCT00661778|Growth Inhibitors|growth inhibitors|mesh-ancestor
110623838|NCT00661778|Tubulin Modulators|tubulin modulators|mesh-ancestor
110623839|NCT00661778|Antimitotic Agents|antimitotic agents|mesh-ancestor
110623840|NCT00661778|Mitosis Modulators|mitosis modulators|mesh-ancestor
110623841|NCT00661778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110623842|NCT01062139|Cetirizine|cetirizine|mesh-list
110623843|NCT01062139|Levocetirizine|levocetirizine|mesh-list
110252685|NCT04724343|Cetrorelix|cetrorelix|mesh-list
110623844|NCT01062139|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110623845|NCT01062139|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110638339|NCT00842114|Hormones|hormones|mesh-ancestor
110623846|NCT01062139|Histamine Antagonists|histamine antagonists|mesh-ancestor
110623847|NCT01062139|Histamine Agents|histamine agents|mesh-ancestor
110623848|NCT01062139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110623849|NCT01062139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110623850|NCT01062139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110623851|NCT01062139|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110623852|NCT00780650|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
110623853|NCT00780650|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110623854|NCT00780650|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110623855|NCT00780650|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110623856|NCT00780650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110623857|NCT00780650|Adrenergic Agents|adrenergic agents|mesh-ancestor
110623858|NCT00780650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110623859|NCT00780650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110623860|NCT00653328|Doxorubicin|doxorubicin|mesh-list
110623861|NCT00653328|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110623862|NCT00653328|Atrasentan|atrasentan|mesh-list
110623863|NCT00653328|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110623864|NCT00653328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110623865|NCT00653328|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110623866|NCT00653328|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110623867|NCT00653328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110623868|NCT00653328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110623869|NCT00653328|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
110623870|NCT00653328|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
110623871|NCT01664182|Bevacizumab|bevacizumab|mesh-list
110623872|NCT01664182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110623873|NCT01664182|Sunitinib|sunitinib|mesh-list
110623874|NCT01664182|Trebananib|trebananib|mesh-list
110623875|NCT01664182|Sorafenib|sorafenib|mesh-list
110623876|NCT01664182|Endothelial Growth Factors|endothelial growth factors|mesh-list
110623877|NCT01664182|Antibodies|antibodies|mesh-list
110623878|NCT01664182|Immunoglobulins|immunoglobulins|mesh-list
110623879|NCT01664182|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110623880|NCT01664182|Immunoglobulin G|immunoglobulin g|mesh-list
110623881|NCT01664182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110623882|NCT01664182|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110623883|NCT01664182|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110623884|NCT01664182|Growth Substances|growth substances|mesh-ancestor
110623885|NCT01664182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110623886|NCT01664182|Growth Inhibitors|growth inhibitors|mesh-ancestor
110623887|NCT01664182|Immunologic Factors|immunologic factors|mesh-ancestor
110623888|NCT01664182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110623889|NCT01664182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110623890|NCT01664182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110623891|NCT00780728|Sildenafil Citrate|sildenafil citrate|mesh-list
110623892|NCT00780728|Vasodilator Agents|vasodilator agents|mesh-ancestor
110623893|NCT00780728|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110623894|NCT00780728|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110623895|NCT00780728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110623896|NCT00780728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110623897|NCT00780728|Urological Agents|urological agents|mesh-ancestor
110623898|NCT00809172|Cyclosporine|cyclosporine|mesh-list
110623899|NCT00809172|Methotrexate|methotrexate|mesh-list
110623900|NCT00809172|Cyclosporins|cyclosporins|mesh-list
110623901|NCT00809172|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110623902|NCT00809172|Abortifacient Agents|abortifacient agents|mesh-ancestor
110623903|NCT00809172|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110623904|NCT00809172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110623905|NCT00809172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110623906|NCT00809172|Antimetabolites|antimetabolites|mesh-ancestor
110623907|NCT00809172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110623908|NCT00809172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110623909|NCT00809172|Dermatologic Agents|dermatologic agents|mesh-ancestor
110623910|NCT00809172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110623911|NCT00809172|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110623912|NCT00809172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110623913|NCT00809172|Immunologic Factors|immunologic factors|mesh-ancestor
110623914|NCT00809172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110623915|NCT00809172|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110638631|NCT00844454|Ethanol|ethanol|mesh-list
110623917|NCT00809172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110623918|NCT00809172|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110623919|NCT00784862|Tamoxifen|tamoxifen|mesh-list
110623920|NCT00784862|Anastrozole|anastrozole|mesh-list
110623921|NCT00784862|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110623922|NCT00784862|Hormone Antagonists|hormone antagonists|mesh-ancestor
110623923|NCT00784862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110623924|NCT00784862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110623925|NCT00784862|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110623926|NCT00784862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110623927|NCT00784862|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110623928|NCT00784862|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110623929|NCT00784862|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110623930|NCT00784862|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110623931|NCT00784862|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110623932|NCT00784862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110623933|NCT00784862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110623935|NCT00784940|Anastrozole|anastrozole|mesh-list
110623936|NCT00784940|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110623937|NCT00784940|Hormone Antagonists|hormone antagonists|mesh-ancestor
110623938|NCT00784940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110623939|NCT00784940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110623940|NCT00784940|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110623941|NCT00784940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110623942|NCT00784940|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110392907|NCT01609647|Clopidogrel|clopidogrel|mesh-list
110623943|NCT00784940|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110623944|NCT00784940|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110623945|NCT00784940|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110623946|NCT00784940|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110623947|NCT00784940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110638744|NCT00855530|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110623948|NCT00784940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110623949|NCT00790244|Doxorubicin|doxorubicin|mesh-list
110623950|NCT00790244|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110623951|NCT00790244|Ifosfamide|ifosfamide|mesh-list
110623952|NCT00790244|Isophosphamide mustard|isophosphamide mustard|mesh-list
110623953|NCT00790244|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110623954|NCT00790244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110623955|NCT00790244|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110623956|NCT00790244|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110623957|NCT00790244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110623958|NCT00790244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110623959|NCT00790244|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110623960|NCT00790244|Alkylating Agents|alkylating agents|mesh-ancestor
110623961|NCT00785018|Complement C1s|complement c1s|mesh-list
110623962|NCT00785018|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
110623963|NCT00785018|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
110623965|NCT00785018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110623966|NCT00785018|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
110623967|NCT00785018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110623968|NCT00534352|Ritonavir|ritonavir|mesh-list
110623969|NCT00534352|Darunavir|darunavir|mesh-list
110623970|NCT00534352|Etravirine|etravirine|mesh-list
110623971|NCT00534352|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110623972|NCT00534352|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110623973|NCT00534352|Protease Inhibitors|protease inhibitors|mesh-ancestor
110623974|NCT00534352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110623975|NCT00534352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110623977|NCT00534352|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110623978|NCT00534352|Antiviral Agents|antiviral agents|mesh-ancestor
110623979|NCT00534352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110623980|NCT00534352|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110623981|NCT00534352|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110623982|NCT00534352|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110623983|NCT00534352|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110623984|NCT00642174|Clopidogrel|clopidogrel|mesh-list
110623985|NCT00642174|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
110623986|NCT00642174|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110623987|NCT00642174|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110623988|NCT00642174|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110623989|NCT00642174|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110623990|NCT00642174|Purinergic Agents|purinergic agents|mesh-ancestor
110623991|NCT00642174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110623992|NCT00642174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110623993|NCT00642174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110623994|NCT02550444|Clonidine|clonidine|mesh-list
110623995|NCT02550444|Analgesics|analgesics|mesh-ancestor
110623996|NCT02550444|Sensory System Agents|sensory system agents|mesh-ancestor
110623997|NCT02550444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110623998|NCT02550444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110623999|NCT02550444|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110624000|NCT02550444|Sympatholytics|sympatholytics|mesh-ancestor
110624001|NCT02550444|Autonomic Agents|autonomic agents|mesh-ancestor
110638987|NCT02592863|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110624002|NCT02550444|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110624003|NCT02550444|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110624004|NCT02550444|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110624005|NCT02550444|Adrenergic Agents|adrenergic agents|mesh-ancestor
110624006|NCT02550444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110624007|NCT02550444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110624008|NCT00665366|Valproic Acid|valproic acid|mesh-list
110271278|NCT00177372|Oxytocics|oxytocics|mesh-ancestor
110624009|NCT00665366|Aripiprazole|aripiprazole|mesh-list
110624010|NCT00665366|Antidepressive Agents|antidepressive agents|mesh-ancestor
110624011|NCT00665366|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110624012|NCT00665366|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110624013|NCT00665366|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110624014|NCT00665366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110639117|NCT00857558|Protease Inhibitors|protease inhibitors|mesh-ancestor
110624015|NCT00665366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110624016|NCT00665366|Dopamine Agonists|dopamine agonists|mesh-ancestor
110624017|NCT00665366|Dopamine Agents|dopamine agents|mesh-ancestor
110624018|NCT00665366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110624019|NCT00665366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110624020|NCT00665366|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110624021|NCT00665366|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110624022|NCT00665366|Serotonin Agents|serotonin agents|mesh-ancestor
110624023|NCT00665366|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110624024|NCT00665366|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110624025|NCT00665366|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110624026|NCT00665366|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110624027|NCT00665366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110624028|NCT00665366|Antimanic Agents|antimanic agents|mesh-ancestor
110624029|NCT00665366|Anticonvulsants|anticonvulsants|mesh-ancestor
110624030|NCT00665366|GABA Agents|gaba agents|mesh-ancestor
110624031|NCT00775684|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110624032|NCT00775684|Exenatide|exenatide|mesh-list
110624033|NCT00775684|Glimepiride|glimepiride|mesh-list
110624034|NCT00775684|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110624035|NCT00775684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110624036|NCT00775684|Incretins|incretins|mesh-ancestor
110624037|NCT00775684|Hormones|hormones|mesh-ancestor
110624038|NCT00775684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110624039|NCT00775684|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110624040|NCT00775684|Protease Inhibitors|protease inhibitors|mesh-ancestor
110624041|NCT00775684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110624042|NCT00775684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110624043|NCT00775684|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110624044|NCT00775684|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110624045|NCT00775684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110624046|NCT00775684|Immunologic Factors|immunologic factors|mesh-ancestor
110624047|NCT02556008|Cannabidiol|cannabidiol|mesh-list
110624048|NCT02556008|Anticonvulsants|anticonvulsants|mesh-ancestor
110624049|NCT00992524|Misoprostol|misoprostol|mesh-list
110624050|NCT00992524|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110624051|NCT00992524|Abortifacient Agents|abortifacient agents|mesh-ancestor
110624052|NCT00992524|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110624053|NCT00992524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110624054|NCT00992524|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110624055|NCT00992524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110624056|NCT00992524|Oxytocics|oxytocics|mesh-ancestor
110624057|NCT00642018|Prednisone|prednisone|mesh-list
110624058|NCT00642018|Docetaxel|docetaxel|mesh-list
110624059|NCT00642018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110624060|NCT00642018|Tubulin Modulators|tubulin modulators|mesh-ancestor
110624061|NCT00642018|Antimitotic Agents|antimitotic agents|mesh-ancestor
110624062|NCT00642018|Mitosis Modulators|mitosis modulators|mesh-ancestor
110624063|NCT00642018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110624064|NCT00642018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110624065|NCT00642018|Glucocorticoids|glucocorticoids|mesh-ancestor
110624066|NCT00642018|Hormones|hormones|mesh-ancestor
110624067|NCT00642018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110624068|NCT00642018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110624069|NCT00642018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110624070|NCT00532948|Capecitabine|capecitabine|mesh-list
110624071|NCT00532948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110624072|NCT00532948|Antimetabolites|antimetabolites|mesh-ancestor
110392919|NCT01580202|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110624073|NCT00532948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110624074|NCT00532948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110624076|NCT00998920|Phytoestrogens|phytoestrogens|mesh-ancestor
110624077|NCT00998920|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
110624078|NCT00998920|Estrogens|estrogens|mesh-ancestor
110624079|NCT00998920|Hormones|hormones|mesh-ancestor
110271349|NCT00177567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110624080|NCT00998920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110624081|NCT00998920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110624082|NCT00992758|Tositumomab I-131|tositumomab i-131|mesh-list
110624083|NCT00992758|Antibodies|antibodies|mesh-list
110624084|NCT00992758|Immunologic Factors|immunologic factors|mesh-ancestor
110624085|NCT00992758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110154267|NCT00010075|Mitoxantrone|mitoxantrone|mesh-list
110624086|NCT00992758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110624088|NCT00641706|Vorinostat|vorinostat|mesh-list
110624089|NCT00641706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110624090|NCT00641706|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110624091|NCT00641706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110624092|NCT00641706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110624093|NCT00995332|Cytarabine|cytarabine|mesh-list
110624094|NCT00995332|Tretinoin|tretinoin|mesh-list
110624095|NCT00995332|Valproic Acid|valproic acid|mesh-list
110624096|NCT00995332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110624097|NCT00995332|Antimetabolites|antimetabolites|mesh-ancestor
110624098|NCT00995332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110624099|NCT00995332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110624100|NCT00995332|Antiviral Agents|antiviral agents|mesh-ancestor
110624101|NCT00995332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110624102|NCT00995332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110624103|NCT00995332|Immunologic Factors|immunologic factors|mesh-ancestor
110624104|NCT00995332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110624105|NCT00995332|Keratolytic Agents|keratolytic agents|mesh-ancestor
110624106|NCT00995332|Dermatologic Agents|dermatologic agents|mesh-ancestor
110624107|NCT00995332|Anticonvulsants|anticonvulsants|mesh-ancestor
110624108|NCT00995332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110624109|NCT00995332|GABA Agents|gaba agents|mesh-ancestor
110624110|NCT00995332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110624111|NCT00995332|Antimanic Agents|antimanic agents|mesh-ancestor
110624112|NCT00995332|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110624113|NCT00995332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110624114|NCT00995332|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110624115|NCT00992914|Lidocaine|lidocaine|mesh-list
110624116|NCT00992914|Anesthetics, Local|anesthetics, local|mesh-ancestor
110624117|NCT00992914|Anesthetics|anesthetics|mesh-ancestor
110624118|NCT00992914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110624119|NCT00992914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110624120|NCT00992914|Sensory System Agents|sensory system agents|mesh-ancestor
110624121|NCT00992914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110624122|NCT00992914|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110624123|NCT00992914|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110624124|NCT00992914|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110624125|NCT00992914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110624126|NCT00992914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110624128|NCT00999232|Erythromycin Estolate|erythromycin estolate|mesh-list
110624129|NCT00999232|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
110624130|NCT00999232|Erythromycin stearate|erythromycin stearate|mesh-list
110624131|NCT00999232|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110624132|NCT00999232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110624133|NCT00999232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110624134|NCT00999232|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110624135|NCT00999232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110624136|NCT00999232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110624138|NCT00993070|Antipruritics|antipruritics|mesh-ancestor
110624139|NCT00993070|Dermatologic Agents|dermatologic agents|mesh-ancestor
110624140|NCT00993070|Sensory System Agents|sensory system agents|mesh-ancestor
110392933|NCT01609881|Analgesics|analgesics|mesh-ancestor
110624141|NCT00993070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110624142|NCT00993070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110624143|NCT00993304|Liraglutide|liraglutide|mesh-list
110624144|NCT00993304|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110624145|NCT00993304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110624146|NCT00993304|Incretins|incretins|mesh-ancestor
110624147|NCT00993304|Hormones|hormones|mesh-ancestor
110624148|NCT00993304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110624149|NCT05189002|Dalteparin|dalteparin|mesh-list
110624150|NCT05189002|Anticoagulants|anticoagulants|mesh-ancestor
110624151|NCT05189002|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110624152|NCT05189002|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110624153|NCT05189002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110624154|NCT00644358|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
110624155|NCT00644358|Antidepressive Agents|antidepressive agents|mesh-ancestor
110624156|NCT00644358|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110624157|NCT00644358|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110624158|NCT00644358|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110624159|NCT00644358|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110624160|NCT00644358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110624161|NCT00644358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110624162|NCT00644358|Serotonin Agents|serotonin agents|mesh-ancestor
110624163|NCT00644358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110624164|NCT00644358|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110624165|NCT00644358|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110624166|NCT00993694|Dapsone|dapsone|mesh-list
110624167|NCT00993694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110624168|NCT00993694|Antimalarials|antimalarials|mesh-ancestor
110624169|NCT00993694|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110624170|NCT00993694|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110624171|NCT00993694|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110624172|NCT00993694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110624173|NCT00993694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110639901|NCT00992823|Iron|iron|mesh-list
110624174|NCT00993694|Leprostatic Agents|leprostatic agents|mesh-ancestor
110624175|NCT00993694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110624176|NCT00640926|Radezolid|radezolid|mesh-list
110624177|NCT00640926|Oxazolidinones|oxazolidinones|mesh-list
110624178|NCT00640926|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110624179|NCT00640926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110624180|NCT00640926|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110624181|NCT00640926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110624182|NCT00640926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110624183|NCT00821496|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110624184|NCT00821496|Norethindrone|norethindrone|mesh-list
110624185|NCT00821496|Norethindrone Acetate|norethindrone acetate|mesh-list
110624186|NCT00821496|Norinyl|norinyl|mesh-list
110624187|NCT00821496|Estradiol|estradiol|mesh-list
110624188|NCT00821496|Estrogens|estrogens|mesh-ancestor
110624189|NCT00821496|Hormones|hormones|mesh-ancestor
110624190|NCT00821496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110624191|NCT00821496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110624192|NCT00821496|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110624194|NCT00821496|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110624195|NCT00821496|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110624196|NCT00821496|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110624197|NCT00821496|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110624198|NCT00821496|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110624199|NCT00821496|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110624200|NCT02550912|Vitamin D|vitamin d|mesh-list
110624201|NCT02550912|Ergocalciferols|ergocalciferols|mesh-list
110624202|NCT02550912|Cholecalciferol|cholecalciferol|mesh-list
110624203|NCT02550912|Vitamins|vitamins|mesh-list
110624204|NCT02550912|Micronutrients|micronutrients|mesh-ancestor
110624205|NCT02550912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110639997|NCT00871910|Dexamethasone|dexamethasone|mesh-list
110624206|NCT02550912|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110624207|NCT02550912|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110624209|NCT00999700|Docetaxel|docetaxel|mesh-list
110624210|NCT00999700|Fluorouracil|fluorouracil|mesh-list
110624211|NCT00999700|Cetuximab|cetuximab|mesh-list
110624212|NCT00999700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110624213|NCT00999700|Tubulin Modulators|tubulin modulators|mesh-ancestor
110624214|NCT00999700|Antimitotic Agents|antimitotic agents|mesh-ancestor
110624215|NCT00999700|Mitosis Modulators|mitosis modulators|mesh-ancestor
110624216|NCT00999700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110624217|NCT00999700|Antimetabolites|antimetabolites|mesh-ancestor
110624218|NCT00999700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110624219|NCT00999700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110624220|NCT00999700|Immunologic Factors|immunologic factors|mesh-ancestor
110624221|NCT00999700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110624222|NCT00999700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110624224|NCT00818298|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110624225|NCT00818298|Serotonin Agents|serotonin agents|mesh-ancestor
110624226|NCT00818298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110624227|NCT00818298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110624228|NCT00818298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110624229|NCT00818298|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110624230|NCT00818298|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110252743|NCT00140309|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110624231|NCT00818298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110624232|NCT00818298|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110624233|NCT00818298|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110271496|NCT03888079|Anesthetics|anesthetics|mesh-list
110624234|NCT00818298|Dopamine Agents|dopamine agents|mesh-ancestor
110624235|NCT00821574|Valsartan|valsartan|mesh-list
110624236|NCT00821574|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110624237|NCT00821574|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110624238|NCT00821574|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110624239|NCT00821574|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110640111|NCT00867152|Dolutegravir|dolutegravir|mesh-list
110624240|NCT00821574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110624241|NCT00821574|Diuretics|diuretics|mesh-ancestor
110624242|NCT00821574|Natriuretic Agents|natriuretic agents|mesh-ancestor
110624243|NCT00821574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110624244|NCT00821574|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110624245|NCT00821574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110624246|NCT00995800|Fluticasone|fluticasone|mesh-list
110624248|NCT00995800|Formoterol Fumarate|formoterol fumarate|mesh-list
110624249|NCT00995800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110624250|NCT00995800|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110624251|NCT00995800|Autonomic Agents|autonomic agents|mesh-ancestor
110624252|NCT00995800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110624253|NCT00995800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110624254|NCT00995800|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110624255|NCT00995800|Respiratory System Agents|respiratory system agents|mesh-ancestor
110624256|NCT00995800|Dermatologic Agents|dermatologic agents|mesh-ancestor
110624257|NCT00995800|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110624258|NCT00995800|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110624259|NCT00995800|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110624260|NCT00995800|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110624261|NCT00995800|Adrenergic Agents|adrenergic agents|mesh-ancestor
110624262|NCT00995800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110624263|NCT00995800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110624264|NCT00821652|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
110624265|NCT00821652|Freund's Adjuvant|freund's adjuvant|mesh-list
110624266|NCT00821652|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110624267|NCT00821652|Immunologic Factors|immunologic factors|mesh-ancestor
110624268|NCT00821652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110624269|NCT00319501|Diazepam|diazepam|mesh-list
110624270|NCT00319501|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110624271|NCT00319501|Anticonvulsants|anticonvulsants|mesh-ancestor
110624272|NCT00319501|Antiemetics|antiemetics|mesh-ancestor
110624273|NCT00319501|Autonomic Agents|autonomic agents|mesh-ancestor
110624274|NCT00319501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110624275|NCT00319501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110624276|NCT00319501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110624277|NCT00319501|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110624278|NCT00319501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110624279|NCT00319501|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110624280|NCT00319501|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110624281|NCT00319501|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110624282|NCT00319501|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110624283|NCT00319501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110252751|NCT00140309|Antimetabolites|antimetabolites|mesh-ancestor
110624284|NCT00319501|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110624285|NCT00319501|Anesthetics, General|anesthetics, general|mesh-ancestor
110624286|NCT00319501|Anesthetics|anesthetics|mesh-ancestor
110624287|NCT00319501|GABA Modulators|gaba modulators|mesh-ancestor
110624288|NCT00319501|GABA Agents|gaba agents|mesh-ancestor
110624289|NCT00319501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110624290|NCT00319501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110624291|NCT00994006|Magnesium citrate|magnesium citrate|mesh-list
110624292|NCT00994006|Magnesium Oxide|magnesium oxide|mesh-list
110624293|NCT00994006|Levulinic acid|levulinic acid|mesh-list
110624294|NCT00994006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110624295|NCT00994006|Cathartics|cathartics|mesh-ancestor
110624296|NCT00994006|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110624297|NCT00994006|Antacids|antacids|mesh-ancestor
110624298|NCT00994006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110624299|NCT00818610|Amoxicillin|amoxicillin|mesh-list
110624300|NCT00818610|Clarithromycin|clarithromycin|mesh-list
110624301|NCT00818610|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
110624302|NCT00818610|Cefuroxime|cefuroxime|mesh-list
110624303|NCT00818610|Cefuroxime axetil|cefuroxime axetil|mesh-list
110624304|NCT00818610|Lactams|lactams|mesh-list
110624305|NCT00818610|beta-Lactams|beta-lactams|mesh-list
110271570|NCT00167843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110624306|NCT00818610|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110624307|NCT00818610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110624308|NCT00818610|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110624309|NCT00818610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110624310|NCT00818610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110624311|NCT00818610|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110624312|NCT00818610|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110624313|NCT00818610|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110624314|NCT00761579|Paliperidone Palmitate|paliperidone palmitate|mesh-list
110624315|NCT00761579|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110624316|NCT00761579|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110624317|NCT00761579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110624318|NCT00761579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110624319|NCT00761579|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110158605|NCT00086359|Lopinavir|lopinavir|mesh-list
110624320|NCT00761579|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110624321|NCT00761579|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110624322|NCT00761579|Serotonin Agents|serotonin agents|mesh-ancestor
110624323|NCT00761579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110624324|NCT00761579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110624325|NCT00761579|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110624326|NCT00761579|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110624327|NCT00761579|Dopamine Agents|dopamine agents|mesh-ancestor
110624328|NCT00627042|Ramucirumab|ramucirumab|mesh-list
110624329|NCT00627042|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110624330|NCT00627042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110624331|NCT00627042|Immunologic Factors|immunologic factors|mesh-ancestor
110624332|NCT00627042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110624333|NCT00319111|Bosentan|bosentan|mesh-list
110624334|NCT00319111|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110624335|NCT00319111|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
110624336|NCT00319111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110624337|NCT00994396|Vitamin D|vitamin d|mesh-list
110624338|NCT00994396|Cholecalciferol|cholecalciferol|mesh-list
110624339|NCT00994396|Vitamins|vitamins|mesh-ancestor
110624340|NCT00994396|Micronutrients|micronutrients|mesh-ancestor
110624341|NCT00994396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110624342|NCT00994396|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110624343|NCT00994396|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110624344|NCT00816426|Moxifloxacin|moxifloxacin|mesh-list
110624345|NCT00816426|Rifampin|rifampin|mesh-list
110624346|NCT00816426|Isoniazid|isoniazid|mesh-list
110624347|NCT00816426|Pyrazinamide|pyrazinamide|mesh-list
110624348|NCT00816426|Kanamycin|kanamycin|mesh-list
110624349|NCT00816426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110624350|NCT00816426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110624351|NCT00816426|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110624352|NCT00816426|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110624353|NCT00816426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110624354|NCT00816426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110640584|NCT05653661|Tubulin Modulators|tubulin modulators|mesh-ancestor
110624355|NCT00816426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110624356|NCT00816426|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110624357|NCT00816426|Antitubercular Agents|antitubercular agents|mesh-ancestor
110624359|NCT00816426|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110624360|NCT00816426|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110624361|NCT00816426|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110624362|NCT00816426|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110624363|NCT00816426|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110624364|NCT00816426|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110624365|NCT00816426|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110624366|NCT00816426|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
110624367|NCT00816426|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110624368|NCT00816426|Antimetabolites|antimetabolites|mesh-ancestor
110624369|NCT00816426|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110624370|NCT00816426|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110624371|NCT00996190|Phenylephrine|phenylephrine|mesh-list
110624372|NCT00996190|Oxymetazoline|oxymetazoline|mesh-list
110624373|NCT00996190|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110624374|NCT00996190|Mydriatics|mydriatics|mesh-ancestor
110624375|NCT00996190|Autonomic Agents|autonomic agents|mesh-ancestor
110624376|NCT00996190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110624377|NCT00996190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110624378|NCT00996190|Sympathomimetics|sympathomimetics|mesh-ancestor
110624379|NCT00996190|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110624380|NCT00996190|Nasal Decongestants|nasal decongestants|mesh-ancestor
110624381|NCT00996190|Respiratory System Agents|respiratory system agents|mesh-ancestor
110624382|NCT00996190|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110624383|NCT00996190|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110624385|NCT00996190|Adrenergic Agents|adrenergic agents|mesh-ancestor
110624386|NCT00996190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110624387|NCT00996190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110624388|NCT00996190|Protective Agents|protective agents|mesh-ancestor
110624389|NCT00640224|Rosiglitazone|rosiglitazone|mesh-list
110624390|NCT00640224|Drospirenone|drospirenone|mesh-list
110624391|NCT00640224|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110624392|NCT00640224|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
110624393|NCT00640224|Estradiol|estradiol|mesh-list
110624394|NCT00640224|Estrogens|estrogens|mesh-ancestor
110624395|NCT00640224|Hormones|hormones|mesh-ancestor
110624396|NCT00640224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110624397|NCT00640224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110624398|NCT00640224|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110624399|NCT00640224|Contraceptive Agents|contraceptive agents|mesh-ancestor
110624400|NCT00640224|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110624401|NCT00640224|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110624402|NCT00640224|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110640768|NCT00485134|Vaccines|vaccines|mesh-list
110624403|NCT00640224|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110624404|NCT00640224|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110624405|NCT00640224|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110624406|NCT00640224|Hormone Antagonists|hormone antagonists|mesh-ancestor
110624407|NCT00640224|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110624408|NCT00640224|Diuretics|diuretics|mesh-ancestor
110624409|NCT00640224|Natriuretic Agents|natriuretic agents|mesh-ancestor
110624410|NCT01000792|Cetirizine|cetirizine|mesh-list
110624411|NCT01000792|Levocetirizine|levocetirizine|mesh-list
110624412|NCT01000792|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110624413|NCT01000792|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110624414|NCT01000792|Histamine Antagonists|histamine antagonists|mesh-ancestor
110624415|NCT01000792|Histamine Agents|histamine agents|mesh-ancestor
110624416|NCT01000792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110624417|NCT01000792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110624418|NCT01000792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110624419|NCT01000792|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110624420|NCT02550756|Capsaicin|capsaicin|mesh-list
110624421|NCT02550756|Antipruritics|antipruritics|mesh-ancestor
110624422|NCT02550756|Dermatologic Agents|dermatologic agents|mesh-ancestor
110624423|NCT02550756|Sensory System Agents|sensory system agents|mesh-ancestor
110624424|NCT02550756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110624425|NCT02550756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110624426|NCT01001260|Aspirin|aspirin|mesh-list
110624427|NCT01001260|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110624428|NCT01001260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110624429|NCT01001260|Analgesics|analgesics|mesh-ancestor
110624430|NCT01001260|Sensory System Agents|sensory system agents|mesh-ancestor
110624431|NCT01001260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110624432|NCT01001260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110624433|NCT01001260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110624434|NCT01001260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110624435|NCT01001260|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110624436|NCT01001260|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110624437|NCT01001260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110624438|NCT01001260|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110624439|NCT01001260|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110624440|NCT01001260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110624441|NCT01001260|Antipyretics|antipyretics|mesh-ancestor
110624442|NCT00996424|Acetylcysteine|acetylcysteine|mesh-list
110624443|NCT00996424|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110624444|NCT00996424|Antiviral Agents|antiviral agents|mesh-ancestor
110624445|NCT00996424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110624446|NCT00996424|Expectorants|expectorants|mesh-ancestor
110624447|NCT00996424|Respiratory System Agents|respiratory system agents|mesh-ancestor
110624448|NCT00996424|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110624449|NCT00996424|Antioxidants|antioxidants|mesh-ancestor
110624450|NCT00996424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110624451|NCT00996424|Protective Agents|protective agents|mesh-ancestor
110624452|NCT00996424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110624453|NCT00996424|Antidotes|antidotes|mesh-ancestor
110624454|NCT05220280|Infliximab|infliximab|mesh-list
110624455|NCT05220280|Imatinib Mesylate|imatinib mesylate|mesh-list
110624456|NCT05220280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110641082|NCT02582177|Miconazole|miconazole|mesh-list
110624457|NCT05220280|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110624458|NCT05220280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110624459|NCT05220280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110624460|NCT05220280|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110624461|NCT05220280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110624462|NCT05220280|Dermatologic Agents|dermatologic agents|mesh-ancestor
110624463|NCT05220280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110624464|NCT05220280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110624466|NCT00318643|Mitomycin|mitomycin|mesh-list
110624467|NCT00318643|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110624468|NCT00318643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110624469|NCT00318643|Alkylating Agents|alkylating agents|mesh-ancestor
110624470|NCT00318643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110624471|NCT00318643|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110624472|NCT00318643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110624473|NCT00994708|Esomeprazole|esomeprazole|mesh-list
110624474|NCT00994708|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110624475|NCT00994708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110624476|NCT00994708|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110624477|NCT00994708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110624478|NCT00994708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110624479|NCT01064557|Tretinoin|tretinoin|mesh-list
110624480|NCT01064557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110624481|NCT01064557|Keratolytic Agents|keratolytic agents|mesh-ancestor
110624482|NCT01064557|Dermatologic Agents|dermatologic agents|mesh-ancestor
110624483|NCT01001962|Metformin|metformin|mesh-list
110624484|NCT01001962|Empagliflozin|empagliflozin|mesh-list
110624485|NCT01001962|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110641203|NCT00997347|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
110392962|NCT01605162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110624486|NCT01001962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110624487|NCT01001962|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110624488|NCT01001962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110624490|NCT01066429|Dexamethasone acetate|dexamethasone acetate|mesh-list
110624491|NCT01066429|BB 1101|bb 1101|mesh-list
110624492|NCT01066429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110624493|NCT01066429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110624494|NCT01066429|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110624495|NCT01066429|Antiemetics|antiemetics|mesh-ancestor
110624496|NCT01066429|Autonomic Agents|autonomic agents|mesh-ancestor
110624497|NCT01066429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110624498|NCT01066429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110624499|NCT01066429|Glucocorticoids|glucocorticoids|mesh-ancestor
110624500|NCT01066429|Hormones|hormones|mesh-ancestor
110641277|NCT04077983|Paclitaxel|paclitaxel|mesh-list
110624501|NCT01066429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110624502|NCT01066429|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110624503|NCT01066429|Protease Inhibitors|protease inhibitors|mesh-ancestor
110624504|NCT01066429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110624505|NCT01066429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110624506|NCT00994786|Pregabalin|pregabalin|mesh-list
110624507|NCT00994786|Analgesics|analgesics|mesh-ancestor
110624508|NCT00994786|Sensory System Agents|sensory system agents|mesh-ancestor
110624509|NCT00994786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110624510|NCT00994786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110624511|NCT00994786|Anticonvulsants|anticonvulsants|mesh-ancestor
110624512|NCT00994786|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110624513|NCT00994786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110624514|NCT00994786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110624515|NCT00994786|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110624516|NCT00994786|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110624517|NCT00994786|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110624518|NCT00994786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110624519|NCT00994786|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110624520|NCT00994942|Morphine|morphine|mesh-list
110624521|NCT00994942|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110624522|NCT00994942|Narcotics|narcotics|mesh-ancestor
110624523|NCT00994942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110624524|NCT00994942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110624525|NCT00994942|Analgesics|analgesics|mesh-ancestor
110624526|NCT00994942|Sensory System Agents|sensory system agents|mesh-ancestor
110624527|NCT00994942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110624528|NCT01002898|Ritonavir|ritonavir|mesh-list
110624529|NCT01002898|Lopinavir|lopinavir|mesh-list
110624530|NCT01002898|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110624531|NCT01002898|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110624532|NCT01002898|Protease Inhibitors|protease inhibitors|mesh-ancestor
110624533|NCT01002898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110624534|NCT01002898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110624535|NCT01002898|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110624536|NCT01002898|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110624537|NCT01002898|Antiviral Agents|antiviral agents|mesh-ancestor
110624538|NCT01002898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110624539|NCT01002898|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110624540|NCT01002898|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110624541|NCT01003054|Cyclophosphamide|cyclophosphamide|mesh-list
110624542|NCT01003054|Busulfan|busulfan|mesh-list
110624543|NCT01003054|Imatinib Mesylate|imatinib mesylate|mesh-list
110624544|NCT01003054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110624545|NCT01003054|Immunologic Factors|immunologic factors|mesh-ancestor
110624546|NCT01003054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110624547|NCT01003054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110624548|NCT01003054|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110624549|NCT01003054|Alkylating Agents|alkylating agents|mesh-ancestor
110624550|NCT01003054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110624551|NCT01003054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110624552|NCT01003054|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110624553|NCT01003054|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110624554|NCT01003054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110624555|NCT01004068|Clomiphene|clomiphene|mesh-list
110624556|NCT01004068|Enclomiphene|enclomiphene|mesh-list
110624557|NCT01004068|Zuclomiphene|zuclomiphene|mesh-list
110624558|NCT01004068|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110624559|NCT01004068|Hormone Antagonists|hormone antagonists|mesh-ancestor
110624560|NCT01004068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110624561|NCT01004068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110624562|NCT01004068|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110624563|NCT01004068|Fertility Agents|fertility agents|mesh-ancestor
110624564|NCT01004068|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110624565|NCT01004068|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110624566|NCT01004068|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110624567|NCT01004224|Infigratinib|infigratinib|mesh-list
110624568|NCT01004224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110624569|NCT00530920|Ritonavir|ritonavir|mesh-list
110624570|NCT00530920|Tipranavir|tipranavir|mesh-list
110624571|NCT00530920|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110624572|NCT00530920|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110624573|NCT00530920|Protease Inhibitors|protease inhibitors|mesh-ancestor
110624574|NCT00530920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110624575|NCT00530920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110624576|NCT00530920|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110624577|NCT00530920|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110624578|NCT00530920|Antiviral Agents|antiviral agents|mesh-ancestor
110624579|NCT00530920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110641555|NCT01000857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110624580|NCT00530920|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110624581|NCT00530920|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110624583|NCT01004380|Farletuzumab|farletuzumab|mesh-list
110624584|NCT01004380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110624585|NCT01003522|Anesthetics|anesthetics|mesh-list
110624586|NCT01003522|Anesthetics, General|anesthetics, general|mesh-list
110624587|NCT01003522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110624588|NCT01003522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110624589|NCT01003678|Clofarabine|clofarabine|mesh-list
110624590|NCT01003678|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110624591|NCT01003678|Antimetabolites|antimetabolites|mesh-ancestor
110624592|NCT01003678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110624593|NCT01003678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110624594|NCT01004692|Salicylic Acid|salicylic acid|mesh-list
110624595|NCT01004692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110624596|NCT01004692|Antifungal Agents|antifungal agents|mesh-ancestor
110624597|NCT01004692|Keratolytic Agents|keratolytic agents|mesh-ancestor
110624598|NCT01004692|Dermatologic Agents|dermatologic agents|mesh-ancestor
110624599|NCT04000126|Lidocaine|lidocaine|mesh-list
110624600|NCT04000126|Anesthetics, Local|anesthetics, local|mesh-ancestor
110624602|NCT04000126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110624603|NCT04000126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110624604|NCT04000126|Sensory System Agents|sensory system agents|mesh-ancestor
110624605|NCT04000126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110624606|NCT04000126|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110624607|NCT04000126|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110624608|NCT04000126|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110624609|NCT04000126|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110624610|NCT04000126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110624611|NCT01008982|Belimumab|belimumab|mesh-list
110624612|NCT01008982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110624613|NCT01008982|Immunologic Factors|immunologic factors|mesh-ancestor
110624614|NCT01008982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110624615|NCT01005160|Metformin|metformin|mesh-list
110624616|NCT01005160|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110624617|NCT01005160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110624618|NCT01005238|Lamivudine|lamivudine|mesh-list
110641689|NCT02580773|Tinzaparin|tinzaparin|mesh-list
110624620|NCT01005238|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110624621|NCT01005238|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110624622|NCT01005238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110624623|NCT01005238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110624624|NCT01005238|Antiviral Agents|antiviral agents|mesh-ancestor
110624625|NCT01005238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110624626|NCT01005238|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110624627|NCT01005238|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110624628|NCT01005472|Temozolomide|temozolomide|mesh-list
110624629|NCT01005472|Sunitinib|sunitinib|mesh-list
110624630|NCT01005472|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110624631|NCT01005472|Alkylating Agents|alkylating agents|mesh-ancestor
110624632|NCT01005472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110624633|NCT01005472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110624634|NCT01005472|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110624635|NCT01005472|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110624636|NCT01005472|Growth Substances|growth substances|mesh-ancestor
110624637|NCT01005472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110624638|NCT01005472|Growth Inhibitors|growth inhibitors|mesh-ancestor
110624639|NCT01005472|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110624640|NCT01005472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110624641|NCT01005550|Ropivacaine|ropivacaine|mesh-list
110624642|NCT01005550|Anesthetics, Local|anesthetics, local|mesh-ancestor
110624643|NCT01005550|Anesthetics|anesthetics|mesh-ancestor
110624644|NCT01005550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110624645|NCT01005550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110624646|NCT01005550|Sensory System Agents|sensory system agents|mesh-ancestor
110624647|NCT01005550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110624648|NCT03999580|Vitamin D|vitamin d|mesh-list
110624649|NCT03999580|Cholecalciferol|cholecalciferol|mesh-list
110624650|NCT03999580|Vitamins|vitamins|mesh-ancestor
110624651|NCT03999580|Micronutrients|micronutrients|mesh-ancestor
110624652|NCT03999580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110624653|NCT03999580|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110624654|NCT03999580|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110624655|NCT00768755|Pemetrexed|pemetrexed|mesh-list
110624656|NCT00768755|Axitinib|axitinib|mesh-list
110624657|NCT00768755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110624658|NCT00768755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110624659|NCT00768755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110624660|NCT00768755|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110624661|NCT00768755|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110624662|NCT00768755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110624663|NCT01005628|Bortezomib|bortezomib|mesh-list
110624664|NCT01005628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110624665|NCT00530842|Fluticasone|fluticasone|mesh-list
110624666|NCT00530842|Tiotropium Bromide|tiotropium bromide|mesh-list
110641874|NCT05232357|Antidotes|antidotes|mesh-ancestor
110624667|NCT00530842|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110624668|NCT00530842|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
110624669|NCT00530842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110624670|NCT00530842|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110624671|NCT00530842|Autonomic Agents|autonomic agents|mesh-ancestor
110624672|NCT00530842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110624673|NCT00530842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110624674|NCT00530842|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110624675|NCT00530842|Respiratory System Agents|respiratory system agents|mesh-ancestor
110624676|NCT00530842|Dermatologic Agents|dermatologic agents|mesh-ancestor
110624677|NCT00530842|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110624678|NCT00530842|Parasympatholytics|parasympatholytics|mesh-ancestor
110624679|NCT00530842|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110624680|NCT00530842|Cholinergic Agents|cholinergic agents|mesh-ancestor
110624681|NCT00530842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110624682|NCT00530842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110624683|NCT00530842|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110624684|NCT00530842|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110624685|NCT00530842|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110624686|NCT00530842|Adrenergic Agents|adrenergic agents|mesh-ancestor
110624687|NCT00530842|Glucocorticoids|glucocorticoids|mesh-ancestor
110624688|NCT00530842|Hormones|hormones|mesh-ancestor
110624689|NCT00530842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110624690|NCT00530842|Sympathomimetics|sympathomimetics|mesh-ancestor
110624691|NCT01005784|Cetrorelix|cetrorelix|mesh-list
110624692|NCT01005784|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110624693|NCT01005784|Fertility Agents|fertility agents|mesh-ancestor
110624694|NCT01005784|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110624695|NCT01005784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110624696|NCT01005784|Hormone Antagonists|hormone antagonists|mesh-ancestor
110624697|NCT01005784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110624698|NCT01006096|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110624699|NCT01006096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110624700|NCT01006096|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110624701|NCT01006096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110624702|NCT01006096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110624703|NCT05733364|Vitamin B Complex|vitamin b complex|mesh-list
110624704|NCT05733364|Vitamins|vitamins|mesh-ancestor
110624705|NCT05733364|Micronutrients|micronutrients|mesh-ancestor
110252870|NCT00140894|Rofecoxib|rofecoxib|mesh-list
110624706|NCT05733364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110624707|NCT01006720|Neostigmine|neostigmine|mesh-list
110624708|NCT01006720|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110624709|NCT01006720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110624710|NCT01006720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110624711|NCT01006720|Cholinergic Agents|cholinergic agents|mesh-ancestor
110624712|NCT01006720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110624713|NCT01006720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110624714|NCT01006720|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110624715|NCT01006720|Autonomic Agents|autonomic agents|mesh-ancestor
110624716|NCT01006720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110624718|NCT01006798|Immunologic Factors|immunologic factors|mesh-ancestor
110624719|NCT01006798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110624720|NCT01006876|Warfarin|warfarin|mesh-list
110624721|NCT01006876|Anticoagulants|anticoagulants|mesh-ancestor
110624722|NCT03882424|Bevacizumab|bevacizumab|mesh-list
110624723|NCT03882424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110624724|NCT03882424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110624725|NCT03882424|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110624726|NCT03882424|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110624727|NCT03882424|Growth Substances|growth substances|mesh-ancestor
110624728|NCT03882424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110624729|NCT03882424|Growth Inhibitors|growth inhibitors|mesh-ancestor
110624730|NCT03879772|Mometasone Furoate|mometasone furoate|mesh-list
110624731|NCT03879772|Chlorpheniramine|chlorpheniramine|mesh-list
110624732|NCT03879772|Beclomethasone|beclomethasone|mesh-list
110624733|NCT03879772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110624734|NCT03879772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110624735|NCT03879772|Dermatologic Agents|dermatologic agents|mesh-ancestor
110624736|NCT03879772|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110624737|NCT03879772|Glucocorticoids|glucocorticoids|mesh-ancestor
110624738|NCT03879772|Hormones|hormones|mesh-ancestor
110624739|NCT03879772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110624740|NCT03879772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110624741|NCT03879772|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110624742|NCT03879772|Respiratory System Agents|respiratory system agents|mesh-ancestor
110624743|NCT03879772|Antipruritics|antipruritics|mesh-ancestor
110624744|NCT03879772|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110624745|NCT03879772|Histamine Antagonists|histamine antagonists|mesh-ancestor
110624746|NCT03879772|Histamine Agents|histamine agents|mesh-ancestor
110624747|NCT03879772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110624748|NCT01007500|Dexamethasone|dexamethasone|mesh-list
110624749|NCT01007500|Ondansetron|ondansetron|mesh-list
110624750|NCT01007500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110624751|NCT01007500|Antiemetics|antiemetics|mesh-ancestor
110624752|NCT01007500|Autonomic Agents|autonomic agents|mesh-ancestor
110624753|NCT01007500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110624754|NCT01007500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110624755|NCT01007500|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110624756|NCT01007500|Glucocorticoids|glucocorticoids|mesh-ancestor
110624757|NCT01007500|Hormones|hormones|mesh-ancestor
110624758|NCT01007500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110624759|NCT01007500|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110624760|NCT01007500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110624762|NCT01007500|Dermatologic Agents|dermatologic agents|mesh-ancestor
110624763|NCT01007500|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110624765|NCT01007500|Serotonin Agents|serotonin agents|mesh-ancestor
110624766|NCT01007500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110624767|NCT01007500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110624768|NCT00642954|Dexamethasone|dexamethasone|mesh-list
110624769|NCT00642954|Lenalidomide|lenalidomide|mesh-list
110624770|NCT00642954|Vorinostat|vorinostat|mesh-list
110624771|NCT00642954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110624772|NCT00642954|Antiemetics|antiemetics|mesh-ancestor
110624773|NCT00642954|Autonomic Agents|autonomic agents|mesh-ancestor
110624774|NCT00642954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110624775|NCT00642954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110624776|NCT00642954|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110624777|NCT00642954|Glucocorticoids|glucocorticoids|mesh-ancestor
110624778|NCT00642954|Hormones|hormones|mesh-ancestor
110624779|NCT00642954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110624780|NCT00642954|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110624781|NCT00642954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110624782|NCT00642954|Immunologic Factors|immunologic factors|mesh-ancestor
110624783|NCT00642954|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110624784|NCT00642954|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110624786|NCT00642954|Growth Inhibitors|growth inhibitors|mesh-ancestor
110624787|NCT00642954|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110624788|NCT00642954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110624789|NCT00642954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110624790|NCT00816660|Factor VIII|factor viii|mesh-list
110624791|NCT00816660|Coagulants|coagulants|mesh-ancestor
110624792|NCT00819000|Interferon-beta|interferon-beta|mesh-list
110624793|NCT00819000|Glatiramer Acetate|glatiramer acetate|mesh-list
110624794|NCT00819000|Interferon beta-1b|interferon beta-1b|mesh-list
110624795|NCT00819000|(T,G)-A-L|(t,g)-a-l|mesh-list
110624796|NCT00819000|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110624797|NCT00819000|Immunologic Factors|immunologic factors|mesh-ancestor
110624798|NCT00819000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110624799|NCT00819000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110624800|NCT00819000|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110624801|NCT00819000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110624802|NCT00819000|Antiviral Agents|antiviral agents|mesh-ancestor
110624803|NCT00819000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110624804|NCT00640146|Bromides|bromides|mesh-list
110624805|NCT00640146|Methylnaltrexone|methylnaltrexone|mesh-list
110624806|NCT00640146|Anticonvulsants|anticonvulsants|mesh-ancestor
110624807|NCT00640146|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110624808|NCT00640146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110624809|NCT00640146|Sensory System Agents|sensory system agents|mesh-ancestor
110624810|NCT00640146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110624811|NCT00819078|Bupropion|bupropion|mesh-list
110624812|NCT00819078|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110624813|NCT00819078|Antidepressive Agents|antidepressive agents|mesh-ancestor
110624814|NCT00819078|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110624815|NCT00819078|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110624816|NCT00819078|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110624817|NCT00819078|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110624818|NCT00819078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110624819|NCT00819078|Dopamine Agents|dopamine agents|mesh-ancestor
110624820|NCT00819078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110624821|NCT00819078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110624822|NCT00819078|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110624823|NCT00819078|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110624824|NCT00819078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110624826|NCT01008046|Acetylcysteine|acetylcysteine|mesh-list
110624827|NCT01008046|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110624828|NCT01008046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110624829|NCT01008046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110624830|NCT01008046|Antiviral Agents|antiviral agents|mesh-ancestor
110624831|NCT01008046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110624832|NCT01008046|Expectorants|expectorants|mesh-ancestor
110624833|NCT01008046|Respiratory System Agents|respiratory system agents|mesh-ancestor
110624834|NCT01008046|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110624835|NCT01008046|Antioxidants|antioxidants|mesh-ancestor
110624836|NCT01008046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110624837|NCT01008046|Protective Agents|protective agents|mesh-ancestor
110624838|NCT01008046|Antidotes|antidotes|mesh-ancestor
110624839|NCT00317473|Vaccines|vaccines|mesh-list
110624840|NCT00317473|Immunologic Factors|immunologic factors|mesh-ancestor
110624841|NCT00317473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110624842|NCT00530218|Ganciclovir|ganciclovir|mesh-list
110624843|NCT00530218|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
110624844|NCT00530218|Antiviral Agents|antiviral agents|mesh-ancestor
110624845|NCT00530218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110642228|NCT00617084|Everolimus|everolimus|mesh-list
110624846|NCT00530218|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110624847|NCT00530218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110624848|NCT00530218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110624849|NCT00761267|Fluconazole|fluconazole|mesh-list
110624850|NCT00761267|Anidulafungin|anidulafungin|mesh-list
110624851|NCT00761267|Antifungal Agents|antifungal agents|mesh-ancestor
110624852|NCT00761267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110624853|NCT00761267|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110624854|NCT00761267|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110624855|NCT00761267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110624856|NCT00761267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110624857|NCT00761267|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110624858|NCT00761267|Hormone Antagonists|hormone antagonists|mesh-ancestor
110624859|NCT00761267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110642272|NCT00869570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110624860|NCT00761267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110624861|NCT00761267|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110624862|NCT00761267|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110624863|NCT00303667|Vidarabine|vidarabine|mesh-list
110624864|NCT00303667|Aldesleukin|aldesleukin|mesh-list
110624865|NCT00303667|Cyclosporine|cyclosporine|mesh-list
110624866|NCT00303667|Cyclophosphamide|cyclophosphamide|mesh-list
110624867|NCT00303667|Fludarabine|fludarabine|mesh-list
110624868|NCT00303667|Fludarabine phosphate|fludarabine phosphate|mesh-list
110624869|NCT00303667|Interleukin-2|interleukin-2|mesh-list
110624870|NCT00303667|Cyclosporins|cyclosporins|mesh-list
110624871|NCT00303667|Thymoglobulin|thymoglobulin|mesh-list
110624872|NCT00303667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110624873|NCT00303667|Immunologic Factors|immunologic factors|mesh-ancestor
110624874|NCT00303667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110624875|NCT00303667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110624876|NCT00303667|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110624877|NCT00303667|Alkylating Agents|alkylating agents|mesh-ancestor
110624878|NCT00303667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110624879|NCT00303667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110624880|NCT00303667|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110624881|NCT00303667|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110624882|NCT00303667|Antimetabolites|antimetabolites|mesh-ancestor
110624883|NCT00303667|Antiviral Agents|antiviral agents|mesh-ancestor
110624884|NCT00303667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110624885|NCT00303667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110624886|NCT00303667|Antifungal Agents|antifungal agents|mesh-ancestor
110624887|NCT00303667|Dermatologic Agents|dermatologic agents|mesh-ancestor
110624888|NCT00303667|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110624889|NCT00303667|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110624890|NCT00303667|Analgesics|analgesics|mesh-ancestor
110624891|NCT00303667|Sensory System Agents|sensory system agents|mesh-ancestor
110624892|NCT00303667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110624893|NCT00303667|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110624894|NCT00303667|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110642392|NCT04013880|Decitabine|decitabine|mesh-list
110624895|NCT00761189|Paliperidone Palmitate|paliperidone palmitate|mesh-list
110624896|NCT00761189|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110624897|NCT00761189|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110624898|NCT00761189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110624899|NCT00761189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110624900|NCT00761189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110624901|NCT00761189|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110624902|NCT00761189|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110624903|NCT00761189|Serotonin Agents|serotonin agents|mesh-ancestor
110624904|NCT00761189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110642444|NCT00935298|Immunologic Factors|immunologic factors|mesh-ancestor
110624905|NCT00761189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110624906|NCT00761189|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110624907|NCT00761189|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110624908|NCT00761189|Dopamine Agents|dopamine agents|mesh-ancestor
110624909|NCT01008358|Tremelimumab|tremelimumab|mesh-list
110624910|NCT01008358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110624912|NCT01008592|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110642508|NCT00870038|Antimitotic Agents|antimitotic agents|mesh-ancestor
110624913|NCT01008592|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110624914|NCT01008592|Histamine Antagonists|histamine antagonists|mesh-ancestor
110624915|NCT01008592|Histamine Agents|histamine agents|mesh-ancestor
110624916|NCT01008592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110624917|NCT01008592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110624918|NCT01008592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110624919|NCT01062529|Somatostatin|somatostatin|mesh-list
110624921|NCT01062529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110642574|NCT00141817|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110624922|NCT01062529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110624923|NCT00760877|Imatinib Mesylate|imatinib mesylate|mesh-list
110624924|NCT00760877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110624925|NCT00760877|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110624926|NCT00760877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110624927|NCT00760877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110624928|NCT00302731|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110624929|NCT00302731|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110624930|NCT00302731|Hormones|hormones|mesh-list
110624932|NCT00302731|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110624933|NCT00302731|Progesterone|progesterone|mesh-list
110624934|NCT00302731|Estrogens|estrogens|mesh-list
110624935|NCT00302731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110624936|NCT00302731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110624937|NCT00302731|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110624938|NCT00302731|Contraceptive Agents|contraceptive agents|mesh-ancestor
110624939|NCT00302731|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110624940|NCT00302731|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110624941|NCT00302731|Progestins|progestins|mesh-ancestor
110624942|NCT00780143|Cytarabine|cytarabine|mesh-list
110624943|NCT00780143|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110624944|NCT00780143|Antimetabolites|antimetabolites|mesh-ancestor
110624945|NCT00780143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110624946|NCT00780143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110624947|NCT00780143|Antiviral Agents|antiviral agents|mesh-ancestor
110624948|NCT00780143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110624949|NCT00780143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110624950|NCT00780143|Immunologic Factors|immunologic factors|mesh-ancestor
110624951|NCT00780143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110624952|NCT01007968|Panobinostat|panobinostat|mesh-list
110252924|NCT00141011|Ancrod|ancrod|mesh-list
110624953|NCT01007968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110624954|NCT01007968|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110624955|NCT01007968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110624956|NCT01007968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110624957|NCT00779909|Vitamin D|vitamin d|mesh-list
110624958|NCT00779909|Cholecalciferol|cholecalciferol|mesh-list
110624959|NCT00779909|Vitamins|vitamins|mesh-ancestor
110624960|NCT00779909|Micronutrients|micronutrients|mesh-ancestor
110624961|NCT00779909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110624962|NCT00779909|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110624963|NCT00779909|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110624965|NCT05559112|Vitamins|vitamins|mesh-ancestor
110624966|NCT05559112|Micronutrients|micronutrients|mesh-ancestor
110624967|NCT05559112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110624968|NCT05559112|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110624969|NCT00302107|Mirtazapine|mirtazapine|mesh-list
110624970|NCT00302107|Antidepressive Agents|antidepressive agents|mesh-ancestor
110624971|NCT00302107|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110624972|NCT00302107|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110624973|NCT00302107|Histamine Antagonists|histamine antagonists|mesh-ancestor
110624974|NCT00302107|Histamine Agents|histamine agents|mesh-ancestor
110624975|NCT00302107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110624976|NCT00302107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110624977|NCT00302107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110624978|NCT00302107|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110624979|NCT00302107|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110624980|NCT00302107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110624981|NCT00302107|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
110624982|NCT00302107|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110624983|NCT00302107|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110624984|NCT00302107|Adrenergic Agents|adrenergic agents|mesh-ancestor
110624985|NCT00302107|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110624986|NCT00302107|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110624987|NCT00302107|Serotonin Agents|serotonin agents|mesh-ancestor
110624988|NCT00302107|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110624989|NCT02602301|Oxytocin|oxytocin|mesh-list
110624990|NCT02602301|Oxytocics|oxytocics|mesh-ancestor
110624991|NCT02602301|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110624992|NCT02602301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110624993|NCT00316225|Pemetrexed|pemetrexed|mesh-list
110624994|NCT00316225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110624995|NCT00316225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110624996|NCT00316225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110624997|NCT00316225|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110624998|NCT00316225|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110624999|NCT04988152|Sotrovimab|sotrovimab|mesh-list
110625000|NCT04988152|Antiviral Agents|antiviral agents|mesh-ancestor
110625001|NCT04988152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110642879|NCT00881738|Clarithromycin|clarithromycin|mesh-list
110625003|NCT00586625|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110625004|NCT00636168|Ipilimumab|ipilimumab|mesh-list
110625005|NCT00636168|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110625006|NCT00636168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110625007|NCT00636168|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110625008|NCT00636168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110625009|NCT00759941|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110625010|NCT00759941|Latanoprost|latanoprost|mesh-list
110625011|NCT00759941|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110625012|NCT00759941|Brinzolamide|brinzolamide|mesh-list
110625013|NCT00759941|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110625014|NCT00759941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110625015|NCT00759941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110625016|NCT00315445|Acetaminophen|acetaminophen|mesh-list
110625017|NCT00315445|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
110625018|NCT00315445|Oxycodone|oxycodone|mesh-list
110625019|NCT00315445|Buprenorphine|buprenorphine|mesh-list
110625020|NCT00315445|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110625021|NCT00315445|Analgesics|analgesics|mesh-ancestor
110625022|NCT00315445|Sensory System Agents|sensory system agents|mesh-ancestor
110625023|NCT00315445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110643001|NCT00885872|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110625024|NCT00315445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110625025|NCT00315445|Antipyretics|antipyretics|mesh-ancestor
110625026|NCT00315445|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110625027|NCT00315445|Narcotics|narcotics|mesh-ancestor
110625028|NCT00315445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110625029|NCT00315445|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110625030|NCT00315445|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110625031|NCT00315445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110625032|NCT00315445|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110625033|NCT03687736|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110625034|NCT03687736|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110625035|NCT03687736|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110625036|NCT03687736|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110625037|NCT03687736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110625038|NCT03687736|Cholinergic Agents|cholinergic agents|mesh-ancestor
110625039|NCT03687736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110625040|NCT03687736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110625041|NCT03687736|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110625042|NCT03687736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110625043|NCT00779675|Infliximab|infliximab|mesh-list
110625044|NCT00779675|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110625045|NCT00779675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110625046|NCT00779675|Dermatologic Agents|dermatologic agents|mesh-ancestor
110625047|NCT00779675|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110625048|NCT00779675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110625049|NCT04102943|Tacrolimus|tacrolimus|mesh-list
110625050|NCT04102943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110625051|NCT04102943|Immunologic Factors|immunologic factors|mesh-ancestor
110625052|NCT04102943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110625053|NCT04102943|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110625054|NCT04102943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110643064|NCT00889148|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110625055|NCT04102943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110625056|NCT00759785|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110625057|NCT00759785|Immunologic Factors|immunologic factors|mesh-ancestor
110252967|NCT00407082|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
110625058|NCT00759785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110625059|NCT00315055|Vaccines|vaccines|mesh-list
110625060|NCT00315055|Immunologic Factors|immunologic factors|mesh-ancestor
110625061|NCT00315055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110625062|NCT00528970|Methylnaltrexone|methylnaltrexone|mesh-list
110625063|NCT00528970|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110625064|NCT00528970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110625065|NCT00528970|Sensory System Agents|sensory system agents|mesh-ancestor
110625066|NCT00528970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110625068|NCT00293293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110625072|NCT05774574|Cannabidiol|cannabidiol|mesh-list
110625073|NCT05774574|Anticonvulsants|anticonvulsants|mesh-ancestor
110625074|NCT05774275|Doxorubicin|doxorubicin|mesh-list
110625075|NCT05774275|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110625076|NCT05774275|Antibodies|antibodies|mesh-list
110625077|NCT05774275|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110625078|NCT05774275|Immunologic Factors|immunologic factors|mesh-ancestor
110625079|NCT05774275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110625080|NCT05774275|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110625081|NCT05774275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110625082|NCT05774275|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110625083|NCT05774275|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110625084|NCT05774275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110625085|NCT05774275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110625086|NCT05774028|Dexamethasone|dexamethasone|mesh-list
110625087|NCT05774028|Gemcitabine|gemcitabine|mesh-list
110625088|NCT05774028|Etoposide|etoposide|mesh-list
110625089|NCT05774028|Mitoxantrone|mitoxantrone|mesh-list
110625090|NCT05774028|Pegaspargase|pegaspargase|mesh-list
110625091|NCT05774028|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110625092|NCT05774028|Antiemetics|antiemetics|mesh-ancestor
110625093|NCT05774028|Autonomic Agents|autonomic agents|mesh-ancestor
110625094|NCT05774028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110625095|NCT05774028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110625096|NCT05774028|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110625097|NCT05774028|Glucocorticoids|glucocorticoids|mesh-ancestor
110625098|NCT05774028|Hormones|hormones|mesh-ancestor
110625099|NCT05774028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110625100|NCT05774028|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110625101|NCT05774028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110625102|NCT05774028|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110625103|NCT05774028|Antimetabolites|antimetabolites|mesh-ancestor
110625104|NCT05774028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110625105|NCT05774028|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110625106|NCT05774028|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110625107|NCT05774028|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110625108|NCT05774028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110625109|NCT05774028|Analgesics|analgesics|mesh-ancestor
110625110|NCT05774028|Sensory System Agents|sensory system agents|mesh-ancestor
110625111|NCT05774015|Magnesium Oxide|magnesium oxide|mesh-list
110625112|NCT05774015|Antacids|antacids|mesh-ancestor
110625113|NCT05774015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110625114|NCT05774015|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110625115|NCT05773911|Chitosan|chitosan|mesh-list
110625116|NCT05773911|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110625118|NCT05773911|Antimetabolites|antimetabolites|mesh-ancestor
110625119|NCT05773911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110625120|NCT05773911|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110625121|NCT05773911|Chelating Agents|chelating agents|mesh-ancestor
110625122|NCT05773911|Sequestering Agents|sequestering agents|mesh-ancestor
110625123|NCT05773911|Hemostatics|hemostatics|mesh-ancestor
110625124|NCT05773911|Coagulants|coagulants|mesh-ancestor
110625125|NCT05773859|Vaccines|vaccines|mesh-list
110625126|NCT05773859|Immunologic Factors|immunologic factors|mesh-ancestor
110643276|NCT02541500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110625127|NCT05773859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110625128|NCT05773846|Ropivacaine|ropivacaine|mesh-list
110625129|NCT05773846|Anesthetics, Local|anesthetics, local|mesh-ancestor
110625130|NCT05773846|Anesthetics|anesthetics|mesh-ancestor
110625131|NCT05773846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110625132|NCT05773846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110625133|NCT05773846|Sensory System Agents|sensory system agents|mesh-ancestor
110625134|NCT05773846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110625135|NCT05773807|Propofol|propofol|mesh-list
110625136|NCT05773807|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110625137|NCT05773807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110625138|NCT05773807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110643341|NCT04037774|Analgesics|analgesics|mesh-ancestor
110625139|NCT05773807|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110625140|NCT05773807|Anesthetics, General|anesthetics, general|mesh-ancestor
110625141|NCT05773807|Anesthetics|anesthetics|mesh-ancestor
110625142|NCT05773183|Testosterone|testosterone|mesh-list
110625143|NCT05773183|Androgens|androgens|mesh-ancestor
110625144|NCT05773183|Hormones|hormones|mesh-ancestor
110625145|NCT05773183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110625146|NCT05773183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110625147|NCT05732051|Niacinamide|niacinamide|mesh-list
110625148|NCT05732051|Niacin|niacin|mesh-list
110625149|NCT05732051|Nicotinic Acids|nicotinic acids|mesh-list
110154343|NCT00010231|Vitamins|vitamins|mesh-ancestor
110625150|NCT05732051|Vitamin B Complex|vitamin b complex|mesh-ancestor
110625152|NCT05732051|Micronutrients|micronutrients|mesh-ancestor
110625153|NCT05732051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110625154|NCT05732051|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110625155|NCT05732051|Antimetabolites|antimetabolites|mesh-ancestor
110625156|NCT05732051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110625157|NCT05732051|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110625158|NCT05732051|Vasodilator Agents|vasodilator agents|mesh-ancestor
110625159|NCT05667922|Tacrolimus|tacrolimus|mesh-list
110625160|NCT05667922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110625161|NCT05667922|Immunologic Factors|immunologic factors|mesh-ancestor
110625162|NCT05667922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110625163|NCT05667922|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110625164|NCT05667922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110643406|NCT00528957|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110625165|NCT05667922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110625166|NCT05667909|Rituximab|rituximab|mesh-list
110625167|NCT05667909|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110625168|NCT05667909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110625169|NCT05667909|Immunologic Factors|immunologic factors|mesh-ancestor
110625170|NCT05667909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110625171|NCT05667909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110625172|NCT05667896|Tacrolimus|tacrolimus|mesh-list
110625173|NCT05667896|Glucocorticoids|glucocorticoids|mesh-list
110625174|NCT05667896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110625175|NCT05667896|Immunologic Factors|immunologic factors|mesh-ancestor
110625176|NCT05667896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110643472|NCT00942318|Insulin|insulin|mesh-list
110625177|NCT05667896|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110625178|NCT05667896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110625179|NCT05667896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110625181|NCT05667896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110625182|NCT05667883|Cyclophosphamide|cyclophosphamide|mesh-list
110625183|NCT05667883|Glucocorticoids|glucocorticoids|mesh-list
110625184|NCT05667883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110625185|NCT05667883|Immunologic Factors|immunologic factors|mesh-ancestor
110393019|NCT01645787|4-Aminopyridine|4-aminopyridine|mesh-list
110625186|NCT05667883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110625187|NCT05667883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110625188|NCT05667883|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110625189|NCT05667883|Alkylating Agents|alkylating agents|mesh-ancestor
110625190|NCT05667883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110625192|NCT05667883|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110625193|NCT05667883|Hormones|hormones|mesh-ancestor
110625194|NCT05667883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110625195|NCT05667805|Thrombin|thrombin|mesh-list
110625196|NCT05667805|Hemostatics|hemostatics|mesh-ancestor
110625197|NCT05667805|Coagulants|coagulants|mesh-ancestor
110625198|NCT05644496|Meloxicam|meloxicam|mesh-list
110625199|NCT05644496|Bupivacaine|bupivacaine|mesh-list
110625200|NCT05644496|Anesthetics, Local|anesthetics, local|mesh-ancestor
110625201|NCT05644496|Anesthetics|anesthetics|mesh-ancestor
110625202|NCT05644496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110625203|NCT05644496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110625204|NCT05644496|Sensory System Agents|sensory system agents|mesh-ancestor
110625205|NCT05644496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110625206|NCT05644496|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110154344|NCT00010231|Micronutrients|micronutrients|mesh-ancestor
110625207|NCT05644496|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110625208|NCT05644496|Analgesics|analgesics|mesh-ancestor
110625209|NCT05644496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110625210|NCT05644496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110625211|NCT05644496|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110625212|NCT05644496|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110625214|NCT05644496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110625215|NCT05613608|Cannabidiol|cannabidiol|mesh-list
110625216|NCT05613608|Anticonvulsants|anticonvulsants|mesh-ancestor
110625217|NCT05592613|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110625218|NCT05592613|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
110625219|NCT05592613|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110625220|NCT05592613|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110625221|NCT05592613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110625222|NCT05592613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110625223|NCT05592613|Antiviral Agents|antiviral agents|mesh-ancestor
110625224|NCT05592613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110625225|NCT05592613|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110625226|NCT05567562|Clopidogrel|clopidogrel|mesh-list
110625227|NCT05567562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110625228|NCT05567562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110625229|NCT05567562|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110625230|NCT05567562|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110625231|NCT05567562|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110625232|NCT05567562|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110625233|NCT05567562|Purinergic Agents|purinergic agents|mesh-ancestor
110625234|NCT05567562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110625235|NCT05554978|Landiolol|landiolol|mesh-list
110625236|NCT05554978|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110625237|NCT05554978|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110625238|NCT05554978|Adrenergic Agents|adrenergic agents|mesh-ancestor
110625239|NCT05554978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110625240|NCT05554978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110625241|NCT05554978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110625242|NCT05554978|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110625243|NCT05543642|Vaccines|vaccines|mesh-list
110625244|NCT05543642|Immunologic Factors|immunologic factors|mesh-ancestor
110393021|NCT01645787|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110393023|NCT02270034|Crizotinib|crizotinib|mesh-list
110625245|NCT05543642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110625247|NCT05476770|Dexamethasone|dexamethasone|mesh-list
110625248|NCT05476770|Hydrocortisone|hydrocortisone|mesh-list
110625249|NCT05476770|Methotrexate|methotrexate|mesh-list
110625250|NCT05476770|Fludarabine|fludarabine|mesh-list
110625251|NCT05476770|Vincristine|vincristine|mesh-list
110625252|NCT05476770|Azacitidine|azacitidine|mesh-list
110625253|NCT05476770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110625254|NCT05476770|Antiemetics|antiemetics|mesh-ancestor
110625255|NCT05476770|Autonomic Agents|autonomic agents|mesh-ancestor
110625256|NCT05476770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110625257|NCT05476770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110625258|NCT05476770|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110625259|NCT05476770|Glucocorticoids|glucocorticoids|mesh-ancestor
110625260|NCT05476770|Hormones|hormones|mesh-ancestor
110625261|NCT05476770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110625262|NCT05476770|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110625263|NCT05476770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110625264|NCT05476770|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110625265|NCT05476770|Abortifacient Agents|abortifacient agents|mesh-ancestor
110625266|NCT05476770|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110625267|NCT05476770|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110625268|NCT05476770|Antimetabolites|antimetabolites|mesh-ancestor
110625269|NCT05476770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110625270|NCT05476770|Dermatologic Agents|dermatologic agents|mesh-ancestor
110625271|NCT05476770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110625272|NCT05476770|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110625273|NCT05476770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110625274|NCT05476770|Immunologic Factors|immunologic factors|mesh-ancestor
110625275|NCT05476770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110625276|NCT05476770|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110625277|NCT05476770|Antiviral Agents|antiviral agents|mesh-ancestor
110625278|NCT05476770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110625279|NCT05476770|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110625280|NCT05476770|Tubulin Modulators|tubulin modulators|mesh-ancestor
110625281|NCT05476770|Antimitotic Agents|antimitotic agents|mesh-ancestor
110625282|NCT05476770|Mitosis Modulators|mitosis modulators|mesh-ancestor
110625283|NCT05475678|Carboplatin|carboplatin|mesh-list
110625284|NCT05475678|Docetaxel|docetaxel|mesh-list
110625285|NCT05475678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110625286|NCT05475678|Tubulin Modulators|tubulin modulators|mesh-ancestor
110625287|NCT05475678|Antimitotic Agents|antimitotic agents|mesh-ancestor
110625288|NCT05475678|Mitosis Modulators|mitosis modulators|mesh-ancestor
110625289|NCT05475678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110625291|NCT05438888|Apixaban|apixaban|mesh-list
110625292|NCT05438888|Anticoagulants|anticoagulants|mesh-ancestor
110625293|NCT05438888|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110625294|NCT05438888|Antithrombins|antithrombins|mesh-ancestor
110625295|NCT05438888|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110625296|NCT05438888|Protease Inhibitors|protease inhibitors|mesh-ancestor
110625297|NCT05438888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110625298|NCT05438888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110625299|NCT05430074|Calpastatin|calpastatin|mesh-list
110625300|NCT05430074|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
110625301|NCT05430074|Protease Inhibitors|protease inhibitors|mesh-ancestor
110625302|NCT05430074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110625303|NCT05430074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110625304|NCT05351736|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
110625305|NCT05351736|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110625306|NCT05351736|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110625307|NCT05351736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110625308|NCT05351736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110625309|NCT05351736|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110625310|NCT05351736|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
110625311|NCT05351736|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110625312|NCT05351736|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110625313|NCT05351736|Adrenergic Agents|adrenergic agents|mesh-ancestor
110625314|NCT05351736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110625315|NCT05351736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110625316|NCT05351736|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110625317|NCT05351736|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110625318|NCT05351736|Serotonin Agents|serotonin agents|mesh-ancestor
110625319|NCT05351736|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110625320|NCT05351736|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110625321|NCT05351736|Dopamine Agents|dopamine agents|mesh-ancestor
110625322|NCT05335928|Abatacept|abatacept|mesh-list
110625323|NCT05335928|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110625324|NCT05335928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110625325|NCT05335928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110625326|NCT05335928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110625327|NCT05335928|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110253002|NCT00141245|Analgesics|analgesics|mesh-ancestor
110625328|NCT05335928|Immunologic Factors|immunologic factors|mesh-ancestor
110625329|NCT05335928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110625330|NCT05335928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110625331|NCT05319561|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110625332|NCT05319561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110625333|NCT05286957|Tislelizumab|tislelizumab|mesh-list
110625334|NCT05286957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110625335|NCT05286957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110625336|NCT05282108|Imatinib Mesylate|imatinib mesylate|mesh-list
110625337|NCT05282108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110625338|NCT05282108|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110625339|NCT05282108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110625340|NCT05282108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110625341|NCT05255276|Itraconazole|itraconazole|mesh-list
110625342|NCT05255276|Rifampin|rifampin|mesh-list
110625343|NCT05255276|Antifungal Agents|antifungal agents|mesh-ancestor
110625344|NCT05255276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110625345|NCT05255276|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110625346|NCT05255276|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110625347|NCT05255276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110625348|NCT05255276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110625349|NCT05255276|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110643909|NCT00527787|Naproxen|naproxen|mesh-list
110625350|NCT05255276|Hormone Antagonists|hormone antagonists|mesh-ancestor
110625351|NCT05255276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110625352|NCT05255276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110625353|NCT05255276|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110625354|NCT05255276|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110625355|NCT05255276|Antitubercular Agents|antitubercular agents|mesh-ancestor
110643945|NCT00896558|Midazolam|midazolam|mesh-list
110625356|NCT05255276|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110625357|NCT05255276|Leprostatic Agents|leprostatic agents|mesh-ancestor
110625358|NCT05255276|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110625359|NCT05255276|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110625360|NCT05255276|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110625361|NCT05255276|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110625362|NCT05255276|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110625363|NCT05255276|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110625364|NCT05255276|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110625365|NCT05243199|Valsartan|valsartan|mesh-list
110625366|NCT05243199|Irbesartan|irbesartan|mesh-list
110625367|NCT05243199|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
110625368|NCT05243199|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110625369|NCT05243199|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110625370|NCT05243199|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110625371|NCT05243199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110625372|NCT05227716|Magnesium Sulfate|magnesium sulfate|mesh-list
110625373|NCT05227716|Analgesics|analgesics|mesh-ancestor
110625374|NCT05227716|Sensory System Agents|sensory system agents|mesh-ancestor
110625375|NCT05227716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110625376|NCT05227716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110625377|NCT05227716|Anesthetics|anesthetics|mesh-ancestor
110625378|NCT05227716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110625379|NCT05227716|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110625381|NCT05227716|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110625382|NCT05227716|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110625383|NCT05227716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110625384|NCT05227716|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110625385|NCT05227716|Tocolytic Agents|tocolytic agents|mesh-ancestor
110644075|NCT00127933|Antimetabolites|antimetabolites|mesh-ancestor
110625386|NCT05227716|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110625387|NCT05195996|Propranolol|propranolol|mesh-list
110625388|NCT05195996|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110625389|NCT05195996|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110625390|NCT05195996|Adrenergic Agents|adrenergic agents|mesh-ancestor
110625391|NCT05195996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110625392|NCT05195996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110625393|NCT05195996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110625394|NCT05195996|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110625395|NCT05195996|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110625396|NCT05195996|Vasodilator Agents|vasodilator agents|mesh-ancestor
110625397|NCT05113966|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
110625398|NCT05113966|Immunoconjugates|immunoconjugates|mesh-ancestor
110625399|NCT05113966|Immunologic Factors|immunologic factors|mesh-ancestor
110625400|NCT05113966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110625401|NCT05101564|Tamoxifen|tamoxifen|mesh-list
110644142|NCT00945360|Letrozole|letrozole|mesh-list
110625402|NCT05101564|Fulvestrant|fulvestrant|mesh-list
110625403|NCT05101564|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110625404|NCT05101564|Hormone Antagonists|hormone antagonists|mesh-ancestor
110625405|NCT05101564|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110625406|NCT05101564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110625407|NCT05101564|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110625408|NCT05101564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110625409|NCT05101564|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110625410|NCT05101564|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110625411|NCT05101564|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110644201|NCT00944346|Metformin|metformin|mesh-list
110625412|NCT05101564|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110625414|NCT05073484|Immunoglobulins|immunoglobulins|mesh-list
110625415|NCT05073484|Immunologic Factors|immunologic factors|mesh-ancestor
110625416|NCT05073484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110625417|NCT05071014|Pembrolizumab|pembrolizumab|mesh-list
110625418|NCT05071014|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110625419|NCT05071014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110625420|NCT05071014|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110625421|NCT05071014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110625422|NCT05025865|Hyaluronic Acid|hyaluronic acid|mesh-list
110625423|NCT05025865|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110625424|NCT05025865|Immunologic Factors|immunologic factors|mesh-ancestor
110625425|NCT05025865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110625427|NCT05025865|Protective Agents|protective agents|mesh-ancestor
110625428|NCT05005741|Dulaglutide|dulaglutide|mesh-list
110625429|NCT05005741|Glucagon|glucagon|mesh-list
110625430|NCT05005741|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
110625431|NCT05005741|Incretins|incretins|mesh-ancestor
110625432|NCT05005741|Hormones|hormones|mesh-ancestor
110625433|NCT05005741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110625434|NCT05005741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110625435|NCT05005741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110625436|NCT05005741|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110625437|NCT05002829|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110625438|NCT05002829|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
110625439|NCT05002829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110625440|NCT05002829|Antitubercular Agents|antitubercular agents|mesh-ancestor
110625441|NCT04994990|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110625442|NCT04994990|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110625443|NCT04994990|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110625444|NCT04994990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110644311|NCT01565109|Docetaxel|docetaxel|mesh-list
110625445|NCT04994990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110644367|NCT01326325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110625446|NCT04994990|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110625447|NCT04994990|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110625448|NCT04994990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110625449|NCT04994990|Cholinergic Agents|cholinergic agents|mesh-ancestor
110625450|NCT04994990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110625453|NCT04974216|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110625454|NCT04974216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110644516|NCT00524589|Hormones|hormones|mesh-ancestor
110625455|NCT04974216|Immunologic Factors|immunologic factors|mesh-ancestor
110253014|NCT00141245|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110625456|NCT04974216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110625457|NCT04974216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110625458|NCT04974216|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110625459|NCT04974216|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110625460|NCT04974216|Growth Substances|growth substances|mesh-ancestor
110625461|NCT04974216|Growth Inhibitors|growth inhibitors|mesh-ancestor
110625462|NCT04972552|Ubiquinone|ubiquinone|mesh-list
110625463|NCT04972552|Coenzyme Q10|coenzyme q10|mesh-list
110625464|NCT04972552|Micronutrients|micronutrients|mesh-ancestor
110625465|NCT04972552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110625466|NCT04972552|Vitamins|vitamins|mesh-ancestor
110625467|NCT04924699|Trastuzumab|trastuzumab|mesh-list
110625468|NCT04924699|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
110625469|NCT04924699|Maytansine|maytansine|mesh-list
110644584|NCT00132769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110625470|NCT04924699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110625471|NCT04924699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110625472|NCT04924699|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110625473|NCT04924699|Tubulin Modulators|tubulin modulators|mesh-ancestor
110625474|NCT04924699|Antimitotic Agents|antimitotic agents|mesh-ancestor
110625475|NCT04924699|Mitosis Modulators|mitosis modulators|mesh-ancestor
110644645|NCT02390427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110625476|NCT04924699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110625477|NCT04924699|Immunotoxins|immunotoxins|mesh-ancestor
110625478|NCT04924699|Immunoconjugates|immunoconjugates|mesh-ancestor
110625479|NCT04924699|Immunologic Factors|immunologic factors|mesh-ancestor
110625480|NCT04924699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110625481|NCT04907539|Denosumab|denosumab|mesh-list
110625482|NCT04907539|Nivolumab|nivolumab|mesh-list
110625483|NCT04907539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110644714|NCT06027723|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110644715|NCT06027723|Cholinergic Agents|cholinergic agents|mesh-ancestor
110644716|NCT06027723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110644717|NCT06027723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110644718|NCT06027619|Aminolevulinic Acid|aminolevulinic acid|mesh-list
110644719|NCT06027619|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110644720|NCT06027619|Dermatologic Agents|dermatologic agents|mesh-ancestor
110644721|NCT06027606|Budesonide|budesonide|mesh-list
110644722|NCT06027606|Albuterol|albuterol|mesh-list
110644723|NCT06027606|Formoterol Fumarate|formoterol fumarate|mesh-list
110644724|NCT06027606|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110644725|NCT06027606|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110625484|NCT04907539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110625485|NCT04907539|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110625486|NCT04907539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110625487|NCT04907539|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110625488|NCT04907539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110625490|NCT04877288|Mycophenolic Acid|mycophenolic acid|mesh-list
110625491|NCT04877288|Abatacept|abatacept|mesh-list
110625492|NCT04877288|Tacrolimus|tacrolimus|mesh-list
110625493|NCT04877288|Cyclosporins|cyclosporins|mesh-list
110625494|NCT04877288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110625495|NCT04877288|Immunologic Factors|immunologic factors|mesh-ancestor
110625496|NCT04877288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110625497|NCT04877288|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110625498|NCT04877288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110625499|NCT04877288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110625500|NCT04877288|Antifungal Agents|antifungal agents|mesh-ancestor
110625501|NCT04877288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110625502|NCT04877288|Dermatologic Agents|dermatologic agents|mesh-ancestor
110625503|NCT04877288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110625504|NCT04877288|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110625505|NCT04877288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110625506|NCT04877288|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110253029|NCT00155259|Docetaxel|docetaxel|mesh-list
110625507|NCT04877288|Antitubercular Agents|antitubercular agents|mesh-ancestor
110625508|NCT04877288|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110625509|NCT04877288|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110625510|NCT04877288|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110625511|NCT04830397|Timolol|timolol|mesh-list
110625512|NCT04830397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110625513|NCT04830397|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110625514|NCT04830397|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110625515|NCT04830397|Adrenergic Agents|adrenergic agents|mesh-ancestor
110625516|NCT04830397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110625517|NCT04830397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110625518|NCT04830397|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110625519|NCT04830397|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110625521|NCT04815876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110625522|NCT04802590|Venetoclax|venetoclax|mesh-list
110625523|NCT04802590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110625524|NCT04776993|Methimazole|methimazole|mesh-list
110625525|NCT04776993|Antithyroid Agents|antithyroid agents|mesh-ancestor
110625526|NCT04776993|Hormone Antagonists|hormone antagonists|mesh-ancestor
110625527|NCT04776993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110625528|NCT04776993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110625529|NCT04671875|Antibodies|antibodies|mesh-list
110625530|NCT04671875|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110625531|NCT04671875|Immunologic Factors|immunologic factors|mesh-ancestor
110625532|NCT04671875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110625533|NCT04664972|Cyclophosphamide|cyclophosphamide|mesh-list
110625534|NCT04664972|Docetaxel|docetaxel|mesh-list
110625535|NCT04664972|Doxorubicin|doxorubicin|mesh-list
110625536|NCT04664972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110625537|NCT04664972|Immunologic Factors|immunologic factors|mesh-ancestor
110625538|NCT04664972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110625539|NCT04664972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110625540|NCT04664972|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110625541|NCT04664972|Alkylating Agents|alkylating agents|mesh-ancestor
110625542|NCT04664972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110625543|NCT04664972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110625544|NCT04664972|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110625545|NCT04664972|Tubulin Modulators|tubulin modulators|mesh-ancestor
110625546|NCT04664972|Antimitotic Agents|antimitotic agents|mesh-ancestor
110625547|NCT04664972|Mitosis Modulators|mitosis modulators|mesh-ancestor
110625548|NCT04664972|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110625549|NCT04664972|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110625550|NCT04664972|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110625551|NCT04664972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110645053|NCT05759156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110645054|NCT05759156|Hemostatics|hemostatics|mesh-ancestor
110645055|NCT05759156|Coagulants|coagulants|mesh-ancestor
110645063|NCT05705349|Islatravir|islatravir|mesh-list
110645064|NCT05705349|Antiviral Agents|antiviral agents|mesh-ancestor
110625552|NCT04652076|Paclitaxel|paclitaxel|mesh-list
110625553|NCT04652076|Carboplatin|carboplatin|mesh-list
110625554|NCT04652076|Pembrolizumab|pembrolizumab|mesh-list
110625555|NCT04652076|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110625556|NCT04652076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110625557|NCT04652076|Tubulin Modulators|tubulin modulators|mesh-ancestor
110625558|NCT04652076|Antimitotic Agents|antimitotic agents|mesh-ancestor
110625559|NCT04652076|Mitosis Modulators|mitosis modulators|mesh-ancestor
110625560|NCT04652076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110625561|NCT04652076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110625562|NCT04652076|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110625564|NCT04632069|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110625565|NCT04632069|Antiviral Agents|antiviral agents|mesh-ancestor
110625566|NCT04632069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110625567|NCT04632069|Expectorants|expectorants|mesh-ancestor
110625568|NCT04632069|Respiratory System Agents|respiratory system agents|mesh-ancestor
110625569|NCT04632069|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110625570|NCT04632069|Antioxidants|antioxidants|mesh-ancestor
110625571|NCT04632069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110625572|NCT04632069|Protective Agents|protective agents|mesh-ancestor
110625573|NCT04632069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110625574|NCT04632069|Antidotes|antidotes|mesh-ancestor
110625575|NCT04618913|Rivaroxaban|rivaroxaban|mesh-list
110625576|NCT04618913|Apixaban|apixaban|mesh-list
110625577|NCT04618913|Edoxaban|edoxaban|mesh-list
110625578|NCT04618913|Dabigatran|dabigatran|mesh-list
110625579|NCT04618913|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110625580|NCT04618913|Antithrombins|antithrombins|mesh-ancestor
110625581|NCT04618913|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110625582|NCT04618913|Protease Inhibitors|protease inhibitors|mesh-ancestor
110625583|NCT04618913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110625584|NCT04618913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110625586|NCT04547907|Paclitaxel|paclitaxel|mesh-list
110625587|NCT04547907|Docetaxel|docetaxel|mesh-list
110625588|NCT04547907|Carboplatin|carboplatin|mesh-list
110625589|NCT04547907|Trastuzumab|trastuzumab|mesh-list
110625590|NCT04547907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110625591|NCT04547907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110625592|NCT04547907|Tubulin Modulators|tubulin modulators|mesh-ancestor
110625593|NCT04547907|Antimitotic Agents|antimitotic agents|mesh-ancestor
110625594|NCT04547907|Mitosis Modulators|mitosis modulators|mesh-ancestor
110625595|NCT04547907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110625596|NCT04547907|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110625597|NCT04545944|Midazolam|midazolam|mesh-list
110625598|NCT04545944|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110625599|NCT04545944|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110625600|NCT04545944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110625601|NCT04545944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110625602|NCT04545944|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110625603|NCT04545944|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110625604|NCT04545944|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110625605|NCT04545944|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110625606|NCT04545944|Anesthetics, General|anesthetics, general|mesh-ancestor
110625607|NCT04545944|Anesthetics|anesthetics|mesh-ancestor
110625608|NCT04545944|GABA Modulators|gaba modulators|mesh-ancestor
110625609|NCT04545944|GABA Agents|gaba agents|mesh-ancestor
110625610|NCT04545944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110625611|NCT04545944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110625612|NCT04522804|Psilocybin|psilocybin|mesh-list
110154398|NCT00011089|Tenofovir|tenofovir|mesh-list
110625613|NCT04522804|Hallucinogens|hallucinogens|mesh-ancestor
110625614|NCT04522804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110625615|NCT04522804|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110625616|NCT04393285|Letrozole|letrozole|mesh-list
110625617|NCT04393285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110625618|NCT04393285|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110625619|NCT04393285|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110645309|NCT05457257|Olaparib|olaparib|mesh-list
110625620|NCT04393285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110625621|NCT04393285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110625622|NCT04393285|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110625623|NCT04393285|Hormone Antagonists|hormone antagonists|mesh-ancestor
110625624|NCT04393285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110625625|NCT04393285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110625626|NCT04391283|Osimertinib|osimertinib|mesh-list
110625627|NCT04391283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110625628|NCT04391283|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110625629|NCT04391283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110625630|NCT04391283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110625631|NCT04374799|Heparin|heparin|mesh-list
110625632|NCT04374799|Anticoagulants|anticoagulants|mesh-ancestor
110625633|NCT04374799|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110625634|NCT04374799|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110625635|NCT04374799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110625636|NCT04266275|Curcumin|curcumin|mesh-list
110625637|NCT04266275|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110625638|NCT04266275|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110625639|NCT04266275|Analgesics|analgesics|mesh-ancestor
110645440|NCT05248919|Velpatasvir|velpatasvir|mesh-list
110625640|NCT04266275|Sensory System Agents|sensory system agents|mesh-ancestor
110625641|NCT04266275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110625642|NCT04266275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110625643|NCT04266275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110625644|NCT04266275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110625645|NCT04266275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110625646|NCT04266275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110625647|NCT04266275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110625649|NCT04207086|Lenvatinib|lenvatinib|mesh-list
110625650|NCT04207086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110625652|NCT04207086|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110625653|NCT04207086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110625654|NCT04207086|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110625655|NCT04207086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110625656|NCT04194359|Bevacizumab|bevacizumab|mesh-list
110625657|NCT04194359|Capecitabine|capecitabine|mesh-list
110625658|NCT04194359|Oxaliplatin|oxaliplatin|mesh-list
110625659|NCT04194359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110625661|NCT04194359|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110625662|NCT04194359|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110625663|NCT04194359|Growth Substances|growth substances|mesh-ancestor
110625664|NCT04194359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110625665|NCT04194359|Growth Inhibitors|growth inhibitors|mesh-ancestor
110625666|NCT04194359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110625667|NCT04194359|Antimetabolites|antimetabolites|mesh-ancestor
110625668|NCT04194359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110625669|NCT04118010|Vitamin D|vitamin d|mesh-list
110625670|NCT04118010|Ergocalciferols|ergocalciferols|mesh-list
110625671|NCT04118010|Cholecalciferol|cholecalciferol|mesh-list
110625672|NCT04118010|Vitamins|vitamins|mesh-list
110625673|NCT04118010|Micronutrients|micronutrients|mesh-ancestor
110625674|NCT04118010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110625675|NCT04118010|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110625676|NCT04118010|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110625677|NCT04113863|Anastrozole|anastrozole|mesh-list
110625678|NCT04113863|Tretinoin|tretinoin|mesh-list
110625679|NCT04113863|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110625680|NCT04113863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110625681|NCT04113863|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110625682|NCT04113863|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110625683|NCT04113863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110625684|NCT04113863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110625685|NCT04113863|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110625686|NCT04113863|Hormone Antagonists|hormone antagonists|mesh-ancestor
110625687|NCT04113863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110625688|NCT04113863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110625689|NCT04113863|Keratolytic Agents|keratolytic agents|mesh-ancestor
110625690|NCT04113863|Dermatologic Agents|dermatologic agents|mesh-ancestor
110625691|NCT04053491|Anesthetics|anesthetics|mesh-list
110625692|NCT04053491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110625693|NCT04053491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110625694|NCT04041232|Glycerol|glycerol|mesh-list
110625695|NCT04041232|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
110625696|NCT04041232|Protective Agents|protective agents|mesh-ancestor
110625697|NCT04041232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110625698|NCT04030000|Paclitaxel|paclitaxel|mesh-list
110625699|NCT04030000|Carboplatin|carboplatin|mesh-list
110625700|NCT04030000|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110625701|NCT04030000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110625702|NCT04030000|Tubulin Modulators|tubulin modulators|mesh-ancestor
110625703|NCT04030000|Antimitotic Agents|antimitotic agents|mesh-ancestor
110625704|NCT04030000|Mitosis Modulators|mitosis modulators|mesh-ancestor
110625705|NCT04030000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110625706|NCT04010539|Azithromycin|azithromycin|mesh-list
110625707|NCT04010539|Ceftriaxone|ceftriaxone|mesh-list
110625708|NCT04010539|Gepotidacin|gepotidacin|mesh-list
110625709|NCT04010539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110625710|NCT04010539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110625711|NCT04010539|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110625712|NCT04010539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110625713|NCT04010539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110625714|NCT04010539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110625716|NCT03957590|Tislelizumab|tislelizumab|mesh-list
110625717|NCT03957590|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110625718|NCT03957590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110625720|NCT03957590|Antimitotic Agents|antimitotic agents|mesh-ancestor
110625721|NCT03957590|Mitosis Modulators|mitosis modulators|mesh-ancestor
110625722|NCT03957590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110625723|NCT03957590|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110625725|NCT03921866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110625726|NCT03921866|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110625727|NCT03921866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110625728|NCT03921866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110625729|NCT03919955|Oxybutynin|oxybutynin|mesh-list
110625730|NCT03919955|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
110625731|NCT03919955|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110625732|NCT03919955|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110273004|NCT03819088|Astringents|astringents|mesh-ancestor
110625733|NCT03919955|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110625734|NCT03919955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110625735|NCT03919955|Adrenergic Agents|adrenergic agents|mesh-ancestor
110625736|NCT03919955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110625737|NCT03919955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110625738|NCT03919955|Parasympatholytics|parasympatholytics|mesh-ancestor
110625740|NCT03919955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110625741|NCT03919955|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110625742|NCT03919955|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110625743|NCT03919955|Cholinergic Agents|cholinergic agents|mesh-ancestor
110625744|NCT03919955|Urological Agents|urological agents|mesh-ancestor
110625745|NCT03760588|Valsartan|valsartan|mesh-list
110625746|NCT03760588|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
110625747|NCT03760588|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110625748|NCT03760588|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110625749|NCT03760588|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110646161|NCT04099251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110625750|NCT03760588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110625751|NCT03729778|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110625752|NCT03729778|Immunologic Factors|immunologic factors|mesh-ancestor
110625753|NCT03729778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110625755|NCT03681561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110625756|NCT03681561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110625757|NCT03681561|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110625758|NCT03681561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110625759|NCT03656081|Itraconazole|itraconazole|mesh-list
110625760|NCT03656081|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
110625761|NCT03656081|Amphotericin B|amphotericin b|mesh-list
110625762|NCT03656081|Antifungal Agents|antifungal agents|mesh-ancestor
110625763|NCT03656081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110625764|NCT03656081|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110625766|NCT03656081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110625767|NCT03656081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110625768|NCT03656081|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110625769|NCT03656081|Hormone Antagonists|hormone antagonists|mesh-ancestor
110625770|NCT03656081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110625771|NCT03656081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110625772|NCT03656081|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110625773|NCT03656081|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110625774|NCT03656081|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110625775|NCT03656081|Amebicides|amebicides|mesh-ancestor
110625776|NCT03656081|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110625777|NCT03649048|Cisplatin|cisplatin|mesh-list
110625778|NCT03649048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110625779|NCT03642626|Vidarabine|vidarabine|mesh-list
110625780|NCT03642626|Cyclophosphamide|cyclophosphamide|mesh-list
110625781|NCT03642626|Fludarabine|fludarabine|mesh-list
110625782|NCT03642626|Fludarabine phosphate|fludarabine phosphate|mesh-list
110625783|NCT03642626|Tisagenlecleucel|tisagenlecleucel|mesh-list
110625784|NCT03642626|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
110625785|NCT03642626|Brexucabtagene autoleucel|brexucabtagene autoleucel|mesh-list
110625786|NCT03642626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110625787|NCT03642626|Immunologic Factors|immunologic factors|mesh-ancestor
110625788|NCT03642626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110625789|NCT03642626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110625790|NCT03642626|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110625791|NCT03642626|Alkylating Agents|alkylating agents|mesh-ancestor
110625792|NCT03642626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110625793|NCT03642626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110625794|NCT03642626|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110646359|NCT03716180|Paclitaxel|paclitaxel|mesh-list
110625795|NCT03642626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110625796|NCT03642626|Antimetabolites|antimetabolites|mesh-ancestor
110625797|NCT03642626|Antiviral Agents|antiviral agents|mesh-ancestor
110625798|NCT03642626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110625799|NCT03642626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110625801|NCT03621982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110625802|NCT03621982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110625803|NCT03621982|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110646413|NCT03568383|Vitamin B Complex|vitamin b complex|mesh-ancestor
110646414|NCT03568383|Antitubercular Agents|antitubercular agents|mesh-ancestor
110646415|NCT03568383|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110646416|NCT03568383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110646417|NCT03568383|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
110646418|NCT03568383|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110646419|NCT03568383|Antimetabolites|antimetabolites|mesh-ancestor
110646420|NCT03568383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110625804|NCT03621982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110625805|NCT03608163|Diazoxide|diazoxide|mesh-list
110625806|NCT03608163|Naloxone|naloxone|mesh-list
110625807|NCT03608163|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110625808|NCT03608163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110625809|NCT03608163|Sensory System Agents|sensory system agents|mesh-ancestor
110625810|NCT03608163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110625811|NCT03608163|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110625812|NCT03608163|Vasodilator Agents|vasodilator agents|mesh-ancestor
110625813|NCT03604406|Vaccines|vaccines|mesh-list
110625814|NCT03604406|Immunologic Factors|immunologic factors|mesh-ancestor
110625816|NCT03573700|Cyclophosphamide|cyclophosphamide|mesh-list
110625817|NCT03573700|Fludarabine|fludarabine|mesh-list
110625818|NCT03573700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110625819|NCT03573700|Immunologic Factors|immunologic factors|mesh-ancestor
110625820|NCT03573700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110625821|NCT03573700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110625822|NCT03573700|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110625823|NCT03573700|Alkylating Agents|alkylating agents|mesh-ancestor
110625824|NCT03573700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110625825|NCT03573700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110625826|NCT03573700|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110625827|NCT03534947|Imiquimod|imiquimod|mesh-list
110625828|NCT03534947|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110625829|NCT03534947|Immunologic Factors|immunologic factors|mesh-ancestor
110625830|NCT03534947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110625831|NCT03534947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110625832|NCT03534947|Interferon Inducers|interferon inducers|mesh-ancestor
110625834|NCT03530371|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110625835|NCT03530371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110625836|NCT03530371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110625837|NCT03530371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110625838|NCT03530371|Analgesics|analgesics|mesh-ancestor
110625839|NCT03530371|Sensory System Agents|sensory system agents|mesh-ancestor
110625840|NCT03530371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110625841|NCT03530371|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110625842|NCT03530371|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110625843|NCT03530371|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110625844|NCT03530371|Adrenergic Agents|adrenergic agents|mesh-ancestor
110625845|NCT03530371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110646740|NCT02639702|GABA Agents|gaba agents|mesh-ancestor
110625846|NCT03530371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110625848|NCT03521830|Ipilimumab|ipilimumab|mesh-list
110625849|NCT03521830|Relatlimab|relatlimab|mesh-list
110625850|NCT03521830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110625851|NCT03521830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110625852|NCT03521830|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110625853|NCT03521830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110625855|NCT03496610|Anesthetics, Local|anesthetics, local|mesh-ancestor
110625856|NCT03496610|Anesthetics|anesthetics|mesh-ancestor
110625857|NCT03496610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110625858|NCT03496610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110625859|NCT03496610|Sensory System Agents|sensory system agents|mesh-ancestor
110625860|NCT03496610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110625861|NCT03449485|Chlorprothixene|chlorprothixene|mesh-list
110625862|NCT03449485|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110625863|NCT03449485|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110625864|NCT03449485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110625865|NCT03449485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110625866|NCT03449485|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110625867|NCT03449485|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110625868|NCT03449485|Dopamine Agents|dopamine agents|mesh-ancestor
110625869|NCT03449485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110625870|NCT03449485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110625872|NCT03448783|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110625873|NCT03448783|Antithrombins|antithrombins|mesh-ancestor
110625874|NCT03448783|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110625875|NCT03448783|Protease Inhibitors|protease inhibitors|mesh-ancestor
110625876|NCT03448783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110625877|NCT03448783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110625878|NCT03448783|Anticoagulants|anticoagulants|mesh-ancestor
110625879|NCT03434730|Cyclosporine|cyclosporine|mesh-list
110625880|NCT03434730|Mycophenolic Acid|mycophenolic acid|mesh-list
110625881|NCT03434730|Lenograstim|lenograstim|mesh-list
110625882|NCT03434730|Cyclosporins|cyclosporins|mesh-list
110625883|NCT03434730|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110625884|NCT03434730|Immunologic Factors|immunologic factors|mesh-ancestor
110625885|NCT03434730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110625886|NCT03434730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110625887|NCT03434730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110625888|NCT03434730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110625889|NCT03434730|Antifungal Agents|antifungal agents|mesh-ancestor
110625890|NCT03434730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110625891|NCT03434730|Dermatologic Agents|dermatologic agents|mesh-ancestor
110625892|NCT03434730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110625893|NCT03434730|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110154415|NCT00011362|Dexamethasone|dexamethasone|mesh-list
110625894|NCT03434730|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110625895|NCT03434730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110625896|NCT03434730|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110625897|NCT03434730|Antitubercular Agents|antitubercular agents|mesh-ancestor
110625898|NCT03434730|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110625899|NCT03418649|Eplerenone|eplerenone|mesh-list
110625900|NCT03418649|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110625901|NCT03418649|Hormone Antagonists|hormone antagonists|mesh-ancestor
110625902|NCT03418649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110647309|NCT00487240|Insulin|insulin|mesh-list
110625903|NCT03418649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110625904|NCT03418649|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110625905|NCT03418649|Diuretics|diuretics|mesh-ancestor
110625906|NCT03418649|Natriuretic Agents|natriuretic agents|mesh-ancestor
110625907|NCT03418649|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110625908|NCT03315832|Valsartan|valsartan|mesh-list
110625909|NCT03315832|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110625910|NCT03315832|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110625911|NCT03315832|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110625912|NCT03315832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110625913|NCT03260920|Oxytocin|oxytocin|mesh-list
110625914|NCT03260920|Oxytocics|oxytocics|mesh-ancestor
110625915|NCT03260920|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110625916|NCT03260920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110625917|NCT03124355|Bromides|bromides|mesh-list
110625918|NCT03124355|Galantamine|galantamine|mesh-list
110625919|NCT03124355|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
110625920|NCT03124355|Anticonvulsants|anticonvulsants|mesh-ancestor
110625921|NCT03124355|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110625922|NCT03124355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110625923|NCT03124355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110625924|NCT03124355|Cholinergic Agents|cholinergic agents|mesh-ancestor
110625925|NCT03124355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110625926|NCT03124355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110625927|NCT03124355|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110625928|NCT03124355|Autonomic Agents|autonomic agents|mesh-ancestor
110625929|NCT03124355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110625930|NCT03124355|Nootropic Agents|nootropic agents|mesh-ancestor
110625931|NCT03122652|Teriflunomide|teriflunomide|mesh-list
110625932|NCT03122652|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110625933|NCT03122652|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110625934|NCT03122652|Analgesics|analgesics|mesh-ancestor
110625935|NCT03122652|Sensory System Agents|sensory system agents|mesh-ancestor
110625936|NCT03122652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110625937|NCT03122652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110625938|NCT03122652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110625939|NCT03122652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110625940|NCT03122652|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110625941|NCT03122652|Immunologic Factors|immunologic factors|mesh-ancestor
110625942|NCT03011268|Adalimumab|adalimumab|mesh-list
110625943|NCT03011268|Infliximab|infliximab|mesh-list
110625944|NCT03011268|Golimumab|golimumab|mesh-list
110625946|NCT03011268|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110625947|NCT03011268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110625948|NCT03011268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110625949|NCT03011268|Dermatologic Agents|dermatologic agents|mesh-ancestor
110625950|NCT03011268|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110625951|NCT03011268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110625952|NCT03011268|Immunologic Factors|immunologic factors|mesh-ancestor
110625953|NCT03011268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110625954|NCT02944578|Curcumin|curcumin|mesh-list
110625955|NCT02944578|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110625956|NCT02944578|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110625957|NCT02944578|Analgesics|analgesics|mesh-ancestor
110625958|NCT02944578|Sensory System Agents|sensory system agents|mesh-ancestor
110625959|NCT02944578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110625960|NCT02944578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110625961|NCT02944578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110625962|NCT02944578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110647646|NCT01969643|SGN-LIV1A|sgn-liv1a|mesh-list
110625963|NCT02944578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110625964|NCT02944578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110625965|NCT02944578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110625967|NCT02889523|Cyclophosphamide|cyclophosphamide|mesh-list
110625969|NCT02889523|Doxorubicin|doxorubicin|mesh-list
110625970|NCT02889523|Vincristine|vincristine|mesh-list
110625971|NCT02889523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110625972|NCT02889523|Immunologic Factors|immunologic factors|mesh-ancestor
110625973|NCT02889523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110625974|NCT02889523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110625975|NCT02889523|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110625976|NCT02889523|Alkylating Agents|alkylating agents|mesh-ancestor
110625977|NCT02889523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110625978|NCT02889523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110625979|NCT02889523|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110625980|NCT02889523|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110625981|NCT02889523|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110625982|NCT02889523|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110625983|NCT02889523|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110625984|NCT02889523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110625985|NCT02889523|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110625986|NCT02889523|Tubulin Modulators|tubulin modulators|mesh-ancestor
110625987|NCT02889523|Antimitotic Agents|antimitotic agents|mesh-ancestor
110625988|NCT02889523|Mitosis Modulators|mitosis modulators|mesh-ancestor
110625989|NCT02889523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110625990|NCT02889523|Glucocorticoids|glucocorticoids|mesh-ancestor
110625991|NCT02889523|Hormones|hormones|mesh-ancestor
110625992|NCT02889523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110625993|NCT02889523|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110625994|NCT02771626|Nivolumab|nivolumab|mesh-list
110647764|NCT00555906|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110625995|NCT02771626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110625996|NCT02771626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110625997|NCT02771626|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110625998|NCT02771626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110625999|NCT02616302|Dexlansoprazole|dexlansoprazole|mesh-list
110626000|NCT02616302|Lansoprazole|lansoprazole|mesh-list
110626001|NCT02616302|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110626002|NCT02616302|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110626003|NCT02616302|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110626004|NCT02616302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110626005|NCT02616302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110626006|NCT02469753|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
110626007|NCT02469753|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110626008|NCT02469753|Analgesics|analgesics|mesh-ancestor
110626009|NCT02469753|Sensory System Agents|sensory system agents|mesh-ancestor
110626010|NCT02469753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110626011|NCT02469753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110626012|NCT02469753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110626013|NCT02469753|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110626015|NCT02374242|Ipilimumab|ipilimumab|mesh-list
110626016|NCT02374242|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110626017|NCT02374242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110626018|NCT02374242|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110626019|NCT02374242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110626020|NCT02314988|Tranexamic Acid|tranexamic acid|mesh-list
110626021|NCT02314988|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110626022|NCT02314988|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110626023|NCT02314988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110626024|NCT02314988|Hemostatics|hemostatics|mesh-ancestor
110626025|NCT02314988|Coagulants|coagulants|mesh-ancestor
110626026|NCT02272790|Paclitaxel|paclitaxel|mesh-list
110626027|NCT02272790|Carboplatin|carboplatin|mesh-list
110626028|NCT02272790|Gemcitabine|gemcitabine|mesh-list
110626029|NCT02272790|Adavosertib|adavosertib|mesh-list
110626030|NCT02272790|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110626031|NCT02272790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110626032|NCT02272790|Tubulin Modulators|tubulin modulators|mesh-ancestor
110626033|NCT02272790|Antimitotic Agents|antimitotic agents|mesh-ancestor
110626034|NCT02272790|Mitosis Modulators|mitosis modulators|mesh-ancestor
110626035|NCT02272790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110626036|NCT02272790|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110626037|NCT02272790|Antimetabolites|antimetabolites|mesh-ancestor
110626038|NCT02272790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110626039|NCT02032953|Amino-acid, glucose, and electrolyte solution|amino-acid, glucose, and electrolyte solution|mesh-list
110626040|NCT02032953|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
110626041|NCT02032953|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110626042|NCT01850355|Buspirone|buspirone|mesh-list
110648012|NCT00946764|Imipramine|imipramine|mesh-list
110626043|NCT01850355|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110626044|NCT01850355|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110626045|NCT01850355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110626046|NCT01850355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110626047|NCT01850355|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110626048|NCT01850355|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110626049|NCT01850355|Serotonin Agents|serotonin agents|mesh-ancestor
110626050|NCT01850355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110626051|NCT01850355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110626052|NCT01582776|Lenalidomide|lenalidomide|mesh-list
110626053|NCT01582776|Obinutuzumab|obinutuzumab|mesh-list
110626054|NCT01582776|Immunologic Factors|immunologic factors|mesh-ancestor
110626055|NCT01582776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110626056|NCT01582776|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110626057|NCT01582776|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110626058|NCT01582776|Growth Substances|growth substances|mesh-ancestor
110626059|NCT01582776|Growth Inhibitors|growth inhibitors|mesh-ancestor
110626060|NCT01582776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110626061|NCT01582776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110626062|NCT01464164|Prednisone|prednisone|mesh-list
110626063|NCT01464164|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110626064|NCT01464164|Glucocorticoids|glucocorticoids|mesh-ancestor
110626065|NCT01464164|Hormones|hormones|mesh-ancestor
110626066|NCT01464164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110626067|NCT01464164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110626068|NCT01464164|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110626069|NCT01464164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110626126|NCT00199069|Dexamethasone|dexamethasone|mesh-list
110626127|NCT00199069|Prednisolone|prednisolone|mesh-list
110626128|NCT00199069|Cyclophosphamide|cyclophosphamide|mesh-list
110626130|NCT00199069|Methotrexate|methotrexate|mesh-list
110626131|NCT00199069|Vincristine|vincristine|mesh-list
110626132|NCT00199069|Doxorubicin|doxorubicin|mesh-list
110626133|NCT00199069|Daunorubicin|daunorubicin|mesh-list
110626134|NCT00199069|Asparaginase|asparaginase|mesh-list
110626135|NCT00199069|Mitoxantrone|mitoxantrone|mesh-list
110626136|NCT00199069|Mercaptopurine|mercaptopurine|mesh-list
110626137|NCT00199069|Thioguanine|thioguanine|mesh-list
110626138|NCT00199069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110626139|NCT00199069|Immunologic Factors|immunologic factors|mesh-ancestor
110626140|NCT00199069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110626141|NCT00199069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110626142|NCT00199069|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110626143|NCT00199069|Alkylating Agents|alkylating agents|mesh-ancestor
110626144|NCT00199069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110626145|NCT00199069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110626146|NCT00199069|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110626147|NCT00199069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110626148|NCT00199069|Antiemetics|antiemetics|mesh-ancestor
110626149|NCT00199069|Autonomic Agents|autonomic agents|mesh-ancestor
110626150|NCT00199069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110626151|NCT00199069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110626152|NCT00199069|Glucocorticoids|glucocorticoids|mesh-ancestor
110626153|NCT00199069|Hormones|hormones|mesh-ancestor
110626154|NCT00199069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110626155|NCT00199069|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110626156|NCT00199069|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110626157|NCT00199069|Abortifacient Agents|abortifacient agents|mesh-ancestor
110626158|NCT00199069|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110626159|NCT00199069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110626160|NCT00199069|Antimetabolites|antimetabolites|mesh-ancestor
110626161|NCT00199069|Dermatologic Agents|dermatologic agents|mesh-ancestor
110626162|NCT00199069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110626163|NCT00199069|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110626164|NCT00199069|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110626165|NCT00199069|Antiviral Agents|antiviral agents|mesh-ancestor
110626166|NCT00199069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110626167|NCT00199069|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110626168|NCT00199069|Tubulin Modulators|tubulin modulators|mesh-ancestor
110626169|NCT00199069|Antimitotic Agents|antimitotic agents|mesh-ancestor
110626170|NCT00199069|Mitosis Modulators|mitosis modulators|mesh-ancestor
110626171|NCT00199069|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110626172|NCT00199069|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110626173|NCT00199069|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110626174|NCT00199069|Analgesics|analgesics|mesh-ancestor
110626175|NCT00199069|Sensory System Agents|sensory system agents|mesh-ancestor
110626176|NCT00199043|Allopurinol|allopurinol|mesh-list
110626177|NCT00199043|Rasburicase|rasburicase|mesh-list
110626178|NCT00199043|Antimetabolites|antimetabolites|mesh-ancestor
110626179|NCT00199043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110626180|NCT00199043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110626181|NCT00199043|Gout Suppressants|gout suppressants|mesh-ancestor
110626182|NCT00199043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110626183|NCT00199043|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110626184|NCT00199043|Antioxidants|antioxidants|mesh-ancestor
110626185|NCT00199043|Protective Agents|protective agents|mesh-ancestor
110626186|NCT00199043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110626187|NCT02601989|Tadalafil|tadalafil|mesh-list
110626188|NCT02601989|Vasodilator Agents|vasodilator agents|mesh-ancestor
110626189|NCT02601989|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110626190|NCT02601989|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110626191|NCT02601989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110626192|NCT02601989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110626193|NCT02601989|Urological Agents|urological agents|mesh-ancestor
110626194|NCT01067053|Bevacizumab|bevacizumab|mesh-list
110626195|NCT01067053|Capecitabine|capecitabine|mesh-list
110626197|NCT01067053|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110626198|NCT01067053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110626199|NCT01067053|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110626200|NCT01067053|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110626201|NCT01067053|Growth Substances|growth substances|mesh-ancestor
110626202|NCT01067053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110626203|NCT01067053|Growth Inhibitors|growth inhibitors|mesh-ancestor
110626204|NCT01067053|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110626205|NCT01067053|Antimetabolites|antimetabolites|mesh-ancestor
110626206|NCT01067053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110626207|NCT02601287|Botulinum Toxins|botulinum toxins|mesh-list
110626208|NCT02601287|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110626209|NCT02601287|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110626210|NCT02601287|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110626211|NCT02601287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110648722|NCT00715871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110626212|NCT02601287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110626213|NCT02601287|Cholinergic Agents|cholinergic agents|mesh-ancestor
110626214|NCT02601287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110626215|NCT02601287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110626216|NCT02601287|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110626217|NCT02601287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110626220|NCT01067365|Enclomiphene|enclomiphene|mesh-list
110626221|NCT01067365|Clomiphene|clomiphene|mesh-list
110626222|NCT01067365|Zuclomiphene|zuclomiphene|mesh-list
110626223|NCT01067365|Anticoagulants|anticoagulants|mesh-ancestor
110626224|NCT01067365|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110626225|NCT01067365|Chelating Agents|chelating agents|mesh-ancestor
110626226|NCT01067365|Sequestering Agents|sequestering agents|mesh-ancestor
110626227|NCT01067365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110626228|NCT01067365|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110626229|NCT01067365|Hormone Antagonists|hormone antagonists|mesh-ancestor
110648843|NCT00115765|Growth Inhibitors|growth inhibitors|mesh-ancestor
110626230|NCT01067365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110626231|NCT01067365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110626232|NCT01067365|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110626233|NCT01067365|Fertility Agents|fertility agents|mesh-ancestor
110626234|NCT01067365|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110626235|NCT01067365|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110626236|NCT01067365|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110626237|NCT00568776|Inositol|inositol|mesh-list
110626238|NCT00568776|Vitamin B Complex|vitamin b complex|mesh-ancestor
110626239|NCT00568776|Vitamins|vitamins|mesh-ancestor
110626240|NCT00568776|Micronutrients|micronutrients|mesh-ancestor
110626241|NCT00568776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110626242|NCT01067443|Amphotericin B|amphotericin b|mesh-list
110626243|NCT01067443|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
110626244|NCT01067443|Miltefosine|miltefosine|mesh-list
110626245|NCT01067443|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
110626246|NCT01067443|Amebicides|amebicides|mesh-ancestor
110626247|NCT01067443|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110626248|NCT01067443|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110626249|NCT01067443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110626250|NCT01067443|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110626251|NCT01067443|Antifungal Agents|antifungal agents|mesh-ancestor
110626252|NCT01067443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110626253|NCT01067443|Schistosomicides|schistosomicides|mesh-ancestor
110626254|NCT01067443|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110626255|NCT01067443|Anthelmintics|anthelmintics|mesh-ancestor
110626256|NCT01065259|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
110626257|NCT01065259|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110626258|NCT01065259|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110626259|NCT01065259|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110253154|NCT00162396|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110626260|NCT01065259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110626262|NCT01065259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110626263|NCT01065259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110626265|NCT00822666|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110626266|NCT00822666|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110626267|NCT00822666|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110626268|NCT00822666|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110626269|NCT00822666|Purinergic Agents|purinergic agents|mesh-ancestor
110626270|NCT00822666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110626271|NCT00822666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110626272|NCT00822666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110626273|NCT00816816|Docetaxel|docetaxel|mesh-list
110626274|NCT00816816|Fluorouracil|fluorouracil|mesh-list
110626275|NCT00816816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110626276|NCT00816816|Tubulin Modulators|tubulin modulators|mesh-ancestor
110626277|NCT00816816|Antimitotic Agents|antimitotic agents|mesh-ancestor
110626278|NCT00816816|Mitosis Modulators|mitosis modulators|mesh-ancestor
110649395|NCT00723515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110626279|NCT00816816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110626280|NCT00816816|Antimetabolites|antimetabolites|mesh-ancestor
110626281|NCT00816816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110626282|NCT00816816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110626283|NCT00816816|Immunologic Factors|immunologic factors|mesh-ancestor
110626284|NCT00816816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110626286|NCT00816894|Antiemetics|antiemetics|mesh-ancestor
110626287|NCT00816894|Autonomic Agents|autonomic agents|mesh-ancestor
110626288|NCT00816894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110626289|NCT00816894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110626290|NCT00816894|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110626291|NCT00816894|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110626292|NCT00816894|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110626293|NCT00816894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110626294|NCT00816894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110626295|NCT00816894|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110626296|NCT00816894|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110626297|NCT00816894|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110626298|NCT00816894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110626299|NCT00816894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110626300|NCT00816894|Serotonin Agents|serotonin agents|mesh-ancestor
110626301|NCT00635154|Dexamethasone|dexamethasone|mesh-list
110649605|NCT00895076|Hormones|hormones|mesh-ancestor
110626302|NCT00635154|Dexamethasone acetate|dexamethasone acetate|mesh-list
110626303|NCT00635154|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
110626304|NCT00635154|BB 1101|bb 1101|mesh-list
110626305|NCT00635154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110626306|NCT00635154|Antiemetics|antiemetics|mesh-ancestor
110626307|NCT00635154|Autonomic Agents|autonomic agents|mesh-ancestor
110626308|NCT00635154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110649667|NCT01080079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110626309|NCT00635154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110626310|NCT00635154|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110626311|NCT00635154|Glucocorticoids|glucocorticoids|mesh-ancestor
110626312|NCT00635154|Hormones|hormones|mesh-ancestor
110649735|NCT00908336|Tubulin Modulators|tubulin modulators|mesh-ancestor
110626313|NCT00635154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110626314|NCT00635154|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110626315|NCT00635154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110626316|NCT00635154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110626317|NCT00635154|Protease Inhibitors|protease inhibitors|mesh-ancestor
110626318|NCT00635154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110626319|NCT00635154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110626321|NCT00822744|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110626322|NCT00822744|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110626323|NCT00822744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110626324|NCT00822744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110626325|NCT00822744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110626326|NCT00822744|Serotonin Agents|serotonin agents|mesh-ancestor
110626327|NCT00822744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110626328|NCT00819468|Teduglutide|teduglutide|mesh-list
110626329|NCT00819468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110649891|NCT00908726|Propofol|propofol|mesh-list
110273609|NCT00178698|Interferons|interferons|mesh-list
110626330|NCT00819468|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110626331|NCT00819468|Protective Agents|protective agents|mesh-ancestor
110626332|NCT00819468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110626333|NCT01067599|Nicotine|nicotine|mesh-list
110626334|NCT01067599|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110626335|NCT01067599|Autonomic Agents|autonomic agents|mesh-ancestor
110626336|NCT01067599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110626337|NCT01067599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110626338|NCT01067599|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110626339|NCT01067599|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110626340|NCT01067599|Cholinergic Agents|cholinergic agents|mesh-ancestor
110626341|NCT01067599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110650018|NCT00509067|Antidepressive Agents|antidepressive agents|mesh-ancestor
110626342|NCT01067599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110626344|NCT00778817|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110626345|NCT00778817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110626346|NCT00293059|Dienogest|dienogest|mesh-list
110626347|NCT00293059|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110626348|NCT00293059|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110626349|NCT00293059|Estradiol|estradiol|mesh-list
110626350|NCT00293059|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110626351|NCT00293059|Estrogens|estrogens|mesh-ancestor
110626352|NCT00293059|Hormones|hormones|mesh-ancestor
110626353|NCT00293059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110626354|NCT00293059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110626355|NCT00293059|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110626356|NCT00293059|Contraceptive Agents|contraceptive agents|mesh-ancestor
110650154|NCT00927602|Fondaparinux|fondaparinux|mesh-list
110626357|NCT00293059|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110626358|NCT00293059|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110626359|NCT00293059|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110626360|NCT00293059|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110626361|NCT00293059|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110626362|NCT00293059|Hormone Antagonists|hormone antagonists|mesh-ancestor
110650227|NCT02430077|Cathartics|cathartics|mesh-ancestor
110626363|NCT00293059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110626364|NCT00293059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110626366|NCT00756275|Varenicline|varenicline|mesh-list
110626367|NCT00756275|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110626368|NCT00756275|Autonomic Agents|autonomic agents|mesh-ancestor
110626369|NCT00756275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110626370|NCT00756275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110626371|NCT00756275|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110626372|NCT00756275|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110626373|NCT00756275|Cholinergic Agents|cholinergic agents|mesh-ancestor
110626374|NCT00756275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110626375|NCT00756275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110626376|NCT04096547|Rivaroxaban|rivaroxaban|mesh-list
110626377|NCT04096547|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110626378|NCT04096547|Antithrombins|antithrombins|mesh-ancestor
110626379|NCT04096547|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110626380|NCT04096547|Protease Inhibitors|protease inhibitors|mesh-ancestor
110626382|NCT04096547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110626383|NCT04096547|Anticoagulants|anticoagulants|mesh-ancestor
110626384|NCT00298831|Rocuronium|rocuronium|mesh-list
110626385|NCT00298831|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110650422|NCT00567476|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110626386|NCT00298831|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110626387|NCT00298831|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110626388|NCT00298831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110626389|NCT00298831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110626390|NCT00758069|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110626391|NCT00758069|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110626392|NCT00758069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110626393|NCT00758069|Incretins|incretins|mesh-ancestor
110626394|NCT00758069|Hormones|hormones|mesh-ancestor
110626395|NCT00758069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110626396|NCT00758069|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110626397|NCT00758069|Protease Inhibitors|protease inhibitors|mesh-ancestor
110626398|NCT00758069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110626399|NCT00758069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110626400|NCT01067677|Diphenhydramine|diphenhydramine|mesh-list
110626401|NCT01067677|Promethazine|promethazine|mesh-list
110626402|NCT01067677|Ondansetron|ondansetron|mesh-list
110626403|NCT01067677|Metoclopramide|metoclopramide|mesh-list
110626404|NCT01067677|Antiemetics|antiemetics|mesh-ancestor
110626405|NCT01067677|Autonomic Agents|autonomic agents|mesh-ancestor
110626406|NCT01067677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110626407|NCT01067677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110626408|NCT01067677|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110626409|NCT01067677|Antipruritics|antipruritics|mesh-ancestor
110626410|NCT01067677|Dermatologic Agents|dermatologic agents|mesh-ancestor
110626411|NCT01067677|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110626412|NCT01067677|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110626413|NCT01067677|Serotonin Agents|serotonin agents|mesh-ancestor
110650697|NCT01815359|Vitamins|vitamins|mesh-ancestor
110626414|NCT01067677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110650775|NCT00507507|Tenofovir|tenofovir|mesh-list
110626415|NCT01067677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110626416|NCT01067677|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110626417|NCT01067677|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110626418|NCT01067677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110626419|NCT01067677|Anesthetics, Local|anesthetics, local|mesh-ancestor
110626420|NCT01067677|Anesthetics|anesthetics|mesh-ancestor
110626421|NCT01067677|Sensory System Agents|sensory system agents|mesh-ancestor
110626422|NCT01067677|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110626423|NCT01067677|Histamine Antagonists|histamine antagonists|mesh-ancestor
110626424|NCT01067677|Histamine Agents|histamine agents|mesh-ancestor
110626425|NCT01067677|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110626426|NCT01067677|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110626427|NCT01067677|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110626428|NCT01067677|Dopamine Agents|dopamine agents|mesh-ancestor
110626429|NCT03979651|Hydroxychloroquine|hydroxychloroquine|mesh-list
110626430|NCT03979651|Trametinib|trametinib|mesh-list
110626431|NCT03979651|Antimalarials|antimalarials|mesh-ancestor
110626432|NCT03979651|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110626433|NCT03979651|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110626434|NCT03979651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110626435|NCT03979651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110154464|NCT00011635|Silymarin|silymarin|mesh-list
110626436|NCT03979651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110626437|NCT03979651|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110626438|NCT03979651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110626439|NCT03979651|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110626440|NCT02600741|Droperidol|droperidol|mesh-list
110626441|NCT02600741|Haloperidol|haloperidol|mesh-list
110626442|NCT02600741|Pimozide|pimozide|mesh-list
110626443|NCT02600741|Olanzapine|olanzapine|mesh-list
110626444|NCT02600741|Prochlorperazine|prochlorperazine|mesh-list
110626445|NCT02600741|Chlorpromazine|chlorpromazine|mesh-list
110626446|NCT02600741|Trifluoperazine|trifluoperazine|mesh-list
110626447|NCT02600741|Risperidone|risperidone|mesh-list
110626448|NCT02600741|Aripiprazole|aripiprazole|mesh-list
110626449|NCT02600741|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110626450|NCT02600741|Paliperidone Palmitate|paliperidone palmitate|mesh-list
110626451|NCT02600741|Ziprasidone|ziprasidone|mesh-list
110626452|NCT02600741|Clozapine|clozapine|mesh-list
110626453|NCT02600741|Asenapine|asenapine|mesh-list
110626454|NCT02600741|Loxapine|loxapine|mesh-list
110626455|NCT02600741|Iloperidone|iloperidone|mesh-list
110626456|NCT02600741|Perphenazine|perphenazine|mesh-list
110626457|NCT02600741|Fluphenazine|fluphenazine|mesh-list
110626458|NCT02600741|Fluphenazine depot|fluphenazine depot|mesh-list
110626459|NCT02600741|Fluphenazine enanthate|fluphenazine enanthate|mesh-list
110626460|NCT02600741|Thioridazine|thioridazine|mesh-list
110626461|NCT02600741|Thiothixene|thiothixene|mesh-list
110626462|NCT02600741|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110626463|NCT02600741|Serotonin Agents|serotonin agents|mesh-ancestor
110626464|NCT02600741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110650970|NCT01011699|Niacin|niacin|mesh-list
110626465|NCT02600741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110626466|NCT02600741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110626467|NCT02600741|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110626468|NCT02600741|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110626469|NCT02600741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110626471|NCT02600741|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110626472|NCT02600741|Dopamine Agents|dopamine agents|mesh-ancestor
110626473|NCT02600741|Antiemetics|antiemetics|mesh-ancestor
110626474|NCT02600741|Autonomic Agents|autonomic agents|mesh-ancestor
110626475|NCT02600741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110626476|NCT02600741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110626477|NCT02600741|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110626478|NCT02600741|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110626479|NCT02600741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110626480|NCT02600741|Antidepressive Agents|antidepressive agents|mesh-ancestor
110626481|NCT02600741|Dopamine Agonists|dopamine agonists|mesh-ancestor
110626482|NCT02600741|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110626483|NCT02600741|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110626484|NCT02600741|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110626485|NCT02600741|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110626487|NCT02600741|GABA Antagonists|gaba antagonists|mesh-ancestor
110626489|NCT02600741|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110626490|NCT01065649|Nortriptyline|nortriptyline|mesh-list
110626491|NCT01065649|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110626492|NCT01065649|Antidepressive Agents|antidepressive agents|mesh-ancestor
110626493|NCT01065649|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110626494|NCT01065649|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110626495|NCT01065649|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110626496|NCT01065649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110626497|NCT01065649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110626498|NCT01065649|Adrenergic Agents|adrenergic agents|mesh-ancestor
110626499|NCT01065649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110626500|NCT01065649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110626501|NCT01065727|Mitoxantrone|mitoxantrone|mesh-list
110626502|NCT01065727|Natalizumab|natalizumab|mesh-list
110626503|NCT01065727|Immunologic Factors|immunologic factors|mesh-list
110626504|NCT01065727|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
110626505|NCT01065727|Immunomodulating Agents|immunomodulating agents|mesh-list
110626506|NCT01065727|Analgesics|analgesics|mesh-ancestor
110626507|NCT01065727|Sensory System Agents|sensory system agents|mesh-ancestor
110626509|NCT01065727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110626510|NCT01065727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110626511|NCT01065727|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110626512|NCT01065727|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110626513|NCT01065727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110626514|NCT01065727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110626516|NCT01065805|Antiviral Agents|antiviral agents|mesh-ancestor
110626517|NCT01065805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110626518|NCT00311623|Sirolimus|sirolimus|mesh-list
110626519|NCT00311623|Temsirolimus|temsirolimus|mesh-list
110626520|NCT00311623|MTOR Inhibitors|mtor inhibitors|mesh-list
110626521|NCT00311623|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110626522|NCT00311623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110626523|NCT00311623|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110626524|NCT00311623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110626525|NCT00311623|Antifungal Agents|antifungal agents|mesh-ancestor
110626526|NCT00311623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110626528|NCT00311623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110626529|NCT00311623|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110626530|NCT00311623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110626531|NCT00311623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110626532|NCT01067989|Zoledronic Acid|zoledronic acid|mesh-list
110626533|NCT01067989|Pamidronate|pamidronate|mesh-list
110626534|NCT01067989|Celecoxib|celecoxib|mesh-list
110626535|NCT01067989|Cyclophosphamide|cyclophosphamide|mesh-list
110626536|NCT01067989|Capecitabine|capecitabine|mesh-list
110626537|NCT01067989|Methotrexate|methotrexate|mesh-list
110626538|NCT01067989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110626539|NCT01067989|Immunologic Factors|immunologic factors|mesh-ancestor
110626540|NCT01067989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110626541|NCT01067989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110626542|NCT01067989|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110626543|NCT01067989|Alkylating Agents|alkylating agents|mesh-ancestor
110651630|NCT00933374|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110626544|NCT01067989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110626545|NCT01067989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110626546|NCT01067989|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110626547|NCT01067989|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110626548|NCT01067989|Antimetabolites|antimetabolites|mesh-ancestor
110626549|NCT01067989|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110626550|NCT01067989|Abortifacient Agents|abortifacient agents|mesh-ancestor
110626551|NCT01067989|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110626552|NCT01067989|Dermatologic Agents|dermatologic agents|mesh-ancestor
110626553|NCT01067989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110626554|NCT01067989|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110651716|NCT00503139|Etanercept|etanercept|mesh-list
110626555|NCT01067989|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110626556|NCT01067989|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110626557|NCT01067989|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110626559|NCT01067989|Sensory System Agents|sensory system agents|mesh-ancestor
110626560|NCT01067989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110626561|NCT01067989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110626562|NCT01067989|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110626563|NCT01067989|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110626564|NCT01067989|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110626565|NCT00633594|Rituximab|rituximab|mesh-list
110626566|NCT00633594|Lenalidomide|lenalidomide|mesh-list
110626567|NCT00633594|Bortezomib|bortezomib|mesh-list
110626568|NCT00633594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110626569|NCT00633594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110626570|NCT00633594|Immunologic Factors|immunologic factors|mesh-ancestor
110626571|NCT00633594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110626572|NCT00633594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110626573|NCT00633594|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110626574|NCT00633594|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110626575|NCT00633594|Growth Substances|growth substances|mesh-ancestor
110626576|NCT00633594|Growth Inhibitors|growth inhibitors|mesh-ancestor
110626577|NCT04840888|Itraconazole|itraconazole|mesh-list
110626578|NCT04840888|Carbamazepine|carbamazepine|mesh-list
110626580|NCT04840888|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110626581|NCT04840888|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110626582|NCT04840888|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110626583|NCT04840888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110626584|NCT04840888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110626585|NCT04840888|Antifungal Agents|antifungal agents|mesh-ancestor
110626586|NCT04840888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110626587|NCT04840888|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110626588|NCT04840888|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110626589|NCT04840888|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110626590|NCT04840888|Hormone Antagonists|hormone antagonists|mesh-ancestor
110626591|NCT04840888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110626592|NCT04840888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110626593|NCT04840888|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110626594|NCT04840888|Anticonvulsants|anticonvulsants|mesh-ancestor
110626595|NCT04840888|Antimanic Agents|antimanic agents|mesh-ancestor
110626596|NCT04840888|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110626597|NCT04840888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110626598|NCT04840888|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110626599|NCT04840888|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110626600|NCT04840888|Analgesics|analgesics|mesh-ancestor
110626601|NCT04840888|Sensory System Agents|sensory system agents|mesh-ancestor
110626602|NCT04840888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110626603|NCT04840888|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110626604|NCT04840888|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110626605|NCT04840888|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110626606|NCT04840888|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110626607|NCT00755807|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110626608|NCT00755807|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110626609|NCT00755807|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110652013|NCT02565719|Interferons|interferons|mesh-list
110626610|NCT00755807|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110626611|NCT00755807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110626612|NCT00755807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110626613|NCT00755807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110626615|NCT00755807|Sensory System Agents|sensory system agents|mesh-ancestor
110626616|NCT00755807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110626617|NCT00755807|Antidepressive Agents|antidepressive agents|mesh-ancestor
110626618|NCT00755807|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110626619|NCT00755807|Dopamine Agents|dopamine agents|mesh-ancestor
110626620|NCT05372224|Cholecalciferol|cholecalciferol|mesh-list
110626621|NCT05372224|Vitamin D|vitamin d|mesh-list
110626622|NCT05372224|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110652078|NCT00935246|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110626623|NCT05372224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110626624|NCT05372224|Vitamins|vitamins|mesh-ancestor
110626625|NCT05372224|Micronutrients|micronutrients|mesh-ancestor
110626626|NCT05372224|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110626627|NCT00631410|Sunitinib|sunitinib|mesh-list
110626628|NCT00631410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110626629|NCT00631410|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110626630|NCT00631410|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110626631|NCT00631410|Growth Substances|growth substances|mesh-ancestor
110626632|NCT00631410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110626633|NCT00631410|Growth Inhibitors|growth inhibitors|mesh-ancestor
110626635|NCT00631410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110652206|NCT02566733|Narcotics|narcotics|mesh-ancestor
110626636|NCT00631410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110626638|NCT00817284|Irinotecan|irinotecan|mesh-list
110626639|NCT00817284|Temozolomide|temozolomide|mesh-list
110652280|NCT00944684|Ribavirin|ribavirin|mesh-list
110626640|NCT00817284|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110626641|NCT00817284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110626642|NCT00817284|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110626643|NCT00817284|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110626644|NCT00817284|Growth Substances|growth substances|mesh-ancestor
110626645|NCT00817284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110626646|NCT00817284|Growth Inhibitors|growth inhibitors|mesh-ancestor
110626648|NCT00817284|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110626649|NCT00817284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110154488|NCT00005942|Daunorubicin|daunorubicin|mesh-list
110626650|NCT00817284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110626651|NCT00817284|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110626653|NCT04096157|Isavuconazole|isavuconazole|mesh-list
110626654|NCT04096157|Antifungal Agents|antifungal agents|mesh-ancestor
110626655|NCT04096157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110626656|NCT00823290|Sorafenib|sorafenib|mesh-list
110626657|NCT00823290|Panobinostat|panobinostat|mesh-list
110626658|NCT00823290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110626659|NCT00823290|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110626660|NCT00823290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110626661|NCT00823290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110626662|NCT00823290|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110626663|NCT00755417|Gabapentin|gabapentin|mesh-list
110626664|NCT00755417|Analgesics|analgesics|mesh-ancestor
110626665|NCT00755417|Sensory System Agents|sensory system agents|mesh-ancestor
110626666|NCT00755417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110626667|NCT00755417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110626668|NCT00755417|Anticonvulsants|anticonvulsants|mesh-ancestor
110626669|NCT00755417|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110626670|NCT00755417|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110626671|NCT00755417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110626672|NCT00755417|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110626674|NCT00755417|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110626675|NCT00755417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110626676|NCT00755417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110626677|NCT00755417|Antimanic Agents|antimanic agents|mesh-ancestor
110626678|NCT00777803|Botulinum Toxins|botulinum toxins|mesh-list
110626679|NCT00777803|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110626680|NCT00777803|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110626681|NCT00777803|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
110626682|NCT00777803|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110626683|NCT00777803|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110626684|NCT00777803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110626685|NCT00777803|Cholinergic Agents|cholinergic agents|mesh-ancestor
110626686|NCT00777803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110626687|NCT00777803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110626688|NCT00777803|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110626689|NCT00777803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110626690|NCT00825864|Dexamethasone|dexamethasone|mesh-list
110626691|NCT00825864|Diclofenac|diclofenac|mesh-list
110626692|NCT00825864|Dexamethasone acetate|dexamethasone acetate|mesh-list
110626693|NCT00825864|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110626694|NCT00825864|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
110626695|NCT00825864|BB 1101|bb 1101|mesh-list
110626696|NCT00825864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110626697|NCT00825864|Antiemetics|antiemetics|mesh-ancestor
110626698|NCT00825864|Autonomic Agents|autonomic agents|mesh-ancestor
110626699|NCT00825864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110626700|NCT00825864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110626701|NCT00825864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110626702|NCT00825864|Glucocorticoids|glucocorticoids|mesh-ancestor
110626703|NCT00825864|Hormones|hormones|mesh-ancestor
110626704|NCT00825864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110626705|NCT00825864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110626706|NCT00825864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110626707|NCT00825864|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110626708|NCT00825864|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110626709|NCT00825864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110626710|NCT00825864|Analgesics|analgesics|mesh-ancestor
110626711|NCT00825864|Sensory System Agents|sensory system agents|mesh-ancestor
110626712|NCT00825864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110626713|NCT00825864|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110626714|NCT00825864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110626715|NCT00825864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110626716|NCT00825864|Protease Inhibitors|protease inhibitors|mesh-ancestor
110626717|NCT00825942|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110626720|NCT00527332|Morphine|morphine|mesh-list
110626721|NCT00527332|Bupivacaine|bupivacaine|mesh-list
110626722|NCT00527332|Propofol|propofol|mesh-list
110626723|NCT00527332|Anesthetics, Local|anesthetics, local|mesh-ancestor
110626724|NCT00527332|Anesthetics|anesthetics|mesh-ancestor
110626725|NCT00527332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110626726|NCT00527332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110626727|NCT00527332|Sensory System Agents|sensory system agents|mesh-ancestor
110626728|NCT00527332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110626729|NCT00527332|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110626730|NCT00527332|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110626731|NCT00527332|Anesthetics, General|anesthetics, general|mesh-ancestor
110626732|NCT00527332|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110626733|NCT00527332|Narcotics|narcotics|mesh-ancestor
110626734|NCT00527332|Analgesics|analgesics|mesh-ancestor
110626735|NCT00527332|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110626736|NCT00820092|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
110626738|NCT00820092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110626739|NCT00820092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110626740|NCT00823602|Buserelin|buserelin|mesh-list
110626741|NCT00823602|Ganirelix|ganirelix|mesh-list
110626742|NCT00823602|Hormone Antagonists|hormone antagonists|mesh-ancestor
110626743|NCT00823602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110626744|NCT00823602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110652934|NCT02917564|Hormones|hormones|mesh-ancestor
110626745|NCT00823602|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110626746|NCT00823602|Fertility Agents|fertility agents|mesh-ancestor
110626747|NCT00823602|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110626749|NCT00820326|Antiemetics|antiemetics|mesh-ancestor
110626750|NCT00820326|Autonomic Agents|autonomic agents|mesh-ancestor
110626751|NCT00820326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110626752|NCT00820326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110626753|NCT00820326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110626754|NCT00820326|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110626755|NCT00820326|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110626756|NCT00820326|Serotonin Agents|serotonin agents|mesh-ancestor
110626757|NCT00820326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110626758|NCT00820326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110626759|NCT00916097|Docetaxel|docetaxel|mesh-list
110626760|NCT00916097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110626761|NCT00916097|Tubulin Modulators|tubulin modulators|mesh-ancestor
110626762|NCT00916097|Antimitotic Agents|antimitotic agents|mesh-ancestor
110626763|NCT00916097|Mitosis Modulators|mitosis modulators|mesh-ancestor
110626764|NCT00916097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110626765|NCT00629772|Infliximab|infliximab|mesh-list
110626766|NCT00629772|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110626767|NCT00629772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110626768|NCT00629772|Dermatologic Agents|dermatologic agents|mesh-ancestor
110626769|NCT00629772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110626770|NCT00629772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110626771|NCT00526630|Methylphenidate|methylphenidate|mesh-list
110626772|NCT00526630|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110626773|NCT00526630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110626774|NCT00526630|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110626775|NCT00526630|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110626776|NCT00526630|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110626777|NCT00526630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110626778|NCT00526630|Dopamine Agents|dopamine agents|mesh-ancestor
110626779|NCT00526630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110626780|NCT00755183|Methyltestosterone|methyltestosterone|mesh-list
110626781|NCT00755183|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110626782|NCT00755183|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110626783|NCT00755183|Testosterone|testosterone|mesh-list
110626784|NCT00755183|Testosterone undecanoate|testosterone undecanoate|mesh-list
110626785|NCT00755183|Testosterone enanthate|testosterone enanthate|mesh-list
110626786|NCT00755183|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
110626787|NCT00755183|Androgens|androgens|mesh-ancestor
110626789|NCT00755183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110626790|NCT00755183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110626791|NCT00755183|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110626792|NCT00755183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110626793|NCT00755183|Anabolic Agents|anabolic agents|mesh-ancestor
110626794|NCT00826254|Vitamins|vitamins|mesh-list
110626795|NCT00826254|Vitamin K|vitamin k|mesh-list
110626796|NCT00826254|Micronutrients|micronutrients|mesh-ancestor
110626797|NCT00826254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110626798|NCT00826254|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110626799|NCT00826254|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110626800|NCT00826254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110626801|NCT00826254|Hemostatics|hemostatics|mesh-ancestor
110626802|NCT00826254|Coagulants|coagulants|mesh-ancestor
110626803|NCT03875482|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110626804|NCT03875482|Immunologic Factors|immunologic factors|mesh-ancestor
110626805|NCT03875482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110626806|NCT00820404|BLI-489|bli-489|mesh-list
110626807|NCT00820404|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110626808|NCT00820404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110626809|NCT00820404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110626810|NCT00820404|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110626811|NCT00820404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110626812|NCT00820482|Menotropins|menotropins|mesh-list
110626813|NCT00820482|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110626814|NCT00820482|Fertility Agents|fertility agents|mesh-ancestor
110626815|NCT00820482|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110626816|NCT00820482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110626817|NCT00754793|Dexetimide|dexetimide|mesh-list
110626818|NCT00754793|Citalopram|citalopram|mesh-list
110626819|NCT00754793|Escitalopram|escitalopram|mesh-list
110626820|NCT00754793|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110626821|NCT00754793|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110626822|NCT00754793|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110653262|NCT00954564|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110626823|NCT00754793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110626824|NCT00754793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110626825|NCT00754793|Serotonin Agents|serotonin agents|mesh-ancestor
110253273|NCT02275702|Dexamethasone|dexamethasone|mesh-list
110626826|NCT00754793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110626827|NCT00754793|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110626828|NCT00754793|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110626829|NCT00754793|Parasympatholytics|parasympatholytics|mesh-ancestor
110626830|NCT00754793|Autonomic Agents|autonomic agents|mesh-ancestor
110626831|NCT00754793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110626832|NCT00754793|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110626833|NCT00754793|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110626834|NCT00754793|Cholinergic Agents|cholinergic agents|mesh-ancestor
110626835|NCT00754793|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110626836|NCT00754793|Antidepressive Agents|antidepressive agents|mesh-ancestor
110626837|NCT00754793|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110626838|NCT00826566|Caffeine|caffeine|mesh-list
110626839|NCT00826566|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110626840|NCT00826566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110626841|NCT00826566|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110626842|NCT00826566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110626843|NCT00826566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110626844|NCT00826566|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110626845|NCT00826566|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110626846|NCT00826566|Purinergic Agents|purinergic agents|mesh-ancestor
110626847|NCT00826566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110626848|NCT03999190|Raclopride|raclopride|mesh-list
110626849|NCT03999190|Dextroamphetamine|dextroamphetamine|mesh-list
110626850|NCT03999190|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110626851|NCT03999190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110626852|NCT03999190|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110653362|NCT00435370|Dopamine Agents|dopamine agents|mesh-ancestor
110626853|NCT03999190|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110626854|NCT03999190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110626855|NCT03999190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110626856|NCT03999190|Dopamine Agents|dopamine agents|mesh-ancestor
110626857|NCT03999190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110626858|NCT03999190|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110626859|NCT03999190|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110626860|NCT03999190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110626861|NCT03999190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110626862|NCT03999190|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110626864|NCT05244694|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110626865|NCT05244694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110626866|NCT00626028|Nitric Oxide|nitric oxide|mesh-list
110626867|NCT00626028|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110626868|NCT00626028|Autonomic Agents|autonomic agents|mesh-ancestor
110653430|NCT00549848|Antiemetics|antiemetics|mesh-ancestor
110626870|NCT00626028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110626871|NCT00626028|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110626872|NCT00626028|Respiratory System Agents|respiratory system agents|mesh-ancestor
110626873|NCT00626028|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110626874|NCT00626028|Antioxidants|antioxidants|mesh-ancestor
110626875|NCT00626028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110626876|NCT00626028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110626877|NCT00626028|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
110626878|NCT00626028|Vasodilator Agents|vasodilator agents|mesh-ancestor
110626879|NCT00626028|Gasotransmitters|gasotransmitters|mesh-ancestor
110626880|NCT00626028|Protective Agents|protective agents|mesh-ancestor
110626881|NCT00826644|Etoposide|etoposide|mesh-list
110626882|NCT00826644|Belotecan|belotecan|mesh-list
110626883|NCT00826644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110626884|NCT00826644|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110626885|NCT00826644|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110626886|NCT00826644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110626887|NCT00826644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110626888|NCT00826644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110626889|NCT00826644|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110626890|NCT00826722|Levetiracetam|levetiracetam|mesh-list
110626891|NCT00826722|Anticonvulsants|anticonvulsants|mesh-ancestor
110626892|NCT00826722|Nootropic Agents|nootropic agents|mesh-ancestor
110626893|NCT04922944|Vaccines|vaccines|mesh-list
110626894|NCT04922944|Immunologic Factors|immunologic factors|mesh-ancestor
110626895|NCT04922944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110626896|NCT00820794|Lithium Carbonate|lithium carbonate|mesh-list
110626897|NCT00820794|Antidepressive Agents|antidepressive agents|mesh-ancestor
110626898|NCT00820794|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110626899|NCT00820794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110626900|NCT00820794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110626901|NCT00820794|Antimanic Agents|antimanic agents|mesh-ancestor
110626902|NCT00820794|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110626903|NCT00820794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110626904|NCT00820794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110626905|NCT04044378|Ifosfamide|ifosfamide|mesh-list
110626906|NCT04044378|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110626907|NCT04044378|Alkylating Agents|alkylating agents|mesh-ancestor
110626908|NCT04044378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110626909|NCT04044378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110626910|NCT00628758|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
110626911|NCT00628758|Formoterol Fumarate|formoterol fumarate|mesh-list
110626912|NCT00628758|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110626913|NCT00628758|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110626914|NCT00628758|Respiratory System Agents|respiratory system agents|mesh-ancestor
110626915|NCT00628758|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110626916|NCT00628758|Autonomic Agents|autonomic agents|mesh-ancestor
110626917|NCT00628758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110626918|NCT00628758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110626919|NCT00628758|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110626920|NCT00628758|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110626921|NCT00628758|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110626922|NCT00628758|Adrenergic Agents|adrenergic agents|mesh-ancestor
110626923|NCT00628758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110626924|NCT00628758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110626926|NCT00821028|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110626927|NCT00821028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110626928|NCT00821028|Tubulin Modulators|tubulin modulators|mesh-ancestor
110626929|NCT00821028|Antimitotic Agents|antimitotic agents|mesh-ancestor
110626930|NCT00821028|Mitosis Modulators|mitosis modulators|mesh-ancestor
110626931|NCT00821028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110626932|NCT00826878|Tivozanib|tivozanib|mesh-list
110626933|NCT00826878|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110626934|NCT00826878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110626935|NCT00826878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110626936|NCT00827034|Warfarin|warfarin|mesh-list
110626937|NCT00827034|Anticoagulants|anticoagulants|mesh-ancestor
110626938|NCT02600585|Vaccines|vaccines|mesh-list
110626939|NCT02600585|Immunologic Factors|immunologic factors|mesh-ancestor
110626940|NCT02600585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110626941|NCT00525148|Afatinib|afatinib|mesh-list
110626942|NCT00525148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110626943|NCT00525148|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110626944|NCT00525148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110626945|NCT00525148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110626946|NCT00754325|Dasatinib|dasatinib|mesh-list
110626947|NCT00754325|Fulvestrant|fulvestrant|mesh-list
110626948|NCT00754325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110626949|NCT00754325|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110626950|NCT00754325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110626951|NCT00754325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110626952|NCT00754325|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110626953|NCT00754325|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110626954|NCT00754325|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110626955|NCT00754325|Hormone Antagonists|hormone antagonists|mesh-ancestor
110626956|NCT00754325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110626957|NCT00754325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110626958|NCT00524680|Cholecalciferol|cholecalciferol|mesh-list
110626959|NCT00524680|Vitamin D|vitamin d|mesh-list
110253284|NCT02275702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110626960|NCT00524680|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110626961|NCT00524680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110626962|NCT00524680|Vitamins|vitamins|mesh-ancestor
110626963|NCT00524680|Micronutrients|micronutrients|mesh-ancestor
110626964|NCT00524680|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110626965|NCT00298363|Tenofovir|tenofovir|mesh-list
110626966|NCT00298363|Emtricitabine|emtricitabine|mesh-list
110651628|NCT00933374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110626967|NCT00298363|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110626968|NCT00298363|Entecavir|entecavir|mesh-list
110626969|NCT00298363|Antiviral Agents|antiviral agents|mesh-ancestor
110626970|NCT00298363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110626971|NCT00298363|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110626972|NCT00298363|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110626973|NCT00298363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110653983|NCT00962286|Furosemide|furosemide|mesh-list
110626974|NCT00298363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110626975|NCT00298363|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110626976|NCT00298363|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110626977|NCT00821262|Propofol|propofol|mesh-list
110626978|NCT00821262|Sevoflurane|sevoflurane|mesh-list
110626979|NCT00821262|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110626980|NCT00821262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110626981|NCT00821262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110626982|NCT00821262|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110626983|NCT00821262|Anesthetics, General|anesthetics, general|mesh-ancestor
110626984|NCT00821262|Anesthetics|anesthetics|mesh-ancestor
110626985|NCT00821262|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110626986|NCT00821262|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110626987|NCT00524368|Ritonavir|ritonavir|mesh-list
110626988|NCT00524368|Darunavir|darunavir|mesh-list
110626989|NCT00524368|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110626990|NCT00524368|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110626991|NCT00524368|Protease Inhibitors|protease inhibitors|mesh-ancestor
110626992|NCT00524368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110626993|NCT00524368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110626994|NCT00524368|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110626995|NCT00524368|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110626996|NCT00524368|Antiviral Agents|antiviral agents|mesh-ancestor
110626997|NCT00524368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110626998|NCT00524368|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110626999|NCT00524368|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110627000|NCT00777101|Capecitabine|capecitabine|mesh-list
110627002|NCT00777101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110627003|NCT00777101|Antimetabolites|antimetabolites|mesh-ancestor
110651629|NCT00933374|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110627004|NCT00777101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110627005|NCT00777101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110627006|NCT00777101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110627007|NCT00777101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110627008|NCT00830856|Lamivudine|lamivudine|mesh-list
110627009|NCT00830856|Nevirapine|nevirapine|mesh-list
110627010|NCT00830856|Stavudine|stavudine|mesh-list
110627011|NCT00830856|Stavudine, lamivudine, nevirapine drug combination|stavudine, lamivudine, nevirapine drug combination|mesh-list
110627012|NCT00830856|Fluconazole|fluconazole|mesh-list
110627013|NCT00830856|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110627014|NCT00830856|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110627015|NCT00830856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110627016|NCT00830856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110627017|NCT00830856|Antiviral Agents|antiviral agents|mesh-ancestor
110627018|NCT00830856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110627019|NCT00830856|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110627020|NCT00830856|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110627021|NCT00830856|Antifungal Agents|antifungal agents|mesh-ancestor
110627022|NCT00830856|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110627023|NCT00830856|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110627024|NCT00830856|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110627025|NCT00830856|Hormone Antagonists|hormone antagonists|mesh-ancestor
110654311|NCT04010318|Anesthetics|anesthetics|mesh-list
110627026|NCT00830856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110627027|NCT00830856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110627028|NCT00830856|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110627029|NCT00830856|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110627030|NCT00830856|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110627031|NCT00830856|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110627032|NCT00830856|Antimetabolites|antimetabolites|mesh-ancestor
110627034|NCT01068067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110627035|NCT01068067|Immunologic Factors|immunologic factors|mesh-ancestor
110627036|NCT01068067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110627037|NCT01068067|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110627038|NCT01068067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110651631|NCT00933374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110627039|NCT01068067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110627041|NCT00524134|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110627042|NCT00524134|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110627043|NCT00524134|Adrenergic Agents|adrenergic agents|mesh-ancestor
110627044|NCT00524134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110627045|NCT00524134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110627046|NCT00524134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110627047|NCT00524134|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110627048|NCT00524134|Antioxidants|antioxidants|mesh-ancestor
110627049|NCT00524134|Protective Agents|protective agents|mesh-ancestor
110627050|NCT00524134|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110627051|NCT00524134|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110627052|NCT00524134|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110627053|NCT00524134|Vasodilator Agents|vasodilator agents|mesh-ancestor
110154524|NCT00012181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110627054|NCT00524134|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110627055|NCT00524134|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110627056|NCT00777023|Gabapentin|gabapentin|mesh-list
110627057|NCT00777023|Analgesics|analgesics|mesh-ancestor
110627058|NCT00777023|Sensory System Agents|sensory system agents|mesh-ancestor
110627059|NCT00777023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110627060|NCT00777023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110627061|NCT00777023|Anticonvulsants|anticonvulsants|mesh-ancestor
110627062|NCT00777023|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110627063|NCT00777023|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110627064|NCT00777023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110627065|NCT00777023|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110627066|NCT00777023|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110627067|NCT00777023|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110627068|NCT00777023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110654561|NCT02563847|Erythritol|erythritol|mesh-list
110627069|NCT00777023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110627070|NCT00777023|Antimanic Agents|antimanic agents|mesh-ancestor
110627071|NCT05062330|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110627072|NCT05062330|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110627073|NCT00297037|Pimecrolimus|pimecrolimus|mesh-list
110627074|NCT00297037|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110627075|NCT00297037|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110627076|NCT00297037|Analgesics|analgesics|mesh-ancestor
110654635|NCT00964626|Paclitaxel|paclitaxel|mesh-list
110627077|NCT00297037|Sensory System Agents|sensory system agents|mesh-ancestor
110627078|NCT00297037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110627079|NCT00297037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110627080|NCT00297037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110627081|NCT00297037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110627082|NCT00297037|Dermatologic Agents|dermatologic agents|mesh-ancestor
110627083|NCT00297037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110627084|NCT00297037|Immunologic Factors|immunologic factors|mesh-ancestor
110627085|NCT00297037|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110627086|NCT00297037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110627087|NCT00297037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110627088|NCT00292981|Complement C1s|complement c1s|mesh-list
110627089|NCT00292981|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
110627090|NCT00292981|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
110627091|NCT00292981|Immunologic Factors|immunologic factors|mesh-ancestor
110627092|NCT00292981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110627093|NCT00292981|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
110627094|NCT00292981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110627095|NCT02598869|Triamcinolone|triamcinolone|mesh-list
110627096|NCT02598869|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110627097|NCT02598869|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110627098|NCT02598869|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110627099|NCT02598869|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110627100|NCT02598869|Glucocorticoids|glucocorticoids|mesh-ancestor
110627101|NCT02598869|Hormones|hormones|mesh-ancestor
110627102|NCT02598869|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110627103|NCT02598869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110627104|NCT02598869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110627105|NCT02598869|Immunologic Factors|immunologic factors|mesh-ancestor
110627106|NCT02598869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110627107|NCT02598869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110627108|NCT04095455|Ketamine|ketamine|mesh-list
110627109|NCT04095455|Analgesics|analgesics|mesh-ancestor
110627110|NCT04095455|Sensory System Agents|sensory system agents|mesh-ancestor
110627111|NCT04095455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110627112|NCT04095455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110627113|NCT04095455|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110627114|NCT04095455|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110627115|NCT04095455|Anesthetics, General|anesthetics, general|mesh-ancestor
110627117|NCT04095455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110627118|NCT04095455|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110627119|NCT04095455|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110627120|NCT04095455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110627121|NCT04095455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110627122|NCT04095299|Capecitabine|capecitabine|mesh-list
110627123|NCT04095299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110627124|NCT04095299|Antimetabolites|antimetabolites|mesh-ancestor
110627125|NCT04095299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110627126|NCT04095299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110627127|NCT00296725|Fluoxetine|fluoxetine|mesh-list
110627128|NCT00296725|Imipramine|imipramine|mesh-list
110627129|NCT00296725|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110627130|NCT00296725|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110627131|NCT00296725|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110627132|NCT00296725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110627133|NCT00296725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110627134|NCT00296725|Serotonin Agents|serotonin agents|mesh-ancestor
110627135|NCT00296725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110627136|NCT00296725|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110627137|NCT00296725|Antidepressive Agents|antidepressive agents|mesh-ancestor
110627138|NCT00296725|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110627139|NCT00296725|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110627140|NCT00296725|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110627141|NCT00296725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110627142|NCT00296725|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110627143|NCT00296725|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110627144|NCT00296725|Adrenergic Agents|adrenergic agents|mesh-ancestor
110627146|NCT00523978|Flecainide|flecainide|mesh-list
110627147|NCT00523978|Propafenone|propafenone|mesh-list
110627148|NCT00523978|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110627149|NCT00523978|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110627150|NCT00523978|Adrenergic Agents|adrenergic agents|mesh-ancestor
110627151|NCT00523978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110627152|NCT00523978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110627153|NCT00523978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110627154|NCT00523978|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110627155|NCT00523978|Sympatholytics|sympatholytics|mesh-ancestor
110627156|NCT00523978|Autonomic Agents|autonomic agents|mesh-ancestor
110627157|NCT00523978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110627158|NCT00523978|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110627159|NCT00523978|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110627160|NCT00523978|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110627161|NCT00296647|Bupropion|bupropion|mesh-list
110627162|NCT00296647|Nicotine|nicotine|mesh-list
110627163|NCT00296647|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110627164|NCT00296647|Autonomic Agents|autonomic agents|mesh-ancestor
110627165|NCT00296647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110627166|NCT00296647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110627167|NCT00296647|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110627168|NCT00296647|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110627169|NCT00296647|Cholinergic Agents|cholinergic agents|mesh-ancestor
110627170|NCT00296647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110627171|NCT00296647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110627173|NCT00296647|Antidepressive Agents|antidepressive agents|mesh-ancestor
110627174|NCT00296647|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110655043|NCT00105469|Tobramycin|tobramycin|mesh-list
110627175|NCT00296647|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110627176|NCT00296647|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110627177|NCT00296647|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110627178|NCT00296647|Dopamine Agents|dopamine agents|mesh-ancestor
110154551|NCT00005945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110627179|NCT00296647|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110627180|NCT00296647|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110627181|NCT00296647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110627182|NCT00754013|Donepezil|donepezil|mesh-list
110627183|NCT00754013|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110627184|NCT00754013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110627185|NCT00754013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110627186|NCT00754013|Cholinergic Agents|cholinergic agents|mesh-ancestor
110627187|NCT00754013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110627188|NCT00754013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110627189|NCT00754013|Nootropic Agents|nootropic agents|mesh-ancestor
110627190|NCT00523744|Amlodipine|amlodipine|mesh-list
110627191|NCT00523744|Valsartan|valsartan|mesh-list
110655176|NCT00502203|Paclitaxel|paclitaxel|mesh-list
110627193|NCT00523744|Olmesartan|olmesartan|mesh-list
110627194|NCT00523744|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
110627195|NCT00523744|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110627196|NCT00523744|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110393320|NCT01689311|Abortifacient Agents|abortifacient agents|mesh-ancestor
110627197|NCT00523744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110627198|NCT00523744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110627199|NCT00523744|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110627200|NCT00523744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110627202|NCT00523744|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110627203|NCT00523744|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110627204|NCT00523744|Diuretics|diuretics|mesh-ancestor
110627205|NCT00523744|Natriuretic Agents|natriuretic agents|mesh-ancestor
110627206|NCT00523744|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110627208|NCT03979625|Antibodies|antibodies|mesh-list
110627209|NCT03979625|Immunologic Factors|immunologic factors|mesh-ancestor
110627210|NCT03979625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110627211|NCT03979625|Anticoagulants|anticoagulants|mesh-ancestor
110627212|NCT03979625|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110627213|NCT03979625|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110627214|NCT03979625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110627215|NCT02548494|Insulin|insulin|mesh-list
110627216|NCT02548494|Insulin Glargine|insulin glargine|mesh-list
110627217|NCT02548494|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110627218|NCT02548494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110627219|NCT00752219|Metronidazole|metronidazole|mesh-list
110627220|NCT00752219|Meropenem|meropenem|mesh-list
110627221|NCT00752219|Ceftazidime|ceftazidime|mesh-list
110627223|NCT00752219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110627224|NCT00752219|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110627225|NCT00752219|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110627226|NCT00752219|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110627227|NCT00752219|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110627228|NCT00752219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110627229|NCT00752219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110627230|NCT02598791|Glucagon|glucagon|mesh-list
110274569|NCT00171938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110627231|NCT02598791|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
110627232|NCT02598791|Incretins|incretins|mesh-ancestor
110627234|NCT02598791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110627235|NCT02598791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110627236|NCT02598791|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110627237|NCT00827346|Clopidogrel|clopidogrel|mesh-list
110627238|NCT00827346|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110627239|NCT00827346|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110627240|NCT00827346|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110655508|NCT00965640|Botulinum Toxins|botulinum toxins|mesh-list
110627241|NCT00827346|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110627242|NCT00827346|Purinergic Agents|purinergic agents|mesh-ancestor
110627243|NCT00827346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110627244|NCT00827346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110627245|NCT00827346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110627246|NCT00997750|Lornoxicam|lornoxicam|mesh-list
110627247|NCT00997750|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110627248|NCT00997750|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110627249|NCT00997750|Analgesics|analgesics|mesh-ancestor
110627250|NCT00997750|Sensory System Agents|sensory system agents|mesh-ancestor
110627251|NCT00997750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110393338|NCT02272101|Vitamin D|vitamin d|mesh-list
110627252|NCT00997750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110627253|NCT00997750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110627254|NCT00997750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110627255|NCT00622908|Besifloxacin|besifloxacin|mesh-list
110627256|NCT00622908|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110627257|NCT00622908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110627258|NCT00622908|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110627259|NCT00622908|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110627260|NCT00622908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110627261|NCT00622908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110627262|NCT00622908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110627263|NCT00997828|Everolimus|everolimus|mesh-list
110627264|NCT00997828|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110627265|NCT00997828|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110627266|NCT00997828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110627267|NCT00997828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110627268|NCT00997828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110627269|NCT00997828|Immunologic Factors|immunologic factors|mesh-ancestor
110627270|NCT00997828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110627271|NCT00997828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110627272|NCT02598635|Cholecalciferol|cholecalciferol|mesh-list
110627273|NCT02598635|Vitamin D|vitamin d|mesh-list
110627274|NCT02598635|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110627275|NCT02598635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110627276|NCT02598635|Vitamins|vitamins|mesh-ancestor
110627277|NCT02598635|Micronutrients|micronutrients|mesh-ancestor
110627278|NCT02598635|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110627279|NCT04093271|Diphenhydramine|diphenhydramine|mesh-list
110627280|NCT04093271|Promethazine|promethazine|mesh-list
110627281|NCT04093271|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110627282|NCT04093271|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110627283|NCT04093271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110627284|NCT04093271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110627285|NCT04093271|Anesthetics, Local|anesthetics, local|mesh-ancestor
110627286|NCT04093271|Anesthetics|anesthetics|mesh-ancestor
110627287|NCT04093271|Sensory System Agents|sensory system agents|mesh-ancestor
110627288|NCT04093271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110627289|NCT04093271|Antiemetics|antiemetics|mesh-ancestor
110627290|NCT04093271|Autonomic Agents|autonomic agents|mesh-ancestor
110627291|NCT04093271|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110627292|NCT04093271|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110627293|NCT04093271|Histamine Antagonists|histamine antagonists|mesh-ancestor
110627294|NCT04093271|Histamine Agents|histamine agents|mesh-ancestor
110627295|NCT04093271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110627296|NCT04093271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110627297|NCT04093271|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110627298|NCT04093271|Antipruritics|antipruritics|mesh-ancestor
110627299|NCT04093271|Dermatologic Agents|dermatologic agents|mesh-ancestor
110627300|NCT00827580|Eniluracil|eniluracil|mesh-list
110627301|NCT00827580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110627302|NCT00827580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110627303|NCT04094909|Paclitaxel|paclitaxel|mesh-list
110627304|NCT04094909|Cisplatin|cisplatin|mesh-list
110627305|NCT04094909|Carboplatin|carboplatin|mesh-list
110627307|NCT04094909|Pemetrexed|pemetrexed|mesh-list
110627308|NCT04094909|Endostatins|endostatins|mesh-list
110627309|NCT04094909|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110627310|NCT04094909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110627311|NCT04094909|Tubulin Modulators|tubulin modulators|mesh-ancestor
110627312|NCT04094909|Antimitotic Agents|antimitotic agents|mesh-ancestor
110627313|NCT04094909|Mitosis Modulators|mitosis modulators|mesh-ancestor
110627314|NCT04094909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110655944|NCT00414466|Anticonvulsants|anticonvulsants|mesh-ancestor
110627315|NCT04094909|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110627316|NCT04094909|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110627317|NCT04094909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110627318|NCT04094909|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110627319|NCT04094909|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110627320|NCT04094909|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110627321|NCT04094909|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110627322|NCT04094909|Growth Substances|growth substances|mesh-ancestor
110627323|NCT04094909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110627324|NCT04094909|Growth Inhibitors|growth inhibitors|mesh-ancestor
110627325|NCT02599571|Nicotine|nicotine|mesh-list
110627326|NCT02599571|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110627327|NCT02599571|Autonomic Agents|autonomic agents|mesh-ancestor
110627328|NCT02599571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110656091|NCT00981708|BB 1101|bb 1101|mesh-list
110627329|NCT02599571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110627330|NCT02599571|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110627331|NCT02599571|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110627332|NCT02599571|Cholinergic Agents|cholinergic agents|mesh-ancestor
110627333|NCT02599571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110627334|NCT02599571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110627335|NCT00296491|Fluticasone|fluticasone|mesh-list
110627336|NCT00296491|Xhance|xhance|mesh-list
110627337|NCT00296491|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110627338|NCT00296491|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
110627339|NCT00296491|Montelukast|montelukast|mesh-list
110627340|NCT00296491|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110627341|NCT00296491|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110627342|NCT00296491|Autonomic Agents|autonomic agents|mesh-ancestor
110627343|NCT00296491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110627344|NCT00296491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110627345|NCT00296491|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110627346|NCT00296491|Respiratory System Agents|respiratory system agents|mesh-ancestor
110627347|NCT00296491|Dermatologic Agents|dermatologic agents|mesh-ancestor
110627348|NCT00296491|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110627349|NCT00296491|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110627350|NCT00296491|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110627351|NCT00296491|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110627352|NCT00296491|Adrenergic Agents|adrenergic agents|mesh-ancestor
110627353|NCT00296491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110627354|NCT00296491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110627355|NCT00296491|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110627356|NCT00296491|Hormone Antagonists|hormone antagonists|mesh-ancestor
110627357|NCT00296491|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110627358|NCT00296491|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110627359|NCT00296491|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110627360|NCT00296491|Glucocorticoids|glucocorticoids|mesh-ancestor
110627361|NCT00296491|Hormones|hormones|mesh-ancestor
110627362|NCT00296491|Sympathomimetics|sympathomimetics|mesh-ancestor
110627363|NCT00747617|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
110627364|NCT00747617|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110627365|NCT00747617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110627366|NCT02599493|Rifampin|rifampin|mesh-list
110627367|NCT02599493|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110656360|NCT00982722|Vitamin D|vitamin d|mesh-list
110627368|NCT02599493|Antitubercular Agents|antitubercular agents|mesh-ancestor
110627369|NCT02599493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110627370|NCT02599493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110627371|NCT02599493|Leprostatic Agents|leprostatic agents|mesh-ancestor
110627372|NCT02599493|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110627373|NCT02599493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110627374|NCT02599493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110627375|NCT02599493|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110627376|NCT02599493|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110627377|NCT02599493|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110627378|NCT02599493|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110627379|NCT02599493|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110627380|NCT02599493|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110656483|NCT00429364|Atenolol|atenolol|mesh-list
110627381|NCT04092725|Ibrexafungerp|ibrexafungerp|mesh-list
110627382|NCT04092725|Antifungal Agents|antifungal agents|mesh-ancestor
110627383|NCT04092725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110627384|NCT00296335|Mitomycins|mitomycins|mesh-list
110627385|NCT00296335|Mitomycin|mitomycin|mesh-list
110627386|NCT00296335|Doxifluridine|doxifluridine|mesh-list
110627387|NCT00296335|Floxuridine|floxuridine|mesh-list
110627388|NCT00296335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110393351|NCT01687868|Analgesics|analgesics|mesh-ancestor
110627389|NCT00296335|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110627390|NCT00296335|Alkylating Agents|alkylating agents|mesh-ancestor
110627391|NCT00296335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110627392|NCT00296335|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110627393|NCT00296335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110627394|NCT00296335|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110627395|NCT00296335|Antimetabolites|antimetabolites|mesh-ancestor
110627396|NCT00296335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110627397|NCT00296335|Immunologic Factors|immunologic factors|mesh-ancestor
110627398|NCT00296335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110627399|NCT00296335|Appetite Stimulants|appetite stimulants|mesh-ancestor
110627400|NCT00296335|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110627401|NCT04094597|Lactoferrin|lactoferrin|mesh-list
110627402|NCT04094597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110627403|NCT01065961|Dexamethasone|dexamethasone|mesh-list
110627404|NCT01065961|Dexamethasone acetate|dexamethasone acetate|mesh-list
110627405|NCT01065961|BB 1101|bb 1101|mesh-list
110627406|NCT01065961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110627407|NCT01065961|Antiemetics|antiemetics|mesh-ancestor
110627408|NCT01065961|Autonomic Agents|autonomic agents|mesh-ancestor
110627409|NCT01065961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110627410|NCT01065961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110627412|NCT01065961|Glucocorticoids|glucocorticoids|mesh-ancestor
110627413|NCT01065961|Hormones|hormones|mesh-ancestor
110627414|NCT01065961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110627415|NCT01065961|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110627416|NCT01065961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110627417|NCT01065961|Protease Inhibitors|protease inhibitors|mesh-ancestor
110627418|NCT01065961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110627419|NCT01065961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110627420|NCT01068223|Cetirizine|cetirizine|mesh-list
110627421|NCT01068223|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110627422|NCT01068223|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110627423|NCT01068223|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110627424|NCT01068223|Histamine Antagonists|histamine antagonists|mesh-ancestor
110627425|NCT01068223|Histamine Agents|histamine agents|mesh-ancestor
110627426|NCT01068223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110627427|NCT01068223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110627428|NCT01068223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110627429|NCT02600273|Nicotine|nicotine|mesh-list
110627430|NCT02600273|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110627431|NCT02600273|Autonomic Agents|autonomic agents|mesh-ancestor
110627432|NCT02600273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110627433|NCT02600273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110627434|NCT02600273|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110627435|NCT02600273|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110627436|NCT02600273|Cholinergic Agents|cholinergic agents|mesh-ancestor
110627437|NCT02600273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110656788|NCT05712642|Growth Substances|growth substances|mesh-ancestor
110627438|NCT02600273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110627439|NCT04187872|Pembrolizumab|pembrolizumab|mesh-list
110627440|NCT04187872|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110627441|NCT04187872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110627442|NCT04187872|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110627443|NCT04187872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110627445|NCT01068301|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110627446|NCT01068301|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110627448|NCT01068301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110627449|NCT04999228|Infliximab|infliximab|mesh-list
110627450|NCT04999228|Mesalamine|mesalamine|mesh-list
110627451|NCT04999228|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110627452|NCT04999228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110627453|NCT04999228|Dermatologic Agents|dermatologic agents|mesh-ancestor
110627454|NCT04999228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110627455|NCT04999228|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110627456|NCT04999228|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110627457|NCT04999228|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110627458|NCT04999228|Analgesics|analgesics|mesh-ancestor
110627459|NCT04999228|Sensory System Agents|sensory system agents|mesh-ancestor
110627460|NCT04999228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110627461|NCT04999228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110627463|NCT01564810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110627464|NCT01564810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110627465|NCT04093895|Taurolidine|taurolidine|mesh-list
110627466|NCT04093895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110627467|NCT04093895|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110627468|NCT04093895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110627469|NCT00624780|Pregabalin|pregabalin|mesh-list
110627470|NCT00624780|Lorazepam|lorazepam|mesh-list
110627471|NCT00624780|Analgesics|analgesics|mesh-ancestor
110627472|NCT00624780|Sensory System Agents|sensory system agents|mesh-ancestor
110627473|NCT00624780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110627474|NCT00624780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110627475|NCT00624780|Anticonvulsants|anticonvulsants|mesh-ancestor
110627476|NCT00624780|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110627477|NCT00624780|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110627478|NCT00624780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110627479|NCT00624780|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110627480|NCT00624780|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110627481|NCT00624780|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110627482|NCT00624780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110627483|NCT00624780|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110627484|NCT00624780|Antiemetics|antiemetics|mesh-ancestor
110627485|NCT00624780|Autonomic Agents|autonomic agents|mesh-ancestor
110627486|NCT00624780|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110627487|NCT00624780|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110627488|NCT00624780|GABA Modulators|gaba modulators|mesh-ancestor
110627489|NCT00624780|GABA Agents|gaba agents|mesh-ancestor
110627490|NCT00624780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110627491|NCT02599337|Sorafenib|sorafenib|mesh-list
110627492|NCT02599337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110627493|NCT02599337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110627494|NCT02599337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110627495|NCT02599337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110627496|NCT00831636|Cytarabine|cytarabine|mesh-list
110657038|NCT05917522|Abatacept|abatacept|mesh-list
110627497|NCT00831636|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110627499|NCT00831636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110657102|NCT05874245|Midazolam|midazolam|mesh-list
110627501|NCT00831636|Antiviral Agents|antiviral agents|mesh-ancestor
110627502|NCT00831636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110627503|NCT00831636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110627504|NCT00831636|Immunologic Factors|immunologic factors|mesh-ancestor
110627505|NCT00831636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110627506|NCT00750737|Amphotericin B|amphotericin b|mesh-list
110627507|NCT00750737|Posaconazole|posaconazole|mesh-list
110627508|NCT00750737|Amebicides|amebicides|mesh-ancestor
110627509|NCT00750737|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110627510|NCT00750737|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110627511|NCT00750737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110627512|NCT00750737|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110627513|NCT00750737|Antifungal Agents|antifungal agents|mesh-ancestor
110627514|NCT00750737|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
110627515|NCT00750737|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110627516|NCT00750737|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110627517|NCT00750737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110627518|NCT00750737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110627519|NCT00750737|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110627520|NCT00750737|Hormone Antagonists|hormone antagonists|mesh-ancestor
110627521|NCT00750737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110627522|NCT00750737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110627523|NCT04093505|Gemtuzumab|gemtuzumab|mesh-list
110627524|NCT04093505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110627525|NCT04093505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110627526|NCT04093505|Immunotoxins|immunotoxins|mesh-ancestor
110627527|NCT04093505|Immunoconjugates|immunoconjugates|mesh-ancestor
110627528|NCT04093505|Immunologic Factors|immunologic factors|mesh-ancestor
110627529|NCT04093505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110627530|NCT00831714|Rivaroxaban|rivaroxaban|mesh-list
110627531|NCT00831714|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110154575|NCT01929811|Docetaxel|docetaxel|mesh-list
110627533|NCT00831714|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110627534|NCT00831714|Protease Inhibitors|protease inhibitors|mesh-ancestor
110627535|NCT00831714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110627536|NCT00831714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110627537|NCT00831714|Anticoagulants|anticoagulants|mesh-ancestor
110627538|NCT02597699|Lidocaine|lidocaine|mesh-list
110627539|NCT02597699|Sufentanil|sufentanil|mesh-list
110627540|NCT02597699|Remifentanil|remifentanil|mesh-list
110627542|NCT02597699|Anesthetics, Local|anesthetics, local|mesh-ancestor
110627543|NCT02597699|Anesthetics|anesthetics|mesh-ancestor
110627544|NCT02597699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110627545|NCT02597699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110627546|NCT02597699|Sensory System Agents|sensory system agents|mesh-ancestor
110627547|NCT02597699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110627548|NCT02597699|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110627549|NCT02597699|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110627550|NCT02597699|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110627551|NCT02597699|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110627552|NCT02597699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110627553|NCT02597699|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110627554|NCT02597699|Narcotics|narcotics|mesh-ancestor
110627555|NCT02597699|Analgesics|analgesics|mesh-ancestor
110627556|NCT02597699|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110627557|NCT02597699|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110627558|NCT02597699|Anesthetics, General|anesthetics, general|mesh-ancestor
110627559|NCT02574910|Abiraterone Acetate|abiraterone acetate|mesh-list
110627560|NCT02574910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110627561|NCT02574910|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110627562|NCT02574910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110627563|NCT02574910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110627564|NCT02574910|Hormone Antagonists|hormone antagonists|mesh-ancestor
110627565|NCT02574910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110627566|NCT02574910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110627567|NCT02574910|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110627568|NCT00744653|Bleomycin|bleomycin|mesh-list
110627569|NCT00744653|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110627570|NCT00744653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110627571|NCT00998218|Ranolazine|ranolazine|mesh-list
110627572|NCT00998218|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110627573|NCT00998218|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110627574|NCT00998218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110627575|NCT00825396|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110627576|NCT00825396|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110627578|NCT00311311|Sirolimus|sirolimus|mesh-list
110627579|NCT00311311|Prednisone|prednisone|mesh-list
110627580|NCT00311311|Tacrolimus|tacrolimus|mesh-list
110627581|NCT00311311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110627583|NCT00311311|Hormones|hormones|mesh-ancestor
110627584|NCT00311311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110627585|NCT00311311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110627586|NCT00311311|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110627587|NCT00311311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110627588|NCT00311311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110627589|NCT00311311|Immunologic Factors|immunologic factors|mesh-ancestor
110627590|NCT00311311|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110627591|NCT00311311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110627592|NCT00311311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110627593|NCT00311311|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110627594|NCT00311311|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110627595|NCT00311311|Antitubercular Agents|antitubercular agents|mesh-ancestor
110627596|NCT00311311|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110627597|NCT00311311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110627598|NCT00311311|Antifungal Agents|antifungal agents|mesh-ancestor
110627599|NCT04089605|Dexamethasone|dexamethasone|mesh-list
110627600|NCT04089605|Dexamethasone acetate|dexamethasone acetate|mesh-list
110627601|NCT04089605|Ranibizumab|ranibizumab|mesh-list
110627603|NCT04089605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110627604|NCT04089605|Antiemetics|antiemetics|mesh-ancestor
110627605|NCT04089605|Autonomic Agents|autonomic agents|mesh-ancestor
110627606|NCT04089605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110627607|NCT04089605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110627608|NCT04089605|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110627609|NCT04089605|Glucocorticoids|glucocorticoids|mesh-ancestor
110627610|NCT04089605|Hormones|hormones|mesh-ancestor
110627611|NCT04089605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110627612|NCT04089605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110627613|NCT04089605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110627614|NCT04089605|Protease Inhibitors|protease inhibitors|mesh-ancestor
110627615|NCT04089605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110627616|NCT04089605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110627617|NCT04089605|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110627618|NCT04089605|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110253373|NCT00141830|Antimetabolites|antimetabolites|mesh-ancestor
110627619|NCT04089605|Growth Substances|growth substances|mesh-ancestor
110627620|NCT04089605|Growth Inhibitors|growth inhibitors|mesh-ancestor
110627621|NCT00521404|Gemcitabine|gemcitabine|mesh-list
110627622|NCT00521404|Antibodies|antibodies|mesh-list
110627623|NCT00521404|Immunologic Factors|immunologic factors|mesh-ancestor
110627624|NCT00521404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110627625|NCT00521404|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110627626|NCT00521404|Antimetabolites|antimetabolites|mesh-ancestor
110627627|NCT00521404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110627628|NCT00521404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110627629|NCT00311155|Amlodipine|amlodipine|mesh-list
110627630|NCT00311155|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110627631|NCT00311155|Olmesartan|olmesartan|mesh-list
110627632|NCT00311155|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
110627634|NCT00311155|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110627635|NCT00311155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110627636|NCT00311155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110627637|NCT00311155|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110657962|NCT03172975|Antimitotic Agents|antimitotic agents|mesh-ancestor
110627639|NCT00311155|Vasodilator Agents|vasodilator agents|mesh-ancestor
110627640|NCT00311155|Diuretics|diuretics|mesh-ancestor
110627641|NCT00311155|Natriuretic Agents|natriuretic agents|mesh-ancestor
110627642|NCT00311155|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110627643|NCT00311155|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110627644|NCT00311155|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110627645|NCT03981601|Lovastatin|lovastatin|mesh-list
110627646|NCT03981601|L 647318|l 647318|mesh-list
110627647|NCT03981601|Dihydromevinolin|dihydromevinolin|mesh-list
110627648|NCT03981601|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110627649|NCT03981601|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110627650|NCT03981601|Antimetabolites|antimetabolites|mesh-ancestor
110627651|NCT03981601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110627652|NCT03981601|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110627653|NCT03981601|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110627654|NCT03981601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110627655|NCT00274651|Belinostat|belinostat|mesh-list
110627656|NCT00274651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110627657|NCT00274651|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110627658|NCT00274651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110627659|NCT00274651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110627660|NCT00274261|Nonoxynol|nonoxynol|mesh-list
110627661|NCT00274261|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
110627662|NCT00274261|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
110627663|NCT00274261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110627664|NCT00274261|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110627665|NCT00274261|Contraceptive Agents|contraceptive agents|mesh-ancestor
110627666|NCT00274261|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110627667|NCT00274261|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110627668|NCT00827814|Dutasteride|dutasteride|mesh-list
110627669|NCT00827814|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
110627670|NCT00827814|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110627671|NCT00827814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110154582|NCT01929811|Mitosis Modulators|mitosis modulators|mesh-ancestor
110627672|NCT00827814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110627673|NCT00827814|Hormone Antagonists|hormone antagonists|mesh-ancestor
110627674|NCT00827814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110627675|NCT00827814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110627676|NCT01068847|Cycloserine|cycloserine|mesh-list
110627678|NCT01068847|Nifedipine|nifedipine|mesh-list
110627679|NCT01068847|Tizanidine|tizanidine|mesh-list
110627681|NCT01068847|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110627682|NCT01068847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110627683|NCT01068847|Sensory System Agents|sensory system agents|mesh-ancestor
110627684|NCT01068847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110627685|NCT01068847|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110627686|NCT01068847|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110627687|NCT01068847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110627688|NCT01068847|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110627689|NCT01068847|Vasodilator Agents|vasodilator agents|mesh-ancestor
110627690|NCT01068847|Tocolytic Agents|tocolytic agents|mesh-ancestor
110627691|NCT01068847|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110627692|NCT01068847|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110627693|NCT01068847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110627694|NCT01068847|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110627695|NCT01068847|Antitubercular Agents|antitubercular agents|mesh-ancestor
110627696|NCT01068847|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110627698|NCT01068847|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110627699|NCT01068847|Analgesics|analgesics|mesh-ancestor
110627700|NCT01068847|Anticonvulsants|anticonvulsants|mesh-ancestor
110627701|NCT01068847|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110627702|NCT01068847|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110627703|NCT01068847|Parasympatholytics|parasympatholytics|mesh-ancestor
110627704|NCT01068847|Autonomic Agents|autonomic agents|mesh-ancestor
110627705|NCT01068847|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110627706|NCT01068847|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110627707|NCT01068847|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110627708|NCT01068847|Adrenergic Agents|adrenergic agents|mesh-ancestor
110627709|NCT01068847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110627710|NCT00827892|Pioglitazone|pioglitazone|mesh-list
110627711|NCT00827892|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110627712|NCT00827892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110627714|NCT01070875|Calcium heparin|calcium heparin|mesh-list
110627715|NCT01070875|Anticoagulants|anticoagulants|mesh-ancestor
110627716|NCT01070875|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110627717|NCT01070875|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110627718|NCT01070875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110627720|NCT04043676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110627721|NCT04043676|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110627722|NCT04043676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110627723|NCT04043676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110627724|NCT01325935|Clopidogrel|clopidogrel|mesh-list
110627725|NCT01325935|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110658482|NCT01085617|Immunologic Factors|immunologic factors|mesh-ancestor
110658483|NCT01085617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110658484|NCT01085617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110658485|NCT01085617|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110658486|NCT01085617|Alkylating Agents|alkylating agents|mesh-ancestor
110658487|NCT01085617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110658488|NCT01085617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110658489|NCT01085617|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110658490|NCT01085617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110658491|NCT01085617|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110658492|NCT01085617|Abortifacient Agents|abortifacient agents|mesh-ancestor
110658493|NCT01085617|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110658494|NCT01085617|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110658495|NCT01085617|Antimetabolites|antimetabolites|mesh-ancestor
110658496|NCT01085617|Dermatologic Agents|dermatologic agents|mesh-ancestor
110658497|NCT01085617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110658498|NCT01085617|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110658499|NCT01085617|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110658500|NCT01085617|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110658501|NCT01085617|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110658502|NCT01085617|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110658503|NCT01085617|Antiviral Agents|antiviral agents|mesh-ancestor
110658504|NCT01085617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110658505|NCT01085617|Tubulin Modulators|tubulin modulators|mesh-ancestor
110658506|NCT01085617|Antimitotic Agents|antimitotic agents|mesh-ancestor
110658507|NCT01085617|Mitosis Modulators|mitosis modulators|mesh-ancestor
110658508|NCT01085617|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110658509|NCT01085617|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110658546|NCT01087879|NuvaRing|nuvaring|mesh-list
110627726|NCT01325935|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110627727|NCT01325935|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110627728|NCT01325935|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110627729|NCT01325935|Purinergic Agents|purinergic agents|mesh-ancestor
110627730|NCT01325935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110627731|NCT01325935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110627732|NCT01325935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110627734|NCT02549742|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110627735|NCT02549742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110627736|NCT00521014|Cytarabine|cytarabine|mesh-list
110627737|NCT00521014|Rituximab|rituximab|mesh-list
110627738|NCT00521014|Etoposide|etoposide|mesh-list
110627739|NCT00521014|Melphalan|melphalan|mesh-list
110627740|NCT00521014|Carmustine|carmustine|mesh-list
110627741|NCT00521014|Sargramostim|sargramostim|mesh-list
110627742|NCT00521014|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110627743|NCT00521014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110627744|NCT00521014|Immunologic Factors|immunologic factors|mesh-ancestor
110627745|NCT00521014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110627746|NCT00521014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110627747|NCT00521014|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110627748|NCT00521014|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110627749|NCT00521014|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110627750|NCT00521014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110627751|NCT00521014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110627752|NCT00521014|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110627754|NCT00521014|Antiviral Agents|antiviral agents|mesh-ancestor
110627755|NCT00521014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110627756|NCT00521014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110627757|NCT00521014|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110627758|NCT00521014|Alkylating Agents|alkylating agents|mesh-ancestor
110627759|NCT00521014|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110627760|NCT00825552|Risperidone|risperidone|mesh-list
110627761|NCT00825552|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110627762|NCT00825552|Serotonin Agents|serotonin agents|mesh-ancestor
110627763|NCT00825552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110627764|NCT00825552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110627765|NCT00825552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110627766|NCT00825552|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110627767|NCT00825552|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110627768|NCT00825552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110627769|NCT00825552|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110627770|NCT00825552|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110658746|NCT03853551|Osimertinib|osimertinib|mesh-list
110627771|NCT00825552|Dopamine Agents|dopamine agents|mesh-ancestor
110627772|NCT00291577|Docetaxel|docetaxel|mesh-list
110627773|NCT00291577|Sunitinib|sunitinib|mesh-list
110627774|NCT00291577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110627775|NCT00291577|Tubulin Modulators|tubulin modulators|mesh-ancestor
110627776|NCT00291577|Antimitotic Agents|antimitotic agents|mesh-ancestor
110627777|NCT00291577|Mitosis Modulators|mitosis modulators|mesh-ancestor
110393404|NCT02272647|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110627778|NCT00291577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110627779|NCT00291577|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110627780|NCT00291577|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110627781|NCT00291577|Growth Substances|growth substances|mesh-ancestor
110627782|NCT00291577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110627783|NCT00291577|Growth Inhibitors|growth inhibitors|mesh-ancestor
110627784|NCT00291577|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110627785|NCT00291577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110627786|NCT00520936|Pemetrexed|pemetrexed|mesh-list
110627787|NCT00520936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110627788|NCT00520936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110627789|NCT00520936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110627790|NCT00520936|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110627791|NCT00520936|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110627792|NCT02549430|Letrozole|letrozole|mesh-list
110627793|NCT02549430|Fulvestrant|fulvestrant|mesh-list
110627794|NCT02549430|Palbociclib|palbociclib|mesh-list
110627795|NCT02549430|Anastrozole|anastrozole|mesh-list
110627796|NCT02549430|Exemestane|exemestane|mesh-list
110627797|NCT02549430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110627798|NCT02549430|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110627799|NCT02549430|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110627800|NCT02549430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110627801|NCT02549430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110627802|NCT02549430|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110627803|NCT02549430|Hormone Antagonists|hormone antagonists|mesh-ancestor
110658862|NCT00752843|Luteolytic Agents|luteolytic agents|mesh-ancestor
110627804|NCT02549430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110627805|NCT02549430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110627806|NCT02549430|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110627807|NCT02549430|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110627808|NCT02549430|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110627809|NCT00943839|Sunitinib|sunitinib|mesh-list
110627810|NCT00943839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110658985|NCT00757523|Analgesics|analgesics|mesh-ancestor
110627811|NCT00943839|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110627812|NCT00943839|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110627813|NCT00943839|Growth Substances|growth substances|mesh-ancestor
110627814|NCT00943839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110627815|NCT00943839|Growth Inhibitors|growth inhibitors|mesh-ancestor
110627816|NCT00943839|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110627817|NCT00943839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110627818|NCT00943839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110627819|NCT00832182|Insulin|insulin|mesh-list
110627820|NCT00832182|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110627821|NCT00832182|Insulin Aspart|insulin aspart|mesh-list
110627822|NCT00832182|Isophane Insulin, Human|isophane insulin, human|mesh-list
110627823|NCT00832182|Insulin, Isophane|insulin, isophane|mesh-list
110627824|NCT00832182|Isophane insulin, beef|isophane insulin, beef|mesh-list
110627825|NCT00832182|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110627826|NCT00832182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110627827|NCT00952497|Capecitabine|capecitabine|mesh-list
110627828|NCT00952497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110627829|NCT00952497|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110627830|NCT00952497|Antimetabolites|antimetabolites|mesh-ancestor
110627831|NCT00952497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110627832|NCT00828282|Simvastatin|simvastatin|mesh-list
110627833|NCT00828282|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110627834|NCT00828282|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110627835|NCT00828282|Antimetabolites|antimetabolites|mesh-ancestor
110627836|NCT00828282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110627837|NCT00828282|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110627838|NCT00828282|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110627839|NCT00828282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110627840|NCT00952575|Immunoglobulins|immunoglobulins|mesh-list
110627841|NCT00952575|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110627842|NCT00952575|Antibodies|antibodies|mesh-list
110627843|NCT00952575|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110627844|NCT00952575|gamma-Globulins|gamma-globulins|mesh-list
110627845|NCT00952575|Immunologic Factors|immunologic factors|mesh-ancestor
110627846|NCT00952575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110627848|NCT03865732|Ganaxolone|ganaxolone|mesh-list
110627849|NCT03865732|Neurosteroids|neurosteroids|mesh-ancestor
110627850|NCT03865732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110253406|NCT04515979|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110627851|NCT03865732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110627852|NCT03865732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110627853|NCT03865732|GABA Modulators|gaba modulators|mesh-ancestor
110627854|NCT03865732|GABA Agents|gaba agents|mesh-ancestor
110627855|NCT03865732|Anesthetics|anesthetics|mesh-ancestor
110627856|NCT03865732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110627857|NCT00944307|Raltegravir Potassium|raltegravir potassium|mesh-list
110627858|NCT00944307|Antacids|antacids|mesh-list
110627859|NCT00944307|Aluminum hydroxide, magnesium hydroxide, simethicone drug combination|aluminum hydroxide, magnesium hydroxide, simethicone drug combination|mesh-list
110627860|NCT00944307|TEMPO|tempo|mesh-list
110627861|NCT00944307|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110627862|NCT00944307|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110627863|NCT00944307|Antiviral Agents|antiviral agents|mesh-ancestor
110627864|NCT00944307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110627865|NCT00944307|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110627866|NCT00944307|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110627867|NCT00944307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110627868|NCT00944307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110627869|NCT00944307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110627870|NCT00944307|Antioxidants|antioxidants|mesh-ancestor
110627871|NCT00944307|Protective Agents|protective agents|mesh-ancestor
110627872|NCT00944307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110627873|NCT00944385|Urinastatin|urinastatin|mesh-list
110627874|NCT00944385|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
110627875|NCT00944385|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110627876|NCT00944385|Protease Inhibitors|protease inhibitors|mesh-ancestor
110627877|NCT00944385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110627878|NCT00944385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110627879|NCT00953355|Metformin|metformin|mesh-list
110627880|NCT00953355|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110627881|NCT00953355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110627882|NCT00944463|Gemcitabine|gemcitabine|mesh-list
110627883|NCT00944463|Simvastatin|simvastatin|mesh-list
110627884|NCT00944463|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110627885|NCT00944463|Antimetabolites|antimetabolites|mesh-ancestor
110627886|NCT00944463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110627887|NCT00944463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110627888|NCT00944463|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110627889|NCT00944463|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110627890|NCT00944463|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110627891|NCT00944463|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110627892|NCT00944463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110627893|NCT00956397|Rifaximin|rifaximin|mesh-list
110627894|NCT00956397|Lactulose|lactulose|mesh-list
110627895|NCT00956397|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110627896|NCT00956397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110627897|NCT00956397|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110627898|NCT05300373|Adenosine|adenosine|mesh-list
110627899|NCT05300373|Analgesics|analgesics|mesh-ancestor
110627900|NCT05300373|Sensory System Agents|sensory system agents|mesh-ancestor
110627901|NCT05300373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110659351|NCT00420004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110627902|NCT05300373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110627903|NCT05300373|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110627904|NCT05300373|Vasodilator Agents|vasodilator agents|mesh-ancestor
110627905|NCT05300373|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
110627906|NCT05300373|Purinergic Agonists|purinergic agonists|mesh-ancestor
110627907|NCT05300373|Purinergic Agents|purinergic agents|mesh-ancestor
110627908|NCT05300373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110627909|NCT05300373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110627911|NCT00953589|Antimetabolites|antimetabolites|mesh-ancestor
110253420|NCT00505531|Anesthetics|anesthetics|mesh-ancestor
110627912|NCT00953589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110627913|NCT00953589|Antiviral Agents|antiviral agents|mesh-ancestor
110627914|NCT00953589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110627915|NCT00947739|Camptothecin|camptothecin|mesh-list
110627916|NCT00947739|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110627917|NCT00947739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110627918|NCT00947739|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110627919|NCT00947739|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110627920|NCT00947739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110627921|NCT00947739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110627922|NCT00956787|10-hydroxycamptothecin|10-hydroxycamptothecin|mesh-list
110627923|NCT00956787|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110627924|NCT00956787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110627925|NCT00947895|Methylprednisolone|methylprednisolone|mesh-list
110627926|NCT00947895|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110627927|NCT00947895|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110627928|NCT00947895|Prednisolone|prednisolone|mesh-list
110627929|NCT00947895|Prednisolone acetate|prednisolone acetate|mesh-list
110627930|NCT00947895|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110627931|NCT00947895|Prednisolone phosphate|prednisolone phosphate|mesh-list
110627932|NCT00947895|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
110627933|NCT00947895|Hormones|hormones|mesh-ancestor
110627934|NCT00947895|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110627935|NCT00947895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110627936|NCT00947895|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110627937|NCT00947895|Antiemetics|antiemetics|mesh-ancestor
110627938|NCT00947895|Autonomic Agents|autonomic agents|mesh-ancestor
110627939|NCT00947895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110627940|NCT00947895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110627941|NCT00947895|Glucocorticoids|glucocorticoids|mesh-ancestor
110627942|NCT00947895|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110627943|NCT00947895|Protective Agents|protective agents|mesh-ancestor
110627944|NCT00947895|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110627945|NCT00947895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110627947|NCT00623766|Prednisone|prednisone|mesh-list
110627948|NCT00623766|Methylprednisolone|methylprednisolone|mesh-list
110627949|NCT00623766|Prednisolone|prednisolone|mesh-list
110627950|NCT00623766|Triamcinolone|triamcinolone|mesh-list
110627951|NCT00623766|Hydrocortisone|hydrocortisone|mesh-list
110627952|NCT00623766|Betamethasone|betamethasone|mesh-list
110627954|NCT00623766|Ipilimumab|ipilimumab|mesh-list
110627955|NCT00623766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110627956|NCT00623766|Antiemetics|antiemetics|mesh-ancestor
110627957|NCT00623766|Autonomic Agents|autonomic agents|mesh-ancestor
110627958|NCT00623766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110627959|NCT00623766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110627960|NCT00623766|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110627961|NCT00623766|Glucocorticoids|glucocorticoids|mesh-ancestor
110627962|NCT00623766|Hormones|hormones|mesh-ancestor
110627963|NCT00623766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110627964|NCT00623766|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110627965|NCT00623766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110627966|NCT00623766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110627967|NCT00623766|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110627968|NCT00623766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110627969|NCT00623766|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110659738|NCT00545714|Cyclophosphamide|cyclophosphamide|mesh-list
110627970|NCT00623766|Protective Agents|protective agents|mesh-ancestor
110627971|NCT00623766|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110627972|NCT00623766|Respiratory System Agents|respiratory system agents|mesh-ancestor
110627973|NCT00832494|Paclitaxel|paclitaxel|mesh-list
110627974|NCT00832494|Carboplatin|carboplatin|mesh-list
110627975|NCT00832494|Vadimezan|vadimezan|mesh-list
110627976|NCT00832494|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110627977|NCT00832494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110627978|NCT00832494|Tubulin Modulators|tubulin modulators|mesh-ancestor
110627979|NCT00832494|Antimitotic Agents|antimitotic agents|mesh-ancestor
110275321|NCT00555100|Glucocorticoids|glucocorticoids|mesh-ancestor
110627980|NCT00832494|Mitosis Modulators|mitosis modulators|mesh-ancestor
110627981|NCT00832494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110627982|NCT00837564|Escitalopram|escitalopram|mesh-list
110627983|NCT00837564|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110627984|NCT00837564|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110627985|NCT00837564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110627986|NCT00837564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110627987|NCT00837564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110627988|NCT00837564|Serotonin Agents|serotonin agents|mesh-ancestor
110627989|NCT00837564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110627990|NCT00954135|Cyclophosphamide|cyclophosphamide|mesh-list
110627992|NCT00954135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110627993|NCT00954135|Immunologic Factors|immunologic factors|mesh-ancestor
110627994|NCT00954135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110627995|NCT00954135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110659932|NCT00545948|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110627996|NCT00954135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110627997|NCT00954135|Alkylating Agents|alkylating agents|mesh-ancestor
110627998|NCT00954135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110627999|NCT00954135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110628000|NCT00954135|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110628001|NCT00954135|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110628002|NCT00954135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110628003|NCT00832806|Varenicline|varenicline|mesh-list
110628004|NCT00832806|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110628005|NCT00832806|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110628006|NCT00832806|Cholinergic Agents|cholinergic agents|mesh-ancestor
110628007|NCT00832806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110628008|NCT00832806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110628009|NCT00832806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110628010|NCT00832884|Lacosamide|lacosamide|mesh-list
110628011|NCT00832884|Anticonvulsants|anticonvulsants|mesh-ancestor
110628012|NCT00832884|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110628013|NCT00832884|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110628014|NCT00832884|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110628015|NCT00832884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110628016|NCT02549118|Tenoxicam|tenoxicam|mesh-list
110628018|NCT02549118|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110628019|NCT02549118|Narcotics|narcotics|mesh-ancestor
110628020|NCT02549118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110628021|NCT02549118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110628022|NCT02549118|Analgesics|analgesics|mesh-ancestor
110628023|NCT02549118|Sensory System Agents|sensory system agents|mesh-ancestor
110628024|NCT02549118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110628025|NCT02549118|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110154605|NCT00012259|Antiviral Agents|antiviral agents|mesh-ancestor
110628026|NCT02549118|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110628027|NCT02549118|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110628028|NCT02549118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110628029|NCT02549118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110628030|NCT02549118|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110628031|NCT02549118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110628032|NCT02549118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110628033|NCT00957177|Pregabalin|pregabalin|mesh-list
110628034|NCT00957177|Analgesics|analgesics|mesh-ancestor
110628035|NCT00957177|Sensory System Agents|sensory system agents|mesh-ancestor
110628036|NCT00957177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110628037|NCT00957177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110628038|NCT00957177|Anticonvulsants|anticonvulsants|mesh-ancestor
110628039|NCT00957177|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110628040|NCT00957177|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110660261|NCT02897076|Betamethasone|betamethasone|mesh-list
110628041|NCT00957177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110628042|NCT00957177|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110628043|NCT00957177|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110628044|NCT00957177|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110628045|NCT00957177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110253441|NCT00162669|Bevacizumab|bevacizumab|mesh-list
110628046|NCT00957177|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110628047|NCT00828594|Sorafenib|sorafenib|mesh-list
110628048|NCT00828594|Everolimus|everolimus|mesh-list
110628049|NCT00828594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110628050|NCT00828594|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110628051|NCT00828594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110628052|NCT00828594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110628053|NCT00828594|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110628054|NCT00828594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110628055|NCT00828594|Immunologic Factors|immunologic factors|mesh-ancestor
110628056|NCT00828594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110628057|NCT00550407|Lamotrigine|lamotrigine|mesh-list
110628058|NCT00550407|Anticonvulsants|anticonvulsants|mesh-ancestor
110628059|NCT00550407|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110628060|NCT00550407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110628061|NCT00550407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110628062|NCT00550407|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110628063|NCT00550407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110628064|NCT00550407|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110628065|NCT00550407|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110628066|NCT00550407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110628067|NCT00550407|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110098771|NCT01744236|Exenatide|exenatide|mesh-list
110628069|NCT00957411|Cetuximab|cetuximab|mesh-list
110628070|NCT00957411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110628071|NCT00957411|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110628072|NCT00837954|Cellulose, Oxidized|cellulose, oxidized|mesh-list
110628073|NCT00837954|Hemostatics|hemostatics|mesh-ancestor
110628074|NCT00837954|Coagulants|coagulants|mesh-ancestor
110628075|NCT00954525|Gemcitabine|gemcitabine|mesh-list
110628076|NCT00954525|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110628077|NCT00954525|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110628078|NCT00954525|Antimetabolites|antimetabolites|mesh-ancestor
110628079|NCT00954525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110628080|NCT00954525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110628081|NCT00954525|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110628082|NCT00954525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110628083|NCT00838032|Haloperidol|haloperidol|mesh-list
110628084|NCT00838032|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110628085|NCT00838032|Haloperidol decanoate|haloperidol decanoate|mesh-list
110628086|NCT00838032|Antidepressive Agents|antidepressive agents|mesh-ancestor
110628087|NCT00838032|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110628088|NCT00838032|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110628089|NCT00838032|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110628090|NCT00838032|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110098904|NCT01744964|Dopamine Agents|dopamine agents|mesh-ancestor
110628091|NCT00838032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110628092|NCT00838032|Antiemetics|antiemetics|mesh-ancestor
110628093|NCT00838032|Autonomic Agents|autonomic agents|mesh-ancestor
110628094|NCT00838032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110154612|NCT00012376|Bryostatin 1|bryostatin 1|mesh-list
110628095|NCT00838032|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110628096|NCT00838032|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110628097|NCT00838032|Dopamine Agents|dopamine agents|mesh-ancestor
110628098|NCT00838032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110628099|NCT00838032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110628100|NCT00838032|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110628101|NCT00954603|Haloperidol|haloperidol|mesh-list
110628102|NCT00954603|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110628103|NCT00954603|Haloperidol decanoate|haloperidol decanoate|mesh-list
110098964|NCT01745575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110628104|NCT00954603|Antidepressive Agents|antidepressive agents|mesh-ancestor
110628105|NCT00954603|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110253449|NCT00141947|Bexarotene|bexarotene|mesh-list
110628106|NCT00954603|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110628107|NCT00954603|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110628108|NCT00954603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110628109|NCT00954603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110628111|NCT00954603|Autonomic Agents|autonomic agents|mesh-ancestor
110628112|NCT00954603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110628113|NCT00954603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110628114|NCT00954603|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110628115|NCT00954603|Dopamine Agents|dopamine agents|mesh-ancestor
110628116|NCT00954603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110628117|NCT00954603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110628118|NCT00954603|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110628119|NCT00531934|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110628120|NCT00531934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110628121|NCT00531934|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110628122|NCT00531934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110628123|NCT00531934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110628124|NCT02548806|Clonidine|clonidine|mesh-list
110628125|NCT02548806|Analgesics|analgesics|mesh-ancestor
110628126|NCT02548806|Sensory System Agents|sensory system agents|mesh-ancestor
110099026|NCT01745666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110628127|NCT02548806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110628128|NCT02548806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110275470|NCT00174200|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110628130|NCT02548806|Sympatholytics|sympatholytics|mesh-ancestor
110628131|NCT02548806|Autonomic Agents|autonomic agents|mesh-ancestor
110628132|NCT02548806|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110628133|NCT02548806|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110628134|NCT02548806|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110628135|NCT02548806|Adrenergic Agents|adrenergic agents|mesh-ancestor
110628136|NCT02548806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110628137|NCT02548806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110628138|NCT00549939|Alfuzosin|alfuzosin|mesh-list
110628139|NCT00549939|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110628140|NCT00549939|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110628141|NCT00549939|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110628142|NCT00549939|Adrenergic Agents|adrenergic agents|mesh-ancestor
110628143|NCT00549939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110628144|NCT00549939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110628145|NCT00549939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110628146|NCT00549939|Urological Agents|urological agents|mesh-ancestor
110628147|NCT00272779|Emtricitabine|emtricitabine|mesh-list
110628148|NCT00272779|Atazanavir Sulfate|atazanavir sulfate|mesh-list
110628149|NCT00272779|Antiviral Agents|antiviral agents|mesh-ancestor
110628150|NCT00272779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110628151|NCT00272779|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110628152|NCT00272779|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110628153|NCT00272779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110628154|NCT00272779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110628155|NCT00272779|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110628156|NCT00272779|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110628157|NCT00272779|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110628158|NCT00272779|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110628159|NCT00272779|Protease Inhibitors|protease inhibitors|mesh-ancestor
110628160|NCT00957879|Calcitriol|calcitriol|mesh-list
110628161|NCT00957879|Ergocalciferols|ergocalciferols|mesh-list
110628162|NCT00957879|Vitamin D|vitamin d|mesh-list
110628163|NCT00957879|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110628164|NCT00957879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110628165|NCT00957879|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
110628166|NCT00957879|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110628167|NCT00957879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110628168|NCT00957879|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110628170|NCT00957879|Micronutrients|micronutrients|mesh-ancestor
110628171|NCT00957879|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110628172|NCT00838266|Grape Seed Extract|grape seed extract|mesh-list
110253461|NCT00141986|Cholecalciferol|cholecalciferol|mesh-list
110628173|NCT00838266|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110628174|NCT00838266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110628175|NCT00838266|Antioxidants|antioxidants|mesh-ancestor
110628176|NCT00838266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110628177|NCT00838266|Protective Agents|protective agents|mesh-ancestor
110628178|NCT00838266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110628179|NCT04011033|Cyclophosphamide|cyclophosphamide|mesh-list
110628180|NCT04011033|Interleukin-2|interleukin-2|mesh-list
110628181|NCT04011033|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110099208|NCT01746992|Hormones|hormones|mesh-ancestor
110628182|NCT04011033|Immunologic Factors|immunologic factors|mesh-ancestor
110628183|NCT04011033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110628184|NCT04011033|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110628185|NCT04011033|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110628186|NCT04011033|Alkylating Agents|alkylating agents|mesh-ancestor
110628187|NCT04011033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110628188|NCT04011033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110628189|NCT04011033|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110628190|NCT04011033|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110628191|NCT04011033|Analgesics|analgesics|mesh-ancestor
110628192|NCT04011033|Sensory System Agents|sensory system agents|mesh-ancestor
110628193|NCT04011033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110628194|NCT00998608|Risperidone|risperidone|mesh-list
110628195|NCT00998608|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110628196|NCT00998608|Serotonin Agents|serotonin agents|mesh-ancestor
110628197|NCT00998608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110628198|NCT00998608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110628199|NCT00998608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110628200|NCT00998608|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110628201|NCT00998608|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110628202|NCT00998608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110628203|NCT00998608|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110628204|NCT00998608|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110628206|NCT04011813|Antioxidants|antioxidants|mesh-list
110628207|NCT04011813|Hypotaurine|hypotaurine|mesh-list
110628208|NCT04011813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110628209|NCT04011813|Protective Agents|protective agents|mesh-ancestor
110628210|NCT04011813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110628211|NCT00998686|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110628212|NCT00998686|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110628213|NCT00998686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110628214|NCT00998686|Incretins|incretins|mesh-ancestor
110628215|NCT00998686|Hormones|hormones|mesh-ancestor
110628216|NCT00998686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110628217|NCT00998686|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110628218|NCT00998686|Protease Inhibitors|protease inhibitors|mesh-ancestor
110099453|NCT01748344|Cetirizine|cetirizine|mesh-list
110628219|NCT00998686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110628220|NCT00998686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110628221|NCT00958269|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110628222|NCT00958269|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110628223|NCT00958269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110628224|NCT00958269|Incretins|incretins|mesh-ancestor
110628226|NCT00958269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110628227|NCT00958269|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110628228|NCT00958269|Protease Inhibitors|protease inhibitors|mesh-ancestor
110628229|NCT00958269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110154623|NCT00001266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110628230|NCT00958269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110628231|NCT02547402|CXA-10|cxa-10|mesh-list
110628232|NCT02547402|Simvastatin|simvastatin|mesh-list
110628233|NCT02547402|Ezetimibe|ezetimibe|mesh-list
110628234|NCT02547402|Pravastatin|pravastatin|mesh-list
110628235|NCT02547402|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
110628236|NCT02547402|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110628237|NCT02547402|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110628238|NCT02547402|Antimetabolites|antimetabolites|mesh-ancestor
110628239|NCT02547402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110628240|NCT02547402|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110628241|NCT02547402|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110628242|NCT02547402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110628243|NCT02547402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110628244|NCT01068925|Dolutegravir|dolutegravir|mesh-list
110628245|NCT01068925|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110628246|NCT01068925|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110628247|NCT01068925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110628248|NCT01068925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110628249|NCT01068925|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110628250|NCT01068925|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110628251|NCT01068925|Antiviral Agents|antiviral agents|mesh-ancestor
110628252|NCT01068925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110628253|NCT00834600|Amlodipine|amlodipine|mesh-list
110628254|NCT00834600|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110628255|NCT00834600|Olmesartan|olmesartan|mesh-list
110628256|NCT00834600|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
110628257|NCT00834600|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110628258|NCT00834600|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110628259|NCT00834600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110628260|NCT00834600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110628261|NCT00834600|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110628262|NCT00834600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110628263|NCT00834600|Vasodilator Agents|vasodilator agents|mesh-ancestor
110628264|NCT00834600|Diuretics|diuretics|mesh-ancestor
110628265|NCT00834600|Natriuretic Agents|natriuretic agents|mesh-ancestor
110628266|NCT00834600|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110628267|NCT00834600|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110628268|NCT00834600|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110628269|NCT00958425|Hyaluronic Acid|hyaluronic acid|mesh-list
110628270|NCT00958425|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110628271|NCT00958425|Immunologic Factors|immunologic factors|mesh-ancestor
110628272|NCT00958425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110628273|NCT00958425|Viscosupplements|viscosupplements|mesh-ancestor
110628274|NCT00958425|Protective Agents|protective agents|mesh-ancestor
110628275|NCT02547480|Irinotecan|irinotecan|mesh-list
110628276|NCT02547480|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110628277|NCT02547480|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110628278|NCT02547480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110628279|NCT02547480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110628280|NCT02547480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110628281|NCT00838656|Paclitaxel|paclitaxel|mesh-list
110628282|NCT00838656|Carboplatin|carboplatin|mesh-list
110628283|NCT00838656|Gemcitabine|gemcitabine|mesh-list
110628284|NCT00838656|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110628285|NCT00838656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110628286|NCT00838656|Tubulin Modulators|tubulin modulators|mesh-ancestor
110628287|NCT00838656|Antimitotic Agents|antimitotic agents|mesh-ancestor
110628288|NCT00838656|Mitosis Modulators|mitosis modulators|mesh-ancestor
110628289|NCT00838656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110099639|NCT01749111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110628290|NCT00838656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110628291|NCT00838656|Antimetabolites|antimetabolites|mesh-ancestor
110628293|NCT00829608|Immunologic Factors|immunologic factors|mesh-ancestor
110628294|NCT00829608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110628295|NCT00553605|Ketoprofen|ketoprofen|mesh-list
110628296|NCT00553605|Parecoxib|parecoxib|mesh-list
110628297|NCT00553605|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110628298|NCT00553605|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110628299|NCT00553605|Analgesics|analgesics|mesh-ancestor
110154629|NCT00005948|Busulfan|busulfan|mesh-list
110628300|NCT00553605|Sensory System Agents|sensory system agents|mesh-ancestor
110628301|NCT00553605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110628302|NCT00553605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110628303|NCT00553605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110628304|NCT00553605|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110628305|NCT00553605|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110628306|NCT00553605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110628307|NCT00553605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110628308|NCT00553605|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110628309|NCT00838968|Interferons|interferons|mesh-list
110628310|NCT00838968|Interferon-alpha|interferon-alpha|mesh-list
110628311|NCT00838968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110628312|NCT00838968|Antiviral Agents|antiviral agents|mesh-ancestor
110628313|NCT00838968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110628314|NCT00838968|Immunologic Factors|immunologic factors|mesh-ancestor
110628315|NCT00838968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110628316|NCT04010955|Edoxaban|edoxaban|mesh-list
110628317|NCT04010955|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110628318|NCT04010955|Antithrombins|antithrombins|mesh-ancestor
110628319|NCT04010955|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110628320|NCT04010955|Protease Inhibitors|protease inhibitors|mesh-ancestor
110628321|NCT04010955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110628322|NCT04010955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110628323|NCT04010955|Anticoagulants|anticoagulants|mesh-ancestor
110628324|NCT00948987|Aspirin|aspirin|mesh-list
110628325|NCT00948987|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110628326|NCT00948987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110628327|NCT00948987|Analgesics|analgesics|mesh-ancestor
110628328|NCT00948987|Sensory System Agents|sensory system agents|mesh-ancestor
110628329|NCT00948987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110099724|NCT01749397|Fluorouracil|fluorouracil|mesh-list
110628330|NCT00948987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110628331|NCT00948987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110628332|NCT00948987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110628333|NCT00948987|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110628334|NCT00948987|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110628335|NCT00948987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110628336|NCT00948987|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110628337|NCT00948987|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110628338|NCT00948987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110628339|NCT00948987|Antipyretics|antipyretics|mesh-ancestor
110628340|NCT00744497|Prednisone|prednisone|mesh-list
110628341|NCT00744497|Docetaxel|docetaxel|mesh-list
110628342|NCT00744497|Dasatinib|dasatinib|mesh-list
110628343|NCT00744497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110628344|NCT00744497|Tubulin Modulators|tubulin modulators|mesh-ancestor
110628345|NCT00744497|Antimitotic Agents|antimitotic agents|mesh-ancestor
110628346|NCT00744497|Mitosis Modulators|mitosis modulators|mesh-ancestor
110628347|NCT00744497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110628348|NCT00744497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110628349|NCT00744497|Glucocorticoids|glucocorticoids|mesh-ancestor
110628350|NCT00744497|Hormones|hormones|mesh-ancestor
110628351|NCT00744497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110628352|NCT00744497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110628353|NCT00744497|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110628354|NCT00744497|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110628355|NCT00744497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110628356|NCT00949065|Immunoglobulins|immunoglobulins|mesh-list
110099781|NCT01749579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110628357|NCT00949065|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110628358|NCT00949065|Antibodies|antibodies|mesh-list
110628359|NCT00949065|gamma-Globulins|gamma-globulins|mesh-list
110628360|NCT00949065|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110628361|NCT00949065|Immunologic Factors|immunologic factors|mesh-ancestor
110628362|NCT00949065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110628363|NCT00955149|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110628364|NCT00955149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110628365|NCT00955149|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110628366|NCT00955149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110628367|NCT00955149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110628368|NCT05351385|Dimercaprol|dimercaprol|mesh-list
110628369|NCT05351385|Chelating Agents|chelating agents|mesh-ancestor
110628370|NCT05351385|Sequestering Agents|sequestering agents|mesh-ancestor
110628371|NCT05351385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110628372|NCT00955227|Ezetimibe|ezetimibe|mesh-list
110253484|NCT04514419|Pertuzumab|pertuzumab|mesh-list
110628373|NCT00955227|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110628374|NCT00955227|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110628375|NCT00955227|Antimetabolites|antimetabolites|mesh-ancestor
110628376|NCT00955227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110628377|NCT00955227|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110628378|NCT00949299|Buprenorphine|buprenorphine|mesh-list
110628379|NCT00949299|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110628381|NCT00949299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110628382|NCT00949299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110628383|NCT00949299|Analgesics|analgesics|mesh-ancestor
110628384|NCT00949299|Sensory System Agents|sensory system agents|mesh-ancestor
110628385|NCT00949299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110628386|NCT00949299|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110628387|NCT00747149|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110628388|NCT00747149|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110628389|NCT00747149|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110628390|NCT00747149|Antimetabolites|antimetabolites|mesh-ancestor
110099879|NCT01750476|Contraceptive Agents|contraceptive agents|mesh-ancestor
110628391|NCT00747149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110628392|NCT00747149|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110628393|NCT00747149|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110099950|NCT01750801|Disinfectants|disinfectants|mesh-ancestor
110628394|NCT00747149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110628395|NCT00271609|Bevacizumab|bevacizumab|mesh-list
110628396|NCT00271609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110628397|NCT00271609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110628398|NCT00271609|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110628399|NCT00271609|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110628401|NCT00271609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110628402|NCT00271609|Growth Inhibitors|growth inhibitors|mesh-ancestor
110628403|NCT00548847|Interferons|interferons|mesh-list
110628404|NCT00548847|Interferon-alpha|interferon-alpha|mesh-list
110628405|NCT00548847|Interferon alpha-2|interferon alpha-2|mesh-list
110628406|NCT00548847|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110628407|NCT00548847|Molgramostim|molgramostim|mesh-list
110628408|NCT00548847|Sargramostim|sargramostim|mesh-list
110628409|NCT00548847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110628410|NCT00548847|Antiviral Agents|antiviral agents|mesh-ancestor
110628411|NCT00548847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110628412|NCT00548847|Immunologic Factors|immunologic factors|mesh-ancestor
110628413|NCT00548847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110628414|NCT00949377|Bromides|bromides|mesh-list
110628415|NCT00949377|Methylnaltrexone|methylnaltrexone|mesh-list
110628416|NCT00949377|Anticonvulsants|anticonvulsants|mesh-ancestor
110628417|NCT00949377|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110628418|NCT00949377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110628419|NCT00949377|Sensory System Agents|sensory system agents|mesh-ancestor
110628420|NCT00949377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110628421|NCT00290407|Rituximab|rituximab|mesh-list
110628422|NCT00290407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110628423|NCT00290407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110628424|NCT00290407|Immunologic Factors|immunologic factors|mesh-ancestor
110628425|NCT00290407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110628426|NCT00290407|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110628427|NCT02597387|Mitoxantrone|mitoxantrone|mesh-list
110628428|NCT02597387|Analgesics|analgesics|mesh-ancestor
110628429|NCT02597387|Sensory System Agents|sensory system agents|mesh-ancestor
110628430|NCT02597387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110628431|NCT02597387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110628432|NCT02597387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110628433|NCT02597387|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110628434|NCT02597387|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110628435|NCT02597387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110628436|NCT02597387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110628437|NCT01069081|Cisplatin|cisplatin|mesh-list
110628438|NCT01069081|Docetaxel|docetaxel|mesh-list
110628439|NCT01069081|Esomeprazole|esomeprazole|mesh-list
110628440|NCT01069081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110628441|NCT01069081|Tubulin Modulators|tubulin modulators|mesh-ancestor
110628442|NCT01069081|Antimitotic Agents|antimitotic agents|mesh-ancestor
110628443|NCT01069081|Mitosis Modulators|mitosis modulators|mesh-ancestor
110628444|NCT01069081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110628445|NCT01069081|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110628446|NCT01069081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110628447|NCT01069081|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110628448|NCT01069081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110628450|NCT00949455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110628451|NCT00949455|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110628452|NCT00949455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110628453|NCT00949455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110628454|NCT05296161|Ocrelizumab|ocrelizumab|mesh-list
110628455|NCT05296161|Immunologic Factors|immunologic factors|mesh-ancestor
110628456|NCT05296161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110628457|NCT00955695|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110628458|NCT00955695|Gefitinib|gefitinib|mesh-list
110628459|NCT00955695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110628460|NCT00955695|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110628461|NCT00955695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110628462|NCT00955695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110628463|NCT00955773|Everolimus|everolimus|mesh-list
110628464|NCT00955773|Trametinib|trametinib|mesh-list
110628465|NCT00955773|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110628466|NCT00955773|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110628467|NCT00955773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110628468|NCT00955773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110628469|NCT00955773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110628470|NCT00955773|Immunologic Factors|immunologic factors|mesh-ancestor
110628471|NCT00955773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110628472|NCT00955773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110628473|NCT00549549|Celecoxib|celecoxib|mesh-list
110628474|NCT00549549|Indomethacin|indomethacin|mesh-list
110628475|NCT00549549|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110628476|NCT00549549|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110628477|NCT00549549|Analgesics|analgesics|mesh-ancestor
110628478|NCT00549549|Sensory System Agents|sensory system agents|mesh-ancestor
110628479|NCT00549549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110628480|NCT00549549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110628481|NCT00549549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110628482|NCT00549549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110628483|NCT00549549|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110628484|NCT00549549|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110628485|NCT00549549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110628486|NCT00549549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110628487|NCT00549549|Gout Suppressants|gout suppressants|mesh-ancestor
110628488|NCT00549549|Tocolytic Agents|tocolytic agents|mesh-ancestor
110628489|NCT00549549|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110628490|NCT00622284|Glimepiride|glimepiride|mesh-list
110628491|NCT00622284|Linagliptin|linagliptin|mesh-list
110628492|NCT00622284|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110628493|NCT00622284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110628494|NCT00622284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110628496|NCT00622284|Immunologic Factors|immunologic factors|mesh-ancestor
110628497|NCT00622284|Incretins|incretins|mesh-ancestor
110628498|NCT00622284|Hormones|hormones|mesh-ancestor
110628499|NCT00622284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110628500|NCT00622284|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110628501|NCT00622284|Protease Inhibitors|protease inhibitors|mesh-ancestor
110628502|NCT00622284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110628503|NCT00622284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110628504|NCT00269113|Rituximab|rituximab|mesh-list
110628505|NCT00269113|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110628506|NCT00269113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110628507|NCT00269113|Immunologic Factors|immunologic factors|mesh-ancestor
110628508|NCT00269113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110628509|NCT00269113|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110628510|NCT01069159|Propranolol|propranolol|mesh-list
110628511|NCT01069159|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110628512|NCT01069159|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110628513|NCT01069159|Adrenergic Agents|adrenergic agents|mesh-ancestor
110154641|NCT00005948|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110628514|NCT01069159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110628515|NCT01069159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110628516|NCT01069159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110628517|NCT01069159|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110628518|NCT01069159|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110628519|NCT01069159|Vasodilator Agents|vasodilator agents|mesh-ancestor
110628520|NCT03975205|Doxorubicin|doxorubicin|mesh-list
110628521|NCT03975205|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110628522|NCT03975205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110628523|NCT03975205|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110628524|NCT03975205|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110628525|NCT03975205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110628526|NCT03975205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110628528|NCT01325779|Enoxaparin|enoxaparin|mesh-list
110628529|NCT01325779|Anticoagulants|anticoagulants|mesh-ancestor
110628530|NCT01325779|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110628531|NCT01325779|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110628532|NCT01325779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110628533|NCT05170659|Relatlimab|relatlimab|mesh-list
110628534|NCT05170659|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110628535|NCT05170659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110628536|NCT05170659|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110628537|NCT05170659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110628538|NCT05352165|Pembrolizumab|pembrolizumab|mesh-list
110628539|NCT05352165|Fluorouracil|fluorouracil|mesh-list
110628540|NCT05352165|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110628541|NCT05352165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110628542|NCT05352165|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110628543|NCT05352165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110628544|NCT05352165|Antimetabolites|antimetabolites|mesh-ancestor
110628545|NCT05352165|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110628546|NCT05352165|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110628547|NCT05352165|Immunologic Factors|immunologic factors|mesh-ancestor
110628548|NCT05352165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110628549|NCT00956163|Diphosphonates|diphosphonates|mesh-list
110628550|NCT00956163|Methylene diphosphonate|methylene diphosphonate|mesh-list
110628551|NCT00956163|Listerine|listerine|mesh-list
110628552|NCT00956163|Fluorides|fluorides|mesh-list
110628553|NCT00956163|Sodium Fluoride|sodium fluoride|mesh-list
110628554|NCT00956163|Technetium Tc 99m Medronate|technetium tc 99m medronate|mesh-list
110628555|NCT00956163|Cariostatic Agents|cariostatic agents|mesh-ancestor
110628556|NCT00956163|Protective Agents|protective agents|mesh-ancestor
110628557|NCT00956163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110628558|NCT00956163|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110628559|NCT00956163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110628560|NCT00956163|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110628561|NCT00956163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110628562|NCT00956163|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110628563|NCT00956319|Estazolam|estazolam|mesh-list
110628564|NCT00956319|Zolpidem|zolpidem|mesh-list
110628565|NCT00956319|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110628566|NCT00956319|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110628567|NCT00956319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110628568|NCT00956319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110628569|NCT00956319|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
110628570|NCT00956319|GABA Agonists|gaba agonists|mesh-ancestor
110628571|NCT00956319|GABA Agents|gaba agents|mesh-ancestor
110628572|NCT00956319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110100439|NCT01755299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110628573|NCT00956319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110628574|NCT00956319|Anticonvulsants|anticonvulsants|mesh-ancestor
110628575|NCT00956319|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110628576|NCT00956319|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110628577|NCT00956319|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110628578|NCT00956319|GABA Modulators|gaba modulators|mesh-ancestor
110628580|NCT00835848|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110628581|NCT00835848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110628582|NCT00835848|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110628583|NCT00835848|Incretins|incretins|mesh-ancestor
110628584|NCT00835848|Hormones|hormones|mesh-ancestor
110154646|NCT00012688|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110628585|NCT00835848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110628587|NCT00961857|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110628588|NCT00961857|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110100442|NCT01755299|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110628589|NCT00961857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110628591|NCT00961857|Hormones|hormones|mesh-ancestor
110628592|NCT00961857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110628593|NCT00961857|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110628594|NCT00961857|Protease Inhibitors|protease inhibitors|mesh-ancestor
110628595|NCT00961857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110628596|NCT00961857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110628597|NCT02547792|Vaccines|vaccines|mesh-list
110628598|NCT02547792|Immunologic Factors|immunologic factors|mesh-ancestor
110628599|NCT02547792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110628600|NCT00830466|Sirolimus|sirolimus|mesh-list
110628601|NCT00830466|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110628602|NCT00830466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110628603|NCT00830466|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110628604|NCT00830466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110628605|NCT00830466|Antifungal Agents|antifungal agents|mesh-ancestor
110628606|NCT00830466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110628607|NCT00830466|Immunologic Factors|immunologic factors|mesh-ancestor
110100576|NCT01755728|Antipyretics|antipyretics|mesh-ancestor
110628608|NCT00830466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110628609|NCT00843570|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110628610|NCT00843570|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110628611|NCT00843570|Nafarelin|nafarelin|mesh-list
110628612|NCT00843570|Estradiol|estradiol|mesh-list
110628613|NCT00843570|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110628614|NCT00843570|Progesterone|progesterone|mesh-list
110100636|NCT01756183|Paclitaxel|paclitaxel|mesh-list
110628615|NCT00843570|Estrogens|estrogens|mesh-ancestor
110628616|NCT00843570|Hormones|hormones|mesh-ancestor
110628617|NCT00843570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110628618|NCT00843570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110628619|NCT00843570|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110628620|NCT00843570|Contraceptive Agents|contraceptive agents|mesh-ancestor
110628621|NCT00843570|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110628622|NCT00843570|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110628623|NCT00843570|Progestins|progestins|mesh-ancestor
110628624|NCT00843570|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110628625|NCT00843570|Fertility Agents|fertility agents|mesh-ancestor
110628626|NCT02547870|Rilpivirine|rilpivirine|mesh-list
110628627|NCT02547870|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110100702|NCT01756443|Mydriatics|mydriatics|mesh-ancestor
110628628|NCT02547870|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110628629|NCT02547870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110628630|NCT02547870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110628631|NCT02547870|Antiviral Agents|antiviral agents|mesh-ancestor
110628632|NCT02547870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110628633|NCT02547870|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110628634|NCT02547870|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110628635|NCT00836316|Levobupivacaine|levobupivacaine|mesh-list
110628636|NCT00836316|Anesthetics, Local|anesthetics, local|mesh-ancestor
110628638|NCT00836316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110628639|NCT00836316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110628640|NCT00836316|Sensory System Agents|sensory system agents|mesh-ancestor
110628641|NCT00836316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110628642|NCT00621504|Clarithromycin|clarithromycin|mesh-list
110628643|NCT00621504|Ceftriaxone|ceftriaxone|mesh-list
110628644|NCT00621504|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
110628645|NCT00621504|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110628646|NCT00621504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110628647|NCT00621504|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110628648|NCT00621504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110628649|NCT00621504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110628650|NCT00621504|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110628651|NCT00621504|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110628652|NCT00548145|Ezetimibe|ezetimibe|mesh-list
110628653|NCT00548145|Pitavastatin|pitavastatin|mesh-list
110628654|NCT00548145|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110628655|NCT00548145|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110628656|NCT00548145|Antimetabolites|antimetabolites|mesh-ancestor
110154649|NCT00012688|Dermatologic Agents|dermatologic agents|mesh-ancestor
110628657|NCT00548145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110628658|NCT00548145|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110628659|NCT00548145|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110628660|NCT00548145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110628661|NCT00547911|Carbidopa|carbidopa|mesh-list
110628662|NCT00547911|Entacapone|entacapone|mesh-list
110628663|NCT00547911|Droxidopa|droxidopa|mesh-list
110628664|NCT00547911|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110628665|NCT00547911|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110628666|NCT00547911|Dopamine Agents|dopamine agents|mesh-ancestor
110628667|NCT00547911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110628668|NCT00547911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110628669|NCT00547911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110628670|NCT00547911|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
110628671|NCT00547911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110628672|NCT00547911|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
110628673|NCT00839280|Pantothenic Acid|pantothenic acid|mesh-list
110628674|NCT00839280|Vitamin B Complex|vitamin b complex|mesh-ancestor
110628675|NCT00839280|Vitamins|vitamins|mesh-ancestor
110628676|NCT00839280|Micronutrients|micronutrients|mesh-ancestor
110628677|NCT00839280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110628678|NCT00836628|Busulfan|busulfan|mesh-list
110628679|NCT00836628|Alkylating Agents|alkylating agents|mesh-ancestor
110628680|NCT00836628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110628681|NCT00836628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110100837|NCT01757236|Vancomycin|vancomycin|mesh-list
110628682|NCT00836628|Immunologic Factors|immunologic factors|mesh-ancestor
110628683|NCT00836628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110628684|NCT00836628|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110628685|NCT00836628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110628686|NCT00836628|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110628687|NCT00962637|Citric Acid|citric acid|mesh-list
110628688|NCT00962637|Sodium Citrate|sodium citrate|mesh-list
110628689|NCT00962637|Enclomiphene|enclomiphene|mesh-list
110628690|NCT00962637|Clomiphene|clomiphene|mesh-list
110628691|NCT00962637|Zuclomiphene|zuclomiphene|mesh-list
110628692|NCT00962637|Testosterone|testosterone|mesh-list
110628693|NCT00962637|Anticoagulants|anticoagulants|mesh-ancestor
110628694|NCT00962637|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110628695|NCT00962637|Chelating Agents|chelating agents|mesh-ancestor
110628696|NCT00962637|Sequestering Agents|sequestering agents|mesh-ancestor
110628697|NCT00962637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110628698|NCT00962637|Androgens|androgens|mesh-ancestor
110628699|NCT00962637|Hormones|hormones|mesh-ancestor
110628700|NCT00962637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110628701|NCT00962637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110628702|NCT00962637|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110628703|NCT00962637|Hormone Antagonists|hormone antagonists|mesh-ancestor
110628704|NCT00962637|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110628705|NCT00962637|Fertility Agents|fertility agents|mesh-ancestor
110628706|NCT00962637|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110628707|NCT00962637|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110628708|NCT00962637|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110628709|NCT00839358|Midodrine|midodrine|mesh-list
110628710|NCT00839358|Sympathomimetics|sympathomimetics|mesh-ancestor
110628711|NCT00839358|Autonomic Agents|autonomic agents|mesh-ancestor
110628712|NCT00839358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110628713|NCT00839358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110628714|NCT00839358|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110628715|NCT00839358|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110628716|NCT00839358|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110628717|NCT00839358|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110628718|NCT00839358|Adrenergic Agents|adrenergic agents|mesh-ancestor
110628719|NCT00839358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110628720|NCT00839358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110628721|NCT00962715|Interferons|interferons|mesh-list
110628722|NCT00962715|Interferon-alpha|interferon-alpha|mesh-list
110628723|NCT00962715|Interferon alpha-2|interferon alpha-2|mesh-list
110628724|NCT00962715|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110628725|NCT00962715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110628726|NCT00962715|Antiviral Agents|antiviral agents|mesh-ancestor
110628727|NCT00962715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110628728|NCT00962715|Immunologic Factors|immunologic factors|mesh-ancestor
110628729|NCT00962715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110276073|NCT00204321|Sirolimus|sirolimus|mesh-list
110628730|NCT00963027|Treprostinil|treprostinil|mesh-list
110628731|NCT00963027|Esomeprazole|esomeprazole|mesh-list
110628732|NCT00963027|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110628733|NCT00963027|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110628734|NCT00963027|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110628735|NCT00963027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110628736|NCT00963027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110628737|NCT00963027|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110628739|NCT00837174|Vorinostat|vorinostat|mesh-list
110628740|NCT00837174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110628741|NCT00837174|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110628742|NCT00837174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110628743|NCT00837174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110628744|NCT04042974|Dinoprostone|dinoprostone|mesh-list
110628745|NCT04042974|Oxytocics|oxytocics|mesh-ancestor
110628746|NCT04042974|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110628747|NCT04042974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110628748|NCT00844350|Letrozole|letrozole|mesh-list
110628749|NCT00844350|Oxytocin|oxytocin|mesh-list
110628750|NCT00844350|Clomiphene|clomiphene|mesh-list
110628751|NCT00844350|Enclomiphene|enclomiphene|mesh-list
110628752|NCT00844350|Zuclomiphene|zuclomiphene|mesh-list
110628753|NCT00844350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110628754|NCT00844350|Oxytocics|oxytocics|mesh-ancestor
110628755|NCT00844350|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110628756|NCT00844350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110628757|NCT00844350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110628758|NCT00844350|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110628759|NCT00844350|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110628760|NCT00844350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110628761|NCT00844350|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110628762|NCT00844350|Hormone Antagonists|hormone antagonists|mesh-ancestor
110628763|NCT00844350|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110628764|NCT00844350|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110628765|NCT00844350|Fertility Agents|fertility agents|mesh-ancestor
110628766|NCT00844350|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110628767|NCT00844350|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110628768|NCT00844506|Cyclophosphamide|cyclophosphamide|mesh-list
110628769|NCT00844506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110628770|NCT00844506|Immunologic Factors|immunologic factors|mesh-ancestor
110628771|NCT00844506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110628772|NCT00844506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110628773|NCT00844506|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110628774|NCT00844506|Alkylating Agents|alkylating agents|mesh-ancestor
110628775|NCT00844506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110628776|NCT00844506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110628777|NCT00844506|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110628778|NCT00839826|Enoxaparin|enoxaparin|mesh-list
110628779|NCT00839826|Rivaroxaban|rivaroxaban|mesh-list
110628780|NCT00839826|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110101383|NCT01760148|Interferon alpha-2|interferon alpha-2|mesh-list
110628781|NCT00839826|Antithrombins|antithrombins|mesh-ancestor
110628782|NCT00839826|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110628783|NCT00839826|Protease Inhibitors|protease inhibitors|mesh-ancestor
110628784|NCT00839826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110628785|NCT00839826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110628786|NCT00839826|Anticoagulants|anticoagulants|mesh-ancestor
110628787|NCT00839826|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110628788|NCT00839826|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110628789|NCT00844662|Sevelamer|sevelamer|mesh-list
110628790|NCT00844662|Chelating Agents|chelating agents|mesh-ancestor
110628791|NCT00844662|Sequestering Agents|sequestering agents|mesh-ancestor
110628792|NCT00844662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110628794|NCT04678089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110628795|NCT00963573|Loratadine|loratadine|mesh-list
110628796|NCT00963573|Betamethasone|betamethasone|mesh-list
110628797|NCT00963573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110628798|NCT00963573|Glucocorticoids|glucocorticoids|mesh-ancestor
110628799|NCT00963573|Hormones|hormones|mesh-ancestor
110628800|NCT00963573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110628801|NCT00963573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110628802|NCT00963573|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110628803|NCT00963573|Respiratory System Agents|respiratory system agents|mesh-ancestor
110276154|NCT04173364|Ropivacaine|ropivacaine|mesh-list
110628804|NCT00963573|Antipruritics|antipruritics|mesh-ancestor
110628805|NCT00963573|Dermatologic Agents|dermatologic agents|mesh-ancestor
110628806|NCT00963573|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110628807|NCT00963573|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110628808|NCT00963573|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110628809|NCT00963573|Histamine Antagonists|histamine antagonists|mesh-ancestor
110628810|NCT00963573|Histamine Agents|histamine agents|mesh-ancestor
110628811|NCT00963573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110628812|NCT00963573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110628813|NCT05299593|Timolol|timolol|mesh-list
110628814|NCT05299593|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110628815|NCT05299593|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110628816|NCT05299593|Adrenergic Agents|adrenergic agents|mesh-ancestor
110628817|NCT05299593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110393563|NCT01335399|Immunologic Factors|immunologic factors|mesh-ancestor
110628818|NCT05299593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110628819|NCT05299593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110628820|NCT05299593|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110628821|NCT05299593|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110628823|NCT00844740|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110628824|NCT00844740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110628825|NCT00844740|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
110628826|NCT00844740|Hormone Antagonists|hormone antagonists|mesh-ancestor
110101626|NCT01760980|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110628827|NCT00844740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110628828|NCT00963729|Cyclophosphamide|cyclophosphamide|mesh-list
110628829|NCT00963729|Docetaxel|docetaxel|mesh-list
110628830|NCT00963729|Fluorouracil|fluorouracil|mesh-list
110628831|NCT00963729|Letrozole|letrozole|mesh-list
110628832|NCT00963729|Epirubicin|epirubicin|mesh-list
110628833|NCT00963729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110628834|NCT00963729|Immunologic Factors|immunologic factors|mesh-ancestor
110628835|NCT00963729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110628836|NCT00963729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110628837|NCT00963729|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110628838|NCT00963729|Alkylating Agents|alkylating agents|mesh-ancestor
110628839|NCT00963729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110628840|NCT00963729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110628841|NCT00963729|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110628842|NCT00963729|Tubulin Modulators|tubulin modulators|mesh-ancestor
110628843|NCT00963729|Antimitotic Agents|antimitotic agents|mesh-ancestor
110628844|NCT00963729|Mitosis Modulators|mitosis modulators|mesh-ancestor
110628845|NCT00963729|Antimetabolites|antimetabolites|mesh-ancestor
110628846|NCT00963729|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110628847|NCT00963729|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110628848|NCT00963729|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110628849|NCT00963729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110628850|NCT00963729|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110101778|NCT01761994|Nafamostat|nafamostat|mesh-list
110628851|NCT00963729|Hormone Antagonists|hormone antagonists|mesh-ancestor
110628852|NCT00963729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110628853|NCT00963729|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110628854|NCT00963729|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110628855|NCT00963729|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110628856|NCT00964041|Cycloserine|cycloserine|mesh-list
110628857|NCT00964041|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110628858|NCT00964041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110628859|NCT00964041|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110628860|NCT00964041|Antitubercular Agents|antitubercular agents|mesh-ancestor
110628861|NCT00964041|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110628862|NCT00964041|Antimetabolites|antimetabolites|mesh-ancestor
110628863|NCT00964041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110628864|NCT04009317|Crizotinib|crizotinib|mesh-list
110628865|NCT04009317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110628866|NCT04009317|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110628867|NCT04009317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110628868|NCT04009317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110628870|NCT03641547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110628871|NCT03641547|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110628872|NCT03641547|Antimetabolites|antimetabolites|mesh-ancestor
110628873|NCT03641547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110628874|NCT00851370|Omalizumab|omalizumab|mesh-list
110628875|NCT00851370|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110628876|NCT00851370|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110628878|NCT00967629|Calcium Carbonate|calcium carbonate|mesh-list
110276225|NCT00199602|Heparin|heparin|mesh-list
110628880|NCT00967629|Sevelamer|sevelamer|mesh-list
110628881|NCT00967629|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110628882|NCT00967629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110628883|NCT00967629|Antacids|antacids|mesh-ancestor
110628884|NCT00967629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110628885|NCT00967629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110628886|NCT00967629|Chelating Agents|chelating agents|mesh-ancestor
110628887|NCT00967629|Sequestering Agents|sequestering agents|mesh-ancestor
110628888|NCT00289783|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110628889|NCT00289783|Immunologic Factors|immunologic factors|mesh-ancestor
110628890|NCT00289783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110628891|NCT00840606|Buspirone|buspirone|mesh-list
110628892|NCT00840606|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110628894|NCT00840606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110628895|NCT00840606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110628896|NCT00840606|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110628897|NCT00840606|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110628898|NCT00840606|Serotonin Agents|serotonin agents|mesh-ancestor
110628899|NCT00840606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110628900|NCT00840606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110628901|NCT00840684|Cytarabine|cytarabine|mesh-list
110628902|NCT00840684|Melphalan|melphalan|mesh-list
110628903|NCT00840684|Busulfan|busulfan|mesh-list
110628904|NCT00840684|Daunorubicin|daunorubicin|mesh-list
110628905|NCT00840684|Mitoxantrone|mitoxantrone|mesh-list
110628906|NCT00840684|Amsacrine|amsacrine|mesh-list
110628907|NCT00840684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110628908|NCT00840684|Antimetabolites|antimetabolites|mesh-ancestor
110628909|NCT00840684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110628910|NCT00840684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110628911|NCT00840684|Antiviral Agents|antiviral agents|mesh-ancestor
110628912|NCT00840684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110102082|NCT01763463|Xhance|xhance|mesh-list
110628913|NCT00840684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110628914|NCT00840684|Immunologic Factors|immunologic factors|mesh-ancestor
110628915|NCT00840684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110628916|NCT00840684|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110628917|NCT00840684|Alkylating Agents|alkylating agents|mesh-ancestor
110628918|NCT00840684|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110628919|NCT00840684|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110628920|NCT00840684|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110628921|NCT00840684|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110628922|NCT00840684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110628924|NCT00840684|Sensory System Agents|sensory system agents|mesh-ancestor
110628925|NCT00840684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110628926|NCT00574080|Cytarabine|cytarabine|mesh-list
110628927|NCT00574080|Thalidomide|thalidomide|mesh-list
110628928|NCT00574080|Dexamethasone|dexamethasone|mesh-list
110628929|NCT00574080|Dexamethasone acetate|dexamethasone acetate|mesh-list
110628930|NCT00574080|Cyclophosphamide|cyclophosphamide|mesh-list
110628931|NCT00574080|Melphalan|melphalan|mesh-list
110628932|NCT00574080|Carmustine|carmustine|mesh-list
110628933|NCT00574080|Cisplatin|cisplatin|mesh-list
110628934|NCT00574080|Etoposide|etoposide|mesh-list
110628935|NCT00574080|Etoposide phosphate|etoposide phosphate|mesh-list
110628936|NCT00574080|Doxorubicin|doxorubicin|mesh-list
110628937|NCT00574080|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110628938|NCT00574080|Bortezomib|bortezomib|mesh-list
110628939|NCT00574080|BB 1101|bb 1101|mesh-list
110628940|NCT00574080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110628941|NCT00574080|Immunologic Factors|immunologic factors|mesh-ancestor
110628942|NCT00574080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110628943|NCT00574080|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110628944|NCT00574080|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110102272|NCT01764672|Dopamine Agents|dopamine agents|mesh-ancestor
110628945|NCT00574080|Alkylating Agents|alkylating agents|mesh-ancestor
110628946|NCT00574080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110628947|NCT00574080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110628948|NCT00574080|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110628949|NCT00574080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110628950|NCT00574080|Antiemetics|antiemetics|mesh-ancestor
110628951|NCT00574080|Autonomic Agents|autonomic agents|mesh-ancestor
110628952|NCT00574080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110628953|NCT00574080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110628954|NCT00574080|Glucocorticoids|glucocorticoids|mesh-ancestor
110628956|NCT00574080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110628957|NCT00574080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110628958|NCT00574080|Protease Inhibitors|protease inhibitors|mesh-ancestor
110628959|NCT00574080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110628960|NCT00574080|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110628961|NCT00574080|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110628962|NCT00574080|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110628963|NCT00574080|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110628964|NCT00574080|Antimetabolites|antimetabolites|mesh-ancestor
110628965|NCT00574080|Antiviral Agents|antiviral agents|mesh-ancestor
110628966|NCT00574080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110628967|NCT00574080|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110628968|NCT00574080|Leprostatic Agents|leprostatic agents|mesh-ancestor
110628969|NCT00574080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110628970|NCT00574080|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110628971|NCT00574080|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110628972|NCT00574080|Growth Substances|growth substances|mesh-ancestor
110628973|NCT00574080|Growth Inhibitors|growth inhibitors|mesh-ancestor
110628974|NCT00845364|Perhexiline|perhexiline|mesh-list
110628975|NCT00845364|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110628976|NCT00845364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110628977|NCT00845364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110102459|NCT01765829|Clozapine|clozapine|mesh-list
110628978|NCT00845364|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110628979|NCT00845364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110628982|NCT00267865|Rituximab|rituximab|mesh-list
110628983|NCT00267865|Methotrexate|methotrexate|mesh-list
110628984|NCT00267865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110628985|NCT00267865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110628986|NCT00267865|Immunologic Factors|immunologic factors|mesh-ancestor
110628987|NCT00267865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110628988|NCT00267865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110628989|NCT00267865|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110628990|NCT00267865|Abortifacient Agents|abortifacient agents|mesh-ancestor
110628991|NCT00267865|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110102589|NCT01766375|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110628992|NCT00267865|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110628993|NCT00267865|Antimetabolites|antimetabolites|mesh-ancestor
110628994|NCT00267865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110628995|NCT00267865|Dermatologic Agents|dermatologic agents|mesh-ancestor
110628996|NCT00267865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110628997|NCT00267865|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110628998|NCT00267865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110628999|NCT00267865|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110629000|NCT00267865|Antidotes|antidotes|mesh-ancestor
110629001|NCT00267865|Protective Agents|protective agents|mesh-ancestor
110629002|NCT00267865|Vitamin B Complex|vitamin b complex|mesh-ancestor
110629003|NCT00267865|Vitamins|vitamins|mesh-ancestor
110629004|NCT00267865|Micronutrients|micronutrients|mesh-ancestor
110629005|NCT00840918|Lidocaine|lidocaine|mesh-list
110629006|NCT00840918|Anesthetics, Local|anesthetics, local|mesh-ancestor
110629007|NCT00840918|Anesthetics|anesthetics|mesh-ancestor
110629008|NCT00840918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110629009|NCT00840918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110629011|NCT00840918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110629012|NCT00840918|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110154670|NCT00005954|Temozolomide|temozolomide|mesh-list
110629013|NCT00840918|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110629014|NCT00840918|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110629015|NCT00840918|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110629016|NCT00840918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110629017|NCT00546117|Lansoprazole|lansoprazole|mesh-list
110629018|NCT00546117|Dexlansoprazole|dexlansoprazole|mesh-list
110629019|NCT00546117|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110629020|NCT00546117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110629021|NCT00546117|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110629022|NCT00546117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110629023|NCT00546117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110629024|NCT01582165|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110629025|NCT01582165|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110629026|NCT01582165|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110629027|NCT01582165|Antimetabolites|antimetabolites|mesh-ancestor
110629028|NCT01582165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110629029|NCT01582165|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110629030|NCT01582165|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110629031|NCT01582165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110629032|NCT00841074|Chlorhexidine|chlorhexidine|mesh-list
110629033|NCT00841074|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110629034|NCT00841074|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110629035|NCT00841074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110629036|NCT00841074|Disinfectants|disinfectants|mesh-ancestor
110629037|NCT00841074|Dermatologic Agents|dermatologic agents|mesh-ancestor
110629038|NCT00967707|Gabapentin|gabapentin|mesh-list
110629039|NCT00967707|Donepezil|donepezil|mesh-list
110629040|NCT00967707|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
110629041|NCT00967707|Analgesics|analgesics|mesh-ancestor
110629042|NCT00967707|Sensory System Agents|sensory system agents|mesh-ancestor
110629043|NCT00967707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110629044|NCT00967707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110629045|NCT00967707|Anticonvulsants|anticonvulsants|mesh-ancestor
110629046|NCT00967707|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110629047|NCT00967707|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110629048|NCT00967707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110629049|NCT00967707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110629050|NCT00967707|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110629051|NCT00967707|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110629052|NCT00967707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110629053|NCT00967707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110629054|NCT00967707|Antimanic Agents|antimanic agents|mesh-ancestor
110629055|NCT00967707|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110629056|NCT00967707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110629057|NCT00967707|Cholinergic Agents|cholinergic agents|mesh-ancestor
110629058|NCT00967707|Nootropic Agents|nootropic agents|mesh-ancestor
110629059|NCT00967707|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110629060|NCT00967707|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110629061|NCT00967707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110629062|NCT00967707|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110629063|NCT00967707|Antidepressive Agents|antidepressive agents|mesh-ancestor
110629064|NCT00964275|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110629065|NCT00964275|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110629066|NCT00964275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110629067|NCT00845598|Fluticasone|fluticasone|mesh-list
110629068|NCT00845598|Xhance|xhance|mesh-list
110629069|NCT00845598|Azelastine|azelastine|mesh-list
110629070|NCT00845598|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110629071|NCT00845598|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110629072|NCT00845598|Autonomic Agents|autonomic agents|mesh-ancestor
110629073|NCT00845598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110629074|NCT00845598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110629075|NCT00845598|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110629076|NCT00845598|Respiratory System Agents|respiratory system agents|mesh-ancestor
110629077|NCT00845598|Dermatologic Agents|dermatologic agents|mesh-ancestor
110629078|NCT00845598|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110629079|NCT00845598|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
110629080|NCT00845598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110629081|NCT00845598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110629082|NCT00845598|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110629083|NCT00845598|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110629084|NCT00845598|Histamine Antagonists|histamine antagonists|mesh-ancestor
110629085|NCT00845598|Histamine Agents|histamine agents|mesh-ancestor
110629086|NCT00845598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110629088|NCT00251719|Dexlansoprazole|dexlansoprazole|mesh-list
110629089|NCT00251719|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110629090|NCT00251719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110629091|NCT00251719|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110629092|NCT00251719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110629093|NCT00251719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110651632|NCT00933374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110629095|NCT00845754|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110629097|NCT00845754|Analgesics|analgesics|mesh-ancestor
110629098|NCT00845754|Sensory System Agents|sensory system agents|mesh-ancestor
110651633|NCT00933374|Immunologic Factors|immunologic factors|mesh-ancestor
110629099|NCT00845754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110629100|NCT00845754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110629101|NCT00845754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110629102|NCT00845754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110276449|NCT02470039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110629103|NCT00845754|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110629104|NCT00845754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110629105|NCT00845754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110629106|NCT00964665|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110629107|NCT00964665|Interferon-alpha|interferon-alpha|mesh-list
110629108|NCT00964665|Antiviral Agents|antiviral agents|mesh-ancestor
110629109|NCT00964665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110629110|NCT00964665|Immunologic Factors|immunologic factors|mesh-ancestor
110629111|NCT00964665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110629112|NCT00841386|Riboflavin|riboflavin|mesh-list
110629113|NCT00841386|Flavin Mononucleotide|flavin mononucleotide|mesh-list
110629114|NCT00841386|Vitamin B Complex|vitamin b complex|mesh-ancestor
110629116|NCT00841386|Micronutrients|micronutrients|mesh-ancestor
110629117|NCT00841386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110629118|NCT00841386|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110629119|NCT00841386|Dermatologic Agents|dermatologic agents|mesh-ancestor
110629120|NCT03952143|Insulin|insulin|mesh-list
110629121|NCT03952143|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110629122|NCT03952143|Insulin Glargine|insulin glargine|mesh-list
110629123|NCT03952143|Insulin Lispro|insulin lispro|mesh-list
110629124|NCT03952143|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110103215|NCT01769820|Hormones|hormones|mesh-ancestor
110629125|NCT03952143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110629126|NCT00968331|Rituximab|rituximab|mesh-list
110629127|NCT00968331|Lenalidomide|lenalidomide|mesh-list
110629128|NCT00968331|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110629129|NCT00968331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110629130|NCT00968331|Immunologic Factors|immunologic factors|mesh-ancestor
110629131|NCT00968331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110629132|NCT00968331|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110629133|NCT00968331|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110629134|NCT00968331|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110629135|NCT00968331|Growth Substances|growth substances|mesh-ancestor
110629136|NCT00968331|Growth Inhibitors|growth inhibitors|mesh-ancestor
110629137|NCT00852228|Cetuximab|cetuximab|mesh-list
110629138|NCT00852228|Oxaliplatin|oxaliplatin|mesh-list
110629139|NCT00852228|Irinotecan|irinotecan|mesh-list
110629140|NCT00852228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110629141|NCT00852228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110629142|NCT00852228|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110629143|NCT00852228|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110629144|NCT00852228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110629145|NCT00852228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110629146|NCT00267007|Epoetin Alfa|epoetin alfa|mesh-list
110629147|NCT00267007|Hematinics|hematinics|mesh-ancestor
110629148|NCT00841854|Metronidazole|metronidazole|mesh-list
110629149|NCT00841854|Tetracycline|tetracycline|mesh-list
110629150|NCT00841854|Pantoprazole|pantoprazole|mesh-list
110629151|NCT00841854|Bismuth|bismuth|mesh-list
110629152|NCT00841854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110629153|NCT00841854|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110629154|NCT00841854|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110629155|NCT00841854|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110629156|NCT00841854|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110629157|NCT00841854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110629158|NCT00841854|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110629159|NCT00841854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110651634|NCT00933374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110629160|NCT00841854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110629162|NCT00841854|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110629163|NCT00848562|Nicorandil|nicorandil|mesh-list
110629164|NCT00848562|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110629165|NCT00848562|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110629166|NCT00848562|Vasodilator Agents|vasodilator agents|mesh-ancestor
110629167|NCT00848562|Vitamin B Complex|vitamin b complex|mesh-ancestor
110629168|NCT00848562|Vitamins|vitamins|mesh-ancestor
110629169|NCT00848562|Micronutrients|micronutrients|mesh-ancestor
110629170|NCT00848562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110629171|NCT02879409|Insulin|insulin|mesh-list
110629172|NCT02879409|Metformin|metformin|mesh-list
110629173|NCT02879409|Pioglitazone|pioglitazone|mesh-list
110629174|NCT02879409|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110629175|NCT02879409|Dapagliflozin|dapagliflozin|mesh-list
110629176|NCT02879409|Liraglutide|liraglutide|mesh-list
110629177|NCT02879409|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110629178|NCT02879409|Gliclazide|gliclazide|mesh-list
110629179|NCT02879409|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110629180|NCT02879409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110629181|NCT02879409|Incretins|incretins|mesh-ancestor
110629182|NCT02879409|Hormones|hormones|mesh-ancestor
110651635|NCT03303105|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110629183|NCT02879409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110629184|NCT02879409|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110629185|NCT02879409|Protease Inhibitors|protease inhibitors|mesh-ancestor
110629186|NCT02879409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110629187|NCT02879409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110629188|NCT02879409|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110629189|NCT02546154|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
110629190|NCT02546154|Hematinics|hematinics|mesh-ancestor
110629191|NCT03943095|Fluorides|fluorides|mesh-list
110629192|NCT03943095|Tin Fluorides|tin fluorides|mesh-list
110629193|NCT03943095|Cariostatic Agents|cariostatic agents|mesh-ancestor
110629194|NCT03943095|Protective Agents|protective agents|mesh-ancestor
110629195|NCT03943095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110629196|NCT00848640|Sorafenib|sorafenib|mesh-list
110629197|NCT00848640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110629198|NCT00848640|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110629199|NCT00848640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110629200|NCT00848640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110629201|NCT00968565|Citric Acid|citric acid|mesh-list
110629202|NCT00968565|Sodium Citrate|sodium citrate|mesh-list
110629203|NCT00968565|Anticoagulants|anticoagulants|mesh-ancestor
110629204|NCT00968565|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110629205|NCT00968565|Chelating Agents|chelating agents|mesh-ancestor
110629206|NCT00968565|Sequestering Agents|sequestering agents|mesh-ancestor
110629207|NCT00968565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110629208|NCT00848796|Heparin|heparin|mesh-list
110629209|NCT00848796|Calcium heparin|calcium heparin|mesh-list
110629210|NCT00848796|Anticoagulants|anticoagulants|mesh-ancestor
110629211|NCT00848796|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110629212|NCT00848796|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110629213|NCT00848796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110629214|NCT00965289|Rituximab|rituximab|mesh-list
110629215|NCT00965289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110629216|NCT00965289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110629217|NCT00965289|Immunologic Factors|immunologic factors|mesh-ancestor
110629218|NCT00965289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110629219|NCT00965289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110629220|NCT04042506|Nivolumab|nivolumab|mesh-list
110629221|NCT04042506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110629222|NCT04042506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110629223|NCT04042506|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110629224|NCT04042506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110629225|NCT00251641|Infliximab|infliximab|mesh-list
110629226|NCT00251641|Methotrexate|methotrexate|mesh-list
110629227|NCT00251641|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110629228|NCT00251641|Abortifacient Agents|abortifacient agents|mesh-ancestor
110629229|NCT00251641|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110629230|NCT00251641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110629231|NCT00251641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110629232|NCT00251641|Antimetabolites|antimetabolites|mesh-ancestor
110629233|NCT00251641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110629234|NCT00251641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110629235|NCT00251641|Dermatologic Agents|dermatologic agents|mesh-ancestor
110629236|NCT00251641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110629237|NCT00251641|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110629238|NCT00251641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110629239|NCT00251641|Immunologic Factors|immunologic factors|mesh-ancestor
110629240|NCT00251641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110629241|NCT00251641|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110629242|NCT00251641|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110629243|NCT00251641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110629244|NCT00251641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110629245|NCT00250705|Aripiprazole|aripiprazole|mesh-list
110629246|NCT00250705|Antidepressive Agents|antidepressive agents|mesh-ancestor
110629247|NCT00250705|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110629248|NCT00250705|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110629249|NCT00250705|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110629250|NCT00250705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110629251|NCT00250705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110629252|NCT00250705|Dopamine Agonists|dopamine agonists|mesh-ancestor
110629253|NCT00250705|Dopamine Agents|dopamine agents|mesh-ancestor
110629254|NCT00250705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110629255|NCT00250705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110629256|NCT00250705|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110629257|NCT00250705|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110629258|NCT00250705|Serotonin Agents|serotonin agents|mesh-ancestor
110629259|NCT00250705|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110629260|NCT00250705|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110629261|NCT00250705|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110629262|NCT00250705|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110629263|NCT00849030|Tamoxifen|tamoxifen|mesh-list
110629264|NCT00849030|Anastrozole|anastrozole|mesh-list
110629265|NCT00849030|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110629266|NCT00849030|Hormone Antagonists|hormone antagonists|mesh-ancestor
110629267|NCT00849030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110629268|NCT00849030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110629269|NCT00849030|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110629270|NCT00849030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110629271|NCT00849030|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110629272|NCT00849030|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110629273|NCT00849030|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110629274|NCT00849030|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110629275|NCT00849030|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110629276|NCT00849030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110629277|NCT00849030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110629278|NCT00842400|Metformin|metformin|mesh-list
110629279|NCT00842400|Probenecid|probenecid|mesh-list
110629280|NCT00842400|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110629281|NCT00842400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110629283|NCT00842400|Gout Suppressants|gout suppressants|mesh-ancestor
110629284|NCT00842400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110629285|NCT00266695|Ruboxistaurin|ruboxistaurin|mesh-list
110629286|NCT00266695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110629287|NCT00266695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110629288|NCT00849264|Fluorouracil|fluorouracil|mesh-list
110629289|NCT00849264|Endostar protein|endostar protein|mesh-list
110629290|NCT00849264|Antimetabolites|antimetabolites|mesh-ancestor
110629291|NCT00849264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110629292|NCT00849264|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110629293|NCT00849264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110629294|NCT00849264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110629295|NCT00849264|Immunologic Factors|immunologic factors|mesh-ancestor
110629296|NCT00849264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110629297|NCT00849264|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110629298|NCT00849264|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110629299|NCT00849264|Growth Substances|growth substances|mesh-ancestor
110629300|NCT00849264|Growth Inhibitors|growth inhibitors|mesh-ancestor
110629301|NCT00849342|Insulin Detemir|insulin detemir|mesh-list
110629302|NCT00849342|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110629303|NCT00849342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110629304|NCT00842556|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110629306|NCT00842556|Glimepiride|glimepiride|mesh-list
110629307|NCT00842556|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110629308|NCT00842556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110629309|NCT00842556|Incretins|incretins|mesh-ancestor
110629310|NCT00842556|Hormones|hormones|mesh-ancestor
110629311|NCT00842556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110629312|NCT00842556|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110629313|NCT00842556|Protease Inhibitors|protease inhibitors|mesh-ancestor
110629314|NCT00842556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110629315|NCT00842556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110629316|NCT00842556|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110629317|NCT00842556|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110629318|NCT00842556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110629319|NCT00842556|Immunologic Factors|immunologic factors|mesh-ancestor
110629320|NCT00849966|Celecoxib|celecoxib|mesh-list
110629321|NCT00849966|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110629322|NCT00849966|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110629323|NCT00849966|Analgesics|analgesics|mesh-ancestor
110629324|NCT00849966|Sensory System Agents|sensory system agents|mesh-ancestor
110629325|NCT00849966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110629326|NCT00849966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110629327|NCT00849966|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110629328|NCT00849966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110629329|NCT00849966|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110629330|NCT00849966|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110629331|NCT00849966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110629332|NCT00849966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110629334|NCT00853008|Dexamethasone|dexamethasone|mesh-list
110629335|NCT00853008|Prednisone|prednisone|mesh-list
110629336|NCT00853008|Hydrocortisone|hydrocortisone|mesh-list
110629337|NCT00853008|Methotrexate|methotrexate|mesh-list
110629338|NCT00853008|Vincristine|vincristine|mesh-list
110629339|NCT00853008|Daunorubicin|daunorubicin|mesh-list
110629340|NCT00853008|Mitoxantrone|mitoxantrone|mesh-list
110629341|NCT00853008|Mercaptopurine|mercaptopurine|mesh-list
110629342|NCT00853008|Teniposide|teniposide|mesh-list
110629343|NCT00853008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110629344|NCT00853008|Antiemetics|antiemetics|mesh-ancestor
110629345|NCT00853008|Autonomic Agents|autonomic agents|mesh-ancestor
110629346|NCT00853008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110154713|NCT00013624|Levodopa|levodopa|mesh-list
110629347|NCT00853008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110629348|NCT00853008|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110629349|NCT00853008|Glucocorticoids|glucocorticoids|mesh-ancestor
110629350|NCT00853008|Hormones|hormones|mesh-ancestor
110629351|NCT00853008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110629352|NCT00853008|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110629353|NCT00853008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110629354|NCT00853008|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110629355|NCT00853008|Abortifacient Agents|abortifacient agents|mesh-ancestor
110629356|NCT00853008|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110629357|NCT00853008|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110629358|NCT00853008|Antimetabolites|antimetabolites|mesh-ancestor
110629359|NCT00853008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110629360|NCT00853008|Dermatologic Agents|dermatologic agents|mesh-ancestor
110629361|NCT00853008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110629362|NCT00853008|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110629363|NCT00853008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110629364|NCT00853008|Immunologic Factors|immunologic factors|mesh-ancestor
110629365|NCT00853008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110629366|NCT00853008|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110629367|NCT00853008|Antiviral Agents|antiviral agents|mesh-ancestor
110629368|NCT00853008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110629369|NCT00853008|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110629370|NCT00853008|Tubulin Modulators|tubulin modulators|mesh-ancestor
110629371|NCT00853008|Antimitotic Agents|antimitotic agents|mesh-ancestor
110629372|NCT00853008|Mitosis Modulators|mitosis modulators|mesh-ancestor
110629373|NCT00853008|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110629374|NCT00853008|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110629375|NCT00853008|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110629376|NCT00853008|Analgesics|analgesics|mesh-ancestor
110629377|NCT00853008|Sensory System Agents|sensory system agents|mesh-ancestor
110629378|NCT02545530|Clonidine|clonidine|mesh-list
110629379|NCT02545530|Analgesics|analgesics|mesh-ancestor
110629380|NCT02545530|Sensory System Agents|sensory system agents|mesh-ancestor
110629381|NCT02545530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110629382|NCT02545530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110629383|NCT02545530|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110629384|NCT02545530|Sympatholytics|sympatholytics|mesh-ancestor
110629385|NCT02545530|Autonomic Agents|autonomic agents|mesh-ancestor
110629386|NCT02545530|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110629387|NCT02545530|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110629388|NCT02545530|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110629389|NCT02545530|Adrenergic Agents|adrenergic agents|mesh-ancestor
110629390|NCT02545530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110629391|NCT02545530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110629392|NCT00853320|Oxycodone|oxycodone|mesh-list
110629393|NCT00853320|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110629394|NCT00853320|Narcotics|narcotics|mesh-ancestor
110629395|NCT00853320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110629396|NCT00853320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110629397|NCT00853320|Analgesics|analgesics|mesh-ancestor
110629398|NCT00853320|Sensory System Agents|sensory system agents|mesh-ancestor
110629399|NCT00853320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110629400|NCT00547521|Methotrexate|methotrexate|mesh-list
110629401|NCT00547521|Abatacept|abatacept|mesh-list
110629402|NCT00547521|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110629403|NCT00547521|Abortifacient Agents|abortifacient agents|mesh-ancestor
110629404|NCT00547521|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110629405|NCT00547521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110276751|NCT00554710|Hormones|hormones|mesh-ancestor
110629406|NCT00547521|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110629407|NCT00547521|Antimetabolites|antimetabolites|mesh-ancestor
110629408|NCT00547521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110629409|NCT00547521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110629410|NCT00547521|Dermatologic Agents|dermatologic agents|mesh-ancestor
110629411|NCT00547521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110629412|NCT00547521|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110629413|NCT00547521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110629414|NCT00547521|Immunologic Factors|immunologic factors|mesh-ancestor
110629415|NCT00547521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110629416|NCT00547521|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110629417|NCT00547521|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110629418|NCT00547521|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110629419|NCT00850044|Ritonavir|ritonavir|mesh-list
110253647|NCT00142610|Antioxidants|antioxidants|mesh-ancestor
110629420|NCT00850044|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110629421|NCT00850044|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110629422|NCT00850044|Protease Inhibitors|protease inhibitors|mesh-ancestor
110629423|NCT00850044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110629424|NCT00850044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110629425|NCT00850044|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110629426|NCT00850044|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110629427|NCT00850044|Antiviral Agents|antiviral agents|mesh-ancestor
110629428|NCT00850044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110629429|NCT00850044|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110629430|NCT00850044|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110629431|NCT00266227|Rituximab|rituximab|mesh-list
110629432|NCT00266227|Methotrexate|methotrexate|mesh-list
110629433|NCT00266227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110629434|NCT00266227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110629435|NCT00266227|Immunologic Factors|immunologic factors|mesh-ancestor
110629436|NCT00266227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110629437|NCT00266227|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110629438|NCT00266227|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110629439|NCT00266227|Abortifacient Agents|abortifacient agents|mesh-ancestor
110629440|NCT00266227|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110629441|NCT00266227|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110629442|NCT00266227|Antimetabolites|antimetabolites|mesh-ancestor
110629443|NCT00266227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110629444|NCT00266227|Dermatologic Agents|dermatologic agents|mesh-ancestor
110629445|NCT00266227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110629446|NCT00266227|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110629447|NCT00266227|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110629448|NCT00266227|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110629450|NCT04233216|Antiviral Agents|antiviral agents|mesh-ancestor
110629451|NCT04233216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110629452|NCT04233216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110629453|NCT04233216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110629454|NCT04233216|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110629455|NCT04233216|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110629456|NCT04233216|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110629457|NCT00968877|Cholecalciferol|cholecalciferol|mesh-list
110629458|NCT00968877|Vitamin D|vitamin d|mesh-list
110629459|NCT00968877|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110629460|NCT00968877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110629461|NCT00968877|Vitamins|vitamins|mesh-ancestor
110629462|NCT00968877|Micronutrients|micronutrients|mesh-ancestor
110629463|NCT00968877|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110629464|NCT00850122|Cefazolin|cefazolin|mesh-list
110629465|NCT00850122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110629466|NCT00850122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110629467|NCT00968955|Ropivacaine|ropivacaine|mesh-list
110629468|NCT00968955|Anesthetics, Local|anesthetics, local|mesh-ancestor
110629469|NCT00968955|Anesthetics|anesthetics|mesh-ancestor
110629470|NCT00968955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110629471|NCT00968955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110629472|NCT00968955|Sensory System Agents|sensory system agents|mesh-ancestor
110629473|NCT00968955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110629474|NCT00853554|Hydromorphone|hydromorphone|mesh-list
110629475|NCT00853554|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110629476|NCT00853554|Narcotics|narcotics|mesh-ancestor
110629477|NCT00853554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110629478|NCT00853554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110629479|NCT00853554|Analgesics|analgesics|mesh-ancestor
110629480|NCT00853554|Sensory System Agents|sensory system agents|mesh-ancestor
110629481|NCT00853554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110629482|NCT00969033|Irinotecan|irinotecan|mesh-list
110629483|NCT00969033|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110629484|NCT00969033|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110629485|NCT00969033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110629486|NCT00969033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110629487|NCT00969033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110154720|NCT00013663|Aldesleukin|aldesleukin|mesh-list
110104312|NCT01778803|Paclitaxel|paclitaxel|mesh-list
110629489|NCT00573768|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110629491|NCT00573768|Analgesics|analgesics|mesh-ancestor
110629492|NCT00573768|Sensory System Agents|sensory system agents|mesh-ancestor
110629493|NCT00573768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110629494|NCT00573768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110629495|NCT00573768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110629496|NCT00573768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110629497|NCT00573768|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110629498|NCT00573768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110629499|NCT00573768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110629500|NCT00965913|Nicotine|nicotine|mesh-list
110629501|NCT00965913|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110629502|NCT00965913|Autonomic Agents|autonomic agents|mesh-ancestor
110629503|NCT00965913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110629504|NCT00965913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110104340|NCT01779258|Desonide|desonide|mesh-list
110629505|NCT00965913|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110629506|NCT00965913|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110629507|NCT00965913|Cholinergic Agents|cholinergic agents|mesh-ancestor
110629508|NCT00965913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110629509|NCT00965913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110629510|NCT00853866|Reboxetine|reboxetine|mesh-list
110629511|NCT00853866|Antidepressive Agents|antidepressive agents|mesh-ancestor
110629512|NCT00853866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110629513|NCT00853866|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110629514|NCT00853866|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110651636|NCT03303105|Immunologic Factors|immunologic factors|mesh-ancestor
110629515|NCT00853866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110629516|NCT00853866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110629517|NCT00853866|Adrenergic Agents|adrenergic agents|mesh-ancestor
110629518|NCT00853866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110629519|NCT00853866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110629520|NCT00855660|Riociguat|riociguat|mesh-list
110629521|NCT00855660|Enzyme Activators|enzyme activators|mesh-ancestor
110629522|NCT00855660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110629523|NCT00965991|Metformin|metformin|mesh-list
110629524|NCT00965991|Glyburide|glyburide|mesh-list
110629525|NCT00965991|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110629526|NCT00965991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110629527|NCT00853944|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110629528|NCT00853944|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
110629529|NCT00853944|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110629530|NCT00853944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110629531|NCT00853944|Incretins|incretins|mesh-ancestor
110629532|NCT00853944|Hormones|hormones|mesh-ancestor
110629533|NCT00853944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110629534|NCT00853944|Protease Inhibitors|protease inhibitors|mesh-ancestor
110629535|NCT00853944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110629536|NCT00853944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110629537|NCT02545452|Anastrozole|anastrozole|mesh-list
110629538|NCT02545452|Levonorgestrel|levonorgestrel|mesh-list
110629539|NCT02545452|Nonoxynol|nonoxynol|mesh-list
110629540|NCT02545452|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110629541|NCT02545452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110629542|NCT02545452|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110629543|NCT02545452|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110629544|NCT02545452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110629545|NCT02545452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110629546|NCT02545452|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110629547|NCT02545452|Hormone Antagonists|hormone antagonists|mesh-ancestor
110629548|NCT02545452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110629549|NCT02545452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110629550|NCT02545452|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110629551|NCT02545452|Contraceptive Agents|contraceptive agents|mesh-ancestor
110629552|NCT02545452|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110629553|NCT02545452|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110629554|NCT02545452|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110629555|NCT02545452|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110629556|NCT02545452|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
110629557|NCT02545452|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
110629558|NCT02545452|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110629560|NCT00547365|Antibodies|antibodies|mesh-list
110629561|NCT00547365|gamma-Globulins|gamma-globulins|mesh-list
110629562|NCT00547365|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110629563|NCT00547365|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110629564|NCT00547365|Immunologic Factors|immunologic factors|mesh-ancestor
110629565|NCT00547365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110629566|NCT00854178|Anesthetics|anesthetics|mesh-list
110629567|NCT00854178|Isoflurane|isoflurane|mesh-list
110629568|NCT00854178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110629569|NCT00854178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110629570|NCT00854178|Anesthetics, General|anesthetics, general|mesh-ancestor
110629571|NCT00854178|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110629572|NCT00850668|Hypoxanthine arabinoside|hypoxanthine arabinoside|mesh-list
110629573|NCT00850668|Antiviral Agents|antiviral agents|mesh-ancestor
110629574|NCT00850668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110629575|NCT00850746|Moxifloxacin|moxifloxacin|mesh-list
110629576|NCT00850746|Z 338|z 338|mesh-list
110629577|NCT00850746|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110629578|NCT00850746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110629579|NCT00850746|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110629580|NCT00850746|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110629581|NCT00850746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110629582|NCT00850746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110629583|NCT00850746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110629584|NCT00850746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110629585|NCT00850746|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110629586|NCT00850746|Cholinergic Agents|cholinergic agents|mesh-ancestor
110629587|NCT00850746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110629588|NCT00850746|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110629589|NCT00969813|Tofacitinib|tofacitinib|mesh-list
110629590|NCT00969813|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
110629591|NCT00969813|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110629592|NCT00969813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110629593|NCT00969813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110629594|NCT00854256|Mitomycins|mitomycins|mesh-list
110629595|NCT00854256|Mitomycin|mitomycin|mesh-list
110629596|NCT00854256|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110629597|NCT00854256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110629598|NCT00854256|Alkylating Agents|alkylating agents|mesh-ancestor
110629599|NCT00854256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110629600|NCT00854256|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110629601|NCT00854256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110629602|NCT00855972|Naltrexone|naltrexone|mesh-list
110104767|NCT01781988|Antimetabolites|antimetabolites|mesh-ancestor
110629603|NCT00855972|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110629604|NCT00855972|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110629605|NCT00855972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110629606|NCT00855972|Sensory System Agents|sensory system agents|mesh-ancestor
110629607|NCT00855972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110629608|NCT02544906|Propofol|propofol|mesh-list
110629609|NCT02544906|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110629610|NCT02544906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110104837|NCT01782651|Capecitabine|capecitabine|mesh-list
110629611|NCT02544906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110629612|NCT02544906|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110629613|NCT02544906|Anesthetics, General|anesthetics, general|mesh-ancestor
110629614|NCT02544906|Anesthetics|anesthetics|mesh-ancestor
110629615|NCT00861276|Nicotine|nicotine|mesh-list
110629616|NCT00861276|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110629617|NCT00861276|Autonomic Agents|autonomic agents|mesh-ancestor
110629618|NCT00861276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110393671|NCT01332318|Antimanic Agents|antimanic agents|mesh-ancestor
110253670|NCT02276092|Anti-Infective Agents|anti-infective agents|mesh-list
110629619|NCT00861276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110629620|NCT00861276|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110629621|NCT00861276|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110629622|NCT00861276|Cholinergic Agents|cholinergic agents|mesh-ancestor
110629623|NCT00861276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110629624|NCT00861276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110629625|NCT02544828|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
110629626|NCT02544828|Hematinics|hematinics|mesh-ancestor
110276997|NCT00200694|Valsartan|valsartan|mesh-list
110629628|NCT00861510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110629629|NCT00861510|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110629631|NCT00861510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110629632|NCT01095003|Capecitabine|capecitabine|mesh-list
110629633|NCT01095003|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110629635|NCT01095003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110629636|NCT01095003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110629637|NCT00854646|ON 01910|on 01910|mesh-list
110629638|NCT00854646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110629639|NCT00854646|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110629640|NCT00854646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110629641|NCT00854646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110629642|NCT00856362|Moxidectin|moxidectin|mesh-list
110629643|NCT00856362|Midazolam|midazolam|mesh-list
110629644|NCT00856362|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110629645|NCT00856362|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110629646|NCT00856362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110629647|NCT00856362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110629648|NCT00856362|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110629649|NCT00856362|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110105037|NCT01784250|Clonidine|clonidine|mesh-list
110629650|NCT00856362|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110629651|NCT00856362|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110629652|NCT00856362|Anesthetics, General|anesthetics, general|mesh-ancestor
110629653|NCT00856362|Anesthetics|anesthetics|mesh-ancestor
110629654|NCT00856362|GABA Modulators|gaba modulators|mesh-ancestor
110629655|NCT00856362|GABA Agents|gaba agents|mesh-ancestor
110629656|NCT00856362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110629657|NCT00856362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110629658|NCT00856362|Anthelmintics|anthelmintics|mesh-ancestor
110629659|NCT00856362|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110629660|NCT00856362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110629661|NCT00856362|Antinematodal Agents|antinematodal agents|mesh-ancestor
110629662|NCT00854802|Ribavirin|ribavirin|mesh-list
110629663|NCT00854802|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110629664|NCT00854802|Cyclosporine|cyclosporine|mesh-list
110629665|NCT00854802|Antimetabolites|antimetabolites|mesh-ancestor
110629666|NCT00854802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110629667|NCT00854802|Antiviral Agents|antiviral agents|mesh-ancestor
110629668|NCT00854802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110629669|NCT00854802|Antifungal Agents|antifungal agents|mesh-ancestor
110629670|NCT00854802|Dermatologic Agents|dermatologic agents|mesh-ancestor
110629671|NCT00854802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110629672|NCT00854802|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110629673|NCT00854802|Immunologic Factors|immunologic factors|mesh-ancestor
110629674|NCT00854802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110629675|NCT00854802|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110629676|NCT00854802|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110629678|NCT00958503|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110629679|NCT00958503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110629680|NCT04119024|Cyclophosphamide|cyclophosphamide|mesh-list
110629681|NCT04119024|Fludarabine|fludarabine|mesh-list
110629682|NCT04119024|Fludarabine phosphate|fludarabine phosphate|mesh-list
110629683|NCT04119024|Interleukin-2|interleukin-2|mesh-list
110629684|NCT04119024|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110629685|NCT04119024|Immunologic Factors|immunologic factors|mesh-ancestor
110629686|NCT04119024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110629687|NCT04119024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110629688|NCT04119024|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110629689|NCT04119024|Alkylating Agents|alkylating agents|mesh-ancestor
110105303|NCT01785693|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110629690|NCT04119024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110629691|NCT04119024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110629692|NCT04119024|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110629693|NCT04119024|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110629694|NCT04119024|Antimetabolites|antimetabolites|mesh-ancestor
110629695|NCT04119024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110629696|NCT04119024|Analgesics|analgesics|mesh-ancestor
110629698|NCT04119024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110629699|NCT00966615|Dialysis Solutions|dialysis solutions|mesh-list
110629700|NCT00966615|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110629702|NCT00966771|Levonorgestrel|levonorgestrel|mesh-list
110629703|NCT00966771|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110629704|NCT00966771|Contraceptive Agents|contraceptive agents|mesh-ancestor
110277049|NCT04653415|Hormones|hormones|mesh-ancestor
110629705|NCT00966771|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110629706|NCT00966771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110629707|NCT00966771|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110629708|NCT00966771|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110629709|NCT00966771|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110629710|NCT00966771|Trace Elements|trace elements|mesh-ancestor
110629711|NCT00966771|Micronutrients|micronutrients|mesh-ancestor
110629712|NCT00856596|Sertaconazole|sertaconazole|mesh-list
110629713|NCT00856596|Antifungal Agents|antifungal agents|mesh-ancestor
110629714|NCT00856596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110105508|NCT01787123|Cerebrolysin|cerebrolysin|mesh-list
110629716|NCT00855114|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110629717|NCT00855114|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110629718|NCT00855114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110629719|NCT00855114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110629720|NCT00855114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110629721|NCT00855114|Immunologic Factors|immunologic factors|mesh-ancestor
110629722|NCT00855114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110629723|NCT00855114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110629724|NCT00855270|Hydrocortisone|hydrocortisone|mesh-list
110629725|NCT00855270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110629726|NCT03937479|Tiotropium Bromide|tiotropium bromide|mesh-list
110629727|NCT03937479|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110629728|NCT03937479|Autonomic Agents|autonomic agents|mesh-ancestor
110629729|NCT03937479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110629730|NCT03937479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110629731|NCT03937479|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110629732|NCT03937479|Respiratory System Agents|respiratory system agents|mesh-ancestor
110629733|NCT03937479|Parasympatholytics|parasympatholytics|mesh-ancestor
110629734|NCT03937479|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110629735|NCT03937479|Cholinergic Agents|cholinergic agents|mesh-ancestor
110629736|NCT03937479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110629737|NCT03937479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110629738|NCT00970905|Ondansetron|ondansetron|mesh-list
110629739|NCT00970905|Aprepitant|aprepitant|mesh-list
110629740|NCT00970905|Antiemetics|antiemetics|mesh-ancestor
110629741|NCT00970905|Autonomic Agents|autonomic agents|mesh-ancestor
110629742|NCT00970905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110629743|NCT00970905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110629744|NCT00970905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110629746|NCT00970905|Dermatologic Agents|dermatologic agents|mesh-ancestor
110629747|NCT00970905|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110105709|NCT01788605|Ramosetron|ramosetron|mesh-list
110629748|NCT00970905|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110629749|NCT00970905|Serotonin Agents|serotonin agents|mesh-ancestor
110629750|NCT00970905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110629751|NCT00970905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110629752|NCT00970905|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110629753|NCT00619476|Gabapentin|gabapentin|mesh-list
110629754|NCT00619476|Analgesics|analgesics|mesh-ancestor
110629755|NCT00619476|Sensory System Agents|sensory system agents|mesh-ancestor
110629756|NCT00619476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110629757|NCT00619476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110629758|NCT00619476|Anticonvulsants|anticonvulsants|mesh-ancestor
110629759|NCT00619476|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110629760|NCT00619476|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110629761|NCT00619476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110629762|NCT00619476|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110629763|NCT00619476|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110629764|NCT00619476|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110629765|NCT00619476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110629766|NCT00619476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110629767|NCT00619476|Antimanic Agents|antimanic agents|mesh-ancestor
110629769|NCT00973713|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110629770|NCT00973713|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110629771|NCT00973713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110629772|NCT00973713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110629773|NCT00973713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110629774|NCT00973713|Immunologic Factors|immunologic factors|mesh-ancestor
110629775|NCT00973713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110629776|NCT00973713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110629777|NCT00857142|Oxymorphone|oxymorphone|mesh-list
110629778|NCT00857142|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110629779|NCT00857142|Narcotics|narcotics|mesh-ancestor
110629780|NCT00857142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110629781|NCT00857142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110629782|NCT00857142|Analgesics|analgesics|mesh-ancestor
110629784|NCT00857142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110629785|NCT00857142|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110629786|NCT00865176|Eplerenone|eplerenone|mesh-list
110629787|NCT00865176|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110629788|NCT00865176|Hormone Antagonists|hormone antagonists|mesh-ancestor
110629789|NCT00865176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110629790|NCT00865176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110629792|NCT00865176|Diuretics|diuretics|mesh-ancestor
110629793|NCT00865176|Natriuretic Agents|natriuretic agents|mesh-ancestor
110629794|NCT00865176|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110629795|NCT00973869|Curcumin|curcumin|mesh-list
110629796|NCT00973869|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110629797|NCT00973869|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110629798|NCT00973869|Analgesics|analgesics|mesh-ancestor
110629799|NCT00973869|Sensory System Agents|sensory system agents|mesh-ancestor
110393708|NCT01331109|Analgesics|analgesics|mesh-ancestor
110629800|NCT00973869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110629801|NCT00973869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110629802|NCT00973869|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110629803|NCT00973869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110629804|NCT00973869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110629805|NCT00973869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110629806|NCT00973869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110629808|NCT00959439|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110629809|NCT00959439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110629810|NCT00959439|Analgesics|analgesics|mesh-ancestor
110629811|NCT00959439|Sensory System Agents|sensory system agents|mesh-ancestor
110629812|NCT00959439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110629813|NCT00959439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110629814|NCT00959439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110629815|NCT00959439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110629816|NCT00959439|Gout Suppressants|gout suppressants|mesh-ancestor
110629817|NCT00959439|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110629818|NCT00959439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110105938|NCT01792570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110629819|NCT00959439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110629820|NCT04041492|Vitamin D|vitamin d|mesh-list
110629821|NCT04041492|Cholecalciferol|cholecalciferol|mesh-list
110629822|NCT04041492|Vitamins|vitamins|mesh-ancestor
110629823|NCT04041492|Micronutrients|micronutrients|mesh-ancestor
110629824|NCT04041492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110629825|NCT04041492|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110629826|NCT04041492|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110629827|NCT00857376|Thioctic Acid|thioctic acid|mesh-list
110629828|NCT00857376|Antioxidants|antioxidants|mesh-ancestor
110629829|NCT00857376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110629830|NCT00857376|Protective Agents|protective agents|mesh-ancestor
110629831|NCT00857376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110629832|NCT00857376|Vitamin B Complex|vitamin b complex|mesh-ancestor
110629833|NCT00857376|Vitamins|vitamins|mesh-ancestor
110629834|NCT00857376|Micronutrients|micronutrients|mesh-ancestor
110629835|NCT00618072|Metformin|metformin|mesh-list
110629836|NCT00618072|Rosiglitazone|rosiglitazone|mesh-list
110105985|NCT01794182|Glyburide|glyburide|mesh-list
110629837|NCT00618072|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110629838|NCT00618072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110629839|NCT00959517|Artesunate|artesunate|mesh-list
110629840|NCT00959517|Chloroquine|chloroquine|mesh-list
110629841|NCT00959517|Pyrimethamine|pyrimethamine|mesh-list
110629842|NCT00959517|Primaquine|primaquine|mesh-list
110629843|NCT00959517|Sulfadoxine|sulfadoxine|mesh-list
110629844|NCT00959517|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
110629845|NCT00959517|Antimalarials|antimalarials|mesh-ancestor
110629846|NCT00959517|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110629847|NCT00959517|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110629848|NCT00959517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110629849|NCT00959517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110629850|NCT00959517|Antiviral Agents|antiviral agents|mesh-ancestor
110629851|NCT00959517|Schistosomicides|schistosomicides|mesh-ancestor
110629852|NCT00959517|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110629853|NCT00959517|Anthelmintics|anthelmintics|mesh-ancestor
110629854|NCT00959517|Amebicides|amebicides|mesh-ancestor
110629855|NCT00959517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110629856|NCT00959517|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110629857|NCT00959517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110629858|NCT00959517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110629860|NCT00959595|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
110629861|NCT00959595|Anesthetics, Local|anesthetics, local|mesh-ancestor
110629862|NCT00959595|Anesthetics|anesthetics|mesh-ancestor
110629863|NCT00959595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110629864|NCT00959595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110629865|NCT00959595|Sensory System Agents|sensory system agents|mesh-ancestor
110629866|NCT00959595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110629867|NCT00959595|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
110629869|NCT00865410|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110629870|NCT00865410|Antidepressive Agents|antidepressive agents|mesh-ancestor
110629871|NCT00865410|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110629872|NCT00865410|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110629873|NCT00865410|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110629874|NCT00865410|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110629875|NCT00865410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110629876|NCT00865410|Dopamine Agents|dopamine agents|mesh-ancestor
110629877|NCT00865410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110629878|NCT00865410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110629879|NCT00865410|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110629880|NCT00865410|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110629881|NCT00865410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110629882|NCT00974181|Paclitaxel|paclitaxel|mesh-list
110629883|NCT00974181|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110629884|NCT00974181|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110629885|NCT00974181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110629886|NCT00974181|Tubulin Modulators|tubulin modulators|mesh-ancestor
110629887|NCT00974181|Antimitotic Agents|antimitotic agents|mesh-ancestor
110629888|NCT00974181|Mitosis Modulators|mitosis modulators|mesh-ancestor
110629889|NCT00974181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110629890|NCT00971607|Sevoflurane|sevoflurane|mesh-list
110629891|NCT00971607|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110106169|NCT01799863|Ketorolac|ketorolac|mesh-list
110629892|NCT00971607|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110629893|NCT00971607|Anesthetics, General|anesthetics, general|mesh-ancestor
110629894|NCT00971607|Anesthetics|anesthetics|mesh-ancestor
110629895|NCT00971607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110629896|NCT00971607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110629897|NCT00971685|Dexamethasone|dexamethasone|mesh-list
110629898|NCT00971685|Lenalidomide|lenalidomide|mesh-list
110106214|NCT01800227|Metformin|metformin|mesh-list
110629899|NCT00971685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110629900|NCT00971685|Antiemetics|antiemetics|mesh-ancestor
110629901|NCT00971685|Autonomic Agents|autonomic agents|mesh-ancestor
110629902|NCT00971685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110629903|NCT00971685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110629904|NCT00971685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110629905|NCT00971685|Glucocorticoids|glucocorticoids|mesh-ancestor
110629907|NCT00971685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110629908|NCT00971685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110629909|NCT00971685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110629911|NCT00971685|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110629912|NCT00971685|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110629913|NCT00971685|Growth Substances|growth substances|mesh-ancestor
110629914|NCT00971685|Growth Inhibitors|growth inhibitors|mesh-ancestor
110629915|NCT03861052|Dulaglutide|dulaglutide|mesh-list
110629917|NCT03861052|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110629918|NCT03861052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110629919|NCT03861052|Incretins|incretins|mesh-ancestor
110629920|NCT03861052|Hormones|hormones|mesh-ancestor
110629921|NCT03861052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110629922|NCT00971763|Prednisolone|prednisolone|mesh-list
110629923|NCT00971763|Cyclophosphamide|cyclophosphamide|mesh-list
110629924|NCT00971763|Rituximab|rituximab|mesh-list
110629925|NCT00971763|Gemcitabine|gemcitabine|mesh-list
110629926|NCT00971763|Vincristine|vincristine|mesh-list
110629927|NCT00971763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110629928|NCT00971763|Immunologic Factors|immunologic factors|mesh-ancestor
110629929|NCT00971763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110629930|NCT00971763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110629931|NCT00971763|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110629932|NCT00971763|Alkylating Agents|alkylating agents|mesh-ancestor
110629933|NCT00971763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110629934|NCT00971763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110629935|NCT00971763|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110629936|NCT00971763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110629937|NCT00971763|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110629938|NCT00971763|Antimetabolites|antimetabolites|mesh-ancestor
110629939|NCT00971763|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110629940|NCT00971763|Tubulin Modulators|tubulin modulators|mesh-ancestor
110629941|NCT00971763|Antimitotic Agents|antimitotic agents|mesh-ancestor
110629942|NCT00971763|Mitosis Modulators|mitosis modulators|mesh-ancestor
110629943|NCT00971763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110629944|NCT00971763|Glucocorticoids|glucocorticoids|mesh-ancestor
110629945|NCT00971763|Hormones|hormones|mesh-ancestor
110629946|NCT00971763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110629947|NCT00971763|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110629948|NCT00781196|Folic Acid|folic acid|mesh-list
110629949|NCT00781196|Hematinics|hematinics|mesh-ancestor
110629950|NCT00781196|Vitamin B Complex|vitamin b complex|mesh-ancestor
110629951|NCT00781196|Vitamins|vitamins|mesh-ancestor
110629952|NCT00781196|Micronutrients|micronutrients|mesh-ancestor
110629953|NCT00781196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110629954|NCT00865644|Imiquimod|imiquimod|mesh-list
110629955|NCT00865644|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110629956|NCT00865644|Immunologic Factors|immunologic factors|mesh-ancestor
110629957|NCT00865644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110629958|NCT00865644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110629959|NCT00865644|Interferon Inducers|interferon inducers|mesh-ancestor
110629960|NCT00785330|Rituximab|rituximab|mesh-list
110629961|NCT00785330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110629962|NCT00785330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110629963|NCT00785330|Immunologic Factors|immunologic factors|mesh-ancestor
110629964|NCT00785330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110629965|NCT00785330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110629966|NCT02555150|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
110629967|NCT02555150|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110629968|NCT02555150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110629969|NCT02555150|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110629970|NCT02555150|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110629971|NCT02555150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110629972|NCT02555150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110629973|NCT02555150|Dopamine Agents|dopamine agents|mesh-ancestor
110629974|NCT02555150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110629975|NCT05279469|Fibrin fragment D|fibrin fragment d|mesh-list
110629976|NCT05279469|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110629977|NCT05279469|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110651637|NCT03303105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110629978|NCT05279469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110629979|NCT05279469|Hemostatics|hemostatics|mesh-ancestor
110629980|NCT05279469|Coagulants|coagulants|mesh-ancestor
110629982|NCT00790946|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110629983|NCT00790946|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110629984|NCT00790946|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110629985|NCT00790946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110629986|NCT05179239|Paclitaxel|paclitaxel|mesh-list
110629987|NCT05179239|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110629988|NCT05179239|Cisplatin|cisplatin|mesh-list
110629989|NCT05179239|Carboplatin|carboplatin|mesh-list
110629990|NCT05179239|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110629991|NCT05179239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110629994|NCT05179239|Mitosis Modulators|mitosis modulators|mesh-ancestor
110629995|NCT05179239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110629996|NCT00972075|Melatonin|melatonin|mesh-list
110629997|NCT00972075|Antioxidants|antioxidants|mesh-ancestor
110629998|NCT00972075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110629999|NCT00972075|Protective Agents|protective agents|mesh-ancestor
110630000|NCT00972075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110630001|NCT00972075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110630002|NCT00974805|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
110630003|NCT00974805|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110630004|NCT00974805|Autonomic Agents|autonomic agents|mesh-ancestor
110630005|NCT00974805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110630006|NCT00974805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110630007|NCT00974805|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110630008|NCT00974805|Respiratory System Agents|respiratory system agents|mesh-ancestor
110630009|NCT00974805|Glucocorticoids|glucocorticoids|mesh-ancestor
110630010|NCT00974805|Hormones|hormones|mesh-ancestor
110630011|NCT00974805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110630012|NCT00974805|Sympathomimetics|sympathomimetics|mesh-ancestor
110630013|NCT00781352|Nitrous Oxide|nitrous oxide|mesh-list
110630014|NCT00781352|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110630015|NCT00781352|Anesthetics, General|anesthetics, general|mesh-ancestor
110630016|NCT00781352|Anesthetics|anesthetics|mesh-ancestor
110630017|NCT00781352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110630018|NCT00781352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110630019|NCT00781352|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110630020|NCT00781352|Analgesics|analgesics|mesh-ancestor
110630021|NCT00781352|Sensory System Agents|sensory system agents|mesh-ancestor
110630022|NCT00781352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110630023|NCT00791024|Lidocaine|lidocaine|mesh-list
110630024|NCT00791024|Anesthetics, Local|anesthetics, local|mesh-ancestor
110630025|NCT00791024|Anesthetics|anesthetics|mesh-ancestor
110253715|NCT00163137|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110630026|NCT00791024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110630027|NCT00791024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110630028|NCT00791024|Sensory System Agents|sensory system agents|mesh-ancestor
110630029|NCT00791024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110630030|NCT00791024|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110630031|NCT00791024|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110630032|NCT00791024|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110630033|NCT00791024|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110630034|NCT00791024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110630035|NCT03897244|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110630036|NCT03897244|Amoxicillin|amoxicillin|mesh-list
110630037|NCT03897244|Metronidazole|metronidazole|mesh-list
110630038|NCT03897244|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
110630039|NCT03897244|Rabeprazole|rabeprazole|mesh-list
110630040|NCT03897244|Bismuth|bismuth|mesh-list
110630041|NCT03897244|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
110630042|NCT03897244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110630043|NCT03897244|Antitubercular Agents|antitubercular agents|mesh-ancestor
110630044|NCT03897244|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110630045|NCT03897244|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110630046|NCT03897244|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110630047|NCT03897244|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110630048|NCT03897244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110630049|NCT03897244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110630051|NCT00666536|Amlodipine|amlodipine|mesh-list
110630052|NCT00666536|Valsartan|valsartan|mesh-list
110630053|NCT00666536|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
110630054|NCT00666536|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110630055|NCT00666536|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110630056|NCT00666536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110630057|NCT00666536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110630058|NCT00666536|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110630059|NCT00666536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110630060|NCT00666536|Vasodilator Agents|vasodilator agents|mesh-ancestor
110630061|NCT00666536|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110630062|NCT00666536|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110630063|NCT00519532|Rotigotine|rotigotine|mesh-list
110630064|NCT00519532|Dopamine Agonists|dopamine agonists|mesh-ancestor
110630065|NCT00519532|Dopamine Agents|dopamine agents|mesh-ancestor
110106850|NCT01805310|Cathartics|cathartics|mesh-ancestor
110630066|NCT00519532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110630067|NCT00519532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110630068|NCT00519532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110630069|NCT00666458|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110630070|NCT00666458|Saxagliptin|saxagliptin|mesh-list
110630071|NCT00666458|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110630072|NCT00666458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110630073|NCT00666458|Incretins|incretins|mesh-ancestor
110630074|NCT00666458|Hormones|hormones|mesh-ancestor
110630075|NCT00666458|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110630076|NCT00666458|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110630077|NCT00666458|Protease Inhibitors|protease inhibitors|mesh-ancestor
110630078|NCT00666458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110630079|NCT00666458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110277416|NCT00201318|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110630081|NCT00974961|Levobupivacaine|levobupivacaine|mesh-list
110630082|NCT00974961|Anesthetics, Local|anesthetics, local|mesh-ancestor
110630083|NCT00974961|Anesthetics|anesthetics|mesh-ancestor
110630084|NCT00974961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110630085|NCT00974961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110630086|NCT00974961|Sensory System Agents|sensory system agents|mesh-ancestor
110630087|NCT00974961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110630089|NCT00511108|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110630090|NCT00511108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110630091|NCT00511108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110630092|NCT00511108|Incretins|incretins|mesh-ancestor
110630093|NCT00511108|Hormones|hormones|mesh-ancestor
110630094|NCT00511108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110630095|NCT00511108|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110630096|NCT00511108|Protease Inhibitors|protease inhibitors|mesh-ancestor
110630097|NCT00511108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110630098|NCT00511108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110630099|NCT00781586|Caffeine|caffeine|mesh-list
110630100|NCT00781586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110630101|NCT00781586|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110630102|NCT00781586|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110630103|NCT00781586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110630104|NCT00781586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110107146|NCT01810354|Cefazolin|cefazolin|mesh-list
110630105|NCT00781586|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110630106|NCT00781586|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110630107|NCT00781586|Purinergic Agents|purinergic agents|mesh-ancestor
110630108|NCT00781586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110630110|NCT00510952|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110630112|NCT00510952|Insulin Lispro|insulin lispro|mesh-list
110630113|NCT00510952|Protamines|protamines|mesh-list
110630114|NCT00510952|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110630115|NCT00510952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110630116|NCT00510952|Heparin Antagonists|heparin antagonists|mesh-ancestor
110630117|NCT00510952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110630118|NCT00510952|Coagulants|coagulants|mesh-ancestor
110630119|NCT00617604|Mycophenolic Acid|mycophenolic acid|mesh-list
110630120|NCT00617604|Alefacept|alefacept|mesh-list
110630121|NCT00617604|Tacrolimus|tacrolimus|mesh-list
110630122|NCT00617604|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110630123|NCT00617604|Immunologic Factors|immunologic factors|mesh-ancestor
110630124|NCT00617604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110630125|NCT00617604|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110630126|NCT00617604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110630127|NCT00617604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110630128|NCT00617604|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110630129|NCT00617604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110630130|NCT00617604|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110630131|NCT00617604|Antitubercular Agents|antitubercular agents|mesh-ancestor
110630132|NCT00617604|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110630133|NCT00617604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110630134|NCT00617604|Dermatologic Agents|dermatologic agents|mesh-ancestor
110630135|NCT01012570|Adalimumab|adalimumab|mesh-list
110630136|NCT01012570|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110630137|NCT01012570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110630138|NCT01012570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110630139|NCT00865878|Aminolevulinic Acid|aminolevulinic acid|mesh-list
110630140|NCT00865878|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110630141|NCT00865878|Dermatologic Agents|dermatologic agents|mesh-ancestor
110630142|NCT00661622|Molgramostim|molgramostim|mesh-list
110630143|NCT00661622|Sargramostim|sargramostim|mesh-list
110630144|NCT00661622|Immunologic Factors|immunologic factors|mesh-ancestor
110630145|NCT00661622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110630146|NCT00661622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110630147|NCT00781820|Bifonazole|bifonazole|mesh-list
110630148|NCT00781820|Antifungal Agents|antifungal agents|mesh-ancestor
110630149|NCT00781820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110630150|NCT00786110|Paclitaxel|paclitaxel|mesh-list
110630151|NCT00786110|Sorafenib|sorafenib|mesh-list
110630152|NCT00786110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110630153|NCT00786110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110630154|NCT00786110|Tubulin Modulators|tubulin modulators|mesh-ancestor
110630155|NCT00786110|Antimitotic Agents|antimitotic agents|mesh-ancestor
110630156|NCT00786110|Mitosis Modulators|mitosis modulators|mesh-ancestor
110393806|NCT04445415|Immunologic Factors|immunologic factors|mesh-ancestor
110107409|NCT01812122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110630157|NCT00786110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110630158|NCT00786110|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110630159|NCT00786110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110630161|NCT00791804|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110630162|NCT00791804|Narcotics|narcotics|mesh-ancestor
110630163|NCT00791804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110630164|NCT00791804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110630165|NCT00791804|Analgesics|analgesics|mesh-ancestor
110630166|NCT00791804|Sensory System Agents|sensory system agents|mesh-ancestor
110630167|NCT00791804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110630168|NCT00791804|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110630169|NCT00791804|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110630170|NCT00791804|Anesthetics, General|anesthetics, general|mesh-ancestor
110630171|NCT00791804|Anesthetics|anesthetics|mesh-ancestor
110630172|NCT00791960|Dimenhydrinate|dimenhydrinate|mesh-list
110630174|NCT00791960|Autonomic Agents|autonomic agents|mesh-ancestor
110630175|NCT00791960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110630176|NCT00791960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110630177|NCT00791960|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110630178|NCT00791960|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110630179|NCT00791960|Histamine Antagonists|histamine antagonists|mesh-ancestor
110630180|NCT00791960|Histamine Agents|histamine agents|mesh-ancestor
110630181|NCT00791960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110107603|NCT01813240|Minocycline|minocycline|mesh-list
110630182|NCT00791960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110630183|NCT00792350|Sorafenib|sorafenib|mesh-list
110630184|NCT00792350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110630185|NCT00792350|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110630186|NCT00792350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110630187|NCT00792350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110630189|NCT00792584|Etravirine|etravirine|mesh-list
110630190|NCT00792584|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110630191|NCT00792584|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110630192|NCT00792584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110630193|NCT00792584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110630195|NCT00792584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110630196|NCT00792584|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110630197|NCT00792584|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110630198|NCT00792584|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110630199|NCT00792584|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110630200|NCT00792584|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110630201|NCT00792584|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110630202|NCT02556086|Sofosbuvir|sofosbuvir|mesh-list
110630203|NCT02556086|Antiviral Agents|antiviral agents|mesh-ancestor
110630204|NCT02556086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110630205|NCT04093752|Insulin Glargine|insulin glargine|mesh-list
110630206|NCT04093752|Tirzepatide|tirzepatide|mesh-list
110630207|NCT04093752|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110630208|NCT04093752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110630209|NCT04093752|Incretins|incretins|mesh-ancestor
110630210|NCT04093752|Hormones|hormones|mesh-ancestor
110630211|NCT04093752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110630212|NCT02544282|Acetaminophen|acetaminophen|mesh-list
110630213|NCT02544282|Sufentanil|sufentanil|mesh-list
110630214|NCT02544282|Tramadol|tramadol|mesh-list
110630215|NCT02544282|Pirinitramide|pirinitramide|mesh-list
110630216|NCT02544282|Propofol|propofol|mesh-list
110630217|NCT02544282|Sevoflurane|sevoflurane|mesh-list
110630218|NCT02544282|Levobupivacaine|levobupivacaine|mesh-list
110630219|NCT02544282|Atracurium|atracurium|mesh-list
110253755|NCT00163254|Abciximab|abciximab|mesh-list
110630220|NCT02544282|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110630221|NCT02544282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110107860|NCT01814449|Letrozole|letrozole|mesh-list
110630222|NCT02544282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110630223|NCT02544282|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110630224|NCT02544282|Anesthetics, General|anesthetics, general|mesh-ancestor
110630225|NCT02544282|Anesthetics|anesthetics|mesh-ancestor
110630226|NCT02544282|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110630227|NCT02544282|Analgesics|analgesics|mesh-ancestor
110630228|NCT02544282|Sensory System Agents|sensory system agents|mesh-ancestor
110630229|NCT02544282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110630230|NCT02544282|Antipyretics|antipyretics|mesh-ancestor
110630231|NCT02544282|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110630232|NCT02544282|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110630233|NCT02544282|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110630234|NCT02544282|Narcotics|narcotics|mesh-ancestor
110630235|NCT02544282|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110630236|NCT02544282|Anesthetics, Local|anesthetics, local|mesh-ancestor
110630237|NCT02544282|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110630238|NCT02544282|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110630239|NCT02544282|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110630240|NCT02544282|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
110630241|NCT02544282|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110630242|NCT02544282|Cholinergic Agents|cholinergic agents|mesh-ancestor
110630243|NCT02544282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110630244|NCT02544282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110630245|NCT04041648|Treprostinil|treprostinil|mesh-list
110107992|NCT01815021|Calcium, Dietary|calcium, dietary|mesh-list
110630246|NCT04041648|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110630247|NCT04041648|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110630248|NCT00666224|Glatiramer Acetate|glatiramer acetate|mesh-list
110630249|NCT00666224|(T,G)-A-L|(t,g)-a-l|mesh-list
110630250|NCT00666224|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110630251|NCT00666224|Immunologic Factors|immunologic factors|mesh-ancestor
110630252|NCT00666224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110154780|NCT00005972|Irinotecan|irinotecan|mesh-list
110630253|NCT00666224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110630254|NCT00666224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110630255|NCT00663962|Pregabalin|pregabalin|mesh-list
110630256|NCT00663962|Analgesics|analgesics|mesh-ancestor
110630257|NCT00663962|Sensory System Agents|sensory system agents|mesh-ancestor
110630258|NCT00663962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110630259|NCT00663962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110630260|NCT00663962|Anticonvulsants|anticonvulsants|mesh-ancestor
110630261|NCT00663962|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110630262|NCT00663962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110630263|NCT00663962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110630264|NCT00663962|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110630265|NCT00663962|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110630266|NCT00663962|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110630267|NCT00663962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110630268|NCT00663962|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110630270|NCT00858624|Analgesics|analgesics|mesh-ancestor
110108110|NCT01816191|Diltiazem|diltiazem|mesh-list
110630271|NCT00858624|Sensory System Agents|sensory system agents|mesh-ancestor
110630272|NCT00858624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110630273|NCT00858624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110630274|NCT00858624|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110630275|NCT00858624|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110630276|NCT00858624|Anesthetics, General|anesthetics, general|mesh-ancestor
110630278|NCT00858624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110108177|NCT01816581|Naloxone|naloxone|mesh-list
110393823|NCT01340625|Norethindrone Acetate|norethindrone acetate|mesh-list
110630279|NCT00858624|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110630280|NCT00858624|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110630281|NCT00858624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110630282|NCT00858624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110630283|NCT00960453|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110630284|NCT00960453|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110630285|NCT00960453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110630286|NCT00960453|Incretins|incretins|mesh-ancestor
110630287|NCT00960453|Hormones|hormones|mesh-ancestor
110630288|NCT00960453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110630289|NCT00960453|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110630290|NCT00960453|Protease Inhibitors|protease inhibitors|mesh-ancestor
110630291|NCT00960453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110630292|NCT00960453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110630293|NCT00265759|Letrozole|letrozole|mesh-list
110108244|NCT01817023|Cisplatin|cisplatin|mesh-list
110630294|NCT00265759|Anastrozole|anastrozole|mesh-list
110630295|NCT00265759|Exemestane|exemestane|mesh-list
110630296|NCT00265759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110630297|NCT00265759|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110630298|NCT00265759|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110630299|NCT00265759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110630300|NCT00265759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110630301|NCT00265759|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110630302|NCT00265759|Hormone Antagonists|hormone antagonists|mesh-ancestor
110630303|NCT00265759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110630304|NCT00265759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110630305|NCT00265759|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110630306|NCT00972387|Prednisone|prednisone|mesh-list
110630307|NCT00972387|Prednisolone|prednisolone|mesh-list
110630308|NCT00972387|Cyclophosphamide|cyclophosphamide|mesh-list
110630309|NCT00972387|Doxorubicin|doxorubicin|mesh-list
110630310|NCT00972387|Vincristine|vincristine|mesh-list
110630311|NCT00972387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110630312|NCT00972387|Immunologic Factors|immunologic factors|mesh-ancestor
110630313|NCT00972387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110630314|NCT00972387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110630315|NCT00972387|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110630316|NCT00972387|Alkylating Agents|alkylating agents|mesh-ancestor
110630317|NCT00972387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110630318|NCT00972387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110630319|NCT00972387|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110630320|NCT00972387|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110630321|NCT00972387|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110630322|NCT00972387|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110630323|NCT00972387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110630324|NCT00972387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110630325|NCT00972387|Glucocorticoids|glucocorticoids|mesh-ancestor
110630326|NCT00972387|Hormones|hormones|mesh-ancestor
110630327|NCT00972387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110630328|NCT00972387|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110630329|NCT00972387|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110630330|NCT00972387|Tubulin Modulators|tubulin modulators|mesh-ancestor
110630331|NCT00972387|Antimitotic Agents|antimitotic agents|mesh-ancestor
110630332|NCT00972387|Mitosis Modulators|mitosis modulators|mesh-ancestor
110630333|NCT00744263|Vaccines|vaccines|mesh-list
110630334|NCT00744263|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110630335|NCT00744263|Immunologic Factors|immunologic factors|mesh-ancestor
110630336|NCT00744263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110630337|NCT00783068|3-(2,4-dimethoxybenzylidene)anabaseine|3-(2,4-dimethoxybenzylidene)anabaseine|mesh-list
110630338|NCT00783068|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110630339|NCT00783068|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110630340|NCT00783068|Cholinergic Agents|cholinergic agents|mesh-ancestor
110630341|NCT00783068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110630342|NCT00783068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110630343|NCT00783068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110630344|NCT00866736|Dasatinib|dasatinib|mesh-list
110630345|NCT00866736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110630346|NCT00866736|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110630347|NCT00866736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110630348|NCT00866736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110630349|NCT00792818|Ibuprofen|ibuprofen|mesh-list
110630350|NCT00792818|Curcumin|curcumin|mesh-list
110630351|NCT00792818|Turmeric extract|turmeric extract|mesh-list
110630352|NCT00792818|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110630353|NCT00792818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110630354|NCT00792818|Analgesics|analgesics|mesh-ancestor
110630355|NCT00792818|Sensory System Agents|sensory system agents|mesh-ancestor
110630356|NCT00792818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110630357|NCT00792818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110630358|NCT00792818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110630359|NCT00792818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110630360|NCT00792818|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110630361|NCT00792818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110108693|NCT01820325|Paclitaxel|paclitaxel|mesh-list
110630362|NCT00792818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110630363|NCT00792818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110630365|NCT00792818|Protective Agents|protective agents|mesh-ancestor
110630366|NCT00972465|Nimotuzumab|nimotuzumab|mesh-list
110630367|NCT00972465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110630368|NCT00972465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110630369|NCT00975351|Tetrahydrofolates|tetrahydrofolates|mesh-list
110630370|NCT00975351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110630371|NCT00975351|Vitamin B Complex|vitamin b complex|mesh-ancestor
110630372|NCT00975351|Vitamins|vitamins|mesh-ancestor
110630373|NCT00975351|Micronutrients|micronutrients|mesh-ancestor
110630374|NCT01071187|Varenicline|varenicline|mesh-list
110630375|NCT01071187|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110630376|NCT01071187|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110630377|NCT01071187|Cholinergic Agents|cholinergic agents|mesh-ancestor
110630378|NCT01071187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110630379|NCT01071187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110630380|NCT01071187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110630381|NCT00618774|Amlodipine|amlodipine|mesh-list
110630382|NCT00618774|Telmisartan|telmisartan|mesh-list
110630383|NCT00618774|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110630384|NCT00618774|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110630385|NCT00618774|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110630386|NCT00618774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110630387|NCT00618774|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110630388|NCT00618774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110630389|NCT00618774|Vasodilator Agents|vasodilator agents|mesh-ancestor
110630390|NCT00618774|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110630391|NCT00618774|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110630392|NCT00917345|Captopril|captopril|mesh-list
110630393|NCT00917345|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110630394|NCT00917345|Protease Inhibitors|protease inhibitors|mesh-ancestor
110630395|NCT00917345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110630396|NCT00917345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110630397|NCT00917345|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110630399|NCT00793052|Etoricoxib|etoricoxib|mesh-list
110630400|NCT00793052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110630401|NCT00793052|Antiemetics|antiemetics|mesh-ancestor
110630402|NCT00793052|Autonomic Agents|autonomic agents|mesh-ancestor
110630403|NCT00793052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110630404|NCT00793052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110630405|NCT00793052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110630406|NCT00793052|Glucocorticoids|glucocorticoids|mesh-ancestor
110630407|NCT00793052|Hormones|hormones|mesh-ancestor
110630408|NCT00793052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110630409|NCT00793052|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110630410|NCT00793052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110630411|NCT00793052|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110630412|NCT00793052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110630413|NCT00793052|Analgesics|analgesics|mesh-ancestor
110630414|NCT00793052|Sensory System Agents|sensory system agents|mesh-ancestor
110630415|NCT00793052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110630416|NCT00793052|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110108931|NCT01821612|Antidotes|antidotes|mesh-ancestor
110630417|NCT00793052|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110630418|NCT00793052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110253779|NCT04514029|Antimetabolites|antimetabolites|mesh-ancestor
110630419|NCT00793052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110630420|NCT02555852|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
110630421|NCT02555852|Esomeprazole|esomeprazole|mesh-list
110630422|NCT02555852|Omeprazole|omeprazole|mesh-list
110630423|NCT02555852|Rabeprazole|rabeprazole|mesh-list
110630424|NCT02555852|Pantoprazole|pantoprazole|mesh-list
110630425|NCT02555852|Lansoprazole|lansoprazole|mesh-list
110630426|NCT02555852|Famotidine|famotidine|mesh-list
110630427|NCT02555852|Ranitidine|ranitidine|mesh-list
110630428|NCT02555852|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
110630429|NCT02555852|Cimetidine|cimetidine|mesh-list
110630430|NCT02555852|Nizatidine|nizatidine|mesh-list
110630431|NCT02555852|Lafutidine|lafutidine|mesh-list
110630432|NCT02555852|Roxatidine acetate|roxatidine acetate|mesh-list
110630433|NCT02555852|Bismuth|bismuth|mesh-list
110630434|NCT02555852|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
110630435|NCT02555852|Histamine H2 Antagonists|histamine h2 antagonists|mesh-list
110630436|NCT02555852|Histamine|histamine|mesh-list
110630437|NCT02555852|Histamine phosphate|histamine phosphate|mesh-list
110109192|NCT01823770|Rotigotine|rotigotine|mesh-list
110630438|NCT02555852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110630439|NCT02555852|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110630440|NCT02555852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110630441|NCT02555852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110630443|NCT02555852|Histamine Antagonists|histamine antagonists|mesh-ancestor
110630444|NCT02555852|Histamine Agents|histamine agents|mesh-ancestor
110630445|NCT02555852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110630446|NCT02555852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110630447|NCT02555852|Histamine Agonists|histamine agonists|mesh-ancestor
110630448|NCT02555852|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110630449|NCT02555852|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110630450|NCT02555852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110630451|NCT04091009|Buprenorphine|buprenorphine|mesh-list
110651638|NCT00933452|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110630452|NCT04091009|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
110630454|NCT04091009|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110630455|NCT04091009|Narcotics|narcotics|mesh-ancestor
110630456|NCT04091009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110630457|NCT04091009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110109408|NCT01825109|Vaccines|vaccines|mesh-list
110630458|NCT04091009|Analgesics|analgesics|mesh-ancestor
110630459|NCT04091009|Sensory System Agents|sensory system agents|mesh-ancestor
110630460|NCT04091009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110630462|NCT02597231|Melatonin|melatonin|mesh-list
110630464|NCT02597231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110630465|NCT02597231|Protective Agents|protective agents|mesh-ancestor
110630466|NCT02597231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110109461|NCT01825551|Lenograstim|lenograstim|mesh-list
110630467|NCT02597231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110630468|NCT00545571|Epoetin Alfa|epoetin alfa|mesh-list
110630469|NCT00545571|Hematinics|hematinics|mesh-ancestor
110630470|NCT00783380|Vaccines|vaccines|mesh-list
110630471|NCT00783380|Immunologic Factors|immunologic factors|mesh-ancestor
110630472|NCT00783380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110630473|NCT04008225|Dimercaprol|dimercaprol|mesh-list
110630474|NCT04008225|Chelating Agents|chelating agents|mesh-ancestor
110630475|NCT04008225|Sequestering Agents|sequestering agents|mesh-ancestor
110630476|NCT04008225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110630477|NCT00748709|Afatinib|afatinib|mesh-list
110630478|NCT00748709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110630479|NCT00748709|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110630480|NCT00748709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110630481|NCT00748709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110630482|NCT02597309|Canagliflozin|canagliflozin|mesh-list
110630483|NCT02597309|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110630484|NCT02597309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110630486|NCT02597309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110630487|NCT00863148|Busulfan|busulfan|mesh-list
110630488|NCT00863148|Clofarabine|clofarabine|mesh-list
110630489|NCT00863148|Alkylating Agents|alkylating agents|mesh-ancestor
110630490|NCT00863148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110630492|NCT00863148|Immunologic Factors|immunologic factors|mesh-ancestor
110630493|NCT00863148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110253781|NCT04514029|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110630494|NCT00863148|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110630495|NCT00863148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110630496|NCT00863148|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110630497|NCT00863148|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110109731|NCT01827722|Hormones|hormones|mesh-ancestor
110630498|NCT00863148|Antimetabolites|antimetabolites|mesh-ancestor
110630499|NCT00786734|Pitavastatin|pitavastatin|mesh-list
110630500|NCT00786734|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110630501|NCT00786734|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110630502|NCT00786734|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110630503|NCT00786734|Antimetabolites|antimetabolites|mesh-ancestor
110630504|NCT00786734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110630505|NCT00786734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110630506|NCT00786734|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110630507|NCT00263887|Protease Inhibitors|protease inhibitors|mesh-list
110630508|NCT00263887|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
110630509|NCT00263887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110630510|NCT00263887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110630511|NCT00263887|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
110109940|NCT01829659|Ticagrelor|ticagrelor|mesh-list
110630512|NCT00263887|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110630514|NCT00867126|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110630515|NCT00867126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110630517|NCT00748553|Azacitidine|azacitidine|mesh-list
110630518|NCT00748553|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110630519|NCT00748553|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110630520|NCT00748553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110630521|NCT00748553|Tubulin Modulators|tubulin modulators|mesh-ancestor
110630522|NCT00748553|Antimitotic Agents|antimitotic agents|mesh-ancestor
110630523|NCT00748553|Mitosis Modulators|mitosis modulators|mesh-ancestor
110110008|NCT01830153|Everolimus|everolimus|mesh-list
110630524|NCT00748553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110630525|NCT00748553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110630526|NCT00748553|Antimetabolites|antimetabolites|mesh-ancestor
110630527|NCT00748553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110630528|NCT00661388|Epoetin Alfa|epoetin alfa|mesh-list
110630529|NCT00661388|Hematinics|hematinics|mesh-ancestor
110630530|NCT00972855|Bicalutamide|bicalutamide|mesh-list
110630531|NCT00972855|Androgen Antagonists|androgen antagonists|mesh-ancestor
110630532|NCT00972855|Hormone Antagonists|hormone antagonists|mesh-ancestor
110630533|NCT00972855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110630534|NCT00972855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110630535|NCT00972855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110630537|NCT00972933|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110630538|NCT00972933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110630539|NCT00972933|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110630540|NCT00972933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110630542|NCT00263575|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110630543|NCT00263575|Narcotics|narcotics|mesh-ancestor
110630544|NCT00263575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110630545|NCT00263575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110630546|NCT00263575|Analgesics|analgesics|mesh-ancestor
110630547|NCT00263575|Sensory System Agents|sensory system agents|mesh-ancestor
110630548|NCT00263575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110630549|NCT00263575|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110630550|NCT00263575|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110630551|NCT00263575|Anesthetics, General|anesthetics, general|mesh-ancestor
110630552|NCT00263575|Anesthetics|anesthetics|mesh-ancestor
110630553|NCT00975663|Tacrolimus|tacrolimus|mesh-list
110630554|NCT00975663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110630555|NCT00975663|Immunologic Factors|immunologic factors|mesh-ancestor
110630556|NCT00975663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110630557|NCT00975663|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110630558|NCT00975663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110630559|NCT00975663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110630560|NCT00570128|Donepezil|donepezil|mesh-list
110630561|NCT00570128|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110630562|NCT00570128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110110242|NCT01837446|Immunologic Factors|immunologic factors|mesh-ancestor
110630563|NCT00570128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110630564|NCT00570128|Cholinergic Agents|cholinergic agents|mesh-ancestor
110630565|NCT00570128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110630566|NCT00570128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110630567|NCT00570128|Nootropic Agents|nootropic agents|mesh-ancestor
110630569|NCT00960921|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
110630570|NCT00960921|Trace Elements|trace elements|mesh-ancestor
110630571|NCT00960921|Micronutrients|micronutrients|mesh-ancestor
110630572|NCT00960921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110630573|NCT00960921|Hematinics|hematinics|mesh-ancestor
110630574|NCT00863460|Cytarabine|cytarabine|mesh-list
110630575|NCT00863460|Prednisone|prednisone|mesh-list
110630576|NCT00863460|Cyclophosphamide|cyclophosphamide|mesh-list
110630577|NCT00863460|Busulfan|busulfan|mesh-list
110630578|NCT00863460|Thiotepa|thiotepa|mesh-list
110630579|NCT00863460|Carmustine|carmustine|mesh-list
110630580|NCT00863460|Methotrexate|methotrexate|mesh-list
110630581|NCT00863460|Etoposide|etoposide|mesh-list
110630582|NCT00863460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110630583|NCT00863460|Immunologic Factors|immunologic factors|mesh-ancestor
110630584|NCT00863460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110630585|NCT00863460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110630586|NCT00863460|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110630587|NCT00863460|Alkylating Agents|alkylating agents|mesh-ancestor
110630588|NCT00863460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110630589|NCT00863460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110630590|NCT00863460|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110630591|NCT00863460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110630592|NCT00863460|Glucocorticoids|glucocorticoids|mesh-ancestor
110630593|NCT00863460|Hormones|hormones|mesh-ancestor
110630594|NCT00863460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110630595|NCT00863460|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110630596|NCT00863460|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110630597|NCT00863460|Abortifacient Agents|abortifacient agents|mesh-ancestor
110630598|NCT00863460|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110630599|NCT00863460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110630600|NCT00863460|Antimetabolites|antimetabolites|mesh-ancestor
110630601|NCT00863460|Dermatologic Agents|dermatologic agents|mesh-ancestor
110630602|NCT00863460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110630603|NCT00863460|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110630604|NCT00863460|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110630605|NCT00863460|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110630606|NCT00863460|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110154807|NCT00014209|Antimetabolites|antimetabolites|mesh-ancestor
110630607|NCT00863460|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110630608|NCT00863460|Antiviral Agents|antiviral agents|mesh-ancestor
110630609|NCT00863460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110630610|NCT00262951|Interferons|interferons|mesh-list
110630612|NCT00262951|Interferon alpha-2|interferon alpha-2|mesh-list
110630613|NCT00262951|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
110630614|NCT00262951|Cisplatin|cisplatin|mesh-list
110630615|NCT00262951|Fluorouracil|fluorouracil|mesh-list
110630616|NCT00262951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110630617|NCT00262951|Antimetabolites|antimetabolites|mesh-ancestor
110630618|NCT00262951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110630619|NCT00262951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110630620|NCT00262951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110630621|NCT00262951|Immunologic Factors|immunologic factors|mesh-ancestor
110630622|NCT00262951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110630623|NCT00262951|Antiviral Agents|antiviral agents|mesh-ancestor
110630624|NCT00262951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110630625|NCT02597153|Mitoxantrone|mitoxantrone|mesh-list
110630626|NCT02597153|Analgesics|analgesics|mesh-ancestor
110630627|NCT02597153|Sensory System Agents|sensory system agents|mesh-ancestor
110630628|NCT02597153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110630629|NCT02597153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110630630|NCT02597153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110110492|NCT01841827|Cilostazol|cilostazol|mesh-list
110630631|NCT02597153|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110630632|NCT02597153|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110630634|NCT02597153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110630635|NCT00975741|Mometasone Furoate|mometasone furoate|mesh-list
110630636|NCT00975741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110630637|NCT00975741|Dermatologic Agents|dermatologic agents|mesh-ancestor
110630638|NCT00975741|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110630640|NCT00262873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110630641|NCT00975819|Sirolimus|sirolimus|mesh-list
110630642|NCT00975819|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110630643|NCT00975819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110630644|NCT00975819|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110630645|NCT00975819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110630646|NCT00975819|Antifungal Agents|antifungal agents|mesh-ancestor
110630647|NCT00975819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110630648|NCT00975819|Immunologic Factors|immunologic factors|mesh-ancestor
110630649|NCT00975819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110630650|NCT00859872|Haloperidol|haloperidol|mesh-list
110630651|NCT00859872|Risperidone|risperidone|mesh-list
110630652|NCT00859872|Haloperidol decanoate|haloperidol decanoate|mesh-list
110630653|NCT00859872|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110630654|NCT00859872|Serotonin Agents|serotonin agents|mesh-ancestor
110630655|NCT00859872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110630656|NCT00859872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110630657|NCT00859872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110630658|NCT00859872|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110630659|NCT00859872|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110630660|NCT00859872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110630661|NCT00859872|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110630662|NCT00859872|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110630663|NCT00859872|Dopamine Agents|dopamine agents|mesh-ancestor
110630664|NCT00859872|Antiemetics|antiemetics|mesh-ancestor
110630665|NCT00859872|Autonomic Agents|autonomic agents|mesh-ancestor
110630666|NCT00859872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110630667|NCT00859872|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110630668|NCT00859872|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110630669|NCT02555696|Paclitaxel|paclitaxel|mesh-list
110630670|NCT02555696|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110630671|NCT02555696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110630672|NCT02555696|Tubulin Modulators|tubulin modulators|mesh-ancestor
110630673|NCT02555696|Antimitotic Agents|antimitotic agents|mesh-ancestor
110630674|NCT02555696|Mitosis Modulators|mitosis modulators|mesh-ancestor
110630675|NCT02555696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110630676|NCT00961077|Oxaliplatin|oxaliplatin|mesh-list
110630677|NCT00961077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110630678|NCT05147493|Dexamethasone|dexamethasone|mesh-list
110630679|NCT05147493|Cyclophosphamide|cyclophosphamide|mesh-list
110630680|NCT05147493|Lenalidomide|lenalidomide|mesh-list
110630681|NCT05147493|Bortezomib|bortezomib|mesh-list
110630682|NCT05147493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110630683|NCT05147493|Immunologic Factors|immunologic factors|mesh-ancestor
110630684|NCT05147493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110630685|NCT05147493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110630686|NCT05147493|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110630687|NCT05147493|Alkylating Agents|alkylating agents|mesh-ancestor
110630688|NCT05147493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110630689|NCT05147493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110630690|NCT05147493|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110630691|NCT05147493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110630693|NCT05147493|Autonomic Agents|autonomic agents|mesh-ancestor
110630694|NCT05147493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110630695|NCT05147493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110630696|NCT05147493|Glucocorticoids|glucocorticoids|mesh-ancestor
110630697|NCT05147493|Hormones|hormones|mesh-ancestor
110630698|NCT05147493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110630699|NCT05147493|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110630700|NCT05147493|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110630701|NCT05147493|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110630702|NCT05147493|Growth Substances|growth substances|mesh-ancestor
110630703|NCT05147493|Growth Inhibitors|growth inhibitors|mesh-ancestor
110630704|NCT00573534|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
110630705|NCT00573534|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110630706|NCT00573534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110630707|NCT00573534|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110630708|NCT00573534|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110110747|NCT01843439|Pyridoxine|pyridoxine|mesh-list
110630709|NCT00573534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110630710|NCT00573534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110630711|NCT00573534|Dopamine Agents|dopamine agents|mesh-ancestor
110630712|NCT00573534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110630713|NCT03974425|Aflibercept|aflibercept|mesh-list
110630714|NCT03974425|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110630715|NCT03974425|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110630716|NCT03974425|Growth Substances|growth substances|mesh-ancestor
110630717|NCT03974425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110630718|NCT03974425|Growth Inhibitors|growth inhibitors|mesh-ancestor
110630719|NCT03974425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110630720|NCT00975897|Leucovorin|leucovorin|mesh-list
110630721|NCT00975897|Bevacizumab|bevacizumab|mesh-list
110630722|NCT00975897|Cetuximab|cetuximab|mesh-list
110630723|NCT00975897|Fluorouracil|fluorouracil|mesh-list
110630724|NCT00975897|Oxaliplatin|oxaliplatin|mesh-list
110630725|NCT00975897|Irinotecan|irinotecan|mesh-list
110630726|NCT00975897|Calcium|calcium|mesh-list
110630727|NCT00975897|Levoleucovorin|levoleucovorin|mesh-list
110630728|NCT00975897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110630729|NCT00975897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110154821|NCT00005975|Megestrol|megestrol|mesh-list
110630730|NCT00975897|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110630731|NCT00975897|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110630732|NCT00975897|Growth Substances|growth substances|mesh-ancestor
110630733|NCT00975897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110630734|NCT00975897|Growth Inhibitors|growth inhibitors|mesh-ancestor
110630735|NCT00975897|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110630736|NCT00975897|Antimetabolites|antimetabolites|mesh-ancestor
110630737|NCT00975897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110630738|NCT00975897|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110630739|NCT00975897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110630740|NCT00975897|Immunologic Factors|immunologic factors|mesh-ancestor
110630741|NCT00975897|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110630742|NCT00975897|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110630743|NCT00975897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110630744|NCT00975897|Antidotes|antidotes|mesh-ancestor
110630745|NCT00975897|Protective Agents|protective agents|mesh-ancestor
110630746|NCT00975897|Vitamin B Complex|vitamin b complex|mesh-ancestor
110630748|NCT00975897|Micronutrients|micronutrients|mesh-ancestor
110630749|NCT00867672|Decitabine|decitabine|mesh-list
110630750|NCT00867672|Tretinoin|tretinoin|mesh-list
110630751|NCT00867672|Valproic Acid|valproic acid|mesh-list
110630752|NCT00867672|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110630753|NCT00867672|Antimetabolites|antimetabolites|mesh-ancestor
110630754|NCT00867672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110630755|NCT00867672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110630756|NCT00867672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110630757|NCT00867672|Keratolytic Agents|keratolytic agents|mesh-ancestor
110630758|NCT00867672|Dermatologic Agents|dermatologic agents|mesh-ancestor
110630759|NCT00867672|Anticonvulsants|anticonvulsants|mesh-ancestor
110630760|NCT00867672|GABA Agents|gaba agents|mesh-ancestor
110630761|NCT00867672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110630762|NCT00867672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110630763|NCT00867672|Antimanic Agents|antimanic agents|mesh-ancestor
110630765|NCT00867672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110630766|NCT00867672|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110630767|NCT00783926|Hemagglutinins|hemagglutinins|mesh-list
110630768|NCT00783926|Vaccines|vaccines|mesh-list
110630769|NCT00783926|Immunologic Factors|immunologic factors|mesh-ancestor
110630770|NCT00783926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110630771|NCT00783926|Agglutinins|agglutinins|mesh-ancestor
110630772|NCT00783926|Coagulants|coagulants|mesh-ancestor
110630773|NCT01071499|Morphine|morphine|mesh-list
110630774|NCT01071499|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110630775|NCT01071499|Narcotics|narcotics|mesh-ancestor
110630776|NCT01071499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110630777|NCT01071499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110630778|NCT01071499|Analgesics|analgesics|mesh-ancestor
110630779|NCT01071499|Sensory System Agents|sensory system agents|mesh-ancestor
110110997|NCT01844947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110630780|NCT01071499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110630781|NCT00961155|Formoterol Fumarate|formoterol fumarate|mesh-list
110630782|NCT00961155|Montelukast|montelukast|mesh-list
110630783|NCT00961155|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110630784|NCT00961155|Autonomic Agents|autonomic agents|mesh-ancestor
110630785|NCT00961155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110630786|NCT00961155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110630787|NCT00961155|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110630788|NCT00961155|Respiratory System Agents|respiratory system agents|mesh-ancestor
110630789|NCT00961155|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110630790|NCT00961155|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110630791|NCT00961155|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110630792|NCT00961155|Adrenergic Agents|adrenergic agents|mesh-ancestor
110630793|NCT00961155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110630794|NCT00961155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110630795|NCT00961155|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110630796|NCT00961155|Hormone Antagonists|hormone antagonists|mesh-ancestor
110630797|NCT00961155|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110630798|NCT00961155|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110630799|NCT00961155|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110630800|NCT00260533|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
110630801|NCT00260533|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110630802|NCT00260533|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110630803|NCT00260533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110630804|NCT00260533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110630805|NCT00260533|Adrenergic Agents|adrenergic agents|mesh-ancestor
110630806|NCT00260533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110630807|NCT00260533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110630808|NCT00973245|Warfarin|warfarin|mesh-list
110630809|NCT00973245|Rivaroxaban|rivaroxaban|mesh-list
110630810|NCT00973245|Anticoagulants|anticoagulants|mesh-ancestor
110630811|NCT00973245|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110630812|NCT00973245|Antithrombins|antithrombins|mesh-ancestor
110630813|NCT00973245|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110630814|NCT00973245|Protease Inhibitors|protease inhibitors|mesh-ancestor
110630815|NCT00973245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110630816|NCT00973245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110630817|NCT00793754|Aspirin|aspirin|mesh-list
110630818|NCT00793754|Atorvastatin|atorvastatin|mesh-list
110630819|NCT00793754|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110630820|NCT00793754|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110630821|NCT00793754|Analgesics|analgesics|mesh-ancestor
110630822|NCT00793754|Sensory System Agents|sensory system agents|mesh-ancestor
110111186|NCT01845701|Schistosomicides|schistosomicides|mesh-ancestor
110630823|NCT00793754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110630824|NCT00793754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110630825|NCT00793754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110630826|NCT00793754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110630827|NCT00793754|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110630828|NCT00793754|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110630829|NCT00793754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110630830|NCT00793754|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110630831|NCT00793754|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110630832|NCT00793754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110630833|NCT00793754|Antipyretics|antipyretics|mesh-ancestor
110630834|NCT00793754|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110630835|NCT00793754|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110630836|NCT00793754|Antimetabolites|antimetabolites|mesh-ancestor
110630837|NCT00793754|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110630838|NCT00793754|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110630840|NCT02596763|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110630841|NCT02596763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110630842|NCT02596763|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110630843|NCT02596763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110630844|NCT02596763|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
110630845|NCT02596763|GABA Agonists|gaba agonists|mesh-ancestor
110630846|NCT02596763|GABA Agents|gaba agents|mesh-ancestor
110630847|NCT02596763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110630848|NCT02596763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110630849|NCT00973323|Warfarin|warfarin|mesh-list
110630850|NCT00973323|Rivaroxaban|rivaroxaban|mesh-list
110630851|NCT00973323|Anticoagulants|anticoagulants|mesh-ancestor
110630852|NCT00973323|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110630853|NCT00973323|Antithrombins|antithrombins|mesh-ancestor
110630854|NCT00973323|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110630855|NCT00973323|Protease Inhibitors|protease inhibitors|mesh-ancestor
110630856|NCT00973323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110630857|NCT00973323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110630858|NCT00793988|Anesthetics|anesthetics|mesh-list
110630859|NCT00793988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110630860|NCT00793988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110630861|NCT00973401|Insulin|insulin|mesh-list
110630862|NCT00973401|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110630863|NCT00973401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110630864|NCT04040322|Iloprost|iloprost|mesh-list
110630865|NCT04040322|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110630866|NCT04040322|Vasodilator Agents|vasodilator agents|mesh-ancestor
110630867|NCT00787436|Thalidomide|thalidomide|mesh-list
110630868|NCT00787436|Timolol|timolol|mesh-list
110630869|NCT00787436|Propranolol|propranolol|mesh-list
110630870|NCT00787436|Nadolol|nadolol|mesh-list
110630871|NCT00787436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110630872|NCT00787436|Immunologic Factors|immunologic factors|mesh-ancestor
110630873|NCT00787436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110630874|NCT00787436|Leprostatic Agents|leprostatic agents|mesh-ancestor
110630875|NCT00787436|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110630876|NCT00787436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110630877|NCT00787436|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110630878|NCT00787436|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110630879|NCT00787436|Growth Substances|growth substances|mesh-ancestor
110630880|NCT00787436|Growth Inhibitors|growth inhibitors|mesh-ancestor
110630881|NCT00787436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110630882|NCT00787436|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110630883|NCT00787436|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110630884|NCT00787436|Adrenergic Agents|adrenergic agents|mesh-ancestor
110630885|NCT00787436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110630886|NCT00787436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110630887|NCT00787436|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110630888|NCT00787436|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110630889|NCT00787436|Vasodilator Agents|vasodilator agents|mesh-ancestor
110630890|NCT00787436|Sympatholytics|sympatholytics|mesh-ancestor
110630891|NCT00787436|Autonomic Agents|autonomic agents|mesh-ancestor
110630892|NCT00787436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110630893|NCT03945981|Lamivudine|lamivudine|mesh-list
110630894|NCT03945981|Dolutegravir|dolutegravir|mesh-list
110630895|NCT03945981|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110630896|NCT03945981|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110630897|NCT03945981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110630898|NCT03945981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110630899|NCT03945981|Antiviral Agents|antiviral agents|mesh-ancestor
110630900|NCT03945981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110630901|NCT03945981|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110630902|NCT03945981|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110630903|NCT03945981|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110630904|NCT03945981|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110630905|NCT00784082|Hydroxyurea|hydroxyurea|mesh-list
110630906|NCT00784082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110630907|NCT00784082|Antisickling Agents|antisickling agents|mesh-ancestor
110630908|NCT00784082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110630909|NCT00784082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110630910|NCT00784082|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110630911|NCT00979563|Irinotecan|irinotecan|mesh-list
110630912|NCT00979563|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110630915|NCT00979563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110630916|NCT00979563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110630918|NCT00745901|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110630919|NCT00745901|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110630920|NCT00745901|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110630921|NCT00745901|Norgestimate|norgestimate|mesh-list
110630922|NCT00745901|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
110630923|NCT00745901|Estradiol|estradiol|mesh-list
110630924|NCT00745901|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110630925|NCT00745901|Estrogens|estrogens|mesh-ancestor
110630926|NCT00745901|Hormones|hormones|mesh-ancestor
110630927|NCT00745901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110630928|NCT00745901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110630929|NCT00745901|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110630930|NCT00745901|Contraceptive Agents|contraceptive agents|mesh-ancestor
110630931|NCT00745901|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110630932|NCT00745901|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110112120|NCT01852903|Vitamins|vitamins|mesh-list
110630933|NCT00745901|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110630934|NCT00745901|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110630935|NCT00745901|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110630936|NCT00745901|Hormone Antagonists|hormone antagonists|mesh-ancestor
110630937|NCT00745901|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110630938|NCT00745901|Diuretics|diuretics|mesh-ancestor
110630939|NCT00745901|Natriuretic Agents|natriuretic agents|mesh-ancestor
110630940|NCT00745901|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110630941|NCT00863850|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110630942|NCT00863850|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110630943|NCT00863850|Alkylating Agents|alkylating agents|mesh-ancestor
110630944|NCT00863850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110630945|NCT00863850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110630946|NCT00860340|Spironolactone|spironolactone|mesh-list
110630947|NCT00860340|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110630948|NCT00860340|Hormone Antagonists|hormone antagonists|mesh-ancestor
110630949|NCT00860340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110630950|NCT00860340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110112321|NCT01854502|Cariostatic Agents|cariostatic agents|mesh-ancestor
110630951|NCT00860340|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110630952|NCT00860340|Diuretics|diuretics|mesh-ancestor
110630953|NCT00860340|Natriuretic Agents|natriuretic agents|mesh-ancestor
110630954|NCT00784316|Metoprolol|metoprolol|mesh-list
110630955|NCT00784316|Amiodarone|amiodarone|mesh-list
110630956|NCT00784316|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110630957|NCT00784316|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110630958|NCT00784316|Sympatholytics|sympatholytics|mesh-ancestor
110630959|NCT00784316|Autonomic Agents|autonomic agents|mesh-ancestor
110630960|NCT00784316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110630961|NCT00784316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110112465|NCT01855490|Hormones|hormones|mesh-ancestor
110630962|NCT00784316|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110630963|NCT00784316|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110630964|NCT00784316|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110630965|NCT00784316|Adrenergic Agents|adrenergic agents|mesh-ancestor
110630966|NCT00784316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110630967|NCT00784316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110630968|NCT00784316|Vasodilator Agents|vasodilator agents|mesh-ancestor
110630969|NCT00784316|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
110630970|NCT00784316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110630971|NCT00784316|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110630972|NCT00784316|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110630973|NCT00784316|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110630974|NCT00784316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110630975|NCT00784316|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110630976|NCT00784316|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110630977|NCT00784316|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110630978|NCT00286429|Insulin|insulin|mesh-list
110630979|NCT00286429|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110630980|NCT00286429|Alogliptin|alogliptin|mesh-list
110630981|NCT00286429|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110630982|NCT00286429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110630983|NCT00286429|Incretins|incretins|mesh-ancestor
110630984|NCT00286429|Hormones|hormones|mesh-ancestor
110630985|NCT00286429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110630986|NCT00286429|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110630987|NCT00286429|Protease Inhibitors|protease inhibitors|mesh-ancestor
110630988|NCT00286429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110630989|NCT00286429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110630990|NCT00665444|Aripiprazole|aripiprazole|mesh-list
110112744|NCT01856959|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110630991|NCT00665444|Antidepressive Agents|antidepressive agents|mesh-ancestor
110630992|NCT00665444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110630993|NCT00665444|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110630994|NCT00665444|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110630995|NCT00665444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110630996|NCT00665444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110630997|NCT00665444|Dopamine Agonists|dopamine agonists|mesh-ancestor
110630998|NCT00665444|Dopamine Agents|dopamine agents|mesh-ancestor
110630999|NCT00665444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110631000|NCT00665444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110631001|NCT00665444|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110112879|NCT01857544|Growth Inhibitors|growth inhibitors|mesh-ancestor
110631002|NCT00665444|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110631003|NCT00665444|Serotonin Agents|serotonin agents|mesh-ancestor
110631004|NCT00665444|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110631005|NCT00665444|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110631006|NCT00665444|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110631007|NCT00665444|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110631008|NCT00864006|Valproic Acid|valproic acid|mesh-list
110631009|NCT00864006|Anticonvulsants|anticonvulsants|mesh-ancestor
110631010|NCT00864006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110631011|NCT00864006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110631012|NCT00864006|GABA Agents|gaba agents|mesh-ancestor
110631013|NCT00864006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110631014|NCT00864006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110112944|NCT01857817|Analgesics|analgesics|mesh-ancestor
110631015|NCT00864006|Antimanic Agents|antimanic agents|mesh-ancestor
110631016|NCT00864006|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110631017|NCT00864006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110631018|NCT00864006|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110631019|NCT00860496|Cyclosporine|cyclosporine|mesh-list
110631020|NCT00860496|Tacrolimus|tacrolimus|mesh-list
110631021|NCT00860496|Cyclosporins|cyclosporins|mesh-list
110631022|NCT00860496|Tofacitinib|tofacitinib|mesh-list
110631023|NCT00860496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110631024|NCT00860496|Immunologic Factors|immunologic factors|mesh-ancestor
110631025|NCT00860496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110631026|NCT00860496|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110631027|NCT00860496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110631028|NCT00860496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110631029|NCT00860496|Antifungal Agents|antifungal agents|mesh-ancestor
110631030|NCT00860496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110631031|NCT00860496|Dermatologic Agents|dermatologic agents|mesh-ancestor
110631032|NCT00860496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110631033|NCT00860496|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
110631034|NCT00860496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110631036|NCT00864162|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110631037|NCT00864162|Protease Inhibitors|protease inhibitors|mesh-ancestor
110631038|NCT00864162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110113143|NCT01858571|Thalidomide|thalidomide|mesh-list
110631039|NCT00864162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110631040|NCT00864162|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110631041|NCT00787826|Vaccines|vaccines|mesh-list
110631042|NCT00787826|Immunologic Factors|immunologic factors|mesh-ancestor
110631043|NCT00787826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110631044|NCT00795314|Fentanyl|fentanyl|mesh-list
110631045|NCT00795314|Butorphanol|butorphanol|mesh-list
110113212|NCT01858662|Leucovorin|leucovorin|mesh-list
110631046|NCT00795314|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110631047|NCT00795314|Narcotics|narcotics|mesh-ancestor
110631048|NCT00795314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110631049|NCT00795314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110631050|NCT00795314|Analgesics|analgesics|mesh-ancestor
110631051|NCT00795314|Sensory System Agents|sensory system agents|mesh-ancestor
110631052|NCT00795314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110631053|NCT00795314|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110631054|NCT00795314|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110631055|NCT00795314|Anesthetics, General|anesthetics, general|mesh-ancestor
110631056|NCT00795314|Anesthetics|anesthetics|mesh-ancestor
110631057|NCT00795314|Antitussive Agents|antitussive agents|mesh-ancestor
110631058|NCT00795314|Respiratory System Agents|respiratory system agents|mesh-ancestor
110631059|NCT00795314|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110631060|NCT03926169|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110631061|NCT03926169|Immunologic Factors|immunologic factors|mesh-ancestor
110154872|NCT00001332|Cisplatin|cisplatin|mesh-list
110113272|NCT01859377|Ibuprofen|ibuprofen|mesh-list
110631062|NCT03926169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110631064|NCT00864240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110631065|NCT00864240|Glucocorticoids|glucocorticoids|mesh-ancestor
110631067|NCT00864240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110631068|NCT00864240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110631069|NCT00979641|Docetaxel|docetaxel|mesh-list
110631070|NCT00979641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110631071|NCT00979641|Tubulin Modulators|tubulin modulators|mesh-ancestor
110631072|NCT00979641|Antimitotic Agents|antimitotic agents|mesh-ancestor
110631073|NCT00979641|Mitosis Modulators|mitosis modulators|mesh-ancestor
110631074|NCT00979641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110631075|NCT00864318|Paclitaxel|paclitaxel|mesh-list
110631076|NCT00864318|Etoposide|etoposide|mesh-list
110631077|NCT00864318|Ifosfamide|ifosfamide|mesh-list
110631078|NCT00864318|Carboplatin|carboplatin|mesh-list
110631079|NCT00864318|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110631080|NCT00864318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110631081|NCT00864318|Tubulin Modulators|tubulin modulators|mesh-ancestor
110631082|NCT00864318|Antimitotic Agents|antimitotic agents|mesh-ancestor
110631083|NCT00864318|Mitosis Modulators|mitosis modulators|mesh-ancestor
110631084|NCT00864318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110631085|NCT00864318|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110631086|NCT00864318|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110631087|NCT00864318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110631088|NCT00864318|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110631089|NCT00864318|Alkylating Agents|alkylating agents|mesh-ancestor
110631090|NCT00788060|Everolimus|everolimus|mesh-list
110631091|NCT00788060|Sunitinib|sunitinib|mesh-list
110631092|NCT00788060|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110631093|NCT00788060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110631094|NCT00788060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110631095|NCT00788060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110631096|NCT00788060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110631097|NCT00788060|Immunologic Factors|immunologic factors|mesh-ancestor
110631098|NCT00788060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110631099|NCT00788060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110631100|NCT00788060|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110631101|NCT00788060|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110631102|NCT00788060|Growth Substances|growth substances|mesh-ancestor
110631103|NCT00788060|Growth Inhibitors|growth inhibitors|mesh-ancestor
110631104|NCT00788138|Vitamin D|vitamin d|mesh-list
110631105|NCT00788138|Cholecalciferol|cholecalciferol|mesh-list
110631106|NCT00788138|Vitamins|vitamins|mesh-ancestor
110631107|NCT00788138|Micronutrients|micronutrients|mesh-ancestor
110631108|NCT00788138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110631109|NCT00788138|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110631110|NCT00788138|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110631112|NCT00864396|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110631113|NCT00864396|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110631114|NCT00864396|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110631115|NCT00864396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110631116|NCT00864396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110631117|NCT00745823|Raltegravir Potassium|raltegravir potassium|mesh-list
110631118|NCT00745823|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110631119|NCT00745823|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110631120|NCT00745823|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110631121|NCT00745823|Antiviral Agents|antiviral agents|mesh-ancestor
110631122|NCT00745823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110631123|NCT00745823|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110631124|NCT00745823|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110631125|NCT00745823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110631126|NCT00745823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110631127|NCT00745823|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110631128|NCT00745823|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110631129|NCT00961467|Thalidomide|thalidomide|mesh-list
110631130|NCT00961467|Prednisone|prednisone|mesh-list
110631131|NCT00961467|Melphalan|melphalan|mesh-list
110631132|NCT00961467|Lenalidomide|lenalidomide|mesh-list
110631133|NCT00961467|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110631135|NCT00961467|Hormones|hormones|mesh-ancestor
110631136|NCT00961467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110631137|NCT00961467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110631138|NCT00961467|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110631139|NCT00961467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110631140|NCT00961467|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110631141|NCT00961467|Alkylating Agents|alkylating agents|mesh-ancestor
110631142|NCT00961467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110631143|NCT00961467|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110631144|NCT00961467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110631145|NCT00961467|Immunologic Factors|immunologic factors|mesh-ancestor
110631146|NCT00961467|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110631147|NCT00961467|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110631148|NCT00961467|Growth Substances|growth substances|mesh-ancestor
110631149|NCT00961467|Growth Inhibitors|growth inhibitors|mesh-ancestor
110631150|NCT00961467|Leprostatic Agents|leprostatic agents|mesh-ancestor
110631151|NCT00961467|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110631152|NCT00961467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110631153|NCT00980031|Eplerenone|eplerenone|mesh-list
110631154|NCT00980031|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110631155|NCT00980031|Hormone Antagonists|hormone antagonists|mesh-ancestor
110631156|NCT00980031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110631157|NCT00980031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110631158|NCT00980031|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110631159|NCT00980031|Diuretics|diuretics|mesh-ancestor
110631160|NCT00980031|Natriuretic Agents|natriuretic agents|mesh-ancestor
110631161|NCT00980031|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110631162|NCT00663260|Dapagliflozin|dapagliflozin|mesh-list
110631163|NCT00663260|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110631164|NCT00663260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110631165|NCT00663260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110631166|NCT00663260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110631168|NCT00980109|Zanamivir|zanamivir|mesh-list
110631169|NCT00980109|Antiviral Agents|antiviral agents|mesh-ancestor
110631170|NCT00980109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110631171|NCT00980109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110631172|NCT00980109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110631173|NCT00980187|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110631174|NCT00980187|Indapamide|indapamide|mesh-list
110631175|NCT00980187|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110631176|NCT00980187|Diuretics|diuretics|mesh-ancestor
110631177|NCT00980187|Natriuretic Agents|natriuretic agents|mesh-ancestor
110631178|NCT00980187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110631179|NCT00980187|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110631180|NCT00980187|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110631181|NCT00980187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110631182|NCT00795470|Anti-Infective Agents|anti-infective agents|mesh-list
110631183|NCT00795470|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110631184|NCT00284089|Ranibizumab|ranibizumab|mesh-list
110631185|NCT00284089|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110631186|NCT00284089|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110631187|NCT00284089|Growth Substances|growth substances|mesh-ancestor
110631188|NCT00284089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110631189|NCT00284089|Growth Inhibitors|growth inhibitors|mesh-ancestor
110631190|NCT00284089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110631191|NCT00984633|Bromides|bromides|mesh-list
110631192|NCT00984633|Propofol|propofol|mesh-list
110631193|NCT00984633|Sevoflurane|sevoflurane|mesh-list
110631194|NCT00984633|Rocuronium|rocuronium|mesh-list
110631195|NCT00984633|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110631196|NCT00984633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110631197|NCT00984633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110631198|NCT00984633|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110631199|NCT00984633|Anesthetics, General|anesthetics, general|mesh-ancestor
110631200|NCT00984633|Anesthetics|anesthetics|mesh-ancestor
110631201|NCT00984633|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110631202|NCT00984633|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110631203|NCT00984633|Anticonvulsants|anticonvulsants|mesh-ancestor
110631204|NCT00984633|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110631205|NCT00984633|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110631206|NCT00984633|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110631207|NCT00984633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110631208|NCT00659984|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
110631209|NCT00659984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110631210|NCT00659984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110631211|NCT00659984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110631212|NCT00659984|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110631213|NCT00976755|Everolimus|everolimus|mesh-list
110631214|NCT00976755|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110631215|NCT00976755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110631216|NCT00976755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110631217|NCT00976755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110631218|NCT00976755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110631219|NCT00976755|Immunologic Factors|immunologic factors|mesh-ancestor
110631220|NCT00976755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110631221|NCT00976755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110631222|NCT00864474|Maraviroc|maraviroc|mesh-list
110631223|NCT00864474|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110631224|NCT00864474|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110631225|NCT00864474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110631226|NCT00864474|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110631227|NCT00864474|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110631228|NCT00864474|Antiviral Agents|antiviral agents|mesh-ancestor
110631229|NCT00864474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110631230|NCT00864474|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
110631231|NCT00283387|Betaine|betaine|mesh-list
110631232|NCT00283387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110631233|NCT00283387|Lipotropic Agents|lipotropic agents|mesh-ancestor
110631234|NCT00283387|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110631235|NCT00283387|Antimetabolites|antimetabolites|mesh-ancestor
110631236|NCT00283387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110631237|NCT00283387|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110631238|NCT00788294|Tanezumab|tanezumab|mesh-list
110631239|NCT00788294|Analgesics|analgesics|mesh-ancestor
110631240|NCT00788294|Sensory System Agents|sensory system agents|mesh-ancestor
110631241|NCT00788294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110114031|NCT01864161|Iron|iron|mesh-list
110631242|NCT00788294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110631243|NCT00795548|Azacitidine|azacitidine|mesh-list
110631244|NCT00795548|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110631245|NCT00795548|Antimetabolites|antimetabolites|mesh-ancestor
110631246|NCT00795548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110631247|NCT00795548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110631248|NCT00795548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110631249|NCT00282919|Azithromycin|azithromycin|mesh-list
110631250|NCT00282919|Chloroquine|chloroquine|mesh-list
110631251|NCT00282919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110631252|NCT00282919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110631253|NCT00282919|Amebicides|amebicides|mesh-ancestor
110631254|NCT00282919|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110631255|NCT00282919|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110631256|NCT00282919|Antimalarials|antimalarials|mesh-ancestor
110631257|NCT00282919|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110631258|NCT00984789|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110631259|NCT00984789|Gestodene|gestodene|mesh-list
110631260|NCT00984789|Norelgestromin|norelgestromin|mesh-list
110631261|NCT00984789|Femovan|femovan|mesh-list
110631262|NCT00984789|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110631263|NCT00984789|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110631264|NCT00984789|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110631265|NCT00984789|Contraceptive Agents|contraceptive agents|mesh-ancestor
110631266|NCT00984789|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110631267|NCT00984789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110631268|NCT00984789|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110631269|NCT00984789|Estrogens|estrogens|mesh-ancestor
110631270|NCT00984789|Hormones|hormones|mesh-ancestor
110631271|NCT00984789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110631272|NCT00984789|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110631273|NCT00984789|Progestins|progestins|mesh-ancestor
110631274|NCT00984789|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110631275|NCT00864552|Factor VIII|factor viii|mesh-list
110631276|NCT00864552|Coagulants|coagulants|mesh-ancestor
110631277|NCT04046822|Liraglutide|liraglutide|mesh-list
110631278|NCT04046822|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110631279|NCT04046822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110631280|NCT04046822|Incretins|incretins|mesh-ancestor
110631281|NCT04046822|Hormones|hormones|mesh-ancestor
110631282|NCT04046822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110631283|NCT04007835|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110631284|NCT04007835|Gefitinib|gefitinib|mesh-list
110631285|NCT04007835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110631286|NCT04007835|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110631287|NCT04007835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110631288|NCT04007835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110631289|NCT00800930|Butyric Acid|butyric acid|mesh-list
110631290|NCT00800930|Histamine Antagonists|histamine antagonists|mesh-ancestor
110631291|NCT00800930|Histamine Agents|histamine agents|mesh-ancestor
110631292|NCT00800930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110631293|NCT00800930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110631294|NCT00800930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110631295|NCT00868062|Polygeline|polygeline|mesh-list
110631296|NCT00868062|Plasma Substitutes|plasma substitutes|mesh-ancestor
110631297|NCT00868062|Blood Substitutes|blood substitutes|mesh-ancestor
110631298|NCT00742781|Vitamin D|vitamin d|mesh-list
110631299|NCT00742781|Cholecalciferol|cholecalciferol|mesh-list
110631300|NCT00742781|Vitamins|vitamins|mesh-ancestor
110631301|NCT00742781|Micronutrients|micronutrients|mesh-ancestor
110631302|NCT00742781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110631303|NCT00742781|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110393963|NCT02893371|Dopamine Agonists|dopamine agonists|mesh-ancestor
110631304|NCT00742781|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110631305|NCT00280735|Carboplatin|carboplatin|mesh-list
110631306|NCT00280735|Docetaxel|docetaxel|mesh-list
110631307|NCT00280735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110631308|NCT00280735|Tubulin Modulators|tubulin modulators|mesh-ancestor
110631309|NCT00280735|Antimitotic Agents|antimitotic agents|mesh-ancestor
110631310|NCT00280735|Mitosis Modulators|mitosis modulators|mesh-ancestor
110631311|NCT00280735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110631312|NCT03975283|Bupivacaine|bupivacaine|mesh-list
110631313|NCT03975283|Anesthetics, Local|anesthetics, local|mesh-ancestor
110631314|NCT03975283|Anesthetics|anesthetics|mesh-ancestor
110631315|NCT03975283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110631316|NCT03975283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110631317|NCT03975283|Sensory System Agents|sensory system agents|mesh-ancestor
110631318|NCT03975283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110631319|NCT01070407|Cloricromen|cloricromen|mesh-list
110631320|NCT01070407|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110631321|NCT00801086|Ethanol|ethanol|mesh-list
110631322|NCT00801086|Tempol|tempol|mesh-list
110631323|NCT00801086|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110631324|NCT00801086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110631325|NCT00801086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110631326|NCT00801086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110631327|NCT00801086|Antioxidants|antioxidants|mesh-ancestor
110631328|NCT00801086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110631329|NCT00801086|Protective Agents|protective agents|mesh-ancestor
110631330|NCT00801086|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110631331|NCT00801086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110631332|NCT00801086|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110631333|NCT00801086|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110631334|NCT00788606|Bevacizumab|bevacizumab|mesh-list
110631335|NCT00788606|Rituximab|rituximab|mesh-list
110631336|NCT00788606|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110631337|NCT00788606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110631338|NCT00788606|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110631339|NCT00788606|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110631340|NCT00788606|Growth Substances|growth substances|mesh-ancestor
110631341|NCT00788606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110631342|NCT00788606|Growth Inhibitors|growth inhibitors|mesh-ancestor
110114051|NCT01864213|Anesthetics|anesthetics|mesh-ancestor
110631344|NCT00788606|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110631345|NCT00795938|Sildenafil Citrate|sildenafil citrate|mesh-list
110631346|NCT00795938|Vasodilator Agents|vasodilator agents|mesh-ancestor
110631347|NCT00795938|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110631348|NCT00795938|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110631349|NCT00795938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110631350|NCT00795938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110631351|NCT00795938|Urological Agents|urological agents|mesh-ancestor
110631352|NCT00260065|Decitabine|decitabine|mesh-list
110631353|NCT00260065|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110631354|NCT00260065|Antimetabolites|antimetabolites|mesh-ancestor
110631355|NCT00260065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110631356|NCT00260065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110631357|NCT00260065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110631358|NCT01071655|Fluorouracil|fluorouracil|mesh-list
110631359|NCT01071655|Antimetabolites|antimetabolites|mesh-ancestor
110631360|NCT01071655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110253893|NCT00163605|Hemostatics|hemostatics|mesh-ancestor
110631361|NCT01071655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110631362|NCT01071655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110278703|NCT00585091|Phenylephrine|phenylephrine|mesh-list
110631363|NCT01071655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110631364|NCT01071655|Immunologic Factors|immunologic factors|mesh-ancestor
110631365|NCT01071655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110631366|NCT02531581|Furosemide|furosemide|mesh-list
110631367|NCT02531581|Diuretics|diuretics|mesh-list
110631368|NCT02531581|Natriuretic Agents|natriuretic agents|mesh-ancestor
110631369|NCT02531581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110631370|NCT02531581|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110631371|NCT02531581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110631372|NCT02531581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110631373|NCT04046510|Oxytocin|oxytocin|mesh-list
110631374|NCT04046510|Oxytocics|oxytocics|mesh-ancestor
110631375|NCT04046510|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110631376|NCT04046510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110631377|NCT00506350|Vaccines|vaccines|mesh-list
110631378|NCT00506350|Immunologic Factors|immunologic factors|mesh-ancestor
110631379|NCT00506350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110631380|NCT00788840|Isophane Insulin, Human|isophane insulin, human|mesh-list
110631381|NCT00788840|Insulin, Isophane|insulin, isophane|mesh-list
110631382|NCT00788840|Isophane insulin, beef|isophane insulin, beef|mesh-list
110631383|NCT00788840|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110631384|NCT00788840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110631385|NCT00742625|Cytarabine|cytarabine|mesh-list
110631386|NCT00742625|Bortezomib|bortezomib|mesh-list
110631387|NCT00742625|Daunorubicin|daunorubicin|mesh-list
110631388|NCT00742625|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110631389|NCT00742625|Antimetabolites|antimetabolites|mesh-ancestor
110631390|NCT00742625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110631391|NCT00742625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110631392|NCT00742625|Antiviral Agents|antiviral agents|mesh-ancestor
110631393|NCT00742625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110631394|NCT00742625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110631395|NCT00742625|Immunologic Factors|immunologic factors|mesh-ancestor
110631396|NCT00742625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110631397|NCT00742625|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110631398|NCT00742625|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110631399|NCT00742625|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110631400|NCT00742625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110631401|NCT00801788|Oxycodone|oxycodone|mesh-list
110631402|NCT00801788|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110631403|NCT00801788|Narcotics|narcotics|mesh-ancestor
110631404|NCT00801788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110631405|NCT00801788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110631406|NCT00801788|Analgesics|analgesics|mesh-ancestor
110631407|NCT00801788|Sensory System Agents|sensory system agents|mesh-ancestor
110631408|NCT00801788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110631409|NCT01070485|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
110631410|NCT01070485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110631411|NCT00618618|Deoxycholic Acid|deoxycholic acid|mesh-list
110631412|NCT00618618|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
110631413|NCT00618618|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110631414|NCT00796250|Prednisolone|prednisolone|mesh-list
110631415|NCT00796250|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110631416|NCT00796250|Methylprednisolone|methylprednisolone|mesh-list
110631417|NCT00796250|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110154900|NCT00001341|Antimetabolites|antimetabolites|mesh-ancestor
110631418|NCT00796250|Prednisolone acetate|prednisolone acetate|mesh-list
110631420|NCT00796250|Azathioprine|azathioprine|mesh-list
110631421|NCT00796250|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110631422|NCT00796250|Prednisolone phosphate|prednisolone phosphate|mesh-list
110631423|NCT00796250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110114108|NCT01864824|Vitamins|vitamins|mesh-list
110631424|NCT00796250|Glucocorticoids|glucocorticoids|mesh-ancestor
110631426|NCT00796250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110631427|NCT00796250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110631428|NCT00796250|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110631429|NCT00796250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110631430|NCT00796250|Antiemetics|antiemetics|mesh-ancestor
110631431|NCT00796250|Autonomic Agents|autonomic agents|mesh-ancestor
110631432|NCT00796250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110631433|NCT00796250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110631434|NCT00796250|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110631435|NCT00796250|Protective Agents|protective agents|mesh-ancestor
110631436|NCT00796250|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110631437|NCT00796250|Dermatologic Agents|dermatologic agents|mesh-ancestor
110631438|NCT00796250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110631439|NCT00796250|Antimetabolites|antimetabolites|mesh-ancestor
110278772|NCT00585871|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110631440|NCT00796250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110631441|NCT00796250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110631442|NCT00796250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110631443|NCT00796250|Immunologic Factors|immunologic factors|mesh-ancestor
110631444|NCT00788918|Interferons|interferons|mesh-list
110631445|NCT00788918|Ribavirin|ribavirin|mesh-list
110631446|NCT00788918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110631447|NCT00788918|Antiviral Agents|antiviral agents|mesh-ancestor
110631448|NCT00788918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110631449|NCT00788918|Antimetabolites|antimetabolites|mesh-ancestor
110631450|NCT00788918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110631451|NCT02596373|Mitoxantrone|mitoxantrone|mesh-list
110631452|NCT02596373|Analgesics|analgesics|mesh-ancestor
110631453|NCT02596373|Sensory System Agents|sensory system agents|mesh-ancestor
110631454|NCT02596373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110631455|NCT02596373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110631456|NCT02596373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110631457|NCT02596373|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110631458|NCT02596373|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110631459|NCT02596373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110114143|NCT01865201|Mannitol|mannitol|mesh-list
110631460|NCT02596373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110631461|NCT00801866|Bevacizumab|bevacizumab|mesh-list
110631462|NCT00801866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110631463|NCT00801866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110631464|NCT00801866|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110631465|NCT00801866|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110631466|NCT00801866|Growth Substances|growth substances|mesh-ancestor
110631467|NCT00801866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110631468|NCT00801866|Growth Inhibitors|growth inhibitors|mesh-ancestor
110631469|NCT03973879|Atezolizumab|atezolizumab|mesh-list
110631470|NCT03973879|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110631471|NCT03973879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110631472|NCT03973879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110631473|NCT03973879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110631474|NCT00860964|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110631475|NCT00860964|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110631476|NCT00860964|Estradiol|estradiol|mesh-list
110631477|NCT00860964|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110631478|NCT00860964|Estrogens|estrogens|mesh-ancestor
110631479|NCT00860964|Hormones|hormones|mesh-ancestor
110631480|NCT00860964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110631481|NCT00860964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110631482|NCT00860964|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110631483|NCT00860964|Contraceptive Agents|contraceptive agents|mesh-ancestor
110631484|NCT00860964|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110631485|NCT00860964|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110631486|NCT00861042|Lacosamide|lacosamide|mesh-list
110631487|NCT00861042|Anticonvulsants|anticonvulsants|mesh-ancestor
110631488|NCT00861042|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110631489|NCT00861042|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110631490|NCT00861042|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110631491|NCT00861042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110631492|NCT04088903|Daratumumab|daratumumab|mesh-list
110631493|NCT04088903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110114167|NCT01865305|Insulin|insulin|mesh-list
110631494|NCT00861120|Doxorubicin|doxorubicin|mesh-list
110393996|NCT05138978|Listerine|listerine|mesh-list
110631495|NCT00861120|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110631496|NCT00861120|Panitumumab|panitumumab|mesh-list
110631497|NCT00861120|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110631498|NCT00861120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110631499|NCT00861120|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110631500|NCT00861120|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110631501|NCT00861120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110631502|NCT00861120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110631503|NCT00861120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110631504|NCT00740051|Glimepiride|glimepiride|mesh-list
110631505|NCT00740051|Linagliptin|linagliptin|mesh-list
110631506|NCT00740051|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110631507|NCT00740051|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110631508|NCT00740051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110631509|NCT00740051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110631510|NCT00740051|Immunologic Factors|immunologic factors|mesh-ancestor
110631511|NCT00740051|Incretins|incretins|mesh-ancestor
110631512|NCT00740051|Hormones|hormones|mesh-ancestor
110631513|NCT00740051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110631514|NCT00740051|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110631515|NCT00740051|Protease Inhibitors|protease inhibitors|mesh-ancestor
110631516|NCT00740051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110631517|NCT00740051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110631518|NCT00864864|Sunitinib|sunitinib|mesh-list
110631520|NCT00864864|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110631521|NCT00864864|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110631522|NCT00864864|Growth Substances|growth substances|mesh-ancestor
110631523|NCT00864864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110631524|NCT00864864|Growth Inhibitors|growth inhibitors|mesh-ancestor
110631525|NCT00864864|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110631526|NCT00864864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110631527|NCT00864864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110631528|NCT00868764|Granisetron|granisetron|mesh-list
110631529|NCT00868764|Antiemetics|antiemetics|mesh-ancestor
110631530|NCT00868764|Autonomic Agents|autonomic agents|mesh-ancestor
110631531|NCT00868764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110631532|NCT00868764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110631533|NCT00868764|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110631534|NCT00868764|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110631535|NCT00868764|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110631536|NCT00868764|Serotonin Agents|serotonin agents|mesh-ancestor
110631537|NCT00868764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110631538|NCT00868764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110631539|NCT00518986|Modafinil|modafinil|mesh-list
110631540|NCT00518986|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110631541|NCT00518986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110114269|NCT01866241|Oxytocics|oxytocics|mesh-ancestor
110631542|NCT00518986|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
110631543|NCT00518986|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110631544|NCT00518986|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110631545|NCT00518986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110631546|NCT00864942|Lenalidomide|lenalidomide|mesh-list
110631548|NCT00864942|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110631549|NCT00864942|Immunologic Factors|immunologic factors|mesh-ancestor
110631550|NCT00864942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110631551|NCT00864942|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110631552|NCT00864942|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110631553|NCT00864942|Growth Substances|growth substances|mesh-ancestor
110631554|NCT00864942|Growth Inhibitors|growth inhibitors|mesh-ancestor
110631555|NCT00864942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110631556|NCT00864942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110631557|NCT00864942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110631558|NCT00864942|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110631559|NCT00864942|Alkylating Agents|alkylating agents|mesh-ancestor
110631560|NCT00864942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110631561|NCT00870402|Spironolactone|spironolactone|mesh-list
110631562|NCT00870402|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110631563|NCT00870402|Hormone Antagonists|hormone antagonists|mesh-ancestor
110631564|NCT00870402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110631565|NCT00870402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110631566|NCT00870402|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110631567|NCT00870402|Diuretics|diuretics|mesh-ancestor
110631568|NCT00870402|Natriuretic Agents|natriuretic agents|mesh-ancestor
110631569|NCT00742235|Vitamin D|vitamin d|mesh-list
110631570|NCT00742235|Ergocalciferols|ergocalciferols|mesh-list
110631571|NCT00742235|Vitamins|vitamins|mesh-ancestor
110631572|NCT00742235|Micronutrients|micronutrients|mesh-ancestor
110631573|NCT00742235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110631574|NCT00742235|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110631575|NCT00742235|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110631576|NCT00742079|Cycloserine|cycloserine|mesh-list
110631577|NCT00742079|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110631578|NCT00742079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110631579|NCT00742079|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110631580|NCT00742079|Antitubercular Agents|antitubercular agents|mesh-ancestor
110631581|NCT00742079|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110631582|NCT00742079|Antimetabolites|antimetabolites|mesh-ancestor
110631583|NCT00742079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110631584|NCT04730362|Propofol|propofol|mesh-list
110631585|NCT04730362|Sevoflurane|sevoflurane|mesh-list
110631586|NCT04730362|Anesthetics|anesthetics|mesh-ancestor
110631587|NCT04730362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110631588|NCT04730362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110631589|NCT04730362|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110631590|NCT04730362|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110631591|NCT04730362|Anesthetics, General|anesthetics, general|mesh-ancestor
110631592|NCT04730362|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110631593|NCT04730362|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110631594|NCT00662792|Tiotropium Bromide|tiotropium bromide|mesh-list
110631595|NCT00662792|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110631596|NCT00662792|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110631597|NCT00662792|Autonomic Agents|autonomic agents|mesh-ancestor
110631598|NCT00662792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110631599|NCT00662792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110631600|NCT00662792|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110631601|NCT00662792|Respiratory System Agents|respiratory system agents|mesh-ancestor
110631602|NCT00662792|Parasympatholytics|parasympatholytics|mesh-ancestor
110631603|NCT00662792|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110631604|NCT00662792|Cholinergic Agents|cholinergic agents|mesh-ancestor
110631605|NCT00662792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110631606|NCT00662792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110631607|NCT00662792|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110631608|NCT00662792|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110631609|NCT00662792|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110631610|NCT00662792|Adrenergic Agents|adrenergic agents|mesh-ancestor
110631611|NCT00870480|Finasteride|finasteride|mesh-list
110631612|NCT00870480|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
110631613|NCT00870480|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110631614|NCT00870480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110631615|NCT00870480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110631616|NCT00870480|Hormone Antagonists|hormone antagonists|mesh-ancestor
110154922|NCT00005984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110631617|NCT00870480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110631618|NCT00870480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110631620|NCT00870558|Ethiodized Oil|ethiodized oil|mesh-list
110631621|NCT00870558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110631622|NCT01565278|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
110631623|NCT01565278|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
110114337|NCT01866644|Acetylcysteine|acetylcysteine|mesh-list
110631624|NCT01565278|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
110631625|NCT01565278|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110631626|NCT00616902|Ergocalciferols|ergocalciferols|mesh-list
110631627|NCT00616902|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110631628|NCT00616902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110631629|NCT00616902|Vitamins|vitamins|mesh-ancestor
110631630|NCT00616902|Micronutrients|micronutrients|mesh-ancestor
110631631|NCT00616902|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110631632|NCT00801944|Solifenacin Succinate|solifenacin succinate|mesh-list
110631633|NCT00801944|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110631634|NCT00801944|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110631635|NCT00801944|Cholinergic Agents|cholinergic agents|mesh-ancestor
110631636|NCT00801944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110394044|NCT01176916|Exemestane|exemestane|mesh-list
110394055|NCT02894268|Doxycycline|doxycycline|mesh-list
110631637|NCT00801944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110631638|NCT00801944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110631639|NCT00801944|Urological Agents|urological agents|mesh-ancestor
110631641|NCT00870636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110114357|NCT01867255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110114358|NCT01867255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110114359|NCT01867255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110114360|NCT01867255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110114361|NCT01867255|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110114362|NCT01867255|Antidepressive Agents|antidepressive agents|mesh-ancestor
110114363|NCT01867255|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110114364|NCT01867268|Acetazolamide|acetazolamide|mesh-list
110631642|NCT00870636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110631643|NCT00870636|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110631644|NCT00870636|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110631645|NCT00870636|Growth Substances|growth substances|mesh-ancestor
110631646|NCT00870636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110631647|NCT00870636|Growth Inhibitors|growth inhibitors|mesh-ancestor
110631648|NCT00741611|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
110631649|NCT00870714|Ketoconazole|ketoconazole|mesh-list
110631650|NCT00870714|Docetaxel|docetaxel|mesh-list
110631651|NCT00870714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110631652|NCT00870714|Tubulin Modulators|tubulin modulators|mesh-ancestor
110631653|NCT00870714|Antimitotic Agents|antimitotic agents|mesh-ancestor
110631654|NCT00870714|Mitosis Modulators|mitosis modulators|mesh-ancestor
110631655|NCT00870714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110631656|NCT00870714|Antifungal Agents|antifungal agents|mesh-ancestor
110631657|NCT00870714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110631658|NCT00870714|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110278993|NCT00216684|Analgesics|analgesics|mesh-ancestor
110631659|NCT00870714|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110631660|NCT00870714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110631661|NCT00870714|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110631662|NCT00870714|Hormone Antagonists|hormone antagonists|mesh-ancestor
110631663|NCT00870714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110631664|NCT00870714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110631665|NCT00870714|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110631666|NCT02596217|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110631667|NCT02596217|Immunologic Factors|immunologic factors|mesh-ancestor
110631668|NCT02596217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110631669|NCT00876330|Antihypertensive Agents|antihypertensive agents|mesh-list
110631670|NCT02598011|Flucytosine|flucytosine|mesh-list
110631671|NCT02598011|Antifungal Agents|antifungal agents|mesh-ancestor
110631672|NCT02598011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110631673|NCT02598011|Antimetabolites|antimetabolites|mesh-ancestor
110114396|NCT01867502|Vildagliptin|vildagliptin|mesh-list
110631674|NCT02598011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110631675|NCT00869310|Dexamethasone|dexamethasone|mesh-list
110631676|NCT00869310|Dexamethasone acetate|dexamethasone acetate|mesh-list
110631678|NCT00869310|Metoclopramide|metoclopramide|mesh-list
110631679|NCT00869310|BB 1101|bb 1101|mesh-list
110631680|NCT00869310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110631681|NCT00869310|Antiemetics|antiemetics|mesh-ancestor
110631682|NCT00869310|Autonomic Agents|autonomic agents|mesh-ancestor
110631683|NCT00869310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110631684|NCT00869310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110631685|NCT00869310|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110631686|NCT00869310|Glucocorticoids|glucocorticoids|mesh-ancestor
110631687|NCT00869310|Hormones|hormones|mesh-ancestor
110631688|NCT00869310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110631689|NCT00869310|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110631690|NCT00869310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110631691|NCT00869310|Protease Inhibitors|protease inhibitors|mesh-ancestor
110631692|NCT00869310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110631693|NCT00869310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110631694|NCT00869310|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110114428|NCT01867697|Antidotes|antidotes|mesh-ancestor
110631695|NCT00869310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110631696|NCT00869310|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110631697|NCT00869310|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110631698|NCT00869310|Dopamine Agents|dopamine agents|mesh-ancestor
110631699|NCT00662558|Celecoxib|celecoxib|mesh-list
110631700|NCT00662558|Tramadol|tramadol|mesh-list
110631701|NCT00662558|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110631702|NCT00662558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110631703|NCT00662558|Analgesics|analgesics|mesh-ancestor
110631704|NCT00662558|Sensory System Agents|sensory system agents|mesh-ancestor
110631705|NCT00662558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110631706|NCT00662558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110631707|NCT00662558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110631708|NCT00662558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110631709|NCT00662558|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110631710|NCT00662558|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110631711|NCT00662558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110631712|NCT00662558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110631713|NCT00662558|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110631714|NCT00662558|Narcotics|narcotics|mesh-ancestor
110631715|NCT00662558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110631716|NCT00869700|Lumefantrine|lumefantrine|mesh-list
110631717|NCT00869700|Artemether|artemether|mesh-list
110631718|NCT00869700|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
110631719|NCT00869700|Antimalarials|antimalarials|mesh-ancestor
110631720|NCT00869700|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110631721|NCT00869700|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110631722|NCT00869700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110631723|NCT00869856|Epoetin Alfa|epoetin alfa|mesh-list
110631724|NCT00869856|Hematinics|hematinics|mesh-ancestor
110631725|NCT00876486|genexol-PM|genexol-pm|mesh-list
110631726|NCT00876486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110631727|NCT00876486|Tubulin Modulators|tubulin modulators|mesh-ancestor
110631728|NCT00876486|Antimitotic Agents|antimitotic agents|mesh-ancestor
110631729|NCT00876486|Mitosis Modulators|mitosis modulators|mesh-ancestor
110631730|NCT00876486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110631731|NCT00802334|Ritonavir|ritonavir|mesh-list
110631732|NCT00802334|Lopinavir|lopinavir|mesh-list
110631733|NCT00802334|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110631734|NCT00802334|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110631735|NCT00802334|Protease Inhibitors|protease inhibitors|mesh-ancestor
110631736|NCT00802334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110253953|NCT00143702|Riboflavin|riboflavin|mesh-list
110631737|NCT00802334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110631738|NCT00802334|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110631739|NCT00802334|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110631740|NCT00802334|Antiviral Agents|antiviral agents|mesh-ancestor
110631741|NCT00802334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110631742|NCT00802334|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110631743|NCT00802334|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110631744|NCT00796640|Paliperidone Palmitate|paliperidone palmitate|mesh-list
110631745|NCT00796640|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110631746|NCT00796640|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110631747|NCT00796640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110631748|NCT00796640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110631749|NCT00796640|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110631750|NCT00796640|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110631751|NCT00796640|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110631752|NCT00796640|Serotonin Agents|serotonin agents|mesh-ancestor
110631753|NCT00796640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110154930|NCT00005984|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110631754|NCT00796640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110631755|NCT00796640|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110631756|NCT00796640|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110631757|NCT00796640|Dopamine Agents|dopamine agents|mesh-ancestor
110631758|NCT00796796|Sirolimus|sirolimus|mesh-list
110631759|NCT00796796|Temsirolimus|temsirolimus|mesh-list
110631760|NCT00796796|MTOR Inhibitors|mtor inhibitors|mesh-list
110631761|NCT00796796|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110631762|NCT00796796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110631763|NCT00796796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110631764|NCT00796796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110631765|NCT00796796|Immunologic Factors|immunologic factors|mesh-ancestor
110631766|NCT00796796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110631767|NCT00796796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110631768|NCT00796796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110631769|NCT00796796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110631771|NCT00796796|Antifungal Agents|antifungal agents|mesh-ancestor
110631772|NCT03794076|Cromolyn Sodium|cromolyn sodium|mesh-list
110631773|NCT03794076|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
110631774|NCT03794076|Immunologic Factors|immunologic factors|mesh-ancestor
110631775|NCT03794076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110631776|NCT03794076|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110631777|NCT03794076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110631778|NCT03794076|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110631779|NCT03794076|Respiratory System Agents|respiratory system agents|mesh-ancestor
110631780|NCT00739973|Amlodipine|amlodipine|mesh-list
110631781|NCT00739973|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110631782|NCT00739973|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110631783|NCT00739973|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110631784|NCT00739973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110631785|NCT00739973|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110631786|NCT00739973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110631788|NCT00802568|Fludarabine|fludarabine|mesh-list
110631789|NCT00802568|Fludarabine phosphate|fludarabine phosphate|mesh-list
110631790|NCT00802568|Busulfan|busulfan|mesh-list
110631791|NCT00802568|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110631792|NCT00802568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110631793|NCT00802568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110631794|NCT00802568|Antimetabolites|antimetabolites|mesh-ancestor
110631795|NCT00802568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110631796|NCT00802568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110631797|NCT00802568|Immunologic Factors|immunologic factors|mesh-ancestor
110631798|NCT00802568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110631799|NCT00802568|Alkylating Agents|alkylating agents|mesh-ancestor
110631800|NCT00802568|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110631801|NCT00802568|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110631802|NCT00802802|Efavirenz|efavirenz|mesh-list
110631803|NCT00802802|Rifampin|rifampin|mesh-list
110631804|NCT00802802|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110631805|NCT00802802|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110631806|NCT00802802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110631807|NCT00802802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110631808|NCT00802802|Antiviral Agents|antiviral agents|mesh-ancestor
110631809|NCT00802802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110631810|NCT00802802|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110631811|NCT00802802|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110631812|NCT00802802|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110631813|NCT00802802|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110631815|NCT00802802|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110631816|NCT00802802|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110631817|NCT00802802|Antitubercular Agents|antitubercular agents|mesh-ancestor
110631818|NCT00802802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110631819|NCT00802802|Leprostatic Agents|leprostatic agents|mesh-ancestor
110631820|NCT00802802|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110631821|NCT00802802|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110631822|NCT00802802|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110631824|NCT00802958|Halobetasol|halobetasol|mesh-list
110631825|NCT00802958|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110631826|NCT00802958|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110631827|NCT00802958|Glucocorticoids|glucocorticoids|mesh-ancestor
110631828|NCT00802958|Hormones|hormones|mesh-ancestor
110631829|NCT00802958|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110631830|NCT00802958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110631831|NCT01565512|Bupivacaine|bupivacaine|mesh-list
110631832|NCT01565512|Anesthetics, Local|anesthetics, local|mesh-ancestor
110631833|NCT01565512|Anesthetics|anesthetics|mesh-ancestor
110631834|NCT01565512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110631835|NCT01565512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110631836|NCT01565512|Sensory System Agents|sensory system agents|mesh-ancestor
110631837|NCT01565512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110631838|NCT04895930|Aflutinib|aflutinib|mesh-list
110631839|NCT04895930|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110631840|NCT04895930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110631841|NCT04895930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110631842|NCT00615030|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110631843|NCT00615030|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110631844|NCT00615030|Autonomic Agents|autonomic agents|mesh-ancestor
110631845|NCT00615030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110631846|NCT00615030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110631847|NCT00615030|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110631848|NCT00615030|Respiratory System Agents|respiratory system agents|mesh-ancestor
110631849|NCT00615030|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110631850|NCT00615030|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110631851|NCT00615030|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110631852|NCT00615030|Adrenergic Agents|adrenergic agents|mesh-ancestor
110631853|NCT00615030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110631854|NCT00615030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110631855|NCT00789308|Cyclosporine|cyclosporine|mesh-list
110631856|NCT00789308|Sirolimus|sirolimus|mesh-list
110631857|NCT00789308|Mycophenolic Acid|mycophenolic acid|mesh-list
110631858|NCT00789308|Etanercept|etanercept|mesh-list
110631859|NCT00789308|Heparin|heparin|mesh-list
110631860|NCT00789308|Dextrans|dextrans|mesh-list
110631861|NCT00789308|Tacrolimus|tacrolimus|mesh-list
110631862|NCT00789308|Cyclosporins|cyclosporins|mesh-list
110631863|NCT00789308|Thymoglobulin|thymoglobulin|mesh-list
110631864|NCT00789308|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110631865|NCT00789308|Basiliximab|basiliximab|mesh-list
110631866|NCT00789308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110631867|NCT00789308|Immunologic Factors|immunologic factors|mesh-ancestor
110631868|NCT00789308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110631869|NCT00789308|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110631870|NCT00789308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110631871|NCT00789308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110631872|NCT00789308|Antifungal Agents|antifungal agents|mesh-ancestor
110631873|NCT00789308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110631874|NCT00789308|Dermatologic Agents|dermatologic agents|mesh-ancestor
110631875|NCT00789308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110631876|NCT00789308|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110631877|NCT00789308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110631878|NCT00789308|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110631879|NCT00789308|Antitubercular Agents|antitubercular agents|mesh-ancestor
110631880|NCT00789308|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110631881|NCT00789308|Anticoagulants|anticoagulants|mesh-ancestor
110631882|NCT00789308|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110631883|NCT00789308|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110631884|NCT00789308|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110114609|NCT01869010|Tenofovir|tenofovir|mesh-list
110631885|NCT00789308|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110631886|NCT00789308|Analgesics|analgesics|mesh-ancestor
110631887|NCT00789308|Sensory System Agents|sensory system agents|mesh-ancestor
110631888|NCT00789308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110631889|NCT00789308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110631890|NCT00789308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110631891|NCT00789308|Plasma Substitutes|plasma substitutes|mesh-ancestor
110631892|NCT00789308|Blood Substitutes|blood substitutes|mesh-ancestor
110631894|NCT00518284|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110631895|NCT00518284|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110631896|NCT00518284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110631897|NCT00518284|Tubulin Modulators|tubulin modulators|mesh-ancestor
110631898|NCT00518284|Antimitotic Agents|antimitotic agents|mesh-ancestor
110631899|NCT00518284|Mitosis Modulators|mitosis modulators|mesh-ancestor
110631900|NCT00518284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110631902|NCT02595359|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110631903|NCT02595359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110631904|NCT02595359|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110631905|NCT02595359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110631906|NCT02595359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110631907|NCT02595359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110631908|NCT02595359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110631909|NCT00871104|Vancomycin|vancomycin|mesh-list
110631910|NCT00871104|Imipenem|imipenem|mesh-list
110631911|NCT00871104|Fosfomycin|fosfomycin|mesh-list
110631912|NCT00871104|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110631913|NCT00871104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110631914|NCT00614874|Rosiglitazone|rosiglitazone|mesh-list
110631915|NCT00614874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110631916|NCT00614874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110631917|NCT00727415|Cyclophosphamide|cyclophosphamide|mesh-list
110631918|NCT00727415|Fludarabine|fludarabine|mesh-list
110631919|NCT00727415|Fludarabine phosphate|fludarabine phosphate|mesh-list
110631920|NCT00727415|Lenalidomide|lenalidomide|mesh-list
110631921|NCT00727415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110114656|NCT01869491|Antacids|antacids|mesh-ancestor
110631922|NCT00727415|Immunologic Factors|immunologic factors|mesh-ancestor
110631923|NCT00727415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110631924|NCT00727415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110631925|NCT00727415|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110631926|NCT00727415|Alkylating Agents|alkylating agents|mesh-ancestor
110631927|NCT00727415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110631928|NCT00727415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110631929|NCT00727415|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110631930|NCT00727415|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110631931|NCT00727415|Antimetabolites|antimetabolites|mesh-ancestor
110631932|NCT00727415|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110631933|NCT00727415|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110631934|NCT00727415|Growth Substances|growth substances|mesh-ancestor
110631935|NCT00727415|Growth Inhibitors|growth inhibitors|mesh-ancestor
110631936|NCT00803192|Famotidine|famotidine|mesh-list
110631937|NCT00803192|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110631938|NCT00803192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110631939|NCT00803192|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110631940|NCT00803192|Histamine Antagonists|histamine antagonists|mesh-ancestor
110631941|NCT00803192|Histamine Agents|histamine agents|mesh-ancestor
110631942|NCT00803192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110631943|NCT00803192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110631944|NCT00803192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110631945|NCT00544557|Etanercept|etanercept|mesh-list
110631946|NCT00544557|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110631947|NCT00544557|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110631948|NCT00544557|Analgesics|analgesics|mesh-ancestor
110631949|NCT00544557|Sensory System Agents|sensory system agents|mesh-ancestor
110154958|NCT00005987|Antiemetics|antiemetics|mesh-ancestor
110631950|NCT00544557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110631951|NCT00544557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110631952|NCT00544557|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110631953|NCT00544557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110631954|NCT00544557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110631955|NCT00544557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110631956|NCT00544557|Immunologic Factors|immunologic factors|mesh-ancestor
110631957|NCT00877110|Cyclophosphamide|cyclophosphamide|mesh-list
110279301|NCT04574791|Tizanidine|tizanidine|mesh-list
110631958|NCT00877110|Vincristine|vincristine|mesh-list
110631959|NCT00877110|Topotecan|topotecan|mesh-list
110631960|NCT00877110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110631961|NCT00877110|Immunologic Factors|immunologic factors|mesh-ancestor
110631962|NCT00877110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110631963|NCT00877110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110631964|NCT00877110|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110631965|NCT00877110|Alkylating Agents|alkylating agents|mesh-ancestor
110631966|NCT00877110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110631967|NCT00877110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110631968|NCT00877110|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110631969|NCT00877110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110631970|NCT00877110|Tubulin Modulators|tubulin modulators|mesh-ancestor
110631971|NCT00877110|Antimitotic Agents|antimitotic agents|mesh-ancestor
110631972|NCT00877110|Mitosis Modulators|mitosis modulators|mesh-ancestor
110631973|NCT00877110|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110631974|NCT00877110|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110631975|NCT00877110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110631976|NCT00727259|Ribavirin|ribavirin|mesh-list
110631977|NCT00727259|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110631978|NCT00727259|Antimetabolites|antimetabolites|mesh-ancestor
110631979|NCT00727259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110631980|NCT00727259|Antiviral Agents|antiviral agents|mesh-ancestor
110631981|NCT00727259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110631982|NCT00789386|Midazolam|midazolam|mesh-list
110631983|NCT00789386|Remifentanil|remifentanil|mesh-list
110631984|NCT00789386|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110631985|NCT00789386|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110631986|NCT00789386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110631987|NCT00789386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110631988|NCT00789386|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110631989|NCT00789386|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110631990|NCT00789386|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110631991|NCT00789386|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110631992|NCT00789386|Anesthetics, General|anesthetics, general|mesh-ancestor
110631993|NCT00789386|Anesthetics|anesthetics|mesh-ancestor
110631994|NCT00789386|GABA Modulators|gaba modulators|mesh-ancestor
110631995|NCT00789386|GABA Agents|gaba agents|mesh-ancestor
110631996|NCT00789386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110254000|NCT00143741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110154966|NCT00005987|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110631997|NCT00789386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110631998|NCT00789386|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110631999|NCT00789386|Narcotics|narcotics|mesh-ancestor
110632000|NCT00789386|Analgesics|analgesics|mesh-ancestor
110632001|NCT00789386|Sensory System Agents|sensory system agents|mesh-ancestor
110632002|NCT00789386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110632003|NCT00789464|Trimethoprim|trimethoprim|mesh-list
110632004|NCT00789464|Sulfamethoxazole|sulfamethoxazole|mesh-list
110632005|NCT00789464|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110632006|NCT00789464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110632007|NCT00789464|Antimalarials|antimalarials|mesh-ancestor
110632008|NCT00789464|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110632009|NCT00789464|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110632010|NCT00789464|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110632011|NCT00789464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110632012|NCT00789464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110632013|NCT00789464|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110632014|NCT00789464|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
110632015|NCT00789464|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110632016|NCT00797030|Cyclosporine|cyclosporine|mesh-list
110632017|NCT00797030|Cyclosporins|cyclosporins|mesh-list
110632018|NCT00797030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110632019|NCT00797030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110632020|NCT00797030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110632021|NCT00797030|Immunologic Factors|immunologic factors|mesh-ancestor
110632022|NCT00797030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110632023|NCT00797030|Antifungal Agents|antifungal agents|mesh-ancestor
110632024|NCT00797030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110632025|NCT00797030|Dermatologic Agents|dermatologic agents|mesh-ancestor
110632026|NCT00797030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110632027|NCT00797030|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110632029|NCT00977145|Antiviral Agents|antiviral agents|mesh-ancestor
110632030|NCT00977145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110632031|NCT00918047|Oxcarbazepine|oxcarbazepine|mesh-list
110632032|NCT00918047|Anticonvulsants|anticonvulsants|mesh-ancestor
110632033|NCT00918047|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110632034|NCT00918047|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110632035|NCT00918047|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110632036|NCT00918047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110632037|NCT00918047|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110632038|NCT00918047|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110632039|NCT00877266|Mepivacaine|mepivacaine|mesh-list
110632040|NCT00877266|Anesthetics, Local|anesthetics, local|mesh-ancestor
110632041|NCT00877266|Anesthetics|anesthetics|mesh-ancestor
110632042|NCT00877266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110632043|NCT00877266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110632044|NCT00877266|Sensory System Agents|sensory system agents|mesh-ancestor
110632045|NCT00877266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110632046|NCT02553824|Topiramate|topiramate|mesh-list
110632047|NCT02553824|Phentermine|phentermine|mesh-list
110632048|NCT02553824|Anticonvulsants|anticonvulsants|mesh-ancestor
110632049|NCT02553824|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110632050|NCT02553824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110632051|NCT02553824|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110632052|NCT02553824|Appetite Depressants|appetite depressants|mesh-ancestor
110632053|NCT02553824|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110632054|NCT02553824|Sympathomimetics|sympathomimetics|mesh-ancestor
110632055|NCT02553824|Autonomic Agents|autonomic agents|mesh-ancestor
110632056|NCT02553824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110632057|NCT02553824|Adrenergic Agents|adrenergic agents|mesh-ancestor
110632058|NCT02553824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110632059|NCT02553824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110632060|NCT04039854|Propofol|propofol|mesh-list
110632061|NCT04039854|Sevoflurane|sevoflurane|mesh-list
110632062|NCT04039854|Desflurane|desflurane|mesh-list
110632063|NCT04039854|Isoflurane|isoflurane|mesh-list
110632064|NCT04039854|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110632065|NCT04039854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110254002|NCT00143780|Immunologic Factors|immunologic factors|mesh-ancestor
110632066|NCT04039854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110632068|NCT04039854|Anesthetics, General|anesthetics, general|mesh-ancestor
110632069|NCT04039854|Anesthetics|anesthetics|mesh-ancestor
110114788|NCT01870115|Antioxidants|antioxidants|mesh-ancestor
110632070|NCT04039854|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110632071|NCT04039854|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110632073|NCT04045730|Gemcitabine|gemcitabine|mesh-list
110632074|NCT04045730|Pembrolizumab|pembrolizumab|mesh-list
110632075|NCT04045730|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110632076|NCT04045730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110632077|NCT04045730|Tubulin Modulators|tubulin modulators|mesh-ancestor
110632078|NCT04045730|Antimitotic Agents|antimitotic agents|mesh-ancestor
110632079|NCT04045730|Mitosis Modulators|mitosis modulators|mesh-ancestor
110632080|NCT04045730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110632081|NCT04045730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110632082|NCT04045730|Antimetabolites|antimetabolites|mesh-ancestor
110632083|NCT04045730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110632084|NCT04045730|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110632085|NCT00977223|Aprepitant|aprepitant|mesh-list
110632086|NCT00977223|Fosaprepitant|fosaprepitant|mesh-list
110632087|NCT00977223|Antiemetics|antiemetics|mesh-ancestor
110632088|NCT00977223|Autonomic Agents|autonomic agents|mesh-ancestor
110632089|NCT00977223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110632090|NCT00977223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110632091|NCT00977223|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110632092|NCT00977223|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110632093|NCT00977223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110394128|NCT01600235|Nasal Decongestants|nasal decongestants|mesh-ancestor
110632094|NCT00977223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110632095|NCT00977301|Ritonavir|ritonavir|mesh-list
110632096|NCT00977301|Fosamprenavir|fosamprenavir|mesh-list
110632097|NCT00977301|Olanzapine|olanzapine|mesh-list
110632098|NCT00977301|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110632099|NCT00977301|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110632100|NCT00977301|Protease Inhibitors|protease inhibitors|mesh-ancestor
110632101|NCT00977301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110632102|NCT00977301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110632103|NCT00977301|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110632104|NCT00977301|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110632105|NCT00977301|Antiviral Agents|antiviral agents|mesh-ancestor
110632106|NCT00977301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110632107|NCT00977301|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110632108|NCT00977301|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110632109|NCT00977301|Antiemetics|antiemetics|mesh-ancestor
110632110|NCT00977301|Autonomic Agents|autonomic agents|mesh-ancestor
110632111|NCT00977301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110632112|NCT00977301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110632113|NCT00977301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110632114|NCT00977301|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110632115|NCT00977301|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110632116|NCT00977301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110632117|NCT00977301|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110632118|NCT00977301|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110632119|NCT00977301|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110632120|NCT00977301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110632121|NCT00977301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110632122|NCT00977301|Serotonin Agents|serotonin agents|mesh-ancestor
110632123|NCT00735371|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
110632124|NCT00735371|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110632125|NCT00735371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110632126|NCT00735371|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110632127|NCT00735371|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110632128|NCT00735371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110632129|NCT00735371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110632130|NCT00735371|Dopamine Agents|dopamine agents|mesh-ancestor
110632131|NCT00735371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110632132|NCT00518206|Cyclophosphamide|cyclophosphamide|mesh-list
110632133|NCT00518206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110632134|NCT00518206|Immunologic Factors|immunologic factors|mesh-ancestor
110632135|NCT00518206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110632136|NCT00518206|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110632137|NCT00518206|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110632138|NCT00518206|Alkylating Agents|alkylating agents|mesh-ancestor
110632139|NCT00518206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110632140|NCT00518206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110632141|NCT00518206|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110632142|NCT00984945|Vaccines|vaccines|mesh-list
110632143|NCT00984945|Immunologic Factors|immunologic factors|mesh-ancestor
110632144|NCT00984945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110632145|NCT00879918|Nicotine|nicotine|mesh-list
110632146|NCT00879918|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110632147|NCT00879918|Autonomic Agents|autonomic agents|mesh-ancestor
110632148|NCT00879918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110632149|NCT00879918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110632150|NCT00879918|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110632151|NCT00879918|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110632152|NCT00879918|Cholinergic Agents|cholinergic agents|mesh-ancestor
110632153|NCT00879918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110632154|NCT00879918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110632155|NCT01565590|Dexmedetomidine|dexmedetomidine|mesh-list
110632156|NCT01565590|Propofol|propofol|mesh-list
110632157|NCT01565590|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110632158|NCT01565590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110632159|NCT01565590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110632160|NCT01565590|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110632161|NCT01565590|Analgesics|analgesics|mesh-ancestor
110632162|NCT01565590|Sensory System Agents|sensory system agents|mesh-ancestor
110632163|NCT01565590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110632164|NCT01565590|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110632165|NCT01565590|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110632166|NCT01565590|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110632167|NCT01565590|Adrenergic Agents|adrenergic agents|mesh-ancestor
110632168|NCT01565590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110632169|NCT01565590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110632170|NCT01565590|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110632171|NCT01565590|Anesthetics, General|anesthetics, general|mesh-ancestor
110632172|NCT01565590|Anesthetics|anesthetics|mesh-ancestor
110632173|NCT00877422|Vitamin D|vitamin d|mesh-list
110632174|NCT00877422|Cholecalciferol|cholecalciferol|mesh-list
110632175|NCT00877422|Vitamins|vitamins|mesh-ancestor
110632176|NCT00877422|Micronutrients|micronutrients|mesh-ancestor
110632177|NCT00877422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110632178|NCT00877422|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110632179|NCT00877422|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110632180|NCT04039698|Sofosbuvir|sofosbuvir|mesh-list
110632181|NCT04039698|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
110632182|NCT04039698|Velpatasvir|velpatasvir|mesh-list
110632183|NCT04039698|Antiviral Agents|antiviral agents|mesh-ancestor
110632184|NCT04039698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110632185|NCT04006821|Apatinib|apatinib|mesh-list
110632186|NCT04006821|Antibodies|antibodies|mesh-list
110632187|NCT04006821|Immunologic Factors|immunologic factors|mesh-ancestor
110632188|NCT04006821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110632189|NCT04006821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110632190|NCT04006821|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110632191|NCT04006821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110632192|NCT04006821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110632193|NCT00803816|Everolimus|everolimus|mesh-list
110632194|NCT00803816|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110632195|NCT00803816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110632196|NCT00803816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110254015|NCT00143975|Antimetabolites|antimetabolites|mesh-ancestor
110632197|NCT00803816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110632198|NCT00803816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110632199|NCT00803816|Immunologic Factors|immunologic factors|mesh-ancestor
110632200|NCT00803816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110632201|NCT00803816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110632202|NCT00797264|Ketamine|ketamine|mesh-list
110632203|NCT00797264|Morphine|morphine|mesh-list
110632204|NCT00797264|Analgesics|analgesics|mesh-ancestor
110632205|NCT00797264|Sensory System Agents|sensory system agents|mesh-ancestor
110632206|NCT00797264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110632207|NCT00797264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110632208|NCT00797264|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110632209|NCT00797264|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110632210|NCT00797264|Anesthetics, General|anesthetics, general|mesh-ancestor
110632211|NCT00797264|Anesthetics|anesthetics|mesh-ancestor
110632212|NCT00797264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110632213|NCT00797264|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110632214|NCT00797264|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110632215|NCT00797264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110632216|NCT00797264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110632217|NCT00797264|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110632218|NCT00797264|Narcotics|narcotics|mesh-ancestor
110632219|NCT00981201|Celecoxib|celecoxib|mesh-list
110632220|NCT00981201|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110632221|NCT00981201|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110632222|NCT00981201|Analgesics|analgesics|mesh-ancestor
110632223|NCT00981201|Sensory System Agents|sensory system agents|mesh-ancestor
110632224|NCT00981201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110632225|NCT00981201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110632226|NCT00981201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110632227|NCT00981201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110632228|NCT00981201|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110632229|NCT00981201|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110632230|NCT00981201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110632231|NCT00981201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110632233|NCT05279391|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
110632234|NCT05279391|Heparin|heparin|mesh-list
110632235|NCT05279391|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
110632236|NCT05279391|Tinzaparin|tinzaparin|mesh-list
110632237|NCT05279391|Dalteparin|dalteparin|mesh-list
110632238|NCT05279391|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110632239|NCT05279391|Antiemetics|antiemetics|mesh-ancestor
110632240|NCT05279391|Autonomic Agents|autonomic agents|mesh-ancestor
110632241|NCT05279391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110632242|NCT05279391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110632243|NCT05279391|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110632244|NCT05279391|Glucocorticoids|glucocorticoids|mesh-ancestor
110632245|NCT05279391|Hormones|hormones|mesh-ancestor
110632246|NCT05279391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110632247|NCT05279391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110632248|NCT05279391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110632249|NCT05279391|Anticoagulants|anticoagulants|mesh-ancestor
110632250|NCT05279391|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110632251|NCT05279391|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110632252|NCT05279391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110632253|NCT05279391|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110632254|NCT02595203|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110632255|NCT00789620|Lidocaine|lidocaine|mesh-list
110632256|NCT00789620|Anesthetics, Local|anesthetics, local|mesh-ancestor
110632257|NCT00789620|Anesthetics|anesthetics|mesh-ancestor
110632258|NCT00789620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110632259|NCT00789620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110632260|NCT00789620|Sensory System Agents|sensory system agents|mesh-ancestor
110632261|NCT00789620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110632262|NCT00789620|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110254025|NCT00143975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110632263|NCT00789620|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110632264|NCT00789620|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110632265|NCT00789620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110632266|NCT00789620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110632268|NCT03970265|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110632269|NCT03970265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110632270|NCT00877656|Zanolimumab|zanolimumab|mesh-list
110632271|NCT00877656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110632272|NCT00877656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110632273|NCT00803894|3-(4-((4-chlorophenyl)sulfonyl)-4-(2,5-difluorophenyl)cyclohexyl)propanoic acid|3-(4-((4-chlorophenyl)sulfonyl)-4-(2,5-difluorophenyl)cyclohexyl)propanoic acid|mesh-list
110632274|NCT00803894|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
110632275|NCT00803894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110632276|NCT00803894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110632277|NCT05371925|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
110632278|NCT05371925|Anticoagulants|anticoagulants|mesh-ancestor
110632279|NCT05371925|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110632280|NCT05371925|Antimetabolites|antimetabolites|mesh-ancestor
110632281|NCT05371925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110632282|NCT05371925|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110632283|NCT05371925|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110632284|NCT05371925|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110632285|NCT05371925|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110632286|NCT05371925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110632287|NCT00797420|Fluconazole|fluconazole|mesh-list
110632288|NCT00797420|Antifungal Agents|antifungal agents|mesh-ancestor
110632289|NCT00797420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110632290|NCT00797420|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110632291|NCT00797420|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110632292|NCT00797420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110632293|NCT00797420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110632294|NCT00797420|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110632295|NCT00797420|Hormone Antagonists|hormone antagonists|mesh-ancestor
110632296|NCT00797420|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110632297|NCT00797420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110632298|NCT00797420|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110632299|NCT00797420|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110632301|NCT00981513|Immunologic Factors|immunologic factors|mesh-ancestor
110632302|NCT00981513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110632303|NCT00872274|Sumatriptan|sumatriptan|mesh-list
110632304|NCT00872274|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110632305|NCT00872274|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110632306|NCT00872274|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110632307|NCT00872274|Serotonin Agents|serotonin agents|mesh-ancestor
110632308|NCT00872274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110632309|NCT00872274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110632310|NCT00872274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110632311|NCT00872586|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110632312|NCT00872586|Olmesartan|olmesartan|mesh-list
110632313|NCT00872586|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
110632314|NCT00872586|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110632315|NCT00872586|Diuretics|diuretics|mesh-ancestor
110632316|NCT00872586|Natriuretic Agents|natriuretic agents|mesh-ancestor
110114959|NCT01870804|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110632317|NCT00872586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110632318|NCT00872586|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110632319|NCT00872586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110632320|NCT00872586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110632321|NCT00872586|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110632322|NCT00872586|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110632323|NCT00726557|Interferons|interferons|mesh-list
110632324|NCT00726557|Ribavirin|ribavirin|mesh-list
110632325|NCT00726557|Interferon-alpha|interferon-alpha|mesh-list
110632326|NCT00726557|Interferon alpha-2|interferon alpha-2|mesh-list
110632327|NCT00726557|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110632328|NCT00726557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110632329|NCT00726557|Antiviral Agents|antiviral agents|mesh-ancestor
110632330|NCT00726557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110632331|NCT00726557|Antimetabolites|antimetabolites|mesh-ancestor
110632332|NCT00726557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110632333|NCT00726557|Immunologic Factors|immunologic factors|mesh-ancestor
110632334|NCT00726557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110632336|NCT00803972|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110632337|NCT00803972|Insulin Lispro|insulin lispro|mesh-list
110632338|NCT00803972|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110632339|NCT00803972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110632341|NCT00880386|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110632342|NCT00880386|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110632343|NCT00880386|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110632344|NCT00880386|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110632345|NCT00880386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110632346|NCT00978081|Aminolevulinic Acid|aminolevulinic acid|mesh-list
110632347|NCT00978081|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110632348|NCT00978081|Dermatologic Agents|dermatologic agents|mesh-ancestor
110632349|NCT00804050|Vitamins|vitamins|mesh-list
110632350|NCT00804050|Micronutrients|micronutrients|mesh-ancestor
110632351|NCT00804050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110632352|NCT00877734|Baclofen|baclofen|mesh-list
110632353|NCT00877734|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110632354|NCT00877734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110632355|NCT00877734|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110632356|NCT00877734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110632357|NCT00877734|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
110632358|NCT00877734|GABA Agonists|gaba agonists|mesh-ancestor
110632359|NCT00877734|GABA Agents|gaba agents|mesh-ancestor
110632360|NCT00877734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110632361|NCT00877734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110632362|NCT00981591|Iloprost|iloprost|mesh-list
110632363|NCT00981591|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110632364|NCT00981591|Vasodilator Agents|vasodilator agents|mesh-ancestor
110632365|NCT00978159|Esomeprazole|esomeprazole|mesh-list
110632366|NCT00978159|Famotidine|famotidine|mesh-list
110632368|NCT00978159|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110632369|NCT00978159|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110632370|NCT00978159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110632371|NCT00978159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110632372|NCT00978159|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110632373|NCT00978159|Histamine Antagonists|histamine antagonists|mesh-ancestor
110394204|NCT04477382|Tretinoin|tretinoin|mesh-list
110632375|NCT00978159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110632376|NCT00978159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110632377|NCT00804206|Bevacizumab|bevacizumab|mesh-list
110632378|NCT00804206|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110632379|NCT00804206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110632380|NCT00804206|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110632381|NCT00804206|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110632382|NCT00804206|Growth Substances|growth substances|mesh-ancestor
110632383|NCT00804206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110632384|NCT00804206|Growth Inhibitors|growth inhibitors|mesh-ancestor
110632385|NCT00877812|Glycine|glycine|mesh-list
110632386|NCT00877812|Glycine Agents|glycine agents|mesh-ancestor
110632387|NCT00877812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110632388|NCT00877812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110632389|NCT00877812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110632390|NCT00981903|Tinzaparin|tinzaparin|mesh-list
110632391|NCT00981903|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
110632392|NCT00981903|Dalteparin|dalteparin|mesh-list
110632393|NCT00981903|Anticoagulants|anticoagulants|mesh-ancestor
110632394|NCT00981903|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110632395|NCT00981903|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110115013|NCT01871454|Pentoxifylline|pentoxifylline|mesh-list
110632396|NCT00981903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110632397|NCT00738881|Pemetrexed|pemetrexed|mesh-list
110632398|NCT00738881|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110632399|NCT00738881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110632400|NCT00738881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110632401|NCT00738881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110632402|NCT00738881|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110632403|NCT00738881|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110632404|NCT00738881|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110632405|NCT00657020|Nicotine|nicotine|mesh-list
110632406|NCT00657020|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110632407|NCT00657020|Autonomic Agents|autonomic agents|mesh-ancestor
110632408|NCT00657020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110632409|NCT00657020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110632410|NCT00657020|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110632411|NCT00657020|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110632412|NCT00657020|Cholinergic Agents|cholinergic agents|mesh-ancestor
110632413|NCT00657020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110632414|NCT00657020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110632415|NCT03921723|Dolutegravir|dolutegravir|mesh-list
110632416|NCT03921723|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110632417|NCT03921723|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110632418|NCT03921723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110632419|NCT03921723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110632420|NCT03921723|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110632421|NCT03921723|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110632422|NCT03921723|Antiviral Agents|antiviral agents|mesh-ancestor
110632423|NCT03921723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110632424|NCT00872664|Carotenoids|carotenoids|mesh-list
110632425|NCT00872664|Antioxidants|antioxidants|mesh-ancestor
110632426|NCT00872664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110632427|NCT00872664|Protective Agents|protective agents|mesh-ancestor
110632428|NCT00872664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110632429|NCT05056155|Lubricant Eye Drops|lubricant eye drops|mesh-list
110632430|NCT05056155|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110632431|NCT05056155|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110632432|NCT00878124|Ubiquinone|ubiquinone|mesh-list
110632433|NCT00878124|Coenzyme Q10|coenzyme q10|mesh-list
110632434|NCT00878124|Micronutrients|micronutrients|mesh-ancestor
110632435|NCT00878124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110632436|NCT00878124|Vitamins|vitamins|mesh-ancestor
110632437|NCT00978315|Cholecalciferol|cholecalciferol|mesh-list
110632438|NCT00978315|Vitamin D|vitamin d|mesh-list
110632439|NCT00978315|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110632440|NCT00978315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110632441|NCT00978315|Vitamins|vitamins|mesh-ancestor
110632442|NCT00978315|Micronutrients|micronutrients|mesh-ancestor
110632443|NCT00978315|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110632444|NCT00978393|Liraglutide|liraglutide|mesh-list
110115035|NCT01871649|Golimumab|golimumab|mesh-list
110115036|NCT01871649|Methotrexate|methotrexate|mesh-list
110115037|NCT01871649|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110115038|NCT01871649|Abortifacient Agents|abortifacient agents|mesh-ancestor
110115039|NCT01871649|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110632445|NCT00978393|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110632446|NCT00978393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110632447|NCT00978393|Incretins|incretins|mesh-ancestor
110632448|NCT00978393|Hormones|hormones|mesh-ancestor
110632449|NCT00978393|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110632450|NCT04740996|Pembrolizumab|pembrolizumab|mesh-list
110632451|NCT04740996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110632452|NCT04740996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110632453|NCT04740996|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110632454|NCT04740996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110632455|NCT00872976|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110632456|NCT00872976|Dasatinib|dasatinib|mesh-list
110632457|NCT00872976|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110632458|NCT00872976|Alkylating Agents|alkylating agents|mesh-ancestor
110632459|NCT00872976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110632460|NCT00872976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110632461|NCT00872976|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110632462|NCT00872976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110632463|NCT00544167|Paclitaxel|paclitaxel|mesh-list
110632464|NCT00544167|Cyclophosphamide|cyclophosphamide|mesh-list
110632465|NCT00544167|Doxorubicin|doxorubicin|mesh-list
110632466|NCT00544167|Sorafenib|sorafenib|mesh-list
110632467|NCT00544167|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110632468|NCT00544167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110632469|NCT00544167|Tubulin Modulators|tubulin modulators|mesh-ancestor
110632470|NCT00544167|Antimitotic Agents|antimitotic agents|mesh-ancestor
110632471|NCT00544167|Mitosis Modulators|mitosis modulators|mesh-ancestor
110632472|NCT00544167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110632473|NCT00544167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110632474|NCT00544167|Immunologic Factors|immunologic factors|mesh-ancestor
110632475|NCT00544167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110394258|NCT00591708|Calcium|calcium|mesh-list
110632476|NCT00544167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110632477|NCT00544167|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110632478|NCT00544167|Alkylating Agents|alkylating agents|mesh-ancestor
110632479|NCT00544167|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110632480|NCT00544167|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110632481|NCT00544167|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110279818|NCT00184574|Metformin|metformin|mesh-list
110632482|NCT00544167|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110632483|NCT00544167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110632484|NCT00544167|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110632486|NCT00659438|Androgen Antagonists|androgen antagonists|mesh-ancestor
110632487|NCT00659438|Hormone Antagonists|hormone antagonists|mesh-ancestor
110632488|NCT00659438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110632489|NCT00659438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110632490|NCT00659438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110632491|NCT05225844|Apatinib|apatinib|mesh-list
110632492|NCT05225844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110632493|NCT05225844|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110632494|NCT05225844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110632495|NCT05225844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110632496|NCT00878514|Alprazolam|alprazolam|mesh-list
110632497|NCT00878514|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110632498|NCT00878514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110632499|NCT00878514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110632500|NCT00878514|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110632501|NCT00878514|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110632502|NCT00878514|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110632503|NCT00878514|GABA Modulators|gaba modulators|mesh-ancestor
110632504|NCT00878514|GABA Agents|gaba agents|mesh-ancestor
110632505|NCT00878514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110632506|NCT00878514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110632507|NCT00804440|Ibuprofen|ibuprofen|mesh-list
110632508|NCT00804440|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110632509|NCT00804440|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110632510|NCT00804440|Analgesics|analgesics|mesh-ancestor
110632511|NCT00804440|Sensory System Agents|sensory system agents|mesh-ancestor
110632512|NCT00804440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110115095|NCT01871701|Contraceptive Agents|contraceptive agents|mesh-ancestor
110632513|NCT00804440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110632514|NCT00804440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110632515|NCT00804440|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110632516|NCT00804440|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110632517|NCT00804440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110632518|NCT00804440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110632519|NCT00880854|Tremelimumab|tremelimumab|mesh-list
110632520|NCT00880854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110632521|NCT00543855|Donepezil|donepezil|mesh-list
110632522|NCT00543855|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110632523|NCT00543855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110632524|NCT00543855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110632525|NCT00543855|Cholinergic Agents|cholinergic agents|mesh-ancestor
110632526|NCT00543855|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110632527|NCT00543855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110632528|NCT00543855|Nootropic Agents|nootropic agents|mesh-ancestor
110632529|NCT00797810|Cytarabine|cytarabine|mesh-list
110632530|NCT00797810|Dexamethasone|dexamethasone|mesh-list
110632531|NCT00797810|Prednisone|prednisone|mesh-list
110632532|NCT00797810|Cyclophosphamide|cyclophosphamide|mesh-list
110632533|NCT00797810|Ifosfamide|ifosfamide|mesh-list
110632534|NCT00797810|Rituximab|rituximab|mesh-list
110632535|NCT00797810|Vincristine|vincristine|mesh-list
110632536|NCT00797810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110632537|NCT00797810|Immunologic Factors|immunologic factors|mesh-ancestor
110632538|NCT00797810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110632539|NCT00797810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110632540|NCT00797810|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110632541|NCT00797810|Alkylating Agents|alkylating agents|mesh-ancestor
110632542|NCT00797810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110632543|NCT00797810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110632544|NCT00797810|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110632545|NCT00797810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110115135|NCT01871792|Pitavastatin|pitavastatin|mesh-list
110632546|NCT00797810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110632547|NCT00797810|Antiemetics|antiemetics|mesh-ancestor
110632548|NCT00797810|Autonomic Agents|autonomic agents|mesh-ancestor
110632549|NCT00797810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110632550|NCT00797810|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110632551|NCT00797810|Glucocorticoids|glucocorticoids|mesh-ancestor
110632552|NCT00797810|Hormones|hormones|mesh-ancestor
110632553|NCT00797810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110632554|NCT00797810|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110632555|NCT00797810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110632556|NCT00797810|Antimetabolites|antimetabolites|mesh-ancestor
110632557|NCT00797810|Antiviral Agents|antiviral agents|mesh-ancestor
110632558|NCT00797810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110632559|NCT00797810|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110632560|NCT00797810|Tubulin Modulators|tubulin modulators|mesh-ancestor
110632561|NCT00797810|Antimitotic Agents|antimitotic agents|mesh-ancestor
110632562|NCT00797810|Mitosis Modulators|mitosis modulators|mesh-ancestor
110632563|NCT00873210|Sunitinib|sunitinib|mesh-list
110632564|NCT00873210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110632565|NCT00873210|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110632566|NCT00873210|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110632567|NCT00873210|Growth Substances|growth substances|mesh-ancestor
110632568|NCT00873210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110632569|NCT00873210|Growth Inhibitors|growth inhibitors|mesh-ancestor
110632570|NCT00873210|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110632571|NCT00873210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110632572|NCT00873210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110632573|NCT00978471|Thiotepa|thiotepa|mesh-list
110632574|NCT00978471|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110632575|NCT00978471|Alkylating Agents|alkylating agents|mesh-ancestor
110632576|NCT00978471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110632577|NCT00978471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110632578|NCT00978471|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110632579|NCT00978471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110632580|NCT00978471|Immunologic Factors|immunologic factors|mesh-ancestor
110632581|NCT00978471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110632582|NCT00804674|Bupivacaine|bupivacaine|mesh-list
110632583|NCT00804674|Anesthetics, Local|anesthetics, local|mesh-ancestor
110632584|NCT00804674|Anesthetics|anesthetics|mesh-ancestor
110632585|NCT00804674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110632586|NCT00804674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110632587|NCT00804674|Sensory System Agents|sensory system agents|mesh-ancestor
110632588|NCT00804674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110632590|NCT00881088|Nadroparin|nadroparin|mesh-list
110632591|NCT00881088|Fondaparinux|fondaparinux|mesh-list
110632592|NCT00881088|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110632593|NCT00881088|Antithrombins|antithrombins|mesh-ancestor
110632594|NCT00881088|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110632595|NCT00881088|Protease Inhibitors|protease inhibitors|mesh-ancestor
110632596|NCT00881088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110632597|NCT00881088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110632598|NCT00881088|Anticoagulants|anticoagulants|mesh-ancestor
110632599|NCT00881088|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110632600|NCT00881088|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110632601|NCT00978549|Docetaxel|docetaxel|mesh-list
110632602|NCT00978549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110632603|NCT00978549|Tubulin Modulators|tubulin modulators|mesh-ancestor
110632604|NCT00978549|Antimitotic Agents|antimitotic agents|mesh-ancestor
110632605|NCT00978549|Mitosis Modulators|mitosis modulators|mesh-ancestor
110632606|NCT00978549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110632608|NCT00656084|Gemcitabine|gemcitabine|mesh-list
110632609|NCT00656084|Mitoxantrone|mitoxantrone|mesh-list
110632610|NCT00656084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110632611|NCT00656084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110632612|NCT00656084|Immunologic Factors|immunologic factors|mesh-ancestor
110632613|NCT00656084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110632614|NCT00656084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110632615|NCT00656084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110632616|NCT00656084|Antimetabolites|antimetabolites|mesh-ancestor
110632617|NCT00656084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110632618|NCT00656084|Analgesics|analgesics|mesh-ancestor
110632619|NCT00656084|Sensory System Agents|sensory system agents|mesh-ancestor
110632620|NCT00656084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110632621|NCT00656084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110632622|NCT00656084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110632623|NCT00656084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110632624|NCT00881166|Paclitaxel|paclitaxel|mesh-list
110632625|NCT00881166|Etoposide|etoposide|mesh-list
110632626|NCT00881166|Docetaxel|docetaxel|mesh-list
110632627|NCT00881166|Carboplatin|carboplatin|mesh-list
110632628|NCT00881166|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110632629|NCT00881166|Topotecan|topotecan|mesh-list
110632630|NCT00881166|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110632631|NCT00881166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110632632|NCT00881166|Tubulin Modulators|tubulin modulators|mesh-ancestor
110632633|NCT00881166|Antimitotic Agents|antimitotic agents|mesh-ancestor
110632634|NCT00881166|Mitosis Modulators|mitosis modulators|mesh-ancestor
110632635|NCT00881166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110632636|NCT00881166|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110632637|NCT00881166|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110632638|NCT00881166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110632639|NCT00881166|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110632640|NCT00881166|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110632641|NCT00804752|Vitamin D|vitamin d|mesh-list
110632642|NCT00804752|Ergocalciferols|ergocalciferols|mesh-list
110632643|NCT00804752|Cholecalciferol|cholecalciferol|mesh-list
110632644|NCT00804752|Vitamins|vitamins|mesh-list
110632645|NCT00804752|Micronutrients|micronutrients|mesh-ancestor
110632646|NCT00804752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110632647|NCT00804752|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110632648|NCT00804752|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110632649|NCT05225766|Bupivacaine|bupivacaine|mesh-list
110632650|NCT05225766|Anesthetics, Local|anesthetics, local|mesh-ancestor
110632651|NCT05225766|Anesthetics|anesthetics|mesh-ancestor
110632652|NCT05225766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110632653|NCT05225766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110632654|NCT05225766|Sensory System Agents|sensory system agents|mesh-ancestor
110632655|NCT05225766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110632656|NCT00804830|Bevacizumab|bevacizumab|mesh-list
110632657|NCT00804830|Doxorubicin|doxorubicin|mesh-list
110632658|NCT00804830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110632659|NCT00804830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110632660|NCT00804830|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110394316|NCT01601093|Sulbactam|sulbactam|mesh-list
110632661|NCT00804830|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110632662|NCT00804830|Growth Substances|growth substances|mesh-ancestor
110632663|NCT00804830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110632664|NCT00804830|Growth Inhibitors|growth inhibitors|mesh-ancestor
110632665|NCT00804830|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110632666|NCT00804830|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110632667|NCT00804830|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110632668|NCT00804830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110632669|NCT00804830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110632670|NCT00982215|Acetaminophen|acetaminophen|mesh-list
110632671|NCT00982215|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110632672|NCT00982215|Analgesics|analgesics|mesh-ancestor
110632673|NCT00982215|Sensory System Agents|sensory system agents|mesh-ancestor
110632674|NCT00982215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110632675|NCT00982215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110632676|NCT00982215|Antipyretics|antipyretics|mesh-ancestor
110632678|NCT00613938|Tapentadol|tapentadol|mesh-list
110632679|NCT00613938|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110632680|NCT00613938|Narcotics|narcotics|mesh-ancestor
110632681|NCT00613938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110632682|NCT00613938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110632683|NCT00613938|Analgesics|analgesics|mesh-ancestor
110632684|NCT00613938|Sensory System Agents|sensory system agents|mesh-ancestor
110632685|NCT00613938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110632686|NCT00613938|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110632687|NCT00613938|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110632688|NCT00613938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110632689|NCT00613938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110632690|NCT00613938|Adrenergic Agents|adrenergic agents|mesh-ancestor
110115221|NCT01871987|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110632691|NCT00613938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110632692|NCT00978861|Hydrogen Peroxide|hydrogen peroxide|mesh-list
110632693|NCT00978861|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110632694|NCT00978861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110632695|NCT00805064|Triamcinolone|triamcinolone|mesh-list
110632696|NCT00805064|Bevacizumab|bevacizumab|mesh-list
110632697|NCT00805064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110632698|NCT00805064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110632699|NCT00805064|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110632700|NCT00805064|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110632701|NCT00805064|Growth Substances|growth substances|mesh-ancestor
110632702|NCT00805064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110632703|NCT00805064|Growth Inhibitors|growth inhibitors|mesh-ancestor
110632704|NCT00805064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110632705|NCT00805064|Glucocorticoids|glucocorticoids|mesh-ancestor
110632706|NCT00805064|Hormones|hormones|mesh-ancestor
110632707|NCT00805064|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110280043|NCT00185510|Prednisolone|prednisolone|mesh-list
110632709|NCT00655928|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110632710|NCT00655928|Antiviral Agents|antiviral agents|mesh-ancestor
110632711|NCT00655928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110632712|NCT00655928|Expectorants|expectorants|mesh-ancestor
110254090|NCT05149339|Vitamins|vitamins|mesh-ancestor
110632713|NCT00655928|Respiratory System Agents|respiratory system agents|mesh-ancestor
110394325|NCT04366830|Remestemcel-l|remestemcel-l|mesh-list
110632714|NCT00655928|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110632715|NCT00655928|Antioxidants|antioxidants|mesh-ancestor
110632716|NCT00655928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110632717|NCT00655928|Protective Agents|protective agents|mesh-ancestor
110632718|NCT00655928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110632719|NCT00655928|Antidotes|antidotes|mesh-ancestor
110632720|NCT00873756|Bevacizumab|bevacizumab|mesh-list
110632721|NCT00873756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110632722|NCT00873756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110632723|NCT00873756|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110632724|NCT00873756|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110632725|NCT00873756|Growth Substances|growth substances|mesh-ancestor
110632726|NCT00873756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110632727|NCT00873756|Growth Inhibitors|growth inhibitors|mesh-ancestor
110632728|NCT00873834|Fluoxetine|fluoxetine|mesh-list
110632729|NCT00873834|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110115253|NCT01872351|Protective Agents|protective agents|mesh-ancestor
110632730|NCT00873834|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110632731|NCT00873834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110632732|NCT00873834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110632733|NCT00873834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110632734|NCT00873834|Serotonin Agents|serotonin agents|mesh-ancestor
110632735|NCT00873834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110632736|NCT00873834|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110632737|NCT00873834|Antidepressive Agents|antidepressive agents|mesh-ancestor
110632738|NCT00873834|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110632739|NCT00873834|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110632740|NCT00873834|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110632741|NCT00873834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110632742|NCT00655850|Paclitaxel|paclitaxel|mesh-list
110632743|NCT00655850|Gemcitabine|gemcitabine|mesh-list
110632744|NCT00655850|Bevacizumab|bevacizumab|mesh-list
110632745|NCT00655850|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110632746|NCT00655850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110632747|NCT00655850|Tubulin Modulators|tubulin modulators|mesh-ancestor
110632748|NCT00655850|Antimitotic Agents|antimitotic agents|mesh-ancestor
110632749|NCT00655850|Mitosis Modulators|mitosis modulators|mesh-ancestor
110632750|NCT00655850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110632751|NCT00655850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110632752|NCT00655850|Antimetabolites|antimetabolites|mesh-ancestor
110632753|NCT00655850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110632754|NCT00655850|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110155049|NCT00015106|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110632755|NCT00655850|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110632756|NCT00655850|Growth Substances|growth substances|mesh-ancestor
110632757|NCT00655850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110632758|NCT00655850|Growth Inhibitors|growth inhibitors|mesh-ancestor
110632760|NCT00874068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110632761|NCT00874068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110632762|NCT00805298|Methylprednisolone|methylprednisolone|mesh-list
110632763|NCT00805298|Epinephrine|epinephrine|mesh-list
110632764|NCT00805298|Racepinephrine|racepinephrine|mesh-list
110632765|NCT00805298|Epinephryl borate|epinephryl borate|mesh-list
110632766|NCT00805298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110632767|NCT00805298|Antiemetics|antiemetics|mesh-ancestor
110632768|NCT00805298|Autonomic Agents|autonomic agents|mesh-ancestor
110632769|NCT00805298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110632770|NCT00805298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110632771|NCT00805298|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110632772|NCT00805298|Glucocorticoids|glucocorticoids|mesh-ancestor
110632773|NCT00805298|Hormones|hormones|mesh-ancestor
110632774|NCT00805298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110632775|NCT00805298|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110632776|NCT00805298|Protective Agents|protective agents|mesh-ancestor
110632777|NCT00805298|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110632778|NCT00805298|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110280117|NCT00211380|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110632779|NCT00805298|Adrenergic Agents|adrenergic agents|mesh-ancestor
110632780|NCT00805298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110115294|NCT01872494|Pentazocine|pentazocine|mesh-list
110632781|NCT00805298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110632782|NCT00805298|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110632783|NCT00805298|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110632784|NCT00805298|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110632785|NCT00805298|Respiratory System Agents|respiratory system agents|mesh-ancestor
110632786|NCT00805298|Mydriatics|mydriatics|mesh-ancestor
110632787|NCT00805298|Sympathomimetics|sympathomimetics|mesh-ancestor
110632788|NCT00805298|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110632789|NCT00881400|Cefprozil|cefprozil|mesh-list
110632790|NCT00881400|Cephalosporins|cephalosporins|mesh-list
110632791|NCT00881400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110632792|NCT00881400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110632793|NCT00246571|Sunitinib|sunitinib|mesh-list
110632794|NCT00246571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110632795|NCT00246571|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110632796|NCT00246571|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110632797|NCT00246571|Growth Substances|growth substances|mesh-ancestor
110632798|NCT00246571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110632799|NCT00246571|Growth Inhibitors|growth inhibitors|mesh-ancestor
110632800|NCT00246571|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110632801|NCT00246571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110632802|NCT00246571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110632803|NCT02553044|Vitamin D|vitamin d|mesh-list
110632804|NCT02553044|Cholecalciferol|cholecalciferol|mesh-list
110632805|NCT02553044|Vitamins|vitamins|mesh-ancestor
110632806|NCT02553044|Micronutrients|micronutrients|mesh-ancestor
110632807|NCT02553044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110632808|NCT02553044|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110632809|NCT02553044|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110632810|NCT00545103|Mesalamine|mesalamine|mesh-list
110632811|NCT00545103|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110632812|NCT00545103|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110632813|NCT00545103|Analgesics|analgesics|mesh-ancestor
110632814|NCT00545103|Sensory System Agents|sensory system agents|mesh-ancestor
110632815|NCT00545103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110632816|NCT00545103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110632817|NCT00545103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110632818|NCT00545103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110632819|NCT00586157|Methylphenidate|methylphenidate|mesh-list
110632820|NCT00586157|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110632821|NCT00586157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110632822|NCT00586157|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110632823|NCT00586157|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110632824|NCT00586157|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110632825|NCT00586157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110632827|NCT00586157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110632828|NCT02552654|Hydrocortisone|hydrocortisone|mesh-list
110632829|NCT02552654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110632830|NCT00809744|Cholecalciferol|cholecalciferol|mesh-list
110632831|NCT00809744|Vitamin D|vitamin d|mesh-list
110632832|NCT00809744|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110632833|NCT00809744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110632834|NCT00809744|Vitamins|vitamins|mesh-ancestor
110632835|NCT00809744|Micronutrients|micronutrients|mesh-ancestor
110632836|NCT00809744|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110632837|NCT00246337|Rizatriptan|rizatriptan|mesh-list
110632838|NCT00246337|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110632839|NCT00246337|Serotonin Agents|serotonin agents|mesh-ancestor
110632840|NCT00246337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110632841|NCT00246337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110632842|NCT00246337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110632843|NCT05012943|Vaccines|vaccines|mesh-list
110632844|NCT05012943|Immunologic Factors|immunologic factors|mesh-ancestor
110632845|NCT05012943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110632846|NCT01581853|Ritonavir|ritonavir|mesh-list
110632847|NCT01581853|Lopinavir|lopinavir|mesh-list
110632848|NCT01581853|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110632849|NCT01581853|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110632850|NCT01581853|Protease Inhibitors|protease inhibitors|mesh-ancestor
110632851|NCT01581853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110632852|NCT01581853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110632853|NCT01581853|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110632854|NCT01581853|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110632855|NCT01581853|Antiviral Agents|antiviral agents|mesh-ancestor
110115365|NCT01872858|Cilostazol|cilostazol|mesh-list
110632856|NCT01581853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110632857|NCT01581853|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110632858|NCT01581853|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110632859|NCT01070641|Carvedilol|carvedilol|mesh-list
110632860|NCT01070641|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110632861|NCT01070641|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110632862|NCT01070641|Adrenergic Agents|adrenergic agents|mesh-ancestor
110632863|NCT01070641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110632864|NCT01070641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110632865|NCT01070641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110632866|NCT01070641|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110632867|NCT01070641|Antioxidants|antioxidants|mesh-ancestor
110632868|NCT01070641|Protective Agents|protective agents|mesh-ancestor
110632869|NCT01070641|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110632870|NCT01070641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110632871|NCT01070641|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110632872|NCT01070641|Vasodilator Agents|vasodilator agents|mesh-ancestor
110632873|NCT01070641|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110632874|NCT01070641|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110632875|NCT00982449|Fialuridine|fialuridine|mesh-list
110632876|NCT00982449|Antiviral Agents|antiviral agents|mesh-ancestor
110632877|NCT00982449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110632878|NCT00982449|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110632879|NCT00982449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110632880|NCT00982449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110632881|NCT02593721|Ibuprofen|ibuprofen|mesh-list
110632882|NCT02593721|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110632883|NCT02593721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110632884|NCT02593721|Analgesics|analgesics|mesh-ancestor
110632885|NCT02593721|Sensory System Agents|sensory system agents|mesh-ancestor
110632886|NCT02593721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110632887|NCT02593721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110632888|NCT02593721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110632889|NCT02593721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110632890|NCT02593721|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110632891|NCT02593721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110632892|NCT02593721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110632893|NCT00985647|Lamivudine|lamivudine|mesh-list
110155059|NCT00005996|Gemcitabine|gemcitabine|mesh-list
110632894|NCT00985647|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110632895|NCT00985647|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110632896|NCT00985647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110632897|NCT00985647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110632898|NCT00985647|Antiviral Agents|antiviral agents|mesh-ancestor
110115390|NCT01872871|Acetaminophen|acetaminophen|mesh-list
110254116|NCT00144287|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110632899|NCT00985647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110632900|NCT00985647|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110632901|NCT00985647|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110632902|NCT00806468|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
110632903|NCT00806468|Hemostatics|hemostatics|mesh-ancestor
110632904|NCT00806468|Coagulants|coagulants|mesh-ancestor
110632905|NCT00806468|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
110632906|NCT00806468|Natriuretic Agents|natriuretic agents|mesh-ancestor
110632907|NCT00806468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110632908|NCT00982527|Fenoldopam|fenoldopam|mesh-list
110632909|NCT00982527|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110632910|NCT00982527|Vasodilator Agents|vasodilator agents|mesh-ancestor
110632911|NCT00982527|Dopamine Agonists|dopamine agonists|mesh-ancestor
110632912|NCT00982527|Dopamine Agents|dopamine agents|mesh-ancestor
110632913|NCT00982527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110632914|NCT00982527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110632915|NCT00982527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110632916|NCT00798980|Levonorgestrel|levonorgestrel|mesh-list
110632917|NCT00798980|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110632918|NCT00798980|Contraceptive Agents|contraceptive agents|mesh-ancestor
110115412|NCT01872884|Anesthetics|anesthetics|mesh-ancestor
110632919|NCT00798980|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110632920|NCT00798980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110632921|NCT00798980|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110632922|NCT00798980|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110632923|NCT00798980|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110632925|NCT00725621|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110632926|NCT00725621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110632927|NCT00725621|Dermatologic Agents|dermatologic agents|mesh-ancestor
110632928|NCT00725621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110632929|NCT00725621|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110632930|NCT00613626|Etoposide|etoposide|mesh-list
110632931|NCT00613626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110632932|NCT00613626|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110632933|NCT00613626|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110632934|NCT00613626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110632935|NCT00613626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110632936|NCT00613626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110632937|NCT00725543|Infliximab|infliximab|mesh-list
110632938|NCT00725543|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110632939|NCT00725543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110632940|NCT00725543|Dermatologic Agents|dermatologic agents|mesh-ancestor
110632941|NCT00725543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110632942|NCT00725543|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110632943|NCT00239005|Mycophenolic Acid|mycophenolic acid|mesh-list
110632944|NCT00239005|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110632945|NCT00239005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110632946|NCT00239005|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110632947|NCT00239005|Antitubercular Agents|antitubercular agents|mesh-ancestor
110632948|NCT00239005|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110632949|NCT00239005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110632950|NCT00239005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110632951|NCT00239005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110632952|NCT00616434|Interferons|interferons|mesh-list
110632953|NCT00616434|Interferon-beta|interferon-beta|mesh-list
110632954|NCT00616434|Interferon beta-1a|interferon beta-1a|mesh-list
110632955|NCT00616434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110632956|NCT00616434|Antiviral Agents|antiviral agents|mesh-ancestor
110632957|NCT00616434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110632958|NCT00616434|Immunologic Factors|immunologic factors|mesh-ancestor
110632959|NCT00616434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110632960|NCT00616434|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110632961|NCT00652340|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110632962|NCT00652340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110115451|NCT01873027|Sirolimus|sirolimus|mesh-list
110632963|NCT00652340|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110632965|NCT00652340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110632966|NCT00257725|Methylphenidate|methylphenidate|mesh-list
110632967|NCT00257725|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110632968|NCT00257725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110632969|NCT00257725|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110254138|NCT02954692|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
110632970|NCT00257725|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110632971|NCT00257725|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110632972|NCT00257725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110632973|NCT00257725|Dopamine Agents|dopamine agents|mesh-ancestor
110632974|NCT00257725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110632975|NCT00544869|Tolvaptan|tolvaptan|mesh-list
110632976|NCT00544869|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
110632977|NCT00544869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110632978|NCT00544869|Natriuretic Agents|natriuretic agents|mesh-ancestor
110632979|NCT00544869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110632981|NCT02593643|Ketamine|ketamine|mesh-list
110632982|NCT02593643|Analgesics|analgesics|mesh-ancestor
110632983|NCT02593643|Sensory System Agents|sensory system agents|mesh-ancestor
110632984|NCT02593643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110632985|NCT02593643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110632986|NCT02593643|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110632987|NCT02593643|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110632988|NCT02593643|Anesthetics, General|anesthetics, general|mesh-ancestor
110632989|NCT02593643|Anesthetics|anesthetics|mesh-ancestor
110632990|NCT02593643|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110632991|NCT02593643|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110632992|NCT02593643|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110632993|NCT02593643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110632994|NCT02593643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110632995|NCT02593643|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110632996|NCT02593643|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110632997|NCT02593643|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110632998|NCT02593643|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110632999|NCT02593643|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110633000|NCT02593643|GABA Modulators|gaba modulators|mesh-ancestor
110633001|NCT02593643|GABA Agents|gaba agents|mesh-ancestor
110633002|NCT00881556|Fludarabine|fludarabine|mesh-list
110633003|NCT00881556|Busulfan|busulfan|mesh-list
110633004|NCT00881556|Alemtuzumab|alemtuzumab|mesh-list
110633005|NCT00881556|Lorazepam|lorazepam|mesh-list
110633006|NCT00881556|Tacrolimus|tacrolimus|mesh-list
110633007|NCT00881556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110633008|NCT00881556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110633009|NCT00881556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110633010|NCT00881556|Immunologic Factors|immunologic factors|mesh-ancestor
110633011|NCT00881556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110633012|NCT00881556|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110633013|NCT00881556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110633014|NCT00881556|Alkylating Agents|alkylating agents|mesh-ancestor
110633015|NCT00881556|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110633016|NCT00881556|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110633017|NCT00881556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110633018|NCT00881556|Anticonvulsants|anticonvulsants|mesh-ancestor
110633019|NCT00881556|Antiemetics|antiemetics|mesh-ancestor
110633020|NCT00881556|Autonomic Agents|autonomic agents|mesh-ancestor
110633021|NCT00881556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110633022|NCT00881556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110633023|NCT00881556|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110633024|NCT00881556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110633025|NCT00881556|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110633026|NCT00881556|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110633027|NCT00881556|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110633028|NCT00881556|GABA Modulators|gaba modulators|mesh-ancestor
110633029|NCT00881556|GABA Agents|gaba agents|mesh-ancestor
110633030|NCT00881556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110633031|NCT00881634|Cetirizine|cetirizine|mesh-list
110633032|NCT00881634|Pseudoephedrine|pseudoephedrine|mesh-list
110633033|NCT00881634|Ephedrine|ephedrine|mesh-list
110633034|NCT00881634|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110633035|NCT00881634|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110633036|NCT00881634|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110115515|NCT05855070|Viscosupplements|viscosupplements|mesh-ancestor
110115516|NCT05855070|Protective Agents|protective agents|mesh-ancestor
110115517|NCT05855070|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110115518|NCT05855070|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110115519|NCT05855070|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110115520|NCT05855070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110115523|NCT05855018|Atropine|atropine|mesh-list
110633037|NCT00881634|Histamine Antagonists|histamine antagonists|mesh-ancestor
110633038|NCT00881634|Histamine Agents|histamine agents|mesh-ancestor
110633039|NCT00881634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110633040|NCT00881634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110633041|NCT00881634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110633042|NCT00881634|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110633044|NCT00881634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110633045|NCT00881634|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110633046|NCT00881634|Respiratory System Agents|respiratory system agents|mesh-ancestor
110633047|NCT00881634|Nasal Decongestants|nasal decongestants|mesh-ancestor
110633048|NCT00881634|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110633049|NCT00881634|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110633050|NCT00881634|Sympathomimetics|sympathomimetics|mesh-ancestor
110633051|NCT00881634|Adrenergic Agents|adrenergic agents|mesh-ancestor
110633052|NCT00878670|Evening primrose oil|evening primrose oil|mesh-list
110633053|NCT00878670|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110633054|NCT00878670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110633055|NCT00878670|Analgesics|analgesics|mesh-ancestor
110633056|NCT00878670|Sensory System Agents|sensory system agents|mesh-ancestor
110633057|NCT00878670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110633058|NCT00878670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110633059|NCT00878670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110633060|NCT00878670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110633061|NCT00878670|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110633062|NCT00878670|Antimetabolites|antimetabolites|mesh-ancestor
110633063|NCT00878670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110633064|NCT00878670|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110633065|NCT00878670|Dermatologic Agents|dermatologic agents|mesh-ancestor
110633066|NCT00878748|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
110633067|NCT00878748|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110633068|NCT00878748|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110633069|NCT00878748|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110633070|NCT00878748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110633071|NCT00878748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110633072|NCT00878748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110633073|NCT00878748|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110633074|NCT00878748|Antidepressive Agents|antidepressive agents|mesh-ancestor
110633075|NCT00878748|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110633076|NCT00652028|Fentanyl|fentanyl|mesh-list
110633077|NCT00652028|Midazolam|midazolam|mesh-list
110633078|NCT00652028|Dexmedetomidine|dexmedetomidine|mesh-list
110280417|NCT00212472|Factor VIII|factor viii|mesh-list
110633079|NCT00652028|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110633080|NCT00652028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110633081|NCT00652028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110633082|NCT00652028|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110633083|NCT00652028|Analgesics|analgesics|mesh-ancestor
110633084|NCT00652028|Sensory System Agents|sensory system agents|mesh-ancestor
110633085|NCT00652028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110633086|NCT00652028|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110633087|NCT00652028|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110633088|NCT00652028|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110633089|NCT00652028|Adrenergic Agents|adrenergic agents|mesh-ancestor
110633090|NCT00652028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110633091|NCT00652028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110633092|NCT00652028|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110633093|NCT00652028|Narcotics|narcotics|mesh-ancestor
110633094|NCT00652028|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110633095|NCT00652028|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110633096|NCT00652028|Anesthetics, General|anesthetics, general|mesh-ancestor
110633097|NCT00652028|Anesthetics|anesthetics|mesh-ancestor
110633098|NCT00652028|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110633099|NCT00652028|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110633100|NCT00652028|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110394394|NCT01607762|Olanzapine|olanzapine|mesh-list
110633101|NCT00652028|GABA Modulators|gaba modulators|mesh-ancestor
110633102|NCT00652028|GABA Agents|gaba agents|mesh-ancestor
110633103|NCT00799136|Prednisone|prednisone|mesh-list
110633104|NCT00799136|Vincristine|vincristine|mesh-list
110633105|NCT00799136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110633106|NCT00799136|Glucocorticoids|glucocorticoids|mesh-ancestor
110633107|NCT00799136|Hormones|hormones|mesh-ancestor
110633108|NCT00799136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110633109|NCT00799136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110633110|NCT00799136|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110633111|NCT00799136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110633112|NCT00799136|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110633113|NCT00799136|Tubulin Modulators|tubulin modulators|mesh-ancestor
110633114|NCT00799136|Antimitotic Agents|antimitotic agents|mesh-ancestor
110633115|NCT00799136|Mitosis Modulators|mitosis modulators|mesh-ancestor
110633116|NCT00799136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110633117|NCT02592395|Folfirinox|folfirinox|mesh-list
110633118|NCT02592395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110633119|NCT00799214|Metronidazole|metronidazole|mesh-list
110633120|NCT00799214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110633121|NCT00799214|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110633122|NCT00799214|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110633123|NCT00799214|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110633124|NCT00733421|Etoricoxib|etoricoxib|mesh-list
110633125|NCT00733421|Tramadol|tramadol|mesh-list
110633126|NCT00733421|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110633127|NCT00733421|Narcotics|narcotics|mesh-ancestor
110633128|NCT00733421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110633129|NCT00733421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110633130|NCT00733421|Analgesics|analgesics|mesh-ancestor
110633131|NCT00733421|Sensory System Agents|sensory system agents|mesh-ancestor
110633132|NCT00733421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110633133|NCT00733421|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110633134|NCT00733421|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110633135|NCT00733421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110633136|NCT00733421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110633137|NCT00733421|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110633138|NCT00733421|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110633139|NCT00733421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110633140|NCT00733421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110633141|NCT00613080|Leucovorin|leucovorin|mesh-list
110633142|NCT00613080|Fluorouracil|fluorouracil|mesh-list
110633143|NCT00613080|Capecitabine|capecitabine|mesh-list
110633144|NCT00613080|Oxaliplatin|oxaliplatin|mesh-list
110633145|NCT00613080|Antimetabolites|antimetabolites|mesh-ancestor
110633146|NCT00613080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110633147|NCT00613080|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110633148|NCT00613080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110633149|NCT00613080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110633150|NCT00613080|Immunologic Factors|immunologic factors|mesh-ancestor
110633151|NCT00613080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110633152|NCT00613080|Antidotes|antidotes|mesh-ancestor
110633153|NCT00613080|Protective Agents|protective agents|mesh-ancestor
110633154|NCT00613080|Vitamin B Complex|vitamin b complex|mesh-ancestor
110633155|NCT00613080|Vitamins|vitamins|mesh-ancestor
110633156|NCT00613080|Micronutrients|micronutrients|mesh-ancestor
110633157|NCT00917891|Dapivirine|dapivirine|mesh-list
110633158|NCT00917891|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110633159|NCT00917891|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110633160|NCT00917891|Antiviral Agents|antiviral agents|mesh-ancestor
110633161|NCT00917891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110633162|NCT00732875|Infliximab|infliximab|mesh-list
110633163|NCT00732875|Methotrexate|methotrexate|mesh-list
110633164|NCT00732875|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110633165|NCT00732875|Abortifacient Agents|abortifacient agents|mesh-ancestor
110633166|NCT00732875|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110633167|NCT00732875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110633168|NCT00732875|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110633169|NCT00732875|Antimetabolites|antimetabolites|mesh-ancestor
110115656|NCT05852730|Antipruritics|antipruritics|mesh-ancestor
110633170|NCT00732875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110633171|NCT00732875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110633172|NCT00732875|Dermatologic Agents|dermatologic agents|mesh-ancestor
110633173|NCT00732875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110633174|NCT00732875|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110633175|NCT00732875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110633176|NCT00732875|Immunologic Factors|immunologic factors|mesh-ancestor
110633177|NCT00732875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110633178|NCT00732875|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110633179|NCT00732875|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110633180|NCT00732875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110633181|NCT00732875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110633182|NCT00881790|Fluorides|fluorides|mesh-list
110633183|NCT00881790|Fluorides, Topical|fluorides, topical|mesh-list
110633184|NCT00881790|Cariostatic Agents|cariostatic agents|mesh-ancestor
110633185|NCT00881790|Protective Agents|protective agents|mesh-ancestor
110633186|NCT00881790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110633187|NCT00810446|Rifabutin|rifabutin|mesh-list
110633188|NCT00810446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110633189|NCT00810446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110633190|NCT00810446|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110633191|NCT00810446|Antitubercular Agents|antitubercular agents|mesh-ancestor
110633192|NCT00810524|Lamivudine|lamivudine|mesh-list
110633193|NCT00810524|Adefovir|adefovir|mesh-list
110633194|NCT00810524|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
110633195|NCT00810524|Telbivudine|telbivudine|mesh-list
110633196|NCT00810524|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110633197|NCT00810524|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110633198|NCT00810524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110633199|NCT00810524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110633200|NCT00810524|Antiviral Agents|antiviral agents|mesh-ancestor
110633201|NCT00810524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110633202|NCT00810524|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110633203|NCT00810524|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110633205|NCT00810680|Anticonvulsants|anticonvulsants|mesh-ancestor
110633206|NCT00810680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110633207|NCT00810680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110633208|NCT00810680|GABA Agents|gaba agents|mesh-ancestor
110633209|NCT00810680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110633210|NCT00810680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110633211|NCT00810680|Antimanic Agents|antimanic agents|mesh-ancestor
110633212|NCT00810680|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110633213|NCT00810680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110633214|NCT00810680|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110633215|NCT00799448|Insulin|insulin|mesh-list
110633216|NCT00799448|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110633217|NCT00799448|Repaglinide|repaglinide|mesh-list
110633218|NCT00799448|Isophane Insulin, Human|isophane insulin, human|mesh-list
110633219|NCT00799448|Insulin, Isophane|insulin, isophane|mesh-list
110633220|NCT00799448|Isophane insulin, beef|isophane insulin, beef|mesh-list
110633221|NCT00799448|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110254184|NCT00507091|Immunologic Factors|immunologic factors|mesh-ancestor
110633222|NCT00799448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110633223|NCT00806936|Insulin|insulin|mesh-list
110633224|NCT00806936|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110633225|NCT00806936|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110633226|NCT00806936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110633227|NCT00799682|Travoprost|travoprost|mesh-list
110280574|NCT00188942|Serotonin Agents|serotonin agents|mesh-ancestor
110633228|NCT00799682|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110633229|NCT00799682|Latanoprost|latanoprost|mesh-list
110633230|NCT00799682|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110633231|NCT00799682|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110633232|NCT03829020|Metformin|metformin|mesh-list
110633233|NCT03829020|Nelfinavir|nelfinavir|mesh-list
110633234|NCT03829020|Bortezomib|bortezomib|mesh-list
110633235|NCT03829020|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110633236|NCT03829020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110633238|NCT03829020|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110633239|NCT03829020|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110633240|NCT03829020|Protease Inhibitors|protease inhibitors|mesh-ancestor
110633241|NCT03829020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110633242|NCT03829020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110633243|NCT03829020|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110633244|NCT03829020|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110633245|NCT03829020|Antiviral Agents|antiviral agents|mesh-ancestor
110633246|NCT03829020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110633247|NCT00810836|Dimethyl Fumarate|dimethyl fumarate|mesh-list
110633248|NCT00810836|Dermatologic Agents|dermatologic agents|mesh-ancestor
110633249|NCT00810836|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110633250|NCT00810836|Immunologic Factors|immunologic factors|mesh-ancestor
110633251|NCT00810836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110633252|NCT00874926|Factor VIII|factor viii|mesh-list
110633253|NCT00874926|Coagulants|coagulants|mesh-ancestor
110633254|NCT00810914|Bupivacaine|bupivacaine|mesh-list
110633255|NCT00810914|Anesthetics, Local|anesthetics, local|mesh-ancestor
110633256|NCT00810914|Anesthetics|anesthetics|mesh-ancestor
110633257|NCT00810914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110633258|NCT00810914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110633259|NCT00810914|Sensory System Agents|sensory system agents|mesh-ancestor
110633260|NCT00810914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110633261|NCT00878904|Epirubicin|epirubicin|mesh-list
110633262|NCT00878904|Panobinostat|panobinostat|mesh-list
110633263|NCT00878904|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110633264|NCT00878904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110633265|NCT00878904|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110633266|NCT00878904|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110633267|NCT00878904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110633268|NCT00878904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110633269|NCT00878904|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110633270|NCT00737711|Epoetin Alfa|epoetin alfa|mesh-list
110633271|NCT00737711|Hematinics|hematinics|mesh-ancestor
110633272|NCT00807326|Simethicone|simethicone|mesh-list
110633273|NCT00807326|Loperamide|loperamide|mesh-list
110633275|NCT00807326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110633276|NCT00807326|Antifoaming Agents|antifoaming agents|mesh-ancestor
110633277|NCT00807326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110633278|NCT00807326|Emollients|emollients|mesh-ancestor
110633279|NCT00807326|Dermatologic Agents|dermatologic agents|mesh-ancestor
110633280|NCT00875082|Montelukast|montelukast|mesh-list
110633281|NCT00875082|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110633282|NCT00875082|Respiratory System Agents|respiratory system agents|mesh-ancestor
110633283|NCT00875082|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110633284|NCT00875082|Hormone Antagonists|hormone antagonists|mesh-ancestor
110633285|NCT00875082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110633286|NCT00875082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110633287|NCT00875082|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110633288|NCT00875082|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110633289|NCT00875082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110633290|NCT02552342|Methylprednisolone|methylprednisolone|mesh-list
110633291|NCT02552342|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110633292|NCT02552342|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110633293|NCT02552342|Prednisolone|prednisolone|mesh-list
110633294|NCT02552342|Prednisolone acetate|prednisolone acetate|mesh-list
110633295|NCT02552342|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110633296|NCT02552342|Prednisolone phosphate|prednisolone phosphate|mesh-list
110633297|NCT02552342|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110633298|NCT02552342|Antiemetics|antiemetics|mesh-ancestor
110633299|NCT02552342|Autonomic Agents|autonomic agents|mesh-ancestor
110633300|NCT02552342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110633301|NCT02552342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110633302|NCT02552342|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110633303|NCT02552342|Glucocorticoids|glucocorticoids|mesh-ancestor
110633304|NCT02552342|Hormones|hormones|mesh-ancestor
110633305|NCT02552342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110633306|NCT02552342|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110633307|NCT02552342|Protective Agents|protective agents|mesh-ancestor
110115873|NCT05514899|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110633308|NCT02552342|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110633310|NCT00811226|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110633311|NCT00811226|Olmesartan|olmesartan|mesh-list
110633312|NCT00811226|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
110633313|NCT00811226|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110633314|NCT00811226|Diuretics|diuretics|mesh-ancestor
110633315|NCT00811226|Natriuretic Agents|natriuretic agents|mesh-ancestor
110633316|NCT00811226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110633317|NCT00811226|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110633318|NCT00811226|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110633319|NCT00811226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110633320|NCT00811226|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110633321|NCT00811226|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110633322|NCT00238303|Vorinostat|vorinostat|mesh-list
110633323|NCT00238303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110633324|NCT00238303|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110633325|NCT00238303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110633326|NCT00238303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110633327|NCT00811460|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
110633328|NCT00811460|Incretins|incretins|mesh-ancestor
110633329|NCT00811460|Hormones|hormones|mesh-ancestor
110633330|NCT00811460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110633331|NCT00811460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110633333|NCT00875238|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110633334|NCT00875238|Trastuzumab|trastuzumab|mesh-list
110633335|NCT00875238|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110633336|NCT00875238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110633337|NCT00875238|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110633338|NCT00875238|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110633339|NCT00875238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110633340|NCT00875238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110633341|NCT00875238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110633342|NCT00732251|Allopurinol|allopurinol|mesh-list
110633343|NCT00732251|Antimetabolites|antimetabolites|mesh-ancestor
110633344|NCT00732251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110633345|NCT00732251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110633346|NCT00732251|Gout Suppressants|gout suppressants|mesh-ancestor
110633347|NCT00732251|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110633348|NCT00732251|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110633349|NCT00732251|Antioxidants|antioxidants|mesh-ancestor
110633350|NCT00732251|Protective Agents|protective agents|mesh-ancestor
110633351|NCT00732251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110633352|NCT00882024|Tranilast|tranilast|mesh-list
110633353|NCT00882024|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110633354|NCT00882024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110633355|NCT00882024|Analgesics|analgesics|mesh-ancestor
110633356|NCT00882024|Sensory System Agents|sensory system agents|mesh-ancestor
110633357|NCT00882024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110633358|NCT00882024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110633359|NCT00882024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110633360|NCT00882024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110633361|NCT00882024|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110633362|NCT00882024|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110633363|NCT00882024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110633364|NCT00882024|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110633365|NCT00882024|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110633366|NCT00882024|Histamine Antagonists|histamine antagonists|mesh-ancestor
110633367|NCT00882024|Histamine Agents|histamine agents|mesh-ancestor
110633368|NCT00882024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110633369|NCT00882024|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110633370|NCT00882024|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110633371|NCT00799760|Oseltamivir|oseltamivir|mesh-list
110633372|NCT00799760|Zanamivir|zanamivir|mesh-list
110633373|NCT00799760|Antiviral Agents|antiviral agents|mesh-ancestor
110633374|NCT00799760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110633375|NCT00799760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110633376|NCT00799760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110633378|NCT00799838|Ketoprofen|ketoprofen|mesh-list
110633379|NCT00799838|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110633380|NCT00799838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110633381|NCT00799838|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110633382|NCT00799838|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110633383|NCT00799838|Analgesics|analgesics|mesh-ancestor
110633384|NCT00799838|Sensory System Agents|sensory system agents|mesh-ancestor
110633385|NCT00799838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110155087|NCT00015340|Naloxone|naloxone|mesh-list
110633386|NCT00799838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110633387|NCT00799838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110633388|NCT00799838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110633389|NCT00799838|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110633390|NCT00799838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110633391|NCT00799838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110633393|NCT00737477|Hematinics|hematinics|mesh-ancestor
110633394|NCT00800150|Fludarabine|fludarabine|mesh-list
110633395|NCT00800150|Fludarabine phosphate|fludarabine phosphate|mesh-list
110633396|NCT00800150|Melphalan|melphalan|mesh-list
110633397|NCT00800150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110633398|NCT00800150|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110633399|NCT00800150|Antimetabolites|antimetabolites|mesh-ancestor
110633400|NCT00800150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110633401|NCT00800150|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110633402|NCT00800150|Immunologic Factors|immunologic factors|mesh-ancestor
110633403|NCT00800150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110116038|NCT05221229|Hormones|hormones|mesh-ancestor
110633404|NCT00800150|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110633405|NCT00800150|Alkylating Agents|alkylating agents|mesh-ancestor
110633406|NCT00800150|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110633407|NCT00800306|Simendan|simendan|mesh-list
110633408|NCT00800306|Dobutamine|dobutamine|mesh-list
110633409|NCT00800306|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110633410|NCT00800306|Vasodilator Agents|vasodilator agents|mesh-ancestor
110633411|NCT00800306|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110394463|NCT01601912|Escitalopram|escitalopram|mesh-list
110633412|NCT00800306|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110633413|NCT00800306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110633414|NCT00800306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110633415|NCT00800306|Protective Agents|protective agents|mesh-ancestor
110633416|NCT00800306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110633417|NCT00800306|Sympathomimetics|sympathomimetics|mesh-ancestor
110633418|NCT00800306|Autonomic Agents|autonomic agents|mesh-ancestor
110633419|NCT00800306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110633420|NCT00800306|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
110633421|NCT00800306|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110633422|NCT00800306|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110633423|NCT00800306|Adrenergic Agents|adrenergic agents|mesh-ancestor
110633424|NCT00800306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110633425|NCT01581775|Valproic Acid|valproic acid|mesh-list
110633426|NCT01581775|Anticonvulsants|anticonvulsants|mesh-ancestor
110633427|NCT01581775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110633428|NCT01581775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110633429|NCT01581775|GABA Agents|gaba agents|mesh-ancestor
110633430|NCT01581775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110633431|NCT01581775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110633432|NCT01581775|Antimanic Agents|antimanic agents|mesh-ancestor
110633433|NCT01581775|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110633434|NCT01581775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110633435|NCT01581775|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110633436|NCT04039152|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110633437|NCT04039152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110633438|NCT01072747|Heparin|heparin|mesh-list
110633439|NCT01072747|Calcium heparin|calcium heparin|mesh-list
110633440|NCT01072747|Anticoagulants|anticoagulants|mesh-ancestor
110633441|NCT01072747|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110633442|NCT01072747|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110633443|NCT01072747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110633444|NCT00879372|Tianeptine|tianeptine|mesh-list
110633445|NCT00879372|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110633446|NCT00879372|Antidepressive Agents|antidepressive agents|mesh-ancestor
110633447|NCT00879372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110633448|NCT00731783|Chlorhexidine|chlorhexidine|mesh-list
110633449|NCT00731783|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110633450|NCT00731783|Mupirocin|mupirocin|mesh-list
110633451|NCT00731783|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110633452|NCT00731783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110633453|NCT00731783|Disinfectants|disinfectants|mesh-ancestor
110633454|NCT00731783|Dermatologic Agents|dermatologic agents|mesh-ancestor
110633455|NCT00731783|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110633456|NCT00731783|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110633457|NCT00731783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110633458|NCT00731783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110633459|NCT03691350|Nicotine|nicotine|mesh-list
110633460|NCT03691350|Dimercaprol|dimercaprol|mesh-list
110633461|NCT03691350|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110633462|NCT03691350|Autonomic Agents|autonomic agents|mesh-ancestor
110633463|NCT03691350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110633464|NCT03691350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110633465|NCT03691350|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110633466|NCT03691350|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110633467|NCT03691350|Cholinergic Agents|cholinergic agents|mesh-ancestor
110633468|NCT03691350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110633469|NCT03691350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110633470|NCT03691350|Chelating Agents|chelating agents|mesh-ancestor
110394478|NCT01601912|Autonomic Agents|autonomic agents|mesh-ancestor
110633471|NCT03691350|Sequestering Agents|sequestering agents|mesh-ancestor
110633472|NCT02592083|Tamoxifen|tamoxifen|mesh-list
110633473|NCT02592083|Goserelin|goserelin|mesh-list
110633474|NCT02592083|Palbociclib|palbociclib|mesh-list
110633475|NCT02592083|Exemestane|exemestane|mesh-list
110633476|NCT02592083|Aromatase Inhibitors|aromatase inhibitors|mesh-list
110633477|NCT02592083|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110633478|NCT02592083|Hormone Antagonists|hormone antagonists|mesh-ancestor
110633479|NCT02592083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110633480|NCT02592083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110633481|NCT02592083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110633482|NCT02592083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110633483|NCT02592083|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110633484|NCT02592083|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110633485|NCT02592083|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110633486|NCT02592083|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110633487|NCT02592083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110633488|NCT02592083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110633489|NCT02592083|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110633490|NCT04589676|Naloxone|naloxone|mesh-list
110633491|NCT04589676|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110633492|NCT04589676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110633493|NCT04589676|Sensory System Agents|sensory system agents|mesh-ancestor
110633494|NCT04589676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110633495|NCT00724451|Ribavirin|ribavirin|mesh-list
110633496|NCT00724451|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110633497|NCT00724451|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110633498|NCT00724451|Antimetabolites|antimetabolites|mesh-ancestor
110633499|NCT00724451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110633500|NCT00724451|Antiviral Agents|antiviral agents|mesh-ancestor
110633501|NCT00724451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110633502|NCT00724373|Ribavirin|ribavirin|mesh-list
110633503|NCT00724373|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110633504|NCT00724373|Antimetabolites|antimetabolites|mesh-ancestor
110633505|NCT00724373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110633506|NCT00724373|Antiviral Agents|antiviral agents|mesh-ancestor
110633507|NCT00724373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110633508|NCT02594579|Vitamin D|vitamin d|mesh-list
110633509|NCT02594579|Cholecalciferol|cholecalciferol|mesh-list
110633510|NCT02594579|Vitamins|vitamins|mesh-ancestor
110633511|NCT02594579|Micronutrients|micronutrients|mesh-ancestor
110633512|NCT02594579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110633513|NCT02594579|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110633514|NCT02594579|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110633515|NCT02593409|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110633516|NCT02593409|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110633517|NCT02593409|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110633518|NCT02593409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110633519|NCT02593409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110633520|NCT02593409|Antiviral Agents|antiviral agents|mesh-ancestor
110633521|NCT02593409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110633522|NCT02593409|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110633523|NCT02593409|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110633524|NCT00724061|Interferons|interferons|mesh-list
110633525|NCT00724061|Interferon-alpha|interferon-alpha|mesh-list
110633526|NCT00724061|Interferon alpha-2|interferon alpha-2|mesh-list
110633527|NCT00724061|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110633528|NCT00724061|Furocoumarins|furocoumarins|mesh-list
110633529|NCT00724061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110633530|NCT00724061|Antiviral Agents|antiviral agents|mesh-ancestor
110633531|NCT00724061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110254258|NCT05148637|Lidocaine|lidocaine|mesh-list
110633532|NCT00724061|Immunologic Factors|immunologic factors|mesh-ancestor
110633533|NCT00724061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110633534|NCT00724061|Dermatologic Agents|dermatologic agents|mesh-ancestor
110633535|NCT00724061|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110394491|NCT01111825|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110633537|NCT02594423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110633538|NCT02594423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110633539|NCT02594423|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110633540|NCT02594423|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110633541|NCT02594423|Growth Substances|growth substances|mesh-ancestor
110633542|NCT02594423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110633543|NCT02594423|Growth Inhibitors|growth inhibitors|mesh-ancestor
110633544|NCT00882414|Ferric Compounds|ferric compounds|mesh-list
110633545|NCT00882414|Hematinics|hematinics|mesh-ancestor
110633546|NCT02593487|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110633547|NCT02593487|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110633548|NCT02593487|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110633549|NCT02593487|Antimetabolites|antimetabolites|mesh-ancestor
110633550|NCT02593487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110633551|NCT02593487|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110633552|NCT02593487|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110633553|NCT02593487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110633554|NCT00875784|Sumatriptan|sumatriptan|mesh-list
110633555|NCT00875784|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110633556|NCT00875784|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110633557|NCT00875784|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110633558|NCT00875784|Serotonin Agents|serotonin agents|mesh-ancestor
110633559|NCT00875784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110633560|NCT00875784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110633561|NCT00875784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110633562|NCT00731549|Aripiprazole|aripiprazole|mesh-list
110633563|NCT00731549|Antidepressive Agents|antidepressive agents|mesh-ancestor
110633564|NCT00731549|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110633565|NCT00731549|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110633566|NCT00731549|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110633567|NCT00731549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110633568|NCT00731549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110633569|NCT00731549|Dopamine Agonists|dopamine agonists|mesh-ancestor
110633570|NCT00731549|Dopamine Agents|dopamine agents|mesh-ancestor
110633571|NCT00731549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110633572|NCT00731549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110116172|NCT04839666|Anesthetics, General|anesthetics, general|mesh-ancestor
110633573|NCT00731549|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110633574|NCT00731549|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110633575|NCT00731549|Serotonin Agents|serotonin agents|mesh-ancestor
110633576|NCT00731549|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110633577|NCT00731549|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110633578|NCT00731549|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110633579|NCT00731549|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110633581|NCT00882570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110633582|NCT00882570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110633583|NCT00882882|Metformin|metformin|mesh-list
110633584|NCT00882882|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110633585|NCT00882882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110633586|NCT00882960|Fentanyl|fentanyl|mesh-list
110633587|NCT00882960|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110633588|NCT00882960|Narcotics|narcotics|mesh-ancestor
110633589|NCT00882960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110633590|NCT00882960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110633591|NCT00882960|Analgesics|analgesics|mesh-ancestor
110633592|NCT00882960|Sensory System Agents|sensory system agents|mesh-ancestor
110633593|NCT00882960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110633594|NCT00882960|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110633595|NCT00882960|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110633596|NCT00882960|Anesthetics, General|anesthetics, general|mesh-ancestor
110633597|NCT00882960|Anesthetics|anesthetics|mesh-ancestor
110633598|NCT00883194|Ropivacaine|ropivacaine|mesh-list
110633599|NCT00883194|Anesthetics, Local|anesthetics, local|mesh-ancestor
110633600|NCT00883194|Anesthetics|anesthetics|mesh-ancestor
110633601|NCT00883194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110633602|NCT00883194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110633603|NCT00883194|Sensory System Agents|sensory system agents|mesh-ancestor
110633604|NCT00883194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110633606|NCT00888732|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110633607|NCT00888732|Insulin Aspart|insulin aspart|mesh-list
110633608|NCT00888732|Insulin, Long-Acting|insulin, long-acting|mesh-list
110633609|NCT00888732|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
110633610|NCT00888732|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110633611|NCT00888732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110633613|NCT00730925|Afatinib|afatinib|mesh-list
110633614|NCT00730925|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110633615|NCT00730925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110633616|NCT00730925|Tubulin Modulators|tubulin modulators|mesh-ancestor
110633617|NCT00730925|Antimitotic Agents|antimitotic agents|mesh-ancestor
110633618|NCT00730925|Mitosis Modulators|mitosis modulators|mesh-ancestor
110633619|NCT00730925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110633620|NCT00730925|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110633621|NCT00730925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110633622|NCT00236899|Paclitaxel|paclitaxel|mesh-list
110633623|NCT00236899|Docetaxel|docetaxel|mesh-list
110633624|NCT00236899|Gemcitabine|gemcitabine|mesh-list
110633625|NCT00236899|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110633626|NCT00236899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110633627|NCT00236899|Tubulin Modulators|tubulin modulators|mesh-ancestor
110633628|NCT00236899|Antimitotic Agents|antimitotic agents|mesh-ancestor
110633629|NCT00236899|Mitosis Modulators|mitosis modulators|mesh-ancestor
110116200|NCT04782180|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110633630|NCT00236899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110633631|NCT00236899|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110633633|NCT00611130|Vigabatrin|vigabatrin|mesh-list
110633634|NCT00611130|Anticonvulsants|anticonvulsants|mesh-ancestor
110633635|NCT00611130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110633636|NCT00611130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110633637|NCT00611130|GABA Agents|gaba agents|mesh-ancestor
110633638|NCT00611130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110633639|NCT00611130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110633640|NCT00885690|Olanzapine|olanzapine|mesh-list
110633641|NCT00885690|Sertindole|sertindole|mesh-list
110633642|NCT00885690|Antiemetics|antiemetics|mesh-ancestor
110633643|NCT00885690|Autonomic Agents|autonomic agents|mesh-ancestor
110633644|NCT00885690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110633645|NCT00885690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110633646|NCT00885690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110633647|NCT00885690|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110633648|NCT00885690|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110633649|NCT00885690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110633650|NCT00885690|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110633651|NCT00885690|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110633652|NCT00885690|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110633653|NCT00885690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110633654|NCT00885690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110633655|NCT00885690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110633656|NCT00885690|Serotonin Agents|serotonin agents|mesh-ancestor
110633657|NCT00888810|Topotecan|topotecan|mesh-list
110633659|NCT00888810|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110633660|NCT00888810|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110633661|NCT00888810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110633662|NCT00888810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110633663|NCT00888810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110633664|NCT00888810|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110633665|NCT00256243|Paclitaxel|paclitaxel|mesh-list
110633666|NCT00256243|Cyclophosphamide|cyclophosphamide|mesh-list
110633667|NCT00256243|Carboplatin|carboplatin|mesh-list
110633668|NCT00256243|Doxorubicin|doxorubicin|mesh-list
110633669|NCT00256243|Trastuzumab|trastuzumab|mesh-list
110633670|NCT00256243|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110633671|NCT00256243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110633672|NCT00256243|Tubulin Modulators|tubulin modulators|mesh-ancestor
110633673|NCT00256243|Antimitotic Agents|antimitotic agents|mesh-ancestor
110633674|NCT00256243|Mitosis Modulators|mitosis modulators|mesh-ancestor
110633675|NCT00256243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110633676|NCT00256243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110633677|NCT00256243|Immunologic Factors|immunologic factors|mesh-ancestor
110633678|NCT00256243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110633679|NCT00256243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110116224|NCT04757584|Sympatholytics|sympatholytics|mesh-ancestor
110116225|NCT04757584|Autonomic Agents|autonomic agents|mesh-ancestor
110633680|NCT00256243|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110633681|NCT00256243|Alkylating Agents|alkylating agents|mesh-ancestor
110633682|NCT00256243|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110633683|NCT00256243|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110633684|NCT00256243|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110633685|NCT00256243|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110633686|NCT00256243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110633687|NCT00256243|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110633688|NCT00236197|Rabeprazole|rabeprazole|mesh-list
110633689|NCT00236197|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110633690|NCT00236197|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110633691|NCT00236197|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110633692|NCT00236197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110633693|NCT00236197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110633694|NCT02541708|Folic Acid|folic acid|mesh-list
110633695|NCT02541708|Hematinics|hematinics|mesh-ancestor
110633696|NCT02541708|Vitamin B Complex|vitamin b complex|mesh-ancestor
110633697|NCT02541708|Vitamins|vitamins|mesh-ancestor
110633698|NCT02541708|Micronutrients|micronutrients|mesh-ancestor
110633699|NCT02541708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110633700|NCT03973567|Norepinephrine|norepinephrine|mesh-list
110633701|NCT03973567|Antidepressive Agents|antidepressive agents|mesh-list
110633702|NCT03973567|Serotonin|serotonin|mesh-list
110633703|NCT03973567|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
110633704|NCT03973567|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110633705|NCT03973567|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110633706|NCT03973567|Serotonin Agents|serotonin agents|mesh-ancestor
110633707|NCT03973567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110633708|NCT03973567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110633709|NCT03973567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110633710|NCT03973567|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110633711|NCT03973567|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110633712|NCT03973567|Adrenergic Agents|adrenergic agents|mesh-ancestor
110633713|NCT03973567|Sympathomimetics|sympathomimetics|mesh-ancestor
110633714|NCT03973567|Autonomic Agents|autonomic agents|mesh-ancestor
110633715|NCT03973567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110633716|NCT03973567|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110633717|NCT03973567|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110633718|NCT03973567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110633719|NCT00885924|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
110633720|NCT00885924|Hemostatics|hemostatics|mesh-ancestor
110633721|NCT00885924|Coagulants|coagulants|mesh-ancestor
110633722|NCT00885924|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
110633723|NCT00885924|Natriuretic Agents|natriuretic agents|mesh-ancestor
110633724|NCT00885924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110633725|NCT01071889|Flumazenil|flumazenil|mesh-list
110633726|NCT01071889|Antidotes|antidotes|mesh-ancestor
110633727|NCT01071889|Protective Agents|protective agents|mesh-ancestor
110633728|NCT01071889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110633729|NCT01071889|GABA Modulators|gaba modulators|mesh-ancestor
110633730|NCT01071889|GABA Agents|gaba agents|mesh-ancestor
110633731|NCT01071889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110633732|NCT01071889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110633733|NCT03973411|Ondansetron|ondansetron|mesh-list
110633734|NCT03973411|Antiemetics|antiemetics|mesh-ancestor
110633736|NCT03973411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110633737|NCT03973411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110633738|NCT03973411|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110633739|NCT03973411|Antipruritics|antipruritics|mesh-ancestor
110633740|NCT03973411|Dermatologic Agents|dermatologic agents|mesh-ancestor
110633741|NCT03973411|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110633742|NCT03973411|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110633743|NCT03973411|Serotonin Agents|serotonin agents|mesh-ancestor
110633744|NCT03973411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110633745|NCT03973411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110633746|NCT00883506|Lisinopril|lisinopril|mesh-list
110633747|NCT00883506|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110633748|NCT00883506|Protease Inhibitors|protease inhibitors|mesh-ancestor
110633749|NCT00883506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110633750|NCT00883506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110633751|NCT00883506|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110633752|NCT00883506|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110633753|NCT00883506|Protective Agents|protective agents|mesh-ancestor
110633754|NCT00883506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110633755|NCT00278395|Vorinostat|vorinostat|mesh-list
110281080|NCT00190892|Carbamazepine|carbamazepine|mesh-list
110633756|NCT00278395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110633757|NCT00278395|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110633758|NCT00278395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110633759|NCT00278395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110633760|NCT00889044|Clopidogrel|clopidogrel|mesh-list
110633761|NCT00889044|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110633762|NCT00889044|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110633763|NCT00889044|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110633764|NCT00889044|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110633765|NCT00889044|Purinergic Agents|purinergic agents|mesh-ancestor
110633766|NCT00889044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110633767|NCT00889044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110633768|NCT00889044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110633769|NCT00886002|Fentanyl|fentanyl|mesh-list
110633770|NCT00886002|Buprenorphine|buprenorphine|mesh-list
110633771|NCT00886002|Naloxone|naloxone|mesh-list
110633772|NCT00886002|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110633773|NCT00886002|Narcotics|narcotics|mesh-ancestor
110633774|NCT00886002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110633775|NCT00886002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110633776|NCT00886002|Analgesics|analgesics|mesh-ancestor
110633777|NCT00886002|Sensory System Agents|sensory system agents|mesh-ancestor
110633778|NCT00886002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110633779|NCT00886002|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110633780|NCT00886002|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110633781|NCT00886002|Anesthetics, General|anesthetics, general|mesh-ancestor
110633782|NCT00886002|Anesthetics|anesthetics|mesh-ancestor
110633783|NCT00886002|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110633784|NCT00883662|Levonorgestrel|levonorgestrel|mesh-list
110633785|NCT00883662|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110633786|NCT00883662|Contraceptive Agents|contraceptive agents|mesh-ancestor
110633787|NCT00883662|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110633788|NCT00883662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110633789|NCT00883662|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110633790|NCT00883662|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110633791|NCT00883662|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110633793|NCT00883818|Doxycycline|doxycycline|mesh-list
110633794|NCT00883818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110633795|NCT00883818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110633796|NCT00883818|Antimalarials|antimalarials|mesh-ancestor
110633797|NCT00883818|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110633798|NCT00883818|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110633799|NCT00889356|Clindamycin|clindamycin|mesh-list
110633800|NCT00889356|Clindamycin palmitate|clindamycin palmitate|mesh-list
110633801|NCT00889356|Clindamycin phosphate|clindamycin phosphate|mesh-list
110633802|NCT00889356|Amphotericin B|amphotericin b|mesh-list
110633803|NCT00889356|Tetracycline|tetracycline|mesh-list
110633804|NCT00889356|Ketoconazole|ketoconazole|mesh-list
110633805|NCT00889356|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
110633806|NCT00889356|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110633807|NCT00889356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110633808|NCT00889356|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110633809|NCT00889356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110633810|NCT00889356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110633811|NCT00889356|Antifungal Agents|antifungal agents|mesh-ancestor
110633812|NCT00889356|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110633813|NCT00889356|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110633814|NCT00889356|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110633815|NCT00889356|Hormone Antagonists|hormone antagonists|mesh-ancestor
110633816|NCT00889356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110633817|NCT00889356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110633818|NCT00889356|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110633819|NCT00889356|Amebicides|amebicides|mesh-ancestor
110633820|NCT00889356|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110633821|NCT00889356|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110633822|NCT00889434|Tocotrienols|tocotrienols|mesh-list
110633823|NCT00889434|Vitamin E|vitamin e|mesh-list
110633824|NCT00889434|Tocopherols|tocopherols|mesh-list
110633825|NCT00889434|Antioxidants|antioxidants|mesh-ancestor
110633826|NCT00889434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110633827|NCT00889434|Protective Agents|protective agents|mesh-ancestor
110633828|NCT00889434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110633829|NCT00889434|Vitamins|vitamins|mesh-ancestor
110633830|NCT00889434|Micronutrients|micronutrients|mesh-ancestor
110633831|NCT00612534|Sufentanil|sufentanil|mesh-list
110633833|NCT00612534|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110633834|NCT00612534|Narcotics|narcotics|mesh-ancestor
110633835|NCT00612534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110633836|NCT00612534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110633837|NCT00612534|Analgesics|analgesics|mesh-ancestor
110633838|NCT00612534|Sensory System Agents|sensory system agents|mesh-ancestor
110633839|NCT00612534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110633840|NCT00612534|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110633841|NCT00612534|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110633843|NCT00612534|Anesthetics|anesthetics|mesh-ancestor
110633844|NCT02542254|Albuterol|albuterol|mesh-list
110633845|NCT02542254|Ipratropium|ipratropium|mesh-list
110633846|NCT02542254|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110633847|NCT02542254|Autonomic Agents|autonomic agents|mesh-ancestor
110633848|NCT02542254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110633849|NCT02542254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110633850|NCT02542254|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110633851|NCT02542254|Respiratory System Agents|respiratory system agents|mesh-ancestor
110633852|NCT02542254|Tocolytic Agents|tocolytic agents|mesh-ancestor
110633853|NCT02542254|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110633854|NCT02542254|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110633855|NCT02542254|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110633856|NCT02542254|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110633858|NCT02542254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110254310|NCT05594849|Glucocorticoids|glucocorticoids|mesh-ancestor
110633859|NCT02542254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110633860|NCT02542254|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110633861|NCT02542254|Cholinergic Agents|cholinergic agents|mesh-ancestor
110633862|NCT00889590|Zoledronic Acid|zoledronic acid|mesh-list
110633863|NCT00889590|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110633864|NCT00889590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110633866|NCT00736853|Tramadol|tramadol|mesh-list
110633867|NCT00736853|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110633868|NCT00736853|Analgesics|analgesics|mesh-ancestor
110633869|NCT00736853|Sensory System Agents|sensory system agents|mesh-ancestor
110633870|NCT00736853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110633871|NCT00736853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110633872|NCT00736853|Antipyretics|antipyretics|mesh-ancestor
110633873|NCT00736853|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110633874|NCT00736853|Narcotics|narcotics|mesh-ancestor
110633875|NCT00736853|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110633876|NCT04037514|Acetaminophen|acetaminophen|mesh-list
110633877|NCT04037514|Ibuprofen|ibuprofen|mesh-list
110633878|NCT04037514|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110633879|NCT04037514|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110633880|NCT04037514|Analgesics|analgesics|mesh-ancestor
110633881|NCT04037514|Sensory System Agents|sensory system agents|mesh-ancestor
110633882|NCT04037514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110633883|NCT04037514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110633884|NCT04037514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110633885|NCT04037514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110633886|NCT04037514|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110633887|NCT04037514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110633888|NCT04037514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110633889|NCT04037514|Antipyretics|antipyretics|mesh-ancestor
110633890|NCT00730847|Vaccines|vaccines|mesh-list
110633891|NCT00730847|Immunologic Factors|immunologic factors|mesh-ancestor
110633892|NCT00730847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110633893|NCT00573066|Dexmedetomidine|dexmedetomidine|mesh-list
110633894|NCT00573066|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110633895|NCT00573066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110633896|NCT00573066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110633897|NCT00573066|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110633898|NCT00573066|Analgesics|analgesics|mesh-ancestor
110633899|NCT00573066|Sensory System Agents|sensory system agents|mesh-ancestor
110633900|NCT00573066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110633901|NCT00573066|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110633902|NCT00573066|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110633903|NCT00573066|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110633904|NCT00573066|Adrenergic Agents|adrenergic agents|mesh-ancestor
110633905|NCT00573066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110633906|NCT00573066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110633907|NCT02541552|Ropivacaine|ropivacaine|mesh-list
110633908|NCT02541552|Anesthetics, Local|anesthetics, local|mesh-ancestor
110633909|NCT02541552|Anesthetics|anesthetics|mesh-ancestor
110633910|NCT02541552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110633911|NCT02541552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110633912|NCT02541552|Sensory System Agents|sensory system agents|mesh-ancestor
110633913|NCT02541552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110633915|NCT00886314|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110633916|NCT00886314|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110633917|NCT00886314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110633918|NCT00886314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110633919|NCT00886314|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110633920|NCT00886314|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110633921|NCT00886314|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110633922|NCT00886314|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110633923|NCT00886314|Anesthetics, General|anesthetics, general|mesh-ancestor
110633924|NCT00886314|Anesthetics|anesthetics|mesh-ancestor
110633925|NCT00886314|GABA Modulators|gaba modulators|mesh-ancestor
110633926|NCT00886314|GABA Agents|gaba agents|mesh-ancestor
110633927|NCT00886314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110633928|NCT00886314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110633929|NCT00890214|Epoprostenol|epoprostenol|mesh-list
110633930|NCT00890214|Heparin|heparin|mesh-list
110633931|NCT00890214|Calcium heparin|calcium heparin|mesh-list
110633932|NCT00890214|Tezosentan|tezosentan|mesh-list
110633933|NCT00890214|Anticoagulants|anticoagulants|mesh-ancestor
110633934|NCT00890214|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110633935|NCT00890214|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110633936|NCT00890214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110633937|NCT00890214|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110633938|NCT00890214|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110633939|NCT00890214|Vasodilator Agents|vasodilator agents|mesh-ancestor
110633940|NCT00730691|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110633941|NCT00730691|Vortioxetine|vortioxetine|mesh-list
110633942|NCT00730691|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110633943|NCT00730691|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110633944|NCT00730691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110633945|NCT00730691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110633946|NCT00730691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110633947|NCT00730691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110633948|NCT00730691|Analgesics|analgesics|mesh-ancestor
110633949|NCT00730691|Sensory System Agents|sensory system agents|mesh-ancestor
110633950|NCT00730691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110633951|NCT00730691|Antidepressive Agents|antidepressive agents|mesh-ancestor
110633952|NCT00730691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110633953|NCT00730691|Dopamine Agents|dopamine agents|mesh-ancestor
110633954|NCT00730691|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110633955|NCT00730691|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110633956|NCT00730691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110633957|NCT00730691|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110633958|NCT00730691|Serotonin Agents|serotonin agents|mesh-ancestor
110633959|NCT00730691|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110633960|NCT00730691|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110633961|NCT00730691|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110633962|NCT00730691|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110633963|NCT00886860|Misoprostol|misoprostol|mesh-list
110155197|NCT00016081|Ribavirin|ribavirin|mesh-list
110633964|NCT00886860|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110633965|NCT00886860|Abortifacient Agents|abortifacient agents|mesh-ancestor
110633966|NCT00886860|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110633967|NCT00886860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110633968|NCT00886860|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110633969|NCT00886860|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110633970|NCT00886860|Oxytocics|oxytocics|mesh-ancestor
110633971|NCT00884442|Nifedipine|nifedipine|mesh-list
110633972|NCT00884442|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110633973|NCT00884442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110633974|NCT00884442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110633975|NCT00884442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110633976|NCT00884442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110633977|NCT00884442|Vasodilator Agents|vasodilator agents|mesh-ancestor
110633978|NCT00884442|Tocolytic Agents|tocolytic agents|mesh-ancestor
110116370|NCT04097730|Vitamins|vitamins|mesh-ancestor
110633979|NCT00884442|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110633981|NCT02543034|Emollients|emollients|mesh-ancestor
110633982|NCT02543034|Dermatologic Agents|dermatologic agents|mesh-ancestor
110633983|NCT00278161|Cyclophosphamide|cyclophosphamide|mesh-list
110633985|NCT00278161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110633986|NCT00278161|Immunologic Factors|immunologic factors|mesh-ancestor
110633987|NCT00278161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110633988|NCT00278161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110633989|NCT00278161|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110633990|NCT00278161|Alkylating Agents|alkylating agents|mesh-ancestor
110633991|NCT00278161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110633992|NCT00278161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110633993|NCT00278161|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110633994|NCT00278161|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110633995|NCT02541396|Ketamine|ketamine|mesh-list
110633996|NCT02541396|Oxycodone|oxycodone|mesh-list
110633997|NCT02541396|Analgesics|analgesics|mesh-ancestor
110633998|NCT02541396|Sensory System Agents|sensory system agents|mesh-ancestor
110633999|NCT02541396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110634000|NCT02541396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110634001|NCT02541396|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110634002|NCT02541396|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110634003|NCT02541396|Anesthetics, General|anesthetics, general|mesh-ancestor
110634004|NCT02541396|Anesthetics|anesthetics|mesh-ancestor
110634005|NCT02541396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110634006|NCT02541396|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110634007|NCT02541396|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110634008|NCT02541396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110634009|NCT02541396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110634010|NCT02541396|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110634011|NCT02541396|Narcotics|narcotics|mesh-ancestor
110634012|NCT00890604|Acetaminophen|acetaminophen|mesh-list
110634013|NCT00890604|Ibuprofen|ibuprofen|mesh-list
110634014|NCT00890604|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110634015|NCT00890604|Analgesics|analgesics|mesh-ancestor
110634016|NCT00890604|Sensory System Agents|sensory system agents|mesh-ancestor
110634017|NCT00890604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110634018|NCT00890604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110634019|NCT00890604|Antipyretics|antipyretics|mesh-ancestor
110634020|NCT00890604|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110634021|NCT00890604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110634022|NCT00890604|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110634023|NCT00890604|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110634024|NCT00890604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110634025|NCT00890604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110634026|NCT00255151|Dexlansoprazole|dexlansoprazole|mesh-list
110634027|NCT00255151|Lansoprazole|lansoprazole|mesh-list
110634028|NCT00255151|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110634029|NCT00255151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110634030|NCT00255151|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110634031|NCT00255151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110634032|NCT00255151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110634033|NCT03973957|Fentanyl|fentanyl|mesh-list
110634034|NCT03973957|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110634035|NCT03973957|Narcotics|narcotics|mesh-ancestor
110634036|NCT03973957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110634037|NCT03973957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110634038|NCT03973957|Analgesics|analgesics|mesh-ancestor
110634039|NCT03973957|Sensory System Agents|sensory system agents|mesh-ancestor
110634040|NCT03973957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110634041|NCT03973957|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110634042|NCT03973957|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110634043|NCT03973957|Anesthetics, General|anesthetics, general|mesh-ancestor
110634045|NCT00658658|Panitumumab|panitumumab|mesh-list
110634046|NCT00658658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110634047|NCT00658658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110634048|NCT00723203|Panobinostat|panobinostat|mesh-list
110394590|NCT01608347|Folic Acid|folic acid|mesh-list
110634049|NCT00723203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110634050|NCT00723203|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110634051|NCT00723203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110634052|NCT00723203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110634053|NCT00891072|Acetic Acid|acetic acid|mesh-list
110634054|NCT00891072|Paclitaxel|paclitaxel|mesh-list
110634055|NCT00891072|Gossypol acetic acid|gossypol acetic acid|mesh-list
110634056|NCT00891072|Carboplatin|carboplatin|mesh-list
110634057|NCT00891072|Retinol acetate|retinol acetate|mesh-list
110634058|NCT00891072|Gossypol|gossypol|mesh-list
110634059|NCT00891072|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110634060|NCT00891072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110634061|NCT00891072|Tubulin Modulators|tubulin modulators|mesh-ancestor
110634062|NCT00891072|Antimitotic Agents|antimitotic agents|mesh-ancestor
110634063|NCT00891072|Mitosis Modulators|mitosis modulators|mesh-ancestor
110634064|NCT00891072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110634065|NCT00891072|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110634066|NCT00891072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110634067|NCT00891072|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110634068|NCT00891072|Immunologic Factors|immunologic factors|mesh-ancestor
110634069|NCT00891072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110634070|NCT00891072|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110634071|NCT00891072|Protective Agents|protective agents|mesh-ancestor
110634072|NCT00891072|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110634073|NCT00891072|Contraceptive Agents|contraceptive agents|mesh-ancestor
110634074|NCT00891072|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110634075|NCT00891072|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110634076|NCT00891072|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
110634077|NCT00891072|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
110634078|NCT02591927|Insulin|insulin|mesh-list
110634079|NCT02591927|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110634080|NCT02591927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110634081|NCT00891150|Oxytocin|oxytocin|mesh-list
110634082|NCT00891150|Oxytocics|oxytocics|mesh-ancestor
110634083|NCT00891150|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110634084|NCT00891150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110634085|NCT00800462|Bromides|bromides|mesh-list
110634086|NCT00800462|Oxybutynin|oxybutynin|mesh-list
110634087|NCT00800462|Darifenacin|darifenacin|mesh-list
110634088|NCT00800462|Anticonvulsants|anticonvulsants|mesh-ancestor
110634089|NCT00800462|Parasympatholytics|parasympatholytics|mesh-ancestor
110634090|NCT00800462|Autonomic Agents|autonomic agents|mesh-ancestor
110634091|NCT00800462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110634092|NCT00800462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110634093|NCT00800462|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110634094|NCT00800462|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110634095|NCT00800462|Cholinergic Agents|cholinergic agents|mesh-ancestor
110634096|NCT00800462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110634097|NCT00800462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110634098|NCT00800462|Urological Agents|urological agents|mesh-ancestor
110634099|NCT00233389|Rebamipide|rebamipide|mesh-list
110634100|NCT00233389|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110634101|NCT00233389|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110634102|NCT00233389|Antioxidants|antioxidants|mesh-ancestor
110155279|NCT00006014|Semaxinib|semaxinib|mesh-list
110634103|NCT00233389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110634104|NCT00233389|Protective Agents|protective agents|mesh-ancestor
110634105|NCT00233389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110634106|NCT00233389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110634107|NCT00891306|Cyclosporine|cyclosporine|mesh-list
110634108|NCT00891306|Mycophenolic Acid|mycophenolic acid|mesh-list
110634109|NCT00891306|Methylprednisolone|methylprednisolone|mesh-list
110634110|NCT00891306|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110634111|NCT00891306|Cyclosporins|cyclosporins|mesh-list
110634112|NCT00891306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110634113|NCT00891306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110634114|NCT00891306|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110634115|NCT00891306|Immunologic Factors|immunologic factors|mesh-ancestor
110634116|NCT00891306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110634117|NCT00891306|Antifungal Agents|antifungal agents|mesh-ancestor
110634118|NCT00891306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110634119|NCT00891306|Dermatologic Agents|dermatologic agents|mesh-ancestor
110634120|NCT00891306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110634121|NCT00891306|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110634122|NCT00891306|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110634123|NCT00891306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110634124|NCT00891306|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110634125|NCT00891306|Antitubercular Agents|antitubercular agents|mesh-ancestor
110634126|NCT00891306|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110634127|NCT00891306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110634128|NCT00891306|Antiemetics|antiemetics|mesh-ancestor
110634129|NCT00891306|Autonomic Agents|autonomic agents|mesh-ancestor
110634130|NCT00891306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110634131|NCT00891306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110634132|NCT00891306|Glucocorticoids|glucocorticoids|mesh-ancestor
110254340|NCT00148356|Tubulin Modulators|tubulin modulators|mesh-ancestor
110634134|NCT00891306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110634135|NCT00891306|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110281445|NCT00214578|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110634136|NCT00891306|Protective Agents|protective agents|mesh-ancestor
110634137|NCT00891306|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110634138|NCT00807872|Antibodies|antibodies|mesh-list
110634139|NCT00807872|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110634141|NCT00807872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110634142|NCT00813722|Losartan|losartan|mesh-list
110634143|NCT00813722|Atenolol|atenolol|mesh-list
110634144|NCT00813722|Amlodipine|amlodipine|mesh-list
110634145|NCT00813722|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110634146|NCT00813722|Calcium|calcium|mesh-list
110634147|NCT00813722|Diuretics|diuretics|mesh-list
110634148|NCT00813722|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
110634149|NCT00813722|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110634150|NCT00813722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110634151|NCT00813722|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110634152|NCT00813722|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110634153|NCT00813722|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110634154|NCT00813722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110634155|NCT00813722|Vasodilator Agents|vasodilator agents|mesh-ancestor
110634156|NCT00813722|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110634157|NCT00813722|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110634158|NCT00813722|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110634159|NCT00813722|Natriuretic Agents|natriuretic agents|mesh-ancestor
110634160|NCT00813722|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110634161|NCT00813722|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110634162|NCT00813722|Adrenergic Agents|adrenergic agents|mesh-ancestor
110634163|NCT00813722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110634164|NCT00813722|Sympatholytics|sympatholytics|mesh-ancestor
110634165|NCT00813722|Autonomic Agents|autonomic agents|mesh-ancestor
110634166|NCT00813722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110634167|NCT00813722|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110634168|NCT00812318|Cabotegravir|cabotegravir|mesh-list
110634169|NCT00812318|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110634170|NCT00812318|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110634171|NCT00812318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110634172|NCT00812318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110634173|NCT00812318|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110634174|NCT00812318|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110634175|NCT00812318|Antiviral Agents|antiviral agents|mesh-ancestor
110634176|NCT00812318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110634177|NCT00812396|Methyltestosterone|methyltestosterone|mesh-list
110634178|NCT00812396|Testosterone|testosterone|mesh-list
110634179|NCT00812396|Testosterone undecanoate|testosterone undecanoate|mesh-list
110634180|NCT00812396|Testosterone enanthate|testosterone enanthate|mesh-list
110634181|NCT00812396|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
110634182|NCT00812396|Androgens|androgens|mesh-ancestor
110634183|NCT00812396|Hormones|hormones|mesh-ancestor
110634184|NCT00812396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110634185|NCT00812396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110634186|NCT00812396|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110634187|NCT00812396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110634188|NCT00812396|Anabolic Agents|anabolic agents|mesh-ancestor
110634189|NCT00807950|Simvastatin|simvastatin|mesh-list
110634190|NCT00807950|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110634191|NCT00807950|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110634192|NCT00807950|Antimetabolites|antimetabolites|mesh-ancestor
110634193|NCT00807950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110634194|NCT00807950|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110634195|NCT00807950|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110634196|NCT00807950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110634198|NCT00649220|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110634199|NCT00649220|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110634200|NCT00649220|Dopamine Agents|dopamine agents|mesh-ancestor
110634201|NCT00649220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110634202|NCT00649220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110634203|NCT00649220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110634204|NCT00649220|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110634205|NCT00649220|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110634206|NCT00654368|Etanercept|etanercept|mesh-list
110634207|NCT00654368|Methotrexate|methotrexate|mesh-list
110634208|NCT00654368|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110634209|NCT00654368|Abortifacient Agents|abortifacient agents|mesh-ancestor
110116566|NCT03664687|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110634210|NCT00654368|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110634211|NCT00654368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110634212|NCT00654368|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110634213|NCT00654368|Antimetabolites|antimetabolites|mesh-ancestor
110634214|NCT00654368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110634215|NCT00654368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110634216|NCT00654368|Dermatologic Agents|dermatologic agents|mesh-ancestor
110634217|NCT00654368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110634218|NCT00654368|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110634219|NCT00654368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110634220|NCT00654368|Immunologic Factors|immunologic factors|mesh-ancestor
110634221|NCT00654368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110634222|NCT00654368|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110634223|NCT00654368|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110634224|NCT00654368|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110634226|NCT00654368|Sensory System Agents|sensory system agents|mesh-ancestor
110634227|NCT00654368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110634228|NCT00654368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110634229|NCT00654368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110634230|NCT00812864|Capecitabine|capecitabine|mesh-list
110634231|NCT00812864|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110634232|NCT00812864|Antimetabolites|antimetabolites|mesh-ancestor
110394635|NCT04310254|Edetic Acid|edetic acid|mesh-list
110634233|NCT00812864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110634234|NCT00812864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110634235|NCT00808184|Raltegravir Potassium|raltegravir potassium|mesh-list
110634236|NCT00808184|Midazolam|midazolam|mesh-list
110634237|NCT00808184|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110634238|NCT00808184|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110634239|NCT00808184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110634240|NCT00808184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110634241|NCT00808184|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110634242|NCT00808184|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110634243|NCT00808184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110634244|NCT00808184|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110634245|NCT00808184|Anesthetics, General|anesthetics, general|mesh-ancestor
110634246|NCT00808184|Anesthetics|anesthetics|mesh-ancestor
110634247|NCT00808184|GABA Modulators|gaba modulators|mesh-ancestor
110634248|NCT00808184|GABA Agents|gaba agents|mesh-ancestor
110634249|NCT00808184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110634250|NCT00808184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110634251|NCT00808184|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110634252|NCT00808184|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110634253|NCT00808184|Antiviral Agents|antiviral agents|mesh-ancestor
110634254|NCT00808184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110634255|NCT00808184|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110634256|NCT00808184|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110634257|NCT00808184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110634258|NCT00647426|Carboplatin|carboplatin|mesh-list
110634259|NCT00647426|Docetaxel|docetaxel|mesh-list
110634260|NCT00647426|Sorafenib|sorafenib|mesh-list
110634261|NCT00647426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110634262|NCT00647426|Tubulin Modulators|tubulin modulators|mesh-ancestor
110634263|NCT00647426|Antimitotic Agents|antimitotic agents|mesh-ancestor
110634264|NCT00647426|Mitosis Modulators|mitosis modulators|mesh-ancestor
110634265|NCT00647426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110634266|NCT00647426|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110634267|NCT00647426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110634268|NCT00647348|Simvastatin|simvastatin|mesh-list
110634269|NCT00647348|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110634270|NCT00647348|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110634271|NCT00647348|Antimetabolites|antimetabolites|mesh-ancestor
110634272|NCT00647348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110634273|NCT00647348|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110634274|NCT00647348|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110634275|NCT00647348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110634276|NCT00647270|Adalimumab|adalimumab|mesh-list
110634277|NCT00647270|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110634278|NCT00647270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110634279|NCT00647270|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110634280|NCT00645944|Eszopiclone|eszopiclone|mesh-list
110634281|NCT00645944|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110634282|NCT00645944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110634283|NCT00645944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110634284|NCT00813332|Docetaxel|docetaxel|mesh-list
110634285|NCT00813332|Endostar protein|endostar protein|mesh-list
110634286|NCT00813332|Endostatins|endostatins|mesh-list
110634287|NCT00813332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110634288|NCT00813332|Tubulin Modulators|tubulin modulators|mesh-ancestor
110634289|NCT00813332|Antimitotic Agents|antimitotic agents|mesh-ancestor
110634291|NCT00813332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110634292|NCT00813332|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110634293|NCT00813332|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110634294|NCT00813332|Growth Substances|growth substances|mesh-ancestor
110634295|NCT00813332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110634296|NCT00813332|Growth Inhibitors|growth inhibitors|mesh-ancestor
110634297|NCT04708496|Efavirenz|efavirenz|mesh-list
110634298|NCT04708496|Dolutegravir|dolutegravir|mesh-list
110634299|NCT04708496|Lumefantrine|lumefantrine|mesh-list
110634300|NCT04708496|Artemether|artemether|mesh-list
110634301|NCT04708496|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
110634302|NCT04708496|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110634303|NCT04708496|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110634304|NCT04708496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110634305|NCT04708496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110634306|NCT04708496|Antiviral Agents|antiviral agents|mesh-ancestor
110634307|NCT04708496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110634308|NCT04708496|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110634309|NCT04708496|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110634310|NCT04708496|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110634311|NCT04708496|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110634312|NCT04708496|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110634313|NCT04708496|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110634314|NCT04708496|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110634315|NCT04708496|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110634316|NCT04708496|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110634317|NCT04708496|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110634318|NCT04708496|Antimalarials|antimalarials|mesh-ancestor
110634319|NCT04708496|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110634320|NCT04708496|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110634322|NCT00646958|Radezolid|radezolid|mesh-list
110634323|NCT00646958|Oxazolidinones|oxazolidinones|mesh-list
110634324|NCT00646958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110634325|NCT00646958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110634326|NCT00646958|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110634327|NCT00646958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110254373|NCT00148395|Mitosis Modulators|mitosis modulators|mesh-ancestor
110634328|NCT00646958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110634329|NCT00813410|Insulin|insulin|mesh-list
110634330|NCT00813410|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110634331|NCT00813410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110634332|NCT00642746|Leucovorin|leucovorin|mesh-list
110634333|NCT00642746|Fluorouracil|fluorouracil|mesh-list
110634334|NCT00642746|Oxaliplatin|oxaliplatin|mesh-list
110634335|NCT00642746|Irinotecan|irinotecan|mesh-list
110634336|NCT00642746|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110634337|NCT00642746|Antimetabolites|antimetabolites|mesh-ancestor
110634338|NCT00642746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110634339|NCT00642746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110634340|NCT00642746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110634341|NCT00642746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110634342|NCT00642746|Immunologic Factors|immunologic factors|mesh-ancestor
110634343|NCT00642746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110634344|NCT00642746|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110634345|NCT00642746|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110634346|NCT00642746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110634347|NCT00642746|Antidotes|antidotes|mesh-ancestor
110634348|NCT00642746|Protective Agents|protective agents|mesh-ancestor
110634349|NCT00642746|Vitamin B Complex|vitamin b complex|mesh-ancestor
110634350|NCT00642746|Vitamins|vitamins|mesh-ancestor
110634351|NCT00642746|Micronutrients|micronutrients|mesh-ancestor
110634352|NCT00642746|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110634353|NCT00814268|Aspirin|aspirin|mesh-list
110634354|NCT00814268|Clopidogrel|clopidogrel|mesh-list
110634355|NCT00814268|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110634356|NCT00814268|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110634357|NCT00814268|Analgesics|analgesics|mesh-ancestor
110634358|NCT00814268|Sensory System Agents|sensory system agents|mesh-ancestor
110634359|NCT00814268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110634360|NCT00814268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110634361|NCT00814268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110634362|NCT00814268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110281664|NCT02277730|Phenylephrine|phenylephrine|mesh-list
110634363|NCT00814268|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110634364|NCT00814268|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110634365|NCT00814268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110634366|NCT00814268|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110634367|NCT00814268|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110634369|NCT00814268|Antipyretics|antipyretics|mesh-ancestor
110634370|NCT00814268|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110634371|NCT00814268|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110634372|NCT00814268|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110634373|NCT00814268|Purinergic Agents|purinergic agents|mesh-ancestor
110634374|NCT00814268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110634375|NCT00817622|Vitamin E|vitamin e|mesh-list
110634376|NCT00817622|Vitamins|vitamins|mesh-ancestor
110634377|NCT00817622|Micronutrients|micronutrients|mesh-ancestor
110634378|NCT00817622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110634380|NCT00817622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110634381|NCT00817622|Protective Agents|protective agents|mesh-ancestor
110634382|NCT00808418|Docetaxel|docetaxel|mesh-list
110634383|NCT00808418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110634384|NCT00808418|Tubulin Modulators|tubulin modulators|mesh-ancestor
110634385|NCT00808418|Antimitotic Agents|antimitotic agents|mesh-ancestor
110634386|NCT00808418|Mitosis Modulators|mitosis modulators|mesh-ancestor
110634387|NCT00808418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110634388|NCT00642668|Epoetin Alfa|epoetin alfa|mesh-list
110634389|NCT00642668|Hematinics|hematinics|mesh-ancestor
110634390|NCT00817934|Bisacodyl|bisacodyl|mesh-list
110634391|NCT00817934|Cathartics|cathartics|mesh-ancestor
110634392|NCT00817934|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110634393|NCT00817934|Laxatives|laxatives|mesh-ancestor
110634394|NCT00729833|Sunitinib|sunitinib|mesh-list
110634395|NCT00729833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110634396|NCT00729833|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110634397|NCT00729833|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110634398|NCT00729833|Growth Substances|growth substances|mesh-ancestor
110634399|NCT00729833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110634400|NCT00729833|Growth Inhibitors|growth inhibitors|mesh-ancestor
110634401|NCT00729833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110634402|NCT00729833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110634403|NCT00729833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110634404|NCT00645788|Ciprofloxacin|ciprofloxacin|mesh-list
110634405|NCT00645788|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110634406|NCT00645788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110634407|NCT00645788|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110634408|NCT00645788|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110634409|NCT00645788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110634410|NCT00645788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110634411|NCT00645788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110634412|NCT00645788|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110634413|NCT00645788|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110634414|NCT00814736|Sildenafil Citrate|sildenafil citrate|mesh-list
110634415|NCT00814736|Vasodilator Agents|vasodilator agents|mesh-ancestor
110634416|NCT00814736|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110634417|NCT00814736|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110634418|NCT00814736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110634419|NCT00814736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110634420|NCT00814736|Urological Agents|urological agents|mesh-ancestor
110634421|NCT00818090|Paclitaxel|paclitaxel|mesh-list
110634422|NCT00818090|Cisplatin|cisplatin|mesh-list
110634423|NCT00818090|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110634424|NCT00818090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110634425|NCT00818090|Tubulin Modulators|tubulin modulators|mesh-ancestor
110634426|NCT00818090|Antimitotic Agents|antimitotic agents|mesh-ancestor
110634427|NCT00818090|Mitosis Modulators|mitosis modulators|mesh-ancestor
110634428|NCT00818090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110634429|NCT00642356|Levodopa|levodopa|mesh-list
110634430|NCT00642356|Carbidopa|carbidopa|mesh-list
110634431|NCT00642356|Entacapone|entacapone|mesh-list
110634432|NCT00642356|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
110634433|NCT00642356|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110634434|NCT00642356|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110634435|NCT00642356|Dopamine Agents|dopamine agents|mesh-ancestor
110634436|NCT00642356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110634437|NCT00642356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110634438|NCT00642356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110281744|NCT00124241|Lamivudine|lamivudine|mesh-list
110394647|NCT01603511|Charcoal|charcoal|mesh-list
110634439|NCT00642356|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
110634440|NCT00642356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110634441|NCT00642356|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
110634442|NCT00642356|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110634443|NCT00642356|Immunologic Factors|immunologic factors|mesh-ancestor
110634444|NCT00642356|Dopamine Agonists|dopamine agonists|mesh-ancestor
110634445|NCT00642278|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110634446|NCT00642278|Canagliflozin|canagliflozin|mesh-list
110634447|NCT00642278|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110634448|NCT00642278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110634449|NCT00642278|Incretins|incretins|mesh-ancestor
110634450|NCT00642278|Hormones|hormones|mesh-ancestor
110634451|NCT00642278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110634452|NCT00642278|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110634453|NCT00642278|Protease Inhibitors|protease inhibitors|mesh-ancestor
110634454|NCT00642278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110634455|NCT00642278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110254394|NCT03451825|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110634456|NCT00642278|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110634457|NCT00812786|Cyclosporine|cyclosporine|mesh-list
110634458|NCT00812786|Mycophenolic Acid|mycophenolic acid|mesh-list
110634459|NCT00812786|Everolimus|everolimus|mesh-list
110634460|NCT00812786|Tacrolimus|tacrolimus|mesh-list
110634461|NCT00812786|Cyclosporins|cyclosporins|mesh-list
110634462|NCT00812786|Immunosuppressive Agents|immunosuppressive agents|mesh-list
110634463|NCT00812786|Immunologic Factors|immunologic factors|mesh-ancestor
110634464|NCT00812786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110634465|NCT00812786|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110634466|NCT00812786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110634467|NCT00812786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110634468|NCT00812786|Antifungal Agents|antifungal agents|mesh-ancestor
110634469|NCT00812786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110634470|NCT00812786|Dermatologic Agents|dermatologic agents|mesh-ancestor
110634471|NCT00812786|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110634472|NCT00812786|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110634473|NCT00812786|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110634474|NCT00812786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110634475|NCT00812786|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110634476|NCT00812786|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110634477|NCT00812786|Antitubercular Agents|antitubercular agents|mesh-ancestor
110634478|NCT00812786|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110634479|NCT00815048|Atropine|atropine|mesh-list
110634480|NCT00815048|Fentanyl|fentanyl|mesh-list
110634481|NCT00815048|Remifentanil|remifentanil|mesh-list
110634482|NCT00815048|Succinylcholine|succinylcholine|mesh-list
110634483|NCT00815048|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110634484|NCT00815048|Narcotics|narcotics|mesh-ancestor
110634485|NCT00815048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110394662|NCT01609049|Antiviral Agents|antiviral agents|mesh-ancestor
110634486|NCT00815048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110634487|NCT00815048|Analgesics|analgesics|mesh-ancestor
110634488|NCT00815048|Sensory System Agents|sensory system agents|mesh-ancestor
110634489|NCT00815048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110634490|NCT00815048|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110116702|NCT02523092|Hormones|hormones|mesh-ancestor
110634491|NCT00815048|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110634492|NCT00815048|Anesthetics, General|anesthetics, general|mesh-ancestor
110634493|NCT00815048|Anesthetics|anesthetics|mesh-ancestor
110634494|NCT00815048|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110634495|NCT00815048|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110634496|NCT00815048|Autonomic Agents|autonomic agents|mesh-ancestor
110634497|NCT00815048|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110634498|NCT00815048|Respiratory System Agents|respiratory system agents|mesh-ancestor
110634499|NCT00815048|Mydriatics|mydriatics|mesh-ancestor
110634500|NCT00815048|Parasympatholytics|parasympatholytics|mesh-ancestor
110634501|NCT00815048|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110634502|NCT00815048|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110634503|NCT00815048|Cholinergic Agents|cholinergic agents|mesh-ancestor
110634504|NCT00815048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110634505|NCT00815048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110634506|NCT00815048|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
110634507|NCT00815048|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110634508|NCT00815048|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110634509|NCT02551796|Levofloxacin|levofloxacin|mesh-list
110634510|NCT02551796|Ofloxacin|ofloxacin|mesh-list
110634511|NCT02551796|Tobramycin|tobramycin|mesh-list
110634512|NCT02551796|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
110634513|NCT02551796|Dexamethasone|dexamethasone|mesh-list
110634514|NCT02551796|Dexamethasone acetate|dexamethasone acetate|mesh-list
110634516|NCT02551796|Hyaluronic Acid|hyaluronic acid|mesh-list
110634518|NCT02551796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110634519|NCT02551796|Antiemetics|antiemetics|mesh-ancestor
110634520|NCT02551796|Autonomic Agents|autonomic agents|mesh-ancestor
110634521|NCT02551796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110634522|NCT02551796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110634523|NCT02551796|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110634524|NCT02551796|Glucocorticoids|glucocorticoids|mesh-ancestor
110634525|NCT02551796|Hormones|hormones|mesh-ancestor
110634526|NCT02551796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110634527|NCT02551796|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110634528|NCT02551796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110634529|NCT02551796|Protease Inhibitors|protease inhibitors|mesh-ancestor
110634530|NCT02551796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110634531|NCT02551796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110634532|NCT02551796|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110634533|NCT02551796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110116719|NCT02397226|Anesthetics|anesthetics|mesh-list
110634534|NCT02551796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110634535|NCT02551796|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110634536|NCT02551796|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110634537|NCT02551796|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110634538|NCT02551796|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110634539|NCT02551796|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110634540|NCT02551796|Immunologic Factors|immunologic factors|mesh-ancestor
110634541|NCT02551796|Viscosupplements|viscosupplements|mesh-ancestor
110634542|NCT02551796|Protective Agents|protective agents|mesh-ancestor
110634543|NCT02551796|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110634544|NCT02551796|Adrenergic Agents|adrenergic agents|mesh-ancestor
110634545|NCT02551796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110634546|NCT02551796|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110155562|NCT00017290|Prednisone|prednisone|mesh-list
110634547|NCT02551796|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110634548|NCT00723125|Paclitaxel|paclitaxel|mesh-list
110634549|NCT00723125|Bevacizumab|bevacizumab|mesh-list
110634550|NCT00723125|Carboplatin|carboplatin|mesh-list
110634551|NCT00723125|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110634552|NCT00723125|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110634553|NCT00723125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110634554|NCT00723125|Tubulin Modulators|tubulin modulators|mesh-ancestor
110634555|NCT00723125|Antimitotic Agents|antimitotic agents|mesh-ancestor
110634556|NCT00723125|Mitosis Modulators|mitosis modulators|mesh-ancestor
110634557|NCT00723125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110634558|NCT00723125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110634559|NCT00723125|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110634560|NCT00723125|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110634561|NCT00723125|Growth Substances|growth substances|mesh-ancestor
110634562|NCT00723125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110634563|NCT00723125|Growth Inhibitors|growth inhibitors|mesh-ancestor
110634564|NCT00640562|Risperidone|risperidone|mesh-list
110634565|NCT00640562|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110634566|NCT00640562|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110634567|NCT00640562|Serotonin Agents|serotonin agents|mesh-ancestor
110634568|NCT00640562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110634569|NCT00640562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110634570|NCT00640562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110634571|NCT00640562|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110634572|NCT00640562|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110634573|NCT00640562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110634574|NCT00640562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110634575|NCT00640562|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110634576|NCT00640562|Dopamine Agents|dopamine agents|mesh-ancestor
110634577|NCT00640562|Antidepressive Agents|antidepressive agents|mesh-ancestor
110634578|NCT00815204|Dexamethasone|dexamethasone|mesh-list
110634579|NCT00815204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110634580|NCT00815204|Antiemetics|antiemetics|mesh-ancestor
110634581|NCT00815204|Autonomic Agents|autonomic agents|mesh-ancestor
110634582|NCT00815204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110634583|NCT00815204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110634584|NCT00815204|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110634585|NCT00815204|Glucocorticoids|glucocorticoids|mesh-ancestor
110634586|NCT00815204|Hormones|hormones|mesh-ancestor
110634587|NCT00815204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110634588|NCT00815204|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110634589|NCT00815204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110634590|NCT00721955|Loxapine|loxapine|mesh-list
110634591|NCT00721955|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110634592|NCT00721955|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110634593|NCT00721955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110634594|NCT00721955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110634595|NCT00721955|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110634596|NCT00721955|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110116800|NCT00408005|Daunorubicin|daunorubicin|mesh-list
110634597|NCT00721955|Dopamine Agents|dopamine agents|mesh-ancestor
110634598|NCT00721955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110634599|NCT00721955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110634601|NCT00585689|Gemcitabine|gemcitabine|mesh-list
110634602|NCT00585689|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110634603|NCT00585689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110634604|NCT00585689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110634606|NCT00585689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110634607|NCT00815282|Vaccines|vaccines|mesh-list
110634608|NCT00815282|Immunologic Factors|immunologic factors|mesh-ancestor
110634609|NCT00815282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110634610|NCT02593019|Adavosertib|adavosertib|mesh-list
110634611|NCT02593019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110634612|NCT02593019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110634613|NCT00729365|Ramipril|ramipril|mesh-list
110634614|NCT00729365|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
110634615|NCT00729365|Protease Inhibitors|protease inhibitors|mesh-ancestor
110634616|NCT00729365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110634617|NCT00729365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110634618|NCT00729365|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110634619|NCT00818870|Omeprazole|omeprazole|mesh-list
110634620|NCT00818870|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110634621|NCT00818870|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110634622|NCT00818870|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110634623|NCT00818870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110634624|NCT00818870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110634625|NCT00254293|Abatacept|abatacept|mesh-list
110634626|NCT00254293|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110634627|NCT00254293|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110634628|NCT00254293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110634629|NCT00254293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110634630|NCT00254293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110634631|NCT00254293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110634632|NCT00254293|Immunologic Factors|immunologic factors|mesh-ancestor
110634633|NCT00254293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110634634|NCT00254293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110634636|NCT00736385|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110634637|NCT00736385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110634638|NCT00585221|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110634639|NCT00585221|Imatinib Mesylate|imatinib mesylate|mesh-list
110634640|NCT00585221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110634641|NCT00585221|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110634642|NCT00585221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110634643|NCT00585221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110634644|NCT00585221|Antiviral Agents|antiviral agents|mesh-ancestor
110634645|NCT00585221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110634646|NCT02594033|Insulin Aspart|insulin aspart|mesh-list
110634647|NCT02594033|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110634648|NCT02594033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110634649|NCT00253747|Methylphenidate|methylphenidate|mesh-list
110634650|NCT00253747|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110634651|NCT00253747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110634652|NCT00253747|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110634653|NCT00253747|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110634654|NCT00253747|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110634655|NCT00253747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110634656|NCT00253747|Dopamine Agents|dopamine agents|mesh-ancestor
110634657|NCT00253747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110634658|NCT00252733|Candesartan|candesartan|mesh-list
110634659|NCT00252733|Candesartan cilexetil|candesartan cilexetil|mesh-list
110634660|NCT00252733|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110634661|NCT00252733|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110634662|NCT00252733|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110634663|NCT00252733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110634665|NCT03974035|Anesthetics, Local|anesthetics, local|mesh-ancestor
110634666|NCT03974035|Anesthetics|anesthetics|mesh-ancestor
110634667|NCT03974035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110634668|NCT03974035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110634669|NCT03974035|Sensory System Agents|sensory system agents|mesh-ancestor
110634670|NCT03974035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110634671|NCT00275821|Ranibizumab|ranibizumab|mesh-list
110634672|NCT00275821|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110155669|NCT00017641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110634673|NCT00275821|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110634674|NCT00275821|Growth Substances|growth substances|mesh-ancestor
110634675|NCT00275821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110634676|NCT00275821|Growth Inhibitors|growth inhibitors|mesh-ancestor
110634677|NCT00275821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110634678|NCT00275509|Mycophenolic Acid|mycophenolic acid|mesh-list
110634679|NCT00275509|Dexamethasone|dexamethasone|mesh-list
110634680|NCT00275509|Prednisone|prednisone|mesh-list
110634681|NCT00275509|Tacrolimus|tacrolimus|mesh-list
110634682|NCT00275509|Thymoglobulin|thymoglobulin|mesh-list
110634683|NCT00275509|Daclizumab|daclizumab|mesh-list
110634684|NCT00275509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110634685|NCT00275509|Antiemetics|antiemetics|mesh-ancestor
110634686|NCT00275509|Autonomic Agents|autonomic agents|mesh-ancestor
110634687|NCT00275509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110634688|NCT00275509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110634689|NCT00275509|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110634690|NCT00275509|Glucocorticoids|glucocorticoids|mesh-ancestor
110634691|NCT00275509|Hormones|hormones|mesh-ancestor
110634692|NCT00275509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110634693|NCT00275509|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110634694|NCT00275509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110634695|NCT00275509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110634696|NCT00275509|Immunologic Factors|immunologic factors|mesh-ancestor
110155716|NCT00017758|Efavirenz|efavirenz|mesh-list
110634697|NCT00275509|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110634698|NCT00275509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110634699|NCT00275509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110634700|NCT00275509|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110634701|NCT00275509|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110634702|NCT00275509|Antitubercular Agents|antitubercular agents|mesh-ancestor
110634703|NCT00275509|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110634704|NCT00275509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110634705|NCT01072045|Prednisone|prednisone|mesh-list
110634706|NCT01072045|Propranolol|propranolol|mesh-list
110634707|NCT01072045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110634708|NCT01072045|Glucocorticoids|glucocorticoids|mesh-ancestor
110634709|NCT01072045|Hormones|hormones|mesh-ancestor
110634710|NCT01072045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110634711|NCT01072045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110634712|NCT01072045|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110634713|NCT01072045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110634714|NCT01072045|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110634715|NCT01072045|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110634716|NCT01072045|Adrenergic Agents|adrenergic agents|mesh-ancestor
110634717|NCT01072045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110634718|NCT01072045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110254426|NCT00156975|Capecitabine|capecitabine|mesh-list
110634719|NCT01072045|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110634720|NCT01072045|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110634721|NCT01072045|Vasodilator Agents|vasodilator agents|mesh-ancestor
110634722|NCT01073059|Ertapenem|ertapenem|mesh-list
110634723|NCT01073059|Valproic Acid|valproic acid|mesh-list
110634724|NCT01073059|Anticonvulsants|anticonvulsants|mesh-ancestor
110634725|NCT01073059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110634726|NCT01073059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110634727|NCT01073059|GABA Agents|gaba agents|mesh-ancestor
110394741|NCT01110382|Amoxicillin|amoxicillin|mesh-list
110634728|NCT01073059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110116884|NCT01873144|Epinephrine|epinephrine|mesh-list
110634729|NCT01073059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110634730|NCT01073059|Antimanic Agents|antimanic agents|mesh-ancestor
110634731|NCT01073059|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110634732|NCT01073059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110634733|NCT01073059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110634734|NCT01073059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110634735|NCT01073059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110634736|NCT00252577|Lithium Carbonate|lithium carbonate|mesh-list
110634737|NCT00252577|Antidepressive Agents|antidepressive agents|mesh-ancestor
110634738|NCT00252577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110282038|NCT00222495|Olanzapine|olanzapine|mesh-list
110634739|NCT00252577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110155755|NCT00017992|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110634740|NCT00252577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110634741|NCT00252577|Antimanic Agents|antimanic agents|mesh-ancestor
110634742|NCT00252577|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110634743|NCT00252577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110634744|NCT00252577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110634746|NCT00252499|Fenofibrate|fenofibrate|mesh-list
110634747|NCT00252499|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110634748|NCT00252499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110634749|NCT00252499|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110634750|NCT00252499|Antimetabolites|antimetabolites|mesh-ancestor
110634751|NCT00252499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110634752|NCT00252499|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110634753|NCT00252187|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
110634754|NCT00252187|Natriuretic Agents|natriuretic agents|mesh-ancestor
110634755|NCT00252187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110634756|NCT00163657|Cyclosporine|cyclosporine|mesh-list
110634757|NCT00163657|Mycophenolic Acid|mycophenolic acid|mesh-list
110634758|NCT00163657|Tacrolimus|tacrolimus|mesh-list
110634759|NCT00163657|Cyclosporins|cyclosporins|mesh-list
110634760|NCT00163657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110634761|NCT00163657|Immunologic Factors|immunologic factors|mesh-ancestor
110634762|NCT00163657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110634763|NCT00163657|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110634764|NCT00163657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110634765|NCT00163657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110634766|NCT00163657|Antifungal Agents|antifungal agents|mesh-ancestor
110634767|NCT00163657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110634768|NCT00163657|Dermatologic Agents|dermatologic agents|mesh-ancestor
110116986|NCT01873768|Hemostatics|hemostatics|mesh-ancestor
110634769|NCT00163657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110634771|NCT00163657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110634772|NCT00163657|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110634773|NCT00163657|Antitubercular Agents|antitubercular agents|mesh-ancestor
110634774|NCT00163657|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110634775|NCT01073683|Docetaxel|docetaxel|mesh-list
110634776|NCT01073683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110634777|NCT01073683|Tubulin Modulators|tubulin modulators|mesh-ancestor
110634778|NCT01073683|Antimitotic Agents|antimitotic agents|mesh-ancestor
110634779|NCT01073683|Mitosis Modulators|mitosis modulators|mesh-ancestor
110634780|NCT01073683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110634781|NCT00609492|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110634782|NCT00609492|Immunologic Factors|immunologic factors|mesh-ancestor
110634783|NCT00609492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110634784|NCT00230971|Metronidazole|metronidazole|mesh-list
110634785|NCT00230971|Ceftriaxone|ceftriaxone|mesh-list
110634786|NCT00230971|Tigecycline|tigecycline|mesh-list
110634787|NCT00230971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110634788|NCT00230971|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110634789|NCT00230971|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110634790|NCT00230971|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110634791|NCT00230971|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110634792|NCT00230971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110634793|NCT00230971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110634794|NCT00211081|Spironolactone|spironolactone|mesh-list
110634795|NCT00211081|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110634796|NCT00211081|Hormone Antagonists|hormone antagonists|mesh-ancestor
110634797|NCT00211081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110634798|NCT00211081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110634799|NCT00211081|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110634800|NCT00211081|Diuretics|diuretics|mesh-ancestor
110634801|NCT00211081|Natriuretic Agents|natriuretic agents|mesh-ancestor
110634803|NCT00884676|Epothilone B|epothilone b|mesh-list
110634804|NCT00884676|Epothilones|epothilones|mesh-list
110155832|NCT00018382|Rosiglitazone|rosiglitazone|mesh-list
110634805|NCT00884676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110634806|NCT00884676|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110634807|NCT00884676|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110634808|NCT00884676|Growth Substances|growth substances|mesh-ancestor
110634809|NCT00884676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110634810|NCT00884676|Growth Inhibitors|growth inhibitors|mesh-ancestor
110634811|NCT00884676|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110634812|NCT00884676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110634813|NCT00884676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110634814|NCT00884676|Tubulin Modulators|tubulin modulators|mesh-ancestor
110634815|NCT00884676|Antimitotic Agents|antimitotic agents|mesh-ancestor
110634816|NCT00884676|Mitosis Modulators|mitosis modulators|mesh-ancestor
110634817|NCT00891384|Lenalidomide|lenalidomide|mesh-list
110634818|NCT00891384|Immunologic Factors|immunologic factors|mesh-ancestor
110634819|NCT00891384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110634820|NCT00891384|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110634821|NCT00891384|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110634822|NCT00891384|Growth Substances|growth substances|mesh-ancestor
110634823|NCT00891384|Growth Inhibitors|growth inhibitors|mesh-ancestor
110634824|NCT00891384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110634825|NCT00887328|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
110634826|NCT00887328|Plasminogen|plasminogen|mesh-list
110634827|NCT00887328|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110634828|NCT00887328|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110117047|NCT01874002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110634829|NCT00887328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110634831|NCT00609336|Capecitabine|capecitabine|mesh-list
110634832|NCT00609336|Docetaxel|docetaxel|mesh-list
110634833|NCT00609336|Oxaliplatin|oxaliplatin|mesh-list
110634834|NCT00609336|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110634835|NCT00609336|Antimetabolites|antimetabolites|mesh-ancestor
110634836|NCT00609336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110634837|NCT00609336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110634838|NCT00609336|Tubulin Modulators|tubulin modulators|mesh-ancestor
110634839|NCT00609336|Antimitotic Agents|antimitotic agents|mesh-ancestor
110634840|NCT00609336|Mitosis Modulators|mitosis modulators|mesh-ancestor
110634841|NCT00612066|Rosiglitazone|rosiglitazone|mesh-list
110634842|NCT00612066|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110634843|NCT00612066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110634844|NCT02541084|Aflibercept|aflibercept|mesh-list
110634845|NCT02541084|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110634846|NCT02541084|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110634847|NCT02541084|Growth Substances|growth substances|mesh-ancestor
110162813|NCT00008177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110634848|NCT02541084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110634849|NCT02541084|Growth Inhibitors|growth inhibitors|mesh-ancestor
110634850|NCT02541084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110634851|NCT04397406|Fentanyl|fentanyl|mesh-list
110634852|NCT04397406|Dexmedetomidine|dexmedetomidine|mesh-list
110634853|NCT04397406|Levobupivacaine|levobupivacaine|mesh-list
110634854|NCT04397406|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110634855|NCT04397406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110634856|NCT04397406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110634857|NCT04397406|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110634858|NCT04397406|Analgesics|analgesics|mesh-ancestor
110634859|NCT04397406|Sensory System Agents|sensory system agents|mesh-ancestor
110634860|NCT04397406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110634861|NCT04397406|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110634862|NCT04397406|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110634863|NCT04397406|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110634864|NCT04397406|Adrenergic Agents|adrenergic agents|mesh-ancestor
110634865|NCT04397406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110634866|NCT04397406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110634867|NCT04397406|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110634868|NCT04397406|Narcotics|narcotics|mesh-ancestor
110634869|NCT04397406|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110634870|NCT04397406|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110634871|NCT04397406|Anesthetics, General|anesthetics, general|mesh-ancestor
110634872|NCT04397406|Anesthetics|anesthetics|mesh-ancestor
110634873|NCT04397406|Anesthetics, Local|anesthetics, local|mesh-ancestor
110634874|NCT00891540|Ropivacaine|ropivacaine|mesh-list
110634875|NCT00891540|Anesthetics, Local|anesthetics, local|mesh-ancestor
110634876|NCT00891540|Anesthetics|anesthetics|mesh-ancestor
110634877|NCT00891540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110634878|NCT00891540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110634879|NCT00891540|Sensory System Agents|sensory system agents|mesh-ancestor
110634880|NCT00891540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110634881|NCT00573144|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
110634882|NCT00573144|Natriuretic Agents|natriuretic agents|mesh-ancestor
110634883|NCT00573144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110634884|NCT00891696|Sirolimus|sirolimus|mesh-list
110634885|NCT00891696|Nitroprusside|nitroprusside|mesh-list
110634886|NCT00891696|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110634887|NCT00891696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110634888|NCT00891696|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110634889|NCT00891696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110634890|NCT00891696|Antifungal Agents|antifungal agents|mesh-ancestor
110634891|NCT00891696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110634892|NCT00891696|Immunologic Factors|immunologic factors|mesh-ancestor
110634893|NCT00891696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110634894|NCT00891696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110634895|NCT00891696|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110634896|NCT00891696|Vasodilator Agents|vasodilator agents|mesh-ancestor
110634897|NCT00891696|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
110634898|NCT00640328|Ofatumumab|ofatumumab|mesh-list
110634900|NCT00640328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110634901|NCT00640328|Immunologic Factors|immunologic factors|mesh-ancestor
110634902|NCT00640328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110634903|NCT04036890|Minocycline|minocycline|mesh-list
110634904|NCT04036890|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110634905|NCT04036890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110634906|NCT00162097|Efavirenz|efavirenz|mesh-list
110634907|NCT00162097|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
110634908|NCT00162097|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110634909|NCT00162097|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110634910|NCT00162097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110634911|NCT00162097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110634912|NCT00162097|Antiviral Agents|antiviral agents|mesh-ancestor
110634913|NCT00162097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110634914|NCT00162097|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110634915|NCT00162097|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110634916|NCT00162097|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110634917|NCT00162097|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110634918|NCT00162097|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110634919|NCT00162097|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110634920|NCT02550782|Dexmedetomidine|dexmedetomidine|mesh-list
110634921|NCT02550782|Bupivacaine|bupivacaine|mesh-list
110634922|NCT02550782|Anesthetics, Local|anesthetics, local|mesh-ancestor
110634923|NCT02550782|Anesthetics|anesthetics|mesh-ancestor
110634924|NCT02550782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110634925|NCT02550782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110634926|NCT02550782|Sensory System Agents|sensory system agents|mesh-ancestor
110634927|NCT02550782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110634928|NCT02550782|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110634929|NCT02550782|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110634930|NCT02550782|Analgesics|analgesics|mesh-ancestor
110634931|NCT02550782|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110634932|NCT02550782|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110634933|NCT02550782|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110117145|NCT01874847|Melatonin|melatonin|mesh-list
110634934|NCT02550782|Adrenergic Agents|adrenergic agents|mesh-ancestor
110634935|NCT02550782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110634936|NCT02550782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110634937|NCT05278728|Irinotecan|irinotecan|mesh-list
110634938|NCT05278728|Nimotuzumab|nimotuzumab|mesh-list
110634939|NCT05278728|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110634940|NCT05278728|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110634941|NCT05278728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110634942|NCT05278728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110634943|NCT05278728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110634944|NCT05278728|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110634945|NCT01073761|Ritonavir|ritonavir|mesh-list
110634946|NCT01073761|Atazanavir Sulfate|atazanavir sulfate|mesh-list
110634947|NCT01073761|Darunavir|darunavir|mesh-list
110634948|NCT01073761|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110634949|NCT01073761|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110634950|NCT01073761|Protease Inhibitors|protease inhibitors|mesh-ancestor
110634951|NCT01073761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110634952|NCT01073761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110634953|NCT01073761|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110634954|NCT01073761|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110634955|NCT01073761|Antiviral Agents|antiviral agents|mesh-ancestor
110634956|NCT01073761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110634957|NCT01073761|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110634958|NCT01073761|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110634959|NCT00819104|Metoprolol|metoprolol|mesh-list
110634960|NCT00819104|Amlodipine|amlodipine|mesh-list
110634961|NCT00819104|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110634962|NCT00819104|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110634963|NCT00819104|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110634964|NCT00819104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110634965|NCT00819104|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110634966|NCT00819104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110634967|NCT00819104|Vasodilator Agents|vasodilator agents|mesh-ancestor
110634968|NCT00819104|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110155922|NCT00001656|Olanzapine|olanzapine|mesh-list
110634969|NCT00819104|Sympatholytics|sympatholytics|mesh-ancestor
110634970|NCT00819104|Autonomic Agents|autonomic agents|mesh-ancestor
110634971|NCT00819104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110634972|NCT00819104|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110634973|NCT00819104|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110634974|NCT00819104|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110634975|NCT00819104|Adrenergic Agents|adrenergic agents|mesh-ancestor
110634976|NCT00819104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110634977|NCT02542098|Hydrocodone|hydrocodone|mesh-list
110634978|NCT02542098|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110634979|NCT02542098|Narcotics|narcotics|mesh-ancestor
110634980|NCT02542098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110634981|NCT02542098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110634982|NCT02542098|Analgesics|analgesics|mesh-ancestor
110634983|NCT02542098|Sensory System Agents|sensory system agents|mesh-ancestor
110634985|NCT02542098|Antitussive Agents|antitussive agents|mesh-ancestor
110634986|NCT02542098|Respiratory System Agents|respiratory system agents|mesh-ancestor
110634987|NCT00640016|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110634988|NCT00640016|Immunologic Factors|immunologic factors|mesh-ancestor
110634989|NCT00640016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110634990|NCT00892242|Zoledronic Acid|zoledronic acid|mesh-list
110634991|NCT00892242|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110634992|NCT00892242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110634993|NCT00885066|Gemcitabine|gemcitabine|mesh-list
110634994|NCT00885066|Capecitabine|capecitabine|mesh-list
110634995|NCT00885066|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110634996|NCT00885066|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110634997|NCT00885066|Antimetabolites|antimetabolites|mesh-ancestor
110634998|NCT00885066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110634999|NCT00885066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110635000|NCT00885066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110635001|NCT00885066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110635002|NCT00888108|Docetaxel|docetaxel|mesh-list
110635003|NCT00888108|Navitoclax|navitoclax|mesh-list
110635004|NCT00888108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110635005|NCT00888108|Tubulin Modulators|tubulin modulators|mesh-ancestor
110635006|NCT00888108|Antimitotic Agents|antimitotic agents|mesh-ancestor
110635007|NCT00888108|Mitosis Modulators|mitosis modulators|mesh-ancestor
110635008|NCT00888108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110635009|NCT00885300|Cloxacillin|cloxacillin|mesh-list
110635010|NCT00885300|Heparin|heparin|mesh-list
110635011|NCT00885300|Anticoagulants|anticoagulants|mesh-ancestor
110635012|NCT00885300|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110635013|NCT00885300|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110635014|NCT00885300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110635015|NCT00885300|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110635016|NCT00885300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110635017|NCT00888186|Levodopa|levodopa|mesh-list
110635018|NCT00888186|Carbidopa|carbidopa|mesh-list
110635019|NCT00888186|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110635020|NCT00888186|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110635021|NCT00888186|Dopamine Agents|dopamine agents|mesh-ancestor
110635022|NCT00888186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110155931|NCT00001656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110635023|NCT00888186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110635024|NCT00888186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110635025|NCT00888186|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
110635026|NCT00888186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110635027|NCT00892320|Paliperidone Palmitate|paliperidone palmitate|mesh-list
110635028|NCT00892320|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110635029|NCT00892320|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110635030|NCT00892320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110635031|NCT00892320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110635032|NCT00892320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110635033|NCT00892320|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110635034|NCT00892320|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110635035|NCT00892320|Serotonin Agents|serotonin agents|mesh-ancestor
110635036|NCT00892320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110635037|NCT00892320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110117204|NCT01875224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110635038|NCT00892320|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110635039|NCT00892320|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110635040|NCT00892320|Dopamine Agents|dopamine agents|mesh-ancestor
110635041|NCT00892398|Ranibizumab|ranibizumab|mesh-list
110635042|NCT00892398|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110635043|NCT00892398|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110635044|NCT00892398|Growth Substances|growth substances|mesh-ancestor
110635045|NCT00892398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110635046|NCT00892398|Growth Inhibitors|growth inhibitors|mesh-ancestor
110635047|NCT00892398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110635048|NCT00892476|Calcium, Dietary|calcium, dietary|mesh-list
110635049|NCT00892476|Calcium|calcium|mesh-list
110635050|NCT00892476|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110635051|NCT00892476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110635052|NCT00892476|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110635054|NCT02541786|Dexlansoprazole|dexlansoprazole|mesh-list
110635055|NCT02541786|Lansoprazole|lansoprazole|mesh-list
110635056|NCT02541786|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110635057|NCT02541786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110635058|NCT02541786|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110635059|NCT02541786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110635060|NCT02541786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110635061|NCT00888342|Ethanol|ethanol|mesh-list
110635062|NCT00888342|Zopiclone|zopiclone|mesh-list
110635063|NCT00888342|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110635064|NCT00888342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110635065|NCT00888342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110635066|NCT00888342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110635067|NCT00888342|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110635068|NCT00608868|Gefitinib|gefitinib|mesh-list
110635069|NCT00608868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110635070|NCT00608868|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110635071|NCT00608868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110635072|NCT00608868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110635073|NCT00900978|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110635074|NCT00900978|Immunologic Factors|immunologic factors|mesh-ancestor
110635075|NCT00900978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110635076|NCT04036500|Estradiol|estradiol|mesh-list
110635077|NCT04036500|Estrogens|estrogens|mesh-ancestor
110635078|NCT04036500|Hormones|hormones|mesh-ancestor
110635079|NCT04036500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110635080|NCT04036500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110635081|NCT00895674|Sorafenib|sorafenib|mesh-list
110635082|NCT00895674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110635083|NCT00895674|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110635084|NCT00895674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110117222|NCT01875653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110635085|NCT00895674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110635087|NCT04035330|Sodium Hypochlorite|sodium hypochlorite|mesh-list
110635089|NCT04035330|Disinfectants|disinfectants|mesh-ancestor
110635090|NCT04035330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110635091|NCT04035330|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110635092|NCT04035330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110635093|NCT04035096|Ascorbic Acid|ascorbic acid|mesh-list
110635094|NCT04035096|Antioxidants|antioxidants|mesh-ancestor
110635095|NCT04035096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110635096|NCT04035096|Protective Agents|protective agents|mesh-ancestor
110635097|NCT04035096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110635098|NCT04035096|Vitamins|vitamins|mesh-ancestor
110635099|NCT04035096|Micronutrients|micronutrients|mesh-ancestor
110635100|NCT00608322|Nitric Oxide|nitric oxide|mesh-list
110635101|NCT00608322|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110635102|NCT00608322|Autonomic Agents|autonomic agents|mesh-ancestor
110635103|NCT00608322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110635104|NCT00608322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110635105|NCT00608322|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110635106|NCT00608322|Respiratory System Agents|respiratory system agents|mesh-ancestor
110635107|NCT00608322|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110635108|NCT00608322|Antioxidants|antioxidants|mesh-ancestor
110635109|NCT00608322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110635110|NCT00608322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110635111|NCT00608322|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
110394805|NCT01173055|Milnacipran|milnacipran|mesh-list
110635112|NCT00608322|Vasodilator Agents|vasodilator agents|mesh-ancestor
110635113|NCT00608322|Gasotransmitters|gasotransmitters|mesh-ancestor
110635114|NCT00608322|Protective Agents|protective agents|mesh-ancestor
110635115|NCT00608244|Tacrolimus|tacrolimus|mesh-list
110635116|NCT00608244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110635118|NCT00608244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110635119|NCT00608244|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110635120|NCT00608244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110635121|NCT00608244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110635122|NCT00893100|Diltiazem|diltiazem|mesh-list
110635123|NCT00893100|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110635124|NCT00893100|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110635125|NCT00893100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110635126|NCT00893100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110635127|NCT00893100|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110635128|NCT00893100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110635129|NCT00893100|Vasodilator Agents|vasodilator agents|mesh-ancestor
110635130|NCT00896376|Trastuzumab|trastuzumab|mesh-list
110635131|NCT00896376|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110635132|NCT00896376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110635133|NCT00901290|Contraceptive Agents|contraceptive agents|mesh-list
110635134|NCT00901290|Contraceptives, Oral|contraceptives, oral|mesh-list
110635135|NCT00901290|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110635136|NCT00901290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110635137|NCT00901290|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110635138|NCT00893256|Risperidone|risperidone|mesh-list
110635139|NCT00893256|Citalopram|citalopram|mesh-list
110635140|NCT00893256|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110635141|NCT00893256|Serotonin Agents|serotonin agents|mesh-ancestor
110635142|NCT00893256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110635143|NCT00893256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110635144|NCT00893256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110635145|NCT00893256|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110635146|NCT00893256|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110635147|NCT00893256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110635148|NCT00893256|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110635149|NCT00893256|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110635150|NCT00893256|Dopamine Agents|dopamine agents|mesh-ancestor
110635151|NCT00893256|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110635152|NCT00893256|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110635153|NCT00893256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110635154|NCT00893256|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110635155|NCT00893256|Antidepressive Agents|antidepressive agents|mesh-ancestor
110635156|NCT00901368|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
110635157|NCT00901368|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110635158|NCT00901368|Autonomic Agents|autonomic agents|mesh-ancestor
110635159|NCT00901368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110635160|NCT00901368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110635161|NCT00901368|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110635162|NCT00901368|Respiratory System Agents|respiratory system agents|mesh-ancestor
110635163|NCT00901368|Glucocorticoids|glucocorticoids|mesh-ancestor
110635164|NCT00901368|Hormones|hormones|mesh-ancestor
110394819|NCT00593502|Oseltamivir|oseltamivir|mesh-list
110635165|NCT00901368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110635166|NCT00901368|Sympathomimetics|sympathomimetics|mesh-ancestor
110635167|NCT00901524|Interferons|interferons|mesh-list
110635168|NCT00901524|Ribavirin|ribavirin|mesh-list
110635169|NCT00901524|Interferon-alpha|interferon-alpha|mesh-list
110635170|NCT00901524|Interferon alpha-2|interferon alpha-2|mesh-list
110635171|NCT00901524|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110635172|NCT00901524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110635174|NCT00901524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110635175|NCT00901524|Antimetabolites|antimetabolites|mesh-ancestor
110635176|NCT00901524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110635177|NCT00901524|Immunologic Factors|immunologic factors|mesh-ancestor
110635178|NCT00901524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110635179|NCT00893412|Tramadol|tramadol|mesh-list
110635180|NCT00893412|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110635181|NCT00893412|Narcotics|narcotics|mesh-ancestor
110635182|NCT00893412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110155996|NCT00386828|Bevacizumab|bevacizumab|mesh-list
110635183|NCT00893412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110635184|NCT00893412|Analgesics|analgesics|mesh-ancestor
110635185|NCT00893412|Sensory System Agents|sensory system agents|mesh-ancestor
110635186|NCT00893412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110635187|NCT00893490|Mitomycins|mitomycins|mesh-list
110635188|NCT00893490|Mitomycin|mitomycin|mesh-list
110635189|NCT00893490|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110282490|NCT00206466|Docetaxel|docetaxel|mesh-list
110254481|NCT00507793|Antifungal Agents|antifungal agents|mesh-ancestor
110635190|NCT00893490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110635191|NCT00893490|Alkylating Agents|alkylating agents|mesh-ancestor
110635192|NCT00893490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110635193|NCT00893490|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110635194|NCT00893490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110635195|NCT00901758|Nitroglycerin|nitroglycerin|mesh-list
110635196|NCT00901758|Vasodilator Agents|vasodilator agents|mesh-ancestor
110635197|NCT00638690|Prednisone|prednisone|mesh-list
110635198|NCT00638690|Prednisolone|prednisolone|mesh-list
110635199|NCT00638690|Abiraterone Acetate|abiraterone acetate|mesh-list
110635200|NCT00638690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110635201|NCT00638690|Glucocorticoids|glucocorticoids|mesh-ancestor
110635202|NCT00638690|Hormones|hormones|mesh-ancestor
110635203|NCT00638690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110635204|NCT00638690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110635205|NCT00638690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110635206|NCT00638690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110635207|NCT00638690|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110635208|NCT00638690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110635209|NCT00638690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110635210|NCT00638690|Hormone Antagonists|hormone antagonists|mesh-ancestor
110635211|NCT00638690|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110635212|NCT02540928|N-(1-(7-fluoro-2-(pyridin-2-yl)quinolin-3-yl)ethyl)-9H-purin-6-amine|n-(1-(7-fluoro-2-(pyridin-2-yl)quinolin-3-yl)ethyl)-9h-purin-6-amine|mesh-list
110635213|NCT02540928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110635214|NCT02540928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110635215|NCT00893724|Tocopherols|tocopherols|mesh-list
110635216|NCT00893724|Vitamin E|vitamin e|mesh-list
110635217|NCT00893724|Tocotrienols|tocotrienols|mesh-list
110635218|NCT00893724|alpha-Tocopherol|alpha-tocopherol|mesh-list
110635219|NCT00893724|Coenzyme Q10|coenzyme q10|mesh-list
110635220|NCT00893724|Niacinamide|niacinamide|mesh-list
110635221|NCT00893724|Niacin|niacin|mesh-list
110117323|NCT01876290|Dexamethasone|dexamethasone|mesh-list
110635222|NCT00893724|Nicotinic Acids|nicotinic acids|mesh-list
110635223|NCT00893724|Ubiquinone|ubiquinone|mesh-list
110635224|NCT00893724|Minocycline|minocycline|mesh-list
110635225|NCT00893724|Acetylcysteine|acetylcysteine|mesh-list
110635226|NCT00893724|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110635227|NCT00893724|Vitamins|vitamins|mesh-ancestor
110635228|NCT00893724|Micronutrients|micronutrients|mesh-ancestor
110635229|NCT00893724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110635230|NCT00893724|Antioxidants|antioxidants|mesh-ancestor
110635231|NCT00893724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110635232|NCT00893724|Protective Agents|protective agents|mesh-ancestor
110635233|NCT00893724|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110635234|NCT00893724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110635235|NCT00893724|Antiviral Agents|antiviral agents|mesh-ancestor
110635236|NCT00893724|Expectorants|expectorants|mesh-ancestor
110635237|NCT00893724|Respiratory System Agents|respiratory system agents|mesh-ancestor
110394837|NCT00593580|Vitamin D|vitamin d|mesh-list
110635238|NCT00893724|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110635239|NCT00893724|Antidotes|antidotes|mesh-ancestor
110635240|NCT00893724|Vitamin B Complex|vitamin b complex|mesh-ancestor
110635241|NCT00893724|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110635242|NCT00893724|Antimetabolites|antimetabolites|mesh-ancestor
110635243|NCT00893724|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110635244|NCT00893724|Vasodilator Agents|vasodilator agents|mesh-ancestor
110635245|NCT00893880|Nitric Oxide|nitric oxide|mesh-list
110635246|NCT00893880|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110635247|NCT00893880|Autonomic Agents|autonomic agents|mesh-ancestor
110635248|NCT00893880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110635249|NCT00893880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110635250|NCT00893880|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110635251|NCT00893880|Respiratory System Agents|respiratory system agents|mesh-ancestor
110635252|NCT00893880|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110635253|NCT00893880|Antioxidants|antioxidants|mesh-ancestor
110635254|NCT00893880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110635255|NCT00893880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110635256|NCT00893880|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
110635257|NCT00893880|Vasodilator Agents|vasodilator agents|mesh-ancestor
110635258|NCT00893880|Gasotransmitters|gasotransmitters|mesh-ancestor
110635259|NCT00893880|Protective Agents|protective agents|mesh-ancestor
110635260|NCT00815594|Bevacizumab|bevacizumab|mesh-list
110635261|NCT00815594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110635262|NCT00815594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110117351|NCT01876433|Mirabegron|mirabegron|mesh-list
110635263|NCT00815594|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110635264|NCT00815594|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110635265|NCT00815594|Growth Substances|growth substances|mesh-ancestor
110282562|NCT00206622|Hormones|hormones|mesh-ancestor
110635266|NCT00815594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110635267|NCT00815594|Growth Inhibitors|growth inhibitors|mesh-ancestor
110635268|NCT00897312|Interferons|interferons|mesh-list
110635269|NCT00897312|Ribavirin|ribavirin|mesh-list
110635270|NCT00897312|Interferon-alpha|interferon-alpha|mesh-list
110635271|NCT00897312|Infliximab|infliximab|mesh-list
110635272|NCT00897312|Tremelimumab|tremelimumab|mesh-list
110635273|NCT00897312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110635274|NCT00897312|Antiviral Agents|antiviral agents|mesh-ancestor
110635275|NCT00897312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110635276|NCT00897312|Antimetabolites|antimetabolites|mesh-ancestor
110635277|NCT00897312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110635278|NCT00897312|Immunologic Factors|immunologic factors|mesh-ancestor
110635279|NCT00897312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110635280|NCT00897312|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110635281|NCT00897312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110635282|NCT00897312|Dermatologic Agents|dermatologic agents|mesh-ancestor
110635283|NCT00897312|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110635284|NCT00897312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110635285|NCT02540460|Delpazolid|delpazolid|mesh-list
110635286|NCT02540460|Oxazolidinones|oxazolidinones|mesh-list
110635287|NCT02540460|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110635288|NCT02540460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110635289|NCT02540460|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110635290|NCT02540460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110635291|NCT02540460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110635292|NCT00543387|Docetaxel|docetaxel|mesh-list
110635293|NCT00543387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110635294|NCT00543387|Tubulin Modulators|tubulin modulators|mesh-ancestor
110635295|NCT00543387|Antimitotic Agents|antimitotic agents|mesh-ancestor
110635296|NCT00543387|Mitosis Modulators|mitosis modulators|mesh-ancestor
110635297|NCT00543387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110635298|NCT03455556|Atezolizumab|atezolizumab|mesh-list
110635299|NCT03455556|Maytansine|maytansine|mesh-list
110635300|NCT03455556|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110635301|NCT03455556|Anetumab ravtansine|anetumab ravtansine|mesh-list
110635302|NCT03455556|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110635303|NCT03455556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110635304|NCT03455556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110635305|NCT03455556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110635306|NCT03455556|Immunologic Factors|immunologic factors|mesh-ancestor
110635307|NCT03455556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110635308|NCT03455556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110635309|NCT03455556|Tubulin Modulators|tubulin modulators|mesh-ancestor
110635310|NCT03455556|Antimitotic Agents|antimitotic agents|mesh-ancestor
110635311|NCT03455556|Mitosis Modulators|mitosis modulators|mesh-ancestor
110635312|NCT03455556|Immunoconjugates|immunoconjugates|mesh-ancestor
110635313|NCT04017624|Nicotine|nicotine|mesh-list
110635314|NCT04017624|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110635315|NCT04017624|Autonomic Agents|autonomic agents|mesh-ancestor
110635316|NCT04017624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110635317|NCT04017624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110635318|NCT04017624|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110635319|NCT04017624|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110635320|NCT04017624|Cholinergic Agents|cholinergic agents|mesh-ancestor
110635321|NCT04017624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110635322|NCT04017624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110635324|NCT00809042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110635325|NCT00809042|Antisickling Agents|antisickling agents|mesh-ancestor
110635326|NCT00809042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110635327|NCT00809042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110635328|NCT00809042|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110635329|NCT00986037|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110635330|NCT00986037|Immunologic Factors|immunologic factors|mesh-ancestor
110635331|NCT00986037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110635332|NCT00983151|Tramadol|tramadol|mesh-list
110635333|NCT00983151|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110635334|NCT00983151|Narcotics|narcotics|mesh-ancestor
110635335|NCT00983151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110635336|NCT00983151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110635337|NCT00983151|Analgesics|analgesics|mesh-ancestor
110635338|NCT00983151|Sensory System Agents|sensory system agents|mesh-ancestor
110635339|NCT00983151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110282636|NCT00473434|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110635340|NCT00635570|Moxifloxacin|moxifloxacin|mesh-list
110635341|NCT00635570|NuvaRing|nuvaring|mesh-list
110635342|NCT00635570|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
110635343|NCT00635570|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110635344|NCT00635570|Contraceptive Agents|contraceptive agents|mesh-ancestor
110635345|NCT00635570|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110635346|NCT00635570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110635347|NCT00635570|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110635348|NCT00635570|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110635349|NCT00635570|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110635350|NCT00635570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110635351|NCT00635570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110635352|NCT00635570|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110635353|NCT00635570|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110635354|NCT00635570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110635355|NCT00635570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110635356|NCT00635570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110635357|NCT00893958|Mycophenolic Acid|mycophenolic acid|mesh-list
110156106|NCT05156905|Docetaxel|docetaxel|mesh-list
110635359|NCT00893958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110635360|NCT00893958|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110635361|NCT00893958|Antitubercular Agents|antitubercular agents|mesh-ancestor
110635362|NCT00893958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110635363|NCT00893958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110635364|NCT00893958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110635365|NCT00893958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110635366|NCT00986115|Memantine|memantine|mesh-list
110635367|NCT00986115|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110635368|NCT00986115|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110635369|NCT00986115|Dopamine Agents|dopamine agents|mesh-ancestor
110635370|NCT00986115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110635371|NCT00986115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110635372|NCT00986115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110394841|NCT00593580|Vitamins|vitamins|mesh-ancestor
110635373|NCT00986115|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110635374|NCT00986115|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110635376|NCT04035876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110635377|NCT04035876|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110635378|NCT04035876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110635379|NCT04035876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110635380|NCT00902070|Rocuronium|rocuronium|mesh-list
110635381|NCT00902070|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110635382|NCT00902070|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110635383|NCT00902070|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110635384|NCT00902070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110635385|NCT00902070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110635386|NCT00635492|Insulin|insulin|mesh-list
110635387|NCT00635492|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110635388|NCT00635492|Exenatide|exenatide|mesh-list
110635389|NCT00635492|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110635390|NCT00635492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110635391|NCT00635492|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110635392|NCT00635492|Incretins|incretins|mesh-ancestor
110635393|NCT00635492|Hormones|hormones|mesh-ancestor
110635394|NCT00635492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110635395|NCT00543309|Milrinone|milrinone|mesh-list
110635396|NCT00543309|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
110635397|NCT00543309|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110635398|NCT00543309|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110635399|NCT00543309|Vasodilator Agents|vasodilator agents|mesh-ancestor
110635400|NCT00543309|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110635401|NCT00543309|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110635402|NCT00543309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110635403|NCT00543309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110635404|NCT00543309|Protective Agents|protective agents|mesh-ancestor
110635405|NCT00543309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110635406|NCT00543309|Natriuretic Agents|natriuretic agents|mesh-ancestor
110635407|NCT00569582|Mifepristone|mifepristone|mesh-list
110635408|NCT00569582|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
110635409|NCT00569582|Abortifacient Agents|abortifacient agents|mesh-ancestor
110635410|NCT00569582|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110635411|NCT00569582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110635412|NCT00569582|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110117436|NCT01877122|Ibuprofen|ibuprofen|mesh-list
110635414|NCT00569582|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110635415|NCT00569582|Contraceptive Agents|contraceptive agents|mesh-ancestor
110635416|NCT00569582|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
110635417|NCT00569582|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
110635418|NCT00569582|Hormone Antagonists|hormone antagonists|mesh-ancestor
110635419|NCT00569582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110635420|NCT00569582|Luteolytic Agents|luteolytic agents|mesh-ancestor
110635421|NCT00569582|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110635422|NCT00569582|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
110635423|NCT00988845|Indole-3-carbinol|indole-3-carbinol|mesh-list
110635424|NCT00988845|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110635425|NCT00988845|Protective Agents|protective agents|mesh-ancestor
110635426|NCT00988845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110635427|NCT00988845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110635428|NCT00983697|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110635429|NCT00983697|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110635430|NCT00983697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110635431|NCT00902460|Midazolam|midazolam|mesh-list
110635432|NCT00902460|Tofacitinib|tofacitinib|mesh-list
110635433|NCT00902460|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110394856|NCT00593619|Hematinics|hematinics|mesh-ancestor
110635434|NCT00902460|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110635435|NCT00902460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110635436|NCT00902460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110635437|NCT00902460|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110635438|NCT00902460|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110635439|NCT00902460|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110635440|NCT00902460|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110635441|NCT00902460|Anesthetics, General|anesthetics, general|mesh-ancestor
110635442|NCT00902460|Anesthetics|anesthetics|mesh-ancestor
110635443|NCT00902460|GABA Modulators|gaba modulators|mesh-ancestor
110635444|NCT00902460|GABA Agents|gaba agents|mesh-ancestor
110635445|NCT00902460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110635446|NCT00902460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110635447|NCT00902460|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
110635448|NCT00902460|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110635449|NCT00902460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110635450|NCT00989079|Ertugliflozin|ertugliflozin|mesh-list
110635451|NCT00989079|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110635452|NCT00989079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110635453|NCT00989079|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110635454|NCT00989079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110635455|NCT00809198|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
110635456|NCT00809198|Hyaluronic Acid|hyaluronic acid|mesh-list
110635457|NCT00809198|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110635458|NCT00809198|Immunologic Factors|immunologic factors|mesh-ancestor
110635459|NCT00809198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110635460|NCT00809198|Viscosupplements|viscosupplements|mesh-ancestor
110635461|NCT00809198|Protective Agents|protective agents|mesh-ancestor
110635462|NCT00809198|Laxatives|laxatives|mesh-ancestor
110635463|NCT00809198|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110635464|NCT00986505|Lidocaine|lidocaine|mesh-list
110635465|NCT00986505|Anesthetics, Local|anesthetics, local|mesh-ancestor
110635466|NCT00986505|Anesthetics|anesthetics|mesh-ancestor
110635467|NCT00986505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110635468|NCT00986505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110635469|NCT00986505|Sensory System Agents|sensory system agents|mesh-ancestor
110635470|NCT00986505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110635471|NCT00986505|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110635472|NCT00986505|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110635473|NCT00986505|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110635474|NCT00986505|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110635475|NCT00986505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110635476|NCT03667443|Inositol|inositol|mesh-list
110635477|NCT03667443|Vitamin B Complex|vitamin b complex|mesh-ancestor
110635478|NCT03667443|Vitamins|vitamins|mesh-ancestor
110635479|NCT03667443|Micronutrients|micronutrients|mesh-ancestor
110635480|NCT03667443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110635481|NCT00902772|Lorazepam|lorazepam|mesh-list
110635482|NCT00902772|Anticonvulsants|anticonvulsants|mesh-ancestor
110635483|NCT00902772|Antiemetics|antiemetics|mesh-ancestor
110635484|NCT00902772|Autonomic Agents|autonomic agents|mesh-ancestor
110635485|NCT00902772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110635486|NCT00902772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110635487|NCT00902772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110635488|NCT00902772|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110635489|NCT00902772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110635490|NCT00902772|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110635491|NCT00902772|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110635492|NCT00902772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110635493|NCT00902772|GABA Modulators|gaba modulators|mesh-ancestor
110635494|NCT00902772|GABA Agents|gaba agents|mesh-ancestor
110635495|NCT00902772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110635496|NCT00902772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110635497|NCT00894660|Amodiaquine|amodiaquine|mesh-list
110635498|NCT00894660|Antimalarials|antimalarials|mesh-ancestor
110635499|NCT00894660|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110635500|NCT00894660|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110635501|NCT00894660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110394864|NCT00593658|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110635502|NCT00721409|Letrozole|letrozole|mesh-list
110635503|NCT00721409|Palbociclib|palbociclib|mesh-list
110635504|NCT00721409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110635505|NCT00721409|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110635506|NCT00721409|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110635507|NCT00721409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110635508|NCT00721409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110635509|NCT00721409|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110635510|NCT00721409|Hormone Antagonists|hormone antagonists|mesh-ancestor
110635511|NCT00721409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110635512|NCT00721409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110635513|NCT00721409|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110635514|NCT00542997|Immunoglobulins|immunoglobulins|mesh-list
110635515|NCT00542997|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110635516|NCT00542997|Antibodies|antibodies|mesh-list
110635517|NCT00542997|Immunologic Factors|immunologic factors|mesh-ancestor
110635518|NCT00542997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110635519|NCT00903084|Tenofovir|tenofovir|mesh-list
110635520|NCT00903084|Antiviral Agents|antiviral agents|mesh-ancestor
110635521|NCT00903084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110635522|NCT00903084|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110635523|NCT00903084|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110635524|NCT00903084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110635525|NCT00903084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110635526|NCT00903084|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110635527|NCT00903084|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110635528|NCT02541006|Tiotropium Bromide|tiotropium bromide|mesh-list
110635529|NCT02541006|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110635530|NCT02541006|Autonomic Agents|autonomic agents|mesh-ancestor
110635531|NCT02541006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110635532|NCT02541006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110635533|NCT02541006|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110635534|NCT02541006|Respiratory System Agents|respiratory system agents|mesh-ancestor
110635535|NCT02541006|Parasympatholytics|parasympatholytics|mesh-ancestor
110635536|NCT02541006|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110635537|NCT02541006|Cholinergic Agents|cholinergic agents|mesh-ancestor
110635538|NCT02541006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110635539|NCT02541006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110635540|NCT02591771|Epinephrine|epinephrine|mesh-list
110635541|NCT02591771|Racepinephrine|racepinephrine|mesh-list
110635542|NCT02591771|Epinephryl borate|epinephryl borate|mesh-list
110635543|NCT02591771|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110635544|NCT02591771|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110635545|NCT02591771|Adrenergic Agents|adrenergic agents|mesh-ancestor
110635546|NCT02591771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110635547|NCT02591771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110635548|NCT02591771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110635549|NCT02591771|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110635550|NCT02591771|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110635551|NCT02591771|Autonomic Agents|autonomic agents|mesh-ancestor
110635552|NCT02591771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110635553|NCT02591771|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110635554|NCT02591771|Respiratory System Agents|respiratory system agents|mesh-ancestor
110635555|NCT02591771|Mydriatics|mydriatics|mesh-ancestor
110635556|NCT02591771|Sympathomimetics|sympathomimetics|mesh-ancestor
110635557|NCT02591771|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110117482|NCT01877590|Vitamins|vitamins|mesh-ancestor
110635558|NCT00986817|Terlipressin|terlipressin|mesh-list
110635559|NCT00986817|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110635560|NCT00986817|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110635561|NCT00572832|Vaccines|vaccines|mesh-list
110635562|NCT00572832|Immunologic Factors|immunologic factors|mesh-ancestor
110635563|NCT00572832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110635564|NCT02591849|Glucagon|glucagon|mesh-list
110635565|NCT02591849|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
110635566|NCT02591849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110635567|NCT02591849|Hormones|hormones|mesh-ancestor
110635568|NCT02591849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110254545|NCT05594186|Coagulants|coagulants|mesh-ancestor
110635569|NCT02591849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110635570|NCT02591849|Incretins|incretins|mesh-ancestor
110635571|NCT00898794|Bevacizumab|bevacizumab|mesh-list
110635572|NCT00898794|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110635573|NCT00898794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110635574|NCT00898794|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110635575|NCT00898794|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110635576|NCT00898794|Growth Substances|growth substances|mesh-ancestor
110635577|NCT00898794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110635578|NCT00898794|Growth Inhibitors|growth inhibitors|mesh-ancestor
110635579|NCT04086719|Pyrimethamine|pyrimethamine|mesh-list
110635580|NCT04086719|Deucravacitinib|deucravacitinib|mesh-list
110635581|NCT04086719|Antimalarials|antimalarials|mesh-ancestor
110635582|NCT04086719|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110635583|NCT04086719|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110635584|NCT04086719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110635585|NCT04086719|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110635586|NCT04086719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110635587|NCT04086719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110635588|NCT04086719|Dermatologic Agents|dermatologic agents|mesh-ancestor
110635589|NCT04086719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110635590|NCT00898950|Aspirin|aspirin|mesh-list
110635591|NCT00898950|Salicylic Acid|salicylic acid|mesh-list
110156267|NCT04733326|Ketorolac|ketorolac|mesh-list
110635592|NCT00898950|Salicylates|salicylates|mesh-list
110635593|NCT00898950|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110635594|NCT00898950|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110635595|NCT00898950|Analgesics|analgesics|mesh-ancestor
110635596|NCT00898950|Sensory System Agents|sensory system agents|mesh-ancestor
110635597|NCT00898950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110635598|NCT00898950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110635599|NCT00898950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110635600|NCT00898950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110635601|NCT00898950|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110635602|NCT00898950|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110635603|NCT00898950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110635604|NCT00898950|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110635605|NCT00898950|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110635606|NCT00898950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110635607|NCT00898950|Antipyretics|antipyretics|mesh-ancestor
110635608|NCT00898950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110635609|NCT00898950|Antifungal Agents|antifungal agents|mesh-ancestor
110635610|NCT00898950|Keratolytic Agents|keratolytic agents|mesh-ancestor
110635611|NCT00898950|Dermatologic Agents|dermatologic agents|mesh-ancestor
110635612|NCT03622515|Anesthetics|anesthetics|mesh-list
110635613|NCT03622515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110635614|NCT03622515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110635615|NCT05279235|Favipiravir|favipiravir|mesh-list
110635616|NCT05279235|Antiviral Agents|antiviral agents|mesh-ancestor
110635617|NCT05279235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110635618|NCT00229723|Gefitinib|gefitinib|mesh-list
110635619|NCT00229723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110635620|NCT00229723|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110635622|NCT00229723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110635623|NCT04035798|Memantine|memantine|mesh-list
110635624|NCT04035798|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110635625|NCT04035798|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110635626|NCT04035798|Dopamine Agents|dopamine agents|mesh-ancestor
110635627|NCT04035798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110635628|NCT04035798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110635629|NCT04035798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110635630|NCT04035798|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110635631|NCT04035798|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110635632|NCT01075477|Rituximab|rituximab|mesh-list
110635633|NCT01075477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110635634|NCT01075477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110635635|NCT01075477|Immunologic Factors|immunologic factors|mesh-ancestor
110635636|NCT01075477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110635637|NCT01075477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110635638|NCT01075555|Sorafenib|sorafenib|mesh-list
110635639|NCT01075555|Pravastatin|pravastatin|mesh-list
110635640|NCT01075555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110635641|NCT01075555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110635642|NCT01075555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110635643|NCT01075555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110635644|NCT01075555|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110635645|NCT01075555|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110635646|NCT01075555|Antimetabolites|antimetabolites|mesh-ancestor
110635647|NCT01075555|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110635648|NCT01075555|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110635649|NCT00627926|Interferons|interferons|mesh-list
110635650|NCT00627926|Ribavirin|ribavirin|mesh-list
110635651|NCT00627926|Interferon-alpha|interferon-alpha|mesh-list
110635652|NCT00627926|Interferon alpha-2|interferon alpha-2|mesh-list
110635653|NCT00627926|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110635654|NCT00627926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110635655|NCT00627926|Antiviral Agents|antiviral agents|mesh-ancestor
110635656|NCT00627926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110635657|NCT00627926|Antimetabolites|antimetabolites|mesh-ancestor
110635658|NCT00627926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110635659|NCT00627926|Immunologic Factors|immunologic factors|mesh-ancestor
110635660|NCT00627926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110635661|NCT00228553|Modafinil|modafinil|mesh-list
110635662|NCT00228553|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110635663|NCT00228553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110635664|NCT00228553|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
110635665|NCT00228553|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110635666|NCT00228553|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110635667|NCT00228553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110635668|NCT00922506|Doxazosin|doxazosin|mesh-list
110635669|NCT00922506|Tolterodine Tartrate|tolterodine tartrate|mesh-list
110635670|NCT00922506|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110635671|NCT00922506|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110635672|NCT00922506|Cholinergic Agents|cholinergic agents|mesh-ancestor
110635673|NCT00922506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110635674|NCT00922506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110635675|NCT00922506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110635676|NCT00922506|Urological Agents|urological agents|mesh-ancestor
110635677|NCT00922506|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110635678|NCT00922506|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110635679|NCT00922506|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110635680|NCT00922506|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110635681|NCT00922506|Adrenergic Agents|adrenergic agents|mesh-ancestor
110635682|NCT00816140|Clarithromycin|clarithromycin|mesh-list
110049021|NCT03595917|Dasatinib|dasatinib|mesh-list
110635683|NCT00816140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110635684|NCT00816140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110635685|NCT00816140|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110635686|NCT00816140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110635687|NCT00816140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110635688|NCT00816140|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110635689|NCT00816140|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110635690|NCT00895128|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110635692|NCT00895128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110635693|NCT00895128|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110635694|NCT00895128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110635695|NCT00895128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110635696|NCT00903942|Paclitaxel|paclitaxel|mesh-list
110635697|NCT00903942|Carboplatin|carboplatin|mesh-list
110635698|NCT00903942|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110635699|NCT00903942|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110635700|NCT00903942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110635701|NCT00903942|Tubulin Modulators|tubulin modulators|mesh-ancestor
110635702|NCT00903942|Antimitotic Agents|antimitotic agents|mesh-ancestor
110635703|NCT00903942|Mitosis Modulators|mitosis modulators|mesh-ancestor
110635704|NCT00903942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110635705|NCT00904020|Lidocaine|lidocaine|mesh-list
110635706|NCT00904020|Anesthetics, Local|anesthetics, local|mesh-ancestor
110635707|NCT00904020|Anesthetics|anesthetics|mesh-ancestor
110635708|NCT00904020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110635709|NCT00904020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110635710|NCT00904020|Sensory System Agents|sensory system agents|mesh-ancestor
110635711|NCT00904020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110635712|NCT00904020|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110635713|NCT00904020|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110635714|NCT00904020|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110635715|NCT00904020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110635716|NCT00904020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110635718|NCT00895362|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110635719|NCT00895362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110635720|NCT00895362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110635721|NCT00895362|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110635722|NCT00895362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110635723|NCT00895362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110635724|NCT00904098|Frovatriptan|frovatriptan|mesh-list
110635725|NCT00904098|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110635726|NCT00904098|Serotonin Agents|serotonin agents|mesh-ancestor
110635727|NCT00904098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110635728|NCT00904098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110635729|NCT00904098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110635730|NCT00904176|Dapagliflozin|dapagliflozin|mesh-list
110635731|NCT00904176|Digoxin|digoxin|mesh-list
110635732|NCT00904176|Warfarin|warfarin|mesh-list
110635733|NCT00904176|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110635734|NCT00904176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110635735|NCT00904176|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110394914|NCT00594126|Imetelstat|imetelstat|mesh-list
110635736|NCT00904176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110635737|NCT00904176|Anticoagulants|anticoagulants|mesh-ancestor
110635738|NCT00904176|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110635739|NCT00904176|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110635740|NCT00904176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110635741|NCT00904176|Protective Agents|protective agents|mesh-ancestor
110635744|NCT02540070|Dexmedetomidine|dexmedetomidine|mesh-list
110635745|NCT02540070|Morphine|morphine|mesh-list
110635746|NCT02540070|Ropivacaine|ropivacaine|mesh-list
110635747|NCT02540070|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110635748|NCT02540070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110635749|NCT02540070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110635750|NCT02540070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110635751|NCT02540070|Analgesics|analgesics|mesh-ancestor
110635752|NCT02540070|Sensory System Agents|sensory system agents|mesh-ancestor
110635753|NCT02540070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110156363|NCT03958942|Sensory System Agents|sensory system agents|mesh-ancestor
110635754|NCT02540070|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110635755|NCT02540070|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110635756|NCT02540070|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110635757|NCT02540070|Adrenergic Agents|adrenergic agents|mesh-ancestor
110635758|NCT02540070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110635759|NCT02540070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110635760|NCT02540070|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110635761|NCT02540070|Narcotics|narcotics|mesh-ancestor
110635762|NCT02540070|Anesthetics, Local|anesthetics, local|mesh-ancestor
110635763|NCT02540070|Anesthetics|anesthetics|mesh-ancestor
110635764|NCT02540070|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110635765|NCT02540070|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110635766|NCT02540070|Autonomic Agents|autonomic agents|mesh-ancestor
110635767|NCT02540070|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110635768|NCT02540070|Respiratory System Agents|respiratory system agents|mesh-ancestor
110635769|NCT02540070|Mydriatics|mydriatics|mesh-ancestor
110635770|NCT02540070|Sympathomimetics|sympathomimetics|mesh-ancestor
110635771|NCT02540070|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110635772|NCT02540070|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110635773|NCT02540070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110635774|NCT02540070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110635775|NCT02540070|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110635776|NCT02540070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110635778|NCT00905814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110635779|NCT00905814|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110635780|NCT00905814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110635781|NCT00905814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110635782|NCT00900510|Trimethoprim|trimethoprim|mesh-list
110635783|NCT00900510|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
110635784|NCT00900510|Sulfamethoxazole|sulfamethoxazole|mesh-list
110635785|NCT00900510|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110635786|NCT00900510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110635787|NCT00900510|Antimalarials|antimalarials|mesh-ancestor
110635788|NCT00900510|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110635789|NCT00900510|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110635790|NCT00900510|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110635792|NCT00900510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110635793|NCT00900510|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110635794|NCT00900510|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
110394934|NCT01605344|Protective Agents|protective agents|mesh-ancestor
110635795|NCT00900510|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110635796|NCT00900510|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110635798|NCT00160693|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110635799|NCT00160693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110635800|NCT00160693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110635801|NCT00160693|Immunologic Factors|immunologic factors|mesh-ancestor
110635802|NCT00160693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110635803|NCT00160693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110635806|NCT00906048|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110635807|NCT00906048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110635808|NCT00906048|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110635809|NCT00906048|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110635810|NCT00906048|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110635811|NCT00906048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110635812|NCT00906048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110635813|NCT00906048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110635814|NCT00906048|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110635815|NCT00906048|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110635816|NCT00906048|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110635817|NCT00906048|Antitubercular Agents|antitubercular agents|mesh-ancestor
110635818|NCT00906048|Leprostatic Agents|leprostatic agents|mesh-ancestor
110635819|NCT00906048|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110635820|NCT00906048|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110635821|NCT00906048|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110635822|NCT00906048|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110635823|NCT00906048|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110635824|NCT00906048|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110635825|NCT00906048|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110635826|NCT00906126|Misoprostol|misoprostol|mesh-list
110635827|NCT00906126|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110635828|NCT00906126|Abortifacient Agents|abortifacient agents|mesh-ancestor
110635829|NCT00906126|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110635830|NCT00906126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110635831|NCT00906126|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110635832|NCT00906126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110635833|NCT00906126|Oxytocics|oxytocics|mesh-ancestor
110635834|NCT00900744|Tamoxifen|tamoxifen|mesh-list
110635835|NCT00900744|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110635836|NCT00900744|Hormone Antagonists|hormone antagonists|mesh-ancestor
110635837|NCT00900744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110635838|NCT00900744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110635839|NCT00900744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110635840|NCT00900744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110635841|NCT00900744|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110635842|NCT00900744|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110635843|NCT00900744|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110635844|NCT00643760|Pregabalin|pregabalin|mesh-list
110635845|NCT00643760|Gabapentin|gabapentin|mesh-list
110635846|NCT00643760|Analgesics|analgesics|mesh-ancestor
110635847|NCT00643760|Sensory System Agents|sensory system agents|mesh-ancestor
110635848|NCT00643760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110635849|NCT00643760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110635851|NCT00643760|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110635852|NCT00643760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110635853|NCT00643760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110635854|NCT00643760|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110635855|NCT00643760|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110635856|NCT00643760|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110394953|NCT00593463|Anticonvulsants|anticonvulsants|mesh-ancestor
110635857|NCT00643760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110635858|NCT00643760|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110635859|NCT00643760|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110635860|NCT00643760|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110635861|NCT00643760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110635862|NCT00643760|Antimanic Agents|antimanic agents|mesh-ancestor
110635863|NCT00904644|Raltegravir Potassium|raltegravir potassium|mesh-list
110635864|NCT00904644|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110635865|NCT00904644|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110635866|NCT00904644|Antiviral Agents|antiviral agents|mesh-ancestor
110635867|NCT00904644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110635868|NCT00904644|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110635869|NCT00904644|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110635870|NCT00904644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110635871|NCT00904644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110635872|NCT00906360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110635873|NCT00906360|Cetuximab|cetuximab|mesh-list
110635874|NCT00906360|Sunitinib|sunitinib|mesh-list
110635875|NCT00906360|Antibodies|antibodies|mesh-list
110635876|NCT00906360|Immunoglobulins|immunoglobulins|mesh-list
110635877|NCT00906360|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110635878|NCT00906360|Immunologic Factors|immunologic factors|mesh-ancestor
110635879|NCT00906360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110635880|NCT00906360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110635881|NCT00906360|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110635882|NCT00906360|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110635883|NCT00906360|Growth Substances|growth substances|mesh-ancestor
110635884|NCT00906360|Growth Inhibitors|growth inhibitors|mesh-ancestor
110635885|NCT00906360|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110635886|NCT00906360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110635887|NCT00906360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110635888|NCT00643604|Treprostinil|treprostinil|mesh-list
110635889|NCT00643604|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110635891|NCT00603798|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110635892|NCT00603798|Immunologic Factors|immunologic factors|mesh-ancestor
110635893|NCT00603798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110635894|NCT00603798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110635895|NCT00603798|Interferon Inducers|interferon inducers|mesh-ancestor
110635896|NCT00819572|Antibodies|antibodies|mesh-list
110635897|NCT00819572|Immunoglobulin Fragments|immunoglobulin fragments|mesh-list
110635898|NCT00819572|Immunologic Factors|immunologic factors|mesh-ancestor
110635899|NCT00819572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110635900|NCT00630812|Mannitol|mannitol|mesh-list
110635901|NCT00630812|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110635902|NCT00630812|Diuretics|diuretics|mesh-ancestor
110635903|NCT00630812|Natriuretic Agents|natriuretic agents|mesh-ancestor
110635904|NCT00630812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110635905|NCT00906516|Bevacizumab|bevacizumab|mesh-list
110635906|NCT00906516|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110635907|NCT00906516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110635908|NCT00906516|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110635909|NCT00906516|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110635910|NCT00906516|Growth Substances|growth substances|mesh-ancestor
110635911|NCT00906516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110635912|NCT00906516|Growth Inhibitors|growth inhibitors|mesh-ancestor
110635913|NCT00629798|Fludarabine|fludarabine|mesh-list
110635914|NCT00629798|Melphalan|melphalan|mesh-list
110635915|NCT00629798|Busulfan|busulfan|mesh-list
110635916|NCT00629798|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110117602|NCT01878578|Phenytoin|phenytoin|mesh-list
110635917|NCT00629798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110635918|NCT00629798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110635919|NCT00629798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110635920|NCT00629798|Immunologic Factors|immunologic factors|mesh-ancestor
110635921|NCT00629798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110635922|NCT00629798|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110635923|NCT00629798|Alkylating Agents|alkylating agents|mesh-ancestor
110635924|NCT00629798|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110635925|NCT00160615|Levetiracetam|levetiracetam|mesh-list
110635926|NCT00160615|Anticonvulsants|anticonvulsants|mesh-ancestor
110635927|NCT00160615|Nootropic Agents|nootropic agents|mesh-ancestor
110635928|NCT00906594|Latanoprost|latanoprost|mesh-list
110635929|NCT00906594|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110635930|NCT00906594|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110635931|NCT03970759|Fluorides|fluorides|mesh-list
110635932|NCT03970759|Tin Fluorides|tin fluorides|mesh-list
110635933|NCT03970759|Cariostatic Agents|cariostatic agents|mesh-ancestor
110635934|NCT03970759|Protective Agents|protective agents|mesh-ancestor
110635935|NCT03970759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110635936|NCT00905190|Ondansetron|ondansetron|mesh-list
110635937|NCT00905190|Antiemetics|antiemetics|mesh-ancestor
110635938|NCT00905190|Autonomic Agents|autonomic agents|mesh-ancestor
110635939|NCT00905190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110635940|NCT00905190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110635941|NCT00905190|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110635942|NCT00905190|Antipruritics|antipruritics|mesh-ancestor
110635943|NCT00905190|Dermatologic Agents|dermatologic agents|mesh-ancestor
110635944|NCT00905190|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110635946|NCT00905190|Serotonin Agents|serotonin agents|mesh-ancestor
110635947|NCT00905190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110635948|NCT00905190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110635949|NCT00905502|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110635950|NCT00604500|Mometasone Furoate|mometasone furoate|mesh-list
110635951|NCT00604500|Formoterol Fumarate|formoterol fumarate|mesh-list
110635952|NCT00604500|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110635953|NCT00604500|Autonomic Agents|autonomic agents|mesh-ancestor
110635954|NCT00604500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110635955|NCT00604500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110635956|NCT00604500|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110635957|NCT00604500|Respiratory System Agents|respiratory system agents|mesh-ancestor
110635958|NCT00604500|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110635959|NCT00604500|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110635960|NCT00604500|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110635961|NCT00604500|Adrenergic Agents|adrenergic agents|mesh-ancestor
110635962|NCT00604500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110635963|NCT00604500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110635964|NCT00604500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110635965|NCT00604500|Dermatologic Agents|dermatologic agents|mesh-ancestor
110635966|NCT00604500|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110635967|NCT00627458|Vaccines|vaccines|mesh-list
110635968|NCT00627458|Immunologic Factors|immunologic factors|mesh-ancestor
110635969|NCT00627458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110635970|NCT00909168|Gemtuzumab|gemtuzumab|mesh-list
110635971|NCT00909168|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110635972|NCT00909168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110635974|NCT00909168|Immunoconjugates|immunoconjugates|mesh-ancestor
110635975|NCT00909168|Immunologic Factors|immunologic factors|mesh-ancestor
110635976|NCT00909168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110635977|NCT00816218|Pioglitazone|pioglitazone|mesh-list
110635978|NCT00816218|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110156523|NCT05633472|Vitamin D|vitamin d|mesh-list
110394979|NCT00592410|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110635979|NCT00816218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110635982|NCT00819728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110635983|NCT00819728|Tubulin Modulators|tubulin modulators|mesh-ancestor
110635984|NCT00819728|Antimitotic Agents|antimitotic agents|mesh-ancestor
110635985|NCT00819728|Mitosis Modulators|mitosis modulators|mesh-ancestor
110635986|NCT00819728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110635987|NCT00819728|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110635988|NCT00819728|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110635989|NCT00819728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110635990|NCT00906828|Levodopa|levodopa|mesh-list
110635991|NCT00906828|Carbidopa|carbidopa|mesh-list
110635992|NCT00906828|Entacapone|entacapone|mesh-list
110635993|NCT00906828|Tolcapone|tolcapone|mesh-list
110635994|NCT00906828|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110635995|NCT00906828|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110635996|NCT00906828|Dopamine Agents|dopamine agents|mesh-ancestor
110635997|NCT00906828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110635998|NCT00906828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110635999|NCT00906828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110636000|NCT00906828|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
110636001|NCT00906828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110636002|NCT00906828|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
110636003|NCT00819806|Cyclophosphamide|cyclophosphamide|mesh-list
110636004|NCT00819806|Vaccines|vaccines|mesh-list
110636005|NCT00819806|Immunologic Factors|immunologic factors|mesh-ancestor
110636006|NCT00819806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110636007|NCT00819806|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110636008|NCT00819806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110636009|NCT00819806|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110636010|NCT00819806|Alkylating Agents|alkylating agents|mesh-ancestor
110636011|NCT00819806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110636012|NCT00819806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110636013|NCT00819806|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110636014|NCT00909402|Capecitabine|capecitabine|mesh-list
110636015|NCT00909402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110636016|NCT00909402|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110636017|NCT00909402|Antimetabolites|antimetabolites|mesh-ancestor
110636018|NCT00909402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110636019|NCT02537964|Chlorhexidine|chlorhexidine|mesh-list
110636020|NCT02537964|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110636021|NCT02537964|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110636022|NCT02537964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110636023|NCT02537964|Disinfectants|disinfectants|mesh-ancestor
110636024|NCT02537964|Dermatologic Agents|dermatologic agents|mesh-ancestor
110636025|NCT00821444|Ziprasidone|ziprasidone|mesh-list
110636026|NCT00821444|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110636027|NCT00821444|Serotonin Agents|serotonin agents|mesh-ancestor
110636028|NCT00821444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110117633|NCT01878708|BB 1101|bb 1101|mesh-list
110636029|NCT00821444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110636030|NCT00821444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110636031|NCT00821444|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110636032|NCT00821444|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110636033|NCT00821444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110636034|NCT00821444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110636035|NCT00821444|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110636036|NCT00821444|Dopamine Agents|dopamine agents|mesh-ancestor
110636037|NCT00909558|Immunomodulating Agents|immunomodulating agents|mesh-list
110636038|NCT00909558|Immunologic Factors|immunologic factors|mesh-ancestor
110636039|NCT00909558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110636040|NCT00819962|Bupivacaine|bupivacaine|mesh-list
110636041|NCT00819962|Anesthetics, Local|anesthetics, local|mesh-ancestor
110636042|NCT00819962|Anesthetics|anesthetics|mesh-ancestor
110636043|NCT00819962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110636044|NCT00819962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110636046|NCT00819962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110156552|NCT03151603|Fosfomycin|fosfomycin|mesh-list
110636047|NCT00820118|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110636048|NCT00820118|Atazanavir Sulfate|atazanavir sulfate|mesh-list
110636049|NCT00820118|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110636050|NCT00820118|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110636051|NCT00820118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110636052|NCT00820118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110636053|NCT00820118|Antiviral Agents|antiviral agents|mesh-ancestor
110636054|NCT00820118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110636055|NCT00820118|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110636056|NCT00820118|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110636057|NCT00820118|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110636058|NCT00820118|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110636059|NCT00820118|Protease Inhibitors|protease inhibitors|mesh-ancestor
110636060|NCT00927498|Cytarabine|cytarabine|mesh-list
110636061|NCT00927498|Daunorubicin|daunorubicin|mesh-list
110636062|NCT00927498|Gemtuzumab|gemtuzumab|mesh-list
110636063|NCT00927498|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110636064|NCT00927498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110636065|NCT00927498|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110636066|NCT00927498|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110636067|NCT00927498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110636068|NCT00927498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110636069|NCT00927498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110636070|NCT00927498|Immunotoxins|immunotoxins|mesh-ancestor
110636071|NCT00927498|Immunoconjugates|immunoconjugates|mesh-ancestor
110636072|NCT00927498|Immunologic Factors|immunologic factors|mesh-ancestor
110636073|NCT00927498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110636074|NCT00927498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110636075|NCT00927498|Antimetabolites|antimetabolites|mesh-ancestor
110636076|NCT00927498|Antiviral Agents|antiviral agents|mesh-ancestor
110636077|NCT00927498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110636078|NCT00927498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110636079|NCT00159913|Sildenafil Citrate|sildenafil citrate|mesh-list
110636080|NCT00159913|Citric Acid|citric acid|mesh-list
110636081|NCT00159913|Sodium Citrate|sodium citrate|mesh-list
110636082|NCT00159913|Anticoagulants|anticoagulants|mesh-ancestor
110636083|NCT00159913|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110636084|NCT00159913|Chelating Agents|chelating agents|mesh-ancestor
110636085|NCT00159913|Sequestering Agents|sequestering agents|mesh-ancestor
110636086|NCT00159913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110636087|NCT00159913|Vasodilator Agents|vasodilator agents|mesh-ancestor
110636088|NCT00159913|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110636089|NCT00159913|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110636090|NCT00159913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110636091|NCT00159913|Urological Agents|urological agents|mesh-ancestor
110636093|NCT05498259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110636094|NCT05498259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110636095|NCT05498259|Immunologic Factors|immunologic factors|mesh-ancestor
110636096|NCT05498259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110636097|NCT05498259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110636098|NCT00821600|Risperidone|risperidone|mesh-list
110636099|NCT00821600|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110636100|NCT00821600|Serotonin Agents|serotonin agents|mesh-ancestor
110636101|NCT00821600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110636102|NCT00821600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110636103|NCT00821600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110636104|NCT00821600|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110636105|NCT00821600|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110636106|NCT00821600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110636107|NCT00821600|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110636108|NCT00821600|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110636109|NCT00821600|Dopamine Agents|dopamine agents|mesh-ancestor
110636110|NCT00987207|Cyclosporine|cyclosporine|mesh-list
110636111|NCT00987207|Cyclosporins|cyclosporins|mesh-list
110636112|NCT00987207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110395005|NCT01605773|Glyburide|glyburide|mesh-list
110636113|NCT00987207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110636115|NCT00987207|Immunologic Factors|immunologic factors|mesh-ancestor
110636116|NCT00987207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110636117|NCT00987207|Antifungal Agents|antifungal agents|mesh-ancestor
110636118|NCT00987207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110636119|NCT00987207|Dermatologic Agents|dermatologic agents|mesh-ancestor
110636120|NCT00987207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110636121|NCT00987207|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110636122|NCT00604188|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
110636123|NCT00604188|Buprenorphine|buprenorphine|mesh-list
110636124|NCT00604188|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110636125|NCT00604188|Narcotics|narcotics|mesh-ancestor
110636126|NCT00604188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110636127|NCT00604188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110636128|NCT00604188|Analgesics|analgesics|mesh-ancestor
110636129|NCT00604188|Sensory System Agents|sensory system agents|mesh-ancestor
110636130|NCT00604188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110636131|NCT00604188|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110636132|NCT00820352|Bosentan|bosentan|mesh-list
110636133|NCT00820352|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110636134|NCT00820352|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
110636135|NCT00820352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110636136|NCT00927654|Iloprost|iloprost|mesh-list
110636137|NCT00927654|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110636138|NCT00927654|Vasodilator Agents|vasodilator agents|mesh-ancestor
110636139|NCT00927732|Quinidine|quinidine|mesh-list
110636140|NCT00927732|Hydroquinidine|hydroquinidine|mesh-list
110636141|NCT00927732|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110636142|NCT00927732|Parasympatholytics|parasympatholytics|mesh-ancestor
110636143|NCT00927732|Autonomic Agents|autonomic agents|mesh-ancestor
110636144|NCT00927732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110636145|NCT00927732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110636146|NCT00927732|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110636147|NCT00927732|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110636148|NCT00927732|Adrenergic Agents|adrenergic agents|mesh-ancestor
110636149|NCT00927732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110636150|NCT00927732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110636151|NCT00927732|Antimalarials|antimalarials|mesh-ancestor
110636152|NCT00927732|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110636153|NCT00927732|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110636154|NCT00927732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110636155|NCT00927732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110636156|NCT00927732|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110636157|NCT00927732|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110636158|NCT00927732|Cholinergic Agents|cholinergic agents|mesh-ancestor
110636159|NCT00927732|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110395012|NCT00594555|Cytarabine|cytarabine|mesh-list
110636160|NCT00927732|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110636161|NCT00927732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110636162|NCT00927732|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110636163|NCT00927732|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110636164|NCT00227539|Pemetrexed|pemetrexed|mesh-list
110636165|NCT00227539|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110636166|NCT00227539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110636167|NCT00227539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110636168|NCT00227539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110636169|NCT00227539|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110636170|NCT00227539|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110636171|NCT00227539|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110636172|NCT00927966|Everolimus|everolimus|mesh-list
110636173|NCT00927966|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110636174|NCT00927966|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110636175|NCT00927966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110636176|NCT00927966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110636177|NCT00927966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110636178|NCT00927966|Immunologic Factors|immunologic factors|mesh-ancestor
110636179|NCT00927966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110636180|NCT00927966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110636181|NCT00227305|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110636182|NCT00227305|Antidepressive Agents|antidepressive agents|mesh-ancestor
110636183|NCT00227305|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110636184|NCT00227305|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110636185|NCT00227305|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110636186|NCT00227305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110636187|NCT00227305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110636188|NCT00720941|Sunitinib|sunitinib|mesh-list
110636189|NCT00720941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110636190|NCT00720941|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110636191|NCT00720941|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110636192|NCT00720941|Growth Substances|growth substances|mesh-ancestor
110636193|NCT00720941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110636194|NCT00720941|Growth Inhibitors|growth inhibitors|mesh-ancestor
110636195|NCT00720941|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110636196|NCT00720941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110117693|NCT01879293|Metformin|metformin|mesh-list
110636197|NCT00720941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110636198|NCT00924222|Propofol|propofol|mesh-list
110636199|NCT00924222|Sevoflurane|sevoflurane|mesh-list
110636200|NCT00924222|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110636201|NCT00924222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110636202|NCT00924222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110636203|NCT00924222|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110636204|NCT00924222|Anesthetics, General|anesthetics, general|mesh-ancestor
110636205|NCT00924222|Anesthetics|anesthetics|mesh-ancestor
110636206|NCT00924222|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110636207|NCT00924222|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110636208|NCT01075711|Prednisone|prednisone|mesh-list
110636209|NCT01075711|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110636210|NCT01075711|Glucocorticoids|glucocorticoids|mesh-ancestor
110636211|NCT01075711|Hormones|hormones|mesh-ancestor
110636212|NCT01075711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110636213|NCT01075711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110636214|NCT01075711|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110636215|NCT01075711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110636216|NCT01073371|Prilocaine|prilocaine|mesh-list
110636217|NCT01073371|Anesthetics, Local|anesthetics, local|mesh-ancestor
110636218|NCT01073371|Anesthetics|anesthetics|mesh-ancestor
110636219|NCT01073371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110636220|NCT01073371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110636221|NCT01073371|Sensory System Agents|sensory system agents|mesh-ancestor
110636222|NCT01073371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110636223|NCT03970213|Tranexamic Acid|tranexamic acid|mesh-list
110636224|NCT03970213|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110636225|NCT03970213|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110636226|NCT03970213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110636227|NCT03970213|Hemostatics|hemostatics|mesh-ancestor
110636228|NCT03970213|Coagulants|coagulants|mesh-ancestor
110636229|NCT00821834|Ticlopidine|ticlopidine|mesh-list
110636230|NCT00821834|Clopidogrel|clopidogrel|mesh-list
110636231|NCT00821834|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110636232|NCT00821834|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110636233|NCT00821834|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110636234|NCT00821834|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110636235|NCT00821834|Purinergic Agents|purinergic agents|mesh-ancestor
110636236|NCT00821834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110636237|NCT00821834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110636238|NCT00821834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110636239|NCT00821834|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110636240|NCT00821834|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110636241|NCT00821834|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110636242|NCT00821834|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110636243|NCT00821834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110636245|NCT04005417|Tin Fluorides|tin fluorides|mesh-list
110636246|NCT04005417|Cariostatic Agents|cariostatic agents|mesh-ancestor
110636247|NCT04005417|Protective Agents|protective agents|mesh-ancestor
110636248|NCT04005417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110636249|NCT01073839|Gemcitabine|gemcitabine|mesh-list
110636250|NCT01073839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110117717|NCT01879488|Edetic Acid|edetic acid|mesh-list
110254632|NCT00148746|Analgesics|analgesics|mesh-ancestor
110636251|NCT01073839|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110636252|NCT01073839|Antimetabolites|antimetabolites|mesh-ancestor
110636253|NCT01073839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110636254|NCT00585533|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110636255|NCT00585533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110636256|NCT00585533|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110636257|NCT00585533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110636258|NCT00585533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110636259|NCT00628862|Formoterol Fumarate|formoterol fumarate|mesh-list
110636260|NCT00628862|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110636261|NCT00628862|Autonomic Agents|autonomic agents|mesh-ancestor
110636262|NCT00628862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110636263|NCT00628862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110636264|NCT00628862|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110636265|NCT00628862|Respiratory System Agents|respiratory system agents|mesh-ancestor
110636266|NCT00628862|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110636267|NCT00628862|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110636268|NCT00628862|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110636269|NCT00628862|Adrenergic Agents|adrenergic agents|mesh-ancestor
110636270|NCT00628862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110636271|NCT00628862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110636272|NCT05420727|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
110636273|NCT05420727|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110636274|NCT05420727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110636275|NCT00987441|Sufentanil|sufentanil|mesh-list
110636277|NCT00987441|Ropivacaine|ropivacaine|mesh-list
110636278|NCT00987441|Anesthetics, Local|anesthetics, local|mesh-ancestor
110636279|NCT00987441|Anesthetics|anesthetics|mesh-ancestor
110636280|NCT00987441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110636281|NCT00987441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110636282|NCT00987441|Sensory System Agents|sensory system agents|mesh-ancestor
110636283|NCT00987441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110636284|NCT00987441|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110636285|NCT00987441|Narcotics|narcotics|mesh-ancestor
110636286|NCT00987441|Analgesics|analgesics|mesh-ancestor
110636287|NCT00987441|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110636288|NCT00987441|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110636289|NCT00987441|Anesthetics, General|anesthetics, general|mesh-ancestor
110636290|NCT00584987|Fluticasone|fluticasone|mesh-list
110636291|NCT00584987|Xhance|xhance|mesh-list
110636292|NCT00584987|Phenylephrine|phenylephrine|mesh-list
110636293|NCT00584987|Oxymetazoline|oxymetazoline|mesh-list
110636294|NCT00584987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110636295|NCT00584987|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110636296|NCT00584987|Autonomic Agents|autonomic agents|mesh-ancestor
110636297|NCT00584987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110636298|NCT00584987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110636299|NCT00584987|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110636300|NCT00584987|Respiratory System Agents|respiratory system agents|mesh-ancestor
110636301|NCT00584987|Dermatologic Agents|dermatologic agents|mesh-ancestor
110636302|NCT00584987|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110636303|NCT00584987|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110636304|NCT00584987|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110636305|NCT00584987|Adrenergic Agents|adrenergic agents|mesh-ancestor
110636306|NCT00584987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110636307|NCT00584987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110636308|NCT00584987|Sympathomimetics|sympathomimetics|mesh-ancestor
110636309|NCT00584987|Nasal Decongestants|nasal decongestants|mesh-ancestor
110636310|NCT00584987|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110636311|NCT00584987|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110636312|NCT00584987|Mydriatics|mydriatics|mesh-ancestor
110636313|NCT00584987|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110636314|NCT00584987|Protective Agents|protective agents|mesh-ancestor
110636315|NCT00727961|Doxorubicin|doxorubicin|mesh-list
110636316|NCT00727961|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110117765|NCT01879917|Incretins|incretins|mesh-ancestor
110636317|NCT00727961|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110636318|NCT00727961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110636319|NCT00727961|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110636320|NCT00727961|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110636321|NCT00727961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110636322|NCT00727961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110636324|NCT00568958|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110636325|NCT00568958|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110636326|NCT00568958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110636327|NCT00568958|Sensory System Agents|sensory system agents|mesh-ancestor
110636328|NCT00568958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110636330|NCT00821912|Capecitabine|capecitabine|mesh-list
110636331|NCT00821912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110636332|NCT00821912|Tubulin Modulators|tubulin modulators|mesh-ancestor
110636333|NCT00821912|Antimitotic Agents|antimitotic agents|mesh-ancestor
110636334|NCT00821912|Mitosis Modulators|mitosis modulators|mesh-ancestor
110636335|NCT00821912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110636336|NCT00821912|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110636337|NCT00821912|Antimetabolites|antimetabolites|mesh-ancestor
110636338|NCT00727649|Loperamide|loperamide|mesh-list
110636339|NCT00727649|Antidiarrheals|antidiarrheals|mesh-list
110636340|NCT00727649|Psyllium|psyllium|mesh-list
110636341|NCT00727649|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110636342|NCT00727649|Cathartics|cathartics|mesh-ancestor
110636343|NCT04006041|Paclitaxel|paclitaxel|mesh-list
110636344|NCT04006041|Cisplatin|cisplatin|mesh-list
110636345|NCT04006041|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110636346|NCT04006041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110636347|NCT04006041|Tubulin Modulators|tubulin modulators|mesh-ancestor
110636348|NCT04006041|Antimitotic Agents|antimitotic agents|mesh-ancestor
110636349|NCT04006041|Mitosis Modulators|mitosis modulators|mesh-ancestor
110636350|NCT04006041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110636351|NCT00225277|Pioglitazone|pioglitazone|mesh-list
110636352|NCT00225277|Glimepiride|glimepiride|mesh-list
110636353|NCT00225277|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110636354|NCT00225277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110636355|NCT00225277|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110636356|NCT00225277|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110636357|NCT00225277|Immunologic Factors|immunologic factors|mesh-ancestor
110636358|NCT00821054|Lapatinib|lapatinib|mesh-list
110636359|NCT00821054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110636360|NCT00821054|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110395066|NCT01606046|Anesthetics|anesthetics|mesh-list
110636361|NCT00821054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110636362|NCT00821054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110636363|NCT00567996|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110636364|NCT00567996|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110636366|NCT00567996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110636367|NCT00567996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110636368|NCT00567996|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110636369|NCT00567996|Respiratory System Agents|respiratory system agents|mesh-ancestor
110636370|NCT00567996|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110636371|NCT00567996|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110636372|NCT00567996|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110636373|NCT00567996|Adrenergic Agents|adrenergic agents|mesh-ancestor
110636374|NCT00567996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110636375|NCT00567996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110636377|NCT04388319|Bupropion|bupropion|mesh-list
110636378|NCT04388319|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110636379|NCT04388319|Antidepressive Agents|antidepressive agents|mesh-ancestor
110636380|NCT04388319|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110636381|NCT04388319|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110636382|NCT04388319|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110636383|NCT04388319|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110636384|NCT04388319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110636385|NCT04388319|Dopamine Agents|dopamine agents|mesh-ancestor
110636386|NCT04388319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110636387|NCT04388319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110636388|NCT04388319|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110636389|NCT04388319|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110636390|NCT04388319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110636391|NCT04388319|Anticonvulsants|anticonvulsants|mesh-ancestor
110636392|NCT04388319|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110254642|NCT00148785|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110636393|NCT04388319|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110636395|NCT04085627|Valsartan|valsartan|mesh-list
110636396|NCT04085627|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
110636397|NCT04085627|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110636398|NCT04085627|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110636399|NCT04085627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110636400|NCT04085627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110156700|NCT03150316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110636401|NCT04085627|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110636402|NCT04085627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110636404|NCT04085627|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110636405|NCT04085627|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110636406|NCT04085393|Granisetron|granisetron|mesh-list
110636407|NCT04085393|Antiemetics|antiemetics|mesh-ancestor
110636408|NCT04085393|Autonomic Agents|autonomic agents|mesh-ancestor
110636409|NCT04085393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110636410|NCT04085393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110636411|NCT04085393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110636412|NCT04085393|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110636413|NCT04085393|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110636414|NCT04085393|Serotonin Agents|serotonin agents|mesh-ancestor
110636415|NCT04085393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110636416|NCT04085393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110636417|NCT00717275|Temozolomide|temozolomide|mesh-list
110636418|NCT00717275|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110636419|NCT00717275|Alkylating Agents|alkylating agents|mesh-ancestor
110636420|NCT00717275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110636421|NCT00717275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110636422|NCT04006353|Rifampin|rifampin|mesh-list
110636423|NCT04006353|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110636424|NCT04006353|Antitubercular Agents|antitubercular agents|mesh-ancestor
110636425|NCT04006353|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110636426|NCT04006353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110636427|NCT04006353|Leprostatic Agents|leprostatic agents|mesh-ancestor
110636428|NCT04006353|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110636429|NCT04006353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110636430|NCT04006353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110636431|NCT04006353|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110636432|NCT04006353|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110636433|NCT04006353|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110636434|NCT04006353|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110636435|NCT04006353|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110636436|NCT04006353|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110636437|NCT01075789|Lidocaine|lidocaine|mesh-list
110636438|NCT01075789|Anesthetics, Local|anesthetics, local|mesh-ancestor
110636439|NCT01075789|Anesthetics|anesthetics|mesh-ancestor
110636440|NCT01075789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110636441|NCT01075789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110636442|NCT01075789|Sensory System Agents|sensory system agents|mesh-ancestor
110636443|NCT01075789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110636444|NCT01075789|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110636445|NCT01075789|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110636446|NCT01075789|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110636447|NCT01075789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110636448|NCT01075789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110636449|NCT00826046|Remestemcel-l|remestemcel-l|mesh-list
110636450|NCT00826046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110636451|NCT00826046|Antiviral Agents|antiviral agents|mesh-ancestor
110636452|NCT00826046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110636453|NCT00584909|Paclitaxel|paclitaxel|mesh-list
110636454|NCT00584909|Carboplatin|carboplatin|mesh-list
110636455|NCT00584909|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110636456|NCT00584909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110636457|NCT00584909|Tubulin Modulators|tubulin modulators|mesh-ancestor
110636458|NCT00584909|Antimitotic Agents|antimitotic agents|mesh-ancestor
110636459|NCT00584909|Mitosis Modulators|mitosis modulators|mesh-ancestor
110636460|NCT00584909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110636461|NCT03947099|Ketamine|ketamine|mesh-list
110636462|NCT03947099|Analgesics|analgesics|mesh-ancestor
110636463|NCT03947099|Sensory System Agents|sensory system agents|mesh-ancestor
110636464|NCT03947099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110636465|NCT03947099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110636466|NCT03947099|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110636467|NCT03947099|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110636468|NCT03947099|Anesthetics, General|anesthetics, general|mesh-ancestor
110636469|NCT03947099|Anesthetics|anesthetics|mesh-ancestor
110636470|NCT03947099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110636471|NCT03947099|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110636472|NCT03947099|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110636473|NCT03947099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110636474|NCT03947099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110636475|NCT05361915|Abivertinib|abivertinib|mesh-list
110636476|NCT05361915|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110636477|NCT05361915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110636478|NCT05361915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110636479|NCT00929058|Bevacizumab|bevacizumab|mesh-list
110636480|NCT00929058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110636481|NCT00929058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110117856|NCT01880385|Antimetabolites|antimetabolites|mesh-ancestor
110636482|NCT00929058|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110636483|NCT00929058|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110636484|NCT00929058|Growth Substances|growth substances|mesh-ancestor
110636485|NCT00929058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110636486|NCT00929058|Growth Inhibitors|growth inhibitors|mesh-ancestor
110636487|NCT00907452|Thalidomide|thalidomide|mesh-list
110636488|NCT00907452|Dexamethasone|dexamethasone|mesh-list
110636489|NCT00907452|Prednisone|prednisone|mesh-list
110636490|NCT00907452|Lenalidomide|lenalidomide|mesh-list
110636491|NCT00907452|Melphalan|melphalan|mesh-list
110636492|NCT00907452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110636493|NCT00907452|Antiemetics|antiemetics|mesh-ancestor
110636494|NCT00907452|Autonomic Agents|autonomic agents|mesh-ancestor
110636495|NCT00907452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110636496|NCT00907452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110636497|NCT00907452|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110636498|NCT00907452|Glucocorticoids|glucocorticoids|mesh-ancestor
110636499|NCT00907452|Hormones|hormones|mesh-ancestor
110636500|NCT00907452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110636501|NCT00907452|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110636502|NCT00907452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110636503|NCT00907452|Immunologic Factors|immunologic factors|mesh-ancestor
110636504|NCT00907452|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110636505|NCT00907452|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110636506|NCT00907452|Growth Substances|growth substances|mesh-ancestor
110636507|NCT00907452|Growth Inhibitors|growth inhibitors|mesh-ancestor
110636508|NCT00907452|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110636509|NCT00907452|Alkylating Agents|alkylating agents|mesh-ancestor
110636510|NCT00907452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110636511|NCT00907452|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110636512|NCT00907452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110636513|NCT00907452|Leprostatic Agents|leprostatic agents|mesh-ancestor
110636514|NCT00907452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110636515|NCT00907452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110636517|NCT00717197|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110636518|NCT00717197|Antimetabolites|antimetabolites|mesh-ancestor
110636519|NCT00717197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110636520|NCT00717197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110636521|NCT00925392|Doripenem|doripenem|mesh-list
110636522|NCT00925392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110636523|NCT00925392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110636524|NCT05315271|Ketamine|ketamine|mesh-list
110636525|NCT05315271|Bupivacaine|bupivacaine|mesh-list
110636526|NCT05315271|Anesthetics, Local|anesthetics, local|mesh-ancestor
110636527|NCT05315271|Anesthetics|anesthetics|mesh-ancestor
110636528|NCT05315271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110636529|NCT05315271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110636530|NCT05315271|Sensory System Agents|sensory system agents|mesh-ancestor
110636531|NCT05315271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110636532|NCT05315271|Analgesics|analgesics|mesh-ancestor
110636533|NCT05315271|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110636534|NCT05315271|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110283849|NCT00196859|Capecitabine|capecitabine|mesh-list
110636535|NCT05315271|Anesthetics, General|anesthetics, general|mesh-ancestor
110636536|NCT05315271|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110636537|NCT05315271|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110636538|NCT05315271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110636539|NCT05315271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110395100|NCT01606241|Vaccines|vaccines|mesh-list
110636541|NCT00147745|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
110636542|NCT00147745|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110636543|NCT00147745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110636544|NCT00147745|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110636545|NCT00147745|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110636546|NCT00147745|Antimetabolites|antimetabolites|mesh-ancestor
110636547|NCT00147745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110636548|NCT00147745|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110636549|NCT05313477|Ergocalciferols|ergocalciferols|mesh-list
110636551|NCT05313477|Calcium Carbonate|calcium carbonate|mesh-list
110636552|NCT05313477|Calcium|calcium|mesh-list
110636553|NCT05313477|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110636554|NCT05313477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110636555|NCT05313477|Antacids|antacids|mesh-ancestor
110636556|NCT05313477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110636557|NCT05313477|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110636558|NCT05313477|Vitamins|vitamins|mesh-ancestor
110636559|NCT05313477|Micronutrients|micronutrients|mesh-ancestor
110636560|NCT05313477|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110636561|NCT00224107|Silodosin|silodosin|mesh-list
110636562|NCT00224107|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110636563|NCT00224107|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110636564|NCT00224107|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110636565|NCT00224107|Adrenergic Agents|adrenergic agents|mesh-ancestor
110636566|NCT00224107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110636567|NCT00224107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110636568|NCT00224107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110636569|NCT00224107|Urological Agents|urological agents|mesh-ancestor
110636570|NCT04696731|Cyclophosphamide|cyclophosphamide|mesh-list
110636571|NCT04696731|Fludarabine|fludarabine|mesh-list
110636572|NCT04696731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110636573|NCT04696731|Immunologic Factors|immunologic factors|mesh-ancestor
110636574|NCT04696731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110636575|NCT04696731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110636576|NCT04696731|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110636577|NCT04696731|Alkylating Agents|alkylating agents|mesh-ancestor
110636578|NCT04696731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110636579|NCT04696731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110636580|NCT04696731|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110636581|NCT04004871|Paclitaxel|paclitaxel|mesh-list
110636582|NCT04004871|Cisplatin|cisplatin|mesh-list
110636583|NCT04004871|Fluorouracil|fluorouracil|mesh-list
110636584|NCT04004871|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110117888|NCT01880749|Everolimus|everolimus|mesh-list
110636585|NCT04004871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110636586|NCT04004871|Tubulin Modulators|tubulin modulators|mesh-ancestor
110636587|NCT04004871|Antimitotic Agents|antimitotic agents|mesh-ancestor
110636588|NCT04004871|Mitosis Modulators|mitosis modulators|mesh-ancestor
110636589|NCT04004871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110636590|NCT04004871|Antimetabolites|antimetabolites|mesh-ancestor
110636591|NCT04004871|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110636592|NCT04004871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110636593|NCT04004871|Immunologic Factors|immunologic factors|mesh-ancestor
110636594|NCT04004871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110636595|NCT00826358|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110636596|NCT00826358|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110636597|NCT00826358|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110636598|NCT00826358|Antimetabolites|antimetabolites|mesh-ancestor
110636599|NCT00826358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110636600|NCT00826358|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110636601|NCT00826358|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110636602|NCT00826358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110636603|NCT00987909|Immunomodulating Agents|immunomodulating agents|mesh-list
110636604|NCT00987909|Immunologic Factors|immunologic factors|mesh-list
110636605|NCT00987909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110636607|NCT00822380|Trace Elements|trace elements|mesh-list
110636608|NCT00822380|Folic Acid|folic acid|mesh-list
110636609|NCT00822380|Ascorbic Acid|ascorbic acid|mesh-list
110636610|NCT00822380|Micronutrients|micronutrients|mesh-list
110636611|NCT00822380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110636612|NCT00822380|Hematinics|hematinics|mesh-ancestor
110636613|NCT00822380|Vitamin B Complex|vitamin b complex|mesh-ancestor
110636615|NCT00822380|Antioxidants|antioxidants|mesh-ancestor
110636616|NCT00822380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110636617|NCT00822380|Protective Agents|protective agents|mesh-ancestor
110636618|NCT00720083|Cisplatin|cisplatin|mesh-list
110636619|NCT00720083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110636620|NCT00209131|Tamsulosin|tamsulosin|mesh-list
110636621|NCT00209131|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110636622|NCT00209131|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110636623|NCT00209131|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110636624|NCT00209131|Adrenergic Agents|adrenergic agents|mesh-ancestor
110636625|NCT00209131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110636626|NCT00209131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110636627|NCT00209131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110636628|NCT00209131|Urological Agents|urological agents|mesh-ancestor
110636629|NCT00907608|Darbepoetin alfa|darbepoetin alfa|mesh-list
110636630|NCT00907608|Hematinics|hematinics|mesh-ancestor
110636631|NCT00224029|Oxybutynin|oxybutynin|mesh-list
110156819|NCT01807429|Midazolam|midazolam|mesh-list
110636632|NCT00224029|Parasympatholytics|parasympatholytics|mesh-ancestor
110636633|NCT00224029|Autonomic Agents|autonomic agents|mesh-ancestor
110636634|NCT00224029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110636635|NCT00224029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110636636|NCT00224029|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110636637|NCT00224029|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110636638|NCT00224029|Cholinergic Agents|cholinergic agents|mesh-ancestor
110636639|NCT00224029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110636640|NCT00224029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110636641|NCT00224029|Urological Agents|urological agents|mesh-ancestor
110636642|NCT00929370|Glycine|glycine|mesh-list
110636643|NCT00929370|Glycine Agents|glycine agents|mesh-ancestor
110636644|NCT00929370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110636645|NCT00929370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110636646|NCT00929370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110636648|NCT00907764|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
110636649|NCT00907764|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
110636650|NCT00907764|Purinergic Agonists|purinergic agonists|mesh-ancestor
110636651|NCT00907764|Purinergic Agents|purinergic agents|mesh-ancestor
110636652|NCT00907764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110636653|NCT00907764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110636654|NCT00907764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110636655|NCT02550314|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
110636656|NCT02550314|Hemostatics|hemostatics|mesh-ancestor
110636657|NCT02550314|Coagulants|coagulants|mesh-ancestor
110636658|NCT01073527|Adenosine|adenosine|mesh-list
110636659|NCT01073527|Albuterol|albuterol|mesh-list
110636660|NCT01073527|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110636661|NCT01073527|Autonomic Agents|autonomic agents|mesh-ancestor
110636662|NCT01073527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110636663|NCT01073527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110636664|NCT01073527|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110636665|NCT01073527|Respiratory System Agents|respiratory system agents|mesh-ancestor
110636666|NCT01073527|Tocolytic Agents|tocolytic agents|mesh-ancestor
110636667|NCT01073527|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110636668|NCT01073527|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110636669|NCT01073527|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110636670|NCT01073527|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110118015|NCT01882179|Hormones|hormones|mesh-ancestor
110636671|NCT01073527|Adrenergic Agents|adrenergic agents|mesh-ancestor
110636672|NCT01073527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110636673|NCT01073527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110636674|NCT01073527|Analgesics|analgesics|mesh-ancestor
110636675|NCT01073527|Sensory System Agents|sensory system agents|mesh-ancestor
110636676|NCT01073527|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110636677|NCT01073527|Vasodilator Agents|vasodilator agents|mesh-ancestor
110636678|NCT01073527|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
110636679|NCT01073527|Purinergic Agonists|purinergic agonists|mesh-ancestor
110636680|NCT01073527|Purinergic Agents|purinergic agents|mesh-ancestor
110636681|NCT02538432|Gemcitabine|gemcitabine|mesh-list
110636682|NCT02538432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110636683|NCT02538432|Antimetabolites|antimetabolites|mesh-ancestor
110636684|NCT02538432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110636685|NCT02538432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110636686|NCT00719849|Cyclosporine|cyclosporine|mesh-list
110636687|NCT00719849|Mycophenolic Acid|mycophenolic acid|mesh-list
110636688|NCT00719849|Cyclophosphamide|cyclophosphamide|mesh-list
110636689|NCT00719849|Fludarabine|fludarabine|mesh-list
110636690|NCT00719849|Fludarabine phosphate|fludarabine phosphate|mesh-list
110636691|NCT00719849|Cyclosporins|cyclosporins|mesh-list
110636692|NCT00719849|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110636693|NCT00719849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110636694|NCT00719849|Immunologic Factors|immunologic factors|mesh-ancestor
110636695|NCT00719849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110636696|NCT00719849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110156872|NCT01806805|Zonisamide|zonisamide|mesh-list
110636697|NCT00719849|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110636698|NCT00719849|Alkylating Agents|alkylating agents|mesh-ancestor
110636699|NCT00719849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110636700|NCT00719849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110636701|NCT00719849|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110636702|NCT00719849|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110636703|NCT00719849|Antimetabolites|antimetabolites|mesh-ancestor
110636704|NCT00719849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110636705|NCT00719849|Antifungal Agents|antifungal agents|mesh-ancestor
110636706|NCT00719849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110636707|NCT00719849|Dermatologic Agents|dermatologic agents|mesh-ancestor
110636708|NCT00719849|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110636709|NCT00719849|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110636710|NCT00719849|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110636711|NCT00719849|Antitubercular Agents|antitubercular agents|mesh-ancestor
110636712|NCT00719849|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110636713|NCT00822536|Aspirin|aspirin|mesh-list
110636714|NCT00822536|Clopidogrel|clopidogrel|mesh-list
110636715|NCT00822536|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110636716|NCT00822536|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110636717|NCT00822536|Analgesics|analgesics|mesh-ancestor
110636718|NCT00822536|Sensory System Agents|sensory system agents|mesh-ancestor
110636719|NCT00822536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110636720|NCT00822536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110118184|NCT01883921|Antibodies|antibodies|mesh-list
110636721|NCT00822536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110636722|NCT00822536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110636723|NCT00822536|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110636724|NCT00822536|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110636725|NCT00822536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110636726|NCT00822536|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110636727|NCT00822536|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110636728|NCT00822536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110636729|NCT00822536|Antipyretics|antipyretics|mesh-ancestor
110636730|NCT00822536|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110636731|NCT00822536|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110636732|NCT00822536|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110636733|NCT00822536|Purinergic Agents|purinergic agents|mesh-ancestor
110636734|NCT00822536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110636735|NCT00826826|Amiodarone|amiodarone|mesh-list
110636736|NCT00826826|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110636737|NCT00826826|Vasodilator Agents|vasodilator agents|mesh-ancestor
110636738|NCT00826826|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
110636739|NCT00826826|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110636740|NCT00826826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110636741|NCT00826826|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110636742|NCT00826826|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110118376|NCT01884909|Metoprolol|metoprolol|mesh-list
110636743|NCT00826826|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110636744|NCT00826826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110636745|NCT00826826|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110636746|NCT00826826|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110636747|NCT00826826|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110636748|NCT02592941|Deflazacort|deflazacort|mesh-list
110636749|NCT02592941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110636750|NCT02592941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110636751|NCT02592941|Immunologic Factors|immunologic factors|mesh-ancestor
110636752|NCT02592941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110636753|NCT00822614|Fentanyl|fentanyl|mesh-list
110636754|NCT00822614|Morphine|morphine|mesh-list
110636755|NCT00822614|Oxycodone|oxycodone|mesh-list
110636756|NCT00822614|Hydromorphone|hydromorphone|mesh-list
110636757|NCT00822614|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110636758|NCT00822614|Narcotics|narcotics|mesh-ancestor
110636759|NCT00822614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110636760|NCT00822614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110284067|NCT00203801|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110636761|NCT00822614|Analgesics|analgesics|mesh-ancestor
110636762|NCT00822614|Sensory System Agents|sensory system agents|mesh-ancestor
110636763|NCT00822614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110636764|NCT00822614|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110636765|NCT00822614|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110636766|NCT00822614|Anesthetics, General|anesthetics, general|mesh-ancestor
110636767|NCT00822614|Anesthetics|anesthetics|mesh-ancestor
110636768|NCT04087967|Cytarabine|cytarabine|mesh-list
110636769|NCT04087967|Decitabine|decitabine|mesh-list
110636770|NCT04087967|Idarubicin|idarubicin|mesh-list
110636771|NCT04087967|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110636772|NCT04087967|Antimetabolites|antimetabolites|mesh-ancestor
110636773|NCT04087967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110636774|NCT04087967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110636775|NCT04087967|Antiviral Agents|antiviral agents|mesh-ancestor
110636776|NCT04087967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110636777|NCT04087967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110636778|NCT04087967|Immunologic Factors|immunologic factors|mesh-ancestor
110118713|NCT01887223|Adrenergic Agents|adrenergic agents|mesh-ancestor
110636779|NCT04087967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110636780|NCT04087967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110636781|NCT04087967|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110636782|NCT04087967|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110636783|NCT04087967|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110636784|NCT00926016|Pioglitazone|pioglitazone|mesh-list
110636785|NCT00926016|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110636786|NCT00926016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110636787|NCT04017104|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110636788|NCT04017104|Edotreotide|edotreotide|mesh-list
110636789|NCT04017104|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110636790|NCT04017104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110636791|NCT00827138|Rebastinib|rebastinib|mesh-list
110636792|NCT00827138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110636793|NCT00827138|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110118779|NCT01887457|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110636795|NCT00827138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110156894|NCT00387413|Vitamins|vitamins|mesh-ancestor
110636797|NCT00817466|Racepinephrine|racepinephrine|mesh-list
110636798|NCT00817466|Epinephryl borate|epinephryl borate|mesh-list
110636799|NCT00817466|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110270507|NCT05077969|Celecoxib|celecoxib|mesh-list
110636800|NCT00817466|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110636801|NCT00817466|Adrenergic Agents|adrenergic agents|mesh-ancestor
110636802|NCT00817466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110636803|NCT00817466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110636804|NCT00817466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110636805|NCT00817466|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110636806|NCT00817466|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110636807|NCT00817466|Autonomic Agents|autonomic agents|mesh-ancestor
110636808|NCT00817466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110636809|NCT00817466|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110636810|NCT00817466|Respiratory System Agents|respiratory system agents|mesh-ancestor
110636811|NCT00817466|Mydriatics|mydriatics|mesh-ancestor
110636812|NCT00817466|Sympathomimetics|sympathomimetics|mesh-ancestor
110636813|NCT00817466|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110636814|NCT00930072|Clonidine|clonidine|mesh-list
110636815|NCT00930072|Bupivacaine|bupivacaine|mesh-list
110636816|NCT00930072|Anesthetics, Local|anesthetics, local|mesh-ancestor
110636817|NCT00930072|Anesthetics|anesthetics|mesh-ancestor
110636818|NCT00930072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110636819|NCT00930072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110636820|NCT00930072|Sensory System Agents|sensory system agents|mesh-ancestor
110636821|NCT00930072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110636822|NCT00930072|Analgesics|analgesics|mesh-ancestor
110636823|NCT00930072|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110636825|NCT00930072|Autonomic Agents|autonomic agents|mesh-ancestor
110636826|NCT00930072|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110636827|NCT00930072|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110636828|NCT00930072|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110636829|NCT00930072|Adrenergic Agents|adrenergic agents|mesh-ancestor
110636830|NCT00930072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110119105|NCT01888835|Histamine Agents|histamine agents|mesh-ancestor
110636831|NCT00930072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110636832|NCT00626522|Bromides|bromides|mesh-list
110636833|NCT00626522|Formoterol Fumarate|formoterol fumarate|mesh-list
110636834|NCT00626522|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110636835|NCT00626522|Autonomic Agents|autonomic agents|mesh-ancestor
110119179|NCT01889173|Cyclobenzaprine|cyclobenzaprine|mesh-list
110636836|NCT00626522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110636837|NCT00626522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110284140|NCT00230568|Cholinergic Agents|cholinergic agents|mesh-ancestor
110636838|NCT00626522|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110636839|NCT00626522|Respiratory System Agents|respiratory system agents|mesh-ancestor
110636840|NCT00626522|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110636841|NCT00626522|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110636842|NCT00626522|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110636843|NCT00626522|Adrenergic Agents|adrenergic agents|mesh-ancestor
110636844|NCT00626522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110156931|NCT05482542|Cyclophosphamide|cyclophosphamide|mesh-list
110636845|NCT00626522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110636846|NCT00626522|Anticonvulsants|anticonvulsants|mesh-ancestor
110636847|NCT00926640|Etoposide|etoposide|mesh-list
110636848|NCT00926640|Belinostat|belinostat|mesh-list
110636849|NCT00926640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110636850|NCT00926640|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110636851|NCT00926640|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110636852|NCT00926640|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110636853|NCT00926640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110395162|NCT02271191|Vasodilator Agents|vasodilator agents|mesh-ancestor
110636854|NCT00926640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110636855|NCT00926640|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110636857|NCT00931398|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110636858|NCT00931398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110636859|NCT00931398|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110636860|NCT00931398|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110636861|NCT00931398|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110636862|NCT00931398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110636863|NCT00931398|Dopamine Agents|dopamine agents|mesh-ancestor
110636864|NCT00931398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110636865|NCT00827216|Erythromycin|erythromycin|mesh-list
110636866|NCT00827216|Erythromycin Estolate|erythromycin estolate|mesh-list
110636867|NCT00827216|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
110636868|NCT00827216|Erythromycin stearate|erythromycin stearate|mesh-list
110636869|NCT00827216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110636870|NCT00827216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110636871|NCT00827216|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110636872|NCT00827216|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110636873|NCT00827216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110636874|NCT00827216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110636875|NCT00822848|Sorafenib|sorafenib|mesh-list
110636876|NCT00822848|Epirubicin|epirubicin|mesh-list
110636877|NCT00822848|Ifosfamide|ifosfamide|mesh-list
110636878|NCT00822848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110636879|NCT00822848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110636880|NCT00822848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110636881|NCT00822848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110636882|NCT00822848|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110119522|NCT01900041|Minoxidil|minoxidil|mesh-list
110636883|NCT00822848|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110636884|NCT00822848|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110636885|NCT00822848|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110636886|NCT00822848|Alkylating Agents|alkylating agents|mesh-ancestor
110636887|NCT00926718|Remifentanil|remifentanil|mesh-list
110636888|NCT00926718|Rocuronium|rocuronium|mesh-list
110636889|NCT00926718|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110636890|NCT00926718|Narcotics|narcotics|mesh-ancestor
110636891|NCT00926718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110636892|NCT00926718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110636893|NCT00926718|Analgesics|analgesics|mesh-ancestor
110636894|NCT00926718|Sensory System Agents|sensory system agents|mesh-ancestor
110636895|NCT00926718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110636896|NCT00926718|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110636897|NCT00926718|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110636898|NCT00926718|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110636899|NCT00823004|Letrozole|letrozole|mesh-list
110636900|NCT00823004|Contraceptive Agents|contraceptive agents|mesh-list
110636901|NCT00823004|Contraceptives, Oral|contraceptives, oral|mesh-list
110636902|NCT00823004|Buserelin|buserelin|mesh-list
110636903|NCT00823004|Ganirelix|ganirelix|mesh-list
110636904|NCT00823004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110636905|NCT00823004|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110636906|NCT00823004|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110636907|NCT00823004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110636908|NCT00823004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110636909|NCT00823004|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110636910|NCT00823004|Hormone Antagonists|hormone antagonists|mesh-ancestor
110636911|NCT00823004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110636912|NCT00823004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110636913|NCT00823004|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110636914|NCT00823004|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110636915|NCT00823004|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110636918|NCT00827450|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110636919|NCT00827450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110636920|NCT00827450|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110636921|NCT00827450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110636922|NCT00827450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110636923|NCT00827450|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110636925|NCT00827450|Purinergic Agents|purinergic agents|mesh-ancestor
110636926|NCT00827450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110636928|NCT00930306|Midazolam|midazolam|mesh-list
110636929|NCT00930306|Caffeine|caffeine|mesh-list
110636930|NCT00930306|Omeprazole|omeprazole|mesh-list
110636931|NCT00930306|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110636932|NCT00930306|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110119981|NCT01902524|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110636933|NCT00930306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110636934|NCT00930306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110636935|NCT00930306|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110636936|NCT00930306|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110636937|NCT00930306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110636938|NCT00930306|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110636939|NCT00930306|Anesthetics, General|anesthetics, general|mesh-ancestor
110636940|NCT00930306|Anesthetics|anesthetics|mesh-ancestor
110636941|NCT00930306|GABA Modulators|gaba modulators|mesh-ancestor
110636942|NCT00930306|GABA Agents|gaba agents|mesh-ancestor
110636943|NCT00930306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110120052|NCT01903018|Cisplatin|cisplatin|mesh-list
110636944|NCT00930306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110636945|NCT00930306|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110636946|NCT00930306|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110636947|NCT00930306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110636948|NCT00930306|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110636949|NCT00930306|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110157029|NCT01466374|Antibodies|antibodies|mesh-list
110636950|NCT00930306|Purinergic Agents|purinergic agents|mesh-ancestor
110636951|NCT00930306|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110120189|NCT01904097|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110636953|NCT00930306|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110636954|NCT00930306|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110636955|NCT00830882|Albuterol|albuterol|mesh-list
110636956|NCT00830882|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110636957|NCT00830882|Autonomic Agents|autonomic agents|mesh-ancestor
110636958|NCT00830882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110636959|NCT00830882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110636960|NCT00830882|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110636961|NCT00830882|Respiratory System Agents|respiratory system agents|mesh-ancestor
110636962|NCT00830882|Tocolytic Agents|tocolytic agents|mesh-ancestor
110395202|NCT02271464|Cyclophosphamide|cyclophosphamide|mesh-list
110636963|NCT00830882|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110636964|NCT00830882|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110636965|NCT00830882|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110636966|NCT00830882|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110636967|NCT00830882|Adrenergic Agents|adrenergic agents|mesh-ancestor
110636968|NCT00830882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110636969|NCT00830882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110636970|NCT00823238|Tobramycin|tobramycin|mesh-list
110636971|NCT00823238|Ceftazidime|ceftazidime|mesh-list
110636972|NCT00823238|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110636973|NCT00823238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110120340|NCT01905059|Lamivudine|lamivudine|mesh-list
110636975|NCT00827684|Sirolimus|sirolimus|mesh-list
110636976|NCT00827684|Irinotecan|irinotecan|mesh-list
110636977|NCT00827684|Temsirolimus|temsirolimus|mesh-list
110636978|NCT00827684|MTOR Inhibitors|mtor inhibitors|mesh-list
110636979|NCT00827684|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110120392|NCT01905150|Antidotes|antidotes|mesh-ancestor
110636980|NCT00827684|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110636981|NCT00827684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110120457|NCT01905904|Sevoflurane|sevoflurane|mesh-list
110636982|NCT00827684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110120534|NCT01906749|Colchicine|colchicine|mesh-list
110636983|NCT00827684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110636984|NCT00827684|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110636985|NCT00827684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110636986|NCT00827684|Immunologic Factors|immunologic factors|mesh-ancestor
110636987|NCT00827684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110636988|NCT00827684|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110636989|NCT00827684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110636990|NCT00827684|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110636992|NCT00927030|Melatonin|melatonin|mesh-list
110636993|NCT00927030|Antioxidants|antioxidants|mesh-ancestor
110636994|NCT00927030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110636995|NCT00927030|Protective Agents|protective agents|mesh-ancestor
110120673|NCT01907529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110636997|NCT00927030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110636998|NCT00931866|Diclofenac|diclofenac|mesh-list
110636999|NCT00931866|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110637000|NCT00931866|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110637001|NCT00931866|Analgesics|analgesics|mesh-ancestor
110637002|NCT00931866|Sensory System Agents|sensory system agents|mesh-ancestor
110157076|NCT01465867|Selenium|selenium|mesh-list
110637003|NCT00931866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110637004|NCT00931866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110637005|NCT00931866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110637006|NCT00931866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110637007|NCT00931866|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110637008|NCT00931866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110637009|NCT00931866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110637010|NCT00827840|Risperidone|risperidone|mesh-list
110637011|NCT00827840|Paliperidone Palmitate|paliperidone palmitate|mesh-list
110637012|NCT00827840|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110637013|NCT00827840|Serotonin Agents|serotonin agents|mesh-ancestor
110120747|NCT01907880|Zoledronic Acid|zoledronic acid|mesh-list
110637014|NCT00827840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110637015|NCT00827840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110637016|NCT00827840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110637017|NCT00827840|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110637018|NCT00827840|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110637019|NCT00827840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110637020|NCT00827840|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110637021|NCT00827840|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110637022|NCT00827840|Dopamine Agents|dopamine agents|mesh-ancestor
110395213|NCT02271464|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110637023|NCT00827840|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110120871|NCT01908556|Letrozole|letrozole|mesh-list
110637024|NCT00827840|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110637025|NCT00827996|Adalimumab|adalimumab|mesh-list
110637026|NCT00827996|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110637027|NCT00827996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110637028|NCT00827996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110637029|NCT00936780|Paclitaxel|paclitaxel|mesh-list
110637030|NCT00936780|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110637031|NCT00936780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110637032|NCT00936780|Tubulin Modulators|tubulin modulators|mesh-ancestor
110637033|NCT00936780|Antimitotic Agents|antimitotic agents|mesh-ancestor
110637034|NCT00936780|Mitosis Modulators|mitosis modulators|mesh-ancestor
110637035|NCT00936780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110637036|NCT00823550|Lamivudine|lamivudine|mesh-list
110637037|NCT00823550|Entecavir|entecavir|mesh-list
110637038|NCT00823550|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110637039|NCT00823550|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110637040|NCT00823550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110637041|NCT00823550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110637042|NCT00823550|Antiviral Agents|antiviral agents|mesh-ancestor
110637043|NCT00823550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110637044|NCT00823550|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110637045|NCT00823550|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110637047|NCT00932100|Calcium heparin|calcium heparin|mesh-list
110637048|NCT00932100|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
110637049|NCT00932100|Tinzaparin|tinzaparin|mesh-list
110637050|NCT00932100|Dalteparin|dalteparin|mesh-list
110637051|NCT00932100|Anticoagulants|anticoagulants|mesh-ancestor
110637052|NCT00932100|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110637053|NCT00932100|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110637054|NCT00932100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110637055|NCT00828230|Budesonide|budesonide|mesh-list
110637056|NCT00828230|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110637057|NCT00828230|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110121213|NCT01910883|Finafloxacin|finafloxacin|mesh-list
110637059|NCT00828230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110637060|NCT00828230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110637061|NCT00828230|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110284375|NCT00230958|Interferons|interferons|mesh-list
110637062|NCT00828230|Respiratory System Agents|respiratory system agents|mesh-ancestor
110637064|NCT00828230|Hormones|hormones|mesh-ancestor
110637065|NCT00828230|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110637066|NCT04469556|Leucovorin|leucovorin|mesh-list
110637067|NCT04469556|Paclitaxel|paclitaxel|mesh-list
110637068|NCT04469556|Gemcitabine|gemcitabine|mesh-list
110637069|NCT04469556|Oxaliplatin|oxaliplatin|mesh-list
110637070|NCT04469556|Irinotecan|irinotecan|mesh-list
110637071|NCT04469556|Folfirinox|folfirinox|mesh-list
110637072|NCT04469556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110637073|NCT04469556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110637074|NCT04469556|Tubulin Modulators|tubulin modulators|mesh-ancestor
110121346|NCT01911624|Argatroban|argatroban|mesh-list
110637075|NCT04469556|Antimitotic Agents|antimitotic agents|mesh-ancestor
110637076|NCT04469556|Mitosis Modulators|mitosis modulators|mesh-ancestor
110637077|NCT04469556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110637078|NCT04469556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110637079|NCT04469556|Antimetabolites|antimetabolites|mesh-ancestor
110637080|NCT04469556|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110637081|NCT04469556|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110637082|NCT04469556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110637083|NCT04469556|Antidotes|antidotes|mesh-ancestor
110637084|NCT04469556|Protective Agents|protective agents|mesh-ancestor
110637085|NCT04469556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110637086|NCT04469556|Vitamin B Complex|vitamin b complex|mesh-ancestor
110637087|NCT04469556|Vitamins|vitamins|mesh-ancestor
110637088|NCT04469556|Micronutrients|micronutrients|mesh-ancestor
110637089|NCT00937092|Dopamine|dopamine|mesh-list
110637090|NCT00937092|Furosemide|furosemide|mesh-list
110637091|NCT00937092|Diuretics|diuretics|mesh-ancestor
110637092|NCT00937092|Natriuretic Agents|natriuretic agents|mesh-ancestor
110637093|NCT00937092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110637094|NCT00937092|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110157134|NCT04201457|Antioxidants|antioxidants|mesh-ancestor
110637095|NCT00937092|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110637096|NCT00937092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110637097|NCT00937092|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110637098|NCT00937092|Sympathomimetics|sympathomimetics|mesh-ancestor
110637099|NCT00937092|Autonomic Agents|autonomic agents|mesh-ancestor
110637100|NCT00937092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110637101|NCT00937092|Dopamine Agents|dopamine agents|mesh-ancestor
110637102|NCT00937092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110637103|NCT00937092|Protective Agents|protective agents|mesh-ancestor
110637104|NCT04124601|Nivolumab|nivolumab|mesh-list
110637105|NCT04124601|Ipilimumab|ipilimumab|mesh-list
110637106|NCT04124601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110637107|NCT04124601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110637108|NCT04124601|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110637109|NCT04124601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110637110|NCT05046639|Lidocaine|lidocaine|mesh-list
110637111|NCT05046639|Anesthetics, Local|anesthetics, local|mesh-ancestor
110637112|NCT05046639|Anesthetics|anesthetics|mesh-ancestor
110637113|NCT05046639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110637114|NCT05046639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110637115|NCT05046639|Sensory System Agents|sensory system agents|mesh-ancestor
110637116|NCT05046639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110637117|NCT05046639|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110637118|NCT05046639|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110637119|NCT05046639|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110121786|NCT01914692|Hormones|hormones|mesh-ancestor
110637120|NCT05046639|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110637121|NCT05046639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110637122|NCT00931008|Docetaxel|docetaxel|mesh-list
110637123|NCT00931008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110637124|NCT00931008|Tubulin Modulators|tubulin modulators|mesh-ancestor
110637125|NCT00931008|Antimitotic Agents|antimitotic agents|mesh-ancestor
110637126|NCT00931008|Mitosis Modulators|mitosis modulators|mesh-ancestor
110637127|NCT00931008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110637128|NCT00932802|Moxifloxacin|moxifloxacin|mesh-list
110637129|NCT00932802|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
110121825|NCT01914900|Antimetabolites|antimetabolites|mesh-ancestor
110637130|NCT00932802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110637131|NCT00932802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110637132|NCT00932802|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110637133|NCT00932802|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110637134|NCT00932802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110637135|NCT00932802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110637136|NCT00932802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110637137|NCT00932802|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110637138|NCT00932802|Contraceptive Agents|contraceptive agents|mesh-ancestor
110637139|NCT00932802|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110395258|NCT01109524|Cetuximab|cetuximab|mesh-list
110637140|NCT00932802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110637141|NCT00932802|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110637142|NCT00932802|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110637143|NCT00932802|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110637144|NCT00932880|Amlodipine|amlodipine|mesh-list
110637145|NCT00932880|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110637146|NCT00932880|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110637147|NCT00932880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110637148|NCT00932880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110637149|NCT00932880|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110637150|NCT00932880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110637151|NCT00932880|Vasodilator Agents|vasodilator agents|mesh-ancestor
110637152|NCT00937482|Cediranib|cediranib|mesh-list
110637153|NCT00937482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110637154|NCT00937482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110637155|NCT00937482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110637156|NCT00937482|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110637158|NCT00931086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110122161|NCT01917019|4-Aminopyridine|4-aminopyridine|mesh-list
110637159|NCT00931086|Immunologic Factors|immunologic factors|mesh-ancestor
110637160|NCT00931086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110637161|NCT04453839|Vasoactive Intestinal Peptide|vasoactive intestinal peptide|mesh-list
110637162|NCT04453839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110637163|NCT04453839|Vasodilator Agents|vasodilator agents|mesh-ancestor
110637164|NCT04453839|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110637165|NCT04453839|Protective Agents|protective agents|mesh-ancestor
110637166|NCT04453839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110637167|NCT03977454|Ropivacaine|ropivacaine|mesh-list
110637168|NCT03977454|Anesthetics, Local|anesthetics, local|mesh-ancestor
110637169|NCT03977454|Anesthetics|anesthetics|mesh-ancestor
110637170|NCT03977454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110637171|NCT03977454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110637172|NCT03977454|Sensory System Agents|sensory system agents|mesh-ancestor
110637173|NCT03977454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110637174|NCT02549066|Milrinone|milrinone|mesh-list
110637175|NCT02549066|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110637176|NCT02549066|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110637177|NCT02549066|Vasodilator Agents|vasodilator agents|mesh-ancestor
110637178|NCT02549066|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110637179|NCT02549066|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110637180|NCT02549066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110637181|NCT02549066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110637182|NCT02549066|Protective Agents|protective agents|mesh-ancestor
110637183|NCT02549066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110637184|NCT00831350|Ranibizumab|ranibizumab|mesh-list
110637185|NCT00831350|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110637186|NCT00831350|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110637187|NCT00831350|Growth Substances|growth substances|mesh-ancestor
110122363|NCT01918098|Oxycodone|oxycodone|mesh-list
110637188|NCT00831350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110637189|NCT00831350|Growth Inhibitors|growth inhibitors|mesh-ancestor
110637190|NCT00831350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110637192|NCT00938184|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110637193|NCT00938184|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110637194|NCT00938184|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110637195|NCT00938184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110637196|NCT00938184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110637197|NCT00938184|Serotonin Agents|serotonin agents|mesh-ancestor
110637198|NCT00938184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110637199|NCT00938184|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110637200|NCT00938184|Antidepressive Agents|antidepressive agents|mesh-ancestor
110637201|NCT00938184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110637202|NCT00938184|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110637203|NCT00938184|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110637204|NCT00938184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110637205|NCT00938262|Rifampin|rifampin|mesh-list
110637206|NCT00938262|Ketoconazole|ketoconazole|mesh-list
110637207|NCT00938262|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110637208|NCT00938262|Antitubercular Agents|antitubercular agents|mesh-ancestor
110637209|NCT00938262|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110637210|NCT00938262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110637211|NCT00938262|Leprostatic Agents|leprostatic agents|mesh-ancestor
110637212|NCT00938262|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110637213|NCT00938262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110637214|NCT00938262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110637215|NCT00938262|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110637216|NCT00938262|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110637217|NCT00938262|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110637218|NCT00938262|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110637219|NCT00938262|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110637220|NCT00938262|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110637221|NCT00938262|Antifungal Agents|antifungal agents|mesh-ancestor
110637222|NCT00938262|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110637223|NCT00938262|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110637224|NCT00938262|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110637225|NCT00938262|Hormone Antagonists|hormone antagonists|mesh-ancestor
110637226|NCT00938262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110637227|NCT00938262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110637228|NCT00938262|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110637230|NCT00933426|Lenalidomide|lenalidomide|mesh-list
110637231|NCT00933426|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110637232|NCT00933426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110637233|NCT00933426|Tubulin Modulators|tubulin modulators|mesh-ancestor
110637234|NCT00933426|Antimitotic Agents|antimitotic agents|mesh-ancestor
110637235|NCT00933426|Mitosis Modulators|mitosis modulators|mesh-ancestor
110637236|NCT00933426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110637237|NCT00933426|Immunologic Factors|immunologic factors|mesh-ancestor
110637238|NCT00933426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110637239|NCT00933426|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110637240|NCT00933426|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110637241|NCT00933426|Growth Substances|growth substances|mesh-ancestor
110637242|NCT00933426|Growth Inhibitors|growth inhibitors|mesh-ancestor
110637243|NCT04013958|Ketamine|ketamine|mesh-list
110122612|NCT01919294|Hormones|hormones|mesh-ancestor
110637244|NCT04013958|Analgesics|analgesics|mesh-ancestor
110637245|NCT04013958|Sensory System Agents|sensory system agents|mesh-ancestor
110637247|NCT04013958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110637248|NCT04013958|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110637249|NCT04013958|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110637250|NCT04013958|Anesthetics, General|anesthetics, general|mesh-ancestor
110637251|NCT04013958|Anesthetics|anesthetics|mesh-ancestor
110122683|NCT01920022|Mifepristone|mifepristone|mesh-list
110637252|NCT04013958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110637253|NCT04013958|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110637254|NCT04013958|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110637255|NCT04013958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110637256|NCT04013958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110637257|NCT00933582|Naproxen|naproxen|mesh-list
110637258|NCT00933582|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110637259|NCT00933582|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110637260|NCT00933582|Analgesics|analgesics|mesh-ancestor
110637261|NCT00933582|Sensory System Agents|sensory system agents|mesh-ancestor
110122744|NCT01921374|Antiviral Agents|antiviral agents|mesh-ancestor
110637262|NCT00933582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110637263|NCT00933582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110637264|NCT00933582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110637265|NCT00933582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110637266|NCT00933582|Gout Suppressants|gout suppressants|mesh-ancestor
110637267|NCT00933582|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110637268|NCT00933582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110637269|NCT00933582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110637270|NCT00938730|Warfarin|warfarin|mesh-list
110637271|NCT00938730|Anticoagulants|anticoagulants|mesh-ancestor
110637272|NCT00933816|Fluorouracil|fluorouracil|mesh-list
110637273|NCT00933816|Sorafenib|sorafenib|mesh-list
110637274|NCT00933816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110637275|NCT00933816|Antimetabolites|antimetabolites|mesh-ancestor
110637276|NCT00933816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110637277|NCT00933816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110637278|NCT00933816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110637279|NCT00933816|Immunologic Factors|immunologic factors|mesh-ancestor
110637280|NCT00933816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110637281|NCT00933816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110637282|NCT00933816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110637283|NCT00538785|Palivizumab|palivizumab|mesh-list
110637284|NCT00538785|Antiviral Agents|antiviral agents|mesh-ancestor
110637285|NCT00538785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110637286|NCT01563939|Remifentanil|remifentanil|mesh-list
110637287|NCT01563939|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110637288|NCT01563939|Narcotics|narcotics|mesh-ancestor
110637289|NCT01563939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110122876|NCT01930019|Thiopental|thiopental|mesh-list
110637290|NCT01563939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110637292|NCT01563939|Sensory System Agents|sensory system agents|mesh-ancestor
110637293|NCT01563939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110637294|NCT03287271|Paclitaxel|paclitaxel|mesh-list
110637295|NCT03287271|Carboplatin|carboplatin|mesh-list
110637296|NCT03287271|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110637297|NCT03287271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110637298|NCT03287271|Tubulin Modulators|tubulin modulators|mesh-ancestor
110637299|NCT03287271|Antimitotic Agents|antimitotic agents|mesh-ancestor
110637300|NCT03287271|Mitosis Modulators|mitosis modulators|mesh-ancestor
110637301|NCT03287271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110637302|NCT00990405|Amoxicillin|amoxicillin|mesh-list
110637303|NCT00990405|Clarithromycin|clarithromycin|mesh-list
110637304|NCT00990405|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110637305|NCT00990405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110637306|NCT00990405|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110637308|NCT00990405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110637309|NCT00990405|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110123002|NCT01930734|Protective Agents|protective agents|mesh-ancestor
110637310|NCT00990405|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110637312|NCT00990639|Candesartan cilexetil|candesartan cilexetil|mesh-list
110637313|NCT00990639|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110637314|NCT00990639|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110637315|NCT00990639|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110123064|NCT01931085|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110637316|NCT00990639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110637318|NCT03742947|Coagulants|coagulants|mesh-ancestor
110637319|NCT05359497|Liver Extracts|liver extracts|mesh-list
110637320|NCT05359497|Hematinics|hematinics|mesh-ancestor
110637321|NCT00990795|Cyclosporine|cyclosporine|mesh-list
110637322|NCT00990795|Cyclosporins|cyclosporins|mesh-list
110637323|NCT00990795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110637324|NCT00990795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110637326|NCT00990795|Immunologic Factors|immunologic factors|mesh-ancestor
110637327|NCT00990795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110637328|NCT00990795|Antifungal Agents|antifungal agents|mesh-ancestor
110637329|NCT00990795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110637330|NCT00990795|Dermatologic Agents|dermatologic agents|mesh-ancestor
110637331|NCT00990795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110637332|NCT00990795|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110637333|NCT00622700|Teriflunomide|teriflunomide|mesh-list
110637334|NCT00622700|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110637335|NCT00622700|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110637336|NCT00622700|Analgesics|analgesics|mesh-ancestor
110637337|NCT00622700|Sensory System Agents|sensory system agents|mesh-ancestor
110637338|NCT00622700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110637339|NCT00622700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110637340|NCT00622700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110637341|NCT00622700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110637342|NCT00622700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110637343|NCT00622700|Immunologic Factors|immunologic factors|mesh-ancestor
110637344|NCT00831506|Digoxin|digoxin|mesh-list
110637345|NCT00831506|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110637346|NCT00831506|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110637347|NCT00831506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110637348|NCT00831506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110637349|NCT00831506|Protective Agents|protective agents|mesh-ancestor
110637350|NCT00831506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110637351|NCT02842359|Irbesartan|irbesartan|mesh-list
110637352|NCT02842359|Atorvastatin|atorvastatin|mesh-list
110637353|NCT02842359|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110637354|NCT02842359|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110637356|NCT02842359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110637357|NCT02842359|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110637358|NCT02842359|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110637359|NCT02842359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110637360|NCT02842359|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110637361|NCT02842359|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110637362|NCT02842359|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110637364|NCT00828776|Calcium heparin|calcium heparin|mesh-list
110637365|NCT00828776|Anticoagulants|anticoagulants|mesh-ancestor
110637366|NCT00828776|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110637367|NCT00828776|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110637368|NCT00828776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110637369|NCT00622466|Paclitaxel|paclitaxel|mesh-list
110637370|NCT00622466|Sorafenib|sorafenib|mesh-list
110637371|NCT00622466|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110637372|NCT00622466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110637373|NCT00622466|Tubulin Modulators|tubulin modulators|mesh-ancestor
110637374|NCT00622466|Antimitotic Agents|antimitotic agents|mesh-ancestor
110123464|NCT01933698|Amoxicillin|amoxicillin|mesh-list
110637375|NCT00622466|Mitosis Modulators|mitosis modulators|mesh-ancestor
110637376|NCT00622466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110637377|NCT00622466|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110637378|NCT00622466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110637380|NCT04043858|Sympathomimetics|sympathomimetics|mesh-ancestor
110637381|NCT04043858|Autonomic Agents|autonomic agents|mesh-ancestor
110637382|NCT04043858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110637383|NCT04043858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110637384|NCT04043858|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110123531|NCT01934127|Immunologic Factors|immunologic factors|mesh-ancestor
110123532|NCT01934127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110637385|NCT04043858|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110637386|NCT04043858|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110637387|NCT04043858|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110637388|NCT04043858|Adrenergic Agents|adrenergic agents|mesh-ancestor
110637389|NCT04043858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110637390|NCT04043858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110123596|NCT01934712|Insulin|insulin|mesh-list
110637391|NCT05359419|Aminolevulinic Acid|aminolevulinic acid|mesh-list
110637392|NCT05359419|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110637393|NCT05359419|Dermatologic Agents|dermatologic agents|mesh-ancestor
110637395|NCT00823862|Antimetabolites|antimetabolites|mesh-ancestor
110637396|NCT00823862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110637397|NCT00823862|Antiviral Agents|antiviral agents|mesh-ancestor
110637398|NCT00823862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110637399|NCT00537771|Tamoxifen|tamoxifen|mesh-list
110637400|NCT00537771|Anastrozole|anastrozole|mesh-list
110637401|NCT00537771|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110637402|NCT00537771|Hormone Antagonists|hormone antagonists|mesh-ancestor
110637403|NCT00537771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110637404|NCT00537771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110637405|NCT00537771|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110637406|NCT00537771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110637407|NCT00537771|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110637408|NCT00537771|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110637409|NCT00537771|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110637410|NCT00537771|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110637411|NCT00537771|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110637412|NCT00537771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110637413|NCT00537771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110637415|NCT00823940|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
110637416|NCT00823940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110637417|NCT00823940|Hormones|hormones|mesh-ancestor
110637418|NCT00823940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110637419|NCT00823940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110637420|NCT00823940|Incretins|incretins|mesh-ancestor
110637421|NCT00829322|Modafinil|modafinil|mesh-list
110637422|NCT00829322|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110637423|NCT00829322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110637424|NCT00829322|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
110637425|NCT00829322|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110637426|NCT00829322|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110123789|NCT01935557|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110637427|NCT00829322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110637428|NCT00623480|Factor VIII|factor viii|mesh-list
110637429|NCT00623480|Coagulants|coagulants|mesh-ancestor
110637430|NCT02513667|Ceritinib|ceritinib|mesh-list
110284751|NCT00410774|Bevacizumab|bevacizumab|mesh-list
110637431|NCT02513667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110637432|NCT02513667|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110637433|NCT02513667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110637434|NCT02513667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110637435|NCT03823911|Sofosbuvir|sofosbuvir|mesh-list
110637436|NCT03823911|Grazoprevir|grazoprevir|mesh-list
110637437|NCT03823911|Ledipasvir|ledipasvir|mesh-list
110637438|NCT03823911|Velpatasvir|velpatasvir|mesh-list
110637439|NCT03823911|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
110395319|NCT00596037|Hormones|hormones|mesh-list
110637440|NCT03823911|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
110637442|NCT03823911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110637443|NCT00829634|Methamphetamine|methamphetamine|mesh-list
110637444|NCT00829634|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110637445|NCT00829634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110637446|NCT00829634|Sympathomimetics|sympathomimetics|mesh-ancestor
110637447|NCT00829634|Autonomic Agents|autonomic agents|mesh-ancestor
110637448|NCT00829634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110637449|NCT00829634|Dopamine Agents|dopamine agents|mesh-ancestor
110637450|NCT00829634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110637451|NCT00829634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110637452|NCT00829634|Adrenergic Agents|adrenergic agents|mesh-ancestor
110637453|NCT00829634|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110637454|NCT00829634|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110637455|NCT00829634|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110254750|NCT00467194|Antifungal Agents|antifungal agents|mesh-ancestor
110637456|NCT00829634|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110637457|NCT04003467|Teriparatide|teriparatide|mesh-list
110637458|NCT04003467|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110637459|NCT04003467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110637460|NCT04003467|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110637461|NCT00832208|Amphotericin B|amphotericin b|mesh-list
110637462|NCT00832208|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
110637463|NCT00832208|Amebicides|amebicides|mesh-ancestor
110124117|NCT01937611|Midazolam|midazolam|mesh-list
110637464|NCT00832208|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110637465|NCT00832208|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110637466|NCT00832208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110637467|NCT00832208|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110637468|NCT00832208|Antifungal Agents|antifungal agents|mesh-ancestor
110637469|NCT05361057|Cytarabine|cytarabine|mesh-list
110637470|NCT05361057|Azacitidine|azacitidine|mesh-list
110637471|NCT05361057|Daunorubicin|daunorubicin|mesh-list
110637472|NCT05361057|Venetoclax|venetoclax|mesh-list
110637473|NCT05361057|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110637474|NCT05361057|Antimetabolites|antimetabolites|mesh-ancestor
110637475|NCT05361057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110637476|NCT05361057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110637477|NCT05361057|Antiviral Agents|antiviral agents|mesh-ancestor
110637478|NCT05361057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110637479|NCT05361057|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110637480|NCT05361057|Immunologic Factors|immunologic factors|mesh-ancestor
110637481|NCT05361057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110637482|NCT05361057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110637483|NCT05361057|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110637484|NCT05361057|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110637485|NCT05361057|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110637486|NCT00832286|Ciprofloxacin|ciprofloxacin|mesh-list
110637487|NCT00832286|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110124194|NCT01937767|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110637488|NCT00832286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110637489|NCT00832286|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110637490|NCT00832286|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110637491|NCT00832286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110637492|NCT00832286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110637493|NCT00832286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110637494|NCT00832286|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110637495|NCT00832286|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110637496|NCT00832364|Etanercept|etanercept|mesh-list
110637497|NCT00832364|Acitretin|acitretin|mesh-list
110395332|NCT02273102|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110637498|NCT00832364|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110637499|NCT00832364|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110637500|NCT00832364|Analgesics|analgesics|mesh-ancestor
110637501|NCT00832364|Sensory System Agents|sensory system agents|mesh-ancestor
110637502|NCT00832364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110637503|NCT00832364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110637504|NCT00832364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110637505|NCT00832364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110637506|NCT00832364|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110637507|NCT00832364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110637508|NCT00832364|Immunologic Factors|immunologic factors|mesh-ancestor
110637509|NCT00832364|Keratolytic Agents|keratolytic agents|mesh-ancestor
110637510|NCT00832364|Dermatologic Agents|dermatologic agents|mesh-ancestor
110637511|NCT00832442|Metoprolol|metoprolol|mesh-list
110637512|NCT00832442|Carvedilol|carvedilol|mesh-list
110637513|NCT00832442|Nebivolol|nebivolol|mesh-list
110637515|NCT00832442|Bucindolol|bucindolol|mesh-list
110637516|NCT00832442|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
110637517|NCT00832442|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110637518|NCT00832442|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110637519|NCT00832442|Sympatholytics|sympatholytics|mesh-ancestor
110637520|NCT00832442|Autonomic Agents|autonomic agents|mesh-ancestor
110637521|NCT00832442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110637522|NCT00832442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110637523|NCT00832442|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110637524|NCT00832442|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110637525|NCT00832442|Adrenergic Agents|adrenergic agents|mesh-ancestor
110637526|NCT00832442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110637527|NCT00832442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110637528|NCT00832442|Antioxidants|antioxidants|mesh-ancestor
110637529|NCT00832442|Protective Agents|protective agents|mesh-ancestor
110124290|NCT01938508|Minocycline|minocycline|mesh-list
110637530|NCT00832442|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110637531|NCT00832442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110637532|NCT00832442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110637533|NCT00832442|Vasodilator Agents|vasodilator agents|mesh-ancestor
110637534|NCT00832442|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110637535|NCT00832442|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110637536|NCT00832442|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
110637537|NCT00832442|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110637538|NCT00832442|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110637539|NCT00832442|Sympathomimetics|sympathomimetics|mesh-ancestor
110637540|NCT00830414|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
110637541|NCT00830414|Medroxyprogesterone|medroxyprogesterone|mesh-list
110395348|NCT02272517|Vortioxetine|vortioxetine|mesh-list
110637542|NCT00830414|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110637543|NCT00830414|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110157399|NCT00846703|Antimetabolites|antimetabolites|mesh-ancestor
110637544|NCT00830414|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110637545|NCT00830414|Contraceptive Agents|contraceptive agents|mesh-ancestor
110637546|NCT00830414|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110637547|NCT00830414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110637548|NCT00830414|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110637549|NCT00830414|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110637550|NCT00830414|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110637551|NCT00830414|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110637552|NCT00830414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110637554|NCT00830492|Enclomiphene|enclomiphene|mesh-list
110637555|NCT00830492|Zuclomiphene|zuclomiphene|mesh-list
110637556|NCT00830492|Buserelin|buserelin|mesh-list
110637557|NCT00830492|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110637558|NCT00830492|Hormone Antagonists|hormone antagonists|mesh-ancestor
110637559|NCT00830492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110637560|NCT00830492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110637561|NCT00830492|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110637562|NCT00830492|Fertility Agents|fertility agents|mesh-ancestor
110637563|NCT00830492|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110124548|NCT01939743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110637564|NCT00830492|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110637565|NCT00830492|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110637566|NCT00830570|Warfarin|warfarin|mesh-list
110637567|NCT00830570|Anticoagulants|anticoagulants|mesh-ancestor
110637568|NCT00837746|Risedronic Acid|risedronic acid|mesh-list
110637569|NCT00837746|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110637570|NCT00837746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110637571|NCT00837746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110637572|NCT00837746|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110637573|NCT00837746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110637574|NCT00837746|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110637575|NCT04043702|Topiramate|topiramate|mesh-list
110637576|NCT04043702|Anticonvulsants|anticonvulsants|mesh-ancestor
110637577|NCT04043702|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110637578|NCT04043702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110637579|NCT02550080|Dapsone|dapsone|mesh-list
110637580|NCT02550080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110637581|NCT02550080|Antimalarials|antimalarials|mesh-ancestor
110637582|NCT02550080|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110637583|NCT02550080|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110637584|NCT02550080|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110637585|NCT02550080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110637586|NCT02550080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110637587|NCT02550080|Leprostatic Agents|leprostatic agents|mesh-ancestor
110637588|NCT02550080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110637589|NCT02547350|Pirarubicin|pirarubicin|mesh-list
110637590|NCT02547350|Epirubicin|epirubicin|mesh-list
110637591|NCT02547350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110637592|NCT02547350|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110637593|NCT02547350|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110637594|NCT02547350|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110637595|NCT02547350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110637596|NCT02547350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110637597|NCT00838214|Prednisone|prednisone|mesh-list
110637598|NCT00838214|Budesonide|budesonide|mesh-list
110637599|NCT00838214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110637600|NCT00838214|Glucocorticoids|glucocorticoids|mesh-ancestor
110637601|NCT00838214|Hormones|hormones|mesh-ancestor
110637602|NCT00838214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110637603|NCT00838214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110637604|NCT00838214|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110637605|NCT00838214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110637606|NCT00838214|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110637607|NCT00838214|Autonomic Agents|autonomic agents|mesh-ancestor
110637608|NCT00838214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110637609|NCT00838214|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110637610|NCT00838214|Respiratory System Agents|respiratory system agents|mesh-ancestor
110637611|NCT00621764|Vaccines|vaccines|mesh-list
110124854|NCT01941888|Midazolam|midazolam|mesh-list
110637612|NCT00621764|Immunologic Factors|immunologic factors|mesh-ancestor
110637613|NCT00621764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110637614|NCT00838370|Fluorouracil|fluorouracil|mesh-list
110637615|NCT00838370|Capecitabine|capecitabine|mesh-list
110637616|NCT00838370|Antimetabolites|antimetabolites|mesh-ancestor
110124878|NCT01941914|Calcium, Dietary|calcium, dietary|mesh-list
110637617|NCT00838370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110637618|NCT00838370|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110637619|NCT00838370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110637620|NCT00838370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110637622|NCT00838370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110637623|NCT00537381|Prednisone|prednisone|mesh-list
110637624|NCT00537381|Docetaxel|docetaxel|mesh-list
110637625|NCT00537381|Intetumumab|intetumumab|mesh-list
110637626|NCT00537381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110637627|NCT00537381|Tubulin Modulators|tubulin modulators|mesh-ancestor
110637628|NCT00537381|Antimitotic Agents|antimitotic agents|mesh-ancestor
110637629|NCT00537381|Mitosis Modulators|mitosis modulators|mesh-ancestor
110637630|NCT00537381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110637631|NCT00537381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110637632|NCT00537381|Glucocorticoids|glucocorticoids|mesh-ancestor
110637633|NCT00537381|Hormones|hormones|mesh-ancestor
110637634|NCT00537381|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110637635|NCT00537381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110637636|NCT00537381|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110637637|NCT00537381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110637638|NCT00833300|Haloperidol|haloperidol|mesh-list
110637639|NCT00833300|Olanzapine|olanzapine|mesh-list
110637640|NCT00833300|Haloperidol decanoate|haloperidol decanoate|mesh-list
110637641|NCT00833300|Antiemetics|antiemetics|mesh-ancestor
110637642|NCT00833300|Autonomic Agents|autonomic agents|mesh-ancestor
110157483|NCT00845962|Sensory System Agents|sensory system agents|mesh-ancestor
110637643|NCT00833300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110637644|NCT00833300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110637645|NCT00833300|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110637646|NCT00833300|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110637647|NCT00833300|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110637648|NCT00833300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110637649|NCT00833300|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110637650|NCT00833300|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110637651|NCT00833300|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110637652|NCT00833300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110637653|NCT00833300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110637654|NCT00833300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110637655|NCT00833300|Serotonin Agents|serotonin agents|mesh-ancestor
110637656|NCT00833300|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110637657|NCT00833300|Dopamine Agents|dopamine agents|mesh-ancestor
110637658|NCT00833300|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110637659|NCT00833378|Ritonavir|ritonavir|mesh-list
110637660|NCT00833378|Lopinavir|lopinavir|mesh-list
110637661|NCT00833378|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110637662|NCT00833378|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110637663|NCT00833378|Protease Inhibitors|protease inhibitors|mesh-ancestor
110637664|NCT00833378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110637665|NCT00833378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110637666|NCT00833378|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110637667|NCT00833378|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110637668|NCT00833378|Antiviral Agents|antiviral agents|mesh-ancestor
110395393|NCT02272868|Laxatives|laxatives|mesh-ancestor
110637669|NCT00833378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110637670|NCT00833378|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110637671|NCT00833378|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110637672|NCT05359341|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110637673|NCT05359341|Empagliflozin|empagliflozin|mesh-list
110637674|NCT05359341|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
110637675|NCT05359341|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
110637676|NCT05359341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110637677|NCT05359341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110637678|NCT05359341|Incretins|incretins|mesh-ancestor
110637679|NCT05359341|Hormones|hormones|mesh-ancestor
110157498|NCT03620942|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110637680|NCT05359341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110637681|NCT05359341|Protease Inhibitors|protease inhibitors|mesh-ancestor
110637682|NCT05359341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110637683|NCT05359341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110637684|NCT05398731|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
110637685|NCT05398731|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110637686|NCT05398731|Adrenergic Agents|adrenergic agents|mesh-ancestor
110637687|NCT05398731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110637688|NCT05398731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110637689|NCT05398731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110637690|NCT00838760|Darunavir|darunavir|mesh-list
110637691|NCT00838760|TMC-310911|tmc-310911|mesh-list
110637692|NCT00838760|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110637693|NCT00838760|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110637694|NCT00838760|Protease Inhibitors|protease inhibitors|mesh-ancestor
110637695|NCT00838760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110637696|NCT00838760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110637697|NCT00838760|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110637698|NCT00838760|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110637699|NCT00838760|Antiviral Agents|antiviral agents|mesh-ancestor
110637700|NCT00838760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110637701|NCT03791398|Nivolumab|nivolumab|mesh-list
110637702|NCT03791398|TIC10 compound|tic10 compound|mesh-list
110637703|NCT03791398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110125611|NCT04487990|Heparin|heparin|mesh-list
110637705|NCT03791398|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110637706|NCT03791398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110637707|NCT00838838|Methyltestosterone|methyltestosterone|mesh-list
110637708|NCT00838838|Testosterone|testosterone|mesh-list
110637709|NCT00838838|Testosterone undecanoate|testosterone undecanoate|mesh-list
110637710|NCT00838838|Testosterone enanthate|testosterone enanthate|mesh-list
110637711|NCT00838838|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
110637713|NCT00838838|Hormones|hormones|mesh-ancestor
110637714|NCT00838838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110637715|NCT00838838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110637716|NCT00838838|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110637717|NCT00838838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110637718|NCT00838838|Anabolic Agents|anabolic agents|mesh-ancestor
110637719|NCT05360979|Endostatins|endostatins|mesh-list
110637720|NCT05360979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110637721|NCT05360979|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110637722|NCT05360979|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110637723|NCT05360979|Growth Substances|growth substances|mesh-ancestor
110395398|NCT02273453|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110637724|NCT05360979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110637725|NCT05360979|Growth Inhibitors|growth inhibitors|mesh-ancestor
110637727|NCT00833534|Lenalidomide|lenalidomide|mesh-list
110637728|NCT00833534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110637729|NCT00833534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110637730|NCT00833534|Immunologic Factors|immunologic factors|mesh-ancestor
110637731|NCT00833534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110637732|NCT00833534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110637733|NCT00833534|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110125838|NCT00504712|Hormones|hormones|mesh-ancestor
110637734|NCT00833534|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110637735|NCT00833534|Growth Substances|growth substances|mesh-ancestor
110637736|NCT00833534|Growth Inhibitors|growth inhibitors|mesh-ancestor
110637737|NCT05591001|Ketamine|ketamine|mesh-list
110637738|NCT05591001|Propofol|propofol|mesh-list
110637739|NCT05591001|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110637740|NCT05591001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110637741|NCT05591001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110637742|NCT05591001|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110637743|NCT05591001|Anesthetics, General|anesthetics, general|mesh-ancestor
110637744|NCT05591001|Anesthetics|anesthetics|mesh-ancestor
110637745|NCT05591001|Analgesics|analgesics|mesh-ancestor
110637746|NCT05591001|Sensory System Agents|sensory system agents|mesh-ancestor
110637747|NCT05591001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110637748|NCT05591001|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110637749|NCT05591001|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110637750|NCT05591001|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110637751|NCT05591001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110637752|NCT05591001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110637753|NCT00517192|Ritonavir|ritonavir|mesh-list
110637754|NCT00517192|Darunavir|darunavir|mesh-list
110637755|NCT00517192|Tipranavir|tipranavir|mesh-list
110637756|NCT00517192|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110157573|NCT00276796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110637757|NCT00517192|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110637758|NCT00517192|Protease Inhibitors|protease inhibitors|mesh-ancestor
110637759|NCT00517192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110637760|NCT00517192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110637761|NCT00517192|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110637762|NCT00517192|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110637763|NCT00517192|Antiviral Agents|antiviral agents|mesh-ancestor
110637764|NCT00517192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110637765|NCT00517192|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110637766|NCT00517192|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110637767|NCT00145327|Zoledronic Acid|zoledronic acid|mesh-list
110637768|NCT00145327|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110637769|NCT00145327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110637770|NCT00833768|Sevelamer|sevelamer|mesh-list
110637771|NCT00833768|Chelating Agents|chelating agents|mesh-ancestor
110637772|NCT00833768|Sequestering Agents|sequestering agents|mesh-ancestor
110637773|NCT00833768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110637774|NCT00510484|Pancrelipase|pancrelipase|mesh-list
110637775|NCT00510484|Pancreatin|pancreatin|mesh-list
110637776|NCT00510484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110637777|NCT00839228|Perhexiline|perhexiline|mesh-list
110637778|NCT00839228|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110637779|NCT00839228|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110637780|NCT00839228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110637781|NCT00839228|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110637782|NCT00839228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110637783|NCT00839228|Vasodilator Agents|vasodilator agents|mesh-ancestor
110637784|NCT05408481|Hydrocortisone|hydrocortisone|mesh-list
110637785|NCT05408481|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110637786|NCT00839462|Pantothenic Acid|pantothenic acid|mesh-list
110637787|NCT00839462|Vitamin B Complex|vitamin b complex|mesh-ancestor
110637788|NCT00839462|Vitamins|vitamins|mesh-ancestor
110637789|NCT00839462|Micronutrients|micronutrients|mesh-ancestor
110637790|NCT00839462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110637791|NCT05590221|Cyclophosphamide|cyclophosphamide|mesh-list
110637792|NCT05590221|Fludarabine|fludarabine|mesh-list
110637793|NCT05590221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110637795|NCT05590221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110637796|NCT05590221|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110637797|NCT05590221|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110637798|NCT05590221|Alkylating Agents|alkylating agents|mesh-ancestor
110637799|NCT05590221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110637800|NCT05590221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110637801|NCT05590221|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110637802|NCT05590143|Dapagliflozin|dapagliflozin|mesh-list
110637803|NCT05590143|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
110637804|NCT05590143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110637805|NCT05590143|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110637806|NCT05590143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110637807|NCT00622388|Ofatumumab|ofatumumab|mesh-list
110637808|NCT00622388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110637809|NCT01156389|Ritonavir|ritonavir|mesh-list
110637810|NCT01156389|Artesunate|artesunate|mesh-list
110637811|NCT01156389|Pyronaridine|pyronaridine|mesh-list
110637812|NCT01156389|Pyronaridine tetraphosphate, artesunate drug combination|pyronaridine tetraphosphate, artesunate drug combination|mesh-list
110637813|NCT01156389|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110637814|NCT01156389|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110637815|NCT01156389|Protease Inhibitors|protease inhibitors|mesh-ancestor
110637816|NCT01156389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110637817|NCT01156389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110637818|NCT01156389|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110637819|NCT01156389|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110637820|NCT01156389|Antiviral Agents|antiviral agents|mesh-ancestor
110637821|NCT01156389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110637822|NCT01156389|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110637823|NCT01156389|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110637824|NCT01156389|Antimalarials|antimalarials|mesh-ancestor
110637825|NCT01156389|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110637826|NCT01156389|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110637827|NCT01156389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110637828|NCT01156389|Schistosomicides|schistosomicides|mesh-ancestor
110637829|NCT01156389|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110637830|NCT01156389|Anthelmintics|anthelmintics|mesh-ancestor
110637831|NCT04043624|Lidocaine|lidocaine|mesh-list
110637832|NCT04043624|Anesthetics, Local|anesthetics, local|mesh-ancestor
110637833|NCT04043624|Anesthetics|anesthetics|mesh-ancestor
110637834|NCT04043624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110637835|NCT04043624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110637836|NCT04043624|Sensory System Agents|sensory system agents|mesh-ancestor
110637837|NCT04043624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110637838|NCT04043624|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110637839|NCT04043624|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110637840|NCT04043624|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110395422|NCT02273258|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110395426|NCT05015686|Vaccines|vaccines|mesh-list
110637841|NCT04043624|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110637842|NCT04043624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110637844|NCT01105767|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110637845|NCT01105767|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110637846|NCT01105767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110637847|NCT01105767|Disinfectants|disinfectants|mesh-ancestor
110637848|NCT01105767|Dermatologic Agents|dermatologic agents|mesh-ancestor
110637849|NCT00625742|Ibuprofen|ibuprofen|mesh-list
110637850|NCT00625742|Atenolol|atenolol|mesh-list
110637851|NCT00625742|Melatonin|melatonin|mesh-list
110637852|NCT00625742|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110637853|NCT00625742|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110637854|NCT00625742|Analgesics|analgesics|mesh-ancestor
110637855|NCT00625742|Sensory System Agents|sensory system agents|mesh-ancestor
110637856|NCT00625742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110637857|NCT00625742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110637858|NCT00625742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110637859|NCT00625742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110637860|NCT00625742|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110637861|NCT00625742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110637862|NCT00625742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110637863|NCT00625742|Antioxidants|antioxidants|mesh-ancestor
110637864|NCT00625742|Protective Agents|protective agents|mesh-ancestor
110637865|NCT00625742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110637866|NCT00625742|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110637867|NCT00625742|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110637868|NCT00625742|Sympatholytics|sympatholytics|mesh-ancestor
110637869|NCT00625742|Autonomic Agents|autonomic agents|mesh-ancestor
110637870|NCT00625742|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110637871|NCT00625742|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110637872|NCT00625742|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110637873|NCT00625742|Adrenergic Agents|adrenergic agents|mesh-ancestor
110637874|NCT00625742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110637875|NCT05589441|Insulin|insulin|mesh-list
110637876|NCT05589441|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110637877|NCT05589441|Albuterol|albuterol|mesh-list
110637878|NCT05589441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110637879|NCT05589441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110637880|NCT05589441|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110637881|NCT05589441|Autonomic Agents|autonomic agents|mesh-ancestor
110637882|NCT05589441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110637883|NCT05589441|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110637884|NCT05589441|Respiratory System Agents|respiratory system agents|mesh-ancestor
110637885|NCT05589441|Tocolytic Agents|tocolytic agents|mesh-ancestor
110637886|NCT05589441|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110637887|NCT05589441|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110637888|NCT05589441|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110637889|NCT05589441|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110637890|NCT05589441|Adrenergic Agents|adrenergic agents|mesh-ancestor
110637891|NCT05589441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110637892|NCT05589441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110637894|NCT00825188|Eplerenone|eplerenone|mesh-list
110637895|NCT00825188|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110637896|NCT00825188|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110637897|NCT00825188|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110637898|NCT00825188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110637899|NCT00825188|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110637900|NCT00825188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110637901|NCT00825188|Vasodilator Agents|vasodilator agents|mesh-ancestor
110637902|NCT00825188|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110637903|NCT00825188|Hormone Antagonists|hormone antagonists|mesh-ancestor
110637904|NCT00825188|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110637905|NCT00825188|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110637906|NCT00825188|Diuretics|diuretics|mesh-ancestor
110637907|NCT00825188|Natriuretic Agents|natriuretic agents|mesh-ancestor
110637908|NCT00834470|Atropine|atropine|mesh-list
110637909|NCT00834470|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110637910|NCT00834470|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110637911|NCT00834470|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110637912|NCT00834470|Autonomic Agents|autonomic agents|mesh-ancestor
110637913|NCT00834470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110637914|NCT00834470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110637915|NCT00834470|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110637916|NCT00834470|Respiratory System Agents|respiratory system agents|mesh-ancestor
110637917|NCT00834470|Mydriatics|mydriatics|mesh-ancestor
110637918|NCT00834470|Parasympatholytics|parasympatholytics|mesh-ancestor
110637919|NCT00834470|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110637920|NCT00834470|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110637921|NCT00834470|Cholinergic Agents|cholinergic agents|mesh-ancestor
110637922|NCT00834470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110637923|NCT00834470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110637924|NCT03997864|Prazosin|prazosin|mesh-list
110637925|NCT03997864|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110637926|NCT03997864|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110637927|NCT03997864|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110637928|NCT03997864|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110637929|NCT03997864|Adrenergic Agents|adrenergic agents|mesh-ancestor
110157700|NCT00276250|Abatacept|abatacept|mesh-list
110637930|NCT03997864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110637931|NCT03997864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110637932|NCT03997864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110637933|NCT05407467|Curcumin|curcumin|mesh-list
110637934|NCT05407467|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110637935|NCT05407467|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110637936|NCT05407467|Analgesics|analgesics|mesh-ancestor
110637937|NCT05407467|Sensory System Agents|sensory system agents|mesh-ancestor
110637938|NCT05407467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110637939|NCT05407467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110637940|NCT05407467|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110637941|NCT05407467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110637942|NCT05407467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110637943|NCT05407467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110637944|NCT05407467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110637945|NCT01010152|Codeine|codeine|mesh-list
110126580|NCT03174184|Clavulanic Acids|clavulanic acids|mesh-list
110126617|NCT02900560|Cc-486|cc-486|mesh-list
110637946|NCT01010152|Analgesics|analgesics|mesh-ancestor
110637947|NCT01010152|Sensory System Agents|sensory system agents|mesh-ancestor
110637948|NCT01010152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110637949|NCT01010152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110637950|NCT01010152|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110637951|NCT01010152|Narcotics|narcotics|mesh-ancestor
110637952|NCT01010152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110637953|NCT01010152|Antitussive Agents|antitussive agents|mesh-ancestor
110285265|NCT00207311|Interferons|interferons|mesh-list
110637954|NCT01010152|Respiratory System Agents|respiratory system agents|mesh-ancestor
110637956|NCT05407233|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110637957|NCT05407233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110637958|NCT05407233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110637959|NCT02549846|Atorvastatin|atorvastatin|mesh-list
110395450|NCT01340027|Mirabegron|mirabegron|mesh-list
110637960|NCT02549846|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110637961|NCT02549846|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110637962|NCT02549846|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110637963|NCT02549846|Antimetabolites|antimetabolites|mesh-ancestor
110637964|NCT02549846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110637965|NCT02549846|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110637966|NCT02549846|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110637967|NCT02549846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110637968|NCT05407155|Paclitaxel|paclitaxel|mesh-list
110637969|NCT05407155|Bevacizumab|bevacizumab|mesh-list
110637970|NCT05407155|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110637971|NCT05407155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110637972|NCT05407155|Tubulin Modulators|tubulin modulators|mesh-ancestor
110637973|NCT05407155|Antimitotic Agents|antimitotic agents|mesh-ancestor
110637974|NCT05407155|Mitosis Modulators|mitosis modulators|mesh-ancestor
110637975|NCT05407155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110637976|NCT05407155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110637977|NCT05407155|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110637978|NCT05407155|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110637979|NCT05407155|Growth Substances|growth substances|mesh-ancestor
110637980|NCT05407155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110637981|NCT05407155|Growth Inhibitors|growth inhibitors|mesh-ancestor
110637982|NCT00840242|Nicotine|nicotine|mesh-list
110637983|NCT00840242|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110637984|NCT00840242|Autonomic Agents|autonomic agents|mesh-ancestor
110637985|NCT00840242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110157728|NCT00276133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110637986|NCT00840242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110637988|NCT00840242|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110637989|NCT00840242|Cholinergic Agents|cholinergic agents|mesh-ancestor
110637990|NCT00840242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110637991|NCT00840242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110637992|NCT00840398|Buspirone|buspirone|mesh-list
110637993|NCT00840398|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110637994|NCT00840398|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110637995|NCT00840398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110637996|NCT00840398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110637997|NCT00840398|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110637998|NCT00840398|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110637999|NCT00840398|Serotonin Agents|serotonin agents|mesh-ancestor
110638000|NCT00840398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110638001|NCT00840398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110638002|NCT00537303|Insulin|insulin|mesh-list
110638003|NCT00537303|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110638004|NCT00537303|Insulin Aspart|insulin aspart|mesh-list
110126749|NCT01946061|Oxaliplatin|oxaliplatin|mesh-list
110638005|NCT00537303|Insulin, Long-Acting|insulin, long-acting|mesh-list
110638006|NCT00537303|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
110638008|NCT00537303|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110638009|NCT00537303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110638010|NCT02548286|Amlodipine|amlodipine|mesh-list
110638011|NCT02548286|Candesartan|candesartan|mesh-list
110395475|NCT01339559|Brivaracetam|brivaracetam|mesh-list
110638012|NCT02548286|Candesartan cilexetil|candesartan cilexetil|mesh-list
110638013|NCT02548286|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110638014|NCT02548286|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110638015|NCT02548286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110638016|NCT02548286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110638017|NCT02548286|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110638018|NCT02548286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110638019|NCT02548286|Vasodilator Agents|vasodilator agents|mesh-ancestor
110638020|NCT02548286|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110638021|NCT02548286|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110638022|NCT05360433|Oxycodone|oxycodone|mesh-list
110638023|NCT05360433|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110638024|NCT05360433|Narcotics|narcotics|mesh-ancestor
110638025|NCT05360433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110638026|NCT05360433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110638027|NCT05360433|Analgesics|analgesics|mesh-ancestor
110638028|NCT05360433|Sensory System Agents|sensory system agents|mesh-ancestor
110638029|NCT05360433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110638030|NCT00834860|Ribavirin|ribavirin|mesh-list
110638031|NCT00834860|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110638032|NCT00834860|Antimetabolites|antimetabolites|mesh-ancestor
110638033|NCT00834860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110638034|NCT00834860|Antiviral Agents|antiviral agents|mesh-ancestor
110638035|NCT00834860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110638036|NCT04696575|Lamivudine|lamivudine|mesh-list
110638037|NCT04696575|Carboplatin|carboplatin|mesh-list
110638038|NCT04696575|Etoposide|etoposide|mesh-list
110638039|NCT04696575|Etoposide phosphate|etoposide phosphate|mesh-list
110638040|NCT04696575|Atezolizumab|atezolizumab|mesh-list
110638041|NCT04696575|Podophyllotoxin|podophyllotoxin|mesh-list
110638042|NCT04696575|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110638043|NCT04696575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110638044|NCT04696575|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110638045|NCT04696575|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110638046|NCT04696575|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110638048|NCT04696575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110638049|NCT04696575|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110638050|NCT04696575|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110638051|NCT04696575|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110638052|NCT04696575|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110638053|NCT04696575|Antiviral Agents|antiviral agents|mesh-ancestor
110126909|NCT01947114|Anesthetics|anesthetics|mesh-ancestor
110638054|NCT04696575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110638055|NCT04696575|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110638056|NCT04696575|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110126993|NCT01947920|Tramadol|tramadol|mesh-list
110638057|NCT04696575|Immunologic Factors|immunologic factors|mesh-ancestor
110638058|NCT04696575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110638059|NCT04696575|Keratolytic Agents|keratolytic agents|mesh-ancestor
110638060|NCT04696575|Dermatologic Agents|dermatologic agents|mesh-ancestor
110638061|NCT04696575|Tubulin Modulators|tubulin modulators|mesh-ancestor
110638062|NCT04696575|Antimitotic Agents|antimitotic agents|mesh-ancestor
110638063|NCT04696575|Mitosis Modulators|mitosis modulators|mesh-ancestor
110638064|NCT00825422|Ropivacaine|ropivacaine|mesh-list
110638065|NCT00825422|Anesthetics, Local|anesthetics, local|mesh-ancestor
110638066|NCT00825422|Anesthetics|anesthetics|mesh-ancestor
110638067|NCT00825422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110638068|NCT00825422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110638069|NCT00825422|Sensory System Agents|sensory system agents|mesh-ancestor
110638070|NCT00825422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110638071|NCT00505414|Morphine|morphine|mesh-list
110638072|NCT00505414|Tapentadol|tapentadol|mesh-list
110638073|NCT00505414|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110638074|NCT00505414|Narcotics|narcotics|mesh-ancestor
110638075|NCT00505414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110638076|NCT00505414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110638077|NCT00505414|Analgesics|analgesics|mesh-ancestor
110638078|NCT00505414|Sensory System Agents|sensory system agents|mesh-ancestor
110638079|NCT00505414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110127051|NCT01948115|Nitrous Oxide|nitrous oxide|mesh-list
110638080|NCT00505414|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110638081|NCT00505414|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110638082|NCT00505414|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110157774|NCT00275548|Ribavirin|ribavirin|mesh-list
110638083|NCT00505414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110638084|NCT00505414|Adrenergic Agents|adrenergic agents|mesh-ancestor
110638085|NCT00505414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110638087|NCT02549924|Antioxidants|antioxidants|mesh-ancestor
110638088|NCT02549924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110638089|NCT02549924|Protective Agents|protective agents|mesh-ancestor
110638090|NCT02549924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110638091|NCT02549924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110638092|NCT02549924|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110638093|NCT01813227|Dexamethasone|dexamethasone|mesh-list
110638094|NCT01813227|Rituximab|rituximab|mesh-list
110638095|NCT01813227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110638096|NCT01813227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110638097|NCT01813227|Immunologic Factors|immunologic factors|mesh-ancestor
110638098|NCT01813227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110638099|NCT01813227|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110638100|NCT01813227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110638101|NCT01813227|Antiemetics|antiemetics|mesh-ancestor
110638102|NCT01813227|Autonomic Agents|autonomic agents|mesh-ancestor
110638103|NCT01813227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110638104|NCT01813227|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110638105|NCT01813227|Glucocorticoids|glucocorticoids|mesh-ancestor
110638106|NCT01813227|Hormones|hormones|mesh-ancestor
110638107|NCT01813227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110638108|NCT01813227|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110127180|NCT01948999|Anesthetics|anesthetics|mesh-list
110638109|NCT01012882|Immunomodulating Agents|immunomodulating agents|mesh-list
110638110|NCT01012882|Immunologic Factors|immunologic factors|mesh-list
110638111|NCT01012882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110638112|NCT00989469|Irinotecan|irinotecan|mesh-list
110638113|NCT00989469|Sorafenib|sorafenib|mesh-list
110638114|NCT00989469|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110638115|NCT00989469|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110638116|NCT00989469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110638117|NCT00989469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110638118|NCT00989469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110638119|NCT00989469|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110638120|NCT01010308|Nadolol|nadolol|mesh-list
110638121|NCT01010308|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110127227|NCT01949233|Doxycycline|doxycycline|mesh-list
110638122|NCT01010308|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110638123|NCT01010308|Adrenergic Agents|adrenergic agents|mesh-ancestor
110638124|NCT01010308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110638125|NCT01010308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110638126|NCT01010308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110638127|NCT01010308|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110638128|NCT01010308|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110638129|NCT01010308|Sympatholytics|sympatholytics|mesh-ancestor
110638131|NCT01010308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110638132|NCT02548052|Betamethasone|betamethasone|mesh-list
110638133|NCT02548052|Betamethasone Valerate|betamethasone valerate|mesh-list
110638134|NCT02548052|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
110638135|NCT02548052|Betamethasone benzoate|betamethasone benzoate|mesh-list
110638136|NCT02548052|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
110638137|NCT02548052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110638138|NCT02548052|Glucocorticoids|glucocorticoids|mesh-ancestor
110638139|NCT02548052|Hormones|hormones|mesh-ancestor
110638140|NCT02548052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110638141|NCT02548052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110638142|NCT02548052|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110638144|NCT04590417|Cyproterone Acetate|cyproterone acetate|mesh-list
110638145|NCT04590417|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110638146|NCT04590417|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110638147|NCT04590417|Estradiol|estradiol|mesh-list
110638148|NCT04590417|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110638149|NCT04590417|Cyproterone|cyproterone|mesh-list
110638150|NCT04590417|Estrogens|estrogens|mesh-ancestor
110638151|NCT04590417|Hormones|hormones|mesh-ancestor
110638152|NCT04590417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110638153|NCT04590417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110638154|NCT04590417|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110638155|NCT04590417|Contraceptive Agents|contraceptive agents|mesh-ancestor
110638156|NCT04590417|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110638157|NCT04590417|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110638158|NCT04590417|Androgen Antagonists|androgen antagonists|mesh-ancestor
110638159|NCT04590417|Hormone Antagonists|hormone antagonists|mesh-ancestor
110638160|NCT04590417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110638161|NCT04590417|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110638162|NCT00825656|Capsaicin|capsaicin|mesh-list
110638163|NCT00825656|Antipruritics|antipruritics|mesh-ancestor
110638164|NCT00825656|Dermatologic Agents|dermatologic agents|mesh-ancestor
110638165|NCT00825656|Sensory System Agents|sensory system agents|mesh-ancestor
110638166|NCT00825656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110638167|NCT00825656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110638168|NCT00989625|Naproxen|naproxen|mesh-list
110638169|NCT00989625|Sumatriptan|sumatriptan|mesh-list
110638170|NCT00989625|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110638171|NCT00989625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110638172|NCT00989625|Analgesics|analgesics|mesh-ancestor
110638173|NCT00989625|Sensory System Agents|sensory system agents|mesh-ancestor
110638174|NCT00989625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110638175|NCT00989625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110285440|NCT00233532|Verapamil|verapamil|mesh-list
110638176|NCT00989625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110638177|NCT00989625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110638178|NCT00989625|Gout Suppressants|gout suppressants|mesh-ancestor
110638179|NCT00989625|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110638180|NCT00989625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110127421|NCT01950507|Micafungin|micafungin|mesh-list
110638181|NCT00989625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110638182|NCT00989625|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110638183|NCT00989625|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110638184|NCT00989625|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110638185|NCT00989625|Serotonin Agents|serotonin agents|mesh-ancestor
110638186|NCT00989625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110638187|NCT00841256|Glycerol|glycerol|mesh-list
110638188|NCT00841256|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
110638189|NCT00841256|Protective Agents|protective agents|mesh-ancestor
110638190|NCT00841256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110638191|NCT00989703|Methotrexate|methotrexate|mesh-list
110638192|NCT00989703|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110638193|NCT00989703|Abortifacient Agents|abortifacient agents|mesh-ancestor
110638194|NCT00989703|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110638195|NCT00989703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110638196|NCT00989703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110638197|NCT00989703|Antimetabolites|antimetabolites|mesh-ancestor
110638198|NCT00989703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110638199|NCT00989703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110638200|NCT00989703|Dermatologic Agents|dermatologic agents|mesh-ancestor
110127456|NCT01950689|Nimorazole|nimorazole|mesh-list
110638201|NCT00989703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110638202|NCT00989703|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110638203|NCT00989703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110638204|NCT00989703|Immunologic Factors|immunologic factors|mesh-ancestor
110638205|NCT00989703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110638206|NCT00989703|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110638207|NCT01012960|Methylnaltrexone|methylnaltrexone|mesh-list
110638208|NCT01012960|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110638209|NCT01012960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110638210|NCT01012960|Sensory System Agents|sensory system agents|mesh-ancestor
110638211|NCT01012960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110638212|NCT00625586|Gemcitabine|gemcitabine|mesh-list
110638213|NCT00625586|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110254887|NCT00149136|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110638215|NCT00625586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110638216|NCT00625586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110638217|NCT02547116|Rifampin|rifampin|mesh-list
110638218|NCT02547116|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110127511|NCT01951079|Digoxin|digoxin|mesh-list
110638219|NCT02547116|Antitubercular Agents|antitubercular agents|mesh-ancestor
110638220|NCT02547116|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110638221|NCT02547116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110638222|NCT02547116|Leprostatic Agents|leprostatic agents|mesh-ancestor
110638223|NCT02547116|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110638225|NCT02547116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110638226|NCT02547116|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110638227|NCT02547116|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110638228|NCT02547116|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110638229|NCT02547116|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110638230|NCT02547116|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110638231|NCT02547116|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110638232|NCT02549690|Testosterone|testosterone|mesh-list
110638233|NCT02549690|Androgens|androgens|mesh-ancestor
110638234|NCT02549690|Hormones|hormones|mesh-ancestor
110638235|NCT02549690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110638236|NCT02549690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110638237|NCT02549768|Dexmedetomidine|dexmedetomidine|mesh-list
110638238|NCT02549768|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110638239|NCT02549768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110638240|NCT02549768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110638241|NCT02549768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110638242|NCT02549768|Analgesics|analgesics|mesh-ancestor
110638243|NCT02549768|Sensory System Agents|sensory system agents|mesh-ancestor
110638244|NCT02549768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110638245|NCT02549768|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110638246|NCT02549768|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110638247|NCT02549768|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110638248|NCT02549768|Adrenergic Agents|adrenergic agents|mesh-ancestor
110638249|NCT02549768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110638250|NCT02549768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110638251|NCT00841724|Fludarabine|fludarabine|mesh-list
110638252|NCT00841724|Busulfan|busulfan|mesh-list
110638253|NCT00841724|Thymoglobulin|thymoglobulin|mesh-list
110638254|NCT00841724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110127702|NCT01952561|Antiviral Agents|antiviral agents|mesh-ancestor
110638255|NCT00841724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110638256|NCT00841724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110638257|NCT00841724|Immunologic Factors|immunologic factors|mesh-ancestor
110638258|NCT00841724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110638259|NCT00841724|Alkylating Agents|alkylating agents|mesh-ancestor
110638260|NCT00841724|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110638261|NCT00841724|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110638263|NCT00843362|Oxytocics|oxytocics|mesh-ancestor
110638264|NCT00843362|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110638265|NCT00843362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110638266|NCT00841802|Prednisone|prednisone|mesh-list
110638267|NCT00841802|Glucocorticoids|glucocorticoids|mesh-list
110638268|NCT00841802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110638269|NCT00841802|Hormones|hormones|mesh-ancestor
110638270|NCT00841802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110638271|NCT00841802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110638272|NCT00841802|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110638273|NCT00841802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110638274|NCT00621140|Linagliptin|linagliptin|mesh-list
110638275|NCT00621140|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110638276|NCT00621140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110638277|NCT00621140|Incretins|incretins|mesh-ancestor
110638278|NCT00621140|Hormones|hormones|mesh-ancestor
110638279|NCT00621140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110638280|NCT00621140|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110638281|NCT00621140|Protease Inhibitors|protease inhibitors|mesh-ancestor
110638282|NCT00621140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110638283|NCT00621140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110638285|NCT00207727|Dermatologic Agents|dermatologic agents|mesh-ancestor
110638286|NCT00841880|Felodipine|felodipine|mesh-list
110638287|NCT00841880|Ramipril|ramipril|mesh-list
110638288|NCT00841880|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110638289|NCT00841880|Protease Inhibitors|protease inhibitors|mesh-ancestor
110638290|NCT00841880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110638291|NCT00841880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110638292|NCT00841880|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110638293|NCT00841880|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110638294|NCT00841880|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110638295|NCT00841880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110638296|NCT00841880|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110638297|NCT00841880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110638298|NCT00841880|Vasodilator Agents|vasodilator agents|mesh-ancestor
110638299|NCT00843440|Bevacizumab|bevacizumab|mesh-list
110638300|NCT00843440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110638301|NCT00843440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110638303|NCT00843440|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110638304|NCT00843440|Growth Substances|growth substances|mesh-ancestor
110638305|NCT00843440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110638306|NCT00843440|Growth Inhibitors|growth inhibitors|mesh-ancestor
110638307|NCT00504556|Warfarin|warfarin|mesh-list
110638308|NCT00504556|Edoxaban|edoxaban|mesh-list
110638309|NCT00504556|Anticoagulants|anticoagulants|mesh-ancestor
110638310|NCT00504556|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110638311|NCT00504556|Antithrombins|antithrombins|mesh-ancestor
110638312|NCT00504556|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110638313|NCT00504556|Protease Inhibitors|protease inhibitors|mesh-ancestor
110638314|NCT00504556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110638315|NCT00504556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110638316|NCT00206323|Topiramate|topiramate|mesh-list
110638317|NCT00206323|Anticonvulsants|anticonvulsants|mesh-ancestor
110638318|NCT00206323|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110638319|NCT00206323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110638320|NCT02546804|Chlorhexidine|chlorhexidine|mesh-list
110638321|NCT02546804|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110638322|NCT02546804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110638323|NCT02546804|Disinfectants|disinfectants|mesh-ancestor
110638324|NCT00842114|Interferons|interferons|mesh-list
110638325|NCT00842114|Prednisone|prednisone|mesh-list
110638326|NCT00842114|Cyclophosphamide|cyclophosphamide|mesh-list
110638327|NCT00842114|Vincristine|vincristine|mesh-list
110157902|NCT05047770|Vaccines|vaccines|mesh-list
110638328|NCT00842114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110638329|NCT00842114|Immunologic Factors|immunologic factors|mesh-ancestor
110128088|NCT05874869|Piperaquine|piperaquine|mesh-list
110638330|NCT00842114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110638331|NCT00842114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110638332|NCT00842114|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110638333|NCT00842114|Alkylating Agents|alkylating agents|mesh-ancestor
110638334|NCT00842114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110638335|NCT00842114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110638336|NCT00842114|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110638337|NCT00842114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110638340|NCT00842114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110638341|NCT00842114|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110638342|NCT00842114|Antiviral Agents|antiviral agents|mesh-ancestor
110638343|NCT00842114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110638344|NCT00842114|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110638345|NCT00842114|Tubulin Modulators|tubulin modulators|mesh-ancestor
110638346|NCT00842114|Antimitotic Agents|antimitotic agents|mesh-ancestor
110638347|NCT00842114|Mitosis Modulators|mitosis modulators|mesh-ancestor
110638348|NCT00842192|Insulin Detemir|insulin detemir|mesh-list
110638349|NCT00842192|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110638350|NCT00842192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110638352|NCT00536991|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
110638353|NCT00536991|Ketoconazole|ketoconazole|mesh-list
110638354|NCT00536991|Hydrocortisone|hydrocortisone|mesh-list
110638355|NCT00536991|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
110638356|NCT00536991|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
110638357|NCT00536991|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
110638358|NCT00536991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110638359|NCT00536991|Antifungal Agents|antifungal agents|mesh-ancestor
110638360|NCT00536991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110638361|NCT00536991|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110638362|NCT00536991|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110638363|NCT00536991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110128303|NCT05184712|Carboplatin|carboplatin|mesh-list
110638364|NCT00536991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110638365|NCT00536991|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110638366|NCT00536991|Hormone Antagonists|hormone antagonists|mesh-ancestor
110638367|NCT00536991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110638368|NCT00536991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110638369|NCT00536991|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110638370|NCT00536991|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110638371|NCT00536991|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
110638372|NCT00536991|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110638373|NCT00536991|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110638374|NCT00536991|Vitamins|vitamins|mesh-ancestor
110638375|NCT00536991|Micronutrients|micronutrients|mesh-ancestor
110638376|NCT00536991|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110638377|NCT03902613|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
110638378|NCT03902613|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110638379|NCT03902613|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110638380|NCT03902613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110128367|NCT05027919|Analgesics|analgesics|mesh-ancestor
110638381|NCT03902613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110638382|NCT03902613|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110638383|NCT03902613|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
110638384|NCT03902613|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110638385|NCT03902613|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110395551|NCT00107120|Escitalopram|escitalopram|mesh-list
110638386|NCT03902613|Adrenergic Agents|adrenergic agents|mesh-ancestor
110638387|NCT03902613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110638388|NCT03902613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110638389|NCT03902613|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110638390|NCT03902613|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110638391|NCT03902613|Serotonin Agents|serotonin agents|mesh-ancestor
110638392|NCT03902613|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110128502|NCT04495452|Fentanyl|fentanyl|mesh-list
110638393|NCT03902613|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110638395|NCT00504166|Alendronate|alendronate|mesh-list
110128567|NCT04198805|Vitamins|vitamins|mesh-list
110638396|NCT00504166|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110638397|NCT00504166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110638398|NCT02546648|Tranexamic Acid|tranexamic acid|mesh-list
110638399|NCT02546648|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110638400|NCT02546648|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110638401|NCT02546648|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110128713|NCT03434275|Analgesics|analgesics|mesh-ancestor
110638402|NCT02546648|Antimetabolites|antimetabolites|mesh-ancestor
110638403|NCT02546648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110638404|NCT02546648|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110638405|NCT02546648|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110638406|NCT02546648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110638407|NCT02546648|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110638408|NCT02546648|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110638409|NCT02546648|Hemostatics|hemostatics|mesh-ancestor
110638410|NCT02546648|Coagulants|coagulants|mesh-ancestor
110638411|NCT00842504|Micafungin|micafungin|mesh-list
110638412|NCT00842504|Antifungal Agents|antifungal agents|mesh-ancestor
110638413|NCT00842504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110638414|NCT00842582|Azacitidine|azacitidine|mesh-list
110638415|NCT00842582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110638416|NCT00842582|Antimetabolites|antimetabolites|mesh-ancestor
110638417|NCT00842582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110638418|NCT00842582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110638419|NCT00842582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110638420|NCT00843908|Imidacloprid|imidacloprid|mesh-list
110638421|NCT00843908|Cholinergic Agents|cholinergic agents|mesh-ancestor
110638422|NCT00843908|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110157963|NCT04712435|Acetylcysteine|acetylcysteine|mesh-list
110638423|NCT00843908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110638424|NCT00843908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110638425|NCT00842660|Gemcitabine|gemcitabine|mesh-list
110638426|NCT00842660|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110638427|NCT00842660|Antimetabolites|antimetabolites|mesh-ancestor
110638428|NCT00842660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110638429|NCT00842660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110638430|NCT00509236|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110638431|NCT00509236|Glipizide|glipizide|mesh-list
110638432|NCT00509236|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110638433|NCT00509236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110638435|NCT00509236|Hormones|hormones|mesh-ancestor
110638436|NCT00509236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110638437|NCT00509236|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110638438|NCT00509236|Protease Inhibitors|protease inhibitors|mesh-ancestor
110638439|NCT00509236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110638440|NCT00509236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110638441|NCT00842894|Insulin|insulin|mesh-list
110638442|NCT00842894|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110638444|NCT00842894|Insulin Detemir|insulin detemir|mesh-list
110395581|NCT02892318|Atezolizumab|atezolizumab|mesh-list
110638445|NCT00842894|Biphasic Insulins|biphasic insulins|mesh-list
110638446|NCT00842894|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
110638447|NCT00842894|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110638448|NCT00842894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110638449|NCT00508924|Heparin|heparin|mesh-list
110638450|NCT00508924|Argatroban|argatroban|mesh-list
110638451|NCT00508924|Anticoagulants|anticoagulants|mesh-ancestor
110638452|NCT00508924|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110638453|NCT00508924|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110638454|NCT00508924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110638455|NCT00508924|Antithrombins|antithrombins|mesh-ancestor
110638456|NCT00508924|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110638457|NCT00508924|Protease Inhibitors|protease inhibitors|mesh-ancestor
110638458|NCT00508924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110638459|NCT00508924|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110638460|NCT00836576|Benazepril|benazepril|mesh-list
110638461|NCT00836576|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110638462|NCT00836576|Protease Inhibitors|protease inhibitors|mesh-ancestor
110638463|NCT00836576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110638464|NCT00836576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110638465|NCT00836576|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110638466|NCT00836654|Catumaxomab|catumaxomab|mesh-list
110157986|NCT04729465|Propofol|propofol|mesh-list
110638467|NCT00836654|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110638468|NCT00844064|Trabedersen|trabedersen|mesh-list
110638469|NCT00844064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110638470|NCT04688788|Fexofenadine|fexofenadine|mesh-list
110638471|NCT04688788|Methylprednisolone|methylprednisolone|mesh-list
110638472|NCT04688788|Rituximab|rituximab|mesh-list
110638473|NCT04688788|Ocrelizumab|ocrelizumab|mesh-list
110638474|NCT04688788|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110638475|NCT04688788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110638476|NCT04688788|Immunologic Factors|immunologic factors|mesh-ancestor
110638477|NCT04688788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110638478|NCT04688788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110638479|NCT04688788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110638480|NCT04688788|Antiemetics|antiemetics|mesh-ancestor
110638481|NCT04688788|Autonomic Agents|autonomic agents|mesh-ancestor
110129501|NCT01955057|Antimetabolites|antimetabolites|mesh-ancestor
110638482|NCT04688788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110638483|NCT04688788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110638484|NCT04688788|Glucocorticoids|glucocorticoids|mesh-ancestor
110638486|NCT04688788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110638487|NCT04688788|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110638488|NCT04688788|Protective Agents|protective agents|mesh-ancestor
110638489|NCT04688788|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110638490|NCT04688788|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110638491|NCT04688788|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110638492|NCT04688788|Histamine Antagonists|histamine antagonists|mesh-ancestor
110638493|NCT04688788|Histamine Agents|histamine agents|mesh-ancestor
110638494|NCT04688788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110638495|NCT04688788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110638496|NCT05221593|Lithium Carbonate|lithium carbonate|mesh-list
110638497|NCT05221593|Antidepressive Agents|antidepressive agents|mesh-ancestor
110638498|NCT05221593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110638499|NCT05221593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110638500|NCT05221593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110638501|NCT05221593|Antimanic Agents|antimanic agents|mesh-ancestor
110638502|NCT05221593|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110638503|NCT05221593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110638504|NCT05221593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110638505|NCT00844142|Sulfasalazine|sulfasalazine|mesh-list
110638506|NCT00844142|Etanercept|etanercept|mesh-list
110638507|NCT00844142|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110638508|NCT00844142|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110638509|NCT00844142|Analgesics|analgesics|mesh-ancestor
110638510|NCT00844142|Sensory System Agents|sensory system agents|mesh-ancestor
110638511|NCT00844142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110638512|NCT00844142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110129553|NCT01955187|Tacrolimus|tacrolimus|mesh-list
110638513|NCT00844142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110638514|NCT00844142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110638515|NCT00844142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110638516|NCT00844142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110638517|NCT00844142|Immunologic Factors|immunologic factors|mesh-ancestor
110638518|NCT00844142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110638520|NCT00837044|Sumatriptan|sumatriptan|mesh-list
110638521|NCT00837044|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110638522|NCT00837044|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110638523|NCT00837044|Analgesics|analgesics|mesh-ancestor
110638524|NCT00837044|Sensory System Agents|sensory system agents|mesh-ancestor
110638525|NCT00837044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110638526|NCT00837044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110638527|NCT00837044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110638528|NCT00837044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110638529|NCT00837044|Gout Suppressants|gout suppressants|mesh-ancestor
110638530|NCT00837044|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110638531|NCT00837044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110638532|NCT00837044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110638533|NCT00837044|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110158051|NCT02966665|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
110638534|NCT00837044|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110638535|NCT00837044|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110638536|NCT00837044|Serotonin Agents|serotonin agents|mesh-ancestor
110638537|NCT00837044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110638538|NCT01013272|Lamivudine|lamivudine|mesh-list
110638539|NCT01013272|Entecavir|entecavir|mesh-list
110638540|NCT01013272|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110638541|NCT01013272|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110638542|NCT01013272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110638543|NCT01013272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110638544|NCT01013272|Antiviral Agents|antiviral agents|mesh-ancestor
110638545|NCT01013272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110638546|NCT01013272|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110638547|NCT01013272|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110638548|NCT04232085|Mycophenolic Acid|mycophenolic acid|mesh-list
110285799|NCT00209300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110638549|NCT04232085|Cyclophosphamide|cyclophosphamide|mesh-list
110638550|NCT04232085|Melphalan|melphalan|mesh-list
110638551|NCT04232085|Fludarabine|fludarabine|mesh-list
110638553|NCT04232085|Tacrolimus|tacrolimus|mesh-list
110638554|NCT04232085|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110638555|NCT04232085|Immunologic Factors|immunologic factors|mesh-ancestor
110638556|NCT04232085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110638557|NCT04232085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110638558|NCT04232085|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110638559|NCT04232085|Alkylating Agents|alkylating agents|mesh-ancestor
110638560|NCT04232085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110638561|NCT04232085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110638562|NCT04232085|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110638563|NCT04232085|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110129775|NCT01956695|Rituximab|rituximab|mesh-list
110638564|NCT04232085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110638565|NCT04232085|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110638566|NCT04232085|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110638567|NCT04232085|Antitubercular Agents|antitubercular agents|mesh-ancestor
110638568|NCT04232085|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110638569|NCT04232085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110638570|NCT04232085|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110638571|NCT02546024|Antidepressive Agents|antidepressive agents|mesh-list
110638572|NCT02546024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110638573|NCT01010698|Acyclovir|acyclovir|mesh-list
110638574|NCT01010698|Cimetidine|cimetidine|mesh-list
110638575|NCT01010698|Antiviral Agents|antiviral agents|mesh-ancestor
110129914|NCT01957449|Sympatholytics|sympatholytics|mesh-ancestor
110638576|NCT01010698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110638577|NCT01010698|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110638578|NCT01010698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110638579|NCT01010698|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110638580|NCT01010698|Histamine Antagonists|histamine antagonists|mesh-ancestor
110638581|NCT01010698|Histamine Agents|histamine agents|mesh-ancestor
110638582|NCT01010698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110158096|NCT02395705|Antimitotic Agents|antimitotic agents|mesh-ancestor
110638583|NCT01010698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110638584|NCT01010698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110638585|NCT01010698|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110638586|NCT01010698|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110638587|NCT01010698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110638589|NCT03541486|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110638590|NCT03541486|Antimetabolites|antimetabolites|mesh-ancestor
110638591|NCT03541486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110638592|NCT03541486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110638593|NCT00620750|Naltrexone|naltrexone|mesh-list
110638594|NCT00620750|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110638595|NCT00620750|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110638596|NCT00620750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110638597|NCT00620750|Sensory System Agents|sensory system agents|mesh-ancestor
110130006|NCT01958684|Copper|copper|mesh-list
110638598|NCT00620750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110638599|NCT02547896|Diclofenac|diclofenac|mesh-list
110638600|NCT02547896|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
110638601|NCT02547896|Codeine|codeine|mesh-list
110638602|NCT02547896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110638603|NCT02547896|Analgesics|analgesics|mesh-ancestor
110638604|NCT02547896|Sensory System Agents|sensory system agents|mesh-ancestor
110638605|NCT02547896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110638606|NCT02547896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110638607|NCT02547896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110638608|NCT02547896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110638609|NCT02547896|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110638610|NCT02547896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110638611|NCT02547896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110638612|NCT02547896|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110638613|NCT02547896|Narcotics|narcotics|mesh-ancestor
110638614|NCT02547896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110638615|NCT02547896|Antitussive Agents|antitussive agents|mesh-ancestor
110638616|NCT02547896|Respiratory System Agents|respiratory system agents|mesh-ancestor
110638617|NCT01564251|Gemcitabine|gemcitabine|mesh-list
110638618|NCT01564251|GDC-0575|gdc-0575|mesh-list
110638619|NCT01564251|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110638620|NCT01564251|Antimetabolites|antimetabolites|mesh-ancestor
110638621|NCT01564251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110638622|NCT01564251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110638623|NCT01564251|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110638624|NCT01564251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110638626|NCT00508144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110638627|NCT00508144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110638628|NCT00508144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110638629|NCT00508144|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110638630|NCT00508144|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110638632|NCT00844454|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110638633|NCT00844454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110638634|NCT00844454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110638635|NCT00844454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110638636|NCT02545712|Ethanol|ethanol|mesh-list
110638637|NCT02545712|Benzyl Alcohol|benzyl alcohol|mesh-list
110638638|NCT02545712|Sorbitol|sorbitol|mesh-list
110638639|NCT02545712|Glycerol|glycerol|mesh-list
110638640|NCT02545712|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110638641|NCT02545712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110638642|NCT02545712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110638643|NCT02545712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110638644|NCT02545712|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
110638645|NCT02545712|Protective Agents|protective agents|mesh-ancestor
110638646|NCT02545712|Cathartics|cathartics|mesh-ancestor
110638647|NCT02545712|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110638648|NCT02545712|Anesthetics, Local|anesthetics, local|mesh-ancestor
110638649|NCT02545712|Anesthetics|anesthetics|mesh-ancestor
110638650|NCT02545712|Sensory System Agents|sensory system agents|mesh-ancestor
110638651|NCT02545712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110638652|NCT01011010|Doxorubicin|doxorubicin|mesh-list
110130203|NCT01959828|Gasotransmitters|gasotransmitters|mesh-ancestor
110638653|NCT01011010|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110638654|NCT01011010|Mitomycins|mitomycins|mesh-list
110638655|NCT01011010|Mitomycin|mitomycin|mesh-list
110638656|NCT01011010|Sorafenib|sorafenib|mesh-list
110638657|NCT01011010|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110638658|NCT01011010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110638659|NCT01011010|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110638660|NCT01011010|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110638661|NCT01011010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110638662|NCT01011010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110130348|NCT01961193|Silicon|silicon|mesh-list
110638664|NCT01011010|Alkylating Agents|alkylating agents|mesh-ancestor
110638665|NCT01011010|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110638666|NCT00851708|Acetylcysteine|acetylcysteine|mesh-list
110638667|NCT00851708|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110638668|NCT00851708|Antiviral Agents|antiviral agents|mesh-ancestor
110638669|NCT00851708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110638670|NCT00851708|Expectorants|expectorants|mesh-ancestor
110638671|NCT00851708|Respiratory System Agents|respiratory system agents|mesh-ancestor
110638672|NCT00851708|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110638673|NCT00851708|Antioxidants|antioxidants|mesh-ancestor
110638674|NCT00851708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110638675|NCT00851708|Protective Agents|protective agents|mesh-ancestor
110638676|NCT00851708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110638677|NCT00851708|Antidotes|antidotes|mesh-ancestor
110638678|NCT01011166|Ribavirin|ribavirin|mesh-list
110638679|NCT01011166|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110638680|NCT01011166|Antimetabolites|antimetabolites|mesh-ancestor
110638681|NCT01011166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110638682|NCT01011166|Antiviral Agents|antiviral agents|mesh-ancestor
110638683|NCT01011166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110638684|NCT00621842|Lamotrigine|lamotrigine|mesh-list
110638685|NCT00621842|Anticonvulsants|anticonvulsants|mesh-list
110638686|NCT00621842|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110638687|NCT00621842|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110395637|NCT01332968|Hormones|hormones|mesh-ancestor
110638688|NCT00621842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110638689|NCT00621842|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110638690|NCT00621842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110638691|NCT00621842|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110638692|NCT00621842|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110638693|NCT00621842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110638694|NCT00621842|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110638695|NCT00621842|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110638696|NCT04849455|Morphine|morphine|mesh-list
110638697|NCT04849455|Ropivacaine|ropivacaine|mesh-list
110638698|NCT04849455|Anesthetics, Local|anesthetics, local|mesh-list
110638699|NCT04849455|Anesthetics|anesthetics|mesh-list
110638700|NCT04849455|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110638701|NCT04849455|Narcotics|narcotics|mesh-ancestor
110638702|NCT04849455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110638703|NCT04849455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110638704|NCT04849455|Analgesics|analgesics|mesh-ancestor
110638705|NCT04849455|Sensory System Agents|sensory system agents|mesh-ancestor
110638706|NCT04849455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110638707|NCT02545010|Paclitaxel|paclitaxel|mesh-list
110638708|NCT02545010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110638709|NCT02545010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110638710|NCT02545010|Tubulin Modulators|tubulin modulators|mesh-ancestor
110638711|NCT02545010|Antimitotic Agents|antimitotic agents|mesh-ancestor
110638712|NCT02545010|Mitosis Modulators|mitosis modulators|mesh-ancestor
110638713|NCT02545010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110638714|NCT01013506|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110638715|NCT01013506|Letrozole|letrozole|mesh-list
110638716|NCT01013506|Goserelin|goserelin|mesh-list
110638717|NCT01013506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110638718|NCT01013506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110638719|NCT01013506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110638720|NCT01013506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110638721|NCT01013506|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110638722|NCT01013506|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110638723|NCT01013506|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110638724|NCT01013506|Hormone Antagonists|hormone antagonists|mesh-ancestor
110638725|NCT01013506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110638726|NCT01013506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110638727|NCT01013506|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110638728|NCT00844688|Gemcitabine|gemcitabine|mesh-list
110638729|NCT00844688|Sorafenib|sorafenib|mesh-list
110638730|NCT00844688|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110638731|NCT00844688|Antimetabolites|antimetabolites|mesh-ancestor
110638732|NCT00844688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110638733|NCT00844688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110638734|NCT00844688|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110638735|NCT00844688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110638736|NCT04541680|Nintedanib|nintedanib|mesh-list
110638737|NCT04541680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110638738|NCT04541680|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110638739|NCT04541680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110638740|NCT04541680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110638741|NCT00855530|Amibegron|amibegron|mesh-list
110638742|NCT00855530|Amibegron hydrochloride|amibegron hydrochloride|mesh-list
110638743|NCT00855530|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110638745|NCT00855530|Adrenergic Agents|adrenergic agents|mesh-ancestor
110638746|NCT00855530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110638747|NCT00855530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110638748|NCT00855530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110638749|NCT00855530|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
110638750|NCT00855608|Adalimumab|adalimumab|mesh-list
110638751|NCT00855608|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110638752|NCT00855608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110638753|NCT00855608|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110638754|NCT00851864|Tinzaparin|tinzaparin|mesh-list
110638755|NCT00851864|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
110638756|NCT00851864|Dalteparin|dalteparin|mesh-list
110638757|NCT00851864|Anticoagulants|anticoagulants|mesh-ancestor
110638758|NCT00851864|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110130558|NCT01963390|Testosterone|testosterone|mesh-list
110638760|NCT00851864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110638761|NCT00851942|Cosyntropin|cosyntropin|mesh-list
110638762|NCT00851942|Hormones|hormones|mesh-ancestor
110130619|NCT01963741|Histamine Agents|histamine agents|mesh-ancestor
110638763|NCT00851942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110638764|NCT00851942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110638765|NCT00503776|Amifostine|amifostine|mesh-list
110638766|NCT00503776|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110638767|NCT00503776|Protective Agents|protective agents|mesh-ancestor
110638768|NCT00503776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110638770|NCT02545634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110638771|NCT02545634|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110638772|NCT02545634|Antimalarials|antimalarials|mesh-ancestor
110638773|NCT02545634|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110638774|NCT02545634|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110638775|NCT00855686|Memantine|memantine|mesh-list
110638776|NCT00855686|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110638777|NCT00855686|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110638778|NCT00855686|Dopamine Agents|dopamine agents|mesh-ancestor
110638779|NCT00855686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110638780|NCT00855686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110638781|NCT00855686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110638782|NCT00855686|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110638783|NCT00855686|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110638784|NCT00619112|Temozolomide|temozolomide|mesh-list
110638785|NCT00619112|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110638786|NCT00619112|Alkylating Agents|alkylating agents|mesh-ancestor
110638787|NCT00619112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110638788|NCT00619112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110638789|NCT00845156|Thioctic Acid|thioctic acid|mesh-list
110638790|NCT00845156|Antioxidants|antioxidants|mesh-ancestor
110638791|NCT00845156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110638792|NCT00845156|Protective Agents|protective agents|mesh-ancestor
110638793|NCT00845156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110638794|NCT00845156|Vitamin B Complex|vitamin b complex|mesh-ancestor
110638796|NCT00845156|Micronutrients|micronutrients|mesh-ancestor
110638797|NCT00852332|Curcumin|curcumin|mesh-list
110638798|NCT00852332|Docetaxel|docetaxel|mesh-list
110638799|NCT00852332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110638800|NCT00852332|Tubulin Modulators|tubulin modulators|mesh-ancestor
110638801|NCT00852332|Antimitotic Agents|antimitotic agents|mesh-ancestor
110638802|NCT00852332|Mitosis Modulators|mitosis modulators|mesh-ancestor
110638803|NCT00852332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110254954|NCT00469768|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110638804|NCT00852332|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110638805|NCT00852332|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110638806|NCT00852332|Analgesics|analgesics|mesh-ancestor
110638807|NCT00852332|Sensory System Agents|sensory system agents|mesh-ancestor
110638808|NCT00852332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110638809|NCT00852332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110638810|NCT00852332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110638811|NCT00852332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110638812|NCT00852332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110638813|NCT00852410|Lidocaine|lidocaine|mesh-list
110638814|NCT00852410|Epinephrine|epinephrine|mesh-list
110638815|NCT00852410|Racepinephrine|racepinephrine|mesh-list
110638816|NCT00852410|Epinephryl borate|epinephryl borate|mesh-list
110638817|NCT00852410|Anesthetics, Local|anesthetics, local|mesh-ancestor
110638818|NCT00852410|Anesthetics|anesthetics|mesh-ancestor
110638819|NCT00852410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110638820|NCT00852410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110638821|NCT00852410|Sensory System Agents|sensory system agents|mesh-ancestor
110638822|NCT00852410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110638823|NCT00852410|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110638824|NCT00852410|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110638825|NCT00852410|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110638826|NCT00852410|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110638827|NCT00852410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110638828|NCT00852410|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110638829|NCT00852410|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110638830|NCT00852410|Adrenergic Agents|adrenergic agents|mesh-ancestor
110638831|NCT00852410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110638832|NCT00852410|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110638833|NCT00852410|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110638834|NCT00852410|Autonomic Agents|autonomic agents|mesh-ancestor
110638835|NCT00852410|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110638836|NCT00852410|Respiratory System Agents|respiratory system agents|mesh-ancestor
110638837|NCT00852410|Mydriatics|mydriatics|mesh-ancestor
110638838|NCT00852410|Sympathomimetics|sympathomimetics|mesh-ancestor
110638839|NCT00852410|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110638840|NCT00992121|Bevacizumab|bevacizumab|mesh-list
110638841|NCT00992121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110638842|NCT00992121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110638843|NCT00992121|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110638844|NCT00992121|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110638845|NCT00992121|Growth Substances|growth substances|mesh-ancestor
110638846|NCT00992121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110638847|NCT00992121|Growth Inhibitors|growth inhibitors|mesh-ancestor
110638848|NCT04420299|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
110638849|NCT04420299|Bemiparin|bemiparin|mesh-list
110638850|NCT04420299|Anticoagulants|anticoagulants|mesh-ancestor
110638851|NCT04420299|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110638852|NCT04420299|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110638853|NCT04420299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110638855|NCT00992199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110638856|NCT00992199|Antimetabolites|antimetabolites|mesh-ancestor
110638857|NCT00992199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110638858|NCT00992199|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110638859|NCT00992199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110638860|NCT00992199|Immunologic Factors|immunologic factors|mesh-ancestor
110638861|NCT00992199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110638862|NCT00856310|Fasinumab|fasinumab|mesh-list
110638863|NCT00856310|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110638864|NCT00856310|Analgesics|analgesics|mesh-ancestor
110638865|NCT00856310|Sensory System Agents|sensory system agents|mesh-ancestor
110638866|NCT00856310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110638867|NCT00856310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110638868|NCT02773485|Cisplatin|cisplatin|mesh-list
110638869|NCT02773485|Gemcitabine|gemcitabine|mesh-list
110638870|NCT02773485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110638871|NCT02773485|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110638872|NCT02773485|Antimetabolites|antimetabolites|mesh-ancestor
110638873|NCT02773485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110638874|NCT04042220|Glucocorticoids|glucocorticoids|mesh-list
110638875|NCT04042220|Hormones|hormones|mesh-ancestor
110638876|NCT04042220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110638877|NCT04042220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110638878|NCT00992355|Tobramycin|tobramycin|mesh-list
110638879|NCT00992355|Dexamethasone|dexamethasone|mesh-list
110638880|NCT00992355|Dexamethasone acetate|dexamethasone acetate|mesh-list
110638881|NCT00992355|Ketorolac|ketorolac|mesh-list
110638882|NCT00992355|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
110638883|NCT00992355|BB 1101|bb 1101|mesh-list
110638884|NCT00992355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110638885|NCT00992355|Antiemetics|antiemetics|mesh-ancestor
110638886|NCT00992355|Autonomic Agents|autonomic agents|mesh-ancestor
110638887|NCT00992355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110638888|NCT00992355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110638889|NCT00992355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110638890|NCT00992355|Glucocorticoids|glucocorticoids|mesh-ancestor
110638891|NCT00992355|Hormones|hormones|mesh-ancestor
110638892|NCT00992355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110638893|NCT00992355|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110638894|NCT00992355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110638895|NCT00992355|Protease Inhibitors|protease inhibitors|mesh-ancestor
110638896|NCT00992355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110638897|NCT00992355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110638898|NCT00992355|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110638899|NCT00992355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110638900|NCT00992355|Analgesics|analgesics|mesh-ancestor
110638901|NCT00992355|Sensory System Agents|sensory system agents|mesh-ancestor
110638902|NCT00992355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110638903|NCT00992355|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110638904|NCT00992355|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110638905|NCT00992355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110638906|NCT00852566|Imatinib Mesylate|imatinib mesylate|mesh-list
110638907|NCT00852566|Dasatinib|dasatinib|mesh-list
110638908|NCT00852566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110638909|NCT00852566|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110638910|NCT00852566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110638911|NCT00852566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110638912|NCT00856622|Timolol|timolol|mesh-list
110638913|NCT00856622|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110638914|NCT00856622|Latanoprost|latanoprost|mesh-list
110638915|NCT00856622|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110638916|NCT00856622|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110638917|NCT00856622|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110638918|NCT00856622|Adrenergic Agents|adrenergic agents|mesh-ancestor
110638919|NCT00856622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110638920|NCT00856622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110638921|NCT00856622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110638922|NCT00856622|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110638923|NCT00856622|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110638924|NCT00856700|Incretins|incretins|mesh-list
110638925|NCT00856700|Hormones|hormones|mesh-ancestor
110638926|NCT00856700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110638927|NCT00856700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110638928|NCT00618956|Milnacipran|milnacipran|mesh-list
110638929|NCT00618956|Levomilnacipran|levomilnacipran|mesh-list
110395695|NCT01332149|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110638930|NCT00618956|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110638931|NCT00618956|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110638932|NCT00618956|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110638933|NCT00618956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110638934|NCT00618956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110638935|NCT00618956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110638936|NCT00618956|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110638938|NCT00618956|Sensory System Agents|sensory system agents|mesh-ancestor
110638939|NCT00618956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110638940|NCT00618956|Antidepressive Agents|antidepressive agents|mesh-ancestor
110638941|NCT00618956|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110638942|NCT00852800|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110638944|NCT00845546|Pseudoephedrine|pseudoephedrine|mesh-list
110638945|NCT00845546|Ephedrine|ephedrine|mesh-list
110638946|NCT00845546|Antipruritics|antipruritics|mesh-ancestor
110638947|NCT00845546|Dermatologic Agents|dermatologic agents|mesh-ancestor
110638948|NCT00845546|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110638949|NCT00845546|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110638950|NCT00845546|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110638951|NCT00845546|Histamine Antagonists|histamine antagonists|mesh-ancestor
110638952|NCT00845546|Histamine Agents|histamine agents|mesh-ancestor
110638953|NCT00845546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110638954|NCT00845546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110638955|NCT00845546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110638956|NCT00845546|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110638957|NCT00845546|Autonomic Agents|autonomic agents|mesh-ancestor
110638958|NCT00845546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110638959|NCT00845546|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110638960|NCT00845546|Respiratory System Agents|respiratory system agents|mesh-ancestor
110638961|NCT00845546|Nasal Decongestants|nasal decongestants|mesh-ancestor
110638962|NCT00845546|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110638963|NCT00845546|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110638964|NCT00845546|Sympathomimetics|sympathomimetics|mesh-ancestor
110638965|NCT00845546|Adrenergic Agents|adrenergic agents|mesh-ancestor
110638966|NCT00852956|Betahistine|betahistine|mesh-list
110638967|NCT00852956|Vasodilator Agents|vasodilator agents|mesh-ancestor
110638968|NCT00852956|Histamine Agonists|histamine agonists|mesh-ancestor
110638969|NCT00852956|Histamine Agents|histamine agents|mesh-ancestor
110638970|NCT00852956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110638971|NCT00852956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110638972|NCT00852956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110638973|NCT00716417|Afatinib|afatinib|mesh-list
110638974|NCT00716417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110638975|NCT00716417|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110638976|NCT00716417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110638977|NCT00716417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110638978|NCT02592863|Pentoxifylline|pentoxifylline|mesh-list
110638979|NCT02592863|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110638980|NCT02592863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110638981|NCT02592863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110638982|NCT02592863|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110638983|NCT02592863|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110638984|NCT02592863|Protective Agents|protective agents|mesh-ancestor
110638985|NCT02592863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110638986|NCT02592863|Vasodilator Agents|vasodilator agents|mesh-ancestor
110638988|NCT02592863|Antioxidants|antioxidants|mesh-ancestor
110638989|NCT00719537|Aspirin|aspirin|mesh-list
110638990|NCT00719537|Progesterone|progesterone|mesh-list
110638991|NCT00719537|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110638992|NCT00719537|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110638993|NCT00719537|Analgesics|analgesics|mesh-ancestor
110638994|NCT00719537|Sensory System Agents|sensory system agents|mesh-ancestor
110638995|NCT00719537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110638996|NCT00719537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110638997|NCT00719537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110638998|NCT00719537|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110638999|NCT00719537|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110639000|NCT00719537|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110639001|NCT00719537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110639002|NCT00719537|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110131813|NCT01971034|Metformin|metformin|mesh-list
110639003|NCT00719537|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110639004|NCT00719537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110639006|NCT00719537|Progestins|progestins|mesh-ancestor
110639007|NCT00719537|Hormones|hormones|mesh-ancestor
110639008|NCT00719537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110639009|NCT00853190|Chlorpheniramine|chlorpheniramine|mesh-list
110639010|NCT00853190|Hydrocodone|hydrocodone|mesh-list
110639011|NCT00853190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110639012|NCT00853190|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110131881|NCT01971515|Tamoxifen|tamoxifen|mesh-list
110639013|NCT00853190|Narcotics|narcotics|mesh-ancestor
110639014|NCT00853190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110639015|NCT00853190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110639016|NCT00853190|Analgesics|analgesics|mesh-ancestor
110639017|NCT00853190|Sensory System Agents|sensory system agents|mesh-ancestor
110639018|NCT00853190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110639019|NCT00853190|Antitussive Agents|antitussive agents|mesh-ancestor
110639020|NCT00853190|Respiratory System Agents|respiratory system agents|mesh-ancestor
110639021|NCT00853190|Antipruritics|antipruritics|mesh-ancestor
110131955|NCT01971684|Antimetabolites|antimetabolites|mesh-ancestor
110639022|NCT00853190|Dermatologic Agents|dermatologic agents|mesh-ancestor
110639023|NCT00853190|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110639024|NCT00853190|Histamine Antagonists|histamine antagonists|mesh-ancestor
110639025|NCT00853190|Histamine Agents|histamine agents|mesh-ancestor
110639026|NCT00853190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110639027|NCT00853190|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110639028|NCT02591225|Phenprocoumon|phenprocoumon|mesh-list
110639029|NCT02591225|Anticoagulants|anticoagulants|mesh-ancestor
110639030|NCT00573794|Adalimumab|adalimumab|mesh-list
110639031|NCT00573794|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110639032|NCT00573794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110639033|NCT00573794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110639034|NCT00715793|Temozolomide|temozolomide|mesh-list
110639035|NCT00715793|Decitabine|decitabine|mesh-list
110639036|NCT00715793|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110639037|NCT00715793|Alkylating Agents|alkylating agents|mesh-ancestor
110639038|NCT00715793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110639039|NCT00715793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110639040|NCT00715793|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110639041|NCT00715793|Antimetabolites|antimetabolites|mesh-ancestor
110639042|NCT00715793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110639043|NCT00924014|Furosemide|furosemide|mesh-list
110639044|NCT00924014|Conivaptan|conivaptan|mesh-list
110639045|NCT00924014|Diuretics|diuretics|mesh-ancestor
110639046|NCT00924014|Natriuretic Agents|natriuretic agents|mesh-ancestor
110639047|NCT00924014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110639048|NCT00924014|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110639049|NCT00924014|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110639050|NCT00924014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110132067|NCT01972828|Blood Substitutes|blood substitutes|mesh-ancestor
110639051|NCT00924014|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
110639052|NCT00853268|Oxycodone|oxycodone|mesh-list
110639053|NCT00853268|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110639054|NCT00853268|Narcotics|narcotics|mesh-ancestor
110639055|NCT00853268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110639056|NCT00853268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110639057|NCT00853268|Analgesics|analgesics|mesh-ancestor
110639058|NCT00853268|Sensory System Agents|sensory system agents|mesh-ancestor
110639059|NCT00853268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110639061|NCT00845780|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110639062|NCT00845780|Vasodilator Agents|vasodilator agents|mesh-ancestor
110639063|NCT00845780|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
110639064|NCT00845780|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110639065|NCT00845780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110639066|NCT00845780|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110639067|NCT00845780|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110639068|NCT00845780|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110255001|NCT00470197|Cytarabine|cytarabine|mesh-list
110639069|NCT00845780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110158306|NCT00084604|Immunoglobulins|immunoglobulins|mesh-list
110639070|NCT00845780|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110639071|NCT00845780|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110639072|NCT00845780|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110639073|NCT00853502|Methyltestosterone|methyltestosterone|mesh-list
110639074|NCT00853502|Testosterone|testosterone|mesh-list
110639075|NCT00853502|Testosterone undecanoate|testosterone undecanoate|mesh-list
110639076|NCT00853502|Testosterone enanthate|testosterone enanthate|mesh-list
110639077|NCT00853502|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
110639078|NCT00853502|Androgens|androgens|mesh-ancestor
110639079|NCT00853502|Hormones|hormones|mesh-ancestor
110639080|NCT00853502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110132336|NCT01974648|Propofol|propofol|mesh-list
110639081|NCT00853502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110639082|NCT00853502|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110639083|NCT00853502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110639084|NCT00853502|Anabolic Agents|anabolic agents|mesh-ancestor
110639085|NCT00853736|Oxycodone|oxycodone|mesh-list
110639086|NCT00853736|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110639087|NCT00853736|Narcotics|narcotics|mesh-ancestor
110639088|NCT00853736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110639089|NCT00853736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110639090|NCT00853736|Analgesics|analgesics|mesh-ancestor
110639091|NCT00853736|Sensory System Agents|sensory system agents|mesh-ancestor
110639092|NCT00853736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110639093|NCT00857168|Testosterone|testosterone|mesh-list
110639094|NCT00857168|Androgens|androgens|mesh-ancestor
110639095|NCT00857168|Hormones|hormones|mesh-ancestor
110639096|NCT00857168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110639097|NCT00857168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110639098|NCT00857324|Vorinostat|vorinostat|mesh-list
110639099|NCT00857324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110639100|NCT00857324|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110639101|NCT00857324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110639102|NCT00857324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110639103|NCT00853892|Oxycodone|oxycodone|mesh-list
110639104|NCT00853892|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110639105|NCT00853892|Narcotics|narcotics|mesh-ancestor
110639106|NCT00853892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110639107|NCT00853892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110639108|NCT00853892|Analgesics|analgesics|mesh-ancestor
110639109|NCT00853892|Sensory System Agents|sensory system agents|mesh-ancestor
110639110|NCT00853892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110639111|NCT00857558|Saxagliptin|saxagliptin|mesh-list
110639112|NCT00857558|Incretins|incretins|mesh-ancestor
110639113|NCT00857558|Hormones|hormones|mesh-ancestor
110639114|NCT00857558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110639115|NCT00857558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110639116|NCT00857558|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110639118|NCT00857558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110639119|NCT00857558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110639120|NCT00857558|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110639121|NCT00718523|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110639122|NCT00718523|Immunologic Factors|immunologic factors|mesh-ancestor
110639123|NCT00718523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110639124|NCT00715559|Cysteamine|cysteamine|mesh-list
110639125|NCT00715559|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
110639126|NCT00715559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110639127|NCT05289869|Oxytocin|oxytocin|mesh-list
110639128|NCT05289869|Oxytocics|oxytocics|mesh-ancestor
110639129|NCT05289869|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110639130|NCT05289869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110639131|NCT00620282|Liraglutide|liraglutide|mesh-list
110639132|NCT00620282|Glimepiride|glimepiride|mesh-list
110639133|NCT00620282|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110639134|NCT00620282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110639135|NCT00620282|Incretins|incretins|mesh-ancestor
110639136|NCT00620282|Hormones|hormones|mesh-ancestor
110639137|NCT00620282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110132575|NCT01976195|Immunologic Factors|immunologic factors|mesh-ancestor
110639139|NCT00620282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110639140|NCT00620282|Immunologic Factors|immunologic factors|mesh-ancestor
110639141|NCT05684861|Isotretinoin|isotretinoin|mesh-list
110639142|NCT05684861|Dermatologic Agents|dermatologic agents|mesh-ancestor
110639143|NCT04042688|Tranexamic Acid|tranexamic acid|mesh-list
110639144|NCT04042688|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110639145|NCT04042688|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110639146|NCT04042688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110639147|NCT04042688|Hemostatics|hemostatics|mesh-ancestor
110639148|NCT04042688|Coagulants|coagulants|mesh-ancestor
110639149|NCT02590133|Fluorouracil|fluorouracil|mesh-list
110639150|NCT02590133|Endostar protein|endostar protein|mesh-list
110639151|NCT02590133|Endostatins|endostatins|mesh-list
110639152|NCT02590133|Nedaplatin|nedaplatin|mesh-list
110639153|NCT02590133|Antimetabolites|antimetabolites|mesh-ancestor
110639154|NCT02590133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110639155|NCT02590133|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110639156|NCT02590133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110639157|NCT02590133|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110639158|NCT02590133|Immunologic Factors|immunologic factors|mesh-ancestor
110639159|NCT02590133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110639160|NCT02590133|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110639161|NCT02590133|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110639162|NCT02590133|Growth Substances|growth substances|mesh-ancestor
110639163|NCT02590133|Growth Inhibitors|growth inhibitors|mesh-ancestor
110639165|NCT00854204|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110639166|NCT00854204|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110639167|NCT00854204|Protease Inhibitors|protease inhibitors|mesh-ancestor
110639168|NCT00854204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110639169|NCT00854204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110639170|NCT00854204|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110639171|NCT00854204|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110639172|NCT00854204|Antiviral Agents|antiviral agents|mesh-ancestor
110639173|NCT00854204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110639174|NCT00857870|Metformin|metformin|mesh-list
110639175|NCT00857870|Insulin Glargine|insulin glargine|mesh-list
110639176|NCT00857870|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110639177|NCT00857870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110639178|NCT00848432|Risperidone|risperidone|mesh-list
110639179|NCT00848432|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110639180|NCT00848432|Serotonin Agents|serotonin agents|mesh-ancestor
110639181|NCT00848432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110639182|NCT00848432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110639183|NCT00848432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110639184|NCT00848432|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110639185|NCT00848432|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110639186|NCT00848432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110395745|NCT01327703|Pancreatin|pancreatin|mesh-list
110639187|NCT00848432|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110639188|NCT00848432|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110639189|NCT00848432|Dopamine Agents|dopamine agents|mesh-ancestor
110639190|NCT00854750|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
110639191|NCT00854750|Hormones|hormones|mesh-ancestor
110639192|NCT00854750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110639193|NCT00854750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110639194|NCT00858182|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110639196|NCT02545244|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110639197|NCT02545244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110639198|NCT02545244|Disinfectants|disinfectants|mesh-ancestor
110639199|NCT00858338|Floxuridine|floxuridine|mesh-list
110639200|NCT00858338|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110639201|NCT00858338|Antimetabolites|antimetabolites|mesh-ancestor
110639202|NCT00858338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110639203|NCT00858338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110639204|NCT00515086|Everolimus|everolimus|mesh-list
110639205|NCT00515086|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110639206|NCT00515086|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110639207|NCT00515086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110639208|NCT00515086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110639209|NCT00515086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110639210|NCT00515086|Immunologic Factors|immunologic factors|mesh-ancestor
110639211|NCT00515086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110639212|NCT00515086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110639213|NCT00858806|Imatinib Mesylate|imatinib mesylate|mesh-list
110639214|NCT00858806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110639215|NCT00858806|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110639216|NCT00858806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110639217|NCT00858806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110639218|NCT00849368|Azathioprine|azathioprine|mesh-list
110639219|NCT00849368|Allopurinol|allopurinol|mesh-list
110639220|NCT00849368|Antimetabolites|antimetabolites|mesh-ancestor
110639221|NCT00849368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110639222|NCT00849368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110639223|NCT00849368|Gout Suppressants|gout suppressants|mesh-ancestor
110639224|NCT00849368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110639225|NCT00849368|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110286506|NCT04569214|PAZ320|paz320|mesh-list
110639226|NCT00849368|Antioxidants|antioxidants|mesh-ancestor
110639227|NCT00849368|Protective Agents|protective agents|mesh-ancestor
110639228|NCT00849368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110639229|NCT00849368|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110132966|NCT01980082|Cefazolin|cefazolin|mesh-list
110639230|NCT00849368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110639231|NCT00849368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110639232|NCT00849368|Immunologic Factors|immunologic factors|mesh-ancestor
110639233|NCT02544932|Warfarin|warfarin|mesh-list
110639234|NCT02544932|Dabigatran|dabigatran|mesh-list
110639235|NCT02544932|Anticoagulants|anticoagulants|mesh-ancestor
110639236|NCT02544932|Antithrombins|antithrombins|mesh-ancestor
110639237|NCT02544932|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110639238|NCT02544932|Protease Inhibitors|protease inhibitors|mesh-ancestor
110639239|NCT02544932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110639240|NCT02544932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110639241|NCT02544854|Propofol|propofol|mesh-list
110639242|NCT02544854|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110639243|NCT02544854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110639244|NCT02544854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110639245|NCT02544854|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110639246|NCT02544854|Anesthetics, General|anesthetics, general|mesh-ancestor
110639247|NCT02544854|Anesthetics|anesthetics|mesh-ancestor
110639248|NCT00861536|Thymoglobulin|thymoglobulin|mesh-list
110639249|NCT00861536|Immunologic Factors|immunologic factors|mesh-ancestor
110639250|NCT00861536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110639251|NCT00861536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110639252|NCT02544776|Amlodipine|amlodipine|mesh-list
110639253|NCT02544776|Clomiphene|clomiphene|mesh-list
110639254|NCT02544776|Enclomiphene|enclomiphene|mesh-list
110639255|NCT02544776|Zuclomiphene|zuclomiphene|mesh-list
110639256|NCT02544776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110639257|NCT02544776|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110639258|NCT02544776|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110639259|NCT02544776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110639260|NCT02544776|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110639261|NCT02544776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110639262|NCT02544776|Vasodilator Agents|vasodilator agents|mesh-ancestor
110639263|NCT02544776|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110639264|NCT02544776|Hormone Antagonists|hormone antagonists|mesh-ancestor
110133074|NCT01980745|Filaricides|filaricides|mesh-ancestor
110639265|NCT02544776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110639266|NCT02544776|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110639267|NCT02544776|Fertility Agents|fertility agents|mesh-ancestor
110639268|NCT02544776|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110639269|NCT02544776|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110639270|NCT02544776|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110639272|NCT00859118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110639273|NCT00859118|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110639274|NCT00859118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110639275|NCT00859118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110639276|NCT00849602|Chloroquine|chloroquine|mesh-list
110639277|NCT00849602|Amebicides|amebicides|mesh-ancestor
110639278|NCT00849602|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110639279|NCT00849602|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110639280|NCT00849602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110639281|NCT00849602|Antimalarials|antimalarials|mesh-ancestor
110639282|NCT00849602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110639283|NCT00859274|Budesonide|budesonide|mesh-list
110639284|NCT00859274|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110639285|NCT00859274|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110639286|NCT00859274|Autonomic Agents|autonomic agents|mesh-ancestor
110639287|NCT00859274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110639288|NCT00859274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110639289|NCT00859274|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110639290|NCT00859274|Respiratory System Agents|respiratory system agents|mesh-ancestor
110639291|NCT00859274|Glucocorticoids|glucocorticoids|mesh-ancestor
110639292|NCT00859274|Hormones|hormones|mesh-ancestor
110133199|NCT01981889|Prednisone|prednisone|mesh-list
110639293|NCT00859274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110639294|NCT00859352|Midazolam|midazolam|mesh-list
110639295|NCT00859352|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110133254|NCT01982578|Genistein|genistein|mesh-list
110639296|NCT00859352|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110639297|NCT00859352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110639298|NCT00859352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110639299|NCT00859352|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110639300|NCT00859352|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110639301|NCT00859352|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110639302|NCT00859352|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110639303|NCT00859352|Anesthetics, General|anesthetics, general|mesh-ancestor
110639304|NCT00859352|Anesthetics|anesthetics|mesh-ancestor
110639305|NCT00859352|GABA Modulators|gaba modulators|mesh-ancestor
110639306|NCT00859352|GABA Agents|gaba agents|mesh-ancestor
110639307|NCT00859352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110639308|NCT00859352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110639310|NCT00861926|Albuterol|albuterol|mesh-list
110639311|NCT00861926|Formoterol Fumarate|formoterol fumarate|mesh-list
110639312|NCT00861926|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110639313|NCT00861926|Autonomic Agents|autonomic agents|mesh-ancestor
110133388|NCT01983527|Methylprednisolone|methylprednisolone|mesh-list
110639314|NCT00861926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110639315|NCT00861926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110639316|NCT00861926|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110639317|NCT00861926|Respiratory System Agents|respiratory system agents|mesh-ancestor
110639318|NCT00861926|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110639319|NCT00861926|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110639320|NCT00861926|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110639321|NCT00861926|Adrenergic Agents|adrenergic agents|mesh-ancestor
110639322|NCT00861926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110133537|NCT01984099|Antimetabolites|antimetabolites|mesh-ancestor
110639323|NCT00861926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110639324|NCT00861926|Tocolytic Agents|tocolytic agents|mesh-ancestor
110639325|NCT00861926|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110639326|NCT00861926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110639327|NCT00861926|Glucocorticoids|glucocorticoids|mesh-ancestor
110639328|NCT00861926|Hormones|hormones|mesh-ancestor
110639329|NCT00861926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110639330|NCT00849992|Imiquimod|imiquimod|mesh-list
110639331|NCT00849992|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110639332|NCT00849992|Immunologic Factors|immunologic factors|mesh-ancestor
110639333|NCT00849992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110639334|NCT00849992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110639335|NCT00849992|Interferon Inducers|interferon inducers|mesh-ancestor
110639336|NCT00618722|Deoxycholic Acid|deoxycholic acid|mesh-list
110639337|NCT00618722|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
110639338|NCT00618722|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110639339|NCT02544698|Vaccines|vaccines|mesh-list
110639340|NCT02544698|Immunologic Factors|immunologic factors|mesh-ancestor
110639341|NCT02544698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110639342|NCT00862394|Formoterol Fumarate|formoterol fumarate|mesh-list
110639343|NCT00862394|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110639344|NCT00862394|Autonomic Agents|autonomic agents|mesh-ancestor
110639345|NCT00862394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110639346|NCT00862394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110639347|NCT00862394|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110639348|NCT00862394|Respiratory System Agents|respiratory system agents|mesh-ancestor
110639349|NCT00862394|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110639350|NCT00862394|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110639351|NCT00862394|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110639352|NCT00862394|Adrenergic Agents|adrenergic agents|mesh-ancestor
110639353|NCT00862394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110158325|NCT00006062|Oxaliplatin|oxaliplatin|mesh-list
110639354|NCT00862394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110639355|NCT00862472|Timolol|timolol|mesh-list
110639356|NCT00862472|Cloprostenol|cloprostenol|mesh-list
110639357|NCT00862472|Luteolytic Agents|luteolytic agents|mesh-ancestor
110639358|NCT00862472|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110639359|NCT00862472|Contraceptive Agents|contraceptive agents|mesh-ancestor
110639360|NCT00862472|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110639361|NCT00862472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110639362|NCT00862472|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110639363|NCT00862472|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110639364|NCT00862472|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110639365|NCT00862472|Adrenergic Agents|adrenergic agents|mesh-ancestor
110639366|NCT00862472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110639367|NCT00862472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110639368|NCT00862472|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110639369|NCT00862472|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110639370|NCT00850304|Arsenic Trioxide|arsenic trioxide|mesh-list
110639371|NCT00850304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110639373|NCT00850382|Daunorubicin|daunorubicin|mesh-list
110639374|NCT00850382|Dasatinib|dasatinib|mesh-list
110639375|NCT00850382|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110639376|NCT00850382|Antimetabolites|antimetabolites|mesh-ancestor
110286632|NCT00238251|Temozolomide|temozolomide|mesh-list
110639377|NCT00850382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110639378|NCT00850382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110639379|NCT00850382|Antiviral Agents|antiviral agents|mesh-ancestor
110639380|NCT00850382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110639381|NCT00850382|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110639382|NCT00850382|Immunologic Factors|immunologic factors|mesh-ancestor
110639383|NCT00850382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110639384|NCT00850382|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110639385|NCT00850382|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110639386|NCT00850382|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110639387|NCT00850382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110639388|NCT00850382|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110639389|NCT00860366|Uric Acid|uric acid|mesh-list
110639390|NCT00860366|Antioxidants|antioxidants|mesh-ancestor
110639391|NCT00860366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110639392|NCT00860366|Protective Agents|protective agents|mesh-ancestor
110639393|NCT00860366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110639394|NCT00862628|Rebamipide|rebamipide|mesh-list
110639395|NCT00862628|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110639396|NCT00862628|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110639397|NCT00862628|Antioxidants|antioxidants|mesh-ancestor
110639398|NCT00862628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110639399|NCT00862628|Protective Agents|protective agents|mesh-ancestor
110639400|NCT00862628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110639401|NCT00862628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110639402|NCT00507442|Dexamethasone|dexamethasone|mesh-list
110639403|NCT00507442|Cyclophosphamide|cyclophosphamide|mesh-list
110639404|NCT00507442|Lenalidomide|lenalidomide|mesh-list
110639405|NCT00507442|Bortezomib|bortezomib|mesh-list
110639406|NCT00507442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110639407|NCT00507442|Immunologic Factors|immunologic factors|mesh-ancestor
110639408|NCT00507442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110639409|NCT00507442|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110639410|NCT00507442|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110639411|NCT00507442|Alkylating Agents|alkylating agents|mesh-ancestor
110639412|NCT00507442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110639413|NCT00507442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110639414|NCT00507442|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110639415|NCT00507442|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110639416|NCT00507442|Antiemetics|antiemetics|mesh-ancestor
110639417|NCT00507442|Autonomic Agents|autonomic agents|mesh-ancestor
110639418|NCT00507442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110639419|NCT00507442|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110639420|NCT00507442|Glucocorticoids|glucocorticoids|mesh-ancestor
110639421|NCT00507442|Hormones|hormones|mesh-ancestor
110158330|NCT00084721|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110639422|NCT00507442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110395787|NCT01379573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110639423|NCT00507442|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110639424|NCT00507442|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110639425|NCT00507442|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110639426|NCT00507442|Growth Substances|growth substances|mesh-ancestor
110639427|NCT00507442|Growth Inhibitors|growth inhibitors|mesh-ancestor
110639428|NCT00862706|Telbivudine|telbivudine|mesh-list
110639429|NCT00862706|Antiviral Agents|antiviral agents|mesh-ancestor
110639430|NCT00862706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110133850|NCT01986218|BMS-986115|bms-986115|mesh-list
110639431|NCT00862706|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110639432|NCT00862706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110639433|NCT00862706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110639434|NCT04041362|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
110639435|NCT04041362|UB-421|ub-421|mesh-list
110639436|NCT04041362|Antiviral Agents|antiviral agents|mesh-ancestor
110639437|NCT04041362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110639438|NCT00850850|Physostigmine|physostigmine|mesh-list
110639439|NCT00850850|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110639440|NCT00850850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110639441|NCT00850850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110639442|NCT00850850|Cholinergic Agents|cholinergic agents|mesh-ancestor
110639443|NCT00850850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110639444|NCT00850850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110639445|NCT00850850|Miotics|miotics|mesh-ancestor
110639446|NCT00850850|Autonomic Agents|autonomic agents|mesh-ancestor
110639447|NCT00850850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110639448|NCT00619892|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110639449|NCT00619892|Antidepressive Agents|antidepressive agents|mesh-ancestor
110639450|NCT00619892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110639451|NCT00619892|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110286705|NCT00238368|Etoposide|etoposide|mesh-list
110639453|NCT00619892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110639454|NCT00619892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110639455|NCT00863096|Vaccines|vaccines|mesh-list
110639456|NCT00863096|Immunologic Factors|immunologic factors|mesh-ancestor
110639457|NCT00863096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110639458|NCT00870272|Misoprostol|misoprostol|mesh-list
110639459|NCT00870272|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110639460|NCT00870272|Abortifacient Agents|abortifacient agents|mesh-ancestor
110639461|NCT00870272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110639462|NCT00870272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110639463|NCT00870272|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110639464|NCT00870272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110639465|NCT00870272|Oxytocics|oxytocics|mesh-ancestor
110639466|NCT00863252|Mycophenolic Acid|mycophenolic acid|mesh-list
110639467|NCT00863252|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110639468|NCT00863252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110639469|NCT00863252|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110255051|NCT05391893|Vasodilator Agents|vasodilator agents|mesh-ancestor
110639470|NCT00863252|Antitubercular Agents|antitubercular agents|mesh-ancestor
110639471|NCT00863252|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110639472|NCT00863252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110639473|NCT00863252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110639474|NCT00863252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110639475|NCT00502996|Rituximab|rituximab|mesh-list
110639476|NCT00502996|Methotrexate|methotrexate|mesh-list
110133933|NCT01986582|Protective Agents|protective agents|mesh-ancestor
110639477|NCT00502996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110639478|NCT00502996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110639480|NCT00502996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110639481|NCT00502996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110639482|NCT00502996|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110639483|NCT00502996|Abortifacient Agents|abortifacient agents|mesh-ancestor
110395804|NCT01371734|Antidepressive Agents|antidepressive agents|mesh-ancestor
110639484|NCT00502996|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110639485|NCT00502996|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110639487|NCT00502996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110639488|NCT00502996|Dermatologic Agents|dermatologic agents|mesh-ancestor
110639489|NCT00502996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110639490|NCT00502996|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110639491|NCT00502996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110639492|NCT00502996|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110639493|NCT00865436|Metformin|metformin|mesh-list
110639494|NCT00865436|Glyburide|glyburide|mesh-list
110639495|NCT00865436|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110639496|NCT00865436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110639497|NCT00715403|Nintedanib|nintedanib|mesh-list
110639498|NCT00715403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110639499|NCT00715403|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110639500|NCT00715403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110639501|NCT00715403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110639502|NCT01013584|Cholecalciferol|cholecalciferol|mesh-list
110639503|NCT01013584|Vitamin D|vitamin d|mesh-list
110639504|NCT01013584|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110639505|NCT01013584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110639506|NCT01013584|Vitamins|vitamins|mesh-ancestor
110639507|NCT01013584|Micronutrients|micronutrients|mesh-ancestor
110639508|NCT01013584|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110639510|NCT00864110|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110639511|NCT00864110|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110639512|NCT00864110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110639513|NCT00864110|Antimetabolites|antimetabolites|mesh-ancestor
110639514|NCT00864110|Antiviral Agents|antiviral agents|mesh-ancestor
110639515|NCT00864110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110639516|NCT00864188|Beta Carotene|beta carotene|mesh-list
110639517|NCT00864188|Carotenoids|carotenoids|mesh-list
110639518|NCT00864188|Antioxidants|antioxidants|mesh-ancestor
110639519|NCT00864188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110639520|NCT00864188|Protective Agents|protective agents|mesh-ancestor
110639521|NCT00864188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110639522|NCT00864188|Provitamins|provitamins|mesh-ancestor
110639523|NCT00864188|Vitamins|vitamins|mesh-ancestor
110639524|NCT00864188|Micronutrients|micronutrients|mesh-ancestor
110639525|NCT00865670|Azithromycin|azithromycin|mesh-list
110286780|NCT02894515|Serotonin Agents|serotonin agents|mesh-ancestor
110639526|NCT00865670|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110639527|NCT00865670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110639528|NCT00864344|Sertraline|sertraline|mesh-list
110134093|NCT01987739|GABA Agonists|gaba agonists|mesh-ancestor
110639529|NCT00864344|Antidepressive Agents|antidepressive agents|mesh-ancestor
110639530|NCT00864344|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110639531|NCT00864344|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110639532|NCT00864344|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110639533|NCT00864344|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110639534|NCT00864344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110639535|NCT00864344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110255066|NCT00470665|Sirolimus|sirolimus|mesh-list
110639536|NCT00864344|Serotonin Agents|serotonin agents|mesh-ancestor
110639537|NCT00864344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110639538|NCT00864500|Clobetasol|clobetasol|mesh-list
110639539|NCT00864500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110639540|NCT00864500|Glucocorticoids|glucocorticoids|mesh-ancestor
110639541|NCT00864500|Hormones|hormones|mesh-ancestor
110639542|NCT00864500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110639543|NCT00864500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110639544|NCT00864734|Metformin|metformin|mesh-list
110639545|NCT00864734|Glyburide|glyburide|mesh-list
110639546|NCT00864734|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110639547|NCT00864734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110639548|NCT00864812|Fluticasone|fluticasone|mesh-list
110639549|NCT00864812|Xhance|xhance|mesh-list
110639550|NCT00864812|Tiotropium Bromide|tiotropium bromide|mesh-list
110639551|NCT00864812|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110639552|NCT00864812|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
110639553|NCT00864812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110639554|NCT00864812|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110639555|NCT00864812|Autonomic Agents|autonomic agents|mesh-ancestor
110639556|NCT00864812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110639557|NCT00864812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110639558|NCT00864812|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110639559|NCT00864812|Respiratory System Agents|respiratory system agents|mesh-ancestor
110639560|NCT00864812|Dermatologic Agents|dermatologic agents|mesh-ancestor
110639561|NCT00864812|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110639562|NCT00864812|Parasympatholytics|parasympatholytics|mesh-ancestor
110639563|NCT00864812|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110639564|NCT00864812|Cholinergic Agents|cholinergic agents|mesh-ancestor
110639565|NCT00864812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110639566|NCT00864812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110639567|NCT00864812|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110639569|NCT00864812|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110639570|NCT00864812|Adrenergic Agents|adrenergic agents|mesh-ancestor
110639571|NCT00864812|Glucocorticoids|glucocorticoids|mesh-ancestor
110639573|NCT00864812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110639574|NCT00864812|Sympathomimetics|sympathomimetics|mesh-ancestor
110639575|NCT02590055|Gemcitabine|gemcitabine|mesh-list
110639576|NCT02590055|Docetaxel|docetaxel|mesh-list
110639577|NCT02590055|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110639578|NCT02590055|Antimetabolites|antimetabolites|mesh-ancestor
110639579|NCT02590055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110639580|NCT02590055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110639581|NCT02590055|Tubulin Modulators|tubulin modulators|mesh-ancestor
110639582|NCT02590055|Antimitotic Agents|antimitotic agents|mesh-ancestor
110639583|NCT02590055|Mitosis Modulators|mitosis modulators|mesh-ancestor
110639584|NCT00864890|Dexetimide|dexetimide|mesh-list
110639585|NCT00864890|Citalopram|citalopram|mesh-list
110639586|NCT00864890|Escitalopram|escitalopram|mesh-list
110639587|NCT00864890|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110639588|NCT00864890|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110639589|NCT00864890|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110639590|NCT00864890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110639591|NCT00864890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110639592|NCT00864890|Serotonin Agents|serotonin agents|mesh-ancestor
110639593|NCT00864890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110639594|NCT00864890|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110639595|NCT00864890|Antidepressive Agents|antidepressive agents|mesh-ancestor
110639596|NCT00864890|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110639597|NCT00864890|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110639598|NCT00864890|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110639599|NCT00864890|Parasympatholytics|parasympatholytics|mesh-ancestor
110639600|NCT00864890|Autonomic Agents|autonomic agents|mesh-ancestor
110639601|NCT00864890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110639602|NCT00864890|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110639603|NCT00864890|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110639604|NCT00864890|Cholinergic Agents|cholinergic agents|mesh-ancestor
110639605|NCT00919295|Mirtazapine|mirtazapine|mesh-list
110639606|NCT00919295|Antidepressive Agents|antidepressive agents|mesh-ancestor
110639607|NCT00919295|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110639608|NCT00919295|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110639609|NCT00919295|Histamine Antagonists|histamine antagonists|mesh-ancestor
110639610|NCT00919295|Histamine Agents|histamine agents|mesh-ancestor
110639611|NCT00919295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110639612|NCT00919295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110639613|NCT00919295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110639614|NCT00919295|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110639615|NCT00919295|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110639616|NCT00919295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110639617|NCT00919295|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
110639618|NCT00919295|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110639619|NCT00919295|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110639620|NCT00919295|Adrenergic Agents|adrenergic agents|mesh-ancestor
110639621|NCT00919295|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110639622|NCT00919295|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110639623|NCT00919295|Serotonin Agents|serotonin agents|mesh-ancestor
110639624|NCT00919295|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110639625|NCT00865748|Metformin|metformin|mesh-list
110639626|NCT00865748|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110639627|NCT00865748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110639628|NCT00865982|Docetaxel|docetaxel|mesh-list
110639629|NCT00865982|Capecitabine|capecitabine|mesh-list
110639630|NCT00865982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110639631|NCT00865982|Tubulin Modulators|tubulin modulators|mesh-ancestor
110639632|NCT00865982|Antimitotic Agents|antimitotic agents|mesh-ancestor
110639633|NCT00865982|Mitosis Modulators|mitosis modulators|mesh-ancestor
110134315|NCT01989884|IDN 5109|idn 5109|mesh-list
110639634|NCT00865982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110639635|NCT00865982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110639636|NCT00865982|Antimetabolites|antimetabolites|mesh-ancestor
110639637|NCT00866060|Memantine|memantine|mesh-list
110639638|NCT00866060|Donepezil|donepezil|mesh-list
110639639|NCT00866060|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110639640|NCT00866060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110639641|NCT00866060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110639642|NCT00866060|Cholinergic Agents|cholinergic agents|mesh-ancestor
110639643|NCT00866060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110639644|NCT00866060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110639645|NCT00866060|Nootropic Agents|nootropic agents|mesh-ancestor
110639646|NCT00866060|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110639647|NCT00866060|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110639648|NCT00866060|Dopamine Agents|dopamine agents|mesh-ancestor
110639649|NCT00866060|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110639650|NCT00866060|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110639651|NCT00871052|Vitamin D|vitamin d|mesh-list
110639652|NCT00871052|Calcipotriene|calcipotriene|mesh-list
110639653|NCT00871052|Vitamins|vitamins|mesh-ancestor
110639654|NCT00871052|Micronutrients|micronutrients|mesh-ancestor
110639655|NCT00871052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110639656|NCT00871052|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110639657|NCT00871052|Dermatologic Agents|dermatologic agents|mesh-ancestor
110639658|NCT00502840|Rituximab|rituximab|mesh-list
110639659|NCT00502840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110639660|NCT00502840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110639661|NCT00502840|Immunologic Factors|immunologic factors|mesh-ancestor
110639662|NCT00502840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110639663|NCT00502840|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110639664|NCT00514540|Carboplatin|carboplatin|mesh-list
110639666|NCT00514540|Etoposide|etoposide|mesh-list
110639667|NCT00514540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110639668|NCT00514540|Tubulin Modulators|tubulin modulators|mesh-ancestor
110639669|NCT00514540|Antimitotic Agents|antimitotic agents|mesh-ancestor
110639670|NCT00514540|Mitosis Modulators|mitosis modulators|mesh-ancestor
110639671|NCT00514540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110639672|NCT00514540|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110639673|NCT00514540|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110639674|NCT00514540|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110255079|NCT00470743|Analgesics|analgesics|mesh-ancestor
110639675|NCT00514540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110639676|NCT03121534|Dexamethasone|dexamethasone|mesh-list
110639677|NCT03121534|Nivolumab|nivolumab|mesh-list
110639678|NCT03121534|Blinatumomab|blinatumomab|mesh-list
110395844|NCT01351025|Atorvastatin|atorvastatin|mesh-list
110639679|NCT03121534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110639680|NCT03121534|Antiemetics|antiemetics|mesh-ancestor
110639681|NCT03121534|Autonomic Agents|autonomic agents|mesh-ancestor
110639682|NCT03121534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110134607|NCT01991834|Cefazolin|cefazolin|mesh-list
110639683|NCT03121534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110639684|NCT03121534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110639685|NCT03121534|Glucocorticoids|glucocorticoids|mesh-ancestor
110639686|NCT03121534|Hormones|hormones|mesh-ancestor
110639687|NCT03121534|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110639688|NCT03121534|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110158366|NCT00085111|Antibodies|antibodies|mesh-list
110639689|NCT03121534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110639690|NCT03121534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110639691|NCT03121534|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110639692|NCT03121534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110639693|NCT01012102|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
110639694|NCT01012102|Freund's Adjuvant|freund's adjuvant|mesh-list
110639695|NCT01012102|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110639696|NCT01012102|Immunologic Factors|immunologic factors|mesh-ancestor
110639697|NCT01012102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110639698|NCT04615624|Furosemide|furosemide|mesh-list
110639699|NCT04615624|Diuretics|diuretics|mesh-ancestor
110639700|NCT04615624|Natriuretic Agents|natriuretic agents|mesh-ancestor
110639701|NCT04615624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110639702|NCT04615624|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110639703|NCT04615624|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110639704|NCT04615624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110639705|NCT00713609|Clindamycin|clindamycin|mesh-list
110639706|NCT00713609|Clindamycin palmitate|clindamycin palmitate|mesh-list
110639707|NCT00713609|Clindamycin phosphate|clindamycin phosphate|mesh-list
110639708|NCT00713609|Benzoyl Peroxide|benzoyl peroxide|mesh-list
110639709|NCT00713609|Tazarotene|tazarotene|mesh-list
110639710|NCT00713609|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110639711|NCT00713609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110639712|NCT00713609|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110639713|NCT00713609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110639714|NCT00713609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110639715|NCT00713609|Dermatologic Agents|dermatologic agents|mesh-ancestor
110639716|NCT00713609|Keratolytic Agents|keratolytic agents|mesh-ancestor
110639717|NCT00513682|Pancrelipase|pancrelipase|mesh-list
110639718|NCT00513682|Pancreatin|pancreatin|mesh-list
110639719|NCT00513682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110639720|NCT00493012|Vitamin D|vitamin d|mesh-list
110639721|NCT00493012|Vitamins|vitamins|mesh-ancestor
110639722|NCT00493012|Micronutrients|micronutrients|mesh-ancestor
110639723|NCT00493012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110135100|NCT01995370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110639724|NCT00493012|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110639725|NCT00918593|Bleomycin|bleomycin|mesh-list
110639726|NCT00918593|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110639727|NCT00918593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110639728|NCT04083833|Tetrodotoxin|tetrodotoxin|mesh-list
110639729|NCT04083833|Anesthetics, Local|anesthetics, local|mesh-ancestor
110639730|NCT04083833|Anesthetics|anesthetics|mesh-ancestor
110135169|NCT01996189|Insulin|insulin|mesh-list
110639731|NCT04083833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110639732|NCT04083833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110639733|NCT04083833|Sensory System Agents|sensory system agents|mesh-ancestor
110639734|NCT04083833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110639735|NCT04083833|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110639736|NCT04083833|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110639737|NCT04083833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110639739|NCT05684705|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110135310|NCT01996683|Siderophores|siderophores|mesh-ancestor
110639740|NCT05684705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110639741|NCT05684705|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110639742|NCT05684705|Antitubercular Agents|antitubercular agents|mesh-ancestor
110639743|NCT05238233|Proxymetacaine|proxymetacaine|mesh-list
110639744|NCT05238233|Pilocarpine|pilocarpine|mesh-list
110639745|NCT05238233|Tropicamide|tropicamide|mesh-list
110639746|NCT05238233|Miotics|miotics|mesh-ancestor
110639747|NCT05238233|Autonomic Agents|autonomic agents|mesh-ancestor
110639748|NCT05238233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110639749|NCT05238233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110639750|NCT05238233|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
110639751|NCT05238233|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110639752|NCT05238233|Cholinergic Agents|cholinergic agents|mesh-ancestor
110639753|NCT05238233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110639754|NCT05238233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110639756|NCT05238233|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110639757|NCT05238233|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110639758|NCT05238233|Anesthetics, Local|anesthetics, local|mesh-ancestor
110639759|NCT05238233|Anesthetics|anesthetics|mesh-ancestor
110639760|NCT05238233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110639761|NCT05238233|Sensory System Agents|sensory system agents|mesh-ancestor
110639762|NCT00617708|Gemcitabine|gemcitabine|mesh-list
110639763|NCT00617708|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110639764|NCT00617708|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110639765|NCT00617708|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110639766|NCT00617708|Antimetabolites|antimetabolites|mesh-ancestor
110639767|NCT00617708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110639768|NCT00617708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110639769|NCT00617708|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110639770|NCT00617708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110639771|NCT00617708|Immunologic Factors|immunologic factors|mesh-ancestor
110639772|NCT00617708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110639773|NCT04083209|Analgesics, Opioid|analgesics, opioid|mesh-list
110639774|NCT04083209|Narcotics|narcotics|mesh-ancestor
110639775|NCT04083209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110639776|NCT04083209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110639777|NCT04083209|Analgesics|analgesics|mesh-ancestor
110639778|NCT04083209|Sensory System Agents|sensory system agents|mesh-ancestor
110639779|NCT04083209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110639780|NCT00864968|Nabumetone|nabumetone|mesh-list
110639781|NCT00864968|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110639782|NCT00864968|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110639783|NCT00864968|Analgesics|analgesics|mesh-ancestor
110639784|NCT00864968|Sensory System Agents|sensory system agents|mesh-ancestor
110639785|NCT00864968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110639786|NCT00864968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110639787|NCT00864968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110639788|NCT00864968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110639789|NCT00864968|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110639790|NCT00864968|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110639791|NCT00864968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110639792|NCT00864968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110639793|NCT00876044|Aflibercept|aflibercept|mesh-list
110135715|NCT01999673|Antimitotic Agents|antimitotic agents|mesh-ancestor
110639794|NCT00876044|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110639795|NCT00876044|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110639796|NCT00876044|Growth Substances|growth substances|mesh-ancestor
110639797|NCT00876044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110639798|NCT00876044|Growth Inhibitors|growth inhibitors|mesh-ancestor
110639799|NCT00876044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110639800|NCT00866216|Azithromycin|azithromycin|mesh-list
110639801|NCT00866216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110639802|NCT00866216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110639803|NCT00871208|Retapamulin|retapamulin|mesh-list
110639804|NCT00871208|Hydrocortisone|hydrocortisone|mesh-list
110135857|NCT02000765|Gepotidacin|gepotidacin|mesh-list
110639805|NCT00871208|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
110639806|NCT00871208|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
110639807|NCT00871208|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
110639808|NCT00871208|Hydrocortisone-17-butyrate|hydrocortisone-17-butyrate|mesh-list
110639809|NCT00871208|Dermatologic Agents|dermatologic agents|mesh-ancestor
110639810|NCT00871208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110639811|NCT00871208|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110639812|NCT00871208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110639813|NCT00871364|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
110639814|NCT00871364|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110639815|NCT00871364|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110639816|NCT00871364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110639817|NCT00871364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110639818|NCT00871364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110639819|NCT00871364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110639820|NCT00871364|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110639821|NCT00871364|Antidepressive Agents|antidepressive agents|mesh-ancestor
110135925|NCT02001259|Lidocaine|lidocaine|mesh-list
110639823|NCT00866450|Calcium, Dietary|calcium, dietary|mesh-list
110639824|NCT00866450|Calcium|calcium|mesh-list
110639825|NCT00866450|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110135977|NCT02001363|Hormones|hormones|mesh-ancestor
110639826|NCT00866450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110639827|NCT00866450|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110287079|NCT04668469|Analgesics|analgesics|mesh-ancestor
110639828|NCT03894969|Vaccines|vaccines|mesh-list
110639829|NCT03894969|Immunologic Factors|immunologic factors|mesh-ancestor
110639830|NCT03894969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110639831|NCT00876434|Sirolimus|sirolimus|mesh-list
110136056|NCT02001909|Neomycin|neomycin|mesh-list
110639832|NCT00876434|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110639833|NCT00876434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110639834|NCT00876434|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110639835|NCT00876434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110639836|NCT00876434|Antifungal Agents|antifungal agents|mesh-ancestor
110639837|NCT00876434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110639838|NCT00876434|Immunologic Factors|immunologic factors|mesh-ancestor
110639839|NCT00876434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110639840|NCT00871442|Fentanyl|fentanyl|mesh-list
110136207|NCT02002403|Danazol|danazol|mesh-list
110639841|NCT00871442|Bupivacaine|bupivacaine|mesh-list
110639842|NCT00871442|Anesthetics|anesthetics|mesh-list
110639843|NCT00871442|Anesthetics, Local|anesthetics, local|mesh-ancestor
110639844|NCT00871442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110136268|NCT02002715|Budesonide|budesonide|mesh-list
110639845|NCT00871442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110639846|NCT00871442|Sensory System Agents|sensory system agents|mesh-ancestor
110639847|NCT00871442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110639848|NCT00871442|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110639849|NCT00871442|Narcotics|narcotics|mesh-ancestor
110639850|NCT00871442|Analgesics|analgesics|mesh-ancestor
110639851|NCT00871442|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110639852|NCT00871442|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110639853|NCT00871442|Anesthetics, General|anesthetics, general|mesh-ancestor
110639854|NCT05355597|Clonidine|clonidine|mesh-list
110639855|NCT05355597|Epinephrine|epinephrine|mesh-list
110639856|NCT05355597|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110639857|NCT05355597|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110639858|NCT05355597|Adrenergic Agents|adrenergic agents|mesh-ancestor
110639859|NCT05355597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110639860|NCT05355597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110639861|NCT05355597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110639862|NCT05355597|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110136402|NCT02004171|Nicotine|nicotine|mesh-list
110639863|NCT05355597|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110639864|NCT05355597|Autonomic Agents|autonomic agents|mesh-ancestor
110639865|NCT05355597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110639866|NCT05355597|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110639867|NCT05355597|Respiratory System Agents|respiratory system agents|mesh-ancestor
110395875|NCT01342913|Xhance|xhance|mesh-list
110639868|NCT05355597|Mydriatics|mydriatics|mesh-ancestor
110136470|NCT02004574|Hormones|hormones|mesh-ancestor
110639869|NCT05355597|Sympathomimetics|sympathomimetics|mesh-ancestor
110639870|NCT05355597|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110639871|NCT05355597|Analgesics|analgesics|mesh-ancestor
110639872|NCT05355597|Sensory System Agents|sensory system agents|mesh-ancestor
110639873|NCT05355597|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110639874|NCT05355597|Sympatholytics|sympatholytics|mesh-ancestor
110639875|NCT05355597|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110639876|NCT00866528|Paclitaxel|paclitaxel|mesh-list
110639877|NCT00866528|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110639878|NCT00866528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110639879|NCT00866528|Tubulin Modulators|tubulin modulators|mesh-ancestor
110639880|NCT00866528|Antimitotic Agents|antimitotic agents|mesh-ancestor
110136694|NCT02006173|Lidocaine|lidocaine|mesh-list
110639881|NCT00866528|Mitosis Modulators|mitosis modulators|mesh-ancestor
110639882|NCT00866528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110639883|NCT00871598|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110639884|NCT00871598|Immunologic Factors|immunologic factors|mesh-ancestor
110639885|NCT00871598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110639886|NCT00992667|Acetovanillone|acetovanillone|mesh-list
110639887|NCT00992667|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110639888|NCT00992667|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110639889|NCT00992667|Analgesics|analgesics|mesh-ancestor
110639890|NCT00992667|Sensory System Agents|sensory system agents|mesh-ancestor
110639891|NCT00992667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110639892|NCT00992667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110639893|NCT00992667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110639894|NCT00992667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110639895|NCT00992667|Antioxidants|antioxidants|mesh-ancestor
110639896|NCT00992667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110639897|NCT00992667|Protective Agents|protective agents|mesh-ancestor
110639898|NCT00992667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110639899|NCT05171972|Ofatumumab|ofatumumab|mesh-list
110639900|NCT05171972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110639902|NCT00992823|Trace Elements|trace elements|mesh-ancestor
110639903|NCT00992823|Micronutrients|micronutrients|mesh-ancestor
110137044|NCT05967377|Vitamin B Complex|vitamin b complex|mesh-ancestor
110639904|NCT00992823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110639905|NCT03894813|Metronidazole|metronidazole|mesh-list
110639906|NCT03894813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110639907|NCT03894813|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110639908|NCT03894813|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110639909|NCT03894813|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110639911|NCT00615992|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110639912|NCT00615992|Autonomic Agents|autonomic agents|mesh-ancestor
110639913|NCT00615992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110639914|NCT00615992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110639915|NCT00615992|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110639916|NCT00615992|Respiratory System Agents|respiratory system agents|mesh-ancestor
110639917|NCT00615992|Parasympatholytics|parasympatholytics|mesh-ancestor
110639918|NCT00615992|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110639919|NCT00615992|Cholinergic Agents|cholinergic agents|mesh-ancestor
110639920|NCT00615992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110639921|NCT00615992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110639923|NCT00876824|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
110639924|NCT00876824|Amebicides|amebicides|mesh-ancestor
110639925|NCT00876824|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110639926|NCT00876824|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110639927|NCT00876824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110639928|NCT00876824|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110395892|NCT01342796|Vaccines|vaccines|mesh-list
110639929|NCT00876824|Antifungal Agents|antifungal agents|mesh-ancestor
110639930|NCT00866684|Cyclosporine|cyclosporine|mesh-list
110639931|NCT00866684|Sirolimus|sirolimus|mesh-list
110639932|NCT00866684|Azathioprine|azathioprine|mesh-list
110639933|NCT00866684|Tacrolimus|tacrolimus|mesh-list
110639934|NCT00866684|Cyclosporins|cyclosporins|mesh-list
110639935|NCT00866684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110639936|NCT00866684|Immunologic Factors|immunologic factors|mesh-ancestor
110639937|NCT00866684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110639938|NCT00866684|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110639939|NCT00866684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110639940|NCT00866684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110639941|NCT00866684|Antifungal Agents|antifungal agents|mesh-ancestor
110639942|NCT00866684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110639943|NCT00866684|Dermatologic Agents|dermatologic agents|mesh-ancestor
110639944|NCT00866684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110639945|NCT00866684|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110639946|NCT00866684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110639947|NCT00866684|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110639948|NCT00866684|Antimetabolites|antimetabolites|mesh-ancestor
110137252|NCT05862545|Hormones|hormones|mesh-ancestor
110639949|NCT00866684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110639951|NCT00993057|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110639952|NCT00993057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110639953|NCT00866762|Vorinostat|vorinostat|mesh-list
110639954|NCT00866762|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
110639955|NCT00866762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110639956|NCT00866762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110639957|NCT00866762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110639958|NCT00876902|polysaccharide-K|polysaccharide-k|mesh-list
110639959|NCT00876902|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110639960|NCT00876902|Immunologic Factors|immunologic factors|mesh-ancestor
110639961|NCT00876902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110639962|NCT00876902|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110639963|NCT00876902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110639964|NCT00876902|Antiviral Agents|antiviral agents|mesh-ancestor
110639965|NCT00876902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110639966|NCT00876902|Interferon Inducers|interferon inducers|mesh-ancestor
110639967|NCT00876902|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110639968|NCT00876902|Protective Agents|protective agents|mesh-ancestor
110639969|NCT00993135|Methotrexate|methotrexate|mesh-list
110639970|NCT00993135|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110639971|NCT00993135|Abortifacient Agents|abortifacient agents|mesh-ancestor
110639972|NCT00993135|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110639973|NCT00993135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110639974|NCT00993135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110639975|NCT00993135|Antimetabolites|antimetabolites|mesh-ancestor
110639976|NCT00993135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110639977|NCT00993135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110639978|NCT00993135|Dermatologic Agents|dermatologic agents|mesh-ancestor
110639979|NCT00993135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110639980|NCT00993135|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110137346|NCT05741502|Olanzapine|olanzapine|mesh-list
110639981|NCT00993135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110639982|NCT00993135|Immunologic Factors|immunologic factors|mesh-ancestor
110639983|NCT00993135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110639984|NCT00993135|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110639985|NCT00866996|Methylphenidate|methylphenidate|mesh-list
110368578|NCT04618146|Analgesics|analgesics|mesh-ancestor
110639986|NCT00866996|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
110639987|NCT00866996|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110639988|NCT00866996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110639989|NCT00866996|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110639990|NCT00866996|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110639991|NCT00866996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110639992|NCT00866996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110639993|NCT00866996|Dopamine Agents|dopamine agents|mesh-ancestor
110639994|NCT00866996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110639995|NCT00866996|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110639996|NCT00866996|Adrenergic Agents|adrenergic agents|mesh-ancestor
110639999|NCT00871910|Aprepitant|aprepitant|mesh-list
110640000|NCT00871910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110640001|NCT00871910|Antiemetics|antiemetics|mesh-ancestor
110640002|NCT00871910|Autonomic Agents|autonomic agents|mesh-ancestor
110640003|NCT00871910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110640004|NCT00871910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110640005|NCT00871910|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110640006|NCT00871910|Glucocorticoids|glucocorticoids|mesh-ancestor
110640007|NCT00871910|Hormones|hormones|mesh-ancestor
110137586|NCT05539365|Pembrolizumab|pembrolizumab|mesh-list
110137587|NCT05539365|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110137588|NCT05539365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110137589|NCT05539365|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110137590|NCT05539365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110137602|NCT05501886|Fulvestrant|fulvestrant|mesh-list
110137603|NCT05501886|Palbociclib|palbociclib|mesh-list
110137604|NCT05501886|Gedatolisib|gedatolisib|mesh-list
110137605|NCT05501886|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110137606|NCT05501886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110137607|NCT05501886|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110640008|NCT00871910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110640009|NCT00871910|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110137651|NCT05469893|Glucocorticoids|glucocorticoids|mesh-ancestor
110640010|NCT00871910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110640011|NCT00871910|Antipruritics|antipruritics|mesh-ancestor
110640012|NCT00871910|Dermatologic Agents|dermatologic agents|mesh-ancestor
110640013|NCT00871910|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110640014|NCT00871910|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110640015|NCT00871910|Serotonin Agents|serotonin agents|mesh-ancestor
110640016|NCT00871910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110640017|NCT00871910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110640018|NCT00871910|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110640019|NCT05355441|Analgesics|analgesics|mesh-list
110640020|NCT05355441|Sensory System Agents|sensory system agents|mesh-ancestor
110640021|NCT05355441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110640022|NCT05355441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110640023|NCT01564329|Endostar protein|endostar protein|mesh-list
110640024|NCT01564329|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110640025|NCT01564329|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110640026|NCT01564329|Growth Substances|growth substances|mesh-ancestor
110640027|NCT01564329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110640028|NCT01564329|Growth Inhibitors|growth inhibitors|mesh-ancestor
110640029|NCT01564329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110640031|NCT05213481|Carbamazepine|carbamazepine|mesh-list
110640032|NCT05213481|Anticonvulsants|anticonvulsants|mesh-ancestor
110640033|NCT05213481|Antimanic Agents|antimanic agents|mesh-ancestor
110640034|NCT05213481|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110640035|NCT05213481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110640036|NCT05213481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110640037|NCT05213481|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110640038|NCT05213481|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110640039|NCT05213481|Analgesics|analgesics|mesh-ancestor
110640040|NCT05213481|Sensory System Agents|sensory system agents|mesh-ancestor
110640041|NCT05213481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110640042|NCT05213481|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110640043|NCT05213481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110640044|NCT05213481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110640045|NCT05213481|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110640046|NCT05213481|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110640047|NCT05213481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110640048|NCT00993525|Ranibizumab|ranibizumab|mesh-list
110640049|NCT00993525|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110640050|NCT00993525|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110640051|NCT00993525|Growth Substances|growth substances|mesh-ancestor
110640052|NCT00993525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110640053|NCT00993525|Growth Inhibitors|growth inhibitors|mesh-ancestor
110640054|NCT00993525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110287303|NCT00212615|Capecitabine|capecitabine|mesh-list
110640055|NCT00993681|Vaccines|vaccines|mesh-list
110640056|NCT00993681|Immunologic Factors|immunologic factors|mesh-ancestor
110640057|NCT00993681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110640058|NCT03892707|Folic Acid|folic acid|mesh-list
110640059|NCT03892707|Vitamin B Complex|vitamin b complex|mesh-list
110640060|NCT03892707|Celecoxib|celecoxib|mesh-list
110640061|NCT03892707|Etoricoxib|etoricoxib|mesh-list
110640062|NCT03892707|Meloxicam|meloxicam|mesh-list
110640063|NCT03892707|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
110640064|NCT03892707|Nimesulide|nimesulide|mesh-list
110640065|NCT03892707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
110640066|NCT03892707|Benphothiamine|benphothiamine|mesh-list
110640067|NCT03892707|Vitamins|vitamins|mesh-ancestor
110640068|NCT03892707|Micronutrients|micronutrients|mesh-ancestor
110640069|NCT03892707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110640070|NCT03892707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110640071|NCT03892707|Analgesics|analgesics|mesh-ancestor
110640072|NCT03892707|Sensory System Agents|sensory system agents|mesh-ancestor
110640073|NCT03892707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110640074|NCT03892707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110640075|NCT03892707|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110640076|NCT03892707|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110640077|NCT03892707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110640078|NCT03892707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110640080|NCT03892707|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110640081|NCT03892707|Immunologic Factors|immunologic factors|mesh-ancestor
110640082|NCT03892707|Chelating Agents|chelating agents|mesh-ancestor
110640083|NCT03892707|Sequestering Agents|sequestering agents|mesh-ancestor
110640084|NCT00513604|Aldesleukin|aldesleukin|mesh-list
110640085|NCT00513604|Cyclophosphamide|cyclophosphamide|mesh-list
110640086|NCT00513604|Fludarabine|fludarabine|mesh-list
110640087|NCT00513604|Fludarabine phosphate|fludarabine phosphate|mesh-list
110640088|NCT00513604|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110640089|NCT00513604|Immunologic Factors|immunologic factors|mesh-ancestor
110640090|NCT00513604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110640091|NCT00513604|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110640092|NCT00513604|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110640093|NCT00513604|Alkylating Agents|alkylating agents|mesh-ancestor
110640094|NCT00513604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110640095|NCT00513604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110640096|NCT00513604|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110640097|NCT00513604|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110640098|NCT00513604|Antimetabolites|antimetabolites|mesh-ancestor
110640099|NCT00513604|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110640100|NCT00513604|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110640101|NCT00513604|Antiviral Agents|antiviral agents|mesh-ancestor
110138468|NCT04298606|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
110640102|NCT00513604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110640103|NCT00872144|Nabiximols|nabiximols|mesh-list
110640104|NCT00872144|Analgesics|analgesics|mesh-ancestor
110640105|NCT00872144|Sensory System Agents|sensory system agents|mesh-ancestor
110640106|NCT00872144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110640107|NCT00872144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110640108|NCT00867152|Ritonavir|ritonavir|mesh-list
110640109|NCT00867152|Lopinavir|lopinavir|mesh-list
110640110|NCT00867152|Darunavir|darunavir|mesh-list
110640112|NCT00867152|Etravirine|etravirine|mesh-list
110640113|NCT00867152|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110640114|NCT00867152|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110640115|NCT00867152|Protease Inhibitors|protease inhibitors|mesh-ancestor
110640116|NCT00867152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110640117|NCT00867152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110640118|NCT00867152|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110640119|NCT00867152|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110640120|NCT00867152|Antiviral Agents|antiviral agents|mesh-ancestor
110640121|NCT00867152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110640122|NCT00867152|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110640123|NCT00867152|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110640124|NCT00867152|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110640125|NCT00867152|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110640126|NCT00867152|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110640127|NCT00867152|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110640128|NCT04039958|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
110640129|NCT04039958|Antiviral Agents|antiviral agents|mesh-ancestor
110640130|NCT04039958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110640132|NCT00872378|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110640133|NCT00872378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110640134|NCT00872378|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110640136|NCT00872378|Hormones|hormones|mesh-ancestor
110640137|NCT00872378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110640138|NCT00994071|Temozolomide|temozolomide|mesh-list
110640139|NCT00994071|Veliparib|veliparib|mesh-list
110640140|NCT00994071|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110640141|NCT00994071|Alkylating Agents|alkylating agents|mesh-ancestor
110640142|NCT00994071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110640143|NCT00994071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110640144|NCT00994071|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110640145|NCT00994071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110640146|NCT00994149|Diazoxide|diazoxide|mesh-list
110640147|NCT00994149|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110640148|NCT00994149|Vasodilator Agents|vasodilator agents|mesh-ancestor
110640149|NCT00573248|Nicotine|nicotine|mesh-list
110640150|NCT00573248|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110640151|NCT00573248|Autonomic Agents|autonomic agents|mesh-ancestor
110640152|NCT00573248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110640153|NCT00573248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110640154|NCT00573248|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110640155|NCT00573248|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110640156|NCT00573248|Cholinergic Agents|cholinergic agents|mesh-ancestor
110138755|NCT03978442|Dopamine Agents|dopamine agents|mesh-ancestor
110640157|NCT00573248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110640158|NCT00573248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110640160|NCT04039880|Antifungal Agents|antifungal agents|mesh-ancestor
110640161|NCT04039880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110640162|NCT00994305|Acetylcysteine|acetylcysteine|mesh-list
110640163|NCT00994305|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110640164|NCT00994305|Antiviral Agents|antiviral agents|mesh-ancestor
110640165|NCT00994305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110640166|NCT00994305|Expectorants|expectorants|mesh-ancestor
110395945|NCT01340768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110640167|NCT00994305|Respiratory System Agents|respiratory system agents|mesh-ancestor
110640168|NCT00994305|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110640169|NCT00994305|Antioxidants|antioxidants|mesh-ancestor
110138815|NCT03948867|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110138841|NCT03936023|Saxagliptin|saxagliptin|mesh-list
110640170|NCT00994305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110640171|NCT00994305|Protective Agents|protective agents|mesh-ancestor
110640172|NCT00994305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110640173|NCT00994305|Antidotes|antidotes|mesh-ancestor
110640174|NCT00877760|Interferons|interferons|mesh-list
110640175|NCT00877760|Entecavir|entecavir|mesh-list
110640176|NCT00877760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110640177|NCT00877760|Antiviral Agents|antiviral agents|mesh-ancestor
110640178|NCT00877760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110640179|NCT04083911|Cytarabine|cytarabine|mesh-list
110640180|NCT04083911|Decitabine|decitabine|mesh-list
110640181|NCT04083911|Homoharringtonine|homoharringtonine|mesh-list
110640182|NCT04083911|Aclarubicin|aclarubicin|mesh-list
110640183|NCT04083911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110640184|NCT04083911|Antimetabolites|antimetabolites|mesh-ancestor
110640185|NCT04083911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110640186|NCT04083911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110640187|NCT04083911|Antiviral Agents|antiviral agents|mesh-ancestor
110640188|NCT04083911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110640189|NCT04083911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110640190|NCT04083911|Immunologic Factors|immunologic factors|mesh-ancestor
110640191|NCT04083911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110640192|NCT04083911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110640193|NCT04083911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110640194|NCT04083911|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110640195|NCT04083911|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110640196|NCT04083911|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110640197|NCT04083911|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110640198|NCT00995241|Raltegravir Potassium|raltegravir potassium|mesh-list
110640200|NCT00995241|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110640201|NCT00995241|Antiviral Agents|antiviral agents|mesh-ancestor
110640202|NCT00995241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110640203|NCT00995241|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110640204|NCT00995241|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110640205|NCT00995241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110640206|NCT00995241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110640207|NCT00994383|Morphine|morphine|mesh-list
110640208|NCT00994383|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110640209|NCT00994383|Narcotics|narcotics|mesh-ancestor
110640210|NCT00994383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110640211|NCT00994383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110640213|NCT00994383|Sensory System Agents|sensory system agents|mesh-ancestor
110640214|NCT00994383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110640215|NCT02588417|Dexamethasone|dexamethasone|mesh-list
110640216|NCT02588417|Levobupivacaine|levobupivacaine|mesh-list
110640217|NCT02588417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110640218|NCT02588417|Antiemetics|antiemetics|mesh-ancestor
110640219|NCT02588417|Autonomic Agents|autonomic agents|mesh-ancestor
110640220|NCT02588417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110640221|NCT02588417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110640222|NCT02588417|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110640224|NCT02588417|Hormones|hormones|mesh-ancestor
110640225|NCT02588417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110640226|NCT02588417|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110640227|NCT02588417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110640228|NCT02588417|Anesthetics, Local|anesthetics, local|mesh-ancestor
110640229|NCT02588417|Anesthetics|anesthetics|mesh-ancestor
110640230|NCT02588417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110640231|NCT02588417|Sensory System Agents|sensory system agents|mesh-ancestor
110640232|NCT00532935|Metformin|metformin|mesh-list
110640233|NCT00532935|Pioglitazone|pioglitazone|mesh-list
110640234|NCT00532935|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110640235|NCT00532935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110640236|NCT00532935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110640237|NCT00532935|Incretins|incretins|mesh-ancestor
110640238|NCT00532935|Hormones|hormones|mesh-ancestor
110640239|NCT00532935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110640240|NCT00532935|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110640241|NCT00532935|Protease Inhibitors|protease inhibitors|mesh-ancestor
110640242|NCT00532935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110640243|NCT00532935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110640244|NCT00994539|Morphine|morphine|mesh-list
110640245|NCT00994539|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110640246|NCT00994539|Narcotics|narcotics|mesh-ancestor
110139199|NCT02960659|Liraglutide|liraglutide|mesh-list
110640247|NCT00994539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110640248|NCT00994539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110640249|NCT00994539|Analgesics|analgesics|mesh-ancestor
110640250|NCT00994539|Sensory System Agents|sensory system agents|mesh-ancestor
110640251|NCT00994539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110640252|NCT00878306|Ritonavir|ritonavir|mesh-list
110640253|NCT00878306|Atazanavir Sulfate|atazanavir sulfate|mesh-list
110640254|NCT00878306|Efavirenz|efavirenz|mesh-list
110640255|NCT00878306|Disulfiram|disulfiram|mesh-list
110640256|NCT00878306|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110139227|NCT02916771|Ixazomib|ixazomib|mesh-list
110640257|NCT00878306|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110640258|NCT00878306|Protease Inhibitors|protease inhibitors|mesh-ancestor
110640259|NCT00878306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110640260|NCT00878306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110640261|NCT00878306|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110640262|NCT00878306|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110640263|NCT00878306|Antiviral Agents|antiviral agents|mesh-ancestor
110640264|NCT00878306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110640265|NCT00878306|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110640266|NCT00878306|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110640267|NCT00878306|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110640268|NCT00878306|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110640269|NCT00878306|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110640270|NCT00878306|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110640271|NCT00878306|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110640272|NCT00878306|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110640273|NCT00878306|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110640274|NCT00878306|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110640275|NCT00878306|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
110640276|NCT00994617|Losartan|losartan|mesh-list
110640277|NCT00994617|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110640278|NCT00994617|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110640279|NCT00994617|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110158525|NCT00006086|Carboplatin|carboplatin|mesh-list
110640280|NCT00994617|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110640281|NCT00994617|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110640282|NCT00994617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110640284|NCT00994617|Natriuretic Agents|natriuretic agents|mesh-ancestor
110640285|NCT00994617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110640286|NCT00994617|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110640287|NCT00994617|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110640288|NCT00995397|Chlorpheniramine|chlorpheniramine|mesh-list
110640289|NCT00995397|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
110640290|NCT00995397|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110640291|NCT00995397|Histamine Antagonists|histamine antagonists|mesh-ancestor
110640292|NCT00995397|Histamine Agents|histamine agents|mesh-ancestor
110640293|NCT00995397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110640294|NCT00995397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110640295|NCT00995397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110640296|NCT00995397|Antipruritics|antipruritics|mesh-ancestor
110640297|NCT00995397|Dermatologic Agents|dermatologic agents|mesh-ancestor
110640298|NCT00995397|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110640299|NCT00919451|Cyclosporine|cyclosporine|mesh-list
110640300|NCT00919451|Cyclosporins|cyclosporins|mesh-list
110640301|NCT00919451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110640302|NCT00919451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110640303|NCT00919451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110640304|NCT00919451|Immunologic Factors|immunologic factors|mesh-ancestor
110640305|NCT00919451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110640306|NCT00919451|Antifungal Agents|antifungal agents|mesh-ancestor
110640307|NCT00919451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110640308|NCT00919451|Dermatologic Agents|dermatologic agents|mesh-ancestor
110640309|NCT00919451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110640310|NCT00919451|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110640311|NCT03016312|Atezolizumab|atezolizumab|mesh-list
110640312|NCT03016312|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110640313|NCT03016312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110139404|NCT02460497|Minoxidil|minoxidil|mesh-list
110640314|NCT03016312|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110640315|NCT03016312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110640316|NCT05059223|Reboxetine|reboxetine|mesh-list
110640317|NCT05059223|Antidepressive Agents|antidepressive agents|mesh-ancestor
110640318|NCT05059223|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110640319|NCT05059223|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110640320|NCT05059223|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110640321|NCT05059223|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110640322|NCT05059223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110640323|NCT05059223|Adrenergic Agents|adrenergic agents|mesh-ancestor
110640324|NCT05059223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110640325|NCT05059223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110640326|NCT00919607|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110640327|NCT00919607|Antidepressive Agents|antidepressive agents|mesh-ancestor
110640328|NCT00919607|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110640329|NCT00919607|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110640330|NCT00919607|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110640331|NCT00919607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110640332|NCT00919607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110640333|NCT01014052|Retinol acetate|retinol acetate|mesh-list
110640334|NCT01014052|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110640335|NCT01014052|Immunologic Factors|immunologic factors|mesh-ancestor
110640336|NCT01014052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110640337|NCT01014052|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110640338|NCT01014052|Protective Agents|protective agents|mesh-ancestor
110640339|NCT01014052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110640340|NCT00512902|Imatinib Mesylate|imatinib mesylate|mesh-list
110640341|NCT00512902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110640342|NCT00512902|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110640343|NCT00512902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110640344|NCT00512902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110640346|NCT01014364|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
110640347|NCT01014364|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
110640348|NCT01014364|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
110640349|NCT01014364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110640350|NCT01015300|Bevacizumab|bevacizumab|mesh-list
110640351|NCT01015300|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110640352|NCT01015300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110640353|NCT01015300|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110640354|NCT01015300|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110640355|NCT01015300|Growth Substances|growth substances|mesh-ancestor
110640356|NCT01015300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110640357|NCT01015300|Growth Inhibitors|growth inhibitors|mesh-ancestor
110640358|NCT01015456|Mycophenolic Acid|mycophenolic acid|mesh-list
110640359|NCT01015456|Cyclophosphamide|cyclophosphamide|mesh-list
110640360|NCT01015456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110640361|NCT01015456|Immunologic Factors|immunologic factors|mesh-ancestor
110640362|NCT01015456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110640363|NCT01015456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110158570|NCT00086125|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110640364|NCT01015456|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110640365|NCT01015456|Alkylating Agents|alkylating agents|mesh-ancestor
110640366|NCT01015456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110640367|NCT01015456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110640368|NCT01015456|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110640369|NCT01015456|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110640370|NCT01015456|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110139711|NCT02006914|Sequestering Agents|sequestering agents|mesh-ancestor
110640371|NCT01015456|Antitubercular Agents|antitubercular agents|mesh-ancestor
110640372|NCT01015456|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110640373|NCT01015456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110640374|NCT01015456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110640375|NCT02589041|Ropivacaine|ropivacaine|mesh-list
110640376|NCT02589041|Anesthetics, Local|anesthetics, local|mesh-ancestor
110640377|NCT02589041|Anesthetics|anesthetics|mesh-ancestor
110640378|NCT02589041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110640379|NCT02589041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110640380|NCT02589041|Sensory System Agents|sensory system agents|mesh-ancestor
110640381|NCT02589041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110640382|NCT00492232|Zolpidem|zolpidem|mesh-list
110640383|NCT00492232|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110640384|NCT00492232|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110640385|NCT00492232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110640386|NCT00492232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110640387|NCT00492232|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
110640388|NCT00492232|GABA Agonists|gaba agonists|mesh-ancestor
110640389|NCT00492232|GABA Agents|gaba agents|mesh-ancestor
110139844|NCT02007928|Olanzapine|olanzapine|mesh-list
110640390|NCT00492232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110640391|NCT00492232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110640392|NCT02587871|Cytarabine|cytarabine|mesh-list
110640393|NCT02587871|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110640394|NCT02587871|Antimetabolites|antimetabolites|mesh-ancestor
110640395|NCT02587871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110640396|NCT02587871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110640397|NCT02587871|Antiviral Agents|antiviral agents|mesh-ancestor
110640398|NCT02587871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110640399|NCT02587871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110640400|NCT02587871|Immunologic Factors|immunologic factors|mesh-ancestor
110139971|NCT02008461|Cholinergic Agents|cholinergic agents|mesh-ancestor
110640401|NCT02587871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110640403|NCT00919919|Progestins|progestins|mesh-ancestor
110640404|NCT00919919|Hormones|hormones|mesh-ancestor
110640405|NCT00919919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110640406|NCT00919919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110640407|NCT00491764|Posaconazole|posaconazole|mesh-list
110640408|NCT00491764|Terbinafine|terbinafine|mesh-list
110640409|NCT00491764|Antifungal Agents|antifungal agents|mesh-ancestor
110640410|NCT00491764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110640411|NCT00491764|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
110396008|NCT00600054|Nimotuzumab|nimotuzumab|mesh-list
110140040|NCT02008981|Antipyretics|antipyretics|mesh-ancestor
110640412|NCT00491764|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110640413|NCT00491764|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110640414|NCT00491764|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110640415|NCT00491764|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110640416|NCT00491764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110640417|NCT00491764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110640418|NCT00491764|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110640419|NCT00491764|Hormone Antagonists|hormone antagonists|mesh-ancestor
110640420|NCT00491764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110640421|NCT00491764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110640423|NCT02586311|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110640424|NCT02586311|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110640425|NCT02586311|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110640426|NCT02586311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110640427|NCT02586311|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110640428|NCT02586311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110640429|NCT02586311|Vasodilator Agents|vasodilator agents|mesh-ancestor
110640430|NCT00615836|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
110640431|NCT00615836|Hemostatics|hemostatics|mesh-ancestor
110640432|NCT00615836|Coagulants|coagulants|mesh-ancestor
110640433|NCT00615836|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
110640434|NCT00615836|Natriuretic Agents|natriuretic agents|mesh-ancestor
110640435|NCT00615836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110640436|NCT05139212|Dexmedetomidine|dexmedetomidine|mesh-list
110640437|NCT05139212|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110640438|NCT05139212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110640439|NCT05139212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110640440|NCT05139212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110640441|NCT05139212|Analgesics|analgesics|mesh-ancestor
110640442|NCT05139212|Sensory System Agents|sensory system agents|mesh-ancestor
110640443|NCT05139212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110640444|NCT05139212|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110640445|NCT05139212|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110640446|NCT05139212|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110255184|NCT00158028|Risperidone|risperidone|mesh-list
110640447|NCT05139212|Adrenergic Agents|adrenergic agents|mesh-ancestor
110640448|NCT05139212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110640449|NCT05139212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110640450|NCT00872924|Sumatriptan|sumatriptan|mesh-list
110640451|NCT00872924|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110640452|NCT00872924|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110640453|NCT00872924|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110640454|NCT00872924|Serotonin Agents|serotonin agents|mesh-ancestor
110640455|NCT00872924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110640456|NCT00872924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110140371|NCT04782830|Autonomic Agents|autonomic agents|mesh-ancestor
110640457|NCT00872924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110640458|NCT00878540|Mirtazapine|mirtazapine|mesh-list
110640459|NCT00878540|Antidepressive Agents|antidepressive agents|mesh-ancestor
110640460|NCT00878540|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110640461|NCT00878540|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110640462|NCT00878540|Histamine Antagonists|histamine antagonists|mesh-ancestor
110640463|NCT00878540|Histamine Agents|histamine agents|mesh-ancestor
110640464|NCT00878540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110640465|NCT00878540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110640466|NCT00878540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110640467|NCT00878540|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110640468|NCT00878540|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110640469|NCT00878540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110640470|NCT00878540|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
110640471|NCT00878540|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110640472|NCT00878540|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110158638|NCT00387569|Vaccines|vaccines|mesh-list
110640473|NCT00878540|Adrenergic Agents|adrenergic agents|mesh-ancestor
110640474|NCT00878540|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110640475|NCT00878540|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110640476|NCT00878540|Serotonin Agents|serotonin agents|mesh-ancestor
110640477|NCT00878540|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110640478|NCT04018274|Levonorgestrel|levonorgestrel|mesh-list
110640479|NCT04018274|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110640480|NCT04018274|Contraceptive Agents|contraceptive agents|mesh-list
110640481|NCT04018274|Contraceptives, Oral|contraceptives, oral|mesh-list
110640482|NCT04018274|Estradiol|estradiol|mesh-list
110640483|NCT04018274|Estrogens|estrogens|mesh-ancestor
110640484|NCT04018274|Hormones|hormones|mesh-ancestor
110640485|NCT04018274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110640486|NCT04018274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110640487|NCT04018274|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110640488|NCT04018274|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110640489|NCT04018274|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110640490|NCT04018274|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110640491|NCT04018274|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110640492|NCT00873002|Sorafenib|sorafenib|mesh-list
110640493|NCT00873002|Panobinostat|panobinostat|mesh-list
110640494|NCT00873002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110640495|NCT00873002|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110640496|NCT00873002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110640497|NCT00873002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110640498|NCT00873002|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110640499|NCT00491530|Calcium, Dietary|calcium, dietary|mesh-list
110640500|NCT00491530|Atorvastatin|atorvastatin|mesh-list
110640501|NCT00491530|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110640502|NCT00491530|Simvastatin|simvastatin|mesh-list
110640503|NCT00491530|Fenofibric acid|fenofibric acid|mesh-list
110640504|NCT00491530|Calcium|calcium|mesh-list
110640505|NCT00491530|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110640506|NCT00491530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110640507|NCT00491530|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110640508|NCT00491530|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110640509|NCT00491530|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110640510|NCT00491530|Antimetabolites|antimetabolites|mesh-ancestor
110640511|NCT00491530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110640512|NCT00491530|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110640513|NCT00491530|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110640514|NCT00491530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110640515|NCT00617240|Metformin|metformin|mesh-list
110640516|NCT00617240|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110640517|NCT00617240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110140625|NCT03556202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110640518|NCT00615290|Tipranavir|tipranavir|mesh-list
110640519|NCT00615290|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110640520|NCT00615290|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110640521|NCT00615290|Antiviral Agents|antiviral agents|mesh-ancestor
110640522|NCT00615290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110640523|NCT02587169|Doxorubicin|doxorubicin|mesh-list
110640524|NCT02587169|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110640525|NCT02587169|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110640526|NCT02587169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110140688|NCT03329508|Dopamine Agents|dopamine agents|mesh-ancestor
110640527|NCT02587169|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110640528|NCT02587169|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110640529|NCT02587169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110640530|NCT02587169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110640531|NCT00873236|Interferons|interferons|mesh-list
110640532|NCT00873236|Interferon-alpha|interferon-alpha|mesh-list
110640533|NCT00873236|Interferon alpha-2|interferon alpha-2|mesh-list
110640534|NCT00873236|Bevacizumab|bevacizumab|mesh-list
110640535|NCT00873236|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110640536|NCT00873236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110640537|NCT00873236|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110640538|NCT00873236|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110640539|NCT00873236|Growth Substances|growth substances|mesh-ancestor
110640540|NCT00873236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110640541|NCT00873236|Growth Inhibitors|growth inhibitors|mesh-ancestor
110640542|NCT00873236|Antiviral Agents|antiviral agents|mesh-ancestor
110640543|NCT00873236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110640544|NCT00873236|Immunologic Factors|immunologic factors|mesh-ancestor
110640546|NCT00868010|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110640547|NCT00868010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110640548|NCT00868010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110640549|NCT00868010|Cholinergic Agents|cholinergic agents|mesh-ancestor
110640550|NCT00868010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110640551|NCT00868010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110640552|NCT00868010|Nootropic Agents|nootropic agents|mesh-ancestor
110640553|NCT05683301|Amlodipine|amlodipine|mesh-list
110640555|NCT05683301|Indapamide|indapamide|mesh-list
110640556|NCT05683301|Indapamide, perindopril drug combination|indapamide, perindopril drug combination|mesh-list
110140895|NCT00967005|Acetylcysteine|acetylcysteine|mesh-list
110640557|NCT05683301|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110640558|NCT05683301|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110640559|NCT05683301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110140955|NCT02009280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110255201|NCT00149565|Antiviral Agents|antiviral agents|mesh-ancestor
110640560|NCT05683301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110640561|NCT05683301|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110640562|NCT05683301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110640563|NCT05683301|Vasodilator Agents|vasodilator agents|mesh-ancestor
110640564|NCT05683301|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110640565|NCT05683301|Protease Inhibitors|protease inhibitors|mesh-ancestor
110640566|NCT05683301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110640567|NCT05683301|Diuretics|diuretics|mesh-ancestor
110640568|NCT05683301|Natriuretic Agents|natriuretic agents|mesh-ancestor
110640569|NCT05683301|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110640570|NCT04770623|Docetaxel|docetaxel|mesh-list
110640571|NCT04770623|Irinotecan|irinotecan|mesh-list
110640572|NCT04770623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110640573|NCT04770623|Tubulin Modulators|tubulin modulators|mesh-ancestor
110640574|NCT04770623|Antimitotic Agents|antimitotic agents|mesh-ancestor
110640575|NCT04770623|Mitosis Modulators|mitosis modulators|mesh-ancestor
110640576|NCT04770623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110640577|NCT04770623|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110640578|NCT04770623|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110640579|NCT04770623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110287830|NCT04668352|Dactolisib|dactolisib|mesh-list
110640580|NCT05653661|Paclitaxel|paclitaxel|mesh-list
110396060|NCT00600990|Vestipitant|vestipitant|mesh-list
110640582|NCT05653661|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110640583|NCT05653661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110640585|NCT05653661|Antimitotic Agents|antimitotic agents|mesh-ancestor
110640586|NCT05653661|Mitosis Modulators|mitosis modulators|mesh-ancestor
110640587|NCT05653661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110640588|NCT00873392|Nicotine|nicotine|mesh-list
110141086|NCT02010827|Hormones|hormones|mesh-ancestor
110640589|NCT00873392|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110640590|NCT00873392|Autonomic Agents|autonomic agents|mesh-ancestor
110640591|NCT00873392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110640592|NCT00873392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110640593|NCT00873392|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110640594|NCT00873392|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110640595|NCT00873392|Cholinergic Agents|cholinergic agents|mesh-ancestor
110640596|NCT00873392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110640597|NCT00873392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110640598|NCT00879008|Moxifloxacin|moxifloxacin|mesh-list
110640599|NCT00879008|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
110640600|NCT00879008|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110640601|NCT00879008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110141151|NCT02011191|Biotin|biotin|mesh-list
110640602|NCT00879008|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110640603|NCT00879008|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110640604|NCT00879008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110640605|NCT00879008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110640606|NCT00879008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110640607|NCT00879008|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110640608|NCT00879008|Contraceptive Agents|contraceptive agents|mesh-ancestor
110640609|NCT00879008|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110640610|NCT00879008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110640611|NCT00879008|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110640612|NCT00879008|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110640613|NCT00879008|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110640614|NCT00879164|Bupivacaine|bupivacaine|mesh-list
110640615|NCT00879164|Anesthetics, Local|anesthetics, local|mesh-ancestor
110640616|NCT00879164|Anesthetics|anesthetics|mesh-ancestor
110640617|NCT00879164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110640618|NCT00879164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110640619|NCT00879164|Sensory System Agents|sensory system agents|mesh-ancestor
110640620|NCT00879164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110640621|NCT04731155|Alirocumab|alirocumab|mesh-list
110640622|NCT04731155|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-list
110640623|NCT04731155|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110640624|NCT04731155|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110640625|NCT04731155|Antimetabolites|antimetabolites|mesh-ancestor
110640626|NCT04731155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110640627|NCT04731155|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110640628|NCT04731155|Protease Inhibitors|protease inhibitors|mesh-ancestor
110640629|NCT04731155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110640630|NCT04731155|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110640631|NCT04729049|Morphine|morphine|mesh-list
110640632|NCT04729049|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110640633|NCT04729049|Narcotics|narcotics|mesh-ancestor
110640634|NCT04729049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110640635|NCT04729049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110640636|NCT04729049|Analgesics|analgesics|mesh-ancestor
110640637|NCT04729049|Sensory System Agents|sensory system agents|mesh-ancestor
110640638|NCT04729049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110640639|NCT02585765|Pioglitazone|pioglitazone|mesh-list
110640640|NCT02585765|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110640641|NCT02585765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110640642|NCT04634669|Dextromethorphan|dextromethorphan|mesh-list
110640643|NCT04634669|Bupropion|bupropion|mesh-list
110640644|NCT04634669|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110640645|NCT04634669|Antidepressive Agents|antidepressive agents|mesh-ancestor
110640646|NCT04634669|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110640647|NCT04634669|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110640648|NCT04634669|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110640649|NCT04634669|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110640650|NCT04634669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110141267|NCT02012036|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110640651|NCT04634669|Dopamine Agents|dopamine agents|mesh-ancestor
110640652|NCT04634669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110640653|NCT04634669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110640654|NCT04634669|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110640655|NCT04634669|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110640656|NCT04634669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110640657|NCT04634669|Antitussive Agents|antitussive agents|mesh-ancestor
110640658|NCT04634669|Respiratory System Agents|respiratory system agents|mesh-ancestor
110640659|NCT04634669|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110640660|NCT04634669|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110640661|NCT02585531|Dexamethasone|dexamethasone|mesh-list
110640662|NCT02585531|Epinephrine|epinephrine|mesh-list
110640663|NCT02585531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110640664|NCT02585531|Antiemetics|antiemetics|mesh-ancestor
110640665|NCT02585531|Autonomic Agents|autonomic agents|mesh-ancestor
110640666|NCT02585531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110640667|NCT02585531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110640668|NCT02585531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110640669|NCT02585531|Glucocorticoids|glucocorticoids|mesh-ancestor
110640671|NCT02585531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110640672|NCT02585531|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110640673|NCT02585531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110640674|NCT02585531|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110640675|NCT02585531|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110640676|NCT02585531|Adrenergic Agents|adrenergic agents|mesh-ancestor
110640677|NCT02585531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110640678|NCT02585531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110640679|NCT02585531|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110640680|NCT02585531|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110640681|NCT02585531|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110640682|NCT02585531|Respiratory System Agents|respiratory system agents|mesh-ancestor
110640683|NCT02585531|Mydriatics|mydriatics|mesh-ancestor
110640685|NCT02585531|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110640686|NCT00920153|Cytarabine|cytarabine|mesh-list
110640687|NCT00920153|Dexamethasone|dexamethasone|mesh-list
110640688|NCT00920153|Methylprednisolone|methylprednisolone|mesh-list
110640689|NCT00920153|Gemcitabine|gemcitabine|mesh-list
110640690|NCT00920153|Doxorubicin|doxorubicin|mesh-list
110640691|NCT00920153|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110640692|NCT00920153|Etoposide|etoposide|mesh-list
110640693|NCT00920153|Vincristine|vincristine|mesh-list
110640694|NCT00920153|Melphalan|melphalan|mesh-list
110640695|NCT00920153|Vinorelbine|vinorelbine|mesh-list
110640696|NCT00920153|Ifosfamide|ifosfamide|mesh-list
110640697|NCT00920153|Dacarbazine|dacarbazine|mesh-list
110640698|NCT00920153|Carmustine|carmustine|mesh-list
110640699|NCT00920153|Bleomycin|bleomycin|mesh-list
110640700|NCT00920153|Vindesine|vindesine|mesh-list
110640701|NCT00920153|Mitoguazone|mitoguazone|mesh-list
110640702|NCT00920153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110640704|NCT00920153|Autonomic Agents|autonomic agents|mesh-ancestor
110640705|NCT00920153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110640706|NCT00920153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110141638|NCT02014103|Tacrolimus|tacrolimus|mesh-list
110640707|NCT00920153|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110640708|NCT00920153|Glucocorticoids|glucocorticoids|mesh-ancestor
110640709|NCT00920153|Hormones|hormones|mesh-ancestor
110640710|NCT00920153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110640711|NCT00920153|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110141707|NCT02014558|Voriconazole|voriconazole|mesh-list
110640712|NCT00920153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110640713|NCT00920153|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110640714|NCT00920153|Antimetabolites|antimetabolites|mesh-ancestor
110640715|NCT00920153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110640716|NCT00920153|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110640717|NCT00920153|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110640718|NCT00920153|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110640719|NCT00920153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110640720|NCT00920153|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110640722|NCT00920153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110640723|NCT00920153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110640724|NCT00920153|Immunologic Factors|immunologic factors|mesh-ancestor
110640725|NCT00920153|Tubulin Modulators|tubulin modulators|mesh-ancestor
110640726|NCT00920153|Antimitotic Agents|antimitotic agents|mesh-ancestor
110287974|NCT00557011|Sympathomimetics|sympathomimetics|mesh-ancestor
110640727|NCT00920153|Mitosis Modulators|mitosis modulators|mesh-ancestor
110640728|NCT00920153|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110640729|NCT00920153|Protective Agents|protective agents|mesh-ancestor
110640730|NCT00920153|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110640732|NCT00920153|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110640734|NCT04080713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110640735|NCT04080713|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110640736|NCT04080713|Autonomic Agents|autonomic agents|mesh-ancestor
110141862|NCT02015507|Ivacaftor|ivacaftor|mesh-list
110640737|NCT04080713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110640738|NCT04080713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110640739|NCT04080713|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110640740|NCT04080713|Respiratory System Agents|respiratory system agents|mesh-ancestor
110640741|NCT04080713|Glucocorticoids|glucocorticoids|mesh-ancestor
110640742|NCT04080713|Hormones|hormones|mesh-ancestor
110640743|NCT04080713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110640744|NCT05519189|Ropivacaine|ropivacaine|mesh-list
110640745|NCT05519189|Anesthetics, Local|anesthetics, local|mesh-ancestor
110640746|NCT05519189|Anesthetics|anesthetics|mesh-ancestor
110640747|NCT05519189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110640748|NCT05519189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110640749|NCT05519189|Sensory System Agents|sensory system agents|mesh-ancestor
110640750|NCT05519189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110640752|NCT04080323|Oxytocics|oxytocics|mesh-ancestor
110640753|NCT04080323|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110640754|NCT04080323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110640755|NCT03930017|Vaccines|vaccines|mesh-list
110640756|NCT03930017|Immunologic Factors|immunologic factors|mesh-ancestor
110640757|NCT03930017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110640758|NCT00533949|Paclitaxel|paclitaxel|mesh-list
110640759|NCT00533949|Carboplatin|carboplatin|mesh-list
110640760|NCT00533949|Cetuximab|cetuximab|mesh-list
110640761|NCT00533949|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110640762|NCT00533949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110640763|NCT00533949|Tubulin Modulators|tubulin modulators|mesh-ancestor
110640764|NCT00533949|Antimitotic Agents|antimitotic agents|mesh-ancestor
110640765|NCT00533949|Mitosis Modulators|mitosis modulators|mesh-ancestor
110640766|NCT00533949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110640767|NCT00533949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110640769|NCT00485134|Immunologic Factors|immunologic factors|mesh-ancestor
110640770|NCT00485134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110640771|NCT02585141|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110640772|NCT02585141|Clindamycin|clindamycin|mesh-list
110640773|NCT02585141|Clindamycin palmitate|clindamycin palmitate|mesh-list
110640774|NCT02585141|Clindamycin phosphate|clindamycin phosphate|mesh-list
110640775|NCT02585141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110640776|NCT02585141|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110640777|NCT02585141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110640778|NCT02585141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110640779|NCT04079231|Aflibercept|aflibercept|mesh-list
110640780|NCT04079231|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110640781|NCT04079231|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110640782|NCT04079231|Growth Substances|growth substances|mesh-ancestor
110640783|NCT04079231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110640784|NCT04079231|Growth Inhibitors|growth inhibitors|mesh-ancestor
110640785|NCT04079231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110640786|NCT00994695|Vaccines|vaccines|mesh-list
110640787|NCT00994695|Immunologic Factors|immunologic factors|mesh-ancestor
110640788|NCT00994695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110640789|NCT04521803|Rifampin|rifampin|mesh-list
110640790|NCT04521803|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110640791|NCT04521803|Antitubercular Agents|antitubercular agents|mesh-ancestor
110640792|NCT04521803|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110640793|NCT04521803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110640794|NCT04521803|Leprostatic Agents|leprostatic agents|mesh-ancestor
110640795|NCT04521803|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110640796|NCT04521803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110640797|NCT04521803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110640798|NCT04521803|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110142157|NCT02017457|Azacitidine|azacitidine|mesh-list
110640799|NCT04521803|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110640800|NCT04521803|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110640801|NCT04521803|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110640802|NCT04521803|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110640803|NCT04521803|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110142223|NCT02018094|Iodine|iodine|mesh-list
110640804|NCT00920465|Misoprostol|misoprostol|mesh-list
110640805|NCT00920465|Mifepristone|mifepristone|mesh-list
110640806|NCT00920465|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110640807|NCT00920465|Abortifacient Agents|abortifacient agents|mesh-ancestor
110640808|NCT00920465|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110640809|NCT00920465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110640810|NCT00920465|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110640811|NCT00920465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110640812|NCT00920465|Oxytocics|oxytocics|mesh-ancestor
110640813|NCT00920465|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
110640814|NCT00920465|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110640815|NCT00920465|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110640816|NCT00920465|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110640817|NCT00920465|Contraceptive Agents|contraceptive agents|mesh-ancestor
110640818|NCT00920465|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
110640819|NCT00920465|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
110640820|NCT00920465|Hormone Antagonists|hormone antagonists|mesh-ancestor
110640821|NCT00920465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110640822|NCT00920465|Luteolytic Agents|luteolytic agents|mesh-ancestor
110640823|NCT00920465|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110640824|NCT00920465|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
110640825|NCT00994773|Tenofovir|tenofovir|mesh-list
110640826|NCT00994773|Entecavir|entecavir|mesh-list
110640827|NCT00994773|Simvastatin|simvastatin|mesh-list
110640828|NCT00994773|Antiviral Agents|antiviral agents|mesh-ancestor
110640829|NCT00994773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110640830|NCT00994773|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110640831|NCT00994773|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110640832|NCT00994773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110640833|NCT00994773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110640834|NCT00994773|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110640835|NCT00994773|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110142501|NCT02019524|Sargramostim|sargramostim|mesh-list
110640836|NCT00994773|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110640837|NCT00994773|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110640838|NCT00994773|Antimetabolites|antimetabolites|mesh-ancestor
110640839|NCT00994773|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110640840|NCT00994773|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110640841|NCT02583191|Rivaroxaban|rivaroxaban|mesh-list
110640842|NCT02583191|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110640843|NCT02583191|Antithrombins|antithrombins|mesh-ancestor
110640844|NCT02583191|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110640845|NCT02583191|Protease Inhibitors|protease inhibitors|mesh-ancestor
110640846|NCT02583191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110640847|NCT02583191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110640848|NCT02583191|Anticoagulants|anticoagulants|mesh-ancestor
110640849|NCT03084237|Docetaxel|docetaxel|mesh-list
110640850|NCT03084237|Trastuzumab|trastuzumab|mesh-list
110640851|NCT03084237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110640852|NCT03084237|Tubulin Modulators|tubulin modulators|mesh-ancestor
110640853|NCT03084237|Antimitotic Agents|antimitotic agents|mesh-ancestor
110640854|NCT03084237|Mitosis Modulators|mitosis modulators|mesh-ancestor
110640855|NCT03084237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110640856|NCT03084237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110640857|NCT00996021|Moxifloxacin|moxifloxacin|mesh-list
110640858|NCT00996021|Dolutegravir|dolutegravir|mesh-list
110640859|NCT00996021|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
110640860|NCT00996021|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110640861|NCT00996021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110640862|NCT00996021|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110640863|NCT00996021|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110640864|NCT00996021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110640865|NCT00996021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110640866|NCT00996021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110640867|NCT00996021|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110640868|NCT00996021|Contraceptive Agents|contraceptive agents|mesh-ancestor
110640869|NCT00996021|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110640870|NCT00996021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110640871|NCT00996021|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110640872|NCT00996021|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110640873|NCT00996021|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110640874|NCT00996021|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110640875|NCT00996021|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110640876|NCT00996021|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110640877|NCT00996021|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110640878|NCT00996021|Antiviral Agents|antiviral agents|mesh-ancestor
110288135|NCT00216164|Rituximab|rituximab|mesh-list
110640879|NCT00996099|Insulin|insulin|mesh-list
110640880|NCT00996099|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110640881|NCT00996099|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110142774|NCT02021422|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110640882|NCT00996099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110640884|NCT04515329|Lubricant Eye Drops|lubricant eye drops|mesh-list
110640885|NCT04515329|Cyclosporins|cyclosporins|mesh-list
110640886|NCT04515329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110640887|NCT04515329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110640888|NCT04515329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110640889|NCT04515329|Immunologic Factors|immunologic factors|mesh-ancestor
110640890|NCT04515329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110640891|NCT04515329|Antifungal Agents|antifungal agents|mesh-ancestor
110640892|NCT04515329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110640893|NCT04515329|Dermatologic Agents|dermatologic agents|mesh-ancestor
110640894|NCT04515329|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110640895|NCT04515329|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110640896|NCT04515329|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110640897|NCT04515329|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110640898|NCT02584751|Nitric Oxide|nitric oxide|mesh-list
110640899|NCT02584751|Omeprazole|omeprazole|mesh-list
110640900|NCT02584751|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110640901|NCT02584751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110640902|NCT02584751|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110640903|NCT02584751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110640904|NCT02584751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110640905|NCT02584751|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110640906|NCT02584751|Autonomic Agents|autonomic agents|mesh-ancestor
110640907|NCT02584751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110640908|NCT02584751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110640909|NCT02584751|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110640910|NCT02584751|Respiratory System Agents|respiratory system agents|mesh-ancestor
110640911|NCT02584751|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110640912|NCT02584751|Antioxidants|antioxidants|mesh-ancestor
110640913|NCT02584751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110143092|NCT02023554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110640914|NCT02584751|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
110640915|NCT02584751|Vasodilator Agents|vasodilator agents|mesh-ancestor
110640916|NCT02584751|Gasotransmitters|gasotransmitters|mesh-ancestor
110158724|NCT00087256|Celecoxib|celecoxib|mesh-list
110640917|NCT02584751|Protective Agents|protective agents|mesh-ancestor
110640918|NCT00999219|Zolpidem|zolpidem|mesh-list
110640919|NCT00999219|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110143171|NCT02024009|Nelfinavir|nelfinavir|mesh-list
110640920|NCT00999219|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110640921|NCT00999219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110640922|NCT00999219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110640923|NCT00999219|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
110640924|NCT00999219|GABA Agonists|gaba agonists|mesh-ancestor
110640925|NCT00999219|GABA Agents|gaba agents|mesh-ancestor
110640926|NCT00999219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110640927|NCT00999219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110640928|NCT00996177|Fentanyl|fentanyl|mesh-list
110640929|NCT00996177|Morphine|morphine|mesh-list
110640930|NCT00996177|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110640931|NCT00996177|Narcotics|narcotics|mesh-ancestor
110640932|NCT00996177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110640933|NCT00996177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110640934|NCT00996177|Analgesics|analgesics|mesh-ancestor
110640935|NCT00996177|Sensory System Agents|sensory system agents|mesh-ancestor
110640936|NCT00996177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110640937|NCT00996177|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110640938|NCT00996177|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110640939|NCT00996177|Anesthetics, General|anesthetics, general|mesh-ancestor
110640941|NCT04079933|Nicotine|nicotine|mesh-list
110640942|NCT04079933|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110640943|NCT04079933|Autonomic Agents|autonomic agents|mesh-ancestor
110640944|NCT04079933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110640945|NCT04079933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110640946|NCT04079933|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110640947|NCT04079933|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110640948|NCT04079933|Cholinergic Agents|cholinergic agents|mesh-ancestor
110640949|NCT04079933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110640950|NCT04079933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110640951|NCT00999297|Capsaicin|capsaicin|mesh-list
110640952|NCT00999297|Antipruritics|antipruritics|mesh-ancestor
110640953|NCT00999297|Dermatologic Agents|dermatologic agents|mesh-ancestor
110255269|NCT00471952|Rizatriptan|rizatriptan|mesh-list
110640954|NCT00999297|Sensory System Agents|sensory system agents|mesh-ancestor
110640955|NCT00999297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110640956|NCT00999297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110143732|NCT02027220|Hormones|hormones|mesh-ancestor
110640957|NCT00583115|Imatinib Mesylate|imatinib mesylate|mesh-list
110640958|NCT00583115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110640959|NCT00583115|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110640960|NCT00583115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110640961|NCT00583115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110640963|NCT05371223|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110143798|NCT02027493|Interferon alpha-2|interferon alpha-2|mesh-list
110640964|NCT05371223|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110640965|NCT05371223|Antimetabolites|antimetabolites|mesh-ancestor
110640966|NCT05371223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110640967|NCT05371223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110640968|NCT00532779|Naltrexone|naltrexone|mesh-list
110640969|NCT00532779|Bupropion|bupropion|mesh-list
110143884|NCT02028234|Omeprazole|omeprazole|mesh-list
110640970|NCT00532779|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110640971|NCT00532779|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110640972|NCT00532779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110640973|NCT00532779|Sensory System Agents|sensory system agents|mesh-ancestor
110640974|NCT00532779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110640975|NCT00532779|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110640976|NCT00532779|Antidepressive Agents|antidepressive agents|mesh-ancestor
110640977|NCT00532779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110640978|NCT00532779|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110143936|NCT02028507|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110640979|NCT00532779|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110640980|NCT00532779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110640981|NCT00532779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110640982|NCT00532779|Dopamine Agents|dopamine agents|mesh-ancestor
110640983|NCT00532779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110640984|NCT00532779|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110640985|NCT00532779|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110640986|NCT00532779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110640987|NCT00500266|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110640988|NCT00500266|Immunologic Factors|immunologic factors|mesh-ancestor
110640989|NCT00500266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110640990|NCT00996411|Salvinorin A|salvinorin a|mesh-list
110640991|NCT00996411|Hallucinogens|hallucinogens|mesh-ancestor
110640992|NCT00996411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110640993|NCT00996411|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110640994|NCT00996567|Cetuximab|cetuximab|mesh-list
110144002|NCT02028910|Autonomic Agents|autonomic agents|mesh-ancestor
110640995|NCT00996567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110640996|NCT00996567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110640997|NCT04120805|Hemostatics|hemostatics|mesh-list
110640998|NCT04120805|Coagulants|coagulants|mesh-ancestor
110640999|NCT02852655|Pembrolizumab|pembrolizumab|mesh-list
110641000|NCT02852655|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110641001|NCT02852655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110641002|NCT02852655|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110641003|NCT02852655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110641004|NCT00500110|Docetaxel|docetaxel|mesh-list
110641005|NCT00500110|Imatinib Mesylate|imatinib mesylate|mesh-list
110641006|NCT00500110|Leuprolide|leuprolide|mesh-list
110641007|NCT00500110|Goserelin|goserelin|mesh-list
110641008|NCT00500110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110641009|NCT00500110|Tubulin Modulators|tubulin modulators|mesh-ancestor
110641010|NCT00500110|Antimitotic Agents|antimitotic agents|mesh-ancestor
110641011|NCT00500110|Mitosis Modulators|mitosis modulators|mesh-ancestor
110641012|NCT00500110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110641013|NCT00500110|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110641014|NCT00500110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110641015|NCT00500110|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110641016|NCT00500110|Fertility Agents|fertility agents|mesh-ancestor
110396153|NCT01167907|Anesthetics|anesthetics|mesh-ancestor
110641017|NCT00500110|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110641018|NCT00500110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110641019|NCT00500110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110641020|NCT04358237|Pembrolizumab|pembrolizumab|mesh-list
110641021|NCT04358237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110641022|NCT04358237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110641023|NCT04358237|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110641024|NCT04358237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110641025|NCT05304533|Itraconazole|itraconazole|mesh-list
110641026|NCT05304533|Verapamil|verapamil|mesh-list
110641027|NCT05304533|Antifungal Agents|antifungal agents|mesh-ancestor
110641028|NCT05304533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110288274|NCT00216554|Risperidone|risperidone|mesh-list
110641029|NCT05304533|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110641030|NCT05304533|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110158752|NCT04762953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110641032|NCT05304533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110641033|NCT05304533|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110641035|NCT05304533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110641036|NCT05304533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110641037|NCT05304533|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110641038|NCT05304533|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110641039|NCT05304533|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110641040|NCT05304533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110641041|NCT05304533|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110641042|NCT05304533|Vasodilator Agents|vasodilator agents|mesh-ancestor
110641044|NCT00534495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110641045|NCT04077827|Propofol|propofol|mesh-list
110641046|NCT04077827|Desflurane|desflurane|mesh-list
110641047|NCT04077827|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110641048|NCT04077827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110144323|NCT02035709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110641049|NCT04077827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110641050|NCT04077827|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110641051|NCT04077827|Anesthetics, General|anesthetics, general|mesh-ancestor
110641052|NCT04077827|Anesthetics|anesthetics|mesh-ancestor
110641053|NCT04077827|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110641054|NCT00996723|Dasatinib|dasatinib|mesh-list
110641055|NCT00996723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110641056|NCT00996723|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110641057|NCT00996723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110641058|NCT00996723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110641059|NCT05332587|Rituximab|rituximab|mesh-list
110641060|NCT05332587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110641061|NCT05332587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110641062|NCT05332587|Immunologic Factors|immunologic factors|mesh-ancestor
110641063|NCT05332587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110641064|NCT05332587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110641065|NCT00996879|Midazolam|midazolam|mesh-list
110641066|NCT00996879|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110641067|NCT00996879|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110641068|NCT00996879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110641069|NCT00996879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110641070|NCT00996879|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110641071|NCT00996879|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110641072|NCT00996879|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110641073|NCT00996879|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110641074|NCT00996879|Anesthetics, General|anesthetics, general|mesh-ancestor
110641075|NCT00996879|Anesthetics|anesthetics|mesh-ancestor
110641076|NCT00996879|GABA Modulators|gaba modulators|mesh-ancestor
110641077|NCT00996879|GABA Agents|gaba agents|mesh-ancestor
110641078|NCT00996879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110641079|NCT00996879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110641080|NCT02582177|Ketoconazole|ketoconazole|mesh-list
110641081|NCT02582177|Clotrimazole|clotrimazole|mesh-list
110641083|NCT02582177|Dexamethasone|dexamethasone|mesh-list
110641084|NCT02582177|Dexamethasone acetate|dexamethasone acetate|mesh-list
110641085|NCT02582177|Betamethasone|betamethasone|mesh-list
110641086|NCT02582177|Betamethasone Valerate|betamethasone valerate|mesh-list
110641087|NCT02582177|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
110641088|NCT02582177|Betamethasone benzoate|betamethasone benzoate|mesh-list
110641089|NCT02582177|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
110641090|NCT02582177|BB 1101|bb 1101|mesh-list
110641091|NCT02582177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110641092|NCT02582177|Antiemetics|antiemetics|mesh-ancestor
110641093|NCT02582177|Autonomic Agents|autonomic agents|mesh-ancestor
110641094|NCT02582177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110641095|NCT02582177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110641096|NCT02582177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110641097|NCT02582177|Glucocorticoids|glucocorticoids|mesh-ancestor
110641098|NCT02582177|Hormones|hormones|mesh-ancestor
110641099|NCT02582177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110641100|NCT02582177|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110641101|NCT02582177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110641102|NCT02582177|Protease Inhibitors|protease inhibitors|mesh-ancestor
110641103|NCT02582177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110641104|NCT02582177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110641105|NCT02582177|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110641106|NCT02582177|Respiratory System Agents|respiratory system agents|mesh-ancestor
110641107|NCT02582177|Antifungal Agents|antifungal agents|mesh-ancestor
110641108|NCT02582177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110641109|NCT02582177|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110641110|NCT02582177|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110641111|NCT02582177|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110641112|NCT02582177|Hormone Antagonists|hormone antagonists|mesh-ancestor
110641113|NCT02582177|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110641114|NCT02582177|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110641115|NCT02582177|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110641116|NCT02626715|Vidarabine|vidarabine|mesh-list
110641117|NCT02626715|Fludarabine phosphate|fludarabine phosphate|mesh-list
110641118|NCT02626715|Fludarabine|fludarabine|mesh-list
110641119|NCT02626715|Alemtuzumab|alemtuzumab|mesh-list
110641120|NCT02626715|Thiotepa|thiotepa|mesh-list
110641121|NCT02626715|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110641122|NCT02626715|Antimetabolites|antimetabolites|mesh-ancestor
110641123|NCT02626715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110641124|NCT02626715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110144600|NCT02041143|Caseins|caseins|mesh-list
110641125|NCT02626715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110641126|NCT02626715|Immunologic Factors|immunologic factors|mesh-ancestor
110641127|NCT02626715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110641128|NCT02626715|Antiviral Agents|antiviral agents|mesh-ancestor
110641129|NCT02626715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110641130|NCT02626715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110641131|NCT02626715|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110641132|NCT02626715|Alkylating Agents|alkylating agents|mesh-ancestor
110641133|NCT02626715|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110641134|NCT05325177|Ibuprofen|ibuprofen|mesh-list
110641135|NCT05325177|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110641136|NCT05325177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110641137|NCT05325177|Analgesics|analgesics|mesh-ancestor
110641138|NCT05325177|Sensory System Agents|sensory system agents|mesh-ancestor
110641139|NCT05325177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110641140|NCT05325177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110641141|NCT05325177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110641142|NCT05325177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110641143|NCT05325177|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110641144|NCT05325177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110641145|NCT05325177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110641146|NCT04099667|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
110396176|NCT02881177|Oxytocin|oxytocin|mesh-list
110641147|NCT04099667|Botulinum Toxins|botulinum toxins|mesh-list
110641148|NCT04099667|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110641149|NCT04099667|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110641150|NCT04099667|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110641151|NCT04099667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110641152|NCT04099667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110641154|NCT04099667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110641155|NCT04099667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110144741|NCT02042664|Metformin|metformin|mesh-list
110641156|NCT04099667|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110641157|NCT04099667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110641158|NCT04099667|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110641159|NCT00997191|Triamcinolone|triamcinolone|mesh-list
110641160|NCT00997191|Bevacizumab|bevacizumab|mesh-list
110641161|NCT00997191|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110641162|NCT00997191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110641163|NCT00997191|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110641164|NCT00997191|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110144803|NCT02043171|Vitamin D|vitamin d|mesh-list
110641165|NCT00997191|Growth Substances|growth substances|mesh-ancestor
110641166|NCT00997191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110641167|NCT00997191|Growth Inhibitors|growth inhibitors|mesh-ancestor
110641168|NCT00997191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110641169|NCT00997191|Glucocorticoids|glucocorticoids|mesh-ancestor
110641170|NCT00997191|Hormones|hormones|mesh-ancestor
110641171|NCT00997191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110641173|NCT00997269|Coenzyme Q10|coenzyme q10|mesh-list
110641174|NCT00997269|Micronutrients|micronutrients|mesh-ancestor
110641175|NCT00997269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110641176|NCT00997269|Vitamins|vitamins|mesh-ancestor
110641177|NCT02582099|Gentamicins|gentamicins|mesh-list
110641178|NCT02582099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110641179|NCT02582099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110641180|NCT02582099|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110641181|NCT02582099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110641182|NCT02582099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110641183|NCT00997347|Misoprostol|misoprostol|mesh-list
110641184|NCT00997347|Mifepristone|mifepristone|mesh-list
110641185|NCT00997347|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110641186|NCT00997347|Abortifacient Agents|abortifacient agents|mesh-ancestor
110641187|NCT00997347|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110144959|NCT02044354|Docetaxel|docetaxel|mesh-list
110641188|NCT00997347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110641189|NCT00997347|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110641190|NCT00997347|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110641191|NCT00997347|Oxytocics|oxytocics|mesh-ancestor
110641192|NCT00997347|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
110144999|NCT02044952|Analgesics|analgesics|mesh-ancestor
110641193|NCT00997347|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110641194|NCT00997347|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110641195|NCT00997347|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110641196|NCT00997347|Contraceptive Agents|contraceptive agents|mesh-ancestor
110641197|NCT00997347|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
110641198|NCT00997347|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
110641199|NCT00997347|Hormone Antagonists|hormone antagonists|mesh-ancestor
110641200|NCT00997347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110641201|NCT00997347|Luteolytic Agents|luteolytic agents|mesh-ancestor
110641202|NCT00997347|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110641204|NCT00997581|Apremilast|apremilast|mesh-list
110641205|NCT00997581|Indomethacin|indomethacin|mesh-list
110641206|NCT00997581|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110641207|NCT00997581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110641208|NCT00997581|Analgesics|analgesics|mesh-ancestor
110641209|NCT00997581|Sensory System Agents|sensory system agents|mesh-ancestor
110158790|NCT00087412|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110641210|NCT00997581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110641211|NCT00997581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110641212|NCT00997581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110641214|NCT00997581|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
110641215|NCT00997581|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110641216|NCT00997581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110641217|NCT00997581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110641218|NCT00997581|Gout Suppressants|gout suppressants|mesh-ancestor
110641219|NCT00997581|Tocolytic Agents|tocolytic agents|mesh-ancestor
110641220|NCT00997581|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110641221|NCT00997581|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110145147|NCT02045914|Ionophores|ionophores|mesh-list
110641222|NCT05183139|Dexamethasone|dexamethasone|mesh-list
110641223|NCT05183139|Lenalidomide|lenalidomide|mesh-list
110641224|NCT05183139|Pomalidomide|pomalidomide|mesh-list
110641225|NCT05183139|Ixazomib|ixazomib|mesh-list
110641226|NCT05183139|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110641227|NCT05183139|Antiemetics|antiemetics|mesh-ancestor
110641228|NCT05183139|Autonomic Agents|autonomic agents|mesh-ancestor
110641229|NCT05183139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110641230|NCT05183139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110641231|NCT05183139|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110641232|NCT05183139|Glucocorticoids|glucocorticoids|mesh-ancestor
110641233|NCT05183139|Hormones|hormones|mesh-ancestor
110641234|NCT05183139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110641235|NCT05183139|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110641236|NCT05183139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110641237|NCT05183139|Immunologic Factors|immunologic factors|mesh-ancestor
110641238|NCT05183139|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110641239|NCT05183139|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110641240|NCT05183139|Growth Substances|growth substances|mesh-ancestor
110641241|NCT05183139|Growth Inhibitors|growth inhibitors|mesh-ancestor
110641242|NCT05183139|Protease Inhibitors|protease inhibitors|mesh-ancestor
110641243|NCT05183139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110641244|NCT05183139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110641245|NCT00999843|Sorafenib|sorafenib|mesh-list
110641246|NCT00999843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110641247|NCT00999843|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110641248|NCT00999843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110641249|NCT00999843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110641250|NCT00997659|Chromium|chromium|mesh-list
110641251|NCT00997659|Picolinic acid|picolinic acid|mesh-list
110641252|NCT00997659|Trace Elements|trace elements|mesh-ancestor
110641253|NCT00997659|Micronutrients|micronutrients|mesh-ancestor
110641254|NCT00997659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110641255|NCT00997659|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110641256|NCT00997659|Chelating Agents|chelating agents|mesh-ancestor
110641257|NCT00997659|Sequestering Agents|sequestering agents|mesh-ancestor
110145532|NCT00005850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110641258|NCT00997659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110641259|NCT03827213|Bupivacaine|bupivacaine|mesh-list
110641260|NCT03827213|Anesthetics, Local|anesthetics, local|mesh-ancestor
110641261|NCT03827213|Anesthetics|anesthetics|mesh-ancestor
110641262|NCT03827213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110641263|NCT03827213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110641264|NCT03827213|Sensory System Agents|sensory system agents|mesh-ancestor
110641265|NCT03827213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110641266|NCT00997815|Botulinum Toxins|botulinum toxins|mesh-list
110641267|NCT00997815|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110641268|NCT00997815|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110145673|NCT00005898|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110641269|NCT00997815|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110641270|NCT00997815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110641271|NCT00997815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110641272|NCT00997815|Cholinergic Agents|cholinergic agents|mesh-ancestor
110641273|NCT00997815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110641274|NCT00997815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110641275|NCT00997815|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110641276|NCT00997815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110641278|NCT04077983|Gemcitabine|gemcitabine|mesh-list
110641279|NCT04077983|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110641280|NCT04077983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110641281|NCT04077983|Tubulin Modulators|tubulin modulators|mesh-ancestor
110641282|NCT04077983|Antimitotic Agents|antimitotic agents|mesh-ancestor
110641283|NCT04077983|Mitosis Modulators|mitosis modulators|mesh-ancestor
110641284|NCT04077983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110641285|NCT04077983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110641286|NCT04077983|Antimetabolites|antimetabolites|mesh-ancestor
110641287|NCT03822845|Edetic Acid|edetic acid|mesh-list
110641288|NCT03822845|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
110641289|NCT03822845|Chelating Agents|chelating agents|mesh-ancestor
110641290|NCT03822845|Sequestering Agents|sequestering agents|mesh-ancestor
110641291|NCT03822845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110641292|NCT03822845|Anticoagulants|anticoagulants|mesh-ancestor
110641293|NCT03822845|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110641294|NCT03822845|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110641295|NCT01000233|Inositol|inositol|mesh-list
110641296|NCT01000233|Vitamin B Complex|vitamin b complex|mesh-ancestor
110641297|NCT01000233|Vitamins|vitamins|mesh-ancestor
110641299|NCT01000233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110641300|NCT04075955|Olanzapine|olanzapine|mesh-list
110641301|NCT04075955|Aprepitant|aprepitant|mesh-list
110641302|NCT04075955|Antiemetics|antiemetics|mesh-ancestor
110641303|NCT04075955|Autonomic Agents|autonomic agents|mesh-ancestor
110641304|NCT04075955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110146018|NCT00005994|Antipruritics|antipruritics|mesh-ancestor
110641305|NCT04075955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110641306|NCT04075955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110641307|NCT04075955|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110641308|NCT04075955|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110641309|NCT04075955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110641310|NCT04075955|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110641311|NCT04075955|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110641312|NCT04075955|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110641314|NCT04075955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110641315|NCT04075955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110641316|NCT04075955|Serotonin Agents|serotonin agents|mesh-ancestor
110641317|NCT04075955|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110641318|NCT00484198|Pioglitazone|pioglitazone|mesh-list
110641319|NCT00484198|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110641320|NCT00484198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110641321|NCT04077905|Methylprednisolone|methylprednisolone|mesh-list
110641322|NCT04077905|Doxorubicin|doxorubicin|mesh-list
110641323|NCT04077905|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110641324|NCT04077905|Etoposide|etoposide|mesh-list
110641325|NCT04077905|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110641326|NCT04077905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110641327|NCT04077905|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110288578|NCT04646824|Pemetrexed|pemetrexed|mesh-list
110641328|NCT04077905|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110641329|NCT04077905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110641330|NCT04077905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110641331|NCT04077905|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110641332|NCT04077905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110641333|NCT04077905|Antiemetics|antiemetics|mesh-ancestor
110641334|NCT04077905|Autonomic Agents|autonomic agents|mesh-ancestor
110641335|NCT04077905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110641336|NCT04077905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110641337|NCT04077905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110641338|NCT04077905|Glucocorticoids|glucocorticoids|mesh-ancestor
110641339|NCT04077905|Hormones|hormones|mesh-ancestor
110641340|NCT04077905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110146219|NCT05680389|Minocycline|minocycline|mesh-list
110255322|NCT00336466|Hematinics|hematinics|mesh-ancestor
110641341|NCT04077905|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110641342|NCT04077905|Protective Agents|protective agents|mesh-ancestor
110641343|NCT04471246|Cephalexin|cephalexin|mesh-list
110641344|NCT04471246|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110641345|NCT04471246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110641346|NCT04276259|Naltrexone|naltrexone|mesh-list
110641347|NCT04276259|Buprenorphine|buprenorphine|mesh-list
110641348|NCT04276259|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110641349|NCT04276259|Narcotics|narcotics|mesh-ancestor
110641350|NCT04276259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110641351|NCT04276259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110641352|NCT04276259|Analgesics|analgesics|mesh-ancestor
110641353|NCT04276259|Sensory System Agents|sensory system agents|mesh-ancestor
110641354|NCT04276259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110641355|NCT04276259|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110641356|NCT04276259|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110641357|NCT00499486|Sirolimus|sirolimus|mesh-list
110641358|NCT00499486|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110641359|NCT00499486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110641360|NCT00499486|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110641361|NCT00499486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110641362|NCT00499486|Antifungal Agents|antifungal agents|mesh-ancestor
110641363|NCT00499486|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110641364|NCT00499486|Immunologic Factors|immunologic factors|mesh-ancestor
110641365|NCT00499486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110641367|NCT01019278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110641368|NCT01014520|Gabapentin|gabapentin|mesh-list
110641369|NCT01014520|Amitriptyline|amitriptyline|mesh-list
110641370|NCT01014520|Analgesics|analgesics|mesh-ancestor
110641371|NCT01014520|Sensory System Agents|sensory system agents|mesh-ancestor
110641372|NCT01014520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110641373|NCT01014520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110641374|NCT01014520|Anticonvulsants|anticonvulsants|mesh-ancestor
110641375|NCT01014520|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110641376|NCT01014520|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110146629|NCT00006054|Cyclosporine|cyclosporine|mesh-list
110641377|NCT01014520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110641378|NCT01014520|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110641379|NCT01014520|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110641380|NCT01014520|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110641381|NCT01014520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110641382|NCT01014520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110641383|NCT01014520|Antimanic Agents|antimanic agents|mesh-ancestor
110641384|NCT01014520|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110641385|NCT01014520|Antidepressive Agents|antidepressive agents|mesh-ancestor
110641386|NCT01014520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110641387|NCT01014520|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110641388|NCT01014520|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110146762|NCT00006114|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110641389|NCT01014520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110641390|NCT01014520|Adrenergic Agents|adrenergic agents|mesh-ancestor
110641391|NCT01016002|Temoporfin|temoporfin|mesh-list
110641392|NCT01016002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110641393|NCT01016002|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110641394|NCT01016002|Dermatologic Agents|dermatologic agents|mesh-ancestor
110641395|NCT01019434|Sirolimus|sirolimus|mesh-list
110641396|NCT01019434|Temozolomide|temozolomide|mesh-list
110146833|NCT00006144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110641397|NCT01019434|Temsirolimus|temsirolimus|mesh-list
110641398|NCT01019434|MTOR Inhibitors|mtor inhibitors|mesh-list
110641399|NCT01019434|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110641400|NCT01019434|Alkylating Agents|alkylating agents|mesh-ancestor
110641401|NCT01019434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110641402|NCT01019434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110288649|NCT00558337|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110641403|NCT01019434|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110641404|NCT01019434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110641405|NCT01019434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110641406|NCT01019434|Immunologic Factors|immunologic factors|mesh-ancestor
110641407|NCT01019434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110641408|NCT01019434|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110641409|NCT01019434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110641410|NCT01019434|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110146964|NCT03751800|Dienogest|dienogest|mesh-list
110641411|NCT01019434|Antifungal Agents|antifungal agents|mesh-ancestor
110641412|NCT01016158|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110641413|NCT01016158|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110641414|NCT00499252|Paclitaxel|paclitaxel|mesh-list
110641415|NCT00499252|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110641416|NCT00499252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110641417|NCT00499252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110641418|NCT00499252|Tubulin Modulators|tubulin modulators|mesh-ancestor
110641419|NCT00499252|Antimitotic Agents|antimitotic agents|mesh-ancestor
110641420|NCT00499252|Mitosis Modulators|mitosis modulators|mesh-ancestor
110641421|NCT00499252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110641422|NCT01019590|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110641424|NCT01019590|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
110641425|NCT01019590|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110641426|NCT01019590|Diuretics|diuretics|mesh-ancestor
110641427|NCT01019590|Natriuretic Agents|natriuretic agents|mesh-ancestor
110641428|NCT01019590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110641429|NCT01019590|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110641430|NCT01019590|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110641431|NCT01019590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110641432|NCT01019590|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110641433|NCT01019590|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110641434|NCT03775421|Macitentan|macitentan|mesh-list
110641435|NCT03775421|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
110641436|NCT03775421|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
110641437|NCT03775421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110641438|NCT03775421|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
110641439|NCT00532155|Dexamethasone|dexamethasone|mesh-list
110641440|NCT00532155|Docetaxel|docetaxel|mesh-list
110641441|NCT00532155|Aflibercept|aflibercept|mesh-list
110641442|NCT00532155|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110641443|NCT00532155|Antiemetics|antiemetics|mesh-ancestor
110641444|NCT00532155|Autonomic Agents|autonomic agents|mesh-ancestor
110641445|NCT00532155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110147171|NCT00005818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110641446|NCT00532155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110641447|NCT00532155|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110641448|NCT00532155|Glucocorticoids|glucocorticoids|mesh-ancestor
110641449|NCT00532155|Hormones|hormones|mesh-ancestor
110641450|NCT00532155|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110641451|NCT00532155|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110147225|NCT00005833|Tipifarnib|tipifarnib|mesh-list
110641453|NCT00532155|Tubulin Modulators|tubulin modulators|mesh-ancestor
110641454|NCT00532155|Antimitotic Agents|antimitotic agents|mesh-ancestor
110641455|NCT00532155|Mitosis Modulators|mitosis modulators|mesh-ancestor
110641456|NCT00532155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110641457|NCT00532155|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110641458|NCT00532155|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110641459|NCT00532155|Growth Substances|growth substances|mesh-ancestor
110641460|NCT00532155|Growth Inhibitors|growth inhibitors|mesh-ancestor
110641461|NCT01019668|Verteporfin|verteporfin|mesh-list
110641462|NCT01019668|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110641463|NCT01019668|Dermatologic Agents|dermatologic agents|mesh-ancestor
110641464|NCT01019746|Propofol|propofol|mesh-list
110641465|NCT01019746|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110641466|NCT01019746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110641467|NCT01019746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110641468|NCT01019746|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110147289|NCT00005854|Antimetabolites|antimetabolites|mesh-ancestor
110641469|NCT01019746|Anesthetics, General|anesthetics, general|mesh-ancestor
110641470|NCT01019746|Anesthetics|anesthetics|mesh-ancestor
110641471|NCT00205777|Bazedoxifene|bazedoxifene|mesh-list
110641472|NCT00205777|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110641473|NCT00205777|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110641474|NCT00205777|Hormone Antagonists|hormone antagonists|mesh-ancestor
110641475|NCT00205777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110641476|NCT00205777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110641477|NCT00205777|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110641478|NCT03762395|CXA-10|cxa-10|mesh-list
110641479|NCT03762395|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110641480|NCT01004055|Anti-Infective Agents|anti-infective agents|mesh-list
110641481|NCT01004055|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110641482|NCT00483652|4-Aminopyridine|4-aminopyridine|mesh-list
110641483|NCT00483652|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
110641484|NCT00483652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110641485|NCT00483652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110641486|NCT00998283|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
110641487|NCT00998283|Immunologic Factors|immunologic factors|mesh-ancestor
110641488|NCT00998283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110641489|NCT01014832|Insulin|insulin|mesh-list
110641490|NCT01014832|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110641491|NCT01014832|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110641492|NCT01014832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110641493|NCT03996473|Pembrolizumab|pembrolizumab|mesh-list
110641494|NCT03996473|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
110641495|NCT03996473|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110641496|NCT03996473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110641497|NCT03996473|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110641498|NCT03996473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110147473|NCT00386581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110641499|NCT01000545|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
110641500|NCT01000545|Anticoagulants|anticoagulants|mesh-ancestor
110641501|NCT01000545|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110641502|NCT01000545|Antimetabolites|antimetabolites|mesh-ancestor
110641503|NCT01000545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110641504|NCT01000545|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110641505|NCT01000545|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110641506|NCT01000545|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110641507|NCT01000545|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110641508|NCT01000545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110641509|NCT03992729|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110641510|NCT03992729|Immunologic Factors|immunologic factors|mesh-ancestor
110641511|NCT03992729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110641512|NCT00483574|Vaccines|vaccines|mesh-list
110641513|NCT00483574|Immunologic Factors|immunologic factors|mesh-ancestor
110641514|NCT00483574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110641515|NCT01000623|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
110641516|NCT01000623|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110147614|NCT00005959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110641517|NCT01000623|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110641518|NCT01000623|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110641519|NCT01000623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110641520|NCT01000623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110641521|NCT01000623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110641522|NCT01000623|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110641523|NCT01000623|Antidepressive Agents|antidepressive agents|mesh-ancestor
110147765|NCT00005998|Hormones|hormones|mesh-ancestor
110641524|NCT01000623|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110641525|NCT00998439|Paclitaxel|paclitaxel|mesh-list
110641526|NCT00998439|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110641527|NCT00998439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110641528|NCT00998439|Tubulin Modulators|tubulin modulators|mesh-ancestor
110641529|NCT00998439|Antimitotic Agents|antimitotic agents|mesh-ancestor
110641530|NCT00998439|Mitosis Modulators|mitosis modulators|mesh-ancestor
110641531|NCT00998439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110641532|NCT01000779|Propranolol|propranolol|mesh-list
110641533|NCT01000779|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110641534|NCT01000779|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110641535|NCT01000779|Adrenergic Agents|adrenergic agents|mesh-ancestor
110641536|NCT01000779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110641537|NCT01000779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110641538|NCT01000779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110641539|NCT01000779|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110641540|NCT01000779|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110641541|NCT01000779|Vasodilator Agents|vasodilator agents|mesh-ancestor
110641542|NCT01000857|Paroxetine|paroxetine|mesh-list
110641543|NCT01000857|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110641544|NCT01000857|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110641545|NCT01000857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110641546|NCT01000857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110641547|NCT01000857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110641548|NCT01000857|Serotonin Agents|serotonin agents|mesh-ancestor
110641550|NCT01000857|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110641551|NCT01000857|Antidepressive Agents|antidepressive agents|mesh-ancestor
110641552|NCT01000857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110396269|NCT02878837|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110641553|NCT01000857|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110641554|NCT01000857|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110641557|NCT01004445|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110148030|NCT00006381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110641558|NCT01004445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110641559|NCT02580695|Hyaluronic Acid|hyaluronic acid|mesh-list
110641560|NCT02580695|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110641561|NCT02580695|Immunologic Factors|immunologic factors|mesh-ancestor
110641562|NCT02580695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110641563|NCT02580695|Viscosupplements|viscosupplements|mesh-ancestor
110641564|NCT02580695|Protective Agents|protective agents|mesh-ancestor
110641565|NCT02581553|Allopurinol|allopurinol|mesh-list
110641567|NCT02581553|Antimetabolites|antimetabolites|mesh-ancestor
110641568|NCT02581553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110641569|NCT02581553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110641570|NCT02581553|Gout Suppressants|gout suppressants|mesh-ancestor
110641571|NCT02581553|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110641572|NCT02581553|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110641573|NCT02581553|Antioxidants|antioxidants|mesh-ancestor
110641574|NCT02581553|Protective Agents|protective agents|mesh-ancestor
110641575|NCT02581553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110641576|NCT02581553|Uricosuric Agents|uricosuric agents|mesh-ancestor
110641577|NCT03944915|Paclitaxel|paclitaxel|mesh-list
110641578|NCT03944915|Carboplatin|carboplatin|mesh-list
110641579|NCT03944915|Fluorouracil|fluorouracil|mesh-list
110641580|NCT03944915|Nivolumab|nivolumab|mesh-list
110641581|NCT03944915|Hydroxyurea|hydroxyurea|mesh-list
110641582|NCT03944915|Lenograstim|lenograstim|mesh-list
110641583|NCT03944915|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110641584|NCT03944915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110641585|NCT03944915|Tubulin Modulators|tubulin modulators|mesh-ancestor
110641586|NCT03944915|Antimitotic Agents|antimitotic agents|mesh-ancestor
110641587|NCT03944915|Mitosis Modulators|mitosis modulators|mesh-ancestor
110641588|NCT03944915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110641589|NCT03944915|Antimetabolites|antimetabolites|mesh-ancestor
110641590|NCT03944915|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110641591|NCT03944915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110641592|NCT03944915|Immunologic Factors|immunologic factors|mesh-ancestor
110641593|NCT03944915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110641594|NCT03944915|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110641595|NCT03944915|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110641596|NCT03944915|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110641597|NCT03944915|Antisickling Agents|antisickling agents|mesh-ancestor
110641598|NCT03944915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110641599|NCT03944915|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110641600|NCT00482170|Etanercept|etanercept|mesh-list
110641601|NCT00482170|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110641602|NCT00482170|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110641603|NCT00482170|Analgesics|analgesics|mesh-ancestor
110641604|NCT00482170|Sensory System Agents|sensory system agents|mesh-ancestor
110641605|NCT00482170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110641606|NCT00482170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110641607|NCT00482170|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110641608|NCT00482170|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110641609|NCT00482170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110382859|NCT06048705|Fludarabine|fludarabine|mesh-list
110383229|NCT06045936|Lidocaine|lidocaine|mesh-list
110641610|NCT00482170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110641611|NCT00482170|Immunologic Factors|immunologic factors|mesh-ancestor
110641612|NCT05228249|Cytarabine|cytarabine|mesh-list
110641613|NCT05228249|Etoposide|etoposide|mesh-list
110641614|NCT05228249|Podophyllotoxin|podophyllotoxin|mesh-list
110641615|NCT05228249|Etoposide phosphate|etoposide phosphate|mesh-list
110641616|NCT05228249|Melphalan|melphalan|mesh-list
110641617|NCT05228249|Mechlorethamine|mechlorethamine|mesh-list
110641618|NCT05228249|Carmustine|carmustine|mesh-list
110641619|NCT05228249|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
110641620|NCT05228249|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
110641621|NCT05228249|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110641622|NCT05228249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110641623|NCT05228249|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110641624|NCT05228249|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110641625|NCT05228249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110641626|NCT05228249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110641627|NCT05228249|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110641628|NCT05228249|Antimetabolites|antimetabolites|mesh-ancestor
110641629|NCT05228249|Antiviral Agents|antiviral agents|mesh-ancestor
110641630|NCT05228249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110641631|NCT05228249|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110641632|NCT05228249|Immunologic Factors|immunologic factors|mesh-ancestor
110641633|NCT05228249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110641634|NCT05228249|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110641635|NCT05228249|Alkylating Agents|alkylating agents|mesh-ancestor
110641636|NCT05228249|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110641637|NCT05228249|Keratolytic Agents|keratolytic agents|mesh-ancestor
110641638|NCT05228249|Dermatologic Agents|dermatologic agents|mesh-ancestor
110641639|NCT05228249|Tubulin Modulators|tubulin modulators|mesh-ancestor
110641640|NCT05228249|Antimitotic Agents|antimitotic agents|mesh-ancestor
110641641|NCT05228249|Mitosis Modulators|mitosis modulators|mesh-ancestor
110641642|NCT05228249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110641643|NCT02580227|Tranexamic Acid|tranexamic acid|mesh-list
110641644|NCT02580227|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110641645|NCT02580227|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110641646|NCT02580227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110641647|NCT02580227|Hemostatics|hemostatics|mesh-ancestor
110641648|NCT02580227|Coagulants|coagulants|mesh-ancestor
110641649|NCT04218695|Ceftriaxone|ceftriaxone|mesh-list
110641650|NCT04218695|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110641651|NCT04218695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110641652|NCT01001013|Pioglitazone|pioglitazone|mesh-list
110641653|NCT01001013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110641654|NCT01001013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110641655|NCT01004601|Docetaxel|docetaxel|mesh-list
110641656|NCT01004601|Pemetrexed|pemetrexed|mesh-list
110641657|NCT01004601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110641658|NCT01004601|Tubulin Modulators|tubulin modulators|mesh-ancestor
110641659|NCT01004601|Antimitotic Agents|antimitotic agents|mesh-ancestor
110641660|NCT01004601|Mitosis Modulators|mitosis modulators|mesh-ancestor
110641661|NCT01004601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110641662|NCT01004601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110641663|NCT01004601|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110641664|NCT01004601|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110641665|NCT01001247|Rilpivirine|rilpivirine|mesh-list
110641666|NCT01001247|Omeprazole|omeprazole|mesh-list
110641667|NCT01001247|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110641668|NCT01001247|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110641669|NCT01001247|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110641670|NCT01001247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110641671|NCT01001247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110641672|NCT01001247|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110641673|NCT01001247|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110641674|NCT01001247|Antiviral Agents|antiviral agents|mesh-ancestor
110641675|NCT01001247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110641676|NCT01001247|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110641677|NCT01001247|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110641678|NCT04205357|Sulfasalazine|sulfasalazine|mesh-list
110641679|NCT04205357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110641680|NCT04205357|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110641681|NCT04205357|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110641682|NCT04205357|Analgesics|analgesics|mesh-ancestor
110641683|NCT04205357|Sensory System Agents|sensory system agents|mesh-ancestor
110308173|NCT00418548|Analgesics|analgesics|mesh-ancestor
110641684|NCT04205357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110641685|NCT04205357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110641686|NCT04205357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110641687|NCT04205357|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110641688|NCT04205357|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110641690|NCT02580773|Anticoagulants|anticoagulants|mesh-ancestor
110308273|NCT00271349|Hormones|hormones|mesh-ancestor
110641691|NCT02580773|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110641692|NCT02580773|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110641693|NCT02580773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110641694|NCT01008813|Vaccines|vaccines|mesh-list
110641695|NCT01008813|Immunologic Factors|immunologic factors|mesh-ancestor
110641696|NCT01008813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110641709|NCT01005147|Tranexamic Acid|tranexamic acid|mesh-list
110641710|NCT01005147|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110641711|NCT01005147|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110641712|NCT01005147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110641713|NCT01005147|Hemostatics|hemostatics|mesh-ancestor
110641714|NCT01005147|Coagulants|coagulants|mesh-ancestor
110641715|NCT01001871|Vitamins|vitamins|mesh-list
110641716|NCT01001871|Micronutrients|micronutrients|mesh-ancestor
110641717|NCT01001871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110641718|NCT01005303|Vitamin D|vitamin d|mesh-list
110641719|NCT01005303|Cholecalciferol|cholecalciferol|mesh-list
110641720|NCT01005303|Vitamins|vitamins|mesh-ancestor
110641721|NCT01005303|Micronutrients|micronutrients|mesh-ancestor
110641722|NCT01005303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110641723|NCT01005303|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110308445|NCT00307632|Estradiol|estradiol|mesh-list
110641724|NCT01005303|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110641726|NCT01005381|Vitamin D|vitamin d|mesh-list
110641727|NCT01005381|Calcium Carbonate|calcium carbonate|mesh-list
110641728|NCT01005381|Calcium|calcium|mesh-list
110641729|NCT01005381|Vitamins|vitamins|mesh-ancestor
110641730|NCT01005381|Micronutrients|micronutrients|mesh-ancestor
110641731|NCT01005381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110641732|NCT01005381|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110641733|NCT01005381|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110641734|NCT01005381|Antacids|antacids|mesh-ancestor
110308582|NCT00272831|Cilostazol|cilostazol|mesh-list
110641735|NCT01005381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110641736|NCT01005381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110641737|NCT01002183|Fosmidomycin|fosmidomycin|mesh-list
110641738|NCT01002183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110308650|NCT00308100|Plasma Substitutes|plasma substitutes|mesh-ancestor
110641739|NCT01002183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110641740|NCT05154279|Terlipressin|terlipressin|mesh-list
110641741|NCT05154279|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110641742|NCT05154279|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110641743|NCT01005537|Aldesleukin|aldesleukin|mesh-list
110641744|NCT01005537|Cyclophosphamide|cyclophosphamide|mesh-list
110641745|NCT01005537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110308727|NCT00273338|Vitamins|vitamins|mesh-ancestor
110641746|NCT01005537|Immunologic Factors|immunologic factors|mesh-ancestor
110641747|NCT01005537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110641748|NCT01005537|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110641749|NCT01005537|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110641750|NCT01005537|Alkylating Agents|alkylating agents|mesh-ancestor
110641751|NCT01005537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110641752|NCT01005537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110641753|NCT01005537|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110641754|NCT01005537|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110641755|NCT01005537|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110641756|NCT01005537|Antiviral Agents|antiviral agents|mesh-ancestor
110641757|NCT01005537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110641758|NCT01005927|Calcium|calcium|mesh-list
110308887|NCT00308451|Biotin|biotin|mesh-list
110641759|NCT01005927|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110641760|NCT01005927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110641761|NCT03742713|Docetaxel|docetaxel|mesh-list
110641762|NCT03742713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110641763|NCT03742713|Tubulin Modulators|tubulin modulators|mesh-ancestor
110641764|NCT03742713|Antimitotic Agents|antimitotic agents|mesh-ancestor
110641765|NCT03742713|Mitosis Modulators|mitosis modulators|mesh-ancestor
110641766|NCT03742713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110641768|NCT01002729|Antiviral Agents|antiviral agents|mesh-ancestor
110641769|NCT01002729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110641770|NCT01002729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110641771|NCT01002729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110641772|NCT01002807|Metformin|metformin|mesh-list
110641773|NCT01002807|Dapagliflozin|dapagliflozin|mesh-list
110289024|NCT04629118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110641774|NCT01002807|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110641775|NCT01002807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110641776|NCT01002807|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110641777|NCT01002807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110641778|NCT05733117|Vitamin D|vitamin d|mesh-list
110641779|NCT05733117|Vitamins|vitamins|mesh-ancestor
110641780|NCT05733117|Micronutrients|micronutrients|mesh-ancestor
110641781|NCT05733117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110641782|NCT05733117|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110641783|NCT01006395|Zoledronic Acid|zoledronic acid|mesh-list
110641784|NCT01006395|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110641785|NCT01006395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110641786|NCT00615056|Leucovorin|leucovorin|mesh-list
110641787|NCT00615056|Bevacizumab|bevacizumab|mesh-list
110641788|NCT00615056|Fluorouracil|fluorouracil|mesh-list
110641789|NCT00615056|Oxaliplatin|oxaliplatin|mesh-list
110641790|NCT00615056|Irinotecan|irinotecan|mesh-list
110641791|NCT00615056|Axitinib|axitinib|mesh-list
110641792|NCT00615056|Levoleucovorin|levoleucovorin|mesh-list
110641793|NCT00615056|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110641794|NCT00615056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110641795|NCT00615056|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110641796|NCT00615056|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110641797|NCT00615056|Growth Substances|growth substances|mesh-ancestor
110641798|NCT00615056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110641799|NCT00615056|Growth Inhibitors|growth inhibitors|mesh-ancestor
110641800|NCT00615056|Antimetabolites|antimetabolites|mesh-ancestor
110641801|NCT00615056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110641802|NCT00615056|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110641803|NCT00615056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110641804|NCT00615056|Immunologic Factors|immunologic factors|mesh-ancestor
110641805|NCT00615056|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110641806|NCT00615056|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110641807|NCT00615056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110641808|NCT00615056|Antidotes|antidotes|mesh-ancestor
110641809|NCT00615056|Protective Agents|protective agents|mesh-ancestor
110641810|NCT00615056|Vitamin B Complex|vitamin b complex|mesh-ancestor
110641811|NCT00615056|Vitamins|vitamins|mesh-ancestor
110641812|NCT00615056|Micronutrients|micronutrients|mesh-ancestor
110641813|NCT00615056|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110641814|NCT01006551|Ziprasidone|ziprasidone|mesh-list
110641815|NCT01006551|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110641816|NCT01006551|Serotonin Agents|serotonin agents|mesh-ancestor
110641817|NCT01006551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110641818|NCT01006551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110641819|NCT01006551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110641820|NCT01006551|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110641821|NCT01006551|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110641822|NCT01006551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110641823|NCT01006551|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110641824|NCT01006551|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110641825|NCT01006551|Dopamine Agents|dopamine agents|mesh-ancestor
110641826|NCT05732727|Antihypertensive Agents|antihypertensive agents|mesh-list
110641827|NCT00873626|Ciprofloxacin|ciprofloxacin|mesh-list
110641828|NCT00873626|Levofloxacin|levofloxacin|mesh-list
110641829|NCT00873626|Ofloxacin|ofloxacin|mesh-list
110641830|NCT00873626|Fluoroquinolones|fluoroquinolones|mesh-list
110641831|NCT00873626|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110641832|NCT00873626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110641833|NCT00873626|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110641834|NCT00873626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110641835|NCT00873626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110641836|NCT00873626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110641837|NCT00873626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110641838|NCT00873626|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110641839|NCT00873626|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110641840|NCT00873626|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110641841|NCT00873626|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110641842|NCT00879242|Deferasirox|deferasirox|mesh-list
110641843|NCT00879242|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110641844|NCT00879242|Chelating Agents|chelating agents|mesh-ancestor
110641845|NCT00879242|Sequestering Agents|sequestering agents|mesh-ancestor
110641846|NCT00879242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110641847|NCT05732493|Capecitabine|capecitabine|mesh-list
110641848|NCT05732493|Oxaliplatin|oxaliplatin|mesh-list
110641849|NCT05732493|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110641850|NCT05732493|Antimetabolites|antimetabolites|mesh-ancestor
110641851|NCT05732493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110641852|NCT05732493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110641853|NCT00868634|Bevacizumab|bevacizumab|mesh-list
110641855|NCT00868634|Vinorelbine|vinorelbine|mesh-list
110641856|NCT00868634|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110641857|NCT00868634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110641858|NCT00868634|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110641859|NCT00868634|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110641860|NCT00868634|Growth Substances|growth substances|mesh-ancestor
110641861|NCT00868634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110641862|NCT00868634|Growth Inhibitors|growth inhibitors|mesh-ancestor
110641863|NCT00868634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110641864|NCT00868634|Antimetabolites|antimetabolites|mesh-ancestor
110641865|NCT00868634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110641866|NCT00868634|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110641867|NCT00868634|Tubulin Modulators|tubulin modulators|mesh-ancestor
110641868|NCT00868634|Antimitotic Agents|antimitotic agents|mesh-ancestor
110641869|NCT00868634|Mitosis Modulators|mitosis modulators|mesh-ancestor
110641870|NCT05232357|Sodium thiosulfate|sodium thiosulfate|mesh-list
110641871|NCT05232357|Methylene Blue|methylene blue|mesh-list
110641872|NCT05232357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110641873|NCT05232357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110641875|NCT05232357|Protective Agents|protective agents|mesh-ancestor
110641876|NCT05232357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110641877|NCT05232357|Antioxidants|antioxidants|mesh-ancestor
110641878|NCT05232357|Antitubercular Agents|antitubercular agents|mesh-ancestor
110641879|NCT05232357|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110641880|NCT05232357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110641881|NCT05232357|Chelating Agents|chelating agents|mesh-ancestor
110641882|NCT05232357|Sequestering Agents|sequestering agents|mesh-ancestor
110641883|NCT00879476|Ramipril|ramipril|mesh-list
110641884|NCT00879476|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110641885|NCT00879476|Protease Inhibitors|protease inhibitors|mesh-ancestor
110641886|NCT00879476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110641887|NCT00879476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110309493|NCT00418860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110641888|NCT00879476|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110641889|NCT00868946|Ribavirin|ribavirin|mesh-list
110641890|NCT00868946|Antimetabolites|antimetabolites|mesh-ancestor
110641891|NCT00868946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110641892|NCT00868946|Antiviral Agents|antiviral agents|mesh-ancestor
110641893|NCT00868946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110641894|NCT00482014|Carboplatin|carboplatin|mesh-list
110641895|NCT00482014|Pemetrexed|pemetrexed|mesh-list
110641896|NCT00482014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110641897|NCT00482014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110641898|NCT00482014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110641899|NCT00482014|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110641900|NCT00482014|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110641901|NCT00879788|Ramipril|ramipril|mesh-list
110641902|NCT00879788|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110641903|NCT00879788|Protease Inhibitors|protease inhibitors|mesh-ancestor
110641904|NCT00879788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110641905|NCT00879788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110641906|NCT00879788|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110641907|NCT03595553|Vancomycin|vancomycin|mesh-list
110641908|NCT03595553|Ridinilazole|ridinilazole|mesh-list
110641909|NCT03595553|Benzimidazole|benzimidazole|mesh-list
110641910|NCT03595553|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110641911|NCT03595553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110641912|NCT03595553|Anthelmintics|anthelmintics|mesh-ancestor
110641913|NCT03595553|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110641915|NCT00874172|Sensory System Agents|sensory system agents|mesh-ancestor
110641916|NCT00874172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110641917|NCT00874172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110641918|NCT00614822|Bevacizumab|bevacizumab|mesh-list
110641919|NCT00614822|Carboplatin|carboplatin|mesh-list
110641920|NCT00614822|Pemetrexed|pemetrexed|mesh-list
110641921|NCT00614822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110641922|NCT00614822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110641923|NCT00614822|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110641924|NCT00614822|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110289170|NCT00219440|Metformin|metformin|mesh-list
110641925|NCT00614822|Growth Substances|growth substances|mesh-ancestor
110641926|NCT00614822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110641927|NCT00614822|Growth Inhibitors|growth inhibitors|mesh-ancestor
110641928|NCT00614822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110641929|NCT00614822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110641930|NCT00614822|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110641931|NCT00614822|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110641932|NCT04861298|Quercetin|quercetin|mesh-list
110641933|NCT04861298|Antioxidants|antioxidants|mesh-ancestor
110641934|NCT04861298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110641935|NCT04861298|Protective Agents|protective agents|mesh-ancestor
110641936|NCT04861298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110641937|NCT03582917|Alfacalcidol|alfacalcidol|mesh-list
110255413|NCT00473005|Everolimus|everolimus|mesh-list
110641938|NCT03582917|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
110641939|NCT03582917|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110641940|NCT03582917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110641941|NCT03582917|Vitamins|vitamins|mesh-ancestor
110641942|NCT03582917|Micronutrients|micronutrients|mesh-ancestor
110641943|NCT05226728|Pembrolizumab|pembrolizumab|mesh-list
110641944|NCT05226728|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110641945|NCT05226728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110641946|NCT05226728|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110641947|NCT05226728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110641948|NCT00869180|Diclofenac|diclofenac|mesh-list
110641949|NCT00869180|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110641950|NCT00869180|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110641951|NCT00869180|Analgesics|analgesics|mesh-ancestor
110641952|NCT00869180|Sensory System Agents|sensory system agents|mesh-ancestor
110641953|NCT00869180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110641954|NCT00869180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110641955|NCT00869180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110641956|NCT00869180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110641957|NCT00869180|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110641958|NCT00869180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110158875|NCT00088036|Serotonin Agents|serotonin agents|mesh-ancestor
110641959|NCT00869180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110641961|NCT00874328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110641962|NCT00874328|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110641963|NCT00874328|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110641964|NCT00874328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110641965|NCT00874328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110641966|NCT00874406|Leucovorin|leucovorin|mesh-list
110641967|NCT00874406|Fluorouracil|fluorouracil|mesh-list
110641968|NCT00874406|Oxaliplatin|oxaliplatin|mesh-list
110641969|NCT00874406|Antimetabolites|antimetabolites|mesh-ancestor
110641970|NCT00874406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110641971|NCT00874406|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110641972|NCT00874406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110641973|NCT00874406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110641974|NCT00874406|Immunologic Factors|immunologic factors|mesh-ancestor
110641975|NCT00874406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110641976|NCT00874406|Antidotes|antidotes|mesh-ancestor
110641977|NCT00874406|Protective Agents|protective agents|mesh-ancestor
110641978|NCT00874406|Vitamin B Complex|vitamin b complex|mesh-ancestor
110641979|NCT00874406|Vitamins|vitamins|mesh-ancestor
110641980|NCT00874406|Micronutrients|micronutrients|mesh-ancestor
110641981|NCT04840628|Respiratory System Agents|respiratory system agents|mesh-list
110641982|NCT00880178|Niacin|niacin|mesh-list
110641983|NCT00880178|Niacinamide|niacinamide|mesh-list
110641984|NCT00880178|Nicotinic Acids|nicotinic acids|mesh-list
110641985|NCT00880178|Simvastatin|simvastatin|mesh-list
110641986|NCT00880178|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110641987|NCT00880178|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110641988|NCT00880178|Antimetabolites|antimetabolites|mesh-ancestor
110641989|NCT00880178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110641990|NCT00880178|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110641991|NCT00880178|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110641992|NCT00880178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110641993|NCT00880178|Vasodilator Agents|vasodilator agents|mesh-ancestor
110641994|NCT00880178|Vitamin B Complex|vitamin b complex|mesh-ancestor
110641995|NCT00880178|Vitamins|vitamins|mesh-ancestor
110641996|NCT00880178|Micronutrients|micronutrients|mesh-ancestor
110641997|NCT00880178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110641998|NCT04077125|Rifaximin|rifaximin|mesh-list
110641999|NCT04077125|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110642000|NCT04077125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110642001|NCT04077125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110642002|NCT05172401|Triamcinolone|triamcinolone|mesh-list
110642003|NCT05172401|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110642004|NCT05172401|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110309988|NCT00417053|Melphalan|melphalan|mesh-list
110642005|NCT05172401|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110642006|NCT05172401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110642008|NCT05172401|Hormones|hormones|mesh-ancestor
110642009|NCT05172401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110642010|NCT05172401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110642011|NCT05172401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110642012|NCT05172401|Immunologic Factors|immunologic factors|mesh-ancestor
110642013|NCT05172401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110642014|NCT05172401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110642015|NCT00143455|Cisplatin|cisplatin|mesh-list
110642016|NCT00143455|Irinotecan|irinotecan|mesh-list
110642017|NCT00143455|Etoposide|etoposide|mesh-list
110642018|NCT00143455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110310110|NCT00317733|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110642019|NCT00143455|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110642020|NCT00143455|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110642021|NCT00143455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110642022|NCT00143455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110642023|NCT00143455|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110642024|NCT00143455|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110642025|NCT01006863|Phenylephrine|phenylephrine|mesh-list
110642026|NCT01006863|Oxymetazoline|oxymetazoline|mesh-list
110642027|NCT01006863|Ephedrine|ephedrine|mesh-list
110642028|NCT01006863|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110642029|NCT01006863|Mydriatics|mydriatics|mesh-ancestor
110642030|NCT01006863|Autonomic Agents|autonomic agents|mesh-ancestor
110642031|NCT01006863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110642032|NCT01006863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110642033|NCT01006863|Sympathomimetics|sympathomimetics|mesh-ancestor
110642034|NCT01006863|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110642035|NCT01006863|Nasal Decongestants|nasal decongestants|mesh-ancestor
110642036|NCT01006863|Respiratory System Agents|respiratory system agents|mesh-ancestor
110642037|NCT01006863|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110642038|NCT01006863|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110642039|NCT01006863|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110642040|NCT01006863|Adrenergic Agents|adrenergic agents|mesh-ancestor
110642041|NCT01006863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110642042|NCT01006863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110642044|NCT01006863|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110642045|NCT03535727|Paclitaxel|paclitaxel|mesh-list
110642046|NCT03535727|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110642047|NCT03535727|Cisplatin|cisplatin|mesh-list
110642048|NCT03535727|Gemcitabine|gemcitabine|mesh-list
110642049|NCT03535727|Capecitabine|capecitabine|mesh-list
110642050|NCT03535727|Irinotecan|irinotecan|mesh-list
110642051|NCT03535727|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110642052|NCT03535727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110310455|NCT00318825|Nitrous Oxide|nitrous oxide|mesh-list
110642053|NCT03535727|Tubulin Modulators|tubulin modulators|mesh-ancestor
110642054|NCT03535727|Antimitotic Agents|antimitotic agents|mesh-ancestor
110642055|NCT03535727|Mitosis Modulators|mitosis modulators|mesh-ancestor
110642056|NCT03535727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110642057|NCT03535727|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110642058|NCT03535727|Antimetabolites|antimetabolites|mesh-ancestor
110642059|NCT03535727|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110642060|NCT03535727|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110642061|NCT03535727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110642062|NCT03529955|Apremilast|apremilast|mesh-list
110642063|NCT03529955|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110642064|NCT03529955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110642065|NCT03529955|Analgesics|analgesics|mesh-ancestor
110642066|NCT03529955|Sensory System Agents|sensory system agents|mesh-ancestor
110642067|NCT03529955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110642068|NCT03529955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110642069|NCT03529955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110642070|NCT03529955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110642071|NCT03529955|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
110310530|NCT00312546|Enfuvirtide|enfuvirtide|mesh-list
110396434|NCT00593996|Ergocalciferols|ergocalciferols|mesh-list
110642072|NCT03529955|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110642073|NCT03529955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110642074|NCT03529955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110642076|NCT00142909|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110642078|NCT00142909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110289321|NCT00219869|Autonomic Agents|autonomic agents|mesh-ancestor
110642079|NCT00142909|Sensory System Agents|sensory system agents|mesh-ancestor
110642080|NCT00142909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110642081|NCT00142909|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110642082|NCT00142909|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110642083|NCT00142909|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110642084|NCT00142909|Adrenergic Agents|adrenergic agents|mesh-ancestor
110642085|NCT00142909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110642086|NCT00142909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110642087|NCT01007019|Esomeprazole|esomeprazole|mesh-list
110642088|NCT01007019|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110642089|NCT01007019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110642090|NCT01007019|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110642091|NCT01007019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110642092|NCT01007019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110642094|NCT03508739|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
110642095|NCT03508739|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110642096|NCT03508739|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110642097|NCT03508739|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110310718|NCT00319683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110642098|NCT03508739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110642099|NCT00205699|Olanzapine|olanzapine|mesh-list
110642100|NCT00205699|Risperidone|risperidone|mesh-list
110642101|NCT00205699|Aripiprazole|aripiprazole|mesh-list
110642102|NCT00205699|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110642103|NCT00205699|Serotonin Agents|serotonin agents|mesh-ancestor
110642104|NCT00205699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110642105|NCT00205699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110642106|NCT00205699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110642107|NCT00205699|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110642108|NCT00205699|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110642109|NCT00205699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110642110|NCT00205699|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110642111|NCT00205699|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110642112|NCT00205699|Dopamine Agents|dopamine agents|mesh-ancestor
110642113|NCT00205699|Antiemetics|antiemetics|mesh-ancestor
110642114|NCT00205699|Autonomic Agents|autonomic agents|mesh-ancestor
110642115|NCT00205699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110642116|NCT00205699|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110310914|NCT00417404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110642117|NCT00205699|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110642118|NCT00205699|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110642119|NCT00205699|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110642120|NCT00205699|Antidepressive Agents|antidepressive agents|mesh-ancestor
110310989|NCT00287261|Zoledronic Acid|zoledronic acid|mesh-list
110642121|NCT00205699|Dopamine Agonists|dopamine agonists|mesh-ancestor
110642122|NCT00205699|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110642123|NCT00205699|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110642124|NCT00205699|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110642125|NCT00205699|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110642126|NCT03503513|Gentamicins|gentamicins|mesh-list
110642127|NCT03503513|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110642128|NCT03503513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110642129|NCT03503513|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110642130|NCT03503513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110642131|NCT03503513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110642132|NCT02580149|Clopidogrel|clopidogrel|mesh-list
110642133|NCT02580149|Ticagrelor|ticagrelor|mesh-list
110642134|NCT02580149|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110311110|NCT00322296|Bexarotene|bexarotene|mesh-list
110642135|NCT02580149|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110642136|NCT02580149|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110642137|NCT02580149|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110642138|NCT02580149|Purinergic Agents|purinergic agents|mesh-ancestor
110642139|NCT02580149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110642140|NCT02580149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110642141|NCT02580149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110158916|NCT00088270|Vitamins|vitamins|mesh-ancestor
110642142|NCT04996017|Atezolizumab|atezolizumab|mesh-list
110642143|NCT04996017|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110642144|NCT04996017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110642145|NCT04996017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110642146|NCT04996017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110642147|NCT04994223|Rivaroxaban|rivaroxaban|mesh-list
110642148|NCT04994223|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110642149|NCT04994223|Antithrombins|antithrombins|mesh-ancestor
110642150|NCT04994223|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110289395|NCT00220064|Leucovorin|leucovorin|mesh-list
110642151|NCT04994223|Protease Inhibitors|protease inhibitors|mesh-ancestor
110642152|NCT04994223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110642153|NCT04994223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110642154|NCT04994223|Anticoagulants|anticoagulants|mesh-ancestor
110642155|NCT01007565|Anesthetics|anesthetics|mesh-list
110642156|NCT01007565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110642157|NCT01007565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110642158|NCT05229003|Irinotecan|irinotecan|mesh-list
110642159|NCT05229003|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110642160|NCT05229003|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110642161|NCT05229003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110642162|NCT05229003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110642163|NCT05229003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110642164|NCT01016626|Mycophenolic Acid|mycophenolic acid|mesh-list
110642165|NCT01016626|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110642166|NCT01016626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110642167|NCT01016626|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110642168|NCT01016626|Antitubercular Agents|antitubercular agents|mesh-ancestor
110642169|NCT01016626|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110642170|NCT01016626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110642171|NCT01016626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110396500|NCT00598052|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110642172|NCT01016626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110642174|NCT02798471|Enoxaparin|enoxaparin|mesh-list
110642175|NCT02798471|Warfarin|warfarin|mesh-list
110642176|NCT02798471|Edoxaban|edoxaban|mesh-list
110642177|NCT02798471|Fondaparinux|fondaparinux|mesh-list
110642178|NCT02798471|Anticoagulants|anticoagulants|mesh-ancestor
110642179|NCT02798471|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110642180|NCT02798471|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110642181|NCT02798471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110642182|NCT02798471|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110642183|NCT02798471|Antithrombins|antithrombins|mesh-ancestor
110642184|NCT02798471|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110642185|NCT02798471|Protease Inhibitors|protease inhibitors|mesh-ancestor
110642186|NCT02798471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110642187|NCT03443765|Vitamin D|vitamin d|mesh-list
110642188|NCT03443765|Immunoglobulins|immunoglobulins|mesh-list
110642189|NCT03443765|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110642190|NCT03443765|Antibodies|antibodies|mesh-list
110642191|NCT03443765|Vitamins|vitamins|mesh-ancestor
110642192|NCT03443765|Micronutrients|micronutrients|mesh-ancestor
110642193|NCT03443765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110642194|NCT03443765|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110642195|NCT03443765|Immunologic Factors|immunologic factors|mesh-ancestor
110642197|NCT03441893|Mesalamine|mesalamine|mesh-list
110642198|NCT03441893|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110642199|NCT03441893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110642200|NCT03441893|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110642201|NCT03441893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110642202|NCT03441893|Analgesics|analgesics|mesh-ancestor
110311624|NCT00289835|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110642203|NCT03441893|Sensory System Agents|sensory system agents|mesh-ancestor
110642204|NCT03441893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110642205|NCT03441893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110642206|NCT03441893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110642207|NCT03441893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110642208|NCT03440177|Ramipril|ramipril|mesh-list
110642209|NCT03440177|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110642210|NCT03440177|Protease Inhibitors|protease inhibitors|mesh-ancestor
110642211|NCT03440177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110642212|NCT03440177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110642213|NCT03440177|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110642215|NCT00489736|Dronedarone|dronedarone|mesh-list
110642216|NCT00489736|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110642217|NCT00489736|Vasodilator Agents|vasodilator agents|mesh-ancestor
110396517|NCT00598676|Sirolimus|sirolimus|mesh-list
110642218|NCT00489736|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
110642219|NCT00489736|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110642220|NCT00489736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110642221|NCT00489736|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110642222|NCT00489736|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110642223|NCT00489736|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110642225|NCT00489736|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110642226|NCT00489736|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110642227|NCT00489736|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110642229|NCT00617084|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110642230|NCT00617084|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110642231|NCT00617084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110642232|NCT00617084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110642233|NCT00617084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110642234|NCT00617084|Immunologic Factors|immunologic factors|mesh-ancestor
110642235|NCT00617084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110642236|NCT00617084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110642237|NCT02758847|Paclitaxel|paclitaxel|mesh-list
110642238|NCT02758847|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110642239|NCT02758847|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110642240|NCT02758847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110642241|NCT02758847|Tubulin Modulators|tubulin modulators|mesh-ancestor
110642242|NCT02758847|Antimitotic Agents|antimitotic agents|mesh-ancestor
110311986|NCT00304200|Growth Substances|growth substances|mesh-ancestor
110642243|NCT02758847|Mitosis Modulators|mitosis modulators|mesh-ancestor
110642244|NCT02758847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110642246|NCT01016860|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110642247|NCT01016860|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110642248|NCT01016860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110642249|NCT01016860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110642250|NCT01016860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110642251|NCT00874484|Enoxaparin|enoxaparin|mesh-list
110642252|NCT00874484|Anticoagulants|anticoagulants|mesh-ancestor
110642253|NCT00874484|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110642254|NCT00874484|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110642255|NCT00874484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110642256|NCT00869492|Benzoyl Peroxide|benzoyl peroxide|mesh-list
110642257|NCT00869492|Dermatologic Agents|dermatologic agents|mesh-ancestor
110642259|NCT00489424|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110642260|NCT00489424|Analgesics|analgesics|mesh-ancestor
110642261|NCT00489424|Sensory System Agents|sensory system agents|mesh-ancestor
110642262|NCT00489424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110642263|NCT00489424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110642264|NCT00489424|Antipyretics|antipyretics|mesh-ancestor
110642265|NCT00869570|Capecitabine|capecitabine|mesh-list
110642266|NCT00869570|Sorafenib|sorafenib|mesh-list
110642267|NCT00869570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110642268|NCT00869570|Antimetabolites|antimetabolites|mesh-ancestor
110255451|NCT00337519|Alemtuzumab|alemtuzumab|mesh-list
110642269|NCT00869570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110642270|NCT00869570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110642271|NCT00869570|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110642274|NCT05127304|Tiotropium Bromide|tiotropium bromide|mesh-list
110642275|NCT05127304|Olodaterol|olodaterol|mesh-list
110642276|NCT05127304|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110642277|NCT05127304|Autonomic Agents|autonomic agents|mesh-ancestor
110642278|NCT05127304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110642279|NCT05127304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110642280|NCT05127304|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110642281|NCT05127304|Respiratory System Agents|respiratory system agents|mesh-ancestor
110642282|NCT05127304|Parasympatholytics|parasympatholytics|mesh-ancestor
110642283|NCT05127304|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110642284|NCT05127304|Cholinergic Agents|cholinergic agents|mesh-ancestor
110642285|NCT05127304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110642286|NCT05127304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110642287|NCT05127304|Anticonvulsants|anticonvulsants|mesh-ancestor
110642289|NCT00880412|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110642290|NCT00880412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110642291|NCT00880412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110642292|NCT00880412|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110642293|NCT00880412|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110642294|NCT00880412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110642295|NCT00880412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110642296|NCT00880412|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110642298|NCT01020136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110642299|NCT01020136|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110642300|NCT01020136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110642301|NCT01020136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110642302|NCT03412643|Paclitaxel|paclitaxel|mesh-list
110642304|NCT03412643|Doxorubicin|doxorubicin|mesh-list
110642305|NCT03412643|Trastuzumab|trastuzumab|mesh-list
110642306|NCT03412643|Pertuzumab|pertuzumab|mesh-list
110642307|NCT03412643|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110642308|NCT03412643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110642309|NCT03412643|Tubulin Modulators|tubulin modulators|mesh-ancestor
110642310|NCT03412643|Antimitotic Agents|antimitotic agents|mesh-ancestor
110642311|NCT03412643|Mitosis Modulators|mitosis modulators|mesh-ancestor
110642312|NCT03412643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110642313|NCT03412643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110642314|NCT03412643|Immunologic Factors|immunologic factors|mesh-ancestor
110642315|NCT03412643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110642316|NCT03412643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110642317|NCT03412643|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110642318|NCT03412643|Alkylating Agents|alkylating agents|mesh-ancestor
110642319|NCT03412643|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110642320|NCT03412643|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110642321|NCT03412643|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110642322|NCT03412643|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110642323|NCT03412643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110642324|NCT03412643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110642325|NCT01017094|Silver Sulfadiazine|silver sulfadiazine|mesh-list
110642326|NCT01017094|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110642327|NCT01017094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110642328|NCT01020214|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110642329|NCT01020214|Olmesartan|olmesartan|mesh-list
110642330|NCT01020214|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
110642331|NCT01020214|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110642332|NCT01020214|Diuretics|diuretics|mesh-ancestor
110642333|NCT01020214|Natriuretic Agents|natriuretic agents|mesh-ancestor
110642334|NCT01020214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110642335|NCT01020214|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110642336|NCT01020214|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110642337|NCT01020214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110642338|NCT01020214|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110642339|NCT01020214|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110642340|NCT03970824|Adalimumab|adalimumab|mesh-list
110642341|NCT03970824|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110642342|NCT03970824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110642343|NCT03970824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110642344|NCT00933894|Escitalopram|escitalopram|mesh-list
110642345|NCT00933894|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110642346|NCT00933894|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110642347|NCT00933894|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110642348|NCT00933894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110642349|NCT00933894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110642350|NCT00933894|Serotonin Agents|serotonin agents|mesh-ancestor
110642351|NCT00933894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110642353|NCT00564486|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110642354|NCT00564486|Analgesics|analgesics|mesh-ancestor
110642355|NCT00564486|Sensory System Agents|sensory system agents|mesh-ancestor
110642356|NCT00564486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110642357|NCT00564486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110642358|NCT00564486|Antipyretics|antipyretics|mesh-ancestor
110642359|NCT00481078|Paclitaxel|paclitaxel|mesh-list
110642360|NCT00481078|Carboplatin|carboplatin|mesh-list
110642361|NCT00481078|Vorinostat|vorinostat|mesh-list
110642362|NCT00481078|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110642363|NCT00481078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110642365|NCT00481078|Antimitotic Agents|antimitotic agents|mesh-ancestor
110642366|NCT00481078|Mitosis Modulators|mitosis modulators|mesh-ancestor
110642367|NCT00481078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110642368|NCT00481078|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110642369|NCT00481078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110642370|NCT00480532|Doxycycline|doxycycline|mesh-list
110642371|NCT00480532|Levonorgestrel|levonorgestrel|mesh-list
110642372|NCT00480532|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110642373|NCT00480532|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
110642374|NCT00480532|Estradiol|estradiol|mesh-list
110642375|NCT00480532|Estrogens|estrogens|mesh-ancestor
110642376|NCT00480532|Hormones|hormones|mesh-ancestor
110289620|NCT00220454|Hydrocortisone|hydrocortisone|mesh-list
110642377|NCT00480532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110642378|NCT00480532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110642379|NCT00480532|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110642380|NCT00480532|Contraceptive Agents|contraceptive agents|mesh-ancestor
110312888|NCT00296933|Dopamine Agents|dopamine agents|mesh-ancestor
110642381|NCT00480532|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110642382|NCT00480532|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110642383|NCT00480532|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110642385|NCT00480532|Antimalarials|antimalarials|mesh-ancestor
110642386|NCT00480532|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110642387|NCT00480532|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110642388|NCT00480532|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110642389|NCT00480532|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110642390|NCT00480532|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110313011|NCT04231773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110313016|NCT00297674|Clarithromycin|clarithromycin|mesh-list
110642391|NCT00480532|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110642393|NCT04013880|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
110642394|NCT04013880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110642395|NCT04013880|Antimetabolites|antimetabolites|mesh-ancestor
110642396|NCT04013880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110642397|NCT04013880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110642398|NCT04013880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110642399|NCT00934518|Cetuximab|cetuximab|mesh-list
110642400|NCT00934518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110642401|NCT00934518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110642402|NCT00496366|Capecitabine|capecitabine|mesh-list
110642403|NCT00496366|Lapatinib|lapatinib|mesh-list
110642404|NCT00496366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110642405|NCT00496366|Antimetabolites|antimetabolites|mesh-ancestor
110158937|NCT00088504|Antimetabolites|antimetabolites|mesh-ancestor
110642406|NCT00496366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110642407|NCT00496366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110642408|NCT00496366|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110642409|NCT00496366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110642410|NCT00934752|Paclitaxel|paclitaxel|mesh-list
110255461|NCT00337558|Urological Agents|urological agents|mesh-ancestor
110642411|NCT00934752|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110642412|NCT00934752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110642413|NCT00934752|Tubulin Modulators|tubulin modulators|mesh-ancestor
110642414|NCT00934752|Antimitotic Agents|antimitotic agents|mesh-ancestor
110642415|NCT00934752|Mitosis Modulators|mitosis modulators|mesh-ancestor
110313142|NCT00298883|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110642416|NCT00934752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110642417|NCT01020292|Nelfinavir|nelfinavir|mesh-list
110642418|NCT01020292|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110642419|NCT01020292|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110642420|NCT01020292|Protease Inhibitors|protease inhibitors|mesh-ancestor
110642421|NCT01020292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110642422|NCT01020292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110642423|NCT01020292|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110642424|NCT01020292|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110642425|NCT01020292|Antiviral Agents|antiviral agents|mesh-ancestor
110642426|NCT01020292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110642428|NCT00934830|Amoxicillin|amoxicillin|mesh-list
110642429|NCT00934830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110642430|NCT02575404|Pembrolizumab|pembrolizumab|mesh-list
110642431|NCT02575404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110642432|NCT02575404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110642433|NCT02575404|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110313342|NCT05373303|Epoetin Alfa|epoetin alfa|mesh-list
110642434|NCT02575404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110642435|NCT00564018|Insulin Detemir|insulin detemir|mesh-list
110642437|NCT00564018|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110642438|NCT00564018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110642439|NCT00564018|Heparin Antagonists|heparin antagonists|mesh-ancestor
110642440|NCT00564018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110642441|NCT00564018|Coagulants|coagulants|mesh-ancestor
110642442|NCT00935298|Tacrolimus|tacrolimus|mesh-list
110642443|NCT00935298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110396596|NCT00623168|Ribavirin|ribavirin|mesh-list
110642445|NCT00935298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110642446|NCT00935298|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110642447|NCT00935298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110642448|NCT00935298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110642449|NCT04014192|Dapagliflozin|dapagliflozin|mesh-list
110289689|NCT00220649|Antimetabolites|antimetabolites|mesh-ancestor
110642450|NCT04014192|Empagliflozin|empagliflozin|mesh-list
110642451|NCT04014192|Canagliflozin|canagliflozin|mesh-list
110642452|NCT04014192|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110642453|NCT04014192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110642454|NCT04014192|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110642455|NCT04014192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110642456|NCT00935610|Caseins|caseins|mesh-list
110313618|NCT00302705|Valsartan|valsartan|mesh-list
110642458|NCT00935610|Sequestering Agents|sequestering agents|mesh-ancestor
110642459|NCT00935610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110642460|NCT04013646|Epoetin Alfa|epoetin alfa|mesh-list
110642461|NCT04013646|Hematinics|hematinics|mesh-ancestor
110642462|NCT04074473|Propranolol|propranolol|mesh-list
110642463|NCT04074473|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110642464|NCT04074473|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110642465|NCT04074473|Adrenergic Agents|adrenergic agents|mesh-ancestor
110642466|NCT04074473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110642467|NCT04074473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110642468|NCT04074473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110642469|NCT04074473|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110642470|NCT04074473|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110642471|NCT04074473|Vasodilator Agents|vasodilator agents|mesh-ancestor
110642472|NCT03093480|Factor VIII|factor viii|mesh-list
110642473|NCT03093480|Coagulants|coagulants|mesh-ancestor
110642474|NCT02578511|Ixazomib|ixazomib|mesh-list
110642475|NCT02578511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110642476|NCT02578511|Protease Inhibitors|protease inhibitors|mesh-ancestor
110642477|NCT02578511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110313822|NCT00304226|Amlodipine|amlodipine|mesh-list
110642478|NCT02578511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110642479|NCT00563784|Paclitaxel|paclitaxel|mesh-list
110642480|NCT00563784|Carboplatin|carboplatin|mesh-list
110642481|NCT00563784|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110313883|NCT00304499|Urological Agents|urological agents|mesh-ancestor
110642482|NCT00563784|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110642484|NCT00563784|Tubulin Modulators|tubulin modulators|mesh-ancestor
110642485|NCT00563784|Antimitotic Agents|antimitotic agents|mesh-ancestor
110642486|NCT00563784|Mitosis Modulators|mitosis modulators|mesh-ancestor
110642487|NCT00563784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110642488|NCT00563784|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110642489|NCT00563784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110642491|NCT00203047|Glatiramer Acetate|glatiramer acetate|mesh-list
110642492|NCT00203047|(T,G)-A-L|(t,g)-a-l|mesh-list
110642493|NCT00203047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110642494|NCT00203047|Glucocorticoids|glucocorticoids|mesh-ancestor
110642495|NCT00203047|Hormones|hormones|mesh-ancestor
110642496|NCT00203047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110642497|NCT00203047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110642498|NCT00203047|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110642499|NCT00203047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110642500|NCT00203047|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110642501|NCT00203047|Immunologic Factors|immunologic factors|mesh-ancestor
110642502|NCT00203047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110642503|NCT00203047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110642504|NCT00870038|Paclitaxel|paclitaxel|mesh-list
110642505|NCT00870038|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110314232|NCT00329628|Anticoagulants|anticoagulants|mesh-ancestor
110642506|NCT00870038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110642507|NCT00870038|Tubulin Modulators|tubulin modulators|mesh-ancestor
110642509|NCT00870038|Mitosis Modulators|mitosis modulators|mesh-ancestor
110642510|NCT00870038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110642511|NCT04074551|Losartan|losartan|mesh-list
110642512|NCT04074551|Amlodipine|amlodipine|mesh-list
110642513|NCT04074551|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110642514|NCT04074551|Ezetimibe|ezetimibe|mesh-list
110642515|NCT04074551|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110642516|NCT04074551|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110642517|NCT04074551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110642518|NCT04074551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110642519|NCT04074551|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110642520|NCT04074551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110642521|NCT04074551|Vasodilator Agents|vasodilator agents|mesh-ancestor
110642522|NCT04074551|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110642523|NCT04074551|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110642524|NCT04074551|Antimetabolites|antimetabolites|mesh-ancestor
110642525|NCT04074551|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110642526|NCT04074551|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110642527|NCT04074551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110158984|NCT00088894|Bevacizumab|bevacizumab|mesh-list
110642528|NCT04074551|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110642529|NCT04074551|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110642530|NCT04074551|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110642531|NCT02608385|Pembrolizumab|pembrolizumab|mesh-list
110642532|NCT02608385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110642533|NCT02608385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110642534|NCT02608385|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110642535|NCT02608385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110642536|NCT00142519|Morphine|morphine|mesh-list
110642537|NCT00142519|Methadone|methadone|mesh-list
110642538|NCT00142519|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110642539|NCT00142519|Narcotics|narcotics|mesh-ancestor
110642540|NCT00142519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110642541|NCT00142519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110642542|NCT00142519|Analgesics|analgesics|mesh-ancestor
110642543|NCT00142519|Sensory System Agents|sensory system agents|mesh-ancestor
110642544|NCT00142519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110642545|NCT00142519|Antitussive Agents|antitussive agents|mesh-ancestor
110642546|NCT00142519|Respiratory System Agents|respiratory system agents|mesh-ancestor
110642547|NCT03713294|Dexamethasone|dexamethasone|mesh-list
110642548|NCT03713294|Dexamethasone acetate|dexamethasone acetate|mesh-list
110642549|NCT03713294|Pomalidomide|pomalidomide|mesh-list
110642552|NCT03713294|BB 1101|bb 1101|mesh-list
110642553|NCT03713294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110642554|NCT03713294|Antiemetics|antiemetics|mesh-ancestor
110642555|NCT03713294|Autonomic Agents|autonomic agents|mesh-ancestor
110642556|NCT03713294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110642557|NCT03713294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110642558|NCT03713294|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110642559|NCT03713294|Glucocorticoids|glucocorticoids|mesh-ancestor
110642560|NCT03713294|Hormones|hormones|mesh-ancestor
110642561|NCT03713294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110642562|NCT03713294|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110642563|NCT03713294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110642564|NCT03713294|Protease Inhibitors|protease inhibitors|mesh-ancestor
110642565|NCT03713294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110642566|NCT03713294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110642567|NCT03713294|Immunologic Factors|immunologic factors|mesh-ancestor
110642568|NCT03713294|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110642569|NCT03713294|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110642570|NCT03713294|Growth Substances|growth substances|mesh-ancestor
110642571|NCT03713294|Growth Inhibitors|growth inhibitors|mesh-ancestor
110642572|NCT03713294|Dermatologic Agents|dermatologic agents|mesh-ancestor
110642573|NCT00141817|Pantoprazole|pantoprazole|mesh-list
110396625|NCT00601562|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110642575|NCT00141817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110642576|NCT00141817|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110642577|NCT00141817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110642578|NCT00141817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110642579|NCT03967171|Oxytocin|oxytocin|mesh-list
110642580|NCT03967171|Oxytocics|oxytocics|mesh-ancestor
110314838|NCT00335088|Trace Elements|trace elements|mesh-ancestor
110642581|NCT03967171|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110642582|NCT03967171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110642583|NCT03967327|Morphine|morphine|mesh-list
110642584|NCT03967327|Buprenorphine|buprenorphine|mesh-list
110642585|NCT03967327|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110642586|NCT03967327|Narcotics|narcotics|mesh-ancestor
110642587|NCT03967327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110642588|NCT03967327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110642589|NCT03967327|Analgesics|analgesics|mesh-ancestor
110642590|NCT03967327|Sensory System Agents|sensory system agents|mesh-ancestor
110642591|NCT03967327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110642592|NCT03967327|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110642593|NCT01075945|Lumefantrine|lumefantrine|mesh-list
110314900|NCT00453167|Antimetabolites|antimetabolites|mesh-ancestor
110642595|NCT01075945|Piperaquine|piperaquine|mesh-list
110642596|NCT01075945|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
110642597|NCT01075945|Artenimol|artenimol|mesh-list
110642598|NCT01075945|Antimalarials|antimalarials|mesh-ancestor
110642599|NCT01075945|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110642600|NCT01075945|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110642601|NCT01075945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110642602|NCT00874562|Sirolimus|sirolimus|mesh-list
110642603|NCT00874562|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110642604|NCT00874562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110642605|NCT00874562|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110642606|NCT00874562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110642607|NCT00874562|Antifungal Agents|antifungal agents|mesh-ancestor
110642608|NCT00874562|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110642609|NCT00874562|Immunologic Factors|immunologic factors|mesh-ancestor
110642610|NCT00874562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110642612|NCT00201643|Betamethasone|betamethasone|mesh-list
110642613|NCT00201643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110642614|NCT00201643|Antiemetics|antiemetics|mesh-ancestor
110642615|NCT00201643|Autonomic Agents|autonomic agents|mesh-ancestor
110642616|NCT00201643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110642617|NCT00201643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110642618|NCT00201643|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110642619|NCT00201643|Glucocorticoids|glucocorticoids|mesh-ancestor
110642620|NCT00201643|Hormones|hormones|mesh-ancestor
110642621|NCT00201643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110642622|NCT00201643|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110642623|NCT00201643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110642624|NCT00201643|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110642625|NCT00201643|Respiratory System Agents|respiratory system agents|mesh-ancestor
110642626|NCT03798314|Nivolumab|nivolumab|mesh-list
110642627|NCT03798314|Pomalidomide|pomalidomide|mesh-list
110642628|NCT03798314|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110642629|NCT03798314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110642630|NCT03798314|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110642631|NCT03798314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110642632|NCT03798314|Immunologic Factors|immunologic factors|mesh-ancestor
110642633|NCT03798314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110642634|NCT03798314|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110642635|NCT03798314|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110642636|NCT03798314|Growth Substances|growth substances|mesh-ancestor
110642637|NCT03798314|Growth Inhibitors|growth inhibitors|mesh-ancestor
110642638|NCT01077427|Gemcitabine|gemcitabine|mesh-list
110315391|NCT00308165|Topotecan|topotecan|mesh-list
110642639|NCT01077427|Capecitabine|capecitabine|mesh-list
110642640|NCT01077427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110396633|NCT00601874|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110642641|NCT01077427|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110642642|NCT01077427|Antimetabolites|antimetabolites|mesh-ancestor
110642643|NCT01077427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110642644|NCT00883064|Lisinopril|lisinopril|mesh-list
110642645|NCT00883064|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110642646|NCT00883064|Protease Inhibitors|protease inhibitors|mesh-ancestor
110642647|NCT00883064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110642648|NCT00883064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110642649|NCT00883064|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110642650|NCT00883064|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110642652|NCT00883064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110642653|NCT01077505|Contraceptive Agents|contraceptive agents|mesh-list
110642654|NCT01077505|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
110642655|NCT01077505|Contraceptives, Oral|contraceptives, oral|mesh-list
110642657|NCT01077505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110642658|NCT01077505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110642659|NCT01077505|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110642660|NCT01077505|Incretins|incretins|mesh-ancestor
110642661|NCT01077505|Hormones|hormones|mesh-ancestor
110642662|NCT01077505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110642663|NCT01077505|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110642664|NCT01077505|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110642665|NCT01077505|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110642666|NCT01077505|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
110642667|NCT01077505|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110642669|NCT01073995|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110642670|NCT01073995|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110642671|NCT01073995|Bupivacaine|bupivacaine|mesh-list
110642672|NCT01073995|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110396643|NCT01097629|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110642673|NCT01073995|Anesthetics, Local|anesthetics, local|mesh-ancestor
110642675|NCT01073995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110642676|NCT01073995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110642677|NCT01073995|Sensory System Agents|sensory system agents|mesh-ancestor
110642678|NCT01073995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110642679|NCT01073995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110642680|NCT01073995|Glucocorticoids|glucocorticoids|mesh-ancestor
110642681|NCT01073995|Hormones|hormones|mesh-ancestor
110642682|NCT01073995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110642683|NCT01073995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110642684|NCT01073995|Immunologic Factors|immunologic factors|mesh-ancestor
110642685|NCT01073995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110642686|NCT01073995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110642687|NCT01074073|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
110642688|NCT01074073|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110642689|NCT01074073|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110642690|NCT01074073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110642691|NCT01074073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110642692|NCT01074073|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110642693|NCT01074073|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
110642694|NCT01074073|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110642695|NCT01074073|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110642696|NCT01074073|Adrenergic Agents|adrenergic agents|mesh-ancestor
110642697|NCT01074073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110642698|NCT01074073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110642699|NCT01074073|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110642700|NCT01074073|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110642701|NCT01074073|Serotonin Agents|serotonin agents|mesh-ancestor
110642702|NCT01074073|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110642703|NCT01074073|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110642704|NCT01074073|Dopamine Agents|dopamine agents|mesh-ancestor
110642705|NCT00874874|Sorafenib|sorafenib|mesh-list
110642706|NCT00874874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110642707|NCT00874874|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110642708|NCT00874874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110642709|NCT00874874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110642710|NCT04489628|Vitamin D|vitamin d|mesh-list
110642711|NCT04489628|Cholecalciferol|cholecalciferol|mesh-list
110642712|NCT04489628|Vitamins|vitamins|mesh-ancestor
110642713|NCT04489628|Micronutrients|micronutrients|mesh-ancestor
110642714|NCT04489628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110642715|NCT04489628|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110642716|NCT04489628|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110642717|NCT00130039|Cilostazol|cilostazol|mesh-list
110642718|NCT00130039|Clopidogrel|clopidogrel|mesh-list
110642719|NCT00130039|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110642720|NCT00130039|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110642721|NCT00130039|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110642722|NCT00130039|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110642723|NCT00130039|Purinergic Agents|purinergic agents|mesh-ancestor
110642724|NCT00130039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110642725|NCT00130039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110642726|NCT00130039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110642727|NCT00130039|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110642728|NCT00130039|Autonomic Agents|autonomic agents|mesh-ancestor
110642729|NCT00130039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110642730|NCT00130039|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110642731|NCT00130039|Respiratory System Agents|respiratory system agents|mesh-ancestor
110642732|NCT00130039|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110642733|NCT00130039|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110642734|NCT00130039|Vasodilator Agents|vasodilator agents|mesh-ancestor
110642735|NCT00130039|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110642736|NCT00130039|Protective Agents|protective agents|mesh-ancestor
110642737|NCT00130039|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110642738|NCT00130039|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110642739|NCT00130039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110642740|NCT00875030|Artesunate|artesunate|mesh-list
110642741|NCT00875030|Antimalarials|antimalarials|mesh-ancestor
110642742|NCT00875030|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110642743|NCT00875030|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110642744|NCT00875030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110642745|NCT00875030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110642746|NCT00875030|Antiviral Agents|antiviral agents|mesh-ancestor
110642747|NCT00875030|Schistosomicides|schistosomicides|mesh-ancestor
110642748|NCT00875030|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110642749|NCT00875030|Anthelmintics|anthelmintics|mesh-ancestor
110642750|NCT00883298|Bevacizumab|bevacizumab|mesh-list
110642751|NCT00883298|Temozolomide|temozolomide|mesh-list
110642752|NCT00883298|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110642753|NCT00883298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110642754|NCT00883298|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110642755|NCT00883298|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110642756|NCT00883298|Growth Substances|growth substances|mesh-ancestor
110642757|NCT00883298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110642758|NCT00883298|Growth Inhibitors|growth inhibitors|mesh-ancestor
110642759|NCT00883298|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110642760|NCT00883298|Alkylating Agents|alkylating agents|mesh-ancestor
110642761|NCT00883298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110642762|NCT00881114|Cetuximab|cetuximab|mesh-list
110642763|NCT00881114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110642764|NCT00881114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110642765|NCT00475852|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
110642766|NCT00475852|Natriuretic Agents|natriuretic agents|mesh-ancestor
110642767|NCT00475852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110642768|NCT00141271|Ziprasidone|ziprasidone|mesh-list
110642769|NCT00141271|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110642770|NCT00141271|Serotonin Agents|serotonin agents|mesh-ancestor
110642771|NCT00141271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110315959|NCT00311636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110642772|NCT00141271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110642773|NCT00141271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110642775|NCT00141271|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110642776|NCT00141271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110642777|NCT00141271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110642778|NCT00141271|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110642779|NCT00141271|Dopamine Agents|dopamine agents|mesh-ancestor
110642780|NCT01017640|Mitomycins|mitomycins|mesh-list
110642781|NCT01017640|Mitomycin|mitomycin|mesh-list
110642782|NCT01017640|Veliparib|veliparib|mesh-list
110642783|NCT01017640|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110642784|NCT01017640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110642785|NCT01017640|Alkylating Agents|alkylating agents|mesh-ancestor
110642786|NCT01017640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110642787|NCT01017640|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110642788|NCT01017640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110642789|NCT01017640|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110642790|NCT00614120|Metformin|metformin|mesh-list
110642791|NCT00614120|Liraglutide|liraglutide|mesh-list
110642792|NCT00614120|Glimepiride|glimepiride|mesh-list
110642793|NCT00614120|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110642794|NCT00614120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110642795|NCT00614120|Incretins|incretins|mesh-ancestor
110642796|NCT00614120|Hormones|hormones|mesh-ancestor
110642797|NCT00614120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110642798|NCT00614120|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110642799|NCT00614120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110642800|NCT00614120|Immunologic Factors|immunologic factors|mesh-ancestor
110642801|NCT00496054|Vaccines|vaccines|mesh-list
110642802|NCT00496054|Immunologic Factors|immunologic factors|mesh-ancestor
110642803|NCT00496054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110642804|NCT00495820|Methylphenidate|methylphenidate|mesh-list
110642805|NCT00495820|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110642806|NCT00495820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110642807|NCT00495820|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110642808|NCT00495820|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110642809|NCT00495820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110642810|NCT00495820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110642811|NCT00495820|Dopamine Agents|dopamine agents|mesh-ancestor
110642812|NCT00495820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110642814|NCT04387240|Artemisinins|artemisinins|mesh-list
110642815|NCT04387240|Artemisinin|artemisinin|mesh-list
110642816|NCT04387240|Antimalarials|antimalarials|mesh-ancestor
110642818|NCT04387240|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110642819|NCT04387240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110642820|NCT04387240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110642821|NCT04387240|Antiviral Agents|antiviral agents|mesh-ancestor
110642822|NCT04387240|Schistosomicides|schistosomicides|mesh-ancestor
110642823|NCT04387240|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110642824|NCT04387240|Anthelmintics|anthelmintics|mesh-ancestor
110642825|NCT00495586|Amoxicillin|amoxicillin|mesh-list
110642826|NCT00495586|Clavulanic Acids|clavulanic acids|mesh-list
110290066|NCT00251277|Rituximab|rituximab|mesh-list
110642827|NCT00495586|Clavulanic Acid|clavulanic acid|mesh-list
110642828|NCT00495586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110642829|NCT00495586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110642830|NCT00495586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110642831|NCT00495586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110642832|NCT00495586|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110642833|NCT00613730|Gemcitabine|gemcitabine|mesh-list
110642834|NCT00613730|Panitumumab|panitumumab|mesh-list
110642835|NCT00613730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110642836|NCT00613730|Antimetabolites|antimetabolites|mesh-ancestor
110642837|NCT00613730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110642838|NCT00613730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110642839|NCT00613730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110642840|NCT00613574|Bromides|bromides|mesh-list
110642841|NCT00613574|Tiotropium Bromide|tiotropium bromide|mesh-list
110642842|NCT00613574|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110642843|NCT00613574|Autonomic Agents|autonomic agents|mesh-ancestor
110642844|NCT00613574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110642845|NCT00613574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110642846|NCT00613574|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110642847|NCT00613574|Respiratory System Agents|respiratory system agents|mesh-ancestor
110642848|NCT00613574|Parasympatholytics|parasympatholytics|mesh-ancestor
110642849|NCT00613574|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110642850|NCT00613574|Cholinergic Agents|cholinergic agents|mesh-ancestor
110642851|NCT00613574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110642852|NCT00613574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110642853|NCT00613574|Anticonvulsants|anticonvulsants|mesh-ancestor
110642854|NCT00881426|Cefprozil|cefprozil|mesh-list
110642855|NCT00881426|Cephalosporins|cephalosporins|mesh-list
110642856|NCT00881426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110642857|NCT00881426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110642858|NCT00883532|Budesonide|budesonide|mesh-list
110642859|NCT00883532|Pulmonary Surfactants|pulmonary surfactants|mesh-list
110642860|NCT00883532|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110642861|NCT00883532|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110642862|NCT00883532|Autonomic Agents|autonomic agents|mesh-ancestor
110316019|NCT00312104|Insulin|insulin|mesh-list
110642863|NCT00883532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110642864|NCT00883532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110642865|NCT00883532|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110642866|NCT00883532|Respiratory System Agents|respiratory system agents|mesh-ancestor
110642867|NCT00883532|Glucocorticoids|glucocorticoids|mesh-ancestor
110642869|NCT00883532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110642870|NCT00881582|Interferons|interferons|mesh-list
110642871|NCT00881582|Interferon-alpha|interferon-alpha|mesh-list
110642872|NCT00881582|Interferon alpha-2|interferon alpha-2|mesh-list
110642873|NCT00881582|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110642874|NCT00881582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110642875|NCT00881582|Antiviral Agents|antiviral agents|mesh-ancestor
110642876|NCT00881582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110642877|NCT00881582|Immunologic Factors|immunologic factors|mesh-ancestor
110642878|NCT00881582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110642880|NCT00881738|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110642881|NCT00881738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110642882|NCT00881738|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110642883|NCT00881738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110642884|NCT00881738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110642885|NCT00881738|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110642886|NCT00881738|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110642887|NCT00613106|Ibuprofen|ibuprofen|mesh-list
110642888|NCT00613106|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110642889|NCT00613106|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110642890|NCT00613106|Analgesics|analgesics|mesh-ancestor
110642891|NCT00613106|Sensory System Agents|sensory system agents|mesh-ancestor
110642892|NCT00613106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110642893|NCT00613106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110642894|NCT00613106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110642895|NCT00613106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110642896|NCT00613106|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110642897|NCT00613106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110642898|NCT00613106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110642899|NCT00881816|Paclitaxel|paclitaxel|mesh-list
110642900|NCT00881816|Capecitabine|capecitabine|mesh-list
110642901|NCT00881816|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110642902|NCT00881816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110642903|NCT00881816|Tubulin Modulators|tubulin modulators|mesh-ancestor
110642904|NCT00881816|Antimitotic Agents|antimitotic agents|mesh-ancestor
110642905|NCT00881816|Mitosis Modulators|mitosis modulators|mesh-ancestor
110642906|NCT00881816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110642907|NCT00881816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110642908|NCT00881816|Antimetabolites|antimetabolites|mesh-ancestor
110642910|NCT03712904|Endothelial Growth Factors|endothelial growth factors|mesh-list
110642911|NCT03712904|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110642912|NCT03712904|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110642913|NCT03712904|Growth Substances|growth substances|mesh-ancestor
110642914|NCT03712904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110642915|NCT03712904|Growth Inhibitors|growth inhibitors|mesh-ancestor
110642916|NCT03712904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110642917|NCT00875966|Azithromycin|azithromycin|mesh-list
110642918|NCT00875966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110642919|NCT00875966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110642920|NCT00141037|Mycophenolic Acid|mycophenolic acid|mesh-list
110642921|NCT00141037|Trimethoprim|trimethoprim|mesh-list
110642922|NCT00141037|Sulfamethoxazole|sulfamethoxazole|mesh-list
110642923|NCT00141037|Valganciclovir|valganciclovir|mesh-list
110642924|NCT00141037|Ganciclovir|ganciclovir|mesh-list
110642925|NCT00141037|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
110642926|NCT00141037|Prednisone|prednisone|mesh-list
110642927|NCT00141037|Tacrolimus|tacrolimus|mesh-list
110642928|NCT00141037|Daclizumab|daclizumab|mesh-list
110642929|NCT00141037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110642930|NCT00141037|Glucocorticoids|glucocorticoids|mesh-ancestor
110642931|NCT00141037|Hormones|hormones|mesh-ancestor
110642932|NCT00141037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110642933|NCT00141037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110642934|NCT00141037|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110642935|NCT00141037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110396713|NCT01102231|Cetuximab|cetuximab|mesh-list
110642936|NCT00141037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110642937|NCT00141037|Immunologic Factors|immunologic factors|mesh-ancestor
110642938|NCT00141037|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110642939|NCT00141037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110642940|NCT00141037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110642941|NCT00141037|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110316080|NCT00312416|Brimonidine Tartrate|brimonidine tartrate|mesh-list
110642942|NCT00141037|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110642943|NCT00141037|Antitubercular Agents|antitubercular agents|mesh-ancestor
110642944|NCT00141037|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110642945|NCT00141037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110642946|NCT00141037|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110642947|NCT00141037|Antimalarials|antimalarials|mesh-ancestor
110642948|NCT00141037|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110642949|NCT00141037|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110642950|NCT00141037|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110642951|NCT00141037|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110642952|NCT00141037|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
110642953|NCT00141037|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110642954|NCT00141037|Antiviral Agents|antiviral agents|mesh-ancestor
110642955|NCT00141037|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110642956|NCT01582555|Acetylcysteine|acetylcysteine|mesh-list
110642957|NCT01582555|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110642958|NCT01582555|Antidotes|antidotes|mesh-ancestor
110642959|NCT01582555|Protective Agents|protective agents|mesh-ancestor
110642960|NCT01582555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110642961|NCT01582555|Antioxidants|antioxidants|mesh-ancestor
110642962|NCT01582555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110642963|NCT01582555|Antiviral Agents|antiviral agents|mesh-ancestor
110642964|NCT01582555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110642965|NCT01582555|Expectorants|expectorants|mesh-ancestor
110642966|NCT01582555|Respiratory System Agents|respiratory system agents|mesh-ancestor
110642967|NCT01582555|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110642968|NCT00923390|Aldesleukin|aldesleukin|mesh-list
110642969|NCT00923390|Cyclophosphamide|cyclophosphamide|mesh-list
110642970|NCT00923390|Fludarabine|fludarabine|mesh-list
110642971|NCT00923390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110642972|NCT00923390|Immunologic Factors|immunologic factors|mesh-ancestor
110316138|NCT00347685|Tramadol|tramadol|mesh-list
110642973|NCT00923390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110642974|NCT00923390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110642975|NCT00923390|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110642976|NCT00923390|Alkylating Agents|alkylating agents|mesh-ancestor
110642977|NCT00923390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110642978|NCT00923390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110642979|NCT00923390|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110642980|NCT00923390|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110642981|NCT00923390|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110642982|NCT00923390|Antiviral Agents|antiviral agents|mesh-ancestor
110642983|NCT00923390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110642984|NCT00885794|Ranibizumab|ranibizumab|mesh-list
110642985|NCT00885794|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110642986|NCT00885794|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110642987|NCT00885794|Growth Substances|growth substances|mesh-ancestor
110642988|NCT00885794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110642989|NCT00885794|Growth Inhibitors|growth inhibitors|mesh-ancestor
110642990|NCT00885794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110642991|NCT00888602|Psyllium|psyllium|mesh-list
110642992|NCT00888602|Calcium polycarbophil|calcium polycarbophil|mesh-list
110642993|NCT00888602|Cathartics|cathartics|mesh-ancestor
110642994|NCT00888602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110642995|NCT00888602|Antidiarrheals|antidiarrheals|mesh-ancestor
110642996|NCT00885872|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110642997|NCT00885872|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110642998|NCT00885872|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110642999|NCT00885872|Antimetabolites|antimetabolites|mesh-ancestor
110643000|NCT00885872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110643002|NCT00885872|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110643003|NCT00885872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110643004|NCT00888758|Sirolimus|sirolimus|mesh-list
110643005|NCT00888758|Umirolimus|umirolimus|mesh-list
110643006|NCT00888758|Everolimus|everolimus|mesh-list
110643007|NCT00888758|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110643008|NCT00888758|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110643009|NCT00888758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110159020|NCT00088933|Docetaxel|docetaxel|mesh-list
110643010|NCT00888758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110643011|NCT00888758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110643012|NCT00888758|Immunologic Factors|immunologic factors|mesh-ancestor
110643013|NCT00888758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110643014|NCT00888758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110643015|NCT00888758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110643016|NCT00888758|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110643017|NCT00888758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110643018|NCT00888758|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110643019|NCT00888758|Antifungal Agents|antifungal agents|mesh-ancestor
110643020|NCT00888836|Hypoglycemic Agents|hypoglycemic agents|mesh-list
110643021|NCT00888836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110643022|NCT04038320|Sofosbuvir|sofosbuvir|mesh-list
110643023|NCT04038320|Ledipasvir|ledipasvir|mesh-list
110643024|NCT04038320|Antiviral Agents|antiviral agents|mesh-ancestor
110643025|NCT04038320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110643026|NCT00563706|Risperidone|risperidone|mesh-list
110643027|NCT00563706|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110643028|NCT00563706|Serotonin Agents|serotonin agents|mesh-ancestor
110643029|NCT00563706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110643030|NCT00563706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110643031|NCT00563706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110643032|NCT00563706|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110643033|NCT00563706|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110643034|NCT00563706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110643035|NCT00563706|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110643036|NCT00563706|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110643037|NCT00563706|Dopamine Agents|dopamine agents|mesh-ancestor
110643038|NCT02543606|Esomeprazole|esomeprazole|mesh-list
110643039|NCT02543606|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110643040|NCT02543606|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110643041|NCT02543606|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110643042|NCT02543606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110643043|NCT02543606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110643044|NCT00939588|Valsartan|valsartan|mesh-list
110643045|NCT00939588|Telmisartan|telmisartan|mesh-list
110643046|NCT00939588|Ramipril|ramipril|mesh-list
110643047|NCT00939588|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110316204|NCT00313157|Antioxidants|antioxidants|mesh-ancestor
110643048|NCT00939588|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110643049|NCT00939588|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110643050|NCT00939588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110643051|NCT00939588|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110643052|NCT00939588|Protease Inhibitors|protease inhibitors|mesh-ancestor
110643053|NCT00939588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110643054|NCT00889148|Gabapentin|gabapentin|mesh-list
110643055|NCT00889148|Analgesics|analgesics|mesh-ancestor
110643056|NCT00889148|Sensory System Agents|sensory system agents|mesh-ancestor
110643057|NCT00889148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110643058|NCT00889148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110643059|NCT00889148|Anticonvulsants|anticonvulsants|mesh-ancestor
110643060|NCT00889148|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110643061|NCT00889148|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110643062|NCT00889148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110643063|NCT00889148|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110396735|NCT01324232|Quinidine|quinidine|mesh-list
110643065|NCT00889148|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110643066|NCT00889148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110643067|NCT00889148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110643068|NCT00889148|Antimanic Agents|antimanic agents|mesh-ancestor
110643069|NCT00936156|Carboplatin|carboplatin|mesh-list
110643070|NCT00936156|Etoposide|etoposide|mesh-list
110643071|NCT00936156|Thiotepa|thiotepa|mesh-list
110643072|NCT00936156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110643073|NCT00936156|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110643074|NCT00936156|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110643075|NCT00936156|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110643076|NCT00936156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110159032|NCT00088933|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110643077|NCT00936156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110643078|NCT00936156|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110643079|NCT00936156|Alkylating Agents|alkylating agents|mesh-ancestor
110643080|NCT00936156|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110643081|NCT00936156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110643082|NCT00936156|Immunologic Factors|immunologic factors|mesh-ancestor
110643083|NCT00936156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110643085|NCT00129961|Sirolimus|sirolimus|mesh-list
110643086|NCT00129961|Tacrolimus|tacrolimus|mesh-list
110643087|NCT00129961|Cyclosporins|cyclosporins|mesh-list
110643088|NCT00129961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110643089|NCT00129961|Immunologic Factors|immunologic factors|mesh-ancestor
110643090|NCT00129961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110643091|NCT00129961|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110643092|NCT00129961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110643093|NCT00129961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110643094|NCT00129961|Antifungal Agents|antifungal agents|mesh-ancestor
110643095|NCT00129961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110643096|NCT00129961|Dermatologic Agents|dermatologic agents|mesh-ancestor
110643097|NCT00129961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110643098|NCT00129961|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110643099|NCT00129961|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110643100|NCT00129961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110643101|NCT00528567|Bevacizumab|bevacizumab|mesh-list
110643102|NCT00528567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110643103|NCT00528567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110643104|NCT00528567|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110643105|NCT00528567|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110643106|NCT00528567|Growth Substances|growth substances|mesh-ancestor
110643107|NCT00528567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110643108|NCT00528567|Growth Inhibitors|growth inhibitors|mesh-ancestor
110643109|NCT00936234|Vildagliptin|vildagliptin|mesh-list
110643110|NCT00936234|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110643111|NCT00936234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110643112|NCT00936234|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110643113|NCT00936234|Protease Inhibitors|protease inhibitors|mesh-ancestor
110643114|NCT00936234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110643115|NCT00936234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110643116|NCT00886028|Doxorubicin|doxorubicin|mesh-list
110643117|NCT00886028|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110643118|NCT00886028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110643119|NCT00886028|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110643120|NCT00886028|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110643121|NCT00886028|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110643122|NCT00886028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110643123|NCT00886028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110643124|NCT00936546|Rituximab|rituximab|mesh-list
110643125|NCT00936546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110643126|NCT00936546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110643127|NCT00936546|Immunologic Factors|immunologic factors|mesh-ancestor
110290375|NCT00564148|Bevacizumab|bevacizumab|mesh-list
110643128|NCT00936546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110643129|NCT00936546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110643130|NCT00936624|Montelukast|montelukast|mesh-list
110643131|NCT00936624|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110643132|NCT00936624|Respiratory System Agents|respiratory system agents|mesh-ancestor
110643133|NCT00936624|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110643134|NCT00936624|Hormone Antagonists|hormone antagonists|mesh-ancestor
110643135|NCT00936624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110316282|NCT00313391|Risperidone|risperidone|mesh-list
110643136|NCT00936624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110643137|NCT00936624|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110643138|NCT00936624|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110643139|NCT00936624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110643140|NCT00138151|Interferons|interferons|mesh-list
110643141|NCT00138151|Interferon-alpha|interferon-alpha|mesh-list
110643142|NCT00138151|Interferon alpha-2|interferon alpha-2|mesh-list
110643143|NCT00138151|Paclitaxel|paclitaxel|mesh-list
110643144|NCT00138151|Isotretinoin|isotretinoin|mesh-list
110643145|NCT00138151|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110643146|NCT00138151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110643147|NCT00138151|Tubulin Modulators|tubulin modulators|mesh-ancestor
110643148|NCT00138151|Antimitotic Agents|antimitotic agents|mesh-ancestor
110643149|NCT00138151|Mitosis Modulators|mitosis modulators|mesh-ancestor
110396773|NCT01323920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110643150|NCT00138151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110643151|NCT00138151|Antiviral Agents|antiviral agents|mesh-ancestor
110643152|NCT00138151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110643153|NCT00138151|Immunologic Factors|immunologic factors|mesh-ancestor
110643154|NCT00138151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110643155|NCT00138151|Dermatologic Agents|dermatologic agents|mesh-ancestor
110643156|NCT02543060|Fluorides|fluorides|mesh-list
110643157|NCT02543060|Tin Fluorides|tin fluorides|mesh-list
110643158|NCT02543060|Cariostatic Agents|cariostatic agents|mesh-ancestor
110643159|NCT02543060|Protective Agents|protective agents|mesh-ancestor
110643160|NCT02543060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110643161|NCT00889616|Aluminum Hydroxide|aluminum hydroxide|mesh-list
110643162|NCT00889616|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110643163|NCT00889616|Immunologic Factors|immunologic factors|mesh-ancestor
110643164|NCT00889616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110643165|NCT00889616|Antacids|antacids|mesh-ancestor
110643166|NCT00889616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110643167|NCT00889616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110643168|NCT02581631|Nivolumab|nivolumab|mesh-list
110643169|NCT02581631|Brentuximab Vedotin|brentuximab vedotin|mesh-list
110643170|NCT02581631|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110643171|NCT02581631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110643172|NCT02581631|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110643173|NCT02581631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110643174|NCT02581631|Immunotoxins|immunotoxins|mesh-ancestor
110643175|NCT02581631|Immunoconjugates|immunoconjugates|mesh-ancestor
110643176|NCT02581631|Immunologic Factors|immunologic factors|mesh-ancestor
110643177|NCT02581631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110643178|NCT00884546|Dexamethasone|dexamethasone|mesh-list
110643179|NCT00884546|Lenalidomide|lenalidomide|mesh-list
110643180|NCT00884546|Bortezomib|bortezomib|mesh-list
110643181|NCT00884546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110643182|NCT00884546|Antiemetics|antiemetics|mesh-ancestor
110643183|NCT00884546|Autonomic Agents|autonomic agents|mesh-ancestor
110643184|NCT00884546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110643185|NCT00884546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110643186|NCT00884546|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110643187|NCT00884546|Glucocorticoids|glucocorticoids|mesh-ancestor
110643188|NCT00884546|Hormones|hormones|mesh-ancestor
110643189|NCT00884546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110643190|NCT00884546|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110643191|NCT00884546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110643192|NCT00884546|Immunologic Factors|immunologic factors|mesh-ancestor
110643193|NCT00884546|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110643194|NCT00884546|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110643195|NCT00884546|Growth Substances|growth substances|mesh-ancestor
110643196|NCT00884546|Growth Inhibitors|growth inhibitors|mesh-ancestor
110643198|NCT00886106|Remifentanil|remifentanil|mesh-list
110643199|NCT00886106|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110159049|NCT00089050|Immunotoxins|immunotoxins|mesh-ancestor
110643200|NCT00886106|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110643201|NCT00886106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110643202|NCT00886106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110643203|NCT00886106|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110643204|NCT00886106|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110643205|NCT00886106|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110643206|NCT00886106|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110643207|NCT00886106|Anesthetics, General|anesthetics, general|mesh-ancestor
110643208|NCT00886106|Anesthetics|anesthetics|mesh-ancestor
110643209|NCT00886106|GABA Modulators|gaba modulators|mesh-ancestor
110643210|NCT00886106|GABA Agents|gaba agents|mesh-ancestor
110643211|NCT00886106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110643212|NCT00886106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110643213|NCT00886106|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110643214|NCT00886106|Narcotics|narcotics|mesh-ancestor
110643215|NCT00886106|Analgesics|analgesics|mesh-ancestor
110643216|NCT00886106|Sensory System Agents|sensory system agents|mesh-ancestor
110643217|NCT00886106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110643218|NCT00889694|Sulfasalazine|sulfasalazine|mesh-list
110643219|NCT00889694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110643220|NCT00889694|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110643221|NCT00889694|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110643222|NCT00889694|Analgesics|analgesics|mesh-ancestor
110643223|NCT00889694|Sensory System Agents|sensory system agents|mesh-ancestor
110643224|NCT00889694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110643225|NCT00889694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110643226|NCT00889694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110643227|NCT00889694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110643228|NCT00889694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110643229|NCT00529035|Interleukin-2|interleukin-2|mesh-list
110643230|NCT00529035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110643231|NCT00529035|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110643232|NCT00529035|Analgesics|analgesics|mesh-ancestor
110643233|NCT00529035|Sensory System Agents|sensory system agents|mesh-ancestor
110643234|NCT00529035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110643235|NCT00529035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110643236|NCT04421664|Hydroxychloroquine|hydroxychloroquine|mesh-list
110643237|NCT04421664|Antimalarials|antimalarials|mesh-ancestor
110643238|NCT04421664|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110643239|NCT04421664|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110643240|NCT04421664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110643241|NCT04421664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110643242|NCT04421664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110643243|NCT04421664|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110643244|NCT02578043|Clindamycin|clindamycin|mesh-list
110643245|NCT02578043|Clindamycin palmitate|clindamycin palmitate|mesh-list
110643246|NCT02578043|Clindamycin phosphate|clindamycin phosphate|mesh-list
110643247|NCT02578043|Benzoyl Peroxide|benzoyl peroxide|mesh-list
110643248|NCT02578043|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110643249|NCT02578043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110643250|NCT02578043|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110643251|NCT02578043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110643252|NCT02578043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110643253|NCT02578043|Dermatologic Agents|dermatologic agents|mesh-ancestor
110643254|NCT00889850|Esomeprazole|esomeprazole|mesh-list
110643255|NCT00889850|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110643256|NCT00889850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110643257|NCT00889850|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110643258|NCT00889850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110643259|NCT00889850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110643261|NCT04074317|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110643262|NCT04074317|Pramlintide|pramlintide|mesh-list
110643263|NCT04074317|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110643264|NCT04074317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110643265|NCT00941148|Insulin|insulin|mesh-list
110643266|NCT00941148|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110643267|NCT00941148|Metformin|metformin|mesh-list
110643268|NCT00941148|Insulin Detemir|insulin detemir|mesh-list
110643269|NCT00941148|Insulin, Isophane|insulin, isophane|mesh-list
110643270|NCT00941148|Isophane Insulin, Human|isophane insulin, human|mesh-list
110643271|NCT00941148|Isophane insulin, beef|isophane insulin, beef|mesh-list
110643272|NCT00941148|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110643273|NCT00941148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110643274|NCT02541500|Minocycline|minocycline|mesh-list
110643275|NCT02541500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110643277|NCT04073849|Epoetin Alfa|epoetin alfa|mesh-list
110643278|NCT04073849|Hematinics|hematinics|mesh-ancestor
110643280|NCT03263429|Panitumumab|panitumumab|mesh-list
110255573|NCT00405119|Esomeprazole|esomeprazole|mesh-list
110643281|NCT03263429|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110643282|NCT03263429|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110643283|NCT03263429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110643284|NCT03263429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110643285|NCT03263429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110316353|NCT00343980|Insulin|insulin|mesh-list
110643286|NCT03263429|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110643287|NCT00609674|Fluticasone|fluticasone|mesh-list
110643289|NCT00609674|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110643290|NCT00609674|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110643291|NCT00609674|Autonomic Agents|autonomic agents|mesh-ancestor
110643292|NCT00609674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110643293|NCT00609674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110643294|NCT00609674|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110643295|NCT00609674|Respiratory System Agents|respiratory system agents|mesh-ancestor
110643296|NCT00609674|Dermatologic Agents|dermatologic agents|mesh-ancestor
110643297|NCT00609674|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110643298|NCT00941382|Metformin|metformin|mesh-list
110643299|NCT00941382|Sibutramine|sibutramine|mesh-list
110643300|NCT00941382|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110643301|NCT00941382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110643302|NCT00941382|Antidepressive Agents|antidepressive agents|mesh-ancestor
110643303|NCT00941382|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110643304|NCT00941382|Appetite Depressants|appetite depressants|mesh-ancestor
110643305|NCT00941382|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110643306|NCT00137839|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110643307|NCT00137839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110643308|NCT00137839|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110643309|NCT00137839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110643310|NCT00137839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110643311|NCT00941460|Temozolomide|temozolomide|mesh-list
110643312|NCT00941460|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110643313|NCT00941460|Alkylating Agents|alkylating agents|mesh-ancestor
110643314|NCT00941460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110643315|NCT00941460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110643316|NCT00890318|Ketoconazole|ketoconazole|mesh-list
110643317|NCT00890318|Antifungal Agents|antifungal agents|mesh-ancestor
110643318|NCT00890318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110643319|NCT00890318|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110643320|NCT00890318|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110643321|NCT00890318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110643322|NCT00890318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110643323|NCT00890318|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110643325|NCT00890318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110643326|NCT00890318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110643327|NCT00890318|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110643328|NCT00563316|Irinotecan|irinotecan|mesh-list
110643329|NCT00563316|Panitumumab|panitumumab|mesh-list
110643330|NCT00563316|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110643331|NCT00563316|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110643332|NCT00563316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110643333|NCT00563316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110643334|NCT00563316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110643335|NCT00563316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110643336|NCT04037774|Dexmedetomidine|dexmedetomidine|mesh-list
110643337|NCT04037774|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110643338|NCT04037774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110643339|NCT04037774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110643340|NCT04037774|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110643342|NCT04037774|Sensory System Agents|sensory system agents|mesh-ancestor
110643343|NCT04037774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110643344|NCT04037774|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110643345|NCT04037774|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110643346|NCT04037774|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110643347|NCT04037774|Adrenergic Agents|adrenergic agents|mesh-ancestor
110643348|NCT04037774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110643349|NCT04037774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110643350|NCT02542748|Norepinephrine|norepinephrine|mesh-list
110643351|NCT02542748|Ephedrine|ephedrine|mesh-list
110643352|NCT02542748|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110643353|NCT02542748|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110643354|NCT02542748|Adrenergic Agents|adrenergic agents|mesh-ancestor
110643355|NCT02542748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110643356|NCT02542748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110643357|NCT02542748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110643359|NCT02542748|Autonomic Agents|autonomic agents|mesh-ancestor
110643360|NCT02542748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110643361|NCT02542748|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110643362|NCT02542748|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110643363|NCT00941616|Factor VIII|factor viii|mesh-list
110643364|NCT00941616|Coagulants|coagulants|mesh-ancestor
110643365|NCT02542592|Methylprednisolone|methylprednisolone|mesh-list
110643366|NCT02542592|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110643367|NCT02542592|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110643368|NCT02542592|Prednisolone|prednisolone|mesh-list
110643369|NCT02542592|Prednisolone acetate|prednisolone acetate|mesh-list
110643370|NCT02542592|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110643371|NCT02542592|Prednisolone phosphate|prednisolone phosphate|mesh-list
110643372|NCT02542592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110643373|NCT02542592|Antiemetics|antiemetics|mesh-ancestor
110643374|NCT02542592|Autonomic Agents|autonomic agents|mesh-ancestor
110643375|NCT02542592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110643376|NCT02542592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110643377|NCT02542592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110643378|NCT02542592|Glucocorticoids|glucocorticoids|mesh-ancestor
110643379|NCT02542592|Hormones|hormones|mesh-ancestor
110643380|NCT02542592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110643381|NCT02542592|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110643382|NCT02542592|Protective Agents|protective agents|mesh-ancestor
110643383|NCT02542592|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110643384|NCT02542592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110643385|NCT03178487|Upadacitinib|upadacitinib|mesh-list
110643386|NCT03178487|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
110643387|NCT03178487|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110643388|NCT03178487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110643389|NCT03178487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110643390|NCT03178487|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110643391|NCT04430036|Cisplatin|cisplatin|mesh-list
110643392|NCT04430036|Gemcitabine|gemcitabine|mesh-list
110643393|NCT04430036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110643394|NCT04430036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110643395|NCT04430036|Antimetabolites|antimetabolites|mesh-ancestor
110643396|NCT04430036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110643397|NCT00528957|Tenofovir|tenofovir|mesh-list
110643398|NCT00528957|Zidovudine|zidovudine|mesh-list
110643399|NCT00528957|Stavudine|stavudine|mesh-list
110643400|NCT00528957|Antiviral Agents|antiviral agents|mesh-ancestor
110643401|NCT00528957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110643402|NCT00528957|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110643403|NCT00528957|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110643404|NCT00528957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110643405|NCT00528957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110643407|NCT00528957|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110643408|NCT00528957|Antimetabolites|antimetabolites|mesh-ancestor
110643409|NCT00890630|Oxytocin|oxytocin|mesh-list
110643410|NCT00890630|Oxytocics|oxytocics|mesh-ancestor
110643411|NCT00890630|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110643412|NCT00890630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110643413|NCT00890708|Voriconazole|voriconazole|mesh-list
110643414|NCT00890708|Antifungal Agents|antifungal agents|mesh-ancestor
110643415|NCT00890708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110643416|NCT00890708|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110643417|NCT00890708|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110643418|NCT00890708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110643419|NCT00890708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110643420|NCT00890708|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110643421|NCT00890708|Hormone Antagonists|hormone antagonists|mesh-ancestor
110643422|NCT00890708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110643423|NCT00890708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110643424|NCT00890708|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110643426|NCT00890786|Irinotecan|irinotecan|mesh-list
110643427|NCT00890786|Temozolomide|temozolomide|mesh-list
110643428|NCT00890786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110643429|NCT00890786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110643430|NCT00890786|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110643431|NCT00890786|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110643432|NCT00890786|Growth Substances|growth substances|mesh-ancestor
110643433|NCT00890786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110643434|NCT00890786|Growth Inhibitors|growth inhibitors|mesh-ancestor
110643435|NCT00890786|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110643436|NCT00890786|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110643437|NCT00890786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110643438|NCT00890786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110643439|NCT00890786|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110643440|NCT00890786|Alkylating Agents|alkylating agents|mesh-ancestor
110643441|NCT00560508|Pramipexole|pramipexole|mesh-list
110643442|NCT00560508|Antioxidants|antioxidants|mesh-ancestor
110643443|NCT00560508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110643444|NCT00560508|Protective Agents|protective agents|mesh-ancestor
110643445|NCT00560508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110643446|NCT00560508|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110643447|NCT00560508|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110643448|NCT00560508|Dopamine Agonists|dopamine agonists|mesh-ancestor
110643449|NCT00560508|Dopamine Agents|dopamine agents|mesh-ancestor
110643450|NCT00560508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110643451|NCT00890942|Naloxone|naloxone|mesh-list
110643452|NCT00890942|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110643453|NCT00890942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110643454|NCT00890942|Sensory System Agents|sensory system agents|mesh-ancestor
110643455|NCT00890942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110643456|NCT00942006|Doxycycline|doxycycline|mesh-list
110643457|NCT00942006|Ceftriaxone|ceftriaxone|mesh-list
110643458|NCT00942006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110643459|NCT00942006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110643460|NCT00942006|Antimalarials|antimalarials|mesh-ancestor
110643461|NCT00942006|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110643462|NCT00942006|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110643463|NCT02542124|Interleukin-12|interleukin-12|mesh-list
110643464|NCT02542124|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110316541|NCT00344526|Melphalan|melphalan|mesh-list
110643465|NCT02542124|Immunologic Factors|immunologic factors|mesh-ancestor
110643466|NCT02542124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110643467|NCT02542124|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110643468|NCT02542124|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110643469|NCT02542124|Growth Substances|growth substances|mesh-ancestor
110643470|NCT02542124|Growth Inhibitors|growth inhibitors|mesh-ancestor
110643471|NCT02542124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110643473|NCT00942318|Metformin|metformin|mesh-list
110643474|NCT00942318|Insulin Aspart|insulin aspart|mesh-list
110643475|NCT00942318|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110643476|NCT00942318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110643477|NCT04819269|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110643478|NCT04819269|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110643479|NCT05280054|Probenecid|probenecid|mesh-list
110643480|NCT05280054|Uricosuric Agents|uricosuric agents|mesh-ancestor
110643481|NCT05280054|Gout Suppressants|gout suppressants|mesh-ancestor
110643482|NCT05280054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110643483|NCT03999099|Suvorexant|suvorexant|mesh-list
110643484|NCT03999099|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110643485|NCT03999099|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110643486|NCT03999099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110643487|NCT03999099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110643488|NCT03999099|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
110643489|NCT03999099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110643490|NCT03999099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110643491|NCT01007799|Vitamin D|vitamin d|mesh-list
110643492|NCT01007799|Ergocalciferols|ergocalciferols|mesh-list
110643493|NCT01007799|Cholecalciferol|cholecalciferol|mesh-list
110643494|NCT01007799|Vitamins|vitamins|mesh-list
110643495|NCT01007799|Micronutrients|micronutrients|mesh-ancestor
110316580|NCT00314990|Folic Acid|folic acid|mesh-list
110643497|NCT01007799|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110643498|NCT01007799|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110643499|NCT00609518|Folic Acid|folic acid|mesh-list
110643500|NCT00609518|Vitamin B 12|vitamin b 12|mesh-list
110643501|NCT00609518|Vitamin B Complex|vitamin b complex|mesh-list
110643502|NCT00609518|Dexamethasone|dexamethasone|mesh-list
110643503|NCT00609518|Dexamethasone acetate|dexamethasone acetate|mesh-list
110643504|NCT00609518|Pemetrexed|pemetrexed|mesh-list
110643505|NCT00609518|BB 1101|bb 1101|mesh-list
110643506|NCT00609518|Vitamins|vitamins|mesh-ancestor
110643507|NCT00609518|Micronutrients|micronutrients|mesh-ancestor
110643508|NCT00609518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110290749|NCT04603729|Hormones|hormones|mesh-ancestor
110643509|NCT00609518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110643510|NCT00609518|Antiemetics|antiemetics|mesh-ancestor
110643511|NCT00609518|Autonomic Agents|autonomic agents|mesh-ancestor
110643512|NCT00609518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110643513|NCT00609518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110643514|NCT00609518|Glucocorticoids|glucocorticoids|mesh-ancestor
110643515|NCT00609518|Hormones|hormones|mesh-ancestor
110643516|NCT00609518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110643517|NCT00609518|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110643518|NCT00609518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110643519|NCT00609518|Protease Inhibitors|protease inhibitors|mesh-ancestor
110643520|NCT00609518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110643521|NCT00609518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110643522|NCT00609518|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110643523|NCT00609518|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110643524|NCT00609518|Hematinics|hematinics|mesh-ancestor
110643525|NCT01008111|Hydrogen Peroxide|hydrogen peroxide|mesh-list
110643526|NCT01008111|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110643527|NCT01008111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110643528|NCT00886496|Lectins|lectins|mesh-list
110643529|NCT00886496|Agglutinins|agglutinins|mesh-ancestor
110643530|NCT00886496|Immunologic Factors|immunologic factors|mesh-ancestor
110643531|NCT00886496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110643532|NCT00886496|Coagulants|coagulants|mesh-ancestor
110643533|NCT00884858|Maraviroc|maraviroc|mesh-list
110643534|NCT00884858|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110643535|NCT00884858|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110643536|NCT00884858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110643537|NCT00884858|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110643538|NCT00884858|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110643539|NCT00884858|Antiviral Agents|antiviral agents|mesh-ancestor
110643540|NCT00884858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110643541|NCT00884858|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
110643542|NCT00891332|Leucovorin|leucovorin|mesh-list
110643543|NCT00891332|Antidotes|antidotes|mesh-ancestor
110643544|NCT00891332|Protective Agents|protective agents|mesh-ancestor
110643545|NCT00891332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110643546|NCT00891332|Vitamin B Complex|vitamin b complex|mesh-ancestor
110643547|NCT00891332|Vitamins|vitamins|mesh-ancestor
110643548|NCT00891332|Micronutrients|micronutrients|mesh-ancestor
110643549|NCT00609362|Rosiglitazone|rosiglitazone|mesh-list
110643550|NCT00609362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110643551|NCT00609362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110643552|NCT04038008|Fluconazole|fluconazole|mesh-list
110643553|NCT04038008|Antifungal Agents|antifungal agents|mesh-ancestor
110643554|NCT04038008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110159087|NCT00089167|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110643556|NCT04038008|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110643557|NCT04038008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110643558|NCT04038008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110643559|NCT04038008|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110643560|NCT04038008|Hormone Antagonists|hormone antagonists|mesh-ancestor
110643561|NCT04038008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110643562|NCT04038008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110643563|NCT04038008|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110643564|NCT04038008|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110643565|NCT00886574|Aspirin|aspirin|mesh-list
110643566|NCT00886574|Cilostazol|cilostazol|mesh-list
110643567|NCT00886574|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110643568|NCT00886574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110643569|NCT00886574|Analgesics|analgesics|mesh-ancestor
110643570|NCT00886574|Sensory System Agents|sensory system agents|mesh-ancestor
110643571|NCT00886574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110643572|NCT00886574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110643573|NCT00886574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110643574|NCT00886574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110643575|NCT00886574|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110643576|NCT00886574|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110643577|NCT00886574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110643578|NCT00886574|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110643579|NCT00886574|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110643580|NCT00886574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110643581|NCT00886574|Antipyretics|antipyretics|mesh-ancestor
110643582|NCT00886574|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110643583|NCT00886574|Autonomic Agents|autonomic agents|mesh-ancestor
110643584|NCT00886574|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110643586|NCT00886574|Vasodilator Agents|vasodilator agents|mesh-ancestor
110643587|NCT00886574|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110643588|NCT00886574|Protective Agents|protective agents|mesh-ancestor
110643589|NCT00886574|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110643590|NCT00886574|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110643591|NCT00611858|Fluorouracil|fluorouracil|mesh-list
110643592|NCT00611858|Cetuximab|cetuximab|mesh-list
110643593|NCT00611858|Antimetabolites|antimetabolites|mesh-ancestor
110643594|NCT00611858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110643595|NCT00611858|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110643596|NCT00611858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110643597|NCT00611858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110643598|NCT00611858|Immunologic Factors|immunologic factors|mesh-ancestor
110643599|NCT00611858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110643600|NCT00611858|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110643601|NCT00137449|Sunitinib|sunitinib|mesh-list
110643602|NCT00137449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110643603|NCT00137449|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110643604|NCT00137449|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110643605|NCT00137449|Growth Substances|growth substances|mesh-ancestor
110643606|NCT00137449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110643607|NCT00137449|Growth Inhibitors|growth inhibitors|mesh-ancestor
110643608|NCT00137449|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110643609|NCT00137449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110643610|NCT00137449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110643611|NCT00886886|Reboxetine|reboxetine|mesh-list
110643612|NCT00886886|Antidepressive Agents|antidepressive agents|mesh-ancestor
110643613|NCT00886886|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110643614|NCT00886886|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110643615|NCT00886886|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110643616|NCT00886886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110643617|NCT00886886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110643618|NCT00886886|Adrenergic Agents|adrenergic agents|mesh-ancestor
110643619|NCT00886886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110643620|NCT00886886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110643621|NCT00887042|Fludarabine|fludarabine|mesh-list
110643622|NCT00887042|Busulfan|busulfan|mesh-list
110643623|NCT00887042|Thymoglobulin|thymoglobulin|mesh-list
110159096|NCT00089206|Sargramostim|sargramostim|mesh-list
110643624|NCT00887042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110643625|NCT00887042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110643626|NCT00887042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110643627|NCT00887042|Immunologic Factors|immunologic factors|mesh-ancestor
110643628|NCT00887042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110643629|NCT00887042|Alkylating Agents|alkylating agents|mesh-ancestor
110643630|NCT00887042|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110643631|NCT00887042|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110396906|NCT00600873|Pramipexole|pramipexole|mesh-list
110643633|NCT00892112|Immunoglobulins|immunoglobulins|mesh-list
110643634|NCT00892112|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110643635|NCT00892112|Antibodies|antibodies|mesh-list
110643636|NCT00892112|gamma-Globulins|gamma-globulins|mesh-list
110643637|NCT00892112|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110643638|NCT00892112|Immunologic Factors|immunologic factors|mesh-ancestor
110643639|NCT00892112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110643640|NCT00892112|Blood Substitutes|blood substitutes|mesh-ancestor
110643641|NCT00887120|Ritonavir|ritonavir|mesh-list
110643642|NCT00887120|Lopinavir|lopinavir|mesh-list
110643643|NCT00887120|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110643644|NCT00887120|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110643645|NCT00887120|Protease Inhibitors|protease inhibitors|mesh-ancestor
110643646|NCT00887120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110643647|NCT00887120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110643648|NCT00887120|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110643649|NCT00887120|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110643650|NCT00887120|Antiviral Agents|antiviral agents|mesh-ancestor
110643651|NCT00887120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110643652|NCT00887120|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110643653|NCT00887120|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110643654|NCT00892190|Dasatinib|dasatinib|mesh-list
110643655|NCT00892190|Tretinoin|tretinoin|mesh-list
110643656|NCT00892190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110643657|NCT00892190|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110643658|NCT00892190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110290889|NCT00252408|Hormones|hormones|mesh-list
110643659|NCT00892190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110643661|NCT00892190|Dermatologic Agents|dermatologic agents|mesh-ancestor
110643662|NCT00887276|Amoxicillin|amoxicillin|mesh-list
110643663|NCT00887276|Moxifloxacin|moxifloxacin|mesh-list
110643664|NCT00887276|Ampicillin|ampicillin|mesh-list
110643665|NCT00887276|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110643666|NCT00887276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110643667|NCT00887276|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110643668|NCT00887276|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110643669|NCT00887276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110643670|NCT00887276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110643671|NCT00887276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110643672|NCT00528879|Metformin|metformin|mesh-list
110643673|NCT00528879|Dapagliflozin|dapagliflozin|mesh-list
110643674|NCT00528879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110643675|NCT00528879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110643676|NCT00528879|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110643677|NCT00528879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110643678|NCT00608894|Prednisone|prednisone|mesh-list
110643679|NCT00608894|Azathioprine|azathioprine|mesh-list
110643680|NCT00608894|Tacrolimus|tacrolimus|mesh-list
110643681|NCT00608894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110643682|NCT00608894|Glucocorticoids|glucocorticoids|mesh-ancestor
110643683|NCT00608894|Hormones|hormones|mesh-ancestor
110643684|NCT00608894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110643685|NCT00608894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110643686|NCT00608894|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110643687|NCT00608894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110643688|NCT00608894|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110643689|NCT00608894|Immunologic Factors|immunologic factors|mesh-ancestor
110643690|NCT00608894|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110643691|NCT00608894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110643692|NCT00608894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110643693|NCT00608894|Antimetabolites|antimetabolites|mesh-ancestor
110643694|NCT00608894|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110643695|NCT00608894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110643696|NCT00892346|Thalidomide|thalidomide|mesh-list
110643698|NCT00892346|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110643699|NCT00892346|Alkylating Agents|alkylating agents|mesh-ancestor
110643700|NCT00892346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110643701|NCT00892346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110643702|NCT00892346|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110643703|NCT00892346|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110643704|NCT00892346|Immunologic Factors|immunologic factors|mesh-ancestor
110643705|NCT00892346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110643706|NCT00892346|Leprostatic Agents|leprostatic agents|mesh-ancestor
110643707|NCT00892346|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110643708|NCT00892346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110643709|NCT00892346|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110643710|NCT00892346|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110643711|NCT00892346|Growth Substances|growth substances|mesh-ancestor
110643712|NCT00892346|Growth Inhibitors|growth inhibitors|mesh-ancestor
110643713|NCT00892424|Sorafenib|sorafenib|mesh-list
110643714|NCT00892424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110643715|NCT00892424|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110643716|NCT00892424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110643717|NCT00892424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110643718|NCT02541032|Minocycline|minocycline|mesh-list
110643719|NCT02541032|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110643720|NCT02541032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110643721|NCT00892502|Bismuth|bismuth|mesh-list
110643722|NCT00892502|Antacids|antacids|mesh-ancestor
110643723|NCT00892502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110643724|NCT00892502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110643725|NCT00885404|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110643726|NCT00885404|Plasma-lyte 148|plasma-lyte 148|mesh-list
110643727|NCT00885404|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110643728|NCT00191113|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
110643729|NCT00191113|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110643730|NCT00191113|Medroxyprogesterone|medroxyprogesterone|mesh-list
110643731|NCT00191113|Estradiol|estradiol|mesh-list
110643732|NCT00191113|Hormones|hormones|mesh-ancestor
110643733|NCT00191113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110643735|NCT00191113|Estrogens|estrogens|mesh-ancestor
110643736|NCT00191113|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110643737|NCT00191113|Contraceptive Agents|contraceptive agents|mesh-ancestor
110643738|NCT00191113|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110643739|NCT00191113|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110643740|NCT00191113|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110643741|NCT00191113|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110643742|NCT00191113|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110643743|NCT00191113|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110643744|NCT00191113|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110643745|NCT00191113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110643746|NCT03965052|Travoprost|travoprost|mesh-list
110396963|NCT01325493|Anesthetics|anesthetics|mesh-ancestor
110643747|NCT03965052|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110643748|NCT03965052|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110643749|NCT03965052|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110643750|NCT00892658|Sorafenib|sorafenib|mesh-list
110643751|NCT00892658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110643752|NCT00892658|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110643753|NCT00892658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110643754|NCT00892658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110643755|NCT00892736|Veliparib|veliparib|mesh-list
110643756|NCT00892736|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110643757|NCT00892736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110643758|NCT00892736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110643759|NCT00892736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110643760|NCT03966235|Melatonin|melatonin|mesh-list
110643761|NCT03966235|Antioxidants|antioxidants|mesh-ancestor
110316844|NCT00316433|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110643762|NCT03966235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110643763|NCT03966235|Protective Agents|protective agents|mesh-ancestor
110643764|NCT03966235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110643765|NCT03966235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110643766|NCT01077661|Nebivolol|nebivolol|mesh-list
110643767|NCT01077661|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110643768|NCT01077661|Vasodilator Agents|vasodilator agents|mesh-ancestor
110643769|NCT01077661|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
110643770|NCT01077661|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110643771|NCT01077661|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110643772|NCT01077661|Adrenergic Agents|adrenergic agents|mesh-ancestor
110643773|NCT01077661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110643774|NCT01077661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110643775|NCT01077661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110643776|NCT00606320|Aripiprazole|aripiprazole|mesh-list
110643777|NCT00606320|Antidepressive Agents|antidepressive agents|mesh-ancestor
110643778|NCT00606320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110643779|NCT00606320|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110643780|NCT00606320|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110643781|NCT00606320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110643782|NCT00606320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110643783|NCT00606320|Dopamine Agonists|dopamine agonists|mesh-ancestor
110643784|NCT00606320|Dopamine Agents|dopamine agents|mesh-ancestor
110643785|NCT00606320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110643786|NCT00606320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110396966|NCT01325493|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110643787|NCT00606320|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110643788|NCT00606320|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110643789|NCT00606320|Serotonin Agents|serotonin agents|mesh-ancestor
110643790|NCT00606320|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110643791|NCT00606320|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110643792|NCT00606320|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110643793|NCT00606320|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110643794|NCT03966079|Plasminogen|plasminogen|mesh-list
110643795|NCT03966079|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
110316884|NCT00349635|Metformin|metformin|mesh-list
110643796|NCT03966079|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110643797|NCT03966079|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110255671|NCT02953210|Ranitidine|ranitidine|mesh-list
110255674|NCT02953210|Rocuronium|rocuronium|mesh-list
110643798|NCT03966079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110643799|NCT02540486|Insulin Glargine|insulin glargine|mesh-list
110643800|NCT02540486|Insulin, Long-Acting|insulin, long-acting|mesh-list
110643801|NCT02540486|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110643802|NCT02540486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110643803|NCT03966859|Atorvastatin|atorvastatin|mesh-list
110643804|NCT03966859|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110643805|NCT03966859|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110643806|NCT03966859|Antimetabolites|antimetabolites|mesh-ancestor
110643807|NCT03966859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110643808|NCT03966859|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110643809|NCT03966859|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110643810|NCT03966859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110643811|NCT00528411|Aspirin|aspirin|mesh-list
110643812|NCT00528411|Clopidogrel|clopidogrel|mesh-list
110643813|NCT00528411|Ticagrelor|ticagrelor|mesh-list
110643814|NCT00528411|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110643815|NCT00528411|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110643816|NCT00528411|Analgesics|analgesics|mesh-ancestor
110643817|NCT00528411|Sensory System Agents|sensory system agents|mesh-ancestor
110643818|NCT00528411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110643819|NCT00528411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110643820|NCT00528411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110643821|NCT00528411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110643822|NCT00528411|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110159122|NCT00423826|Antimetabolites|antimetabolites|mesh-ancestor
110643824|NCT00528411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110643825|NCT00528411|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110643826|NCT00528411|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110643827|NCT00528411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110643828|NCT00528411|Antipyretics|antipyretics|mesh-ancestor
110643829|NCT00528411|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110643830|NCT00528411|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110643831|NCT00528411|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110643832|NCT00528411|Purinergic Agents|purinergic agents|mesh-ancestor
110643833|NCT00528411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110643834|NCT00895544|Vaccines|vaccines|mesh-list
110643835|NCT00895544|Immunologic Factors|immunologic factors|mesh-ancestor
110397002|NCT01324323|Romidepsin|romidepsin|mesh-list
110643836|NCT00895544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110643837|NCT00895778|Rocuronium|rocuronium|mesh-list
110643838|NCT00895778|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110643839|NCT00895778|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110643840|NCT00895778|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110643841|NCT00895778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110643842|NCT00895778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110643843|NCT00187135|Fentanyl|fentanyl|mesh-list
110643844|NCT00187135|Propofol|propofol|mesh-list
110643845|NCT00187135|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110643846|NCT00187135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110643847|NCT00187135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110643848|NCT00187135|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110643849|NCT00187135|Anesthetics, General|anesthetics, general|mesh-ancestor
110643850|NCT00187135|Anesthetics|anesthetics|mesh-ancestor
110643851|NCT00187135|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110643852|NCT00187135|Narcotics|narcotics|mesh-ancestor
110643853|NCT00187135|Analgesics|analgesics|mesh-ancestor
110643854|NCT00187135|Sensory System Agents|sensory system agents|mesh-ancestor
110643855|NCT00187135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110643856|NCT00187135|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110643857|NCT00896402|Iodine|iodine|mesh-list
110643858|NCT00896402|Chlorhexidine|chlorhexidine|mesh-list
110643859|NCT00896402|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110643860|NCT00896402|Povidone-Iodine|povidone-iodine|mesh-list
110643861|NCT00896402|Povidone|povidone|mesh-list
110643862|NCT00896402|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110643863|NCT00896402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110643864|NCT00896402|Disinfectants|disinfectants|mesh-ancestor
110643865|NCT00896402|Dermatologic Agents|dermatologic agents|mesh-ancestor
110643866|NCT00896402|Trace Elements|trace elements|mesh-ancestor
110643867|NCT00896402|Micronutrients|micronutrients|mesh-ancestor
110643868|NCT00896402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110643869|NCT00896402|Plasma Substitutes|plasma substitutes|mesh-ancestor
110643870|NCT00896402|Blood Substitutes|blood substitutes|mesh-ancestor
110643871|NCT00560352|Dexamethasone|dexamethasone|mesh-list
110643872|NCT00560352|Bortezomib|bortezomib|mesh-list
110643873|NCT00560352|Dasatinib|dasatinib|mesh-list
110643874|NCT00560352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110643875|NCT00560352|Antiemetics|antiemetics|mesh-ancestor
110643876|NCT00560352|Autonomic Agents|autonomic agents|mesh-ancestor
110643877|NCT00560352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110643878|NCT00560352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110643879|NCT00560352|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110643880|NCT00560352|Glucocorticoids|glucocorticoids|mesh-ancestor
110643881|NCT00560352|Hormones|hormones|mesh-ancestor
110643882|NCT00560352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110643883|NCT00560352|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110643884|NCT00560352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110643885|NCT00560352|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110643886|NCT00560352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110397024|NCT02879227|Cisplatin|cisplatin|mesh-list
110643887|NCT00560352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110643888|NCT00892892|Nitrendipine|nitrendipine|mesh-list
110643889|NCT00892892|Rilmenidine|rilmenidine|mesh-list
110643890|NCT00892892|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110643891|NCT00892892|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110643892|NCT00892892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110643893|NCT00892892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110643894|NCT00892892|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110643895|NCT00892892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110643896|NCT00892892|Vasodilator Agents|vasodilator agents|mesh-ancestor
110643897|NCT00892892|Sympatholytics|sympatholytics|mesh-ancestor
110643898|NCT00892892|Autonomic Agents|autonomic agents|mesh-ancestor
110643899|NCT00892892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110643900|NCT00892892|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110643901|NCT00892892|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110643902|NCT00892892|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110643903|NCT00892892|Adrenergic Agents|adrenergic agents|mesh-ancestor
110643904|NCT00892892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110643906|NCT00944814|Trace Elements|trace elements|mesh-ancestor
110643907|NCT00944814|Micronutrients|micronutrients|mesh-ancestor
110643908|NCT00944814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110643910|NCT00527787|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110643911|NCT00527787|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110643912|NCT00527787|Analgesics|analgesics|mesh-ancestor
110643913|NCT00527787|Sensory System Agents|sensory system agents|mesh-ancestor
110643914|NCT00527787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110643915|NCT00527787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110643916|NCT00527787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110643917|NCT00527787|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110643918|NCT00527787|Gout Suppressants|gout suppressants|mesh-ancestor
110643919|NCT00527787|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110317005|NCT00317408|Leucovorin|leucovorin|mesh-list
110643921|NCT00527787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110643922|NCT00893048|Prednisone|prednisone|mesh-list
110643923|NCT00893048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110643924|NCT00893048|Glucocorticoids|glucocorticoids|mesh-ancestor
110643925|NCT00893048|Hormones|hormones|mesh-ancestor
110643926|NCT00893048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110643927|NCT00893048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110643928|NCT00893048|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110643929|NCT00893048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110643930|NCT00942864|Ranibizumab|ranibizumab|mesh-list
110643931|NCT00942864|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110643932|NCT00942864|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110643933|NCT00942864|Growth Substances|growth substances|mesh-ancestor
110643934|NCT00942864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110643935|NCT00942864|Growth Inhibitors|growth inhibitors|mesh-ancestor
110643936|NCT00942864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110643937|NCT04036448|Lenalidomide|lenalidomide|mesh-list
110643938|NCT04036448|Immunologic Factors|immunologic factors|mesh-ancestor
110643939|NCT04036448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110643940|NCT04036448|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110643941|NCT04036448|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110643942|NCT04036448|Growth Substances|growth substances|mesh-ancestor
110643943|NCT04036448|Growth Inhibitors|growth inhibitors|mesh-ancestor
110643944|NCT04036448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110643946|NCT00896558|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110643947|NCT00896558|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110643948|NCT00896558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110643949|NCT00896558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110643950|NCT00896558|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110643951|NCT00896558|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110643952|NCT00896558|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110643953|NCT00896558|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110643954|NCT00896558|Anesthetics, General|anesthetics, general|mesh-ancestor
110643955|NCT00896558|Anesthetics|anesthetics|mesh-ancestor
110643956|NCT00896558|GABA Modulators|gaba modulators|mesh-ancestor
110643957|NCT00896558|GABA Agents|gaba agents|mesh-ancestor
110643958|NCT00896558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110643959|NCT00896558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110643960|NCT00943176|Modafinil|modafinil|mesh-list
110643961|NCT00943176|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110317032|NCT00317408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110643963|NCT00943176|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
110643964|NCT00943176|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110643965|NCT00943176|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110643966|NCT00943176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110643967|NCT00129259|Iron|iron|mesh-list
110643968|NCT00129259|Trace Elements|trace elements|mesh-ancestor
110643969|NCT00129259|Micronutrients|micronutrients|mesh-ancestor
110643970|NCT00129259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110643971|NCT00896714|Anesthetics|anesthetics|mesh-list
110643972|NCT00896714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110643973|NCT00896714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110643974|NCT00940524|Cytarabine|cytarabine|mesh-list
110643975|NCT00940524|Cyclophosphamide|cyclophosphamide|mesh-list
110643976|NCT00940524|Methotrexate|methotrexate|mesh-list
110643977|NCT00940524|Etoposide|etoposide|mesh-list
110643978|NCT00940524|Asparaginase|asparaginase|mesh-list
110643979|NCT00940524|Dasatinib|dasatinib|mesh-list
110643980|NCT00940524|Mitoxantrone|mitoxantrone|mesh-list
110643981|NCT00940524|Pegaspargase|pegaspargase|mesh-list
110643982|NCT00940524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110643983|NCT00940524|Immunologic Factors|immunologic factors|mesh-ancestor
110643984|NCT00940524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110643985|NCT00940524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110643986|NCT00940524|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110643987|NCT00940524|Alkylating Agents|alkylating agents|mesh-ancestor
110643988|NCT00940524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110643989|NCT00940524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110643990|NCT00940524|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110643991|NCT00940524|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110643992|NCT00940524|Abortifacient Agents|abortifacient agents|mesh-ancestor
110643993|NCT00940524|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110643994|NCT00940524|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110643995|NCT00940524|Antimetabolites|antimetabolites|mesh-ancestor
110643996|NCT00940524|Dermatologic Agents|dermatologic agents|mesh-ancestor
110643997|NCT00940524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110643998|NCT00940524|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110643999|NCT00940524|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110644000|NCT00940524|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110644001|NCT00940524|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110644002|NCT00940524|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110644003|NCT00940524|Antiviral Agents|antiviral agents|mesh-ancestor
110644004|NCT00940524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110644005|NCT00940524|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110644006|NCT00940524|Analgesics|analgesics|mesh-ancestor
110644007|NCT00940524|Sensory System Agents|sensory system agents|mesh-ancestor
110644008|NCT00940524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110644009|NCT00186901|Vitamin D|vitamin d|mesh-list
110644010|NCT00186901|Calcium Carbonate|calcium carbonate|mesh-list
110644011|NCT00186901|Calcium|calcium|mesh-list
110644012|NCT00186901|Vitamins|vitamins|mesh-ancestor
110644013|NCT00186901|Micronutrients|micronutrients|mesh-ancestor
110397068|NCT01320033|Doxycycline|doxycycline|mesh-list
110644014|NCT00186901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110255689|NCT02953210|Sensory System Agents|sensory system agents|mesh-ancestor
110644015|NCT00186901|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110644016|NCT00186901|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110644017|NCT00186901|Antacids|antacids|mesh-ancestor
110644018|NCT00186901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110644019|NCT00186901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110644020|NCT00943410|Trastuzumab|trastuzumab|mesh-list
110644021|NCT00943410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110644022|NCT00943410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110644023|NCT00896948|Antibodies|antibodies|mesh-list
110644024|NCT00896948|Immunologic Factors|immunologic factors|mesh-ancestor
110644025|NCT00896948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110644027|NCT00186121|Goserelin|goserelin|mesh-list
110644028|NCT00186121|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110644029|NCT00186121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110644030|NCT00186121|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110644031|NCT00186121|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110644032|NCT00186121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110644033|NCT00186121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110644034|NCT00186121|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110644036|NCT00186121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110644037|NCT00186121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110644039|NCT00897026|Cyclophosphamide|cyclophosphamide|mesh-list
110644040|NCT00897026|Doxorubicin|doxorubicin|mesh-list
110644041|NCT00897026|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110644042|NCT00897026|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110644043|NCT00897026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110644044|NCT00897026|Tubulin Modulators|tubulin modulators|mesh-ancestor
110644045|NCT00897026|Antimitotic Agents|antimitotic agents|mesh-ancestor
110644046|NCT00897026|Mitosis Modulators|mitosis modulators|mesh-ancestor
110644047|NCT00897026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110644048|NCT00897026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110644049|NCT00897026|Immunologic Factors|immunologic factors|mesh-ancestor
110644050|NCT00897026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110644051|NCT00897026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110644052|NCT00897026|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110644053|NCT00897026|Alkylating Agents|alkylating agents|mesh-ancestor
110644054|NCT00897026|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110644055|NCT00897026|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110644056|NCT00897026|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110644057|NCT00897026|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110644058|NCT00897026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110644059|NCT00186043|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110644060|NCT00186043|Antidepressive Agents|antidepressive agents|mesh-ancestor
110644061|NCT00186043|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110644062|NCT00186043|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110644063|NCT00186043|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110644064|NCT00186043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110317151|NCT00345501|Vasodilator Agents|vasodilator agents|mesh-ancestor
110644066|NCT01076491|Mannitol|mannitol|mesh-list
110644067|NCT01076491|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110644068|NCT01076491|Diuretics|diuretics|mesh-ancestor
110644069|NCT01076491|Natriuretic Agents|natriuretic agents|mesh-ancestor
110644070|NCT01076491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110644071|NCT00127933|Capecitabine|capecitabine|mesh-list
110644072|NCT00127933|Docetaxel|docetaxel|mesh-list
110644073|NCT00127933|Trastuzumab|trastuzumab|mesh-list
110397074|NCT05644743|Gemcitabine|gemcitabine|mesh-list
110644074|NCT00127933|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110644076|NCT00127933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110644077|NCT00127933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110644078|NCT00127933|Tubulin Modulators|tubulin modulators|mesh-ancestor
110644079|NCT00127933|Antimitotic Agents|antimitotic agents|mesh-ancestor
110644080|NCT00127933|Mitosis Modulators|mitosis modulators|mesh-ancestor
110644081|NCT00127933|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110644082|NCT03875313|Talazoparib|talazoparib|mesh-list
110644083|NCT03875313|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110644084|NCT03875313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110644085|NCT03875313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110644086|NCT03875313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110644087|NCT01008345|Ezetimibe|ezetimibe|mesh-list
110644088|NCT01008345|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110644089|NCT01008345|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110644090|NCT01008345|Antimetabolites|antimetabolites|mesh-ancestor
110644091|NCT01008345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110644092|NCT01008345|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110644093|NCT05239533|Nivolumab|nivolumab|mesh-list
110644094|NCT05239533|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110644095|NCT05239533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110159147|NCT00423982|Vancomycin|vancomycin|mesh-list
110644096|NCT05239533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110644097|NCT05239533|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110644098|NCT05239533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110644099|NCT05239533|Immunologic Factors|immunologic factors|mesh-ancestor
110644100|NCT05239533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110644101|NCT04828083|Lidocaine|lidocaine|mesh-list
110644102|NCT04828083|Anesthetics, Local|anesthetics, local|mesh-ancestor
110644103|NCT04828083|Anesthetics|anesthetics|mesh-ancestor
110644104|NCT04828083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110644105|NCT04828083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110644106|NCT04828083|Sensory System Agents|sensory system agents|mesh-ancestor
110644107|NCT04828083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110644108|NCT04828083|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110644109|NCT04828083|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110644110|NCT04828083|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110644111|NCT04828083|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110644112|NCT04828083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110644113|NCT05225961|Aspirin|aspirin|mesh-list
110644114|NCT05225961|Tirofiban|tirofiban|mesh-list
110644115|NCT05225961|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110644116|NCT05225961|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110644117|NCT05225961|Analgesics|analgesics|mesh-ancestor
110644118|NCT05225961|Sensory System Agents|sensory system agents|mesh-ancestor
110644119|NCT05225961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110644120|NCT05225961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110644121|NCT05225961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110644122|NCT05225961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110644123|NCT05225961|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110644124|NCT05225961|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110644125|NCT05225961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110644126|NCT05225961|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110644127|NCT05225961|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110644128|NCT05225961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110644129|NCT05225961|Antipyretics|antipyretics|mesh-ancestor
110644130|NCT00556998|Voriconazole|voriconazole|mesh-list
110644131|NCT00556998|Antifungal Agents|antifungal agents|mesh-ancestor
110644132|NCT00556998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110644133|NCT00556998|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110644134|NCT00556998|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110644135|NCT00556998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110644136|NCT00556998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110644137|NCT00556998|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110644138|NCT00556998|Hormone Antagonists|hormone antagonists|mesh-ancestor
110644139|NCT00556998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110644140|NCT00556998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110644141|NCT00556998|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110644144|NCT00945360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110644145|NCT00945360|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110644146|NCT00945360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110644147|NCT00945360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110644148|NCT00945360|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110644149|NCT00945360|Hormone Antagonists|hormone antagonists|mesh-ancestor
110644150|NCT00945360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110644151|NCT00945360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110644152|NCT00943566|Sufentanil|sufentanil|mesh-list
110644153|NCT00943566|Morphine|morphine|mesh-list
110644154|NCT00943566|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110644155|NCT00943566|Narcotics|narcotics|mesh-ancestor
110644156|NCT00943566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110644157|NCT00943566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110644158|NCT00943566|Analgesics|analgesics|mesh-ancestor
110644159|NCT00943566|Sensory System Agents|sensory system agents|mesh-ancestor
110644160|NCT00943566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110644161|NCT00943566|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110644162|NCT00943566|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110644163|NCT00943566|Anesthetics, General|anesthetics, general|mesh-ancestor
110644165|NCT00940680|Losartan|losartan|mesh-list
110644166|NCT00940680|Amlodipine|amlodipine|mesh-list
110644167|NCT00940680|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110644168|NCT00940680|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110644169|NCT00940680|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110644170|NCT00940680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110644171|NCT00940680|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110644172|NCT00940680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110644173|NCT00940680|Vasodilator Agents|vasodilator agents|mesh-ancestor
110644174|NCT00940680|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110644175|NCT00940680|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110644176|NCT00940680|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110644177|NCT00945438|Vaccines|vaccines|mesh-list
110644178|NCT00945438|Immunologic Factors|immunologic factors|mesh-ancestor
110644179|NCT00945438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110644180|NCT00527397|Insulin|insulin|mesh-list
110644181|NCT00527397|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110644182|NCT00527397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110644183|NCT00943956|Everolimus|everolimus|mesh-list
110644185|NCT00943956|Bicalutamide|bicalutamide|mesh-list
110644186|NCT00943956|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110644187|NCT00943956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110644188|NCT00943956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110397106|NCT01078675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110644189|NCT00943956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110644190|NCT00943956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110644191|NCT00943956|Immunologic Factors|immunologic factors|mesh-ancestor
110644192|NCT00943956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110644193|NCT00943956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110644194|NCT00943956|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110644195|NCT00943956|Fertility Agents|fertility agents|mesh-ancestor
110644196|NCT00943956|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110644197|NCT00943956|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110644198|NCT00943956|Androgen Antagonists|androgen antagonists|mesh-ancestor
110644199|NCT00943956|Hormone Antagonists|hormone antagonists|mesh-ancestor
110644200|NCT00943956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110644202|NCT00944346|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110644203|NCT00944346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110644204|NCT04115319|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110644205|NCT04115319|Antidepressive Agents|antidepressive agents|mesh-ancestor
110644206|NCT04115319|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110644207|NCT04115319|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110644208|NCT04115319|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110644209|NCT04115319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110644210|NCT04115319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110644211|NCT00134719|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110644212|NCT00134719|Immunologic Factors|immunologic factors|mesh-ancestor
110644213|NCT00134719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110644214|NCT00940836|Acetaminophen|acetaminophen|mesh-list
110644215|NCT00940836|Chlorpheniramine|chlorpheniramine|mesh-list
110644216|NCT00940836|Phenylephrine|phenylephrine|mesh-list
110644217|NCT00940836|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110644218|NCT00940836|Analgesics|analgesics|mesh-ancestor
110644219|NCT00940836|Sensory System Agents|sensory system agents|mesh-ancestor
110644221|NCT00940836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110644222|NCT00940836|Antipyretics|antipyretics|mesh-ancestor
110644223|NCT00940836|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110644224|NCT00940836|Mydriatics|mydriatics|mesh-ancestor
110644225|NCT00940836|Autonomic Agents|autonomic agents|mesh-ancestor
110644226|NCT00940836|Sympathomimetics|sympathomimetics|mesh-ancestor
110644227|NCT00940836|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110644228|NCT00940836|Nasal Decongestants|nasal decongestants|mesh-ancestor
110644229|NCT00940836|Respiratory System Agents|respiratory system agents|mesh-ancestor
110644230|NCT00940836|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110644231|NCT00940836|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110644232|NCT00940836|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110644233|NCT00940836|Adrenergic Agents|adrenergic agents|mesh-ancestor
110644234|NCT00940836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110644235|NCT00940836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110644236|NCT00940836|Protective Agents|protective agents|mesh-ancestor
110644237|NCT00940836|Antipruritics|antipruritics|mesh-ancestor
110644238|NCT00940836|Dermatologic Agents|dermatologic agents|mesh-ancestor
110644239|NCT00940836|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110644240|NCT00940836|Histamine Antagonists|histamine antagonists|mesh-ancestor
110644241|NCT00940836|Histamine Agents|histamine agents|mesh-ancestor
110644242|NCT00940836|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110644243|NCT00940914|2beta-carbomethoxy-3beta-(4-iodophenyl)tropane|2beta-carbomethoxy-3beta-(4-iodophenyl)tropane|mesh-list
110644244|NCT00940914|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110644245|NCT00940914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110644246|NCT00944424|Vitamin D|vitamin d|mesh-list
110644247|NCT00944424|Ergocalciferols|ergocalciferols|mesh-list
110397123|NCT01314261|Interferons|interferons|mesh-list
110397124|NCT01314261|Ribavirin|ribavirin|mesh-list
110397125|NCT01314261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110397126|NCT01314261|Antiviral Agents|antiviral agents|mesh-ancestor
110317333|NCT00318890|Docetaxel|docetaxel|mesh-list
110397127|NCT01314261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110644248|NCT00944424|Cholecalciferol|cholecalciferol|mesh-list
110644249|NCT00944424|Vitamins|vitamins|mesh-list
110644250|NCT00944424|Docetaxel|docetaxel|mesh-list
110644251|NCT00944424|Micronutrients|micronutrients|mesh-ancestor
110644252|NCT00944424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110644253|NCT00944424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110644254|NCT00944424|Tubulin Modulators|tubulin modulators|mesh-ancestor
110644255|NCT00944424|Antimitotic Agents|antimitotic agents|mesh-ancestor
110644256|NCT00944424|Mitosis Modulators|mitosis modulators|mesh-ancestor
110644257|NCT00944424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110644258|NCT00944424|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110644259|NCT00944424|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110644260|NCT00944502|Dexamethasone|dexamethasone|mesh-list
110644261|NCT00944502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110644262|NCT00944502|Antiemetics|antiemetics|mesh-ancestor
110644263|NCT00944502|Autonomic Agents|autonomic agents|mesh-ancestor
110644264|NCT00944502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110644265|NCT00944502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110644266|NCT00944502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110644267|NCT00944502|Glucocorticoids|glucocorticoids|mesh-ancestor
110644268|NCT00944502|Hormones|hormones|mesh-ancestor
110644269|NCT00944502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110644270|NCT00944502|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110644271|NCT00944502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110644272|NCT00949962|Leuprolide|leuprolide|mesh-list
110644273|NCT00949962|Androgen Antagonists|androgen antagonists|mesh-list
110644274|NCT00949962|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110644275|NCT00949962|Fertility Agents|fertility agents|mesh-ancestor
110644276|NCT00949962|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110644277|NCT00949962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110644278|NCT00949962|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110644279|NCT00949962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110644280|NCT00949962|Hormone Antagonists|hormone antagonists|mesh-ancestor
110644281|NCT00949962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110644282|NCT00946374|Cyclosporine|cyclosporine|mesh-list
110644283|NCT00946374|Doxorubicin|doxorubicin|mesh-list
110644284|NCT00946374|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110644285|NCT00946374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110644286|NCT00946374|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110644287|NCT00946374|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110644288|NCT00946374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110644289|NCT00946374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110644290|NCT00946374|Immunologic Factors|immunologic factors|mesh-ancestor
110644291|NCT00946374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110644292|NCT00946374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110644293|NCT00946374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110644294|NCT00946374|Antifungal Agents|antifungal agents|mesh-ancestor
110644295|NCT00946374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110644296|NCT00946374|Dermatologic Agents|dermatologic agents|mesh-ancestor
110644297|NCT00946374|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110644299|NCT00950196|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110644300|NCT00950196|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110644301|NCT00950196|Antiviral Agents|antiviral agents|mesh-ancestor
110644302|NCT00950196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110644303|NCT00950196|Dopamine Agents|dopamine agents|mesh-ancestor
110644304|NCT00950196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110644305|NCT00950196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110644306|NCT00950196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110644307|NCT00950196|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110644308|NCT00950196|Analgesics|analgesics|mesh-ancestor
110644309|NCT00950196|Sensory System Agents|sensory system agents|mesh-ancestor
110644310|NCT00950196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110644312|NCT01565109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110644313|NCT01565109|Tubulin Modulators|tubulin modulators|mesh-ancestor
110644314|NCT01565109|Antimitotic Agents|antimitotic agents|mesh-ancestor
110644315|NCT01565109|Mitosis Modulators|mitosis modulators|mesh-ancestor
110644316|NCT01565109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110644317|NCT00525915|Fluorouracil|fluorouracil|mesh-list
110644318|NCT00525915|Oxaliplatin|oxaliplatin|mesh-list
110644319|NCT00525915|Antimetabolites|antimetabolites|mesh-ancestor
110644320|NCT00525915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110644321|NCT00525915|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110644322|NCT00525915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110644323|NCT00525915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110644324|NCT00525915|Immunologic Factors|immunologic factors|mesh-ancestor
110644325|NCT00525915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110644326|NCT00521001|Everolimus|everolimus|mesh-list
110644327|NCT00521001|Temozolomide|temozolomide|mesh-list
110644328|NCT00521001|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110644329|NCT00521001|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110644330|NCT00521001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110644331|NCT00521001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110644332|NCT00521001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110644333|NCT00521001|Immunologic Factors|immunologic factors|mesh-ancestor
110644334|NCT00521001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110644335|NCT00521001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110644336|NCT00521001|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110644337|NCT00521001|Alkylating Agents|alkylating agents|mesh-ancestor
110644339|NCT00134563|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110644340|NCT00134563|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110644341|NCT00134563|Analgesics|analgesics|mesh-ancestor
110644342|NCT00134563|Sensory System Agents|sensory system agents|mesh-ancestor
110644343|NCT00134563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110644344|NCT00134563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110644345|NCT00134563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110644346|NCT00134563|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110644347|NCT00134563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110644348|NCT00134563|Immunologic Factors|immunologic factors|mesh-ancestor
110644349|NCT03966547|Anesthetics|anesthetics|mesh-list
110644350|NCT03966547|Anesthetics, Local|anesthetics, local|mesh-list
110644351|NCT03966547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110644352|NCT03966547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110644353|NCT03966547|Sensory System Agents|sensory system agents|mesh-ancestor
110644354|NCT03966547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110644356|NCT01326325|Analgesics|analgesics|mesh-ancestor
110644357|NCT01326325|Sensory System Agents|sensory system agents|mesh-ancestor
110644358|NCT01326325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110644359|NCT01326325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110644360|NCT01326325|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110644361|NCT01326325|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110644362|NCT01326325|Anesthetics, General|anesthetics, general|mesh-ancestor
110644363|NCT01326325|Anesthetics|anesthetics|mesh-ancestor
110644364|NCT01326325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110644365|NCT01326325|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110644366|NCT01326325|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110644368|NCT01326325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110644369|NCT01326403|Tranexamic Acid|tranexamic acid|mesh-list
110644370|NCT01326403|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110644371|NCT01326403|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110644372|NCT01326403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110644373|NCT01326403|Hemostatics|hemostatics|mesh-ancestor
110644374|NCT01326403|Coagulants|coagulants|mesh-ancestor
110644375|NCT00520845|Celecoxib|celecoxib|mesh-list
110644376|NCT00520845|Docetaxel|docetaxel|mesh-list
110644377|NCT00520845|Pemetrexed|pemetrexed|mesh-list
110644378|NCT00520845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110644379|NCT00520845|Tubulin Modulators|tubulin modulators|mesh-ancestor
110644380|NCT00520845|Antimitotic Agents|antimitotic agents|mesh-ancestor
110644381|NCT00520845|Mitosis Modulators|mitosis modulators|mesh-ancestor
110644382|NCT00520845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110644383|NCT00520845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110644384|NCT00520845|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110644385|NCT00520845|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110644386|NCT00520845|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110644387|NCT00520845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110644389|NCT00520845|Sensory System Agents|sensory system agents|mesh-ancestor
110644390|NCT00520845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110644391|NCT00520845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110644392|NCT00520845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110644393|NCT00520845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110644394|NCT00520845|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110644395|NCT00520845|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110644396|NCT00185731|Atorvastatin|atorvastatin|mesh-list
110644397|NCT00185731|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110644398|NCT00185731|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110644399|NCT00185731|Antimetabolites|antimetabolites|mesh-ancestor
110644400|NCT00185731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110644401|NCT00185731|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110644402|NCT00185731|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110644403|NCT00185731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110644404|NCT00582491|Modafinil|modafinil|mesh-list
110644405|NCT00582491|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110291635|NCT04589299|Antibodies|antibodies|mesh-list
110644406|NCT00582491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110644407|NCT00582491|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
110644408|NCT00582491|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110644409|NCT00582491|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110644410|NCT00582491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110644411|NCT00520767|Dexamethasone|dexamethasone|mesh-list
110644412|NCT00520767|Dexamethasone acetate|dexamethasone acetate|mesh-list
110644413|NCT00520767|Bortezomib|bortezomib|mesh-list
110644414|NCT00520767|Melphalan|melphalan|mesh-list
110644415|NCT00520767|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
110644416|NCT00520767|BB 1101|bb 1101|mesh-list
110644417|NCT00520767|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110644418|NCT00520767|Antiemetics|antiemetics|mesh-ancestor
110644419|NCT00520767|Autonomic Agents|autonomic agents|mesh-ancestor
110644420|NCT00520767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110644421|NCT00520767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110644422|NCT00520767|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110644423|NCT00520767|Glucocorticoids|glucocorticoids|mesh-ancestor
110644424|NCT00520767|Hormones|hormones|mesh-ancestor
110644425|NCT00520767|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110644426|NCT00520767|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110644427|NCT00520767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110644428|NCT00520767|Protease Inhibitors|protease inhibitors|mesh-ancestor
110644429|NCT00520767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110644430|NCT00520767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110644431|NCT00520767|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110644432|NCT00520767|Alkylating Agents|alkylating agents|mesh-ancestor
110644433|NCT00520767|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110644434|NCT00520767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110644435|NCT00520767|Immunologic Factors|immunologic factors|mesh-ancestor
110644436|NCT03873987|Oritavancin|oritavancin|mesh-list
110644437|NCT03873987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110644438|NCT03873987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110644439|NCT02579681|Dimethyl Fumarate|dimethyl fumarate|mesh-list
110644440|NCT02579681|Dermatologic Agents|dermatologic agents|mesh-ancestor
110644441|NCT02579681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110644442|NCT02579681|Immunologic Factors|immunologic factors|mesh-ancestor
110644443|NCT02579681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110644444|NCT00528645|Saracatinib|saracatinib|mesh-list
110644445|NCT00528645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110644446|NCT00528645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110644447|NCT00528645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110644448|NCT01017796|Ascorbic Acid|ascorbic acid|mesh-list
110644449|NCT01017796|Acetylcysteine|acetylcysteine|mesh-list
110644450|NCT01017796|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110644451|NCT01017796|Antiviral Agents|antiviral agents|mesh-ancestor
110644452|NCT01017796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110644453|NCT01017796|Expectorants|expectorants|mesh-ancestor
110644454|NCT01017796|Respiratory System Agents|respiratory system agents|mesh-ancestor
110644455|NCT01017796|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110644456|NCT01017796|Antioxidants|antioxidants|mesh-ancestor
110644457|NCT01017796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110644458|NCT01017796|Protective Agents|protective agents|mesh-ancestor
110644459|NCT01017796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110644460|NCT01017796|Antidotes|antidotes|mesh-ancestor
110644461|NCT01017796|Vitamins|vitamins|mesh-ancestor
110644462|NCT01017796|Micronutrients|micronutrients|mesh-ancestor
110644463|NCT01783535|Cyclophosphamide|cyclophosphamide|mesh-list
110644464|NCT01783535|Carboplatin|carboplatin|mesh-list
110644465|NCT01783535|Doxorubicin|doxorubicin|mesh-list
110644466|NCT01783535|Etoposide|etoposide|mesh-list
110644467|NCT01783535|Vincristine|vincristine|mesh-list
110644468|NCT01783535|Topotecan|topotecan|mesh-list
110644469|NCT01783535|Lenograstim|lenograstim|mesh-list
110644470|NCT01783535|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110644471|NCT01783535|Immunologic Factors|immunologic factors|mesh-ancestor
110644472|NCT01783535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110644473|NCT01783535|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110644474|NCT01783535|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110644475|NCT01783535|Alkylating Agents|alkylating agents|mesh-ancestor
110644476|NCT01783535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110644477|NCT01783535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110644478|NCT01783535|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110644479|NCT01783535|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110644480|NCT01783535|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110644481|NCT01783535|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110644482|NCT01783535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110644483|NCT01783535|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110644484|NCT01783535|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110644485|NCT01783535|Tubulin Modulators|tubulin modulators|mesh-ancestor
110644486|NCT01783535|Antimitotic Agents|antimitotic agents|mesh-ancestor
110644487|NCT01783535|Mitosis Modulators|mitosis modulators|mesh-ancestor
110644488|NCT01783535|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110644489|NCT04073537|Paclitaxel|paclitaxel|mesh-list
110317528|NCT00320099|Insulin|insulin|mesh-list
110644491|NCT04073537|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110644492|NCT04073537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110644493|NCT04073537|Tubulin Modulators|tubulin modulators|mesh-ancestor
110644494|NCT04073537|Antimitotic Agents|antimitotic agents|mesh-ancestor
110644495|NCT04073537|Mitosis Modulators|mitosis modulators|mesh-ancestor
110644496|NCT04073537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110644497|NCT01020994|Octenidine|octenidine|mesh-list
110644498|NCT01020994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110644499|NCT01020994|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110644500|NCT00494026|Carboplatin|carboplatin|mesh-list
110644501|NCT00494026|Pemetrexed|pemetrexed|mesh-list
110644502|NCT00494026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110644503|NCT00494026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110644504|NCT00494026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110644505|NCT00494026|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110644506|NCT00494026|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110644507|NCT00524589|Calcitriol|calcitriol|mesh-list
110644508|NCT00524589|Dexamethasone|dexamethasone|mesh-list
110644509|NCT00524589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110644510|NCT00524589|Antiemetics|antiemetics|mesh-ancestor
110644511|NCT00524589|Autonomic Agents|autonomic agents|mesh-ancestor
110644512|NCT00524589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110644513|NCT00524589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110644514|NCT00524589|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110644515|NCT00524589|Glucocorticoids|glucocorticoids|mesh-ancestor
110644517|NCT00524589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110644518|NCT00524589|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110644519|NCT00524589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110644520|NCT00524589|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110644521|NCT00524589|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
110644522|NCT00524589|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110644523|NCT00524589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110644524|NCT00524589|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110644525|NCT00524589|Vitamins|vitamins|mesh-ancestor
110644526|NCT00524589|Micronutrients|micronutrients|mesh-ancestor
110644527|NCT00524589|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110644528|NCT01015066|Naltrexone|naltrexone|mesh-list
110644529|NCT01015066|Buprenorphine|buprenorphine|mesh-list
110644530|NCT01015066|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
110644531|NCT01015066|Naloxone|naloxone|mesh-list
110644532|NCT01015066|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110644533|NCT01015066|Narcotics|narcotics|mesh-ancestor
110644534|NCT01015066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110644535|NCT01015066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110644536|NCT01015066|Analgesics|analgesics|mesh-ancestor
110644537|NCT01015066|Sensory System Agents|sensory system agents|mesh-ancestor
110644538|NCT01015066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110644539|NCT01015066|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110644540|NCT01015066|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110644541|NCT00472030|Omalizumab|omalizumab|mesh-list
110644542|NCT00472030|Prednisone|prednisone|mesh-list
110644543|NCT00472030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110644544|NCT00472030|Glucocorticoids|glucocorticoids|mesh-ancestor
110644545|NCT00472030|Hormones|hormones|mesh-ancestor
110644546|NCT00472030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110644547|NCT00472030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110644548|NCT00472030|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110644549|NCT00472030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110644550|NCT00472030|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110644551|NCT00472030|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110644552|NCT00472030|Respiratory System Agents|respiratory system agents|mesh-ancestor
110644554|NCT00127855|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110644555|NCT00127855|Immunologic Factors|immunologic factors|mesh-ancestor
110644556|NCT00127855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110644557|NCT00493636|Gemcitabine|gemcitabine|mesh-list
110644558|NCT00493636|Capecitabine|capecitabine|mesh-list
110644559|NCT00493636|Sorafenib|sorafenib|mesh-list
110644560|NCT00493636|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110644561|NCT00493636|Antimetabolites|antimetabolites|mesh-ancestor
110644562|NCT00493636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110644563|NCT00493636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110644564|NCT00493636|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110644565|NCT00493636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110644566|NCT00524121|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110644567|NCT00524121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110644568|NCT00524121|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110644569|NCT00524121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110159197|NCT00089401|Melphalan|melphalan|mesh-list
110644570|NCT00524121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110644571|NCT01018342|Nitrofurantoin|nitrofurantoin|mesh-list
110644572|NCT01018342|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110644573|NCT01018342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110644574|NCT01018342|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110644575|NCT03965767|Tranexamic Acid|tranexamic acid|mesh-list
110644576|NCT03965767|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110644578|NCT03965767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110644579|NCT03965767|Hemostatics|hemostatics|mesh-ancestor
110644580|NCT03965767|Coagulants|coagulants|mesh-ancestor
110644581|NCT00132769|MK 0873|mk 0873|mesh-list
110644582|NCT00132769|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
110644583|NCT00132769|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110644585|NCT00132769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110644586|NCT02478255|Xenon|xenon|mesh-list
110644587|NCT02478255|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110644588|NCT02478255|Anesthetics, General|anesthetics, general|mesh-ancestor
110644589|NCT02478255|Anesthetics|anesthetics|mesh-ancestor
110644590|NCT02478255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110644591|NCT02478255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110644592|NCT00132691|Cyclosporine|cyclosporine|mesh-list
110644593|NCT00132691|Mycophenolic Acid|mycophenolic acid|mesh-list
110644594|NCT00132691|Infliximab|infliximab|mesh-list
110644595|NCT00132691|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
110644596|NCT00132691|Cyclophosphamide|cyclophosphamide|mesh-list
110644597|NCT00132691|Chlorambucil|chlorambucil|mesh-list
110644598|NCT00132691|Methotrexate|methotrexate|mesh-list
110644599|NCT00132691|Azathioprine|azathioprine|mesh-list
110644600|NCT00132691|Tacrolimus|tacrolimus|mesh-list
110644601|NCT00132691|Cyclosporins|cyclosporins|mesh-list
110644602|NCT00132691|Daclizumab|daclizumab|mesh-list
110644603|NCT00132691|Immunosuppressive Agents|immunosuppressive agents|mesh-list
110644604|NCT00132691|Alkylating Agents|alkylating agents|mesh-list
110644605|NCT00132691|Immunologic Factors|immunologic factors|mesh-ancestor
110644606|NCT00132691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110644607|NCT00132691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110644608|NCT00132691|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110644609|NCT00132691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110644610|NCT00132691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110644611|NCT00132691|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110644612|NCT00132691|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110644613|NCT00132691|Abortifacient Agents|abortifacient agents|mesh-ancestor
110644614|NCT00132691|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110644615|NCT00132691|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110644616|NCT00132691|Antimetabolites|antimetabolites|mesh-ancestor
110644617|NCT00132691|Dermatologic Agents|dermatologic agents|mesh-ancestor
110644618|NCT00132691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110644619|NCT00132691|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110644620|NCT00132691|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110644621|NCT00132691|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110644622|NCT00132691|Antifungal Agents|antifungal agents|mesh-ancestor
110644623|NCT00132691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110644624|NCT00132691|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110644625|NCT00132691|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110644626|NCT00132691|Antitubercular Agents|antitubercular agents|mesh-ancestor
110644627|NCT00132691|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110644628|NCT00132691|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110644629|NCT00132691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110644630|NCT00132691|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110644631|NCT00132691|Glucocorticoids|glucocorticoids|mesh-ancestor
110644632|NCT00132691|Hormones|hormones|mesh-ancestor
110644633|NCT00132691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110644634|NCT02390427|Paclitaxel|paclitaxel|mesh-list
110644635|NCT02390427|Maytansine|maytansine|mesh-list
110644637|NCT02390427|Trastuzumab|trastuzumab|mesh-list
110644638|NCT02390427|Pertuzumab|pertuzumab|mesh-list
110644639|NCT02390427|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110644640|NCT02390427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110644641|NCT02390427|Tubulin Modulators|tubulin modulators|mesh-ancestor
110644642|NCT02390427|Antimitotic Agents|antimitotic agents|mesh-ancestor
110644643|NCT02390427|Mitosis Modulators|mitosis modulators|mesh-ancestor
110159202|NCT00089401|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110644644|NCT02390427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110397182|NCT01320722|Probenecid|probenecid|mesh-list
110644646|NCT02390427|Immunotoxins|immunotoxins|mesh-ancestor
110644647|NCT02390427|Immunoconjugates|immunoconjugates|mesh-ancestor
110644648|NCT02390427|Immunologic Factors|immunologic factors|mesh-ancestor
110644649|NCT02390427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110644650|NCT00125359|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110644651|NCT00125359|Bexarotene|bexarotene|mesh-list
110644652|NCT00125359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110644653|NCT00125359|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110644654|NCT00125359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110644655|NCT00125359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110644656|NCT00524043|Paliperidone Palmitate|paliperidone palmitate|mesh-list
110644657|NCT00524043|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110644658|NCT00524043|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110317820|NCT00322400|Antimitotic Agents|antimitotic agents|mesh-ancestor
110644659|NCT00524043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110644660|NCT00524043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110644661|NCT00524043|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110644662|NCT00524043|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110644663|NCT00524043|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110644664|NCT00524043|Serotonin Agents|serotonin agents|mesh-ancestor
110644665|NCT00524043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110644666|NCT00524043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110644667|NCT00524043|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110644668|NCT00524043|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110644669|NCT00524043|Dopamine Agents|dopamine agents|mesh-ancestor
110644670|NCT01076803|Lanreotide|lanreotide|mesh-list
110644671|NCT01076803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110644672|NCT00523419|Pemetrexed|pemetrexed|mesh-list
110644673|NCT00523419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110644674|NCT00523419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110644675|NCT00523419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110644676|NCT00523419|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110644677|NCT00523419|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110644678|NCT03868059|Methyltestosterone|methyltestosterone|mesh-list
110644679|NCT03868059|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
110644680|NCT03868059|Testosterone|testosterone|mesh-list
110644681|NCT03868059|Testosterone undecanoate|testosterone undecanoate|mesh-list
110644682|NCT03868059|Testosterone enanthate|testosterone enanthate|mesh-list
110644683|NCT03868059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110644684|NCT03868059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110644685|NCT03868059|Anabolic Agents|anabolic agents|mesh-ancestor
110644686|NCT03868059|Hormones|hormones|mesh-ancestor
110644687|NCT03868059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110644688|NCT03868059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110644689|NCT03868059|Androgens|androgens|mesh-ancestor
110644690|NCT04028115|Ixazomib|ixazomib|mesh-list
110644691|NCT04028115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110644692|NCT04028115|Protease Inhibitors|protease inhibitors|mesh-ancestor
110644693|NCT04028115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110644694|NCT04028115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110644695|NCT06027970|Terlipressin|terlipressin|mesh-list
110644696|NCT06027970|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110644697|NCT06027970|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110644698|NCT06027840|Varenicline|varenicline|mesh-list
110644699|NCT06027840|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110644700|NCT06027840|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110644701|NCT06027840|Cholinergic Agents|cholinergic agents|mesh-ancestor
110644702|NCT06027840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110644703|NCT06027840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110644704|NCT06027840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110644705|NCT06027801|Vaccines|vaccines|mesh-list
110644706|NCT06027801|Immunologic Factors|immunologic factors|mesh-ancestor
110644707|NCT06027801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110644708|NCT06027723|Nicotine|nicotine|mesh-list
110644709|NCT06027723|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110644710|NCT06027723|Autonomic Agents|autonomic agents|mesh-ancestor
110644711|NCT06027723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110644712|NCT06027723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110644726|NCT06027606|Autonomic Agents|autonomic agents|mesh-ancestor
110644727|NCT06027606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110644728|NCT06027606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110644729|NCT06027606|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110644730|NCT06027606|Respiratory System Agents|respiratory system agents|mesh-ancestor
110644731|NCT06027606|Glucocorticoids|glucocorticoids|mesh-ancestor
110644732|NCT06027606|Hormones|hormones|mesh-ancestor
110644733|NCT06027606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110644734|NCT06027606|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110644735|NCT06027606|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110644736|NCT06027606|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110644737|NCT06027606|Adrenergic Agents|adrenergic agents|mesh-ancestor
110644738|NCT06027606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110317913|NCT00322907|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110644739|NCT06027606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110644740|NCT06027606|Tocolytic Agents|tocolytic agents|mesh-ancestor
110644741|NCT06027606|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110644754|NCT06027151|Metronidazole|metronidazole|mesh-list
110644755|NCT06027151|Minocycline|minocycline|mesh-list
110644756|NCT06027151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110644757|NCT06027151|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110644758|NCT06027151|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110644759|NCT06027151|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110644760|NCT06027086|Durvalumab|durvalumab|mesh-list
110644761|NCT06027086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110644762|NCT06027086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110644763|NCT06027073|Omalizumab|omalizumab|mesh-list
110644764|NCT06027073|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110644765|NCT06027073|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110644766|NCT06027073|Respiratory System Agents|respiratory system agents|mesh-ancestor
110644767|NCT06026878|Gemcitabine|gemcitabine|mesh-list
110644768|NCT06026878|Nimotuzumab|nimotuzumab|mesh-list
110644769|NCT06026878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110644770|NCT06026878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110644771|NCT06026878|Antimetabolites|antimetabolites|mesh-ancestor
110644772|NCT06026878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110644773|NCT06026878|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110644774|NCT06026787|Dapagliflozin|dapagliflozin|mesh-list
110644775|NCT06026787|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110644776|NCT06026787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110644777|NCT06026787|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110644778|NCT06026787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110644779|NCT06026657|Gemcitabine|gemcitabine|mesh-list
110644780|NCT06026657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110644781|NCT06026657|Antibodies|antibodies|mesh-list
110644782|NCT06026657|Immunoglobulins|immunoglobulins|mesh-list
110644783|NCT06026657|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110644784|NCT06026657|Immunologic Factors|immunologic factors|mesh-ancestor
110292013|NCT00223691|Acarbose|acarbose|mesh-list
110644785|NCT06026657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110159210|NCT00089440|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110644786|NCT06026657|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110644788|NCT06026657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110644789|NCT06026657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110644790|NCT06026553|Ketorolac|ketorolac|mesh-list
110644791|NCT06026553|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
110644792|NCT06026553|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110644793|NCT06026553|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110644794|NCT06026553|Analgesics|analgesics|mesh-ancestor
110644795|NCT06026553|Sensory System Agents|sensory system agents|mesh-ancestor
110644796|NCT06026553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110644797|NCT06026553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110644798|NCT06026553|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110644799|NCT06026553|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110644800|NCT06026553|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110644801|NCT06026553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110644802|NCT06026553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110644803|NCT06026527|Magnesium Sulfate|magnesium sulfate|mesh-list
110644804|NCT06026527|Analgesics|analgesics|mesh-ancestor
110644805|NCT06026527|Sensory System Agents|sensory system agents|mesh-ancestor
110644806|NCT06026527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110644807|NCT06026527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110644808|NCT06026527|Anesthetics|anesthetics|mesh-ancestor
110644809|NCT06026527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110644810|NCT06026527|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110644811|NCT06026527|Anticonvulsants|anticonvulsants|mesh-ancestor
110644812|NCT06026527|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110644813|NCT06026527|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110644814|NCT06026527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110644815|NCT06026527|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110644816|NCT06026527|Tocolytic Agents|tocolytic agents|mesh-ancestor
110644817|NCT06026527|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110644818|NCT06022302|Laxatives|laxatives|mesh-list
110644819|NCT06022302|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110644820|NCT06022068|Sirolimus|sirolimus|mesh-list
110644821|NCT06022068|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110644822|NCT06022068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110644823|NCT06022068|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110644824|NCT06022068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110644825|NCT06022068|Antifungal Agents|antifungal agents|mesh-ancestor
110644826|NCT06022068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110644827|NCT06022068|Immunologic Factors|immunologic factors|mesh-ancestor
110644828|NCT06022068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110644829|NCT06017817|Anti-Infective Agents|anti-infective agents|mesh-list
110644830|NCT06016634|Alendronate|alendronate|mesh-list
110644831|NCT06016634|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110644832|NCT06016634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110644833|NCT05997199|Vitamin D|vitamin d|mesh-list
110644834|NCT05997199|Vitamins|vitamins|mesh-ancestor
110644835|NCT05997199|Micronutrients|micronutrients|mesh-ancestor
110644836|NCT05997199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110318038|NCT00353340|Antioxidants|antioxidants|mesh-ancestor
110644837|NCT05997199|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110644838|NCT05980702|Paclitaxel|paclitaxel|mesh-list
110644839|NCT05980702|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110644840|NCT05980702|Carboplatin|carboplatin|mesh-list
110644841|NCT05980702|Pembrolizumab|pembrolizumab|mesh-list
110644842|NCT05980702|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110644843|NCT05980702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110644844|NCT05980702|Tubulin Modulators|tubulin modulators|mesh-ancestor
110397221|NCT01310127|Nepafenac|nepafenac|mesh-list
110644845|NCT05980702|Antimitotic Agents|antimitotic agents|mesh-ancestor
110644846|NCT05980702|Mitosis Modulators|mitosis modulators|mesh-ancestor
110644847|NCT05980702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110644848|NCT05980702|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110644849|NCT05980702|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110644850|NCT05974748|Propolis|propolis|mesh-list
110644851|NCT05974748|Sodium Hypochlorite|sodium hypochlorite|mesh-list
110644852|NCT05974748|Eusol|eusol|mesh-list
110644853|NCT05974748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110644854|NCT05974748|Disinfectants|disinfectants|mesh-ancestor
110644855|NCT05965726|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
110644856|NCT05965726|Antiviral Agents|antiviral agents|mesh-ancestor
110644857|NCT05965726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110644858|NCT05963984|Fulvestrant|fulvestrant|mesh-list
110292091|NCT00223691|Diuretics|diuretics|mesh-ancestor
110644859|NCT05963984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110644860|NCT05963984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110318087|NCT01059773|Antimetabolites|antimetabolites|mesh-ancestor
110644861|NCT05963984|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110644862|NCT05963984|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110644863|NCT05963984|Hormone Antagonists|hormone antagonists|mesh-ancestor
110644864|NCT05963984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110644865|NCT05963984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110644866|NCT05959850|Ambroxol|ambroxol|mesh-list
110644867|NCT05959850|Expectorants|expectorants|mesh-ancestor
110270832|NCT00165347|Vatalanib|vatalanib|mesh-list
110644868|NCT05959850|Respiratory System Agents|respiratory system agents|mesh-ancestor
110644869|NCT05955768|Lidocaine|lidocaine|mesh-list
110644870|NCT05955768|Anesthetics, Local|anesthetics, local|mesh-ancestor
110644871|NCT05955768|Anesthetics|anesthetics|mesh-ancestor
110644872|NCT05955768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110644873|NCT05955768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110644874|NCT05955768|Sensory System Agents|sensory system agents|mesh-ancestor
110644875|NCT05955768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110644876|NCT05955768|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110644877|NCT05955768|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110644878|NCT05955768|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110644879|NCT05955768|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110644880|NCT05955768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110644881|NCT05938699|Bimatoprost|bimatoprost|mesh-list
110644882|NCT05938699|Nitric Oxide|nitric oxide|mesh-list
110644883|NCT05938699|Lubricant Eye Drops|lubricant eye drops|mesh-list
110644884|NCT05938699|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110644885|NCT05938699|Autonomic Agents|autonomic agents|mesh-ancestor
110644886|NCT05938699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110644887|NCT05938699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110644888|NCT05938699|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110644889|NCT05938699|Respiratory System Agents|respiratory system agents|mesh-ancestor
110644890|NCT05938699|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110644891|NCT05938699|Antioxidants|antioxidants|mesh-ancestor
110644892|NCT05938699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110644893|NCT05938699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110644894|NCT05938699|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
110644895|NCT05938699|Vasodilator Agents|vasodilator agents|mesh-ancestor
110644896|NCT05938699|Gasotransmitters|gasotransmitters|mesh-ancestor
110644897|NCT05938699|Protective Agents|protective agents|mesh-ancestor
110644898|NCT05938699|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110644899|NCT05938699|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110644900|NCT05938699|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110644901|NCT05927142|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
110644903|NCT05927142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110644904|NCT05927142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110644905|NCT05927142|Antiviral Agents|antiviral agents|mesh-ancestor
110644906|NCT05927142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110644907|NCT05909995|Ipilimumab|ipilimumab|mesh-list
110644908|NCT05909995|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110644909|NCT05909995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110644910|NCT05909995|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110644911|NCT05909995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110644912|NCT05904743|Insulin|insulin|mesh-list
110644913|NCT05904743|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110644914|NCT05904743|Insulin, Short-Acting|insulin, short-acting|mesh-list
110644915|NCT05904743|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110644916|NCT05904743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110644917|NCT05899816|KHK4083|khk4083|mesh-list
110644918|NCT05899816|Dermatologic Agents|dermatologic agents|mesh-ancestor
110644921|NCT05892887|Bupivacaine|bupivacaine|mesh-list
110644922|NCT05892887|Anesthetics, Local|anesthetics, local|mesh-ancestor
110644923|NCT05892887|Anesthetics|anesthetics|mesh-ancestor
110644924|NCT05892887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110644925|NCT05892887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110644926|NCT05892887|Sensory System Agents|sensory system agents|mesh-ancestor
110644927|NCT05892887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110644928|NCT05892744|Sertraline|sertraline|mesh-list
110644930|NCT05892744|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110644931|NCT05892744|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110644932|NCT05892744|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110318184|NCT00324467|Analgesics|analgesics|mesh-ancestor
110644933|NCT05892744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110644934|NCT05892744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110644935|NCT05892744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110644936|NCT05892744|Serotonin Agents|serotonin agents|mesh-ancestor
110644937|NCT05892744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110644938|NCT05872256|Halobetasol|halobetasol|mesh-list
110644939|NCT05872256|Tazarotene|tazarotene|mesh-list
110644940|NCT05872256|Dermatologic Agents|dermatologic agents|mesh-ancestor
110644941|NCT05872256|Keratolytic Agents|keratolytic agents|mesh-ancestor
110644942|NCT05872256|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110644943|NCT05866315|Remifentanil|remifentanil|mesh-list
110644944|NCT05866315|Desflurane|desflurane|mesh-list
110644945|NCT05866315|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110644946|NCT05866315|Narcotics|narcotics|mesh-ancestor
110644947|NCT05866315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110644948|NCT05866315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110644949|NCT05866315|Analgesics|analgesics|mesh-ancestor
110644950|NCT05866315|Sensory System Agents|sensory system agents|mesh-ancestor
110644951|NCT05866315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110644952|NCT05866315|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110644953|NCT05866315|Anesthetics, General|anesthetics, general|mesh-ancestor
110644954|NCT05866315|Anesthetics|anesthetics|mesh-ancestor
110644955|NCT05848128|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110644956|NCT05848128|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110644957|NCT05843838|Bupivacaine|bupivacaine|mesh-list
110644958|NCT05843838|Anesthetics|anesthetics|mesh-list
110644959|NCT05843838|Anesthetics, Local|anesthetics, local|mesh-ancestor
110644960|NCT05843838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110644961|NCT05843838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110644962|NCT05843838|Sensory System Agents|sensory system agents|mesh-ancestor
110644963|NCT05843838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110644964|NCT05838716|Vitamin D|vitamin d|mesh-list
110644965|NCT05838716|Ergocalciferols|ergocalciferols|mesh-list
110644966|NCT05838716|Cholecalciferol|cholecalciferol|mesh-list
110644967|NCT05838716|Vitamins|vitamins|mesh-list
110644968|NCT05838716|Micronutrients|micronutrients|mesh-ancestor
110644969|NCT05838716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110644970|NCT05838716|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110644971|NCT05838716|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110644972|NCT05828095|MEDI9197|medi9197|mesh-list
110644973|NCT05828095|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110644974|NCT05828095|Immunologic Factors|immunologic factors|mesh-ancestor
110644975|NCT05828095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110644976|NCT05816356|Decitabine|decitabine|mesh-list
110644977|NCT05816356|Tetrahydrouridine|tetrahydrouridine|mesh-list
110644978|NCT05816356|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110644979|NCT05816356|Antimetabolites|antimetabolites|mesh-ancestor
110644980|NCT05816356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110644981|NCT05816356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110644982|NCT05816356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110644983|NCT05801757|Propofol|propofol|mesh-list
110644984|NCT05801757|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110644985|NCT05801757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110644986|NCT05801757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110644987|NCT05801757|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110644988|NCT05801757|Anesthetics, General|anesthetics, general|mesh-ancestor
110644989|NCT05801757|Anesthetics|anesthetics|mesh-ancestor
110644990|NCT05799755|Nintedanib|nintedanib|mesh-list
110644991|NCT05799755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110644992|NCT05799755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110644993|NCT05799755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110644994|NCT05799755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110644995|NCT05796089|Carboplatin|carboplatin|mesh-list
110644996|NCT05796089|Etoposide|etoposide|mesh-list
110644997|NCT05796089|Etoposide phosphate|etoposide phosphate|mesh-list
110644998|NCT05796089|Durvalumab|durvalumab|mesh-list
110644999|NCT05796089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110645000|NCT05796089|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110645001|NCT05796089|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110645002|NCT05796089|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110645003|NCT05796089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110645004|NCT05796089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110645007|NCT05794503|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110645008|NCT05794503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110645009|NCT05794503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110645010|NCT05794503|Cholinergic Agents|cholinergic agents|mesh-ancestor
110645012|NCT05794503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110645013|NCT05794503|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110645014|NCT05794503|Autonomic Agents|autonomic agents|mesh-ancestor
110645015|NCT05794503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110645033|NCT05777993|Enzyme Activators|enzyme activators|mesh-ancestor
110645034|NCT05777993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110645035|NCT05774691|Heparin|heparin|mesh-list
110645036|NCT05774691|Calcium heparin|calcium heparin|mesh-list
110645037|NCT05774691|Protamines|protamines|mesh-list
110645038|NCT05774691|Anticoagulants|anticoagulants|mesh-ancestor
110645039|NCT05774691|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110645040|NCT05774691|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110645041|NCT05774691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110645042|NCT05774691|Heparin Antagonists|heparin antagonists|mesh-ancestor
110645043|NCT05774691|Coagulants|coagulants|mesh-ancestor
110645044|NCT05774366|Desflurane|desflurane|mesh-list
110645045|NCT05774366|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110645046|NCT05774366|Anesthetics, General|anesthetics, general|mesh-ancestor
110645047|NCT05774366|Anesthetics|anesthetics|mesh-ancestor
110645048|NCT05774366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110645049|NCT05774366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110645050|NCT05759156|Tranexamic Acid|tranexamic acid|mesh-list
110645051|NCT05759156|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110645052|NCT05759156|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110397249|NCT01313858|Golimumab|golimumab|mesh-list
110645065|NCT05705349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110645066|NCT05705349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110645067|NCT05705349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110645068|NCT05705349|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110645069|NCT05705349|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110645070|NCT05705349|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110645071|NCT05704049|Dexamethasone|dexamethasone|mesh-list
110645072|NCT05704049|Dexamethasone acetate|dexamethasone acetate|mesh-list
110645073|NCT05704049|BB 1101|bb 1101|mesh-list
110645074|NCT05704049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110645075|NCT05704049|Antiemetics|antiemetics|mesh-ancestor
110645076|NCT05704049|Autonomic Agents|autonomic agents|mesh-ancestor
110645077|NCT05704049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110645078|NCT05704049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110645079|NCT05704049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110645080|NCT05704049|Glucocorticoids|glucocorticoids|mesh-ancestor
110645081|NCT05704049|Hormones|hormones|mesh-ancestor
110645082|NCT05704049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110645083|NCT05704049|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110645084|NCT05704049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110645085|NCT05704049|Protease Inhibitors|protease inhibitors|mesh-ancestor
110292316|NCT00224354|Immunoconjugates|immunoconjugates|mesh-ancestor
110645086|NCT05704049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110645087|NCT05704049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110645088|NCT05692167|Dexmedetomidine|dexmedetomidine|mesh-list
110645089|NCT05692167|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110645090|NCT05692167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110645091|NCT05692167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110645092|NCT05692167|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110645093|NCT05692167|Analgesics|analgesics|mesh-ancestor
110645094|NCT05692167|Sensory System Agents|sensory system agents|mesh-ancestor
110645095|NCT05692167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110645096|NCT05692167|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110645097|NCT05692167|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110645098|NCT05692167|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110645099|NCT05692167|Adrenergic Agents|adrenergic agents|mesh-ancestor
110645100|NCT05692167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110645101|NCT05692167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110645102|NCT05689047|Artesunate|artesunate|mesh-list
110645103|NCT05689047|Pyronaridine|pyronaridine|mesh-list
110645104|NCT05689047|Pyronaridine tetraphosphate, artesunate drug combination|pyronaridine tetraphosphate, artesunate drug combination|mesh-list
110645105|NCT05689047|Antimalarials|antimalarials|mesh-ancestor
110645106|NCT05689047|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110645107|NCT05689047|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110645108|NCT05689047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110645109|NCT05689047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110645110|NCT05689047|Antiviral Agents|antiviral agents|mesh-ancestor
110645111|NCT05689047|Schistosomicides|schistosomicides|mesh-ancestor
110645112|NCT05689047|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110397263|NCT01313858|Immunologic Factors|immunologic factors|mesh-ancestor
110645113|NCT05689047|Anthelmintics|anthelmintics|mesh-ancestor
110645114|NCT05687266|Paclitaxel|paclitaxel|mesh-list
110645115|NCT05687266|Carboplatin|carboplatin|mesh-list
110645116|NCT05687266|Pembrolizumab|pembrolizumab|mesh-list
110645117|NCT05687266|Pemetrexed|pemetrexed|mesh-list
110645118|NCT05687266|Durvalumab|durvalumab|mesh-list
110645119|NCT05687266|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110645120|NCT05687266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110645121|NCT05687266|Tubulin Modulators|tubulin modulators|mesh-ancestor
110645122|NCT05687266|Antimitotic Agents|antimitotic agents|mesh-ancestor
110645123|NCT05687266|Mitosis Modulators|mitosis modulators|mesh-ancestor
110645124|NCT05687266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110645125|NCT05687266|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110645126|NCT05687266|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110645127|NCT05687266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110645128|NCT05687266|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110645129|NCT05687266|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110645130|NCT05678673|Nivolumab|nivolumab|mesh-list
110645131|NCT05678673|Sunitinib|sunitinib|mesh-list
110645132|NCT05678673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110645133|NCT05678673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110645134|NCT05678673|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110645135|NCT05678673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110645136|NCT05678673|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110645137|NCT05678673|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110645138|NCT05678673|Growth Substances|growth substances|mesh-ancestor
110645139|NCT05678673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110645140|NCT05678673|Growth Inhibitors|growth inhibitors|mesh-ancestor
110645141|NCT05678673|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110645142|NCT05678673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110645143|NCT05669846|Pembrolizumab|pembrolizumab|mesh-list
110645144|NCT05669846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110159224|NCT00089518|Valsartan|valsartan|mesh-list
110645157|NCT05650775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110645158|NCT05635604|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
110645159|NCT05635604|Growth Substances|growth substances|mesh-ancestor
110645160|NCT05635604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110645161|NCT05635604|Vasodilator Agents|vasodilator agents|mesh-ancestor
110645162|NCT05635604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110645163|NCT05635604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110645164|NCT05630222|Acetaminophen|acetaminophen|mesh-list
110645165|NCT05630222|Ibuprofen|ibuprofen|mesh-list
110645166|NCT05630222|Morphine|morphine|mesh-list
110645167|NCT05630222|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110645168|NCT05630222|Narcotics|narcotics|mesh-ancestor
110645169|NCT05630222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110645170|NCT05630222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110645171|NCT05630222|Analgesics|analgesics|mesh-ancestor
110645172|NCT05630222|Sensory System Agents|sensory system agents|mesh-ancestor
110645173|NCT05630222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110645174|NCT05630222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110645175|NCT05630222|Antipyretics|antipyretics|mesh-ancestor
110645176|NCT05630222|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110645177|NCT05630222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110645178|NCT05630222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110645179|NCT05630222|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110645180|NCT05630222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110645181|NCT05630222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110645196|NCT05618730|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110645197|NCT05618730|Lubricant Eye Drops|lubricant eye drops|mesh-list
110645198|NCT05618730|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110645199|NCT05598619|Ascorbic Acid|ascorbic acid|mesh-list
110645200|NCT05598619|Vitamins|vitamins|mesh-ancestor
110645201|NCT05598619|Micronutrients|micronutrients|mesh-ancestor
110645202|NCT05598619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110645203|NCT05598619|Antioxidants|antioxidants|mesh-ancestor
110645204|NCT05598619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110645205|NCT05598619|Protective Agents|protective agents|mesh-ancestor
110645206|NCT05596747|Insulin Glargine|insulin glargine|mesh-list
110159230|NCT00089557|Antipruritics|antipruritics|mesh-ancestor
110645207|NCT05596747|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110645208|NCT05596747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110645209|NCT05565378|Pembrolizumab|pembrolizumab|mesh-list
110645210|NCT05565378|Dostarlimab|dostarlimab|mesh-list
110645211|NCT05565378|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110645212|NCT05565378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110645213|NCT05565378|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110318620|NCT00354549|Antimetabolites|antimetabolites|mesh-ancestor
110645214|NCT05565378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110645216|NCT05557578|Oxaliplatin|oxaliplatin|mesh-list
110645217|NCT05557578|Tislelizumab|tislelizumab|mesh-list
110645218|NCT05557578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110645219|NCT05557578|Antimetabolites|antimetabolites|mesh-ancestor
110645220|NCT05557578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110645221|NCT05557578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110645222|NCT05557578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110645223|NCT05546866|Osimertinib|osimertinib|mesh-list
110645224|NCT05546866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110645225|NCT05546866|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110645226|NCT05546866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110645227|NCT05546866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110645228|NCT05546554|Suvorexant|suvorexant|mesh-list
110645229|NCT05546554|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110645230|NCT05546554|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110645231|NCT05546554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110645232|NCT05546554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110645233|NCT05546554|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
110645234|NCT05546554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110645235|NCT05546554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110645236|NCT05540574|Zolpidem|zolpidem|mesh-list
110645237|NCT05540574|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110645238|NCT05540574|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110645239|NCT05540574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110645240|NCT05540574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110645241|NCT05540574|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
110645242|NCT05540574|GABA Agonists|gaba agonists|mesh-ancestor
110645243|NCT05540574|GABA Agents|gaba agents|mesh-ancestor
110645244|NCT05540574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110645245|NCT05540574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110645246|NCT05523986|Vitamin D|vitamin d|mesh-list
110645247|NCT05523986|Vitamins|vitamins|mesh-ancestor
110645248|NCT05523986|Micronutrients|micronutrients|mesh-ancestor
110645249|NCT05523986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110645250|NCT05523986|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110645251|NCT05501678|Diphenhydramine|diphenhydramine|mesh-list
110645252|NCT05501678|Promethazine|promethazine|mesh-list
110645253|NCT05501678|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110318710|NCT00426972|Hormones|hormones|mesh-ancestor
110645254|NCT05501678|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110645255|NCT05501678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110645256|NCT05501678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110645257|NCT05501678|Anesthetics, Local|anesthetics, local|mesh-ancestor
110645258|NCT05501678|Anesthetics|anesthetics|mesh-ancestor
110645259|NCT05501678|Sensory System Agents|sensory system agents|mesh-ancestor
110318772|NCT00425997|Valsartan|valsartan|mesh-list
110645260|NCT05501678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110645262|NCT05501678|Autonomic Agents|autonomic agents|mesh-ancestor
110645263|NCT05501678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110645264|NCT05501678|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110645265|NCT05501678|Histamine Antagonists|histamine antagonists|mesh-ancestor
110645266|NCT05501678|Histamine Agents|histamine agents|mesh-ancestor
110645267|NCT05501678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110645268|NCT05501678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110645269|NCT05501678|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110645270|NCT05501678|Antipruritics|antipruritics|mesh-ancestor
110645271|NCT05501678|Dermatologic Agents|dermatologic agents|mesh-ancestor
110645272|NCT05497596|Vitamin D|vitamin d|mesh-list
110645273|NCT05497596|Vitamins|vitamins|mesh-ancestor
110645274|NCT05497596|Micronutrients|micronutrients|mesh-ancestor
110645275|NCT05497596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110645276|NCT05497596|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110645277|NCT05495204|Ibalizumab|ibalizumab|mesh-list
110645278|NCT05495204|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110645279|NCT05495204|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110645280|NCT05495204|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110645281|NCT05495204|Antiviral Agents|antiviral agents|mesh-ancestor
110645282|NCT05495204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110645283|NCT05495204|Immunologic Factors|immunologic factors|mesh-ancestor
110645284|NCT05495204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110645286|NCT05488405|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110645287|NCT05488405|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110645289|NCT05488405|Sensory System Agents|sensory system agents|mesh-ancestor
110645290|NCT05488405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110645291|NCT05488405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110645292|NCT05488405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110645293|NCT05488405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110645294|NCT05468697|Palbociclib|palbociclib|mesh-list
110645295|NCT05468697|Belzutifan|belzutifan|mesh-list
110645296|NCT05468697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110645297|NCT05468697|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110645298|NCT05468697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110645299|NCT05468697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110645300|NCT05466799|Oxaliplatin|oxaliplatin|mesh-list
110645301|NCT05466799|Irinotecan|irinotecan|mesh-list
110645302|NCT05466799|Folfirinox|folfirinox|mesh-list
110645303|NCT05466799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110645304|NCT05466799|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110645305|NCT05466799|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110645306|NCT05466799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110645307|NCT05466799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110645308|NCT05457257|Prednisone|prednisone|mesh-list
110645310|NCT05457257|Abiraterone Acetate|abiraterone acetate|mesh-list
110645311|NCT05457257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110645312|NCT05457257|Glucocorticoids|glucocorticoids|mesh-ancestor
110645313|NCT05457257|Hormones|hormones|mesh-ancestor
110645314|NCT05457257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110645315|NCT05457257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110645316|NCT05457257|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110645317|NCT05457257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110645318|NCT05457257|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110645319|NCT05457257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110645320|NCT05457257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110645321|NCT05457257|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110645322|NCT05457257|Hormone Antagonists|hormone antagonists|mesh-ancestor
110645323|NCT05457257|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110645324|NCT05440786|Irinotecan|irinotecan|mesh-list
110645325|NCT05440786|Temozolomide|temozolomide|mesh-list
110645326|NCT05440786|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110645327|NCT05440786|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110645328|NCT05440786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110645329|NCT05440786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110645330|NCT05440786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110645331|NCT05440786|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110645332|NCT05440786|Alkylating Agents|alkylating agents|mesh-ancestor
110645333|NCT05430438|Dialysis Solutions|dialysis solutions|mesh-list
110645334|NCT05430438|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110645335|NCT05400369|Moxifloxacin|moxifloxacin|mesh-list
110645336|NCT05400369|Sitafloxacin|sitafloxacin|mesh-list
110645337|NCT05400369|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
110645338|NCT05400369|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110645339|NCT05400369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110645340|NCT05400369|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110645341|NCT05400369|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110645342|NCT05400369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110645343|NCT05400369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110645344|NCT05400369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110645345|NCT05400369|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110645346|NCT05400369|Contraceptive Agents|contraceptive agents|mesh-ancestor
110645347|NCT05400369|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110159246|NCT00089830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110645348|NCT05400369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110645349|NCT05400369|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110645350|NCT05400369|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110319135|NCT00433095|Tubulin Modulators|tubulin modulators|mesh-ancestor
110645351|NCT05400369|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110645352|NCT05322577|Nivolumab|nivolumab|mesh-list
110645353|NCT05322577|Bemarituzumab|bemarituzumab|mesh-list
110645354|NCT05322577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110645355|NCT05322577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110645356|NCT05322577|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110319198|NCT00428766|Farletuzumab|farletuzumab|mesh-list
110645357|NCT05322577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110645358|NCT05320393|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110645359|NCT05320393|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110645360|NCT05320393|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110645361|NCT05320393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110645362|NCT05320393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110645363|NCT05320393|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110645364|NCT05320393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110645365|NCT05320393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110645366|NCT05320393|Cholinergic Agents|cholinergic agents|mesh-ancestor
110645367|NCT05320393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110645369|NCT05317858|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110645370|NCT05317858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110645371|NCT05317858|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110319334|NCT04704297|Analgesics|analgesics|mesh-ancestor
110645372|NCT05317858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110645374|NCT05283980|Anesthetics, Local|anesthetics, local|mesh-ancestor
110645375|NCT05283980|Anesthetics|anesthetics|mesh-ancestor
110645376|NCT05283980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110645377|NCT05283980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110645378|NCT05283980|Sensory System Agents|sensory system agents|mesh-ancestor
110645379|NCT05283980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110645380|NCT05272254|Povidone-Iodine|povidone-iodine|mesh-list
110645381|NCT05272254|Povidone|povidone|mesh-list
110645382|NCT05272254|Plasma Substitutes|plasma substitutes|mesh-ancestor
110645383|NCT05272254|Blood Substitutes|blood substitutes|mesh-ancestor
110645384|NCT05272254|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110645385|NCT05272254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110645387|NCT05271162|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110645388|NCT05271162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110645389|NCT05271162|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110645390|NCT05271162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110645391|NCT05269004|Ocrelizumab|ocrelizumab|mesh-list
110645392|NCT05269004|Immunologic Factors|immunologic factors|mesh-ancestor
110645393|NCT05269004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110645394|NCT05264896|Leucovorin|leucovorin|mesh-list
110645395|NCT05264896|Docetaxel|docetaxel|mesh-list
110645396|NCT05264896|Oxaliplatin|oxaliplatin|mesh-list
110645397|NCT05264896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110645398|NCT05264896|Tubulin Modulators|tubulin modulators|mesh-ancestor
110645399|NCT05264896|Antimitotic Agents|antimitotic agents|mesh-ancestor
110645400|NCT05264896|Mitosis Modulators|mitosis modulators|mesh-ancestor
110645401|NCT05264896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110645402|NCT05264896|Antidotes|antidotes|mesh-ancestor
110645403|NCT05264896|Protective Agents|protective agents|mesh-ancestor
110645404|NCT05264896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110645406|NCT05264896|Vitamins|vitamins|mesh-ancestor
110645407|NCT05264896|Micronutrients|micronutrients|mesh-ancestor
110645408|NCT05263388|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
110645409|NCT05263388|Hormones|hormones|mesh-ancestor
110319737|NCT00330278|Cefazolin|cefazolin|mesh-list
110645410|NCT05263388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110645411|NCT05263388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110645413|NCT05256745|Docetaxel|docetaxel|mesh-list
110645414|NCT05256745|Cyclophosphamide|cyclophosphamide|mesh-list
110645415|NCT05256745|Carboplatin|carboplatin|mesh-list
110645416|NCT05256745|Doxorubicin|doxorubicin|mesh-list
110645417|NCT05256745|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110645418|NCT05256745|Trastuzumab|trastuzumab|mesh-list
110645419|NCT05256745|Pertuzumab|pertuzumab|mesh-list
110645420|NCT05256745|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110645421|NCT05256745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110645422|NCT05256745|Tubulin Modulators|tubulin modulators|mesh-ancestor
110645423|NCT05256745|Antimitotic Agents|antimitotic agents|mesh-ancestor
110645424|NCT05256745|Mitosis Modulators|mitosis modulators|mesh-ancestor
110645425|NCT05256745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110645426|NCT05256745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110645427|NCT05256745|Immunologic Factors|immunologic factors|mesh-ancestor
110645428|NCT05256745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110319894|NCT00331058|Hormones|hormones|mesh-ancestor
110645429|NCT05256745|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110645430|NCT05256745|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110645431|NCT05256745|Alkylating Agents|alkylating agents|mesh-ancestor
110645432|NCT05256745|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110645433|NCT05256745|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110645434|NCT05256745|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110645435|NCT05256745|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110645436|NCT05256745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110645437|NCT05256745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110645439|NCT05248919|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
110645441|NCT05248919|Antiviral Agents|antiviral agents|mesh-ancestor
110645442|NCT05248919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110645443|NCT05236842|Sulthiame|sulthiame|mesh-list
110645444|NCT05236842|Anticonvulsants|anticonvulsants|mesh-ancestor
110645445|NCT05228574|Amiloride|amiloride|mesh-list
110645446|NCT05228574|Diuretics|diuretics|mesh-ancestor
110645447|NCT05228574|Natriuretic Agents|natriuretic agents|mesh-ancestor
110645448|NCT05228574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110645449|NCT05228574|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
110645450|NCT05228574|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110645451|NCT05228574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110645452|NCT05228574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110645453|NCT05228574|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
110645454|NCT05228574|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110645456|NCT05194124|Hormones|hormones|mesh-ancestor
110645457|NCT05194124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110645458|NCT05194124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110645459|NCT05176509|Pembrolizumab|pembrolizumab|mesh-list
110645460|NCT05176509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110645461|NCT05176509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110645462|NCT05176509|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110645463|NCT05176509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110645464|NCT05176483|Nivolumab|nivolumab|mesh-list
110645465|NCT05176483|Ipilimumab|ipilimumab|mesh-list
110645466|NCT05176483|Relatlimab|relatlimab|mesh-list
110645467|NCT05176483|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110645468|NCT05176483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110645469|NCT05176483|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110320073|NCT00332072|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110645470|NCT05176483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110645472|NCT05176288|Avelumab|avelumab|mesh-list
110645473|NCT05176288|Axitinib|axitinib|mesh-list
110645474|NCT05176288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110645475|NCT05176288|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110645476|NCT05176288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110320124|NCT00332345|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110645477|NCT05176288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110645478|NCT05176288|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110645480|NCT05159934|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110645481|NCT05159934|Autonomic Agents|autonomic agents|mesh-ancestor
110645482|NCT05159934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110645483|NCT05159934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110645484|NCT05159934|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110645485|NCT05159934|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110645486|NCT05159934|Cholinergic Agents|cholinergic agents|mesh-ancestor
110645488|NCT05159934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110645489|NCT05150340|Immunoglobulins|immunoglobulins|mesh-list
110645490|NCT05150340|Immunologic Factors|immunologic factors|mesh-ancestor
110645491|NCT05150340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110645493|NCT05123703|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
110645494|NCT05123703|Immunologic Factors|immunologic factors|mesh-ancestor
110645495|NCT05123703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110255943|NCT00339196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110645496|NCT05123703|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
110645497|NCT05123703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110645498|NCT05123703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110645499|NCT05116241|Vaccines|vaccines|mesh-list
110645500|NCT05116241|Immunologic Factors|immunologic factors|mesh-ancestor
110645501|NCT05116241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110645502|NCT05098028|Rifaximin|rifaximin|mesh-list
110645503|NCT05098028|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110645504|NCT05098028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110645505|NCT05098028|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110645506|NCT05082753|Ivermectin|ivermectin|mesh-list
110645507|NCT05082753|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110645508|NCT05082753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110645509|NCT05081986|Cycloserine|cycloserine|mesh-list
110645510|NCT05081986|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110645511|NCT05081986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110645512|NCT05081986|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110645513|NCT05081986|Antitubercular Agents|antitubercular agents|mesh-ancestor
110645514|NCT05081986|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110645515|NCT05081986|Antimetabolites|antimetabolites|mesh-ancestor
110645516|NCT05081986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110645517|NCT05067634|Cenobamate|cenobamate|mesh-list
110645518|NCT05067634|Anticonvulsants|anticonvulsants|mesh-ancestor
110645524|NCT05053737|Atezolizumab|atezolizumab|mesh-list
110645525|NCT05053737|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110645526|NCT05053737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110645527|NCT05053737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110645528|NCT05053737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110645529|NCT05043090|Durvalumab|durvalumab|mesh-list
110645530|NCT05043090|Sunitinib|sunitinib|mesh-list
110645531|NCT05043090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110645532|NCT05043090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110645533|NCT05043090|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110292776|NCT00225173|Hormones|hormones|mesh-ancestor
110645534|NCT05043090|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110645535|NCT05043090|Growth Substances|growth substances|mesh-ancestor
110645536|NCT05043090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110645537|NCT05043090|Growth Inhibitors|growth inhibitors|mesh-ancestor
110645538|NCT05043090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110645539|NCT05043090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110645540|NCT05043090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110645541|NCT05038735|Fulvestrant|fulvestrant|mesh-list
110645542|NCT05038735|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110645543|NCT05038735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110645544|NCT05038735|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110645545|NCT05038735|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110645546|NCT05038735|Hormone Antagonists|hormone antagonists|mesh-ancestor
110645547|NCT05038735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110645548|NCT05038735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110645550|NCT05031780|Enzyme Activators|enzyme activators|mesh-ancestor
110645551|NCT05031780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110645552|NCT05021484|Felzartamab|felzartamab|mesh-list
110645553|NCT05021484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110645554|NCT05021484|Immunologic Factors|immunologic factors|mesh-ancestor
110645555|NCT05021484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110645556|NCT05019885|Ketamine|ketamine|mesh-list
110645557|NCT05019885|Analgesics|analgesics|mesh-ancestor
110645558|NCT05019885|Sensory System Agents|sensory system agents|mesh-ancestor
110645559|NCT05019885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110645560|NCT05019885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110645562|NCT05019885|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110645563|NCT05019885|Anesthetics, General|anesthetics, general|mesh-ancestor
110645564|NCT05019885|Anesthetics|anesthetics|mesh-ancestor
110645565|NCT05019885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110645566|NCT05019885|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110645567|NCT05019885|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110645568|NCT05019885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110645569|NCT05019885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110645597|NCT05002270|Cetuximab|cetuximab|mesh-list
110645598|NCT05002270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110645599|NCT05002270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110645600|NCT04998812|Ocrelizumab|ocrelizumab|mesh-list
110645601|NCT04998812|Immunologic Factors|immunologic factors|mesh-ancestor
110645602|NCT04998812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110645603|NCT04990323|Vidarabine|vidarabine|mesh-list
110645604|NCT04990323|Cyclophosphamide|cyclophosphamide|mesh-list
110645605|NCT04990323|Busulfan|busulfan|mesh-list
110645606|NCT04990323|Thiotepa|thiotepa|mesh-list
110645607|NCT04990323|Fludarabine|fludarabine|mesh-list
110645608|NCT04990323|Fludarabine phosphate|fludarabine phosphate|mesh-list
110645609|NCT04990323|Clofarabine|clofarabine|mesh-list
110645610|NCT04990323|Tacrolimus|tacrolimus|mesh-list
110645611|NCT04990323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110645612|NCT04990323|Immunologic Factors|immunologic factors|mesh-ancestor
110645613|NCT04990323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110645614|NCT04990323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110645615|NCT04990323|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110645616|NCT04990323|Alkylating Agents|alkylating agents|mesh-ancestor
110645617|NCT04990323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110645618|NCT04990323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110645619|NCT04990323|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110645621|NCT04990323|Antimetabolites|antimetabolites|mesh-ancestor
110645622|NCT04990323|Antiviral Agents|antiviral agents|mesh-ancestor
110645623|NCT04990323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110645624|NCT04990323|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110645625|NCT04990323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110645626|NCT04989348|Hormones|hormones|mesh-list
110645627|NCT04989348|Progestins|progestins|mesh-list
110645628|NCT04989348|Hormone Antagonists|hormone antagonists|mesh-list
110645629|NCT04989348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110645630|NCT04989348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110645631|NCT04965155|Dexamethasone|dexamethasone|mesh-list
110645632|NCT04965155|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110645633|NCT04965155|Antiemetics|antiemetics|mesh-ancestor
110645642|NCT04965155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110645643|NCT04965064|Capecitabine|capecitabine|mesh-list
110320827|NCT00335348|Hormones|hormones|mesh-ancestor
110645644|NCT04965064|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110645645|NCT04965064|Antimetabolites|antimetabolites|mesh-ancestor
110645646|NCT04965064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110645647|NCT04965064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110645648|NCT04952753|Leucovorin|leucovorin|mesh-list
110645649|NCT04952753|Bevacizumab|bevacizumab|mesh-list
110645650|NCT04952753|Tislelizumab|tislelizumab|mesh-list
110645651|NCT04952753|Oxaliplatin|oxaliplatin|mesh-list
110645652|NCT04952753|Irinotecan|irinotecan|mesh-list
110645653|NCT04952753|Levoleucovorin|levoleucovorin|mesh-list
110645654|NCT04952753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110645655|NCT04952753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110645656|NCT04952753|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110645657|NCT04952753|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110645658|NCT04952753|Growth Substances|growth substances|mesh-ancestor
110645659|NCT04952753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110645660|NCT04952753|Growth Inhibitors|growth inhibitors|mesh-ancestor
110645661|NCT04952753|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110645662|NCT04952753|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110645663|NCT04952753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110645664|NCT04952753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110645665|NCT04952753|Antidotes|antidotes|mesh-ancestor
110645666|NCT04952753|Protective Agents|protective agents|mesh-ancestor
110645667|NCT04952753|Vitamin B Complex|vitamin b complex|mesh-ancestor
110645668|NCT04952753|Vitamins|vitamins|mesh-ancestor
110645669|NCT04952753|Micronutrients|micronutrients|mesh-ancestor
110645670|NCT04938024|Ascorbic Acid|ascorbic acid|mesh-list
110645671|NCT04938024|Vitamins|vitamins|mesh-ancestor
110645672|NCT04938024|Micronutrients|micronutrients|mesh-ancestor
110645673|NCT04938024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110645674|NCT04938024|Antioxidants|antioxidants|mesh-ancestor
110645675|NCT04938024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110645676|NCT04938024|Protective Agents|protective agents|mesh-ancestor
110645685|NCT04925752|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110645686|NCT04925752|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110645687|NCT04925752|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110645688|NCT04925752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110645689|NCT04925752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110645690|NCT04925752|Antiviral Agents|antiviral agents|mesh-ancestor
110645691|NCT04925752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110645692|NCT04925752|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110645693|NCT04925752|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110645694|NCT04910269|Immunoglobulins|immunoglobulins|mesh-list
110645695|NCT04910269|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110645696|NCT04910269|Antibodies|antibodies|mesh-list
110645697|NCT04910269|Immunologic Factors|immunologic factors|mesh-ancestor
110645698|NCT04910269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110645699|NCT04899778|Iron|iron|mesh-list
110645700|NCT04899778|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110159271|NCT00089869|Serotonin Agents|serotonin agents|mesh-ancestor
110645701|NCT04899778|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110645702|NCT04899778|Contraceptive Agents|contraceptive agents|mesh-list
110645703|NCT04899778|Contraceptives, Oral|contraceptives, oral|mesh-list
110645704|NCT04899778|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
110645706|NCT04899778|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110645707|NCT04899778|Trace Elements|trace elements|mesh-ancestor
110645708|NCT04899778|Micronutrients|micronutrients|mesh-ancestor
110645709|NCT04899778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110645710|NCT04899778|Estrogens|estrogens|mesh-ancestor
110645711|NCT04899778|Hormones|hormones|mesh-ancestor
110645712|NCT04899778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110645713|NCT04899778|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110645714|NCT04899778|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110645715|NCT04899778|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110645716|NCT04892706|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
110645717|NCT04892706|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110645718|NCT04892706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110645719|NCT04892706|Analgesics|analgesics|mesh-ancestor
110645720|NCT04892706|Sensory System Agents|sensory system agents|mesh-ancestor
110645721|NCT04892706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110645722|NCT04892706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110645723|NCT04892706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110645724|NCT04892706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110645725|NCT04892706|Dermatologic Agents|dermatologic agents|mesh-ancestor
110645726|NCT04843982|Esketamine|esketamine|mesh-list
110645727|NCT04843982|Antidepressive Agents|antidepressive agents|mesh-ancestor
110645728|NCT04843982|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110645730|NCT04835441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110645731|NCT04835441|Immunologic Factors|immunologic factors|mesh-ancestor
110645732|NCT04835441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110645733|NCT04824599|Ropivacaine|ropivacaine|mesh-list
110645734|NCT04824599|Anesthetics, Local|anesthetics, local|mesh-list
110645735|NCT04824599|Anesthetics|anesthetics|mesh-list
110645736|NCT04824599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110645737|NCT04824599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110645738|NCT04824599|Sensory System Agents|sensory system agents|mesh-ancestor
110645739|NCT04824599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110645740|NCT04817800|Azelastine|azelastine|mesh-list
110645741|NCT04817800|Beclomethasone|beclomethasone|mesh-list
110645742|NCT04817800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110645743|NCT04817800|Glucocorticoids|glucocorticoids|mesh-ancestor
110645744|NCT04817800|Hormones|hormones|mesh-ancestor
110645745|NCT04817800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110255976|NCT00150423|Pregabalin|pregabalin|mesh-list
110645746|NCT04817800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110321475|NCT00340184|Paclitaxel|paclitaxel|mesh-list
110645747|NCT04817800|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110645748|NCT04817800|Respiratory System Agents|respiratory system agents|mesh-ancestor
110645749|NCT04817800|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110645750|NCT04817800|Autonomic Agents|autonomic agents|mesh-ancestor
110645751|NCT04817800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110645752|NCT04817800|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
110645753|NCT04817800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110645754|NCT04817800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110645755|NCT04817800|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110645756|NCT04817800|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110645757|NCT04817800|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110645758|NCT04817800|Histamine Antagonists|histamine antagonists|mesh-ancestor
110645759|NCT04817800|Histamine Agents|histamine agents|mesh-ancestor
110645760|NCT04817800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110645761|NCT04802408|Listerine|listerine|mesh-list
110645762|NCT04802408|Sodium Fluoride|sodium fluoride|mesh-list
110645763|NCT04802408|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110645764|NCT04802408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110645765|NCT04802408|Cariostatic Agents|cariostatic agents|mesh-ancestor
110645766|NCT04802408|Protective Agents|protective agents|mesh-ancestor
110645767|NCT04802408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110645769|NCT04770779|Enzyme Activators|enzyme activators|mesh-ancestor
110645770|NCT04770779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110645771|NCT04770753|Mitapivat|mitapivat|mesh-list
110645772|NCT04770753|Enzyme Activators|enzyme activators|mesh-ancestor
110645773|NCT04770753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110645774|NCT04770155|Bosentan|bosentan|mesh-list
110645775|NCT04770155|Sildenafil Citrate|sildenafil citrate|mesh-list
110645776|NCT04770155|Vasodilator Agents|vasodilator agents|mesh-ancestor
110645777|NCT04770155|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110645778|NCT04770155|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110645779|NCT04770155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110645780|NCT04770155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110645781|NCT04770155|Urological Agents|urological agents|mesh-ancestor
110645782|NCT04770155|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110645783|NCT04770155|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
110645784|NCT04745949|Prednisone|prednisone|mesh-list
110645785|NCT04745949|Cortisone|cortisone|mesh-list
110645786|NCT04745949|Cyclophosphamide|cyclophosphamide|mesh-list
110645787|NCT04745949|Rituximab|rituximab|mesh-list
110645788|NCT04745949|Doxorubicin|doxorubicin|mesh-list
110645789|NCT04745949|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110645790|NCT04745949|Nivolumab|nivolumab|mesh-list
110645791|NCT04745949|Daunorubicin|daunorubicin|mesh-list
110645792|NCT04745949|Brentuximab Vedotin|brentuximab vedotin|mesh-list
110645793|NCT04745949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110645794|NCT04745949|Antibodies|antibodies|mesh-list
110645795|NCT04745949|Immunoglobulins|immunoglobulins|mesh-list
110645796|NCT04745949|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110645797|NCT04745949|Immunoconjugates|immunoconjugates|mesh-list
110645798|NCT04745949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110645799|NCT04745949|Immunologic Factors|immunologic factors|mesh-ancestor
110645800|NCT04745949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110645801|NCT04745949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110645802|NCT04745949|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110645803|NCT04745949|Alkylating Agents|alkylating agents|mesh-ancestor
110645804|NCT04745949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110645805|NCT04745949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110645806|NCT04745949|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110645807|NCT04745949|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110645808|NCT04745949|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110645809|NCT04745949|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110645810|NCT04745949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110645811|NCT04745949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110645812|NCT04745949|Glucocorticoids|glucocorticoids|mesh-ancestor
110645813|NCT04745949|Hormones|hormones|mesh-ancestor
110645814|NCT04745949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110645815|NCT04745949|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110645816|NCT04745949|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110645817|NCT04745949|Immunotoxins|immunotoxins|mesh-ancestor
110645818|NCT04740593|Methamphetamine|methamphetamine|mesh-list
110645819|NCT04740593|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110645820|NCT04740593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110645821|NCT04740593|Sympathomimetics|sympathomimetics|mesh-ancestor
110645822|NCT04740593|Autonomic Agents|autonomic agents|mesh-ancestor
110645823|NCT04740593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110645824|NCT04740593|Dopamine Agents|dopamine agents|mesh-ancestor
110645825|NCT04740593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110321766|NCT00343187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110645826|NCT04740593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110645827|NCT04740593|Adrenergic Agents|adrenergic agents|mesh-ancestor
110645828|NCT04740593|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110645829|NCT04740593|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110645830|NCT04740593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110645831|NCT04740593|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110645832|NCT04704934|Paclitaxel|paclitaxel|mesh-list
110645833|NCT04704934|Trastuzumab|trastuzumab|mesh-list
110645834|NCT04704934|Ramucirumab|ramucirumab|mesh-list
110645835|NCT04704934|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
110321834|NCT00343655|Antimetabolites|antimetabolites|mesh-ancestor
110645836|NCT04704934|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110645837|NCT04704934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110645839|NCT04704934|Antimitotic Agents|antimitotic agents|mesh-ancestor
110645840|NCT04704934|Mitosis Modulators|mitosis modulators|mesh-ancestor
110645841|NCT04704934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110645842|NCT04704934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110645843|NCT04704934|Immunoconjugates|immunoconjugates|mesh-ancestor
110645844|NCT04704934|Immunologic Factors|immunologic factors|mesh-ancestor
110645845|NCT04704934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110645846|NCT04695054|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
110645847|NCT04695054|Anesthetics, Local|anesthetics, local|mesh-ancestor
110645848|NCT04695054|Anesthetics|anesthetics|mesh-ancestor
110645849|NCT04695054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110645850|NCT04695054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110645851|NCT04695054|Sensory System Agents|sensory system agents|mesh-ancestor
110645852|NCT04695054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110645853|NCT04695054|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
110645854|NCT04675151|Phentolamine|phentolamine|mesh-list
110645855|NCT04675151|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110645856|NCT04675151|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110645857|NCT04675151|Pilocarpine|pilocarpine|mesh-list
110645859|NCT04675151|Autonomic Agents|autonomic agents|mesh-ancestor
110645860|NCT04675151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110645861|NCT04675151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110645862|NCT04675151|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
110645863|NCT04675151|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110645864|NCT04675151|Cholinergic Agents|cholinergic agents|mesh-ancestor
110645865|NCT04675151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110645866|NCT04675151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110645867|NCT04675151|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110645868|NCT04675151|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110645869|NCT04675151|Adrenergic Agents|adrenergic agents|mesh-ancestor
110645870|NCT04675151|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110645871|NCT04674670|Bromocriptine|bromocriptine|mesh-list
110645872|NCT04674670|Amisulpride|amisulpride|mesh-list
110645873|NCT04674670|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110645874|NCT04674670|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110645875|NCT04674670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110645876|NCT04674670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110645877|NCT04674670|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110645878|NCT04674670|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110645879|NCT04674670|Dopamine Agents|dopamine agents|mesh-ancestor
110645880|NCT04674670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110645881|NCT04674670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110645882|NCT04674670|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110645883|NCT04674670|Antidepressive Agents|antidepressive agents|mesh-ancestor
110645884|NCT04674670|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110645885|NCT04674670|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110645886|NCT04674670|Hormone Antagonists|hormone antagonists|mesh-ancestor
110645887|NCT04674670|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110645888|NCT04674670|Dopamine Agonists|dopamine agonists|mesh-ancestor
110645890|NCT04663308|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110645891|NCT04629547|Suvorexant|suvorexant|mesh-list
110645892|NCT04629547|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110645893|NCT04629547|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110645894|NCT04629547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110645895|NCT04629547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110645896|NCT04629547|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
110645897|NCT04629547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110645898|NCT04629547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110645899|NCT04629209|TIC10 compound|tic10 compound|mesh-list
110645900|NCT04629209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110645901|NCT04603807|Crizotinib|crizotinib|mesh-list
110645902|NCT04603807|Entrectinib|entrectinib|mesh-list
110645903|NCT04603807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110645904|NCT04603807|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110645905|NCT04603807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110645906|NCT04603807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110645907|NCT04598074|Analgesics, Opioid|analgesics, opioid|mesh-list
110645908|NCT04598074|Narcotics|narcotics|mesh-ancestor
110645909|NCT04598074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110645910|NCT04598074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110645911|NCT04598074|Analgesics|analgesics|mesh-ancestor
110645912|NCT04598074|Sensory System Agents|sensory system agents|mesh-ancestor
110645913|NCT04598074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110645914|NCT04586660|Denosumab|denosumab|mesh-list
110645915|NCT04586660|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110645916|NCT04586660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110645918|NCT04585750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110645919|NCT04585750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110645920|NCT04585750|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110645921|NCT04585750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110645922|NCT04520451|Glucocorticoids|glucocorticoids|mesh-list
110645923|NCT04520451|Hormones|hormones|mesh-ancestor
110645924|NCT04520451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110645925|NCT04520451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110645926|NCT04507412|Dexamethasone|dexamethasone|mesh-list
110645927|NCT04507412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110645928|NCT04507412|Antiemetics|antiemetics|mesh-ancestor
110645929|NCT04507412|Autonomic Agents|autonomic agents|mesh-ancestor
110645930|NCT04507412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110645931|NCT04507412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110645932|NCT04507412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110645933|NCT04507412|Glucocorticoids|glucocorticoids|mesh-ancestor
110645934|NCT04507412|Hormones|hormones|mesh-ancestor
110645935|NCT04507412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110645936|NCT04507412|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110645937|NCT04507412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110645938|NCT04488926|Palmidrol|palmidrol|mesh-list
110645939|NCT04488926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110645940|NCT04488926|Analgesics|analgesics|mesh-ancestor
110645941|NCT04488926|Sensory System Agents|sensory system agents|mesh-ancestor
110645942|NCT04488926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110645943|NCT04488926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110645944|NCT04488926|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110645945|NCT04488926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110645946|NCT04488926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110645947|NCT04488926|Antiviral Agents|antiviral agents|mesh-ancestor
110645948|NCT04488926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110322193|NCT00454701|Alefacept|alefacept|mesh-list
110645949|NCT04488926|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
110645950|NCT04488926|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110645951|NCT04488926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110645952|NCT04488926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110645953|NCT04488926|Hormones|hormones|mesh-ancestor
110645954|NCT04488926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110645955|NCT04483739|Dexamethasone|dexamethasone|mesh-list
110645956|NCT04483739|Dexamethasone acetate|dexamethasone acetate|mesh-list
110645957|NCT04483739|Lenalidomide|lenalidomide|mesh-list
110645958|NCT04483739|BB 1101|bb 1101|mesh-list
110645959|NCT04483739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110645960|NCT04483739|Antiemetics|antiemetics|mesh-ancestor
110645961|NCT04483739|Autonomic Agents|autonomic agents|mesh-ancestor
110645962|NCT04483739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110645963|NCT04483739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110645964|NCT04483739|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110645965|NCT04483739|Glucocorticoids|glucocorticoids|mesh-ancestor
110645966|NCT04483739|Hormones|hormones|mesh-ancestor
110645967|NCT04483739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110645968|NCT04483739|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110645969|NCT04483739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110645970|NCT04483739|Protease Inhibitors|protease inhibitors|mesh-ancestor
110645971|NCT04483739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110645972|NCT04483739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110645973|NCT04483739|Immunologic Factors|immunologic factors|mesh-ancestor
110645974|NCT04483739|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110645975|NCT04483739|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110645976|NCT04483739|Growth Substances|growth substances|mesh-ancestor
110645977|NCT04483739|Growth Inhibitors|growth inhibitors|mesh-ancestor
110645997|NCT04432012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110645999|NCT04432012|Hormones|hormones|mesh-ancestor
110646000|NCT04432012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110646001|NCT04432012|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110646002|NCT04432012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110646003|NCT04432012|Protease Inhibitors|protease inhibitors|mesh-ancestor
110646004|NCT04432012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110646005|NCT04432012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110646024|NCT04420598|Trastuzumab|trastuzumab|mesh-list
110646025|NCT04420598|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
110646026|NCT04420598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110646027|NCT04420598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110646028|NCT04420598|Immunoconjugates|immunoconjugates|mesh-ancestor
110646029|NCT04420598|Immunologic Factors|immunologic factors|mesh-ancestor
110646030|NCT04420598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110646032|NCT04369937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110646033|NCT04369937|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110646034|NCT04369937|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110646035|NCT04369937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110646036|NCT04312360|Metronidazole|metronidazole|mesh-list
110646037|NCT04312360|Fosfomycin|fosfomycin|mesh-list
110646038|NCT04312360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110646039|NCT04312360|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110646040|NCT04312360|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110646041|NCT04312360|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110646042|NCT04302025|Atezolizumab|atezolizumab|mesh-list
110646043|NCT04302025|Vemurafenib|vemurafenib|mesh-list
110646044|NCT04302025|Pralsetinib|pralsetinib|mesh-list
110646045|NCT04302025|Entrectinib|entrectinib|mesh-list
110646046|NCT04302025|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110646047|NCT04302025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110646048|NCT04302025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110322562|NCT00348062|Bimatoprost|bimatoprost|mesh-list
110646049|NCT04302025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110646050|NCT04302025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110646051|NCT04302025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110646052|NCT04272372|Ketoprofen|ketoprofen|mesh-list
110646053|NCT04272372|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110322623|NCT00348296|Antibodies|antibodies|mesh-list
110646054|NCT04272372|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110646055|NCT04272372|Analgesics|analgesics|mesh-ancestor
110646056|NCT04272372|Sensory System Agents|sensory system agents|mesh-ancestor
110646057|NCT04272372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110646058|NCT04272372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110646059|NCT04272372|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110646060|NCT04272372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110646061|NCT04272372|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110646062|NCT04272372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110322696|NCT00348452|Narcotics|narcotics|mesh-ancestor
110646063|NCT04272372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110646064|NCT04256473|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
110646065|NCT04256473|Saruplase|saruplase|mesh-list
110646066|NCT04256473|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110646067|NCT04256473|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110646068|NCT04256473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110646069|NCT04256421|Carboplatin|carboplatin|mesh-list
110646070|NCT04256421|Etoposide|etoposide|mesh-list
110646071|NCT04256421|Atezolizumab|atezolizumab|mesh-list
110646072|NCT04256421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110646073|NCT04256421|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110646074|NCT04256421|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110646075|NCT04256421|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110646076|NCT04256421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110646077|NCT04256421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110256096|NCT00150579|Adderall|adderall|mesh-list
110646078|NCT04256421|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110646079|NCT04256421|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110646080|NCT04221542|Docetaxel|docetaxel|mesh-list
110646081|NCT04221542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110646082|NCT04221542|Tubulin Modulators|tubulin modulators|mesh-ancestor
110646083|NCT04221542|Antimitotic Agents|antimitotic agents|mesh-ancestor
110646084|NCT04221542|Mitosis Modulators|mitosis modulators|mesh-ancestor
110646085|NCT04221542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110646086|NCT04198363|Amoxicillin|amoxicillin|mesh-list
110646087|NCT04198363|Clarithromycin|clarithromycin|mesh-list
110646088|NCT04198363|Potassium Citrate|potassium citrate|mesh-list
110646089|NCT04198363|Esomeprazole|esomeprazole|mesh-list
110646090|NCT04198363|Bismuth|bismuth|mesh-list
110646091|NCT04198363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110322845|NCT00456339|Hormones|hormones|mesh-ancestor
110646092|NCT04198363|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110646093|NCT04198363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110646094|NCT04198363|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110646095|NCT04198363|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110646096|NCT04198363|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110646097|NCT04198363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110256198|NCT04695925|Carboplatin|carboplatin|mesh-list
110646098|NCT04198363|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110646099|NCT04198363|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110646100|NCT04198363|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110646101|NCT04198363|Antacids|antacids|mesh-ancestor
110646102|NCT04198363|Diuretics|diuretics|mesh-ancestor
110646103|NCT04198363|Natriuretic Agents|natriuretic agents|mesh-ancestor
110646104|NCT04198363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110646105|NCT04198363|Expectorants|expectorants|mesh-ancestor
110646106|NCT04198363|Respiratory System Agents|respiratory system agents|mesh-ancestor
110646107|NCT04195828|Paclitaxel|paclitaxel|mesh-list
110646108|NCT04195828|Apatinib|apatinib|mesh-list
110646109|NCT04195828|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110159313|NCT00091039|Paclitaxel|paclitaxel|mesh-list
110646110|NCT04195828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110646111|NCT04195828|Tubulin Modulators|tubulin modulators|mesh-ancestor
110646112|NCT04195828|Antimitotic Agents|antimitotic agents|mesh-ancestor
110646113|NCT04195828|Mitosis Modulators|mitosis modulators|mesh-ancestor
110646114|NCT04195828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110646115|NCT04195828|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110646116|NCT04195828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110646118|NCT04175613|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110646119|NCT04175613|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110646120|NCT04175613|Analgesics|analgesics|mesh-ancestor
110646121|NCT04175613|Sensory System Agents|sensory system agents|mesh-ancestor
110646122|NCT04175613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110646123|NCT04175613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110646124|NCT04175613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110646125|NCT04175613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110256328|NCT00512980|Antimitotic Agents|antimitotic agents|mesh-ancestor
110646126|NCT04175613|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
110646127|NCT04175613|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110646128|NCT04175613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110646129|NCT04175613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110646130|NCT04173247|Mineral Oil|mineral oil|mesh-list
110646131|NCT04173247|Emollients|emollients|mesh-ancestor
110646132|NCT04173247|Dermatologic Agents|dermatologic agents|mesh-ancestor
110646133|NCT04166773|Tirzepatide|tirzepatide|mesh-list
110646134|NCT04166773|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110646135|NCT04166773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110646136|NCT04166773|Incretins|incretins|mesh-ancestor
110646137|NCT04166773|Hormones|hormones|mesh-ancestor
110646138|NCT04166773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110646139|NCT04113382|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
110646140|NCT04113382|Laxatives|laxatives|mesh-ancestor
110646141|NCT04113382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110646142|NCT04112823|Dexamethasone|dexamethasone|mesh-list
110646143|NCT04112823|Dexamethasone acetate|dexamethasone acetate|mesh-list
110646145|NCT04112823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110646146|NCT04112823|Antiemetics|antiemetics|mesh-ancestor
110646147|NCT04112823|Autonomic Agents|autonomic agents|mesh-ancestor
110646148|NCT04112823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110646149|NCT04112823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110646150|NCT04112823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110646152|NCT04112823|Hormones|hormones|mesh-ancestor
110646153|NCT04112823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110646154|NCT04112823|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110646155|NCT04112823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110646156|NCT04112823|Protease Inhibitors|protease inhibitors|mesh-ancestor
110646157|NCT04112823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110646158|NCT04112823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110646159|NCT04099251|Nivolumab|nivolumab|mesh-list
110646160|NCT04099251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110646162|NCT04099251|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110646163|NCT04099251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110646164|NCT04098250|Erenumab|erenumab|mesh-list
110646165|NCT04098250|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
110646166|NCT04098250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110646167|NCT04098250|Analgesics|analgesics|mesh-ancestor
110646168|NCT04098250|Sensory System Agents|sensory system agents|mesh-ancestor
110256525|NCT00514618|Oxytocics|oxytocics|mesh-ancestor
110646169|NCT04098250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110646170|NCT04098250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110646171|NCT04093219|Acetaminophen|acetaminophen|mesh-list
110646172|NCT04093219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110646173|NCT04093219|Analgesics|analgesics|mesh-ancestor
110646174|NCT04093219|Sensory System Agents|sensory system agents|mesh-ancestor
110646175|NCT04093219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110646176|NCT04093219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110646177|NCT04093219|Antipyretics|antipyretics|mesh-ancestor
110646178|NCT04092673|Trastuzumab|trastuzumab|mesh-list
110646179|NCT04092673|Sotorasib|sotorasib|mesh-list
110646180|NCT04092673|Fulvestrant|fulvestrant|mesh-list
110646181|NCT04092673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110646182|NCT04092673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110646183|NCT04092673|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110646184|NCT04092673|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110646185|NCT04092673|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110646186|NCT04092673|Hormone Antagonists|hormone antagonists|mesh-ancestor
110646187|NCT04092673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110646188|NCT04092673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110646189|NCT04092673|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110323236|NCT00352625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110646190|NCT04092673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110646191|NCT04046107|Cemiplimab|cemiplimab|mesh-list
110646192|NCT04046107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110646193|NCT04046107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110646194|NCT04035005|Ocrelizumab|ocrelizumab|mesh-list
110646195|NCT04035005|Immunologic Factors|immunologic factors|mesh-ancestor
110646196|NCT04035005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110646197|NCT03969901|Relebactam|relebactam|mesh-list
110646198|NCT03969901|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110646199|NCT03969901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110646200|NCT03969901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110646201|NCT03969901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110646202|NCT03969901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110646204|NCT03896737|Dexamethasone|dexamethasone|mesh-list
110646205|NCT03896737|Dexamethasone acetate|dexamethasone acetate|mesh-list
110646206|NCT03896737|Cyclophosphamide|cyclophosphamide|mesh-list
110646207|NCT03896737|Bortezomib|bortezomib|mesh-list
110646208|NCT03896737|Daratumumab|daratumumab|mesh-list
110646209|NCT03896737|BB 1101|bb 1101|mesh-list
110323362|NCT00353678|Darexaban|darexaban|mesh-list
110646210|NCT03896737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110646211|NCT03896737|Immunologic Factors|immunologic factors|mesh-ancestor
110646212|NCT03896737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110646213|NCT03896737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110646214|NCT03896737|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110646215|NCT03896737|Alkylating Agents|alkylating agents|mesh-ancestor
110646216|NCT03896737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110646217|NCT03896737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110646218|NCT03896737|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110646219|NCT03896737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110646220|NCT03896737|Antiemetics|antiemetics|mesh-ancestor
110646221|NCT03896737|Autonomic Agents|autonomic agents|mesh-ancestor
110646222|NCT03896737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110646223|NCT03896737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110646224|NCT03896737|Glucocorticoids|glucocorticoids|mesh-ancestor
110646226|NCT03896737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110646227|NCT03896737|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110646228|NCT03896737|Protease Inhibitors|protease inhibitors|mesh-ancestor
110646229|NCT03896737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110646230|NCT03896737|Leprostatic Agents|leprostatic agents|mesh-ancestor
110646231|NCT03896737|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110646232|NCT03896737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110646233|NCT03896737|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110646234|NCT03896737|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110646235|NCT03896737|Growth Substances|growth substances|mesh-ancestor
110646236|NCT03896737|Growth Inhibitors|growth inhibitors|mesh-ancestor
110646237|NCT03875235|Durvalumab|durvalumab|mesh-list
110646238|NCT03875235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110646239|NCT03875235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110646241|NCT03838159|Carboplatin|carboplatin|mesh-list
110646242|NCT03838159|Nivolumab|nivolumab|mesh-list
110256896|NCT05860153|Antiemetics|antiemetics|mesh-ancestor
110646243|NCT03838159|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110646244|NCT03838159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110646245|NCT03838159|Tubulin Modulators|tubulin modulators|mesh-ancestor
110646246|NCT03838159|Antimitotic Agents|antimitotic agents|mesh-ancestor
110646247|NCT03838159|Mitosis Modulators|mitosis modulators|mesh-ancestor
110646248|NCT03838159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110646249|NCT03838159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110323431|NCT00353990|Insulin Aspart|insulin aspart|mesh-list
110646250|NCT03838159|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110646251|NCT03832998|Erenumab|erenumab|mesh-list
110646252|NCT03832998|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110646253|NCT03832998|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
110646254|NCT03832998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110646255|NCT03832998|Analgesics|analgesics|mesh-ancestor
110646256|NCT03832998|Sensory System Agents|sensory system agents|mesh-ancestor
110646257|NCT03832998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110646258|NCT03832998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110646259|NCT03832998|Immunologic Factors|immunologic factors|mesh-ancestor
110646260|NCT03815929|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110646261|NCT03815929|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110646262|NCT03815929|Estradiol|estradiol|mesh-list
110323470|NCT00458367|Dopamine Agents|dopamine agents|mesh-ancestor
110646263|NCT03815929|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110646264|NCT03815929|Estrogens|estrogens|mesh-ancestor
110646265|NCT03815929|Hormones|hormones|mesh-ancestor
110646266|NCT03815929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110646267|NCT03815929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110646268|NCT03815929|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110646269|NCT03815929|Contraceptive Agents|contraceptive agents|mesh-ancestor
110646270|NCT03815929|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110646271|NCT03815929|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110646272|NCT03809988|Letrozole|letrozole|mesh-list
110646273|NCT03809988|Fulvestrant|fulvestrant|mesh-list
110646274|NCT03809988|Palbociclib|palbociclib|mesh-list
110646275|NCT03809988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110646276|NCT03809988|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110646277|NCT03809988|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110646278|NCT03809988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110646279|NCT03809988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110646280|NCT03809988|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110646281|NCT03809988|Hormone Antagonists|hormone antagonists|mesh-ancestor
110646282|NCT03809988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110646283|NCT03809988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110646284|NCT03809988|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110646285|NCT03809988|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110646286|NCT03809988|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110646288|NCT03798626|Paclitaxel|paclitaxel|mesh-list
110646289|NCT03798626|Bevacizumab|bevacizumab|mesh-list
110646290|NCT03798626|Fluorouracil|fluorouracil|mesh-list
110646291|NCT03798626|Oxaliplatin|oxaliplatin|mesh-list
110646292|NCT03798626|Irinotecan|irinotecan|mesh-list
110646293|NCT03798626|Ramucirumab|ramucirumab|mesh-list
110646294|NCT03798626|Levoleucovorin|levoleucovorin|mesh-list
110646295|NCT03798626|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110646296|NCT03798626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110646297|NCT03798626|Tubulin Modulators|tubulin modulators|mesh-ancestor
110646298|NCT03798626|Antimitotic Agents|antimitotic agents|mesh-ancestor
110646299|NCT03798626|Mitosis Modulators|mitosis modulators|mesh-ancestor
110646300|NCT03798626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110646301|NCT03798626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110646302|NCT03798626|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110646303|NCT03798626|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110646304|NCT03798626|Growth Substances|growth substances|mesh-ancestor
110646305|NCT03798626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110646306|NCT03798626|Growth Inhibitors|growth inhibitors|mesh-ancestor
110646307|NCT03798626|Antimetabolites|antimetabolites|mesh-ancestor
110257218|NCT05457582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110646308|NCT03798626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110646309|NCT03798626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110646310|NCT03798626|Immunologic Factors|immunologic factors|mesh-ancestor
110646311|NCT03798626|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110646312|NCT03798626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110646313|NCT03798626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110646314|NCT03798626|Antidotes|antidotes|mesh-ancestor
110646315|NCT03798626|Protective Agents|protective agents|mesh-ancestor
110646316|NCT03798626|Vitamin B Complex|vitamin b complex|mesh-ancestor
110646317|NCT03798626|Vitamins|vitamins|mesh-ancestor
110646318|NCT03798626|Micronutrients|micronutrients|mesh-ancestor
110646319|NCT03778957|Bevacizumab|bevacizumab|mesh-list
110646320|NCT03778957|Durvalumab|durvalumab|mesh-list
110646321|NCT03778957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110646322|NCT03778957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110646323|NCT03778957|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110646324|NCT03778957|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110646325|NCT03778957|Growth Substances|growth substances|mesh-ancestor
110646326|NCT03778957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110646327|NCT03778957|Growth Inhibitors|growth inhibitors|mesh-ancestor
110646328|NCT03778229|Osimertinib|osimertinib|mesh-list
110646329|NCT03778229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110646330|NCT03778229|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110646331|NCT03778229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110257349|NCT04898231|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110646332|NCT03778229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110646333|NCT03776136|Pembrolizumab|pembrolizumab|mesh-list
110646334|NCT03776136|Lenvatinib|lenvatinib|mesh-list
110646335|NCT03776136|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110646336|NCT03776136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110646337|NCT03776136|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110646338|NCT03776136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110646339|NCT03776136|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110646340|NCT03776136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110646341|NCT03773107|Dexamethasone|dexamethasone|mesh-list
110646342|NCT03773107|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110646343|NCT03773107|Antiemetics|antiemetics|mesh-ancestor
110646344|NCT03773107|Autonomic Agents|autonomic agents|mesh-ancestor
110646345|NCT03773107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110257422|NCT04797767|Cytarabine|cytarabine|mesh-list
110646346|NCT03773107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110646347|NCT03773107|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110646348|NCT03773107|Glucocorticoids|glucocorticoids|mesh-ancestor
110646349|NCT03773107|Hormones|hormones|mesh-ancestor
110646350|NCT03773107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110646351|NCT03773107|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110646352|NCT03773107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110646353|NCT03743766|Nivolumab|nivolumab|mesh-list
110646355|NCT03743766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110646356|NCT03743766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110646357|NCT03743766|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110323668|NCT00458991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110646358|NCT03743766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110646361|NCT03716180|Pertuzumab|pertuzumab|mesh-list
110646362|NCT03716180|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110646363|NCT03716180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110646364|NCT03716180|Tubulin Modulators|tubulin modulators|mesh-ancestor
110646365|NCT03716180|Antimitotic Agents|antimitotic agents|mesh-ancestor
110646366|NCT03716180|Mitosis Modulators|mitosis modulators|mesh-ancestor
110646367|NCT03716180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110646368|NCT03716180|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110646370|NCT03710161|Vitamins|vitamins|mesh-ancestor
110646371|NCT03710161|Micronutrients|micronutrients|mesh-ancestor
110646372|NCT03710161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110646373|NCT03710161|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110646374|NCT03706365|Prednisone|prednisone|mesh-list
110646375|NCT03706365|Abiraterone Acetate|abiraterone acetate|mesh-list
110646376|NCT03706365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110646377|NCT03706365|Glucocorticoids|glucocorticoids|mesh-ancestor
110646378|NCT03706365|Hormones|hormones|mesh-ancestor
110323890|NCT01057433|Pitavastatin|pitavastatin|mesh-list
110646379|NCT03706365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110646380|NCT03706365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110323963|NCT00427271|Antipyretics|antipyretics|mesh-ancestor
110646381|NCT03706365|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110646382|NCT03706365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110646383|NCT03706365|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110646384|NCT03706365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110646385|NCT03706365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110646386|NCT03706365|Hormone Antagonists|hormone antagonists|mesh-ancestor
110646387|NCT03706365|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110646388|NCT03696199|Anesthetics|anesthetics|mesh-list
110646389|NCT03696199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110646390|NCT03696199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110646391|NCT03635788|Rilpivirine|rilpivirine|mesh-list
110646392|NCT03635788|Cabotegravir|cabotegravir|mesh-list
110646393|NCT03635788|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110646394|NCT03635788|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110324102|NCT00460473|Analgesics|analgesics|mesh-ancestor
110646395|NCT03635788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110646396|NCT03635788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110646397|NCT03635788|Antiviral Agents|antiviral agents|mesh-ancestor
110646398|NCT03635788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110646399|NCT03635788|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110646400|NCT03635788|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110646401|NCT03635788|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110646402|NCT03635788|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110646403|NCT03568461|Tisagenlecleucel|tisagenlecleucel|mesh-list
110646404|NCT03568461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110646405|NCT03568461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110646406|NCT03568383|Pyridoxine|pyridoxine|mesh-list
110646407|NCT03568383|Pyridoxal|pyridoxal|mesh-list
110646408|NCT03568383|Vitamin B 6|vitamin b 6|mesh-list
110646409|NCT03568383|Isoniazid|isoniazid|mesh-list
110646410|NCT03568383|Vitamins|vitamins|mesh-ancestor
110646411|NCT03568383|Micronutrients|micronutrients|mesh-ancestor
110646412|NCT03568383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110646421|NCT03568383|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110646422|NCT03566667|Metoprolol|metoprolol|mesh-list
110646423|NCT03566667|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110646424|NCT03566667|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110646425|NCT03566667|Sympatholytics|sympatholytics|mesh-ancestor
110646426|NCT03566667|Autonomic Agents|autonomic agents|mesh-ancestor
110646427|NCT03566667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110646429|NCT03566667|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110646430|NCT03566667|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110646431|NCT03566667|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110646432|NCT03566667|Adrenergic Agents|adrenergic agents|mesh-ancestor
110646433|NCT03566667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110646434|NCT03566667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110646444|NCT03539614|Prazosin|prazosin|mesh-list
110646445|NCT03539614|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110646446|NCT03539614|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110159349|NCT00091234|Gemtuzumab|gemtuzumab|mesh-list
110646448|NCT03539614|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110646449|NCT03539614|Adrenergic Agents|adrenergic agents|mesh-ancestor
110646450|NCT03539614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110646451|NCT03539614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110646452|NCT03539614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110646453|NCT03517137|Cyclophosphamide|cyclophosphamide|mesh-list
110646454|NCT03517137|Dacarbazine|dacarbazine|mesh-list
110646455|NCT03517137|Etoposide|etoposide|mesh-list
110646456|NCT03517137|Doxorubicin|doxorubicin|mesh-list
110646457|NCT03517137|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110646458|NCT03517137|Brentuximab Vedotin|brentuximab vedotin|mesh-list
110646459|NCT03517137|Vinblastine|vinblastine|mesh-list
110646460|NCT03517137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110324385|NCT00430196|Tizanidine|tizanidine|mesh-list
110646462|NCT03517137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110646463|NCT03517137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110646464|NCT03517137|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110646465|NCT03517137|Alkylating Agents|alkylating agents|mesh-ancestor
110646466|NCT03517137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110646467|NCT03517137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110646468|NCT03517137|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110646469|NCT03517137|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110646470|NCT03517137|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110646471|NCT03517137|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110646472|NCT03517137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110646473|NCT03517137|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110646474|NCT03517137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110646475|NCT03517137|Immunotoxins|immunotoxins|mesh-ancestor
110646476|NCT03517137|Immunoconjugates|immunoconjugates|mesh-ancestor
110646477|NCT03517137|Tubulin Modulators|tubulin modulators|mesh-ancestor
110646478|NCT03517137|Antimitotic Agents|antimitotic agents|mesh-ancestor
110646479|NCT03517137|Mitosis Modulators|mitosis modulators|mesh-ancestor
110646480|NCT03514589|Cosyntropin|cosyntropin|mesh-list
110646482|NCT03514589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110646483|NCT03514589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110646484|NCT03511664|177Lu-PSMA-617|177lu-psma-617|mesh-list
110646485|NCT03511664|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110646486|NCT03511664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110646487|NCT03495609|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
110646488|NCT03495609|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110646489|NCT03495609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110646490|NCT03475810|Midazolam|midazolam|mesh-list
110646491|NCT03475810|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110646492|NCT03475810|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110646493|NCT03475810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110646494|NCT03475810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110646495|NCT03475810|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110646496|NCT03475810|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110646497|NCT03475810|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110646499|NCT03475810|Anesthetics, General|anesthetics, general|mesh-ancestor
110646500|NCT03475810|Anesthetics|anesthetics|mesh-ancestor
110646501|NCT03475810|GABA Modulators|gaba modulators|mesh-ancestor
110646502|NCT03475810|GABA Agents|gaba agents|mesh-ancestor
110646503|NCT03475810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110646504|NCT03475810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110646522|NCT03389750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110646523|NCT03389750|Analgesics|analgesics|mesh-ancestor
110646524|NCT03389750|Sensory System Agents|sensory system agents|mesh-ancestor
110646525|NCT03389750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110646526|NCT03389750|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110646527|NCT03328884|Irinotecan|irinotecan|mesh-list
110646528|NCT03328884|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110646529|NCT03328884|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110646530|NCT03328884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110646531|NCT03328884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110646532|NCT03328884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110646533|NCT03282981|Timolol|timolol|mesh-list
110646534|NCT03282981|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110646535|NCT03282981|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110324753|NCT00471393|Antioxidants|antioxidants|mesh-ancestor
110646536|NCT03282981|Adrenergic Agents|adrenergic agents|mesh-ancestor
110646537|NCT03282981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110646538|NCT03282981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110646539|NCT03282981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110646540|NCT03282981|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110646541|NCT03282981|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110646542|NCT03161379|Cyclophosphamide|cyclophosphamide|mesh-list
110646543|NCT03161379|Nivolumab|nivolumab|mesh-list
110646544|NCT03161379|Pancrelipase|pancrelipase|mesh-list
110646545|NCT03161379|Vaccines|vaccines|mesh-list
110646546|NCT03161379|Immunologic Factors|immunologic factors|mesh-ancestor
110646547|NCT03161379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110646548|NCT03161379|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110646549|NCT03161379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110324945|NCT03273075|Ticagrelor|ticagrelor|mesh-list
110646550|NCT03161379|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110646551|NCT03161379|Alkylating Agents|alkylating agents|mesh-ancestor
110646552|NCT03161379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110646553|NCT03161379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110646554|NCT03161379|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110646555|NCT03161379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110646556|NCT03161379|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110646557|NCT03161379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110646558|NCT03156036|Capecitabine|capecitabine|mesh-list
110646559|NCT03156036|Temozolomide|temozolomide|mesh-list
110397530|NCT01074931|Ritonavir|ritonavir|mesh-list
110646560|NCT03156036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110646561|NCT03156036|Antimetabolites|antimetabolites|mesh-ancestor
110646562|NCT03156036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110646563|NCT03156036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110646564|NCT03156036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110646593|NCT02998528|Mitosis Modulators|mitosis modulators|mesh-ancestor
110646594|NCT02998528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110646595|NCT02998528|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110646596|NCT02998528|Antimetabolites|antimetabolites|mesh-ancestor
110646597|NCT02998528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110646598|NCT02998528|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110646599|NCT02998528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110646600|NCT02998528|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110325289|NCT03272802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110646601|NCT02998528|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110646602|NCT02994927|Prednisone|prednisone|mesh-list
110646603|NCT02994927|Cyclophosphamide|cyclophosphamide|mesh-list
110646604|NCT02994927|Rituximab|rituximab|mesh-list
110646605|NCT02994927|Azathioprine|azathioprine|mesh-list
110325368|NCT01055015|Morphine|morphine|mesh-list
110646606|NCT02994927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110646607|NCT02994927|Immunologic Factors|immunologic factors|mesh-ancestor
110646608|NCT02994927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110646609|NCT02994927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110325433|NCT00465192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110646610|NCT02994927|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110646611|NCT02994927|Alkylating Agents|alkylating agents|mesh-ancestor
110646612|NCT02994927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110646613|NCT02994927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110646614|NCT02994927|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110646615|NCT02994927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110646616|NCT02994927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110646617|NCT02994927|Glucocorticoids|glucocorticoids|mesh-ancestor
110646618|NCT02994927|Hormones|hormones|mesh-ancestor
110646619|NCT02994927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110646620|NCT02994927|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110646621|NCT02994927|Antimetabolites|antimetabolites|mesh-ancestor
110646622|NCT02994927|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110646636|NCT02881554|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
110646637|NCT02881554|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110646638|NCT02881554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110646639|NCT02873338|Cytarabine|cytarabine|mesh-list
110646640|NCT02873338|Idarubicin|idarubicin|mesh-list
110646641|NCT02873338|Heparin|heparin|mesh-list
110646642|NCT02873338|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110646643|NCT02873338|Antimetabolites|antimetabolites|mesh-ancestor
110646644|NCT02873338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110646645|NCT02873338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110646646|NCT02873338|Antiviral Agents|antiviral agents|mesh-ancestor
110646647|NCT02873338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110646648|NCT02873338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110646649|NCT02873338|Immunologic Factors|immunologic factors|mesh-ancestor
110646650|NCT02873338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110646651|NCT02873338|Anticoagulants|anticoagulants|mesh-ancestor
110646652|NCT02873338|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110646653|NCT02873338|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110646654|NCT02873338|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110646655|NCT02873338|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110646656|NCT02873338|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110646657|NCT02873338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110646658|NCT02864147|Imiquimod|imiquimod|mesh-list
110646659|NCT02864147|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110646660|NCT02864147|Immunologic Factors|immunologic factors|mesh-ancestor
110646661|NCT02864147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110646663|NCT02864147|Interferon Inducers|interferon inducers|mesh-ancestor
110293885|NCT00256737|Omeprazole|omeprazole|mesh-list
110646665|NCT02863055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110646666|NCT02863055|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110646667|NCT02863055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110325690|NCT00481728|Urological Agents|urological agents|mesh-ancestor
110646668|NCT02863055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110646669|NCT02861573|Dexamethasone|dexamethasone|mesh-list
110646670|NCT02861573|Prednisone|prednisone|mesh-list
110646671|NCT02861573|Carboplatin|carboplatin|mesh-list
110646672|NCT02861573|Docetaxel|docetaxel|mesh-list
110646673|NCT02861573|Pembrolizumab|pembrolizumab|mesh-list
110646674|NCT02861573|Etoposide|etoposide|mesh-list
110646675|NCT02861573|Lenvatinib|lenvatinib|mesh-list
110646676|NCT02861573|Olaparib|olaparib|mesh-list
110646677|NCT02861573|Abiraterone Acetate|abiraterone acetate|mesh-list
110646678|NCT02861573|Belzutifan|belzutifan|mesh-list
110646679|NCT02861573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110646680|NCT02861573|Antiemetics|antiemetics|mesh-ancestor
110646681|NCT02861573|Autonomic Agents|autonomic agents|mesh-ancestor
110646682|NCT02861573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110646683|NCT02861573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110646684|NCT02861573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110646685|NCT02861573|Glucocorticoids|glucocorticoids|mesh-ancestor
110646686|NCT02861573|Hormones|hormones|mesh-ancestor
110646687|NCT02861573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110325910|NCT00438113|Atenolol|atenolol|mesh-list
110646688|NCT02861573|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110646689|NCT02861573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110646690|NCT02861573|Tubulin Modulators|tubulin modulators|mesh-ancestor
110646691|NCT02861573|Antimitotic Agents|antimitotic agents|mesh-ancestor
110646692|NCT02861573|Mitosis Modulators|mitosis modulators|mesh-ancestor
110646693|NCT02861573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110646694|NCT02861573|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110646695|NCT02861573|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110326038|NCT00475137|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110646696|NCT02861573|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110646697|NCT02861573|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110646698|NCT02861573|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110646699|NCT02861573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110646700|NCT02861573|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110646701|NCT02861573|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110646702|NCT02861573|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110646703|NCT02861573|Hormone Antagonists|hormone antagonists|mesh-ancestor
110646704|NCT02861573|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110646705|NCT02809690|Clevudine|clevudine|mesh-list
110646706|NCT02809690|Antiviral Agents|antiviral agents|mesh-ancestor
110646707|NCT02809690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110646708|NCT02788773|Durvalumab|durvalumab|mesh-list
110646709|NCT02788773|Tremelimumab|tremelimumab|mesh-list
110646710|NCT02788773|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110646711|NCT02788773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110646715|NCT02777385|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110326107|NCT00475527|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110646716|NCT02777385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110646717|NCT02725567|Ivacaftor|ivacaftor|mesh-list
110646718|NCT02725567|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
110646719|NCT02725567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110646720|NCT02725567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110646729|NCT02639702|Clozapine|clozapine|mesh-list
110646730|NCT02639702|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110646731|NCT02639702|Serotonin Agents|serotonin agents|mesh-ancestor
110646732|NCT02639702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110397555|NCT01303172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110646733|NCT02639702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110646734|NCT02639702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110646735|NCT02639702|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110646736|NCT02639702|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110646737|NCT02639702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110646738|NCT02639702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110646739|NCT02639702|GABA Antagonists|gaba antagonists|mesh-ancestor
110646741|NCT02592356|Lenvatinib|lenvatinib|mesh-list
110646742|NCT02592356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110646743|NCT02592356|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110646744|NCT02592356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110646745|NCT02592356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110646746|NCT02584933|Ceritinib|ceritinib|mesh-list
110326327|NCT00439751|Goserelin|goserelin|mesh-list
110646747|NCT02584933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110646748|NCT02584933|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110646749|NCT02584933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110646750|NCT02584933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110646754|NCT02517684|Prednisolone|prednisolone|mesh-list
110646755|NCT02517684|Infliximab|infliximab|mesh-list
110646756|NCT02517684|Azathioprine|azathioprine|mesh-list
110646757|NCT02517684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110646758|NCT02517684|Glucocorticoids|glucocorticoids|mesh-ancestor
110646759|NCT02517684|Hormones|hormones|mesh-ancestor
110646760|NCT02517684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110646761|NCT02517684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110646762|NCT02517684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110646763|NCT02517684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110646764|NCT02517684|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110646765|NCT02517684|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110646766|NCT02517684|Dermatologic Agents|dermatologic agents|mesh-ancestor
110646767|NCT02517684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110646768|NCT02517684|Antimetabolites|antimetabolites|mesh-ancestor
110326575|NCT00106002|Pemetrexed|pemetrexed|mesh-list
110326581|NCT00476853|Nevirapine|nevirapine|mesh-list
110646769|NCT02517684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110646770|NCT02517684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110646771|NCT02517684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110646773|NCT02344290|Pitavastatin|pitavastatin|mesh-list
110646774|NCT02344290|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110646775|NCT02344290|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110646776|NCT02344290|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110646777|NCT02344290|Antimetabolites|antimetabolites|mesh-ancestor
110646778|NCT02344290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110646779|NCT02344290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110646780|NCT02344290|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110646791|NCT02231749|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110646792|NCT02231749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110646793|NCT02231749|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110646794|NCT02231749|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110646795|NCT02231749|Growth Substances|growth substances|mesh-ancestor
110646796|NCT02231749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110646797|NCT02231749|Growth Inhibitors|growth inhibitors|mesh-ancestor
110646798|NCT02231749|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110646799|NCT02231749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110646800|NCT02209545|Pyridoxine|pyridoxine|mesh-list
110646801|NCT02209545|Vitamin B 6|vitamin b 6|mesh-list
110646802|NCT02209545|Misoprostol|misoprostol|mesh-list
110646803|NCT02209545|Vitamins|vitamins|mesh-ancestor
110646804|NCT02209545|Micronutrients|micronutrients|mesh-ancestor
110646805|NCT02209545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110646806|NCT02209545|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110646807|NCT02209545|Abortifacient Agents|abortifacient agents|mesh-ancestor
110646808|NCT02209545|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110646809|NCT02209545|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110646810|NCT02209545|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110646812|NCT02209545|Vitamin B Complex|vitamin b complex|mesh-ancestor
110646814|NCT02108964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110646825|NCT01976065|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110646826|NCT01976065|Metronidazole|metronidazole|mesh-list
110646827|NCT01976065|Ciprofloxacin|ciprofloxacin|mesh-list
110646828|NCT01976065|Minocycline|minocycline|mesh-list
110326976|NCT00440739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110646829|NCT01976065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110646830|NCT01976065|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110646831|NCT01976065|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110646832|NCT01976065|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110646833|NCT01976065|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110646834|NCT01976065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110646835|NCT01976065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110646836|NCT01976065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110646837|NCT01976065|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110646838|NCT01976065|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110646839|NCT01928394|Nivolumab|nivolumab|mesh-list
110646841|NCT01928394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110646842|NCT01928394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110646843|NCT01928394|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110327110|NCT00478998|Tamsulosin|tamsulosin|mesh-list
110646844|NCT01928394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110646845|NCT01921335|Trastuzumab|trastuzumab|mesh-list
110646846|NCT01921335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110646847|NCT01921335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110646848|NCT01915810|Nicotine|nicotine|mesh-list
110646850|NCT01915810|Autonomic Agents|autonomic agents|mesh-ancestor
110646851|NCT01915810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110646852|NCT01915810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110646853|NCT01915810|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110646854|NCT01915810|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110257961|NCT02636582|Vaccines|vaccines|mesh-list
110646855|NCT01915810|Cholinergic Agents|cholinergic agents|mesh-ancestor
110646856|NCT01915810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110646857|NCT01915810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110646858|NCT01909453|Vemurafenib|vemurafenib|mesh-list
110646859|NCT01909453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110646860|NCT01909453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110646861|NCT01909453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110646862|NCT01909453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110646864|NCT01844986|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110171408|NCT00018291|Gabapentin|gabapentin|mesh-list
110646865|NCT01844986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110646866|NCT01844986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110646867|NCT01844986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110646868|NCT01797523|Metformin|metformin|mesh-list
110646869|NCT01797523|Everolimus|everolimus|mesh-list
110646870|NCT01797523|Letrozole|letrozole|mesh-list
110646871|NCT01797523|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110646872|NCT01797523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110646873|NCT01797523|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110327308|NCT00445094|Cilastatin|cilastatin|mesh-list
110646874|NCT01797523|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110646875|NCT01797523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110646876|NCT01797523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110646877|NCT01797523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110646878|NCT01797523|Immunologic Factors|immunologic factors|mesh-ancestor
110646879|NCT01797523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110646880|NCT01797523|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110646881|NCT01797523|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110646882|NCT01797523|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110646883|NCT01797523|Hormone Antagonists|hormone antagonists|mesh-ancestor
110646884|NCT01797523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110646885|NCT01787500|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110646886|NCT01787500|Cetuximab|cetuximab|mesh-list
110646887|NCT01787500|Irinotecan|irinotecan|mesh-list
110646888|NCT01787500|Camptothecin|camptothecin|mesh-list
110646889|NCT01787500|Vemurafenib|vemurafenib|mesh-list
110646890|NCT01787500|Antibodies|antibodies|mesh-list
110646891|NCT01787500|Immunoglobulins|immunoglobulins|mesh-list
110646892|NCT01787500|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110646893|NCT01787500|Immunologic Factors|immunologic factors|mesh-ancestor
110646894|NCT01787500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110646895|NCT01787500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110646896|NCT01787500|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110646897|NCT01787500|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110646898|NCT01787500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110646899|NCT01787500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110646900|NCT01787500|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110646901|NCT01787500|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110646902|NCT01669824|Aspirin|aspirin|mesh-list
110646903|NCT01669824|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110646904|NCT01669824|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110646905|NCT01669824|Analgesics|analgesics|mesh-ancestor
110646906|NCT01669824|Sensory System Agents|sensory system agents|mesh-ancestor
110646907|NCT01669824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110646908|NCT01669824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110646909|NCT01669824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110646910|NCT01669824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110646911|NCT01669824|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110646912|NCT01669824|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110646913|NCT01669824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110646914|NCT01669824|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110327713|NCT00480675|Antiemetics|antiemetics|mesh-ancestor
110646915|NCT01669824|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110646917|NCT01669824|Antipyretics|antipyretics|mesh-ancestor
110646918|NCT01472562|Rituximab|rituximab|mesh-list
110646919|NCT01472562|Lenalidomide|lenalidomide|mesh-list
110646920|NCT01472562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110646921|NCT01472562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110646922|NCT01472562|Immunologic Factors|immunologic factors|mesh-ancestor
110646923|NCT01472562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110646924|NCT01472562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110646925|NCT01472562|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110646926|NCT01472562|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110646927|NCT01472562|Growth Substances|growth substances|mesh-ancestor
110646928|NCT01472562|Growth Inhibitors|growth inhibitors|mesh-ancestor
110646929|NCT01307956|Calcium, Dietary|calcium, dietary|mesh-list
110646930|NCT01307956|Leucovorin|leucovorin|mesh-list
110646931|NCT01307956|Folic Acid|folic acid|mesh-list
110646932|NCT01307956|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110646933|NCT01307956|Panitumumab|panitumumab|mesh-list
110646934|NCT01307956|Fluorouracil|fluorouracil|mesh-list
110646935|NCT01307956|Oxaliplatin|oxaliplatin|mesh-list
110646936|NCT01307956|Antibodies|antibodies|mesh-list
110646937|NCT01307956|Immunoglobulins|immunoglobulins|mesh-list
110646938|NCT01307956|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110646939|NCT01307956|Calcium|calcium|mesh-list
110646940|NCT01307956|Levoleucovorin|levoleucovorin|mesh-list
110646941|NCT01307956|Immunologic Factors|immunologic factors|mesh-ancestor
110646942|NCT01307956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110646943|NCT01307956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110646944|NCT01307956|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110327776|NCT00456872|Sensory System Agents|sensory system agents|mesh-ancestor
110646945|NCT01307956|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110646946|NCT01307956|Antimetabolites|antimetabolites|mesh-ancestor
110646947|NCT01307956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110646948|NCT01307956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110646949|NCT01307956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110646951|NCT01307956|Protective Agents|protective agents|mesh-ancestor
110646952|NCT01307956|Vitamin B Complex|vitamin b complex|mesh-ancestor
110646953|NCT01307956|Vitamins|vitamins|mesh-ancestor
110646954|NCT01307956|Micronutrients|micronutrients|mesh-ancestor
110646955|NCT01307956|Hematinics|hematinics|mesh-ancestor
110646956|NCT01196390|Paclitaxel|paclitaxel|mesh-list
110646958|NCT01196390|Trastuzumab|trastuzumab|mesh-list
110646959|NCT01196390|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110646960|NCT01196390|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
110646961|NCT01196390|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110646962|NCT01196390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110646963|NCT01196390|Tubulin Modulators|tubulin modulators|mesh-ancestor
110646964|NCT01196390|Antimitotic Agents|antimitotic agents|mesh-ancestor
110646965|NCT01196390|Mitosis Modulators|mitosis modulators|mesh-ancestor
110646966|NCT01196390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110646967|NCT01196390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110646968|NCT01164995|Carboplatin|carboplatin|mesh-list
110646969|NCT01164995|Adavosertib|adavosertib|mesh-list
110646970|NCT01164995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110646971|NCT01164995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110328094|NCT00495183|Caffeine|caffeine|mesh-list
110646972|NCT01164995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110646973|NCT01156129|Bisacodyl|bisacodyl|mesh-list
110646974|NCT01156129|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
110646975|NCT01156129|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110646976|NCT01156129|Cathartics|cathartics|mesh-ancestor
110328188|NCT00460382|Darunavir|darunavir|mesh-list
110646977|NCT01156129|Laxatives|laxatives|mesh-ancestor
110646978|NCT01156129|Antidiarrheals|antidiarrheals|mesh-ancestor
110646979|NCT00956007|Cetuximab|cetuximab|mesh-list
110646980|NCT00956007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110646981|NCT00956007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110646982|NCT00905515|Cyclosporine|cyclosporine|mesh-list
110646983|NCT00905515|Tacrolimus|tacrolimus|mesh-list
110646984|NCT00905515|Cyclosporins|cyclosporins|mesh-list
110646985|NCT00905515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110646986|NCT00905515|Immunologic Factors|immunologic factors|mesh-ancestor
110646987|NCT00905515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110646988|NCT00905515|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110646989|NCT00905515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110328232|NCT00488787|Anesthetics, General|anesthetics, general|mesh-ancestor
110646990|NCT00905515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110646992|NCT00905515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110646993|NCT00905515|Dermatologic Agents|dermatologic agents|mesh-ancestor
110646994|NCT00905515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110646995|NCT00877500|Epothilones|epothilones|mesh-list
110646996|NCT00877500|Epothilone B|epothilone b|mesh-list
110646997|NCT00877500|Tubulin Modulators|tubulin modulators|mesh-ancestor
110646998|NCT00877500|Antimitotic Agents|antimitotic agents|mesh-ancestor
110646999|NCT00877500|Mitosis Modulators|mitosis modulators|mesh-ancestor
110647000|NCT00877500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110647001|NCT00877500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110647002|NCT00659126|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
110647003|NCT00659126|Hematinics|hematinics|mesh-ancestor
110647004|NCT00659126|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
110647006|NCT00581139|Midazolam|midazolam|mesh-list
110647007|NCT00581139|Anesthetics|anesthetics|mesh-ancestor
110647008|NCT00581139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110647009|NCT00581139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110647010|NCT00581139|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110647011|NCT00581139|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110647012|NCT00581139|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110647013|NCT00581139|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110647014|NCT00581139|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110647015|NCT00581139|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110647016|NCT00581139|Anesthetics, General|anesthetics, general|mesh-ancestor
110647018|NCT00581139|GABA Agents|gaba agents|mesh-ancestor
110647019|NCT00581139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110647020|NCT00581139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110647021|NCT00572013|Rituximab|rituximab|mesh-list
110647022|NCT00572013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110647023|NCT00572013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110647024|NCT00572013|Immunologic Factors|immunologic factors|mesh-ancestor
110647025|NCT00572013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110647026|NCT00572013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110647027|NCT00493831|Nicotine|nicotine|mesh-list
110647028|NCT00493831|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110647029|NCT00493831|Autonomic Agents|autonomic agents|mesh-ancestor
110647030|NCT00493831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110647031|NCT00493831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110647032|NCT00493831|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110647033|NCT00493831|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110647034|NCT00493831|Cholinergic Agents|cholinergic agents|mesh-ancestor
110647035|NCT00493831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110328745|NCT00497523|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110647036|NCT00493831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110647038|NCT00482690|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110647039|NCT00482690|Autonomic Agents|autonomic agents|mesh-ancestor
110647040|NCT00482690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110294259|NCT04709172|Cefditoren pivoxil|cefditoren pivoxil|mesh-list
110647041|NCT00482690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110647042|NCT00482690|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110647043|NCT00482690|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110647044|NCT00482690|Cholinergic Agents|cholinergic agents|mesh-ancestor
110647045|NCT00482690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110647046|NCT00482690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110647047|NCT00004197|Prednisone|prednisone|mesh-list
110328887|NCT03272321|Oxytocics|oxytocics|mesh-ancestor
110647048|NCT00004197|Cyclophosphamide|cyclophosphamide|mesh-list
110647049|NCT00004197|Doxorubicin|doxorubicin|mesh-list
110647050|NCT00004197|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110647051|NCT00004197|Vincristine|vincristine|mesh-list
110647052|NCT00004197|Mitoxantrone|mitoxantrone|mesh-list
110647053|NCT00004197|Sargramostim|sargramostim|mesh-list
110647054|NCT00004197|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
110647055|NCT00004197|Vaccines|vaccines|mesh-list
110647056|NCT00004197|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110647057|NCT00004197|Immunologic Factors|immunologic factors|mesh-ancestor
110647058|NCT00004197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110647059|NCT00004197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110647060|NCT00004197|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110647061|NCT00004197|Alkylating Agents|alkylating agents|mesh-ancestor
110647062|NCT00004197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110647063|NCT00004197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110647064|NCT00004197|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110159414|NCT00006200|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110647065|NCT00004197|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110647066|NCT00004197|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110647067|NCT00004197|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110647068|NCT00004197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110647069|NCT00004197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110647070|NCT00004197|Glucocorticoids|glucocorticoids|mesh-ancestor
110647072|NCT00004197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110647073|NCT00004197|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110647074|NCT00004197|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110647075|NCT00004197|Tubulin Modulators|tubulin modulators|mesh-ancestor
110647076|NCT00004197|Antimitotic Agents|antimitotic agents|mesh-ancestor
110647077|NCT00004197|Mitosis Modulators|mitosis modulators|mesh-ancestor
110647078|NCT00004197|Analgesics|analgesics|mesh-ancestor
110647079|NCT00004197|Sensory System Agents|sensory system agents|mesh-ancestor
110647080|NCT00004197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110647081|NCT00004197|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110647082|NCT03865407|Allopurinol|allopurinol|mesh-list
110647083|NCT03865407|Antimetabolites|antimetabolites|mesh-ancestor
110647084|NCT03865407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110647085|NCT03865407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110647086|NCT03865407|Gout Suppressants|gout suppressants|mesh-ancestor
110647087|NCT03865407|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110647088|NCT03865407|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110647089|NCT03865407|Antioxidants|antioxidants|mesh-ancestor
110647090|NCT03865407|Protective Agents|protective agents|mesh-ancestor
110647091|NCT03865407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110647092|NCT00487942|Modafinil|modafinil|mesh-list
110647093|NCT00487942|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110647094|NCT00487942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110647095|NCT00487942|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
110647096|NCT00487942|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110647097|NCT00487942|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110647098|NCT00487942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110647099|NCT00132301|Prednisone|prednisone|mesh-list
110647100|NCT00132301|Docetaxel|docetaxel|mesh-list
110647101|NCT00132301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110647102|NCT00132301|Tubulin Modulators|tubulin modulators|mesh-ancestor
110647103|NCT00132301|Antimitotic Agents|antimitotic agents|mesh-ancestor
110647104|NCT00132301|Mitosis Modulators|mitosis modulators|mesh-ancestor
110647105|NCT00132301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110647106|NCT00132301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110647107|NCT00132301|Glucocorticoids|glucocorticoids|mesh-ancestor
110647108|NCT00132301|Hormones|hormones|mesh-ancestor
110647109|NCT00132301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110647110|NCT00132301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110647111|NCT00132301|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110647113|NCT00519831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110647114|NCT00519831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110647116|NCT04303845|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
110647117|NCT04303845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110647118|NCT04303845|Analgesics|analgesics|mesh-ancestor
110647119|NCT04303845|Sensory System Agents|sensory system agents|mesh-ancestor
110647120|NCT04303845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110647121|NCT04303845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110647122|NCT04187703|Azacitidine|azacitidine|mesh-list
110647124|NCT04187703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110647125|NCT04187703|Antimetabolites|antimetabolites|mesh-ancestor
110647126|NCT04187703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110647127|NCT04187703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110647128|NCT04187703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110647129|NCT00131911|Sorafenib|sorafenib|mesh-list
110647130|NCT00131911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110329684|NCT00492687|Alkylating Agents|alkylating agents|mesh-ancestor
110647131|NCT00131911|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110647132|NCT00131911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110647133|NCT00131911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110647134|NCT00184093|Gemcitabine|gemcitabine|mesh-list
110329752|NCT00499668|Antiemetics|antiemetics|mesh-ancestor
110647135|NCT00184093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110647136|NCT00184093|Antimetabolites|antimetabolites|mesh-ancestor
110647137|NCT00184093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110647138|NCT00184093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110647139|NCT01074619|Memantine|memantine|mesh-list
110647140|NCT01074619|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110647141|NCT01074619|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110647142|NCT01074619|Dopamine Agents|dopamine agents|mesh-ancestor
110647143|NCT01074619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110647144|NCT01074619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110647145|NCT01074619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110647146|NCT01074619|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110647147|NCT01074619|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110647148|NCT00183625|Olanzapine|olanzapine|mesh-list
110647149|NCT00183625|Risperidone|risperidone|mesh-list
110647150|NCT00183625|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110647151|NCT00183625|Serotonin Agents|serotonin agents|mesh-ancestor
110647152|NCT00183625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110647153|NCT00183625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110647154|NCT00183625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110647155|NCT00183625|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110647156|NCT00183625|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110647157|NCT00183625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110330040|NCT00500409|Vitamin D|vitamin d|mesh-list
110647158|NCT00183625|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110647159|NCT00183625|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110647160|NCT00183625|Dopamine Agents|dopamine agents|mesh-ancestor
110647161|NCT00183625|Antiemetics|antiemetics|mesh-ancestor
110647162|NCT00183625|Autonomic Agents|autonomic agents|mesh-ancestor
110330099|NCT00500721|Desipramine|desipramine|mesh-list
110647163|NCT00183625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110647164|NCT00183625|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110647165|NCT00183625|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110647166|NCT00183625|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110647167|NCT00183625|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110647169|NCT00511875|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110647170|NCT00511875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110647171|NCT00511875|Antimalarials|antimalarials|mesh-ancestor
110647172|NCT00511875|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110330246|NCT00474773|Celecoxib|celecoxib|mesh-list
110647173|NCT00511875|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110647174|NCT02576327|Dexamethasone|dexamethasone|mesh-list
110647175|NCT02576327|Dexamethasone acetate|dexamethasone acetate|mesh-list
110647176|NCT02576327|Aprepitant|aprepitant|mesh-list
110647177|NCT02576327|Tropisetron|tropisetron|mesh-list
110647178|NCT02576327|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
110647179|NCT02576327|BB 1101|bb 1101|mesh-list
110647180|NCT02576327|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110647181|NCT02576327|Antiemetics|antiemetics|mesh-ancestor
110647183|NCT02576327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110647184|NCT02576327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110647185|NCT02576327|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110647186|NCT02576327|Glucocorticoids|glucocorticoids|mesh-ancestor
110647187|NCT02576327|Hormones|hormones|mesh-ancestor
110330376|NCT00501384|Satavaptan|satavaptan|mesh-list
110647188|NCT02576327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110647189|NCT02576327|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110647190|NCT02576327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110647191|NCT02576327|Protease Inhibitors|protease inhibitors|mesh-ancestor
110647192|NCT02576327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110647193|NCT02576327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110647194|NCT02576327|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110330445|NCT00600145|Mirtazapine|mirtazapine|mesh-list
110647196|NCT02576327|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110647197|NCT02576327|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110647198|NCT02576327|Serotonin Agents|serotonin agents|mesh-ancestor
110647199|NCT00183391|Methylphenidate|methylphenidate|mesh-list
110647200|NCT00183391|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
110647201|NCT00183391|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110647202|NCT00183391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110647203|NCT00183391|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110159422|NCT00006200|Alkylating Agents|alkylating agents|mesh-ancestor
110647204|NCT00183391|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110647205|NCT00183391|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110647206|NCT00183391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110647208|NCT00183391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110647209|NCT00183391|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110647211|NCT00493246|Acetaminophen|acetaminophen|mesh-list
110647212|NCT00493246|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110647213|NCT00493246|Analgesics|analgesics|mesh-ancestor
110647214|NCT00493246|Sensory System Agents|sensory system agents|mesh-ancestor
110647215|NCT00493246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110647216|NCT00493246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110647217|NCT00493246|Antipyretics|antipyretics|mesh-ancestor
110647218|NCT01021150|Cisplatin|cisplatin|mesh-list
110647219|NCT01021150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110647220|NCT03997006|Atropine|atropine|mesh-list
110647221|NCT03997006|Aminophylline|aminophylline|mesh-list
110647222|NCT03997006|Neostigmine|neostigmine|mesh-list
110647223|NCT03997006|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110647224|NCT03997006|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110647225|NCT03997006|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110647226|NCT03997006|Autonomic Agents|autonomic agents|mesh-ancestor
110647227|NCT03997006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110647228|NCT03997006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110647229|NCT03997006|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110647230|NCT03997006|Respiratory System Agents|respiratory system agents|mesh-ancestor
110647231|NCT03997006|Mydriatics|mydriatics|mesh-ancestor
110647232|NCT03997006|Parasympatholytics|parasympatholytics|mesh-ancestor
110330779|NCT01246362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110647233|NCT03997006|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110397609|NCT01074229|Ropivacaine|ropivacaine|mesh-list
110647234|NCT03997006|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110647235|NCT03997006|Cholinergic Agents|cholinergic agents|mesh-ancestor
110647236|NCT03997006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110647237|NCT03997006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110647238|NCT03997006|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110647239|NCT03997006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110647240|NCT03997006|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110647241|NCT03997006|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110647242|NCT03997006|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110647243|NCT03997006|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110647244|NCT03997006|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110647245|NCT03997006|Purinergic Agents|purinergic agents|mesh-ancestor
110647246|NCT03997006|Protective Agents|protective agents|mesh-ancestor
110647247|NCT02281955|Cisplatin|cisplatin|mesh-list
110647248|NCT02281955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110647249|NCT02272049|Xenon|xenon|mesh-list
110647250|NCT02272049|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110647251|NCT02272049|Anesthetics, General|anesthetics, general|mesh-ancestor
110647252|NCT02272049|Anesthetics|anesthetics|mesh-ancestor
110647253|NCT02272049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110647254|NCT02272049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110647255|NCT03996538|Metformin|metformin|mesh-list
110647256|NCT03996538|Vaccines|vaccines|mesh-list
110647257|NCT03996538|Immunologic Factors|immunologic factors|mesh-ancestor
110330911|NCT00475826|Ezetimibe|ezetimibe|mesh-list
110647258|NCT03996538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110647259|NCT03996538|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110647260|NCT02576015|Lidocaine|lidocaine|mesh-list
110647261|NCT02576015|Ropivacaine|ropivacaine|mesh-list
110647262|NCT02576015|Anesthetics, Local|anesthetics, local|mesh-ancestor
110647263|NCT02576015|Anesthetics|anesthetics|mesh-ancestor
110647264|NCT02576015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110647265|NCT02576015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110647266|NCT02576015|Sensory System Agents|sensory system agents|mesh-ancestor
110647267|NCT02576015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110647268|NCT02576015|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110647269|NCT02576015|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110647270|NCT02576015|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110647271|NCT02576015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110647272|NCT02576015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110647273|NCT02577965|Everolimus|everolimus|mesh-list
110647274|NCT02577965|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110647275|NCT02577965|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110647276|NCT02577965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110647277|NCT02577965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110647278|NCT02577965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110647279|NCT02577965|Immunologic Factors|immunologic factors|mesh-ancestor
110647280|NCT02577965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110647281|NCT02577965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110647282|NCT00182689|Sorafenib|sorafenib|mesh-list
110647283|NCT00182689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110647284|NCT00182689|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110647285|NCT00182689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110331098|NCT04325698|Paclitaxel|paclitaxel|mesh-list
110647286|NCT00182689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110647287|NCT02578121|Dexamethasone|dexamethasone|mesh-list
110647288|NCT02578121|Pomalidomide|pomalidomide|mesh-list
110647289|NCT02578121|Ixazomib|ixazomib|mesh-list
110647290|NCT02578121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110647291|NCT02578121|Antiemetics|antiemetics|mesh-ancestor
110647292|NCT02578121|Autonomic Agents|autonomic agents|mesh-ancestor
110647293|NCT02578121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110647294|NCT02578121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110647295|NCT02578121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110647296|NCT02578121|Glucocorticoids|glucocorticoids|mesh-ancestor
110647297|NCT02578121|Hormones|hormones|mesh-ancestor
110647298|NCT02578121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110647299|NCT02578121|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110647300|NCT02578121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110647301|NCT02578121|Immunologic Factors|immunologic factors|mesh-ancestor
110647302|NCT02578121|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110647303|NCT02578121|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110647304|NCT02578121|Growth Substances|growth substances|mesh-ancestor
110647305|NCT02578121|Growth Inhibitors|growth inhibitors|mesh-ancestor
110647306|NCT02578121|Protease Inhibitors|protease inhibitors|mesh-ancestor
110647307|NCT02578121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110647308|NCT02578121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110647310|NCT00487240|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110647311|NCT00487240|Insulin Lispro|insulin lispro|mesh-list
110647312|NCT00487240|Insulin Detemir|insulin detemir|mesh-list
110647313|NCT00487240|Protamines|protamines|mesh-list
110647314|NCT00487240|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110647315|NCT00487240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110647316|NCT00487240|Heparin Antagonists|heparin antagonists|mesh-ancestor
110647317|NCT00487240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110647318|NCT00487240|Coagulants|coagulants|mesh-ancestor
110647319|NCT02577809|Indomethacin|indomethacin|mesh-list
110647320|NCT02577809|Fentanyl|fentanyl|mesh-list
110647321|NCT02577809|Morphine|morphine|mesh-list
110647322|NCT02577809|Bupivacaine|bupivacaine|mesh-list
110647323|NCT02577809|Anesthetics, Local|anesthetics, local|mesh-ancestor
110647324|NCT02577809|Anesthetics|anesthetics|mesh-ancestor
110647325|NCT02577809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110647326|NCT02577809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110647327|NCT02577809|Sensory System Agents|sensory system agents|mesh-ancestor
110647328|NCT02577809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110647329|NCT02577809|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110647331|NCT02577809|Analgesics|analgesics|mesh-ancestor
110331343|NCT00477074|Chelating Agents|chelating agents|mesh-ancestor
110647332|NCT02577809|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110647333|NCT02577809|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110647334|NCT02577809|Anesthetics, General|anesthetics, general|mesh-ancestor
110647335|NCT02577809|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110647336|NCT02577809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110647337|NCT02577809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110647338|NCT02577809|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110647339|NCT02577809|Gout Suppressants|gout suppressants|mesh-ancestor
110647340|NCT02577809|Tocolytic Agents|tocolytic agents|mesh-ancestor
110647341|NCT02577809|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110647342|NCT02577809|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110647343|NCT02577809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110647344|NCT02577809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110647345|NCT02224391|Nicotine|nicotine|mesh-list
110647346|NCT02224391|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110647347|NCT02224391|Autonomic Agents|autonomic agents|mesh-ancestor
110647348|NCT02224391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110647349|NCT02224391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110647350|NCT02224391|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110647351|NCT02224391|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110647352|NCT02224391|Cholinergic Agents|cholinergic agents|mesh-ancestor
110647353|NCT02224391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110331548|NCT00477815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110647354|NCT02224391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110647355|NCT00487162|Insulin|insulin|mesh-list
110647356|NCT00487162|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110647357|NCT00487162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110647358|NCT03871959|Pembrolizumab|pembrolizumab|mesh-list
110647359|NCT03871959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110647360|NCT03871959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110647361|NCT03871959|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110647362|NCT03871959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110647363|NCT00487084|Lidocaine|lidocaine|mesh-list
110647364|NCT00487084|Morphine|morphine|mesh-list
110647365|NCT00487084|Anesthetics, Local|anesthetics, local|mesh-ancestor
110647367|NCT00487084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110647368|NCT00487084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110647369|NCT00487084|Sensory System Agents|sensory system agents|mesh-ancestor
110647370|NCT00487084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110647371|NCT00487084|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110647372|NCT00487084|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110647373|NCT00487084|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110647374|NCT00487084|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110331764|NCT02483247|Antimetabolites|antimetabolites|mesh-ancestor
110647375|NCT00487084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110647376|NCT00487084|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110647378|NCT00487084|Analgesics|analgesics|mesh-ancestor
110647379|NCT00466726|Sargramostim|sargramostim|mesh-list
110647380|NCT00466726|Immunologic Factors|immunologic factors|mesh-ancestor
110647381|NCT00466726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110647382|NCT01721291|Albuterol|albuterol|mesh-list
110647383|NCT01721291|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110647384|NCT01721291|Autonomic Agents|autonomic agents|mesh-ancestor
110647385|NCT01721291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110647386|NCT01721291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110647387|NCT01721291|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110647388|NCT01721291|Respiratory System Agents|respiratory system agents|mesh-ancestor
110647389|NCT01721291|Tocolytic Agents|tocolytic agents|mesh-ancestor
110647390|NCT01721291|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110647391|NCT01721291|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110647392|NCT01721291|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110647393|NCT01721291|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110647394|NCT01721291|Adrenergic Agents|adrenergic agents|mesh-ancestor
110647395|NCT01721291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110647396|NCT01721291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110647397|NCT01021540|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
110647398|NCT01021540|Hormones|hormones|mesh-ancestor
110647399|NCT01021540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110647400|NCT01021540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110647401|NCT04840511|Lidocaine|lidocaine|mesh-list
110647402|NCT04840511|Anesthetics, Local|anesthetics, local|mesh-ancestor
110647403|NCT04840511|Anesthetics|anesthetics|mesh-ancestor
110647404|NCT04840511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110647405|NCT04840511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110647406|NCT04840511|Sensory System Agents|sensory system agents|mesh-ancestor
110647407|NCT04840511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110647408|NCT04840511|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110647409|NCT04840511|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110647410|NCT04840511|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110647411|NCT04840511|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110647412|NCT04840511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110647413|NCT02199665|Dexamethasone|dexamethasone|mesh-list
110647414|NCT02199665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110647415|NCT02199665|Antiemetics|antiemetics|mesh-ancestor
110647416|NCT02199665|Autonomic Agents|autonomic agents|mesh-ancestor
110332243|NCT00482222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110647417|NCT02199665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110647418|NCT02199665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110647419|NCT02199665|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110647420|NCT02199665|Glucocorticoids|glucocorticoids|mesh-ancestor
110647421|NCT02199665|Hormones|hormones|mesh-ancestor
110647422|NCT02199665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110647423|NCT02199665|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110647424|NCT02199665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110647425|NCT01021696|Acetaminophen|acetaminophen|mesh-list
110647426|NCT01021696|Pregabalin|pregabalin|mesh-list
110647427|NCT01021696|Morphine|morphine|mesh-list
110647428|NCT01021696|Buprenorphine|buprenorphine|mesh-list
110647429|NCT01021696|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110647430|NCT01021696|Narcotics|narcotics|mesh-ancestor
110647431|NCT01021696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110647432|NCT01021696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110647433|NCT01021696|Analgesics|analgesics|mesh-ancestor
110647434|NCT01021696|Sensory System Agents|sensory system agents|mesh-ancestor
110647435|NCT01021696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110647436|NCT01021696|Anticonvulsants|anticonvulsants|mesh-ancestor
110647437|NCT01021696|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110647438|NCT01021696|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110647439|NCT01021696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110647440|NCT01021696|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110647441|NCT01021696|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110647442|NCT01021696|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110647443|NCT01021696|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110647444|NCT01021696|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110647445|NCT01021696|Antipyretics|antipyretics|mesh-ancestor
110647446|NCT01021696|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110647448|NCT02577575|Oxytocics|oxytocics|mesh-ancestor
110647449|NCT02577575|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110647450|NCT02577575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110647451|NCT00485758|Niacin|niacin|mesh-list
110647452|NCT00485758|Niacinamide|niacinamide|mesh-list
110647453|NCT00485758|Nicotinic Acids|nicotinic acids|mesh-list
110647454|NCT00485758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110647455|NCT00485758|Antimetabolites|antimetabolites|mesh-ancestor
110647456|NCT00485758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110647457|NCT00485758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110647458|NCT00485758|Vasodilator Agents|vasodilator agents|mesh-ancestor
110647459|NCT00485758|Vitamin B Complex|vitamin b complex|mesh-ancestor
110647460|NCT00485758|Vitamins|vitamins|mesh-ancestor
110647461|NCT00485758|Micronutrients|micronutrients|mesh-ancestor
110647462|NCT00485758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110647463|NCT02577341|Docetaxel|docetaxel|mesh-list
110332438|NCT00480935|Sunitinib|sunitinib|mesh-list
110647464|NCT02577341|Nimotuzumab|nimotuzumab|mesh-list
110647465|NCT02577341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110647466|NCT02577341|Tubulin Modulators|tubulin modulators|mesh-ancestor
110647467|NCT02577341|Antimitotic Agents|antimitotic agents|mesh-ancestor
110647468|NCT02577341|Mitosis Modulators|mitosis modulators|mesh-ancestor
110647469|NCT02577341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110647470|NCT02577341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110647471|NCT02577497|Fluticasone|fluticasone|mesh-list
110647472|NCT02577497|Beclomethasone|beclomethasone|mesh-list
110647473|NCT02577497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110647474|NCT02577497|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110647475|NCT02577497|Autonomic Agents|autonomic agents|mesh-ancestor
110647476|NCT02577497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110647477|NCT02577497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110647478|NCT02577497|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110647479|NCT02577497|Respiratory System Agents|respiratory system agents|mesh-ancestor
110647480|NCT02577497|Dermatologic Agents|dermatologic agents|mesh-ancestor
110647481|NCT02577497|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110647482|NCT02577497|Glucocorticoids|glucocorticoids|mesh-ancestor
110647483|NCT02577497|Hormones|hormones|mesh-ancestor
110647484|NCT02577497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110647485|NCT02575859|Cisplatin|cisplatin|mesh-list
110647486|NCT02575859|Mitomycins|mitomycins|mesh-list
110647487|NCT02575859|Mitomycin|mitomycin|mesh-list
110647488|NCT02575859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110647489|NCT02575859|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110647490|NCT02575859|Alkylating Agents|alkylating agents|mesh-ancestor
110647491|NCT02575859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110397648|NCT05320705|Analgesics|analgesics|mesh-ancestor
110647492|NCT02575859|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110647493|NCT02575859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110647494|NCT00469456|Memantine|memantine|mesh-list
110647495|NCT00469456|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110647496|NCT00469456|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110647497|NCT00469456|Dopamine Agents|dopamine agents|mesh-ancestor
110647498|NCT00469456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110647499|NCT00469456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110647500|NCT00469456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110647501|NCT00469456|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110647502|NCT00469456|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110332615|NCT01240824|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110647504|NCT00581555|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110647505|NCT00581555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110647506|NCT00581555|Analgesics|analgesics|mesh-ancestor
110647507|NCT00581555|Sensory System Agents|sensory system agents|mesh-ancestor
110647508|NCT00581555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110647509|NCT00581555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110647510|NCT00581555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110647512|NCT00581555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110647513|NCT00581555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110647514|NCT00581555|Immunologic Factors|immunologic factors|mesh-ancestor
110647515|NCT00469144|Fludarabine|fludarabine|mesh-list
110647516|NCT00469144|Busulfan|busulfan|mesh-list
110647517|NCT00469144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110647518|NCT00469144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110647519|NCT00469144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110647520|NCT00469144|Immunologic Factors|immunologic factors|mesh-ancestor
110332745|NCT00483392|Metformin|metformin|mesh-list
110647522|NCT00469144|Alkylating Agents|alkylating agents|mesh-ancestor
110647523|NCT00469144|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110332809|NCT05644210|Hormones|hormones|mesh-ancestor
110647524|NCT00469144|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110647526|NCT03987022|Ketorolac|ketorolac|mesh-list
110647527|NCT03987022|Oxycodone|oxycodone|mesh-list
110647528|NCT03987022|Hydromorphone|hydromorphone|mesh-list
110647529|NCT03987022|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110647530|NCT03987022|Narcotics|narcotics|mesh-ancestor
110647531|NCT03987022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110647532|NCT03987022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110647533|NCT03987022|Analgesics|analgesics|mesh-ancestor
110647534|NCT03987022|Sensory System Agents|sensory system agents|mesh-ancestor
110647535|NCT03987022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110647536|NCT03987022|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110647537|NCT03987022|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110647538|NCT03987022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110647539|NCT03987022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110647540|NCT03987022|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110647541|NCT03987022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110647542|NCT03987022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110647543|NCT03987022|Antipyretics|antipyretics|mesh-ancestor
110647544|NCT01025128|Vitamin D|vitamin d|mesh-list
110647545|NCT01025128|Vitamins|vitamins|mesh-ancestor
110647546|NCT01025128|Micronutrients|micronutrients|mesh-ancestor
110647547|NCT01025128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110647548|NCT01025128|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110647549|NCT00468910|Aspirin|aspirin|mesh-list
110647550|NCT00468910|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110647551|NCT00468910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110647552|NCT00468910|Analgesics|analgesics|mesh-ancestor
110647553|NCT00468910|Sensory System Agents|sensory system agents|mesh-ancestor
110647554|NCT00468910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110647555|NCT00468910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110647556|NCT00468910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110647557|NCT00468910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110647558|NCT00468910|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110258166|NCT00517621|Paclitaxel|paclitaxel|mesh-list
110647559|NCT00468910|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110647560|NCT00468910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110647561|NCT00468910|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110647562|NCT00468910|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110647563|NCT00468910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110647564|NCT00468910|Antipyretics|antipyretics|mesh-ancestor
110647565|NCT01412333|Interferons|interferons|mesh-list
110647566|NCT01412333|Interferon-beta|interferon-beta|mesh-list
110647567|NCT01412333|Interferon beta-1a|interferon beta-1a|mesh-list
110647568|NCT01412333|Ocrelizumab|ocrelizumab|mesh-list
110647569|NCT01412333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110647570|NCT01412333|Antiviral Agents|antiviral agents|mesh-ancestor
110647571|NCT01412333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110294781|NCT00410540|Morphine|morphine|mesh-list
110647572|NCT01412333|Immunologic Factors|immunologic factors|mesh-ancestor
110332918|NCT04515732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110332921|NCT04515732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110647573|NCT01412333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110647574|NCT01412333|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110647575|NCT02577185|Botulinum Toxins|botulinum toxins|mesh-list
110647576|NCT02577185|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110647577|NCT02577185|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110647578|NCT02577185|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110647579|NCT02577185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110647580|NCT02577185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110647581|NCT02577185|Cholinergic Agents|cholinergic agents|mesh-ancestor
110647582|NCT02577185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110647583|NCT02577185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110647584|NCT02577185|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110647585|NCT02577185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110647586|NCT00519285|Prednisone|prednisone|mesh-list
110647587|NCT00519285|Prednisolone|prednisolone|mesh-list
110647589|NCT00519285|Aflibercept|aflibercept|mesh-list
110647590|NCT00519285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110647591|NCT00519285|Tubulin Modulators|tubulin modulators|mesh-ancestor
110647592|NCT00519285|Antimitotic Agents|antimitotic agents|mesh-ancestor
110647593|NCT00519285|Mitosis Modulators|mitosis modulators|mesh-ancestor
110647594|NCT00519285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110647595|NCT00519285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110647596|NCT00519285|Glucocorticoids|glucocorticoids|mesh-ancestor
110647598|NCT00519285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110647599|NCT00519285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110647600|NCT00519285|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110647601|NCT00519285|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110647602|NCT00519285|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110647603|NCT00519285|Growth Substances|growth substances|mesh-ancestor
110647604|NCT00519285|Growth Inhibitors|growth inhibitors|mesh-ancestor
110647605|NCT00464620|Dasatinib|dasatinib|mesh-list
110647606|NCT00464620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110647607|NCT00464620|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110647608|NCT00464620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110647609|NCT00464620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110647610|NCT05212857|Leuprolide|leuprolide|mesh-list
110647611|NCT05212857|Goserelin|goserelin|mesh-list
110647612|NCT05212857|Triptorelin Pamoate|triptorelin pamoate|mesh-list
110647613|NCT05212857|Abiraterone Acetate|abiraterone acetate|mesh-list
110647614|NCT05212857|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110647615|NCT05212857|Fertility Agents|fertility agents|mesh-ancestor
110647616|NCT05212857|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110647617|NCT05212857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110647618|NCT05212857|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110647619|NCT05212857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110647620|NCT05212857|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110647621|NCT05212857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110647622|NCT05212857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110647623|NCT05212857|Hormone Antagonists|hormone antagonists|mesh-ancestor
110647624|NCT05212857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110647625|NCT05212857|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110333308|NCT02275845|Metformin|metformin|mesh-list
110647626|NCT05212857|Luteolytic Agents|luteolytic agents|mesh-ancestor
110647627|NCT05212857|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110647628|NCT05212857|Contraceptive Agents|contraceptive agents|mesh-ancestor
110647629|NCT05212857|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110647631|NCT02099123|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110647632|NCT02099123|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110647633|NCT02099123|Antimetabolites|antimetabolites|mesh-ancestor
110333376|NCT00485030|Everolimus|everolimus|mesh-list
110647634|NCT02099123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110647635|NCT02099123|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110647636|NCT02099123|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110647637|NCT02099123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110647638|NCT00464542|Metronidazole|metronidazole|mesh-list
110647639|NCT00464542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110647640|NCT00464542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110647641|NCT00464542|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110647642|NCT00464542|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110647643|NCT02578823|Antipyretics|antipyretics|mesh-list
110647644|NCT02578823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110647645|NCT01969643|Trastuzumab|trastuzumab|mesh-list
110647647|NCT01969643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110647648|NCT01969643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110647649|NCT01969643|Immunoconjugates|immunoconjugates|mesh-ancestor
110647650|NCT01969643|Immunologic Factors|immunologic factors|mesh-ancestor
110647651|NCT01969643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110647652|NCT00464308|Esomeprazole|esomeprazole|mesh-list
110647653|NCT00464308|Rabeprazole|rabeprazole|mesh-list
110647654|NCT00464308|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110647655|NCT00464308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110647656|NCT00464308|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110647657|NCT00464308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110647658|NCT00464308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110647659|NCT00463840|Fluorouracil|fluorouracil|mesh-list
110647660|NCT00463840|Oxaliplatin|oxaliplatin|mesh-list
110647661|NCT00463840|Antimetabolites|antimetabolites|mesh-ancestor
110647662|NCT00463840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110647663|NCT00463840|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110647664|NCT00463840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110647665|NCT00463840|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110333492|NCT01241487|Amlodipine|amlodipine|mesh-list
110647666|NCT00463840|Immunologic Factors|immunologic factors|mesh-ancestor
110647667|NCT00463840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110647668|NCT00129389|Paclitaxel|paclitaxel|mesh-list
110647669|NCT00129389|Cyclophosphamide|cyclophosphamide|mesh-list
110647670|NCT00129389|Doxorubicin|doxorubicin|mesh-list
110647671|NCT00129389|Fluorouracil|fluorouracil|mesh-list
110647672|NCT00129389|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110647673|NCT00129389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110647674|NCT00129389|Tubulin Modulators|tubulin modulators|mesh-ancestor
110647675|NCT00129389|Antimitotic Agents|antimitotic agents|mesh-ancestor
110647676|NCT00129389|Mitosis Modulators|mitosis modulators|mesh-ancestor
110647677|NCT00129389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110647678|NCT00129389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110647679|NCT00129389|Immunologic Factors|immunologic factors|mesh-ancestor
110647680|NCT00129389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110647681|NCT00129389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110647682|NCT00129389|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110647683|NCT00129389|Alkylating Agents|alkylating agents|mesh-ancestor
110647684|NCT00129389|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110647685|NCT00129389|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110647686|NCT00129389|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110647687|NCT00129389|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110159465|NCT00091858|Darbepoetin alfa|darbepoetin alfa|mesh-list
110647688|NCT00129389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110647689|NCT00129389|Antimetabolites|antimetabolites|mesh-ancestor
110647690|NCT00129389|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110647692|NCT00468052|Dexmedetomidine|dexmedetomidine|mesh-list
110647693|NCT00468052|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110647694|NCT00468052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110647695|NCT00468052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110647696|NCT00468052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110647697|NCT00468052|Analgesics|analgesics|mesh-ancestor
110647698|NCT00468052|Sensory System Agents|sensory system agents|mesh-ancestor
110647699|NCT00468052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110647700|NCT00468052|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110647701|NCT00468052|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110647702|NCT00468052|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110647703|NCT00468052|Adrenergic Agents|adrenergic agents|mesh-ancestor
110647704|NCT00468052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110333600|NCT00485667|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110647705|NCT00468052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110647707|NCT00468052|Narcotics|narcotics|mesh-ancestor
110647708|NCT00468052|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110647709|NCT00468052|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110647710|NCT00468052|Anesthetics, General|anesthetics, general|mesh-ancestor
110647711|NCT00468052|Anesthetics|anesthetics|mesh-ancestor
110647712|NCT00453310|Sunitinib|sunitinib|mesh-list
110647713|NCT00453310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110647714|NCT00453310|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110647715|NCT00453310|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110647716|NCT00453310|Growth Substances|growth substances|mesh-ancestor
110647717|NCT00453310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110647718|NCT00453310|Growth Inhibitors|growth inhibitors|mesh-ancestor
110647719|NCT00453310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110647720|NCT00453310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110647721|NCT00453310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110647723|NCT00128843|Exemestane|exemestane|mesh-list
110647724|NCT00128843|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110647725|NCT00128843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110647726|NCT00128843|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110647727|NCT00128843|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110647728|NCT00128843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110647729|NCT00128843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110647730|NCT00128843|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110647731|NCT00128843|Hormone Antagonists|hormone antagonists|mesh-ancestor
110647732|NCT00128843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110647733|NCT00128843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110647734|NCT04073927|Butyric Acid|butyric acid|mesh-list
110647735|NCT04073927|Histamine Antagonists|histamine antagonists|mesh-ancestor
110647736|NCT04073927|Histamine Agents|histamine agents|mesh-ancestor
110647737|NCT04073927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110647738|NCT04073927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110647739|NCT04073927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110647740|NCT00124657|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110647741|NCT00124657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110647742|NCT00124657|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110647743|NCT00124657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110647744|NCT00124657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110647745|NCT02578277|BMS-955176|bms-955176|mesh-list
110647746|NCT02578277|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110647747|NCT02578277|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110647748|NCT02578277|Antiviral Agents|antiviral agents|mesh-ancestor
110647749|NCT02578277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110647750|NCT00555906|Dexamethasone|dexamethasone|mesh-list
110647751|NCT00555906|Bortezomib|bortezomib|mesh-list
110647752|NCT00555906|Palbociclib|palbociclib|mesh-list
110647753|NCT00555906|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110647754|NCT00555906|Antiemetics|antiemetics|mesh-ancestor
110647755|NCT00555906|Autonomic Agents|autonomic agents|mesh-ancestor
110647756|NCT00555906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110647757|NCT00555906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110647758|NCT00555906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110647759|NCT00555906|Glucocorticoids|glucocorticoids|mesh-ancestor
110647761|NCT00555906|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110647762|NCT00555906|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110647763|NCT00555906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110397688|NCT01104376|Voriconazole|voriconazole|mesh-list
110647765|NCT00555906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110647766|NCT00555906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110647767|NCT04071353|Interferons|interferons|mesh-list
110647768|NCT04071353|Ribavirin|ribavirin|mesh-list
110647769|NCT04071353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110647770|NCT04071353|Antiviral Agents|antiviral agents|mesh-ancestor
110647771|NCT04071353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110647772|NCT04071353|Antimetabolites|antimetabolites|mesh-ancestor
110647773|NCT04071353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110647774|NCT00709475|Insulin Detemir|insulin detemir|mesh-list
110647775|NCT00709475|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110647776|NCT00709475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110647777|NCT00555672|Fluorouracil|fluorouracil|mesh-list
110647778|NCT00555672|Sunitinib|sunitinib|mesh-list
110647779|NCT00555672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110647780|NCT00555672|Antimetabolites|antimetabolites|mesh-ancestor
110647781|NCT00555672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110647782|NCT00555672|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110647783|NCT00555672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110647784|NCT00555672|Immunologic Factors|immunologic factors|mesh-ancestor
110647785|NCT00555672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110647786|NCT00555672|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110647787|NCT00555672|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110647788|NCT00555672|Growth Substances|growth substances|mesh-ancestor
110647789|NCT00555672|Growth Inhibitors|growth inhibitors|mesh-ancestor
110647790|NCT00555672|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110647791|NCT00555672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110647792|NCT02575547|Docetaxel|docetaxel|mesh-list
110647793|NCT02575547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110647794|NCT02575547|Tubulin Modulators|tubulin modulators|mesh-ancestor
110647795|NCT02575547|Antimitotic Agents|antimitotic agents|mesh-ancestor
110647796|NCT02575547|Mitosis Modulators|mitosis modulators|mesh-ancestor
110647797|NCT02575547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110647798|NCT01037387|Bronchodilator Agents|bronchodilator agents|mesh-list
110647800|NCT01037387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110647801|NCT01037387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110647802|NCT01037387|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110647803|NCT01037387|Respiratory System Agents|respiratory system agents|mesh-ancestor
110647804|NCT02574533|Pembrolizumab|pembrolizumab|mesh-list
110647805|NCT02574533|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
110647806|NCT02574533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110647807|NCT02574533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110647808|NCT02574533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110333713|NCT00485823|Olanzapine|olanzapine|mesh-list
110647809|NCT04652375|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110647810|NCT00709553|Midazolam|midazolam|mesh-list
110397691|NCT01104376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110647811|NCT00709553|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110647812|NCT00709553|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110647813|NCT00709553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110647814|NCT00709553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110647815|NCT00709553|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110647816|NCT00709553|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110647817|NCT00709553|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110647818|NCT00709553|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110647819|NCT00709553|Anesthetics, General|anesthetics, general|mesh-ancestor
110647820|NCT00709553|Anesthetics|anesthetics|mesh-ancestor
110647821|NCT00709553|GABA Modulators|gaba modulators|mesh-ancestor
110647822|NCT00709553|GABA Agents|gaba agents|mesh-ancestor
110647823|NCT00709553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110333828|NCT00486083|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110647824|NCT00709553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110647825|NCT03958656|Cyclophosphamide|cyclophosphamide|mesh-list
110647826|NCT03958656|Fludarabine|fludarabine|mesh-list
110647827|NCT03958656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110647828|NCT03958656|Immunologic Factors|immunologic factors|mesh-ancestor
110647829|NCT03958656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110647830|NCT03958656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110647831|NCT03958656|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110647833|NCT03958656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110647834|NCT03958656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110647835|NCT03958656|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110647836|NCT00561912|Interferons|interferons|mesh-list
110647837|NCT00561912|Interferon-alpha|interferon-alpha|mesh-list
110647838|NCT00561912|Interferon alpha-2|interferon alpha-2|mesh-list
110647839|NCT00561912|Decitabine|decitabine|mesh-list
110647840|NCT00561912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110647841|NCT00561912|Antiviral Agents|antiviral agents|mesh-ancestor
110333896|NCT00486369|Katacalcin|katacalcin|mesh-list
110647842|NCT00561912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110647843|NCT00561912|Immunologic Factors|immunologic factors|mesh-ancestor
110647844|NCT00561912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110647845|NCT00561912|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110647846|NCT00561912|Antimetabolites|antimetabolites|mesh-ancestor
110647847|NCT00561912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110647848|NCT00561912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110647849|NCT00561678|Dexmedetomidine|dexmedetomidine|mesh-list
110647850|NCT00561678|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110647851|NCT00561678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110647852|NCT00561678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110647853|NCT00561678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110647854|NCT00561678|Analgesics|analgesics|mesh-ancestor
110647855|NCT00561678|Sensory System Agents|sensory system agents|mesh-ancestor
110258251|NCT02949232|Hormones|hormones|mesh-ancestor
110647856|NCT00561678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110647857|NCT00561678|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110333954|NCT00486668|Mitosis Modulators|mitosis modulators|mesh-ancestor
110647858|NCT00561678|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110647859|NCT00561678|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110647860|NCT00561678|Adrenergic Agents|adrenergic agents|mesh-ancestor
110647861|NCT00561678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110647862|NCT00561678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110647863|NCT00946608|Loratadine|loratadine|mesh-list
110647864|NCT00946608|Antipruritics|antipruritics|mesh-ancestor
110647865|NCT00946608|Dermatologic Agents|dermatologic agents|mesh-ancestor
110647866|NCT00946608|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110647867|NCT00946608|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110647868|NCT00946608|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110647869|NCT00946608|Histamine Antagonists|histamine antagonists|mesh-ancestor
110647870|NCT00946608|Histamine Agents|histamine agents|mesh-ancestor
110647871|NCT00946608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110334009|NCT04324411|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110647872|NCT00946608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110647873|NCT00946608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110647874|NCT00463684|Vaccines|vaccines|mesh-list
110647875|NCT00463684|Immunologic Factors|immunologic factors|mesh-ancestor
110647876|NCT00463684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110647877|NCT00463606|Calcium, Dietary|calcium, dietary|mesh-list
110647878|NCT00463606|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110647879|NCT00463606|Fenofibric acid|fenofibric acid|mesh-list
110647880|NCT00463606|Calcium|calcium|mesh-list
110647881|NCT00463606|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110647882|NCT00463606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110647883|NCT00463606|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110647884|NCT00463606|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110647885|NCT00463606|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110647886|NCT00463606|Antimetabolites|antimetabolites|mesh-ancestor
110647887|NCT00463606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110647888|NCT00463606|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110647889|NCT00463606|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110647890|NCT00463606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110647891|NCT03961308|Vedolizumab|vedolizumab|mesh-list
110647892|NCT03961308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110647893|NCT00956436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110647894|NCT00956436|Sorafenib|sorafenib|mesh-list
110647895|NCT00956436|Liver Extracts|liver extracts|mesh-list
110647896|NCT00956436|Antibodies|antibodies|mesh-list
110647897|NCT00956436|Immunoglobulins|immunoglobulins|mesh-list
110647898|NCT00956436|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110647899|NCT00956436|Immunologic Factors|immunologic factors|mesh-ancestor
110647900|NCT00956436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110647901|NCT00956436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110647902|NCT00956436|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110647903|NCT00956436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110647904|NCT00956436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110647905|NCT00956436|Hematinics|hematinics|mesh-ancestor
110647906|NCT00950586|Dextromethorphan|dextromethorphan|mesh-list
110647907|NCT00950586|Antitussive Agents|antitussive agents|mesh-ancestor
110647908|NCT00950586|Respiratory System Agents|respiratory system agents|mesh-ancestor
110647909|NCT00950586|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110258260|NCT00518908|Anesthetics|anesthetics|mesh-ancestor
110647910|NCT00950586|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110647911|NCT00950586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110647912|NCT00950586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110647913|NCT00950586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110647914|NCT00467896|Iloprost|iloprost|mesh-list
110647915|NCT00467896|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110647916|NCT00467896|Vasodilator Agents|vasodilator agents|mesh-ancestor
110647917|NCT00946686|Leflunomide|leflunomide|mesh-list
110647918|NCT00946686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110647919|NCT00946686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110647920|NCT00946686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110647921|NCT00946686|Immunologic Factors|immunologic factors|mesh-ancestor
110647922|NCT00946686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110647923|NCT02531737|Docetaxel|docetaxel|mesh-list
110647924|NCT02531737|Nintedanib|nintedanib|mesh-list
110647925|NCT02531737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110647926|NCT02531737|Tubulin Modulators|tubulin modulators|mesh-ancestor
110647927|NCT02531737|Antimitotic Agents|antimitotic agents|mesh-ancestor
110647928|NCT02531737|Mitosis Modulators|mitosis modulators|mesh-ancestor
110647929|NCT02531737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110647930|NCT02531737|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110647931|NCT02531737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110647932|NCT01326559|Docetaxel|docetaxel|mesh-list
110647933|NCT01326559|Cetuximab|cetuximab|mesh-list
110647934|NCT01326559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110647935|NCT01326559|Tubulin Modulators|tubulin modulators|mesh-ancestor
110647936|NCT01326559|Antimitotic Agents|antimitotic agents|mesh-ancestor
110647937|NCT01326559|Mitosis Modulators|mitosis modulators|mesh-ancestor
110647938|NCT01326559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110647939|NCT01326559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110647940|NCT04069949|Sorafenib|sorafenib|mesh-list
110647941|NCT04069949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110647942|NCT04069949|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110647943|NCT04069949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110647944|NCT04069949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110295155|NCT00266487|Pyridoxine|pyridoxine|mesh-list
110647945|NCT02575235|Cetylpyridinium|cetylpyridinium|mesh-list
110647946|NCT02575235|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110647947|NCT02575235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110647948|NCT00467740|Olodaterol|olodaterol|mesh-list
110647949|NCT00467740|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110647950|NCT00467740|Autonomic Agents|autonomic agents|mesh-ancestor
110647951|NCT00467740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110647952|NCT00467740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110647953|NCT00467740|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110647954|NCT00467740|Respiratory System Agents|respiratory system agents|mesh-ancestor
110647955|NCT00710099|Sildenafil Citrate|sildenafil citrate|mesh-list
110647956|NCT00710099|Vasodilator Agents|vasodilator agents|mesh-ancestor
110647957|NCT00710099|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110647958|NCT00710099|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110647959|NCT00710099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110647960|NCT00710099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110647961|NCT00710099|Urological Agents|urological agents|mesh-ancestor
110647962|NCT03944044|Acetaminophen|acetaminophen|mesh-list
110647963|NCT03944044|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110647964|NCT03944044|Analgesics|analgesics|mesh-ancestor
110647965|NCT03944044|Sensory System Agents|sensory system agents|mesh-ancestor
110647966|NCT03944044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110647967|NCT03944044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110647968|NCT03944044|Antipyretics|antipyretics|mesh-ancestor
110647969|NCT00714623|Sirolimus|sirolimus|mesh-list
110647970|NCT00714623|Temsirolimus|temsirolimus|mesh-list
110647971|NCT00714623|MTOR Inhibitors|mtor inhibitors|mesh-list
110647972|NCT00714623|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110647973|NCT00714623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110647974|NCT00714623|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110647975|NCT00714623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110647976|NCT00714623|Antifungal Agents|antifungal agents|mesh-ancestor
110647977|NCT00714623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110647978|NCT00714623|Immunologic Factors|immunologic factors|mesh-ancestor
110647979|NCT00714623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110647980|NCT00714623|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110647981|NCT00714623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110647982|NCT00714623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110647983|NCT01022476|Raltegravir Potassium|raltegravir potassium|mesh-list
110647984|NCT01022476|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110647985|NCT01022476|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110647986|NCT01022476|Antiviral Agents|antiviral agents|mesh-ancestor
110647987|NCT01022476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110647988|NCT01022476|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110647989|NCT01022476|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110647990|NCT01022476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110647991|NCT01022476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110647992|NCT02575001|Hydrocortisone|hydrocortisone|mesh-list
110647993|NCT02575001|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
110647994|NCT02575001|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
110647995|NCT02575001|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
110647996|NCT02575001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110647997|NCT01021930|Sirolimus|sirolimus|mesh-list
110647998|NCT01021930|Paclitaxel|paclitaxel|mesh-list
110647999|NCT01021930|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110051853|NCT01476683|Racecadotril|racecadotril|mesh-list
110648000|NCT01021930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110648001|NCT01021930|Tubulin Modulators|tubulin modulators|mesh-ancestor
110648002|NCT01021930|Antimitotic Agents|antimitotic agents|mesh-ancestor
110648004|NCT01021930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110648005|NCT01021930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110648006|NCT01021930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110648007|NCT01021930|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110648008|NCT01021930|Antifungal Agents|antifungal agents|mesh-ancestor
110648009|NCT01021930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110648010|NCT01021930|Immunologic Factors|immunologic factors|mesh-ancestor
110648011|NCT01021930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110648013|NCT00946764|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110648014|NCT00946764|Antidepressive Agents|antidepressive agents|mesh-ancestor
110648015|NCT00946764|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110648016|NCT00946764|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110648017|NCT00946764|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110648018|NCT00946764|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110648019|NCT00946764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110648020|NCT00946764|Adrenergic Agents|adrenergic agents|mesh-ancestor
110648021|NCT00946764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110648022|NCT00946764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110648023|NCT00950820|Capecitabine|capecitabine|mesh-list
110648024|NCT00950820|Oxaliplatin|oxaliplatin|mesh-list
110648025|NCT00950820|Panitumumab|panitumumab|mesh-list
110258306|NCT02949310|Nefopam|nefopam|mesh-list
110648026|NCT00950820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110648027|NCT00950820|Antimetabolites|antimetabolites|mesh-ancestor
110648028|NCT00950820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110648029|NCT00950820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110648030|NCT00950820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110648031|NCT00950898|Caffeine|caffeine|mesh-list
110648032|NCT00950898|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110648033|NCT00950898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110648034|NCT00950898|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110648035|NCT00950898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110648036|NCT00950898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110648037|NCT00950898|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110648038|NCT00950898|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110648039|NCT00950898|Purinergic Agents|purinergic agents|mesh-ancestor
110648040|NCT00950898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110648041|NCT00168805|Enoxaparin|enoxaparin|mesh-list
110648042|NCT00168805|Dabigatran|dabigatran|mesh-list
110648043|NCT00168805|Anticoagulants|anticoagulants|mesh-ancestor
110648045|NCT00168805|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110334653|NCT00495560|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110648046|NCT00168805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110648047|NCT00168805|Antithrombins|antithrombins|mesh-ancestor
110648048|NCT00168805|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110648049|NCT00168805|Protease Inhibitors|protease inhibitors|mesh-ancestor
110648050|NCT00168805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110648051|NCT00467584|Aspirin|aspirin|mesh-list
110648052|NCT00467584|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110648053|NCT00467584|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110648054|NCT00467584|Analgesics|analgesics|mesh-ancestor
110648055|NCT00467584|Sensory System Agents|sensory system agents|mesh-ancestor
110648056|NCT00467584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110648057|NCT00467584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110648058|NCT00467584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110648059|NCT00467584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110648060|NCT00467584|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110648061|NCT00467584|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110648062|NCT00467584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110648063|NCT00467584|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110648064|NCT00467584|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110648065|NCT00467584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110648066|NCT00467584|Antipyretics|antipyretics|mesh-ancestor
110648067|NCT02574611|Glycopyrrolate|glycopyrrolate|mesh-list
110648069|NCT02574611|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110648070|NCT02574611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110648071|NCT02574611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110648072|NCT02574611|Cholinergic Agents|cholinergic agents|mesh-ancestor
110648073|NCT02574611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110648074|NCT02574611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110648075|NCT02574611|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110648076|NCT02574611|Autonomic Agents|autonomic agents|mesh-ancestor
110648077|NCT02574611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110648078|NCT02574611|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110648079|NCT02574611|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110648080|NCT02574611|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110648081|NCT00714779|Fluoxetine|fluoxetine|mesh-list
110648082|NCT00714779|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110334776|NCT01298362|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110648083|NCT00714779|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110648084|NCT00714779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110648085|NCT00714779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110648086|NCT00714779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110648087|NCT00714779|Serotonin Agents|serotonin agents|mesh-ancestor
110648088|NCT00714779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110648089|NCT00714779|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110648090|NCT00714779|Antidepressive Agents|antidepressive agents|mesh-ancestor
110648091|NCT00714779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110648092|NCT00714779|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110295313|NCT04559113|Hormones|hormones|mesh-ancestor
110648093|NCT00714779|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110648094|NCT00714779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110648095|NCT00168103|Complement C1s|complement c1s|mesh-list
110648096|NCT00168103|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
110648097|NCT00168103|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
110648098|NCT00168103|Immunologic Factors|immunologic factors|mesh-ancestor
110648099|NCT00168103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110648100|NCT00168103|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
110648101|NCT00168103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110648102|NCT00463060|Sunitinib|sunitinib|mesh-list
110648103|NCT00463060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110648105|NCT00463060|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110648106|NCT00463060|Growth Substances|growth substances|mesh-ancestor
110648107|NCT00463060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110648108|NCT00463060|Growth Inhibitors|growth inhibitors|mesh-ancestor
110648109|NCT00463060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110648110|NCT00463060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110648111|NCT00463060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110648112|NCT03964753|Paclitaxel|paclitaxel|mesh-list
110648113|NCT03964753|Cisplatin|cisplatin|mesh-list
110648114|NCT03964753|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110648115|NCT03964753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110648116|NCT03964753|Tubulin Modulators|tubulin modulators|mesh-ancestor
110648117|NCT03964753|Antimitotic Agents|antimitotic agents|mesh-ancestor
110648118|NCT03964753|Mitosis Modulators|mitosis modulators|mesh-ancestor
110648119|NCT03964753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110648120|NCT00956748|Acetylcysteine|acetylcysteine|mesh-list
110648121|NCT00956748|Ciprofloxacin|ciprofloxacin|mesh-list
110648122|NCT00956748|Dexamethasone|dexamethasone|mesh-list
110648123|NCT00956748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110648124|NCT00956748|Antiemetics|antiemetics|mesh-ancestor
110648125|NCT00956748|Autonomic Agents|autonomic agents|mesh-ancestor
110648126|NCT00956748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110648127|NCT00956748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110648128|NCT00956748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110648129|NCT00956748|Glucocorticoids|glucocorticoids|mesh-ancestor
110648130|NCT00956748|Hormones|hormones|mesh-ancestor
110648131|NCT00956748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110648132|NCT00956748|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110648133|NCT00956748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110648134|NCT00956748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110648135|NCT00956748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110648137|NCT00956748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110648138|NCT00956748|Expectorants|expectorants|mesh-ancestor
110648139|NCT00956748|Respiratory System Agents|respiratory system agents|mesh-ancestor
110648140|NCT00956748|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110648141|NCT00956748|Antioxidants|antioxidants|mesh-ancestor
110648142|NCT00956748|Protective Agents|protective agents|mesh-ancestor
110648143|NCT00956748|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110648144|NCT00956748|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110648145|NCT00956748|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110648146|NCT00956748|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110648147|NCT00956748|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110648148|NCT01079923|Vitamin D|vitamin d|mesh-list
110648149|NCT01079923|Ergocalciferols|ergocalciferols|mesh-list
110648150|NCT01079923|Cholecalciferol|cholecalciferol|mesh-list
110648151|NCT01079923|Vitamins|vitamins|mesh-list
110258325|NCT02949349|Hormones|hormones|mesh-ancestor
110648152|NCT01079923|Micronutrients|micronutrients|mesh-ancestor
110648153|NCT01079923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110648154|NCT01079923|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110648155|NCT01079923|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110648156|NCT00947076|Fluoxetine|fluoxetine|mesh-list
110648157|NCT00947076|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110648158|NCT00947076|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110648159|NCT00947076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110648160|NCT00947076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110648161|NCT00947076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110648162|NCT00947076|Serotonin Agents|serotonin agents|mesh-ancestor
110648163|NCT00947076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110648164|NCT00947076|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110648165|NCT00947076|Antidepressive Agents|antidepressive agents|mesh-ancestor
110648166|NCT00947076|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110648167|NCT00947076|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110648168|NCT00947076|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110648169|NCT00947076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110648171|NCT00462982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110648172|NCT00462982|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110648173|NCT00462982|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110648174|NCT00462982|Growth Substances|growth substances|mesh-ancestor
110172398|NCT00050947|Oxcarbazepine|oxcarbazepine|mesh-list
110648175|NCT00462982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110648176|NCT00462982|Growth Inhibitors|growth inhibitors|mesh-ancestor
110648177|NCT00462982|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110648178|NCT00462982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110335038|NCT00497003|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110648179|NCT00462982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110648180|NCT02573597|Sufentanil|sufentanil|mesh-list
110648181|NCT02573597|Bupivacaine|bupivacaine|mesh-list
110648182|NCT02573597|Anesthetics, Local|anesthetics, local|mesh-ancestor
110648183|NCT02573597|Anesthetics|anesthetics|mesh-ancestor
110648184|NCT02573597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110648185|NCT02573597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110648186|NCT02573597|Sensory System Agents|sensory system agents|mesh-ancestor
110648187|NCT02573597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110648188|NCT02573597|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110648189|NCT02573597|Narcotics|narcotics|mesh-ancestor
110648190|NCT02573597|Analgesics|analgesics|mesh-ancestor
110648191|NCT02573597|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110648192|NCT02573597|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110648193|NCT02573597|Anesthetics, General|anesthetics, general|mesh-ancestor
110648194|NCT05300958|Deferoxamine|deferoxamine|mesh-list
110648195|NCT05300958|Siderophores|siderophores|mesh-ancestor
110648196|NCT05300958|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110648197|NCT05300958|Chelating Agents|chelating agents|mesh-ancestor
110648198|NCT05300958|Sequestering Agents|sequestering agents|mesh-ancestor
110648199|NCT05300958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110648200|NCT04070729|Hyaluronic Acid|hyaluronic acid|mesh-list
110648201|NCT04070729|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110648202|NCT04070729|Immunologic Factors|immunologic factors|mesh-ancestor
110648203|NCT04070729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110648204|NCT04070729|Viscosupplements|viscosupplements|mesh-ancestor
110648205|NCT04070729|Protective Agents|protective agents|mesh-ancestor
110648206|NCT00467272|Daptomycin|daptomycin|mesh-list
110648207|NCT00467272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110648208|NCT00467272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110648209|NCT00956982|Interferons|interferons|mesh-list
110648210|NCT00956982|Ribavirin|ribavirin|mesh-list
110648211|NCT00956982|Interferon-alpha|interferon-alpha|mesh-list
110648212|NCT00956982|Interferon alpha-2|interferon alpha-2|mesh-list
110648213|NCT00956982|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110648214|NCT00956982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110648215|NCT00956982|Antiviral Agents|antiviral agents|mesh-ancestor
110648216|NCT00956982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110648217|NCT00956982|Antimetabolites|antimetabolites|mesh-ancestor
110648218|NCT00956982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110648219|NCT00956982|Immunologic Factors|immunologic factors|mesh-ancestor
110648220|NCT00956982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110648221|NCT00714857|Dexmedetomidine|dexmedetomidine|mesh-list
110648222|NCT00714857|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110648223|NCT00714857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110648224|NCT00714857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110648225|NCT00714857|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110648226|NCT00714857|Analgesics|analgesics|mesh-ancestor
110648227|NCT00714857|Sensory System Agents|sensory system agents|mesh-ancestor
110648228|NCT00714857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110648229|NCT00714857|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110648230|NCT00714857|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110648231|NCT00714857|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110648232|NCT00714857|Adrenergic Agents|adrenergic agents|mesh-ancestor
110648233|NCT00714857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110648234|NCT00714857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110648235|NCT00957060|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110648236|NCT00957060|Glimepiride|glimepiride|mesh-list
110648237|NCT00957060|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110648238|NCT00957060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110648239|NCT00957060|Incretins|incretins|mesh-ancestor
110648240|NCT00957060|Hormones|hormones|mesh-ancestor
110648241|NCT00957060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110648242|NCT00957060|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110648243|NCT00957060|Protease Inhibitors|protease inhibitors|mesh-ancestor
110648244|NCT00957060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110648245|NCT00957060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110648246|NCT00957060|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110648247|NCT00957060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110648248|NCT00957060|Immunologic Factors|immunologic factors|mesh-ancestor
110648249|NCT02573519|Acetylcholine|acetylcholine|mesh-list
110648250|NCT02573519|Donepezil|donepezil|mesh-list
110648251|NCT02573519|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
110648252|NCT02573519|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110648253|NCT02573519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110648254|NCT02573519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110648255|NCT02573519|Cholinergic Agents|cholinergic agents|mesh-ancestor
110648256|NCT02573519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110648257|NCT02573519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110648258|NCT02573519|Nootropic Agents|nootropic agents|mesh-ancestor
110648259|NCT02573519|Vasodilator Agents|vasodilator agents|mesh-ancestor
110648260|NCT02573519|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110648261|NCT02572583|Oseltamivir|oseltamivir|mesh-list
110648262|NCT02572583|Antiviral Agents|antiviral agents|mesh-ancestor
110648263|NCT02572583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110648264|NCT02572583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110648265|NCT02572583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110648266|NCT00951444|Carboplatin|carboplatin|mesh-list
110648267|NCT00951444|Gemcitabine|gemcitabine|mesh-list
110648268|NCT00951444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110648269|NCT00951444|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110648270|NCT00951444|Antimetabolites|antimetabolites|mesh-ancestor
110648271|NCT00951444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110648272|NCT00462826|Aflibercept|aflibercept|mesh-list
110648273|NCT00462826|Endothelial Growth Factors|endothelial growth factors|mesh-list
110648274|NCT00462826|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110648275|NCT00462826|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110648276|NCT00462826|Growth Substances|growth substances|mesh-ancestor
110648277|NCT00462826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110648278|NCT00462826|Growth Inhibitors|growth inhibitors|mesh-ancestor
110648279|NCT00462826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110648280|NCT00718601|Imetelstat|imetelstat|mesh-list
110648281|NCT00718601|Motesanib diphosphate|motesanib diphosphate|mesh-list
110648282|NCT00718601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110648283|NCT00718601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110648284|NCT00718601|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110648285|NCT00947388|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110648286|NCT00947388|Alemtuzumab|alemtuzumab|mesh-list
110648287|NCT00947388|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110648288|NCT00947388|Antibodies|antibodies|mesh-list
110648289|NCT00947388|Immunoglobulins|immunoglobulins|mesh-list
110648290|NCT00947388|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110648291|NCT00947388|Immunologic Factors|immunologic factors|mesh-ancestor
110648292|NCT00947388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110648293|NCT00947388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110648294|NCT00947388|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110648295|NCT00947388|Alkylating Agents|alkylating agents|mesh-ancestor
110648296|NCT00947388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110648297|NCT00951600|Oxcarbazepine|oxcarbazepine|mesh-list
110648298|NCT00951600|Anticonvulsants|anticonvulsants|mesh-ancestor
110648299|NCT00951600|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110648300|NCT00951600|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110648301|NCT00951600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110648302|NCT00951600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110648303|NCT00951600|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110648304|NCT00951600|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110648305|NCT03910985|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
110648306|NCT03910985|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110648307|NCT03910985|Autonomic Agents|autonomic agents|mesh-ancestor
110335513|NCT05145270|Dexetimide|dexetimide|mesh-list
110648308|NCT03910985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110648309|NCT03910985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110648310|NCT03910985|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110648311|NCT03910985|Respiratory System Agents|respiratory system agents|mesh-ancestor
110648312|NCT00957216|Ubiquinone|ubiquinone|mesh-list
110397800|NCT01102972|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110648313|NCT00957216|Coenzyme Q10|coenzyme q10|mesh-list
110648314|NCT00957216|Micronutrients|micronutrients|mesh-ancestor
110648315|NCT00957216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110648317|NCT00718757|Dexamethasone|dexamethasone|mesh-list
110648319|NCT00718757|Vincristine|vincristine|mesh-list
110648320|NCT00718757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110648321|NCT00718757|Antiemetics|antiemetics|mesh-ancestor
110648322|NCT00718757|Autonomic Agents|autonomic agents|mesh-ancestor
110648323|NCT00718757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110648324|NCT00718757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110648325|NCT00718757|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110648326|NCT00718757|Glucocorticoids|glucocorticoids|mesh-ancestor
110648327|NCT00718757|Hormones|hormones|mesh-ancestor
110648328|NCT00718757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110648329|NCT00718757|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110648331|NCT00718757|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110648332|NCT00718757|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110648333|NCT00718757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110648334|NCT00718757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110335753|NCT05146713|Eusol|eusol|mesh-list
110648335|NCT00718757|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110648336|NCT00718757|Tubulin Modulators|tubulin modulators|mesh-ancestor
110648337|NCT00718757|Antimitotic Agents|antimitotic agents|mesh-ancestor
110648338|NCT00718757|Mitosis Modulators|mitosis modulators|mesh-ancestor
110648339|NCT00947466|Buprenorphine|buprenorphine|mesh-list
110648340|NCT00947466|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110648341|NCT00947466|Narcotics|narcotics|mesh-ancestor
110648342|NCT00947466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110648343|NCT00947466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110648344|NCT00947466|Analgesics|analgesics|mesh-ancestor
110648345|NCT00947466|Sensory System Agents|sensory system agents|mesh-ancestor
110648346|NCT00947466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110648347|NCT00947466|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110648348|NCT00951834|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
110648349|NCT00951834|Antioxidants|antioxidants|mesh-ancestor
110648350|NCT00951834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110648351|NCT00951834|Protective Agents|protective agents|mesh-ancestor
110648352|NCT00951834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110648353|NCT00951834|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
110648354|NCT00951834|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110648355|NCT00951834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110648356|NCT00951834|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110648357|NCT00715013|Epothilone B|epothilone b|mesh-list
110648358|NCT00715013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110648359|NCT00715013|Tubulin Modulators|tubulin modulators|mesh-ancestor
110648360|NCT00715013|Antimitotic Agents|antimitotic agents|mesh-ancestor
110648361|NCT00715013|Mitosis Modulators|mitosis modulators|mesh-ancestor
110648362|NCT00715013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110648363|NCT00715091|Diclofenac|diclofenac|mesh-list
110648364|NCT00715091|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110648365|NCT00715091|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110648366|NCT00715091|Analgesics|analgesics|mesh-ancestor
110648367|NCT00715091|Sensory System Agents|sensory system agents|mesh-ancestor
110648368|NCT00715091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110648369|NCT00715091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110648370|NCT00715091|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110648371|NCT00715091|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110648372|NCT00715091|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110648373|NCT00715091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110648374|NCT00715091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110648375|NCT00718913|Docetaxel|docetaxel|mesh-list
110648376|NCT00718913|Capecitabine|capecitabine|mesh-list
110648377|NCT00718913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110648378|NCT00718913|Tubulin Modulators|tubulin modulators|mesh-ancestor
110648379|NCT00718913|Antimitotic Agents|antimitotic agents|mesh-ancestor
110648380|NCT00718913|Mitosis Modulators|mitosis modulators|mesh-ancestor
110335889|NCT00508287|Exenatide|exenatide|mesh-list
110648381|NCT00718913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110648382|NCT00718913|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110648383|NCT00718913|Antimetabolites|antimetabolites|mesh-ancestor
110648384|NCT04011930|Vitamin D|vitamin d|mesh-list
110648385|NCT04011930|Cholecalciferol|cholecalciferol|mesh-list
110648386|NCT04011930|Calcitriol|calcitriol|mesh-list
110648387|NCT04011930|Vitamins|vitamins|mesh-ancestor
110648388|NCT04011930|Micronutrients|micronutrients|mesh-ancestor
110648389|NCT04011930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110648390|NCT04011930|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110648391|NCT04011930|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110648392|NCT04011930|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
110295640|NCT04564456|Xhance|xhance|mesh-list
110648393|NCT04011930|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110648394|NCT04011930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110648395|NCT04011930|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110648396|NCT00551616|Levonorgestrel|levonorgestrel|mesh-list
110648397|NCT00551616|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110648398|NCT00551616|Contraceptive Agents|contraceptive agents|mesh-ancestor
110648399|NCT00551616|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110648400|NCT00551616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110648401|NCT00551616|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110648402|NCT00551616|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110648403|NCT00551616|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110648404|NCT02574221|Fluorides|fluorides|mesh-list
110648405|NCT02574221|Tin Fluorides|tin fluorides|mesh-list
110336096|NCT00509379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110648406|NCT02574221|Cariostatic Agents|cariostatic agents|mesh-ancestor
110648407|NCT02574221|Protective Agents|protective agents|mesh-ancestor
110648408|NCT02574221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110648409|NCT00452530|Enoxaparin|enoxaparin|mesh-list
110648410|NCT00452530|Enoxaparin sodium|enoxaparin sodium|mesh-list
110648411|NCT00452530|Apixaban|apixaban|mesh-list
110648412|NCT00452530|Anticoagulants|anticoagulants|mesh-ancestor
110648413|NCT00452530|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110648414|NCT00452530|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110648415|NCT00452530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110648416|NCT00452530|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110648417|NCT00452530|Antithrombins|antithrombins|mesh-ancestor
110648418|NCT00452530|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110648419|NCT00452530|Protease Inhibitors|protease inhibitors|mesh-ancestor
110648420|NCT00452530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110648421|NCT00549198|Tenofovir|tenofovir|mesh-list
110648422|NCT00549198|Lamivudine|lamivudine|mesh-list
110648423|NCT00549198|Emtricitabine|emtricitabine|mesh-list
110648424|NCT00549198|Efavirenz|efavirenz|mesh-list
110648425|NCT00549198|Abacavir|abacavir|mesh-list
110648426|NCT00549198|Antiviral Agents|antiviral agents|mesh-ancestor
110648427|NCT00549198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110648428|NCT00549198|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110648429|NCT00549198|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110648430|NCT00549198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110648431|NCT00549198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110648432|NCT00549198|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110648433|NCT00549198|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110336365|NCT00502034|Interleukin-2|interleukin-2|mesh-list
110648434|NCT00549198|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110648435|NCT00549198|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110336437|NCT01249001|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110648436|NCT00549198|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110648437|NCT00549198|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110648438|NCT00549198|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110648439|NCT00549198|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110648440|NCT00506415|Rivastigmine|rivastigmine|mesh-list
110648441|NCT00506415|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110648442|NCT00506415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110648443|NCT00506415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110648444|NCT00506415|Cholinergic Agents|cholinergic agents|mesh-ancestor
110648445|NCT00506415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110648446|NCT00506415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110648447|NCT00506415|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110648448|NCT00506415|Protective Agents|protective agents|mesh-ancestor
110648449|NCT04036526|Vaccines|vaccines|mesh-list
110648450|NCT04036526|Immunologic Factors|immunologic factors|mesh-ancestor
110648451|NCT04036526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110648452|NCT00452452|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110648453|NCT00452452|Immunologic Factors|immunologic factors|mesh-ancestor
110336652|NCT00511719|Insulin|insulin|mesh-list
110648454|NCT00452452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110648456|NCT01009437|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110648457|NCT01009437|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110648458|NCT01009437|Protease Inhibitors|protease inhibitors|mesh-ancestor
110648459|NCT01009437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110336720|NCT02951754|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110648460|NCT01009437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110648462|NCT01009437|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110648463|NCT01009437|Antiviral Agents|antiviral agents|mesh-ancestor
110648464|NCT01009437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110648465|NCT01009437|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110648466|NCT01009437|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110648467|NCT00719381|Pioglitazone|pioglitazone|mesh-list
110648468|NCT00719381|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110648469|NCT00719381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110648470|NCT00510783|Phenytoin|phenytoin|mesh-list
110648471|NCT00510783|Fosphenytoin|fosphenytoin|mesh-list
110648472|NCT00510783|Levetiracetam|levetiracetam|mesh-list
110648473|NCT00510783|Anticonvulsants|anticonvulsants|mesh-ancestor
110648474|NCT00510783|Nootropic Agents|nootropic agents|mesh-ancestor
110336789|NCT00513201|Insulin|insulin|mesh-list
110648475|NCT00510783|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110648476|NCT00510783|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110648477|NCT00510783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110648478|NCT00510783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110648479|NCT00510783|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110648480|NCT00510783|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110648482|NCT00952302|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
110648484|NCT00952302|Micronutrients|micronutrients|mesh-ancestor
110648485|NCT00952302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110648486|NCT00952302|Hematinics|hematinics|mesh-ancestor
110648487|NCT00518973|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110648489|NCT00518973|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110648490|NCT00518973|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110648491|NCT00518973|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110648492|NCT00518973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110648493|NCT00518973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110648494|NCT05300334|Adenosine|adenosine|mesh-list
110648495|NCT05300334|Analgesics|analgesics|mesh-ancestor
110648497|NCT05300334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110648498|NCT05300334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110337060|NCT00514293|Carboplatin|carboplatin|mesh-list
110648499|NCT05300334|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110648500|NCT05300334|Vasodilator Agents|vasodilator agents|mesh-ancestor
110648501|NCT05300334|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
110648502|NCT05300334|Purinergic Agonists|purinergic agonists|mesh-ancestor
110648503|NCT05300334|Purinergic Agents|purinergic agents|mesh-ancestor
110648504|NCT05300334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110648505|NCT05300334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110648506|NCT00897884|Metformin|metformin|mesh-list
110648507|NCT00897884|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110271427|NCT04299880|Leucovorin|leucovorin|mesh-list
110648508|NCT00897884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110337203|NCT03459144|Ranibizumab|ranibizumab|mesh-list
110648509|NCT01022164|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
110648510|NCT01022164|Hemostatics|hemostatics|mesh-ancestor
110648511|NCT01022164|Coagulants|coagulants|mesh-ancestor
110648512|NCT01012479|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110648513|NCT01012479|Candesartan|candesartan|mesh-list
110648514|NCT01012479|Candesartan cilexetil|candesartan cilexetil|mesh-list
110648515|NCT01012479|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110648516|NCT01012479|Diuretics|diuretics|mesh-ancestor
110648517|NCT01012479|Natriuretic Agents|natriuretic agents|mesh-ancestor
110648518|NCT01012479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110648519|NCT01012479|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110337277|NCT00516282|Temozolomide|temozolomide|mesh-list
110648520|NCT01012479|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110648521|NCT01012479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110648522|NCT01012479|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110648523|NCT01012479|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110648524|NCT02541734|Exenatide|exenatide|mesh-list
110648525|NCT02541734|Polygeline|polygeline|mesh-list
110648526|NCT02541734|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110648527|NCT02541734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110648528|NCT02541734|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110648529|NCT02541734|Incretins|incretins|mesh-ancestor
110648530|NCT02541734|Hormones|hormones|mesh-ancestor
110648531|NCT02541734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110648532|NCT02541734|Plasma Substitutes|plasma substitutes|mesh-ancestor
110648533|NCT02541734|Blood Substitutes|blood substitutes|mesh-ancestor
110648534|NCT00462670|Tolvaptan|tolvaptan|mesh-list
110648535|NCT00462670|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
110337337|NCT01244256|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110648536|NCT00462670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110648537|NCT00462670|Natriuretic Agents|natriuretic agents|mesh-ancestor
110648538|NCT00462670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110648539|NCT01009593|Sorafenib|sorafenib|mesh-list
110648540|NCT01009593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110648541|NCT01009593|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110648542|NCT01009593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110295763|NCT04673812|Fentanyl|fentanyl|mesh-list
110648543|NCT01009593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110648546|NCT00719459|Trace Elements|trace elements|mesh-ancestor
110648547|NCT00719459|Micronutrients|micronutrients|mesh-ancestor
110648548|NCT00719459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110648549|NCT00719459|Hematinics|hematinics|mesh-ancestor
110648550|NCT00711503|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
110648551|NCT00711503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110648552|NCT00948168|Exenatide|exenatide|mesh-list
110648553|NCT00948168|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110648554|NCT00948168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110648555|NCT00948168|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110648556|NCT00948168|Incretins|incretins|mesh-ancestor
110648557|NCT00948168|Hormones|hormones|mesh-ancestor
110648558|NCT00948168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110648559|NCT00958386|Irinotecan|irinotecan|mesh-list
110648560|NCT00958386|Panitumumab|panitumumab|mesh-list
110648561|NCT00958386|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110648562|NCT00958386|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110648563|NCT00958386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110648564|NCT00958386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110648565|NCT00958386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110648566|NCT00958386|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110648567|NCT00719693|Calcium, Dietary|calcium, dietary|mesh-list
110648568|NCT00719693|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110648569|NCT00719693|Fenofibric acid|fenofibric acid|mesh-list
110648570|NCT00719693|Fenofibrate|fenofibrate|mesh-list
110648571|NCT00719693|Calcium|calcium|mesh-list
110337455|NCT01248780|Immunologic Factors|immunologic factors|mesh-ancestor
110648572|NCT00719693|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110648573|NCT00719693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110648574|NCT00719693|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110648575|NCT00719693|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110648576|NCT00719693|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110648578|NCT00719693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110648579|NCT00719693|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110648580|NCT00719693|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110648581|NCT00719693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110648582|NCT00948402|Metformin|metformin|mesh-list
110648583|NCT00948402|Biguanides|biguanides|mesh-list
110648584|NCT00948402|Contraceptive Agents|contraceptive agents|mesh-list
110648585|NCT00948402|Contraceptives, Oral|contraceptives, oral|mesh-list
110648586|NCT00948402|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110648587|NCT00948402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110648588|NCT00948402|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110648589|NCT00948402|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110648590|NCT05352126|Disinfectants|disinfectants|mesh-list
110258972|NCT00512473|Hormones|hormones|mesh-list
110648591|NCT05352126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110648592|NCT00948480|Sargramostim|sargramostim|mesh-list
110648593|NCT00948480|Immunologic Factors|immunologic factors|mesh-ancestor
110337712|NCT02275598|Immunotoxins|immunotoxins|mesh-ancestor
110648594|NCT00948480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110648595|NCT03753555|Calcium, Dietary|calcium, dietary|mesh-list
110648596|NCT03753555|Atorvastatin|atorvastatin|mesh-list
110648597|NCT03753555|Probucol|probucol|mesh-list
110648598|NCT03753555|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-list
110648599|NCT03753555|Calcium|calcium|mesh-list
110397821|NCT01087489|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110648600|NCT03753555|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110648601|NCT03753555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110648602|NCT03753555|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110648603|NCT03753555|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110648604|NCT03753555|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110648605|NCT03753555|Antimetabolites|antimetabolites|mesh-ancestor
110648606|NCT03753555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110648607|NCT03753555|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110648608|NCT03753555|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110648609|NCT03753555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110648610|NCT03753555|Antioxidants|antioxidants|mesh-ancestor
110648611|NCT03753555|Protective Agents|protective agents|mesh-ancestor
110648612|NCT03753555|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110648613|NCT03753555|Protease Inhibitors|protease inhibitors|mesh-ancestor
110648614|NCT00606086|Interferons|interferons|mesh-list
110648615|NCT00606086|Ribavirin|ribavirin|mesh-list
110648616|NCT00606086|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110648617|NCT00606086|Interferon-alpha|interferon-alpha|mesh-list
110648618|NCT00606086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110648619|NCT00606086|Antiviral Agents|antiviral agents|mesh-ancestor
110648620|NCT00606086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110648621|NCT00606086|Antimetabolites|antimetabolites|mesh-ancestor
110648622|NCT00606086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110648623|NCT00606086|Immunologic Factors|immunologic factors|mesh-ancestor
110648624|NCT00606086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110648625|NCT02573363|Cytarabine|cytarabine|mesh-list
110648627|NCT02573363|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110648628|NCT02573363|Antimetabolites|antimetabolites|mesh-ancestor
110648629|NCT02573363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110648630|NCT02573363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110648631|NCT02573363|Antiviral Agents|antiviral agents|mesh-ancestor
110648632|NCT02573363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110648633|NCT02573363|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110648634|NCT02573363|Immunologic Factors|immunologic factors|mesh-ancestor
110648635|NCT02573363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110648636|NCT02573363|Analgesics|analgesics|mesh-ancestor
110648637|NCT02573363|Sensory System Agents|sensory system agents|mesh-ancestor
110648638|NCT02573363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110648639|NCT02573363|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110648640|NCT02573363|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110648641|NCT02573363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110648642|NCT00715637|Cytarabine|cytarabine|mesh-list
110648643|NCT00715637|Amonafide|amonafide|mesh-list
110648644|NCT00715637|Daunorubicin|daunorubicin|mesh-list
110648645|NCT00715637|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110259220|NCT03585452|Propofol|propofol|mesh-list
110648646|NCT00715637|Antimetabolites|antimetabolites|mesh-ancestor
110648647|NCT00715637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110648649|NCT00715637|Antiviral Agents|antiviral agents|mesh-ancestor
110648650|NCT00715637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110648651|NCT00715637|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110648652|NCT00715637|Immunologic Factors|immunologic factors|mesh-ancestor
110648653|NCT00715637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110648654|NCT00715637|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110648655|NCT00715637|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110259299|NCT04693312|Prednisolone|prednisolone|mesh-list
110648657|NCT00715637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110648658|NCT05300490|Prednisolone|prednisolone|mesh-list
110648659|NCT05300490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110648660|NCT05300490|Glucocorticoids|glucocorticoids|mesh-ancestor
110648661|NCT05300490|Hormones|hormones|mesh-ancestor
110648662|NCT05300490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110648663|NCT05300490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110648664|NCT05300490|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110648665|NCT05300490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110648666|NCT00893594|Naproxen|naproxen|mesh-list
110648667|NCT00893594|Sumatriptan|sumatriptan|mesh-list
110648668|NCT00893594|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110648669|NCT00893594|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110648670|NCT00893594|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110648671|NCT00893594|Serotonin Agents|serotonin agents|mesh-ancestor
110648672|NCT00893594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110338455|NCT00521742|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110648673|NCT00893594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110648674|NCT00893594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110648675|NCT00893594|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110648676|NCT00893594|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110648677|NCT00893594|Analgesics|analgesics|mesh-ancestor
110648678|NCT00893594|Sensory System Agents|sensory system agents|mesh-ancestor
110648679|NCT00893594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110648681|NCT00893594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110648682|NCT00893594|Gout Suppressants|gout suppressants|mesh-ancestor
110648683|NCT00893594|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110648684|NCT00893594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110648685|NCT00715715|Prednisone|prednisone|mesh-list
110338595|NCT00523692|Antimetabolites|antimetabolites|mesh-ancestor
110648686|NCT00715715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110648687|NCT00715715|Glucocorticoids|glucocorticoids|mesh-ancestor
110648688|NCT00715715|Hormones|hormones|mesh-ancestor
110648689|NCT00715715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110648690|NCT00715715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110648691|NCT00715715|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110295906|NCT00267657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110648692|NCT00715715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110648694|NCT00953394|Fluorouracil|fluorouracil|mesh-list
110648695|NCT00953394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110648696|NCT00953394|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110338759|NCT00524199|Mesna|mesna|mesh-list
110648697|NCT00953394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110648698|NCT00953394|Antimetabolites|antimetabolites|mesh-ancestor
110648699|NCT00953394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110259464|NCT00525772|Ciclesonide|ciclesonide|mesh-list
110648700|NCT00953394|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110648701|NCT00953394|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110648702|NCT00953394|Immunologic Factors|immunologic factors|mesh-ancestor
110648703|NCT00953394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110648704|NCT00720161|Metformin|metformin|mesh-list
110648705|NCT00720161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110648706|NCT00720161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110648707|NCT00898508|Antibodies|antibodies|mesh-list
110648708|NCT00898508|Immunologic Factors|immunologic factors|mesh-ancestor
110648709|NCT00898508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110648710|NCT00609986|Insulin|insulin|mesh-list
110648711|NCT00609986|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110648712|NCT00609986|Insulin Glargine|insulin glargine|mesh-list
110648713|NCT00609986|Insulin, Isophane|insulin, isophane|mesh-list
110648714|NCT00609986|Isophane Insulin, Human|isophane insulin, human|mesh-list
110648715|NCT00609986|Isophane insulin, beef|isophane insulin, beef|mesh-list
110648716|NCT00609986|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110648717|NCT00609986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110648719|NCT00715871|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110648720|NCT00715871|Autonomic Agents|autonomic agents|mesh-ancestor
110648721|NCT00715871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110648723|NCT00715871|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110648724|NCT00715871|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110648725|NCT00715871|Cholinergic Agents|cholinergic agents|mesh-ancestor
110648726|NCT00715871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110648727|NCT00715871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110648728|NCT00712049|Nicotinic Acids|nicotinic acids|mesh-list
110648729|NCT00712049|Niacin|niacin|mesh-list
110338958|NCT00525096|Exemestane|exemestane|mesh-list
110648730|NCT00712049|Niacinamide|niacinamide|mesh-list
110648731|NCT00712049|Simvastatin|simvastatin|mesh-list
110648732|NCT00712049|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110648733|NCT00712049|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110648734|NCT00712049|Antimetabolites|antimetabolites|mesh-ancestor
110159540|NCT00092287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110648735|NCT00712049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110648736|NCT00712049|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110648737|NCT00712049|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110648738|NCT00712049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110648739|NCT00712049|Vitamin B Complex|vitamin b complex|mesh-ancestor
110648741|NCT00712049|Micronutrients|micronutrients|mesh-ancestor
110648742|NCT00712049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110648743|NCT00712049|Vasodilator Agents|vasodilator agents|mesh-ancestor
110648744|NCT00712205|Calcitriol|calcitriol|mesh-list
110648745|NCT00712205|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110648746|NCT00712205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110648747|NCT00712205|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
110648748|NCT00712205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110648749|NCT00712205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110648750|NCT00712205|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110648751|NCT00712205|Vitamins|vitamins|mesh-ancestor
110648752|NCT00712205|Micronutrients|micronutrients|mesh-ancestor
110648753|NCT00712205|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110648754|NCT00451906|Bevacizumab|bevacizumab|mesh-list
110339204|NCT02954276|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110648755|NCT00451906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110648756|NCT00451906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110648757|NCT00451906|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110648758|NCT00451906|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110648759|NCT00451906|Growth Substances|growth substances|mesh-ancestor
110648760|NCT00451906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110648761|NCT00451906|Growth Inhibitors|growth inhibitors|mesh-ancestor
110648762|NCT04070495|Clarithromycin|clarithromycin|mesh-list
110648763|NCT04070495|Rifampin|rifampin|mesh-list
110339272|NCT00508040|Hormones|hormones|mesh-ancestor
110648764|NCT04070495|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110648765|NCT04070495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110648766|NCT04070495|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110648767|NCT04070495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110259696|NCT00529867|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110648768|NCT04070495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110648769|NCT04070495|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110648770|NCT04070495|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110648771|NCT04070495|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110648772|NCT04070495|Antitubercular Agents|antitubercular agents|mesh-ancestor
110648773|NCT04070495|Leprostatic Agents|leprostatic agents|mesh-ancestor
110648774|NCT04070495|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110648775|NCT04070495|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110648776|NCT04070495|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110648777|NCT04070495|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110648778|NCT04070495|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110259760|NCT00173901|Ceftazidime|ceftazidime|mesh-list
110648779|NCT04070495|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110648780|NCT04070495|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110648781|NCT00712439|Gabapentin|gabapentin|mesh-list
110648782|NCT00712439|Analgesics|analgesics|mesh-ancestor
110648783|NCT00712439|Sensory System Agents|sensory system agents|mesh-ancestor
110339394|NCT00510419|Serotonin Agents|serotonin agents|mesh-ancestor
110648784|NCT00712439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110648785|NCT00712439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110648787|NCT00712439|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110648788|NCT00712439|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110339466|NCT00528060|Ritonavir|ritonavir|mesh-list
110648789|NCT00712439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110648790|NCT00712439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110648791|NCT00712439|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110648792|NCT00712439|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110648793|NCT00712439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110648794|NCT00712439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110648795|NCT00712439|Antimanic Agents|antimanic agents|mesh-ancestor
110648796|NCT00716183|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110339628|NCT05648487|Antibodies|antibodies|mesh-list
110648797|NCT00716183|Amoxicillin|amoxicillin|mesh-list
110648798|NCT00716183|Clavulanic Acids|clavulanic acids|mesh-list
110339677|NCT00515190|Oxaliplatin|oxaliplatin|mesh-list
110648799|NCT00716183|Clavulanic Acid|clavulanic acid|mesh-list
110648800|NCT00716183|Lactams|lactams|mesh-list
110648801|NCT00716183|beta-Lactams|beta-lactams|mesh-list
110648802|NCT00716183|Cloxacillin|cloxacillin|mesh-list
110648803|NCT00716183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110648804|NCT00716183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110648805|NCT00716183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110339751|NCT00515268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110648806|NCT00716183|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110648808|NCT00712517|Sevoflurane|sevoflurane|mesh-list
110648809|NCT00712517|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110648810|NCT00712517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110648811|NCT00712517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110339819|NCT00529620|Piperaquine|piperaquine|mesh-list
110648813|NCT00712517|Anesthetics, General|anesthetics, general|mesh-ancestor
110648814|NCT00712517|Anesthetics|anesthetics|mesh-ancestor
110339901|NCT00513188|Leucovorin|leucovorin|mesh-list
110648815|NCT00712517|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110648816|NCT00712517|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110648817|NCT00712595|Mifepristone|mifepristone|mesh-list
110648818|NCT00712595|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
110648819|NCT00712595|Abortifacient Agents|abortifacient agents|mesh-ancestor
110339972|NCT00513266|Antidotes|antidotes|mesh-ancestor
110648821|NCT00712595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110648822|NCT00712595|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110648823|NCT00712595|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110648824|NCT00712595|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110648825|NCT00712595|Contraceptive Agents|contraceptive agents|mesh-ancestor
110648826|NCT00712595|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
110648827|NCT00712595|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
110648828|NCT00712595|Hormone Antagonists|hormone antagonists|mesh-ancestor
110648829|NCT00712595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110648830|NCT00712595|Luteolytic Agents|luteolytic agents|mesh-ancestor
110648831|NCT00712595|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110648832|NCT00712595|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
110648833|NCT00115765|Bevacizumab|bevacizumab|mesh-list
110648834|NCT00115765|Panitumumab|panitumumab|mesh-list
110648835|NCT00115765|Oxaliplatin|oxaliplatin|mesh-list
110648836|NCT00115765|Irinotecan|irinotecan|mesh-list
110648837|NCT00115765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110648838|NCT00115765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110648839|NCT00115765|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110648840|NCT00115765|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110648841|NCT00115765|Growth Substances|growth substances|mesh-ancestor
110397875|NCT01102426|Hormones|hormones|mesh-ancestor
110648842|NCT00115765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110648844|NCT00115765|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110648845|NCT00115765|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110648846|NCT00115765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110648847|NCT00115765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110648849|NCT00606008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110648850|NCT00606008|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110648851|NCT00606008|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110648852|NCT00606008|Growth Substances|growth substances|mesh-ancestor
110648853|NCT00606008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110648854|NCT00606008|Growth Inhibitors|growth inhibitors|mesh-ancestor
110648855|NCT00606008|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110648856|NCT00606008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110340318|NCT02951234|gamma-Globulins|gamma-globulins|mesh-list
110648857|NCT00606008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110648858|NCT00461812|Mometasone Furoate|mometasone furoate|mesh-list
110648859|NCT00461812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110648860|NCT00461812|Dermatologic Agents|dermatologic agents|mesh-ancestor
110648861|NCT00461812|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110648862|NCT00721331|Mometasone Furoate|mometasone furoate|mesh-list
110648864|NCT00721331|Nortriptyline|nortriptyline|mesh-list
110648865|NCT00721331|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110648866|NCT00721331|Dermatologic Agents|dermatologic agents|mesh-ancestor
110648867|NCT00721331|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110648868|NCT00721331|Antipruritics|antipruritics|mesh-ancestor
110648869|NCT00721331|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110648870|NCT00721331|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110648871|NCT00721331|Histamine Antagonists|histamine antagonists|mesh-ancestor
110648873|NCT00721331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110648874|NCT00721331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110260005|NCT00528619|Carboplatin|carboplatin|mesh-list
110648875|NCT00721331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110648876|NCT00721331|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110648877|NCT00721331|Antidepressive Agents|antidepressive agents|mesh-ancestor
110648878|NCT00721331|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110648879|NCT00721331|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110648880|NCT00721331|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110648881|NCT00721331|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110648882|NCT00721331|Adrenergic Agents|adrenergic agents|mesh-ancestor
110648884|NCT00123955|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110648885|NCT00123955|Hormone Antagonists|hormone antagonists|mesh-ancestor
110648886|NCT00123955|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110648887|NCT00123955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110340677|NCT02942550|Bromides|bromides|mesh-list
110648888|NCT00123955|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110648889|NCT00123955|Diuretics|diuretics|mesh-ancestor
110648890|NCT00123955|Natriuretic Agents|natriuretic agents|mesh-ancestor
110648891|NCT01027546|Tranexamic Acid|tranexamic acid|mesh-list
110648892|NCT01027546|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110648893|NCT01027546|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110648894|NCT01027546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110648895|NCT01027546|Hemostatics|hemostatics|mesh-ancestor
110648896|NCT01027546|Coagulants|coagulants|mesh-ancestor
110648897|NCT00115063|Orlistat|orlistat|mesh-list
110648898|NCT00115063|Sibutramine|sibutramine|mesh-list
110648899|NCT00115063|Diethylpropion|diethylpropion|mesh-list
110648900|NCT00115063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110648901|NCT00115063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110648902|NCT00115063|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110648903|NCT00115063|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110648904|NCT00115063|Antidepressive Agents|antidepressive agents|mesh-ancestor
110648905|NCT00115063|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110648906|NCT00115063|Appetite Depressants|appetite depressants|mesh-ancestor
110648907|NCT01026064|Azithromycin|azithromycin|mesh-list
110340944|NCT04690920|Remdesivir|remdesivir|mesh-list
110648908|NCT01026064|Cantharidin|cantharidin|mesh-list
110648909|NCT01026064|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110648910|NCT01026064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110648911|NCT01026064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110648912|NCT01026064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110648913|NCT02571959|Amoxicillin|amoxicillin|mesh-list
110648914|NCT02571959|Clavulanic Acids|clavulanic acids|mesh-list
110648915|NCT02571959|Clavulanic Acid|clavulanic acid|mesh-list
110648916|NCT02571959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110648917|NCT02571959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110648918|NCT02571959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110648919|NCT02571959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110648920|NCT02571959|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110648921|NCT00461500|Fluticasone|fluticasone|mesh-list
110648923|NCT00461500|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110648924|NCT00461500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110341086|NCT02940444|Heparin|heparin|mesh-list
110648925|NCT00461500|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110648926|NCT00461500|Autonomic Agents|autonomic agents|mesh-ancestor
110648927|NCT00461500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110648928|NCT00461500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110648929|NCT00461500|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110648930|NCT00461500|Respiratory System Agents|respiratory system agents|mesh-ancestor
110648931|NCT00461500|Dermatologic Agents|dermatologic agents|mesh-ancestor
110648932|NCT00461500|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110648933|NCT00461500|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110648934|NCT00461500|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110648935|NCT00461500|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110648936|NCT00461500|Adrenergic Agents|adrenergic agents|mesh-ancestor
110648937|NCT00461500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110648938|NCT00461500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110341222|NCT00520754|Levocetirizine|levocetirizine|mesh-list
110648940|NCT00893906|Immunologic Factors|immunologic factors|mesh-ancestor
110648941|NCT00893906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110648943|NCT00721487|Antifungal Agents|antifungal agents|mesh-ancestor
110648944|NCT00721487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110260145|NCT02944552|Antimetabolites|antimetabolites|mesh-ancestor
110648945|NCT00721487|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110648946|NCT00721487|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110648947|NCT00721487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110648948|NCT00721487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110648949|NCT00721487|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110648950|NCT00721487|Hormone Antagonists|hormone antagonists|mesh-ancestor
110648951|NCT00721487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110648952|NCT00721487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110648953|NCT00721487|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110648954|NCT00721487|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110648955|NCT00167245|Topiramate|topiramate|mesh-list
110648956|NCT00167245|Anticonvulsants|anticonvulsants|mesh-ancestor
110648957|NCT00167245|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110648958|NCT00167245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110648959|NCT00894062|Everolimus|everolimus|mesh-list
110648960|NCT00894062|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110648961|NCT00894062|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110648962|NCT00894062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110648963|NCT00894062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110648964|NCT00894062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110648965|NCT00894062|Immunologic Factors|immunologic factors|mesh-ancestor
110260192|NCT00168909|Vitamins|vitamins|mesh-ancestor
110648966|NCT00894062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110648967|NCT00894062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110648968|NCT00443560|Fentanyl|fentanyl|mesh-list
110648969|NCT00443560|Bupivacaine|bupivacaine|mesh-list
110648970|NCT00443560|Anesthetics, Local|anesthetics, local|mesh-ancestor
110648971|NCT00443560|Anesthetics|anesthetics|mesh-ancestor
110648972|NCT00443560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110648973|NCT00443560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110648974|NCT00443560|Sensory System Agents|sensory system agents|mesh-ancestor
110648975|NCT00443560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110648976|NCT00443560|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110648977|NCT00443560|Narcotics|narcotics|mesh-ancestor
110648978|NCT00443560|Analgesics|analgesics|mesh-ancestor
110648979|NCT00443560|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110648980|NCT00443560|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110397890|NCT01327547|Maraviroc|maraviroc|mesh-list
110648981|NCT00443560|Anesthetics, General|anesthetics, general|mesh-ancestor
110648982|NCT01022632|Curcumin|curcumin|mesh-list
110648983|NCT01022632|Fluoxetine|fluoxetine|mesh-list
110648984|NCT01022632|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110648985|NCT01022632|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110648986|NCT01022632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110341617|NCT00523757|Diuretics|diuretics|mesh-ancestor
110648987|NCT01022632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110648988|NCT01022632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110648989|NCT01022632|Serotonin Agents|serotonin agents|mesh-ancestor
110648990|NCT01022632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110648991|NCT01022632|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110648992|NCT01022632|Antidepressive Agents|antidepressive agents|mesh-ancestor
110648993|NCT01022632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110648994|NCT01022632|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110648995|NCT01022632|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110648996|NCT01022632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110648997|NCT01022632|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110648998|NCT01022632|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110648999|NCT01022632|Analgesics|analgesics|mesh-ancestor
110649000|NCT01022632|Sensory System Agents|sensory system agents|mesh-ancestor
110649001|NCT01022632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110649002|NCT01022632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110649003|NCT01022632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110649004|NCT01022632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110649005|NCT01026376|Decitabine|decitabine|mesh-list
110649006|NCT01026376|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110649007|NCT01026376|Antimetabolites|antimetabolites|mesh-ancestor
110649008|NCT01026376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110649009|NCT01026376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110649010|NCT01026376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110649011|NCT00716573|Everolimus|everolimus|mesh-list
110649012|NCT00716573|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110649013|NCT00716573|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110649014|NCT00716573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110649015|NCT00716573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110649016|NCT00716573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110649017|NCT00716573|Immunologic Factors|immunologic factors|mesh-ancestor
110649018|NCT00716573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110649019|NCT00716573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110649020|NCT02539706|Rocuronium|rocuronium|mesh-list
110649021|NCT02539706|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110649022|NCT02539706|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110649023|NCT02539706|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110649024|NCT02539706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110649025|NCT02539706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110649026|NCT00451204|Glatiramer Acetate|glatiramer acetate|mesh-list
110649027|NCT00451204|Estrogens|estrogens|mesh-list
110649028|NCT00451204|(T,G)-A-L|(t,g)-a-l|mesh-list
110649029|NCT00451204|Hormones|hormones|mesh-ancestor
110649030|NCT00451204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110649031|NCT00451204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110649032|NCT00451204|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110649033|NCT00451204|Immunologic Factors|immunologic factors|mesh-ancestor
110649034|NCT00451204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110649035|NCT00451204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110649036|NCT00721877|Resveratrol|resveratrol|mesh-list
110649037|NCT00721877|Antioxidants|antioxidants|mesh-ancestor
110649038|NCT00721877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110649039|NCT00721877|Protective Agents|protective agents|mesh-ancestor
110342185|NCT00526409|Hormones|hormones|mesh-ancestor
110649040|NCT00721877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110649041|NCT00721877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110649042|NCT00721877|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110649043|NCT03537586|Adenosine|adenosine|mesh-list
110649044|NCT03537586|Heparin|heparin|mesh-list
110649045|NCT03537586|Bivalirudin|bivalirudin|mesh-list
110649046|NCT03537586|Anticoagulants|anticoagulants|mesh-ancestor
110649047|NCT03537586|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110649048|NCT03537586|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110397894|NCT01327547|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110649049|NCT03537586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110649050|NCT03537586|Analgesics|analgesics|mesh-ancestor
110649051|NCT03537586|Sensory System Agents|sensory system agents|mesh-ancestor
110649052|NCT03537586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110649053|NCT03537586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110649054|NCT03537586|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110649055|NCT03537586|Vasodilator Agents|vasodilator agents|mesh-ancestor
110649056|NCT03537586|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
110649057|NCT03537586|Purinergic Agonists|purinergic agonists|mesh-ancestor
110649058|NCT03537586|Purinergic Agents|purinergic agents|mesh-ancestor
110649059|NCT03537586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110649060|NCT03537586|Antithrombins|antithrombins|mesh-ancestor
110649061|NCT03537586|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110649062|NCT03537586|Protease Inhibitors|protease inhibitors|mesh-ancestor
110649063|NCT03537586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110649064|NCT00722033|Indomethacin|indomethacin|mesh-list
110649065|NCT00722033|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110649066|NCT00722033|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110649067|NCT00722033|Analgesics|analgesics|mesh-ancestor
110296289|NCT02211625|Oxycodone|oxycodone|mesh-list
110649069|NCT00722033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110342306|NCT02927535|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110649070|NCT00722033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110649071|NCT00722033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110649072|NCT00722033|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110649073|NCT00722033|Gout Suppressants|gout suppressants|mesh-ancestor
110649074|NCT00722033|Tocolytic Agents|tocolytic agents|mesh-ancestor
110649075|NCT00722033|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110649076|NCT00722033|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110649077|NCT00722033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110649078|NCT00722033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110649079|NCT00894374|Artesunate|artesunate|mesh-list
110649080|NCT00894374|Antimalarials|antimalarials|mesh-ancestor
110649081|NCT00894374|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110649082|NCT00894374|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110649083|NCT00894374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110649084|NCT00894374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110649085|NCT00894374|Antiviral Agents|antiviral agents|mesh-ancestor
110649086|NCT00894374|Schistosomicides|schistosomicides|mesh-ancestor
110649087|NCT00894374|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110649088|NCT00894374|Anthelmintics|anthelmintics|mesh-ancestor
110649089|NCT04920149|Mesalamine|mesalamine|mesh-list
110342511|NCT00528671|Phenprocoumon|phenprocoumon|mesh-list
110649090|NCT04920149|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110649091|NCT04920149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110649092|NCT04920149|Analgesics|analgesics|mesh-ancestor
110649093|NCT04920149|Sensory System Agents|sensory system agents|mesh-ancestor
110649094|NCT04920149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110649095|NCT04920149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110649096|NCT04920149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110649097|NCT04920149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110649098|NCT01026610|Entecavir|entecavir|mesh-list
110649099|NCT01026610|Antiviral Agents|antiviral agents|mesh-ancestor
110649100|NCT01026610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110649101|NCT00901550|Infliximab|infliximab|mesh-list
110649102|NCT00901550|Methotrexate|methotrexate|mesh-list
110649103|NCT00901550|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110649104|NCT00901550|Abortifacient Agents|abortifacient agents|mesh-ancestor
110649105|NCT00901550|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110649106|NCT00901550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110649107|NCT00901550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110649108|NCT00901550|Antimetabolites|antimetabolites|mesh-ancestor
110649109|NCT00901550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110649110|NCT00901550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110649111|NCT00901550|Dermatologic Agents|dermatologic agents|mesh-ancestor
110649112|NCT00901550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110649113|NCT00901550|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110649114|NCT00901550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110649115|NCT00901550|Immunologic Factors|immunologic factors|mesh-ancestor
110649116|NCT00901550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110649117|NCT00901550|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110649118|NCT00901550|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110649119|NCT00901550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110649120|NCT00901550|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110649121|NCT02573051|Isosorbide|isosorbide|mesh-list
110649122|NCT02573051|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
110649123|NCT02573051|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
110649124|NCT02573051|Misoprostol|misoprostol|mesh-list
110342648|NCT02945033|Aspirin|aspirin|mesh-list
110649125|NCT02573051|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110649126|NCT02573051|Abortifacient Agents|abortifacient agents|mesh-ancestor
110649127|NCT02573051|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110342697|NCT00529646|APD791|apd791|mesh-list
110649128|NCT02573051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110649129|NCT02573051|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110649130|NCT02573051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110649131|NCT02573051|Oxytocics|oxytocics|mesh-ancestor
110649132|NCT02573051|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110649133|NCT02573051|Diuretics|diuretics|mesh-ancestor
110649134|NCT02573051|Natriuretic Agents|natriuretic agents|mesh-ancestor
110649135|NCT02573051|Vasodilator Agents|vasodilator agents|mesh-ancestor
110649136|NCT02573051|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
110649137|NCT02573051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110649138|NCT02539940|Paclitaxel|paclitaxel|mesh-list
110649139|NCT02539940|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110649140|NCT02539940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110342841|NCT02922387|Varenicline|varenicline|mesh-list
110649141|NCT02539940|Tubulin Modulators|tubulin modulators|mesh-ancestor
110649142|NCT02539940|Antimitotic Agents|antimitotic agents|mesh-ancestor
110649143|NCT02539940|Mitosis Modulators|mitosis modulators|mesh-ancestor
110649144|NCT02539940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110649145|NCT01028092|Cyclosporine|cyclosporine|mesh-list
110649146|NCT01028092|Everolimus|everolimus|mesh-list
110649147|NCT01028092|Interleukin-2|interleukin-2|mesh-list
110649148|NCT01028092|Cyclosporins|cyclosporins|mesh-list
110649149|NCT01028092|Thymoglobulin|thymoglobulin|mesh-list
110649150|NCT01028092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110649151|NCT01028092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110649152|NCT01028092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110649153|NCT01028092|Immunologic Factors|immunologic factors|mesh-ancestor
110342910|NCT00530387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110649154|NCT01028092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110649155|NCT01028092|Antifungal Agents|antifungal agents|mesh-ancestor
110649156|NCT01028092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110649157|NCT01028092|Dermatologic Agents|dermatologic agents|mesh-ancestor
110649158|NCT01028092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110649159|NCT01028092|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110649160|NCT01028092|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110342988|NCT00531674|Vitamins|vitamins|mesh-ancestor
110649161|NCT01028092|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110649162|NCT01028092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110649163|NCT01028092|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110649164|NCT01028092|Analgesics|analgesics|mesh-ancestor
110649165|NCT01028092|Sensory System Agents|sensory system agents|mesh-ancestor
110649166|NCT01028092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110649167|NCT00605306|Mometasone Furoate|mometasone furoate|mesh-list
110649168|NCT00605306|Maleic acid|maleic acid|mesh-list
110649169|NCT00605306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110649170|NCT00605306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110649171|NCT00605306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110649172|NCT00605306|Dermatologic Agents|dermatologic agents|mesh-ancestor
110649173|NCT00605306|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110649174|NCT00905918|Vitamin E|vitamin e|mesh-list
110649175|NCT00905918|Vitamins|vitamins|mesh-ancestor
110649176|NCT00905918|Micronutrients|micronutrients|mesh-ancestor
110649177|NCT00905918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110649178|NCT00905918|Antioxidants|antioxidants|mesh-ancestor
110649179|NCT00905918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110649180|NCT00905918|Protective Agents|protective agents|mesh-ancestor
110649181|NCT00894608|Letrozole|letrozole|mesh-list
110649182|NCT00894608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110649183|NCT00894608|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110649184|NCT00894608|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110649185|NCT00894608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110649186|NCT00894608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110649187|NCT00894608|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110260336|NCT00169143|Rituximab|rituximab|mesh-list
110649188|NCT00894608|Hormone Antagonists|hormone antagonists|mesh-ancestor
110649189|NCT00894608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110649190|NCT00894608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110649191|NCT00901784|Topiramate|topiramate|mesh-list
110649192|NCT00901784|Anticonvulsants|anticonvulsants|mesh-ancestor
110649193|NCT00901784|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110649194|NCT00901784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110649195|NCT00905996|Propranolol|propranolol|mesh-list
110649196|NCT00905996|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
110343161|NCT02942420|Analgesics|analgesics|mesh-ancestor
110649197|NCT00905996|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110649198|NCT00905996|Adrenergic Agents|adrenergic agents|mesh-ancestor
110649199|NCT00905996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110649200|NCT00905996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110649201|NCT00905996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110649202|NCT00905996|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110649203|NCT00905996|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110649204|NCT00905996|Vasodilator Agents|vasodilator agents|mesh-ancestor
110649205|NCT02539628|Ropivacaine|ropivacaine|mesh-list
110649206|NCT02539628|Anesthetics, Local|anesthetics, local|mesh-ancestor
110649207|NCT02539628|Anesthetics|anesthetics|mesh-ancestor
110649208|NCT02539628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110649209|NCT02539628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110649210|NCT02539628|Sensory System Agents|sensory system agents|mesh-ancestor
110649211|NCT02539628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110649212|NCT02573987|Lidocaine|lidocaine|mesh-list
110649213|NCT02573987|Nitrous Oxide|nitrous oxide|mesh-list
110649214|NCT02573987|Anesthetics, Local|anesthetics, local|mesh-ancestor
110649215|NCT02573987|Anesthetics|anesthetics|mesh-ancestor
110649216|NCT02573987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110649217|NCT02573987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110649218|NCT02573987|Sensory System Agents|sensory system agents|mesh-ancestor
110649219|NCT02573987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110649220|NCT02573987|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110649221|NCT02573987|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110649222|NCT02573987|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110649223|NCT02573987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110649224|NCT02573987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110649225|NCT02573987|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110649226|NCT02573987|Anesthetics, General|anesthetics, general|mesh-ancestor
110649227|NCT02573987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110649228|NCT02573987|Analgesics|analgesics|mesh-ancestor
110649229|NCT00906386|Varenicline|varenicline|mesh-list
110649230|NCT00906386|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110649231|NCT00906386|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110649232|NCT00906386|Cholinergic Agents|cholinergic agents|mesh-ancestor
110649233|NCT00906386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110649234|NCT00906386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110649235|NCT00906386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110649238|NCT00722579|Trace Elements|trace elements|mesh-ancestor
110649239|NCT00722579|Micronutrients|micronutrients|mesh-ancestor
110649240|NCT00722579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110649241|NCT00713687|Gemcitabine|gemcitabine|mesh-list
110649242|NCT00713687|Oxaliplatin|oxaliplatin|mesh-list
110343295|NCT02919501|Serotonin Agents|serotonin agents|mesh-ancestor
110649243|NCT00713687|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110649244|NCT00713687|Antimetabolites|antimetabolites|mesh-ancestor
110649245|NCT00713687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110649246|NCT00713687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110649247|NCT02540876|Ilorasertib|ilorasertib|mesh-list
110649248|NCT02540876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110649249|NCT02540876|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110649250|NCT02540876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110649251|NCT02540876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110649252|NCT00894920|Biotin|biotin|mesh-list
110649253|NCT00894920|Vitamin B Complex|vitamin b complex|mesh-ancestor
110649254|NCT00894920|Vitamins|vitamins|mesh-ancestor
110649255|NCT00894920|Micronutrients|micronutrients|mesh-ancestor
110649256|NCT00894920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110649257|NCT00722735|Ciprofloxacin|ciprofloxacin|mesh-list
110649258|NCT00722735|Finafloxacin|finafloxacin|mesh-list
110649259|NCT00722735|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110649260|NCT00722735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110649261|NCT00722735|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110649262|NCT00722735|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110649263|NCT00722735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110649264|NCT00722735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110649265|NCT00722735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110649266|NCT00722735|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110649267|NCT00722735|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110649268|NCT00722735|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110649269|NCT04067531|Clindamycin|clindamycin|mesh-list
110649270|NCT04067531|Clindamycin palmitate|clindamycin palmitate|mesh-list
110649271|NCT04067531|Clindamycin phosphate|clindamycin phosphate|mesh-list
110649272|NCT04067531|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110649273|NCT04067531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110649274|NCT04067531|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110649275|NCT04067531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110649276|NCT04067531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110649277|NCT00713765|Donepezil|donepezil|mesh-list
110649278|NCT00713765|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110649279|NCT00713765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110649280|NCT00713765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110649281|NCT00713765|Cholinergic Agents|cholinergic agents|mesh-ancestor
110649282|NCT00713765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110649283|NCT00713765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110649284|NCT00713765|Nootropic Agents|nootropic agents|mesh-ancestor
110649285|NCT00717587|Sunitinib|sunitinib|mesh-list
110649286|NCT00717587|Motexafin gadolinium|motexafin gadolinium|mesh-list
110649287|NCT00717587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110343620|NCT06024707|Omalizumab|omalizumab|mesh-list
110649288|NCT00717587|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110649289|NCT00717587|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110649290|NCT00717587|Growth Substances|growth substances|mesh-ancestor
110649291|NCT00717587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110649292|NCT00717587|Growth Inhibitors|growth inhibitors|mesh-ancestor
110649293|NCT00717587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110649294|NCT00717587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110649295|NCT00717587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110649296|NCT00717587|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110649297|NCT00717587|Dermatologic Agents|dermatologic agents|mesh-ancestor
110649299|NCT00894998|Calcium heparin|calcium heparin|mesh-list
110649300|NCT00894998|Anticoagulants|anticoagulants|mesh-ancestor
110260463|NCT00169221|Gefitinib|gefitinib|mesh-list
110649301|NCT00894998|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110649302|NCT00894998|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110159574|NCT00092404|Vaccines|vaccines|mesh-list
110343737|NCT06023043|Hormones|hormones|mesh-ancestor
110649303|NCT00894998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110649305|NCT00713921|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110649306|NCT00713921|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110649307|NCT00713921|Cholinergic Agents|cholinergic agents|mesh-ancestor
110649308|NCT00713921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110649309|NCT00713921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110534676|NCT02675868|Phenylephrine|phenylephrine|mesh-list
110649310|NCT00713921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110649311|NCT00713921|Urological Agents|urological agents|mesh-ancestor
110649312|NCT00713999|Praziquantel|praziquantel|mesh-list
110649313|NCT00713999|Anthelmintics|anthelmintics|mesh-ancestor
110649314|NCT00713999|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110649315|NCT00713999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110649316|NCT04072601|Atorvastatin|atorvastatin|mesh-list
110649317|NCT04072601|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110649318|NCT04072601|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110649319|NCT04072601|Antimetabolites|antimetabolites|mesh-ancestor
110260503|NCT00169299|Estrogens|estrogens|mesh-list
110649320|NCT04072601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110649321|NCT04072601|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110649322|NCT04072601|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110649323|NCT04072601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110649324|NCT00717821|Epoetin Alfa|epoetin alfa|mesh-list
110649325|NCT00717821|Darbepoetin alfa|darbepoetin alfa|mesh-list
110649326|NCT00717821|Hematinics|hematinics|mesh-ancestor
110649327|NCT03476369|Fentanyl|fentanyl|mesh-list
110649328|NCT03476369|Ticagrelor|ticagrelor|mesh-list
110649329|NCT03476369|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110649330|NCT03476369|Narcotics|narcotics|mesh-ancestor
110649331|NCT03476369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110649332|NCT03476369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110649333|NCT03476369|Analgesics|analgesics|mesh-ancestor
110649334|NCT03476369|Sensory System Agents|sensory system agents|mesh-ancestor
110649335|NCT03476369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110649336|NCT03476369|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110649337|NCT03476369|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110649338|NCT03476369|Anesthetics, General|anesthetics, general|mesh-ancestor
110649339|NCT03476369|Anesthetics|anesthetics|mesh-ancestor
110649340|NCT03476369|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110649341|NCT03476369|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110260632|NCT02940808|Caffeine|caffeine|mesh-list
110649342|NCT03476369|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110649343|NCT03476369|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110649344|NCT03476369|Purinergic Agents|purinergic agents|mesh-ancestor
110649345|NCT03476369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110649346|NCT03476369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110649347|NCT00722969|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110649348|NCT00722969|Sorafenib|sorafenib|mesh-list
110649349|NCT00722969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110649350|NCT00722969|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110649351|NCT00722969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110649352|NCT00722969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110649353|NCT04069325|Febuxostat|febuxostat|mesh-list
110649354|NCT04069325|Gout Suppressants|gout suppressants|mesh-ancestor
110649355|NCT04069325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110649356|NCT00723047|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
110649357|NCT00723047|Hemostatics|hemostatics|mesh-ancestor
110649358|NCT00723047|Coagulants|coagulants|mesh-ancestor
110649359|NCT00450814|Cyclophosphamide|cyclophosphamide|mesh-list
110649360|NCT00450814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110649361|NCT00450814|Immunologic Factors|immunologic factors|mesh-ancestor
110649362|NCT00450814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110649363|NCT00450814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110649364|NCT00450814|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110649365|NCT00450814|Alkylating Agents|alkylating agents|mesh-ancestor
110649366|NCT00450814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110649367|NCT00450814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110649368|NCT00450814|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110649369|NCT02571491|Ketamine|ketamine|mesh-list
110649370|NCT02571491|Morphine|morphine|mesh-list
110649371|NCT02571491|Remifentanil|remifentanil|mesh-list
110649372|NCT02571491|Analgesics|analgesics|mesh-ancestor
110649373|NCT02571491|Sensory System Agents|sensory system agents|mesh-ancestor
110649374|NCT02571491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110649375|NCT02571491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110649376|NCT02571491|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110649377|NCT02571491|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110649379|NCT02571491|Anesthetics|anesthetics|mesh-ancestor
110649380|NCT02571491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110649381|NCT02571491|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110649382|NCT02571491|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110649383|NCT02571491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110260752|NCT00175032|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110649384|NCT02571491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110649385|NCT02571491|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110649386|NCT02571491|Narcotics|narcotics|mesh-ancestor
110649387|NCT00723437|Acitretin|acitretin|mesh-list
110534971|NCT00645372|Dopamine Agents|dopamine agents|mesh-ancestor
110649389|NCT00723437|Dermatologic Agents|dermatologic agents|mesh-ancestor
110649390|NCT00723515|Listerine|listerine|mesh-list
110649391|NCT00723515|Calcium|calcium|mesh-list
110649392|NCT00723515|Fluorides|fluorides|mesh-list
110649393|NCT00723515|Sodium Fluoride|sodium fluoride|mesh-list
110649394|NCT00723515|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110649396|NCT00723515|Cariostatic Agents|cariostatic agents|mesh-ancestor
110649397|NCT00723515|Protective Agents|protective agents|mesh-ancestor
110649398|NCT00723515|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110260812|NCT02944045|Hormones|hormones|mesh-ancestor
110649399|NCT00723515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110649400|NCT01028170|Furosemide|furosemide|mesh-list
110649402|NCT01028170|Natriuretic Agents|natriuretic agents|mesh-ancestor
110649403|NCT01028170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110649404|NCT01028170|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110649405|NCT01028170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110649406|NCT01028170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110649408|NCT00518115|rGLP-1 protein|rglp-1 protein|mesh-list
110649409|NCT00518115|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110260861|NCT00169611|Dopamine Agents|dopamine agents|mesh-ancestor
110649410|NCT00518115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110649411|NCT00518115|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110649412|NCT00518115|Incretins|incretins|mesh-ancestor
110649414|NCT00518115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110649415|NCT00723983|Sumatriptan|sumatriptan|mesh-list
110649416|NCT00723983|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110649417|NCT00723983|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110649418|NCT00723983|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110649419|NCT00723983|Serotonin Agents|serotonin agents|mesh-ancestor
110649420|NCT00723983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110649421|NCT00723983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110649422|NCT00723983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110649423|NCT00450658|Ibuprofen|ibuprofen|mesh-list
110649424|NCT00450658|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110649425|NCT00450658|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110649426|NCT00450658|Analgesics|analgesics|mesh-ancestor
110649427|NCT00450658|Sensory System Agents|sensory system agents|mesh-ancestor
110649428|NCT00450658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110649429|NCT00450658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110649430|NCT00450658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110649431|NCT00450658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110649432|NCT00450658|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110649433|NCT00450658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110649434|NCT00450658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110649435|NCT02572505|Tenofovir|tenofovir|mesh-list
110649436|NCT02572505|Emtricitabine|emtricitabine|mesh-list
110649437|NCT02572505|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110649438|NCT02572505|Antiviral Agents|antiviral agents|mesh-ancestor
110649439|NCT02572505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110649440|NCT02572505|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110649441|NCT02572505|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110649442|NCT02572505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110649443|NCT02572505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110649445|NCT02572505|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110649446|NCT00517881|Epoetin Alfa|epoetin alfa|mesh-list
110649447|NCT00517881|Hematinics|hematinics|mesh-ancestor
110649448|NCT01010139|Codeine|codeine|mesh-list
110649449|NCT01010139|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110649450|NCT01010139|Narcotics|narcotics|mesh-ancestor
110649451|NCT01010139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110649452|NCT01010139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110649453|NCT01010139|Analgesics|analgesics|mesh-ancestor
110649454|NCT01010139|Sensory System Agents|sensory system agents|mesh-ancestor
110649455|NCT01010139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110649456|NCT01010139|Antitussive Agents|antitussive agents|mesh-ancestor
110649457|NCT01010139|Respiratory System Agents|respiratory system agents|mesh-ancestor
110649458|NCT00724295|Ribavirin|ribavirin|mesh-list
110649459|NCT00724295|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110649460|NCT00724295|Antimetabolites|antimetabolites|mesh-ancestor
110649461|NCT00724295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110649462|NCT00724295|Antiviral Agents|antiviral agents|mesh-ancestor
110649463|NCT00724295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110649464|NCT00718289|Dialysis Solutions|dialysis solutions|mesh-list
110649465|NCT00718289|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110649466|NCT00517413|Epoetin Alfa|epoetin alfa|mesh-list
110649467|NCT00517413|Hematinics|hematinics|mesh-ancestor
110649468|NCT00724529|Infliximab|infliximab|mesh-list
110649469|NCT00724529|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110649470|NCT00724529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110649471|NCT00724529|Dermatologic Agents|dermatologic agents|mesh-ancestor
110649472|NCT00724529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110649473|NCT00724529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110649474|NCT01012869|Everolimus|everolimus|mesh-list
110649475|NCT01012869|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110649476|NCT01012869|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110649477|NCT01012869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110649478|NCT01012869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110649479|NCT01012869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110649480|NCT01012869|Immunologic Factors|immunologic factors|mesh-ancestor
110649481|NCT01012869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110649482|NCT01012869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110649483|NCT01010295|Doxycycline|doxycycline|mesh-list
110649484|NCT01010295|Tetracycline|tetracycline|mesh-list
110649485|NCT01010295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110649486|NCT01010295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110649487|NCT01010295|Antimalarials|antimalarials|mesh-ancestor
110649488|NCT01010295|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110649489|NCT01010295|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110649490|NCT01010295|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110649491|NCT01010295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110649492|NCT01010295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110649493|NCT01010373|Ammonium trichloro(dioxoethylene-O,O'-)tellurate|ammonium trichloro(dioxoethylene-o,o'-)tellurate|mesh-list
110649494|NCT01010373|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110649495|NCT01010373|Immunologic Factors|immunologic factors|mesh-ancestor
110649496|NCT01010373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110649497|NCT01010373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110649498|NCT01010373|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110649499|NCT01010373|Protective Agents|protective agents|mesh-ancestor
110649500|NCT01010373|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110649501|NCT01010373|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110649502|NCT01010373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110649503|NCT01010373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110649504|NCT01010373|Antiviral Agents|antiviral agents|mesh-ancestor
110649505|NCT01010373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110649506|NCT01010451|Anti-Infective Agents|anti-infective agents|mesh-list
110649507|NCT01010451|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110649508|NCT01010451|Calcium|calcium|mesh-list
110649509|NCT01010451|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110649510|NCT01010451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110649511|NCT02570789|Sunitinib|sunitinib|mesh-list
110649512|NCT02570789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110649513|NCT02570789|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110649514|NCT02570789|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110649515|NCT02570789|Growth Substances|growth substances|mesh-ancestor
110649516|NCT02570789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110649517|NCT02570789|Growth Inhibitors|growth inhibitors|mesh-ancestor
110649518|NCT02570789|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110649519|NCT02570789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110649520|NCT02570789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110296729|NCT00261261|Midazolam|midazolam|mesh-list
110535604|NCT02831543|Mosapride|mosapride|mesh-list
110649521|NCT00604214|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
110649522|NCT00604214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110649523|NCT00450580|Ritonavir|ritonavir|mesh-list
110649524|NCT00450580|Fosamprenavir|fosamprenavir|mesh-list
110649525|NCT00450580|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110649526|NCT00450580|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110649527|NCT00450580|Protease Inhibitors|protease inhibitors|mesh-ancestor
110535662|NCT02658396|Bortezomib|bortezomib|mesh-list
110649529|NCT00450580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110649530|NCT00450580|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110649531|NCT00450580|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110649532|NCT00450580|Antiviral Agents|antiviral agents|mesh-ancestor
110649533|NCT00450580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110649534|NCT00450580|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110649535|NCT00450580|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110649536|NCT00724685|Ropivacaine|ropivacaine|mesh-list
110649537|NCT00724685|Anesthetics, Local|anesthetics, local|mesh-ancestor
110649538|NCT00724685|Anesthetics|anesthetics|mesh-ancestor
110649539|NCT00724685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110649540|NCT00724685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110649541|NCT00724685|Sensory System Agents|sensory system agents|mesh-ancestor
110649542|NCT00724685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110649543|NCT00123487|Dasatinib|dasatinib|mesh-list
110649544|NCT00123487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110649545|NCT00123487|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110649546|NCT00123487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110649547|NCT00123487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110649548|NCT00509925|Insulin|insulin|mesh-list
110649549|NCT00509925|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110649550|NCT00509925|Insulin Aspart|insulin aspart|mesh-list
110649551|NCT00509925|Insulin Detemir|insulin detemir|mesh-list
110649552|NCT00509925|Isophane Insulin, Human|isophane insulin, human|mesh-list
110649553|NCT00509925|Insulin, Isophane|insulin, isophane|mesh-list
110649554|NCT00509925|Isophane insulin, beef|isophane insulin, beef|mesh-list
110649555|NCT00509925|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110649556|NCT00509925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110649557|NCT05277974|Dexamethasone|dexamethasone|mesh-list
110649558|NCT05277974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110649559|NCT05277974|Antiemetics|antiemetics|mesh-ancestor
110649560|NCT05277974|Autonomic Agents|autonomic agents|mesh-ancestor
110649561|NCT05277974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110649562|NCT05277974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110649563|NCT05277974|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110649564|NCT05277974|Glucocorticoids|glucocorticoids|mesh-ancestor
110649565|NCT05277974|Hormones|hormones|mesh-ancestor
110649566|NCT05277974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110649567|NCT05277974|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110649568|NCT05277974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110649569|NCT00504777|Rituximab|rituximab|mesh-list
110649570|NCT00504777|Methotrexate|methotrexate|mesh-list
110649571|NCT00504777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110649572|NCT00504777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110649573|NCT00504777|Immunologic Factors|immunologic factors|mesh-ancestor
110649574|NCT00504777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110649575|NCT00504777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110649576|NCT00504777|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110649577|NCT00504777|Abortifacient Agents|abortifacient agents|mesh-ancestor
110649578|NCT00504777|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110535725|NCT02657616|Hemostatics|hemostatics|mesh-ancestor
110649579|NCT00504777|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110649580|NCT00504777|Antimetabolites|antimetabolites|mesh-ancestor
110159598|NCT00093184|Protease Inhibitors|protease inhibitors|mesh-ancestor
110649581|NCT00504777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110649582|NCT00504777|Dermatologic Agents|dermatologic agents|mesh-ancestor
110649583|NCT00504777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110649584|NCT00504777|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110261527|NCT02928328|Anesthetics|anesthetics|mesh-ancestor
110649585|NCT00504777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110649586|NCT00504777|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110649587|NCT03968263|Hydrocodone|hydrocodone|mesh-list
110649588|NCT03968263|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110649589|NCT03968263|Narcotics|narcotics|mesh-ancestor
110649590|NCT03968263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110649591|NCT03968263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110649592|NCT03968263|Analgesics|analgesics|mesh-ancestor
110649593|NCT03968263|Sensory System Agents|sensory system agents|mesh-ancestor
110649594|NCT03968263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110649595|NCT03968263|Antitussive Agents|antitussive agents|mesh-ancestor
110649596|NCT03968263|Respiratory System Agents|respiratory system agents|mesh-ancestor
110649597|NCT00895076|Dexamethasone|dexamethasone|mesh-list
110649598|NCT00895076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110649599|NCT00895076|Antiemetics|antiemetics|mesh-ancestor
110649600|NCT00895076|Autonomic Agents|autonomic agents|mesh-ancestor
110649601|NCT00895076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110535756|NCT02831231|Xanomeline|xanomeline|mesh-list
110649602|NCT00895076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110649603|NCT00895076|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110649604|NCT00895076|Glucocorticoids|glucocorticoids|mesh-ancestor
110649606|NCT00895076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110649607|NCT00895076|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110649608|NCT00895076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110649609|NCT01078519|Anesthetics|anesthetics|mesh-list
110649610|NCT01078519|Anesthetics, Local|anesthetics, local|mesh-list
110649611|NCT01078519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110649612|NCT01078519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110649613|NCT01078519|Sensory System Agents|sensory system agents|mesh-ancestor
110535799|NCT02660658|Sensory System Agents|sensory system agents|mesh-ancestor
110649614|NCT01078519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110649615|NCT02539316|SMOFlipid|smoflipid|mesh-list
110649616|NCT02539316|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
110649617|NCT02539316|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
110649618|NCT02539316|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110649619|NCT03968185|Analgesics|analgesics|mesh-list
110649620|NCT03968185|Sensory System Agents|sensory system agents|mesh-ancestor
110649621|NCT03968185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110649622|NCT03968185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110649623|NCT00509769|Trastuzumab|trastuzumab|mesh-list
110649624|NCT00509769|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
110649625|NCT00509769|Maytansine|maytansine|mesh-list
110649626|NCT00509769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110649627|NCT00509769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110649628|NCT00509769|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110649630|NCT00509769|Antimitotic Agents|antimitotic agents|mesh-ancestor
110649631|NCT00509769|Mitosis Modulators|mitosis modulators|mesh-ancestor
110649632|NCT00509769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110649633|NCT00509769|Immunotoxins|immunotoxins|mesh-ancestor
110649634|NCT00509769|Immunoconjugates|immunoconjugates|mesh-ancestor
110649635|NCT00509769|Immunologic Factors|immunologic factors|mesh-ancestor
110535923|NCT00649974|Valacyclovir|valacyclovir|mesh-list
110649636|NCT00509769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110649637|NCT05206877|Insulin|insulin|mesh-list
110649638|NCT05206877|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110649639|NCT05206877|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110649640|NCT05206877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110649641|NCT02977715|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
110649642|NCT02977715|Antiviral Agents|antiviral agents|mesh-ancestor
110649643|NCT02977715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110649644|NCT01074697|Dexamethasone|dexamethasone|mesh-list
110649645|NCT01074697|Palonosetron|palonosetron|mesh-list
110649646|NCT01074697|Fosaprepitant|fosaprepitant|mesh-list
110649647|NCT01074697|Aprepitant|aprepitant|mesh-list
110649648|NCT01074697|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110649649|NCT01074697|Antiemetics|antiemetics|mesh-ancestor
110649650|NCT01074697|Autonomic Agents|autonomic agents|mesh-ancestor
110649651|NCT01074697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110159601|NCT00006224|Gemcitabine|gemcitabine|mesh-list
110649652|NCT01074697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110649653|NCT01074697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110649654|NCT01074697|Glucocorticoids|glucocorticoids|mesh-ancestor
110649655|NCT01074697|Hormones|hormones|mesh-ancestor
110649656|NCT01074697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110649657|NCT01074697|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110649658|NCT01074697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110649659|NCT01074697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110261838|NCT02916160|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110649660|NCT01074697|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110649661|NCT01074697|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110649662|NCT01074697|Serotonin Agents|serotonin agents|mesh-ancestor
110649663|NCT01074697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110536123|NCT02832947|Anticoagulants|anticoagulants|mesh-ancestor
110649664|NCT01074697|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110649666|NCT01080079|Antifungal Agents|antifungal agents|mesh-ancestor
110649668|NCT01080079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110649669|NCT01080079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110649670|NCT00725231|Alemtuzumab|alemtuzumab|mesh-list
110296882|NCT04553458|Ethanol|ethanol|mesh-list
110649671|NCT00725231|Doxorubicin|doxorubicin|mesh-list
110649672|NCT00725231|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110649673|NCT00725231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110649674|NCT00725231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110649675|NCT00725231|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110649676|NCT00725231|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110649677|NCT00725231|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110649678|NCT00725231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110649679|NCT00725231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110649680|NCT00114127|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110649681|NCT00114127|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110649682|NCT00114127|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110649683|NCT00114127|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110261898|NCT00171015|Diuretics|diuretics|mesh-ancestor
110649684|NCT00114127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110649685|NCT00114127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110649686|NCT00114127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110649687|NCT00114127|Analgesics|analgesics|mesh-ancestor
110649688|NCT00114127|Sensory System Agents|sensory system agents|mesh-ancestor
110536240|NCT00650598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110649689|NCT00114127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110649690|NCT00114127|Antidepressive Agents|antidepressive agents|mesh-ancestor
110649691|NCT00114127|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110649692|NCT00114127|Dopamine Agents|dopamine agents|mesh-ancestor
110649694|NCT00902954|Anastrozole|anastrozole|mesh-list
110649695|NCT00902954|Exemestane|exemestane|mesh-list
110649696|NCT00902954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110649697|NCT00902954|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110649698|NCT00902954|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110649699|NCT00902954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110649700|NCT00902954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110649701|NCT00902954|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110649702|NCT00902954|Hormone Antagonists|hormone antagonists|mesh-ancestor
110649703|NCT00902954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110649704|NCT00902954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110536308|NCT02829281|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110649705|NCT00902954|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110649706|NCT02540720|Dexamethasone|dexamethasone|mesh-list
110649707|NCT02540720|gamma-Globulins|gamma-globulins|mesh-list
110649708|NCT02540720|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110649709|NCT02540720|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110649710|NCT02540720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110649711|NCT02540720|Antiemetics|antiemetics|mesh-ancestor
110649712|NCT02540720|Autonomic Agents|autonomic agents|mesh-ancestor
110649713|NCT02540720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110649714|NCT02540720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110649715|NCT02540720|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110649716|NCT02540720|Glucocorticoids|glucocorticoids|mesh-ancestor
110649717|NCT02540720|Hormones|hormones|mesh-ancestor
110649718|NCT02540720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110649719|NCT02540720|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110649720|NCT02540720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110649721|NCT02540720|Immunologic Factors|immunologic factors|mesh-ancestor
110649722|NCT02540642|Vitamin B 12|vitamin b 12|mesh-list
110649724|NCT02540642|Micronutrients|micronutrients|mesh-ancestor
110649725|NCT02540642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110649726|NCT02540642|Vitamin B Complex|vitamin b complex|mesh-ancestor
110649727|NCT00122317|Eculizumab|eculizumab|mesh-list
110261983|NCT05785234|Sufentanil|sufentanil|mesh-list
110649728|NCT00122317|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
110649729|NCT00122317|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110649730|NCT00122317|Immunologic Factors|immunologic factors|mesh-ancestor
110649731|NCT00122317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110649732|NCT00908336|Docetaxel|docetaxel|mesh-list
110649733|NCT00908336|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110649734|NCT00908336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110649736|NCT00908336|Antimitotic Agents|antimitotic agents|mesh-ancestor
110649737|NCT00908336|Mitosis Modulators|mitosis modulators|mesh-ancestor
110649738|NCT00908336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110649739|NCT00908336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110649740|NCT00908336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110649741|NCT00908414|TMC-310911|tmc-310911|mesh-list
110649742|NCT00908414|Protease Inhibitors|protease inhibitors|mesh-ancestor
110649743|NCT00908414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110649744|NCT00908414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110649746|NCT01074853|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110649747|NCT01074853|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110649748|NCT01074853|Adrenergic Agents|adrenergic agents|mesh-ancestor
110649749|NCT01074853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110649750|NCT01074853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110649751|NCT01074853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110649752|NCT01074853|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110649753|NCT01074853|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110649754|NCT01074853|Vasodilator Agents|vasodilator agents|mesh-ancestor
110649756|NCT00725777|Artemether|artemether|mesh-list
110649757|NCT00725777|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
110649758|NCT00725777|Antimalarials|antimalarials|mesh-ancestor
110649759|NCT00725777|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110649760|NCT00725777|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110649761|NCT00725777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110649762|NCT00165841|Rabeprazole|rabeprazole|mesh-list
110649763|NCT00165841|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110649764|NCT00165841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110649765|NCT00165841|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110649766|NCT00165841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110536571|NCT04244591|Prednisolone|prednisolone|mesh-list
110649767|NCT00165841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110649768|NCT00907166|Gemcitabine|gemcitabine|mesh-list
110649769|NCT00907166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110649770|NCT00907166|Antimetabolites|antimetabolites|mesh-ancestor
110649771|NCT00907166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110649772|NCT00907166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110649774|NCT00460798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110649775|NCT00460798|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110649776|NCT00460798|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110649777|NCT00460798|Growth Substances|growth substances|mesh-ancestor
110649778|NCT00460798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110649779|NCT00460798|Growth Inhibitors|growth inhibitors|mesh-ancestor
110536676|NCT00888329|Antiemetics|antiemetics|mesh-ancestor
110649780|NCT00460798|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110649782|NCT00460798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110649797|NCT00726869|Elotuzumab|elotuzumab|mesh-list
110649798|NCT00726869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110649799|NCT01028248|Ranibizumab|ranibizumab|mesh-list
110649800|NCT01028248|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110262253|NCT05111262|Budesonide|budesonide|mesh-list
110649801|NCT01028248|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110649802|NCT01028248|Growth Substances|growth substances|mesh-ancestor
110649803|NCT01028248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110649804|NCT01028248|Growth Inhibitors|growth inhibitors|mesh-ancestor
110649805|NCT01028248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110649806|NCT00726011|Tetrodotoxin|tetrodotoxin|mesh-list
110649807|NCT00726011|Anesthetics, Local|anesthetics, local|mesh-ancestor
110649808|NCT00726011|Anesthetics|anesthetics|mesh-ancestor
110649809|NCT00726011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110649810|NCT00726011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110649811|NCT00726011|Sensory System Agents|sensory system agents|mesh-ancestor
110649812|NCT00726011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110649814|NCT00726011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110649815|NCT00726011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110649816|NCT00603980|Alprazolam|alprazolam|mesh-list
110536868|NCT02827331|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110649817|NCT00603980|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110649818|NCT00603980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110649819|NCT00603980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110649820|NCT00603980|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110649821|NCT00603980|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110649822|NCT00603980|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110649823|NCT00603980|GABA Modulators|gaba modulators|mesh-ancestor
110649824|NCT00603980|GABA Agents|gaba agents|mesh-ancestor
110649825|NCT00603980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110649826|NCT00603980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110649827|NCT01028404|Insulin|insulin|mesh-list
110649828|NCT01028404|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110649829|NCT01028404|Insulin Aspart|insulin aspart|mesh-list
110537029|NCT00652860|Ifosfamide|ifosfamide|mesh-list
110649830|NCT01028404|Insulin, Long-Acting|insulin, long-acting|mesh-list
110649831|NCT01028404|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
110649832|NCT01028404|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110649833|NCT01028404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110649834|NCT00727103|Varenicline|varenicline|mesh-list
110649835|NCT00727103|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110649836|NCT00727103|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110649837|NCT00727103|Cholinergic Agents|cholinergic agents|mesh-ancestor
110649839|NCT00727103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110649840|NCT00727103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110649841|NCT01028482|Sertraline|sertraline|mesh-list
110649842|NCT01028482|Antidepressive Agents|antidepressive agents|mesh-ancestor
110649843|NCT01028482|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110537141|NCT00637949|Analgesics|analgesics|mesh-ancestor
110649844|NCT01028482|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110649845|NCT01028482|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110649846|NCT01028482|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110649847|NCT01028482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110649848|NCT01028482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110649849|NCT01028482|Serotonin Agents|serotonin agents|mesh-ancestor
110649850|NCT01028482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110649851|NCT00903188|Cyclosporine|cyclosporine|mesh-list
110262524|NCT04298983|Androgens|androgens|mesh-list
110649852|NCT00903188|Mycophenolic Acid|mycophenolic acid|mesh-list
110649853|NCT00903188|Methylprednisolone|methylprednisolone|mesh-list
110649854|NCT00903188|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110649855|NCT00903188|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110649856|NCT00903188|Prednisolone|prednisolone|mesh-list
110649857|NCT00903188|Prednisolone acetate|prednisolone acetate|mesh-list
110649858|NCT00903188|Everolimus|everolimus|mesh-list
110649859|NCT00903188|Cyclosporins|cyclosporins|mesh-list
110649860|NCT00903188|Basiliximab|basiliximab|mesh-list
110649861|NCT00903188|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110649862|NCT00903188|Prednisolone phosphate|prednisolone phosphate|mesh-list
110649863|NCT00903188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110159611|NCT00093223|Antimitotic Agents|antimitotic agents|mesh-ancestor
110649864|NCT00903188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110649865|NCT00903188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110649866|NCT00903188|Immunologic Factors|immunologic factors|mesh-ancestor
110649867|NCT00903188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110649868|NCT00903188|Antifungal Agents|antifungal agents|mesh-ancestor
110537207|NCT04241705|Primaquine|primaquine|mesh-list
110649869|NCT00903188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110649870|NCT00903188|Dermatologic Agents|dermatologic agents|mesh-ancestor
110649871|NCT00903188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110649872|NCT00903188|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110649873|NCT00903188|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110649874|NCT00903188|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110649875|NCT00903188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110649876|NCT00903188|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110649878|NCT00903188|Autonomic Agents|autonomic agents|mesh-ancestor
110649879|NCT00903188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110649880|NCT00903188|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110649881|NCT00903188|Glucocorticoids|glucocorticoids|mesh-ancestor
110649882|NCT00903188|Hormones|hormones|mesh-ancestor
110537326|NCT02652312|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110649883|NCT00903188|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110649884|NCT00903188|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110649885|NCT00903188|Protective Agents|protective agents|mesh-ancestor
110649886|NCT00903188|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110649887|NCT00903188|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110649888|NCT00903188|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110537400|NCT00654108|Vitamins|vitamins|mesh-ancestor
110649889|NCT00903188|Antitubercular Agents|antitubercular agents|mesh-ancestor
110649890|NCT00903188|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110297103|NCT00269217|Simvastatin|simvastatin|mesh-list
110649892|NCT00908726|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110649893|NCT00908726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110649894|NCT00908726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110537471|NCT02642484|Antacids|antacids|mesh-ancestor
110649895|NCT00908726|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110649896|NCT00908726|Anesthetics, General|anesthetics, general|mesh-ancestor
110649898|NCT02948309|Viscum album peptide|viscum album peptide|mesh-list
110649899|NCT02948309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110649900|NCT02948309|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110649901|NCT02948309|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110649902|NCT02948309|Antiviral Agents|antiviral agents|mesh-ancestor
110649903|NCT02948309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110649904|NCT00449956|Timolol|timolol|mesh-list
110649905|NCT00449956|Dorzolamide|dorzolamide|mesh-list
110649906|NCT00449956|Maleic acid|maleic acid|mesh-list
110649907|NCT00449956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110649908|NCT00449956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110649909|NCT00449956|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110649910|NCT00449956|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110649911|NCT00449956|Adrenergic Agents|adrenergic agents|mesh-ancestor
110649912|NCT00449956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110649913|NCT00449956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110649914|NCT00449956|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110649915|NCT00449956|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110649916|NCT00449956|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110649917|NCT00907400|Naproxen|naproxen|mesh-list
110649918|NCT00907400|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110649919|NCT00907400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110649920|NCT00907400|Analgesics|analgesics|mesh-ancestor
110649921|NCT00907400|Sensory System Agents|sensory system agents|mesh-ancestor
110649922|NCT00907400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110537687|NCT00598650|Donepezil|donepezil|mesh-list
110649923|NCT00907400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110649924|NCT00907400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110649925|NCT00907400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110649926|NCT00907400|Gout Suppressants|gout suppressants|mesh-ancestor
110537727|NCT00681135|Olaflur|olaflur|mesh-list
110649927|NCT00907400|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110649928|NCT00907400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110262806|NCT02726581|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110649929|NCT00907400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110649930|NCT00727493|Alendronate|alendronate|mesh-list
110649931|NCT00727493|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110649932|NCT00727493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110649933|NCT00727727|Piribedil|piribedil|mesh-list
110649934|NCT00727727|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110649935|NCT00727727|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110649936|NCT00727727|Dopamine Agonists|dopamine agonists|mesh-ancestor
110649937|NCT00727727|Dopamine Agents|dopamine agents|mesh-ancestor
110649938|NCT00727727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110649939|NCT00727727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110649940|NCT00727727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110649941|NCT00903656|Lapatinib|lapatinib|mesh-list
110649942|NCT00903656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110649943|NCT00903656|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110649944|NCT00903656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110262871|NCT01711554|Vitamin A|vitamin a|mesh-list
110649945|NCT00903656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110649946|NCT00730067|Sildenafil Citrate|sildenafil citrate|mesh-list
110649947|NCT00730067|Vasodilator Agents|vasodilator agents|mesh-ancestor
110649948|NCT00730067|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110649949|NCT00730067|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110649950|NCT00730067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110649951|NCT00730067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110649952|NCT00730067|Urological Agents|urological agents|mesh-ancestor
110649953|NCT02538224|Doxycycline|doxycycline|mesh-list
110649954|NCT02538224|Ketoprofen|ketoprofen|mesh-list
110649955|NCT02538224|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110649956|NCT02538224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110649957|NCT02538224|Antimalarials|antimalarials|mesh-ancestor
110649958|NCT02538224|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110649959|NCT02538224|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110649960|NCT02538224|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110649961|NCT02538224|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110649962|NCT02538224|Analgesics|analgesics|mesh-ancestor
110649963|NCT02538224|Sensory System Agents|sensory system agents|mesh-ancestor
110649964|NCT02538224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110649965|NCT02538224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110649966|NCT02538224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110649967|NCT02538224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110297177|NCT00236561|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110649968|NCT02538224|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110649969|NCT02538224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110649970|NCT02538224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110649971|NCT02538302|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
110649972|NCT02538302|Oxybutynin|oxybutynin|mesh-list
110649973|NCT02538302|Parasympatholytics|parasympatholytics|mesh-ancestor
110649974|NCT02538302|Autonomic Agents|autonomic agents|mesh-ancestor
110649975|NCT02538302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110649976|NCT02538302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110649977|NCT02538302|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110649978|NCT02538302|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110649979|NCT02538302|Cholinergic Agents|cholinergic agents|mesh-ancestor
110649980|NCT02538302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110649981|NCT02538302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110649982|NCT02538302|Urological Agents|urological agents|mesh-ancestor
110649983|NCT02538302|Hemostatics|hemostatics|mesh-ancestor
110649984|NCT02538302|Coagulants|coagulants|mesh-ancestor
110649985|NCT02538302|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
110649986|NCT02538302|Natriuretic Agents|natriuretic agents|mesh-ancestor
110649987|NCT00903734|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110649988|NCT00903734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110649989|NCT00903734|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110649990|NCT00903734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110649991|NCT00903734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110649993|NCT00509067|Risperidone|risperidone|mesh-list
110649994|NCT00509067|Aripiprazole|aripiprazole|mesh-list
110649995|NCT00509067|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110649996|NCT00509067|Ziprasidone|ziprasidone|mesh-list
110649997|NCT00509067|Choline|choline|mesh-list
110649998|NCT00509067|Galantamine|galantamine|mesh-list
110649999|NCT00509067|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
110650000|NCT00509067|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110650001|NCT00509067|Serotonin Agents|serotonin agents|mesh-ancestor
110650002|NCT00509067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110159620|NCT00093301|Simendan|simendan|mesh-list
110263064|NCT02914054|Dexamethasone|dexamethasone|mesh-list
110650003|NCT00509067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110650004|NCT00509067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110650005|NCT00509067|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110650007|NCT00509067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110650008|NCT00509067|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110650009|NCT00509067|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110650010|NCT00509067|Dopamine Agents|dopamine agents|mesh-ancestor
110650011|NCT00509067|Antiemetics|antiemetics|mesh-ancestor
110650012|NCT00509067|Autonomic Agents|autonomic agents|mesh-ancestor
110263117|NCT00150137|Methimazole|methimazole|mesh-list
110650013|NCT00509067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110650014|NCT00509067|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110650015|NCT00509067|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110650016|NCT00509067|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110650017|NCT00509067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110650019|NCT00509067|Dopamine Agonists|dopamine agonists|mesh-ancestor
110650020|NCT00509067|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110650021|NCT00509067|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110650022|NCT00509067|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110650023|NCT00509067|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110650024|NCT00509067|Lipotropic Agents|lipotropic agents|mesh-ancestor
110650025|NCT00509067|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110650026|NCT00509067|Antimetabolites|antimetabolites|mesh-ancestor
110650027|NCT00509067|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110650028|NCT00509067|Nootropic Agents|nootropic agents|mesh-ancestor
110650029|NCT00509067|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110650030|NCT00509067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110650031|NCT00509067|Cholinergic Agents|cholinergic agents|mesh-ancestor
110650032|NCT00509067|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110650034|NCT02538146|Vitamin B Complex|vitamin b complex|mesh-ancestor
110650036|NCT02538146|Micronutrients|micronutrients|mesh-ancestor
110650037|NCT02538146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110650038|NCT02538146|Nootropic Agents|nootropic agents|mesh-ancestor
110650039|NCT00908024|Cetuximab|cetuximab|mesh-list
110650040|NCT00908024|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110650041|NCT00908024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110650042|NCT00730223|Efavirenz|efavirenz|mesh-list
110650044|NCT00730223|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110650045|NCT00730223|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110650046|NCT00730223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110538656|NCT02804711|Vaccines|vaccines|mesh-list
110650047|NCT00730223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110650048|NCT00730223|Antiviral Agents|antiviral agents|mesh-ancestor
110263243|NCT00171288|Antimetabolites|antimetabolites|mesh-ancestor
110650049|NCT00730223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110650050|NCT00730223|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110650051|NCT00730223|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110538723|NCT04183556|Analgesics|analgesics|mesh-ancestor
110650052|NCT00730223|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110650053|NCT00730223|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110650054|NCT00730223|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110650055|NCT00730223|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110650056|NCT00730223|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110650057|NCT00730223|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110650058|NCT00908180|Cytarabine|cytarabine|mesh-list
110650059|NCT00908180|Cyclosporine|cyclosporine|mesh-list
110650060|NCT00908180|Etoposide|etoposide|mesh-list
110650061|NCT00908180|Melphalan|melphalan|mesh-list
110650062|NCT00908180|Alemtuzumab|alemtuzumab|mesh-list
110650063|NCT00908180|Carmustine|carmustine|mesh-list
110650064|NCT00908180|Cyclosporins|cyclosporins|mesh-list
110650065|NCT00908180|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110650066|NCT00908180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110650067|NCT00908180|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110538869|NCT02682134|Lidocaine|lidocaine|mesh-list
110650068|NCT00908180|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110650069|NCT00908180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110650070|NCT00908180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110650071|NCT00908180|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110650072|NCT00908180|Antimetabolites|antimetabolites|mesh-ancestor
110650073|NCT00908180|Antiviral Agents|antiviral agents|mesh-ancestor
110650074|NCT00908180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110650075|NCT00908180|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110650076|NCT00908180|Immunologic Factors|immunologic factors|mesh-ancestor
110650077|NCT00908180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110650078|NCT00908180|Antifungal Agents|antifungal agents|mesh-ancestor
110650079|NCT00908180|Dermatologic Agents|dermatologic agents|mesh-ancestor
110650080|NCT00908180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110650081|NCT00908180|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110650082|NCT00908180|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110650083|NCT00908180|Alkylating Agents|alkylating agents|mesh-ancestor
110650084|NCT00908180|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110538927|NCT04011241|Hormone Antagonists|hormone antagonists|mesh-ancestor
110650085|NCT00908180|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110650086|NCT04480463|Aflibercept|aflibercept|mesh-list
110650087|NCT04480463|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110650088|NCT04480463|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110650089|NCT04480463|Growth Substances|growth substances|mesh-ancestor
110650090|NCT04480463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110650091|NCT04480463|Growth Inhibitors|growth inhibitors|mesh-ancestor
110650092|NCT04480463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110650093|NCT00909506|Metformin|metformin|mesh-list
110650094|NCT00909506|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110650095|NCT00909506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110650096|NCT03997539|Vinorelbine|vinorelbine|mesh-list
110650097|NCT03997539|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110650098|NCT03997539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110538987|NCT03973177|Disinfectants|disinfectants|mesh-ancestor
110650099|NCT03997539|Tubulin Modulators|tubulin modulators|mesh-ancestor
110650100|NCT03997539|Antimitotic Agents|antimitotic agents|mesh-ancestor
110650101|NCT03997539|Mitosis Modulators|mitosis modulators|mesh-ancestor
110650102|NCT03997539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110650103|NCT02570243|Heparin|heparin|mesh-list
110650104|NCT02570243|Calcium heparin|calcium heparin|mesh-list
110650105|NCT02570243|Anticoagulants|anticoagulants|mesh-ancestor
110650106|NCT02570243|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110650107|NCT02570243|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110650108|NCT02570243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110650109|NCT00927212|Ammonium trichloro(dioxoethylene-O,O'-)tellurate|ammonium trichloro(dioxoethylene-o,o'-)tellurate|mesh-list
110650110|NCT00927212|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110650111|NCT00927212|Immunologic Factors|immunologic factors|mesh-ancestor
110650112|NCT00927212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110650113|NCT00927212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110650114|NCT00927212|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110650115|NCT00927212|Protective Agents|protective agents|mesh-ancestor
110650116|NCT00927212|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110650117|NCT00927212|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110297335|NCT02215447|Paclitaxel|paclitaxel|mesh-list
110539183|NCT05662904|Immunotoxins|immunotoxins|mesh-ancestor
110650118|NCT00927212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110650119|NCT00927212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110650120|NCT00927212|Antiviral Agents|antiviral agents|mesh-ancestor
110650121|NCT00927212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110650122|NCT00927290|Pioglitazone|pioglitazone|mesh-list
110650123|NCT00927290|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110650124|NCT00927290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110650125|NCT00728195|Olanzapine|olanzapine|mesh-list
110651639|NCT00933452|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110650126|NCT00728195|N-(1-(3,4-difluorobenzyl)piperidin-4-yl)-6-(trifluoromethyl)pyridazin-3-amine|n-(1-(3,4-difluorobenzyl)piperidin-4-yl)-6-(trifluoromethyl)pyridazin-3-amine|mesh-list
110650127|NCT00728195|Antiemetics|antiemetics|mesh-ancestor
110650128|NCT00728195|Autonomic Agents|autonomic agents|mesh-ancestor
110650129|NCT00728195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110650130|NCT00728195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110539330|NCT04032834|Budesonide|budesonide|mesh-list
110650131|NCT00728195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110650132|NCT00728195|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110650133|NCT00728195|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110650134|NCT00728195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110650135|NCT00728195|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110650136|NCT00728195|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110539391|NCT02801357|Lofexidine|lofexidine|mesh-list
110650137|NCT00728195|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110650138|NCT00728195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110650139|NCT00728195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110650140|NCT00728195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110650142|NCT00728195|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110650143|NCT00728195|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110539459|NCT00546871|Antibodies|antibodies|mesh-list
110650144|NCT00728195|Dopamine Agents|dopamine agents|mesh-ancestor
110650146|NCT00927524|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110650147|NCT00927524|Insulin glulisine|insulin glulisine|mesh-list
110650148|NCT00927524|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110650149|NCT00927524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110650150|NCT00728273|Micronutrients|micronutrients|mesh-list
110650151|NCT00728273|Trace Elements|trace elements|mesh-list
110650152|NCT00728273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110650153|NCT00927602|PENTA|penta|mesh-list
110650155|NCT00927602|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110650156|NCT00927602|Antithrombins|antithrombins|mesh-ancestor
110650157|NCT00927602|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110650158|NCT00927602|Protease Inhibitors|protease inhibitors|mesh-ancestor
110650159|NCT00927602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110650160|NCT00927602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110650161|NCT00927602|Anticoagulants|anticoagulants|mesh-ancestor
110263664|NCT05466019|Oxaliplatin|oxaliplatin|mesh-list
110650162|NCT00927602|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110650163|NCT00927602|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110650164|NCT04286867|Ethanol|ethanol|mesh-list
110650165|NCT04286867|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110650166|NCT04286867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110650167|NCT04286867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110650168|NCT04286867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110650169|NCT00730535|Tolterodine Tartrate|tolterodine tartrate|mesh-list
110650170|NCT00730535|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110650171|NCT00730535|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110650172|NCT00730535|Cholinergic Agents|cholinergic agents|mesh-ancestor
110650173|NCT00730535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110650174|NCT00730535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110650175|NCT00730535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110650176|NCT00730535|Urological Agents|urological agents|mesh-ancestor
110650177|NCT00904202|Lidocaine|lidocaine|mesh-list
110650178|NCT00904202|Gabapentin|gabapentin|mesh-list
110650179|NCT00904202|Anesthetics, Local|anesthetics, local|mesh-ancestor
110650180|NCT00904202|Anesthetics|anesthetics|mesh-ancestor
110650181|NCT00904202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110650182|NCT00904202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110650183|NCT00904202|Sensory System Agents|sensory system agents|mesh-ancestor
110650184|NCT00904202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110650185|NCT00904202|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110650186|NCT00904202|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110650187|NCT00904202|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110650188|NCT00904202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110650189|NCT00904202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110650190|NCT00904202|Analgesics|analgesics|mesh-ancestor
110650191|NCT00904202|Anticonvulsants|anticonvulsants|mesh-ancestor
110650192|NCT00904202|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110297400|NCT00237263|Entacapone|entacapone|mesh-list
110650193|NCT00904202|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110650194|NCT00904202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110650195|NCT00904202|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110650196|NCT00904202|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110650197|NCT00904202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110650198|NCT00904202|Antimanic Agents|antimanic agents|mesh-ancestor
110650199|NCT00927836|Lenograstim|lenograstim|mesh-list
110263840|NCT05308030|Analgesics|analgesics|mesh-ancestor
110650200|NCT00927836|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110650201|NCT00927836|Immunologic Factors|immunologic factors|mesh-ancestor
110650202|NCT00927836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110650203|NCT00904280|Oxymorphone|oxymorphone|mesh-list
110650204|NCT00904280|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110650205|NCT00904280|Narcotics|narcotics|mesh-ancestor
110650206|NCT00904280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110650207|NCT00904280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110650208|NCT00904280|Analgesics|analgesics|mesh-ancestor
110650209|NCT00904280|Sensory System Agents|sensory system agents|mesh-ancestor
110650210|NCT00904280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110650211|NCT00904280|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110650212|NCT00928148|Amphetamine|amphetamine|mesh-list
110650213|NCT00928148|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110650214|NCT00928148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110650215|NCT00928148|Sympathomimetics|sympathomimetics|mesh-ancestor
110650216|NCT00928148|Autonomic Agents|autonomic agents|mesh-ancestor
110650217|NCT00928148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110650218|NCT00928148|Dopamine Agents|dopamine agents|mesh-ancestor
110650219|NCT00928148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110650220|NCT00928148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110650221|NCT00928148|Adrenergic Agents|adrenergic agents|mesh-ancestor
110263978|NCT00151970|Dopamine Agents|dopamine agents|mesh-ancestor
110650222|NCT00928148|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110650223|NCT00928148|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110650224|NCT00928148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110650225|NCT00928148|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110650226|NCT02430077|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
110650228|NCT02430077|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110650229|NCT00904436|Ipratropium|ipratropium|mesh-list
110539694|NCT02635230|Antipyretics|antipyretics|mesh-ancestor
110650230|NCT00904436|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110650231|NCT00904436|Autonomic Agents|autonomic agents|mesh-ancestor
110650232|NCT00904436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110650233|NCT00904436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110650234|NCT00904436|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110650235|NCT00904436|Respiratory System Agents|respiratory system agents|mesh-ancestor
110650236|NCT00904436|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110650237|NCT00904436|Cholinergic Agents|cholinergic agents|mesh-ancestor
110650238|NCT00904436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110650239|NCT00904436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110650240|NCT00728585|Mitogens|mitogens|mesh-list
110650241|NCT00728585|Mitosis Modulators|mitosis modulators|mesh-ancestor
110650242|NCT00728585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110650243|NCT00730769|Valganciclovir|valganciclovir|mesh-list
110650244|NCT00730769|Ganciclovir|ganciclovir|mesh-list
110264115|NCT00152399|Hormones|hormones|mesh-ancestor
110650245|NCT00730769|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
110650246|NCT00730769|Antiviral Agents|antiviral agents|mesh-ancestor
110650247|NCT00730769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110650248|NCT00730769|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110650249|NCT00730769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110650250|NCT00730769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110650251|NCT00728663|Docetaxel|docetaxel|mesh-list
110650252|NCT00728663|Cetuximab|cetuximab|mesh-list
110650253|NCT00728663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110650254|NCT00728663|Tubulin Modulators|tubulin modulators|mesh-ancestor
110650255|NCT00728663|Antimitotic Agents|antimitotic agents|mesh-ancestor
110650256|NCT00728663|Mitosis Modulators|mitosis modulators|mesh-ancestor
110650257|NCT00728663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110650258|NCT00728663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110650259|NCT00731003|Tryptophan|tryptophan|mesh-list
110650260|NCT00731003|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
110650261|NCT00731003|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110650262|NCT00731003|Antidepressive Agents|antidepressive agents|mesh-ancestor
110650263|NCT00731003|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110650264|NCT00729131|Etanercept|etanercept|mesh-list
110650265|NCT00729131|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110297476|NCT00416169|Galantamine|galantamine|mesh-list
110650266|NCT00729131|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110650267|NCT00729131|Analgesics|analgesics|mesh-ancestor
110650268|NCT00729131|Sensory System Agents|sensory system agents|mesh-ancestor
110650269|NCT00729131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110650270|NCT00729131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110650271|NCT00729131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110650272|NCT00729131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110650273|NCT00729131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110650274|NCT00729131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110650275|NCT00729131|Immunologic Factors|immunologic factors|mesh-ancestor
110650277|NCT00729287|Antioxidants|antioxidants|mesh-ancestor
110539871|NCT02816567|Anesthetics|anesthetics|mesh-ancestor
110650278|NCT00729287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110650279|NCT00729287|Protective Agents|protective agents|mesh-ancestor
110159638|NCT00093418|Tipifarnib|tipifarnib|mesh-list
110650280|NCT00729287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110650281|NCT00729287|Trace Elements|trace elements|mesh-ancestor
110650282|NCT00729287|Micronutrients|micronutrients|mesh-ancestor
110650283|NCT00731393|Vaccines|vaccines|mesh-list
110650284|NCT00731393|Immunologic Factors|immunologic factors|mesh-ancestor
110650285|NCT00731393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110650286|NCT04390217|Tranexamic Acid|tranexamic acid|mesh-list
110398019|NCT02875717|Antipyretics|antipyretics|mesh-ancestor
110650287|NCT04390217|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110650288|NCT04390217|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110650289|NCT04390217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110650290|NCT04390217|Hemostatics|hemostatics|mesh-ancestor
110650291|NCT04390217|Coagulants|coagulants|mesh-ancestor
110650292|NCT02569463|Aldesleukin|aldesleukin|mesh-list
110650293|NCT02569463|Interleukin-2|interleukin-2|mesh-list
110650294|NCT02569463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110650295|NCT02569463|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110650296|NCT02569463|Analgesics|analgesics|mesh-ancestor
110650297|NCT02569463|Sensory System Agents|sensory system agents|mesh-ancestor
110650298|NCT02569463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110650299|NCT02569463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110650300|NCT02569463|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110650301|NCT02569463|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110650302|NCT02569463|Antiviral Agents|antiviral agents|mesh-ancestor
110650303|NCT02569463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110650304|NCT00731627|Simvastatin|simvastatin|mesh-list
110264270|NCT00165048|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110650305|NCT00731627|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110650306|NCT00731627|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110650307|NCT00731627|Antimetabolites|antimetabolites|mesh-ancestor
110650308|NCT00731627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110650309|NCT00731627|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110650310|NCT00731627|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110650311|NCT00731627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110650312|NCT00568178|Losartan|losartan|mesh-list
110650313|NCT00568178|Amlodipine|amlodipine|mesh-list
110650314|NCT00568178|Enalapril|enalapril|mesh-list
110264352|NCT00152867|Hormones|hormones|mesh-ancestor
110650315|NCT00568178|Enalaprilat|enalaprilat|mesh-list
110650316|NCT00568178|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110650317|NCT00568178|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110650318|NCT00568178|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110650319|NCT00568178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110650320|NCT00568178|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110650321|NCT00568178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110650322|NCT00568178|Vasodilator Agents|vasodilator agents|mesh-ancestor
110650323|NCT00568178|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110650324|NCT00568178|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110650325|NCT00568178|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110650326|NCT00568178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110650327|NCT00568178|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110650328|NCT00568178|Protease Inhibitors|protease inhibitors|mesh-ancestor
110650329|NCT00577889|Gemcitabine|gemcitabine|mesh-list
110650330|NCT00577889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110650331|NCT00577889|Antimetabolites|antimetabolites|mesh-ancestor
110650332|NCT00577889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110650333|NCT00577889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110650334|NCT00729599|Cetylpyridinium|cetylpyridinium|mesh-list
110650335|NCT00729599|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110650336|NCT00729599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110650337|NCT02538926|Prednisone|prednisone|mesh-list
110650339|NCT02538926|Cyclophosphamide|cyclophosphamide|mesh-list
110650340|NCT02538926|Rituximab|rituximab|mesh-list
110650341|NCT02538926|Doxorubicin|doxorubicin|mesh-list
110650342|NCT02538926|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110650343|NCT02538926|Etoposide|etoposide|mesh-list
110650344|NCT02538926|Vincristine|vincristine|mesh-list
110540163|NCT03967847|Ketorolac|ketorolac|mesh-list
110650345|NCT02538926|Etoposide phosphate|etoposide phosphate|mesh-list
110650346|NCT02538926|Imatinib Mesylate|imatinib mesylate|mesh-list
110650347|NCT02538926|Asparaginase|asparaginase|mesh-list
110650348|NCT02538926|Podophyllotoxin|podophyllotoxin|mesh-list
110650349|NCT02538926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110650350|NCT02538926|Antibodies|antibodies|mesh-list
110650351|NCT02538926|Immunoglobulins|immunoglobulins|mesh-list
110650352|NCT02538926|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110650353|NCT02538926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110650354|NCT02538926|Immunologic Factors|immunologic factors|mesh-ancestor
110650355|NCT02538926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110650356|NCT02538926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110650357|NCT02538926|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110650358|NCT02538926|Alkylating Agents|alkylating agents|mesh-ancestor
110650359|NCT02538926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110650360|NCT02538926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110650361|NCT02538926|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110650362|NCT02538926|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110650363|NCT02538926|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110650364|NCT02538926|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110650365|NCT02538926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110650366|NCT02538926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110650367|NCT02538926|Glucocorticoids|glucocorticoids|mesh-ancestor
110650368|NCT02538926|Hormones|hormones|mesh-ancestor
110650369|NCT02538926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110650370|NCT02538926|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110650371|NCT02538926|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110650372|NCT02538926|Tubulin Modulators|tubulin modulators|mesh-ancestor
110650373|NCT02538926|Antimitotic Agents|antimitotic agents|mesh-ancestor
110650374|NCT02538926|Mitosis Modulators|mitosis modulators|mesh-ancestor
110650375|NCT02538926|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110650376|NCT02538926|Keratolytic Agents|keratolytic agents|mesh-ancestor
110650377|NCT02538926|Dermatologic Agents|dermatologic agents|mesh-ancestor
110650378|NCT00904904|Ketorolac|ketorolac|mesh-list
110650379|NCT00904904|Indomethacin|indomethacin|mesh-list
110650380|NCT00904904|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110650381|NCT00904904|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110650382|NCT00904904|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110650383|NCT00904904|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110650384|NCT00904904|Analgesics|analgesics|mesh-ancestor
110650385|NCT00904904|Sensory System Agents|sensory system agents|mesh-ancestor
110650386|NCT00904904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110650387|NCT00904904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110650388|NCT00904904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110650389|NCT00904904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110650390|NCT00904904|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110650391|NCT00904904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110650392|NCT00904904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110650393|NCT00904904|Gout Suppressants|gout suppressants|mesh-ancestor
110650394|NCT00904904|Tocolytic Agents|tocolytic agents|mesh-ancestor
110650395|NCT00904904|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110650396|NCT00731861|Paclitaxel|paclitaxel|mesh-list
110650397|NCT00731861|Vatalanib|vatalanib|mesh-list
110650398|NCT00731861|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110650399|NCT00731861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110650400|NCT00731861|Tubulin Modulators|tubulin modulators|mesh-ancestor
110650401|NCT00731861|Antimitotic Agents|antimitotic agents|mesh-ancestor
110650402|NCT00731861|Mitosis Modulators|mitosis modulators|mesh-ancestor
110650403|NCT00731861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110650404|NCT00731861|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110650405|NCT00731861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110650406|NCT00567476|Omalizumab|omalizumab|mesh-list
110650407|NCT00567476|Terbutaline|terbutaline|mesh-list
110650408|NCT00567476|Adrenergic Agents|adrenergic agents|mesh-list
110650409|NCT00567476|Adrenergic Agonists|adrenergic agonists|mesh-list
110650410|NCT00567476|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110650411|NCT00567476|Autonomic Agents|autonomic agents|mesh-ancestor
110650412|NCT00567476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110650413|NCT00567476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110650414|NCT00567476|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110650415|NCT00567476|Respiratory System Agents|respiratory system agents|mesh-ancestor
110650416|NCT00567476|Tocolytic Agents|tocolytic agents|mesh-ancestor
110264872|NCT02924974|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110650417|NCT00567476|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110650418|NCT00567476|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110650419|NCT00567476|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110650420|NCT00567476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110398030|NCT00593099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110650421|NCT00567476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110650423|NCT00567476|Sympathomimetics|sympathomimetics|mesh-ancestor
110650424|NCT00729911|Amiodarone|amiodarone|mesh-list
110650425|NCT00729911|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110650426|NCT00729911|Vasodilator Agents|vasodilator agents|mesh-ancestor
110650427|NCT00729911|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
110650428|NCT00729911|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110650429|NCT00729911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110650430|NCT00729911|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110650431|NCT00729911|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110650432|NCT00729911|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110650433|NCT00729911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110650434|NCT00729911|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110650435|NCT00729911|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110650436|NCT00729911|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110650437|NCT04018703|Midazolam|midazolam|mesh-list
110650438|NCT04018703|Dexmedetomidine|dexmedetomidine|mesh-list
110650439|NCT04018703|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110650440|NCT04018703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110650441|NCT04018703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110650442|NCT04018703|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110650443|NCT04018703|Analgesics|analgesics|mesh-ancestor
110650444|NCT04018703|Sensory System Agents|sensory system agents|mesh-ancestor
110650445|NCT04018703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110650446|NCT04018703|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110650447|NCT04018703|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110650448|NCT04018703|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110650449|NCT04018703|Adrenergic Agents|adrenergic agents|mesh-ancestor
110650450|NCT04018703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110650451|NCT04018703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110650452|NCT04018703|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110650453|NCT04018703|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110650454|NCT04018703|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110650455|NCT04018703|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110650456|NCT04018703|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110650457|NCT04018703|Anesthetics, General|anesthetics, general|mesh-ancestor
110650458|NCT04018703|Anesthetics|anesthetics|mesh-ancestor
110650459|NCT04018703|GABA Modulators|gaba modulators|mesh-ancestor
110650460|NCT04018703|GABA Agents|gaba agents|mesh-ancestor
110650461|NCT04629872|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
110650462|NCT04629872|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
110650463|NCT04629872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110650464|NCT04629872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110650465|NCT04629872|Immunologic Factors|immunologic factors|mesh-ancestor
110650466|NCT04629872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110650467|NCT04065581|Metformin|metformin|mesh-list
110650468|NCT04065581|Acarbose|acarbose|mesh-list
110650469|NCT04065581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110650470|NCT04065581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110650471|NCT04065581|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
110650472|NCT04065581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110650473|NCT04065581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110650474|NCT00733889|Docetaxel|docetaxel|mesh-list
110650475|NCT00733889|Fluorouracil|fluorouracil|mesh-list
110650476|NCT00733889|Cetuximab|cetuximab|mesh-list
110650477|NCT00733889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110650478|NCT00733889|Tubulin Modulators|tubulin modulators|mesh-ancestor
110650479|NCT00733889|Antimitotic Agents|antimitotic agents|mesh-ancestor
110650480|NCT00733889|Mitosis Modulators|mitosis modulators|mesh-ancestor
110650481|NCT00733889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110650482|NCT00733889|Antimetabolites|antimetabolites|mesh-ancestor
110540639|NCT00966121|Vasodilator Agents|vasodilator agents|mesh-ancestor
110650483|NCT00733889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110650484|NCT00733889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110650485|NCT00733889|Immunologic Factors|immunologic factors|mesh-ancestor
110650486|NCT00733889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110650487|NCT00733889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110650489|NCT00733967|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110650490|NCT00733967|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110650491|NCT00733967|Cholinergic Agents|cholinergic agents|mesh-ancestor
110650492|NCT00733967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110297696|NCT04538365|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110650493|NCT00733967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110650494|NCT00733967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110650495|NCT04650243|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
110650496|NCT04650243|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
110265148|NCT00180843|Bromides|bromides|mesh-list
110650497|NCT04650243|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110650498|NCT00738569|Raltegravir Potassium|raltegravir potassium|mesh-list
110650499|NCT00738569|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110650500|NCT00738569|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110650501|NCT00738569|Antiviral Agents|antiviral agents|mesh-ancestor
110650502|NCT00738569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110650503|NCT00738569|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110650504|NCT00738569|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110650505|NCT00738569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110650506|NCT00738569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110650507|NCT04644627|Gentamicins|gentamicins|mesh-list
110650508|NCT04644627|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110650509|NCT04644627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110650510|NCT04644627|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110650511|NCT04644627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110650512|NCT04644627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110650513|NCT00732407|Losartan|losartan|mesh-list
110650514|NCT00732407|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110650515|NCT00732407|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110650516|NCT00732407|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110650517|NCT00732407|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110650518|NCT00732407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110650519|NCT00507819|Sildenafil Citrate|sildenafil citrate|mesh-list
110650520|NCT00507819|Vasodilator Agents|vasodilator agents|mesh-ancestor
110650521|NCT00507819|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110540817|NCT02668796|Estradiol|estradiol|mesh-list
110650522|NCT00507819|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110650523|NCT00507819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110650524|NCT00507819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110650525|NCT00507819|Urological Agents|urological agents|mesh-ancestor
110650526|NCT02569307|Minocycline|minocycline|mesh-list
110650527|NCT02569307|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110650528|NCT02569307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110650529|NCT01013103|Atorvastatin|atorvastatin|mesh-list
110650530|NCT01013103|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110650531|NCT01013103|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110650532|NCT01013103|Antimetabolites|antimetabolites|mesh-ancestor
110650533|NCT01013103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110650534|NCT01013103|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110650535|NCT01013103|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110650536|NCT01013103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110650537|NCT00732485|Fenofibrate|fenofibrate|mesh-list
110650538|NCT00732485|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110650539|NCT00732485|Antimetabolites|antimetabolites|mesh-ancestor
110650540|NCT00732485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110650541|NCT00732485|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110650542|NCT02569073|Dronabinol|dronabinol|mesh-list
110650543|NCT02569073|Hallucinogens|hallucinogens|mesh-ancestor
110650544|NCT02569073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110650545|NCT02569073|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110650546|NCT02569073|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110650547|NCT02569073|Analgesics|analgesics|mesh-ancestor
110650548|NCT02569073|Sensory System Agents|sensory system agents|mesh-ancestor
110650549|NCT02569073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110265351|NCT02909413|Desflurane|desflurane|mesh-list
110650550|NCT02569073|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
110650551|NCT02569073|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110650552|NCT02569073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110650553|NCT02569073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110650554|NCT02569073|Hormones|hormones|mesh-ancestor
110650555|NCT02569073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110650556|NCT00732563|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110650557|NCT00732563|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110650558|NCT00732563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110650559|NCT00734123|Aspirin|aspirin|mesh-list
110650560|NCT00734123|Rimonabant|rimonabant|mesh-list
110650561|NCT00734123|Enalapril|enalapril|mesh-list
110650562|NCT00734123|Clopidogrel|clopidogrel|mesh-list
110650563|NCT00734123|Atorvastatin|atorvastatin|mesh-list
110650564|NCT00734123|Simvastatin|simvastatin|mesh-list
110650565|NCT00734123|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
110297779|NCT02216149|Capecitabine|capecitabine|mesh-list
110650567|NCT00734123|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110650568|NCT00734123|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110650569|NCT00734123|Analgesics|analgesics|mesh-ancestor
110159650|NCT00093652|Oxaliplatin|oxaliplatin|mesh-list
110650574|NCT00734123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110650575|NCT00734123|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110650576|NCT00734123|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110650577|NCT00734123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110650578|NCT00734123|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110650579|NCT00734123|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110650580|NCT00734123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110650582|NCT00734123|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110650583|NCT00734123|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110650584|NCT00734123|Antimetabolites|antimetabolites|mesh-ancestor
110650585|NCT00734123|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110650586|NCT00734123|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110650587|NCT00734123|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110650588|NCT00734123|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110650589|NCT00734123|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110650590|NCT00734123|Purinergic Agents|purinergic agents|mesh-ancestor
110650591|NCT00734123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110650592|NCT00734123|Protease Inhibitors|protease inhibitors|mesh-ancestor
110650593|NCT00734123|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110650594|NCT00734123|Natriuretic Agents|natriuretic agents|mesh-ancestor
110650595|NCT00734123|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110540975|NCT00656214|Protective Agents|protective agents|mesh-ancestor
110650596|NCT00734123|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
110650597|NCT00734123|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110650599|NCT00734123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110650600|NCT00734279|Leuprolide|leuprolide|mesh-list
110650601|NCT00734279|Ganirelix|ganirelix|mesh-list
110541032|NCT02666768|Interferons|interferons|mesh-list
110650602|NCT00734279|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110650603|NCT00734279|Fertility Agents|fertility agents|mesh-ancestor
110650604|NCT00734279|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110650605|NCT00734279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110650606|NCT00734279|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110650607|NCT00734279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110650608|NCT00734279|Hormone Antagonists|hormone antagonists|mesh-ancestor
110650609|NCT00734279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110650610|NCT00442936|Oxazolidinones|oxazolidinones|mesh-list
110650611|NCT00442936|Zolmitriptan|zolmitriptan|mesh-list
110650612|NCT00442936|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110650613|NCT00442936|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110650614|NCT00442936|Serotonin Agents|serotonin agents|mesh-ancestor
110650615|NCT00442936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110650616|NCT00442936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110650617|NCT00442936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110650618|NCT00442936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110650619|NCT00442936|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110650620|NCT00442936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110650626|NCT00732953|Paclitaxel|paclitaxel|mesh-list
110650627|NCT00732953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110650628|NCT00732953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110650629|NCT00732953|Tubulin Modulators|tubulin modulators|mesh-ancestor
110650630|NCT00732953|Antimitotic Agents|antimitotic agents|mesh-ancestor
110650631|NCT00732953|Mitosis Modulators|mitosis modulators|mesh-ancestor
110651640|NCT00933452|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110650632|NCT00732953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110650633|NCT00577655|Albuterol|albuterol|mesh-list
110398049|NCT00593801|Epoetin Alfa|epoetin alfa|mesh-list
110650634|NCT00577655|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110650635|NCT00577655|Autonomic Agents|autonomic agents|mesh-ancestor
110650636|NCT00577655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110650637|NCT00577655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110650638|NCT00577655|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110650639|NCT00577655|Respiratory System Agents|respiratory system agents|mesh-ancestor
110650640|NCT00577655|Tocolytic Agents|tocolytic agents|mesh-ancestor
110650641|NCT00577655|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110650642|NCT00577655|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110650643|NCT00577655|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110650644|NCT00577655|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110650645|NCT00577655|Adrenergic Agents|adrenergic agents|mesh-ancestor
110650646|NCT00577655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110650647|NCT00577655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110650649|NCT00733031|Pemetrexed|pemetrexed|mesh-list
110265696|NCT02569645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110650650|NCT00733031|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110650651|NCT00733031|Antimetabolites|antimetabolites|mesh-ancestor
110650652|NCT00733031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110650653|NCT00733031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110541200|NCT00646880|Autonomic Agents|autonomic agents|mesh-ancestor
110650654|NCT00733031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110650655|NCT00733031|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110650656|NCT00733031|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110650657|NCT00734669|Glyburide|glyburide|mesh-list
110650658|NCT00734669|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110650659|NCT00734669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110650660|NCT00113269|Mycophenolic Acid|mycophenolic acid|mesh-list
110650661|NCT00113269|Alemtuzumab|alemtuzumab|mesh-list
110650662|NCT00113269|Tacrolimus|tacrolimus|mesh-list
110650663|NCT00113269|Thymoglobulin|thymoglobulin|mesh-list
110650664|NCT00113269|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110650666|NCT00113269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110650667|NCT00113269|Immunologic Factors|immunologic factors|mesh-ancestor
110650668|NCT00113269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110650669|NCT00113269|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110650670|NCT00113269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110650671|NCT00113269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110541421|NCT04156464|Lorazepam|lorazepam|mesh-list
110650673|NCT00113269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110650674|NCT00113269|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110650675|NCT00113269|Antitubercular Agents|antitubercular agents|mesh-ancestor
110650676|NCT00113269|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110650677|NCT00113269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110650678|NCT00113269|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110650679|NCT04065269|Olaparib|olaparib|mesh-list
110650680|NCT04065269|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110650681|NCT04065269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110650682|NCT04065269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110650683|NCT04065269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110650684|NCT00515619|Lacosamide|lacosamide|mesh-list
110650685|NCT00515619|Anticonvulsants|anticonvulsants|mesh-ancestor
110650686|NCT00515619|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110650687|NCT00515619|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110650688|NCT00515619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110650689|NCT00515619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110650690|NCT01815359|Leucovorin|leucovorin|mesh-list
110650691|NCT01815359|Mitomycins|mitomycins|mesh-list
110650692|NCT01815359|Mitomycin|mitomycin|mesh-list
110650693|NCT01815359|Antidotes|antidotes|mesh-ancestor
110650694|NCT01815359|Protective Agents|protective agents|mesh-ancestor
110650695|NCT01815359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110650696|NCT01815359|Vitamin B Complex|vitamin b complex|mesh-ancestor
110650698|NCT01815359|Micronutrients|micronutrients|mesh-ancestor
110650699|NCT01815359|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110650700|NCT01815359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110650701|NCT01815359|Alkylating Agents|alkylating agents|mesh-ancestor
110650702|NCT01815359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110650703|NCT01815359|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110650704|NCT01815359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110650706|NCT00449644|Antitubercular Agents|antitubercular agents|mesh-ancestor
110650707|NCT00449644|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110650708|NCT00449644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110541595|NCT00974389|Antimetabolites|antimetabolites|mesh-ancestor
110650710|NCT00733265|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110650711|NCT00733265|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110650712|NCT00733265|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110297923|NCT04536493|Sensory System Agents|sensory system agents|mesh-ancestor
110650713|NCT00733265|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110650714|NCT00733265|Purinergic Agents|purinergic agents|mesh-ancestor
110650715|NCT00733265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110650716|NCT00733265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110650717|NCT00733265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110650719|NCT00112489|Carboplatin|carboplatin|mesh-list
110650720|NCT00112489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110650721|NCT00112489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110650722|NCT00112489|Tubulin Modulators|tubulin modulators|mesh-ancestor
110650723|NCT00112489|Antimitotic Agents|antimitotic agents|mesh-ancestor
110650724|NCT00112489|Mitosis Modulators|mitosis modulators|mesh-ancestor
110650725|NCT00112489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110650726|NCT01023100|Tofacitinib|tofacitinib|mesh-list
110650727|NCT01023100|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
110650728|NCT01023100|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110650729|NCT01023100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110650730|NCT01023100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110650731|NCT00515463|Denosumab|denosumab|mesh-list
110650732|NCT00515463|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110650733|NCT00515463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110650734|NCT01082731|Artesunate|artesunate|mesh-list
110650735|NCT01082731|Lumefantrine|lumefantrine|mesh-list
110650736|NCT01082731|Artemether|artemether|mesh-list
110650737|NCT01082731|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
110650738|NCT01082731|Mefloquine|mefloquine|mesh-list
110650739|NCT01082731|Antimalarials|antimalarials|mesh-ancestor
110650740|NCT01082731|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110650741|NCT01082731|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110650742|NCT01082731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110650743|NCT01082731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110650744|NCT01082731|Antiviral Agents|antiviral agents|mesh-ancestor
110650745|NCT01082731|Schistosomicides|schistosomicides|mesh-ancestor
110650746|NCT01082731|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110650747|NCT01082731|Anthelmintics|anthelmintics|mesh-ancestor
110650748|NCT00739193|Amiodarone|amiodarone|mesh-list
110650749|NCT00739193|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110650750|NCT00739193|Vasodilator Agents|vasodilator agents|mesh-ancestor
110650751|NCT00739193|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
110650752|NCT00739193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110650753|NCT00739193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110541859|NCT05342597|Edaravone|edaravone|mesh-list
110650754|NCT00739193|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110650755|NCT00739193|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110650756|NCT00739193|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110650757|NCT00739193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110650758|NCT00739193|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110650759|NCT00739193|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110650760|NCT00739193|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110650761|NCT01011543|Dimercaprol|dimercaprol|mesh-list
110650762|NCT01011543|Chelating Agents|chelating agents|mesh-ancestor
110650763|NCT01011543|Sequestering Agents|sequestering agents|mesh-ancestor
110650764|NCT01011543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110650765|NCT00733811|Deferiprone|deferiprone|mesh-list
110650766|NCT00733811|Deferoxamine|deferoxamine|mesh-list
110650767|NCT00733811|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110650768|NCT00733811|Chelating Agents|chelating agents|mesh-ancestor
110650769|NCT00733811|Sequestering Agents|sequestering agents|mesh-ancestor
110650770|NCT00733811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110650771|NCT00733811|Siderophores|siderophores|mesh-ancestor
110650772|NCT00739505|Immunoglobulin G|immunoglobulin g|mesh-list
110650773|NCT00739505|Immunologic Factors|immunologic factors|mesh-ancestor
110650774|NCT00739505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110650776|NCT00507507|Antiviral Agents|antiviral agents|mesh-ancestor
110650777|NCT00507507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110159662|NCT00093769|Rituximab|rituximab|mesh-list
110542057|NCT00693849|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110650778|NCT00507507|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110650779|NCT00507507|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110650780|NCT00507507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110542124|NCT03921151|Mirtazapine|mirtazapine|mesh-list
110650781|NCT00507507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110650782|NCT00507507|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110650783|NCT00507507|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110650785|NCT00459706|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110650786|NCT00459706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110650787|NCT00459706|Analgesics|analgesics|mesh-ancestor
110650788|NCT00459706|Sensory System Agents|sensory system agents|mesh-ancestor
110650789|NCT00459706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110542203|NCT04229459|Nivolumab|nivolumab|mesh-list
110650790|NCT00459706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110650791|NCT00459706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110650792|NCT00459706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110650793|NCT00459706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110650794|NCT00459706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110650795|NCT00459706|Immunologic Factors|immunologic factors|mesh-ancestor
110650796|NCT00735527|Lorazepam|lorazepam|mesh-list
110650797|NCT00735527|Anticonvulsants|anticonvulsants|mesh-ancestor
110650798|NCT00735527|Antiemetics|antiemetics|mesh-ancestor
110650799|NCT00735527|Autonomic Agents|autonomic agents|mesh-ancestor
110650800|NCT00735527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110650801|NCT00735527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110650802|NCT00735527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110650803|NCT00735527|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110650804|NCT00735527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110650805|NCT00735527|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110650806|NCT00735527|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110650807|NCT00735527|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110650808|NCT00735527|GABA Modulators|gaba modulators|mesh-ancestor
110650809|NCT00735527|GABA Agents|gaba agents|mesh-ancestor
110650810|NCT00735527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110650811|NCT00735527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110650812|NCT00735761|Acyclovir|acyclovir|mesh-list
110650813|NCT00735761|Hydrocortisone|hydrocortisone|mesh-list
110650814|NCT00735761|Antiviral Agents|antiviral agents|mesh-ancestor
110650815|NCT00735761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110650816|NCT00735761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110650817|NCT00740285|Lidocaine|lidocaine|mesh-list
110650818|NCT00740285|Anesthetics, Local|anesthetics, local|mesh-ancestor
110650819|NCT00740285|Anesthetics|anesthetics|mesh-ancestor
110650820|NCT00740285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110650821|NCT00740285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110650822|NCT00740285|Sensory System Agents|sensory system agents|mesh-ancestor
110650823|NCT00740285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110650824|NCT00740285|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110651641|NCT00933452|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110650825|NCT00740285|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110650826|NCT00740285|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110650827|NCT00740285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110650828|NCT00740285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110650829|NCT00507429|Paclitaxel|paclitaxel|mesh-list
110650830|NCT00507429|Fosbretabulin|fosbretabulin|mesh-list
110650831|NCT00507429|Combretastatin|combretastatin|mesh-list
110650832|NCT00507429|Carboplatin|carboplatin|mesh-list
110650833|NCT00507429|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110650834|NCT00507429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110650835|NCT00507429|Tubulin Modulators|tubulin modulators|mesh-ancestor
110650836|NCT00507429|Antimitotic Agents|antimitotic agents|mesh-ancestor
110650837|NCT00507429|Mitosis Modulators|mitosis modulators|mesh-ancestor
110650838|NCT00507429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110650839|NCT01011621|Prednisolone|prednisolone|mesh-list
110650840|NCT01011621|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110650841|NCT01011621|Methylprednisolone|methylprednisolone|mesh-list
110650842|NCT01011621|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110650843|NCT01011621|Prednisolone acetate|prednisolone acetate|mesh-list
110650844|NCT01011621|Betamethasone|betamethasone|mesh-list
110650845|NCT01011621|Betamethasone Valerate|betamethasone valerate|mesh-list
110650846|NCT01011621|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
110650847|NCT01011621|Betamethasone benzoate|betamethasone benzoate|mesh-list
110650848|NCT01011621|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110650849|NCT01011621|Prednisolone phosphate|prednisolone phosphate|mesh-list
110650850|NCT01011621|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
110650851|NCT01011621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110650852|NCT01011621|Glucocorticoids|glucocorticoids|mesh-ancestor
110650853|NCT01011621|Hormones|hormones|mesh-ancestor
110650854|NCT01011621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110650855|NCT01011621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110650856|NCT01011621|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110650857|NCT01011621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110650858|NCT01011621|Antiemetics|antiemetics|mesh-ancestor
110650859|NCT01011621|Autonomic Agents|autonomic agents|mesh-ancestor
110650860|NCT01011621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110650861|NCT01011621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110650862|NCT01011621|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110650863|NCT01011621|Protective Agents|protective agents|mesh-ancestor
110650864|NCT01011621|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110650865|NCT01011621|Respiratory System Agents|respiratory system agents|mesh-ancestor
110650866|NCT00449176|Oxycodone|oxycodone|mesh-list
110650867|NCT00449176|Tapentadol|tapentadol|mesh-list
110650868|NCT00449176|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110650869|NCT00449176|Narcotics|narcotics|mesh-ancestor
110650870|NCT00449176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110650871|NCT00449176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110650872|NCT00449176|Analgesics|analgesics|mesh-ancestor
110650873|NCT00449176|Sensory System Agents|sensory system agents|mesh-ancestor
110650874|NCT00449176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110650875|NCT00449176|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110650876|NCT00449176|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110650877|NCT00449176|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110542509|NCT00971659|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110650878|NCT00449176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110650879|NCT00449176|Adrenergic Agents|adrenergic agents|mesh-ancestor
110650880|NCT00449176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110650881|NCT00515073|Diphenhydramine|diphenhydramine|mesh-list
110650882|NCT00515073|Promethazine|promethazine|mesh-list
110650883|NCT00515073|Dexamethasone|dexamethasone|mesh-list
110650885|NCT00515073|Cimetidine|cimetidine|mesh-list
110650886|NCT00515073|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110265963|NCT00156689|Nootropic Agents|nootropic agents|mesh-ancestor
110650887|NCT00515073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110650888|NCT00515073|Tubulin Modulators|tubulin modulators|mesh-ancestor
110650889|NCT00515073|Antimitotic Agents|antimitotic agents|mesh-ancestor
110650890|NCT00515073|Mitosis Modulators|mitosis modulators|mesh-ancestor
110650891|NCT00515073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110650892|NCT00515073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110650893|NCT00515073|Antiemetics|antiemetics|mesh-ancestor
110650894|NCT00515073|Autonomic Agents|autonomic agents|mesh-ancestor
110650895|NCT00515073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110650896|NCT00515073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110650897|NCT00515073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110542564|NCT00971893|Hormones|hormones|mesh-ancestor
110650898|NCT00515073|Glucocorticoids|glucocorticoids|mesh-ancestor
110650899|NCT00515073|Hormones|hormones|mesh-ancestor
110650900|NCT00515073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110650901|NCT00515073|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110650902|NCT00515073|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110650903|NCT00515073|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110650904|NCT00515073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110650905|NCT00515073|Anesthetics, Local|anesthetics, local|mesh-ancestor
110650906|NCT00515073|Anesthetics|anesthetics|mesh-ancestor
110650907|NCT00515073|Sensory System Agents|sensory system agents|mesh-ancestor
110650908|NCT00515073|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110650909|NCT00515073|Histamine Antagonists|histamine antagonists|mesh-ancestor
110650910|NCT00515073|Histamine Agents|histamine agents|mesh-ancestor
110650911|NCT00515073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110650912|NCT00515073|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110650913|NCT00515073|Antipruritics|antipruritics|mesh-ancestor
110650914|NCT00515073|Dermatologic Agents|dermatologic agents|mesh-ancestor
110650915|NCT00515073|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110650916|NCT00515073|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110650917|NCT00515073|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110650918|NCT00515073|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110650919|NCT00515073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110650920|NCT00710021|Vitamin D|vitamin d|mesh-list
110542669|NCT02779283|Prednisolone|prednisolone|mesh-list
110650921|NCT00710021|Ergocalciferols|ergocalciferols|mesh-list
110650922|NCT00710021|Cholecalciferol|cholecalciferol|mesh-list
110650923|NCT00710021|Vitamins|vitamins|mesh-list
110650924|NCT00710021|Micronutrients|micronutrients|mesh-ancestor
110650925|NCT00710021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110650926|NCT00710021|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110650927|NCT00710021|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110650928|NCT00504153|Dasatinib|dasatinib|mesh-list
110650929|NCT00504153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110650930|NCT00504153|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110650931|NCT00504153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110650932|NCT00504153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110650933|NCT00740363|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110650934|NCT00740363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110650935|NCT00740363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110650936|NCT00740363|Incretins|incretins|mesh-ancestor
110650937|NCT00740363|Hormones|hormones|mesh-ancestor
110650938|NCT00740363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110650939|NCT00740363|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110650940|NCT00740363|Protease Inhibitors|protease inhibitors|mesh-ancestor
110650941|NCT00740363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110650942|NCT00740363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110650943|NCT04065035|Sunscreening Agents|sunscreening agents|mesh-list
110650944|NCT04065035|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110650945|NCT04065035|Protective Agents|protective agents|mesh-ancestor
110650946|NCT04065035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110650947|NCT04065035|Dermatologic Agents|dermatologic agents|mesh-ancestor
110650948|NCT00442702|Darbepoetin alfa|darbepoetin alfa|mesh-list
110650949|NCT00442702|Hematinics|hematinics|mesh-ancestor
110650950|NCT00740519|Insulin Detemir|insulin detemir|mesh-list
110650951|NCT00740519|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110650952|NCT00740519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110650954|NCT00514917|Leuprolide|leuprolide|mesh-list
110650955|NCT00514917|Bicalutamide|bicalutamide|mesh-list
110650956|NCT00514917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110650957|NCT00514917|Tubulin Modulators|tubulin modulators|mesh-ancestor
110542792|NCT04973345|Terbutaline|terbutaline|mesh-list
110650958|NCT00514917|Antimitotic Agents|antimitotic agents|mesh-ancestor
110650959|NCT00514917|Mitosis Modulators|mitosis modulators|mesh-ancestor
110650960|NCT00514917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110650961|NCT00514917|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110650962|NCT00514917|Fertility Agents|fertility agents|mesh-ancestor
110650963|NCT00514917|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110650964|NCT00514917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110650965|NCT00514917|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110650966|NCT00514917|Androgen Antagonists|androgen antagonists|mesh-ancestor
110650967|NCT00514917|Hormone Antagonists|hormone antagonists|mesh-ancestor
110650968|NCT00514917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110650969|NCT01011699|Niacinamide|niacinamide|mesh-list
110650971|NCT01011699|Nicotinic Acids|nicotinic acids|mesh-list
110650972|NCT01011699|Sevelamer|sevelamer|mesh-list
110650973|NCT01011699|Cinacalcet|cinacalcet|mesh-list
110650974|NCT01011699|Vitamin B Complex|vitamin b complex|mesh-ancestor
110650975|NCT01011699|Vitamins|vitamins|mesh-ancestor
110650976|NCT01011699|Micronutrients|micronutrients|mesh-ancestor
110650977|NCT01011699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110650978|NCT01011699|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110650979|NCT01011699|Antimetabolites|antimetabolites|mesh-ancestor
110650980|NCT01011699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110650981|NCT01011699|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110650982|NCT01011699|Vasodilator Agents|vasodilator agents|mesh-ancestor
110650983|NCT01011699|Chelating Agents|chelating agents|mesh-ancestor
110542910|NCT00972985|Autonomic Agents|autonomic agents|mesh-ancestor
110650984|NCT01011699|Sequestering Agents|sequestering agents|mesh-ancestor
110650985|NCT01011699|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110650986|NCT01011699|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
110650987|NCT01011699|Hormone Antagonists|hormone antagonists|mesh-ancestor
110650988|NCT01011699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110650989|NCT00504075|Immunoglobulins|immunoglobulins|mesh-list
110650990|NCT00504075|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110650991|NCT00504075|Antibodies|antibodies|mesh-list
110650992|NCT00504075|gamma-Globulins|gamma-globulins|mesh-list
110650993|NCT00504075|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110650995|NCT00504075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110650996|NCT00503997|Oxaliplatin|oxaliplatin|mesh-list
110650997|NCT00503997|Pemetrexed|pemetrexed|mesh-list
110650998|NCT00503997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110650999|NCT00503997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110651000|NCT00503997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110651001|NCT00503997|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110651002|NCT00503997|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110651003|NCT00741143|Fe(III)-EDTA|fe(iii)-edta|mesh-list
110651004|NCT00741143|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110651005|NCT00741143|Chelating Agents|chelating agents|mesh-ancestor
110651006|NCT00741143|Sequestering Agents|sequestering agents|mesh-ancestor
110651007|NCT00741143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110651008|NCT00736463|Atorvastatin|atorvastatin|mesh-list
110651009|NCT00736463|Simvastatin|simvastatin|mesh-list
110651010|NCT00736463|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110651011|NCT00736463|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110651012|NCT00736463|Antimetabolites|antimetabolites|mesh-ancestor
110651013|NCT00736463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110651014|NCT00736463|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110651015|NCT00736463|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110651016|NCT00736463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110651018|NCT00736541|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110651019|NCT00736541|Cystatins|cystatins|mesh-list
110651020|NCT00736541|Antiviral Agents|antiviral agents|mesh-ancestor
110651021|NCT00736541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110651022|NCT00736541|Expectorants|expectorants|mesh-ancestor
110651023|NCT00736541|Respiratory System Agents|respiratory system agents|mesh-ancestor
110651024|NCT00736541|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110651025|NCT00736541|Antioxidants|antioxidants|mesh-ancestor
110651026|NCT00736541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110651027|NCT00736541|Protective Agents|protective agents|mesh-ancestor
110651028|NCT00736541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110651029|NCT00736541|Antidotes|antidotes|mesh-ancestor
110651030|NCT00736541|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
110651031|NCT00736541|Protease Inhibitors|protease inhibitors|mesh-ancestor
110651032|NCT00736541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110651033|NCT00096265|Temozolomide|temozolomide|mesh-list
110651034|NCT00096265|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110651035|NCT00096265|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110651036|NCT00096265|Alkylating Agents|alkylating agents|mesh-ancestor
110651037|NCT00096265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110651038|NCT00096265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110651039|NCT00096265|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110651040|NCT00096265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110651041|NCT01082809|Sunitinib|sunitinib|mesh-list
110651042|NCT01082809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110651043|NCT01082809|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110651044|NCT01082809|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110651045|NCT01082809|Growth Substances|growth substances|mesh-ancestor
110651046|NCT01082809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110651047|NCT01082809|Growth Inhibitors|growth inhibitors|mesh-ancestor
110651048|NCT01082809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110651049|NCT01082809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110651050|NCT01082809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110651051|NCT01080469|Tacrolimus|tacrolimus|mesh-list
110651052|NCT01080469|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110651053|NCT01080469|Immunologic Factors|immunologic factors|mesh-ancestor
110651054|NCT01080469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110651055|NCT01080469|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110651056|NCT01080469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110651057|NCT01080469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110651058|NCT01079065|Famotidine|famotidine|mesh-list
110651059|NCT01079065|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110651060|NCT01079065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110651061|NCT01079065|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110651062|NCT01079065|Histamine Antagonists|histamine antagonists|mesh-ancestor
110651064|NCT01079065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110543156|NCT04226885|Sensory System Agents|sensory system agents|mesh-ancestor
110651065|NCT01079065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110651066|NCT01079065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110651067|NCT00711191|Antibodies|antibodies|mesh-list
110651068|NCT00711191|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110651069|NCT00711191|Immunologic Factors|immunologic factors|mesh-ancestor
110651070|NCT00711191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110651071|NCT00741221|Bevacizumab|bevacizumab|mesh-list
110651072|NCT00741221|Pemetrexed|pemetrexed|mesh-list
110651073|NCT00741221|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110651074|NCT00741221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110651075|NCT00741221|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110651076|NCT00741221|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110651077|NCT00741221|Growth Substances|growth substances|mesh-ancestor
110651078|NCT00741221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110651079|NCT00741221|Growth Inhibitors|growth inhibitors|mesh-ancestor
110651080|NCT00741221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110651081|NCT00741221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110651082|NCT00741221|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110651083|NCT00741221|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110651084|NCT00736619|Paclitaxel|paclitaxel|mesh-list
110651085|NCT00736619|Cetuximab|cetuximab|mesh-list
110651086|NCT00736619|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110651087|NCT00736619|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110651088|NCT00736619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110651089|NCT00736619|Tubulin Modulators|tubulin modulators|mesh-ancestor
110298297|NCT05896930|Ertapenem|ertapenem|mesh-list
110651090|NCT00736619|Antimitotic Agents|antimitotic agents|mesh-ancestor
110651091|NCT00736619|Mitosis Modulators|mitosis modulators|mesh-ancestor
110543218|NCT02660762|Hormones|hormones|mesh-ancestor
110651092|NCT00736619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110651093|NCT00736619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110651094|NCT00741377|Zoledronic Acid|zoledronic acid|mesh-list
110651095|NCT00741377|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110651096|NCT00741377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110651097|NCT05742269|Atezolizumab|atezolizumab|mesh-list
110651098|NCT05742269|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110651099|NCT05742269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110651100|NCT05742269|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110651101|NCT05742269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110651102|NCT00448864|Ecallantide|ecallantide|mesh-list
110651103|NCT00448864|Analgesics|analgesics|mesh-ancestor
110651104|NCT00448864|Sensory System Agents|sensory system agents|mesh-ancestor
110651105|NCT00448864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110651106|NCT00448864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110651107|NCT00448864|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110651108|NCT00448864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110651109|NCT00448864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110651110|NCT00448864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110651112|NCT00567398|Dialysis Solutions|dialysis solutions|mesh-ancestor
110651113|NCT00567398|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110651114|NCT00448708|Paclitaxel|paclitaxel|mesh-list
110651115|NCT00448708|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110651116|NCT00448708|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110651117|NCT00448708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110651118|NCT00448708|Tubulin Modulators|tubulin modulators|mesh-ancestor
110651119|NCT00448708|Antimitotic Agents|antimitotic agents|mesh-ancestor
110651120|NCT00448708|Mitosis Modulators|mitosis modulators|mesh-ancestor
110651121|NCT00448708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110651122|NCT00925028|Warfarin|warfarin|mesh-list
110651123|NCT00925028|Anticoagulants|anticoagulants|mesh-ancestor
110651124|NCT00905216|Heparin|heparin|mesh-list
110651125|NCT00905216|Calcium heparin|calcium heparin|mesh-list
110651126|NCT00905216|Anticoagulants|anticoagulants|mesh-ancestor
110651127|NCT00905216|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110651128|NCT00905216|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110651129|NCT00905216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110651130|NCT00929630|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
110651131|NCT00929630|Hemostatics|hemostatics|mesh-ancestor
110651132|NCT00929630|Coagulants|coagulants|mesh-ancestor
110651133|NCT00925106|Celecoxib|celecoxib|mesh-list
110651134|NCT00925106|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110651135|NCT00925106|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110651136|NCT00925106|Analgesics|analgesics|mesh-ancestor
110651137|NCT00925106|Sensory System Agents|sensory system agents|mesh-ancestor
110651138|NCT00925106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110651139|NCT00925106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110651140|NCT00925106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110651141|NCT00925106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110651142|NCT00925106|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110651143|NCT00925106|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110651144|NCT00925106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110651145|NCT00925106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110651146|NCT00905528|Telmisartan|telmisartan|mesh-list
110651147|NCT00905528|Ramipril|ramipril|mesh-list
110651148|NCT00905528|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110651149|NCT00905528|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110651150|NCT00905528|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110651151|NCT00905528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110651152|NCT00905528|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110651153|NCT00905528|Protease Inhibitors|protease inhibitors|mesh-ancestor
110651154|NCT00905528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110651156|NCT00736697|Anthelmintics|anthelmintics|mesh-ancestor
110651157|NCT00736697|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110651158|NCT00736697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110651159|NCT00736697|Antinematodal Agents|antinematodal agents|mesh-ancestor
110651160|NCT02568995|Ketorolac|ketorolac|mesh-list
110651161|NCT02568995|Epinephrine|epinephrine|mesh-list
110651162|NCT02568995|Racepinephrine|racepinephrine|mesh-list
110651163|NCT02568995|Ropivacaine|ropivacaine|mesh-list
110651164|NCT02568995|Epinephryl borate|epinephryl borate|mesh-list
110651165|NCT02568995|Anesthetics, Local|anesthetics, local|mesh-ancestor
110651166|NCT02568995|Anesthetics|anesthetics|mesh-ancestor
110651167|NCT02568995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110651168|NCT02568995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110651169|NCT02568995|Sensory System Agents|sensory system agents|mesh-ancestor
110651170|NCT02568995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110651171|NCT02568995|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110651172|NCT02568995|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110651173|NCT02568995|Analgesics|analgesics|mesh-ancestor
110651174|NCT02568995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110651175|NCT02568995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110651176|NCT02568995|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110651177|NCT02568995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110651178|NCT02568995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110651179|NCT02568995|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110651180|NCT02568995|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110651181|NCT02568995|Adrenergic Agents|adrenergic agents|mesh-ancestor
110651182|NCT02568995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110651183|NCT02568995|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110651184|NCT02568995|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110651185|NCT02568995|Autonomic Agents|autonomic agents|mesh-ancestor
110651186|NCT02568995|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110651187|NCT02568995|Respiratory System Agents|respiratory system agents|mesh-ancestor
110651188|NCT02568995|Mydriatics|mydriatics|mesh-ancestor
110651189|NCT02568995|Sympathomimetics|sympathomimetics|mesh-ancestor
110651190|NCT02568995|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110651191|NCT00930020|Minocycline|minocycline|mesh-list
110651192|NCT00930020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110651193|NCT00930020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110651194|NCT00930098|Clofarabine|clofarabine|mesh-list
110651195|NCT00930098|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110651196|NCT00930098|Antimetabolites|antimetabolites|mesh-ancestor
110651197|NCT00930098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110651198|NCT00930098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110651199|NCT00905684|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
110651200|NCT00905684|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110651201|NCT00905684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110651202|NCT00905762|Moxifloxacin|moxifloxacin|mesh-list
110651203|NCT00905762|Gatifloxacin|gatifloxacin|mesh-list
110651204|NCT00905762|Besifloxacin|besifloxacin|mesh-list
110651205|NCT00905762|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110651206|NCT00905762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110651207|NCT00905762|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110651208|NCT00905762|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110651209|NCT00905762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110651210|NCT00905762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110651211|NCT00905762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110651212|NCT00905762|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110651213|NCT00905762|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110651214|NCT02568839|Docetaxel|docetaxel|mesh-list
110651215|NCT02568839|Trastuzumab|trastuzumab|mesh-list
110651216|NCT02568839|Pertuzumab|pertuzumab|mesh-list
110651217|NCT02568839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110651218|NCT02568839|Tubulin Modulators|tubulin modulators|mesh-ancestor
110651219|NCT02568839|Antimitotic Agents|antimitotic agents|mesh-ancestor
110651220|NCT02568839|Mitosis Modulators|mitosis modulators|mesh-ancestor
110543446|NCT00983203|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110651221|NCT02568839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110651222|NCT02568839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110651223|NCT00930488|Moxifloxacin|moxifloxacin|mesh-list
110651224|NCT00930488|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
110651225|NCT00930488|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110651226|NCT00930488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110651227|NCT00930488|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110543509|NCT02776397|Vitamin E|vitamin e|mesh-list
110651228|NCT00930488|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110651229|NCT00930488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110651230|NCT00930488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110651231|NCT00930488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110651232|NCT00930488|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110651233|NCT00930488|Contraceptive Agents|contraceptive agents|mesh-ancestor
110651234|NCT00930488|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110651235|NCT00930488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110651236|NCT00930488|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110651237|NCT00930488|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110651238|NCT00930488|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110651239|NCT00736931|Levetiracetam|levetiracetam|mesh-list
110651240|NCT00736931|Lorazepam|lorazepam|mesh-list
110651241|NCT00736931|Brivaracetam|brivaracetam|mesh-list
110651242|NCT00736931|Anticonvulsants|anticonvulsants|mesh-ancestor
110651243|NCT00736931|Nootropic Agents|nootropic agents|mesh-ancestor
110651244|NCT00736931|Antiemetics|antiemetics|mesh-ancestor
110651245|NCT00736931|Autonomic Agents|autonomic agents|mesh-ancestor
110651246|NCT00736931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110651247|NCT00736931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110651248|NCT00736931|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110651249|NCT00736931|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110543634|NCT00600938|Siderophores|siderophores|mesh-ancestor
110651250|NCT00736931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110651251|NCT00736931|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110651252|NCT00736931|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110651253|NCT00736931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110651254|NCT00736931|GABA Modulators|gaba modulators|mesh-ancestor
110651255|NCT00736931|GABA Agents|gaba agents|mesh-ancestor
110651256|NCT00736931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110651257|NCT00736931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110651258|NCT00567164|Drospirenone|drospirenone|mesh-list
110651259|NCT00567164|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110651260|NCT00567164|Hormone Antagonists|hormone antagonists|mesh-ancestor
110651261|NCT00567164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110651262|NCT00567164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110651263|NCT00567164|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110651264|NCT00567164|Diuretics|diuretics|mesh-ancestor
110651265|NCT00567164|Natriuretic Agents|natriuretic agents|mesh-ancestor
110651266|NCT00920933|Prednisolone|prednisolone|mesh-list
110651267|NCT00920933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110651268|NCT00920933|Glucocorticoids|glucocorticoids|mesh-ancestor
110651269|NCT00920933|Hormones|hormones|mesh-ancestor
110651270|NCT00920933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110651271|NCT00920933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110651272|NCT00920933|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110651273|NCT00920933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110651274|NCT00930566|Methoxsalen|methoxsalen|mesh-list
110651275|NCT00930566|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110651277|NCT00925730|Pimecrolimus|pimecrolimus|mesh-list
110651278|NCT00925730|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110651279|NCT00925730|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110651280|NCT00925730|Analgesics|analgesics|mesh-ancestor
110651281|NCT00925730|Sensory System Agents|sensory system agents|mesh-ancestor
110651282|NCT00925730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110651283|NCT00925730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110651284|NCT00925730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110651285|NCT00925730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110651286|NCT00925730|Dermatologic Agents|dermatologic agents|mesh-ancestor
110651287|NCT00925730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110651288|NCT00925730|Immunologic Factors|immunologic factors|mesh-ancestor
110651289|NCT00925730|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110651290|NCT00925730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110651291|NCT00925730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110651292|NCT00713219|Docetaxel|docetaxel|mesh-list
110651293|NCT00713219|Cetuximab|cetuximab|mesh-list
110651294|NCT00713219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110651295|NCT00713219|Tubulin Modulators|tubulin modulators|mesh-ancestor
110651296|NCT00713219|Antimitotic Agents|antimitotic agents|mesh-ancestor
110543895|NCT00910754|Prednisone|prednisone|mesh-list
110651297|NCT00713219|Mitosis Modulators|mitosis modulators|mesh-ancestor
110651298|NCT00713219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110651299|NCT00713219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110651300|NCT00931580|Vitamin D|vitamin d|mesh-list
110651301|NCT00931580|Cholecalciferol|cholecalciferol|mesh-list
110651302|NCT00931580|Vitamins|vitamins|mesh-ancestor
110651303|NCT00931580|Micronutrients|micronutrients|mesh-ancestor
110651304|NCT00931580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110543962|NCT02766803|Resveratrol|resveratrol|mesh-list
110651305|NCT00931580|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110651306|NCT00931580|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110651307|NCT05661461|Sirolimus|sirolimus|mesh-list
110651308|NCT05661461|Temsirolimus|temsirolimus|mesh-list
110544023|NCT02651792|Narcotics|narcotics|mesh-ancestor
110651309|NCT05661461|MTOR Inhibitors|mtor inhibitors|mesh-list
110651310|NCT05661461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110651311|NCT05661461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110544101|NCT02771795|Trastuzumab|trastuzumab|mesh-list
110651312|NCT05661461|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110651313|NCT05661461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110651314|NCT05661461|Antifungal Agents|antifungal agents|mesh-ancestor
110651315|NCT05661461|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110651316|NCT05661461|Immunologic Factors|immunologic factors|mesh-ancestor
110651317|NCT05661461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110651318|NCT05661461|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110651319|NCT05661461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110651320|NCT05661461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110651321|NCT00931736|Rifampin|rifampin|mesh-list
110651322|NCT00931736|Isoniazid|isoniazid|mesh-list
110651323|NCT00931736|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110651324|NCT00931736|Antitubercular Agents|antitubercular agents|mesh-ancestor
110651325|NCT00931736|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110651326|NCT00931736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110651327|NCT00931736|Leprostatic Agents|leprostatic agents|mesh-ancestor
110651328|NCT00931736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110651329|NCT00931736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110651330|NCT00931736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110651331|NCT00931736|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110651332|NCT00931736|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110651333|NCT00931736|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110651334|NCT00931736|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110651335|NCT00931736|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110651336|NCT00931736|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110651337|NCT00931736|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
110651338|NCT00931736|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110651339|NCT00931736|Antimetabolites|antimetabolites|mesh-ancestor
110651340|NCT00931736|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110651342|NCT02567981|Micronutrients|micronutrients|mesh-list
110651343|NCT02567981|Trace Elements|trace elements|mesh-list
110651344|NCT02567981|Vitamins|vitamins|mesh-ancestor
110651345|NCT02567981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110651346|NCT00737555|Tosedostat|tosedostat|mesh-list
110651347|NCT00737555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110651348|NCT00737555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110651349|NCT00932048|Atorvastatin|atorvastatin|mesh-list
110651350|NCT00932048|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110651351|NCT00932048|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110651352|NCT00932048|Antimetabolites|antimetabolites|mesh-ancestor
110651353|NCT00932048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110544366|NCT00662454|Estradiol|estradiol|mesh-list
110651354|NCT00932048|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110651355|NCT00932048|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110651356|NCT00932048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110651357|NCT04015778|Paclitaxel|paclitaxel|mesh-list
110651358|NCT04015778|Carboplatin|carboplatin|mesh-list
110651359|NCT04015778|Nivolumab|nivolumab|mesh-list
110651360|NCT04015778|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110651361|NCT04015778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110651362|NCT04015778|Tubulin Modulators|tubulin modulators|mesh-ancestor
110651363|NCT04015778|Antimitotic Agents|antimitotic agents|mesh-ancestor
110651364|NCT04015778|Mitosis Modulators|mitosis modulators|mesh-ancestor
110651365|NCT04015778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110651366|NCT04015778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110651367|NCT04015778|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110651368|NCT00926354|Ammonium trichloro(dioxoethylene-O,O'-)tellurate|ammonium trichloro(dioxoethylene-o,o'-)tellurate|mesh-list
110651370|NCT00926354|Immunologic Factors|immunologic factors|mesh-ancestor
110651371|NCT00926354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110651372|NCT00926354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110651373|NCT00926354|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110651374|NCT00926354|Protective Agents|protective agents|mesh-ancestor
110651375|NCT00926354|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110544546|NCT00883740|Anticonvulsants|anticonvulsants|mesh-ancestor
110651376|NCT00926354|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110651377|NCT00926354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110651378|NCT00926354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110651379|NCT00926354|Antiviral Agents|antiviral agents|mesh-ancestor
110651380|NCT00926354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110651381|NCT00712985|Zoledronic Acid|zoledronic acid|mesh-list
110651382|NCT00712985|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110651383|NCT00712985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110651384|NCT00737789|Mesalamine|mesalamine|mesh-list
110651385|NCT00737789|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110651386|NCT00737789|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110651387|NCT00737789|Analgesics|analgesics|mesh-ancestor
110651388|NCT00737789|Sensory System Agents|sensory system agents|mesh-ancestor
110651389|NCT00737789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110651390|NCT00737789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110651391|NCT00737789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110544618|NCT00649688|Sympatholytics|sympatholytics|mesh-ancestor
110651392|NCT00737789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110651393|NCT00700115|Ritonavir|ritonavir|mesh-list
110651394|NCT00700115|Lopinavir|lopinavir|mesh-list
110651395|NCT00700115|Raltegravir Potassium|raltegravir potassium|mesh-list
110651396|NCT00700115|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
110651397|NCT00700115|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110651398|NCT00700115|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110651399|NCT00700115|Protease Inhibitors|protease inhibitors|mesh-ancestor
110651400|NCT00700115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110651401|NCT00700115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110651402|NCT00700115|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110651403|NCT00700115|Antiviral Agents|antiviral agents|mesh-ancestor
110651404|NCT00700115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110651405|NCT00700115|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110651406|NCT00700115|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110651408|NCT00700115|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110651409|NCT05556473|Tryptophan|tryptophan|mesh-list
110651410|NCT05556473|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110651411|NCT05556473|Antidepressive Agents|antidepressive agents|mesh-ancestor
110651412|NCT05556473|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110651413|NCT00566852|Memantine|memantine|mesh-list
110651414|NCT00566852|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110651415|NCT00566852|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110651416|NCT00566852|Dopamine Agents|dopamine agents|mesh-ancestor
110651417|NCT00566852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110651418|NCT00566852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110651419|NCT00566852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110651420|NCT00566852|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110651421|NCT00566852|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110651423|NCT00936650|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110651424|NCT00936650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110651425|NCT00936650|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
110651426|NCT00936650|Hormone Antagonists|hormone antagonists|mesh-ancestor
110651427|NCT00936650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110651429|NCT00442546|Analgesics|analgesics|mesh-ancestor
110651430|NCT00442546|Sensory System Agents|sensory system agents|mesh-ancestor
110651431|NCT00442546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110651432|NCT00442546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110651433|NCT00442546|Anticonvulsants|anticonvulsants|mesh-ancestor
110651434|NCT00442546|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110651435|NCT00442546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110651436|NCT00442546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110651437|NCT00442546|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110651438|NCT00442546|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110651439|NCT00442546|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110651440|NCT00442546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110651441|NCT00442546|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110651442|NCT00936962|Vaccines|vaccines|mesh-list
110651443|NCT00936962|Immunologic Factors|immunologic factors|mesh-ancestor
110651444|NCT00936962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110651445|NCT00514683|Nintedanib|nintedanib|mesh-list
110651446|NCT00514683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110651447|NCT00514683|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110651448|NCT00514683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110651449|NCT00514683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110651450|NCT00566696|Mycophenolic Acid|mycophenolic acid|mesh-list
110651451|NCT00566696|Cyclophosphamide|cyclophosphamide|mesh-list
110651452|NCT00566696|Melphalan|melphalan|mesh-list
110651453|NCT00566696|Mechlorethamine|mechlorethamine|mesh-list
110651454|NCT00566696|Thiotepa|thiotepa|mesh-list
110651455|NCT00566696|Rituximab|rituximab|mesh-list
110651456|NCT00566696|Fludarabine|fludarabine|mesh-list
110651457|NCT00566696|Alemtuzumab|alemtuzumab|mesh-list
110651458|NCT00566696|Thymoglobulin|thymoglobulin|mesh-list
110651459|NCT00566696|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110651460|NCT00566696|Muromonab-CD3|muromonab-cd3|mesh-list
110651461|NCT00566696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110651462|NCT00566696|Immunologic Factors|immunologic factors|mesh-ancestor
110651463|NCT00566696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110651464|NCT00566696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110651465|NCT00566696|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110651466|NCT00566696|Alkylating Agents|alkylating agents|mesh-ancestor
110651467|NCT00566696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110651469|NCT00566696|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110651470|NCT00566696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110651471|NCT00566696|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110651472|NCT00566696|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110651473|NCT00566696|Antitubercular Agents|antitubercular agents|mesh-ancestor
110651474|NCT00566696|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110651475|NCT00566696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110651476|NCT00566696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110651477|NCT00926666|Levobupivacaine|levobupivacaine|mesh-list
110651478|NCT00926666|Anesthetics, Local|anesthetics, local|mesh-ancestor
110651479|NCT00926666|Anesthetics|anesthetics|mesh-ancestor
110651480|NCT00926666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110651481|NCT00926666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110651482|NCT00926666|Sensory System Agents|sensory system agents|mesh-ancestor
110651483|NCT00926666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110651484|NCT00926900|Cycloserine|cycloserine|mesh-list
110651485|NCT00926900|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110651486|NCT00926900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110651487|NCT00926900|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110651488|NCT00926900|Antitubercular Agents|antitubercular agents|mesh-ancestor
110651489|NCT00926900|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110651490|NCT00926900|Antimetabolites|antimetabolites|mesh-ancestor
110651491|NCT00926900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110651492|NCT00503841|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110651493|NCT00503841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110651494|NCT00503841|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110651495|NCT00503841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110651496|NCT00503841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110651497|NCT00937508|Varenicline|varenicline|mesh-list
110651498|NCT00937508|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110651499|NCT00937508|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110651500|NCT00937508|Cholinergic Agents|cholinergic agents|mesh-ancestor
110651501|NCT00937508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110651502|NCT00937508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110651503|NCT00937508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110651504|NCT00937664|Gemcitabine|gemcitabine|mesh-list
110651505|NCT00937664|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110651506|NCT00937664|Antimetabolites|antimetabolites|mesh-ancestor
110651507|NCT00937664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110651508|NCT00937664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110651509|NCT00937820|Darexaban|darexaban|mesh-list
110651510|NCT00937820|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110651511|NCT00937820|Antithrombins|antithrombins|mesh-ancestor
110651512|NCT00937820|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110651513|NCT00937820|Protease Inhibitors|protease inhibitors|mesh-ancestor
110651514|NCT00937820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110651515|NCT00937820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110651516|NCT00937820|Anticoagulants|anticoagulants|mesh-ancestor
110651517|NCT00506883|Colchicine|colchicine|mesh-list
110651518|NCT00506883|Gout Suppressants|gout suppressants|mesh-ancestor
110651519|NCT00506883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110651520|NCT00506883|Tubulin Modulators|tubulin modulators|mesh-ancestor
110651521|NCT00506883|Antimitotic Agents|antimitotic agents|mesh-ancestor
110651522|NCT00506883|Mitosis Modulators|mitosis modulators|mesh-ancestor
110651523|NCT00506883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110651524|NCT00506883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110651525|NCT01028638|Bevacizumab|bevacizumab|mesh-list
110651526|NCT01028638|89Zr-bevacizumab|89zr-bevacizumab|mesh-list
110651527|NCT01028638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110651528|NCT01028638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110651529|NCT01028638|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110651530|NCT01028638|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110651531|NCT01028638|Growth Substances|growth substances|mesh-ancestor
110651532|NCT01028638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110651533|NCT01028638|Growth Inhibitors|growth inhibitors|mesh-ancestor
110651534|NCT01028638|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110651535|NCT01028638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110651536|NCT00938132|Warfarin|warfarin|mesh-list
110651537|NCT00938132|Anticoagulants|anticoagulants|mesh-ancestor
110651538|NCT01023334|Lidocaine|lidocaine|mesh-list
110651539|NCT01023334|Anesthetics|anesthetics|mesh-list
110651540|NCT01023334|Anesthetics, Local|anesthetics, local|mesh-ancestor
110298747|NCT04521920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110651541|NCT01023334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110651542|NCT01023334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110651543|NCT01023334|Sensory System Agents|sensory system agents|mesh-ancestor
110651544|NCT01023334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110651545|NCT01023334|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110651546|NCT01023334|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110651547|NCT01023334|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110651548|NCT01023334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110651549|NCT01023334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110651550|NCT00938522|Cilostazol|cilostazol|mesh-list
110651551|NCT00938522|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110651552|NCT00938522|Autonomic Agents|autonomic agents|mesh-ancestor
110651553|NCT00938522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110651554|NCT00938522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110651556|NCT00938522|Respiratory System Agents|respiratory system agents|mesh-ancestor
110651557|NCT00938522|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110651558|NCT00938522|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110545188|NCT00669786|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110651559|NCT00938522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110651560|NCT00938522|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110651562|NCT00938522|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110651563|NCT00938522|Protective Agents|protective agents|mesh-ancestor
110651564|NCT00938522|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110651565|NCT00938522|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110398164|NCT00596531|Acamprosate|acamprosate|mesh-list
110651566|NCT00938522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110651568|NCT00938600|Ergocalciferols|ergocalciferols|mesh-list
110651569|NCT00938600|Cholecalciferol|cholecalciferol|mesh-list
110651570|NCT00938600|Vitamins|vitamins|mesh-list
110651571|NCT00938600|Micronutrients|micronutrients|mesh-ancestor
110651572|NCT00938600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110651573|NCT00938600|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110651574|NCT00938600|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110651575|NCT00503685|Cetuximab|cetuximab|mesh-list
110651576|NCT00503685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110651577|NCT00503685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110651578|NCT00712673|Metformin|metformin|mesh-list
110651579|NCT00712673|Lixisenatide|lixisenatide|mesh-list
110651580|NCT00712673|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110651581|NCT00712673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110651582|NCT01562990|Rituximab|rituximab|mesh-list
110651583|NCT01562990|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
110651584|NCT01562990|Gemcitabine|gemcitabine|mesh-list
110651585|NCT01562990|Oxaliplatin|oxaliplatin|mesh-list
110651586|NCT01562990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110651587|NCT01562990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110651588|NCT01562990|Immunologic Factors|immunologic factors|mesh-ancestor
110651589|NCT01562990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110651590|NCT01562990|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110651591|NCT01562990|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110651592|NCT01562990|Antimetabolites|antimetabolites|mesh-ancestor
110651593|NCT01562990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110651594|NCT01562990|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110651595|NCT01562990|Immunotoxins|immunotoxins|mesh-ancestor
110651596|NCT01562990|Immunoconjugates|immunoconjugates|mesh-ancestor
110651597|NCT00737867|Carboplatin|carboplatin|mesh-list
110651598|NCT00737867|Gemcitabine|gemcitabine|mesh-list
110651599|NCT00737867|Vinorelbine|vinorelbine|mesh-list
110651600|NCT00737867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110651601|NCT00737867|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110651602|NCT00737867|Antimetabolites|antimetabolites|mesh-ancestor
110545309|NCT05338801|Menthol|menthol|mesh-list
110651603|NCT00737867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110651604|NCT00737867|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110651605|NCT00737867|Tubulin Modulators|tubulin modulators|mesh-ancestor
110651606|NCT00737867|Antimitotic Agents|antimitotic agents|mesh-ancestor
110651607|NCT00737867|Mitosis Modulators|mitosis modulators|mesh-ancestor
110651608|NCT03976466|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110478559|NCT01018862|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110478560|NCT01018862|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110478561|NCT01018862|Histamine Antagonists|histamine antagonists|mesh-ancestor
110478562|NCT01018862|Histamine Agents|histamine agents|mesh-ancestor
110478563|NCT01018862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110478564|NCT01018394|Nicotine|nicotine|mesh-list
110478565|NCT01018394|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110478566|NCT01018394|Autonomic Agents|autonomic agents|mesh-ancestor
110478567|NCT01018394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110478568|NCT01018394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110478593|NCT04301336|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110478594|NCT04301336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110478595|NCT04301336|Trace Elements|trace elements|mesh-ancestor
110478596|NCT04301336|Micronutrients|micronutrients|mesh-ancestor
110478597|NCT04301336|Hematinics|hematinics|mesh-ancestor
110478598|NCT04301336|Vitamins|vitamins|mesh-ancestor
110478599|NCT04301336|Astringents|astringents|mesh-ancestor
110478600|NCT04301336|Dermatologic Agents|dermatologic agents|mesh-ancestor
110478601|NCT04301336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110478602|NCT04301336|Antisickling Agents|antisickling agents|mesh-ancestor
110478603|NCT04301336|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110478604|NCT00627848|Rivastigmine|rivastigmine|mesh-list
110478605|NCT00627848|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110478606|NCT00627848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110478607|NCT00627848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110478608|NCT00627848|Cholinergic Agents|cholinergic agents|mesh-ancestor
110478609|NCT00627848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110478610|NCT00627848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110545435|NCT00670566|Irbesartan|irbesartan|mesh-list
110478611|NCT00627848|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110478612|NCT00627848|Protective Agents|protective agents|mesh-ancestor
110478613|NCT04299854|Dinoprostone|dinoprostone|mesh-list
110478614|NCT04299854|Oxytocics|oxytocics|mesh-ancestor
110478615|NCT04299854|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110478616|NCT04299854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110478618|NCT01017146|Dermatologic Agents|dermatologic agents|mesh-ancestor
110478619|NCT01017146|Keratolytic Agents|keratolytic agents|mesh-ancestor
110478620|NCT02872064|Verteporfin|verteporfin|mesh-list
110478621|NCT02872064|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110478622|NCT02872064|Dermatologic Agents|dermatologic agents|mesh-ancestor
110478647|NCT01010750|Amphetamine|amphetamine|mesh-list
110478648|NCT01010750|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
110478649|NCT01010750|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110478650|NCT01010750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110478651|NCT01010750|Sympathomimetics|sympathomimetics|mesh-ancestor
110478652|NCT01010750|Autonomic Agents|autonomic agents|mesh-ancestor
110478653|NCT01010750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110478654|NCT01010750|Dopamine Agents|dopamine agents|mesh-ancestor
110478655|NCT01010750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110478656|NCT01010750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110478657|NCT01010750|Adrenergic Agents|adrenergic agents|mesh-ancestor
110478658|NCT01010750|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110478659|NCT01010750|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110478660|NCT01010750|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110478661|NCT01010750|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110478662|NCT01012622|Methylphenidate|methylphenidate|mesh-list
110478663|NCT01012622|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110478664|NCT01012622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110478665|NCT01012622|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110545486|NCT02576782|Anesthetics|anesthetics|mesh-ancestor
110478666|NCT01012622|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110478667|NCT01012622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110478668|NCT01012622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110478669|NCT01012622|Dopamine Agents|dopamine agents|mesh-ancestor
110478670|NCT01012622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110478671|NCT00722371|Metformin|metformin|mesh-list
110478672|NCT00722371|Pioglitazone|pioglitazone|mesh-list
110478673|NCT00722371|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110478674|NCT00722371|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110478675|NCT00722371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110478676|NCT00722371|Incretins|incretins|mesh-ancestor
110478677|NCT00722371|Hormones|hormones|mesh-ancestor
110478678|NCT00722371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110478679|NCT00722371|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110478680|NCT00722371|Protease Inhibitors|protease inhibitors|mesh-ancestor
110478681|NCT00722371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110478682|NCT00722371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110478684|NCT02871986|Hormones|hormones|mesh-ancestor
110478685|NCT02871986|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110478686|NCT02871986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110478687|NCT00722137|Prednisone|prednisone|mesh-list
110478688|NCT00722137|Cyclophosphamide|cyclophosphamide|mesh-list
110478689|NCT00722137|Rituximab|rituximab|mesh-list
110478690|NCT00722137|Doxorubicin|doxorubicin|mesh-list
110478691|NCT00722137|Vincristine|vincristine|mesh-list
110478692|NCT00722137|Bortezomib|bortezomib|mesh-list
110478693|NCT00722137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110478694|NCT00722137|Immunologic Factors|immunologic factors|mesh-ancestor
110478695|NCT00722137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110478696|NCT00722137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110478697|NCT00722137|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110545526|NCT02656472|Hemostatics|hemostatics|mesh-ancestor
110478698|NCT00722137|Alkylating Agents|alkylating agents|mesh-ancestor
110478699|NCT00722137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110478700|NCT00722137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110478701|NCT00722137|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110478702|NCT00722137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110478703|NCT00722137|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110545569|NCT02653898|Primaquine|primaquine|mesh-list
110478704|NCT00722137|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110478705|NCT00722137|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110478706|NCT00722137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110478707|NCT00722137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110478708|NCT00722137|Glucocorticoids|glucocorticoids|mesh-ancestor
110478709|NCT00722137|Hormones|hormones|mesh-ancestor
110478710|NCT00722137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110478711|NCT00722137|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110478712|NCT00722137|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110478713|NCT00722137|Tubulin Modulators|tubulin modulators|mesh-ancestor
110478714|NCT00722137|Antimitotic Agents|antimitotic agents|mesh-ancestor
110478715|NCT00722137|Mitosis Modulators|mitosis modulators|mesh-ancestor
110478716|NCT04114396|Antibodies|antibodies|mesh-list
110478717|NCT04114396|Immunologic Factors|immunologic factors|mesh-ancestor
110478718|NCT04114396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110478719|NCT00796666|Sildenafil Citrate|sildenafil citrate|mesh-list
110478720|NCT00796666|Sitaxsentan|sitaxsentan|mesh-list
110478721|NCT00796666|Vasodilator Agents|vasodilator agents|mesh-ancestor
110478722|NCT00796666|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110478723|NCT00796666|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110478724|NCT00796666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110545716|NCT02653742|Ketorolac|ketorolac|mesh-list
110478725|NCT00796666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110478726|NCT00796666|Urological Agents|urological agents|mesh-ancestor
110478727|NCT00796666|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
110478728|NCT00799708|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110478729|NCT00799708|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110478731|NCT00799708|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110478732|NCT00799708|Estrogens|estrogens|mesh-ancestor
110478733|NCT00799708|Hormones|hormones|mesh-ancestor
110478734|NCT00799708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110478735|NCT00799708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110545773|NCT04724044|Lactams|lactams|mesh-list
110478736|NCT00799708|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110478737|NCT00799708|Contraceptive Agents|contraceptive agents|mesh-ancestor
110478738|NCT00799708|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110478739|NCT00799708|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110478740|NCT00796510|Sildenafil Citrate|sildenafil citrate|mesh-list
110478741|NCT00796510|Sitaxsentan|sitaxsentan|mesh-list
110478742|NCT00796510|Vasodilator Agents|vasodilator agents|mesh-ancestor
110478743|NCT00796510|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110478744|NCT00796510|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110478745|NCT00796510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110478746|NCT00796510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110478747|NCT00796510|Urological Agents|urological agents|mesh-ancestor
110478748|NCT00796510|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
110478749|NCT04111432|Vaccines|vaccines|mesh-list
110165824|NCT00025402|Interferons|interferons|mesh-list
110478750|NCT04111432|Immunologic Factors|immunologic factors|mesh-ancestor
110478751|NCT04111432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110478752|NCT00915070|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
110478753|NCT00915070|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110478754|NCT00915070|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
110478755|NCT00915070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110478757|NCT00588640|D-methadone|d-methadone|mesh-list
110478758|NCT00588640|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110478759|NCT00588640|Narcotics|narcotics|mesh-ancestor
110478760|NCT00588640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110478761|NCT00588640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110478762|NCT00588640|Analgesics|analgesics|mesh-ancestor
110478763|NCT00588640|Sensory System Agents|sensory system agents|mesh-ancestor
110125958|NCT04898478|Analgesics|analgesics|mesh-ancestor
110478764|NCT00588640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110478765|NCT00588640|Antitussive Agents|antitussive agents|mesh-ancestor
110478766|NCT00588640|Respiratory System Agents|respiratory system agents|mesh-ancestor
110478767|NCT00588640|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110478768|NCT01016912|Ribavirin|ribavirin|mesh-list
110478769|NCT01016912|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110478770|NCT01016912|Antimetabolites|antimetabolites|mesh-ancestor
110478771|NCT01016912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110478772|NCT01016912|Antiviral Agents|antiviral agents|mesh-ancestor
110478773|NCT01016912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110478774|NCT02604940|Dexmedetomidine|dexmedetomidine|mesh-list
110478775|NCT02604940|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110478776|NCT02604940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110478777|NCT02604940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110478778|NCT02604940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110478779|NCT02604940|Analgesics|analgesics|mesh-ancestor
110478780|NCT02604940|Sensory System Agents|sensory system agents|mesh-ancestor
110478781|NCT02604940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110478782|NCT02604940|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110478783|NCT02604940|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110478784|NCT02604940|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110478785|NCT02604940|Adrenergic Agents|adrenergic agents|mesh-ancestor
110478786|NCT02604940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110478787|NCT02604940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110478788|NCT02605798|Sofosbuvir|sofosbuvir|mesh-list
110478789|NCT02605798|Antiviral Agents|antiviral agents|mesh-ancestor
110478790|NCT02605798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110478791|NCT00802672|Ciclopirox|ciclopirox|mesh-list
110478792|NCT00802672|Antifungal Agents|antifungal agents|mesh-ancestor
110478793|NCT00802672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110478794|NCT04113772|Nitisinone|nitisinone|mesh-list
110401529|NCT01028014|Ephedrine|ephedrine|mesh-list
110478795|NCT04113772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110478796|NCT04113772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110478797|NCT04113928|Mechlorethamine|mechlorethamine|mesh-list
110478798|NCT04113928|Alkylating Agents|alkylating agents|mesh-ancestor
110478799|NCT04113928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110478800|NCT04113928|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110478801|NCT04113928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110478803|NCT04115800|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110478804|NCT04115800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110478805|NCT04115800|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110478806|NCT04115800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110478807|NCT04115800|Antifungal Agents|antifungal agents|mesh-ancestor
110478808|NCT04115800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110478809|NCT04115800|Immunologic Factors|immunologic factors|mesh-ancestor
110478810|NCT04115800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110478811|NCT04115410|Cisplatin|cisplatin|mesh-list
110478812|NCT04115410|Carboplatin|carboplatin|mesh-list
110165828|NCT00025402|Busulfan|busulfan|mesh-list
110478813|NCT04115410|Gemcitabine|gemcitabine|mesh-list
110478814|NCT04115410|Docetaxel|docetaxel|mesh-list
110478815|NCT04115410|Pemetrexed|pemetrexed|mesh-list
110478816|NCT04115410|Vinorelbine|vinorelbine|mesh-list
110478817|NCT04115410|Gefitinib|gefitinib|mesh-list
110478818|NCT04115410|Mitomycins|mitomycins|mesh-list
110478819|NCT04115410|Mitomycin|mitomycin|mesh-list
110478820|NCT04115410|Osimertinib|osimertinib|mesh-list
110478821|NCT04115410|Afatinib|afatinib|mesh-list
110478822|NCT04115410|Vinblastine|vinblastine|mesh-list
110478823|NCT04115410|Crizotinib|crizotinib|mesh-list
110478824|NCT04115410|Ceritinib|ceritinib|mesh-list
110478825|NCT04115410|Antineoplastic Agents|antineoplastic agents|mesh-list
110478826|NCT04115410|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
110478827|NCT04115410|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110478828|NCT04115410|Antimetabolites|antimetabolites|mesh-ancestor
110478829|NCT04115410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110478830|NCT04115410|Tubulin Modulators|tubulin modulators|mesh-ancestor
110546050|NCT01563835|Fentanyl|fentanyl|mesh-list
110478831|NCT04115410|Antimitotic Agents|antimitotic agents|mesh-ancestor
110478832|NCT04115410|Mitosis Modulators|mitosis modulators|mesh-ancestor
110478833|NCT04115410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110478834|NCT04115410|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110478835|NCT04115410|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110478836|NCT04115410|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110478837|NCT04115410|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110478838|NCT04115410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110478839|NCT04115410|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110478840|NCT04115410|Alkylating Agents|alkylating agents|mesh-ancestor
110478841|NCT02604628|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110478842|NCT02604628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110478844|NCT02604784|Doxorubicin|doxorubicin|mesh-list
110478845|NCT02604784|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110478846|NCT02604784|Oxaliplatin|oxaliplatin|mesh-list
110478847|NCT02604784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110478848|NCT02604784|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110478849|NCT02604784|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110478850|NCT02604784|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110478851|NCT02604784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110478852|NCT02604784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110478853|NCT04110808|Phentolamine|phentolamine|mesh-list
110546182|NCT02695901|Disinfectants|disinfectants|mesh-ancestor
110478854|NCT04110808|Antihypertensive Agents|antihypertensive agents|mesh-list
110478855|NCT04110808|Nitroglycerin|nitroglycerin|mesh-list
110478856|NCT04110808|Anesthetics|anesthetics|mesh-list
110478857|NCT04110808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110478858|NCT04110808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110478859|NCT04110808|Vasodilator Agents|vasodilator agents|mesh-ancestor
110478860|NCT04110808|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110478861|NCT04110808|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110478862|NCT04110808|Adrenergic Agents|adrenergic agents|mesh-ancestor
110478863|NCT04110808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110546325|NCT04067011|Doxycycline|doxycycline|mesh-list
110478864|NCT04110808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110478865|NCT00714259|Fludarabine|fludarabine|mesh-list
110478866|NCT00714259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110478867|NCT00796120|Doxorubicin|doxorubicin|mesh-list
110478868|NCT00796120|Ifosfamide|ifosfamide|mesh-list
110478869|NCT00796120|Trabectedin|trabectedin|mesh-list
110478870|NCT00796120|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110478871|NCT00796120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110478872|NCT00796120|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110478873|NCT00796120|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110478874|NCT00796120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110478875|NCT00796120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110478876|NCT00796120|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110478877|NCT00796120|Alkylating Agents|alkylating agents|mesh-ancestor
110478878|NCT00795886|Sirolimus|sirolimus|mesh-list
110478879|NCT00795886|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110478880|NCT00795886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110478881|NCT00795886|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110478882|NCT00795886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110478883|NCT00795886|Antifungal Agents|antifungal agents|mesh-ancestor
110478884|NCT00795886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110478885|NCT00795886|Immunologic Factors|immunologic factors|mesh-ancestor
110478886|NCT00795886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110478887|NCT04110418|Terlipressin|terlipressin|mesh-list
110478888|NCT04110418|Methylene Blue|methylene blue|mesh-list
110478889|NCT04110418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110478890|NCT04110418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110478891|NCT04110418|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110478892|NCT04110418|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110478893|NCT04110028|Niacinamide|niacinamide|mesh-list
110478894|NCT04110028|Niacin|niacin|mesh-list
110478895|NCT04110028|Nicotinic Acids|nicotinic acids|mesh-list
110478896|NCT04110028|Vitamin B Complex|vitamin b complex|mesh-ancestor
110478897|NCT04110028|Vitamins|vitamins|mesh-ancestor
110478898|NCT04110028|Micronutrients|micronutrients|mesh-ancestor
110478899|NCT04110028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110478900|NCT04110028|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110478901|NCT04110028|Antimetabolites|antimetabolites|mesh-ancestor
110478902|NCT04110028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110478903|NCT04110028|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110478904|NCT04110028|Vasodilator Agents|vasodilator agents|mesh-ancestor
110478905|NCT02589457|Tenofovir|tenofovir|mesh-list
110478906|NCT02589457|Antiviral Agents|antiviral agents|mesh-ancestor
110478907|NCT02589457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110478908|NCT02589457|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110478909|NCT02589457|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110478910|NCT02589457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110546443|NCT00652886|Anabolic Agents|anabolic agents|mesh-ancestor
110478911|NCT02589457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110478912|NCT02589457|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110478913|NCT02589457|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110478914|NCT00718861|Zoledronic Acid|zoledronic acid|mesh-list
110478915|NCT00718861|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110478916|NCT00718861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110478917|NCT05310643|Nivolumab|nivolumab|mesh-list
110478918|NCT05310643|Ipilimumab|ipilimumab|mesh-list
110478919|NCT05310643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110478920|NCT05310643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110478921|NCT05310643|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110478922|NCT05310643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110478924|NCT05257213|Anticoagulants|anticoagulants|mesh-ancestor
110478925|NCT05257213|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110478926|NCT05257213|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110478927|NCT05257213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110478928|NCT00918853|Pancrelipase|pancrelipase|mesh-list
110478929|NCT00918853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110478930|NCT01016600|Lenalidomide|lenalidomide|mesh-list
110478931|NCT01016600|Azacitidine|azacitidine|mesh-list
110478932|NCT01016600|Immunologic Factors|immunologic factors|mesh-ancestor
110478933|NCT01016600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110478934|NCT01016600|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110478935|NCT01016600|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110478936|NCT01016600|Growth Substances|growth substances|mesh-ancestor
110478937|NCT01016600|Growth Inhibitors|growth inhibitors|mesh-ancestor
110478938|NCT01016600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110478939|NCT01016600|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110478940|NCT01016600|Antimetabolites|antimetabolites|mesh-ancestor
110478941|NCT01016600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110478942|NCT01016600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110478943|NCT05175235|Pembrolizumab|pembrolizumab|mesh-list
110478944|NCT05175235|Nivolumab|nivolumab|mesh-list
110478945|NCT05175235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110478946|NCT05175235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110478947|NCT05175235|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110266271|NCT00182715|Vitamins|vitamins|mesh-ancestor
110478948|NCT05175235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110478949|NCT04298684|Metformin|metformin|mesh-list
110478950|NCT04298684|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110478952|NCT04298684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110478953|NCT04298684|Incretins|incretins|mesh-ancestor
110478954|NCT04298684|Hormones|hormones|mesh-ancestor
110478955|NCT04298684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110478956|NCT04298684|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110478957|NCT04298684|Protease Inhibitors|protease inhibitors|mesh-ancestor
110478958|NCT04298684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110478959|NCT04298684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110478960|NCT04298372|Lenalidomide|lenalidomide|mesh-list
110478961|NCT04298372|Immunologic Factors|immunologic factors|mesh-ancestor
110478962|NCT04298372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110478963|NCT04298372|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110478964|NCT04298372|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110478965|NCT04298372|Growth Substances|growth substances|mesh-ancestor
110478966|NCT04298372|Growth Inhibitors|growth inhibitors|mesh-ancestor
110478967|NCT04298372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110478968|NCT01010204|Varenicline|varenicline|mesh-list
110478969|NCT01010204|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110194226|NCT00066417|Hormones|hormones|mesh-ancestor
110478970|NCT01010204|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110478971|NCT01010204|Cholinergic Agents|cholinergic agents|mesh-ancestor
110478972|NCT01010204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110478973|NCT01010204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110478974|NCT01010204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110478975|NCT00718549|Cyclophosphamide|cyclophosphamide|mesh-list
110478976|NCT00718549|Rituximab|rituximab|mesh-list
110478977|NCT00718549|Cladribine|cladribine|mesh-list
110478978|NCT00718549|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110478979|NCT00718549|Immunologic Factors|immunologic factors|mesh-ancestor
110478980|NCT00718549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110478981|NCT00718549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110478982|NCT00718549|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110478983|NCT00718549|Alkylating Agents|alkylating agents|mesh-ancestor
110478984|NCT00718549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110478985|NCT00718549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110478986|NCT00718549|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110478987|NCT00718549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110478988|NCT00793624|Formoterol Fumarate|formoterol fumarate|mesh-list
110478989|NCT00793624|Olodaterol|olodaterol|mesh-list
110478990|NCT00793624|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110478991|NCT00793624|Autonomic Agents|autonomic agents|mesh-ancestor
110478992|NCT00793624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110478993|NCT00793624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110546671|NCT04165850|Celecoxib|celecoxib|mesh-list
110478995|NCT00793624|Respiratory System Agents|respiratory system agents|mesh-ancestor
110478996|NCT00793624|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110478997|NCT00793624|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110478998|NCT00793624|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110478999|NCT00793624|Adrenergic Agents|adrenergic agents|mesh-ancestor
110479000|NCT00793624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110479001|NCT00793624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110479002|NCT00919243|Prednisone|prednisone|mesh-list
110479003|NCT00919243|Allopurinol|allopurinol|mesh-list
110479004|NCT00919243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110479005|NCT00919243|Glucocorticoids|glucocorticoids|mesh-ancestor
110479006|NCT00919243|Hormones|hormones|mesh-ancestor
110479007|NCT00919243|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110479008|NCT00919243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110479009|NCT00919243|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110479010|NCT00919243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110479011|NCT00919243|Antimetabolites|antimetabolites|mesh-ancestor
110479012|NCT00919243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110479013|NCT00919243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110479014|NCT00919243|Gout Suppressants|gout suppressants|mesh-ancestor
110479015|NCT00919243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110479016|NCT00919243|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110479017|NCT00919243|Antioxidants|antioxidants|mesh-ancestor
110479018|NCT00919243|Protective Agents|protective agents|mesh-ancestor
110479019|NCT00794950|Sunitinib|sunitinib|mesh-list
110479020|NCT00794950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110479021|NCT00794950|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110479022|NCT00794950|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110479023|NCT00794950|Growth Substances|growth substances|mesh-ancestor
110479024|NCT00794950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110479025|NCT00794950|Growth Inhibitors|growth inhibitors|mesh-ancestor
110479026|NCT00794950|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110479028|NCT00794950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110479029|NCT02591173|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
110479030|NCT02591173|Angiotensin II|angiotensin ii|mesh-list
110479031|NCT02591173|Angiotensinogen|angiotensinogen|mesh-list
110479032|NCT02591173|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110479033|NCT02591173|Vasodilator Agents|vasodilator agents|mesh-ancestor
110479034|NCT02591173|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110479035|NCT02591173|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110479036|NCT02591173|Protease Inhibitors|protease inhibitors|mesh-ancestor
110479037|NCT02591173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110479038|NCT02591173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110479039|NCT00793546|Exemestane|exemestane|mesh-list
110479040|NCT00793546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110479041|NCT00793546|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110479042|NCT00793546|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110479043|NCT00793546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110479044|NCT00793546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110479045|NCT00793546|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110479046|NCT00793546|Hormone Antagonists|hormone antagonists|mesh-ancestor
110479047|NCT00793546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110479048|NCT00793546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110479049|NCT02604238|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
110479050|NCT02604238|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110479051|NCT02604238|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110479052|NCT02604238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110479053|NCT00798694|Travoprost|travoprost|mesh-list
110479054|NCT00798694|Latanoprost|latanoprost|mesh-list
110479055|NCT00798694|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110479056|NCT00798694|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110479057|NCT00798694|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110479058|NCT00718315|Erythromycin|erythromycin|mesh-list
110479059|NCT00718315|Erythromycin Estolate|erythromycin estolate|mesh-list
110479060|NCT00718315|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
110479061|NCT00718315|Erythromycin stearate|erythromycin stearate|mesh-list
110479062|NCT00718315|Fusidic Acid|fusidic acid|mesh-list
110479063|NCT00718315|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110479064|NCT00718315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110479065|NCT00718315|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110479066|NCT00718315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110479067|NCT00718315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110479068|NCT00718315|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110479069|NCT00718315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110479070|NCT00718315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110479071|NCT00718315|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110479073|NCT00798304|Immunologic Factors|immunologic factors|mesh-ancestor
110479074|NCT00798304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110479075|NCT04109872|Lenalidomide|lenalidomide|mesh-list
110479076|NCT04109872|Immunologic Factors|immunologic factors|mesh-ancestor
110479077|NCT04109872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110479078|NCT04109872|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110479079|NCT04109872|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110479080|NCT04109872|Growth Substances|growth substances|mesh-ancestor
110479081|NCT04109872|Growth Inhibitors|growth inhibitors|mesh-ancestor
110479082|NCT04109872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110479083|NCT00793780|Naltrexone|naltrexone|mesh-list
110479084|NCT00793780|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110479085|NCT00793780|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110479086|NCT00793780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110479087|NCT00793780|Sensory System Agents|sensory system agents|mesh-ancestor
110479088|NCT00793780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110479089|NCT04107220|Valsartan|valsartan|mesh-list
110479090|NCT04107220|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
110479091|NCT04107220|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110479092|NCT04107220|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110479093|NCT04107220|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110479094|NCT04107220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110479095|NCT02591017|Ketamine|ketamine|mesh-list
110479096|NCT02591017|Morphine|morphine|mesh-list
110479097|NCT02591017|Chitosan|chitosan|mesh-list
110479098|NCT02591017|Analgesics|analgesics|mesh-ancestor
110479099|NCT02591017|Sensory System Agents|sensory system agents|mesh-ancestor
110401811|NCT06055153|Disitamab vedotin|disitamab vedotin|mesh-list
110479100|NCT02591017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110479101|NCT02591017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110479102|NCT02591017|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110479103|NCT02591017|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110479106|NCT02591017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110479107|NCT02591017|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110479108|NCT02591017|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110479109|NCT02591017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110479110|NCT02591017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110479111|NCT02591017|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110547585|NCT02742467|Amlodipine|amlodipine|mesh-list
110479112|NCT02591017|Narcotics|narcotics|mesh-ancestor
110479113|NCT02591017|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110479114|NCT02591017|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110479115|NCT02591017|Antimetabolites|antimetabolites|mesh-ancestor
110479116|NCT02591017|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110479117|NCT02591017|Chelating Agents|chelating agents|mesh-ancestor
110479118|NCT02591017|Sequestering Agents|sequestering agents|mesh-ancestor
110479119|NCT02591017|Hemostatics|hemostatics|mesh-ancestor
110479120|NCT02591017|Coagulants|coagulants|mesh-ancestor
110479121|NCT02591095|Navitoclax|navitoclax|mesh-list
110479122|NCT02591095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110479123|NCT02588755|Chlorotrianisene|chlorotrianisene|mesh-list
110479124|NCT02588755|Tegafur|tegafur|mesh-list
110479125|NCT02588755|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
110479126|NCT02588755|Estrogens|estrogens|mesh-ancestor
110479127|NCT02588755|Hormones|hormones|mesh-ancestor
110479128|NCT02588755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110479129|NCT02588755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110479130|NCT02588755|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110479131|NCT02588755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110479132|NCT02588755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110479133|NCT02588755|Antimetabolites|antimetabolites|mesh-ancestor
110479134|NCT02588755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110479135|NCT00919321|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110479136|NCT00919321|Immunologic Factors|immunologic factors|mesh-ancestor
110479137|NCT00919321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110479138|NCT02643303|Durvalumab|durvalumab|mesh-list
110479139|NCT02643303|Tremelimumab|tremelimumab|mesh-list
110479140|NCT02643303|Poly ICLC|poly iclc|mesh-list
110479141|NCT02643303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110479142|NCT02643303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110479143|NCT02643303|Interferon Inducers|interferon inducers|mesh-ancestor
110479144|NCT02643303|Immunologic Factors|immunologic factors|mesh-ancestor
110479145|NCT02643303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110479146|NCT00615147|Fibrin fragment D|fibrin fragment d|mesh-list
110479147|NCT00615147|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110479148|NCT00615147|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110479149|NCT00615147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110479150|NCT00615147|Hemostatics|hemostatics|mesh-ancestor
110479151|NCT00615147|Coagulants|coagulants|mesh-ancestor
110479152|NCT01029717|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110479153|NCT01029717|Minocycline|minocycline|mesh-list
110479154|NCT01029717|Rifampin|rifampin|mesh-list
110479155|NCT01029717|Heparin|heparin|mesh-list
110479156|NCT01029717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110479157|NCT01029717|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110479158|NCT01029717|Antitubercular Agents|antitubercular agents|mesh-ancestor
110479159|NCT01029717|Anticoagulants|anticoagulants|mesh-ancestor
110479160|NCT01029717|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110479161|NCT01029717|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110479162|NCT01029717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110479164|NCT01029717|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110479165|NCT01029717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110479166|NCT01029717|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110479167|NCT01029717|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110548062|NCT04137978|Potassium Citrate|potassium citrate|mesh-list
110479168|NCT01029717|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110479169|NCT01029717|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110479170|NCT01029717|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110479171|NCT01029717|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110479173|NCT00790036|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110479174|NCT00790036|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110479175|NCT00790036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110479176|NCT00790036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110479177|NCT00790036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110479178|NCT00790036|Immunologic Factors|immunologic factors|mesh-ancestor
110479179|NCT00790036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110479180|NCT00790036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110479181|NCT05563168|Diltiazem|diltiazem|mesh-list
110479182|NCT05563168|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110479183|NCT05563168|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110548127|NCT00717808|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110479184|NCT05563168|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110479185|NCT05563168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110479186|NCT05563168|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110479187|NCT05563168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110479188|NCT05563168|Vasodilator Agents|vasodilator agents|mesh-ancestor
110479190|NCT00789958|Capecitabine|capecitabine|mesh-list
110479191|NCT00789958|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110479192|NCT00789958|Antimetabolites|antimetabolites|mesh-ancestor
110479193|NCT00789958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110479194|NCT00789958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110479195|NCT00789880|Vitamin D|vitamin d|mesh-list
110479196|NCT00789880|Ergocalciferols|ergocalciferols|mesh-list
110479197|NCT00789880|Cholecalciferol|cholecalciferol|mesh-list
110479198|NCT00789880|Vitamins|vitamins|mesh-list
110479199|NCT00789880|Micronutrients|micronutrients|mesh-ancestor
110479200|NCT00789880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110479201|NCT00789880|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110479202|NCT00789880|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110479203|NCT00915616|Melatonin|melatonin|mesh-list
110479204|NCT00915616|Antioxidants|antioxidants|mesh-ancestor
110548324|NCT00718354|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110479205|NCT00915616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110479206|NCT00915616|Protective Agents|protective agents|mesh-ancestor
110479207|NCT00915616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110479208|NCT00915616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110479209|NCT00914836|Betamethasone|betamethasone|mesh-list
110479210|NCT00914836|Betamethasone Valerate|betamethasone valerate|mesh-list
110479211|NCT00914836|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
110479212|NCT00914836|Betamethasone benzoate|betamethasone benzoate|mesh-list
110651609|NCT03976466|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
110479213|NCT00914836|Betamethasone dipropionate, betamethasone sodium phosphate drug combination|betamethasone dipropionate, betamethasone sodium phosphate drug combination|mesh-list
110479214|NCT00914836|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
110479215|NCT00914836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110479216|NCT00914836|Glucocorticoids|glucocorticoids|mesh-ancestor
110479217|NCT00914836|Hormones|hormones|mesh-ancestor
110479218|NCT00914836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110479219|NCT00914836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110479220|NCT00914836|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110479221|NCT00914836|Respiratory System Agents|respiratory system agents|mesh-ancestor
110479222|NCT04106752|Caffeine|caffeine|mesh-list
110479223|NCT04106752|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110479225|NCT04106752|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110479226|NCT04106752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110479227|NCT04106752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110479228|NCT04106752|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110479229|NCT04106752|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110479230|NCT04106752|Purinergic Agents|purinergic agents|mesh-ancestor
110479231|NCT04106752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110479232|NCT00792298|Suvorexant|suvorexant|mesh-list
110479233|NCT00792298|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110479234|NCT00792298|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110479235|NCT00792298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110479236|NCT00792298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110479237|NCT00792298|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
110479238|NCT00792298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110479239|NCT00792298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110479240|NCT04108468|Golimumab|golimumab|mesh-list
110479241|NCT04108468|Methotrexate|methotrexate|mesh-list
110479242|NCT04108468|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110479243|NCT04108468|Abortifacient Agents|abortifacient agents|mesh-ancestor
110479244|NCT04108468|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110479245|NCT04108468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110479246|NCT04108468|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110479247|NCT04108468|Antimetabolites|antimetabolites|mesh-ancestor
110479248|NCT04108468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110479250|NCT04108468|Dermatologic Agents|dermatologic agents|mesh-ancestor
110479251|NCT04108468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110479252|NCT04108468|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110479253|NCT04108468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110479254|NCT04108468|Immunologic Factors|immunologic factors|mesh-ancestor
110479255|NCT04108468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110479256|NCT04108468|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110479257|NCT04108468|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110479258|NCT04108468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110479260|NCT02603068|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110479261|NCT00718081|Sufentanil|sufentanil|mesh-list
110479262|NCT00718081|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110479263|NCT00718081|Narcotics|narcotics|mesh-ancestor
110479264|NCT00718081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110479265|NCT00718081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110479266|NCT00718081|Analgesics|analgesics|mesh-ancestor
110479267|NCT00718081|Sensory System Agents|sensory system agents|mesh-ancestor
110479268|NCT00718081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110479269|NCT00718081|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110479270|NCT00718081|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110479271|NCT00718081|Anesthetics, General|anesthetics, general|mesh-ancestor
110479272|NCT00718081|Anesthetics|anesthetics|mesh-ancestor
110479273|NCT00788710|Etoricoxib|etoricoxib|mesh-list
110479274|NCT00788710|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110479275|NCT00788710|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110479276|NCT00788710|Analgesics|analgesics|mesh-ancestor
110479277|NCT00788710|Sensory System Agents|sensory system agents|mesh-ancestor
110479278|NCT00788710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110479279|NCT00788710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110479280|NCT00788710|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110479281|NCT00788710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110479282|NCT00788710|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110479283|NCT00788710|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110479284|NCT00788710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110479285|NCT00788710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110479286|NCT04084093|Pulmonary Surfactants|pulmonary surfactants|mesh-list
110479287|NCT04084093|Respiratory System Agents|respiratory system agents|mesh-ancestor
110479288|NCT04083625|Carbetocin|carbetocin|mesh-list
110479290|NCT04083625|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110479291|NCT04083625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110479292|NCT00787930|Valproic Acid|valproic acid|mesh-list
110479293|NCT00787930|Anticonvulsants|anticonvulsants|mesh-ancestor
110479294|NCT00787930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110479295|NCT00787930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110479296|NCT00787930|GABA Agents|gaba agents|mesh-ancestor
110479297|NCT00787930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110479298|NCT00787930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110479299|NCT00787930|Antimanic Agents|antimanic agents|mesh-ancestor
110479300|NCT00787930|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110479301|NCT00787930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110479302|NCT00787930|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110479303|NCT04106050|Lidocaine|lidocaine|mesh-list
110479304|NCT04106050|Anesthetics, Local|anesthetics, local|mesh-ancestor
110479305|NCT04106050|Anesthetics|anesthetics|mesh-ancestor
110651610|NCT03976466|Calcium|calcium|mesh-list
110479306|NCT04106050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110479307|NCT04106050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110479308|NCT04106050|Sensory System Agents|sensory system agents|mesh-ancestor
110479309|NCT04106050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110479310|NCT04106050|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110479311|NCT04106050|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110479312|NCT04106050|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110479313|NCT04106050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110479314|NCT04106050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110479316|NCT00588094|Carboplatin|carboplatin|mesh-list
110479317|NCT00588094|Etoposide|etoposide|mesh-list
110479318|NCT00588094|Ifosfamide|ifosfamide|mesh-list
110479319|NCT00588094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110479320|NCT00588094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110479321|NCT00588094|Immunologic Factors|immunologic factors|mesh-ancestor
110479322|NCT00588094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110479323|NCT00588094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110165862|NCT00025441|Immunologic Factors|immunologic factors|mesh-ancestor
110479324|NCT00588094|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110479325|NCT00588094|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110479326|NCT00588094|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110479327|NCT00588094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110479328|NCT00588094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110479329|NCT00588094|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110479330|NCT00588094|Alkylating Agents|alkylating agents|mesh-ancestor
110479332|NCT03373383|Anticonvulsants|anticonvulsants|mesh-ancestor
110479333|NCT02605252|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110479334|NCT02605252|Antiviral Agents|antiviral agents|mesh-ancestor
110479335|NCT02605252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110479336|NCT00482157|Vitamin D|vitamin d|mesh-list
110479337|NCT00482157|Calcitriol|calcitriol|mesh-list
110479338|NCT00482157|Vitamins|vitamins|mesh-ancestor
110479339|NCT00482157|Micronutrients|micronutrients|mesh-ancestor
110479340|NCT00482157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110479341|NCT00482157|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110549456|NCT05366062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110479342|NCT00482157|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110479343|NCT00482157|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
110479344|NCT00482157|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110479345|NCT00482157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110479346|NCT00482157|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110479347|NCT02706015|Dipyrone|dipyrone|mesh-list
110479348|NCT02706015|Dihydroergotamine|dihydroergotamine|mesh-list
110479349|NCT02706015|Caffeine|caffeine|mesh-list
110479350|NCT02706015|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110479351|NCT02706015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110479352|NCT02706015|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110479353|NCT02706015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110479354|NCT02706015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110479355|NCT02706015|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110479356|NCT02706015|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110479357|NCT02706015|Purinergic Agents|purinergic agents|mesh-ancestor
110479358|NCT02706015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110549589|NCT02721329|Acetaminophen|acetaminophen|mesh-list
110479359|NCT02706015|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110479360|NCT02706015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110479361|NCT02706015|Analgesics|analgesics|mesh-ancestor
110479362|NCT02706015|Sensory System Agents|sensory system agents|mesh-ancestor
110479364|NCT02706015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110479365|NCT02706015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110479366|NCT02706015|Antipyretics|antipyretics|mesh-ancestor
110479367|NCT02706015|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110479368|NCT02706015|Dopamine Agonists|dopamine agonists|mesh-ancestor
110479369|NCT02706015|Dopamine Agents|dopamine agents|mesh-ancestor
110479371|NCT02707575|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110479372|NCT02707575|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110479373|NCT02707575|Growth Substances|growth substances|mesh-ancestor
110479374|NCT02707575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110479375|NCT02707575|Growth Inhibitors|growth inhibitors|mesh-ancestor
110479376|NCT02707575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110479377|NCT00919399|Tamoxifen|tamoxifen|mesh-list
110479378|NCT00919399|Exemestane|exemestane|mesh-list
110479379|NCT00919399|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110479380|NCT00919399|Hormone Antagonists|hormone antagonists|mesh-ancestor
110479381|NCT00919399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110549863|NCT00689208|Atropine|atropine|mesh-list
110479382|NCT00919399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110479383|NCT00919399|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110479384|NCT00919399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110479385|NCT00919399|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110479386|NCT00919399|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110479387|NCT00919399|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110479388|NCT00919399|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110479389|NCT00919399|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110479390|NCT00919399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110479391|NCT00919399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110479392|NCT00784654|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
110479393|NCT00784654|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110479394|NCT00784654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110479395|NCT00784654|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110479396|NCT00784654|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110479397|NCT00784654|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110479398|NCT00784654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110479400|NCT00784654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110479403|NCT02588287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110479404|NCT02588287|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110479405|NCT02588287|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110479406|NCT02588287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110479407|NCT02588287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110479408|NCT02588287|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110479409|NCT02588287|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110479410|NCT02707107|Cefepime-zidebactam|cefepime-zidebactam|mesh-list
110479411|NCT02707107|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110479412|NCT02707107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110479413|NCT02707263|Heparin|heparin|mesh-list
110479414|NCT02707263|Calcium heparin|calcium heparin|mesh-list
110479415|NCT02707263|Anticoagulants|anticoagulants|mesh-ancestor
110479416|NCT02707263|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110479417|NCT02707263|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110479418|NCT02707263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110479419|NCT02705547|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110479420|NCT02705547|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110479421|NCT02705547|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110479423|NCT02705547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110479424|NCT02705547|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110479425|NCT02705547|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110479426|NCT02705547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110550206|NCT02570230|Ketamine|ketamine|mesh-list
110479427|NCT00615303|Simethicone|simethicone|mesh-list
110479428|NCT00615303|Antifoaming Agents|antifoaming agents|mesh-ancestor
110479429|NCT00615303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110479430|NCT00615303|Emollients|emollients|mesh-ancestor
110479431|NCT00615303|Dermatologic Agents|dermatologic agents|mesh-ancestor
110479432|NCT00787150|Warfarin|warfarin|mesh-list
110479433|NCT00787150|Apixaban|apixaban|mesh-list
110479434|NCT00787150|Anticoagulants|anticoagulants|mesh-ancestor
110479435|NCT00787150|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110479436|NCT00787150|Antithrombins|antithrombins|mesh-ancestor
110479437|NCT00787150|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110479438|NCT00787150|Protease Inhibitors|protease inhibitors|mesh-ancestor
110479439|NCT00787150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110479440|NCT00787150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110479441|NCT03606837|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
110479442|NCT03606837|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110479443|NCT03606837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110479444|NCT02705313|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
110479445|NCT02705313|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110479446|NCT02705313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110479447|NCT00786838|Trabectedin|trabectedin|mesh-list
110479448|NCT00786838|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110479449|NCT00786838|Alkylating Agents|alkylating agents|mesh-ancestor
110479450|NCT00786838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110479451|NCT00786838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110479453|NCT02604004|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110479454|NCT02604004|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110479455|NCT02604004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110479456|NCT02604004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110479457|NCT02604004|Antiviral Agents|antiviral agents|mesh-ancestor
110479458|NCT02604004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110479459|NCT02604004|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110479460|NCT02604004|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110479461|NCT05095207|Bicalutamide|bicalutamide|mesh-list
110479462|NCT05095207|Androgen Antagonists|androgen antagonists|mesh-ancestor
110479463|NCT05095207|Hormone Antagonists|hormone antagonists|mesh-ancestor
110651611|NCT03976466|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110479464|NCT05095207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110479465|NCT05095207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110479466|NCT05095207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110479467|NCT03354039|Tamoxifen|tamoxifen|mesh-list
110479468|NCT03354039|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110479469|NCT03354039|Hormone Antagonists|hormone antagonists|mesh-ancestor
110479470|NCT03354039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110479471|NCT03354039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110479473|NCT03354039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110479474|NCT03354039|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110479475|NCT03354039|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110479476|NCT03354039|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110479477|NCT04105426|Antioxidants|antioxidants|mesh-list
110479478|NCT04105426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110479479|NCT04105426|Protective Agents|protective agents|mesh-ancestor
110479480|NCT04105426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110479482|NCT02704923|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110479483|NCT02704923|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110479484|NCT02704923|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110479485|NCT02704923|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110479486|NCT02704923|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110479487|NCT02704923|Autonomic Agents|autonomic agents|mesh-ancestor
110479488|NCT02704923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110479489|NCT02704923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110479490|NCT02704923|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110479491|NCT02704923|Respiratory System Agents|respiratory system agents|mesh-ancestor
110479492|NCT02704923|Mydriatics|mydriatics|mesh-ancestor
110479493|NCT02704923|Parasympatholytics|parasympatholytics|mesh-ancestor
110479494|NCT02704923|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110479495|NCT02704923|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110479496|NCT02704923|Cholinergic Agents|cholinergic agents|mesh-ancestor
110479497|NCT02704923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110479498|NCT02704923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110479499|NCT04815967|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
110479500|NCT04815967|Botulinum Toxins|botulinum toxins|mesh-list
110479501|NCT04815967|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110479502|NCT04815967|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110479503|NCT04815967|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110479504|NCT04815967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110651612|NCT03976466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110479505|NCT04815967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110479506|NCT04815967|Cholinergic Agents|cholinergic agents|mesh-ancestor
110479507|NCT04815967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110479508|NCT04815967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110479509|NCT04815967|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110479510|NCT04815967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110479511|NCT04815967|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110479512|NCT02704767|Apatinib|apatinib|mesh-list
110479513|NCT02704767|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110479514|NCT02704767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110479515|NCT02704767|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110479517|NCT02704767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110479518|NCT02587273|Fentanyl|fentanyl|mesh-list
110479519|NCT02587273|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110479520|NCT02587273|Narcotics|narcotics|mesh-ancestor
110551218|NCT01000597|Xhance|xhance|mesh-list
110479521|NCT02587273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110479522|NCT02587273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110479523|NCT02587273|Analgesics|analgesics|mesh-ancestor
110479524|NCT02587273|Sensory System Agents|sensory system agents|mesh-ancestor
110479525|NCT02587273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110479526|NCT02587273|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110479527|NCT02587273|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110479528|NCT02587273|Anesthetics, General|anesthetics, general|mesh-ancestor
110479530|NCT02704299|Immunomodulating Agents|immunomodulating agents|mesh-list
110479531|NCT02704299|Immunologic Factors|immunologic factors|mesh-ancestor
110551323|NCT02714699|Scopolamine|scopolamine|mesh-list
110479532|NCT02704299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110479533|NCT02587741|Metformin|metformin|mesh-list
110479534|NCT02587741|Acarbose|acarbose|mesh-list
110479535|NCT02587741|Gliclazide|gliclazide|mesh-list
110266458|NCT03748810|Dapagliflozin|dapagliflozin|mesh-list
110479536|NCT02587741|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
110479537|NCT02587741|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110479538|NCT02587741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110479539|NCT02587741|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
110479540|NCT02587741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110551498|NCT04234217|Niacin|niacin|mesh-list
110479541|NCT02587741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110479542|NCT02703363|Minocycline|minocycline|mesh-list
110479543|NCT02703363|Celecoxib|celecoxib|mesh-list
110479544|NCT02703363|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110479545|NCT02703363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110479546|NCT02703363|Analgesics|analgesics|mesh-ancestor
110479547|NCT02703363|Sensory System Agents|sensory system agents|mesh-ancestor
110479548|NCT02703363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110479549|NCT02703363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110479550|NCT02703363|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110479551|NCT02703363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110479552|NCT02703363|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110551538|NCT05429567|Narcotics|narcotics|mesh-ancestor
110479553|NCT02703363|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110479554|NCT02703363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110479555|NCT02703363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110479556|NCT02703363|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110479557|NCT02703363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110479559|NCT05018221|Vitamin K|vitamin k|mesh-list
110479560|NCT05018221|Vitamin K 1|vitamin k 1|mesh-list
110479561|NCT05018221|Sodium thiosulfate|sodium thiosulfate|mesh-list
110479562|NCT05018221|Magnesium citrate|magnesium citrate|mesh-list
110479563|NCT05018221|Citric Acid|citric acid|mesh-list
110165908|NCT00025480|Carboplatin|carboplatin|mesh-list
110479564|NCT05018221|Sodium Citrate|sodium citrate|mesh-list
110479565|NCT05018221|Micronutrients|micronutrients|mesh-ancestor
110479566|NCT05018221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110479567|NCT05018221|Anticoagulants|anticoagulants|mesh-ancestor
110479568|NCT05018221|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110479569|NCT05018221|Chelating Agents|chelating agents|mesh-ancestor
110551741|NCT01002703|Hormones|hormones|mesh-ancestor
110479570|NCT05018221|Sequestering Agents|sequestering agents|mesh-ancestor
110479571|NCT05018221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110479572|NCT05018221|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110479573|NCT05018221|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110479574|NCT05018221|Hemostatics|hemostatics|mesh-ancestor
110479576|NCT05018221|Antidotes|antidotes|mesh-ancestor
110479577|NCT05018221|Protective Agents|protective agents|mesh-ancestor
110479578|NCT05018221|Antioxidants|antioxidants|mesh-ancestor
110479579|NCT05018221|Antitubercular Agents|antitubercular agents|mesh-ancestor
110479580|NCT05018221|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110479581|NCT05018221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110479583|NCT05018221|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110479584|NCT00615381|Insulin|insulin|mesh-list
110479585|NCT00615381|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110479586|NCT00615381|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110479587|NCT00615381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110479588|NCT00785980|Ciprofloxacin|ciprofloxacin|mesh-list
110479589|NCT00785980|Quinine|quinine|mesh-list
110479590|NCT00785980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110479591|NCT00785980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110479592|NCT00785980|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110552018|NCT01003561|Anesthetics|anesthetics|mesh-list
110479593|NCT00785980|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110479595|NCT00785980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110479596|NCT00785980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110266485|NCT00157898|Metronidazole|metronidazole|mesh-list
110479597|NCT00785980|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110479598|NCT00785980|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110479599|NCT00785980|Antimalarials|antimalarials|mesh-ancestor
110479600|NCT00785980|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110479601|NCT00785980|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110479602|NCT00785980|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110479603|NCT00785980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110479604|NCT00785980|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110479605|NCT00785980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110479606|NCT00785980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110479607|NCT00785980|Analgesics|analgesics|mesh-ancestor
110479608|NCT00785980|Sensory System Agents|sensory system agents|mesh-ancestor
110479609|NCT04805073|Promethazine|promethazine|mesh-list
110479610|NCT04805073|Diphenhydramine|diphenhydramine|mesh-list
110479611|NCT04805073|Antipruritics|antipruritics|mesh-ancestor
110479612|NCT04805073|Dermatologic Agents|dermatologic agents|mesh-ancestor
110479613|NCT04805073|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110552151|NCT01006525|GABA Agents|gaba agents|mesh-ancestor
110479614|NCT04805073|Histamine Antagonists|histamine antagonists|mesh-ancestor
110479615|NCT04805073|Histamine Agents|histamine agents|mesh-ancestor
110479616|NCT04805073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110479617|NCT04805073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110479618|NCT04805073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110479619|NCT04805073|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110479620|NCT04805073|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110479621|NCT04805073|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110479622|NCT04805073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110479623|NCT04805073|Anesthetics, Local|anesthetics, local|mesh-ancestor
110479624|NCT04805073|Anesthetics|anesthetics|mesh-ancestor
110479625|NCT04805073|Sensory System Agents|sensory system agents|mesh-ancestor
110479626|NCT04805073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110479627|NCT04805073|Antiemetics|antiemetics|mesh-ancestor
110479628|NCT04805073|Autonomic Agents|autonomic agents|mesh-ancestor
110479629|NCT04805073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110479631|NCT00915694|Temozolomide|temozolomide|mesh-list
110552428|NCT00733564|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110479632|NCT00915694|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110479633|NCT00915694|Alkylating Agents|alkylating agents|mesh-ancestor
110479634|NCT00915694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110479635|NCT00915694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110479636|NCT00915694|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110479637|NCT00915694|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110479638|NCT00915694|Protease Inhibitors|protease inhibitors|mesh-ancestor
110479639|NCT00915694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110479640|NCT00915694|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110479641|NCT00915694|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110479642|NCT00915694|Antiviral Agents|antiviral agents|mesh-ancestor
110479643|NCT00915694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110479644|NCT02703051|Lenograstim|lenograstim|mesh-list
110479645|NCT02703051|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110479646|NCT02703051|Immunologic Factors|immunologic factors|mesh-ancestor
110479647|NCT02703051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110479649|NCT00785512|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110479650|NCT00785512|Vasodilator Agents|vasodilator agents|mesh-ancestor
110479651|NCT00785512|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
110479652|NCT00785512|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110479653|NCT00785512|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110479654|NCT00785512|Adrenergic Agents|adrenergic agents|mesh-ancestor
110479655|NCT00785512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110651613|NCT03976466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110479656|NCT00785512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110479657|NCT00785512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110479658|NCT02702817|Naproxen|naproxen|mesh-list
110479659|NCT02702817|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110479660|NCT02702817|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110479661|NCT02702817|Analgesics|analgesics|mesh-ancestor
110479662|NCT02702817|Sensory System Agents|sensory system agents|mesh-ancestor
110479663|NCT02702817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110479664|NCT02702817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110479665|NCT02702817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110479666|NCT02702817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110479667|NCT02702817|Gout Suppressants|gout suppressants|mesh-ancestor
110479668|NCT02702817|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110479669|NCT02702817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110479670|NCT02702817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110479672|NCT02702739|Sofosbuvir|sofosbuvir|mesh-list
110479673|NCT02702739|Simeprevir|simeprevir|mesh-list
110479674|NCT02702739|Antimetabolites|antimetabolites|mesh-ancestor
110479675|NCT02702739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110479676|NCT02702739|Antiviral Agents|antiviral agents|mesh-ancestor
110479677|NCT02702739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110479678|NCT02702739|Protease Inhibitors|protease inhibitors|mesh-ancestor
110479681|NCT02602444|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110479682|NCT02602444|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110479683|NCT02602444|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110479684|NCT02602444|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110479685|NCT02602444|Purinergic Agents|purinergic agents|mesh-ancestor
110479686|NCT02602444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110479687|NCT02602444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110479688|NCT02602444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110479689|NCT02702661|Anesthetics|anesthetics|mesh-list
110479690|NCT02702661|Levobupivacaine|levobupivacaine|mesh-list
110479691|NCT02702661|Anesthetics, Local|anesthetics, local|mesh-list
110479692|NCT02702661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110479693|NCT02702661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110479694|NCT02702661|Sensory System Agents|sensory system agents|mesh-ancestor
110479695|NCT02702661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110479696|NCT02702349|Penicillins|penicillins|mesh-list
110479697|NCT02702349|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110479698|NCT02702349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110479699|NCT04104334|Remifentanil|remifentanil|mesh-list
110479700|NCT04104334|Desflurane|desflurane|mesh-list
110479701|NCT04104334|Anesthetics|anesthetics|mesh-ancestor
110479702|NCT04104334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110479703|NCT04104334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110479704|NCT04104334|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110479705|NCT04104334|Narcotics|narcotics|mesh-ancestor
110479706|NCT04104334|Analgesics|analgesics|mesh-ancestor
110479707|NCT04104334|Sensory System Agents|sensory system agents|mesh-ancestor
110479708|NCT04104334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110479709|NCT04104334|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110479710|NCT04104334|Anesthetics, General|anesthetics, general|mesh-ancestor
110479711|NCT04215393|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110479712|NCT04215393|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110479713|NCT02602600|Liraglutide|liraglutide|mesh-list
110479714|NCT02602600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110479715|NCT02602600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110479716|NCT02602600|Incretins|incretins|mesh-ancestor
110479717|NCT02602600|Hormones|hormones|mesh-ancestor
110479718|NCT02602600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110479719|NCT00615615|Levetiracetam|levetiracetam|mesh-list
110479720|NCT00615615|Anticonvulsants|anticonvulsants|mesh-ancestor
110479721|NCT00615615|Nootropic Agents|nootropic agents|mesh-ancestor
110479722|NCT00784810|Acetaminophen|acetaminophen|mesh-list
110479723|NCT00784810|Oxycodone|oxycodone|mesh-list
110479724|NCT00784810|Codeine|codeine|mesh-list
110479725|NCT00784810|Naloxone|naloxone|mesh-list
110479726|NCT00784810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110479727|NCT00784810|Analgesics|analgesics|mesh-ancestor
110479728|NCT00784810|Sensory System Agents|sensory system agents|mesh-ancestor
110479729|NCT00784810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110479730|NCT00784810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110479731|NCT00784810|Antipyretics|antipyretics|mesh-ancestor
110479732|NCT00784810|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110479733|NCT00784810|Narcotics|narcotics|mesh-ancestor
110479734|NCT00784810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110479735|NCT00784810|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110479736|NCT00784810|Antitussive Agents|antitussive agents|mesh-ancestor
110479737|NCT00784810|Respiratory System Agents|respiratory system agents|mesh-ancestor
110479739|NCT02603770|L 647318|l 647318|mesh-list
110479740|NCT02603770|Dihydromevinolin|dihydromevinolin|mesh-list
110479741|NCT02603770|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110479742|NCT02603770|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110479743|NCT02603770|Antimetabolites|antimetabolites|mesh-ancestor
110479744|NCT02603770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110479745|NCT02603770|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110479746|NCT02603770|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110479747|NCT02603770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110479749|NCT04081909|Dexmedetomidine|dexmedetomidine|mesh-list
110479750|NCT04081909|Ketamine|ketamine|mesh-list
110479751|NCT04081909|Remifentanil|remifentanil|mesh-list
110553368|NCT00729118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110479752|NCT04081909|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110479753|NCT04081909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110479754|NCT04081909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110479755|NCT04081909|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110479756|NCT04081909|Analgesics|analgesics|mesh-ancestor
110479757|NCT04081909|Sensory System Agents|sensory system agents|mesh-ancestor
110479758|NCT04081909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110553517|NCT04188431|Hormones|hormones|mesh-ancestor
110479759|NCT04081909|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110479760|NCT04081909|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110479761|NCT04081909|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110479762|NCT04081909|Adrenergic Agents|adrenergic agents|mesh-ancestor
110479763|NCT04081909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110479764|NCT04081909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110479765|NCT04081909|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110479766|NCT04081909|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110479767|NCT04081909|Anesthetics, General|anesthetics, general|mesh-ancestor
110479768|NCT04081909|Anesthetics|anesthetics|mesh-ancestor
110479769|NCT04081909|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110553647|NCT03462017|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110479770|NCT04081909|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110479771|NCT04081909|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110479772|NCT04081909|Narcotics|narcotics|mesh-ancestor
110479773|NCT04081909|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110479774|NCT03272217|Bevacizumab|bevacizumab|mesh-list
110479777|NCT03272217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110479778|NCT03272217|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110479779|NCT03272217|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110479780|NCT03272217|Growth Substances|growth substances|mesh-ancestor
110479781|NCT03272217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110479782|NCT03272217|Growth Inhibitors|growth inhibitors|mesh-ancestor
110479783|NCT03272217|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110479784|NCT03272217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110479785|NCT03262701|Hydrogen Peroxide|hydrogen peroxide|mesh-list
110479786|NCT03262701|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110479787|NCT03262701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110479789|NCT00915382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110479790|NCT05344443|Lemborexant|lemborexant|mesh-list
110479791|NCT05344443|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
110479792|NCT05344443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110479793|NCT05344443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110479794|NCT05344443|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110479795|NCT05344443|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110479796|NCT05344443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110479797|NCT05344443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110479798|NCT00919555|Pioglitazone|pioglitazone|mesh-list
110479800|NCT00919555|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110479801|NCT00919555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110479802|NCT00919555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110479803|NCT00919555|Keratolytic Agents|keratolytic agents|mesh-ancestor
110479804|NCT00919555|Dermatologic Agents|dermatologic agents|mesh-ancestor
110479806|NCT02979093|Oxytocics|oxytocics|mesh-ancestor
110479807|NCT02979093|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110553836|NCT02544308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110479808|NCT02979093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110479809|NCT02588131|Durvalumab|durvalumab|mesh-list
110479810|NCT02588131|Tremelimumab|tremelimumab|mesh-list
110479811|NCT02588131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110479812|NCT02588131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110479813|NCT04766983|Dimercaprol|dimercaprol|mesh-list
110479814|NCT04766983|Chelating Agents|chelating agents|mesh-ancestor
110479815|NCT04766983|Sequestering Agents|sequestering agents|mesh-ancestor
110479816|NCT04766983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110479818|NCT04766437|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
110479819|NCT04766437|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110479820|NCT04766437|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110479821|NCT04766437|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110479822|NCT04766437|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110479823|NCT04766437|Purinergic Agents|purinergic agents|mesh-ancestor
110479824|NCT04766437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110479826|NCT04766437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110479827|NCT00776230|Vaccines|vaccines|mesh-list
110479828|NCT00776230|Immunologic Factors|immunologic factors|mesh-ancestor
110479829|NCT00776230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110479832|NCT02586259|Budesonide|budesonide|mesh-list
110479833|NCT02586259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110554042|NCT02617680|Anesthetics|anesthetics|mesh-ancestor
110479834|NCT02586259|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110479835|NCT02586259|Autonomic Agents|autonomic agents|mesh-ancestor
110479836|NCT02586259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110479837|NCT02586259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110479838|NCT02586259|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110479839|NCT02586259|Respiratory System Agents|respiratory system agents|mesh-ancestor
110479840|NCT02586259|Glucocorticoids|glucocorticoids|mesh-ancestor
110479841|NCT02586259|Hormones|hormones|mesh-ancestor
110479842|NCT02586259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110479843|NCT00775606|Ritonavir|ritonavir|mesh-list
110479844|NCT00775606|Lopinavir|lopinavir|mesh-list
110479845|NCT00775606|Efavirenz|efavirenz|mesh-list
110479846|NCT00775606|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110479847|NCT00775606|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110479848|NCT00775606|Protease Inhibitors|protease inhibitors|mesh-ancestor
110479849|NCT00775606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110479850|NCT00775606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110479851|NCT00775606|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110479852|NCT00775606|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110479853|NCT00775606|Antiviral Agents|antiviral agents|mesh-ancestor
110479854|NCT00775606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110479855|NCT00775606|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110479856|NCT00775606|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110479857|NCT00775606|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110479858|NCT00775606|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110479859|NCT00775606|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110479860|NCT00775606|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110479861|NCT00775606|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110479862|NCT00775606|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110479863|NCT00775606|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110479864|NCT04761601|Paclitaxel|paclitaxel|mesh-list
110479865|NCT04761601|Gemcitabine|gemcitabine|mesh-list
110479866|NCT04761601|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110479867|NCT04761601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110479868|NCT04761601|Tubulin Modulators|tubulin modulators|mesh-ancestor
110479869|NCT04761601|Antimitotic Agents|antimitotic agents|mesh-ancestor
110479870|NCT04761601|Mitosis Modulators|mitosis modulators|mesh-ancestor
110479871|NCT04761601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110479872|NCT04761601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110479873|NCT04761601|Antimetabolites|antimetabolites|mesh-ancestor
110479874|NCT02960763|Aripiprazole|aripiprazole|mesh-list
110479875|NCT02960763|Lithium Carbonate|lithium carbonate|mesh-list
110479876|NCT02960763|Bupropion|bupropion|mesh-list
110479877|NCT02960763|Nortriptyline|nortriptyline|mesh-list
110479878|NCT02960763|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110479879|NCT02960763|Antidepressive Agents|antidepressive agents|mesh-ancestor
110479880|NCT02960763|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110479881|NCT02960763|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110479882|NCT02960763|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110479883|NCT02960763|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110266579|NCT03370783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110479884|NCT02960763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110479885|NCT02960763|Dopamine Agents|dopamine agents|mesh-ancestor
110479886|NCT02960763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110479887|NCT02960763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110479888|NCT02960763|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110554509|NCT00597506|Bevacizumab|bevacizumab|mesh-list
110479889|NCT02960763|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110479890|NCT02960763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110479891|NCT02960763|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110479892|NCT02960763|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110479893|NCT02960763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110479894|NCT02960763|Dopamine Agonists|dopamine agonists|mesh-ancestor
110479895|NCT02960763|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110479896|NCT02960763|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110479898|NCT02960763|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110479899|NCT02960763|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110479900|NCT02960763|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110554637|NCT01936831|Pyridoxal|pyridoxal|mesh-list
110479901|NCT02960763|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110479902|NCT02960763|Antimanic Agents|antimanic agents|mesh-ancestor
110127171|NCT01948960|Everolimus|everolimus|mesh-list
110479903|NCT02960763|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110479904|NCT02960763|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110479905|NCT02960763|Adrenergic Agents|adrenergic agents|mesh-ancestor
110479906|NCT00775528|Pancrelipase|pancrelipase|mesh-list
110479907|NCT00775528|Pancreatin|pancreatin|mesh-list
110479908|NCT00775528|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110479909|NCT04977271|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
110554705|NCT01455389|Histamine Antagonists|histamine antagonists|mesh-ancestor
110479910|NCT04977271|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110479911|NCT04977271|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110479912|NCT04977271|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110479913|NCT04977271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110479914|NCT04977271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110479915|NCT04977271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110479916|NCT04977271|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110479917|NCT04977271|Antidepressive Agents|antidepressive agents|mesh-ancestor
110479918|NCT04977271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110479919|NCT02701179|Lidocaine|lidocaine|mesh-list
110479920|NCT02701179|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110479921|NCT02701179|Anesthetics, Local|anesthetics, local|mesh-ancestor
110479922|NCT02701179|Anesthetics|anesthetics|mesh-ancestor
110266611|NCT00158405|Ritonavir|ritonavir|mesh-list
110479923|NCT02701179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110479924|NCT02701179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110479925|NCT02701179|Sensory System Agents|sensory system agents|mesh-ancestor
110479926|NCT02701179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110479927|NCT02701179|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110554771|NCT00193427|Antimitotic Agents|antimitotic agents|mesh-ancestor
110479928|NCT02701179|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110479930|NCT02701179|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110479931|NCT02701179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110479932|NCT02586961|Betamethasone|betamethasone|mesh-list
110479933|NCT02586961|Betamethasone Valerate|betamethasone valerate|mesh-list
110479934|NCT02586961|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
110479935|NCT02586961|Betamethasone benzoate|betamethasone benzoate|mesh-list
110479936|NCT02586961|Epinephrine|epinephrine|mesh-list
110479937|NCT02586961|Racepinephrine|racepinephrine|mesh-list
110479938|NCT02586961|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
110479939|NCT02586961|Epinephryl borate|epinephryl borate|mesh-list
110479940|NCT02586961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110479941|NCT02586961|Glucocorticoids|glucocorticoids|mesh-ancestor
110479942|NCT02586961|Hormones|hormones|mesh-ancestor
110479943|NCT02586961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110479944|NCT02586961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110479945|NCT02586961|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110479946|NCT02586961|Respiratory System Agents|respiratory system agents|mesh-ancestor
110479947|NCT02586961|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110479948|NCT02586961|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110479949|NCT02586961|Adrenergic Agents|adrenergic agents|mesh-ancestor
110479950|NCT02586961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110479951|NCT02586961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110479952|NCT02586961|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110479953|NCT02586961|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110479954|NCT02586961|Autonomic Agents|autonomic agents|mesh-ancestor
110479955|NCT02586961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110479956|NCT02586961|Mydriatics|mydriatics|mesh-ancestor
110479957|NCT02586961|Sympathomimetics|sympathomimetics|mesh-ancestor
110479958|NCT02586961|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110479959|NCT02700711|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110479960|NCT02700711|Methylphenidate|methylphenidate|mesh-list
110479961|NCT02700711|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110479962|NCT02700711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110479963|NCT02700711|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110479964|NCT02700711|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110479965|NCT02700711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110479966|NCT02700711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110479967|NCT02700711|Dopamine Agents|dopamine agents|mesh-ancestor
110479968|NCT02700711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110479969|NCT02700711|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110479970|NCT02700711|Analgesics|analgesics|mesh-ancestor
110479971|NCT02700711|Sensory System Agents|sensory system agents|mesh-ancestor
110479972|NCT02700711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110479973|NCT02700711|Antidepressive Agents|antidepressive agents|mesh-ancestor
110479974|NCT02700711|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110479975|NCT04215159|Gemcitabine|gemcitabine|mesh-list
110479976|NCT04215159|Trastuzumab|trastuzumab|mesh-list
110479978|NCT04215159|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110479979|NCT04215159|Antimetabolites|antimetabolites|mesh-ancestor
110479980|NCT04215159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110479981|NCT04215159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110479982|NCT04215159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110479983|NCT04215159|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110479984|NCT04215159|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110479985|NCT04215159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110479987|NCT00775450|Immunologic Factors|immunologic factors|mesh-ancestor
110479988|NCT00775450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110479989|NCT02700477|Fenugreek seed meal|fenugreek seed meal|mesh-list
110479990|NCT02700477|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110479991|NCT02700477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110479992|NCT02699385|Domperidone|domperidone|mesh-list
110479993|NCT02699385|Antiemetics|antiemetics|mesh-ancestor
110479995|NCT02699385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110479996|NCT02699385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110479997|NCT02699385|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110479998|NCT02699385|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110479999|NCT02699385|Dopamine Agents|dopamine agents|mesh-ancestor
110480000|NCT02699385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110480001|NCT02699385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110480002|NCT02700087|Famotidine|famotidine|mesh-list
110480003|NCT02700087|Ranitidine|ranitidine|mesh-list
110480004|NCT02700087|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
110480005|NCT02700087|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110480006|NCT02700087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110480007|NCT02700087|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110480008|NCT02700087|Histamine Antagonists|histamine antagonists|mesh-ancestor
110480009|NCT02700087|Histamine Agents|histamine agents|mesh-ancestor
110480010|NCT02700087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110480011|NCT02700087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110480012|NCT02700087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110480013|NCT02586181|Calcium, Dietary|calcium, dietary|mesh-list
110480014|NCT02586181|Vitamin D|vitamin d|mesh-list
110480015|NCT02586181|Ergocalciferols|ergocalciferols|mesh-list
110480016|NCT02586181|Cholecalciferol|cholecalciferol|mesh-list
110480017|NCT02586181|Vitamins|vitamins|mesh-list
110480018|NCT02586181|Folic Acid|folic acid|mesh-list
110480019|NCT02586181|Calcium|calcium|mesh-list
110480020|NCT02586181|Micronutrients|micronutrients|mesh-ancestor
110480021|NCT02586181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110480022|NCT02586181|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110480023|NCT02586181|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110480024|NCT02586181|Vitamin B Complex|vitamin b complex|mesh-ancestor
110480025|NCT02586181|Hematinics|hematinics|mesh-ancestor
110480026|NCT03181035|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
110555270|NCT00662714|Insulin|insulin|mesh-list
110480027|NCT03181035|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110480028|NCT03181035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110480029|NCT00775138|Amikacin|amikacin|mesh-list
110480030|NCT00775138|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110480031|NCT00775138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110480033|NCT03236805|Morphine|morphine|mesh-list
110480034|NCT03236805|Analgesics|analgesics|mesh-ancestor
110480035|NCT03236805|Sensory System Agents|sensory system agents|mesh-ancestor
110480036|NCT03236805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110480037|NCT03236805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110480038|NCT03236805|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110555328|NCT00668330|Alfacalcidol|alfacalcidol|mesh-list
110266663|NCT05169229|Tobramycin|tobramycin|mesh-list
110480039|NCT03236805|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110480040|NCT03236805|Anesthetics, General|anesthetics, general|mesh-ancestor
110480041|NCT03236805|Anesthetics|anesthetics|mesh-ancestor
110480042|NCT03236805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110480043|NCT03236805|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110480044|NCT03236805|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110480046|NCT03236805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110480047|NCT03236805|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110555503|NCT02701127|Niacin|niacin|mesh-list
110480048|NCT03236805|Narcotics|narcotics|mesh-ancestor
110480049|NCT02698995|Acetaminophen|acetaminophen|mesh-list
110480050|NCT02698995|Dexamethasone|dexamethasone|mesh-list
110480051|NCT02698995|Lidocaine|lidocaine|mesh-list
110480052|NCT02698995|Morphine|morphine|mesh-list
110480053|NCT02698995|Ropivacaine|ropivacaine|mesh-list
110480054|NCT02698995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110480055|NCT02698995|Antiemetics|antiemetics|mesh-ancestor
110480056|NCT02698995|Autonomic Agents|autonomic agents|mesh-ancestor
110480057|NCT02698995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110480058|NCT02698995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110480059|NCT02698995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110480060|NCT02698995|Glucocorticoids|glucocorticoids|mesh-ancestor
110480061|NCT02698995|Hormones|hormones|mesh-ancestor
110480062|NCT02698995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110480063|NCT02698995|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110480064|NCT02698995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110480065|NCT02698995|Anesthetics, Local|anesthetics, local|mesh-ancestor
110480066|NCT02698995|Anesthetics|anesthetics|mesh-ancestor
110480067|NCT02698995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110480068|NCT02698995|Sensory System Agents|sensory system agents|mesh-ancestor
110480069|NCT02698995|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110480070|NCT02698995|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110480071|NCT02698995|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110555674|NCT00669812|Antiviral Agents|antiviral agents|mesh-ancestor
110480072|NCT02698995|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110480073|NCT02698995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110480074|NCT02698995|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110480076|NCT02698995|Analgesics|analgesics|mesh-ancestor
110480077|NCT02698995|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110480078|NCT02698995|Antipyretics|antipyretics|mesh-ancestor
110480079|NCT00920101|Atorvastatin|atorvastatin|mesh-list
110555742|NCT00669890|Abortifacient Agents|abortifacient agents|mesh-ancestor
110480080|NCT00920101|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110480081|NCT00920101|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110480082|NCT00920101|Antimetabolites|antimetabolites|mesh-ancestor
110651614|NCT03976466|Antitubercular Agents|antitubercular agents|mesh-ancestor
110480083|NCT00920101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110480084|NCT00920101|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110480085|NCT00920101|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110480086|NCT00920101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110480087|NCT00616785|Irinotecan|irinotecan|mesh-list
110480088|NCT00616785|Etoposide|etoposide|mesh-list
110480089|NCT00616785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110480090|NCT00616785|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110480091|NCT00616785|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110480092|NCT00616785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110480093|NCT00616785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110480094|NCT00616785|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110480095|NCT00616785|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110480097|NCT00616005|Temozolomide|temozolomide|mesh-list
110480098|NCT00616005|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110480099|NCT00616005|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110480100|NCT00616005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110480101|NCT00616005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110480102|NCT00616005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110556014|NCT01009957|Everolimus|everolimus|mesh-list
110480103|NCT00616005|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110480104|NCT00616005|Alkylating Agents|alkylating agents|mesh-ancestor
110480105|NCT02698527|Lidocaine|lidocaine|mesh-list
110556080|NCT02622906|Pasireotide|pasireotide|mesh-list
110480106|NCT02698527|Anesthetics, Local|anesthetics, local|mesh-ancestor
110480108|NCT02698527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110480109|NCT02698527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110480110|NCT02698527|Sensory System Agents|sensory system agents|mesh-ancestor
110480111|NCT02698527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110480112|NCT02698527|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110480113|NCT02698527|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110480114|NCT02698527|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110480115|NCT02698527|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110480116|NCT02698527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110480117|NCT04215237|Atorvastatin|atorvastatin|mesh-list
110480118|NCT04215237|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110480119|NCT04215237|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110480120|NCT04215237|Antimetabolites|antimetabolites|mesh-ancestor
110298822|NCT04108897|Doxycycline|doxycycline|mesh-list
110480121|NCT04215237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110480122|NCT04215237|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110480123|NCT04215237|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110480124|NCT04215237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110480125|NCT02586649|Bromides|bromides|mesh-list
110480126|NCT02586649|Tiotropium Bromide|tiotropium bromide|mesh-list
110480127|NCT02586649|Cholinergic Antagonists|cholinergic antagonists|mesh-list
110480128|NCT02586649|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110480129|NCT02586649|Autonomic Agents|autonomic agents|mesh-ancestor
110480130|NCT02586649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110480131|NCT02586649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110480132|NCT02586649|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110480133|NCT02586649|Respiratory System Agents|respiratory system agents|mesh-ancestor
110480134|NCT02586649|Parasympatholytics|parasympatholytics|mesh-ancestor
110480135|NCT02586649|Cholinergic Agents|cholinergic agents|mesh-ancestor
110480136|NCT02586649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110480137|NCT02586649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110480138|NCT02586649|Anticonvulsants|anticonvulsants|mesh-ancestor
110480139|NCT04213833|Lidocaine|lidocaine|mesh-list
110480140|NCT04213833|Dexmedetomidine|dexmedetomidine|mesh-list
110480141|NCT04213833|Propofol|propofol|mesh-list
110480142|NCT04213833|Anesthetics, Local|anesthetics, local|mesh-ancestor
110480143|NCT04213833|Anesthetics|anesthetics|mesh-ancestor
110480144|NCT04213833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110480145|NCT04213833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110480146|NCT04213833|Sensory System Agents|sensory system agents|mesh-ancestor
110480147|NCT04213833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110556497|NCT00855738|Antimanic Agents|antimanic agents|mesh-ancestor
110480148|NCT04213833|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110480149|NCT04213833|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110480150|NCT04213833|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110480151|NCT04213833|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110651615|NCT02536755|Eliglustat|eliglustat|mesh-list
110480152|NCT04213833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110480153|NCT04213833|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110480154|NCT04213833|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110480156|NCT04213833|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110480157|NCT04213833|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110480158|NCT04213833|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110556643|NCT02565862|Metformin|metformin|mesh-list
110480159|NCT04213833|Adrenergic Agents|adrenergic agents|mesh-ancestor
110480160|NCT04213833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110480161|NCT04213833|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110480162|NCT04213833|Anesthetics, General|anesthetics, general|mesh-ancestor
110480163|NCT04605991|Insulin Glargine|insulin glargine|mesh-list
110480164|NCT04605991|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110480165|NCT04605991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110480166|NCT00783796|Everolimus|everolimus|mesh-list
110480167|NCT00783796|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110480168|NCT00783796|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110480169|NCT00783796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110165995|NCT00025636|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110480170|NCT00783796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110480171|NCT00783796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110480173|NCT00783796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110480174|NCT00783796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110480175|NCT00637065|Bosentan|bosentan|mesh-list
110480176|NCT00637065|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110480177|NCT00637065|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
110480178|NCT00637065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110480179|NCT00616863|Oxcarbazepine|oxcarbazepine|mesh-list
110480180|NCT00616863|Anticonvulsants|anticonvulsants|mesh-ancestor
110480181|NCT00616863|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110480182|NCT00616863|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110480183|NCT00616863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110480184|NCT00616863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110480185|NCT00616863|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110480186|NCT00616863|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110480187|NCT04947553|Dextromethorphan|dextromethorphan|mesh-list
110480188|NCT04947553|Bupropion|bupropion|mesh-list
110480189|NCT04947553|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110480190|NCT04947553|Antidepressive Agents|antidepressive agents|mesh-ancestor
110480191|NCT04947553|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110480192|NCT04947553|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110480193|NCT04947553|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110480194|NCT04947553|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110480195|NCT04947553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110480196|NCT04947553|Dopamine Agents|dopamine agents|mesh-ancestor
110480197|NCT04947553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110480198|NCT04947553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110480199|NCT04947553|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110480200|NCT04947553|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110480201|NCT04947553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110480202|NCT04947553|Antitussive Agents|antitussive agents|mesh-ancestor
110480203|NCT04947553|Respiratory System Agents|respiratory system agents|mesh-ancestor
110480204|NCT04947553|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110480205|NCT04947553|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110480206|NCT04079647|Immunomodulating Agents|immunomodulating agents|mesh-list
110480207|NCT04079647|Immunologic Factors|immunologic factors|mesh-ancestor
110480208|NCT04079647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110480209|NCT00617253|Sunitinib|sunitinib|mesh-list
110480210|NCT00617253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110480211|NCT00617253|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110480212|NCT00617253|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110480213|NCT00617253|Growth Substances|growth substances|mesh-ancestor
110480214|NCT00617253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110480215|NCT00617253|Growth Inhibitors|growth inhibitors|mesh-ancestor
110480216|NCT00617253|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110480217|NCT00617253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110480218|NCT00617253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110480220|NCT02585947|Antiviral Agents|antiviral agents|mesh-ancestor
110557388|NCT04210739|Hormones|hormones|mesh-ancestor
110480221|NCT02585947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110480222|NCT02585947|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110266713|NCT00538486|Telmisartan|telmisartan|mesh-list
110480223|NCT02585947|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110480224|NCT02585947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110480225|NCT02585947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110480226|NCT02585947|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110480227|NCT02585947|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110480228|NCT02607891|Cannabidiol|cannabidiol|mesh-list
110480229|NCT02607891|Anticonvulsants|anticonvulsants|mesh-ancestor
110480230|NCT02607813|Spartalizumab|spartalizumab|mesh-list
110480231|NCT02607813|Naporafenib|naporafenib|mesh-list
110480232|NCT02607813|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110480233|NCT02607813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110480234|NCT02607813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110480235|NCT02607813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110480236|NCT02607813|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110480237|NCT02607813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110480239|NCT04079725|Mitomycin|mitomycin|mesh-list
110480240|NCT04079725|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110480241|NCT04079725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110480242|NCT04079725|Alkylating Agents|alkylating agents|mesh-ancestor
110557679|NCT00709215|Cordycepin|cordycepin|mesh-list
110480243|NCT04079725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110480244|NCT04079725|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110480245|NCT04079725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110480246|NCT00783718|Vedolizumab|vedolizumab|mesh-list
110480247|NCT00783718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110480248|NCT04213287|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
110480249|NCT04213287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110480250|NCT04213287|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110480251|NCT04213287|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110480252|NCT04213287|Analgesics|analgesics|mesh-ancestor
110480253|NCT04213287|Sensory System Agents|sensory system agents|mesh-ancestor
110480254|NCT04213287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110480255|NCT04213287|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110480256|NCT04213287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110480257|NCT02585791|Glycerol|glycerol|mesh-list
110480258|NCT02585791|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
110480259|NCT02585791|Protective Agents|protective agents|mesh-ancestor
110480260|NCT02585791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110480261|NCT04913389|Acetazolamide|acetazolamide|mesh-list
110480262|NCT04913389|Anticonvulsants|anticonvulsants|mesh-ancestor
110480263|NCT04913389|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110480264|NCT04913389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110480265|NCT04913389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110480266|NCT04913389|Diuretics|diuretics|mesh-ancestor
110480267|NCT04913389|Natriuretic Agents|natriuretic agents|mesh-ancestor
110480268|NCT04913389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110480269|NCT04904965|Propofol|propofol|mesh-list
110480270|NCT04904965|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110480271|NCT04904965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110557805|NCT00622115|Enoxaparin|enoxaparin|mesh-list
110480272|NCT04904965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110480273|NCT04904965|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110480274|NCT04904965|Anesthetics, General|anesthetics, general|mesh-ancestor
110480275|NCT04904965|Anesthetics|anesthetics|mesh-ancestor
110480276|NCT00617565|Insulin|insulin|mesh-list
110480277|NCT00617565|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110480278|NCT00617565|Insulin Aspart|insulin aspart|mesh-list
110480279|NCT00617565|Biphasic Insulins|biphasic insulins|mesh-list
110480280|NCT00617565|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110480281|NCT00617565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110480282|NCT04079413|Insulin|insulin|mesh-list
110480283|NCT04079413|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110480284|NCT04079413|Insulin Aspart|insulin aspart|mesh-list
110480285|NCT04079413|Insulin, Long-Acting|insulin, long-acting|mesh-list
110480286|NCT04079413|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
110480287|NCT04079413|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110480288|NCT04079413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110480289|NCT00915460|Interferons|interferons|mesh-list
110480290|NCT00915460|Interferon-beta|interferon-beta|mesh-list
110480291|NCT00915460|Interferon beta-1a|interferon beta-1a|mesh-list
110480292|NCT00915460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110480293|NCT00915460|Antiviral Agents|antiviral agents|mesh-ancestor
110480300|NCT00617643|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110480302|NCT00617643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110480303|NCT00617643|Antiviral Agents|antiviral agents|mesh-ancestor
110480304|NCT00617643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110480305|NCT00617643|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110480306|NCT00617643|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110480307|NCT00617643|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110480308|NCT00617643|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110480309|NCT02584075|Metformin|metformin|mesh-list
110480310|NCT02584075|Exenatide|exenatide|mesh-list
110480311|NCT02584075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110480312|NCT02584075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110480313|NCT02584075|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110480314|NCT02584075|Incretins|incretins|mesh-ancestor
110480315|NCT02584075|Hormones|hormones|mesh-ancestor
110480316|NCT02584075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110480317|NCT02585479|Oxaliplatin|oxaliplatin|mesh-list
110480318|NCT02585479|Ethiodized Oil|ethiodized oil|mesh-list
110480319|NCT02585479|Pirarubicin|pirarubicin|mesh-list
110480320|NCT02585479|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
110480321|NCT02585479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110480322|NCT02585479|Hemostatics|hemostatics|mesh-ancestor
110480323|NCT02585479|Coagulants|coagulants|mesh-ancestor
110480324|NCT00583453|Celecoxib|celecoxib|mesh-list
110480325|NCT00583453|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110558044|NCT00819585|Antioxidants|antioxidants|mesh-ancestor
110480326|NCT00583453|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110480327|NCT00583453|Analgesics|analgesics|mesh-ancestor
110480328|NCT00583453|Sensory System Agents|sensory system agents|mesh-ancestor
110480329|NCT00583453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110480330|NCT00583453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110480331|NCT00583453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110480332|NCT00583453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110480333|NCT00583453|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110480334|NCT00583453|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110480335|NCT00583453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110480336|NCT00583453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110480337|NCT02584231|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
110480338|NCT02584231|Hemostatics|hemostatics|mesh-ancestor
110480339|NCT02584231|Coagulants|coagulants|mesh-ancestor
110480340|NCT02584231|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
110480341|NCT02584231|Natriuretic Agents|natriuretic agents|mesh-ancestor
110480342|NCT02584231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110480343|NCT04630873|Botulinum Toxins|botulinum toxins|mesh-list
110480344|NCT04630873|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110480345|NCT04630873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110480346|NCT04630873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110480347|NCT04630873|Cholinergic Agents|cholinergic agents|mesh-ancestor
110480348|NCT04630873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110480349|NCT04630873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110480350|NCT02584153|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
110480351|NCT02584153|Hemostatics|hemostatics|mesh-ancestor
110480352|NCT02584153|Coagulants|coagulants|mesh-ancestor
110480353|NCT02585401|Aflibercept|aflibercept|mesh-list
110480354|NCT02585401|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110480355|NCT02585401|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110480356|NCT02585401|Growth Substances|growth substances|mesh-ancestor
110480357|NCT02585401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110480358|NCT02585401|Growth Inhibitors|growth inhibitors|mesh-ancestor
110480359|NCT02585401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110480367|NCT04873453|Cannabidiol|cannabidiol|mesh-list
110480368|NCT04873453|Anticonvulsants|anticonvulsants|mesh-ancestor
110480369|NCT04080349|Misoprostol|misoprostol|mesh-list
110480370|NCT04080349|Dinoprostone|dinoprostone|mesh-list
110558383|NCT00682136|Ropivacaine|ropivacaine|mesh-list
110480371|NCT04080349|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110480372|NCT04080349|Abortifacient Agents|abortifacient agents|mesh-ancestor
110480373|NCT04080349|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110480374|NCT04080349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110480375|NCT04080349|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110480376|NCT04080349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110480377|NCT04080349|Oxytocics|oxytocics|mesh-ancestor
110480378|NCT02585011|Epinephrine|epinephrine|mesh-list
110480379|NCT02585011|Ropivacaine|ropivacaine|mesh-list
110480380|NCT02585011|Anesthetics, Local|anesthetics, local|mesh-ancestor
110480381|NCT02585011|Anesthetics|anesthetics|mesh-ancestor
110480382|NCT02585011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110480383|NCT02585011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110480384|NCT02585011|Sensory System Agents|sensory system agents|mesh-ancestor
110480385|NCT02585011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110480386|NCT02585011|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110480387|NCT02585011|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110480388|NCT02585011|Adrenergic Agents|adrenergic agents|mesh-ancestor
110480389|NCT02585011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110166015|NCT00025636|Antimitotic Agents|antimitotic agents|mesh-ancestor
110480390|NCT02585011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110480391|NCT02585011|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110480392|NCT02585011|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110480393|NCT02585011|Autonomic Agents|autonomic agents|mesh-ancestor
110480394|NCT02585011|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110480395|NCT02585011|Respiratory System Agents|respiratory system agents|mesh-ancestor
110480396|NCT02585011|Mydriatics|mydriatics|mesh-ancestor
110480397|NCT02585011|Sympathomimetics|sympathomimetics|mesh-ancestor
110480398|NCT02585011|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110480399|NCT00920725|Insulin|insulin|mesh-list
110480400|NCT00920725|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110480402|NCT00920725|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110480403|NCT00920725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110480404|NCT02583451|Lemborexant|lemborexant|mesh-list
110480405|NCT02583451|Zopiclone|zopiclone|mesh-list
110480406|NCT02583451|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
110480407|NCT02583451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110480408|NCT02583451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110480409|NCT02583451|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110480410|NCT02583451|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110480411|NCT02583451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110480412|NCT02583451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110480413|NCT05435911|Propofol|propofol|mesh-list
110480414|NCT05435911|Flumazenil|flumazenil|mesh-list
110480415|NCT05435911|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110480416|NCT05435911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110651616|NCT02536755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110480417|NCT05435911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110480418|NCT05435911|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110480419|NCT05435911|Anesthetics, General|anesthetics, general|mesh-ancestor
110480420|NCT05435911|Anesthetics|anesthetics|mesh-ancestor
110480421|NCT05435911|Antidotes|antidotes|mesh-ancestor
110480422|NCT05435911|Protective Agents|protective agents|mesh-ancestor
110480423|NCT05435911|GABA Modulators|gaba modulators|mesh-ancestor
110480424|NCT05435911|GABA Agents|gaba agents|mesh-ancestor
110480425|NCT05435911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110480426|NCT05435911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110480427|NCT04472299|Ropivacaine|ropivacaine|mesh-list
110480428|NCT04472299|Anesthetics, Local|anesthetics, local|mesh-ancestor
110480429|NCT04472299|Anesthetics|anesthetics|mesh-ancestor
110480430|NCT04472299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110480431|NCT04472299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110480432|NCT04472299|Sensory System Agents|sensory system agents|mesh-ancestor
110480433|NCT04472299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110480434|NCT02583685|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110480435|NCT02583685|Interferon-alpha|interferon-alpha|mesh-list
110480436|NCT02583685|Ribavirin|ribavirin|mesh-list
110480437|NCT02583685|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
110480438|NCT02583685|Simeprevir|simeprevir|mesh-list
110480439|NCT02583685|Antiviral Agents|antiviral agents|mesh-ancestor
110480440|NCT02583685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110480441|NCT02583685|Immunologic Factors|immunologic factors|mesh-ancestor
110480442|NCT02583685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110480443|NCT02583685|Antimetabolites|antimetabolites|mesh-ancestor
110480444|NCT02583685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110480445|NCT02583685|Protease Inhibitors|protease inhibitors|mesh-ancestor
110480446|NCT02583685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110480447|NCT04606771|Osimertinib|osimertinib|mesh-list
110480448|NCT04606771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110480449|NCT04606771|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110480450|NCT04606771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110558981|NCT00684164|Conivaptan|conivaptan|mesh-list
110480451|NCT04606771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110480453|NCT04504123|Doxycycline|doxycycline|mesh-list
110480454|NCT04504123|Tetracycline|tetracycline|mesh-list
110480455|NCT04504123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110480456|NCT04504123|Antimalarials|antimalarials|mesh-ancestor
110480457|NCT04504123|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110480458|NCT04504123|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110480459|NCT04504123|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110480460|NCT04504123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110480461|NCT04504123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110480463|NCT02584543|Immunologic Factors|immunologic factors|mesh-ancestor
110480464|NCT02584543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110480465|NCT04077853|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
110559048|NCT00696566|Rifampin|rifampin|mesh-list
110480467|NCT04077853|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110480468|NCT04077853|Hormone Antagonists|hormone antagonists|mesh-ancestor
110480469|NCT04077853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110480470|NCT04077853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110480471|NCT04077853|Progestins|progestins|mesh-ancestor
110480472|NCT04077853|Hormones|hormones|mesh-ancestor
110480474|NCT04502407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110480475|NCT00583219|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110480476|NCT00583219|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110480477|NCT00583219|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
110480478|NCT00583219|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110559187|NCT01014793|Cabergoline|cabergoline|mesh-list
110480479|NCT00583219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110480480|NCT00583219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110480481|NCT00583219|Cholinergic Agents|cholinergic agents|mesh-ancestor
110480482|NCT00583219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110480483|NCT00583219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110480484|NCT00583219|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
110480485|NCT00583219|Protective Agents|protective agents|mesh-ancestor
110480486|NCT00583219|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110480487|NCT00583219|Antioxidants|antioxidants|mesh-ancestor
110480488|NCT00583219|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110480489|NCT00583219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110480490|NCT04501939|Venetoclax|venetoclax|mesh-list
110480491|NCT04501939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110480492|NCT05674669|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
110480493|NCT05674669|Hallucinogens|hallucinogens|mesh-ancestor
110480494|NCT05674669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110480495|NCT05674669|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110480496|NCT05674669|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110480497|NCT05674669|Serotonin Agents|serotonin agents|mesh-ancestor
110480498|NCT05674669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110480499|NCT05674669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110480500|NCT05674669|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110480501|NCT02581501|Gemcitabine|gemcitabine|mesh-list
110480502|NCT02581501|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110480503|NCT02581501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110480504|NCT02581501|Antimetabolites|antimetabolites|mesh-ancestor
110480505|NCT02581501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110480506|NCT02581501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110480507|NCT01072175|Trametinib|trametinib|mesh-list
110480508|NCT01072175|Dabrafenib|dabrafenib|mesh-list
110480509|NCT01072175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110480510|NCT01072175|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110480511|NCT01072175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110480512|NCT01072175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110480513|NCT04078711|Losartan|losartan|mesh-list
110480514|NCT04078711|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110480515|NCT04078711|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110480516|NCT04078711|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110480517|NCT04078711|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110480518|NCT04078711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110480520|NCT04304573|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110480521|NCT04304573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110480522|NCT04426669|Aldesleukin|aldesleukin|mesh-list
110480523|NCT04426669|Cyclophosphamide|cyclophosphamide|mesh-list
110480524|NCT04426669|Fludarabine|fludarabine|mesh-list
110480525|NCT04426669|Interleukin-2|interleukin-2|mesh-list
110480526|NCT04426669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110480527|NCT04426669|Immunologic Factors|immunologic factors|mesh-ancestor
110480528|NCT04426669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110480529|NCT04426669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110480530|NCT04426669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110480531|NCT04426669|Alkylating Agents|alkylating agents|mesh-ancestor
110166025|NCT00025792|Pramipexole|pramipexole|mesh-list
110480532|NCT04426669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110480534|NCT04426669|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110480535|NCT04426669|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110480536|NCT04426669|Analgesics|analgesics|mesh-ancestor
110480537|NCT04426669|Sensory System Agents|sensory system agents|mesh-ancestor
110480538|NCT04426669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110480539|NCT04426669|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110480540|NCT04426669|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110480541|NCT04426669|Antiviral Agents|antiviral agents|mesh-ancestor
110480542|NCT04426669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110480544|NCT02874989|Quercetin|quercetin|mesh-list
110480545|NCT02874989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110480546|NCT02874989|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110480547|NCT02874989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110480548|NCT02874989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110480549|NCT02874989|Antioxidants|antioxidants|mesh-ancestor
110480550|NCT02874989|Protective Agents|protective agents|mesh-ancestor
110480551|NCT02874989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110480552|NCT01071317|Naproxen|naproxen|mesh-list
110480553|NCT01071317|Sumatriptan|sumatriptan|mesh-list
110266779|NCT00538720|Micronutrients|micronutrients|mesh-ancestor
110480554|NCT01071317|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110480555|NCT01071317|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110480556|NCT01071317|Analgesics|analgesics|mesh-ancestor
110480557|NCT01071317|Sensory System Agents|sensory system agents|mesh-ancestor
110480558|NCT01071317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110480559|NCT01071317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110480560|NCT01071317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110480561|NCT01071317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110559494|NCT00603239|Exenatide|exenatide|mesh-list
110480562|NCT01071317|Gout Suppressants|gout suppressants|mesh-ancestor
110480563|NCT01071317|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110480564|NCT01071317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110480565|NCT01071317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110480566|NCT01071317|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110480567|NCT01071317|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110480568|NCT01071317|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110480569|NCT01071317|Serotonin Agents|serotonin agents|mesh-ancestor
110480570|NCT01071317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110480572|NCT00783094|Vasodilator Agents|vasodilator agents|mesh-ancestor
110480573|NCT00783094|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110559527|NCT00639587|Histamine Agents|histamine agents|mesh-ancestor
110480574|NCT00783094|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110480575|NCT00783094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110480576|NCT00783094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110480577|NCT00783094|Urological Agents|urological agents|mesh-ancestor
110127853|NCT05875571|Ketorolac|ketorolac|mesh-list
110480578|NCT00790582|Lithium Carbonate|lithium carbonate|mesh-list
110480579|NCT00790582|Antidepressive Agents|antidepressive agents|mesh-ancestor
110480580|NCT00790582|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110480581|NCT00790582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110480582|NCT00790582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110480583|NCT00790582|Antimanic Agents|antimanic agents|mesh-ancestor
110480584|NCT00790582|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110480585|NCT00790582|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110480586|NCT00790582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110480588|NCT02583217|Remifentanil|remifentanil|mesh-list
110480589|NCT02583217|Propofol|propofol|mesh-list
110480590|NCT02583217|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110480591|NCT02583217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110480592|NCT02583217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110480593|NCT02583217|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110480594|NCT02583217|Anesthetics, General|anesthetics, general|mesh-ancestor
110480595|NCT02583217|Anesthetics|anesthetics|mesh-ancestor
110480596|NCT02583217|Analgesics|analgesics|mesh-ancestor
110480597|NCT02583217|Sensory System Agents|sensory system agents|mesh-ancestor
110480598|NCT02583217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110480599|NCT02583217|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110480600|NCT02583217|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110480601|NCT02583217|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110480602|NCT02583217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110480603|NCT02583217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110480605|NCT02583217|Narcotics|narcotics|mesh-ancestor
110480606|NCT00774046|Cytarabine|cytarabine|mesh-list
110480607|NCT00774046|Etoposide|etoposide|mesh-list
110480608|NCT00774046|Mitoxantrone|mitoxantrone|mesh-list
110480609|NCT00774046|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110480610|NCT00774046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110480611|NCT00774046|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110480612|NCT00774046|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110480613|NCT00774046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110480614|NCT00774046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110480615|NCT00774046|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110480616|NCT00774046|Antimetabolites|antimetabolites|mesh-ancestor
110559739|NCT00593606|Rotigotine|rotigotine|mesh-list
110480617|NCT00774046|Antiviral Agents|antiviral agents|mesh-ancestor
110480618|NCT00774046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110480619|NCT00774046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110480620|NCT00774046|Immunologic Factors|immunologic factors|mesh-ancestor
110480621|NCT00774046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110480623|NCT00774046|Sensory System Agents|sensory system agents|mesh-ancestor
110480624|NCT00774046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110480625|NCT01046903|Dalteparin|dalteparin|mesh-list
110480626|NCT01046903|Tinzaparin|tinzaparin|mesh-list
110480627|NCT01046903|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
110480628|NCT01046903|Anticoagulants|anticoagulants|mesh-ancestor
110480629|NCT01046903|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110480630|NCT01046903|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110480631|NCT01046903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110480632|NCT02581423|Capecitabine|capecitabine|mesh-list
110480633|NCT02581423|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110480634|NCT02581423|Antimetabolites|antimetabolites|mesh-ancestor
110480635|NCT02581423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110480636|NCT02581423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110480637|NCT04102072|Dobutamine|dobutamine|mesh-list
110480638|NCT04102072|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110480639|NCT04102072|Sympathomimetics|sympathomimetics|mesh-ancestor
110480640|NCT04102072|Autonomic Agents|autonomic agents|mesh-ancestor
110480641|NCT04102072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110480642|NCT04102072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110480643|NCT04102072|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
110480644|NCT04102072|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110480645|NCT04102072|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110480646|NCT04102072|Adrenergic Agents|adrenergic agents|mesh-ancestor
110480647|NCT04102072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110480648|NCT04102072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110480649|NCT04102072|Protective Agents|protective agents|mesh-ancestor
110480650|NCT02875457|Cisplatin|cisplatin|mesh-list
110480651|NCT02875457|Etoposide|etoposide|mesh-list
110480652|NCT02875457|Etoposide phosphate|etoposide phosphate|mesh-list
110480653|NCT02875457|Apatinib|apatinib|mesh-list
110480654|NCT02875457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110480655|NCT02875457|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110480656|NCT02875457|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110559767|NCT04134416|Nootropic Agents|nootropic agents|mesh-ancestor
110480657|NCT02875457|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110480658|NCT02875457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110480659|NCT02875457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110480660|NCT02875457|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110480661|NCT00773968|Epoetin Alfa|epoetin alfa|mesh-list
110480662|NCT00773968|Hematinics|hematinics|mesh-ancestor
110480663|NCT04060381|Ibuprofen|ibuprofen|mesh-list
110480664|NCT04060381|Dopamine|dopamine|mesh-list
110480665|NCT04060381|Epinephrine|epinephrine|mesh-list
110480666|NCT04060381|Norepinephrine|norepinephrine|mesh-list
110480667|NCT04060381|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110480668|NCT04060381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110480669|NCT04060381|Analgesics|analgesics|mesh-ancestor
110480670|NCT04060381|Sensory System Agents|sensory system agents|mesh-ancestor
110480671|NCT04060381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110480672|NCT04060381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110480673|NCT04060381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110480674|NCT04060381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110480675|NCT04060381|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110480676|NCT04060381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110480677|NCT04060381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110480678|NCT04060381|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110480679|NCT04060381|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110559803|NCT00870194|Hormones|hormones|mesh-ancestor
110480680|NCT04060381|Adrenergic Agents|adrenergic agents|mesh-ancestor
110480681|NCT04060381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110480682|NCT04060381|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110480683|NCT04060381|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110480684|NCT04060381|Autonomic Agents|autonomic agents|mesh-ancestor
110480685|NCT04060381|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110480686|NCT04060381|Respiratory System Agents|respiratory system agents|mesh-ancestor
110480687|NCT04060381|Mydriatics|mydriatics|mesh-ancestor
110480688|NCT04060381|Sympathomimetics|sympathomimetics|mesh-ancestor
110480689|NCT04060381|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110480690|NCT04060381|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110480691|NCT04060381|Dopamine Agents|dopamine agents|mesh-ancestor
110480692|NCT04060381|Protective Agents|protective agents|mesh-ancestor
110480693|NCT00782626|Everolimus|everolimus|mesh-list
110480694|NCT00782626|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110480695|NCT00782626|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110480696|NCT00782626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110480697|NCT00782626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110480698|NCT00782626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110480699|NCT00782626|Immunologic Factors|immunologic factors|mesh-ancestor
110480700|NCT00782626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110480701|NCT00782626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110480702|NCT04076371|Olanzapine|olanzapine|mesh-list
110480703|NCT04076371|Risperidone|risperidone|mesh-list
110480704|NCT04076371|Paliperidone Palmitate|paliperidone palmitate|mesh-list
110480705|NCT04076371|Ziprasidone|ziprasidone|mesh-list
110480706|NCT04076371|Sertraline|sertraline|mesh-list
110480707|NCT04076371|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110480708|NCT04076371|Serotonin Agents|serotonin agents|mesh-ancestor
110480709|NCT04076371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110480710|NCT04076371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110480711|NCT04076371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110480712|NCT04076371|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110480713|NCT04076371|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110480714|NCT04076371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110480715|NCT04076371|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110480716|NCT04076371|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110480717|NCT04076371|Dopamine Agents|dopamine agents|mesh-ancestor
110480718|NCT04076371|Antiemetics|antiemetics|mesh-ancestor
110480719|NCT04076371|Autonomic Agents|autonomic agents|mesh-ancestor
110480720|NCT04076371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110480721|NCT04076371|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110480722|NCT04076371|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110480723|NCT04076371|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110480724|NCT04076371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110480725|NCT04076371|Antidepressive Agents|antidepressive agents|mesh-ancestor
110266827|NCT00537121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110480726|NCT04076371|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110480727|NCT04076371|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110480728|NCT01071083|Interferons|interferons|mesh-list
110480729|NCT01071083|Interferon-beta|interferon-beta|mesh-list
110480730|NCT01071083|Interferon beta-1a|interferon beta-1a|mesh-list
110480732|NCT01071083|Glatiramer Acetate|glatiramer acetate|mesh-list
110480733|NCT01071083|Natalizumab|natalizumab|mesh-list
110480734|NCT01071083|(T,G)-A-L|(t,g)-a-l|mesh-list
110480735|NCT01071083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110480736|NCT01071083|Antiviral Agents|antiviral agents|mesh-ancestor
110480737|NCT01071083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110480738|NCT01071083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110480739|NCT01071083|Antiemetics|antiemetics|mesh-ancestor
110480740|NCT01071083|Autonomic Agents|autonomic agents|mesh-ancestor
110480741|NCT01071083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110480742|NCT01071083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110480743|NCT01071083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110480744|NCT01071083|Glucocorticoids|glucocorticoids|mesh-ancestor
110480745|NCT01071083|Hormones|hormones|mesh-ancestor
110480746|NCT01071083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110480747|NCT01071083|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110480748|NCT01071083|Protective Agents|protective agents|mesh-ancestor
110480749|NCT01071083|Immunologic Factors|immunologic factors|mesh-ancestor
110559957|NCT02619032|Fentanyl|fentanyl|mesh-list
110480750|NCT01071083|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110480751|NCT01071083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110480752|NCT01071083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110480758|NCT03968341|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110480759|NCT03968341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110480760|NCT04078399|Interferons|interferons|mesh-list
110480761|NCT04078399|Azacitidine|azacitidine|mesh-list
110480762|NCT04078399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110480763|NCT04078399|Antiviral Agents|antiviral agents|mesh-ancestor
110480764|NCT04078399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110480765|NCT04078399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110480766|NCT04078399|Antimetabolites|antimetabolites|mesh-ancestor
110480767|NCT04078399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110480768|NCT04078399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110480769|NCT05189509|Plasminogen|plasminogen|mesh-list
110480770|NCT05189509|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
110480771|NCT05189509|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110480772|NCT05189509|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110266868|NCT00158990|Sertraline|sertraline|mesh-list
110480773|NCT05189509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110559995|NCT00862082|Alkylating Agents|alkylating agents|mesh-ancestor
110480774|NCT03897751|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110480776|NCT01010126|Bevacizumab|bevacizumab|mesh-list
110480777|NCT01010126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110480778|NCT01010126|Temsirolimus|temsirolimus|mesh-list
110480779|NCT01010126|MTOR Inhibitors|mtor inhibitors|mesh-list
110480780|NCT01010126|Endothelial Growth Factors|endothelial growth factors|mesh-list
110480781|NCT01010126|Antibodies|antibodies|mesh-list
110480782|NCT01010126|Immunoglobulins|immunoglobulins|mesh-list
110480783|NCT01010126|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110480784|NCT01010126|Immunoglobulin G|immunoglobulin g|mesh-list
110480785|NCT01010126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110480786|NCT01010126|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110480787|NCT01010126|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110480788|NCT01010126|Growth Substances|growth substances|mesh-ancestor
110480789|NCT01010126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110480790|NCT01010126|Growth Inhibitors|growth inhibitors|mesh-ancestor
110480791|NCT01010126|Immunologic Factors|immunologic factors|mesh-ancestor
110480792|NCT01010126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110480793|NCT01010126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110480794|NCT01010126|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110480795|NCT01010126|Antifungal Agents|antifungal agents|mesh-ancestor
110480796|NCT01010126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110480797|NCT01010126|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110480798|NCT01010126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110480799|NCT01010126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110480800|NCT04076137|Decitabine|decitabine|mesh-list
110480801|NCT04076137|Antibodies|antibodies|mesh-list
110480802|NCT04076137|Antibodies, Bispecific|antibodies, bispecific|mesh-list
110480803|NCT04076137|Immunologic Factors|immunologic factors|mesh-ancestor
110166058|NCT00026104|Antimetabolites|antimetabolites|mesh-ancestor
110480804|NCT04076137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110480805|NCT04076137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110480806|NCT04076137|Antimetabolites|antimetabolites|mesh-ancestor
110128065|NCT05860439|Polidocanol|polidocanol|mesh-list
110480807|NCT04076137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110480808|NCT04076137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110480811|NCT03879577|Docetaxel|docetaxel|mesh-list
110480812|NCT03879577|Trastuzumab|trastuzumab|mesh-list
110480813|NCT03879577|Letrozole|letrozole|mesh-list
110480814|NCT03879577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110480815|NCT03879577|Tubulin Modulators|tubulin modulators|mesh-ancestor
110480816|NCT03879577|Antimitotic Agents|antimitotic agents|mesh-ancestor
110480817|NCT03879577|Mitosis Modulators|mitosis modulators|mesh-ancestor
110480818|NCT03879577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110480819|NCT03879577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110480820|NCT03879577|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110480821|NCT03879577|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110480822|NCT03879577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110480823|NCT03879577|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110480824|NCT03879577|Hormone Antagonists|hormone antagonists|mesh-ancestor
110480825|NCT03879577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110403544|NCT04615403|Travoprost|travoprost|mesh-list
110480826|NCT03879577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110480827|NCT03879577|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110480828|NCT03879577|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110480829|NCT03879577|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110480830|NCT03879577|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110480831|NCT00617799|Aldesleukin|aldesleukin|mesh-list
110480832|NCT00617799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110480833|NCT00617799|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110480834|NCT00617799|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110480835|NCT00617799|Antiviral Agents|antiviral agents|mesh-ancestor
110480836|NCT00617799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110480838|NCT00617877|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110480839|NCT00617877|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110480840|NCT00617877|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110480841|NCT00617877|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110480842|NCT00617877|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110480843|NCT00617877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110480845|NCT00617877|Natriuretic Agents|natriuretic agents|mesh-ancestor
110480846|NCT00617877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110480847|NCT00617877|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110480848|NCT00617877|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110480849|NCT00617955|Aprotinin|aprotinin|mesh-list
110480850|NCT00617955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110480851|NCT00617955|Hemostatics|hemostatics|mesh-ancestor
110480852|NCT00617955|Coagulants|coagulants|mesh-ancestor
110480853|NCT00617955|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
110480854|NCT00617955|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110480855|NCT00617955|Protease Inhibitors|protease inhibitors|mesh-ancestor
110480856|NCT00617955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110480857|NCT02582437|Analgesics, Opioid|analgesics, opioid|mesh-list
110480858|NCT02582437|Narcotics|narcotics|mesh-ancestor
110480859|NCT02582437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110480860|NCT02582437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110480861|NCT02582437|Analgesics|analgesics|mesh-ancestor
110480862|NCT02582437|Sensory System Agents|sensory system agents|mesh-ancestor
110480863|NCT02582437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110480864|NCT05674201|Dexmedetomidine|dexmedetomidine|mesh-list
110480865|NCT05674201|Remifentanil|remifentanil|mesh-list
110480866|NCT05674201|Propofol|propofol|mesh-list
110480867|NCT05674201|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110480868|NCT05674201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110480869|NCT05674201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110683093|NCT03986008|Hormones|hormones|mesh-ancestor
110480870|NCT05674201|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110480871|NCT05674201|Analgesics|analgesics|mesh-ancestor
110480872|NCT05674201|Sensory System Agents|sensory system agents|mesh-ancestor
110480873|NCT05674201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110166061|NCT00026143|Interferon alpha-2|interferon alpha-2|mesh-list
110480874|NCT05674201|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110480875|NCT05674201|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110480876|NCT05674201|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110128139|NCT05775809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110128140|NCT05775809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110128141|NCT05775809|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110128142|NCT05775809|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110128162|NCT05698407|Dsuvia|dsuvia|mesh-list
110480877|NCT05674201|Adrenergic Agents|adrenergic agents|mesh-ancestor
110266909|NCT00159107|Acamprosate|acamprosate|mesh-list
110480878|NCT05674201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110480879|NCT05674201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110480880|NCT05674201|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110480881|NCT05674201|Anesthetics, General|anesthetics, general|mesh-ancestor
110480882|NCT05674201|Anesthetics|anesthetics|mesh-ancestor
110480883|NCT05674201|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110480884|NCT05674201|Narcotics|narcotics|mesh-ancestor
110480885|NCT01070303|Adalimumab|adalimumab|mesh-list
110480886|NCT01070303|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110480887|NCT01070303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110480888|NCT01070303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110480890|NCT00618111|Antiemetics|antiemetics|mesh-ancestor
110480891|NCT00618111|Autonomic Agents|autonomic agents|mesh-ancestor
110480892|NCT00618111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110480893|NCT00618111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110480894|NCT00618111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110480895|NCT00618111|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110480896|NCT00618111|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110480897|NCT00618111|Serotonin Agents|serotonin agents|mesh-ancestor
110480898|NCT00618111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110480899|NCT00618111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110480901|NCT01009814|Fostemsavir|fostemsavir|mesh-list
110480902|NCT01009814|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110480903|NCT01009814|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110480904|NCT01009814|Protease Inhibitors|protease inhibitors|mesh-ancestor
110480905|NCT01009814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110480906|NCT01009814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110480907|NCT01009814|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110480908|NCT01009814|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110480909|NCT01009814|Antiviral Agents|antiviral agents|mesh-ancestor
110480910|NCT01009814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110480911|NCT01009814|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110480912|NCT01009814|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110480913|NCT01009814|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110480914|NCT01009814|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110480915|NCT03824587|Calcium, Dietary|calcium, dietary|mesh-list
110480916|NCT03824587|Calcium Carbonate|calcium carbonate|mesh-list
110480917|NCT03824587|Calcium|calcium|mesh-list
110480918|NCT03824587|Sevelamer|sevelamer|mesh-list
110480919|NCT03824587|Calcium acetate|calcium acetate|mesh-list
110480920|NCT03824587|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110480921|NCT03824587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110480922|NCT03824587|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110480923|NCT03824587|Chelating Agents|chelating agents|mesh-ancestor
110480924|NCT03824587|Sequestering Agents|sequestering agents|mesh-ancestor
110266937|NCT00159146|Pindolol|pindolol|mesh-list
110480925|NCT03824587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110480926|NCT03824587|Antacids|antacids|mesh-ancestor
110480927|NCT03824587|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110480928|NCT00773734|Thalidomide|thalidomide|mesh-list
110480929|NCT00773734|Apremilast|apremilast|mesh-list
110480930|NCT00773734|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110480931|NCT00773734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110480932|NCT00773734|Analgesics|analgesics|mesh-ancestor
110480933|NCT00773734|Sensory System Agents|sensory system agents|mesh-ancestor
110480934|NCT00773734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110480935|NCT00773734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110480936|NCT00773734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110480937|NCT00773734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110480938|NCT00773734|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
110480939|NCT00773734|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110480940|NCT00773734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110480941|NCT00773734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110480942|NCT00773734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110128213|NCT05574712|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110128214|NCT05574712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110128215|NCT05574712|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110480943|NCT00773734|Immunologic Factors|immunologic factors|mesh-ancestor
110128216|NCT05574712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110128217|NCT05574712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110683349|NCT00338728|Letrozole|letrozole|mesh-list
110128218|NCT05574712|Hormone Antagonists|hormone antagonists|mesh-ancestor
110480944|NCT00773734|Leprostatic Agents|leprostatic agents|mesh-ancestor
110480945|NCT00773734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110480946|NCT00773734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110480947|NCT00773734|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110480948|NCT00773734|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110480949|NCT00773734|Growth Substances|growth substances|mesh-ancestor
110480950|NCT00773734|Growth Inhibitors|growth inhibitors|mesh-ancestor
110480951|NCT00773734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110480953|NCT04297202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110480954|NCT04297202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110480955|NCT04297202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110480956|NCT04297202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110480957|NCT02691897|Melatonin|melatonin|mesh-list
110480958|NCT02691897|Antioxidants|antioxidants|mesh-ancestor
110480959|NCT02691897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110480960|NCT02691897|Protective Agents|protective agents|mesh-ancestor
110480961|NCT02691897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110480962|NCT02691897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110480963|NCT03067155|Antiviral Agents|antiviral agents|mesh-list
110480964|NCT03067155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110480965|NCT01009580|Insulin|insulin|mesh-list
110480966|NCT01009580|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110480967|NCT01009580|Insulin Aspart|insulin aspart|mesh-list
110480968|NCT01009580|Insulin, Long-Acting|insulin, long-acting|mesh-list
110480969|NCT01009580|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
110480970|NCT01009580|Biphasic Insulins|biphasic insulins|mesh-list
110480971|NCT01009580|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
110480972|NCT01009580|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110480973|NCT01009580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110480974|NCT01009346|Cisplatin|cisplatin|mesh-list
110480975|NCT01009346|Carboplatin|carboplatin|mesh-list
110480976|NCT01009346|Cetuximab|cetuximab|mesh-list
110480977|NCT01009346|Everolimus|everolimus|mesh-list
110266956|NCT00538954|Magnesium Oxide|magnesium oxide|mesh-list
110480978|NCT01009346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110480979|NCT01009346|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110480980|NCT01009346|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110480981|NCT01009346|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110480982|NCT01009346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110480983|NCT01009346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110480984|NCT01009346|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110480985|NCT01009346|Immunologic Factors|immunologic factors|mesh-ancestor
110480986|NCT01009346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110480987|NCT04101682|Bupivacaine|bupivacaine|mesh-list
110480988|NCT04101682|Anesthetics, Local|anesthetics, local|mesh-ancestor
110480989|NCT04101682|Anesthetics|anesthetics|mesh-ancestor
110480990|NCT04101682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110480991|NCT04101682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110480992|NCT04101682|Sensory System Agents|sensory system agents|mesh-ancestor
110480993|NCT04101682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110480994|NCT01001702|Aripiprazole|aripiprazole|mesh-list
110480995|NCT01001702|Antidepressive Agents|antidepressive agents|mesh-ancestor
110480996|NCT01001702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110480997|NCT01001702|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110480998|NCT01001702|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110480999|NCT01001702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110481000|NCT01001702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110481001|NCT01001702|Dopamine Agonists|dopamine agonists|mesh-ancestor
110481002|NCT01001702|Dopamine Agents|dopamine agents|mesh-ancestor
110481003|NCT01001702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110166071|NCT00026143|Growth Substances|growth substances|mesh-ancestor
110481004|NCT01001702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110481005|NCT01001702|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110481006|NCT01001702|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110481007|NCT01001702|Serotonin Agents|serotonin agents|mesh-ancestor
110481008|NCT01001702|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110481009|NCT01001702|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110481010|NCT01001702|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110481011|NCT01001702|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110481012|NCT02602210|Hydrocortisone|hydrocortisone|mesh-list
110481013|NCT02602210|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
110481014|NCT02602210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110481016|NCT00618345|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110128288|NCT05312645|Emollients|emollients|mesh-ancestor
110481017|NCT00618345|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110481018|NCT00618345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110481019|NCT00618345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110481020|NCT00618345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110481021|NCT00618345|Immunologic Factors|immunologic factors|mesh-ancestor
110481022|NCT00618345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110481023|NCT00618345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110481025|NCT02601898|Progesterone|progesterone|mesh-list
110481026|NCT02601898|Progestins|progestins|mesh-ancestor
110481027|NCT02601898|Hormones|hormones|mesh-ancestor
110481028|NCT02601898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110481029|NCT02601898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110481030|NCT02601898|Antioxidants|antioxidants|mesh-ancestor
110481031|NCT02601898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110481032|NCT02601898|Protective Agents|protective agents|mesh-ancestor
110481033|NCT02601898|Vitamin B Complex|vitamin b complex|mesh-ancestor
110481034|NCT02601898|Vitamins|vitamins|mesh-ancestor
110481035|NCT02601898|Micronutrients|micronutrients|mesh-ancestor
110481036|NCT00618423|Ketamine|ketamine|mesh-list
110481037|NCT00618423|Analgesics|analgesics|mesh-ancestor
110481038|NCT00618423|Sensory System Agents|sensory system agents|mesh-ancestor
110481039|NCT00618423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110481040|NCT00618423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110481041|NCT00618423|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110481042|NCT00618423|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110481043|NCT00618423|Anesthetics, General|anesthetics, general|mesh-ancestor
110481044|NCT00618423|Anesthetics|anesthetics|mesh-ancestor
110481045|NCT00618423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110481046|NCT00618423|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110481047|NCT00618423|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110481048|NCT00618423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110481049|NCT00618423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110481050|NCT04101760|Lenograstim|lenograstim|mesh-list
110481051|NCT04101760|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110481052|NCT04101760|Immunologic Factors|immunologic factors|mesh-ancestor
110481053|NCT04101760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110481054|NCT00616551|Octreotide|octreotide|mesh-list
110481055|NCT00616551|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110481056|NCT00616551|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110481057|NCT00616551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110481058|NCT04478942|Misoprostol|misoprostol|mesh-list
110481059|NCT04478942|Oxytocin|oxytocin|mesh-list
110481060|NCT04478942|Oxytocics|oxytocics|mesh-ancestor
110481061|NCT04478942|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110481062|NCT04478942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110481063|NCT04478942|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110481064|NCT04478942|Abortifacient Agents|abortifacient agents|mesh-ancestor
110481065|NCT04478942|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110166074|NCT00026182|Interleukin-12|interleukin-12|mesh-list
110481066|NCT04478942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110481067|NCT04214145|Phenylephrine|phenylephrine|mesh-list
110481068|NCT04214145|Vasopressins|vasopressins|mesh-list
110481069|NCT04214145|Arginine Vasopressin|arginine vasopressin|mesh-list
110481070|NCT04214145|Oxymetazoline|oxymetazoline|mesh-list
110481071|NCT04214145|Norepinephrine|norepinephrine|mesh-list
110481072|NCT04214145|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110481073|NCT04214145|Mydriatics|mydriatics|mesh-ancestor
110481074|NCT04214145|Autonomic Agents|autonomic agents|mesh-ancestor
110481075|NCT04214145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110481076|NCT04214145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110481077|NCT04214145|Sympathomimetics|sympathomimetics|mesh-ancestor
110481078|NCT04214145|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110481079|NCT04214145|Nasal Decongestants|nasal decongestants|mesh-ancestor
110481080|NCT04214145|Respiratory System Agents|respiratory system agents|mesh-ancestor
110481081|NCT04214145|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110481082|NCT04214145|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110481083|NCT04214145|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110481084|NCT04214145|Adrenergic Agents|adrenergic agents|mesh-ancestor
110481085|NCT04214145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110481086|NCT04214145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110481087|NCT04214145|Protective Agents|protective agents|mesh-ancestor
110481088|NCT04214145|Hemostatics|hemostatics|mesh-ancestor
110481089|NCT04214145|Coagulants|coagulants|mesh-ancestor
110481090|NCT04214145|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
110481091|NCT04214145|Natriuretic Agents|natriuretic agents|mesh-ancestor
110481092|NCT04212429|Moxifloxacin|moxifloxacin|mesh-list
110481093|NCT04212429|Levofloxacin|levofloxacin|mesh-list
110481094|NCT04212429|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110481095|NCT04212429|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110481096|NCT04212429|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110481097|NCT04212429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110481098|NCT04212429|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110481099|NCT04212429|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110481100|NCT04212429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110481101|NCT04212429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110481102|NCT04212429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110481103|NCT04212429|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110481104|NCT04212429|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110481105|NCT04212429|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110481107|NCT01068665|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110481108|NCT01068665|Insulin Glargine|insulin glargine|mesh-list
110481109|NCT01068665|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110481110|NCT01068665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110481111|NCT00618501|Leucovorin|leucovorin|mesh-list
110481112|NCT00618501|Cytarabine|cytarabine|mesh-list
110481113|NCT00618501|Prednisolone|prednisolone|mesh-list
110481114|NCT00618501|Hydrocortisone|hydrocortisone|mesh-list
110481115|NCT00618501|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
110481116|NCT00618501|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
110481117|NCT00618501|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
110481118|NCT00618501|Methotrexate|methotrexate|mesh-list
110481119|NCT00618501|Etoposide|etoposide|mesh-list
110481120|NCT00618501|Vincristine|vincristine|mesh-list
110481121|NCT00618501|Imatinib Mesylate|imatinib mesylate|mesh-list
110481122|NCT00618501|Daunorubicin|daunorubicin|mesh-list
110481123|NCT00618501|Levoleucovorin|levoleucovorin|mesh-list
110481124|NCT00618501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110481125|NCT00618501|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110481126|NCT00618501|Abortifacient Agents|abortifacient agents|mesh-ancestor
110481127|NCT00618501|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110481128|NCT00618501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110481129|NCT00618501|Antimetabolites|antimetabolites|mesh-ancestor
110481130|NCT00618501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110481131|NCT00618501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110481132|NCT00618501|Dermatologic Agents|dermatologic agents|mesh-ancestor
110267020|NCT00183846|Irinotecan|irinotecan|mesh-list
110481133|NCT00618501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110481134|NCT00618501|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110481135|NCT00618501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110481136|NCT00618501|Immunologic Factors|immunologic factors|mesh-ancestor
110481137|NCT00618501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110481138|NCT00618501|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110481139|NCT00618501|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110481140|NCT00618501|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110481141|NCT00618501|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110481142|NCT00618501|Antiviral Agents|antiviral agents|mesh-ancestor
110481143|NCT00618501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110481144|NCT00618501|Antidotes|antidotes|mesh-ancestor
110481145|NCT00618501|Protective Agents|protective agents|mesh-ancestor
110481146|NCT00618501|Vitamin B Complex|vitamin b complex|mesh-ancestor
110481148|NCT00618501|Micronutrients|micronutrients|mesh-ancestor
110481149|NCT00618501|Tubulin Modulators|tubulin modulators|mesh-ancestor
110481150|NCT00618501|Antimitotic Agents|antimitotic agents|mesh-ancestor
110481151|NCT00618501|Mitosis Modulators|mitosis modulators|mesh-ancestor
110481152|NCT00618501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110481153|NCT00618501|Glucocorticoids|glucocorticoids|mesh-ancestor
110481154|NCT00618501|Hormones|hormones|mesh-ancestor
110481155|NCT00618501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110481156|NCT00618501|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110481157|NCT00618501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110481158|NCT00618501|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110481159|NCT00772954|Vaccines|vaccines|mesh-list
110481160|NCT00772954|Immunologic Factors|immunologic factors|mesh-ancestor
110481161|NCT00772954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110481162|NCT05322681|Pregabalin|pregabalin|mesh-list
110481163|NCT05322681|Analgesics|analgesics|mesh-ancestor
110481164|NCT05322681|Sensory System Agents|sensory system agents|mesh-ancestor
110481165|NCT05322681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110481166|NCT05322681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110481167|NCT05322681|Anticonvulsants|anticonvulsants|mesh-ancestor
110481168|NCT05322681|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110481169|NCT05322681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110481170|NCT05322681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110128435|NCT04846231|Antimetabolites|antimetabolites|mesh-ancestor
110481171|NCT05322681|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110481172|NCT05322681|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110481173|NCT05322681|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110481174|NCT05322681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110481175|NCT05322681|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110481176|NCT05322603|Diclofenac|diclofenac|mesh-list
110481177|NCT05322603|Morphine|morphine|mesh-list
110481178|NCT05322603|Analgesics|analgesics|mesh-list
110481179|NCT05322603|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
110481180|NCT05322603|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110481181|NCT05322603|Narcotics|narcotics|mesh-ancestor
110481182|NCT05322603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110481183|NCT05322603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110481184|NCT05322603|Sensory System Agents|sensory system agents|mesh-ancestor
110481185|NCT05322603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110481186|NCT05322603|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110481187|NCT05322603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110481188|NCT05322603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110481189|NCT05322603|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110481190|NCT05322603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110481191|NCT05322603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110481193|NCT00618579|Anticoagulants|anticoagulants|mesh-ancestor
110481194|NCT00781768|Ondansetron|ondansetron|mesh-list
110481195|NCT00781768|Aprepitant|aprepitant|mesh-list
110481196|NCT00781768|Antiemetics|antiemetics|mesh-ancestor
110481197|NCT00781768|Autonomic Agents|autonomic agents|mesh-ancestor
110481198|NCT00781768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110481199|NCT00781768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110683700|NCT00926315|Vitamins|vitamins|mesh-ancestor
110481200|NCT00781768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110481201|NCT00781768|Antipruritics|antipruritics|mesh-ancestor
110481202|NCT00781768|Dermatologic Agents|dermatologic agents|mesh-ancestor
110481203|NCT00781768|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110481204|NCT00781768|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110481205|NCT00781768|Serotonin Agents|serotonin agents|mesh-ancestor
110481206|NCT00781768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110481207|NCT00781768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110481208|NCT00781768|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110481209|NCT01005680|Gemcitabine|gemcitabine|mesh-list
110481210|NCT01005680|Pemetrexed|pemetrexed|mesh-list
110481211|NCT01005680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110166090|NCT00026260|Growth Inhibitors|growth inhibitors|mesh-ancestor
110481212|NCT01005680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110481213|NCT01005680|Antimetabolites|antimetabolites|mesh-ancestor
110481214|NCT01005680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110481215|NCT01005680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110481216|NCT01005680|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110481217|NCT01005680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110481218|NCT04101370|Bosentan|bosentan|mesh-list
110481219|NCT04101370|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110481220|NCT04101370|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
110481221|NCT04101370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110481222|NCT00618657|Paclitaxel|paclitaxel|mesh-list
110481223|NCT00618657|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110481224|NCT00618657|Bevacizumab|bevacizumab|mesh-list
110481225|NCT00618657|Carboplatin|carboplatin|mesh-list
110481226|NCT00618657|Trastuzumab|trastuzumab|mesh-list
110683828|NCT00926705|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110481227|NCT00618657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110481228|NCT00618657|Antibodies|antibodies|mesh-list
110481229|NCT00618657|Immunoglobulins|immunoglobulins|mesh-list
110481230|NCT00618657|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110481231|NCT00618657|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110481232|NCT00618657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110481233|NCT00618657|Tubulin Modulators|tubulin modulators|mesh-ancestor
110481234|NCT00618657|Antimitotic Agents|antimitotic agents|mesh-ancestor
110481235|NCT00618657|Mitosis Modulators|mitosis modulators|mesh-ancestor
110481236|NCT00618657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110481237|NCT00618657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110481238|NCT00618657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110481239|NCT00618657|Growth Substances|growth substances|mesh-ancestor
110481240|NCT00618657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110481241|NCT00618657|Growth Inhibitors|growth inhibitors|mesh-ancestor
110481242|NCT00618657|Immunologic Factors|immunologic factors|mesh-ancestor
110481243|NCT04188249|Golimumab|golimumab|mesh-list
110481244|NCT04188249|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110481245|NCT04188249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110128513|NCT04495452|Anesthetics|anesthetics|mesh-ancestor
110267082|NCT00159302|Nitric Oxide|nitric oxide|mesh-list
110481246|NCT04188249|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110481247|NCT04188249|Immunologic Factors|immunologic factors|mesh-ancestor
110481248|NCT04188249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110481249|NCT01005602|Digoxin|digoxin|mesh-list
110481250|NCT01005602|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110481251|NCT01005602|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110481252|NCT01005602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110481253|NCT01005602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110481254|NCT01005602|Protective Agents|protective agents|mesh-ancestor
110481255|NCT01005602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110481256|NCT05490940|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
110481257|NCT05490940|Hemostatics|hemostatics|mesh-ancestor
110481258|NCT05490940|Coagulants|coagulants|mesh-ancestor
110481259|NCT04304261|Metformin|metformin|mesh-list
110481260|NCT04304261|Dapagliflozin|dapagliflozin|mesh-list
110481261|NCT04304261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110481262|NCT04304261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110481263|NCT04304261|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110481264|NCT04304261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110481265|NCT00768430|Midazolam|midazolam|mesh-list
110683961|NCT00930995|Candesartan|candesartan|mesh-list
110481267|NCT00768430|Analgesics|analgesics|mesh-ancestor
110481268|NCT00768430|Sensory System Agents|sensory system agents|mesh-ancestor
110481269|NCT00768430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110481270|NCT00768430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110481271|NCT00768430|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110481272|NCT00768430|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110481273|NCT00768430|Anesthetics, General|anesthetics, general|mesh-ancestor
110481274|NCT00768430|Anesthetics|anesthetics|mesh-ancestor
110481275|NCT00768430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110481276|NCT00768430|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110481277|NCT00768430|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110481278|NCT00768430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110481279|NCT00768430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110481280|NCT00768430|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110481281|NCT00768430|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110481282|NCT00768430|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110683998|NCT01018914|Tacrolimus|tacrolimus|mesh-list
110481283|NCT00768430|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110481284|NCT00768430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110481285|NCT00768430|GABA Modulators|gaba modulators|mesh-ancestor
110481286|NCT00768430|GABA Agents|gaba agents|mesh-ancestor
110481287|NCT04101136|Atorvastatin|atorvastatin|mesh-list
110481288|NCT04101136|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110481289|NCT04101136|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110481290|NCT04101136|Antimetabolites|antimetabolites|mesh-ancestor
110481291|NCT04101136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110481292|NCT04101136|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110481293|NCT04101136|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110481294|NCT04101136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110481296|NCT00618969|Melphalan|melphalan|mesh-list
110481297|NCT00618969|Alkylating Agents|alkylating agents|mesh-ancestor
110481298|NCT00618969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110481299|NCT00618969|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110481300|NCT00618969|Immunologic Factors|immunologic factors|mesh-ancestor
110481301|NCT00618969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110481302|NCT00618969|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110481303|NCT00618969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110481304|NCT00618969|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110481305|NCT01064297|Lamotrigine|lamotrigine|mesh-list
110481306|NCT01064297|Anticonvulsants|anticonvulsants|mesh-list
110481307|NCT01064297|Valproic Acid|valproic acid|mesh-list
110481308|NCT01064297|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110481309|NCT01064297|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110481310|NCT01064297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110481311|NCT01064297|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110481312|NCT01064297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110481313|NCT01064297|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110481314|NCT01064297|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110481315|NCT01064297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110481316|NCT01064297|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110481317|NCT01064297|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110481318|NCT01064297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110481319|NCT01064297|GABA Agents|gaba agents|mesh-ancestor
110481320|NCT01064297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110481321|NCT01064297|Antimanic Agents|antimanic agents|mesh-ancestor
110481322|NCT00781456|Contraceptive Agents|contraceptive agents|mesh-list
110481323|NCT00781456|Levonorgestrel|levonorgestrel|mesh-list
110481324|NCT00781456|Contraceptives, Oral|contraceptives, oral|mesh-list
110481325|NCT00781456|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110481326|NCT00781456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110481327|NCT00781456|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110481328|NCT00781456|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110481329|NCT00781456|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110481330|NCT00582907|Rilonacept|rilonacept|mesh-list
110481331|NCT00582907|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110481332|NCT01062113|Celecoxib|celecoxib|mesh-list
110481333|NCT01062113|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110481334|NCT01062113|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110481335|NCT01062113|Analgesics|analgesics|mesh-ancestor
110481336|NCT01062113|Sensory System Agents|sensory system agents|mesh-ancestor
110481337|NCT01062113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110481338|NCT01062113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110481339|NCT01062113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110481340|NCT01062113|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110481341|NCT01062113|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110481342|NCT01062113|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110481343|NCT01062113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110481344|NCT01062113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110481345|NCT00916396|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
110481346|NCT00916396|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110481347|NCT00916396|Immunologic Factors|immunologic factors|mesh-ancestor
110481348|NCT00916396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110481350|NCT04075201|Immunologic Factors|immunologic factors|mesh-ancestor
110481351|NCT04075201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110481352|NCT01038869|Azelaic acid|azelaic acid|mesh-list
110481353|NCT01038869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110481354|NCT01038869|Dermatologic Agents|dermatologic agents|mesh-ancestor
110481355|NCT02580331|Metformin|metformin|mesh-list
110481356|NCT02580331|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110481357|NCT02580331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110481358|NCT00767806|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110684178|NCT05280275|Hormones|hormones|mesh-ancestor
110481359|NCT00767806|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110481360|NCT00767806|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110481361|NCT00767806|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110481362|NCT00767806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110481363|NCT00767806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110481364|NCT00767806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110481365|NCT00767806|Analgesics|analgesics|mesh-ancestor
110481366|NCT00767806|Sensory System Agents|sensory system agents|mesh-ancestor
110481367|NCT00767806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110481368|NCT00767806|Antidepressive Agents|antidepressive agents|mesh-ancestor
110481369|NCT00767806|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110481370|NCT00767806|Dopamine Agents|dopamine agents|mesh-ancestor
110481371|NCT00780910|Ribavirin|ribavirin|mesh-list
110481372|NCT00780910|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110481373|NCT00780910|Antimetabolites|antimetabolites|mesh-ancestor
110481374|NCT00780910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110481375|NCT00780910|Antiviral Agents|antiviral agents|mesh-ancestor
110481376|NCT00780910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110481377|NCT02582203|Vancomycin|vancomycin|mesh-list
110481378|NCT02582203|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
110481379|NCT02582203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110481380|NCT02582203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110481381|NCT05035927|Psilocybin|psilocybin|mesh-list
110481382|NCT05035927|Hallucinogens|hallucinogens|mesh-ancestor
110481383|NCT05035927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110481384|NCT05035927|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110481386|NCT00771472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110481387|NCT00771472|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110481388|NCT00771472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110481389|NCT00771472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110481390|NCT00771316|Meropenem|meropenem|mesh-list
110481391|NCT00771316|Ertapenem|ertapenem|mesh-list
110481392|NCT00771316|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110481393|NCT00771316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110481394|NCT00770770|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
110481395|NCT00770770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110128661|NCT03649659|Fluorides|fluorides|mesh-list
110481396|NCT00770770|Glucocorticoids|glucocorticoids|mesh-ancestor
110481397|NCT00770770|Hormones|hormones|mesh-ancestor
110684330|NCT00563381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110481398|NCT00770770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110481399|NCT00770770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110481400|NCT00766636|Gemcitabine|gemcitabine|mesh-list
110481401|NCT00766636|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110481402|NCT00766636|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110481403|NCT00766636|Antimetabolites|antimetabolites|mesh-ancestor
110481404|NCT00766636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110481405|NCT00766636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110481406|NCT00766636|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110481409|NCT04348045|Olaparib|olaparib|mesh-list
110481410|NCT04348045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110481411|NCT04348045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110481412|NCT04348045|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110481413|NCT04348045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110684451|NCT00522392|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110481414|NCT04348045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110481415|NCT02581969|Factor VIII|factor viii|mesh-list
110481416|NCT02581969|Coagulants|coagulants|mesh-ancestor
110481417|NCT00770692|Eszopiclone|eszopiclone|mesh-list
110481418|NCT00770692|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110481419|NCT00770692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110481420|NCT00770692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110481421|NCT02816203|Hemostatics|hemostatics|mesh-list
110481422|NCT02816203|Coagulants|coagulants|mesh-ancestor
110481423|NCT04099732|Dabigatran|dabigatran|mesh-list
110481424|NCT04099732|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110481425|NCT04099732|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110481426|NCT04099732|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110481427|NCT04099732|Antimetabolites|antimetabolites|mesh-ancestor
110481428|NCT04099732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110481429|NCT04099732|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110481430|NCT04099732|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110481431|NCT04099732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110481432|NCT04099732|Antithrombins|antithrombins|mesh-ancestor
110481433|NCT04099732|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110481434|NCT04099732|Protease Inhibitors|protease inhibitors|mesh-ancestor
110481435|NCT04099732|Anticoagulants|anticoagulants|mesh-ancestor
110481436|NCT03183115|Lugol's solution|lugol's solution|mesh-list
110481437|NCT03183115|Hemostatics|hemostatics|mesh-ancestor
110481438|NCT03183115|Coagulants|coagulants|mesh-ancestor
110481439|NCT02743897|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
110481440|NCT02743897|Antiviral Agents|antiviral agents|mesh-ancestor
110481441|NCT02743897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110481442|NCT02743819|Pembrolizumab|pembrolizumab|mesh-list
110481443|NCT02743819|Ipilimumab|ipilimumab|mesh-list
110481444|NCT02743819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110481445|NCT02743819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110481446|NCT02743819|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110481447|NCT02743819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110481448|NCT04074421|Rifaximin|rifaximin|mesh-list
110481449|NCT04074421|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110481450|NCT04074421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110481451|NCT04074421|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110481452|NCT02579707|Ivosidenib|ivosidenib|mesh-list
110481453|NCT02579707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110481454|NCT02579707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110481455|NCT02579707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110481456|NCT02713009|Vitamin D|vitamin d|mesh-list
110481457|NCT02713009|Ergocalciferols|ergocalciferols|mesh-list
110481458|NCT02713009|Cholecalciferol|cholecalciferol|mesh-list
110481459|NCT02713009|Vitamins|vitamins|mesh-list
110481460|NCT02713009|Micronutrients|micronutrients|mesh-ancestor
110481461|NCT02713009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110481462|NCT02713009|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110481463|NCT02713009|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110481464|NCT03085225|Durvalumab|durvalumab|mesh-list
110481465|NCT03085225|Trabectedin|trabectedin|mesh-list
110481466|NCT03085225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110481467|NCT03085225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110481468|NCT03085225|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110481469|NCT03085225|Alkylating Agents|alkylating agents|mesh-ancestor
110481470|NCT03085225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110481472|NCT02705287|Ergocalciferols|ergocalciferols|mesh-list
110481473|NCT02705287|Cholecalciferol|cholecalciferol|mesh-list
110481474|NCT02705287|Vitamins|vitamins|mesh-list
110481475|NCT02705287|Micronutrients|micronutrients|mesh-ancestor
110481476|NCT02705287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110481477|NCT02705287|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110481478|NCT02705287|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110481479|NCT04295408|Ropivacaine|ropivacaine|mesh-list
110481480|NCT04295408|Anesthetics, Local|anesthetics, local|mesh-ancestor
110481481|NCT04295408|Anesthetics|anesthetics|mesh-ancestor
110481482|NCT04295408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110481483|NCT04295408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110481484|NCT04295408|Sensory System Agents|sensory system agents|mesh-ancestor
110481485|NCT04295408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110481486|NCT02578537|Clopidogrel|clopidogrel|mesh-list
110481487|NCT02578537|Ticagrelor|ticagrelor|mesh-list
110481488|NCT02578537|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110481489|NCT02578537|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110481490|NCT02578537|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110481491|NCT02578537|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110331882|NCT01315678|Tobramycin|tobramycin|mesh-list
110481492|NCT02578537|Purinergic Agents|purinergic agents|mesh-ancestor
110481493|NCT02578537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110481494|NCT02578537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110481497|NCT03011671|Acetazolamide|acetazolamide|mesh-list
110481498|NCT03011671|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110481499|NCT03011671|Alkylating Agents|alkylating agents|mesh-ancestor
110481500|NCT03011671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110481501|NCT03011671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110481502|NCT03011671|Anticonvulsants|anticonvulsants|mesh-ancestor
110481503|NCT03011671|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110481504|NCT03011671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110481506|NCT03011671|Natriuretic Agents|natriuretic agents|mesh-ancestor
110481507|NCT03011671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110481508|NCT00628706|Dronabinol|dronabinol|mesh-list
110481509|NCT00628706|Hallucinogens|hallucinogens|mesh-ancestor
110481510|NCT00628706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110481511|NCT00628706|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110481512|NCT00628706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110481514|NCT00628706|Sensory System Agents|sensory system agents|mesh-ancestor
110481515|NCT00628706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110481516|NCT00628706|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
110481517|NCT00628706|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110481518|NCT00628706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110685109|NCT00503984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110481519|NCT00628706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110481520|NCT00628706|Hormones|hormones|mesh-ancestor
110481521|NCT00628706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110481522|NCT01001234|Rizatriptan|rizatriptan|mesh-list
110481523|NCT01001234|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110481524|NCT01001234|Serotonin Agents|serotonin agents|mesh-ancestor
110481525|NCT01001234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110481526|NCT01001234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110481527|NCT01001234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110481528|NCT01004510|Zoledronic Acid|zoledronic acid|mesh-list
110481529|NCT01004510|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110481530|NCT01004510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110481531|NCT04073953|Primaquine|primaquine|mesh-list
110481532|NCT04073953|Antimalarials|antimalarials|mesh-ancestor
110481533|NCT04073953|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110481534|NCT04073953|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110481535|NCT04073953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110481536|NCT01004432|Golimumab|golimumab|mesh-list
110481537|NCT01004432|Methotrexate|methotrexate|mesh-list
110481538|NCT01004432|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110481539|NCT01004432|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110481540|NCT01004432|Abortifacient Agents|abortifacient agents|mesh-ancestor
110481541|NCT01004432|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110481542|NCT01004432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110481543|NCT01004432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110481544|NCT01004432|Antimetabolites|antimetabolites|mesh-ancestor
110481545|NCT01004432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110481546|NCT01004432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110481547|NCT01004432|Dermatologic Agents|dermatologic agents|mesh-ancestor
110481548|NCT01004432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110481549|NCT01004432|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110481550|NCT01004432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110481551|NCT01004432|Immunologic Factors|immunologic factors|mesh-ancestor
110481552|NCT01004432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110481553|NCT01004432|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110481554|NCT01004432|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110481555|NCT01004432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110685310|NCT01010516|Niacin|niacin|mesh-list
110481557|NCT02539537|Folic Acid|folic acid|mesh-list
110481558|NCT02539537|Gemcitabine|gemcitabine|mesh-list
110481559|NCT02539537|Fluorouracil|fluorouracil|mesh-list
110481560|NCT02539537|Oxaliplatin|oxaliplatin|mesh-list
110481561|NCT02539537|Irinotecan|irinotecan|mesh-list
110481562|NCT02539537|Levoleucovorin|levoleucovorin|mesh-list
110481563|NCT02539537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110481564|NCT02539537|Antimetabolites|antimetabolites|mesh-ancestor
110481565|NCT02539537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110481566|NCT02539537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110481567|NCT02539537|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110481568|NCT02539537|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110685503|NCT00320398|PENTA|penta|mesh-list
110481569|NCT02539537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110481570|NCT02539537|Antidotes|antidotes|mesh-ancestor
110481571|NCT02539537|Protective Agents|protective agents|mesh-ancestor
110481572|NCT02539537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110481573|NCT02539537|Vitamin B Complex|vitamin b complex|mesh-ancestor
110481574|NCT02539537|Vitamins|vitamins|mesh-ancestor
110481575|NCT02539537|Micronutrients|micronutrients|mesh-ancestor
110481576|NCT02539537|Hematinics|hematinics|mesh-ancestor
110481577|NCT02539537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110481578|NCT02539537|Immunologic Factors|immunologic factors|mesh-ancestor
110481579|NCT02576275|Rituximab|rituximab|mesh-list
110481580|NCT02576275|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110481581|NCT02576275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110481582|NCT02576275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110481583|NCT02576275|Immunologic Factors|immunologic factors|mesh-ancestor
110481584|NCT02576275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110481585|NCT02576275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110481586|NCT02576275|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110481587|NCT02576275|Alkylating Agents|alkylating agents|mesh-ancestor
110481588|NCT02576275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110481589|NCT01000610|Methylprednisolone|methylprednisolone|mesh-list
110481590|NCT01000610|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110685504|NCT00320398|Fondaparinux|fondaparinux|mesh-list
110481591|NCT01000610|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110481592|NCT01000610|Prednisolone|prednisolone|mesh-list
110481593|NCT01000610|Prednisolone acetate|prednisolone acetate|mesh-list
110481594|NCT01000610|Rituximab|rituximab|mesh-list
110481595|NCT01000610|Methotrexate|methotrexate|mesh-list
110481596|NCT01000610|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110481597|NCT01000610|Prednisolone phosphate|prednisolone phosphate|mesh-list
110481598|NCT01000610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110481599|NCT01000610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110481600|NCT01000610|Immunologic Factors|immunologic factors|mesh-ancestor
110481601|NCT01000610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110481602|NCT01000610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110481603|NCT01000610|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110481604|NCT01000610|Abortifacient Agents|abortifacient agents|mesh-ancestor
110481605|NCT01000610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110481606|NCT01000610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110481607|NCT01000610|Antimetabolites|antimetabolites|mesh-ancestor
110481608|NCT01000610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110481609|NCT01000610|Dermatologic Agents|dermatologic agents|mesh-ancestor
110481610|NCT01000610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110481611|NCT01000610|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110481612|NCT01000610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110481613|NCT01000610|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110481614|NCT01000610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110481615|NCT01000610|Antiemetics|antiemetics|mesh-ancestor
110481616|NCT01000610|Autonomic Agents|autonomic agents|mesh-ancestor
110481617|NCT01000610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110481618|NCT01000610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110481619|NCT01000610|Glucocorticoids|glucocorticoids|mesh-ancestor
110481620|NCT01000610|Hormones|hormones|mesh-ancestor
110481621|NCT01000610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110481622|NCT01000610|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110481623|NCT01000610|Protective Agents|protective agents|mesh-ancestor
110481624|NCT01000610|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110481625|NCT02523469|Nivolumab|nivolumab|mesh-list
110481626|NCT02523469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110481627|NCT02523469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110481628|NCT02523469|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110481629|NCT02523469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110481630|NCT00586924|Immunotoxin HA22|immunotoxin ha22|mesh-list
110481631|NCT00586924|Immunotoxins|immunotoxins|mesh-ancestor
110481632|NCT00586924|Immunoconjugates|immunoconjugates|mesh-ancestor
110481633|NCT00586924|Immunologic Factors|immunologic factors|mesh-ancestor
110481634|NCT00586924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110481635|NCT00586924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110481636|NCT04211961|Scopolamine|scopolamine|mesh-list
110481637|NCT04211961|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
110481638|NCT04211961|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110481639|NCT04211961|Antiemetics|antiemetics|mesh-ancestor
110481640|NCT04211961|Autonomic Agents|autonomic agents|mesh-ancestor
110481641|NCT04211961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110481642|NCT04211961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110481643|NCT04211961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110481644|NCT04211961|Mydriatics|mydriatics|mesh-ancestor
110481645|NCT04211961|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110481646|NCT04211961|Cholinergic Agents|cholinergic agents|mesh-ancestor
110481647|NCT04211961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110481648|NCT04211961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110481649|NCT04211961|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110481650|NCT04211961|Parasympatholytics|parasympatholytics|mesh-ancestor
110481651|NCT01000376|Ketoconazole|ketoconazole|mesh-list
110481652|NCT01000376|Antifungal Agents|antifungal agents|mesh-ancestor
110481653|NCT01000376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110481654|NCT01000376|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110481655|NCT01000376|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110481656|NCT01000376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110481657|NCT01000376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110481658|NCT01000376|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110481659|NCT01000376|Hormone Antagonists|hormone antagonists|mesh-ancestor
110481660|NCT01000376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110685693|NCT00319696|Bosentan|bosentan|mesh-list
110481661|NCT01000376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110481662|NCT01000376|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110481663|NCT01038635|Lenalidomide|lenalidomide|mesh-list
110481664|NCT01038635|Azacitidine|azacitidine|mesh-list
110481665|NCT01038635|Immunologic Factors|immunologic factors|mesh-ancestor
110481666|NCT01038635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110481667|NCT01038635|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110481668|NCT01038635|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110481669|NCT01038635|Growth Substances|growth substances|mesh-ancestor
110481670|NCT01038635|Growth Inhibitors|growth inhibitors|mesh-ancestor
110481671|NCT01038635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110481672|NCT01038635|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110481673|NCT01038635|Antimetabolites|antimetabolites|mesh-ancestor
110481674|NCT01038635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110481675|NCT01038635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110481676|NCT00619203|Acetaminophen|acetaminophen|mesh-list
110481677|NCT00619203|Glycerol|glycerol|mesh-list
110481678|NCT00619203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110481679|NCT00619203|Analgesics|analgesics|mesh-ancestor
110481680|NCT00619203|Sensory System Agents|sensory system agents|mesh-ancestor
110481681|NCT00619203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110481682|NCT00619203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110481683|NCT00619203|Antipyretics|antipyretics|mesh-ancestor
110481684|NCT00619203|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
110481685|NCT00619203|Protective Agents|protective agents|mesh-ancestor
110481686|NCT04072471|Lesinurad|lesinurad|mesh-list
110481687|NCT04072471|Gout Suppressants|gout suppressants|mesh-ancestor
110481688|NCT04072471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110481689|NCT04072471|Uricosuric Agents|uricosuric agents|mesh-ancestor
110481690|NCT01000064|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
110481691|NCT01000064|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110481692|NCT01000064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110481693|NCT01000064|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110128968|NCT02333565|Octreotide|octreotide|mesh-list
110481694|NCT01000064|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110481695|NCT01000064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110481696|NCT01000064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110481697|NCT01000064|Dopamine Agents|dopamine agents|mesh-ancestor
110481698|NCT01000064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110481699|NCT01812603|Nabiximols|nabiximols|mesh-list
110481700|NCT01812603|Analgesics|analgesics|mesh-ancestor
110481701|NCT01812603|Sensory System Agents|sensory system agents|mesh-ancestor
110481702|NCT01812603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110481703|NCT01812603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110481704|NCT04211805|Tenofovir|tenofovir|mesh-list
110481705|NCT04211805|Vaccines|vaccines|mesh-list
110481707|NCT04211805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110481708|NCT04211805|Antiviral Agents|antiviral agents|mesh-ancestor
110481709|NCT04211805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110481710|NCT04211805|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110481711|NCT04211805|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110481712|NCT04211805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110481713|NCT04211805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110481714|NCT04211805|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110481715|NCT04211805|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110481716|NCT02874287|Hydroxychloroquine|hydroxychloroquine|mesh-list
110481717|NCT02874287|Antimalarials|antimalarials|mesh-ancestor
110166163|NCT00026962|Progestins|progestins|mesh-ancestor
110481718|NCT02874287|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110481719|NCT02874287|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110481720|NCT02874287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110481721|NCT02874287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110481722|NCT02874287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110481723|NCT02874287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110481724|NCT00580801|Interferons|interferons|mesh-list
110481725|NCT00580801|Ribavirin|ribavirin|mesh-list
110481726|NCT00580801|Interferon-alpha|interferon-alpha|mesh-list
110481727|NCT00580801|Interferon alpha-2|interferon alpha-2|mesh-list
110481728|NCT00580801|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110481729|NCT00580801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110481730|NCT00580801|Antiviral Agents|antiviral agents|mesh-ancestor
110481731|NCT00580801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110481732|NCT00580801|Antimetabolites|antimetabolites|mesh-ancestor
110481733|NCT00580801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110481734|NCT00580801|Immunologic Factors|immunologic factors|mesh-ancestor
110481735|NCT00580801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110481736|NCT00619671|Rituximab|rituximab|mesh-list
110481737|NCT00619671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110481738|NCT00619671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110481739|NCT00619671|Immunologic Factors|immunologic factors|mesh-ancestor
110481740|NCT00619671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110481741|NCT00619671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110481742|NCT00628550|Vasopressins|vasopressins|mesh-list
110481743|NCT00628550|Arginine Vasopressin|arginine vasopressin|mesh-list
110481744|NCT00628550|Epinephrine|epinephrine|mesh-list
110481745|NCT00628550|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110481746|NCT00628550|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110481747|NCT00628550|Adrenergic Agents|adrenergic agents|mesh-ancestor
110481748|NCT00628550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110481749|NCT00628550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110481750|NCT00628550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110481751|NCT00628550|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110481752|NCT00628550|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110481753|NCT00628550|Autonomic Agents|autonomic agents|mesh-ancestor
110686232|NCT00499616|Dermatologic Agents|dermatologic agents|mesh-ancestor
110481755|NCT00628550|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110481756|NCT00628550|Respiratory System Agents|respiratory system agents|mesh-ancestor
110481757|NCT00628550|Mydriatics|mydriatics|mesh-ancestor
110481758|NCT00628550|Sympathomimetics|sympathomimetics|mesh-ancestor
110481759|NCT00628550|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110481760|NCT00628550|Hemostatics|hemostatics|mesh-ancestor
110481761|NCT00628550|Coagulants|coagulants|mesh-ancestor
110481762|NCT00628550|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
110481763|NCT00628550|Natriuretic Agents|natriuretic agents|mesh-ancestor
110481764|NCT01059539|Cariprazine|cariprazine|mesh-list
110481765|NCT01059539|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110481766|NCT01059539|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110481767|NCT01059539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110481768|NCT01059539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110481769|NCT01059539|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110481770|NCT00999908|Tiotropium Bromide|tiotropium bromide|mesh-list
110481771|NCT00999908|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110481773|NCT00999908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110481774|NCT00999908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110481775|NCT00999908|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110481776|NCT00999908|Respiratory System Agents|respiratory system agents|mesh-ancestor
110481777|NCT00999908|Parasympatholytics|parasympatholytics|mesh-ancestor
110481778|NCT00999908|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110481779|NCT00999908|Cholinergic Agents|cholinergic agents|mesh-ancestor
110481780|NCT00999908|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110481781|NCT00999908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110481782|NCT02576119|Moxifloxacin|moxifloxacin|mesh-list
110481783|NCT02576119|BMS-955176|bms-955176|mesh-list
110481784|NCT02576119|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110481785|NCT02576119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110481786|NCT02576119|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110481787|NCT02576119|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110481788|NCT02576119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110481789|NCT02576119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110481790|NCT02576119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110166192|NCT00011778|Bortezomib|bortezomib|mesh-list
110481791|NCT02576119|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110686375|NCT03732495|Denosumab|denosumab|mesh-list
110481792|NCT02576119|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110481793|NCT02576119|Antiviral Agents|antiviral agents|mesh-ancestor
110481794|NCT02871518|Cisplatin|cisplatin|mesh-list
110481795|NCT02871518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110481796|NCT04304144|Dexamethasone|dexamethasone|mesh-list
110686412|NCT00468546|Rituximab|rituximab|mesh-list
110481799|NCT04304144|Daratumumab|daratumumab|mesh-list
110481800|NCT04304144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110481801|NCT04304144|Immunologic Factors|immunologic factors|mesh-ancestor
110481802|NCT04304144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110481803|NCT04304144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110481804|NCT04304144|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110686490|NCT00331552|Antibodies|antibodies|mesh-list
110481805|NCT04304144|Alkylating Agents|alkylating agents|mesh-ancestor
110481806|NCT04304144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110481807|NCT04304144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110481808|NCT04304144|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110481809|NCT04304144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110481810|NCT04304144|Antiemetics|antiemetics|mesh-ancestor
110481811|NCT04304144|Autonomic Agents|autonomic agents|mesh-ancestor
110481812|NCT04304144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110481813|NCT04304144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110481814|NCT04304144|Glucocorticoids|glucocorticoids|mesh-ancestor
110481815|NCT04304144|Hormones|hormones|mesh-ancestor
110481816|NCT04304144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110481817|NCT04304144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110481818|NCT04676867|Dalcetrapib|dalcetrapib|mesh-list
110481819|NCT04676867|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110481820|NCT04676867|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110481821|NCT04676867|Antimetabolites|antimetabolites|mesh-ancestor
110481822|NCT04676867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110481823|NCT04676867|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110481824|NCT00770224|Prednisone|prednisone|mesh-list
110481825|NCT00770224|Cyclophosphamide|cyclophosphamide|mesh-list
110481826|NCT00770224|Rituximab|rituximab|mesh-list
110481827|NCT00770224|Doxorubicin|doxorubicin|mesh-list
110481828|NCT00770224|Vincristine|vincristine|mesh-list
110481829|NCT00770224|Tositumomab I-131|tositumomab i-131|mesh-list
110481830|NCT00770224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110481831|NCT00770224|Immunologic Factors|immunologic factors|mesh-ancestor
110481832|NCT00770224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110481833|NCT00770224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110481834|NCT00770224|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110481835|NCT00770224|Alkylating Agents|alkylating agents|mesh-ancestor
110481836|NCT00770224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110481837|NCT00770224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110481838|NCT00770224|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110481839|NCT00770224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110481841|NCT00770224|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110481842|NCT00770224|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110481843|NCT00770224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110481844|NCT00770224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110481845|NCT00770224|Glucocorticoids|glucocorticoids|mesh-ancestor
110481846|NCT00770224|Hormones|hormones|mesh-ancestor
110481847|NCT00770224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110481848|NCT00770224|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110481849|NCT00770224|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110481850|NCT00770224|Tubulin Modulators|tubulin modulators|mesh-ancestor
110481851|NCT00770224|Antimitotic Agents|antimitotic agents|mesh-ancestor
110686737|NCT00412113|Calcium, Dietary|calcium, dietary|mesh-list
110481852|NCT00770224|Mitosis Modulators|mitosis modulators|mesh-ancestor
110481853|NCT02399215|Nintedanib|nintedanib|mesh-list
110481854|NCT02399215|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
110481855|NCT02399215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110481856|NCT02399215|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110481857|NCT02399215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110481858|NCT02399215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110481859|NCT02389465|Celecoxib|celecoxib|mesh-list
110481860|NCT02389465|Dexetimide|dexetimide|mesh-list
110481861|NCT02389465|Citalopram|citalopram|mesh-list
110481862|NCT02389465|Escitalopram|escitalopram|mesh-list
110481863|NCT02389465|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110481864|NCT02389465|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110481865|NCT02389465|Analgesics|analgesics|mesh-ancestor
110481866|NCT02389465|Sensory System Agents|sensory system agents|mesh-ancestor
110481867|NCT02389465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110481868|NCT02389465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110481869|NCT02389465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110404607|NCT03321643|Rituximab|rituximab|mesh-list
110481871|NCT02389465|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110481872|NCT02389465|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110481873|NCT02389465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110481874|NCT02389465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110481875|NCT02389465|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110481876|NCT02389465|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110481877|NCT02389465|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110481878|NCT02389465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110481879|NCT02389465|Serotonin Agents|serotonin agents|mesh-ancestor
110481880|NCT02389465|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110481881|NCT02389465|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110481882|NCT02389465|Parasympatholytics|parasympatholytics|mesh-ancestor
110481883|NCT02389465|Autonomic Agents|autonomic agents|mesh-ancestor
110481884|NCT02389465|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110481885|NCT02389465|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110481886|NCT02389465|Cholinergic Agents|cholinergic agents|mesh-ancestor
110481887|NCT02389465|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110481888|NCT02389465|Antidepressive Agents|antidepressive agents|mesh-ancestor
110481889|NCT02389465|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110481890|NCT01057589|Folic Acid|folic acid|mesh-list
110481891|NCT01057589|Vitamin B 12|vitamin b 12|mesh-list
110481892|NCT01057589|Pemetrexed|pemetrexed|mesh-list
110481893|NCT01057589|Cetuximab|cetuximab|mesh-list
110481894|NCT01057589|Vitamins|vitamins|mesh-ancestor
110481895|NCT01057589|Micronutrients|micronutrients|mesh-ancestor
110481896|NCT01057589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110686894|NCT00949949|Everolimus|everolimus|mesh-list
110481897|NCT01057589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110481898|NCT01057589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110481899|NCT01057589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110481900|NCT01057589|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110481901|NCT01057589|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110481902|NCT01057589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110481903|NCT01057589|Hematinics|hematinics|mesh-ancestor
110481904|NCT01057589|Vitamin B Complex|vitamin b complex|mesh-ancestor
110481905|NCT02575885|Nicotine|nicotine|mesh-list
110481906|NCT02575885|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110481907|NCT02575885|Autonomic Agents|autonomic agents|mesh-ancestor
110481908|NCT02575885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110481909|NCT02575885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110481911|NCT02575885|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110481912|NCT02575885|Cholinergic Agents|cholinergic agents|mesh-ancestor
110481913|NCT02575885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110481914|NCT02575885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110481915|NCT02575729|Betamethasone|betamethasone|mesh-list
110481916|NCT02575729|Glucocorticoids|glucocorticoids|mesh-list
110481917|NCT02575729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110481918|NCT02575729|Hormones|hormones|mesh-ancestor
110481919|NCT02575729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110481920|NCT02575729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110481921|NCT02575729|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110481922|NCT02575729|Respiratory System Agents|respiratory system agents|mesh-ancestor
110481923|NCT02575651|Fluzoparib|fluzoparib|mesh-list
110481924|NCT02575651|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110481925|NCT02575651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110481926|NCT02575651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110481927|NCT02575651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110481928|NCT01716117|Calcium Carbonate|calcium carbonate|mesh-list
110481929|NCT01716117|Antacids|antacids|mesh-ancestor
110481930|NCT01716117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110481931|NCT01716117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110481932|NCT00579553|Progesterone|progesterone|mesh-list
110481933|NCT00579553|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
110481934|NCT00579553|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
110481935|NCT00579553|Progestins|progestins|mesh-ancestor
110481936|NCT00579553|Hormones|hormones|mesh-ancestor
110481937|NCT00579553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110481938|NCT00579553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110481939|NCT00579553|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110481940|NCT00579553|Hormone Antagonists|hormone antagonists|mesh-ancestor
110481941|NCT04209933|Potassium Citrate|potassium citrate|mesh-list
110481942|NCT04209933|Bismuth|bismuth|mesh-list
110481943|NCT04209933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110481944|NCT04209933|Antacids|antacids|mesh-ancestor
110481945|NCT04209933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110481946|NCT04209933|Diuretics|diuretics|mesh-ancestor
110481947|NCT04209933|Natriuretic Agents|natriuretic agents|mesh-ancestor
110481948|NCT04209933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110481949|NCT04209933|Expectorants|expectorants|mesh-ancestor
110481950|NCT04209933|Respiratory System Agents|respiratory system agents|mesh-ancestor
110481952|NCT00619905|Immunologic Factors|immunologic factors|mesh-ancestor
110481953|NCT00619905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110481954|NCT04209699|Deucravacitinib|deucravacitinib|mesh-list
110481955|NCT04209699|Famotidine|famotidine|mesh-list
110481956|NCT04209699|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110481957|NCT04209699|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110481958|NCT04209699|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110481959|NCT04209699|Histamine Antagonists|histamine antagonists|mesh-ancestor
110481960|NCT04209699|Histamine Agents|histamine agents|mesh-ancestor
110481961|NCT04209699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110481962|NCT04209699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110481963|NCT04209699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110481964|NCT04209699|Dermatologic Agents|dermatologic agents|mesh-ancestor
110481965|NCT04209699|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110481966|NCT04209699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110481967|NCT00620295|Gemcitabine|gemcitabine|mesh-list
110481968|NCT00620295|Bortezomib|bortezomib|mesh-list
110481969|NCT00620295|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110481970|NCT00620295|Antimetabolites|antimetabolites|mesh-ancestor
110267284|NCT00541567|Hormones|hormones|mesh-ancestor
110481971|NCT00620295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110481972|NCT00620295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110481974|NCT00581893|Anticonvulsants|anticonvulsants|mesh-ancestor
110481975|NCT00581893|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110481976|NCT00581893|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110166236|NCT00027391|Hormones|hormones|mesh-ancestor
110481978|NCT00581893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110481979|NCT00581893|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110481980|NCT00581893|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110481981|NCT04211103|Pembrolizumab|pembrolizumab|mesh-list
110481982|NCT04211103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110481983|NCT04211103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110481984|NCT04211103|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110481985|NCT04211103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110481986|NCT04209777|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110481987|NCT04209777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110481988|NCT02334865|Lenalidomide|lenalidomide|mesh-list
110481989|NCT02334865|Sargramostim|sargramostim|mesh-list
110481990|NCT02334865|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
110481991|NCT02334865|Freund's Adjuvant|freund's adjuvant|mesh-list
110481992|NCT02334865|Immunologic Factors|immunologic factors|mesh-ancestor
110481993|NCT02334865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110481994|NCT02334865|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110129279|NCT01953770|Antimetabolites|antimetabolites|mesh-ancestor
110481995|NCT02334865|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110481996|NCT02334865|Growth Substances|growth substances|mesh-ancestor
110481997|NCT02334865|Growth Inhibitors|growth inhibitors|mesh-ancestor
110481998|NCT02334865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110481999|NCT02334865|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110482000|NCT04073719|Acetic Acid|acetic acid|mesh-list
110482001|NCT04073719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110482002|NCT04073719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110482003|NCT00379431|Methylprednisolone|methylprednisolone|mesh-list
110482004|NCT00379431|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110482005|NCT00379431|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110482006|NCT00379431|Prednisolone|prednisolone|mesh-list
110482007|NCT00379431|Prednisolone acetate|prednisolone acetate|mesh-list
110482008|NCT00379431|Rituximab|rituximab|mesh-list
110482009|NCT00379431|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110482010|NCT00379431|Prednisolone phosphate|prednisolone phosphate|mesh-list
110687400|NCT00408681|Antimanic Agents|antimanic agents|mesh-ancestor
110482011|NCT00379431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110482012|NCT00379431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110482013|NCT00379431|Immunologic Factors|immunologic factors|mesh-ancestor
110482014|NCT00379431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110482015|NCT00379431|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110482016|NCT00379431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110482017|NCT00379431|Antiemetics|antiemetics|mesh-ancestor
110482018|NCT00379431|Autonomic Agents|autonomic agents|mesh-ancestor
110482019|NCT00379431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110482020|NCT00379431|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110482021|NCT00379431|Glucocorticoids|glucocorticoids|mesh-ancestor
110482022|NCT00379431|Hormones|hormones|mesh-ancestor
110482023|NCT00379431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110482024|NCT00379431|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110482025|NCT00379431|Protective Agents|protective agents|mesh-ancestor
110482026|NCT00379431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110482027|NCT04954989|Epoetin Alfa|epoetin alfa|mesh-list
110482029|NCT00621699|Ezetimibe|ezetimibe|mesh-list
110482030|NCT00621699|Tacrolimus|tacrolimus|mesh-list
110482031|NCT00621699|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110482032|NCT00621699|Immunologic Factors|immunologic factors|mesh-ancestor
110482033|NCT00621699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110482034|NCT00621699|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110482035|NCT00621699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110166239|NCT00000461|Niacin|niacin|mesh-list
110482036|NCT00621699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110482037|NCT00621699|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110482038|NCT00621699|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110482039|NCT00621699|Antimetabolites|antimetabolites|mesh-ancestor
110482040|NCT00621699|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110482041|NCT00612183|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110482042|NCT00612183|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110482043|NCT00612183|Alkylating Agents|alkylating agents|mesh-ancestor
110482044|NCT00612183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110482045|NCT00612183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110482047|NCT00770146|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110482048|NCT00770146|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110482049|NCT00770146|Antimetabolites|antimetabolites|mesh-ancestor
110482050|NCT00770146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110482051|NCT00770146|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110482052|NCT00915850|Cisplatin|cisplatin|mesh-list
110482053|NCT00915850|Docetaxel|docetaxel|mesh-list
110482054|NCT00915850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110482055|NCT00915850|Tubulin Modulators|tubulin modulators|mesh-ancestor
110482056|NCT00915850|Antimitotic Agents|antimitotic agents|mesh-ancestor
110482057|NCT00915850|Mitosis Modulators|mitosis modulators|mesh-ancestor
110482058|NCT00915850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110482060|NCT04208763|Colistin|colistin|mesh-list
110482061|NCT04208763|Tigecycline|tigecycline|mesh-list
110482062|NCT04208763|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110482063|NCT04208763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110482064|NCT04208763|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110482065|NCT04208763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110482066|NCT04208763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110482067|NCT00620919|Secretin|secretin|mesh-list
110482068|NCT00620919|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110482069|NCT00620919|Hormones|hormones|mesh-ancestor
110482070|NCT00620919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110482071|NCT00620919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110482072|NCT00916552|Epoetin Alfa|epoetin alfa|mesh-list
110482073|NCT00916552|Hematinics|hematinics|mesh-ancestor
110482074|NCT03950037|Albendazole|albendazole|mesh-list
110482075|NCT03950037|Anthelmintics|anthelmintics|mesh-ancestor
110482076|NCT03950037|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110482077|NCT03950037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110482078|NCT03950037|Anticestodal Agents|anticestodal agents|mesh-ancestor
110482079|NCT03950037|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110482080|NCT03950037|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110482081|NCT03950037|Tubulin Modulators|tubulin modulators|mesh-ancestor
110482082|NCT03950037|Antimitotic Agents|antimitotic agents|mesh-ancestor
110482083|NCT03950037|Mitosis Modulators|mitosis modulators|mesh-ancestor
110482084|NCT03950037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110482085|NCT03950037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110482086|NCT04188171|Polidocanol|polidocanol|mesh-list
110482087|NCT04188171|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
110482088|NCT04188171|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110482089|NCT00620997|Proxymetacaine|proxymetacaine|mesh-list
110482090|NCT00620997|Anesthetics, Local|anesthetics, local|mesh-ancestor
110482091|NCT00620997|Anesthetics|anesthetics|mesh-ancestor
110482092|NCT00620997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110482093|NCT00620997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110482094|NCT00620997|Sensory System Agents|sensory system agents|mesh-ancestor
110482095|NCT00620997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110482096|NCT00622011|Risperidone|risperidone|mesh-list
110482097|NCT00622011|Zotepine|zotepine|mesh-list
110482098|NCT00622011|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110482099|NCT00622011|Serotonin Agents|serotonin agents|mesh-ancestor
110482100|NCT00622011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110482101|NCT00622011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110482102|NCT00622011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110482104|NCT00622011|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110482105|NCT00622011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110482106|NCT00622011|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110482107|NCT00622011|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110482108|NCT00622011|Dopamine Agents|dopamine agents|mesh-ancestor
110482110|NCT03936309|Anesthetics, Local|anesthetics, local|mesh-ancestor
110482111|NCT03936309|Anesthetics|anesthetics|mesh-ancestor
110482112|NCT03936309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110482113|NCT03936309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110482114|NCT03936309|Sensory System Agents|sensory system agents|mesh-ancestor
110482115|NCT03936309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110482116|NCT03936309|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110482117|NCT03936309|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110482118|NCT03936309|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110482119|NCT03936309|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110482120|NCT03936309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110482121|NCT04208373|Itraconazole|itraconazole|mesh-list
110482122|NCT04208373|Etravirine|etravirine|mesh-list
110482123|NCT04208373|Antifungal Agents|antifungal agents|mesh-ancestor
110482124|NCT04208373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110482125|NCT04208373|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110482126|NCT04208373|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110482127|NCT04208373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110482128|NCT04208373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110482129|NCT04208373|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110482130|NCT04208373|Hormone Antagonists|hormone antagonists|mesh-ancestor
110482131|NCT04208373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110482132|NCT04208373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110482133|NCT04208373|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110482134|NCT04208373|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110482135|NCT04208373|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110482136|NCT04208373|Antiviral Agents|antiviral agents|mesh-ancestor
110482137|NCT00622245|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110482138|NCT00622245|Antidepressive Agents|antidepressive agents|mesh-ancestor
110482139|NCT00622245|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110482140|NCT00622245|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110482141|NCT00622245|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110482142|NCT00622245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110482143|NCT00622245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110482144|NCT01056341|Propranolol|propranolol|mesh-list
110482145|NCT01056341|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110482146|NCT01056341|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110482147|NCT01056341|Adrenergic Agents|adrenergic agents|mesh-ancestor
110482148|NCT01056341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110482149|NCT01056341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110482150|NCT01056341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110482151|NCT01056341|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110482152|NCT01056341|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110482153|NCT01056341|Vasodilator Agents|vasodilator agents|mesh-ancestor
110482154|NCT00999518|Tanezumab|tanezumab|mesh-list
110482155|NCT00999518|Analgesics|analgesics|mesh-ancestor
110482156|NCT00999518|Sensory System Agents|sensory system agents|mesh-ancestor
110482157|NCT00999518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110482158|NCT00999518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110482159|NCT00621387|Ofloxacin|ofloxacin|mesh-list
110482160|NCT00621387|Roxithromycin|roxithromycin|mesh-list
110482161|NCT00621387|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110482162|NCT00621387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110482163|NCT00621387|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110482164|NCT00621387|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110482165|NCT00621387|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110482166|NCT00621387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110482167|NCT00621387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110482169|NCT00621387|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110482170|NCT00621387|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110482171|NCT02873273|Dexamethasone|dexamethasone|mesh-list
110482172|NCT02873273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110482173|NCT02873273|Antiemetics|antiemetics|mesh-ancestor
110482174|NCT02873273|Autonomic Agents|autonomic agents|mesh-ancestor
110482175|NCT02873273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110482176|NCT02873273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110482177|NCT02873273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110482178|NCT02873273|Glucocorticoids|glucocorticoids|mesh-ancestor
110482179|NCT02873273|Hormones|hormones|mesh-ancestor
110406042|NCT03377478|Sofosbuvir|sofosbuvir|mesh-list
110482180|NCT02873273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110482181|NCT02873273|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110482182|NCT02873273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110482183|NCT04208841|Sulfamethazine|sulfamethazine|mesh-list
110482184|NCT04208841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110482185|NCT01056263|Axitinib|axitinib|mesh-list
110482186|NCT01056263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110482187|NCT01056263|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110482188|NCT01056263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110482189|NCT01056263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110482190|NCT00637143|Cyclosporine|cyclosporine|mesh-list
110482191|NCT00637143|Tacrolimus|tacrolimus|mesh-list
110482192|NCT00637143|Cyclosporins|cyclosporins|mesh-list
110482193|NCT00637143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110482194|NCT00637143|Immunologic Factors|immunologic factors|mesh-ancestor
110482195|NCT00637143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110482196|NCT00637143|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110482197|NCT00637143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110406182|NCT01232127|Ritonavir|ritonavir|mesh-list
110482198|NCT00637143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110482199|NCT00637143|Antifungal Agents|antifungal agents|mesh-ancestor
110482200|NCT00637143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110482201|NCT00637143|Dermatologic Agents|dermatologic agents|mesh-ancestor
110482202|NCT00637143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110482203|NCT01056107|Glucagon|glucagon|mesh-list
110482204|NCT01056107|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
110482205|NCT01056107|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110482206|NCT01056107|Hormones|hormones|mesh-ancestor
110482207|NCT01056107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110482208|NCT01056107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110482209|NCT01056107|Incretins|incretins|mesh-ancestor
110482210|NCT03548805|Mitomycins|mitomycins|mesh-list
110482211|NCT03548805|Mitomycin|mitomycin|mesh-list
110482212|NCT03548805|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110482213|NCT03548805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110482214|NCT03548805|Alkylating Agents|alkylating agents|mesh-ancestor
110482215|NCT03548805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110482216|NCT03548805|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110482217|NCT03548805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110482218|NCT01003886|Doxazosin|doxazosin|mesh-list
110482219|NCT01003886|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110482220|NCT01003886|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110482221|NCT01003886|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110482222|NCT01003886|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110482223|NCT01003886|Adrenergic Agents|adrenergic agents|mesh-ancestor
110482224|NCT01003886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110482225|NCT01003886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110482226|NCT01003886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110482228|NCT04138641|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110406237|NCT01054222|Cholinergic Agents|cholinergic agents|mesh-ancestor
110482229|NCT04138641|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110482230|NCT04138641|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110482232|NCT04138641|Purinergic Agents|purinergic agents|mesh-ancestor
110482233|NCT04138641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110482234|NCT04138641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110482235|NCT04138641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110482236|NCT01003184|Exenatide|exenatide|mesh-list
110482237|NCT01003184|Insulin Detemir|insulin detemir|mesh-list
110482238|NCT01003184|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110482239|NCT01003184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110482240|NCT01003184|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110482241|NCT01003184|Incretins|incretins|mesh-ancestor
110482242|NCT01003184|Hormones|hormones|mesh-ancestor
110482243|NCT01003184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110482244|NCT04314219|Cyclophosphamide|cyclophosphamide|mesh-list
110482245|NCT04314219|Methotrexate|methotrexate|mesh-list
110482246|NCT04314219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110482247|NCT04314219|Immunologic Factors|immunologic factors|mesh-ancestor
110482248|NCT04314219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110482249|NCT04314219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110482250|NCT04314219|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110482251|NCT04314219|Alkylating Agents|alkylating agents|mesh-ancestor
110482252|NCT04314219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110482253|NCT04314219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110482254|NCT04314219|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110482255|NCT04314219|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110482256|NCT04314219|Abortifacient Agents|abortifacient agents|mesh-ancestor
110482257|NCT04314219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110482258|NCT04314219|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110482259|NCT04314219|Antimetabolites|antimetabolites|mesh-ancestor
110482260|NCT04314219|Dermatologic Agents|dermatologic agents|mesh-ancestor
110482261|NCT04314219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110482262|NCT04314219|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110482263|NCT04314219|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110482264|NCT02407119|Amoxicillin|amoxicillin|mesh-list
110482265|NCT02407119|Clarithromycin|clarithromycin|mesh-list
110482266|NCT02407119|Omeprazole|omeprazole|mesh-list
110482267|NCT02407119|Rabeprazole|rabeprazole|mesh-list
110482268|NCT02407119|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
110482269|NCT02407119|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110482270|NCT02407119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110482271|NCT02407119|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110482272|NCT02407119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110482273|NCT02407119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110482274|NCT02407119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110482275|NCT02407119|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110482276|NCT02407119|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110482277|NCT02407119|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110482278|NCT01008410|Budesonide|budesonide|mesh-list
110482279|NCT01008410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110482280|NCT01008410|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110482281|NCT01008410|Autonomic Agents|autonomic agents|mesh-ancestor
110482282|NCT01008410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110482283|NCT01008410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110482284|NCT01008410|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110482285|NCT01008410|Respiratory System Agents|respiratory system agents|mesh-ancestor
110482286|NCT01008410|Glucocorticoids|glucocorticoids|mesh-ancestor
110482287|NCT01008410|Hormones|hormones|mesh-ancestor
110482288|NCT01008410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110482289|NCT00627653|Fenofibrate|fenofibrate|mesh-list
110482290|NCT00627653|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110482291|NCT00627653|Antimetabolites|antimetabolites|mesh-ancestor
110482292|NCT00627653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110482293|NCT00627653|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110482294|NCT02347917|Pemetrexed|pemetrexed|mesh-list
110129569|NCT01955187|Antiemetics|antiemetics|mesh-ancestor
110482295|NCT02347917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110482296|NCT02347917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110482297|NCT02347917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110482298|NCT02347917|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110482299|NCT02347917|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110482300|NCT01972035|Valacyclovir|valacyclovir|mesh-list
110482301|NCT01972035|Valganciclovir|valganciclovir|mesh-list
110482302|NCT01972035|Antiviral Agents|antiviral agents|mesh-ancestor
110482303|NCT01972035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110482304|NCT00622479|Sorafenib|sorafenib|mesh-list
110482305|NCT00622479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110482306|NCT00622479|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110482307|NCT00622479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110482308|NCT00622479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110482309|NCT01207011|Docetaxel|docetaxel|mesh-list
110482311|NCT01207011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110482312|NCT01207011|Tubulin Modulators|tubulin modulators|mesh-ancestor
110482313|NCT01207011|Antimitotic Agents|antimitotic agents|mesh-ancestor
110482314|NCT01207011|Mitosis Modulators|mitosis modulators|mesh-ancestor
110482315|NCT01207011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110482316|NCT05264805|Bupivacaine|bupivacaine|mesh-list
110482317|NCT05264805|Anesthetics, Local|anesthetics, local|mesh-ancestor
110482318|NCT05264805|Anesthetics|anesthetics|mesh-ancestor
110482319|NCT05264805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110482320|NCT05264805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110482321|NCT05264805|Sensory System Agents|sensory system agents|mesh-ancestor
110482322|NCT05264805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110482323|NCT05264493|Naloxone|naloxone|mesh-list
110482324|NCT05264493|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110482325|NCT05264493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110482326|NCT05264493|Sensory System Agents|sensory system agents|mesh-ancestor
110482327|NCT05264493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110482328|NCT00612261|Triamcinolone|triamcinolone|mesh-list
110482329|NCT00612261|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110482330|NCT00612261|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110482331|NCT00612261|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110482332|NCT00612261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110482333|NCT00612261|Glucocorticoids|glucocorticoids|mesh-ancestor
110482334|NCT00612261|Hormones|hormones|mesh-ancestor
110406432|NCT01002547|Vitamins|vitamins|mesh-list
110482335|NCT00612261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110482336|NCT00612261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110482337|NCT00612261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110482338|NCT00612261|Immunologic Factors|immunologic factors|mesh-ancestor
110482339|NCT00612261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110482340|NCT00612261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110482341|NCT00636909|Cyclosporine|cyclosporine|mesh-list
110482342|NCT00636909|Cyclophosphamide|cyclophosphamide|mesh-list
110482343|NCT00636909|Methotrexate|methotrexate|mesh-list
110482344|NCT00636909|Fludarabine|fludarabine|mesh-list
110482345|NCT00636909|Cyclosporins|cyclosporins|mesh-list
110482346|NCT00636909|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110482347|NCT00636909|Immunologic Factors|immunologic factors|mesh-ancestor
110482348|NCT00636909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110482349|NCT00636909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110482350|NCT00636909|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110482351|NCT00636909|Alkylating Agents|alkylating agents|mesh-ancestor
110482352|NCT00636909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110482353|NCT00636909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110482354|NCT00636909|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110482355|NCT00636909|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110482356|NCT00636909|Abortifacient Agents|abortifacient agents|mesh-ancestor
110482357|NCT00636909|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110406605|NCT01293968|Histamine Agents|histamine agents|mesh-ancestor
110482358|NCT00636909|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110482359|NCT00636909|Antimetabolites|antimetabolites|mesh-ancestor
110482360|NCT00636909|Dermatologic Agents|dermatologic agents|mesh-ancestor
110482361|NCT00636909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110482362|NCT00636909|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110482363|NCT00636909|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110482364|NCT00636909|Antifungal Agents|antifungal agents|mesh-ancestor
110482365|NCT00636909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110482366|NCT00636909|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110482367|NCT02697669|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110482368|NCT02697669|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110482369|NCT02697669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110482370|NCT02697201|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
110482371|NCT02697201|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
110482372|NCT02697201|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
110482373|NCT02697201|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110482374|NCT02697045|Aripiprazole|aripiprazole|mesh-list
110482375|NCT02697045|Antidepressive Agents|antidepressive agents|mesh-ancestor
110482376|NCT02697045|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110482377|NCT02697045|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110482378|NCT02697045|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110482379|NCT02697045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110482380|NCT02697045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110482381|NCT02697045|Dopamine Agonists|dopamine agonists|mesh-ancestor
110482382|NCT02697045|Dopamine Agents|dopamine agents|mesh-ancestor
110482383|NCT02697045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110482384|NCT02697045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110482385|NCT02697045|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110482386|NCT02697045|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110482388|NCT02697045|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110482389|NCT02697045|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110482390|NCT02697045|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110482391|NCT02697045|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110482392|NCT01007942|Trastuzumab|trastuzumab|mesh-list
110482393|NCT01007942|Everolimus|everolimus|mesh-list
110482394|NCT01007942|Vinorelbine|vinorelbine|mesh-list
110482395|NCT01007942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110482396|NCT01007942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110482397|NCT01007942|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110482398|NCT01007942|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110482399|NCT01007942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110482400|NCT01007942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110482401|NCT01007942|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110482402|NCT01007942|Immunologic Factors|immunologic factors|mesh-ancestor
110406828|NCT04291729|Interferons|interferons|mesh-list
110482403|NCT01007942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110482404|NCT01007942|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110482405|NCT01007942|Tubulin Modulators|tubulin modulators|mesh-ancestor
110482406|NCT01007942|Antimitotic Agents|antimitotic agents|mesh-ancestor
110482407|NCT01007942|Mitosis Modulators|mitosis modulators|mesh-ancestor
110482408|NCT01023035|Ribavirin|ribavirin|mesh-list
110482409|NCT01023035|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110482410|NCT01023035|Epoetin Alfa|epoetin alfa|mesh-list
110482411|NCT01023035|Antimetabolites|antimetabolites|mesh-ancestor
110482412|NCT01023035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110482413|NCT01023035|Antiviral Agents|antiviral agents|mesh-ancestor
110482414|NCT01023035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110482415|NCT01023035|Hematinics|hematinics|mesh-ancestor
110482417|NCT01028651|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110482418|NCT00627731|Methylprednisolone|methylprednisolone|mesh-list
110482419|NCT00627731|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110482420|NCT00627731|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110482421|NCT00627731|Prednisolone|prednisolone|mesh-list
110482422|NCT00627731|Prednisolone acetate|prednisolone acetate|mesh-list
110482423|NCT00627731|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110482424|NCT00627731|Prednisolone phosphate|prednisolone phosphate|mesh-list
110482425|NCT00627731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110482426|NCT00627731|Antiemetics|antiemetics|mesh-ancestor
110482427|NCT00627731|Autonomic Agents|autonomic agents|mesh-ancestor
110482428|NCT00627731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110482429|NCT00627731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110482430|NCT00627731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110406993|NCT00985621|Oxycodone|oxycodone|mesh-list
110482431|NCT00627731|Glucocorticoids|glucocorticoids|mesh-ancestor
110482432|NCT00627731|Hormones|hormones|mesh-ancestor
110482433|NCT00627731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110482434|NCT00627731|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110482435|NCT00627731|Protective Agents|protective agents|mesh-ancestor
110482436|NCT00627731|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110482437|NCT00627731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110482438|NCT01028027|Loteprednol Etabonate|loteprednol etabonate|mesh-list
110482439|NCT01028027|Tobramycin|tobramycin|mesh-list
110482440|NCT01028027|Dexamethasone|dexamethasone|mesh-list
110482441|NCT01028027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110482442|NCT01028027|Antiemetics|antiemetics|mesh-ancestor
110482443|NCT01028027|Autonomic Agents|autonomic agents|mesh-ancestor
110482444|NCT01028027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110482445|NCT01028027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110482446|NCT01028027|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110482447|NCT01028027|Glucocorticoids|glucocorticoids|mesh-ancestor
110482449|NCT01028027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110166284|NCT00027547|Antiviral Agents|antiviral agents|mesh-ancestor
110482450|NCT01028027|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110482451|NCT01028027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110482452|NCT01028027|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110482453|NCT01028027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110482454|NCT01028027|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110482455|NCT01007552|Bevacizumab|bevacizumab|mesh-list
110482456|NCT01007552|Gemcitabine|gemcitabine|mesh-list
110482457|NCT01007552|Capecitabine|capecitabine|mesh-list
110482458|NCT01007552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110482459|NCT01007552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110482460|NCT01007552|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110482461|NCT01007552|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110482462|NCT01007552|Growth Substances|growth substances|mesh-ancestor
110482463|NCT01007552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110482464|NCT01007552|Growth Inhibitors|growth inhibitors|mesh-ancestor
110482465|NCT01007552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110482466|NCT01007552|Antimetabolites|antimetabolites|mesh-ancestor
110407243|NCT01214421|Tolvaptan|tolvaptan|mesh-list
110482467|NCT01007552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110482469|NCT02870036|Thalidomide|thalidomide|mesh-list
110482470|NCT02870036|Fluorouracil|fluorouracil|mesh-list
110482471|NCT02870036|Calcium|calcium|mesh-list
110482472|NCT02870036|Levoleucovorin|levoleucovorin|mesh-list
110482473|NCT02870036|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110267460|NCT00184041|Cytarabine|cytarabine|mesh-list
110482474|NCT02870036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110482475|NCT02870036|Antimetabolites|antimetabolites|mesh-ancestor
110482476|NCT02870036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110482477|NCT02870036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110482478|NCT02870036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110482479|NCT02870036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110482480|NCT02870036|Immunologic Factors|immunologic factors|mesh-ancestor
110482481|NCT02870036|Antidotes|antidotes|mesh-ancestor
110482482|NCT02870036|Protective Agents|protective agents|mesh-ancestor
110482483|NCT02870036|Vitamin B Complex|vitamin b complex|mesh-ancestor
110482484|NCT02870036|Vitamins|vitamins|mesh-ancestor
110482485|NCT02870036|Micronutrients|micronutrients|mesh-ancestor
110482486|NCT02870036|Leprostatic Agents|leprostatic agents|mesh-ancestor
110482487|NCT02870036|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110482488|NCT02870036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110482489|NCT02870036|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110482490|NCT02870036|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110482491|NCT02870036|Growth Substances|growth substances|mesh-ancestor
110482492|NCT02870036|Growth Inhibitors|growth inhibitors|mesh-ancestor
110482494|NCT04296422|Diclofenac|diclofenac|mesh-list
110482495|NCT04296422|Naproxen|naproxen|mesh-list
110482496|NCT04296422|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
110482497|NCT04296422|Piroxicam|piroxicam|mesh-list
110482498|NCT04296422|Contraceptive Agents|contraceptive agents|mesh-list
110482499|NCT04296422|Contraceptives, Oral|contraceptives, oral|mesh-list
110482500|NCT04296422|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110482501|NCT04296422|Analgesics|analgesics|mesh-ancestor
110482502|NCT04296422|Sensory System Agents|sensory system agents|mesh-ancestor
110482503|NCT04296422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110482504|NCT04296422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110482505|NCT04296422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110482506|NCT04296422|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110482507|NCT04296422|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110482508|NCT04296422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110482509|NCT04296422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110482510|NCT04296422|Gout Suppressants|gout suppressants|mesh-ancestor
110482511|NCT04296422|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110482512|NCT04296422|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110482513|NCT00998738|Calcium, Dietary|calcium, dietary|mesh-list
110482514|NCT00998738|Magnesium Sulfate|magnesium sulfate|mesh-list
110482515|NCT00998738|Calcium|calcium|mesh-list
110482516|NCT00998738|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110482517|NCT00998738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110482518|NCT00998738|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110482520|NCT00998738|Sensory System Agents|sensory system agents|mesh-ancestor
110482521|NCT00998738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110482522|NCT00998738|Anesthetics|anesthetics|mesh-ancestor
110482523|NCT00998738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110482525|NCT00998738|Anticonvulsants|anticonvulsants|mesh-ancestor
110482526|NCT00998738|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110482527|NCT00998738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110482528|NCT00998738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110482529|NCT00998738|Tocolytic Agents|tocolytic agents|mesh-ancestor
110482530|NCT00998738|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110482531|NCT00997334|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110482533|NCT00997334|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110482534|NCT00997334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110407625|NCT02887677|Dapagliflozin|dapagliflozin|mesh-list
110482535|NCT00997334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110482536|NCT04369664|Atorvastatin|atorvastatin|mesh-list
110482537|NCT04369664|Ezetimibe|ezetimibe|mesh-list
110482538|NCT04369664|Evolocumab|evolocumab|mesh-list
110482539|NCT04369664|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-list
110267478|NCT00184041|Abortifacient Agents|abortifacient agents|mesh-ancestor
110482540|NCT04369664|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110482541|NCT04369664|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110482542|NCT04369664|Antimetabolites|antimetabolites|mesh-ancestor
110482543|NCT04369664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110407694|NCT01200069|Analgesics|analgesics|mesh-ancestor
110482544|NCT04369664|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110482545|NCT04369664|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110482547|NCT04369664|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110482548|NCT04369664|Protease Inhibitors|protease inhibitors|mesh-ancestor
110482549|NCT04296578|Selenious Acid|selenious acid|mesh-list
110482550|NCT04296578|Sodium Selenite|sodium selenite|mesh-list
110482551|NCT04296578|Prednisone|prednisone|mesh-list
110482552|NCT04296578|Abiraterone Acetate|abiraterone acetate|mesh-list
110482553|NCT04296578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110482554|NCT04296578|Glucocorticoids|glucocorticoids|mesh-ancestor
110482555|NCT04296578|Hormones|hormones|mesh-ancestor
110407758|NCT00977431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110482556|NCT04296578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110482557|NCT04296578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110482558|NCT04296578|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110482559|NCT04296578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110482560|NCT04296578|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110482561|NCT04296578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110482562|NCT04296578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110482563|NCT04296578|Hormone Antagonists|hormone antagonists|mesh-ancestor
110482564|NCT04296578|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110482565|NCT04296578|Trace Elements|trace elements|mesh-ancestor
110482566|NCT04296578|Micronutrients|micronutrients|mesh-ancestor
110482567|NCT00996944|Ropinirole|ropinirole|mesh-list
110482568|NCT00996944|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110482569|NCT00996944|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110482570|NCT00996944|Dopamine Agonists|dopamine agonists|mesh-ancestor
110482571|NCT00996944|Dopamine Agents|dopamine agents|mesh-ancestor
110407885|NCT01193517|Capecitabine|capecitabine|mesh-list
110482573|NCT00996944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110482574|NCT00996944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110482575|NCT01027949|Treprostinil|treprostinil|mesh-list
110482576|NCT01027949|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110482577|NCT01038323|Milnacipran|milnacipran|mesh-list
110482578|NCT01038323|Levomilnacipran|levomilnacipran|mesh-list
110482579|NCT01038323|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110482580|NCT01038323|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110482581|NCT01038323|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110482582|NCT01038323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110482583|NCT01038323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110482584|NCT01038323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110482585|NCT01038323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110482586|NCT01038323|Analgesics|analgesics|mesh-ancestor
110482587|NCT01038323|Sensory System Agents|sensory system agents|mesh-ancestor
110482588|NCT01038323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110482589|NCT01038323|Antidepressive Agents|antidepressive agents|mesh-ancestor
110482590|NCT01038323|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110482591|NCT01027871|Insulin Glargine|insulin glargine|mesh-list
110482592|NCT01027871|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110482593|NCT01027871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110482594|NCT04301375|Paclitaxel|paclitaxel|mesh-list
110482595|NCT04301375|Trastuzumab|trastuzumab|mesh-list
110482596|NCT04301375|Pertuzumab|pertuzumab|mesh-list
110482597|NCT04301375|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110407955|NCT01307267|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110482598|NCT04301375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110482600|NCT04301375|Antimitotic Agents|antimitotic agents|mesh-ancestor
110482601|NCT04301375|Mitosis Modulators|mitosis modulators|mesh-ancestor
110482602|NCT04301375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110482603|NCT04301375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110482604|NCT01021553|Diketopiperazines|diketopiperazines|mesh-list
110482605|NCT01021553|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110482606|NCT01021553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110482607|NCT01026389|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
110482608|NCT01026389|Chelating Agents|chelating agents|mesh-ancestor
110482609|NCT01026389|Sequestering Agents|sequestering agents|mesh-ancestor
110482610|NCT01026389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110482611|NCT01025843|Candesartan|candesartan|mesh-list
110482612|NCT01025843|Candesartan cilexetil|candesartan cilexetil|mesh-list
110482613|NCT01025843|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110482614|NCT01025843|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110482615|NCT01025843|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110482616|NCT01025843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110482618|NCT02873351|Carbidopa|carbidopa|mesh-list
110482619|NCT02873351|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
110482620|NCT02873351|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110482621|NCT02873351|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110482622|NCT02873351|Dopamine Agents|dopamine agents|mesh-ancestor
110482623|NCT02873351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110482624|NCT02873351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110482625|NCT02873351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110482626|NCT02873351|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
110482627|NCT02873351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110408003|NCT00624663|Protective Agents|protective agents|mesh-ancestor
110482628|NCT02873351|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110482629|NCT02873351|Immunologic Factors|immunologic factors|mesh-ancestor
110482630|NCT02873351|Dopamine Agonists|dopamine agonists|mesh-ancestor
110482631|NCT04299971|Methotrexate|methotrexate|mesh-list
110482632|NCT04299971|Tofacitinib|tofacitinib|mesh-list
110482633|NCT04299971|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110482634|NCT04299971|Abortifacient Agents|abortifacient agents|mesh-ancestor
110482635|NCT04299971|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110482636|NCT04299971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110482637|NCT04299971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110482638|NCT04299971|Antimetabolites|antimetabolites|mesh-ancestor
110482639|NCT04299971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110482640|NCT04299971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110482641|NCT04299971|Dermatologic Agents|dermatologic agents|mesh-ancestor
110482642|NCT04299971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110482643|NCT04299971|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110482644|NCT04299971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110482645|NCT04299971|Immunologic Factors|immunologic factors|mesh-ancestor
110482646|NCT04299971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110482647|NCT04299971|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110482648|NCT04299971|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
110482649|NCT04299971|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110482650|NCT01020305|Sirolimus|sirolimus|mesh-list
110482651|NCT01020305|Temsirolimus|temsirolimus|mesh-list
110482652|NCT01020305|MTOR Inhibitors|mtor inhibitors|mesh-list
110482653|NCT01020305|Bicalutamide|bicalutamide|mesh-list
110482654|NCT01020305|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110482655|NCT01020305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110482656|NCT01020305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110482657|NCT01020305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110482658|NCT01020305|Immunologic Factors|immunologic factors|mesh-ancestor
110482659|NCT01020305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110482660|NCT01020305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110482661|NCT01020305|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110482662|NCT01020305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110482663|NCT01020305|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110482664|NCT01020305|Antifungal Agents|antifungal agents|mesh-ancestor
110482665|NCT01020305|Androgen Antagonists|androgen antagonists|mesh-ancestor
110482666|NCT01020305|Hormone Antagonists|hormone antagonists|mesh-ancestor
110408044|NCT01305941|Immunologic Factors|immunologic factors|mesh-ancestor
110482667|NCT01020305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110482668|NCT00627575|Lamotrigine|lamotrigine|mesh-list
110482669|NCT00627575|Phenytoin|phenytoin|mesh-list
110482670|NCT00627575|Atorvastatin|atorvastatin|mesh-list
110482671|NCT00627575|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110482672|NCT00627575|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110482673|NCT00627575|Antimetabolites|antimetabolites|mesh-ancestor
110482674|NCT00627575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110482675|NCT00627575|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110482676|NCT00627575|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110482677|NCT00627575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110482678|NCT00627575|Anticonvulsants|anticonvulsants|mesh-ancestor
110408068|NCT05658159|Ergocalciferols|ergocalciferols|mesh-list
110482679|NCT00627575|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110482680|NCT00627575|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110482681|NCT00627575|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110482682|NCT00627575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110482683|NCT00627575|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110482684|NCT00627575|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110482685|NCT00627575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110482686|NCT00627575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110482687|NCT00627575|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110482688|NCT00627575|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110482689|NCT00627575|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110482690|NCT00627575|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110482691|NCT00627809|Streptokinase|streptokinase|mesh-list
110482692|NCT00627809|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110482693|NCT00627809|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110482694|NCT00627809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110482695|NCT01024751|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110482696|NCT02872649|Warfarin|warfarin|mesh-list
110482697|NCT02872649|Dabigatran|dabigatran|mesh-list
110482698|NCT02872649|Phenprocoumon|phenprocoumon|mesh-list
110482699|NCT02872649|Anticoagulants|anticoagulants|mesh-ancestor
110482700|NCT02872649|Antithrombins|antithrombins|mesh-ancestor
110482701|NCT02872649|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110482702|NCT02872649|Protease Inhibitors|protease inhibitors|mesh-ancestor
110482703|NCT02872649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110482704|NCT02872649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110482705|NCT01019369|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
110482706|NCT01019369|Medroxyprogesterone|medroxyprogesterone|mesh-list
110482707|NCT01019369|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110482708|NCT01019369|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110482709|NCT01019369|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110482710|NCT01019369|Contraceptive Agents|contraceptive agents|mesh-ancestor
110482711|NCT01019369|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110482712|NCT01019369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110482713|NCT01019369|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110482714|NCT01019369|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110482715|NCT01019369|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110482716|NCT01019369|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110482717|NCT01019369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110482718|NCT01018511|Tamsulosin|tamsulosin|mesh-list
110482719|NCT01018511|Solifenacin Succinate|solifenacin succinate|mesh-list
110482720|NCT01018511|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110482721|NCT01018511|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110482722|NCT01018511|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110482724|NCT01018511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110482725|NCT01018511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110482726|NCT01018511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110482727|NCT01018511|Urological Agents|urological agents|mesh-ancestor
110482728|NCT01018511|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110482729|NCT01018511|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110482730|NCT01018511|Cholinergic Agents|cholinergic agents|mesh-ancestor
110482731|NCT00996476|Simeprevir|simeprevir|mesh-list
110482732|NCT00996476|Antiviral Agents|antiviral agents|mesh-ancestor
110482733|NCT00996476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110482734|NCT00996476|Protease Inhibitors|protease inhibitors|mesh-ancestor
110482735|NCT00996476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110482736|NCT00996476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110482737|NCT02269267|Imatinib Mesylate|imatinib mesylate|mesh-list
110482738|NCT02269267|Dasatinib|dasatinib|mesh-list
110482739|NCT02269267|Tin Fluorides|tin fluorides|mesh-list
110482740|NCT02269267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110482741|NCT02269267|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110482742|NCT02269267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110482743|NCT02269267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110482745|NCT02269267|Protective Agents|protective agents|mesh-ancestor
110482746|NCT02269267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110482747|NCT02575495|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110482748|NCT02575495|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
110482749|NCT02575495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110482750|NCT02575495|Antitubercular Agents|antitubercular agents|mesh-ancestor
110482751|NCT02575261|Immunomodulating Agents|immunomodulating agents|mesh-list
110482752|NCT02575261|Immunologic Factors|immunologic factors|mesh-ancestor
110482753|NCT02575261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110482754|NCT01017731|Diphenhydramine|diphenhydramine|mesh-list
110482755|NCT01017731|Promethazine|promethazine|mesh-list
110482756|NCT01017731|Moxifloxacin|moxifloxacin|mesh-list
110482757|NCT01017731|Ramucirumab|ramucirumab|mesh-list
110482758|NCT01017731|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110482759|NCT01017731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110482760|NCT01017731|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110482761|NCT01017731|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110482762|NCT01017731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110482763|NCT01017731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110482764|NCT01017731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110482765|NCT01017731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110482766|NCT01017731|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110482767|NCT01017731|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110482768|NCT01017731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110482769|NCT01017731|Anesthetics, Local|anesthetics, local|mesh-ancestor
110482770|NCT01017731|Anesthetics|anesthetics|mesh-ancestor
110482771|NCT01017731|Sensory System Agents|sensory system agents|mesh-ancestor
110482772|NCT01017731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110482773|NCT01017731|Antiemetics|antiemetics|mesh-ancestor
110482774|NCT01017731|Autonomic Agents|autonomic agents|mesh-ancestor
110482775|NCT01017731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110482776|NCT01017731|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110482777|NCT01017731|Histamine Antagonists|histamine antagonists|mesh-ancestor
110482778|NCT01017731|Histamine Agents|histamine agents|mesh-ancestor
110482779|NCT01017731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110482780|NCT01017731|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110482781|NCT01017731|Antipruritics|antipruritics|mesh-ancestor
110482782|NCT01017731|Dermatologic Agents|dermatologic agents|mesh-ancestor
110482783|NCT02575183|Varenicline|varenicline|mesh-list
110482784|NCT02575183|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110482785|NCT02575183|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110482786|NCT02575183|Cholinergic Agents|cholinergic agents|mesh-ancestor
110482787|NCT02575183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110482788|NCT02575183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110482789|NCT02575183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110482790|NCT02255305|Anti-Infective Agents|anti-infective agents|mesh-list
110482791|NCT02255305|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110482792|NCT00779584|Gemcitabine|gemcitabine|mesh-list
110482793|NCT00779584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110482794|NCT00779584|Antimetabolites|antimetabolites|mesh-ancestor
110482795|NCT00779584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110482796|NCT00779584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110482797|NCT00779506|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110482798|NCT00779506|Antidepressive Agents|antidepressive agents|mesh-ancestor
110482799|NCT00779506|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110482800|NCT00779506|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110482801|NCT00779506|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110408528|NCT05356936|Vitamin D|vitamin d|mesh-list
110482802|NCT00779506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110482803|NCT00779506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110482805|NCT01385059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110482806|NCT01385059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110482807|NCT01385059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110482808|NCT01385059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110482809|NCT00769132|Niacin|niacin|mesh-list
110482810|NCT00769132|Niacinamide|niacinamide|mesh-list
110482811|NCT00769132|Nicotinic Acids|nicotinic acids|mesh-list
110482812|NCT00769132|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110482813|NCT00769132|Antimetabolites|antimetabolites|mesh-ancestor
110482814|NCT00769132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110482815|NCT00769132|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110482816|NCT00769132|Vasodilator Agents|vasodilator agents|mesh-ancestor
110482817|NCT00769132|Vitamin B Complex|vitamin b complex|mesh-ancestor
110482818|NCT00769132|Vitamins|vitamins|mesh-ancestor
110482819|NCT00769132|Micronutrients|micronutrients|mesh-ancestor
110482820|NCT00769132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110482822|NCT04070755|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110482823|NCT04070755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110482824|NCT04100434|Evolocumab|evolocumab|mesh-list
110482825|NCT04100434|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
110482826|NCT04100434|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110482828|NCT04100434|Antimetabolites|antimetabolites|mesh-ancestor
110308017|NCT00269867|Infliximab|infliximab|mesh-list
110308170|NCT00418548|Etanercept|etanercept|mesh-list
110308653|NCT00273026|Xhance|xhance|mesh-list
110309070|NCT00308763|Dopamine Agents|dopamine agents|mesh-ancestor
110482829|NCT04100434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110267548|NCT00543244|Interferons|interferons|mesh-list
110309521|NCT00309855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110482830|NCT04100434|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110309757|NCT00280280|Baclofen|baclofen|mesh-list
110310356|NCT00283946|Zolpidem|zolpidem|mesh-list
110482831|NCT04100434|Protease Inhibitors|protease inhibitors|mesh-ancestor
110482832|NCT04100434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110310525|NCT00319059|Annexin A5|annexin a5|mesh-list
110482833|NCT04100434|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110482835|NCT00991952|Alvocidib|alvocidib|mesh-list
110311158|NCT00287885|Antimitotic Agents|antimitotic agents|mesh-ancestor
110311242|NCT00322569|Analgesics|analgesics|mesh-ancestor
110311308|NCT00288353|Aripiprazole|aripiprazole|mesh-list
110311381|NCT00417677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110482836|NCT00991952|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110482837|NCT00991952|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110482838|NCT00991952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110482839|NCT00991952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110482840|NCT00991952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110482842|NCT00991952|Growth Substances|growth substances|mesh-ancestor
110482843|NCT00991952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110482844|NCT00991952|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110482845|NCT00779038|Fentanyl|fentanyl|mesh-list
110482846|NCT00779038|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110482847|NCT00779038|Narcotics|narcotics|mesh-ancestor
110482848|NCT00779038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110482849|NCT00779038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110482850|NCT00779038|Analgesics|analgesics|mesh-ancestor
110482851|NCT00779038|Sensory System Agents|sensory system agents|mesh-ancestor
110482852|NCT00779038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110482853|NCT00779038|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110482854|NCT00779038|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110482855|NCT00779038|Anesthetics, General|anesthetics, general|mesh-ancestor
110482856|NCT00779038|Anesthetics|anesthetics|mesh-ancestor
110482857|NCT04292990|Fentanyl|fentanyl|mesh-list
110482858|NCT04292990|Morphine|morphine|mesh-list
110482859|NCT04292990|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110482860|NCT04292990|Narcotics|narcotics|mesh-ancestor
110482861|NCT04292990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110482862|NCT04292990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110482863|NCT04292990|Analgesics|analgesics|mesh-ancestor
110482864|NCT04292990|Sensory System Agents|sensory system agents|mesh-ancestor
110482865|NCT04292990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110482866|NCT04292990|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110482867|NCT04292990|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110482868|NCT04292990|Anesthetics, General|anesthetics, general|mesh-ancestor
110482869|NCT04292990|Anesthetics|anesthetics|mesh-ancestor
110482870|NCT02868632|Durvalumab|durvalumab|mesh-list
110482871|NCT02868632|Tremelimumab|tremelimumab|mesh-list
110482872|NCT02868632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110482873|NCT02868632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110482874|NCT04021498|Simvastatin|simvastatin|mesh-list
110482875|NCT04021498|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110482876|NCT04021498|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110482877|NCT04021498|Antimetabolites|antimetabolites|mesh-ancestor
110482878|NCT04021498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110482879|NCT04021498|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110408739|NCT04283656|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110482880|NCT04021498|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110482881|NCT04021498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110482882|NCT00994682|Pioglitazone|pioglitazone|mesh-list
110482883|NCT00994682|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110482884|NCT00994682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110482885|NCT00994448|Bupropion|bupropion|mesh-list
110267568|NCT03456661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110482886|NCT00994448|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110482887|NCT00994448|Antidepressive Agents|antidepressive agents|mesh-ancestor
110482888|NCT00994448|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110482889|NCT00994448|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110482890|NCT00994448|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110482891|NCT00994448|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110482892|NCT00994448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110482893|NCT00994448|Dopamine Agents|dopamine agents|mesh-ancestor
110482894|NCT00994448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110482895|NCT00994448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110482896|NCT00994448|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110482897|NCT00994448|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110482898|NCT00994448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110482899|NCT04292444|Oxytocin|oxytocin|mesh-list
110482900|NCT04292444|Oxytocics|oxytocics|mesh-ancestor
110482901|NCT04292444|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110482902|NCT04292444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110482903|NCT01017575|Ribavirin|ribavirin|mesh-list
110482904|NCT01017575|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110482905|NCT01017575|Antimetabolites|antimetabolites|mesh-ancestor
110408856|NCT03933397|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110482906|NCT01017575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110482907|NCT01017575|Antiviral Agents|antiviral agents|mesh-ancestor
110482908|NCT01017575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110482909|NCT01017263|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
110482910|NCT01017263|Dextroamphetamine|dextroamphetamine|mesh-list
110482911|NCT01017263|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110482912|NCT01017263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110482913|NCT01017263|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110482914|NCT01017263|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110482915|NCT01017263|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110482916|NCT01017263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110482917|NCT01017263|Dopamine Agents|dopamine agents|mesh-ancestor
110482918|NCT01017263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110482919|NCT01253161|Pasireotide|pasireotide|mesh-list
110482921|NCT01253161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110482922|NCT01253161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110482923|NCT00709423|Moxaverine|moxaverine|mesh-list
110409056|NCT03023631|Vaccines|vaccines|mesh-list
110482924|NCT00709423|Parasympatholytics|parasympatholytics|mesh-ancestor
110482925|NCT00709423|Autonomic Agents|autonomic agents|mesh-ancestor
110482926|NCT00709423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110482927|NCT00709423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110482928|NCT00627887|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
110482929|NCT00627887|Antidepressive Agents|antidepressive agents|mesh-ancestor
110482930|NCT00627887|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110482931|NCT00627887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110482932|NCT00627887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110482933|NCT00627887|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110482935|NCT00627887|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110482936|NCT00627887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110482937|NCT00627887|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110482938|NCT02576665|Flucytosine|flucytosine|mesh-list
110482939|NCT02576665|Antifungal Agents|antifungal agents|mesh-ancestor
110482940|NCT02576665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110409199|NCT02471144|Etanercept|etanercept|mesh-list
110482941|NCT02576665|Antimetabolites|antimetabolites|mesh-ancestor
110482942|NCT02576665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110482943|NCT00627965|Sildenafil Citrate|sildenafil citrate|mesh-list
110482944|NCT00627965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110482945|NCT00627965|Vasodilator Agents|vasodilator agents|mesh-ancestor
110267583|NCT03456544|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110482946|NCT00627965|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110482947|NCT00627965|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110482948|NCT00627965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110482949|NCT00627965|Urological Agents|urological agents|mesh-ancestor
110482950|NCT02576353|Fentanyl|fentanyl|mesh-list
110482951|NCT02576353|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110482952|NCT02576353|Narcotics|narcotics|mesh-ancestor
110482953|NCT02576353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110482954|NCT02576353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110482955|NCT02576353|Analgesics|analgesics|mesh-ancestor
110482956|NCT02576353|Sensory System Agents|sensory system agents|mesh-ancestor
110482957|NCT02576353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110482958|NCT02576353|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110482959|NCT02576353|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110482960|NCT02576353|Anesthetics, General|anesthetics, general|mesh-ancestor
110482961|NCT02576353|Anesthetics|anesthetics|mesh-ancestor
110482962|NCT01016015|Sirolimus|sirolimus|mesh-list
110482963|NCT01016015|Temsirolimus|temsirolimus|mesh-list
110482964|NCT01016015|MTOR Inhibitors|mtor inhibitors|mesh-list
110482965|NCT01016015|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110482966|NCT01016015|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110482967|NCT01016015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110482968|NCT01016015|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110482969|NCT01016015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110482970|NCT01016015|Antifungal Agents|antifungal agents|mesh-ancestor
110482971|NCT01016015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110482972|NCT01016015|Immunologic Factors|immunologic factors|mesh-ancestor
110482973|NCT01016015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110482974|NCT01016015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110482975|NCT01016015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110166349|NCT00000464|Antimalarials|antimalarials|mesh-ancestor
110482976|NCT01016015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110482978|NCT00628043|Hematinics|hematinics|mesh-ancestor
110482979|NCT00709657|Bevacizumab|bevacizumab|mesh-list
110482980|NCT00709657|Ranibizumab|ranibizumab|mesh-list
110482981|NCT00709657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110482982|NCT00709657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110482983|NCT00709657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110482984|NCT00709657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110482985|NCT00709657|Growth Substances|growth substances|mesh-ancestor
110482986|NCT00709657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110482987|NCT00709657|Growth Inhibitors|growth inhibitors|mesh-ancestor
110482988|NCT04073173|Analgesics, Opioid|analgesics, opioid|mesh-list
110482990|NCT04073173|Narcotics|narcotics|mesh-ancestor
110482991|NCT04073173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110482992|NCT04073173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110482993|NCT04073173|Sensory System Agents|sensory system agents|mesh-ancestor
110482994|NCT04073173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110482996|NCT00628121|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110482997|NCT00628121|Fertility Agents|fertility agents|mesh-ancestor
110482998|NCT00628121|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110482999|NCT00628121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110483000|NCT00628121|Hormone Antagonists|hormone antagonists|mesh-ancestor
110483001|NCT00628121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110483002|NCT00709969|Lumefantrine|lumefantrine|mesh-list
110483003|NCT00709969|Artemether|artemether|mesh-list
110483004|NCT00709969|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
110483005|NCT00709969|Antimalarials|antimalarials|mesh-ancestor
110483006|NCT00709969|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110483007|NCT00709969|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110483008|NCT00709969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110483009|NCT00710125|Doxorubicin|doxorubicin|mesh-list
110483010|NCT00710125|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110483011|NCT00710125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110483012|NCT00710125|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110483013|NCT00710125|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110483014|NCT00710125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110483015|NCT00710125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110483016|NCT02573701|Risperidone|risperidone|mesh-list
110483017|NCT02573701|Antipsychotic Agents|antipsychotic agents|mesh-list
110483018|NCT02573701|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110483019|NCT02573701|Serotonin Agents|serotonin agents|mesh-ancestor
110483020|NCT02573701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110483021|NCT02573701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110483022|NCT02573701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110483023|NCT02573701|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110483024|NCT02573701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110483025|NCT02573701|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110483026|NCT02573701|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110483027|NCT02573701|Dopamine Agents|dopamine agents|mesh-ancestor
110483028|NCT01017029|Mycophenolic Acid|mycophenolic acid|mesh-list
110483030|NCT01017029|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110483031|NCT01017029|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110483032|NCT01017029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110483033|NCT01017029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110483034|NCT01017029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110483035|NCT01017029|Immunologic Factors|immunologic factors|mesh-ancestor
110483036|NCT01017029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110483037|NCT01017029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110483038|NCT01017029|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110483039|NCT01017029|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110483040|NCT01017029|Antitubercular Agents|antitubercular agents|mesh-ancestor
110483041|NCT01017029|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110483042|NCT01017029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110483044|NCT00714649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110483045|NCT00714649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110483047|NCT00710359|Vitamin B 12|vitamin b 12|mesh-list
110483048|NCT00710359|Hydroxocobalamin|hydroxocobalamin|mesh-list
110483049|NCT00710359|Vitamin B Complex|vitamin b complex|mesh-list
110483050|NCT00710359|Micronutrients|micronutrients|mesh-ancestor
110483051|NCT00710359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110483052|NCT00710359|Hematinics|hematinics|mesh-ancestor
110483053|NCT02578849|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
110483054|NCT02578849|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110483055|NCT02578849|Immunologic Factors|immunologic factors|mesh-ancestor
110409972|NCT00997984|Guanfacine|guanfacine|mesh-list
110483056|NCT02578849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110483057|NCT02578849|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110483058|NCT02578849|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110483059|NCT02578849|Dopamine Agonists|dopamine agonists|mesh-ancestor
110483060|NCT02578849|Dopamine Agents|dopamine agents|mesh-ancestor
110483061|NCT02578849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110483062|NCT02578849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110483063|NCT00710437|Dexmedetomidine|dexmedetomidine|mesh-list
110483064|NCT00710437|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110483065|NCT00710437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110483066|NCT00710437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110483067|NCT00710437|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110483068|NCT00710437|Analgesics|analgesics|mesh-ancestor
110483069|NCT00710437|Sensory System Agents|sensory system agents|mesh-ancestor
110483070|NCT00710437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110311517|NCT00323154|Analgesics|analgesics|mesh-ancestor
110410041|NCT01298765|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110483071|NCT00710437|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110483073|NCT00710437|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110483074|NCT00710437|Adrenergic Agents|adrenergic agents|mesh-ancestor
110483075|NCT00710437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110483076|NCT00710437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110483077|NCT02574715|Levonorgestrel|levonorgestrel|mesh-list
110483078|NCT02574715|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110483079|NCT02574715|Contraceptive Agents|contraceptive agents|mesh-ancestor
110483080|NCT02574715|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110483081|NCT02574715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110483082|NCT02574715|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110483083|NCT02574715|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110483084|NCT02574715|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110483085|NCT00714883|Sirolimus|sirolimus|mesh-list
110483086|NCT00714883|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110483087|NCT00714883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110483088|NCT00714883|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110483089|NCT00714883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110483090|NCT00714883|Antifungal Agents|antifungal agents|mesh-ancestor
110483091|NCT00714883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110483092|NCT00714883|Immunologic Factors|immunologic factors|mesh-ancestor
110483093|NCT00714883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110483094|NCT00710827|Testosterone undecanoate|testosterone undecanoate|mesh-list
110483095|NCT00710827|Androgens|androgens|mesh-ancestor
110483096|NCT00710827|Hormones|hormones|mesh-ancestor
110483097|NCT00710827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110483098|NCT00710827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110483099|NCT01034657|Panobinostat|panobinostat|mesh-list
110483100|NCT01034657|Epoetin Alfa|epoetin alfa|mesh-list
110483101|NCT01034657|Hematinics|hematinics|mesh-ancestor
110483102|NCT01034657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110267645|NCT00190827|Analgesics|analgesics|mesh-ancestor
110483103|NCT01034657|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110483104|NCT01034657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110483105|NCT01034657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110483106|NCT01014767|Leucovorin|leucovorin|mesh-list
110483107|NCT01014767|Dactinomycin|dactinomycin|mesh-list
110483108|NCT01014767|Cyclophosphamide|cyclophosphamide|mesh-list
110483109|NCT01014767|Temozolomide|temozolomide|mesh-list
110483110|NCT01014767|Cisplatin|cisplatin|mesh-list
110483111|NCT01014767|Carboplatin|carboplatin|mesh-list
110483112|NCT01014767|Doxorubicin|doxorubicin|mesh-list
110483113|NCT01014767|Methotrexate|methotrexate|mesh-list
110483114|NCT01014767|Irinotecan|irinotecan|mesh-list
110483115|NCT01014767|Etoposide|etoposide|mesh-list
110483116|NCT01014767|Vincristine|vincristine|mesh-list
110483117|NCT01014767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110483118|NCT01014767|Immunologic Factors|immunologic factors|mesh-ancestor
110483119|NCT01014767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110483120|NCT01014767|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110483121|NCT01014767|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110483122|NCT01014767|Alkylating Agents|alkylating agents|mesh-ancestor
110483123|NCT01014767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110410239|NCT01172535|Ritonavir|ritonavir|mesh-list
110483124|NCT01014767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110483125|NCT01014767|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110483126|NCT01014767|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110483127|NCT01014767|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110483128|NCT01014767|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110483129|NCT01014767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110483130|NCT01014767|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110483131|NCT01014767|Abortifacient Agents|abortifacient agents|mesh-ancestor
110483132|NCT01014767|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110483133|NCT01014767|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110483134|NCT01014767|Antimetabolites|antimetabolites|mesh-ancestor
110483135|NCT01014767|Dermatologic Agents|dermatologic agents|mesh-ancestor
110483136|NCT01014767|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110483137|NCT01014767|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110483138|NCT01014767|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110483139|NCT01014767|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110483141|NCT01014767|Protective Agents|protective agents|mesh-ancestor
110483142|NCT01014767|Vitamin B Complex|vitamin b complex|mesh-ancestor
110483143|NCT01014767|Vitamins|vitamins|mesh-ancestor
110483144|NCT01014767|Micronutrients|micronutrients|mesh-ancestor
110483145|NCT01014767|Tubulin Modulators|tubulin modulators|mesh-ancestor
110483146|NCT01014767|Antimitotic Agents|antimitotic agents|mesh-ancestor
110483147|NCT01014767|Mitosis Modulators|mitosis modulators|mesh-ancestor
110483149|NCT01014767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110483150|NCT01014767|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110483151|NCT01014689|Lymecycline|lymecycline|mesh-list
110483152|NCT01014689|Adapalene|adapalene|mesh-list
110483153|NCT01014689|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110483154|NCT01014689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110483155|NCT01014689|Analgesics|analgesics|mesh-ancestor
110483156|NCT01014689|Sensory System Agents|sensory system agents|mesh-ancestor
110483157|NCT01014689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110483158|NCT01014689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110483159|NCT01014689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110483160|NCT01014689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110483161|NCT01014689|Dermatologic Agents|dermatologic agents|mesh-ancestor
110483162|NCT01014689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110483163|NCT01014689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110483164|NCT01014533|Gabapentin|gabapentin|mesh-list
110483165|NCT01014533|Analgesics|analgesics|mesh-ancestor
110483166|NCT01014533|Sensory System Agents|sensory system agents|mesh-ancestor
110483167|NCT01014533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110483168|NCT01014533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110483169|NCT01014533|Anticonvulsants|anticonvulsants|mesh-ancestor
110483170|NCT01014533|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110483171|NCT01014533|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110483172|NCT01014533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110483173|NCT01014533|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110483174|NCT01014533|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110483175|NCT01014533|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110483176|NCT01014533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110483177|NCT01014533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110483178|NCT01014533|Antimanic Agents|antimanic agents|mesh-ancestor
110483179|NCT02013427|Naproxen|naproxen|mesh-list
110483180|NCT02013427|Omeprazole|omeprazole|mesh-list
110483181|NCT02013427|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110483182|NCT02013427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110483183|NCT02013427|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110483184|NCT02013427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110483185|NCT02013427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110483186|NCT02013427|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110483187|NCT02013427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110483188|NCT02013427|Analgesics|analgesics|mesh-ancestor
110483189|NCT02013427|Sensory System Agents|sensory system agents|mesh-ancestor
110483190|NCT02013427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110166364|NCT00027625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110483191|NCT02013427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110483192|NCT02013427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110483193|NCT02013427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110410510|NCT01254630|Vaccines|vaccines|mesh-list
110483194|NCT02013427|Gout Suppressants|gout suppressants|mesh-ancestor
110483195|NCT02013427|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110483196|NCT01014143|Chlorhexidine|chlorhexidine|mesh-list
110483197|NCT01014143|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110483198|NCT01014143|Triclosan|triclosan|mesh-list
110483199|NCT01014143|Fluorides|fluorides|mesh-list
110483200|NCT01014143|Cariostatic Agents|cariostatic agents|mesh-ancestor
110483201|NCT01014143|Protective Agents|protective agents|mesh-ancestor
110483202|NCT01014143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110483203|NCT01014143|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110483204|NCT01014143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110483205|NCT01014143|Disinfectants|disinfectants|mesh-ancestor
110483206|NCT01014143|Dermatologic Agents|dermatologic agents|mesh-ancestor
110483207|NCT01014143|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
110483208|NCT01014143|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110483209|NCT01014143|Antimetabolites|antimetabolites|mesh-ancestor
110483210|NCT01014143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110483211|NCT01014143|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110483212|NCT00714961|Clopidogrel|clopidogrel|mesh-list
110483213|NCT00714961|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110483214|NCT00714961|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110483215|NCT00714961|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110483217|NCT00714961|Purinergic Agents|purinergic agents|mesh-ancestor
110483218|NCT00714961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110483219|NCT00714961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110483220|NCT00714961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110483221|NCT02574403|Eculizumab|eculizumab|mesh-list
110483222|NCT02574403|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
110483223|NCT02574403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110267691|NCT00544219|Hormones|hormones|mesh-ancestor
110483224|NCT02574403|Immunologic Factors|immunologic factors|mesh-ancestor
110483225|NCT02574403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110483226|NCT01013753|Formoterol Fumarate|formoterol fumarate|mesh-list
110483228|NCT01013753|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110483229|NCT01013753|Autonomic Agents|autonomic agents|mesh-ancestor
110483230|NCT01013753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110483231|NCT01013753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110483232|NCT01013753|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110483233|NCT01013753|Respiratory System Agents|respiratory system agents|mesh-ancestor
110483234|NCT01013753|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110483235|NCT01013753|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110483236|NCT01013753|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110483237|NCT01013753|Adrenergic Agents|adrenergic agents|mesh-ancestor
110483238|NCT01013753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110483239|NCT01013753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110483240|NCT00715039|Lorazepam|lorazepam|mesh-list
110483241|NCT00715039|Paroxetine|paroxetine|mesh-list
110483242|NCT00715039|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110483243|NCT00715039|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110483244|NCT00715039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110410758|NCT02860819|Gemcitabine|gemcitabine|mesh-list
110483245|NCT00715039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110483246|NCT00715039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110483247|NCT00715039|Serotonin Agents|serotonin agents|mesh-ancestor
110483248|NCT00715039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110483249|NCT00715039|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110483250|NCT00715039|Antidepressive Agents|antidepressive agents|mesh-ancestor
110483251|NCT00715039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110483252|NCT00715039|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110483253|NCT00715039|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110483254|NCT00715039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110483255|NCT00715039|Anticonvulsants|anticonvulsants|mesh-ancestor
110483256|NCT00715039|Antiemetics|antiemetics|mesh-ancestor
110483258|NCT00715039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110483259|NCT00715039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110483260|NCT00715039|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110483261|NCT00715039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110483262|NCT00715039|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110483263|NCT00715039|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110483264|NCT00715039|GABA Modulators|gaba modulators|mesh-ancestor
110483265|NCT00715039|GABA Agents|gaba agents|mesh-ancestor
110483266|NCT00711295|Vaccines|vaccines|mesh-list
110483267|NCT00711295|Immunologic Factors|immunologic factors|mesh-ancestor
110483268|NCT00711295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110483269|NCT02871869|Buformin|buformin|mesh-list
110483270|NCT02871869|Prednisone|prednisone|mesh-list
110483271|NCT02871869|Cyclophosphamide|cyclophosphamide|mesh-list
110483273|NCT02871869|Epirubicin|epirubicin|mesh-list
110483274|NCT02871869|Vindesine|vindesine|mesh-list
110483275|NCT02871869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110483276|NCT02871869|Immunologic Factors|immunologic factors|mesh-ancestor
110483277|NCT02871869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110483278|NCT02871869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110483279|NCT02871869|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110483280|NCT02871869|Alkylating Agents|alkylating agents|mesh-ancestor
110483281|NCT02871869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110483282|NCT02871869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110483283|NCT02871869|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110483284|NCT02871869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110483285|NCT02871869|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110483286|NCT02871869|Glucocorticoids|glucocorticoids|mesh-ancestor
110483287|NCT02871869|Hormones|hormones|mesh-ancestor
110483288|NCT02871869|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110267696|NCT00544219|Antimitotic Agents|antimitotic agents|mesh-ancestor
110483289|NCT02871869|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110483290|NCT02871869|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110483291|NCT02871869|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110483292|NCT02871869|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110483293|NCT02871869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110483294|NCT02871869|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110483295|NCT02871869|Tubulin Modulators|tubulin modulators|mesh-ancestor
110483296|NCT02871869|Antimitotic Agents|antimitotic agents|mesh-ancestor
110483297|NCT02871869|Mitosis Modulators|mitosis modulators|mesh-ancestor
110483298|NCT02871869|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110483299|NCT01013597|Panobinostat|panobinostat|mesh-list
110483300|NCT01013597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110483301|NCT01013597|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110483302|NCT01013597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110483303|NCT01013597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110483304|NCT00715273|Niacin|niacin|mesh-list
110483305|NCT00715273|Niacinamide|niacinamide|mesh-list
110483306|NCT00715273|Nicotinic Acids|nicotinic acids|mesh-list
110483307|NCT00715273|Atorvastatin|atorvastatin|mesh-list
110483308|NCT00715273|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
110483309|NCT00715273|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110483310|NCT00715273|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110483311|NCT00715273|Antimetabolites|antimetabolites|mesh-ancestor
110483312|NCT00715273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110483314|NCT00715273|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110483315|NCT00715273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110411066|NCT02857309|Hormones|hormones|mesh-ancestor
110483316|NCT00715273|Vasodilator Agents|vasodilator agents|mesh-ancestor
110483317|NCT00715273|Vitamin B Complex|vitamin b complex|mesh-ancestor
110483318|NCT00715273|Vitamins|vitamins|mesh-ancestor
110483319|NCT00715273|Micronutrients|micronutrients|mesh-ancestor
110483320|NCT00715273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110483321|NCT01013285|Bevacizumab|bevacizumab|mesh-list
110483322|NCT01013285|Temozolomide|temozolomide|mesh-list
110483323|NCT01013285|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110483324|NCT01013285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110483325|NCT01013285|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110483326|NCT01013285|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110483327|NCT01013285|Growth Substances|growth substances|mesh-ancestor
110483328|NCT01013285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110483330|NCT01013285|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110483331|NCT01013285|Alkylating Agents|alkylating agents|mesh-ancestor
110483332|NCT01013285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110483333|NCT00715351|Insulin|insulin|mesh-list
110483334|NCT00715351|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110483335|NCT00715351|Insulin Detemir|insulin detemir|mesh-list
110483336|NCT00715351|Isophane Insulin, Human|isophane insulin, human|mesh-list
110483337|NCT00715351|Insulin, Isophane|insulin, isophane|mesh-list
110483338|NCT00715351|Isophane insulin, beef|isophane insulin, beef|mesh-list
110483339|NCT00715351|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110483340|NCT00715351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110483341|NCT00711841|Dexamethasone|dexamethasone|mesh-list
110483342|NCT00711841|Dexamethasone acetate|dexamethasone acetate|mesh-list
110483343|NCT00711841|BB 1101|bb 1101|mesh-list
110483344|NCT00711841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110483345|NCT00711841|Antiemetics|antiemetics|mesh-ancestor
110483346|NCT00711841|Autonomic Agents|autonomic agents|mesh-ancestor
110483347|NCT00711841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110483348|NCT00711841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110483349|NCT00711841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110483350|NCT00711841|Glucocorticoids|glucocorticoids|mesh-ancestor
110483351|NCT00711841|Hormones|hormones|mesh-ancestor
110483352|NCT00711841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110483353|NCT00711841|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110483354|NCT00711841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110483355|NCT00711841|Protease Inhibitors|protease inhibitors|mesh-ancestor
110483356|NCT00711841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110483357|NCT00711841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110483358|NCT00711919|Pitavastatin|pitavastatin|mesh-list
110483359|NCT00711919|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110483360|NCT00711919|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110483361|NCT00711919|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110483362|NCT00711919|Antimetabolites|antimetabolites|mesh-ancestor
110483363|NCT00711919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110483364|NCT00711919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110483365|NCT00711919|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110483366|NCT00715663|Insulin Aspart|insulin aspart|mesh-list
110483367|NCT00715663|Biphasic Insulins|biphasic insulins|mesh-list
110483368|NCT00715663|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
110483369|NCT00715663|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110411296|NCT01232556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110483370|NCT00715663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110483371|NCT00712465|Digoxin|digoxin|mesh-list
110483372|NCT00712465|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110483373|NCT00712465|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110483374|NCT00712465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110483375|NCT00712465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110483376|NCT00712465|Protective Agents|protective agents|mesh-ancestor
110483377|NCT00712465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110483378|NCT00715975|Clobetasol|clobetasol|mesh-list
110483379|NCT00715975|Halobetasol|halobetasol|mesh-list
110411377|NCT01155531|Sertraline|sertraline|mesh-list
110483380|NCT00715975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110483381|NCT00715975|Glucocorticoids|glucocorticoids|mesh-ancestor
110483382|NCT00715975|Hormones|hormones|mesh-ancestor
110483383|NCT00715975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110483384|NCT00715975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110483385|NCT00715975|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110483386|NCT02572687|Durvalumab|durvalumab|mesh-list
110483387|NCT02572687|Ramucirumab|ramucirumab|mesh-list
110483388|NCT02572687|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110483389|NCT02572687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110483390|NCT00712777|Brimonidine Tartrate|brimonidine tartrate|mesh-list
110483391|NCT00712777|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110483392|NCT00712777|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110483393|NCT00712777|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110483394|NCT00712777|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110483395|NCT00712777|Adrenergic Agents|adrenergic agents|mesh-ancestor
110483396|NCT00712777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110483397|NCT00712777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110411511|NCT01153425|Zoledronic Acid|zoledronic acid|mesh-list
110483398|NCT00712777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110483399|NCT00603447|Dexamethasone|dexamethasone|mesh-list
110483400|NCT00603447|Lenalidomide|lenalidomide|mesh-list
110483401|NCT00603447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110483402|NCT00603447|Antiemetics|antiemetics|mesh-ancestor
110483403|NCT00603447|Autonomic Agents|autonomic agents|mesh-ancestor
110483404|NCT00603447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110411581|NCT01149369|Aprepitant|aprepitant|mesh-list
110483405|NCT00603447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110483406|NCT00603447|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110483407|NCT00603447|Glucocorticoids|glucocorticoids|mesh-ancestor
110483408|NCT00603447|Hormones|hormones|mesh-ancestor
110483409|NCT00603447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110483410|NCT00603447|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110483411|NCT00603447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110483412|NCT00603447|Immunologic Factors|immunologic factors|mesh-ancestor
110483413|NCT00603447|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110483414|NCT00603447|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110483415|NCT00603447|Growth Substances|growth substances|mesh-ancestor
110483416|NCT00603447|Growth Inhibitors|growth inhibitors|mesh-ancestor
110483417|NCT00718705|Josamycin|josamycin|mesh-list
110483418|NCT00718705|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110411629|NCT00739141|Fludarabine|fludarabine|mesh-list
110483419|NCT00718705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110483420|NCT00639015|Phenylephrine|phenylephrine|mesh-list
110483421|NCT00639015|Oxymetazoline|oxymetazoline|mesh-list
110483422|NCT00639015|Norepinephrine|norepinephrine|mesh-list
110483423|NCT00639015|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110483424|NCT00639015|Mydriatics|mydriatics|mesh-ancestor
110483425|NCT00639015|Autonomic Agents|autonomic agents|mesh-ancestor
110483426|NCT00639015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110483427|NCT00639015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110483428|NCT00639015|Sympathomimetics|sympathomimetics|mesh-ancestor
110483429|NCT00639015|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110483430|NCT00639015|Nasal Decongestants|nasal decongestants|mesh-ancestor
110483431|NCT00639015|Respiratory System Agents|respiratory system agents|mesh-ancestor
110483432|NCT00639015|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110483433|NCT00639015|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110483434|NCT00639015|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110483435|NCT00639015|Adrenergic Agents|adrenergic agents|mesh-ancestor
110411767|NCT00943111|Eliglustat|eliglustat|mesh-list
110483436|NCT00639015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110483437|NCT00639015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110483438|NCT00639015|Protective Agents|protective agents|mesh-ancestor
110483440|NCT00712855|Mapatumumab|mapatumumab|mesh-list
110483441|NCT00712855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110483442|NCT00712855|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110483443|NCT00712855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110483444|NCT00712855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110483445|NCT02537925|Celecoxib|celecoxib|mesh-list
110483446|NCT02537925|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
110483448|NCT02537925|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110483449|NCT02537925|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110483450|NCT02537925|Analgesics|analgesics|mesh-ancestor
110483451|NCT02537925|Sensory System Agents|sensory system agents|mesh-ancestor
110483452|NCT02537925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110483453|NCT02537925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110483454|NCT02537925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110483455|NCT02537925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110483456|NCT02537925|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110483457|NCT02537925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110483458|NCT02537925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110483459|NCT02537925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110483460|NCT00713011|Nifedipine|nifedipine|mesh-list
110483461|NCT00713011|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110483462|NCT00713011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110483463|NCT00713011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110483464|NCT00713011|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110483465|NCT00713011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110483466|NCT00713011|Vasodilator Agents|vasodilator agents|mesh-ancestor
110483467|NCT00713011|Tocolytic Agents|tocolytic agents|mesh-ancestor
110483468|NCT00713011|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110483469|NCT04185675|Anesthetics|anesthetics|mesh-list
110483470|NCT04185675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110483471|NCT04185675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110483472|NCT04208061|Ritonavir|ritonavir|mesh-list
110483473|NCT04208061|Darunavir|darunavir|mesh-list
110483474|NCT04208061|Dabigatran|dabigatran|mesh-list
110483475|NCT04208061|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110483476|NCT04208061|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110483477|NCT04208061|Protease Inhibitors|protease inhibitors|mesh-ancestor
110483478|NCT04208061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110483479|NCT04208061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110483481|NCT04208061|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110483482|NCT04208061|Antiviral Agents|antiviral agents|mesh-ancestor
110483483|NCT04208061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110483484|NCT04208061|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110483485|NCT04208061|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110483486|NCT04208061|Antithrombins|antithrombins|mesh-ancestor
110483487|NCT04208061|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110483488|NCT04208061|Anticoagulants|anticoagulants|mesh-ancestor
110483489|NCT00988208|Prednisone|prednisone|mesh-list
110483490|NCT00988208|Docetaxel|docetaxel|mesh-list
110483491|NCT00988208|Lenalidomide|lenalidomide|mesh-list
110483492|NCT00988208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110483493|NCT00988208|Tubulin Modulators|tubulin modulators|mesh-ancestor
110483494|NCT00988208|Antimitotic Agents|antimitotic agents|mesh-ancestor
110483495|NCT00988208|Mitosis Modulators|mitosis modulators|mesh-ancestor
110483496|NCT00988208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110483497|NCT00988208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110483499|NCT00988208|Hormones|hormones|mesh-ancestor
110483500|NCT00988208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110483501|NCT00988208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110483502|NCT00988208|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110483503|NCT00988208|Immunologic Factors|immunologic factors|mesh-ancestor
110483504|NCT00988208|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110483505|NCT00988208|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110483506|NCT00988208|Growth Substances|growth substances|mesh-ancestor
110483507|NCT00988208|Growth Inhibitors|growth inhibitors|mesh-ancestor
110483508|NCT00639249|SA 4503|sa 4503|mesh-list
110483509|NCT00639249|Nootropic Agents|nootropic agents|mesh-ancestor
110483510|NCT04185831|Everolimus|everolimus|mesh-list
110483511|NCT04185831|Atezolizumab|atezolizumab|mesh-list
110483512|NCT04185831|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110483513|NCT04185831|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110483514|NCT04185831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110483515|NCT04185831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110483516|NCT04185831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110483517|NCT04185831|Immunologic Factors|immunologic factors|mesh-ancestor
110483518|NCT04185831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110483519|NCT04185831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110483520|NCT04185831|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110483521|NCT04185831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110483523|NCT02686983|Anesthetics|anesthetics|mesh-list
110483524|NCT02686983|Anesthetics, Local|anesthetics, local|mesh-list
110483525|NCT02686983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110483526|NCT02686983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110483527|NCT02686983|Sensory System Agents|sensory system agents|mesh-ancestor
110483528|NCT02686983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110483529|NCT02686983|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110483530|NCT02686983|Glucocorticoids|glucocorticoids|mesh-ancestor
110483531|NCT02686983|Hormones|hormones|mesh-ancestor
110483532|NCT02686983|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110483533|NCT02686983|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110483534|NCT02686983|Respiratory System Agents|respiratory system agents|mesh-ancestor
110483535|NCT02686905|Calcium, Dietary|calcium, dietary|mesh-list
110483536|NCT02686905|Vitamin D|vitamin d|mesh-list
110483537|NCT02686905|Vitamins|vitamins|mesh-list
110483538|NCT02686905|Hydroxocobalamin|hydroxocobalamin|mesh-list
110483539|NCT02686905|Vitamin B 12|vitamin b 12|mesh-list
110483540|NCT02686905|Calcium|calcium|mesh-list
110483541|NCT02686905|Micronutrients|micronutrients|mesh-ancestor
110483542|NCT02686905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110483543|NCT02686905|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110483544|NCT02686905|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110483545|NCT02686905|Hematinics|hematinics|mesh-ancestor
110483546|NCT02686905|Vitamin B Complex|vitamin b complex|mesh-ancestor
110483547|NCT00990704|Maxacalcitol|maxacalcitol|mesh-list
110483548|NCT00990704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110483549|NCT00990704|Dermatologic Agents|dermatologic agents|mesh-ancestor
110483550|NCT00990704|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110483551|NCT00990704|Protective Agents|protective agents|mesh-ancestor
110483552|NCT00990704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110483554|NCT00639327|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110483555|NCT00639327|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110483556|NCT00639327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110483557|NCT00639327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110483558|NCT00639327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110483559|NCT02686749|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
110483561|NCT04089553|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110483562|NCT04089553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110483563|NCT02867852|Abiraterone Acetate|abiraterone acetate|mesh-list
110483564|NCT02867852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110483565|NCT02867852|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110483566|NCT02867852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110483567|NCT02867852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110483568|NCT02867852|Hormone Antagonists|hormone antagonists|mesh-ancestor
110483569|NCT02867852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110483570|NCT02867852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110483571|NCT02867852|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110483572|NCT02686827|Vitamin D|vitamin d|mesh-list
110130840|NCT01964586|Lidocaine|lidocaine|mesh-list
110483573|NCT02686827|Ergocalciferols|ergocalciferols|mesh-list
110483574|NCT02686827|Vitamins|vitamins|mesh-ancestor
110483575|NCT02686827|Micronutrients|micronutrients|mesh-ancestor
110483576|NCT02686827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110483577|NCT02686827|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110483578|NCT02686827|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110483579|NCT00713167|Grape Seed Extract|grape seed extract|mesh-list
110412362|NCT00605683|Bromocriptine|bromocriptine|mesh-list
110483580|NCT00713167|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110483581|NCT00713167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110483582|NCT00713167|Antioxidants|antioxidants|mesh-ancestor
110483583|NCT00713167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110483584|NCT00713167|Protective Agents|protective agents|mesh-ancestor
110483585|NCT00713167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110483586|NCT00716521|Zolpidem|zolpidem|mesh-list
110483587|NCT00716521|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110483588|NCT00716521|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110483589|NCT00716521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110483590|NCT00716521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110483591|NCT00716521|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
110483592|NCT00716521|GABA Agonists|gaba agonists|mesh-ancestor
110267781|NCT02963181|Yohimbine|yohimbine|mesh-list
110483593|NCT00716521|GABA Agents|gaba agents|mesh-ancestor
110483594|NCT00716521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110483595|NCT00716521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110483596|NCT00993668|Certolizumab Pegol|certolizumab pegol|mesh-list
110483597|NCT00993668|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110483598|NCT00993668|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110483599|NCT00993668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110483600|NCT00993668|Immunologic Factors|immunologic factors|mesh-ancestor
110483601|NCT00993668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110483602|NCT00993668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110483603|NCT00778102|Leucovorin|leucovorin|mesh-list
110483604|NCT00778102|Bevacizumab|bevacizumab|mesh-list
110483605|NCT00778102|Oxaliplatin|oxaliplatin|mesh-list
110483606|NCT00778102|Irinotecan|irinotecan|mesh-list
110483607|NCT00778102|Fluorouracil|fluorouracil|mesh-list
110483608|NCT00778102|Levoleucovorin|levoleucovorin|mesh-list
110483609|NCT00778102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110483610|NCT00778102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110483611|NCT00778102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110483612|NCT00778102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110483613|NCT00778102|Growth Substances|growth substances|mesh-ancestor
110483614|NCT00778102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110483615|NCT00778102|Growth Inhibitors|growth inhibitors|mesh-ancestor
110483616|NCT00778102|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110483617|NCT00778102|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110483618|NCT00778102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110483619|NCT00778102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110483620|NCT00778102|Antidotes|antidotes|mesh-ancestor
110483621|NCT00778102|Protective Agents|protective agents|mesh-ancestor
110483622|NCT00778102|Vitamin B Complex|vitamin b complex|mesh-ancestor
110483623|NCT00778102|Vitamins|vitamins|mesh-ancestor
110483624|NCT00778102|Micronutrients|micronutrients|mesh-ancestor
110483625|NCT00778102|Antimetabolites|antimetabolites|mesh-ancestor
110483626|NCT00778102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110483627|NCT00778102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110483628|NCT00778102|Immunologic Factors|immunologic factors|mesh-ancestor
110483629|NCT00713557|Tirofiban|tirofiban|mesh-list
110483630|NCT00713557|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110483631|NCT00713557|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110412835|NCT05798533|Tislelizumab|tislelizumab|mesh-list
110483632|NCT00713557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110483633|NCT00713557|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110483635|NCT00719095|Buprenorphine|buprenorphine|mesh-list
110483636|NCT00719095|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110483637|NCT00719095|Narcotics|narcotics|mesh-ancestor
110483638|NCT00719095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110483639|NCT00719095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110483640|NCT00719095|Analgesics|analgesics|mesh-ancestor
110483641|NCT00719095|Sensory System Agents|sensory system agents|mesh-ancestor
110483642|NCT00719095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110483643|NCT00719095|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110483644|NCT00719095|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110483645|NCT00916630|Pemetrexed|pemetrexed|mesh-list
110483646|NCT00916630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110130912|NCT01964846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110483647|NCT00916630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110483648|NCT00916630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110483649|NCT00916630|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110483650|NCT00916630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110483651|NCT02572375|Phenylpropanolamine|phenylpropanolamine|mesh-list
110483653|NCT02572375|Guaifenesin|guaifenesin|mesh-list
110483654|NCT02572375|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
110483655|NCT02572375|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110483656|NCT02572375|Narcotics|narcotics|mesh-ancestor
110483657|NCT02572375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110412906|NCT05624281|Nintedanib|nintedanib|mesh-list
110483658|NCT02572375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110483659|NCT02572375|Analgesics|analgesics|mesh-ancestor
110483660|NCT02572375|Sensory System Agents|sensory system agents|mesh-ancestor
110483661|NCT02572375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110483662|NCT02572375|Antitussive Agents|antitussive agents|mesh-ancestor
110483663|NCT02572375|Respiratory System Agents|respiratory system agents|mesh-ancestor
110483664|NCT02572375|Expectorants|expectorants|mesh-ancestor
110483665|NCT02572375|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110483666|NCT02572375|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110483667|NCT02572375|Adrenergic Agents|adrenergic agents|mesh-ancestor
110483668|NCT02572375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110483669|NCT02572375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110413041|NCT04793867|Xenon|xenon|mesh-list
110483671|NCT02572375|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110483672|NCT02572375|Sympathomimetics|sympathomimetics|mesh-ancestor
110483673|NCT02572375|Autonomic Agents|autonomic agents|mesh-ancestor
110483674|NCT02572375|Nasal Decongestants|nasal decongestants|mesh-ancestor
110483675|NCT02572375|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110483676|NCT00716911|Ganciclovir|ganciclovir|mesh-list
110483677|NCT00716911|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
110483678|NCT00716911|Antiviral Agents|antiviral agents|mesh-ancestor
110413072|NCT04520490|Exenatide|exenatide|mesh-list
110483679|NCT00716911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110166413|NCT00027742|Immunologic Factors|immunologic factors|mesh-ancestor
110483680|NCT00716911|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110483681|NCT00716911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110483682|NCT00716911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110413150|NCT04268498|Hormones|hormones|mesh-ancestor
110483684|NCT00612495|Oxaliplatin|oxaliplatin|mesh-list
110483685|NCT00612495|Antimetabolites|antimetabolites|mesh-ancestor
110483686|NCT00612495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110483687|NCT00612495|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110483688|NCT00612495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110483689|NCT00612495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110483690|NCT00612495|Immunologic Factors|immunologic factors|mesh-ancestor
110483691|NCT00612495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110483692|NCT00719173|Cyclophosphamide|cyclophosphamide|mesh-list
110483694|NCT00719173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110483695|NCT00719173|Immunologic Factors|immunologic factors|mesh-ancestor
110483696|NCT00719173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110483697|NCT00719173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110483698|NCT00719173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110483699|NCT00719173|Alkylating Agents|alkylating agents|mesh-ancestor
110483700|NCT00719173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110483701|NCT00719173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110483702|NCT00719173|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110483704|NCT00719173|Autonomic Agents|autonomic agents|mesh-ancestor
110483705|NCT00719173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110483706|NCT00719173|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110483707|NCT00719173|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110483708|NCT00719173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110483709|NCT00756886|Atorvastatin|atorvastatin|mesh-list
110483710|NCT00756886|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110483711|NCT00756886|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110483712|NCT00756886|Antimetabolites|antimetabolites|mesh-ancestor
110483713|NCT00756886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110483714|NCT00756886|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110483715|NCT00756886|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110483716|NCT00756886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110483717|NCT00756730|Atazanavir Sulfate|atazanavir sulfate|mesh-list
110483718|NCT00756730|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110483719|NCT00756730|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110483720|NCT00756730|Protease Inhibitors|protease inhibitors|mesh-ancestor
110483721|NCT00756730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110483722|NCT00756730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110483723|NCT00756730|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110483724|NCT00756730|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110483725|NCT00756730|Antiviral Agents|antiviral agents|mesh-ancestor
110483726|NCT00756730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110483727|NCT02573935|Clarithromycin|clarithromycin|mesh-list
110483728|NCT02573935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110483729|NCT02573935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110483730|NCT02573935|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110483731|NCT02573935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110483732|NCT02573935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110413417|NCT02811861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110483733|NCT02573935|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110483734|NCT02573935|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110483735|NCT00984620|Interferons|interferons|mesh-list
110483736|NCT00984620|Ribavirin|ribavirin|mesh-list
110483737|NCT00984620|Interferon-alpha|interferon-alpha|mesh-list
110483738|NCT00984620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110483739|NCT00984620|Antiviral Agents|antiviral agents|mesh-ancestor
110483740|NCT00984620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110483741|NCT00984620|Antimetabolites|antimetabolites|mesh-ancestor
110483742|NCT00984620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110483743|NCT00984620|Immunologic Factors|immunologic factors|mesh-ancestor
110483744|NCT00984620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110483745|NCT00717145|Risedronic Acid|risedronic acid|mesh-list
110483746|NCT00717145|Etidronic Acid|etidronic acid|mesh-list
110483747|NCT00717145|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110483748|NCT00717145|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110483749|NCT00717145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110483750|NCT00717145|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110483751|NCT00717145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110483752|NCT00717145|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110483753|NCT00639483|Celecoxib|celecoxib|mesh-list
110483754|NCT00639483|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110483755|NCT00639483|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110483756|NCT00639483|Analgesics|analgesics|mesh-ancestor
110483757|NCT00639483|Sensory System Agents|sensory system agents|mesh-ancestor
110483758|NCT00639483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110483759|NCT00639483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110483760|NCT00639483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110483761|NCT00639483|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110483762|NCT00639483|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110483763|NCT00639483|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110483764|NCT00639483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110483765|NCT00639483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110483766|NCT00777946|Amlodipine|amlodipine|mesh-list
110483767|NCT00777946|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110483768|NCT00777946|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110483769|NCT00777946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110483770|NCT00777946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110483771|NCT00777946|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110483772|NCT00777946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110483773|NCT00777946|Vasodilator Agents|vasodilator agents|mesh-ancestor
110483774|NCT02686047|Hyaluronic Acid|hyaluronic acid|mesh-list
110483776|NCT02686047|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110483777|NCT02686047|Immunologic Factors|immunologic factors|mesh-ancestor
110483778|NCT02686047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110483779|NCT02686047|Viscosupplements|viscosupplements|mesh-ancestor
110483780|NCT02686047|Protective Agents|protective agents|mesh-ancestor
110483781|NCT00713947|Amoxicillin|amoxicillin|mesh-list
110483782|NCT00713947|Metronidazole|metronidazole|mesh-list
110483783|NCT00713947|Clarithromycin|clarithromycin|mesh-list
110483784|NCT00713947|Pantoprazole|pantoprazole|mesh-list
110483785|NCT00713947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110483786|NCT00713947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110483787|NCT00713947|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110483788|NCT00713947|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110483789|NCT00713947|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110483790|NCT00713947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110483791|NCT00713947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110483792|NCT00713947|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110483793|NCT00713947|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110483794|NCT00713947|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110483795|NCT00713947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110483796|NCT00713947|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110483797|NCT00990314|Epoprostenol|epoprostenol|mesh-list
110483798|NCT00990314|Beraprost|beraprost|mesh-list
110483799|NCT00990314|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110483800|NCT00990314|Vasodilator Agents|vasodilator agents|mesh-ancestor
110483801|NCT00990314|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110483802|NCT00909831|Hydroxychloroquine|hydroxychloroquine|mesh-list
110166437|NCT00011973|Fenretinide|fenretinide|mesh-list
110483804|NCT00909831|Temsirolimus|temsirolimus|mesh-list
110483805|NCT00909831|MTOR Inhibitors|mtor inhibitors|mesh-list
110483806|NCT00909831|Antimalarials|antimalarials|mesh-ancestor
110483807|NCT00909831|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110413519|NCT02580058|Doxorubicin|doxorubicin|mesh-list
110483808|NCT00909831|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110483809|NCT00909831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110483810|NCT00909831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110483811|NCT00909831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110483812|NCT00909831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110483813|NCT00909831|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110483814|NCT00909831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110483815|NCT00909831|Immunologic Factors|immunologic factors|mesh-ancestor
110483816|NCT00909831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110483817|NCT00909831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110483818|NCT00909831|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110483819|NCT00909831|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110483820|NCT00909831|Antifungal Agents|antifungal agents|mesh-ancestor
110483821|NCT00717379|Mycophenolic Acid|mycophenolic acid|mesh-list
110483822|NCT00717379|Prednisone|prednisone|mesh-list
110483823|NCT00717379|Methylprednisolone|methylprednisolone|mesh-list
110483824|NCT00717379|Tacrolimus|tacrolimus|mesh-list
110483825|NCT00717379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110483826|NCT00717379|Glucocorticoids|glucocorticoids|mesh-ancestor
110483827|NCT00717379|Hormones|hormones|mesh-ancestor
110483828|NCT00717379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110483829|NCT00717379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110483830|NCT00717379|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110483831|NCT00717379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110483832|NCT00717379|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110483833|NCT00717379|Immunologic Factors|immunologic factors|mesh-ancestor
110483834|NCT00717379|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110483835|NCT00717379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110483836|NCT00717379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110483837|NCT00717379|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110483838|NCT00717379|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110483839|NCT00717379|Antitubercular Agents|antitubercular agents|mesh-ancestor
110483840|NCT00717379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110483841|NCT00717379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110483842|NCT00717379|Antiemetics|antiemetics|mesh-ancestor
110483843|NCT00717379|Autonomic Agents|autonomic agents|mesh-ancestor
110483844|NCT00717379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110483845|NCT00717379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110483846|NCT00717379|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110483847|NCT00717379|Protective Agents|protective agents|mesh-ancestor
110483848|NCT02867306|Methotrexate|methotrexate|mesh-list
110483849|NCT02867306|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110483850|NCT02867306|Abortifacient Agents|abortifacient agents|mesh-ancestor
110483851|NCT02867306|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110483852|NCT02867306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110483853|NCT02867306|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110483854|NCT02867306|Antimetabolites|antimetabolites|mesh-ancestor
110483855|NCT02867306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110413675|NCT05940909|Amlodipine|amlodipine|mesh-list
110483856|NCT02867306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110483857|NCT02867306|Dermatologic Agents|dermatologic agents|mesh-ancestor
110483858|NCT02867306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110483859|NCT02867306|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110483860|NCT02867306|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110483861|NCT02867306|Immunologic Factors|immunologic factors|mesh-ancestor
110483862|NCT02867306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110483863|NCT02867306|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110483864|NCT00777556|Levonorgestrel|levonorgestrel|mesh-list
110483865|NCT00777556|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110483866|NCT00777556|Contraceptive Agents|contraceptive agents|mesh-ancestor
110483867|NCT00777556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110483868|NCT00777556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110483869|NCT00777556|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110483870|NCT00777556|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110483871|NCT00777556|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110131140|NCT01966575|Progestins|progestins|mesh-list
110483872|NCT02685657|Cyclophosphamide|cyclophosphamide|mesh-list
110483873|NCT02685657|Docetaxel|docetaxel|mesh-list
110483874|NCT02685657|Doxorubicin|doxorubicin|mesh-list
110483875|NCT02685657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110483876|NCT02685657|Immunologic Factors|immunologic factors|mesh-ancestor
110483877|NCT02685657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110483878|NCT02685657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110483879|NCT02685657|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110483880|NCT02685657|Alkylating Agents|alkylating agents|mesh-ancestor
110267854|NCT00160394|Adapalene|adapalene|mesh-list
110483881|NCT02685657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110483882|NCT02685657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110483883|NCT02685657|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110483884|NCT02685657|Tubulin Modulators|tubulin modulators|mesh-ancestor
110483885|NCT02685657|Antimitotic Agents|antimitotic agents|mesh-ancestor
110483886|NCT02685657|Mitosis Modulators|mitosis modulators|mesh-ancestor
110413818|NCT05939726|Tocotrienols|tocotrienols|mesh-list
110483887|NCT02685657|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110483888|NCT02685657|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110483889|NCT02685657|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110483890|NCT02685657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110483891|NCT04290884|Tranexamic Acid|tranexamic acid|mesh-list
110483892|NCT04290884|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110413872|NCT05939037|Zanubrutinib|zanubrutinib|mesh-list
110483893|NCT04290884|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110483894|NCT04290884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110483896|NCT04290884|Coagulants|coagulants|mesh-ancestor
110483897|NCT00719407|Epoetin Alfa|epoetin alfa|mesh-list
110483898|NCT00719407|Hematinics|hematinics|mesh-ancestor
110483899|NCT00714025|Everolimus|everolimus|mesh-list
110413944|NCT05933642|Aminophylline|aminophylline|mesh-list
110483900|NCT00714025|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110483901|NCT00714025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110483902|NCT00714025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110483903|NCT00714025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110483904|NCT00714025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110483905|NCT00714025|Immunologic Factors|immunologic factors|mesh-ancestor
110483906|NCT00714025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110414012|NCT05919173|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110483907|NCT00714025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110483908|NCT02685345|Firuglipel|firuglipel|mesh-list
110483909|NCT02685345|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110483910|NCT02685345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110483911|NCT02869100|Listerine|listerine|mesh-list
110483912|NCT02869100|Fluorides|fluorides|mesh-list
110483913|NCT02869100|Sodium Fluoride|sodium fluoride|mesh-list
110483914|NCT02869100|Cariostatic Agents|cariostatic agents|mesh-ancestor
110483915|NCT02869100|Protective Agents|protective agents|mesh-ancestor
110483916|NCT02869100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110483917|NCT02869100|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110483918|NCT02869100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110483919|NCT04096768|Dexmedetomidine|dexmedetomidine|mesh-list
110483920|NCT04096768|Ketamine|ketamine|mesh-list
110483921|NCT04096768|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110483922|NCT04096768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110483923|NCT04096768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110414343|NCT05505630|Midazolam|midazolam|mesh-list
110483924|NCT04096768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110483925|NCT04096768|Analgesics|analgesics|mesh-ancestor
110483926|NCT04096768|Sensory System Agents|sensory system agents|mesh-ancestor
110483927|NCT04096768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110483928|NCT04096768|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110483929|NCT04096768|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110483930|NCT04096768|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110483931|NCT04096768|Adrenergic Agents|adrenergic agents|mesh-ancestor
110483932|NCT04096768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110267873|NCT00191022|Antidepressive Agents|antidepressive agents|mesh-ancestor
110483933|NCT04096768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110483934|NCT04096768|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110483935|NCT04096768|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110483936|NCT04096768|Anesthetics, General|anesthetics, general|mesh-ancestor
110483937|NCT04096768|Anesthetics|anesthetics|mesh-ancestor
110483938|NCT04096768|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110483939|NCT04096768|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110483940|NCT00714103|Adenosine|adenosine|mesh-list
110483941|NCT00714103|Analgesics|analgesics|mesh-ancestor
110483942|NCT00714103|Sensory System Agents|sensory system agents|mesh-ancestor
110483943|NCT00714103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110483944|NCT00714103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110483945|NCT00714103|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110131212|NCT01967017|Lidocaine|lidocaine|mesh-list
110483946|NCT00714103|Vasodilator Agents|vasodilator agents|mesh-ancestor
110483947|NCT00714103|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
110483948|NCT00714103|Purinergic Agonists|purinergic agonists|mesh-ancestor
110483949|NCT00714103|Purinergic Agents|purinergic agents|mesh-ancestor
110483950|NCT00714103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110414508|NCT05255666|Pembrolizumab|pembrolizumab|mesh-list
110483951|NCT00714103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110483953|NCT00993044|Irinotecan|irinotecan|mesh-list
110483954|NCT00993044|Vincristine|vincristine|mesh-list
110483955|NCT00993044|Temozolomide|temozolomide|mesh-list
110483956|NCT00993044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110483957|NCT00993044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110483958|NCT00993044|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110483959|NCT00993044|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110483960|NCT00993044|Growth Substances|growth substances|mesh-ancestor
110483961|NCT00993044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110483962|NCT00993044|Growth Inhibitors|growth inhibitors|mesh-ancestor
110483963|NCT00993044|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110483964|NCT00993044|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110483965|NCT00993044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110483966|NCT00993044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110483967|NCT00993044|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110483968|NCT00993044|Tubulin Modulators|tubulin modulators|mesh-ancestor
110483969|NCT00993044|Antimitotic Agents|antimitotic agents|mesh-ancestor
110414719|NCT04499950|Naltrexone|naltrexone|mesh-list
110483970|NCT00993044|Mitosis Modulators|mitosis modulators|mesh-ancestor
110483971|NCT00993044|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110483972|NCT00993044|Alkylating Agents|alkylating agents|mesh-ancestor
110483974|NCT00714181|Temozolomide|temozolomide|mesh-list
110483975|NCT00714181|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110483976|NCT00714181|Alkylating Agents|alkylating agents|mesh-ancestor
110483977|NCT00714181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110483978|NCT00714181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110483979|NCT00714181|Antimalarials|antimalarials|mesh-ancestor
110483980|NCT00714181|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110483981|NCT00714181|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110483982|NCT00714181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110483983|NCT00714181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110483984|NCT00714181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110483985|NCT02600806|Azithromycin|azithromycin|mesh-list
110483986|NCT02600806|Levofloxacin|levofloxacin|mesh-list
110483987|NCT02600806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110483988|NCT02600806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110483989|NCT02600806|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110483990|NCT02600806|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110483991|NCT02600806|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110483992|NCT02600806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110483993|NCT02600806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110483994|NCT02600806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110483995|NCT02600806|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110483996|NCT02600806|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110483997|NCT00639873|Doxycycline|doxycycline|mesh-list
110483998|NCT00639873|Artesunate|artesunate|mesh-list
110483999|NCT00639873|Quinine|quinine|mesh-list
110484000|NCT00639873|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110484001|NCT00639873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110484002|NCT00639873|Antimalarials|antimalarials|mesh-ancestor
110484003|NCT00639873|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110484004|NCT00639873|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110484005|NCT00639873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110484006|NCT00639873|Antiviral Agents|antiviral agents|mesh-ancestor
110484007|NCT00639873|Schistosomicides|schistosomicides|mesh-ancestor
110484008|NCT00639873|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110484009|NCT00639873|Anthelmintics|anthelmintics|mesh-ancestor
110484010|NCT00639873|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110484011|NCT00639873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110484012|NCT00639873|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110484013|NCT00639873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110484015|NCT00639873|Analgesics|analgesics|mesh-ancestor
110484016|NCT00639873|Sensory System Agents|sensory system agents|mesh-ancestor
110484017|NCT04291118|Budesonide|budesonide|mesh-list
110484018|NCT04291118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110415201|NCT01331018|Antiemetics|antiemetics|mesh-ancestor
110484019|NCT04291118|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110484021|NCT04291118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110484022|NCT04291118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110484023|NCT04291118|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110484024|NCT04291118|Respiratory System Agents|respiratory system agents|mesh-ancestor
110484025|NCT04291118|Glucocorticoids|glucocorticoids|mesh-ancestor
110484027|NCT04291118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110484028|NCT02868944|Sufentanil|sufentanil|mesh-list
110484029|NCT02868944|Morphine|morphine|mesh-list
110484030|NCT02868944|Levobupivacaine|levobupivacaine|mesh-list
110484031|NCT02868944|Anesthetics|anesthetics|mesh-list
110484032|NCT02868944|Anesthetics, Local|anesthetics, local|mesh-list
110484033|NCT02868944|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110484034|NCT02868944|Narcotics|narcotics|mesh-ancestor
110484035|NCT02868944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110415408|NCT00929695|Prednisolone acetate|prednisolone acetate|mesh-list
110484036|NCT02868944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110484037|NCT02868944|Analgesics|analgesics|mesh-ancestor
110484038|NCT02868944|Sensory System Agents|sensory system agents|mesh-ancestor
110484039|NCT02868944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110484041|NCT02868944|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110484042|NCT02868944|Anesthetics, General|anesthetics, general|mesh-ancestor
110484043|NCT03292809|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110484044|NCT03292809|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110484045|NCT00722839|Vaccines|vaccines|mesh-list
110484046|NCT00722839|Immunologic Factors|immunologic factors|mesh-ancestor
110484047|NCT00722839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110484048|NCT04096690|Pegaspargase|pegaspargase|mesh-list
110484049|NCT04096690|Antibodies|antibodies|mesh-list
110484050|NCT04096690|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110484051|NCT04096690|Immunologic Factors|immunologic factors|mesh-ancestor
110484052|NCT04096690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110484053|NCT04096690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110484054|NCT00719797|Leucovorin|leucovorin|mesh-list
110484055|NCT00719797|Bevacizumab|bevacizumab|mesh-list
110484057|NCT00719797|Oxaliplatin|oxaliplatin|mesh-list
110484058|NCT00719797|Irinotecan|irinotecan|mesh-list
110484059|NCT00719797|Calcium|calcium|mesh-list
110484060|NCT00719797|Levoleucovorin|levoleucovorin|mesh-list
110484061|NCT00719797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110484062|NCT00719797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110484063|NCT00719797|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110484064|NCT00719797|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110484065|NCT00719797|Growth Substances|growth substances|mesh-ancestor
110484066|NCT00719797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110484067|NCT00719797|Growth Inhibitors|growth inhibitors|mesh-ancestor
110484068|NCT00719797|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110484069|NCT00719797|Antimetabolites|antimetabolites|mesh-ancestor
110484070|NCT00719797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110484071|NCT00719797|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110484072|NCT00719797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110484073|NCT00719797|Immunologic Factors|immunologic factors|mesh-ancestor
110415754|NCT01133379|Fluorides|fluorides|mesh-list
110484074|NCT00719797|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110484075|NCT00719797|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110484076|NCT00719797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110484077|NCT00719797|Antidotes|antidotes|mesh-ancestor
110484078|NCT00719797|Protective Agents|protective agents|mesh-ancestor
110484079|NCT00719797|Vitamin B Complex|vitamin b complex|mesh-ancestor
110484080|NCT00719797|Vitamins|vitamins|mesh-ancestor
110484082|NCT00979628|Insulin|insulin|mesh-list
110484083|NCT00979628|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110484084|NCT00979628|Insulin Glargine|insulin glargine|mesh-list
110484085|NCT00979628|Insulin glulisine|insulin glulisine|mesh-list
110484086|NCT00979628|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110484087|NCT00979628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110484088|NCT00719875|Vorinostat|vorinostat|mesh-list
110484089|NCT00719875|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
110484090|NCT00719875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110415881|NCT01130103|Paroxetine|paroxetine|mesh-list
110484091|NCT00719875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110484092|NCT00719875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110484093|NCT02685111|Lenograstim|lenograstim|mesh-list
110484094|NCT02685111|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110484095|NCT02685111|Immunologic Factors|immunologic factors|mesh-ancestor
110131359|NCT01967927|Imidazole|imidazole|mesh-list
110484096|NCT02685111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110484097|NCT00717925|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
110484098|NCT00717925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110484099|NCT00717925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110484100|NCT00717925|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110484101|NCT00717925|Immunotoxins|immunotoxins|mesh-ancestor
110416087|NCT00925015|Irinotecan|irinotecan|mesh-list
110484102|NCT00717925|Immunoconjugates|immunoconjugates|mesh-ancestor
110484103|NCT00717925|Immunologic Factors|immunologic factors|mesh-ancestor
110484104|NCT00717925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110484106|NCT03258723|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110484107|NCT03258723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110484108|NCT00640029|Meloxicam|meloxicam|mesh-list
110484109|NCT00640029|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110484110|NCT00640029|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110484111|NCT00640029|Analgesics|analgesics|mesh-ancestor
110484112|NCT00640029|Sensory System Agents|sensory system agents|mesh-ancestor
110484113|NCT00640029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110484114|NCT00640029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110484115|NCT00640029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110484116|NCT00640029|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110484117|NCT00640029|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110484118|NCT00640029|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110484119|NCT00640029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110484120|NCT00640029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110484122|NCT02684799|Omeprazole|omeprazole|mesh-list
110484123|NCT02684799|Famotidine|famotidine|mesh-list
110484124|NCT02684799|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110484125|NCT02684799|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110484126|NCT02684799|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110484127|NCT02684799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110416362|NCT00910273|Sensory System Agents|sensory system agents|mesh-ancestor
110484128|NCT02684799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110484129|NCT02684799|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110484130|NCT02684799|Histamine Antagonists|histamine antagonists|mesh-ancestor
110484131|NCT02684799|Histamine Agents|histamine agents|mesh-ancestor
110484132|NCT02684799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110484133|NCT02684799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110484134|NCT02684799|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
110484135|NCT02684799|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110484136|NCT02684799|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110484137|NCT02684799|Antiviral Agents|antiviral agents|mesh-ancestor
110484138|NCT02684799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110484139|NCT02685189|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
110416497|NCT04323761|Antimetabolites|antimetabolites|mesh-ancestor
110484140|NCT02685189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110484141|NCT02685189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110484142|NCT00992108|Lidocaine|lidocaine|mesh-list
110484143|NCT00992108|Anesthetics, Local|anesthetics, local|mesh-ancestor
110484144|NCT00992108|Anesthetics|anesthetics|mesh-ancestor
110166476|NCT00012051|Cytarabine|cytarabine|mesh-list
110484145|NCT00992108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110484147|NCT00992108|Sensory System Agents|sensory system agents|mesh-ancestor
110484148|NCT00992108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110484149|NCT00992108|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110484150|NCT00992108|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110484151|NCT00992108|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110484152|NCT00992108|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110484153|NCT00992108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110484154|NCT00752986|Fulvestrant|fulvestrant|mesh-list
110484155|NCT00752986|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110484156|NCT00752986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110484157|NCT00752986|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110484158|NCT00752986|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110484159|NCT00752986|Hormone Antagonists|hormone antagonists|mesh-ancestor
110484160|NCT00752986|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110484161|NCT00752986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110484164|NCT02684487|Vitamins|vitamins|mesh-ancestor
110484166|NCT02684487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110484167|NCT02684487|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110484168|NCT02684487|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110484169|NCT02684409|Sumatriptan|sumatriptan|mesh-list
110484170|NCT02684409|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110416914|NCT04293172|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110484171|NCT02684409|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110484172|NCT02684409|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110484173|NCT02684409|Serotonin Agents|serotonin agents|mesh-ancestor
110484174|NCT02684409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110131433|NCT01968161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110484175|NCT02684409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110484176|NCT02684409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110484177|NCT00762892|Tenofovir|tenofovir|mesh-list
110484178|NCT00762892|Emtricitabine|emtricitabine|mesh-list
110484179|NCT00762892|Raltegravir Potassium|raltegravir potassium|mesh-list
110484180|NCT00762892|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110484181|NCT00762892|Atazanavir Sulfate|atazanavir sulfate|mesh-list
110484182|NCT00762892|Antiviral Agents|antiviral agents|mesh-ancestor
110484183|NCT00762892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110484184|NCT00762892|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110484185|NCT00762892|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110484186|NCT00762892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110484187|NCT00762892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110484188|NCT00762892|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110484189|NCT00762892|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110484190|NCT00762892|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110484191|NCT00762892|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110484192|NCT00762892|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110484193|NCT00762892|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110484194|NCT00762892|Protease Inhibitors|protease inhibitors|mesh-ancestor
110484195|NCT04290572|Isotretinoin|isotretinoin|mesh-list
110484196|NCT04290572|Dermatologic Agents|dermatologic agents|mesh-ancestor
110484197|NCT04069429|Heparin|heparin|mesh-list
110484198|NCT04069429|Anticoagulants|anticoagulants|mesh-ancestor
110484199|NCT04069429|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110484200|NCT04069429|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110484201|NCT04069429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110484202|NCT00755716|Topiramate|topiramate|mesh-list
110484203|NCT00755716|Nicotine|nicotine|mesh-list
110484204|NCT00755716|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110484205|NCT00755716|Autonomic Agents|autonomic agents|mesh-ancestor
110484206|NCT00755716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110484207|NCT00755716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110484208|NCT00755716|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110484209|NCT00755716|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110484210|NCT00755716|Cholinergic Agents|cholinergic agents|mesh-ancestor
110484211|NCT00755716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110484212|NCT00755716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110484213|NCT00755716|Anticonvulsants|anticonvulsants|mesh-ancestor
110484214|NCT00755716|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110484215|NCT00629252|Risperidone|risperidone|mesh-list
110484216|NCT00629252|Sertindole|sertindole|mesh-list
110484217|NCT00629252|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110484218|NCT00629252|Serotonin Agents|serotonin agents|mesh-ancestor
110484219|NCT00629252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110484220|NCT00629252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110417386|NCT00991276|Pregabalin|pregabalin|mesh-list
110484221|NCT00629252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110484222|NCT00629252|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110484223|NCT00629252|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110484224|NCT00629252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110484225|NCT00629252|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110484226|NCT00629252|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110484227|NCT00629252|Dopamine Agents|dopamine agents|mesh-ancestor
110484229|NCT04096144|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110484230|NCT04096144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110484231|NCT04096144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110484232|NCT04095754|Dexmedetomidine|dexmedetomidine|mesh-list
110484233|NCT04095754|Anesthetics|anesthetics|mesh-list
110484234|NCT04095754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110484235|NCT04095754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110484236|NCT04095754|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110484237|NCT04095754|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110484238|NCT04095754|Analgesics|analgesics|mesh-ancestor
110484239|NCT04095754|Sensory System Agents|sensory system agents|mesh-ancestor
110484240|NCT04095754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110484241|NCT04095754|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110267958|NCT00546130|Antiviral Agents|antiviral agents|mesh-ancestor
110484242|NCT04095754|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110484243|NCT04095754|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110484244|NCT04095754|Adrenergic Agents|adrenergic agents|mesh-ancestor
110484245|NCT04095754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110484246|NCT04095754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110484248|NCT00720265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110484249|NCT00720265|Immunologic Factors|immunologic factors|mesh-ancestor
110417658|NCT01259492|Dopamine Agents|dopamine agents|mesh-ancestor
110484250|NCT00720265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110484251|NCT00720265|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110484252|NCT00720265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110484253|NCT00720265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110484254|NCT02600650|Testosterone|testosterone|mesh-list
110484255|NCT02600650|Androgens|androgens|mesh-ancestor
110484256|NCT02600650|Hormones|hormones|mesh-ancestor
110484257|NCT02600650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110484258|NCT02600650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110484259|NCT03084471|Durvalumab|durvalumab|mesh-list
110484260|NCT03084471|Tremelimumab|tremelimumab|mesh-list
110484261|NCT03084471|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110484262|NCT03084471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110484263|NCT03084471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110484264|NCT03084471|Immunologic Factors|immunologic factors|mesh-ancestor
110484265|NCT03084471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110484267|NCT00718471|Enoxaparin|enoxaparin|mesh-list
110484268|NCT00718471|Calcium heparin|calcium heparin|mesh-list
110484269|NCT00718471|Anticoagulants|anticoagulants|mesh-ancestor
110484270|NCT00718471|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110484271|NCT00718471|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110484272|NCT00718471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110484273|NCT00723307|Metformin|metformin|mesh-list
110484274|NCT00723307|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110484275|NCT00723307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110484276|NCT00723385|Vitamin D|vitamin d|mesh-list
110484277|NCT00723385|Cholecalciferol|cholecalciferol|mesh-list
110484278|NCT00723385|Vitamins|vitamins|mesh-ancestor
110484279|NCT00723385|Micronutrients|micronutrients|mesh-ancestor
110484280|NCT00723385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110484281|NCT00723385|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110484282|NCT00723385|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110484284|NCT00754936|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110484285|NCT00754936|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110484286|NCT00754936|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110484287|NCT00754936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110484288|NCT00754936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110484289|NCT00754936|Serotonin Agents|serotonin agents|mesh-ancestor
110484290|NCT00754936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110484291|NCT02684019|Magnesium Sulfate|magnesium sulfate|mesh-list
110484292|NCT02684019|Dexmedetomidine|dexmedetomidine|mesh-list
110484293|NCT02684019|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110484294|NCT02684019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110484295|NCT02684019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110484296|NCT02684019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110484297|NCT02684019|Analgesics|analgesics|mesh-ancestor
110417981|NCT01204710|Hormones|hormones|mesh-ancestor
110484298|NCT02684019|Sensory System Agents|sensory system agents|mesh-ancestor
110484299|NCT02684019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110484300|NCT02684019|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110484301|NCT02684019|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110484302|NCT02684019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110484303|NCT02684019|Adrenergic Agents|adrenergic agents|mesh-ancestor
110484304|NCT02684019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110484305|NCT02684019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110484306|NCT02684019|Anesthetics|anesthetics|mesh-ancestor
110484307|NCT02684019|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110484308|NCT02684019|Anticonvulsants|anticonvulsants|mesh-ancestor
110484309|NCT02684019|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110484310|NCT02684019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110484311|NCT02684019|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110484312|NCT02684019|Tocolytic Agents|tocolytic agents|mesh-ancestor
110484313|NCT02684019|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110484314|NCT00720421|Lorazepam|lorazepam|mesh-list
110484315|NCT00720421|Anticonvulsants|anticonvulsants|mesh-ancestor
110484316|NCT00720421|Antiemetics|antiemetics|mesh-ancestor
110484317|NCT00720421|Autonomic Agents|autonomic agents|mesh-ancestor
110484318|NCT00720421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110484319|NCT00720421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110484320|NCT00720421|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110484321|NCT00720421|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110484322|NCT00720421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110484323|NCT00720421|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110484324|NCT00720421|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110484325|NCT00720421|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110484326|NCT00720421|GABA Modulators|gaba modulators|mesh-ancestor
110484327|NCT00720421|GABA Agents|gaba agents|mesh-ancestor
110484328|NCT00720421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110484329|NCT00720421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110484330|NCT02689713|Voriconazole|voriconazole|mesh-list
110484331|NCT02689713|Antifungal Agents|antifungal agents|mesh-ancestor
110484332|NCT02689713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110484333|NCT02689713|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110484334|NCT02689713|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110484335|NCT02689713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110484336|NCT02689713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110484337|NCT02689713|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110484338|NCT02689713|Hormone Antagonists|hormone antagonists|mesh-ancestor
110484339|NCT02689713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110484340|NCT02689713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110484341|NCT02689713|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110484342|NCT02601508|Rocuronium|rocuronium|mesh-list
110484343|NCT02601508|Atracurium|atracurium|mesh-list
110484344|NCT02601508|Cisatracurium|cisatracurium|mesh-list
110484345|NCT02601508|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110484346|NCT02601508|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110484347|NCT02601508|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110166494|NCT00012051|Glucocorticoids|glucocorticoids|mesh-ancestor
110484348|NCT02601508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110484349|NCT02601508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110484350|NCT02601508|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
110484351|NCT02601508|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110484352|NCT02601508|Cholinergic Agents|cholinergic agents|mesh-ancestor
110484353|NCT02601508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110484354|NCT02601508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110484355|NCT02570581|Acetaminophen|acetaminophen|mesh-list
110484356|NCT02570581|Ramipril|ramipril|mesh-list
110484357|NCT02570581|Furosemide|furosemide|mesh-list
110484358|NCT02570581|Memantine|memantine|mesh-list
110484359|NCT02570581|Alprazolam|alprazolam|mesh-list
110484360|NCT02570581|Zopiclone|zopiclone|mesh-list
110484361|NCT02570581|Oxazepam|oxazepam|mesh-list
110484362|NCT02570581|Donepezil|donepezil|mesh-list
110484363|NCT02570581|Clopidogrel|clopidogrel|mesh-list
110484364|NCT02570581|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110484365|NCT02570581|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110267998|NCT00546325|Hormones|hormones|mesh-ancestor
110484366|NCT02570581|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110484367|NCT02570581|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110484368|NCT02570581|Purinergic Agents|purinergic agents|mesh-ancestor
110484369|NCT02570581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110484370|NCT02570581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110484371|NCT02570581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110484372|NCT02570581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110484373|NCT02570581|Analgesics|analgesics|mesh-ancestor
110484374|NCT02570581|Sensory System Agents|sensory system agents|mesh-ancestor
110484375|NCT02570581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110484376|NCT02570581|Antipyretics|antipyretics|mesh-ancestor
110484377|NCT02570581|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110484378|NCT02570581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110484379|NCT02570581|Cholinergic Agents|cholinergic agents|mesh-ancestor
110484380|NCT02570581|Nootropic Agents|nootropic agents|mesh-ancestor
110484381|NCT02570581|Diuretics|diuretics|mesh-ancestor
110484382|NCT02570581|Natriuretic Agents|natriuretic agents|mesh-ancestor
110484383|NCT02570581|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110484384|NCT02570581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110484385|NCT02570581|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110484386|NCT02570581|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110484387|NCT02570581|Dopamine Agents|dopamine agents|mesh-ancestor
110484388|NCT02570581|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110484389|NCT02570581|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110484390|NCT02570581|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110484391|NCT02570581|Protease Inhibitors|protease inhibitors|mesh-ancestor
110484392|NCT02570581|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110484393|NCT02570581|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110484394|NCT02570581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110484395|NCT02570581|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110484396|NCT02570581|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110484397|NCT02570581|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110484398|NCT02570581|GABA Modulators|gaba modulators|mesh-ancestor
110484399|NCT02570581|GABA Agents|gaba agents|mesh-ancestor
110484400|NCT00640263|Ritonavir|ritonavir|mesh-list
110484401|NCT00640263|Lopinavir|lopinavir|mesh-list
110484402|NCT00640263|Lamivudine|lamivudine|mesh-list
110484403|NCT00640263|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110484404|NCT00640263|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110484405|NCT00640263|Protease Inhibitors|protease inhibitors|mesh-ancestor
110484406|NCT00640263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110484407|NCT00640263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110484408|NCT00640263|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110484409|NCT00640263|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110484410|NCT00640263|Antiviral Agents|antiviral agents|mesh-ancestor
110484411|NCT00640263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110484412|NCT00640263|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110484413|NCT00640263|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110484414|NCT00640263|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110484415|NCT00640263|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110484417|NCT02683863|Dermatologic Agents|dermatologic agents|mesh-ancestor
110484418|NCT02683863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110484419|NCT02683863|Immunologic Factors|immunologic factors|mesh-ancestor
110484420|NCT02683863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110484421|NCT02865668|Metformin|metformin|mesh-list
110484422|NCT02865668|Canagliflozin|canagliflozin|mesh-list
110484423|NCT02865668|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110484424|NCT02865668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110484425|NCT02865668|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110484426|NCT02865668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110484427|NCT02867930|Dexmedetomidine|dexmedetomidine|mesh-list
110484428|NCT02867930|Ketamine|ketamine|mesh-list
110484429|NCT02867930|Propofol|propofol|mesh-list
110484430|NCT02867930|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110484431|NCT02867930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110484432|NCT02867930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110484433|NCT02867930|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110484434|NCT02867930|Analgesics|analgesics|mesh-ancestor
110484435|NCT02867930|Sensory System Agents|sensory system agents|mesh-ancestor
110484436|NCT02867930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110484437|NCT02867930|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110484438|NCT02867930|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110484439|NCT02867930|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110484440|NCT02867930|Adrenergic Agents|adrenergic agents|mesh-ancestor
110484441|NCT02867930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110484442|NCT02867930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110484443|NCT02867930|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110484444|NCT02867930|Anesthetics, General|anesthetics, general|mesh-ancestor
110484445|NCT02867930|Anesthetics|anesthetics|mesh-ancestor
110484446|NCT02867930|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110418507|NCT01106625|Metformin|metformin|mesh-list
110484447|NCT02867930|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110484448|NCT02867930|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110484449|NCT02570893|Paclitaxel|paclitaxel|mesh-list
110484450|NCT02570893|Carboplatin|carboplatin|mesh-list
110484451|NCT02570893|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110484452|NCT02570893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110484453|NCT02570893|Tubulin Modulators|tubulin modulators|mesh-ancestor
110484454|NCT02570893|Antimitotic Agents|antimitotic agents|mesh-ancestor
110484455|NCT02570893|Mitosis Modulators|mitosis modulators|mesh-ancestor
110484456|NCT02570893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110484457|NCT02538081|Risperidone|risperidone|mesh-list
110484458|NCT02538081|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110484459|NCT02538081|Serotonin Agents|serotonin agents|mesh-ancestor
110484460|NCT02538081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110484461|NCT02538081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110484463|NCT02538081|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110484464|NCT02538081|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110484465|NCT02538081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110484466|NCT02538081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110484467|NCT02538081|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110484468|NCT02538081|Dopamine Agents|dopamine agents|mesh-ancestor
110484469|NCT02570971|Mannitol|mannitol|mesh-list
110484470|NCT02570971|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110484471|NCT02570971|Diuretics|diuretics|mesh-ancestor
110484472|NCT02570971|Natriuretic Agents|natriuretic agents|mesh-ancestor
110484473|NCT02570971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110484474|NCT02866214|Febuxostat|febuxostat|mesh-list
110484475|NCT02866214|Gout Suppressants|gout suppressants|mesh-ancestor
110484476|NCT02866214|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110484477|NCT02866448|Aspirin|aspirin|mesh-list
110484478|NCT02866448|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110484479|NCT02866448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110484480|NCT02866448|Analgesics|analgesics|mesh-ancestor
110484481|NCT02866448|Sensory System Agents|sensory system agents|mesh-ancestor
110484482|NCT02866448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110484483|NCT02866448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110484484|NCT02866448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110484485|NCT02866448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110484486|NCT02866448|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110484487|NCT02866448|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110484488|NCT02866448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110484489|NCT02866448|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110484490|NCT02866448|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110484491|NCT02866448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110484493|NCT00578227|Vaccines|vaccines|mesh-list
110484494|NCT00578227|Immunologic Factors|immunologic factors|mesh-ancestor
110484495|NCT00578227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110484496|NCT00720577|Pioglitazone|pioglitazone|mesh-list
110484497|NCT00720577|Losartan|losartan|mesh-list
110484498|NCT00720577|Simvastatin|simvastatin|mesh-list
110484499|NCT00720577|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110484500|NCT00720577|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110484502|NCT00720577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110484503|NCT00720577|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110484504|NCT00720577|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110484505|NCT00720577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110484506|NCT00720577|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110484507|NCT00720577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110484508|NCT00720577|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110484509|NCT00720577|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110484510|NCT00720577|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110484511|NCT00720577|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110484512|NCT05373277|Ticagrelor|ticagrelor|mesh-list
110484513|NCT05373277|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110484514|NCT05373277|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110484515|NCT05373277|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110484516|NCT05373277|Antimetabolites|antimetabolites|mesh-ancestor
110484517|NCT05373277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110484518|NCT05373277|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110484519|NCT05373277|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110484520|NCT05373277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110484521|NCT05373277|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110484522|NCT05373277|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110484523|NCT05373277|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110484524|NCT05373277|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110484525|NCT05373277|Purinergic Agents|purinergic agents|mesh-ancestor
110484526|NCT05373277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110484527|NCT05373277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110484528|NCT00724321|Iloprost|iloprost|mesh-list
110484529|NCT00724321|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110484530|NCT00724321|Vasodilator Agents|vasodilator agents|mesh-ancestor
110484531|NCT00720811|Acetaminophen|acetaminophen|mesh-list
110484532|NCT00720811|Amoxicillin|amoxicillin|mesh-list
110484533|NCT00720811|Lumefantrine|lumefantrine|mesh-list
110484534|NCT00720811|Artemether|artemether|mesh-list
110484535|NCT00720811|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
110484536|NCT00720811|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110484537|NCT00720811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110484538|NCT00720811|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110484539|NCT00720811|Analgesics|analgesics|mesh-ancestor
110484540|NCT00720811|Sensory System Agents|sensory system agents|mesh-ancestor
110268040|NCT00160745|Antimetabolites|antimetabolites|mesh-ancestor
110484541|NCT00720811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110484542|NCT00720811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110484543|NCT00720811|Antipyretics|antipyretics|mesh-ancestor
110484544|NCT00720811|Antimalarials|antimalarials|mesh-ancestor
110484545|NCT00720811|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110484546|NCT00720811|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110484547|NCT00724633|Dialysis Solutions|dialysis solutions|mesh-list
110484548|NCT00724633|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110484549|NCT00577993|Interferons|interferons|mesh-list
110484550|NCT00577993|Interferon-alpha|interferon-alpha|mesh-list
110484551|NCT00577993|Interferon alpha-2|interferon alpha-2|mesh-list
110131805|NCT01970904|Ribavirin|ribavirin|mesh-list
110484552|NCT00577993|Dexamethasone|dexamethasone|mesh-list
110484553|NCT00577993|Prednisone|prednisone|mesh-list
110484554|NCT00577993|Prednisolone|prednisolone|mesh-list
110484555|NCT00577993|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110484556|NCT00577993|Methylprednisolone|methylprednisolone|mesh-list
110484557|NCT00577993|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110484558|NCT00577993|Prednisolone acetate|prednisolone acetate|mesh-list
110484559|NCT00577993|Cyclophosphamide|cyclophosphamide|mesh-list
110484562|NCT00577993|Fludarabine|fludarabine|mesh-list
110484563|NCT00577993|Etoposide|etoposide|mesh-list
110484564|NCT00577993|Vincristine|vincristine|mesh-list
110484565|NCT00577993|Mitoxantrone|mitoxantrone|mesh-list
110484566|NCT00577993|Bleomycin|bleomycin|mesh-list
110484567|NCT00577993|Procarbazine|procarbazine|mesh-list
110484568|NCT00577993|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110484569|NCT00577993|Prednisolone phosphate|prednisolone phosphate|mesh-list
110484570|NCT00577993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110484571|NCT00577993|Immunologic Factors|immunologic factors|mesh-ancestor
110484572|NCT00577993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110484573|NCT00577993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110484574|NCT00577993|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110484575|NCT00577993|Alkylating Agents|alkylating agents|mesh-ancestor
110484576|NCT00577993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110484577|NCT00577993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110484578|NCT00577993|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110484579|NCT00577993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110484580|NCT00577993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110484581|NCT00577993|Antiemetics|antiemetics|mesh-ancestor
110484582|NCT00577993|Autonomic Agents|autonomic agents|mesh-ancestor
110484583|NCT00577993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110484584|NCT00577993|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110484585|NCT00577993|Glucocorticoids|glucocorticoids|mesh-ancestor
110484586|NCT00577993|Hormones|hormones|mesh-ancestor
110484587|NCT00577993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110484588|NCT00577993|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110484589|NCT00577993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110484590|NCT00577993|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110484591|NCT00577993|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110484592|NCT00577993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110484593|NCT00577993|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110484594|NCT00577993|Antiviral Agents|antiviral agents|mesh-ancestor
110484595|NCT00577993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110484596|NCT00577993|Tubulin Modulators|tubulin modulators|mesh-ancestor
110484597|NCT00577993|Antimitotic Agents|antimitotic agents|mesh-ancestor
110484598|NCT00577993|Mitosis Modulators|mitosis modulators|mesh-ancestor
110484599|NCT00577993|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110484600|NCT00577993|Protective Agents|protective agents|mesh-ancestor
110484601|NCT00577993|Analgesics|analgesics|mesh-ancestor
110484602|NCT00577993|Sensory System Agents|sensory system agents|mesh-ancestor
110484603|NCT00975806|Lenalidomide|lenalidomide|mesh-list
110484604|NCT00975806|Sunitinib|sunitinib|mesh-list
110484605|NCT00975806|Immunologic Factors|immunologic factors|mesh-ancestor
110484606|NCT00975806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110484607|NCT00975806|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110484608|NCT00975806|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110484609|NCT00975806|Growth Substances|growth substances|mesh-ancestor
110484610|NCT00975806|Growth Inhibitors|growth inhibitors|mesh-ancestor
110484611|NCT00975806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110484612|NCT00975806|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110484613|NCT00975806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110484614|NCT00975806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110484615|NCT00721201|Mifepristone|mifepristone|mesh-list
110484616|NCT00721201|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
110484617|NCT00721201|Abortifacient Agents|abortifacient agents|mesh-ancestor
110484618|NCT00721201|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110484619|NCT00721201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110484620|NCT00721201|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110484621|NCT00721201|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110484622|NCT00721201|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110484623|NCT00721201|Contraceptive Agents|contraceptive agents|mesh-ancestor
110484624|NCT00721201|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
110484625|NCT00721201|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
110484626|NCT00721201|Hormone Antagonists|hormone antagonists|mesh-ancestor
110484627|NCT00721201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110484628|NCT00721201|Luteolytic Agents|luteolytic agents|mesh-ancestor
110484629|NCT00721201|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110484630|NCT00721201|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
110484632|NCT02866370|Carboplatin|carboplatin|mesh-list
110484633|NCT02866370|Doxorubicin|doxorubicin|mesh-list
110484634|NCT02866370|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110484635|NCT02866370|Topotecan|topotecan|mesh-list
110484636|NCT02866370|Nintedanib|nintedanib|mesh-list
110166512|NCT00012051|Antiviral Agents|antiviral agents|mesh-ancestor
110484637|NCT02866370|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110484638|NCT02866370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110484639|NCT02866370|Tubulin Modulators|tubulin modulators|mesh-ancestor
110484640|NCT02866370|Antimitotic Agents|antimitotic agents|mesh-ancestor
110484641|NCT02866370|Mitosis Modulators|mitosis modulators|mesh-ancestor
110484642|NCT02866370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110484643|NCT02866370|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110484644|NCT02866370|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110484645|NCT02866370|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110484646|NCT02866370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110484647|NCT02866370|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110484649|NCT00978068|Ritonavir|ritonavir|mesh-list
110484650|NCT00978068|Lopinavir|lopinavir|mesh-list
110484651|NCT00978068|Nevirapine|nevirapine|mesh-list
110484652|NCT00978068|Efavirenz|efavirenz|mesh-list
110484653|NCT00978068|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
110484654|NCT00978068|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110484655|NCT00978068|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110484656|NCT00978068|Protease Inhibitors|protease inhibitors|mesh-ancestor
110484657|NCT00978068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110484658|NCT00978068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110484659|NCT00978068|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110484660|NCT00978068|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110484661|NCT00978068|Antiviral Agents|antiviral agents|mesh-ancestor
110484662|NCT00978068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110484663|NCT00978068|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110484664|NCT00978068|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110484665|NCT00978068|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110484666|NCT00978068|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110484667|NCT00978068|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110484668|NCT00978068|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110484669|NCT00978068|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110484670|NCT00978068|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110484671|NCT00629642|Solifenacin Succinate|solifenacin succinate|mesh-list
110484672|NCT00629642|Oxybutynin|oxybutynin|mesh-list
110484673|NCT00629642|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110484674|NCT00629642|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110484675|NCT00629642|Cholinergic Agents|cholinergic agents|mesh-ancestor
110484676|NCT00629642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110484677|NCT00629642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110484678|NCT00629642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110484679|NCT00629642|Urological Agents|urological agents|mesh-ancestor
110484680|NCT00629642|Parasympatholytics|parasympatholytics|mesh-ancestor
110484681|NCT00629642|Autonomic Agents|autonomic agents|mesh-ancestor
110484682|NCT00629642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110484683|NCT02865356|Cyclosporine|cyclosporine|mesh-list
110484684|NCT02865356|Cyclosporins|cyclosporins|mesh-list
110484685|NCT02865356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110484686|NCT02865356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110484687|NCT02865356|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110484688|NCT02865356|Immunologic Factors|immunologic factors|mesh-ancestor
110166517|NCT00027976|Celecoxib|celecoxib|mesh-list
110484689|NCT02865356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110484690|NCT02865356|Antifungal Agents|antifungal agents|mesh-ancestor
110484691|NCT02865356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110484692|NCT02865356|Dermatologic Agents|dermatologic agents|mesh-ancestor
110484693|NCT02865356|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110419551|NCT01075815|Hormones|hormones|mesh-list
110484694|NCT02865356|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110484695|NCT04287842|Sevoflurane|sevoflurane|mesh-list
110484696|NCT04287842|Desflurane|desflurane|mesh-list
110484697|NCT04287842|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110484698|NCT04287842|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110484699|NCT04287842|Anesthetics, General|anesthetics, general|mesh-ancestor
110484700|NCT04287842|Anesthetics|anesthetics|mesh-ancestor
110484701|NCT04287842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110484702|NCT04287842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110484703|NCT00721747|Cyclophosphamide|cyclophosphamide|mesh-list
110484704|NCT00721747|Docetaxel|docetaxel|mesh-list
110484705|NCT00721747|Doxorubicin|doxorubicin|mesh-list
110484706|NCT00721747|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110484707|NCT00721747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110484708|NCT00721747|Immunologic Factors|immunologic factors|mesh-ancestor
110484709|NCT00721747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110484710|NCT00721747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110484711|NCT00721747|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110484712|NCT00721747|Alkylating Agents|alkylating agents|mesh-ancestor
110484713|NCT00721747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110484714|NCT00721747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110484715|NCT00721747|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110484716|NCT00721747|Tubulin Modulators|tubulin modulators|mesh-ancestor
110484717|NCT00721747|Antimitotic Agents|antimitotic agents|mesh-ancestor
110484718|NCT00721747|Mitosis Modulators|mitosis modulators|mesh-ancestor
110484719|NCT00721747|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110484720|NCT00721747|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110484721|NCT00721747|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110484722|NCT00721747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110484723|NCT00603525|Ofatumumab|ofatumumab|mesh-list
110484724|NCT00603525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110484725|NCT02570191|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110484726|NCT02570191|Antiviral Agents|antiviral agents|mesh-ancestor
110484727|NCT02570191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110484728|NCT02689401|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
110484729|NCT02689401|Hematinics|hematinics|mesh-ancestor
110268082|NCT00184626|Insulin|insulin|mesh-list
110484730|NCT02689401|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
110484731|NCT02689401|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110484732|NCT00640575|Triamcinolone|triamcinolone|mesh-list
110484733|NCT00640575|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110484734|NCT00640575|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110484735|NCT00640575|Lidocaine|lidocaine|mesh-list
110484736|NCT00640575|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110484737|NCT00640575|Anesthetics, Local|anesthetics, local|mesh-ancestor
110484738|NCT00640575|Anesthetics|anesthetics|mesh-ancestor
110484739|NCT00640575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110484740|NCT00640575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110484741|NCT00640575|Sensory System Agents|sensory system agents|mesh-ancestor
110484742|NCT00640575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110419641|NCT04937413|Evolocumab|evolocumab|mesh-list
110484743|NCT00640575|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110484744|NCT00640575|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110484745|NCT00640575|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110484746|NCT00640575|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110484747|NCT00640575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110484748|NCT00640575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110484749|NCT00640575|Glucocorticoids|glucocorticoids|mesh-ancestor
110484751|NCT00640575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110484752|NCT00640575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110484753|NCT00640575|Immunologic Factors|immunologic factors|mesh-ancestor
110484754|NCT00640575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110484755|NCT04067791|Melatonin|melatonin|mesh-list
110484756|NCT04067791|Antioxidants|antioxidants|mesh-ancestor
110484757|NCT04067791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110484758|NCT04067791|Protective Agents|protective agents|mesh-ancestor
110484759|NCT04067791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110484760|NCT04067791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110484761|NCT00762034|Paclitaxel|paclitaxel|mesh-list
110484762|NCT00762034|Bevacizumab|bevacizumab|mesh-list
110484763|NCT00762034|Carboplatin|carboplatin|mesh-list
110484764|NCT00762034|Pemetrexed|pemetrexed|mesh-list
110484765|NCT00762034|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110484766|NCT00762034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110484767|NCT00762034|Tubulin Modulators|tubulin modulators|mesh-ancestor
110484768|NCT00762034|Antimitotic Agents|antimitotic agents|mesh-ancestor
110484769|NCT00762034|Mitosis Modulators|mitosis modulators|mesh-ancestor
110484770|NCT00762034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110484771|NCT00762034|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110484772|NCT00762034|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110484773|NCT00762034|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110484774|NCT00762034|Growth Substances|growth substances|mesh-ancestor
110484775|NCT00762034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110484776|NCT00762034|Growth Inhibitors|growth inhibitors|mesh-ancestor
110484777|NCT00762034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110484778|NCT00762034|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110484779|NCT00762034|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110484780|NCT02387229|Rivaroxaban|rivaroxaban|mesh-list
110484781|NCT02387229|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110484782|NCT02387229|Antithrombins|antithrombins|mesh-ancestor
110484783|NCT02387229|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110484784|NCT02387229|Protease Inhibitors|protease inhibitors|mesh-ancestor
110484785|NCT02387229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110484786|NCT02387229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110484787|NCT02387229|Anticoagulants|anticoagulants|mesh-ancestor
110484788|NCT04183881|Brodalumab|brodalumab|mesh-list
110484789|NCT04183881|Dermatologic Agents|dermatologic agents|mesh-ancestor
110484790|NCT04093648|Cyclophosphamide|cyclophosphamide|mesh-list
110484791|NCT04093648|Fludarabine|fludarabine|mesh-list
110484792|NCT04093648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110484793|NCT04093648|Immunologic Factors|immunologic factors|mesh-ancestor
110484794|NCT04093648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110484795|NCT04093648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110484796|NCT04093648|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110484797|NCT04093648|Alkylating Agents|alkylating agents|mesh-ancestor
110484798|NCT04093648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110484799|NCT04093648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110484800|NCT04093648|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110484801|NCT04184115|Scopolamine|scopolamine|mesh-list
110484802|NCT04184115|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110484803|NCT04184115|Antiemetics|antiemetics|mesh-ancestor
110484804|NCT04184115|Autonomic Agents|autonomic agents|mesh-ancestor
110484805|NCT04184115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110419738|NCT04862065|Immunologic Factors|immunologic factors|mesh-ancestor
110484806|NCT04184115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110484807|NCT04184115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110484809|NCT04184115|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110484810|NCT04184115|Cholinergic Agents|cholinergic agents|mesh-ancestor
110484811|NCT04184115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110484812|NCT04184115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110484813|NCT04184115|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110484814|NCT00722215|Nifedipine|nifedipine|mesh-list
110484815|NCT00722215|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-list
110484816|NCT00722215|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110484817|NCT00722215|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110484818|NCT00722215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110484819|NCT00722215|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110484820|NCT00722215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110484821|NCT00722215|Vasodilator Agents|vasodilator agents|mesh-ancestor
110484822|NCT00722215|Tocolytic Agents|tocolytic agents|mesh-ancestor
110484823|NCT00722215|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110484824|NCT00722215|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
110484825|NCT00640809|Ibuprofen|ibuprofen|mesh-list
110484826|NCT00640809|Celecoxib|celecoxib|mesh-list
110484827|NCT00640809|Omeprazole|omeprazole|mesh-list
110484828|NCT00640809|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110484829|NCT00640809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110484831|NCT00640809|Sensory System Agents|sensory system agents|mesh-ancestor
110484832|NCT00640809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110484833|NCT00640809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110484834|NCT00640809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110484835|NCT00640809|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110484836|NCT00640809|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110484837|NCT00640809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110484838|NCT00640809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110268111|NCT00547495|Urological Agents|urological agents|mesh-ancestor
110484839|NCT00640809|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110484840|NCT00640809|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110419920|NCT02848183|Antimetabolites|antimetabolites|mesh-ancestor
110484841|NCT00640809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110484842|NCT00640809|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110484844|NCT00754624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110484845|NCT00754624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110484846|NCT05630209|Doxorubicin|doxorubicin|mesh-list
110484847|NCT05630209|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110484848|NCT05630209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110484849|NCT05630209|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110484850|NCT05630209|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110484851|NCT05630209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110419966|NCT02848339|Analgesics|analgesics|mesh-ancestor
110484852|NCT05630209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110484853|NCT00722293|Doxorubicin|doxorubicin|mesh-list
110484854|NCT00722293|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110484856|NCT00722293|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110484857|NCT00722293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110484858|NCT00722293|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110484859|NCT00722293|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110484860|NCT00722293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110484861|NCT00722293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110484863|NCT00726505|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110484864|NCT00726505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110484865|NCT00726505|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110484867|NCT02683005|Sofosbuvir|sofosbuvir|mesh-list
110484868|NCT02683005|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
110484869|NCT02683005|Ledipasvir|ledipasvir|mesh-list
110484870|NCT02683005|Antiviral Agents|antiviral agents|mesh-ancestor
110484871|NCT02683005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110484872|NCT03583957|Caffeine|caffeine|mesh-list
110484873|NCT03583957|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110484874|NCT03583957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110484875|NCT03583957|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110484876|NCT03583957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110484877|NCT03583957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110484878|NCT03583957|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110484879|NCT03583957|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110484880|NCT03583957|Purinergic Agents|purinergic agents|mesh-ancestor
110484881|NCT03583957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110484882|NCT02176863|Immunoglobulins|immunoglobulins|mesh-list
110484883|NCT02176863|gamma-Globulins|gamma-globulins|mesh-list
110484884|NCT02176863|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110484885|NCT02176863|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110484886|NCT02176863|Immunologic Factors|immunologic factors|mesh-ancestor
110484887|NCT02176863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110484889|NCT02571283|Bupivacaine|bupivacaine|mesh-list
110484890|NCT02571283|Anesthetics, Local|anesthetics, local|mesh-ancestor
110484891|NCT02571283|Anesthetics|anesthetics|mesh-ancestor
110484892|NCT02571283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110484893|NCT02571283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110484894|NCT02571283|Sensory System Agents|sensory system agents|mesh-ancestor
110484895|NCT02571283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110484896|NCT02571283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110484897|NCT02571283|Autonomic Agents|autonomic agents|mesh-ancestor
110484898|NCT02571283|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110484899|NCT02571283|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110484900|NCT02571283|Adrenergic Agents|adrenergic agents|mesh-ancestor
110484901|NCT02571283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110484902|NCT02571283|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110484903|NCT02571283|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110484904|NCT02571283|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110484905|NCT02571283|Respiratory System Agents|respiratory system agents|mesh-ancestor
110484906|NCT02571283|Mydriatics|mydriatics|mesh-ancestor
110484907|NCT02571283|Sympathomimetics|sympathomimetics|mesh-ancestor
110484908|NCT02571283|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110484909|NCT02682693|Denosumab|denosumab|mesh-list
110484910|NCT02682693|Paclitaxel|paclitaxel|mesh-list
110484911|NCT02682693|Cyclophosphamide|cyclophosphamide|mesh-list
110484912|NCT02682693|Carboplatin|carboplatin|mesh-list
110484913|NCT02682693|Trastuzumab|trastuzumab|mesh-list
110484914|NCT02682693|Epirubicin|epirubicin|mesh-list
110484915|NCT02682693|Pertuzumab|pertuzumab|mesh-list
110484916|NCT02682693|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110484917|NCT02682693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110484918|NCT02682693|Tubulin Modulators|tubulin modulators|mesh-ancestor
110484919|NCT02682693|Antimitotic Agents|antimitotic agents|mesh-ancestor
110484920|NCT02682693|Mitosis Modulators|mitosis modulators|mesh-ancestor
110484921|NCT02682693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110484922|NCT02682693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110484923|NCT02682693|Immunologic Factors|immunologic factors|mesh-ancestor
110484924|NCT02682693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110484925|NCT02682693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110484926|NCT02682693|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110484927|NCT02682693|Alkylating Agents|alkylating agents|mesh-ancestor
110484928|NCT02682693|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110132180|NCT01973660|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110484929|NCT02682693|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110484930|NCT02682693|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110311538|NCT00323505|Interferon-alpha|interferon-alpha|mesh-list
110484931|NCT02682693|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110484932|NCT02682693|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110484933|NCT02682693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110484934|NCT02682693|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110484935|NCT02571517|Methylprednisolone|methylprednisolone|mesh-list
110484936|NCT02571517|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110484937|NCT02571517|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110484938|NCT02571517|Prednisolone|prednisolone|mesh-list
110484939|NCT02571517|Prednisolone acetate|prednisolone acetate|mesh-list
110484940|NCT02571517|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110484941|NCT02571517|Prednisolone phosphate|prednisolone phosphate|mesh-list
110484942|NCT02571517|Glucocorticoids|glucocorticoids|mesh-list
110484943|NCT02571517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110484944|NCT02571517|Antiemetics|antiemetics|mesh-ancestor
110484945|NCT02571517|Autonomic Agents|autonomic agents|mesh-ancestor
110484946|NCT02571517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110484947|NCT02571517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110484948|NCT02571517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110484950|NCT02571517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110484951|NCT02571517|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110484952|NCT02571517|Protective Agents|protective agents|mesh-ancestor
110484953|NCT02571517|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110484954|NCT02571517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110484955|NCT00586846|Doxorubicin|doxorubicin|mesh-list
110484956|NCT00586846|Methotrexate|methotrexate|mesh-list
110484957|NCT00586846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110484958|NCT00586846|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110484959|NCT00586846|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110484960|NCT00586846|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110484961|NCT00586846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110484962|NCT00586846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110484963|NCT00586846|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110420401|NCT03679546|Infliximab|infliximab|mesh-list
110484964|NCT00586846|Abortifacient Agents|abortifacient agents|mesh-ancestor
110484965|NCT00586846|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110484966|NCT00586846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110484967|NCT00586846|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110484968|NCT00586846|Antimetabolites|antimetabolites|mesh-ancestor
110484969|NCT00586846|Dermatologic Agents|dermatologic agents|mesh-ancestor
110484970|NCT00586846|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110484971|NCT00586846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110484972|NCT00586846|Immunologic Factors|immunologic factors|mesh-ancestor
110484973|NCT00586846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110484974|NCT00586846|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110484975|NCT04144465|Phenylephrine|phenylephrine|mesh-list
110484976|NCT04144465|Oxymetazoline|oxymetazoline|mesh-list
110484977|NCT04144465|Norepinephrine|norepinephrine|mesh-list
110484978|NCT04144465|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110484979|NCT04144465|Mydriatics|mydriatics|mesh-ancestor
110484980|NCT04144465|Autonomic Agents|autonomic agents|mesh-ancestor
110484981|NCT04144465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110484982|NCT04144465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110484983|NCT04144465|Sympathomimetics|sympathomimetics|mesh-ancestor
110484984|NCT04144465|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110484985|NCT04144465|Nasal Decongestants|nasal decongestants|mesh-ancestor
110484986|NCT04144465|Respiratory System Agents|respiratory system agents|mesh-ancestor
110484987|NCT04144465|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110484988|NCT04144465|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110484989|NCT04144465|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110484990|NCT04144465|Adrenergic Agents|adrenergic agents|mesh-ancestor
110484991|NCT04144465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110484992|NCT04144465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110484993|NCT04144465|Protective Agents|protective agents|mesh-ancestor
110484994|NCT00754390|Calcium, Dietary|calcium, dietary|mesh-list
110484995|NCT00754390|Calcium|calcium|mesh-list
110484996|NCT00754390|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110484997|NCT00754390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110484998|NCT00754390|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110484999|NCT04066621|Ceftriaxone|ceftriaxone|mesh-list
110485000|NCT04066621|Sulbactam|sulbactam|mesh-list
110485001|NCT04066621|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110485002|NCT04066621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110485003|NCT04066621|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110485004|NCT04066621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110485005|NCT04066621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110485006|NCT00629564|Esomeprazole|esomeprazole|mesh-list
110485007|NCT00629564|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110420492|NCT00140959|Vasodilator Agents|vasodilator agents|mesh-ancestor
110485008|NCT00629564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110485009|NCT00629564|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110485010|NCT00629564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110485011|NCT00629564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110485012|NCT02865824|Aspirin|aspirin|mesh-list
110485013|NCT02865824|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110485014|NCT02865824|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110485015|NCT02865824|Analgesics|analgesics|mesh-ancestor
110485016|NCT02865824|Sensory System Agents|sensory system agents|mesh-ancestor
110485017|NCT02865824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110485018|NCT02865824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110485019|NCT02865824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110485020|NCT02865824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110485021|NCT02865824|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110485022|NCT02865824|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110485023|NCT02865824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110485024|NCT02865824|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110485025|NCT02865824|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110485026|NCT02865824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110485027|NCT02865824|Antipyretics|antipyretics|mesh-ancestor
110485028|NCT02570035|Mirabegron|mirabegron|mesh-list
110485029|NCT02570035|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
110485030|NCT02570035|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110485031|NCT02570035|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110485032|NCT02570035|Adrenergic Agents|adrenergic agents|mesh-ancestor
110485033|NCT02570035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110485034|NCT02570035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110485035|NCT02570035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110485036|NCT02570035|Urological Agents|urological agents|mesh-ancestor
110420612|NCT01228019|Niacin|niacin|mesh-list
110485037|NCT02865980|Povidone-Iodine|povidone-iodine|mesh-list
110485038|NCT02865980|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110485039|NCT02865980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110485040|NCT04098796|Antibodies|antibodies|mesh-list
110485041|NCT04098796|Immunologic Factors|immunologic factors|mesh-ancestor
110485042|NCT04098796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110485043|NCT00522145|XL647|xl647|mesh-list
110485044|NCT00522145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110485045|NCT00522145|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110485046|NCT00522145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110485047|NCT00522145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110485048|NCT00726973|Ranibizumab|ranibizumab|mesh-list
110485049|NCT00726973|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110485050|NCT00726973|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110485051|NCT00726973|Growth Substances|growth substances|mesh-ancestor
110485052|NCT00726973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110485053|NCT00726973|Growth Inhibitors|growth inhibitors|mesh-ancestor
110485054|NCT00726973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110485055|NCT02571361|Acetaminophen|acetaminophen|mesh-list
110485056|NCT02571361|Ibuprofen|ibuprofen|mesh-list
110485057|NCT02571361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110485058|NCT02571361|Analgesics|analgesics|mesh-ancestor
110420744|NCT00895453|Trace Elements|trace elements|mesh-ancestor
110485059|NCT02571361|Sensory System Agents|sensory system agents|mesh-ancestor
110485060|NCT02571361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110485061|NCT02571361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110485062|NCT02571361|Antipyretics|antipyretics|mesh-ancestor
110485063|NCT02571361|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110485064|NCT02571361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110485065|NCT02571361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110485066|NCT02571361|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110485067|NCT02571361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110311540|NCT00323505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110485068|NCT02571361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110485069|NCT04290104|Ampicillin|ampicillin|mesh-list
110485070|NCT04290104|Sulbactam|sulbactam|mesh-list
110485071|NCT04290104|Sultamicillin|sultamicillin|mesh-list
110485072|NCT04290104|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110485073|NCT04290104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110485074|NCT04290104|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110485075|NCT04290104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110485076|NCT04290104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110485077|NCT02571205|Testosterone|testosterone|mesh-list
110485078|NCT02571205|Androgens|androgens|mesh-ancestor
110485079|NCT02571205|Hormones|hormones|mesh-ancestor
110485080|NCT02571205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110485081|NCT02571205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110420879|NCT00967798|Hormones|hormones|mesh-ancestor
110485082|NCT04290026|Metoclopramide|metoclopramide|mesh-list
110485083|NCT04290026|Granisetron|granisetron|mesh-list
110485084|NCT04290026|Antiemetics|antiemetics|mesh-ancestor
110485085|NCT04290026|Autonomic Agents|autonomic agents|mesh-ancestor
110485086|NCT04290026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110485087|NCT04290026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110485088|NCT04290026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110485089|NCT04290026|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110485090|NCT04290026|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110485091|NCT04290026|Dopamine Agents|dopamine agents|mesh-ancestor
110485092|NCT04290026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110485093|NCT04290026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110485094|NCT04290026|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110485095|NCT04290026|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110485096|NCT04290026|Serotonin Agents|serotonin agents|mesh-ancestor
110485098|NCT00640887|Lopinavir|lopinavir|mesh-list
110485099|NCT00640887|Nevirapine|nevirapine|mesh-list
110485100|NCT00640887|Efavirenz|efavirenz|mesh-list
110485101|NCT00640887|Rifabutin|rifabutin|mesh-list
110485102|NCT00640887|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110485103|NCT00640887|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110485104|NCT00640887|Protease Inhibitors|protease inhibitors|mesh-ancestor
110485105|NCT00640887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110485106|NCT00640887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110485107|NCT00640887|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110485108|NCT00640887|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110485109|NCT00640887|Antiviral Agents|antiviral agents|mesh-ancestor
110485110|NCT00640887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110485111|NCT00640887|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110485112|NCT00640887|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110485113|NCT00640887|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110485114|NCT00640887|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110485115|NCT00640887|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110485116|NCT00640887|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110485117|NCT00640887|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110485118|NCT00640887|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110485119|NCT00640887|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110485120|NCT00640887|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110485121|NCT00640887|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110485122|NCT00640887|Antitubercular Agents|antitubercular agents|mesh-ancestor
110485123|NCT05615623|Doxorubicin|doxorubicin|mesh-list
110485124|NCT05615623|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110485125|NCT05615623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110485126|NCT05615623|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110485127|NCT05615623|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110485128|NCT05615623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110485129|NCT05615623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110485130|NCT00730093|Vitamin B 12|vitamin b 12|mesh-list
110485131|NCT00730093|Hydroxocobalamin|hydroxocobalamin|mesh-list
110485132|NCT00730093|Vitamins|vitamins|mesh-ancestor
110328390|NCT00461747|Dexamethasone|dexamethasone|mesh-list
110485133|NCT00730093|Micronutrients|micronutrients|mesh-ancestor
110485134|NCT00730093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110485135|NCT00730093|Vitamin B Complex|vitamin b complex|mesh-ancestor
110311553|NCT00323544|Tenofovir|tenofovir|mesh-list
110485136|NCT00730093|Hematinics|hematinics|mesh-ancestor
110485137|NCT00727129|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110485138|NCT00727129|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110485139|NCT00727129|Estradiol|estradiol|mesh-list
110485140|NCT00727129|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110485141|NCT00727129|Estrogens|estrogens|mesh-ancestor
110485142|NCT00727129|Hormones|hormones|mesh-ancestor
110485143|NCT00727129|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110485144|NCT00727129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110485145|NCT00727129|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110485146|NCT00727129|Contraceptive Agents|contraceptive agents|mesh-ancestor
110485147|NCT00727129|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110421398|NCT02821000|Pembrolizumab|pembrolizumab|mesh-list
110485148|NCT00727129|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110485149|NCT04183725|Oseltamivir|oseltamivir|mesh-list
110485150|NCT04183725|Antiviral Agents|antiviral agents|mesh-ancestor
110485151|NCT04183725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110485152|NCT04183725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110485153|NCT04183725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110485155|NCT00730249|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110485156|NCT00730249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110485157|NCT00730249|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110485158|NCT00730249|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110485159|NCT00730249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110421534|NCT02827903|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110485160|NCT00730249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110485161|NCT00730249|Dopamine Agents|dopamine agents|mesh-ancestor
110485162|NCT00730249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110485163|NCT02570347|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
110485164|NCT02570347|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110485165|NCT02570347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110485166|NCT02570347|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110485167|NCT02570347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110485168|NCT02570347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110485169|NCT01632657|Sumatriptan|sumatriptan|mesh-list
110485170|NCT01632657|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110485171|NCT01632657|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110485172|NCT01632657|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110485173|NCT01632657|Serotonin Agents|serotonin agents|mesh-ancestor
110485174|NCT01632657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110485175|NCT01632657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110485176|NCT01632657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110485177|NCT00727207|Everolimus|everolimus|mesh-list
110485178|NCT00727207|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110485179|NCT00727207|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110485180|NCT00727207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110485181|NCT00727207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110485182|NCT00727207|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110485183|NCT00727207|Immunologic Factors|immunologic factors|mesh-ancestor
110485184|NCT00727207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110485185|NCT00727207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110485186|NCT02682459|Lisinopril|lisinopril|mesh-list
110485187|NCT02682459|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110485188|NCT02682459|Protease Inhibitors|protease inhibitors|mesh-ancestor
110485189|NCT02682459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110485190|NCT02682459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110485191|NCT02682459|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110485192|NCT02682459|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110485193|NCT02682459|Protective Agents|protective agents|mesh-ancestor
110485194|NCT02682459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110485195|NCT02620579|Propranolol|propranolol|mesh-list
110485196|NCT02620579|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110485197|NCT02620579|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110485198|NCT02620579|Adrenergic Agents|adrenergic agents|mesh-ancestor
110485199|NCT02620579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110485200|NCT02620579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110485201|NCT02620579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110485202|NCT02620579|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110421936|NCT00633763|Fallypride|fallypride|mesh-list
110485203|NCT02620579|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110485204|NCT02620579|Vasodilator Agents|vasodilator agents|mesh-ancestor
110485205|NCT02682225|Ketamine|ketamine|mesh-list
110485206|NCT02682225|Esketamine|esketamine|mesh-list
110485207|NCT02682225|Analgesics|analgesics|mesh-ancestor
110485208|NCT02682225|Sensory System Agents|sensory system agents|mesh-ancestor
110485209|NCT02682225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110485210|NCT02682225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110485211|NCT02682225|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110485213|NCT02682225|Anesthetics, General|anesthetics, general|mesh-ancestor
110485214|NCT02682225|Anesthetics|anesthetics|mesh-ancestor
110485215|NCT02682225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110485216|NCT02682225|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110485217|NCT02682225|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110485218|NCT02682225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110485219|NCT02682225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110485220|NCT02682225|Antidepressive Agents|antidepressive agents|mesh-ancestor
110485221|NCT02682225|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110485222|NCT04066231|Erythromycin|erythromycin|mesh-list
110485223|NCT04066231|Erythromycin Estolate|erythromycin estolate|mesh-list
110485224|NCT04066231|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
110485226|NCT04066231|Erythromycin lactobionate|erythromycin lactobionate|mesh-list
110485227|NCT04066231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110485228|NCT04066231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110485229|NCT04066231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110485230|NCT04066231|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110485231|NCT04066231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110485232|NCT04066231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110485233|NCT04183491|Interferons|interferons|mesh-list
110485234|NCT04183491|Interferon-beta|interferon-beta|mesh-list
110485235|NCT04183491|Interferon beta-1a|interferon beta-1a|mesh-list
110485236|NCT04183491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110485237|NCT04183491|Antiviral Agents|antiviral agents|mesh-ancestor
110485238|NCT04183491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110485239|NCT04183491|Immunologic Factors|immunologic factors|mesh-ancestor
110485240|NCT04183491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110485241|NCT04183491|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110485242|NCT03702283|Penicillins|penicillins|mesh-list
110485243|NCT03702283|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110485244|NCT03702283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110485245|NCT00727753|Bevacizumab|bevacizumab|mesh-list
110485246|NCT00727753|Ranibizumab|ranibizumab|mesh-list
110485247|NCT00727753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110422344|NCT04275661|Anesthetics|anesthetics|mesh-ancestor
110485248|NCT00727753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110485249|NCT00727753|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110485250|NCT00727753|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110485251|NCT00727753|Growth Substances|growth substances|mesh-ancestor
110485252|NCT00727753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110485253|NCT00727753|Growth Inhibitors|growth inhibitors|mesh-ancestor
110485255|NCT00727831|Methotrexate|methotrexate|mesh-list
110485256|NCT00727831|Calcium|calcium|mesh-list
110485257|NCT00727831|Levoleucovorin|levoleucovorin|mesh-list
110422479|NCT02888054|Lesinurad|lesinurad|mesh-list
110485258|NCT00727831|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110485259|NCT00727831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110485260|NCT00727831|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110485261|NCT00727831|Abortifacient Agents|abortifacient agents|mesh-ancestor
110485262|NCT00727831|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110485263|NCT00727831|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110485264|NCT00727831|Antimetabolites|antimetabolites|mesh-ancestor
110485265|NCT00727831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110485266|NCT00727831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110485267|NCT00727831|Dermatologic Agents|dermatologic agents|mesh-ancestor
110485268|NCT00727831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110485269|NCT00727831|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110485270|NCT00727831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110485271|NCT00727831|Immunologic Factors|immunologic factors|mesh-ancestor
110485272|NCT00727831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110485273|NCT00727831|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110485274|NCT00727831|Antidotes|antidotes|mesh-ancestor
110485275|NCT00727831|Protective Agents|protective agents|mesh-ancestor
110485276|NCT00727831|Vitamin B Complex|vitamin b complex|mesh-ancestor
110485277|NCT00727831|Vitamins|vitamins|mesh-ancestor
110485278|NCT00727831|Micronutrients|micronutrients|mesh-ancestor
110485279|NCT00727987|Golimumab|golimumab|mesh-list
110485280|NCT00727987|Methotrexate|methotrexate|mesh-list
110485281|NCT00727987|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110485282|NCT00727987|Abortifacient Agents|abortifacient agents|mesh-ancestor
110485283|NCT00727987|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110485284|NCT00727987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110485285|NCT00727987|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110485287|NCT00727987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110485288|NCT00727987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110485289|NCT00727987|Dermatologic Agents|dermatologic agents|mesh-ancestor
110422743|NCT04207177|Immunologic Factors|immunologic factors|mesh-ancestor
110485290|NCT00727987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110485291|NCT00727987|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110485292|NCT00727987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110485293|NCT00727987|Immunologic Factors|immunologic factors|mesh-ancestor
110485294|NCT00727987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110485295|NCT00727987|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110485296|NCT00727987|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110485297|NCT00727987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110485298|NCT02681913|Adenosine|adenosine|mesh-list
110485299|NCT02681913|Analgesics|analgesics|mesh-ancestor
110485300|NCT02681913|Sensory System Agents|sensory system agents|mesh-ancestor
110485301|NCT02681913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110485302|NCT02681913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110485304|NCT02681913|Vasodilator Agents|vasodilator agents|mesh-ancestor
110485305|NCT02681913|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
110485306|NCT02681913|Purinergic Agonists|purinergic agonists|mesh-ancestor
110485307|NCT02681913|Purinergic Agents|purinergic agents|mesh-ancestor
110485308|NCT02681913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110485309|NCT02681913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110485310|NCT02681679|Bromfenac|bromfenac|mesh-list
110485311|NCT02681679|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110485312|NCT02681679|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110485313|NCT02681679|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110485314|NCT02681679|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110485315|NCT02681679|Analgesics|analgesics|mesh-ancestor
110485316|NCT02681679|Sensory System Agents|sensory system agents|mesh-ancestor
110485317|NCT02681679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110485318|NCT02681679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110485319|NCT02681679|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110485320|NCT02681679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110485321|NCT04183257|Vitamin D|vitamin d|mesh-list
110485322|NCT04183257|Ergocalciferols|ergocalciferols|mesh-list
110485323|NCT04183257|Cholecalciferol|cholecalciferol|mesh-list
110485324|NCT04183257|Vitamins|vitamins|mesh-list
110485325|NCT04183257|Micronutrients|micronutrients|mesh-ancestor
110485326|NCT04183257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110485327|NCT04183257|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110485328|NCT04183257|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110485329|NCT00641433|Sulfadiazine|sulfadiazine|mesh-list
110485330|NCT00641433|Silver Sulfadiazine|silver sulfadiazine|mesh-list
110485331|NCT00641433|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110485332|NCT00641433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110485333|NCT00641433|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110485334|NCT00641433|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110485335|NCT00641433|Coccidiostats|coccidiostats|mesh-ancestor
110485336|NCT00641433|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110485338|NCT00641589|Hematinics|hematinics|mesh-ancestor
110485339|NCT00734383|Propofol|propofol|mesh-list
110485340|NCT00734383|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110485341|NCT00734383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110422842|NCT05598853|Nivolumab|nivolumab|mesh-list
110485342|NCT00734383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110485343|NCT00734383|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110485344|NCT00734383|Anesthetics, General|anesthetics, general|mesh-ancestor
110485345|NCT00734383|Anesthetics|anesthetics|mesh-ancestor
110485346|NCT00586612|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110485347|NCT00586612|Immunologic Factors|immunologic factors|mesh-ancestor
110485348|NCT00586612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110485349|NCT02680977|Levodopa|levodopa|mesh-list
110485350|NCT02680977|Benserazide|benserazide|mesh-list
110485351|NCT02680977|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110485352|NCT02680977|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110485353|NCT02680977|Dopamine Agents|dopamine agents|mesh-ancestor
110485354|NCT02680977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110485355|NCT02680977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110268289|NCT00184899|Glycerol|glycerol|mesh-list
110485356|NCT02680977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110485357|NCT02680977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110485358|NCT00734695|Vitamins|vitamins|mesh-list
110485359|NCT00734695|Ascorbic Acid|ascorbic acid|mesh-list
110485360|NCT00734695|Micronutrients|micronutrients|mesh-ancestor
110485361|NCT00734695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110485363|NCT00734695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110485364|NCT00734695|Protective Agents|protective agents|mesh-ancestor
110485365|NCT00586690|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110485366|NCT00586690|Antibodies|antibodies|mesh-list
110485367|NCT00586690|Immunoglobulins|immunoglobulins|mesh-list
110485368|NCT00586690|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110485369|NCT00586690|Immunologic Factors|immunologic factors|mesh-ancestor
110485370|NCT00586690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110166605|NCT00012129|Annamycin|annamycin|mesh-list
110485371|NCT00586690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110485372|NCT00728611|Hyaluronic Acid|hyaluronic acid|mesh-list
110485373|NCT00728611|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110485374|NCT00728611|Immunologic Factors|immunologic factors|mesh-ancestor
110132631|NCT01976936|Dihydromevinolin|dihydromevinolin|mesh-list
110485375|NCT00728611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110485376|NCT00728611|Viscosupplements|viscosupplements|mesh-ancestor
110485377|NCT00728611|Protective Agents|protective agents|mesh-ancestor
110485378|NCT05663775|Mesalamine|mesalamine|mesh-list
110485379|NCT05663775|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110485380|NCT05663775|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110485381|NCT05663775|Analgesics|analgesics|mesh-ancestor
110485382|NCT05663775|Sensory System Agents|sensory system agents|mesh-ancestor
110485383|NCT05663775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110485384|NCT05663775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110485385|NCT05663775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110485386|NCT05663775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110485387|NCT00909987|Bevacizumab|bevacizumab|mesh-list
110485388|NCT00909987|Capecitabine|capecitabine|mesh-list
110485389|NCT00909987|Oxaliplatin|oxaliplatin|mesh-list
110485390|NCT00909987|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110485391|NCT00909987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110422983|NCT01038609|Morphine|morphine|mesh-list
110485392|NCT00909987|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110485393|NCT00909987|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110485394|NCT00909987|Growth Substances|growth substances|mesh-ancestor
110485395|NCT00909987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110485396|NCT00909987|Growth Inhibitors|growth inhibitors|mesh-ancestor
110485397|NCT00909987|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110485398|NCT00909987|Antimetabolites|antimetabolites|mesh-ancestor
110485399|NCT00909987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110485400|NCT00729001|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110485401|NCT00729001|Immunologic Factors|immunologic factors|mesh-ancestor
110485402|NCT00729001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110485404|NCT00760474|Analgesics|analgesics|mesh-ancestor
110485405|NCT00760474|Sensory System Agents|sensory system agents|mesh-ancestor
110485406|NCT00760474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110485407|NCT00760474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110485408|NCT00760474|Anticonvulsants|anticonvulsants|mesh-ancestor
110485409|NCT00760474|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110485410|NCT00760474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110485411|NCT00760474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110485412|NCT00760474|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110485413|NCT00760474|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110485414|NCT00760474|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110485415|NCT00760474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110485416|NCT00760474|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110485417|NCT02843035|Venglustat|venglustat|mesh-list
110485418|NCT02843035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110485419|NCT02843035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110485420|NCT02680119|Esomeprazole|esomeprazole|mesh-list
110485421|NCT02680119|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110485422|NCT02680119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110485423|NCT02680119|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110485424|NCT02680119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110485425|NCT02680119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110485426|NCT00734773|Cytarabine|cytarabine|mesh-list
110485427|NCT00734773|Rituximab|rituximab|mesh-list
110485428|NCT00734773|Methotrexate|methotrexate|mesh-list
110485429|NCT00734773|Vincristine|vincristine|mesh-list
110485430|NCT00734773|Procarbazine|procarbazine|mesh-list
110485431|NCT00734773|Motexafin gadolinium|motexafin gadolinium|mesh-list
110423355|NCT02797717|Etoposide|etoposide|mesh-list
110485432|NCT00734773|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110485433|NCT00734773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110485434|NCT00734773|Immunologic Factors|immunologic factors|mesh-ancestor
110485435|NCT00734773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110485436|NCT00734773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110485437|NCT00734773|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110485438|NCT00734773|Abortifacient Agents|abortifacient agents|mesh-ancestor
110485439|NCT00734773|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110485440|NCT00734773|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110423425|NCT02797249|Analgesics|analgesics|mesh-ancestor
110485441|NCT00734773|Antimetabolites|antimetabolites|mesh-ancestor
110485442|NCT00734773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110485443|NCT00734773|Dermatologic Agents|dermatologic agents|mesh-ancestor
110485444|NCT00734773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110485445|NCT00734773|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110485446|NCT00734773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110485447|NCT00734773|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110485448|NCT00734773|Antiviral Agents|antiviral agents|mesh-ancestor
110485449|NCT00734773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110485450|NCT00734773|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110485451|NCT00734773|Tubulin Modulators|tubulin modulators|mesh-ancestor
110485452|NCT00734773|Antimitotic Agents|antimitotic agents|mesh-ancestor
110485453|NCT00734773|Mitosis Modulators|mitosis modulators|mesh-ancestor
110485454|NCT00734773|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110485455|NCT04289090|Propofol|propofol|mesh-list
110485456|NCT04289090|Sevoflurane|sevoflurane|mesh-list
110485457|NCT04289090|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110485458|NCT04289090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110485459|NCT04289090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110485460|NCT04289090|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110485461|NCT04289090|Anesthetics, General|anesthetics, general|mesh-ancestor
110485462|NCT04289090|Anesthetics|anesthetics|mesh-ancestor
110485463|NCT04289090|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110423627|NCT02785549|Antipyretics|antipyretics|mesh-ancestor
110485464|NCT04289090|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110485465|NCT00975416|Oxytocin|oxytocin|mesh-list
110485466|NCT00975416|Oxytocics|oxytocics|mesh-ancestor
110485467|NCT00975416|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110485468|NCT00975416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110485469|NCT02679963|Olaparib|olaparib|mesh-list
110485470|NCT02679963|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110485471|NCT02679963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110485472|NCT02679963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110485473|NCT02679963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110485474|NCT00760084|Decitabine|decitabine|mesh-list
110485475|NCT00760084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110485476|NCT00760084|Antimetabolites|antimetabolites|mesh-ancestor
110485477|NCT00760084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110485478|NCT00760084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110485479|NCT00760084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110485480|NCT00735241|Leucovorin|leucovorin|mesh-list
110485481|NCT00735241|Folic Acid|folic acid|mesh-list
110485482|NCT00735241|Bevacizumab|bevacizumab|mesh-list
110485483|NCT00735241|Fluorouracil|fluorouracil|mesh-list
110485484|NCT00735241|Oxaliplatin|oxaliplatin|mesh-list
110485485|NCT00735241|Levoleucovorin|levoleucovorin|mesh-list
110485486|NCT00735241|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110485487|NCT00735241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110485488|NCT00735241|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110485489|NCT00735241|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110485490|NCT00735241|Growth Substances|growth substances|mesh-ancestor
110485491|NCT00735241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110485492|NCT00735241|Growth Inhibitors|growth inhibitors|mesh-ancestor
110485493|NCT00735241|Antimetabolites|antimetabolites|mesh-ancestor
110485494|NCT00735241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110485495|NCT00735241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110485496|NCT00735241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110485497|NCT00735241|Immunologic Factors|immunologic factors|mesh-ancestor
110485498|NCT00735241|Antidotes|antidotes|mesh-ancestor
110485499|NCT00735241|Protective Agents|protective agents|mesh-ancestor
110485500|NCT00735241|Vitamin B Complex|vitamin b complex|mesh-ancestor
110485501|NCT00735241|Vitamins|vitamins|mesh-ancestor
110485502|NCT00735241|Micronutrients|micronutrients|mesh-ancestor
110485503|NCT00735241|Hematinics|hematinics|mesh-ancestor
110485504|NCT00729313|Lanreotide|lanreotide|mesh-list
110485505|NCT00729313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110485506|NCT00641979|Budesonide|budesonide|mesh-list
110485507|NCT00641979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110485508|NCT00641979|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110485509|NCT00641979|Autonomic Agents|autonomic agents|mesh-ancestor
110485510|NCT00641979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110485511|NCT00641979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110485512|NCT00641979|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110485513|NCT00641979|Respiratory System Agents|respiratory system agents|mesh-ancestor
110485516|NCT00641979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110485517|NCT02679339|Lidocaine|lidocaine|mesh-list
110485518|NCT02679339|Anesthetics, Local|anesthetics, local|mesh-ancestor
110485519|NCT02679339|Anesthetics|anesthetics|mesh-ancestor
110485520|NCT02679339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110485521|NCT02679339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110485522|NCT02679339|Sensory System Agents|sensory system agents|mesh-ancestor
110485523|NCT02679339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110485524|NCT02679339|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110485525|NCT02679339|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110485526|NCT02679339|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110485527|NCT02679339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110485528|NCT02679339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110485529|NCT02679261|Atorvastatin|atorvastatin|mesh-list
110485530|NCT02679261|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110485531|NCT02679261|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110485532|NCT02679261|Antimetabolites|antimetabolites|mesh-ancestor
110424307|NCT02772211|Anesthetics, General|anesthetics, general|mesh-ancestor
110485533|NCT02679261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110485534|NCT02679261|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110485535|NCT02679261|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110485536|NCT02679261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110485537|NCT00752206|Saracatinib|saracatinib|mesh-list
110485538|NCT00752206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110485539|NCT00752206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110485540|NCT00752206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110485541|NCT02678949|Fluticasone|fluticasone|mesh-list
110485542|NCT02678949|Xhance|xhance|mesh-list
110485543|NCT02678949|Albuterol|albuterol|mesh-list
110485544|NCT02678949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110485545|NCT02678949|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110485546|NCT02678949|Autonomic Agents|autonomic agents|mesh-ancestor
110485547|NCT02678949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110485548|NCT02678949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110485549|NCT02678949|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110166653|NCT00028366|Ritonavir|ritonavir|mesh-list
110485550|NCT02678949|Respiratory System Agents|respiratory system agents|mesh-ancestor
110485552|NCT02678949|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110485553|NCT02678949|Tocolytic Agents|tocolytic agents|mesh-ancestor
110485554|NCT02678949|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110485555|NCT02678949|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110485556|NCT02678949|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110485557|NCT02678949|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110485558|NCT02678949|Adrenergic Agents|adrenergic agents|mesh-ancestor
110485559|NCT02678949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110485560|NCT02678949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110485561|NCT00642135|Phenylephrine|phenylephrine|mesh-list
110485562|NCT00642135|Oxymetazoline|oxymetazoline|mesh-list
110424574|NCT02770261|Candesartan|candesartan|mesh-list
110485563|NCT00642135|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110485564|NCT00642135|Tropicamide|tropicamide|mesh-list
110485565|NCT00642135|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110485566|NCT00642135|Mydriatics|mydriatics|mesh-ancestor
110485567|NCT00642135|Autonomic Agents|autonomic agents|mesh-ancestor
110485568|NCT00642135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110485569|NCT00642135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110485571|NCT00642135|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110485572|NCT00642135|Nasal Decongestants|nasal decongestants|mesh-ancestor
110485573|NCT00642135|Respiratory System Agents|respiratory system agents|mesh-ancestor
110485574|NCT00642135|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110485575|NCT00642135|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110485576|NCT00642135|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110485577|NCT00642135|Adrenergic Agents|adrenergic agents|mesh-ancestor
110485578|NCT00642135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110485579|NCT00642135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110485580|NCT00642135|Protective Agents|protective agents|mesh-ancestor
110485581|NCT00642135|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110485582|NCT00642135|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110485583|NCT00642135|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110485584|NCT00642135|Cholinergic Agents|cholinergic agents|mesh-ancestor
110485586|NCT00642291|Antiviral Agents|antiviral agents|mesh-ancestor
110485587|NCT00642291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110485588|NCT00642291|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110485589|NCT00642291|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110485590|NCT00642291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110485591|NCT00642291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110485592|NCT00642291|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110485593|NCT00642291|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110485595|NCT02600260|Enoxaparin sodium|enoxaparin sodium|mesh-list
110485596|NCT02600260|Anticoagulants|anticoagulants|mesh-ancestor
110485597|NCT02600260|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110485598|NCT02600260|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110424933|NCT04314336|Coal Tar|coal tar|mesh-list
110485599|NCT02600260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110485600|NCT02537379|Ribavirin|ribavirin|mesh-list
110485601|NCT02537379|Antimetabolites|antimetabolites|mesh-ancestor
110485602|NCT02537379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110485603|NCT02537379|Antiviral Agents|antiviral agents|mesh-ancestor
110485604|NCT02537379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110485605|NCT04179747|Sildenafil Citrate|sildenafil citrate|mesh-list
110485606|NCT04179747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110485607|NCT04179747|Vasodilator Agents|vasodilator agents|mesh-ancestor
110485608|NCT04179747|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110485609|NCT04179747|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110485610|NCT04179747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110485611|NCT04179747|Urological Agents|urological agents|mesh-ancestor
110485613|NCT04204772|Antidotes|antidotes|mesh-ancestor
110485614|NCT04204772|Protective Agents|protective agents|mesh-ancestor
110485615|NCT04204772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110485616|NCT02675205|Aspirin|aspirin|mesh-list
110485617|NCT02675205|Clopidogrel|clopidogrel|mesh-list
110485618|NCT02675205|Ticagrelor|ticagrelor|mesh-list
110485619|NCT02675205|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110485620|NCT02675205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110485621|NCT02675205|Analgesics|analgesics|mesh-ancestor
110485622|NCT02675205|Sensory System Agents|sensory system agents|mesh-ancestor
110485623|NCT02675205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110425053|NCT02761291|Valproic Acid|valproic acid|mesh-list
110485624|NCT02675205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110485625|NCT02675205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110485626|NCT02675205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110485627|NCT02675205|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110485628|NCT02675205|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110485629|NCT02675205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110485630|NCT02675205|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110485631|NCT02675205|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110485632|NCT02675205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110485633|NCT02675205|Antipyretics|antipyretics|mesh-ancestor
110485634|NCT02675205|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110485635|NCT02675205|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110485636|NCT02675205|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110485637|NCT02675205|Purinergic Agents|purinergic agents|mesh-ancestor
110485638|NCT02675205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110485639|NCT00753454|Certolizumab Pegol|certolizumab pegol|mesh-list
110485640|NCT00753454|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110485641|NCT00753454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110485642|NCT00753454|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110485643|NCT00753454|Immunologic Factors|immunologic factors|mesh-ancestor
110485644|NCT00753454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110485645|NCT00753454|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110485646|NCT00643539|Azithromycin|azithromycin|mesh-list
110485647|NCT00643539|Amoxicillin|amoxicillin|mesh-list
110485648|NCT00643539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110485649|NCT00643539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110485650|NCT00759148|Moxifloxacin|moxifloxacin|mesh-list
110485651|NCT00759148|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110485652|NCT00759148|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
110485654|NCT00759148|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110485655|NCT00759148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110485656|NCT00759148|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110485657|NCT00759148|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110485658|NCT00759148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110485659|NCT00759148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110485660|NCT00759148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110485661|NCT00759148|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110485662|NCT00759148|Contraceptive Agents|contraceptive agents|mesh-ancestor
110485663|NCT00759148|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110485664|NCT00759148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110485665|NCT00759148|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110485666|NCT00759148|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110485667|NCT00759148|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110485668|NCT00910065|Aspirin|aspirin|mesh-list
110485669|NCT00910065|Acetylsalicylic acid lysinate|acetylsalicylic acid lysinate|mesh-list
110485670|NCT00910065|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110485671|NCT00910065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110425256|NCT02852122|Choline|choline|mesh-list
110485672|NCT00910065|Analgesics|analgesics|mesh-ancestor
110485673|NCT00910065|Sensory System Agents|sensory system agents|mesh-ancestor
110485674|NCT00910065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110485675|NCT00910065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110485676|NCT00910065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110485677|NCT00910065|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110485678|NCT00910065|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110485679|NCT00910065|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110485680|NCT00910065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110485681|NCT00910065|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110485682|NCT00910065|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110485683|NCT00910065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110485684|NCT00910065|Antipyretics|antipyretics|mesh-ancestor
110485686|NCT02601040|Immunologic Factors|immunologic factors|mesh-ancestor
110485687|NCT02601040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110485688|NCT04179513|Methotrexate|methotrexate|mesh-list
110485689|NCT04179513|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110485690|NCT04179513|Abortifacient Agents|abortifacient agents|mesh-ancestor
110485691|NCT04179513|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110485692|NCT04179513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110485693|NCT04179513|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110485694|NCT04179513|Antimetabolites|antimetabolites|mesh-ancestor
110485695|NCT04179513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110485696|NCT04179513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110485697|NCT04179513|Dermatologic Agents|dermatologic agents|mesh-ancestor
110485698|NCT04179513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110485699|NCT04179513|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110485700|NCT04179513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110485701|NCT04179513|Immunologic Factors|immunologic factors|mesh-ancestor
110485702|NCT04179513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110485703|NCT04179513|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110485704|NCT02675049|Dexmedetomidine|dexmedetomidine|mesh-list
110485705|NCT02675049|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110485706|NCT02675049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110485707|NCT02675049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110485708|NCT02675049|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110485709|NCT02675049|Analgesics|analgesics|mesh-ancestor
110485710|NCT02675049|Sensory System Agents|sensory system agents|mesh-ancestor
110485711|NCT02675049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110485712|NCT02675049|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110485713|NCT02675049|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110485714|NCT02675049|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110485715|NCT02675049|Adrenergic Agents|adrenergic agents|mesh-ancestor
110425351|NCT00938470|Docetaxel|docetaxel|mesh-list
110485716|NCT02675049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110485717|NCT02675049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110485719|NCT02674737|Dexmedetomidine|dexmedetomidine|mesh-list
110485721|NCT02674737|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110485722|NCT02674737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110425393|NCT05381428|Tocolytic Agents|tocolytic agents|mesh-ancestor
110485723|NCT02674737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110485724|NCT02674737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110485725|NCT02674737|Analgesics|analgesics|mesh-ancestor
110485726|NCT02674737|Sensory System Agents|sensory system agents|mesh-ancestor
110485727|NCT02674737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110485728|NCT02674737|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110485729|NCT02674737|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110485730|NCT02674737|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110485731|NCT02674737|Adrenergic Agents|adrenergic agents|mesh-ancestor
110485732|NCT02674737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110485733|NCT02674737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110485734|NCT02674737|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110485735|NCT02674737|Narcotics|narcotics|mesh-ancestor
110485736|NCT02674737|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110485737|NCT02674737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110485738|NCT02674737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110485739|NCT02674737|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110485740|NCT02674737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110485741|NCT02674893|Liraglutide|liraglutide|mesh-list
110485742|NCT02674893|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110485743|NCT02674893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110485744|NCT02674893|Incretins|incretins|mesh-ancestor
110485745|NCT02674893|Hormones|hormones|mesh-ancestor
110485746|NCT02674893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110485747|NCT02717455|Panobinostat|panobinostat|mesh-list
110166681|NCT00012207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110485748|NCT02717455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110485749|NCT02717455|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110485750|NCT02717455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110485751|NCT02717455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110133007|NCT01980407|Vitamin B Complex|vitamin b complex|mesh-ancestor
110485752|NCT02674581|Fostemsavir|fostemsavir|mesh-list
110485753|NCT02674581|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110485754|NCT02674581|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110485755|NCT02674581|Antiviral Agents|antiviral agents|mesh-ancestor
110485756|NCT02674581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110485757|NCT02674581|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110485758|NCT02674581|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110485759|NCT02674581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110485760|NCT04065919|Epinephrine|epinephrine|mesh-list
110485761|NCT04065919|Bupivacaine|bupivacaine|mesh-list
110485762|NCT04065919|Anesthetics, Local|anesthetics, local|mesh-ancestor
110485763|NCT04065919|Anesthetics|anesthetics|mesh-ancestor
110425505|NCT04269928|Mydriatics|mydriatics|mesh-ancestor
110485764|NCT04065919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110485765|NCT04065919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110485766|NCT04065919|Sensory System Agents|sensory system agents|mesh-ancestor
110485767|NCT04065919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110485768|NCT04065919|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110485769|NCT04065919|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110485770|NCT04065919|Adrenergic Agents|adrenergic agents|mesh-ancestor
110485771|NCT04065919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110485772|NCT04065919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110485773|NCT04065919|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110485774|NCT04065919|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110485776|NCT04065919|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110425570|NCT01227044|Naltrexone|naltrexone|mesh-list
110485777|NCT04065919|Respiratory System Agents|respiratory system agents|mesh-ancestor
110485779|NCT04065919|Sympathomimetics|sympathomimetics|mesh-ancestor
110485780|NCT04065919|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110485782|NCT04065529|Trace Elements|trace elements|mesh-ancestor
110485783|NCT04065529|Micronutrients|micronutrients|mesh-ancestor
110425632|NCT02885454|Diuretics|diuretics|mesh-ancestor
110485784|NCT04065529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110485785|NCT04179045|Sirolimus|sirolimus|mesh-list
110485786|NCT04179045|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110485787|NCT04179045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110485788|NCT04179045|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110485789|NCT04179045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110485790|NCT04179045|Antifungal Agents|antifungal agents|mesh-ancestor
110485791|NCT04179045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110485792|NCT04179045|Immunologic Factors|immunologic factors|mesh-ancestor
110485793|NCT04179045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110485795|NCT00970268|Anticonvulsants|anticonvulsants|mesh-ancestor
110485796|NCT02674113|Bupivacaine|bupivacaine|mesh-list
110485797|NCT02674113|Anesthetics|anesthetics|mesh-list
110485798|NCT02674113|Anesthetics, Local|anesthetics, local|mesh-ancestor
110485799|NCT02674113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110485800|NCT02674113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110485801|NCT02674113|Sensory System Agents|sensory system agents|mesh-ancestor
110485802|NCT02674113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110485803|NCT00644085|Aspirin|aspirin|mesh-list
110485804|NCT00644085|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110485805|NCT00644085|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110485806|NCT00644085|Analgesics|analgesics|mesh-ancestor
110485807|NCT00644085|Sensory System Agents|sensory system agents|mesh-ancestor
110485808|NCT00644085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110425775|NCT00635713|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110485809|NCT00644085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110485810|NCT00644085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110485811|NCT00644085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110485812|NCT00644085|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110485813|NCT00644085|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110485814|NCT00644085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110485815|NCT00644085|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110485816|NCT00644085|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110485817|NCT00644085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110485818|NCT00644085|Antipyretics|antipyretics|mesh-ancestor
110485819|NCT00731575|Prednisolone|prednisolone|mesh-list
110485820|NCT00731575|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110485821|NCT00731575|Methylprednisolone|methylprednisolone|mesh-list
110485822|NCT00731575|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110485823|NCT00731575|Prednisolone acetate|prednisolone acetate|mesh-list
110485824|NCT00731575|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110485825|NCT00731575|Prednisolone phosphate|prednisolone phosphate|mesh-list
110133085|NCT01980849|Nadroparin|nadroparin|mesh-list
110485826|NCT00731575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110485827|NCT00731575|Glucocorticoids|glucocorticoids|mesh-ancestor
110485828|NCT00731575|Hormones|hormones|mesh-ancestor
110485829|NCT00731575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110485830|NCT00731575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110485831|NCT00731575|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110485832|NCT00731575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110485833|NCT00731575|Antiemetics|antiemetics|mesh-ancestor
110485834|NCT00731575|Autonomic Agents|autonomic agents|mesh-ancestor
110485835|NCT00731575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110485836|NCT00731575|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110485837|NCT00731575|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110485838|NCT00731575|Protective Agents|protective agents|mesh-ancestor
110485839|NCT02674191|Clindamycin|clindamycin|mesh-list
110485840|NCT02674191|Clindamycin palmitate|clindamycin palmitate|mesh-list
110485841|NCT02674191|Clindamycin phosphate|clindamycin phosphate|mesh-list
110485842|NCT02674191|Povidone-Iodine|povidone-iodine|mesh-list
110485843|NCT02674191|Mepivacaine|mepivacaine|mesh-list
110485844|NCT02674191|Benzocaine|benzocaine|mesh-list
110485845|NCT02674191|Povidone|povidone|mesh-list
110485846|NCT02674191|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110485847|NCT02674191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110485848|NCT02674191|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110485849|NCT02674191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110485850|NCT02674191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110485851|NCT02674191|Plasma Substitutes|plasma substitutes|mesh-ancestor
110485852|NCT02674191|Blood Substitutes|blood substitutes|mesh-ancestor
110485853|NCT02674191|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110485854|NCT02674191|Anesthetics, Local|anesthetics, local|mesh-ancestor
110485855|NCT02674191|Anesthetics|anesthetics|mesh-ancestor
110485856|NCT02674191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110485857|NCT02674191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110485858|NCT02674191|Sensory System Agents|sensory system agents|mesh-ancestor
110485859|NCT02674191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110485860|NCT00736021|Escitalopram|escitalopram|mesh-list
110485861|NCT00736021|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110485862|NCT00736021|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110426085|NCT02750059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110485863|NCT00736021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110485864|NCT00736021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110485865|NCT00736021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110485866|NCT00736021|Serotonin Agents|serotonin agents|mesh-ancestor
110485867|NCT00736021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110485868|NCT04178655|Tranexamic Acid|tranexamic acid|mesh-list
110485869|NCT04178655|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110485870|NCT04178655|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110485871|NCT04178655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110485873|NCT04178655|Coagulants|coagulants|mesh-ancestor
110485874|NCT00738517|Immunoglobulins|immunoglobulins|mesh-list
110485875|NCT00738517|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110485876|NCT00738517|Antibodies|antibodies|mesh-list
110485877|NCT00738517|Immunologic Factors|immunologic factors|mesh-ancestor
110485878|NCT00738517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110485879|NCT02673879|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
110485880|NCT02673879|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110485881|NCT02673879|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110485882|NCT02673879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110485884|NCT00738595|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110485885|NCT00738595|Autonomic Agents|autonomic agents|mesh-ancestor
110485886|NCT00738595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110485887|NCT00738595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110485888|NCT00738595|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110485889|NCT00738595|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110485890|NCT00738595|Cholinergic Agents|cholinergic agents|mesh-ancestor
110485891|NCT00738595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110485892|NCT00738595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110485893|NCT05273775|Vitamin K|vitamin k|mesh-list
110485894|NCT05273775|Vitamin K 1|vitamin k 1|mesh-list
110485895|NCT05273775|Digoxin|digoxin|mesh-list
110485896|NCT05273775|Midazolam|midazolam|mesh-list
110485897|NCT05273775|Omeprazole|omeprazole|mesh-list
110485898|NCT05273775|Warfarin|warfarin|mesh-list
110485899|NCT05273775|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110485900|NCT05273775|Vitamins|vitamins|mesh-ancestor
110485901|NCT05273775|Micronutrients|micronutrients|mesh-ancestor
110133159|NCT01981499|Histamine Agents|histamine agents|mesh-ancestor
110485902|NCT05273775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110485903|NCT05273775|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110485904|NCT05273775|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110485905|NCT05273775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110485906|NCT05273775|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110485907|NCT05273775|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110485908|NCT05273775|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110485909|NCT05273775|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110485910|NCT05273775|Anesthetics, General|anesthetics, general|mesh-ancestor
110485912|NCT05273775|GABA Modulators|gaba modulators|mesh-ancestor
110485913|NCT05273775|GABA Agents|gaba agents|mesh-ancestor
110485914|NCT05273775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110485915|NCT05273775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110485916|NCT05273775|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110485917|NCT05273775|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110485919|NCT05273775|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110268400|NCT00184977|Expectorants|expectorants|mesh-ancestor
110485920|NCT05273775|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110485921|NCT05273775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110485922|NCT05273775|Anticoagulants|anticoagulants|mesh-ancestor
110485923|NCT05273775|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110426319|NCT02655523|Anesthetics, Local|anesthetics, local|mesh-ancestor
110485924|NCT05273775|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110485925|NCT05273775|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110485926|NCT05273775|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110485927|NCT05273775|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110485928|NCT05273775|Protective Agents|protective agents|mesh-ancestor
110485929|NCT05273775|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110485930|NCT05273775|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110485931|NCT05273775|Hemostatics|hemostatics|mesh-ancestor
110485932|NCT05273775|Coagulants|coagulants|mesh-ancestor
110485933|NCT02671851|Acetaminophen|acetaminophen|mesh-list
110485934|NCT02671851|Dipyrone|dipyrone|mesh-list
110485935|NCT02671851|Fentanyl|fentanyl|mesh-list
110485936|NCT02671851|Tramadol|tramadol|mesh-list
110485937|NCT02671851|Bupivacaine|bupivacaine|mesh-list
110485938|NCT02671851|Anesthetics, Local|anesthetics, local|mesh-ancestor
110485939|NCT02671851|Anesthetics|anesthetics|mesh-ancestor
110426399|NCT00636259|Bicalutamide|bicalutamide|mesh-list
110485940|NCT02671851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110485941|NCT02671851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110485942|NCT02671851|Sensory System Agents|sensory system agents|mesh-ancestor
110485943|NCT02671851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110311567|NCT00289445|Leucovorin|leucovorin|mesh-list
110485944|NCT02671851|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110485945|NCT02671851|Narcotics|narcotics|mesh-ancestor
110485946|NCT02671851|Analgesics|analgesics|mesh-ancestor
110485947|NCT02671851|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110485948|NCT02671851|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110485949|NCT02671851|Anesthetics, General|anesthetics, general|mesh-ancestor
110485950|NCT02671851|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110485951|NCT02671851|Antipyretics|antipyretics|mesh-ancestor
110485952|NCT02671851|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110485953|NCT02671851|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110485954|NCT02671851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110485955|NCT04177095|Sirolimus|sirolimus|mesh-list
110485956|NCT04177095|Prednisone|prednisone|mesh-list
110485957|NCT04177095|Everolimus|everolimus|mesh-list
110485958|NCT04177095|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110485959|NCT04177095|Glucocorticoids|glucocorticoids|mesh-ancestor
110485960|NCT04177095|Hormones|hormones|mesh-ancestor
110485961|NCT04177095|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110485962|NCT04177095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110485963|NCT04177095|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110485964|NCT04177095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110485965|NCT04177095|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110485966|NCT04177095|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110485967|NCT04177095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110073398|NCT01578200|Calcium|calcium|mesh-list
110485968|NCT04177095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110485969|NCT04177095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110485970|NCT04177095|Immunologic Factors|immunologic factors|mesh-ancestor
110485971|NCT04177095|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110485972|NCT04177095|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110485973|NCT04177095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110485974|NCT04177095|Antifungal Agents|antifungal agents|mesh-ancestor
110485975|NCT02671695|Amlodipine|amlodipine|mesh-list
110485976|NCT02671695|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110485977|NCT02671695|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110485978|NCT02671695|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110485979|NCT02671695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110485980|NCT02671695|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110485981|NCT02671695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110485982|NCT02671695|Vasodilator Agents|vasodilator agents|mesh-ancestor
110485983|NCT00644631|Sildenafil Citrate|sildenafil citrate|mesh-list
110485984|NCT00644631|Vasodilator Agents|vasodilator agents|mesh-ancestor
110485985|NCT00644631|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110485986|NCT00644631|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110485987|NCT00644631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110485988|NCT00644631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110485990|NCT02671383|Lopinavir|lopinavir|mesh-list
110485991|NCT02671383|Darunavir|darunavir|mesh-list
110485992|NCT02671383|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110485993|NCT02671383|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110485994|NCT02671383|Protease Inhibitors|protease inhibitors|mesh-ancestor
110485995|NCT02671383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110485996|NCT02671383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110485997|NCT02671383|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110485998|NCT02671383|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110485999|NCT02671383|Antiviral Agents|antiviral agents|mesh-ancestor
110486000|NCT02671383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110486001|NCT02671383|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110486002|NCT02671383|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110486003|NCT00738751|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110486004|NCT00738751|Panobinostat|panobinostat|mesh-list
110486005|NCT00738751|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
110486006|NCT00738751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110486007|NCT00738751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110486008|NCT00738751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110486009|NCT00738751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110486010|NCT05243823|Estradiol|estradiol|mesh-list
110486011|NCT05243823|Estrogens|estrogens|mesh-ancestor
110486012|NCT05243823|Hormones|hormones|mesh-ancestor
110486013|NCT05243823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110486014|NCT05243823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110486016|NCT00736801|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110426553|NCT02738905|Rifaximin|rifaximin|mesh-list
110486017|NCT00736801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110486018|NCT00736801|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110486019|NCT00736801|Autonomic Agents|autonomic agents|mesh-ancestor
110486020|NCT00736801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110486021|NCT00736801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110486022|NCT00736801|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110486023|NCT00736801|Respiratory System Agents|respiratory system agents|mesh-ancestor
110486024|NCT00736801|Dermatologic Agents|dermatologic agents|mesh-ancestor
110486025|NCT00736801|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110268443|NCT00161486|Methyltestosterone|methyltestosterone|mesh-list
110486026|NCT00736801|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110486027|NCT00736801|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110486028|NCT00736801|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110486029|NCT00736801|Adrenergic Agents|adrenergic agents|mesh-ancestor
110486030|NCT00736801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110486031|NCT00736801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110486032|NCT00738829|Rituximab|rituximab|mesh-list
110486033|NCT00738829|Fludarabine|fludarabine|mesh-list
110486034|NCT00738829|Fludarabine phosphate|fludarabine phosphate|mesh-list
110486035|NCT00738829|Lenalidomide|lenalidomide|mesh-list
110486036|NCT00738829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110486037|NCT00738829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110486038|NCT00738829|Immunologic Factors|immunologic factors|mesh-ancestor
110486039|NCT00738829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110486040|NCT00738829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110486041|NCT00738829|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110486043|NCT00738829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110486044|NCT00738829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110486045|NCT00738829|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110486046|NCT00738829|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110486047|NCT00738829|Growth Substances|growth substances|mesh-ancestor
110486048|NCT00738829|Growth Inhibitors|growth inhibitors|mesh-ancestor
110486049|NCT02671227|Bupivacaine|bupivacaine|mesh-list
110486050|NCT02671227|Anesthetics, Local|anesthetics, local|mesh-ancestor
110486051|NCT02671227|Anesthetics|anesthetics|mesh-ancestor
110486052|NCT02671227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110486053|NCT02671227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110486054|NCT02671227|Sensory System Agents|sensory system agents|mesh-ancestor
110133306|NCT01982799|Antitussive Agents|antitussive agents|mesh-ancestor
110486055|NCT02671227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110486056|NCT00644709|Atorvastatin|atorvastatin|mesh-list
110486057|NCT00644709|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110486058|NCT00644709|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110486059|NCT00644709|Antimetabolites|antimetabolites|mesh-ancestor
110426655|NCT02743663|Autonomic Agents|autonomic agents|mesh-ancestor
110486060|NCT00644709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110486061|NCT00644709|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110486062|NCT00644709|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110486063|NCT00644709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110486065|NCT00738985|Ezetimibe|ezetimibe|mesh-list
110486066|NCT00738985|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
110486067|NCT00738985|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110486068|NCT00738985|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110486069|NCT00738985|Antimetabolites|antimetabolites|mesh-ancestor
110486070|NCT00738985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110486071|NCT00738985|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110486072|NCT00738985|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110486073|NCT00738985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110486074|NCT05216211|Bupivacaine|bupivacaine|mesh-list
110486075|NCT05216211|Anesthetics, Local|anesthetics, local|mesh-ancestor
110486076|NCT05216211|Anesthetics|anesthetics|mesh-ancestor
110486077|NCT05216211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110486078|NCT05216211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110486079|NCT05216211|Sensory System Agents|sensory system agents|mesh-ancestor
110486080|NCT05216211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110486081|NCT00732121|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110486082|NCT00732121|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110486083|NCT00732121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110486084|NCT00732121|Incretins|incretins|mesh-ancestor
110486085|NCT00732121|Hormones|hormones|mesh-ancestor
110268468|NCT00161564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110486086|NCT00732121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110486087|NCT00732121|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110486088|NCT00732121|Protease Inhibitors|protease inhibitors|mesh-ancestor
110486089|NCT00732121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110486090|NCT00732121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110486091|NCT02537223|Cisplatin|cisplatin|mesh-list
110426762|NCT02690389|GABA Agents|gaba agents|mesh-ancestor
110486092|NCT02537223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110486093|NCT02568943|Panobinostat|panobinostat|mesh-list
110486094|NCT02568943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110486095|NCT02568943|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110486096|NCT02568943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110486097|NCT02568943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110486098|NCT00732277|Hydrocortisone|hydrocortisone|mesh-list
110486099|NCT00732277|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
110486100|NCT00732277|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
110486101|NCT00732277|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
110486102|NCT00732277|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110486103|NCT00739453|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110486104|NCT00739453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110486105|NCT00739453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110486106|NCT00739453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110486107|NCT00739453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110486108|NCT02668497|Botulinum Toxins|botulinum toxins|mesh-list
110486109|NCT02668497|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110486110|NCT02668497|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110486111|NCT02668497|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
110486112|NCT02668497|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110486113|NCT02668497|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110486114|NCT02668497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110486115|NCT02668497|Cholinergic Agents|cholinergic agents|mesh-ancestor
110426956|NCT02718547|Adrenergic Agents|adrenergic agents|mesh-ancestor
110486116|NCT02668497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110486117|NCT02668497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110486118|NCT02668497|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110486119|NCT02668497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110486121|NCT00737113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110486122|NCT00737113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110486123|NCT00737191|Olanzapine|olanzapine|mesh-list
110486124|NCT00737191|Antiemetics|antiemetics|mesh-ancestor
110486125|NCT00737191|Autonomic Agents|autonomic agents|mesh-ancestor
110486126|NCT00737191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110486127|NCT00737191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110486128|NCT00737191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110486129|NCT00737191|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110486130|NCT00737191|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110311584|NCT00289445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110486131|NCT00737191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110486132|NCT00737191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110486133|NCT00737191|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110486134|NCT00737191|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110486135|NCT00737191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110486136|NCT00737191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110486137|NCT00737191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110486138|NCT00737191|Serotonin Agents|serotonin agents|mesh-ancestor
110486139|NCT04175067|Antioxidants|antioxidants|mesh-list
110486140|NCT04175067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110486141|NCT04175067|Protective Agents|protective agents|mesh-ancestor
110486142|NCT04175067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110486143|NCT00758602|Mycophenolic Acid|mycophenolic acid|mesh-list
110486144|NCT00758602|Tacrolimus|tacrolimus|mesh-list
110486145|NCT00758602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110486146|NCT00758602|Immunologic Factors|immunologic factors|mesh-ancestor
110486147|NCT00758602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110486148|NCT00758602|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110486149|NCT00758602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110486150|NCT00758602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110486151|NCT00758602|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110486152|NCT00758602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110486153|NCT00758602|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110486154|NCT00758602|Antitubercular Agents|antitubercular agents|mesh-ancestor
110486155|NCT00758602|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110486156|NCT00758602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110486157|NCT02667561|Methyltestosterone|methyltestosterone|mesh-list
110486158|NCT02667561|Testosterone|testosterone|mesh-list
110486159|NCT02667561|Testosterone undecanoate|testosterone undecanoate|mesh-list
110486160|NCT02667561|Testosterone enanthate|testosterone enanthate|mesh-list
110427029|NCT02716129|Morphine|morphine|mesh-list
110486161|NCT02667561|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
110486162|NCT02667561|Androgens|androgens|mesh-ancestor
110486163|NCT02667561|Hormones|hormones|mesh-ancestor
110486164|NCT02667561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110427048|NCT02718079|Expectorants|expectorants|mesh-ancestor
110486165|NCT02667561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110486166|NCT02667561|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110486167|NCT02667561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110486168|NCT02667561|Anabolic Agents|anabolic agents|mesh-ancestor
110486169|NCT00732511|Metoprolol|metoprolol|mesh-list
110486170|NCT00732511|Carvedilol|carvedilol|mesh-list
110486171|NCT00732511|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110486172|NCT00732511|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110486173|NCT00732511|Sympatholytics|sympatholytics|mesh-ancestor
110486174|NCT00732511|Autonomic Agents|autonomic agents|mesh-ancestor
110486175|NCT00732511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110486176|NCT00732511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110486177|NCT00732511|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110486178|NCT00732511|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110486179|NCT00732511|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110486180|NCT00732511|Adrenergic Agents|adrenergic agents|mesh-ancestor
110486181|NCT00732511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110486182|NCT00732511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110486183|NCT00732511|Antioxidants|antioxidants|mesh-ancestor
110486184|NCT00732511|Protective Agents|protective agents|mesh-ancestor
110486185|NCT00732511|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110486186|NCT00732511|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110486187|NCT00732511|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110486188|NCT00732511|Vasodilator Agents|vasodilator agents|mesh-ancestor
110486189|NCT00732511|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110486190|NCT00732511|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110486192|NCT00739531|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110486193|NCT00739531|Autonomic Agents|autonomic agents|mesh-ancestor
110486194|NCT00739531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110486195|NCT00739531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110486196|NCT00739531|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110486197|NCT00739531|Respiratory System Agents|respiratory system agents|mesh-ancestor
110486198|NCT00739531|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110486199|NCT00739531|Antioxidants|antioxidants|mesh-ancestor
110486200|NCT00739531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110486201|NCT00739531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110268500|NCT00185094|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110486202|NCT00739531|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
110486203|NCT00739531|Vasodilator Agents|vasodilator agents|mesh-ancestor
110486204|NCT00739531|Gasotransmitters|gasotransmitters|mesh-ancestor
110486205|NCT00739531|Protective Agents|protective agents|mesh-ancestor
110486206|NCT00739609|Tryptophan|tryptophan|mesh-list
110486207|NCT00739609|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110486208|NCT00739609|Antidepressive Agents|antidepressive agents|mesh-ancestor
110486209|NCT00739609|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110486210|NCT00645723|Colistin|colistin|mesh-list
110486211|NCT00645723|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110486212|NCT00645723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110486213|NCT00711529|Gabapentin|gabapentin|mesh-list
110427255|NCT01222247|Hormones|hormones|mesh-ancestor
110486214|NCT00711529|Analgesics|analgesics|mesh-ancestor
110486215|NCT00711529|Sensory System Agents|sensory system agents|mesh-ancestor
110486216|NCT00711529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110486217|NCT00711529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110486218|NCT00711529|Anticonvulsants|anticonvulsants|mesh-ancestor
110486219|NCT00711529|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110486220|NCT00711529|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110486221|NCT00711529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110486222|NCT00711529|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110486223|NCT00711529|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110486224|NCT00711529|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110486225|NCT00711529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110486226|NCT00711529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110486227|NCT00711529|Antimanic Agents|antimanic agents|mesh-ancestor
110486228|NCT00732589|Lidocaine|lidocaine|mesh-list
110486229|NCT00732589|Anesthetics, Local|anesthetics, local|mesh-ancestor
110486230|NCT00732589|Anesthetics|anesthetics|mesh-ancestor
110486231|NCT00732589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110486232|NCT00732589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110486233|NCT00732589|Sensory System Agents|sensory system agents|mesh-ancestor
110486234|NCT00732589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110486235|NCT00732589|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110486236|NCT00732589|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110486237|NCT00732589|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110486238|NCT00732589|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110427311|NCT02712619|Metformin|metformin|mesh-list
110486239|NCT00732589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110486240|NCT00645879|Citric Acid|citric acid|mesh-list
110486241|NCT00645879|Sodium Citrate|sodium citrate|mesh-list
110486242|NCT00645879|Anticoagulants|anticoagulants|mesh-ancestor
110486243|NCT00645879|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110486244|NCT00645879|Chelating Agents|chelating agents|mesh-ancestor
110486245|NCT00645879|Sequestering Agents|sequestering agents|mesh-ancestor
110486246|NCT00645879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110486247|NCT00737659|Mycophenolic Acid|mycophenolic acid|mesh-list
110486248|NCT00737659|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110486249|NCT00737659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110486250|NCT00737659|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110486251|NCT00737659|Antitubercular Agents|antitubercular agents|mesh-ancestor
110486252|NCT00737659|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110486253|NCT00737659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110486254|NCT00737659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110486255|NCT00737659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110486256|NCT02666703|Methylprednisolone|methylprednisolone|mesh-list
110486257|NCT02666703|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110486258|NCT02666703|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110486259|NCT02666703|Prednisolone|prednisolone|mesh-list
110486260|NCT02666703|Prednisolone acetate|prednisolone acetate|mesh-list
110486261|NCT02666703|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110486262|NCT02666703|Prednisolone phosphate|prednisolone phosphate|mesh-list
110486263|NCT02666703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110486264|NCT02666703|Antiemetics|antiemetics|mesh-ancestor
110486265|NCT02666703|Autonomic Agents|autonomic agents|mesh-ancestor
110486266|NCT02666703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110486267|NCT02666703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110486268|NCT02666703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110486269|NCT02666703|Glucocorticoids|glucocorticoids|mesh-ancestor
110486270|NCT02666703|Hormones|hormones|mesh-ancestor
110486271|NCT02666703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110486272|NCT02666703|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110486273|NCT02666703|Protective Agents|protective agents|mesh-ancestor
110486274|NCT02666703|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110486275|NCT02666703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110486277|NCT05560009|Fluorides|fluorides|mesh-list
110486279|NCT05560009|Protective Agents|protective agents|mesh-ancestor
110486280|NCT05560009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110486281|NCT05560009|Dopamine Agents|dopamine agents|mesh-ancestor
110486282|NCT05560009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110427545|NCT00604942|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110486283|NCT05560009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110486285|NCT05560009|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110486286|NCT04174131|Lidocaine|lidocaine|mesh-list
110486287|NCT04174131|Hyaluronic Acid|hyaluronic acid|mesh-list
110486288|NCT04174131|Anesthetics, Local|anesthetics, local|mesh-ancestor
110486289|NCT04174131|Anesthetics|anesthetics|mesh-ancestor
110486290|NCT04174131|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110486291|NCT04174131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110486292|NCT04174131|Sensory System Agents|sensory system agents|mesh-ancestor
110486293|NCT04174131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110486294|NCT04174131|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110486295|NCT04174131|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110486296|NCT04174131|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110486297|NCT04174131|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110486298|NCT04174131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110486299|NCT04174131|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110486300|NCT04174131|Immunologic Factors|immunologic factors|mesh-ancestor
110486301|NCT04174131|Viscosupplements|viscosupplements|mesh-ancestor
110486302|NCT04174131|Protective Agents|protective agents|mesh-ancestor
110486303|NCT00646035|Ergocalciferols|ergocalciferols|mesh-list
110486304|NCT00646035|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110486305|NCT00646035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110486306|NCT00646035|Vitamins|vitamins|mesh-ancestor
110427677|NCT02706535|Itraconazole|itraconazole|mesh-list
110486307|NCT00646035|Micronutrients|micronutrients|mesh-ancestor
110486308|NCT00646035|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110486309|NCT00646191|Adalimumab|adalimumab|mesh-list
110486310|NCT00646191|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110486311|NCT00646191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110486312|NCT00646191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110486313|NCT02666157|Rivaroxaban|rivaroxaban|mesh-list
110486314|NCT02666157|Apixaban|apixaban|mesh-list
110486315|NCT02666157|Dabigatran|dabigatran|mesh-list
110486316|NCT02666157|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110486317|NCT02666157|Antithrombins|antithrombins|mesh-ancestor
110486318|NCT02666157|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110486319|NCT02666157|Protease Inhibitors|protease inhibitors|mesh-ancestor
110486320|NCT02666157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110486321|NCT02666157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110486322|NCT02666157|Anticoagulants|anticoagulants|mesh-ancestor
110486323|NCT02666001|Fostemsavir|fostemsavir|mesh-list
110486324|NCT02666001|Buprenorphine|buprenorphine|mesh-list
110486325|NCT02666001|Methadone|methadone|mesh-list
110486326|NCT02666001|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110486327|NCT02666001|Narcotics|narcotics|mesh-ancestor
110486328|NCT02666001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110486329|NCT02666001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110486330|NCT02666001|Analgesics|analgesics|mesh-ancestor
110486331|NCT02666001|Sensory System Agents|sensory system agents|mesh-ancestor
110486332|NCT02666001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110486333|NCT02666001|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110486334|NCT02666001|Antitussive Agents|antitussive agents|mesh-ancestor
110486335|NCT02666001|Respiratory System Agents|respiratory system agents|mesh-ancestor
110486336|NCT02666001|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110486337|NCT02666001|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110486338|NCT02666001|Antiviral Agents|antiviral agents|mesh-ancestor
110486339|NCT02666001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110486340|NCT02666001|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110486341|NCT02666001|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110486342|NCT02666001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110486343|NCT02665845|Mesalamine|mesalamine|mesh-list
110486344|NCT02665845|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110486345|NCT02665845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110486346|NCT02665845|Analgesics|analgesics|mesh-ancestor
110486347|NCT02665845|Sensory System Agents|sensory system agents|mesh-ancestor
110486348|NCT02665845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110486349|NCT02665845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110486350|NCT02665845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110486351|NCT02665845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110486352|NCT00646425|Basiliximab|basiliximab|mesh-list
110486353|NCT00646425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110486354|NCT00646425|Immunologic Factors|immunologic factors|mesh-ancestor
110486355|NCT00646425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110486357|NCT04837209|Dostarlimab|dostarlimab|mesh-list
110486358|NCT04837209|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110486359|NCT04837209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110486360|NCT04837209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110486361|NCT04837209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110486362|NCT02665533|Dexamethasone|dexamethasone|mesh-list
110486363|NCT02665533|Dexamethasone acetate|dexamethasone acetate|mesh-list
110486364|NCT02665533|Diclofenac|diclofenac|mesh-list
110486365|NCT02665533|Codeine|codeine|mesh-list
110486366|NCT02665533|BB 1101|bb 1101|mesh-list
110486367|NCT02665533|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110486368|NCT02665533|Antiemetics|antiemetics|mesh-ancestor
110486369|NCT02665533|Autonomic Agents|autonomic agents|mesh-ancestor
110486370|NCT02665533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110486371|NCT02665533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110486372|NCT02665533|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110486373|NCT02665533|Glucocorticoids|glucocorticoids|mesh-ancestor
110486374|NCT02665533|Hormones|hormones|mesh-ancestor
110486375|NCT02665533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110486376|NCT02665533|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110486377|NCT02665533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110486378|NCT02665533|Protease Inhibitors|protease inhibitors|mesh-ancestor
110486379|NCT02665533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110486380|NCT02665533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110486381|NCT02665533|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110486382|NCT02665533|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110486383|NCT02665533|Analgesics|analgesics|mesh-ancestor
110486384|NCT02665533|Sensory System Agents|sensory system agents|mesh-ancestor
110486385|NCT02665533|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110427916|NCT02709265|Amikacin|amikacin|mesh-list
110486386|NCT02665533|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110486387|NCT02665533|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110486388|NCT02665533|Narcotics|narcotics|mesh-ancestor
110486389|NCT02665533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110486390|NCT02665533|Antitussive Agents|antitussive agents|mesh-ancestor
110486391|NCT02665533|Respiratory System Agents|respiratory system agents|mesh-ancestor
110486392|NCT00646503|Telbivudine|telbivudine|mesh-list
110486393|NCT00646503|Antiviral Agents|antiviral agents|mesh-ancestor
110486394|NCT00646503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110486395|NCT00646503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110486396|NCT00646503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110486397|NCT00646503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110486399|NCT04173039|Immunologic Factors|immunologic factors|mesh-ancestor
110486400|NCT04173039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110486401|NCT00646659|Carboplatin|carboplatin|mesh-list
110486402|NCT00646659|Docetaxel|docetaxel|mesh-list
110486403|NCT00646659|Fluorouracil|fluorouracil|mesh-list
110486404|NCT00646659|Cetuximab|cetuximab|mesh-list
110486405|NCT00646659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110486406|NCT00646659|Tubulin Modulators|tubulin modulators|mesh-ancestor
110486407|NCT00646659|Antimitotic Agents|antimitotic agents|mesh-ancestor
110486408|NCT00646659|Mitosis Modulators|mitosis modulators|mesh-ancestor
110486409|NCT00646659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110486410|NCT00646659|Antimetabolites|antimetabolites|mesh-ancestor
110486411|NCT00646659|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110486412|NCT00646659|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110486413|NCT00646659|Immunologic Factors|immunologic factors|mesh-ancestor
110428024|NCT02709031|Cicletanine|cicletanine|mesh-list
110486414|NCT00646659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110486415|NCT00646659|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110486417|NCT00648531|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110486418|NCT00648531|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110486419|NCT00648531|Analgesics|analgesics|mesh-ancestor
110486420|NCT00648531|Sensory System Agents|sensory system agents|mesh-ancestor
110486421|NCT00648531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110486422|NCT00648531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110486423|NCT00648531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110486424|NCT00648531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110428154|NCT00607984|Melphalan|melphalan|mesh-list
110486425|NCT00648531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110486426|NCT00648765|Anagrelide|anagrelide|mesh-list
110486427|NCT00648765|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110486428|NCT00648765|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110486429|NCT00648765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110486430|NCT00648765|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110486432|NCT00648843|Parasympatholytics|parasympatholytics|mesh-ancestor
110486433|NCT00648843|Autonomic Agents|autonomic agents|mesh-ancestor
110486434|NCT00648843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110486435|NCT00648843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110486436|NCT00648843|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110486437|NCT00648843|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110486438|NCT00648843|Cholinergic Agents|cholinergic agents|mesh-ancestor
110486439|NCT00648843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110486440|NCT00648843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110486441|NCT00648843|Urological Agents|urological agents|mesh-ancestor
110486442|NCT02662959|Irinotecan|irinotecan|mesh-list
110486443|NCT02662959|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110486444|NCT02662959|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110486445|NCT02662959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110486446|NCT02662959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110486447|NCT02662959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110486448|NCT02662647|Cytarabine|cytarabine|mesh-list
110486449|NCT02662647|Decitabine|decitabine|mesh-list
110486450|NCT02662647|Aclacinomycins|aclacinomycins|mesh-list
110428431|NCT04074187|Glucocorticoids|glucocorticoids|mesh-ancestor
110486451|NCT02662647|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110486453|NCT02662647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110486454|NCT02662647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110486455|NCT02662647|Antiviral Agents|antiviral agents|mesh-ancestor
110486456|NCT02662647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110486457|NCT02662647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110486458|NCT02662647|Immunologic Factors|immunologic factors|mesh-ancestor
110486459|NCT02662647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110486460|NCT02662647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110486461|NCT02662647|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110486462|NCT02662647|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110486463|NCT02662725|Ipilimumab|ipilimumab|mesh-list
110486464|NCT02662725|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110486465|NCT02662725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110486466|NCT02662725|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110486467|NCT02662725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110486468|NCT00648921|Olanzapine|olanzapine|mesh-list
110486469|NCT00648921|Antiemetics|antiemetics|mesh-ancestor
110486470|NCT00648921|Autonomic Agents|autonomic agents|mesh-ancestor
110486471|NCT00648921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110486472|NCT00648921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110486473|NCT00648921|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110486474|NCT00648921|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110486475|NCT00648921|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110486476|NCT00648921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110486477|NCT00648921|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110486478|NCT00648921|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110486479|NCT00648921|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110486480|NCT00648921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110166773|NCT00028717|Alkylating Agents|alkylating agents|mesh-ancestor
110486481|NCT00648921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110486482|NCT00648921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110486483|NCT00648921|Serotonin Agents|serotonin agents|mesh-ancestor
110486484|NCT02662491|Calcium, Dietary|calcium, dietary|mesh-list
110486485|NCT02662491|Vitamin D|vitamin d|mesh-list
110486486|NCT02662491|Ergocalciferols|ergocalciferols|mesh-list
110486487|NCT02662491|Cholecalciferol|cholecalciferol|mesh-list
110486488|NCT02662491|Vitamins|vitamins|mesh-list
110486489|NCT02662491|Calcium|calcium|mesh-list
110486490|NCT02662491|Micronutrients|micronutrients|mesh-ancestor
110486491|NCT02662491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110486492|NCT02662491|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110486493|NCT02662491|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110486494|NCT00648999|Ritonavir|ritonavir|mesh-list
110486495|NCT00648999|Lopinavir|lopinavir|mesh-list
110486497|NCT00648999|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110486498|NCT00648999|Protease Inhibitors|protease inhibitors|mesh-ancestor
110486499|NCT00648999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110428750|NCT04215835|Letrozole|letrozole|mesh-list
110486500|NCT00648999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110486501|NCT00648999|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110486502|NCT00648999|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110486503|NCT00648999|Antiviral Agents|antiviral agents|mesh-ancestor
110486504|NCT00648999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110486505|NCT00648999|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110486506|NCT00648999|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110486507|NCT02661711|Aflibercept|aflibercept|mesh-list
110486508|NCT02661711|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110486509|NCT02661711|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110486510|NCT02661711|Growth Substances|growth substances|mesh-ancestor
110486511|NCT02661711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110486512|NCT02661711|Growth Inhibitors|growth inhibitors|mesh-ancestor
110486513|NCT02661711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110486514|NCT02661789|Goserelin|goserelin|mesh-list
110486515|NCT02661789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110486516|NCT02661789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110486517|NCT02661477|Interferons|interferons|mesh-list
110486518|NCT02661477|Interferon-alpha|interferon-alpha|mesh-list
110486519|NCT02661477|Interferon alpha-2|interferon alpha-2|mesh-list
110486520|NCT02661477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110486521|NCT02661477|Antiviral Agents|antiviral agents|mesh-ancestor
110486522|NCT02661477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110486523|NCT02661477|Immunologic Factors|immunologic factors|mesh-ancestor
110486524|NCT02661477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110486526|NCT00649077|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110486527|NCT00649077|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110486528|NCT00649077|Analgesics|analgesics|mesh-ancestor
110486529|NCT00649077|Sensory System Agents|sensory system agents|mesh-ancestor
110486530|NCT00649077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110486531|NCT00649077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110486532|NCT00649077|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110486533|NCT00649077|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110486534|NCT00649077|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110429085|NCT02700685|Methylphenidate|methylphenidate|mesh-list
110486535|NCT00649077|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110486536|NCT00649077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110486537|NCT00649077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110486538|NCT02656251|Ethanol|ethanol|mesh-list
110486539|NCT02656251|Chlorhexidine|chlorhexidine|mesh-list
110486540|NCT02656251|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110486541|NCT02656251|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110486542|NCT02656251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110429216|NCT01208051|Growth Inhibitors|growth inhibitors|mesh-ancestor
110486543|NCT02656251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110486544|NCT02656251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110486545|NCT02656251|Disinfectants|disinfectants|mesh-ancestor
110486546|NCT02656251|Dermatologic Agents|dermatologic agents|mesh-ancestor
110486547|NCT02656095|Heparin|heparin|mesh-list
110486549|NCT02656095|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110486550|NCT02656095|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110486551|NCT02656095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110486553|NCT00649935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110486554|NCT00649935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110486555|NCT02655705|Cyclosporine|cyclosporine|mesh-list
110486556|NCT02655705|Methotrexate|methotrexate|mesh-list
110486557|NCT02655705|Cyclosporins|cyclosporins|mesh-list
110486558|NCT02655705|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110486559|NCT02655705|Abortifacient Agents|abortifacient agents|mesh-ancestor
110486560|NCT02655705|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110486561|NCT02655705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110486562|NCT02655705|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110486563|NCT02655705|Antimetabolites|antimetabolites|mesh-ancestor
110486564|NCT02655705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110429425|NCT00637117|Interferons|interferons|mesh-list
110486565|NCT02655705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110486566|NCT02655705|Dermatologic Agents|dermatologic agents|mesh-ancestor
110486567|NCT02655705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110486568|NCT02655705|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110486569|NCT02655705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110486570|NCT02655705|Immunologic Factors|immunologic factors|mesh-ancestor
110486571|NCT02655705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110486572|NCT02655705|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110486574|NCT02655705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110486575|NCT02655705|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110486576|NCT02655471|Zidovudine|zidovudine|mesh-list
110486577|NCT02655471|Raltegravir Potassium|raltegravir potassium|mesh-list
110486578|NCT02655471|Antimetabolites|antimetabolites|mesh-ancestor
110486579|NCT02655471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110486580|NCT02655471|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110486581|NCT02655471|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110486583|NCT02655471|Antiviral Agents|antiviral agents|mesh-ancestor
110486584|NCT02655471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110486585|NCT02655471|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110486586|NCT02655471|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110486587|NCT02655471|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110486588|NCT02655471|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110486589|NCT00650013|Midodrine|midodrine|mesh-list
110486590|NCT00650013|Sympathomimetics|sympathomimetics|mesh-ancestor
110486591|NCT00650013|Autonomic Agents|autonomic agents|mesh-ancestor
110486592|NCT00650013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110486593|NCT00650013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110486594|NCT00650013|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110486595|NCT00650013|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110486596|NCT00650013|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110486597|NCT00650013|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110486598|NCT00650013|Adrenergic Agents|adrenergic agents|mesh-ancestor
110486599|NCT00650013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110486600|NCT00650013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110486601|NCT00712933|Belimumab|belimumab|mesh-list
110486602|NCT00712933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110486603|NCT00712933|Immunologic Factors|immunologic factors|mesh-ancestor
110429760|NCT04223661|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110486604|NCT00712933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110486605|NCT02654847|Norepinephrine|norepinephrine|mesh-list
110486606|NCT02654847|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110486607|NCT02654847|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110486608|NCT02654847|Adrenergic Agents|adrenergic agents|mesh-ancestor
110486609|NCT02654847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110486610|NCT02654847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110486611|NCT02654847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110486612|NCT02654847|Sympathomimetics|sympathomimetics|mesh-ancestor
110486613|NCT02654847|Autonomic Agents|autonomic agents|mesh-ancestor
110486614|NCT02654847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110486615|NCT02654847|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110486617|NCT02536209|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110486618|NCT02536209|Narcotics|narcotics|mesh-ancestor
110486619|NCT02536209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110486620|NCT02536209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110486621|NCT02536209|Analgesics|analgesics|mesh-ancestor
110486622|NCT02536209|Sensory System Agents|sensory system agents|mesh-ancestor
110486623|NCT02536209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110486624|NCT00732745|Docetaxel|docetaxel|mesh-list
110486625|NCT00732745|Oxaliplatin|oxaliplatin|mesh-list
110486626|NCT00732745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110486627|NCT00732745|Tubulin Modulators|tubulin modulators|mesh-ancestor
110486628|NCT00732745|Antimitotic Agents|antimitotic agents|mesh-ancestor
110486629|NCT00732745|Mitosis Modulators|mitosis modulators|mesh-ancestor
110486630|NCT00732745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110486631|NCT00737815|Magnesium citrate|magnesium citrate|mesh-list
110486632|NCT00737815|Cathartics|cathartics|mesh-ancestor
110486633|NCT00737815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110486634|NCT02654379|Rituximab|rituximab|mesh-list
110486635|NCT02654379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110486636|NCT02654379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110486637|NCT02654379|Immunologic Factors|immunologic factors|mesh-ancestor
110486638|NCT02654379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110486639|NCT02654379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110486640|NCT04341129|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
110486641|NCT04341129|Chelating Agents|chelating agents|mesh-ancestor
110486642|NCT04341129|Sequestering Agents|sequestering agents|mesh-ancestor
110430240|NCT05392127|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110486643|NCT04341129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110486644|NCT00712543|Lactulose|lactulose|mesh-list
110486645|NCT00712543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110486646|NCT00650169|Clopidogrel|clopidogrel|mesh-list
110486647|NCT00650169|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110486648|NCT00650169|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110486649|NCT00650169|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110486650|NCT00650169|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110486651|NCT00650169|Purinergic Agents|purinergic agents|mesh-ancestor
110486652|NCT00650169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110486653|NCT00650169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110486654|NCT00650169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110486655|NCT04064125|Minocycline|minocycline|mesh-list
110486656|NCT04064125|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110486657|NCT04064125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110486658|NCT00740389|Etravirine|etravirine|mesh-list
110486659|NCT00740389|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110486660|NCT00740389|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110486661|NCT00740389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110486662|NCT00740389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110486663|NCT00740389|Antiviral Agents|antiviral agents|mesh-ancestor
110486664|NCT00740389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110486665|NCT00740467|Cyclosporine|cyclosporine|mesh-list
110486666|NCT00740467|Mycophenolic Acid|mycophenolic acid|mesh-list
110486667|NCT00740467|Cyclophosphamide|cyclophosphamide|mesh-list
110486668|NCT00740467|Busulfan|busulfan|mesh-list
110486669|NCT00740467|Fludarabine|fludarabine|mesh-list
110486670|NCT00740467|Fludarabine phosphate|fludarabine phosphate|mesh-list
110486671|NCT00740467|Cyclosporins|cyclosporins|mesh-list
110486672|NCT00740467|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110486673|NCT00740467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110486674|NCT00740467|Immunologic Factors|immunologic factors|mesh-ancestor
110486675|NCT00740467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110486676|NCT00740467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110486677|NCT00740467|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110430362|NCT02685085|Oxytocics|oxytocics|mesh-ancestor
110486678|NCT00740467|Alkylating Agents|alkylating agents|mesh-ancestor
110486679|NCT00740467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110486680|NCT00740467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110486681|NCT00740467|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110486682|NCT00740467|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110486683|NCT00740467|Antimetabolites|antimetabolites|mesh-ancestor
110486684|NCT00740467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110486685|NCT00740467|Antifungal Agents|antifungal agents|mesh-ancestor
110486686|NCT00740467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110486687|NCT00740467|Dermatologic Agents|dermatologic agents|mesh-ancestor
110486688|NCT00740467|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110486689|NCT00740467|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110486690|NCT00740467|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110486691|NCT00740467|Antitubercular Agents|antitubercular agents|mesh-ancestor
110486692|NCT00740467|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110486694|NCT00740545|Anticoagulants|anticoagulants|mesh-ancestor
110486695|NCT00740545|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110486696|NCT00740545|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110486697|NCT00740545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110486698|NCT02653833|Tadalafil|tadalafil|mesh-list
110486699|NCT02653833|Vasodilator Agents|vasodilator agents|mesh-ancestor
110486700|NCT02653833|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110486701|NCT02653833|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110486702|NCT02653833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110486703|NCT02653833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110486704|NCT02653833|Urological Agents|urological agents|mesh-ancestor
110486705|NCT00733057|Minocycline|minocycline|mesh-list
110486706|NCT00733057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110486707|NCT00733057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110486708|NCT00737971|Triamcinolone|triamcinolone|mesh-list
110486709|NCT00737971|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110486710|NCT00737971|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110486711|NCT00737971|Bevacizumab|bevacizumab|mesh-list
110486712|NCT00737971|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110486713|NCT00737971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110486714|NCT00737971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110430623|NCT02940769|Sympathomimetics|sympathomimetics|mesh-ancestor
110486715|NCT00737971|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110486716|NCT00737971|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110486717|NCT00737971|Growth Substances|growth substances|mesh-ancestor
110486718|NCT00737971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110486719|NCT00737971|Growth Inhibitors|growth inhibitors|mesh-ancestor
110486720|NCT00737971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110486721|NCT00737971|Glucocorticoids|glucocorticoids|mesh-ancestor
110486723|NCT00737971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110486724|NCT00737971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110486725|NCT00737971|Immunologic Factors|immunologic factors|mesh-ancestor
110486726|NCT00737971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110486727|NCT00737971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110486729|NCT00650247|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110486730|NCT00650247|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110486732|NCT00650247|Serotonin Agents|serotonin agents|mesh-ancestor
110486733|NCT00650247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110273708|NCT02897986|Vinorelbine|vinorelbine|mesh-list
110486734|NCT00650247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110486735|NCT00650247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110486736|NCT02568709|Oxytocin|oxytocin|mesh-list
110486737|NCT02568709|Oxytocics|oxytocics|mesh-ancestor
110486738|NCT02568709|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110486739|NCT02568709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110486740|NCT04316169|Hydroxychloroquine|hydroxychloroquine|mesh-list
110486741|NCT04316169|Letrozole|letrozole|mesh-list
110486742|NCT04316169|Fulvestrant|fulvestrant|mesh-list
110486743|NCT04316169|Anastrozole|anastrozole|mesh-list
110486744|NCT04316169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110486745|NCT04316169|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110486746|NCT04316169|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110486747|NCT04316169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110486748|NCT04316169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110486749|NCT04316169|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110486750|NCT04316169|Hormone Antagonists|hormone antagonists|mesh-ancestor
110486751|NCT04316169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110430888|NCT00983385|Narcotics|narcotics|mesh-ancestor
110486752|NCT04316169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110486754|NCT04316169|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110486755|NCT04316169|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110486756|NCT04316169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110486757|NCT04316169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110486758|NCT04316169|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110430958|NCT01195103|Fentanyl|fentanyl|mesh-list
110486759|NCT04316169|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110486760|NCT02653209|Pioglitazone|pioglitazone|mesh-list
110486761|NCT02653209|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110486762|NCT02653209|Canagliflozin|canagliflozin|mesh-list
110486763|NCT02653209|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110486764|NCT02653209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110486765|NCT02653209|Incretins|incretins|mesh-ancestor
110486766|NCT02653209|Hormones|hormones|mesh-ancestor
110486767|NCT02653209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110486768|NCT02653209|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110486769|NCT02653209|Protease Inhibitors|protease inhibitors|mesh-ancestor
110486770|NCT02653209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110486771|NCT02653209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110486772|NCT02653209|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110486773|NCT02653131|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110486774|NCT02653131|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
110486775|NCT02653131|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110486776|NCT02653131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110486777|NCT02653131|Incretins|incretins|mesh-ancestor
110486778|NCT02653131|Hormones|hormones|mesh-ancestor
110486779|NCT02653131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110486780|NCT02653131|Protease Inhibitors|protease inhibitors|mesh-ancestor
110486781|NCT02653131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110486782|NCT02653131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110486783|NCT02652585|Naltrexone|naltrexone|mesh-list
110486784|NCT02652585|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110486785|NCT02652585|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110486786|NCT02652585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110486787|NCT02652585|Sensory System Agents|sensory system agents|mesh-ancestor
110486788|NCT02652585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110486789|NCT00741169|Rifampin|rifampin|mesh-list
110486790|NCT00741169|Simeprevir|simeprevir|mesh-list
110486791|NCT00741169|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110486792|NCT00741169|Antitubercular Agents|antitubercular agents|mesh-ancestor
110486793|NCT00741169|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110486794|NCT00741169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110486795|NCT00741169|Leprostatic Agents|leprostatic agents|mesh-ancestor
110486796|NCT00741169|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110486797|NCT00741169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110486798|NCT00741169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110486799|NCT00741169|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110486800|NCT00741169|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110486801|NCT00741169|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110134074|NCT01987375|Cetuximab|cetuximab|mesh-list
110486802|NCT00741169|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110431152|NCT04289103|Inolimomab|inolimomab|mesh-list
110486803|NCT00741169|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110486804|NCT00741169|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110486806|NCT00741169|Protease Inhibitors|protease inhibitors|mesh-ancestor
110486807|NCT00741325|Plerixafor|plerixafor|mesh-list
110486808|NCT00741325|Lenograstim|lenograstim|mesh-list
110486809|NCT00741325|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110486810|NCT00741325|Immunologic Factors|immunologic factors|mesh-ancestor
110431208|NCT01181921|Nootropic Agents|nootropic agents|mesh-ancestor
110486811|NCT00741325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110486813|NCT00741325|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110486814|NCT00741325|Antiviral Agents|antiviral agents|mesh-ancestor
110486815|NCT00741325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110486816|NCT02652741|Enalapril|enalapril|mesh-list
110486817|NCT02652741|Enalaprilat|enalaprilat|mesh-list
110486818|NCT02652741|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110486819|NCT02652741|Protease Inhibitors|protease inhibitors|mesh-ancestor
110486820|NCT02652741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110486821|NCT02652741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110486822|NCT02652741|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110486823|NCT02652507|Dexmedetomidine|dexmedetomidine|mesh-list
110486824|NCT02652507|Ketamine|ketamine|mesh-list
110486825|NCT02652507|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110486826|NCT02652507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110486827|NCT02652507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110486828|NCT02652507|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110486829|NCT02652507|Analgesics|analgesics|mesh-ancestor
110486830|NCT02652507|Sensory System Agents|sensory system agents|mesh-ancestor
110486831|NCT02652507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110486832|NCT02652507|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110486833|NCT02652507|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110486834|NCT02652507|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110486835|NCT02652507|Adrenergic Agents|adrenergic agents|mesh-ancestor
110486836|NCT02652507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110486837|NCT02652507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110486838|NCT02652507|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110486839|NCT02652507|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110486840|NCT02652507|Anesthetics, General|anesthetics, general|mesh-ancestor
110486841|NCT02652507|Anesthetics|anesthetics|mesh-ancestor
110486842|NCT02652507|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110486843|NCT02652507|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110486844|NCT05742295|Vitamin K|vitamin k|mesh-list
110486845|NCT05742295|Vitamins|vitamins|mesh-ancestor
110486846|NCT05742295|Micronutrients|micronutrients|mesh-ancestor
110486847|NCT05742295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110486848|NCT05742295|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110486849|NCT05742295|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110486850|NCT05742295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110486851|NCT05742295|Hemostatics|hemostatics|mesh-ancestor
110486852|NCT05742295|Coagulants|coagulants|mesh-ancestor
110486853|NCT02652273|Abatacept|abatacept|mesh-list
110486854|NCT02652273|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110486855|NCT02652273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110486856|NCT02652273|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110486857|NCT02652273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110486858|NCT02652273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110486859|NCT02652273|Immunologic Factors|immunologic factors|mesh-ancestor
110486860|NCT02652273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110486861|NCT02652273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110486862|NCT00650325|Sertraline|sertraline|mesh-list
110486863|NCT00650325|Antidepressive Agents|antidepressive agents|mesh-ancestor
110486864|NCT00650325|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110486865|NCT00650325|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110486866|NCT00650325|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110486867|NCT00650325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110486868|NCT00650325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110486869|NCT00650325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110486870|NCT00650325|Serotonin Agents|serotonin agents|mesh-ancestor
110486871|NCT00650325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110486872|NCT00650403|Paroxetine|paroxetine|mesh-list
110486873|NCT00650403|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110486874|NCT00650403|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110486875|NCT00650403|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110486876|NCT00650403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110486877|NCT00650403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110486878|NCT00650403|Serotonin Agents|serotonin agents|mesh-ancestor
110486879|NCT00650403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110486880|NCT00650403|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110486881|NCT00650403|Antidepressive Agents|antidepressive agents|mesh-ancestor
110486882|NCT00650403|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110486883|NCT00650403|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110486884|NCT00650403|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110486885|NCT00650403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110486886|NCT02568319|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110431425|NCT01181141|Edoxaban|edoxaban|mesh-list
110166815|NCT00028756|Tubulin Modulators|tubulin modulators|mesh-ancestor
110486887|NCT02568319|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110486888|NCT02568319|Autonomic Agents|autonomic agents|mesh-ancestor
110486889|NCT02568319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110486890|NCT02568319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110486891|NCT02568319|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110486892|NCT02568319|Respiratory System Agents|respiratory system agents|mesh-ancestor
110486893|NCT02568319|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110486894|NCT02568319|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110486895|NCT02568319|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110486896|NCT02568319|Adrenergic Agents|adrenergic agents|mesh-ancestor
110486897|NCT02568319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110486898|NCT02568319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110486899|NCT00920803|Resveratrol|resveratrol|mesh-list
110486900|NCT00920803|Antioxidants|antioxidants|mesh-ancestor
110486901|NCT00920803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110486902|NCT00920803|Protective Agents|protective agents|mesh-ancestor
110486903|NCT00920803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110486904|NCT00920803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110486905|NCT00920803|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110486906|NCT03912363|Insulin|insulin|mesh-list
110486907|NCT03912363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110486908|NCT03912363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110486909|NCT05740969|Fluorouracil|fluorouracil|mesh-list
110486910|NCT05740969|Imiquimod|imiquimod|mesh-list
110486912|NCT05740969|Antimetabolites|antimetabolites|mesh-ancestor
110486913|NCT05740969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110486914|NCT05740969|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110486915|NCT05740969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110486916|NCT05740969|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110486917|NCT05740969|Immunologic Factors|immunologic factors|mesh-ancestor
110486918|NCT05740969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110486919|NCT05740969|Antioxidants|antioxidants|mesh-ancestor
110486920|NCT05740969|Protective Agents|protective agents|mesh-ancestor
110486921|NCT05740969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110486922|NCT05740969|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110486923|NCT05740969|Interferon Inducers|interferon inducers|mesh-ancestor
110486924|NCT02568241|Interferons|interferons|mesh-list
110486925|NCT02568241|Interferon-alpha|interferon-alpha|mesh-list
110486926|NCT02568241|Interferon alpha-2|interferon alpha-2|mesh-list
110486927|NCT02568241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110486928|NCT02568241|Antiviral Agents|antiviral agents|mesh-ancestor
110486929|NCT02568241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110486930|NCT02568241|Immunologic Factors|immunologic factors|mesh-ancestor
110486931|NCT02568241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110486932|NCT05551897|Itraconazole|itraconazole|mesh-list
110486933|NCT05551897|Antifungal Agents|antifungal agents|mesh-ancestor
110486934|NCT05551897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110486935|NCT05551897|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110486936|NCT05551897|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110486937|NCT05551897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110486938|NCT05551897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110486939|NCT05551897|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110486940|NCT05551897|Hormone Antagonists|hormone antagonists|mesh-ancestor
110431618|NCT00641173|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110486941|NCT05551897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110486942|NCT05551897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110486943|NCT05551897|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110486944|NCT02647671|Calcium Carbonate|calcium carbonate|mesh-list
110486945|NCT02647671|Calcium|calcium|mesh-list
110486946|NCT02647671|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110486947|NCT02647671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110486948|NCT02647671|Antacids|antacids|mesh-ancestor
110134218|NCT01989091|Heparin|heparin|mesh-list
110486949|NCT02647671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110486950|NCT02647671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110486951|NCT04578613|Rituximab|rituximab|mesh-list
110486952|NCT04578613|Chlorambucil|chlorambucil|mesh-list
110486953|NCT04578613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110486954|NCT04578613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110486955|NCT04578613|Immunologic Factors|immunologic factors|mesh-ancestor
110166820|NCT00012324|Nolatrexed|nolatrexed|mesh-list
110486956|NCT04578613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110486957|NCT04578613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110486958|NCT04578613|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110486959|NCT04578613|Alkylating Agents|alkylating agents|mesh-ancestor
110431724|NCT00640705|Diclofenac|diclofenac|mesh-list
110486960|NCT04578613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110486961|NCT02647515|Ranibizumab|ranibizumab|mesh-list
110486962|NCT02647515|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110486963|NCT02647515|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110486964|NCT02647515|Growth Substances|growth substances|mesh-ancestor
110486965|NCT02647515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110486966|NCT02647515|Growth Inhibitors|growth inhibitors|mesh-ancestor
110486967|NCT02647515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110486968|NCT03818763|Factor VIII|factor viii|mesh-list
110486969|NCT03818763|Coagulants|coagulants|mesh-ancestor
110486970|NCT02647047|Acetaminophen|acetaminophen|mesh-list
110486971|NCT02647047|Ketorolac|ketorolac|mesh-list
110486972|NCT02647047|Sufentanil|sufentanil|mesh-list
110486973|NCT02647047|Ropivacaine|ropivacaine|mesh-list
110486974|NCT02647047|Anesthetics, Local|anesthetics, local|mesh-ancestor
110486975|NCT02647047|Anesthetics|anesthetics|mesh-ancestor
110486976|NCT02647047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110486977|NCT02647047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110486978|NCT02647047|Sensory System Agents|sensory system agents|mesh-ancestor
110486979|NCT02647047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110486980|NCT02647047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110486981|NCT02647047|Analgesics|analgesics|mesh-ancestor
110486982|NCT02647047|Antipyretics|antipyretics|mesh-ancestor
110486983|NCT02647047|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110486984|NCT02647047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110486985|NCT02647047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110486986|NCT02647047|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110486987|NCT02647047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110486988|NCT02647047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110486989|NCT02647047|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110486990|NCT02647047|Narcotics|narcotics|mesh-ancestor
110486991|NCT02647047|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110486992|NCT02647047|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110486993|NCT02647047|Anesthetics, General|anesthetics, general|mesh-ancestor
110486994|NCT00651651|Budesonide|budesonide|mesh-list
110486995|NCT00651651|Formoterol Fumarate|formoterol fumarate|mesh-list
110486996|NCT00651651|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110486997|NCT00651651|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110486998|NCT00651651|Autonomic Agents|autonomic agents|mesh-ancestor
110486999|NCT00651651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110487000|NCT00651651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110487001|NCT00651651|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110431912|NCT00931762|Panobinostat|panobinostat|mesh-list
110487002|NCT00651651|Respiratory System Agents|respiratory system agents|mesh-ancestor
110487003|NCT00651651|Glucocorticoids|glucocorticoids|mesh-ancestor
110487004|NCT00651651|Hormones|hormones|mesh-ancestor
110487005|NCT00651651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110487006|NCT00651651|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110487007|NCT00651651|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110487008|NCT00651651|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110487010|NCT00651651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110487011|NCT00651651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110487013|NCT00709111|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110487014|NCT00709111|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110487015|NCT00709111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110487017|NCT00709111|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110487018|NCT00709111|Antiviral Agents|antiviral agents|mesh-ancestor
110487019|NCT00709111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110487020|NCT00709111|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
110487021|NCT00651729|Botulinum Toxins|botulinum toxins|mesh-list
110134290|NCT01989663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110487022|NCT00651729|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110487023|NCT00651729|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110487024|NCT00651729|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110487025|NCT00651729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110487026|NCT00651729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110487027|NCT00651729|Cholinergic Agents|cholinergic agents|mesh-ancestor
110432130|NCT00928486|Hormones|hormones|mesh-ancestor
110487028|NCT00651729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110487029|NCT00651729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110487030|NCT00651729|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110487031|NCT00651729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110487032|NCT02646735|Fulvestrant|fulvestrant|mesh-list
110487033|NCT02646735|Exemestane|exemestane|mesh-list
110487034|NCT02646735|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110487035|NCT02646735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110487036|NCT02646735|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110487037|NCT02646735|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110487038|NCT02646735|Hormone Antagonists|hormone antagonists|mesh-ancestor
110487039|NCT02646735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110487040|NCT02646735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110487041|NCT02646735|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110487042|NCT02646735|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110487043|NCT02646735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110487044|NCT02646735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110487045|NCT02646501|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
110487047|NCT02646657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110487048|NCT00652041|Thalidomide|thalidomide|mesh-list
110487049|NCT00652041|Bortezomib|bortezomib|mesh-list
110487050|NCT00652041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110487051|NCT00652041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110487052|NCT00652041|Immunologic Factors|immunologic factors|mesh-ancestor
110487053|NCT00652041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110487054|NCT00652041|Leprostatic Agents|leprostatic agents|mesh-ancestor
110487055|NCT00652041|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110487056|NCT00652041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110487057|NCT00652041|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110487058|NCT00652041|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110487059|NCT00652041|Growth Substances|growth substances|mesh-ancestor
110487060|NCT00652041|Growth Inhibitors|growth inhibitors|mesh-ancestor
110487061|NCT02646111|Ribavirin|ribavirin|mesh-list
110487062|NCT02646111|Antimetabolites|antimetabolites|mesh-ancestor
110432455|NCT05907902|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110487063|NCT02646111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110487064|NCT02646111|Antiviral Agents|antiviral agents|mesh-ancestor
110487065|NCT02646111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110487066|NCT00652119|Paclitaxel|paclitaxel|mesh-list
110487067|NCT00652119|Bevacizumab|bevacizumab|mesh-list
110487068|NCT00652119|Carboplatin|carboplatin|mesh-list
110487069|NCT00652119|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110487070|NCT00652119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110487071|NCT00652119|Tubulin Modulators|tubulin modulators|mesh-ancestor
110487072|NCT00652119|Antimitotic Agents|antimitotic agents|mesh-ancestor
110487073|NCT00652119|Mitosis Modulators|mitosis modulators|mesh-ancestor
110268770|NCT00185328|Estrogens|estrogens|mesh-ancestor
110487074|NCT00652119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110487075|NCT00652119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110487076|NCT00652119|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110487077|NCT00652119|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110487078|NCT00652119|Growth Substances|growth substances|mesh-ancestor
110487079|NCT00652119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110487080|NCT00652119|Growth Inhibitors|growth inhibitors|mesh-ancestor
110487081|NCT05740657|Fentanyl|fentanyl|mesh-list
110487082|NCT05740657|Sufentanil|sufentanil|mesh-list
110487083|NCT05740657|Morphine|morphine|mesh-list
110487084|NCT05740657|Remifentanil|remifentanil|mesh-list
110487085|NCT05740657|Oxycodone|oxycodone|mesh-list
110487086|NCT05740657|Hydromorphone|hydromorphone|mesh-list
110487087|NCT05740657|Alfentanil|alfentanil|mesh-list
110487088|NCT05740657|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110487089|NCT05740657|Narcotics|narcotics|mesh-ancestor
110487090|NCT05740657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110432628|NCT05736874|Xhance|xhance|mesh-list
110487091|NCT05740657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110487092|NCT05740657|Analgesics|analgesics|mesh-ancestor
110487093|NCT05740657|Sensory System Agents|sensory system agents|mesh-ancestor
110487094|NCT05740657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110487095|NCT05740657|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110487096|NCT05740657|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110487097|NCT05740657|Anesthetics, General|anesthetics, general|mesh-ancestor
110487098|NCT05740657|Anesthetics|anesthetics|mesh-ancestor
110134378|NCT01990144|Rituximab|rituximab|mesh-list
110487099|NCT02646267|Warfarin|warfarin|mesh-list
110487100|NCT02646267|Dabigatran|dabigatran|mesh-list
110487102|NCT02646267|Antithrombins|antithrombins|mesh-ancestor
110487103|NCT02646267|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110487104|NCT02646267|Protease Inhibitors|protease inhibitors|mesh-ancestor
110487105|NCT02646267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110432723|NCT05536349|Antiviral Agents|antiviral agents|mesh-ancestor
110487106|NCT02646267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110487107|NCT02646189|Interferons|interferons|mesh-list
110487108|NCT02646189|Interferon-alpha|interferon-alpha|mesh-list
110487109|NCT02646189|Interferon alpha-2|interferon alpha-2|mesh-list
110487110|NCT02646189|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110487111|NCT02646189|REP 2139|rep 2139|mesh-list
110487112|NCT02646189|Thymalfasin|thymalfasin|mesh-list
110487113|NCT02646189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110487114|NCT02646189|Antiviral Agents|antiviral agents|mesh-ancestor
110487115|NCT02646189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110487116|NCT02646189|Immunologic Factors|immunologic factors|mesh-ancestor
110487117|NCT02646189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110487118|NCT02646189|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110487119|NCT02645565|Methylprednisolone|methylprednisolone|mesh-list
110487120|NCT02645565|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110487121|NCT02645565|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110487122|NCT02645565|Prednisolone|prednisolone|mesh-list
110487123|NCT02645565|Prednisolone acetate|prednisolone acetate|mesh-list
110487124|NCT02645565|Cyclophosphamide|cyclophosphamide|mesh-list
110487125|NCT02645565|Azathioprine|azathioprine|mesh-list
110487126|NCT02645565|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110487127|NCT02645565|Prednisolone phosphate|prednisolone phosphate|mesh-list
110487128|NCT02645565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110487129|NCT02645565|Immunologic Factors|immunologic factors|mesh-ancestor
110487130|NCT02645565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110487131|NCT02645565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110487132|NCT02645565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110487133|NCT02645565|Alkylating Agents|alkylating agents|mesh-ancestor
110487134|NCT02645565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110487135|NCT02645565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110487136|NCT02645565|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110487137|NCT02645565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110487138|NCT02645565|Antiemetics|antiemetics|mesh-ancestor
110487139|NCT02645565|Autonomic Agents|autonomic agents|mesh-ancestor
110487140|NCT02645565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110487141|NCT02645565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110487142|NCT02645565|Glucocorticoids|glucocorticoids|mesh-ancestor
110487143|NCT02645565|Hormones|hormones|mesh-ancestor
110166858|NCT00028834|Growth Substances|growth substances|mesh-ancestor
110487144|NCT02645565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110487145|NCT02645565|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110487146|NCT02645565|Protective Agents|protective agents|mesh-ancestor
110487147|NCT02645565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110487148|NCT02645565|Antimetabolites|antimetabolites|mesh-ancestor
110487149|NCT02645565|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110487150|NCT00699907|Flutamide|flutamide|mesh-list
110487151|NCT00699907|Androgen Antagonists|androgen antagonists|mesh-ancestor
110487152|NCT00699907|Hormone Antagonists|hormone antagonists|mesh-ancestor
110487153|NCT00699907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110487154|NCT00699907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110487155|NCT00699907|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110487156|NCT00699907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110487157|NCT00599313|Sunitinib|sunitinib|mesh-list
110487158|NCT00599313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110433190|NCT03493152|Immunologic Factors|immunologic factors|mesh-ancestor
110487159|NCT00599313|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110487160|NCT00599313|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110487161|NCT00599313|Growth Substances|growth substances|mesh-ancestor
110487162|NCT00599313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110487163|NCT00599313|Growth Inhibitors|growth inhibitors|mesh-ancestor
110487164|NCT00599313|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110487165|NCT00599313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110433263|NCT02901184|Natriuretic Agents|natriuretic agents|mesh-ancestor
110487166|NCT00599313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110487167|NCT00708175|Pioglitazone|pioglitazone|mesh-list
110487168|NCT00708175|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110487169|NCT00708175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110487170|NCT05740345|Metformin|metformin|mesh-list
110487171|NCT05740345|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110487172|NCT05740345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110487173|NCT02641431|Ajmaline|ajmaline|mesh-list
110487174|NCT02641431|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110134439|NCT01990781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110134446|NCT01990781|Hormones|hormones|mesh-ancestor
110487175|NCT02641431|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110487176|NCT02641431|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110487177|NCT02641431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110487178|NCT02641431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110487179|NCT00733525|Fluoxetine|fluoxetine|mesh-list
110487180|NCT00733525|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110487181|NCT00733525|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110487182|NCT00733525|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110487183|NCT00733525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110487184|NCT00733525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110487185|NCT00733525|Serotonin Agents|serotonin agents|mesh-ancestor
110487186|NCT00733525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110487187|NCT00733525|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110487188|NCT00733525|Antidepressive Agents|antidepressive agents|mesh-ancestor
110487189|NCT00733525|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110268799|NCT00162188|Efavirenz|efavirenz|mesh-list
110487190|NCT00733525|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110487191|NCT00733525|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110487192|NCT00733525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110487193|NCT02567149|Cidofovir|cidofovir|mesh-list
110487194|NCT02567149|Antiviral Agents|antiviral agents|mesh-ancestor
110487195|NCT02567149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110487196|NCT02567149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110487197|NCT02567149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110487198|NCT00707239|Imipenem|imipenem|mesh-list
110487199|NCT00707239|Tigecycline|tigecycline|mesh-list
110487200|NCT00707239|Cilastatin|cilastatin|mesh-list
110487201|NCT00707239|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110487202|NCT00707239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110487203|NCT00707239|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110487204|NCT00707239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110487205|NCT00707239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110487206|NCT00707239|Protease Inhibitors|protease inhibitors|mesh-ancestor
110487207|NCT00968708|Alogliptin|alogliptin|mesh-list
110487208|NCT00968708|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110487209|NCT00968708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110487210|NCT00968708|Incretins|incretins|mesh-ancestor
110487211|NCT00968708|Hormones|hormones|mesh-ancestor
110487212|NCT00968708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110487213|NCT00968708|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110487214|NCT00968708|Protease Inhibitors|protease inhibitors|mesh-ancestor
110487215|NCT00968708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110433510|NCT00004223|Tubulin Modulators|tubulin modulators|mesh-ancestor
110487216|NCT00968708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110487217|NCT05417269|Dimethyl Fumarate|dimethyl fumarate|mesh-list
110487218|NCT05417269|Dermatologic Agents|dermatologic agents|mesh-ancestor
110487219|NCT05417269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110487220|NCT05417269|Immunologic Factors|immunologic factors|mesh-ancestor
110487221|NCT05417269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110487222|NCT04062565|Treprostinil|treprostinil|mesh-list
110487223|NCT04062565|Riociguat|riociguat|mesh-list
110487224|NCT04062565|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110487225|NCT04062565|Enzyme Activators|enzyme activators|mesh-ancestor
110487226|NCT04062565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110487227|NCT00967694|Nitrous Oxide|nitrous oxide|mesh-list
110487228|NCT00967694|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110487229|NCT00967694|Anesthetics, General|anesthetics, general|mesh-ancestor
110487230|NCT00967694|Anesthetics|anesthetics|mesh-ancestor
110487231|NCT00967694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110487232|NCT00967694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110487233|NCT00967694|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110487234|NCT00967694|Analgesics|analgesics|mesh-ancestor
110487235|NCT00967694|Sensory System Agents|sensory system agents|mesh-ancestor
110487236|NCT00967694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110487239|NCT04288700|Captopril|captopril|mesh-list
110487240|NCT04288700|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110487241|NCT04288700|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110487242|NCT04288700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110487243|NCT04288700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110487244|NCT04288700|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110487245|NCT04288700|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110487246|NCT04288700|Adrenergic Agents|adrenergic agents|mesh-ancestor
110487247|NCT04288700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110134516|NCT01991158|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110487248|NCT04288700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110487249|NCT04288700|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110487250|NCT04288700|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110487251|NCT04288700|Vasodilator Agents|vasodilator agents|mesh-ancestor
110487252|NCT04288700|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110487253|NCT04288700|Protease Inhibitors|protease inhibitors|mesh-ancestor
110487255|NCT02863406|Chelating Agents|chelating agents|mesh-ancestor
110487256|NCT02863406|Sequestering Agents|sequestering agents|mesh-ancestor
110487257|NCT02863406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110487258|NCT03664232|JNJ-42165279|jnj-42165279|mesh-list
110487259|NCT03664232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110487260|NCT03664232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110487261|NCT00629720|Alfuzosin|alfuzosin|mesh-list
110487262|NCT00629720|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110487263|NCT00629720|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110487264|NCT00629720|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110487265|NCT00629720|Adrenergic Agents|adrenergic agents|mesh-ancestor
110487266|NCT00629720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110487267|NCT00629720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110487268|NCT00629720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110487269|NCT00629720|Urological Agents|urological agents|mesh-ancestor
110487270|NCT00967616|Leucovorin|leucovorin|mesh-list
110487271|NCT00967616|Fluorouracil|fluorouracil|mesh-list
110487272|NCT00967616|Irinotecan|irinotecan|mesh-list
110487273|NCT00967616|Efatutazone|efatutazone|mesh-list
110487274|NCT00967616|Levoleucovorin|levoleucovorin|mesh-list
110487275|NCT00967616|Antimetabolites|antimetabolites|mesh-ancestor
110433839|NCT04287387|Incretins|incretins|mesh-ancestor
110487276|NCT00967616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110487277|NCT00967616|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110487278|NCT00967616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110487279|NCT00967616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110487280|NCT00967616|Immunologic Factors|immunologic factors|mesh-ancestor
110487281|NCT00967616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110487282|NCT00967616|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110487283|NCT00967616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110487284|NCT00967616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110487286|NCT00967616|Protective Agents|protective agents|mesh-ancestor
110487287|NCT00967616|Vitamin B Complex|vitamin b complex|mesh-ancestor
110487288|NCT00967616|Vitamins|vitamins|mesh-ancestor
110487289|NCT00967616|Micronutrients|micronutrients|mesh-ancestor
110487290|NCT04288232|Aflibercept|aflibercept|mesh-list
110487291|NCT04288232|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110487292|NCT04288232|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110487293|NCT04288232|Growth Substances|growth substances|mesh-ancestor
110487294|NCT04288232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110487295|NCT04288232|Growth Inhibitors|growth inhibitors|mesh-ancestor
110487296|NCT04288232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110487297|NCT02864264|Interferons|interferons|mesh-list
110487298|NCT02864264|Interferon-gamma|interferon-gamma|mesh-list
110487299|NCT02864264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110487300|NCT02864264|Antiviral Agents|antiviral agents|mesh-ancestor
110487301|NCT02864264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110487302|NCT02640417|Vitamin B Complex|vitamin b complex|mesh-list
110487303|NCT02640417|Vitamins|vitamins|mesh-ancestor
110487304|NCT02640417|Micronutrients|micronutrients|mesh-ancestor
110487305|NCT02640417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110487306|NCT02640495|Artesunate|artesunate|mesh-list
110487307|NCT02640495|Antimalarials|antimalarials|mesh-ancestor
110487308|NCT02640495|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110487309|NCT02640495|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110487310|NCT02640495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110487311|NCT02640495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110487312|NCT02640495|Antiviral Agents|antiviral agents|mesh-ancestor
110487313|NCT02640495|Schistosomicides|schistosomicides|mesh-ancestor
110487314|NCT02640495|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110487315|NCT02640495|Anthelmintics|anthelmintics|mesh-ancestor
110487317|NCT00653757|Goserelin|goserelin|mesh-list
110487318|NCT00653757|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110487319|NCT00653757|Fertility Agents|fertility agents|mesh-ancestor
110487320|NCT00653757|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110487321|NCT00653757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110487322|NCT00653757|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110487323|NCT00653757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110487325|NCT00654225|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110134597|NCT01991626|Iron|iron|mesh-list
110487326|NCT00654225|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110487327|NCT00654225|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110487328|NCT00654225|Antimetabolites|antimetabolites|mesh-ancestor
110487329|NCT00654225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110487330|NCT00654225|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110487331|NCT00654225|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110487332|NCT00654225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110487333|NCT00974090|Glimepiride|glimepiride|mesh-list
110487334|NCT00974090|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110487335|NCT00974090|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110487336|NCT00974090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110487337|NCT00974090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110487338|NCT00974090|Immunologic Factors|immunologic factors|mesh-ancestor
110487339|NCT00654303|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110487340|NCT00654303|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110487341|NCT00654303|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110487342|NCT00654303|Antimetabolites|antimetabolites|mesh-ancestor
110487343|NCT00654303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110487344|NCT00654303|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110487345|NCT00654303|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110487348|NCT02639091|Anetumab ravtansine|anetumab ravtansine|mesh-list
110487349|NCT02639091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110487350|NCT02639091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110487351|NCT02639091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110487352|NCT02639091|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110487353|NCT02639091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110487354|NCT02639091|Immunoconjugates|immunoconjugates|mesh-ancestor
110487355|NCT02639091|Immunologic Factors|immunologic factors|mesh-ancestor
110487356|NCT02639091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110487357|NCT00654459|Policosanol|policosanol|mesh-list
110434205|NCT02669641|Nootropic Agents|nootropic agents|mesh-ancestor
110487358|NCT00654459|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110487359|NCT00654459|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110487360|NCT00654459|Antimetabolites|antimetabolites|mesh-ancestor
110487361|NCT00654459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110487362|NCT00654459|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110487363|NCT00654459|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110487365|NCT00654537|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110487366|NCT00654537|Simvastatin|simvastatin|mesh-list
110487367|NCT00654537|Pravastatin|pravastatin|mesh-list
110487368|NCT00654537|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110487369|NCT00654537|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110487370|NCT00654537|Antimetabolites|antimetabolites|mesh-ancestor
110487371|NCT00654537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110268852|NCT04684498|Oseltamivir|oseltamivir|mesh-list
110487372|NCT00654537|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110487373|NCT00654537|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110487374|NCT00654537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110487375|NCT02638857|Epirubicin|epirubicin|mesh-list
110487376|NCT02638857|Mitomycins|mitomycins|mesh-list
110487377|NCT02638857|Mitomycin|mitomycin|mesh-list
110487378|NCT02638857|Ethiodized Oil|ethiodized oil|mesh-list
110487379|NCT02638857|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110487380|NCT02638857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110487381|NCT02638857|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110487382|NCT02638857|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110487383|NCT02638857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110487384|NCT02638857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110487385|NCT02638857|Alkylating Agents|alkylating agents|mesh-ancestor
110487386|NCT02638857|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110487387|NCT02638545|Dexmedetomidine|dexmedetomidine|mesh-list
110434273|NCT00645151|Atorvastatin|atorvastatin|mesh-list
110487388|NCT02638545|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110487389|NCT02638545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110487390|NCT02638545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110487391|NCT02638545|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110487392|NCT02638545|Analgesics|analgesics|mesh-ancestor
110487393|NCT02638545|Sensory System Agents|sensory system agents|mesh-ancestor
110487394|NCT02638545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110487395|NCT02638545|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110487396|NCT02638545|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110487397|NCT02638545|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110487398|NCT02638545|Adrenergic Agents|adrenergic agents|mesh-ancestor
110487399|NCT02638545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110487400|NCT02638545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110487401|NCT02638233|Sofosbuvir|sofosbuvir|mesh-list
110487402|NCT02638233|Ledipasvir|ledipasvir|mesh-list
110487403|NCT02638233|Antiviral Agents|antiviral agents|mesh-ancestor
110487404|NCT02638233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110487405|NCT04285268|Rituximab|rituximab|mesh-list
110487406|NCT04285268|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110487408|NCT04285268|Venetoclax|venetoclax|mesh-list
110487409|NCT04285268|Antibodies|antibodies|mesh-list
110487410|NCT04285268|Immunoglobulins|immunoglobulins|mesh-list
110487411|NCT04285268|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110487412|NCT04285268|Immunologic Factors|immunologic factors|mesh-ancestor
110487413|NCT04285268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110487414|NCT04285268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110487415|NCT04285268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110487416|NCT00699751|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
110487417|NCT00699751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110487418|NCT01842399|Resveratrol|resveratrol|mesh-list
110487419|NCT01842399|Antioxidants|antioxidants|mesh-ancestor
110487420|NCT01842399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110487421|NCT01842399|Protective Agents|protective agents|mesh-ancestor
110434439|NCT04255576|Vitamin D|vitamin d|mesh-list
110487422|NCT01842399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110487423|NCT01842399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110487424|NCT01842399|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110487425|NCT00970502|Celecoxib|celecoxib|mesh-list
110487426|NCT00970502|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110487427|NCT00970502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110487428|NCT00970502|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110166875|NCT00028912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110487430|NCT00970502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110487431|NCT00970502|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110487433|NCT00970502|Analgesics|analgesics|mesh-ancestor
110487434|NCT00970502|Sensory System Agents|sensory system agents|mesh-ancestor
110487435|NCT00970502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110487436|NCT00970502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110487437|NCT00970502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110487438|NCT00970502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110487439|NCT00970502|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110487440|NCT00970502|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110487441|NCT02635893|Cycloserine|cycloserine|mesh-list
110487442|NCT02635893|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110487443|NCT02635893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110487444|NCT02635893|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110487445|NCT02635893|Antitubercular Agents|antitubercular agents|mesh-ancestor
110487446|NCT02635893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110487447|NCT02635893|Antimetabolites|antimetabolites|mesh-ancestor
110487448|NCT02635893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110487449|NCT02567773|Itraconazole|itraconazole|mesh-list
110487450|NCT02567773|GSK2881078|gsk2881078|mesh-list
110487451|NCT02567773|Antifungal Agents|antifungal agents|mesh-ancestor
110487452|NCT02567773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110487453|NCT02567773|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110487454|NCT02567773|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110487455|NCT02567773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110487456|NCT02567773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110487457|NCT02567773|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110487458|NCT02567773|Hormone Antagonists|hormone antagonists|mesh-ancestor
110487459|NCT02567773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110487460|NCT02567773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110487461|NCT02567773|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110487463|NCT02567773|Hormones|hormones|mesh-ancestor
110487464|NCT00967226|Prednisolone|prednisolone|mesh-list
110487465|NCT00967226|Propranolol|propranolol|mesh-list
110487466|NCT00967226|Prednisolone phosphate|prednisolone phosphate|mesh-list
110487467|NCT00967226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110487469|NCT00967226|Hormones|hormones|mesh-ancestor
110487470|NCT00967226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110487471|NCT00967226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110434843|NCT01166646|Clobetasol|clobetasol|mesh-list
110487472|NCT00967226|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110487473|NCT00967226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110487474|NCT00967226|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110487475|NCT00967226|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110487476|NCT00967226|Adrenergic Agents|adrenergic agents|mesh-ancestor
110487477|NCT00967226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110487478|NCT00967226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110487479|NCT00967226|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110487480|NCT00967226|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110487481|NCT00967226|Vasodilator Agents|vasodilator agents|mesh-ancestor
110487482|NCT00706381|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
110487483|NCT00706381|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
110487484|NCT00706381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110487486|NCT00964886|Desipramine|desipramine|mesh-list
110487487|NCT00964886|Clomipramine|clomipramine|mesh-list
110487488|NCT00964886|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110487489|NCT00964886|Antidepressive Agents|antidepressive agents|mesh-ancestor
110487490|NCT00964886|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110487491|NCT00964886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110487492|NCT00964886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110487493|NCT00964886|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110487494|NCT00964886|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110487495|NCT00964886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110487496|NCT00964886|Adrenergic Agents|adrenergic agents|mesh-ancestor
110487497|NCT00964886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110487498|NCT00964886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110487499|NCT00964886|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110487500|NCT00964886|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110487501|NCT00964886|Parasympatholytics|parasympatholytics|mesh-ancestor
110487502|NCT00964886|Autonomic Agents|autonomic agents|mesh-ancestor
110487503|NCT00964886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110487504|NCT00964886|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110487505|NCT00964886|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110487506|NCT00964886|Cholinergic Agents|cholinergic agents|mesh-ancestor
110487507|NCT00964886|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110487508|NCT00964886|Dopamine Agents|dopamine agents|mesh-ancestor
110435024|NCT01218308|Vaccines|vaccines|mesh-list
110487509|NCT00964886|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110487510|NCT00964886|Serotonin Agents|serotonin agents|mesh-ancestor
110487511|NCT02861222|Doxorubicin|doxorubicin|mesh-list
110487512|NCT02861222|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110487513|NCT02861222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110487514|NCT02861222|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110487515|NCT02861222|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110487516|NCT02861222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110487517|NCT02861222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110487518|NCT04062019|Aldesleukin|aldesleukin|mesh-list
110487519|NCT04062019|Interleukin-2|interleukin-2|mesh-list
110487520|NCT04062019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110487521|NCT04062019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110487522|NCT04062019|Analgesics|analgesics|mesh-ancestor
110487523|NCT04062019|Sensory System Agents|sensory system agents|mesh-ancestor
110435161|NCT02664493|Methylprednisolone|methylprednisolone|mesh-list
110487524|NCT04062019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110487525|NCT04062019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110487526|NCT04062019|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110487527|NCT04062019|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110487528|NCT04062019|Antiviral Agents|antiviral agents|mesh-ancestor
110487529|NCT04062019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110487530|NCT04061863|Nivolumab|nivolumab|mesh-list
110487531|NCT04061863|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110487532|NCT04061863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110487533|NCT04061863|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110487534|NCT04061863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110487536|NCT02861378|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110487537|NCT02861378|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110487539|NCT02861378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110487540|NCT02861378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110487541|NCT02861378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110487542|NCT02861378|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110487543|NCT03630224|Plasma-lyte 148|plasma-lyte 148|mesh-list
110487544|NCT03630224|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110487545|NCT03630224|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110487546|NCT00705757|Bimatoprost|bimatoprost|mesh-list
110487547|NCT00705757|Travoprost|travoprost|mesh-list
110487548|NCT00705757|Latanoprost|latanoprost|mesh-list
110487549|NCT00705757|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110487550|NCT00705757|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110487551|NCT00705757|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110487552|NCT04284644|Propofol|propofol|mesh-list
110487553|NCT04284644|Sevoflurane|sevoflurane|mesh-list
110487554|NCT04284644|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110487555|NCT04284644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110487556|NCT04284644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110487557|NCT04284644|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110487558|NCT04284644|Anesthetics, General|anesthetics, general|mesh-ancestor
110487560|NCT04284644|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110487561|NCT04284644|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110487562|NCT05330143|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
110487563|NCT05330143|Antiviral Agents|antiviral agents|mesh-ancestor
110487564|NCT05330143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110487565|NCT04284722|Metformin|metformin|mesh-list
110487566|NCT04284722|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110487567|NCT04284722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110487568|NCT04283240|Sildenafil Citrate|sildenafil citrate|mesh-list
110487569|NCT04283240|Vasodilator Agents|vasodilator agents|mesh-ancestor
110487570|NCT04283240|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110435411|NCT00648193|Paroxetine|paroxetine|mesh-list
110487571|NCT04283240|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110487572|NCT04283240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110487573|NCT04283240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110166884|NCT01803555|Autonomic Agents|autonomic agents|mesh-ancestor
110435510|NCT02659033|Cefotaxime|cefotaxime|mesh-list
110487574|NCT04283240|Urological Agents|urological agents|mesh-ancestor
110487575|NCT03588884|Cholecalciferol|cholecalciferol|mesh-list
110487576|NCT03588884|Vitamin D|vitamin d|mesh-list
110487577|NCT03588884|Calcifediol|calcifediol|mesh-list
110487578|NCT03588884|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110487579|NCT03588884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110487580|NCT03588884|Vitamins|vitamins|mesh-ancestor
110487581|NCT03588884|Micronutrients|micronutrients|mesh-ancestor
110487582|NCT03588884|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110487583|NCT02862782|Triptorelin Pamoate|triptorelin pamoate|mesh-list
110487584|NCT02862782|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
110487585|NCT02862782|Luteolytic Agents|luteolytic agents|mesh-ancestor
110487586|NCT02862782|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110487587|NCT02862782|Contraceptive Agents|contraceptive agents|mesh-ancestor
110487588|NCT02862782|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110487589|NCT02862782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110487590|NCT02862782|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110487591|NCT02862782|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110487592|NCT02862782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110487593|NCT04283162|Calcium, Dietary|calcium, dietary|mesh-list
110487594|NCT04283162|Calcium Dobesilate|calcium dobesilate|mesh-list
110487595|NCT04283162|Calcium|calcium|mesh-list
110487596|NCT04283162|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110487597|NCT04283162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110487598|NCT04283162|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110487599|NCT04283162|Hemostatics|hemostatics|mesh-ancestor
110487600|NCT04283162|Coagulants|coagulants|mesh-ancestor
110487601|NCT00758524|Eplerenone|eplerenone|mesh-list
110487602|NCT00758524|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110487603|NCT00758524|Hormone Antagonists|hormone antagonists|mesh-ancestor
110487604|NCT00758524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110487605|NCT00758524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110487606|NCT00758524|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110487607|NCT00758524|Diuretics|diuretics|mesh-ancestor
110487608|NCT00758524|Natriuretic Agents|natriuretic agents|mesh-ancestor
110487609|NCT00758524|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110487610|NCT02601196|Ulipristal acetate|ulipristal acetate|mesh-list
110487611|NCT02601196|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110487612|NCT02601196|Contraceptive Agents|contraceptive agents|mesh-ancestor
110487613|NCT02601196|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110487614|NCT02601196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110487615|NCT02601196|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110487617|NCT00757588|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110487618|NCT00757588|Saxagliptin|saxagliptin|mesh-list
110487619|NCT00757588|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110487620|NCT00757588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110487621|NCT00757588|Incretins|incretins|mesh-ancestor
110487622|NCT00757588|Hormones|hormones|mesh-ancestor
110487623|NCT00757588|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110487624|NCT00757588|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110487625|NCT00757588|Protease Inhibitors|protease inhibitors|mesh-ancestor
110487626|NCT00757588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110487627|NCT00757588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110487628|NCT00917254|Enoxaparin|enoxaparin|mesh-list
110487629|NCT00917254|Anticoagulants|anticoagulants|mesh-ancestor
110487630|NCT00917254|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110487631|NCT00917254|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110487632|NCT00917254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110487633|NCT02599792|Ivacaftor|ivacaftor|mesh-list
110487634|NCT02599792|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
110487635|NCT02599792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110487636|NCT02599792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110487637|NCT00705679|Tenofovir|tenofovir|mesh-list
110487638|NCT00705679|Emtricitabine|emtricitabine|mesh-list
110487639|NCT00705679|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110487640|NCT00705679|Antiviral Agents|antiviral agents|mesh-ancestor
110487641|NCT00705679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110487642|NCT00705679|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110487643|NCT00705679|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110487644|NCT00705679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110487645|NCT00705679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110487646|NCT00705679|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110487647|NCT00705679|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110487648|NCT04092868|Protamines|protamines|mesh-list
110487649|NCT04092868|Heparin Antagonists|heparin antagonists|mesh-ancestor
110487650|NCT04092868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110487651|NCT04092868|Coagulants|coagulants|mesh-ancestor
110487652|NCT05695573|Cystatins|cystatins|mesh-list
110487653|NCT05695573|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
110487654|NCT05695573|Protease Inhibitors|protease inhibitors|mesh-ancestor
110487655|NCT05695573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110487656|NCT05695573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110487657|NCT00916942|Lidocaine|lidocaine|mesh-list
110487658|NCT00916942|Prilocaine|prilocaine|mesh-list
110487659|NCT00916942|Capsaicin|capsaicin|mesh-list
110487660|NCT00916942|Anesthetics, Local|anesthetics, local|mesh-ancestor
110487661|NCT00916942|Anesthetics|anesthetics|mesh-ancestor
110487662|NCT00916942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110487663|NCT00916942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110487664|NCT00916942|Sensory System Agents|sensory system agents|mesh-ancestor
110487665|NCT00916942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110487666|NCT00916942|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110487667|NCT00916942|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110487668|NCT00916942|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110487669|NCT00916942|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110487670|NCT00916942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110435998|NCT00650221|Pravastatin|pravastatin|mesh-list
110487671|NCT00916942|Antipruritics|antipruritics|mesh-ancestor
110487672|NCT00916942|Dermatologic Agents|dermatologic agents|mesh-ancestor
110487673|NCT00751114|Metformin|metformin|mesh-list
110487674|NCT00751114|Insulin Glargine|insulin glargine|mesh-list
110487675|NCT00751114|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110487676|NCT00751114|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110487677|NCT00751114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110487678|NCT00751114|Incretins|incretins|mesh-ancestor
110487679|NCT00751114|Hormones|hormones|mesh-ancestor
110487680|NCT00751114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110487681|NCT00751114|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110487682|NCT00751114|Protease Inhibitors|protease inhibitors|mesh-ancestor
110487683|NCT00751114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110487684|NCT00751114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110487685|NCT00960440|Tofacitinib|tofacitinib|mesh-list
110487686|NCT00960440|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
110487687|NCT00960440|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110487688|NCT00960440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110487689|NCT00960440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110487690|NCT04092478|Anesthetics|anesthetics|mesh-list
110487691|NCT04092478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110487692|NCT04092478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110487693|NCT02598466|Abatacept|abatacept|mesh-list
110487694|NCT02598466|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110487695|NCT02598466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110487696|NCT02598466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110487697|NCT02598466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110487698|NCT02598466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110487700|NCT02598466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110487701|NCT02598466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110487702|NCT05973422|Insulin|insulin|mesh-list
110487703|NCT05973422|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110487704|NCT05973422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110487705|NCT05973370|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
110487706|NCT05973370|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
110487707|NCT05973370|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110487708|NCT05973318|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110487709|NCT05973318|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110487710|NCT05973305|Dorzolamide|dorzolamide|mesh-list
110487711|NCT05973305|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110487712|NCT05973305|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110487713|NCT05973305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110487714|NCT05973305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110487715|NCT05973253|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
110487716|NCT05973253|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110487717|NCT05973253|Contraceptive Agents|contraceptive agents|mesh-ancestor
110487718|NCT05973253|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110487719|NCT05973253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110487720|NCT05973253|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110487721|NCT05973253|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110487722|NCT05973253|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110487723|NCT05973253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110487725|NCT05973188|Rivaroxaban|rivaroxaban|mesh-list
110487726|NCT05973188|Apixaban|apixaban|mesh-list
110487727|NCT05973188|Anticoagulants|anticoagulants|mesh-ancestor
110436232|NCT00649675|Meloxicam|meloxicam|mesh-list
110487728|NCT05973188|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110487729|NCT05973188|Antithrombins|antithrombins|mesh-ancestor
110487730|NCT05973188|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110487731|NCT05973188|Protease Inhibitors|protease inhibitors|mesh-ancestor
110487732|NCT05973188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110487733|NCT05973188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110487734|NCT05973071|Contraceptive Agents|contraceptive agents|mesh-list
110487735|NCT05973071|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110487736|NCT05973071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110487737|NCT05972967|Ravulizumab|ravulizumab|mesh-list
110487738|NCT05972967|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
110487739|NCT05972967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110487740|NCT05972967|Immunologic Factors|immunologic factors|mesh-ancestor
110487741|NCT05972967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110487742|NCT05972928|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110487743|NCT05972928|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110487744|NCT05972928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110487746|NCT05972928|Hormones|hormones|mesh-ancestor
110487747|NCT05972928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110487748|NCT05972928|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110487749|NCT05972928|Protease Inhibitors|protease inhibitors|mesh-ancestor
110487750|NCT05972928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110487751|NCT05972928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110487752|NCT05972902|Triptorelin Pamoate|triptorelin pamoate|mesh-list
110487753|NCT05972902|Cetrorelix|cetrorelix|mesh-list
110487754|NCT05972902|Dydrogesterone|dydrogesterone|mesh-list
110487755|NCT05972902|Luteolytic Agents|luteolytic agents|mesh-ancestor
110487756|NCT05972902|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110487757|NCT05972902|Contraceptive Agents|contraceptive agents|mesh-ancestor
110487758|NCT05972902|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110487759|NCT05972902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110487760|NCT05972902|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110487761|NCT05972902|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110436431|NCT04251364|Anticonvulsants|anticonvulsants|mesh-ancestor
110487762|NCT05972902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110487763|NCT05972902|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110487764|NCT05972902|Fertility Agents|fertility agents|mesh-ancestor
110487765|NCT05972902|Hormone Antagonists|hormone antagonists|mesh-ancestor
110487766|NCT05972902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110487768|NCT05972902|Hormones|hormones|mesh-ancestor
110487769|NCT05972785|Calcium Channel Blockers|calcium channel blockers|mesh-list
110487771|NCT05972785|Diuretics|diuretics|mesh-list
110487772|NCT05972785|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
110135051|NCT01995214|Propofol|propofol|mesh-list
110487773|NCT05972785|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110166901|NCT00000488|Antimetabolites|antimetabolites|mesh-ancestor
110487774|NCT05972785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110487775|NCT05972785|Natriuretic Agents|natriuretic agents|mesh-ancestor
110487776|NCT05972785|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110487777|NCT05972785|Adrenergic Agents|adrenergic agents|mesh-ancestor
110487778|NCT05972785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110083522|NCT01655628|Cisplatin|cisplatin|mesh-list
110487779|NCT05972785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110487780|NCT05972785|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110487782|NCT05972772|Doxycycline|doxycycline|mesh-list
110487783|NCT05972772|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110487784|NCT05972772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110487785|NCT05972772|Antimalarials|antimalarials|mesh-ancestor
110487786|NCT05972772|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110487787|NCT05972772|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110487788|NCT05972720|Cyclophosphamide|cyclophosphamide|mesh-list
110487789|NCT05972720|Fludarabine|fludarabine|mesh-list
110487790|NCT05972720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110487791|NCT05972720|Immunologic Factors|immunologic factors|mesh-ancestor
110487792|NCT05972720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110487793|NCT05972720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110487794|NCT05972720|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110487795|NCT05972720|Alkylating Agents|alkylating agents|mesh-ancestor
110487796|NCT05972720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110487797|NCT05972720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110487798|NCT05972720|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110487799|NCT05972681|Epinephrine|epinephrine|mesh-list
110487800|NCT05972681|Bupivacaine|bupivacaine|mesh-list
110487801|NCT05972681|Anesthetics, Local|anesthetics, local|mesh-ancestor
110487802|NCT05972681|Anesthetics|anesthetics|mesh-ancestor
110487803|NCT05972681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110436679|NCT00910897|Bortezomib|bortezomib|mesh-list
110487804|NCT05972681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110487805|NCT05972681|Sensory System Agents|sensory system agents|mesh-ancestor
110487806|NCT05972681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110487807|NCT05972681|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110487808|NCT05972681|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110487809|NCT05972681|Adrenergic Agents|adrenergic agents|mesh-ancestor
110487810|NCT05972681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110268938|NCT00552838|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110487811|NCT05972681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110487812|NCT05972681|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110487813|NCT05972681|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110487814|NCT05972681|Autonomic Agents|autonomic agents|mesh-ancestor
110487815|NCT05972681|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110487816|NCT05972681|Respiratory System Agents|respiratory system agents|mesh-ancestor
110487817|NCT05972681|Mydriatics|mydriatics|mesh-ancestor
110487818|NCT05972681|Sympathomimetics|sympathomimetics|mesh-ancestor
110487819|NCT05972681|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110487820|NCT05972603|Vancomycin|vancomycin|mesh-list
110487821|NCT05972603|Povidone-Iodine|povidone-iodine|mesh-list
110487822|NCT05972603|Povidone|povidone|mesh-list
110487823|NCT05972603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110487824|NCT05972603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110487825|NCT05972603|Plasma Substitutes|plasma substitutes|mesh-ancestor
110487826|NCT05972603|Blood Substitutes|blood substitutes|mesh-ancestor
110487827|NCT05972603|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110487828|NCT05972564|Empagliflozin|empagliflozin|mesh-list
110487829|NCT05972564|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110311638|NCT00290030|Alfuzosin|alfuzosin|mesh-list
110487830|NCT05972564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110487831|NCT05972564|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110487832|NCT05972564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110487834|NCT05972512|Vitamin B Complex|vitamin b complex|mesh-ancestor
110487835|NCT05972512|Vitamins|vitamins|mesh-ancestor
110487836|NCT05972512|Micronutrients|micronutrients|mesh-ancestor
110487837|NCT05972512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110487838|NCT05972473|Aflibercept|aflibercept|mesh-list
110487839|NCT05972473|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110487840|NCT05972473|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110487841|NCT05972473|Growth Substances|growth substances|mesh-ancestor
110487842|NCT05972473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110487843|NCT05972473|Growth Inhibitors|growth inhibitors|mesh-ancestor
110487844|NCT05972473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110487845|NCT05972434|Sunscreening Agents|sunscreening agents|mesh-list
110487846|NCT05972434|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110487848|NCT05972434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110487849|NCT05972434|Dermatologic Agents|dermatologic agents|mesh-ancestor
110487850|NCT05971849|Hormones|hormones|mesh-list
110487851|NCT05971849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110487852|NCT05971849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110487853|NCT05971680|Vitamins|vitamins|mesh-list
110487854|NCT05971680|Thiamine|thiamine|mesh-list
110487855|NCT05971680|Vitamin B Complex|vitamin b complex|mesh-list
110487856|NCT05971680|Contraceptive Agents|contraceptive agents|mesh-list
110487857|NCT05971680|Micronutrients|micronutrients|mesh-ancestor
110487858|NCT05971680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110487859|NCT05971680|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110487860|NCT05971654|Azithromycin|azithromycin|mesh-list
110487861|NCT05971654|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110487862|NCT05971654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110487863|NCT05971563|Caseins|caseins|mesh-list
110487864|NCT05971563|Chelating Agents|chelating agents|mesh-ancestor
110487865|NCT05971563|Sequestering Agents|sequestering agents|mesh-ancestor
110487866|NCT05971563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110487867|NCT05971550|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110487868|NCT05971550|Ceftriaxone|ceftriaxone|mesh-list
110487869|NCT05971550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110487870|NCT05971537|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110487871|NCT05971537|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
110487872|NCT05971537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110487873|NCT05971537|Antitubercular Agents|antitubercular agents|mesh-ancestor
110487874|NCT05971485|Melatonin|melatonin|mesh-list
110487875|NCT05971485|Antioxidants|antioxidants|mesh-ancestor
110487876|NCT05971485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110487877|NCT05971485|Protective Agents|protective agents|mesh-ancestor
110487878|NCT05971485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110487879|NCT05971485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110487880|NCT05971394|Sirolimus|sirolimus|mesh-list
110487881|NCT05971394|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110487882|NCT05971394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110487883|NCT05971394|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110487884|NCT05971394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110487885|NCT05971394|Antifungal Agents|antifungal agents|mesh-ancestor
110487886|NCT05971394|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110487887|NCT05971394|Immunologic Factors|immunologic factors|mesh-ancestor
110487888|NCT05971394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110487889|NCT05971355|Emollients|emollients|mesh-list
110487890|NCT05971355|Dermatologic Agents|dermatologic agents|mesh-ancestor
110487891|NCT05971186|Ibuprofen|ibuprofen|mesh-list
110487892|NCT05971186|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110487893|NCT05971186|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110487894|NCT05971186|Analgesics|analgesics|mesh-ancestor
110487895|NCT05971186|Sensory System Agents|sensory system agents|mesh-ancestor
110487896|NCT05971186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110487897|NCT05971186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110487898|NCT05971186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110487899|NCT05971186|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110487900|NCT05971186|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110487901|NCT05971186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110487902|NCT05971186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110487903|NCT05971004|Methylprednisolone|methylprednisolone|mesh-list
110487904|NCT05971004|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110487905|NCT05971004|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110487906|NCT05971004|Prednisolone|prednisolone|mesh-list
110487907|NCT05971004|Prednisolone acetate|prednisolone acetate|mesh-list
110437025|NCT00912340|Immunologic Factors|immunologic factors|mesh-ancestor
110487908|NCT05971004|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110487909|NCT05971004|Prednisolone phosphate|prednisolone phosphate|mesh-list
110487910|NCT05971004|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110487911|NCT05971004|Antiemetics|antiemetics|mesh-ancestor
110487912|NCT05971004|Autonomic Agents|autonomic agents|mesh-ancestor
110487913|NCT05971004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110487914|NCT05971004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110487915|NCT05971004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110487916|NCT05971004|Glucocorticoids|glucocorticoids|mesh-ancestor
110487917|NCT05971004|Hormones|hormones|mesh-ancestor
110487918|NCT05971004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110487919|NCT05971004|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110487920|NCT05971004|Protective Agents|protective agents|mesh-ancestor
110487921|NCT05971004|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110487922|NCT05971004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110135197|NCT01996358|Rocuronium|rocuronium|mesh-list
110487923|NCT05967052|Pregabalin|pregabalin|mesh-list
110487924|NCT05967052|Analgesics|analgesics|mesh-ancestor
110487925|NCT05967052|Sensory System Agents|sensory system agents|mesh-ancestor
110487926|NCT05967052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110487927|NCT05967052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110487929|NCT05967052|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110487930|NCT05967052|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110487931|NCT05967052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110487932|NCT05967052|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110487933|NCT05967052|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110487934|NCT05967052|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110487935|NCT05967052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110437382|NCT00909532|Ivacaftor|ivacaftor|mesh-list
110487936|NCT05967052|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110487937|NCT05966584|Fulvestrant|fulvestrant|mesh-list
110487938|NCT05966584|Benralizumab|benralizumab|mesh-list
110487939|NCT05966584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110487940|NCT05966584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110487941|NCT05966584|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110487942|NCT05966584|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110487943|NCT05966584|Hormone Antagonists|hormone antagonists|mesh-ancestor
110487944|NCT05966584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110487945|NCT05966584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110487946|NCT05966584|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110487947|NCT05966584|Respiratory System Agents|respiratory system agents|mesh-ancestor
110487949|NCT05963139|Bupivacaine|bupivacaine|mesh-list
110487950|NCT05963139|Anesthetics, Local|anesthetics, local|mesh-ancestor
110487951|NCT05963139|Anesthetics|anesthetics|mesh-ancestor
110487952|NCT05963139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110487953|NCT05963139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110487954|NCT05963139|Sensory System Agents|sensory system agents|mesh-ancestor
110487955|NCT05963139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110487956|NCT05963139|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110487957|NCT05963139|Narcotics|narcotics|mesh-ancestor
110487958|NCT05963139|Analgesics|analgesics|mesh-ancestor
110487959|NCT05945147|Midazolam|midazolam|mesh-list
110487960|NCT05945147|Ketamine|ketamine|mesh-list
110487961|NCT05945147|Analgesics|analgesics|mesh-ancestor
110487962|NCT05945147|Sensory System Agents|sensory system agents|mesh-ancestor
110487963|NCT05945147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110487964|NCT05945147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110437508|NCT04164823|Analgesics|analgesics|mesh-list
110487965|NCT05945147|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110487966|NCT05945147|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110487967|NCT05945147|Anesthetics, General|anesthetics, general|mesh-ancestor
110487968|NCT05945147|Anesthetics|anesthetics|mesh-ancestor
110487969|NCT05945147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110487970|NCT05945147|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110487971|NCT05945147|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110487972|NCT05945147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110437557|NCT01134250|Mitosis Modulators|mitosis modulators|mesh-ancestor
110487973|NCT05945147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110487974|NCT05945147|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110487975|NCT05945147|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110487976|NCT05945147|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110487977|NCT05945147|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110487978|NCT05945147|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110487979|NCT05945147|GABA Modulators|gaba modulators|mesh-ancestor
110487980|NCT05945147|GABA Agents|gaba agents|mesh-ancestor
110487981|NCT05930808|Bisoprolol|bisoprolol|mesh-list
110487982|NCT05930808|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110487983|NCT05930808|Sympatholytics|sympatholytics|mesh-ancestor
110487984|NCT05930808|Autonomic Agents|autonomic agents|mesh-ancestor
110487985|NCT05930808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110487986|NCT05930808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110487987|NCT05930808|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110487988|NCT05930808|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110487989|NCT05930808|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110487990|NCT05930808|Adrenergic Agents|adrenergic agents|mesh-ancestor
110487991|NCT05930808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110487992|NCT05930808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110487994|NCT05924256|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110487995|NCT05924256|Fertility Agents|fertility agents|mesh-ancestor
110487996|NCT05924256|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110487997|NCT05924256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110487998|NCT05924256|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110487999|NCT05924256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110488000|NCT05916352|Caffeine|caffeine|mesh-list
110488001|NCT05916352|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110437833|NCT00883129|Mycophenolic Acid|mycophenolic acid|mesh-list
110488002|NCT05916352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110488003|NCT05916352|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110488004|NCT05916352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110488005|NCT05916352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110488006|NCT05916352|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110488007|NCT05916352|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110488008|NCT05916352|Purinergic Agents|purinergic agents|mesh-ancestor
110488009|NCT05916352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110488011|NCT05904470|Antiviral Agents|antiviral agents|mesh-ancestor
110488012|NCT05904470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110488013|NCT05859464|Pembrolizumab|pembrolizumab|mesh-list
110488014|NCT05859464|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110488015|NCT05859464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110488016|NCT05859464|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110488017|NCT05859464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110488018|NCT05855967|Ixekizumab|ixekizumab|mesh-list
110488019|NCT05855967|Dermatologic Agents|dermatologic agents|mesh-ancestor
110488020|NCT05844735|Ciprofloxacin|ciprofloxacin|mesh-list
110488021|NCT05844735|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110488022|NCT05844735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110488023|NCT05844735|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110488024|NCT05844735|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110488025|NCT05844735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110488026|NCT05844735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110488027|NCT05844735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110488028|NCT05844735|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110488029|NCT05844735|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110488030|NCT05821374|Deucravacitinib|deucravacitinib|mesh-list
110488031|NCT05821374|Dermatologic Agents|dermatologic agents|mesh-ancestor
110488032|NCT05821374|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110488033|NCT05821374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110488034|NCT05821374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110488035|NCT05813964|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110488036|NCT05813964|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
110488037|NCT05813964|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110488038|NCT05813964|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110488039|NCT05813964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110488040|NCT05813964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110438245|NCT00902668|Lovastatin|lovastatin|mesh-list
110488041|NCT05813964|Antiviral Agents|antiviral agents|mesh-ancestor
110488042|NCT05813964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110488043|NCT05813964|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110488044|NCT05813964|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110488045|NCT05766371|Pembrolizumab|pembrolizumab|mesh-list
110488046|NCT05766371|177Lu-PSMA-617|177lu-psma-617|mesh-list
110488047|NCT05766371|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110488048|NCT05766371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110488049|NCT05766371|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110488050|NCT05766371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110488051|NCT05766371|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110488052|NCT05748834|Doxorubicin|doxorubicin|mesh-list
110488053|NCT05748834|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110488054|NCT05748834|Tucatinib|tucatinib|mesh-list
110488055|NCT05748834|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110488056|NCT05748834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110488057|NCT05748834|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110438365|NCT02844634|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110488058|NCT05748834|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110488059|NCT05748834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110488060|NCT05748834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110488061|NCT05748834|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110488062|NCT05746572|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
110488063|NCT05746572|Hallucinogens|hallucinogens|mesh-ancestor
110488064|NCT05746572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110488065|NCT05746572|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110488066|NCT05746572|Serotonin Agents|serotonin agents|mesh-ancestor
110488067|NCT05746572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110488068|NCT05746572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110488069|NCT05746572|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110488070|NCT05746572|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110488071|NCT05746572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110488072|NCT05746572|Adrenergic Agents|adrenergic agents|mesh-ancestor
110488073|NCT05741294|Tirbanibulin|tirbanibulin|mesh-list
110488074|NCT05741294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110488075|NCT05741294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110488077|NCT05741060|Phytoestrogens|phytoestrogens|mesh-ancestor
110488078|NCT05741060|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
110488079|NCT05741060|Estrogens|estrogens|mesh-ancestor
110488080|NCT05741060|Hormones|hormones|mesh-ancestor
110438437|NCT05242120|Anesthetics|anesthetics|mesh-list
110488081|NCT05741060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110488082|NCT05741060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110488083|NCT05739006|Pembrolizumab|pembrolizumab|mesh-list
110488084|NCT05739006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110488085|NCT05739006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110488086|NCT05739006|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110488087|NCT05739006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110488088|NCT05700630|Vorinostat|vorinostat|mesh-list
110488089|NCT05700630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110488090|NCT05700630|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110488091|NCT05700630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110488092|NCT05700630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110488093|NCT05695027|Niacinamide|niacinamide|mesh-list
110488094|NCT05695027|Niacin|niacin|mesh-list
110488095|NCT05695027|Nicotinic Acids|nicotinic acids|mesh-list
110488096|NCT05695027|Vitamin B Complex|vitamin b complex|mesh-ancestor
110488097|NCT05695027|Vitamins|vitamins|mesh-ancestor
110488098|NCT05695027|Micronutrients|micronutrients|mesh-ancestor
110488099|NCT05695027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110488100|NCT05695027|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110488101|NCT05695027|Antimetabolites|antimetabolites|mesh-ancestor
110438546|NCT04782700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110488102|NCT05695027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110488103|NCT05695027|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110488104|NCT05695027|Vasodilator Agents|vasodilator agents|mesh-ancestor
110488106|NCT05680857|Coenzyme Q10|coenzyme q10|mesh-list
110488107|NCT05680857|Micronutrients|micronutrients|mesh-ancestor
110488108|NCT05680857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110488109|NCT05680857|Vitamins|vitamins|mesh-ancestor
110488110|NCT05631795|Fulvestrant|fulvestrant|mesh-list
110488111|NCT05631795|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110488112|NCT05631795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110488113|NCT05631795|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110488114|NCT05631795|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110488115|NCT05631795|Hormone Antagonists|hormone antagonists|mesh-ancestor
110488116|NCT05631795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110488117|NCT05631795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110488118|NCT05612594|Ertugliflozin|ertugliflozin|mesh-list
110488119|NCT05612594|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110488120|NCT05612594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110488121|NCT05612594|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110438674|NCT00656773|Narcotics|narcotics|mesh-ancestor
110488122|NCT05612594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110488123|NCT05597462|Minocycline|minocycline|mesh-list
110488124|NCT05597462|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110488125|NCT05597462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110488126|NCT05574101|Cemiplimab|cemiplimab|mesh-list
110488127|NCT05574101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110488129|NCT05484687|Anesthetics|anesthetics|mesh-list
110488130|NCT05484687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110488131|NCT05484687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110488132|NCT05480384|Nivolumab|nivolumab|mesh-list
110488133|NCT05480384|Trastuzumab|trastuzumab|mesh-list
110488134|NCT05480384|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
110488135|NCT05480384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110438815|NCT00884377|Schistosomicides|schistosomicides|mesh-ancestor
110488136|NCT05480384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110488137|NCT05480384|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110438883|NCT00212836|Asenapine|asenapine|mesh-list
110488138|NCT05480384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110488139|NCT05480384|Immunoconjugates|immunoconjugates|mesh-ancestor
110488140|NCT05480384|Immunologic Factors|immunologic factors|mesh-ancestor
110488141|NCT05480384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110488142|NCT05469412|Midazolam|midazolam|mesh-list
110488143|NCT05469412|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110488144|NCT05469412|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110438968|NCT02841982|Morphine|morphine|mesh-list
110488145|NCT05469412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110488146|NCT05469412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110488147|NCT05469412|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110488148|NCT05469412|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110488149|NCT05469412|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110488150|NCT05469412|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110488151|NCT05469412|Anesthetics, General|anesthetics, general|mesh-ancestor
110488152|NCT05469412|Anesthetics|anesthetics|mesh-ancestor
110488153|NCT05469412|GABA Modulators|gaba modulators|mesh-ancestor
110488154|NCT05469412|GABA Agents|gaba agents|mesh-ancestor
110488155|NCT05469412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110488156|NCT05469412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110488157|NCT05343455|Doxycycline|doxycycline|mesh-list
110488158|NCT05343455|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110488159|NCT05343455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110488160|NCT05343455|Antimalarials|antimalarials|mesh-ancestor
110488161|NCT05343455|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110488162|NCT05343455|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110488163|NCT05327686|Pembrolizumab|pembrolizumab|mesh-list
110488164|NCT05327686|Nivolumab|nivolumab|mesh-list
110488165|NCT05327686|Ipilimumab|ipilimumab|mesh-list
110488166|NCT05327686|Avelumab|avelumab|mesh-list
110488167|NCT05327686|Lenvatinib|lenvatinib|mesh-list
110488168|NCT05327686|Axitinib|axitinib|mesh-list
110488169|NCT05327686|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110439024|NCT01822288|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110488170|NCT05327686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110488171|NCT05327686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110488172|NCT05327686|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110488173|NCT05327686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110439077|NCT05334316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110488174|NCT05327686|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110488176|NCT05327686|Immunologic Factors|immunologic factors|mesh-ancestor
110488177|NCT05327686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110488178|NCT05303324|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
110488179|NCT05303324|Choline|choline|mesh-list
110488180|NCT05303324|Lipotropic Agents|lipotropic agents|mesh-ancestor
110488181|NCT05303324|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110488182|NCT05303324|Antimetabolites|antimetabolites|mesh-ancestor
110439147|NCT05404724|Itraconazole|itraconazole|mesh-list
110488183|NCT05303324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110394193|NCT00592332|Alprazolam|alprazolam|mesh-list
110488184|NCT05303324|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110488185|NCT05303324|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110488186|NCT05303324|Nootropic Agents|nootropic agents|mesh-ancestor
110488187|NCT05303324|Chelating Agents|chelating agents|mesh-ancestor
110488188|NCT05303324|Sequestering Agents|sequestering agents|mesh-ancestor
110488189|NCT05303324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110488190|NCT05303324|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110488191|NCT05303324|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110488192|NCT05303324|Growth Substances|growth substances|mesh-ancestor
110269007|NCT00162734|Ribavirin|ribavirin|mesh-list
110488193|NCT05303324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110488194|NCT05303324|Growth Inhibitors|growth inhibitors|mesh-ancestor
110488195|NCT05303324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110488196|NCT05238207|Psyllium|psyllium|mesh-list
110488197|NCT05238207|Cathartics|cathartics|mesh-ancestor
110488198|NCT05238207|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110488202|NCT05213104|Flecainide|flecainide|mesh-list
110488203|NCT05213104|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110488204|NCT05213104|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110488205|NCT05213104|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110488206|NCT05213104|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110488207|NCT05213104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110488208|NCT05195177|Anesthetics|anesthetics|mesh-list
110488209|NCT05195177|Anesthetics, Local|anesthetics, local|mesh-list
110488210|NCT05195177|Histamine|histamine|mesh-list
110488211|NCT05195177|Histamine Antagonists|histamine antagonists|mesh-list
110488212|NCT05195177|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
110488213|NCT05195177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110488214|NCT05195177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110488215|NCT05195177|Sensory System Agents|sensory system agents|mesh-ancestor
110488216|NCT05195177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110439429|NCT02631031|Valsartan|valsartan|mesh-list
110488217|NCT05195177|Histamine Agonists|histamine agonists|mesh-ancestor
110488218|NCT05195177|Histamine Agents|histamine agents|mesh-ancestor
110488219|NCT05195177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110488220|NCT05195177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110488221|NCT05165433|Pembrolizumab|pembrolizumab|mesh-list
110488222|NCT05165433|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110488223|NCT05165433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110488224|NCT05165433|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110488225|NCT05165433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110488227|NCT05150431|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110488228|NCT05150431|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110488229|NCT05150431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110488230|NCT05150431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110488231|NCT05150431|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110488232|NCT05150431|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110488234|NCT05150431|Sensory System Agents|sensory system agents|mesh-ancestor
110488235|NCT05150431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110488236|NCT05150431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110488237|NCT05150431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110488238|NCT05150431|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110488239|NCT05141006|Botulinum Toxins|botulinum toxins|mesh-list
110488240|NCT05141006|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110488241|NCT05141006|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110488242|NCT05141006|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110488243|NCT05141006|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110488244|NCT05141006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110488245|NCT05141006|Cholinergic Agents|cholinergic agents|mesh-ancestor
110488246|NCT05141006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110488247|NCT05141006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110488248|NCT05141006|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110488249|NCT05141006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110488250|NCT05077527|Cyclophosphamide|cyclophosphamide|mesh-list
110488251|NCT05077527|Fludarabine|fludarabine|mesh-list
110488252|NCT05077527|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
110488253|NCT05077527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110488254|NCT05077527|Immunologic Factors|immunologic factors|mesh-ancestor
110488255|NCT05077527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110488256|NCT05077527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110488257|NCT05077527|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110439623|NCT00658099|Insulin|insulin|mesh-list
110488258|NCT05077527|Alkylating Agents|alkylating agents|mesh-ancestor
110269018|NCT00162812|Epirubicin|epirubicin|mesh-list
110488259|NCT05077527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110488260|NCT05077527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110488261|NCT05077527|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110488262|NCT05077527|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110488263|NCT05074810|Sotorasib|sotorasib|mesh-list
110488264|NCT05074810|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110488265|NCT05074810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110488266|NCT05074810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110488267|NCT05074810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110488268|NCT05055323|Pyrvinium|pyrvinium|mesh-list
110488269|NCT05055323|Anthelmintics|anthelmintics|mesh-ancestor
110488270|NCT05055323|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110488271|NCT05055323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110488273|NCT05050136|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110488274|NCT05013502|Empagliflozin|empagliflozin|mesh-list
110488275|NCT05013502|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110439801|NCT02631499|Ethiodized Oil|ethiodized oil|mesh-list
110488276|NCT05013502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110488278|NCT05013502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110488279|NCT05007392|Febuxostat|febuxostat|mesh-list
110488280|NCT05007392|Dotinurad|dotinurad|mesh-list
110488281|NCT05007392|Gout Suppressants|gout suppressants|mesh-ancestor
110488282|NCT05007392|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110488283|NCT05007392|Uricosuric Agents|uricosuric agents|mesh-ancestor
110488284|NCT04948333|Niacinamide|niacinamide|mesh-list
110488285|NCT04948333|Vitamin B Complex|vitamin b complex|mesh-ancestor
110488286|NCT04948333|Vitamins|vitamins|mesh-ancestor
110488287|NCT04948333|Micronutrients|micronutrients|mesh-ancestor
110488288|NCT04948333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110488289|NCT04947501|Cyclophosphamide|cyclophosphamide|mesh-list
110488290|NCT04947501|Ifosfamide|ifosfamide|mesh-list
110488291|NCT04947501|Carboplatin|carboplatin|mesh-list
110488292|NCT04947501|Doxorubicin|doxorubicin|mesh-list
110488293|NCT04947501|Etoposide|etoposide|mesh-list
110488294|NCT04947501|Vincristine|vincristine|mesh-list
110488295|NCT04947501|Topotecan|topotecan|mesh-list
110488296|NCT04947501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110488297|NCT04947501|Immunologic Factors|immunologic factors|mesh-ancestor
110135572|NCT01998503|Autonomic Agents|autonomic agents|mesh-ancestor
110488298|NCT04947501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110488299|NCT04947501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110488300|NCT04947501|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110488301|NCT04947501|Alkylating Agents|alkylating agents|mesh-ancestor
110488302|NCT04947501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110488303|NCT04947501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110488304|NCT04947501|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110488305|NCT04947501|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110488306|NCT04947501|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110488307|NCT04947501|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110488308|NCT04947501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110488309|NCT04947501|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110488310|NCT04947501|Tubulin Modulators|tubulin modulators|mesh-ancestor
110488311|NCT04947501|Antimitotic Agents|antimitotic agents|mesh-ancestor
110488312|NCT04947501|Mitosis Modulators|mitosis modulators|mesh-ancestor
110488313|NCT04947501|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110488315|NCT04909853|Nirmatrelvir|nirmatrelvir|mesh-list
110488316|NCT04909853|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110488317|NCT04909853|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110488318|NCT04909853|Protease Inhibitors|protease inhibitors|mesh-ancestor
110488319|NCT04909853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110488320|NCT04909853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110440208|NCT00891904|Cetuximab|cetuximab|mesh-list
110488321|NCT04909853|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110269025|NCT00162851|Alemtuzumab|alemtuzumab|mesh-list
110488322|NCT04909853|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110488323|NCT04909853|Antiviral Agents|antiviral agents|mesh-ancestor
110488324|NCT04909853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110488352|NCT04727307|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110488353|NCT04727307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110488354|NCT04727307|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110488355|NCT04727307|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110488356|NCT04727307|Growth Substances|growth substances|mesh-ancestor
110488357|NCT04727307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110488358|NCT04727307|Growth Inhibitors|growth inhibitors|mesh-ancestor
110488359|NCT04727307|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110488360|NCT04727307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110488361|NCT04727307|Immunologic Factors|immunologic factors|mesh-ancestor
110488363|NCT04683939|Gemcitabine|gemcitabine|mesh-list
110488364|NCT04683939|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110488365|NCT04683939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110488366|NCT04683939|Tubulin Modulators|tubulin modulators|mesh-ancestor
110488367|NCT04683939|Antimitotic Agents|antimitotic agents|mesh-ancestor
110488368|NCT04683939|Mitosis Modulators|mitosis modulators|mesh-ancestor
110488369|NCT04683939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110488370|NCT04683939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110488371|NCT04683939|Antimetabolites|antimetabolites|mesh-ancestor
110488372|NCT04680598|Antiviral Agents|antiviral agents|mesh-list
110488373|NCT04680598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110488374|NCT04669002|Olaparib|olaparib|mesh-list
110488375|NCT04669002|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110488376|NCT04669002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110488377|NCT04669002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110488378|NCT04669002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110488379|NCT04640493|Dapagliflozin|dapagliflozin|mesh-list
110488380|NCT04640493|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110488381|NCT04640493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110488382|NCT04640493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110488383|NCT04640493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110488384|NCT04590963|Cetuximab|cetuximab|mesh-list
110488385|NCT04590963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110488386|NCT04590963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110488387|NCT04528173|Ketorolac|ketorolac|mesh-list
110488388|NCT04528173|Fentanyl|fentanyl|mesh-list
110488389|NCT04528173|Dexmedetomidine|dexmedetomidine|mesh-list
110488390|NCT04528173|Morphine|morphine|mesh-list
110488391|NCT04528173|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110488392|NCT04528173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110488393|NCT04528173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110488394|NCT04528173|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110488395|NCT04528173|Analgesics|analgesics|mesh-ancestor
110488396|NCT04528173|Sensory System Agents|sensory system agents|mesh-ancestor
110488397|NCT04528173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110488398|NCT04528173|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110488399|NCT04528173|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110488400|NCT04528173|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110488401|NCT04528173|Adrenergic Agents|adrenergic agents|mesh-ancestor
110488402|NCT04528173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110488403|NCT04528173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110488404|NCT04528173|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110488405|NCT04528173|Narcotics|narcotics|mesh-ancestor
110488406|NCT04528173|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110488407|NCT04528173|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110488408|NCT04528173|Anesthetics, General|anesthetics, general|mesh-ancestor
110488409|NCT04528173|Anesthetics|anesthetics|mesh-ancestor
110488410|NCT04528173|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110488411|NCT04528173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110488412|NCT04528173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110488413|NCT04528173|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110488414|NCT04528173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110488415|NCT04519944|Edoxaban|edoxaban|mesh-list
110488416|NCT04519944|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110488417|NCT04519944|Antithrombins|antithrombins|mesh-ancestor
110488418|NCT04519944|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110488419|NCT04519944|Protease Inhibitors|protease inhibitors|mesh-ancestor
110488420|NCT04519944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110440467|NCT05210764|Ketamine|ketamine|mesh-list
110488421|NCT04519944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110488424|NCT04494425|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110488425|NCT04494425|Capecitabine|capecitabine|mesh-list
110488426|NCT04494425|Trastuzumab|trastuzumab|mesh-list
110488427|NCT04494425|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
110488428|NCT04494425|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110488429|NCT04494425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110488430|NCT04494425|Tubulin Modulators|tubulin modulators|mesh-ancestor
110488431|NCT04494425|Antimitotic Agents|antimitotic agents|mesh-ancestor
110488432|NCT04494425|Mitosis Modulators|mitosis modulators|mesh-ancestor
110488433|NCT04494425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110488434|NCT04494425|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110488435|NCT04494425|Antimetabolites|antimetabolites|mesh-ancestor
110488436|NCT04494425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110488437|NCT04494425|Immunoconjugates|immunoconjugates|mesh-ancestor
110488438|NCT04494425|Immunologic Factors|immunologic factors|mesh-ancestor
110488439|NCT04494425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110488440|NCT04454437|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
110488441|NCT04454437|Immunoconjugates|immunoconjugates|mesh-ancestor
110488442|NCT04454437|Immunologic Factors|immunologic factors|mesh-ancestor
110488443|NCT04454437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110488444|NCT04430452|Durvalumab|durvalumab|mesh-list
110488445|NCT04430452|Ipilimumab|ipilimumab|mesh-list
110488446|NCT04430452|Tremelimumab|tremelimumab|mesh-list
110488447|NCT04430452|Immunoglobulins|immunoglobulins|mesh-list
110488448|NCT04430452|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110488449|NCT04430452|Immunoglobulin G|immunoglobulin g|mesh-list
110488450|NCT04430452|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110488451|NCT04430452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110488452|NCT04430452|Immunologic Factors|immunologic factors|mesh-ancestor
110488453|NCT04430452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110488454|NCT04430452|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110488455|NCT04430452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110488457|NCT04353661|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110488458|NCT04353661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110488459|NCT04321330|Atezolizumab|atezolizumab|mesh-list
110488460|NCT04321330|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110488461|NCT04321330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110488462|NCT04321330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110488463|NCT04321330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110488464|NCT04251533|Paclitaxel|paclitaxel|mesh-list
110488465|NCT04251533|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110488466|NCT04251533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110488467|NCT04251533|Tubulin Modulators|tubulin modulators|mesh-ancestor
110488468|NCT04251533|Antimitotic Agents|antimitotic agents|mesh-ancestor
110488469|NCT04251533|Mitosis Modulators|mitosis modulators|mesh-ancestor
110488470|NCT04251533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110488471|NCT04158141|Cisplatin|cisplatin|mesh-list
110488472|NCT04158141|Carboplatin|carboplatin|mesh-list
110488473|NCT04158141|Pemetrexed|pemetrexed|mesh-list
110488474|NCT04158141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110488475|NCT04158141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110488476|NCT04158141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110488477|NCT04158141|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110488478|NCT04158141|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110488479|NCT04154982|Acetylcysteine|acetylcysteine|mesh-list
110488480|NCT04154982|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110488481|NCT04154982|Antiviral Agents|antiviral agents|mesh-ancestor
110488482|NCT04154982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110488483|NCT04154982|Expectorants|expectorants|mesh-ancestor
110488484|NCT04154982|Respiratory System Agents|respiratory system agents|mesh-ancestor
110488485|NCT04154982|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110488486|NCT04154982|Antioxidants|antioxidants|mesh-ancestor
110441061|NCT00602589|Ofloxacin|ofloxacin|mesh-list
110488487|NCT04154982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110488488|NCT04154982|Protective Agents|protective agents|mesh-ancestor
110488489|NCT04154982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110488491|NCT04145258|Aspirin|aspirin|mesh-list
110488492|NCT04145258|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110488493|NCT04145258|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110488494|NCT04145258|Analgesics|analgesics|mesh-ancestor
110488495|NCT04145258|Sensory System Agents|sensory system agents|mesh-ancestor
110488496|NCT04145258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110488497|NCT04145258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110488499|NCT04145258|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110488500|NCT04145258|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110488501|NCT04145258|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110488502|NCT04145258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110488503|NCT04145258|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110488504|NCT04145258|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110488505|NCT04145258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110488506|NCT04145258|Antipyretics|antipyretics|mesh-ancestor
110488507|NCT04113616|Cytarabine|cytarabine|mesh-list
110488508|NCT04113616|Decitabine|decitabine|mesh-list
110488509|NCT04113616|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110488510|NCT04113616|Antimetabolites|antimetabolites|mesh-ancestor
110488511|NCT04113616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110488512|NCT04113616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110488513|NCT04113616|Antiviral Agents|antiviral agents|mesh-ancestor
110488514|NCT04113616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110488515|NCT04113616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110488516|NCT04113616|Immunologic Factors|immunologic factors|mesh-ancestor
110488517|NCT04113616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110488518|NCT04113616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110488519|NCT04040231|Nivolumab|nivolumab|mesh-list
110488520|NCT04040231|Sargramostim|sargramostim|mesh-list
110488521|NCT04040231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110488522|NCT04040231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110488523|NCT04040231|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110488524|NCT04040231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110488525|NCT04040231|Immunologic Factors|immunologic factors|mesh-ancestor
110488526|NCT04040231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110488527|NCT04035486|Carboplatin|carboplatin|mesh-list
110488528|NCT04035486|Pemetrexed|pemetrexed|mesh-list
110488529|NCT04035486|Osimertinib|osimertinib|mesh-list
110488530|NCT04035486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110488531|NCT04035486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110488532|NCT04035486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110441300|NCT00674089|Vitamin A|vitamin a|mesh-list
110488533|NCT04035486|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110488534|NCT04035486|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110488535|NCT04035486|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110488536|NCT04026256|Denosumab|denosumab|mesh-list
110488537|NCT04026256|Teriparatide|teriparatide|mesh-list
110488538|NCT04026256|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110488539|NCT04026256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110488540|NCT04026256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110488541|NCT04012138|Insulin|insulin|mesh-list
110441382|NCT00677521|Acarbose|acarbose|mesh-list
110488542|NCT04012138|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110488543|NCT04012138|Insulin Aspart|insulin aspart|mesh-list
110488544|NCT04012138|Albuterol|albuterol|mesh-list
110488545|NCT04012138|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110488546|NCT04012138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110488547|NCT04012138|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110488548|NCT04012138|Autonomic Agents|autonomic agents|mesh-ancestor
110488549|NCT04012138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110488550|NCT04012138|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110488551|NCT04012138|Respiratory System Agents|respiratory system agents|mesh-ancestor
110488553|NCT04012138|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110488554|NCT04012138|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110488555|NCT04012138|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110488556|NCT04012138|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110488558|NCT04012138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110488559|NCT04012138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110488560|NCT03928288|Cabergoline|cabergoline|mesh-list
110488561|NCT03928288|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110488562|NCT03928288|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110488563|NCT03928288|Dopamine Agonists|dopamine agonists|mesh-ancestor
110488564|NCT03928288|Dopamine Agents|dopamine agents|mesh-ancestor
110488565|NCT03928288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110488566|NCT03928288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110488567|NCT03928288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110488568|NCT03789604|Antibodies|antibodies|mesh-list
110488569|NCT03789604|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110488570|NCT03789604|Immunologic Factors|immunologic factors|mesh-ancestor
110088544|NCT05290324|Anesthetics|anesthetics|mesh-ancestor
110488571|NCT03789604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110488572|NCT03767348|Nivolumab|nivolumab|mesh-list
110488573|NCT03767348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110488575|NCT03767348|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110488576|NCT03767348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110488577|NCT03735875|Venetoclax|venetoclax|mesh-list
110488578|NCT03735875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110488579|NCT03735420|Xanthohumol|xanthohumol|mesh-list
110488580|NCT03735420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110488581|NCT03735420|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110488582|NCT03735420|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110488583|NCT03735420|Growth Substances|growth substances|mesh-ancestor
110441703|NCT02821468|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
110488584|NCT03735420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110488585|NCT03735420|Growth Inhibitors|growth inhibitors|mesh-ancestor
110488586|NCT03715933|Carboplatin|carboplatin|mesh-list
110488587|NCT03715933|Fluorouracil|fluorouracil|mesh-list
110488588|NCT03715933|Irinotecan|irinotecan|mesh-list
110488589|NCT03715933|Pemetrexed|pemetrexed|mesh-list
110488590|NCT03715933|Temozolomide|temozolomide|mesh-list
110488591|NCT03715933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110488592|NCT03715933|Antimetabolites|antimetabolites|mesh-ancestor
110488593|NCT03715933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110488594|NCT03715933|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110488595|NCT03715933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110166988|NCT00012519|Ritonavir|ritonavir|mesh-list
110488596|NCT03715933|Immunologic Factors|immunologic factors|mesh-ancestor
110488597|NCT03715933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110488598|NCT03715933|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110488599|NCT03715933|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110488600|NCT03715933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110488601|NCT03715933|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110488602|NCT03715933|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110488603|NCT03715933|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110488604|NCT03715933|Alkylating Agents|alkylating agents|mesh-ancestor
110488607|NCT03662074|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110488608|NCT03662074|Antimetabolites|antimetabolites|mesh-ancestor
110488609|NCT03662074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110488610|NCT03662074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110488611|NCT03662074|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110488612|NCT03662074|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110488613|NCT03602859|Niraparib|niraparib|mesh-list
110488614|NCT03602859|Dostarlimab|dostarlimab|mesh-list
110488615|NCT03602859|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110488616|NCT03602859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110269139|NCT03516604|Serotonin Agents|serotonin agents|mesh-ancestor
110488617|NCT03602859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110488618|NCT03602859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110488619|NCT03573401|Aminolevulinic Acid|aminolevulinic acid|mesh-list
110488620|NCT03573401|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110488621|NCT03573401|Dermatologic Agents|dermatologic agents|mesh-ancestor
110488622|NCT03542175|Rucaparib|rucaparib|mesh-list
110488623|NCT03542175|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110488624|NCT03542175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110488625|NCT03542175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110488626|NCT03542175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110488627|NCT03519230|Pamiparib|pamiparib|mesh-list
110488628|NCT03519230|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110488629|NCT03519230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110488630|NCT03519230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110488631|NCT03519230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110488632|NCT03505762|Prednisone|prednisone|mesh-list
110488633|NCT03505762|Cortisone|cortisone|mesh-list
110488634|NCT03505762|Cyclophosphamide|cyclophosphamide|mesh-list
110488635|NCT03505762|Rituximab|rituximab|mesh-list
110488636|NCT03505762|Doxorubicin|doxorubicin|mesh-list
110488637|NCT03505762|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110488638|NCT03505762|Vincristine|vincristine|mesh-list
110488639|NCT03505762|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110488640|NCT03505762|Antibodies|antibodies|mesh-list
110488641|NCT03505762|Immunoglobulins|immunoglobulins|mesh-list
110442250|NCT00685633|Bicalutamide|bicalutamide|mesh-list
110488642|NCT03505762|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110488643|NCT03505762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110488644|NCT03505762|Immunologic Factors|immunologic factors|mesh-ancestor
110488645|NCT03505762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110488646|NCT03505762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110488647|NCT03505762|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110488648|NCT03505762|Alkylating Agents|alkylating agents|mesh-ancestor
110488649|NCT03505762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110488651|NCT03505762|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110488652|NCT03505762|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110488653|NCT03505762|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110488654|NCT03505762|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110488655|NCT03505762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110488656|NCT03505762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110488659|NCT03505762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110488660|NCT03505762|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110488661|NCT03505762|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110488662|NCT03505762|Tubulin Modulators|tubulin modulators|mesh-ancestor
110488663|NCT03505762|Antimitotic Agents|antimitotic agents|mesh-ancestor
110488664|NCT03505762|Mitosis Modulators|mitosis modulators|mesh-ancestor
110488665|NCT03483038|Irinotecan|irinotecan|mesh-list
110442456|NCT02809768|Rifampin|rifampin|mesh-list
110488666|NCT03483038|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110488667|NCT03483038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110488668|NCT03483038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110488669|NCT03483038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110488670|NCT03483038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110488673|NCT03439046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110135948|NCT02001285|Narcotics|narcotics|mesh-ancestor
110488674|NCT03439046|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110488675|NCT03439046|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110488676|NCT03439046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110488677|NCT03439046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110488678|NCT03439046|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110488679|NCT03439046|Hormone Antagonists|hormone antagonists|mesh-ancestor
110488680|NCT03439046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110488681|NCT03439046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110488682|NCT03439046|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110488683|NCT03439046|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110488684|NCT03406156|Venetoclax|venetoclax|mesh-list
110488685|NCT03406156|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110488687|NCT03406156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110488688|NCT03406156|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110488689|NCT03406156|Alkylating Agents|alkylating agents|mesh-ancestor
110488690|NCT03406156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110488691|NCT03406156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110488692|NCT03402503|Montelukast|montelukast|mesh-list
110488693|NCT03402503|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110488694|NCT03402503|Respiratory System Agents|respiratory system agents|mesh-ancestor
110488695|NCT03402503|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110488696|NCT03402503|Hormone Antagonists|hormone antagonists|mesh-ancestor
110488697|NCT03402503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110442638|NCT02808988|Zoledronic Acid|zoledronic acid|mesh-list
110488698|NCT03402503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110488699|NCT03402503|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110488700|NCT03402503|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110488701|NCT03402503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110488702|NCT03395197|Talazoparib|talazoparib|mesh-list
110488703|NCT03395197|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110488704|NCT03395197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110442705|NCT00689143|Sargramostim|sargramostim|mesh-list
110488705|NCT03395197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110488706|NCT03395197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110488707|NCT03389412|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
110488708|NCT03389412|Hemostatics|hemostatics|mesh-ancestor
110488709|NCT03389412|Coagulants|coagulants|mesh-ancestor
110488710|NCT03389412|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
110488711|NCT03389412|Natriuretic Agents|natriuretic agents|mesh-ancestor
110488712|NCT03389412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110488713|NCT03358472|Carboplatin|carboplatin|mesh-list
110488714|NCT03358472|Pembrolizumab|pembrolizumab|mesh-list
110488715|NCT03358472|Fluorouracil|fluorouracil|mesh-list
110488716|NCT03358472|Cetuximab|cetuximab|mesh-list
110488717|NCT03358472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110488718|NCT03358472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110488719|NCT03358472|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110488720|NCT03358472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110488722|NCT03358472|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110488723|NCT03358472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110488724|NCT03358472|Immunologic Factors|immunologic factors|mesh-ancestor
110488725|NCT03358472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110488726|NCT03327805|Choline|choline|mesh-list
110488727|NCT03327805|Lipotropic Agents|lipotropic agents|mesh-ancestor
110442828|NCT00689845|Etoposide|etoposide|mesh-list
110488728|NCT03327805|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110488729|NCT03327805|Antimetabolites|antimetabolites|mesh-ancestor
110488730|NCT03327805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110488731|NCT03327805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110488732|NCT03327805|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110488733|NCT03327805|Nootropic Agents|nootropic agents|mesh-ancestor
110488734|NCT03260023|Avelumab|avelumab|mesh-list
110269190|NCT00192660|Efavirenz|efavirenz|mesh-list
110488735|NCT03260023|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110488736|NCT03260023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110488737|NCT03220477|Pembrolizumab|pembrolizumab|mesh-list
110488738|NCT03220477|Guadecitabine|guadecitabine|mesh-list
110488739|NCT03220477|Mocetinostat|mocetinostat|mesh-list
110488740|NCT03220477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110488741|NCT03220477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110488742|NCT03220477|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110488743|NCT03220477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110488744|NCT03220477|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110488745|NCT03220477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110488746|NCT03131908|Pembrolizumab|pembrolizumab|mesh-list
110488748|NCT03131908|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110488749|NCT03131908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110488750|NCT03131908|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110488751|NCT03131908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110488752|NCT03131908|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110488753|NCT03131908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110488754|NCT03095612|Docetaxel|docetaxel|mesh-list
110488755|NCT03095612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110488756|NCT03095612|Tubulin Modulators|tubulin modulators|mesh-ancestor
110488757|NCT03095612|Antimitotic Agents|antimitotic agents|mesh-ancestor
110488758|NCT03095612|Mitosis Modulators|mitosis modulators|mesh-ancestor
110488759|NCT03095612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110488761|NCT03068624|Cyclophosphamide|cyclophosphamide|mesh-list
110488762|NCT03068624|Ipilimumab|ipilimumab|mesh-list
110488763|NCT03068624|Interleukin-2|interleukin-2|mesh-list
110488764|NCT03068624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110488765|NCT03068624|Immunologic Factors|immunologic factors|mesh-ancestor
110488766|NCT03068624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110488767|NCT03068624|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110488768|NCT03068624|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110488769|NCT03068624|Alkylating Agents|alkylating agents|mesh-ancestor
110488770|NCT03068624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110488771|NCT03068624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110488772|NCT03068624|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110488773|NCT03068624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110488774|NCT03068624|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110488775|NCT03068624|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110488776|NCT03068624|Analgesics|analgesics|mesh-ancestor
110488777|NCT03068624|Sensory System Agents|sensory system agents|mesh-ancestor
110488778|NCT03068624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110488779|NCT03068624|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110488780|NCT03068624|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110488781|NCT03068624|Antiviral Agents|antiviral agents|mesh-ancestor
110488782|NCT03068624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110488783|NCT03028350|Ifetroban|ifetroban|mesh-list
110488784|NCT03028350|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110488785|NCT03025256|Nivolumab|nivolumab|mesh-list
110488786|NCT03025256|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110488787|NCT03025256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110488788|NCT03025256|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110488789|NCT03025256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110488790|NCT03017820|Iodine|iodine|mesh-list
110488791|NCT03017820|Interferons|interferons|mesh-list
110488792|NCT03017820|Interferon-beta|interferon-beta|mesh-list
110488793|NCT03017820|Cyclophosphamide|cyclophosphamide|mesh-list
110488794|NCT03017820|Nivolumab|nivolumab|mesh-list
110488796|NCT03017820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110488797|NCT03017820|Immunologic Factors|immunologic factors|mesh-ancestor
110488798|NCT03017820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110488799|NCT03017820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110488800|NCT03017820|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110488801|NCT03017820|Alkylating Agents|alkylating agents|mesh-ancestor
110488802|NCT03017820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110488803|NCT03017820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110488804|NCT03017820|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110488805|NCT03017820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110488806|NCT03017820|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110488807|NCT03017820|Antiviral Agents|antiviral agents|mesh-ancestor
110488808|NCT03017820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110488809|NCT03017820|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110488810|NCT03017820|Trace Elements|trace elements|mesh-ancestor
110488811|NCT03017820|Micronutrients|micronutrients|mesh-ancestor
110488813|NCT02918370|Antidepressive Agents|antidepressive agents|mesh-ancestor
110488814|NCT02918370|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110488815|NCT02918370|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110443127|NCT02805010|Abatacept|abatacept|mesh-list
110488816|NCT02918370|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110488817|NCT02918370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110443194|NCT02621359|Doxycycline|doxycycline|mesh-list
110488818|NCT02918370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110488819|NCT02918370|Dopamine Agonists|dopamine agonists|mesh-ancestor
110488820|NCT02918370|Dopamine Agents|dopamine agents|mesh-ancestor
110488821|NCT02918370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110136097|NCT02002000|Vitamins|vitamins|mesh-ancestor
110488822|NCT02918370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110488823|NCT02918370|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110488824|NCT02918370|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110488825|NCT02918370|Serotonin Agents|serotonin agents|mesh-ancestor
110488826|NCT02918370|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110488827|NCT02918370|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110488828|NCT02918370|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110488829|NCT02918370|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110488831|NCT02914405|Dinutuximab|dinutuximab|mesh-list
110488832|NCT02914405|Immunoglobulins|immunoglobulins|mesh-list
110488833|NCT02914405|Immunoglobulin G|immunoglobulin g|mesh-list
110488834|NCT02914405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110488835|NCT02914405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110488836|NCT02914405|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110488837|NCT02914405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110488838|NCT02914405|Immunologic Factors|immunologic factors|mesh-ancestor
110488839|NCT02914405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110488840|NCT02868567|4-Aminopyridine|4-aminopyridine|mesh-list
110488841|NCT02868567|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
110488842|NCT02868567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110443390|NCT00593827|Epothilones|epothilones|mesh-list
110488843|NCT02868567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110488845|NCT02861898|Mannitol|mannitol|mesh-list
110488846|NCT02861898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110488847|NCT02861898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110488848|NCT02861898|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110488849|NCT02861898|Diuretics|diuretics|mesh-ancestor
110488850|NCT02861898|Natriuretic Agents|natriuretic agents|mesh-ancestor
110488851|NCT02861898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110488852|NCT02773030|Dexamethasone|dexamethasone|mesh-list
110488853|NCT02773030|Bortezomib|bortezomib|mesh-list
110488854|NCT02773030|Daratumumab|daratumumab|mesh-list
110488855|NCT02773030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110488856|NCT02773030|Antiemetics|antiemetics|mesh-ancestor
110488857|NCT02773030|Autonomic Agents|autonomic agents|mesh-ancestor
110488858|NCT02773030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110443517|NCT02795884|Tubulin Modulators|tubulin modulators|mesh-ancestor
110488859|NCT02773030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110488860|NCT02773030|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110488861|NCT02773030|Glucocorticoids|glucocorticoids|mesh-ancestor
110488862|NCT02773030|Hormones|hormones|mesh-ancestor
110488863|NCT02773030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110488864|NCT02773030|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110488865|NCT02773030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110488866|NCT02724228|Natriuretic Peptide, C-Type|natriuretic peptide, c-type|mesh-list
110488867|NCT02724228|Natriuretic Agents|natriuretic agents|mesh-ancestor
110443588|NCT01149863|Plerixafor|plerixafor|mesh-list
110488868|NCT02724228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110488870|NCT02723955|Docetaxel|docetaxel|mesh-list
110488871|NCT02723955|Carboplatin|carboplatin|mesh-list
110488872|NCT02723955|Gemcitabine|gemcitabine|mesh-list
110488873|NCT02723955|Pembrolizumab|pembrolizumab|mesh-list
110488874|NCT02723955|Fluorouracil|fluorouracil|mesh-list
110488875|NCT02723955|Pemetrexed|pemetrexed|mesh-list
110488876|NCT02723955|Dostarlimab|dostarlimab|mesh-list
110488877|NCT02723955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110488878|NCT02723955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110488879|NCT02723955|Tubulin Modulators|tubulin modulators|mesh-ancestor
110488880|NCT02723955|Antimitotic Agents|antimitotic agents|mesh-ancestor
110488881|NCT02723955|Mitosis Modulators|mitosis modulators|mesh-ancestor
110488882|NCT02723955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110488883|NCT02723955|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110488884|NCT02723955|Antimetabolites|antimetabolites|mesh-ancestor
110488885|NCT02723955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110488886|NCT02723955|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110488887|NCT02723955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110488888|NCT02723955|Immunologic Factors|immunologic factors|mesh-ancestor
110488889|NCT02723955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110488890|NCT02723955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110488891|NCT02723955|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110488892|NCT02723955|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110488893|NCT02632175|Adalimumab|adalimumab|mesh-list
110488894|NCT02632175|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110488895|NCT02632175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110488896|NCT02632175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110488897|NCT02582905|Choline|choline|mesh-list
110488898|NCT02582905|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
110488899|NCT02582905|Lipotropic Agents|lipotropic agents|mesh-ancestor
110488900|NCT02582905|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110488901|NCT02582905|Antimetabolites|antimetabolites|mesh-ancestor
110488902|NCT02582905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110488903|NCT02582905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110488904|NCT02582905|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110488905|NCT02582905|Nootropic Agents|nootropic agents|mesh-ancestor
110488906|NCT02566304|Mycophenolic Acid|mycophenolic acid|mesh-list
110488907|NCT02566304|Cyclophosphamide|cyclophosphamide|mesh-list
110488908|NCT02566304|Fludarabine|fludarabine|mesh-list
110488909|NCT02566304|Fludarabine phosphate|fludarabine phosphate|mesh-list
110488910|NCT02566304|Tacrolimus|tacrolimus|mesh-list
110488911|NCT02566304|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110488912|NCT02566304|Immunologic Factors|immunologic factors|mesh-ancestor
110488913|NCT02566304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110488914|NCT02566304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110488915|NCT02566304|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110488916|NCT02566304|Alkylating Agents|alkylating agents|mesh-ancestor
110488917|NCT02566304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110488918|NCT02566304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110488919|NCT02566304|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110488920|NCT02566304|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110488921|NCT02566304|Antimetabolites|antimetabolites|mesh-ancestor
110488922|NCT02566304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110488923|NCT02566304|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110488924|NCT02566304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110488925|NCT02566304|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110488926|NCT02566304|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110488927|NCT02566304|Antitubercular Agents|antitubercular agents|mesh-ancestor
110339694|NCT02953184|Pirarubicin|pirarubicin|mesh-list
110488928|NCT02566304|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110488929|NCT02358031|Carboplatin|carboplatin|mesh-list
110488930|NCT02358031|Pembrolizumab|pembrolizumab|mesh-list
110488932|NCT02358031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110488933|NCT02358031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110488934|NCT02358031|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110488935|NCT02358031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110488936|NCT02270814|Paclitaxel|paclitaxel|mesh-list
110488937|NCT02270814|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110488939|NCT02270814|Carboplatin|carboplatin|mesh-list
110488940|NCT02270814|Cetuximab|cetuximab|mesh-list
110488941|NCT02270814|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110488942|NCT02270814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110488943|NCT02270814|Tubulin Modulators|tubulin modulators|mesh-ancestor
110488944|NCT02270814|Antimitotic Agents|antimitotic agents|mesh-ancestor
110488945|NCT02270814|Mitosis Modulators|mitosis modulators|mesh-ancestor
110488946|NCT02270814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110488947|NCT02270814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110488949|NCT02258451|Exemestane|exemestane|mesh-list
110488950|NCT02258451|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
110488951|NCT02258451|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110488952|NCT02258451|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110488953|NCT02258451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110488954|NCT02258451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110488955|NCT02258451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110488956|NCT02258451|Immunologic Factors|immunologic factors|mesh-ancestor
110488957|NCT02258451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110488958|NCT02258451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110488959|NCT02258451|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110488960|NCT02258451|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110488961|NCT02258451|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110488962|NCT02258451|Hormone Antagonists|hormone antagonists|mesh-ancestor
110488963|NCT02258451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110488964|NCT01946529|Cyclophosphamide|cyclophosphamide|mesh-list
110488965|NCT01946529|Temozolomide|temozolomide|mesh-list
110488966|NCT01946529|Ifosfamide|ifosfamide|mesh-list
110488967|NCT01946529|Bevacizumab|bevacizumab|mesh-list
110488968|NCT01946529|Doxorubicin|doxorubicin|mesh-list
110488969|NCT01946529|Etoposide|etoposide|mesh-list
110488970|NCT01946529|Vincristine|vincristine|mesh-list
110488971|NCT01946529|Sorafenib|sorafenib|mesh-list
110488972|NCT01946529|Temsirolimus|temsirolimus|mesh-list
110488973|NCT01946529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110353886|NCT00544986|Anastrozole|anastrozole|mesh-list
110488974|NCT01946529|Immunologic Factors|immunologic factors|mesh-ancestor
110488975|NCT01946529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110488976|NCT01946529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110488977|NCT01946529|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110488978|NCT01946529|Alkylating Agents|alkylating agents|mesh-ancestor
110488979|NCT01946529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110488980|NCT01946529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110488981|NCT01946529|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110488982|NCT01946529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110488983|NCT01946529|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110488984|NCT01946529|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110488985|NCT01946529|Growth Substances|growth substances|mesh-ancestor
110488986|NCT01946529|Growth Inhibitors|growth inhibitors|mesh-ancestor
110488987|NCT01946529|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110488988|NCT01946529|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110488989|NCT01946529|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110488990|NCT01946529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110488991|NCT01946529|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110488992|NCT01946529|Tubulin Modulators|tubulin modulators|mesh-ancestor
110488993|NCT01946529|Antimitotic Agents|antimitotic agents|mesh-ancestor
110488994|NCT01946529|Mitosis Modulators|mitosis modulators|mesh-ancestor
110488995|NCT01946529|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110488996|NCT01946529|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110488997|NCT01899989|Carboplatin|carboplatin|mesh-list
110488998|NCT01899989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110488999|NCT01386710|Bevacizumab|bevacizumab|mesh-list
110489000|NCT01386710|Carboplatin|carboplatin|mesh-list
110489001|NCT01386710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110489002|NCT01386710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110489003|NCT01386710|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110489004|NCT01386710|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110489005|NCT01386710|Growth Substances|growth substances|mesh-ancestor
110489006|NCT01386710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110489007|NCT01386710|Growth Inhibitors|growth inhibitors|mesh-ancestor
110489009|NCT00878254|Cytarabine|cytarabine|mesh-list
110489010|NCT00878254|Cyclophosphamide|cyclophosphamide|mesh-list
110489011|NCT00878254|Ifosfamide|ifosfamide|mesh-list
110489012|NCT00878254|Rituximab|rituximab|mesh-list
110489013|NCT00878254|Doxorubicin|doxorubicin|mesh-list
110489014|NCT00878254|Methotrexate|methotrexate|mesh-list
110489015|NCT00878254|Etoposide|etoposide|mesh-list
110489016|NCT00878254|Vincristine|vincristine|mesh-list
110489017|NCT00878254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110489018|NCT00878254|Immunologic Factors|immunologic factors|mesh-ancestor
110489019|NCT00878254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110489020|NCT00878254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110489021|NCT00878254|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110489023|NCT00878254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110489024|NCT00878254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110489025|NCT00878254|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110489026|NCT00878254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110489027|NCT00878254|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110489028|NCT00878254|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110489029|NCT00878254|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110489030|NCT00878254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110489031|NCT00878254|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110489032|NCT00878254|Abortifacient Agents|abortifacient agents|mesh-ancestor
110489033|NCT00878254|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110489034|NCT00878254|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110489035|NCT00878254|Antimetabolites|antimetabolites|mesh-ancestor
110489036|NCT00878254|Dermatologic Agents|dermatologic agents|mesh-ancestor
110489037|NCT00878254|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110489038|NCT00878254|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110489039|NCT00878254|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110489040|NCT00878254|Antiviral Agents|antiviral agents|mesh-ancestor
110489041|NCT00878254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110489042|NCT00878254|Antidotes|antidotes|mesh-ancestor
110489043|NCT00878254|Protective Agents|protective agents|mesh-ancestor
110489044|NCT00878254|Vitamin B Complex|vitamin b complex|mesh-ancestor
110489045|NCT00878254|Vitamins|vitamins|mesh-ancestor
110489046|NCT00878254|Micronutrients|micronutrients|mesh-ancestor
110489047|NCT00878254|Tubulin Modulators|tubulin modulators|mesh-ancestor
110489048|NCT00878254|Antimitotic Agents|antimitotic agents|mesh-ancestor
110489049|NCT00878254|Mitosis Modulators|mitosis modulators|mesh-ancestor
110489050|NCT00813423|Hydroxychloroquine|hydroxychloroquine|mesh-list
110489051|NCT00813423|Sunitinib|sunitinib|mesh-list
110489052|NCT00813423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110489053|NCT00813423|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110489054|NCT00813423|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110489055|NCT00813423|Growth Substances|growth substances|mesh-ancestor
110489056|NCT00813423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110489057|NCT00813423|Growth Inhibitors|growth inhibitors|mesh-ancestor
110489058|NCT00813423|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110489059|NCT00813423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110489060|NCT00813423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110489061|NCT00813423|Antimalarials|antimalarials|mesh-ancestor
110489062|NCT00813423|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110489063|NCT00813423|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110489064|NCT00813423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110489065|NCT00813423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110489066|NCT00146562|Paclitaxel|paclitaxel|mesh-list
110489067|NCT00146562|Cyclophosphamide|cyclophosphamide|mesh-list
110489068|NCT00146562|Doxorubicin|doxorubicin|mesh-list
110489069|NCT00146562|Darbepoetin alfa|darbepoetin alfa|mesh-list
110489070|NCT00146562|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110489071|NCT00146562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110489072|NCT00146562|Tubulin Modulators|tubulin modulators|mesh-ancestor
110489073|NCT00146562|Antimitotic Agents|antimitotic agents|mesh-ancestor
110489074|NCT00146562|Mitosis Modulators|mitosis modulators|mesh-ancestor
110489075|NCT00146562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110489076|NCT00146562|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110489077|NCT00146562|Immunologic Factors|immunologic factors|mesh-ancestor
110489078|NCT00146562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110444674|NCT02782078|Clindamycin|clindamycin|mesh-list
110489079|NCT00146562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110489080|NCT00146562|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110489081|NCT00146562|Alkylating Agents|alkylating agents|mesh-ancestor
110489082|NCT00146562|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110489083|NCT00146562|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110489084|NCT00146562|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110489085|NCT00146562|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110489086|NCT00146562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110489087|NCT00146562|Hematinics|hematinics|mesh-ancestor
110489088|NCT04089592|Fentanyl|fentanyl|mesh-list
110489089|NCT04089592|Dexmedetomidine|dexmedetomidine|mesh-list
110489090|NCT04089592|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110489091|NCT04089592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110489092|NCT04089592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110489093|NCT04089592|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110489094|NCT04089592|Analgesics|analgesics|mesh-ancestor
110489095|NCT04089592|Sensory System Agents|sensory system agents|mesh-ancestor
110489096|NCT04089592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110444798|NCT05298163|Calcitriol|calcitriol|mesh-list
110489097|NCT04089592|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110489098|NCT04089592|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110489099|NCT04089592|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110489100|NCT04089592|Adrenergic Agents|adrenergic agents|mesh-ancestor
110489101|NCT04089592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110489102|NCT04089592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110489103|NCT04089592|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110489104|NCT04089592|Narcotics|narcotics|mesh-ancestor
110489105|NCT04089592|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110489106|NCT04089592|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110489107|NCT04089592|Anesthetics, General|anesthetics, general|mesh-ancestor
110489108|NCT04089592|Anesthetics|anesthetics|mesh-ancestor
110489109|NCT00751036|Imatinib Mesylate|imatinib mesylate|mesh-list
110489110|NCT00751036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110489111|NCT00751036|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110489112|NCT00751036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110489113|NCT00751036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110489114|NCT00961298|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110489115|NCT00961298|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110489116|NCT00961298|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110489117|NCT00961298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110489118|NCT00961298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110489119|NCT00961298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110489120|NCT00961298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110489121|NCT00961298|Analgesics|analgesics|mesh-ancestor
110489122|NCT00961298|Sensory System Agents|sensory system agents|mesh-ancestor
110489123|NCT00961298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110489124|NCT00961298|Antidepressive Agents|antidepressive agents|mesh-ancestor
110489125|NCT00961298|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110489126|NCT00961298|Dopamine Agents|dopamine agents|mesh-ancestor
110489127|NCT00744328|Sertraline|sertraline|mesh-list
110489128|NCT00744328|Estradiol|estradiol|mesh-list
110489129|NCT00744328|Estrogens|estrogens|mesh-ancestor
110489130|NCT00744328|Hormones|hormones|mesh-ancestor
110489131|NCT00744328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110489132|NCT00744328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110489133|NCT00744328|Antidepressive Agents|antidepressive agents|mesh-ancestor
110489134|NCT00744328|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110489135|NCT00744328|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110489136|NCT00744328|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110489137|NCT00744328|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110489138|NCT00744328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110489139|NCT00744328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110489140|NCT00744328|Serotonin Agents|serotonin agents|mesh-ancestor
110489142|NCT04019782|Viscosupplements|viscosupplements|mesh-ancestor
110489143|NCT04019782|Protective Agents|protective agents|mesh-ancestor
110489144|NCT04019782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110489145|NCT02599480|Mirabegron|mirabegron|mesh-list
110489146|NCT02599480|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
110489147|NCT02599480|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110489148|NCT02599480|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110489149|NCT02599480|Adrenergic Agents|adrenergic agents|mesh-ancestor
110489150|NCT02599480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110489151|NCT02599480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110489152|NCT02599480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110489153|NCT02599480|Urological Agents|urological agents|mesh-ancestor
110489154|NCT03245840|Budesonide|budesonide|mesh-list
110489155|NCT03245840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110489156|NCT03245840|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110489157|NCT03245840|Autonomic Agents|autonomic agents|mesh-ancestor
110489158|NCT03245840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110489159|NCT03245840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110489160|NCT03245840|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110489161|NCT03245840|Respiratory System Agents|respiratory system agents|mesh-ancestor
110489162|NCT03245840|Glucocorticoids|glucocorticoids|mesh-ancestor
110489163|NCT03245840|Hormones|hormones|mesh-ancestor
110489164|NCT03245840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110489165|NCT04091698|Coenzyme Q10|coenzyme q10|mesh-list
110489166|NCT04091698|Ubiquinone|ubiquinone|mesh-list
110489167|NCT04091698|Vitamins|vitamins|mesh-ancestor
110489168|NCT04091698|Micronutrients|micronutrients|mesh-ancestor
110489169|NCT04091698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110489171|NCT04281290|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110489172|NCT04281290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110489173|NCT04091932|Pembrolizumab|pembrolizumab|mesh-list
110489174|NCT04091932|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
110489175|NCT04091932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110489176|NCT04091932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110489177|NCT04091932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110489179|NCT00959894|Emtricitabine|emtricitabine|mesh-list
110489180|NCT00959894|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110489181|NCT00959894|Etravirine|etravirine|mesh-list
110489182|NCT00959894|Antiviral Agents|antiviral agents|mesh-ancestor
110489183|NCT00959894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110489184|NCT00959894|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110489185|NCT00959894|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110489186|NCT00959894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110489187|NCT00959894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110489188|NCT00959894|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110489189|NCT00959894|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110489190|NCT02599168|Dexmedetomidine|dexmedetomidine|mesh-list
110489191|NCT02599168|Propofol|propofol|mesh-list
110489192|NCT02599168|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110269358|NCT00192777|Antimetabolites|antimetabolites|mesh-ancestor
110489193|NCT02599168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110489194|NCT02599168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110489196|NCT02599168|Analgesics|analgesics|mesh-ancestor
110489197|NCT02599168|Sensory System Agents|sensory system agents|mesh-ancestor
110489198|NCT02599168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110489199|NCT02599168|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110489200|NCT02599168|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110489201|NCT02599168|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110489202|NCT02599168|Adrenergic Agents|adrenergic agents|mesh-ancestor
110489203|NCT02599168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110489204|NCT02599168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110489205|NCT02599168|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110489206|NCT02599168|Anesthetics, General|anesthetics, general|mesh-ancestor
110489207|NCT02599168|Anesthetics|anesthetics|mesh-ancestor
110489208|NCT00746590|Tretazicar|tretazicar|mesh-list
110445679|NCT02855307|Insulin|insulin|mesh-list
110489209|NCT00746590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110489210|NCT01032629|Canagliflozin|canagliflozin|mesh-list
110489211|NCT01032629|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110489212|NCT01032629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110489213|NCT01032629|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110489214|NCT01032629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110489215|NCT04205201|Brimonidine Tartrate|brimonidine tartrate|mesh-list
110489216|NCT04205201|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110489217|NCT04205201|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110489218|NCT04205201|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110489219|NCT04205201|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110489220|NCT04205201|Adrenergic Agents|adrenergic agents|mesh-ancestor
110489221|NCT04205201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110489222|NCT04205201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110489223|NCT04205201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110489224|NCT00749944|Varenicline|varenicline|mesh-list
110489225|NCT00749944|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110489226|NCT00749944|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110489227|NCT00749944|Cholinergic Agents|cholinergic agents|mesh-ancestor
110445728|NCT02878122|Carboplatin|carboplatin|mesh-list
110489228|NCT00749944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110489229|NCT00749944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110489230|NCT00749944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110489231|NCT02597140|Lidocaine|lidocaine|mesh-list
110489232|NCT02597140|Propofol|propofol|mesh-list
110489233|NCT02597140|Anesthetics, Local|anesthetics, local|mesh-ancestor
110489234|NCT02597140|Anesthetics|anesthetics|mesh-ancestor
110489235|NCT02597140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110489236|NCT02597140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110489237|NCT02597140|Sensory System Agents|sensory system agents|mesh-ancestor
110489238|NCT02597140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110489239|NCT02597140|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110489240|NCT02597140|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110489241|NCT02597140|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110489242|NCT02597140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110489243|NCT02597140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110489244|NCT02597140|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110489245|NCT02597140|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110489246|NCT02597140|Anesthetics, General|anesthetics, general|mesh-ancestor
110489249|NCT02598310|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110489250|NCT02598310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110489251|NCT02598310|Tubulin Modulators|tubulin modulators|mesh-ancestor
110489252|NCT02598310|Antimitotic Agents|antimitotic agents|mesh-ancestor
110489253|NCT02598310|Mitosis Modulators|mitosis modulators|mesh-ancestor
110097890|NCT01738867|Naltrexone|naltrexone|mesh-list
110489254|NCT02598310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110489255|NCT02598310|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110489256|NCT04091074|Clopidogrel|clopidogrel|mesh-list
110489257|NCT04091074|Ticagrelor|ticagrelor|mesh-list
110571425|NCT00851552|Rituximab|rituximab|mesh-list
110489258|NCT04091074|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110489259|NCT04091074|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110489260|NCT04091074|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110489261|NCT04091074|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110489262|NCT04091074|Purinergic Agents|purinergic agents|mesh-ancestor
110489263|NCT04091074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110489264|NCT04091074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110489265|NCT04091074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110489266|NCT00749398|Infliximab|infliximab|mesh-list
110489267|NCT00749398|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110489268|NCT00749398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110489269|NCT00749398|Dermatologic Agents|dermatologic agents|mesh-ancestor
110489270|NCT00749398|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110489271|NCT00749398|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110489272|NCT01012973|Aflibercept|aflibercept|mesh-list
110489273|NCT01012973|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110489274|NCT01012973|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110489275|NCT01012973|Growth Substances|growth substances|mesh-ancestor
110489276|NCT01012973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110489277|NCT01012973|Growth Inhibitors|growth inhibitors|mesh-ancestor
110489278|NCT01012973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110489279|NCT03974464|Arginine Vasopressin|arginine vasopressin|mesh-list
110489280|NCT03974464|Hemostatics|hemostatics|mesh-ancestor
110489281|NCT03974464|Coagulants|coagulants|mesh-ancestor
110489282|NCT03974464|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110489283|NCT03974464|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
110489284|NCT03974464|Natriuretic Agents|natriuretic agents|mesh-ancestor
110489285|NCT03974464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110489286|NCT00742924|Zoledronic Acid|zoledronic acid|mesh-list
110489287|NCT00742924|Leucovorin|leucovorin|mesh-list
110489288|NCT00742924|Cisplatin|cisplatin|mesh-list
110489289|NCT00742924|Doxorubicin|doxorubicin|mesh-list
110489290|NCT00742924|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110489291|NCT00742924|Methotrexate|methotrexate|mesh-list
110489292|NCT00742924|Etoposide|etoposide|mesh-list
110489293|NCT00742924|Ifosfamide|ifosfamide|mesh-list
110489294|NCT00742924|Isophosphamide mustard|isophosphamide mustard|mesh-list
110489295|NCT00742924|Dexrazoxane|dexrazoxane|mesh-list
110489296|NCT00742924|Razoxane|razoxane|mesh-list
110489297|NCT00742924|Imidazole|imidazole|mesh-list
110489298|NCT00742924|Lenograstim|lenograstim|mesh-list
110489299|NCT00742924|Levoleucovorin|levoleucovorin|mesh-list
110489300|NCT00742924|Mesna|mesna|mesh-list
110489301|NCT00742924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110489302|NCT00742924|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110489303|NCT00742924|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110489304|NCT00742924|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110489305|NCT00742924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110489306|NCT00742924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110489307|NCT00742924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110489308|NCT00742924|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110489309|NCT00742924|Abortifacient Agents|abortifacient agents|mesh-ancestor
110489310|NCT00742924|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110489311|NCT00742924|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110489312|NCT00742924|Antimetabolites|antimetabolites|mesh-ancestor
110489313|NCT00742924|Dermatologic Agents|dermatologic agents|mesh-ancestor
110489314|NCT00742924|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110489315|NCT00742924|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110489316|NCT00742924|Immunologic Factors|immunologic factors|mesh-ancestor
110489317|NCT00742924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110489318|NCT00742924|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110489319|NCT00742924|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110489320|NCT00742924|Antidotes|antidotes|mesh-ancestor
110489321|NCT00742924|Protective Agents|protective agents|mesh-ancestor
110489322|NCT00742924|Vitamin B Complex|vitamin b complex|mesh-ancestor
110489323|NCT00742924|Vitamins|vitamins|mesh-ancestor
110489324|NCT00742924|Micronutrients|micronutrients|mesh-ancestor
110489325|NCT00742924|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110489326|NCT00742924|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110489327|NCT00742924|Alkylating Agents|alkylating agents|mesh-ancestor
110489328|NCT00742924|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110489329|NCT00742924|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110489330|NCT00742924|Antimitotic Agents|antimitotic agents|mesh-ancestor
110489331|NCT00742924|Mitosis Modulators|mitosis modulators|mesh-ancestor
110489332|NCT02596984|Caspofungin|caspofungin|mesh-list
110489333|NCT02596984|Antifungal Agents|antifungal agents|mesh-ancestor
110489334|NCT02596984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110489335|NCT02596984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110489336|NCT02596984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110489337|NCT00698815|Pemetrexed|pemetrexed|mesh-list
110489338|NCT00698815|Sunitinib|sunitinib|mesh-list
110489339|NCT00698815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110489340|NCT00698815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110571827|NCT00796276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110489341|NCT00698815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110489342|NCT00698815|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110489343|NCT00698815|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110489344|NCT00698815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110489345|NCT00698815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110489346|NCT00698815|Growth Substances|growth substances|mesh-ancestor
110489347|NCT00698815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110489348|NCT00698815|Growth Inhibitors|growth inhibitors|mesh-ancestor
110489349|NCT00698815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110489350|NCT02599090|Temozolomide|temozolomide|mesh-list
110489351|NCT02599090|Sorafenib|sorafenib|mesh-list
110489352|NCT02599090|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110489353|NCT02599090|Alkylating Agents|alkylating agents|mesh-ancestor
110489354|NCT02599090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110489355|NCT02599090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110571964|NCT00791830|Irbesartan|irbesartan|mesh-list
110489356|NCT02599090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110489357|NCT02599090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110489359|NCT00745498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110489360|NCT00745498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110489361|NCT00745498|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110489362|NCT00745498|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110489363|NCT00745498|Growth Substances|growth substances|mesh-ancestor
110489364|NCT00745498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110489365|NCT00745498|Growth Inhibitors|growth inhibitors|mesh-ancestor
110489366|NCT02596828|Sirolimus|sirolimus|mesh-list
110489367|NCT02596828|Irinotecan|irinotecan|mesh-list
110489368|NCT02596828|Temozolomide|temozolomide|mesh-list
110489369|NCT02596828|Dasatinib|dasatinib|mesh-list
110572097|NCT02616731|Tranexamic Acid|tranexamic acid|mesh-list
110489370|NCT02596828|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110489371|NCT02596828|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110489372|NCT02596828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110489373|NCT02596828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110489374|NCT02596828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110489375|NCT02596828|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110489376|NCT02596828|Alkylating Agents|alkylating agents|mesh-ancestor
110489377|NCT02596828|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110489378|NCT02596828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110489379|NCT02596828|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110489380|NCT02596828|Antifungal Agents|antifungal agents|mesh-ancestor
110489381|NCT02596828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110489382|NCT02596828|Immunologic Factors|immunologic factors|mesh-ancestor
110489383|NCT02596828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110489384|NCT02596828|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110489385|NCT03896815|INCB054329|incb054329|mesh-list
110489386|NCT03896815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110489387|NCT02598856|Naloxone|naloxone|mesh-list
110489388|NCT02598856|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110489389|NCT02598856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110489390|NCT02598856|Sensory System Agents|sensory system agents|mesh-ancestor
110489391|NCT02598856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110489392|NCT04827979|Daratumumab|daratumumab|mesh-list
110489393|NCT04827979|Abatacept|abatacept|mesh-list
110489394|NCT04827979|Immunoglobulins|immunoglobulins|mesh-list
110489395|NCT04827979|Immunoglobulin G|immunoglobulin g|mesh-list
110489396|NCT04827979|Immunologic Factors|immunologic factors|mesh-ancestor
110489397|NCT04827979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110489398|NCT04827979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110489399|NCT04827979|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110489400|NCT04827979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110489401|NCT04827979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110489402|NCT04827979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110489403|NCT04827979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110489404|NCT02597998|BI 409306|bi 409306|mesh-list
110489405|NCT02597998|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110489406|NCT02597998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110489407|NCT02597998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110489408|NCT02595658|Insulin, Short-Acting|insulin, short-acting|mesh-list
110489409|NCT02595658|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110489410|NCT02595658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110489411|NCT00576901|Bevacizumab|bevacizumab|mesh-list
110489412|NCT00576901|Docetaxel|docetaxel|mesh-list
110489413|NCT00576901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110489414|NCT00576901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110489415|NCT00576901|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110489416|NCT00576901|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110489417|NCT00576901|Growth Substances|growth substances|mesh-ancestor
110489418|NCT00576901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110489419|NCT00576901|Growth Inhibitors|growth inhibitors|mesh-ancestor
110489420|NCT00576901|Tubulin Modulators|tubulin modulators|mesh-ancestor
110489421|NCT00576901|Antimitotic Agents|antimitotic agents|mesh-ancestor
110489422|NCT00576901|Mitosis Modulators|mitosis modulators|mesh-ancestor
110489423|NCT00576901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110489424|NCT00699283|Brivaracetam|brivaracetam|mesh-list
110489425|NCT00699283|Anticonvulsants|anticonvulsants|mesh-ancestor
110489426|NCT04062721|Immunomodulating Agents|immunomodulating agents|mesh-list
110489427|NCT04062721|Immunologic Factors|immunologic factors|mesh-ancestor
110489428|NCT04062721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110489429|NCT01023815|Cyclosporine|cyclosporine|mesh-list
110489430|NCT01023815|Everolimus|everolimus|mesh-list
110489431|NCT01023815|Cyclosporins|cyclosporins|mesh-list
110489432|NCT01023815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110489433|NCT01023815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110489434|NCT01023815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110489435|NCT01023815|Immunologic Factors|immunologic factors|mesh-ancestor
110489436|NCT01023815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110489437|NCT01023815|Antifungal Agents|antifungal agents|mesh-ancestor
110489438|NCT01023815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110489439|NCT01023815|Dermatologic Agents|dermatologic agents|mesh-ancestor
110489440|NCT01023815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110489441|NCT01023815|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110489442|NCT01023815|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110572416|NCT00659230|Sympathomimetics|sympathomimetics|mesh-ancestor
110489443|NCT01023815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110489444|NCT01023815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110489445|NCT02567383|Docetaxel|docetaxel|mesh-list
110489446|NCT02567383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110489447|NCT02567383|Tubulin Modulators|tubulin modulators|mesh-ancestor
110489448|NCT02567383|Antimitotic Agents|antimitotic agents|mesh-ancestor
110489449|NCT02567383|Mitosis Modulators|mitosis modulators|mesh-ancestor
110489450|NCT02567383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110489451|NCT01023659|Bupropion|bupropion|mesh-list
110489452|NCT01023659|Varenicline|varenicline|mesh-list
110489453|NCT01023659|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110489454|NCT01023659|Antidepressive Agents|antidepressive agents|mesh-ancestor
110489455|NCT01023659|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110489456|NCT01023659|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110489457|NCT01023659|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110489458|NCT01023659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110489459|NCT01023659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110489460|NCT01023659|Dopamine Agents|dopamine agents|mesh-ancestor
110489461|NCT01023659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110489462|NCT01023659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110572535|NCT02615561|Vitamins|vitamins|mesh-ancestor
110489463|NCT01023659|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110489464|NCT01023659|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110489466|NCT01023659|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110489467|NCT01023659|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110572598|NCT04132583|Analgesics|analgesics|mesh-ancestor
110489468|NCT01023659|Cholinergic Agents|cholinergic agents|mesh-ancestor
110489469|NCT00740116|Tranexamic Acid|tranexamic acid|mesh-list
110489470|NCT00740116|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110489471|NCT00740116|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110489472|NCT00740116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110489473|NCT00740116|Hemostatics|hemostatics|mesh-ancestor
110489474|NCT00740116|Coagulants|coagulants|mesh-ancestor
110489475|NCT02567461|Aspirin|aspirin|mesh-list
110489476|NCT02567461|Edoxaban|edoxaban|mesh-list
110489477|NCT02567461|Clopidogrel|clopidogrel|mesh-list
110489478|NCT02567461|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110489479|NCT02567461|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110489480|NCT02567461|Analgesics|analgesics|mesh-ancestor
110489481|NCT02567461|Sensory System Agents|sensory system agents|mesh-ancestor
110489482|NCT02567461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110489483|NCT02567461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110489484|NCT02567461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110489485|NCT02567461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110489486|NCT02567461|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110489487|NCT02567461|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110489488|NCT02567461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110489489|NCT02567461|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110489490|NCT02567461|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110489491|NCT02567461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110489492|NCT02567461|Antipyretics|antipyretics|mesh-ancestor
110489493|NCT02567461|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110489494|NCT02567461|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110489495|NCT02567461|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110489496|NCT02567461|Purinergic Agents|purinergic agents|mesh-ancestor
110489497|NCT02567461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110489498|NCT02567461|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110489499|NCT02567461|Antithrombins|antithrombins|mesh-ancestor
110489500|NCT02567461|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110489501|NCT02567461|Protease Inhibitors|protease inhibitors|mesh-ancestor
110489502|NCT02567461|Anticoagulants|anticoagulants|mesh-ancestor
110489503|NCT00698581|Brivaracetam|brivaracetam|mesh-list
110136785|NCT05970302|Antimetabolites|antimetabolites|mesh-ancestor
110489504|NCT00698581|Anticonvulsants|anticonvulsants|mesh-ancestor
110489505|NCT02595346|Hydroxychloroquine|hydroxychloroquine|mesh-list
110489506|NCT02595346|Antimalarials|antimalarials|mesh-ancestor
110489507|NCT02595346|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110489508|NCT02595346|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110489509|NCT02595346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110489510|NCT02595346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110489511|NCT02595346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110489512|NCT02595346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110489513|NCT01023581|Metformin|metformin|mesh-list
110489514|NCT01023581|Alogliptin|alogliptin|mesh-list
110489515|NCT01023581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110489516|NCT01023581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110489517|NCT01023581|Incretins|incretins|mesh-ancestor
110489518|NCT01023581|Hormones|hormones|mesh-ancestor
110572994|NCT04016220|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110489519|NCT01023581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110489520|NCT01023581|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110489521|NCT01023581|Protease Inhibitors|protease inhibitors|mesh-ancestor
110489522|NCT01023581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110489523|NCT01023581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110489524|NCT05571787|Rabeprazole|rabeprazole|mesh-list
110489525|NCT05571787|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110489526|NCT05571787|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110269468|NCT05807347|Antimetabolites|antimetabolites|mesh-ancestor
110489527|NCT05571787|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110489528|NCT05571787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110489529|NCT05571787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110489530|NCT04063189|Clarithromycin|clarithromycin|mesh-list
110489531|NCT04063189|Dexamethasone|dexamethasone|mesh-list
110489532|NCT04063189|Lenalidomide|lenalidomide|mesh-list
110489533|NCT04063189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110489534|NCT04063189|Antiemetics|antiemetics|mesh-ancestor
110489535|NCT04063189|Autonomic Agents|autonomic agents|mesh-ancestor
110489536|NCT04063189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110489537|NCT04063189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110489538|NCT04063189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110489539|NCT04063189|Glucocorticoids|glucocorticoids|mesh-ancestor
110489540|NCT04063189|Hormones|hormones|mesh-ancestor
110489541|NCT04063189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110489542|NCT04063189|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110489543|NCT04063189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110573195|NCT00703898|Antiviral Agents|antiviral agents|mesh-ancestor
110489544|NCT04063189|Immunologic Factors|immunologic factors|mesh-ancestor
110489545|NCT04063189|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110489546|NCT04063189|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110489547|NCT04063189|Growth Substances|growth substances|mesh-ancestor
110489548|NCT04063189|Growth Inhibitors|growth inhibitors|mesh-ancestor
110489549|NCT04063189|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110573264|NCT02614937|Protective Agents|protective agents|mesh-ancestor
110489550|NCT04063189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110489551|NCT04063189|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110489552|NCT04063189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110489553|NCT04063189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110573331|NCT00707798|Immunologic Factors|immunologic factors|mesh-ancestor
110489554|NCT04063189|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110489555|NCT04063189|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110489556|NCT02567929|Propofol|propofol|mesh-list
110489557|NCT02567929|Sevoflurane|sevoflurane|mesh-list
110489558|NCT02567929|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110489559|NCT02567929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110489560|NCT02567929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110489561|NCT02567929|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110489562|NCT02567929|Anesthetics, General|anesthetics, general|mesh-ancestor
110489563|NCT02567929|Anesthetics|anesthetics|mesh-ancestor
110489564|NCT02567929|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110489565|NCT02567929|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110489566|NCT05188417|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
110489567|NCT05188417|Tirofiban|tirofiban|mesh-list
110489568|NCT05188417|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110489569|NCT05188417|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110489570|NCT05188417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110489571|NCT05188417|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110489573|NCT00962780|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110573400|NCT04045678|Rotigotine|rotigotine|mesh-list
110489574|NCT00962780|Immunologic Factors|immunologic factors|mesh-ancestor
110489575|NCT00962780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110489576|NCT02567851|Brentuximab Vedotin|brentuximab vedotin|mesh-list
110489577|NCT02567851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110489578|NCT02567851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110489579|NCT02567851|Immunotoxins|immunotoxins|mesh-ancestor
110489580|NCT02567851|Immunoconjugates|immunoconjugates|mesh-ancestor
110489581|NCT02567851|Immunologic Factors|immunologic factors|mesh-ancestor
110489582|NCT02567851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110489584|NCT00739882|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110489585|NCT00739882|Immunologic Factors|immunologic factors|mesh-ancestor
110489586|NCT00739882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110489587|NCT00961220|Carmustine|carmustine|mesh-list
110489588|NCT00961220|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
110489589|NCT00961220|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110489590|NCT00961220|Alkylating Agents|alkylating agents|mesh-ancestor
110489591|NCT00961220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110489592|NCT00961220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110489593|NCT00961220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110489594|NCT00734656|Ethanol|ethanol|mesh-list
110489595|NCT00734656|Dutasteride|dutasteride|mesh-list
110489596|NCT00734656|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110489597|NCT00734656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110221015|NCT00300664|Hormones|hormones|mesh-list
110489598|NCT00734656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110489599|NCT00734656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110489600|NCT00734656|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
110489601|NCT00734656|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110489602|NCT00734656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110489603|NCT00734656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110489604|NCT00734656|Hormone Antagonists|hormone antagonists|mesh-ancestor
110489605|NCT00734656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110489607|NCT04644289|Olaparib|olaparib|mesh-list
110489608|NCT04644289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110489609|NCT04644289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110489610|NCT04644289|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110489611|NCT04644289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110489612|NCT04644289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110489613|NCT02565979|Resveratrol|resveratrol|mesh-list
110489614|NCT02565979|Antioxidants|antioxidants|mesh-ancestor
110489615|NCT02565979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110489616|NCT02565979|Protective Agents|protective agents|mesh-ancestor
110489617|NCT02565979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110489618|NCT02565979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110489619|NCT02565979|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110489620|NCT04062175|Azithromycin|azithromycin|mesh-list
110489621|NCT04062175|Cephalosporins|cephalosporins|mesh-list
110489622|NCT04062175|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110489623|NCT04062175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110489624|NCT02859584|Hydrocortisone|hydrocortisone|mesh-list
110489625|NCT02859584|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
110489626|NCT02859584|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
110489627|NCT02859584|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
110489628|NCT02859584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110489629|NCT04391569|Ganaxolone|ganaxolone|mesh-list
110489630|NCT04391569|Neurosteroids|neurosteroids|mesh-ancestor
110489631|NCT04391569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110489632|NCT04391569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110489633|NCT04391569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110489634|NCT04391569|GABA Modulators|gaba modulators|mesh-ancestor
110489636|NCT05324917|Rituximab|rituximab|mesh-list
110489637|NCT05324917|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110489638|NCT05324917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110489639|NCT05324917|Immunologic Factors|immunologic factors|mesh-ancestor
110489640|NCT05324917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110489641|NCT05324917|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110489642|NCT00739648|Levofloxacin|levofloxacin|mesh-list
110489643|NCT00739648|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110489644|NCT00739648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110489645|NCT00739648|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110489646|NCT00739648|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110489647|NCT00739648|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110489648|NCT00739648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110489649|NCT00739648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110489650|NCT00739648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110489651|NCT00739648|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110489652|NCT00739648|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110136927|NCT05968937|Baclofen|baclofen|mesh-list
110489653|NCT01032239|Baclofen|baclofen|mesh-list
110489654|NCT01032239|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110489655|NCT01032239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110489656|NCT01032239|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110489657|NCT01032239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110489658|NCT01032239|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
110489659|NCT01032239|GABA Agonists|gaba agonists|mesh-ancestor
110489660|NCT01032239|GABA Agents|gaba agents|mesh-ancestor
110489661|NCT01032239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110489662|NCT01032239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110489663|NCT02871713|Morphine|morphine|mesh-list
110489664|NCT02871713|Ropivacaine|ropivacaine|mesh-list
110489665|NCT02871713|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110489666|NCT02871713|Narcotics|narcotics|mesh-ancestor
110489667|NCT02871713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110489668|NCT02871713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110489670|NCT02871713|Sensory System Agents|sensory system agents|mesh-ancestor
110489671|NCT02871713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110489672|NCT02871713|Anesthetics, Local|anesthetics, local|mesh-ancestor
110489673|NCT02871713|Anesthetics|anesthetics|mesh-ancestor
110489674|NCT04342975|Niacinamide|niacinamide|mesh-list
110489675|NCT04342975|Niacin|niacin|mesh-list
110489676|NCT04342975|Nicotinic Acids|nicotinic acids|mesh-list
110489677|NCT04342975|Vitamin B Complex|vitamin b complex|mesh-ancestor
110489679|NCT04342975|Micronutrients|micronutrients|mesh-ancestor
110489680|NCT04342975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110489681|NCT04342975|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110489682|NCT04342975|Antimetabolites|antimetabolites|mesh-ancestor
110489683|NCT04342975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110489684|NCT04342975|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110489685|NCT04342975|Vasodilator Agents|vasodilator agents|mesh-ancestor
110489686|NCT00734578|Guanfacine|guanfacine|mesh-list
110489687|NCT00734578|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110489688|NCT00734578|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110489690|NCT00734578|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110489691|NCT00734578|Adrenergic Agents|adrenergic agents|mesh-ancestor
110489692|NCT00734578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110489693|NCT00734578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110489694|NCT00734578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110489695|NCT00637715|Alfuzosin|alfuzosin|mesh-list
110489696|NCT00637715|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110489697|NCT00637715|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110489698|NCT00637715|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110489699|NCT00637715|Adrenergic Agents|adrenergic agents|mesh-ancestor
110489700|NCT00637715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110489701|NCT00637715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110489702|NCT00637715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110574090|NCT02607540|Fluorouracil|fluorouracil|mesh-list
110489703|NCT00637715|Urological Agents|urological agents|mesh-ancestor
110489704|NCT02596282|Anesthetics|anesthetics|mesh-list
110489705|NCT02596282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110489706|NCT02596282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110489707|NCT04557085|Cenobamate|cenobamate|mesh-list
110489708|NCT04557085|Anticonvulsants|anticonvulsants|mesh-ancestor
110489709|NCT02593708|Paclitaxel|paclitaxel|mesh-list
110489710|NCT02593708|Trastuzumab|trastuzumab|mesh-list
110489711|NCT02593708|Pertuzumab|pertuzumab|mesh-list
110489712|NCT02593708|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110489713|NCT02593708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110489714|NCT02593708|Tubulin Modulators|tubulin modulators|mesh-ancestor
110489715|NCT02593708|Antimitotic Agents|antimitotic agents|mesh-ancestor
110489716|NCT02593708|Mitosis Modulators|mitosis modulators|mesh-ancestor
110489717|NCT02593708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110489718|NCT02593708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110489719|NCT00959192|Saponin QA-21V1|saponin qa-21v1|mesh-list
110489720|NCT00959192|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110489721|NCT00959192|Immunologic Factors|immunologic factors|mesh-ancestor
110489722|NCT00959192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110489723|NCT00696787|Pregabalin|pregabalin|mesh-list
110489724|NCT00696787|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
110489725|NCT00696787|Analgesics|analgesics|mesh-ancestor
110489726|NCT00696787|Sensory System Agents|sensory system agents|mesh-ancestor
110489727|NCT00696787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110489728|NCT00696787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110489729|NCT00696787|Anticonvulsants|anticonvulsants|mesh-ancestor
110489730|NCT00696787|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110489731|NCT00696787|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110489732|NCT00696787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110489733|NCT00696787|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110489734|NCT00696787|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110489735|NCT00696787|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110574301|NCT02607072|Antipyretics|antipyretics|mesh-ancestor
110489736|NCT00696787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110489737|NCT00696787|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110489738|NCT00696787|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110489739|NCT00696787|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110489740|NCT00696787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110489741|NCT00696787|Antidepressive Agents|antidepressive agents|mesh-ancestor
110489743|NCT01012037|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110489744|NCT01012037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110489745|NCT01012037|Incretins|incretins|mesh-ancestor
110489746|NCT01012037|Hormones|hormones|mesh-ancestor
110489747|NCT01012037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110489748|NCT01012037|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110489749|NCT01012037|Protease Inhibitors|protease inhibitors|mesh-ancestor
110489750|NCT01012037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110489751|NCT01012037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110489752|NCT00630110|Docetaxel|docetaxel|mesh-list
110489753|NCT00630110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110489754|NCT00630110|Tubulin Modulators|tubulin modulators|mesh-ancestor
110489756|NCT00630110|Mitosis Modulators|mitosis modulators|mesh-ancestor
110489757|NCT00630110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110489758|NCT00734032|Darapladib|darapladib|mesh-list
110489759|NCT00734032|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
110489760|NCT00734032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110489761|NCT00734032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110489763|NCT04284098|Bupivacaine|bupivacaine|mesh-list
110489764|NCT04284098|Anesthetics, Local|anesthetics, local|mesh-ancestor
110489765|NCT04284098|Anesthetics|anesthetics|mesh-ancestor
110489766|NCT04284098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110489767|NCT04284098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110489768|NCT04284098|Sensory System Agents|sensory system agents|mesh-ancestor
110489769|NCT04284098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110489770|NCT04284098|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110489771|NCT04284098|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110489773|NCT04284098|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110489774|NCT04284098|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110489775|NCT04284098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110489777|NCT04284098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110489778|NCT04284098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110574768|NCT03995485|Sofosbuvir|sofosbuvir|mesh-list
110489779|NCT01010633|Loteprednol Etabonate|loteprednol etabonate|mesh-list
110489780|NCT01010633|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110489781|NCT00733954|Clobetasol|clobetasol|mesh-list
110489782|NCT00733954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110489783|NCT00733954|Glucocorticoids|glucocorticoids|mesh-ancestor
110489784|NCT00733954|Hormones|hormones|mesh-ancestor
110489785|NCT00733954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110489786|NCT00733954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110489787|NCT02595268|Pitavastatin|pitavastatin|mesh-list
110489788|NCT02595268|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110489789|NCT02595268|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110489790|NCT02595268|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110489791|NCT02595268|Antimetabolites|antimetabolites|mesh-ancestor
110489792|NCT02595268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110489793|NCT02595268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110489794|NCT02595268|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110489795|NCT00921505|Acetaminophen|acetaminophen|mesh-list
110489796|NCT00921505|Ibuprofen|ibuprofen|mesh-list
110489797|NCT00921505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110489798|NCT00921505|Analgesics|analgesics|mesh-ancestor
110489799|NCT00921505|Sensory System Agents|sensory system agents|mesh-ancestor
110489800|NCT00921505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110489801|NCT00921505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110489802|NCT00921505|Antipyretics|antipyretics|mesh-ancestor
110489803|NCT00921505|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110489804|NCT00921505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110489805|NCT00921505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110489806|NCT00921505|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110489807|NCT00921505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110489808|NCT00921505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110489810|NCT04280588|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
110489811|NCT04280588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110489812|NCT04280588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110489813|NCT04280588|Immunologic Factors|immunologic factors|mesh-ancestor
110489814|NCT04280588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110489815|NCT04298021|Durvalumab|durvalumab|mesh-list
110489816|NCT04298021|Olaparib|olaparib|mesh-list
110489817|NCT04298021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110489818|NCT04298021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110489819|NCT04298021|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110489820|NCT04298021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110489821|NCT04298021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110489822|NCT02595190|Gabapentin|gabapentin|mesh-list
110489823|NCT02595190|Tramadol|tramadol|mesh-list
110575041|NCT00448435|Xhance|xhance|mesh-list
110489824|NCT02595190|Analgesics|analgesics|mesh-ancestor
110489825|NCT02595190|Sensory System Agents|sensory system agents|mesh-ancestor
110489826|NCT02595190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110489827|NCT02595190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110489828|NCT02595190|Anticonvulsants|anticonvulsants|mesh-ancestor
110489829|NCT02595190|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110489830|NCT02595190|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110575090|NCT02602743|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110489831|NCT02595190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110489833|NCT02595190|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110489834|NCT02595190|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110489835|NCT02595190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110489836|NCT02595190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110489837|NCT02595190|Antimanic Agents|antimanic agents|mesh-ancestor
110489838|NCT02595190|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110489839|NCT02595190|Narcotics|narcotics|mesh-ancestor
110489841|NCT04061473|Empagliflozin|empagliflozin|mesh-list
110489842|NCT04061473|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110489843|NCT04061473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110489844|NCT04061473|Incretins|incretins|mesh-ancestor
110489845|NCT04061473|Hormones|hormones|mesh-ancestor
110489846|NCT04061473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110489847|NCT04061473|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110489848|NCT04061473|Protease Inhibitors|protease inhibitors|mesh-ancestor
110489849|NCT04061473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110489850|NCT04061473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110489851|NCT04061473|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110489852|NCT00733408|Paclitaxel|paclitaxel|mesh-list
110489853|NCT00733408|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110489854|NCT00733408|Bevacizumab|bevacizumab|mesh-list
110489855|NCT00733408|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110489856|NCT00733408|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110489857|NCT00733408|Antibodies|antibodies|mesh-list
110489858|NCT00733408|Immunoglobulins|immunoglobulins|mesh-list
110489860|NCT00733408|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110489861|NCT00733408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110489862|NCT00733408|Tubulin Modulators|tubulin modulators|mesh-ancestor
110489863|NCT00733408|Antimitotic Agents|antimitotic agents|mesh-ancestor
110489864|NCT00733408|Mitosis Modulators|mitosis modulators|mesh-ancestor
110489865|NCT00733408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110489866|NCT00733408|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110489867|NCT00733408|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110489868|NCT00733408|Growth Substances|growth substances|mesh-ancestor
110489869|NCT00733408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110489870|NCT00733408|Growth Inhibitors|growth inhibitors|mesh-ancestor
110489871|NCT00733408|Immunologic Factors|immunologic factors|mesh-ancestor
110489872|NCT00733408|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110489873|NCT00733408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110489874|NCT04296383|Azithromycin|azithromycin|mesh-list
110489875|NCT04296383|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110489876|NCT04296383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110489878|NCT00576823|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110489879|NCT00576823|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110489880|NCT00576823|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110489881|NCT00576823|Adrenergic Agents|adrenergic agents|mesh-ancestor
110489882|NCT00576823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110489883|NCT00576823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110489884|NCT00576823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110489885|NCT00576823|Urological Agents|urological agents|mesh-ancestor
110489886|NCT00732940|Belimumab|belimumab|mesh-list
110489887|NCT00732940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110489888|NCT00732940|Immunologic Factors|immunologic factors|mesh-ancestor
110489889|NCT00732940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110489890|NCT00962390|Equol|equol|mesh-list
110489891|NCT00962390|Phytoestrogens|phytoestrogens|mesh-ancestor
110575700|NCT00862979|Everolimus|everolimus|mesh-list
110489892|NCT00962390|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
110489893|NCT00962390|Estrogens|estrogens|mesh-ancestor
110489894|NCT00962390|Hormones|hormones|mesh-ancestor
110489895|NCT00962390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110489896|NCT00962390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110489897|NCT00742807|Alfentanil|alfentanil|mesh-list
110489898|NCT00742807|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110489899|NCT00742807|Narcotics|narcotics|mesh-ancestor
110489900|NCT00742807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110489901|NCT00742807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110489902|NCT00742807|Analgesics|analgesics|mesh-ancestor
110489903|NCT00742807|Sensory System Agents|sensory system agents|mesh-ancestor
110489904|NCT00742807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110489905|NCT00742807|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110489906|NCT00742807|Anesthetics, General|anesthetics, general|mesh-ancestor
110489907|NCT00742807|Anesthetics|anesthetics|mesh-ancestor
110489908|NCT03221257|Mycophenolic Acid|mycophenolic acid|mesh-list
110489909|NCT03221257|Pirfenidone|pirfenidone|mesh-list
110489910|NCT03221257|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110489911|NCT03221257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110489912|NCT03221257|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110489913|NCT03221257|Antitubercular Agents|antitubercular agents|mesh-ancestor
110489914|NCT03221257|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110489915|NCT03221257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110489916|NCT03221257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110489917|NCT03221257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110489918|NCT03221257|Analgesics|analgesics|mesh-ancestor
110489919|NCT03221257|Sensory System Agents|sensory system agents|mesh-ancestor
110489920|NCT03221257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110489921|NCT03221257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110489922|NCT03221257|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110489923|NCT03221257|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110489924|NCT03221257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110489925|NCT03221257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110489926|NCT00960986|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110575882|NCT04117919|Immunologic Factors|immunologic factors|mesh-ancestor
110489927|NCT00960986|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110489928|NCT00960986|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110489929|NCT00960986|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110489930|NCT00960986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110489931|NCT00960986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110575970|NCT02604420|Eculizumab|eculizumab|mesh-list
110489932|NCT00960986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110489933|NCT00960986|Analgesics|analgesics|mesh-ancestor
110489934|NCT00960986|Sensory System Agents|sensory system agents|mesh-ancestor
110489935|NCT00960986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110489936|NCT00960986|Antidepressive Agents|antidepressive agents|mesh-ancestor
110489937|NCT00960986|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110489938|NCT00960986|Dopamine Agents|dopamine agents|mesh-ancestor
110489939|NCT00732238|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110489940|NCT00732238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110489941|NCT00958880|Yohimbine|yohimbine|mesh-list
110489942|NCT00958880|Mydriatics|mydriatics|mesh-ancestor
110489943|NCT00958880|Autonomic Agents|autonomic agents|mesh-ancestor
110489944|NCT00958880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110489945|NCT00958880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110489946|NCT00958880|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
110489947|NCT00958880|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110489948|NCT00958880|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110489949|NCT00958880|Adrenergic Agents|adrenergic agents|mesh-ancestor
110489950|NCT00958880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110489951|NCT00958880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110489952|NCT00958880|Urological Agents|urological agents|mesh-ancestor
110489954|NCT02595034|Clindamycin palmitate|clindamycin palmitate|mesh-list
110167208|NCT00000527|Dipyridamole|dipyridamole|mesh-list
110489955|NCT02595034|Clindamycin phosphate|clindamycin phosphate|mesh-list
110489956|NCT02595034|Benzoyl Peroxide|benzoyl peroxide|mesh-list
110489957|NCT02595034|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110489958|NCT02595034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110489959|NCT02595034|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110489960|NCT02595034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110576252|NCT00814658|Nimodipine|nimodipine|mesh-list
110489961|NCT02595034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110489962|NCT02595034|Dermatologic Agents|dermatologic agents|mesh-ancestor
110489964|NCT00958724|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110489965|NCT00958724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110489966|NCT00958724|Tubulin Modulators|tubulin modulators|mesh-ancestor
110489967|NCT00958724|Antimitotic Agents|antimitotic agents|mesh-ancestor
110489968|NCT00958724|Mitosis Modulators|mitosis modulators|mesh-ancestor
110489969|NCT00958724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110489970|NCT00738400|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
110489971|NCT00738400|Vasodilator Agents|vasodilator agents|mesh-ancestor
110489972|NCT00738400|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110489973|NCT00738400|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110489974|NCT00738400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110489975|NCT00738400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110489976|NCT00738400|Urological Agents|urological agents|mesh-ancestor
110489977|NCT00958568|Olanzapine|olanzapine|mesh-list
110489978|NCT00958568|Fluoxetine|fluoxetine|mesh-list
110489979|NCT00958568|Antiemetics|antiemetics|mesh-ancestor
110489980|NCT00958568|Autonomic Agents|autonomic agents|mesh-ancestor
110489981|NCT00958568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110489982|NCT00958568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110489983|NCT00958568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110489984|NCT00958568|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110489985|NCT00958568|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110489986|NCT00958568|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110489987|NCT00958568|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110489988|NCT00958568|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110489989|NCT00958568|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110489990|NCT00958568|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110489991|NCT00958568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110489992|NCT00958568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110489993|NCT00958568|Serotonin Agents|serotonin agents|mesh-ancestor
110489994|NCT00958568|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110489995|NCT00958568|Antidepressive Agents|antidepressive agents|mesh-ancestor
110489996|NCT00958568|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110489997|NCT00958568|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110489998|NCT00958568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110490000|NCT00630500|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110490001|NCT00630500|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110490002|NCT00630500|Dopamine Agents|dopamine agents|mesh-ancestor
110490003|NCT00630500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110490004|NCT00630500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110490005|NCT00630500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110490006|NCT00630500|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110490007|NCT00630500|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110490009|NCT02858804|Thalidomide|thalidomide|mesh-list
110490010|NCT02858804|Dexamethasone|dexamethasone|mesh-list
110490011|NCT02858804|Prednisone|prednisone|mesh-list
110490012|NCT02858804|Cyclophosphamide|cyclophosphamide|mesh-list
110490013|NCT02858804|Rituximab|rituximab|mesh-list
110490014|NCT02858804|Doxorubicin|doxorubicin|mesh-list
110490015|NCT02858804|Etoposide|etoposide|mesh-list
110490016|NCT02858804|Vincristine|vincristine|mesh-list
110490017|NCT02858804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110490018|NCT02858804|Immunologic Factors|immunologic factors|mesh-ancestor
110490019|NCT02858804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110490020|NCT02858804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110490021|NCT02858804|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110490022|NCT02858804|Alkylating Agents|alkylating agents|mesh-ancestor
110490023|NCT02858804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110490024|NCT02858804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110490025|NCT02858804|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110490026|NCT02858804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110490027|NCT02858804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110490028|NCT02858804|Antiemetics|antiemetics|mesh-ancestor
110490029|NCT02858804|Autonomic Agents|autonomic agents|mesh-ancestor
110490030|NCT02858804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110490031|NCT02858804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110490032|NCT02858804|Glucocorticoids|glucocorticoids|mesh-ancestor
110490033|NCT02858804|Hormones|hormones|mesh-ancestor
110490034|NCT02858804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110576832|NCT00826930|Antioxidants|antioxidants|mesh-ancestor
110490035|NCT02858804|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110490036|NCT02858804|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110490037|NCT02858804|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110490038|NCT02858804|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110490039|NCT02858804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110490040|NCT02858804|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110490041|NCT02858804|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110490042|NCT02858804|Antimetabolites|antimetabolites|mesh-ancestor
110490043|NCT02858804|Antiviral Agents|antiviral agents|mesh-ancestor
110490044|NCT02858804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110490045|NCT02858804|Tubulin Modulators|tubulin modulators|mesh-ancestor
110490046|NCT02858804|Antimitotic Agents|antimitotic agents|mesh-ancestor
110490047|NCT02858804|Mitosis Modulators|mitosis modulators|mesh-ancestor
110490048|NCT02858804|Leprostatic Agents|leprostatic agents|mesh-ancestor
110490049|NCT02858804|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110490050|NCT02858804|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110490051|NCT02858804|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110490052|NCT02858804|Growth Substances|growth substances|mesh-ancestor
110490054|NCT00958256|Cyclophosphamide|cyclophosphamide|mesh-list
110490055|NCT00958256|Rituximab|rituximab|mesh-list
110490056|NCT00958256|Bortezomib|bortezomib|mesh-list
110490057|NCT00958256|Lenograstim|lenograstim|mesh-list
110490058|NCT00958256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110490059|NCT00958256|Immunologic Factors|immunologic factors|mesh-ancestor
110490060|NCT00958256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110490061|NCT00958256|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110490062|NCT00958256|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110490063|NCT00958256|Alkylating Agents|alkylating agents|mesh-ancestor
110490064|NCT00958256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110490065|NCT00958256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110490066|NCT00958256|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110490067|NCT00958256|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110490068|NCT00958256|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110490069|NCT01006265|Ponesimod|ponesimod|mesh-list
110490070|NCT01006265|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
110490071|NCT01006265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110490072|NCT01006265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110490073|NCT01006265|Immunologic Factors|immunologic factors|mesh-ancestor
110490074|NCT01006265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110490075|NCT02861690|Paclitaxel|paclitaxel|mesh-list
110490076|NCT02861690|Nedaplatin|nedaplatin|mesh-list
110490077|NCT02861690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110490078|NCT02861690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110490079|NCT02861690|Tubulin Modulators|tubulin modulators|mesh-ancestor
110490080|NCT02861690|Antimitotic Agents|antimitotic agents|mesh-ancestor
110490081|NCT02861690|Mitosis Modulators|mitosis modulators|mesh-ancestor
110490082|NCT02861690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110490083|NCT05141552|Dapagliflozin|dapagliflozin|mesh-list
110577304|NCT00829114|Contraceptive Agents|contraceptive agents|mesh-ancestor
110490084|NCT05141552|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110167218|NCT00000527|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110490085|NCT05141552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110490086|NCT05141552|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110490087|NCT05141552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110490088|NCT02564107|Ibandronic Acid|ibandronic acid|mesh-list
110577377|NCT00831376|Albuterol|albuterol|mesh-list
110490089|NCT02564107|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110490090|NCT02564107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110490091|NCT00628667|Esomeprazole|esomeprazole|mesh-list
110490092|NCT00628667|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110490093|NCT00628667|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110269745|NCT04962503|Afamelanotide|afamelanotide|mesh-list
110490094|NCT00628667|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110490095|NCT00628667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110490096|NCT00628667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110490097|NCT02858258|Rituximab|rituximab|mesh-list
110490098|NCT02858258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110490099|NCT02858258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110490100|NCT02858258|Immunologic Factors|immunologic factors|mesh-ancestor
110490101|NCT02858258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110490102|NCT02858258|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110490103|NCT01008995|Ustekinumab|ustekinumab|mesh-list
110490104|NCT01008995|Dermatologic Agents|dermatologic agents|mesh-ancestor
110490105|NCT04295993|Norepinephrine|norepinephrine|mesh-list
110490106|NCT04295993|Methylene Blue|methylene blue|mesh-list
110490107|NCT04295993|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110490108|NCT04295993|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110490109|NCT04295993|Adrenergic Agents|adrenergic agents|mesh-ancestor
110577504|NCT04102566|Ibuprofen|ibuprofen|mesh-list
110490110|NCT04295993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110490111|NCT04295993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110490112|NCT04295993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110490113|NCT04295993|Sympathomimetics|sympathomimetics|mesh-ancestor
110490114|NCT04295993|Autonomic Agents|autonomic agents|mesh-ancestor
110490115|NCT04295993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110490116|NCT04295993|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110490117|NCT04295993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110490118|NCT00743587|Naproxen|naproxen|mesh-list
110490119|NCT00743587|Oxycodone|oxycodone|mesh-list
110490120|NCT00743587|Tramadol|tramadol|mesh-list
110490121|NCT00743587|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110490122|NCT00743587|Narcotics|narcotics|mesh-ancestor
110490123|NCT00743587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110490124|NCT00743587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110490125|NCT00743587|Analgesics|analgesics|mesh-ancestor
110490126|NCT00743587|Sensory System Agents|sensory system agents|mesh-ancestor
110311663|NCT00290069|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110490128|NCT00743587|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110490129|NCT00743587|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110490130|NCT00743587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110490131|NCT00743587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110490132|NCT00743587|Gout Suppressants|gout suppressants|mesh-ancestor
110490133|NCT00743587|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110490134|NCT00743587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110490135|NCT00743587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110490137|NCT00957944|Dopamine Agonists|dopamine agonists|mesh-ancestor
110490138|NCT00957944|Dopamine Agents|dopamine agents|mesh-ancestor
110490139|NCT00957944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110490140|NCT00957944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110490141|NCT00957944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110490142|NCT02871323|Durvalumab|durvalumab|mesh-list
110490143|NCT02871323|Immunoglobulins|immunoglobulins|mesh-list
110490144|NCT02871323|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110490145|NCT02871323|Immunoglobulin G|immunoglobulin g|mesh-list
110490146|NCT02871323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110490147|NCT02871323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110490148|NCT02871323|Immunologic Factors|immunologic factors|mesh-ancestor
110490149|NCT02871323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110490150|NCT04296149|Octreotide|octreotide|mesh-list
110490151|NCT04296149|Edotreotide|edotreotide|mesh-list
110490152|NCT04296149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110490153|NCT04296149|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110490154|NCT04296149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110490155|NCT04296149|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110490156|NCT04296149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110490157|NCT01005875|Sorafenib|sorafenib|mesh-list
110490158|NCT01005875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110490159|NCT01005875|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110490160|NCT01005875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110490161|NCT01005875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110490162|NCT02701088|Mitomycins|mitomycins|mesh-list
110490163|NCT02701088|Mitomycin|mitomycin|mesh-list
110490164|NCT02701088|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110490165|NCT02701088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110490166|NCT02701088|Alkylating Agents|alkylating agents|mesh-ancestor
110490167|NCT02701088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110490168|NCT02701088|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110490169|NCT02701088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110490170|NCT04279106|Chlorhexidine|chlorhexidine|mesh-list
110490171|NCT04279106|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110490172|NCT04279106|Listerine|listerine|mesh-list
110490173|NCT04279106|Fluorides|fluorides|mesh-list
110490174|NCT04279106|Sodium Fluoride|sodium fluoride|mesh-list
110490175|NCT04279106|Cariostatic Agents|cariostatic agents|mesh-ancestor
110490176|NCT04279106|Protective Agents|protective agents|mesh-ancestor
110490177|NCT04279106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110490178|NCT04279106|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110490179|NCT04279106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110490180|NCT04279106|Disinfectants|disinfectants|mesh-ancestor
110490181|NCT04279106|Dermatologic Agents|dermatologic agents|mesh-ancestor
110490182|NCT00743743|Resveratrol|resveratrol|mesh-list
110490183|NCT00743743|Antioxidants|antioxidants|mesh-ancestor
110577827|NCT00846365|Diuretics|diuretics|mesh-ancestor
110490184|NCT00743743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110490185|NCT00743743|Protective Agents|protective agents|mesh-ancestor
110490186|NCT00743743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110490187|NCT00743743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110490188|NCT00743743|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110490189|NCT01005719|Omeprazole|omeprazole|mesh-list
110490190|NCT01005719|Lansoprazole|lansoprazole|mesh-list
110490191|NCT01005719|Omeprazole, sodium bicarbonate drug combination|omeprazole, sodium bicarbonate drug combination|mesh-list
110490193|NCT01005719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110490194|NCT01005719|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110490195|NCT01005719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110577944|NCT02602860|Levetiracetam|levetiracetam|mesh-list
110490196|NCT01005719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110490198|NCT02856854|Oxazepam|oxazepam|mesh-list
110490199|NCT02856854|Metyrapone|metyrapone|mesh-list
110490200|NCT02856854|Anesthetics, Local|anesthetics, local|mesh-ancestor
110490201|NCT02856854|Anesthetics|anesthetics|mesh-ancestor
110490202|NCT02856854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110490203|NCT02856854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110578012|NCT00784875|Zolpidem|zolpidem|mesh-list
110490204|NCT02856854|Sensory System Agents|sensory system agents|mesh-ancestor
110490205|NCT02856854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110490206|NCT02856854|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110490207|NCT02856854|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110490208|NCT02856854|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110490209|NCT02856854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110490210|NCT02856854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110490211|NCT02856854|Dopamine Agents|dopamine agents|mesh-ancestor
110490212|NCT02856854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110490213|NCT02856854|Antimetabolites|antimetabolites|mesh-ancestor
110490214|NCT02856854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110490215|NCT02856854|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110490216|NCT02856854|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110490217|NCT02856854|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110490218|NCT02856854|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110490219|NCT02856854|GABA Modulators|gaba modulators|mesh-ancestor
110490221|NCT02857166|Antibodies|antibodies|mesh-list
110490222|NCT02857166|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110490223|NCT02857166|Immunologic Factors|immunologic factors|mesh-ancestor
110490224|NCT02857166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110490225|NCT02856932|Methamphetamine|methamphetamine|mesh-list
110490226|NCT02856932|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110490227|NCT02856932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110490228|NCT02856932|Sympathomimetics|sympathomimetics|mesh-ancestor
110490229|NCT02856932|Autonomic Agents|autonomic agents|mesh-ancestor
110578145|NCT00700583|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110490230|NCT02856932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110490232|NCT02856932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110490233|NCT02856932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110490234|NCT02856932|Adrenergic Agents|adrenergic agents|mesh-ancestor
110490235|NCT02856932|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110490236|NCT02856932|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110490237|NCT02856932|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110490238|NCT02856932|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110490239|NCT02563951|Granisetron|granisetron|mesh-list
110490240|NCT02563951|Antiemetics|antiemetics|mesh-ancestor
110490241|NCT02563951|Autonomic Agents|autonomic agents|mesh-ancestor
110490242|NCT02563951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110490243|NCT02563951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110490244|NCT02563951|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110490245|NCT02563951|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110490246|NCT02563951|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110490247|NCT02563951|Serotonin Agents|serotonin agents|mesh-ancestor
110490248|NCT02563951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110490249|NCT02563951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110490250|NCT00953576|Ketoconazole|ketoconazole|mesh-list
110490251|NCT00953576|Hydrocortisone|hydrocortisone|mesh-list
110490252|NCT00953576|Lapatinib|lapatinib|mesh-list
110490253|NCT00953576|Dutasteride|dutasteride|mesh-list
110490254|NCT00953576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110490255|NCT00953576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110490256|NCT00953576|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110490257|NCT00953576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110490258|NCT00953576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110490259|NCT00953576|Antifungal Agents|antifungal agents|mesh-ancestor
110490260|NCT00953576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110490261|NCT00953576|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110490262|NCT00953576|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110578401|NCT00850343|Certolizumab Pegol|certolizumab pegol|mesh-list
110490263|NCT00953576|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110490264|NCT00953576|Hormone Antagonists|hormone antagonists|mesh-ancestor
110269798|NCT04716699|Sensory System Agents|sensory system agents|mesh-ancestor
110490265|NCT00953576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110490266|NCT00953576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110490267|NCT00953576|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110490268|NCT00953576|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
110490269|NCT02100956|Oxytocin|oxytocin|mesh-list
110490270|NCT02100956|Oxytocics|oxytocics|mesh-ancestor
110490271|NCT02100956|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110490272|NCT02100956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110490273|NCT02073968|Paclitaxel|paclitaxel|mesh-list
110490274|NCT02073968|Carboplatin|carboplatin|mesh-list
110490275|NCT02073968|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110578526|NCT00840827|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110490276|NCT02073968|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110490277|NCT02073968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110490278|NCT02073968|Tubulin Modulators|tubulin modulators|mesh-ancestor
110490279|NCT02073968|Antimitotic Agents|antimitotic agents|mesh-ancestor
110490280|NCT02073968|Mitosis Modulators|mitosis modulators|mesh-ancestor
110490281|NCT02073968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110490282|NCT01005329|Paclitaxel|paclitaxel|mesh-list
110490283|NCT01005329|Bevacizumab|bevacizumab|mesh-list
110490284|NCT01005329|Cisplatin|cisplatin|mesh-list
110490285|NCT01005329|Carboplatin|carboplatin|mesh-list
110490286|NCT01005329|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110490287|NCT01005329|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110490288|NCT01005329|Endothelial Growth Factors|endothelial growth factors|mesh-list
110490289|NCT01005329|Antibodies|antibodies|mesh-list
110490290|NCT01005329|Immunoglobulins|immunoglobulins|mesh-list
110490291|NCT01005329|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110490292|NCT01005329|Immunoglobulin G|immunoglobulin g|mesh-list
110490293|NCT01005329|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110490294|NCT01005329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110490295|NCT01005329|Tubulin Modulators|tubulin modulators|mesh-ancestor
110490296|NCT01005329|Antimitotic Agents|antimitotic agents|mesh-ancestor
110490297|NCT01005329|Mitosis Modulators|mitosis modulators|mesh-ancestor
110578594|NCT00703625|MTOR Inhibitors|mtor inhibitors|mesh-list
110490298|NCT01005329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110490300|NCT01005329|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110490301|NCT01005329|Growth Substances|growth substances|mesh-ancestor
110490302|NCT01005329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110490303|NCT01005329|Growth Inhibitors|growth inhibitors|mesh-ancestor
110490304|NCT01005329|Immunologic Factors|immunologic factors|mesh-ancestor
110490305|NCT00921349|Nadolol|nadolol|mesh-list
110490306|NCT00921349|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110490307|NCT00921349|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110490308|NCT00921349|Adrenergic Agents|adrenergic agents|mesh-ancestor
110490309|NCT00921349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110490310|NCT00921349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110490311|NCT00921349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110490312|NCT00921349|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110490313|NCT00921349|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110490314|NCT00921349|Sympatholytics|sympatholytics|mesh-ancestor
110490315|NCT00921349|Autonomic Agents|autonomic agents|mesh-ancestor
110490316|NCT00921349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110490317|NCT01005251|Lesogaberan|lesogaberan|mesh-list
110490318|NCT01005251|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110490319|NCT01005251|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
110490320|NCT01005251|GABA Agonists|gaba agonists|mesh-ancestor
110490321|NCT01005251|GABA Agents|gaba agents|mesh-ancestor
110490322|NCT01005251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110490323|NCT01005251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110490324|NCT01005251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110490325|NCT03048578|Liraglutide|liraglutide|mesh-list
110490326|NCT03048578|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110490327|NCT03048578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110490328|NCT03048578|Incretins|incretins|mesh-ancestor
110490329|NCT03048578|Hormones|hormones|mesh-ancestor
110490330|NCT03048578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110490331|NCT02856776|Vitamin D|vitamin d|mesh-list
110490332|NCT02856776|Cholecalciferol|cholecalciferol|mesh-list
110490333|NCT02856776|Vitamins|vitamins|mesh-ancestor
110490334|NCT02856776|Micronutrients|micronutrients|mesh-ancestor
110490335|NCT02856776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110490336|NCT02856776|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110490337|NCT02856776|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110490338|NCT04296851|Niclosamide|niclosamide|mesh-list
110490339|NCT04296851|Anticestodal Agents|anticestodal agents|mesh-ancestor
110490340|NCT04296851|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110490341|NCT04296851|Anthelmintics|anthelmintics|mesh-ancestor
110490342|NCT04296851|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110490343|NCT04296851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110490344|NCT04296851|Antinematodal Agents|antinematodal agents|mesh-ancestor
110490346|NCT02858024|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110490347|NCT02858024|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110490348|NCT02858024|Antiviral Agents|antiviral agents|mesh-ancestor
110490349|NCT02858024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110490350|NCT02857946|Linagliptin|linagliptin|mesh-list
110490351|NCT02857946|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110490352|NCT02857946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110490353|NCT02857946|Incretins|incretins|mesh-ancestor
110490354|NCT02857946|Hormones|hormones|mesh-ancestor
110490355|NCT02857946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110490356|NCT02857946|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110490357|NCT02857946|Protease Inhibitors|protease inhibitors|mesh-ancestor
110490358|NCT02857946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110490359|NCT02857946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110490360|NCT02857712|Axitinib|axitinib|mesh-list
110490361|NCT02857712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110490362|NCT02857712|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110490363|NCT02857712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110490364|NCT02857712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110490365|NCT00696241|Olmesartan|olmesartan|mesh-list
110490366|NCT00696241|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
110490367|NCT00696241|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
110490368|NCT00696241|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110490369|NCT00696241|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110490370|NCT00696241|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110578818|NCT05500092|Antimitotic Agents|antimitotic agents|mesh-ancestor
110490371|NCT00696241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110490372|NCT00630968|Levetiracetam|levetiracetam|mesh-list
110490373|NCT00630968|Anticonvulsants|anticonvulsants|mesh-ancestor
110490374|NCT00630968|Nootropic Agents|nootropic agents|mesh-ancestor
110490375|NCT00952484|Immunoglobulin G|immunoglobulin g|mesh-list
110490376|NCT00952484|Immunologic Factors|immunologic factors|mesh-ancestor
110490377|NCT00952484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110490378|NCT00689611|Bupropion|bupropion|mesh-list
110490379|NCT00689611|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110490380|NCT00689611|Antidepressive Agents|antidepressive agents|mesh-ancestor
110490381|NCT00689611|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110490382|NCT00689611|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110490383|NCT00689611|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110490384|NCT00689611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110490385|NCT00689611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110490387|NCT00689611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110490388|NCT00689611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110490389|NCT00689611|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110490390|NCT00689611|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110490391|NCT00689611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110490392|NCT02563795|Fentanyl|fentanyl|mesh-list
110490393|NCT02563795|Bupivacaine|bupivacaine|mesh-list
110490394|NCT02563795|Anesthetics, Local|anesthetics, local|mesh-ancestor
110490395|NCT02563795|Anesthetics|anesthetics|mesh-ancestor
110490396|NCT02563795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110490397|NCT02563795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110490398|NCT02563795|Sensory System Agents|sensory system agents|mesh-ancestor
110490399|NCT02563795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110490400|NCT02563795|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110490401|NCT02563795|Narcotics|narcotics|mesh-ancestor
110490402|NCT02563795|Analgesics|analgesics|mesh-ancestor
110490403|NCT02563795|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110490404|NCT02563795|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110490405|NCT02563795|Anesthetics, General|anesthetics, general|mesh-ancestor
110490407|NCT04281680|Pasireotide|pasireotide|mesh-list
110490408|NCT04281680|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110490409|NCT04281680|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110490410|NCT04281680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110490411|NCT04281680|Hormones|hormones|mesh-ancestor
110490412|NCT04281680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110490413|NCT04281680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110490414|NCT00744445|Epoetin Alfa|epoetin alfa|mesh-list
110490415|NCT00744445|Hematinics|hematinics|mesh-ancestor
110490416|NCT02854748|Empagliflozin|empagliflozin|mesh-list
110490417|NCT02854748|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110490418|NCT02854748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110490419|NCT02854748|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110490420|NCT02854748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110490421|NCT03881917|Cystatins|cystatins|mesh-list
110490422|NCT03881917|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
110490423|NCT03881917|Protease Inhibitors|protease inhibitors|mesh-ancestor
110490424|NCT03881917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110490425|NCT03881917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110490427|NCT00744679|Immunologic Factors|immunologic factors|mesh-ancestor
110490428|NCT00744679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110490429|NCT04060459|Paclitaxel|paclitaxel|mesh-list
110490430|NCT04060459|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110490431|NCT04060459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110490432|NCT04060459|Tubulin Modulators|tubulin modulators|mesh-ancestor
110490433|NCT04060459|Antimitotic Agents|antimitotic agents|mesh-ancestor
110490434|NCT04060459|Mitosis Modulators|mitosis modulators|mesh-ancestor
110490435|NCT04060459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110490436|NCT01007435|Methotrexate|methotrexate|mesh-list
110490437|NCT01007435|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110490438|NCT01007435|Abortifacient Agents|abortifacient agents|mesh-ancestor
110490439|NCT01007435|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110490440|NCT01007435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110490441|NCT01007435|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110490442|NCT01007435|Antimetabolites|antimetabolites|mesh-ancestor
110490443|NCT01007435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110490444|NCT01007435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110490445|NCT01007435|Dermatologic Agents|dermatologic agents|mesh-ancestor
110490446|NCT01007435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110490447|NCT01007435|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110490448|NCT01007435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110490449|NCT01007435|Immunologic Factors|immunologic factors|mesh-ancestor
110490450|NCT01007435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110490451|NCT01007435|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110490452|NCT00948896|Pyrimethamine|pyrimethamine|mesh-list
110490453|NCT00948896|Piperaquine|piperaquine|mesh-list
110490454|NCT00948896|Sulfadoxine|sulfadoxine|mesh-list
110490455|NCT00948896|Trimethoprim|trimethoprim|mesh-list
110490456|NCT00948896|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
110490457|NCT00948896|Artenimol|artenimol|mesh-list
110490458|NCT00948896|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
110490459|NCT00948896|Sulfamethoxazole|sulfamethoxazole|mesh-list
110490460|NCT00948896|Antimalarials|antimalarials|mesh-ancestor
110490461|NCT00948896|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110490462|NCT00948896|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110490463|NCT00948896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110490464|NCT00948896|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110490465|NCT00948896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110490466|NCT00948896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110490467|NCT00948896|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110490468|NCT00948896|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110269906|NCT04303390|Cefuroxime|cefuroxime|mesh-list
110490469|NCT00948896|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
110579181|NCT00833261|Paclitaxel|paclitaxel|mesh-list
110490470|NCT00948896|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110490471|NCT00948896|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110490472|NCT01004159|Irinotecan|irinotecan|mesh-list
110490473|NCT01004159|Cetuximab|cetuximab|mesh-list
110490474|NCT01004159|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110490475|NCT01004159|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110579241|NCT04095390|Letrozole|letrozole|mesh-list
110490476|NCT01004159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110490477|NCT01004159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110490478|NCT01004159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110490479|NCT01004159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110490480|NCT00948818|Linaclotide|linaclotide|mesh-list
110490481|NCT00948818|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
110579309|NCT05425355|Acetaminophen|acetaminophen|mesh-list
110490482|NCT00948818|Enzyme Activators|enzyme activators|mesh-ancestor
110490483|NCT00948818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110490484|NCT00948818|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110490485|NCT02854592|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
110490486|NCT02854592|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110579415|NCT00759954|Morphine|morphine|mesh-list
110490487|NCT02854592|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110490488|NCT02854592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110490489|NCT00948506|Cidofovir|cidofovir|mesh-list
110490490|NCT00948506|Antiviral Agents|antiviral agents|mesh-ancestor
110490491|NCT00948506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110490492|NCT00948506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110490493|NCT00948506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110490494|NCT00689221|Temozolomide|temozolomide|mesh-list
110490495|NCT00689221|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110490496|NCT00689221|Alkylating Agents|alkylating agents|mesh-ancestor
110490497|NCT00689221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110490498|NCT00689221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110490499|NCT04060771|Dexamethasone|dexamethasone|mesh-list
110490500|NCT04060771|Palonosetron|palonosetron|mesh-list
110490501|NCT04060771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110490502|NCT04060771|Antiemetics|antiemetics|mesh-ancestor
110490503|NCT04060771|Autonomic Agents|autonomic agents|mesh-ancestor
110490504|NCT04060771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110490505|NCT04060771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110490506|NCT04060771|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110490507|NCT04060771|Glucocorticoids|glucocorticoids|mesh-ancestor
110490508|NCT04060771|Hormones|hormones|mesh-ancestor
110490509|NCT04060771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110490510|NCT04060771|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110490511|NCT04060771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110490512|NCT04060771|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110490513|NCT04060771|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110490514|NCT04060771|Serotonin Agents|serotonin agents|mesh-ancestor
110490515|NCT04060771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110490516|NCT04060771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110490517|NCT00744913|Nicotine|nicotine|mesh-list
110490518|NCT00744913|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110490519|NCT00744913|Autonomic Agents|autonomic agents|mesh-ancestor
110490520|NCT00744913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110490521|NCT00744913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110490522|NCT00744913|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110490523|NCT00744913|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110490524|NCT00744913|Cholinergic Agents|cholinergic agents|mesh-ancestor
110490525|NCT00744913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110490526|NCT00744913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110490527|NCT01875445|Inositol|inositol|mesh-list
110490528|NCT01875445|Vitamin B Complex|vitamin b complex|mesh-ancestor
110490529|NCT01875445|Vitamins|vitamins|mesh-ancestor
110490530|NCT01875445|Micronutrients|micronutrients|mesh-ancestor
110490531|NCT01875445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110490532|NCT00745069|Tapentadol|tapentadol|mesh-list
110490533|NCT00745069|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110490534|NCT00745069|Narcotics|narcotics|mesh-ancestor
110490535|NCT00745069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110490536|NCT00745069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110490537|NCT00745069|Analgesics|analgesics|mesh-ancestor
110490538|NCT00745069|Sensory System Agents|sensory system agents|mesh-ancestor
110490539|NCT00745069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110490540|NCT00745069|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110490541|NCT00745069|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110490542|NCT00745069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110490543|NCT00745069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110490544|NCT00745069|Adrenergic Agents|adrenergic agents|mesh-ancestor
110490545|NCT00745069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110490546|NCT00745147|Laxatives|laxatives|mesh-list
110490547|NCT00745147|Lactulose|lactulose|mesh-list
110490548|NCT00745147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110490549|NCT00688909|Letrozole|letrozole|mesh-list
110490550|NCT00688909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110490551|NCT00688909|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110490552|NCT00688909|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110490553|NCT00688909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110490554|NCT00688909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110490555|NCT00688909|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110490556|NCT00688909|Hormone Antagonists|hormone antagonists|mesh-ancestor
110490557|NCT00688909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110167280|NCT00030784|Alkylating Agents|alkylating agents|mesh-ancestor
110490558|NCT00688909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110490559|NCT00948428|Imiquimod|imiquimod|mesh-list
110490560|NCT00948428|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110490561|NCT00948428|Immunologic Factors|immunologic factors|mesh-ancestor
110490562|NCT00948428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110490563|NCT00948428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110490564|NCT00948428|Interferon Inducers|interferon inducers|mesh-ancestor
110490565|NCT00948194|Nitric Oxide|nitric oxide|mesh-list
110490566|NCT00948194|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110490567|NCT00948194|Autonomic Agents|autonomic agents|mesh-ancestor
110490568|NCT00948194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110490569|NCT00948194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110490570|NCT00948194|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110490571|NCT00948194|Respiratory System Agents|respiratory system agents|mesh-ancestor
110490572|NCT00948194|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110490574|NCT00948194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110490575|NCT00948194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110490576|NCT00948194|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
110579743|NCT00751881|Teriflunomide|teriflunomide|mesh-list
110490577|NCT00948194|Vasodilator Agents|vasodilator agents|mesh-ancestor
110490578|NCT00948194|Gasotransmitters|gasotransmitters|mesh-ancestor
110490579|NCT00948194|Protective Agents|protective agents|mesh-ancestor
110490580|NCT00691483|Varenicline|varenicline|mesh-list
110490581|NCT00691483|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110490582|NCT00691483|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110490583|NCT00691483|Cholinergic Agents|cholinergic agents|mesh-ancestor
110490584|NCT00691483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110490585|NCT00691483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110490586|NCT00691483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110490587|NCT00691093|Fesoterodine|fesoterodine|mesh-list
110490588|NCT00691093|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110490589|NCT00691093|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110490590|NCT00691093|Cholinergic Agents|cholinergic agents|mesh-ancestor
110490591|NCT00691093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110490592|NCT00691093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110490593|NCT00691093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110490594|NCT00691093|Urological Agents|urological agents|mesh-ancestor
110490595|NCT03646825|Antioxidants|antioxidants|mesh-list
110490596|NCT03646825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110490597|NCT03646825|Protective Agents|protective agents|mesh-ancestor
110490598|NCT03646825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110490599|NCT00745225|Pioglitazone|pioglitazone|mesh-list
110490600|NCT00745225|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110490601|NCT00745225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110490602|NCT02856542|Betamethasone|betamethasone|mesh-list
110490603|NCT02856542|Betamethasone Valerate|betamethasone valerate|mesh-list
110490604|NCT02856542|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
110490605|NCT02856542|Betamethasone benzoate|betamethasone benzoate|mesh-list
110490606|NCT02856542|Calcipotriene|calcipotriene|mesh-list
110490607|NCT02856542|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
110490608|NCT02856542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110490609|NCT02856542|Glucocorticoids|glucocorticoids|mesh-ancestor
110490610|NCT02856542|Hormones|hormones|mesh-ancestor
110167287|NCT00000539|Vitamins|vitamins|mesh-list
110490611|NCT02856542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110490612|NCT02856542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110490613|NCT02856542|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110490614|NCT02856542|Respiratory System Agents|respiratory system agents|mesh-ancestor
110490616|NCT00688753|Everolimus|everolimus|mesh-list
110490617|NCT00688753|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110490618|NCT00688753|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110490619|NCT00688753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110490620|NCT00688753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110490621|NCT00688753|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110490622|NCT00688753|Immunologic Factors|immunologic factors|mesh-ancestor
110490623|NCT00688753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110490624|NCT00688753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110490625|NCT04204382|Levofloxacin|levofloxacin|mesh-list
110490626|NCT04204382|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110580143|NCT00738699|Antimitotic Agents|antimitotic agents|mesh-ancestor
110490627|NCT04204382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110490628|NCT04204382|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110490629|NCT04204382|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110490630|NCT04204382|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110490631|NCT04204382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110490632|NCT04204382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110490633|NCT04204382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110490634|NCT04204382|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110490635|NCT04204382|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110490636|NCT02856230|Paclitaxel|paclitaxel|mesh-list
110490637|NCT02856230|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110490638|NCT02856230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110490639|NCT02856230|Tubulin Modulators|tubulin modulators|mesh-ancestor
110490640|NCT02856230|Antimitotic Agents|antimitotic agents|mesh-ancestor
110269958|NCT03528408|Nivolumab|nivolumab|mesh-list
110490641|NCT02856230|Mitosis Modulators|mitosis modulators|mesh-ancestor
110311672|NCT04718259|Sensory System Agents|sensory system agents|mesh-ancestor
110490642|NCT02856230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110490643|NCT00631124|Drospirenone|drospirenone|mesh-list
110490644|NCT00631124|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110490645|NCT00631124|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110490646|NCT00631124|Estradiol|estradiol|mesh-list
110490647|NCT00631124|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110490648|NCT00631124|Estrogens|estrogens|mesh-ancestor
110490649|NCT00631124|Hormones|hormones|mesh-ancestor
110490650|NCT00631124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110490651|NCT00631124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110490652|NCT00631124|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110490653|NCT00631124|Contraceptive Agents|contraceptive agents|mesh-ancestor
110490654|NCT00631124|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110490655|NCT00631124|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110490656|NCT00631124|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110490657|NCT00631124|Hormone Antagonists|hormone antagonists|mesh-ancestor
110490658|NCT00631124|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110490659|NCT00631124|Diuretics|diuretics|mesh-ancestor
110490660|NCT00631124|Natriuretic Agents|natriuretic agents|mesh-ancestor
110490661|NCT02855684|Insulin|insulin|mesh-list
110490662|NCT02855684|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110490663|NCT02855684|Insulin Glargine|insulin glargine|mesh-list
110490664|NCT02855684|Hypoglycemic Agents|hypoglycemic agents|mesh-list
110490665|NCT02855684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110490666|NCT01667744|Citalopram|citalopram|mesh-list
110490667|NCT01667744|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110490668|NCT01667744|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110490669|NCT01667744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110490670|NCT01667744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110490671|NCT01667744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110580617|NCT00809783|Tanezumab|tanezumab|mesh-list
110490673|NCT01667744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110490674|NCT01667744|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110490675|NCT01667744|Antidepressive Agents|antidepressive agents|mesh-ancestor
110490676|NCT01667744|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110490677|NCT04274270|Endostar protein|endostar protein|mesh-list
110490678|NCT04274270|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110490679|NCT04274270|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110490680|NCT04274270|Growth Substances|growth substances|mesh-ancestor
110490681|NCT04274270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110490682|NCT04274270|Growth Inhibitors|growth inhibitors|mesh-ancestor
110490683|NCT04274270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110490685|NCT02855294|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110490686|NCT02855294|Hormone Antagonists|hormone antagonists|mesh-ancestor
110490687|NCT02855294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110580751|NCT00797108|Clavulanic Acids|clavulanic acids|mesh-list
110490688|NCT02855294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110490689|NCT02855294|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110490690|NCT02855294|Diuretics|diuretics|mesh-ancestor
110490691|NCT02855294|Natriuretic Agents|natriuretic agents|mesh-ancestor
110490692|NCT00950690|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110490693|NCT00950690|Latanoprost|latanoprost|mesh-list
110490694|NCT00950690|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110490695|NCT02855138|Isotretinoin|isotretinoin|mesh-list
110490696|NCT02855138|Dermatologic Agents|dermatologic agents|mesh-ancestor
110490697|NCT00694369|Acetaminophen|acetaminophen|mesh-list
110490698|NCT00694369|Ibuprofen|ibuprofen|mesh-list
110490699|NCT00694369|Etoricoxib|etoricoxib|mesh-list
110490700|NCT00694369|Codeine|codeine|mesh-list
110490701|NCT00694369|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110490703|NCT00694369|Sensory System Agents|sensory system agents|mesh-ancestor
110490704|NCT00694369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110580822|NCT04025840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110490705|NCT00694369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110490707|NCT00694369|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110490708|NCT00694369|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110490709|NCT00694369|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110490710|NCT00694369|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110490711|NCT00694369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110490712|NCT00694369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110490713|NCT00694369|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110490714|NCT00694369|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110490715|NCT00694369|Narcotics|narcotics|mesh-ancestor
110490717|NCT00694369|Antitussive Agents|antitussive agents|mesh-ancestor
110490718|NCT00694369|Respiratory System Agents|respiratory system agents|mesh-ancestor
110490719|NCT00745693|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
110490721|NCT00745693|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110490722|NCT00745693|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
110490723|NCT00745693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110490724|NCT00745693|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
110490725|NCT02563405|Doxazosin|doxazosin|mesh-list
110490726|NCT02563405|Nifedipine|nifedipine|mesh-list
110490727|NCT02563405|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110490728|NCT02563405|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110490729|NCT02563405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110490730|NCT02563405|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110490731|NCT02563405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110490732|NCT02563405|Vasodilator Agents|vasodilator agents|mesh-ancestor
110490733|NCT02563405|Tocolytic Agents|tocolytic agents|mesh-ancestor
110490734|NCT02563405|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110490735|NCT02563405|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110490736|NCT02563405|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110490737|NCT02563405|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110490738|NCT02563405|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110490739|NCT02563405|Adrenergic Agents|adrenergic agents|mesh-ancestor
110490740|NCT02563405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110490741|NCT03412747|Adalimumab|adalimumab|mesh-list
110490742|NCT03412747|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110490743|NCT03412747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110490744|NCT03412747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110490745|NCT00513019|Lamotrigine|lamotrigine|mesh-list
110490746|NCT00513019|Anticonvulsants|anticonvulsants|mesh-list
110490747|NCT00513019|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110490748|NCT00513019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110490749|NCT00513019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110490750|NCT00513019|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110490751|NCT00513019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110490752|NCT00513019|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110490753|NCT00513019|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110490754|NCT00513019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110490755|NCT00513019|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110490756|NCT00513019|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110490758|NCT00053677|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110490759|NCT00053677|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110490760|NCT00053677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110490761|NCT00053677|Sensory System Agents|sensory system agents|mesh-ancestor
110490762|NCT00053677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110490764|NCT00954512|Folic Acid|folic acid|mesh-list
110490765|NCT00954512|Carboplatin|carboplatin|mesh-list
110490766|NCT00954512|Gemcitabine|gemcitabine|mesh-list
110490767|NCT00954512|Trastuzumab|trastuzumab|mesh-list
110490768|NCT00954512|Irinotecan|irinotecan|mesh-list
110490769|NCT00954512|Cetuximab|cetuximab|mesh-list
110490770|NCT00954512|Everolimus|everolimus|mesh-list
110490771|NCT00954512|Epirubicin|epirubicin|mesh-list
110490772|NCT00954512|Levoleucovorin|levoleucovorin|mesh-list
110490773|NCT00954512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110490774|NCT00954512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110490775|NCT00954512|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110490776|NCT00954512|Antimetabolites|antimetabolites|mesh-ancestor
110490777|NCT00954512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110490778|NCT00954512|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110490779|NCT00954512|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110490780|NCT00954512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110490781|NCT00954512|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110490782|NCT00954512|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110490783|NCT00954512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110490784|NCT00954512|Immunologic Factors|immunologic factors|mesh-ancestor
110490785|NCT00954512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110490786|NCT00954512|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110490787|NCT00954512|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110490788|NCT00954512|Antidotes|antidotes|mesh-ancestor
110490789|NCT00954512|Protective Agents|protective agents|mesh-ancestor
110490792|NCT00954512|Micronutrients|micronutrients|mesh-ancestor
110490793|NCT00954512|Hematinics|hematinics|mesh-ancestor
110490794|NCT00691015|Cytarabine|cytarabine|mesh-list
110490795|NCT00691015|Cyclophosphamide|cyclophosphamide|mesh-list
110490796|NCT00691015|Melphalan|melphalan|mesh-list
110490797|NCT00691015|Busulfan|busulfan|mesh-list
110490798|NCT00691015|Carmustine|carmustine|mesh-list
110490799|NCT00691015|Rituximab|rituximab|mesh-list
110490800|NCT00691015|Fludarabine|fludarabine|mesh-list
110490801|NCT00691015|Fludarabine phosphate|fludarabine phosphate|mesh-list
110490802|NCT00691015|Etoposide|etoposide|mesh-list
110490803|NCT00691015|Thymoglobulin|thymoglobulin|mesh-list
110490804|NCT00691015|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110581037|NCT00806819|BB 1101|bb 1101|mesh-list
110490805|NCT00691015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110490806|NCT00691015|Immunologic Factors|immunologic factors|mesh-ancestor
110490807|NCT00691015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110490808|NCT00691015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110581097|NCT00800540|Timolol|timolol|mesh-list
110490809|NCT00691015|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110490810|NCT00691015|Alkylating Agents|alkylating agents|mesh-ancestor
110490811|NCT00691015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110490812|NCT00691015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110490813|NCT00691015|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110490814|NCT00691015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110581164|NCT00915200|Acetylcysteine|acetylcysteine|mesh-list
110490815|NCT00691015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110490816|NCT00691015|Antimetabolites|antimetabolites|mesh-ancestor
110490817|NCT00691015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110490818|NCT00691015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110490819|NCT00691015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110490821|NCT00691015|Antiviral Agents|antiviral agents|mesh-ancestor
110490822|NCT00691015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110490823|NCT00950300|Cyclophosphamide|cyclophosphamide|mesh-list
110490824|NCT00950300|Docetaxel|docetaxel|mesh-list
110490825|NCT00950300|Fluorouracil|fluorouracil|mesh-list
110490826|NCT00950300|Trastuzumab|trastuzumab|mesh-list
110490827|NCT00950300|Epirubicin|epirubicin|mesh-list
110490828|NCT00950300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110490829|NCT00950300|Immunologic Factors|immunologic factors|mesh-ancestor
110490830|NCT00950300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110490831|NCT00950300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110490832|NCT00950300|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110490833|NCT00950300|Alkylating Agents|alkylating agents|mesh-ancestor
110490834|NCT00950300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110490835|NCT00950300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110490836|NCT00950300|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110490837|NCT00950300|Tubulin Modulators|tubulin modulators|mesh-ancestor
110490838|NCT00950300|Antimitotic Agents|antimitotic agents|mesh-ancestor
110490839|NCT00950300|Mitosis Modulators|mitosis modulators|mesh-ancestor
110490840|NCT00950300|Antimetabolites|antimetabolites|mesh-ancestor
110490841|NCT00950300|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110490842|NCT00950300|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110490843|NCT00950300|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110490844|NCT00950300|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110490845|NCT00950300|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110490846|NCT00950300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110490848|NCT00949988|Dasatinib|dasatinib|mesh-list
110490849|NCT00949988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110490850|NCT00949988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110490851|NCT00949988|Immunologic Factors|immunologic factors|mesh-ancestor
110490852|NCT00949988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110490853|NCT00949988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110581505|NCT04106726|Ivermectin|ivermectin|mesh-list
110490854|NCT00949988|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110490856|NCT00949988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110229040|NCT02494258|Cc-486|cc-486|mesh-list
110490857|NCT00731692|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
110490858|NCT00731692|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
110490859|NCT00731692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110490860|NCT00731692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110490861|NCT00731692|Immunologic Factors|immunologic factors|mesh-ancestor
110490862|NCT00731692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110490864|NCT02593474|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110490865|NCT02593474|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110490866|NCT02593474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110490867|NCT02593474|Sensory System Agents|sensory system agents|mesh-ancestor
110490868|NCT02593474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110490869|NCT00687193|Tofacitinib|tofacitinib|mesh-list
110490870|NCT00687193|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
110270039|NCT03330028|Hormones|hormones|mesh-ancestor
110490871|NCT00687193|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110490872|NCT00687193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110581704|NCT00807599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110490873|NCT00687193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110490874|NCT00917878|Calcium|calcium|mesh-list
110490875|NCT00917878|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110490876|NCT00917878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110490877|NCT00730912|Loratadine|loratadine|mesh-list
110490878|NCT00730912|Antipruritics|antipruritics|mesh-ancestor
110490879|NCT00730912|Dermatologic Agents|dermatologic agents|mesh-ancestor
110490880|NCT00730912|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110490881|NCT00730912|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110490882|NCT00730912|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110490883|NCT00730912|Histamine Antagonists|histamine antagonists|mesh-ancestor
110490884|NCT00730912|Histamine Agents|histamine agents|mesh-ancestor
110490885|NCT00730912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110490886|NCT00730912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110490887|NCT00730912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110490888|NCT00730756|Fluticasone|fluticasone|mesh-list
110490890|NCT00730756|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110490891|NCT00730756|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110490892|NCT00730756|Autonomic Agents|autonomic agents|mesh-ancestor
110490893|NCT00730756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110490895|NCT00730756|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110490896|NCT00730756|Respiratory System Agents|respiratory system agents|mesh-ancestor
110490897|NCT00730756|Dermatologic Agents|dermatologic agents|mesh-ancestor
110490898|NCT00730756|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110490900|NCT00730132|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110490901|NCT00730132|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110490902|NCT00730132|Antimetabolites|antimetabolites|mesh-ancestor
110490903|NCT00730132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110490904|NCT00730132|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110490905|NCT00737464|Epoetin Alfa|epoetin alfa|mesh-list
110490906|NCT00737464|Hematinics|hematinics|mesh-ancestor
110490907|NCT00729586|Tamoxifen|tamoxifen|mesh-list
110490908|NCT00729586|Sirolimus|sirolimus|mesh-list
110490909|NCT00729586|Temsirolimus|temsirolimus|mesh-list
110490910|NCT00729586|Megestrol|megestrol|mesh-list
110490911|NCT00729586|Megestrol Acetate|megestrol acetate|mesh-list
110490912|NCT00729586|MTOR Inhibitors|mtor inhibitors|mesh-list
110490913|NCT00729586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110490914|NCT00729586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110490915|NCT00729586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110490916|NCT00729586|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110490917|NCT00729586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110490918|NCT00729586|Antifungal Agents|antifungal agents|mesh-ancestor
110490919|NCT00729586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110490920|NCT00729586|Immunologic Factors|immunologic factors|mesh-ancestor
110490921|NCT00729586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110490922|NCT00729586|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110490923|NCT00729586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110582041|NCT00733824|Plerixafor|plerixafor|mesh-list
110490924|NCT00729586|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110490925|NCT00729586|Hormone Antagonists|hormone antagonists|mesh-ancestor
110490926|NCT00729586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110490927|NCT00729586|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110490928|NCT00729586|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110490929|NCT00729586|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110490930|NCT00729586|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110490931|NCT00729586|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110490932|NCT00729586|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110490933|NCT00729586|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110490934|NCT00729586|Contraceptive Agents|contraceptive agents|mesh-ancestor
110490935|NCT00729586|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110490936|NCT00729586|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110490937|NCT00729586|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110490938|NCT00729586|Appetite Stimulants|appetite stimulants|mesh-ancestor
110490939|NCT00729586|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110490940|NCT00949910|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110490941|NCT00949910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110490942|NCT00949910|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110490944|NCT00949910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110490945|NCT02594800|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110490946|NCT02594800|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110490947|NCT02594800|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110490949|NCT02594800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110490950|NCT02594800|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110167327|NCT00031057|Thiamine|thiamine|mesh-list
110490951|NCT02594800|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110490952|NCT02594800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110490953|NCT02593162|Ribavirin|ribavirin|mesh-list
110490954|NCT02593162|Antimetabolites|antimetabolites|mesh-ancestor
110490955|NCT02593162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110490956|NCT02593162|Antiviral Agents|antiviral agents|mesh-ancestor
110490957|NCT02593162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110490958|NCT00686959|Paclitaxel|paclitaxel|mesh-list
110490959|NCT00686959|Etoposide|etoposide|mesh-list
110490960|NCT00686959|Vinorelbine|vinorelbine|mesh-list
110490961|NCT00686959|Carboplatin|carboplatin|mesh-list
110490962|NCT00686959|Pemetrexed|pemetrexed|mesh-list
110490963|NCT00686959|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110490964|NCT00686959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110490965|NCT00686959|Tubulin Modulators|tubulin modulators|mesh-ancestor
110490966|NCT00686959|Antimitotic Agents|antimitotic agents|mesh-ancestor
110490967|NCT00686959|Mitosis Modulators|mitosis modulators|mesh-ancestor
110490968|NCT00686959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110490969|NCT00686959|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110490970|NCT00686959|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110490971|NCT00686959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110490972|NCT00686959|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110490973|NCT00686959|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110490974|NCT04088110|Trastuzumab|trastuzumab|mesh-list
110490975|NCT04088110|Letrozole|letrozole|mesh-list
110490976|NCT04088110|Anastrozole|anastrozole|mesh-list
110490977|NCT04088110|Exemestane|exemestane|mesh-list
110490978|NCT04088110|Aromatase Inhibitors|aromatase inhibitors|mesh-list
110490979|NCT04088110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110490980|NCT04088110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110490981|NCT04088110|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110490982|NCT04088110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110490983|NCT04088110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110490984|NCT04088110|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110490985|NCT04088110|Hormone Antagonists|hormone antagonists|mesh-ancestor
110490986|NCT04088110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110490987|NCT04088110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110490988|NCT04088110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110490989|NCT04088266|Buprenorphine|buprenorphine|mesh-list
110490990|NCT04088266|Naloxone|naloxone|mesh-list
110490991|NCT04088266|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110490992|NCT04088266|Narcotics|narcotics|mesh-ancestor
110490993|NCT04088266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110490994|NCT04088266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110490995|NCT04088266|Analgesics|analgesics|mesh-ancestor
110490996|NCT04088266|Sensory System Agents|sensory system agents|mesh-ancestor
110490997|NCT04088266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110490998|NCT04088266|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110138222|NCT04734730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110138223|NCT04734730|Hormone Antagonists|hormone antagonists|mesh-ancestor
110138224|NCT04734730|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110138225|NCT04734730|Androgen Antagonists|androgen antagonists|mesh-ancestor
110491000|NCT05311579|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110491001|NCT05311579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110491002|NCT05311579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110491003|NCT05311579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110491005|NCT00602342|Antifungal Agents|antifungal agents|mesh-ancestor
110491006|NCT00602342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110582398|NCT04107194|Rifabutin|rifabutin|mesh-list
110491007|NCT00602342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110491008|NCT00602342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110491009|NCT00602498|Clarithromycin|clarithromycin|mesh-list
110491010|NCT00602498|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110491011|NCT00602498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110491012|NCT00602498|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110491013|NCT00602498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110491014|NCT00602498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110491015|NCT00602498|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110491016|NCT00602498|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110491017|NCT00749359|Paroxetine|paroxetine|mesh-list
110491018|NCT00749359|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110491019|NCT00749359|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110491020|NCT00749359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110491021|NCT00749359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110491022|NCT00749359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110491023|NCT00749359|Serotonin Agents|serotonin agents|mesh-ancestor
110582536|NCT00730158|Irinotecan|irinotecan|mesh-list
110491024|NCT00749359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110491025|NCT00749359|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110491026|NCT00749359|Antidepressive Agents|antidepressive agents|mesh-ancestor
110491027|NCT00749359|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110491028|NCT00749359|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110491029|NCT00749359|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110491030|NCT00749359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110491031|NCT00946088|Progesterone|progesterone|mesh-list
110491032|NCT00946088|Progestins|progestins|mesh-ancestor
110491033|NCT00946088|Hormones|hormones|mesh-ancestor
110491034|NCT00946088|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110491035|NCT00946088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110491036|NCT02562313|Insulin Lispro|insulin lispro|mesh-list
110491037|NCT02562313|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110491038|NCT02562313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110491039|NCT00736996|Pioglitazone|pioglitazone|mesh-list
110491040|NCT00736996|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110491041|NCT00736996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110491043|NCT00741949|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110491044|NCT00741949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110491045|NCT00741949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110491046|NCT00741949|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110491047|NCT00741949|Anesthetics, General|anesthetics, general|mesh-ancestor
110491048|NCT00741949|Anesthetics|anesthetics|mesh-ancestor
110491049|NCT01410344|Vidarabine|vidarabine|mesh-list
110491050|NCT01410344|Cyclophosphamide|cyclophosphamide|mesh-list
110491051|NCT01410344|Melphalan|melphalan|mesh-list
110491052|NCT01410344|Busulfan|busulfan|mesh-list
110491053|NCT01410344|Fludarabine|fludarabine|mesh-list
110491054|NCT01410344|Fludarabine phosphate|fludarabine phosphate|mesh-list
110491055|NCT01410344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110491056|NCT01410344|Immunologic Factors|immunologic factors|mesh-ancestor
110491057|NCT01410344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110491058|NCT01410344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110491059|NCT01410344|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110491060|NCT01410344|Alkylating Agents|alkylating agents|mesh-ancestor
110491061|NCT01410344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110491062|NCT01410344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110491063|NCT01410344|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110491064|NCT01410344|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110491066|NCT01410344|Antiviral Agents|antiviral agents|mesh-ancestor
110138301|NCT04574960|Carboplatin|carboplatin|mesh-list
110138302|NCT04574960|Gemcitabine|gemcitabine|mesh-list
110138303|NCT04574960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110138304|NCT04574960|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110138305|NCT04574960|Antimetabolites|antimetabolites|mesh-ancestor
110138307|NCT04539314|Dexmedetomidine|dexmedetomidine|mesh-list
110491067|NCT01410344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110491068|NCT02594410|Lercanidipine|lercanidipine|mesh-list
110491069|NCT02594410|Clopidogrel|clopidogrel|mesh-list
110491070|NCT02594410|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110491071|NCT02594410|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110491072|NCT02594410|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110491073|NCT02594410|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110491074|NCT02594410|Purinergic Agents|purinergic agents|mesh-ancestor
110491075|NCT02594410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110491076|NCT02594410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110491077|NCT02594410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110491078|NCT02594410|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110491079|NCT02594410|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110491080|NCT02594410|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110491081|NCT02594410|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110491082|NCT00954122|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110491083|NCT00954122|Antidepressive Agents|antidepressive agents|mesh-ancestor
110491084|NCT00954122|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110491085|NCT00954122|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110491086|NCT00954122|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110491087|NCT00954122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110491088|NCT00954122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110491090|NCT00586066|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110491091|NCT00586066|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110491092|NCT00586066|Dopamine Agents|dopamine agents|mesh-ancestor
110491093|NCT00586066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110491094|NCT00586066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110491095|NCT00586066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110167381|NCT00396058|Dopamine Agents|dopamine agents|mesh-ancestor
110491096|NCT00586066|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110491097|NCT00586066|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110491098|NCT00630890|Capecitabine|capecitabine|mesh-list
110491099|NCT00630890|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110491100|NCT00630890|Antimetabolites|antimetabolites|mesh-ancestor
110491101|NCT00630890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110491102|NCT00630890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110491103|NCT00728494|Ribavirin|ribavirin|mesh-list
110491104|NCT00728494|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110491105|NCT00728494|Interferon-alpha|interferon-alpha|mesh-list
110491106|NCT00728494|Antimetabolites|antimetabolites|mesh-ancestor
110491107|NCT00728494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110491108|NCT00728494|Antiviral Agents|antiviral agents|mesh-ancestor
110491109|NCT00728494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110582976|NCT01020643|Anesthetics|anesthetics|mesh-ancestor
110491110|NCT00728494|Immunologic Factors|immunologic factors|mesh-ancestor
110491111|NCT00728494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110491112|NCT02854904|Dexmedetomidine|dexmedetomidine|mesh-list
110491113|NCT02854904|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110491114|NCT02854904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110491115|NCT02854904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110491116|NCT02854904|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110491117|NCT02854904|Analgesics|analgesics|mesh-ancestor
110491118|NCT02854904|Sensory System Agents|sensory system agents|mesh-ancestor
110491119|NCT02854904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110491120|NCT02854904|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110491121|NCT02854904|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110491122|NCT02854904|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110491123|NCT02854904|Adrenergic Agents|adrenergic agents|mesh-ancestor
110491124|NCT02854904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110491125|NCT02854904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110491126|NCT00728416|Mometasone Furoate|mometasone furoate|mesh-list
110491127|NCT00728416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110491128|NCT00728416|Dermatologic Agents|dermatologic agents|mesh-ancestor
110491129|NCT00728416|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110491130|NCT00941330|Cyclophosphamide|cyclophosphamide|mesh-list
110491131|NCT00941330|Docetaxel|docetaxel|mesh-list
110491132|NCT00941330|Exemestane|exemestane|mesh-list
110491133|NCT00941330|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110491134|NCT00941330|Immunologic Factors|immunologic factors|mesh-ancestor
110491135|NCT00941330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110491136|NCT00941330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110491137|NCT00941330|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110491138|NCT00941330|Alkylating Agents|alkylating agents|mesh-ancestor
110138373|NCT04429022|Celecoxib|celecoxib|mesh-list
110491139|NCT00941330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110491140|NCT00941330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110491141|NCT00941330|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110491142|NCT00941330|Tubulin Modulators|tubulin modulators|mesh-ancestor
110491143|NCT00941330|Antimitotic Agents|antimitotic agents|mesh-ancestor
110491144|NCT00941330|Mitosis Modulators|mitosis modulators|mesh-ancestor
110491145|NCT00941330|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110491146|NCT00941330|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110491147|NCT00941330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110491148|NCT00941330|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110491149|NCT00941330|Hormone Antagonists|hormone antagonists|mesh-ancestor
110491150|NCT00941330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110491151|NCT00686881|Interferons|interferons|mesh-list
110491152|NCT00686881|Interferon-alpha|interferon-alpha|mesh-list
110491153|NCT00686881|Interferon alpha-2|interferon alpha-2|mesh-list
110491154|NCT00686881|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110491155|NCT00686881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110491156|NCT00686881|Antiviral Agents|antiviral agents|mesh-ancestor
110491157|NCT00686881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110491158|NCT00686881|Immunologic Factors|immunologic factors|mesh-ancestor
110491159|NCT00686881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110491160|NCT02857244|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110491161|NCT02857244|Modafinil|modafinil|mesh-list
110491162|NCT02857244|Donepezil|donepezil|mesh-list
110491163|NCT02857244|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110583238|NCT00799487|Dopamine Agents|dopamine agents|mesh-ancestor
110491164|NCT02857244|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110491165|NCT02857244|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110491166|NCT02857244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110491167|NCT02857244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110491168|NCT02857244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110491169|NCT02857244|Analgesics|analgesics|mesh-ancestor
110491170|NCT02857244|Sensory System Agents|sensory system agents|mesh-ancestor
110491171|NCT02857244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110491172|NCT02857244|Antidepressive Agents|antidepressive agents|mesh-ancestor
110583438|NCT00920283|Cobalt|cobalt|mesh-list
110491173|NCT02857244|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110491174|NCT02857244|Dopamine Agents|dopamine agents|mesh-ancestor
110491175|NCT02857244|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110491176|NCT02857244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110491177|NCT02857244|Cholinergic Agents|cholinergic agents|mesh-ancestor
110491178|NCT02857244|Nootropic Agents|nootropic agents|mesh-ancestor
110583458|NCT00772928|Vaccines|vaccines|mesh-list
110491179|NCT02857244|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110491180|NCT02857244|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
110491181|NCT02857244|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110491182|NCT02857244|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110491183|NCT04273256|Inositol|inositol|mesh-list
110491184|NCT04273256|Vitamin B Complex|vitamin b complex|mesh-ancestor
110491185|NCT04273256|Vitamins|vitamins|mesh-ancestor
110491186|NCT04273256|Micronutrients|micronutrients|mesh-ancestor
110491187|NCT04273256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110491188|NCT00921661|Aflibercept|aflibercept|mesh-list
110491189|NCT00921661|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110491190|NCT00921661|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110491191|NCT00921661|Growth Substances|growth substances|mesh-ancestor
110491192|NCT00921661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110491193|NCT00921661|Growth Inhibitors|growth inhibitors|mesh-ancestor
110491194|NCT00921661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110491195|NCT04088032|Durvalumab|durvalumab|mesh-list
110491196|NCT04088032|Aromatase Inhibitors|aromatase inhibitors|mesh-list
110491197|NCT04088032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110491198|NCT04088032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110491199|NCT04088032|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110491200|NCT04088032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110491201|NCT04088032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110491202|NCT04088032|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110491203|NCT04088032|Hormone Antagonists|hormone antagonists|mesh-ancestor
110491204|NCT04088032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110491205|NCT04088032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110491206|NCT00688597|1-Deoxynojirimycin|1-deoxynojirimycin|mesh-list
110491207|NCT00688597|Antiviral Agents|antiviral agents|mesh-ancestor
110491208|NCT00688597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110491209|NCT00688597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110491210|NCT00688597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110491211|NCT00735904|Gemcitabine|gemcitabine|mesh-list
110491212|NCT00735904|Axitinib|axitinib|mesh-list
110138448|NCT04324606|Antipyretics|antipyretics|mesh-ancestor
110491213|NCT00735904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110491214|NCT00735904|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110491215|NCT00735904|Antimetabolites|antimetabolites|mesh-ancestor
110491216|NCT00735904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110491217|NCT00735904|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110491218|NCT00735904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110491219|NCT02561923|Rivaroxaban|rivaroxaban|mesh-list
110491220|NCT02561923|Tranexamic Acid|tranexamic acid|mesh-list
110491221|NCT02561923|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110491222|NCT02561923|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110491223|NCT02561923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110491224|NCT02561923|Hemostatics|hemostatics|mesh-ancestor
110491226|NCT02561923|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110491227|NCT02561923|Antithrombins|antithrombins|mesh-ancestor
110491228|NCT02561923|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110491229|NCT02561923|Protease Inhibitors|protease inhibitors|mesh-ancestor
110491230|NCT02561923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110491231|NCT02561923|Anticoagulants|anticoagulants|mesh-ancestor
110491232|NCT00918190|Dexamethasone|dexamethasone|mesh-list
110491233|NCT00918190|Dexamethasone acetate|dexamethasone acetate|mesh-list
110491234|NCT00918190|Midazolam|midazolam|mesh-list
110491235|NCT00918190|Ondansetron|ondansetron|mesh-list
110491236|NCT00918190|BB 1101|bb 1101|mesh-list
110491237|NCT00918190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110491238|NCT00918190|Antiemetics|antiemetics|mesh-ancestor
110491239|NCT00918190|Autonomic Agents|autonomic agents|mesh-ancestor
110491240|NCT00918190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110491241|NCT00918190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110491242|NCT00918190|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110491243|NCT00918190|Glucocorticoids|glucocorticoids|mesh-ancestor
110491244|NCT00918190|Hormones|hormones|mesh-ancestor
110491245|NCT00918190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110491246|NCT00918190|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110491247|NCT00918190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110491248|NCT00918190|Protease Inhibitors|protease inhibitors|mesh-ancestor
110491249|NCT00918190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110491250|NCT00918190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110491251|NCT00918190|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110491252|NCT00918190|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110491253|NCT00918190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110491254|NCT00918190|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110491255|NCT00918190|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110491256|NCT00918190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110491257|NCT00918190|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110491258|NCT00918190|Anesthetics, General|anesthetics, general|mesh-ancestor
110491259|NCT00918190|Anesthetics|anesthetics|mesh-ancestor
110491260|NCT00918190|GABA Modulators|gaba modulators|mesh-ancestor
110491261|NCT00918190|GABA Agents|gaba agents|mesh-ancestor
110491262|NCT00918190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110491263|NCT00918190|Antipruritics|antipruritics|mesh-ancestor
110491264|NCT00918190|Dermatologic Agents|dermatologic agents|mesh-ancestor
110491265|NCT00918190|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110491266|NCT00918190|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110491267|NCT00918190|Serotonin Agents|serotonin agents|mesh-ancestor
110491268|NCT02563327|Pyridoxine|pyridoxine|mesh-list
110491269|NCT02563327|Vitamin B 6|vitamin b 6|mesh-list
110491270|NCT02563327|Moxifloxacin|moxifloxacin|mesh-list
110491271|NCT02563327|Rifampin|rifampin|mesh-list
110491272|NCT02563327|Isoniazid|isoniazid|mesh-list
110491273|NCT02563327|Pyrazinamide|pyrazinamide|mesh-list
110491274|NCT02563327|Ethambutol|ethambutol|mesh-list
110491275|NCT02563327|Rifapentine|rifapentine|mesh-list
110491276|NCT02563327|Vitamins|vitamins|mesh-ancestor
110491277|NCT02563327|Micronutrients|micronutrients|mesh-ancestor
110491278|NCT02563327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110491279|NCT02563327|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110491280|NCT02563327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110491281|NCT02563327|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110491282|NCT02563327|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110491283|NCT02563327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110584017|NCT00779324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110491284|NCT02563327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110491285|NCT02563327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110491286|NCT02563327|Vitamin B Complex|vitamin b complex|mesh-ancestor
110491287|NCT02563327|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110491288|NCT02563327|Antitubercular Agents|antitubercular agents|mesh-ancestor
110491289|NCT02563327|Leprostatic Agents|leprostatic agents|mesh-ancestor
110584085|NCT02581683|Ropivacaine|ropivacaine|mesh-list
110491290|NCT02563327|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110491291|NCT02563327|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110491292|NCT02563327|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110491293|NCT02563327|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110491295|NCT02563327|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110491296|NCT02563327|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110491297|NCT02563327|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
110491298|NCT02563327|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110491299|NCT02563327|Antimetabolites|antimetabolites|mesh-ancestor
110584221|NCT04109261|Palbociclib|palbociclib|mesh-list
110491300|NCT02563327|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110491301|NCT00918034|Talaporfin|talaporfin|mesh-list
110491302|NCT00918034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110491303|NCT00918034|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110491304|NCT00918034|Dermatologic Agents|dermatologic agents|mesh-ancestor
110491305|NCT02593942|Remifentanil|remifentanil|mesh-list
110491306|NCT02593942|Propofol|propofol|mesh-list
110491307|NCT02593942|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110491308|NCT02593942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110491309|NCT02593942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110491310|NCT02593942|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110491311|NCT02593942|Anesthetics, General|anesthetics, general|mesh-ancestor
110491312|NCT02593942|Anesthetics|anesthetics|mesh-ancestor
110491313|NCT02593942|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110491314|NCT02593942|Narcotics|narcotics|mesh-ancestor
110491315|NCT02593942|Analgesics|analgesics|mesh-ancestor
110491316|NCT02593942|Sensory System Agents|sensory system agents|mesh-ancestor
110491317|NCT02593942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110491318|NCT00742339|Octreotide|octreotide|mesh-list
110491319|NCT00742339|Terlipressin|terlipressin|mesh-list
110491320|NCT00742339|Midodrine|midodrine|mesh-list
110491321|NCT00742339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110491322|NCT00742339|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110491323|NCT00742339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110491325|NCT00742339|Autonomic Agents|autonomic agents|mesh-ancestor
110491326|NCT00742339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110491327|NCT00742339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110491328|NCT00742339|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110584425|NCT04076865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110491329|NCT00742339|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110491330|NCT00742339|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110491331|NCT00742339|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110491332|NCT00742339|Adrenergic Agents|adrenergic agents|mesh-ancestor
110491333|NCT00742339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110491334|NCT00742339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110491335|NCT00742339|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110491336|NCT02592772|Menthol|menthol|mesh-list
110491337|NCT02592772|Nicotine|nicotine|mesh-list
110491338|NCT02592772|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110491339|NCT02592772|Autonomic Agents|autonomic agents|mesh-ancestor
110491340|NCT02592772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110491341|NCT02592772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110491342|NCT02592772|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110491343|NCT02592772|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110491344|NCT02592772|Cholinergic Agents|cholinergic agents|mesh-ancestor
110584567|NCT00756470|Antimetabolites|antimetabolites|mesh-ancestor
110491345|NCT02592772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110491346|NCT02592772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110491348|NCT02592772|Dermatologic Agents|dermatologic agents|mesh-ancestor
110491349|NCT00631202|Epoetin Alfa|epoetin alfa|mesh-list
110491350|NCT00631202|Hematinics|hematinics|mesh-ancestor
110491351|NCT02851784|Immunomodulating Agents|immunomodulating agents|mesh-list
110491352|NCT02851784|Immunologic Factors|immunologic factors|mesh-ancestor
110491353|NCT02851784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110491354|NCT00721630|Capecitabine|capecitabine|mesh-list
110491355|NCT00721630|Lapatinib|lapatinib|mesh-list
110491356|NCT00721630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110491357|NCT00721630|Antimetabolites|antimetabolites|mesh-ancestor
110491358|NCT00721630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110491359|NCT00721630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110491360|NCT00721630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110491361|NCT00721630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110491362|NCT00686725|Temozolomide|temozolomide|mesh-list
110491363|NCT00686725|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110491364|NCT00686725|Alkylating Agents|alkylating agents|mesh-ancestor
110491365|NCT00686725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110491366|NCT00686725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110491368|NCT04055623|Interleukin-2|interleukin-2|mesh-list
110491369|NCT04055623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110491370|NCT04055623|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110491371|NCT04055623|Analgesics|analgesics|mesh-ancestor
110491372|NCT04055623|Sensory System Agents|sensory system agents|mesh-ancestor
110491373|NCT04055623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110491374|NCT04055623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110491375|NCT04055623|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110584839|NCT02603315|Mitogens|mitogens|mesh-list
110491376|NCT04055623|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110491377|NCT04055623|Antiviral Agents|antiviral agents|mesh-ancestor
110491378|NCT04055623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110491379|NCT02561845|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110491380|NCT02561845|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110491381|NCT02561845|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110491382|NCT02561845|Antimetabolites|antimetabolites|mesh-ancestor
110491383|NCT02561845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110491384|NCT02561845|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110491385|NCT02561845|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110491386|NCT02561845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110491388|NCT00727246|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
110491389|NCT00727246|Lipotropic Agents|lipotropic agents|mesh-ancestor
110491390|NCT00727246|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110491391|NCT00727246|Antimetabolites|antimetabolites|mesh-ancestor
110491392|NCT00727246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110491393|NCT00727246|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110491394|NCT00727246|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110491396|NCT05381558|Triamcinolone|triamcinolone|mesh-list
110491397|NCT05381558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110491398|NCT05381558|Glucocorticoids|glucocorticoids|mesh-ancestor
110491399|NCT05381558|Hormones|hormones|mesh-ancestor
110491400|NCT05381558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110585104|NCT01021267|Saw palmetto extract|saw palmetto extract|mesh-list
110491401|NCT05381558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110491403|NCT04055233|Polihexanide|polihexanide|mesh-list
110491404|NCT04055233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110491405|NCT04055233|Disinfectants|disinfectants|mesh-ancestor
110491406|NCT04055233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110491407|NCT04055233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110491408|NCT04268966|Brincidofovir|brincidofovir|mesh-list
110491409|NCT04268966|Antiviral Agents|antiviral agents|mesh-ancestor
110491410|NCT04268966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110491411|NCT04269278|Dexmedetomidine|dexmedetomidine|mesh-list
110491412|NCT04269278|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110491413|NCT04269278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110491414|NCT04269278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110491415|NCT04269278|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110491416|NCT04269278|Analgesics|analgesics|mesh-ancestor
110491417|NCT04269278|Sensory System Agents|sensory system agents|mesh-ancestor
110491418|NCT04269278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110491419|NCT04269278|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110491420|NCT04269278|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110491421|NCT04269278|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110585238|NCT00442117|Budesonide|budesonide|mesh-list
110491422|NCT04269278|Adrenergic Agents|adrenergic agents|mesh-ancestor
110491423|NCT04269278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110491424|NCT04269278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110491426|NCT02853578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110491427|NCT02853578|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110491428|NCT02853578|Autonomic Agents|autonomic agents|mesh-ancestor
110491429|NCT02853578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110491430|NCT02853578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110491431|NCT02853578|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110491432|NCT02853578|Respiratory System Agents|respiratory system agents|mesh-ancestor
110491433|NCT02853578|Glucocorticoids|glucocorticoids|mesh-ancestor
110491434|NCT02853578|Hormones|hormones|mesh-ancestor
110491435|NCT02853578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110491436|NCT02592694|Tenecteplase|tenecteplase|mesh-list
110491437|NCT02592694|Tirofiban|tirofiban|mesh-list
110491438|NCT02592694|Bivalirudin|bivalirudin|mesh-list
110491439|NCT02592694|Antithrombins|antithrombins|mesh-ancestor
110491440|NCT02592694|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110491441|NCT02592694|Protease Inhibitors|protease inhibitors|mesh-ancestor
110491442|NCT02592694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110491443|NCT02592694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110491445|NCT02592694|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110491446|NCT02592694|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110491447|NCT02592694|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110491448|NCT02591836|Atorvastatin|atorvastatin|mesh-list
110491449|NCT02591836|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110491450|NCT02591836|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110491451|NCT02591836|Antimetabolites|antimetabolites|mesh-ancestor
110491452|NCT02591836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110491453|NCT02591836|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110491454|NCT02591836|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110491455|NCT02591836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110491456|NCT02851472|Nitric Oxide|nitric oxide|mesh-list
110491457|NCT02851472|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110491458|NCT02851472|Autonomic Agents|autonomic agents|mesh-ancestor
110491459|NCT02851472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110491460|NCT02851472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110491461|NCT02851472|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110491462|NCT02851472|Respiratory System Agents|respiratory system agents|mesh-ancestor
110491463|NCT02851472|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110491464|NCT02851472|Antioxidants|antioxidants|mesh-ancestor
110491465|NCT02851472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110491466|NCT02851472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110491467|NCT02851472|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
110491468|NCT02851472|Vasodilator Agents|vasodilator agents|mesh-ancestor
110585728|NCT04071639|Antiemetics|antiemetics|mesh-ancestor
110491469|NCT02851472|Gasotransmitters|gasotransmitters|mesh-ancestor
110491470|NCT02851472|Protective Agents|protective agents|mesh-ancestor
110491471|NCT00687973|Atenolol|atenolol|mesh-list
110491472|NCT00687973|Amlodipine|amlodipine|mesh-list
110491473|NCT00687973|Valsartan|valsartan|mesh-list
110491474|NCT00687973|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110491475|NCT00687973|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110491476|NCT00687973|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110585786|NCT01298193|Autonomic Agents|autonomic agents|mesh-ancestor
110491477|NCT00687973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110491478|NCT00687973|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110491479|NCT00687973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110491480|NCT00687973|Vasodilator Agents|vasodilator agents|mesh-ancestor
110491481|NCT00687973|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110491482|NCT00687973|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110491483|NCT00687973|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110491484|NCT00687973|Sympatholytics|sympatholytics|mesh-ancestor
110491485|NCT00687973|Autonomic Agents|autonomic agents|mesh-ancestor
110491486|NCT00687973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110491487|NCT00687973|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110491488|NCT00687973|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110491489|NCT00687973|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110491490|NCT00687973|Adrenergic Agents|adrenergic agents|mesh-ancestor
110491492|NCT00747097|Gemcitabine|gemcitabine|mesh-list
110491493|NCT00747097|Cetuximab|cetuximab|mesh-list
110491494|NCT00747097|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110491495|NCT00747097|Antimetabolites|antimetabolites|mesh-ancestor
110491496|NCT00747097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110491497|NCT00747097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110491498|NCT00747097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110491499|NCT00747331|Fenoldopam|fenoldopam|mesh-list
110491500|NCT00747331|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110491501|NCT00747331|Vasodilator Agents|vasodilator agents|mesh-ancestor
110491502|NCT00747331|Dopamine Agonists|dopamine agonists|mesh-ancestor
110491503|NCT00747331|Dopamine Agents|dopamine agents|mesh-ancestor
110491504|NCT00747331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110491505|NCT00747331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110491506|NCT00747331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110491507|NCT00747409|Insulin|insulin|mesh-list
110491508|NCT00747409|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110491509|NCT00747409|Insulin Aspart|insulin aspart|mesh-list
110491510|NCT00747409|Insulin Detemir|insulin detemir|mesh-list
110491511|NCT00747409|Insulin, Long-Acting|insulin, long-acting|mesh-list
110138747|NCT03978442|Bupropion|bupropion|mesh-list
110585989|NCT02576301|Mitosis Modulators|mitosis modulators|mesh-ancestor
110138748|NCT03978442|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110138749|NCT03978442|Antidepressive Agents|antidepressive agents|mesh-ancestor
110138750|NCT03978442|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110138751|NCT03978442|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110138752|NCT03978442|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110491512|NCT00747409|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
110491513|NCT00747409|Insulin, Isophane|insulin, isophane|mesh-list
110491514|NCT00747409|Isophane Insulin, Human|isophane insulin, human|mesh-list
110491515|NCT00747409|Isophane insulin, beef|isophane insulin, beef|mesh-list
110491516|NCT00747409|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110491517|NCT00747409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110491518|NCT00752011|Carboplatin|carboplatin|mesh-list
110491519|NCT00752011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110491520|NCT00721396|Vaccines|vaccines|mesh-list
110491521|NCT00721396|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110491522|NCT00721396|Immunologic Factors|immunologic factors|mesh-ancestor
110491523|NCT00721396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110491524|NCT00943826|Bevacizumab|bevacizumab|mesh-list
110491525|NCT00943826|Temozolomide|temozolomide|mesh-list
110491526|NCT00943826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110491527|NCT00943826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110491528|NCT00943826|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110491529|NCT00943826|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110491530|NCT00943826|Growth Substances|growth substances|mesh-ancestor
110491531|NCT00943826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110491532|NCT00943826|Growth Inhibitors|growth inhibitors|mesh-ancestor
110491533|NCT00943826|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110491534|NCT00943826|Alkylating Agents|alkylating agents|mesh-ancestor
110491535|NCT00943826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110491536|NCT04268888|Nivolumab|nivolumab|mesh-list
110491537|NCT04268888|Chlorotrianisene|chlorotrianisene|mesh-list
110491538|NCT04268888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110491539|NCT04268888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110491540|NCT04268888|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110491541|NCT04268888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110491542|NCT04268888|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
110491543|NCT04268888|Estrogens|estrogens|mesh-ancestor
110491544|NCT04268888|Hormones|hormones|mesh-ancestor
110491545|NCT04268888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110491546|NCT04268888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110491547|NCT04268888|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110491548|NCT00603356|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110491549|NCT00603356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110491550|NCT00603356|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110491551|NCT00603356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110491552|NCT00603356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110491553|NCT02851394|Tramadol|tramadol|mesh-list
110491554|NCT02851394|Levobupivacaine|levobupivacaine|mesh-list
110491555|NCT02851394|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110491557|NCT02851394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110491558|NCT02851394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110491559|NCT02851394|Analgesics|analgesics|mesh-ancestor
110491560|NCT02851394|Sensory System Agents|sensory system agents|mesh-ancestor
110397564|NCT01076647|Insulin|insulin|mesh-list
110491561|NCT02851394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110491562|NCT02851394|Anesthetics, Local|anesthetics, local|mesh-ancestor
110491563|NCT02851394|Anesthetics|anesthetics|mesh-ancestor
110491564|NCT00603434|Methylphenidate|methylphenidate|mesh-list
110491565|NCT00603434|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110491566|NCT00603434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110491567|NCT00603434|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110491568|NCT00603434|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110491569|NCT00603434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110491570|NCT00603434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110491571|NCT00603434|Dopamine Agents|dopamine agents|mesh-ancestor
110491572|NCT00603434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110491573|NCT01004003|Sorafenib|sorafenib|mesh-list
110491574|NCT01004003|Nintedanib|nintedanib|mesh-list
110491575|NCT01004003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110491576|NCT01004003|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110138831|NCT03936829|Cyclophosphamide|cyclophosphamide|mesh-list
110138832|NCT03936829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110138833|NCT03936829|Immunologic Factors|immunologic factors|mesh-ancestor
110138834|NCT03936829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110138835|NCT03936829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110138836|NCT03936829|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110138837|NCT03936829|Alkylating Agents|alkylating agents|mesh-ancestor
110138838|NCT03936829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110491577|NCT01004003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110491578|NCT01004003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110491580|NCT00943670|Pertuzumab|pertuzumab|mesh-list
110491581|NCT00943670|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
110491582|NCT00943670|Maytansine|maytansine|mesh-list
110491583|NCT00943670|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110586426|NCT02574663|Antidotes|antidotes|mesh-ancestor
110491584|NCT00943670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110491585|NCT00943670|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110491586|NCT00943670|Tubulin Modulators|tubulin modulators|mesh-ancestor
110491587|NCT00943670|Antimitotic Agents|antimitotic agents|mesh-ancestor
110491588|NCT00943670|Mitosis Modulators|mitosis modulators|mesh-ancestor
110491589|NCT00943670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110491590|NCT00943670|Immunotoxins|immunotoxins|mesh-ancestor
110491591|NCT00943670|Immunoconjugates|immunoconjugates|mesh-ancestor
110491592|NCT00943670|Immunologic Factors|immunologic factors|mesh-ancestor
110491593|NCT00943670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110491594|NCT02851004|Pembrolizumab|pembrolizumab|mesh-list
110491595|NCT02851004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110586566|NCT04971720|Valsartan|valsartan|mesh-list
110491596|NCT02851004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110491597|NCT02851004|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110491598|NCT02851004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110491599|NCT00938366|Cladribine|cladribine|mesh-list
110491600|NCT00938366|Pantoprazole|pantoprazole|mesh-list
110491601|NCT00938366|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110491602|NCT00938366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110491603|NCT00938366|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110491604|NCT00938366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110491605|NCT00938366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110491606|NCT00938366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110491607|NCT00938366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110491608|NCT00938366|Immunologic Factors|immunologic factors|mesh-ancestor
110491609|NCT00938366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110491610|NCT00943592|Melphalan|melphalan|mesh-list
110491611|NCT00943592|Alemtuzumab|alemtuzumab|mesh-list
110491612|NCT00943592|Clofarabine|clofarabine|mesh-list
110491613|NCT00943592|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110491614|NCT00943592|Alkylating Agents|alkylating agents|mesh-ancestor
110491615|NCT00943592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110491616|NCT00943592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110491617|NCT00943592|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110491618|NCT00943592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110491619|NCT00943592|Immunologic Factors|immunologic factors|mesh-ancestor
110491620|NCT00943592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110491621|NCT00943592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110167466|NCT01791816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110491622|NCT00943592|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110491623|NCT00943592|Antimetabolites|antimetabolites|mesh-ancestor
110491625|NCT00943124|Niacinamide|niacinamide|mesh-list
110491626|NCT00943124|Nicotinic Acids|nicotinic acids|mesh-list
110491627|NCT00943124|Simvastatin|simvastatin|mesh-list
110491628|NCT00943124|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110491629|NCT00943124|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110491630|NCT00943124|Antimetabolites|antimetabolites|mesh-ancestor
110491631|NCT00943124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110491632|NCT00943124|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110491633|NCT00943124|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110491634|NCT00943124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110491635|NCT00943124|Vasodilator Agents|vasodilator agents|mesh-ancestor
110491636|NCT00943124|Vitamin B Complex|vitamin b complex|mesh-ancestor
110491638|NCT00943124|Micronutrients|micronutrients|mesh-ancestor
110491639|NCT00943124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110491640|NCT00940316|Irinotecan|irinotecan|mesh-list
110491641|NCT00940316|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110491642|NCT00940316|Panitumumab|panitumumab|mesh-list
110491643|NCT00940316|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110491644|NCT00940316|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110491645|NCT00940316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110491646|NCT00940316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110491647|NCT00940316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110138899|NCT03859024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110138900|NCT03859024|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110138901|NCT03859024|Narcotics|narcotics|mesh-ancestor
110138902|NCT03859024|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110491648|NCT00940316|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110491649|NCT00940316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110491651|NCT02850848|Antiviral Agents|antiviral agents|mesh-ancestor
110491652|NCT02850848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110491653|NCT05381168|Calcium, Dietary|calcium, dietary|mesh-list
110491654|NCT05381168|Calcium Carbonate|calcium carbonate|mesh-list
110491655|NCT05381168|Calcium|calcium|mesh-list
110491656|NCT05381168|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110491657|NCT05381168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110491658|NCT05381168|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110491659|NCT05381168|Antacids|antacids|mesh-ancestor
110491660|NCT05381168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110491661|NCT05381168|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110491662|NCT00726388|Diclofenac|diclofenac|mesh-list
110491663|NCT00726388|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110491664|NCT00726388|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110491665|NCT00726388|Analgesics|analgesics|mesh-ancestor
110491666|NCT00726388|Sensory System Agents|sensory system agents|mesh-ancestor
110491667|NCT00726388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110491668|NCT00726388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110491669|NCT00726388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110491670|NCT00726388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110491671|NCT00726388|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110491672|NCT00726388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110491673|NCT00726388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110491674|NCT00572455|Latanoprost|latanoprost|mesh-list
110491675|NCT00572455|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110491676|NCT00572455|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110491677|NCT00752323|Aminolevulinic Acid|aminolevulinic acid|mesh-list
110491678|NCT00752323|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110491679|NCT00752323|Dermatologic Agents|dermatologic agents|mesh-ancestor
110491680|NCT00686335|Prednisone|prednisone|mesh-list
110491681|NCT00686335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110491682|NCT00686335|Glucocorticoids|glucocorticoids|mesh-ancestor
110491683|NCT00686335|Hormones|hormones|mesh-ancestor
110587244|NCT00713271|AZD-3199|azd-3199|mesh-list
110491684|NCT00686335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110491685|NCT00686335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110491686|NCT00686335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110491687|NCT00686335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110491689|NCT00685945|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
110491690|NCT00685945|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
110491691|NCT00685945|Sildenafil Citrate|sildenafil citrate|mesh-list
110491692|NCT00685945|Bradykinin|bradykinin|mesh-list
110491693|NCT00685945|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
110491694|NCT00685945|Kininogens|kininogens|mesh-list
110491696|NCT00685945|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110491697|NCT00685945|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110491698|NCT00685945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110491699|NCT00685945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110491700|NCT00685945|Urological Agents|urological agents|mesh-ancestor
110491701|NCT00685945|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110491702|NCT00685945|Diuretics|diuretics|mesh-ancestor
110491703|NCT00685945|Natriuretic Agents|natriuretic agents|mesh-ancestor
110491704|NCT00685945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110491705|NCT00685945|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
110491706|NCT00685945|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
110491707|NCT00685945|Protease Inhibitors|protease inhibitors|mesh-ancestor
110491709|NCT00747487|Antioxidants|antioxidants|mesh-ancestor
110491710|NCT00747487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110491711|NCT00747487|Protective Agents|protective agents|mesh-ancestor
110491712|NCT00747487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110491713|NCT00750217|Buprenorphine|buprenorphine|mesh-list
110491714|NCT00750217|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110491716|NCT00750217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110491717|NCT00750217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110491718|NCT00750217|Analgesics|analgesics|mesh-ancestor
110491719|NCT00750217|Sensory System Agents|sensory system agents|mesh-ancestor
110491720|NCT00750217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110491721|NCT00750217|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110491722|NCT00687739|Leuprolide|leuprolide|mesh-list
110491723|NCT00687739|Estradiol|estradiol|mesh-list
110491724|NCT00687739|Estrogens|estrogens|mesh-ancestor
110491725|NCT00687739|Hormones|hormones|mesh-ancestor
110491726|NCT00687739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110491727|NCT00687739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110491728|NCT00687739|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110491729|NCT00687739|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110587596|NCT04066803|Folic Acid|folic acid|mesh-list
110491730|NCT00687739|Fertility Agents|fertility agents|mesh-ancestor
110491731|NCT00687739|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110491732|NCT00687739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110491733|NCT00752401|Vitamin D|vitamin d|mesh-list
110491734|NCT00752401|Cholecalciferol|cholecalciferol|mesh-list
110491735|NCT00752401|Vitamins|vitamins|mesh-ancestor
110491736|NCT00752401|Micronutrients|micronutrients|mesh-ancestor
110491737|NCT00752401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110491738|NCT00752401|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110491739|NCT00752401|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110491740|NCT00750451|Heparin|heparin|mesh-list
110491742|NCT00750451|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
110491743|NCT00750451|Tinzaparin|tinzaparin|mesh-list
110491744|NCT00750451|Dalteparin|dalteparin|mesh-list
110491745|NCT00750451|Enoxaparin sodium|enoxaparin sodium|mesh-list
110491746|NCT00750451|Anticoagulants|anticoagulants|mesh-ancestor
110491747|NCT00750451|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110491748|NCT00750451|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110491749|NCT00750451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110491750|NCT00747721|Dexmedetomidine|dexmedetomidine|mesh-list
110491751|NCT00747721|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110491752|NCT00747721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110491753|NCT00747721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110491754|NCT00747721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110491755|NCT00747721|Analgesics|analgesics|mesh-ancestor
110270348|NCT00324922|Trimethoprim|trimethoprim|mesh-list
110491756|NCT00747721|Sensory System Agents|sensory system agents|mesh-ancestor
110491757|NCT00747721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110491758|NCT00747721|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110491759|NCT00747721|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110167477|NCT00031798|Dopamine Agents|dopamine agents|mesh-ancestor
110491761|NCT00747721|Adrenergic Agents|adrenergic agents|mesh-ancestor
110491762|NCT00747721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110491763|NCT00747721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110491764|NCT01006889|Exenatide|exenatide|mesh-list
110491765|NCT01006889|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110491766|NCT01006889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110491767|NCT01006889|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110491768|NCT01006889|Incretins|incretins|mesh-ancestor
110491769|NCT01006889|Hormones|hormones|mesh-ancestor
110491770|NCT01006889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110491771|NCT02561767|Mycophenolic Acid|mycophenolic acid|mesh-list
110491772|NCT02561767|Tacrolimus|tacrolimus|mesh-list
110491773|NCT02561767|Basiliximab|basiliximab|mesh-list
110491774|NCT02561767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110491775|NCT02561767|Immunologic Factors|immunologic factors|mesh-ancestor
110491776|NCT02561767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110491777|NCT02561767|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110491778|NCT02561767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110587700|NCT04250883|Micronutrients|micronutrients|mesh-ancestor
110491779|NCT02561767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110491780|NCT02561767|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110491781|NCT02561767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110491782|NCT02561767|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110491783|NCT02561767|Antitubercular Agents|antitubercular agents|mesh-ancestor
110491784|NCT02561767|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110587740|NCT04066179|Prednisolone|prednisolone|mesh-list
110491785|NCT02561767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110491786|NCT00747799|Fluorouracil|fluorouracil|mesh-list
110491787|NCT00747799|Sorafenib|sorafenib|mesh-list
110491788|NCT00747799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110491789|NCT00747799|Antimetabolites|antimetabolites|mesh-ancestor
110491790|NCT00747799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110491791|NCT00747799|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110491792|NCT00747799|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110491793|NCT00747799|Immunologic Factors|immunologic factors|mesh-ancestor
110587810|NCT04066257|Metronidazole|metronidazole|mesh-list
110491794|NCT00747799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110491795|NCT00747799|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110491796|NCT00747799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110491797|NCT04294823|Esomeprazole|esomeprazole|mesh-list
110491798|NCT04294823|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110491799|NCT04294823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110491800|NCT04294823|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110491802|NCT04294823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110491803|NCT04294511|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
110587870|NCT00730509|Hydroxocobalamin|hydroxocobalamin|mesh-list
110491804|NCT04294511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110491805|NCT04294511|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110491806|NCT04294511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110491807|NCT01001429|Dexmedetomidine|dexmedetomidine|mesh-list
110491808|NCT01001429|Propofol|propofol|mesh-list
110491809|NCT01001429|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110587941|NCT04019652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110491810|NCT01001429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110491811|NCT01001429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110491812|NCT01001429|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110491813|NCT01001429|Analgesics|analgesics|mesh-ancestor
110491814|NCT01001429|Sensory System Agents|sensory system agents|mesh-ancestor
110270371|NCT00407186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110491815|NCT01001429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110491816|NCT01001429|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110491817|NCT01001429|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110491818|NCT01001429|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110491819|NCT01001429|Adrenergic Agents|adrenergic agents|mesh-ancestor
110491820|NCT01001429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110491821|NCT01001429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110491822|NCT01001429|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110491824|NCT01001429|Anesthetics|anesthetics|mesh-ancestor
110491825|NCT01000961|Cysteamine|cysteamine|mesh-list
110491826|NCT01000961|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
110491827|NCT01000961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110491828|NCT01000805|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110491829|NCT01000805|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110491830|NCT01000805|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110491831|NCT01000805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110491832|NCT01000805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110491833|NCT01000805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110491834|NCT01000805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110491835|NCT01000805|Analgesics|analgesics|mesh-ancestor
110491836|NCT01000805|Sensory System Agents|sensory system agents|mesh-ancestor
110491837|NCT01000805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110491838|NCT01000805|Antidepressive Agents|antidepressive agents|mesh-ancestor
110491839|NCT01000805|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110491840|NCT01000805|Dopamine Agents|dopamine agents|mesh-ancestor
110491841|NCT00684307|Vitamin K|vitamin k|mesh-list
110491842|NCT00684307|Warfarin|warfarin|mesh-list
110491843|NCT00684307|Vitamins|vitamins|mesh-ancestor
110491844|NCT00684307|Micronutrients|micronutrients|mesh-ancestor
110491845|NCT00684307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110491846|NCT00684307|Anticoagulants|anticoagulants|mesh-ancestor
110491847|NCT00684307|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110491848|NCT00684307|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110491849|NCT00684307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110491850|NCT00684307|Hemostatics|hemostatics|mesh-ancestor
110491851|NCT00684307|Coagulants|coagulants|mesh-ancestor
110491852|NCT00683917|Leuprolide|leuprolide|mesh-list
110491853|NCT00683917|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110491854|NCT00683917|Fertility Agents|fertility agents|mesh-ancestor
110491855|NCT00683917|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110491856|NCT00683917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110491857|NCT00683917|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110491858|NCT00683917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110491859|NCT00750529|Donepezil|donepezil|mesh-list
110491861|NCT00750529|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110491862|NCT00750529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110491863|NCT00750529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110491864|NCT00750529|Cholinergic Agents|cholinergic agents|mesh-ancestor
110491865|NCT00750529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110491866|NCT00750529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110491867|NCT00750529|Nootropic Agents|nootropic agents|mesh-ancestor
110491868|NCT00750529|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110491869|NCT00750529|Autonomic Agents|autonomic agents|mesh-ancestor
110491870|NCT00750529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110491871|NCT00747877|Cyclophosphamide|cyclophosphamide|mesh-list
110491872|NCT00747877|Melphalan|melphalan|mesh-list
110491873|NCT00747877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110491874|NCT00747877|Immunologic Factors|immunologic factors|mesh-ancestor
110491875|NCT00747877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110491876|NCT00747877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110491877|NCT00747877|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110491878|NCT00747877|Alkylating Agents|alkylating agents|mesh-ancestor
110491879|NCT00747877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110491880|NCT00747877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110491881|NCT00747877|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110491882|NCT00750763|Picosulfate sodium|picosulfate sodium|mesh-list
110491883|NCT00750763|Cathartics|cathartics|mesh-ancestor
110491884|NCT00750763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110491885|NCT00752479|Cyclosporine|cyclosporine|mesh-list
110491886|NCT00752479|Mycophenolic Acid|mycophenolic acid|mesh-list
110491887|NCT00752479|Methylprednisolone|methylprednisolone|mesh-list
110491888|NCT00752479|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110491889|NCT00752479|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110491891|NCT00752479|Prednisolone acetate|prednisolone acetate|mesh-list
110491892|NCT00752479|Cyclosporins|cyclosporins|mesh-list
110491893|NCT00752479|Basiliximab|basiliximab|mesh-list
110491894|NCT00752479|Thymoglobulin|thymoglobulin|mesh-list
110491895|NCT00752479|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110491896|NCT00752479|Prednisolone phosphate|prednisolone phosphate|mesh-list
110588693|NCT02583594|Hormones|hormones|mesh-ancestor
110491897|NCT00752479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110491898|NCT00752479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110491899|NCT00752479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110491900|NCT00752479|Immunologic Factors|immunologic factors|mesh-ancestor
110491901|NCT00752479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110491902|NCT00752479|Antifungal Agents|antifungal agents|mesh-ancestor
110491903|NCT00752479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110491905|NCT00752479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110491906|NCT00752479|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110491907|NCT00752479|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110491908|NCT00752479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110491909|NCT00752479|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110491910|NCT00752479|Antitubercular Agents|antitubercular agents|mesh-ancestor
110491911|NCT00752479|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110588844|NCT00918086|Vitamin D|vitamin d|mesh-list
110491912|NCT00752479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110491913|NCT00752479|Antiemetics|antiemetics|mesh-ancestor
110491914|NCT00752479|Autonomic Agents|autonomic agents|mesh-ancestor
110491915|NCT00752479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110491916|NCT00752479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110491917|NCT00752479|Glucocorticoids|glucocorticoids|mesh-ancestor
110491919|NCT00752479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110491920|NCT00752479|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110491921|NCT00752479|Protective Agents|protective agents|mesh-ancestor
110491922|NCT00752479|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110491923|NCT00752635|Moxifloxacin|moxifloxacin|mesh-list
110491924|NCT00752635|Cyproterone Acetate|cyproterone acetate|mesh-list
110491925|NCT00752635|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110491926|NCT00752635|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110491927|NCT00752635|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110491928|NCT00752635|Norgestimate|norgestimate|mesh-list
110491929|NCT00752635|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
110491930|NCT00752635|Estradiol|estradiol|mesh-list
110491931|NCT00752635|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110491932|NCT00752635|Cyproterone|cyproterone|mesh-list
110491933|NCT00752635|Estrogens|estrogens|mesh-ancestor
110491934|NCT00752635|Hormones|hormones|mesh-ancestor
110491935|NCT00752635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110491936|NCT00752635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110491937|NCT00752635|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110491938|NCT00752635|Contraceptive Agents|contraceptive agents|mesh-ancestor
110491939|NCT00752635|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110491940|NCT00752635|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110491941|NCT00752635|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110491942|NCT00752635|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110491944|NCT00752635|Hormone Antagonists|hormone antagonists|mesh-ancestor
110491945|NCT00752635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110491946|NCT00752635|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110491947|NCT00752635|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110491948|NCT00752635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110491950|NCT00752635|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110491951|NCT00752635|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110491952|NCT00752635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110491953|NCT00752635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110491954|NCT00752635|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110491955|NCT00750997|Dextrans|dextrans|mesh-list
110491956|NCT00750997|Anticoagulants|anticoagulants|mesh-ancestor
110491957|NCT00750997|Plasma Substitutes|plasma substitutes|mesh-ancestor
110491958|NCT00750997|Blood Substitutes|blood substitutes|mesh-ancestor
110491959|NCT00748345|Caspofungin|caspofungin|mesh-list
110491960|NCT00748345|Antifungal Agents|antifungal agents|mesh-ancestor
110491961|NCT00748345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110491962|NCT00748345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110589319|NCT02592746|Antimetabolites|antimetabolites|mesh-ancestor
110491963|NCT00748345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110491964|NCT00752869|Dutasteride|dutasteride|mesh-list
110491965|NCT00752869|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
110491966|NCT00752869|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110491967|NCT00752869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110491968|NCT00752869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110491969|NCT00752869|Hormone Antagonists|hormone antagonists|mesh-ancestor
110491970|NCT00752869|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110491971|NCT00752869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110491972|NCT00751153|Raltegravir Potassium|raltegravir potassium|mesh-list
110491973|NCT00751153|Atazanavir Sulfate|atazanavir sulfate|mesh-list
110491974|NCT00751153|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110491975|NCT00751153|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110491976|NCT00751153|Antiviral Agents|antiviral agents|mesh-ancestor
110491977|NCT00751153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110491978|NCT00751153|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110491979|NCT00751153|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110491980|NCT00751153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110491981|NCT00751153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110491982|NCT00751153|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110491983|NCT00751153|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110491984|NCT00751153|Protease Inhibitors|protease inhibitors|mesh-ancestor
110491985|NCT00748423|Nitric Oxide|nitric oxide|mesh-list
110491986|NCT00748423|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110491987|NCT00748423|Autonomic Agents|autonomic agents|mesh-ancestor
110491988|NCT00748423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110491989|NCT00748423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110491990|NCT00748423|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110491991|NCT00748423|Respiratory System Agents|respiratory system agents|mesh-ancestor
110270414|NCT00193089|Docetaxel|docetaxel|mesh-list
110491992|NCT00748423|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110491993|NCT00748423|Antioxidants|antioxidants|mesh-ancestor
110491994|NCT00748423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110491995|NCT00748423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110491996|NCT00748423|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
110491997|NCT00748423|Vasodilator Agents|vasodilator agents|mesh-ancestor
110491998|NCT00748423|Gasotransmitters|gasotransmitters|mesh-ancestor
110491999|NCT00748423|Protective Agents|protective agents|mesh-ancestor
110492000|NCT00687271|Atorvastatin|atorvastatin|mesh-list
110492001|NCT00687271|Calcium|calcium|mesh-list
110492002|NCT00687271|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110492003|NCT00687271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110492004|NCT00687271|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110492005|NCT00687271|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110492006|NCT00687271|Antimetabolites|antimetabolites|mesh-ancestor
110492007|NCT00687271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110492008|NCT00687271|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110492009|NCT00687271|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110492010|NCT00687271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110492011|NCT02562625|Pembrolizumab|pembrolizumab|mesh-list
110492012|NCT02562625|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110492013|NCT02562625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110492014|NCT02562625|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110492015|NCT02562625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110492016|NCT00752947|Moxifloxacin|moxifloxacin|mesh-list
110492018|NCT00752947|Levofloxacin|levofloxacin|mesh-list
110492019|NCT00752947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110492020|NCT00752947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110492021|NCT00752947|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110492022|NCT00752947|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110492023|NCT00752947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110492024|NCT00752947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110492025|NCT00752947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110492026|NCT00752947|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110492027|NCT00752947|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110492028|NCT00752947|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110492029|NCT00752947|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110492030|NCT00752947|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110492032|NCT04614545|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110589845|NCT00776555|Dopamine Agents|dopamine agents|mesh-ancestor
110492033|NCT04614545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110492034|NCT04614545|Appetite Depressants|appetite depressants|mesh-ancestor
110492036|NCT04614545|Sympathomimetics|sympathomimetics|mesh-ancestor
110492037|NCT04614545|Autonomic Agents|autonomic agents|mesh-ancestor
110492038|NCT04614545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110492039|NCT04614545|Adrenergic Agents|adrenergic agents|mesh-ancestor
110492040|NCT04614545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110492041|NCT04614545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110492042|NCT01031381|Bevacizumab|bevacizumab|mesh-list
110492043|NCT01031381|Everolimus|everolimus|mesh-list
110492044|NCT01031381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110492045|NCT01031381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110492046|NCT01031381|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110492047|NCT01031381|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110492048|NCT01031381|Growth Substances|growth substances|mesh-ancestor
110589985|NCT00717314|Mycophenolic Acid|mycophenolic acid|mesh-list
110492049|NCT01031381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110492050|NCT01031381|Growth Inhibitors|growth inhibitors|mesh-ancestor
110492051|NCT01031381|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110492052|NCT01031381|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110492053|NCT01031381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110492054|NCT01031381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110492055|NCT01031381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110492056|NCT01031381|Immunologic Factors|immunologic factors|mesh-ancestor
110492057|NCT00685399|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110492058|NCT00685399|Immunologic Factors|immunologic factors|mesh-ancestor
110492059|NCT00685399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110492060|NCT00751699|Mesalamine|mesalamine|mesh-list
110492061|NCT00751699|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110492062|NCT00751699|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110492063|NCT00751699|Analgesics|analgesics|mesh-ancestor
110492064|NCT00751699|Sensory System Agents|sensory system agents|mesh-ancestor
110492065|NCT00751699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110492066|NCT00751699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110492067|NCT00751699|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110492068|NCT00751699|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110492069|NCT00753103|Mycophenolic Acid|mycophenolic acid|mesh-list
110492070|NCT00753103|Methylprednisolone|methylprednisolone|mesh-list
110492071|NCT00753103|Prednisolone|prednisolone|mesh-list
110492072|NCT00753103|Infliximab|infliximab|mesh-list
110492073|NCT00753103|Cyclophosphamide|cyclophosphamide|mesh-list
110492074|NCT00753103|Azathioprine|azathioprine|mesh-list
110492075|NCT00753103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110492076|NCT00753103|Immunologic Factors|immunologic factors|mesh-ancestor
110492077|NCT00753103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110492078|NCT00753103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110492079|NCT00753103|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110492080|NCT00753103|Alkylating Agents|alkylating agents|mesh-ancestor
110492081|NCT00753103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110492082|NCT00753103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110492083|NCT00753103|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110590180|NCT00741585|Adrenergic Agents|adrenergic agents|mesh-ancestor
110492084|NCT00753103|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110492085|NCT00753103|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110492086|NCT00753103|Antitubercular Agents|antitubercular agents|mesh-ancestor
110492087|NCT00753103|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110492088|NCT00753103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110492089|NCT00753103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110492090|NCT00753103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110492091|NCT00753103|Antiemetics|antiemetics|mesh-ancestor
110492092|NCT00753103|Autonomic Agents|autonomic agents|mesh-ancestor
110492093|NCT00753103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110492094|NCT00753103|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110492095|NCT00753103|Glucocorticoids|glucocorticoids|mesh-ancestor
110590239|NCT00741897|Fexofenadine|fexofenadine|mesh-list
110492097|NCT00753103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110492098|NCT00753103|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110492099|NCT00753103|Protective Agents|protective agents|mesh-ancestor
110590301|NCT00719264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110492100|NCT00753103|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110492101|NCT00753103|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110270456|NCT00163982|Norfloxacin|norfloxacin|mesh-list
110492102|NCT00753103|Dermatologic Agents|dermatologic agents|mesh-ancestor
110492103|NCT00753103|Antimetabolites|antimetabolites|mesh-ancestor
110492104|NCT00753103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110492105|NCT00748891|Cediranib|cediranib|mesh-list
110492106|NCT00748891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110492107|NCT00748891|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110492108|NCT00748891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110492109|NCT00748891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110492110|NCT00685165|Primidone|primidone|mesh-list
110492111|NCT00685165|Anticonvulsants|anticonvulsants|mesh-ancestor
110492112|NCT00685165|GABA Modulators|gaba modulators|mesh-ancestor
110492113|NCT00685165|GABA Agents|gaba agents|mesh-ancestor
110492114|NCT00685165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110492115|NCT00685165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110492116|NCT00685165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110492117|NCT00749047|Pioglitazone|pioglitazone|mesh-list
110590431|NCT00749385|Esomeprazole|esomeprazole|mesh-list
110492118|NCT00749047|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110492119|NCT00749047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110492120|NCT00751855|Hydrocortisone|hydrocortisone|mesh-list
110492121|NCT00751855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110492122|NCT00755833|Insulin Aspart|insulin aspart|mesh-list
110492123|NCT00755833|Biphasic Insulins|biphasic insulins|mesh-list
110492124|NCT00755833|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110492125|NCT00755833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110492127|NCT00753493|Anticonvulsants|anticonvulsants|mesh-ancestor
110492128|NCT00753493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110492129|NCT00753493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110492130|NCT00753571|Cardiac Glycosides|cardiac glycosides|mesh-list
110492131|NCT00753571|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110492132|NCT00753571|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110492133|NCT00753571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110492134|NCT00753571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110492135|NCT00753571|Protective Agents|protective agents|mesh-ancestor
110492136|NCT00753571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110492137|NCT00753727|Sunitinib|sunitinib|mesh-list
110492138|NCT00753727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110492139|NCT00753727|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110492140|NCT00753727|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110590659|NCT00755859|Prednisone|prednisone|mesh-list
110492141|NCT00753727|Growth Substances|growth substances|mesh-ancestor
110492142|NCT00753727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110492143|NCT00753727|Growth Inhibitors|growth inhibitors|mesh-ancestor
110492144|NCT00753727|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110492145|NCT00753727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110492146|NCT00753727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110492147|NCT00755989|Morphine|morphine|mesh-list
110492148|NCT00755989|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110492149|NCT00755989|Narcotics|narcotics|mesh-ancestor
110492150|NCT00755989|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110492151|NCT00755989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110492152|NCT00755989|Analgesics|analgesics|mesh-ancestor
110492153|NCT00755989|Sensory System Agents|sensory system agents|mesh-ancestor
110492154|NCT00755989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110492155|NCT00756067|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110492156|NCT00756067|Immunologic Factors|immunologic factors|mesh-ancestor
110492157|NCT00756067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110492158|NCT04053205|Paclitaxel|paclitaxel|mesh-list
110492159|NCT04053205|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110492160|NCT04053205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110492161|NCT04053205|Tubulin Modulators|tubulin modulators|mesh-ancestor
110492162|NCT04053205|Antimitotic Agents|antimitotic agents|mesh-ancestor
110492163|NCT04053205|Mitosis Modulators|mitosis modulators|mesh-ancestor
110492164|NCT04053205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110492165|NCT02559973|Buprenorphine|buprenorphine|mesh-list
110492166|NCT02559973|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
110492167|NCT02559973|Naloxone|naloxone|mesh-list
110492168|NCT02559973|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110492169|NCT02559973|Narcotics|narcotics|mesh-ancestor
110492170|NCT02559973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110492171|NCT02559973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110492172|NCT02559973|Analgesics|analgesics|mesh-ancestor
110492174|NCT02559973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110492175|NCT02559973|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110492177|NCT00753883|Ezetimibe|ezetimibe|mesh-list
110492178|NCT00753883|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110492179|NCT00753883|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110492180|NCT00753883|Antimetabolites|antimetabolites|mesh-ancestor
110492181|NCT00753883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110492182|NCT00753883|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110492183|NCT00753883|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110492184|NCT00753883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110492185|NCT00720382|Mometasone Furoate|mometasone furoate|mesh-list
110492187|NCT00720382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110492188|NCT00720382|Dermatologic Agents|dermatologic agents|mesh-ancestor
110492189|NCT00720382|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110492190|NCT00720382|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110492191|NCT00720382|Autonomic Agents|autonomic agents|mesh-ancestor
110492192|NCT00720382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110492193|NCT00720382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110492194|NCT00720382|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110492195|NCT00720382|Respiratory System Agents|respiratory system agents|mesh-ancestor
110492196|NCT00720382|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
110492197|NCT00720382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110492198|NCT00720382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110492199|NCT00720382|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110492200|NCT00720382|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110590956|NCT00918554|Methotrexate|methotrexate|mesh-list
110492201|NCT00720382|Histamine Antagonists|histamine antagonists|mesh-ancestor
110492202|NCT00720382|Histamine Agents|histamine agents|mesh-ancestor
110492203|NCT00720382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110492204|NCT00754039|Fenofibrate|fenofibrate|mesh-list
110492205|NCT00754039|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
110492206|NCT00754039|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110492207|NCT00754039|Antimetabolites|antimetabolites|mesh-ancestor
110492208|NCT00754039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110492209|NCT00754039|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110492210|NCT00754039|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110492211|NCT02560909|Vaccines|vaccines|mesh-list
110492212|NCT02560909|Immunologic Factors|immunologic factors|mesh-ancestor
110492213|NCT02560909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110492214|NCT02592226|Anesthetics|anesthetics|mesh-list
110492215|NCT02592226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110591161|NCT05266040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110492216|NCT02592226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110492217|NCT00756301|Lidocaine|lidocaine|mesh-list
110492218|NCT00756301|Anesthetics, Local|anesthetics, local|mesh-ancestor
110492219|NCT00756301|Anesthetics|anesthetics|mesh-ancestor
110492220|NCT00756301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110492221|NCT00756301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110492222|NCT00756301|Sensory System Agents|sensory system agents|mesh-ancestor
110492223|NCT00756301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110492224|NCT00756301|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110492225|NCT00756301|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110492226|NCT00756301|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110492227|NCT00756301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110492228|NCT00756301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110492229|NCT00756691|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
110492230|NCT00756691|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110492231|NCT00756691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110492232|NCT00720226|Losartan|losartan|mesh-list
110492233|NCT00720226|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110492234|NCT00720226|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110492235|NCT00720226|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110492236|NCT00720226|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110492237|NCT00720226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110492238|NCT00725920|Topiramate|topiramate|mesh-list
110492239|NCT00725920|Anticonvulsants|anticonvulsants|mesh-ancestor
110492240|NCT00725920|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110492241|NCT00725920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110492242|NCT00725842|Ribavirin|ribavirin|mesh-list
110492243|NCT00725842|Interferon alpha-2|interferon alpha-2|mesh-list
110492245|NCT00725842|Antimetabolites|antimetabolites|mesh-ancestor
110492246|NCT00725842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110492247|NCT00725842|Antiviral Agents|antiviral agents|mesh-ancestor
110492248|NCT00725842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110492250|NCT04051723|Dexamethasone|dexamethasone|mesh-list
110492251|NCT04051723|Ropivacaine|ropivacaine|mesh-list
110492252|NCT04051723|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110492253|NCT04051723|Antiemetics|antiemetics|mesh-ancestor
110492254|NCT04051723|Autonomic Agents|autonomic agents|mesh-ancestor
110492255|NCT04051723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110492256|NCT04051723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110492257|NCT04051723|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110492258|NCT04051723|Glucocorticoids|glucocorticoids|mesh-ancestor
110492259|NCT04051723|Hormones|hormones|mesh-ancestor
110492260|NCT04051723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110492261|NCT04051723|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110492262|NCT04051723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110591276|NCT05428293|Acetaminophen|acetaminophen|mesh-list
110492263|NCT04051723|Anesthetics, Local|anesthetics, local|mesh-ancestor
110492264|NCT04051723|Anesthetics|anesthetics|mesh-ancestor
110492265|NCT04051723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110492266|NCT04051723|Sensory System Agents|sensory system agents|mesh-ancestor
110492267|NCT00918424|Oxcarbazepine|oxcarbazepine|mesh-list
110492268|NCT00918424|Anticonvulsants|anticonvulsants|mesh-ancestor
110492269|NCT00918424|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110492270|NCT00918424|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110492271|NCT00918424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110492272|NCT00918424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110492273|NCT00918424|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110492274|NCT00918424|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110492275|NCT00756847|Paclitaxel|paclitaxel|mesh-list
110492276|NCT00756847|Carboplatin|carboplatin|mesh-list
110492277|NCT00756847|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110492278|NCT00756847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110492279|NCT00756847|Tubulin Modulators|tubulin modulators|mesh-ancestor
110492280|NCT00756847|Antimitotic Agents|antimitotic agents|mesh-ancestor
110492281|NCT00756847|Mitosis Modulators|mitosis modulators|mesh-ancestor
110492282|NCT00756847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110492283|NCT04051567|Aspirin|aspirin|mesh-list
110492284|NCT04051567|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110492285|NCT04051567|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110492286|NCT04051567|Analgesics|analgesics|mesh-ancestor
110591475|NCT04082858|GABA Modulators|gaba modulators|mesh-ancestor
110492287|NCT04051567|Sensory System Agents|sensory system agents|mesh-ancestor
110492288|NCT04051567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110492289|NCT04051567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110492290|NCT04051567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110492291|NCT04051567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110492292|NCT04051567|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110492293|NCT04051567|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110492294|NCT04051567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110492295|NCT04051567|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110492296|NCT04051567|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110492297|NCT04051567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110492298|NCT04051567|Antipyretics|antipyretics|mesh-ancestor
110492299|NCT00757081|Deoxycholic Acid|deoxycholic acid|mesh-list
110492300|NCT00757081|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
110492301|NCT00757081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110492302|NCT00757315|Triamcinolone|triamcinolone|mesh-list
110492303|NCT00757315|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110591535|NCT05122221|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110492304|NCT00757315|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110492305|NCT00757315|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110492306|NCT00757315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110492307|NCT00757315|Glucocorticoids|glucocorticoids|mesh-ancestor
110492308|NCT00757315|Hormones|hormones|mesh-ancestor
110492309|NCT00757315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110492310|NCT00757315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110492311|NCT00757315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110492312|NCT00757315|Immunologic Factors|immunologic factors|mesh-ancestor
110492313|NCT00757315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110492314|NCT00757315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110492315|NCT00757393|Calcium, Dietary|calcium, dietary|mesh-list
110492316|NCT00757393|Vitamin D|vitamin d|mesh-list
110492317|NCT00757393|Ergocalciferols|ergocalciferols|mesh-list
110492318|NCT00757393|Cholecalciferol|cholecalciferol|mesh-list
110492320|NCT00757393|Calcium|calcium|mesh-list
110492321|NCT00757393|Micronutrients|micronutrients|mesh-ancestor
110591660|NCT02586194|Immunologic Factors|immunologic factors|mesh-ancestor
110492322|NCT00757393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110139581|NCT01134614|Ipilimumab|ipilimumab|mesh-list
110492323|NCT00757393|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110492324|NCT00757393|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110492326|NCT00754351|Gemcitabine|gemcitabine|mesh-list
110492327|NCT00754351|Docetaxel|docetaxel|mesh-list
110591723|NCT02583464|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110492328|NCT00754351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110492329|NCT00754351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110492330|NCT00754351|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110492331|NCT00754351|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110492332|NCT00754351|Growth Substances|growth substances|mesh-ancestor
110492333|NCT00754351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110591796|NCT00673179|Leucovorin|leucovorin|mesh-list
110492334|NCT00754351|Growth Inhibitors|growth inhibitors|mesh-ancestor
110492335|NCT00754351|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110492336|NCT00754351|Antimetabolites|antimetabolites|mesh-ancestor
110492337|NCT00754351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110492338|NCT00754351|Tubulin Modulators|tubulin modulators|mesh-ancestor
110591866|NCT02585882|Fluorides|fluorides|mesh-list
110492339|NCT00754351|Antimitotic Agents|antimitotic agents|mesh-ancestor
110492340|NCT00754351|Mitosis Modulators|mitosis modulators|mesh-ancestor
110492342|NCT00754429|Amlodipine|amlodipine|mesh-list
110492343|NCT00754429|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110492344|NCT00754429|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110492345|NCT00754429|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110492346|NCT00754429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110492347|NCT00754429|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110492348|NCT00754429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110492349|NCT00754429|Vasodilator Agents|vasodilator agents|mesh-ancestor
110592006|NCT00762099|Anticonvulsants|anticonvulsants|mesh-ancestor
110492350|NCT00754429|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110492351|NCT00754429|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110492352|NCT00754429|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110492353|NCT00754507|Atorvastatin|atorvastatin|mesh-list
110492354|NCT00754507|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
110492355|NCT00754507|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110492356|NCT00754507|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110492357|NCT00754507|Antimetabolites|antimetabolites|mesh-ancestor
110492358|NCT00754507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110592076|NCT00765921|Ranibizumab|ranibizumab|mesh-list
110492359|NCT00754507|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110492360|NCT00754507|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110492361|NCT00754507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110492363|NCT00725608|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
110492364|NCT00725608|Naloxone|naloxone|mesh-list
110492365|NCT00725608|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110492366|NCT00725608|Narcotics|narcotics|mesh-ancestor
110492367|NCT00725608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110492368|NCT00725608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110492369|NCT00725608|Analgesics|analgesics|mesh-ancestor
110492370|NCT00725608|Sensory System Agents|sensory system agents|mesh-ancestor
110492371|NCT00725608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110492372|NCT00725608|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110492373|NCT00725452|Infliximab|infliximab|mesh-list
110492374|NCT00725452|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110492375|NCT00725452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110492376|NCT00725452|Dermatologic Agents|dermatologic agents|mesh-ancestor
110492377|NCT00725452|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110492378|NCT00725452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110492379|NCT00725296|Infliximab|infliximab|mesh-list
110492380|NCT00725296|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110492381|NCT00725296|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110492382|NCT00725296|Dermatologic Agents|dermatologic agents|mesh-ancestor
110492383|NCT00725296|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110492384|NCT00725296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110492385|NCT00585052|Paclitaxel|paclitaxel|mesh-list
110492386|NCT00585052|Lovastatin|lovastatin|mesh-list
110492387|NCT00585052|L 647318|l 647318|mesh-list
110492388|NCT00585052|Dihydromevinolin|dihydromevinolin|mesh-list
110492389|NCT00585052|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110492390|NCT00585052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110492391|NCT00585052|Tubulin Modulators|tubulin modulators|mesh-ancestor
110492392|NCT00585052|Antimitotic Agents|antimitotic agents|mesh-ancestor
110492393|NCT00585052|Mitosis Modulators|mitosis modulators|mesh-ancestor
110492394|NCT00585052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110492395|NCT00585052|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110492396|NCT00585052|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110492397|NCT00585052|Antimetabolites|antimetabolites|mesh-ancestor
110492398|NCT00585052|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110492399|NCT00585052|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110270718|NCT00194064|Olanzapine|olanzapine|mesh-list
110492400|NCT00585052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110492401|NCT00724282|Eszopiclone|eszopiclone|mesh-list
110492402|NCT00724282|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110492403|NCT00724282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110492404|NCT00724282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110492405|NCT04086238|Decitabine|decitabine|mesh-list
110492406|NCT04086238|Tetrahydrouridine|tetrahydrouridine|mesh-list
110492407|NCT04086238|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110492408|NCT04086238|Antimetabolites|antimetabolites|mesh-ancestor
110492409|NCT04086238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110492410|NCT04086238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110492411|NCT04086238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110492412|NCT00724126|Rifaximin|rifaximin|mesh-list
110492413|NCT00724126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110492414|NCT00724126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110492415|NCT00724126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110492416|NCT00723892|Ribavirin|ribavirin|mesh-list
110492417|NCT00723892|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110492418|NCT00723892|Interferon-alpha|interferon-alpha|mesh-list
110492419|NCT00723892|Antimetabolites|antimetabolites|mesh-ancestor
110492420|NCT00723892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110492421|NCT00723892|Antiviral Agents|antiviral agents|mesh-ancestor
110492422|NCT00723892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110492423|NCT00723892|Immunologic Factors|immunologic factors|mesh-ancestor
110492424|NCT00723892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110492425|NCT04086940|Esmolol|esmolol|mesh-list
110492426|NCT04086940|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110492427|NCT04086940|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110492428|NCT04086940|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110492429|NCT04086940|Adrenergic Agents|adrenergic agents|mesh-ancestor
110492430|NCT04086940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110492431|NCT04086940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110492432|NCT04086940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110492433|NCT02590900|Acetaminophen|acetaminophen|mesh-list
110492434|NCT02590900|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110492435|NCT02590900|Analgesics|analgesics|mesh-ancestor
110492436|NCT02590900|Sensory System Agents|sensory system agents|mesh-ancestor
110592685|NCT02556411|Levonorgestrel|levonorgestrel|mesh-list
110492437|NCT02590900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110492438|NCT02590900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110492439|NCT02590900|Antipyretics|antipyretics|mesh-ancestor
110492440|NCT02591914|Bevacizumab|bevacizumab|mesh-list
110492441|NCT02591914|Ranibizumab|ranibizumab|mesh-list
110492442|NCT02591914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110492443|NCT02591914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110492444|NCT02591914|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110492445|NCT02591914|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110492446|NCT02591914|Growth Substances|growth substances|mesh-ancestor
110492447|NCT02591914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110492448|NCT02591914|Growth Inhibitors|growth inhibitors|mesh-ancestor
110492449|NCT00723190|Clonidine|clonidine|mesh-list
110492450|NCT00723190|Analgesics|analgesics|mesh-ancestor
110492451|NCT00723190|Sensory System Agents|sensory system agents|mesh-ancestor
110492452|NCT00723190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110492453|NCT00723190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110492454|NCT00723190|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110492455|NCT00723190|Sympatholytics|sympatholytics|mesh-ancestor
110492456|NCT00723190|Autonomic Agents|autonomic agents|mesh-ancestor
110492457|NCT00723190|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110492458|NCT00723190|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110492459|NCT00723190|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110492460|NCT00723190|Adrenergic Agents|adrenergic agents|mesh-ancestor
110492461|NCT00723190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110492462|NCT00723190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110492463|NCT00722800|Drospirenone|drospirenone|mesh-list
110492464|NCT00722800|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110492465|NCT00722800|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
110492466|NCT00722800|Estradiol|estradiol|mesh-list
110492467|NCT00722800|Estrogens|estrogens|mesh-ancestor
110492468|NCT00722800|Hormones|hormones|mesh-ancestor
110492469|NCT00722800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110492470|NCT00722800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110492471|NCT00722800|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110492472|NCT00722800|Contraceptive Agents|contraceptive agents|mesh-ancestor
110492473|NCT00722800|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110492474|NCT00722800|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110492475|NCT00722800|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110492476|NCT00722800|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110492477|NCT00722800|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110492478|NCT00722800|Hormone Antagonists|hormone antagonists|mesh-ancestor
110492479|NCT00722800|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110492480|NCT00722800|Diuretics|diuretics|mesh-ancestor
110492481|NCT00722800|Natriuretic Agents|natriuretic agents|mesh-ancestor
110492482|NCT00741598|Galantamine|galantamine|mesh-list
110492483|NCT00741598|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110492484|NCT00741598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110492485|NCT00741598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110492486|NCT00741598|Cholinergic Agents|cholinergic agents|mesh-ancestor
110492487|NCT00741598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110492488|NCT00741598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110492489|NCT00741598|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110492490|NCT00741598|Autonomic Agents|autonomic agents|mesh-ancestor
110492491|NCT00741598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110492492|NCT00741598|Nootropic Agents|nootropic agents|mesh-ancestor
110492493|NCT03947632|Chrysarobin|chrysarobin|mesh-list
110492494|NCT03947632|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110492495|NCT03947632|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110492496|NCT03947632|Analgesics|analgesics|mesh-ancestor
110492497|NCT03947632|Sensory System Agents|sensory system agents|mesh-ancestor
110492498|NCT03947632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110492499|NCT03947632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110492500|NCT03947632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110492501|NCT03947632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110492502|NCT04085770|Alfacalcidol|alfacalcidol|mesh-list
110492503|NCT04085770|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
110492504|NCT04085770|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110492505|NCT04085770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110492506|NCT04085770|Vitamins|vitamins|mesh-ancestor
110492507|NCT04085770|Micronutrients|micronutrients|mesh-ancestor
110492508|NCT00741286|Aspirin|aspirin|mesh-list
110492509|NCT00741286|Cilostazol|cilostazol|mesh-list
110492510|NCT00741286|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110492511|NCT00741286|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110492513|NCT00741286|Sensory System Agents|sensory system agents|mesh-ancestor
110492514|NCT00741286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110492515|NCT00741286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110492516|NCT00741286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110492517|NCT00741286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110492518|NCT00741286|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110492519|NCT00741286|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110492520|NCT00741286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110492521|NCT00741286|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110492522|NCT00741286|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110492523|NCT00741286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110492524|NCT00741286|Antipyretics|antipyretics|mesh-ancestor
110492525|NCT00741286|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110492526|NCT00741286|Autonomic Agents|autonomic agents|mesh-ancestor
110492527|NCT00741286|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110492528|NCT00741286|Respiratory System Agents|respiratory system agents|mesh-ancestor
110492529|NCT00741286|Vasodilator Agents|vasodilator agents|mesh-ancestor
110492530|NCT00741286|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110492531|NCT00741286|Protective Agents|protective agents|mesh-ancestor
110492532|NCT00741286|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110593025|NCT00777543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110593026|NCT00777543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110593027|NCT00777543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110593028|NCT00777543|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110593029|NCT00777543|Anticoagulants|anticoagulants|mesh-ancestor
110593030|NCT00777543|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110492533|NCT00741286|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110492534|NCT05040334|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110492535|NCT05040334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110492536|NCT00716092|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110492537|NCT00716092|Linagliptin|linagliptin|mesh-list
110492538|NCT00716092|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110492539|NCT00716092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110492540|NCT00716092|Incretins|incretins|mesh-ancestor
110492541|NCT00716092|Hormones|hormones|mesh-ancestor
110492542|NCT00716092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110492543|NCT00716092|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110492545|NCT00716092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110492546|NCT00716092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110492547|NCT02590510|Methotrexate|methotrexate|mesh-list
110492548|NCT02590510|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110492549|NCT02590510|Abortifacient Agents|abortifacient agents|mesh-ancestor
110593101|NCT00441103|Interferon beta-1a|interferon beta-1a|mesh-list
110492550|NCT02590510|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110492551|NCT02590510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110492552|NCT02590510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110492553|NCT02590510|Antimetabolites|antimetabolites|mesh-ancestor
110492554|NCT02590510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110492555|NCT02590510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110492556|NCT02590510|Dermatologic Agents|dermatologic agents|mesh-ancestor
110492557|NCT02590510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110492558|NCT02590510|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110492559|NCT02590510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110492560|NCT02590510|Immunologic Factors|immunologic factors|mesh-ancestor
110492561|NCT02590510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110492562|NCT02590510|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110492563|NCT00919204|Axitinib|axitinib|mesh-list
110492564|NCT00919204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110492565|NCT00919204|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110492566|NCT00919204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110492567|NCT00919204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110492568|NCT00715624|Metformin|metformin|mesh-list
110492569|NCT00715624|Lixisenatide|lixisenatide|mesh-list
110492570|NCT00715624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110492571|NCT00715624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110492572|NCT00919282|Leucovorin|leucovorin|mesh-list
110492573|NCT00919282|Folic Acid|folic acid|mesh-list
110492574|NCT00919282|Gemcitabine|gemcitabine|mesh-list
110492575|NCT00919282|Levoleucovorin|levoleucovorin|mesh-list
110492576|NCT00919282|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110492577|NCT00919282|Antimetabolites|antimetabolites|mesh-ancestor
110593225|NCT00778011|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110492578|NCT00919282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110492579|NCT00919282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110492580|NCT00919282|Antidotes|antidotes|mesh-ancestor
110492581|NCT00919282|Protective Agents|protective agents|mesh-ancestor
110492582|NCT00919282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110492583|NCT00919282|Vitamin B Complex|vitamin b complex|mesh-ancestor
110492584|NCT00919282|Vitamins|vitamins|mesh-ancestor
110492585|NCT00919282|Micronutrients|micronutrients|mesh-ancestor
110492586|NCT00919282|Hematinics|hematinics|mesh-ancestor
110492587|NCT05414305|Lidocaine|lidocaine|mesh-list
110492588|NCT05414305|Heparin|heparin|mesh-list
110492589|NCT05414305|Anesthetics, Local|anesthetics, local|mesh-ancestor
110492590|NCT05414305|Anesthetics|anesthetics|mesh-ancestor
110492591|NCT05414305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110492592|NCT05414305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110492593|NCT05414305|Sensory System Agents|sensory system agents|mesh-ancestor
110492594|NCT05414305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110492595|NCT05414305|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110492596|NCT05414305|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110492597|NCT05414305|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110492598|NCT05414305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110492599|NCT05414305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110492600|NCT05414305|Anticoagulants|anticoagulants|mesh-ancestor
110492601|NCT05414305|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110492602|NCT05414305|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110492603|NCT00757549|Cetuximab|cetuximab|mesh-list
110492604|NCT00757549|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110492605|NCT00757549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110492606|NCT00757549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110492607|NCT00757549|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110492608|NCT00757549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110492609|NCT00576199|Bevacizumab|bevacizumab|mesh-list
110492610|NCT00576199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110492611|NCT00576199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110492612|NCT00576199|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110492613|NCT00576199|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110492614|NCT00576199|Growth Substances|growth substances|mesh-ancestor
110492615|NCT00576199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110492616|NCT00576199|Growth Inhibitors|growth inhibitors|mesh-ancestor
110492617|NCT00754819|Colchicine|colchicine|mesh-list
110492618|NCT00754819|Gout Suppressants|gout suppressants|mesh-ancestor
110492619|NCT00754819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110492620|NCT00754819|Tubulin Modulators|tubulin modulators|mesh-ancestor
110492621|NCT00754819|Antimitotic Agents|antimitotic agents|mesh-ancestor
110492622|NCT00754819|Mitosis Modulators|mitosis modulators|mesh-ancestor
110492623|NCT00754819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110492626|NCT05684692|Erenumab|erenumab|mesh-list
110492627|NCT05684692|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110492628|NCT05684692|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
110492629|NCT05684692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110492630|NCT05684692|Analgesics|analgesics|mesh-ancestor
110492631|NCT05684692|Sensory System Agents|sensory system agents|mesh-ancestor
110492632|NCT05684692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110492633|NCT05684692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110492634|NCT05684692|Immunologic Factors|immunologic factors|mesh-ancestor
110492635|NCT05684692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110492636|NCT02589652|Interferons|interferons|mesh-list
110492637|NCT02589652|Interferon-alpha|interferon-alpha|mesh-list
110492638|NCT02589652|Interferon alpha-2|interferon alpha-2|mesh-list
110492640|NCT02589652|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110492641|NCT02589652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110492642|NCT02589652|Antiviral Agents|antiviral agents|mesh-ancestor
110492643|NCT02589652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110492644|NCT02589652|Immunologic Factors|immunologic factors|mesh-ancestor
110492645|NCT02589652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110492646|NCT00679627|Galantamine|galantamine|mesh-list
110492647|NCT00679627|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110492648|NCT00679627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110492649|NCT00679627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110492650|NCT00679627|Cholinergic Agents|cholinergic agents|mesh-ancestor
110492651|NCT00679627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110492652|NCT00679627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110492654|NCT00679627|Autonomic Agents|autonomic agents|mesh-ancestor
110492655|NCT00679627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110492656|NCT00679627|Nootropic Agents|nootropic agents|mesh-ancestor
110492657|NCT00714688|Methylphenidate|methylphenidate|mesh-list
110492658|NCT00714688|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110492659|NCT00714688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110492660|NCT00714688|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110492661|NCT00714688|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110492662|NCT00714688|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110492663|NCT00714688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110492664|NCT00714688|Dopamine Agents|dopamine agents|mesh-ancestor
110492665|NCT00714688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110492666|NCT05165212|Amoxicillin|amoxicillin|mesh-list
110492667|NCT05165212|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110492668|NCT05165212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110492669|NCT04051099|Dexmedetomidine|dexmedetomidine|mesh-list
110492670|NCT04051099|Bupivacaine|bupivacaine|mesh-list
110492671|NCT04051099|Propofol|propofol|mesh-list
110492672|NCT04051099|Anesthetics, Local|anesthetics, local|mesh-ancestor
110492673|NCT04051099|Anesthetics|anesthetics|mesh-ancestor
110492674|NCT04051099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110492675|NCT04051099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110492676|NCT04051099|Sensory System Agents|sensory system agents|mesh-ancestor
110492677|NCT04051099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110492678|NCT04051099|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110492679|NCT04051099|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110492680|NCT04051099|Analgesics|analgesics|mesh-ancestor
110492681|NCT04051099|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110492682|NCT04051099|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110492683|NCT04051099|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110492684|NCT04051099|Adrenergic Agents|adrenergic agents|mesh-ancestor
110492685|NCT04051099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110492686|NCT04051099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110492687|NCT04051099|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110492688|NCT04051099|Anesthetics, General|anesthetics, general|mesh-ancestor
110492689|NCT01031069|Vaccines|vaccines|mesh-list
110492690|NCT01031069|Immunologic Factors|immunologic factors|mesh-ancestor
110492691|NCT01031069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110492692|NCT04084912|Dexamethasone|dexamethasone|mesh-list
110492693|NCT04084912|Dexamethasone acetate|dexamethasone acetate|mesh-list
110492694|NCT04084912|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
110492695|NCT04084912|BB 1101|bb 1101|mesh-list
110492696|NCT04084912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110492697|NCT04084912|Antiemetics|antiemetics|mesh-ancestor
110139955|NCT02008422|Tegafur|tegafur|mesh-list
110492698|NCT04084912|Autonomic Agents|autonomic agents|mesh-ancestor
110492699|NCT04084912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110492700|NCT04084912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110492701|NCT04084912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110492702|NCT04084912|Glucocorticoids|glucocorticoids|mesh-ancestor
110492704|NCT04084912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110492705|NCT04084912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110492706|NCT04084912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110492707|NCT04084912|Protease Inhibitors|protease inhibitors|mesh-ancestor
110492708|NCT04084912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110492709|NCT04084912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110492710|NCT00755053|Clotrimazole|clotrimazole|mesh-list
110492711|NCT00755053|Miconazole|miconazole|mesh-list
110492712|NCT00755053|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110492713|NCT00755053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110492714|NCT00755053|Antifungal Agents|antifungal agents|mesh-ancestor
110492715|NCT00755053|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110492716|NCT00755053|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110167573|NCT00032149|Hormones|hormones|mesh-ancestor
110492717|NCT00755053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110492718|NCT00755053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110492719|NCT00755053|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110492720|NCT00755053|Hormone Antagonists|hormone antagonists|mesh-ancestor
110492721|NCT00755053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110492722|NCT00755053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110492723|NCT00755053|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110492724|NCT00755053|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110492725|NCT00755209|Tranexamic Acid|tranexamic acid|mesh-list
110492726|NCT00755209|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110492727|NCT00755209|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110492728|NCT00755209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110492730|NCT00755209|Coagulants|coagulants|mesh-ancestor
110492732|NCT02589340|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110492733|NCT02589340|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110492734|NCT02589340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110492735|NCT02589340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110492736|NCT02589340|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110492737|NCT02589340|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110492738|NCT02589340|Serotonin Agents|serotonin agents|mesh-ancestor
110492739|NCT02589340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110492740|NCT02589340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110492741|NCT00682435|Hydromorphone|hydromorphone|mesh-list
110492742|NCT00682435|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110492743|NCT00682435|Narcotics|narcotics|mesh-ancestor
110594025|NCT00791505|Antimalarials|antimalarials|mesh-ancestor
110492744|NCT00682435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110492745|NCT00682435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110492746|NCT00682435|Analgesics|analgesics|mesh-ancestor
110492747|NCT00682435|Sensory System Agents|sensory system agents|mesh-ancestor
110492748|NCT00682435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110492749|NCT05340205|Misoprostol|misoprostol|mesh-list
110492750|NCT05340205|Tranexamic Acid|tranexamic acid|mesh-list
110492751|NCT05340205|Oxytocin|oxytocin|mesh-list
110492752|NCT05340205|Oxytocics|oxytocics|mesh-ancestor
110492753|NCT05340205|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110492754|NCT05340205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110492755|NCT05340205|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110492756|NCT05340205|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110492757|NCT05340205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110492759|NCT05340205|Coagulants|coagulants|mesh-ancestor
110492760|NCT05340205|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110492761|NCT05340205|Abortifacient Agents|abortifacient agents|mesh-ancestor
110492762|NCT05340205|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110492763|NCT05340205|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110492765|NCT00713830|Lixisenatide|lixisenatide|mesh-list
110492766|NCT00713830|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110492768|NCT00755521|Etoricoxib|etoricoxib|mesh-list
110492769|NCT00755521|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110492770|NCT00755521|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110492771|NCT00755521|Analgesics|analgesics|mesh-ancestor
110492772|NCT00755521|Sensory System Agents|sensory system agents|mesh-ancestor
110492773|NCT00755521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110492774|NCT00755521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110594385|NCT01773278|Antioxidants|antioxidants|mesh-list
110492775|NCT00755521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110492776|NCT00755521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110492777|NCT00755521|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110492778|NCT00755521|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110492779|NCT00755521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110492780|NCT00755521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110492781|NCT00681187|Lanreotide|lanreotide|mesh-list
110492782|NCT00681187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110492783|NCT00681109|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
110492784|NCT00681109|Lubricant Eye Drops|lubricant eye drops|mesh-list
110270852|NCT00165464|Docetaxel|docetaxel|mesh-list
110492785|NCT00681109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110492786|NCT00681109|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110492787|NCT00681109|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110492788|NCT00680407|Silymarin|silymarin|mesh-list
110492789|NCT00680407|Antioxidants|antioxidants|mesh-ancestor
110492790|NCT00680407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110492791|NCT00680407|Protective Agents|protective agents|mesh-ancestor
110594571|NCT00711698|Analgesics|analgesics|mesh-ancestor
110492792|NCT00680407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110492793|NCT02560519|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110492794|NCT04007809|Glucagon|glucagon|mesh-list
110492795|NCT04007809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110492796|NCT04007809|Hormones|hormones|mesh-ancestor
110594639|NCT03015792|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110492797|NCT04007809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110492798|NCT04007809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110492799|NCT04083664|Hepcidins|hepcidins|mesh-list
110492800|NCT04083664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110492801|NCT05202730|Anesthetics|anesthetics|mesh-list
110492802|NCT05202730|Anesthetics, Local|anesthetics, local|mesh-list
110492803|NCT05202730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110492804|NCT05202730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110492805|NCT05202730|Sensory System Agents|sensory system agents|mesh-ancestor
110492806|NCT05202730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110492807|NCT00677365|Levofloxacin|levofloxacin|mesh-list
110492808|NCT00677365|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110492809|NCT00677365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110492810|NCT00677365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110492811|NCT00677365|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110492812|NCT00677365|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110492813|NCT00677365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110492814|NCT00677365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110492815|NCT00677365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110492816|NCT00677365|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110492817|NCT00677365|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110492818|NCT05039944|Irinotecan|irinotecan|mesh-list
110492819|NCT05039944|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110492820|NCT05039944|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110492821|NCT05039944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110492822|NCT05039944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110492823|NCT05039944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110492824|NCT05038462|Lactoferrin|lactoferrin|mesh-list
110492825|NCT05038462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110492826|NCT03719131|Rituximab|rituximab|mesh-list
110492827|NCT03719131|Nivolumab|nivolumab|mesh-list
110492828|NCT03719131|Ipilimumab|ipilimumab|mesh-list
110492829|NCT03719131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110492830|NCT03719131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110492831|NCT03719131|Immunologic Factors|immunologic factors|mesh-ancestor
110492832|NCT03719131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110492833|NCT03719131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110492834|NCT03719131|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110492835|NCT03719131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110492836|NCT05190094|Letrozole|letrozole|mesh-list
110492837|NCT05190094|Palbociclib|palbociclib|mesh-list
110492838|NCT05190094|Anastrozole|anastrozole|mesh-list
110492839|NCT05190094|Aromatase Inhibitors|aromatase inhibitors|mesh-list
110492840|NCT05190094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110492841|NCT05190094|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110492843|NCT05190094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110594900|NCT00800709|Memantine|memantine|mesh-list
110492844|NCT05190094|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110492845|NCT05190094|Hormone Antagonists|hormone antagonists|mesh-ancestor
110492846|NCT05190094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110492847|NCT05190094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110492848|NCT05190094|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110492849|NCT05190094|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110492850|NCT00680017|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110492851|NCT00680017|Fenofibric acid|fenofibric acid|mesh-list
110492852|NCT00680017|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110492853|NCT00680017|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110492854|NCT00680017|Antimetabolites|antimetabolites|mesh-ancestor
110492855|NCT00680017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110492856|NCT00680017|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110492857|NCT00680017|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110492858|NCT00680017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110492860|NCT00676663|Entinostat|entinostat|mesh-list
110492861|NCT00676663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110492862|NCT00676663|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110492863|NCT00676663|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110492864|NCT00676663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110492865|NCT00676663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110492866|NCT00676663|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110492867|NCT00676663|Hormone Antagonists|hormone antagonists|mesh-ancestor
110492868|NCT00676663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110492869|NCT00676663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110492870|NCT00676663|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110492872|NCT02560207|Cefoxitin|cefoxitin|mesh-list
110492873|NCT02560207|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110492874|NCT02560207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110492875|NCT00678691|Modafinil|modafinil|mesh-list
110492876|NCT00678691|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110492877|NCT00678691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110492878|NCT00678691|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
110492879|NCT00678691|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110492880|NCT00678691|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110492881|NCT00678691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110492882|NCT05003752|Goserelin|goserelin|mesh-list
110492883|NCT05003752|Androgens|androgens|mesh-list
110595154|NCT00794703|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110492884|NCT05003752|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110492885|NCT05003752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110492886|NCT05003752|Hormones|hormones|mesh-ancestor
110492887|NCT05003752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110492888|NCT05003752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110492889|NCT04997980|Amiodarone|amiodarone|mesh-list
110492890|NCT04997980|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110492891|NCT04997980|Vasodilator Agents|vasodilator agents|mesh-ancestor
110492892|NCT04997980|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
110492893|NCT04997980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110492894|NCT04997980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110492895|NCT04997980|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110492896|NCT04997980|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110492897|NCT04997980|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110492898|NCT04997980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110492899|NCT04997980|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110492900|NCT04997980|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110492901|NCT04997980|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110492902|NCT05101798|Aminolevulinic Acid|aminolevulinic acid|mesh-list
110492903|NCT05101798|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110492904|NCT05101798|Dermatologic Agents|dermatologic agents|mesh-ancestor
110492905|NCT05683912|Aflibercept|aflibercept|mesh-list
110492906|NCT05683912|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110492907|NCT05683912|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110492908|NCT05683912|Growth Substances|growth substances|mesh-ancestor
110492909|NCT05683912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110595221|NCT00621244|Panobinostat|panobinostat|mesh-list
110492910|NCT05683912|Growth Inhibitors|growth inhibitors|mesh-ancestor
110492917|NCT04082260|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110492918|NCT04082260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110492920|NCT02587390|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110492921|NCT02587390|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110492922|NCT02587390|Antimetabolites|antimetabolites|mesh-ancestor
110492923|NCT02587390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110492924|NCT02587390|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110492925|NCT02587390|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110492926|NCT02587390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110492927|NCT00760981|Imatinib Mesylate|imatinib mesylate|mesh-list
110492928|NCT00760981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110492929|NCT00760981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110492930|NCT00760981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110492931|NCT00760981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110492932|NCT02588716|Terlipressin|terlipressin|mesh-list
110492933|NCT02588716|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110492934|NCT02588716|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110492935|NCT00673933|Aminolevulinic Acid|aminolevulinic acid|mesh-list
110492936|NCT00673933|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
110492937|NCT00673933|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110492938|NCT00673933|Dermatologic Agents|dermatologic agents|mesh-ancestor
110492939|NCT00761449|Lenalidomide|lenalidomide|mesh-list
110492940|NCT00761449|Immunologic Factors|immunologic factors|mesh-ancestor
110492941|NCT00761449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110492942|NCT00761449|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110492943|NCT00761449|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110492944|NCT00761449|Growth Substances|growth substances|mesh-ancestor
110492945|NCT00761449|Growth Inhibitors|growth inhibitors|mesh-ancestor
110492946|NCT00761449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110492947|NCT04968106|Doxorubicin|doxorubicin|mesh-list
110492949|NCT04968106|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110492950|NCT04968106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110492951|NCT04968106|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110492952|NCT04968106|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110492953|NCT04968106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110492954|NCT04968106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110492955|NCT04968106|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110492956|NCT04968106|Alkylating Agents|alkylating agents|mesh-ancestor
110492957|NCT00919438|Diuretics|diuretics|mesh-list
110492958|NCT00919438|Natriuretic Agents|natriuretic agents|mesh-ancestor
110492959|NCT00919438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110492960|NCT04082182|Immunomodulating Agents|immunomodulating agents|mesh-list
110492961|NCT04082182|Immunologic Factors|immunologic factors|mesh-ancestor
110492962|NCT04082182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110492963|NCT00571519|Metformin|metformin|mesh-list
110492964|NCT00571519|Pioglitazone|pioglitazone|mesh-list
110492965|NCT00571519|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110492966|NCT00571519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110492967|NCT02588404|Triptorelin Pamoate|triptorelin pamoate|mesh-list
110492968|NCT02588404|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110492969|NCT02588404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110492970|NCT02588404|Luteolytic Agents|luteolytic agents|mesh-ancestor
110492971|NCT02588404|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110492972|NCT02588404|Contraceptive Agents|contraceptive agents|mesh-ancestor
110492973|NCT02588404|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110492974|NCT02588404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110492975|NCT02588404|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110492978|NCT04935034|Micronutrients|micronutrients|mesh-ancestor
110492979|NCT04935034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110492980|NCT04935034|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110167616|NCT00000596|Antimalarials|antimalarials|mesh-ancestor
110492986|NCT00762151|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110492987|NCT00762151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110492988|NCT00921973|Vaccines|vaccines|mesh-list
110492989|NCT00921973|Immunologic Factors|immunologic factors|mesh-ancestor
110492990|NCT00921973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110492991|NCT00676195|Acetylcysteine|acetylcysteine|mesh-list
110492992|NCT00676195|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110492993|NCT00676195|Antiviral Agents|antiviral agents|mesh-ancestor
110492994|NCT00676195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110492995|NCT00676195|Expectorants|expectorants|mesh-ancestor
110492996|NCT00676195|Respiratory System Agents|respiratory system agents|mesh-ancestor
110492997|NCT00676195|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110492998|NCT00676195|Antioxidants|antioxidants|mesh-ancestor
110492999|NCT00676195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110493000|NCT00676195|Protective Agents|protective agents|mesh-ancestor
110493001|NCT00676195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110493002|NCT00676195|Antidotes|antidotes|mesh-ancestor
110493003|NCT02558959|Capecitabine|capecitabine|mesh-list
110493004|NCT02558959|Irinotecan|irinotecan|mesh-list
110493005|NCT02558959|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110493006|NCT02558959|Antimetabolites|antimetabolites|mesh-ancestor
110493007|NCT02558959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110493008|NCT02558959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110493009|NCT02558959|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110493010|NCT02558959|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110493011|NCT02558959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110493012|NCT04082962|Dexamethasone|dexamethasone|mesh-list
110493013|NCT04082962|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110493014|NCT04082962|Antiemetics|antiemetics|mesh-ancestor
110493015|NCT04082962|Autonomic Agents|autonomic agents|mesh-ancestor
110493016|NCT04082962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110493017|NCT04082962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110493018|NCT04082962|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110493019|NCT04082962|Glucocorticoids|glucocorticoids|mesh-ancestor
110493020|NCT04082962|Hormones|hormones|mesh-ancestor
110493021|NCT04082962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110493022|NCT04082962|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110493023|NCT04082962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110493024|NCT02471833|Telmisartan|telmisartan|mesh-list
110493025|NCT02471833|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110493026|NCT02471833|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110493027|NCT02471833|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110493028|NCT02471833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110493029|NCT04895410|Dexamethasone|dexamethasone|mesh-list
110493030|NCT04895410|Daratumumab|daratumumab|mesh-list
110493031|NCT04895410|Pomalidomide|pomalidomide|mesh-list
110493032|NCT04895410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110493033|NCT04895410|Antiemetics|antiemetics|mesh-ancestor
110493034|NCT04895410|Autonomic Agents|autonomic agents|mesh-ancestor
110493035|NCT04895410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110493036|NCT04895410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110493037|NCT04895410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110493038|NCT04895410|Glucocorticoids|glucocorticoids|mesh-ancestor
110493039|NCT04895410|Hormones|hormones|mesh-ancestor
110493040|NCT04895410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110595833|NCT00719420|Omeprazole|omeprazole|mesh-list
110493041|NCT04895410|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110493042|NCT04895410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110493043|NCT04895410|Immunologic Factors|immunologic factors|mesh-ancestor
110493044|NCT04895410|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110493045|NCT04895410|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110493046|NCT04895410|Growth Substances|growth substances|mesh-ancestor
110493047|NCT04895410|Growth Inhibitors|growth inhibitors|mesh-ancestor
110493048|NCT00675025|Donepezil|donepezil|mesh-list
110493049|NCT00675025|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110493050|NCT00675025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110493051|NCT00675025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110493052|NCT00675025|Cholinergic Agents|cholinergic agents|mesh-ancestor
110493053|NCT00675025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110493054|NCT00675025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110595973|NCT00806871|Prednisolone|prednisolone|mesh-list
110493055|NCT00675025|Nootropic Agents|nootropic agents|mesh-ancestor
110493056|NCT00758407|Methylphenidate|methylphenidate|mesh-list
110493057|NCT00758407|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110596032|NCT00763451|Metformin|metformin|mesh-list
110493059|NCT00758407|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110493060|NCT00758407|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110493061|NCT00758407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110493062|NCT00758407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110493063|NCT00758407|Dopamine Agents|dopamine agents|mesh-ancestor
110493064|NCT00758407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110493066|NCT00759421|Sertindole|sertindole|mesh-list
110493067|NCT00759421|Antiemetics|antiemetics|mesh-ancestor
110493068|NCT00759421|Autonomic Agents|autonomic agents|mesh-ancestor
110493069|NCT00759421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110493070|NCT00759421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110493071|NCT00759421|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110493072|NCT00759421|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110493073|NCT00759421|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110493074|NCT00759421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110493075|NCT00759421|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110167628|NCT00000599|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110493076|NCT00759421|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110493077|NCT00759421|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110493078|NCT00759421|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110493079|NCT00759421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110493080|NCT00759421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110493081|NCT00759421|Serotonin Agents|serotonin agents|mesh-ancestor
110493082|NCT00762775|Vitamin D|vitamin d|mesh-list
110493083|NCT00762775|Calcium|calcium|mesh-list
110493084|NCT00762775|Vitamins|vitamins|mesh-ancestor
110493085|NCT00762775|Micronutrients|micronutrients|mesh-ancestor
110493086|NCT00762775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110493087|NCT00762775|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110493088|NCT00762775|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110493089|NCT00763165|Triclosan|triclosan|mesh-list
110493090|NCT00763165|Fluorides|fluorides|mesh-list
110493091|NCT00763165|Cariostatic Agents|cariostatic agents|mesh-ancestor
110493092|NCT00763165|Protective Agents|protective agents|mesh-ancestor
110493093|NCT00763165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110493094|NCT00763165|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110493095|NCT00763165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110493096|NCT00763165|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
110493097|NCT00763165|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110596382|NCT00415597|Naltrexone|naltrexone|mesh-list
110493098|NCT00763165|Antimetabolites|antimetabolites|mesh-ancestor
110493099|NCT00763165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110493100|NCT00763165|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110493102|NCT04049227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110493103|NCT04049227|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110493104|NCT04049227|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110493105|NCT04049227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110493106|NCT04049227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110493107|NCT04049227|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110493108|NCT04049227|Hormone Antagonists|hormone antagonists|mesh-ancestor
110493109|NCT04049227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110493110|NCT04049227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110493111|NCT00759733|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
110493112|NCT00759733|Natriuretic Agents|natriuretic agents|mesh-ancestor
110493113|NCT00759733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110493114|NCT00760045|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110493115|NCT00760045|Hyaluronic Acid|hyaluronic acid|mesh-list
110493116|NCT00760045|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110493117|NCT00760045|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110493118|NCT00760045|Immunologic Factors|immunologic factors|mesh-ancestor
110493119|NCT00760045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110493120|NCT00760045|Viscosupplements|viscosupplements|mesh-ancestor
110493121|NCT00760045|Protective Agents|protective agents|mesh-ancestor
110493122|NCT00678379|Lidocaine|lidocaine|mesh-list
110493123|NCT00678379|Clonidine|clonidine|mesh-list
110493124|NCT00678379|Bupivacaine|bupivacaine|mesh-list
110493125|NCT00678379|Anesthetics, Local|anesthetics, local|mesh-ancestor
110493126|NCT00678379|Anesthetics|anesthetics|mesh-ancestor
110596575|NCT05809609|Anesthetics, General|anesthetics, general|mesh-ancestor
110493127|NCT00678379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110493128|NCT00678379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110493129|NCT00678379|Sensory System Agents|sensory system agents|mesh-ancestor
110493130|NCT00678379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110493131|NCT00678379|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110270976|NCT03421639|Aromatase Inhibitors|aromatase inhibitors|mesh-list
110493132|NCT00678379|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110493133|NCT00678379|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110493134|NCT00678379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110493135|NCT00678379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110493137|NCT00678379|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110493138|NCT00678379|Sympatholytics|sympatholytics|mesh-ancestor
110493139|NCT00678379|Autonomic Agents|autonomic agents|mesh-ancestor
110493140|NCT00678379|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110493141|NCT00678379|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110493142|NCT00678379|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110140401|NCT04567420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110140402|NCT04567420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110493144|NCT00678379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110493146|NCT00760279|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110493147|NCT00760279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110493148|NCT00674323|Ranibizumab|ranibizumab|mesh-list
110493149|NCT00674323|Verteporfin|verteporfin|mesh-list
110493150|NCT00674323|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110493151|NCT00674323|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110493152|NCT00674323|Growth Substances|growth substances|mesh-ancestor
110493153|NCT00674323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110493154|NCT00674323|Growth Inhibitors|growth inhibitors|mesh-ancestor
110493155|NCT00674323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110493156|NCT00674323|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110493157|NCT00674323|Dermatologic Agents|dermatologic agents|mesh-ancestor
110493158|NCT00763633|Vitamins|vitamins|mesh-list
110493159|NCT00763633|Vitamin B 6|vitamin b 6|mesh-list
110493160|NCT00763633|Pyridoxal|pyridoxal|mesh-list
110493161|NCT00763633|Pyridoxine|pyridoxine|mesh-list
110493162|NCT00763633|Vitamin B Complex|vitamin b complex|mesh-list
110493163|NCT00763633|Micronutrients|micronutrients|mesh-ancestor
110493164|NCT00763633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110493165|NCT00763789|Remifentanil|remifentanil|mesh-list
110493166|NCT00763789|Anesthetics|anesthetics|mesh-list
110493167|NCT00763789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110493168|NCT00763789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110493169|NCT00763789|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110493170|NCT00763789|Narcotics|narcotics|mesh-ancestor
110493171|NCT00763789|Analgesics|analgesics|mesh-ancestor
110493172|NCT00763789|Sensory System Agents|sensory system agents|mesh-ancestor
110493173|NCT00763789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110493174|NCT04115956|Dexamethasone|dexamethasone|mesh-list
110493175|NCT04115956|Melphalan|melphalan|mesh-list
110493176|NCT04115956|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110493177|NCT04115956|Antiemetics|antiemetics|mesh-ancestor
110493178|NCT04115956|Autonomic Agents|autonomic agents|mesh-ancestor
110493179|NCT04115956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110493180|NCT04115956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110493181|NCT04115956|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110493182|NCT04115956|Glucocorticoids|glucocorticoids|mesh-ancestor
110493183|NCT04115956|Hormones|hormones|mesh-ancestor
110493184|NCT04115956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110596901|NCT05355051|Antimetabolites|antimetabolites|mesh-ancestor
110493185|NCT04115956|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110493186|NCT04115956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110493187|NCT04115956|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110493188|NCT04115956|Alkylating Agents|alkylating agents|mesh-ancestor
110493189|NCT04115956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110493190|NCT04115956|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110493191|NCT04115956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110493192|NCT04115956|Immunologic Factors|immunologic factors|mesh-ancestor
110493193|NCT04081480|Valacyclovir|valacyclovir|mesh-list
110493194|NCT04081480|Antiviral Agents|antiviral agents|mesh-ancestor
110493195|NCT04081480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110493196|NCT00678301|Vaccines|vaccines|mesh-list
110493197|NCT00678301|Immunologic Factors|immunologic factors|mesh-ancestor
110493198|NCT00678301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110493199|NCT02586454|Morphine|morphine|mesh-list
110493200|NCT02586454|Ropivacaine|ropivacaine|mesh-list
110493201|NCT02586454|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110493202|NCT02586454|Narcotics|narcotics|mesh-ancestor
110493203|NCT02586454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110493204|NCT02586454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110493205|NCT02586454|Analgesics|analgesics|mesh-ancestor
110493206|NCT02586454|Sensory System Agents|sensory system agents|mesh-ancestor
110493207|NCT02586454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110493208|NCT02586454|Anesthetics, Local|anesthetics, local|mesh-ancestor
110493209|NCT02586454|Anesthetics|anesthetics|mesh-ancestor
110493210|NCT00939770|Crizotinib|crizotinib|mesh-list
110493211|NCT00939770|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
110493212|NCT00939770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110493213|NCT00939770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110597032|NCT04981899|Carboplatin|carboplatin|mesh-list
110493214|NCT00939770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110493215|NCT00939770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110493216|NCT02558569|Levobupivacaine|levobupivacaine|mesh-list
110493217|NCT02558569|Anesthetics, Local|anesthetics, local|mesh-ancestor
110493219|NCT02558569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110597088|NCT04824417|Itraconazole|itraconazole|mesh-list
110493220|NCT02558569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110493221|NCT02558569|Sensory System Agents|sensory system agents|mesh-ancestor
110493222|NCT02558569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110493224|NCT00939692|Anticonvulsants|anticonvulsants|mesh-ancestor
110493225|NCT00939692|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110493226|NCT00939692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110493227|NCT00920608|Methotrexate|methotrexate|mesh-list
110493228|NCT00920608|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110493229|NCT00920608|Abortifacient Agents|abortifacient agents|mesh-ancestor
110493230|NCT00920608|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110493231|NCT00920608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110493232|NCT00920608|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110493234|NCT00920608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110493235|NCT00920608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110493236|NCT00920608|Dermatologic Agents|dermatologic agents|mesh-ancestor
110493237|NCT00920608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110493238|NCT00920608|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110493239|NCT00920608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110493240|NCT00920608|Immunologic Factors|immunologic factors|mesh-ancestor
110493241|NCT00920608|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110493242|NCT00920608|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110493243|NCT04674514|Dexamethasone|dexamethasone|mesh-list
110493244|NCT04674514|Lenalidomide|lenalidomide|mesh-list
110493245|NCT04674514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110493246|NCT04674514|Antiemetics|antiemetics|mesh-ancestor
110493247|NCT04674514|Autonomic Agents|autonomic agents|mesh-ancestor
110493248|NCT04674514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110493249|NCT04674514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110271018|NCT05336812|Venetoclax|venetoclax|mesh-list
110493250|NCT04674514|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110493251|NCT04674514|Glucocorticoids|glucocorticoids|mesh-ancestor
110493252|NCT04674514|Hormones|hormones|mesh-ancestor
110493253|NCT04674514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110493254|NCT04674514|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110597367|NCT04216524|Antimetabolites|antimetabolites|mesh-ancestor
110493255|NCT04674514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110493256|NCT04674514|Immunologic Factors|immunologic factors|mesh-ancestor
110493257|NCT04674514|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110493258|NCT04674514|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110493259|NCT04674514|Growth Substances|growth substances|mesh-ancestor
110493260|NCT04674514|Growth Inhibitors|growth inhibitors|mesh-ancestor
110493261|NCT04081012|Acetylcysteine|acetylcysteine|mesh-list
110493262|NCT04081012|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110493263|NCT04081012|Antiviral Agents|antiviral agents|mesh-ancestor
110493264|NCT04081012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110493265|NCT04081012|Expectorants|expectorants|mesh-ancestor
110493266|NCT04081012|Respiratory System Agents|respiratory system agents|mesh-ancestor
110493267|NCT04081012|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110493268|NCT04081012|Antioxidants|antioxidants|mesh-ancestor
110493269|NCT04081012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110493270|NCT04081012|Protective Agents|protective agents|mesh-ancestor
110493271|NCT04081012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110493272|NCT04081012|Antidotes|antidotes|mesh-ancestor
110493274|NCT04551040|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110493275|NCT04551040|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110597429|NCT04147208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110597430|NCT04147208|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110597431|NCT04147208|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110597432|NCT04147208|Antiviral Agents|antiviral agents|mesh-ancestor
110597433|NCT04147208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110597436|NCT04008706|Acalabrutinib|acalabrutinib|mesh-list
110493276|NCT04551040|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110493277|NCT04551040|Adrenergic Agents|adrenergic agents|mesh-ancestor
110493278|NCT04551040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110493279|NCT04551040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110493280|NCT04551040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110493281|NCT04551040|Urological Agents|urological agents|mesh-ancestor
110493282|NCT00942968|Dalteparin|dalteparin|mesh-list
110493283|NCT00942968|Tinzaparin|tinzaparin|mesh-list
110493284|NCT00942968|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
110493285|NCT00942968|Anticoagulants|anticoagulants|mesh-ancestor
110493286|NCT00942968|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110493287|NCT00942968|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110493288|NCT00942968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110493289|NCT00942734|Everolimus|everolimus|mesh-list
110493290|NCT00942734|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110493291|NCT00942734|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110493292|NCT00942734|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110493293|NCT00942734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110493294|NCT00942734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110493295|NCT00942734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110493296|NCT00942734|Immunologic Factors|immunologic factors|mesh-ancestor
110493297|NCT00942734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110493298|NCT00942734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110493299|NCT02586142|Botulinum Toxins|botulinum toxins|mesh-list
110493300|NCT02586142|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110493301|NCT02586142|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110493302|NCT02586142|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110493303|NCT02586142|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110493304|NCT02586142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110493305|NCT02586142|Cholinergic Agents|cholinergic agents|mesh-ancestor
110493306|NCT02586142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110493307|NCT02586142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110493308|NCT02586142|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110493309|NCT02586142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110493311|NCT00919984|Carboplatin|carboplatin|mesh-list
110493312|NCT00919984|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110493313|NCT00919984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110493314|NCT00919984|Tubulin Modulators|tubulin modulators|mesh-ancestor
110493315|NCT00919984|Antimitotic Agents|antimitotic agents|mesh-ancestor
110493316|NCT00919984|Mitosis Modulators|mitosis modulators|mesh-ancestor
110493317|NCT00919984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110493318|NCT00942422|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
110493319|NCT00942422|Antioxidants|antioxidants|mesh-ancestor
110493320|NCT00942422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110493321|NCT00942422|Protective Agents|protective agents|mesh-ancestor
110493322|NCT00942422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110493323|NCT00942422|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
110493324|NCT00942422|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110493325|NCT00942422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110493326|NCT00942422|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110493327|NCT05380934|Methotrexate|methotrexate|mesh-list
110493328|NCT05380934|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110493329|NCT05380934|Abortifacient Agents|abortifacient agents|mesh-ancestor
110493330|NCT05380934|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110493331|NCT05380934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110493332|NCT05380934|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110493333|NCT05380934|Antimetabolites|antimetabolites|mesh-ancestor
110493334|NCT05380934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110493335|NCT05380934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110493336|NCT05380934|Dermatologic Agents|dermatologic agents|mesh-ancestor
110493337|NCT05380934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110493338|NCT05380934|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110493339|NCT05380934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110493340|NCT05380934|Immunologic Factors|immunologic factors|mesh-ancestor
110493341|NCT05380934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110493342|NCT05380934|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110493344|NCT00603824|Lepirudin|lepirudin|mesh-list
110493345|NCT00603824|Fondaparinux|fondaparinux|mesh-list
110493346|NCT00603824|Argatroban|argatroban|mesh-list
110493347|NCT00603824|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110493348|NCT00603824|Antithrombins|antithrombins|mesh-ancestor
110597755|NCT02366494|Androgen Antagonists|androgen antagonists|mesh-ancestor
110493349|NCT00603824|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110493350|NCT00603824|Protease Inhibitors|protease inhibitors|mesh-ancestor
110493351|NCT00603824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110311710|NCT00290264|Budesonide|budesonide|mesh-list
110493352|NCT00603824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110493353|NCT00603824|Anticoagulants|anticoagulants|mesh-ancestor
110493354|NCT00603824|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110493355|NCT00603824|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110493356|NCT00603824|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110493357|NCT00677833|Azithromycin|azithromycin|mesh-list
110493358|NCT00677833|Chloroquine|chloroquine|mesh-list
110493359|NCT00677833|Lumefantrine|lumefantrine|mesh-list
110493360|NCT00677833|Artemether|artemether|mesh-list
110493361|NCT00677833|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
110493362|NCT00677833|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110493363|NCT00677833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110493364|NCT00677833|Amebicides|amebicides|mesh-ancestor
110493365|NCT00677833|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110493366|NCT00677833|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110493367|NCT00677833|Antimalarials|antimalarials|mesh-ancestor
110493368|NCT00677833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110493369|NCT05086874|3-n-butylphthalide|3-n-butylphthalide|mesh-list
110493370|NCT05086874|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110493371|NCT05086874|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110493372|NCT05086874|Protective Agents|protective agents|mesh-ancestor
110493373|NCT05086874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110493374|NCT02585674|Insulin Glargine|insulin glargine|mesh-list
110493375|NCT02585674|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110493376|NCT02585674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110493377|NCT00942266|Calcium, Dietary|calcium, dietary|mesh-list
110493378|NCT00942266|Leucovorin|leucovorin|mesh-list
110493379|NCT00942266|Fluorouracil|fluorouracil|mesh-list
110493380|NCT00942266|Vorinostat|vorinostat|mesh-list
110493381|NCT00942266|Calcium|calcium|mesh-list
110493382|NCT00942266|Levoleucovorin|levoleucovorin|mesh-list
110493383|NCT00942266|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110493384|NCT00942266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110493385|NCT00942266|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110493386|NCT00942266|Antimetabolites|antimetabolites|mesh-ancestor
110493387|NCT00942266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110493388|NCT00942266|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110597843|NCT01337089|Analgesics|analgesics|mesh-ancestor
110597847|NCT01297400|Sulfadiazine|sulfadiazine|mesh-list
110493389|NCT00942266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110493390|NCT00942266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110493392|NCT00942266|Antidotes|antidotes|mesh-ancestor
110493393|NCT00942266|Protective Agents|protective agents|mesh-ancestor
110493394|NCT00942266|Vitamin B Complex|vitamin b complex|mesh-ancestor
110493395|NCT00942266|Vitamins|vitamins|mesh-ancestor
110493396|NCT00942266|Micronutrients|micronutrients|mesh-ancestor
110493397|NCT00942266|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110493398|NCT00942266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110493399|NCT05382182|Androgens|androgens|mesh-list
110493400|NCT05382182|Hormones|hormones|mesh-ancestor
110597972|NCT02575092|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110493401|NCT05382182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110493402|NCT05382182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110493403|NCT04079374|Etanercept|etanercept|mesh-list
110493404|NCT04079374|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110493405|NCT04079374|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110493406|NCT04079374|Analgesics|analgesics|mesh-ancestor
110493407|NCT04079374|Sensory System Agents|sensory system agents|mesh-ancestor
110493408|NCT04079374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110493409|NCT04079374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110493410|NCT04079374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110493411|NCT04079374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110598114|NCT02545738|Incretins|incretins|mesh-ancestor
110493412|NCT04079374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110493413|NCT04079374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110493415|NCT00673231|Dapagliflozin|dapagliflozin|mesh-list
110493416|NCT00673231|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110493417|NCT00673231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110493418|NCT00673231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110245516|NCT00462787|Antimetabolites|antimetabolites|mesh-ancestor
110493419|NCT00673231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110493420|NCT02583958|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
110493422|NCT02583958|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110493423|NCT00604058|Vaccines|vaccines|mesh-list
110493424|NCT00604058|Immunologic Factors|immunologic factors|mesh-ancestor
110493425|NCT00604058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110493426|NCT02852798|Docetaxel|docetaxel|mesh-list
110493427|NCT02852798|Apatinib|apatinib|mesh-list
110493428|NCT02852798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110493429|NCT02852798|Tubulin Modulators|tubulin modulators|mesh-ancestor
110493430|NCT02852798|Antimitotic Agents|antimitotic agents|mesh-ancestor
110493431|NCT02852798|Mitosis Modulators|mitosis modulators|mesh-ancestor
110493432|NCT02852798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110493433|NCT02852798|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110493434|NCT02852798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110493436|NCT02586610|Capecitabine|capecitabine|mesh-list
110493437|NCT02586610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110493438|NCT02586610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110493439|NCT02586610|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110493440|NCT02586610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110493441|NCT02586610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110493442|NCT02586610|Antimetabolites|antimetabolites|mesh-ancestor
110493443|NCT00604682|Apremilast|apremilast|mesh-list
110493444|NCT00604682|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110493445|NCT00604682|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110493446|NCT00604682|Analgesics|analgesics|mesh-ancestor
110493447|NCT00604682|Sensory System Agents|sensory system agents|mesh-ancestor
110493448|NCT00604682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110493449|NCT00604682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110493451|NCT00604682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110493452|NCT00604682|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
110493453|NCT00604682|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110493454|NCT00604682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110271177|NCT00166595|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110493455|NCT00604682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110493456|NCT00672841|Antifungal Agents|antifungal agents|mesh-list
110493457|NCT00672841|Clotrimazole|clotrimazole|mesh-list
110493458|NCT00672841|Miconazole|miconazole|mesh-list
110493459|NCT00672841|Anidulafungin|anidulafungin|mesh-list
110598519|NCT03992456|Antimetabolites|antimetabolites|mesh-ancestor
110493460|NCT00672841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110493461|NCT00672841|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110493462|NCT00672841|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110493463|NCT00672841|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110493464|NCT00672841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110493465|NCT00672841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110271200|NCT05124067|Dexamethasone|dexamethasone|mesh-list
110493467|NCT00672841|Hormone Antagonists|hormone antagonists|mesh-ancestor
110493468|NCT00672841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110493469|NCT00672841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110493470|NCT00672841|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110493471|NCT00672841|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110493472|NCT00920296|Cabotegravir|cabotegravir|mesh-list
110493473|NCT00920296|Etravirine|etravirine|mesh-list
110493474|NCT00920296|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110493475|NCT00920296|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110493476|NCT00920296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110493477|NCT00920296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110493478|NCT00920296|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110493479|NCT00920296|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110493480|NCT00920296|Antiviral Agents|antiviral agents|mesh-ancestor
110493481|NCT00920296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110493482|NCT00920296|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110493483|NCT00920296|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110493484|NCT04080388|Diuretics|diuretics|mesh-list
110167724|NCT00033085|Serotonin Agents|serotonin agents|mesh-ancestor
110493485|NCT04080388|Natriuretic Agents|natriuretic agents|mesh-ancestor
110493486|NCT04080388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110651617|NCT02536755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110651618|NCT02567279|Denosumab|denosumab|mesh-list
110598726|NCT00723164|GABA Modulators|gaba modulators|mesh-ancestor
110493487|NCT00765115|N2-((2S)-2-(3,5-difluorophenyl)-2-hydroxyethanoyl)-N1-((7S)-5-methyl-6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-L-alaninamide|n2-((2s)-2-(3,5-difluorophenyl)-2-hydroxyethanoyl)-n1-((7s)-5-methyl-6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-l-alaninamide|mesh-list
110493488|NCT00765115|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
110493489|NCT00765115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110493490|NCT00765115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110493491|NCT04080622|Selenium|selenium|mesh-list
110493492|NCT04080622|Antioxidants|antioxidants|mesh-ancestor
110493493|NCT04080622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110493494|NCT04080622|Protective Agents|protective agents|mesh-ancestor
110493495|NCT04080622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110493497|NCT04080622|Micronutrients|micronutrients|mesh-ancestor
110493498|NCT04079140|Dinoprostone|dinoprostone|mesh-list
110493500|NCT04079140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110598842|NCT05659290|Antimetabolites|antimetabolites|mesh-ancestor
110493501|NCT04079140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110493503|NCT00673465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110493504|NCT00673465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110493505|NCT00764413|Methylprednisolone|methylprednisolone|mesh-list
110493506|NCT00764413|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110493507|NCT00764413|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110493508|NCT00764413|Prednisolone|prednisolone|mesh-list
110493509|NCT00764413|Prednisolone acetate|prednisolone acetate|mesh-list
110493510|NCT00764413|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110493511|NCT00764413|Prednisolone phosphate|prednisolone phosphate|mesh-list
110493512|NCT00764413|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110493513|NCT00764413|Antiemetics|antiemetics|mesh-ancestor
110493514|NCT00764413|Autonomic Agents|autonomic agents|mesh-ancestor
110493515|NCT00764413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110493516|NCT00764413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110493517|NCT00764413|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110493518|NCT00764413|Glucocorticoids|glucocorticoids|mesh-ancestor
110493519|NCT00764413|Hormones|hormones|mesh-ancestor
110140781|NCT02358538|GABA Modulators|gaba modulators|mesh-ancestor
110493520|NCT00764413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110493521|NCT00764413|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110493522|NCT00764413|Protective Agents|protective agents|mesh-ancestor
110493523|NCT00764413|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110493524|NCT00764413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110493525|NCT00941798|Mometasone Furoate|mometasone furoate|mesh-list
110493526|NCT00941798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110493527|NCT00941798|Dermatologic Agents|dermatologic agents|mesh-ancestor
110493528|NCT00941798|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110493530|NCT00583102|Lovastatin|lovastatin|mesh-list
110493531|NCT00583102|L 647318|l 647318|mesh-list
110493532|NCT00583102|Dihydromevinolin|dihydromevinolin|mesh-list
110493533|NCT00583102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110493534|NCT00583102|Antimetabolites|antimetabolites|mesh-ancestor
110493535|NCT00583102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110493536|NCT00583102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110493537|NCT00583102|Antiviral Agents|antiviral agents|mesh-ancestor
110493538|NCT00583102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110493539|NCT00583102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110493540|NCT00583102|Immunologic Factors|immunologic factors|mesh-ancestor
110493541|NCT00583102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110493543|NCT00583102|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110493544|NCT00583102|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110493545|NCT00583102|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110493546|NCT00583102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110493547|NCT02585440|Hexadecyloxypropyl 9-(2-(phosphonomethoxy)propyl)adenine|hexadecyloxypropyl 9-(2-(phosphonomethoxy)propyl)adenine|mesh-list
110493549|NCT02585440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110493550|NCT02585440|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110493551|NCT02585440|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110493552|NCT00605930|Niacinamide|niacinamide|mesh-list
110493553|NCT00605930|Niacin|niacin|mesh-list
110493554|NCT00605930|Nicotinic Acids|nicotinic acids|mesh-list
110493555|NCT00605930|Vitamin B Complex|vitamin b complex|mesh-ancestor
110493556|NCT00605930|Vitamins|vitamins|mesh-ancestor
110493557|NCT00605930|Micronutrients|micronutrients|mesh-ancestor
110493558|NCT00605930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110493559|NCT00605930|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110493560|NCT00605930|Antimetabolites|antimetabolites|mesh-ancestor
110493561|NCT00605930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110493562|NCT00605930|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110493563|NCT00605930|Vasodilator Agents|vasodilator agents|mesh-ancestor
110493564|NCT00602186|Prazosin|prazosin|mesh-list
110493565|NCT00602186|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110493566|NCT00602186|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110493567|NCT00602186|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110493568|NCT00602186|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110493569|NCT00602186|Adrenergic Agents|adrenergic agents|mesh-ancestor
110493570|NCT00602186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110493571|NCT00602186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110493572|NCT00602186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110493573|NCT04204304|Isotretinoin|isotretinoin|mesh-list
110493574|NCT04204304|Dermatologic Agents|dermatologic agents|mesh-ancestor
110493576|NCT05380778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110493577|NCT05380778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110493578|NCT02852720|Anesthetics|anesthetics|mesh-list
110493580|NCT02852720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110493581|NCT02852720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110493582|NCT02852720|Anesthetics, Local|anesthetics, local|mesh-ancestor
110493583|NCT02852720|Sensory System Agents|sensory system agents|mesh-ancestor
110599439|NCT00724074|Anesthetics, Local|anesthetics, local|mesh-ancestor
110493584|NCT02852720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110493586|NCT05857631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110493587|NCT05857306|Olvanil|olvanil|mesh-list
110493588|NCT05857306|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110493589|NCT05857306|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110493590|NCT05857306|Analgesics|analgesics|mesh-ancestor
110493591|NCT05857306|Sensory System Agents|sensory system agents|mesh-ancestor
110493592|NCT05857306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110493593|NCT05857306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110493594|NCT05857306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110493595|NCT05857306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110493597|NCT05857267|Dorzolamide|dorzolamide|mesh-list
110493598|NCT05857267|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110493599|NCT05857267|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110599651|NCT00855088|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110493600|NCT05857267|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110493601|NCT05857267|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110493602|NCT05857267|Adrenergic Agents|adrenergic agents|mesh-ancestor
110493603|NCT05857267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110493604|NCT05857267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110493605|NCT05857267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110493606|NCT05857267|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110493607|NCT05857267|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110493608|NCT05857267|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110493609|NCT05857267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110493610|NCT05857202|Analgesics, Opioid|analgesics, opioid|mesh-list
110493611|NCT05857202|Analgesics|analgesics|mesh-list
110493612|NCT05857202|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
110493613|NCT05857202|Narcotics|narcotics|mesh-ancestor
110493614|NCT05857202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110493615|NCT05857202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110493616|NCT05857202|Sensory System Agents|sensory system agents|mesh-ancestor
110493617|NCT05857202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110493618|NCT05857085|Empagliflozin|empagliflozin|mesh-list
110493619|NCT05857085|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110493620|NCT05857085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110493621|NCT05857085|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110493622|NCT05857085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110493623|NCT05857059|Misoprostol|misoprostol|mesh-list
110493624|NCT05857059|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110493625|NCT05857059|Abortifacient Agents|abortifacient agents|mesh-ancestor
110493626|NCT05857059|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110493627|NCT05857059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110493628|NCT05857059|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110493629|NCT05857059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110493630|NCT05857059|Oxytocics|oxytocics|mesh-ancestor
110493631|NCT05857046|Melatonin|melatonin|mesh-list
110493632|NCT05857046|Antioxidants|antioxidants|mesh-ancestor
110493633|NCT05857046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110493634|NCT05857046|Protective Agents|protective agents|mesh-ancestor
110493635|NCT05857046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110493636|NCT05857046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110493637|NCT05856630|Goserelin|goserelin|mesh-list
110493638|NCT05856630|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110493639|NCT05856630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110493640|NCT05856578|Canagliflozin|canagliflozin|mesh-list
110493642|NCT05856578|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110493643|NCT05856578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110493644|NCT05856578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110493645|NCT05856396|Vaccines|vaccines|mesh-list
110493646|NCT05856396|Immunologic Factors|immunologic factors|mesh-ancestor
110493647|NCT05856396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110493649|NCT05856383|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110493650|NCT05856383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110493651|NCT05856383|Tubulin Modulators|tubulin modulators|mesh-ancestor
110493652|NCT05856383|Antimitotic Agents|antimitotic agents|mesh-ancestor
110493653|NCT05856383|Mitosis Modulators|mitosis modulators|mesh-ancestor
110493654|NCT05856383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110493655|NCT05856084|Vaccines|vaccines|mesh-list
110493656|NCT05856084|Immunologic Factors|immunologic factors|mesh-ancestor
110493657|NCT05856084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110493658|NCT05852132|Temazepam|temazepam|mesh-list
110493659|NCT05852132|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110493660|NCT05852132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110493661|NCT05852132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110493662|NCT05852132|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110493663|NCT05852132|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110493664|NCT05852132|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110493665|NCT05852132|GABA Modulators|gaba modulators|mesh-ancestor
110493666|NCT05852132|GABA Agents|gaba agents|mesh-ancestor
110493667|NCT05852132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110493668|NCT05852132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110493669|NCT05851313|Vitamin D|vitamin d|mesh-list
110493670|NCT05851313|Vitamins|vitamins|mesh-ancestor
110493671|NCT05851313|Micronutrients|micronutrients|mesh-ancestor
110493672|NCT05851313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110493673|NCT05851313|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110600109|NCT00726726|Warfarin|warfarin|mesh-list
110493674|NCT05850611|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
110493675|NCT05850611|Methylene Blue|methylene blue|mesh-list
110493676|NCT05850611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110493677|NCT05850611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110493678|NCT05850611|Hemostatics|hemostatics|mesh-ancestor
110493679|NCT05850611|Coagulants|coagulants|mesh-ancestor
110493680|NCT05844813|Doxorubicin|doxorubicin|mesh-list
110493681|NCT05844813|Ifosfamide|ifosfamide|mesh-list
110493682|NCT05844813|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110493683|NCT05844813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110493684|NCT05844813|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110493685|NCT05844813|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110493686|NCT05844813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110493687|NCT05844813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110493689|NCT05844813|Alkylating Agents|alkylating agents|mesh-ancestor
110493690|NCT05812417|DA-8010|da-8010|mesh-list
110493691|NCT05812417|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110493692|NCT05812417|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110493693|NCT05812417|Cholinergic Agents|cholinergic agents|mesh-ancestor
110600311|NCT00799149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110493694|NCT05812417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110493695|NCT05812417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110493696|NCT05812417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110493698|NCT05766540|Aripiprazole|aripiprazole|mesh-list
110493699|NCT05766540|Clozapine|clozapine|mesh-list
110493700|NCT05766540|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110493701|NCT05766540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110493702|NCT05766540|Antidepressive Agents|antidepressive agents|mesh-ancestor
110493703|NCT05766540|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110493704|NCT05766540|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110493705|NCT05766540|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110600452|NCT04065308|Daratumumab|daratumumab|mesh-list
110493706|NCT05766540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110493707|NCT05766540|Dopamine Agonists|dopamine agonists|mesh-ancestor
110493708|NCT05766540|Dopamine Agents|dopamine agents|mesh-ancestor
110493709|NCT05766540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110493710|NCT05766540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110493711|NCT05766540|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110493712|NCT05766540|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110493713|NCT05766540|Serotonin Agents|serotonin agents|mesh-ancestor
110600547|NCT04066296|Bupivacaine|bupivacaine|mesh-list
110493714|NCT05766540|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110493715|NCT05766540|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110493716|NCT05766540|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110493717|NCT05766540|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110493719|NCT05766540|GABA Agents|gaba agents|mesh-ancestor
110493720|NCT05765084|Pemetrexed|pemetrexed|mesh-list
110493721|NCT05765084|Atezolizumab|atezolizumab|mesh-list
110493722|NCT05765084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110493723|NCT05765084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110493724|NCT05765084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110493725|NCT05765084|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110493726|NCT05765084|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110493727|NCT05765084|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110493728|NCT05765084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110493730|NCT05746806|Hormones|hormones|mesh-ancestor
110493731|NCT05746806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110493732|NCT05746806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110493733|NCT05741229|Nitroglycerin|nitroglycerin|mesh-list
110493734|NCT05741229|Vasodilator Agents|vasodilator agents|mesh-ancestor
110493735|NCT05733715|Pembrolizumab|pembrolizumab|mesh-list
110493736|NCT05733715|Lenvatinib|lenvatinib|mesh-list
110493737|NCT05733715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110493738|NCT05733715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110493739|NCT05733715|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110493740|NCT05733715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110493741|NCT05733715|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110493742|NCT05733715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110493743|NCT05721755|Paclitaxel|paclitaxel|mesh-list
110493744|NCT05721755|Cisplatin|cisplatin|mesh-list
110493745|NCT05721755|Carboplatin|carboplatin|mesh-list
110493746|NCT05721755|Pembrolizumab|pembrolizumab|mesh-list
110493748|NCT05721755|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110493749|NCT05721755|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110493750|NCT05721755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110493751|NCT05721755|Tubulin Modulators|tubulin modulators|mesh-ancestor
110493752|NCT05721755|Antimitotic Agents|antimitotic agents|mesh-ancestor
110493753|NCT05721755|Mitosis Modulators|mitosis modulators|mesh-ancestor
110493754|NCT05721755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110493755|NCT05721755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110493756|NCT05721755|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110493757|NCT05721755|Antimetabolites|antimetabolites|mesh-ancestor
110493758|NCT05721755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110167751|NCT00000620|Insulin Aspart|insulin aspart|mesh-list
110493759|NCT05721755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110493760|NCT05721755|Immunologic Factors|immunologic factors|mesh-ancestor
110493761|NCT05721755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110493763|NCT05678647|Trace Elements|trace elements|mesh-ancestor
110493764|NCT05678647|Micronutrients|micronutrients|mesh-ancestor
110493765|NCT05678647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110493766|NCT05639907|Ethanol|ethanol|mesh-list
110493767|NCT05639907|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110493768|NCT05639907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110600784|NCT00862966|Heparin|heparin|mesh-list
110493769|NCT05639907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110493770|NCT05639907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110493771|NCT05625334|Aspirin|aspirin|mesh-list
110493772|NCT05625334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110493773|NCT05625334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110493774|NCT05625334|Analgesics|analgesics|mesh-ancestor
110493775|NCT05625334|Sensory System Agents|sensory system agents|mesh-ancestor
110493776|NCT05625334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110493777|NCT05625334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110493778|NCT05625334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110493779|NCT05625334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110493780|NCT05625334|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110493781|NCT05625334|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110493782|NCT05625334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110493783|NCT05625334|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110493784|NCT05625334|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110493785|NCT05625334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110493786|NCT05625334|Antipyretics|antipyretics|mesh-ancestor
110493787|NCT05615636|Lenalidomide|lenalidomide|mesh-list
110493788|NCT05615636|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
110493789|NCT05615636|Immunologic Factors|immunologic factors|mesh-ancestor
110271458|NCT04299880|Vitamins|vitamins|mesh-ancestor
110493790|NCT05615636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110493791|NCT05615636|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110493792|NCT05615636|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110493793|NCT05615636|Growth Substances|growth substances|mesh-ancestor
110493794|NCT05615636|Growth Inhibitors|growth inhibitors|mesh-ancestor
110493795|NCT05615636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110493796|NCT05615636|Immunoconjugates|immunoconjugates|mesh-ancestor
110493797|NCT05614115|Empagliflozin|empagliflozin|mesh-list
110493798|NCT05614115|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110493799|NCT05614115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110493801|NCT05614115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110493803|NCT05604794|Analgesics|analgesics|mesh-ancestor
110493804|NCT05604794|Sensory System Agents|sensory system agents|mesh-ancestor
110493805|NCT05604794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110493806|NCT05604794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110493807|NCT05604794|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110493808|NCT05604794|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110493809|NCT05604794|Anesthetics, General|anesthetics, general|mesh-ancestor
110493810|NCT05604794|Anesthetics|anesthetics|mesh-ancestor
110493811|NCT05604794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110493812|NCT05604794|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110493813|NCT05604794|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110493814|NCT05604794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110493815|NCT05604794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110493816|NCT05589688|Acyclovir|acyclovir|mesh-list
110493817|NCT05589688|Antiviral Agents|antiviral agents|mesh-ancestor
110493818|NCT05589688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110493819|NCT05551936|Rituximab|rituximab|mesh-list
110493820|NCT05551936|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110493821|NCT05551936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110493822|NCT05551936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110493823|NCT05551936|Immunologic Factors|immunologic factors|mesh-ancestor
110493824|NCT05551936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110493825|NCT05551936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110493826|NCT05551936|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110493827|NCT05551936|Alkylating Agents|alkylating agents|mesh-ancestor
110493828|NCT05551936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110493829|NCT05542134|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
110493831|NCT05419089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110493832|NCT05366829|Tislelizumab|tislelizumab|mesh-list
110493833|NCT05366829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110493834|NCT05366829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110493836|NCT05305248|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110493837|NCT05305248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110493838|NCT05305248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110493839|NCT05305248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110493840|NCT05305248|Analgesics|analgesics|mesh-ancestor
110493841|NCT05305248|Sensory System Agents|sensory system agents|mesh-ancestor
110493842|NCT05305248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110493843|NCT05305248|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110493844|NCT05305248|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110493845|NCT05305248|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110493846|NCT05305248|Adrenergic Agents|adrenergic agents|mesh-ancestor
110493847|NCT05305248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110493848|NCT05305248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110493849|NCT05286996|Anesthetics|anesthetics|mesh-list
110493850|NCT05286996|Anesthetics, Local|anesthetics, local|mesh-list
110493851|NCT05286996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110493852|NCT05286996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110493853|NCT05286996|Sensory System Agents|sensory system agents|mesh-ancestor
110493854|NCT05286996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110493855|NCT05248984|Ketorolac|ketorolac|mesh-list
110493856|NCT05248984|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110493857|NCT05248984|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110493858|NCT05248984|Analgesics|analgesics|mesh-ancestor
110493859|NCT05248984|Sensory System Agents|sensory system agents|mesh-ancestor
110493860|NCT05248984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110493861|NCT05248984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110493862|NCT05248984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110493863|NCT05248984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110493864|NCT05248984|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110493865|NCT05248984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110493866|NCT05248984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110493867|NCT05210166|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
110493868|NCT05210166|Antioxidants|antioxidants|mesh-ancestor
110311717|NCT00290264|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110493869|NCT05210166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110493870|NCT05210166|Protective Agents|protective agents|mesh-ancestor
110493871|NCT05210166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110493872|NCT05210166|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110493873|NCT05210166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110493874|NCT05169593|Adalimumab|adalimumab|mesh-list
110493875|NCT05169593|Infliximab|infliximab|mesh-list
110493876|NCT05169593|Ustekinumab|ustekinumab|mesh-list
110493877|NCT05169593|Vedolizumab|vedolizumab|mesh-list
110493878|NCT05169593|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110493879|NCT05169593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110493880|NCT05169593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110493881|NCT05169593|Dermatologic Agents|dermatologic agents|mesh-ancestor
110493882|NCT05169593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110493883|NCT05158153|Furosemide|furosemide|mesh-list
110493884|NCT05158153|Diuretics|diuretics|mesh-ancestor
110493885|NCT05158153|Natriuretic Agents|natriuretic agents|mesh-ancestor
110493886|NCT05158153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110493887|NCT05158153|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110493888|NCT05158153|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110493889|NCT05158153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110493890|NCT05148234|Decitabine|decitabine|mesh-list
110493891|NCT05148234|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
110493892|NCT05148234|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110493893|NCT05148234|Antimetabolites|antimetabolites|mesh-ancestor
110493894|NCT05148234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110493895|NCT05148234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110493896|NCT05148234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110493897|NCT05147558|Pembrolizumab|pembrolizumab|mesh-list
110493898|NCT05147558|Lenvatinib|lenvatinib|mesh-list
110493899|NCT05147558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110493900|NCT05147558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110493901|NCT05147558|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110493902|NCT05147558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110493903|NCT05147558|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110493904|NCT05147558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110493905|NCT05110001|Chlorhexidine|chlorhexidine|mesh-list
110493906|NCT05110001|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110493908|NCT05110001|Moxifloxacin|moxifloxacin|mesh-list
110493909|NCT05110001|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110493910|NCT05110001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110493911|NCT05110001|Disinfectants|disinfectants|mesh-ancestor
110493912|NCT05110001|Dermatologic Agents|dermatologic agents|mesh-ancestor
110493913|NCT05110001|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110493914|NCT05110001|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110493915|NCT05110001|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110493916|NCT05110001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110493917|NCT05110001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110493918|NCT05110001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110493919|NCT05110001|Antifungal Agents|antifungal agents|mesh-ancestor
110493920|NCT05098366|Furosemide|furosemide|mesh-list
110493921|NCT05098366|Diuretics|diuretics|mesh-ancestor
110493922|NCT05098366|Natriuretic Agents|natriuretic agents|mesh-ancestor
110493923|NCT05098366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110493924|NCT05098366|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110493925|NCT05098366|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110493926|NCT05098366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110493927|NCT05082480|Hyaluronic Acid|hyaluronic acid|mesh-list
110493928|NCT05082480|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110493929|NCT05082480|Immunologic Factors|immunologic factors|mesh-ancestor
110493930|NCT05082480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110493931|NCT05082480|Viscosupplements|viscosupplements|mesh-ancestor
110493932|NCT05082480|Protective Agents|protective agents|mesh-ancestor
110493933|NCT05073250|Rituximab|rituximab|mesh-list
110493934|NCT05073250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110493935|NCT05073250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110493936|NCT05073250|Immunologic Factors|immunologic factors|mesh-ancestor
110493937|NCT05073250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110493938|NCT05073250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110493939|NCT05041270|Dexmedetomidine|dexmedetomidine|mesh-list
110493940|NCT05041270|Nalbuphine|nalbuphine|mesh-list
110493941|NCT05041270|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110493942|NCT05041270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110493943|NCT05041270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110493944|NCT05041270|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110493945|NCT05041270|Analgesics|analgesics|mesh-ancestor
110493946|NCT05041270|Sensory System Agents|sensory system agents|mesh-ancestor
110493947|NCT05041270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110493948|NCT05041270|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110493949|NCT05041270|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110493950|NCT05041270|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110493951|NCT05041270|Adrenergic Agents|adrenergic agents|mesh-ancestor
110493952|NCT05041270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110493953|NCT05041270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110493954|NCT05041270|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110493955|NCT05041270|Narcotics|narcotics|mesh-ancestor
110493956|NCT05039736|Nivolumab|nivolumab|mesh-list
110493957|NCT05039736|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110493958|NCT05039736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110493959|NCT05039736|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110493960|NCT05039736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110493961|NCT05010590|Denosumab|denosumab|mesh-list
110493962|NCT05010590|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110493963|NCT05010590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110493964|NCT04983940|Methyltestosterone|methyltestosterone|mesh-list
110493965|NCT04983940|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
110493966|NCT04983940|Testosterone|testosterone|mesh-list
110493967|NCT04983940|Testosterone undecanoate|testosterone undecanoate|mesh-list
110493968|NCT04983940|Testosterone enanthate|testosterone enanthate|mesh-list
110493970|NCT04983940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110493971|NCT04983940|Anabolic Agents|anabolic agents|mesh-ancestor
110493973|NCT04983940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110493974|NCT04983940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110493975|NCT04983940|Androgens|androgens|mesh-ancestor
110493976|NCT04940637|Niraparib|niraparib|mesh-list
110493977|NCT04940637|Dostarlimab|dostarlimab|mesh-list
110493978|NCT04940637|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110493979|NCT04940637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110493980|NCT04940637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110493981|NCT04940637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110493982|NCT04939090|Megestrol|megestrol|mesh-list
110493983|NCT04939090|Megestrol Acetate|megestrol acetate|mesh-list
110493984|NCT04939090|Olanzapine|olanzapine|mesh-list
110493985|NCT04939090|Antiemetics|antiemetics|mesh-ancestor
110493986|NCT04939090|Autonomic Agents|autonomic agents|mesh-ancestor
110493987|NCT04939090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110493988|NCT04939090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110493989|NCT04939090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110493990|NCT04939090|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110493991|NCT04939090|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110493992|NCT04939090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110493993|NCT04939090|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110493994|NCT04939090|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110493995|NCT04939090|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110493996|NCT04939090|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110493997|NCT04939090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110493999|NCT04939090|Serotonin Agents|serotonin agents|mesh-ancestor
110494000|NCT04939090|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110494001|NCT04939090|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110494002|NCT04939090|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110494003|NCT04939090|Contraceptive Agents|contraceptive agents|mesh-ancestor
110494004|NCT04939090|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110494005|NCT04939090|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110494006|NCT04939090|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110494007|NCT04939090|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110494008|NCT04939090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110494009|NCT04939090|Appetite Stimulants|appetite stimulants|mesh-ancestor
110494010|NCT04939090|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110494011|NCT04911660|Empagliflozin|empagliflozin|mesh-list
110494012|NCT04911660|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110494013|NCT04911660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110494014|NCT04911660|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110494015|NCT04911660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110494017|NCT04881682|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110494018|NCT04881682|Antibodies|antibodies|mesh-list
110494019|NCT04881682|Immunologic Factors|immunologic factors|mesh-ancestor
110494020|NCT04881682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110494021|NCT04839185|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
110494022|NCT04839185|Hematinics|hematinics|mesh-ancestor
110494023|NCT04839185|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
110271609|NCT02905708|Charcoal|charcoal|mesh-list
110494024|NCT04839185|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110494025|NCT04806906|Azacitidine|azacitidine|mesh-list
110494027|NCT04806906|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110494028|NCT04806906|Antimetabolites|antimetabolites|mesh-ancestor
110494029|NCT04806906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110494030|NCT04806906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110494031|NCT04806906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110494032|NCT04752059|Trastuzumab|trastuzumab|mesh-list
110494033|NCT04752059|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
110494034|NCT04752059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110167776|NCT00000620|Furosemide|furosemide|mesh-list
110494035|NCT04752059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110494036|NCT04752059|Immunoconjugates|immunoconjugates|mesh-ancestor
110494037|NCT04752059|Immunologic Factors|immunologic factors|mesh-ancestor
110494038|NCT04752059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110494039|NCT04750473|Edetic Acid|edetic acid|mesh-list
110494040|NCT04750473|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
110494041|NCT04750473|Chelating Agents|chelating agents|mesh-ancestor
110494042|NCT04750473|Sequestering Agents|sequestering agents|mesh-ancestor
110494043|NCT04750473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110494044|NCT04750473|Anticoagulants|anticoagulants|mesh-ancestor
110494045|NCT04750473|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110494046|NCT04750473|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110494047|NCT04745351|Remdesivir|remdesivir|mesh-list
110494048|NCT04745351|Antimetabolites|antimetabolites|mesh-ancestor
110494049|NCT04745351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110494050|NCT04745351|Antiviral Agents|antiviral agents|mesh-ancestor
110494051|NCT04745351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110494052|NCT04735549|Hormones|hormones|mesh-list
110494053|NCT04735549|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110494054|NCT04735549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110494055|NCT04710277|Analgesics, Opioid|analgesics, opioid|mesh-list
110494056|NCT04710277|Narcotics|narcotics|mesh-ancestor
110494057|NCT04710277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110494058|NCT04710277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110494059|NCT04710277|Analgesics|analgesics|mesh-ancestor
110494060|NCT04710277|Sensory System Agents|sensory system agents|mesh-ancestor
110494061|NCT04710277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110494062|NCT04665089|Erythromycin|erythromycin|mesh-list
110494063|NCT04665089|Erythromycin Estolate|erythromycin estolate|mesh-list
110494064|NCT04665089|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
110494065|NCT04665089|Erythromycin stearate|erythromycin stearate|mesh-list
110494066|NCT04665089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110494067|NCT04665089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110494068|NCT04665089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110494069|NCT04665089|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110494070|NCT04665089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110271624|NCT00167960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110494071|NCT04665089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110494072|NCT04612790|Benralizumab|benralizumab|mesh-list
110494073|NCT04612790|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110494074|NCT04612790|Respiratory System Agents|respiratory system agents|mesh-ancestor
110494075|NCT04591002|Osimertinib|osimertinib|mesh-list
110494076|NCT04591002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110494077|NCT04591002|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110494078|NCT04591002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110494079|NCT04591002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110494080|NCT04498780|Valsartan|valsartan|mesh-list
110494081|NCT04498780|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
110494082|NCT04498780|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110601219|NCT00732810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110494083|NCT04498780|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110494084|NCT04498780|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110494085|NCT04498780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110494086|NCT04493333|Calcium polycarbophil|calcium polycarbophil|mesh-list
110494087|NCT04493333|Psyllium|psyllium|mesh-list
110494088|NCT04493333|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
110494089|NCT04493333|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110494090|NCT04493333|Immunologic Factors|immunologic factors|mesh-ancestor
110494091|NCT04493333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110494092|NCT04493333|Antidiarrheals|antidiarrheals|mesh-ancestor
110494093|NCT04493333|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110494094|NCT04493333|Cathartics|cathartics|mesh-ancestor
110494095|NCT04427501|Bamlanivimab|bamlanivimab|mesh-list
110494096|NCT04427501|Antiviral Agents|antiviral agents|mesh-ancestor
110494097|NCT04427501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110494098|NCT04403165|Norepinephrine|norepinephrine|mesh-list
110494099|NCT04403165|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110494100|NCT04403165|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110494101|NCT04403165|Adrenergic Agents|adrenergic agents|mesh-ancestor
110494102|NCT04403165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110494103|NCT04403165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110494104|NCT04403165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110494105|NCT04403165|Sympathomimetics|sympathomimetics|mesh-ancestor
110494106|NCT04403165|Autonomic Agents|autonomic agents|mesh-ancestor
110494107|NCT04403165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110494108|NCT04403165|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110494109|NCT04289779|Atezolizumab|atezolizumab|mesh-list
110494110|NCT04289779|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110494111|NCT04289779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110494112|NCT04289779|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110494113|NCT04289779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110494114|NCT04271202|Erenumab|erenumab|mesh-list
110494115|NCT04271202|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
110141389|NCT02012387|Omalizumab|omalizumab|mesh-list
110494116|NCT04271202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110494117|NCT04271202|Analgesics|analgesics|mesh-ancestor
110494118|NCT04271202|Sensory System Agents|sensory system agents|mesh-ancestor
110494119|NCT04271202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110494120|NCT04271202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110494121|NCT04197687|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110494122|NCT04197687|Trastuzumab|trastuzumab|mesh-list
110494123|NCT04197687|Pertuzumab|pertuzumab|mesh-list
110494124|NCT04197687|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
110494125|NCT04197687|Maytansine|maytansine|mesh-list
110494126|NCT04197687|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
110494127|NCT04197687|Vaccines|vaccines|mesh-list
110494128|NCT04197687|Antibodies|antibodies|mesh-list
110494129|NCT04197687|Immunoglobulins|immunoglobulins|mesh-list
110494130|NCT04197687|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110494132|NCT04197687|Immunoconjugates|immunoconjugates|mesh-list
110494133|NCT04197687|Immunologic Factors|immunologic factors|mesh-ancestor
110494134|NCT04197687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110494135|NCT04197687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110494136|NCT04197687|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110494137|NCT04197687|Tubulin Modulators|tubulin modulators|mesh-ancestor
110494138|NCT04197687|Antimitotic Agents|antimitotic agents|mesh-ancestor
110494139|NCT04197687|Mitosis Modulators|mitosis modulators|mesh-ancestor
110494140|NCT04197687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110494141|NCT04197687|Immunotoxins|immunotoxins|mesh-ancestor
110494142|NCT04130516|Pembrolizumab|pembrolizumab|mesh-list
110494143|NCT04130516|Antibodies|antibodies|mesh-list
110494144|NCT04130516|Immunologic Factors|immunologic factors|mesh-ancestor
110494145|NCT04130516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110494146|NCT04130516|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110494147|NCT04130516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110494148|NCT04130516|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110494149|NCT04130516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110494150|NCT03989778|Vitamin D|vitamin d|mesh-list
110494151|NCT03989778|Vitamins|vitamins|mesh-ancestor
110494152|NCT03989778|Micronutrients|micronutrients|mesh-ancestor
110494153|NCT03989778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110494154|NCT03989778|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110494155|NCT03976063|Nifedipine|nifedipine|mesh-list
110494156|NCT03976063|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110494157|NCT03976063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110494158|NCT03976063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110494159|NCT03976063|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110494160|NCT03976063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110494161|NCT03976063|Vasodilator Agents|vasodilator agents|mesh-ancestor
110494162|NCT03976063|Tocolytic Agents|tocolytic agents|mesh-ancestor
110494163|NCT03976063|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110494165|NCT03962855|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110494166|NCT03959527|Azithromycin|azithromycin|mesh-list
110494167|NCT03959527|Ceftriaxone|ceftriaxone|mesh-list
110494168|NCT03959527|Zoliflodacin|zoliflodacin|mesh-list
110494169|NCT03959527|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110494170|NCT03959527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110494171|NCT03959527|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110494172|NCT03959527|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110494173|NCT03959527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110494174|NCT03959527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110494175|NCT03959527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110494176|NCT03955172|Everolimus|everolimus|mesh-list
110494177|NCT03955172|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110494178|NCT03955172|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110494179|NCT03955172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110494180|NCT03955172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110494181|NCT03955172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110494182|NCT03955172|Immunologic Factors|immunologic factors|mesh-ancestor
110494183|NCT03955172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110494184|NCT03955172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110494185|NCT03947216|Pimavanserin|pimavanserin|mesh-list
110494186|NCT03947216|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110601431|NCT00864526|Ibuprofen|ibuprofen|mesh-list
110494187|NCT03947216|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110494188|NCT03947216|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110494189|NCT03947216|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110494190|NCT03947216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110494191|NCT03947216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110494192|NCT03947216|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110494193|NCT03947216|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110494194|NCT03947216|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110494195|NCT03947216|Serotonin Agents|serotonin agents|mesh-ancestor
110494196|NCT03947216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110494197|NCT03947216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110494198|NCT03889249|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
110494199|NCT03889249|Tenecteplase|tenecteplase|mesh-list
110494200|NCT03889249|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110494201|NCT03889249|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110494202|NCT03889249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110494203|NCT03844620|Trifluridine|trifluridine|mesh-list
110494204|NCT03844620|Antimetabolites|antimetabolites|mesh-ancestor
110494205|NCT03844620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110494206|NCT03844620|Antiviral Agents|antiviral agents|mesh-ancestor
110601460|NCT04064138|Anesthetics|anesthetics|mesh-list
110494207|NCT03844620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110494209|NCT03841201|Lenvatinib|lenvatinib|mesh-list
110494210|NCT03841201|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110494211|NCT03841201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110494212|NCT03841201|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110494213|NCT03841201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110494214|NCT03841201|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110494215|NCT03841201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110494216|NCT03806166|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110271751|NCT02904499|Dabigatran|dabigatran|mesh-list
110494217|NCT03806166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110494218|NCT03733535|Benralizumab|benralizumab|mesh-list
110494219|NCT03733535|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110494220|NCT03733535|Respiratory System Agents|respiratory system agents|mesh-ancestor
110494221|NCT03719092|Vitamins|vitamins|mesh-list
110494222|NCT03719092|Vitamin A|vitamin a|mesh-list
110494223|NCT03719092|Retinol palmitate|retinol palmitate|mesh-list
110494224|NCT03719092|Micronutrients|micronutrients|mesh-ancestor
110494225|NCT03719092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110494226|NCT03719092|Antioxidants|antioxidants|mesh-ancestor
110494227|NCT03719092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110494228|NCT03719092|Protective Agents|protective agents|mesh-ancestor
110494229|NCT03719092|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110494230|NCT03719092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110494231|NCT03661385|Nitric Oxide|nitric oxide|mesh-list
110494232|NCT03661385|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110494233|NCT03661385|Autonomic Agents|autonomic agents|mesh-ancestor
110494234|NCT03661385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110494235|NCT03661385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110494236|NCT03661385|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110494237|NCT03661385|Respiratory System Agents|respiratory system agents|mesh-ancestor
110494238|NCT03661385|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110494239|NCT03661385|Antioxidants|antioxidants|mesh-ancestor
110494240|NCT03661385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110494241|NCT03661385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110494242|NCT03661385|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
110494243|NCT03661385|Vasodilator Agents|vasodilator agents|mesh-ancestor
110494244|NCT03661385|Gasotransmitters|gasotransmitters|mesh-ancestor
110494245|NCT03661385|Protective Agents|protective agents|mesh-ancestor
110494246|NCT03630055|Rivaroxaban|rivaroxaban|mesh-list
110494247|NCT03630055|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110494248|NCT03630055|Antithrombins|antithrombins|mesh-ancestor
110494249|NCT03630055|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110494250|NCT03630055|Protease Inhibitors|protease inhibitors|mesh-ancestor
110494251|NCT03630055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110494252|NCT03630055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110494253|NCT03630055|Anticoagulants|anticoagulants|mesh-ancestor
110494254|NCT03617731|Dexamethasone|dexamethasone|mesh-list
110494255|NCT03617731|Lenalidomide|lenalidomide|mesh-list
110494257|NCT03617731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110494258|NCT03617731|Antiemetics|antiemetics|mesh-ancestor
110494259|NCT03617731|Autonomic Agents|autonomic agents|mesh-ancestor
110494260|NCT03617731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110494261|NCT03617731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110494262|NCT03617731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110494263|NCT03617731|Glucocorticoids|glucocorticoids|mesh-ancestor
110494264|NCT03617731|Hormones|hormones|mesh-ancestor
110494265|NCT03617731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110494266|NCT03617731|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110494267|NCT03617731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110494268|NCT03617731|Immunologic Factors|immunologic factors|mesh-ancestor
110494269|NCT03617731|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110494270|NCT03617731|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110494271|NCT03617731|Growth Substances|growth substances|mesh-ancestor
110494272|NCT03617731|Growth Inhibitors|growth inhibitors|mesh-ancestor
110494273|NCT03531736|Cyclophosphamide|cyclophosphamide|mesh-list
110494274|NCT03531736|Fludarabine|fludarabine|mesh-list
110494275|NCT03531736|Rituximab|rituximab|mesh-list
110494276|NCT03531736|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110494277|NCT03531736|Thymoglobulin|thymoglobulin|mesh-list
110494278|NCT03531736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110494279|NCT03531736|Immunologic Factors|immunologic factors|mesh-ancestor
110494280|NCT03531736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110494281|NCT03531736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110494282|NCT03531736|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110494283|NCT03531736|Alkylating Agents|alkylating agents|mesh-ancestor
110494284|NCT03531736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110494285|NCT03531736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110494286|NCT03531736|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110494287|NCT03531736|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110494288|NCT03526874|Lidocaine|lidocaine|mesh-list
110494289|NCT03526874|Anesthetics, Local|anesthetics, local|mesh-ancestor
110494290|NCT03526874|Anesthetics|anesthetics|mesh-ancestor
110494291|NCT03526874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110494292|NCT03526874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110494293|NCT03526874|Sensory System Agents|sensory system agents|mesh-ancestor
110494294|NCT03526874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110494295|NCT03526874|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110494296|NCT03526874|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110494297|NCT03526874|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110494298|NCT03526874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110651619|NCT02567279|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110494299|NCT03526874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110494301|NCT03493789|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110494302|NCT03493789|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110494303|NCT03493789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110494304|NCT03493789|Antimetabolites|antimetabolites|mesh-ancestor
110494305|NCT03493789|Antiviral Agents|antiviral agents|mesh-ancestor
110494306|NCT03493789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110494307|NCT03451799|Temozolomide|temozolomide|mesh-list
110494308|NCT03451799|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110494309|NCT03451799|Alkylating Agents|alkylating agents|mesh-ancestor
110494310|NCT03451799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110494311|NCT03451799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110494312|NCT03439124|Cephalosporins|cephalosporins|mesh-list
110494313|NCT03439124|Ceftobiprole|ceftobiprole|mesh-list
110494314|NCT03439124|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
110494315|NCT03439124|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110494316|NCT03439124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110494317|NCT03393741|Paclitaxel|paclitaxel|mesh-list
110494318|NCT03393741|Vinorelbine|vinorelbine|mesh-list
110494319|NCT03393741|Docetaxel|docetaxel|mesh-list
110494320|NCT03393741|Epothilones|epothilones|mesh-list
110494321|NCT03393741|Vinca Alkaloids|vinca alkaloids|mesh-list
110494322|NCT03393741|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110494323|NCT03393741|Taxane|taxane|mesh-list
110494324|NCT03393741|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110494325|NCT03393741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110494326|NCT03393741|Tubulin Modulators|tubulin modulators|mesh-ancestor
110494327|NCT03393741|Antimitotic Agents|antimitotic agents|mesh-ancestor
110494328|NCT03393741|Mitosis Modulators|mitosis modulators|mesh-ancestor
110494329|NCT03393741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110494330|NCT03304093|Nivolumab|nivolumab|mesh-list
110494331|NCT03304093|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110494332|NCT03304093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110494333|NCT03304093|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110494334|NCT03304093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110494335|NCT03279471|Sertraline|sertraline|mesh-list
110494336|NCT03279471|Antidepressive Agents|antidepressive agents|mesh-ancestor
110494337|NCT03279471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110651620|NCT02567279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110601661|NCT00873262|Estradiol|estradiol|mesh-list
110494338|NCT03279471|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110494339|NCT03279471|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110494340|NCT03279471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110494341|NCT03279471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110494342|NCT03279471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110494343|NCT03279471|Serotonin Agents|serotonin agents|mesh-ancestor
110494344|NCT03279471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110494345|NCT03267888|Pembrolizumab|pembrolizumab|mesh-list
110494346|NCT03267888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110494347|NCT03267888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110494348|NCT03267888|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110494349|NCT03267888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110494350|NCT03263117|Anesthetics|anesthetics|mesh-list
110494351|NCT03263117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110494352|NCT03263117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110494354|NCT03232918|Oxytocics|oxytocics|mesh-ancestor
110651621|NCT00933374|Paclitaxel|paclitaxel|mesh-list
110494355|NCT03232918|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110494356|NCT03232918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110494357|NCT03212989|Vorinostat|vorinostat|mesh-list
110494358|NCT03212989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110494359|NCT03212989|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110494360|NCT03212989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110494361|NCT03212989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110494362|NCT03158688|Dexamethasone|dexamethasone|mesh-list
110494363|NCT03158688|Daratumumab|daratumumab|mesh-list
110494364|NCT03158688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110494365|NCT03158688|Antiemetics|antiemetics|mesh-ancestor
110494366|NCT03158688|Autonomic Agents|autonomic agents|mesh-ancestor
110494367|NCT03158688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110494368|NCT03158688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110271905|NCT05995704|Acetaminophen|acetaminophen|mesh-list
110494369|NCT03158688|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110494370|NCT03158688|Glucocorticoids|glucocorticoids|mesh-ancestor
110494371|NCT03158688|Hormones|hormones|mesh-ancestor
110494372|NCT03158688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110494373|NCT03158688|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110494374|NCT03158688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110494375|NCT03138733|Daptomycin|daptomycin|mesh-list
110494376|NCT03138733|Ceftobiprole|ceftobiprole|mesh-list
110494377|NCT03138733|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
110494378|NCT03138733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110494379|NCT03138733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110494380|NCT03137173|Vancomycin|vancomycin|mesh-list
110494381|NCT03137173|Aztreonam|aztreonam|mesh-list
110494382|NCT03137173|Ceftobiprole|ceftobiprole|mesh-list
110494383|NCT03137173|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
110494384|NCT03137173|Cephalosporins|cephalosporins|mesh-list
110601773|NCT04039126|Iodine|iodine|mesh-list
110494385|NCT03137173|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110494386|NCT03137173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110494389|NCT03107988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110494390|NCT03107988|Immunologic Factors|immunologic factors|mesh-ancestor
110494391|NCT03107988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110494392|NCT03107988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110494393|NCT03107988|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110494394|NCT03107988|Alkylating Agents|alkylating agents|mesh-ancestor
110494395|NCT03107988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110494396|NCT03107988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110494397|NCT03107988|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110494398|NCT03107988|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110494399|NCT03107988|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110494400|NCT03107988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110494401|NCT03089957|Urinastatin|urinastatin|mesh-list
110494402|NCT03089957|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
110494403|NCT03089957|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110494404|NCT03089957|Protease Inhibitors|protease inhibitors|mesh-ancestor
110494405|NCT03089957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110494406|NCT03089957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110494407|NCT03080883|Apixaban|apixaban|mesh-list
110494408|NCT03080883|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110494409|NCT03080883|Antithrombins|antithrombins|mesh-ancestor
110494410|NCT03080883|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110494411|NCT03080883|Protease Inhibitors|protease inhibitors|mesh-ancestor
110494412|NCT03080883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110494413|NCT03080883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110494414|NCT03080883|Anticoagulants|anticoagulants|mesh-ancestor
110494415|NCT03072147|Teriparatide|teriparatide|mesh-list
110494416|NCT03072147|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110494417|NCT03072147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110494418|NCT03072147|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110494419|NCT02835222|Cytarabine|cytarabine|mesh-list
110494420|NCT02835222|Daunorubicin|daunorubicin|mesh-list
110494421|NCT02835222|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110494422|NCT02835222|Antimetabolites|antimetabolites|mesh-ancestor
110494423|NCT02835222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110494424|NCT02835222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110494425|NCT02835222|Antiviral Agents|antiviral agents|mesh-ancestor
110601791|NCT00873808|Clodronic Acid|clodronic acid|mesh-list
110494426|NCT02835222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110494427|NCT02835222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110494428|NCT02835222|Immunologic Factors|immunologic factors|mesh-ancestor
110494429|NCT02835222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110494430|NCT02835222|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110494431|NCT02835222|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110494432|NCT02835222|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110494433|NCT02835222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110494435|NCT02723513|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110494436|NCT02723513|Anesthetics, General|anesthetics, general|mesh-ancestor
110494437|NCT02723513|Anesthetics|anesthetics|mesh-ancestor
110494438|NCT02723513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110494439|NCT02723513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110494441|NCT02706054|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110494442|NCT02706054|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110494443|NCT02706054|Analgesics|analgesics|mesh-ancestor
110494444|NCT02706054|Sensory System Agents|sensory system agents|mesh-ancestor
110494445|NCT02706054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110494446|NCT02706054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110494447|NCT02706054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110494448|NCT02706054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110494449|NCT02706054|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110494450|NCT02706054|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110494451|NCT02706054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110494452|NCT02706054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110494453|NCT02630641|Hormones|hormones|mesh-list
110494454|NCT02630641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110651622|NCT00933374|Everolimus|everolimus|mesh-list
110494455|NCT02630641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110494456|NCT02600117|Tenofovir|tenofovir|mesh-list
110494457|NCT02600117|Antiviral Agents|antiviral agents|mesh-ancestor
110494458|NCT02600117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110494459|NCT02600117|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110494460|NCT02600117|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110494462|NCT02600117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110494463|NCT02600117|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110494464|NCT02600117|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110494465|NCT02599714|Fulvestrant|fulvestrant|mesh-list
110494466|NCT02599714|Palbociclib|palbociclib|mesh-list
110494467|NCT02599714|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110494468|NCT02599714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110494469|NCT02599714|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110494470|NCT02599714|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110494471|NCT02599714|Hormone Antagonists|hormone antagonists|mesh-ancestor
110494472|NCT02599714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110494473|NCT02599714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110494474|NCT02599714|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110494475|NCT02599714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110494476|NCT02599714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110494477|NCT02337634|Silymarin|silymarin|mesh-list
110494478|NCT02337634|Antioxidants|antioxidants|mesh-ancestor
110494479|NCT02337634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110494480|NCT02337634|Protective Agents|protective agents|mesh-ancestor
110494481|NCT02337634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110494482|NCT02288195|Capecitabine|capecitabine|mesh-list
110494483|NCT02288195|Oxaliplatin|oxaliplatin|mesh-list
110494484|NCT02288195|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110494485|NCT02288195|Antimetabolites|antimetabolites|mesh-ancestor
110494486|NCT02288195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110494487|NCT02288195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110494488|NCT02265874|Nicotine|nicotine|mesh-list
110494489|NCT02265874|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110494490|NCT02265874|Autonomic Agents|autonomic agents|mesh-ancestor
110494491|NCT02265874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110494492|NCT02265874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110494493|NCT02265874|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110494494|NCT02265874|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110494495|NCT02265874|Cholinergic Agents|cholinergic agents|mesh-ancestor
110494496|NCT02265874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110494497|NCT02265874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110494498|NCT02168140|Thioctic Acid|thioctic acid|mesh-list
110494499|NCT02168140|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110494500|NCT02168140|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110494501|NCT02168140|Alkylating Agents|alkylating agents|mesh-ancestor
110494502|NCT02168140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110494503|NCT02168140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110494505|NCT02168140|Protective Agents|protective agents|mesh-ancestor
110494506|NCT02168140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110494507|NCT02168140|Vitamin B Complex|vitamin b complex|mesh-ancestor
110494508|NCT02168140|Vitamins|vitamins|mesh-ancestor
110494509|NCT02168140|Micronutrients|micronutrients|mesh-ancestor
110494510|NCT02087423|Durvalumab|durvalumab|mesh-list
110494511|NCT02087423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110494512|NCT02087423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110494513|NCT01996436|Verapamil|verapamil|mesh-list
110494514|NCT01996436|Nicardipine|nicardipine|mesh-list
110494515|NCT01996436|Nitroglycerin|nitroglycerin|mesh-list
110494516|NCT01996436|Vasodilator Agents|vasodilator agents|mesh-ancestor
110494517|NCT01996436|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110494518|NCT01996436|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110494519|NCT01996436|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110494520|NCT01996436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110494521|NCT01996436|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110494522|NCT01996436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110494523|NCT01996436|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110494524|NCT01845337|Capecitabine|capecitabine|mesh-list
110494525|NCT01845337|Tegafur|tegafur|mesh-list
110494526|NCT01845337|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110494527|NCT01845337|Antimetabolites|antimetabolites|mesh-ancestor
110601895|NCT00737126|Folic Acid|folic acid|mesh-list
110494528|NCT01845337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110494529|NCT01845337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110494530|NCT01760005|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110494531|NCT01760005|Immunologic Factors|immunologic factors|mesh-ancestor
110494532|NCT01760005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110494534|NCT01613118|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110494535|NCT01613118|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110494536|NCT01613118|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110494537|NCT01613118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110494538|NCT00836537|Benazepril|benazepril|mesh-list
110494539|NCT00836537|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110494540|NCT00836537|Protease Inhibitors|protease inhibitors|mesh-ancestor
110494541|NCT00836537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110494542|NCT00836537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110494543|NCT00836537|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110494544|NCT00572169|Thalidomide|thalidomide|mesh-list
110494545|NCT00572169|Dexamethasone|dexamethasone|mesh-list
110494546|NCT00572169|Cyclophosphamide|cyclophosphamide|mesh-list
110494547|NCT00572169|Cisplatin|cisplatin|mesh-list
110494548|NCT00572169|Doxorubicin|doxorubicin|mesh-list
110494549|NCT00572169|Etoposide|etoposide|mesh-list
110494550|NCT00572169|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110494551|NCT00572169|Bortezomib|bortezomib|mesh-list
110494552|NCT00572169|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110494553|NCT00572169|Immunologic Factors|immunologic factors|mesh-ancestor
110494554|NCT00572169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110494555|NCT00572169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110494556|NCT00572169|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110494557|NCT00572169|Alkylating Agents|alkylating agents|mesh-ancestor
110494558|NCT00572169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110494559|NCT00572169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110494560|NCT00572169|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110494561|NCT00572169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110494562|NCT00572169|Antiemetics|antiemetics|mesh-ancestor
110494563|NCT00572169|Autonomic Agents|autonomic agents|mesh-ancestor
110494564|NCT00572169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110494565|NCT00572169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110494566|NCT00572169|Glucocorticoids|glucocorticoids|mesh-ancestor
110494567|NCT00572169|Hormones|hormones|mesh-ancestor
110141839|NCT02015312|Protective Agents|protective agents|mesh-ancestor
110494568|NCT00572169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110494569|NCT00572169|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110494570|NCT00572169|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110494571|NCT00572169|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110494572|NCT00572169|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110494573|NCT00572169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110494574|NCT00572169|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110494575|NCT00572169|Leprostatic Agents|leprostatic agents|mesh-ancestor
110494576|NCT00572169|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110494577|NCT00572169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110494578|NCT00572169|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110494579|NCT00572169|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110494580|NCT00572169|Growth Substances|growth substances|mesh-ancestor
110494581|NCT00572169|Growth Inhibitors|growth inhibitors|mesh-ancestor
110494582|NCT00941720|Cyclophosphamide|cyclophosphamide|mesh-list
110494583|NCT00941720|Busulfan|busulfan|mesh-list
110494584|NCT00941720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110494585|NCT00941720|Immunologic Factors|immunologic factors|mesh-ancestor
110494586|NCT00941720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110494587|NCT00941720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110494588|NCT00941720|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110494589|NCT00941720|Alkylating Agents|alkylating agents|mesh-ancestor
110494590|NCT00941720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110494591|NCT00941720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110494592|NCT00941720|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110494593|NCT02583568|Bevacizumab|bevacizumab|mesh-list
110494594|NCT02583568|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110494595|NCT02583568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110494596|NCT02583568|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110494597|NCT02583568|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110494598|NCT02583568|Growth Substances|growth substances|mesh-ancestor
110494599|NCT02583568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110494600|NCT02583568|Growth Inhibitors|growth inhibitors|mesh-ancestor
110494601|NCT02852564|Ethacrynic Acid|ethacrynic acid|mesh-list
110494602|NCT02852564|Diuretics|diuretics|mesh-ancestor
110494604|NCT02852564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110494605|NCT02852564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110494606|NCT02852564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110494607|NCT05593042|Vaccines|vaccines|mesh-list
110494608|NCT05593042|Immunologic Factors|immunologic factors|mesh-ancestor
110494609|NCT05593042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110494610|NCT05509816|Midazolam|midazolam|mesh-list
110494611|NCT05509816|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110494612|NCT05509816|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110494613|NCT05509816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110494614|NCT05509816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110494615|NCT05509816|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110494616|NCT05509816|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110494617|NCT05509816|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110494618|NCT05509816|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110494619|NCT05509816|Anesthetics, General|anesthetics, general|mesh-ancestor
110494620|NCT05509816|Anesthetics|anesthetics|mesh-ancestor
110494621|NCT05509816|GABA Modulators|gaba modulators|mesh-ancestor
110494622|NCT05509816|GABA Agents|gaba agents|mesh-ancestor
110494623|NCT05509816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110494624|NCT05509816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110494625|NCT04080310|Ezetimibe|ezetimibe|mesh-list
110494626|NCT04080310|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
110494627|NCT04080310|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110494628|NCT04080310|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110494629|NCT04080310|Antimetabolites|antimetabolites|mesh-ancestor
110494630|NCT04080310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110494631|NCT04080310|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110494632|NCT04080310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110494633|NCT04078048|Vitamins|vitamins|mesh-list
110494634|NCT04078048|Vitamin E|vitamin e|mesh-list
110494635|NCT04078048|Antioxidants|antioxidants|mesh-list
110494636|NCT04078048|Micronutrients|micronutrients|mesh-ancestor
110494637|NCT04078048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110494638|NCT04078048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110494639|NCT04078048|Protective Agents|protective agents|mesh-ancestor
110494640|NCT00673387|Pramlintide|pramlintide|mesh-list
110494641|NCT00673387|Islet Amyloid Polypeptide|islet amyloid polypeptide|mesh-list
110494642|NCT00673387|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110494643|NCT00673387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110494644|NCT00673387|Appetite Depressants|appetite depressants|mesh-ancestor
110494645|NCT00673387|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110494646|NCT00673387|Amylin Receptor Agonists|amylin receptor agonists|mesh-ancestor
110494647|NCT00673387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110494648|NCT00933608|Memantine|memantine|mesh-list
110494649|NCT00933608|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110494650|NCT00933608|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110494651|NCT00933608|Dopamine Agents|dopamine agents|mesh-ancestor
110494652|NCT00933608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110494653|NCT00933608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110494654|NCT00933608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110494655|NCT00933608|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110494656|NCT00933608|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110494657|NCT05380310|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110494658|NCT02558023|Nicardipine|nicardipine|mesh-list
110494659|NCT02558023|Urapidil|urapidil|mesh-list
110494660|NCT02558023|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110494661|NCT02558023|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110494662|NCT02558023|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110494663|NCT02558023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110494664|NCT02558023|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110494665|NCT02558023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110494666|NCT02558023|Vasodilator Agents|vasodilator agents|mesh-ancestor
110494667|NCT02558023|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110494668|NCT02558023|Serotonin Agents|serotonin agents|mesh-ancestor
110494669|NCT02558023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110494670|NCT02558023|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110494671|NCT02558023|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110494672|NCT02558023|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110494673|NCT02558023|Adrenergic Agents|adrenergic agents|mesh-ancestor
110494674|NCT00607568|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
110494675|NCT00607568|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110602186|NCT00874744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110494676|NCT00607568|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110494677|NCT00607568|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110494678|NCT00607568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110494679|NCT00607568|Adrenergic Agents|adrenergic agents|mesh-ancestor
110494680|NCT00607568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110494681|NCT00607568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110494682|NCT00606164|Bryostatin 1|bryostatin 1|mesh-list
110494683|NCT00606164|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110494684|NCT00606164|Immunologic Factors|immunologic factors|mesh-ancestor
110494685|NCT00606164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110494686|NCT00606164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110494687|NCT00574951|Motesanib diphosphate|motesanib diphosphate|mesh-list
110494689|NCT00574951|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110494690|NCT00574951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110494691|NCT00574951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110494692|NCT02584816|Vaccines|vaccines|mesh-list
110494693|NCT02584816|Immunologic Factors|immunologic factors|mesh-ancestor
110494694|NCT02584816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110494695|NCT02584738|Methylprednisolone|methylprednisolone|mesh-list
110494696|NCT02584738|Prednisolone|prednisolone|mesh-list
110494697|NCT02584738|Magnesium Sulfate|magnesium sulfate|mesh-list
110494698|NCT02584738|Bromides|bromides|mesh-list
110494699|NCT02584738|Albuterol|albuterol|mesh-list
110494700|NCT02584738|Ipratropium|ipratropium|mesh-list
110494701|NCT02584738|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110494702|NCT02584738|Antiemetics|antiemetics|mesh-ancestor
110494703|NCT02584738|Autonomic Agents|autonomic agents|mesh-ancestor
110494704|NCT02584738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110494705|NCT02584738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110494706|NCT02584738|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110494707|NCT02584738|Glucocorticoids|glucocorticoids|mesh-ancestor
110494708|NCT02584738|Hormones|hormones|mesh-ancestor
110494709|NCT02584738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110494710|NCT02584738|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110494711|NCT02584738|Protective Agents|protective agents|mesh-ancestor
110494712|NCT02584738|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110494713|NCT02584738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110494714|NCT02584738|Anticonvulsants|anticonvulsants|mesh-ancestor
110494715|NCT02584738|Analgesics|analgesics|mesh-ancestor
110494716|NCT02584738|Sensory System Agents|sensory system agents|mesh-ancestor
110494717|NCT02584738|Anesthetics|anesthetics|mesh-ancestor
110494718|NCT02584738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110494719|NCT02584738|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110494720|NCT02584738|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110494721|NCT02584738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110494722|NCT02584738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110494723|NCT02584738|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110494724|NCT02584738|Tocolytic Agents|tocolytic agents|mesh-ancestor
110494725|NCT02584738|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110494726|NCT02584738|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110494727|NCT02584738|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110494728|NCT02584738|Respiratory System Agents|respiratory system agents|mesh-ancestor
110494729|NCT02584738|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110494730|NCT02584738|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110494731|NCT02584738|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110494732|NCT02584738|Adrenergic Agents|adrenergic agents|mesh-ancestor
110494733|NCT02584738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110494734|NCT02584738|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110494735|NCT02584738|Cholinergic Agents|cholinergic agents|mesh-ancestor
110494736|NCT00765271|Ritonavir|ritonavir|mesh-list
110494737|NCT00765271|Darunavir|darunavir|mesh-list
110494738|NCT00765271|Raltegravir Potassium|raltegravir potassium|mesh-list
110494739|NCT00765271|Abacavir|abacavir|mesh-list
110494740|NCT00765271|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110494741|NCT00765271|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110494742|NCT00765271|Protease Inhibitors|protease inhibitors|mesh-ancestor
110494743|NCT00765271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110494744|NCT00765271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110494745|NCT00765271|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110494746|NCT00765271|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110494747|NCT00765271|Antiviral Agents|antiviral agents|mesh-ancestor
110494748|NCT00765271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110494749|NCT00765271|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110494750|NCT00765271|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110494751|NCT00765271|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110494752|NCT00765271|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110494753|NCT00765271|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110494754|NCT00765271|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110494755|NCT04416568|Nivolumab|nivolumab|mesh-list
110494756|NCT04416568|Ipilimumab|ipilimumab|mesh-list
110494757|NCT04416568|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110494758|NCT04416568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110494759|NCT04416568|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110494760|NCT04416568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110494761|NCT02583022|Pimecrolimus|pimecrolimus|mesh-list
110494762|NCT02583022|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110494763|NCT02583022|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110494764|NCT02583022|Analgesics|analgesics|mesh-ancestor
110494765|NCT02583022|Sensory System Agents|sensory system agents|mesh-ancestor
110494766|NCT02583022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110494767|NCT02583022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110494768|NCT02583022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110494769|NCT02583022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110494770|NCT02583022|Dermatologic Agents|dermatologic agents|mesh-ancestor
110494771|NCT02583022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110494772|NCT02583022|Immunologic Factors|immunologic factors|mesh-ancestor
110494773|NCT02583022|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110494774|NCT02583022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110602329|NCT00614380|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110494775|NCT02583022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110494776|NCT00764725|Sulfasalazine|sulfasalazine|mesh-list
110494778|NCT00764725|Methotrexate|methotrexate|mesh-list
110494779|NCT00764725|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110494780|NCT00764725|Abortifacient Agents|abortifacient agents|mesh-ancestor
110494781|NCT00764725|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110494782|NCT00764725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110494783|NCT00764725|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110494784|NCT00764725|Antimetabolites|antimetabolites|mesh-ancestor
110494785|NCT00764725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110494786|NCT00764725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110494787|NCT00764725|Dermatologic Agents|dermatologic agents|mesh-ancestor
110494788|NCT00764725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110494789|NCT00764725|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110494790|NCT00764725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110142064|NCT02016664|Ketamine|ketamine|mesh-list
110494791|NCT00764725|Immunologic Factors|immunologic factors|mesh-ancestor
110494792|NCT00764725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110494793|NCT00764725|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110494794|NCT00764725|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110494795|NCT00764725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110494796|NCT00764725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110494797|NCT00764725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110494798|NCT00764725|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110494799|NCT00764725|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110494800|NCT00764725|Analgesics|analgesics|mesh-ancestor
110494801|NCT00764725|Sensory System Agents|sensory system agents|mesh-ancestor
110494802|NCT00764725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110494803|NCT00936884|Methylnaltrexone|methylnaltrexone|mesh-list
110494804|NCT00936884|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110494805|NCT00936884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110494806|NCT00936884|Sensory System Agents|sensory system agents|mesh-ancestor
110494807|NCT00936884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110494809|NCT04077892|Montelukast|montelukast|mesh-list
110494810|NCT04077892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110494811|NCT04077892|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110494812|NCT04077892|Autonomic Agents|autonomic agents|mesh-ancestor
110494813|NCT04077892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110494814|NCT04077892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110494815|NCT04077892|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110494816|NCT04077892|Respiratory System Agents|respiratory system agents|mesh-ancestor
110494817|NCT04077892|Glucocorticoids|glucocorticoids|mesh-ancestor
110494818|NCT04077892|Hormones|hormones|mesh-ancestor
110272212|NCT05755048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110494819|NCT04077892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110494820|NCT04077892|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110494821|NCT04077892|Hormone Antagonists|hormone antagonists|mesh-ancestor
110494822|NCT04077892|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110494823|NCT04077892|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110494824|NCT04077892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110494825|NCT00606242|Fluticasone|fluticasone|mesh-list
110494826|NCT00606242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110494827|NCT00606242|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110494828|NCT00606242|Autonomic Agents|autonomic agents|mesh-ancestor
110494829|NCT00606242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110494830|NCT00606242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110494831|NCT00606242|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110494832|NCT00606242|Respiratory System Agents|respiratory system agents|mesh-ancestor
110494833|NCT00606242|Dermatologic Agents|dermatologic agents|mesh-ancestor
110494834|NCT00606242|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110494835|NCT00607646|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
110494836|NCT00607646|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110494837|NCT00607646|Immunologic Factors|immunologic factors|mesh-ancestor
110494838|NCT00607646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110494839|NCT00770263|Sirolimus|sirolimus|mesh-list
110494840|NCT00770263|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110494841|NCT00770263|Temsirolimus|temsirolimus|mesh-list
110494842|NCT00770263|MTOR Inhibitors|mtor inhibitors|mesh-list
110494843|NCT00770263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110494844|NCT00770263|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110494845|NCT00770263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110494846|NCT00770263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110494847|NCT00770263|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110494848|NCT00770263|Immunologic Factors|immunologic factors|mesh-ancestor
110494849|NCT00770263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110494850|NCT00770263|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110494851|NCT00770263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110494852|NCT00770263|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110494853|NCT00770263|Antifungal Agents|antifungal agents|mesh-ancestor
110494854|NCT02691026|Pembrolizumab|pembrolizumab|mesh-list
110494855|NCT02691026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110494856|NCT02691026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110494857|NCT02691026|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110494858|NCT02691026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110494859|NCT05400148|Bupivacaine|bupivacaine|mesh-list
110494860|NCT05400148|Anesthetics, Local|anesthetics, local|mesh-ancestor
110494861|NCT05400148|Anesthetics|anesthetics|mesh-ancestor
110494862|NCT05400148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110494863|NCT05400148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110494864|NCT05400148|Sensory System Agents|sensory system agents|mesh-ancestor
110494865|NCT05400148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110494866|NCT00765427|Retinol acetate|retinol acetate|mesh-list
110494867|NCT00765427|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110494868|NCT00765427|Immunologic Factors|immunologic factors|mesh-ancestor
110494869|NCT00765427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110494870|NCT00765427|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110494871|NCT00765427|Protective Agents|protective agents|mesh-ancestor
110494872|NCT00765427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110494873|NCT02584582|Liraglutide|liraglutide|mesh-list
110494874|NCT02584582|Exenatide|exenatide|mesh-list
110494875|NCT02584582|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110494876|NCT02584582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110494877|NCT02584582|Incretins|incretins|mesh-ancestor
110494878|NCT02584582|Hormones|hormones|mesh-ancestor
110494879|NCT02584582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110494880|NCT02584582|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110494881|NCT04266002|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
110494882|NCT04266002|Antiviral Agents|antiviral agents|mesh-ancestor
110494883|NCT04266002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110494884|NCT00765973|Topotecan|topotecan|mesh-list
110494885|NCT00765973|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110494886|NCT00765973|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110494887|NCT00765973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110651623|NCT00933374|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110494888|NCT00765973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110494889|NCT00765973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110494890|NCT00775177|Doxycycline|doxycycline|mesh-list
110494891|NCT00775177|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110494892|NCT00775177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110494893|NCT00775177|Antimalarials|antimalarials|mesh-ancestor
110494894|NCT00775177|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110494895|NCT00775177|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110494896|NCT00770497|Pioglitazone|pioglitazone|mesh-list
110494897|NCT00770497|Ramipril|ramipril|mesh-list
110494898|NCT00770497|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110311725|NCT00290264|Adrenergic Agents|adrenergic agents|mesh-ancestor
110167888|NCT00033436|Vasodilator Agents|vasodilator agents|mesh-ancestor
110494899|NCT00770497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110494900|NCT00770497|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110494903|NCT00770497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110494904|NCT00770497|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110494905|NCT02581696|Irsogladine|irsogladine|mesh-list
110494906|NCT02581696|Lafutidine|lafutidine|mesh-list
110494907|NCT02581696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110494908|NCT02581696|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110494909|NCT02581696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110494910|NCT02581696|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110494911|NCT02581696|Histamine Antagonists|histamine antagonists|mesh-ancestor
110494912|NCT02581696|Histamine Agents|histamine agents|mesh-ancestor
110494913|NCT02581696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110494914|NCT02581696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110494915|NCT02581696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110494916|NCT02581696|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110494917|NCT02581696|Protective Agents|protective agents|mesh-ancestor
110494918|NCT02581696|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110494919|NCT00607958|Ritonavir|ritonavir|mesh-list
110494920|NCT00607958|Tipranavir|tipranavir|mesh-list
110494921|NCT00607958|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110494922|NCT00607958|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110602495|NCT00885586|Gabapentin|gabapentin|mesh-list
110494924|NCT00607958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110494925|NCT00607958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110494926|NCT00607958|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110494927|NCT00607958|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110494928|NCT00607958|Antiviral Agents|antiviral agents|mesh-ancestor
110494929|NCT00607958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110494930|NCT00607958|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110494931|NCT00607958|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110494932|NCT00770575|Pioglitazone|pioglitazone|mesh-list
110494933|NCT00770575|Atorvastatin|atorvastatin|mesh-list
110494934|NCT00770575|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110494935|NCT00770575|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110494936|NCT00770575|Antimetabolites|antimetabolites|mesh-ancestor
110494937|NCT00770575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110494938|NCT00770575|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110494939|NCT00770575|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110494940|NCT00770575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110494941|NCT00770575|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110494942|NCT00770575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110494943|NCT00770731|Sirolimus|sirolimus|mesh-list
110494944|NCT00770731|Bortezomib|bortezomib|mesh-list
110494945|NCT00770731|Topotecan|topotecan|mesh-list
110494946|NCT00770731|Temsirolimus|temsirolimus|mesh-list
110494947|NCT00770731|MTOR Inhibitors|mtor inhibitors|mesh-list
110602517|NCT04038034|Coenzyme Q10|coenzyme q10|mesh-list
110494948|NCT00770731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110494949|NCT00770731|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110494950|NCT00770731|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110494951|NCT00770731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110494952|NCT00770731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110494953|NCT00770731|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110494954|NCT00770731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110494955|NCT00770731|Immunologic Factors|immunologic factors|mesh-ancestor
110494956|NCT00770731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110494957|NCT00770731|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110494958|NCT00770731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110494959|NCT00770731|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110494960|NCT00770731|Antifungal Agents|antifungal agents|mesh-ancestor
110494962|NCT00775255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110494963|NCT00775255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110494964|NCT00775255|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110494965|NCT00775255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110494966|NCT00775255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110494967|NCT00775255|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110494968|NCT00775255|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110494969|NCT00606866|Sorafenib|sorafenib|mesh-list
110494970|NCT00606866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110494971|NCT00606866|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110494972|NCT00606866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110494973|NCT00606866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110494974|NCT00766285|Vaccines|vaccines|mesh-list
110494975|NCT00766285|Immunologic Factors|immunologic factors|mesh-ancestor
110494976|NCT00766285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110494977|NCT04265456|Acetaminophen|acetaminophen|mesh-list
110494978|NCT04265456|Pregabalin|pregabalin|mesh-list
110494979|NCT04265456|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110494980|NCT04265456|Analgesics|analgesics|mesh-ancestor
110494981|NCT04265456|Sensory System Agents|sensory system agents|mesh-ancestor
110494982|NCT04265456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110494983|NCT04265456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110494984|NCT04265456|Antipyretics|antipyretics|mesh-ancestor
110494985|NCT04265456|Anticonvulsants|anticonvulsants|mesh-ancestor
110494986|NCT04265456|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110494987|NCT04265456|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110494988|NCT04265456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110602580|NCT02567838|Lidocaine|lidocaine|mesh-list
110494989|NCT04265456|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110494990|NCT04265456|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110494991|NCT04265456|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110494992|NCT04265456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110494993|NCT04265456|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110494994|NCT04379518|Interferons|interferons|mesh-list
110494995|NCT04379518|Interferon-alpha|interferon-alpha|mesh-list
110494996|NCT04379518|Interferon alpha-2|interferon alpha-2|mesh-list
110494997|NCT04379518|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
110494998|NCT04379518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110494999|NCT04379518|Antiviral Agents|antiviral agents|mesh-ancestor
110495000|NCT04379518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110495001|NCT04379518|Immunologic Factors|immunologic factors|mesh-ancestor
110495002|NCT04379518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110495003|NCT04378426|Midazolam|midazolam|mesh-list
110495004|NCT04378426|Nitrous Oxide|nitrous oxide|mesh-list
110495005|NCT04378426|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110495006|NCT04378426|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110495007|NCT04378426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110495008|NCT04378426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110495009|NCT04378426|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110495010|NCT04378426|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110495011|NCT04378426|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110495012|NCT04378426|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110495013|NCT04378426|Anesthetics, General|anesthetics, general|mesh-ancestor
110495014|NCT04378426|Anesthetics|anesthetics|mesh-ancestor
110495015|NCT04378426|GABA Modulators|gaba modulators|mesh-ancestor
110495016|NCT04378426|GABA Agents|gaba agents|mesh-ancestor
110142288|NCT02018328|Analgesics|analgesics|mesh-ancestor
110495017|NCT04378426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110495018|NCT04378426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110495019|NCT04378426|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110495020|NCT04378426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110495021|NCT04378426|Analgesics|analgesics|mesh-ancestor
110495022|NCT04378426|Sensory System Agents|sensory system agents|mesh-ancestor
110495023|NCT04378426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110495024|NCT02581462|Trastuzumab|trastuzumab|mesh-list
110495025|NCT02581462|Pertuzumab|pertuzumab|mesh-list
110495026|NCT02581462|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110495027|NCT02581462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110495028|NCT00668863|Leucovorin|leucovorin|mesh-list
110495029|NCT00668863|Fluorouracil|fluorouracil|mesh-list
110495030|NCT00668863|Irinotecan|irinotecan|mesh-list
110495031|NCT00668863|Sunitinib|sunitinib|mesh-list
110495032|NCT00668863|Levoleucovorin|levoleucovorin|mesh-list
110495033|NCT00668863|Antimetabolites|antimetabolites|mesh-ancestor
110495034|NCT00668863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110495035|NCT00668863|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110495036|NCT00668863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110495037|NCT00668863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110495038|NCT00668863|Immunologic Factors|immunologic factors|mesh-ancestor
110495039|NCT00668863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110495040|NCT00668863|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110495041|NCT00668863|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110495042|NCT00668863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110495044|NCT00668863|Protective Agents|protective agents|mesh-ancestor
110495045|NCT00668863|Vitamin B Complex|vitamin b complex|mesh-ancestor
110495046|NCT00668863|Vitamins|vitamins|mesh-ancestor
110495047|NCT00668863|Micronutrients|micronutrients|mesh-ancestor
110495048|NCT00668863|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110495049|NCT00668863|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110495050|NCT00668863|Growth Substances|growth substances|mesh-ancestor
110495051|NCT00668863|Growth Inhibitors|growth inhibitors|mesh-ancestor
110495052|NCT00668863|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110495053|NCT04077736|Aldesleukin|aldesleukin|mesh-list
110495054|NCT04077736|Interleukin-2|interleukin-2|mesh-list
110495055|NCT04077736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110495056|NCT04077736|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110495057|NCT04077736|Analgesics|analgesics|mesh-ancestor
110495058|NCT04077736|Sensory System Agents|sensory system agents|mesh-ancestor
110495059|NCT04077736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110495060|NCT04077736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110495061|NCT04077736|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110495062|NCT04077736|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110495063|NCT04077736|Antiviral Agents|antiviral agents|mesh-ancestor
110495064|NCT04077736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110495065|NCT00766441|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110495066|NCT00766441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110495067|NCT00766441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110495068|NCT00766441|Incretins|incretins|mesh-ancestor
110495070|NCT00766441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110495071|NCT00766441|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110495072|NCT00766441|Protease Inhibitors|protease inhibitors|mesh-ancestor
110495073|NCT00766441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110495074|NCT00766441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110495075|NCT00771043|Natalizumab|natalizumab|mesh-list
110495076|NCT00771043|Immunologic Factors|immunologic factors|mesh-ancestor
110495077|NCT00771043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110495078|NCT04267250|Levonorgestrel|levonorgestrel|mesh-list
110495079|NCT04267250|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110495080|NCT04267250|Estradiol|estradiol|mesh-list
110495081|NCT04267250|PF-06700841|pf-06700841|mesh-list
110495082|NCT04267250|Estrogens|estrogens|mesh-ancestor
110495083|NCT04267250|Hormones|hormones|mesh-ancestor
110495084|NCT04267250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110495085|NCT04267250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110495086|NCT04267250|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110495087|NCT04267250|Contraceptive Agents|contraceptive agents|mesh-ancestor
110495088|NCT04267250|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110495089|NCT04267250|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110495090|NCT04267250|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110495091|NCT04267250|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110495092|NCT04267250|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110495093|NCT04267250|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110495094|NCT04267250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110495095|NCT04267250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110495096|NCT00775489|Beclomethasone|beclomethasone|mesh-list
110495098|NCT00775489|Glucocorticoids|glucocorticoids|mesh-ancestor
110495099|NCT00775489|Hormones|hormones|mesh-ancestor
110495100|NCT00775489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110495101|NCT00775489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110495102|NCT00775489|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110495103|NCT00775489|Respiratory System Agents|respiratory system agents|mesh-ancestor
110495104|NCT00771199|Fentanyl|fentanyl|mesh-list
110495105|NCT00771199|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110495106|NCT00771199|Narcotics|narcotics|mesh-ancestor
110495107|NCT00771199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110495108|NCT00771199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110495109|NCT00771199|Analgesics|analgesics|mesh-ancestor
110495110|NCT00771199|Sensory System Agents|sensory system agents|mesh-ancestor
110495111|NCT00771199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110495112|NCT00771199|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110495113|NCT00771199|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110495115|NCT00771199|Anesthetics|anesthetics|mesh-ancestor
110495116|NCT04264130|Artesunate|artesunate|mesh-list
110495117|NCT04264130|Lumefantrine|lumefantrine|mesh-list
110495118|NCT04264130|Artemether|artemether|mesh-list
110495119|NCT04264130|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
110495120|NCT04264130|Pyronaridine|pyronaridine|mesh-list
110495121|NCT04264130|Artefenomel|artefenomel|mesh-list
110495122|NCT04264130|Ferroquine|ferroquine|mesh-list
110311729|NCT00324051|Antiemetics|antiemetics|mesh-ancestor
110495123|NCT04264130|Antimalarials|antimalarials|mesh-ancestor
110495124|NCT04264130|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110495125|NCT04264130|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110495126|NCT04264130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110495127|NCT04264130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110495128|NCT04264130|Antiviral Agents|antiviral agents|mesh-ancestor
110495129|NCT04264130|Schistosomicides|schistosomicides|mesh-ancestor
110495130|NCT04264130|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110495131|NCT04264130|Anthelmintics|anthelmintics|mesh-ancestor
110495132|NCT02557867|Dexmedetomidine|dexmedetomidine|mesh-list
110495133|NCT02557867|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110495134|NCT02557867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110495135|NCT02557867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110495136|NCT02557867|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110495137|NCT02557867|Analgesics|analgesics|mesh-ancestor
110495138|NCT02557867|Sensory System Agents|sensory system agents|mesh-ancestor
110495139|NCT02557867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110495140|NCT02557867|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110495141|NCT02557867|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110495142|NCT02557867|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110495143|NCT02557867|Adrenergic Agents|adrenergic agents|mesh-ancestor
110495144|NCT02557867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110495145|NCT02557867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110495146|NCT00605774|Epinephrine|epinephrine|mesh-list
110495147|NCT00605774|Racepinephrine|racepinephrine|mesh-list
110495148|NCT00605774|Epinephryl borate|epinephryl borate|mesh-list
110495149|NCT00605774|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110495150|NCT00605774|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110495151|NCT00605774|Adrenergic Agents|adrenergic agents|mesh-ancestor
110495152|NCT00605774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110495153|NCT00605774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110495154|NCT00605774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110495155|NCT00605774|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110495156|NCT00605774|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110495157|NCT00605774|Autonomic Agents|autonomic agents|mesh-ancestor
110495158|NCT00605774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110495159|NCT00605774|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110495160|NCT00605774|Respiratory System Agents|respiratory system agents|mesh-ancestor
110495161|NCT00605774|Mydriatics|mydriatics|mesh-ancestor
110495162|NCT00605774|Sympathomimetics|sympathomimetics|mesh-ancestor
110495163|NCT00605774|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110495164|NCT04264286|Esmolol|esmolol|mesh-list
110495165|NCT04264286|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110495166|NCT04264286|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110495167|NCT04264286|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110142442|NCT02019355|Fluorouracil|fluorouracil|mesh-list
110495168|NCT04264286|Adrenergic Agents|adrenergic agents|mesh-ancestor
110495169|NCT04264286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110495170|NCT04264286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110495171|NCT04264286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110495172|NCT02582476|Bumetanide|bumetanide|mesh-list
110495173|NCT02582476|Diuretics|diuretics|mesh-ancestor
110495174|NCT02582476|Natriuretic Agents|natriuretic agents|mesh-ancestor
110495175|NCT02582476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110495176|NCT02582476|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110495177|NCT02582476|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110495178|NCT02582476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110495179|NCT04078204|3-n-butylphthalide|3-n-butylphthalide|mesh-list
110495180|NCT04078204|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110495181|NCT04078204|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110167909|NCT00033553|Antimetabolites|antimetabolites|mesh-ancestor
110495182|NCT04078204|Protective Agents|protective agents|mesh-ancestor
110495183|NCT04078204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110495184|NCT00668707|Melatonin|melatonin|mesh-list
110495185|NCT00668707|Antioxidants|antioxidants|mesh-ancestor
110495186|NCT00668707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110495187|NCT00668707|Protective Agents|protective agents|mesh-ancestor
110495188|NCT00668707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110495189|NCT00668707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110495190|NCT00766909|Cyclosporine|cyclosporine|mesh-list
110495191|NCT00766909|Tacrolimus|tacrolimus|mesh-list
110495192|NCT00766909|Cyclosporins|cyclosporins|mesh-list
110495193|NCT00766909|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110495194|NCT00766909|Immunologic Factors|immunologic factors|mesh-ancestor
110495195|NCT00766909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110495196|NCT00766909|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110495197|NCT00766909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110602816|NCT00811785|Copper|copper|mesh-list
110495198|NCT00766909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110495199|NCT00766909|Antifungal Agents|antifungal agents|mesh-ancestor
110495200|NCT00766909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110495201|NCT00766909|Dermatologic Agents|dermatologic agents|mesh-ancestor
110495202|NCT00766909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110495203|NCT00771433|Lenograstim|lenograstim|mesh-list
110495204|NCT00771433|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110495205|NCT00771433|Immunologic Factors|immunologic factors|mesh-ancestor
110495206|NCT00771433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110495207|NCT00668395|Efavirenz|efavirenz|mesh-list
110495208|NCT00668395|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110495209|NCT00668395|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110495210|NCT00668395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110495211|NCT00668395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110495212|NCT00668395|Antiviral Agents|antiviral agents|mesh-ancestor
110495213|NCT00668395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110495214|NCT00668395|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110495215|NCT00668395|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110495216|NCT00668395|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110495217|NCT00668395|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110495218|NCT00668395|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110495219|NCT00668395|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110495220|NCT00668317|Omeprazole|omeprazole|mesh-list
110495221|NCT00668317|Ranitidine|ranitidine|mesh-list
110495222|NCT00668317|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
110495223|NCT00668317|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110495224|NCT00668317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110495225|NCT00668317|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110495226|NCT00668317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110495227|NCT00668317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110602849|NCT00884884|Topiramate|topiramate|mesh-list
110495229|NCT00668317|Histamine Antagonists|histamine antagonists|mesh-ancestor
110495230|NCT00668317|Histamine Agents|histamine agents|mesh-ancestor
110495231|NCT00668317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110495232|NCT00668317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110495233|NCT00775879|Sevoflurane|sevoflurane|mesh-list
110495234|NCT00775879|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110495235|NCT00775879|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110495236|NCT00775879|Anesthetics, General|anesthetics, general|mesh-ancestor
110495237|NCT00775879|Anesthetics|anesthetics|mesh-ancestor
110272601|NCT05014282|Nicotine|nicotine|mesh-list
110495238|NCT00775879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110495239|NCT00775879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110495240|NCT00767221|Budesonide|budesonide|mesh-list
110495241|NCT00767221|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
110495242|NCT00767221|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110495243|NCT00767221|Autonomic Agents|autonomic agents|mesh-ancestor
110495244|NCT00767221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110495245|NCT00767221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110495246|NCT00767221|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110495247|NCT00767221|Respiratory System Agents|respiratory system agents|mesh-ancestor
110495248|NCT00767221|Glucocorticoids|glucocorticoids|mesh-ancestor
110495250|NCT00767221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110495251|NCT04024072|Brinzolamide|brinzolamide|mesh-list
110495252|NCT04024072|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110495253|NCT04024072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110602888|NCT00413959|Rituximab|rituximab|mesh-list
110495254|NCT04024072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110495256|NCT00771511|Antipruritics|antipruritics|mesh-ancestor
110495257|NCT00771511|Dermatologic Agents|dermatologic agents|mesh-ancestor
110495258|NCT00771511|Sensory System Agents|sensory system agents|mesh-ancestor
110495259|NCT00771511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110495260|NCT00771511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110495261|NCT00776113|Carvedilol|carvedilol|mesh-list
110495262|NCT00776113|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110495263|NCT00776113|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110495264|NCT00776113|Adrenergic Agents|adrenergic agents|mesh-ancestor
110495265|NCT00776113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110495266|NCT00776113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110495267|NCT00776113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110495268|NCT00776113|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110495269|NCT00776113|Antioxidants|antioxidants|mesh-ancestor
110495270|NCT00776113|Protective Agents|protective agents|mesh-ancestor
110495271|NCT00776113|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110495272|NCT00776113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110495273|NCT00776113|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110495274|NCT00776113|Vasodilator Agents|vasodilator agents|mesh-ancestor
110495275|NCT00776113|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110495276|NCT00776113|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110495277|NCT02580448|Seviteronel|seviteronel|mesh-list
110495278|NCT02580448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110495279|NCT02580448|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110495280|NCT02580448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110602940|NCT00413413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110495281|NCT02580448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110495282|NCT04008238|Trabectedin|trabectedin|mesh-list
110495283|NCT04008238|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110495284|NCT04008238|Alkylating Agents|alkylating agents|mesh-ancestor
110495285|NCT04008238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110272614|NCT04956094|Protective Agents|protective agents|mesh-ancestor
110495286|NCT04008238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110495287|NCT00672139|Bromides|bromides|mesh-list
110495288|NCT00672139|Methylnaltrexone|methylnaltrexone|mesh-list
110495289|NCT00672139|Anticonvulsants|anticonvulsants|mesh-ancestor
110495290|NCT00672139|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110495291|NCT00672139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110495292|NCT00672139|Sensory System Agents|sensory system agents|mesh-ancestor
110495293|NCT00672139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110495294|NCT02557789|Lefamulin|lefamulin|mesh-list
110495295|NCT02557789|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110495296|NCT02557789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110495297|NCT00771823|Maraviroc|maraviroc|mesh-list
110495298|NCT00771823|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110495299|NCT00771823|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110495300|NCT00771823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110495301|NCT00771823|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110495302|NCT00771823|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110495303|NCT00771823|Antiviral Agents|antiviral agents|mesh-ancestor
110495304|NCT00771823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110495305|NCT00771823|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
110495306|NCT04219540|Buprenorphine|buprenorphine|mesh-list
110495307|NCT04219540|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110495308|NCT04219540|Narcotics|narcotics|mesh-ancestor
110495309|NCT04219540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110495310|NCT04219540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110495311|NCT04219540|Analgesics|analgesics|mesh-ancestor
110495312|NCT04219540|Sensory System Agents|sensory system agents|mesh-ancestor
110495313|NCT04219540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110495314|NCT04219540|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110495315|NCT03955042|Pemetrexed|pemetrexed|mesh-list
110495316|NCT03955042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110495317|NCT03955042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110495318|NCT03955042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110495319|NCT03955042|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110167918|NCT00033592|Cholinergic Agents|cholinergic agents|mesh-ancestor
110495320|NCT03955042|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110495321|NCT00570739|Metformin|metformin|mesh-list
110495322|NCT00570739|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
110495323|NCT00570739|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110495324|NCT00570739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110495325|NCT00570739|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110495326|NCT00570739|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110495327|NCT00570739|Antimetabolites|antimetabolites|mesh-ancestor
110495328|NCT00570739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110495329|NCT00570739|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110495330|NCT04076098|Minocycline|minocycline|mesh-list
110495331|NCT04076098|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110495332|NCT04076098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110495333|NCT00771979|Saracatinib|saracatinib|mesh-list
110495334|NCT00771979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110495335|NCT00771979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110495336|NCT00771979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110495337|NCT00767689|Pyridoxine|pyridoxine|mesh-list
110495338|NCT00767689|Pyridoxal|pyridoxal|mesh-list
110495339|NCT00767689|Vitamin B 6|vitamin b 6|mesh-list
110495340|NCT00767689|Vitamins|vitamins|mesh-ancestor
110495341|NCT00767689|Micronutrients|micronutrients|mesh-ancestor
110495342|NCT00767689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110495344|NCT00772057|Propranolol|propranolol|mesh-list
110495345|NCT00772057|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110495346|NCT00772057|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110495347|NCT00772057|Adrenergic Agents|adrenergic agents|mesh-ancestor
110495348|NCT00772057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110495349|NCT00772057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110495350|NCT00772057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110495351|NCT00772057|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110495352|NCT00772057|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110495353|NCT00772057|Vasodilator Agents|vasodilator agents|mesh-ancestor
110495354|NCT00776347|Donepezil|donepezil|mesh-list
110495355|NCT00776347|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110495356|NCT00776347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110495357|NCT00776347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110495358|NCT00776347|Cholinergic Agents|cholinergic agents|mesh-ancestor
110495359|NCT00776347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110495360|NCT00776347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110495361|NCT00776347|Nootropic Agents|nootropic agents|mesh-ancestor
110495362|NCT00776425|Epoetin Alfa|epoetin alfa|mesh-list
110495363|NCT00776425|Hematinics|hematinics|mesh-ancestor
110495364|NCT03913702|Methylprednisolone|methylprednisolone|mesh-list
110495365|NCT03913702|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110495366|NCT03913702|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110495367|NCT03913702|Prednisolone|prednisolone|mesh-list
110495368|NCT03913702|Prednisolone acetate|prednisolone acetate|mesh-list
110495369|NCT03913702|Ketorolac|ketorolac|mesh-list
110603078|NCT00886990|Ritonavir|ritonavir|mesh-list
110495370|NCT03913702|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
110495371|NCT03913702|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110495372|NCT03913702|Prednisolone phosphate|prednisolone phosphate|mesh-list
110495373|NCT03913702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110495374|NCT03913702|Antiemetics|antiemetics|mesh-ancestor
110495375|NCT03913702|Autonomic Agents|autonomic agents|mesh-ancestor
110495376|NCT03913702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110495377|NCT03913702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110495378|NCT03913702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110495379|NCT03913702|Glucocorticoids|glucocorticoids|mesh-ancestor
110495380|NCT03913702|Hormones|hormones|mesh-ancestor
110495381|NCT03913702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110495382|NCT03913702|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110495383|NCT03913702|Protective Agents|protective agents|mesh-ancestor
110495384|NCT03913702|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110495385|NCT03913702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110495386|NCT03913702|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110495387|NCT03913702|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110495388|NCT03913702|Analgesics|analgesics|mesh-ancestor
110495389|NCT03913702|Sensory System Agents|sensory system agents|mesh-ancestor
110495390|NCT03913702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110495391|NCT03913702|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110495392|NCT03913702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110495393|NCT03913702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110495394|NCT03909412|Dexamethasone|dexamethasone|mesh-list
110495395|NCT03909412|Cyclophosphamide|cyclophosphamide|mesh-list
110495396|NCT03909412|Lenograstim|lenograstim|mesh-list
110495397|NCT03909412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110495398|NCT03909412|Immunologic Factors|immunologic factors|mesh-ancestor
110495399|NCT03909412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110495400|NCT03909412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110495401|NCT03909412|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110495402|NCT03909412|Alkylating Agents|alkylating agents|mesh-ancestor
110495403|NCT03909412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110495404|NCT03909412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110495405|NCT03909412|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110495406|NCT03909412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110495407|NCT03909412|Antiemetics|antiemetics|mesh-ancestor
110495408|NCT03909412|Autonomic Agents|autonomic agents|mesh-ancestor
110495409|NCT03909412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110495410|NCT03909412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110495411|NCT03909412|Glucocorticoids|glucocorticoids|mesh-ancestor
110495412|NCT03909412|Hormones|hormones|mesh-ancestor
110495413|NCT03909412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110495414|NCT03909412|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110495415|NCT03909412|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110495416|NCT00772135|Sildenafil Citrate|sildenafil citrate|mesh-list
110495417|NCT00772135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110495418|NCT00772135|Vasodilator Agents|vasodilator agents|mesh-ancestor
110495419|NCT00772135|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110495420|NCT00772135|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110495421|NCT00772135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110495422|NCT00772135|Urological Agents|urological agents|mesh-ancestor
110495423|NCT00776503|Vorinostat|vorinostat|mesh-list
110495424|NCT00776503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110495425|NCT00776503|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110495426|NCT00776503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110495427|NCT00776503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110495428|NCT04075006|Ketamine|ketamine|mesh-list
110495429|NCT04075006|Analgesics|analgesics|mesh-ancestor
110495430|NCT04075006|Sensory System Agents|sensory system agents|mesh-ancestor
110495431|NCT04075006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110495432|NCT04075006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110495433|NCT04075006|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110495434|NCT04075006|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110495435|NCT04075006|Anesthetics, General|anesthetics, general|mesh-ancestor
110495436|NCT04075006|Anesthetics|anesthetics|mesh-ancestor
110495437|NCT04075006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110495438|NCT04075006|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110495439|NCT04075006|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110272695|NCT04801589|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110495440|NCT04075006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110495441|NCT04075006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110495442|NCT04188106|Hydroxyzine|hydroxyzine|mesh-list
110495443|NCT04188106|Varenicline|varenicline|mesh-list
110495444|NCT04188106|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110495445|NCT04188106|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110603153|NCT00889642|Lidocaine|lidocaine|mesh-list
110495446|NCT04188106|Cholinergic Agents|cholinergic agents|mesh-ancestor
110495447|NCT04188106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110495448|NCT04188106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110495449|NCT04188106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110495450|NCT04188106|Antipruritics|antipruritics|mesh-ancestor
110495451|NCT04188106|Dermatologic Agents|dermatologic agents|mesh-ancestor
110495452|NCT04188106|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110495453|NCT04188106|Histamine Antagonists|histamine antagonists|mesh-ancestor
110495454|NCT04188106|Histamine Agents|histamine agents|mesh-ancestor
110495455|NCT00669955|Amoxicillin|amoxicillin|mesh-list
110495456|NCT00669955|Metronidazole|metronidazole|mesh-list
110495457|NCT00669955|Clarithromycin|clarithromycin|mesh-list
110495458|NCT00669955|Tetracycline|tetracycline|mesh-list
110495459|NCT00669955|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
110495460|NCT00669955|Omeprazole|omeprazole|mesh-list
110495461|NCT00669955|Bismuth|bismuth|mesh-list
110495462|NCT00669955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110495463|NCT00669955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110495464|NCT00669955|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110495465|NCT00669955|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110495466|NCT00669955|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110495467|NCT00669955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110495468|NCT00669955|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110495469|NCT00669955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110495470|NCT00669955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110495471|NCT00669955|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110495472|NCT00669955|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110495473|NCT00669955|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110495474|NCT00669955|Antacids|antacids|mesh-ancestor
110495476|NCT00772291|Analgesics|analgesics|mesh-ancestor
110495477|NCT00772291|Sensory System Agents|sensory system agents|mesh-ancestor
110495478|NCT00772291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110495479|NCT00772291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110495480|NCT00772291|Anticonvulsants|anticonvulsants|mesh-ancestor
110495481|NCT00772291|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110495482|NCT00772291|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110495483|NCT00772291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110495484|NCT00772291|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110495485|NCT00772291|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110495486|NCT00772291|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110495487|NCT00772291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110495488|NCT00772291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110495489|NCT03595150|Diclofenac|diclofenac|mesh-list
110311734|NCT00324051|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110495490|NCT03595150|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110495491|NCT03595150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110495492|NCT03595150|Analgesics|analgesics|mesh-ancestor
110495493|NCT03595150|Sensory System Agents|sensory system agents|mesh-ancestor
110495494|NCT03595150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110272716|NCT04796948|Immunologic Factors|immunologic factors|mesh-ancestor
110495495|NCT03595150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110495496|NCT03595150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110495497|NCT03595150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110495498|NCT03595150|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110495499|NCT03595150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110495500|NCT03595150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110495502|NCT00768157|Entecavir|entecavir|mesh-list
110495503|NCT00768157|Antiviral Agents|antiviral agents|mesh-list
110495504|NCT00768157|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110495505|NCT00768157|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110495506|NCT00768157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110495507|NCT00768157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110495508|NCT00768157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110495509|NCT00768157|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110495510|NCT00768157|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110495511|NCT00671749|Clindamycin|clindamycin|mesh-list
110495512|NCT00671749|Clindamycin palmitate|clindamycin palmitate|mesh-list
110495513|NCT00671749|Clindamycin phosphate|clindamycin phosphate|mesh-list
110495514|NCT00671749|Adapalene|adapalene|mesh-list
110495515|NCT00671749|Benzoyl Peroxide|benzoyl peroxide|mesh-list
110495516|NCT00671749|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110495517|NCT00671749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110495518|NCT00671749|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110495519|NCT00671749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110495520|NCT00671749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110495521|NCT00671749|Dermatologic Agents|dermatologic agents|mesh-ancestor
110495522|NCT00671749|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110495523|NCT00671749|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110495524|NCT00671749|Analgesics|analgesics|mesh-ancestor
110495525|NCT00671749|Sensory System Agents|sensory system agents|mesh-ancestor
110495526|NCT00671749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110495527|NCT00671749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110495528|NCT00671749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110495529|NCT00671749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110495530|NCT04149106|Pyrimethamine|pyrimethamine|mesh-list
110495531|NCT04149106|Sulfadoxine|sulfadoxine|mesh-list
110495532|NCT04149106|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
110495533|NCT04149106|Amodiaquine|amodiaquine|mesh-list
110495534|NCT04149106|Artenimol|artenimol|mesh-list
110495535|NCT04149106|Antimalarials|antimalarials|mesh-ancestor
110495536|NCT04149106|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110495537|NCT04149106|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110495538|NCT04149106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110495539|NCT04149106|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110495540|NCT04149106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110495541|NCT04149106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110495542|NCT04149106|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110495543|NCT00768391|Olaratumab|olaratumab|mesh-list
110495544|NCT00768391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110495546|NCT00669877|Dexamethasone|dexamethasone|mesh-list
110495547|NCT00669877|Cyclophosphamide|cyclophosphamide|mesh-list
110495548|NCT00669877|Rituximab|rituximab|mesh-list
110495549|NCT00669877|Doxorubicin|doxorubicin|mesh-list
110495550|NCT00669877|Methotrexate|methotrexate|mesh-list
110495551|NCT00669877|Vincristine|vincristine|mesh-list
110495552|NCT00669877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110495553|NCT00669877|Immunologic Factors|immunologic factors|mesh-ancestor
110495554|NCT00669877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110495555|NCT00669877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110495556|NCT00669877|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110495557|NCT00669877|Alkylating Agents|alkylating agents|mesh-ancestor
110495558|NCT00669877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110495559|NCT00669877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110495560|NCT00669877|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110495561|NCT00669877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110495562|NCT00669877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110495563|NCT00669877|Antiemetics|antiemetics|mesh-ancestor
110495564|NCT00669877|Autonomic Agents|autonomic agents|mesh-ancestor
110495565|NCT00669877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110495566|NCT00669877|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110167970|NCT00000641|Clofazimine|clofazimine|mesh-list
110495567|NCT00669877|Glucocorticoids|glucocorticoids|mesh-ancestor
110495569|NCT00669877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110495570|NCT00669877|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110495571|NCT00669877|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110495572|NCT00669877|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110495573|NCT00669877|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110495574|NCT00669877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110495575|NCT00669877|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110495576|NCT00669877|Abortifacient Agents|abortifacient agents|mesh-ancestor
110495577|NCT00669877|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110495578|NCT00669877|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110495579|NCT00669877|Antimetabolites|antimetabolites|mesh-ancestor
110495580|NCT00669877|Dermatologic Agents|dermatologic agents|mesh-ancestor
110495581|NCT00669877|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110495582|NCT00669877|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110495583|NCT00669877|Antiviral Agents|antiviral agents|mesh-ancestor
110495584|NCT00669877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110495585|NCT00669877|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110495586|NCT00669877|Tubulin Modulators|tubulin modulators|mesh-ancestor
110495587|NCT00669877|Antimitotic Agents|antimitotic agents|mesh-ancestor
110495588|NCT00669877|Mitosis Modulators|mitosis modulators|mesh-ancestor
110495589|NCT00772681|Docetaxel|docetaxel|mesh-list
110495590|NCT00772681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110495591|NCT00772681|Tubulin Modulators|tubulin modulators|mesh-ancestor
110495592|NCT00772681|Antimitotic Agents|antimitotic agents|mesh-ancestor
110495593|NCT00772681|Mitosis Modulators|mitosis modulators|mesh-ancestor
110495594|NCT00772681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110495595|NCT00772759|AZD-3199|azd-3199|mesh-list
110495596|NCT00772759|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110495597|NCT00772759|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110495598|NCT00772759|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110495599|NCT00772759|Adrenergic Agents|adrenergic agents|mesh-ancestor
110495600|NCT00772759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110495601|NCT00772759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110495602|NCT00772759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110495603|NCT03866668|Esomeprazole|esomeprazole|mesh-list
110495604|NCT03866668|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110495605|NCT03866668|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110495606|NCT03866668|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110495607|NCT03866668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110495608|NCT03866668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110495609|NCT00772837|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110495610|NCT00772837|Amoxicillin|amoxicillin|mesh-list
110495611|NCT00772837|Clarithromycin|clarithromycin|mesh-list
110495612|NCT00772837|Omeprazole|omeprazole|mesh-list
110495613|NCT00772837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110495614|NCT00772837|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110495615|NCT00772837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110495616|NCT00772837|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110495617|NCT00772837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110495618|NCT00772837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110495619|NCT00772837|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110495620|NCT00772837|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110603416|NCT00641667|Anesthetics|anesthetics|mesh-ancestor
110495621|NCT00772837|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110495623|NCT00773149|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110495624|NCT00773149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110495625|NCT00768859|Paclitaxel|paclitaxel|mesh-list
110495626|NCT00768859|Carboplatin|carboplatin|mesh-list
110495627|NCT00768859|Trastuzumab|trastuzumab|mesh-list
110495628|NCT00768859|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110495629|NCT00768859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110495630|NCT00768859|Tubulin Modulators|tubulin modulators|mesh-ancestor
110495631|NCT00768859|Antimitotic Agents|antimitotic agents|mesh-ancestor
110495632|NCT00768859|Mitosis Modulators|mitosis modulators|mesh-ancestor
110167979|NCT00000641|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110495633|NCT00768859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110495634|NCT00768859|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110495635|NCT00768937|Sorafenib|sorafenib|mesh-list
110495636|NCT00768937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110495637|NCT00768937|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110495638|NCT00768937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110495639|NCT00768937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110495640|NCT04047745|Bupivacaine|bupivacaine|mesh-list
110495641|NCT04047745|Ropivacaine|ropivacaine|mesh-list
110495642|NCT04047745|Anesthetics, Local|anesthetics, local|mesh-ancestor
110495643|NCT04047745|Anesthetics|anesthetics|mesh-ancestor
110495644|NCT04047745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110495645|NCT04047745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110495646|NCT04047745|Sensory System Agents|sensory system agents|mesh-ancestor
110495647|NCT04047745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110495648|NCT00777439|Domperidone|domperidone|mesh-list
110495649|NCT00777439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110495650|NCT00777439|Antiemetics|antiemetics|mesh-ancestor
110495651|NCT00777439|Autonomic Agents|autonomic agents|mesh-ancestor
110495652|NCT00777439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110495653|NCT00777439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110495654|NCT00777439|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110495655|NCT00777439|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110495656|NCT00777439|Dopamine Agents|dopamine agents|mesh-ancestor
110495657|NCT00777439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110495658|NCT00769093|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
110495659|NCT00769093|Hematinics|hematinics|mesh-ancestor
110495660|NCT00769093|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
110495661|NCT00769093|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110495663|NCT00671437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110495664|NCT00671437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110495665|NCT00777517|Atorvastatin|atorvastatin|mesh-list
110495666|NCT00777517|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110495667|NCT00777517|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110495668|NCT00777517|Antimetabolites|antimetabolites|mesh-ancestor
110603564|NCT00888082|Goserelin|goserelin|mesh-list
110495669|NCT00777517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110495670|NCT00777517|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110495671|NCT00777517|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110495672|NCT00777517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110495673|NCT00769171|Moxifloxacin|moxifloxacin|mesh-list
110495674|NCT00769171|Metronidazole|metronidazole|mesh-list
110495675|NCT00769171|Ceftriaxone|ceftriaxone|mesh-list
110495676|NCT00769171|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
110495677|NCT00769171|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110495678|NCT00769171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110495679|NCT00769171|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110495680|NCT00769171|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110495681|NCT00769171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110495682|NCT00769171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110495683|NCT00769171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110495684|NCT00769171|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110495685|NCT00769171|Contraceptive Agents|contraceptive agents|mesh-ancestor
110495686|NCT00769171|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110495687|NCT00769171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110495688|NCT00769171|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110495689|NCT00769171|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110495690|NCT00769171|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110495691|NCT00769171|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110495692|NCT00769171|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110495693|NCT00777595|Moxifloxacin|moxifloxacin|mesh-list
110495694|NCT00777595|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110495695|NCT00777595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110495696|NCT00777595|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110495697|NCT00777595|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110495698|NCT00777595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110495699|NCT00777595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110495700|NCT00777595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110495701|NCT00769405|Leucovorin|leucovorin|mesh-list
110495702|NCT00769405|Fluorouracil|fluorouracil|mesh-list
110495703|NCT00769405|Oxaliplatin|oxaliplatin|mesh-list
110495704|NCT00769405|Calcium|calcium|mesh-list
110495705|NCT00769405|Levoleucovorin|levoleucovorin|mesh-list
110495706|NCT00769405|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110495707|NCT00769405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110495708|NCT00769405|Antimetabolites|antimetabolites|mesh-ancestor
110495709|NCT00769405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110272802|NCT04464629|Antiemetics|antiemetics|mesh-ancestor
110495710|NCT00769405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110495711|NCT00769405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110495712|NCT00769405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110495713|NCT00769405|Immunologic Factors|immunologic factors|mesh-ancestor
110495714|NCT00769405|Antidotes|antidotes|mesh-ancestor
110495715|NCT00769405|Protective Agents|protective agents|mesh-ancestor
110495716|NCT00769405|Vitamin B Complex|vitamin b complex|mesh-ancestor
110495717|NCT00769405|Vitamins|vitamins|mesh-ancestor
110495718|NCT00769405|Micronutrients|micronutrients|mesh-ancestor
110495719|NCT02829502|Exenatide|exenatide|mesh-list
110495720|NCT02829502|Glucagon|glucagon|mesh-list
110495721|NCT02829502|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
110495722|NCT02829502|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110495723|NCT02829502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110495724|NCT02829502|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110495726|NCT02829502|Hormones|hormones|mesh-ancestor
110495727|NCT02829502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110495728|NCT02829502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110495729|NCT02635191|Amoxicillin|amoxicillin|mesh-list
110495730|NCT02635191|Metronidazole|metronidazole|mesh-list
110495731|NCT02635191|Clarithromycin|clarithromycin|mesh-list
110495732|NCT02635191|Esomeprazole|esomeprazole|mesh-list
110495733|NCT02635191|Omeprazole|omeprazole|mesh-list
110495734|NCT02635191|Rabeprazole|rabeprazole|mesh-list
110495735|NCT02635191|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110495736|NCT02635191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110495737|NCT02635191|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110495738|NCT02635191|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110495739|NCT02635191|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110495740|NCT02635191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110495741|NCT02635191|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110495742|NCT02635191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110495743|NCT02635191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110495744|NCT02635191|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110495745|NCT02635191|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110495746|NCT02635191|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110495747|NCT00777673|Paclitaxel|paclitaxel|mesh-list
110495748|NCT00777673|Cyclophosphamide|cyclophosphamide|mesh-list
110495749|NCT00777673|Bevacizumab|bevacizumab|mesh-list
110495750|NCT00777673|Carboplatin|carboplatin|mesh-list
110495751|NCT00777673|Doxorubicin|doxorubicin|mesh-list
110495752|NCT00777673|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110495753|NCT00777673|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110495754|NCT00777673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110495755|NCT00777673|Tubulin Modulators|tubulin modulators|mesh-ancestor
110495756|NCT00777673|Antimitotic Agents|antimitotic agents|mesh-ancestor
110495757|NCT00777673|Mitosis Modulators|mitosis modulators|mesh-ancestor
110495758|NCT00777673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110495759|NCT00777673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110495760|NCT00777673|Immunologic Factors|immunologic factors|mesh-ancestor
110495761|NCT00777673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110495762|NCT00777673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110495763|NCT00777673|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110495764|NCT00777673|Alkylating Agents|alkylating agents|mesh-ancestor
110495765|NCT00777673|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110495766|NCT00777673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110495767|NCT00777673|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110495768|NCT00777673|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110495769|NCT00777673|Growth Substances|growth substances|mesh-ancestor
110495770|NCT00777673|Growth Inhibitors|growth inhibitors|mesh-ancestor
110495771|NCT00777673|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110495772|NCT00777673|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110495773|NCT00777673|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110495774|NCT00777673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110495776|NCT02579902|Cholecalciferol|cholecalciferol|mesh-list
110495777|NCT02579902|Vitamins|vitamins|mesh-ancestor
110495778|NCT02579902|Micronutrients|micronutrients|mesh-ancestor
110495779|NCT02579902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110495780|NCT02579902|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110495781|NCT02579902|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110495782|NCT02557087|Meperidine|meperidine|mesh-list
110495783|NCT02557087|Scopolamine|scopolamine|mesh-list
110495784|NCT02557087|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110495785|NCT02557087|Narcotics|narcotics|mesh-ancestor
110495786|NCT02557087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110495787|NCT02557087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110495788|NCT02557087|Analgesics|analgesics|mesh-ancestor
110495789|NCT02557087|Sensory System Agents|sensory system agents|mesh-ancestor
110495790|NCT02557087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110495791|NCT02557087|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110495793|NCT02557087|Autonomic Agents|autonomic agents|mesh-ancestor
110495794|NCT02557087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110495795|NCT02557087|Mydriatics|mydriatics|mesh-ancestor
110495796|NCT02557087|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110495797|NCT02557087|Cholinergic Agents|cholinergic agents|mesh-ancestor
110495798|NCT02557087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110495799|NCT02557087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110495800|NCT02557087|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110495801|NCT02579590|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
110495802|NCT02579590|Medroxyprogesterone|medroxyprogesterone|mesh-list
110495803|NCT02579590|Desogestrel|desogestrel|mesh-list
110495804|NCT02579590|Etonogestrel|etonogestrel|mesh-list
110495805|NCT02579590|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110495806|NCT02579590|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110495807|NCT02579590|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110495808|NCT02579590|Contraceptive Agents|contraceptive agents|mesh-ancestor
110495809|NCT02579590|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110495810|NCT02579590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110495811|NCT02579590|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110495812|NCT02579590|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110495813|NCT02579590|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110495814|NCT02579590|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110495815|NCT02579590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110495816|NCT02579590|Progestins|progestins|mesh-ancestor
110495817|NCT02579590|Hormones|hormones|mesh-ancestor
110495818|NCT02579590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110495819|NCT02634723|Factor VIII|factor viii|mesh-list
110495820|NCT02634723|Coagulants|coagulants|mesh-ancestor
110495821|NCT02634489|Tamsulosin|tamsulosin|mesh-list
110495822|NCT02634489|Solifenacin Succinate|solifenacin succinate|mesh-list
110495823|NCT02634489|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110495824|NCT02634489|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110495825|NCT02634489|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110495826|NCT02634489|Adrenergic Agents|adrenergic agents|mesh-ancestor
110495827|NCT02634489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110495828|NCT02634489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110495829|NCT02634489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110495830|NCT02634489|Urological Agents|urological agents|mesh-ancestor
110495831|NCT02634489|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110495832|NCT02634489|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110495833|NCT02634489|Cholinergic Agents|cholinergic agents|mesh-ancestor
110495834|NCT00582712|Lithium Carbonate|lithium carbonate|mesh-list
110495835|NCT00582712|Antidepressive Agents|antidepressive agents|mesh-ancestor
110495836|NCT00582712|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110495837|NCT00582712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110495838|NCT00582712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110495839|NCT00582712|Antimanic Agents|antimanic agents|mesh-ancestor
110495840|NCT00582712|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110495841|NCT00582712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110495842|NCT00582712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110495843|NCT03920566|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
110495844|NCT03920566|Dalteparin|dalteparin|mesh-list
110495845|NCT03920566|Anticoagulants|anticoagulants|mesh-ancestor
110495846|NCT03920566|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110495847|NCT03920566|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110495848|NCT03920566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110495850|NCT00582790|Interleukin-2|interleukin-2|mesh-list
110495851|NCT00582790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110495852|NCT00582790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110495853|NCT00582790|Analgesics|analgesics|mesh-ancestor
110495854|NCT00582790|Sensory System Agents|sensory system agents|mesh-ancestor
110495855|NCT00582790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110495856|NCT00582790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110495857|NCT00582790|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110495858|NCT00774007|Mesalamine|mesalamine|mesh-list
110495859|NCT00774007|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110495860|NCT00774007|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110495861|NCT00774007|Analgesics|analgesics|mesh-ancestor
110495862|NCT00774007|Sensory System Agents|sensory system agents|mesh-ancestor
110495863|NCT00774007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110495864|NCT00774007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110495865|NCT00774007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110495866|NCT00774007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110495867|NCT00769873|Heparin|heparin|mesh-list
110495868|NCT00769873|Enoxaparin|enoxaparin|mesh-list
110495869|NCT00769873|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
110495870|NCT00769873|Tinzaparin|tinzaparin|mesh-list
110495871|NCT00769873|Dalteparin|dalteparin|mesh-list
110495872|NCT00769873|Anticoagulants|anticoagulants|mesh-ancestor
110495873|NCT00769873|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110495874|NCT00769873|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110495875|NCT00769873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110495876|NCT00777985|Bosentan|bosentan|mesh-list
110495877|NCT00777985|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110495878|NCT00777985|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
110495879|NCT00777985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110495880|NCT00770107|Thiamine|thiamine|mesh-list
110495881|NCT00770107|Vitamin B Complex|vitamin b complex|mesh-ancestor
110495882|NCT00770107|Vitamins|vitamins|mesh-ancestor
110495883|NCT00770107|Micronutrients|micronutrients|mesh-ancestor
110495884|NCT00770107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110495886|NCT00774241|Docetaxel|docetaxel|mesh-list
110495887|NCT00774241|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110495888|NCT00774241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110495889|NCT00774241|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110495890|NCT00774241|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110495891|NCT00774241|Growth Substances|growth substances|mesh-ancestor
110495892|NCT00774241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110495893|NCT00774241|Growth Inhibitors|growth inhibitors|mesh-ancestor
110495894|NCT00774241|Tubulin Modulators|tubulin modulators|mesh-ancestor
110495895|NCT00774241|Antimitotic Agents|antimitotic agents|mesh-ancestor
110495896|NCT00774241|Mitosis Modulators|mitosis modulators|mesh-ancestor
110495897|NCT00774241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110495898|NCT00774319|Cisplatin|cisplatin|mesh-list
110495899|NCT00774319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110495900|NCT00881751|Bevacizumab|bevacizumab|mesh-list
110495901|NCT00881751|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110495902|NCT00881751|Sorafenib|sorafenib|mesh-list
110495903|NCT00881751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110495904|NCT00881751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110495905|NCT00881751|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110495906|NCT00881751|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110495907|NCT00881751|Growth Substances|growth substances|mesh-ancestor
110495908|NCT00881751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110495909|NCT00881751|Growth Inhibitors|growth inhibitors|mesh-ancestor
110495910|NCT00881751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110495911|NCT00881751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110168004|NCT02971423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110495912|NCT00881751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110495913|NCT02634255|Fentanyl|fentanyl|mesh-list
110495914|NCT02634255|Propofol|propofol|mesh-list
110495915|NCT02634255|Rocuronium|rocuronium|mesh-list
110495916|NCT02634255|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110495917|NCT02634255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110495918|NCT02634255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110495919|NCT02634255|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110495920|NCT02634255|Anesthetics, General|anesthetics, general|mesh-ancestor
110495921|NCT02634255|Anesthetics|anesthetics|mesh-ancestor
110495922|NCT02634255|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110495923|NCT02634255|Narcotics|narcotics|mesh-ancestor
110495924|NCT02634255|Analgesics|analgesics|mesh-ancestor
110495925|NCT02634255|Sensory System Agents|sensory system agents|mesh-ancestor
110495926|NCT02634255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110495927|NCT02634255|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110495928|NCT02634255|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110495929|NCT02634255|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110495930|NCT02634255|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110495932|NCT02634021|Dexmedetomidine|dexmedetomidine|mesh-list
110495933|NCT02634021|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110495934|NCT02634021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110495935|NCT02634021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110495936|NCT02634021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110495937|NCT02634021|Analgesics|analgesics|mesh-ancestor
110495938|NCT02634021|Sensory System Agents|sensory system agents|mesh-ancestor
110495939|NCT02634021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110495940|NCT02634021|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110495941|NCT02634021|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110495942|NCT02634021|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110495943|NCT02634021|Adrenergic Agents|adrenergic agents|mesh-ancestor
110495944|NCT02634021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110495945|NCT02634021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110495946|NCT02634021|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110495947|NCT02634021|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110495948|NCT02634021|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110495949|NCT02634021|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110495950|NCT02634021|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110495951|NCT02634021|Anesthetics, General|anesthetics, general|mesh-ancestor
110495952|NCT02634021|Anesthetics|anesthetics|mesh-ancestor
110495953|NCT02634021|GABA Modulators|gaba modulators|mesh-ancestor
110495954|NCT02634021|GABA Agents|gaba agents|mesh-ancestor
110495955|NCT04161729|Magnesium Sulfate|magnesium sulfate|mesh-list
110495956|NCT04161729|Analgesics|analgesics|mesh-ancestor
110495957|NCT04161729|Sensory System Agents|sensory system agents|mesh-ancestor
110495958|NCT04161729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110495959|NCT04161729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110495960|NCT04161729|Anesthetics|anesthetics|mesh-ancestor
110495961|NCT04161729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110495962|NCT04161729|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110495963|NCT04161729|Anticonvulsants|anticonvulsants|mesh-ancestor
110495964|NCT04161729|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110495965|NCT04161729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110495966|NCT04161729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110274701|NCT00197730|Hematinics|hematinics|mesh-ancestor
110495967|NCT04161729|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110495968|NCT04161729|Tocolytic Agents|tocolytic agents|mesh-ancestor
110495969|NCT04161729|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110495970|NCT04161339|Hydroxychloroquine|hydroxychloroquine|mesh-list
110495971|NCT04161339|Antimalarials|antimalarials|mesh-ancestor
110495972|NCT04161339|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110495973|NCT04161339|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110495974|NCT04161339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110495975|NCT04161339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110495976|NCT04161339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110495977|NCT04161339|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110495978|NCT00934856|Docetaxel|docetaxel|mesh-list
110495979|NCT00934856|Trastuzumab|trastuzumab|mesh-list
110495980|NCT00934856|Pertuzumab|pertuzumab|mesh-list
110495981|NCT00934856|Maytansine|maytansine|mesh-list
110495982|NCT00934856|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
110495983|NCT00934856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110495984|NCT00934856|Tubulin Modulators|tubulin modulators|mesh-ancestor
110495985|NCT00934856|Antimitotic Agents|antimitotic agents|mesh-ancestor
110495987|NCT00934856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110495988|NCT00934856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110495989|NCT00934856|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110495990|NCT00934856|Immunotoxins|immunotoxins|mesh-ancestor
110495991|NCT00934856|Immunoconjugates|immunoconjugates|mesh-ancestor
110495992|NCT00934856|Immunologic Factors|immunologic factors|mesh-ancestor
110495993|NCT00934856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110495994|NCT00934700|Xenon|xenon|mesh-list
110495995|NCT00934700|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110495996|NCT00934700|Anesthetics, General|anesthetics, general|mesh-ancestor
110495997|NCT00934700|Anesthetics|anesthetics|mesh-ancestor
110495998|NCT00934700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110495999|NCT00934700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110496000|NCT00669409|Tanezumab|tanezumab|mesh-list
110496001|NCT00669409|Analgesics|analgesics|mesh-ancestor
110496002|NCT00669409|Sensory System Agents|sensory system agents|mesh-ancestor
110496003|NCT00669409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110496004|NCT00669409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110496005|NCT00778141|Metformin|metformin|mesh-list
110496006|NCT00778141|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110496007|NCT00778141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110496008|NCT00774475|Clopidogrel|clopidogrel|mesh-list
110496009|NCT00774475|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110496010|NCT00774475|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110496011|NCT00774475|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110496012|NCT00774475|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110496013|NCT00774475|Purinergic Agents|purinergic agents|mesh-ancestor
110496014|NCT00774475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110496015|NCT00774475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110496016|NCT00774475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110496017|NCT00669331|Mannitol|mannitol|mesh-list
110496018|NCT00669331|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110496019|NCT00669331|Diuretics|diuretics|mesh-ancestor
110496020|NCT00669331|Natriuretic Agents|natriuretic agents|mesh-ancestor
110496021|NCT00669331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110496022|NCT00778297|Vaccines|vaccines|mesh-list
110496023|NCT00778297|Immunologic Factors|immunologic factors|mesh-ancestor
110496024|NCT00778297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110496025|NCT00779233|Zidovudine|zidovudine|mesh-list
110496026|NCT00779233|Antimetabolites|antimetabolites|mesh-ancestor
110496027|NCT00779233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110496028|NCT00779233|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110496029|NCT00779233|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110496030|NCT00779233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110496031|NCT00779233|Antiviral Agents|antiviral agents|mesh-ancestor
110496032|NCT00779233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110496033|NCT00779233|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110496034|NCT00779233|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110496036|NCT00607178|Immunologic Factors|immunologic factors|mesh-ancestor
110272962|NCT03933163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110496037|NCT00607178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110496038|NCT02556463|Durvalumab|durvalumab|mesh-list
110496039|NCT02556463|MEDI9197|medi9197|mesh-list
110496040|NCT02556463|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110496041|NCT02556463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110496042|NCT02556463|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110496043|NCT02556463|Immunologic Factors|immunologic factors|mesh-ancestor
110168021|NCT00033982|Posaconazole|posaconazole|mesh-list
110496044|NCT02556463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110496045|NCT00779389|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110496047|NCT00779389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110496048|NCT00779389|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110496049|NCT00779389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110496050|NCT00779389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110496051|NCT00778609|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
110496052|NCT00778609|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
110496053|NCT00778609|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110496054|NCT00778609|Contraceptive Agents|contraceptive agents|mesh-ancestor
110496055|NCT00778609|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110496056|NCT00778609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110496057|NCT00778609|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110496058|NCT00778609|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110496059|NCT00778609|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110496060|NCT00778609|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110496061|NCT00778609|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110496062|NCT00778609|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
110496063|NCT00778609|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
110496064|NCT00778609|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
110496065|NCT00778765|Gabapentin|gabapentin|mesh-list
110496066|NCT00778765|Analgesics|analgesics|mesh-ancestor
110496067|NCT00778765|Sensory System Agents|sensory system agents|mesh-ancestor
110496068|NCT00778765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110496069|NCT00778765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110496070|NCT00778765|Anticonvulsants|anticonvulsants|mesh-ancestor
110496071|NCT00778765|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110496072|NCT00778765|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110496073|NCT00778765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110496074|NCT00778765|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110496075|NCT00778765|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110496076|NCT00778765|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110496077|NCT00778765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110496078|NCT00778765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110496079|NCT00778765|Antimanic Agents|antimanic agents|mesh-ancestor
110496080|NCT00779935|Infliximab|infliximab|mesh-list
110496081|NCT00779935|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110496082|NCT00779935|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110496083|NCT00779935|Dermatologic Agents|dermatologic agents|mesh-ancestor
110496084|NCT00779935|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110496085|NCT00779935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110496086|NCT00780013|Metformin|metformin|mesh-list
110496087|NCT00780013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110496088|NCT00780013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110496089|NCT00667225|Cantharidin|cantharidin|mesh-list
110496090|NCT00667225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110496091|NCT00667225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110496092|NCT00780169|Sorafenib|sorafenib|mesh-list
110496093|NCT00780169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110496094|NCT00780169|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110496095|NCT00780169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110496096|NCT00780169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110496097|NCT00780325|Celecoxib|celecoxib|mesh-list
110496098|NCT00780325|Naproxen|naproxen|mesh-list
110496099|NCT00780325|Acetazolamide|acetazolamide|mesh-list
110496100|NCT00780325|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110496101|NCT00780325|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110496102|NCT00780325|Analgesics|analgesics|mesh-ancestor
110496103|NCT00780325|Sensory System Agents|sensory system agents|mesh-ancestor
110496104|NCT00780325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110496105|NCT00780325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110496106|NCT00780325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110496107|NCT00780325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110496108|NCT00780325|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110496109|NCT00780325|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110496110|NCT00780325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110496111|NCT00780325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110496112|NCT00780325|Gout Suppressants|gout suppressants|mesh-ancestor
110496113|NCT00780325|Anticonvulsants|anticonvulsants|mesh-ancestor
110496114|NCT00780325|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110496116|NCT00780325|Natriuretic Agents|natriuretic agents|mesh-ancestor
110496117|NCT02556229|Aflibercept|aflibercept|mesh-list
110496118|NCT02556229|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110496119|NCT02556229|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110496120|NCT02556229|Growth Substances|growth substances|mesh-ancestor
110496121|NCT02556229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110496122|NCT02556229|Growth Inhibitors|growth inhibitors|mesh-ancestor
110496123|NCT02556229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110496124|NCT00929864|Adalimumab|adalimumab|mesh-list
110496125|NCT00929864|Abatacept|abatacept|mesh-list
110496126|NCT00929864|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110496127|NCT00929864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110496128|NCT00929864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110496129|NCT00929864|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110496130|NCT00929864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110496131|NCT00929864|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110496132|NCT00929864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110496133|NCT00929864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110496134|NCT00929864|Immunologic Factors|immunologic factors|mesh-ancestor
110496135|NCT00929864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110496136|NCT00597753|Epoetin Alfa|epoetin alfa|mesh-list
110496137|NCT00597753|Hematinics|hematinics|mesh-ancestor
110496138|NCT04262804|Gemcitabine|gemcitabine|mesh-list
110496139|NCT04262804|Capecitabine|capecitabine|mesh-list
110496140|NCT04262804|Trastuzumab|trastuzumab|mesh-list
110496141|NCT04262804|Vinorelbine|vinorelbine|mesh-list
110496142|NCT04262804|Margetuximab|margetuximab|mesh-list
110496143|NCT04262804|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110496144|NCT04262804|Antimetabolites|antimetabolites|mesh-ancestor
110496145|NCT04262804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110496146|NCT04262804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110496147|NCT04262804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110496148|NCT04262804|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110496149|NCT04262804|Tubulin Modulators|tubulin modulators|mesh-ancestor
110496150|NCT04262804|Antimitotic Agents|antimitotic agents|mesh-ancestor
110496151|NCT04262804|Mitosis Modulators|mitosis modulators|mesh-ancestor
110496152|NCT00665431|Celecoxib|celecoxib|mesh-list
110496153|NCT00665431|Antacids|antacids|mesh-list
110496154|NCT00665431|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110272987|NCT03854370|Chlorhexidine|chlorhexidine|mesh-list
110496155|NCT00665431|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110496156|NCT00665431|Analgesics|analgesics|mesh-ancestor
110496157|NCT00665431|Sensory System Agents|sensory system agents|mesh-ancestor
110496158|NCT00665431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110496159|NCT00665431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110496160|NCT00665431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110496161|NCT00665431|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110496162|NCT00665431|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110496163|NCT00665431|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110496164|NCT00665431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110496165|NCT00665431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110496167|NCT02633709|Itraconazole|itraconazole|mesh-list
110496168|NCT02633709|Risdiplam|risdiplam|mesh-list
110496169|NCT02633709|Antifungal Agents|antifungal agents|mesh-ancestor
110496170|NCT02633709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110496171|NCT02633709|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110496172|NCT02633709|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110496173|NCT02633709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110496174|NCT02633709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110496175|NCT02633709|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110496176|NCT02633709|Hormone Antagonists|hormone antagonists|mesh-ancestor
110496177|NCT02633709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110496178|NCT02633709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110496179|NCT02633709|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110496180|NCT02633709|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110496181|NCT02633709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110496183|NCT04264988|Cariostatic Agents|cariostatic agents|mesh-ancestor
110496184|NCT04264988|Protective Agents|protective agents|mesh-ancestor
110496185|NCT04264988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110496186|NCT00657033|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
110496187|NCT00657033|Vasodilator Agents|vasodilator agents|mesh-ancestor
110496188|NCT00657033|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110496189|NCT00657033|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110496190|NCT00657033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110496191|NCT00657033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110496192|NCT00657033|Urological Agents|urological agents|mesh-ancestor
110496193|NCT02633007|Levodopa|levodopa|mesh-list
110496194|NCT02633007|Carbidopa|carbidopa|mesh-list
110496195|NCT02633007|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110496196|NCT02633007|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110496197|NCT02633007|Dopamine Agents|dopamine agents|mesh-ancestor
110496198|NCT02633007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110496199|NCT02633007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110496200|NCT02633007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110496201|NCT02633007|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
110496202|NCT02633007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110496203|NCT01000727|Darapladib|darapladib|mesh-list
110496204|NCT01000727|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
110496205|NCT01000727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110496206|NCT01000727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110496207|NCT00881205|Rivastigmine|rivastigmine|mesh-list
110496208|NCT00881205|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110496209|NCT00881205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110496210|NCT00881205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110496211|NCT00881205|Cholinergic Agents|cholinergic agents|mesh-ancestor
110496212|NCT00881205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110496213|NCT00881205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110496214|NCT00881205|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110496215|NCT00881205|Protective Agents|protective agents|mesh-ancestor
110496216|NCT00879879|Losartan|losartan|mesh-list
110496217|NCT00879879|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110496218|NCT00879879|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110496219|NCT00879879|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110496220|NCT00879879|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110496221|NCT00879879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110496222|NCT00661999|Darbepoetin alfa|darbepoetin alfa|mesh-list
110496223|NCT00661999|Ferric gluconate|ferric gluconate|mesh-list
110496224|NCT00661999|Hematinics|hematinics|mesh-ancestor
110496225|NCT00661167|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110496226|NCT00661167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110496227|NCT04156815|Isotretinoin|isotretinoin|mesh-list
110604186|NCT00822783|Omalizumab|omalizumab|mesh-list
110496228|NCT04156815|Dermatologic Agents|dermatologic agents|mesh-ancestor
110496229|NCT04156425|Golimumab|golimumab|mesh-list
110496230|NCT04156425|Dexetimide|dexetimide|mesh-list
110496231|NCT04156425|Citalopram|citalopram|mesh-list
110496232|NCT04156425|Calcium|calcium|mesh-list
110496233|NCT04156425|Escitalopram|escitalopram|mesh-list
110496234|NCT04156425|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110496235|NCT04156425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110168046|NCT00034060|Immunologic Factors|immunologic factors|mesh-ancestor
110496236|NCT04156425|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110496237|NCT04156425|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110496238|NCT04156425|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110496239|NCT04156425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110496240|NCT04156425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110496241|NCT04156425|Serotonin Agents|serotonin agents|mesh-ancestor
110496242|NCT04156425|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110496243|NCT04156425|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110496244|NCT04156425|Parasympatholytics|parasympatholytics|mesh-ancestor
110496245|NCT04156425|Autonomic Agents|autonomic agents|mesh-ancestor
110496246|NCT04156425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110496247|NCT04156425|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110496248|NCT04156425|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110496249|NCT04156425|Cholinergic Agents|cholinergic agents|mesh-ancestor
110496250|NCT04156425|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110496251|NCT04156425|Antidepressive Agents|antidepressive agents|mesh-ancestor
110496252|NCT04156425|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110496253|NCT04156425|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110496254|NCT04156425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110496255|NCT04156425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110496256|NCT04156425|Immunologic Factors|immunologic factors|mesh-ancestor
110496257|NCT02555059|Ciprofloxacin|ciprofloxacin|mesh-list
110496258|NCT02555059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110496259|NCT02555059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110496260|NCT02555059|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110496261|NCT02555059|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110496262|NCT02555059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110496263|NCT02555059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110496264|NCT02555059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110496265|NCT02555059|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110496266|NCT02555059|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110496267|NCT00790075|Risperidone|risperidone|mesh-list
110496268|NCT00790075|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110496269|NCT00790075|Serotonin Agents|serotonin agents|mesh-ancestor
110496270|NCT00790075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110496271|NCT00790075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110496272|NCT00790075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110496273|NCT00790075|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110496274|NCT00790075|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110496275|NCT00790075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110496276|NCT00790075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110496277|NCT00790075|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110496278|NCT00790075|Dopamine Agents|dopamine agents|mesh-ancestor
110496279|NCT00785083|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
110496280|NCT00785083|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
110496281|NCT00785083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110496282|NCT00785083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110496283|NCT00785083|Immunologic Factors|immunologic factors|mesh-ancestor
110496284|NCT00785083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110496286|NCT00780637|Kininogens|kininogens|mesh-list
110496287|NCT00780637|Vasodilator Agents|vasodilator agents|mesh-ancestor
110496288|NCT00780637|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
110496289|NCT00780637|Protease Inhibitors|protease inhibitors|mesh-ancestor
110496290|NCT00780637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110496291|NCT00780637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110496292|NCT00661401|gamma-Globulins|gamma-globulins|mesh-list
110496293|NCT00661401|Immunologic Factors|immunologic factors|mesh-ancestor
110496294|NCT00661401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110496295|NCT00790153|Insulin|insulin|mesh-list
110496296|NCT00790153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110496297|NCT00790153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110496298|NCT02631603|Prednisolone|prednisolone|mesh-list
110496299|NCT02631603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110496301|NCT02631603|Hormones|hormones|mesh-ancestor
110496302|NCT02631603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110496303|NCT02631603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110496304|NCT02631603|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110496305|NCT02631603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110496306|NCT00790387|Heparin|heparin|mesh-list
110496308|NCT00790387|Calcium heparin|calcium heparin|mesh-list
110496309|NCT00790387|Tirofiban|tirofiban|mesh-list
110496310|NCT00790387|Anticoagulants|anticoagulants|mesh-ancestor
110496311|NCT00790387|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110496312|NCT00790387|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110496313|NCT00790387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110496314|NCT00790387|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110496315|NCT04156035|Lamotrigine|lamotrigine|mesh-list
110496316|NCT04156035|Ketamine|ketamine|mesh-list
110496317|NCT04156035|Analgesics|analgesics|mesh-ancestor
110496318|NCT04156035|Sensory System Agents|sensory system agents|mesh-ancestor
110496319|NCT04156035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110496320|NCT04156035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110496321|NCT04156035|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110496322|NCT04156035|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110496323|NCT04156035|Anesthetics, General|anesthetics, general|mesh-ancestor
110496324|NCT04156035|Anesthetics|anesthetics|mesh-ancestor
110496325|NCT04156035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110496326|NCT04156035|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110496327|NCT04156035|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110496328|NCT04156035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110496329|NCT04156035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110496330|NCT04156035|Anticonvulsants|anticonvulsants|mesh-ancestor
110496331|NCT04156035|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110496332|NCT04156035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110496333|NCT04156035|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110496334|NCT04156035|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110496335|NCT04156035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110496336|NCT04156035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110496337|NCT04156035|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110496338|NCT00662337|Diphenhydramine|diphenhydramine|mesh-list
110496339|NCT00662337|Promethazine|promethazine|mesh-list
110496340|NCT00662337|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110496341|NCT00662337|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110496342|NCT00662337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110496343|NCT00662337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110496344|NCT00662337|Anesthetics, Local|anesthetics, local|mesh-ancestor
110496345|NCT00662337|Anesthetics|anesthetics|mesh-ancestor
110496346|NCT00662337|Sensory System Agents|sensory system agents|mesh-ancestor
110496347|NCT00662337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110496348|NCT00662337|Antiemetics|antiemetics|mesh-ancestor
110496349|NCT00662337|Autonomic Agents|autonomic agents|mesh-ancestor
110496350|NCT00662337|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110496351|NCT00662337|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110496352|NCT00662337|Histamine Antagonists|histamine antagonists|mesh-ancestor
110496353|NCT00662337|Histamine Agents|histamine agents|mesh-ancestor
110496354|NCT00662337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110496355|NCT00662337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110496356|NCT00662337|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110496357|NCT00662337|Antipruritics|antipruritics|mesh-ancestor
110496358|NCT00662337|Dermatologic Agents|dermatologic agents|mesh-ancestor
110496359|NCT00665353|Pioglitazone|pioglitazone|mesh-list
110496360|NCT00665353|Ribavirin|ribavirin|mesh-list
110496361|NCT00665353|Antimetabolites|antimetabolites|mesh-ancestor
110496362|NCT00665353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110496363|NCT00665353|Antiviral Agents|antiviral agents|mesh-ancestor
110496364|NCT00665353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110496365|NCT00665353|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110496366|NCT00665353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110496367|NCT00785395|Oxytocin|oxytocin|mesh-list
110496368|NCT00785395|Oxytocics|oxytocics|mesh-ancestor
110496369|NCT00785395|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110496370|NCT00785395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110496371|NCT00662571|Acamprosate|acamprosate|mesh-list
110496372|NCT00662571|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110496373|NCT00780793|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
110143659|NCT02026817|Metformin|metformin|mesh-list
110496374|NCT00780793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110496375|NCT00661635|Valdecoxib|valdecoxib|mesh-list
110496376|NCT00661635|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110168072|NCT00389129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110496377|NCT00661635|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110496378|NCT00661635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110496379|NCT00661635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110496380|NCT00661635|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110496381|NCT00661635|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110496382|NCT00661635|Analgesics|analgesics|mesh-ancestor
110496383|NCT00661635|Sensory System Agents|sensory system agents|mesh-ancestor
110496384|NCT00661635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110496385|NCT00661635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110496386|NCT00661635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110496387|NCT00661635|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110496388|NCT02555761|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110496389|NCT02555761|Alcaftadine|alcaftadine|mesh-list
110496390|NCT02555761|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110496391|NCT02555761|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110496392|NCT02555761|Histamine Antagonists|histamine antagonists|mesh-ancestor
110496393|NCT02555761|Histamine Agents|histamine agents|mesh-ancestor
110496394|NCT02555761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110496395|NCT02555761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110496396|NCT02555761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110496397|NCT04155879|Colchicine|colchicine|mesh-list
110496398|NCT04155879|Gout Suppressants|gout suppressants|mesh-ancestor
110496399|NCT04155879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110496400|NCT04155879|Tubulin Modulators|tubulin modulators|mesh-ancestor
110496401|NCT04155879|Antimitotic Agents|antimitotic agents|mesh-ancestor
110496402|NCT04155879|Mitosis Modulators|mitosis modulators|mesh-ancestor
110496403|NCT04155879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110496404|NCT04155879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110496405|NCT00662805|Fluticasone|fluticasone|mesh-list
110496406|NCT00662805|Xhance|xhance|mesh-list
110496407|NCT00662805|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110496408|NCT00662805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110496409|NCT00662805|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110496410|NCT00662805|Autonomic Agents|autonomic agents|mesh-ancestor
110496411|NCT00662805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110496412|NCT00662805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110496413|NCT00662805|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110496414|NCT00662805|Respiratory System Agents|respiratory system agents|mesh-ancestor
110496415|NCT00662805|Dermatologic Agents|dermatologic agents|mesh-ancestor
110496416|NCT00662805|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110496417|NCT00662805|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110604299|NCT02550483|Beta Carotene|beta carotene|mesh-list
110496418|NCT00662805|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110496419|NCT00662805|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110496420|NCT00662805|Adrenergic Agents|adrenergic agents|mesh-ancestor
110496421|NCT00662805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110496422|NCT00662805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110496423|NCT00662883|Mometasone Furoate|mometasone furoate|mesh-list
110496424|NCT00662883|Ketamine|ketamine|mesh-list
110496425|NCT00662883|Analgesics|analgesics|mesh-ancestor
110496426|NCT00662883|Sensory System Agents|sensory system agents|mesh-ancestor
110496427|NCT00662883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110496428|NCT00662883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110496429|NCT00662883|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110496430|NCT00662883|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110496431|NCT00662883|Anesthetics, General|anesthetics, general|mesh-ancestor
110496432|NCT00662883|Anesthetics|anesthetics|mesh-ancestor
110496433|NCT00662883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110496434|NCT00662883|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110496435|NCT00662883|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110496436|NCT00662883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110496437|NCT00662883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110496438|NCT00662883|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110496439|NCT00662883|Dermatologic Agents|dermatologic agents|mesh-ancestor
110496440|NCT00662883|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110496441|NCT00785473|Cholecalciferol|cholecalciferol|mesh-list
110496442|NCT00785473|Vitamin D|vitamin d|mesh-list
110496443|NCT00785473|Calcium Carbonate|calcium carbonate|mesh-list
110496444|NCT00785473|Calcium|calcium|mesh-list
110496445|NCT00785473|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110168074|NCT00013962|Vitamin D|vitamin d|mesh-list
110496446|NCT00785473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110143716|NCT02027220|Bortezomib|bortezomib|mesh-list
110496448|NCT00785473|Micronutrients|micronutrients|mesh-ancestor
110496449|NCT00785473|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110496450|NCT00785473|Antacids|antacids|mesh-ancestor
110496451|NCT00785473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110496452|NCT00785473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110496454|NCT00785551|Antimalarials|antimalarials|mesh-ancestor
110496455|NCT00785551|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110496456|NCT00785551|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110311743|NCT00324051|Serotonin Agents|serotonin agents|mesh-ancestor
110496457|NCT00785551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110496458|NCT00785551|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110496459|NCT00785551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110496460|NCT00785551|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110496461|NCT00785551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110496462|NCT00785551|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110496463|NCT00785551|Analgesics|analgesics|mesh-ancestor
110496464|NCT00785551|Sensory System Agents|sensory system agents|mesh-ancestor
110496465|NCT00790777|Paliperidone Palmitate|paliperidone palmitate|mesh-list
110496466|NCT00790777|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110496467|NCT00790777|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110496468|NCT00790777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110496469|NCT00790777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110496470|NCT00790777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110496471|NCT00790777|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110496472|NCT00790777|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110496473|NCT00790777|Serotonin Agents|serotonin agents|mesh-ancestor
110496474|NCT00790777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110496475|NCT00790777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110496476|NCT00790777|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110496477|NCT00790777|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110496478|NCT00790777|Dopamine Agents|dopamine agents|mesh-ancestor
110496479|NCT00663195|Furosemide|furosemide|mesh-list
110496480|NCT00663195|Spironolactone|spironolactone|mesh-list
110496481|NCT00663195|Diuretics|diuretics|mesh-ancestor
110496482|NCT00663195|Natriuretic Agents|natriuretic agents|mesh-ancestor
110496483|NCT00663195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110496484|NCT00663195|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110496485|NCT00663195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110496486|NCT00663195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110496487|NCT00663195|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110496488|NCT00663195|Hormone Antagonists|hormone antagonists|mesh-ancestor
110496489|NCT00663195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110496490|NCT00663195|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110496491|NCT00791011|Bortezomib|bortezomib|mesh-list
110496492|NCT00791011|Vorinostat|vorinostat|mesh-list
110496493|NCT00791011|Conatumumab|conatumumab|mesh-list
110496494|NCT00791011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110496495|NCT00791011|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110496496|NCT00791011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110496497|NCT00791011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110496498|NCT00791011|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110496499|NCT00781105|Telbivudine|telbivudine|mesh-list
110496500|NCT00781105|Antiviral Agents|antiviral agents|mesh-ancestor
110496501|NCT00781105|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110496502|NCT00781105|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110496503|NCT00781105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110496504|NCT00781105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110496505|NCT00785863|Ketorolac|ketorolac|mesh-list
110496506|NCT00785863|Parecoxib|parecoxib|mesh-list
110496507|NCT00785863|Remifentanil|remifentanil|mesh-list
110496508|NCT00785863|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110496509|NCT00785863|Narcotics|narcotics|mesh-ancestor
110496510|NCT00785863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110496511|NCT00785863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110496512|NCT00785863|Analgesics|analgesics|mesh-ancestor
110496513|NCT00785863|Sensory System Agents|sensory system agents|mesh-ancestor
110496514|NCT00785863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110496515|NCT00785863|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110496516|NCT00785863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110496517|NCT00785863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110496518|NCT00785863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110496519|NCT00785863|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110496520|NCT00785863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110496521|NCT00785863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110496522|NCT00785863|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110496523|NCT00664105|Carboplatin|carboplatin|mesh-list
110496524|NCT00664105|Docetaxel|docetaxel|mesh-list
110496525|NCT00664105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110496526|NCT00664105|Tubulin Modulators|tubulin modulators|mesh-ancestor
110496527|NCT00664105|Antimitotic Agents|antimitotic agents|mesh-ancestor
110496528|NCT00664105|Mitosis Modulators|mitosis modulators|mesh-ancestor
110496529|NCT00664105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110496530|NCT00785941|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110496531|NCT00785941|Immunologic Factors|immunologic factors|mesh-ancestor
110496532|NCT00785941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110496533|NCT02555605|Dexmedetomidine|dexmedetomidine|mesh-list
110496534|NCT02555605|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110496535|NCT02555605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110496536|NCT02555605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110496537|NCT02555605|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110496538|NCT02555605|Analgesics|analgesics|mesh-ancestor
110496539|NCT02555605|Sensory System Agents|sensory system agents|mesh-ancestor
110496540|NCT02555605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110496541|NCT02555605|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110496542|NCT02555605|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110496543|NCT02555605|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110496544|NCT02555605|Adrenergic Agents|adrenergic agents|mesh-ancestor
110496545|NCT02555605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110496546|NCT02555605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110496547|NCT00791167|Paliperidone Palmitate|paliperidone palmitate|mesh-list
110496548|NCT00791167|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110496549|NCT00791167|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110496550|NCT00791167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110496551|NCT00791167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110496552|NCT00791167|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110496553|NCT00791167|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110496554|NCT00791167|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110496555|NCT00791167|Serotonin Agents|serotonin agents|mesh-ancestor
110496556|NCT00791167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110496557|NCT00791167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110496558|NCT00791167|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110496559|NCT00791167|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110496560|NCT00791167|Dopamine Agents|dopamine agents|mesh-ancestor
110496562|NCT00663741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110496563|NCT00663741|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110273104|NCT03215693|Ensartinib|ensartinib|mesh-list
110496564|NCT00663741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110496565|NCT00663741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110496566|NCT00663897|Lansoprazole|lansoprazole|mesh-list
110496567|NCT00663897|Dexlansoprazole|dexlansoprazole|mesh-list
110496568|NCT00663897|Mosapride|mosapride|mesh-list
110496569|NCT00663897|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110496570|NCT00663897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110496571|NCT00663897|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110496572|NCT00663897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110496573|NCT00663897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110496574|NCT00663897|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110496575|NCT00663897|Serotonin Agents|serotonin agents|mesh-ancestor
110496576|NCT00663897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110496577|NCT00663897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110496578|NCT00664053|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
110496579|NCT00664053|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110496580|NCT00664053|Immunologic Factors|immunologic factors|mesh-ancestor
110496581|NCT00664053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110496583|NCT04031859|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110496584|NCT04031859|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110496585|NCT04031859|Analgesics|analgesics|mesh-ancestor
110496586|NCT04031859|Sensory System Agents|sensory system agents|mesh-ancestor
110496587|NCT04031859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110496588|NCT04031859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110496589|NCT04031859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110496590|NCT04031859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110496591|NCT04031859|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110496592|NCT04031859|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110496593|NCT04031859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110496594|NCT04031859|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110496595|NCT04031859|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110496596|NCT04031859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110496597|NCT04031859|Antipyretics|antipyretics|mesh-ancestor
110496598|NCT00664287|Niacin|niacin|mesh-list
110496599|NCT00664287|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110496600|NCT00664287|Antimetabolites|antimetabolites|mesh-ancestor
110496601|NCT00664287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110496602|NCT00664287|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110496603|NCT00664287|Vasodilator Agents|vasodilator agents|mesh-ancestor
110496604|NCT00664287|Vitamin B Complex|vitamin b complex|mesh-ancestor
110496605|NCT00664287|Vitamins|vitamins|mesh-ancestor
110496606|NCT00664287|Micronutrients|micronutrients|mesh-ancestor
110496607|NCT00664287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110496608|NCT00664599|Rituximab|rituximab|mesh-list
110496609|NCT00664599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110496610|NCT00664599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110496611|NCT00664599|Immunologic Factors|immunologic factors|mesh-ancestor
110496612|NCT00664599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110496613|NCT00664599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110496614|NCT02631135|Dexmedetomidine|dexmedetomidine|mesh-list
110496615|NCT02631135|Remifentanil|remifentanil|mesh-list
110496616|NCT02631135|Propofol|propofol|mesh-list
110496617|NCT02631135|Rocuronium|rocuronium|mesh-list
110496618|NCT02631135|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110496619|NCT02631135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110496620|NCT02631135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110496621|NCT02631135|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110496622|NCT02631135|Analgesics|analgesics|mesh-ancestor
110496623|NCT02631135|Sensory System Agents|sensory system agents|mesh-ancestor
110496624|NCT02631135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110496625|NCT02631135|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110496626|NCT02631135|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110496627|NCT02631135|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110496628|NCT02631135|Adrenergic Agents|adrenergic agents|mesh-ancestor
110496629|NCT02631135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110496630|NCT02631135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110496631|NCT02631135|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110496632|NCT02631135|Anesthetics, General|anesthetics, general|mesh-ancestor
110496633|NCT02631135|Anesthetics|anesthetics|mesh-ancestor
110496634|NCT02631135|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110496635|NCT02631135|Narcotics|narcotics|mesh-ancestor
110496636|NCT02631135|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110496637|NCT02631135|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110496638|NCT02631135|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110496639|NCT00664677|Masoprocol|masoprocol|mesh-list
110496640|NCT00664677|Antioxidants|antioxidants|mesh-ancestor
110496641|NCT00664677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110496642|NCT00664677|Protective Agents|protective agents|mesh-ancestor
110496643|NCT00664677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110496644|NCT00664677|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
110496645|NCT00664677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110496646|NCT00664677|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110496647|NCT00664677|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110496648|NCT00664677|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110496649|NCT00664677|Analgesics|analgesics|mesh-ancestor
110496650|NCT00664677|Sensory System Agents|sensory system agents|mesh-ancestor
110496651|NCT00664677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110496652|NCT00664677|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110496653|NCT00664677|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110496654|NCT00596817|Vortioxetine|vortioxetine|mesh-list
110496655|NCT00596817|Antidepressive Agents|antidepressive agents|mesh-ancestor
110496656|NCT00596817|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110496657|NCT00596817|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110496658|NCT00596817|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110496659|NCT00596817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110496660|NCT00596817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110651624|NCT00933374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110496661|NCT00596817|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110496662|NCT00596817|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110496663|NCT00596817|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110496664|NCT00596817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110496665|NCT00596817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110496666|NCT00596817|Serotonin Agents|serotonin agents|mesh-ancestor
110496667|NCT00596817|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110496668|NCT00596817|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110496669|NCT00596817|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110496670|NCT00596817|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110496671|NCT01000649|Vasopressins|vasopressins|mesh-list
110496672|NCT01000649|Hemostatics|hemostatics|mesh-ancestor
110496673|NCT01000649|Coagulants|coagulants|mesh-ancestor
110496674|NCT01000649|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110496675|NCT01000649|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
110496676|NCT01000649|Natriuretic Agents|natriuretic agents|mesh-ancestor
110496677|NCT01000649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110496678|NCT00664833|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
110496679|NCT00664833|Vasodilator Agents|vasodilator agents|mesh-ancestor
110496680|NCT00664833|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110496681|NCT00664833|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110496682|NCT00664833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110496683|NCT00664833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110496684|NCT00664833|Urological Agents|urological agents|mesh-ancestor
110496685|NCT00879411|Telmisartan|telmisartan|mesh-list
110496686|NCT00879411|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110496687|NCT00879411|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110496688|NCT00879411|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110496689|NCT00879411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110496690|NCT00671151|Theophylline|theophylline|mesh-list
110496691|NCT00671151|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110496693|NCT00671151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110496694|NCT00671151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110496695|NCT00671151|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110496696|NCT00671151|Respiratory System Agents|respiratory system agents|mesh-ancestor
110496697|NCT00671151|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110496698|NCT00671151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110496699|NCT00671151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110496700|NCT00671151|Vasodilator Agents|vasodilator agents|mesh-ancestor
110496701|NCT00671151|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110496702|NCT00671151|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110496703|NCT00671151|Purinergic Agents|purinergic agents|mesh-ancestor
110496704|NCT00671151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110496705|NCT00666757|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110496706|NCT00666757|Sertraline|sertraline|mesh-list
110496707|NCT00666757|Fluoxetine|fluoxetine|mesh-list
110496708|NCT00666757|Paroxetine|paroxetine|mesh-list
110496709|NCT00666757|Citalopram|citalopram|mesh-list
110496710|NCT00666757|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110496711|NCT00666757|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110496712|NCT00666757|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110496713|NCT00666757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110496714|NCT00666757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110496715|NCT00666757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110496716|NCT00666757|Analgesics|analgesics|mesh-ancestor
110496717|NCT00666757|Sensory System Agents|sensory system agents|mesh-ancestor
110496718|NCT00666757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110496719|NCT00666757|Antidepressive Agents|antidepressive agents|mesh-ancestor
110496720|NCT00666757|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110496721|NCT00666757|Dopamine Agents|dopamine agents|mesh-ancestor
110496722|NCT00666757|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110496723|NCT00666757|Serotonin Agents|serotonin agents|mesh-ancestor
110496724|NCT00666757|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110496725|NCT00666757|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110496726|NCT00666757|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110496727|NCT00666757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110496728|NCT01000337|Propofol|propofol|mesh-list
110496729|NCT01000337|Sevoflurane|sevoflurane|mesh-list
110496730|NCT01000337|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110496731|NCT01000337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110496732|NCT01000337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110496733|NCT01000337|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110496734|NCT01000337|Anesthetics, General|anesthetics, general|mesh-ancestor
110496735|NCT01000337|Anesthetics|anesthetics|mesh-ancestor
110496736|NCT01000337|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110496737|NCT01000337|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110496739|NCT02869763|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110496740|NCT02869763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110496741|NCT02869763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110496742|NCT02869763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110144017|NCT02028923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110496754|NCT00671697|Arsenic Trioxide|arsenic trioxide|mesh-list
110496755|NCT00671697|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110496756|NCT00671697|Antimetabolites|antimetabolites|mesh-ancestor
110496757|NCT00671697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110496758|NCT00671697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110496759|NCT00671697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110496760|NCT00666679|Mometasone Furoate|mometasone furoate|mesh-list
110496761|NCT00666679|Montelukast|montelukast|mesh-list
110496762|NCT00666679|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110496763|NCT00666679|Respiratory System Agents|respiratory system agents|mesh-ancestor
110496764|NCT00666679|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110496765|NCT00666679|Hormone Antagonists|hormone antagonists|mesh-ancestor
110496766|NCT00666679|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110496767|NCT00666679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110496768|NCT00666679|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110496769|NCT00666679|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110496770|NCT00666679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110496771|NCT00666679|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110496772|NCT00666679|Dermatologic Agents|dermatologic agents|mesh-ancestor
110496773|NCT00666679|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110496774|NCT00791401|Paliperidone Palmitate|paliperidone palmitate|mesh-list
110496775|NCT00791401|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110496776|NCT00791401|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110496777|NCT00791401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110496778|NCT00791401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110496779|NCT00791401|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110496780|NCT00791401|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110496781|NCT00791401|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110496782|NCT00791401|Serotonin Agents|serotonin agents|mesh-ancestor
110496783|NCT00791401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110496784|NCT00791401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110496785|NCT00791401|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110496786|NCT00791401|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110496787|NCT00791401|Dopamine Agents|dopamine agents|mesh-ancestor
110496788|NCT00786253|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
110496789|NCT00786253|Vasodilator Agents|vasodilator agents|mesh-ancestor
110496790|NCT00786253|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110496791|NCT00786253|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110496792|NCT00786253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110496793|NCT00786253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110496794|NCT00786253|Urological Agents|urological agents|mesh-ancestor
110496795|NCT00595413|Adalimumab|adalimumab|mesh-list
110496796|NCT00595413|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110496797|NCT00595413|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110496798|NCT00595413|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110496799|NCT00781261|Zoledronic Acid|zoledronic acid|mesh-list
110496800|NCT00781261|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110496801|NCT00781261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110496802|NCT00786331|Carboplatin|carboplatin|mesh-list
110496803|NCT00786331|Pemetrexed|pemetrexed|mesh-list
110496804|NCT00786331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110496805|NCT00786331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110496806|NCT00786331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110496807|NCT00786331|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110496808|NCT00786331|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110604726|NCT04016740|Narcotics|narcotics|mesh-ancestor
110496809|NCT00791713|Paliperidone Palmitate|paliperidone palmitate|mesh-list
110496810|NCT00791713|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110496811|NCT00791713|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110496812|NCT00791713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110496813|NCT00791713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110496814|NCT00791713|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110168160|NCT00396487|Fluorouracil|fluorouracil|mesh-list
110168161|NCT00396487|Capecitabine|capecitabine|mesh-list
110496815|NCT00791713|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110496816|NCT00791713|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110496817|NCT00791713|Serotonin Agents|serotonin agents|mesh-ancestor
110496818|NCT00791713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110496819|NCT00791713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110496820|NCT00791713|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110496821|NCT00791713|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110496823|NCT00595335|Methylprednisolone|methylprednisolone|mesh-list
110496824|NCT00595335|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110496825|NCT00595335|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110496826|NCT00595335|Prednisolone|prednisolone|mesh-list
110496827|NCT00595335|Prednisolone acetate|prednisolone acetate|mesh-list
110496828|NCT00595335|Rituximab|rituximab|mesh-list
110496829|NCT00595335|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110496830|NCT00595335|Prednisolone phosphate|prednisolone phosphate|mesh-list
110496831|NCT00595335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110496832|NCT00595335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110496833|NCT00595335|Immunologic Factors|immunologic factors|mesh-ancestor
110496834|NCT00595335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110496835|NCT00595335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110496836|NCT00595335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110496837|NCT00595335|Antiemetics|antiemetics|mesh-ancestor
110496838|NCT00595335|Autonomic Agents|autonomic agents|mesh-ancestor
110496839|NCT00595335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110496840|NCT00595335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110496841|NCT00595335|Glucocorticoids|glucocorticoids|mesh-ancestor
110496842|NCT00595335|Hormones|hormones|mesh-ancestor
110496843|NCT00595335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110496844|NCT00595335|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110496845|NCT00595335|Protective Agents|protective agents|mesh-ancestor
110496846|NCT00595335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110496847|NCT00781417|Vitamin D|vitamin d|mesh-list
110496848|NCT00781417|Ergocalciferols|ergocalciferols|mesh-list
110496849|NCT00781417|Cholecalciferol|cholecalciferol|mesh-list
110496850|NCT00781417|Vitamins|vitamins|mesh-list
110496851|NCT00781417|Micronutrients|micronutrients|mesh-ancestor
110496852|NCT00781417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110496853|NCT00781417|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110496854|NCT00781417|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110496855|NCT00672165|Antibodies|antibodies|mesh-list
110496856|NCT00672165|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110496857|NCT00672165|Immunologic Factors|immunologic factors|mesh-ancestor
110496858|NCT00672165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110496859|NCT04293809|Bupivacaine|bupivacaine|mesh-list
110496860|NCT04293809|Anesthetics, Local|anesthetics, local|mesh-ancestor
110496862|NCT04293809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110496863|NCT04293809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110496864|NCT04293809|Sensory System Agents|sensory system agents|mesh-ancestor
110496865|NCT04293809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110496866|NCT00672399|Exenatide|exenatide|mesh-list
110496867|NCT00672399|Moxifloxacin|moxifloxacin|mesh-list
110496868|NCT00672399|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110496869|NCT00672399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110496870|NCT00672399|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110496871|NCT00672399|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110496872|NCT00672399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110496873|NCT00672399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110496874|NCT00672399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110496875|NCT00672399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110496876|NCT00672399|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110496877|NCT00672399|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110496878|NCT00672399|Incretins|incretins|mesh-ancestor
110496879|NCT00672399|Hormones|hormones|mesh-ancestor
110496880|NCT00672399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110496881|NCT00661531|Anastrozole|anastrozole|mesh-list
110496882|NCT00661531|Estradiol|estradiol|mesh-list
110496883|NCT00661531|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110496884|NCT00661531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110496885|NCT00661531|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110496886|NCT00661531|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110496887|NCT00661531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110496888|NCT00661531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110496889|NCT00661531|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110496890|NCT00661531|Hormone Antagonists|hormone antagonists|mesh-ancestor
110496891|NCT00661531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110496892|NCT00661531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110496893|NCT00661531|Estrogens|estrogens|mesh-ancestor
110496894|NCT00661531|Hormones|hormones|mesh-ancestor
110496895|NCT00998309|Azithromycin|azithromycin|mesh-list
110496896|NCT00998309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110496897|NCT00998309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110496898|NCT02629575|Sirolimus|sirolimus|mesh-list
110496899|NCT02629575|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110496900|NCT02629575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110496901|NCT02629575|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110496902|NCT02629575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110496903|NCT02629575|Antifungal Agents|antifungal agents|mesh-ancestor
110496904|NCT02629575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110496905|NCT02629575|Immunologic Factors|immunologic factors|mesh-ancestor
110496906|NCT02629575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110496907|NCT00781573|Clopidogrel|clopidogrel|mesh-list
110496908|NCT00781573|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110496909|NCT00781573|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110496910|NCT00781573|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110496911|NCT00781573|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110496912|NCT00781573|Purinergic Agents|purinergic agents|mesh-ancestor
110496913|NCT00781573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110496914|NCT00781573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110496915|NCT00781573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110496916|NCT00671541|Gentamicins|gentamicins|mesh-list
110496917|NCT00671541|Bacitracin|bacitracin|mesh-list
110496918|NCT00671541|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110496919|NCT00671541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110496920|NCT00671541|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110496921|NCT00671541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110496922|NCT00671541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110496923|NCT00671541|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110496924|NCT04152681|Apatinib|apatinib|mesh-list
110496925|NCT04152681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110496926|NCT04152681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110496927|NCT04152681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110496928|NCT04152681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110496929|NCT00999713|Calfactant|calfactant|mesh-list
110496930|NCT00999713|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
110496931|NCT00999713|Respiratory System Agents|respiratory system agents|mesh-ancestor
110496932|NCT00672867|Adefovir|adefovir|mesh-list
110496933|NCT00672867|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
110496934|NCT00672867|Clevudine|clevudine|mesh-list
110496935|NCT00672867|Antiviral Agents|antiviral agents|mesh-ancestor
110496936|NCT00672867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110496937|NCT00672867|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110496938|NCT00672867|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110496939|NCT00672867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110496940|NCT00672867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110496941|NCT00997373|Letrozole|letrozole|mesh-list
110496942|NCT00997373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110496943|NCT00997373|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110496944|NCT00997373|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110496945|NCT00997373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110496946|NCT00997373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110496947|NCT00997373|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110496948|NCT00997373|Hormone Antagonists|hormone antagonists|mesh-ancestor
110168177|NCT00000674|Pyrimethamine|pyrimethamine|mesh-list
110496949|NCT00997373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110496950|NCT00997373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110496951|NCT04152759|Golimumab|golimumab|mesh-list
110496952|NCT04152759|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110496953|NCT04152759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110496954|NCT04152759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110496955|NCT04152759|Immunologic Factors|immunologic factors|mesh-ancestor
110496956|NCT04152759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110496957|NCT00792025|Sunitinib|sunitinib|mesh-list
110496958|NCT00792025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110496959|NCT00792025|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110496960|NCT00792025|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110496961|NCT00792025|Growth Substances|growth substances|mesh-ancestor
110496962|NCT00792025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110496963|NCT00792025|Growth Inhibitors|growth inhibitors|mesh-ancestor
110496964|NCT00792025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110496965|NCT00792025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110273265|NCT01011478|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110496966|NCT00792025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110496968|NCT02870231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110496969|NCT02870231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110496970|NCT02870231|Incretins|incretins|mesh-ancestor
110496971|NCT02870231|Hormones|hormones|mesh-ancestor
110496972|NCT02870231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110496973|NCT00782041|Leucovorin|leucovorin|mesh-list
110496974|NCT00782041|Folic Acid|folic acid|mesh-list
110496975|NCT00782041|Fluorouracil|fluorouracil|mesh-list
110496976|NCT00782041|Oxaliplatin|oxaliplatin|mesh-list
110496977|NCT00782041|Levoleucovorin|levoleucovorin|mesh-list
110496978|NCT00782041|Antimetabolites|antimetabolites|mesh-ancestor
110496979|NCT00782041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110496980|NCT00782041|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110496981|NCT00782041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110496982|NCT00782041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110496983|NCT00782041|Immunologic Factors|immunologic factors|mesh-ancestor
110496984|NCT00782041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110496985|NCT00782041|Antidotes|antidotes|mesh-ancestor
110496986|NCT00782041|Protective Agents|protective agents|mesh-ancestor
110496987|NCT00782041|Vitamin B Complex|vitamin b complex|mesh-ancestor
110496988|NCT00782041|Vitamins|vitamins|mesh-ancestor
110496989|NCT00782041|Micronutrients|micronutrients|mesh-ancestor
110496990|NCT00782041|Hematinics|hematinics|mesh-ancestor
110496991|NCT00673569|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110496992|NCT00673569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110496993|NCT00673569|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110496994|NCT00673569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110496995|NCT00673569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110496996|NCT00792181|Midazolam|midazolam|mesh-list
110496997|NCT00792181|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110496998|NCT00792181|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110496999|NCT00792181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110497000|NCT00792181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110497001|NCT00792181|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110497002|NCT00792181|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110497003|NCT00792181|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110497004|NCT00792181|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110497005|NCT00792181|Anesthetics, General|anesthetics, general|mesh-ancestor
110497006|NCT00792181|Anesthetics|anesthetics|mesh-ancestor
110497007|NCT00792181|GABA Modulators|gaba modulators|mesh-ancestor
110497008|NCT00792181|GABA Agents|gaba agents|mesh-ancestor
110497009|NCT00792181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110497010|NCT00792181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110497011|NCT00792337|Simvastatin|simvastatin|mesh-list
110497012|NCT00792337|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110497013|NCT00792337|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110497014|NCT00792337|Antimetabolites|antimetabolites|mesh-ancestor
110497015|NCT00792337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110497016|NCT00792337|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110497017|NCT00792337|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110497018|NCT00792337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110497019|NCT00787111|Fluoxetine|fluoxetine|mesh-list
110497020|NCT00787111|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110497021|NCT00787111|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110497022|NCT00787111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110497023|NCT00787111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110497024|NCT00787111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110497025|NCT00787111|Serotonin Agents|serotonin agents|mesh-ancestor
110497026|NCT00787111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110497027|NCT00787111|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110497028|NCT00787111|Antidepressive Agents|antidepressive agents|mesh-ancestor
110497029|NCT00787111|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110497030|NCT00787111|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110497031|NCT00787111|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110497032|NCT00787111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110497033|NCT00782197|Hyaluronic Acid|hyaluronic acid|mesh-list
110497034|NCT00782197|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110497035|NCT00782197|Immunologic Factors|immunologic factors|mesh-ancestor
110497036|NCT00782197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110497037|NCT00782197|Viscosupplements|viscosupplements|mesh-ancestor
110497038|NCT00782197|Protective Agents|protective agents|mesh-ancestor
110497039|NCT04152291|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
110497040|NCT04152291|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110497041|NCT04152291|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110497043|NCT00996593|Tositumomab I-131|tositumomab i-131|mesh-list
110497044|NCT00996593|Antibodies|antibodies|mesh-list
110497045|NCT00996593|Immunoglobulins|immunoglobulins|mesh-list
110497046|NCT00996593|Immunologic Factors|immunologic factors|mesh-ancestor
110497047|NCT00996593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110497048|NCT00996593|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110497049|NCT00996593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110497050|NCT00996593|Trace Elements|trace elements|mesh-ancestor
110497051|NCT00996593|Micronutrients|micronutrients|mesh-ancestor
110497052|NCT00996593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110497053|NCT00570661|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
110497054|NCT00570661|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
110497055|NCT00570661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110497056|NCT00570661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110497057|NCT02870153|Oxaliplatin|oxaliplatin|mesh-list
110497058|NCT02870153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110497059|NCT00787501|Fluoxetine|fluoxetine|mesh-list
110497060|NCT00787501|Sertraline|sertraline|mesh-list
110497061|NCT00787501|Escitalopram|escitalopram|mesh-list
110497062|NCT00787501|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110497063|NCT00787501|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110497064|NCT00787501|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110497065|NCT00787501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110497066|NCT00787501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110497067|NCT00787501|Serotonin Agents|serotonin agents|mesh-ancestor
110497068|NCT00787501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110497069|NCT00787501|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110497070|NCT00787501|Antidepressive Agents|antidepressive agents|mesh-ancestor
110497071|NCT00787501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110497072|NCT00787501|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110497073|NCT00787501|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110497074|NCT00787501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110497075|NCT00787657|Interferons|interferons|mesh-list
110497076|NCT00787657|Interferon-beta|interferon-beta|mesh-list
110497077|NCT00787657|Interferon beta-1b|interferon beta-1b|mesh-list
110497078|NCT00787657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110497079|NCT00787657|Antiviral Agents|antiviral agents|mesh-ancestor
110497080|NCT00787657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110497081|NCT00787657|Immunologic Factors|immunologic factors|mesh-ancestor
110497082|NCT00787657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110497083|NCT00787657|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110497084|NCT04264676|Metronidazole|metronidazole|mesh-list
110497085|NCT04264676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110273305|NCT00980460|Antifungal Agents|antifungal agents|mesh-ancestor
110497086|NCT04264676|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110497087|NCT04264676|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110497088|NCT04264676|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110497089|NCT02869841|Levobupivacaine|levobupivacaine|mesh-list
110497090|NCT02869841|Anesthetics, Local|anesthetics, local|mesh-ancestor
110497091|NCT02869841|Anesthetics|anesthetics|mesh-ancestor
110497092|NCT02869841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110497093|NCT02869841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110497094|NCT02869841|Sensory System Agents|sensory system agents|mesh-ancestor
110497095|NCT02869841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110497096|NCT00637637|Ritonavir|ritonavir|mesh-list
110497097|NCT00637637|Indinavir|indinavir|mesh-list
110497098|NCT00637637|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110497099|NCT00637637|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110497100|NCT00637637|Protease Inhibitors|protease inhibitors|mesh-ancestor
110497101|NCT00637637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110497102|NCT00637637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110497103|NCT00637637|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110497104|NCT00637637|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110497105|NCT00637637|Antiviral Agents|antiviral agents|mesh-ancestor
110497106|NCT00637637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110497107|NCT00637637|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110497108|NCT00637637|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110497109|NCT00927758|Fluticasone|fluticasone|mesh-list
110497110|NCT00927758|Xhance|xhance|mesh-list
110497111|NCT00927758|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110497112|NCT00927758|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
110497113|NCT00927758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110497114|NCT00927758|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110497115|NCT00927758|Autonomic Agents|autonomic agents|mesh-ancestor
110497116|NCT00927758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110497117|NCT00927758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110497118|NCT00927758|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110497119|NCT00927758|Respiratory System Agents|respiratory system agents|mesh-ancestor
110497120|NCT00927758|Dermatologic Agents|dermatologic agents|mesh-ancestor
110497121|NCT00927758|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110497122|NCT00927758|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110497123|NCT00927758|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110497124|NCT00927758|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110497125|NCT00927758|Adrenergic Agents|adrenergic agents|mesh-ancestor
110497126|NCT00927758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110497127|NCT00927758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110497130|NCT00927758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110497131|NCT00927758|Sympathomimetics|sympathomimetics|mesh-ancestor
110497132|NCT00783523|Doxycycline|doxycycline|mesh-list
110497133|NCT00783523|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110497134|NCT00783523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110497135|NCT00783523|Antimalarials|antimalarials|mesh-ancestor
110497136|NCT00783523|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110497137|NCT00783523|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110497138|NCT00783601|Montelukast|montelukast|mesh-list
110497139|NCT00783601|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110497140|NCT00783601|Respiratory System Agents|respiratory system agents|mesh-ancestor
110497141|NCT00783601|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110497142|NCT00783601|Hormone Antagonists|hormone antagonists|mesh-ancestor
110497143|NCT00783601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110497144|NCT00783601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110497145|NCT00783601|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110497146|NCT00783601|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110497147|NCT00783601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110497148|NCT00787813|Acetylcysteine|acetylcysteine|mesh-list
110497149|NCT00787813|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110497150|NCT00787813|Antiviral Agents|antiviral agents|mesh-ancestor
110497151|NCT00787813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110497152|NCT00787813|Expectorants|expectorants|mesh-ancestor
110497153|NCT00787813|Respiratory System Agents|respiratory system agents|mesh-ancestor
110497154|NCT00787813|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110168195|NCT00000674|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110497155|NCT00787813|Antioxidants|antioxidants|mesh-ancestor
110497156|NCT00787813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110497157|NCT00787813|Protective Agents|protective agents|mesh-ancestor
110497158|NCT00787813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110497159|NCT00787813|Antidotes|antidotes|mesh-ancestor
110497160|NCT04261634|Mitogens|mitogens|mesh-list
110497161|NCT04261634|Mitosis Modulators|mitosis modulators|mesh-ancestor
110497162|NCT04261634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110497163|NCT00787969|Sirolimus|sirolimus|mesh-list
110497164|NCT00787969|Rituximab|rituximab|mesh-list
110497165|NCT00787969|Temsirolimus|temsirolimus|mesh-list
110497167|NCT00787969|MTOR Inhibitors|mtor inhibitors|mesh-list
110497168|NCT00787969|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110497169|NCT00787969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110497170|NCT00787969|Immunologic Factors|immunologic factors|mesh-ancestor
110497171|NCT00787969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110497172|NCT00787969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110497173|NCT00787969|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110497174|NCT00787969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110497175|NCT00787969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110497176|NCT00787969|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110497177|NCT00787969|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110497178|NCT00787969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110497179|NCT00787969|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110497180|NCT00787969|Antifungal Agents|antifungal agents|mesh-ancestor
110497181|NCT00609596|Dutasteride|dutasteride|mesh-list
110497182|NCT00609596|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
110497183|NCT00609596|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110497184|NCT00609596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110497185|NCT00609596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110497186|NCT00609596|Hormone Antagonists|hormone antagonists|mesh-ancestor
110497187|NCT00609596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110497188|NCT00609596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110497189|NCT00608816|Epinephrine|epinephrine|mesh-list
110497190|NCT00608816|Racepinephrine|racepinephrine|mesh-list
110497191|NCT00608816|Epinephryl borate|epinephryl borate|mesh-list
110497192|NCT00608816|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110497193|NCT00608816|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110497194|NCT00608816|Adrenergic Agents|adrenergic agents|mesh-ancestor
110497195|NCT00608816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110159710|NCT00093925|Nicardipine|nicardipine|mesh-list
110497196|NCT00608816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110497197|NCT00608816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110497198|NCT00608816|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110497199|NCT00608816|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110497200|NCT00608816|Autonomic Agents|autonomic agents|mesh-ancestor
110497201|NCT00608816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110497202|NCT00608816|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110497203|NCT00608816|Respiratory System Agents|respiratory system agents|mesh-ancestor
110497204|NCT00608816|Mydriatics|mydriatics|mesh-ancestor
110497205|NCT00608816|Sympathomimetics|sympathomimetics|mesh-ancestor
110497206|NCT00608816|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110497207|NCT02535273|Lidocaine|lidocaine|mesh-list
110497208|NCT02535273|Dexmedetomidine|dexmedetomidine|mesh-list
110497209|NCT02535273|Anesthetics, Local|anesthetics, local|mesh-ancestor
110497210|NCT02535273|Anesthetics|anesthetics|mesh-ancestor
110497211|NCT02535273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110497212|NCT02535273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110497213|NCT02535273|Sensory System Agents|sensory system agents|mesh-ancestor
110497214|NCT02535273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110497215|NCT02535273|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110497216|NCT02535273|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110497217|NCT02535273|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110497218|NCT02535273|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110497219|NCT02535273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110497220|NCT02535273|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110497221|NCT02535273|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110497222|NCT02535273|Analgesics|analgesics|mesh-ancestor
110497223|NCT02535273|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110497224|NCT02535273|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110497225|NCT02535273|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110497226|NCT02535273|Adrenergic Agents|adrenergic agents|mesh-ancestor
110497227|NCT02535273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110497228|NCT00788047|Dextromethorphan|dextromethorphan|mesh-list
110497229|NCT00788047|Antitussive Agents|antitussive agents|mesh-ancestor
110497230|NCT00788047|Respiratory System Agents|respiratory system agents|mesh-ancestor
110497231|NCT00788047|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110497232|NCT00788047|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110497233|NCT00788047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110497234|NCT00788047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110497235|NCT00788047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110497236|NCT04152369|Anti-Infective Agents|anti-infective agents|mesh-list
110497237|NCT04152369|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110497239|NCT04259684|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110497240|NCT04259684|Autonomic Agents|autonomic agents|mesh-ancestor
110497241|NCT04259684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110497242|NCT04259684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110497243|NCT04259684|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110497244|NCT04259684|Respiratory System Agents|respiratory system agents|mesh-ancestor
110497245|NCT04259684|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110497246|NCT04259684|Antioxidants|antioxidants|mesh-ancestor
110497247|NCT04259684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110497248|NCT04259684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110497249|NCT04259684|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
110497250|NCT04259684|Vasodilator Agents|vasodilator agents|mesh-ancestor
110497251|NCT04259684|Gasotransmitters|gasotransmitters|mesh-ancestor
110497252|NCT04259684|Protective Agents|protective agents|mesh-ancestor
110497253|NCT00788515|Lormetazepam|lormetazepam|mesh-list
110497254|NCT00788515|Volinanserin|volinanserin|mesh-list
110497255|NCT00788515|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110497256|NCT00788515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110497257|NCT00788515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110497258|NCT00788515|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110497259|NCT00788515|Serotonin Agents|serotonin agents|mesh-ancestor
110497260|NCT00788515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110311754|NCT00290420|Amebicides|amebicides|mesh-ancestor
110497261|NCT00788515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110497262|NCT04259606|Magnesium Oxide|magnesium oxide|mesh-list
110497263|NCT04259606|Antacids|antacids|mesh-ancestor
110497264|NCT04259606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110497265|NCT04259606|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110497266|NCT00788749|Fluticasone|fluticasone|mesh-list
110497268|NCT00788749|Prednisolone|prednisolone|mesh-list
110497269|NCT00788749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110497270|NCT00788749|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110497271|NCT00788749|Autonomic Agents|autonomic agents|mesh-ancestor
110497272|NCT00788749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110605385|NCT00621777|Varenicline|varenicline|mesh-list
110497273|NCT00788749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110497274|NCT00788749|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110497275|NCT00788749|Respiratory System Agents|respiratory system agents|mesh-ancestor
110497276|NCT00788749|Dermatologic Agents|dermatologic agents|mesh-ancestor
110497277|NCT00788749|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110497279|NCT00788749|Hormones|hormones|mesh-ancestor
110497280|NCT00788749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110497281|NCT00788749|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110497282|NCT00788749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110497283|NCT00609752|Prednisolone|prednisolone|mesh-list
110497284|NCT00609752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110497285|NCT00609752|Glucocorticoids|glucocorticoids|mesh-ancestor
110497286|NCT00609752|Hormones|hormones|mesh-ancestor
110497287|NCT00609752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110497288|NCT00609752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110497289|NCT00609752|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110497290|NCT00609752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110497291|NCT00662857|Insulin|insulin|mesh-list
110497292|NCT00662857|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110497293|NCT00662857|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110497294|NCT00662857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110497295|NCT00878553|Zaleplon|zaleplon|mesh-list
110497296|NCT00878553|Anticonvulsants|anticonvulsants|mesh-ancestor
110497297|NCT00878553|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110497298|NCT00878553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110497299|NCT00878553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110497300|NCT00878553|GABA Modulators|gaba modulators|mesh-ancestor
110497301|NCT00878553|GABA Agents|gaba agents|mesh-ancestor
110497302|NCT00878553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110497303|NCT00878553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110497304|NCT05220020|Lenvatinib|lenvatinib|mesh-list
110497305|NCT05220020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110497306|NCT05220020|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110497307|NCT05220020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110497308|NCT05220020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110497309|NCT00789061|Lansoprazole|lansoprazole|mesh-list
110497310|NCT00789061|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
110497311|NCT00789061|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110497312|NCT00789061|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110497313|NCT00789061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110497314|NCT00789061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110497315|NCT00996437|Ranibizumab|ranibizumab|mesh-list
110497316|NCT00996437|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110497317|NCT00996437|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110497318|NCT00996437|Growth Substances|growth substances|mesh-ancestor
110497319|NCT00996437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110497320|NCT00996437|Growth Inhibitors|growth inhibitors|mesh-ancestor
110497321|NCT00996437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110497323|NCT02628951|Ramucirumab|ramucirumab|mesh-list
110497324|NCT02628951|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110497325|NCT02628951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110497326|NCT02628951|Tubulin Modulators|tubulin modulators|mesh-ancestor
110497327|NCT02628951|Antimitotic Agents|antimitotic agents|mesh-ancestor
110497328|NCT02628951|Mitosis Modulators|mitosis modulators|mesh-ancestor
110651626|NCT00933374|Antimitotic Agents|antimitotic agents|mesh-ancestor
110497329|NCT02628951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110497330|NCT00662311|Paclitaxel|paclitaxel|mesh-list
110497331|NCT00662311|Vorinostat|vorinostat|mesh-list
110497332|NCT00662311|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110497333|NCT00662311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110497334|NCT00662311|Tubulin Modulators|tubulin modulators|mesh-ancestor
110497335|NCT00662311|Antimitotic Agents|antimitotic agents|mesh-ancestor
110497336|NCT00662311|Mitosis Modulators|mitosis modulators|mesh-ancestor
110497337|NCT00662311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110497338|NCT00662311|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110497339|NCT00662311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110497340|NCT00929708|Formoterol Fumarate|formoterol fumarate|mesh-list
110497342|NCT00929708|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110497343|NCT00929708|Autonomic Agents|autonomic agents|mesh-ancestor
110497344|NCT00929708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110497345|NCT00929708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110168211|NCT00034528|Prednisone|prednisone|mesh-list
110497346|NCT00929708|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110497347|NCT00929708|Respiratory System Agents|respiratory system agents|mesh-ancestor
110497348|NCT00929708|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110497349|NCT00929708|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110497350|NCT00929708|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110497351|NCT00929708|Adrenergic Agents|adrenergic agents|mesh-ancestor
110497352|NCT00929708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110497353|NCT00929708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110497354|NCT00996281|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110497356|NCT00996281|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
110497357|NCT00996281|Chlorthalidone|chlorthalidone|mesh-list
110497358|NCT00996281|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
110497359|NCT00996281|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110497360|NCT00996281|Diuretics|diuretics|mesh-ancestor
110497361|NCT00996281|Natriuretic Agents|natriuretic agents|mesh-ancestor
110497362|NCT00996281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110497363|NCT00996281|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110497364|NCT00996281|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110497365|NCT00996281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110497366|NCT00996281|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110497367|NCT00996281|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110497368|NCT04046653|Sulforaphane|sulforaphane|mesh-list
110497369|NCT04046653|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110497370|NCT04046653|Protective Agents|protective agents|mesh-ancestor
110497371|NCT04046653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110497372|NCT04046653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110497373|NCT04293887|Interferons|interferons|mesh-list
110497374|NCT04293887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110497375|NCT04293887|Antiviral Agents|antiviral agents|mesh-ancestor
110497376|NCT04293887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110497377|NCT00675207|Brimonidine Tartrate|brimonidine tartrate|mesh-list
110497378|NCT00675207|Dorzolamide|dorzolamide|mesh-list
110497379|NCT00675207|Brinzolamide|brinzolamide|mesh-list
110497380|NCT00675207|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110497381|NCT00675207|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110497382|NCT00675207|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110497383|NCT00675207|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110497384|NCT00675207|Adrenergic Agents|adrenergic agents|mesh-ancestor
110497385|NCT00675207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110497386|NCT00675207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110497387|NCT00675207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110497388|NCT00675207|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110497389|NCT00675207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110497391|NCT00795223|Bupivacaine|bupivacaine|mesh-list
110497392|NCT00795223|Anesthetics, Local|anesthetics, local|mesh-ancestor
110497393|NCT00795223|Anesthetics|anesthetics|mesh-ancestor
110497394|NCT00795223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110497395|NCT00795223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110497396|NCT00795223|Sensory System Agents|sensory system agents|mesh-ancestor
110497397|NCT00795223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110497398|NCT00795223|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110497399|NCT00795223|Narcotics|narcotics|mesh-ancestor
110497400|NCT00795223|Analgesics|analgesics|mesh-ancestor
110497401|NCT00795301|Capecitabine|capecitabine|mesh-list
110497402|NCT00795301|Oxaliplatin|oxaliplatin|mesh-list
110497404|NCT00795301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110497405|NCT00795301|Antimetabolites|antimetabolites|mesh-ancestor
110497406|NCT00795301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110497407|NCT00795301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110497408|NCT00795301|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110497409|NCT00675285|Montelukast|montelukast|mesh-list
110311758|NCT00290420|Antimalarials|antimalarials|mesh-ancestor
110497410|NCT00675285|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110497411|NCT00675285|Respiratory System Agents|respiratory system agents|mesh-ancestor
110497412|NCT00675285|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110497413|NCT00675285|Hormone Antagonists|hormone antagonists|mesh-ancestor
110497414|NCT00675285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110497415|NCT00675285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110497416|NCT00675285|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110497417|NCT00675285|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110497418|NCT00675285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110497419|NCT00996203|Antirheumatic Agents|antirheumatic agents|mesh-list
110497420|NCT00789763|Gemcitabine|gemcitabine|mesh-list
110497421|NCT00789763|Sorafenib|sorafenib|mesh-list
110497422|NCT00789763|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110497423|NCT00789763|Antimetabolites|antimetabolites|mesh-ancestor
110497424|NCT00789763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110497425|NCT00789763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110497426|NCT00789763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110497427|NCT00789763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110497428|NCT02554357|Bupivacaine|bupivacaine|mesh-list
110497429|NCT02554357|Anesthetics, Local|anesthetics, local|mesh-ancestor
110497430|NCT02554357|Anesthetics|anesthetics|mesh-ancestor
110497431|NCT02554357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110497432|NCT02554357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110497433|NCT02554357|Sensory System Agents|sensory system agents|mesh-ancestor
110497434|NCT02554357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110497435|NCT00877929|Amlodipine|amlodipine|mesh-list
110497436|NCT00877929|Telmisartan|telmisartan|mesh-list
110497437|NCT00877929|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110497438|NCT00877929|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110497439|NCT00877929|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110497440|NCT00877929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110497441|NCT00877929|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110497442|NCT00877929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110497443|NCT00877929|Vasodilator Agents|vasodilator agents|mesh-ancestor
110497444|NCT00877929|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110497445|NCT00877929|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110497446|NCT00795457|Poly I-C|poly i-c|mesh-list
110497447|NCT00795457|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
110497448|NCT00795457|Vaccines|vaccines|mesh-list
110497449|NCT00795457|Poly ICLC|poly iclc|mesh-list
110497450|NCT00795457|Immunologic Factors|immunologic factors|mesh-ancestor
110497451|NCT00795457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110497452|NCT00795457|Interferon Inducers|interferon inducers|mesh-ancestor
110497453|NCT00795457|Laxatives|laxatives|mesh-ancestor
110497454|NCT00795457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110497455|NCT00795457|Antiviral Agents|antiviral agents|mesh-ancestor
110497456|NCT00795457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110497457|NCT00793195|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
110497458|NCT00793195|SMOFlipid|smoflipid|mesh-list
110497459|NCT00793195|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
110497460|NCT00793195|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
110497461|NCT00793195|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110497462|NCT00793273|Insulin Detemir|insulin detemir|mesh-list
110497463|NCT00793273|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110497464|NCT00793273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110497465|NCT04979780|Heparin|heparin|mesh-list
110497466|NCT04979780|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
110497467|NCT04979780|Tinzaparin|tinzaparin|mesh-list
110497468|NCT04979780|Dalteparin|dalteparin|mesh-list
110497469|NCT04979780|Rivaroxaban|rivaroxaban|mesh-list
110497470|NCT04979780|Anticoagulants|anticoagulants|mesh-list
110273451|NCT00168740|Rituximab|rituximab|mesh-list
110497471|NCT04979780|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110497472|NCT04979780|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110497473|NCT04979780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110497474|NCT04979780|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110497475|NCT04979780|Antithrombins|antithrombins|mesh-ancestor
110497476|NCT04979780|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110497477|NCT04979780|Protease Inhibitors|protease inhibitors|mesh-ancestor
110497478|NCT04979780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110497479|NCT00795613|Doxorubicin|doxorubicin|mesh-list
110497480|NCT00795613|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110497481|NCT00795613|Vincristine|vincristine|mesh-list
110497482|NCT00795613|Procarbazine|procarbazine|mesh-list
110497483|NCT00795613|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110497484|NCT00795613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110497485|NCT00795613|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110497486|NCT00795613|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110497487|NCT00795613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110497488|NCT00795613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110497489|NCT00795613|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110497491|NCT00795613|Antimitotic Agents|antimitotic agents|mesh-ancestor
110497492|NCT00795613|Mitosis Modulators|mitosis modulators|mesh-ancestor
110497493|NCT00800761|Deferiprone|deferiprone|mesh-list
110497494|NCT00800761|Deferoxamine|deferoxamine|mesh-list
110497495|NCT00800761|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110497496|NCT00800761|Chelating Agents|chelating agents|mesh-ancestor
110497497|NCT00800761|Sequestering Agents|sequestering agents|mesh-ancestor
110497498|NCT00800761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110497499|NCT00800761|Siderophores|siderophores|mesh-ancestor
110497500|NCT00676221|Mycophenolic Acid|mycophenolic acid|mesh-list
110497501|NCT00676221|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110497502|NCT00676221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110497503|NCT00676221|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110497504|NCT00676221|Antitubercular Agents|antitubercular agents|mesh-ancestor
110497505|NCT00676221|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110497506|NCT00676221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110497507|NCT00676221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110497508|NCT00676221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110497509|NCT00800917|Sirolimus|sirolimus|mesh-list
110497510|NCT00800917|Bevacizumab|bevacizumab|mesh-list
110497511|NCT00800917|Temsirolimus|temsirolimus|mesh-list
110497512|NCT00800917|MTOR Inhibitors|mtor inhibitors|mesh-list
110497513|NCT00800917|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110497514|NCT00800917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110497515|NCT00800917|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110497516|NCT00800917|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110497517|NCT00800917|Growth Substances|growth substances|mesh-ancestor
110497518|NCT00800917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110497519|NCT00800917|Growth Inhibitors|growth inhibitors|mesh-ancestor
110497520|NCT00800917|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110497521|NCT00800917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110497522|NCT00800917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110497523|NCT00800917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110497524|NCT00800917|Immunologic Factors|immunologic factors|mesh-ancestor
110497525|NCT00800917|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110497526|NCT00800917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110497527|NCT00800917|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110497528|NCT00800917|Antifungal Agents|antifungal agents|mesh-ancestor
110497529|NCT05003102|Fentanyl|fentanyl|mesh-list
110497530|NCT05003102|Dexmedetomidine|dexmedetomidine|mesh-list
110497531|NCT05003102|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110497532|NCT05003102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110497533|NCT05003102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110497534|NCT05003102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110497535|NCT05003102|Analgesics|analgesics|mesh-ancestor
110497536|NCT05003102|Sensory System Agents|sensory system agents|mesh-ancestor
110497537|NCT05003102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110497538|NCT05003102|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110497539|NCT05003102|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110497540|NCT05003102|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110497541|NCT05003102|Adrenergic Agents|adrenergic agents|mesh-ancestor
110497542|NCT05003102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110497543|NCT05003102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110497544|NCT05003102|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110497546|NCT05003102|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110497547|NCT05003102|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110497548|NCT05003102|Anesthetics, General|anesthetics, general|mesh-ancestor
110497550|NCT00676377|Neostigmine|neostigmine|mesh-list
110497551|NCT00676377|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110497552|NCT00676377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110497553|NCT00676377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110497554|NCT00676377|Cholinergic Agents|cholinergic agents|mesh-ancestor
110497555|NCT00676377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110497556|NCT00676377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110497557|NCT00676377|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110497558|NCT00676377|Autonomic Agents|autonomic agents|mesh-ancestor
110497559|NCT00676377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110497561|NCT00676533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110497562|NCT00676533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110497563|NCT00676533|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110497564|NCT00676533|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110497565|NCT00676533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110497566|NCT00676533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110497567|NCT00676533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110497568|NCT00676533|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110497569|NCT00676533|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110497570|NCT00676845|Olmesartan|olmesartan|mesh-list
110497571|NCT00676845|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
110497572|NCT00676845|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110497573|NCT00676845|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110497574|NCT00676845|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110497575|NCT00676845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110497576|NCT04152057|Paclitaxel|paclitaxel|mesh-list
110497577|NCT04152057|Trastuzumab|trastuzumab|mesh-list
110253120|NCT00404456|Melatonin|melatonin|mesh-list
110497578|NCT04152057|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110497579|NCT04152057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110497580|NCT04152057|Tubulin Modulators|tubulin modulators|mesh-ancestor
110497581|NCT04152057|Antimitotic Agents|antimitotic agents|mesh-ancestor
110497582|NCT04152057|Mitosis Modulators|mitosis modulators|mesh-ancestor
110497583|NCT04152057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110497584|NCT04152057|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110497585|NCT00610142|Hydrocortisone|hydrocortisone|mesh-list
110497586|NCT00610142|Pimecrolimus|pimecrolimus|mesh-list
110497587|NCT00610142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110497588|NCT00610142|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110497589|NCT00610142|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110497590|NCT00610142|Analgesics|analgesics|mesh-ancestor
110497591|NCT00610142|Sensory System Agents|sensory system agents|mesh-ancestor
110497592|NCT00610142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110497593|NCT00610142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110497594|NCT00610142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110497595|NCT00610142|Dermatologic Agents|dermatologic agents|mesh-ancestor
110497596|NCT00610142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110497597|NCT00610142|Immunologic Factors|immunologic factors|mesh-ancestor
110497598|NCT00610142|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110497599|NCT00610142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110497600|NCT00610142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110497601|NCT04151823|Vitamin D|vitamin d|mesh-list
110497602|NCT04151823|Cholecalciferol|cholecalciferol|mesh-list
110497603|NCT04151823|Vitamins|vitamins|mesh-ancestor
110497604|NCT04151823|Micronutrients|micronutrients|mesh-ancestor
110497605|NCT04151823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110497606|NCT04151823|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110497607|NCT04151823|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110497608|NCT05199038|Octreotide|octreotide|mesh-list
110497609|NCT05199038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110497610|NCT05199038|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110497611|NCT05199038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110497612|NCT00660907|Metformin|metformin|mesh-list
110497613|NCT00660907|Dapagliflozin|dapagliflozin|mesh-list
110497614|NCT00660907|Glipizide|glipizide|mesh-list
110497615|NCT00660907|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110497616|NCT00660907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110497617|NCT00660907|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110497618|NCT00660907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110497619|NCT04992572|Lidocaine|lidocaine|mesh-list
110497620|NCT04992572|Propofol|propofol|mesh-list
110497621|NCT04992572|Anesthetics, Local|anesthetics, local|mesh-ancestor
110497622|NCT04992572|Anesthetics|anesthetics|mesh-ancestor
110497623|NCT04992572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110497624|NCT04992572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110497625|NCT04992572|Sensory System Agents|sensory system agents|mesh-ancestor
110497626|NCT04992572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110497627|NCT04992572|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110497628|NCT04992572|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110497629|NCT04992572|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110497630|NCT04992572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110497631|NCT04992572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110497632|NCT04992572|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110497633|NCT04992572|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110497634|NCT04992572|Anesthetics, General|anesthetics, general|mesh-ancestor
110497635|NCT05083052|Propolis|propolis|mesh-list
110497636|NCT05083052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110144923|NCT02044224|Dexmedetomidine|dexmedetomidine|mesh-list
110497638|NCT04031703|Docetaxel|docetaxel|mesh-list
110497639|NCT04031703|Cyclophosphamide|cyclophosphamide|mesh-list
110497640|NCT04031703|Carboplatin|carboplatin|mesh-list
110497641|NCT04031703|Fluorouracil|fluorouracil|mesh-list
110497642|NCT04031703|Epirubicin|epirubicin|mesh-list
110497643|NCT04031703|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110497644|NCT04031703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110497645|NCT04031703|Tubulin Modulators|tubulin modulators|mesh-ancestor
110497646|NCT04031703|Antimitotic Agents|antimitotic agents|mesh-ancestor
110497647|NCT04031703|Mitosis Modulators|mitosis modulators|mesh-ancestor
110497648|NCT04031703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110497649|NCT04031703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110497650|NCT04031703|Immunologic Factors|immunologic factors|mesh-ancestor
110497651|NCT04031703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110497652|NCT04031703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110497653|NCT04031703|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110497654|NCT04031703|Alkylating Agents|alkylating agents|mesh-ancestor
110497655|NCT04031703|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110497656|NCT04031703|Antimetabolites|antimetabolites|mesh-ancestor
110497657|NCT04031703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110497658|NCT04031703|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110497659|NCT04031703|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110497660|NCT04031703|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110497661|NCT04031703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110497662|NCT00795847|Losartan|losartan|mesh-list
110497663|NCT00795847|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110497664|NCT00795847|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110497665|NCT00795847|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110497666|NCT00795847|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110497667|NCT00795847|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110497668|NCT00795847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110497669|NCT00795847|Diuretics|diuretics|mesh-ancestor
110497670|NCT00795847|Natriuretic Agents|natriuretic agents|mesh-ancestor
110651627|NCT00933374|Mitosis Modulators|mitosis modulators|mesh-ancestor
110497671|NCT00795847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110497672|NCT00795847|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110497673|NCT00795847|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110497675|NCT00877773|Temsirolimus|temsirolimus|mesh-list
110497676|NCT00877773|MTOR Inhibitors|mtor inhibitors|mesh-list
110497677|NCT00877773|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110497678|NCT00877773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110497679|NCT00877773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110497680|NCT00877773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110497681|NCT00877773|Immunologic Factors|immunologic factors|mesh-ancestor
110497682|NCT00877773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110497683|NCT00877773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110497684|NCT00877773|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110497685|NCT00877773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110497686|NCT00877773|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110497687|NCT00877773|Antifungal Agents|antifungal agents|mesh-ancestor
110497688|NCT00659815|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110497689|NCT00994643|Aldesleukin|aldesleukin|mesh-list
110497691|NCT00994643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110497692|NCT00994643|Interleukin-2|interleukin-2|mesh-list
110497693|NCT00994643|Antibodies|antibodies|mesh-list
110497694|NCT00994643|Immunoglobulins|immunoglobulins|mesh-list
110497695|NCT00994643|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110497696|NCT00994643|Immunologic Factors|immunologic factors|mesh-ancestor
110497697|NCT00994643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110497698|NCT00994643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110497699|NCT00994643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110497700|NCT00994643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110497701|NCT00994643|Analgesics|analgesics|mesh-ancestor
110497702|NCT00994643|Sensory System Agents|sensory system agents|mesh-ancestor
110497703|NCT00994643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110497704|NCT00994643|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110497705|NCT00994643|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110497706|NCT00994643|Antiviral Agents|antiviral agents|mesh-ancestor
110497707|NCT00994643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110497708|NCT00912171|Budesonide|budesonide|mesh-list
110497709|NCT00912171|Montelukast|montelukast|mesh-list
110144998|NCT02044952|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110497710|NCT00912171|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110497711|NCT00912171|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110497712|NCT00912171|Autonomic Agents|autonomic agents|mesh-ancestor
110497713|NCT00912171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110497714|NCT00912171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110497715|NCT00912171|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110497716|NCT00912171|Respiratory System Agents|respiratory system agents|mesh-ancestor
110497717|NCT00912171|Glucocorticoids|glucocorticoids|mesh-ancestor
110497718|NCT00912171|Hormones|hormones|mesh-ancestor
110497719|NCT00912171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110497720|NCT00912171|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110497721|NCT00912171|Hormone Antagonists|hormone antagonists|mesh-ancestor
110497722|NCT00912171|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110497723|NCT00912171|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110497724|NCT00912171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110497725|NCT00677391|Sibutramine|sibutramine|mesh-list
110497726|NCT00677391|Antidepressive Agents|antidepressive agents|mesh-ancestor
110497727|NCT00677391|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110497728|NCT00677391|Appetite Depressants|appetite depressants|mesh-ancestor
110497729|NCT00677391|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110497730|NCT00629057|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
110497731|NCT00629057|Antiviral Agents|antiviral agents|mesh-ancestor
110497732|NCT00629057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110497733|NCT00660829|Azelastine|azelastine|mesh-list
110497734|NCT00660829|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110497735|NCT00660829|Autonomic Agents|autonomic agents|mesh-ancestor
110497736|NCT00660829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110497737|NCT00660829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110497738|NCT00660829|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110606168|NCT00393367|Prednisolone phosphate|prednisolone phosphate|mesh-list
110497739|NCT00660829|Respiratory System Agents|respiratory system agents|mesh-ancestor
110497740|NCT00660829|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
110168283|NCT00034801|Antiemetics|antiemetics|mesh-ancestor
110497742|NCT00660829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110497743|NCT00660829|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110497744|NCT00660829|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110497745|NCT00660829|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110497746|NCT00660829|Histamine Antagonists|histamine antagonists|mesh-ancestor
110497747|NCT00660829|Histamine Agents|histamine agents|mesh-ancestor
110497748|NCT00660829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110497749|NCT00677469|Cholestyramine Resin|cholestyramine resin|mesh-list
110497750|NCT00677469|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110497751|NCT00677469|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110497752|NCT00677469|Antimetabolites|antimetabolites|mesh-ancestor
110497753|NCT00677469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110497754|NCT00677469|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110497755|NCT00629135|Moxifloxacin|moxifloxacin|mesh-list
110497756|NCT00629135|Metronidazole|metronidazole|mesh-list
110497757|NCT00629135|Tazobactam|tazobactam|mesh-list
110497758|NCT00629135|Piperacillin|piperacillin|mesh-list
110497759|NCT00629135|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
110497760|NCT00629135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110497761|NCT00629135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110497762|NCT00629135|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110497763|NCT00629135|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110497764|NCT00629135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110497765|NCT00629135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110497766|NCT00629135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110497767|NCT00629135|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110497768|NCT00629135|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110497769|NCT00629135|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110497770|NCT00795925|Propiverine|propiverine|mesh-list
110497771|NCT00795925|Parasympatholytics|parasympatholytics|mesh-ancestor
110497772|NCT00795925|Autonomic Agents|autonomic agents|mesh-ancestor
110497773|NCT00795925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110497774|NCT00795925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110497775|NCT00795925|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110497776|NCT00795925|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110497777|NCT00795925|Cholinergic Agents|cholinergic agents|mesh-ancestor
110497778|NCT00795925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110497779|NCT00795925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110497780|NCT00795925|Urological Agents|urological agents|mesh-ancestor
110497781|NCT04293419|Durvalumab|durvalumab|mesh-list
110497782|NCT04293419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110497783|NCT04293419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110497784|NCT00793429|Prucalopride|prucalopride|mesh-list
110145100|NCT02045667|Mexiletine|mexiletine|mesh-list
110497785|NCT00793429|Laxatives|laxatives|mesh-ancestor
110497786|NCT00793429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110497787|NCT00793429|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
110497788|NCT00793429|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110497789|NCT00793429|Serotonin Agents|serotonin agents|mesh-ancestor
110497790|NCT00793429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110497791|NCT00793429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110497792|NCT00793429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110497793|NCT00801151|Vinorelbine|vinorelbine|mesh-list
110497794|NCT00801151|Vorinostat|vorinostat|mesh-list
110497795|NCT00801151|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110497796|NCT00801151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110497797|NCT00801151|Tubulin Modulators|tubulin modulators|mesh-ancestor
110497798|NCT00801151|Antimitotic Agents|antimitotic agents|mesh-ancestor
110497799|NCT00801151|Mitosis Modulators|mitosis modulators|mesh-ancestor
110497800|NCT00801151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110497801|NCT00801151|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110497802|NCT00801151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110497803|NCT00796081|Paliperidone Palmitate|paliperidone palmitate|mesh-list
110497804|NCT00796081|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110497805|NCT00796081|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110497806|NCT00796081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110168288|NCT00034801|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110497807|NCT00796081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110497808|NCT00796081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110497809|NCT00796081|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110497810|NCT00796081|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110497811|NCT00796081|Serotonin Agents|serotonin agents|mesh-ancestor
110497812|NCT00796081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110497813|NCT00796081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110497814|NCT00796081|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110497815|NCT00796081|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110497816|NCT00796081|Dopamine Agents|dopamine agents|mesh-ancestor
110497817|NCT00877383|Tiotropium Bromide|tiotropium bromide|mesh-list
110497818|NCT00877383|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110497819|NCT00877383|Autonomic Agents|autonomic agents|mesh-ancestor
110497820|NCT00877383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110497821|NCT00877383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110497822|NCT00877383|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110497823|NCT00877383|Respiratory System Agents|respiratory system agents|mesh-ancestor
110497824|NCT00877383|Parasympatholytics|parasympatholytics|mesh-ancestor
110497825|NCT00877383|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110497826|NCT00877383|Cholinergic Agents|cholinergic agents|mesh-ancestor
110497827|NCT00877383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110497828|NCT00877383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110497829|NCT00796159|Olmesartan|olmesartan|mesh-list
110497830|NCT00796159|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
110497831|NCT00796159|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110497832|NCT00796159|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110497833|NCT00796159|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110497834|NCT00796159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110497835|NCT00993473|Insulin|insulin|mesh-list
110497836|NCT00993473|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110497837|NCT00993473|Insulin Glargine|insulin glargine|mesh-list
110497838|NCT00993473|Insulin Lispro|insulin lispro|mesh-list
110497839|NCT00993473|Protamines|protamines|mesh-list
110497840|NCT00993473|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110497841|NCT00993473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110497842|NCT00993473|Heparin Antagonists|heparin antagonists|mesh-ancestor
110497843|NCT00993473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110497844|NCT00993473|Coagulants|coagulants|mesh-ancestor
110497845|NCT00660595|Risperidone|risperidone|mesh-list
110497846|NCT00660595|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110497847|NCT00660595|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110497848|NCT00660595|Serotonin Agents|serotonin agents|mesh-ancestor
110497849|NCT00660595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110497850|NCT00660595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110497851|NCT00660595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110497852|NCT00660595|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110497853|NCT00660595|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110497854|NCT00660595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110497855|NCT00660595|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110497856|NCT00660595|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110497857|NCT00660595|Dopamine Agents|dopamine agents|mesh-ancestor
110497858|NCT00660595|Antidepressive Agents|antidepressive agents|mesh-ancestor
110145146|NCT02045914|Calcium|calcium|mesh-list
110497859|NCT00929240|Bevacizumab|bevacizumab|mesh-list
110497860|NCT00929240|Capecitabine|capecitabine|mesh-list
110497861|NCT00929240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110497862|NCT00929240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110497863|NCT00929240|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110497864|NCT00929240|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110497865|NCT00929240|Growth Substances|growth substances|mesh-ancestor
110497866|NCT00929240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110497867|NCT00929240|Growth Inhibitors|growth inhibitors|mesh-ancestor
110497868|NCT00929240|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110497870|NCT00929240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110497871|NCT00793663|Dexamethasone|dexamethasone|mesh-list
110497872|NCT00793663|Dexamethasone acetate|dexamethasone acetate|mesh-list
110497873|NCT00793663|Ondansetron|ondansetron|mesh-list
110497874|NCT00793663|Sevoflurane|sevoflurane|mesh-list
110497875|NCT00793663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110497876|NCT00793663|Antiemetics|antiemetics|mesh-ancestor
110497877|NCT00793663|Autonomic Agents|autonomic agents|mesh-ancestor
110497878|NCT00793663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110497879|NCT00793663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110497880|NCT00793663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110497881|NCT00793663|Glucocorticoids|glucocorticoids|mesh-ancestor
110497882|NCT00793663|Hormones|hormones|mesh-ancestor
110497883|NCT00793663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110497884|NCT00793663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110497885|NCT00793663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110497886|NCT00793663|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110497887|NCT00793663|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110497888|NCT00793663|Anesthetics, General|anesthetics, general|mesh-ancestor
110497890|NCT00793663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110497891|NCT00793663|Antipruritics|antipruritics|mesh-ancestor
110497892|NCT00793663|Dermatologic Agents|dermatologic agents|mesh-ancestor
110497893|NCT00793663|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110497894|NCT00793663|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110497895|NCT00793663|Serotonin Agents|serotonin agents|mesh-ancestor
110497896|NCT00793663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110273554|NCT00169091|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110497897|NCT00793663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110497898|NCT02554045|Tadalafil|tadalafil|mesh-list
110497899|NCT02554045|Vasodilator Agents|vasodilator agents|mesh-ancestor
110497900|NCT02554045|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110497901|NCT02554045|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110497902|NCT02554045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110497903|NCT02554045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110497904|NCT02554045|Urological Agents|urological agents|mesh-ancestor
110497905|NCT05330390|Levetiracetam|levetiracetam|mesh-list
110497906|NCT05330390|Anticonvulsants|anticonvulsants|mesh-ancestor
110497907|NCT05330390|Nootropic Agents|nootropic agents|mesh-ancestor
110497908|NCT00993317|Certolizumab Pegol|certolizumab pegol|mesh-list
110497909|NCT00993317|Methotrexate|methotrexate|mesh-list
110497910|NCT00993317|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110497911|NCT00993317|Abortifacient Agents|abortifacient agents|mesh-ancestor
110497912|NCT00993317|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110497913|NCT00993317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110497914|NCT00993317|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110497915|NCT00993317|Antimetabolites|antimetabolites|mesh-ancestor
110497916|NCT00993317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110497917|NCT00993317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110497918|NCT00993317|Dermatologic Agents|dermatologic agents|mesh-ancestor
110497919|NCT00993317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110497920|NCT00993317|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110497921|NCT00993317|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110497922|NCT00993317|Immunologic Factors|immunologic factors|mesh-ancestor
110497923|NCT00993317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110497924|NCT00993317|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110497925|NCT00993317|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110497926|NCT00993317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110497927|NCT00801385|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110497928|NCT00801385|Sorafenib|sorafenib|mesh-list
110497929|NCT00801385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110497930|NCT00801385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110497931|NCT00801385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110497932|NCT00801385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110145236|NCT02046486|Ticagrelor|ticagrelor|mesh-list
110497933|NCT00677001|R 306465|r 306465|mesh-list
110497934|NCT00677001|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110497935|NCT00677001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110168307|NCT00034840|Valsartan|valsartan|mesh-list
110497936|NCT00677001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110497938|NCT00877071|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110497939|NCT00877071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110497940|NCT00877071|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110497941|NCT00877071|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110497942|NCT00877071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110497943|NCT00877071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110497944|NCT02868827|Vitamin D|vitamin d|mesh-list
110497945|NCT02868827|Cholecalciferol|cholecalciferol|mesh-list
110497946|NCT02868827|Vitamins|vitamins|mesh-ancestor
110497947|NCT02868827|Micronutrients|micronutrients|mesh-ancestor
110497948|NCT02868827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110497949|NCT02868827|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110497950|NCT02868827|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110497951|NCT00987389|Glucocorticoids|glucocorticoids|mesh-list
110497952|NCT00987389|Hormones|hormones|mesh-ancestor
110497953|NCT00987389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110497954|NCT00987389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110497955|NCT00929162|Paclitaxel|paclitaxel|mesh-list
110497956|NCT00929162|Carboplatin|carboplatin|mesh-list
110497957|NCT00929162|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110497958|NCT00929162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110497959|NCT00929162|Tubulin Modulators|tubulin modulators|mesh-ancestor
110497960|NCT00929162|Antimitotic Agents|antimitotic agents|mesh-ancestor
110497961|NCT00929162|Mitosis Modulators|mitosis modulators|mesh-ancestor
110497962|NCT00929162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110497963|NCT02627625|Tiotropium Bromide|tiotropium bromide|mesh-list
110497964|NCT02627625|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110497965|NCT02627625|Autonomic Agents|autonomic agents|mesh-ancestor
110497966|NCT02627625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110497967|NCT02627625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110497968|NCT02627625|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110497969|NCT02627625|Respiratory System Agents|respiratory system agents|mesh-ancestor
110497970|NCT02627625|Parasympatholytics|parasympatholytics|mesh-ancestor
110497971|NCT02627625|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110497972|NCT02627625|Cholinergic Agents|cholinergic agents|mesh-ancestor
110497973|NCT02627625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110497974|NCT02627625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110497975|NCT00678483|Rimonabant|rimonabant|mesh-list
110497976|NCT00678483|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110497977|NCT00678483|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
110497978|NCT00678483|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110497979|NCT00678483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110497980|NCT00678483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110497981|NCT00678483|Hormones|hormones|mesh-ancestor
110497982|NCT00678483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110497983|NCT00678483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110497984|NCT00610454|Levetiracetam|levetiracetam|mesh-list
110497985|NCT00610454|Anticonvulsants|anticonvulsants|mesh-ancestor
110497986|NCT00610454|Nootropic Agents|nootropic agents|mesh-ancestor
110497987|NCT04151355|Atorvastatin|atorvastatin|mesh-list
110497988|NCT04151355|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110497989|NCT04151355|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110497990|NCT04151355|Antimetabolites|antimetabolites|mesh-ancestor
110497991|NCT04151355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110497992|NCT04151355|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110311764|NCT00324129|Mocetinostat|mocetinostat|mesh-list
110497993|NCT04151355|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110497994|NCT04151355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110497995|NCT00609284|Carboplatin|carboplatin|mesh-list
110497996|NCT00609284|Cetuximab|cetuximab|mesh-list
110497997|NCT00609284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110497998|NCT00609284|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110497999|NCT00992459|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
110498000|NCT00992459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110498001|NCT00930722|Quinapril|quinapril|mesh-list
110498002|NCT00930722|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110498003|NCT00930722|Protease Inhibitors|protease inhibitors|mesh-ancestor
110498004|NCT00930722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110498005|NCT00930722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110498006|NCT00930722|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110606645|NCT01046539|Analgesics|analgesics|mesh-ancestor
110498008|NCT00610610|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110498009|NCT00610610|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110498010|NCT00610610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110498011|NCT00610610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110498012|NCT00610610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110498013|NCT00610610|Serotonin Agents|serotonin agents|mesh-ancestor
110498014|NCT00610610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110498015|NCT00610610|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110498016|NCT00610610|Antidepressive Agents|antidepressive agents|mesh-ancestor
110498017|NCT00610610|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110498018|NCT00610610|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110498019|NCT00610610|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110273603|NCT00169208|Analgesics|analgesics|mesh-ancestor
110498020|NCT00610610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110498021|NCT00912327|Cetuximab|cetuximab|mesh-list
110498022|NCT00912327|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110498023|NCT00912327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110498024|NCT04257812|Tazobactam|tazobactam|mesh-list
110498025|NCT04257812|Ceftolozane|ceftolozane|mesh-list
110498026|NCT04257812|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
110498027|NCT04257812|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110498028|NCT04257812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110498029|NCT04257812|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110498030|NCT04257812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110498031|NCT04257812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110498032|NCT04257812|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110498033|NCT02868749|Hyaluronic Acid|hyaluronic acid|mesh-list
110498034|NCT02868749|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110498035|NCT02868749|Immunologic Factors|immunologic factors|mesh-ancestor
110498036|NCT02868749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110498037|NCT02868749|Viscosupplements|viscosupplements|mesh-ancestor
110498039|NCT00659581|Telmisartan|telmisartan|mesh-list
110498040|NCT00659581|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110498041|NCT00659581|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110498042|NCT00659581|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110498043|NCT00659581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110498044|NCT00793741|Somatostatin|somatostatin|mesh-list
110498045|NCT00793741|Hormones|hormones|mesh-ancestor
110498046|NCT00793741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110498047|NCT00793741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110498048|NCT00796471|Paliperidone Palmitate|paliperidone palmitate|mesh-list
110498049|NCT00796471|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110498050|NCT00796471|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110498051|NCT00796471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110498052|NCT00796471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110498053|NCT00796471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110498054|NCT00796471|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110498055|NCT00796471|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110498056|NCT00796471|Serotonin Agents|serotonin agents|mesh-ancestor
110498057|NCT00796471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110498058|NCT00796471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110498059|NCT00796471|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110498060|NCT00796471|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110498061|NCT00796471|Dopamine Agents|dopamine agents|mesh-ancestor
110498062|NCT00991289|Interferons|interferons|mesh-list
110498063|NCT00991289|Ribavirin|ribavirin|mesh-list
110498064|NCT00991289|Interferon-alpha|interferon-alpha|mesh-list
110498065|NCT00991289|Interferon alpha-2|interferon alpha-2|mesh-list
110498066|NCT00991289|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110498067|NCT00991289|Nitazoxanide|nitazoxanide|mesh-list
110498068|NCT00991289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110498069|NCT00991289|Antiviral Agents|antiviral agents|mesh-ancestor
110498070|NCT00991289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110498071|NCT00991289|Antimetabolites|antimetabolites|mesh-ancestor
110498072|NCT00991289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110498073|NCT00991289|Immunologic Factors|immunologic factors|mesh-ancestor
110498074|NCT00991289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110498075|NCT00991289|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110498078|NCT04046029|Anticoagulants|anticoagulants|mesh-ancestor
110498079|NCT04046029|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110145364|NCT02047006|Rivaroxaban|rivaroxaban|mesh-list
110498080|NCT04046029|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110498081|NCT04046029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110498083|NCT04046029|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110498084|NCT04046029|Protease Inhibitors|protease inhibitors|mesh-ancestor
110498085|NCT04046029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110498086|NCT00679653|Sibutramine|sibutramine|mesh-list
110498087|NCT00679653|Metoprolol|metoprolol|mesh-list
110498088|NCT00679653|Verapamil|verapamil|mesh-list
110498089|NCT00679653|Felodipine|felodipine|mesh-list
110498090|NCT00679653|Ramipril|ramipril|mesh-list
110498091|NCT00679653|Trandolapril|trandolapril|mesh-list
110498092|NCT00679653|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110498093|NCT00679653|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110498094|NCT00679653|Sympatholytics|sympatholytics|mesh-ancestor
110498095|NCT00679653|Autonomic Agents|autonomic agents|mesh-ancestor
110498096|NCT00679653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110498097|NCT00679653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110498098|NCT00679653|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110498099|NCT00679653|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110498100|NCT00679653|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110498101|NCT00679653|Adrenergic Agents|adrenergic agents|mesh-ancestor
110498102|NCT00679653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110498103|NCT00679653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110498104|NCT00679653|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110498105|NCT00679653|Protease Inhibitors|protease inhibitors|mesh-ancestor
110498106|NCT00679653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110498107|NCT00679653|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110498108|NCT00679653|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110498109|NCT00679653|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110498110|NCT00679653|Vasodilator Agents|vasodilator agents|mesh-ancestor
110606844|NCT00574275|Gemcitabine|gemcitabine|mesh-list
110498112|NCT00679653|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110498113|NCT00679653|Appetite Depressants|appetite depressants|mesh-ancestor
110498114|NCT00679653|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110498115|NCT00793897|Paclitaxel|paclitaxel|mesh-list
110498116|NCT00793897|Carboplatin|carboplatin|mesh-list
110498117|NCT00793897|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110498118|NCT00793897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110498119|NCT00793897|Tubulin Modulators|tubulin modulators|mesh-ancestor
110498120|NCT00793897|Antimitotic Agents|antimitotic agents|mesh-ancestor
110498121|NCT00793897|Mitosis Modulators|mitosis modulators|mesh-ancestor
110498122|NCT00793897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110498123|NCT00793975|Ramucirumab|ramucirumab|mesh-list
110498124|NCT00793975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110498125|NCT00679965|Tavaborole|tavaborole|mesh-list
110498126|NCT00679965|Antifungal Agents|antifungal agents|mesh-ancestor
110498127|NCT00679965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110498128|NCT00930644|Teduglutide|teduglutide|mesh-list
110498129|NCT00930644|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110498130|NCT00930644|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110498131|NCT00930644|Protective Agents|protective agents|mesh-ancestor
110498132|NCT00930644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110498133|NCT02627469|Listerine|listerine|mesh-list
110498134|NCT02627469|Fluorides|fluorides|mesh-list
110498135|NCT02627469|Sodium Fluoride|sodium fluoride|mesh-list
110498136|NCT02627469|Cariostatic Agents|cariostatic agents|mesh-ancestor
110498137|NCT02627469|Protective Agents|protective agents|mesh-ancestor
110498138|NCT02627469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110498139|NCT02627469|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110498140|NCT02627469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110498141|NCT00680277|Carotenoids|carotenoids|mesh-list
110498142|NCT00680277|Antioxidants|antioxidants|mesh-ancestor
110498143|NCT00680277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110498144|NCT00680277|Protective Agents|protective agents|mesh-ancestor
110168320|NCT00000689|Vincristine|vincristine|mesh-list
110498145|NCT00680277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110498146|NCT00680355|Carotenoids|carotenoids|mesh-list
110498147|NCT00680355|Antioxidants|antioxidants|mesh-ancestor
110498148|NCT00680355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110498149|NCT00680355|Protective Agents|protective agents|mesh-ancestor
110498150|NCT00680355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110498151|NCT00801697|Vaccines|vaccines|mesh-list
110498152|NCT00801697|Immunologic Factors|immunologic factors|mesh-ancestor
110498153|NCT00801697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110498154|NCT00684489|Antihypertensive Agents|antihypertensive agents|mesh-list
110498155|NCT00684489|Coal Tar|coal tar|mesh-list
110498156|NCT00684489|Keratolytic Agents|keratolytic agents|mesh-ancestor
110498157|NCT00684489|Dermatologic Agents|dermatologic agents|mesh-ancestor
110498159|NCT00990821|Aprepitant|aprepitant|mesh-list
110498160|NCT00990821|Fosaprepitant|fosaprepitant|mesh-list
110498161|NCT00990821|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110498162|NCT00990821|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110498163|NCT00990821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110498164|NCT00990821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110498165|NCT00990821|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110498166|NCT00990821|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110498167|NCT00990821|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110498168|NCT00990821|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110498169|NCT00990821|Anesthetics, General|anesthetics, general|mesh-ancestor
110498170|NCT00990821|Anesthetics|anesthetics|mesh-ancestor
110498171|NCT00990821|GABA Modulators|gaba modulators|mesh-ancestor
110498172|NCT00990821|GABA Agents|gaba agents|mesh-ancestor
110498173|NCT00990821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110498174|NCT00990821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110498175|NCT00990821|Antiemetics|antiemetics|mesh-ancestor
110498176|NCT00990821|Autonomic Agents|autonomic agents|mesh-ancestor
110498177|NCT00990821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110606942|NCT00829257|Hormones|hormones|mesh-ancestor
110498178|NCT00990821|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110498179|NCT00990821|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110498180|NCT00801853|Interleukin-4|interleukin-4|mesh-list
110498181|NCT00801853|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110498182|NCT00801853|Immunologic Factors|immunologic factors|mesh-ancestor
110498183|NCT00801853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110498184|NCT00801853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110498185|NCT00801853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110498186|NCT00990665|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
110498187|NCT00990665|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110498188|NCT00990665|Contraceptive Agents|contraceptive agents|mesh-ancestor
110498189|NCT00990665|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110498190|NCT00990665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110498191|NCT00990665|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110498192|NCT00990665|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110498193|NCT00990665|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110498194|NCT00658567|Pimavanserin|pimavanserin|mesh-list
110498195|NCT00658567|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110498196|NCT00658567|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110498197|NCT00658567|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110498198|NCT00658567|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110498199|NCT00658567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110498200|NCT00658567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110498201|NCT00658567|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110498202|NCT00658567|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110498203|NCT00658567|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110498204|NCT00658567|Serotonin Agents|serotonin agents|mesh-ancestor
110498205|NCT00658567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110498206|NCT00658567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110498207|NCT00875433|Afatinib|afatinib|mesh-list
110498208|NCT00875433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110498209|NCT00875433|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110498210|NCT00875433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110606977|NCT00840489|Antimitotic Agents|antimitotic agents|mesh-ancestor
110498211|NCT00875433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110498212|NCT00684957|Hormones|hormones|mesh-list
110273744|NCT00408252|Growth Inhibitors|growth inhibitors|mesh-ancestor
110498213|NCT00684957|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110498214|NCT00684957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110498215|NCT00685191|Raltegravir Potassium|raltegravir potassium|mesh-list
110498216|NCT00685191|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
110498218|NCT00685191|Antiviral Agents|antiviral agents|mesh-ancestor
110168326|NCT00000689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110498219|NCT00685191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110498220|NCT00685191|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110498222|NCT00685191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110498223|NCT00685191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110498224|NCT00685269|Eszopiclone|eszopiclone|mesh-list
110498225|NCT00685269|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110498226|NCT00685269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110498227|NCT00685269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110498228|NCT00794209|Fentanyl|fentanyl|mesh-list
110273784|NCT04681027|Analgesics|analgesics|mesh-ancestor
110498229|NCT00794209|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110145515|NCT00005841|Freund's Adjuvant|freund's adjuvant|mesh-list
110498230|NCT00794209|Narcotics|narcotics|mesh-ancestor
110498231|NCT00794209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110498232|NCT00794209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110498233|NCT00794209|Analgesics|analgesics|mesh-ancestor
110498234|NCT00794209|Sensory System Agents|sensory system agents|mesh-ancestor
110498235|NCT00794209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110498236|NCT00794209|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110498237|NCT00794209|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110498238|NCT00794209|Anesthetics, General|anesthetics, general|mesh-ancestor
110498239|NCT00794209|Anesthetics|anesthetics|mesh-ancestor
110498241|NCT00985985|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110498242|NCT00985985|Autonomic Agents|autonomic agents|mesh-ancestor
110498243|NCT00985985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110498244|NCT00985985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110498245|NCT00985985|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110498246|NCT00985985|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110498247|NCT00985985|Cholinergic Agents|cholinergic agents|mesh-ancestor
110498248|NCT00985985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110498249|NCT00985985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110498251|NCT00685347|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110498252|NCT00685347|Autonomic Agents|autonomic agents|mesh-ancestor
110498253|NCT00685347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110498254|NCT00685347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110498256|NCT00685347|Respiratory System Agents|respiratory system agents|mesh-ancestor
110498257|NCT00685347|Tocolytic Agents|tocolytic agents|mesh-ancestor
110498258|NCT00685347|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110498259|NCT00685347|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110498260|NCT00685347|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110498261|NCT00685347|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110498262|NCT00685347|Adrenergic Agents|adrenergic agents|mesh-ancestor
110498263|NCT00685347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110498264|NCT00685347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110498265|NCT00685425|Albuterol|albuterol|mesh-list
110498266|NCT00685425|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110498267|NCT00685425|Autonomic Agents|autonomic agents|mesh-ancestor
110498268|NCT00685425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110498269|NCT00685425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110498270|NCT00685425|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110498271|NCT00685425|Respiratory System Agents|respiratory system agents|mesh-ancestor
110498272|NCT00685425|Tocolytic Agents|tocolytic agents|mesh-ancestor
110498273|NCT00685425|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110498274|NCT00685425|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110498275|NCT00685425|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110498276|NCT00685425|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110498277|NCT00685425|Adrenergic Agents|adrenergic agents|mesh-ancestor
110498278|NCT00685425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110607130|NCT00830349|Risperidone|risperidone|mesh-list
110498279|NCT00685425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110498280|NCT04290455|Castor Oil|castor oil|mesh-list
110498281|NCT04290455|Cathartics|cathartics|mesh-ancestor
110498282|NCT04290455|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110498283|NCT00685503|Ranibizumab|ranibizumab|mesh-list
110498284|NCT00685503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110498285|NCT00685503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110498286|NCT00685503|Growth Substances|growth substances|mesh-ancestor
110498287|NCT00685503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110498288|NCT00685503|Growth Inhibitors|growth inhibitors|mesh-ancestor
110498289|NCT00685503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110498290|NCT00802009|Dexamethasone|dexamethasone|mesh-list
110498291|NCT00802009|Mepivacaine|mepivacaine|mesh-list
110404244|NCT03868124|Travoprost|travoprost|mesh-list
110498292|NCT00802009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110498293|NCT00802009|Antiemetics|antiemetics|mesh-ancestor
110498294|NCT00802009|Autonomic Agents|autonomic agents|mesh-ancestor
110498295|NCT00802009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110498296|NCT00802009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110498297|NCT00802009|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110498298|NCT00802009|Glucocorticoids|glucocorticoids|mesh-ancestor
110498299|NCT00802009|Hormones|hormones|mesh-ancestor
110498300|NCT00802009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110498301|NCT00802009|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110498302|NCT00802009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110498303|NCT00802009|Anesthetics, Local|anesthetics, local|mesh-ancestor
110498304|NCT00802009|Anesthetics|anesthetics|mesh-ancestor
110498305|NCT00802009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110498307|NCT02868437|Hyaluronic Acid|hyaluronic acid|mesh-list
110498308|NCT02868437|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110498309|NCT02868437|Immunologic Factors|immunologic factors|mesh-ancestor
110498310|NCT02868437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110498311|NCT02868437|Viscosupplements|viscosupplements|mesh-ancestor
110498312|NCT02868437|Protective Agents|protective agents|mesh-ancestor
110498313|NCT00802087|Acetaminophen|acetaminophen|mesh-list
110498314|NCT00802087|Hydrocodone|hydrocodone|mesh-list
110498315|NCT00802087|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110498316|NCT00802087|Analgesics|analgesics|mesh-ancestor
110498317|NCT00802087|Sensory System Agents|sensory system agents|mesh-ancestor
110498318|NCT00802087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110498319|NCT00802087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110498320|NCT00802087|Antipyretics|antipyretics|mesh-ancestor
110498321|NCT00802087|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110498322|NCT00802087|Narcotics|narcotics|mesh-ancestor
110498323|NCT00802087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110498324|NCT00802087|Antitussive Agents|antitussive agents|mesh-ancestor
110498325|NCT00802087|Respiratory System Agents|respiratory system agents|mesh-ancestor
110498326|NCT00923936|Bevacizumab|bevacizumab|mesh-list
110498327|NCT00923936|Doxorubicin|doxorubicin|mesh-list
110498328|NCT00923936|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110498329|NCT00923936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110498330|NCT00923936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110498331|NCT00923936|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110498332|NCT00923936|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110498333|NCT00923936|Growth Substances|growth substances|mesh-ancestor
110498334|NCT00923936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110498335|NCT00923936|Growth Inhibitors|growth inhibitors|mesh-ancestor
110607223|NCT00938236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110498336|NCT00923936|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110498337|NCT00923936|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110498338|NCT00923936|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110498339|NCT00923936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110498340|NCT00923936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110498341|NCT00797017|Fentanyl|fentanyl|mesh-list
110498342|NCT00797017|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110498343|NCT00797017|Narcotics|narcotics|mesh-ancestor
110498344|NCT00797017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110498345|NCT00797017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110498346|NCT00797017|Analgesics|analgesics|mesh-ancestor
110498347|NCT00797017|Sensory System Agents|sensory system agents|mesh-ancestor
110498348|NCT00797017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110498349|NCT00797017|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110498350|NCT00797017|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110498351|NCT00797017|Anesthetics, General|anesthetics, general|mesh-ancestor
110498352|NCT00797017|Anesthetics|anesthetics|mesh-ancestor
110498353|NCT05330000|Voriconazole|voriconazole|mesh-list
110498354|NCT05330000|Antifungal Agents|antifungal agents|mesh-ancestor
110498355|NCT05330000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110498356|NCT05330000|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110607268|NCT00936520|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110498357|NCT05330000|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110498358|NCT05330000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110498359|NCT05330000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110498360|NCT05330000|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110498361|NCT05330000|Hormone Antagonists|hormone antagonists|mesh-ancestor
110498362|NCT05330000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110498363|NCT05330000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110498364|NCT05330000|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110498366|NCT00794443|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110498367|NCT00794443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110498370|NCT00924950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110498371|NCT00924950|Glucocorticoids|glucocorticoids|mesh-ancestor
110498372|NCT00924950|Hormones|hormones|mesh-ancestor
110498373|NCT00924950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110498374|NCT00924950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110498375|NCT00924950|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110498376|NCT00924950|Respiratory System Agents|respiratory system agents|mesh-ancestor
110498377|NCT00924950|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110498378|NCT00924950|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
110498379|NCT00924950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110498380|NCT00924950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110498381|NCT00924950|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110498383|NCT00924950|Micronutrients|micronutrients|mesh-ancestor
110498384|NCT00924950|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110498385|NCT02626065|Nivolumab|nivolumab|mesh-list
110498386|NCT02626065|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110498387|NCT02626065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110498388|NCT02626065|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110607320|NCT00841581|Ranibizumab|ranibizumab|mesh-list
110498389|NCT02626065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110498390|NCT00794755|Vitamin K|vitamin k|mesh-list
110498391|NCT00794755|Vitamin K 1|vitamin k 1|mesh-list
110498392|NCT00794755|Vitamins|vitamins|mesh-ancestor
110498393|NCT00794755|Micronutrients|micronutrients|mesh-ancestor
110498394|NCT00794755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110498395|NCT00794755|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110498396|NCT00794755|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110498397|NCT00794755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110498398|NCT00794755|Hemostatics|hemostatics|mesh-ancestor
110498399|NCT00794755|Coagulants|coagulants|mesh-ancestor
110498400|NCT00685971|Cholecalciferol|cholecalciferol|mesh-list
110498401|NCT00685971|Vitamin D|vitamin d|mesh-list
110498402|NCT00685971|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110498403|NCT00685971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110498404|NCT00685971|Vitamins|vitamins|mesh-ancestor
110498405|NCT00685971|Micronutrients|micronutrients|mesh-ancestor
110498406|NCT00685971|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110498408|NCT00802243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110498409|NCT00802243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110498410|NCT00802243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110498411|NCT00802243|Immunologic Factors|immunologic factors|mesh-ancestor
110498412|NCT00802243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110498413|NCT00988637|Calcitriol|calcitriol|mesh-list
110498414|NCT00988637|Clobetasol|clobetasol|mesh-list
110498415|NCT00988637|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110498416|NCT00988637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110498417|NCT00988637|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
110498418|NCT00988637|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110498419|NCT00988637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110498420|NCT00988637|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110498421|NCT00988637|Vitamins|vitamins|mesh-ancestor
110498422|NCT00988637|Micronutrients|micronutrients|mesh-ancestor
110498423|NCT00988637|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110498424|NCT00988637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110498425|NCT00988637|Glucocorticoids|glucocorticoids|mesh-ancestor
110498426|NCT00988637|Hormones|hormones|mesh-ancestor
110498427|NCT00988637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110498428|NCT00802321|Dutasteride|dutasteride|mesh-list
110498429|NCT00802321|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
110498430|NCT00802321|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110498431|NCT00802321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110498432|NCT00802321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110498433|NCT00802321|Hormone Antagonists|hormone antagonists|mesh-ancestor
110498434|NCT00802321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110498435|NCT00802321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110498436|NCT00686361|Choline|choline|mesh-list
110498437|NCT00686361|Lipotropic Agents|lipotropic agents|mesh-ancestor
110498438|NCT00686361|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110498439|NCT00686361|Antimetabolites|antimetabolites|mesh-ancestor
110498440|NCT00686361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110498441|NCT00686361|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110498442|NCT00686361|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110498443|NCT00686361|Nootropic Agents|nootropic agents|mesh-ancestor
110498444|NCT00686439|Adalimumab|adalimumab|mesh-list
110498445|NCT00686439|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110498446|NCT00686439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110498447|NCT00686439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110498448|NCT00797485|Leucovorin|leucovorin|mesh-list
110498449|NCT00797485|Bevacizumab|bevacizumab|mesh-list
110498450|NCT00797485|Fluorouracil|fluorouracil|mesh-list
110498451|NCT00797485|Capecitabine|capecitabine|mesh-list
110498452|NCT00797485|Irinotecan|irinotecan|mesh-list
110498454|NCT00797485|Levoleucovorin|levoleucovorin|mesh-list
110498455|NCT00797485|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110498456|NCT00797485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110498457|NCT00797485|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110498458|NCT00797485|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110498459|NCT00797485|Growth Substances|growth substances|mesh-ancestor
110607457|NCT00835965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110498460|NCT00797485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110498461|NCT00797485|Growth Inhibitors|growth inhibitors|mesh-ancestor
110498462|NCT00797485|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110498464|NCT00797485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110498465|NCT00797485|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110498466|NCT00797485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110498467|NCT00797485|Immunologic Factors|immunologic factors|mesh-ancestor
110498468|NCT00797485|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110498469|NCT00797485|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110498470|NCT00797485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110498471|NCT00797485|Antidotes|antidotes|mesh-ancestor
110498472|NCT00797485|Protective Agents|protective agents|mesh-ancestor
110498473|NCT00797485|Vitamin B Complex|vitamin b complex|mesh-ancestor
110498474|NCT00797485|Vitamins|vitamins|mesh-ancestor
110498475|NCT00797485|Micronutrients|micronutrients|mesh-ancestor
110498476|NCT00686985|Carboplatin|carboplatin|mesh-list
110498477|NCT00686985|Docetaxel|docetaxel|mesh-list
110498478|NCT00686985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110498479|NCT00686985|Tubulin Modulators|tubulin modulators|mesh-ancestor
110498480|NCT00686985|Antimitotic Agents|antimitotic agents|mesh-ancestor
110498481|NCT00686985|Mitosis Modulators|mitosis modulators|mesh-ancestor
110498482|NCT00686985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110498483|NCT00687063|Insulin Detemir|insulin detemir|mesh-list
110498484|NCT00687063|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110498485|NCT00687063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110498486|NCT02866955|Tamoxifen|tamoxifen|mesh-list
110498487|NCT02866955|Estramustine|estramustine|mesh-list
110498488|NCT02866955|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110498489|NCT02866955|Hormone Antagonists|hormone antagonists|mesh-ancestor
110498490|NCT02866955|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110498491|NCT02866955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110498492|NCT02866955|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110498493|NCT02866955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110498494|NCT02866955|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110498495|NCT02866955|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110498496|NCT02866955|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110498497|NCT02866955|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110498498|NCT02866955|Alkylating Agents|alkylating agents|mesh-ancestor
110498499|NCT02866955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110498500|NCT02625753|Acetaminophen|acetaminophen|mesh-list
110498501|NCT02625753|Codeine|codeine|mesh-list
110607502|NCT05664542|Dexmedetomidine|dexmedetomidine|mesh-list
110168404|NCT00000710|Antiviral Agents|antiviral agents|mesh-ancestor
110498503|NCT02625753|Analgesics|analgesics|mesh-ancestor
110498504|NCT02625753|Sensory System Agents|sensory system agents|mesh-ancestor
110498505|NCT02625753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110498506|NCT02625753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110498507|NCT02625753|Antipyretics|antipyretics|mesh-ancestor
110498508|NCT02625753|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110498509|NCT02625753|Narcotics|narcotics|mesh-ancestor
110498510|NCT02625753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110498511|NCT02625753|Antitussive Agents|antitussive agents|mesh-ancestor
110498512|NCT02625753|Respiratory System Agents|respiratory system agents|mesh-ancestor
110498513|NCT04257656|Remdesivir|remdesivir|mesh-list
110498514|NCT04257656|Antimetabolites|antimetabolites|mesh-ancestor
110498515|NCT04257656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110498516|NCT04257656|Antiviral Agents|antiviral agents|mesh-ancestor
110498517|NCT04257656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110498518|NCT05329844|Vildagliptin|vildagliptin|mesh-list
110498519|NCT05329844|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110498520|NCT05329844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110498521|NCT05329844|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110498522|NCT05329844|Protease Inhibitors|protease inhibitors|mesh-ancestor
110498523|NCT05329844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110498524|NCT05329844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110498526|NCT00687999|Ribavirin|ribavirin|mesh-list
110498527|NCT00687999|Interferon-alpha|interferon-alpha|mesh-list
110498528|NCT00687999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110498529|NCT00687999|Antiviral Agents|antiviral agents|mesh-ancestor
110498530|NCT00687999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110498531|NCT00687999|Antimetabolites|antimetabolites|mesh-ancestor
110498532|NCT00687999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110498534|NCT00687999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110498535|NCT00688077|Calcitonin|calcitonin|mesh-list
110273992|NCT02895061|Vitamins|vitamins|mesh-ancestor
110498536|NCT00688077|Salmon calcitonin|salmon calcitonin|mesh-list
110498537|NCT00688077|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
110498538|NCT00688077|Katacalcin|katacalcin|mesh-list
110498539|NCT00688077|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110498540|NCT00688077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110498541|NCT00688077|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110498542|NCT00688077|Vasodilator Agents|vasodilator agents|mesh-ancestor
110498543|NCT00923156|Ramipril|ramipril|mesh-list
110498544|NCT00923156|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110498545|NCT00923156|Protease Inhibitors|protease inhibitors|mesh-ancestor
110498546|NCT00923156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110498547|NCT00923156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110498548|NCT00923156|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110498549|NCT00688857|Diazoxide|diazoxide|mesh-list
110498550|NCT00688857|Choline|choline|mesh-list
110498551|NCT00688857|Lipotropic Agents|lipotropic agents|mesh-ancestor
110498552|NCT00688857|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110498553|NCT00688857|Antimetabolites|antimetabolites|mesh-ancestor
110498554|NCT00688857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110498555|NCT00688857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110498556|NCT00688857|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110498557|NCT00688857|Nootropic Agents|nootropic agents|mesh-ancestor
110498558|NCT00688857|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110498559|NCT00688857|Vasodilator Agents|vasodilator agents|mesh-ancestor
110498560|NCT04256798|Chlorhexidine|chlorhexidine|mesh-list
110498561|NCT04256798|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110498562|NCT04256798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110498563|NCT04256798|Disinfectants|disinfectants|mesh-ancestor
110498564|NCT00687843|polysaccharide-K|polysaccharide-k|mesh-list
110498565|NCT00687843|Tegafur|tegafur|mesh-list
110274008|NCT02895022|Lidocaine|lidocaine|mesh-list
110498566|NCT00687843|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110498567|NCT00687843|Antimetabolites|antimetabolites|mesh-ancestor
110498568|NCT00687843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110498569|NCT00687843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110498570|NCT00687843|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110498571|NCT00687843|Immunologic Factors|immunologic factors|mesh-ancestor
110498572|NCT00687843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110498573|NCT00687843|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110498575|NCT00687843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110498576|NCT00687843|Interferon Inducers|interferon inducers|mesh-ancestor
110498577|NCT00687843|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110498578|NCT00687843|Protective Agents|protective agents|mesh-ancestor
110498579|NCT00689169|Cytarabine|cytarabine|mesh-list
110498580|NCT00689169|Rituximab|rituximab|mesh-list
110498581|NCT00689169|Etoposide|etoposide|mesh-list
110498582|NCT00689169|Melphalan|melphalan|mesh-list
110498583|NCT00689169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110498584|NCT00689169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110498585|NCT00689169|Immunologic Factors|immunologic factors|mesh-ancestor
110498586|NCT00689169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110498587|NCT00689169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110498588|NCT00689169|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110498589|NCT00689169|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110498590|NCT00689169|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110498591|NCT00689169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110498592|NCT00689169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110498593|NCT00689169|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110498594|NCT00689169|Alkylating Agents|alkylating agents|mesh-ancestor
110498595|NCT00689169|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110498596|NCT00689169|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110498597|NCT00689169|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110498598|NCT00689169|Antimetabolites|antimetabolites|mesh-ancestor
110498599|NCT00689169|Antiviral Agents|antiviral agents|mesh-ancestor
110498600|NCT00689169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110498601|NCT04203914|Empagliflozin|empagliflozin|mesh-list
110607680|NCT00845559|Exenatide|exenatide|mesh-list
110498602|NCT04203914|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110498603|NCT04203914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110498604|NCT04203914|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110498605|NCT04203914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110498606|NCT00874731|Sirolimus|sirolimus|mesh-list
110498607|NCT00874731|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110498608|NCT00874731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110498609|NCT00874731|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110498610|NCT00874731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110498611|NCT00874731|Antifungal Agents|antifungal agents|mesh-ancestor
110498612|NCT00874731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110498613|NCT00874731|Immunologic Factors|immunologic factors|mesh-ancestor
110498614|NCT00874731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110498616|NCT02625519|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
110498617|NCT02625519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110498618|NCT02625519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110498619|NCT00912483|Heparin|heparin|mesh-list
110498620|NCT00912483|Calcium heparin|calcium heparin|mesh-list
110498621|NCT00912483|Anticoagulants|anticoagulants|mesh-ancestor
110498622|NCT00912483|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110498623|NCT00912483|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110498624|NCT00912483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110498625|NCT04257032|Dabigatran|dabigatran|mesh-list
110498626|NCT04257032|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110498627|NCT04257032|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110498628|NCT04257032|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110274162|NCT00170690|Treosulfan|treosulfan|mesh-list
110498629|NCT04257032|Antimetabolites|antimetabolites|mesh-ancestor
110498630|NCT04257032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110498631|NCT04257032|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110498632|NCT04257032|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110498633|NCT04257032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110498634|NCT04257032|Antithrombins|antithrombins|mesh-ancestor
110498635|NCT04257032|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110607741|NCT02566226|Morphine|morphine|mesh-list
110498636|NCT04257032|Protease Inhibitors|protease inhibitors|mesh-ancestor
110498637|NCT04257032|Anticoagulants|anticoagulants|mesh-ancestor
110498638|NCT00924560|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110498639|NCT00924560|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110498640|NCT00924560|Levonorgestrel|levonorgestrel|mesh-list
110498641|NCT00924560|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110498642|NCT00924560|Contraceptive Agents|contraceptive agents|mesh-list
110498643|NCT00924560|Contraceptives, Oral|contraceptives, oral|mesh-list
110498644|NCT00924560|Estradiol|estradiol|mesh-list
110498645|NCT00924560|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110498646|NCT00924560|Estrogens|estrogens|mesh-ancestor
110498647|NCT00924560|Hormones|hormones|mesh-ancestor
110498648|NCT00924560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110498649|NCT00924560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110498650|NCT00924560|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110498651|NCT00924560|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110498652|NCT00924560|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110498653|NCT00924560|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110498654|NCT00924560|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110498655|NCT00689559|Aripiprazole|aripiprazole|mesh-list
110498656|NCT00689559|Antidepressive Agents|antidepressive agents|mesh-ancestor
110498657|NCT00689559|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110498658|NCT00689559|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110498659|NCT00689559|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110498660|NCT00689559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110498661|NCT00689559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110498662|NCT00689559|Dopamine Agonists|dopamine agonists|mesh-ancestor
110498663|NCT00689559|Dopamine Agents|dopamine agents|mesh-ancestor
110498664|NCT00689559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110498665|NCT00689559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110498666|NCT00689559|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110607781|NCT02546349|Dermatologic Agents|dermatologic agents|mesh-ancestor
110498667|NCT00689559|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110498669|NCT00689559|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110498670|NCT00689559|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110498671|NCT00689559|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110498672|NCT00689559|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110498673|NCT00689637|Warfarin|warfarin|mesh-list
110498674|NCT00689637|Anticoagulants|anticoagulants|mesh-ancestor
110498675|NCT00689715|Ethanol|ethanol|mesh-list
110498676|NCT00689715|Paclitaxel|paclitaxel|mesh-list
110498677|NCT00689715|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110498678|NCT00689715|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110498679|NCT00689715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110498680|NCT00689715|Tubulin Modulators|tubulin modulators|mesh-ancestor
110498681|NCT00689715|Antimitotic Agents|antimitotic agents|mesh-ancestor
110498682|NCT00689715|Mitosis Modulators|mitosis modulators|mesh-ancestor
110498683|NCT00689715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110498684|NCT00689715|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110498685|NCT00689715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110498686|NCT00689715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110498687|NCT00689715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110498689|NCT00689949|Hematinics|hematinics|mesh-ancestor
110498690|NCT00689949|Vitamin B Complex|vitamin b complex|mesh-ancestor
110498691|NCT00689949|Vitamins|vitamins|mesh-ancestor
110498692|NCT00689949|Micronutrients|micronutrients|mesh-ancestor
110498693|NCT00689949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110498694|NCT04256642|Morphine|morphine|mesh-list
110498695|NCT04256642|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110498696|NCT04256642|Narcotics|narcotics|mesh-ancestor
110498697|NCT04256642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110498698|NCT04256642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110498699|NCT04256642|Analgesics|analgesics|mesh-ancestor
110498700|NCT04256642|Sensory System Agents|sensory system agents|mesh-ancestor
110498701|NCT04256642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110498702|NCT00611000|Folic Acid|folic acid|mesh-list
110498703|NCT00611000|Hematinics|hematinics|mesh-ancestor
110498704|NCT00611000|Vitamin B Complex|vitamin b complex|mesh-ancestor
110498705|NCT00611000|Vitamins|vitamins|mesh-ancestor
110498706|NCT00611000|Micronutrients|micronutrients|mesh-ancestor
110498707|NCT00611000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110498708|NCT04031157|Antidepressive Agents|antidepressive agents|mesh-list
110498709|NCT04031157|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110498710|NCT00690105|Fluticasone|fluticasone|mesh-list
110498711|NCT00690105|Tacrolimus|tacrolimus|mesh-list
110498712|NCT00690105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110498713|NCT00690105|Immunologic Factors|immunologic factors|mesh-ancestor
110498714|NCT00690105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110498716|NCT00690105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110274384|NCT01330030|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110498717|NCT00690105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110498718|NCT00690105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110498719|NCT00690105|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110498720|NCT00690105|Autonomic Agents|autonomic agents|mesh-ancestor
110498721|NCT00690105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110498722|NCT00690105|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110498723|NCT00690105|Respiratory System Agents|respiratory system agents|mesh-ancestor
110498724|NCT00690105|Dermatologic Agents|dermatologic agents|mesh-ancestor
110498725|NCT00690105|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110498726|NCT00694317|Zaleplon|zaleplon|mesh-list
110498727|NCT00694317|Anticonvulsants|anticonvulsants|mesh-ancestor
110498728|NCT00694317|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110498729|NCT00694317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110498730|NCT00694317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110498731|NCT00694317|GABA Modulators|gaba modulators|mesh-ancestor
110498732|NCT00694317|GABA Agents|gaba agents|mesh-ancestor
110498733|NCT00694317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110498734|NCT00694317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110498735|NCT04136613|Copper|copper|mesh-list
110498736|NCT04136613|Trace Elements|trace elements|mesh-ancestor
110498737|NCT04136613|Micronutrients|micronutrients|mesh-ancestor
110498738|NCT04136613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110498739|NCT00978731|Dasatinib|dasatinib|mesh-list
110498740|NCT00978731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110498741|NCT00978731|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110498742|NCT00978731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110498743|NCT00978731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110498745|NCT04136535|Pemetrexed|pemetrexed|mesh-list
110498746|NCT04136535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110498747|NCT04136535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110498748|NCT04136535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110498749|NCT04136535|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110498750|NCT04136535|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110498751|NCT00694629|Rifampin|rifampin|mesh-list
110498752|NCT00694629|Rifapentine|rifapentine|mesh-list
110498753|NCT00694629|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110498754|NCT00694629|Antitubercular Agents|antitubercular agents|mesh-ancestor
110498755|NCT00694629|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110498756|NCT00694629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110498757|NCT00694629|Leprostatic Agents|leprostatic agents|mesh-ancestor
110498758|NCT00694629|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110498759|NCT00694629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110498760|NCT00694629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110498761|NCT00694629|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110498762|NCT00694629|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110498763|NCT00694629|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110498764|NCT00694629|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110498765|NCT00694629|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110498766|NCT00694629|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110498769|NCT00912639|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110498770|NCT00912639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110498771|NCT00912639|Tubulin Modulators|tubulin modulators|mesh-ancestor
110498772|NCT00912639|Antimitotic Agents|antimitotic agents|mesh-ancestor
110498773|NCT00912639|Mitosis Modulators|mitosis modulators|mesh-ancestor
110498774|NCT00912639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110498775|NCT02866409|Dexmedetomidine|dexmedetomidine|mesh-list
110498776|NCT02866409|Bupivacaine|bupivacaine|mesh-list
110498777|NCT02866409|Anesthetics, Local|anesthetics, local|mesh-ancestor
110498778|NCT02866409|Anesthetics|anesthetics|mesh-ancestor
110498779|NCT02866409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110498780|NCT02866409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110498781|NCT02866409|Sensory System Agents|sensory system agents|mesh-ancestor
110498782|NCT02866409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110498783|NCT02866409|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110498784|NCT02866409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110498785|NCT02866409|Analgesics|analgesics|mesh-ancestor
110498786|NCT02866409|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110498787|NCT02866409|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110498788|NCT02866409|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110498789|NCT02866409|Adrenergic Agents|adrenergic agents|mesh-ancestor
110498790|NCT02866409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110498791|NCT02866409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110498792|NCT05833984|Tislelizumab|tislelizumab|mesh-list
110498793|NCT05833984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110498794|NCT05833984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110498795|NCT05833919|Capecitabine|capecitabine|mesh-list
110498796|NCT05833919|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110498797|NCT05833919|Antimetabolites|antimetabolites|mesh-ancestor
110498798|NCT05833919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110498799|NCT05833919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110498800|NCT05833815|Everolimus|everolimus|mesh-list
110498801|NCT05833815|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110498802|NCT05833815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110498803|NCT05833815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110498804|NCT05833815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110498805|NCT05833815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110498806|NCT05833815|Immunologic Factors|immunologic factors|mesh-ancestor
110498807|NCT05833815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110498808|NCT05833815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110498809|NCT05833802|Antineoplastic Agents|antineoplastic agents|mesh-list
110498810|NCT05833763|Obinutuzumab|obinutuzumab|mesh-list
110498811|NCT05833763|Pirtobrutinib|pirtobrutinib|mesh-list
110607937|NCT00848523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110498812|NCT05833763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110498813|NCT05833763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110498814|NCT05833763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110498815|NCT05833763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110498816|NCT05833763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110498817|NCT05833477|Epoetin Alfa|epoetin alfa|mesh-list
110498818|NCT05833477|Hematinics|hematinics|mesh-ancestor
110498819|NCT05833399|Carbamazepine|carbamazepine|mesh-list
110498820|NCT05833399|Amitriptyline|amitriptyline|mesh-list
110498821|NCT05833399|Olanzapine|olanzapine|mesh-list
110498822|NCT05833399|Chlorpromazine|chlorpromazine|mesh-list
110498823|NCT05833399|Risperidone|risperidone|mesh-list
110498824|NCT05833399|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110498825|NCT05833399|Mirtazapine|mirtazapine|mesh-list
110498826|NCT05833399|Sertraline|sertraline|mesh-list
110498827|NCT05833399|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110498828|NCT05833399|Serotonin Agents|serotonin agents|mesh-ancestor
110498829|NCT05833399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110498830|NCT05833399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110498831|NCT05833399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110498832|NCT05833399|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110146118|NCT00006027|Paclitaxel|paclitaxel|mesh-list
110498833|NCT05833399|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110498834|NCT05833399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110498835|NCT05833399|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110498836|NCT05833399|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110498837|NCT05833399|Dopamine Agents|dopamine agents|mesh-ancestor
110498838|NCT05833399|Antiemetics|antiemetics|mesh-ancestor
110498839|NCT05833399|Autonomic Agents|autonomic agents|mesh-ancestor
110498840|NCT05833399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110498841|NCT05833399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110498842|NCT05833399|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110498843|NCT05833399|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110498844|NCT05833399|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110498845|NCT05833399|Antidepressive Agents|antidepressive agents|mesh-ancestor
110498846|NCT05833399|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110498847|NCT05833399|Histamine Antagonists|histamine antagonists|mesh-ancestor
110498848|NCT05833399|Histamine Agents|histamine agents|mesh-ancestor
110498849|NCT05833399|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110498850|NCT05833399|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
110498851|NCT05833399|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110498852|NCT05833399|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110498853|NCT05833399|Adrenergic Agents|adrenergic agents|mesh-ancestor
110498854|NCT05833399|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110498855|NCT05833399|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110498856|NCT05833399|Anticonvulsants|anticonvulsants|mesh-ancestor
110498857|NCT05833399|Antimanic Agents|antimanic agents|mesh-ancestor
110498858|NCT05833399|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110498859|NCT05833399|Analgesics|analgesics|mesh-ancestor
110498860|NCT05833399|Sensory System Agents|sensory system agents|mesh-ancestor
110498861|NCT05833399|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110498862|NCT05833399|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110498863|NCT05833399|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110498864|NCT05833399|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110498865|NCT05833399|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110498866|NCT05832996|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110498867|NCT05832996|Lubricant Eye Drops|lubricant eye drops|mesh-list
110498868|NCT05832996|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110498869|NCT05832827|Paclitaxel|paclitaxel|mesh-list
110498870|NCT05832827|Carboplatin|carboplatin|mesh-list
110498871|NCT05832827|Pembrolizumab|pembrolizumab|mesh-list
110498872|NCT05832827|Lenvatinib|lenvatinib|mesh-list
110498873|NCT05832827|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110274693|NCT00202293|Serotonin Agents|serotonin agents|mesh-ancestor
110498874|NCT05832827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110498875|NCT05832827|Tubulin Modulators|tubulin modulators|mesh-ancestor
110498876|NCT05832827|Antimitotic Agents|antimitotic agents|mesh-ancestor
110498877|NCT05832827|Mitosis Modulators|mitosis modulators|mesh-ancestor
110498878|NCT05832827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110498879|NCT05832827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110498880|NCT05832827|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110498881|NCT05832827|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110498882|NCT05832827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110498883|NCT05832749|Hyaluronic Acid|hyaluronic acid|mesh-list
110498884|NCT05832749|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110498885|NCT05832749|Immunologic Factors|immunologic factors|mesh-ancestor
110498886|NCT05832749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110498887|NCT05832749|Viscosupplements|viscosupplements|mesh-ancestor
110498888|NCT05832749|Protective Agents|protective agents|mesh-ancestor
110498890|NCT05832697|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
110498891|NCT05832697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110498892|NCT05832619|Serotonin|serotonin|mesh-list
110498893|NCT05832619|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110498894|NCT05832619|Serotonin Agents|serotonin agents|mesh-ancestor
110498895|NCT05832619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110498896|NCT05832619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110498897|NCT05832619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110498898|NCT05832580|Etidronic Acid|etidronic acid|mesh-list
110498899|NCT05832580|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110498900|NCT05832580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110498901|NCT05832515|Fludarabine|fludarabine|mesh-list
110498903|NCT05832515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110498904|NCT05832515|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110498905|NCT05832515|Antimetabolites|antimetabolites|mesh-ancestor
110498906|NCT05832515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110498907|NCT05832515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110498908|NCT05832515|Immunologic Factors|immunologic factors|mesh-ancestor
110498909|NCT05832515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110498910|NCT05832489|Methylphenidate|methylphenidate|mesh-list
110498911|NCT05832489|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110498912|NCT05832489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110498913|NCT05832489|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110168450|NCT00000719|Zidovudine|zidovudine|mesh-list
110498914|NCT05832489|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110498915|NCT05832489|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110498916|NCT05832489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110498917|NCT05832489|Dopamine Agents|dopamine agents|mesh-ancestor
110498918|NCT05832489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110498919|NCT05832333|Vaccines|vaccines|mesh-list
110498920|NCT05832333|Immunologic Factors|immunologic factors|mesh-ancestor
110498921|NCT05832333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110498922|NCT05832320|Etoposide|etoposide|mesh-list
110498923|NCT05832320|Daunorubicin|daunorubicin|mesh-list
110498924|NCT05832320|Tretinoin|tretinoin|mesh-list
110498925|NCT05832320|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110498926|NCT05832320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110608040|NCT00689052|Pramipexole|pramipexole|mesh-list
110498927|NCT05832320|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110498928|NCT05832320|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110498929|NCT05832320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110498930|NCT05832320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110498931|NCT05832320|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110498932|NCT05832320|Keratolytic Agents|keratolytic agents|mesh-ancestor
110498933|NCT05832320|Dermatologic Agents|dermatologic agents|mesh-ancestor
110498935|NCT05832216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110498936|NCT05832190|Biotin|biotin|mesh-list
110498937|NCT05832190|Vitamin B Complex|vitamin b complex|mesh-ancestor
110498938|NCT05832190|Vitamins|vitamins|mesh-ancestor
110498939|NCT05832190|Micronutrients|micronutrients|mesh-ancestor
110498940|NCT05832190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110608080|NCT05602064|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110498941|NCT05832073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110498942|NCT05832073|Antibodies|antibodies|mesh-list
110498943|NCT05832073|Immunoglobulins|immunoglobulins|mesh-list
110498944|NCT05832073|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110498945|NCT05832073|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110498946|NCT05832073|Immunologic Factors|immunologic factors|mesh-ancestor
110498947|NCT05832073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110498948|NCT05832073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110498949|NCT05832034|Immunoglobulins|immunoglobulins|mesh-list
110498950|NCT05832034|Antibodies|antibodies|mesh-list
110498951|NCT05832034|gamma-Globulins|gamma-globulins|mesh-list
110498952|NCT05832034|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110498953|NCT05832034|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110498954|NCT05832034|Immunologic Factors|immunologic factors|mesh-ancestor
110498955|NCT05832034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110498956|NCT05830539|Doxorubicin|doxorubicin|mesh-list
110498957|NCT05830539|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110498958|NCT05830539|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110498959|NCT05830539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110498960|NCT05830539|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110498961|NCT05830539|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110498962|NCT05830539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110498963|NCT05830539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110498964|NCT05828940|Losartan|losartan|mesh-list
110498965|NCT05828940|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110498966|NCT05828940|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110498967|NCT05828940|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110498968|NCT05828940|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110498969|NCT05828940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110498970|NCT05818423|Benzocaine|benzocaine|mesh-list
110498971|NCT05818423|Anesthetics, Local|anesthetics, local|mesh-ancestor
110498972|NCT05818423|Anesthetics|anesthetics|mesh-ancestor
110608127|NCT02562690|Thrombin|thrombin|mesh-list
110498973|NCT05818423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110498974|NCT05818423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110498975|NCT05818423|Sensory System Agents|sensory system agents|mesh-ancestor
110498976|NCT05818423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110498977|NCT05816785|Cetuximab|cetuximab|mesh-list
110498978|NCT05816785|Imatinib Mesylate|imatinib mesylate|mesh-list
110498979|NCT05816785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110498980|NCT05816785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110498981|NCT05816785|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110498982|NCT05816785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110146270|NCT05679375|Anesthetics|anesthetics|mesh-ancestor
110498983|NCT05816785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110498985|NCT05813912|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110498986|NCT05813912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110498987|NCT05807399|Moxifloxacin|moxifloxacin|mesh-list
110498988|NCT05807399|Rifampin|rifampin|mesh-list
110498989|NCT05807399|Isoniazid|isoniazid|mesh-list
110498990|NCT05807399|Pyrazinamide|pyrazinamide|mesh-list
110498991|NCT05807399|Bedaquiline|bedaquiline|mesh-list
110498992|NCT05807399|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110498993|NCT05807399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110498994|NCT05807399|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110498995|NCT05807399|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110498996|NCT05807399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110498997|NCT05807399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110274886|NCT00202917|Fludarabine|fludarabine|mesh-list
110498998|NCT05807399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110498999|NCT05807399|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110499000|NCT05807399|Antitubercular Agents|antitubercular agents|mesh-ancestor
110499001|NCT05807399|Leprostatic Agents|leprostatic agents|mesh-ancestor
110499002|NCT05807399|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110499003|NCT05807399|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110499004|NCT05807399|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110499005|NCT05807399|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110499006|NCT05807399|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110499007|NCT05807399|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110499008|NCT05807399|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110499009|NCT05807399|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
110499010|NCT05807399|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110499011|NCT05807399|Antimetabolites|antimetabolites|mesh-ancestor
110499012|NCT05807399|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110499013|NCT05798390|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
110499014|NCT05798390|Ezetimibe|ezetimibe|mesh-list
110499015|NCT05798390|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110499016|NCT05798390|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110499017|NCT05798390|Antimetabolites|antimetabolites|mesh-ancestor
110499018|NCT05798390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110499019|NCT05798390|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110499020|NCT05798390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110499021|NCT05798390|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110499022|NCT05798390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110499023|NCT05796401|Leucovorin|leucovorin|mesh-list
110499024|NCT05796401|Folic Acid|folic acid|mesh-list
110499025|NCT05796401|Vitamin B 12|vitamin b 12|mesh-list
110499026|NCT05796401|Levoleucovorin|levoleucovorin|mesh-list
110499027|NCT05796401|Vitamins|vitamins|mesh-ancestor
110499028|NCT05796401|Micronutrients|micronutrients|mesh-ancestor
110499029|NCT05796401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110499030|NCT05796401|Antidotes|antidotes|mesh-ancestor
110499031|NCT05796401|Protective Agents|protective agents|mesh-ancestor
110499032|NCT05796401|Vitamin B Complex|vitamin b complex|mesh-ancestor
110499033|NCT05796401|Hematinics|hematinics|mesh-ancestor
110499034|NCT05771402|Antibodies|antibodies|mesh-list
110499035|NCT05771402|Immunologic Factors|immunologic factors|mesh-ancestor
110499036|NCT05771402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110499037|NCT05769816|Antibodies|antibodies|mesh-list
110499038|NCT05769816|Immunologic Factors|immunologic factors|mesh-ancestor
110499039|NCT05769816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110499041|NCT05745142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110499042|NCT05745142|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110499043|NCT05745142|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110499044|NCT05745142|Growth Substances|growth substances|mesh-ancestor
110608217|NCT00619359|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110499045|NCT05745142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110499046|NCT05745142|Growth Inhibitors|growth inhibitors|mesh-ancestor
110499047|NCT05745142|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110499048|NCT05745142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110499049|NCT05745142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110499051|NCT05737069|Ibuprofen arginine|ibuprofen arginine|mesh-list
110499052|NCT05737069|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110499053|NCT05737069|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110499054|NCT05737069|Analgesics|analgesics|mesh-ancestor
110274974|NCT00198432|Paclitaxel|paclitaxel|mesh-list
110499055|NCT05737069|Sensory System Agents|sensory system agents|mesh-ancestor
110499056|NCT05737069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110499057|NCT05737069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110499058|NCT05737069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110499059|NCT05737069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110499060|NCT05737069|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110499061|NCT05737069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110168470|NCT00035074|Abortifacient Agents|abortifacient agents|mesh-ancestor
110499062|NCT05737069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110499064|NCT05709483|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110499065|NCT05709483|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110499066|NCT05709483|Analgesics|analgesics|mesh-ancestor
110499067|NCT05709483|Sensory System Agents|sensory system agents|mesh-ancestor
110499068|NCT05709483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110499069|NCT05709483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110499070|NCT05709483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110499071|NCT05709483|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110499072|NCT05709483|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110499073|NCT05709483|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110499074|NCT05709483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110499075|NCT05709483|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110499076|NCT05709483|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110608253|NCT00852189|Folic Acid|folic acid|mesh-list
110499077|NCT05709483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110499078|NCT05709483|Antipyretics|antipyretics|mesh-ancestor
110499079|NCT05672134|Geranylgeranylacetone|geranylgeranylacetone|mesh-list
110499080|NCT05672134|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110499081|NCT05672134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110499082|NCT05672134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110499083|NCT05647057|Polygeline|polygeline|mesh-list
110499084|NCT05647057|Plasma Substitutes|plasma substitutes|mesh-ancestor
110499085|NCT05647057|Blood Substitutes|blood substitutes|mesh-ancestor
110499086|NCT05639322|Ketamine|ketamine|mesh-list
110499087|NCT05639322|Analgesics|analgesics|mesh-ancestor
110499088|NCT05639322|Sensory System Agents|sensory system agents|mesh-ancestor
110499089|NCT05639322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110499090|NCT05639322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110499091|NCT05639322|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110499092|NCT05639322|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110499093|NCT05639322|Anesthetics, General|anesthetics, general|mesh-ancestor
110499094|NCT05639322|Anesthetics|anesthetics|mesh-ancestor
110499095|NCT05639322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110499096|NCT05639322|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110499097|NCT05639322|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110499098|NCT05639322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110499099|NCT05639322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110499100|NCT05594615|Midazolam|midazolam|mesh-list
110499101|NCT05594615|Caffeine|caffeine|mesh-list
110499102|NCT05594615|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110499103|NCT05594615|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110499104|NCT05594615|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110499105|NCT05594615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110499106|NCT05594615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110499107|NCT05594615|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110499108|NCT05594615|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110499109|NCT05594615|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110499110|NCT05594615|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110499111|NCT05594615|Anesthetics, General|anesthetics, general|mesh-ancestor
110499112|NCT05594615|Anesthetics|anesthetics|mesh-ancestor
110499113|NCT05594615|GABA Modulators|gaba modulators|mesh-ancestor
110499114|NCT05594615|GABA Agents|gaba agents|mesh-ancestor
110499115|NCT05594615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110499116|NCT05594615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110499117|NCT05594615|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110499118|NCT05594615|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110499119|NCT05594615|Antimetabolites|antimetabolites|mesh-ancestor
110499120|NCT05594615|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110499121|NCT05594615|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110499122|NCT05594615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110499123|NCT05594615|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110499124|NCT05594615|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110608330|NCT00852423|Artesunate|artesunate|mesh-list
110499125|NCT05594615|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110499126|NCT05594615|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110499128|NCT05594602|Itraconazole|itraconazole|mesh-list
110499129|NCT05594602|Quinidine|quinidine|mesh-list
110499130|NCT05594602|Carbamazepine|carbamazepine|mesh-list
110499131|NCT05594602|Antifungal Agents|antifungal agents|mesh-ancestor
110499132|NCT05594602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110499133|NCT05594602|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110499134|NCT05594602|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110499135|NCT05594602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110499136|NCT05594602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110499137|NCT05594602|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110499138|NCT05594602|Hormone Antagonists|hormone antagonists|mesh-ancestor
110499139|NCT05594602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110499140|NCT05594602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110499141|NCT05594602|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110499142|NCT05594602|Anticonvulsants|anticonvulsants|mesh-ancestor
110275194|NCT01930357|Vaccines|vaccines|mesh-list
110499143|NCT05594602|Antimanic Agents|antimanic agents|mesh-ancestor
110499144|NCT05594602|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110499145|NCT05594602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110499146|NCT05594602|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110499147|NCT05594602|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110499148|NCT05594602|Analgesics|analgesics|mesh-ancestor
110499149|NCT05594602|Sensory System Agents|sensory system agents|mesh-ancestor
110499150|NCT05594602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110499151|NCT05594602|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110499152|NCT05594602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110499153|NCT05594602|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110499154|NCT05594602|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110499155|NCT05594602|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110499156|NCT05594602|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110499157|NCT05594602|Adrenergic Agents|adrenergic agents|mesh-ancestor
110499158|NCT05594602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110499159|NCT05594602|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110499160|NCT05594602|Antimalarials|antimalarials|mesh-ancestor
110499161|NCT05594602|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110499162|NCT05594602|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110499163|NCT05594602|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110499164|NCT05594602|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110499165|NCT05594602|Cholinergic Agents|cholinergic agents|mesh-ancestor
110499166|NCT05594602|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110499167|NCT05594602|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110499169|NCT05590260|Trace Elements|trace elements|mesh-ancestor
110499170|NCT05590260|Micronutrients|micronutrients|mesh-ancestor
110499171|NCT05590260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110499172|NCT05589844|Vaccines|vaccines|mesh-list
110499173|NCT05589844|Immunologic Factors|immunologic factors|mesh-ancestor
110499174|NCT05589844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110499175|NCT05485519|Midazolam|midazolam|mesh-list
110499176|NCT05485519|Dexmedetomidine|dexmedetomidine|mesh-list
110499177|NCT05485519|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110499178|NCT05485519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110499179|NCT05485519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110499180|NCT05485519|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110499181|NCT05485519|Analgesics|analgesics|mesh-ancestor
110499182|NCT05485519|Sensory System Agents|sensory system agents|mesh-ancestor
110499183|NCT05485519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110499184|NCT05485519|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110499185|NCT05485519|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110499186|NCT05485519|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110499187|NCT05485519|Adrenergic Agents|adrenergic agents|mesh-ancestor
110499188|NCT05485519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110499189|NCT05485519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110499190|NCT05485519|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110499191|NCT05485519|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110499192|NCT05485519|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110499193|NCT05485519|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110499194|NCT05485519|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110499195|NCT05485519|Anesthetics, General|anesthetics, general|mesh-ancestor
110499196|NCT05485519|Anesthetics|anesthetics|mesh-ancestor
110499198|NCT05485519|GABA Agents|gaba agents|mesh-ancestor
110499199|NCT05411744|Vitamin B 6|vitamin b 6|mesh-list
110499200|NCT05411744|Pyridoxal|pyridoxal|mesh-list
110499201|NCT05411744|Pyridoxine|pyridoxine|mesh-list
110499202|NCT05411744|Isoniazid|isoniazid|mesh-list
110499203|NCT05411744|Rifapentine|rifapentine|mesh-list
110499204|NCT05411744|Vitamins|vitamins|mesh-ancestor
110499205|NCT05411744|Micronutrients|micronutrients|mesh-ancestor
110499206|NCT05411744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110499207|NCT05411744|Vitamin B Complex|vitamin b complex|mesh-ancestor
110499208|NCT05411744|Antitubercular Agents|antitubercular agents|mesh-ancestor
110499209|NCT05411744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110499210|NCT05411744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110275238|NCT01874626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110499211|NCT05411744|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
110499212|NCT05411744|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110499213|NCT05411744|Antimetabolites|antimetabolites|mesh-ancestor
110499214|NCT05411744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110499215|NCT05411744|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110499216|NCT05411744|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110499217|NCT05411744|Leprostatic Agents|leprostatic agents|mesh-ancestor
110499218|NCT05359627|Polymyxins|polymyxins|mesh-list
110499219|NCT05359627|Polymyxin B|polymyxin b|mesh-list
110499220|NCT05359627|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110499221|NCT05359627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110499222|NCT05612490|Furosemide|furosemide|mesh-list
110499223|NCT05612490|Diuretics|diuretics|mesh-ancestor
110499224|NCT05612490|Natriuretic Agents|natriuretic agents|mesh-ancestor
110499225|NCT05612490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110499226|NCT05612490|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110499227|NCT05612490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110499228|NCT05612490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110499229|NCT05295784|Caffeine|caffeine|mesh-list
110499230|NCT05295784|Caffeine citrate|caffeine citrate|mesh-list
110499231|NCT05295784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110499232|NCT05295784|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110499233|NCT05295784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110499234|NCT05295784|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110499235|NCT05295784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110499236|NCT05295784|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110499237|NCT05295784|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110499238|NCT05295784|Purinergic Agents|purinergic agents|mesh-ancestor
110499239|NCT05295784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110499240|NCT05246293|Tofacitinib|tofacitinib|mesh-list
110499241|NCT05246293|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
110499242|NCT05246293|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110499243|NCT05246293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110499244|NCT05246293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110499245|NCT05243147|Polyvinyl alcohol formaldehyde foam|polyvinyl alcohol formaldehyde foam|mesh-list
110499246|NCT05243147|Hemostatics|hemostatics|mesh-ancestor
110499247|NCT05243147|Coagulants|coagulants|mesh-ancestor
110499248|NCT05212610|Vaccines|vaccines|mesh-list
110499249|NCT05212610|Immunologic Factors|immunologic factors|mesh-ancestor
110499250|NCT05212610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110499251|NCT05207280|Terlipressin|terlipressin|mesh-list
110499252|NCT05207280|Norepinephrine|norepinephrine|mesh-list
110499253|NCT05207280|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110499254|NCT05207280|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110499255|NCT05207280|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110499256|NCT05207280|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110499257|NCT05207280|Adrenergic Agents|adrenergic agents|mesh-ancestor
110499258|NCT05207280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110499259|NCT05207280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110608442|NCT00852579|Azithromycin|azithromycin|mesh-list
110499260|NCT05207280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110499261|NCT05207280|Sympathomimetics|sympathomimetics|mesh-ancestor
110499262|NCT05207280|Autonomic Agents|autonomic agents|mesh-ancestor
110311781|NCT00303576|Dapivirine|dapivirine|mesh-list
110499263|NCT05207280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110499277|NCT05149378|Azacitidine|azacitidine|mesh-list
110499278|NCT05149378|Venetoclax|venetoclax|mesh-list
110499279|NCT05149378|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110499280|NCT05149378|Antimetabolites|antimetabolites|mesh-ancestor
110499281|NCT05149378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110499282|NCT05149378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110499283|NCT05149378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110499284|NCT05134857|Zonisamide|zonisamide|mesh-list
110499285|NCT05134857|Anticonvulsants|anticonvulsants|mesh-ancestor
110499286|NCT05134857|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110281431|NCT00221520|GABA Agents|gaba agents|mesh-ancestor
110499287|NCT05134857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110499288|NCT05134857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110499289|NCT05134857|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110499290|NCT05134857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110499291|NCT05114590|Insulin Glargine|insulin glargine|mesh-list
110499292|NCT05114590|Lixisenatide|lixisenatide|mesh-list
110499293|NCT05114590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110499294|NCT05114590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110608477|NCT00951574|Calcium|calcium|mesh-list
110499295|NCT05108935|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110499296|NCT05108935|Buprenorphine|buprenorphine|mesh-list
110499297|NCT05108935|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
110499298|NCT05108935|Naloxone|naloxone|mesh-list
110499299|NCT05108935|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110499300|NCT05108935|Narcotics|narcotics|mesh-ancestor
110499301|NCT05108935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110499302|NCT05108935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110499303|NCT05108935|Analgesics|analgesics|mesh-ancestor
110499304|NCT05108935|Sensory System Agents|sensory system agents|mesh-ancestor
110499305|NCT05108935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110499306|NCT05108935|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110499307|NCT05108935|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110499308|NCT05108935|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110499309|NCT05108935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110499310|NCT05108935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110499311|NCT05108935|Antiviral Agents|antiviral agents|mesh-ancestor
110499312|NCT05108935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110499313|NCT05108935|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110499314|NCT05108935|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110499315|NCT05051527|Silymarin|silymarin|mesh-list
110499316|NCT05051527|Antioxidants|antioxidants|mesh-ancestor
110499317|NCT05051527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110499318|NCT05051527|Protective Agents|protective agents|mesh-ancestor
110499319|NCT05051527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110499320|NCT04939753|Sevoflurane|sevoflurane|mesh-list
110499321|NCT04939753|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110499322|NCT04939753|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110499323|NCT04939753|Anesthetics, General|anesthetics, general|mesh-ancestor
110499324|NCT04939753|Anesthetics|anesthetics|mesh-ancestor
110499325|NCT04939753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110608543|NCT00946504|Glipizide|glipizide|mesh-list
110281486|NCT00214617|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110499326|NCT04939753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110499327|NCT04924036|Glycopyrrolate|glycopyrrolate|mesh-list
110499328|NCT04924036|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110499329|NCT04924036|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110499330|NCT04924036|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110499331|NCT04924036|Cholinergic Agents|cholinergic agents|mesh-ancestor
110499332|NCT04924036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110499333|NCT04924036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110499334|NCT04924036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110499335|NCT04902885|Carboplatin|carboplatin|mesh-list
110499337|NCT04902885|Topotecan|topotecan|mesh-list
110499338|NCT04902885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110499339|NCT04902885|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110499340|NCT04902885|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110499341|NCT04902885|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110499342|NCT04902885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110499343|NCT04902885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110499344|NCT04902885|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110499345|NCT04868058|Ropivacaine|ropivacaine|mesh-list
110499346|NCT04868058|Anesthetics, Local|anesthetics, local|mesh-ancestor
110499347|NCT04868058|Anesthetics|anesthetics|mesh-ancestor
110499348|NCT04868058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110499349|NCT04868058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110499350|NCT04868058|Sensory System Agents|sensory system agents|mesh-ancestor
110168497|NCT00035152|Paclitaxel|paclitaxel|mesh-list
110499351|NCT04868058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110499352|NCT04763759|Antibodies|antibodies|mesh-list
110499353|NCT04763759|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110499354|NCT04763759|Immunologic Factors|immunologic factors|mesh-ancestor
110499355|NCT04763759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110499356|NCT04614363|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
110499357|NCT04614363|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110499358|NCT04614363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110499359|NCT04525274|Dexmedetomidine|dexmedetomidine|mesh-list
110499360|NCT04525274|Ketamine|ketamine|mesh-list
110499361|NCT04525274|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110499362|NCT04525274|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110499363|NCT04525274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110499364|NCT04525274|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110499365|NCT04525274|Analgesics|analgesics|mesh-ancestor
110499366|NCT04525274|Sensory System Agents|sensory system agents|mesh-ancestor
110499367|NCT04525274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110499368|NCT04525274|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110499369|NCT04525274|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110499370|NCT04525274|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110499371|NCT04525274|Adrenergic Agents|adrenergic agents|mesh-ancestor
110499372|NCT04525274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110499373|NCT04525274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110499374|NCT04525274|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110499375|NCT04525274|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110499376|NCT04525274|Anesthetics, General|anesthetics, general|mesh-ancestor
110499377|NCT04525274|Anesthetics|anesthetics|mesh-ancestor
110499378|NCT04525274|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110499379|NCT04525274|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110499380|NCT04481113|Niraparib|niraparib|mesh-list
110499381|NCT04481113|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110499382|NCT04481113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110499383|NCT04481113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110499384|NCT04481113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110499385|NCT04472611|Colchicine|colchicine|mesh-list
110499386|NCT04472611|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110499387|NCT04472611|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110499388|NCT04472611|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110608621|NCT00854139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110608622|NCT00854139|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110608623|NCT00854139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110608624|NCT00854139|Antifungal Agents|antifungal agents|mesh-ancestor
110608625|NCT00854139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110608626|NCT00854139|Dermatologic Agents|dermatologic agents|mesh-ancestor
110608627|NCT00854139|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110608628|NCT00755820|Cycloserine|cycloserine|mesh-list
110608629|NCT00755820|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110608630|NCT00755820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110608631|NCT00755820|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110608632|NCT00755820|Antitubercular Agents|antitubercular agents|mesh-ancestor
110499389|NCT04472611|Antimetabolites|antimetabolites|mesh-ancestor
110499390|NCT04472611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110499391|NCT04472611|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110499392|NCT04472611|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110499393|NCT04472611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110499394|NCT04472611|Gout Suppressants|gout suppressants|mesh-ancestor
110499395|NCT04472611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110499396|NCT04472611|Tubulin Modulators|tubulin modulators|mesh-ancestor
110499397|NCT04472611|Antimitotic Agents|antimitotic agents|mesh-ancestor
110499398|NCT04472611|Mitosis Modulators|mitosis modulators|mesh-ancestor
110499399|NCT04472611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110499400|NCT04472598|Navitoclax|navitoclax|mesh-list
110499401|NCT04472598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110499402|NCT04367233|Anesthetics|anesthetics|mesh-list
110499403|NCT04367233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110499404|NCT04367233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110499405|NCT04193215|Vaccines|vaccines|mesh-list
110499406|NCT04193215|Immunologic Factors|immunologic factors|mesh-ancestor
110499407|NCT04193215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110499408|NCT04125563|Capsaicin|capsaicin|mesh-list
110499409|NCT04125563|Antipruritics|antipruritics|mesh-ancestor
110499410|NCT04125563|Dermatologic Agents|dermatologic agents|mesh-ancestor
110499411|NCT04125563|Sensory System Agents|sensory system agents|mesh-ancestor
110499412|NCT04125563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110499413|NCT04125563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110499414|NCT04078295|Nivolumab|nivolumab|mesh-list
110499415|NCT04078295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110168506|NCT00014352|Docetaxel|docetaxel|mesh-list
110499416|NCT04078295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110499417|NCT04078295|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110499418|NCT04078295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110499420|NCT04004611|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110499421|NCT04004611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110499423|NCT04004611|Sensory System Agents|sensory system agents|mesh-ancestor
110499424|NCT04004611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110499425|NCT04004611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110499426|NCT04004611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110499427|NCT04004611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110499428|NCT04004611|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110499429|NCT04004611|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110499430|NCT03974828|Anesthetics|anesthetics|mesh-list
110499431|NCT03974828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110499432|NCT03974828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110499433|NCT03953677|Dexmedetomidine|dexmedetomidine|mesh-list
110499434|NCT03953677|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110499435|NCT03953677|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110281606|NCT00474955|Antiviral Agents|antiviral agents|mesh-ancestor
110499436|NCT03953677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110499437|NCT03953677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110499438|NCT03953677|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110499439|NCT03953677|Analgesics|analgesics|mesh-ancestor
110499440|NCT03953677|Sensory System Agents|sensory system agents|mesh-ancestor
110499441|NCT03953677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110499442|NCT03953677|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110499443|NCT03953677|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110499444|NCT03953677|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110499445|NCT03953677|Adrenergic Agents|adrenergic agents|mesh-ancestor
110499446|NCT03953677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110499447|NCT03953677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110499448|NCT03937713|Eszopiclone|eszopiclone|mesh-list
110499449|NCT03937713|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110499450|NCT03937713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110499451|NCT03937713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110168509|NCT00014352|Estramustine|estramustine|mesh-list
110499452|NCT03934216|Deucravacitinib|deucravacitinib|mesh-list
110499453|NCT03934216|Dermatologic Agents|dermatologic agents|mesh-ancestor
110499454|NCT03934216|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110499455|NCT03934216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110499456|NCT03934216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110499457|NCT03925480|Azithromycin|azithromycin|mesh-list
110499458|NCT03925480|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110499459|NCT03925480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110499460|NCT03878069|Elapegademase|elapegademase|mesh-list
110499461|NCT03878069|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
110499462|NCT03878069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110281652|NCT00221871|Anesthetics|anesthetics|mesh-ancestor
110499463|NCT03878069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110499464|NCT03876873|Anesthetics|anesthetics|mesh-list
110499465|NCT03876873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110499466|NCT03876873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110499467|NCT03842696|Cyclosporine|cyclosporine|mesh-list
110499468|NCT03842696|Mycophenolic Acid|mycophenolic acid|mesh-list
110499469|NCT03842696|Cyclophosphamide|cyclophosphamide|mesh-list
110499470|NCT03842696|Methotrexate|methotrexate|mesh-list
110499472|NCT03842696|Tacrolimus|tacrolimus|mesh-list
110499473|NCT03842696|Cyclosporins|cyclosporins|mesh-list
110499474|NCT03842696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110499475|NCT03842696|Immunologic Factors|immunologic factors|mesh-ancestor
110499476|NCT03842696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110499477|NCT03842696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110499478|NCT03842696|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110499479|NCT03842696|Alkylating Agents|alkylating agents|mesh-ancestor
110499480|NCT03842696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110499481|NCT03842696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110499482|NCT03842696|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110311783|NCT00303576|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110499483|NCT03842696|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110499484|NCT03842696|Abortifacient Agents|abortifacient agents|mesh-ancestor
110499485|NCT03842696|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110499486|NCT03842696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110499487|NCT03842696|Antimetabolites|antimetabolites|mesh-ancestor
110499488|NCT03842696|Dermatologic Agents|dermatologic agents|mesh-ancestor
110499489|NCT03842696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110499490|NCT03842696|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110499491|NCT03842696|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110499492|NCT03842696|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110499493|NCT03842696|Antifungal Agents|antifungal agents|mesh-ancestor
110499494|NCT03842696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110499495|NCT03842696|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110499496|NCT03842696|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110499497|NCT03842696|Antitubercular Agents|antitubercular agents|mesh-ancestor
110499498|NCT03842696|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110499499|NCT03842696|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110499500|NCT03832361|Mirvetuximab soravtansine|mirvetuximab soravtansine|mesh-list
110499501|NCT03832361|Immunoconjugates|immunoconjugates|mesh-ancestor
110499502|NCT03832361|Immunologic Factors|immunologic factors|mesh-ancestor
110499503|NCT03832361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110499504|NCT03601078|Idecabtagene vicleucel|idecabtagene vicleucel|mesh-list
110499505|NCT03601078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110499506|NCT03601078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110499507|NCT03479502|Doxycycline|doxycycline|mesh-list
110499508|NCT03479502|Prednisone|prednisone|mesh-list
110499509|NCT03479502|Methylprednisolone|methylprednisolone|mesh-list
110499510|NCT03479502|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110499511|NCT03479502|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110499512|NCT03479502|Prednisolone|prednisolone|mesh-list
110499513|NCT03479502|Prednisolone acetate|prednisolone acetate|mesh-list
110499514|NCT03479502|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110499515|NCT03479502|Prednisolone phosphate|prednisolone phosphate|mesh-list
110499516|NCT03479502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110499517|NCT03479502|Glucocorticoids|glucocorticoids|mesh-ancestor
110499518|NCT03479502|Hormones|hormones|mesh-ancestor
110499519|NCT03479502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110499520|NCT03479502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110499521|NCT03479502|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110499522|NCT03479502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110499523|NCT03479502|Antiemetics|antiemetics|mesh-ancestor
110499524|NCT03479502|Autonomic Agents|autonomic agents|mesh-ancestor
110168544|NCT00035230|Topiramate|topiramate|mesh-list
110499525|NCT03479502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110499526|NCT03479502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110499527|NCT03479502|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110499528|NCT03479502|Protective Agents|protective agents|mesh-ancestor
110499529|NCT03479502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110499530|NCT03479502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110499531|NCT03479502|Antimalarials|antimalarials|mesh-ancestor
110499532|NCT03479502|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110499533|NCT03479502|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110499534|NCT03097796|Pam2CSK4 acetate and ODN M362 combination|pam2csk4 acetate and odn m362 combination|mesh-list
110499535|NCT03097796|Respiratory System Agents|respiratory system agents|mesh-ancestor
110499536|NCT03067051|Verteporfin|verteporfin|mesh-list
110499537|NCT03067051|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110499538|NCT03067051|Dermatologic Agents|dermatologic agents|mesh-ancestor
110499539|NCT03013998|Cytarabine|cytarabine|mesh-list
110499540|NCT03013998|Azacitidine|azacitidine|mesh-list
110499541|NCT03013998|Decitabine|decitabine|mesh-list
110499542|NCT03013998|Daunorubicin|daunorubicin|mesh-list
110499543|NCT03013998|Venetoclax|venetoclax|mesh-list
110499544|NCT03013998|AZD5991|azd5991|mesh-list
110499545|NCT03013998|Pevonedistat|pevonedistat|mesh-list
110499546|NCT03013998|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110499547|NCT03013998|Antimetabolites|antimetabolites|mesh-ancestor
110608773|NCT00861627|Carboplatin|carboplatin|mesh-list
110499548|NCT03013998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110499549|NCT03013998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110499551|NCT03013998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110499552|NCT03013998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110499553|NCT03013998|Immunologic Factors|immunologic factors|mesh-ancestor
110499554|NCT03013998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110499555|NCT03013998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110499556|NCT03013998|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110499557|NCT03013998|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110311784|NCT00303576|Antiviral Agents|antiviral agents|mesh-ancestor
110499558|NCT03013998|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110499559|NCT02901067|Aspirin|aspirin|mesh-list
110499560|NCT02901067|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110499561|NCT02901067|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110499562|NCT02901067|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110499563|NCT02901067|Analgesics|analgesics|mesh-ancestor
110499564|NCT02901067|Sensory System Agents|sensory system agents|mesh-ancestor
110499565|NCT02901067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110499566|NCT02901067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110499567|NCT02901067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110499568|NCT02901067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110499569|NCT02901067|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110499570|NCT02901067|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110499571|NCT02901067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110499572|NCT02901067|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110499573|NCT02901067|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110499574|NCT02901067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110499575|NCT02901067|Antipyretics|antipyretics|mesh-ancestor
110499576|NCT02901067|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110499577|NCT02901067|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110499578|NCT02901067|Antimetabolites|antimetabolites|mesh-ancestor
110499579|NCT02901067|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110499580|NCT02901067|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110499581|NCT02859896|Calcitriol|calcitriol|mesh-list
110608803|NCT00943930|Hormones|hormones|mesh-ancestor
110499582|NCT02859896|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
110499583|NCT02859896|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110499584|NCT02859896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110499585|NCT02859896|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
110499586|NCT02859896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110499587|NCT02859896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110499588|NCT02859896|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110499590|NCT02859896|Micronutrients|micronutrients|mesh-ancestor
110499591|NCT02859896|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110499592|NCT02711670|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110499593|NCT02711670|Chlorthalidone|chlorthalidone|mesh-list
110499594|NCT02711670|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110499595|NCT02711670|Diuretics|diuretics|mesh-ancestor
110499596|NCT02711670|Natriuretic Agents|natriuretic agents|mesh-ancestor
110499597|NCT02711670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110499598|NCT02711670|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110499599|NCT02711670|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110499600|NCT02711670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110499602|NCT02658097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110499603|NCT02658097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110499604|NCT02658097|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110281931|NCT00411996|Ritonavir|ritonavir|mesh-list
110499605|NCT02658097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110499606|NCT02581527|Rifampin|rifampin|mesh-list
110499607|NCT02581527|Isoniazid|isoniazid|mesh-list
110499608|NCT02581527|Pyrazinamide|pyrazinamide|mesh-list
110499609|NCT02581527|Ethambutol|ethambutol|mesh-list
110499610|NCT02581527|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110499611|NCT02581527|Antitubercular Agents|antitubercular agents|mesh-ancestor
110499612|NCT02581527|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110499613|NCT02581527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110499614|NCT02581527|Leprostatic Agents|leprostatic agents|mesh-ancestor
110499615|NCT02581527|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110499616|NCT02581527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110499617|NCT02581527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110499618|NCT02581527|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110499619|NCT02581527|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110499620|NCT02581527|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110499621|NCT02581527|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110499622|NCT02581527|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110499623|NCT02581527|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110499624|NCT02581527|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
110499625|NCT02581527|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110499626|NCT02581527|Antimetabolites|antimetabolites|mesh-ancestor
110499627|NCT02581527|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110499628|NCT02558010|Morphine|morphine|mesh-list
110499629|NCT02558010|Methadone|methadone|mesh-list
110499630|NCT02558010|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110499631|NCT02558010|Narcotics|narcotics|mesh-ancestor
110499632|NCT02558010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110499633|NCT02558010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110499634|NCT02558010|Analgesics|analgesics|mesh-ancestor
110499635|NCT02558010|Sensory System Agents|sensory system agents|mesh-ancestor
110499636|NCT02558010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110499637|NCT02558010|Antitussive Agents|antitussive agents|mesh-ancestor
110499638|NCT02558010|Respiratory System Agents|respiratory system agents|mesh-ancestor
110499639|NCT02473497|Crizotinib|crizotinib|mesh-list
110499640|NCT02473497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110499641|NCT02473497|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110499642|NCT02473497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110168550|NCT00014391|Ribavirin|ribavirin|mesh-list
110168556|NCT00035308|Abetimus|abetimus|mesh-list
110499643|NCT02473497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110499644|NCT02466074|Acetazolamide|acetazolamide|mesh-list
110499645|NCT02466074|Anticonvulsants|anticonvulsants|mesh-ancestor
110499646|NCT02466074|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110499647|NCT02466074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110499648|NCT02466074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110499649|NCT02466074|Diuretics|diuretics|mesh-ancestor
110499650|NCT02466074|Natriuretic Agents|natriuretic agents|mesh-ancestor
110499651|NCT02466074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110499652|NCT02393794|Nivolumab|nivolumab|mesh-list
110499653|NCT02393794|Romidepsin|romidepsin|mesh-list
110499654|NCT02393794|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
110499655|NCT02393794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110499656|NCT02393794|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110499657|NCT02393794|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110499658|NCT02393794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110499659|NCT02393794|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110499660|NCT02393794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110499661|NCT02159950|Vaccines|vaccines|mesh-list
110499662|NCT02159950|Immunologic Factors|immunologic factors|mesh-ancestor
110499663|NCT02159950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110499664|NCT02152137|Paclitaxel|paclitaxel|mesh-list
110499665|NCT02152137|Efatutazone|efatutazone|mesh-list
110499666|NCT02152137|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110499667|NCT02152137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110499668|NCT02152137|Tubulin Modulators|tubulin modulators|mesh-ancestor
110499669|NCT02152137|Antimitotic Agents|antimitotic agents|mesh-ancestor
110499670|NCT02152137|Mitosis Modulators|mitosis modulators|mesh-ancestor
110499671|NCT02152137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110499672|NCT02007512|Exemestane|exemestane|mesh-list
110499673|NCT02007512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110499674|NCT02007512|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110499675|NCT02007512|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110499676|NCT02007512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110499677|NCT02007512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110499678|NCT02007512|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110499679|NCT02007512|Hormone Antagonists|hormone antagonists|mesh-ancestor
110281980|NCT00193076|Carboplatin|carboplatin|mesh-list
110499680|NCT02007512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110282020|NCT00193193|Carboplatin|carboplatin|mesh-list
110499681|NCT02007512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110499682|NCT01971489|Cisplatin|cisplatin|mesh-list
110499683|NCT01971489|Gemcitabine|gemcitabine|mesh-list
110499684|NCT01971489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110499685|NCT01971489|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110499686|NCT01971489|Antimetabolites|antimetabolites|mesh-ancestor
110499687|NCT01971489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110499688|NCT01942135|Fulvestrant|fulvestrant|mesh-list
110499689|NCT01942135|Palbociclib|palbociclib|mesh-list
110499690|NCT01942135|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110499691|NCT01942135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110499692|NCT01942135|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110499693|NCT01942135|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110499694|NCT01942135|Hormone Antagonists|hormone antagonists|mesh-ancestor
110499695|NCT01942135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110499696|NCT01942135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110499697|NCT01942135|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110499698|NCT01942135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110499699|NCT01942135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110499700|NCT01838174|Methylprednisolone|methylprednisolone|mesh-list
110499701|NCT01838174|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110608964|NCT00865059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110499702|NCT01838174|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110499703|NCT01838174|Prednisolone|prednisolone|mesh-list
110499704|NCT01838174|Prednisolone acetate|prednisolone acetate|mesh-list
110499705|NCT01838174|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110499706|NCT01838174|Prednisolone phosphate|prednisolone phosphate|mesh-list
110499707|NCT01838174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110499708|NCT01838174|Antiemetics|antiemetics|mesh-ancestor
110499709|NCT01838174|Autonomic Agents|autonomic agents|mesh-ancestor
110499710|NCT01838174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110499711|NCT01838174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110499712|NCT01838174|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110499713|NCT01838174|Glucocorticoids|glucocorticoids|mesh-ancestor
110499715|NCT01838174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110499716|NCT01838174|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110499717|NCT01838174|Protective Agents|protective agents|mesh-ancestor
110499718|NCT01838174|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110499719|NCT01838174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110499720|NCT01743131|Abatacept|abatacept|mesh-list
110499721|NCT01743131|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110499722|NCT01743131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110499723|NCT01743131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110499724|NCT01743131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110499725|NCT01743131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110499726|NCT01743131|Immunologic Factors|immunologic factors|mesh-ancestor
110499727|NCT01743131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110499728|NCT01743131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110499729|NCT01685814|Lenalidomide|lenalidomide|mesh-list
110499730|NCT01685814|Bortezomib|bortezomib|mesh-list
110147020|NCT00006249|Antiviral Agents|antiviral agents|mesh-ancestor
110499731|NCT01685814|Immunologic Factors|immunologic factors|mesh-ancestor
110499732|NCT01685814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110499733|NCT01685814|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110499734|NCT01685814|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110499735|NCT01685814|Growth Substances|growth substances|mesh-ancestor
110499736|NCT01685814|Growth Inhibitors|growth inhibitors|mesh-ancestor
110499737|NCT01685814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110499738|NCT01147016|Paclitaxel|paclitaxel|mesh-list
110499739|NCT01147016|Cyclophosphamide|cyclophosphamide|mesh-list
110499740|NCT01147016|Doxorubicin|doxorubicin|mesh-list
110499741|NCT01147016|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110499742|NCT01147016|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110499743|NCT01147016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110499744|NCT01147016|Tubulin Modulators|tubulin modulators|mesh-ancestor
110499745|NCT01147016|Antimitotic Agents|antimitotic agents|mesh-ancestor
110499746|NCT01147016|Mitosis Modulators|mitosis modulators|mesh-ancestor
110499747|NCT01147016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110499748|NCT01147016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110499749|NCT01147016|Immunologic Factors|immunologic factors|mesh-ancestor
110499750|NCT01147016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110499751|NCT01147016|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110499752|NCT01147016|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110609078|NCT00554788|Thiotepa|thiotepa|mesh-list
110499753|NCT01147016|Alkylating Agents|alkylating agents|mesh-ancestor
110499754|NCT01147016|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110499755|NCT01147016|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110499756|NCT01147016|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110499757|NCT01147016|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110499758|NCT01147016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110499759|NCT00200200|Bevacizumab|bevacizumab|mesh-list
110499760|NCT00200200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110499761|NCT00200200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110499762|NCT00200200|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110499763|NCT00200200|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110499764|NCT00200200|Growth Substances|growth substances|mesh-ancestor
110499765|NCT00200200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110499766|NCT00200200|Growth Inhibitors|growth inhibitors|mesh-ancestor
110499767|NCT00106587|Paclitaxel|paclitaxel|mesh-list
110499768|NCT00106587|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110499769|NCT00106587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110499770|NCT00106587|Tubulin Modulators|tubulin modulators|mesh-ancestor
110499771|NCT00106587|Antimitotic Agents|antimitotic agents|mesh-ancestor
110499772|NCT00106587|Mitosis Modulators|mitosis modulators|mesh-ancestor
110499773|NCT00106587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110499774|NCT00694863|Cosyntropin|cosyntropin|mesh-list
110499775|NCT00694863|Adrenocorticotropin zinc|adrenocorticotropin zinc|mesh-list
110499776|NCT00694863|Hormones|hormones|mesh-ancestor
110499777|NCT00694863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110499778|NCT00694863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110499779|NCT00629213|Acarbose|acarbose|mesh-list
110499780|NCT00629213|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
110499781|NCT00629213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110168583|NCT00035425|Vancomycin|vancomycin|mesh-list
110499782|NCT00629213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110499783|NCT00629213|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110499784|NCT00629213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110499785|NCT00978341|Pregabalin|pregabalin|mesh-list
110499786|NCT00978341|Analgesics|analgesics|mesh-ancestor
110499787|NCT00978341|Sensory System Agents|sensory system agents|mesh-ancestor
110499788|NCT00978341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110499789|NCT00978341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110499790|NCT00978341|Anticonvulsants|anticonvulsants|mesh-ancestor
110499791|NCT00978341|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110499792|NCT00978341|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110499793|NCT00978341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110499794|NCT00978341|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110499795|NCT00978341|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110499796|NCT00978341|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110609166|NCT02565836|Hemostatics|hemostatics|mesh-ancestor
110499797|NCT00978341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110499798|NCT00978341|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110499799|NCT00695331|Misoprostol|misoprostol|mesh-list
110499800|NCT00695331|Oxytocin|oxytocin|mesh-list
110499801|NCT00695331|Oxytocics|oxytocics|mesh-ancestor
110499802|NCT00695331|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110499803|NCT00695331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110499804|NCT00695331|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110499805|NCT00695331|Abortifacient Agents|abortifacient agents|mesh-ancestor
110499806|NCT00695331|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110499807|NCT00695331|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110499808|NCT00695643|Mesalamine|mesalamine|mesh-list
110499809|NCT00695643|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110499810|NCT00695643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110499811|NCT00695643|Analgesics|analgesics|mesh-ancestor
110499812|NCT00695643|Sensory System Agents|sensory system agents|mesh-ancestor
110499813|NCT00695643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110499814|NCT00695643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110499815|NCT00695643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110499816|NCT00695643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110499817|NCT02623881|Progesterone|progesterone|mesh-list
110499818|NCT02623881|Progestins|progestins|mesh-ancestor
110499819|NCT02623881|Hormones|hormones|mesh-ancestor
110499820|NCT02623881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110499821|NCT02623881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110499822|NCT04135833|Itraconazole|itraconazole|mesh-list
110499823|NCT04135833|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
110499824|NCT04135833|Rifampin|rifampin|mesh-list
110499825|NCT04135833|Antifungal Agents|antifungal agents|mesh-ancestor
110499826|NCT04135833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110499827|NCT04135833|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110499828|NCT04135833|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110499829|NCT04135833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110609216|NCT00752466|Topiramate|topiramate|mesh-list
110499830|NCT04135833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110499831|NCT04135833|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110499832|NCT04135833|Hormone Antagonists|hormone antagonists|mesh-ancestor
110499833|NCT04135833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110499834|NCT04135833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110499835|NCT04135833|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110499836|NCT04135833|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110499837|NCT04135833|Antitubercular Agents|antitubercular agents|mesh-ancestor
110499838|NCT04135833|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110499839|NCT04135833|Leprostatic Agents|leprostatic agents|mesh-ancestor
110499840|NCT04135833|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110499841|NCT04135833|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110499842|NCT04135833|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110499843|NCT04135833|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110499844|NCT04135833|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110499845|NCT04135833|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110499846|NCT04135833|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110499847|NCT00696033|Diazepam|diazepam|mesh-list
110499848|NCT00696033|Lorazepam|lorazepam|mesh-list
110499849|NCT00696033|Anticonvulsants|anticonvulsants|mesh-ancestor
110499850|NCT00696033|Antiemetics|antiemetics|mesh-ancestor
110499851|NCT00696033|Autonomic Agents|autonomic agents|mesh-ancestor
110499852|NCT00696033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110499853|NCT00696033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110499854|NCT00696033|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110499855|NCT00696033|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110499856|NCT00696033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110499858|NCT00696033|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110499859|NCT00696033|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110499860|NCT00696033|GABA Modulators|gaba modulators|mesh-ancestor
110499861|NCT00696033|GABA Agents|gaba agents|mesh-ancestor
110499862|NCT00696033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110499863|NCT00696033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110499864|NCT00696033|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110499865|NCT00696033|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110499866|NCT00696033|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110499867|NCT00696033|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110499868|NCT00696033|Anesthetics, General|anesthetics, general|mesh-ancestor
110499869|NCT00696033|Anesthetics|anesthetics|mesh-ancestor
110499870|NCT02623569|Atenolol|atenolol|mesh-list
110499871|NCT02623569|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110499872|NCT02623569|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110499873|NCT02623569|Sympatholytics|sympatholytics|mesh-ancestor
110499874|NCT02623569|Autonomic Agents|autonomic agents|mesh-ancestor
110499875|NCT02623569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110499876|NCT02623569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110499877|NCT02623569|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110499878|NCT02623569|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110282272|NCT00473590|Bevacizumab|bevacizumab|mesh-list
110499879|NCT02623569|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110499880|NCT02623569|Adrenergic Agents|adrenergic agents|mesh-ancestor
110499881|NCT02623569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110499882|NCT02623569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110499883|NCT00977561|Cisplatin|cisplatin|mesh-list
110499884|NCT00977561|Carboplatin|carboplatin|mesh-list
110499885|NCT00977561|Etoposide|etoposide|mesh-list
110499886|NCT00977561|Etoposide phosphate|etoposide phosphate|mesh-list
110499887|NCT00977561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110499888|NCT00977561|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110499889|NCT00977561|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110499890|NCT00977561|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110499891|NCT00977561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110499892|NCT00977561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110499894|NCT04291313|Ergocalciferols|ergocalciferols|mesh-list
110499895|NCT04291313|Cholecalciferol|cholecalciferol|mesh-list
110499896|NCT04291313|Vitamins|vitamins|mesh-list
110499897|NCT04291313|Micronutrients|micronutrients|mesh-ancestor
110499898|NCT04291313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110499899|NCT04291313|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110499900|NCT04291313|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110499901|NCT02866253|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
110499902|NCT02866253|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110499903|NCT02866253|Immunologic Factors|immunologic factors|mesh-ancestor
110499904|NCT02866253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110499905|NCT02865785|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
110499906|NCT02865785|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
110499907|NCT02865785|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
110499908|NCT02865785|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110499909|NCT00594165|Rotigotine|rotigotine|mesh-list
110499910|NCT00594165|Dopamine Agonists|dopamine agonists|mesh-ancestor
110499911|NCT00594165|Dopamine Agents|dopamine agents|mesh-ancestor
110499912|NCT00594165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110499913|NCT00594165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110499914|NCT00594165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110499915|NCT00928070|Fesoterodine|fesoterodine|mesh-list
110499916|NCT00928070|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110499917|NCT00928070|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110499918|NCT00928070|Cholinergic Agents|cholinergic agents|mesh-ancestor
110499919|NCT00928070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110499920|NCT00928070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110499921|NCT00928070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110499922|NCT00928070|Urological Agents|urological agents|mesh-ancestor
110499923|NCT04012073|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
110499924|NCT04012073|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110499925|NCT04012073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110499926|NCT04012073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110499928|NCT04001621|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110499929|NCT04001621|Antimetabolites|antimetabolites|mesh-ancestor
110499930|NCT04001621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110499931|NCT04001621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110499932|NCT00976937|Metformin|metformin|mesh-list
110499933|NCT00976937|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110499934|NCT00976937|Lixisenatide|lixisenatide|mesh-list
110499935|NCT00976937|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110499936|NCT00976937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110499937|NCT00976937|Incretins|incretins|mesh-ancestor
110499938|NCT00976937|Hormones|hormones|mesh-ancestor
110499939|NCT00976937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110499940|NCT00976937|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110499941|NCT00976937|Protease Inhibitors|protease inhibitors|mesh-ancestor
110499942|NCT00976937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110499943|NCT00976937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110499944|NCT02623023|Brimonidine Tartrate, Timolol Maleate Drug Combination|brimonidine tartrate, timolol maleate drug combination|mesh-list
110499945|NCT02623023|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110499946|NCT02623023|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110499947|NCT02623023|Adrenergic Agents|adrenergic agents|mesh-ancestor
110499948|NCT02623023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110499949|NCT02623023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110499950|NCT02623023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110499951|NCT02623023|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110499952|NCT02623023|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110499953|NCT02623023|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110499954|NCT04256252|Rituximab|rituximab|mesh-list
110499955|NCT04256252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110499956|NCT04256252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110499957|NCT04256252|Immunologic Factors|immunologic factors|mesh-ancestor
110609383|NCT00757458|Anesthetics|anesthetics|mesh-ancestor
110499958|NCT04256252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110499959|NCT04256252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110499961|NCT02622555|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
110499962|NCT02622555|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110499963|NCT02622555|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110499964|NCT02622555|Adrenergic Agents|adrenergic agents|mesh-ancestor
110499965|NCT02622555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110499966|NCT02622555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110499967|NCT02622555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110499968|NCT02622555|Urological Agents|urological agents|mesh-ancestor
110499969|NCT05329454|Ibuprofen|ibuprofen|mesh-list
110499970|NCT05329454|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110499971|NCT05329454|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110499972|NCT05329454|Analgesics|analgesics|mesh-ancestor
110499973|NCT05329454|Sensory System Agents|sensory system agents|mesh-ancestor
110499974|NCT05329454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110499975|NCT05329454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110499976|NCT05329454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110499977|NCT05329454|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110499978|NCT05329454|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110499979|NCT05329454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110499980|NCT05329454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110499981|NCT00629447|Tinzaparin|tinzaparin|mesh-list
110499982|NCT00629447|Anticoagulants|anticoagulants|mesh-ancestor
110499983|NCT00629447|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110499984|NCT00629447|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110499985|NCT00629447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110499987|NCT02622477|Analgesics|analgesics|mesh-ancestor
110499988|NCT02622477|Sensory System Agents|sensory system agents|mesh-ancestor
110499989|NCT02622477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110311792|NCT00303615|Anastrozole|anastrozole|mesh-list
110499990|NCT02622477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110499991|NCT02622477|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110499992|NCT02622477|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110499993|NCT02622477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110499994|NCT02622477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110499995|NCT02622477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110499997|NCT02622243|Tiotropium Bromide|tiotropium bromide|mesh-list
110499998|NCT02622243|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110499999|NCT02622243|Autonomic Agents|autonomic agents|mesh-ancestor
110500000|NCT02622243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110500001|NCT02622243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110500002|NCT02622243|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110500003|NCT02622243|Respiratory System Agents|respiratory system agents|mesh-ancestor
110500004|NCT02622243|Parasympatholytics|parasympatholytics|mesh-ancestor
110500005|NCT02622243|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110500006|NCT02622243|Cholinergic Agents|cholinergic agents|mesh-ancestor
110500007|NCT02622243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110500008|NCT02622243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110500009|NCT02622243|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110500010|NCT02622243|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110500011|NCT04289675|Interferons|interferons|mesh-list
110500012|NCT04289675|Interferon-beta|interferon-beta|mesh-list
110500013|NCT04289675|Teriflunomide|teriflunomide|mesh-list
110500014|NCT04289675|Dimethyl Fumarate|dimethyl fumarate|mesh-list
110500015|NCT04289675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110500016|NCT04289675|Antiviral Agents|antiviral agents|mesh-ancestor
110500017|NCT04289675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110500018|NCT04289675|Immunologic Factors|immunologic factors|mesh-ancestor
110500019|NCT04289675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110500020|NCT04289675|Dermatologic Agents|dermatologic agents|mesh-ancestor
110500021|NCT04289675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110500022|NCT04289675|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110500023|NCT04289675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110500024|NCT04289675|Analgesics|analgesics|mesh-ancestor
110500025|NCT04289675|Sensory System Agents|sensory system agents|mesh-ancestor
110500026|NCT04289675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110500027|NCT04289675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110500028|NCT04289675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110500029|NCT00696579|Gemcitabine|gemcitabine|mesh-list
110500030|NCT00696579|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110500031|NCT00696579|Antimetabolites|antimetabolites|mesh-ancestor
110500032|NCT00696579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110500033|NCT00696579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110500034|NCT02865629|Acetylcysteine|acetylcysteine|mesh-list
110500035|NCT02865629|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110500036|NCT02865629|Antiviral Agents|antiviral agents|mesh-ancestor
110500037|NCT02865629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110500038|NCT02865629|Expectorants|expectorants|mesh-ancestor
110500039|NCT02865629|Respiratory System Agents|respiratory system agents|mesh-ancestor
110500040|NCT02865629|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110500041|NCT02865629|Antioxidants|antioxidants|mesh-ancestor
110500042|NCT02865629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110500043|NCT02865629|Protective Agents|protective agents|mesh-ancestor
110500044|NCT02865629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110500045|NCT02865629|Antidotes|antidotes|mesh-ancestor
110500046|NCT02867345|Cyclophosphamide|cyclophosphamide|mesh-list
110500047|NCT02867345|Interleukin-2|interleukin-2|mesh-list
110500048|NCT02867345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110500049|NCT02867345|Immunologic Factors|immunologic factors|mesh-ancestor
110500050|NCT02867345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110500051|NCT02867345|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110500052|NCT02867345|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110500053|NCT02867345|Alkylating Agents|alkylating agents|mesh-ancestor
110500054|NCT02867345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110500055|NCT02867345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110500056|NCT02867345|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110500057|NCT02867345|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110500059|NCT02867345|Sensory System Agents|sensory system agents|mesh-ancestor
110500060|NCT02867345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110500061|NCT00975689|Acetylcysteine|acetylcysteine|mesh-list
110500062|NCT00975689|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110500063|NCT00975689|Antiviral Agents|antiviral agents|mesh-ancestor
110500065|NCT00975689|Expectorants|expectorants|mesh-ancestor
110500066|NCT00975689|Respiratory System Agents|respiratory system agents|mesh-ancestor
110500067|NCT00975689|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110500068|NCT00975689|Antioxidants|antioxidants|mesh-ancestor
110500069|NCT00975689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110500070|NCT00975689|Protective Agents|protective agents|mesh-ancestor
110500071|NCT00975689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110500072|NCT00975689|Antidotes|antidotes|mesh-ancestor
110500074|NCT02621385|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110500075|NCT02621385|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110500076|NCT02621385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110500077|NCT02621385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110609538|NCT00753402|Adrenergic Agents|adrenergic agents|mesh-ancestor
110609539|NCT00753402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110609540|NCT00753402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110500078|NCT02621385|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110500079|NCT02621385|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110500080|NCT02621385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110500081|NCT02621385|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110500082|NCT02621385|Anesthetics, General|anesthetics, general|mesh-ancestor
110500084|NCT02621385|GABA Modulators|gaba modulators|mesh-ancestor
110500085|NCT02621385|GABA Agents|gaba agents|mesh-ancestor
110500086|NCT02621385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110500087|NCT02621385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110500088|NCT00922766|Dalteparin|dalteparin|mesh-list
110500089|NCT00922766|Tinzaparin|tinzaparin|mesh-list
110500090|NCT00922766|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
110500091|NCT00922766|Anticoagulants|anticoagulants|mesh-ancestor
110500092|NCT00922766|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110500093|NCT00922766|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110500094|NCT00922766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110500095|NCT04134897|Capecitabine|capecitabine|mesh-list
110500096|NCT04134897|Oxaliplatin|oxaliplatin|mesh-list
110500097|NCT04134897|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110500098|NCT04134897|Antimetabolites|antimetabolites|mesh-ancestor
110500099|NCT04134897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110500100|NCT04134897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110500101|NCT02620995|Sildenafil Citrate|sildenafil citrate|mesh-list
110282616|NCT00125489|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110500102|NCT02620995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110500103|NCT02620995|Vasodilator Agents|vasodilator agents|mesh-ancestor
110500104|NCT02620995|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110500105|NCT02620995|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110500106|NCT02620995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110500107|NCT02620995|Urological Agents|urological agents|mesh-ancestor
110500109|NCT02620839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110500110|NCT02620605|Cabergoline|cabergoline|mesh-list
110500111|NCT02620605|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110500112|NCT02620605|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110500113|NCT02620605|Dopamine Agonists|dopamine agonists|mesh-ancestor
110500114|NCT02620605|Dopamine Agents|dopamine agents|mesh-ancestor
110500115|NCT02620605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110500116|NCT02620605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110500117|NCT02620605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110500118|NCT00976391|Insulin|insulin|mesh-list
110500119|NCT00976391|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110500120|NCT00976391|Insulin Glargine|insulin glargine|mesh-list
110500121|NCT00976391|Insulin Lispro|insulin lispro|mesh-list
110500122|NCT00976391|rGLP-1 protein|rglp-1 protein|mesh-list
110500123|NCT00976391|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110500124|NCT00976391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110609605|NCT00753792|Hormones|hormones|mesh-ancestor
110500125|NCT00976391|Incretins|incretins|mesh-ancestor
110500126|NCT00976391|Hormones|hormones|mesh-ancestor
110500127|NCT00976391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110500128|NCT04252664|Remdesivir|remdesivir|mesh-list
110500129|NCT04252664|Antimetabolites|antimetabolites|mesh-ancestor
110500130|NCT04252664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110500131|NCT04252664|Antiviral Agents|antiviral agents|mesh-ancestor
110500132|NCT04252664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110500133|NCT00696969|Amphotericin B|amphotericin b|mesh-list
110500134|NCT00696969|Paromomycin|paromomycin|mesh-list
110500135|NCT00696969|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
110500136|NCT00696969|Miltefosine|miltefosine|mesh-list
110500137|NCT00696969|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
110500138|NCT00696969|Deoxycholic Acid|deoxycholic acid|mesh-list
110500139|NCT00696969|Amebicides|amebicides|mesh-ancestor
110275619|NCT00203814|Artesunate|artesunate|mesh-list
110500141|NCT00696969|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110500142|NCT00696969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110500143|NCT00696969|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110500144|NCT00696969|Antifungal Agents|antifungal agents|mesh-ancestor
110500145|NCT00696969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110500146|NCT00696969|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
110500147|NCT00696969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110500148|NCT04203680|Cardioplegic Solutions|cardioplegic solutions|mesh-list
110500149|NCT04203680|Tryptophan|tryptophan|mesh-list
110500150|NCT04203680|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110500151|NCT04203680|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110500152|NCT04203680|Antidepressive Agents|antidepressive agents|mesh-ancestor
110500153|NCT04203680|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110500154|NCT02620215|Dinoprostone|dinoprostone|mesh-list
110500155|NCT02620215|Oxytocics|oxytocics|mesh-ancestor
110500156|NCT02620215|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110500157|NCT02620215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110500158|NCT02620293|Emollients|emollients|mesh-list
110500159|NCT02620293|Dermatologic Agents|dermatologic agents|mesh-ancestor
110500160|NCT02619981|Lidocaine|lidocaine|mesh-list
110500161|NCT02619981|Anesthetics, Local|anesthetics, local|mesh-ancestor
110500162|NCT02619981|Anesthetics|anesthetics|mesh-ancestor
110500163|NCT02619981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110500164|NCT02619981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110500165|NCT02619981|Sensory System Agents|sensory system agents|mesh-ancestor
110500166|NCT02619981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110500167|NCT02619981|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110500168|NCT02619981|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110500169|NCT02619981|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110500170|NCT02619981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110500171|NCT02619981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110500172|NCT02619669|Letrozole|letrozole|mesh-list
110500173|NCT02619669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110500174|NCT02619669|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110500175|NCT02619669|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110500176|NCT02619669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110147474|NCT00006345|Dexamethasone|dexamethasone|mesh-list
110500177|NCT02619669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110609674|NCT00694304|Vortioxetine|vortioxetine|mesh-list
110500178|NCT02619669|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110500179|NCT02619669|Hormone Antagonists|hormone antagonists|mesh-ancestor
110500180|NCT02619669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110500181|NCT02619669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110500182|NCT03965117|Norepinephrine|norepinephrine|mesh-list
110500183|NCT03965117|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110500184|NCT03965117|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110500185|NCT03965117|Adrenergic Agents|adrenergic agents|mesh-ancestor
110500186|NCT03965117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110500187|NCT03965117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110500188|NCT03965117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110500189|NCT03965117|Sympathomimetics|sympathomimetics|mesh-ancestor
110500190|NCT03965117|Autonomic Agents|autonomic agents|mesh-ancestor
110500191|NCT03965117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110500192|NCT03965117|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110500193|NCT00917462|Sorafenib|sorafenib|mesh-list
110500194|NCT00917462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110500195|NCT00917462|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110500196|NCT00917462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110500197|NCT00917462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110500198|NCT02619513|Dexmedetomidine|dexmedetomidine|mesh-list
110500199|NCT02619513|Ropivacaine|ropivacaine|mesh-list
110500200|NCT02619513|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110500201|NCT02619513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110500202|NCT02619513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110500203|NCT02619513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110500204|NCT02619513|Analgesics|analgesics|mesh-ancestor
110500205|NCT02619513|Sensory System Agents|sensory system agents|mesh-ancestor
110500206|NCT02619513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110500207|NCT02619513|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110500208|NCT02619513|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110500209|NCT02619513|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110500210|NCT02619513|Adrenergic Agents|adrenergic agents|mesh-ancestor
110500211|NCT02619513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110500212|NCT02619513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110500213|NCT02619513|Anesthetics, Local|anesthetics, local|mesh-ancestor
110500214|NCT02619513|Anesthetics|anesthetics|mesh-ancestor
110500215|NCT03947255|Brentuximab Vedotin|brentuximab vedotin|mesh-list
110500216|NCT03947255|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110500217|NCT03947255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110500218|NCT03947255|Immunotoxins|immunotoxins|mesh-ancestor
110500219|NCT03947255|Immunoconjugates|immunoconjugates|mesh-ancestor
110500220|NCT03947255|Immunologic Factors|immunologic factors|mesh-ancestor
110500221|NCT03947255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110500222|NCT02619747|Alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|mesh-list
110500223|NCT02619747|Antacids|antacids|mesh-ancestor
110500224|NCT02619747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110500225|NCT02619747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110500226|NCT00697125|Vaccines|vaccines|mesh-list
110500227|NCT00697125|Immunologic Factors|immunologic factors|mesh-ancestor
110500228|NCT00697125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110500229|NCT04134273|Clindamycin|clindamycin|mesh-list
110500230|NCT04134273|Clindamycin palmitate|clindamycin palmitate|mesh-list
110500231|NCT04134273|Clindamycin phosphate|clindamycin phosphate|mesh-list
110500232|NCT04134273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110500233|NCT04134273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110500234|NCT04134273|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110500235|NCT04134273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110500236|NCT04134273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110500237|NCT04134117|Tisagenlecleucel|tisagenlecleucel|mesh-list
110500238|NCT04134117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110500239|NCT04134117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110500240|NCT03853187|Durvalumab|durvalumab|mesh-list
110500241|NCT03853187|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110500242|NCT03853187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110500243|NCT03853187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110500244|NCT03853187|Immunologic Factors|immunologic factors|mesh-ancestor
110500245|NCT03853187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110500246|NCT03849443|Tranexamic Acid|tranexamic acid|mesh-list
110500247|NCT03849443|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110500248|NCT03849443|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110500249|NCT03849443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110500250|NCT03849443|Hemostatics|hemostatics|mesh-ancestor
110500251|NCT03849443|Coagulants|coagulants|mesh-ancestor
110500252|NCT00697281|Indoleacetic Acids|indoleacetic acids|mesh-list
110500253|NCT00697281|Plant Growth Regulators|plant growth regulators|mesh-ancestor
110500254|NCT00697281|Growth Substances|growth substances|mesh-ancestor
110500255|NCT00697281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110500256|NCT00979901|Loratadine|loratadine|mesh-list
110500257|NCT00979901|Montelukast|montelukast|mesh-list
110500258|NCT00979901|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110500259|NCT00979901|Respiratory System Agents|respiratory system agents|mesh-ancestor
110275631|NCT00203814|Anthelmintics|anthelmintics|mesh-ancestor
110500260|NCT00979901|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110500261|NCT00979901|Hormone Antagonists|hormone antagonists|mesh-ancestor
110500262|NCT00979901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110500263|NCT00979901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110168622|NCT00035464|Azimilide|azimilide|mesh-list
110500264|NCT00979901|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110500265|NCT00979901|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110500266|NCT00979901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110500267|NCT00979901|Antipruritics|antipruritics|mesh-ancestor
110500268|NCT00979901|Dermatologic Agents|dermatologic agents|mesh-ancestor
110500269|NCT00979901|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110500270|NCT00979901|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110500271|NCT00979901|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110500272|NCT00979901|Histamine Antagonists|histamine antagonists|mesh-ancestor
110500273|NCT00979901|Histamine Agents|histamine agents|mesh-ancestor
110500274|NCT00979901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110500275|NCT02619201|Ondansetron|ondansetron|mesh-list
110500276|NCT02619201|Metoclopramide|metoclopramide|mesh-list
110500277|NCT02619201|Antiemetics|antiemetics|mesh-ancestor
110500278|NCT02619201|Autonomic Agents|autonomic agents|mesh-ancestor
110500279|NCT02619201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110500280|NCT02619201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110500281|NCT02619201|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110500282|NCT02619201|Antipruritics|antipruritics|mesh-ancestor
110500283|NCT02619201|Dermatologic Agents|dermatologic agents|mesh-ancestor
110500284|NCT02619201|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110500285|NCT02619201|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110500287|NCT02619201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110500288|NCT02619201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110500289|NCT02619201|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110500290|NCT02619201|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110500291|NCT02619201|Dopamine Agents|dopamine agents|mesh-ancestor
110500292|NCT00975611|Amantadine|amantadine|mesh-list
110500293|NCT00975611|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110500294|NCT00975611|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110500295|NCT00975611|Antiviral Agents|antiviral agents|mesh-ancestor
110500296|NCT00975611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110500297|NCT00975611|Dopamine Agents|dopamine agents|mesh-ancestor
110500298|NCT00975611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110500299|NCT00975611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110500300|NCT00975611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110500301|NCT00975611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110500302|NCT00975611|Analgesics|analgesics|mesh-ancestor
110500303|NCT00975611|Sensory System Agents|sensory system agents|mesh-ancestor
110500304|NCT00975611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110500305|NCT02865005|Dapsone|dapsone|mesh-list
110500306|NCT02865005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110500307|NCT02865005|Antimalarials|antimalarials|mesh-ancestor
110500308|NCT02865005|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110500309|NCT02865005|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110500310|NCT02865005|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110500311|NCT02865005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110500312|NCT02865005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110500313|NCT02865005|Leprostatic Agents|leprostatic agents|mesh-ancestor
110500314|NCT02865005|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110500315|NCT02862977|Ketoprofen|ketoprofen|mesh-list
110500316|NCT02862977|Amitriptyline|amitriptyline|mesh-list
110500317|NCT02862977|Cyclobenzaprine|cyclobenzaprine|mesh-list
110500318|NCT02862977|Caffeine|caffeine|mesh-list
110500319|NCT02862977|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110282702|NCT00125684|Morphine|morphine|mesh-list
110500320|NCT02862977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110500321|NCT02862977|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110500322|NCT02862977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110500323|NCT02862977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110500324|NCT02862977|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110500325|NCT02862977|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110500326|NCT02862977|Purinergic Agents|purinergic agents|mesh-ancestor
110500327|NCT02862977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110500328|NCT02862977|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110500329|NCT02862977|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110500330|NCT02862977|Analgesics|analgesics|mesh-ancestor
110500331|NCT02862977|Sensory System Agents|sensory system agents|mesh-ancestor
110500332|NCT02862977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110500333|NCT02862977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110500334|NCT02862977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110500335|NCT02862977|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110500336|NCT02862977|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110500337|NCT02862977|Antidepressive Agents|antidepressive agents|mesh-ancestor
110500338|NCT02862977|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110500339|NCT02862977|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110500340|NCT02862977|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110500341|NCT02862977|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110500342|NCT02862977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110500343|NCT02862977|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110500344|NCT02862977|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110500345|NCT02862977|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110500346|NCT02862977|Adrenergic Agents|adrenergic agents|mesh-ancestor
110500347|NCT02864927|Vaccines|vaccines|mesh-list
110500348|NCT02864927|Immunologic Factors|immunologic factors|mesh-ancestor
110500349|NCT02864927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110500350|NCT02618499|Oxytocin|oxytocin|mesh-list
110500351|NCT02618499|Oxytocics|oxytocics|mesh-ancestor
110500352|NCT02618499|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110500353|NCT02618499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110500354|NCT04133961|Phenylephrine|phenylephrine|mesh-list
110500355|NCT04133961|Oxymetazoline|oxymetazoline|mesh-list
110500356|NCT04133961|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110500357|NCT04133961|Mydriatics|mydriatics|mesh-ancestor
110500358|NCT04133961|Autonomic Agents|autonomic agents|mesh-ancestor
110500359|NCT04133961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110500360|NCT04133961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110500362|NCT04133961|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110500363|NCT04133961|Nasal Decongestants|nasal decongestants|mesh-ancestor
110500364|NCT04133961|Respiratory System Agents|respiratory system agents|mesh-ancestor
110500365|NCT04133961|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110500366|NCT04133961|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110500367|NCT04133961|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110500368|NCT04133961|Adrenergic Agents|adrenergic agents|mesh-ancestor
110500369|NCT04133961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110500370|NCT04133961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110500371|NCT04133961|Protective Agents|protective agents|mesh-ancestor
110500372|NCT02618733|Clopidogrel|clopidogrel|mesh-list
110500373|NCT02618733|Ticagrelor|ticagrelor|mesh-list
110500374|NCT02618733|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110500375|NCT02618733|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110500376|NCT02618733|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110500377|NCT02618733|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110500378|NCT02618733|Purinergic Agents|purinergic agents|mesh-ancestor
110500379|NCT02618733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110500380|NCT02618733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110500381|NCT02618733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110500382|NCT00970307|Vaccines|vaccines|mesh-list
110500383|NCT00970307|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110500384|NCT00970307|Immunologic Factors|immunologic factors|mesh-ancestor
110500385|NCT00970307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110500386|NCT00917384|Ramucirumab|ramucirumab|mesh-list
110500387|NCT00917384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110500388|NCT04133571|Lidocaine|lidocaine|mesh-list
110500389|NCT04133571|Anesthetics, Local|anesthetics, local|mesh-ancestor
110500390|NCT04133571|Anesthetics|anesthetics|mesh-ancestor
110500391|NCT04133571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110500392|NCT04133571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110500393|NCT04133571|Sensory System Agents|sensory system agents|mesh-ancestor
110500394|NCT04133571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110500395|NCT04133571|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110500396|NCT04133571|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110500397|NCT04133571|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110500398|NCT04133571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110500399|NCT04133571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110147703|NCT00005977|Antimetabolites|antimetabolites|mesh-ancestor
110500400|NCT00629681|Pregabalin|pregabalin|mesh-list
110500401|NCT00629681|Analgesics|analgesics|mesh-ancestor
110500402|NCT00629681|Sensory System Agents|sensory system agents|mesh-ancestor
110500403|NCT00629681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110500404|NCT00629681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110500405|NCT00629681|Anticonvulsants|anticonvulsants|mesh-ancestor
110500406|NCT00629681|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110500407|NCT00629681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110500408|NCT00629681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110500409|NCT00629681|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110500410|NCT00629681|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110500411|NCT00629681|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110500412|NCT00629681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110500413|NCT00629681|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110500414|NCT02617485|Prednisone|prednisone|mesh-list
110500415|NCT02617485|Cyclophosphamide|cyclophosphamide|mesh-list
110500416|NCT02617485|Rituximab|rituximab|mesh-list
110500417|NCT02617485|Doxorubicin|doxorubicin|mesh-list
110500418|NCT02617485|Vincristine|vincristine|mesh-list
110500419|NCT02617485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110500420|NCT02617485|Immunologic Factors|immunologic factors|mesh-ancestor
110500421|NCT02617485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110500422|NCT02617485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110500423|NCT02617485|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110500424|NCT02617485|Alkylating Agents|alkylating agents|mesh-ancestor
110500425|NCT02617485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110500426|NCT02617485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110500427|NCT02617485|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110500428|NCT02617485|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110500429|NCT02617485|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110500430|NCT02617485|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110500431|NCT02617485|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110500433|NCT02617485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110500434|NCT02617485|Glucocorticoids|glucocorticoids|mesh-ancestor
110500435|NCT02617485|Hormones|hormones|mesh-ancestor
110500436|NCT02617485|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110609940|NCT00955240|Fluorouracil|fluorouracil|mesh-list
110500437|NCT02617485|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110500438|NCT02617485|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110282866|NCT00206973|Diuretics|diuretics|mesh-ancestor
110500439|NCT02617485|Tubulin Modulators|tubulin modulators|mesh-ancestor
110500440|NCT02617485|Antimitotic Agents|antimitotic agents|mesh-ancestor
110500441|NCT02617485|Mitosis Modulators|mitosis modulators|mesh-ancestor
110500442|NCT04289207|Danazol|danazol|mesh-list
110500443|NCT04289207|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110500444|NCT04289207|Hormone Antagonists|hormone antagonists|mesh-ancestor
110500445|NCT04289207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110500446|NCT04289207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110500447|NCT02863835|Albuterol|albuterol|mesh-list
110500448|NCT02863835|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110500449|NCT02863835|Autonomic Agents|autonomic agents|mesh-ancestor
110500450|NCT02863835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110500451|NCT02863835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110500452|NCT02863835|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110500453|NCT02863835|Respiratory System Agents|respiratory system agents|mesh-ancestor
110500454|NCT02863835|Tocolytic Agents|tocolytic agents|mesh-ancestor
110500455|NCT02863835|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110500456|NCT02863835|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110500457|NCT02863835|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110500458|NCT02863835|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110500459|NCT02863835|Adrenergic Agents|adrenergic agents|mesh-ancestor
110282886|NCT00471445|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110500460|NCT02863835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110500461|NCT02863835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110500462|NCT00697437|Ketoconazole|ketoconazole|mesh-list
110500463|NCT00697437|Docetaxel|docetaxel|mesh-list
110500464|NCT00697437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110500465|NCT00697437|Tubulin Modulators|tubulin modulators|mesh-ancestor
110500466|NCT00697437|Antimitotic Agents|antimitotic agents|mesh-ancestor
110500467|NCT00697437|Mitosis Modulators|mitosis modulators|mesh-ancestor
110500468|NCT00697437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110500469|NCT00697437|Antifungal Agents|antifungal agents|mesh-ancestor
110500470|NCT00697437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110500471|NCT00697437|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110500472|NCT00697437|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110500473|NCT00697437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110500474|NCT00697437|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110500475|NCT00697437|Hormone Antagonists|hormone antagonists|mesh-ancestor
110500476|NCT00697437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110500477|NCT00697437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110500478|NCT00697437|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110500480|NCT04252274|Cobicistat|cobicistat|mesh-list
110500481|NCT04252274|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
110500482|NCT04252274|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110500483|NCT04252274|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110500484|NCT04252274|Protease Inhibitors|protease inhibitors|mesh-ancestor
110500485|NCT04252274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110500486|NCT04252274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110500487|NCT04252274|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110500488|NCT04252274|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110500489|NCT04252274|Antiviral Agents|antiviral agents|mesh-ancestor
110500490|NCT04252274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110500491|NCT04252274|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110500492|NCT04252274|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110500493|NCT00864513|Pemetrexed|pemetrexed|mesh-list
110500494|NCT00864513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110500495|NCT00864513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110500496|NCT00864513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110500497|NCT00864513|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110500498|NCT00864513|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110500499|NCT04128891|Valsartan|valsartan|mesh-list
110500500|NCT04128891|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
110500501|NCT04128891|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110500502|NCT04128891|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110500503|NCT04128891|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110500504|NCT04128891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110500506|NCT04251962|Bupivacaine|bupivacaine|mesh-list
110500507|NCT04251962|Anesthetics, Local|anesthetics, local|mesh-ancestor
110500508|NCT04251962|Anesthetics|anesthetics|mesh-ancestor
110500509|NCT04251962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110500510|NCT04251962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110500511|NCT04251962|Sensory System Agents|sensory system agents|mesh-ancestor
110500512|NCT04251962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110500513|NCT04251962|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110500514|NCT04251962|Narcotics|narcotics|mesh-ancestor
110500515|NCT04251962|Analgesics|analgesics|mesh-ancestor
110500516|NCT04251962|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110500517|NCT04251962|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110500519|NCT04255238|Dapagliflozin|dapagliflozin|mesh-list
110500520|NCT04255238|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110500521|NCT04255238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110500522|NCT04255238|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110500523|NCT04255238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110500524|NCT05251766|Paclitaxel|paclitaxel|mesh-list
110500525|NCT05251766|Docetaxel|docetaxel|mesh-list
110500526|NCT05251766|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110500527|NCT05251766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110500528|NCT05251766|Tubulin Modulators|tubulin modulators|mesh-ancestor
110500529|NCT05251766|Antimitotic Agents|antimitotic agents|mesh-ancestor
110500530|NCT05251766|Mitosis Modulators|mitosis modulators|mesh-ancestor
110500531|NCT05251766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110500532|NCT04254380|Insulin Lispro|insulin lispro|mesh-list
110500533|NCT04254380|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110500534|NCT04254380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110500535|NCT00631514|Acetaminophen|acetaminophen|mesh-list
110500536|NCT00631514|Ibuprofen|ibuprofen|mesh-list
110500537|NCT00631514|Piroxicam|piroxicam|mesh-list
110500538|NCT00631514|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110500539|NCT00631514|Analgesics|analgesics|mesh-ancestor
110500540|NCT00631514|Sensory System Agents|sensory system agents|mesh-ancestor
110500541|NCT00631514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110500542|NCT00631514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110500543|NCT00631514|Antipyretics|antipyretics|mesh-ancestor
110500544|NCT00631514|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110500545|NCT00631514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110500546|NCT00631514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110500547|NCT00631514|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110500548|NCT00631514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110500549|NCT00631514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110500550|NCT05253014|Acetaminophen|acetaminophen|mesh-list
110610090|NCT05300386|Escitalopram|escitalopram|mesh-list
110500551|NCT05253014|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110500552|NCT05253014|Analgesics|analgesics|mesh-ancestor
110500553|NCT05253014|Sensory System Agents|sensory system agents|mesh-ancestor
110500554|NCT05253014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110500555|NCT05253014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110500556|NCT05253014|Antipyretics|antipyretics|mesh-ancestor
110500557|NCT00659425|Immunotoxin HA22|immunotoxin ha22|mesh-list
110500558|NCT00659425|Immunotoxins|immunotoxins|mesh-ancestor
110500559|NCT00659425|Immunoconjugates|immunoconjugates|mesh-ancestor
110500560|NCT00659425|Immunologic Factors|immunologic factors|mesh-ancestor
110500561|NCT00659425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110500562|NCT00659425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110500563|NCT00656851|Pioglitazone|pioglitazone|mesh-list
110500564|NCT00656851|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110500565|NCT00656851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110500567|NCT00803335|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
110500568|NCT00803335|Hormones|hormones|mesh-ancestor
110500569|NCT00803335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110500570|NCT00803335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110500571|NCT00797953|Cardiotonic Agents|cardiotonic agents|mesh-list
110500572|NCT00656617|Cytarabine|cytarabine|mesh-list
110500573|NCT00656617|Vorinostat|vorinostat|mesh-list
110500574|NCT00656617|Idarubicin|idarubicin|mesh-list
110500575|NCT00656617|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110500576|NCT00656617|Antimetabolites|antimetabolites|mesh-ancestor
110500577|NCT00656617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110500578|NCT00656617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110500579|NCT00656617|Antiviral Agents|antiviral agents|mesh-ancestor
110500580|NCT00656617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110500581|NCT00656617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110500582|NCT00656617|Immunologic Factors|immunologic factors|mesh-ancestor
110500583|NCT00656617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110500584|NCT00656617|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110500585|NCT00656617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110500586|NCT00656617|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110500587|NCT00656617|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110500588|NCT00656617|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110500589|NCT00798343|Vaccines|vaccines|mesh-list
110500590|NCT00798343|Immunologic Factors|immunologic factors|mesh-ancestor
110500591|NCT00798343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110500592|NCT00803725|Fentanyl|fentanyl|mesh-list
110500593|NCT00803725|Mepivacaine|mepivacaine|mesh-list
110500594|NCT00803725|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110500595|NCT00803725|Narcotics|narcotics|mesh-ancestor
110500596|NCT00803725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110500597|NCT00803725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110500598|NCT00803725|Analgesics|analgesics|mesh-ancestor
110500599|NCT00803725|Sensory System Agents|sensory system agents|mesh-ancestor
110500600|NCT00803725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110500601|NCT00803725|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110500602|NCT00803725|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110500603|NCT00803725|Anesthetics, General|anesthetics, general|mesh-ancestor
110610131|NCT00755118|Vitamins|vitamins|mesh-ancestor
110500605|NCT00803725|Anesthetics, Local|anesthetics, local|mesh-ancestor
110500606|NCT00803803|Pilocarpine|pilocarpine|mesh-list
110500607|NCT00803803|Miotics|miotics|mesh-ancestor
110500608|NCT00803803|Autonomic Agents|autonomic agents|mesh-ancestor
110500609|NCT00803803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110500610|NCT00803803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110500611|NCT00803803|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
110500612|NCT00803803|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110500613|NCT00803803|Cholinergic Agents|cholinergic agents|mesh-ancestor
110500614|NCT00803803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110500615|NCT00803803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110500616|NCT04775329|Rifaximin|rifaximin|mesh-list
110500617|NCT04775329|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110500618|NCT04775329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110500619|NCT04775329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110500620|NCT00659269|Vitamins|vitamins|mesh-list
110500621|NCT00659269|Vitamin B 12|vitamin b 12|mesh-list
110500622|NCT00659269|Vitamin B 6|vitamin b 6|mesh-list
110500623|NCT00659269|Pyridoxal|pyridoxal|mesh-list
110500624|NCT00659269|Pyridoxine|pyridoxine|mesh-list
110500625|NCT00659269|Vitamin B Complex|vitamin b complex|mesh-list
110500626|NCT00659269|Vincristine|vincristine|mesh-list
110500627|NCT00659269|Vinorelbine|vinorelbine|mesh-list
110500629|NCT00659269|Cisplatin|cisplatin|mesh-list
110500630|NCT00659269|Oxaliplatin|oxaliplatin|mesh-list
110500631|NCT00659269|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110500632|NCT00659269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110500633|NCT00659269|Tubulin Modulators|tubulin modulators|mesh-ancestor
110500634|NCT00659269|Antimitotic Agents|antimitotic agents|mesh-ancestor
110500635|NCT00659269|Mitosis Modulators|mitosis modulators|mesh-ancestor
110500636|NCT00659269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110500637|NCT00659269|Micronutrients|micronutrients|mesh-ancestor
110500638|NCT00659269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110500639|NCT00922129|Cyclosporine|cyclosporine|mesh-list
110500640|NCT00922129|Sirolimus|sirolimus|mesh-list
110500641|NCT00922129|Temsirolimus|temsirolimus|mesh-list
110500642|NCT00922129|MTOR Inhibitors|mtor inhibitors|mesh-list
110500643|NCT00922129|Tacrolimus|tacrolimus|mesh-list
110500644|NCT00922129|Cyclosporins|cyclosporins|mesh-list
110500645|NCT00922129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110500646|NCT00922129|Immunologic Factors|immunologic factors|mesh-ancestor
110500647|NCT00922129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110500648|NCT00922129|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110500649|NCT00922129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110500650|NCT00922129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110500651|NCT00922129|Antifungal Agents|antifungal agents|mesh-ancestor
110610142|NCT00549640|Methylphenidate|methylphenidate|mesh-list
110500652|NCT00922129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110500654|NCT00922129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110500655|NCT00922129|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110500656|NCT00922129|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110500657|NCT00922129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110283019|NCT00207402|Antimetabolites|antimetabolites|mesh-ancestor
110500658|NCT00922129|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110500659|NCT00806299|Loperamide|loperamide|mesh-list
110500660|NCT00806299|Antidiarrheals|antidiarrheals|mesh-list
110500661|NCT00806299|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110500662|NCT00804115|Timolol|timolol|mesh-list
110500663|NCT00804115|Latanoprost|latanoprost|mesh-list
110500664|NCT00804115|Pilocarpine|pilocarpine|mesh-list
110500665|NCT00804115|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110500666|NCT00804115|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110500667|NCT00804115|Adrenergic Agents|adrenergic agents|mesh-ancestor
110168675|NCT00000758|Immunologic Factors|immunologic factors|mesh-ancestor
110500668|NCT00804115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110500669|NCT00804115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110500670|NCT00804115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110500671|NCT00804115|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110500672|NCT00804115|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110500673|NCT00804115|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110500674|NCT00804115|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110500676|NCT00804115|Autonomic Agents|autonomic agents|mesh-ancestor
110500677|NCT00804115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110500678|NCT00804115|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
110500679|NCT00804115|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110500680|NCT00804115|Cholinergic Agents|cholinergic agents|mesh-ancestor
110500682|NCT02554123|Petrolatum|petrolatum|mesh-list
110500683|NCT02554123|Vitamins|vitamins|mesh-ancestor
110500684|NCT02554123|Micronutrients|micronutrients|mesh-ancestor
110500685|NCT02554123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110500686|NCT02554123|Antioxidants|antioxidants|mesh-ancestor
110500687|NCT02554123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110500688|NCT02554123|Protective Agents|protective agents|mesh-ancestor
110500689|NCT02554123|Emollients|emollients|mesh-ancestor
110500690|NCT02554123|Dermatologic Agents|dermatologic agents|mesh-ancestor
110500691|NCT00799045|Clopidogrel|clopidogrel|mesh-list
110500692|NCT00799045|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110500693|NCT00799045|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110500694|NCT00799045|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110500695|NCT00799045|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110500696|NCT00799045|Purinergic Agents|purinergic agents|mesh-ancestor
110500697|NCT00799045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110500698|NCT00799045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110500699|NCT00799045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110500700|NCT00658333|Mycophenolic Acid|mycophenolic acid|mesh-list
110148006|NCT00006372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110500701|NCT00658333|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110500702|NCT00658333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110500703|NCT00658333|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110500704|NCT00658333|Antitubercular Agents|antitubercular agents|mesh-ancestor
110500705|NCT00658333|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110500706|NCT00658333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110500707|NCT00658333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110500708|NCT00658333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110500709|NCT00804271|Memantine|memantine|mesh-list
110500710|NCT00804271|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110500711|NCT00804271|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110500712|NCT00804271|Dopamine Agents|dopamine agents|mesh-ancestor
110500713|NCT00804271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110500714|NCT00804271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110500715|NCT00804271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110500716|NCT00804271|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110500717|NCT00804271|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110500718|NCT00799201|Naloxone|naloxone|mesh-list
110500719|NCT00799201|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110500720|NCT00799201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110500721|NCT00799201|Sensory System Agents|sensory system agents|mesh-ancestor
110500722|NCT00799201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110500723|NCT00806611|Ethanol|ethanol|mesh-list
110500724|NCT00806611|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110500725|NCT00806611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110500726|NCT00806611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110500727|NCT00806611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110500728|NCT00799513|Lenalidomide|lenalidomide|mesh-list
110500729|NCT00799513|Immunologic Factors|immunologic factors|mesh-ancestor
110500730|NCT00799513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110500731|NCT00799513|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110500732|NCT00799513|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110500733|NCT00799513|Growth Substances|growth substances|mesh-ancestor
110168677|NCT00035620|Lenograstim|lenograstim|mesh-list
110500734|NCT00799513|Growth Inhibitors|growth inhibitors|mesh-ancestor
110500735|NCT00799513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110500736|NCT00806767|Fludarabine|fludarabine|mesh-list
110500737|NCT00806767|Fludarabine phosphate|fludarabine phosphate|mesh-list
110500738|NCT00806767|Busulfan|busulfan|mesh-list
110500739|NCT00806767|Immunoglobulins|immunoglobulins|mesh-list
110500740|NCT00806767|Antibodies|antibodies|mesh-list
110500741|NCT00806767|gamma-Globulins|gamma-globulins|mesh-list
110500742|NCT00806767|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110500743|NCT00806767|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110500744|NCT00806767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110500745|NCT00806767|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110500746|NCT00806767|Antimetabolites|antimetabolites|mesh-ancestor
110500747|NCT00806767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110500748|NCT00806767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110500749|NCT00806767|Immunologic Factors|immunologic factors|mesh-ancestor
110500750|NCT00806767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110500751|NCT00806767|Alkylating Agents|alkylating agents|mesh-ancestor
110500752|NCT00806767|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110500753|NCT00806767|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110500754|NCT00863655|Everolimus|everolimus|mesh-list
110500755|NCT00863655|Exemestane|exemestane|mesh-list
110500756|NCT00863655|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110500757|NCT00863655|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110500758|NCT00863655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110500759|NCT00863655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110500760|NCT00863655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110500761|NCT00863655|Immunologic Factors|immunologic factors|mesh-ancestor
110500762|NCT00863655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110500763|NCT00863655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110500765|NCT00863655|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110500766|NCT00863655|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110500767|NCT00863655|Hormone Antagonists|hormone antagonists|mesh-ancestor
110500768|NCT00863655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110500769|NCT00806923|Bevacizumab|bevacizumab|mesh-list
110500770|NCT00806923|Gemcitabine|gemcitabine|mesh-list
110500771|NCT00806923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110500772|NCT00806923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110500773|NCT00806923|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110500774|NCT00806923|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110500775|NCT00806923|Growth Substances|growth substances|mesh-ancestor
110500776|NCT00806923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110500777|NCT00806923|Growth Inhibitors|growth inhibitors|mesh-ancestor
110148077|NCT00006396|Zidovudine|zidovudine|mesh-list
110500778|NCT00806923|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110500779|NCT00806923|Antimetabolites|antimetabolites|mesh-ancestor
110500780|NCT00806923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110500781|NCT00698607|Sirolimus|sirolimus|mesh-list
110500782|NCT00698607|Everolimus|everolimus|mesh-list
110500783|NCT00698607|Clopidogrel|clopidogrel|mesh-list
110500784|NCT00698607|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110500785|NCT00698607|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110500786|NCT00698607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110500787|NCT00698607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110500788|NCT00698607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110500789|NCT00698607|Immunologic Factors|immunologic factors|mesh-ancestor
110500790|NCT00698607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110500791|NCT00698607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110500792|NCT00698607|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110500793|NCT00698607|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110500794|NCT00698607|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110500795|NCT00698607|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110500796|NCT00698607|Purinergic Agents|purinergic agents|mesh-ancestor
110500797|NCT00698607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110500798|NCT00698607|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110500799|NCT00698607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110500800|NCT00698607|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110500801|NCT00698607|Antifungal Agents|antifungal agents|mesh-ancestor
110500802|NCT04124757|Rocuronium|rocuronium|mesh-list
110500803|NCT04124757|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110500804|NCT04124757|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110500805|NCT04124757|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110500806|NCT04124757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110500807|NCT04124757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110500808|NCT04123041|Nicotine|nicotine|mesh-list
110500809|NCT04123041|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110500810|NCT04123041|Autonomic Agents|autonomic agents|mesh-ancestor
110500811|NCT04123041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110500812|NCT04123041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110500813|NCT04123041|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110500814|NCT04123041|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110500815|NCT04123041|Cholinergic Agents|cholinergic agents|mesh-ancestor
110500816|NCT04123041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110500817|NCT04123041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110500818|NCT00698763|Simendan|simendan|mesh-list
110500819|NCT00698763|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110500820|NCT00698763|Vasodilator Agents|vasodilator agents|mesh-ancestor
110500821|NCT00698763|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110500822|NCT00698763|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110500823|NCT00698763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110500824|NCT00698763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110500825|NCT00698763|Protective Agents|protective agents|mesh-ancestor
110500826|NCT00698763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110500827|NCT00804895|Cortivazol|cortivazol|mesh-list
110500828|NCT00804895|Verapamil|verapamil|mesh-list
110500829|NCT00804895|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110500831|NCT00804895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110500832|NCT00804895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110500833|NCT00804895|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110500834|NCT00804895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110500835|NCT00804895|Vasodilator Agents|vasodilator agents|mesh-ancestor
110500836|NCT00804895|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110500837|NCT00800137|Heparin|heparin|mesh-list
110500838|NCT00800137|Calcium heparin|calcium heparin|mesh-list
110500839|NCT00800137|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
110500840|NCT00800137|Tinzaparin|tinzaparin|mesh-list
110500841|NCT00800137|Dalteparin|dalteparin|mesh-list
110500842|NCT00800137|Warfarin|warfarin|mesh-list
110500843|NCT00800137|Anticoagulants|anticoagulants|mesh-ancestor
110500844|NCT00800137|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110500845|NCT00800137|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110500846|NCT00800137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110500847|NCT00807079|Carboplatin|carboplatin|mesh-list
110500848|NCT00807079|Topotecan|topotecan|mesh-list
110500849|NCT00807079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110500850|NCT00807079|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110500851|NCT00807079|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110148198|NCT05431543|Aceclidine|aceclidine|mesh-list
110500852|NCT00807079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110500853|NCT00807079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110500854|NCT00800293|Betamethasone|betamethasone|mesh-list
110500855|NCT00800293|Betamethasone Valerate|betamethasone valerate|mesh-list
110500856|NCT00800293|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
110500857|NCT00800293|Betamethasone benzoate|betamethasone benzoate|mesh-list
110500858|NCT00800293|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
110500859|NCT00800293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110500860|NCT00800293|Glucocorticoids|glucocorticoids|mesh-ancestor
110500861|NCT00800293|Hormones|hormones|mesh-ancestor
110500862|NCT00800293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110500863|NCT00800293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110500864|NCT00800293|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110500865|NCT00800293|Respiratory System Agents|respiratory system agents|mesh-ancestor
110500866|NCT00658021|Exenatide|exenatide|mesh-list
110500867|NCT00658021|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110500868|NCT00658021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110500869|NCT00658021|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110500870|NCT00658021|Incretins|incretins|mesh-ancestor
110500871|NCT00658021|Hormones|hormones|mesh-ancestor
110500872|NCT00658021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110500873|NCT00920816|Sorafenib|sorafenib|mesh-list
110500874|NCT00920816|Axitinib|axitinib|mesh-list
110500875|NCT00920816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110500876|NCT00920816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110500877|NCT00920816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110500878|NCT00920816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110500879|NCT00631592|Dolutegravir|dolutegravir|mesh-list
110500880|NCT00631592|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110500881|NCT00631592|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110500882|NCT00631592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110500883|NCT00631592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110500884|NCT00631592|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110500885|NCT00631592|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110500886|NCT00631592|Antiviral Agents|antiviral agents|mesh-ancestor
110500887|NCT00631592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110500889|NCT05251610|Oxytocin|oxytocin|mesh-list
110500890|NCT05251610|Oxytocics|oxytocics|mesh-ancestor
110275717|NCT00174551|Prazosin|prazosin|mesh-list
110500891|NCT05251610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110500892|NCT05251610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110500893|NCT05251610|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110500894|NCT05251610|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110500895|NCT05251610|Adrenergic Agents|adrenergic agents|mesh-ancestor
110500896|NCT05251610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110500897|NCT05251610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110500898|NCT05251610|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110500899|NCT05251610|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110500900|NCT05251610|Vasodilator Agents|vasodilator agents|mesh-ancestor
110500901|NCT00657709|Vaccines|vaccines|mesh-list
110500902|NCT00657709|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110500903|NCT00657709|Immunologic Factors|immunologic factors|mesh-ancestor
110500904|NCT00657709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110500905|NCT00657553|Bortezomib|bortezomib|mesh-list
110500906|NCT00657553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110500907|NCT04253912|Povidone-Iodine|povidone-iodine|mesh-list
110500908|NCT04253912|Povidone|povidone|mesh-list
110500909|NCT04253912|Plasma Substitutes|plasma substitutes|mesh-ancestor
110500910|NCT04253912|Blood Substitutes|blood substitutes|mesh-ancestor
110500911|NCT04253912|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110500912|NCT04253912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110500913|NCT00800527|Diclofenac|diclofenac|mesh-list
110500914|NCT00800527|Gabapentin|gabapentin|mesh-list
110500915|NCT00800527|Analgesics|analgesics|mesh-ancestor
110500916|NCT00800527|Sensory System Agents|sensory system agents|mesh-ancestor
110500917|NCT00800527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110500918|NCT00800527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110500919|NCT00800527|Anticonvulsants|anticonvulsants|mesh-ancestor
110500920|NCT00800527|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110500921|NCT00800527|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110500922|NCT00800527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110610538|NCT00371683|Antithrombins|antithrombins|mesh-ancestor
110500923|NCT00800527|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110500924|NCT00800527|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110500925|NCT00800527|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110500926|NCT00800527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110500927|NCT00800527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110500928|NCT00800527|Antimanic Agents|antimanic agents|mesh-ancestor
110500929|NCT00800527|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110500930|NCT00800527|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110500931|NCT00800527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110500932|NCT00800527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110500933|NCT00800527|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110500934|NCT00800527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110500935|NCT00862719|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110500936|NCT00862719|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110500937|NCT00862719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110168704|NCT00014586|Androgen Antagonists|androgen antagonists|mesh-ancestor
110500940|NCT00862719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110500941|NCT00862719|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110500942|NCT00862719|Protease Inhibitors|protease inhibitors|mesh-ancestor
110500943|NCT00862719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110500944|NCT00862719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110500945|NCT04120779|Sulfamethazine|sulfamethazine|mesh-list
110500946|NCT04120779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110500947|NCT00862641|Regadenoson|regadenoson|mesh-list
110500948|NCT00862641|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
110500949|NCT00862641|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
110500950|NCT00862641|Purinergic Agonists|purinergic agonists|mesh-ancestor
110500951|NCT00862641|Purinergic Agents|purinergic agents|mesh-ancestor
110500952|NCT00862641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110500953|NCT00862641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110500954|NCT00862641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110500955|NCT04119921|Ketorolac|ketorolac|mesh-list
110500956|NCT04119921|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
110500957|NCT04119921|Lubricant Eye Drops|lubricant eye drops|mesh-list
110500958|NCT04119921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110500959|NCT04119921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110500960|NCT04119921|Analgesics|analgesics|mesh-ancestor
110500961|NCT04119921|Sensory System Agents|sensory system agents|mesh-ancestor
110500962|NCT04119921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110500963|NCT04119921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110500964|NCT04119921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110500965|NCT04119921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110500966|NCT04119921|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110500967|NCT04119921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110500968|NCT04119921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110500969|NCT04119921|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110500970|NCT04119921|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110500971|NCT00861471|Docetaxel|docetaxel|mesh-list
110500972|NCT00861471|Imatinib Mesylate|imatinib mesylate|mesh-list
110500973|NCT00861471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110500974|NCT00861471|Tubulin Modulators|tubulin modulators|mesh-ancestor
110500975|NCT00861471|Antimitotic Agents|antimitotic agents|mesh-ancestor
110500976|NCT00861471|Mitosis Modulators|mitosis modulators|mesh-ancestor
110500977|NCT00861471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110500978|NCT00861471|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110500979|NCT00861471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110500980|NCT02613585|Permethrin|permethrin|mesh-list
110500981|NCT02613585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110500982|NCT02613585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110500983|NCT04119297|Heparinoids|heparinoids|mesh-list
110500984|NCT04119297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110500985|NCT04119297|Anticoagulants|anticoagulants|mesh-ancestor
110500986|NCT00699387|Benzonidazole|benzonidazole|mesh-list
110500987|NCT00699387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110500988|NCT00699387|Immunologic Factors|immunologic factors|mesh-ancestor
110168708|NCT04732390|Magnesium Sulfate|magnesium sulfate|mesh-list
110500989|NCT00699387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110500990|NCT00699387|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
110500991|NCT00699387|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110500992|NCT00699387|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110500993|NCT00699387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110500994|NCT00699465|Enoxaparin|enoxaparin|mesh-list
110500995|NCT00699465|Enoxaparin sodium|enoxaparin sodium|mesh-list
110500996|NCT00699465|Anticoagulants|anticoagulants|mesh-ancestor
110500997|NCT00699465|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110500998|NCT00699465|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110500999|NCT00699465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110501000|NCT00858117|Rituximab|rituximab|mesh-list
110501001|NCT00858117|Alemtuzumab|alemtuzumab|mesh-list
110501002|NCT00858117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110148309|NCT00006459|Antimetabolites|antimetabolites|mesh-ancestor
110501003|NCT00858117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110501004|NCT00858117|Immunologic Factors|immunologic factors|mesh-ancestor
110501005|NCT00858117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110501007|NCT00700947|Metoprolol|metoprolol|mesh-list
110501008|NCT00700947|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
110501009|NCT00700947|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110501010|NCT00700947|Adrenergic Agents|adrenergic agents|mesh-ancestor
110501011|NCT00700947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110501012|NCT00700947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110501013|NCT00700947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110501014|NCT00700947|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110501015|NCT00700947|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110501016|NCT00700947|Sympatholytics|sympatholytics|mesh-ancestor
110501017|NCT00700947|Autonomic Agents|autonomic agents|mesh-ancestor
110501018|NCT00700947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110501019|NCT00700947|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110501020|NCT00652951|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110501021|NCT00652951|Immunologic Factors|immunologic factors|mesh-ancestor
110501022|NCT00652951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110501023|NCT04116255|Salicylic Acid|salicylic acid|mesh-list
110501024|NCT04116255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110501025|NCT04116255|Antifungal Agents|antifungal agents|mesh-ancestor
110501026|NCT04116255|Keratolytic Agents|keratolytic agents|mesh-ancestor
110501027|NCT04116255|Dermatologic Agents|dermatologic agents|mesh-ancestor
110501028|NCT00805519|Chloroquine|chloroquine|mesh-list
110501029|NCT00805519|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
110501030|NCT00805519|Prednisolone|prednisolone|mesh-list
110501031|NCT00805519|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110501032|NCT00805519|Methylprednisolone|methylprednisolone|mesh-list
110501033|NCT00805519|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110501034|NCT00805519|Prednisolone acetate|prednisolone acetate|mesh-list
110501035|NCT00805519|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110501036|NCT00805519|Prednisolone phosphate|prednisolone phosphate|mesh-list
110501037|NCT00805519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110501038|NCT00805519|Glucocorticoids|glucocorticoids|mesh-ancestor
110501039|NCT00805519|Hormones|hormones|mesh-ancestor
110501040|NCT00805519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110501041|NCT00805519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110501042|NCT00805519|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110501043|NCT00805519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110501044|NCT00805519|Antiemetics|antiemetics|mesh-ancestor
110501045|NCT00805519|Autonomic Agents|autonomic agents|mesh-ancestor
110501046|NCT00805519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110501047|NCT00805519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110501048|NCT00805519|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110501049|NCT00805519|Protective Agents|protective agents|mesh-ancestor
110501050|NCT00805519|Amebicides|amebicides|mesh-ancestor
110501051|NCT00805519|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110501052|NCT00805519|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110501053|NCT00805519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110501054|NCT00805519|Antimalarials|antimalarials|mesh-ancestor
110501055|NCT00805519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110501056|NCT00805519|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110501057|NCT00805519|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110501058|NCT00805519|Analgesics|analgesics|mesh-ancestor
110501059|NCT00805519|Sensory System Agents|sensory system agents|mesh-ancestor
110501060|NCT00805519|Filaricides|filaricides|mesh-ancestor
110501061|NCT00805519|Antinematodal Agents|antinematodal agents|mesh-ancestor
110501062|NCT00805519|Anthelmintics|anthelmintics|mesh-ancestor
110501063|NCT00592683|Aripiprazole|aripiprazole|mesh-list
110501064|NCT00592683|Antidepressive Agents|antidepressive agents|mesh-ancestor
110501065|NCT00592683|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110501066|NCT00592683|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110501067|NCT00592683|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110501068|NCT00592683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110501069|NCT00592683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110501070|NCT00592683|Dopamine Agonists|dopamine agonists|mesh-ancestor
110501071|NCT00592683|Dopamine Agents|dopamine agents|mesh-ancestor
110501072|NCT00592683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110501073|NCT00592683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110501074|NCT00592683|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110501075|NCT00592683|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110501076|NCT00592683|Serotonin Agents|serotonin agents|mesh-ancestor
110501077|NCT00592683|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110501079|NCT00592683|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110501080|NCT00592683|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110501081|NCT02613039|Contraceptive Agents|contraceptive agents|mesh-list
110501082|NCT02613039|Contraceptives, Oral|contraceptives, oral|mesh-list
110501083|NCT02613039|Estrogens|estrogens|mesh-list
110501084|NCT02613039|Progestins|progestins|mesh-list
110501085|NCT02613039|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110501086|NCT02613039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110501087|NCT02613039|Hormones|hormones|mesh-ancestor
110501088|NCT02613039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110501089|NCT02613039|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110501090|NCT00813475|Insulin|insulin|mesh-list
110501091|NCT00813475|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110501092|NCT00813475|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110501093|NCT00813475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110501094|NCT00701259|Lansoprazole|lansoprazole|mesh-list
110501095|NCT00701259|Dexlansoprazole|dexlansoprazole|mesh-list
110501096|NCT00701259|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110501097|NCT00701259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110501098|NCT00701259|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110501099|NCT00701259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110501100|NCT00701259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110501101|NCT00701337|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110501102|NCT00701337|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110501103|NCT00701337|Estradiol|estradiol|mesh-list
110501104|NCT00701337|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110501105|NCT00701337|Estrogens|estrogens|mesh-ancestor
110501106|NCT00701337|Hormones|hormones|mesh-ancestor
110501107|NCT00701337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110501108|NCT00701337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110501109|NCT00701337|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110501110|NCT00701337|Contraceptive Agents|contraceptive agents|mesh-ancestor
110501111|NCT00701337|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110501112|NCT00701337|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110501113|NCT00654901|Vaccines|vaccines|mesh-list
110501114|NCT00654901|Immunologic Factors|immunologic factors|mesh-ancestor
110501115|NCT00654901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110501116|NCT00701493|Topiramate|topiramate|mesh-list
110501117|NCT00701493|Anticonvulsants|anticonvulsants|mesh-ancestor
110501118|NCT00701493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110501119|NCT00701493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110501120|NCT04253678|Vortioxetine|vortioxetine|mesh-list
110501121|NCT04253678|Antidepressive Agents|antidepressive agents|mesh-ancestor
110501122|NCT04253678|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110501123|NCT04253678|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110501124|NCT04253678|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110501125|NCT04253678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110501126|NCT04253678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110501127|NCT04253678|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110501128|NCT04253678|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110501129|NCT04253678|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110501130|NCT04253678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110501131|NCT04253678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110501132|NCT04253678|Serotonin Agents|serotonin agents|mesh-ancestor
110501133|NCT04253678|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110501134|NCT04253678|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110501135|NCT04253678|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110501136|NCT04253678|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110501137|NCT00813631|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
110501138|NCT00813631|Laxatives|laxatives|mesh-ancestor
110501139|NCT00813631|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110501140|NCT02551861|Ribavirin|ribavirin|mesh-list
110501141|NCT02551861|Sofosbuvir|sofosbuvir|mesh-list
110501142|NCT02551861|Antimetabolites|antimetabolites|mesh-ancestor
110501143|NCT02551861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110501144|NCT02551861|Antiviral Agents|antiviral agents|mesh-ancestor
110501145|NCT02551861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110501146|NCT00846495|Topiramate|topiramate|mesh-list
110501147|NCT00846495|Frovatriptan|frovatriptan|mesh-list
110501148|NCT00846495|Anticonvulsants|anticonvulsants|mesh-ancestor
110501149|NCT00846495|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110501150|NCT00846495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110501151|NCT00846495|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110501152|NCT00846495|Serotonin Agents|serotonin agents|mesh-ancestor
110501154|NCT00846495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110501155|NCT00654745|Amlodipine|amlodipine|mesh-list
110501156|NCT00654745|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110501157|NCT00654745|Olmesartan|olmesartan|mesh-list
110501158|NCT00654745|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
110501159|NCT00654745|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110501160|NCT00654745|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110501161|NCT00654745|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110501162|NCT00654745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110501163|NCT00654745|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110501164|NCT00654745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110501165|NCT00654745|Vasodilator Agents|vasodilator agents|mesh-ancestor
110501166|NCT00654745|Diuretics|diuretics|mesh-ancestor
110501167|NCT00654745|Natriuretic Agents|natriuretic agents|mesh-ancestor
110501168|NCT00654745|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110501169|NCT00654745|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110501170|NCT00654745|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110501171|NCT00809887|Micafungin|micafungin|mesh-list
110501172|NCT00809887|Antifungal Agents|antifungal agents|mesh-ancestor
110501173|NCT00809887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110501174|NCT00846027|Paclitaxel|paclitaxel|mesh-list
110501175|NCT00846027|Bevacizumab|bevacizumab|mesh-list
110501176|NCT00846027|Gemcitabine|gemcitabine|mesh-list
110501177|NCT00846027|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110501178|NCT00846027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110501179|NCT00846027|Tubulin Modulators|tubulin modulators|mesh-ancestor
110501180|NCT00846027|Antimitotic Agents|antimitotic agents|mesh-ancestor
110501181|NCT00846027|Mitosis Modulators|mitosis modulators|mesh-ancestor
110501182|NCT00846027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110501183|NCT00846027|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110501184|NCT00846027|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110501185|NCT00846027|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110501186|NCT00846027|Growth Substances|growth substances|mesh-ancestor
110501187|NCT00846027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110501188|NCT00846027|Growth Inhibitors|growth inhibitors|mesh-ancestor
110501189|NCT00846027|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110501190|NCT00846027|Antimetabolites|antimetabolites|mesh-ancestor
110501192|NCT00807625|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
110501193|NCT00807625|Medroxyprogesterone|medroxyprogesterone|mesh-list
110501194|NCT00807625|Trace Elements|trace elements|mesh-ancestor
110501195|NCT00807625|Micronutrients|micronutrients|mesh-ancestor
110501196|NCT00807625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110501197|NCT00807625|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110501198|NCT00807625|Contraceptive Agents|contraceptive agents|mesh-ancestor
110501199|NCT00807625|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110501200|NCT00807625|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110501201|NCT00807625|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110501202|NCT00807625|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110501203|NCT00807625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110501204|NCT00807625|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110501205|NCT00807625|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110501206|NCT00807625|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110501208|NCT02551549|Antifungal Agents|antifungal agents|mesh-ancestor
110501209|NCT02551549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110501210|NCT00810121|Ketoprofen|ketoprofen|mesh-list
110501211|NCT00810121|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110501212|NCT00810121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110501213|NCT00810121|Analgesics|analgesics|mesh-ancestor
110501214|NCT00810121|Sensory System Agents|sensory system agents|mesh-ancestor
110501215|NCT00810121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110501216|NCT00810121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110501217|NCT00810121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110501218|NCT00810121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110501219|NCT00810121|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110501220|NCT00810121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110501221|NCT00810121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110501222|NCT00652327|Atorvastatin|atorvastatin|mesh-list
110501223|NCT00652327|Simvastatin|simvastatin|mesh-list
110501225|NCT00652327|Pravastatin|pravastatin|mesh-list
110501226|NCT00652327|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
110501227|NCT00652327|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110501228|NCT00652327|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110501229|NCT00652327|Antimetabolites|antimetabolites|mesh-ancestor
110501230|NCT00652327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110501231|NCT00652327|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110501232|NCT00652327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110501233|NCT00814021|Sunitinib|sunitinib|mesh-list
110501234|NCT00814021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110501235|NCT00814021|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110501236|NCT00814021|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110501237|NCT00814021|Growth Substances|growth substances|mesh-ancestor
110501238|NCT00814021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110501239|NCT00814021|Growth Inhibitors|growth inhibitors|mesh-ancestor
110501240|NCT00814021|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110501241|NCT00814021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110501242|NCT00814021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110501243|NCT00645853|Warfarin|warfarin|mesh-list
110501244|NCT00645853|Anticoagulants|anticoagulants|mesh-ancestor
110501245|NCT00652093|Acetaminophen|acetaminophen|mesh-list
110501246|NCT00652093|Oxymorphone|oxymorphone|mesh-list
110501247|NCT00652093|Acetaminophen, dextropropoxyphene, drug combination|acetaminophen, dextropropoxyphene, drug combination|mesh-list
110501248|NCT00652093|Dextropropoxyphene|dextropropoxyphene|mesh-list
110610941|NCT00676338|Metformin|metformin|mesh-list
110501249|NCT00652093|Levopropoxyphene|levopropoxyphene|mesh-list
110501250|NCT00652093|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110501251|NCT00652093|Analgesics|analgesics|mesh-ancestor
110501252|NCT00652093|Sensory System Agents|sensory system agents|mesh-ancestor
110501253|NCT00652093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110501254|NCT00652093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110501255|NCT00652093|Antipyretics|antipyretics|mesh-ancestor
110501256|NCT00652093|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110501257|NCT00652093|Narcotics|narcotics|mesh-ancestor
110501258|NCT00652093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110501259|NCT00652093|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110501260|NCT00652093|Antitussive Agents|antitussive agents|mesh-ancestor
110501261|NCT00652093|Respiratory System Agents|respiratory system agents|mesh-ancestor
110501262|NCT00651937|Melphalan|melphalan|mesh-list
110501263|NCT00651937|Lenograstim|lenograstim|mesh-list
110501264|NCT00651937|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110501265|NCT00651937|Alkylating Agents|alkylating agents|mesh-ancestor
110501266|NCT00651937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110501267|NCT00651937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110501268|NCT00651937|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110501269|NCT00651937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110501270|NCT00651937|Immunologic Factors|immunologic factors|mesh-ancestor
110501271|NCT00651937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110501272|NCT00651937|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110501273|NCT00654355|Tacrolimus|tacrolimus|mesh-list
110501274|NCT00654355|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110501275|NCT00654355|Immunologic Factors|immunologic factors|mesh-ancestor
110501276|NCT00654355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110501277|NCT00654355|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110501279|NCT00654355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110501280|NCT00651313|Lidocaine|lidocaine|mesh-list
110501281|NCT00651313|Anesthetics, Local|anesthetics, local|mesh-ancestor
110501282|NCT00651313|Anesthetics|anesthetics|mesh-ancestor
110501283|NCT00651313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110501284|NCT00651313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110501285|NCT00651313|Sensory System Agents|sensory system agents|mesh-ancestor
110501286|NCT00651313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110501287|NCT00651313|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110501288|NCT00651313|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110501289|NCT00651313|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110501290|NCT00651313|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110501291|NCT00651313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110501292|NCT00808171|Lidocaine|lidocaine|mesh-list
110501293|NCT00808171|Nitrous Oxide|nitrous oxide|mesh-list
110501294|NCT00808171|Anesthetics, Local|anesthetics, local|mesh-list
110501295|NCT00808171|Prilocaine|prilocaine|mesh-list
110501296|NCT00808171|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
110501297|NCT00808171|Anesthetics|anesthetics|mesh-list
110501298|NCT00808171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110501299|NCT00808171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110611037|NCT01050985|Sirolimus|sirolimus|mesh-list
110501300|NCT00808171|Sensory System Agents|sensory system agents|mesh-ancestor
110501301|NCT00808171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110501302|NCT00808171|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110501303|NCT00808171|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110501304|NCT00808171|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110501305|NCT00808171|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110501306|NCT00808171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110501307|NCT00808171|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110501308|NCT00808171|Anesthetics, General|anesthetics, general|mesh-ancestor
110501309|NCT00808171|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110501310|NCT00808171|Analgesics|analgesics|mesh-ancestor
110501311|NCT00808171|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
110501312|NCT04703257|Dipyrone|dipyrone|mesh-list
110283258|NCT00479713|Simvastatin|simvastatin|mesh-list
110501313|NCT04703257|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110501314|NCT04703257|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110501315|NCT04703257|Analgesics|analgesics|mesh-ancestor
110501316|NCT04703257|Sensory System Agents|sensory system agents|mesh-ancestor
110501317|NCT04703257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110501318|NCT04703257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110501319|NCT04703257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110501320|NCT04703257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110501321|NCT04703257|Antipyretics|antipyretics|mesh-ancestor
110501322|NCT00808327|Fentanyl|fentanyl|mesh-list
110501323|NCT00808327|Bupivacaine|bupivacaine|mesh-list
110501324|NCT00808327|Anesthetics, Local|anesthetics, local|mesh-ancestor
110501325|NCT00808327|Anesthetics|anesthetics|mesh-ancestor
110501326|NCT00808327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110501327|NCT00808327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110501328|NCT00808327|Sensory System Agents|sensory system agents|mesh-ancestor
110501329|NCT00808327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110501330|NCT00808327|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110501331|NCT00808327|Narcotics|narcotics|mesh-ancestor
110501332|NCT00808327|Analgesics|analgesics|mesh-ancestor
110501333|NCT00808327|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110501334|NCT00808327|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110501335|NCT00808327|Anesthetics, General|anesthetics, general|mesh-ancestor
110501336|NCT00814645|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110501337|NCT00814723|Ezetimibe|ezetimibe|mesh-list
110501338|NCT00814723|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110501339|NCT00814723|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110501340|NCT00814723|Antimetabolites|antimetabolites|mesh-ancestor
110501341|NCT00814723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110501342|NCT00814723|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110501343|NCT00845871|Deferasirox|deferasirox|mesh-list
110501344|NCT00845871|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110501345|NCT00845871|Chelating Agents|chelating agents|mesh-ancestor
110501346|NCT00845871|Sequestering Agents|sequestering agents|mesh-ancestor
110501347|NCT00845871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110501348|NCT02864849|Capecitabine|capecitabine|mesh-list
110501349|NCT02864849|Oxaliplatin|oxaliplatin|mesh-list
110501350|NCT02864849|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110501351|NCT02864849|Antimetabolites|antimetabolites|mesh-ancestor
110501352|NCT02864849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110501353|NCT02864849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110501354|NCT00701961|Artesunate|artesunate|mesh-list
110501355|NCT00701961|Mefloquine|mefloquine|mesh-list
110501356|NCT00701961|Antimalarials|antimalarials|mesh-ancestor
110501357|NCT00701961|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110501358|NCT00701961|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110501359|NCT00701961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110501360|NCT00701961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110501361|NCT00701961|Antiviral Agents|antiviral agents|mesh-ancestor
110501362|NCT00701961|Schistosomicides|schistosomicides|mesh-ancestor
110501363|NCT00701961|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110501364|NCT00701961|Anthelmintics|anthelmintics|mesh-ancestor
110501365|NCT04286711|Paclitaxel|paclitaxel|mesh-list
110501366|NCT04286711|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110501367|NCT04286711|Apatinib|apatinib|mesh-list
110501368|NCT04286711|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110501369|NCT04286711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110501370|NCT04286711|Tubulin Modulators|tubulin modulators|mesh-ancestor
110501371|NCT04286711|Antimitotic Agents|antimitotic agents|mesh-ancestor
110501372|NCT04286711|Mitosis Modulators|mitosis modulators|mesh-ancestor
110501373|NCT04286711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110501374|NCT04286711|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110501375|NCT04286711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110501376|NCT02863913|Cyclophosphamide|cyclophosphamide|mesh-list
110501377|NCT02863913|Interleukin-2|interleukin-2|mesh-list
110501378|NCT02863913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110501379|NCT02863913|Immunologic Factors|immunologic factors|mesh-ancestor
110501380|NCT02863913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110501381|NCT02863913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110501382|NCT02863913|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110501383|NCT02863913|Alkylating Agents|alkylating agents|mesh-ancestor
110501384|NCT02863913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110501385|NCT02863913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110501386|NCT02863913|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110501387|NCT02863913|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110501388|NCT02863913|Analgesics|analgesics|mesh-ancestor
110501389|NCT02863913|Sensory System Agents|sensory system agents|mesh-ancestor
110501390|NCT02863913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110501391|NCT02612649|Ramosetron|ramosetron|mesh-list
110501392|NCT02612649|Antiemetics|antiemetics|mesh-ancestor
110501393|NCT02612649|Autonomic Agents|autonomic agents|mesh-ancestor
110501394|NCT02612649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110501395|NCT02612649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110611164|NCT00881127|Cetirizine|cetirizine|mesh-list
110501397|NCT02612649|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110501398|NCT02612649|Serotonin Agents|serotonin agents|mesh-ancestor
110501399|NCT02612649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110501400|NCT02612649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110501401|NCT04908800|Itraconazole|itraconazole|mesh-list
110501402|NCT04908800|Antifungal Agents|antifungal agents|mesh-ancestor
110501403|NCT04908800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110501404|NCT04908800|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110501405|NCT04908800|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110501406|NCT04908800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110501407|NCT04908800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110501408|NCT04908800|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110501409|NCT04908800|Hormone Antagonists|hormone antagonists|mesh-ancestor
110501410|NCT04908800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110501411|NCT04908800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110501412|NCT04908800|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110501413|NCT00844857|Olanzapine|olanzapine|mesh-list
110501414|NCT00844857|Fluoxetine|fluoxetine|mesh-list
110501415|NCT00844857|Antiemetics|antiemetics|mesh-ancestor
110501416|NCT00844857|Autonomic Agents|autonomic agents|mesh-ancestor
110501417|NCT00844857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110501418|NCT00844857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110501419|NCT00844857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110501420|NCT00844857|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110501421|NCT00844857|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110168749|NCT00035971|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110501422|NCT00844857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110501423|NCT00844857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110501424|NCT00844857|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110501425|NCT00844857|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110501426|NCT00844857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110501427|NCT00844857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110501428|NCT00844857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110501429|NCT00844857|Serotonin Agents|serotonin agents|mesh-ancestor
110501430|NCT00844857|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110501431|NCT00844857|Antidepressive Agents|antidepressive agents|mesh-ancestor
110501432|NCT00844857|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110501433|NCT00844857|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110501434|NCT00844857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110501435|NCT00702117|Flecainide|flecainide|mesh-list
110501436|NCT00702117|Procainamide|procainamide|mesh-list
110501437|NCT00702117|Ajmaline|ajmaline|mesh-list
110501438|NCT00702117|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110501439|NCT00702117|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110501440|NCT00702117|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110501441|NCT00702117|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110501442|NCT00702117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110501443|NCT00913107|Lamotrigine|lamotrigine|mesh-list
110501444|NCT00913107|Carbamazepine|carbamazepine|mesh-list
110501445|NCT00913107|Anticonvulsants|anticonvulsants|mesh-list
110501446|NCT00913107|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110501447|NCT00913107|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110501448|NCT00913107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110501449|NCT00913107|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110501450|NCT00913107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110501452|NCT00913107|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110501453|NCT00913107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110501454|NCT00913107|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110501455|NCT00913107|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110501457|NCT00913107|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110501458|NCT00913107|Analgesics|analgesics|mesh-ancestor
110501459|NCT00913107|Sensory System Agents|sensory system agents|mesh-ancestor
110501460|NCT00913107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110501461|NCT00913107|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110501462|NCT00913107|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110501463|NCT00569803|Abatacept|abatacept|mesh-list
110501464|NCT00569803|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110501465|NCT00569803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110501466|NCT00569803|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110501467|NCT00569803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110501468|NCT00569803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110501469|NCT00569803|Immunologic Factors|immunologic factors|mesh-ancestor
110501470|NCT00569803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110501471|NCT00569803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110501472|NCT00920426|Cabotegravir|cabotegravir|mesh-list
110501473|NCT00920426|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110501474|NCT00920426|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110501475|NCT00920426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110501476|NCT00920426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110501477|NCT00920426|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110501478|NCT00920426|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110501479|NCT00920426|Antiviral Agents|antiviral agents|mesh-ancestor
110501480|NCT00920426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110501481|NCT04046185|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
110501482|NCT04046185|Progesterone|progesterone|mesh-list
110501483|NCT04046185|Progestins|progestins|mesh-ancestor
110501484|NCT04046185|Hormones|hormones|mesh-ancestor
110501485|NCT04046185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110501486|NCT04046185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110501487|NCT04046185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110168753|NCT00035971|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110501488|NCT04046185|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110501489|NCT04046185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110501490|NCT00810589|Insulin|insulin|mesh-list
110501491|NCT00810589|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110501492|NCT00810589|Insulin Lispro|insulin lispro|mesh-list
110501493|NCT00810589|Insulin Detemir|insulin detemir|mesh-list
110501494|NCT00810589|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110501495|NCT00810589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110501496|NCT00810667|(2-(6-fluoro-1H-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|(2-(6-fluoro-1h-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|mesh-list
110501497|NCT00810667|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110501498|NCT00810667|Serotonin Agents|serotonin agents|mesh-ancestor
110501499|NCT00810667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110501500|NCT00810667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110501501|NCT00810667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110501502|NCT04253132|Tolfenamic acid|tolfenamic acid|mesh-list
110501503|NCT04253132|Analgesics|analgesics|mesh-ancestor
110501504|NCT04253132|Sensory System Agents|sensory system agents|mesh-ancestor
110501505|NCT04253132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110501506|NCT04253132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110501507|NCT04253132|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110501508|NCT04253132|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110501509|NCT04253132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110501510|NCT04253132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110501511|NCT04253132|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110501512|NCT04253132|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110501513|NCT04253132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110501514|NCT04253132|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110501515|NCT04253132|Prostaglandin Antagonists|prostaglandin antagonists|mesh-ancestor
110501516|NCT04253132|Hormone Antagonists|hormone antagonists|mesh-ancestor
110501517|NCT04253132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110501518|NCT04253132|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110501519|NCT04253132|Serotonin Agents|serotonin agents|mesh-ancestor
110501520|NCT04253132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110501521|NCT00914966|Complement C1s|complement c1s|mesh-list
110501522|NCT00914966|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
110501523|NCT00914966|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
110501524|NCT00914966|Immunologic Factors|immunologic factors|mesh-ancestor
110501525|NCT00914966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110501526|NCT00914966|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
110501527|NCT00914966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110501528|NCT00815269|Sevoflurane|sevoflurane|mesh-list
110501530|NCT00815269|Isoflurane|isoflurane|mesh-list
110501531|NCT00815269|Halothane|halothane|mesh-list
110501532|NCT00815269|Enflurane|enflurane|mesh-list
110501533|NCT00815269|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110501534|NCT00815269|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110501535|NCT00815269|Anesthetics, General|anesthetics, general|mesh-ancestor
110501536|NCT00815269|Anesthetics|anesthetics|mesh-ancestor
110501537|NCT00815269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110501538|NCT00815269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110501539|NCT00914810|Vitamin D|vitamin d|mesh-list
110501540|NCT00914810|Cholecalciferol|cholecalciferol|mesh-list
110501541|NCT00914810|Vitamins|vitamins|mesh-ancestor
110501542|NCT00914810|Micronutrients|micronutrients|mesh-ancestor
110501543|NCT00914810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110501544|NCT00914810|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110501545|NCT00914810|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110501546|NCT00808717|Atorvastatin|atorvastatin|mesh-list
110501547|NCT00808717|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110501548|NCT00808717|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110501549|NCT00808717|Antimetabolites|antimetabolites|mesh-ancestor
110501550|NCT00808717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110501551|NCT00808717|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110501552|NCT00808717|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110501553|NCT00808717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110501554|NCT00914732|Vaccines|vaccines|mesh-list
110501555|NCT00914732|Immunologic Factors|immunologic factors|mesh-ancestor
110501556|NCT00914732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110501557|NCT00844545|Eculizumab|eculizumab|mesh-list
110501558|NCT00844545|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
110501559|NCT00844545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110501560|NCT00844545|Immunologic Factors|immunologic factors|mesh-ancestor
110501561|NCT00844545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110501562|NCT00815503|Ropivacaine|ropivacaine|mesh-list
110501563|NCT00815503|Anesthetics, Local|anesthetics, local|mesh-ancestor
110501564|NCT00815503|Anesthetics|anesthetics|mesh-ancestor
110501565|NCT00815503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110501566|NCT00815503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110501567|NCT00815503|Sensory System Agents|sensory system agents|mesh-ancestor
110501568|NCT00815503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110501569|NCT00702819|Bevacizumab|bevacizumab|mesh-list
110501570|NCT00702819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110501571|NCT00702819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110501572|NCT00702819|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110501573|NCT00702819|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110501574|NCT00702819|Growth Substances|growth substances|mesh-ancestor
110501575|NCT00702819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110501576|NCT00702819|Growth Inhibitors|growth inhibitors|mesh-ancestor
110501577|NCT00650845|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
110501578|NCT00650845|Chelating Agents|chelating agents|mesh-ancestor
110501579|NCT00650845|Sequestering Agents|sequestering agents|mesh-ancestor
110501580|NCT00650845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110501581|NCT00842985|Dronabinol|dronabinol|mesh-list
110501582|NCT00842985|Modafinil|modafinil|mesh-list
110501583|NCT00842985|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110501584|NCT00842985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110501585|NCT00842985|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
110501586|NCT00842985|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110501587|NCT00842985|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110501588|NCT00842985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110501589|NCT00842985|Hallucinogens|hallucinogens|mesh-ancestor
110501590|NCT00842985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110501591|NCT00842985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110501592|NCT00842985|Analgesics|analgesics|mesh-ancestor
110501593|NCT00842985|Sensory System Agents|sensory system agents|mesh-ancestor
110501594|NCT00842985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110501595|NCT00842985|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
110501596|NCT00842985|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110501597|NCT00842985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110501598|NCT00842985|Hormones|hormones|mesh-ancestor
110501599|NCT00842985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110501600|NCT00808795|Acetylcysteine|acetylcysteine|mesh-list
110501601|NCT00808795|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110501602|NCT00808795|Antiviral Agents|antiviral agents|mesh-ancestor
110501603|NCT00808795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110501604|NCT00808795|Expectorants|expectorants|mesh-ancestor
110501605|NCT00808795|Respiratory System Agents|respiratory system agents|mesh-ancestor
110501606|NCT00808795|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110501607|NCT00808795|Antioxidants|antioxidants|mesh-ancestor
110501608|NCT00808795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110501609|NCT00808795|Protective Agents|protective agents|mesh-ancestor
110501610|NCT00808795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110501611|NCT00808795|Antidotes|antidotes|mesh-ancestor
110501612|NCT00808951|Artesunate|artesunate|mesh-list
110501613|NCT00808951|Lumefantrine|lumefantrine|mesh-list
110501614|NCT00808951|Artemether|artemether|mesh-list
110501615|NCT00808951|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
110501616|NCT00808951|Amodiaquine|amodiaquine|mesh-list
110501617|NCT00808951|Antimalarials|antimalarials|mesh-ancestor
110501618|NCT00808951|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110501619|NCT00808951|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110501620|NCT00808951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110501621|NCT00808951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110501622|NCT00808951|Antiviral Agents|antiviral agents|mesh-ancestor
110501623|NCT00808951|Schistosomicides|schistosomicides|mesh-ancestor
110501624|NCT00808951|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110501625|NCT00808951|Anthelmintics|anthelmintics|mesh-ancestor
110501626|NCT00809029|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
110501627|NCT00809029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110501628|NCT00809029|Incretins|incretins|mesh-ancestor
110501629|NCT00809029|Hormones|hormones|mesh-ancestor
110501630|NCT00809029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110501631|NCT00809029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110501632|NCT00842829|Fentanyl|fentanyl|mesh-list
110501633|NCT00842829|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110501634|NCT00842829|Narcotics|narcotics|mesh-ancestor
110501635|NCT00842829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110501636|NCT00842829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110501637|NCT00842829|Analgesics|analgesics|mesh-ancestor
110501638|NCT00842829|Sensory System Agents|sensory system agents|mesh-ancestor
110501639|NCT00842829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110501640|NCT00842829|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110501641|NCT00842829|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110501642|NCT00842829|Anesthetics, General|anesthetics, general|mesh-ancestor
110501643|NCT00842829|Anesthetics|anesthetics|mesh-ancestor
110501644|NCT04045093|Warfarin|warfarin|mesh-list
110501645|NCT04045093|Dabigatran|dabigatran|mesh-list
110501646|NCT04045093|Anticoagulants|anticoagulants|mesh-ancestor
110501647|NCT04045093|Antithrombins|antithrombins|mesh-ancestor
110501648|NCT04045093|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110501649|NCT04045093|Protease Inhibitors|protease inhibitors|mesh-ancestor
110611417|NCT00882453|Interferons|interferons|mesh-list
110501651|NCT04045093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110501652|NCT00811291|Calcium, Dietary|calcium, dietary|mesh-list
110501653|NCT00811291|Folic Acid|folic acid|mesh-list
110501654|NCT00811291|Calcium|calcium|mesh-list
110501655|NCT00811291|Vitamins|vitamins|mesh-ancestor
110501656|NCT00811291|Micronutrients|micronutrients|mesh-ancestor
110501657|NCT00811291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110501658|NCT00811291|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110501659|NCT00811291|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110501660|NCT00811291|Hematinics|hematinics|mesh-ancestor
110501661|NCT00811291|Vitamin B Complex|vitamin b complex|mesh-ancestor
110501662|NCT00811369|Fulvestrant|fulvestrant|mesh-list
110501663|NCT00811369|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110501664|NCT00811369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110501665|NCT00811369|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110501666|NCT00811369|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110501667|NCT00811369|Hormone Antagonists|hormone antagonists|mesh-ancestor
110501668|NCT00811369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110501669|NCT00811369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110501670|NCT00842361|Insulin|insulin|mesh-list
110501671|NCT00842361|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110501672|NCT00842361|Insulin Aspart|insulin aspart|mesh-list
110501673|NCT00842361|Insulin, Long-Acting|insulin, long-acting|mesh-list
110501674|NCT00842361|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
110501675|NCT00842361|Biphasic Insulins|biphasic insulins|mesh-list
110501676|NCT00842361|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
110501677|NCT00842361|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110501678|NCT00842361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110501679|NCT00811447|Docetaxel|docetaxel|mesh-list
110501680|NCT00811447|Fluorouracil|fluorouracil|mesh-list
110501681|NCT00811447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110501682|NCT00811447|Tubulin Modulators|tubulin modulators|mesh-ancestor
110501683|NCT00811447|Antimitotic Agents|antimitotic agents|mesh-ancestor
110501684|NCT00811447|Mitosis Modulators|mitosis modulators|mesh-ancestor
110501685|NCT00811447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110501686|NCT00811447|Antimetabolites|antimetabolites|mesh-ancestor
110501687|NCT00811447|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110501688|NCT00811447|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110501689|NCT00811447|Immunologic Factors|immunologic factors|mesh-ancestor
110501690|NCT00811447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110501691|NCT00702975|Paclitaxel|paclitaxel|mesh-list
110501692|NCT00702975|Bevacizumab|bevacizumab|mesh-list
110501693|NCT00702975|Carboplatin|carboplatin|mesh-list
110501694|NCT00702975|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110501695|NCT00702975|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110501696|NCT00702975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110501697|NCT00702975|Tubulin Modulators|tubulin modulators|mesh-ancestor
110501698|NCT00702975|Antimitotic Agents|antimitotic agents|mesh-ancestor
110501699|NCT00702975|Mitosis Modulators|mitosis modulators|mesh-ancestor
110611504|NCT00761670|Antidepressive Agents|antidepressive agents|mesh-ancestor
110501700|NCT00702975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110501701|NCT00702975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110501702|NCT00702975|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110501703|NCT00702975|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110275763|NCT00174629|Docetaxel|docetaxel|mesh-list
110501704|NCT00702975|Growth Substances|growth substances|mesh-ancestor
110501705|NCT00702975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110501706|NCT00702975|Growth Inhibitors|growth inhibitors|mesh-ancestor
110501707|NCT00702975|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110501708|NCT00702975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110501709|NCT00809107|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
110501710|NCT00809107|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110501711|NCT00809107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110501712|NCT02612181|Dexmedetomidine|dexmedetomidine|mesh-list
110501713|NCT02612181|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110501714|NCT02612181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110501715|NCT02612181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110501716|NCT02612181|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110501718|NCT02612181|Sensory System Agents|sensory system agents|mesh-ancestor
110501719|NCT02612181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110501720|NCT02612181|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110501721|NCT02612181|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110501722|NCT02612181|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110501723|NCT02612181|Adrenergic Agents|adrenergic agents|mesh-ancestor
110501724|NCT02612181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110501725|NCT02612181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110501726|NCT02612259|Tryptophan|tryptophan|mesh-list
110611547|NCT00963976|Protease Inhibitors|protease inhibitors|mesh-ancestor
110501727|NCT02612259|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110501728|NCT02612259|Antidepressive Agents|antidepressive agents|mesh-ancestor
110501729|NCT02612259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110501730|NCT00841035|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110501731|NCT00841035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110501732|NCT00841035|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110501733|NCT00841035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110501734|NCT00841035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110501736|NCT00642811|Clopidogrel|clopidogrel|mesh-list
110501737|NCT00642811|Ticagrelor|ticagrelor|mesh-list
110501738|NCT00642811|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110501739|NCT00642811|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110501740|NCT00642811|Analgesics|analgesics|mesh-ancestor
110501741|NCT00642811|Sensory System Agents|sensory system agents|mesh-ancestor
110501742|NCT00642811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110501743|NCT00642811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110501744|NCT00642811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110501745|NCT00642811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110501746|NCT00642811|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110501747|NCT00642811|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110501748|NCT00642811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110501749|NCT00642811|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110501750|NCT00642811|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110501751|NCT00642811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110501753|NCT00642811|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110501754|NCT00642811|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110501755|NCT00642811|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110501756|NCT00642811|Purinergic Agents|purinergic agents|mesh-ancestor
110501757|NCT00642811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110501758|NCT00838929|Vorinostat|vorinostat|mesh-list
110501759|NCT00838929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110501760|NCT00838929|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110501761|NCT00838929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110501762|NCT00838929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110501763|NCT00811603|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110501764|NCT00811603|Cefazolin|cefazolin|mesh-list
110501765|NCT00811603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110501766|NCT00811681|Pioglitazone|pioglitazone|mesh-list
110501767|NCT00811681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110501768|NCT00811681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110501770|NCT00811759|Sorafenib|sorafenib|mesh-list
110501771|NCT00811759|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110501772|NCT00811759|Alkylating Agents|alkylating agents|mesh-ancestor
110501773|NCT00811759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110501774|NCT00811759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110501775|NCT00811759|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110501776|NCT00811759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110501777|NCT00815893|Dexmedetomidine|dexmedetomidine|mesh-list
110501778|NCT00815893|Propofol|propofol|mesh-list
110501779|NCT00815893|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110501780|NCT00815893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110501781|NCT00815893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110501782|NCT00815893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110501783|NCT00815893|Analgesics|analgesics|mesh-ancestor
110501784|NCT00815893|Sensory System Agents|sensory system agents|mesh-ancestor
110501785|NCT00815893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110501786|NCT00815893|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110501787|NCT00815893|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110501788|NCT00815893|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110501789|NCT00815893|Adrenergic Agents|adrenergic agents|mesh-ancestor
110501790|NCT00815893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110501791|NCT00815893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110501792|NCT00815893|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110501793|NCT00815893|Anesthetics, General|anesthetics, general|mesh-ancestor
110501794|NCT00815893|Anesthetics|anesthetics|mesh-ancestor
110501795|NCT00816049|Mercaptopurine|mercaptopurine|mesh-list
110501796|NCT00816049|Antimetabolites|antimetabolites|mesh-ancestor
110501797|NCT00816049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110501798|NCT00816049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110501799|NCT00816049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110501800|NCT00816049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110501801|NCT00816049|Immunologic Factors|immunologic factors|mesh-ancestor
110501802|NCT00816049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110501803|NCT00816049|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110501804|NCT00816049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110501805|NCT04648891|Lidocaine|lidocaine|mesh-list
110501806|NCT04648891|Anesthetics, Local|anesthetics, local|mesh-ancestor
110501807|NCT04648891|Anesthetics|anesthetics|mesh-ancestor
110501808|NCT04648891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110501809|NCT04648891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110501810|NCT04648891|Sensory System Agents|sensory system agents|mesh-ancestor
110501811|NCT04648891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110501812|NCT04648891|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110501813|NCT04648891|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110501814|NCT04648891|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110501815|NCT04648891|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110283419|NCT00202787|Cetuximab|cetuximab|mesh-list
110501816|NCT04648891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110501817|NCT04045015|Glycyrrhizic Acid|glycyrrhizic acid|mesh-list
110501818|NCT04045015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110501820|NCT00811837|Remifentanil|remifentanil|mesh-list
110501821|NCT00811837|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110501822|NCT00811837|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110501823|NCT00811837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110501824|NCT00811837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110149157|NCT00006247|Semaxinib|semaxinib|mesh-list
110501825|NCT00811837|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110501826|NCT00811837|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110501827|NCT00811837|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110501828|NCT00811837|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110501829|NCT00811837|Anesthetics, General|anesthetics, general|mesh-ancestor
110501830|NCT00811837|Anesthetics|anesthetics|mesh-ancestor
110501831|NCT00811837|GABA Modulators|gaba modulators|mesh-ancestor
110501832|NCT00811837|GABA Agents|gaba agents|mesh-ancestor
110501833|NCT00811837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110501834|NCT00811837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110501835|NCT00811837|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110501836|NCT00811837|Narcotics|narcotics|mesh-ancestor
110501837|NCT00811837|Analgesics|analgesics|mesh-ancestor
110501838|NCT00811837|Sensory System Agents|sensory system agents|mesh-ancestor
110501839|NCT00811837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110501841|NCT00811915|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110501842|NCT00811915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110501843|NCT00811915|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110501844|NCT00811915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110501845|NCT00811915|Antifungal Agents|antifungal agents|mesh-ancestor
110501846|NCT00811915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110501847|NCT00811915|Immunologic Factors|immunologic factors|mesh-ancestor
110501848|NCT00811915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110501849|NCT00816127|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
110501850|NCT00816127|Hemostatics|hemostatics|mesh-ancestor
110501851|NCT00816127|Coagulants|coagulants|mesh-ancestor
110501852|NCT00816127|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
110501853|NCT00816127|Natriuretic Agents|natriuretic agents|mesh-ancestor
110501854|NCT00816127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110501855|NCT00916058|Melphalan|melphalan|mesh-list
110501856|NCT00916058|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110501857|NCT00916058|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110501858|NCT00916058|Alkylating Agents|alkylating agents|mesh-ancestor
110501859|NCT00916058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110501860|NCT00916058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110501861|NCT00916058|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110501862|NCT00916058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110501863|NCT00916058|Immunologic Factors|immunologic factors|mesh-ancestor
110501864|NCT00916058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110501865|NCT04559906|Ethyl Chloride|ethyl chloride|mesh-list
110501866|NCT04559906|Anesthetics, Local|anesthetics, local|mesh-ancestor
110501867|NCT04559906|Anesthetics|anesthetics|mesh-ancestor
110501868|NCT04559906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110501869|NCT04559906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110501870|NCT04559906|Sensory System Agents|sensory system agents|mesh-ancestor
110501871|NCT04559906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110501872|NCT00912782|Vitamin D|vitamin d|mesh-list
110501873|NCT00912782|Cholecalciferol|cholecalciferol|mesh-list
110501874|NCT00912782|Vitamins|vitamins|mesh-ancestor
110501875|NCT00912782|Micronutrients|micronutrients|mesh-ancestor
110501876|NCT00912782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110501877|NCT00912782|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110501878|NCT00912782|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110501879|NCT04202978|Capecitabine|capecitabine|mesh-list
110501880|NCT04202978|Oxaliplatin|oxaliplatin|mesh-list
110501881|NCT04202978|Apatinib|apatinib|mesh-list
110501882|NCT04202978|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110501883|NCT04202978|Antimetabolites|antimetabolites|mesh-ancestor
110501884|NCT04202978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110501885|NCT04202978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110501886|NCT04202978|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110501887|NCT04202978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110501888|NCT04186442|Botulinum Toxins|botulinum toxins|mesh-list
110501889|NCT04186442|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110501890|NCT04186442|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110501891|NCT04186442|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110501892|NCT04186442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110501893|NCT04186442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110501894|NCT04186442|Cholinergic Agents|cholinergic agents|mesh-ancestor
110501895|NCT04186442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110501896|NCT04186442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110501897|NCT04186442|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110501898|NCT04186442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110501900|NCT04203368|Verapamil|verapamil|mesh-list
110501901|NCT04203368|Analgesics|analgesics|mesh-ancestor
110501902|NCT04203368|Sensory System Agents|sensory system agents|mesh-ancestor
110501903|NCT04203368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110501904|NCT04203368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110501905|NCT04203368|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110501906|NCT04203368|Vasodilator Agents|vasodilator agents|mesh-ancestor
110501907|NCT04203368|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
110501908|NCT04203368|Purinergic Agonists|purinergic agonists|mesh-ancestor
110501909|NCT04203368|Purinergic Agents|purinergic agents|mesh-ancestor
110501910|NCT04203368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110501911|NCT04203368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110501912|NCT04203368|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110501913|NCT04203368|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110501914|NCT04203368|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110501917|NCT04133948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110501918|NCT04133948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110501919|NCT04133948|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110501920|NCT04133948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110501921|NCT00911534|Rabeprazole|rabeprazole|mesh-list
110501922|NCT00911534|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110501923|NCT00911534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110501924|NCT00911534|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110501925|NCT00911534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110501926|NCT00911534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110501927|NCT00911300|Vitamin K|vitamin k|mesh-list
110501928|NCT00911300|Heparin|heparin|mesh-list
110501929|NCT00911300|Calcium heparin|calcium heparin|mesh-list
110501930|NCT00911300|PENTA|penta|mesh-list
110501931|NCT00911300|Fondaparinux|fondaparinux|mesh-list
110501932|NCT00911300|Vitamins|vitamins|mesh-ancestor
110501933|NCT00911300|Micronutrients|micronutrients|mesh-ancestor
110501934|NCT00911300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110501935|NCT00911300|Anticoagulants|anticoagulants|mesh-ancestor
110501936|NCT00911300|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110501937|NCT00911300|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110501938|NCT00911300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110501939|NCT00911300|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110501940|NCT00911300|Hemostatics|hemostatics|mesh-ancestor
110501941|NCT00911300|Coagulants|coagulants|mesh-ancestor
110501942|NCT00911300|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110501943|NCT00911300|Antithrombins|antithrombins|mesh-ancestor
110501944|NCT00911300|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110501945|NCT00911300|Protease Inhibitors|protease inhibitors|mesh-ancestor
110501946|NCT00911300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110501947|NCT00911144|Vaccines|vaccines|mesh-list
110501948|NCT00911144|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110501949|NCT00911144|Immunologic Factors|immunologic factors|mesh-ancestor
110501950|NCT00911144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110501951|NCT04395248|Anesthetics|anesthetics|mesh-list
110501952|NCT04395248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110501953|NCT04395248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110501954|NCT00632216|Risedronic Acid|risedronic acid|mesh-list
110501955|NCT00632216|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110501956|NCT00632216|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110501957|NCT00632216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110501958|NCT00632216|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110501959|NCT00632216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110501960|NCT00632216|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110501961|NCT04276298|Metronidazole|metronidazole|mesh-list
110501962|NCT04276298|Lidocaine|lidocaine|mesh-list
110501963|NCT04276298|Diltiazem|diltiazem|mesh-list
110501964|NCT04276298|Anesthetics, Local|anesthetics, local|mesh-ancestor
110501965|NCT04276298|Anesthetics|anesthetics|mesh-ancestor
110168788|NCT00036088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110501966|NCT04276298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110501967|NCT04276298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110501968|NCT04276298|Sensory System Agents|sensory system agents|mesh-ancestor
110501969|NCT04276298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110501970|NCT04276298|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110501971|NCT04276298|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110501972|NCT04276298|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110501973|NCT04276298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110501974|NCT04276298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110149288|NCT00007683|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110501975|NCT04276298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110501976|NCT04276298|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110501977|NCT04276298|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110501978|NCT04276298|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110501979|NCT04276298|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110501980|NCT04276298|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110501981|NCT04276298|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110501982|NCT04276298|Vasodilator Agents|vasodilator agents|mesh-ancestor
110501983|NCT04273880|Ascorbic Acid|ascorbic acid|mesh-list
110501984|NCT04273880|Methylphenidate|methylphenidate|mesh-list
110501985|NCT04273880|Vitamins|vitamins|mesh-ancestor
110501986|NCT04273880|Micronutrients|micronutrients|mesh-ancestor
110501987|NCT04273880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110501988|NCT04273880|Antioxidants|antioxidants|mesh-ancestor
110501989|NCT04273880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110501990|NCT04273880|Protective Agents|protective agents|mesh-ancestor
110501991|NCT04273880|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110501992|NCT04273880|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110501993|NCT04273880|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110501994|NCT04273880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110501995|NCT04273880|Dopamine Agents|dopamine agents|mesh-ancestor
110501996|NCT04273880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110501997|NCT00910988|Olanzapine|olanzapine|mesh-list
110501998|NCT00910988|Ziprasidone|ziprasidone|mesh-list
110501999|NCT00910988|Antiemetics|antiemetics|mesh-ancestor
110502000|NCT00910988|Autonomic Agents|autonomic agents|mesh-ancestor
110502001|NCT00910988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110502002|NCT00910988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110502003|NCT00910988|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110502004|NCT00910988|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110502005|NCT00910988|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110502006|NCT00910988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110502007|NCT00910988|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110502008|NCT00910988|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110502009|NCT00910988|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110502010|NCT00910988|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110502011|NCT00910988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110502012|NCT00910988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110502013|NCT00910988|Serotonin Agents|serotonin agents|mesh-ancestor
110502014|NCT00910988|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110502015|NCT00910988|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110502016|NCT00910988|Dopamine Agents|dopamine agents|mesh-ancestor
110502017|NCT00644059|Vaccines|vaccines|mesh-list
110502018|NCT00644059|Immunologic Factors|immunologic factors|mesh-ancestor
110502019|NCT00644059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110502020|NCT00817687|Mycophenolic Acid|mycophenolic acid|mesh-list
110502021|NCT00817687|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110502022|NCT00817687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110502023|NCT00817687|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110502024|NCT00817687|Antitubercular Agents|antitubercular agents|mesh-ancestor
110502025|NCT00817687|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110502026|NCT00817687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110502027|NCT00817687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110502028|NCT00817687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110502029|NCT00811993|Etoposide|etoposide|mesh-list
110502030|NCT00811993|Docetaxel|docetaxel|mesh-list
110502031|NCT00811993|Bevacizumab|bevacizumab|mesh-list
110502032|NCT00811993|Carboplatin|carboplatin|mesh-list
110502033|NCT00811993|Gemcitabine|gemcitabine|mesh-list
110502034|NCT00811993|Capecitabine|capecitabine|mesh-list
110502035|NCT00811993|Trastuzumab|trastuzumab|mesh-list
110502036|NCT00811993|Irinotecan|irinotecan|mesh-list
110502037|NCT00811993|Cetuximab|cetuximab|mesh-list
110502038|NCT00811993|Temozolomide|temozolomide|mesh-list
110502039|NCT00811993|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110502040|NCT00811993|Sorafenib|sorafenib|mesh-list
110502041|NCT00811993|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110502042|NCT00811993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110502043|NCT00811993|Tubulin Modulators|tubulin modulators|mesh-ancestor
110502044|NCT00811993|Antimitotic Agents|antimitotic agents|mesh-ancestor
110502045|NCT00811993|Mitosis Modulators|mitosis modulators|mesh-ancestor
110502046|NCT00811993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110502047|NCT00811993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110502048|NCT00811993|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110502049|NCT00811993|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110283457|NCT00226044|Omeprazole|omeprazole|mesh-list
110502050|NCT00811993|Growth Substances|growth substances|mesh-ancestor
110149363|NCT03616717|Modafinil|modafinil|mesh-list
110502051|NCT00811993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110502053|NCT00811993|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110502054|NCT00811993|Antimetabolites|antimetabolites|mesh-ancestor
110502055|NCT00811993|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110502056|NCT00811993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110502057|NCT00811993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110502058|NCT00811993|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110502059|NCT00811993|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110502060|NCT00811993|Alkylating Agents|alkylating agents|mesh-ancestor
110502061|NCT00811993|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110502062|NCT00817765|Ritonavir|ritonavir|mesh-list
110502063|NCT00817765|Fosamprenavir|fosamprenavir|mesh-list
110502064|NCT00817765|Posaconazole|posaconazole|mesh-list
110502065|NCT00817765|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110502066|NCT00817765|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110502067|NCT00817765|Protease Inhibitors|protease inhibitors|mesh-ancestor
110502068|NCT00817765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110502069|NCT00817765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110502070|NCT00817765|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110502071|NCT00817765|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110502072|NCT00817765|Antiviral Agents|antiviral agents|mesh-ancestor
110611907|NCT05950802|Cyclophosphamide|cyclophosphamide|mesh-list
110502074|NCT00817765|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110502075|NCT00817765|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110502076|NCT00817765|Antifungal Agents|antifungal agents|mesh-ancestor
110502077|NCT00817765|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
110502078|NCT00817765|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110502079|NCT00817765|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110502080|NCT00817765|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110502081|NCT00817765|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110502082|NCT00817765|Hormone Antagonists|hormone antagonists|mesh-ancestor
110502083|NCT00817765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110502084|NCT00817765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110502085|NCT00816205|Nifedipine|nifedipine|mesh-list
110502086|NCT00816205|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110502087|NCT00816205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110502088|NCT00816205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110502089|NCT00816205|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110502090|NCT00816205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110502091|NCT00816205|Vasodilator Agents|vasodilator agents|mesh-ancestor
110502092|NCT00816205|Tocolytic Agents|tocolytic agents|mesh-ancestor
110502093|NCT00816205|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110502094|NCT00816283|Dasatinib|dasatinib|mesh-list
110502095|NCT00816283|Vorinostat|vorinostat|mesh-list
110502096|NCT00816283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110502097|NCT00816283|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110502098|NCT00816283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110502099|NCT00816283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110502100|NCT00816283|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110502101|NCT00910910|Lenalidomide|lenalidomide|mesh-list
110502102|NCT00910910|Chlorambucil|chlorambucil|mesh-list
110502103|NCT00910910|Immunologic Factors|immunologic factors|mesh-ancestor
110502104|NCT00910910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110502105|NCT00910910|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110502106|NCT00910910|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110502107|NCT00910910|Growth Substances|growth substances|mesh-ancestor
110502108|NCT00910910|Growth Inhibitors|growth inhibitors|mesh-ancestor
110502109|NCT00910910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110502110|NCT00910910|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110502111|NCT00910910|Alkylating Agents|alkylating agents|mesh-ancestor
110502112|NCT00910910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110502113|NCT04384562|Methylphenidate|methylphenidate|mesh-list
110502114|NCT04384562|Reboxetine|reboxetine|mesh-list
110502115|NCT04384562|Nicotine|nicotine|mesh-list
110502116|NCT04384562|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110502117|NCT04384562|Autonomic Agents|autonomic agents|mesh-ancestor
110502118|NCT04384562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110502119|NCT04384562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110502120|NCT04384562|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110502121|NCT04384562|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110502122|NCT04384562|Cholinergic Agents|cholinergic agents|mesh-ancestor
110502123|NCT04384562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110149441|NCT00007917|Gemcitabine|gemcitabine|mesh-list
110502124|NCT04384562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110502125|NCT04384562|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110502126|NCT04384562|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110502127|NCT04384562|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110502128|NCT04384562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110502129|NCT04384562|Dopamine Agents|dopamine agents|mesh-ancestor
110502130|NCT04384562|Antidepressive Agents|antidepressive agents|mesh-ancestor
110502131|NCT04384562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110502132|NCT04384562|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110502133|NCT04384562|Adrenergic Agents|adrenergic agents|mesh-ancestor
110502135|NCT04515134|Coenzyme Q10|coenzyme q10|mesh-list
110502136|NCT04515134|Micronutrients|micronutrients|mesh-ancestor
110502137|NCT04515134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110502138|NCT04515134|Vitamins|vitamins|mesh-ancestor
110502139|NCT04238390|Meropenem|meropenem|mesh-list
110502140|NCT04238390|Tazobactam|tazobactam|mesh-list
110502141|NCT04238390|Ceftolozane|ceftolozane|mesh-list
110502142|NCT04238390|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
110502143|NCT04238390|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110502144|NCT04238390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110502145|NCT04238390|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110502146|NCT04238390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110502147|NCT04238390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110502148|NCT04238390|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110502149|NCT04236830|Fluorides|fluorides|mesh-list
110502150|NCT04236830|Cariostatic Agents|cariostatic agents|mesh-ancestor
110502151|NCT04236830|Protective Agents|protective agents|mesh-ancestor
110502152|NCT04236830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110502153|NCT04203212|Goserelin|goserelin|mesh-list
110502154|NCT04203212|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110502155|NCT04203212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110502156|NCT00637910|Docetaxel|docetaxel|mesh-list
110502157|NCT00637910|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110611972|NCT05895201|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110502158|NCT00637910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110502160|NCT00637910|Antimitotic Agents|antimitotic agents|mesh-ancestor
110502161|NCT00637910|Mitosis Modulators|mitosis modulators|mesh-ancestor
110502162|NCT00637910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110502163|NCT00637910|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110502164|NCT00637910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110502165|NCT03408236|Botulinum Toxins|botulinum toxins|mesh-list
110502166|NCT03408236|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110502167|NCT03408236|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110502168|NCT03408236|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110502169|NCT03408236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110502170|NCT03408236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110502171|NCT03408236|Cholinergic Agents|cholinergic agents|mesh-ancestor
110502172|NCT03408236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110502173|NCT03408236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110502174|NCT03408236|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110502175|NCT03408236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110502176|NCT04449536|Mesna|mesna|mesh-list
110502177|NCT04449536|Protective Agents|protective agents|mesh-ancestor
110502178|NCT04449536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110502179|NCT03960554|Denosumab|denosumab|mesh-list
110502180|NCT03960554|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110502181|NCT03960554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110502183|NCT04084106|Clavulanic Acids|clavulanic acids|mesh-list
110502184|NCT04084106|Clavulanic Acid|clavulanic acid|mesh-list
110502185|NCT04084106|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
110502186|NCT04084106|Penicillin V|penicillin v|mesh-list
110502187|NCT04084106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110502188|NCT04084106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110502189|NCT04084106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110502190|NCT04084106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110502191|NCT04084106|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110502192|NCT02977052|Nivolumab|nivolumab|mesh-list
110502193|NCT02977052|Ipilimumab|ipilimumab|mesh-list
110502194|NCT02977052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110502195|NCT02977052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110502196|NCT02977052|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110502197|NCT02977052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110502198|NCT02973542|Ethosuximide|ethosuximide|mesh-list
110502199|NCT02973542|Anticonvulsants|anticonvulsants|mesh-ancestor
110502200|NCT02973386|Cisplatin|cisplatin|mesh-list
110502201|NCT02973386|Capecitabine|capecitabine|mesh-list
110502202|NCT02973386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110502203|NCT02973386|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110502204|NCT02973386|Antimetabolites|antimetabolites|mesh-ancestor
110502205|NCT02973386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110502206|NCT00909428|Solifenacin Succinate|solifenacin succinate|mesh-list
110502207|NCT00909428|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110502208|NCT00909428|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110502209|NCT00909428|Cholinergic Agents|cholinergic agents|mesh-ancestor
110502210|NCT00909428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110502211|NCT00909428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110502212|NCT00909428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110502213|NCT00909428|Urological Agents|urological agents|mesh-ancestor
110502214|NCT03718130|Vaccines|vaccines|mesh-list
110502215|NCT03718130|Immunologic Factors|immunologic factors|mesh-ancestor
110502216|NCT03718130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110502217|NCT00908960|Enoxaparin|enoxaparin|mesh-list
110502218|NCT00908960|Anticoagulants|anticoagulants|mesh-ancestor
110502219|NCT00908960|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110502220|NCT00908960|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110502221|NCT00908960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110502223|NCT05332106|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110502224|NCT05332106|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110502225|NCT05332106|Estradiol|estradiol|mesh-list
110502226|NCT05332106|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110502227|NCT05332106|Nandrolone|nandrolone|mesh-list
110502228|NCT05332106|Estrogens|estrogens|mesh-ancestor
110502229|NCT05332106|Hormones|hormones|mesh-ancestor
110502230|NCT05332106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110502231|NCT05332106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110502232|NCT05332106|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110502233|NCT05332106|Contraceptive Agents|contraceptive agents|mesh-ancestor
110502234|NCT05332106|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110502235|NCT05332106|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110502236|NCT05332106|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110502237|NCT05332106|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110502238|NCT05332106|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110502239|NCT05332106|Hormone Antagonists|hormone antagonists|mesh-ancestor
110502240|NCT05332106|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110502241|NCT05332106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110502242|NCT05332106|Androgens|androgens|mesh-ancestor
110502243|NCT05332106|Anabolic Agents|anabolic agents|mesh-ancestor
110502244|NCT05332028|Fentanyl|fentanyl|mesh-list
110502245|NCT05332028|Bupivacaine|bupivacaine|mesh-list
110502246|NCT05332028|Propofol|propofol|mesh-list
110502247|NCT05332028|Anesthetics, Local|anesthetics, local|mesh-ancestor
110502248|NCT05332028|Anesthetics|anesthetics|mesh-ancestor
110502249|NCT05332028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110502250|NCT05332028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110502251|NCT05332028|Sensory System Agents|sensory system agents|mesh-ancestor
110502252|NCT05332028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110502253|NCT05332028|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110502254|NCT05332028|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110502255|NCT05332028|Anesthetics, General|anesthetics, general|mesh-ancestor
110502256|NCT05332028|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110502257|NCT05332028|Narcotics|narcotics|mesh-ancestor
110502258|NCT05332028|Analgesics|analgesics|mesh-ancestor
110502259|NCT05332028|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110502260|NCT00816517|Botulinum Toxins|botulinum toxins|mesh-list
110502261|NCT00816517|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110502262|NCT00816517|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110502263|NCT00816517|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110502264|NCT00816517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110502265|NCT00816517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110502266|NCT00816517|Cholinergic Agents|cholinergic agents|mesh-ancestor
110502267|NCT00816517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110502268|NCT00816517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110502269|NCT00816517|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110502270|NCT00816517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110502272|NCT00643201|Warfarin|warfarin|mesh-list
110502273|NCT00643201|Enoxaparin sodium|enoxaparin sodium|mesh-list
110502274|NCT00643201|Apixaban|apixaban|mesh-list
110502275|NCT00643201|Anticoagulants|anticoagulants|mesh-ancestor
110502276|NCT00643201|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110502278|NCT00643201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110502279|NCT00643201|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110502280|NCT00643201|Antithrombins|antithrombins|mesh-ancestor
110502281|NCT00643201|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110502282|NCT00643201|Protease Inhibitors|protease inhibitors|mesh-ancestor
110502283|NCT00643201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110502284|NCT00643123|Allopurinol|allopurinol|mesh-list
110502285|NCT00643123|Antimetabolites|antimetabolites|mesh-ancestor
110502286|NCT00643123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110502287|NCT00643123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110502288|NCT00643123|Gout Suppressants|gout suppressants|mesh-ancestor
110502289|NCT00643123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110502290|NCT00643123|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110502291|NCT00643123|Antioxidants|antioxidants|mesh-ancestor
110502292|NCT00643123|Protective Agents|protective agents|mesh-ancestor
110502293|NCT00643123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110502294|NCT00816673|Melatonin|melatonin|mesh-list
110502295|NCT00816673|Antioxidants|antioxidants|mesh-ancestor
110502296|NCT00816673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110502297|NCT00816673|Protective Agents|protective agents|mesh-ancestor
110502298|NCT00816673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110502299|NCT00816673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110502300|NCT00818155|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
110502301|NCT00818155|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110502302|NCT00818155|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110502303|NCT00818155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110502304|NCT00818155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110612135|NCT05771584|Sargramostim|sargramostim|mesh-list
110502306|NCT00818155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110502307|NCT00818155|Antidepressive Agents|antidepressive agents|mesh-ancestor
110502308|NCT00818155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110502309|NCT00641719|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110502310|NCT00641719|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110502311|NCT00641719|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110502312|NCT00641719|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110502313|NCT00641719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110502314|NCT00641719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110502315|NCT00641719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110502316|NCT00641719|Analgesics|analgesics|mesh-ancestor
110502317|NCT00641719|Sensory System Agents|sensory system agents|mesh-ancestor
110502318|NCT00641719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110502319|NCT00641719|Antidepressive Agents|antidepressive agents|mesh-ancestor
110502320|NCT00641719|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110502321|NCT00641719|Dopamine Agents|dopamine agents|mesh-ancestor
110502322|NCT02863367|Gemcitabine|gemcitabine|mesh-list
110502323|NCT02863367|Apatinib|apatinib|mesh-list
110502324|NCT02863367|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110502325|NCT02863367|Antimetabolites|antimetabolites|mesh-ancestor
110502326|NCT02863367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110502327|NCT02863367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110502328|NCT02863367|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110502329|NCT02863367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110502330|NCT00648895|Metoprolol|metoprolol|mesh-list
110502331|NCT00648895|Nebivolol|nebivolol|mesh-list
110502332|NCT00648895|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110502333|NCT00648895|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110502334|NCT00648895|Sympatholytics|sympatholytics|mesh-ancestor
110502335|NCT00648895|Autonomic Agents|autonomic agents|mesh-ancestor
110502336|NCT00648895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110502337|NCT00648895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110502338|NCT00648895|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110502339|NCT00648895|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110502340|NCT00648895|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110502341|NCT00648895|Adrenergic Agents|adrenergic agents|mesh-ancestor
110502342|NCT00648895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110502343|NCT00648895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110502344|NCT00648895|Vasodilator Agents|vasodilator agents|mesh-ancestor
110502345|NCT00648895|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
110502346|NCT00648895|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110502347|NCT00648895|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110502348|NCT00975221|Cinacalcet|cinacalcet|mesh-list
110502349|NCT00975221|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110502350|NCT00975221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110502351|NCT00975221|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
110502352|NCT00975221|Hormone Antagonists|hormone antagonists|mesh-ancestor
110502353|NCT00975221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110502355|NCT02863679|Anesthetics, Local|anesthetics, local|mesh-ancestor
110502356|NCT02863679|Anesthetics|anesthetics|mesh-ancestor
110275868|NCT00712582|Analgesics|analgesics|mesh-ancestor
110502357|NCT02863679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110502358|NCT02863679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110502359|NCT02863679|Sensory System Agents|sensory system agents|mesh-ancestor
110502360|NCT02863679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110502361|NCT00906698|Vinorelbine|vinorelbine|mesh-list
110502362|NCT00906698|Afatinib|afatinib|mesh-list
110502363|NCT00906698|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110502364|NCT00906698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110502365|NCT00906698|Tubulin Modulators|tubulin modulators|mesh-ancestor
110502366|NCT00906698|Antimitotic Agents|antimitotic agents|mesh-ancestor
110502367|NCT00906698|Mitosis Modulators|mitosis modulators|mesh-ancestor
110502368|NCT00906698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110502369|NCT00906698|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110502370|NCT00906698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110502371|NCT00972023|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
110502372|NCT00972023|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110502373|NCT00972023|Immunologic Factors|immunologic factors|mesh-ancestor
110502374|NCT00972023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110502375|NCT03396926|Bevacizumab|bevacizumab|mesh-list
110502376|NCT03396926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110502377|NCT03396926|Pembrolizumab|pembrolizumab|mesh-list
110502378|NCT03396926|Capecitabine|capecitabine|mesh-list
110502379|NCT03396926|Endothelial Growth Factors|endothelial growth factors|mesh-list
110502380|NCT03396926|Antibodies|antibodies|mesh-list
110502381|NCT03396926|Immunoglobulins|immunoglobulins|mesh-list
110502382|NCT03396926|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110502383|NCT03396926|Immunoglobulin G|immunoglobulin g|mesh-list
110502384|NCT03396926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110502385|NCT03396926|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110502386|NCT03396926|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110502387|NCT03396926|Growth Substances|growth substances|mesh-ancestor
110502388|NCT03396926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110502389|NCT03396926|Growth Inhibitors|growth inhibitors|mesh-ancestor
110502390|NCT03396926|Immunologic Factors|immunologic factors|mesh-ancestor
110502391|NCT03396926|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110502392|NCT03396926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110502393|NCT03396926|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110502394|NCT03396926|Antimetabolites|antimetabolites|mesh-ancestor
110502395|NCT00971945|Paclitaxel|paclitaxel|mesh-list
110502396|NCT00971945|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110502397|NCT00971945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110502398|NCT00971945|Tubulin Modulators|tubulin modulators|mesh-ancestor
110502399|NCT00971945|Antimitotic Agents|antimitotic agents|mesh-ancestor
110502400|NCT00971945|Mitosis Modulators|mitosis modulators|mesh-ancestor
110502401|NCT00971945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110502402|NCT03672500|Epinephrine|epinephrine|mesh-list
110502403|NCT03672500|Bupivacaine|bupivacaine|mesh-list
110502404|NCT03672500|Anesthetics, Local|anesthetics, local|mesh-ancestor
110502405|NCT03672500|Anesthetics|anesthetics|mesh-ancestor
110502406|NCT03672500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110502407|NCT03672500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110502408|NCT03672500|Sensory System Agents|sensory system agents|mesh-ancestor
110502409|NCT03672500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110502410|NCT03672500|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110502411|NCT03672500|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110502412|NCT03672500|Adrenergic Agents|adrenergic agents|mesh-ancestor
110502413|NCT03672500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110502414|NCT03672500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110502415|NCT03672500|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110502416|NCT03672500|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110502417|NCT03672500|Autonomic Agents|autonomic agents|mesh-ancestor
110502418|NCT03672500|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110502419|NCT03672500|Respiratory System Agents|respiratory system agents|mesh-ancestor
110502420|NCT03672500|Mydriatics|mydriatics|mesh-ancestor
110502421|NCT03672500|Sympathomimetics|sympathomimetics|mesh-ancestor
110502422|NCT03672500|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110502423|NCT00971867|Paclitaxel|paclitaxel|mesh-list
110502424|NCT00971867|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110502425|NCT00971867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110502426|NCT00971867|Tubulin Modulators|tubulin modulators|mesh-ancestor
110502427|NCT00971867|Antimitotic Agents|antimitotic agents|mesh-ancestor
110502428|NCT00971867|Mitosis Modulators|mitosis modulators|mesh-ancestor
110502429|NCT00971867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110502430|NCT00812851|Dronabinol|dronabinol|mesh-list
110502431|NCT00812851|Hallucinogens|hallucinogens|mesh-ancestor
110502432|NCT00812851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110502433|NCT00812851|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110502434|NCT00812851|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110502435|NCT00812851|Analgesics|analgesics|mesh-ancestor
110502436|NCT00812851|Sensory System Agents|sensory system agents|mesh-ancestor
110502437|NCT00812851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110502438|NCT00812851|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
110502439|NCT00812851|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110502440|NCT00812851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110502441|NCT00812851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110502442|NCT00812851|Hormones|hormones|mesh-ancestor
110502443|NCT00812851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110502444|NCT00648037|Rituximab|rituximab|mesh-list
110502445|NCT00648037|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110502446|NCT00648037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110502447|NCT00648037|Immunologic Factors|immunologic factors|mesh-ancestor
110502448|NCT00648037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110502449|NCT00648037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110502450|NCT00817375|Milnacipran|milnacipran|mesh-list
110502451|NCT00817375|Mirtazapine|mirtazapine|mesh-list
110502452|NCT00817375|Sertraline|sertraline|mesh-list
110502453|NCT00817375|Fluoxetine|fluoxetine|mesh-list
110502454|NCT00817375|Paroxetine|paroxetine|mesh-list
110502455|NCT00817375|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
110502456|NCT00817375|Nortriptyline|nortriptyline|mesh-list
110502457|NCT00817375|Antidepressive Agents|antidepressive agents|mesh-ancestor
110502458|NCT00817375|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110502459|NCT00817375|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110502460|NCT00817375|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110502461|NCT00817375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110502462|NCT00817375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110502463|NCT00817375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110502464|NCT00817375|Serotonin Agents|serotonin agents|mesh-ancestor
110502465|NCT00817375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110502466|NCT00817375|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110502467|NCT00817375|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110502468|NCT00817375|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110502469|NCT00817375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110502470|NCT00817375|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110283628|NCT00226356|Betaine|betaine|mesh-list
110502472|NCT00817375|Histamine Antagonists|histamine antagonists|mesh-ancestor
110502473|NCT00817375|Histamine Agents|histamine agents|mesh-ancestor
110502474|NCT00817375|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110502475|NCT00817375|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110502476|NCT00817375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110502477|NCT00817375|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
110502478|NCT00817375|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110502479|NCT00817375|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110502480|NCT00817375|Adrenergic Agents|adrenergic agents|mesh-ancestor
110502481|NCT00817375|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110502482|NCT00817375|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110502483|NCT00817375|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110502484|NCT00817375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110502485|NCT00817375|Analgesics|analgesics|mesh-ancestor
110502486|NCT00817375|Sensory System Agents|sensory system agents|mesh-ancestor
110502487|NCT00817375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110502488|NCT00817375|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110502489|NCT00817375|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110502490|NCT00818701|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
110502491|NCT00818701|Sildenafil Citrate|sildenafil citrate|mesh-list
110502492|NCT00818701|Vasodilator Agents|vasodilator agents|mesh-ancestor
110502493|NCT00818701|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110502494|NCT00818701|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110502495|NCT00818701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110149816|NCT00006469|Paclitaxel|paclitaxel|mesh-list
110502496|NCT00818701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110502497|NCT00818701|Urological Agents|urological agents|mesh-ancestor
110502498|NCT00818701|Natriuretic Agents|natriuretic agents|mesh-ancestor
110502499|NCT00818701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110502500|NCT00813241|Celecoxib|celecoxib|mesh-list
110502501|NCT00813241|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110502502|NCT00813241|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110502503|NCT00813241|Analgesics|analgesics|mesh-ancestor
110502504|NCT00813241|Sensory System Agents|sensory system agents|mesh-ancestor
110502505|NCT00813241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110502506|NCT00813241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110502507|NCT00813241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110502508|NCT00813241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110502509|NCT00813241|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110502510|NCT00813241|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110502511|NCT00813241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110502512|NCT00813241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110502513|NCT00640393|Etanercept|etanercept|mesh-list
110502514|NCT00640393|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110502515|NCT00640393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110502516|NCT00640393|Analgesics|analgesics|mesh-ancestor
110502517|NCT00640393|Sensory System Agents|sensory system agents|mesh-ancestor
110502518|NCT00640393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110502519|NCT00640393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110502520|NCT00640393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110502521|NCT00640393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110502522|NCT00640393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110502523|NCT00640393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110502524|NCT00640393|Immunologic Factors|immunologic factors|mesh-ancestor
110502525|NCT00821353|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
110502526|NCT05315024|Imiquimod|imiquimod|mesh-list
110502527|NCT05315024|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110502528|NCT05315024|Immunologic Factors|immunologic factors|mesh-ancestor
110502529|NCT05315024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110502530|NCT05315024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110502531|NCT05315024|Interferon Inducers|interferon inducers|mesh-ancestor
110502532|NCT00627445|Insulin|insulin|mesh-list
110502533|NCT00627445|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110502535|NCT00627445|Insulin Aspart|insulin aspart|mesh-list
110502536|NCT00627445|Insulin, Long-Acting|insulin, long-acting|mesh-list
110502537|NCT00627445|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
110502538|NCT00627445|Biphasic Insulins|biphasic insulins|mesh-list
110612430|NCT05050305|Dexamethasone|dexamethasone|mesh-list
110502539|NCT00627445|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
110502540|NCT00627445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110502541|NCT00627445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110502542|NCT02030990|Fluorometholone|fluorometholone|mesh-list
110502543|NCT02030990|Mitomycins|mitomycins|mesh-list
110502544|NCT02030990|Mitomycin|mitomycin|mesh-list
110502545|NCT02030990|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110502546|NCT02030990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110502547|NCT02030990|Alkylating Agents|alkylating agents|mesh-ancestor
110502548|NCT02030990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110502549|NCT02030990|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110502550|NCT02030990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110502551|NCT02030990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110502552|NCT02030990|Glucocorticoids|glucocorticoids|mesh-ancestor
110502553|NCT02030990|Hormones|hormones|mesh-ancestor
110502554|NCT02030990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110502555|NCT02030990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110502556|NCT02030990|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110502557|NCT00822055|Timolol|timolol|mesh-list
110502558|NCT00822055|Brimonidine Tartrate|brimonidine tartrate|mesh-list
110502559|NCT00822055|Dorzolamide|dorzolamide|mesh-list
110502560|NCT00822055|Maleic acid|maleic acid|mesh-list
110502561|NCT00822055|Brimonidine Tartrate, Timolol Maleate Drug Combination|brimonidine tartrate, timolol maleate drug combination|mesh-list
110502562|NCT00822055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110502563|NCT00822055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110502564|NCT00822055|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110502565|NCT00822055|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110502566|NCT00822055|Adrenergic Agents|adrenergic agents|mesh-ancestor
110502567|NCT00822055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110502568|NCT00822055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110502569|NCT00822055|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110502570|NCT00822055|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110502571|NCT00822055|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110502572|NCT00822055|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110502573|NCT00822055|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110502574|NCT00822055|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110502575|NCT00822133|Lidocaine|lidocaine|mesh-list
110502576|NCT00822133|Ketamine|ketamine|mesh-list
110502577|NCT00822133|Anesthetics, Local|anesthetics, local|mesh-ancestor
110502578|NCT00822133|Anesthetics|anesthetics|mesh-ancestor
110502579|NCT00822133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110502580|NCT00822133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110502581|NCT00822133|Sensory System Agents|sensory system agents|mesh-ancestor
110502582|NCT00822133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110502583|NCT00822133|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110612466|NCT04981951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110502584|NCT00822133|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110502585|NCT00822133|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110502586|NCT00822133|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110502587|NCT00822133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110502588|NCT00822133|Analgesics|analgesics|mesh-ancestor
110502589|NCT00822133|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110502590|NCT00822133|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110502591|NCT00822133|Anesthetics, General|anesthetics, general|mesh-ancestor
110502592|NCT00822133|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110502593|NCT00822133|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110502594|NCT00822133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110502595|NCT00822211|Vildagliptin|vildagliptin|mesh-list
110502596|NCT00822211|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110502597|NCT00822211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110502598|NCT00822211|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110502599|NCT00822211|Protease Inhibitors|protease inhibitors|mesh-ancestor
110502600|NCT00822211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110502601|NCT00822211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110502602|NCT04018417|Amphotericin B|amphotericin b|mesh-list
110502603|NCT04018417|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
110502604|NCT04018417|Amebicides|amebicides|mesh-ancestor
110502605|NCT04018417|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110502606|NCT04018417|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110502607|NCT04018417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110502608|NCT04018417|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110502609|NCT04018417|Antifungal Agents|antifungal agents|mesh-ancestor
110502610|NCT01791920|Botulinum Toxins|botulinum toxins|mesh-list
110502611|NCT01791920|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110502612|NCT01791920|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110502613|NCT01791920|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110283841|NCT00226551|Autonomic Agents|autonomic agents|mesh-ancestor
110502614|NCT01791920|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110502615|NCT01791920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110502616|NCT01791920|Cholinergic Agents|cholinergic agents|mesh-ancestor
110502617|NCT01791920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110502618|NCT01791920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110502619|NCT01791920|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110502620|NCT01791920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110502621|NCT00826657|Vitamin B 12|vitamin b 12|mesh-list
110502622|NCT00826657|Hydroxocobalamin|hydroxocobalamin|mesh-list
110502624|NCT00826657|Micronutrients|micronutrients|mesh-ancestor
110502625|NCT00826657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110502626|NCT00826657|Vitamin B Complex|vitamin b complex|mesh-ancestor
110502627|NCT00826657|Hematinics|hematinics|mesh-ancestor
110502628|NCT02992964|Nivolumab|nivolumab|mesh-list
110502629|NCT02992964|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110502630|NCT02992964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110502631|NCT02992964|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110502632|NCT02992964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110502633|NCT03597776|Lidocaine|lidocaine|mesh-list
110502634|NCT03597776|Anesthetics, Local|anesthetics, local|mesh-ancestor
110502635|NCT03597776|Anesthetics|anesthetics|mesh-ancestor
110283896|NCT00226707|Pimecrolimus|pimecrolimus|mesh-list
110502636|NCT03597776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110502637|NCT03597776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110502638|NCT03597776|Sensory System Agents|sensory system agents|mesh-ancestor
110502639|NCT03597776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110502640|NCT03597776|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110502641|NCT03597776|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110502642|NCT03597776|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110502643|NCT03597776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110502644|NCT03597776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110502646|NCT00625183|Capecitabine|capecitabine|mesh-list
110502647|NCT00625183|Oxaliplatin|oxaliplatin|mesh-list
110502648|NCT00625183|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110502649|NCT00625183|Antimetabolites|antimetabolites|mesh-ancestor
110502650|NCT00625183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110502651|NCT00625183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110502652|NCT00625183|Antioxidants|antioxidants|mesh-ancestor
110502653|NCT00625183|Protective Agents|protective agents|mesh-ancestor
110502654|NCT00625183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110502655|NCT00625183|Trace Elements|trace elements|mesh-ancestor
110502656|NCT00625183|Micronutrients|micronutrients|mesh-ancestor
110502657|NCT00826891|Topotecan|topotecan|mesh-list
110502658|NCT00826891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110612588|NCT04683627|Diclofenac|diclofenac|mesh-list
110502659|NCT00826891|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110502660|NCT00826891|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110502661|NCT00826891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110502662|NCT00826891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110502663|NCT00826969|Ciclesonide|ciclesonide|mesh-list
110502664|NCT00826969|Glucocorticoids|glucocorticoids|mesh-ancestor
110502665|NCT00826969|Hormones|hormones|mesh-ancestor
110311868|NCT00303771|Antidotes|antidotes|mesh-ancestor
110502666|NCT00826969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110502667|NCT00826969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110502668|NCT00826969|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110502669|NCT03560882|Atorvastatin|atorvastatin|mesh-list
110502670|NCT03560882|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110502671|NCT03560882|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110502672|NCT03560882|Antimetabolites|antimetabolites|mesh-ancestor
110502673|NCT03560882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110502674|NCT03560882|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110502675|NCT03560882|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110502676|NCT03560882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110502677|NCT04044547|Rotigotine|rotigotine|mesh-list
110502678|NCT04044547|Dopamine Agonists|dopamine agonists|mesh-ancestor
110502679|NCT04044547|Dopamine Agents|dopamine agents|mesh-ancestor
110502680|NCT04044547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110612629|NCT04563754|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110612630|NCT04563754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110612632|NCT04551521|Atezolizumab|atezolizumab|mesh-list
110612633|NCT04551521|Pertuzumab|pertuzumab|mesh-list
110612634|NCT04551521|Vemurafenib|vemurafenib|mesh-list
110612635|NCT04551521|Ipatasertib|ipatasertib|mesh-list
110612636|NCT04551521|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110612637|NCT04551521|Inavolisib|inavolisib|mesh-list
110502681|NCT04044547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110502683|NCT02768948|Losartan|losartan|mesh-list
110502684|NCT02768948|Telmisartan|telmisartan|mesh-list
110502685|NCT02768948|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110502686|NCT02768948|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110502687|NCT02768948|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110502688|NCT02768948|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110502689|NCT02768948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110502690|NCT00640315|Riociguat|riociguat|mesh-list
110502691|NCT00640315|Enzyme Activators|enzyme activators|mesh-ancestor
110502692|NCT00640315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110502693|NCT00904748|Sildenafil Citrate|sildenafil citrate|mesh-list
110502694|NCT00904748|Citric Acid|citric acid|mesh-list
110502695|NCT00904748|Sodium Citrate|sodium citrate|mesh-list
110502696|NCT00904748|Anticoagulants|anticoagulants|mesh-ancestor
110502697|NCT00904748|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110502698|NCT00904748|Chelating Agents|chelating agents|mesh-ancestor
110502699|NCT00904748|Sequestering Agents|sequestering agents|mesh-ancestor
110502700|NCT00904748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110502701|NCT00904748|Vasodilator Agents|vasodilator agents|mesh-ancestor
110502702|NCT00904748|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110502703|NCT00904748|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110502704|NCT00904748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110502705|NCT00904748|Urological Agents|urological agents|mesh-ancestor
110502706|NCT00574405|Insulin|insulin|mesh-list
110502707|NCT00574405|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110502708|NCT00574405|Insulin Lispro|insulin lispro|mesh-list
110502709|NCT00574405|Insulin Aspart|insulin aspart|mesh-list
110502710|NCT00574405|Insulin, Isophane|insulin, isophane|mesh-list
110502711|NCT00574405|Isophane Insulin, Human|isophane insulin, human|mesh-list
110502712|NCT00574405|Isophane insulin, beef|isophane insulin, beef|mesh-list
110502713|NCT00574405|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110502714|NCT00574405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110502715|NCT00971243|Metformin|metformin|mesh-list
110502716|NCT00971243|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110502717|NCT00971243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110502718|NCT00822913|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110502719|NCT00822913|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110502720|NCT00822913|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110502721|NCT00822913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110502722|NCT00822913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110502723|NCT00822913|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110502724|NCT00822913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110502725|NCT00822913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110502726|NCT00822913|Cholinergic Agents|cholinergic agents|mesh-ancestor
110502727|NCT00822913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110502728|NCT04400383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110502730|NCT04400383|Immunoglobulins|immunoglobulins|mesh-list
110502731|NCT04400383|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110502732|NCT04400383|Immunologic Factors|immunologic factors|mesh-ancestor
110502733|NCT04400383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110502734|NCT04400383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110284077|NCT00208923|Busulfan|busulfan|mesh-list
110502735|NCT04381429|Insulin Aspart|insulin aspart|mesh-list
110502736|NCT04381429|Insulin, Long-Acting|insulin, long-acting|mesh-list
110502737|NCT04381429|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
110502738|NCT04381429|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110311884|NCT00303810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110502739|NCT04381429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110502740|NCT00568555|Naltrexone|naltrexone|mesh-list
110502741|NCT00568555|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110502742|NCT00568555|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110502743|NCT00568555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110502744|NCT00568555|Sensory System Agents|sensory system agents|mesh-ancestor
110502745|NCT00568555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110502746|NCT00819325|Pioglitazone|pioglitazone|mesh-list
110502747|NCT00819325|Hypoglycemic Agents|hypoglycemic agents|mesh-list
110502748|NCT00819325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110502749|NCT00904670|Methylphenidate|methylphenidate|mesh-list
110502750|NCT00904670|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110502751|NCT00904670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110502752|NCT00904670|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110502753|NCT00904670|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110502754|NCT00904670|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110502755|NCT00904670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110502756|NCT00904670|Dopamine Agents|dopamine agents|mesh-ancestor
110502757|NCT00904670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110502758|NCT00827281|Cycloserine|cycloserine|mesh-list
110502759|NCT00827281|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110502760|NCT00827281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110502761|NCT00827281|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110502762|NCT00827281|Antitubercular Agents|antitubercular agents|mesh-ancestor
110502763|NCT00827281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110502764|NCT00827281|Antimetabolites|antimetabolites|mesh-ancestor
110502765|NCT00827281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110502766|NCT00823381|Resveratrol|resveratrol|mesh-list
110502767|NCT00823381|Antioxidants|antioxidants|mesh-ancestor
110502768|NCT00823381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110502769|NCT00823381|Protective Agents|protective agents|mesh-ancestor
110276028|NCT04424602|Dimethoate|dimethoate|mesh-list
110502770|NCT00823381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110502771|NCT00823381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110502772|NCT00823381|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110502773|NCT00638443|Diphenhydramine|diphenhydramine|mesh-list
110502774|NCT00638443|Promethazine|promethazine|mesh-list
110502775|NCT00638443|Pregabalin|pregabalin|mesh-list
110502776|NCT00638443|Analgesics|analgesics|mesh-ancestor
110502777|NCT00638443|Sensory System Agents|sensory system agents|mesh-ancestor
110502778|NCT00638443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110502779|NCT00638443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110502780|NCT00638443|Anticonvulsants|anticonvulsants|mesh-ancestor
110502781|NCT00638443|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110502782|NCT00638443|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110502783|NCT00638443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110502784|NCT00638443|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110502785|NCT00638443|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110502786|NCT00638443|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110502787|NCT00638443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110502788|NCT00638443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110502789|NCT00638443|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110502790|NCT00638443|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110502791|NCT00638443|Anesthetics, Local|anesthetics, local|mesh-ancestor
110502792|NCT00638443|Anesthetics|anesthetics|mesh-ancestor
110502793|NCT00638443|Antiemetics|antiemetics|mesh-ancestor
110502794|NCT00638443|Autonomic Agents|autonomic agents|mesh-ancestor
110285308|NCT00230334|Imatinib Mesylate|imatinib mesylate|mesh-list
110502795|NCT00638443|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110502796|NCT00638443|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110502797|NCT00638443|Histamine Antagonists|histamine antagonists|mesh-ancestor
110502798|NCT00638443|Histamine Agents|histamine agents|mesh-ancestor
110502799|NCT00638443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110502800|NCT00638443|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110502801|NCT00638443|Antipruritics|antipruritics|mesh-ancestor
110502802|NCT00638443|Dermatologic Agents|dermatologic agents|mesh-ancestor
110502803|NCT00568399|Sodium thiosulfate|sodium thiosulfate|mesh-list
110502804|NCT00568399|Antidotes|antidotes|mesh-ancestor
110502805|NCT00568399|Protective Agents|protective agents|mesh-ancestor
110502806|NCT00568399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110502807|NCT00568399|Antioxidants|antioxidants|mesh-ancestor
110502808|NCT00568399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110502809|NCT00568399|Antitubercular Agents|antitubercular agents|mesh-ancestor
110502810|NCT00568399|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110502811|NCT00568399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110502812|NCT00568399|Chelating Agents|chelating agents|mesh-ancestor
110502814|NCT00975143|Isotretinoin|isotretinoin|mesh-list
110502815|NCT00975143|Dermatologic Agents|dermatologic agents|mesh-ancestor
110502816|NCT04286087|Anesthetics|anesthetics|mesh-list
110502817|NCT04286087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110502818|NCT04286087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110502819|NCT04288349|Epinephrine|epinephrine|mesh-list
110502820|NCT04288349|Racepinephrine|racepinephrine|mesh-list
110502821|NCT04288349|Ropivacaine|ropivacaine|mesh-list
110502822|NCT04288349|Epinephryl borate|epinephryl borate|mesh-list
110502823|NCT04288349|Anesthetics, Local|anesthetics, local|mesh-ancestor
110502824|NCT04288349|Anesthetics|anesthetics|mesh-ancestor
110285373|NCT00230490|Adefovir|adefovir|mesh-list
110502825|NCT04288349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110502826|NCT04288349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110502827|NCT04288349|Sensory System Agents|sensory system agents|mesh-ancestor
110502828|NCT04288349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110502829|NCT04288349|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110502830|NCT04288349|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110502831|NCT04288349|Adrenergic Agents|adrenergic agents|mesh-ancestor
110502832|NCT04288349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110502833|NCT04288349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110502834|NCT04288349|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110502835|NCT04288349|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110612857|NCT03864926|Tacrolimus|tacrolimus|mesh-list
110502836|NCT04288349|Autonomic Agents|autonomic agents|mesh-ancestor
110502837|NCT04288349|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110502838|NCT04288349|Respiratory System Agents|respiratory system agents|mesh-ancestor
110502839|NCT04288349|Mydriatics|mydriatics|mesh-ancestor
110502840|NCT04288349|Sympathomimetics|sympathomimetics|mesh-ancestor
110502841|NCT04288349|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110502843|NCT03667313|Paclitaxel|paclitaxel|mesh-list
110502844|NCT03667313|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110502845|NCT03667313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110502846|NCT03667313|Tubulin Modulators|tubulin modulators|mesh-ancestor
110502847|NCT03667313|Antimitotic Agents|antimitotic agents|mesh-ancestor
110502848|NCT03667313|Mitosis Modulators|mitosis modulators|mesh-ancestor
110502849|NCT03667313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110502850|NCT03667313|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110285417|NCT01089127|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110502851|NCT03667313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110502852|NCT03667313|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110502853|NCT03667313|Antifungal Agents|antifungal agents|mesh-ancestor
110502854|NCT03667313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110502855|NCT03667313|Immunologic Factors|immunologic factors|mesh-ancestor
110502856|NCT03667313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110502857|NCT00974675|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110502858|NCT00974675|Immunologic Factors|immunologic factors|mesh-ancestor
110502859|NCT00974675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110502860|NCT04925531|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110502862|NCT04925531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110502863|NCT00634933|Prednisone|prednisone|mesh-list
110502864|NCT00634933|Methylprednisolone|methylprednisolone|mesh-list
110502865|NCT00634933|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110502866|NCT00634933|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110502867|NCT00634933|Prednisolone|prednisolone|mesh-list
110502868|NCT00634933|Prednisolone acetate|prednisolone acetate|mesh-list
110502869|NCT00634933|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110502870|NCT00634933|Prednisolone phosphate|prednisolone phosphate|mesh-list
110502871|NCT00634933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110502872|NCT00634933|Glucocorticoids|glucocorticoids|mesh-ancestor
110502873|NCT00634933|Hormones|hormones|mesh-ancestor
110502874|NCT00634933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110502875|NCT00634933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110502876|NCT00634933|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110502878|NCT00634933|Antiemetics|antiemetics|mesh-ancestor
110502879|NCT00634933|Autonomic Agents|autonomic agents|mesh-ancestor
110502880|NCT00634933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110502881|NCT00634933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110502882|NCT00634933|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110502883|NCT00634933|Protective Agents|protective agents|mesh-ancestor
110502884|NCT00967499|Ondansetron|ondansetron|mesh-list
110502885|NCT00967499|Palonosetron|palonosetron|mesh-list
110502886|NCT00967499|Antiemetics|antiemetics|mesh-ancestor
110502887|NCT00967499|Autonomic Agents|autonomic agents|mesh-ancestor
110502888|NCT00967499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110502889|NCT00967499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110502890|NCT00967499|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110502892|NCT00967499|Dermatologic Agents|dermatologic agents|mesh-ancestor
110502893|NCT00967499|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110502894|NCT00967499|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110502895|NCT00967499|Serotonin Agents|serotonin agents|mesh-ancestor
110502896|NCT00967499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110502897|NCT00967499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110502898|NCT04286399|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
110502899|NCT04286399|Angiotensin II|angiotensin ii|mesh-list
110502900|NCT04286399|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
110502901|NCT04286399|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
110502902|NCT04286399|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
110502903|NCT04286399|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110502904|NCT04286399|Adrenergic Agents|adrenergic agents|mesh-ancestor
110502905|NCT04286399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110502906|NCT04286399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110502907|NCT04286399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110502908|NCT04286399|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110502909|NCT04286399|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110502910|NCT04286399|Protease Inhibitors|protease inhibitors|mesh-ancestor
110502911|NCT04286399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110502912|NCT00629837|Factor VIII|factor viii|mesh-list
110502913|NCT00629837|Coagulants|coagulants|mesh-ancestor
110502914|NCT00827671|Cetuximab|cetuximab|mesh-list
110502915|NCT00827671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110502916|NCT00827671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110502917|NCT03643133|Mifamurtide|mifamurtide|mesh-list
110502918|NCT03643133|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110502919|NCT03643133|Immunologic Factors|immunologic factors|mesh-ancestor
110502920|NCT03643133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110502921|NCT00823849|Cilostazol|cilostazol|mesh-list
110502922|NCT00823849|Probucol|probucol|mesh-list
110502923|NCT00823849|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110502924|NCT00823849|Autonomic Agents|autonomic agents|mesh-ancestor
110502925|NCT00823849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110502926|NCT00823849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110502927|NCT00823849|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110502928|NCT00823849|Respiratory System Agents|respiratory system agents|mesh-ancestor
110502929|NCT00823849|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110502930|NCT00823849|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110502931|NCT00823849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110502932|NCT00823849|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110502933|NCT00823849|Vasodilator Agents|vasodilator agents|mesh-ancestor
110502934|NCT00823849|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110502935|NCT00823849|Protective Agents|protective agents|mesh-ancestor
110502936|NCT00823849|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110502937|NCT00823849|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110502938|NCT00823849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110502939|NCT00823849|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110502940|NCT00823849|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110502941|NCT00823849|Antimetabolites|antimetabolites|mesh-ancestor
110502942|NCT00823849|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110502943|NCT00823849|Antioxidants|antioxidants|mesh-ancestor
110502944|NCT02550067|Copper|copper|mesh-list
110502945|NCT02550067|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
110150276|NCT05637268|Paclitaxel|paclitaxel|mesh-list
110502946|NCT02550067|Levonorgestrel|levonorgestrel|mesh-list
110502947|NCT02550067|Medroxyprogesterone|medroxyprogesterone|mesh-list
110612975|NCT03399318|Sensory System Agents|sensory system agents|mesh-ancestor
110502948|NCT02550067|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110502949|NCT02550067|Contraceptive Agents|contraceptive agents|mesh-ancestor
110502950|NCT02550067|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110502951|NCT02550067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110502952|NCT02550067|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110502953|NCT02550067|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110502954|NCT02550067|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110502955|NCT02550067|Trace Elements|trace elements|mesh-ancestor
110502956|NCT02550067|Micronutrients|micronutrients|mesh-ancestor
110502957|NCT02550067|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110502958|NCT02550067|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110502959|NCT02550067|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110502960|NCT02550067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110502961|NCT02862509|Budesonide|budesonide|mesh-list
110311886|NCT00303810|Alkylating Agents|alkylating agents|mesh-ancestor
110502962|NCT02862509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110502963|NCT02862509|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110276116|NCT04230187|Vitamins|vitamins|mesh-ancestor
110502964|NCT02862509|Autonomic Agents|autonomic agents|mesh-ancestor
110502965|NCT02862509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110502966|NCT02862509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110502967|NCT02862509|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110502968|NCT02862509|Respiratory System Agents|respiratory system agents|mesh-ancestor
110502969|NCT02862509|Glucocorticoids|glucocorticoids|mesh-ancestor
110502970|NCT02862509|Hormones|hormones|mesh-ancestor
110502971|NCT02862509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110502972|NCT04285775|Chrysarobin|chrysarobin|mesh-list
110502973|NCT04285775|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110502974|NCT04285775|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110502975|NCT04285775|Analgesics|analgesics|mesh-ancestor
110502976|NCT04285775|Sensory System Agents|sensory system agents|mesh-ancestor
110502977|NCT04285775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110502978|NCT04285775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110502979|NCT04285775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110502980|NCT04285775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110502981|NCT00965081|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110502982|NCT00965081|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110502983|NCT00965081|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110502984|NCT00965081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110502985|NCT00965081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110502986|NCT00965081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110502987|NCT00965081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110502988|NCT00965081|Analgesics|analgesics|mesh-ancestor
110613007|NCT03380468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110502989|NCT00965081|Sensory System Agents|sensory system agents|mesh-ancestor
110502990|NCT00965081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110502991|NCT00965081|Antidepressive Agents|antidepressive agents|mesh-ancestor
110502992|NCT00965081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110502993|NCT00965081|Dopamine Agents|dopamine agents|mesh-ancestor
110502994|NCT00961649|Brimonidine Tartrate|brimonidine tartrate|mesh-list
110502995|NCT00961649|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110502996|NCT00961649|Brinzolamide|brinzolamide|mesh-list
110502997|NCT00961649|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110502998|NCT00961649|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110502999|NCT00961649|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110503000|NCT00961649|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110503001|NCT00961649|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110503002|NCT00961649|Adrenergic Agents|adrenergic agents|mesh-ancestor
110503003|NCT00961649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110503004|NCT00961649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110503005|NCT00961649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110503006|NCT00961649|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110503007|NCT00961649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110503008|NCT04267601|Anagliptin|anagliptin|mesh-list
110503009|NCT04267601|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110503010|NCT04267601|Protease Inhibitors|protease inhibitors|mesh-ancestor
110503011|NCT04267601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110503012|NCT04267601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110503013|NCT04267601|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110503014|NCT04267601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110503015|NCT02861261|Promethazine|promethazine|mesh-list
110503016|NCT02861261|Diphenhydramine|diphenhydramine|mesh-list
110503017|NCT02861261|Antipruritics|antipruritics|mesh-ancestor
110503018|NCT02861261|Dermatologic Agents|dermatologic agents|mesh-ancestor
110503019|NCT02861261|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110503020|NCT02861261|Histamine Antagonists|histamine antagonists|mesh-ancestor
110503021|NCT02861261|Histamine Agents|histamine agents|mesh-ancestor
110503022|NCT02861261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110503023|NCT02861261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110503024|NCT02861261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110503025|NCT02861261|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110503026|NCT02861261|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110503027|NCT02861261|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110503028|NCT02861261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110503029|NCT02861261|Anesthetics, Local|anesthetics, local|mesh-ancestor
110503030|NCT02861261|Anesthetics|anesthetics|mesh-ancestor
110503031|NCT02861261|Sensory System Agents|sensory system agents|mesh-ancestor
110503032|NCT02861261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110503033|NCT02861261|Antiemetics|antiemetics|mesh-ancestor
110285727|NCT00209144|Insulin|insulin|mesh-list
110503035|NCT02861261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110503036|NCT04283435|Sildenafil Citrate|sildenafil citrate|mesh-list
110503037|NCT04283435|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110503038|NCT04283435|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110503039|NCT04283435|Estradiol|estradiol|mesh-list
110503040|NCT04283435|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110503041|NCT04283435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110503042|NCT04283435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110503043|NCT04283435|Estrogens|estrogens|mesh-ancestor
110503044|NCT04283435|Hormones|hormones|mesh-ancestor
110503045|NCT04283435|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110503046|NCT04283435|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110503047|NCT04283435|Contraceptive Agents|contraceptive agents|mesh-ancestor
110503048|NCT04283435|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110503049|NCT04283435|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110503050|NCT04283435|Vasodilator Agents|vasodilator agents|mesh-ancestor
110503051|NCT04283435|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110503052|NCT04283435|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110503053|NCT04283435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110503054|NCT04283435|Urological Agents|urological agents|mesh-ancestor
110503055|NCT00632125|Epoetin Alfa|epoetin alfa|mesh-list
110503056|NCT00632125|Hematinics|hematinics|mesh-ancestor
110503057|NCT00903968|Plerixafor|plerixafor|mesh-list
110503058|NCT00903968|Dexamethasone|dexamethasone|mesh-list
110503059|NCT00903968|Bortezomib|bortezomib|mesh-list
110503060|NCT00903968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110503061|NCT00903968|Antiemetics|antiemetics|mesh-ancestor
110503062|NCT00903968|Autonomic Agents|autonomic agents|mesh-ancestor
110503063|NCT00903968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110503064|NCT00903968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110613069|NCT02981069|Incretins|incretins|mesh-ancestor
110503065|NCT00903968|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110503066|NCT00903968|Glucocorticoids|glucocorticoids|mesh-ancestor
110503068|NCT00903968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110503069|NCT00903968|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110503070|NCT00903968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110503071|NCT00903968|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110503072|NCT00903968|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110503073|NCT00903968|Antiviral Agents|antiviral agents|mesh-ancestor
110503074|NCT00903968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110503075|NCT00632606|Magnesium Sulfate|magnesium sulfate|mesh-list
110503076|NCT00632606|Metoclopramide|metoclopramide|mesh-list
110503077|NCT00632606|Analgesics|analgesics|mesh-ancestor
110503078|NCT00632606|Sensory System Agents|sensory system agents|mesh-ancestor
110285761|NCT00209222|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110503079|NCT00632606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110503080|NCT00632606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110503081|NCT00632606|Anesthetics|anesthetics|mesh-ancestor
110503082|NCT00632606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110503083|NCT00632606|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110503084|NCT00632606|Anticonvulsants|anticonvulsants|mesh-ancestor
110503085|NCT00632606|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110503086|NCT00632606|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110503087|NCT00632606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110503088|NCT00632606|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110503089|NCT00632606|Tocolytic Agents|tocolytic agents|mesh-ancestor
110503090|NCT00632606|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110503091|NCT00632606|Antiemetics|antiemetics|mesh-ancestor
110503092|NCT00632606|Autonomic Agents|autonomic agents|mesh-ancestor
110503093|NCT00632606|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110503094|NCT00632606|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110503095|NCT00632606|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110503096|NCT00632606|Dopamine Agents|dopamine agents|mesh-ancestor
110503097|NCT00632606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110503098|NCT00903344|Vitamin D|vitamin d|mesh-list
110503099|NCT00903344|Cholecalciferol|cholecalciferol|mesh-list
110503100|NCT00903344|Vitamins|vitamins|mesh-ancestor
110503101|NCT00903344|Micronutrients|micronutrients|mesh-ancestor
110503102|NCT00903344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110503103|NCT00903344|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110503104|NCT00903344|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110503105|NCT02847338|Amlodipine|amlodipine|mesh-list
110503106|NCT02847338|Lisinopril|lisinopril|mesh-list
110503107|NCT02847338|Chlorthalidone|chlorthalidone|mesh-list
110503108|NCT02847338|Amiloride|amiloride|mesh-list
110503109|NCT02847338|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110503110|NCT02847338|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110503111|NCT02847338|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110503112|NCT02847338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110503113|NCT02847338|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110503114|NCT02847338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110503115|NCT02847338|Vasodilator Agents|vasodilator agents|mesh-ancestor
110503116|NCT02847338|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110503117|NCT02847338|Protease Inhibitors|protease inhibitors|mesh-ancestor
110503118|NCT02847338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110503119|NCT02847338|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110503120|NCT02847338|Protective Agents|protective agents|mesh-ancestor
110503121|NCT02847338|Diuretics|diuretics|mesh-ancestor
110503122|NCT02847338|Natriuretic Agents|natriuretic agents|mesh-ancestor
110503123|NCT02847338|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110503124|NCT02847338|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
110503125|NCT02847338|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110503126|NCT02847338|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
110285794|NCT00209300|Analgesics|analgesics|mesh-ancestor
110503127|NCT02847338|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110503128|NCT02847104|Insulin|insulin|mesh-list
110503129|NCT02847104|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110503130|NCT02847104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110503131|NCT02847104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110503132|NCT02849366|Immunomodulating Agents|immunomodulating agents|mesh-list
110503133|NCT02849366|Immunologic Factors|immunologic factors|mesh-ancestor
110503134|NCT02849366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110503136|NCT02849132|Antiviral Agents|antiviral agents|mesh-ancestor
110503137|NCT02849132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110503138|NCT05116826|Nitazoxanide|nitazoxanide|mesh-list
110503139|NCT05116826|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110503140|NCT05116826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110503141|NCT02848508|Metformin|metformin|mesh-list
110503142|NCT02848508|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110503143|NCT02848508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110503144|NCT00902564|Escitalopram|escitalopram|mesh-list
110503145|NCT00902564|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110503146|NCT00902564|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110503147|NCT00902564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110503148|NCT00902564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110503149|NCT00902564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110503150|NCT00902564|Serotonin Agents|serotonin agents|mesh-ancestor
110503151|NCT00902564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110503152|NCT00626197|Mycophenolic Acid|mycophenolic acid|mesh-list
110503153|NCT00626197|Cyclophosphamide|cyclophosphamide|mesh-list
110503154|NCT00626197|Azathioprine|azathioprine|mesh-list
110503155|NCT00626197|Ocrelizumab|ocrelizumab|mesh-list
110503156|NCT00626197|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110503157|NCT00626197|Immunologic Factors|immunologic factors|mesh-ancestor
110503158|NCT00626197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110503159|NCT00626197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110503160|NCT00626197|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110503161|NCT00626197|Alkylating Agents|alkylating agents|mesh-ancestor
110503162|NCT00626197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110503163|NCT00626197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110503164|NCT00626197|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110503165|NCT00626197|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110503166|NCT00626197|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110285894|NCT00209534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110503167|NCT00626197|Antitubercular Agents|antitubercular agents|mesh-ancestor
110503168|NCT00626197|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110503169|NCT00626197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110503170|NCT00626197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110503171|NCT00626197|Antimetabolites|antimetabolites|mesh-ancestor
110503172|NCT00626197|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110503173|NCT00626275|Naproxen|naproxen|mesh-list
110503174|NCT00626275|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110503175|NCT00626275|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110503176|NCT00626275|Analgesics|analgesics|mesh-ancestor
110503177|NCT00626275|Sensory System Agents|sensory system agents|mesh-ancestor
110503178|NCT00626275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110503179|NCT00626275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110285963|NCT01081132|Guanfacine|guanfacine|mesh-list
110503180|NCT00626275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110503181|NCT00626275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110503182|NCT00626275|Gout Suppressants|gout suppressants|mesh-ancestor
110503183|NCT00626275|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110503184|NCT00626275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110503185|NCT00626275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110503186|NCT02847884|Infliximab|infliximab|mesh-list
110503187|NCT02847884|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110503188|NCT02847884|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110503189|NCT02847884|Dermatologic Agents|dermatologic agents|mesh-ancestor
110503190|NCT02847884|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110503191|NCT02847884|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110503192|NCT00623935|Fludarabine|fludarabine|mesh-list
110503193|NCT00623935|Busulfan|busulfan|mesh-list
110503194|NCT00623935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110503195|NCT00623935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110503196|NCT00623935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110503197|NCT00623935|Immunologic Factors|immunologic factors|mesh-ancestor
110503198|NCT00623935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110503199|NCT00623935|Alkylating Agents|alkylating agents|mesh-ancestor
110503200|NCT00623935|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110503201|NCT00623935|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110503202|NCT00623779|Aspirin|aspirin|mesh-list
110503203|NCT00623779|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110503204|NCT00623779|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110503205|NCT00623779|Analgesics|analgesics|mesh-ancestor
110503206|NCT00623779|Sensory System Agents|sensory system agents|mesh-ancestor
110503207|NCT00623779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110503208|NCT00623779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110503209|NCT00623779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110503210|NCT00623779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110503211|NCT00623779|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110503212|NCT00623779|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110503213|NCT00623779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110613161|NCT02828358|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110503214|NCT00623779|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110503215|NCT00623779|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110503216|NCT00623779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110503218|NCT00828373|Lidocaine|lidocaine|mesh-list
110503219|NCT00828373|Anesthetics, Local|anesthetics, local|mesh-ancestor
110503220|NCT00828373|Anesthetics|anesthetics|mesh-ancestor
110503221|NCT00828373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110503222|NCT00828373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110503223|NCT00828373|Sensory System Agents|sensory system agents|mesh-ancestor
110503224|NCT00828373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110503225|NCT00828373|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110503226|NCT00828373|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110503227|NCT00828373|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110503228|NCT00828373|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110503229|NCT00828373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110503230|NCT00824239|Fentanyl|fentanyl|mesh-list
110503231|NCT00824239|Midazolam|midazolam|mesh-list
110503232|NCT00824239|Propofol|propofol|mesh-list
110503233|NCT00824239|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110503234|NCT00824239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110503235|NCT00824239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110503236|NCT00824239|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110503237|NCT00824239|Anesthetics, General|anesthetics, general|mesh-ancestor
110503238|NCT00824239|Anesthetics|anesthetics|mesh-ancestor
110503239|NCT00824239|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110503240|NCT00824239|Narcotics|narcotics|mesh-ancestor
110503241|NCT00824239|Analgesics|analgesics|mesh-ancestor
110503242|NCT00824239|Sensory System Agents|sensory system agents|mesh-ancestor
110503243|NCT00824239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110503244|NCT00824239|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110503245|NCT00824239|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110150575|NCT00000478|Vasodilator Agents|vasodilator agents|mesh-ancestor
110503246|NCT00824239|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110503247|NCT00824239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110503248|NCT00824239|GABA Modulators|gaba modulators|mesh-ancestor
110503249|NCT00824239|GABA Agents|gaba agents|mesh-ancestor
110503250|NCT00824239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110503251|NCT00824239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110503252|NCT04777760|Pulmonary Surfactants|pulmonary surfactants|mesh-list
110503253|NCT04777760|Respiratory System Agents|respiratory system agents|mesh-ancestor
110503254|NCT02548975|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
110503255|NCT02548975|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
110503256|NCT02548975|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110503258|NCT02548975|Antimetabolites|antimetabolites|mesh-ancestor
110503259|NCT02548975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110503260|NCT02548975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110503261|NCT02548975|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110503262|NCT02548975|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110503263|NCT02548975|Adrenergic Agents|adrenergic agents|mesh-ancestor
110503264|NCT02548975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110503265|NCT02548975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110503266|NCT04044703|Vancomycin|vancomycin|mesh-list
110503267|NCT04044703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110503268|NCT04044703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110503269|NCT02848040|Bile Acids and Salts|bile acids and salts|mesh-list
110503270|NCT02848040|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110503271|NCT00824317|Methylphenidate|methylphenidate|mesh-list
110503272|NCT00824317|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110503273|NCT00824317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110613234|NCT02575963|Immunologic Factors|immunologic factors|mesh-ancestor
110503274|NCT00824317|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110503275|NCT00824317|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110503276|NCT00824317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110503277|NCT00824317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110503278|NCT00824317|Dopamine Agents|dopamine agents|mesh-ancestor
110503279|NCT00824317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110503280|NCT02847806|Insulin|insulin|mesh-list
110503281|NCT02847806|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110503282|NCT02847806|Estradiol|estradiol|mesh-list
110503283|NCT02847806|Testosterone|testosterone|mesh-list
110503284|NCT02847806|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110503285|NCT02847806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110503286|NCT02847806|Estrogens|estrogens|mesh-ancestor
110503287|NCT02847806|Hormones|hormones|mesh-ancestor
110503288|NCT02847806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110503289|NCT02847806|Androgens|androgens|mesh-ancestor
110503290|NCT00828529|Bedaquiline|bedaquiline|mesh-list
110286210|NCT04991662|Norepinephrine|norepinephrine|mesh-list
110503291|NCT00828529|Antitubercular Agents|antitubercular agents|mesh-ancestor
110503292|NCT00828529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110503293|NCT00828529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110503294|NCT00632762|Amantadine|amantadine|mesh-list
110503295|NCT00632762|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110503296|NCT00632762|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110503297|NCT00632762|Antiviral Agents|antiviral agents|mesh-ancestor
110503298|NCT00632762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110503299|NCT00632762|Dopamine Agents|dopamine agents|mesh-ancestor
110503300|NCT00632762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110503301|NCT00632762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110503302|NCT00632762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110503303|NCT00632762|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110503304|NCT00632762|Analgesics|analgesics|mesh-ancestor
110503305|NCT00632762|Sensory System Agents|sensory system agents|mesh-ancestor
110613272|NCT02364089|Epinephryl borate|epinephryl borate|mesh-list
110503306|NCT00632762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110503307|NCT01351766|Nicotine|nicotine|mesh-list
110503308|NCT01351766|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110503309|NCT01351766|Autonomic Agents|autonomic agents|mesh-ancestor
110503310|NCT01351766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110503311|NCT01351766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110276230|NCT00554125|Sirolimus|sirolimus|mesh-list
110503312|NCT01351766|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110503313|NCT01351766|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110503314|NCT01351766|Cholinergic Agents|cholinergic agents|mesh-ancestor
110503315|NCT01351766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110503316|NCT01351766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110503317|NCT02846090|Dexmedetomidine|dexmedetomidine|mesh-list
110503318|NCT02846090|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110503319|NCT02846090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110503320|NCT02846090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110503321|NCT02846090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110503322|NCT02846090|Analgesics|analgesics|mesh-ancestor
110503323|NCT02846090|Sensory System Agents|sensory system agents|mesh-ancestor
110276243|NCT00175838|Analgesics|analgesics|mesh-ancestor
110503324|NCT02846090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110503325|NCT02846090|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110503326|NCT02846090|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110503327|NCT02846090|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110503328|NCT02846090|Adrenergic Agents|adrenergic agents|mesh-ancestor
110503329|NCT02846090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110503330|NCT02846090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110503331|NCT00828763|Dolutegravir|dolutegravir|mesh-list
110503332|NCT00828763|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110503333|NCT00828763|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110503334|NCT00828763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110503335|NCT00828763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110276259|NCT00204555|Imiquimod|imiquimod|mesh-list
110503336|NCT00828763|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110503337|NCT00828763|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110503338|NCT00828763|Antiviral Agents|antiviral agents|mesh-ancestor
110503339|NCT00828763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110503340|NCT00824707|Entecavir|entecavir|mesh-list
110503341|NCT00824707|Antiviral Agents|antiviral agents|mesh-ancestor
110503342|NCT00824707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110503343|NCT00824785|Capecitabine|capecitabine|mesh-list
110503344|NCT00824785|Oxaliplatin|oxaliplatin|mesh-list
110503345|NCT00824785|Epirubicin|epirubicin|mesh-list
110503346|NCT00824785|Panitumumab|panitumumab|mesh-list
110503347|NCT00824785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110503348|NCT00824785|Antimetabolites|antimetabolites|mesh-ancestor
110503349|NCT00824785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110503350|NCT00824785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110276265|NCT00175955|Levetiracetam|levetiracetam|mesh-list
110503351|NCT00824785|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110503352|NCT00824785|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110503353|NCT00824785|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110503354|NCT00824785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110503355|NCT00824785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110503356|NCT00824863|Ketoconazole|ketoconazole|mesh-list
110503357|NCT00824863|Antifungal Agents|antifungal agents|mesh-ancestor
110503358|NCT00824863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110276278|NCT00199719|Antiviral Agents|antiviral agents|mesh-ancestor
110503359|NCT00824863|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110503360|NCT00824863|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110503361|NCT00824863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110503362|NCT00824863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110503363|NCT00824863|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110503364|NCT00824863|Hormone Antagonists|hormone antagonists|mesh-ancestor
110503365|NCT00824863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110503366|NCT00824863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110503367|NCT00824863|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110503368|NCT02844530|Epratuzumab|epratuzumab|mesh-list
110276294|NCT03291886|Exemestane|exemestane|mesh-list
110613352|NCT01399372|Dermatologic Agents|dermatologic agents|mesh-ancestor
110503369|NCT02844530|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
110503370|NCT02844530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110503372|NCT02844530|Chelating Agents|chelating agents|mesh-ancestor
110503373|NCT02844530|Sequestering Agents|sequestering agents|mesh-ancestor
110503374|NCT02844530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110503375|NCT00820417|Cetuximab|cetuximab|mesh-list
110503376|NCT00820417|Gefitinib|gefitinib|mesh-list
110503377|NCT00820417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110503378|NCT00820417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110503379|NCT00820417|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110503380|NCT00820417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110503381|NCT00820417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110503382|NCT04923620|Cetuximab|cetuximab|mesh-list
110503383|NCT04923620|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110503384|NCT04923620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110503391|NCT00828997|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110503392|NCT00828997|Immunologic Factors|immunologic factors|mesh-ancestor
110503393|NCT00828997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110503394|NCT02548741|Metformin|metformin|mesh-list
110503395|NCT02548741|Calcium Carbonate|calcium carbonate|mesh-list
110503396|NCT02548741|Calcium|calcium|mesh-list
110503397|NCT02548741|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110503398|NCT02548741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110503399|NCT02548741|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110503400|NCT02548741|Antacids|antacids|mesh-ancestor
110503401|NCT02548741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110503402|NCT02548741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110503403|NCT02845856|Cetuximab|cetuximab|mesh-list
110503404|NCT02845856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110503405|NCT02845856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110503407|NCT00825019|Amibegron|amibegron|mesh-list
110503408|NCT00825019|Amibegron hydrochloride|amibegron hydrochloride|mesh-list
110503409|NCT00825019|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110503410|NCT00825019|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110503411|NCT00825019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110276333|NCT00199953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110503412|NCT00825019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110503413|NCT00825019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110503414|NCT00825019|Serotonin Agents|serotonin agents|mesh-ancestor
110503415|NCT00825019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110503416|NCT00825019|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110503417|NCT00825019|Antidepressive Agents|antidepressive agents|mesh-ancestor
110503418|NCT00825019|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110503419|NCT00825019|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110276343|NCT03160846|Vasodilator Agents|vasodilator agents|mesh-ancestor
110503420|NCT00825019|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110503421|NCT00825019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110503422|NCT00825019|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110503423|NCT00825019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110613411|NCT00612105|Ezogabine|ezogabine|mesh-list
110503424|NCT00825019|Adrenergic Agents|adrenergic agents|mesh-ancestor
110503425|NCT00825019|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
110503426|NCT00929006|Progesterone|progesterone|mesh-list
110503427|NCT00929006|Progestins|progestins|mesh-ancestor
110503428|NCT00929006|Hormones|hormones|mesh-ancestor
110503429|NCT00929006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110503430|NCT00929006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110503431|NCT00877214|Rituximab|rituximab|mesh-list
110503432|NCT00877214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110503433|NCT00877214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110503434|NCT00877214|Immunologic Factors|immunologic factors|mesh-ancestor
110503435|NCT00877214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110503436|NCT00877214|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110503437|NCT00474032|Botulinum Toxins|botulinum toxins|mesh-list
110503438|NCT00474032|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110503439|NCT00474032|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110503440|NCT00474032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110503441|NCT00474032|Cholinergic Agents|cholinergic agents|mesh-ancestor
110503442|NCT00474032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110503443|NCT00474032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110503444|NCT05242718|Palmidrol|palmidrol|mesh-list
110503445|NCT05242718|Acetylcysteine|acetylcysteine|mesh-list
110503446|NCT05242718|Curcumin|curcumin|mesh-list
110503447|NCT05242718|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110503448|NCT05242718|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110503449|NCT05242718|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110503450|NCT05242718|Analgesics|analgesics|mesh-ancestor
110503451|NCT05242718|Sensory System Agents|sensory system agents|mesh-ancestor
110503452|NCT05242718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110503453|NCT05242718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110503454|NCT05242718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110503455|NCT05242718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110503456|NCT05242718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110503457|NCT05242718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110287039|NCT04721301|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110503458|NCT05242718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110503459|NCT05242718|Antiviral Agents|antiviral agents|mesh-ancestor
110503460|NCT05242718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110503461|NCT05242718|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
110503462|NCT05242718|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110503463|NCT05242718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110503464|NCT05242718|Hormones|hormones|mesh-ancestor
110503465|NCT05242718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110503466|NCT05242718|Expectorants|expectorants|mesh-ancestor
110503467|NCT05242718|Respiratory System Agents|respiratory system agents|mesh-ancestor
110503468|NCT05242718|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110503469|NCT05242718|Antioxidants|antioxidants|mesh-ancestor
110503470|NCT05242718|Protective Agents|protective agents|mesh-ancestor
110503471|NCT05242718|Antidotes|antidotes|mesh-ancestor
110503472|NCT00045968|Immunomodulating Agents|immunomodulating agents|mesh-list
110503473|NCT00045968|Immunologic Factors|immunologic factors|mesh-ancestor
110503474|NCT00045968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110503475|NCT02845778|Melatonin|melatonin|mesh-list
110503476|NCT02845778|Antioxidants|antioxidants|mesh-ancestor
110503477|NCT02845778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110503478|NCT02845778|Protective Agents|protective agents|mesh-ancestor
110503479|NCT02845778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110503480|NCT02845778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110503481|NCT05241938|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110503482|NCT05241938|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110503484|NCT05337332|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110503485|NCT05337332|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110503486|NCT05337332|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110503487|NCT05337332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110503488|NCT05337332|Glucocorticoids|glucocorticoids|mesh-ancestor
110503490|NCT05337332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110503491|NCT05337332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110287163|NCT00212108|Celecoxib|celecoxib|mesh-list
110503492|NCT05337332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110503493|NCT05337332|Immunologic Factors|immunologic factors|mesh-ancestor
110503494|NCT05337332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110503495|NCT05337332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110503496|NCT00901394|Folic Acid|folic acid|mesh-list
110503497|NCT00901394|Nitrous Oxide|nitrous oxide|mesh-list
110503498|NCT00901394|Hematinics|hematinics|mesh-ancestor
110503499|NCT00901394|Vitamin B Complex|vitamin b complex|mesh-ancestor
110503500|NCT00901394|Vitamins|vitamins|mesh-ancestor
110503501|NCT00901394|Micronutrients|micronutrients|mesh-ancestor
110503502|NCT00901394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110503503|NCT00901394|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110503504|NCT00901394|Anesthetics, General|anesthetics, general|mesh-ancestor
110503505|NCT00901394|Anesthetics|anesthetics|mesh-ancestor
110503506|NCT00901394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110503507|NCT00901394|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110503508|NCT00901394|Analgesics|analgesics|mesh-ancestor
110503509|NCT00901394|Sensory System Agents|sensory system agents|mesh-ancestor
110503510|NCT00901394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110503511|NCT05337254|Dihydroergotamine|dihydroergotamine|mesh-list
110503512|NCT05337254|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110503513|NCT05337254|Dopamine Agonists|dopamine agonists|mesh-ancestor
110503514|NCT05337254|Dopamine Agents|dopamine agents|mesh-ancestor
110503515|NCT05337254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110503516|NCT05337254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110503517|NCT05337254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110503518|NCT05337254|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110503519|NCT05337254|Analgesics|analgesics|mesh-ancestor
110503520|NCT05337254|Sensory System Agents|sensory system agents|mesh-ancestor
110503521|NCT05337254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110503522|NCT00896532|Zoledronic Acid|zoledronic acid|mesh-list
110503523|NCT00896532|Denosumab|denosumab|mesh-list
110503524|NCT00896532|Alendronate|alendronate|mesh-list
110503525|NCT00896532|Teriparatide|teriparatide|mesh-list
110503526|NCT00896532|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110503527|NCT00896532|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110503528|NCT00896532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110503529|NCT00896532|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110503530|NCT00896532|Immunologic Factors|immunologic factors|mesh-ancestor
110503531|NCT00574873|Imatinib Mesylate|imatinib mesylate|mesh-list
110503532|NCT00574873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110503533|NCT00574873|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110503534|NCT00574873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110503535|NCT00574873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110503536|NCT02843490|Ranibizumab|ranibizumab|mesh-list
110503537|NCT02843490|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110503538|NCT02843490|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110503539|NCT02843490|Growth Substances|growth substances|mesh-ancestor
110503540|NCT02843490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110503541|NCT02843490|Growth Inhibitors|growth inhibitors|mesh-ancestor
110503542|NCT02843490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110503543|NCT00902174|Imatinib Mesylate|imatinib mesylate|mesh-list
110503544|NCT00902174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110503546|NCT00902174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110287358|NCT00213122|Miglitol|miglitol|mesh-list
110503547|NCT00902174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110503548|NCT04201808|Tenofovir|tenofovir|mesh-list
110503549|NCT04201808|Antiviral Agents|antiviral agents|mesh-ancestor
110503550|NCT04201808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110503551|NCT04201808|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110503552|NCT04201808|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110503553|NCT04201808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110503554|NCT04201808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110503555|NCT04201808|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110503556|NCT04201808|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110503557|NCT01341600|Omeprazole|omeprazole|mesh-list
110503558|NCT01341600|Clopidogrel|clopidogrel|mesh-list
110503559|NCT01341600|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110503560|NCT01341600|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110503561|NCT01341600|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110503562|NCT01341600|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110503563|NCT01341600|Purinergic Agents|purinergic agents|mesh-ancestor
110503564|NCT01341600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110503565|NCT01341600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110287411|NCT00213512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110503566|NCT01341600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110503567|NCT01341600|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110503568|NCT01341600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110503569|NCT01341600|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110503570|NCT01341600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110503571|NCT02845388|Sildenafil Citrate|sildenafil citrate|mesh-list
110503572|NCT02845388|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110503573|NCT02845388|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110503575|NCT02845388|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110503576|NCT02845388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110503577|NCT02845388|Estrogens|estrogens|mesh-ancestor
110503578|NCT02845388|Hormones|hormones|mesh-ancestor
110503579|NCT02845388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110503580|NCT02845388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110503581|NCT02845388|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110503582|NCT02845388|Contraceptive Agents|contraceptive agents|mesh-ancestor
110503583|NCT02845388|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110503584|NCT02845388|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110503585|NCT02845388|Vasodilator Agents|vasodilator agents|mesh-ancestor
110503586|NCT02845388|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110503587|NCT02845388|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110503588|NCT02845388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110503589|NCT02845388|Urological Agents|urological agents|mesh-ancestor
110503590|NCT02845466|Becaplermin|becaplermin|mesh-list
110503591|NCT02845466|Anticoagulants|anticoagulants|mesh-ancestor
110503592|NCT02845466|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
110503593|NCT02845466|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110503594|NCT02845466|Growth Substances|growth substances|mesh-ancestor
110503595|NCT02845466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110503596|NCT00623623|Enoxaparin|enoxaparin|mesh-list
110503597|NCT00623623|Tenecteplase|tenecteplase|mesh-list
110503598|NCT00623623|Clopidogrel|clopidogrel|mesh-list
110503599|NCT00623623|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110503600|NCT00623623|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110503601|NCT00623623|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110503602|NCT00623623|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110503603|NCT00623623|Purinergic Agents|purinergic agents|mesh-ancestor
110503604|NCT00623623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110276516|NCT02421679|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110503605|NCT00623623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110503606|NCT00623623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110503607|NCT00623623|Anticoagulants|anticoagulants|mesh-ancestor
110503608|NCT00623623|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110503609|NCT00623623|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110503610|NCT00896454|Denosumab|denosumab|mesh-list
110503611|NCT00896454|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110503612|NCT00896454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110503613|NCT04224584|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110503614|NCT04224584|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110503615|NCT04224584|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110503616|NCT04224584|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110503617|NCT04224584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110503618|NCT04224584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110503619|NCT04224584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110503620|NCT04224584|Analgesics|analgesics|mesh-ancestor
110503621|NCT04224584|Sensory System Agents|sensory system agents|mesh-ancestor
110503622|NCT04224584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110503623|NCT04224584|Antidepressive Agents|antidepressive agents|mesh-ancestor
110503624|NCT04224584|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110503625|NCT04224584|Dopamine Agents|dopamine agents|mesh-ancestor
110503626|NCT02993198|Carvedilol|carvedilol|mesh-list
110503627|NCT02993198|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110503628|NCT02993198|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110503629|NCT02993198|Adrenergic Agents|adrenergic agents|mesh-ancestor
110503630|NCT02993198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110503631|NCT02993198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110503632|NCT02993198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110503633|NCT02993198|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110503634|NCT02993198|Antioxidants|antioxidants|mesh-ancestor
110503635|NCT02993198|Protective Agents|protective agents|mesh-ancestor
110287576|NCT00214370|Propofol|propofol|mesh-list
110503636|NCT02993198|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110503637|NCT02993198|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110503638|NCT02993198|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110503639|NCT02993198|Vasodilator Agents|vasodilator agents|mesh-ancestor
110503640|NCT02993198|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110503641|NCT02993198|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110503642|NCT00829231|Sorafenib|sorafenib|mesh-list
110503643|NCT00829231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110503644|NCT00829231|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110503645|NCT00829231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110503646|NCT00829231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110503647|NCT00901628|Cefuroxime|cefuroxime|mesh-list
110503648|NCT00901628|Cefuroxime axetil|cefuroxime axetil|mesh-list
110503649|NCT00901628|Ketorolac|ketorolac|mesh-list
110503650|NCT00901628|Epinephrine|epinephrine|mesh-list
110503651|NCT00901628|Morphine|morphine|mesh-list
110503652|NCT00901628|Ropivacaine|ropivacaine|mesh-list
110503653|NCT00901628|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110503654|NCT00901628|Narcotics|narcotics|mesh-ancestor
110503655|NCT00901628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110503656|NCT00901628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110503657|NCT00901628|Analgesics|analgesics|mesh-ancestor
110503658|NCT00901628|Sensory System Agents|sensory system agents|mesh-ancestor
110503659|NCT00901628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110503660|NCT00901628|Anesthetics, Local|anesthetics, local|mesh-ancestor
110503661|NCT00901628|Anesthetics|anesthetics|mesh-ancestor
110503662|NCT00901628|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110503663|NCT00901628|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110503664|NCT00901628|Adrenergic Agents|adrenergic agents|mesh-ancestor
110503665|NCT00901628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110503666|NCT00901628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110613596|NCT00888303|Dexamethasone|dexamethasone|mesh-list
110503668|NCT00901628|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110503669|NCT00901628|Autonomic Agents|autonomic agents|mesh-ancestor
110503670|NCT00901628|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110168963|NCT00036790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110503671|NCT00901628|Respiratory System Agents|respiratory system agents|mesh-ancestor
110503672|NCT00901628|Mydriatics|mydriatics|mesh-ancestor
110503673|NCT00901628|Sympathomimetics|sympathomimetics|mesh-ancestor
110503674|NCT00901628|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110503675|NCT00901628|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110503676|NCT00901628|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110503677|NCT00901628|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110287749|NCT00215228|Escitalopram|escitalopram|mesh-list
110503678|NCT00901628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110503679|NCT00901628|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110503680|NCT00901628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110503681|NCT00901628|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110503682|NCT00901628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110503683|NCT00623545|Exenatide|exenatide|mesh-list
110503684|NCT00623545|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110503685|NCT00623545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110503686|NCT00623545|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110503687|NCT00623545|Incretins|incretins|mesh-ancestor
110503688|NCT00623545|Hormones|hormones|mesh-ancestor
110503689|NCT00623545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110503690|NCT00825097|Botulinum Toxins|botulinum toxins|mesh-list
110503691|NCT00825097|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110503692|NCT00825097|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110503693|NCT00825097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110503694|NCT00825097|Cholinergic Agents|cholinergic agents|mesh-ancestor
110503695|NCT00825097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110503696|NCT00825097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110503697|NCT02839668|Acetaminophen|acetaminophen|mesh-list
110503698|NCT02839668|Lidocaine|lidocaine|mesh-list
110503699|NCT02839668|Atropine|atropine|mesh-list
110503700|NCT02839668|Tramadol|tramadol|mesh-list
110503701|NCT02839668|Sevoflurane|sevoflurane|mesh-list
110503702|NCT02839668|Neostigmine|neostigmine|mesh-list
110503703|NCT02839668|Anesthetics, Local|anesthetics, local|mesh-ancestor
110503704|NCT02839668|Anesthetics|anesthetics|mesh-ancestor
110503705|NCT02839668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110503706|NCT02839668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110503707|NCT02839668|Sensory System Agents|sensory system agents|mesh-ancestor
110503708|NCT02839668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110503709|NCT02839668|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110503710|NCT02839668|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110503711|NCT02839668|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110503712|NCT02839668|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110503713|NCT02839668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110503714|NCT02839668|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110503715|NCT02839668|Analgesics|analgesics|mesh-ancestor
110503716|NCT02839668|Antipyretics|antipyretics|mesh-ancestor
110503717|NCT02839668|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110503718|NCT02839668|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110503719|NCT02839668|Anesthetics, General|anesthetics, general|mesh-ancestor
110503720|NCT02839668|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110503721|NCT02839668|Narcotics|narcotics|mesh-ancestor
110503722|NCT02839668|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110503723|NCT02839668|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110503724|NCT02839668|Autonomic Agents|autonomic agents|mesh-ancestor
110503725|NCT02839668|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110287938|NCT04666675|Upadacitinib|upadacitinib|mesh-list
110503726|NCT02839668|Respiratory System Agents|respiratory system agents|mesh-ancestor
110503727|NCT02839668|Mydriatics|mydriatics|mesh-ancestor
110503728|NCT02839668|Parasympatholytics|parasympatholytics|mesh-ancestor
110503729|NCT02839668|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110503730|NCT02839668|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110503731|NCT02839668|Cholinergic Agents|cholinergic agents|mesh-ancestor
110503732|NCT02839668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110503733|NCT02839668|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110503734|NCT02839668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110503735|NCT02839668|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110503736|NCT04701788|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110503737|NCT04701788|Immunologic Factors|immunologic factors|mesh-ancestor
110503738|NCT04701788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110503739|NCT04700618|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110503740|NCT04700618|Immunologic Factors|immunologic factors|mesh-ancestor
110503741|NCT04700618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110503742|NCT00829465|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110503743|NCT00829465|Immunologic Factors|immunologic factors|mesh-ancestor
110503744|NCT00829465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110503746|NCT02839356|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110503747|NCT02839356|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110503748|NCT02839356|Adrenergic Agents|adrenergic agents|mesh-ancestor
110503749|NCT02839356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110503750|NCT02839356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110503751|NCT02839356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110503752|NCT02839356|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110503753|NCT02839356|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110503754|NCT02839356|Autonomic Agents|autonomic agents|mesh-ancestor
110503755|NCT02839356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110503756|NCT02839356|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110503757|NCT02839356|Respiratory System Agents|respiratory system agents|mesh-ancestor
110503758|NCT02839356|Mydriatics|mydriatics|mesh-ancestor
110503759|NCT02839356|Sympathomimetics|sympathomimetics|mesh-ancestor
110503760|NCT02839356|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110503761|NCT04674410|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110503762|NCT04674410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110503763|NCT02840526|Acetaminophen|acetaminophen|mesh-list
110503764|NCT02840526|Fentanyl|fentanyl|mesh-list
110503765|NCT02840526|Bupivacaine|bupivacaine|mesh-list
110503766|NCT02840526|Propofol|propofol|mesh-list
110503767|NCT02840526|Sevoflurane|sevoflurane|mesh-list
110503768|NCT02840526|Anesthetics, Local|anesthetics, local|mesh-ancestor
110503769|NCT02840526|Anesthetics|anesthetics|mesh-ancestor
110503770|NCT02840526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110503771|NCT02840526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110503772|NCT02840526|Sensory System Agents|sensory system agents|mesh-ancestor
110613699|NCT00766350|Analgesics|analgesics|mesh-ancestor
110503773|NCT02840526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110503775|NCT02840526|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110503776|NCT02840526|Anesthetics, General|anesthetics, general|mesh-ancestor
110503777|NCT02840526|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110503778|NCT02840526|Narcotics|narcotics|mesh-ancestor
110503779|NCT02840526|Analgesics|analgesics|mesh-ancestor
110503780|NCT02840526|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110503781|NCT02840526|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110503782|NCT02840526|Antipyretics|antipyretics|mesh-ancestor
110503783|NCT02840526|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110503784|NCT02840526|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110503786|NCT02342444|Enoxaparin sodium|enoxaparin sodium|mesh-list
110503787|NCT02342444|Anticoagulants|anticoagulants|mesh-ancestor
110503788|NCT02342444|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110503789|NCT02342444|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110503790|NCT02342444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110503791|NCT00825253|Insulin|insulin|mesh-list
110503792|NCT00825253|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110503793|NCT00825253|Insulin Aspart|insulin aspart|mesh-list
110503794|NCT00825253|Biphasic Insulins|biphasic insulins|mesh-list
110503795|NCT00825253|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
110503796|NCT00825253|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110613741|NCT00961480|Metformin|metformin|mesh-list
110503797|NCT00825253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110503799|NCT00820885|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110503800|NCT00820885|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110503801|NCT00820885|Protective Agents|protective agents|mesh-ancestor
110503802|NCT00820885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110503803|NCT03845582|Vitamin A|vitamin a|mesh-list
110503804|NCT03845582|Retinol acetate|retinol acetate|mesh-list
110503805|NCT03845582|Vitamins|vitamins|mesh-ancestor
110503806|NCT03845582|Micronutrients|micronutrients|mesh-ancestor
110503807|NCT03845582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110503808|NCT03845582|Protective Agents|protective agents|mesh-ancestor
110503809|NCT03845582|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110503810|NCT03845582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110503811|NCT03845582|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110503812|NCT03845582|Immunologic Factors|immunologic factors|mesh-ancestor
110503813|NCT00820963|Temozolomide|temozolomide|mesh-list
110503814|NCT00820963|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110503815|NCT00820963|Alkylating Agents|alkylating agents|mesh-ancestor
110503816|NCT00820963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110503817|NCT00820963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110503818|NCT02834676|Ethanol|ethanol|mesh-list
110503819|NCT02834676|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110503820|NCT02834676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110503821|NCT02834676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110503822|NCT02834676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110503823|NCT00632840|Atorvastatin|atorvastatin|mesh-list
110503824|NCT00632840|Fenofibrate|fenofibrate|mesh-list
110503825|NCT00632840|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110503826|NCT00632840|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110503827|NCT00632840|Antimetabolites|antimetabolites|mesh-ancestor
110503828|NCT00632840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110503829|NCT00632840|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110503830|NCT00632840|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110503831|NCT00632840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110503832|NCT00829699|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
110503833|NCT00829699|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
110503834|NCT00829699|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
110503835|NCT00829699|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110503836|NCT00829777|Naloxone|naloxone|mesh-list
110503837|NCT00829777|Lactulose|lactulose|mesh-list
110503838|NCT00829777|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110503839|NCT00829777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110503840|NCT00829777|Sensory System Agents|sensory system agents|mesh-ancestor
110503841|NCT00829777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110503842|NCT00829777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110503843|NCT02834754|Vedolizumab|vedolizumab|mesh-list
110503844|NCT02834754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110503845|NCT02839122|Tadalafil|tadalafil|mesh-list
110503846|NCT02839122|Dutasteride|dutasteride|mesh-list
110503847|NCT02839122|Vasodilator Agents|vasodilator agents|mesh-ancestor
110503848|NCT02839122|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110503849|NCT02839122|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110503850|NCT02839122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110503851|NCT02839122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110503852|NCT02839122|Urological Agents|urological agents|mesh-ancestor
110503853|NCT02839122|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
110503854|NCT02839122|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110503855|NCT02839122|Hormone Antagonists|hormone antagonists|mesh-ancestor
110042861|NCT01444612|PENTA|penta|mesh-list
110288220|NCT00216437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110503856|NCT02839122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110503857|NCT02839122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110503859|NCT00633282|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
110503860|NCT00633282|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110503861|NCT00633282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110503862|NCT00830089|Levobupivacaine|levobupivacaine|mesh-list
110503863|NCT00830089|Anesthetics, Local|anesthetics, local|mesh-ancestor
110503864|NCT00830089|Anesthetics|anesthetics|mesh-ancestor
110503865|NCT00830089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110503866|NCT00830089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110503867|NCT00830089|Sensory System Agents|sensory system agents|mesh-ancestor
110503868|NCT00830089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110503869|NCT00830245|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110503870|NCT00830245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110503871|NCT00830245|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110503872|NCT00830245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110503873|NCT00830245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110503874|NCT02837874|Antidiarrheals|antidiarrheals|mesh-list
110503876|NCT02838030|Aspirin|aspirin|mesh-list
110503877|NCT02838030|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110503878|NCT02838030|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110503879|NCT02838030|Analgesics|analgesics|mesh-ancestor
110503880|NCT02838030|Sensory System Agents|sensory system agents|mesh-ancestor
110503881|NCT02838030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110503882|NCT02838030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110503883|NCT02838030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110503884|NCT02838030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110503885|NCT02838030|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110503886|NCT02838030|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110503887|NCT02838030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110503888|NCT02838030|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110503889|NCT02838030|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110503890|NCT02838030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110503891|NCT02838030|Antipyretics|antipyretics|mesh-ancestor
110503892|NCT00825643|Insulin Detemir|insulin detemir|mesh-list
110503893|NCT00825643|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110503894|NCT00825643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110503895|NCT04044079|Misoprostol|misoprostol|mesh-list
110503896|NCT04044079|Dinoprostone|dinoprostone|mesh-list
110503897|NCT04044079|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110503898|NCT04044079|Abortifacient Agents|abortifacient agents|mesh-ancestor
110503899|NCT04044079|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110288373|NCT00241332|Fentanyl|fentanyl|mesh-list
110503900|NCT04044079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110503901|NCT04044079|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110503902|NCT04044079|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110503903|NCT04044079|Oxytocics|oxytocics|mesh-ancestor
110503904|NCT00830323|Oseltamivir|oseltamivir|mesh-list
110503905|NCT00830323|Amantadine|amantadine|mesh-list
110503906|NCT00830323|Zanamivir|zanamivir|mesh-list
110503907|NCT00830323|Antiviral Agents|antiviral agents|mesh-ancestor
110503908|NCT00830323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110503909|NCT00830323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110503910|NCT00830323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110503911|NCT00830323|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110503912|NCT00830323|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110503913|NCT00830323|Dopamine Agents|dopamine agents|mesh-ancestor
110503914|NCT00830323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110503915|NCT00830323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110503916|NCT00830323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110503917|NCT00830323|Analgesics|analgesics|mesh-ancestor
110503918|NCT00830323|Sensory System Agents|sensory system agents|mesh-ancestor
110503919|NCT00830323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110503920|NCT00830401|Doxycycline|doxycycline|mesh-list
110503921|NCT00830401|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110613835|NCT00766818|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110503922|NCT00830401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110503923|NCT00830401|Antimalarials|antimalarials|mesh-ancestor
110503924|NCT00830401|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110503925|NCT00830401|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110503926|NCT04249908|Maleic acid|maleic acid|mesh-list
110503927|NCT04249908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110503928|NCT04249908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110503930|NCT00825721|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110503932|NCT02837640|Carbidopa|carbidopa|mesh-list
110503933|NCT02837640|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
110503935|NCT02837640|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110503936|NCT02837640|Dopamine Agents|dopamine agents|mesh-ancestor
110503937|NCT02837640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110503938|NCT02837640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110503939|NCT02837640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110503940|NCT02837640|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
110503941|NCT02837640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110503942|NCT02837640|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110503943|NCT02837640|Immunologic Factors|immunologic factors|mesh-ancestor
110503944|NCT02837640|Dopamine Agonists|dopamine agonists|mesh-ancestor
110503945|NCT02834286|Dexamethasone|dexamethasone|mesh-list
110503946|NCT02834286|Rituximab|rituximab|mesh-list
110503947|NCT02834286|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110503948|NCT02834286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110503949|NCT02834286|Immunologic Factors|immunologic factors|mesh-ancestor
110503950|NCT02834286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110503951|NCT02834286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110503952|NCT02834286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110503953|NCT02834286|Antiemetics|antiemetics|mesh-ancestor
110503954|NCT02834286|Autonomic Agents|autonomic agents|mesh-ancestor
110503955|NCT02834286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110503956|NCT02834286|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110503957|NCT02834286|Glucocorticoids|glucocorticoids|mesh-ancestor
110503958|NCT02834286|Hormones|hormones|mesh-ancestor
110503959|NCT02834286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110503960|NCT02834286|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110503961|NCT02839044|Vitamin K 2|vitamin k 2|mesh-list
110503962|NCT02839044|Vitamin K|vitamin k|mesh-list
110503963|NCT02839044|Menaquinone 7|menaquinone 7|mesh-list
110503964|NCT02839044|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110614000|NCT00967954|Hormones|hormones|mesh-list
110503965|NCT02839044|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110503966|NCT02839044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110503967|NCT02839044|Hemostatics|hemostatics|mesh-ancestor
110503968|NCT02839044|Coagulants|coagulants|mesh-ancestor
110503969|NCT02839044|Vitamins|vitamins|mesh-ancestor
110503970|NCT02839044|Micronutrients|micronutrients|mesh-ancestor
110503971|NCT02839044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110503972|NCT02833506|Sirolimus|sirolimus|mesh-list
110503973|NCT02833506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110503974|NCT02833506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110503975|NCT02833506|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110503976|NCT02833506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110503977|NCT02833506|Antifungal Agents|antifungal agents|mesh-ancestor
110503978|NCT02833506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110503979|NCT02833506|Immunologic Factors|immunologic factors|mesh-ancestor
110503980|NCT02833506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110503981|NCT02838576|Estrogens|estrogens|mesh-list
110503982|NCT02838576|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
110503983|NCT02838576|Hormones|hormones|mesh-ancestor
110503984|NCT02838576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110503985|NCT02838576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110503986|NCT00838539|Sirolimus|sirolimus|mesh-list
110503987|NCT00838539|Temsirolimus|temsirolimus|mesh-list
110503988|NCT00838539|MTOR Inhibitors|mtor inhibitors|mesh-list
110503989|NCT00838539|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110503990|NCT00838539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110503991|NCT00838539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110503992|NCT00838539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110503993|NCT00838539|Immunologic Factors|immunologic factors|mesh-ancestor
110503994|NCT00838539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110503995|NCT00838539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110503996|NCT00838539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110503997|NCT00838539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110503998|NCT00838539|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110503999|NCT00838539|Antifungal Agents|antifungal agents|mesh-ancestor
110504000|NCT02836548|Vorinostat|vorinostat|mesh-list
110504001|NCT02836548|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
110504002|NCT02836548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110504004|NCT02836548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110504005|NCT02836704|Metformin|metformin|mesh-list
110504006|NCT02836704|Insulin Glargine|insulin glargine|mesh-list
110504007|NCT02836704|Acarbose|acarbose|mesh-list
110504008|NCT02836704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110504009|NCT02836704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110504010|NCT02836704|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
110504011|NCT02836704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110504012|NCT02836704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110504013|NCT02833584|Acetaminophen|acetaminophen|mesh-list
110504014|NCT02833584|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110504015|NCT02833584|Analgesics|analgesics|mesh-ancestor
110504016|NCT02833584|Sensory System Agents|sensory system agents|mesh-ancestor
110504017|NCT02833584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110504018|NCT02833584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110504019|NCT02833584|Antipyretics|antipyretics|mesh-ancestor
110504020|NCT00837759|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110504021|NCT00837759|Lansoprazole|lansoprazole|mesh-list
110504022|NCT00837759|Dexlansoprazole|dexlansoprazole|mesh-list
110504023|NCT00837759|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110504024|NCT00837759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110504025|NCT00837759|Incretins|incretins|mesh-ancestor
110504026|NCT00837759|Hormones|hormones|mesh-ancestor
110504027|NCT00837759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110504028|NCT00837759|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110504029|NCT00837759|Protease Inhibitors|protease inhibitors|mesh-ancestor
110504030|NCT00837759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110504031|NCT00837759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110504032|NCT00837759|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110504033|NCT00837759|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110504034|NCT00837759|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110504035|NCT00703365|Gemcitabine|gemcitabine|mesh-list
110504036|NCT00703365|Sorafenib|sorafenib|mesh-list
110504037|NCT00703365|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110504038|NCT00703365|Antimetabolites|antimetabolites|mesh-ancestor
110504039|NCT00703365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110504040|NCT00703365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110288822|NCT00218231|Dopamine Agents|dopamine agents|mesh-ancestor
110504041|NCT00703365|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110504042|NCT00703365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110504043|NCT05878899|Enoxaparin|enoxaparin|mesh-list
110504044|NCT05878899|Anticoagulants|anticoagulants|mesh-ancestor
110504045|NCT05878899|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110504046|NCT05878899|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110504047|NCT05878899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110504048|NCT05878574|Heparin|heparin|mesh-list
110504049|NCT05878574|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
110504050|NCT05878574|Tinzaparin|tinzaparin|mesh-list
110504051|NCT05878574|Dalteparin|dalteparin|mesh-list
110504052|NCT05878574|Anticoagulants|anticoagulants|mesh-ancestor
110504053|NCT05878574|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110504054|NCT05878574|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110504055|NCT05878574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110504056|NCT05878561|Indapamide|indapamide|mesh-list
110504057|NCT05878561|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110504058|NCT05878561|Diuretics|diuretics|mesh-ancestor
110504059|NCT05878561|Natriuretic Agents|natriuretic agents|mesh-ancestor
110504060|NCT05878561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110504061|NCT05878561|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110504062|NCT05878561|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110504063|NCT05878561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110504065|NCT05878379|Trace Elements|trace elements|mesh-ancestor
110504066|NCT05878379|Micronutrients|micronutrients|mesh-ancestor
110614179|NCT00893217|Interferons|interferons|mesh-list
110504067|NCT05878379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110504068|NCT05878353|Doxycycline|doxycycline|mesh-list
110504069|NCT05878353|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110504070|NCT05878353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110504071|NCT05878353|Antimalarials|antimalarials|mesh-ancestor
110504072|NCT05878353|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110504073|NCT05878353|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110504074|NCT05878288|Cemiplimab|cemiplimab|mesh-list
110504075|NCT05878288|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110504076|NCT05878288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110504077|NCT05878262|Ibuprofen|ibuprofen|mesh-list
110311893|NCT00303810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110504086|NCT05878262|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110504087|NCT05878262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110504088|NCT05878262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110504089|NCT05878249|Sodium Hypochlorite|sodium hypochlorite|mesh-list
110504091|NCT05878249|Edetic Acid|edetic acid|mesh-list
110504092|NCT05878249|Pentetic Acid|pentetic acid|mesh-list
110504093|NCT05878249|Disinfectants|disinfectants|mesh-ancestor
110504094|NCT05878249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110504095|NCT05878249|Anticoagulants|anticoagulants|mesh-ancestor
110504096|NCT05878249|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110504097|NCT05878249|Chelating Agents|chelating agents|mesh-ancestor
110504098|NCT05878249|Sequestering Agents|sequestering agents|mesh-ancestor
110504099|NCT05878249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110504100|NCT05878249|Antidotes|antidotes|mesh-ancestor
110504101|NCT05878249|Protective Agents|protective agents|mesh-ancestor
110504102|NCT05878249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110504103|NCT05878249|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110504104|NCT05878158|Simvastatin|simvastatin|mesh-list
110504105|NCT05878158|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110504106|NCT05878158|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110504107|NCT05878158|Antimetabolites|antimetabolites|mesh-ancestor
110504108|NCT05878158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110504109|NCT05878158|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110504110|NCT05878158|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110504111|NCT05878158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110504112|NCT05878028|Docetaxel|docetaxel|mesh-list
110504113|NCT05878028|Tislelizumab|tislelizumab|mesh-list
110504114|NCT05878028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110504115|NCT05878028|Tubulin Modulators|tubulin modulators|mesh-ancestor
110504116|NCT05878028|Antimitotic Agents|antimitotic agents|mesh-ancestor
110504117|NCT05878028|Mitosis Modulators|mitosis modulators|mesh-ancestor
110504118|NCT05878028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110504119|NCT05878028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110504120|NCT05878015|Acetaminophen|acetaminophen|mesh-list
110504121|NCT05878015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110504122|NCT05878015|Analgesics|analgesics|mesh-ancestor
110504123|NCT05878015|Sensory System Agents|sensory system agents|mesh-ancestor
110504124|NCT05878015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110504125|NCT05878015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110504126|NCT05878015|Antipyretics|antipyretics|mesh-ancestor
110504127|NCT05877911|Sodium sulfate|sodium sulfate|mesh-list
110504128|NCT05877911|Cathartics|cathartics|mesh-ancestor
110504129|NCT05877911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110504130|NCT05877872|Immunomodulating Agents|immunomodulating agents|mesh-list
110504131|NCT05877872|Immunologic Factors|immunologic factors|mesh-ancestor
110504132|NCT05877872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110504141|NCT05877781|Palmidrol|palmidrol|mesh-list
110504142|NCT05877781|Analgesics|analgesics|mesh-ancestor
110289153|NCT04627129|Itraconazole|itraconazole|mesh-list
110504143|NCT05877781|Sensory System Agents|sensory system agents|mesh-ancestor
110504144|NCT05877781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110504145|NCT05877781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110504146|NCT05877781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110504147|NCT05877781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110504148|NCT05877781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110504149|NCT05877781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110504151|NCT05877781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110504152|NCT05877781|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
110504153|NCT05877781|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110504154|NCT05877781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110504155|NCT05877781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110504157|NCT05877781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110504158|NCT05877690|Bupivacaine|bupivacaine|mesh-list
110504160|NCT05877690|Anesthetics, Local|anesthetics, local|mesh-ancestor
110504161|NCT05877690|Anesthetics|anesthetics|mesh-ancestor
110504162|NCT05877690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110504163|NCT05877690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110504164|NCT05877690|Sensory System Agents|sensory system agents|mesh-ancestor
110504165|NCT05877690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110504166|NCT05877638|Sulfadiazine|sulfadiazine|mesh-list
110504167|NCT05877638|Silver Sulfadiazine|silver sulfadiazine|mesh-list
110504168|NCT05877638|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110504169|NCT05877638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110504170|NCT05877638|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110504171|NCT05877638|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110504172|NCT05877638|Coccidiostats|coccidiostats|mesh-ancestor
110614332|NCT00967252|Atorvastatin|atorvastatin|mesh-list
110504173|NCT05877638|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110504174|NCT05877235|Quercetin|quercetin|mesh-list
110504175|NCT05877235|Antioxidants|antioxidants|mesh-ancestor
110504176|NCT05877235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110504177|NCT05877235|Protective Agents|protective agents|mesh-ancestor
110504178|NCT05877235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110504179|NCT05877131|Ropivacaine|ropivacaine|mesh-list
110504180|NCT05877131|Levobupivacaine|levobupivacaine|mesh-list
110504181|NCT05877131|Anesthetics, Local|anesthetics, local|mesh-ancestor
110504182|NCT05877131|Anesthetics|anesthetics|mesh-ancestor
110504183|NCT05877131|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110504184|NCT05877131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110504185|NCT05877131|Sensory System Agents|sensory system agents|mesh-ancestor
110504186|NCT05877131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110504187|NCT05877079|Menthol|menthol|mesh-list
110504188|NCT05877079|Antipruritics|antipruritics|mesh-ancestor
110504189|NCT05877079|Dermatologic Agents|dermatologic agents|mesh-ancestor
110504190|NCT05877040|Rituximab|rituximab|mesh-list
110504191|NCT05877040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110504192|NCT05877040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110504193|NCT05877040|Immunologic Factors|immunologic factors|mesh-ancestor
110504194|NCT05877040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110504195|NCT05877040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110504196|NCT05877001|Tislelizumab|tislelizumab|mesh-list
110504197|NCT05877001|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110504198|NCT05877001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110504199|NCT05873777|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110504200|NCT05873777|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110504201|NCT05873777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110504202|NCT05859009|Propranolol|propranolol|mesh-list
110504203|NCT05859009|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
110504204|NCT05859009|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110504205|NCT05859009|Adrenergic Agents|adrenergic agents|mesh-ancestor
110504206|NCT05859009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110504207|NCT05859009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110504208|NCT05859009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110504209|NCT05859009|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110504210|NCT05859009|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110504211|NCT05859009|Vasodilator Agents|vasodilator agents|mesh-ancestor
110504212|NCT05790707|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
110504213|NCT05737121|Lidocaine|lidocaine|mesh-list
110504214|NCT05737121|Heparin|heparin|mesh-list
110504215|NCT05737121|Calcium heparin|calcium heparin|mesh-list
110504216|NCT05737121|Anesthetics, Local|anesthetics, local|mesh-ancestor
110504217|NCT05737121|Anesthetics|anesthetics|mesh-ancestor
110504218|NCT05737121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110504219|NCT05737121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110504220|NCT05737121|Sensory System Agents|sensory system agents|mesh-ancestor
110504221|NCT05737121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110169035|NCT00000869|Nevirapine|nevirapine|mesh-list
110504222|NCT05737121|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110504223|NCT05737121|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110504224|NCT05737121|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110504225|NCT05737121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110311894|NCT00303810|Antimetabolites|antimetabolites|mesh-ancestor
110504226|NCT05737121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110504228|NCT05737121|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110504229|NCT05737121|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110504230|NCT05721235|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
110504231|NCT05721235|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110504232|NCT05721235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110504233|NCT05721235|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110504234|NCT05721235|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110504235|NCT05721235|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110504236|NCT05721235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110504237|NCT05721235|Dopamine Agents|dopamine agents|mesh-ancestor
110504238|NCT05721235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110614419|NCT00545584|Hormones|hormones|mesh-ancestor
110504239|NCT05675579|Pembrolizumab|pembrolizumab|mesh-list
110504240|NCT05675579|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
110504241|NCT05675579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110504242|NCT05675579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110504243|NCT05675579|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110504244|NCT05675579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110504245|NCT05675579|Immunoconjugates|immunoconjugates|mesh-ancestor
110504246|NCT05675579|Immunologic Factors|immunologic factors|mesh-ancestor
110504247|NCT05675579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110504248|NCT05663658|Morphine|morphine|mesh-list
110504249|NCT05663658|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110504250|NCT05663658|Narcotics|narcotics|mesh-ancestor
110504251|NCT05663658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110504252|NCT05663658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110504253|NCT05663658|Analgesics|analgesics|mesh-ancestor
110504254|NCT05663658|Sensory System Agents|sensory system agents|mesh-ancestor
110504255|NCT05663658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110504256|NCT05660135|Amlodipine|amlodipine|mesh-list
110504257|NCT05660135|Olmesartan|olmesartan|mesh-list
110504258|NCT05660135|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
110504259|NCT05660135|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110504260|NCT05660135|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110504261|NCT05660135|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110504262|NCT05660135|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110504263|NCT05660135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110504264|NCT05660135|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110504265|NCT05660135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110504266|NCT05660135|Vasodilator Agents|vasodilator agents|mesh-ancestor
110504267|NCT05660135|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110504268|NCT05660135|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110504269|NCT05660135|Antimetabolites|antimetabolites|mesh-ancestor
110504270|NCT05660135|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110504271|NCT05660135|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110504272|NCT05660135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110504273|NCT05660135|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110504274|NCT05660135|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110504275|NCT05635929|Betaine|betaine|mesh-list
110504276|NCT05635929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110504277|NCT05635929|Lipotropic Agents|lipotropic agents|mesh-ancestor
110504278|NCT05635929|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110504279|NCT05635929|Antimetabolites|antimetabolites|mesh-ancestor
110504280|NCT05635929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110504281|NCT05635929|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110504283|NCT05606263|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110504284|NCT05606263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110504285|NCT05599451|Pyrithione zinc|pyrithione zinc|mesh-list
110504286|NCT05599451|Keratolytic Agents|keratolytic agents|mesh-ancestor
110504287|NCT05599451|Dermatologic Agents|dermatologic agents|mesh-ancestor
110504288|NCT05597722|Amphetamine|amphetamine|mesh-list
110504289|NCT05597722|Adderall|adderall|mesh-list
110504290|NCT05597722|Dextroamphetamine|dextroamphetamine|mesh-list
110504291|NCT05597722|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110504292|NCT05597722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110504293|NCT05597722|Sympathomimetics|sympathomimetics|mesh-ancestor
110504294|NCT05597722|Autonomic Agents|autonomic agents|mesh-ancestor
110504295|NCT05597722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110504296|NCT05597722|Dopamine Agents|dopamine agents|mesh-ancestor
110504297|NCT05597722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110504298|NCT05597722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110504299|NCT05597722|Adrenergic Agents|adrenergic agents|mesh-ancestor
110277105|NCT00205725|Olanzapine|olanzapine|mesh-list
110504300|NCT05597722|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110504301|NCT05597722|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110504302|NCT05597722|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110504303|NCT05597722|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110504304|NCT05555667|Propofol|propofol|mesh-list
110504305|NCT05555667|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110504306|NCT05555667|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110504307|NCT05555667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110504308|NCT05555667|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110504309|NCT05555667|Anesthetics, General|anesthetics, general|mesh-ancestor
110504311|NCT05462613|Aspirin|aspirin|mesh-list
110504312|NCT05462613|Bevacizumab|bevacizumab|mesh-list
110504313|NCT05462613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110504314|NCT05462613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110504315|NCT05462613|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110504316|NCT05462613|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110504317|NCT05462613|Growth Substances|growth substances|mesh-ancestor
110277132|NCT00205764|Melphalan|melphalan|mesh-list
110504318|NCT05462613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110504319|NCT05462613|Growth Inhibitors|growth inhibitors|mesh-ancestor
110504320|NCT05462613|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110504321|NCT05462613|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110504322|NCT05462613|Analgesics|analgesics|mesh-ancestor
110504323|NCT05462613|Sensory System Agents|sensory system agents|mesh-ancestor
110504324|NCT05462613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110504325|NCT05462613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110504326|NCT05462613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110504327|NCT05462613|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110504328|NCT05462613|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110504329|NCT05462613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110504330|NCT05462613|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110504331|NCT05462613|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110504332|NCT05462613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110504333|NCT05462613|Antipyretics|antipyretics|mesh-ancestor
110504334|NCT05411887|Olmesartan|olmesartan|mesh-list
110504335|NCT05411887|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
110504336|NCT05411887|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110504337|NCT05411887|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110504338|NCT05411887|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110504339|NCT05411887|Antimetabolites|antimetabolites|mesh-ancestor
110504340|NCT05411887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110504341|NCT05411887|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110504342|NCT05411887|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110504343|NCT05411887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110504344|NCT05411887|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110504345|NCT05411887|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110504346|NCT05411887|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110504348|NCT05398081|Cefuroxime|cefuroxime|mesh-list
110504349|NCT05398081|Cefuroxime axetil|cefuroxime axetil|mesh-list
110504350|NCT05398081|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110504351|NCT05398081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110504352|NCT05364008|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
110504353|NCT05364008|Antioxidants|antioxidants|mesh-ancestor
110504354|NCT05364008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110504355|NCT05364008|Protective Agents|protective agents|mesh-ancestor
110504356|NCT05364008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110504358|NCT05364008|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110504359|NCT05364008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110504360|NCT05364008|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110504361|NCT05357898|Pembrolizumab|pembrolizumab|mesh-list
110504362|NCT05357898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110504363|NCT05357898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110504364|NCT05357898|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110504365|NCT05357898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110504366|NCT05318573|Gemcitabine|gemcitabine|mesh-list
110504367|NCT05318573|Pembrolizumab|pembrolizumab|mesh-list
110504368|NCT05318573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110504369|NCT05318573|Antimetabolites|antimetabolites|mesh-ancestor
110504370|NCT05318573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110504371|NCT05318573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110504372|NCT05318573|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110504373|NCT05318573|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110504374|NCT05307770|Melatonin|melatonin|mesh-list
110504376|NCT05307770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110504377|NCT05307770|Protective Agents|protective agents|mesh-ancestor
110504378|NCT05307770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110504379|NCT05307770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110504380|NCT05307458|Buprenorphine|buprenorphine|mesh-list
110504381|NCT05307458|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
110504382|NCT05307458|Naloxone|naloxone|mesh-list
110504383|NCT05307458|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110504384|NCT05307458|Narcotics|narcotics|mesh-ancestor
110504385|NCT05307458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110504386|NCT05307458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110504387|NCT05307458|Analgesics|analgesics|mesh-ancestor
110504388|NCT05307458|Sensory System Agents|sensory system agents|mesh-ancestor
110504389|NCT05307458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110504390|NCT05307458|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110504391|NCT05199662|Tenecteplase|tenecteplase|mesh-list
110504392|NCT05199662|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110504393|NCT05199662|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110504394|NCT05199662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110504395|NCT05123053|Amifampridine|amifampridine|mesh-list
110504396|NCT05123053|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110504397|NCT05123053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110504398|NCT05123053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110504399|NCT05123053|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
110504400|NCT05123053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110504401|NCT05123053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110504402|NCT05109702|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110504403|NCT05109702|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110504405|NCT05060744|Anti-Ulcer Agents|anti-ulcer agents|mesh-list
110504406|NCT05060744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110504407|NCT05060744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110504408|NCT05057117|Botulinum Toxins|botulinum toxins|mesh-list
110504409|NCT05057117|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110504410|NCT05057117|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110504411|NCT05057117|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110504412|NCT05057117|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110504413|NCT05057117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110504414|NCT05057117|Cholinergic Agents|cholinergic agents|mesh-ancestor
110504415|NCT05057117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110504416|NCT05057117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110504417|NCT05057117|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110504418|NCT05057117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110504419|NCT05047939|Propofol|propofol|mesh-list
110504420|NCT05047939|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110504421|NCT05047939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110504422|NCT05047939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110504423|NCT05047939|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110504424|NCT05047939|Anesthetics, General|anesthetics, general|mesh-ancestor
110504425|NCT05047939|Anesthetics|anesthetics|mesh-ancestor
110504426|NCT05041127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110504427|NCT05041127|Cetuximab|cetuximab|mesh-list
110504428|NCT05041127|Antibodies|antibodies|mesh-list
110504430|NCT05041127|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110504431|NCT05041127|Immunologic Factors|immunologic factors|mesh-ancestor
110504432|NCT05041127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110504433|NCT05041127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110504434|NCT04926285|Venetoclax|venetoclax|mesh-list
110504435|NCT04926285|Homoharringtonine|homoharringtonine|mesh-list
110504436|NCT04926285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110504437|NCT04926285|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110504438|NCT04926285|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110504439|NCT04926285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110504440|NCT04926285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110504441|NCT04858854|Sulforaphane|sulforaphane|mesh-list
110504442|NCT04858854|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110504443|NCT04858854|Protective Agents|protective agents|mesh-ancestor
110504444|NCT04858854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110504445|NCT04858854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110504446|NCT04856566|Ethanol|ethanol|mesh-list
110614593|NCT03617913|Immunologic Factors|immunologic factors|mesh-ancestor
110504447|NCT04856566|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110504448|NCT04856566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110504449|NCT04856566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110504450|NCT04856566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110504451|NCT04798482|Dexmedetomidine|dexmedetomidine|mesh-list
110504452|NCT04798482|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110504453|NCT04798482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110504454|NCT04798482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110504455|NCT04798482|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110504456|NCT04798482|Analgesics|analgesics|mesh-ancestor
110504457|NCT04798482|Sensory System Agents|sensory system agents|mesh-ancestor
110504458|NCT04798482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110289964|NCT00221624|Antiviral Agents|antiviral agents|mesh-ancestor
110504459|NCT04798482|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110504460|NCT04798482|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110504461|NCT04798482|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110504462|NCT04798482|Adrenergic Agents|adrenergic agents|mesh-ancestor
110504463|NCT04798482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110504464|NCT04798482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110504465|NCT04774250|Zonisamide|zonisamide|mesh-list
110504466|NCT04774250|Anticonvulsants|anticonvulsants|mesh-ancestor
110504467|NCT04774250|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110504468|NCT04774250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110504469|NCT04774250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110504470|NCT04774250|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110504471|NCT04774250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110504472|NCT04768569|Zonisamide|zonisamide|mesh-list
110504473|NCT04768569|Anticonvulsants|anticonvulsants|mesh-ancestor
110504474|NCT04768569|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110504475|NCT04768569|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110504476|NCT04768569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110504477|NCT04768569|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110169076|NCT00037180|Irinotecan|irinotecan|mesh-list
110504478|NCT04768569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110504479|NCT04711837|Propofol|propofol|mesh-list
110504480|NCT04711837|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110504481|NCT04711837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110504482|NCT04711837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110504483|NCT04711837|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110504484|NCT04711837|Anesthetics, General|anesthetics, general|mesh-ancestor
110504485|NCT04711837|Anesthetics|anesthetics|mesh-ancestor
110504486|NCT04669457|Midazolam|midazolam|mesh-list
110504487|NCT04669457|Dexmedetomidine|dexmedetomidine|mesh-list
110504488|NCT04669457|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110504489|NCT04669457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110504490|NCT04669457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110504491|NCT04669457|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110504492|NCT04669457|Analgesics|analgesics|mesh-ancestor
110504493|NCT04669457|Sensory System Agents|sensory system agents|mesh-ancestor
110504494|NCT04669457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110504495|NCT04669457|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110504496|NCT04669457|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110504497|NCT04669457|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110504498|NCT04669457|Adrenergic Agents|adrenergic agents|mesh-ancestor
110504499|NCT04669457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110504500|NCT04669457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110504503|NCT04669457|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110504504|NCT04669457|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110504505|NCT04669457|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110504506|NCT04669457|Anesthetics, General|anesthetics, general|mesh-ancestor
110504507|NCT04669457|Anesthetics|anesthetics|mesh-ancestor
110504508|NCT04669457|GABA Modulators|gaba modulators|mesh-ancestor
110504509|NCT04669457|GABA Agents|gaba agents|mesh-ancestor
110504510|NCT04642365|Atezolizumab|atezolizumab|mesh-list
110504511|NCT04642365|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110504512|NCT04642365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110504513|NCT04642365|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110504514|NCT04642365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110504515|NCT04626635|Cemiplimab|cemiplimab|mesh-list
110290081|NCT04613869|Esketamine|esketamine|mesh-list
110504516|NCT04626635|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110504517|NCT04626635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110504518|NCT04537715|Itraconazole|itraconazole|mesh-list
110504519|NCT04537715|Rifampin|rifampin|mesh-list
110504520|NCT04537715|Antifungal Agents|antifungal agents|mesh-ancestor
110504521|NCT04537715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110614653|NCT00979966|Growth Substances|growth substances|mesh-ancestor
110504522|NCT04537715|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110504523|NCT04537715|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110504524|NCT04537715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110504525|NCT04537715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110504526|NCT04537715|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110504527|NCT04537715|Hormone Antagonists|hormone antagonists|mesh-ancestor
110504528|NCT04537715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110504529|NCT04537715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110504530|NCT04537715|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110504531|NCT04537715|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110504532|NCT04537715|Antitubercular Agents|antitubercular agents|mesh-ancestor
110504533|NCT04537715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110504534|NCT04537715|Leprostatic Agents|leprostatic agents|mesh-ancestor
110504535|NCT04537715|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110504536|NCT04537715|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110504537|NCT04537715|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110504538|NCT04537715|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110504539|NCT04537715|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110504540|NCT04537715|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110504541|NCT04537715|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110504542|NCT04532528|Dabigatran|dabigatran|mesh-list
110504543|NCT04532528|Antithrombins|antithrombins|mesh-ancestor
110504544|NCT04532528|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110504545|NCT04532528|Protease Inhibitors|protease inhibitors|mesh-ancestor
110504546|NCT04532528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110504547|NCT04532528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110504549|NCT04427956|Riboflavin|riboflavin|mesh-list
110290168|NCT00221975|GABA Agents|gaba agents|mesh-ancestor
110504550|NCT04427956|Vitamin B Complex|vitamin b complex|mesh-ancestor
110504551|NCT04427956|Vitamins|vitamins|mesh-ancestor
110504552|NCT04427956|Micronutrients|micronutrients|mesh-ancestor
110504553|NCT04427956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110504554|NCT04427956|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110504555|NCT04427956|Dermatologic Agents|dermatologic agents|mesh-ancestor
110504556|NCT04427241|Cerebrolysin|cerebrolysin|mesh-list
110504557|NCT04427241|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110504558|NCT04427241|Protective Agents|protective agents|mesh-ancestor
110504559|NCT04427241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110504560|NCT04427241|Nootropic Agents|nootropic agents|mesh-ancestor
110504561|NCT04324463|Aspirin|aspirin|mesh-list
110504562|NCT04324463|Interferons|interferons|mesh-list
110504563|NCT04324463|Interferon-beta|interferon-beta|mesh-list
110504564|NCT04324463|Colchicine|colchicine|mesh-list
110504565|NCT04324463|Rivaroxaban|rivaroxaban|mesh-list
110504566|NCT04324463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110504567|NCT04324463|Antiviral Agents|antiviral agents|mesh-ancestor
110504568|NCT04324463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110504569|NCT04324463|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110504570|NCT04324463|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110504571|NCT04324463|Analgesics|analgesics|mesh-ancestor
110504572|NCT04324463|Sensory System Agents|sensory system agents|mesh-ancestor
110504573|NCT04324463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110504574|NCT04324463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110504575|NCT04324463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110504576|NCT04324463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110504577|NCT04324463|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110504578|NCT04324463|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110504579|NCT04324463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110504580|NCT04324463|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110504581|NCT04324463|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110504582|NCT04324463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110504584|NCT04324463|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110504585|NCT04324463|Antithrombins|antithrombins|mesh-ancestor
110504586|NCT04324463|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110504587|NCT04324463|Protease Inhibitors|protease inhibitors|mesh-ancestor
110504588|NCT04324463|Anticoagulants|anticoagulants|mesh-ancestor
110504589|NCT04324463|Gout Suppressants|gout suppressants|mesh-ancestor
110504590|NCT04324463|Tubulin Modulators|tubulin modulators|mesh-ancestor
110504591|NCT04324463|Antimitotic Agents|antimitotic agents|mesh-ancestor
110504592|NCT04324463|Mitosis Modulators|mitosis modulators|mesh-ancestor
110504593|NCT04324463|Immunologic Factors|immunologic factors|mesh-ancestor
110504594|NCT04315701|Cemiplimab|cemiplimab|mesh-list
110277294|NCT00560092|Magnesium Sulfate|magnesium sulfate|mesh-list
110504595|NCT04315701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110504596|NCT04315701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110504597|NCT04240093|Analgesics, Opioid|analgesics, opioid|mesh-list
110504598|NCT04240093|Narcotics|narcotics|mesh-ancestor
110504599|NCT04240093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110504600|NCT04240093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110504601|NCT04240093|Analgesics|analgesics|mesh-ancestor
110504602|NCT04240093|Sensory System Agents|sensory system agents|mesh-ancestor
110504603|NCT04240093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110504604|NCT04213794|Sodium thiosulfate|sodium thiosulfate|mesh-list
110504605|NCT04213794|Cisplatin|cisplatin|mesh-list
110504606|NCT04213794|Doxorubicin|doxorubicin|mesh-list
110504607|NCT04213794|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110504608|NCT04213794|Daunorubicin|daunorubicin|mesh-list
110504609|NCT04213794|Antidotes|antidotes|mesh-list
110504610|NCT04213794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110504611|NCT04213794|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110504612|NCT04213794|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110504613|NCT04213794|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110504614|NCT04213794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110504615|NCT04213794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110504616|NCT04213794|Protective Agents|protective agents|mesh-ancestor
110504617|NCT04213794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110504618|NCT04213794|Antioxidants|antioxidants|mesh-ancestor
110504619|NCT04213794|Antitubercular Agents|antitubercular agents|mesh-ancestor
110504620|NCT04213794|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110504621|NCT04213794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110504622|NCT04213794|Chelating Agents|chelating agents|mesh-ancestor
110504623|NCT04213794|Sequestering Agents|sequestering agents|mesh-ancestor
110617832|NCT00781482|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
110617833|NCT00781482|GABA Agonists|gaba agonists|mesh-ancestor
110617835|NCT00781482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110617836|NCT00781482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110617837|NCT00603915|Carboplatin|carboplatin|mesh-list
110617838|NCT00603915|Gemcitabine|gemcitabine|mesh-list
110617839|NCT00603915|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110617840|NCT00603915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110617841|NCT00603915|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110617842|NCT00603915|Antimetabolites|antimetabolites|mesh-ancestor
110617843|NCT00603915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110617844|NCT00603915|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110617845|NCT00603915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110617846|NCT00929487|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110617847|NCT00925977|Insulin|insulin|mesh-list
110617848|NCT00925977|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110617849|NCT00925977|Insulin Glargine|insulin glargine|mesh-list
110617850|NCT00925977|Insulin glulisine|insulin glulisine|mesh-list
110617851|NCT00925977|Isophane Insulin, Human|isophane insulin, human|mesh-list
110617852|NCT00925977|Insulin, Isophane|insulin, isophane|mesh-list
110617853|NCT00925977|Isophane insulin, beef|isophane insulin, beef|mesh-list
110617854|NCT00925977|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110617855|NCT00925977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110617856|NCT00926055|Simvastatin|simvastatin|mesh-list
110617857|NCT00926055|Ezetimibe|ezetimibe|mesh-list
110617858|NCT00926055|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
110617859|NCT00926055|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110617860|NCT00926055|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110617861|NCT00926055|Antimetabolites|antimetabolites|mesh-ancestor
110617862|NCT00926055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110617863|NCT00926055|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110617864|NCT00926055|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110617865|NCT00926055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110617866|NCT04034199|Zoledronic Acid|zoledronic acid|mesh-list
110617867|NCT04034199|Denosumab|denosumab|mesh-list
110617868|NCT04034199|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110617869|NCT04034199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110617870|NCT02538237|Ibuprofen|ibuprofen|mesh-list
110617871|NCT02538237|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110617872|NCT02538237|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110617873|NCT02538237|Analgesics|analgesics|mesh-ancestor
110617874|NCT02538237|Sensory System Agents|sensory system agents|mesh-ancestor
110617875|NCT02538237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110265184|NCT02920489|Dsuvia|dsuvia|mesh-list
110617876|NCT02538237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110617877|NCT02538237|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110617879|NCT02538237|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110617880|NCT02538237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110617881|NCT02538237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110617883|NCT00691028|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110617884|NCT00691028|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110617885|NCT00691028|Dermatologic Agents|dermatologic agents|mesh-ancestor
110391618|NCT03222531|Sofosbuvir|sofosbuvir|mesh-list
110391620|NCT03222531|Velpatasvir|velpatasvir|mesh-list
110617894|NCT00666276|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110617895|NCT00666276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110617896|NCT00666276|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110617897|NCT00666276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110617898|NCT00666276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110617900|NCT00567255|Bupropion|bupropion|mesh-list
110617901|NCT00567255|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110617902|NCT00567255|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110617903|NCT00567255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110617904|NCT00567255|Sensory System Agents|sensory system agents|mesh-ancestor
110617905|NCT00567255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110617906|NCT00567255|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110617907|NCT00567255|Antidepressive Agents|antidepressive agents|mesh-ancestor
110617908|NCT00567255|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110617909|NCT00567255|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110617910|NCT00567255|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110617911|NCT00567255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110617912|NCT00567255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110617913|NCT00567255|Dopamine Agents|dopamine agents|mesh-ancestor
110617914|NCT00567255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110617915|NCT00567255|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110290503|NCT00199121|Zidovudine|zidovudine|mesh-list
110617916|NCT00567255|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110617917|NCT00567255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110617918|NCT00746174|Rosiglitazone|rosiglitazone|mesh-list
110617919|NCT00746174|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110617920|NCT00746174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110617921|NCT00784446|Bevacizumab|bevacizumab|mesh-list
110617922|NCT00784446|Capecitabine|capecitabine|mesh-list
110617923|NCT00784446|Oxaliplatin|oxaliplatin|mesh-list
110617924|NCT00784446|Imatinib Mesylate|imatinib mesylate|mesh-list
110614843|NCT00978172|Anthelmintics|anthelmintics|mesh-ancestor
110617925|NCT00784446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110617926|NCT00784446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110617927|NCT00784446|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110617928|NCT00784446|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110617929|NCT00784446|Growth Substances|growth substances|mesh-ancestor
110617930|NCT00784446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110617931|NCT00784446|Growth Inhibitors|growth inhibitors|mesh-ancestor
110617932|NCT00784446|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110617933|NCT00784446|Antimetabolites|antimetabolites|mesh-ancestor
110617934|NCT00784446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110617935|NCT00784446|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110617936|NCT00784446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110617937|NCT00744536|Lenalidomide|lenalidomide|mesh-list
110617938|NCT00744536|Melphalan|melphalan|mesh-list
110617939|NCT00744536|Immunologic Factors|immunologic factors|mesh-ancestor
110617940|NCT00744536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110290624|NCT04606225|Losartan|losartan|mesh-list
110617941|NCT00744536|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110617942|NCT00744536|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110617944|NCT00744536|Growth Inhibitors|growth inhibitors|mesh-ancestor
110617945|NCT00744536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110617946|NCT00744536|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110617947|NCT00744536|Alkylating Agents|alkylating agents|mesh-ancestor
110617948|NCT00744536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110617949|NCT00744536|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110617950|NCT00744536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110290679|NCT00564772|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110617952|NCT00929799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110391631|NCT03208452|Anticonvulsants|anticonvulsants|mesh-ancestor
110617967|NCT00784680|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110617968|NCT00784680|Hormone Antagonists|hormone antagonists|mesh-ancestor
110617969|NCT00784680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110617970|NCT00784680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110617971|NCT00784680|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110617972|NCT00784680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110617973|NCT00784680|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110617974|NCT00784680|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110617975|NCT00784680|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110617976|NCT00784680|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110617977|NCT00784680|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110617978|NCT00784680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110617979|NCT00784680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110617980|NCT00908271|Dapagliflozin|dapagliflozin|mesh-list
110617981|NCT00908271|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110617982|NCT00908271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110617983|NCT00908271|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110617984|NCT00908271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110617986|NCT02556840|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110617987|NCT02556840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110617988|NCT00929877|Ketoprofen|ketoprofen|mesh-list
110617989|NCT00929877|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110617990|NCT00929877|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110617991|NCT00929877|Analgesics|analgesics|mesh-ancestor
110617992|NCT00929877|Sensory System Agents|sensory system agents|mesh-ancestor
110617993|NCT00929877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110617994|NCT00929877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110617995|NCT00929877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110617996|NCT00929877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110617997|NCT00929877|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110617998|NCT00929877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110617999|NCT00929877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110618000|NCT00741884|Varenicline|varenicline|mesh-list
110618001|NCT00741884|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110618002|NCT00741884|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110618003|NCT00741884|Cholinergic Agents|cholinergic agents|mesh-ancestor
110290790|NCT00252291|Miotics|miotics|mesh-ancestor
110618004|NCT00741884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110618005|NCT00741884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110618006|NCT00741884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110618007|NCT00931437|Vitamin K|vitamin k|mesh-list
110618008|NCT00931437|Vitamins|vitamins|mesh-ancestor
110618009|NCT00931437|Micronutrients|micronutrients|mesh-ancestor
110618010|NCT00931437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110618011|NCT00931437|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110618012|NCT00931437|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110618027|NCT00782106|gamma-Globulins|gamma-globulins|mesh-list
110618028|NCT00782106|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110618029|NCT00782106|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110618030|NCT00782106|Immunoglobulin G|immunoglobulin g|mesh-list
110614998|NCT00377455|Bosentan|bosentan|mesh-list
110618031|NCT00782106|Immunologic Factors|immunologic factors|mesh-ancestor
110618032|NCT00782106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110618033|NCT00929955|Ondansetron|ondansetron|mesh-list
110618034|NCT00929955|Simvastatin|simvastatin|mesh-list
110618035|NCT00929955|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110618036|NCT00929955|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110618037|NCT00929955|Antimetabolites|antimetabolites|mesh-ancestor
110618038|NCT00929955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110618039|NCT00929955|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110618040|NCT00929955|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110618041|NCT00929955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110618042|NCT00929955|Antiemetics|antiemetics|mesh-ancestor
110618043|NCT00929955|Autonomic Agents|autonomic agents|mesh-ancestor
110618044|NCT00929955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110618045|NCT00929955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110618046|NCT00929955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110618047|NCT00929955|Antipruritics|antipruritics|mesh-ancestor
110618048|NCT00929955|Dermatologic Agents|dermatologic agents|mesh-ancestor
110290953|NCT04599205|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110618049|NCT00929955|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110618050|NCT00929955|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110618051|NCT00929955|Serotonin Agents|serotonin agents|mesh-ancestor
110618052|NCT00929955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110618053|NCT00784914|Sirolimus|sirolimus|mesh-list
110618054|NCT00784914|Temsirolimus|temsirolimus|mesh-list
110618055|NCT00784914|MTOR Inhibitors|mtor inhibitors|mesh-list
110618056|NCT00784914|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110618057|NCT00784914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110618058|NCT00784914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110618059|NCT00784914|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110618060|NCT00784914|Immunologic Factors|immunologic factors|mesh-ancestor
110291016|NCT00565708|Aspirin|aspirin|mesh-list
110618061|NCT00784914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110618062|NCT00784914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110618063|NCT00784914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110618064|NCT00784914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110618065|NCT00784914|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110618066|NCT00784914|Antifungal Agents|antifungal agents|mesh-ancestor
110618067|NCT00745004|Ondansetron|ondansetron|mesh-list
110618068|NCT00745004|Antiemetics|antiemetics|mesh-ancestor
110618069|NCT00745004|Autonomic Agents|autonomic agents|mesh-ancestor
110618070|NCT00745004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110618071|NCT00745004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110618072|NCT00745004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110618073|NCT00745004|Antipruritics|antipruritics|mesh-ancestor
110618074|NCT00745004|Dermatologic Agents|dermatologic agents|mesh-ancestor
110618075|NCT00745004|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110618079|NCT00745004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110618081|NCT05450978|Levetiracetam|levetiracetam|mesh-list
110618082|NCT05450978|Anticonvulsants|anticonvulsants|mesh-list
110618083|NCT05450978|Nootropic Agents|nootropic agents|mesh-ancestor
110618084|NCT05450978|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110618085|NCT05450978|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110618086|NCT05450978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110618087|NCT05450978|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110618088|NCT05450978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110618089|NCT05450978|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110618090|NCT05450978|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110618091|NCT05450978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110618092|NCT05450978|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110618093|NCT05450978|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110618094|NCT04060550|Omalizumab|omalizumab|mesh-list
110618095|NCT04060550|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110618096|NCT04060550|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110618097|NCT04060550|Respiratory System Agents|respiratory system agents|mesh-ancestor
110618098|NCT00921674|Ivermectin|ivermectin|mesh-list
110618099|NCT00921674|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110618100|NCT00921674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110618102|NCT00667446|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110618103|NCT00667446|Fertility Agents|fertility agents|mesh-ancestor
110618104|NCT00667446|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110618105|NCT00667446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110618106|NCT00667446|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110618107|NCT00667446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110618108|NCT00777972|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110618109|NCT00777972|Fosinopril|fosinopril|mesh-list
110618110|NCT00777972|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110618111|NCT00777972|Diuretics|diuretics|mesh-ancestor
110618112|NCT00777972|Natriuretic Agents|natriuretic agents|mesh-ancestor
110618113|NCT00777972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110618114|NCT00777972|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110618115|NCT00777972|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110618116|NCT00777972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110618117|NCT00777972|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110618118|NCT00777972|Protease Inhibitors|protease inhibitors|mesh-ancestor
110618119|NCT00777972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110618120|NCT00778050|Amoxicillin|amoxicillin|mesh-list
110618121|NCT00778050|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110618122|NCT00778050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110618123|NCT00746486|Budesonide|budesonide|mesh-list
110618124|NCT00746486|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110618125|NCT00746486|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110618126|NCT00746486|Autonomic Agents|autonomic agents|mesh-ancestor
110618127|NCT00746486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110615120|NCT05178628|Paclitaxel|paclitaxel|mesh-list
110618128|NCT00746486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110618129|NCT00746486|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110618130|NCT00746486|Respiratory System Agents|respiratory system agents|mesh-ancestor
110618131|NCT00746486|Glucocorticoids|glucocorticoids|mesh-ancestor
110618132|NCT00746486|Hormones|hormones|mesh-ancestor
110618133|NCT00746486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110618134|NCT00778128|Gemcitabine|gemcitabine|mesh-list
110291227|NCT00249366|GABA Agents|gaba agents|mesh-ancestor
110618135|NCT00778128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110618136|NCT00778128|Antimetabolites|antimetabolites|mesh-ancestor
110618137|NCT00778128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110618138|NCT00778128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110618139|NCT00778284|Amoxicillin|amoxicillin|mesh-list
110618140|NCT00778284|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110618141|NCT00778284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110618142|NCT00749138|Tamoxifen|tamoxifen|mesh-list
110618143|NCT00749138|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110618144|NCT00749138|Hormone Antagonists|hormone antagonists|mesh-ancestor
110618145|NCT00749138|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110618146|NCT00749138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110618147|NCT00749138|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110618154|NCT02563340|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110618155|NCT02563340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110618156|NCT02563340|Immunologic Factors|immunologic factors|mesh-ancestor
110618157|NCT02563340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110618158|NCT02563340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110618159|NCT00782652|Nitric Oxide|nitric oxide|mesh-list
110618160|NCT00782652|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110618161|NCT00782652|Autonomic Agents|autonomic agents|mesh-ancestor
110618162|NCT00782652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110618163|NCT00782652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110618164|NCT00782652|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110618165|NCT00782652|Respiratory System Agents|respiratory system agents|mesh-ancestor
110618166|NCT00782652|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110618167|NCT00782652|Antioxidants|antioxidants|mesh-ancestor
110618168|NCT00782652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110618169|NCT00782652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110618170|NCT00782652|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
110618171|NCT00782652|Vasodilator Agents|vasodilator agents|mesh-ancestor
110618172|NCT00782652|Gasotransmitters|gasotransmitters|mesh-ancestor
110265458|NCT00155558|Vitamins|vitamins|mesh-ancestor
110618173|NCT00782652|Protective Agents|protective agents|mesh-ancestor
110618175|NCT00785382|Analgesics|analgesics|mesh-ancestor
110618176|NCT00785382|Sensory System Agents|sensory system agents|mesh-ancestor
110153575|NCT00001005|Zidovudine|zidovudine|mesh-list
110618177|NCT00785382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110618178|NCT00785382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110618179|NCT00785382|Anticonvulsants|anticonvulsants|mesh-ancestor
110618180|NCT00785382|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110618181|NCT00785382|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110618182|NCT00785382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110618183|NCT00785382|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110618184|NCT00785382|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110618185|NCT00785382|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110291316|NCT00566761|Hormones|hormones|mesh-ancestor
110618186|NCT00785382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110618187|NCT00785382|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110618188|NCT00667368|Metronidazole|metronidazole|mesh-list
110618189|NCT00667368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110618190|NCT00667368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110618191|NCT00667368|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110618192|NCT00667368|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110618193|NCT00785460|Benphothiamine|benphothiamine|mesh-list
110618194|NCT00785460|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110618195|NCT00785460|Immunologic Factors|immunologic factors|mesh-ancestor
110618196|NCT00785460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110618197|NCT00785460|Chelating Agents|chelating agents|mesh-ancestor
110618198|NCT00785460|Sequestering Agents|sequestering agents|mesh-ancestor
110618199|NCT00785460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110618200|NCT00567567|Vitamin A|vitamin a|mesh-list
110618201|NCT00567567|Cyclophosphamide|cyclophosphamide|mesh-list
110618202|NCT00567567|Melphalan|melphalan|mesh-list
110618203|NCT00567567|Mechlorethamine|mechlorethamine|mesh-list
110618204|NCT00567567|Thiotepa|thiotepa|mesh-list
110618205|NCT00567567|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
110618206|NCT00567567|Cisplatin|cisplatin|mesh-list
110618207|NCT00567567|Carboplatin|carboplatin|mesh-list
110618208|NCT00567567|Doxorubicin|doxorubicin|mesh-list
110618209|NCT00567567|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110618210|NCT00567567|Etoposide|etoposide|mesh-list
110618211|NCT00567567|Vincristine|vincristine|mesh-list
110618212|NCT00567567|Etoposide phosphate|etoposide phosphate|mesh-list
110618213|NCT00567567|Topotecan|topotecan|mesh-list
110618214|NCT00567567|Tretinoin|tretinoin|mesh-list
110618215|NCT00567567|Podophyllotoxin|podophyllotoxin|mesh-list
110618216|NCT00567567|Isotretinoin|isotretinoin|mesh-list
110618217|NCT00567567|Lenograstim|lenograstim|mesh-list
110618218|NCT00567567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110618225|NCT00567567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110618226|NCT00567567|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110618228|NCT00567567|Micronutrients|micronutrients|mesh-ancestor
110618229|NCT00567567|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110618230|NCT00567567|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110618231|NCT00567567|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110618232|NCT00567567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110618233|NCT00567567|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110618234|NCT00567567|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110618235|NCT00567567|Tubulin Modulators|tubulin modulators|mesh-ancestor
110618236|NCT00567567|Antimitotic Agents|antimitotic agents|mesh-ancestor
110618237|NCT00567567|Mitosis Modulators|mitosis modulators|mesh-ancestor
110618238|NCT00567567|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110618239|NCT00567567|Keratolytic Agents|keratolytic agents|mesh-ancestor
110618240|NCT00567567|Dermatologic Agents|dermatologic agents|mesh-ancestor
110618241|NCT00666198|Sildenafil Citrate|sildenafil citrate|mesh-list
110618242|NCT00666198|Vasodilator Agents|vasodilator agents|mesh-ancestor
110615224|NCT00972712|Tipifarnib|tipifarnib|mesh-list
110618243|NCT00666198|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110618244|NCT00666198|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110618245|NCT00666198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110277561|NCT00201708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110618246|NCT00666198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110618247|NCT00666198|Urological Agents|urological agents|mesh-ancestor
110618248|NCT00778596|Prednisolone|prednisolone|mesh-list
110618249|NCT00778596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110618250|NCT00778596|Glucocorticoids|glucocorticoids|mesh-ancestor
110618251|NCT00778596|Hormones|hormones|mesh-ancestor
110618252|NCT00778596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110618253|NCT00778596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110618254|NCT00778596|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110618255|NCT00778596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110618256|NCT00778674|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110618257|NCT00778674|Benazepril|benazepril|mesh-list
110618258|NCT00778674|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110618259|NCT00778674|Diuretics|diuretics|mesh-ancestor
110618260|NCT00778674|Natriuretic Agents|natriuretic agents|mesh-ancestor
110277579|NCT00179699|Lenalidomide|lenalidomide|mesh-list
110618261|NCT00778674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110618262|NCT00778674|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110618263|NCT00778674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110618264|NCT00778674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110618265|NCT00778674|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110618266|NCT00778674|Protease Inhibitors|protease inhibitors|mesh-ancestor
110618267|NCT00778674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110618269|NCT00778752|Immunologic Factors|immunologic factors|mesh-ancestor
110618270|NCT00778752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110618271|NCT00778752|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110618272|NCT00778752|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110618273|NCT00778752|Growth Substances|growth substances|mesh-ancestor
110618274|NCT00778752|Growth Inhibitors|growth inhibitors|mesh-ancestor
110618275|NCT00778752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110618276|NCT00926835|Lamotrigine|lamotrigine|mesh-list
110618277|NCT00926835|Dexetimide|dexetimide|mesh-list
110618278|NCT00926835|Aripiprazole|aripiprazole|mesh-list
110618279|NCT00926835|Mirtazapine|mirtazapine|mesh-list
110618280|NCT00926835|Citalopram|citalopram|mesh-list
110618281|NCT00926835|Bupropion|bupropion|mesh-list
110618282|NCT00926835|Paroxetine|paroxetine|mesh-list
110618283|NCT00926835|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
110618284|NCT00926835|Escitalopram|escitalopram|mesh-list
110618285|NCT00926835|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110618286|NCT00926835|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110391673|NCT02882282|Pembrolizumab|pembrolizumab|mesh-list
110618295|NCT00926835|Autonomic Agents|autonomic agents|mesh-ancestor
110615313|NCT00985270|Leprostatic Agents|leprostatic agents|mesh-ancestor
110618296|NCT00926835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110618297|NCT00926835|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110618298|NCT00926835|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110618299|NCT00926835|Cholinergic Agents|cholinergic agents|mesh-ancestor
110618300|NCT00926835|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110618301|NCT00926835|Antidepressive Agents|antidepressive agents|mesh-ancestor
110618302|NCT00926835|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110618303|NCT00926835|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110618304|NCT00926835|Dopamine Agents|dopamine agents|mesh-ancestor
110618305|NCT00926835|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110618306|NCT00926835|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110618307|NCT00926835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110291581|NCT00253422|Fulvestrant|fulvestrant|mesh-list
110618308|NCT00926835|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110618309|NCT00926835|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110618310|NCT00926835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110618311|NCT00926835|Dopamine Agonists|dopamine agonists|mesh-ancestor
110618312|NCT00926835|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110618313|NCT00926835|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110618314|NCT00926835|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110618315|NCT00926835|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110618316|NCT00926835|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110618317|NCT00926835|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110618318|NCT00926835|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110618319|NCT00926835|Anticonvulsants|anticonvulsants|mesh-ancestor
110618320|NCT00926835|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110618321|NCT00926835|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110618322|NCT00926835|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110618323|NCT00926835|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110618324|NCT00926835|Histamine Antagonists|histamine antagonists|mesh-ancestor
110618326|NCT00926835|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110618327|NCT00926835|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
110618328|NCT00926835|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110618329|NCT00926835|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110618330|NCT00926835|Adrenergic Agents|adrenergic agents|mesh-ancestor
110618331|NCT00926835|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110618332|NCT00930033|Sunitinib|sunitinib|mesh-list
110618333|NCT00930033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110618334|NCT00930033|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110618335|NCT00930033|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110618336|NCT00930033|Growth Substances|growth substances|mesh-ancestor
110618337|NCT00930033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110618338|NCT00930033|Growth Inhibitors|growth inhibitors|mesh-ancestor
110618339|NCT00930033|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110618340|NCT00930033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110618341|NCT00930033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110618342|NCT00664560|Celecoxib|celecoxib|mesh-list
110618343|NCT00664560|Antacids|antacids|mesh-list
110618344|NCT00664560|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110618345|NCT00664560|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110618346|NCT00664560|Analgesics|analgesics|mesh-ancestor
110618347|NCT00664560|Sensory System Agents|sensory system agents|mesh-ancestor
110618348|NCT00664560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110618349|NCT00664560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110618350|NCT00664560|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110618376|NCT00688688|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110618377|NCT00688688|Cholinergic Agents|cholinergic agents|mesh-ancestor
110618378|NCT00930189|Triamcinolone|triamcinolone|mesh-list
110618379|NCT00930189|Ranibizumab|ranibizumab|mesh-list
110618380|NCT00930189|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110618381|NCT00930189|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110618382|NCT00930189|Growth Substances|growth substances|mesh-ancestor
110618383|NCT00930189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110618385|NCT00930189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110618386|NCT00930189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110618387|NCT00930189|Glucocorticoids|glucocorticoids|mesh-ancestor
110618388|NCT00930189|Hormones|hormones|mesh-ancestor
110618389|NCT00930189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110618390|NCT00936819|Plasma-lyte 148|plasma-lyte 148|mesh-list
110618391|NCT00936819|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110618392|NCT00936819|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110618393|NCT00931827|Levonorgestrel|levonorgestrel|mesh-list
110618394|NCT00931827|Etonogestrel|etonogestrel|mesh-list
110618395|NCT00931827|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110618396|NCT00931827|Contraceptive Agents|contraceptive agents|mesh-ancestor
110618397|NCT00931827|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110265674|NCT04883632|Lidocaine|lidocaine|mesh-list
110618398|NCT00931827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110618424|NCT00930345|Growth Substances|growth substances|mesh-ancestor
110618425|NCT00930345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110618426|NCT00930345|Growth Inhibitors|growth inhibitors|mesh-ancestor
110618427|NCT00930345|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110618428|NCT00930345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110618429|NCT00930345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110618430|NCT02562326|Insulin Lispro|insulin lispro|mesh-list
110618431|NCT02562326|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110618432|NCT02562326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110618434|NCT00746720|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110618435|NCT00746720|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110618436|NCT00746720|Analgesics|analgesics|mesh-ancestor
110618437|NCT00746720|Sensory System Agents|sensory system agents|mesh-ancestor
110291782|NCT00403286|Xhance|xhance|mesh-list
110618438|NCT00746720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110618439|NCT00746720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110618440|NCT00746720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110618441|NCT00746720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110618442|NCT00746720|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110618443|NCT00746720|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110618444|NCT00746720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110618445|NCT00746720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110618446|NCT00686972|Glucagon|glucagon|mesh-list
110618447|NCT00686972|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
110618448|NCT00686972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110618455|NCT00665652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110618456|NCT00665652|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110618457|NCT00665652|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110618459|NCT00665652|Growth Inhibitors|growth inhibitors|mesh-ancestor
110618460|NCT00665652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110618461|NCT00752024|Hemostatics|hemostatics|mesh-list
110618462|NCT00752024|Coagulants|coagulants|mesh-ancestor
110618463|NCT00937677|Natalizumab|natalizumab|mesh-list
110618464|NCT00937677|Immunologic Factors|immunologic factors|mesh-ancestor
110618465|NCT00937677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110618466|NCT00786240|Fesoterodine|fesoterodine|mesh-list
110618467|NCT00786240|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110618468|NCT00786240|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110618469|NCT00786240|Cholinergic Agents|cholinergic agents|mesh-ancestor
110618470|NCT00786240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110618471|NCT00786240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110618472|NCT00786240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110618473|NCT00786240|Urological Agents|urological agents|mesh-ancestor
110618474|NCT04498923|Dexamethasone|dexamethasone|mesh-list
110618475|NCT04498923|Epinephrine|epinephrine|mesh-list
110618476|NCT04498923|Bupivacaine|bupivacaine|mesh-list
110618477|NCT04498923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110618478|NCT04498923|Antiemetics|antiemetics|mesh-ancestor
110618479|NCT04498923|Autonomic Agents|autonomic agents|mesh-ancestor
110618480|NCT04498923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110618481|NCT04498923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110618482|NCT04498923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110618483|NCT04498923|Glucocorticoids|glucocorticoids|mesh-ancestor
110618484|NCT04498923|Hormones|hormones|mesh-ancestor
110618485|NCT04498923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110615503|NCT04006054|Analgesics|analgesics|mesh-ancestor
110277668|NCT00186810|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110618486|NCT04498923|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110618487|NCT04498923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110618488|NCT04498923|Anesthetics, Local|anesthetics, local|mesh-ancestor
110618489|NCT04498923|Anesthetics|anesthetics|mesh-ancestor
110618490|NCT04498923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110618491|NCT04498923|Sensory System Agents|sensory system agents|mesh-ancestor
110618492|NCT04498923|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110618493|NCT04498923|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110618494|NCT04498923|Adrenergic Agents|adrenergic agents|mesh-ancestor
110618495|NCT04498923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110618496|NCT04498923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110618497|NCT04498923|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110277679|NCT00561028|Antibodies|antibodies|mesh-list
110618498|NCT04498923|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110618499|NCT04498923|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110618500|NCT04498923|Respiratory System Agents|respiratory system agents|mesh-ancestor
110618501|NCT04498923|Mydriatics|mydriatics|mesh-ancestor
110618502|NCT04498923|Sympathomimetics|sympathomimetics|mesh-ancestor
110618503|NCT04498923|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110618504|NCT00779064|Rivaroxaban|rivaroxaban|mesh-list
110618505|NCT00779064|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110618506|NCT00779064|Antithrombins|antithrombins|mesh-ancestor
110618507|NCT00779064|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110618508|NCT00779064|Protease Inhibitors|protease inhibitors|mesh-ancestor
110618509|NCT00779064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110618510|NCT00779064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110618511|NCT00779064|Anticoagulants|anticoagulants|mesh-ancestor
110618512|NCT04046874|Analgesics|analgesics|mesh-list
110618513|NCT04046874|Sensory System Agents|sensory system agents|mesh-ancestor
110618514|NCT04046874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110618515|NCT04046874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110618516|NCT00932217|Lenograstim|lenograstim|mesh-list
110618517|NCT00932217|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110618518|NCT00932217|Immunologic Factors|immunologic factors|mesh-ancestor
110618537|NCT00566631|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110618538|NCT00566631|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110618539|NCT00566631|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110618540|NCT00566631|Serotonin Agents|serotonin agents|mesh-ancestor
110618541|NCT00566631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110618542|NCT00566631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110618543|NCT00566631|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110618544|NCT00566631|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110618545|NCT00566631|Dopamine Agents|dopamine agents|mesh-ancestor
110618547|NCT00937911|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110618548|NCT00937911|Antithrombins|antithrombins|mesh-ancestor
110618549|NCT00937911|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110618550|NCT00937911|Protease Inhibitors|protease inhibitors|mesh-ancestor
110618551|NCT00937911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110618552|NCT00937911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110618553|NCT00937911|Anticoagulants|anticoagulants|mesh-ancestor
110618554|NCT00930891|Bevacizumab|bevacizumab|mesh-list
110277705|NCT00561106|Prednisone|prednisone|mesh-list
110618555|NCT00930891|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110618556|NCT00930891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110618557|NCT00930891|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110618558|NCT00930891|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110618559|NCT00930891|Growth Substances|growth substances|mesh-ancestor
110618560|NCT00930891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110618561|NCT00930891|Growth Inhibitors|growth inhibitors|mesh-ancestor
110618562|NCT00938379|Insect Repellents|insect repellents|mesh-list
110618563|NCT00938379|Protective Agents|protective agents|mesh-ancestor
110618564|NCT00938379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110618565|NCT00661830|Gemcitabine|gemcitabine|mesh-list
110618566|NCT00661830|Sorafenib|sorafenib|mesh-list
110618567|NCT00661830|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110618568|NCT00661830|Antimetabolites|antimetabolites|mesh-ancestor
110618569|NCT00661830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110618570|NCT00661830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110618571|NCT00661830|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110618572|NCT00661830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110618573|NCT00932529|Olanzapine|olanzapine|mesh-list
110618574|NCT00932529|Risperidone|risperidone|mesh-list
110153625|NCT00391261|Metformin|metformin|mesh-list
110618586|NCT00932529|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110618587|NCT00932529|Dopamine Agents|dopamine agents|mesh-ancestor
110618588|NCT00932529|Antiemetics|antiemetics|mesh-ancestor
110618589|NCT00932529|Autonomic Agents|autonomic agents|mesh-ancestor
110618590|NCT00932529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110618591|NCT00932529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110618592|NCT00932529|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110618593|NCT00932529|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110615615|NCT00902811|Amodiaquine|amodiaquine|mesh-list
110618594|NCT00932529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110618595|NCT00932529|Antidepressive Agents|antidepressive agents|mesh-ancestor
110618596|NCT00783744|Insulin|insulin|mesh-list
110618597|NCT00783744|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110618598|NCT00783744|Metformin|metformin|mesh-list
110618599|NCT00783744|Insulin Glargine|insulin glargine|mesh-list
110618600|NCT00783744|Glimepiride|glimepiride|mesh-list
110618601|NCT00783744|Isophane Insulin, Human|isophane insulin, human|mesh-list
110618602|NCT00783744|Insulin, Isophane|insulin, isophane|mesh-list
110618603|NCT00783744|Isophane insulin, beef|isophane insulin, beef|mesh-list
110618604|NCT00783744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110618605|NCT00783744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110618606|NCT00783744|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110618607|NCT00783744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110023134|NCT00003402|Hormones|hormones|mesh-ancestor
110618608|NCT00783744|Immunologic Factors|immunologic factors|mesh-ancestor
110618609|NCT00932607|Immunomodulating Agents|immunomodulating agents|mesh-list
110618610|NCT00932607|Immunologic Factors|immunologic factors|mesh-ancestor
110618611|NCT00932607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110618612|NCT00932685|Midazolam|midazolam|mesh-list
110618613|NCT00932685|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110618614|NCT00932685|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110618615|NCT00932685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110618616|NCT00932685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110618617|NCT00932685|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110618618|NCT00932685|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110292287|NCT00224315|Risperidone|risperidone|mesh-list
110618619|NCT00932685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110618620|NCT00932685|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110618621|NCT00932685|Anesthetics, General|anesthetics, general|mesh-ancestor
110618622|NCT00932685|Anesthetics|anesthetics|mesh-ancestor
110618623|NCT00932685|GABA Modulators|gaba modulators|mesh-ancestor
110618624|NCT00932685|GABA Agents|gaba agents|mesh-ancestor
110618625|NCT00932685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110618626|NCT00932685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110618627|NCT00931125|Ranibizumab|ranibizumab|mesh-list
110618628|NCT00931125|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110618629|NCT00931125|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110618630|NCT00931125|Growth Substances|growth substances|mesh-ancestor
110618631|NCT00931125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110618632|NCT00931125|Growth Inhibitors|growth inhibitors|mesh-ancestor
110618633|NCT00931125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110618634|NCT00932763|Amlodipine|amlodipine|mesh-list
110618635|NCT00932763|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110618636|NCT00932763|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110618637|NCT00932763|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110618638|NCT00932763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110618639|NCT00932763|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110618668|NCT00938613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110618669|NCT00786552|Paclitaxel|paclitaxel|mesh-list
110618670|NCT00786552|Pemetrexed|pemetrexed|mesh-list
110618671|NCT00786552|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110618672|NCT00786552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110618673|NCT00786552|Tubulin Modulators|tubulin modulators|mesh-ancestor
110618674|NCT00786552|Antimitotic Agents|antimitotic agents|mesh-ancestor
110618675|NCT00786552|Mitosis Modulators|mitosis modulators|mesh-ancestor
110618676|NCT00786552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110618677|NCT00786552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110618678|NCT00786552|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110618679|NCT00786552|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110618680|NCT04047186|Nivolumab|nivolumab|mesh-list
110618681|NCT04047186|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110618682|NCT04047186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110618683|NCT04047186|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110618684|NCT04047186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110618685|NCT00931203|Celecoxib|celecoxib|mesh-list
110618686|NCT00931203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110618689|NCT00931203|Sensory System Agents|sensory system agents|mesh-ancestor
110618690|NCT00931203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110618691|NCT00931203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110618692|NCT00931203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110618693|NCT00931203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110618694|NCT00931203|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110618695|NCT00931203|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110618696|NCT00931203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110618697|NCT00931203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110618701|NCT00565773|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110618702|NCT00565773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110618703|NCT00565773|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110618704|NCT00565773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110618705|NCT00565773|Antifungal Agents|antifungal agents|mesh-ancestor
110618706|NCT00565773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110618707|NCT00565773|Immunologic Factors|immunologic factors|mesh-ancestor
110618708|NCT00565773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110618709|NCT00565773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110618710|NCT00565773|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110277780|NCT00180050|Budesonide|budesonide|mesh-list
110618711|NCT00565773|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110618712|NCT00565773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110618713|NCT00570492|Fluticasone|fluticasone|mesh-list
110618714|NCT00570492|Xhance|xhance|mesh-list
110618715|NCT00570492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110618716|NCT00570492|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110618717|NCT00570492|Autonomic Agents|autonomic agents|mesh-ancestor
110618718|NCT00570492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110618719|NCT00570492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110618720|NCT00570492|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110618721|NCT00570492|Respiratory System Agents|respiratory system agents|mesh-ancestor
110618722|NCT00570492|Dermatologic Agents|dermatologic agents|mesh-ancestor
110618723|NCT00570492|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110618725|NCT00931281|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110618726|NCT00931281|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110618727|NCT00931281|Protease Inhibitors|protease inhibitors|mesh-ancestor
110618728|NCT00931281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110618729|NCT00931281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110618730|NCT00931281|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110618731|NCT00931281|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110618732|NCT00931281|Antiviral Agents|antiviral agents|mesh-ancestor
110618733|NCT00931281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110618734|NCT00931281|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110618735|NCT00931281|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110618736|NCT04014855|Lactoferrin|lactoferrin|mesh-list
110618737|NCT04014855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110618738|NCT00571922|Acamprosate|acamprosate|mesh-list
110618739|NCT00571922|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110618740|NCT00933231|Mycophenolic Acid|mycophenolic acid|mesh-list
110618741|NCT00933231|Prednisone|prednisone|mesh-list
110618742|NCT00933231|Methylprednisolone|methylprednisolone|mesh-list
110618743|NCT00933231|Ramipril|ramipril|mesh-list
110618744|NCT00933231|Irbesartan|irbesartan|mesh-list
110618745|NCT00933231|Tacrolimus|tacrolimus|mesh-list
110618746|NCT00933231|Basiliximab|basiliximab|mesh-list
110618747|NCT00933231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110618748|NCT00933231|Glucocorticoids|glucocorticoids|mesh-ancestor
110618749|NCT00933231|Hormones|hormones|mesh-ancestor
110618750|NCT00933231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110618751|NCT00933231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110618752|NCT00933231|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110618753|NCT00933231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110618754|NCT00933231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110618755|NCT00933231|Immunologic Factors|immunologic factors|mesh-ancestor
110618756|NCT00933231|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110618757|NCT00933231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110618758|NCT00933231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110615798|NCT01055821|Ribavirin|ribavirin|mesh-list
110618759|NCT00933231|Antiemetics|antiemetics|mesh-ancestor
110618760|NCT00933231|Autonomic Agents|autonomic agents|mesh-ancestor
110618761|NCT00933231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110618762|NCT00933231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110618776|NCT03489525|Immunoglobulins|immunoglobulins|mesh-list
110618777|NCT03489525|Immunoconjugates|immunoconjugates|mesh-list
110618778|NCT03489525|Immunologic Factors|immunologic factors|mesh-ancestor
110277792|NCT00575302|Hormones|hormones|mesh-ancestor
110618779|NCT03489525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110618781|NCT00752180|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110618782|NCT00752180|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110618783|NCT00752180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110618784|NCT00784290|Orantinib|orantinib|mesh-list
110618785|NCT00784290|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110618786|NCT00784290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110618787|NCT00784290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110618789|NCT00752414|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110618790|NCT00752414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110618791|NCT00752414|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110618792|NCT00752414|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110618793|NCT00752414|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110618794|NCT00752414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110618795|NCT00752414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110618796|NCT00752414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110618797|NCT00752414|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110618798|NCT00752414|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110618799|NCT00686894|Infliximab|infliximab|mesh-list
110618800|NCT00686894|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110618801|NCT00686894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110618802|NCT00686894|Dermatologic Agents|dermatologic agents|mesh-ancestor
110618803|NCT00686894|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110618804|NCT00686894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110618805|NCT00328627|Pioglitazone|pioglitazone|mesh-list
110618806|NCT00328627|Alogliptin|alogliptin|mesh-list
110618807|NCT00328627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110618808|NCT00328627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110618809|NCT00328627|Incretins|incretins|mesh-ancestor
110618810|NCT00328627|Hormones|hormones|mesh-ancestor
110618811|NCT00328627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110618812|NCT00328627|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110618813|NCT00328627|Protease Inhibitors|protease inhibitors|mesh-ancestor
110618814|NCT00328627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110618815|NCT00328627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110618816|NCT03977727|Insulin Aspart|insulin aspart|mesh-list
110618817|NCT03977727|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110618818|NCT03977727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110618819|NCT00663858|Cetrorelix|cetrorelix|mesh-list
110618820|NCT00663858|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110618821|NCT00663858|Fertility Agents|fertility agents|mesh-ancestor
110618822|NCT00663858|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110618823|NCT00663858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110618829|NCT05223400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110618830|NCT05223400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110618831|NCT05223400|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110618832|NCT05223400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110618833|NCT05223400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110618834|NCT00790608|Nitric Oxide|nitric oxide|mesh-list
110618835|NCT00790608|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110618836|NCT00790608|Autonomic Agents|autonomic agents|mesh-ancestor
110618837|NCT00790608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110618838|NCT00790608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110618839|NCT00790608|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110618840|NCT00790608|Respiratory System Agents|respiratory system agents|mesh-ancestor
110618841|NCT00790608|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110618842|NCT00790608|Antioxidants|antioxidants|mesh-ancestor
110615869|NCT00905229|Vitamin K|vitamin k|mesh-list
110618843|NCT00790608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110618845|NCT00790608|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
110618846|NCT00790608|Vasodilator Agents|vasodilator agents|mesh-ancestor
110618847|NCT00790608|Gasotransmitters|gasotransmitters|mesh-ancestor
110292533|NCT00571285|Vitamins|vitamins|mesh-list
110618848|NCT00790608|Protective Agents|protective agents|mesh-ancestor
110618850|NCT00749450|Capecitabine|capecitabine|mesh-list
110618851|NCT00749450|Oxaliplatin|oxaliplatin|mesh-list
110618852|NCT00749450|Antimetabolites|antimetabolites|mesh-ancestor
110618853|NCT00749450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110618854|NCT00749450|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110618855|NCT00749450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110618856|NCT00749450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110618857|NCT00749450|Immunologic Factors|immunologic factors|mesh-ancestor
110618858|NCT00749450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110618859|NCT00795444|Maraviroc|maraviroc|mesh-list
110618860|NCT00795444|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110618861|NCT00795444|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110618862|NCT00795444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110618863|NCT00795444|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110618864|NCT00795444|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110618865|NCT00795444|Antiviral Agents|antiviral agents|mesh-ancestor
110618866|NCT00795444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110618867|NCT00795444|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
110618868|NCT02561936|Rilpivirine|rilpivirine|mesh-list
110618869|NCT02561936|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110618870|NCT02561936|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110618871|NCT02561936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110618872|NCT02561936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110618873|NCT02561936|Antiviral Agents|antiviral agents|mesh-ancestor
110618874|NCT02561936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110618875|NCT02561936|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110618876|NCT02561936|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110618877|NCT00752648|Simeprevir|simeprevir|mesh-list
110618878|NCT00752648|Antiviral Agents|antiviral agents|mesh-ancestor
110618879|NCT00752648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110618880|NCT00752648|Protease Inhibitors|protease inhibitors|mesh-ancestor
110618881|NCT00752648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110618882|NCT00752648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110618883|NCT00790920|Salivary plasminogen activator alpha 1, Desmodus rotundus|salivary plasminogen activator alpha 1, desmodus rotundus|mesh-list
110618884|NCT00790920|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110618885|NCT00790920|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110618886|NCT00790920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110618887|NCT00752882|Ceftazidime|ceftazidime|mesh-list
110618888|NCT00752882|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110618889|NCT00752882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110618890|NCT01060735|Vitamin D|vitamin d|mesh-list
110618891|NCT01060735|Vitamins|vitamins|mesh-ancestor
110618892|NCT01060735|Micronutrients|micronutrients|mesh-ancestor
110618902|NCT02555358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110618904|NCT02555358|Antimetabolites|antimetabolites|mesh-ancestor
110618905|NCT00683774|Diazoxide|diazoxide|mesh-list
110618906|NCT00683774|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110292685|NCT00572689|Exenatide|exenatide|mesh-list
110618907|NCT00683774|Vasodilator Agents|vasodilator agents|mesh-ancestor
110618909|NCT00787410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110618910|NCT00787410|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110618911|NCT00787410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110618912|NCT00787410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110618913|NCT03989557|Aspirin|aspirin|mesh-list
110618914|NCT03989557|Clopidogrel|clopidogrel|mesh-list
110618915|NCT03989557|Ticagrelor|ticagrelor|mesh-list
110618916|NCT03989557|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110618917|NCT03989557|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110618918|NCT03989557|Analgesics|analgesics|mesh-ancestor
110618919|NCT03989557|Sensory System Agents|sensory system agents|mesh-ancestor
110618920|NCT03989557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110618921|NCT03989557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110618922|NCT03989557|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110266204|NCT00189618|Aspirin|aspirin|mesh-list
110618923|NCT03989557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110618924|NCT03989557|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110618925|NCT03989557|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110618926|NCT03989557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110618927|NCT03989557|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110618928|NCT03989557|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110618929|NCT03989557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110618931|NCT03989557|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110618932|NCT03989557|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110618933|NCT03989557|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110618934|NCT03989557|Purinergic Agents|purinergic agents|mesh-ancestor
110618935|NCT03989557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110618936|NCT00790998|Ivermectin|ivermectin|mesh-list
110618937|NCT00790998|Moxidectin|moxidectin|mesh-list
110618938|NCT00790998|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110618939|NCT00790998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110618940|NCT00790998|Anthelmintics|anthelmintics|mesh-ancestor
110618941|NCT00790998|Antinematodal Agents|antinematodal agents|mesh-ancestor
110618942|NCT02555046|Anesthetics|anesthetics|mesh-list
110618943|NCT02555046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110618944|NCT02555046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110618945|NCT00354679|Bevacizumab|bevacizumab|mesh-list
110618946|NCT00354679|Irinotecan|irinotecan|mesh-list
110618947|NCT00354679|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110618948|NCT00354679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110618949|NCT00354679|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110618950|NCT00354679|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110618951|NCT00354679|Growth Substances|growth substances|mesh-ancestor
110618952|NCT00354679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110618953|NCT00354679|Growth Inhibitors|growth inhibitors|mesh-ancestor
110615999|NCT01060189|Hemostatics|hemostatics|mesh-ancestor
110618954|NCT00354679|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110618955|NCT00354679|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110618956|NCT00354679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110618957|NCT00354679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110618958|NCT00540514|Paclitaxel|paclitaxel|mesh-list
110618959|NCT00540514|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110618983|NCT02022592|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110618984|NCT02022592|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110618985|NCT02022592|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110618986|NCT02022592|Anesthetics, General|anesthetics, general|mesh-ancestor
110618987|NCT02022592|Anesthetics|anesthetics|mesh-ancestor
110618988|NCT02022592|GABA Modulators|gaba modulators|mesh-ancestor
110618989|NCT02022592|GABA Agents|gaba agents|mesh-ancestor
110618990|NCT02022592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110618991|NCT02022592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110618992|NCT00683618|Atorvastatin|atorvastatin|mesh-list
110277872|NCT00576433|Rituximab|rituximab|mesh-list
110618993|NCT00683618|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110618994|NCT00683618|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110618995|NCT00683618|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110618996|NCT00683618|Antimetabolites|antimetabolites|mesh-ancestor
110618997|NCT00683618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110618998|NCT00683618|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110618999|NCT00683618|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110619000|NCT00683618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110619001|NCT00795678|Paclitaxel|paclitaxel|mesh-list
110619003|NCT00795678|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110619004|NCT00795678|Cyclophosphamide|cyclophosphamide|mesh-list
110619005|NCT00795678|Gemcitabine|gemcitabine|mesh-list
110619006|NCT00795678|Doxorubicin|doxorubicin|mesh-list
110619007|NCT00795678|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110619008|NCT00795678|Capecitabine|capecitabine|mesh-list
110619009|NCT00795678|Trastuzumab|trastuzumab|mesh-list
110619010|NCT00795678|Lapatinib|lapatinib|mesh-list
110619011|NCT00795678|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110619012|NCT00795678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110619019|NCT00795678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110619020|NCT00795678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110619021|NCT00795678|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110619022|NCT00795678|Alkylating Agents|alkylating agents|mesh-ancestor
110619023|NCT00795678|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110619024|NCT00795678|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110619025|NCT00795678|Antimetabolites|antimetabolites|mesh-ancestor
110619026|NCT00795678|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110619027|NCT00795678|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110619028|NCT00795678|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110619029|NCT00795678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110619030|NCT00795678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110619031|NCT00795678|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110619033|NCT00753038|Carboplatin|carboplatin|mesh-list
110619034|NCT00753038|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110619035|NCT00753038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110619036|NCT00753038|Tubulin Modulators|tubulin modulators|mesh-ancestor
110619037|NCT00753038|Antimitotic Agents|antimitotic agents|mesh-ancestor
110619038|NCT00753038|Mitosis Modulators|mitosis modulators|mesh-ancestor
110619039|NCT00753038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110619040|NCT00795756|Cytarabine|cytarabine|mesh-list
110619041|NCT00795756|Methotrexate|methotrexate|mesh-list
110619042|NCT00795756|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110619043|NCT00795756|Abortifacient Agents|abortifacient agents|mesh-ancestor
110619044|NCT00795756|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110619045|NCT00795756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110619046|NCT00795756|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110619047|NCT00795756|Antimetabolites|antimetabolites|mesh-ancestor
110619048|NCT00795756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110619049|NCT00795756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110619050|NCT00795756|Dermatologic Agents|dermatologic agents|mesh-ancestor
110619051|NCT00795756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110619052|NCT00795756|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110619053|NCT00795756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110619054|NCT00795756|Immunologic Factors|immunologic factors|mesh-ancestor
110619055|NCT00795756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110619056|NCT00795756|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110619057|NCT00795756|Antiviral Agents|antiviral agents|mesh-ancestor
110619058|NCT00795756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110619059|NCT04058522|Triamcinolone|triamcinolone|mesh-list
110292954|NCT00574483|Anthelmintics|anthelmintics|mesh-ancestor
110619060|NCT04058522|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110619061|NCT04058522|Glucocorticoids|glucocorticoids|mesh-ancestor
110619062|NCT04058522|Hormones|hormones|mesh-ancestor
110619063|NCT04058522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110619064|NCT04058522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110619065|NCT00791232|Paliperidone Palmitate|paliperidone palmitate|mesh-list
110619066|NCT00791232|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110619067|NCT00791232|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110619068|NCT00791232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110619069|NCT00791232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110619070|NCT00791232|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110619071|NCT00791232|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110619072|NCT00791232|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110277906|NCT00576550|Hormones|hormones|mesh-ancestor
110619073|NCT00791232|Serotonin Agents|serotonin agents|mesh-ancestor
110619074|NCT00791232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110619075|NCT00791232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110619076|NCT00791232|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110619077|NCT00791232|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110619078|NCT00791232|Dopamine Agents|dopamine agents|mesh-ancestor
110619079|NCT01563952|Sirolimus|sirolimus|mesh-list
110619080|NCT01563952|Umirolimus|umirolimus|mesh-list
110619085|NCT01563952|Antifungal Agents|antifungal agents|mesh-ancestor
110619086|NCT01563952|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110619087|NCT01563952|Immunologic Factors|immunologic factors|mesh-ancestor
110619088|NCT01563952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110619089|NCT01563952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110619090|NCT00795912|Atorvastatin|atorvastatin|mesh-list
110619091|NCT00795912|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110619092|NCT00795912|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110619093|NCT00795912|Antimetabolites|antimetabolites|mesh-ancestor
110619094|NCT00795912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110619095|NCT00795912|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110619096|NCT00795912|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110619097|NCT00795912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110619098|NCT00788034|Vortioxetine|vortioxetine|mesh-list
110619099|NCT00788034|Antidepressive Agents|antidepressive agents|mesh-ancestor
110619100|NCT00788034|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110619101|NCT00788034|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110619102|NCT00788034|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110619103|NCT00788034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110619104|NCT00788034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110619105|NCT00788034|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110619106|NCT00788034|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110619107|NCT00788034|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110619108|NCT00788034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110619109|NCT00788034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110619110|NCT00788034|Serotonin Agents|serotonin agents|mesh-ancestor
110619111|NCT00788034|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110619112|NCT00788034|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110619113|NCT00788034|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110619114|NCT00788034|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110619115|NCT04004884|Ulipristal acetate|ulipristal acetate|mesh-list
110619116|NCT04004884|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110153674|NCT00001014|Leucovorin|leucovorin|mesh-list
110619119|NCT04004884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110619120|NCT04004884|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110619121|NCT00688064|Doxycycline|doxycycline|mesh-list
110619122|NCT00688064|Adapalene|adapalene|mesh-list
110619123|NCT00688064|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110619124|NCT00688064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110619125|NCT00688064|Antimalarials|antimalarials|mesh-ancestor
110619126|NCT00688064|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110619127|NCT00688064|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110619128|NCT00688064|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110619129|NCT00688064|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110619130|NCT00688064|Analgesics|analgesics|mesh-ancestor
110619131|NCT00688064|Sensory System Agents|sensory system agents|mesh-ancestor
110619132|NCT00688064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110619133|NCT00688064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110619134|NCT00688064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110619135|NCT00688064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110619137|NCT00788112|Vorinostat|vorinostat|mesh-list
110619138|NCT00788112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110619139|NCT00788112|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110619140|NCT00788112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110619141|NCT00788112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110619144|NCT00749918|Vitamin D|vitamin d|mesh-list
110619145|NCT00749918|Cholecalciferol|cholecalciferol|mesh-list
110619146|NCT00749918|Vitamins|vitamins|mesh-ancestor
110619147|NCT00749918|Micronutrients|micronutrients|mesh-ancestor
110266421|NCT00182871|Testosterone|testosterone|mesh-list
110619148|NCT00749918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110619149|NCT00749918|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110619150|NCT00749918|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110619151|NCT04058132|Sildenafil Citrate|sildenafil citrate|mesh-list
110619152|NCT04058132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110619157|NCT04058132|Urological Agents|urological agents|mesh-ancestor
110619158|NCT00791544|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110619160|NCT00791544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110619161|NCT00791544|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110619162|NCT00791544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110619163|NCT00791544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110619164|NCT05171686|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110619165|NCT05171686|Chlorthalidone|chlorthalidone|mesh-list
110619166|NCT05171686|Torsemide|torsemide|mesh-list
110619167|NCT05171686|Furosemide|furosemide|mesh-list
110619168|NCT05171686|Bumetanide|bumetanide|mesh-list
110619169|NCT05171686|Diuretics|diuretics|mesh-list
110619170|NCT05171686|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110619171|NCT05171686|Natriuretic Agents|natriuretic agents|mesh-ancestor
110619172|NCT05171686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110619173|NCT05171686|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110619174|NCT05171686|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110619175|NCT05171686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110619176|NCT05171686|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110619177|NCT00990028|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110619178|NCT00990028|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110619179|NCT00990028|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110619180|NCT00990028|Antimetabolites|antimetabolites|mesh-ancestor
110619181|NCT00990028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110619182|NCT00990028|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110619183|NCT00990028|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110619184|NCT00990028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110619186|NCT00663234|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110619187|NCT00663234|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110619188|NCT00663234|Antimetabolites|antimetabolites|mesh-ancestor
110619189|NCT00663234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110619190|NCT00663234|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110619191|NCT00663234|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110619192|NCT00663234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110619193|NCT00683384|Etanercept|etanercept|mesh-list
110619194|NCT00683384|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110619195|NCT00683384|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110619196|NCT00683384|Analgesics|analgesics|mesh-ancestor
110619197|NCT00683384|Sensory System Agents|sensory system agents|mesh-ancestor
110619198|NCT00683384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110619199|NCT00683384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110619200|NCT00683384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110619201|NCT00683384|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110619202|NCT00683384|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110619203|NCT00683384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110619204|NCT00683384|Immunologic Factors|immunologic factors|mesh-ancestor
110619205|NCT00753740|Camptothecin|camptothecin|mesh-list
110619206|NCT00753740|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110619207|NCT00753740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110619208|NCT00753740|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110619209|NCT00753740|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110619210|NCT00753740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110619211|NCT00753740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110619212|NCT00326911|Bevacizumab|bevacizumab|mesh-list
110619213|NCT00326911|Cetuximab|cetuximab|mesh-list
110619214|NCT00326911|Gemcitabine|gemcitabine|mesh-list
110619215|NCT00326911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110619216|NCT00326911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110619217|NCT00326911|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110619218|NCT00326911|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110619219|NCT00326911|Growth Substances|growth substances|mesh-ancestor
110619220|NCT00326911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110619221|NCT00326911|Growth Inhibitors|growth inhibitors|mesh-ancestor
110619222|NCT00326911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110619223|NCT00326911|Antimetabolites|antimetabolites|mesh-ancestor
110619230|NCT00791622|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110619231|NCT00791622|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110619232|NCT00791622|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110619233|NCT00791622|Serotonin Agents|serotonin agents|mesh-ancestor
110619234|NCT00791622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110619235|NCT00791622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110619236|NCT00791622|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110619237|NCT00791622|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110619238|NCT00791622|Dopamine Agents|dopamine agents|mesh-ancestor
110619240|NCT00747110|Mesalamine|mesalamine|mesh-list
110619241|NCT00747110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110619242|NCT00747110|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110619243|NCT00747110|Autonomic Agents|autonomic agents|mesh-ancestor
110619244|NCT00747110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110619245|NCT00747110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110619246|NCT00747110|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110619247|NCT00747110|Respiratory System Agents|respiratory system agents|mesh-ancestor
110619248|NCT00747110|Glucocorticoids|glucocorticoids|mesh-ancestor
110619250|NCT00747110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110619251|NCT00747110|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110619252|NCT00747110|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110619253|NCT00747110|Analgesics|analgesics|mesh-ancestor
110619254|NCT00747110|Sensory System Agents|sensory system agents|mesh-ancestor
110619255|NCT00747110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110619256|NCT00796458|Docetaxel|docetaxel|mesh-list
110619257|NCT00796458|Hormones|hormones|mesh-list
110619258|NCT00796458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110619259|NCT00796458|Tubulin Modulators|tubulin modulators|mesh-ancestor
110619260|NCT00796458|Antimitotic Agents|antimitotic agents|mesh-ancestor
110619261|NCT00796458|Mitosis Modulators|mitosis modulators|mesh-ancestor
110619262|NCT00796458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110619263|NCT00796458|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110619264|NCT00796458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110619265|NCT04046016|Paclitaxel|paclitaxel|mesh-list
110619266|NCT04046016|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110619267|NCT04046016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110619269|NCT04046016|Antimitotic Agents|antimitotic agents|mesh-ancestor
110619270|NCT04046016|Mitosis Modulators|mitosis modulators|mesh-ancestor
110619271|NCT04046016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110619272|NCT01057615|Ascorbic Acid|ascorbic acid|mesh-list
110619273|NCT01057615|Vitamins|vitamins|mesh-ancestor
110293529|NCT00227474|Vaccines|vaccines|mesh-list
110619274|NCT01057615|Micronutrients|micronutrients|mesh-ancestor
110619275|NCT01057615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110619276|NCT01057615|Antioxidants|antioxidants|mesh-ancestor
110619277|NCT01057615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110619278|NCT01057615|Protective Agents|protective agents|mesh-ancestor
110619279|NCT00788424|Ammonium trichloro(dioxoethylene-O,O'-)tellurate|ammonium trichloro(dioxoethylene-o,o'-)tellurate|mesh-list
110619280|NCT00788424|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110619281|NCT00788424|Immunologic Factors|immunologic factors|mesh-ancestor
110619282|NCT00788424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110619283|NCT00788424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110619284|NCT00788424|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110619285|NCT00788424|Protective Agents|protective agents|mesh-ancestor
110619286|NCT00788424|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110293559|NCT00235794|Temsirolimus|temsirolimus|mesh-list
110619287|NCT00788424|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110619288|NCT00788424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110619289|NCT00788424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110619312|NCT00540436|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110619313|NCT00788580|Sirolimus|sirolimus|mesh-list
110619314|NCT00788580|Temsirolimus|temsirolimus|mesh-list
110619315|NCT00788580|MTOR Inhibitors|mtor inhibitors|mesh-list
110619316|NCT00788580|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110619317|NCT00788580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110619318|NCT00788580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110619319|NCT00788580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110619320|NCT00788580|Immunologic Factors|immunologic factors|mesh-ancestor
110619321|NCT00788580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110619322|NCT00788580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110619323|NCT00788580|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110619324|NCT00788580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110619325|NCT00788580|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110619326|NCT00788580|Antifungal Agents|antifungal agents|mesh-ancestor
110619327|NCT00792012|Temozolomide|temozolomide|mesh-list
110619328|NCT00792012|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110619329|NCT00792012|Alkylating Agents|alkylating agents|mesh-ancestor
110619330|NCT00792012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110619331|NCT00792012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110619333|NCT00990418|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110619334|NCT00990418|Narcotics|narcotics|mesh-ancestor
110619335|NCT00990418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110619336|NCT00990418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110619337|NCT00990418|Analgesics|analgesics|mesh-ancestor
110619338|NCT00990418|Sensory System Agents|sensory system agents|mesh-ancestor
110619339|NCT00990418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110619340|NCT00990418|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110619341|NCT00990418|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110619342|NCT00990418|Anesthetics, General|anesthetics, general|mesh-ancestor
110619343|NCT00990418|Anesthetics|anesthetics|mesh-ancestor
110619354|NCT02562950|Anesthetics|anesthetics|mesh-ancestor
110619355|NCT02562950|GABA Modulators|gaba modulators|mesh-ancestor
110619356|NCT02562950|GABA Agents|gaba agents|mesh-ancestor
110619357|NCT02562950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110619358|NCT02562950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110293656|NCT00227981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110619359|NCT00792168|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
110619360|NCT00792168|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110619361|NCT00792168|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110619362|NCT00792168|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110619363|NCT00792168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110619364|NCT00792168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110619365|NCT00792168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110619366|NCT00792168|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110619367|NCT00792168|Antidepressive Agents|antidepressive agents|mesh-ancestor
110266647|NCT00158561|Pyrimethamine|pyrimethamine|mesh-list
110619368|NCT00792168|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110619369|NCT00687440|Docetaxel|docetaxel|mesh-list
110619370|NCT00687440|Doxorubicin|doxorubicin|mesh-list
110619371|NCT00687440|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110619372|NCT00687440|Trastuzumab|trastuzumab|mesh-list
110619373|NCT00687440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110619374|NCT00687440|Tubulin Modulators|tubulin modulators|mesh-ancestor
110619375|NCT00687440|Antimitotic Agents|antimitotic agents|mesh-ancestor
110619376|NCT00687440|Mitosis Modulators|mitosis modulators|mesh-ancestor
110619377|NCT00687440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110619378|NCT00687440|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110619379|NCT00687440|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110619380|NCT00687440|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110619381|NCT00687440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110619382|NCT00687440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110619383|NCT02554734|Levodopa|levodopa|mesh-list
110619384|NCT02554734|Carbidopa|carbidopa|mesh-list
110619385|NCT02554734|Entacapone|entacapone|mesh-list
110619386|NCT02554734|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110619387|NCT02554734|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110619388|NCT02554734|Dopamine Agents|dopamine agents|mesh-ancestor
110619389|NCT02554734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110619390|NCT02554734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110293797|NCT00193063|Gemcitabine|gemcitabine|mesh-list
110619391|NCT02554734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110619392|NCT02554734|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
110619393|NCT02554734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110619394|NCT02554734|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
110619395|NCT00990496|Cyclophosphamide|cyclophosphamide|mesh-list
110619396|NCT00990496|Fludarabine|fludarabine|mesh-list
110619397|NCT00990496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110619398|NCT00990496|Immunologic Factors|immunologic factors|mesh-ancestor
110619399|NCT00990496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110619400|NCT00990496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110619401|NCT00990496|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110619402|NCT00990496|Alkylating Agents|alkylating agents|mesh-ancestor
110619403|NCT00990496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110619404|NCT00990496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110619405|NCT00990496|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110619406|NCT00754910|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
110619407|NCT00754910|Trioxsalen|trioxsalen|mesh-list
110619426|NCT00659490|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110619427|NCT00659490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110619428|NCT00659490|Analgesics|analgesics|mesh-ancestor
110619429|NCT00659490|Sensory System Agents|sensory system agents|mesh-ancestor
110619430|NCT00659490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110619431|NCT00659490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110619432|NCT00659490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110619433|NCT00659490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110619434|NCT00659490|Gout Suppressants|gout suppressants|mesh-ancestor
110619435|NCT00659490|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110619436|NCT00659490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110619437|NCT00659490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110619438|NCT00792246|Voriconazole|voriconazole|mesh-list
110619439|NCT00792246|Antifungal Agents|antifungal agents|mesh-ancestor
110619440|NCT00792246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110293881|NCT00229112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110619441|NCT00792246|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110619442|NCT00792246|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110619443|NCT00792246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110616621|NCT00909129|Interferons|interferons|mesh-list
110619444|NCT00792246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110619445|NCT00792246|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110619446|NCT00792246|Hormone Antagonists|hormone antagonists|mesh-ancestor
110619447|NCT00792246|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110619448|NCT00792246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110619449|NCT00792246|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110619451|NCT00539500|Etoposide|etoposide|mesh-list
110619452|NCT00539500|Melphalan|melphalan|mesh-list
110619453|NCT00539500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110619454|NCT00539500|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110619455|NCT00539500|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110619456|NCT00539500|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110619457|NCT00539500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110619458|NCT00539500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110619459|NCT00539500|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110619460|NCT00539500|Alkylating Agents|alkylating agents|mesh-ancestor
110619461|NCT00539500|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110619462|NCT00539500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110619463|NCT00539500|Immunologic Factors|immunologic factors|mesh-ancestor
110391904|NCT00709865|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110619488|NCT00990808|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110619489|NCT00990808|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110619490|NCT00990808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110619491|NCT00797160|Propofol|propofol|mesh-list
110619492|NCT00797160|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110619493|NCT00797160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110619494|NCT00797160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110619495|NCT00797160|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110293996|NCT00236301|Estradiol|estradiol|mesh-list
110619496|NCT00797160|Anesthetics, General|anesthetics, general|mesh-ancestor
110619498|NCT00682448|Metformin|metformin|mesh-list
110619499|NCT00682448|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110619500|NCT00682448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110619501|NCT04003792|Bevacizumab|bevacizumab|mesh-list
110619502|NCT04003792|Oxaliplatin|oxaliplatin|mesh-list
110619503|NCT04003792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110619504|NCT04003792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110619505|NCT04003792|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110619506|NCT04003792|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110619507|NCT04003792|Growth Substances|growth substances|mesh-ancestor
110619508|NCT04003792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110619509|NCT04003792|Growth Inhibitors|growth inhibitors|mesh-ancestor
110619510|NCT00990886|Oxybutynin|oxybutynin|mesh-list
110619511|NCT00990886|Parasympatholytics|parasympatholytics|mesh-ancestor
110619512|NCT00990886|Autonomic Agents|autonomic agents|mesh-ancestor
110619513|NCT00990886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110391916|NCT00626990|Alkylating Agents|alkylating agents|mesh-ancestor
110619524|NCT00681824|Thrombin|thrombin|mesh-list
110619525|NCT00681824|Aprotinin|aprotinin|mesh-list
110619526|NCT00681824|Hemostatics|hemostatics|mesh-ancestor
110619527|NCT00681824|Coagulants|coagulants|mesh-ancestor
110619528|NCT00681824|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
110619529|NCT00681824|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110619530|NCT00681824|Protease Inhibitors|protease inhibitors|mesh-ancestor
110619531|NCT00681824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110619532|NCT00681824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110619533|NCT00797472|Bleomycin|bleomycin|mesh-list
110619534|NCT00797472|Dacarbazine|dacarbazine|mesh-list
110619535|NCT00797472|Vinblastine|vinblastine|mesh-list
110619536|NCT00797472|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110619537|NCT00797472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110619538|NCT00797472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110619539|NCT00797472|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110619540|NCT00797472|Alkylating Agents|alkylating agents|mesh-ancestor
110619541|NCT00797472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110619542|NCT00797472|Tubulin Modulators|tubulin modulators|mesh-ancestor
110619543|NCT00797472|Antimitotic Agents|antimitotic agents|mesh-ancestor
110619544|NCT00797472|Mitosis Modulators|mitosis modulators|mesh-ancestor
110619545|NCT00681668|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110619546|NCT00681668|Antidepressive Agents|antidepressive agents|mesh-ancestor
110619547|NCT00681668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110619548|NCT00681668|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110619549|NCT00681668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110619550|NCT00681668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110619551|NCT00681668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110619552|NCT00539188|Acetylcysteine|acetylcysteine|mesh-list
110619553|NCT00539188|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110619554|NCT00539188|Antiviral Agents|antiviral agents|mesh-ancestor
110619555|NCT00539188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110619556|NCT00539188|Expectorants|expectorants|mesh-ancestor
110619557|NCT00539188|Respiratory System Agents|respiratory system agents|mesh-ancestor
110619558|NCT00539188|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110619559|NCT00539188|Antioxidants|antioxidants|mesh-ancestor
110616706|NCT00927771|Hydroquinone|hydroquinone|mesh-list
110619560|NCT00539188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110619561|NCT00539188|Protective Agents|protective agents|mesh-ancestor
110619562|NCT00539188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110619563|NCT00539188|Antidotes|antidotes|mesh-ancestor
110619565|NCT00681590|Ergocalciferols|ergocalciferols|mesh-list
110619566|NCT00681590|Cholecalciferol|cholecalciferol|mesh-list
110619567|NCT00681590|Vitamins|vitamins|mesh-list
110619568|NCT00681590|Micronutrients|micronutrients|mesh-ancestor
110619569|NCT00681590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110619570|NCT00681590|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110619571|NCT00681590|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110619572|NCT05359432|Empagliflozin|empagliflozin|mesh-list
110619573|NCT05359432|Vildagliptin|vildagliptin|mesh-list
110619574|NCT05359432|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110619575|NCT05359432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110619576|NCT05359432|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110619577|NCT05359432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110619578|NCT05359432|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110619579|NCT05359432|Protease Inhibitors|protease inhibitors|mesh-ancestor
110619580|NCT05359432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110619586|NCT00755534|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110619587|NCT00755534|Antimetabolites|antimetabolites|mesh-ancestor
110619588|NCT00755534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110619589|NCT00755534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110294116|NCT00193219|Growth Substances|growth substances|mesh-ancestor
110619590|NCT00755534|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110619591|NCT00755534|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110619592|NCT00755534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110619593|NCT00755534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110619594|NCT00326599|Carboplatin|carboplatin|mesh-list
110619596|NCT00326599|Cediranib|cediranib|mesh-list
110619597|NCT00326599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110619598|NCT00326599|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110619599|NCT00326599|Antimetabolites|antimetabolites|mesh-ancestor
110619600|NCT00326599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110619601|NCT00326599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110619602|NCT00326599|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110619603|NCT05004688|BCG Vaccine|bcg vaccine|mesh-list
110619604|NCT05004688|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110619605|NCT05004688|Immunologic Factors|immunologic factors|mesh-ancestor
110619606|NCT05004688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110619607|NCT00750386|Paclitaxel|paclitaxel|mesh-list
110619608|NCT00750386|Carboplatin|carboplatin|mesh-list
110619609|NCT00750386|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110278142|NCT00187122|Glucocorticoids|glucocorticoids|mesh-ancestor
110619610|NCT00750386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110619611|NCT00750386|Tubulin Modulators|tubulin modulators|mesh-ancestor
110619612|NCT00750386|Antimitotic Agents|antimitotic agents|mesh-ancestor
110619613|NCT00750386|Mitosis Modulators|mitosis modulators|mesh-ancestor
110619614|NCT00750386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110619615|NCT00539032|Vaccines|vaccines|mesh-list
110619616|NCT00539032|Immunologic Factors|immunologic factors|mesh-ancestor
110619617|NCT00539032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110619618|NCT00685802|Cilostazol|cilostazol|mesh-list
110619619|NCT00685802|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110619620|NCT00685802|Autonomic Agents|autonomic agents|mesh-ancestor
110619621|NCT00685802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110619622|NCT00685802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110619623|NCT00685802|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110619624|NCT00685802|Respiratory System Agents|respiratory system agents|mesh-ancestor
110619625|NCT00685802|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110619626|NCT00685802|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110153770|NCT00001032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110619627|NCT00685802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110619628|NCT00685802|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110619629|NCT00685802|Vasodilator Agents|vasodilator agents|mesh-ancestor
110619630|NCT00685802|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110619631|NCT00685802|Protective Agents|protective agents|mesh-ancestor
110619632|NCT00685802|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110619633|NCT00685802|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110619634|NCT00685802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110619635|NCT01054651|Artesunate|artesunate|mesh-list
110619636|NCT01054651|Pyrimethamine|pyrimethamine|mesh-list
110619637|NCT01054651|Sulfalene|sulfalene|mesh-list
110619638|NCT01054651|Praziquantel|praziquantel|mesh-list
110619639|NCT01054651|Antimalarials|antimalarials|mesh-ancestor
110619640|NCT01054651|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110619641|NCT01054651|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110619642|NCT01054651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110619643|NCT01054651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110619644|NCT01054651|Antiviral Agents|antiviral agents|mesh-ancestor
110619645|NCT01054651|Schistosomicides|schistosomicides|mesh-ancestor
110619646|NCT01054651|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110619647|NCT01054651|Anthelmintics|anthelmintics|mesh-ancestor
110619648|NCT01054651|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110619649|NCT01054651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110619650|NCT01054651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110619651|NCT01054651|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110619652|NCT00792714|Mannitol|mannitol|mesh-list
110619653|NCT00792714|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110619662|NCT00354601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110619664|NCT00354601|Antimitotic Agents|antimitotic agents|mesh-ancestor
110619665|NCT00354601|Mitosis Modulators|mitosis modulators|mesh-ancestor
110619666|NCT00354601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110619667|NCT00354601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110619668|NCT00354601|Antimetabolites|antimetabolites|mesh-ancestor
110619669|NCT01563640|Permethrin|permethrin|mesh-list
110619670|NCT01563640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110266950|NCT00538876|Decitabine|decitabine|mesh-list
110619671|NCT01563640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110619672|NCT00750620|Mirabegron|mirabegron|mesh-list
110619673|NCT00750620|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
110619674|NCT00750620|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110619675|NCT00750620|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110619676|NCT00750620|Adrenergic Agents|adrenergic agents|mesh-ancestor
110619677|NCT00750620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110619678|NCT00750620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110619679|NCT00750620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110619680|NCT00750620|Urological Agents|urological agents|mesh-ancestor
110619681|NCT03827473|Ascorbic Acid|ascorbic acid|mesh-list
110619682|NCT03827473|Prednisone|prednisone|mesh-list
110619683|NCT03827473|Cortisone|cortisone|mesh-list
110619684|NCT03827473|Docetaxel|docetaxel|mesh-list
110619685|NCT03827473|Abiraterone Acetate|abiraterone acetate|mesh-list
110619686|NCT03827473|Methyltestosterone|methyltestosterone|mesh-list
110619687|NCT03827473|Hormones|hormones|mesh-list
110619688|NCT03827473|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
110619689|NCT03827473|Androgens|androgens|mesh-list
110619690|NCT03827473|Androgen Antagonists|androgen antagonists|mesh-list
110619691|NCT03827473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110619692|NCT03827473|Tubulin Modulators|tubulin modulators|mesh-ancestor
110619693|NCT03827473|Antimitotic Agents|antimitotic agents|mesh-ancestor
110619694|NCT03827473|Mitosis Modulators|mitosis modulators|mesh-ancestor
110619695|NCT03827473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110619696|NCT03827473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110619697|NCT03827473|Glucocorticoids|glucocorticoids|mesh-ancestor
110153774|NCT00005837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110619698|NCT03827473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110619699|NCT03827473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110619700|NCT03827473|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110619701|NCT03827473|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110619702|NCT03827473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110619703|NCT03827473|Hormone Antagonists|hormone antagonists|mesh-ancestor
110619704|NCT03827473|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110619706|NCT03827473|Protective Agents|protective agents|mesh-ancestor
110619707|NCT03827473|Vitamins|vitamins|mesh-ancestor
110619708|NCT03827473|Micronutrients|micronutrients|mesh-ancestor
110619709|NCT03827473|Estrogens|estrogens|mesh-ancestor
110619710|NCT03827473|Anabolic Agents|anabolic agents|mesh-ancestor
110619711|NCT00800592|Sildenafil Citrate|sildenafil citrate|mesh-list
110619712|NCT00800592|Vasodilator Agents|vasodilator agents|mesh-ancestor
110619713|NCT00800592|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110619714|NCT00800592|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110619715|NCT00800592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110619716|NCT00800592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110619717|NCT00800592|Urological Agents|urological agents|mesh-ancestor
110619718|NCT00797784|Etanercept|etanercept|mesh-list
110619719|NCT00797784|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110619720|NCT00797784|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110619727|NCT00797784|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110619728|NCT00797784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110619729|NCT00797784|Immunologic Factors|immunologic factors|mesh-ancestor
110619730|NCT00747968|Exenatide|exenatide|mesh-list
110619731|NCT00747968|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110619732|NCT00747968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110619733|NCT00747968|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110619734|NCT00747968|Incretins|incretins|mesh-ancestor
110619735|NCT00747968|Hormones|hormones|mesh-ancestor
110619736|NCT00747968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110619737|NCT00755924|Acetic Acid|acetic acid|mesh-list
110619738|NCT00755924|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110619739|NCT00755924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110619740|NCT00800748|Ribavirin|ribavirin|mesh-list
110619741|NCT00800748|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110619742|NCT00800748|Antimetabolites|antimetabolites|mesh-ancestor
110619743|NCT00800748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110619744|NCT00800748|Antiviral Agents|antiviral agents|mesh-ancestor
110619745|NCT00800748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110619746|NCT00798252|Paclitaxel|paclitaxel|mesh-list
110619747|NCT00798252|Docetaxel|docetaxel|mesh-list
110619748|NCT00798252|Doxorubicin|doxorubicin|mesh-list
110619749|NCT00798252|Capecitabine|capecitabine|mesh-list
110619750|NCT00798252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110619751|NCT00798252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110619752|NCT00798252|Tubulin Modulators|tubulin modulators|mesh-ancestor
110619753|NCT00798252|Antimitotic Agents|antimitotic agents|mesh-ancestor
110619754|NCT00798252|Mitosis Modulators|mitosis modulators|mesh-ancestor
110619755|NCT00798252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110619756|NCT00798252|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110619757|NCT00798252|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110619758|NCT00798252|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110619759|NCT00798252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110619760|NCT00798252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110619761|NCT00798252|Antimetabolites|antimetabolites|mesh-ancestor
110619762|NCT00748046|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
110619763|NCT00748046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110619764|NCT00326209|Mesalamine|mesalamine|mesh-list
110619765|NCT00326209|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110619766|NCT00326209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110619767|NCT00326209|Analgesics|analgesics|mesh-ancestor
110619768|NCT00326209|Sensory System Agents|sensory system agents|mesh-ancestor
110153780|NCT00005840|Cisplatin|cisplatin|mesh-list
110619769|NCT00326209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110619770|NCT00326209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110619772|NCT00326209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110619773|NCT00537940|Pregabalin|pregabalin|mesh-list
110619774|NCT00537940|Gabapentin|gabapentin|mesh-list
110619775|NCT00537940|Analgesics|analgesics|mesh-ancestor
110619776|NCT00537940|Sensory System Agents|sensory system agents|mesh-ancestor
110616948|NCT03986905|Antiemetics|antiemetics|mesh-ancestor
110619777|NCT00537940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110619778|NCT00537940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110619780|NCT00537940|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110619781|NCT00537940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110619782|NCT00537940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110619783|NCT00537940|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110619784|NCT00537940|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110619785|NCT00537940|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110619786|NCT00537940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110619787|NCT00537940|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110619788|NCT00537940|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110619789|NCT00537940|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110619790|NCT00537940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110619803|NCT00748202|Complement C1s|complement c1s|mesh-list
110619804|NCT00748202|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
110619805|NCT00748202|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
110619806|NCT00748202|Immunologic Factors|immunologic factors|mesh-ancestor
110619807|NCT00748202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110619808|NCT00748202|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
110619809|NCT00748202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110619810|NCT00325897|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110619811|NCT00325897|Azithromycin|azithromycin|mesh-list
110619812|NCT00325897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110619813|NCT00800826|Dexmedetomidine|dexmedetomidine|mesh-list
110619814|NCT00800826|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110619815|NCT00800826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110619816|NCT00800826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110619817|NCT00800826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110619818|NCT00800826|Analgesics|analgesics|mesh-ancestor
110619819|NCT00800826|Sensory System Agents|sensory system agents|mesh-ancestor
110619820|NCT00800826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110619821|NCT00800826|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110619822|NCT00800826|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110619823|NCT00800826|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110619824|NCT00800826|Adrenergic Agents|adrenergic agents|mesh-ancestor
110619825|NCT00800826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110619826|NCT00800826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110619827|NCT03989089|Pembrolizumab|pembrolizumab|mesh-list
110619828|NCT03989089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110619829|NCT03989089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110619830|NCT03989089|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110619831|NCT03989089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110619832|NCT00793338|Sildenafil Citrate|sildenafil citrate|mesh-list
110619833|NCT00793338|Vasodilator Agents|vasodilator agents|mesh-ancestor
110619834|NCT00793338|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110619835|NCT00793338|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110619836|NCT00793338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110153787|NCT00005843|Tipifarnib|tipifarnib|mesh-list
110619837|NCT00793338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110619838|NCT00793338|Urological Agents|urological agents|mesh-ancestor
110619839|NCT05406856|Cisplatin|cisplatin|mesh-list
110619840|NCT05406856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110619841|NCT00344773|Gefitinib|gefitinib|mesh-list
110619842|NCT00344773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110278261|NCT00180791|Carboplatin|carboplatin|mesh-list
110619843|NCT00344773|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110619844|NCT00344773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110619845|NCT00344773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110619846|NCT02554344|Curcumin|curcumin|mesh-list
110619847|NCT02554344|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110619848|NCT02554344|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110619849|NCT02554344|Analgesics|analgesics|mesh-ancestor
110619850|NCT02554344|Sensory System Agents|sensory system agents|mesh-ancestor
110619851|NCT02554344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110619863|NCT01055041|Autonomic Agents|autonomic agents|mesh-ancestor
110619864|NCT01055041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110619865|NCT01055041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110619866|NCT01055041|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110619867|NCT01055041|Respiratory System Agents|respiratory system agents|mesh-ancestor
110619868|NCT01055041|Glucocorticoids|glucocorticoids|mesh-ancestor
110619869|NCT01055041|Hormones|hormones|mesh-ancestor
110619870|NCT01055041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110619871|NCT01055041|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110619873|NCT01055041|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110619874|NCT01055041|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110619875|NCT01055041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110619876|NCT01055041|Antitussive Agents|antitussive agents|mesh-ancestor
110619877|NCT01055041|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110619878|NCT01055041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110619879|NCT00325819|Acetaminophen|acetaminophen|mesh-list
110619880|NCT00325819|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110619881|NCT00325819|Analgesics|analgesics|mesh-ancestor
110619882|NCT00325819|Sensory System Agents|sensory system agents|mesh-ancestor
110619883|NCT00325819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110619884|NCT00325819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110619885|NCT00325819|Antipyretics|antipyretics|mesh-ancestor
110619886|NCT00748358|Sunitinib|sunitinib|mesh-list
110619887|NCT00748358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110619888|NCT00748358|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110619889|NCT00748358|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110619890|NCT00748358|Growth Substances|growth substances|mesh-ancestor
110619891|NCT00748358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110619892|NCT00748358|Growth Inhibitors|growth inhibitors|mesh-ancestor
110619893|NCT00748358|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110619894|NCT00748358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110619895|NCT00748358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110267173|NCT00159458|Oxaliplatin|oxaliplatin|mesh-list
110619896|NCT00748436|Betahistine|betahistine|mesh-list
110619897|NCT00748436|Vasodilator Agents|vasodilator agents|mesh-ancestor
110619898|NCT00748436|Histamine Agonists|histamine agonists|mesh-ancestor
110619899|NCT00748436|Histamine Agents|histamine agents|mesh-ancestor
110619900|NCT00748436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110294720|NCT00201695|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110294721|NCT00201695|Antiemetics|antiemetics|mesh-ancestor
110619901|NCT00748436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110619902|NCT00748436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110619904|NCT00756860|Chelating Agents|chelating agents|mesh-ancestor
110619905|NCT00756860|Sequestering Agents|sequestering agents|mesh-ancestor
110619906|NCT00756860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110619907|NCT00757016|Triamcinolone|triamcinolone|mesh-list
110619908|NCT00757016|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110619909|NCT00757016|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110619910|NCT00757016|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110619911|NCT00757016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110619912|NCT00757016|Glucocorticoids|glucocorticoids|mesh-ancestor
110619913|NCT00757016|Hormones|hormones|mesh-ancestor
110619914|NCT00757016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110391979|NCT04488237|Vitamins|vitamins|mesh-ancestor
110619928|NCT00757250|Vasodilator Agents|vasodilator agents|mesh-ancestor
110619929|NCT00751478|Naltrexone|naltrexone|mesh-list
110619930|NCT00751478|Morphine|morphine|mesh-list
110619931|NCT00751478|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110619932|NCT00751478|Narcotics|narcotics|mesh-ancestor
110619933|NCT00751478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110619934|NCT00751478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110619935|NCT00751478|Analgesics|analgesics|mesh-ancestor
110619936|NCT00751478|Sensory System Agents|sensory system agents|mesh-ancestor
110619937|NCT00751478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110619938|NCT00751478|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110619939|NCT00751478|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110619940|NCT00751556|Naproxen|naproxen|mesh-list
110619941|NCT00751556|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110619942|NCT00751556|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110619943|NCT00751556|Analgesics|analgesics|mesh-ancestor
110619944|NCT00751556|Sensory System Agents|sensory system agents|mesh-ancestor
110619945|NCT00751556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110619946|NCT00751556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110619947|NCT00751556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110619948|NCT00751556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110619949|NCT00751556|Gout Suppressants|gout suppressants|mesh-ancestor
110619950|NCT00751556|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110619951|NCT00751556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110294812|NCT00201812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110619952|NCT00751556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110619953|NCT00685334|Olanzapine|olanzapine|mesh-list
110619954|NCT00685334|Aripiprazole|aripiprazole|mesh-list
110619955|NCT00685334|Antiemetics|antiemetics|mesh-ancestor
110619956|NCT00685334|Autonomic Agents|autonomic agents|mesh-ancestor
110619957|NCT00685334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110619958|NCT00685334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110619959|NCT00685334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110619960|NCT00685334|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110619961|NCT00685334|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110619962|NCT00685334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110619963|NCT00685334|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110619964|NCT00685334|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110619965|NCT00685334|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110619966|NCT00685334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110619967|NCT00685334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110619968|NCT00685334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110619969|NCT00685334|Serotonin Agents|serotonin agents|mesh-ancestor
110294868|NCT00202007|Serotonin Agents|serotonin agents|mesh-ancestor
110619970|NCT00685334|Antidepressive Agents|antidepressive agents|mesh-ancestor
110619971|NCT00685334|Dopamine Agonists|dopamine agonists|mesh-ancestor
110619972|NCT00685334|Dopamine Agents|dopamine agents|mesh-ancestor
110619973|NCT00685334|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110619974|NCT00685334|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110619975|NCT00685334|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110619976|NCT00685334|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110619996|NCT00344461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110619997|NCT00344461|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110619998|NCT00344461|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110619999|NCT00344461|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110294913|NCT00266058|Antimalarials|antimalarials|mesh-ancestor
110620000|NCT00344461|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110620002|NCT00685178|Anticonvulsants|anticonvulsants|mesh-ancestor
110620003|NCT00685178|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110620004|NCT00685178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110620005|NCT00537394|Raltegravir Potassium|raltegravir potassium|mesh-list
110620006|NCT00537394|Maraviroc|maraviroc|mesh-list
110620007|NCT00537394|Darunavir|darunavir|mesh-list
110620008|NCT00537394|Tipranavir|tipranavir|mesh-list
110620009|NCT00537394|Enfuvirtide|enfuvirtide|mesh-list
110620010|NCT00537394|Etravirine|etravirine|mesh-list
110620011|NCT00537394|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110620012|NCT00537394|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110294964|NCT00266136|Antiviral Agents|antiviral agents|mesh-ancestor
110620013|NCT00537394|Antiviral Agents|antiviral agents|mesh-ancestor
110620014|NCT00537394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110620015|NCT00537394|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110620016|NCT00537394|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110620017|NCT00537394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110620018|NCT00537394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110620019|NCT00537394|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110620020|NCT00537394|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110620021|NCT00537394|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
110620022|NCT00537394|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110620023|NCT00537394|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110620024|NCT00537394|Protease Inhibitors|protease inhibitors|mesh-ancestor
110620025|NCT00537394|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110620026|NCT00537394|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110620027|NCT00933309|Metformin|metformin|mesh-list
110620028|NCT00933309|Rosiglitazone|rosiglitazone|mesh-list
110620029|NCT00933309|Exemestane|exemestane|mesh-list
110620030|NCT00933309|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110620031|NCT00933309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110620032|NCT00933309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110617243|NCT05386576|Venetoclax|venetoclax|mesh-list
110620033|NCT00933309|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110620034|NCT00933309|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110620035|NCT00933309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110620057|NCT00660660|Esomeprazole|esomeprazole|mesh-list
110620058|NCT00660660|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110620059|NCT00660660|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110620060|NCT00660660|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110620061|NCT00660660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110620062|NCT00660660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110620063|NCT02560766|Gabapentin|gabapentin|mesh-list
110620064|NCT02560766|Analgesics|analgesics|mesh-ancestor
110295059|NCT00478777|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110620065|NCT02560766|Sensory System Agents|sensory system agents|mesh-ancestor
110620066|NCT02560766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110620067|NCT02560766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110620068|NCT02560766|Anticonvulsants|anticonvulsants|mesh-ancestor
110620069|NCT02560766|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110620070|NCT02560766|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110620071|NCT02560766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110620072|NCT02560766|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110620073|NCT02560766|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110620074|NCT02560766|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110620075|NCT02560766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110620076|NCT02560766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110620078|NCT00933465|Loperamide|loperamide|mesh-list
110620079|NCT00933465|Antidiarrheals|antidiarrheals|mesh-list
110620080|NCT00933465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110620081|NCT00757874|Clobetasol|clobetasol|mesh-list
110620082|NCT00757874|Tacrolimus|tacrolimus|mesh-list
110620083|NCT00757874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110620084|NCT00757874|Immunologic Factors|immunologic factors|mesh-ancestor
110620085|NCT00757874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110620086|NCT00757874|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110620101|NCT00933777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110620103|NCT00933777|Immunologic Factors|immunologic factors|mesh-ancestor
110295183|NCT00231491|Cholinergic Agents|cholinergic agents|mesh-ancestor
110620104|NCT00933777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110620105|NCT00933777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110620106|NCT00801450|Triamcinolone|triamcinolone|mesh-list
110620107|NCT00801450|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110620108|NCT00801450|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110620109|NCT00801450|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110620110|NCT00801450|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110620111|NCT00801450|Glucocorticoids|glucocorticoids|mesh-ancestor
110620112|NCT00801450|Hormones|hormones|mesh-ancestor
110620113|NCT00801450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110620114|NCT00801450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110620115|NCT00801450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110620116|NCT00801450|Immunologic Factors|immunologic factors|mesh-ancestor
110620117|NCT00801450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110620118|NCT00801450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110620120|NCT00660816|Pemetrexed|pemetrexed|mesh-list
110620121|NCT00660816|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110267397|NCT00408915|Lisuride|lisuride|mesh-list
110620123|NCT00660816|Tubulin Modulators|tubulin modulators|mesh-ancestor
110620124|NCT00660816|Antimitotic Agents|antimitotic agents|mesh-ancestor
110620125|NCT00660816|Mitosis Modulators|mitosis modulators|mesh-ancestor
110620126|NCT00660816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110620127|NCT00660816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110620128|NCT00660816|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110295221|NCT04561336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110620129|NCT00660816|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110620130|NCT00660816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110620131|NCT00801528|Diclofenac|diclofenac|mesh-list
110617415|NCT00776022|Cetirizine|cetirizine|mesh-list
110620132|NCT00801528|Ropivacaine|ropivacaine|mesh-list
110620133|NCT00801528|Anesthetics, Local|anesthetics, local|mesh-ancestor
110620134|NCT00801528|Anesthetics|anesthetics|mesh-ancestor
110620135|NCT00801528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110620136|NCT00801528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110620137|NCT00801528|Sensory System Agents|sensory system agents|mesh-ancestor
110620138|NCT00801528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110620139|NCT00801528|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110620140|NCT00801528|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110620141|NCT00801528|Analgesics|analgesics|mesh-ancestor
110620142|NCT00801528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110620143|NCT00801528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110620144|NCT00801528|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110295286|NCT04559308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110620145|NCT00801528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110620146|NCT00801528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110620149|NCT01060891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110620151|NCT04003402|ASP8062|asp8062|mesh-list
110620152|NCT04003402|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110620153|NCT04003402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110620154|NCT04003402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110620155|NCT04003402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110620156|NCT04003402|Analgesics|analgesics|mesh-ancestor
110620157|NCT04003402|Sensory System Agents|sensory system agents|mesh-ancestor
110620158|NCT04003402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110620159|NCT04003402|GABA Modulators|gaba modulators|mesh-ancestor
110620160|NCT04003402|GABA Agents|gaba agents|mesh-ancestor
110620161|NCT04003402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110620162|NCT04003402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110620163|NCT00576056|Sorafenib|sorafenib|mesh-list
110620164|NCT00576056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110620165|NCT00576056|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110620166|NCT00576056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110620167|NCT00576056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110620168|NCT05360602|Thioctic Acid|thioctic acid|mesh-list
110620169|NCT05360602|Antioxidants|antioxidants|mesh-ancestor
110620170|NCT05360602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110620171|NCT05360602|Protective Agents|protective agents|mesh-ancestor
110620172|NCT05360602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110620173|NCT05360602|Vitamin B Complex|vitamin b complex|mesh-ancestor
110620175|NCT05360602|Micronutrients|micronutrients|mesh-ancestor
110620176|NCT00991744|Cytarabine|cytarabine|mesh-list
110620177|NCT00991744|Cortisone|cortisone|mesh-list
110620178|NCT00991744|Prednisolone|prednisolone|mesh-list
110620179|NCT00991744|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110620180|NCT00991744|Methylprednisolone|methylprednisolone|mesh-list
110620181|NCT00991744|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110620182|NCT00991744|Prednisolone acetate|prednisolone acetate|mesh-list
110620183|NCT00991744|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110620184|NCT00991744|Prednisolone phosphate|prednisolone phosphate|mesh-list
110620185|NCT00991744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110620187|NCT00991744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110620188|NCT00991744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110026284|NCT00423228|Nootropic Agents|nootropic agents|mesh-ancestor
110620189|NCT00991744|Antiviral Agents|antiviral agents|mesh-ancestor
110620190|NCT00991744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110620191|NCT00991744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110267502|NCT00543049|Sunitinib|sunitinib|mesh-list
110620192|NCT00991744|Immunologic Factors|immunologic factors|mesh-ancestor
110620193|NCT00991744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110620194|NCT00991744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110620196|NCT00991744|Hormones|hormones|mesh-ancestor
110620197|NCT00991744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110620198|NCT00991744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110620199|NCT00991744|Antiemetics|antiemetics|mesh-ancestor
110620200|NCT00991744|Autonomic Agents|autonomic agents|mesh-ancestor
110620201|NCT00991744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110620202|NCT00991744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110620203|NCT00991744|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110620204|NCT00991744|Protective Agents|protective agents|mesh-ancestor
110620205|NCT00798876|Vitamin E|vitamin e|mesh-list
110620206|NCT00798876|Vitamins|vitamins|mesh-ancestor
110620207|NCT00798876|Micronutrients|micronutrients|mesh-ancestor
110620208|NCT00798876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110620209|NCT00798876|Antioxidants|antioxidants|mesh-ancestor
110620210|NCT00798876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110620211|NCT00798876|Protective Agents|protective agents|mesh-ancestor
110617585|NCT00669396|Copper|copper|mesh-list
110620212|NCT00989404|Zanamivir|zanamivir|mesh-list
110620213|NCT00989404|Antiviral Agents|antiviral agents|mesh-ancestor
110620214|NCT00989404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110620215|NCT00989404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110620216|NCT00989404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110620217|NCT00758030|Paliperidone Palmitate|paliperidone palmitate|mesh-list
110620218|NCT00758030|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110620219|NCT00758030|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110620220|NCT00758030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110620221|NCT00758030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110620252|NCT00798954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110620253|NCT00798954|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110620254|NCT00798954|Antifungal Agents|antifungal agents|mesh-ancestor
110620255|NCT00798954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110620256|NCT00798954|Immunologic Factors|immunologic factors|mesh-ancestor
110620257|NCT00798954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110620258|NCT00934011|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110620259|NCT00934011|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
110620260|NCT00934011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110620261|NCT00934011|Antitubercular Agents|antitubercular agents|mesh-ancestor
110620262|NCT00934167|Heparin|heparin|mesh-list
110620263|NCT00934167|Calcium heparin|calcium heparin|mesh-list
110620264|NCT00934167|Anticoagulants|anticoagulants|mesh-ancestor
110620265|NCT00934167|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110620266|NCT00934167|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110620269|NCT00801606|Trace Elements|trace elements|mesh-list
110620270|NCT00801606|Micronutrients|micronutrients|mesh-list
110620271|NCT00801606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110620273|NCT00934245|Immunologic Factors|immunologic factors|mesh-ancestor
110620274|NCT00934245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110620275|NCT02560688|Clopidogrel|clopidogrel|mesh-list
110620276|NCT02560688|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110620277|NCT02560688|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110620278|NCT02560688|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110620279|NCT02560688|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110620280|NCT02560688|Purinergic Agents|purinergic agents|mesh-ancestor
110620281|NCT02560688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110620282|NCT02560688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110620283|NCT02560688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110620284|NCT00939549|Cyclophosphamide|cyclophosphamide|mesh-list
110620285|NCT00939549|Glatiramer Acetate|glatiramer acetate|mesh-list
110620286|NCT00939549|(T,G)-A-L|(t,g)-a-l|mesh-list
110295520|NCT00259701|Cholinergic Agents|cholinergic agents|mesh-ancestor
110295532|NCT04566211|Bismuth|bismuth|mesh-list
110620287|NCT00939549|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110620288|NCT00939549|Immunologic Factors|immunologic factors|mesh-ancestor
110620289|NCT00939549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110620290|NCT00939549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110620291|NCT00939549|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110620292|NCT00939549|Alkylating Agents|alkylating agents|mesh-ancestor
110620293|NCT00939549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110620294|NCT00939549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110620295|NCT00939549|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110620296|NCT00939549|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110620297|NCT00934323|Metformin|metformin|mesh-list
110620298|NCT00934323|Glimepiride|glimepiride|mesh-list
110620299|NCT00934323|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110620300|NCT00934323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110620301|NCT00934323|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110620302|NCT00934323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110620303|NCT00934323|Immunologic Factors|immunologic factors|mesh-ancestor
110620305|NCT00575666|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110620306|NCT00575666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110620307|NCT00934479|Lubiprostone|lubiprostone|mesh-list
110620308|NCT00934479|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
110620309|NCT00934479|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110620310|NCT00934479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110620311|NCT00658632|Esomeprazole|esomeprazole|mesh-list
110620312|NCT00658632|Rabeprazole|rabeprazole|mesh-list
110620313|NCT00658632|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110617702|NCT00400946|Antiemetics|antiemetics|mesh-ancestor
110620314|NCT00658632|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110620315|NCT00658632|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110620317|NCT00658632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110620318|NCT00677534|Vitamin D|vitamin d|mesh-list
110620319|NCT00677534|Cholecalciferol|cholecalciferol|mesh-list
110620320|NCT00677534|Ergocalciferols|ergocalciferols|mesh-list
110620321|NCT00677534|Vitamins|vitamins|mesh-ancestor
110620322|NCT00677534|Micronutrients|micronutrients|mesh-ancestor
110620323|NCT00677534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110620324|NCT00677534|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110620325|NCT00677534|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110620326|NCT00989716|Antihypertensive Agents|antihypertensive agents|mesh-list
110620327|NCT00989716|Nitroglycerin|nitroglycerin|mesh-list
110620328|NCT00989716|Vasodilator Agents|vasodilator agents|mesh-ancestor
110620329|NCT00660348|Morphine|morphine|mesh-list
110620330|NCT00660348|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110620331|NCT00660348|Narcotics|narcotics|mesh-ancestor
110620332|NCT00660348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110620333|NCT00660348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110620334|NCT00660348|Analgesics|analgesics|mesh-ancestor
110620335|NCT00660348|Sensory System Agents|sensory system agents|mesh-ancestor
110620336|NCT00660348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110620337|NCT03734198|Daratumumab|daratumumab|mesh-list
110620338|NCT03734198|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110620339|NCT03734198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110620340|NCT03734198|Immunologic Factors|immunologic factors|mesh-ancestor
110620341|NCT03734198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110620347|NCT01564108|Growth Inhibitors|growth inhibitors|mesh-ancestor
110620348|NCT01564108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110620349|NCT00801918|Cyclophosphamide|cyclophosphamide|mesh-list
110620350|NCT00801918|Ifosfamide|ifosfamide|mesh-list
110620351|NCT00801918|Etoposide|etoposide|mesh-list
110620352|NCT00801918|Denileukin diftitox|denileukin diftitox|mesh-list
110620353|NCT00801918|Interleukin-2|interleukin-2|mesh-list
110620354|NCT00801918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110620355|NCT00801918|Immunologic Factors|immunologic factors|mesh-ancestor
110278611|NCT00411372|Dermatologic Agents|dermatologic agents|mesh-ancestor
110620356|NCT00801918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110620357|NCT00801918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110620358|NCT00801918|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110620359|NCT00801918|Alkylating Agents|alkylating agents|mesh-ancestor
110620360|NCT00801918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110620361|NCT00801918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110620362|NCT00801918|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110620363|NCT00801918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110620364|NCT00801918|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110620365|NCT00801918|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110620367|NCT00801918|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110620368|NCT00801918|Analgesics|analgesics|mesh-ancestor
110620369|NCT00801918|Sensory System Agents|sensory system agents|mesh-ancestor
110620370|NCT00801918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110620371|NCT00799188|Everolimus|everolimus|mesh-list
110620372|NCT00799188|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110620373|NCT00799188|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110620374|NCT00799188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110620375|NCT00799188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110620376|NCT00799188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110620377|NCT00799188|Immunologic Factors|immunologic factors|mesh-ancestor
110620378|NCT00799188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110620379|NCT00799188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110278646|NCT00182039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110620380|NCT00571688|Risperidone|risperidone|mesh-list
110620381|NCT00571688|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110620382|NCT00571688|Serotonin Agents|serotonin agents|mesh-ancestor
110620383|NCT00571688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110620384|NCT00571688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110620385|NCT00571688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110620386|NCT00571688|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110620387|NCT00571688|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110153839|NCT00005852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110620388|NCT00571688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110620389|NCT00571688|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110620390|NCT00571688|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110620391|NCT00571688|Dopamine Agents|dopamine agents|mesh-ancestor
110620392|NCT00799656|5-chloro-2-(5-chlorothiophene-2-sulfonylamino)-N-(4-(morpholine-4-sulfonyl)phenyl)benzamide|5-chloro-2-(5-chlorothiophene-2-sulfonylamino)-n-(4-(morpholine-4-sulfonyl)phenyl)benzamide|mesh-list
110620393|NCT00799656|Enzyme Activators|enzyme activators|mesh-ancestor
110620394|NCT00799656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110620395|NCT05408104|Tolvaptan|tolvaptan|mesh-list
110620396|NCT05408104|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
110620397|NCT05408104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110278654|NCT00584389|Hormones|hormones|mesh-ancestor
110339842|NCT00513110|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110339843|NCT00513110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110339844|NCT00513110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110339845|NCT00513110|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110339846|NCT00513110|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110339847|NCT00513110|Purinergic Agents|purinergic agents|mesh-ancestor
110339848|NCT00513110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110339850|NCT02951897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110174269|NCT02967211|Insulin Glargine|insulin glargine|mesh-list
110339851|NCT02951897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110339852|NCT02951897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110339853|NCT02951897|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110339854|NCT02951897|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110339855|NCT00511823|Rosiglitazone|rosiglitazone|mesh-list
110339856|NCT00511823|Granisetron|granisetron|mesh-list
110339857|NCT00511823|Casopitant|casopitant|mesh-list
110295784|NCT04673500|Anesthetics|anesthetics|mesh-ancestor
110339858|NCT00511823|Dolasetron|dolasetron|mesh-list
110339859|NCT00511823|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110174339|NCT04488081|Immunologic Factors|immunologic factors|mesh-ancestor
110339860|NCT00511823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110339861|NCT00511823|Antiemetics|antiemetics|mesh-ancestor
110339862|NCT00511823|Autonomic Agents|autonomic agents|mesh-ancestor
110339863|NCT00511823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110339864|NCT00511823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110339865|NCT00511823|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110339866|NCT00511823|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110339868|NCT00511823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110295802|NCT00267540|Vitamin D|vitamin d|mesh-list
110339869|NCT00511823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110339870|NCT00511823|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110339871|NCT00515736|Vitamins|vitamins|mesh-list
110339872|NCT00515736|Vitamin E|vitamin e|mesh-list
110339873|NCT00515736|Thiamine|thiamine|mesh-list
110339875|NCT00515736|Selenium|selenium|mesh-list
110339876|NCT00515736|Micronutrients|micronutrients|mesh-ancestor
110339877|NCT00515736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110339878|NCT00515736|Trace Elements|trace elements|mesh-ancestor
110339879|NCT00515736|Antioxidants|antioxidants|mesh-ancestor
110339880|NCT00515736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110339881|NCT00515736|Protective Agents|protective agents|mesh-ancestor
110339882|NCT00515736|Vitamin B Complex|vitamin b complex|mesh-ancestor
110339883|NCT00511940|Acamprosate|acamprosate|mesh-list
110295853|NCT04671589|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110339884|NCT00511940|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110339885|NCT00513149|Clopidogrel|clopidogrel|mesh-list
110339886|NCT00513149|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110339887|NCT00513149|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110339888|NCT00513149|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110339889|NCT00513149|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110339890|NCT00513149|Purinergic Agents|purinergic agents|mesh-ancestor
110339891|NCT00513149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110339892|NCT00513149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110339893|NCT00513149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110339895|NCT02944227|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110295903|NCT00267657|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110295919|NCT00233714|Sirolimus|sirolimus|mesh-list
110339896|NCT02944227|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110339897|NCT02944227|Growth Substances|growth substances|mesh-ancestor
110339898|NCT02944227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110339899|NCT02944227|Growth Inhibitors|growth inhibitors|mesh-ancestor
110339900|NCT02944227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110339902|NCT00513188|Cytarabine|cytarabine|mesh-list
110339903|NCT00513188|Prednisone|prednisone|mesh-list
110339904|NCT00513188|Cyclophosphamide|cyclophosphamide|mesh-list
110339905|NCT00513188|Doxorubicin|doxorubicin|mesh-list
110339906|NCT00513188|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110339907|NCT00513188|Methotrexate|methotrexate|mesh-list
110339908|NCT00513188|Vincristine|vincristine|mesh-list
110339909|NCT00513188|Denileukin diftitox|denileukin diftitox|mesh-list
110339910|NCT00513188|Levoleucovorin|levoleucovorin|mesh-list
110339911|NCT00513188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110339912|NCT00513188|Immunologic Factors|immunologic factors|mesh-ancestor
110339913|NCT00513188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110339914|NCT00513188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110339915|NCT00513188|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110339917|NCT00513188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110339918|NCT00513188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110339919|NCT00513188|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110339920|NCT00513188|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110339921|NCT00513188|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110339922|NCT00513188|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110339923|NCT00513188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110339924|NCT00513188|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110339925|NCT00513188|Glucocorticoids|glucocorticoids|mesh-ancestor
110339926|NCT00513188|Hormones|hormones|mesh-ancestor
110339927|NCT00513188|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110296016|NCT00260520|Tinzaparin|tinzaparin|mesh-list
110296018|NCT00260520|Anticoagulants|anticoagulants|mesh-ancestor
110339928|NCT00513188|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110339929|NCT00513188|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110339930|NCT00513188|Abortifacient Agents|abortifacient agents|mesh-ancestor
110339931|NCT00513188|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110339932|NCT00513188|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110339933|NCT00513188|Antimetabolites|antimetabolites|mesh-ancestor
110339934|NCT00513188|Dermatologic Agents|dermatologic agents|mesh-ancestor
110339935|NCT00513188|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110339936|NCT00513188|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110339937|NCT00513188|Antiviral Agents|antiviral agents|mesh-ancestor
110339938|NCT00513188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110339939|NCT00513188|Antidotes|antidotes|mesh-ancestor
110339940|NCT00513188|Protective Agents|protective agents|mesh-ancestor
110339941|NCT00513188|Vitamin B Complex|vitamin b complex|mesh-ancestor
110339942|NCT00513188|Vitamins|vitamins|mesh-ancestor
110339943|NCT00513188|Micronutrients|micronutrients|mesh-ancestor
110339944|NCT00513188|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110339945|NCT00513188|Tubulin Modulators|tubulin modulators|mesh-ancestor
110339946|NCT00513188|Antimitotic Agents|antimitotic agents|mesh-ancestor
110339947|NCT00513188|Mitosis Modulators|mitosis modulators|mesh-ancestor
110339948|NCT00513266|Leucovorin|leucovorin|mesh-list
110339949|NCT00513266|Bevacizumab|bevacizumab|mesh-list
110339950|NCT00513266|Cetuximab|cetuximab|mesh-list
110339951|NCT00513266|Fluorouracil|fluorouracil|mesh-list
110339952|NCT00513266|Oxaliplatin|oxaliplatin|mesh-list
110339953|NCT00513266|Irinotecan|irinotecan|mesh-list
110339954|NCT00513266|Calcium|calcium|mesh-list
110296067|NCT00556348|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110339955|NCT00513266|Levoleucovorin|levoleucovorin|mesh-list
110339956|NCT00513266|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110339957|NCT00513266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110339958|NCT00513266|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110339959|NCT00513266|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110339960|NCT00513266|Growth Substances|growth substances|mesh-ancestor
110339961|NCT00513266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110173430|NCT00058279|Aldesleukin|aldesleukin|mesh-list
110339962|NCT00513266|Growth Inhibitors|growth inhibitors|mesh-ancestor
110339963|NCT00513266|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110339964|NCT00513266|Antimetabolites|antimetabolites|mesh-ancestor
110339965|NCT00513266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110339966|NCT00513266|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110339967|NCT00513266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110339968|NCT00513266|Immunologic Factors|immunologic factors|mesh-ancestor
110174506|NCT00066625|Bortezomib|bortezomib|mesh-list
110339969|NCT00513266|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110339970|NCT00513266|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110339971|NCT00513266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110339973|NCT00513266|Protective Agents|protective agents|mesh-ancestor
110339974|NCT00513266|Vitamin B Complex|vitamin b complex|mesh-ancestor
110339975|NCT00513266|Vitamins|vitamins|mesh-ancestor
110339976|NCT00513266|Micronutrients|micronutrients|mesh-ancestor
110339977|NCT00513383|Paclitaxel|paclitaxel|mesh-list
110339978|NCT00513383|Docetaxel|docetaxel|mesh-list
110339979|NCT00513383|Carboplatin|carboplatin|mesh-list
110339980|NCT00513383|Fluorouracil|fluorouracil|mesh-list
110339981|NCT00513383|Panitumumab|panitumumab|mesh-list
110339982|NCT00513383|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110339983|NCT00513383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110339984|NCT00513383|Tubulin Modulators|tubulin modulators|mesh-ancestor
110339985|NCT00513383|Antimitotic Agents|antimitotic agents|mesh-ancestor
110339986|NCT00513383|Mitosis Modulators|mitosis modulators|mesh-ancestor
110339987|NCT00513383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110339988|NCT00513383|Antimetabolites|antimetabolites|mesh-ancestor
110339989|NCT00513383|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110339990|NCT00513383|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110339991|NCT00513383|Immunologic Factors|immunologic factors|mesh-ancestor
110339992|NCT00513383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110339993|NCT00513383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110339994|NCT00515892|Immunotoxin HA22|immunotoxin ha22|mesh-list
110339995|NCT00515892|Antibodies|antibodies|mesh-list
110339996|NCT00515892|Immunoglobulins|immunoglobulins|mesh-list
110339997|NCT00515892|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110339998|NCT00515892|Immunotoxins|immunotoxins|mesh-list
110339999|NCT00515892|Immunologic Factors|immunologic factors|mesh-ancestor
110340000|NCT00515892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110340001|NCT00515892|Immunoconjugates|immunoconjugates|mesh-ancestor
110340002|NCT00515892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110340003|NCT00513539|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
110340004|NCT00513539|Trioxsalen|trioxsalen|mesh-list
110340005|NCT00513539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110340006|NCT00513539|Dermatologic Agents|dermatologic agents|mesh-ancestor
110278781|NCT03452722|Plasminogen|plasminogen|mesh-list
110340007|NCT00513539|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110340008|NCT00511979|Insulin|insulin|mesh-list
110340010|NCT00511979|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110340011|NCT00511979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110340012|NCT00513578|Sargramostim|sargramostim|mesh-list
110340013|NCT00513578|Freund's Adjuvant|freund's adjuvant|mesh-list
110340014|NCT00513578|Immunologic Factors|immunologic factors|mesh-ancestor
110340015|NCT00513578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110340016|NCT00513578|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110340017|NCT00513656|Oxycodone|oxycodone|mesh-list
110340018|NCT00513656|Naloxone|naloxone|mesh-list
110340019|NCT00513656|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110340020|NCT00513656|Narcotics|narcotics|mesh-ancestor
110340021|NCT00513656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110340022|NCT00513656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110340023|NCT00513656|Analgesics|analgesics|mesh-ancestor
110340024|NCT00513656|Sensory System Agents|sensory system agents|mesh-ancestor
110340025|NCT00513656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110340026|NCT00513656|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110340027|NCT00530127|Deferiprone|deferiprone|mesh-list
110340028|NCT00530127|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110340029|NCT00530127|Chelating Agents|chelating agents|mesh-ancestor
110340030|NCT00530127|Sequestering Agents|sequestering agents|mesh-ancestor
110340031|NCT00530127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110340032|NCT04691934|Anesthetics|anesthetics|mesh-list
110340033|NCT04691934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110340034|NCT04691934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110296135|NCT00234377|Antidepressive Agents|antidepressive agents|mesh-ancestor
110296136|NCT00234377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110340035|NCT00512057|Allopurinol|allopurinol|mesh-list
110340036|NCT00512057|Antimetabolites|antimetabolites|mesh-ancestor
110340037|NCT00512057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110340038|NCT00512057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110340039|NCT00512057|Gout Suppressants|gout suppressants|mesh-ancestor
110340041|NCT00512057|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110340042|NCT00512057|Antioxidants|antioxidants|mesh-ancestor
110340043|NCT00512057|Protective Agents|protective agents|mesh-ancestor
110340044|NCT00512057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110340045|NCT00513929|Zinc Sulfate|zinc sulfate|mesh-list
110340046|NCT00513929|Astringents|astringents|mesh-ancestor
110340047|NCT00513929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110340048|NCT00513929|Dermatologic Agents|dermatologic agents|mesh-ancestor
110340049|NCT00513968|Adefovir|adefovir|mesh-list
110340050|NCT00513968|Antiviral Agents|antiviral agents|mesh-ancestor
110278800|NCT00408551|Immunologic Factors|immunologic factors|mesh-ancestor
110340051|NCT00513968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110340052|NCT00513968|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110340053|NCT00513968|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110340054|NCT00513968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110340055|NCT00513968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110340056|NCT03459248|Anesthetics|anesthetics|mesh-list
110340057|NCT03459248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110340058|NCT03459248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110340059|NCT00512291|Olanzapine|olanzapine|mesh-list
110340060|NCT00512291|Fluoxetine|fluoxetine|mesh-list
110340061|NCT00512291|Antiemetics|antiemetics|mesh-ancestor
110340062|NCT00512291|Autonomic Agents|autonomic agents|mesh-ancestor
110340063|NCT00512291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110340064|NCT00512291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110340065|NCT00512291|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110340066|NCT00512291|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110340067|NCT00512291|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110340068|NCT00512291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110340069|NCT00512291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110340070|NCT00512291|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110340071|NCT00512291|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110340072|NCT00512291|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110340073|NCT00512291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110340074|NCT00512291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110340076|NCT00512291|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110340077|NCT00512291|Antidepressive Agents|antidepressive agents|mesh-ancestor
110340078|NCT00512291|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110340079|NCT00512291|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110340080|NCT00512291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110340081|NCT00514163|Gemcitabine|gemcitabine|mesh-list
110340082|NCT00514163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110340083|NCT00514163|Antimetabolites|antimetabolites|mesh-ancestor
110340084|NCT00514163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110340085|NCT00514163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110340086|NCT00514202|Dextroamphetamine|dextroamphetamine|mesh-list
110340087|NCT00514202|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110340088|NCT00514202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110340089|NCT00514202|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110340090|NCT00514202|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110340091|NCT00514202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110340092|NCT00514202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110340093|NCT00514202|Dopamine Agents|dopamine agents|mesh-ancestor
110340094|NCT00514202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110340095|NCT00530361|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
110340096|NCT00530361|Natriuretic Agents|natriuretic agents|mesh-ancestor
110340097|NCT00530361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110340098|NCT00512408|Testosterone|testosterone|mesh-list
110340099|NCT00512408|Androgens|androgens|mesh-ancestor
110340101|NCT00512408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110340102|NCT00512408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110340103|NCT00530400|Cefuroxime|cefuroxime|mesh-list
110340104|NCT00530400|Cefuroxime axetil|cefuroxime axetil|mesh-list
110340105|NCT00530400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110340106|NCT00530400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110340108|NCT00531336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110340109|NCT00531336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110340110|NCT00531336|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110340111|NCT00531336|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110340112|NCT00531336|Growth Substances|growth substances|mesh-ancestor
110340113|NCT00531336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110340114|NCT00531336|Growth Inhibitors|growth inhibitors|mesh-ancestor
110340115|NCT00530478|Donepezil|donepezil|mesh-list
110340116|NCT00530478|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110340117|NCT00530478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110340118|NCT00530478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110340119|NCT00530478|Cholinergic Agents|cholinergic agents|mesh-ancestor
110340120|NCT00530478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110340121|NCT00530478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110340122|NCT00530478|Nootropic Agents|nootropic agents|mesh-ancestor
110340123|NCT00530556|Zolpidem|zolpidem|mesh-list
110340124|NCT00530556|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110340125|NCT00530556|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110340126|NCT00530556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110340127|NCT00530556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110278837|NCT00209625|Antidotes|antidotes|mesh-ancestor
110340128|NCT00530556|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
110340129|NCT00530556|GABA Agonists|gaba agonists|mesh-ancestor
110340130|NCT00530556|GABA Agents|gaba agents|mesh-ancestor
110340131|NCT00530556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110340132|NCT00530556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110340133|NCT00512486|Benralizumab|benralizumab|mesh-list
110340134|NCT00512486|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110340135|NCT00512486|Respiratory System Agents|respiratory system agents|mesh-ancestor
110340136|NCT00530595|Losartan|losartan|mesh-list
110340137|NCT00530595|Valsartan|valsartan|mesh-list
110340138|NCT00530595|Candesartan|candesartan|mesh-list
110340139|NCT00530595|Candesartan cilexetil|candesartan cilexetil|mesh-list
110340140|NCT00530595|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110340141|NCT00530595|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110340142|NCT00530595|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110340143|NCT00530595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110340144|NCT00530595|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110340146|NCT02943759|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110340147|NCT02943759|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110340148|NCT02943759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110340149|NCT02943759|Disinfectants|disinfectants|mesh-ancestor
110340150|NCT02943759|Dermatologic Agents|dermatologic agents|mesh-ancestor
110340151|NCT02944110|Glucagon|glucagon|mesh-list
110340152|NCT02944110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110340153|NCT02944110|Hormones|hormones|mesh-ancestor
110340154|NCT02944110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110340155|NCT02944110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110340156|NCT02951975|Dexamethasone|dexamethasone|mesh-list
110340157|NCT02951975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110340158|NCT02951975|Antiemetics|antiemetics|mesh-ancestor
110340159|NCT02951975|Autonomic Agents|autonomic agents|mesh-ancestor
110340160|NCT02951975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110340161|NCT02951975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110340162|NCT02951975|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110340163|NCT02951975|Glucocorticoids|glucocorticoids|mesh-ancestor
110340164|NCT02951975|Hormones|hormones|mesh-ancestor
110340165|NCT02951975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110296281|NCT00234845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110340166|NCT02951975|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110340167|NCT02951975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110340168|NCT00514397|Temozolomide|temozolomide|mesh-list
110340169|NCT00514397|Motexafin gadolinium|motexafin gadolinium|mesh-list
110340170|NCT00514397|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110340171|NCT00514397|Alkylating Agents|alkylating agents|mesh-ancestor
110173448|NCT00058357|Anesthetics|anesthetics|mesh-ancestor
110340172|NCT00514397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110340173|NCT00514397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110340174|NCT00514397|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110340175|NCT00514397|Dermatologic Agents|dermatologic agents|mesh-ancestor
110340176|NCT02943603|Pembrolizumab|pembrolizumab|mesh-list
110340177|NCT02943603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110340178|NCT02943603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110340179|NCT02943603|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110340180|NCT02943603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110340182|NCT00531687|Gemcitabine|gemcitabine|mesh-list
110340183|NCT00531687|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110340184|NCT00531687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110340185|NCT00531687|Tubulin Modulators|tubulin modulators|mesh-ancestor
110340186|NCT00531687|Antimitotic Agents|antimitotic agents|mesh-ancestor
110340187|NCT00531687|Mitosis Modulators|mitosis modulators|mesh-ancestor
110340188|NCT00531687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110340189|NCT00531687|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110340190|NCT00531687|Antimetabolites|antimetabolites|mesh-ancestor
110340191|NCT00514475|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110340192|NCT00514475|Immunologic Factors|immunologic factors|mesh-ancestor
110340193|NCT00514475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110340194|NCT00512681|Oxaliplatin|oxaliplatin|mesh-list
110340195|NCT00512681|Irinotecan|irinotecan|mesh-list
110340196|NCT00512681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110340197|NCT00512681|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110340198|NCT00512681|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110340199|NCT00512681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110340200|NCT00512681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110340201|NCT00530868|Bevacizumab|bevacizumab|mesh-list
110340202|NCT00530868|Letrozole|letrozole|mesh-list
110340203|NCT00530868|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110340204|NCT00530868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110340205|NCT00530868|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110340206|NCT00530868|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110340207|NCT00530868|Growth Substances|growth substances|mesh-ancestor
110296321|NCT02213887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110340208|NCT00530868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110340209|NCT00530868|Growth Inhibitors|growth inhibitors|mesh-ancestor
110340210|NCT00530868|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110340211|NCT00530868|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110340212|NCT00530868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110340213|NCT00530868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110340214|NCT00530868|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110340215|NCT00530868|Hormone Antagonists|hormone antagonists|mesh-ancestor
110340216|NCT00530868|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110340217|NCT00530907|Bevacizumab|bevacizumab|mesh-list
110340218|NCT00530907|Valproic Acid|valproic acid|mesh-list
110340219|NCT00530907|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110340220|NCT00530907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110340221|NCT00530907|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110340222|NCT00530907|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110340223|NCT00530907|Growth Substances|growth substances|mesh-ancestor
110340224|NCT00530907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110340225|NCT00530907|Growth Inhibitors|growth inhibitors|mesh-ancestor
110340226|NCT00530907|Anticonvulsants|anticonvulsants|mesh-ancestor
110340227|NCT00530907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110340228|NCT00530907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110340229|NCT00530907|GABA Agents|gaba agents|mesh-ancestor
110174565|NCT00067444|Paroxetine|paroxetine|mesh-list
110340230|NCT00530907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110340231|NCT00530907|Antimanic Agents|antimanic agents|mesh-ancestor
110340233|NCT00530907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110340234|NCT00530907|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110340235|NCT00531024|Bevacizumab|bevacizumab|mesh-list
110340236|NCT00531024|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110340237|NCT00531024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110340238|NCT00531024|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110340239|NCT00531024|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110340240|NCT00531024|Growth Substances|growth substances|mesh-ancestor
110340242|NCT00531024|Growth Inhibitors|growth inhibitors|mesh-ancestor
110340243|NCT00512759|Nitroglycerin|nitroglycerin|mesh-list
110340244|NCT00512759|Vasodilator Agents|vasodilator agents|mesh-ancestor
110340245|NCT00514670|Hand Sanitizers|hand sanitizers|mesh-list
110340246|NCT00514670|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110340247|NCT00514670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110340248|NCT00514670|Disinfectants|disinfectants|mesh-ancestor
110340249|NCT00531063|Everolimus|everolimus|mesh-list
110340250|NCT00531063|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110340251|NCT00531063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110340252|NCT00531063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110340253|NCT00531063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110340254|NCT00531063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110340255|NCT00531063|Immunologic Factors|immunologic factors|mesh-ancestor
110340256|NCT00531063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110340257|NCT00531063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110340258|NCT02943798|Paclitaxel|paclitaxel|mesh-list
110340259|NCT02943798|Etoposide|etoposide|mesh-list
110340260|NCT02943798|Carboplatin|carboplatin|mesh-list
110340261|NCT02943798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110340262|NCT02943798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110340263|NCT02943798|Tubulin Modulators|tubulin modulators|mesh-ancestor
110340264|NCT02943798|Antimitotic Agents|antimitotic agents|mesh-ancestor
110340265|NCT02943798|Mitosis Modulators|mitosis modulators|mesh-ancestor
110340266|NCT02943798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110340267|NCT02943798|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110340268|NCT02943798|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110340269|NCT02943798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110340270|NCT02943369|Ticagrelor|ticagrelor|mesh-list
110340271|NCT02943369|Cangrelor|cangrelor|mesh-list
110340272|NCT02943369|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110340273|NCT02943369|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110340274|NCT02943369|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110340275|NCT02943369|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110340276|NCT02943369|Purinergic Agents|purinergic agents|mesh-ancestor
110340277|NCT02943369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110296392|NCT00235079|Tubulin Modulators|tubulin modulators|mesh-ancestor
110340278|NCT02943369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110340279|NCT02943369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110340280|NCT00514748|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
110340281|NCT00514748|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110340282|NCT00514748|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110340283|NCT00514748|Analgesics|analgesics|mesh-ancestor
110340284|NCT00514748|Sensory System Agents|sensory system agents|mesh-ancestor
110340285|NCT00514748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110340286|NCT00514748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110340287|NCT00514748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110340288|NCT00514748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110340289|NCT00515957|Antibodies|antibodies|mesh-list
110340290|NCT00515957|Immunologic Factors|immunologic factors|mesh-ancestor
110340291|NCT00515957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110340292|NCT02943642|Vorinostat|vorinostat|mesh-list
110340293|NCT02943642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110340294|NCT02943642|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110296439|NCT00235235|Gemcitabine|gemcitabine|mesh-list
110340295|NCT02943642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110340296|NCT02943642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110340297|NCT04695509|Propofol|propofol|mesh-list
110340298|NCT04695509|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110173461|NCT00058474|Fluorouracil|fluorouracil|mesh-list
110340299|NCT04695509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110340300|NCT04695509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110340301|NCT04695509|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110340302|NCT04695509|Anesthetics, General|anesthetics, general|mesh-ancestor
110340303|NCT04695509|Anesthetics|anesthetics|mesh-ancestor
110340304|NCT02943135|Lidocaine|lidocaine|mesh-list
110340305|NCT02943135|Anesthetics, Local|anesthetics, local|mesh-ancestor
110340306|NCT02943135|Anesthetics|anesthetics|mesh-ancestor
110340307|NCT02943135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110340308|NCT02943135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110340309|NCT02943135|Sensory System Agents|sensory system agents|mesh-ancestor
110340310|NCT02943135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110340311|NCT02943135|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110340312|NCT02943135|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110340313|NCT02943135|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110340314|NCT02943135|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110340315|NCT02943135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110340317|NCT02951234|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110340319|NCT02951234|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110340320|NCT02951234|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110340321|NCT02951234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110340322|NCT02951234|Analgesics|analgesics|mesh-ancestor
110340323|NCT02951234|Sensory System Agents|sensory system agents|mesh-ancestor
110340324|NCT02951234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110340325|NCT02951234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110340326|NCT02951234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110340327|NCT02951234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110340328|NCT02951234|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110340329|NCT02951234|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110340330|NCT02951234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110340331|NCT02951234|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110340332|NCT02951234|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110340333|NCT02951234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110340334|NCT02951234|Antipyretics|antipyretics|mesh-ancestor
110340335|NCT02951234|Immunologic Factors|immunologic factors|mesh-ancestor
110340336|NCT02943252|Apatinib|apatinib|mesh-list
110340337|NCT02943252|Tegafur|tegafur|mesh-list
110340338|NCT02943252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110340339|NCT02943252|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110278882|NCT00587119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110278883|NCT00587119|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110278884|NCT00587119|Autonomic Agents|autonomic agents|mesh-ancestor
110340340|NCT02943252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110340341|NCT02943252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110340342|NCT02943252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110340343|NCT02943252|Antimetabolites|antimetabolites|mesh-ancestor
110340344|NCT00514982|Adalimumab|adalimumab|mesh-list
110340345|NCT00514982|Infliximab|infliximab|mesh-list
110340346|NCT00514982|Mesalamine|mesalamine|mesh-list
110340347|NCT00514982|Mercaptopurine|mercaptopurine|mesh-list
110340348|NCT00514982|Tacrolimus|tacrolimus|mesh-list
110340349|NCT00514982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110340350|NCT00514982|Immunologic Factors|immunologic factors|mesh-ancestor
110340351|NCT00514982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110340352|NCT00514982|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110340353|NCT00514982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110340354|NCT00514982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110340355|NCT00514982|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110340356|NCT00514982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110340357|NCT00514982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110296489|NCT00268398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110296490|NCT00268398|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110296493|NCT00268398|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110296495|NCT00268398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110296497|NCT00268398|Protective Agents|protective agents|mesh-ancestor
110296499|NCT00268398|Vitamins|vitamins|mesh-ancestor
110340358|NCT00514982|Dermatologic Agents|dermatologic agents|mesh-ancestor
110340359|NCT00514982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110340360|NCT00514982|Antimetabolites|antimetabolites|mesh-ancestor
110340361|NCT00514982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110340362|NCT00514982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110340363|NCT00514982|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110340364|NCT00514982|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110340365|NCT00514982|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110340366|NCT00514982|Analgesics|analgesics|mesh-ancestor
110340367|NCT00514982|Sensory System Agents|sensory system agents|mesh-ancestor
110340368|NCT00514982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110340371|NCT00531999|Raltegravir Potassium|raltegravir potassium|mesh-list
110340372|NCT00531999|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110340373|NCT00531999|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110340374|NCT00531999|Protease Inhibitors|protease inhibitors|mesh-ancestor
110340375|NCT00531999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110340376|NCT00531999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110340377|NCT00531999|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110340378|NCT00531999|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110340379|NCT00531999|Antiviral Agents|antiviral agents|mesh-ancestor
110340380|NCT00531999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110340381|NCT00531999|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110340382|NCT00531999|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110340384|NCT00531999|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110340385|NCT05319912|Molybdenum|molybdenum|mesh-list
110340386|NCT05319912|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
110340387|NCT05319912|Choline|choline|mesh-list
110340388|NCT05319912|Omeprazole|omeprazole|mesh-list
110340389|NCT05319912|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110340390|NCT05319912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110340391|NCT05319912|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110340392|NCT05319912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110340393|NCT05319912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110340394|NCT05319912|Lipotropic Agents|lipotropic agents|mesh-ancestor
110340395|NCT05319912|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110340396|NCT05319912|Antimetabolites|antimetabolites|mesh-ancestor
110340397|NCT05319912|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110340398|NCT05319912|Nootropic Agents|nootropic agents|mesh-ancestor
110340399|NCT05319912|Chelating Agents|chelating agents|mesh-ancestor
110340400|NCT05319912|Sequestering Agents|sequestering agents|mesh-ancestor
110340401|NCT05319912|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110340402|NCT05319912|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110278919|NCT00209703|Antidotes|antidotes|mesh-ancestor
110278920|NCT00209703|Protective Agents|protective agents|mesh-ancestor
110278922|NCT00209703|Vitamins|vitamins|mesh-ancestor
110340403|NCT05319912|Growth Substances|growth substances|mesh-ancestor
110340404|NCT05319912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110340405|NCT05319912|Growth Inhibitors|growth inhibitors|mesh-ancestor
110340406|NCT05319912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110340407|NCT05319912|Trace Elements|trace elements|mesh-ancestor
110340408|NCT05319912|Micronutrients|micronutrients|mesh-ancestor
110340409|NCT00515138|Rituximab|rituximab|mesh-list
110340410|NCT00515138|Carboplatin|carboplatin|mesh-list
110340411|NCT00515138|Etoposide|etoposide|mesh-list
110340412|NCT00515138|Bortezomib|bortezomib|mesh-list
110340413|NCT00515138|Ifosfamide|ifosfamide|mesh-list
110340414|NCT00515138|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110340415|NCT00515138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110340416|NCT00515138|Immunologic Factors|immunologic factors|mesh-ancestor
110340417|NCT00515138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110340418|NCT00515138|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110340419|NCT00515138|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110340420|NCT00515138|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110340421|NCT00515138|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110340422|NCT00515138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110340423|NCT00515138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110340424|NCT00515138|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110340425|NCT00515138|Alkylating Agents|alkylating agents|mesh-ancestor
110340426|NCT05319834|Aspirin|aspirin|mesh-list
110340427|NCT05319834|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110340428|NCT05319834|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110340429|NCT05319834|Analgesics|analgesics|mesh-ancestor
110340430|NCT05319834|Sensory System Agents|sensory system agents|mesh-ancestor
110340431|NCT05319834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110340432|NCT05319834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110340433|NCT05319834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110340434|NCT05319834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110340435|NCT05319834|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110340436|NCT05319834|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110340437|NCT05319834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110340438|NCT05319834|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110340439|NCT05319834|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110340440|NCT05319834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110340441|NCT05319834|Antipyretics|antipyretics|mesh-ancestor
110340442|NCT00515255|Minocycline|minocycline|mesh-list
110340443|NCT00515255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110340444|NCT00515255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110340445|NCT00516113|Paroxetine|paroxetine|mesh-list
110340446|NCT00516113|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110340447|NCT00516113|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110340448|NCT00516113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110343828|NCT06020755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110340449|NCT00516113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110340450|NCT00516113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110340451|NCT00516113|Serotonin Agents|serotonin agents|mesh-ancestor
110340452|NCT00516113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110340453|NCT00516113|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110340454|NCT00516113|Antidepressive Agents|antidepressive agents|mesh-ancestor
110340455|NCT00516113|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110340456|NCT00516113|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110340457|NCT00516113|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110340458|NCT00516113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110340460|NCT04695197|Lumefantrine|lumefantrine|mesh-list
110340461|NCT04695197|Artemether|artemether|mesh-list
110340462|NCT04695197|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
110340463|NCT04695197|Pyronaridine|pyronaridine|mesh-list
110296627|NCT00268593|Antimitotic Agents|antimitotic agents|mesh-ancestor
110278940|NCT00587665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110278941|NCT00587665|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110278942|NCT00587665|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110278943|NCT00587665|Anesthetics, General|anesthetics, general|mesh-ancestor
110278944|NCT00587665|Anesthetics|anesthetics|mesh-ancestor
110340464|NCT04695197|Pyronaridine tetraphosphate, artesunate drug combination|pyronaridine tetraphosphate, artesunate drug combination|mesh-list
110340465|NCT04695197|Antimalarials|antimalarials|mesh-ancestor
110340466|NCT04695197|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110340467|NCT04695197|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110340468|NCT04695197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110340469|NCT04695197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110340470|NCT04695197|Antiviral Agents|antiviral agents|mesh-ancestor
110340471|NCT04695197|Schistosomicides|schistosomicides|mesh-ancestor
110340472|NCT04695197|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110340473|NCT04695197|Anthelmintics|anthelmintics|mesh-ancestor
110340474|NCT00516152|Methotrexate|methotrexate|mesh-list
110340475|NCT00516152|Fludarabine phosphate|fludarabine phosphate|mesh-list
110340476|NCT00516152|Fludarabine|fludarabine|mesh-list
110340477|NCT00516152|Busulfan|busulfan|mesh-list
110340478|NCT00516152|Tacrolimus|tacrolimus|mesh-list
110340479|NCT00516152|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110340480|NCT00516152|Abortifacient Agents|abortifacient agents|mesh-ancestor
110340481|NCT00516152|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110340482|NCT00516152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110340483|NCT00516152|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110296646|NCT00268632|Risedronic Acid|risedronic acid|mesh-list
110296647|NCT00268632|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110340484|NCT00516152|Antimetabolites|antimetabolites|mesh-ancestor
110340485|NCT00516152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110340486|NCT00516152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110340487|NCT00516152|Dermatologic Agents|dermatologic agents|mesh-ancestor
110340488|NCT00516152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110340489|NCT00516152|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110340490|NCT00516152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110340491|NCT00516152|Immunologic Factors|immunologic factors|mesh-ancestor
110340492|NCT00516152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110340493|NCT00516152|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110340494|NCT00516152|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110340495|NCT00516152|Alkylating Agents|alkylating agents|mesh-ancestor
110340496|NCT00516152|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110340497|NCT00516152|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110340498|NCT00516191|Doxorubicin|doxorubicin|mesh-list
110340499|NCT00516191|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110340500|NCT00516191|Bortezomib|bortezomib|mesh-list
110340501|NCT00516191|Melphalan|melphalan|mesh-list
110340502|NCT00516191|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110340503|NCT00516191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110340504|NCT00516191|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110340505|NCT00516191|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110340506|NCT00516191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110340507|NCT00516191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110173487|NCT00058903|Sertraline|sertraline|mesh-list
110340508|NCT00516191|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110340509|NCT00516191|Alkylating Agents|alkylating agents|mesh-ancestor
110340510|NCT00516191|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110340511|NCT00516191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110340512|NCT00516191|Immunologic Factors|immunologic factors|mesh-ancestor
110296690|NCT04554433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110296691|NCT04554433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110278991|NCT00216684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110278992|NCT00216684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110278994|NCT00216684|Sensory System Agents|sensory system agents|mesh-ancestor
110278995|NCT00216684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110278996|NCT00216684|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110278997|NCT00216684|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110278998|NCT00216684|Anesthetics, General|anesthetics, general|mesh-ancestor
110340513|NCT00516191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110340514|NCT00515450|Immunoglobulins|immunoglobulins|mesh-list
110340515|NCT00515450|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110340516|NCT00515450|Antibodies|antibodies|mesh-list
110340517|NCT00515450|gamma-Globulins|gamma-globulins|mesh-list
110340518|NCT00515450|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110340519|NCT00515450|Immunologic Factors|immunologic factors|mesh-ancestor
110340520|NCT00515450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110340521|NCT00515489|Risperidone|risperidone|mesh-list
110340522|NCT00515489|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110340523|NCT00515489|Serotonin Agents|serotonin agents|mesh-ancestor
110340524|NCT00515489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110340525|NCT00515489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110340526|NCT00515489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110340527|NCT00515489|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110340528|NCT00515489|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110340529|NCT00515489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110340530|NCT00515489|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110340531|NCT00515489|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110340532|NCT00515489|Dopamine Agents|dopamine agents|mesh-ancestor
110340533|NCT02941575|Methamphetamine|methamphetamine|mesh-list
110340534|NCT02941575|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110340535|NCT02941575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110340536|NCT02941575|Sympathomimetics|sympathomimetics|mesh-ancestor
110340537|NCT02941575|Autonomic Agents|autonomic agents|mesh-ancestor
110174625|NCT04091880|Vaccines|vaccines|mesh-list
110340538|NCT02941575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110340539|NCT02941575|Dopamine Agents|dopamine agents|mesh-ancestor
110340540|NCT02941575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110340541|NCT02941575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110279033|NCT00209742|Vitamins|vitamins|mesh-ancestor
110279034|NCT00209742|Micronutrients|micronutrients|mesh-ancestor
110279035|NCT00209742|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110279036|NCT00209742|Antimetabolites|antimetabolites|mesh-ancestor
110279037|NCT00209742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110279038|NCT00209742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110279039|NCT00209742|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110279077|NCT00182663|Dexamethasone|dexamethasone|mesh-list
110279078|NCT00182663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110279079|NCT00182663|Antiemetics|antiemetics|mesh-ancestor
110279080|NCT00182663|Autonomic Agents|autonomic agents|mesh-ancestor
110279081|NCT00182663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110279082|NCT00182663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110340542|NCT02941575|Adrenergic Agents|adrenergic agents|mesh-ancestor
110340543|NCT02941575|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110340544|NCT02941575|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110340545|NCT02941575|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110340546|NCT02941575|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110340547|NCT02941731|Oseltamivir|oseltamivir|mesh-list
110340548|NCT02941731|Antiviral Agents|antiviral agents|mesh-ancestor
110340549|NCT02941731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110340550|NCT02941731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110340551|NCT02941731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110340552|NCT02951039|Edoxaban|edoxaban|mesh-list
110340553|NCT02951039|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110340554|NCT02951039|Antithrombins|antithrombins|mesh-ancestor
110340555|NCT02951039|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110340556|NCT02951039|Protease Inhibitors|protease inhibitors|mesh-ancestor
110340557|NCT02951039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110340558|NCT02951039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110340559|NCT02951039|Anticoagulants|anticoagulants|mesh-ancestor
110340560|NCT02951117|Dexamethasone|dexamethasone|mesh-list
110340561|NCT02951117|Venetoclax|venetoclax|mesh-list
110296717|NCT02212795|Fluoroquinolones|fluoroquinolones|mesh-list
110340562|NCT02951117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110340563|NCT02951117|Antiemetics|antiemetics|mesh-ancestor
110340564|NCT02951117|Autonomic Agents|autonomic agents|mesh-ancestor
110340565|NCT02951117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110340566|NCT02951117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110340567|NCT02951117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110340568|NCT02951117|Glucocorticoids|glucocorticoids|mesh-ancestor
110340569|NCT02951117|Hormones|hormones|mesh-ancestor
110340570|NCT02951117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110340571|NCT02951117|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110174636|NCT00067912|Analgesics|analgesics|mesh-ancestor
110340572|NCT02951117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110340573|NCT02950220|Pembrolizumab|pembrolizumab|mesh-list
110340574|NCT02950220|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110340575|NCT02950220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110340576|NCT02950220|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110173497|NCT02969473|Cisplatin|cisplatin|mesh-list
110340577|NCT02950220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110340578|NCT00515684|Bevacizumab|bevacizumab|mesh-list
110340579|NCT00515684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110340580|NCT00515684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110340581|NCT00515684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110340582|NCT00515684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110340583|NCT00515684|Growth Substances|growth substances|mesh-ancestor
110340584|NCT00515684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110340585|NCT00515684|Growth Inhibitors|growth inhibitors|mesh-ancestor
110340586|NCT05317767|Vaccines|vaccines|mesh-list
110340587|NCT05317767|Immunologic Factors|immunologic factors|mesh-ancestor
110340588|NCT05317767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110340589|NCT00515801|Glyburide|glyburide|mesh-list
110340590|NCT00515801|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110340591|NCT00515801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110340592|NCT05317611|Ondansetron|ondansetron|mesh-list
110340593|NCT05317611|Bupivacaine|bupivacaine|mesh-list
110340594|NCT05317611|Anesthetics, Local|anesthetics, local|mesh-ancestor
110340595|NCT05317611|Anesthetics|anesthetics|mesh-ancestor
110340596|NCT05317611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110340597|NCT05317611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110340598|NCT05317611|Sensory System Agents|sensory system agents|mesh-ancestor
110340599|NCT05317611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110340600|NCT05317611|Antiemetics|antiemetics|mesh-ancestor
110340601|NCT05317611|Autonomic Agents|autonomic agents|mesh-ancestor
110340602|NCT05317611|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110340603|NCT05317611|Antipruritics|antipruritics|mesh-ancestor
110340604|NCT05317611|Dermatologic Agents|dermatologic agents|mesh-ancestor
110340605|NCT05317611|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110340606|NCT05317611|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110340607|NCT05317611|Serotonin Agents|serotonin agents|mesh-ancestor
110340608|NCT05317611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110340609|NCT05317611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110340611|NCT05317572|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110340612|NCT05317572|Narcotics|narcotics|mesh-ancestor
110340613|NCT05317572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110340614|NCT05317572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110340615|NCT05317572|Analgesics|analgesics|mesh-ancestor
110340616|NCT05317572|Sensory System Agents|sensory system agents|mesh-ancestor
110340617|NCT05317572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110340618|NCT00516425|Cyclophosphamide|cyclophosphamide|mesh-list
110340619|NCT00516425|Doxorubicin|doxorubicin|mesh-list
110340620|NCT00516425|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110340621|NCT00516425|Epirubicin|epirubicin|mesh-list
110340622|NCT00516425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110340623|NCT00516425|Immunologic Factors|immunologic factors|mesh-ancestor
110340624|NCT00516425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110340625|NCT00516425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110340626|NCT00516425|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110340627|NCT00516425|Alkylating Agents|alkylating agents|mesh-ancestor
110340628|NCT00516425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110340629|NCT00516425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110340630|NCT00516425|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110340631|NCT00516425|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110340632|NCT00516425|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110340633|NCT00516425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110340635|NCT02942706|Cetuximab|cetuximab|mesh-list
110340636|NCT02942706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110340637|NCT02942706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110340638|NCT00516464|Ranibizumab|ranibizumab|mesh-list
110340639|NCT00516464|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110340640|NCT00516464|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110340641|NCT00516464|Growth Substances|growth substances|mesh-ancestor
110174673|NCT00068302|Sirolimus|sirolimus|mesh-list
110296872|NCT00236015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110340642|NCT00516464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110340643|NCT00516464|Growth Inhibitors|growth inhibitors|mesh-ancestor
110340644|NCT00516464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110340645|NCT00516542|Letrozole|letrozole|mesh-list
110340646|NCT00516542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110340647|NCT00516542|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110340648|NCT00516542|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110173499|NCT02969473|Fluorouracil|fluorouracil|mesh-list
110340649|NCT00516542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110340650|NCT00516542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110340651|NCT00516542|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110340652|NCT00516542|Hormone Antagonists|hormone antagonists|mesh-ancestor
110296934|NCT02213614|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110340653|NCT00516542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110340654|NCT00516542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110340655|NCT03458481|Sofosbuvir|sofosbuvir|mesh-list
110340656|NCT03458481|Yimitasvir|yimitasvir|mesh-list
110340657|NCT03458481|Antiviral Agents|antiviral agents|mesh-ancestor
110340658|NCT03458481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110340659|NCT02949752|Aripiprazole|aripiprazole|mesh-list
110340660|NCT02949752|Antidepressive Agents|antidepressive agents|mesh-ancestor
110340661|NCT02949752|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110340662|NCT02949752|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110340663|NCT02949752|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110340664|NCT02949752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110340665|NCT02949752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110340666|NCT02949752|Dopamine Agonists|dopamine agonists|mesh-ancestor
110340667|NCT02949752|Dopamine Agents|dopamine agents|mesh-ancestor
110340668|NCT02949752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110340669|NCT02949752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110340670|NCT02949752|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110340671|NCT02949752|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110340672|NCT02949752|Serotonin Agents|serotonin agents|mesh-ancestor
110340673|NCT02949752|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110340674|NCT02949752|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110340675|NCT02949752|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110340676|NCT02949752|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110340678|NCT02942550|Methylnaltrexone|methylnaltrexone|mesh-list
110340679|NCT02942550|Anticonvulsants|anticonvulsants|mesh-ancestor
110340680|NCT02942550|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110340681|NCT02942550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110340682|NCT02942550|Sensory System Agents|sensory system agents|mesh-ancestor
110340683|NCT02942550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110340684|NCT04694612|Remdesivir|remdesivir|mesh-list
110340685|NCT04694612|Favipiravir|favipiravir|mesh-list
110340686|NCT04694612|Antimetabolites|antimetabolites|mesh-ancestor
110340687|NCT04694612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110340688|NCT04694612|Antiviral Agents|antiviral agents|mesh-ancestor
110340689|NCT04694612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110340690|NCT02941224|Sirolimus|sirolimus|mesh-list
110340691|NCT02941224|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110340692|NCT02941224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110340693|NCT02941224|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110340694|NCT02941224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110340695|NCT02941224|Antifungal Agents|antifungal agents|mesh-ancestor
110340696|NCT02941224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110340697|NCT02941224|Immunologic Factors|immunologic factors|mesh-ancestor
110340698|NCT02941224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110340699|NCT00516854|Chlordiazepoxide|chlordiazepoxide|mesh-list
110340700|NCT00516854|Clidinium|clidinium|mesh-list
110340701|NCT00516854|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110340702|NCT00516854|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110340703|NCT00516854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110340704|NCT00516854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110340705|NCT00516854|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110340706|NCT00516854|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110340707|NCT00516854|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110340708|NCT00516854|GABA Modulators|gaba modulators|mesh-ancestor
110340710|NCT00516854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110340711|NCT00516854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110340712|NCT00516854|Parasympatholytics|parasympatholytics|mesh-ancestor
110340713|NCT00516854|Autonomic Agents|autonomic agents|mesh-ancestor
110340714|NCT00516854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110340715|NCT02940990|Paclitaxel|paclitaxel|mesh-list
110340716|NCT02940990|Etoposide|etoposide|mesh-list
110340717|NCT02940990|Vinorelbine|vinorelbine|mesh-list
110340718|NCT02940990|Docetaxel|docetaxel|mesh-list
110340719|NCT02940990|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110340720|NCT02940990|Carboplatin|carboplatin|mesh-list
110340721|NCT02940990|Gemcitabine|gemcitabine|mesh-list
110340722|NCT02940990|Pemetrexed|pemetrexed|mesh-list
110340723|NCT02940990|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110340724|NCT02940990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110340725|NCT02940990|Tubulin Modulators|tubulin modulators|mesh-ancestor
110340726|NCT02940990|Antimitotic Agents|antimitotic agents|mesh-ancestor
110340727|NCT02940990|Mitosis Modulators|mitosis modulators|mesh-ancestor
110340728|NCT02940990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110340729|NCT02940990|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110340730|NCT02940990|Antimetabolites|antimetabolites|mesh-ancestor
110340731|NCT02940990|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110340732|NCT02940990|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110340733|NCT02940990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110340734|NCT02940990|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110340735|NCT02940990|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110340736|NCT00518297|Raltegravir Potassium|raltegravir potassium|mesh-list
110340737|NCT00518297|Atazanavir Sulfate|atazanavir sulfate|mesh-list
110340738|NCT00518297|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110340739|NCT00518297|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110340740|NCT00518297|Antiviral Agents|antiviral agents|mesh-ancestor
110340741|NCT00518297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110340742|NCT00518297|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110340743|NCT00518297|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110340744|NCT00518297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110340745|NCT00518297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110340746|NCT00518297|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110340747|NCT00518297|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110340748|NCT00518297|Protease Inhibitors|protease inhibitors|mesh-ancestor
110340749|NCT00518375|Cyclosporine|cyclosporine|mesh-list
110340750|NCT00518375|Sirolimus|sirolimus|mesh-list
110297079|NCT04547179|Erenumab|erenumab|mesh-list
110340751|NCT00518375|Cyclosporins|cyclosporins|mesh-list
110340752|NCT00518375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110340753|NCT00518375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110340754|NCT00518375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110340755|NCT00518375|Immunologic Factors|immunologic factors|mesh-ancestor
110340756|NCT00518375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110340757|NCT00518375|Antifungal Agents|antifungal agents|mesh-ancestor
110340758|NCT00518375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110340759|NCT00518375|Dermatologic Agents|dermatologic agents|mesh-ancestor
110340760|NCT00518375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110340761|NCT00518375|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110340762|NCT00518375|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110340763|NCT00518375|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110340764|NCT00518375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110340765|NCT02942043|Bevacizumab|bevacizumab|mesh-list
110340766|NCT02942043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110340767|NCT02942043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110340768|NCT02942043|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110340769|NCT02942043|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110340770|NCT02942043|Growth Substances|growth substances|mesh-ancestor
110340771|NCT02942043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110340772|NCT02942043|Growth Inhibitors|growth inhibitors|mesh-ancestor
110340773|NCT00516971|Esomeprazole|esomeprazole|mesh-list
110340774|NCT00516971|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110340775|NCT00516971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110340776|NCT00516971|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110340777|NCT00516971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110174687|NCT00068497|Gefitinib|gefitinib|mesh-list
110340778|NCT00516971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110340780|NCT00518570|Anticonvulsants|anticonvulsants|mesh-ancestor
110340781|NCT00518570|Nootropic Agents|nootropic agents|mesh-ancestor
110340782|NCT03458208|Metformin|metformin|mesh-list
110340783|NCT03458208|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110340784|NCT03458208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110340785|NCT00517283|Exenatide|exenatide|mesh-list
110340786|NCT00517283|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110340787|NCT00517283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110340788|NCT00517283|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110340789|NCT00517283|Incretins|incretins|mesh-ancestor
110340790|NCT00517283|Hormones|hormones|mesh-ancestor
110340791|NCT00517283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110340792|NCT02940912|Apomorphine|apomorphine|mesh-list
110340793|NCT02940912|Emetics|emetics|mesh-ancestor
110340794|NCT02940912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110340796|NCT02940912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110340797|NCT02940912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110340798|NCT02940912|Dopamine Agonists|dopamine agonists|mesh-ancestor
110340799|NCT02940912|Dopamine Agents|dopamine agents|mesh-ancestor
110340800|NCT02940912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110340801|NCT02940912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110340802|NCT00517322|Ramipril|ramipril|mesh-list
110340803|NCT00517322|Irbesartan|irbesartan|mesh-list
110340804|NCT00517322|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110340805|NCT00517322|Protease Inhibitors|protease inhibitors|mesh-ancestor
110340806|NCT00517322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110340807|NCT00517322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110340808|NCT00517322|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110340809|NCT00517322|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110340810|NCT00517322|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110340811|NCT02939430|Atropine|atropine|mesh-list
110340812|NCT02939430|Neostigmine|neostigmine|mesh-list
110340813|NCT02939430|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110340814|NCT02939430|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110340815|NCT02939430|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110340816|NCT02939430|Autonomic Agents|autonomic agents|mesh-ancestor
110340817|NCT02939430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110340818|NCT02939430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110340819|NCT02939430|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110340820|NCT02939430|Respiratory System Agents|respiratory system agents|mesh-ancestor
110340821|NCT02939430|Mydriatics|mydriatics|mesh-ancestor
110340822|NCT02939430|Parasympatholytics|parasympatholytics|mesh-ancestor
110340823|NCT02939430|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110340824|NCT02939430|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110340825|NCT02939430|Cholinergic Agents|cholinergic agents|mesh-ancestor
110340826|NCT02939430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110340827|NCT02939430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110340828|NCT02939430|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110340829|NCT02939430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110340830|NCT02939430|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110340831|NCT02940717|Lithium Carbonate|lithium carbonate|mesh-list
110340832|NCT02940717|Antidepressive Agents|antidepressive agents|mesh-ancestor
110340833|NCT02940717|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110340834|NCT02940717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110340835|NCT02940717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110340836|NCT02940717|Antimanic Agents|antimanic agents|mesh-ancestor
110340837|NCT02940717|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110340838|NCT02940717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110340839|NCT02940717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110340840|NCT00517517|Hemagglutinins|hemagglutinins|mesh-list
110340841|NCT00517517|Agglutinins|agglutinins|mesh-ancestor
110340842|NCT00517517|Immunologic Factors|immunologic factors|mesh-ancestor
110340843|NCT00517517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110340844|NCT00517517|Coagulants|coagulants|mesh-ancestor
110340845|NCT02940756|Artesunate|artesunate|mesh-list
110340846|NCT02940756|Lumefantrine|lumefantrine|mesh-list
110340847|NCT02940756|Artemether|artemether|mesh-list
110340848|NCT02940756|Piperaquine|piperaquine|mesh-list
110174696|NCT00068653|Analgesics|analgesics|mesh-ancestor
110340849|NCT02940756|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
110340850|NCT02940756|Amodiaquine|amodiaquine|mesh-list
110340851|NCT02940756|Artenimol|artenimol|mesh-list
110340852|NCT02940756|Antimalarials|antimalarials|mesh-ancestor
110340853|NCT02940756|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110340854|NCT02940756|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110340855|NCT02940756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110340856|NCT02940756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110340857|NCT02940756|Antiviral Agents|antiviral agents|mesh-ancestor
110340858|NCT02940756|Schistosomicides|schistosomicides|mesh-ancestor
110340859|NCT02940756|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110340860|NCT02940756|Anthelmintics|anthelmintics|mesh-ancestor
110340862|NCT02939547|Sequestering Agents|sequestering agents|mesh-ancestor
110340863|NCT02939547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110340864|NCT02941068|Fluconazole|fluconazole|mesh-list
110340865|NCT02941068|Caspofungin|caspofungin|mesh-list
110340866|NCT02941068|Antifungal Agents|antifungal agents|mesh-ancestor
110340867|NCT02941068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110340868|NCT02941068|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110340869|NCT02941068|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110340870|NCT02941068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110340871|NCT02941068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110340872|NCT02941068|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110340873|NCT02941068|Hormone Antagonists|hormone antagonists|mesh-ancestor
110340874|NCT02941068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110340875|NCT02941068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110340876|NCT02941068|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110340877|NCT02941068|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110340878|NCT00517712|Arsenic Trioxide|arsenic trioxide|mesh-list
110340879|NCT00517712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110340880|NCT02939274|Verteporfin|verteporfin|mesh-list
110340881|NCT02939274|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110340882|NCT02939274|Dermatologic Agents|dermatologic agents|mesh-ancestor
110340883|NCT04694183|Paclitaxel|paclitaxel|mesh-list
110340884|NCT04694183|Antibodies|antibodies|mesh-list
110340885|NCT04694183|Immunoglobulins|immunoglobulins|mesh-list
110340886|NCT04694183|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110340887|NCT04694183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110340888|NCT04694183|Tubulin Modulators|tubulin modulators|mesh-ancestor
110340889|NCT04694183|Antimitotic Agents|antimitotic agents|mesh-ancestor
110297544|NCT00269685|Hemostatics|hemostatics|mesh-ancestor
110340890|NCT04694183|Mitosis Modulators|mitosis modulators|mesh-ancestor
110340891|NCT04694183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110340892|NCT04694183|Immunologic Factors|immunologic factors|mesh-ancestor
110340893|NCT04694183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110340894|NCT00517946|Cetirizine|cetirizine|mesh-list
110340895|NCT00517946|Pseudoephedrine|pseudoephedrine|mesh-list
110340896|NCT00517946|Ephedrine|ephedrine|mesh-list
110340897|NCT00517946|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110340898|NCT00517946|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110340899|NCT00517946|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110340900|NCT00517946|Histamine Antagonists|histamine antagonists|mesh-ancestor
110340901|NCT00517946|Histamine Agents|histamine agents|mesh-ancestor
110340902|NCT00517946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110340903|NCT00517946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110340904|NCT00517946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110340905|NCT00517946|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110340906|NCT00517946|Autonomic Agents|autonomic agents|mesh-ancestor
110340907|NCT00517946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110340908|NCT00517946|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110340909|NCT00517946|Respiratory System Agents|respiratory system agents|mesh-ancestor
110340910|NCT00517946|Nasal Decongestants|nasal decongestants|mesh-ancestor
110340911|NCT00517946|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110340912|NCT00517946|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110340913|NCT00517946|Sympathomimetics|sympathomimetics|mesh-ancestor
110340914|NCT00517946|Adrenergic Agents|adrenergic agents|mesh-ancestor
110340915|NCT04988685|Sirolimus|sirolimus|mesh-list
110340916|NCT04988685|Paclitaxel|paclitaxel|mesh-list
110340917|NCT04988685|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110340919|NCT04988685|Tubulin Modulators|tubulin modulators|mesh-ancestor
110340920|NCT04988685|Antimitotic Agents|antimitotic agents|mesh-ancestor
110340921|NCT04988685|Mitosis Modulators|mitosis modulators|mesh-ancestor
110340922|NCT04988685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110340923|NCT04988685|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110340924|NCT04988685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110340925|NCT04988685|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110340926|NCT04988685|Antifungal Agents|antifungal agents|mesh-ancestor
110340927|NCT04988685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110340928|NCT04988685|Immunologic Factors|immunologic factors|mesh-ancestor
110340929|NCT04988685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110340930|NCT00517985|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110340931|NCT00517985|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110340932|NCT00517985|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110340933|NCT00517985|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110340934|NCT00517985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110340935|NCT00517985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110340936|NCT00517985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110340937|NCT00517985|Analgesics|analgesics|mesh-ancestor
110340938|NCT00517985|Sensory System Agents|sensory system agents|mesh-ancestor
110340939|NCT00517985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110340940|NCT00517985|Antidepressive Agents|antidepressive agents|mesh-ancestor
110340941|NCT00517985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110340942|NCT00517985|Dopamine Agents|dopamine agents|mesh-ancestor
110340943|NCT04690920|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110340945|NCT04690920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110340946|NCT04690920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110340947|NCT04690920|Antimetabolites|antimetabolites|mesh-ancestor
110340948|NCT04690920|Antiviral Agents|antiviral agents|mesh-ancestor
110340949|NCT00518102|Becaplermin|becaplermin|mesh-list
110340950|NCT00518102|Anticoagulants|anticoagulants|mesh-ancestor
110340951|NCT00518102|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
110340952|NCT00518102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110340953|NCT00518102|Growth Substances|growth substances|mesh-ancestor
110340954|NCT00518102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110340955|NCT02939235|Morphine|morphine|mesh-list
110340956|NCT02939235|Metoclopramide|metoclopramide|mesh-list
110297787|NCT00238004|Niacin|niacin|mesh-list
110340957|NCT02939235|Ticagrelor|ticagrelor|mesh-list
110340958|NCT02939235|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110340959|NCT02939235|Narcotics|narcotics|mesh-ancestor
110340960|NCT02939235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110340961|NCT02939235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110340962|NCT02939235|Analgesics|analgesics|mesh-ancestor
110340963|NCT02939235|Sensory System Agents|sensory system agents|mesh-ancestor
110340964|NCT02939235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110340965|NCT02939235|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110340966|NCT02939235|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110340967|NCT02939235|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110340968|NCT02939235|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110340969|NCT02939235|Purinergic Agents|purinergic agents|mesh-ancestor
110340970|NCT02939235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110340971|NCT02939235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110340972|NCT02939235|Antiemetics|antiemetics|mesh-ancestor
110340973|NCT02939235|Autonomic Agents|autonomic agents|mesh-ancestor
110340974|NCT02939235|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110340975|NCT02939235|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110340976|NCT02939235|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110340977|NCT02939235|Dopamine Agents|dopamine agents|mesh-ancestor
110340978|NCT00518141|Aspirin|aspirin|mesh-list
110340979|NCT00518141|Salicylic Acid|salicylic acid|mesh-list
110340980|NCT00518141|Salicylates|salicylates|mesh-list
110340981|NCT00518141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110340982|NCT00518141|Antifungal Agents|antifungal agents|mesh-ancestor
110340983|NCT00518141|Keratolytic Agents|keratolytic agents|mesh-ancestor
110340984|NCT00518141|Dermatologic Agents|dermatologic agents|mesh-ancestor
110340985|NCT00518141|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110340986|NCT00518141|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110340987|NCT00518141|Analgesics|analgesics|mesh-ancestor
110340988|NCT00518141|Sensory System Agents|sensory system agents|mesh-ancestor
110340989|NCT00518141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110340990|NCT00518141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110340991|NCT00518141|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110340992|NCT00518141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110340993|NCT00518141|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110340994|NCT00518141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110340995|NCT00518141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110340996|NCT00518141|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110340997|NCT00518141|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110340998|NCT00518141|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110340999|NCT00518141|Antipyretics|antipyretics|mesh-ancestor
110341000|NCT02938962|Tranexamic Acid|tranexamic acid|mesh-list
110341002|NCT02938962|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110341003|NCT02938962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110341004|NCT02938962|Hemostatics|hemostatics|mesh-ancestor
110341005|NCT02938962|Coagulants|coagulants|mesh-ancestor
110341006|NCT00519701|Hydroxyurea|hydroxyurea|mesh-list
110341007|NCT00519701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110341008|NCT00519701|Antisickling Agents|antisickling agents|mesh-ancestor
110341009|NCT00519701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110341010|NCT00519701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110341011|NCT00519701|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110341013|NCT00519116|Tacrolimus|tacrolimus|mesh-list
110341014|NCT00519116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110341015|NCT00519116|Immunologic Factors|immunologic factors|mesh-ancestor
110341016|NCT00519116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110341017|NCT00519116|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110341018|NCT00519116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110341019|NCT00519116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110297899|NCT00238199|Calcitriol|calcitriol|mesh-list
110341020|NCT00519116|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110341021|NCT00519116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110341022|NCT00519116|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110341023|NCT00519116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110341024|NCT00519116|Antifungal Agents|antifungal agents|mesh-ancestor
110341025|NCT04691076|Fentanyl|fentanyl|mesh-list
110341026|NCT04691076|Propofol|propofol|mesh-list
110341027|NCT04691076|Esketamine|esketamine|mesh-list
110341028|NCT04691076|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110341029|NCT04691076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110341030|NCT04691076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110341031|NCT04691076|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110341032|NCT04691076|Anesthetics, General|anesthetics, general|mesh-ancestor
110341033|NCT04691076|Anesthetics|anesthetics|mesh-ancestor
110341034|NCT04691076|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110341035|NCT04691076|Narcotics|narcotics|mesh-ancestor
110341036|NCT04691076|Analgesics|analgesics|mesh-ancestor
110341037|NCT04691076|Sensory System Agents|sensory system agents|mesh-ancestor
110341038|NCT04691076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110341039|NCT04691076|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110297954|NCT02216227|Iodine|iodine|mesh-list
110341040|NCT04691076|Antidepressive Agents|antidepressive agents|mesh-ancestor
110341041|NCT04691076|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110341042|NCT02949206|Thrombin|thrombin|mesh-list
110341043|NCT02949206|Hemostatics|hemostatics|mesh-ancestor
110341044|NCT02949206|Coagulants|coagulants|mesh-ancestor
110341045|NCT05108454|Micronutrients|micronutrients|mesh-list
110341046|NCT05108454|Trace Elements|trace elements|mesh-list
110341047|NCT05108454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110341048|NCT02940561|Methotrexate|methotrexate|mesh-list
110279524|NCT02963402|Adalimumab|adalimumab|mesh-list
110341049|NCT02940561|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110341050|NCT02940561|Abortifacient Agents|abortifacient agents|mesh-ancestor
110341051|NCT02940561|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110341052|NCT02940561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110341053|NCT02940561|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110341054|NCT02940561|Antimetabolites|antimetabolites|mesh-ancestor
110341055|NCT02940561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110341056|NCT02940561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110341057|NCT02940561|Dermatologic Agents|dermatologic agents|mesh-ancestor
110341058|NCT02940561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110341059|NCT02940561|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110341060|NCT02940561|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110341061|NCT02940561|Immunologic Factors|immunologic factors|mesh-ancestor
110341062|NCT02940561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110341063|NCT02940561|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110341064|NCT02940366|Atorvastatin|atorvastatin|mesh-list
110341065|NCT02940366|Pitavastatin|pitavastatin|mesh-list
110341066|NCT02940366|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110341067|NCT02940366|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110341068|NCT02940366|Antimetabolites|antimetabolites|mesh-ancestor
110341069|NCT02940366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110341070|NCT02940366|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110341071|NCT02940366|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110341072|NCT02940366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110341073|NCT02940405|Ketorolac|ketorolac|mesh-list
110341074|NCT02940405|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
110341075|NCT02940405|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110341076|NCT02940405|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110341077|NCT02940405|Analgesics|analgesics|mesh-ancestor
110341078|NCT02940405|Sensory System Agents|sensory system agents|mesh-ancestor
110341079|NCT02940405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110341080|NCT02940405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110341081|NCT02940405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110341082|NCT02940405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110341083|NCT02940405|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110341084|NCT02940405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110341085|NCT02940405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110341087|NCT02940444|Anticoagulants|anticoagulants|mesh-ancestor
110341088|NCT02940444|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110341089|NCT02940444|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110341090|NCT02940444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110298130|NCT04534231|Nicotine|nicotine|mesh-list
110341091|NCT00520052|Zoledronic Acid|zoledronic acid|mesh-list
110341092|NCT00520052|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110341093|NCT00520052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110341094|NCT04690647|Dexamethasone|dexamethasone|mesh-list
110341095|NCT04690647|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
110341096|NCT04690647|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110341097|NCT04690647|Antiemetics|antiemetics|mesh-ancestor
110341098|NCT04690647|Autonomic Agents|autonomic agents|mesh-ancestor
110341099|NCT04690647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110341100|NCT04690647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110341101|NCT04690647|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110341102|NCT04690647|Glucocorticoids|glucocorticoids|mesh-ancestor
110341103|NCT04690647|Hormones|hormones|mesh-ancestor
110341104|NCT04690647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110341105|NCT04690647|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110341106|NCT04690647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110341107|NCT04690647|Analgesics|analgesics|mesh-ancestor
110341108|NCT04690647|Sensory System Agents|sensory system agents|mesh-ancestor
110341109|NCT00519467|Artesunate|artesunate|mesh-list
110341110|NCT00519467|Dapsone|dapsone|mesh-list
110341111|NCT00519467|Chlorproguanil|chlorproguanil|mesh-list
110341112|NCT00519467|Antimalarials|antimalarials|mesh-ancestor
110341113|NCT00519467|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110174725|NCT00399061|Cyclosporine|cyclosporine|mesh-list
110341114|NCT00519467|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110341115|NCT00519467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110341116|NCT00519467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110341117|NCT00519467|Antiviral Agents|antiviral agents|mesh-ancestor
110341118|NCT00519467|Schistosomicides|schistosomicides|mesh-ancestor
110341119|NCT00519467|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110341120|NCT00519467|Anthelmintics|anthelmintics|mesh-ancestor
110341121|NCT00519467|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110341122|NCT00519467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110341123|NCT00519467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110341124|NCT00519467|Leprostatic Agents|leprostatic agents|mesh-ancestor
110341125|NCT00519467|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110341126|NCT02940483|Azacitidine|azacitidine|mesh-list
110341127|NCT02940483|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110341128|NCT02940483|Antimetabolites|antimetabolites|mesh-ancestor
110341129|NCT02940483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110341130|NCT02940483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110341131|NCT02940483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110341132|NCT04974684|Apixaban|apixaban|mesh-list
110341133|NCT04974684|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110341134|NCT04974684|Antithrombins|antithrombins|mesh-ancestor
110341135|NCT04974684|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110341136|NCT04974684|Protease Inhibitors|protease inhibitors|mesh-ancestor
110341137|NCT04974684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110341138|NCT04974684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110341139|NCT04974684|Anticoagulants|anticoagulants|mesh-ancestor
110341140|NCT00520091|Celecoxib|celecoxib|mesh-list
110341141|NCT00520091|Irinotecan|irinotecan|mesh-list
110341142|NCT00520091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110341143|NCT00520091|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110341144|NCT00520091|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110341145|NCT00520091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110341146|NCT00520091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110341147|NCT00520091|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110341148|NCT00520091|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110341150|NCT00520091|Sensory System Agents|sensory system agents|mesh-ancestor
110341151|NCT00520091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110341152|NCT00520091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110341153|NCT00520091|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110341154|NCT00520091|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110341155|NCT00520091|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110341156|NCT00520091|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110341157|NCT00520169|Ketamine|ketamine|mesh-list
110341158|NCT00520169|Analgesics|analgesics|mesh-ancestor
110341159|NCT00520169|Sensory System Agents|sensory system agents|mesh-ancestor
110341160|NCT00520169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110341161|NCT00520169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110341162|NCT00520169|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110341163|NCT00520169|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110341164|NCT00520169|Anesthetics, General|anesthetics, general|mesh-ancestor
110341165|NCT00520169|Anesthetics|anesthetics|mesh-ancestor
110341166|NCT00520169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110341167|NCT00520169|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110341168|NCT00520169|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110341169|NCT00520169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110341170|NCT00520169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110341171|NCT00520247|Folic Acid|folic acid|mesh-list
110341172|NCT00520247|Enalapril|enalapril|mesh-list
110341173|NCT00520247|Hematinics|hematinics|mesh-ancestor
110341174|NCT00520247|Vitamin B Complex|vitamin b complex|mesh-ancestor
110341175|NCT00520247|Vitamins|vitamins|mesh-ancestor
110341176|NCT00520247|Micronutrients|micronutrients|mesh-ancestor
110341177|NCT00520247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110341178|NCT00520247|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110341179|NCT00520247|Protease Inhibitors|protease inhibitors|mesh-ancestor
110341180|NCT00520247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110341181|NCT00520247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110341182|NCT00520247|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110341183|NCT02949050|Immunomodulating Agents|immunomodulating agents|mesh-list
110341184|NCT02949050|Immunologic Factors|immunologic factors|mesh-ancestor
110341185|NCT02949050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110341186|NCT00520325|Lectins|lectins|mesh-list
110341187|NCT00520325|Agglutinins|agglutinins|mesh-ancestor
110341188|NCT00520325|Immunologic Factors|immunologic factors|mesh-ancestor
110341189|NCT00520325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110341190|NCT00520325|Coagulants|coagulants|mesh-ancestor
110341191|NCT00520442|Ibuprofen|ibuprofen|mesh-list
110341192|NCT00520442|Codeine|codeine|mesh-list
110341193|NCT00520442|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110341194|NCT00520442|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110341195|NCT00520442|Analgesics|analgesics|mesh-ancestor
110341196|NCT00520442|Sensory System Agents|sensory system agents|mesh-ancestor
110341197|NCT00520442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110341198|NCT00520442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110341199|NCT00520442|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110341200|NCT00520442|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110341201|NCT00520442|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110341202|NCT00520442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110341203|NCT00520442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110341204|NCT00520442|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110341205|NCT00520442|Narcotics|narcotics|mesh-ancestor
110341206|NCT00520442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110341207|NCT00520442|Antitussive Agents|antitussive agents|mesh-ancestor
110341208|NCT00520442|Respiratory System Agents|respiratory system agents|mesh-ancestor
110341209|NCT02938572|Insulin Aspart|insulin aspart|mesh-list
110341210|NCT02938572|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110341211|NCT02938572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110341212|NCT02939898|Letrozole|letrozole|mesh-list
110341213|NCT02939898|Aromatase Inhibitors|aromatase inhibitors|mesh-list
110341214|NCT02939898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110341215|NCT02939898|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110341216|NCT02939898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110341217|NCT02939898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110341218|NCT02939898|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110341219|NCT02939898|Hormone Antagonists|hormone antagonists|mesh-ancestor
110341220|NCT02939898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110341221|NCT02939898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110341223|NCT00520754|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110298487|NCT05694533|Anesthetics|anesthetics|mesh-ancestor
110341225|NCT00520754|Histamine Antagonists|histamine antagonists|mesh-ancestor
110341226|NCT00520754|Histamine Agents|histamine agents|mesh-ancestor
110341227|NCT00520754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110341228|NCT00520754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110341229|NCT00520754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110341230|NCT02277132|Sildenafil Citrate|sildenafil citrate|mesh-list
110341231|NCT02277132|Vasodilator Agents|vasodilator agents|mesh-ancestor
110341232|NCT02277132|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110341233|NCT02277132|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110341234|NCT02277132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110341235|NCT02277132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110341236|NCT02277132|Urological Agents|urological agents|mesh-ancestor
110341237|NCT00520949|Amoxicillin|amoxicillin|mesh-list
110341238|NCT00520949|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
110341239|NCT00520949|Furazolidone|furazolidone|mesh-list
110341240|NCT00520949|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
110341241|NCT00520949|Esomeprazole|esomeprazole|mesh-list
110341242|NCT00520949|Bismuth|bismuth|mesh-list
110341243|NCT00520949|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110341244|NCT00520949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110341245|NCT00520949|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110341246|NCT00520949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110341247|NCT00520949|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110341248|NCT00520949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110341249|NCT00520949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110341250|NCT00520949|Antacids|antacids|mesh-ancestor
110341251|NCT00520949|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110341252|NCT00520949|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110341253|NCT00520949|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110341254|NCT00520949|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
110341255|NCT00520949|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110341256|NCT00520949|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110341257|NCT00520949|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
110341258|NCT02938260|Metoprolol|metoprolol|mesh-list
110341259|NCT02938260|Diltiazem|diltiazem|mesh-list
110341260|NCT02938260|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110341261|NCT02938260|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110341262|NCT02938260|Sympatholytics|sympatholytics|mesh-ancestor
110341263|NCT02938260|Autonomic Agents|autonomic agents|mesh-ancestor
110341264|NCT02938260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110341265|NCT02938260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110341266|NCT02938260|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110341267|NCT02938260|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110341268|NCT02938260|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110341269|NCT02938260|Adrenergic Agents|adrenergic agents|mesh-ancestor
110341270|NCT02938260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110341271|NCT02938260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110341272|NCT02938260|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110341273|NCT02938260|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110341274|NCT02938260|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110341275|NCT02938260|Vasodilator Agents|vasodilator agents|mesh-ancestor
110341276|NCT02938182|Clopidogrel|clopidogrel|mesh-list
110341277|NCT02938182|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110341278|NCT02938182|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110341279|NCT02938182|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110341280|NCT02938182|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110341281|NCT02938182|Purinergic Agents|purinergic agents|mesh-ancestor
110341282|NCT02938182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110341283|NCT02938182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110341284|NCT02938182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110341285|NCT00521183|Tetrahydrouridine|tetrahydrouridine|mesh-list
110341286|NCT00521183|Antimetabolites|antimetabolites|mesh-ancestor
110341287|NCT00521183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110341288|NCT00521612|Sevoflurane|sevoflurane|mesh-list
110341289|NCT00521612|Isoflurane|isoflurane|mesh-list
110341290|NCT00521612|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110341291|NCT00521612|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110341292|NCT00521612|Anesthetics, General|anesthetics, general|mesh-ancestor
110341293|NCT00521612|Anesthetics|anesthetics|mesh-ancestor
110341294|NCT00521612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110341295|NCT00521612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110341296|NCT00521261|Antibodies|antibodies|mesh-list
110341298|NCT00521261|Immunologic Factors|immunologic factors|mesh-ancestor
110341299|NCT00521261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110341300|NCT02931591|Metformin|metformin|mesh-list
110341301|NCT02931591|Hormones|hormones|mesh-list
110341302|NCT02931591|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110341303|NCT02931591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110341304|NCT02931591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110341305|NCT00521300|Octreotide|octreotide|mesh-list
110341306|NCT00521300|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110341307|NCT00521300|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110341308|NCT00521300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110341309|NCT00521690|Insulin Detemir|insulin detemir|mesh-list
110341310|NCT00521690|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110341311|NCT00521690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110341312|NCT00523133|Naltrexone|naltrexone|mesh-list
110341313|NCT00523133|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110341314|NCT00523133|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110341315|NCT00523133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110341316|NCT00523133|Sensory System Agents|sensory system agents|mesh-ancestor
110341317|NCT00523133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110341318|NCT02937792|Bupivacaine|bupivacaine|mesh-list
110341319|NCT02937792|Anesthetics, Local|anesthetics, local|mesh-ancestor
110341320|NCT02937792|Anesthetics|anesthetics|mesh-ancestor
110341321|NCT02937792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110341322|NCT02937792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110341323|NCT02937792|Sensory System Agents|sensory system agents|mesh-ancestor
110341324|NCT02937792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110341325|NCT02931474|Tesamorelin|tesamorelin|mesh-list
110341326|NCT02931474|Growth Substances|growth substances|mesh-ancestor
110341327|NCT02931474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110341328|NCT02931357|Cetylpyridinium|cetylpyridinium|mesh-list
110341329|NCT02931357|Lidocaine|lidocaine|mesh-list
110341330|NCT02931357|Hyaluronic Acid|hyaluronic acid|mesh-list
110341331|NCT02931357|Anesthetics, Local|anesthetics, local|mesh-ancestor
110341332|NCT02931357|Anesthetics|anesthetics|mesh-ancestor
110341333|NCT02931357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110341334|NCT02931357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110341335|NCT02931357|Sensory System Agents|sensory system agents|mesh-ancestor
110341336|NCT02931357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110341337|NCT02931357|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110341338|NCT02931357|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110341339|NCT02931357|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110341340|NCT02931357|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110341341|NCT02931357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110341342|NCT02931357|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110341343|NCT02931357|Immunologic Factors|immunologic factors|mesh-ancestor
110341344|NCT02931357|Viscosupplements|viscosupplements|mesh-ancestor
110341345|NCT02931357|Protective Agents|protective agents|mesh-ancestor
110341346|NCT02931357|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110341347|NCT02931357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110341348|NCT02937519|Cisplatin|cisplatin|mesh-list
110341349|NCT02937519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110341350|NCT00521963|Infliximab|infliximab|mesh-list
110341351|NCT00521963|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110341352|NCT00521963|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110341353|NCT00521963|Dermatologic Agents|dermatologic agents|mesh-ancestor
110341354|NCT00521963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110341355|NCT00521963|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110341356|NCT02937402|Dimercaprol|dimercaprol|mesh-list
110341357|NCT02937402|Chelating Agents|chelating agents|mesh-ancestor
110341358|NCT02937402|Sequestering Agents|sequestering agents|mesh-ancestor
110341359|NCT02937402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110341360|NCT02937363|Thioctic Acid|thioctic acid|mesh-list
110341361|NCT02937363|Antioxidants|antioxidants|mesh-ancestor
110341362|NCT02937363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110341363|NCT02937363|Protective Agents|protective agents|mesh-ancestor
110341364|NCT02937363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110341365|NCT02937363|Vitamin B Complex|vitamin b complex|mesh-ancestor
110341367|NCT02937363|Micronutrients|micronutrients|mesh-ancestor
110341368|NCT02948348|Capecitabine|capecitabine|mesh-list
110341369|NCT02948348|Nivolumab|nivolumab|mesh-list
110341370|NCT02948348|Ipilimumab|ipilimumab|mesh-list
110341371|NCT02948348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110341372|NCT02948348|Antimetabolites|antimetabolites|mesh-ancestor
110341373|NCT02948348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110341374|NCT02948348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110341375|NCT02948348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110341376|NCT02948348|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110341377|NCT04693910|Hormones|hormones|mesh-list
110341378|NCT04693910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110341379|NCT04693910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110341380|NCT00522158|Atorvastatin|atorvastatin|mesh-list
110341381|NCT00522158|Simvastatin|simvastatin|mesh-list
110341382|NCT00522158|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110341383|NCT00522158|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110341384|NCT00522158|Antimetabolites|antimetabolites|mesh-ancestor
110341385|NCT00522158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110341386|NCT00522158|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110341387|NCT00522158|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110341388|NCT00522158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110341389|NCT02931123|Rifaximin|rifaximin|mesh-list
110341390|NCT02931123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110341391|NCT02931123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110341392|NCT02931123|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110341393|NCT02936934|Morphine|morphine|mesh-list
110341394|NCT02936934|Oxycodone|oxycodone|mesh-list
110341395|NCT02936934|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110341396|NCT02936934|Narcotics|narcotics|mesh-ancestor
110341397|NCT02936934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110341398|NCT02936934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110341399|NCT02936934|Analgesics|analgesics|mesh-ancestor
110341400|NCT02936934|Sensory System Agents|sensory system agents|mesh-ancestor
110341401|NCT02936934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110341402|NCT00522470|Rosiglitazone|rosiglitazone|mesh-list
110341403|NCT00522470|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110341404|NCT00522470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110341405|NCT00522509|Floxuridine|floxuridine|mesh-list
110341406|NCT00522509|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110341407|NCT00522509|Antimetabolites|antimetabolites|mesh-ancestor
110341408|NCT00522509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110341409|NCT00522509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110341410|NCT00522587|Remifentanil|remifentanil|mesh-list
110341411|NCT00522587|Sevoflurane|sevoflurane|mesh-list
110174790|NCT00390026|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110341412|NCT00522587|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110341413|NCT00522587|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110341414|NCT00522587|Anesthetics, General|anesthetics, general|mesh-ancestor
110341415|NCT00522587|Anesthetics|anesthetics|mesh-ancestor
110341416|NCT00522587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110341417|NCT00522587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110341418|NCT00522587|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110341419|NCT00522587|Narcotics|narcotics|mesh-ancestor
110341420|NCT00522587|Analgesics|analgesics|mesh-ancestor
110341421|NCT00522587|Sensory System Agents|sensory system agents|mesh-ancestor
110341422|NCT00522587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110341423|NCT00522665|Irinotecan|irinotecan|mesh-list
110341424|NCT00522665|Cetuximab|cetuximab|mesh-list
110341425|NCT00522665|Everolimus|everolimus|mesh-list
110341426|NCT00522665|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110341427|NCT00522665|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110341428|NCT00522665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110341429|NCT00522665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110341430|NCT00522665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110341431|NCT00522665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110341432|NCT00522665|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110341433|NCT00522665|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110341434|NCT00522665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110341435|NCT00522665|Immunologic Factors|immunologic factors|mesh-ancestor
110341436|NCT00522665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110341437|NCT00522743|Hormones|hormones|mesh-list
110341438|NCT00522743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110279683|NCT00184106|Paroxetine|paroxetine|mesh-list
110341439|NCT00522743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110341440|NCT02937012|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
110341441|NCT02937012|Bezafibrate|bezafibrate|mesh-list
110341442|NCT02937012|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
110341443|NCT02937012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110341444|NCT02937012|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110341445|NCT02937012|Antimetabolites|antimetabolites|mesh-ancestor
110341446|NCT02937012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110341447|NCT02937012|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110341449|NCT00522782|Nitric Oxide|nitric oxide|mesh-list
110341450|NCT00522782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110341451|NCT00522782|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110341452|NCT00522782|Autonomic Agents|autonomic agents|mesh-ancestor
110341453|NCT00522782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110341454|NCT00522782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110341455|NCT00522782|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110341456|NCT00522782|Respiratory System Agents|respiratory system agents|mesh-ancestor
110341457|NCT00522782|Glucocorticoids|glucocorticoids|mesh-ancestor
110341458|NCT00522782|Hormones|hormones|mesh-ancestor
110341459|NCT00522782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110341460|NCT00522782|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110341461|NCT00522782|Antioxidants|antioxidants|mesh-ancestor
110341462|NCT00522782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110341463|NCT00522782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110341464|NCT00522782|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
110341465|NCT00522782|Vasodilator Agents|vasodilator agents|mesh-ancestor
110341466|NCT00522782|Gasotransmitters|gasotransmitters|mesh-ancestor
110341467|NCT00522782|Protective Agents|protective agents|mesh-ancestor
110341468|NCT00522821|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110341469|NCT00522821|Immunoglobulins|immunoglobulins|mesh-list
110341470|NCT00522821|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110341471|NCT00522821|Antibodies|antibodies|mesh-list
110341472|NCT00522821|gamma-Globulins|gamma-globulins|mesh-list
110341473|NCT00522821|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110341474|NCT00522821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110341475|NCT00522821|Immunologic Factors|immunologic factors|mesh-ancestor
110341476|NCT00522821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110341477|NCT02936895|Vitamin D|vitamin d|mesh-list
110341478|NCT02936895|Cholecalciferol|cholecalciferol|mesh-list
110341479|NCT02936895|Vitamins|vitamins|mesh-ancestor
110341480|NCT02936895|Micronutrients|micronutrients|mesh-ancestor
110174812|NCT00070174|Cyclophosphamide|cyclophosphamide|mesh-list
110341481|NCT02936895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110341482|NCT02936895|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110341483|NCT02936895|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110341484|NCT00522938|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110341485|NCT00522938|Tosedostat|tosedostat|mesh-list
110341486|NCT00522938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110341487|NCT00522938|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110341488|NCT00522938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110341489|NCT00522938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110341490|NCT04694105|Dexamethasone|dexamethasone|mesh-list
110341491|NCT04694105|Dexmedetomidine|dexmedetomidine|mesh-list
110341492|NCT04694105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110341493|NCT04694105|Antiemetics|antiemetics|mesh-ancestor
110341494|NCT04694105|Autonomic Agents|autonomic agents|mesh-ancestor
110341495|NCT04694105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110341496|NCT04694105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110341497|NCT04694105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110341498|NCT04694105|Glucocorticoids|glucocorticoids|mesh-ancestor
110341499|NCT04694105|Hormones|hormones|mesh-ancestor
110341500|NCT04694105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110341501|NCT04694105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110341502|NCT04694105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110341503|NCT04694105|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110341504|NCT04694105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110341505|NCT04694105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110341506|NCT04694105|Analgesics|analgesics|mesh-ancestor
110341507|NCT04694105|Sensory System Agents|sensory system agents|mesh-ancestor
110341508|NCT04694105|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110341509|NCT04694105|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110341510|NCT04694105|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110341511|NCT04694105|Adrenergic Agents|adrenergic agents|mesh-ancestor
110341512|NCT04694105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110341513|NCT04694105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110341514|NCT02930733|Bupivacaine|bupivacaine|mesh-list
110341515|NCT02930733|Anesthetics, Local|anesthetics, local|mesh-ancestor
110341516|NCT02930733|Anesthetics|anesthetics|mesh-ancestor
110341517|NCT02930733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110341518|NCT02930733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110341519|NCT02930733|Sensory System Agents|sensory system agents|mesh-ancestor
110341520|NCT02930733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110341522|NCT00523055|Anesthetics, Local|anesthetics, local|mesh-ancestor
110341523|NCT00523055|Anesthetics|anesthetics|mesh-ancestor
110341524|NCT00523055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110341525|NCT00523055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110341526|NCT00523055|Sensory System Agents|sensory system agents|mesh-ancestor
110341527|NCT00523055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110341528|NCT00523055|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110341529|NCT00523055|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110341530|NCT00523055|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110341531|NCT00523055|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110341532|NCT00523055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110341533|NCT00523289|Bupivacaine|bupivacaine|mesh-list
110341534|NCT00523289|Ropivacaine|ropivacaine|mesh-list
110341535|NCT00523289|Anesthetics, Local|anesthetics, local|mesh-ancestor
110341536|NCT00523289|Anesthetics|anesthetics|mesh-ancestor
110341537|NCT00523289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110341538|NCT00523289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110341539|NCT00523289|Sensory System Agents|sensory system agents|mesh-ancestor
110341540|NCT00523289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110341541|NCT00524381|Etanercept|etanercept|mesh-list
110341542|NCT00524381|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110341543|NCT00524381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110341544|NCT00524381|Analgesics|analgesics|mesh-ancestor
110341545|NCT00524381|Sensory System Agents|sensory system agents|mesh-ancestor
110341546|NCT00524381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110341547|NCT00524381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110341548|NCT00524381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110341549|NCT00524381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110341550|NCT00524381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110341551|NCT00524381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110341552|NCT00524381|Immunologic Factors|immunologic factors|mesh-ancestor
110341553|NCT04502667|Vitamin D|vitamin d|mesh-list
110341554|NCT04502667|Cholecalciferol|cholecalciferol|mesh-list
110341555|NCT04502667|Vitamins|vitamins|mesh-ancestor
110341556|NCT04502667|Micronutrients|micronutrients|mesh-ancestor
110341557|NCT04502667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110341558|NCT04502667|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110341559|NCT04502667|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110341560|NCT00524498|Cisplatin|cisplatin|mesh-list
110341561|NCT00524498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110341562|NCT00523406|Triamcinolone|triamcinolone|mesh-list
110341563|NCT00523406|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110341564|NCT00523406|Glucocorticoids|glucocorticoids|mesh-ancestor
110341565|NCT00523406|Hormones|hormones|mesh-ancestor
110341566|NCT00523406|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110341567|NCT00523406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110341568|NCT00524615|Spironolactone|spironolactone|mesh-list
110341569|NCT00524615|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110341570|NCT00524615|Hormone Antagonists|hormone antagonists|mesh-ancestor
110341571|NCT00524615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110341572|NCT00524615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110341573|NCT00524615|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110341574|NCT00524615|Diuretics|diuretics|mesh-ancestor
110341575|NCT00524615|Natriuretic Agents|natriuretic agents|mesh-ancestor
110341576|NCT00523445|Varenicline|varenicline|mesh-list
110341577|NCT00523445|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110341578|NCT00523445|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110341579|NCT00523445|Cholinergic Agents|cholinergic agents|mesh-ancestor
110341580|NCT00523445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110341581|NCT00523445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110341582|NCT00523445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110341583|NCT02936661|Tranexamic Acid|tranexamic acid|mesh-list
110341584|NCT02936661|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110341585|NCT02936661|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110341586|NCT02936661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110173613|NCT02968927|Vitamin D|vitamin d|mesh-list
110341587|NCT02936661|Hemostatics|hemostatics|mesh-ancestor
110341588|NCT02936661|Coagulants|coagulants|mesh-ancestor
110341589|NCT02948075|Paclitaxel|paclitaxel|mesh-list
110341590|NCT02948075|Carboplatin|carboplatin|mesh-list
110341592|NCT02948075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110341593|NCT02948075|Tubulin Modulators|tubulin modulators|mesh-ancestor
110341594|NCT02948075|Antimitotic Agents|antimitotic agents|mesh-ancestor
110341595|NCT02948075|Mitosis Modulators|mitosis modulators|mesh-ancestor
110341596|NCT02948075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110341597|NCT02930811|Sildenafil Citrate|sildenafil citrate|mesh-list
110341598|NCT02930811|Vasodilator Agents|vasodilator agents|mesh-ancestor
110341599|NCT02930811|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110341600|NCT02930811|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110341601|NCT02930811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110341602|NCT02930811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110341603|NCT02930811|Urological Agents|urological agents|mesh-ancestor
110341604|NCT02947880|Bumetanide|bumetanide|mesh-list
110341605|NCT02947880|Diuretics|diuretics|mesh-ancestor
110341606|NCT02947880|Natriuretic Agents|natriuretic agents|mesh-ancestor
110341607|NCT02947880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110341608|NCT02947880|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110298646|NCT04983836|Anesthetics|anesthetics|mesh-list
110341609|NCT02947880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110341610|NCT02947880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110341611|NCT00523757|Spironolactone|spironolactone|mesh-list
110341612|NCT00523757|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110341613|NCT00523757|Hormone Antagonists|hormone antagonists|mesh-ancestor
110341614|NCT00523757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110341615|NCT00523757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110341616|NCT00523757|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110341618|NCT00523757|Natriuretic Agents|natriuretic agents|mesh-ancestor
110341619|NCT00524693|Montelukast|montelukast|mesh-list
110341620|NCT00524693|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110341621|NCT00524693|Respiratory System Agents|respiratory system agents|mesh-ancestor
110341622|NCT00524693|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110341623|NCT00524693|Hormone Antagonists|hormone antagonists|mesh-ancestor
110341624|NCT00524693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110341625|NCT00524693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110341626|NCT00524693|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110341627|NCT00524693|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110341628|NCT00524693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110341629|NCT02931201|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110341630|NCT02931201|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110341631|NCT02931201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110341632|NCT02936427|Dexamethasone|dexamethasone|mesh-list
110341633|NCT02936427|Dexamethasone acetate|dexamethasone acetate|mesh-list
110341634|NCT02936427|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
110341635|NCT02936427|BB 1101|bb 1101|mesh-list
110341636|NCT02936427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110341637|NCT02936427|Antiemetics|antiemetics|mesh-ancestor
110341638|NCT02936427|Autonomic Agents|autonomic agents|mesh-ancestor
110341639|NCT02936427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110341640|NCT02936427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110341641|NCT02936427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110341642|NCT02936427|Glucocorticoids|glucocorticoids|mesh-ancestor
110341643|NCT02936427|Hormones|hormones|mesh-ancestor
110341644|NCT02936427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110341645|NCT02936427|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110341646|NCT02936427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110341647|NCT02936427|Protease Inhibitors|protease inhibitors|mesh-ancestor
110341648|NCT02936427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110341649|NCT02936427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110341650|NCT00523913|Rosiglitazone|rosiglitazone|mesh-list
110341652|NCT00523913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110341653|NCT02947763|Metronidazole|metronidazole|mesh-list
110341654|NCT02947763|Ciprofloxacin|ciprofloxacin|mesh-list
110341655|NCT02947763|Minocycline|minocycline|mesh-list
110341656|NCT02947763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110341657|NCT02947763|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110341658|NCT02947763|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110341659|NCT02947763|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110341660|NCT02947763|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110341661|NCT02947763|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110341662|NCT02947763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110341663|NCT02947763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110341665|NCT02947763|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110341666|NCT02947763|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110341668|NCT00523952|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110341669|NCT00523952|Immunologic Factors|immunologic factors|mesh-ancestor
110341670|NCT00523952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110341671|NCT00523952|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110341672|NCT00523952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110341673|NCT00523952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110341674|NCT00524069|Bevacizumab|bevacizumab|mesh-list
110341675|NCT00524069|Gemcitabine|gemcitabine|mesh-list
110341676|NCT00524069|Capecitabine|capecitabine|mesh-list
110341677|NCT00524069|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110341678|NCT00524069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110341679|NCT00524069|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110341680|NCT00524069|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110341681|NCT00524069|Growth Substances|growth substances|mesh-ancestor
110341682|NCT00524069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110341683|NCT00524069|Growth Inhibitors|growth inhibitors|mesh-ancestor
110341684|NCT00524069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110341685|NCT00524069|Antimetabolites|antimetabolites|mesh-ancestor
110341686|NCT00524069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110341687|NCT00524810|Docetaxel|docetaxel|mesh-list
110341688|NCT00524810|Doxorubicin|doxorubicin|mesh-list
110341689|NCT00524810|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110341690|NCT00524810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110341691|NCT00524810|Tubulin Modulators|tubulin modulators|mesh-ancestor
110341692|NCT00524810|Antimitotic Agents|antimitotic agents|mesh-ancestor
110341693|NCT00524810|Mitosis Modulators|mitosis modulators|mesh-ancestor
110341694|NCT00524810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110341695|NCT00524810|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110341696|NCT00524810|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110341697|NCT00524810|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110341698|NCT00524810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110341699|NCT00524849|Zoledronic Acid|zoledronic acid|mesh-list
110341700|NCT00524849|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110341701|NCT00524849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110341702|NCT00524927|Methoxyflurane|methoxyflurane|mesh-list
110341703|NCT00524927|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110341704|NCT00524927|Anesthetics, General|anesthetics, general|mesh-ancestor
110341705|NCT00524927|Anesthetics|anesthetics|mesh-ancestor
110341706|NCT00524927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110341707|NCT00524927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110341709|NCT00524966|Coagulants|coagulants|mesh-ancestor
110341710|NCT02276846|Paclitaxel|paclitaxel|mesh-list
110341711|NCT02276846|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110341712|NCT02276846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110341713|NCT02276846|Tubulin Modulators|tubulin modulators|mesh-ancestor
110341714|NCT02276846|Antimitotic Agents|antimitotic agents|mesh-ancestor
110341715|NCT02276846|Mitosis Modulators|mitosis modulators|mesh-ancestor
110341716|NCT02276846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110341717|NCT02935725|Ketamine|ketamine|mesh-list
110341718|NCT02935725|Analgesics|analgesics|mesh-ancestor
110341719|NCT02935725|Sensory System Agents|sensory system agents|mesh-ancestor
110341720|NCT02935725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110341721|NCT02935725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110341722|NCT02935725|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110341723|NCT02935725|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110341724|NCT02935725|Anesthetics, General|anesthetics, general|mesh-ancestor
110341725|NCT02935725|Anesthetics|anesthetics|mesh-ancestor
110341726|NCT02935725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110341727|NCT02935725|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110341728|NCT02935725|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110341729|NCT02935725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110341730|NCT02935725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110341731|NCT02935764|Leucovorin|leucovorin|mesh-list
110341732|NCT02935764|Fluorouracil|fluorouracil|mesh-list
110341733|NCT02935764|Irinotecan|irinotecan|mesh-list
110341734|NCT02935764|Antimetabolites|antimetabolites|mesh-ancestor
110341735|NCT02935764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110341736|NCT02935764|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110341737|NCT02935764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110298675|NCT04899583|Tubulin Modulators|tubulin modulators|mesh-ancestor
110341738|NCT02935764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110341740|NCT02935764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110341741|NCT02935764|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110341742|NCT02935764|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110341743|NCT02935764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110341744|NCT02935764|Antidotes|antidotes|mesh-ancestor
110341745|NCT02935764|Protective Agents|protective agents|mesh-ancestor
110341746|NCT02935764|Vitamin B Complex|vitamin b complex|mesh-ancestor
110341748|NCT02935764|Micronutrients|micronutrients|mesh-ancestor
110341749|NCT02935998|Ziprasidone|ziprasidone|mesh-list
110341750|NCT02935998|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110341751|NCT02935998|Serotonin Agents|serotonin agents|mesh-ancestor
110341752|NCT02935998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110341753|NCT02935998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110341754|NCT02935998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110341755|NCT02935998|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110341756|NCT02935998|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110341757|NCT02935998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110341758|NCT02935998|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110341759|NCT02935998|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110341760|NCT02935998|Dopamine Agents|dopamine agents|mesh-ancestor
110341761|NCT02930109|Cytarabine|cytarabine|mesh-list
110341762|NCT02930109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110341763|NCT02930109|Antimetabolites|antimetabolites|mesh-ancestor
110341764|NCT02930109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110341765|NCT02930109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110341766|NCT02930109|Antiviral Agents|antiviral agents|mesh-ancestor
110341767|NCT02930109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110341768|NCT02930109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110341769|NCT02930109|Immunologic Factors|immunologic factors|mesh-ancestor
110341770|NCT02930109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110341771|NCT00524186|Leucovorin|leucovorin|mesh-list
110341772|NCT00524186|Fluorouracil|fluorouracil|mesh-list
110341773|NCT00524186|Irinotecan|irinotecan|mesh-list
110341774|NCT00524186|Sunitinib|sunitinib|mesh-list
110341775|NCT00524186|Calcium|calcium|mesh-list
110341776|NCT00524186|Levoleucovorin|levoleucovorin|mesh-list
110341777|NCT00524186|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110341778|NCT00524186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110341779|NCT00524186|Antimetabolites|antimetabolites|mesh-ancestor
110341780|NCT00524186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110341781|NCT00524186|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110341782|NCT00524186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110341783|NCT00524186|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110341784|NCT00524186|Immunologic Factors|immunologic factors|mesh-ancestor
110341785|NCT00524186|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110341786|NCT00524186|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110341787|NCT00524186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110341788|NCT00524186|Antidotes|antidotes|mesh-ancestor
110341789|NCT00524186|Protective Agents|protective agents|mesh-ancestor
110341790|NCT00524186|Vitamin B Complex|vitamin b complex|mesh-ancestor
110341791|NCT00524186|Vitamins|vitamins|mesh-ancestor
110341792|NCT00524186|Micronutrients|micronutrients|mesh-ancestor
110341793|NCT00524186|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110341794|NCT00524186|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110341795|NCT00524186|Growth Substances|growth substances|mesh-ancestor
110341796|NCT00524186|Growth Inhibitors|growth inhibitors|mesh-ancestor
110341797|NCT00524186|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110341798|NCT00525005|Docetaxel|docetaxel|mesh-list
110341799|NCT00525005|Oxaliplatin|oxaliplatin|mesh-list
110341800|NCT00525005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110341801|NCT00525005|Tubulin Modulators|tubulin modulators|mesh-ancestor
110341802|NCT00525005|Antimitotic Agents|antimitotic agents|mesh-ancestor
110341803|NCT00525005|Mitosis Modulators|mitosis modulators|mesh-ancestor
110341804|NCT00525005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110341805|NCT00525200|Docetaxel|docetaxel|mesh-list
110341806|NCT00525200|Cisplatin|cisplatin|mesh-list
110341807|NCT00525200|Fluorouracil|fluorouracil|mesh-list
110341808|NCT00525200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110341809|NCT00525200|Tubulin Modulators|tubulin modulators|mesh-ancestor
110341810|NCT00525200|Antimitotic Agents|antimitotic agents|mesh-ancestor
110341811|NCT00525200|Mitosis Modulators|mitosis modulators|mesh-ancestor
110341812|NCT00525200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110341813|NCT00525200|Antimetabolites|antimetabolites|mesh-ancestor
110341814|NCT00525200|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110341815|NCT00525200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110341816|NCT00525200|Immunologic Factors|immunologic factors|mesh-ancestor
110341817|NCT00525200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110341819|NCT02930265|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110341820|NCT02930265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110341821|NCT02930265|Incretins|incretins|mesh-ancestor
110341822|NCT02930265|Hormones|hormones|mesh-ancestor
110341823|NCT02930265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110341824|NCT02947178|Bupivacaine|bupivacaine|mesh-list
110341825|NCT02947178|Anesthetics, Local|anesthetics, local|mesh-ancestor
110341826|NCT02947178|Anesthetics|anesthetics|mesh-ancestor
110341827|NCT02947178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110341828|NCT02947178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110341829|NCT02947178|Sensory System Agents|sensory system agents|mesh-ancestor
110341830|NCT02947178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110341831|NCT02929797|Gemcitabine|gemcitabine|mesh-list
110341832|NCT02929797|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110341833|NCT02929797|Antimetabolites|antimetabolites|mesh-ancestor
110341834|NCT02929797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110341835|NCT02929797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110341837|NCT00525239|Lopinavir|lopinavir|mesh-list
110341838|NCT00525239|Atazanavir Sulfate|atazanavir sulfate|mesh-list
110341839|NCT00525239|Efavirenz|efavirenz|mesh-list
110341840|NCT00525239|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110341841|NCT00525239|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110341842|NCT00525239|Protease Inhibitors|protease inhibitors|mesh-ancestor
110341843|NCT00525239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110341844|NCT00525239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110341845|NCT00525239|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110341846|NCT00525239|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110341847|NCT00525239|Antiviral Agents|antiviral agents|mesh-ancestor
110341848|NCT00525239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110341849|NCT00525239|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110341850|NCT00525239|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110341851|NCT00525239|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110341852|NCT00525239|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110341853|NCT00525239|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110341854|NCT00525239|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110341855|NCT00525239|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110341856|NCT00525239|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110341857|NCT00525239|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110341858|NCT02929914|Anti-Infective Agents|anti-infective agents|mesh-list
110341859|NCT02929914|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110341860|NCT02947334|Bococizumab|bococizumab|mesh-list
110341861|NCT02947334|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110341862|NCT02947334|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110341863|NCT02947334|Antimetabolites|antimetabolites|mesh-ancestor
110341864|NCT02947334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110341865|NCT02947334|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110341866|NCT00525278|Levocetirizine|levocetirizine|mesh-list
110341867|NCT00525278|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110341868|NCT00525278|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110341869|NCT00525278|Histamine Antagonists|histamine antagonists|mesh-ancestor
110341870|NCT00525278|Histamine Agents|histamine agents|mesh-ancestor
110341871|NCT00525278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110341872|NCT00525278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110341873|NCT00525278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110341874|NCT02929719|Dapsone|dapsone|mesh-list
110341875|NCT02929719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110341876|NCT02929719|Antimalarials|antimalarials|mesh-ancestor
110341877|NCT02929719|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110341878|NCT02929719|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110341879|NCT02929719|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110341880|NCT02929719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110341881|NCT02929719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110341882|NCT02929719|Leprostatic Agents|leprostatic agents|mesh-ancestor
110341883|NCT02929719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110341884|NCT04325685|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
110341885|NCT04325685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110341886|NCT02929524|Ketamine|ketamine|mesh-list
110341887|NCT02929524|Analgesics|analgesics|mesh-ancestor
110341888|NCT02929524|Sensory System Agents|sensory system agents|mesh-ancestor
110341889|NCT02929524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110341890|NCT02929524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110341891|NCT02929524|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110341892|NCT02929524|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110341893|NCT02929524|Anesthetics, General|anesthetics, general|mesh-ancestor
110341895|NCT02929524|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110341896|NCT02929524|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110341897|NCT02929524|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110341898|NCT02929524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110341899|NCT02929524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110341900|NCT00525473|Azathioprine|azathioprine|mesh-list
110341901|NCT00525473|Antimetabolites|antimetabolites|mesh-ancestor
110341902|NCT00525473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110341903|NCT00525473|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110341904|NCT00525473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110341905|NCT00525473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110341906|NCT00525473|Immunologic Factors|immunologic factors|mesh-ancestor
110341907|NCT00525473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110341908|NCT00525473|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110341910|NCT00526175|Prednisone|prednisone|mesh-list
110341911|NCT00526175|Cyclophosphamide|cyclophosphamide|mesh-list
110341912|NCT00526175|Methotrexate|methotrexate|mesh-list
110341913|NCT00526175|Vincristine|vincristine|mesh-list
110341914|NCT00526175|Daunorubicin|daunorubicin|mesh-list
110341915|NCT00526175|Asparaginase|asparaginase|mesh-list
110341916|NCT00526175|Mercaptopurine|mercaptopurine|mesh-list
110341917|NCT00526175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110341918|NCT00526175|Immunologic Factors|immunologic factors|mesh-ancestor
110341919|NCT00526175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110341920|NCT00526175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110341921|NCT00526175|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110341922|NCT00526175|Alkylating Agents|alkylating agents|mesh-ancestor
110341923|NCT00526175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110341924|NCT00526175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110341925|NCT00526175|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110341926|NCT00526175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110341927|NCT00526175|Glucocorticoids|glucocorticoids|mesh-ancestor
110341928|NCT00526175|Hormones|hormones|mesh-ancestor
110341929|NCT00526175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110341930|NCT00526175|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110341931|NCT00526175|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110341932|NCT00526175|Abortifacient Agents|abortifacient agents|mesh-ancestor
110341933|NCT00526175|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110341934|NCT00526175|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110341935|NCT00526175|Antimetabolites|antimetabolites|mesh-ancestor
110341936|NCT00526175|Dermatologic Agents|dermatologic agents|mesh-ancestor
110341937|NCT00526175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110341938|NCT00526175|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110341939|NCT00526175|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110341940|NCT00526175|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110341941|NCT00526175|Tubulin Modulators|tubulin modulators|mesh-ancestor
110341942|NCT00526175|Antimitotic Agents|antimitotic agents|mesh-ancestor
110341943|NCT00526175|Mitosis Modulators|mitosis modulators|mesh-ancestor
110341944|NCT00526175|Antiviral Agents|antiviral agents|mesh-ancestor
110341945|NCT00526175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110341946|NCT00526175|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110341947|NCT00526175|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110341948|NCT00526175|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110341949|NCT02930031|Acetylcysteine|acetylcysteine|mesh-list
110341950|NCT02930031|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110174911|NCT03959865|Glucagon|glucagon|mesh-list
110341951|NCT02930031|Antiviral Agents|antiviral agents|mesh-ancestor
110341952|NCT02930031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110341953|NCT02930031|Expectorants|expectorants|mesh-ancestor
110341954|NCT02930031|Respiratory System Agents|respiratory system agents|mesh-ancestor
110341955|NCT02930031|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110341956|NCT02930031|Antioxidants|antioxidants|mesh-ancestor
110341957|NCT02930031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110341958|NCT02930031|Protective Agents|protective agents|mesh-ancestor
110341959|NCT02930031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110341961|NCT02929563|Pantoprazole|pantoprazole|mesh-list
110341962|NCT02929563|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110341963|NCT02929563|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110341964|NCT02929563|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110341965|NCT02929563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110341966|NCT02929563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110341967|NCT00525551|Acetylcysteine|acetylcysteine|mesh-list
110341968|NCT00525551|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110341969|NCT00525551|Antiviral Agents|antiviral agents|mesh-ancestor
110341970|NCT00525551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110341971|NCT00525551|Expectorants|expectorants|mesh-ancestor
110341972|NCT00525551|Respiratory System Agents|respiratory system agents|mesh-ancestor
110341973|NCT00525551|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110341974|NCT00525551|Antioxidants|antioxidants|mesh-ancestor
110341975|NCT00525551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110341976|NCT00525551|Protective Agents|protective agents|mesh-ancestor
110341977|NCT00525551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110341978|NCT00525551|Antidotes|antidotes|mesh-ancestor
110341979|NCT04288323|Diethylenetriamine|diethylenetriamine|mesh-list
110341980|NCT04288323|Edetic Acid|edetic acid|mesh-list
110341981|NCT04288323|Pentetic Acid|pentetic acid|mesh-list
110341982|NCT04288323|Antidotes|antidotes|mesh-ancestor
110341983|NCT04288323|Protective Agents|protective agents|mesh-ancestor
110341984|NCT04288323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110341985|NCT04288323|Chelating Agents|chelating agents|mesh-ancestor
110341986|NCT04288323|Sequestering Agents|sequestering agents|mesh-ancestor
110341987|NCT04288323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110341988|NCT04288323|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110341989|NCT04288323|Anticoagulants|anticoagulants|mesh-ancestor
110341990|NCT04288323|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110341991|NCT04288323|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
110341992|NCT02946359|Bevacizumab|bevacizumab|mesh-list
110341993|NCT02946359|Crizotinib|crizotinib|mesh-list
110341994|NCT02946359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110341995|NCT02946359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110341996|NCT02946359|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110341997|NCT02946359|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110341998|NCT02946359|Growth Substances|growth substances|mesh-ancestor
110341999|NCT02946359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110342000|NCT02946359|Growth Inhibitors|growth inhibitors|mesh-ancestor
110342001|NCT02946359|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110342002|NCT02946359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110342003|NCT02946359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110342004|NCT02946437|Midazolam|midazolam|mesh-list
110342005|NCT02946437|Propofol|propofol|mesh-list
110342006|NCT02946437|Sevoflurane|sevoflurane|mesh-list
110342007|NCT02946437|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110342008|NCT02946437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110342009|NCT02946437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110342010|NCT02946437|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110342011|NCT02946437|Anesthetics, General|anesthetics, general|mesh-ancestor
110342012|NCT02946437|Anesthetics|anesthetics|mesh-ancestor
110342013|NCT02946437|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110342014|NCT02946437|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110342015|NCT02946437|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110342016|NCT02946437|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110342017|NCT02946437|GABA Modulators|gaba modulators|mesh-ancestor
110342018|NCT02946437|GABA Agents|gaba agents|mesh-ancestor
110342019|NCT02946437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110174927|NCT00070486|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110342020|NCT02946437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110342021|NCT02946437|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110342022|NCT02946437|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110342023|NCT02946632|Metformin|metformin|mesh-list
110342024|NCT02946632|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110342025|NCT02946632|Dapagliflozin|dapagliflozin|mesh-list
110342026|NCT02946632|Glimepiride|glimepiride|mesh-list
110342027|NCT02946632|Saxagliptin|saxagliptin|mesh-list
110342028|NCT02946632|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110342029|NCT02946632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110342030|NCT02946632|Incretins|incretins|mesh-ancestor
110342031|NCT02946632|Hormones|hormones|mesh-ancestor
110342032|NCT02946632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110342033|NCT02946632|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110342034|NCT02946632|Protease Inhibitors|protease inhibitors|mesh-ancestor
110342035|NCT02946632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110342036|NCT02946632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110173692|NCT00060385|Hormones|hormones|mesh-ancestor
110342037|NCT02946632|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110342038|NCT02946632|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110342039|NCT02946632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110342040|NCT02946632|Immunologic Factors|immunologic factors|mesh-ancestor
110342041|NCT02929134|Doxycycline|doxycycline|mesh-list
110342042|NCT02929134|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110342043|NCT02929134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110342044|NCT02929134|Antimalarials|antimalarials|mesh-ancestor
110342045|NCT02929134|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110342046|NCT02929134|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110342047|NCT02929212|Acetaminophen|acetaminophen|mesh-list
110342048|NCT02929212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110342049|NCT02929212|Analgesics|analgesics|mesh-ancestor
110342050|NCT02929212|Sensory System Agents|sensory system agents|mesh-ancestor
110342051|NCT02929212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110342052|NCT02929212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110342053|NCT02929212|Antipyretics|antipyretics|mesh-ancestor
110342054|NCT02929251|Adalimumab|adalimumab|mesh-list
110342055|NCT02929251|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
110342056|NCT02929251|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110342057|NCT02929251|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110342058|NCT02929251|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110342059|NCT02929095|Midazolam|midazolam|mesh-list
110342060|NCT02929095|Dexmedetomidine|dexmedetomidine|mesh-list
110342061|NCT02929095|Remifentanil|remifentanil|mesh-list
110342062|NCT02929095|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110342063|NCT02929095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110342064|NCT02929095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110342065|NCT02929095|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110342066|NCT02929095|Analgesics|analgesics|mesh-ancestor
110342067|NCT02929095|Sensory System Agents|sensory system agents|mesh-ancestor
110342068|NCT02929095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110342069|NCT02929095|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110342070|NCT02929095|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110342071|NCT02929095|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110342072|NCT02929095|Adrenergic Agents|adrenergic agents|mesh-ancestor
110342073|NCT02929095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110342074|NCT02929095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110342075|NCT02929095|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110174941|NCT00070525|Tipifarnib|tipifarnib|mesh-list
110342076|NCT02929095|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110342077|NCT02929095|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110342078|NCT02929095|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110342079|NCT02929095|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110342080|NCT02929095|Anesthetics, General|anesthetics, general|mesh-ancestor
110342081|NCT02929095|Anesthetics|anesthetics|mesh-ancestor
110342082|NCT02929095|GABA Modulators|gaba modulators|mesh-ancestor
110342083|NCT02929095|GABA Agents|gaba agents|mesh-ancestor
110342084|NCT02929095|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110342085|NCT02929095|Narcotics|narcotics|mesh-ancestor
110342086|NCT02928861|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110342087|NCT02928861|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110342088|NCT02928861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110342089|NCT00525668|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
110342090|NCT00525668|Antioxidants|antioxidants|mesh-ancestor
110342091|NCT00525668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110342092|NCT00525668|Protective Agents|protective agents|mesh-ancestor
110342093|NCT00525668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110342094|NCT00525668|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
110342095|NCT00525668|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110342096|NCT00525668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110342097|NCT00525668|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110342098|NCT00525707|Tezosentan|tezosentan|mesh-list
110342099|NCT00525707|Vasodilator Agents|vasodilator agents|mesh-ancestor
110342100|NCT00526214|Celecoxib|celecoxib|mesh-list
110342101|NCT00526214|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110342102|NCT00526214|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110342103|NCT00526214|Analgesics|analgesics|mesh-ancestor
110342104|NCT00526214|Sensory System Agents|sensory system agents|mesh-ancestor
110342105|NCT00526214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110342106|NCT00526214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110342107|NCT00526214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110342108|NCT00526214|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110342109|NCT00526214|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110342110|NCT00526214|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110342111|NCT00526214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110342112|NCT00526214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110342114|NCT02928510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110342115|NCT02928510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110342116|NCT02928510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110342117|NCT02946944|Sildenafil Citrate|sildenafil citrate|mesh-list
110342119|NCT02946944|Vasodilator Agents|vasodilator agents|mesh-ancestor
110342120|NCT02946944|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110342121|NCT02946944|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110342122|NCT02946944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110342123|NCT02946944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110342124|NCT02946944|Urological Agents|urological agents|mesh-ancestor
110342125|NCT02946944|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110342126|NCT02946944|Antithrombins|antithrombins|mesh-ancestor
110342127|NCT02946944|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110342128|NCT02946944|Protease Inhibitors|protease inhibitors|mesh-ancestor
110342129|NCT02946944|Anticoagulants|anticoagulants|mesh-ancestor
110342130|NCT02947061|Docetaxel|docetaxel|mesh-list
110342131|NCT02947061|Capecitabine|capecitabine|mesh-list
110342132|NCT02947061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110342133|NCT02947061|Tubulin Modulators|tubulin modulators|mesh-ancestor
110342134|NCT02947061|Antimitotic Agents|antimitotic agents|mesh-ancestor
110342135|NCT02947061|Mitosis Modulators|mitosis modulators|mesh-ancestor
110342136|NCT02947061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110342137|NCT02947061|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110342138|NCT02947061|Antimetabolites|antimetabolites|mesh-ancestor
110342139|NCT02928315|Magnesium Sulfate|magnesium sulfate|mesh-list
110342140|NCT02928315|Analgesics|analgesics|mesh-ancestor
110342141|NCT02928315|Sensory System Agents|sensory system agents|mesh-ancestor
110342142|NCT02928315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110342143|NCT02928315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110342144|NCT02928315|Anesthetics|anesthetics|mesh-ancestor
110174952|NCT00070837|Antibodies|antibodies|mesh-list
110342145|NCT02928315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110342146|NCT02928315|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110342148|NCT02928315|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110342149|NCT02928315|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110342150|NCT02928315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110342151|NCT02928315|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110342152|NCT02928315|Tocolytic Agents|tocolytic agents|mesh-ancestor
110342153|NCT02928315|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110342154|NCT00526409|Cytarabine|cytarabine|mesh-list
110342155|NCT00526409|Prednisolone|prednisolone|mesh-list
110342156|NCT00526409|Cyclophosphamide|cyclophosphamide|mesh-list
110342157|NCT00526409|Methotrexate|methotrexate|mesh-list
110342158|NCT00526409|Vincristine|vincristine|mesh-list
110342159|NCT00526409|Daunorubicin|daunorubicin|mesh-list
110342160|NCT00526409|Asparaginase|asparaginase|mesh-list
110342161|NCT00526409|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110342162|NCT00526409|Immunologic Factors|immunologic factors|mesh-ancestor
110342163|NCT00526409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110342164|NCT00526409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110342165|NCT00526409|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110342166|NCT00526409|Alkylating Agents|alkylating agents|mesh-ancestor
110342167|NCT00526409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110342168|NCT00526409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110342169|NCT00526409|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110342170|NCT00526409|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110342171|NCT00526409|Abortifacient Agents|abortifacient agents|mesh-ancestor
110342172|NCT00526409|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110342173|NCT00526409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110342174|NCT00526409|Antimetabolites|antimetabolites|mesh-ancestor
110342175|NCT00526409|Dermatologic Agents|dermatologic agents|mesh-ancestor
110342176|NCT00526409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110342177|NCT00526409|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110342186|NCT00526409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110342187|NCT00526409|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110342188|NCT00526409|Antiviral Agents|antiviral agents|mesh-ancestor
110342189|NCT00526409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110342190|NCT00526409|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110342191|NCT00526409|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110342192|NCT00526409|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110342194|NCT00526448|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110342195|NCT00526448|Antimetabolites|antimetabolites|mesh-ancestor
110342196|NCT00526448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110342197|NCT00526448|Antiviral Agents|antiviral agents|mesh-ancestor
110342198|NCT00526448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110342199|NCT02946671|Nivolumab|nivolumab|mesh-list
110342200|NCT02946671|Mogamulizumab|mogamulizumab|mesh-list
110342201|NCT02946671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110342202|NCT02946671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110342203|NCT02946671|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110342204|NCT02946671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110342205|NCT02927886|Botulinum Toxins|botulinum toxins|mesh-list
110342206|NCT02927886|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110342207|NCT02927886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110342208|NCT02927886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110342209|NCT02927886|Cholinergic Agents|cholinergic agents|mesh-ancestor
110174964|NCT00071227|Triamcinolone|triamcinolone|mesh-list
110342210|NCT02927886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110342211|NCT02927886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110342220|NCT02945241|Vancomycin|vancomycin|mesh-list
110342221|NCT02945241|Cystatins|cystatins|mesh-list
110342222|NCT02945241|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110342223|NCT02945241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110342224|NCT02945241|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
110342225|NCT02945241|Protease Inhibitors|protease inhibitors|mesh-ancestor
110342226|NCT02945241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110342227|NCT02945241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110342228|NCT00526643|Gemcitabine|gemcitabine|mesh-list
110342229|NCT00526643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110342230|NCT00526643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110342231|NCT00526643|Antimetabolites|antimetabolites|mesh-ancestor
110342232|NCT00526643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110342233|NCT02945163|Tenofovir|tenofovir|mesh-list
110342234|NCT02945163|Lamivudine|lamivudine|mesh-list
110342235|NCT02945163|Efavirenz|efavirenz|mesh-list
110342236|NCT02945163|Antiviral Agents|antiviral agents|mesh-ancestor
110342237|NCT02945163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110342238|NCT02945163|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110342239|NCT02945163|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110342240|NCT02945163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110342241|NCT02945163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110173716|NCT00060502|Infliximab|infliximab|mesh-list
110342243|NCT02945163|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110342244|NCT02945163|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110342245|NCT02945163|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110342246|NCT02945163|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110342247|NCT02945163|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110342248|NCT02945163|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110342249|NCT02945163|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110342250|NCT00526760|Dexmedetomidine|dexmedetomidine|mesh-list
110342251|NCT00526760|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110342252|NCT00526760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110342253|NCT00526760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110342254|NCT00526760|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110342255|NCT00526760|Analgesics|analgesics|mesh-ancestor
110342256|NCT00526760|Sensory System Agents|sensory system agents|mesh-ancestor
110342257|NCT00526760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110342258|NCT00526760|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110342259|NCT00526760|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110342260|NCT00526760|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110342261|NCT00526760|Adrenergic Agents|adrenergic agents|mesh-ancestor
110342262|NCT00526760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110342263|NCT00526760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110342264|NCT02927379|Dexmedetomidine|dexmedetomidine|mesh-list
110342265|NCT02927379|Ketamine|ketamine|mesh-list
110342266|NCT02927379|Bupivacaine|bupivacaine|mesh-list
110342267|NCT02927379|Anesthetics, Local|anesthetics, local|mesh-ancestor
110342268|NCT02927379|Anesthetics|anesthetics|mesh-ancestor
110342269|NCT02927379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110342270|NCT02927379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110342271|NCT02927379|Sensory System Agents|sensory system agents|mesh-ancestor
110342272|NCT02927379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110342273|NCT02927379|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110342274|NCT02927379|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110342275|NCT02927379|Analgesics|analgesics|mesh-ancestor
110342276|NCT02927379|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110342277|NCT02927379|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110342278|NCT02927379|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110342279|NCT02927379|Adrenergic Agents|adrenergic agents|mesh-ancestor
110342280|NCT02927379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110342281|NCT02927379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110342282|NCT02927379|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110174978|NCT00071266|Lovastatin|lovastatin|mesh-list
110342283|NCT02927379|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110342285|NCT02927379|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110342286|NCT02927379|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110342287|NCT00526877|Risperidone|risperidone|mesh-list
110342288|NCT00526877|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110342289|NCT00526877|Serotonin Agents|serotonin agents|mesh-ancestor
110342290|NCT00526877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110342291|NCT00526877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110342292|NCT00526877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110342293|NCT00526877|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110342294|NCT00526877|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110342295|NCT00526877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110342296|NCT00526877|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110342297|NCT00526877|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110342298|NCT00526877|Dopamine Agents|dopamine agents|mesh-ancestor
110342299|NCT02927496|Doxycycline|doxycycline|mesh-list
110342300|NCT02927496|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110342301|NCT02927496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110342302|NCT02927496|Antimalarials|antimalarials|mesh-ancestor
110342303|NCT02927496|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110342304|NCT02927496|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110342305|NCT02927535|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
110342307|NCT00527033|Mirabegron|mirabegron|mesh-list
110342308|NCT00527033|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
110342309|NCT00527033|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110342310|NCT00527033|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110342311|NCT00527033|Adrenergic Agents|adrenergic agents|mesh-ancestor
110342312|NCT00527033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110342313|NCT00527033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110342314|NCT00527033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110342315|NCT00527033|Urological Agents|urological agents|mesh-ancestor
110342316|NCT02945072|Sevoflurane|sevoflurane|mesh-list
110342317|NCT02945072|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110342318|NCT02945072|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110342319|NCT02945072|Anesthetics, General|anesthetics, general|mesh-ancestor
110342320|NCT02945072|Anesthetics|anesthetics|mesh-ancestor
110342321|NCT02945072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110342322|NCT02945072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110342323|NCT02924922|Mannitol|mannitol|mesh-list
110342324|NCT02924922|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110342325|NCT02924922|Diuretics|diuretics|mesh-ancestor
110342326|NCT02924922|Natriuretic Agents|natriuretic agents|mesh-ancestor
110342327|NCT02924922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110342328|NCT04692896|Lidocaine|lidocaine|mesh-list
110342329|NCT04692896|Anesthetics, Local|anesthetics, local|mesh-ancestor
110342330|NCT04692896|Anesthetics|anesthetics|mesh-ancestor
110342331|NCT04692896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110342332|NCT04692896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110342333|NCT04692896|Sensory System Agents|sensory system agents|mesh-ancestor
110342334|NCT04692896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110342335|NCT04692896|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110342336|NCT04692896|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110342337|NCT04692896|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110342338|NCT04692896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110342339|NCT04692896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110342340|NCT00528008|Chlorhexidine|chlorhexidine|mesh-list
110342341|NCT00528008|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110342342|NCT00528008|Povidone-Iodine|povidone-iodine|mesh-list
110342343|NCT00528008|Povidone|povidone|mesh-list
110342344|NCT00528008|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110342345|NCT00528008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110342346|NCT00528008|Disinfectants|disinfectants|mesh-ancestor
110342347|NCT00528008|Dermatologic Agents|dermatologic agents|mesh-ancestor
110342348|NCT00528008|Plasma Substitutes|plasma substitutes|mesh-ancestor
110342349|NCT00528008|Blood Substitutes|blood substitutes|mesh-ancestor
110342350|NCT04692740|Chlorambucil|chlorambucil|mesh-list
110342351|NCT04692740|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110342352|NCT04692740|Alkylating Agents|alkylating agents|mesh-ancestor
110342353|NCT04692740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110342354|NCT04692740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110342355|NCT02925000|Vinorelbine|vinorelbine|mesh-list
110342356|NCT02925000|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110342357|NCT02925000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110342358|NCT02925000|Tubulin Modulators|tubulin modulators|mesh-ancestor
110342359|NCT02925000|Antimitotic Agents|antimitotic agents|mesh-ancestor
110342360|NCT02925000|Mitosis Modulators|mitosis modulators|mesh-ancestor
110342361|NCT02925000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110342362|NCT02926989|Plasma-lyte 148|plasma-lyte 148|mesh-list
110342363|NCT02926989|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110342364|NCT02926989|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110342365|NCT02945696|Ropivacaine|ropivacaine|mesh-list
110342366|NCT02945696|Anesthetics, Local|anesthetics, local|mesh-ancestor
110342367|NCT02945696|Anesthetics|anesthetics|mesh-ancestor
110342368|NCT02945696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110342369|NCT02945696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110342370|NCT02945696|Sensory System Agents|sensory system agents|mesh-ancestor
110342371|NCT02945696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110342372|NCT02924766|Prednisone|prednisone|mesh-list
110342373|NCT02924766|Abiraterone Acetate|abiraterone acetate|mesh-list
110342374|NCT02924766|Niraparib|niraparib|mesh-list
110342375|NCT02924766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110342376|NCT02924766|Glucocorticoids|glucocorticoids|mesh-ancestor
110342377|NCT02924766|Hormones|hormones|mesh-ancestor
110173728|NCT05312372|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110342378|NCT02924766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110342379|NCT02924766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110342380|NCT02924766|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110342381|NCT02924766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110342382|NCT02924766|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110342383|NCT02924766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110342384|NCT02924766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110342385|NCT02924766|Hormone Antagonists|hormone antagonists|mesh-ancestor
110342386|NCT02924766|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110342387|NCT02924766|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110342388|NCT00528281|Pemetrexed|pemetrexed|mesh-list
110342389|NCT00528281|Lapatinib|lapatinib|mesh-list
110342390|NCT00528281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110342391|NCT00528281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110342392|NCT00528281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110342393|NCT00528281|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110342394|NCT00528281|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110342395|NCT00528281|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110342396|NCT01580501|Sildenafil Citrate|sildenafil citrate|mesh-list
110342397|NCT01580501|Tadalafil|tadalafil|mesh-list
110342398|NCT01580501|Vasodilator Agents|vasodilator agents|mesh-ancestor
110342399|NCT01580501|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110342400|NCT01580501|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110342401|NCT01580501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110342402|NCT01580501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110342403|NCT01580501|Urological Agents|urological agents|mesh-ancestor
110342404|NCT02924532|Hormones|hormones|mesh-list
110342405|NCT02924532|Parathyroid Hormone|parathyroid hormone|mesh-list
110342406|NCT02924532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110342407|NCT02924532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110342408|NCT02924532|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110342409|NCT00528359|Olanzapine|olanzapine|mesh-list
110342410|NCT00528359|Risperidone|risperidone|mesh-list
110342411|NCT00528359|Aripiprazole|aripiprazole|mesh-list
110342412|NCT00528359|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110342413|NCT00528359|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110342414|NCT00528359|Serotonin Agents|serotonin agents|mesh-ancestor
110342415|NCT00528359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110342416|NCT00528359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110342417|NCT00528359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110342418|NCT00528359|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110342419|NCT00528359|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110342420|NCT00528359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110342421|NCT00528359|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110342422|NCT00528359|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110342423|NCT00528359|Dopamine Agents|dopamine agents|mesh-ancestor
110342424|NCT00528359|Antiemetics|antiemetics|mesh-ancestor
110342425|NCT00528359|Autonomic Agents|autonomic agents|mesh-ancestor
110342426|NCT00528359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110342427|NCT00528359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110342428|NCT00528359|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110342429|NCT00528359|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110342430|NCT00528359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110342431|NCT00528359|Antidepressive Agents|antidepressive agents|mesh-ancestor
110342432|NCT00528359|Dopamine Agonists|dopamine agonists|mesh-ancestor
110342433|NCT00528359|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110342434|NCT00528359|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110342435|NCT00528359|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110298887|NCT03832010|Glucocorticoids|glucocorticoids|mesh-ancestor
110342436|NCT00528359|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110342437|NCT00527150|Varenicline|varenicline|mesh-list
110342438|NCT00527150|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110342439|NCT00527150|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110342440|NCT00527150|Cholinergic Agents|cholinergic agents|mesh-ancestor
110342441|NCT00527150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110175015|NCT02966743|GABA Modulators|gaba modulators|mesh-ancestor
110342442|NCT00527150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110342443|NCT00527150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110342444|NCT00527228|Deflazacort|deflazacort|mesh-list
110342445|NCT00527228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110342446|NCT00527228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110342447|NCT00527228|Immunologic Factors|immunologic factors|mesh-ancestor
110342448|NCT00527228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110342449|NCT00527267|Cinacalcet|cinacalcet|mesh-list
110342450|NCT00527267|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110342451|NCT00527267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110342452|NCT00527267|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
110342453|NCT00527267|Hormone Antagonists|hormone antagonists|mesh-ancestor
110342454|NCT00527267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110342455|NCT02924454|Metoprolol|metoprolol|mesh-list
110342456|NCT02924454|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110342457|NCT02924454|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
110342458|NCT02924454|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
110342459|NCT02924454|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110342460|NCT02924454|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110342461|NCT02924454|Sympatholytics|sympatholytics|mesh-ancestor
110342462|NCT02924454|Autonomic Agents|autonomic agents|mesh-ancestor
110342463|NCT02924454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110342464|NCT02924454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110342465|NCT02924454|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110342466|NCT02924454|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110342467|NCT02924454|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110342468|NCT02924454|Adrenergic Agents|adrenergic agents|mesh-ancestor
110342469|NCT02924454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110342470|NCT02924454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110342471|NCT02924454|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
110342472|NCT02924337|Moxifloxacin|moxifloxacin|mesh-list
110342473|NCT02924337|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110342474|NCT02924337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110342475|NCT02924337|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110342476|NCT02924337|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110342477|NCT02924337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110342478|NCT02924337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110342479|NCT02924337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110342480|NCT00528515|Propofol|propofol|mesh-list
110342481|NCT00528515|Desflurane|desflurane|mesh-list
110342482|NCT00528515|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110342483|NCT00528515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110342484|NCT00528515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110342485|NCT00528515|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110342486|NCT00528515|Anesthetics, General|anesthetics, general|mesh-ancestor
110342487|NCT00528515|Anesthetics|anesthetics|mesh-ancestor
110342488|NCT00528515|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110342489|NCT02923986|Dasatinib|dasatinib|mesh-list
110342490|NCT02923986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110342491|NCT02923986|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110342492|NCT02923986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110342493|NCT02923986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110342494|NCT02926248|Colchicine|colchicine|mesh-list
110342495|NCT02926248|Gout Suppressants|gout suppressants|mesh-ancestor
110342496|NCT02926248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110342497|NCT02926248|Tubulin Modulators|tubulin modulators|mesh-ancestor
110342498|NCT02926248|Antimitotic Agents|antimitotic agents|mesh-ancestor
110342499|NCT02926248|Mitosis Modulators|mitosis modulators|mesh-ancestor
110342500|NCT02926248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110342501|NCT02926248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110342502|NCT00528593|Epoetin Alfa|epoetin alfa|mesh-list
110342503|NCT00528593|Hematinics|hematinics|mesh-ancestor
110342504|NCT02926326|Azithromycin|azithromycin|mesh-list
110342505|NCT02926326|Acumapimod|acumapimod|mesh-list
110342506|NCT02926326|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110342507|NCT02926326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110342508|NCT02926326|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110342509|NCT02926326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110343829|NCT06020755|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110342510|NCT02926326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110342512|NCT00528671|Anticoagulants|anticoagulants|mesh-ancestor
110342513|NCT00528827|Nicardipine|nicardipine|mesh-list
110342514|NCT00528827|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110342515|NCT00528827|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110342516|NCT00528827|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110342517|NCT00528827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110342518|NCT00528827|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110342519|NCT00528827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110342520|NCT00528827|Vasodilator Agents|vasodilator agents|mesh-ancestor
110342521|NCT02926170|Rivaroxaban|rivaroxaban|mesh-list
110342522|NCT02926170|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110342523|NCT02926170|Antithrombins|antithrombins|mesh-ancestor
110342524|NCT02926170|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110342525|NCT02926170|Protease Inhibitors|protease inhibitors|mesh-ancestor
110342526|NCT02926170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110342527|NCT02926170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110342528|NCT02926170|Anticoagulants|anticoagulants|mesh-ancestor
110342529|NCT04691765|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
110342530|NCT04691765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110342531|NCT04691687|Furosemide|furosemide|mesh-list
110342532|NCT04691687|Diuretics|diuretics|mesh-ancestor
110342533|NCT04691687|Natriuretic Agents|natriuretic agents|mesh-ancestor
110342534|NCT04691687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110342535|NCT04691687|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110342536|NCT04691687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110279835|NCT00184613|Insulin Glargine|insulin glargine|mesh-list
110342537|NCT04691687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110342538|NCT04107675|Cyclosporine|cyclosporine|mesh-list
110342539|NCT04107675|Cyclosporins|cyclosporins|mesh-list
110342540|NCT04107675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110342541|NCT04107675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110342542|NCT04107675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110342543|NCT04107675|Immunologic Factors|immunologic factors|mesh-ancestor
110342544|NCT04107675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110342545|NCT04107675|Antifungal Agents|antifungal agents|mesh-ancestor
110342546|NCT04107675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110342547|NCT04107675|Dermatologic Agents|dermatologic agents|mesh-ancestor
110342548|NCT04107675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110342549|NCT04107675|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110342550|NCT02923869|Bupivacaine|bupivacaine|mesh-list
110342551|NCT02923869|Levobupivacaine|levobupivacaine|mesh-list
110342552|NCT02923869|Anesthetics, Local|anesthetics, local|mesh-ancestor
110342553|NCT02923869|Anesthetics|anesthetics|mesh-ancestor
110342554|NCT02923869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110342555|NCT02923869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110342556|NCT02923869|Sensory System Agents|sensory system agents|mesh-ancestor
110342557|NCT02923869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110342558|NCT02923791|Lenograstim|lenograstim|mesh-list
110342559|NCT02923791|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110342560|NCT02923791|Immunologic Factors|immunologic factors|mesh-ancestor
110342561|NCT02923791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110342562|NCT00527540|Interferons|interferons|mesh-list
110342563|NCT00527540|Ribavirin|ribavirin|mesh-list
110342564|NCT00527540|Interferon-alpha|interferon-alpha|mesh-list
110342565|NCT00527540|Interferon alpha-2|interferon alpha-2|mesh-list
110342566|NCT00527540|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110342567|NCT00527540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110342568|NCT00527540|Antiviral Agents|antiviral agents|mesh-ancestor
110342569|NCT00527540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110342570|NCT00527540|Antimetabolites|antimetabolites|mesh-ancestor
110342571|NCT00527540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110342572|NCT00527540|Immunologic Factors|immunologic factors|mesh-ancestor
110342573|NCT00527540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110342574|NCT02926053|Cyclophosphamide|cyclophosphamide|mesh-list
110342575|NCT02926053|Fludarabine|fludarabine|mesh-list
110342576|NCT02926053|Interleukin-2|interleukin-2|mesh-list
110342577|NCT02926053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110342578|NCT02926053|Immunologic Factors|immunologic factors|mesh-ancestor
110342579|NCT02926053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110342580|NCT02926053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110342581|NCT02926053|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110342583|NCT02926053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110342584|NCT02926053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110342585|NCT02926053|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110342586|NCT02926053|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110342587|NCT02926053|Analgesics|analgesics|mesh-ancestor
110342588|NCT02926053|Sensory System Agents|sensory system agents|mesh-ancestor
110342589|NCT02926053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110342590|NCT00527657|Thalidomide|thalidomide|mesh-list
110342591|NCT00527657|Temozolomide|temozolomide|mesh-list
110342592|NCT00527657|Lomustine|lomustine|mesh-list
110342593|NCT00527657|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110342594|NCT00527657|Alkylating Agents|alkylating agents|mesh-ancestor
110342595|NCT00527657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110342596|NCT00527657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110342597|NCT00527657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110342598|NCT00527657|Immunologic Factors|immunologic factors|mesh-ancestor
110342599|NCT00527657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110342600|NCT00527657|Leprostatic Agents|leprostatic agents|mesh-ancestor
110342601|NCT00527657|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110342602|NCT00527657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110342603|NCT00527657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110342604|NCT00527657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110342605|NCT00527657|Growth Substances|growth substances|mesh-ancestor
110342606|NCT00527657|Growth Inhibitors|growth inhibitors|mesh-ancestor
110342607|NCT00528983|Azacitidine|azacitidine|mesh-list
110342608|NCT00528983|Cc-486|cc-486|mesh-list
110342609|NCT00528983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110342610|NCT00528983|Antimetabolites|antimetabolites|mesh-ancestor
110342611|NCT00528983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110342612|NCT00528983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110342613|NCT00528983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110342614|NCT00529022|Carboplatin|carboplatin|mesh-list
110342615|NCT00529022|Azacitidine|azacitidine|mesh-list
110342616|NCT00529022|Valproic Acid|valproic acid|mesh-list
110342617|NCT00529022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110342618|NCT00529022|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110342619|NCT00529022|Antimetabolites|antimetabolites|mesh-ancestor
110342620|NCT00529022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110342621|NCT00529022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110342622|NCT00529022|Anticonvulsants|anticonvulsants|mesh-ancestor
110342623|NCT00529022|GABA Agents|gaba agents|mesh-ancestor
110342624|NCT00529022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110342625|NCT00529022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110342626|NCT00529022|Antimanic Agents|antimanic agents|mesh-ancestor
110342627|NCT00529022|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110342628|NCT00529022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110342629|NCT00529022|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110342630|NCT02923557|Pirarubicin|pirarubicin|mesh-list
110342631|NCT02923557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110342632|NCT02925975|Carvedilol|carvedilol|mesh-list
110342633|NCT02925975|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110342634|NCT02925975|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110342635|NCT02925975|Adrenergic Agents|adrenergic agents|mesh-ancestor
110342636|NCT02925975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110342637|NCT02925975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110342638|NCT02925975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110342640|NCT02925975|Antioxidants|antioxidants|mesh-ancestor
110342641|NCT02925975|Protective Agents|protective agents|mesh-ancestor
110342642|NCT02925975|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110342643|NCT02925975|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110175210|NCT03959397|Tubulin Modulators|tubulin modulators|mesh-ancestor
110342644|NCT02925975|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110342645|NCT02925975|Vasodilator Agents|vasodilator agents|mesh-ancestor
110342646|NCT02925975|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110342647|NCT02925975|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110342649|NCT02945033|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110342650|NCT02945033|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110342651|NCT02945033|Analgesics|analgesics|mesh-ancestor
110342652|NCT02945033|Sensory System Agents|sensory system agents|mesh-ancestor
110342653|NCT02945033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110342654|NCT02945033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110342655|NCT02945033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110342656|NCT02945033|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110342657|NCT02945033|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110342658|NCT02945033|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110342659|NCT02945033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110342660|NCT02945033|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110342661|NCT02945033|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110342662|NCT02945033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110342663|NCT02945033|Antipyretics|antipyretics|mesh-ancestor
110342665|NCT04231968|Antiviral Agents|antiviral agents|mesh-ancestor
110342666|NCT04231968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110342667|NCT00529295|Misoprostol|misoprostol|mesh-list
110342668|NCT00529295|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110342669|NCT00529295|Abortifacient Agents|abortifacient agents|mesh-ancestor
110342670|NCT00529295|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110342671|NCT00529295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110342672|NCT00529295|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110342673|NCT00529295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110342674|NCT00529295|Oxytocics|oxytocics|mesh-ancestor
110342675|NCT02922933|Entinostat|entinostat|mesh-list
110342676|NCT02922933|Omeprazole|omeprazole|mesh-list
110342677|NCT02922933|Famotidine|famotidine|mesh-list
110342678|NCT02922933|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110342679|NCT02922933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110342680|NCT02922933|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110342681|NCT02922933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110342682|NCT02922933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110342683|NCT02922933|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110342684|NCT02922933|Histamine Antagonists|histamine antagonists|mesh-ancestor
110342685|NCT02922933|Histamine Agents|histamine agents|mesh-ancestor
110342686|NCT02922933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110342687|NCT02922933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110342688|NCT02922933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110342689|NCT02922933|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110342690|NCT02945267|Tegafur|tegafur|mesh-list
110342691|NCT02945267|Nimotuzumab|nimotuzumab|mesh-list
110342692|NCT02945267|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110342693|NCT02945267|Antimetabolites|antimetabolites|mesh-ancestor
110342694|NCT02945267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110342695|NCT02945267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110342696|NCT02945267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110342698|NCT00529646|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110342699|NCT00529646|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110342700|NCT00529646|Serotonin Agents|serotonin agents|mesh-ancestor
110342701|NCT00529646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110342702|NCT00529646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110342703|NCT00529646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110342704|NCT00527930|Oxaliplatin|oxaliplatin|mesh-list
110342705|NCT00527930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110342706|NCT00529841|Hydrocortisone|hydrocortisone|mesh-list
110342707|NCT00529841|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
110342708|NCT00529841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110342709|NCT00529880|Cytarabine|cytarabine|mesh-list
110342710|NCT00529880|Fludarabine|fludarabine|mesh-list
110342711|NCT00529880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110342712|NCT00529880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110342713|NCT00529880|Antimetabolites|antimetabolites|mesh-ancestor
110342714|NCT00529880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110342715|NCT00529880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110342716|NCT00529880|Immunologic Factors|immunologic factors|mesh-ancestor
110342717|NCT00529880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110342718|NCT00529880|Antiviral Agents|antiviral agents|mesh-ancestor
110342719|NCT00529880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110342720|NCT02925702|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
110342721|NCT02925702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110342722|NCT00531089|Rituximab|rituximab|mesh-list
110342723|NCT00531089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110342724|NCT00531089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110342725|NCT00531089|Immunologic Factors|immunologic factors|mesh-ancestor
110342726|NCT00531089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110342727|NCT00531089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110342728|NCT02922699|Omeprazole|omeprazole|mesh-list
110342729|NCT02922699|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110342730|NCT02922699|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110342731|NCT02922699|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110342732|NCT02922699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110342733|NCT02922699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110342734|NCT02922660|Remifentanil|remifentanil|mesh-list
110342735|NCT02922660|Anesthetics|anesthetics|mesh-list
110342736|NCT02922660|Propofol|propofol|mesh-list
110342737|NCT02922660|Desflurane|desflurane|mesh-list
110342738|NCT02922660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110342739|NCT02922660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110342740|NCT02922660|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110342741|NCT02922660|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110342742|NCT02922660|Anesthetics, General|anesthetics, general|mesh-ancestor
110342743|NCT02922660|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110342744|NCT02922660|Narcotics|narcotics|mesh-ancestor
110342745|NCT02922660|Analgesics|analgesics|mesh-ancestor
110342746|NCT02922660|Sensory System Agents|sensory system agents|mesh-ancestor
110342747|NCT02922660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110342748|NCT02922660|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110342749|NCT02922465|Clopidogrel|clopidogrel|mesh-list
110342750|NCT02922465|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110342751|NCT02922465|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110342752|NCT02922465|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110342753|NCT02922465|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110342754|NCT02922465|Purinergic Agents|purinergic agents|mesh-ancestor
110342755|NCT02922465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110342756|NCT02922465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110342757|NCT02922465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110342758|NCT02944292|Propofol|propofol|mesh-list
110342759|NCT02944292|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110342760|NCT02944292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110342761|NCT02944292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110342762|NCT02944292|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110342763|NCT02944292|Anesthetics, General|anesthetics, general|mesh-ancestor
110342764|NCT02944292|Anesthetics|anesthetics|mesh-ancestor
110342765|NCT02922426|Olanzapine|olanzapine|mesh-list
110342766|NCT02922426|Antiemetics|antiemetics|mesh-ancestor
110342767|NCT02922426|Autonomic Agents|autonomic agents|mesh-ancestor
110342768|NCT02922426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110342769|NCT02922426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110342770|NCT02922426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110342771|NCT02922426|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110342772|NCT02922426|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110342773|NCT02922426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110342774|NCT02922426|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110342775|NCT02922426|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110342776|NCT02922426|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110342777|NCT02922426|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110342778|NCT02922426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110342779|NCT02922426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110342780|NCT02922426|Serotonin Agents|serotonin agents|mesh-ancestor
110342781|NCT00531128|Gamma-sitosterol|gamma-sitosterol|mesh-list
110342782|NCT00531128|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110342783|NCT00531128|Antimetabolites|antimetabolites|mesh-ancestor
110342784|NCT00531128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110342785|NCT00531128|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110342786|NCT02925351|Clofarabine|clofarabine|mesh-list
110342787|NCT02925351|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110342788|NCT02925351|Antimetabolites|antimetabolites|mesh-ancestor
110342789|NCT02925351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110342790|NCT02925351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110342792|NCT00531167|Adefovir|adefovir|mesh-list
110342793|NCT00531167|Entecavir|entecavir|mesh-list
110342794|NCT00531167|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110342795|NCT00531167|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110342796|NCT00531167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110342797|NCT00531167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110342798|NCT00531167|Antiviral Agents|antiviral agents|mesh-ancestor
110342799|NCT00531167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110342800|NCT00531167|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110342801|NCT00531167|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110342802|NCT02944214|Febuxostat|febuxostat|mesh-list
110342803|NCT02944214|Benzbromarone|benzbromarone|mesh-list
110342804|NCT02944214|Gout Suppressants|gout suppressants|mesh-ancestor
110342805|NCT02944214|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110342806|NCT02944214|Uricosuric Agents|uricosuric agents|mesh-ancestor
110342807|NCT02922075|Amoxicillin|amoxicillin|mesh-list
110342808|NCT02922075|Chlorhexidine|chlorhexidine|mesh-list
110342809|NCT02922075|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110342810|NCT02922075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110342811|NCT02922075|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110342812|NCT02922075|Disinfectants|disinfectants|mesh-ancestor
110342813|NCT00531245|Oxaliplatin|oxaliplatin|mesh-list
110342814|NCT00531245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110342815|NCT02922348|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110342816|NCT02922348|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110342817|NCT02922348|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110342818|NCT02922348|Medroxyprogesterone|medroxyprogesterone|mesh-list
110342819|NCT02922348|Norgestimate|norgestimate|mesh-list
110342820|NCT02922348|Contraceptive Agents|contraceptive agents|mesh-list
110342821|NCT02922348|Contraceptives, Oral|contraceptives, oral|mesh-list
110342822|NCT02922348|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
110342823|NCT02922348|Hormones|hormones|mesh-list
110342824|NCT02922348|Estradiol|estradiol|mesh-list
110342825|NCT02922348|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110342826|NCT02922348|Progestins|progestins|mesh-list
110342827|NCT02922348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110342828|NCT02922348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110342829|NCT02922348|Estrogens|estrogens|mesh-ancestor
110342830|NCT02922348|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110299062|NCT02965027|Prazosin|prazosin|mesh-list
110342831|NCT02922348|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110342832|NCT02922348|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110342833|NCT02922348|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110342834|NCT02922348|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110342835|NCT00527501|Travoprost|travoprost|mesh-list
110342836|NCT00527501|Brinzolamide|brinzolamide|mesh-list
110342837|NCT00527501|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110342838|NCT00527501|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110342839|NCT00527501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110342840|NCT00527501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110342842|NCT02922387|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110342843|NCT02922387|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110342844|NCT02922387|Cholinergic Agents|cholinergic agents|mesh-ancestor
110342845|NCT02922387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110342846|NCT02922387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110342847|NCT02922387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110342848|NCT00531323|Etravirine|etravirine|mesh-list
110342849|NCT00531323|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110342850|NCT00531323|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110342851|NCT00531323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110342852|NCT00531323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110342853|NCT00531323|Antiviral Agents|antiviral agents|mesh-ancestor
110342854|NCT00531323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110342855|NCT00531362|Aspirin|aspirin|mesh-list
110342856|NCT00531362|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110342857|NCT00531362|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110342858|NCT00531362|Analgesics|analgesics|mesh-ancestor
110342859|NCT00531362|Sensory System Agents|sensory system agents|mesh-ancestor
110342860|NCT00531362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110342861|NCT00531362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110342862|NCT00531362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110342863|NCT00531362|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110342864|NCT00531362|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110342865|NCT00531362|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110342866|NCT00531362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110342867|NCT00531362|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110342868|NCT00531362|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110342869|NCT00531362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110342871|NCT00531401|Farnesylthiosalicylic acid|farnesylthiosalicylic acid|mesh-list
110342872|NCT00531401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110342873|NCT00531401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110342874|NCT00531401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110342875|NCT00531440|Everolimus|everolimus|mesh-list
110342876|NCT00531440|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110342877|NCT00531440|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110342878|NCT00531440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110342879|NCT00531440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110342880|NCT00531440|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110342881|NCT00531440|Immunologic Factors|immunologic factors|mesh-ancestor
110342882|NCT00531440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110342883|NCT00531440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110342884|NCT02944526|Ropivacaine|ropivacaine|mesh-list
110342885|NCT02944526|Anesthetics, Local|anesthetics, local|mesh-ancestor
110342886|NCT02944526|Anesthetics|anesthetics|mesh-ancestor
110342887|NCT02944526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110342888|NCT02944526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110342889|NCT02944526|Sensory System Agents|sensory system agents|mesh-ancestor
110342890|NCT02944526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110342891|NCT04000854|Calcium|calcium|mesh-list
110279936|NCT00218049|Vanoxerine|vanoxerine|mesh-list
110342892|NCT04000854|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110342893|NCT04000854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110342894|NCT00530387|Ibuprofen|ibuprofen|mesh-list
110342895|NCT00530387|Diclofenac|diclofenac|mesh-list
110342896|NCT00530387|Ketoprofen|ketoprofen|mesh-list
110342897|NCT00530387|Piroxicam|piroxicam|mesh-list
110342898|NCT00530387|Salicylates|salicylates|mesh-list
110342899|NCT00530387|Etofenamate|etofenamate|mesh-list
110342900|NCT00530387|Sunscreening Agents|sunscreening agents|mesh-list
110342901|NCT00530387|Homosalate|homosalate|mesh-list
110342902|NCT00530387|Octylmethoxycinnamate|octylmethoxycinnamate|mesh-list
110342903|NCT00530387|Benzophenone|benzophenone|mesh-list
110342904|NCT00530387|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110342905|NCT00530387|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110342906|NCT00530387|Analgesics|analgesics|mesh-ancestor
110342907|NCT00530387|Sensory System Agents|sensory system agents|mesh-ancestor
110342908|NCT00530387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110342909|NCT00530387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110342911|NCT00530387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110342912|NCT00530387|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110342913|NCT00530387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110342914|NCT00530387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110342915|NCT00530387|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110342916|NCT00530387|Protective Agents|protective agents|mesh-ancestor
110342917|NCT00530387|Dermatologic Agents|dermatologic agents|mesh-ancestor
110342918|NCT00530387|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110342919|NCT04689165|Vaccines|vaccines|mesh-list
110342920|NCT04689165|Immunologic Factors|immunologic factors|mesh-ancestor
110342921|NCT04689165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110342922|NCT00530582|Progesterone|progesterone|mesh-list
110342923|NCT00530582|Progestins|progestins|mesh-ancestor
110342924|NCT00530582|Hormones|hormones|mesh-ancestor
110342925|NCT00530582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110342926|NCT00530582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110342927|NCT02944175|Neostigmine|neostigmine|mesh-list
110342928|NCT02944175|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110342929|NCT02944175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110342930|NCT02944175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110342931|NCT02944175|Cholinergic Agents|cholinergic agents|mesh-ancestor
110342932|NCT02944175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110342933|NCT02944175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110342935|NCT02944175|Autonomic Agents|autonomic agents|mesh-ancestor
110342936|NCT02944175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110342937|NCT02917746|Imiquimod|imiquimod|mesh-list
110342938|NCT02917746|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110342939|NCT02917746|Immunologic Factors|immunologic factors|mesh-ancestor
110342940|NCT02917746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110342941|NCT02917746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110342942|NCT02917746|Interferon Inducers|interferon inducers|mesh-ancestor
110342943|NCT00531557|Ritonavir|ritonavir|mesh-list
110342944|NCT00531557|Darunavir|darunavir|mesh-list
110342945|NCT00531557|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110342946|NCT00531557|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110342947|NCT00531557|Protease Inhibitors|protease inhibitors|mesh-ancestor
110342948|NCT00531557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110342949|NCT00531557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110342950|NCT00531557|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110342951|NCT00531557|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110342952|NCT00531557|Antiviral Agents|antiviral agents|mesh-ancestor
110342953|NCT00531557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110342954|NCT00531557|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110342955|NCT00531557|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110342956|NCT00531596|Selegiline|selegiline|mesh-list
110342957|NCT00531596|Antidepressive Agents|antidepressive agents|mesh-ancestor
110342958|NCT00531596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110342959|NCT00531596|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110342960|NCT00531596|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110342961|NCT00531596|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
110342962|NCT00531596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110342963|NCT00531596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110342964|NCT00531596|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110342965|NCT00531596|Protective Agents|protective agents|mesh-ancestor
110342966|NCT00531596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110342967|NCT02943707|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
110342968|NCT02943707|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
110342969|NCT02943707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110342970|NCT00531635|Mycophenolic Acid|mycophenolic acid|mesh-list
110342971|NCT00531635|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110342972|NCT00531635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110342973|NCT00531635|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110342974|NCT00531635|Antitubercular Agents|antitubercular agents|mesh-ancestor
110342975|NCT00531635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110342976|NCT00531635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110342977|NCT00531635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110342978|NCT00531635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110342979|NCT02917551|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110342980|NCT02917551|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
110342981|NCT02917551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110342982|NCT02917551|Antitubercular Agents|antitubercular agents|mesh-ancestor
110342983|NCT00531674|Tocopherols|tocopherols|mesh-list
110342984|NCT00531674|Antioxidants|antioxidants|mesh-ancestor
110342985|NCT00531674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110342986|NCT00531674|Protective Agents|protective agents|mesh-ancestor
110342987|NCT00531674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110342989|NCT00531674|Micronutrients|micronutrients|mesh-ancestor
110342990|NCT00530972|Ribavirin|ribavirin|mesh-list
110342991|NCT00530972|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110342992|NCT00530972|Antimetabolites|antimetabolites|mesh-ancestor
110342993|NCT00530972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110342994|NCT00530972|Antiviral Agents|antiviral agents|mesh-ancestor
110342995|NCT00530972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110342996|NCT02943317|Avelumab|avelumab|mesh-list
110342997|NCT02943317|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110342998|NCT02943317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110342999|NCT02943356|Tadalafil|tadalafil|mesh-list
110343000|NCT02943356|Vasodilator Agents|vasodilator agents|mesh-ancestor
110343001|NCT02943356|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110343002|NCT02943356|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110343003|NCT02943356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110343004|NCT02943356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110343007|NCT02917512|Cyclosporins|cyclosporins|mesh-list
110343008|NCT02917512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110343009|NCT02917512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110343010|NCT02917512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110343011|NCT02917512|Immunologic Factors|immunologic factors|mesh-ancestor
110343012|NCT02917512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110343013|NCT02917512|Antifungal Agents|antifungal agents|mesh-ancestor
110343014|NCT02917512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110343015|NCT02917512|Dermatologic Agents|dermatologic agents|mesh-ancestor
110343016|NCT02917512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110343017|NCT02917512|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110343018|NCT02943902|Vaccines|vaccines|mesh-list
110343019|NCT02943902|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110343020|NCT02943902|Immunologic Factors|immunologic factors|mesh-ancestor
110343021|NCT02943902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110343022|NCT00531908|Furosemide|furosemide|mesh-list
110343023|NCT00531908|Diuretics|diuretics|mesh-ancestor
110343024|NCT00531908|Natriuretic Agents|natriuretic agents|mesh-ancestor
110343025|NCT00531908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110343026|NCT00531908|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110343027|NCT00531908|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110343028|NCT00531908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110343029|NCT03403569|Triptolide|triptolide|mesh-list
110343030|NCT03403569|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
110343031|NCT03403569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110343032|NCT03403569|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110343033|NCT03403569|Contraceptive Agents|contraceptive agents|mesh-ancestor
110343034|NCT03403569|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110343035|NCT03403569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110343036|NCT03403569|Immunologic Factors|immunologic factors|mesh-ancestor
110343037|NCT03403569|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110343038|NCT03403569|Alkylating Agents|alkylating agents|mesh-ancestor
110343039|NCT03403569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110343040|NCT03403569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110343041|NCT00531791|Prednisone|prednisone|mesh-list
110343042|NCT00531791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110343043|NCT00531791|Glucocorticoids|glucocorticoids|mesh-ancestor
110343044|NCT00531791|Hormones|hormones|mesh-ancestor
110343045|NCT00531791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110343046|NCT00531791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110343047|NCT00531791|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110343048|NCT00531791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110343049|NCT02921178|Omalizumab|omalizumab|mesh-list
110343050|NCT02921178|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110343051|NCT02921178|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110343052|NCT02921178|Respiratory System Agents|respiratory system agents|mesh-ancestor
110343053|NCT00531986|Lopinavir|lopinavir|mesh-list
110343054|NCT00531986|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110343055|NCT00531986|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110343056|NCT00531986|Protease Inhibitors|protease inhibitors|mesh-ancestor
110343057|NCT00531986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110343058|NCT00531986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110299085|NCT02935634|Rucaparib|rucaparib|mesh-list
110343059|NCT00531986|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110343060|NCT00531986|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110343061|NCT00531986|Antiviral Agents|antiviral agents|mesh-ancestor
110343062|NCT00531986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110343063|NCT00531986|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110343064|NCT00531986|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110343065|NCT02920827|Dapivirine|dapivirine|mesh-list
110343066|NCT02920827|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110343067|NCT02920827|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110343068|NCT02920827|Antiviral Agents|antiviral agents|mesh-ancestor
110343069|NCT02920827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110343070|NCT02920905|Lidocaine|lidocaine|mesh-list
110343071|NCT02920905|Atracurium|atracurium|mesh-list
110343072|NCT02920905|Anesthetics, Local|anesthetics, local|mesh-ancestor
110343073|NCT02920905|Anesthetics|anesthetics|mesh-ancestor
110343074|NCT02920905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110343075|NCT02920905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110343076|NCT02920905|Sensory System Agents|sensory system agents|mesh-ancestor
110175352|NCT04821830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110343077|NCT02920905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110343078|NCT02920905|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110343079|NCT02920905|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110343080|NCT02920905|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110343081|NCT02920905|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110343082|NCT02920905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110343083|NCT02920905|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110343084|NCT02920905|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110343085|NCT02920905|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110343086|NCT02920905|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
110343087|NCT02920905|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110343088|NCT02920905|Cholinergic Agents|cholinergic agents|mesh-ancestor
110343089|NCT02920905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110343090|NCT02917200|Moxifloxacin|moxifloxacin|mesh-list
110343091|NCT02917200|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110343092|NCT02917200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110343093|NCT02917200|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110343094|NCT02917200|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110343095|NCT02917200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110343096|NCT02917200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110343097|NCT02917200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110343098|NCT02920515|Leuprolide|leuprolide|mesh-list
110343099|NCT02920515|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110343100|NCT02920515|Fertility Agents|fertility agents|mesh-ancestor
110343101|NCT02920515|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110343102|NCT02920515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110343103|NCT02920515|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110343104|NCT02920515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110343105|NCT02917005|Palbociclib|palbociclib|mesh-list
110343107|NCT02917005|Goserelin|goserelin|mesh-list
110343108|NCT02917005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110343109|NCT02917005|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110343110|NCT02917005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110343111|NCT02917005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110343112|NCT02917005|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110343113|NCT02917005|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110343114|NCT02917005|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110343115|NCT02917005|Hormone Antagonists|hormone antagonists|mesh-ancestor
110343116|NCT02917005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110343117|NCT02917005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110299107|NCT02740712|Midazolam|midazolam|mesh-list
110343118|NCT02917005|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110343119|NCT02942810|Cefepime|cefepime|mesh-list
110343120|NCT02942810|Cefepime-zidebactam|cefepime-zidebactam|mesh-list
110343121|NCT02942810|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110343122|NCT02942810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110343123|NCT02920710|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
110343124|NCT02920710|Hormones|hormones|mesh-ancestor
110343125|NCT02920710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110343126|NCT02920710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110343127|NCT02941913|Palonosetron|palonosetron|mesh-list
110343128|NCT02941913|Antiemetics|antiemetics|mesh-ancestor
110343129|NCT02941913|Autonomic Agents|autonomic agents|mesh-ancestor
110173801|NCT00061243|Vaccines|vaccines|mesh-list
110343130|NCT02941913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110343131|NCT02941913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110343132|NCT02941913|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110343133|NCT02941913|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110343134|NCT02941913|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110343136|NCT02941913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110343137|NCT02941913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110343138|NCT02942693|Apatinib|apatinib|mesh-list
110343139|NCT02942693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110343140|NCT02942693|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110343141|NCT02942693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110343142|NCT02942693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110343143|NCT02920593|Vitamin D|vitamin d|mesh-list
110343144|NCT02920593|Ergocalciferols|ergocalciferols|mesh-list
110343145|NCT02920593|Cholecalciferol|cholecalciferol|mesh-list
110343146|NCT02920593|Vitamins|vitamins|mesh-list
110343147|NCT02920593|Micronutrients|micronutrients|mesh-ancestor
110343148|NCT02920593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110343149|NCT02920593|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110343150|NCT02920593|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110343151|NCT02942732|Cholecalciferol|cholecalciferol|mesh-list
110343152|NCT02942732|Vitamin D|vitamin d|mesh-list
110343153|NCT02942732|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110343154|NCT02942732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110343155|NCT02942732|Vitamins|vitamins|mesh-ancestor
110343156|NCT02942732|Micronutrients|micronutrients|mesh-ancestor
110343157|NCT02942732|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110343158|NCT02942420|Bucillamine|bucillamine|mesh-list
110343159|NCT02942420|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110343160|NCT02942420|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110343162|NCT02942420|Sensory System Agents|sensory system agents|mesh-ancestor
110343163|NCT02942420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110343164|NCT02942420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110343165|NCT02942420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110343166|NCT02942420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110343167|NCT02942420|Antioxidants|antioxidants|mesh-ancestor
110343168|NCT02942420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110343169|NCT02942420|Protective Agents|protective agents|mesh-ancestor
110343170|NCT02920359|Leuprolide|leuprolide|mesh-list
110343171|NCT02920359|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110343172|NCT02920359|Fertility Agents|fertility agents|mesh-ancestor
110343173|NCT02920359|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110343174|NCT02920359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110343175|NCT02920359|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110343176|NCT02920359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110343177|NCT02916654|Iron|iron|mesh-list
110343178|NCT02916654|Trace Elements|trace elements|mesh-ancestor
110343179|NCT02916654|Micronutrients|micronutrients|mesh-ancestor
110343180|NCT02916654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110343181|NCT02941562|Leucovorin|leucovorin|mesh-list
110343182|NCT02941562|Fluorouracil|fluorouracil|mesh-list
110343183|NCT02941562|Oxaliplatin|oxaliplatin|mesh-list
110343184|NCT02941562|Antimetabolites|antimetabolites|mesh-ancestor
110343185|NCT02941562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110343186|NCT02941562|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110343187|NCT02941562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110343188|NCT02941562|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110343189|NCT02941562|Immunologic Factors|immunologic factors|mesh-ancestor
110343190|NCT02941562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110343191|NCT02941562|Antidotes|antidotes|mesh-ancestor
110343192|NCT02941562|Protective Agents|protective agents|mesh-ancestor
110343193|NCT02941562|Vitamin B Complex|vitamin b complex|mesh-ancestor
110343194|NCT02941562|Vitamins|vitamins|mesh-ancestor
110343195|NCT02941562|Micronutrients|micronutrients|mesh-ancestor
110343196|NCT02942888|Niacinamide|niacinamide|mesh-list
110343197|NCT02942888|Niacin|niacin|mesh-list
110343198|NCT02942888|Nicotinic Acids|nicotinic acids|mesh-list
110343199|NCT02942888|Vitamin B Complex|vitamin b complex|mesh-ancestor
110343200|NCT02942888|Vitamins|vitamins|mesh-ancestor
110343201|NCT02942888|Micronutrients|micronutrients|mesh-ancestor
110343202|NCT02942888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110343203|NCT02942888|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110343204|NCT02942888|Antimetabolites|antimetabolites|mesh-ancestor
110343205|NCT02942888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110343206|NCT02942888|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110343207|NCT02942888|Vasodilator Agents|vasodilator agents|mesh-ancestor
110343208|NCT02916420|Dexamethasone|dexamethasone|mesh-list
110343209|NCT02916420|Pomalidomide|pomalidomide|mesh-list
110343210|NCT02916420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110343211|NCT02916420|Antiemetics|antiemetics|mesh-ancestor
110343212|NCT02916420|Autonomic Agents|autonomic agents|mesh-ancestor
110343213|NCT02916420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110343214|NCT02916420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110343215|NCT02916420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110343216|NCT02916420|Glucocorticoids|glucocorticoids|mesh-ancestor
110343218|NCT02916420|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110343219|NCT02916420|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110343220|NCT02916420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110343221|NCT02916420|Immunologic Factors|immunologic factors|mesh-ancestor
110343222|NCT02916420|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110343223|NCT02916420|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110343224|NCT02916420|Growth Substances|growth substances|mesh-ancestor
110343225|NCT02916420|Growth Inhibitors|growth inhibitors|mesh-ancestor
110343226|NCT02942381|Hydroxychloroquine|hydroxychloroquine|mesh-list
110343227|NCT02942381|Antimalarials|antimalarials|mesh-ancestor
110343228|NCT02942381|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110343229|NCT02942381|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110343230|NCT02942381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110343231|NCT02942381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110343232|NCT02942381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110343233|NCT02942381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110343234|NCT03458468|Tranexamic Acid|tranexamic acid|mesh-list
110343235|NCT03458468|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110343236|NCT03458468|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110018727|NCT02280252|Antimitotic Agents|antimitotic agents|mesh-ancestor
110343237|NCT03458468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110343238|NCT03458468|Hemostatics|hemostatics|mesh-ancestor
110343239|NCT03458468|Coagulants|coagulants|mesh-ancestor
110343240|NCT02942303|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110343241|NCT02942303|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110343242|NCT02942303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110343243|NCT02942303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110343244|NCT02942303|Cholinergic Agents|cholinergic agents|mesh-ancestor
110343245|NCT02942303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110343246|NCT02942303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110343247|NCT02916381|Anesthetics|anesthetics|mesh-list
110343248|NCT02916381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110343249|NCT02916381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110343251|NCT02920047|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110343252|NCT02920047|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110343253|NCT02920047|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110343254|NCT02920047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110343255|NCT02920047|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110343256|NCT02920047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110343257|NCT02920047|Vasodilator Agents|vasodilator agents|mesh-ancestor
110343258|NCT02941016|Evolocumab|evolocumab|mesh-list
110343259|NCT02941016|Alirocumab|alirocumab|mesh-list
110343260|NCT02941016|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
110343261|NCT02941016|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110343262|NCT02941016|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110343263|NCT02941016|Antimetabolites|antimetabolites|mesh-ancestor
110343264|NCT02941016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110173808|NCT00061321|Nevirapine|nevirapine|mesh-list
110343265|NCT02941016|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110343266|NCT02941016|Protease Inhibitors|protease inhibitors|mesh-ancestor
110343267|NCT02941016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110343268|NCT02941016|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110343269|NCT03200379|Antiviral Agents|antiviral agents|mesh-list
110343270|NCT03200379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110343271|NCT02919735|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110343272|NCT02941445|Metformin|metformin|mesh-list
110343273|NCT02941445|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110343274|NCT02941445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110343275|NCT02941445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110343276|NCT02941445|Incretins|incretins|mesh-ancestor
110343277|NCT02941445|Hormones|hormones|mesh-ancestor
110343278|NCT02941445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110343279|NCT02941445|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110343280|NCT02941445|Protease Inhibitors|protease inhibitors|mesh-ancestor
110343281|NCT02941445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110343282|NCT02941445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110343284|NCT02919501|Antidepressive Agents|antidepressive agents|mesh-ancestor
110343285|NCT02919501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110343286|NCT02919501|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110343287|NCT02919501|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110343288|NCT02919501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110343289|NCT02919501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110343290|NCT02919501|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110343291|NCT02919501|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110343292|NCT02919501|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110343293|NCT02919501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110343294|NCT02919501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110343296|NCT02919501|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110299143|NCT02740712|Coagulants|coagulants|mesh-ancestor
110343297|NCT02919501|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110343298|NCT02919501|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110343299|NCT02919501|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110343300|NCT02919579|Esketamine|esketamine|mesh-list
110343301|NCT02919579|Antidepressive Agents|antidepressive agents|mesh-ancestor
110343302|NCT02919579|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110343303|NCT02940821|Hydrogen Peroxide|hydrogen peroxide|mesh-list
110343304|NCT02940821|Fluorides|fluorides|mesh-list
110343305|NCT02940821|Tin Fluorides|tin fluorides|mesh-list
110343306|NCT02940821|Fluorophosphate|fluorophosphate|mesh-list
110343307|NCT02940821|Cariostatic Agents|cariostatic agents|mesh-ancestor
110343308|NCT02940821|Protective Agents|protective agents|mesh-ancestor
110343309|NCT02940821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110343310|NCT02940821|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110343311|NCT02940821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110343312|NCT02941601|Carboplatin|carboplatin|mesh-list
110343313|NCT02941601|Gemcitabine|gemcitabine|mesh-list
110343314|NCT02941601|Necitumumab|necitumumab|mesh-list
110343315|NCT02941601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110343316|NCT02941601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110343317|NCT02941601|Antimetabolites|antimetabolites|mesh-ancestor
110343318|NCT02941601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110343319|NCT02941601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110343320|NCT03160638|Azithromycin|azithromycin|mesh-list
110343321|NCT03160638|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110343322|NCT03160638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110343323|NCT02919462|Cisplatin|cisplatin|mesh-list
110343324|NCT02919462|Pemetrexed|pemetrexed|mesh-list
110343325|NCT02919462|Vinorelbine|vinorelbine|mesh-list
110343326|NCT02919462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110343327|NCT02919462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110343328|NCT02919462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110343329|NCT02919462|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110343330|NCT02919462|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110173819|NCT00061360|Cyclosporine|cyclosporine|mesh-list
110343331|NCT02919462|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110343332|NCT02919462|Tubulin Modulators|tubulin modulators|mesh-ancestor
110343333|NCT02919462|Antimitotic Agents|antimitotic agents|mesh-ancestor
110343334|NCT02919462|Mitosis Modulators|mitosis modulators|mesh-ancestor
110343335|NCT02941367|Metformin|metformin|mesh-list
110343336|NCT02941367|Lixisenatide|lixisenatide|mesh-list
110343337|NCT02941367|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110343338|NCT02941367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110343339|NCT03153150|Warfarin|warfarin|mesh-list
110343340|NCT03153150|Rivaroxaban|rivaroxaban|mesh-list
110343341|NCT03153150|Dabigatran|dabigatran|mesh-list
110343342|NCT03153150|Apixaban|apixaban|mesh-list
110343343|NCT03153150|Edoxaban|edoxaban|mesh-list
110343344|NCT03153150|Acenocoumarol|acenocoumarol|mesh-list
110343345|NCT03153150|Phenindione|phenindione|mesh-list
110343346|NCT03153150|Anticoagulants|anticoagulants|mesh-ancestor
110343347|NCT03153150|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110343348|NCT03153150|Antithrombins|antithrombins|mesh-ancestor
110343349|NCT03153150|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110343350|NCT03153150|Protease Inhibitors|protease inhibitors|mesh-ancestor
110343351|NCT03153150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110343352|NCT03153150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110343353|NCT02916147|Propofol|propofol|mesh-list
110343354|NCT02916147|Sevoflurane|sevoflurane|mesh-list
110343355|NCT02916147|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110343356|NCT02916147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110343357|NCT02916147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110343358|NCT02916147|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110343359|NCT02916147|Anesthetics, General|anesthetics, general|mesh-ancestor
110343360|NCT02916147|Anesthetics|anesthetics|mesh-ancestor
110343361|NCT02916147|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110343362|NCT02916147|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110343363|NCT05302388|Diphenhydramine|diphenhydramine|mesh-list
110343364|NCT05302388|Promethazine|promethazine|mesh-list
110343365|NCT05302388|Dexamethasone|dexamethasone|mesh-list
110343366|NCT05302388|Prednisolone|prednisolone|mesh-list
110343367|NCT05302388|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110343368|NCT05302388|Methylprednisolone|methylprednisolone|mesh-list
110343369|NCT05302388|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110343370|NCT05302388|Prednisolone acetate|prednisolone acetate|mesh-list
110343371|NCT05302388|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110343372|NCT05302388|Prednisolone phosphate|prednisolone phosphate|mesh-list
110343373|NCT05302388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110343374|NCT05302388|Antiemetics|antiemetics|mesh-ancestor
110343375|NCT05302388|Autonomic Agents|autonomic agents|mesh-ancestor
110343376|NCT05302388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110343377|NCT05302388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110343378|NCT05302388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110343379|NCT05302388|Glucocorticoids|glucocorticoids|mesh-ancestor
110343380|NCT05302388|Hormones|hormones|mesh-ancestor
110343381|NCT05302388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110343382|NCT05302388|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110343383|NCT05302388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110343384|NCT05302388|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110343385|NCT05302388|Protective Agents|protective agents|mesh-ancestor
110343386|NCT05302388|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110343387|NCT05302388|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110343388|NCT05302388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110343389|NCT05302388|Anesthetics, Local|anesthetics, local|mesh-ancestor
110343390|NCT05302388|Anesthetics|anesthetics|mesh-ancestor
110343391|NCT05302388|Sensory System Agents|sensory system agents|mesh-ancestor
110343392|NCT05302388|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110343393|NCT05302388|Histamine Antagonists|histamine antagonists|mesh-ancestor
110343394|NCT05302388|Histamine Agents|histamine agents|mesh-ancestor
110343395|NCT05302388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110343396|NCT05302388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110343397|NCT05302388|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110343398|NCT05302388|Antipruritics|antipruritics|mesh-ancestor
110343399|NCT05302388|Dermatologic Agents|dermatologic agents|mesh-ancestor
110343400|NCT06026163|Caffeine|caffeine|mesh-list
110343401|NCT06026163|Caffeine citrate|caffeine citrate|mesh-list
110173827|NCT00061360|Antifungal Agents|antifungal agents|mesh-ancestor
110343402|NCT06026163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110343404|NCT06026163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110343405|NCT06026163|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110343406|NCT06026163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110343407|NCT06026163|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110343408|NCT06026163|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110343409|NCT06026163|Purinergic Agents|purinergic agents|mesh-ancestor
110343410|NCT06026163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110343411|NCT06026033|Desflurane|desflurane|mesh-list
110343412|NCT06026033|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110343413|NCT06026033|Anesthetics, General|anesthetics, general|mesh-ancestor
110343414|NCT06026033|Anesthetics|anesthetics|mesh-ancestor
110343415|NCT06026033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110343416|NCT06026033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110343417|NCT06025916|Tranexamic Acid|tranexamic acid|mesh-list
110343418|NCT06025916|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110343419|NCT06025916|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110343420|NCT06025916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110343421|NCT06025916|Hemostatics|hemostatics|mesh-ancestor
110343422|NCT06025916|Coagulants|coagulants|mesh-ancestor
110343423|NCT06025851|Antibodies|antibodies|mesh-list
110343424|NCT06025851|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110343425|NCT06025851|Immunologic Factors|immunologic factors|mesh-ancestor
110343426|NCT06025851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110343427|NCT06025825|Lidocaine|lidocaine|mesh-list
110343428|NCT06025825|Epinephrine|epinephrine|mesh-list
110343429|NCT06025825|Racepinephrine|racepinephrine|mesh-list
110343430|NCT06025825|Carticaine|carticaine|mesh-list
110343431|NCT06025825|Epinephryl borate|epinephryl borate|mesh-list
110343432|NCT06025825|Anesthetics, Local|anesthetics, local|mesh-ancestor
110343433|NCT06025825|Anesthetics|anesthetics|mesh-ancestor
110343434|NCT06025825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110343435|NCT06025825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110343436|NCT06025825|Sensory System Agents|sensory system agents|mesh-ancestor
110343437|NCT06025825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110343438|NCT06025825|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110343439|NCT06025825|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110343440|NCT06025825|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110343441|NCT06025825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110343442|NCT06025825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110343443|NCT06025825|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110343444|NCT06025825|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110343445|NCT06025825|Adrenergic Agents|adrenergic agents|mesh-ancestor
110343446|NCT06025825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110343447|NCT06025825|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110343448|NCT06025825|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110343449|NCT06025825|Autonomic Agents|autonomic agents|mesh-ancestor
110343450|NCT06025825|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110343451|NCT06025825|Respiratory System Agents|respiratory system agents|mesh-ancestor
110343452|NCT06025825|Mydriatics|mydriatics|mesh-ancestor
110343453|NCT06025825|Sympathomimetics|sympathomimetics|mesh-ancestor
110343454|NCT06025825|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110343455|NCT06025812|Vaccines|vaccines|mesh-list
110343456|NCT06025812|Immunologic Factors|immunologic factors|mesh-ancestor
110343457|NCT06025812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110343458|NCT06025773|Lansoprazole|lansoprazole|mesh-list
110343459|NCT06025773|Dexlansoprazole|dexlansoprazole|mesh-list
110343460|NCT06025773|Calcium Carbonate|calcium carbonate|mesh-list
110343461|NCT06025773|Calcium|calcium|mesh-list
110343462|NCT06025773|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110343463|NCT06025773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110343464|NCT06025773|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110343465|NCT06025773|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110343466|NCT06025773|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110343467|NCT06025773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110343468|NCT06025773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110343470|NCT06025474|Pregabalin|pregabalin|mesh-list
110343471|NCT06025474|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110343472|NCT06025474|Vortioxetine|vortioxetine|mesh-list
110343474|NCT06025474|Sertraline|sertraline|mesh-list
110343475|NCT06025474|Paroxetine|paroxetine|mesh-list
110343476|NCT06025474|Escitalopram|escitalopram|mesh-list
110343477|NCT06025474|Analgesics|analgesics|mesh-ancestor
110343478|NCT06025474|Sensory System Agents|sensory system agents|mesh-ancestor
110343479|NCT06025474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110343480|NCT06025474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110343481|NCT06025474|Anticonvulsants|anticonvulsants|mesh-ancestor
110343482|NCT06025474|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110343483|NCT06025474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110343484|NCT06025474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110343485|NCT06025474|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110343486|NCT06025474|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110343487|NCT06025474|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110343488|NCT06025474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110343489|NCT06025474|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110343490|NCT06025474|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110343491|NCT06025474|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110343492|NCT06025474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110343493|NCT06025474|Serotonin Agents|serotonin agents|mesh-ancestor
110343494|NCT06025474|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110343495|NCT06025474|Antidepressive Agents|antidepressive agents|mesh-ancestor
110343496|NCT06025474|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110343497|NCT06025474|Dopamine Agents|dopamine agents|mesh-ancestor
110343498|NCT06025474|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110343499|NCT06025474|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110343500|NCT06025474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110343501|NCT06025474|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110343502|NCT06025474|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110343503|NCT06025474|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110343504|NCT06025474|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110343505|NCT06025409|Leuprolide|leuprolide|mesh-list
110343506|NCT06025409|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110343507|NCT06025409|Fertility Agents|fertility agents|mesh-ancestor
110343508|NCT06025409|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110343509|NCT06025409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110343510|NCT06025409|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110343511|NCT06025409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110343512|NCT06025344|Probenecid|probenecid|mesh-list
110343513|NCT06025344|Uricosuric Agents|uricosuric agents|mesh-ancestor
110343514|NCT06025344|Gout Suppressants|gout suppressants|mesh-ancestor
110343515|NCT06025344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110343516|NCT06025240|Antibodies|antibodies|mesh-list
110343517|NCT06025240|Immunologic Factors|immunologic factors|mesh-ancestor
110343518|NCT06025240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110343519|NCT06025214|Fluticasone|fluticasone|mesh-list
110343520|NCT06025214|Xhance|xhance|mesh-list
110343521|NCT06025214|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110343522|NCT06025214|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
110343523|NCT06025214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110343524|NCT06025214|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110343525|NCT06025214|Autonomic Agents|autonomic agents|mesh-ancestor
110343526|NCT06025214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110343527|NCT06025214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110343528|NCT06025214|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110343529|NCT06025214|Respiratory System Agents|respiratory system agents|mesh-ancestor
110343530|NCT06025214|Dermatologic Agents|dermatologic agents|mesh-ancestor
110343531|NCT06025214|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110343532|NCT06025214|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110343533|NCT06025214|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110343534|NCT06025214|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110343535|NCT06025214|Adrenergic Agents|adrenergic agents|mesh-ancestor
110343536|NCT06025214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110343537|NCT06025214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110343538|NCT06025214|Glucocorticoids|glucocorticoids|mesh-ancestor
110343539|NCT06025214|Hormones|hormones|mesh-ancestor
110343540|NCT06025214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110343541|NCT06025214|Sympathomimetics|sympathomimetics|mesh-ancestor
110343542|NCT06025162|Enoxaparin|enoxaparin|mesh-list
110343543|NCT06025162|Anticoagulants|anticoagulants|mesh-ancestor
110343544|NCT06025162|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110343545|NCT06025162|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110343546|NCT06025162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110343547|NCT06025097|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110343548|NCT06025097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110343549|NCT06025097|Glucocorticoids|glucocorticoids|mesh-ancestor
110343550|NCT06025097|Hormones|hormones|mesh-ancestor
110343551|NCT06025097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110343552|NCT06025097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110343553|NCT06025097|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110343554|NCT06025097|Protective Agents|protective agents|mesh-ancestor
110343555|NCT06025097|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110343556|NCT06025097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110343557|NCT06025084|Titanium dioxide|titanium dioxide|mesh-list
110343558|NCT06025084|Sunscreening Agents|sunscreening agents|mesh-ancestor
110343559|NCT06025084|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110343560|NCT06025084|Protective Agents|protective agents|mesh-ancestor
110343561|NCT06025084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110343562|NCT06025084|Dermatologic Agents|dermatologic agents|mesh-ancestor
110343563|NCT06025084|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110343564|NCT06025071|Colchicine|colchicine|mesh-list
110343565|NCT06025071|Gout Suppressants|gout suppressants|mesh-ancestor
110343566|NCT06025071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110343567|NCT06025071|Tubulin Modulators|tubulin modulators|mesh-ancestor
110343568|NCT06025071|Antimitotic Agents|antimitotic agents|mesh-ancestor
110343569|NCT06025071|Mitosis Modulators|mitosis modulators|mesh-ancestor
110343570|NCT06025071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110343571|NCT06025071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110343572|NCT06024928|Insulin|insulin|mesh-list
110343573|NCT06024928|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110343574|NCT06024928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110343575|NCT06024915|Itraconazole|itraconazole|mesh-list
110343576|NCT06024915|Rifampin|rifampin|mesh-list
110343577|NCT06024915|Antifungal Agents|antifungal agents|mesh-ancestor
110343578|NCT06024915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110343579|NCT06024915|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110343580|NCT06024915|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110343581|NCT06024915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110343582|NCT06024915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110343583|NCT06024915|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110343584|NCT06024915|Hormone Antagonists|hormone antagonists|mesh-ancestor
110343585|NCT06024915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110343586|NCT06024915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110343587|NCT06024915|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110343588|NCT06024915|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110343589|NCT06024915|Antitubercular Agents|antitubercular agents|mesh-ancestor
110343590|NCT06024915|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110343591|NCT06024915|Leprostatic Agents|leprostatic agents|mesh-ancestor
110343592|NCT06024915|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110343593|NCT06024915|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110343594|NCT06024915|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110343595|NCT06024915|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110343596|NCT06024915|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110175622|NCT00075595|Vitamins|vitamins|mesh-ancestor
110343597|NCT06024915|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110343598|NCT06024915|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110343600|NCT06024746|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110343601|NCT06024746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110343602|NCT06024746|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110343603|NCT06024746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110343604|NCT06024733|Lidocaine|lidocaine|mesh-list
110343605|NCT06024733|Sevoflurane|sevoflurane|mesh-list
110343606|NCT06024733|Anesthetics, Local|anesthetics, local|mesh-ancestor
110343607|NCT06024733|Anesthetics|anesthetics|mesh-ancestor
110343608|NCT06024733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110343609|NCT06024733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110343610|NCT06024733|Sensory System Agents|sensory system agents|mesh-ancestor
110343611|NCT06024733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110343612|NCT06024733|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110343613|NCT06024733|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110343614|NCT06024733|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110343615|NCT06024733|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110343616|NCT06024733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110343617|NCT06024733|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110343618|NCT06024733|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110018874|NCT01545648|Denosumab|denosumab|mesh-list
110343619|NCT06024733|Anesthetics, General|anesthetics, general|mesh-ancestor
110343621|NCT06024707|Benralizumab|benralizumab|mesh-list
110343622|NCT06024707|Reslizumab|reslizumab|mesh-list
110343623|NCT06024707|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110343624|NCT06024707|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110343625|NCT06024707|Respiratory System Agents|respiratory system agents|mesh-ancestor
110343626|NCT06024525|Paclitaxel|paclitaxel|mesh-list
110343627|NCT06024525|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110343628|NCT06024525|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110343629|NCT06024525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110343630|NCT06024525|Tubulin Modulators|tubulin modulators|mesh-ancestor
110343631|NCT06024525|Antimitotic Agents|antimitotic agents|mesh-ancestor
110343632|NCT06024525|Mitosis Modulators|mitosis modulators|mesh-ancestor
110343633|NCT06024525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110343634|NCT06024421|Favipiravir|favipiravir|mesh-list
110343635|NCT06024421|Antiviral Agents|antiviral agents|mesh-ancestor
110343636|NCT06024421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110343637|NCT06024356|Thymalfasin|thymalfasin|mesh-list
110343638|NCT06024356|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110343639|NCT06024356|Immunologic Factors|immunologic factors|mesh-ancestor
110343640|NCT06024356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110343641|NCT06024252|Atezolizumab|atezolizumab|mesh-list
110175629|NCT00075634|Lenograstim|lenograstim|mesh-list
110343642|NCT06024252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110343643|NCT06024252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110343644|NCT06024252|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110343645|NCT06024252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110343646|NCT06024213|Methylene Blue|methylene blue|mesh-list
110343647|NCT06024213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110343648|NCT06024213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110343649|NCT06024174|Cetuximab|cetuximab|mesh-list
110343650|NCT06024174|Adagrasib|adagrasib|mesh-list
110343651|NCT06024174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110343652|NCT06024174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110343653|NCT06023641|Dactinomycin|dactinomycin|mesh-list
110343654|NCT06023641|Cyclophosphamide|cyclophosphamide|mesh-list
110343655|NCT06023641|Temozolomide|temozolomide|mesh-list
110343656|NCT06023641|Irinotecan|irinotecan|mesh-list
110343657|NCT06023641|Vincristine|vincristine|mesh-list
110343658|NCT06023641|Vinorelbine|vinorelbine|mesh-list
110343659|NCT06023641|Lenograstim|lenograstim|mesh-list
110343660|NCT06023641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110343661|NCT06023641|Immunologic Factors|immunologic factors|mesh-ancestor
110343662|NCT06023641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110343663|NCT06023641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110343664|NCT06023641|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110343665|NCT06023641|Alkylating Agents|alkylating agents|mesh-ancestor
110343830|NCT06020755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110343666|NCT06023641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110343667|NCT06023641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110343668|NCT06023641|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110299246|NCT00239096|Losartan|losartan|mesh-list
110343669|NCT06023641|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110343670|NCT06023641|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110343671|NCT06023641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110343672|NCT06023641|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110343673|NCT06023641|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110343674|NCT06023641|Tubulin Modulators|tubulin modulators|mesh-ancestor
110343675|NCT06023641|Antimitotic Agents|antimitotic agents|mesh-ancestor
110343676|NCT06023641|Mitosis Modulators|mitosis modulators|mesh-ancestor
110343677|NCT06023641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110343678|NCT06023641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110343679|NCT06023641|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110343680|NCT06023641|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110343681|NCT06023641|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110343682|NCT06023602|Cetrorelix|cetrorelix|mesh-list
110343683|NCT06023602|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110343684|NCT06023602|Fertility Agents|fertility agents|mesh-ancestor
110343685|NCT06023602|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110343686|NCT06023602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110343687|NCT06023602|Hormone Antagonists|hormone antagonists|mesh-ancestor
110343688|NCT06023602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110343689|NCT06023576|Antihypertensive Agents|antihypertensive agents|mesh-list
110343690|NCT06023459|Buprenorphine|buprenorphine|mesh-list
110175660|NCT00075673|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110343691|NCT06023459|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
110343692|NCT06023459|Naloxone|naloxone|mesh-list
110343693|NCT06023459|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110343694|NCT06023459|Narcotics|narcotics|mesh-ancestor
110343695|NCT06023459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110343696|NCT06023459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110343698|NCT06023459|Sensory System Agents|sensory system agents|mesh-ancestor
110343699|NCT06023459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110343700|NCT06023459|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110343701|NCT06023368|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
110343702|NCT06023368|Anesthetics, Local|anesthetics, local|mesh-ancestor
110343703|NCT06023368|Anesthetics|anesthetics|mesh-ancestor
110343704|NCT06023368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110343705|NCT06023368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110343706|NCT06023368|Sensory System Agents|sensory system agents|mesh-ancestor
110343707|NCT06023368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110343708|NCT06023368|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
110343709|NCT06023329|Ropivacaine|ropivacaine|mesh-list
110343710|NCT06023329|Anesthetics, Local|anesthetics, local|mesh-ancestor
110343711|NCT06023329|Anesthetics|anesthetics|mesh-ancestor
110343712|NCT06023329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110343713|NCT06023329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110343714|NCT06023329|Sensory System Agents|sensory system agents|mesh-ancestor
110343715|NCT06023329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110343716|NCT06023225|Analgesics, Opioid|analgesics, opioid|mesh-list
110343717|NCT06023225|Narcotics|narcotics|mesh-ancestor
110343718|NCT06023225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110343719|NCT06023225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110343720|NCT06023225|Analgesics|analgesics|mesh-ancestor
110343721|NCT06023225|Sensory System Agents|sensory system agents|mesh-ancestor
110343722|NCT06023225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110343723|NCT06023212|Tranexamic Acid|tranexamic acid|mesh-list
110343724|NCT06023212|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110343725|NCT06023212|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110343726|NCT06023212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110343727|NCT06023212|Hemostatics|hemostatics|mesh-ancestor
110343728|NCT06023212|Coagulants|coagulants|mesh-ancestor
110343729|NCT06023043|Dexamethasone|dexamethasone|mesh-list
110343730|NCT06023043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110343731|NCT06023043|Antiemetics|antiemetics|mesh-ancestor
110343732|NCT06023043|Autonomic Agents|autonomic agents|mesh-ancestor
110343733|NCT06023043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110343734|NCT06023043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110343735|NCT06023043|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110343736|NCT06023043|Glucocorticoids|glucocorticoids|mesh-ancestor
110343738|NCT06023043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110343739|NCT06023043|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110343740|NCT06023043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110343741|NCT06022939|Dexamethasone|dexamethasone|mesh-list
110343742|NCT06022939|Dexamethasone acetate|dexamethasone acetate|mesh-list
110343743|NCT06022939|Cyclophosphamide|cyclophosphamide|mesh-list
110343745|NCT06022939|Mechlorethamine|mechlorethamine|mesh-list
110343746|NCT06022939|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
110343747|NCT06022939|Bortezomib|bortezomib|mesh-list
110343748|NCT06022939|Daratumumab|daratumumab|mesh-list
110343749|NCT06022939|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110343750|NCT06022939|BB 1101|bb 1101|mesh-list
110173857|NCT00061516|Brinzolamide|brinzolamide|mesh-list
110343751|NCT06022939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110343753|NCT06022939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110175683|NCT00075868|Octreotide|octreotide|mesh-list
110343755|NCT06022939|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110343756|NCT06022939|Alkylating Agents|alkylating agents|mesh-ancestor
110343757|NCT06022939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110343758|NCT06022939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110343759|NCT06022939|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110343760|NCT06022939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110343761|NCT06022939|Antiemetics|antiemetics|mesh-ancestor
110343762|NCT06022939|Autonomic Agents|autonomic agents|mesh-ancestor
110343763|NCT06022939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110343764|NCT06022939|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110343765|NCT06022939|Glucocorticoids|glucocorticoids|mesh-ancestor
110343766|NCT06022939|Hormones|hormones|mesh-ancestor
110343767|NCT06022939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110343768|NCT06022939|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110343769|NCT06022939|Protease Inhibitors|protease inhibitors|mesh-ancestor
110343770|NCT06022939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110343771|NCT06022861|Fluorouracil|fluorouracil|mesh-list
110343772|NCT06022861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110343773|NCT06022861|Antimetabolites|antimetabolites|mesh-ancestor
110343774|NCT06022861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110343775|NCT06022861|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110343776|NCT06022861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110343777|NCT06022861|Immunologic Factors|immunologic factors|mesh-ancestor
110343778|NCT06022861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110343780|NCT06022835|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110343781|NCT06022835|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110343782|NCT06022835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110343783|NCT06022835|Disinfectants|disinfectants|mesh-ancestor
110343784|NCT06022835|Dermatologic Agents|dermatologic agents|mesh-ancestor
110343785|NCT06022757|Pembrolizumab|pembrolizumab|mesh-list
110343786|NCT06022757|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110343787|NCT06022757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110343788|NCT06022757|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110343789|NCT06022757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110343790|NCT06022692|Tislelizumab|tislelizumab|mesh-list
110343791|NCT06022692|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
110343792|NCT06022692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110343793|NCT06022692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110343794|NCT06022692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110343795|NCT06022614|Dexmedetomidine|dexmedetomidine|mesh-list
110343796|NCT06022614|Bupivacaine|bupivacaine|mesh-list
110343797|NCT06022614|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110343798|NCT06022614|Anesthetics, Local|anesthetics, local|mesh-ancestor
110343799|NCT06022614|Anesthetics|anesthetics|mesh-ancestor
110343800|NCT06022614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110343801|NCT06022614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110534675|NCT02672358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110534677|NCT02675868|Vasopressins|vasopressins|mesh-list
110534678|NCT02675868|Arginine Vasopressin|arginine vasopressin|mesh-list
110534679|NCT02675868|Oxymetazoline|oxymetazoline|mesh-list
110534680|NCT02675868|Norepinephrine|norepinephrine|mesh-list
110534681|NCT02675868|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110175709|NCT03958383|Ipilimumab|ipilimumab|mesh-list
110534682|NCT02675868|Mydriatics|mydriatics|mesh-ancestor
110534683|NCT02675868|Autonomic Agents|autonomic agents|mesh-ancestor
110534684|NCT02675868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110534685|NCT02675868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110534686|NCT02675868|Sympathomimetics|sympathomimetics|mesh-ancestor
110534687|NCT02675868|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110534688|NCT02675868|Nasal Decongestants|nasal decongestants|mesh-ancestor
110534689|NCT02675868|Respiratory System Agents|respiratory system agents|mesh-ancestor
110534690|NCT02675868|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110534691|NCT02675868|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110534692|NCT02675868|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110534693|NCT02675868|Adrenergic Agents|adrenergic agents|mesh-ancestor
110534694|NCT02675868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110534695|NCT02675868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110534696|NCT02675868|Protective Agents|protective agents|mesh-ancestor
110534697|NCT02675868|Hemostatics|hemostatics|mesh-ancestor
110534698|NCT02675868|Coagulants|coagulants|mesh-ancestor
110534699|NCT02675868|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
110534700|NCT02675868|Natriuretic Agents|natriuretic agents|mesh-ancestor
110534701|NCT05279742|Valsartan|valsartan|mesh-list
110534702|NCT05279742|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
110534703|NCT05279742|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110534704|NCT05279742|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110534705|NCT05279742|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110534706|NCT05279742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110534707|NCT02673840|Ketotifen|ketotifen|mesh-list
110534708|NCT02673840|Antipruritics|antipruritics|mesh-ancestor
110534709|NCT02673840|Dermatologic Agents|dermatologic agents|mesh-ancestor
110534710|NCT02673840|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110534711|NCT02673840|Histamine Antagonists|histamine antagonists|mesh-ancestor
110534712|NCT02673840|Histamine Agents|histamine agents|mesh-ancestor
110534713|NCT02673840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110534714|NCT02673840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110534715|NCT02673840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110534716|NCT02673840|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110534717|NCT00644124|Aflibercept|aflibercept|mesh-list
110534718|NCT00644124|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110534719|NCT00644124|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110534720|NCT00644124|Growth Substances|growth substances|mesh-ancestor
110534721|NCT00644124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110534722|NCT00644124|Growth Inhibitors|growth inhibitors|mesh-ancestor
110534723|NCT00644124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110534724|NCT02670954|Flurbiprofen|flurbiprofen|mesh-list
110534725|NCT02670954|Dexmedetomidine|dexmedetomidine|mesh-list
110534726|NCT02670954|Tramadol|tramadol|mesh-list
110534727|NCT02670954|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110534728|NCT02670954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110534729|NCT02670954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110534730|NCT02670954|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110534731|NCT02670954|Analgesics|analgesics|mesh-ancestor
110534732|NCT02670954|Sensory System Agents|sensory system agents|mesh-ancestor
110534733|NCT02670954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110534734|NCT02670954|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110534735|NCT02670954|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110534736|NCT02670954|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110534737|NCT02670954|Adrenergic Agents|adrenergic agents|mesh-ancestor
110534738|NCT02670954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110534739|NCT02670954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110534740|NCT02670954|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110534741|NCT02670954|Narcotics|narcotics|mesh-ancestor
110534742|NCT02670954|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110534743|NCT02670954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110534744|NCT02670954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110534745|NCT02670954|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110534746|NCT02670954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110534747|NCT00644904|Vitamin D|vitamin d|mesh-list
110534748|NCT00644904|Ergocalciferols|ergocalciferols|mesh-list
110534749|NCT00644904|Cholecalciferol|cholecalciferol|mesh-list
110534750|NCT00644904|Vitamins|vitamins|mesh-list
110534751|NCT00644904|Micronutrients|micronutrients|mesh-ancestor
110534752|NCT00644904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110534753|NCT00644904|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110534754|NCT00644904|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110534755|NCT02670564|Busulfan|busulfan|mesh-list
110534756|NCT02670564|Alkylating Agents|alkylating agents|mesh-ancestor
110534757|NCT02670564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110534758|NCT02670564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110534759|NCT02670564|Immunologic Factors|immunologic factors|mesh-ancestor
110534760|NCT02670564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110534761|NCT02670564|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110175750|NCT00076492|Vitamins|vitamins|mesh-ancestor
110175760|NCT00076609|Capecitabine|capecitabine|mesh-list
110534762|NCT02670564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110534763|NCT02670564|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110534765|NCT02672202|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110534766|NCT02672202|Analgesics|analgesics|mesh-ancestor
110534767|NCT02672202|Sensory System Agents|sensory system agents|mesh-ancestor
110534768|NCT02672202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110534769|NCT02672202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110534770|NCT02672202|Anticonvulsants|anticonvulsants|mesh-ancestor
110534771|NCT02672202|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110534772|NCT02672202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110534773|NCT02672202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110534774|NCT02672202|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110534775|NCT02672202|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110534776|NCT02672202|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110534777|NCT02672202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110534778|NCT02672202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110534779|NCT02672202|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110534780|NCT02672202|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110534781|NCT02672202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110534782|NCT02672202|Antidepressive Agents|antidepressive agents|mesh-ancestor
110534783|NCT02672202|Dopamine Agents|dopamine agents|mesh-ancestor
110534784|NCT02671578|Nitrous Oxide|nitrous oxide|mesh-list
110534785|NCT02671578|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110534786|NCT02671578|Anesthetics, General|anesthetics, general|mesh-ancestor
110534787|NCT02671578|Anesthetics|anesthetics|mesh-ancestor
110534788|NCT02671578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110534789|NCT02671578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110534790|NCT02671578|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110534791|NCT02671578|Analgesics|analgesics|mesh-ancestor
110534792|NCT02671578|Sensory System Agents|sensory system agents|mesh-ancestor
110534793|NCT02671578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110534794|NCT00644982|Sertraline|sertraline|mesh-list
110534795|NCT00644982|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
110534796|NCT00644982|Antidepressive Agents|antidepressive agents|mesh-ancestor
110534797|NCT00644982|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110534798|NCT00644982|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110534799|NCT00644982|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110534800|NCT00644982|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110534801|NCT00644982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110534802|NCT00644982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110534803|NCT00644982|Serotonin Agents|serotonin agents|mesh-ancestor
110534804|NCT00644982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110534805|NCT00644982|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110534806|NCT00644982|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110534807|NCT02670642|Esomeprazole|esomeprazole|mesh-list
110534808|NCT02670642|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110534809|NCT02670642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110534810|NCT02670642|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110534811|NCT02670642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110534812|NCT02670642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110534813|NCT04175496|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110534814|NCT02670018|Metformin|metformin|mesh-list
110182314|NCT00023400|Antiviral Agents|antiviral agents|mesh-ancestor
110534815|NCT02670018|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110534816|NCT02670018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110534817|NCT02670096|Acetazolamide|acetazolamide|mesh-list
110534818|NCT02670096|Anticonvulsants|anticonvulsants|mesh-ancestor
110534819|NCT02670096|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110534820|NCT02670096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110534821|NCT02670096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110534822|NCT02670096|Diuretics|diuretics|mesh-ancestor
110534823|NCT02670096|Natriuretic Agents|natriuretic agents|mesh-ancestor
110534824|NCT02670096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110534825|NCT00645060|Antibodies|antibodies|mesh-list
110534826|NCT00645060|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110534827|NCT00645060|Immunologic Factors|immunologic factors|mesh-ancestor
110534828|NCT00645060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110534829|NCT00644670|Atorvastatin|atorvastatin|mesh-list
110534830|NCT00644670|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110534831|NCT00644670|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110534832|NCT00644670|Antimetabolites|antimetabolites|mesh-ancestor
110534833|NCT00644670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110534834|NCT00644670|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110534835|NCT00644670|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110534836|NCT00644670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110534837|NCT02669706|Pentamidine|pentamidine|mesh-list
110534838|NCT02669706|Antifungal Agents|antifungal agents|mesh-ancestor
110534839|NCT02669706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110534840|NCT02669706|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110534841|NCT02669706|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110534842|NCT02669706|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
110534843|NCT00645138|Anesthetics|anesthetics|mesh-list
110534844|NCT00645138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110534845|NCT00645138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110534846|NCT00895895|Donepezil|donepezil|mesh-list
110534847|NCT00895895|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110534848|NCT00895895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110534849|NCT00895895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110534850|NCT00895895|Cholinergic Agents|cholinergic agents|mesh-ancestor
110534851|NCT00895895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110534852|NCT00895895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110534853|NCT00895895|Nootropic Agents|nootropic agents|mesh-ancestor
110534854|NCT00644748|Gabapentin|gabapentin|mesh-list
110534855|NCT00644748|Analgesics|analgesics|mesh-ancestor
110534856|NCT00644748|Sensory System Agents|sensory system agents|mesh-ancestor
110534857|NCT00644748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110534858|NCT00644748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110534859|NCT00644748|Anticonvulsants|anticonvulsants|mesh-ancestor
110534860|NCT00644748|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110534861|NCT00644748|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110534862|NCT00644748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110175811|NCT03951207|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110534863|NCT00644748|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110534864|NCT00644748|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110534865|NCT00644748|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110534866|NCT00644748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110534867|NCT00644748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110534868|NCT00644748|Antimanic Agents|antimanic agents|mesh-ancestor
110534869|NCT00910416|Remifentanil|remifentanil|mesh-list
110534871|NCT00910416|Sevoflurane|sevoflurane|mesh-list
110534872|NCT00910416|Atracurium|atracurium|mesh-list
110534873|NCT00910416|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110534874|NCT00910416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110280067|NCT00218244|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110534875|NCT00910416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110534876|NCT00910416|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110534877|NCT00910416|Anesthetics, General|anesthetics, general|mesh-ancestor
110534878|NCT00910416|Anesthetics|anesthetics|mesh-ancestor
110534879|NCT00910416|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110534880|NCT00910416|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110534881|NCT00910416|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110534882|NCT00910416|Narcotics|narcotics|mesh-ancestor
110534883|NCT00910416|Analgesics|analgesics|mesh-ancestor
110534884|NCT00910416|Sensory System Agents|sensory system agents|mesh-ancestor
110534885|NCT00910416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110534886|NCT00910416|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110534887|NCT00910416|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110534888|NCT00910416|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110534889|NCT00910416|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
110534890|NCT00910416|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110534891|NCT00910416|Cholinergic Agents|cholinergic agents|mesh-ancestor
110534892|NCT00910416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110534893|NCT00910416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110534894|NCT02669238|Etonogestrel|etonogestrel|mesh-list
110534895|NCT02669238|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110534896|NCT02669238|Contraceptive Agents|contraceptive agents|mesh-ancestor
110534897|NCT02669238|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110534898|NCT02669238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110534899|NCT02669238|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110534900|NCT02669004|Morphine|morphine|mesh-list
110534901|NCT02669004|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110175832|NCT00077233|Antimetabolites|antimetabolites|mesh-ancestor
110175844|NCT00077233|Vitamins|vitamins|mesh-ancestor
110534902|NCT02669004|Narcotics|narcotics|mesh-ancestor
110534903|NCT02669004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110534904|NCT02669004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110534905|NCT02669004|Analgesics|analgesics|mesh-ancestor
110534906|NCT02669004|Sensory System Agents|sensory system agents|mesh-ancestor
110534907|NCT02669004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110534908|NCT00895661|Rituximab|rituximab|mesh-list
110534909|NCT00895661|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110534910|NCT00895661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110534911|NCT00895661|Immunologic Factors|immunologic factors|mesh-ancestor
110534912|NCT00895661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110534913|NCT00895661|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110534914|NCT00645294|Adefovir|adefovir|mesh-list
110534915|NCT00645294|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
110534916|NCT00645294|Antiviral Agents|antiviral agents|mesh-ancestor
110534917|NCT00645294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110534918|NCT00645294|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110534919|NCT00645294|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110534920|NCT00645294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110534921|NCT00645294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110534922|NCT02837003|Aspirin|aspirin|mesh-list
110534923|NCT02837003|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110534924|NCT02837003|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110534925|NCT02837003|Analgesics|analgesics|mesh-ancestor
110534926|NCT02837003|Sensory System Agents|sensory system agents|mesh-ancestor
110534927|NCT02837003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110534928|NCT02837003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110534929|NCT02837003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110534930|NCT02837003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110534931|NCT02837003|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110534932|NCT02837003|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110534933|NCT02837003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110534934|NCT02837003|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110534935|NCT02837003|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110534936|NCT02837003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110534937|NCT02837003|Antipyretics|antipyretics|mesh-ancestor
110534938|NCT02668926|Amphetamine|amphetamine|mesh-list
110534939|NCT02668926|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
110534940|NCT02668926|Dextroamphetamine|dextroamphetamine|mesh-list
110534941|NCT02668926|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110534942|NCT02668926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110534943|NCT02668926|Sympathomimetics|sympathomimetics|mesh-ancestor
110534944|NCT02668926|Autonomic Agents|autonomic agents|mesh-ancestor
110534945|NCT02668926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110534946|NCT02668926|Dopamine Agents|dopamine agents|mesh-ancestor
110534947|NCT02668926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110534948|NCT02668926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110534949|NCT02668926|Adrenergic Agents|adrenergic agents|mesh-ancestor
110534950|NCT02668926|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110534951|NCT02668926|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110534952|NCT02668926|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110534953|NCT02668926|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110534954|NCT02668536|Sunscreening Agents|sunscreening agents|mesh-list
110534955|NCT02668536|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110534956|NCT02668536|Protective Agents|protective agents|mesh-ancestor
110534957|NCT02668536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110534958|NCT02668536|Dermatologic Agents|dermatologic agents|mesh-ancestor
110534959|NCT00645372|Risperidone|risperidone|mesh-list
110534960|NCT00645372|Ziprasidone|ziprasidone|mesh-list
110534961|NCT00645372|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110534962|NCT00645372|Serotonin Agents|serotonin agents|mesh-ancestor
110534963|NCT00645372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110175895|NCT00077584|Bosentan|bosentan|mesh-list
110175896|NCT00077584|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110534964|NCT00645372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110534965|NCT00645372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110534966|NCT00645372|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110534967|NCT00645372|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110534968|NCT00645372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110534969|NCT00645372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110534970|NCT00645372|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110534972|NCT00645918|Clopidogrel|clopidogrel|mesh-list
110534973|NCT00645918|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110534974|NCT00645918|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110534975|NCT00645918|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110534976|NCT00645918|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110534977|NCT00645918|Purinergic Agents|purinergic agents|mesh-ancestor
110534978|NCT00645918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110534979|NCT00645918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110534980|NCT00645918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110534981|NCT00646854|Cyclophosphamide|cyclophosphamide|mesh-list
110534982|NCT00646854|Alemtuzumab|alemtuzumab|mesh-list
110534983|NCT00646854|Doxorubicin|doxorubicin|mesh-list
110534984|NCT00646854|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110534985|NCT00646854|Vincristine|vincristine|mesh-list
110534986|NCT00646854|Lenograstim|lenograstim|mesh-list
110534987|NCT00646854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110534988|NCT00646854|Immunologic Factors|immunologic factors|mesh-ancestor
110534989|NCT00646854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110534990|NCT00646854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110534991|NCT00646854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110534992|NCT00646854|Alkylating Agents|alkylating agents|mesh-ancestor
110534993|NCT00646854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110534994|NCT00646854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110534995|NCT00646854|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110534996|NCT00646854|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110175954|NCT00078442|Interferon alpha-2|interferon alpha-2|mesh-list
110534997|NCT00646854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110534998|NCT00646854|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110534999|NCT00646854|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110535000|NCT00646854|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110535001|NCT00646854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110535002|NCT00646854|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110535003|NCT00646854|Tubulin Modulators|tubulin modulators|mesh-ancestor
110535004|NCT00646854|Antimitotic Agents|antimitotic agents|mesh-ancestor
110535005|NCT00646854|Mitosis Modulators|mitosis modulators|mesh-ancestor
110535007|NCT04173858|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110535008|NCT04173858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110535009|NCT04173858|Sensory System Agents|sensory system agents|mesh-ancestor
110535010|NCT04173858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110535011|NCT00646932|Ergocalciferols|ergocalciferols|mesh-list
110535012|NCT00646932|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110535013|NCT00646932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110535014|NCT00646932|Vitamins|vitamins|mesh-ancestor
110535016|NCT00646932|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110535017|NCT00646152|Poly ICLC|poly iclc|mesh-list
110535018|NCT00646152|Interferon Inducers|interferon inducers|mesh-ancestor
110535019|NCT00646152|Immunologic Factors|immunologic factors|mesh-ancestor
110535020|NCT00646152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110535021|NCT00647166|Azathioprine|azathioprine|mesh-list
110535022|NCT00647166|Antimetabolites|antimetabolites|mesh-ancestor
110535023|NCT00647166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110535024|NCT00647166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110535025|NCT00647166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110535026|NCT00647166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110535027|NCT00647166|Immunologic Factors|immunologic factors|mesh-ancestor
110535028|NCT00647166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110535029|NCT00647166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110535030|NCT00647244|Tenofovir|tenofovir|mesh-list
110535031|NCT00647244|Abacavir|abacavir|mesh-list
110535032|NCT00647244|Antiviral Agents|antiviral agents|mesh-ancestor
110535033|NCT00647244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110280101|NCT00185705|Telmisartan|telmisartan|mesh-list
110535034|NCT00647244|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110535035|NCT00647244|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110535036|NCT00647244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110535037|NCT00647244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110535038|NCT00647244|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110535039|NCT00647244|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110535040|NCT00895583|Sirolimus|sirolimus|mesh-list
110535041|NCT00895583|Tacrolimus|tacrolimus|mesh-list
110535042|NCT00895583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110535043|NCT00895583|Immunologic Factors|immunologic factors|mesh-ancestor
110535044|NCT00895583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110535045|NCT00895583|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110535046|NCT00895583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110535047|NCT00895583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110535048|NCT00895583|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110535049|NCT00895583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110535050|NCT00895583|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110535051|NCT00895583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110535052|NCT00895583|Antifungal Agents|antifungal agents|mesh-ancestor
110535053|NCT00647322|Anticonvulsants|anticonvulsants|mesh-list
110535054|NCT04174872|Midazolam|midazolam|mesh-list
110535055|NCT04174872|Dexmedetomidine|dexmedetomidine|mesh-list
110535056|NCT04174872|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110535057|NCT04174872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110535058|NCT04174872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110535059|NCT04174872|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110535060|NCT04174872|Analgesics|analgesics|mesh-ancestor
110535061|NCT04174872|Sensory System Agents|sensory system agents|mesh-ancestor
110535062|NCT04174872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110535063|NCT04174872|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110535064|NCT04174872|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110535065|NCT04174872|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110535066|NCT04174872|Adrenergic Agents|adrenergic agents|mesh-ancestor
110535067|NCT04174872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110535068|NCT04174872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110535069|NCT04174872|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110535070|NCT04174872|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110535071|NCT04174872|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110535072|NCT04174872|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110535073|NCT04174872|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110535074|NCT04174872|Anesthetics, General|anesthetics, general|mesh-ancestor
110535075|NCT04174872|Anesthetics|anesthetics|mesh-ancestor
110535076|NCT04174872|GABA Modulators|gaba modulators|mesh-ancestor
110535077|NCT04174872|GABA Agents|gaba agents|mesh-ancestor
110535078|NCT02841137|Progesterone|progesterone|mesh-list
110535079|NCT02841137|Progestins|progestins|mesh-ancestor
110535080|NCT02841137|Hormones|hormones|mesh-ancestor
110535081|NCT02841137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110535082|NCT02841137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110535083|NCT00645606|Rituximab|rituximab|mesh-list
110535084|NCT00645606|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110535085|NCT00645606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110535086|NCT00645606|Immunologic Factors|immunologic factors|mesh-ancestor
110535087|NCT00645606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110535088|NCT00645606|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110535089|NCT02836847|Trastuzumab|trastuzumab|mesh-list
110535090|NCT02836847|Cetuximab|cetuximab|mesh-list
110535091|NCT02836847|Everolimus|everolimus|mesh-list
110535092|NCT02836847|Sorafenib|sorafenib|mesh-list
110535093|NCT02836847|Lapatinib|lapatinib|mesh-list
110535094|NCT02836847|Gefitinib|gefitinib|mesh-list
110535095|NCT02836847|Crizotinib|crizotinib|mesh-list
110535096|NCT02836847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110535097|NCT02836847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110535098|NCT02836847|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110535099|NCT02836847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110535100|NCT02836847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110535101|NCT02836847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110535102|NCT02836847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110535103|NCT02836847|Immunologic Factors|immunologic factors|mesh-ancestor
110535104|NCT02836847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110535105|NCT02666040|Anesthetics|anesthetics|mesh-list
110176006|NCT01350128|Cholinergic Agents|cholinergic agents|mesh-ancestor
110535106|NCT02666040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110535107|NCT02666040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110535108|NCT00894413|Tadalafil|tadalafil|mesh-list
110535109|NCT00894413|Vasodilator Agents|vasodilator agents|mesh-ancestor
110535110|NCT00894413|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110535111|NCT00894413|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110535112|NCT00894413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110535113|NCT00894413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110535114|NCT00894413|Urological Agents|urological agents|mesh-ancestor
110535115|NCT04250519|Sodium Hypochlorite|sodium hypochlorite|mesh-list
110535116|NCT04250519|Eusol|eusol|mesh-list
110535117|NCT04250519|Disinfectants|disinfectants|mesh-ancestor
110535118|NCT04250519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110535120|NCT04172220|Anesthetics|anesthetics|mesh-list
110535121|NCT04172220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110535122|NCT04172220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110535123|NCT04172220|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110535124|NCT04172220|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110535125|NCT04172220|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110535126|NCT04172220|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110535127|NCT04172220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110535128|NCT04172220|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110535129|NCT04172220|Anesthetics, General|anesthetics, general|mesh-ancestor
110535130|NCT04172220|GABA Modulators|gaba modulators|mesh-ancestor
110535131|NCT04172220|GABA Agents|gaba agents|mesh-ancestor
110535132|NCT04172220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110535133|NCT04172220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110535134|NCT02665806|Fluticasone|fluticasone|mesh-list
110535135|NCT02665806|Ciclesonide|ciclesonide|mesh-list
110535136|NCT02665806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110535137|NCT02665806|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110535138|NCT02665806|Autonomic Agents|autonomic agents|mesh-ancestor
110535139|NCT02665806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110535140|NCT02665806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110535141|NCT02665806|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110535142|NCT02665806|Respiratory System Agents|respiratory system agents|mesh-ancestor
110535143|NCT02665806|Dermatologic Agents|dermatologic agents|mesh-ancestor
110535144|NCT02665806|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110535145|NCT02665806|Glucocorticoids|glucocorticoids|mesh-ancestor
110535146|NCT02665806|Hormones|hormones|mesh-ancestor
110535147|NCT02665806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110535148|NCT00646386|Adalimumab|adalimumab|mesh-list
110535149|NCT00646386|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110535150|NCT00646386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110535151|NCT00646386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110535152|NCT00647634|Alprazolam|alprazolam|mesh-list
110535153|NCT00647634|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110535154|NCT00647634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110535155|NCT00647634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110535156|NCT00647634|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110535157|NCT00647634|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110535158|NCT00647634|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110535159|NCT00647634|GABA Modulators|gaba modulators|mesh-ancestor
110535160|NCT00647634|GABA Agents|gaba agents|mesh-ancestor
110535161|NCT00647634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110535162|NCT00647634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110535163|NCT04172064|Dobutamine|dobutamine|mesh-list
110535164|NCT04172064|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110535165|NCT04172064|Sympathomimetics|sympathomimetics|mesh-ancestor
110535166|NCT04172064|Autonomic Agents|autonomic agents|mesh-ancestor
110535167|NCT04172064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110535168|NCT04172064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110535169|NCT04172064|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
110535170|NCT04172064|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110535171|NCT04172064|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110535172|NCT04172064|Adrenergic Agents|adrenergic agents|mesh-ancestor
110535173|NCT04172064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110535174|NCT04172064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110535175|NCT04172064|Protective Agents|protective agents|mesh-ancestor
110535176|NCT00647712|Valproic Acid|valproic acid|mesh-list
110535177|NCT00647712|Anticonvulsants|anticonvulsants|mesh-ancestor
110535178|NCT00647712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110535179|NCT00647712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110535180|NCT00647712|GABA Agents|gaba agents|mesh-ancestor
110535181|NCT00647712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110535182|NCT00647712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110535183|NCT00647712|Antimanic Agents|antimanic agents|mesh-ancestor
110535184|NCT00647712|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110535185|NCT00647712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110535186|NCT00647712|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110535188|NCT04173390|Analgesics|analgesics|mesh-ancestor
110535189|NCT04173390|Sensory System Agents|sensory system agents|mesh-ancestor
110535190|NCT04173390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110535191|NCT04173390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110535192|NCT04173390|Anticonvulsants|anticonvulsants|mesh-ancestor
110535193|NCT04173390|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110535194|NCT04173390|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110535195|NCT04173390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110535196|NCT04173390|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110535197|NCT04173390|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110535198|NCT04173390|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110535199|NCT04173390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110535200|NCT04173390|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110535201|NCT02665650|Pembrolizumab|pembrolizumab|mesh-list
110299414|NCT02217631|Prednisolone|prednisolone|mesh-list
110535202|NCT02665650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110535203|NCT02665650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110535204|NCT02665650|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110535205|NCT02665650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110535206|NCT00647868|Testosterone|testosterone|mesh-list
110535207|NCT00647868|Androgens|androgens|mesh-ancestor
110535208|NCT00647868|Hormones|hormones|mesh-ancestor
110535209|NCT00647868|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110535210|NCT00647868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110535211|NCT00647946|Tenofovir|tenofovir|mesh-list
110535212|NCT00647946|Abacavir|abacavir|mesh-list
110535213|NCT00647946|Antiviral Agents|antiviral agents|mesh-ancestor
110535214|NCT00647946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110535215|NCT00647946|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110535216|NCT00647946|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110535217|NCT00647946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110535218|NCT00647946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110535219|NCT00647946|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110535220|NCT00647946|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110535221|NCT00648024|Anagrelide|anagrelide|mesh-list
110535222|NCT00648024|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110535223|NCT00648024|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110535224|NCT00648024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110535225|NCT00648024|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110535226|NCT02665416|Bevacizumab|bevacizumab|mesh-list
110535227|NCT02665416|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110535228|NCT02665416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110535229|NCT02665416|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110535230|NCT02665416|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110535231|NCT02665416|Growth Substances|growth substances|mesh-ancestor
110535232|NCT02665416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110535233|NCT02665416|Growth Inhibitors|growth inhibitors|mesh-ancestor
110535234|NCT00646620|Fluticasone|fluticasone|mesh-list
110535235|NCT00646620|Budesonide|budesonide|mesh-list
110535236|NCT00646620|Albuterol|albuterol|mesh-list
110535237|NCT00646620|Formoterol Fumarate|formoterol fumarate|mesh-list
110535238|NCT00646620|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110535239|NCT00646620|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
110535240|NCT00646620|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
110535241|NCT00646620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110535242|NCT00646620|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110535243|NCT00646620|Autonomic Agents|autonomic agents|mesh-ancestor
110535244|NCT00646620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110535245|NCT00646620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110535246|NCT00646620|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110535247|NCT00646620|Respiratory System Agents|respiratory system agents|mesh-ancestor
110535248|NCT00646620|Dermatologic Agents|dermatologic agents|mesh-ancestor
110535249|NCT00646620|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110535250|NCT00646620|Glucocorticoids|glucocorticoids|mesh-ancestor
110535252|NCT00646620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110535253|NCT00646620|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110535254|NCT00646620|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110535255|NCT00646620|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110535256|NCT00646620|Adrenergic Agents|adrenergic agents|mesh-ancestor
110535257|NCT00646620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110535258|NCT00646620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110535259|NCT00646620|Tocolytic Agents|tocolytic agents|mesh-ancestor
110535260|NCT00646620|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110535261|NCT00646620|Sympathomimetics|sympathomimetics|mesh-ancestor
110535262|NCT00648180|Doxycycline|doxycycline|mesh-list
110535263|NCT00648180|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110535264|NCT00648180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110535265|NCT00648180|Antimalarials|antimalarials|mesh-ancestor
110535266|NCT00648180|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110535267|NCT00648180|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110535268|NCT02664168|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
110535269|NCT02664168|Laxatives|laxatives|mesh-ancestor
110535270|NCT02664168|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110535271|NCT00648492|Metformin|metformin|mesh-list
110535272|NCT00648492|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110535273|NCT00648492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110535274|NCT00648570|Dexetimide|dexetimide|mesh-list
110535275|NCT00648570|Citalopram|citalopram|mesh-list
110535276|NCT00648570|Escitalopram|escitalopram|mesh-list
110535277|NCT00648570|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110535278|NCT00648570|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110535279|NCT00648570|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110535280|NCT00648570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110535281|NCT00648570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110535282|NCT00648570|Serotonin Agents|serotonin agents|mesh-ancestor
110535283|NCT00648570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110535284|NCT00648570|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110535285|NCT00648570|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110535286|NCT00648570|Parasympatholytics|parasympatholytics|mesh-ancestor
110535287|NCT00648570|Autonomic Agents|autonomic agents|mesh-ancestor
110535288|NCT00648570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110535289|NCT00648570|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110535290|NCT00648570|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110535291|NCT00648570|Cholinergic Agents|cholinergic agents|mesh-ancestor
110535292|NCT00648570|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110535293|NCT00648570|Antidepressive Agents|antidepressive agents|mesh-ancestor
110535294|NCT00648570|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110535295|NCT00648258|Naproxen|naproxen|mesh-list
110535296|NCT00648258|Valdecoxib|valdecoxib|mesh-list
110535297|NCT00648258|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110535298|NCT00648258|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110535299|NCT00648258|Analgesics|analgesics|mesh-ancestor
110535300|NCT00648258|Sensory System Agents|sensory system agents|mesh-ancestor
110535301|NCT00648258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110535302|NCT00648258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110535303|NCT00648258|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110535304|NCT00648258|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110535305|NCT00648258|Gout Suppressants|gout suppressants|mesh-ancestor
110535306|NCT00648258|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110535307|NCT00648258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110535308|NCT00648258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110535309|NCT00648258|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110535310|NCT00648336|Mercaptopurine|mercaptopurine|mesh-list
110535311|NCT00648336|Antimetabolites|antimetabolites|mesh-ancestor
110535312|NCT00648336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110535313|NCT00648336|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110535314|NCT00648336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110535315|NCT00648336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110535316|NCT00648336|Immunologic Factors|immunologic factors|mesh-ancestor
110535317|NCT00648336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110535318|NCT00648336|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110535319|NCT00648336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110535320|NCT04650984|Doxorubicin|doxorubicin|mesh-list
110535321|NCT04650984|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110535322|NCT04650984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110535323|NCT04650984|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110535324|NCT04650984|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110535325|NCT04650984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110535326|NCT04650984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110535327|NCT00648414|Fentanyl|fentanyl|mesh-list
110535328|NCT00648414|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110535329|NCT00648414|Narcotics|narcotics|mesh-ancestor
110535330|NCT00648414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110535331|NCT00648414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110535332|NCT00648414|Analgesics|analgesics|mesh-ancestor
110535333|NCT00648414|Sensory System Agents|sensory system agents|mesh-ancestor
110535334|NCT00648414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110535335|NCT00648414|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110535336|NCT00648414|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110535337|NCT00648414|Anesthetics, General|anesthetics, general|mesh-ancestor
110535338|NCT00648414|Anesthetics|anesthetics|mesh-ancestor
110535339|NCT02663700|Artesunate|artesunate|mesh-list
110535340|NCT02663700|Antimalarials|antimalarials|mesh-ancestor
110182845|NCT00026364|Micronutrients|micronutrients|mesh-ancestor
110535341|NCT02663700|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110535342|NCT02663700|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110535343|NCT02663700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110535344|NCT02663700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110535345|NCT02663700|Antiviral Agents|antiviral agents|mesh-ancestor
110535346|NCT02663700|Schistosomicides|schistosomicides|mesh-ancestor
110535347|NCT02663700|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110535348|NCT02663700|Anthelmintics|anthelmintics|mesh-ancestor
110535349|NCT00648726|Azithromycin|azithromycin|mesh-list
110535350|NCT00648726|Erythromycin|erythromycin|mesh-list
110535351|NCT00648726|Erythromycin Estolate|erythromycin estolate|mesh-list
110535352|NCT00648726|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
110535353|NCT00648726|Erythromycin stearate|erythromycin stearate|mesh-list
110535354|NCT00648726|Cefuroxime|cefuroxime|mesh-list
110535355|NCT00648726|Cefuroxime axetil|cefuroxime axetil|mesh-list
110535356|NCT00648726|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110535357|NCT00648726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110535358|NCT00648726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110535359|NCT00648726|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110535360|NCT00648726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110535361|NCT00648726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110535362|NCT04171674|Ceftobiprole|ceftobiprole|mesh-list
110535363|NCT04171674|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
110535364|NCT04171674|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110535365|NCT04171674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110535366|NCT00648804|Ondansetron|ondansetron|mesh-list
110535367|NCT00648804|Antiemetics|antiemetics|mesh-ancestor
110535368|NCT00648804|Autonomic Agents|autonomic agents|mesh-ancestor
110535369|NCT00648804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110535370|NCT00648804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110535371|NCT00648804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110535372|NCT00648804|Antipruritics|antipruritics|mesh-ancestor
110535373|NCT00648804|Dermatologic Agents|dermatologic agents|mesh-ancestor
110535374|NCT00648804|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110535375|NCT00648804|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110535376|NCT00648804|Serotonin Agents|serotonin agents|mesh-ancestor
110535377|NCT00648804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110535378|NCT00648804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110535379|NCT02664012|Menthol|menthol|mesh-list
110535380|NCT02664012|Nicotine|nicotine|mesh-list
110535381|NCT02664012|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110535382|NCT02664012|Autonomic Agents|autonomic agents|mesh-ancestor
110535383|NCT02664012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110535384|NCT02664012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110535385|NCT02664012|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110535386|NCT02664012|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110535387|NCT02664012|Cholinergic Agents|cholinergic agents|mesh-ancestor
110535388|NCT02664012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110343802|NCT06022614|Sensory System Agents|sensory system agents|mesh-ancestor
110535389|NCT02664012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110535390|NCT02664012|Antipruritics|antipruritics|mesh-ancestor
110535391|NCT02664012|Dermatologic Agents|dermatologic agents|mesh-ancestor
110535392|NCT00895037|Factor VIII|factor viii|mesh-list
110535393|NCT00895037|Coagulants|coagulants|mesh-ancestor
110535394|NCT04170504|Methotrexate|methotrexate|mesh-list
110535395|NCT04170504|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110535396|NCT04170504|Abortifacient Agents|abortifacient agents|mesh-ancestor
110535397|NCT04170504|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110535398|NCT04170504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110535399|NCT04170504|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110535400|NCT04170504|Antimetabolites|antimetabolites|mesh-ancestor
110535401|NCT04170504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110535402|NCT04170504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110535403|NCT04170504|Dermatologic Agents|dermatologic agents|mesh-ancestor
110535404|NCT04170504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110535405|NCT04170504|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110535406|NCT04170504|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110535407|NCT04170504|Immunologic Factors|immunologic factors|mesh-ancestor
110535408|NCT04170504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110535409|NCT04170504|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110535410|NCT04170270|Omeprazole|omeprazole|mesh-list
110535411|NCT04170270|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110535412|NCT04170270|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110535413|NCT04170270|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110535414|NCT04170270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110535415|NCT04170270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110535416|NCT00633347|Triptorelin Pamoate|triptorelin pamoate|mesh-list
110535417|NCT00633347|Cetrorelix|cetrorelix|mesh-list
110535418|NCT00633347|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
110535419|NCT00633347|Hormones|hormones|mesh-ancestor
110535420|NCT00633347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110535421|NCT00633347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110535422|NCT00633347|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110535424|NCT00633347|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110535425|NCT00633347|Hormone Antagonists|hormone antagonists|mesh-ancestor
110535426|NCT00633347|Luteolytic Agents|luteolytic agents|mesh-ancestor
110535427|NCT00633347|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110535428|NCT00633347|Contraceptive Agents|contraceptive agents|mesh-ancestor
110535429|NCT00633347|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110535430|NCT00633347|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110535431|NCT00633347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110535432|NCT02838719|Dexamethasone|dexamethasone|mesh-list
110535433|NCT02838719|Dexamethasone acetate|dexamethasone acetate|mesh-list
110535434|NCT02838719|BB 1101|bb 1101|mesh-list
110535435|NCT02838719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110535436|NCT02838719|Antiemetics|antiemetics|mesh-ancestor
110176074|NCT00079105|Antimitotic Agents|antimitotic agents|mesh-ancestor
110176082|NCT00079105|Analgesics|analgesics|mesh-ancestor
110535437|NCT02838719|Autonomic Agents|autonomic agents|mesh-ancestor
110535438|NCT02838719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110535439|NCT02838719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110535440|NCT02838719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110535441|NCT02838719|Glucocorticoids|glucocorticoids|mesh-ancestor
110535442|NCT02838719|Hormones|hormones|mesh-ancestor
110535443|NCT02838719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110535444|NCT02838719|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110535445|NCT02838719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110535446|NCT02838719|Protease Inhibitors|protease inhibitors|mesh-ancestor
110535447|NCT02838719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110535448|NCT02838719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110535449|NCT02659488|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
110535450|NCT02659488|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110535451|NCT02659488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110535452|NCT02659488|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110535453|NCT02659488|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110535454|NCT02659488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110535455|NCT02659488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110535456|NCT02659488|Dopamine Agents|dopamine agents|mesh-ancestor
110535457|NCT02659488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110535458|NCT00649194|Rabeprazole|rabeprazole|mesh-list
110535459|NCT00649194|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110535460|NCT00649194|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110535461|NCT00649194|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110535462|NCT00649194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110535463|NCT00649194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110535464|NCT02659254|Sirolimus|sirolimus|mesh-list
110535465|NCT02659254|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110535466|NCT02659254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110535467|NCT02659254|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110535468|NCT02659254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110535469|NCT02659254|Antifungal Agents|antifungal agents|mesh-ancestor
110535470|NCT02659254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110535471|NCT02659254|Immunologic Factors|immunologic factors|mesh-ancestor
110535472|NCT02659254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110535473|NCT02658864|Lafutidine|lafutidine|mesh-list
110535474|NCT02658864|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110535475|NCT02658864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110535476|NCT02658864|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110535477|NCT02658864|Histamine Antagonists|histamine antagonists|mesh-ancestor
110535478|NCT02658864|Histamine Agents|histamine agents|mesh-ancestor
110535479|NCT02658864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110535480|NCT02658864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110535481|NCT02658864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110535482|NCT02835833|Bevacizumab|bevacizumab|mesh-list
110535483|NCT02835833|Nintedanib|nintedanib|mesh-list
110535484|NCT02835833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110535485|NCT02835833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110535486|NCT02835833|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110535487|NCT02835833|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110535488|NCT02835833|Growth Substances|growth substances|mesh-ancestor
110535489|NCT02835833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110535490|NCT02835833|Growth Inhibitors|growth inhibitors|mesh-ancestor
110535491|NCT02835833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110535492|NCT02835833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110535493|NCT02835833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110535494|NCT04171284|Docetaxel|docetaxel|mesh-list
110535495|NCT04171284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110535496|NCT04171284|Tubulin Modulators|tubulin modulators|mesh-ancestor
110535497|NCT04171284|Antimitotic Agents|antimitotic agents|mesh-ancestor
110535498|NCT04171284|Mitosis Modulators|mitosis modulators|mesh-ancestor
110535499|NCT04171284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110535500|NCT02838329|Ropivacaine|ropivacaine|mesh-list
110535501|NCT02838329|Anesthetics, Local|anesthetics, local|mesh-ancestor
110535502|NCT02838329|Anesthetics|anesthetics|mesh-ancestor
110535503|NCT02838329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110535504|NCT02838329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110535505|NCT02838329|Sensory System Agents|sensory system agents|mesh-ancestor
110535506|NCT02838329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110535507|NCT02662530|Botulinum Toxins|botulinum toxins|mesh-list
110535508|NCT02662530|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110535509|NCT02662530|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110535510|NCT02662530|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110535511|NCT02662530|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110535512|NCT02662530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110535513|NCT02662530|Cholinergic Agents|cholinergic agents|mesh-ancestor
110535514|NCT02662530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110535515|NCT02662530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110535516|NCT02662530|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110535517|NCT02662530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110535518|NCT02835521|Triamcinolone|triamcinolone|mesh-list
110535519|NCT02835521|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110535520|NCT02835521|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110535521|NCT02835521|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110535522|NCT02835521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110535523|NCT02835521|Glucocorticoids|glucocorticoids|mesh-ancestor
110535524|NCT02835521|Hormones|hormones|mesh-ancestor
110535525|NCT02835521|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110535526|NCT02835521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110535527|NCT02835521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110535528|NCT02835521|Immunologic Factors|immunologic factors|mesh-ancestor
110535529|NCT02835521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110299522|NCT02218684|Telmisartan|telmisartan|mesh-list
110535530|NCT02835521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110535531|NCT00649272|Oxybutynin|oxybutynin|mesh-list
110535532|NCT00649272|Parasympatholytics|parasympatholytics|mesh-ancestor
110535533|NCT00649272|Autonomic Agents|autonomic agents|mesh-ancestor
110535534|NCT00649272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110535535|NCT00649272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110535536|NCT00649272|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110535537|NCT00649272|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110535538|NCT00649272|Cholinergic Agents|cholinergic agents|mesh-ancestor
110535539|NCT00649272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110535540|NCT00649272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110535541|NCT00649272|Urological Agents|urological agents|mesh-ancestor
110535542|NCT02666898|Cyclophosphamide|cyclophosphamide|mesh-list
110535543|NCT02666898|Fludarabine|fludarabine|mesh-list
110535544|NCT02666898|Obinutuzumab|obinutuzumab|mesh-list
110535545|NCT02666898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110535546|NCT02666898|Immunologic Factors|immunologic factors|mesh-ancestor
110535547|NCT02666898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110535548|NCT02666898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110535549|NCT02666898|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110535550|NCT02666898|Alkylating Agents|alkylating agents|mesh-ancestor
110535551|NCT02666898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110535552|NCT02666898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110535553|NCT02666898|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110535554|NCT02666898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110535555|NCT00633425|Glimepiride|glimepiride|mesh-list
110535556|NCT00633425|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110535557|NCT00633425|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110535558|NCT00633425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110535559|NCT00633425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110535560|NCT00633425|Immunologic Factors|immunologic factors|mesh-ancestor
110535561|NCT02840279|BPN14770|bpn14770|mesh-list
110535562|NCT02840279|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
110535563|NCT02840279|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110535564|NCT02840279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110535565|NCT02840279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110535566|NCT00648960|Clarithromycin|clarithromycin|mesh-list
110535567|NCT00648960|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110535568|NCT00648960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110535569|NCT00648960|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110535570|NCT00648960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110535571|NCT00648960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110535572|NCT00648960|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110535573|NCT00648960|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110535575|NCT04437329|Docetaxel|docetaxel|mesh-list
110535576|NCT04437329|Fluorouracil|fluorouracil|mesh-list
110535577|NCT04437329|Nedaplatin|nedaplatin|mesh-list
110535578|NCT04437329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110535579|NCT04437329|Tubulin Modulators|tubulin modulators|mesh-ancestor
110535580|NCT04437329|Antimitotic Agents|antimitotic agents|mesh-ancestor
110535581|NCT04437329|Mitosis Modulators|mitosis modulators|mesh-ancestor
110535582|NCT04437329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110535583|NCT04437329|Antimetabolites|antimetabolites|mesh-ancestor
110535584|NCT04437329|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110535585|NCT04437329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110535586|NCT04437329|Immunologic Factors|immunologic factors|mesh-ancestor
110535587|NCT04437329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110535588|NCT02834507|Levodopa|levodopa|mesh-list
110535589|NCT02834507|Carbidopa|carbidopa|mesh-list
110535590|NCT02834507|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
110535591|NCT02834507|Entacapone|entacapone|mesh-list
110535592|NCT02834507|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110535593|NCT02834507|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110535594|NCT02834507|Dopamine Agents|dopamine agents|mesh-ancestor
110535595|NCT02834507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110535596|NCT02834507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110535597|NCT02834507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110535598|NCT02834507|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
110535599|NCT02834507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110535600|NCT02834507|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110535601|NCT02834507|Immunologic Factors|immunologic factors|mesh-ancestor
110535602|NCT02834507|Dopamine Agonists|dopamine agonists|mesh-ancestor
110535603|NCT02834507|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
110535605|NCT02831543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110535606|NCT02831543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110535607|NCT02831543|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110535608|NCT02831543|Serotonin Agents|serotonin agents|mesh-ancestor
110535609|NCT02831543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110535610|NCT02831543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110535611|NCT02840591|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
110535613|NCT02667054|Anesthetics|anesthetics|mesh-list
110535614|NCT02667054|Anesthetics, Local|anesthetics, local|mesh-list
110535615|NCT02667054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110535616|NCT02667054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110535617|NCT02667054|Sensory System Agents|sensory system agents|mesh-ancestor
110535618|NCT02667054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110535619|NCT02662296|Idelalisib|idelalisib|mesh-list
110535620|NCT02662296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110535621|NCT02662296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110535622|NCT02662296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110535623|NCT02662374|Nystatin|nystatin|mesh-list
110535624|NCT02662374|Calcium|calcium|mesh-list
110535625|NCT02662374|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110535626|NCT02662374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110535627|NCT02662374|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110535628|NCT02662374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110535629|NCT02662374|Antifungal Agents|antifungal agents|mesh-ancestor
110535630|NCT02662374|Ionophores|ionophores|mesh-ancestor
110299553|NCT00239447|Autonomic Agents|autonomic agents|mesh-ancestor
110535631|NCT02662374|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110535632|NCT02662374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110535633|NCT05334251|Anesthetics|anesthetics|mesh-list
110535634|NCT05334251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110535635|NCT05334251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110535636|NCT00649350|Metformin|metformin|mesh-list
110535637|NCT00649350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110535638|NCT00649350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110535639|NCT00649506|Nitrofurantoin|nitrofurantoin|mesh-list
110535640|NCT00649506|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110183156|NCT00392561|Vitamin E|vitamin e|mesh-list
110535641|NCT00649506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110535642|NCT00649506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110535643|NCT00649038|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110535644|NCT00649038|Benazepril|benazepril|mesh-list
110535645|NCT00649038|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110535646|NCT00649038|Diuretics|diuretics|mesh-ancestor
110535647|NCT00649038|Natriuretic Agents|natriuretic agents|mesh-ancestor
110535648|NCT00649038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110535649|NCT00649038|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110535650|NCT00649038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110535651|NCT00649038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110535652|NCT00649038|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110535653|NCT00649038|Protease Inhibitors|protease inhibitors|mesh-ancestor
110535654|NCT00649038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110535655|NCT04169256|Bupivacaine|bupivacaine|mesh-list
110535656|NCT04169256|Anesthetics, Local|anesthetics, local|mesh-ancestor
110535657|NCT04169256|Anesthetics|anesthetics|mesh-ancestor
110535658|NCT04169256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110535659|NCT04169256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110535660|NCT04169256|Sensory System Agents|sensory system agents|mesh-ancestor
110535661|NCT04169256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110535663|NCT02658396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110535664|NCT02661438|Ciprofloxacin|ciprofloxacin|mesh-list
110535665|NCT02661438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110535666|NCT02661438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110535667|NCT02661438|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110535668|NCT02661438|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110535669|NCT02661438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110535670|NCT02661438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110535671|NCT02661438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110535672|NCT02661438|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110535673|NCT02661438|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110535674|NCT00894803|Eptifibatide|eptifibatide|mesh-list
110535675|NCT00894803|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110535676|NCT00601458|Naproxen|naproxen|mesh-list
110535677|NCT00601458|Pregabalin|pregabalin|mesh-list
110535678|NCT00601458|Analgesics|analgesics|mesh-ancestor
110535679|NCT00601458|Sensory System Agents|sensory system agents|mesh-ancestor
110535680|NCT00601458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110535681|NCT00601458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110535682|NCT00601458|Anticonvulsants|anticonvulsants|mesh-ancestor
110535683|NCT00601458|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110535684|NCT00601458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110535685|NCT00601458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110535686|NCT00601458|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110535687|NCT00601458|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110535688|NCT00601458|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110535689|NCT00601458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110535690|NCT00601458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110535691|NCT00601458|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110535692|NCT00601458|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110535693|NCT00601458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110535694|NCT00601458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110535695|NCT00601458|Gout Suppressants|gout suppressants|mesh-ancestor
110535696|NCT00601458|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110535697|NCT00601458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110535698|NCT02660736|rGLP-1 protein|rglp-1 protein|mesh-list
110535699|NCT02660736|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
110535700|NCT02660736|Incretins|incretins|mesh-ancestor
110535702|NCT02660736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110535703|NCT02660736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110535704|NCT00649584|Gemcitabine|gemcitabine|mesh-list
110535705|NCT00649584|Brentuximab Vedotin|brentuximab vedotin|mesh-list
110535706|NCT00649584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110535707|NCT00649584|Antimetabolites|antimetabolites|mesh-ancestor
110535708|NCT00649584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110535709|NCT00649584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110299589|NCT00239486|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110535710|NCT00649584|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110535711|NCT00649584|Immunotoxins|immunotoxins|mesh-ancestor
110535712|NCT00649584|Immunoconjugates|immunoconjugates|mesh-ancestor
110535713|NCT00649584|Immunologic Factors|immunologic factors|mesh-ancestor
110535714|NCT00649584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110535715|NCT02141282|Venetoclax|venetoclax|mesh-list
110535716|NCT02141282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110535717|NCT02657616|Vitamin K|vitamin k|mesh-list
110535718|NCT02657616|Anticoagulants|anticoagulants|mesh-list
110535719|NCT02657616|Vitamins|vitamins|mesh-ancestor
110535720|NCT02657616|Micronutrients|micronutrients|mesh-ancestor
110535721|NCT02657616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110535722|NCT02657616|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110535723|NCT02657616|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110535724|NCT02657616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110535726|NCT02657616|Coagulants|coagulants|mesh-ancestor
110535727|NCT02657694|Sofosbuvir|sofosbuvir|mesh-list
110535728|NCT02657694|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
110535729|NCT02657694|Ledipasvir|ledipasvir|mesh-list
110535730|NCT02657694|Velpatasvir|velpatasvir|mesh-list
110535731|NCT02657694|Antiviral Agents|antiviral agents|mesh-ancestor
110535732|NCT02657694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110535733|NCT02657460|Cisplatin|cisplatin|mesh-list
110535734|NCT02657460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110535735|NCT00649896|Estradiol|estradiol|mesh-list
110535736|NCT00649896|Estrogens|estrogens|mesh-ancestor
110535737|NCT00649896|Hormones|hormones|mesh-ancestor
110535738|NCT00649896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110535739|NCT00649896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110535740|NCT00649662|Ciprofloxacin|ciprofloxacin|mesh-list
110535741|NCT00649662|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110535742|NCT00649662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110535743|NCT00649662|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110535744|NCT00649662|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110535745|NCT00649662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110535746|NCT00649662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110535747|NCT00649662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110535748|NCT00649662|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110535749|NCT00649662|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110535750|NCT04188158|Capecitabine|capecitabine|mesh-list
110535751|NCT04188158|Oxaliplatin|oxaliplatin|mesh-list
110535752|NCT04188158|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110535753|NCT04188158|Antimetabolites|antimetabolites|mesh-ancestor
110535754|NCT04188158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110535755|NCT04188158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110535757|NCT02831231|Trospium chloride|trospium chloride|mesh-list
110535758|NCT02831231|Parasympatholytics|parasympatholytics|mesh-ancestor
110535759|NCT02831231|Autonomic Agents|autonomic agents|mesh-ancestor
110535760|NCT02831231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110535761|NCT02831231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110535762|NCT02831231|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110535764|NCT02831231|Cholinergic Agents|cholinergic agents|mesh-ancestor
110535765|NCT02831231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110535766|NCT02831231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110535767|NCT02831231|Urological Agents|urological agents|mesh-ancestor
110535768|NCT02831231|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110535769|NCT02831231|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110535770|NCT02831231|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
110535771|NCT02831231|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110535772|NCT05234606|Pembrolizumab|pembrolizumab|mesh-list
110535773|NCT05234606|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110535774|NCT05234606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110535775|NCT05234606|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110535776|NCT05234606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110535777|NCT00649740|Topiramate|topiramate|mesh-list
110535778|NCT00649740|Anticonvulsants|anticonvulsants|mesh-ancestor
110535779|NCT00649740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110535780|NCT00649740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110535781|NCT04209920|Chromium|chromium|mesh-list
110535782|NCT04209920|Nickel|nickel|mesh-list
110535783|NCT04209920|Trace Elements|trace elements|mesh-ancestor
110535784|NCT04209920|Micronutrients|micronutrients|mesh-ancestor
110535785|NCT04209920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110535786|NCT00616694|Risedronic Acid|risedronic acid|mesh-list
110535787|NCT00616694|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110535788|NCT00616694|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110183299|NCT03959501|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110535789|NCT00616694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110535790|NCT00616694|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110535791|NCT00616694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110535792|NCT00616694|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110535793|NCT02660658|Dexmedetomidine|dexmedetomidine|mesh-list
110535794|NCT02660658|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110535795|NCT02660658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110535796|NCT02660658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110535797|NCT02660658|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110535798|NCT02660658|Analgesics|analgesics|mesh-ancestor
110535800|NCT02660658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110535801|NCT02660658|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110535802|NCT02660658|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110535803|NCT02660658|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110535804|NCT02660658|Adrenergic Agents|adrenergic agents|mesh-ancestor
110535805|NCT02660658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110535806|NCT02660658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110535807|NCT02660502|Insulin|insulin|mesh-list
110535808|NCT02660502|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110535809|NCT02660502|Insulin Lispro|insulin lispro|mesh-list
110535810|NCT02660502|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110535811|NCT02660502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110535812|NCT02660346|Vancomycin|vancomycin|mesh-list
110535813|NCT02660346|Daptomycin|daptomycin|mesh-list
110535814|NCT02660346|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
110535815|NCT02660346|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110535816|NCT02660346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110535817|NCT00620438|Efavirenz|efavirenz|mesh-list
110535818|NCT00620438|Nevirapine|nevirapine|mesh-list
110535819|NCT00620438|Rifampin|rifampin|mesh-list
110535820|NCT00620438|Lumefantrine|lumefantrine|mesh-list
110535821|NCT00620438|Artemether|artemether|mesh-list
110535822|NCT00620438|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
110535823|NCT00620438|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110535824|NCT00620438|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110535825|NCT00620438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110176136|NCT00079261|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110535826|NCT00620438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110535827|NCT00620438|Antiviral Agents|antiviral agents|mesh-ancestor
110535828|NCT00620438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110535829|NCT00620438|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110535830|NCT00620438|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110535831|NCT00620438|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110535832|NCT00620438|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110535833|NCT00620438|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110535834|NCT00620438|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110535835|NCT00620438|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110535836|NCT00620438|Antitubercular Agents|antitubercular agents|mesh-ancestor
110535837|NCT00620438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110535838|NCT00620438|Leprostatic Agents|leprostatic agents|mesh-ancestor
110535839|NCT00620438|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110535840|NCT00620438|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110535841|NCT00620438|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110535842|NCT00620438|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110535843|NCT00620438|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110535844|NCT00620438|Antimalarials|antimalarials|mesh-ancestor
110535845|NCT00620438|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110535846|NCT00620438|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110535847|NCT00891839|Rituximab|rituximab|mesh-list
110535848|NCT00891839|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110535849|NCT00891839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110535850|NCT00891839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110535851|NCT00891839|Immunologic Factors|immunologic factors|mesh-ancestor
110535852|NCT00891839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110535853|NCT00891839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110535854|NCT00891839|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110535855|NCT00891839|Alkylating Agents|alkylating agents|mesh-ancestor
110535856|NCT00891839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110535857|NCT00600756|Risperidone|risperidone|mesh-list
110535858|NCT00600756|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110535859|NCT00600756|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110535860|NCT00600756|Serotonin Agents|serotonin agents|mesh-ancestor
110535861|NCT00600756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110535862|NCT00600756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110535863|NCT00600756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110535864|NCT00600756|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110535865|NCT00600756|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110535866|NCT00600756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110535867|NCT00600756|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110535868|NCT00600756|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110535869|NCT00600756|Dopamine Agents|dopamine agents|mesh-ancestor
110535870|NCT00600756|Antidepressive Agents|antidepressive agents|mesh-ancestor
110535871|NCT02657148|Contraceptive Agents|contraceptive agents|mesh-list
110535872|NCT02657148|Etonogestrel|etonogestrel|mesh-list
110535873|NCT02657148|Desogestrel|desogestrel|mesh-list
110535874|NCT02657148|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110535875|NCT02657148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110535876|NCT02657148|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110535877|NCT02657148|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110535878|NCT02657148|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110535879|NCT02657148|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110535880|NCT02657148|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110535881|NCT02657148|Progestins|progestins|mesh-ancestor
110535882|NCT02657148|Hormones|hormones|mesh-ancestor
110535883|NCT02657148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110535884|NCT04247087|Vitamin K|vitamin k|mesh-list
110535885|NCT04247087|Vitamin K 1|vitamin k 1|mesh-list
110535886|NCT04247087|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110535887|NCT04247087|Vitamins|vitamins|mesh-ancestor
110535888|NCT04247087|Micronutrients|micronutrients|mesh-ancestor
110535889|NCT04247087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110535890|NCT04247087|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110535891|NCT04247087|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110535892|NCT04247087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110535893|NCT04247087|Hemostatics|hemostatics|mesh-ancestor
110535894|NCT04247087|Coagulants|coagulants|mesh-ancestor
110535895|NCT00649116|Metoprolol|metoprolol|mesh-list
110535896|NCT00649116|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110535897|NCT00649116|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110535898|NCT00649116|Sympatholytics|sympatholytics|mesh-ancestor
110535899|NCT00649116|Autonomic Agents|autonomic agents|mesh-ancestor
110535900|NCT00649116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110535901|NCT00649116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110535902|NCT00649116|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110535903|NCT00649116|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110535904|NCT00649116|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110535905|NCT00649116|Adrenergic Agents|adrenergic agents|mesh-ancestor
110535906|NCT00649116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110535907|NCT00649116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110535908|NCT02652234|Endostar protein|endostar protein|mesh-list
110535909|NCT02652234|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110535910|NCT02652234|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110535911|NCT02652234|Growth Substances|growth substances|mesh-ancestor
110535912|NCT02652234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110535913|NCT02652234|Growth Inhibitors|growth inhibitors|mesh-ancestor
110535914|NCT02652234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110535915|NCT04211012|Paclitaxel|paclitaxel|mesh-list
110535916|NCT04211012|Cisplatin|cisplatin|mesh-list
110535917|NCT04211012|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110535918|NCT04211012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110535919|NCT04211012|Tubulin Modulators|tubulin modulators|mesh-ancestor
110535920|NCT04211012|Antimitotic Agents|antimitotic agents|mesh-ancestor
110535921|NCT04211012|Mitosis Modulators|mitosis modulators|mesh-ancestor
110535922|NCT04211012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110535924|NCT00649974|Antiviral Agents|antiviral agents|mesh-ancestor
110535925|NCT00649974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110535926|NCT02536872|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110535927|NCT02536872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110535928|NCT00620594|Dactolisib|dactolisib|mesh-list
110535929|NCT00620594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110535930|NCT02655822|Atezolizumab|atezolizumab|mesh-list
110535931|NCT02655822|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110535932|NCT02655822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110535933|NCT02655822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110535934|NCT02655822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110535935|NCT00650442|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110535936|NCT00650442|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110535937|NCT00650442|Estradiol|estradiol|mesh-list
110535938|NCT00650442|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110535939|NCT00650442|Estrogens|estrogens|mesh-ancestor
110535940|NCT00650442|Hormones|hormones|mesh-ancestor
110183451|NCT00029835|Hormones|hormones|mesh-ancestor
110535941|NCT00650442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110535942|NCT00650442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110535943|NCT00650442|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110535945|NCT00650442|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110535946|NCT00650442|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110535947|NCT00890825|Docetaxel|docetaxel|mesh-list
110535948|NCT00890825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110535949|NCT00890825|Tubulin Modulators|tubulin modulators|mesh-ancestor
110535950|NCT00890825|Antimitotic Agents|antimitotic agents|mesh-ancestor
110535951|NCT00890825|Mitosis Modulators|mitosis modulators|mesh-ancestor
110535952|NCT00890825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110535953|NCT04760132|Vaccines|vaccines|mesh-list
110535954|NCT04760132|Immunologic Factors|immunologic factors|mesh-ancestor
110535955|NCT04760132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110535956|NCT04248101|Silver Nitrate|silver nitrate|mesh-list
110535957|NCT04248101|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110535958|NCT04248101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110535959|NCT00649818|Lorazepam|lorazepam|mesh-list
110535960|NCT00649818|Anticonvulsants|anticonvulsants|mesh-ancestor
110535961|NCT00649818|Antiemetics|antiemetics|mesh-ancestor
110535962|NCT00649818|Autonomic Agents|autonomic agents|mesh-ancestor
110535963|NCT00649818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110535964|NCT00649818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110535965|NCT00649818|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110535966|NCT00649818|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110535967|NCT00649818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110535968|NCT00649818|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110535969|NCT00649818|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110535970|NCT00649818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110535971|NCT00649818|GABA Modulators|gaba modulators|mesh-ancestor
110535972|NCT00649818|GABA Agents|gaba agents|mesh-ancestor
110535973|NCT00649818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110535974|NCT00649818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110535975|NCT02830139|Capecitabine|capecitabine|mesh-list
110535976|NCT02830139|Oxaliplatin|oxaliplatin|mesh-list
110535977|NCT02830139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110535978|NCT02830139|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110535979|NCT02830139|Antimetabolites|antimetabolites|mesh-ancestor
110535980|NCT02830139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110535981|NCT02833025|Thrombin|thrombin|mesh-list
110535982|NCT02833025|Hemostatics|hemostatics|mesh-ancestor
110535983|NCT02833025|Coagulants|coagulants|mesh-ancestor
110535984|NCT02651610|Paclitaxel|paclitaxel|mesh-list
110535985|NCT02651610|Docetaxel|docetaxel|mesh-list
110535986|NCT02651610|Taxane|taxane|mesh-list
110535987|NCT02651610|Bavituximab|bavituximab|mesh-list
110535988|NCT02651610|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110535989|NCT02651610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110535990|NCT02651610|Tubulin Modulators|tubulin modulators|mesh-ancestor
110535991|NCT02651610|Antimitotic Agents|antimitotic agents|mesh-ancestor
110535992|NCT02651610|Mitosis Modulators|mitosis modulators|mesh-ancestor
110535993|NCT02651610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110535994|NCT02651610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110535995|NCT04208594|Propranolol|propranolol|mesh-list
110535996|NCT04208594|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110535997|NCT04208594|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110535998|NCT04208594|Adrenergic Agents|adrenergic agents|mesh-ancestor
110535999|NCT04208594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110536000|NCT04208594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110536001|NCT04208594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110536002|NCT04208594|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110536003|NCT04208594|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110536004|NCT04208594|Vasodilator Agents|vasodilator agents|mesh-ancestor
110536005|NCT04733144|Dexamethasone|dexamethasone|mesh-list
110536006|NCT04733144|Prednisolone|prednisolone|mesh-list
110536007|NCT04733144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110536008|NCT04733144|Antiemetics|antiemetics|mesh-ancestor
110536009|NCT04733144|Autonomic Agents|autonomic agents|mesh-ancestor
110536010|NCT04733144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110536011|NCT04733144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110536012|NCT04733144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110536013|NCT04733144|Glucocorticoids|glucocorticoids|mesh-ancestor
110536014|NCT04733144|Hormones|hormones|mesh-ancestor
110536015|NCT04733144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110183525|NCT00030420|Mitosis Modulators|mitosis modulators|mesh-ancestor
110536016|NCT04733144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110536017|NCT04733144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110536018|NCT04724720|Famotidine|famotidine|mesh-list
110536019|NCT04724720|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110536020|NCT04724720|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110536021|NCT04724720|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110536022|NCT04724720|Histamine Antagonists|histamine antagonists|mesh-ancestor
110536023|NCT04724720|Histamine Agents|histamine agents|mesh-ancestor
110536024|NCT04724720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110536025|NCT04724720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110536026|NCT04724720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110536027|NCT02833103|Pinaverium|pinaverium|mesh-list
110536028|NCT02833103|Bromides|bromides|mesh-list
110536029|NCT02833103|Anticonvulsants|anticonvulsants|mesh-ancestor
110536030|NCT02833103|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110536031|NCT02833103|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110536032|NCT02833103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110176152|NCT00079261|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110536033|NCT02833103|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110536034|NCT02833103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110536035|NCT02833103|Parasympatholytics|parasympatholytics|mesh-ancestor
110536036|NCT02833103|Autonomic Agents|autonomic agents|mesh-ancestor
110536037|NCT02833103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110536038|NCT02648490|Acetaminophen|acetaminophen|mesh-list
110536039|NCT02648490|Diphenhydramine|diphenhydramine|mesh-list
110536040|NCT02648490|Promethazine|promethazine|mesh-list
110536041|NCT02648490|Dexamethasone|dexamethasone|mesh-list
110536042|NCT02648490|Ondansetron|ondansetron|mesh-list
110536043|NCT02648490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110536044|NCT02648490|Antiemetics|antiemetics|mesh-ancestor
110536045|NCT02648490|Autonomic Agents|autonomic agents|mesh-ancestor
110536046|NCT02648490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110536047|NCT02648490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110536048|NCT02648490|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110536049|NCT02648490|Glucocorticoids|glucocorticoids|mesh-ancestor
110536050|NCT02648490|Hormones|hormones|mesh-ancestor
110536051|NCT02648490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110536052|NCT02648490|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110536053|NCT02648490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110536054|NCT02648490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110536055|NCT02648490|Analgesics|analgesics|mesh-ancestor
110536057|NCT02648490|Antipyretics|antipyretics|mesh-ancestor
110536058|NCT02648490|Antipruritics|antipruritics|mesh-ancestor
110536059|NCT02648490|Dermatologic Agents|dermatologic agents|mesh-ancestor
110536060|NCT02648490|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110536061|NCT02648490|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110536062|NCT02648490|Serotonin Agents|serotonin agents|mesh-ancestor
110536063|NCT02648490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110536064|NCT02648490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110536065|NCT02648490|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110536066|NCT02648490|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110536067|NCT02648490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110536068|NCT02648490|Anesthetics, Local|anesthetics, local|mesh-ancestor
110536069|NCT02648490|Anesthetics|anesthetics|mesh-ancestor
110536070|NCT02648490|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110536071|NCT02648490|Histamine Antagonists|histamine antagonists|mesh-ancestor
110536072|NCT02648490|Histamine Agents|histamine agents|mesh-ancestor
110536073|NCT02648490|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110536074|NCT04965272|Cariprazine|cariprazine|mesh-list
110536075|NCT04965272|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110536076|NCT04965272|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110536077|NCT04965272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110536078|NCT04965272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110536079|NCT04965272|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110536080|NCT02648412|Ketamine|ketamine|mesh-list
110536081|NCT02648412|Analgesics|analgesics|mesh-ancestor
110536082|NCT02648412|Sensory System Agents|sensory system agents|mesh-ancestor
110536083|NCT02648412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110536084|NCT02648412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110536085|NCT02648412|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110536086|NCT02648412|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110536087|NCT02648412|Anesthetics, General|anesthetics, general|mesh-ancestor
110536088|NCT02648412|Anesthetics|anesthetics|mesh-ancestor
110536089|NCT02648412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110536090|NCT02648412|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110536091|NCT02648412|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110536092|NCT02648412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110536093|NCT02648412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110536094|NCT00650520|Bromocriptine|bromocriptine|mesh-list
110536095|NCT00650520|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110536096|NCT00650520|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110536097|NCT00650520|Hormone Antagonists|hormone antagonists|mesh-ancestor
110536098|NCT00650520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110536099|NCT00650520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110536100|NCT00650520|Dopamine Agonists|dopamine agonists|mesh-ancestor
110536101|NCT00650520|Dopamine Agents|dopamine agents|mesh-ancestor
110536102|NCT00650520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110176162|NCT00079300|Interferon Inducers|interferon inducers|mesh-ancestor
110176163|NCT00079378|Decitabine|decitabine|mesh-list
110536103|NCT00650520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110536104|NCT04244981|Thrombin|thrombin|mesh-list
110536105|NCT04244981|Hemostatics|hemostatics|mesh-ancestor
110536106|NCT04244981|Coagulants|coagulants|mesh-ancestor
110536107|NCT00621218|Tretinoin|tretinoin|mesh-list
110536108|NCT00621218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110536109|NCT00621218|Keratolytic Agents|keratolytic agents|mesh-ancestor
110536110|NCT00621218|Dermatologic Agents|dermatologic agents|mesh-ancestor
110536111|NCT02655276|Glycine|glycine|mesh-list
110536112|NCT02655276|Glycine Agents|glycine agents|mesh-ancestor
110536113|NCT02655276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110536114|NCT02655276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110536115|NCT02655276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110536116|NCT02832947|Rivaroxaban|rivaroxaban|mesh-list
110536117|NCT02832947|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110536118|NCT02832947|Antithrombins|antithrombins|mesh-ancestor
110280256|NCT00187070|Glucocorticoids|glucocorticoids|mesh-ancestor
110536119|NCT02832947|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110536120|NCT02832947|Protease Inhibitors|protease inhibitors|mesh-ancestor
110536121|NCT02832947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110343803|NCT06022614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110536122|NCT02832947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110536124|NCT00651300|Parecoxib|parecoxib|mesh-list
110536125|NCT00651300|Valdecoxib|valdecoxib|mesh-list
110536126|NCT00651300|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110536127|NCT00651300|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110536128|NCT00651300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110536129|NCT00651300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110312345|NCT00293930|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110536130|NCT00651300|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110536131|NCT00651300|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110536132|NCT00651300|Analgesics|analgesics|mesh-ancestor
110536133|NCT00651300|Sensory System Agents|sensory system agents|mesh-ancestor
110536134|NCT00651300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110536135|NCT00651300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110536136|NCT00651300|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110536137|NCT00651300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110536138|NCT02828033|Rilonacept|rilonacept|mesh-list
110536139|NCT02828033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110536140|NCT00621998|Olanzapine|olanzapine|mesh-list
110536141|NCT00621998|Risperidone|risperidone|mesh-list
110536142|NCT00621998|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110536143|NCT00621998|Serotonin Agents|serotonin agents|mesh-ancestor
110536144|NCT00621998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110536145|NCT00621998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110536146|NCT00621998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110536147|NCT00621998|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110536148|NCT00621998|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110536149|NCT00621998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110536150|NCT00621998|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110536151|NCT00621998|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110536152|NCT00621998|Dopamine Agents|dopamine agents|mesh-ancestor
110536153|NCT00621998|Antiemetics|antiemetics|mesh-ancestor
110536154|NCT00621998|Autonomic Agents|autonomic agents|mesh-ancestor
110536155|NCT00621998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110536156|NCT00621998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110536157|NCT00621998|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110536158|NCT00621998|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110536159|NCT00621998|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110536160|NCT02655198|Fenfluramine|fenfluramine|mesh-list
110536161|NCT02655198|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110536162|NCT02655198|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110536163|NCT02655198|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110536164|NCT02655198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110536165|NCT02655198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110536166|NCT02655198|Serotonin Agents|serotonin agents|mesh-ancestor
110536167|NCT02655198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110536168|NCT00650052|Zonisamide|zonisamide|mesh-list
110536169|NCT00650052|Anticonvulsants|anticonvulsants|mesh-ancestor
110536170|NCT00650052|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110536171|NCT00650052|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110536172|NCT00650052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110536173|NCT00650052|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110536174|NCT00650052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110536175|NCT00891527|Bevacizumab|bevacizumab|mesh-list
110536176|NCT00891527|Imatinib Mesylate|imatinib mesylate|mesh-list
110536177|NCT00891527|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110536178|NCT00891527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110536179|NCT00891527|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110536180|NCT00891527|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110536181|NCT00891527|Growth Substances|growth substances|mesh-ancestor
110536182|NCT00891527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110536183|NCT00891527|Growth Inhibitors|growth inhibitors|mesh-ancestor
110536184|NCT00891527|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110536185|NCT00891527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110536186|NCT00891527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110536187|NCT03861078|Nicotine|nicotine|mesh-list
110536188|NCT03861078|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110536189|NCT03861078|Autonomic Agents|autonomic agents|mesh-ancestor
110536190|NCT03861078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110536191|NCT03861078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110536192|NCT03861078|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110536193|NCT03861078|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110536194|NCT03861078|Cholinergic Agents|cholinergic agents|mesh-ancestor
110536195|NCT03861078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110536196|NCT03861078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110536197|NCT02829359|Entecavir|entecavir|mesh-list
110536198|NCT02829359|Antiviral Agents|antiviral agents|mesh-ancestor
110536199|NCT02829359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110536200|NCT02650752|Capecitabine|capecitabine|mesh-list
110536201|NCT02650752|Lapatinib|lapatinib|mesh-list
110536202|NCT02650752|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110536203|NCT02650752|Antimetabolites|antimetabolites|mesh-ancestor
110536204|NCT02650752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110536205|NCT02650752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110536206|NCT02650752|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110536207|NCT02650752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110536208|NCT02832713|Botulinum Toxins|botulinum toxins|mesh-list
110536209|NCT02832713|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110536210|NCT02832713|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110536211|NCT02832713|Hyaluronic Acid|hyaluronic acid|mesh-list
110536212|NCT02832713|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110536213|NCT02832713|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110536214|NCT02832713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110536215|NCT02832713|Cholinergic Agents|cholinergic agents|mesh-ancestor
110536216|NCT02832713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110536217|NCT02832713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110536218|NCT02832713|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110536219|NCT02832713|Immunologic Factors|immunologic factors|mesh-ancestor
110536220|NCT02832713|Viscosupplements|viscosupplements|mesh-ancestor
110536221|NCT02832713|Protective Agents|protective agents|mesh-ancestor
110536222|NCT02832713|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110536223|NCT02832713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110536224|NCT02832635|Temozolomide|temozolomide|mesh-list
110536225|NCT02832635|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110536227|NCT02832635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110536228|NCT02832635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110536230|NCT00650598|Valdecoxib|valdecoxib|mesh-list
110536231|NCT00650598|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110536232|NCT00650598|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110536233|NCT00650598|Analgesics|analgesics|mesh-ancestor
110536234|NCT00650598|Sensory System Agents|sensory system agents|mesh-ancestor
110536235|NCT00650598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110280273|NCT00187070|Antiviral Agents|antiviral agents|mesh-ancestor
110536236|NCT00650598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110536237|NCT00650598|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110536238|NCT00650598|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110536239|NCT00650598|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110536241|NCT00650598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110536242|NCT00650598|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110536244|NCT00620204|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110536245|NCT00620204|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110536246|NCT00620204|Antimetabolites|antimetabolites|mesh-ancestor
110536247|NCT00620204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110536248|NCT00620204|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110536249|NCT00620204|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110536250|NCT00620204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110536251|NCT02650596|Liraglutide|liraglutide|mesh-list
110536252|NCT02650596|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110536253|NCT02650596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110536254|NCT02650596|Incretins|incretins|mesh-ancestor
110536255|NCT02650596|Hormones|hormones|mesh-ancestor
110536256|NCT02650596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110536257|NCT02650518|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110536258|NCT02650518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110536259|NCT02832089|Carvedilol|carvedilol|mesh-list
110536260|NCT02832089|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110536261|NCT02832089|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110536262|NCT02832089|Adrenergic Agents|adrenergic agents|mesh-ancestor
110536263|NCT02832089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110536264|NCT02832089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110536265|NCT02832089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110536266|NCT02832089|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110536267|NCT02832089|Antioxidants|antioxidants|mesh-ancestor
110536268|NCT02832089|Protective Agents|protective agents|mesh-ancestor
110536269|NCT02832089|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110299820|NCT04720287|Autonomic Agents|autonomic agents|mesh-ancestor
110536270|NCT02832089|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110536271|NCT02832089|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110536272|NCT02832089|Vasodilator Agents|vasodilator agents|mesh-ancestor
110536273|NCT02832089|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110536274|NCT02832089|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110536275|NCT04247633|Palbociclib|palbociclib|mesh-list
110536277|NCT04247633|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110536278|NCT04247633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110536279|NCT04247633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110536280|NCT00891371|Lanreotide|lanreotide|mesh-list
110536281|NCT00891371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110536282|NCT04324229|Liraglutide|liraglutide|mesh-list
110536283|NCT04324229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110536284|NCT04324229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110536285|NCT04324229|Incretins|incretins|mesh-ancestor
110536286|NCT04324229|Hormones|hormones|mesh-ancestor
110536287|NCT04324229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110536288|NCT04430894|Dexamethasone|dexamethasone|mesh-list
110536289|NCT04430894|Lenalidomide|lenalidomide|mesh-list
110536290|NCT04430894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110536291|NCT04430894|Antiemetics|antiemetics|mesh-ancestor
110536292|NCT04430894|Autonomic Agents|autonomic agents|mesh-ancestor
110536293|NCT04430894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110536294|NCT04430894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110536295|NCT04430894|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110536296|NCT04430894|Glucocorticoids|glucocorticoids|mesh-ancestor
110536297|NCT04430894|Hormones|hormones|mesh-ancestor
110536298|NCT04430894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110176195|NCT04467086|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110536299|NCT04430894|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110536300|NCT04430894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110536301|NCT04430894|Immunologic Factors|immunologic factors|mesh-ancestor
110536302|NCT04430894|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110536303|NCT04430894|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110536304|NCT04430894|Growth Substances|growth substances|mesh-ancestor
110536305|NCT04430894|Growth Inhibitors|growth inhibitors|mesh-ancestor
110536306|NCT02829281|Triamcinolone|triamcinolone|mesh-list
110536307|NCT02829281|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110536309|NCT02829281|Botulinum Toxins|botulinum toxins|mesh-list
110536310|NCT02829281|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110536311|NCT02829281|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110536312|NCT02829281|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110536313|NCT02829281|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110536314|NCT02829281|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110536315|NCT02829281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110536316|NCT02829281|Cholinergic Agents|cholinergic agents|mesh-ancestor
110536317|NCT02829281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110536318|NCT02829281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110536319|NCT02829281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110536320|NCT02829281|Glucocorticoids|glucocorticoids|mesh-ancestor
110536321|NCT02829281|Hormones|hormones|mesh-ancestor
110536322|NCT02829281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110536323|NCT02829281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110536324|NCT02829281|Immunologic Factors|immunologic factors|mesh-ancestor
110536325|NCT02829281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110536326|NCT02829281|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110536327|NCT02829281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110536328|NCT04210544|Caseins|caseins|mesh-list
110536329|NCT04210544|Chelating Agents|chelating agents|mesh-ancestor
110536330|NCT04210544|Sequestering Agents|sequestering agents|mesh-ancestor
110536331|NCT04210544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110536332|NCT04168944|Lenvatinib|lenvatinib|mesh-list
110536333|NCT04168944|Immunosuppressive Agents|immunosuppressive agents|mesh-list
110536334|NCT04168944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110536335|NCT04168944|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110536336|NCT04168944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110536337|NCT04168944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110536338|NCT04168944|Immunologic Factors|immunologic factors|mesh-ancestor
110536339|NCT04168944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110536340|NCT02697032|Bicalutamide|bicalutamide|mesh-list
110536341|NCT02697032|Androgen Antagonists|androgen antagonists|mesh-ancestor
110536342|NCT02697032|Hormone Antagonists|hormone antagonists|mesh-ancestor
110536343|NCT02697032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110536344|NCT02697032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110536345|NCT02697032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110536346|NCT04409834|Heparin|heparin|mesh-list
110536347|NCT04409834|Calcium heparin|calcium heparin|mesh-list
110536348|NCT04409834|Enoxaparin|enoxaparin|mesh-list
110536349|NCT04409834|Enoxaparin sodium|enoxaparin sodium|mesh-list
110536350|NCT04409834|Clopidogrel|clopidogrel|mesh-list
110536351|NCT04409834|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110536352|NCT04409834|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110536353|NCT04409834|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110536354|NCT04409834|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110536355|NCT04409834|Purinergic Agents|purinergic agents|mesh-ancestor
110536356|NCT04409834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110536357|NCT04409834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110536358|NCT04409834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110536359|NCT04409834|Anticoagulants|anticoagulants|mesh-ancestor
110536360|NCT04409834|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110536361|NCT04409834|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110536362|NCT02647632|Ribavirin|ribavirin|mesh-list
110536363|NCT02647632|Sofosbuvir|sofosbuvir|mesh-list
110536364|NCT02647632|Grazoprevir|grazoprevir|mesh-list
110536365|NCT02647632|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
110536366|NCT02647632|Antimetabolites|antimetabolites|mesh-ancestor
110536367|NCT02647632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110536368|NCT02647632|Antiviral Agents|antiviral agents|mesh-ancestor
110536369|NCT02647632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110536370|NCT00621452|Aldesleukin|aldesleukin|mesh-list
110536371|NCT00621452|Cyclophosphamide|cyclophosphamide|mesh-list
110536372|NCT00621452|Interleukin-2|interleukin-2|mesh-list
110536373|NCT00621452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110536374|NCT00621452|Immunologic Factors|immunologic factors|mesh-ancestor
110536375|NCT00621452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110536376|NCT00621452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110536377|NCT00621452|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110536378|NCT00621452|Alkylating Agents|alkylating agents|mesh-ancestor
110536379|NCT00621452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110536380|NCT00621452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110536381|NCT00621452|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110536382|NCT00621452|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110536383|NCT00621452|Analgesics|analgesics|mesh-ancestor
110536384|NCT00621452|Sensory System Agents|sensory system agents|mesh-ancestor
110536385|NCT00621452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110536386|NCT00621452|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110536387|NCT00621452|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110536388|NCT00621452|Antiviral Agents|antiviral agents|mesh-ancestor
110536389|NCT00621452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110536390|NCT04336748|Hydroxychloroquine|hydroxychloroquine|mesh-list
110536391|NCT04336748|Antimalarials|antimalarials|mesh-ancestor
110536392|NCT04336748|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110536393|NCT04336748|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110536394|NCT04336748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110536395|NCT04336748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110536396|NCT04336748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110536397|NCT04336748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110536398|NCT00651612|Timolol|timolol|mesh-list
110536399|NCT00651612|Brimonidine Tartrate|brimonidine tartrate|mesh-list
110536400|NCT00651612|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110536401|NCT00651612|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110536402|NCT00651612|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110536403|NCT00651612|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110536404|NCT00651612|Adrenergic Agents|adrenergic agents|mesh-ancestor
110536405|NCT00651612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110536406|NCT00651612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110536407|NCT00651612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110536408|NCT00651612|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110536409|NCT00651612|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110536410|NCT00651612|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110536411|NCT00651612|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110536412|NCT00651612|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110536413|NCT00650754|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
110536414|NCT00650754|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110536415|NCT00650754|Immunologic Factors|immunologic factors|mesh-ancestor
110536416|NCT00650754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110536417|NCT02650206|Liraglutide|liraglutide|mesh-list
110536418|NCT02650206|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110536419|NCT02650206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110536420|NCT02650206|Incretins|incretins|mesh-ancestor
110536421|NCT02650206|Hormones|hormones|mesh-ancestor
110536422|NCT02650206|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110536423|NCT05368766|Diuretics|diuretics|mesh-list
110536424|NCT05368766|Natriuretic Agents|natriuretic agents|mesh-ancestor
110536425|NCT05368766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110536426|NCT00891293|Fenofibrate|fenofibrate|mesh-list
110536427|NCT00891293|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110536428|NCT00891293|Antimetabolites|antimetabolites|mesh-ancestor
110536429|NCT00891293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110536430|NCT00891293|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110536431|NCT05368142|Cell Wall Skeleton|cell wall skeleton|mesh-list
110536432|NCT05368142|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110536433|NCT05368142|Immunologic Factors|immunologic factors|mesh-ancestor
110536434|NCT05368142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110536435|NCT00889421|Apremilast|apremilast|mesh-list
110536436|NCT00889421|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110536437|NCT00889421|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110536438|NCT00889421|Analgesics|analgesics|mesh-ancestor
110536439|NCT00889421|Sensory System Agents|sensory system agents|mesh-ancestor
110536440|NCT00889421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110536441|NCT00889421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110536442|NCT00889421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110536443|NCT00889421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110536444|NCT00889421|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
110536445|NCT00889421|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110536446|NCT00889421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110536447|NCT00889421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110536448|NCT02827643|Vitamin D|vitamin d|mesh-list
110536449|NCT02827643|Ergocalciferols|ergocalciferols|mesh-list
110536450|NCT02827643|Lamivudine|lamivudine|mesh-list
110536451|NCT02827643|Calcium|calcium|mesh-list
110536452|NCT02827643|Vitamins|vitamins|mesh-ancestor
110536453|NCT02827643|Micronutrients|micronutrients|mesh-ancestor
110536454|NCT02827643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110536455|NCT02827643|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110536456|NCT02827643|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110536457|NCT02827643|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110536458|NCT02827643|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110536459|NCT02827643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110536460|NCT02827643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110536461|NCT02827643|Antiviral Agents|antiviral agents|mesh-ancestor
110536462|NCT02827643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110536463|NCT02827643|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110536464|NCT02827643|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110536466|NCT02646774|Antifungal Agents|antifungal agents|mesh-ancestor
110536467|NCT02646774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110536468|NCT02647086|Metoprolol|metoprolol|mesh-list
110536469|NCT02647086|Midazolam|midazolam|mesh-list
110536470|NCT02647086|Caffeine|caffeine|mesh-list
110536471|NCT02647086|Omeprazole|omeprazole|mesh-list
110536472|NCT02647086|Warfarin|warfarin|mesh-list
110536473|NCT02647086|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110536474|NCT02647086|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110536475|NCT02647086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110536476|NCT02647086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110536477|NCT02647086|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110536478|NCT02647086|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110536479|NCT02647086|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110536480|NCT02647086|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110536481|NCT02647086|Anesthetics, General|anesthetics, general|mesh-ancestor
110536482|NCT02647086|Anesthetics|anesthetics|mesh-ancestor
110536483|NCT02647086|GABA Modulators|gaba modulators|mesh-ancestor
110536484|NCT02647086|GABA Agents|gaba agents|mesh-ancestor
110536485|NCT02647086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110536486|NCT02647086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110536487|NCT02647086|Anticoagulants|anticoagulants|mesh-ancestor
110536488|NCT02647086|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110536489|NCT02647086|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110536490|NCT02647086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110536491|NCT02647086|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110536492|NCT02647086|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110536493|NCT02647086|Purinergic Agents|purinergic agents|mesh-ancestor
110536494|NCT02647086|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110536495|NCT02647086|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110536496|NCT02647086|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110536497|NCT02647086|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110536498|NCT02647086|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110536499|NCT02647086|Sympatholytics|sympatholytics|mesh-ancestor
110536500|NCT02647086|Autonomic Agents|autonomic agents|mesh-ancestor
110536501|NCT02647086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110536502|NCT02647086|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110536503|NCT02647086|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110536504|NCT02647086|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110536505|NCT02647086|Adrenergic Agents|adrenergic agents|mesh-ancestor
110536507|NCT00651690|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110536508|NCT00651690|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110536509|NCT00651690|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110536510|NCT00651690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110536511|NCT00651690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110536512|NCT00651690|Cholinergic Agents|cholinergic agents|mesh-ancestor
110536513|NCT00651690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110536514|NCT00651690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110536515|NCT00651690|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110536516|NCT00651690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110536517|NCT00651768|Budesonide|budesonide|mesh-list
110536518|NCT00651768|Formoterol Fumarate|formoterol fumarate|mesh-list
110536519|NCT00651768|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
110536520|NCT00651768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110536521|NCT00651768|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110536522|NCT00651768|Autonomic Agents|autonomic agents|mesh-ancestor
110536523|NCT00651768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110536524|NCT00651768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110536525|NCT00651768|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110536526|NCT00651768|Respiratory System Agents|respiratory system agents|mesh-ancestor
110536527|NCT00651768|Glucocorticoids|glucocorticoids|mesh-ancestor
110536528|NCT00651768|Hormones|hormones|mesh-ancestor
110536529|NCT00651768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110536530|NCT00651768|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110536531|NCT00651768|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110536532|NCT00651768|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110536533|NCT00651768|Adrenergic Agents|adrenergic agents|mesh-ancestor
110536534|NCT00651768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110536535|NCT00651768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110536536|NCT00651846|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
110536537|NCT00651846|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
110536538|NCT00651846|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110536539|NCT00651846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110536540|NCT00651846|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110536541|NCT00651846|Contraceptive Agents|contraceptive agents|mesh-ancestor
110536542|NCT00651846|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110536543|NCT00651846|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110536544|NCT00651846|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110536545|NCT00651846|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110536546|NCT00651846|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110536547|NCT00651846|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
110536548|NCT00651846|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
110536549|NCT00651846|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
110176226|NCT00079768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110195063|NCT00039026|Exenatide|exenatide|mesh-list
110536551|NCT04167306|Varenicline|varenicline|mesh-list
110536552|NCT04167306|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110536553|NCT04167306|Antidepressive Agents|antidepressive agents|mesh-ancestor
110536554|NCT04167306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110536555|NCT04167306|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110536556|NCT04167306|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110536557|NCT04167306|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110536558|NCT04167306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110536559|NCT04167306|Dopamine Agents|dopamine agents|mesh-ancestor
110536560|NCT04167306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110536561|NCT04167306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110536562|NCT04167306|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110536563|NCT04167306|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110536564|NCT04167306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110536565|NCT04167306|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110536566|NCT04167306|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110536567|NCT04167306|Cholinergic Agents|cholinergic agents|mesh-ancestor
110536568|NCT04244591|Methylprednisolone|methylprednisolone|mesh-list
110536569|NCT04244591|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110536570|NCT04244591|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110536572|NCT04244591|Prednisolone acetate|prednisolone acetate|mesh-list
110536573|NCT04244591|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110536574|NCT04244591|Prednisolone phosphate|prednisolone phosphate|mesh-list
110536575|NCT04244591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110536576|NCT04244591|Antiemetics|antiemetics|mesh-ancestor
110536577|NCT04244591|Autonomic Agents|autonomic agents|mesh-ancestor
110536578|NCT04244591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110536579|NCT04244591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110536580|NCT04244591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110536581|NCT04244591|Glucocorticoids|glucocorticoids|mesh-ancestor
110536582|NCT04244591|Hormones|hormones|mesh-ancestor
110536583|NCT04244591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110536584|NCT04244591|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110536585|NCT04244591|Protective Agents|protective agents|mesh-ancestor
110536586|NCT04244591|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110536587|NCT04244591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110536588|NCT02649582|Temozolomide|temozolomide|mesh-list
110536589|NCT02649582|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110536590|NCT02649582|Alkylating Agents|alkylating agents|mesh-ancestor
110536591|NCT02649582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110536592|NCT02649582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110536593|NCT04167696|Cyclophosphamide|cyclophosphamide|mesh-list
110536594|NCT04167696|Fludarabine|fludarabine|mesh-list
110536595|NCT04167696|Fludarabine phosphate|fludarabine phosphate|mesh-list
110536596|NCT04167696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110536597|NCT04167696|Immunologic Factors|immunologic factors|mesh-ancestor
110536598|NCT04167696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110536599|NCT04167696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110536600|NCT04167696|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110536601|NCT04167696|Alkylating Agents|alkylating agents|mesh-ancestor
110536602|NCT04167696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110536603|NCT04167696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110536604|NCT04167696|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110536605|NCT04167696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110536606|NCT04167696|Antimetabolites|antimetabolites|mesh-ancestor
110536607|NCT02827487|Celecoxib|celecoxib|mesh-list
110536608|NCT02827487|Tramadol|tramadol|mesh-list
110536609|NCT02827487|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110536610|NCT02827487|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110536611|NCT02827487|Analgesics|analgesics|mesh-ancestor
110536612|NCT02827487|Sensory System Agents|sensory system agents|mesh-ancestor
110536613|NCT02827487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110536614|NCT02827487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110536615|NCT02827487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110536616|NCT02827487|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110536617|NCT02827487|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110536618|NCT02827487|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110536619|NCT02827487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110536620|NCT02827487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110536622|NCT02827487|Narcotics|narcotics|mesh-ancestor
110536623|NCT02827487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110536624|NCT02649504|Mycophenolic Acid|mycophenolic acid|mesh-list
110536625|NCT02649504|Dexamethasone|dexamethasone|mesh-list
110536626|NCT02649504|Rituximab|rituximab|mesh-list
110536627|NCT02649504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110536628|NCT02649504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110536629|NCT02649504|Immunologic Factors|immunologic factors|mesh-ancestor
110536630|NCT02649504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110536631|NCT02649504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110536632|NCT02649504|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110536633|NCT02649504|Antiemetics|antiemetics|mesh-ancestor
110536634|NCT02649504|Autonomic Agents|autonomic agents|mesh-ancestor
110536635|NCT02649504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110536636|NCT02649504|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110536637|NCT02649504|Glucocorticoids|glucocorticoids|mesh-ancestor
110536638|NCT02649504|Hormones|hormones|mesh-ancestor
110536639|NCT02649504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110536640|NCT02649504|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110536641|NCT02649504|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110280343|NCT00188006|Heparin|heparin|mesh-list
110536642|NCT02649504|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110536643|NCT02649504|Antitubercular Agents|antitubercular agents|mesh-ancestor
110536644|NCT02649504|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110536645|NCT02649504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110536646|NCT02649504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110536647|NCT02649504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110536648|NCT03703856|Memantine|memantine|mesh-list
110536649|NCT03703856|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110536650|NCT03703856|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110536651|NCT03703856|Dopamine Agents|dopamine agents|mesh-ancestor
110536652|NCT03703856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110536653|NCT03703856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110536654|NCT03703856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110536655|NCT03703856|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110536656|NCT03703856|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110536657|NCT00650910|Lapatinib|lapatinib|mesh-list
110536658|NCT00650910|Digoxin|digoxin|mesh-list
110536659|NCT00650910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110536660|NCT00650910|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110536661|NCT00650910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110536662|NCT00650910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110536663|NCT00650910|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110536664|NCT00650910|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110536665|NCT00650910|Protective Agents|protective agents|mesh-ancestor
110536666|NCT00650910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110536667|NCT02654730|Primaquine|primaquine|mesh-list
110536668|NCT02654730|Piperaquine|piperaquine|mesh-list
110536669|NCT02654730|Artenimol|artenimol|mesh-list
110536670|NCT02654730|Artemisinins|artemisinins|mesh-list
110536671|NCT02654730|Antimalarials|antimalarials|mesh-ancestor
110536672|NCT02654730|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110536673|NCT02654730|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110536674|NCT02654730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110536675|NCT00888329|Aprepitant|aprepitant|mesh-list
110536677|NCT00888329|Autonomic Agents|autonomic agents|mesh-ancestor
110536678|NCT00888329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110536679|NCT00888329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110536680|NCT00888329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110536681|NCT00888329|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110536682|NCT00888329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110536683|NCT00888329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110536684|NCT00652002|Budesonide|budesonide|mesh-list
110536685|NCT00652002|Formoterol Fumarate|formoterol fumarate|mesh-list
110184194|NCT00396396|Antioxidants|antioxidants|mesh-ancestor
110536686|NCT00652002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110536687|NCT00652002|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110536688|NCT00652002|Autonomic Agents|autonomic agents|mesh-ancestor
110280348|NCT00188045|Propranolol|propranolol|mesh-list
110536689|NCT00652002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110536690|NCT00652002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110536691|NCT00652002|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110536692|NCT00652002|Respiratory System Agents|respiratory system agents|mesh-ancestor
110536693|NCT00652002|Glucocorticoids|glucocorticoids|mesh-ancestor
110536694|NCT00652002|Hormones|hormones|mesh-ancestor
110536695|NCT00652002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110536696|NCT00652002|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110536697|NCT00652002|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110536698|NCT00652002|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110536699|NCT00652002|Adrenergic Agents|adrenergic agents|mesh-ancestor
110536700|NCT00652002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110536701|NCT00652002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110536702|NCT02646540|Metolazone|metolazone|mesh-list
110536703|NCT02646540|Furosemide|furosemide|mesh-list
110536704|NCT02646540|Tolvaptan|tolvaptan|mesh-list
110536705|NCT02646540|Diuretics|diuretics|mesh-list
110536706|NCT02646540|Natriuretic Agents|natriuretic agents|mesh-ancestor
110536707|NCT02646540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110536708|NCT02646540|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110536709|NCT02646540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110536710|NCT02646540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110536711|NCT02646540|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
110536712|NCT02646540|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110536713|NCT02646540|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110536714|NCT00651066|Ritonavir|ritonavir|mesh-list
110536715|NCT00651066|Lopinavir|lopinavir|mesh-list
110536716|NCT00651066|Rifabutin|rifabutin|mesh-list
110536717|NCT00651066|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110536718|NCT00651066|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110536720|NCT00651066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110536721|NCT00651066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110536722|NCT00651066|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110536723|NCT00651066|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110536724|NCT00651066|Antiviral Agents|antiviral agents|mesh-ancestor
110300006|NCT00415740|Levodopa|levodopa|mesh-list
110536725|NCT00651066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110536726|NCT00651066|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110536727|NCT00651066|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110536728|NCT00651066|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110536729|NCT00651066|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110536730|NCT00651066|Antitubercular Agents|antitubercular agents|mesh-ancestor
110536731|NCT02646072|Ketorolac|ketorolac|mesh-list
110536732|NCT02646072|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
110536733|NCT02646072|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110536734|NCT02646072|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110536735|NCT02646072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110536736|NCT02646072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110536737|NCT02646072|Analgesics|analgesics|mesh-ancestor
110536738|NCT02646072|Sensory System Agents|sensory system agents|mesh-ancestor
110536739|NCT02646072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110536740|NCT02646072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110536741|NCT02646072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110536742|NCT02646072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110536743|NCT02646072|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110536744|NCT02646072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110536745|NCT02646072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110536746|NCT02654106|Temozolomide|temozolomide|mesh-list
110536747|NCT02654106|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110536748|NCT02654106|Alkylating Agents|alkylating agents|mesh-ancestor
110536749|NCT02654106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110536750|NCT02654106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110536751|NCT04243733|Pemetrexed|pemetrexed|mesh-list
110536752|NCT04243733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110536753|NCT04243733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110536754|NCT04243733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110536755|NCT04243733|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110536756|NCT04243733|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110536757|NCT03434366|Dexmedetomidine|dexmedetomidine|mesh-list
110536758|NCT03434366|Ketamine|ketamine|mesh-list
110536759|NCT03434366|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110184280|NCT00033306|Irinotecan|irinotecan|mesh-list
110536760|NCT03434366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110536761|NCT03434366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110536762|NCT03434366|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110536763|NCT03434366|Analgesics|analgesics|mesh-ancestor
110536764|NCT03434366|Sensory System Agents|sensory system agents|mesh-ancestor
110536765|NCT03434366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110536766|NCT03434366|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110536767|NCT03434366|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110536768|NCT03434366|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110536769|NCT03434366|Adrenergic Agents|adrenergic agents|mesh-ancestor
110536770|NCT03434366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110536771|NCT03434366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110536772|NCT03434366|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110536773|NCT03434366|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110536774|NCT03434366|Anesthetics, General|anesthetics, general|mesh-ancestor
110536775|NCT03434366|Anesthetics|anesthetics|mesh-ancestor
110536776|NCT03434366|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110536777|NCT03434366|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110536778|NCT04167228|Ceftazidime|ceftazidime|mesh-list
110536779|NCT04167228|Avibactam|avibactam|mesh-list
110536780|NCT04167228|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
110536781|NCT04167228|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110536782|NCT04167228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110536783|NCT04167228|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110536784|NCT04167228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110536785|NCT04167228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110536786|NCT02687438|Mometasone Furoate|mometasone furoate|mesh-list
110536787|NCT02687438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110536788|NCT02687438|Dermatologic Agents|dermatologic agents|mesh-ancestor
110536789|NCT02687438|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110536790|NCT02537834|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3H),2'-(2H)pyran)-3',4',5'-triol|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3h),2'-(2h)pyran)-3',4',5'-triol|mesh-list
110536791|NCT02537834|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110536792|NCT02537834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110536793|NCT02537834|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110536794|NCT02537834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110536795|NCT02648958|Dexmedetomidine|dexmedetomidine|mesh-list
110536796|NCT02648958|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110536797|NCT02648958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110536798|NCT02648958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110536799|NCT02648958|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110536800|NCT02648958|Analgesics|analgesics|mesh-ancestor
110536801|NCT02648958|Sensory System Agents|sensory system agents|mesh-ancestor
110536802|NCT02648958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110536803|NCT02648958|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110536804|NCT02648958|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110536805|NCT02648958|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110536806|NCT02648958|Adrenergic Agents|adrenergic agents|mesh-ancestor
110536807|NCT02648958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110536808|NCT02648958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110536809|NCT00887549|Pemetrexed|pemetrexed|mesh-list
110536810|NCT00887549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110536811|NCT00887549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110536812|NCT00887549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110536813|NCT00887549|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110536814|NCT00887549|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110536815|NCT04243811|Anesthetics|anesthetics|mesh-list
110536816|NCT04243811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110536817|NCT04243811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110536818|NCT00638300|Dialysis Solutions|dialysis solutions|mesh-list
110536819|NCT00638300|Calcium|calcium|mesh-list
110536820|NCT00638300|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110536821|NCT00638300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110536822|NCT00638300|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110536823|NCT00887315|Cisplatin|cisplatin|mesh-list
110536824|NCT00887315|Docetaxel|docetaxel|mesh-list
110536825|NCT00887315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110536826|NCT00887315|Tubulin Modulators|tubulin modulators|mesh-ancestor
110176253|NCT00079963|Vitamin E|vitamin e|mesh-list
110536827|NCT00887315|Antimitotic Agents|antimitotic agents|mesh-ancestor
110536828|NCT00887315|Mitosis Modulators|mitosis modulators|mesh-ancestor
110300046|NCT00250536|Nandrolone Decanoate|nandrolone decanoate|mesh-list
110536829|NCT00887315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110536830|NCT02645994|Anesthetics|anesthetics|mesh-list
110536831|NCT02645994|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110536832|NCT02645994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110536833|NCT03014648|Atezolizumab|atezolizumab|mesh-list
110536834|NCT03014648|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110536835|NCT03014648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110536836|NCT03014648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110536837|NCT03014648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110536838|NCT02645058|Analgesics|analgesics|mesh-list
110536839|NCT02645058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110536840|NCT02645058|Sensory System Agents|sensory system agents|mesh-ancestor
110536841|NCT02645058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110536842|NCT02644980|Anesthetics|anesthetics|mesh-list
110536843|NCT02644980|Propofol|propofol|mesh-list
110536844|NCT02644980|Etomidate|etomidate|mesh-list
110536845|NCT02644980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110536846|NCT02644980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110536847|NCT02644980|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110536848|NCT02644980|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110536849|NCT02644980|Anesthetics, General|anesthetics, general|mesh-ancestor
110536850|NCT04187456|Midazolam|midazolam|mesh-list
110536851|NCT04187456|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110536852|NCT04187456|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110536853|NCT04187456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110536854|NCT04187456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110536855|NCT04187456|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110536856|NCT04187456|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110536857|NCT04187456|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110536858|NCT04187456|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110536859|NCT04187456|Anesthetics, General|anesthetics, general|mesh-ancestor
110536860|NCT04187456|Anesthetics|anesthetics|mesh-ancestor
110536861|NCT04187456|GABA Modulators|gaba modulators|mesh-ancestor
110536862|NCT04187456|GABA Agents|gaba agents|mesh-ancestor
110536863|NCT04187456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110536864|NCT04187456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110536865|NCT02827331|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
110536866|NCT02827331|Anti-Anxiety Agents|anti-anxiety agents|mesh-list
110536867|NCT02827331|Antidepressive Agents|antidepressive agents|mesh-list
110536869|NCT02827331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110536870|NCT02827331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110536871|NCT02827331|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110536872|NCT02687204|Enoxaparin|enoxaparin|mesh-list
110536873|NCT02687204|Enoxaparin sodium|enoxaparin sodium|mesh-list
110536874|NCT02687204|Anticoagulants|anticoagulants|mesh-ancestor
110536875|NCT02687204|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110536876|NCT02687204|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110536877|NCT02687204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110536878|NCT00650208|Lamotrigine|lamotrigine|mesh-list
110536879|NCT00650208|Anticonvulsants|anticonvulsants|mesh-ancestor
110536880|NCT00650208|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110536881|NCT00650208|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110536882|NCT00650208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110536883|NCT00650208|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110536884|NCT00650208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110536885|NCT00650208|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110536886|NCT00650208|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110536887|NCT00650208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110536888|NCT00650208|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110536889|NCT00650208|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110536890|NCT02645370|Topiramate|topiramate|mesh-list
110536891|NCT02645370|Anticonvulsants|anticonvulsants|mesh-ancestor
110536892|NCT02645370|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110536893|NCT02645370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110536894|NCT00652392|Budesonide|budesonide|mesh-list
110536895|NCT00652392|Formoterol Fumarate|formoterol fumarate|mesh-list
110536896|NCT00652392|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110536897|NCT00652392|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110536898|NCT00652392|Autonomic Agents|autonomic agents|mesh-ancestor
110536899|NCT00652392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110536900|NCT00652392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110536901|NCT00652392|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110536902|NCT00652392|Respiratory System Agents|respiratory system agents|mesh-ancestor
110536903|NCT00652392|Glucocorticoids|glucocorticoids|mesh-ancestor
110536905|NCT00652392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110536906|NCT00652392|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110536907|NCT00652392|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110536908|NCT00652392|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110536909|NCT00652392|Adrenergic Agents|adrenergic agents|mesh-ancestor
110536910|NCT00652392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110536911|NCT00652392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110536912|NCT02645214|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
110536913|NCT02645214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110536914|NCT02653638|Indomethacin|indomethacin|mesh-list
110536915|NCT02653638|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110536916|NCT02653638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110536917|NCT02653638|Analgesics|analgesics|mesh-ancestor
110536918|NCT02653638|Sensory System Agents|sensory system agents|mesh-ancestor
110536919|NCT02653638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110536920|NCT02653638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110536921|NCT02653638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110536922|NCT02653638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110536923|NCT02653638|Gout Suppressants|gout suppressants|mesh-ancestor
110536924|NCT02653638|Tocolytic Agents|tocolytic agents|mesh-ancestor
110536925|NCT02653638|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110536926|NCT02653638|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110536927|NCT02653638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110536928|NCT02653638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110536929|NCT02644590|Melatonin|melatonin|mesh-list
110536930|NCT02644590|Antioxidants|antioxidants|mesh-ancestor
110536931|NCT02644590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110536932|NCT02644590|Protective Agents|protective agents|mesh-ancestor
110312353|NCT00293969|Narcotics|narcotics|mesh-ancestor
110536933|NCT02644590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110536934|NCT02644590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110536936|NCT00910806|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110536937|NCT00910806|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110536938|NCT00910806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110536939|NCT00910806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110536940|NCT00910806|Antiviral Agents|antiviral agents|mesh-ancestor
110536941|NCT00910806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110536942|NCT00910806|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110536943|NCT00910806|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110536944|NCT00910806|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110536945|NCT00910806|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110536946|NCT00652704|Doxycycline|doxycycline|mesh-list
110536947|NCT00652704|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110536948|NCT00652704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110536949|NCT00652704|Antimalarials|antimalarials|mesh-ancestor
110536950|NCT00652704|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110536951|NCT00652704|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110536952|NCT00652782|Rolofylline|rolofylline|mesh-list
110536953|NCT00652782|Diuretics|diuretics|mesh-ancestor
110536954|NCT00652782|Natriuretic Agents|natriuretic agents|mesh-ancestor
110536955|NCT00652782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110536956|NCT00653562|Zolpidem|zolpidem|mesh-list
110536957|NCT00653562|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110536958|NCT00653562|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110536959|NCT00653562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110536960|NCT00653562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110536961|NCT00653562|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
110536962|NCT00653562|GABA Agonists|gaba agonists|mesh-ancestor
110536963|NCT00653562|GABA Agents|gaba agents|mesh-ancestor
110536964|NCT00653562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110536965|NCT00653562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110536966|NCT00887159|Cisplatin|cisplatin|mesh-list
110536967|NCT00887159|Etoposide|etoposide|mesh-list
110536968|NCT00887159|Etoposide phosphate|etoposide phosphate|mesh-list
110536969|NCT00887159|Podophyllotoxin|podophyllotoxin|mesh-list
110536970|NCT00887159|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110536971|NCT00887159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110536972|NCT00887159|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110536973|NCT00887159|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110536974|NCT00887159|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110536975|NCT00887159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110536976|NCT00887159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110536977|NCT00887159|Keratolytic Agents|keratolytic agents|mesh-ancestor
110184506|NCT00034359|Lamivudine|lamivudine|mesh-list
110536978|NCT00887159|Dermatologic Agents|dermatologic agents|mesh-ancestor
110536979|NCT00887159|Tubulin Modulators|tubulin modulators|mesh-ancestor
110536980|NCT00887159|Antimitotic Agents|antimitotic agents|mesh-ancestor
110536981|NCT00887159|Mitosis Modulators|mitosis modulators|mesh-ancestor
110536982|NCT00887159|Immunologic Factors|immunologic factors|mesh-ancestor
110536983|NCT00887159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110536984|NCT00650286|Modafinil|modafinil|mesh-list
110536985|NCT00650286|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110536986|NCT00650286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110300175|NCT04708821|Antiemetics|antiemetics|mesh-ancestor
110536987|NCT00650286|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
110536988|NCT00650286|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110536989|NCT00650286|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110536990|NCT00650286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110536991|NCT02640846|Simendan|simendan|mesh-list
110536992|NCT02640846|Milrinone|milrinone|mesh-list
110536993|NCT02640846|Norepinephrine|norepinephrine|mesh-list
110536994|NCT02640846|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110536995|NCT02640846|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110536996|NCT02640846|Adrenergic Agents|adrenergic agents|mesh-ancestor
110536997|NCT02640846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110536998|NCT02640846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110536999|NCT02640846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110537000|NCT02640846|Sympathomimetics|sympathomimetics|mesh-ancestor
110537001|NCT02640846|Autonomic Agents|autonomic agents|mesh-ancestor
110537002|NCT02640846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110537003|NCT02640846|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110537004|NCT02640846|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110537005|NCT02640846|Vasodilator Agents|vasodilator agents|mesh-ancestor
110537006|NCT02640846|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110537007|NCT02640846|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110537008|NCT02640846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110537009|NCT02640846|Protective Agents|protective agents|mesh-ancestor
110537010|NCT02640846|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110537011|NCT02644044|Methotrexate|methotrexate|mesh-list
110537012|NCT02644044|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110537013|NCT02644044|Abortifacient Agents|abortifacient agents|mesh-ancestor
110537014|NCT02644044|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110537015|NCT02644044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110537016|NCT02644044|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110537017|NCT02644044|Antimetabolites|antimetabolites|mesh-ancestor
110537018|NCT02644044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110537019|NCT02644044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110537020|NCT02644044|Dermatologic Agents|dermatologic agents|mesh-ancestor
110537021|NCT02644044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110537022|NCT02644044|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110537023|NCT02644044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110537024|NCT02644044|Immunologic Factors|immunologic factors|mesh-ancestor
110537025|NCT02644044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110537026|NCT02644044|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110537027|NCT00652860|Doxorubicin|doxorubicin|mesh-list
110537028|NCT00652860|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110537030|NCT00652860|Molgramostim|molgramostim|mesh-list
110537031|NCT00652860|Mitomycins|mitomycins|mesh-list
110537032|NCT00652860|Mitomycin|mitomycin|mesh-list
110537033|NCT00652860|Sargramostim|sargramostim|mesh-list
110537034|NCT00652860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110537035|NCT00652860|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110537036|NCT00652860|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110537037|NCT00652860|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110537038|NCT00652860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110537039|NCT00652860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110537040|NCT00652860|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110537041|NCT00652860|Alkylating Agents|alkylating agents|mesh-ancestor
110537042|NCT00652860|Immunologic Factors|immunologic factors|mesh-ancestor
110537043|NCT00652860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110537044|NCT00652860|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110537046|NCT02536014|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110537047|NCT02536014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110537048|NCT02536014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110537049|NCT02536014|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110537050|NCT02536014|Analgesics|analgesics|mesh-ancestor
110537051|NCT02536014|Sensory System Agents|sensory system agents|mesh-ancestor
110537052|NCT02536014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110184568|NCT01806857|Cholinergic Agents|cholinergic agents|mesh-ancestor
110537053|NCT02536014|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110537054|NCT02536014|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110537055|NCT02536014|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110537056|NCT02536014|Adrenergic Agents|adrenergic agents|mesh-ancestor
110537057|NCT02536014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110537058|NCT02536014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110537059|NCT02653014|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
110537060|NCT02653014|Mineralocorticoids|mineralocorticoids|mesh-list
110537061|NCT02653014|Hormone Antagonists|hormone antagonists|mesh-ancestor
110537062|NCT02653014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110537063|NCT02653014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110537064|NCT02653014|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110537065|NCT02653014|Diuretics|diuretics|mesh-ancestor
110537066|NCT02653014|Natriuretic Agents|natriuretic agents|mesh-ancestor
110537067|NCT02653014|Hormones|hormones|mesh-ancestor
110537068|NCT00886613|Vaccines|vaccines|mesh-list
110537069|NCT00886613|Immunologic Factors|immunologic factors|mesh-ancestor
110537070|NCT00886613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110537071|NCT00653016|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110537072|NCT00653016|Norelgestromin|norelgestromin|mesh-list
110537073|NCT00653016|Estradiol|estradiol|mesh-list
110537074|NCT00653016|Estrogens|estrogens|mesh-ancestor
110537075|NCT00653016|Hormones|hormones|mesh-ancestor
110537076|NCT00653016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110537077|NCT00653016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110537078|NCT00653016|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110537079|NCT00653016|Contraceptive Agents|contraceptive agents|mesh-ancestor
110537080|NCT00653016|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110537081|NCT00653016|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110537082|NCT00653016|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110537083|NCT00653016|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110537084|NCT00886379|Vitamin D|vitamin d|mesh-list
110537085|NCT00886379|Ergocalciferols|ergocalciferols|mesh-list
110537086|NCT00886379|Cholecalciferol|cholecalciferol|mesh-list
110537087|NCT00886379|Vitamins|vitamins|mesh-list
110537088|NCT00886379|Micronutrients|micronutrients|mesh-ancestor
110537089|NCT00886379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110537090|NCT00886379|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110537091|NCT00886379|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110537092|NCT00633581|Ascorbic Acid|ascorbic acid|mesh-list
110537093|NCT00633581|Vitamins|vitamins|mesh-ancestor
110537094|NCT00633581|Micronutrients|micronutrients|mesh-ancestor
110280435|NCT00188552|Micronutrients|micronutrients|mesh-ancestor
110537095|NCT00633581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110537096|NCT00633581|Antioxidants|antioxidants|mesh-ancestor
110537097|NCT00633581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110537098|NCT00633581|Protective Agents|protective agents|mesh-ancestor
110537099|NCT02825147|Dexamethasone|dexamethasone|mesh-list
110537100|NCT02825147|Methotrexate|methotrexate|mesh-list
110537101|NCT02825147|Etoposide|etoposide|mesh-list
110537102|NCT02825147|Pegaspargase|pegaspargase|mesh-list
110537103|NCT02825147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110537104|NCT02825147|Antiemetics|antiemetics|mesh-ancestor
110537105|NCT02825147|Autonomic Agents|autonomic agents|mesh-ancestor
110537106|NCT02825147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110537107|NCT02825147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110537108|NCT02825147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110537109|NCT02825147|Glucocorticoids|glucocorticoids|mesh-ancestor
110537110|NCT02825147|Hormones|hormones|mesh-ancestor
110537111|NCT02825147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110537112|NCT02825147|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110537113|NCT02825147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110537114|NCT02825147|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110537115|NCT02825147|Abortifacient Agents|abortifacient agents|mesh-ancestor
110537116|NCT02825147|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110537117|NCT02825147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110537118|NCT02825147|Antimetabolites|antimetabolites|mesh-ancestor
110537119|NCT02825147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110537120|NCT02825147|Dermatologic Agents|dermatologic agents|mesh-ancestor
110537121|NCT02825147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110537122|NCT02825147|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110537123|NCT02825147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110537124|NCT02825147|Immunologic Factors|immunologic factors|mesh-ancestor
110537125|NCT02825147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110537126|NCT02825147|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110537127|NCT02825147|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110537128|NCT02825147|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110537129|NCT02825147|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110537131|NCT02825225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110537132|NCT02825225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110537133|NCT00637949|Rofecoxib|rofecoxib|mesh-list
110537134|NCT00637949|Lumiracoxib|lumiracoxib|mesh-list
110537135|NCT00637949|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110537136|NCT00637949|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110537137|NCT00637949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110537138|NCT00637949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110537139|NCT00637949|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110537140|NCT00637949|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110537142|NCT00637949|Sensory System Agents|sensory system agents|mesh-ancestor
110537143|NCT00637949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110537144|NCT00637949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110537145|NCT00637949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110537146|NCT00637949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110195143|NCT00410995|Naproxen|naproxen|mesh-list
110300313|NCT01689298|Oxytocin|oxytocin|mesh-list
110537147|NCT04242017|Triptorelin Pamoate|triptorelin pamoate|mesh-list
110537148|NCT04242017|Luteolytic Agents|luteolytic agents|mesh-ancestor
110537149|NCT04242017|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110537150|NCT04242017|Contraceptive Agents|contraceptive agents|mesh-ancestor
110537151|NCT04242017|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110537152|NCT04242017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110537153|NCT04242017|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110537154|NCT04242017|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110537155|NCT04242017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110537157|NCT00599196|Dopamine Agonists|dopamine agonists|mesh-ancestor
110537158|NCT00599196|Dopamine Agents|dopamine agents|mesh-ancestor
110537159|NCT00599196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110537160|NCT00599196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110537161|NCT00599196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110537162|NCT04201145|Pembrolizumab|pembrolizumab|mesh-list
110537163|NCT04201145|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110537164|NCT04201145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110537165|NCT04201145|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110537166|NCT04201145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110537167|NCT02824601|Calcium|calcium|mesh-list
110537168|NCT02824601|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110537169|NCT02824601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110537170|NCT02643732|Methylphenidate|methylphenidate|mesh-list
110537171|NCT02643732|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110537172|NCT02643732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110537173|NCT02643732|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110537174|NCT02643732|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110537175|NCT02643732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110537176|NCT02643732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110537177|NCT02643732|Dopamine Agents|dopamine agents|mesh-ancestor
110537178|NCT02643732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110537179|NCT04876937|Dexmedetomidine|dexmedetomidine|mesh-list
110537180|NCT04876937|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110537181|NCT04876937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110537182|NCT04876937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110537183|NCT04876937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110537184|NCT04876937|Analgesics|analgesics|mesh-ancestor
110537185|NCT04876937|Sensory System Agents|sensory system agents|mesh-ancestor
110537186|NCT04876937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110537187|NCT04876937|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110537188|NCT04876937|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110537189|NCT04876937|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110537190|NCT04876937|Adrenergic Agents|adrenergic agents|mesh-ancestor
110537191|NCT04876937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110537192|NCT04876937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110537193|NCT04165590|Immunomodulating Agents|immunomodulating agents|mesh-list
110537194|NCT04165590|Immunologic Factors|immunologic factors|mesh-ancestor
110537195|NCT04165590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110537196|NCT05660993|Nivolumab|nivolumab|mesh-list
110537197|NCT05660993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110537198|NCT05660993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110537199|NCT05660993|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110184721|NCT00035295|Aprepitant|aprepitant|mesh-list
110537200|NCT05660993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110537201|NCT00633659|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
110537202|NCT00633659|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110537204|NCT00633659|Blood Substitutes|blood substitutes|mesh-ancestor
110537205|NCT04241705|Lumefantrine|lumefantrine|mesh-list
110537206|NCT04241705|Artemether|artemether|mesh-list
110537208|NCT04241705|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
110537209|NCT04241705|Antimalarials|antimalarials|mesh-ancestor
110537210|NCT04241705|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110537211|NCT04241705|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110537212|NCT04241705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110537213|NCT04243109|Dexamethasone|dexamethasone|mesh-list
110537214|NCT04243109|Cyclophosphamide|cyclophosphamide|mesh-list
110537215|NCT04243109|Pomalidomide|pomalidomide|mesh-list
110537216|NCT04243109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110537217|NCT04243109|Immunologic Factors|immunologic factors|mesh-ancestor
110537218|NCT04243109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110537219|NCT04243109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110537220|NCT04243109|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110537221|NCT04243109|Alkylating Agents|alkylating agents|mesh-ancestor
110537222|NCT04243109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110280449|NCT00188669|Vitamin E|vitamin e|mesh-list
110537223|NCT04243109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110537224|NCT04243109|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110537225|NCT04243109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110537227|NCT04243109|Autonomic Agents|autonomic agents|mesh-ancestor
110537228|NCT04243109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110537229|NCT04243109|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110537230|NCT04243109|Glucocorticoids|glucocorticoids|mesh-ancestor
110537232|NCT04243109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110537233|NCT04243109|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110537234|NCT04243109|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110537235|NCT04243109|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110537236|NCT04243109|Growth Substances|growth substances|mesh-ancestor
110537237|NCT04243109|Growth Inhibitors|growth inhibitors|mesh-ancestor
110537238|NCT04861181|Niraparib|niraparib|mesh-list
110537239|NCT04861181|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110537240|NCT04861181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110537241|NCT04861181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110537242|NCT04861181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110537243|NCT00603512|Tofacitinib|tofacitinib|mesh-list
110537244|NCT00603512|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
110537245|NCT00603512|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110537246|NCT00603512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110537247|NCT00603512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110537248|NCT04167774|Paclitaxel|paclitaxel|mesh-list
110537249|NCT04167774|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110537250|NCT04167774|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110537251|NCT04167774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110537252|NCT04167774|Tubulin Modulators|tubulin modulators|mesh-ancestor
110537253|NCT04167774|Antimitotic Agents|antimitotic agents|mesh-ancestor
110537254|NCT04167774|Mitosis Modulators|mitosis modulators|mesh-ancestor
110537255|NCT04167774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110537256|NCT02640300|Clozapine|clozapine|mesh-list
110537257|NCT02640300|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110537258|NCT02640300|Serotonin Agents|serotonin agents|mesh-ancestor
110537259|NCT02640300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110537260|NCT02640300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110537261|NCT02640300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110537262|NCT02640300|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110537263|NCT02640300|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110176327|NCT00080158|Histamine Agents|histamine agents|mesh-ancestor
110537264|NCT02640300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110537265|NCT02640300|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110537267|NCT02640300|GABA Agents|gaba agents|mesh-ancestor
110537268|NCT02640144|Hyaluronic Acid|hyaluronic acid|mesh-list
110537269|NCT02640144|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110537270|NCT02640144|Immunologic Factors|immunologic factors|mesh-ancestor
110537271|NCT02640144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110537272|NCT02640144|Viscosupplements|viscosupplements|mesh-ancestor
110537273|NCT02640144|Protective Agents|protective agents|mesh-ancestor
110537274|NCT02643186|Misoprostol|misoprostol|mesh-list
110537275|NCT02643186|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110537276|NCT02643186|Abortifacient Agents|abortifacient agents|mesh-ancestor
110537277|NCT02643186|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110537278|NCT02643186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110537279|NCT02643186|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110537280|NCT02643186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110537281|NCT02643186|Oxytocics|oxytocics|mesh-ancestor
110537282|NCT02652312|Diclofenac|diclofenac|mesh-list
110537283|NCT02652312|Fentanyl|fentanyl|mesh-list
110537284|NCT02652312|Dexmedetomidine|dexmedetomidine|mesh-list
110537285|NCT02652312|Ondansetron|ondansetron|mesh-list
110537286|NCT02652312|Propofol|propofol|mesh-list
110537287|NCT02652312|Desflurane|desflurane|mesh-list
110537288|NCT02652312|Atracurium|atracurium|mesh-list
110537289|NCT02652312|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110537290|NCT02652312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110537291|NCT02652312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110537292|NCT02652312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110537293|NCT02652312|Analgesics|analgesics|mesh-ancestor
110537294|NCT02652312|Sensory System Agents|sensory system agents|mesh-ancestor
110537295|NCT02652312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110537296|NCT02652312|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110537297|NCT02652312|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110537298|NCT02652312|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110537299|NCT02652312|Adrenergic Agents|adrenergic agents|mesh-ancestor
110537301|NCT02652312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110537302|NCT02652312|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110537303|NCT02652312|Anesthetics, General|anesthetics, general|mesh-ancestor
110537304|NCT02652312|Anesthetics|anesthetics|mesh-ancestor
110537305|NCT02652312|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110537306|NCT02652312|Narcotics|narcotics|mesh-ancestor
110537307|NCT02652312|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110537308|NCT02652312|Antiemetics|antiemetics|mesh-ancestor
110537309|NCT02652312|Autonomic Agents|autonomic agents|mesh-ancestor
110537310|NCT02652312|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110537311|NCT02652312|Antipruritics|antipruritics|mesh-ancestor
110537312|NCT02652312|Dermatologic Agents|dermatologic agents|mesh-ancestor
110537313|NCT02652312|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110537314|NCT02652312|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110537315|NCT02652312|Serotonin Agents|serotonin agents|mesh-ancestor
110537316|NCT02652312|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110537317|NCT02652312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110537318|NCT02652312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110537319|NCT02652312|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110537320|NCT02652312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110537321|NCT02652312|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110537322|NCT02652312|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110537323|NCT02652312|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110537324|NCT02652312|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110537325|NCT02652312|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
110537327|NCT02652312|Cholinergic Agents|cholinergic agents|mesh-ancestor
110537328|NCT04165512|Triamcinolone|triamcinolone|mesh-list
110537329|NCT04165512|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110537330|NCT04165512|Bupivacaine|bupivacaine|mesh-list
110537331|NCT04165512|Anesthetics, Local|anesthetics, local|mesh-ancestor
110537332|NCT04165512|Anesthetics|anesthetics|mesh-ancestor
110537333|NCT04165512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110537334|NCT04165512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110537335|NCT04165512|Sensory System Agents|sensory system agents|mesh-ancestor
110537336|NCT04165512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110537337|NCT04165512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110537338|NCT04165512|Glucocorticoids|glucocorticoids|mesh-ancestor
110537339|NCT04165512|Hormones|hormones|mesh-ancestor
110537340|NCT04165512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110537341|NCT04165512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110537342|NCT04165512|Immunologic Factors|immunologic factors|mesh-ancestor
110537343|NCT02642874|Methocarbamol|methocarbamol|mesh-list
110537344|NCT02642874|Calcium Carbonate|calcium carbonate|mesh-list
110184863|NCT00035997|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110537345|NCT02642874|Calcium|calcium|mesh-list
110537346|NCT02642874|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110537347|NCT02642874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110537348|NCT02642874|Antacids|antacids|mesh-ancestor
110537349|NCT02642874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110537350|NCT02642874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110537351|NCT02642874|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110537352|NCT02642874|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110537353|NCT02642874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110537354|NCT00653874|Bilirubin|bilirubin|mesh-list
110537355|NCT00653874|Antioxidants|antioxidants|mesh-ancestor
110537356|NCT00653874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110537357|NCT00653874|Protective Agents|protective agents|mesh-ancestor
110537358|NCT00653874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110537359|NCT04224701|Vaccines|vaccines|mesh-list
110537360|NCT04224701|Immunologic Factors|immunologic factors|mesh-ancestor
110537361|NCT04224701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110537362|NCT00653952|Paclitaxel|paclitaxel|mesh-list
110537363|NCT00653952|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110537364|NCT00653952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110537365|NCT00653952|Tubulin Modulators|tubulin modulators|mesh-ancestor
110537366|NCT00653952|Antimitotic Agents|antimitotic agents|mesh-ancestor
110537367|NCT00653952|Mitosis Modulators|mitosis modulators|mesh-ancestor
110537368|NCT00653952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110537369|NCT00650364|Midodrine|midodrine|mesh-list
110537370|NCT00650364|Sympathomimetics|sympathomimetics|mesh-ancestor
110537371|NCT00650364|Autonomic Agents|autonomic agents|mesh-ancestor
110537372|NCT00650364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110537373|NCT00650364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110537375|NCT00650364|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110537376|NCT00650364|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110537377|NCT00650364|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110537378|NCT00650364|Adrenergic Agents|adrenergic agents|mesh-ancestor
110537379|NCT00650364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110537380|NCT00650364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110537381|NCT04909697|Sivelestat|sivelestat|mesh-list
110537382|NCT04909697|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110537383|NCT04909697|Protease Inhibitors|protease inhibitors|mesh-ancestor
110537384|NCT04909697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110537385|NCT04909697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110537386|NCT00654108|Ascorbic Acid|ascorbic acid|mesh-list
110537387|NCT00654108|Ciprofloxacin|ciprofloxacin|mesh-list
110537388|NCT00654108|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110537389|NCT00654108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110537390|NCT00654108|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110537391|NCT00654108|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110537392|NCT00654108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110537393|NCT00654108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110537394|NCT00654108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110537395|NCT00654108|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110537396|NCT00654108|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110537397|NCT00654108|Antioxidants|antioxidants|mesh-ancestor
110537398|NCT00654108|Protective Agents|protective agents|mesh-ancestor
110537399|NCT00654108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110537401|NCT00654108|Micronutrients|micronutrients|mesh-ancestor
110176358|NCT00080314|Aripiprazole|aripiprazole|mesh-list
110537402|NCT04165902|Hyaluronic Acid|hyaluronic acid|mesh-list
110537403|NCT04165902|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110537404|NCT04165902|Immunologic Factors|immunologic factors|mesh-ancestor
110537405|NCT04165902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110537406|NCT04165902|Viscosupplements|viscosupplements|mesh-ancestor
110537407|NCT04165902|Protective Agents|protective agents|mesh-ancestor
110537408|NCT02639598|Topiramate|topiramate|mesh-list
110537409|NCT02639598|Flunarizine|flunarizine|mesh-list
110537410|NCT02639598|Anticonvulsants|anticonvulsants|mesh-ancestor
110537411|NCT02639598|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110537412|NCT02639598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110537413|NCT02639598|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110537414|NCT02639598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110537415|NCT02639598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110537416|NCT02639598|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110537417|NCT02639598|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110537418|NCT02639598|Histamine Antagonists|histamine antagonists|mesh-ancestor
110537419|NCT02639598|Histamine Agents|histamine agents|mesh-ancestor
110537420|NCT02639598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110537421|NCT02639598|Vasodilator Agents|vasodilator agents|mesh-ancestor
110537422|NCT04907279|Aripiprazole|aripiprazole|mesh-list
110537423|NCT04907279|Antidepressive Agents|antidepressive agents|mesh-ancestor
110184937|NCT00036309|Analgesics|analgesics|mesh-ancestor
110537424|NCT04907279|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110537425|NCT04907279|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110537426|NCT04907279|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110537427|NCT04907279|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110537428|NCT04907279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110537429|NCT04907279|Dopamine Agonists|dopamine agonists|mesh-ancestor
110537430|NCT04907279|Dopamine Agents|dopamine agents|mesh-ancestor
110537431|NCT04907279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110537432|NCT04907279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110537433|NCT04907279|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110537434|NCT04907279|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110537435|NCT04907279|Serotonin Agents|serotonin agents|mesh-ancestor
110537436|NCT04907279|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110537437|NCT04907279|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110537438|NCT04907279|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110537439|NCT04907279|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110537440|NCT02642718|Ketorolac|ketorolac|mesh-list
110537441|NCT02642718|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
110537442|NCT02642718|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110537443|NCT02642718|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110537444|NCT02642718|Analgesics|analgesics|mesh-ancestor
110537445|NCT02642718|Sensory System Agents|sensory system agents|mesh-ancestor
110537446|NCT02642718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110537447|NCT02642718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110537448|NCT02642718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110537449|NCT02642718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110537450|NCT02642718|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110537451|NCT02642718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110537452|NCT02642718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110537454|NCT02642484|Calcium Carbonate|calcium carbonate|mesh-list
110537455|NCT02642484|Calcium|calcium|mesh-list
110176366|NCT00080314|Dopamine Agents|dopamine agents|mesh-ancestor
110537456|NCT02642484|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110537457|NCT02642484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110537459|NCT02642484|Sensory System Agents|sensory system agents|mesh-ancestor
110537460|NCT02642484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110537461|NCT02642484|Anticonvulsants|anticonvulsants|mesh-ancestor
110537462|NCT02642484|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110537463|NCT02642484|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110537464|NCT02642484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110537465|NCT02642484|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110537466|NCT02642484|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110537467|NCT02642484|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110537468|NCT02642484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110537469|NCT02642484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110537470|NCT02642484|Antimanic Agents|antimanic agents|mesh-ancestor
110537472|NCT02642484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110537473|NCT00639392|Zoledronic Acid|zoledronic acid|mesh-list
110537474|NCT00639392|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110537475|NCT00639392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110537476|NCT04185350|Exenatide|exenatide|mesh-list
110537477|NCT04185350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110537478|NCT04185350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110537479|NCT04185350|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110537480|NCT04185350|Incretins|incretins|mesh-ancestor
110537481|NCT04185350|Hormones|hormones|mesh-ancestor
110537482|NCT04185350|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110537483|NCT00653172|Streptogramin A|streptogramin a|mesh-list
110537484|NCT00653172|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110537485|NCT00653172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110537486|NCT02639520|Fosfomycin|fosfomycin|mesh-list
110537487|NCT02639520|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110537488|NCT02639520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110537489|NCT02822729|Timolol|timolol|mesh-list
110537490|NCT02822729|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110537491|NCT02822729|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110537492|NCT02822729|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110537493|NCT02822729|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110537494|NCT02822729|Adrenergic Agents|adrenergic agents|mesh-ancestor
110537495|NCT02822729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110537496|NCT02822729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110537497|NCT02822729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110537498|NCT02822729|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110537499|NCT02822729|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110537500|NCT02642250|Metronidazole|metronidazole|mesh-list
110537501|NCT02642250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110537502|NCT02642250|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110537503|NCT02642250|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110537504|NCT02642250|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110537505|NCT00653250|Celecoxib|celecoxib|mesh-list
110537506|NCT00653250|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110537507|NCT00653250|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110537508|NCT00653250|Analgesics|analgesics|mesh-ancestor
110537509|NCT00653250|Sensory System Agents|sensory system agents|mesh-ancestor
110537510|NCT00653250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110537511|NCT00653250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110537512|NCT00653250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110537513|NCT00653250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110537514|NCT00653250|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110537515|NCT00653250|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110537516|NCT00653250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110537517|NCT00653250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110537518|NCT00638534|Telithromycin|telithromycin|mesh-list
110537519|NCT00638534|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110537520|NCT00638534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110537521|NCT04240535|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110537522|NCT04240535|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110537523|NCT04240535|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110195276|NCT00072540|Enzyme Inhibitors|enzyme inhibitors|mesh-list
110176384|NCT00080509|Desoxyepothilone B|desoxyepothilone b|mesh-list
110537524|NCT04240535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110537525|NCT04240535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110537526|NCT04240535|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110537527|NCT04240535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110537528|NCT04240535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110537529|NCT04240535|Cholinergic Agents|cholinergic agents|mesh-ancestor
110537530|NCT04240535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110537531|NCT02638896|Sulfasalazine|sulfasalazine|mesh-list
110537532|NCT02638896|Celecoxib|celecoxib|mesh-list
110537533|NCT02638896|Etanercept|etanercept|mesh-list
110537534|NCT02638896|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110537535|NCT02638896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110537536|NCT02638896|Analgesics|analgesics|mesh-ancestor
110537537|NCT02638896|Sensory System Agents|sensory system agents|mesh-ancestor
110537538|NCT02638896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110537539|NCT02638896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110537540|NCT02638896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110537541|NCT02638896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110537542|NCT02638896|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110537543|NCT02638896|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110537544|NCT02638896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110537545|NCT02638896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110537546|NCT02638896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110537547|NCT02638896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110537548|NCT02638896|Immunologic Factors|immunologic factors|mesh-ancestor
110537549|NCT02638896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110537550|NCT04240223|Brilacidin|brilacidin|mesh-list
110537551|NCT04240223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110537552|NCT00653406|Risperidone|risperidone|mesh-list
110537553|NCT00653406|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110537554|NCT00653406|Serotonin Agents|serotonin agents|mesh-ancestor
110537555|NCT00653406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110537556|NCT00653406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110537557|NCT00653406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110537558|NCT00653406|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110537559|NCT00653406|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110537560|NCT00653406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110537561|NCT00653406|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110537562|NCT00653406|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110537563|NCT00653406|Dopamine Agents|dopamine agents|mesh-ancestor
110537564|NCT00655200|Insulin Detemir|insulin detemir|mesh-list
110537565|NCT00655200|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110537566|NCT00655200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110537567|NCT04239755|Doxycycline|doxycycline|mesh-list
110537568|NCT04239755|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110537569|NCT04239755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110537570|NCT04239755|Antimalarials|antimalarials|mesh-ancestor
110537571|NCT04239755|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110537572|NCT04239755|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110537573|NCT04185194|Lidocaine|lidocaine|mesh-list
110537574|NCT04185194|Anesthetics, Local|anesthetics, local|mesh-ancestor
110537575|NCT04185194|Anesthetics|anesthetics|mesh-ancestor
110185084|NCT01465685|Dopamine Agents|dopamine agents|mesh-ancestor
110537576|NCT04185194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110537577|NCT04185194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110537578|NCT04185194|Sensory System Agents|sensory system agents|mesh-ancestor
110537579|NCT04185194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110537580|NCT04185194|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110537581|NCT04185194|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110537582|NCT04185194|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110537583|NCT04185194|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110537584|NCT04185194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110537585|NCT00876447|Botulinum Toxins|botulinum toxins|mesh-list
110537586|NCT00876447|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110537587|NCT00876447|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110537588|NCT00876447|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110537589|NCT00876447|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110537590|NCT00876447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110537591|NCT00876447|Cholinergic Agents|cholinergic agents|mesh-ancestor
110537592|NCT00876447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110537593|NCT00876447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110537594|NCT00876447|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110537595|NCT00876447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110537596|NCT04239833|Gefitinib|gefitinib|mesh-list
110537597|NCT04239833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110537598|NCT04239833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110537599|NCT04239833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110537600|NCT04239833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110537601|NCT03513770|Ketorolac|ketorolac|mesh-list
110537602|NCT03513770|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
110537603|NCT03513770|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110537604|NCT03513770|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110537605|NCT03513770|Analgesics|analgesics|mesh-ancestor
110537606|NCT03513770|Sensory System Agents|sensory system agents|mesh-ancestor
110537607|NCT03513770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110537608|NCT03513770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110537609|NCT03513770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110537610|NCT03513770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110537611|NCT03513770|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110537612|NCT03513770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110537613|NCT03513770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110537614|NCT02638740|Mechlorethamine|mechlorethamine|mesh-list
110537615|NCT02638740|Alkylating Agents|alkylating agents|mesh-ancestor
110537616|NCT02638740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110537617|NCT02638740|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110537618|NCT02638740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110537619|NCT02823977|Dexmedetomidine|dexmedetomidine|mesh-list
110537620|NCT02823977|Ketamine|ketamine|mesh-list
110537621|NCT02823977|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110537622|NCT02823977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110537623|NCT02823977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110537624|NCT02823977|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110537625|NCT02823977|Analgesics|analgesics|mesh-ancestor
110537626|NCT02823977|Sensory System Agents|sensory system agents|mesh-ancestor
110537627|NCT02823977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110537628|NCT02823977|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110537629|NCT02823977|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110537630|NCT02823977|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110537631|NCT02823977|Adrenergic Agents|adrenergic agents|mesh-ancestor
110537632|NCT02823977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110537633|NCT02823977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110537634|NCT02823977|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110537635|NCT02823977|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110537636|NCT02823977|Anesthetics, General|anesthetics, general|mesh-ancestor
110537637|NCT02823977|Anesthetics|anesthetics|mesh-ancestor
110537638|NCT02823977|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110537639|NCT02823977|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110537640|NCT00680511|Methamphetamine|methamphetamine|mesh-list
110537641|NCT00680511|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110537642|NCT00680511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110537643|NCT00680511|Sympathomimetics|sympathomimetics|mesh-ancestor
110537644|NCT00680511|Autonomic Agents|autonomic agents|mesh-ancestor
110537645|NCT00680511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110537646|NCT00680511|Dopamine Agents|dopamine agents|mesh-ancestor
110185168|NCT01464983|Antipyretics|antipyretics|mesh-ancestor
110537647|NCT00680511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110537648|NCT00680511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110537649|NCT00680511|Adrenergic Agents|adrenergic agents|mesh-ancestor
110537650|NCT00680511|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110537651|NCT00680511|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110537652|NCT00680511|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110537653|NCT00680511|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110537655|NCT00654576|Chlorpromazine|chlorpromazine|mesh-list
110537656|NCT00654576|Risperidone|risperidone|mesh-list
110537657|NCT00654576|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110537658|NCT00654576|Clozapine|clozapine|mesh-list
110537659|NCT00654576|Sulpiride|sulpiride|mesh-list
110537660|NCT00654576|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110537661|NCT00654576|Serotonin Agents|serotonin agents|mesh-ancestor
110537662|NCT00654576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110537663|NCT00654576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110537664|NCT00654576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110537665|NCT00654576|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110537666|NCT00654576|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110537667|NCT00654576|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110537669|NCT00654576|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110537670|NCT00654576|Dopamine Agents|dopamine agents|mesh-ancestor
110537671|NCT00654576|Antiemetics|antiemetics|mesh-ancestor
110537672|NCT00654576|Autonomic Agents|autonomic agents|mesh-ancestor
110537673|NCT00654576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110537674|NCT00654576|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110537675|NCT00654576|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110537676|NCT00654576|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110537677|NCT00654576|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110537678|NCT00654576|Antidepressive Agents|antidepressive agents|mesh-ancestor
110537679|NCT00654576|GABA Antagonists|gaba antagonists|mesh-ancestor
110537680|NCT00654576|GABA Agents|gaba agents|mesh-ancestor
110537681|NCT00654576|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110537682|NCT00622622|Gemcitabine|gemcitabine|mesh-list
110537683|NCT00622622|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110537684|NCT00622622|Antimetabolites|antimetabolites|mesh-ancestor
110537685|NCT00622622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110537686|NCT00622622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110537688|NCT00598650|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110537689|NCT00598650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110537690|NCT00598650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110537691|NCT00598650|Cholinergic Agents|cholinergic agents|mesh-ancestor
110537692|NCT00598650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110537693|NCT00598650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110537694|NCT00598650|Nootropic Agents|nootropic agents|mesh-ancestor
110537695|NCT04150731|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110537696|NCT04150731|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110537697|NCT04150731|Estradiol|estradiol|mesh-list
110537698|NCT04150731|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110537699|NCT04150731|Estrogens|estrogens|mesh-ancestor
110537700|NCT04150731|Hormones|hormones|mesh-ancestor
110537701|NCT04150731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110537702|NCT04150731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110537703|NCT04150731|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110537704|NCT04150731|Contraceptive Agents|contraceptive agents|mesh-ancestor
110537705|NCT04150731|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110537706|NCT04150731|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110537707|NCT02641938|Dexmedetomidine|dexmedetomidine|mesh-list
110537708|NCT02641938|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110537709|NCT02641938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110537710|NCT02641938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110537711|NCT02641938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110537712|NCT02641938|Analgesics|analgesics|mesh-ancestor
110537713|NCT02641938|Sensory System Agents|sensory system agents|mesh-ancestor
110537714|NCT02641938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110537715|NCT02641938|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110537716|NCT02641938|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110537717|NCT02641938|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110537718|NCT02641938|Adrenergic Agents|adrenergic agents|mesh-ancestor
110537719|NCT02641938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110185231|NCT00037869|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
110537720|NCT02641938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110537721|NCT04249076|Clobetasol|clobetasol|mesh-list
110537722|NCT04249076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110537723|NCT04249076|Glucocorticoids|glucocorticoids|mesh-ancestor
110537724|NCT04249076|Hormones|hormones|mesh-ancestor
110537725|NCT04249076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110537726|NCT04249076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110537728|NCT00681135|Cariostatic Agents|cariostatic agents|mesh-ancestor
110537729|NCT00681135|Protective Agents|protective agents|mesh-ancestor
110537730|NCT00681135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110537731|NCT02821559|Bevacizumab|bevacizumab|mesh-list
110537732|NCT02821559|Oxaliplatin|oxaliplatin|mesh-list
110537733|NCT02821559|Raltitrexed|raltitrexed|mesh-list
110537734|NCT02821559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110537735|NCT02821559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110537736|NCT02821559|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110537737|NCT02821559|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110537738|NCT02821559|Growth Substances|growth substances|mesh-ancestor
110537739|NCT02821559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110537740|NCT02821559|Growth Inhibitors|growth inhibitors|mesh-ancestor
110537741|NCT02821559|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110537743|NCT02821559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110537744|NCT02821559|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110537745|NCT02821559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110537747|NCT00681213|Temsirolimus|temsirolimus|mesh-list
110537748|NCT00681213|MTOR Inhibitors|mtor inhibitors|mesh-list
110537749|NCT00681213|Tacrolimus|tacrolimus|mesh-list
110537750|NCT00681213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110537751|NCT00681213|Immunologic Factors|immunologic factors|mesh-ancestor
110537752|NCT00681213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110537753|NCT00681213|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110537754|NCT00681213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110537755|NCT00681213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110537756|NCT00681213|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110537757|NCT00681213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110537758|NCT00681213|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110537759|NCT00681213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110537760|NCT00681213|Antifungal Agents|antifungal agents|mesh-ancestor
110537761|NCT00681213|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110537762|NCT02638506|Fentanyl|fentanyl|mesh-list
110537763|NCT02638506|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110537764|NCT02638506|Narcotics|narcotics|mesh-ancestor
110537765|NCT02638506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110537766|NCT02638506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110537767|NCT02638506|Analgesics|analgesics|mesh-ancestor
110537768|NCT02638506|Sensory System Agents|sensory system agents|mesh-ancestor
110537769|NCT02638506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110537770|NCT02638506|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110537771|NCT02638506|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110537772|NCT02638506|Anesthetics, General|anesthetics, general|mesh-ancestor
110537773|NCT02638506|Anesthetics|anesthetics|mesh-ancestor
110537774|NCT04745975|Paclitaxel|paclitaxel|mesh-list
110537775|NCT04745975|Vinorelbine|vinorelbine|mesh-list
110537776|NCT04745975|Gemcitabine|gemcitabine|mesh-list
110537777|NCT04745975|Capecitabine|capecitabine|mesh-list
110537778|NCT04745975|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110537779|NCT04745975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110537780|NCT04745975|Tubulin Modulators|tubulin modulators|mesh-ancestor
110537781|NCT04745975|Antimitotic Agents|antimitotic agents|mesh-ancestor
110537782|NCT04745975|Mitosis Modulators|mitosis modulators|mesh-ancestor
110537783|NCT04745975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110537784|NCT04745975|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110537785|NCT04745975|Antimetabolites|antimetabolites|mesh-ancestor
110537786|NCT04150107|Insulin|insulin|mesh-list
110537787|NCT04150107|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110537788|NCT04150107|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110537789|NCT04150107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110537790|NCT02638428|Cytarabine|cytarabine|mesh-list
110537791|NCT02638428|Carboplatin|carboplatin|mesh-list
110537792|NCT02638428|Trastuzumab|trastuzumab|mesh-list
110537793|NCT02638428|Fludarabine|fludarabine|mesh-list
110185312|NCT00847223|Tipifarnib|tipifarnib|mesh-list
110537794|NCT02638428|Etoposide|etoposide|mesh-list
110537795|NCT02638428|Everolimus|everolimus|mesh-list
110537796|NCT02638428|Sorafenib|sorafenib|mesh-list
110537797|NCT02638428|Dasatinib|dasatinib|mesh-list
110537798|NCT02638428|Ifosfamide|ifosfamide|mesh-list
110537799|NCT02638428|Axitinib|axitinib|mesh-list
110537800|NCT02638428|Vemurafenib|vemurafenib|mesh-list
110537801|NCT02638428|Crizotinib|crizotinib|mesh-list
110537802|NCT02638428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110537803|NCT02638428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110537804|NCT02638428|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110537805|NCT02638428|Antimetabolites|antimetabolites|mesh-ancestor
110537806|NCT02638428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110537807|NCT02638428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110537808|NCT02638428|Immunologic Factors|immunologic factors|mesh-ancestor
110537809|NCT02638428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110537810|NCT02638428|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110537811|NCT02638428|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110537812|NCT02638428|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110537813|NCT02638428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110537814|NCT02638428|Antiviral Agents|antiviral agents|mesh-ancestor
110537815|NCT02638428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110537816|NCT02638428|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110537817|NCT02638428|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110537818|NCT02638428|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110537819|NCT02638428|Alkylating Agents|alkylating agents|mesh-ancestor
110537820|NCT01003964|Cisplatin|cisplatin|mesh-list
110537821|NCT01003964|Gemcitabine|gemcitabine|mesh-list
110537822|NCT01003964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110537823|NCT01003964|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110537824|NCT01003964|Antimetabolites|antimetabolites|mesh-ancestor
110537825|NCT01003964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110537826|NCT02823743|Aspirin|aspirin|mesh-list
110537827|NCT02823743|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110537828|NCT02823743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110537829|NCT02823743|Analgesics|analgesics|mesh-ancestor
110537830|NCT02823743|Sensory System Agents|sensory system agents|mesh-ancestor
110537831|NCT02823743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110537832|NCT02823743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110537833|NCT02823743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110537834|NCT02823743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110537835|NCT02823743|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110537836|NCT02823743|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110537837|NCT02823743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110537838|NCT02823743|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110537839|NCT02823743|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110537840|NCT02823743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110537841|NCT02823743|Antipyretics|antipyretics|mesh-ancestor
110537842|NCT00654888|Mitomycins|mitomycins|mesh-list
110537843|NCT00654888|Mitomycin|mitomycin|mesh-list
110300557|NCT02219659|Analgesics|analgesics|mesh-ancestor
110537844|NCT00654888|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110537845|NCT00654888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110537846|NCT00654888|Alkylating Agents|alkylating agents|mesh-ancestor
110537847|NCT00654888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110537848|NCT00654888|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110537849|NCT00654888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110537850|NCT05299203|Verapamil|verapamil|mesh-list
110537851|NCT05299203|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110537852|NCT05299203|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110537853|NCT05299203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110537854|NCT05299203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110537855|NCT05299203|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110537856|NCT05299203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110537857|NCT05299203|Vasodilator Agents|vasodilator agents|mesh-ancestor
110537858|NCT02638584|Rabeprazole|rabeprazole|mesh-list
110537859|NCT02638584|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110537860|NCT02638584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110537861|NCT02638584|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110537862|NCT02638584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110537863|NCT02638584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110537864|NCT02821169|Ropivacaine|ropivacaine|mesh-list
110537865|NCT02821169|Anesthetics, Local|anesthetics, local|mesh-ancestor
110537866|NCT02821169|Anesthetics|anesthetics|mesh-ancestor
110537867|NCT02821169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110537868|NCT02821169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110537869|NCT02821169|Sensory System Agents|sensory system agents|mesh-ancestor
110537870|NCT02821169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110537871|NCT02820935|Itraconazole|itraconazole|mesh-list
110537872|NCT02820935|Rifampin|rifampin|mesh-list
110537873|NCT02820935|Antifungal Agents|antifungal agents|mesh-ancestor
110537874|NCT02820935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110537875|NCT02820935|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110537876|NCT02820935|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110537877|NCT02820935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110537878|NCT02820935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110537879|NCT02820935|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110537880|NCT02820935|Hormone Antagonists|hormone antagonists|mesh-ancestor
110537881|NCT02820935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110537882|NCT02820935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110537883|NCT02820935|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110537884|NCT02820935|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110537885|NCT02820935|Antitubercular Agents|antitubercular agents|mesh-ancestor
110537886|NCT02820935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110537887|NCT02820935|Leprostatic Agents|leprostatic agents|mesh-ancestor
110280519|NCT00212589|Capecitabine|capecitabine|mesh-list
110537888|NCT02820935|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110537889|NCT02820935|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110537890|NCT02820935|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110537891|NCT02820935|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110537892|NCT02820935|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110537893|NCT02820935|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110537894|NCT02820935|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110537895|NCT02626845|Rituximab|rituximab|mesh-list
110537896|NCT02626845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110537897|NCT02626845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110537898|NCT02626845|Immunologic Factors|immunologic factors|mesh-ancestor
110537899|NCT02626845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110537900|NCT02626845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110537901|NCT02821247|Aflibercept|aflibercept|mesh-list
110537902|NCT02821247|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110537903|NCT02821247|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110537904|NCT02821247|Growth Substances|growth substances|mesh-ancestor
110537905|NCT02821247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110537906|NCT02821247|Growth Inhibitors|growth inhibitors|mesh-ancestor
110537907|NCT02821247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110537908|NCT00681525|Atorvastatin|atorvastatin|mesh-list
110537909|NCT00681525|Ezetimibe|ezetimibe|mesh-list
110537910|NCT00681525|Fenofibric acid|fenofibric acid|mesh-list
110537911|NCT00681525|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110537912|NCT00681525|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110537913|NCT00681525|Antimetabolites|antimetabolites|mesh-ancestor
110537914|NCT00681525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110537915|NCT00681525|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110537916|NCT00681525|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110537917|NCT00681525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110537918|NCT00681603|Bevacizumab|bevacizumab|mesh-list
110537919|NCT00681603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110537920|NCT00681603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110537921|NCT00681603|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110537922|NCT00681603|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110537923|NCT00681603|Growth Substances|growth substances|mesh-ancestor
110537924|NCT00681603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110537925|NCT00681603|Growth Inhibitors|growth inhibitors|mesh-ancestor
110537926|NCT04239443|Apatinib|apatinib|mesh-list
110537927|NCT04239443|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
110537928|NCT04239443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110537929|NCT04239443|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110537930|NCT04239443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110537931|NCT04239443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110537932|NCT04239443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110537933|NCT04200599|Oxytocin|oxytocin|mesh-list
110537934|NCT04200599|Oxytocics|oxytocics|mesh-ancestor
110537935|NCT04200599|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110537936|NCT04200599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110537937|NCT02820077|Hemostatics|hemostatics|mesh-list
110537938|NCT02820077|Coagulants|coagulants|mesh-ancestor
110537939|NCT00681993|Cyclophosphamide|cyclophosphamide|mesh-list
110537940|NCT00681993|Carboplatin|carboplatin|mesh-list
110537941|NCT00681993|Docetaxel|docetaxel|mesh-list
110537942|NCT00681993|Trastuzumab|trastuzumab|mesh-list
110537943|NCT00681993|Doxorubicin|doxorubicin|mesh-list
110537944|NCT00681993|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110537945|NCT00681993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110537946|NCT00681993|Immunologic Factors|immunologic factors|mesh-ancestor
110537947|NCT00681993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110300610|NCT00272805|Carvedilol|carvedilol|mesh-list
110537948|NCT00681993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110537949|NCT00681993|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110537950|NCT00681993|Alkylating Agents|alkylating agents|mesh-ancestor
110537951|NCT00681993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110537952|NCT00681993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110537953|NCT00681993|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110537954|NCT00681993|Tubulin Modulators|tubulin modulators|mesh-ancestor
110537955|NCT00681993|Antimitotic Agents|antimitotic agents|mesh-ancestor
110537956|NCT00681993|Mitosis Modulators|mitosis modulators|mesh-ancestor
110537957|NCT00681993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110537958|NCT00681993|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110537959|NCT00681993|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110537960|NCT00681993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110537961|NCT00681993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110537963|NCT02819999|Rovalpituzumab tesirine|rovalpituzumab tesirine|mesh-list
110537964|NCT02819999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110537965|NCT02819999|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110537966|NCT02819999|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110537967|NCT02819999|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110537968|NCT02819999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110537969|NCT02819999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110537970|NCT02819999|Immunoconjugates|immunoconjugates|mesh-ancestor
110537971|NCT02819999|Immunologic Factors|immunologic factors|mesh-ancestor
110537972|NCT02819999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110537973|NCT04173494|Danazol|danazol|mesh-list
110537974|NCT04173494|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
110537975|NCT04173494|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110537976|NCT04173494|Hormone Antagonists|hormone antagonists|mesh-ancestor
110537977|NCT04173494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110537978|NCT04173494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110537979|NCT04173494|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110537980|NCT04173494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110343804|NCT06022614|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110537981|NCT04173494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110537982|NCT02819921|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
110537983|NCT02819921|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110537984|NCT02819921|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110537985|NCT02819921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110537986|NCT02819921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110537987|NCT02819921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110537988|NCT02819921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110537989|NCT02819921|Antidepressive Agents|antidepressive agents|mesh-ancestor
110537990|NCT02819921|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110537991|NCT00875979|Trastuzumab|trastuzumab|mesh-list
110537992|NCT00875979|Pertuzumab|pertuzumab|mesh-list
110537993|NCT00875979|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
110537994|NCT00875979|Maytansine|maytansine|mesh-list
110537995|NCT00875979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110537996|NCT00875979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110537997|NCT00875979|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110537998|NCT00875979|Tubulin Modulators|tubulin modulators|mesh-ancestor
110537999|NCT00875979|Antimitotic Agents|antimitotic agents|mesh-ancestor
110538000|NCT00875979|Mitosis Modulators|mitosis modulators|mesh-ancestor
110538001|NCT00875979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110538002|NCT00875979|Immunotoxins|immunotoxins|mesh-ancestor
110538003|NCT00875979|Immunoconjugates|immunoconjugates|mesh-ancestor
110538004|NCT00875979|Immunologic Factors|immunologic factors|mesh-ancestor
110538005|NCT00875979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110538006|NCT02818751|Escitalopram|escitalopram|mesh-list
110538007|NCT02818751|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110538008|NCT02818751|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110538009|NCT02818751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110538010|NCT02818751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110538011|NCT02818751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110538012|NCT02818751|Serotonin Agents|serotonin agents|mesh-ancestor
110538013|NCT02818751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110538014|NCT04238975|Vaccines|vaccines|mesh-list
110538015|NCT04238975|Immunologic Factors|immunologic factors|mesh-ancestor
110538016|NCT04238975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110538017|NCT00602420|Naproxen|naproxen|mesh-list
110538018|NCT00602420|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110538019|NCT00602420|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110538020|NCT00602420|Analgesics|analgesics|mesh-ancestor
110538021|NCT00602420|Sensory System Agents|sensory system agents|mesh-ancestor
110538022|NCT00602420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110538023|NCT00602420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110538024|NCT00602420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110538025|NCT00602420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110538026|NCT00602420|Gout Suppressants|gout suppressants|mesh-ancestor
110538027|NCT00602420|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110538028|NCT00602420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110538029|NCT00602420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110538030|NCT04635605|Methylene Blue|methylene blue|mesh-list
110538031|NCT04635605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110312365|NCT00294008|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110538032|NCT04635605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110538034|NCT02688374|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110538035|NCT02688374|Autonomic Agents|autonomic agents|mesh-ancestor
110538036|NCT02688374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110538037|NCT02688374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110538038|NCT02688374|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110538039|NCT02688374|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110176448|NCT04423367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110538040|NCT02688374|Cholinergic Agents|cholinergic agents|mesh-ancestor
110538041|NCT02688374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110343805|NCT06022614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110538042|NCT02688374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110538044|NCT02819375|Remifentanil|remifentanil|mesh-list
110538045|NCT02819375|Propofol|propofol|mesh-list
110538046|NCT02819375|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110538047|NCT02819375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110538048|NCT02819375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110538049|NCT02819375|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110538050|NCT02819375|Anesthetics, General|anesthetics, general|mesh-ancestor
110538051|NCT02819375|Anesthetics|anesthetics|mesh-ancestor
110538052|NCT02819375|Analgesics|analgesics|mesh-ancestor
110538053|NCT02819375|Sensory System Agents|sensory system agents|mesh-ancestor
110538054|NCT02819375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110538055|NCT02819375|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110538056|NCT02819375|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110538057|NCT02819375|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110538058|NCT02819375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110538059|NCT02819375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110538060|NCT02819375|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110538061|NCT02819375|Narcotics|narcotics|mesh-ancestor
110538062|NCT02818985|Dexamethasone|dexamethasone|mesh-list
110538063|NCT02818985|Dexmedetomidine|dexmedetomidine|mesh-list
110538064|NCT02818985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110538065|NCT02818985|Antiemetics|antiemetics|mesh-ancestor
110538066|NCT02818985|Autonomic Agents|autonomic agents|mesh-ancestor
110538067|NCT02818985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110538068|NCT02818985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110538069|NCT02818985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110538070|NCT02818985|Glucocorticoids|glucocorticoids|mesh-ancestor
110538071|NCT02818985|Hormones|hormones|mesh-ancestor
110538072|NCT02818985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110538073|NCT02818985|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110538074|NCT02818985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110538075|NCT02818985|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110538076|NCT02818985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110538077|NCT02818985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110538078|NCT02818985|Analgesics|analgesics|mesh-ancestor
110538079|NCT02818985|Sensory System Agents|sensory system agents|mesh-ancestor
110538080|NCT02818985|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110538081|NCT02818985|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110538082|NCT02818985|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110538083|NCT02818985|Adrenergic Agents|adrenergic agents|mesh-ancestor
110176459|NCT00080782|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110538084|NCT02818985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110538085|NCT02818985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110538087|NCT03362060|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110538088|NCT03362060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110538089|NCT03362060|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110538090|NCT03362060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110538091|NCT02815787|Glyburide|glyburide|mesh-list
110538092|NCT02815787|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110538093|NCT02815787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110538094|NCT00639938|Nevirapine|nevirapine|mesh-list
110538095|NCT00639938|Immunoglobulins|immunoglobulins|mesh-list
110538096|NCT00639938|Antibodies|antibodies|mesh-list
110538097|NCT00639938|gamma-Globulins|gamma-globulins|mesh-list
110538098|NCT00639938|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110538099|NCT00639938|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110538100|NCT00639938|Immunologic Factors|immunologic factors|mesh-ancestor
110538101|NCT00639938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110538102|NCT00639938|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110538103|NCT00639938|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110538104|NCT00639938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110538105|NCT00639938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110538106|NCT00639938|Antiviral Agents|antiviral agents|mesh-ancestor
110538107|NCT00639938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110538108|NCT00639938|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110538109|NCT00639938|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110538110|NCT00639938|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110538111|NCT00639938|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110538112|NCT02815319|Dexamethasone|dexamethasone|mesh-list
110538113|NCT02815319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110538114|NCT02815319|Antiemetics|antiemetics|mesh-ancestor
110538115|NCT02815319|Autonomic Agents|autonomic agents|mesh-ancestor
110538116|NCT02815319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110538117|NCT02815319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110538118|NCT02815319|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110538119|NCT02815319|Glucocorticoids|glucocorticoids|mesh-ancestor
110538120|NCT02815319|Hormones|hormones|mesh-ancestor
110538121|NCT02815319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110538122|NCT02815319|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110538123|NCT02815319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110538124|NCT02815475|Curcumin|curcumin|mesh-list
110538125|NCT02815475|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110538126|NCT02815475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110538127|NCT02815475|Analgesics|analgesics|mesh-ancestor
110538128|NCT02815475|Sensory System Agents|sensory system agents|mesh-ancestor
110538129|NCT02815475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110538130|NCT02815475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110538131|NCT02815475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110538132|NCT02815475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110538133|NCT02815475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110538134|NCT02815475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110538135|NCT02815475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110538136|NCT00640796|Aldesleukin|aldesleukin|mesh-list
110538137|NCT00640796|Cyclophosphamide|cyclophosphamide|mesh-list
110538138|NCT00640796|Fludarabine|fludarabine|mesh-list
110538139|NCT00640796|Interleukin-2|interleukin-2|mesh-list
110538140|NCT00640796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110538141|NCT00640796|Immunologic Factors|immunologic factors|mesh-ancestor
110538142|NCT00640796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110538143|NCT00640796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110538144|NCT00640796|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110538145|NCT00640796|Alkylating Agents|alkylating agents|mesh-ancestor
110538146|NCT00640796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110538147|NCT00640796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110538148|NCT00640796|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110538149|NCT00640796|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110538150|NCT00640796|Analgesics|analgesics|mesh-ancestor
110538151|NCT00640796|Sensory System Agents|sensory system agents|mesh-ancestor
110538152|NCT00640796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110538153|NCT00640796|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110538154|NCT00640796|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110538155|NCT00640796|Antiviral Agents|antiviral agents|mesh-ancestor
110538156|NCT00640796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110538157|NCT02687984|Risperidone|risperidone|mesh-list
110538158|NCT02687984|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110538159|NCT02687984|Serotonin Agents|serotonin agents|mesh-ancestor
110538160|NCT02687984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110538161|NCT02687984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110538162|NCT02687984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110538163|NCT02687984|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110538164|NCT02687984|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110538165|NCT02687984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110538166|NCT02687984|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110538167|NCT02687984|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110538169|NCT02683148|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
110538170|NCT02683148|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110538171|NCT02683148|Immunologic Factors|immunologic factors|mesh-ancestor
110538172|NCT02683148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110538173|NCT02684786|Lidocaine|lidocaine|mesh-list
110538174|NCT02684786|Reserpine|reserpine|mesh-list
110538175|NCT02684786|Anesthetics, Local|anesthetics, local|mesh-ancestor
110538176|NCT02684786|Anesthetics|anesthetics|mesh-ancestor
110538177|NCT02684786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110538178|NCT02684786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110300739|NCT00282594|Insulin|insulin|mesh-list
110538179|NCT02684786|Sensory System Agents|sensory system agents|mesh-ancestor
110538180|NCT02684786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110538181|NCT02684786|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110538182|NCT02684786|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110538183|NCT02684786|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110538184|NCT02684786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110538185|NCT02684786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110538186|NCT02684786|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110538187|NCT02684786|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110538188|NCT02684786|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110538189|NCT02684786|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110538190|NCT02684786|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110538191|NCT02684786|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110538192|NCT02684786|Adrenergic Agents|adrenergic agents|mesh-ancestor
110538193|NCT02684786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110538195|NCT02683070|Ropivacaine|ropivacaine|mesh-list
110538196|NCT02683070|Anesthetics, Local|anesthetics, local|mesh-ancestor
110538197|NCT02683070|Anesthetics|anesthetics|mesh-ancestor
110538198|NCT02683070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110538199|NCT02683070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110538200|NCT02683070|Sensory System Agents|sensory system agents|mesh-ancestor
110538201|NCT02683070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110538202|NCT02683070|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110538203|NCT02683070|Narcotics|narcotics|mesh-ancestor
110538204|NCT02683070|Analgesics|analgesics|mesh-ancestor
110538205|NCT02685176|Charcoal|charcoal|mesh-list
110538206|NCT02685176|Antidotes|antidotes|mesh-ancestor
110538207|NCT02685176|Protective Agents|protective agents|mesh-ancestor
110538208|NCT02685176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110538209|NCT05664074|Ketorolac|ketorolac|mesh-list
110538210|NCT05664074|Indomethacin|indomethacin|mesh-list
110538211|NCT05664074|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110538212|NCT05664074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110538213|NCT05664074|Analgesics|analgesics|mesh-ancestor
110538214|NCT05664074|Sensory System Agents|sensory system agents|mesh-ancestor
110538215|NCT05664074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110538216|NCT05664074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110538217|NCT05664074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110538218|NCT05664074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110538219|NCT05664074|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110538220|NCT05664074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110538221|NCT05664074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110538222|NCT05664074|Gout Suppressants|gout suppressants|mesh-ancestor
110538223|NCT05664074|Tocolytic Agents|tocolytic agents|mesh-ancestor
110538224|NCT05664074|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110538225|NCT00634205|Doxorubicin|doxorubicin|mesh-list
110538226|NCT00634205|Valproic Acid|valproic acid|mesh-list
110538227|NCT00634205|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110538228|NCT00634205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110538229|NCT00634205|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110538230|NCT00634205|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110538231|NCT00634205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110538232|NCT00634205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110538233|NCT00634205|Anticonvulsants|anticonvulsants|mesh-ancestor
110538234|NCT00634205|GABA Agents|gaba agents|mesh-ancestor
110538235|NCT00634205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110538236|NCT00634205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110538237|NCT00634205|Antimanic Agents|antimanic agents|mesh-ancestor
110538238|NCT00634205|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110538239|NCT00634205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110538241|NCT04238195|Moxifloxacin|moxifloxacin|mesh-list
110538242|NCT04238195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110538243|NCT04238195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110538244|NCT04238195|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110538245|NCT04238195|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110538246|NCT04238195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110538247|NCT04238195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110538248|NCT04238195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110538249|NCT02818049|Dimercaprol|dimercaprol|mesh-list
110538250|NCT02818049|Chelating Agents|chelating agents|mesh-ancestor
110538251|NCT02818049|Sequestering Agents|sequestering agents|mesh-ancestor
110538252|NCT02818049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110538254|NCT02684708|Cyclophosphamide|cyclophosphamide|mesh-list
110538255|NCT02684708|Dacarbazine|dacarbazine|mesh-list
110538256|NCT02684708|Vincristine|vincristine|mesh-list
110538257|NCT02684708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110538258|NCT02684708|Immunologic Factors|immunologic factors|mesh-ancestor
110538259|NCT02684708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110538260|NCT02684708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110538261|NCT02684708|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110538262|NCT02684708|Alkylating Agents|alkylating agents|mesh-ancestor
110538263|NCT02684708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110538264|NCT02684708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110538265|NCT02684708|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110538266|NCT02684708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110538267|NCT02684708|Glucocorticoids|glucocorticoids|mesh-ancestor
110538268|NCT02684708|Hormones|hormones|mesh-ancestor
110538269|NCT02684708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110538270|NCT02684708|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110538271|NCT02684708|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110538272|NCT02684708|Tubulin Modulators|tubulin modulators|mesh-ancestor
110538273|NCT02684708|Antimitotic Agents|antimitotic agents|mesh-ancestor
110538274|NCT02684708|Mitosis Modulators|mitosis modulators|mesh-ancestor
110538275|NCT02817503|Folic Acid|folic acid|mesh-list
110538276|NCT02817503|Vitamin B Complex|vitamin b complex|mesh-list
110538277|NCT02817503|Amlodipine|amlodipine|mesh-list
110538278|NCT02817503|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110538279|NCT02817503|Enalapril|enalapril|mesh-list
110538280|NCT02817503|Enalaprilat|enalaprilat|mesh-list
110538281|NCT02817503|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110538282|NCT02817503|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110195961|NCT00209014|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110176559|NCT00081796|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110538283|NCT02817503|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110538284|NCT02817503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110538285|NCT02817503|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110538286|NCT02817503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110538287|NCT02817503|Vasodilator Agents|vasodilator agents|mesh-ancestor
110538289|NCT02817503|Vitamins|vitamins|mesh-ancestor
110538290|NCT02817503|Micronutrients|micronutrients|mesh-ancestor
110538291|NCT02817503|Diuretics|diuretics|mesh-ancestor
110538292|NCT02817503|Natriuretic Agents|natriuretic agents|mesh-ancestor
110538293|NCT02817503|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110538294|NCT02817503|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110538295|NCT02817503|Protease Inhibitors|protease inhibitors|mesh-ancestor
110538296|NCT02817503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110538297|NCT02814461|Axitinib|axitinib|mesh-list
110538298|NCT02814461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110538299|NCT02814461|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110538300|NCT02814461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110538301|NCT02814461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110538302|NCT00875667|Fludarabine|fludarabine|mesh-list
110538303|NCT00875667|Fludarabine phosphate|fludarabine phosphate|mesh-list
110538304|NCT00875667|Lenalidomide|lenalidomide|mesh-list
110538305|NCT00875667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110538306|NCT00875667|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110538307|NCT00875667|Antimetabolites|antimetabolites|mesh-ancestor
110538308|NCT00875667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110538309|NCT00875667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110538310|NCT00875667|Immunologic Factors|immunologic factors|mesh-ancestor
110538311|NCT00875667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110538312|NCT00875667|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110538313|NCT00875667|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110538314|NCT00875667|Growth Substances|growth substances|mesh-ancestor
110538315|NCT00875667|Growth Inhibitors|growth inhibitors|mesh-ancestor
110538316|NCT02811185|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110538317|NCT02811185|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110538318|NCT02811185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110538320|NCT02811341|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
110538321|NCT02811341|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110538322|NCT02811341|Antiemetics|antiemetics|mesh-ancestor
110538323|NCT02811341|Autonomic Agents|autonomic agents|mesh-ancestor
110538324|NCT02811341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110538325|NCT02811341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110538326|NCT02811341|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110538327|NCT02811341|Mydriatics|mydriatics|mesh-ancestor
110538328|NCT02811341|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110538329|NCT02811341|Cholinergic Agents|cholinergic agents|mesh-ancestor
110538330|NCT02811341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110538331|NCT02811341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110538332|NCT02811341|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110538333|NCT02811341|Parasympatholytics|parasympatholytics|mesh-ancestor
110538334|NCT00682383|Docetaxel|docetaxel|mesh-list
110538335|NCT00682383|Etoposide|etoposide|mesh-list
110538336|NCT00682383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110538337|NCT00682383|Tubulin Modulators|tubulin modulators|mesh-ancestor
110538338|NCT00682383|Antimitotic Agents|antimitotic agents|mesh-ancestor
110538339|NCT00682383|Mitosis Modulators|mitosis modulators|mesh-ancestor
110538340|NCT00682383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110538341|NCT00682383|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110538342|NCT00682383|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110538343|NCT00682383|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110538344|NCT00682383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110538345|NCT04237493|Insulin|insulin|mesh-list
110538346|NCT04237493|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110538347|NCT04237493|Metformin|metformin|mesh-list
110538348|NCT04237493|Insulin Glargine|insulin glargine|mesh-list
110538349|NCT04237493|Glimepiride|glimepiride|mesh-list
110538350|NCT04237493|Vildagliptin|vildagliptin|mesh-list
110538351|NCT04237493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110538352|NCT04237493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110538353|NCT04237493|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110538354|NCT04237493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110538355|NCT04237493|Immunologic Factors|immunologic factors|mesh-ancestor
110538356|NCT04237493|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110538357|NCT04237493|Protease Inhibitors|protease inhibitors|mesh-ancestor
110538358|NCT04237493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110538359|NCT04237493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110538360|NCT00683319|Cyclophosphamide|cyclophosphamide|mesh-list
110538361|NCT00683319|Carboplatin|carboplatin|mesh-list
110538362|NCT00683319|Methotrexate|methotrexate|mesh-list
110538363|NCT00683319|Vincristine|vincristine|mesh-list
110538364|NCT00683319|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110538365|NCT00683319|Immunologic Factors|immunologic factors|mesh-ancestor
110538366|NCT00683319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110538367|NCT00683319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110538368|NCT00683319|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110538369|NCT00683319|Alkylating Agents|alkylating agents|mesh-ancestor
110538370|NCT00683319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110538371|NCT00683319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110538372|NCT00683319|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110538373|NCT00683319|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110538374|NCT00683319|Abortifacient Agents|abortifacient agents|mesh-ancestor
110538375|NCT00683319|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110538376|NCT00683319|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110538377|NCT00683319|Antimetabolites|antimetabolites|mesh-ancestor
110538378|NCT00683319|Dermatologic Agents|dermatologic agents|mesh-ancestor
110538379|NCT00683319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110538380|NCT00683319|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110538381|NCT00683319|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110538382|NCT00683319|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110538383|NCT00683319|Tubulin Modulators|tubulin modulators|mesh-ancestor
110538384|NCT00683319|Antimitotic Agents|antimitotic agents|mesh-ancestor
110538385|NCT00683319|Mitosis Modulators|mitosis modulators|mesh-ancestor
110538386|NCT00634361|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
110538387|NCT00634361|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110538388|NCT00634361|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110538389|NCT02810483|Topiramate|topiramate|mesh-list
110538390|NCT02810483|Anticonvulsants|anticonvulsants|mesh-ancestor
110538391|NCT02810483|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110538392|NCT02810483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110538393|NCT00683865|Moxifloxacin|moxifloxacin|mesh-list
110538394|NCT00683865|Ofloxacin|ofloxacin|mesh-list
110538395|NCT00683865|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
110538396|NCT00683865|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110538397|NCT00683865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110538398|NCT00683865|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110538399|NCT00683865|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110538400|NCT00683865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110538401|NCT00683865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110538402|NCT00683865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110538403|NCT00683865|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110538404|NCT00683865|Contraceptive Agents|contraceptive agents|mesh-ancestor
110538405|NCT00683865|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110538406|NCT00683865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110538407|NCT00683865|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110538408|NCT00683865|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110538409|NCT00683865|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110538410|NCT00683865|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110538411|NCT00683865|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110538412|NCT00683865|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110538413|NCT02813369|Naloxegol|naloxegol|mesh-list
110538414|NCT02813369|Laxatives|laxatives|mesh-list
110538415|NCT02813369|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110538416|NCT02813369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110538417|NCT02813369|Sensory System Agents|sensory system agents|mesh-ancestor
110538418|NCT02813369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110538419|NCT02813369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110538420|NCT00683943|Lithium Carbonate|lithium carbonate|mesh-list
110538421|NCT00683943|Antidepressive Agents|antidepressive agents|mesh-ancestor
110538422|NCT00683943|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110538423|NCT00683943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110538424|NCT00683943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110538425|NCT00683943|Antimanic Agents|antimanic agents|mesh-ancestor
110538426|NCT00683943|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110538427|NCT00683943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110538428|NCT00683943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110538429|NCT02810015|Botulinum Toxins|botulinum toxins|mesh-list
110538430|NCT02810015|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110538431|NCT02810015|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110538432|NCT02810015|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110538433|NCT02810015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110538434|NCT02810015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110538435|NCT02810015|Cholinergic Agents|cholinergic agents|mesh-ancestor
110538436|NCT02810015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110538437|NCT02810015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110538438|NCT02810015|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110538439|NCT02810015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110538440|NCT02809781|Etanercept|etanercept|mesh-list
110538441|NCT02809781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110538442|NCT02809781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110538443|NCT02809781|Analgesics|analgesics|mesh-ancestor
110538444|NCT02809781|Sensory System Agents|sensory system agents|mesh-ancestor
110538445|NCT02809781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110538446|NCT02809781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110538447|NCT02809781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110538448|NCT02809781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110538449|NCT02809781|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110538450|NCT02809781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110538451|NCT02809781|Immunologic Factors|immunologic factors|mesh-ancestor
110538452|NCT02809937|Dexmedetomidine|dexmedetomidine|mesh-list
110538453|NCT02809937|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110538454|NCT02809937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110176624|NCT00082225|Antibodies|antibodies|mesh-list
110538455|NCT02809937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110538456|NCT02809937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110538457|NCT02809937|Analgesics|analgesics|mesh-ancestor
110538458|NCT02809937|Sensory System Agents|sensory system agents|mesh-ancestor
110538459|NCT02809937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110538460|NCT02809937|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110538461|NCT02809937|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110538462|NCT02809937|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110538463|NCT02809937|Adrenergic Agents|adrenergic agents|mesh-ancestor
110538464|NCT02809937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110538465|NCT02809937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110185990|NCT00275015|Antiemetics|antiemetics|mesh-ancestor
110538467|NCT02812979|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110538468|NCT02812979|Autonomic Agents|autonomic agents|mesh-ancestor
110538469|NCT02812979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110538470|NCT02812979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110538471|NCT02812979|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110538472|NCT02812979|Respiratory System Agents|respiratory system agents|mesh-ancestor
110538473|NCT02812979|Tocolytic Agents|tocolytic agents|mesh-ancestor
110538474|NCT02812979|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110538475|NCT02812979|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110538476|NCT02812979|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110538477|NCT02812979|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110538478|NCT02812979|Adrenergic Agents|adrenergic agents|mesh-ancestor
110538479|NCT02812979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110538480|NCT02812979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110538481|NCT02809469|Apixaban|apixaban|mesh-list
110538482|NCT02809469|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110538483|NCT02809469|Antithrombins|antithrombins|mesh-ancestor
110538484|NCT02809469|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110538485|NCT02809469|Protease Inhibitors|protease inhibitors|mesh-ancestor
110538486|NCT02809469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110538487|NCT02809469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110538488|NCT02809469|Anticoagulants|anticoagulants|mesh-ancestor
110538489|NCT02809079|Mycophenolic Acid|mycophenolic acid|mesh-list
110538490|NCT02809079|Prednisone|prednisone|mesh-list
110538491|NCT02809079|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110538492|NCT02809079|Glucocorticoids|glucocorticoids|mesh-ancestor
110538493|NCT02809079|Hormones|hormones|mesh-ancestor
110538494|NCT02809079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110538495|NCT02809079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110538496|NCT02809079|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110538497|NCT02809079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110538498|NCT02809079|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110538499|NCT02809079|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110538500|NCT02809079|Antitubercular Agents|antitubercular agents|mesh-ancestor
110538501|NCT02809079|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110538502|NCT02809079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110300956|NCT00244127|Hormones|hormones|mesh-ancestor
110538503|NCT02809079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110538504|NCT02809079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110538505|NCT02812199|Lidocaine|lidocaine|mesh-list
110538506|NCT02812199|Epinephrine|epinephrine|mesh-list
110538507|NCT02812199|Racepinephrine|racepinephrine|mesh-list
110538508|NCT02812199|Epinephryl borate|epinephryl borate|mesh-list
110538509|NCT02812199|Anesthetics, Local|anesthetics, local|mesh-ancestor
110538510|NCT02812199|Anesthetics|anesthetics|mesh-ancestor
110538511|NCT02812199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110538512|NCT02812199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110538513|NCT02812199|Sensory System Agents|sensory system agents|mesh-ancestor
110538514|NCT02812199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110538515|NCT02812199|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110538516|NCT02812199|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110538517|NCT02812199|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110538518|NCT02812199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110176642|NCT00082576|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110176648|NCT00082966|Bortezomib|bortezomib|mesh-list
110538519|NCT02812199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110538520|NCT02812199|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110538522|NCT02812199|Adrenergic Agents|adrenergic agents|mesh-ancestor
110538523|NCT02812199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110538524|NCT02812199|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110538525|NCT02812199|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110538526|NCT02812199|Autonomic Agents|autonomic agents|mesh-ancestor
110538527|NCT02812199|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110538528|NCT02812199|Respiratory System Agents|respiratory system agents|mesh-ancestor
110538529|NCT02812199|Mydriatics|mydriatics|mesh-ancestor
110538530|NCT02812199|Sympathomimetics|sympathomimetics|mesh-ancestor
110538531|NCT02812199|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110538532|NCT02812043|Amorolfine|amorolfine|mesh-list
110538533|NCT02812043|Antifungal Agents|antifungal agents|mesh-ancestor
110538534|NCT02812043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110538535|NCT02808767|Ticagrelor|ticagrelor|mesh-list
110538536|NCT02808767|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
110538537|NCT02808767|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110538538|NCT02808767|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110186054|NCT00130325|Isoniazid|isoniazid|mesh-list
110538539|NCT02808767|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110538540|NCT02808767|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110538541|NCT02808767|Purinergic Agents|purinergic agents|mesh-ancestor
110538542|NCT02808767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110538543|NCT02808767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110538544|NCT02808767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110538546|NCT02812355|Anticoagulants|anticoagulants|mesh-ancestor
110538547|NCT02812355|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110538548|NCT02812355|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110538549|NCT02812355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110538550|NCT02811731|Amlodipine|amlodipine|mesh-list
110538551|NCT02811731|Candesartan|candesartan|mesh-list
110538552|NCT02811731|Candesartan cilexetil|candesartan cilexetil|mesh-list
110538553|NCT02811731|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110538554|NCT02811731|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110538555|NCT02811731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110538556|NCT02811731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110538557|NCT02811731|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110538558|NCT02811731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110538559|NCT02811731|Vasodilator Agents|vasodilator agents|mesh-ancestor
110538560|NCT02811731|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110538561|NCT02811731|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110538562|NCT02811809|Leuprolide|leuprolide|mesh-list
110538563|NCT02811809|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110538564|NCT02811809|Fertility Agents|fertility agents|mesh-ancestor
110538565|NCT02811809|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110538566|NCT02811809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110538567|NCT02811809|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110538568|NCT02811809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110538569|NCT05569421|Budesonide|budesonide|mesh-list
110538570|NCT05569421|Formoterol Fumarate|formoterol fumarate|mesh-list
110538571|NCT05569421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110538572|NCT05569421|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110538573|NCT05569421|Autonomic Agents|autonomic agents|mesh-ancestor
110538574|NCT05569421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110538575|NCT05569421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110538576|NCT05569421|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110538577|NCT05569421|Respiratory System Agents|respiratory system agents|mesh-ancestor
110538578|NCT05569421|Glucocorticoids|glucocorticoids|mesh-ancestor
110538579|NCT05569421|Hormones|hormones|mesh-ancestor
110538580|NCT05569421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110538581|NCT05569421|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110538582|NCT05569421|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110538583|NCT05569421|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110538584|NCT05569421|Adrenergic Agents|adrenergic agents|mesh-ancestor
110538585|NCT05569421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110538586|NCT05569421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110538587|NCT02808611|Propranolol|propranolol|mesh-list
110538588|NCT02808611|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110538589|NCT02808611|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110538590|NCT02808611|Adrenergic Agents|adrenergic agents|mesh-ancestor
110538591|NCT02808611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110538592|NCT02808611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110538593|NCT02808611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110538594|NCT02808611|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110538595|NCT02808611|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110538596|NCT02808611|Vasodilator Agents|vasodilator agents|mesh-ancestor
110538597|NCT02808533|Topiramate|topiramate|mesh-list
110538598|NCT02808533|Anticonvulsants|anticonvulsants|mesh-ancestor
110538599|NCT02808533|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110538600|NCT02808533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110538601|NCT02811497|Azacitidine|azacitidine|mesh-list
110538602|NCT02811497|Durvalumab|durvalumab|mesh-list
110538603|NCT02811497|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110538604|NCT02811497|Antimetabolites|antimetabolites|mesh-ancestor
110538605|NCT02811497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110538606|NCT02811497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110538607|NCT02811497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110538608|NCT02811497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110538609|NCT00634439|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
110538610|NCT00634439|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110538611|NCT00634439|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110186137|NCT00129233|Amlodipine|amlodipine|mesh-list
110538612|NCT00634439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110538613|NCT00634439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110538614|NCT00634439|Adrenergic Agents|adrenergic agents|mesh-ancestor
110538615|NCT00634439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110538616|NCT00634439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110538617|NCT02807909|Itraconazole|itraconazole|mesh-list
110538618|NCT02807909|Diltiazem|diltiazem|mesh-list
110538619|NCT02807909|Antifungal Agents|antifungal agents|mesh-ancestor
110538620|NCT02807909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110538621|NCT02807909|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110538622|NCT02807909|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110538623|NCT02807909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110538624|NCT02807909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110538625|NCT02807909|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110538627|NCT02807909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110538628|NCT02807909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110538629|NCT02807909|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110538630|NCT02807909|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110538631|NCT02807909|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110538632|NCT02807909|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110538633|NCT02807909|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110538634|NCT02807909|Vasodilator Agents|vasodilator agents|mesh-ancestor
110538635|NCT02808065|Mycophenolic Acid|mycophenolic acid|mesh-list
110538636|NCT02808065|Tacrolimus|tacrolimus|mesh-list
110538637|NCT02808065|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110538638|NCT02808065|Immunologic Factors|immunologic factors|mesh-ancestor
110538639|NCT02808065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110538640|NCT02808065|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110538641|NCT02808065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110538642|NCT02808065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110538643|NCT02808065|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110538644|NCT02808065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110538645|NCT02808065|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110538646|NCT02808065|Antitubercular Agents|antitubercular agents|mesh-ancestor
110538647|NCT02808065|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110538648|NCT02808065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110538649|NCT00602030|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110538650|NCT00602030|Entinostat|entinostat|mesh-list
110538651|NCT00602030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110538652|NCT00602030|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110538653|NCT00602030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110538654|NCT00602030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110538655|NCT00602030|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110538657|NCT02804711|Immunologic Factors|immunologic factors|mesh-ancestor
110538658|NCT02804711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110538659|NCT00640094|Melatonin|melatonin|mesh-list
110538660|NCT00640094|Antioxidants|antioxidants|mesh-ancestor
110538661|NCT00640094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110538662|NCT00640094|Protective Agents|protective agents|mesh-ancestor
110538663|NCT00640094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110538664|NCT00640094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110538665|NCT04183634|Rotigotine|rotigotine|mesh-list
110538666|NCT04183634|Dopamine Agonists|dopamine agonists|mesh-ancestor
110538667|NCT04183634|Dopamine Agents|dopamine agents|mesh-ancestor
110538668|NCT04183634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110538669|NCT04183634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110538670|NCT04183634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110538671|NCT02804633|Acetaminophen|acetaminophen|mesh-list
110538672|NCT02804633|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110538673|NCT02804633|Analgesics|analgesics|mesh-ancestor
110538674|NCT02804633|Sensory System Agents|sensory system agents|mesh-ancestor
110538675|NCT02804633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110538676|NCT02804633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110538677|NCT02804633|Antipyretics|antipyretics|mesh-ancestor
110538678|NCT02807441|Aspirin|aspirin|mesh-list
110538679|NCT02807441|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110538680|NCT02807441|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110538681|NCT02807441|Analgesics|analgesics|mesh-ancestor
110538682|NCT02807441|Sensory System Agents|sensory system agents|mesh-ancestor
110538683|NCT02807441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110186205|NCT00470223|Etoposide|etoposide|mesh-list
110538684|NCT02807441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110538685|NCT02807441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110538686|NCT02807441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110538687|NCT02807441|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110538688|NCT02807441|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110538689|NCT02807441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110538690|NCT02807441|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110538691|NCT02807441|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110538692|NCT02807441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110538693|NCT02807441|Antipyretics|antipyretics|mesh-ancestor
110538694|NCT02807285|Ocrelizumab|ocrelizumab|mesh-list
110538695|NCT02807285|Immunologic Factors|immunologic factors|mesh-ancestor
110538697|NCT02682680|Ezetimibe|ezetimibe|mesh-list
110538698|NCT02682680|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
110538699|NCT02682680|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110538700|NCT02682680|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110538701|NCT02682680|Antimetabolites|antimetabolites|mesh-ancestor
110538702|NCT02682680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110538703|NCT02682680|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110538704|NCT02682758|Xenon|xenon|mesh-list
110538705|NCT02682758|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110538706|NCT02682758|Anesthetics, General|anesthetics, general|mesh-ancestor
110538707|NCT02682758|Anesthetics|anesthetics|mesh-ancestor
110538708|NCT02682758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110538709|NCT02682758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110538710|NCT02682524|Aceclofenac|aceclofenac|mesh-list
110538711|NCT02682524|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110538712|NCT02682524|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110538713|NCT02682524|Analgesics|analgesics|mesh-ancestor
110538714|NCT02682524|Sensory System Agents|sensory system agents|mesh-ancestor
110538715|NCT02682524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110538716|NCT02682524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110301009|NCT00244361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110538717|NCT02682524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110538718|NCT02682524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110538719|NCT04183556|Naproxen|naproxen|mesh-list
110538720|NCT04183556|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
110538721|NCT04183556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
110538722|NCT04183556|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110538724|NCT04183556|Sensory System Agents|sensory system agents|mesh-ancestor
110538725|NCT04183556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110538726|NCT04183556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110538727|NCT04183556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110538728|NCT04183556|Gout Suppressants|gout suppressants|mesh-ancestor
110538729|NCT04183556|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110538730|NCT04183556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110538731|NCT04183556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110538732|NCT00640952|Acamprosate|acamprosate|mesh-list
110538733|NCT00640952|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110538734|NCT02684240|Nitazoxanide|nitazoxanide|mesh-list
110538735|NCT02684240|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110538736|NCT02684240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110538737|NCT02807051|Clarithromycin|clarithromycin|mesh-list
110538738|NCT02807051|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110538739|NCT02807051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110538740|NCT02807051|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110538741|NCT02807051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110538742|NCT02807051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110538743|NCT02807051|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110538744|NCT02807051|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110538745|NCT02684084|Dexamethasone|dexamethasone|mesh-list
110538746|NCT02684084|Ranibizumab|ranibizumab|mesh-list
110538747|NCT02684084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110538748|NCT02684084|Antiemetics|antiemetics|mesh-ancestor
110538749|NCT02684084|Autonomic Agents|autonomic agents|mesh-ancestor
110538750|NCT02684084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110538751|NCT02684084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110538752|NCT02684084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110538753|NCT02684084|Glucocorticoids|glucocorticoids|mesh-ancestor
110538754|NCT02684084|Hormones|hormones|mesh-ancestor
110538755|NCT02684084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110538756|NCT02684084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110538757|NCT02684084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110538758|NCT02684084|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110538759|NCT02684084|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110538760|NCT02684084|Growth Substances|growth substances|mesh-ancestor
110538761|NCT02684084|Growth Inhibitors|growth inhibitors|mesh-ancestor
110538762|NCT02684318|Olaparib|olaparib|mesh-list
110538763|NCT02684318|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110538764|NCT02684318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110538765|NCT02684318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110538766|NCT02684318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110538767|NCT02806817|Bevacizumab|bevacizumab|mesh-list
110538768|NCT02806817|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110538769|NCT02806817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110538770|NCT02806817|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110538771|NCT02806817|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110538772|NCT02806817|Growth Substances|growth substances|mesh-ancestor
110538773|NCT02806817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110538774|NCT02806817|Growth Inhibitors|growth inhibitors|mesh-ancestor
110538775|NCT04182854|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110538776|NCT04182854|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110538777|NCT04182854|Diuretics|diuretics|mesh-ancestor
110538778|NCT04182854|Natriuretic Agents|natriuretic agents|mesh-ancestor
110538779|NCT04182854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110538780|NCT04182854|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110538781|NCT04182854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110538782|NCT04182854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110538784|NCT02680808|Midazolam|midazolam|mesh-list
110538785|NCT02680808|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110538786|NCT02680808|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110538787|NCT02680808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110538788|NCT02680808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110538789|NCT02680808|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110538790|NCT02680808|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110538791|NCT02680808|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110538792|NCT02680808|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110538793|NCT02680808|Anesthetics, General|anesthetics, general|mesh-ancestor
110538794|NCT02680808|Anesthetics|anesthetics|mesh-ancestor
110538795|NCT02680808|GABA Modulators|gaba modulators|mesh-ancestor
110538796|NCT02680808|GABA Agents|gaba agents|mesh-ancestor
110538797|NCT02680808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110538798|NCT02680808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110538799|NCT02680808|Antifungal Agents|antifungal agents|mesh-ancestor
110538800|NCT02680808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110538801|NCT05663684|Proxymetacaine|proxymetacaine|mesh-list
110538802|NCT05663684|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110538803|NCT05663684|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110538804|NCT05663684|Anesthetics, Local|anesthetics, local|mesh-ancestor
110301055|NCT00417183|Ganirelix|ganirelix|mesh-list
110538805|NCT05663684|Anesthetics|anesthetics|mesh-ancestor
110538806|NCT05663684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110538807|NCT05663684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110538808|NCT05663684|Sensory System Agents|sensory system agents|mesh-ancestor
110538809|NCT05663684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110538810|NCT04004819|Rituximab|rituximab|mesh-list
110538811|NCT04004819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110538812|NCT04004819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110538813|NCT04004819|Immunologic Factors|immunologic factors|mesh-ancestor
110538814|NCT04004819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110538815|NCT04004819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110538816|NCT00641654|Interferons|interferons|mesh-list
110538817|NCT00641654|Ribavirin|ribavirin|mesh-list
110538818|NCT00641654|Interferon-alpha|interferon-alpha|mesh-list
110538819|NCT00641654|Interferon alpha-2|interferon alpha-2|mesh-list
110538820|NCT00641654|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110538821|NCT00641654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110538822|NCT00641654|Antiviral Agents|antiviral agents|mesh-ancestor
110538823|NCT00641654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110538824|NCT00641654|Antimetabolites|antimetabolites|mesh-ancestor
110538825|NCT00641654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110538826|NCT00641654|Immunologic Factors|immunologic factors|mesh-ancestor
110538827|NCT00641654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110538828|NCT02826434|Durvalumab|durvalumab|mesh-list
110538829|NCT02826434|Poly ICLC|poly iclc|mesh-list
110538830|NCT02826434|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110538831|NCT02826434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110538832|NCT02826434|Interferon Inducers|interferon inducers|mesh-ancestor
110538833|NCT02826434|Immunologic Factors|immunologic factors|mesh-ancestor
110538834|NCT02826434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110538835|NCT00549601|Rivastigmine|rivastigmine|mesh-list
110538836|NCT00549601|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110538837|NCT00549601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110176683|NCT00083083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110538838|NCT00549601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110538839|NCT00549601|Cholinergic Agents|cholinergic agents|mesh-ancestor
110538840|NCT00549601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110538841|NCT00549601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110538842|NCT00549601|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110538843|NCT00549601|Protective Agents|protective agents|mesh-ancestor
110538844|NCT02806349|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
110538845|NCT02806349|Cathartics|cathartics|mesh-ancestor
110538846|NCT02806349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110538848|NCT04184492|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110538849|NCT04184492|Insulin Aspart|insulin aspart|mesh-list
110538850|NCT04184492|Insulin, Long-Acting|insulin, long-acting|mesh-list
110538851|NCT04184492|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
110538852|NCT04184492|Biphasic Insulins|biphasic insulins|mesh-list
110538853|NCT04184492|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
110538854|NCT04184492|Insulin, Isophane|insulin, isophane|mesh-list
110538855|NCT04184492|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110538856|NCT04184492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110538857|NCT02806115|Acetic Acid|acetic acid|mesh-list
110538858|NCT02806115|Retinol acetate|retinol acetate|mesh-list
110538859|NCT02806115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110538860|NCT02806115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110538861|NCT02806115|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110538862|NCT02806115|Immunologic Factors|immunologic factors|mesh-ancestor
110538863|NCT02806115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110538864|NCT02806115|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110538865|NCT02806115|Protective Agents|protective agents|mesh-ancestor
110538866|NCT02806115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110538867|NCT02682134|Dexamethasone|dexamethasone|mesh-list
110538868|NCT02682134|Dexamethasone acetate|dexamethasone acetate|mesh-list
110538870|NCT02682134|BB 1101|bb 1101|mesh-list
110538871|NCT02682134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110538872|NCT02682134|Antiemetics|antiemetics|mesh-ancestor
110538873|NCT02682134|Autonomic Agents|autonomic agents|mesh-ancestor
110538874|NCT02682134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110538875|NCT02682134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110538876|NCT02682134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110538877|NCT02682134|Glucocorticoids|glucocorticoids|mesh-ancestor
110538878|NCT02682134|Hormones|hormones|mesh-ancestor
110538879|NCT02682134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110538880|NCT02682134|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110538881|NCT02682134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110538882|NCT02682134|Protease Inhibitors|protease inhibitors|mesh-ancestor
110538883|NCT02682134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110538884|NCT02682134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110538885|NCT02682134|Anesthetics, Local|anesthetics, local|mesh-ancestor
110538886|NCT02682134|Anesthetics|anesthetics|mesh-ancestor
110538887|NCT02682134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110538888|NCT02682134|Sensory System Agents|sensory system agents|mesh-ancestor
110538889|NCT02682134|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110538890|NCT02682134|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110538891|NCT02682134|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110538892|NCT02682134|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110538893|NCT04236323|Remifentanil|remifentanil|mesh-list
110538894|NCT04236323|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110538895|NCT04236323|Narcotics|narcotics|mesh-ancestor
110538896|NCT04236323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110538897|NCT04236323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110538898|NCT04236323|Analgesics|analgesics|mesh-ancestor
110538899|NCT04236323|Sensory System Agents|sensory system agents|mesh-ancestor
110538900|NCT04236323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110538901|NCT04206163|Edotreotide|edotreotide|mesh-list
110538902|NCT04206163|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110538903|NCT04206163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110538904|NCT00909974|Micronutrients|micronutrients|mesh-list
110538905|NCT00909974|Trace Elements|trace elements|mesh-list
110538906|NCT00909974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110538907|NCT05300347|Adenosine|adenosine|mesh-list
110538908|NCT05300347|Analgesics|analgesics|mesh-ancestor
110538909|NCT05300347|Sensory System Agents|sensory system agents|mesh-ancestor
110186428|NCT05744674|Sensory System Agents|sensory system agents|mesh-ancestor
110538910|NCT05300347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110538911|NCT05300347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110538912|NCT05300347|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110538913|NCT05300347|Vasodilator Agents|vasodilator agents|mesh-ancestor
110538914|NCT05300347|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
110538915|NCT05300347|Purinergic Agonists|purinergic agonists|mesh-ancestor
110538916|NCT05300347|Purinergic Agents|purinergic agents|mesh-ancestor
110538917|NCT05300347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110538918|NCT05300347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110538920|NCT04011241|Antifungal Agents|antifungal agents|mesh-ancestor
110538921|NCT04011241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110538922|NCT04011241|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110538923|NCT04011241|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110538924|NCT04011241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110538925|NCT04011241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110538926|NCT04011241|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110538928|NCT04011241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110538929|NCT04011241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110538930|NCT04011241|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110538931|NCT00956059|Prednisone|prednisone|mesh-list
110538932|NCT00956059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110538933|NCT00956059|Glucocorticoids|glucocorticoids|mesh-ancestor
110538934|NCT00956059|Hormones|hormones|mesh-ancestor
110538935|NCT00956059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110538936|NCT00956059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110538937|NCT00956059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110538938|NCT00956059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110538939|NCT04010929|Pemetrexed|pemetrexed|mesh-list
110538940|NCT04010929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110538941|NCT04010929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110538942|NCT04010929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110538943|NCT04010929|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110538944|NCT04010929|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110538945|NCT00956215|Aprepitant|aprepitant|mesh-list
110538946|NCT00956215|Fosaprepitant|fosaprepitant|mesh-list
110538947|NCT00956215|Antiemetics|antiemetics|mesh-ancestor
110538948|NCT00956215|Autonomic Agents|autonomic agents|mesh-ancestor
110538949|NCT00956215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110538950|NCT00956215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110538951|NCT00956215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110538952|NCT00956215|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110538953|NCT00956215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110538954|NCT00956215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110538955|NCT00640640|Bevacizumab|bevacizumab|mesh-list
110538956|NCT00640640|Ranibizumab|ranibizumab|mesh-list
110538957|NCT00640640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110538958|NCT00640640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110538959|NCT00640640|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110538960|NCT00640640|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110538961|NCT00640640|Growth Substances|growth substances|mesh-ancestor
110538962|NCT00640640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110538963|NCT00640640|Growth Inhibitors|growth inhibitors|mesh-ancestor
110538964|NCT03973177|Phenol|phenol|mesh-list
110538965|NCT03973177|Methylprednisolone|methylprednisolone|mesh-list
110538966|NCT03973177|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110538967|NCT03973177|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110538968|NCT03973177|Prednisolone|prednisolone|mesh-list
110538969|NCT03973177|Prednisolone acetate|prednisolone acetate|mesh-list
110176703|NCT03151863|Narcotics|narcotics|mesh-ancestor
110538971|NCT03973177|Prednisolone phosphate|prednisolone phosphate|mesh-list
110538972|NCT03973177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110538973|NCT03973177|Antiemetics|antiemetics|mesh-ancestor
110538974|NCT03973177|Autonomic Agents|autonomic agents|mesh-ancestor
110538975|NCT03973177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110538976|NCT03973177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110538977|NCT03973177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110538978|NCT03973177|Glucocorticoids|glucocorticoids|mesh-ancestor
110538979|NCT03973177|Hormones|hormones|mesh-ancestor
110538980|NCT03973177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110538981|NCT03973177|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110538982|NCT03973177|Protective Agents|protective agents|mesh-ancestor
110538983|NCT03973177|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110538984|NCT03973177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110538985|NCT03973177|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110538986|NCT03973177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110538988|NCT03973177|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
110538989|NCT03973177|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110538990|NCT03951493|Zoledronic Acid|zoledronic acid|mesh-list
110538991|NCT03951493|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110538992|NCT03951493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110538993|NCT00961909|Metformin|metformin|mesh-list
110538994|NCT00961909|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110538995|NCT00961909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110538996|NCT04115189|Sunitinib|sunitinib|mesh-list
110538997|NCT04115189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110538998|NCT04115189|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110538999|NCT04115189|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110539000|NCT04115189|Growth Substances|growth substances|mesh-ancestor
110539001|NCT04115189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110539002|NCT04115189|Growth Inhibitors|growth inhibitors|mesh-ancestor
110539003|NCT04115189|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110539004|NCT04115189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110539005|NCT04115189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110539006|NCT03940729|Chlorhexidine|chlorhexidine|mesh-list
110539007|NCT03940729|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110539008|NCT03940729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110539009|NCT03940729|Disinfectants|disinfectants|mesh-ancestor
110539010|NCT02678234|Acetaminophen|acetaminophen|mesh-list
110539011|NCT02678234|Phenylephrine|phenylephrine|mesh-list
110539012|NCT02678234|Oxymetazoline|oxymetazoline|mesh-list
110539013|NCT02678234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110539014|NCT02678234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110539015|NCT02678234|Analgesics|analgesics|mesh-ancestor
110539016|NCT02678234|Sensory System Agents|sensory system agents|mesh-ancestor
110539017|NCT02678234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110539018|NCT02678234|Antipyretics|antipyretics|mesh-ancestor
110539019|NCT02678234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110539020|NCT02678234|Protective Agents|protective agents|mesh-ancestor
110539021|NCT02678234|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110539022|NCT02678234|Mydriatics|mydriatics|mesh-ancestor
110539023|NCT02678234|Autonomic Agents|autonomic agents|mesh-ancestor
110539024|NCT02678234|Sympathomimetics|sympathomimetics|mesh-ancestor
110539025|NCT02678234|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110539026|NCT02678234|Nasal Decongestants|nasal decongestants|mesh-ancestor
110539027|NCT02678234|Respiratory System Agents|respiratory system agents|mesh-ancestor
110539028|NCT02678234|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110539029|NCT02678234|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110539030|NCT02678234|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110539031|NCT02678234|Adrenergic Agents|adrenergic agents|mesh-ancestor
110539032|NCT02678234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110539033|NCT00601640|Eflornithine|eflornithine|mesh-list
110539034|NCT00601640|Diclofenac|diclofenac|mesh-list
110539035|NCT00601640|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110539036|NCT00601640|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110539037|NCT00601640|Analgesics|analgesics|mesh-ancestor
110539038|NCT00601640|Sensory System Agents|sensory system agents|mesh-ancestor
110539039|NCT00601640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110539040|NCT00601640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110539041|NCT00601640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110539042|NCT00601640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110539043|NCT00601640|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110539044|NCT00601640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110539045|NCT00601640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110539046|NCT00601640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110539047|NCT00601640|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
110539048|NCT00601640|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110539049|NCT00601640|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110539050|NCT00601640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110301126|NCT00274131|Dopamine Agents|dopamine agents|mesh-ancestor
110539051|NCT00601640|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
110539052|NCT02805725|Cyclophosphamide|cyclophosphamide|mesh-list
110539053|NCT02805725|Trabectedin|trabectedin|mesh-list
110539054|NCT02805725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110539055|NCT02805725|Immunologic Factors|immunologic factors|mesh-ancestor
110539056|NCT02805725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110539057|NCT02805725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110539058|NCT02805725|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110539059|NCT02805725|Alkylating Agents|alkylating agents|mesh-ancestor
110539060|NCT02805725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110539061|NCT02805725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110539062|NCT02805725|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110539064|NCT03549715|Tremelimumab|tremelimumab|mesh-list
110312376|NCT00325689|Risperidone|risperidone|mesh-list
110539065|NCT03549715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110539066|NCT03549715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110539067|NCT02803385|Analgesics, Opioid|analgesics, opioid|mesh-list
110539068|NCT02803385|Anesthetics|anesthetics|mesh-list
110539069|NCT02803385|Anesthetics, Local|anesthetics, local|mesh-list
110539070|NCT02803385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110539071|NCT02803385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110539072|NCT02803385|Narcotics|narcotics|mesh-ancestor
110539073|NCT02803385|Analgesics|analgesics|mesh-ancestor
110539074|NCT02803385|Sensory System Agents|sensory system agents|mesh-ancestor
110539075|NCT02803385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110539076|NCT00958321|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110539077|NCT00958321|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110539078|NCT00958321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110539079|NCT00642434|Metoprolol|metoprolol|mesh-list
110539080|NCT00642434|Carvedilol|carvedilol|mesh-list
110539081|NCT00642434|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110539082|NCT00642434|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110539083|NCT00642434|Sympatholytics|sympatholytics|mesh-ancestor
110539084|NCT00642434|Autonomic Agents|autonomic agents|mesh-ancestor
110539085|NCT00642434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110539086|NCT00642434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110539087|NCT00642434|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110539088|NCT00642434|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110539089|NCT00642434|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110539090|NCT00642434|Adrenergic Agents|adrenergic agents|mesh-ancestor
110539091|NCT00642434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110539092|NCT00642434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110539093|NCT00642434|Antioxidants|antioxidants|mesh-ancestor
110539094|NCT00642434|Protective Agents|protective agents|mesh-ancestor
110539095|NCT00642434|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110539096|NCT00642434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110539097|NCT00642434|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110539098|NCT00642434|Vasodilator Agents|vasodilator agents|mesh-ancestor
110539099|NCT00642434|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110539100|NCT00642434|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110539101|NCT05352373|Calcium|calcium|mesh-list
110539102|NCT05352373|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110539103|NCT05352373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110539104|NCT02677532|Acetaminophen|acetaminophen|mesh-list
110539105|NCT02677532|Sufentanil|sufentanil|mesh-list
110539106|NCT02677532|Morphine|morphine|mesh-list
110539107|NCT02677532|Dsuvia|dsuvia|mesh-list
110539108|NCT02677532|Levobupivacaine|levobupivacaine|mesh-list
110539109|NCT02677532|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110539110|NCT02677532|Narcotics|narcotics|mesh-ancestor
110539111|NCT02677532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110176718|NCT00083161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110539113|NCT02677532|Analgesics|analgesics|mesh-ancestor
110539114|NCT02677532|Sensory System Agents|sensory system agents|mesh-ancestor
110539115|NCT02677532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110539116|NCT02677532|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110539117|NCT02677532|Antipyretics|antipyretics|mesh-ancestor
110539118|NCT02677532|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110539119|NCT02677532|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110539120|NCT02677532|Anesthetics, General|anesthetics, general|mesh-ancestor
110539121|NCT02677532|Anesthetics|anesthetics|mesh-ancestor
110539122|NCT02677532|Anesthetics, Local|anesthetics, local|mesh-ancestor
110539123|NCT00641810|Caffeine|caffeine|mesh-list
110539124|NCT00641810|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110539125|NCT00641810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110539126|NCT00641810|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110539127|NCT00641810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110301193|NCT00245141|Dactinomycin|dactinomycin|mesh-list
110539128|NCT00641810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110539129|NCT00641810|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110539130|NCT00641810|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110539131|NCT00641810|Purinergic Agents|purinergic agents|mesh-ancestor
110539132|NCT00641810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110539133|NCT02802995|Thrombin|thrombin|mesh-list
110539134|NCT02802995|Hemostatics|hemostatics|mesh-ancestor
110539135|NCT02802995|Coagulants|coagulants|mesh-ancestor
110539136|NCT00910052|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
110539137|NCT00910052|Hemostatics|hemostatics|mesh-ancestor
110539138|NCT00910052|Coagulants|coagulants|mesh-ancestor
110539139|NCT02677376|Listerine|listerine|mesh-list
110539140|NCT02677376|Fluorides|fluorides|mesh-list
110539141|NCT02677376|Sodium Fluoride|sodium fluoride|mesh-list
110539142|NCT02677376|Cariostatic Agents|cariostatic agents|mesh-ancestor
110539143|NCT02677376|Protective Agents|protective agents|mesh-ancestor
110539144|NCT02677376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110539145|NCT02677376|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110539146|NCT02677376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110539147|NCT02800889|Pixantrone|pixantrone|mesh-list
110539148|NCT02800889|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110539149|NCT02800889|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110539150|NCT02800889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110539151|NCT02800889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110539152|NCT02800889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110539153|NCT02803073|Methyltestosterone|methyltestosterone|mesh-list
110539154|NCT02803073|Testosterone|testosterone|mesh-list
110539155|NCT02803073|Testosterone undecanoate|testosterone undecanoate|mesh-list
110539156|NCT02803073|Testosterone enanthate|testosterone enanthate|mesh-list
110539157|NCT02803073|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
110539158|NCT02803073|Androgens|androgens|mesh-ancestor
110539159|NCT02803073|Hormones|hormones|mesh-ancestor
110539160|NCT02803073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110539161|NCT02803073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110539162|NCT02803073|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110539163|NCT02803073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110539164|NCT02803073|Anabolic Agents|anabolic agents|mesh-ancestor
110539165|NCT00922532|Nitric Oxide|nitric oxide|mesh-list
110539166|NCT00922532|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110539167|NCT00922532|Autonomic Agents|autonomic agents|mesh-ancestor
110301230|NCT02961803|Biotin|biotin|mesh-list
110539168|NCT00922532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110539169|NCT00922532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110539170|NCT00922532|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110539171|NCT00922532|Respiratory System Agents|respiratory system agents|mesh-ancestor
110539172|NCT00922532|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110539173|NCT00922532|Antioxidants|antioxidants|mesh-ancestor
110539174|NCT00922532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110539175|NCT00922532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110539176|NCT00922532|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
110539177|NCT00922532|Vasodilator Agents|vasodilator agents|mesh-ancestor
110539178|NCT00922532|Gasotransmitters|gasotransmitters|mesh-ancestor
110539179|NCT00922532|Protective Agents|protective agents|mesh-ancestor
110539180|NCT05662904|Gemtuzumab|gemtuzumab|mesh-list
110539181|NCT05662904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110539182|NCT05662904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110539184|NCT05662904|Immunoconjugates|immunoconjugates|mesh-ancestor
110539185|NCT05662904|Immunologic Factors|immunologic factors|mesh-ancestor
110539186|NCT05662904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110539188|NCT00642512|Ondansetron|ondansetron|mesh-list
110539189|NCT00642512|Antiemetics|antiemetics|mesh-ancestor
110539190|NCT00642512|Autonomic Agents|autonomic agents|mesh-ancestor
110539191|NCT00642512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110539192|NCT00642512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110539193|NCT00642512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110539194|NCT00642512|Antipruritics|antipruritics|mesh-ancestor
110539195|NCT00642512|Dermatologic Agents|dermatologic agents|mesh-ancestor
110539196|NCT00642512|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110539197|NCT00642512|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110539198|NCT00642512|Serotonin Agents|serotonin agents|mesh-ancestor
110539199|NCT00642512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110539200|NCT00642512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110539201|NCT00642512|Hallucinogens|hallucinogens|mesh-ancestor
110539202|NCT00642512|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110539203|NCT00642512|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110539204|NCT00642512|Analgesics|analgesics|mesh-ancestor
110539205|NCT00642512|Sensory System Agents|sensory system agents|mesh-ancestor
110539206|NCT00642512|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
110539207|NCT00642512|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110539208|NCT00642512|Hormones|hormones|mesh-ancestor
110539209|NCT00642512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110539210|NCT02802683|Phenylephrine|phenylephrine|mesh-list
110539211|NCT02802683|Oxymetazoline|oxymetazoline|mesh-list
110539212|NCT02802683|Bupivacaine|bupivacaine|mesh-list
110539214|NCT02802683|Anesthetics, Local|anesthetics, local|mesh-ancestor
110539215|NCT02802683|Anesthetics|anesthetics|mesh-ancestor
110539216|NCT02802683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110539217|NCT02802683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110539218|NCT02802683|Sensory System Agents|sensory system agents|mesh-ancestor
110539219|NCT02802683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110539220|NCT02802683|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110539221|NCT02802683|Mydriatics|mydriatics|mesh-ancestor
110539222|NCT02802683|Autonomic Agents|autonomic agents|mesh-ancestor
110539223|NCT02802683|Sympathomimetics|sympathomimetics|mesh-ancestor
110539224|NCT02802683|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110539225|NCT02802683|Nasal Decongestants|nasal decongestants|mesh-ancestor
110539226|NCT02802683|Respiratory System Agents|respiratory system agents|mesh-ancestor
110539227|NCT02802683|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110539228|NCT02802683|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110539229|NCT02802683|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110539230|NCT02802683|Adrenergic Agents|adrenergic agents|mesh-ancestor
110539231|NCT02802683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110539232|NCT02802683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110539233|NCT02802683|Protective Agents|protective agents|mesh-ancestor
110539234|NCT00641264|Omeprazole|omeprazole|mesh-list
110539235|NCT00641264|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110539236|NCT00641264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110539237|NCT00641264|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110539238|NCT00641264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110539239|NCT00641264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110539240|NCT05484167|Methyltestosterone|methyltestosterone|mesh-list
110539241|NCT05484167|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
110539242|NCT05484167|Testosterone|testosterone|mesh-list
110539243|NCT05484167|Testosterone undecanoate|testosterone undecanoate|mesh-list
110539244|NCT05484167|Testosterone enanthate|testosterone enanthate|mesh-list
110539245|NCT05484167|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110539246|NCT05484167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110539247|NCT05484167|Anabolic Agents|anabolic agents|mesh-ancestor
110539248|NCT05484167|Hormones|hormones|mesh-ancestor
110539249|NCT05484167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110539250|NCT05484167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110539251|NCT05484167|Androgens|androgens|mesh-ancestor
110343806|NCT06022614|Analgesics|analgesics|mesh-ancestor
110539252|NCT04183322|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110539253|NCT04183322|Immunologic Factors|immunologic factors|mesh-ancestor
110539254|NCT04183322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110539255|NCT04180982|Febuxostat|febuxostat|mesh-list
110539256|NCT04180982|Gout Suppressants|gout suppressants|mesh-ancestor
110539257|NCT04180982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110539258|NCT02802605|Bemiparin|bemiparin|mesh-list
110539259|NCT02802605|Anticoagulants|anticoagulants|mesh-ancestor
110539260|NCT02800265|Sulforaphane|sulforaphane|mesh-list
110539261|NCT02800265|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110539262|NCT02800265|Protective Agents|protective agents|mesh-ancestor
110539263|NCT02800265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110539264|NCT02800265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110539265|NCT02676986|Exemestane|exemestane|mesh-list
110539266|NCT02676986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110539267|NCT02676986|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110539268|NCT02676986|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110539269|NCT02676986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110539270|NCT02676986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110539271|NCT02676986|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110539272|NCT02676986|Hormone Antagonists|hormone antagonists|mesh-ancestor
110539273|NCT02676986|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110539274|NCT02676986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110539275|NCT02802215|Folic Acid|folic acid|mesh-list
110539276|NCT02802215|Metformin|metformin|mesh-list
110539277|NCT02802215|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110539278|NCT02802215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110539279|NCT02802215|Hematinics|hematinics|mesh-ancestor
110539280|NCT02802215|Vitamin B Complex|vitamin b complex|mesh-ancestor
110539281|NCT02802215|Vitamins|vitamins|mesh-ancestor
110539282|NCT02802215|Micronutrients|micronutrients|mesh-ancestor
110539283|NCT02799797|Sufentanil|sufentanil|mesh-list
110539284|NCT02799797|Dsuvia|dsuvia|mesh-list
110539285|NCT02799797|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110539286|NCT02799797|Narcotics|narcotics|mesh-ancestor
110539287|NCT02799797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110539288|NCT02799797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110539289|NCT02799797|Analgesics|analgesics|mesh-ancestor
110539290|NCT02799797|Sensory System Agents|sensory system agents|mesh-ancestor
110539291|NCT02799797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110539292|NCT02799797|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110539293|NCT02799797|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110539296|NCT05663372|Eplerenone|eplerenone|mesh-list
110539297|NCT05663372|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110539298|NCT05663372|Hormone Antagonists|hormone antagonists|mesh-ancestor
110539299|NCT05663372|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110539300|NCT05663372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110539301|NCT05663372|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110539302|NCT05663372|Diuretics|diuretics|mesh-ancestor
110539303|NCT05663372|Natriuretic Agents|natriuretic agents|mesh-ancestor
110539304|NCT05663372|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110539305|NCT02802137|Timolol|timolol|mesh-list
110539306|NCT02802137|Dorzolamide|dorzolamide|mesh-list
110539307|NCT02802137|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110539308|NCT02802137|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110539309|NCT02802137|Adrenergic Agents|adrenergic agents|mesh-ancestor
110539310|NCT02802137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110539311|NCT02802137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110539312|NCT02802137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110539313|NCT02802137|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110539314|NCT02802137|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110539315|NCT02802137|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110539316|NCT02802137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110539317|NCT04033562|Lidocaine|lidocaine|mesh-list
110539318|NCT04033562|Bupivacaine|bupivacaine|mesh-list
110539319|NCT04033562|Anesthetics, Local|anesthetics, local|mesh-ancestor
110539320|NCT04033562|Anesthetics|anesthetics|mesh-ancestor
110539321|NCT04033562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110539322|NCT04033562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110539323|NCT04033562|Sensory System Agents|sensory system agents|mesh-ancestor
110539324|NCT04033562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110539325|NCT04033562|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110539326|NCT04033562|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110539327|NCT04033562|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110539328|NCT04033562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110539329|NCT04033562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110539331|NCT04032834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110539332|NCT04032834|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110539333|NCT04032834|Autonomic Agents|autonomic agents|mesh-ancestor
110539334|NCT04032834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110539335|NCT04032834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110539336|NCT04032834|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110539337|NCT04032834|Respiratory System Agents|respiratory system agents|mesh-ancestor
110539338|NCT04032834|Glucocorticoids|glucocorticoids|mesh-ancestor
110539340|NCT04032834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110539341|NCT02817191|Tobramycin|tobramycin|mesh-list
110539342|NCT02817191|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
110539343|NCT02817191|Dexamethasone|dexamethasone|mesh-list
110539344|NCT02817191|Dexamethasone acetate|dexamethasone acetate|mesh-list
110539345|NCT02817191|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110539346|NCT02817191|BB 1101|bb 1101|mesh-list
110539347|NCT02817191|Dipivefrin|dipivefrin|mesh-list
110539348|NCT02817191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110539349|NCT02817191|Antiemetics|antiemetics|mesh-ancestor
110539350|NCT02817191|Autonomic Agents|autonomic agents|mesh-ancestor
110539351|NCT02817191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110539352|NCT02817191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110539353|NCT02817191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110539354|NCT02817191|Glucocorticoids|glucocorticoids|mesh-ancestor
110539355|NCT02817191|Hormones|hormones|mesh-ancestor
110539356|NCT02817191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110539357|NCT02817191|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110539358|NCT02817191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110539359|NCT02817191|Protease Inhibitors|protease inhibitors|mesh-ancestor
110539360|NCT02817191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110539361|NCT02817191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110539362|NCT02817191|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110539363|NCT02817191|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110539364|NCT02817191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110539365|NCT02817191|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110539366|NCT02817191|Adrenergic Agents|adrenergic agents|mesh-ancestor
110539367|NCT02817191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110539368|NCT02636010|Pembrolizumab|pembrolizumab|mesh-list
110539369|NCT02636010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110539370|NCT02636010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110539371|NCT02636010|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110539372|NCT02636010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110539373|NCT05474027|Antihypertensive Agents|antihypertensive agents|mesh-list
110539374|NCT05474027|Tranexamic Acid|tranexamic acid|mesh-list
110539375|NCT05474027|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110539376|NCT05474027|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110539377|NCT05474027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110539378|NCT05474027|Hemostatics|hemostatics|mesh-ancestor
110539379|NCT05474027|Coagulants|coagulants|mesh-ancestor
110539380|NCT00642824|Bevacizumab|bevacizumab|mesh-list
110539381|NCT00642824|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110539382|NCT00642824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110539383|NCT00642824|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110539384|NCT00642824|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110539385|NCT00642824|Growth Substances|growth substances|mesh-ancestor
110539386|NCT00642824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110539387|NCT00642824|Growth Inhibitors|growth inhibitors|mesh-ancestor
110539388|NCT02679014|Petesicatib|petesicatib|mesh-list
110539389|NCT02679014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110539390|NCT02679014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110539392|NCT02801357|Buprenorphine|buprenorphine|mesh-list
110539394|NCT02801357|Narcotics|narcotics|mesh-ancestor
110539395|NCT02801357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110539396|NCT02801357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110539397|NCT02801357|Analgesics|analgesics|mesh-ancestor
110539398|NCT02801357|Sensory System Agents|sensory system agents|mesh-ancestor
110539399|NCT02801357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110539400|NCT02801357|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110539401|NCT02801357|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110539402|NCT02801357|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110539403|NCT02801357|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110539404|NCT02801357|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110539405|NCT02801357|Adrenergic Agents|adrenergic agents|mesh-ancestor
110280662|NCT00220116|Antimetabolites|antimetabolites|mesh-ancestor
110539406|NCT02801357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110539407|NCT02801357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110539408|NCT02676674|Vitamin D|vitamin d|mesh-list
110539409|NCT02676674|Cholecalciferol|cholecalciferol|mesh-list
110539410|NCT02676674|Vitamins|vitamins|mesh-ancestor
110539411|NCT02676674|Micronutrients|micronutrients|mesh-ancestor
110539412|NCT02676674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110539413|NCT02676674|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110539414|NCT02676674|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110539415|NCT00962299|Beclomethasone|beclomethasone|mesh-list
110539416|NCT00962299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110539417|NCT00962299|Glucocorticoids|glucocorticoids|mesh-ancestor
110539418|NCT00962299|Hormones|hormones|mesh-ancestor
110539419|NCT00962299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110539420|NCT00962299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110539421|NCT00962299|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110539422|NCT00962299|Respiratory System Agents|respiratory system agents|mesh-ancestor
110539423|NCT02679092|Misoprostol|misoprostol|mesh-list
110539424|NCT02679092|Mifepristone|mifepristone|mesh-list
110539425|NCT02679092|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110539426|NCT02679092|Abortifacient Agents|abortifacient agents|mesh-ancestor
110539427|NCT02679092|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110539428|NCT02679092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110539429|NCT02679092|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110539430|NCT02679092|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110539431|NCT02679092|Oxytocics|oxytocics|mesh-ancestor
110539432|NCT02679092|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
110539433|NCT02679092|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110539434|NCT02679092|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110539435|NCT02679092|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110539436|NCT02679092|Contraceptive Agents|contraceptive agents|mesh-ancestor
110539437|NCT02679092|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
110539438|NCT02679092|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
110539439|NCT02679092|Hormone Antagonists|hormone antagonists|mesh-ancestor
110539440|NCT02679092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110539441|NCT02679092|Luteolytic Agents|luteolytic agents|mesh-ancestor
110196544|NCT00212173|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110539442|NCT02679092|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110539443|NCT02679092|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
110539445|NCT04183088|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110539446|NCT04183088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110539448|NCT00642122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110539449|NCT00642122|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110539450|NCT00642122|Autonomic Agents|autonomic agents|mesh-ancestor
110539451|NCT00642122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110539452|NCT00642122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110539453|NCT00642122|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110539454|NCT00642122|Respiratory System Agents|respiratory system agents|mesh-ancestor
110539455|NCT00642122|Glucocorticoids|glucocorticoids|mesh-ancestor
110539456|NCT00642122|Hormones|hormones|mesh-ancestor
110539457|NCT00642122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110539458|NCT00546871|Immunoglobulins|immunoglobulins|mesh-list
110539460|NCT00546871|gamma-Globulins|gamma-globulins|mesh-list
110539461|NCT00546871|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110539462|NCT00546871|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110539463|NCT00546871|Immunologic Factors|immunologic factors|mesh-ancestor
110539464|NCT00546871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110539465|NCT02817113|Fluorouracil|fluorouracil|mesh-list
110539466|NCT02817113|Cetuximab|cetuximab|mesh-list
110539467|NCT02817113|Antimetabolites|antimetabolites|mesh-ancestor
110539468|NCT02817113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110539469|NCT02817113|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110539470|NCT02817113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110539471|NCT02817113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110539472|NCT02817113|Immunologic Factors|immunologic factors|mesh-ancestor
110539473|NCT02817113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110539474|NCT02817113|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110539475|NCT02801201|Midazolam|midazolam|mesh-list
110539476|NCT02801201|Bupivacaine|bupivacaine|mesh-list
110539477|NCT02801201|Anesthetics, Local|anesthetics, local|mesh-ancestor
110539478|NCT02801201|Anesthetics|anesthetics|mesh-ancestor
110539479|NCT02801201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110539480|NCT02801201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110539481|NCT02801201|Sensory System Agents|sensory system agents|mesh-ancestor
110539482|NCT02801201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110539483|NCT02801201|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110539484|NCT02801201|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110539485|NCT02801201|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110539486|NCT02801201|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110539487|NCT02801201|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110539488|NCT02801201|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110539489|NCT02801201|Anesthetics, General|anesthetics, general|mesh-ancestor
110539490|NCT02801201|GABA Modulators|gaba modulators|mesh-ancestor
110539491|NCT02801201|GABA Agents|gaba agents|mesh-ancestor
110539492|NCT02801201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110539493|NCT02801201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110539494|NCT04182932|Vaccines|vaccines|mesh-list
110539495|NCT04182932|Immunologic Factors|immunologic factors|mesh-ancestor
110539496|NCT04182932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110539497|NCT03951805|Insulin|insulin|mesh-list
110539498|NCT03951805|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110539499|NCT03951805|Insulin Glargine|insulin glargine|mesh-list
110539500|NCT03951805|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110539501|NCT03951805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110539502|NCT02681198|Lofexidine|lofexidine|mesh-list
110539503|NCT02681198|Paroxetine|paroxetine|mesh-list
110539504|NCT02681198|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110539505|NCT02681198|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110539506|NCT02681198|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110539507|NCT02681198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110539508|NCT02681198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110539509|NCT02681198|Serotonin Agents|serotonin agents|mesh-ancestor
110539510|NCT02681198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110539511|NCT02681198|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110539512|NCT02681198|Antidepressive Agents|antidepressive agents|mesh-ancestor
110187056|NCT04199026|Sirolimus|sirolimus|mesh-list
110539513|NCT02681198|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110539514|NCT02681198|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110539515|NCT02681198|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110539516|NCT02681198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110539517|NCT02681198|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110539518|NCT02681198|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110539519|NCT02681198|Sensory System Agents|sensory system agents|mesh-ancestor
110539520|NCT02681198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110539521|NCT02681198|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110539522|NCT02681198|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110539523|NCT02681198|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110539524|NCT02681198|Adrenergic Agents|adrenergic agents|mesh-ancestor
110539525|NCT05597306|Venetoclax|venetoclax|mesh-list
110539526|NCT05597306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110539527|NCT00962533|Telbivudine|telbivudine|mesh-list
110539528|NCT00962533|Antiviral Agents|antiviral agents|mesh-ancestor
110539529|NCT00962533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110539530|NCT00962533|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110539531|NCT00962533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110539532|NCT00962533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110539533|NCT00642980|Clindamycin|clindamycin|mesh-list
110539534|NCT00642980|Clindamycin palmitate|clindamycin palmitate|mesh-list
110539535|NCT00642980|Clindamycin phosphate|clindamycin phosphate|mesh-list
110539536|NCT00642980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110539537|NCT00642980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110539538|NCT00642980|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110539539|NCT00642980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110539540|NCT00642980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110539541|NCT02798159|Sildenafil Citrate|sildenafil citrate|mesh-list
110539542|NCT02798159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110539543|NCT02798159|Vasodilator Agents|vasodilator agents|mesh-ancestor
110539544|NCT02798159|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110539545|NCT02798159|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110539546|NCT02798159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110539547|NCT02798159|Urological Agents|urological agents|mesh-ancestor
110539548|NCT00962767|Gemtuzumab|gemtuzumab|mesh-list
110539549|NCT00962767|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110539550|NCT00962767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110539551|NCT00962767|Immunotoxins|immunotoxins|mesh-ancestor
110539552|NCT00962767|Immunoconjugates|immunoconjugates|mesh-ancestor
110539553|NCT00962767|Immunologic Factors|immunologic factors|mesh-ancestor
110539554|NCT00962767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110539555|NCT02678780|Lenvatinib|lenvatinib|mesh-list
110539556|NCT02678780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110539557|NCT02678780|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110539558|NCT02678780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110539559|NCT02678780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110539560|NCT00963001|Treprostinil|treprostinil|mesh-list
110539561|NCT00963001|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110539562|NCT00643136|Pregabalin|pregabalin|mesh-list
110539563|NCT00643136|Analgesics|analgesics|mesh-ancestor
110539564|NCT00643136|Sensory System Agents|sensory system agents|mesh-ancestor
110539565|NCT00643136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110539566|NCT00643136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110539567|NCT00643136|Anticonvulsants|anticonvulsants|mesh-ancestor
110539568|NCT00643136|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110539569|NCT00643136|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110539570|NCT00643136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110539571|NCT00643136|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110539572|NCT00643136|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110539573|NCT00643136|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110539574|NCT00643136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110539575|NCT00643136|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110539576|NCT01563367|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
110539577|NCT01563367|Hematinics|hematinics|mesh-ancestor
110539578|NCT00963313|Adalimumab|adalimumab|mesh-list
110539579|NCT00963313|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110176767|NCT00083707|Thalidomide|thalidomide|mesh-list
110539580|NCT00963313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110539581|NCT00963313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110539583|NCT02797145|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110539584|NCT02797145|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110539585|NCT02797145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110301295|NCT00274560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110539586|NCT02797145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110539587|NCT02797145|Protective Agents|protective agents|mesh-ancestor
110539588|NCT02797145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110539590|NCT02690129|Progestins|progestins|mesh-ancestor
110539591|NCT02690129|Hormones|hormones|mesh-ancestor
110539592|NCT02690129|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110539593|NCT02690129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110539594|NCT00883116|Paclitaxel|paclitaxel|mesh-list
110539595|NCT00883116|Doxorubicin|doxorubicin|mesh-list
110539596|NCT00883116|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110539597|NCT00883116|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110539598|NCT00883116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110539599|NCT00883116|Tubulin Modulators|tubulin modulators|mesh-ancestor
110539600|NCT00883116|Antimitotic Agents|antimitotic agents|mesh-ancestor
110539601|NCT00883116|Mitosis Modulators|mitosis modulators|mesh-ancestor
110539602|NCT00883116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110539603|NCT00883116|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110539604|NCT00883116|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110539605|NCT00883116|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110539606|NCT00883116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110539607|NCT00643292|Amoxicillin|amoxicillin|mesh-list
110539608|NCT00643292|Azithromycin|azithromycin|mesh-list
110539609|NCT00643292|Clavulanic Acid|clavulanic acid|mesh-list
110539610|NCT00643292|Clavulanic Acids|clavulanic acids|mesh-list
110539611|NCT00643292|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
110539612|NCT00643292|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110539613|NCT00643292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110539614|NCT00643292|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110539615|NCT00643292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110539616|NCT00643292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110539617|NCT02797067|Indomethacin|indomethacin|mesh-list
110539618|NCT02797067|Glycerol|glycerol|mesh-list
110539619|NCT02797067|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110539620|NCT02797067|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110539621|NCT02797067|Analgesics|analgesics|mesh-ancestor
110539622|NCT02797067|Sensory System Agents|sensory system agents|mesh-ancestor
110539623|NCT02797067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110539624|NCT02797067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110539625|NCT02797067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110539626|NCT02797067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110539627|NCT02797067|Gout Suppressants|gout suppressants|mesh-ancestor
110539628|NCT02797067|Tocolytic Agents|tocolytic agents|mesh-ancestor
110539629|NCT02797067|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110539630|NCT02797067|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110539631|NCT02797067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110539632|NCT02797067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110539633|NCT02797067|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
110539634|NCT02797067|Protective Agents|protective agents|mesh-ancestor
110539635|NCT00655044|Insulin Detemir|insulin detemir|mesh-list
110539636|NCT00655044|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110539637|NCT00655044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110539638|NCT00963703|Rituximab|rituximab|mesh-list
110539639|NCT00963703|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110539640|NCT00963703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110539642|NCT00963703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110539643|NCT00963703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110539644|NCT00655122|Dalteparin|dalteparin|mesh-list
110539645|NCT00655122|Tinzaparin|tinzaparin|mesh-list
110539646|NCT00655122|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
110539647|NCT00655122|Anticoagulants|anticoagulants|mesh-ancestor
110539648|NCT00655122|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110539649|NCT00655122|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110539650|NCT00655122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110539651|NCT02638116|Omeprazole|omeprazole|mesh-list
110539652|NCT02638116|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110539653|NCT02638116|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110539654|NCT02638116|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110539655|NCT02638116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110539656|NCT02638116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110539657|NCT04164264|Propofol|propofol|mesh-list
110539658|NCT04164264|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110539659|NCT04164264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110539660|NCT04164264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110539661|NCT04164264|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110539663|NCT04164264|Anesthetics|anesthetics|mesh-ancestor
110539665|NCT02795039|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110539666|NCT02795039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110539667|NCT02795039|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110539668|NCT02795039|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110539669|NCT02795039|Hormone Antagonists|hormone antagonists|mesh-ancestor
110539670|NCT02795039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110539671|NCT02795039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110539672|NCT02796833|SMOFlipid|smoflipid|mesh-list
110539673|NCT02796833|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
110539674|NCT02796833|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
110539675|NCT02796833|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110539676|NCT04009603|Metformin|metformin|mesh-list
110539677|NCT04009603|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110539678|NCT04009603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110539679|NCT02635230|Aspirin|aspirin|mesh-list
110539680|NCT02635230|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110539681|NCT02635230|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110539682|NCT02635230|Analgesics|analgesics|mesh-ancestor
110539683|NCT02635230|Sensory System Agents|sensory system agents|mesh-ancestor
110539684|NCT02635230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110539685|NCT02635230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110539686|NCT02635230|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110539687|NCT02635230|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110539688|NCT02635230|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110539689|NCT02635230|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110539690|NCT02635230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110539691|NCT02635230|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110539692|NCT02635230|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110539693|NCT02635230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110539695|NCT00964015|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
110539696|NCT00964015|Plasma Substitutes|plasma substitutes|mesh-ancestor
110539697|NCT00964015|Blood Substitutes|blood substitutes|mesh-ancestor
110539698|NCT02673632|Triptorelin Pamoate|triptorelin pamoate|mesh-list
110539699|NCT02673632|Luteolytic Agents|luteolytic agents|mesh-ancestor
110539700|NCT02673632|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110539701|NCT02673632|Contraceptive Agents|contraceptive agents|mesh-ancestor
110539702|NCT02673632|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110539703|NCT02673632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110539704|NCT02673632|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110176788|NCT03151707|Micronutrients|micronutrients|mesh-ancestor
110176791|NCT03151707|Antimetabolites|antimetabolites|mesh-ancestor
110539705|NCT02673632|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110539706|NCT02673632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110539707|NCT04009525|Cyclosporine|cyclosporine|mesh-list
110539708|NCT04009525|Mycophenolic Acid|mycophenolic acid|mesh-list
110539709|NCT04009525|Cyclophosphamide|cyclophosphamide|mesh-list
110539710|NCT04009525|Busulfan|busulfan|mesh-list
110539711|NCT04009525|Methotrexate|methotrexate|mesh-list
110539712|NCT04009525|Fludarabine|fludarabine|mesh-list
110539713|NCT04009525|Tacrolimus|tacrolimus|mesh-list
110539714|NCT04009525|Cyclosporins|cyclosporins|mesh-list
110539715|NCT04009525|Thymoglobulin|thymoglobulin|mesh-list
110539716|NCT04009525|Basiliximab|basiliximab|mesh-list
110539717|NCT04009525|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110539718|NCT04009525|Immunologic Factors|immunologic factors|mesh-ancestor
110539719|NCT04009525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110539720|NCT04009525|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110539721|NCT04009525|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110539722|NCT04009525|Alkylating Agents|alkylating agents|mesh-ancestor
110539723|NCT04009525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110539724|NCT04009525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110539725|NCT04009525|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110539726|NCT04009525|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110539727|NCT04009525|Abortifacient Agents|abortifacient agents|mesh-ancestor
110539728|NCT04009525|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110539729|NCT04009525|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110539730|NCT04009525|Antimetabolites|antimetabolites|mesh-ancestor
110539731|NCT04009525|Dermatologic Agents|dermatologic agents|mesh-ancestor
110539732|NCT04009525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110539733|NCT04009525|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110539734|NCT04009525|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110539735|NCT04009525|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110539736|NCT04009525|Antifungal Agents|antifungal agents|mesh-ancestor
110539737|NCT04009525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110539738|NCT04009525|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110539739|NCT04009525|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110539741|NCT04009525|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110539743|NCT04032366|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110539744|NCT04032366|Autonomic Agents|autonomic agents|mesh-ancestor
110539745|NCT04032366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110539746|NCT04032366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110539747|NCT04032366|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110539748|NCT04032366|Respiratory System Agents|respiratory system agents|mesh-ancestor
110539749|NCT04032366|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110539750|NCT04032366|Antioxidants|antioxidants|mesh-ancestor
110539751|NCT04032366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110539752|NCT04032366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110539753|NCT04032366|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
110539754|NCT04032366|Vasodilator Agents|vasodilator agents|mesh-ancestor
110539755|NCT04032366|Gasotransmitters|gasotransmitters|mesh-ancestor
110539756|NCT04032366|Protective Agents|protective agents|mesh-ancestor
110539757|NCT02537600|Vemurafenib|vemurafenib|mesh-list
110539758|NCT02537600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110539759|NCT02537600|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110539760|NCT02537600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110539761|NCT02537600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110539762|NCT00684099|Docetaxel|docetaxel|mesh-list
110539763|NCT00684099|Pemetrexed|pemetrexed|mesh-list
110539764|NCT00684099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110539765|NCT00684099|Tubulin Modulators|tubulin modulators|mesh-ancestor
110539766|NCT00684099|Antimitotic Agents|antimitotic agents|mesh-ancestor
110539767|NCT00684099|Mitosis Modulators|mitosis modulators|mesh-ancestor
110539768|NCT00684099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110539769|NCT00684099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110539770|NCT00684099|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110539771|NCT00684099|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110539772|NCT04159896|Nivolumab|nivolumab|mesh-list
110539773|NCT04159896|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
110539774|NCT04159896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110539775|NCT04159896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110539776|NCT04159896|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110539777|NCT04159896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110539778|NCT04159896|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110539779|NCT04159896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110539781|NCT02635074|Idarubicin|idarubicin|mesh-list
110539782|NCT02635074|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110539783|NCT02635074|Antimetabolites|antimetabolites|mesh-ancestor
110539784|NCT02635074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110539785|NCT02635074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110539786|NCT02635074|Antiviral Agents|antiviral agents|mesh-ancestor
110539787|NCT02635074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110539788|NCT02635074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110539789|NCT02635074|Immunologic Factors|immunologic factors|mesh-ancestor
110539790|NCT02635074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110539791|NCT02635074|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110539792|NCT02635074|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110539793|NCT02635074|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110539794|NCT02635074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110539795|NCT02537366|Dexmedetomidine|dexmedetomidine|mesh-list
110539796|NCT02537366|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110539797|NCT02537366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110539798|NCT02537366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110539799|NCT02537366|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110539800|NCT02537366|Analgesics|analgesics|mesh-ancestor
110539801|NCT02537366|Sensory System Agents|sensory system agents|mesh-ancestor
110539802|NCT02537366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110539803|NCT02537366|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110539804|NCT02537366|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110539805|NCT02537366|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110539806|NCT02537366|Adrenergic Agents|adrenergic agents|mesh-ancestor
110539807|NCT02537366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110539808|NCT02537366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110539809|NCT00690417|Vitamin D|vitamin d|mesh-list
110539810|NCT00690417|Cholecalciferol|cholecalciferol|mesh-list
110539811|NCT00690417|Vitamins|vitamins|mesh-ancestor
110539812|NCT00690417|Micronutrients|micronutrients|mesh-ancestor
110539814|NCT00690417|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110539815|NCT00690417|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110539816|NCT05434559|Insulin|insulin|mesh-list
110539817|NCT05434559|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110539818|NCT05434559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110539819|NCT00546637|Fesoterodine|fesoterodine|mesh-list
110539820|NCT00546637|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110539821|NCT00546637|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110539822|NCT00546637|Cholinergic Agents|cholinergic agents|mesh-ancestor
110539823|NCT00546637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110539824|NCT00546637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110539825|NCT00546637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110539826|NCT00546637|Urological Agents|urological agents|mesh-ancestor
110539827|NCT00690885|Interferons|interferons|mesh-list
110539828|NCT00690885|Interferon-alpha|interferon-alpha|mesh-list
110539829|NCT00690885|Interferon alpha-2|interferon alpha-2|mesh-list
110539830|NCT00690885|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
110539831|NCT00690885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110539832|NCT00690885|Antiviral Agents|antiviral agents|mesh-ancestor
110539833|NCT00690885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110539834|NCT00690885|Immunologic Factors|immunologic factors|mesh-ancestor
110539835|NCT00690885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110539836|NCT04138719|Paclitaxel|paclitaxel|mesh-list
110539837|NCT04138719|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110539838|NCT04138719|Carboplatin|carboplatin|mesh-list
110539839|NCT04138719|Epirubicin|epirubicin|mesh-list
110539840|NCT04138719|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110539841|NCT04138719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110539842|NCT04138719|Tubulin Modulators|tubulin modulators|mesh-ancestor
110539843|NCT04138719|Antimitotic Agents|antimitotic agents|mesh-ancestor
110539844|NCT04138719|Mitosis Modulators|mitosis modulators|mesh-ancestor
110539845|NCT04138719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110539846|NCT04138719|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110539847|NCT04138719|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110539848|NCT04138719|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110539849|NCT04138719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110539850|NCT02790203|Celecoxib|celecoxib|mesh-list
110176800|NCT03151668|Analgesics|analgesics|mesh-ancestor
110539851|NCT02790203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110539852|NCT02790203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110539853|NCT02790203|Analgesics|analgesics|mesh-ancestor
110539854|NCT02790203|Sensory System Agents|sensory system agents|mesh-ancestor
110539855|NCT02790203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110539856|NCT02790203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110539857|NCT02790203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110539858|NCT02790203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110539859|NCT02790203|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110539860|NCT02790203|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110539861|NCT02790203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110539862|NCT02790203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110539864|NCT02816567|Propofol|propofol|mesh-list
110539865|NCT02816567|Cisatracurium|cisatracurium|mesh-list
110539866|NCT02816567|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110539867|NCT02816567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110539868|NCT02816567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110539869|NCT02816567|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110539870|NCT02816567|Anesthetics, General|anesthetics, general|mesh-ancestor
110539872|NCT02816567|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110539873|NCT02816567|Narcotics|narcotics|mesh-ancestor
110539874|NCT02816567|Analgesics|analgesics|mesh-ancestor
110539875|NCT02816567|Sensory System Agents|sensory system agents|mesh-ancestor
110539876|NCT02816567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110539877|NCT02816567|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110539878|NCT02816567|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110539879|NCT02816567|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110539880|NCT00657774|Prednisone|prednisone|mesh-list
110539881|NCT00657774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110539882|NCT00657774|Glucocorticoids|glucocorticoids|mesh-ancestor
110539883|NCT00657774|Hormones|hormones|mesh-ancestor
110539884|NCT00657774|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110539885|NCT00657774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110539886|NCT00657774|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110539887|NCT00657774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110539889|NCT04138485|Immunologic Factors|immunologic factors|mesh-ancestor
110539890|NCT04138485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110539891|NCT02789969|Fentanyl|fentanyl|mesh-list
110539892|NCT02789969|Hydromorphone|hydromorphone|mesh-list
110539893|NCT02789969|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110539894|NCT02789969|Narcotics|narcotics|mesh-ancestor
110539895|NCT02789969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110539896|NCT02789969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110539897|NCT02789969|Analgesics|analgesics|mesh-ancestor
110539898|NCT02789969|Sensory System Agents|sensory system agents|mesh-ancestor
110539899|NCT02789969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110539900|NCT02789969|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110301479|NCT00284271|Tubulin Modulators|tubulin modulators|mesh-ancestor
110539901|NCT02789969|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110539902|NCT02789969|Anesthetics, General|anesthetics, general|mesh-ancestor
110539903|NCT02789969|Anesthetics|anesthetics|mesh-ancestor
110539904|NCT00657852|Pamidronate|pamidronate|mesh-list
110539905|NCT00657852|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110539906|NCT00657852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110539907|NCT00691275|Ondansetron|ondansetron|mesh-list
110539908|NCT00691275|Antiemetics|antiemetics|mesh-ancestor
110539909|NCT00691275|Autonomic Agents|autonomic agents|mesh-ancestor
110539910|NCT00691275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110539911|NCT00691275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110539912|NCT00691275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110539913|NCT00691275|Antipruritics|antipruritics|mesh-ancestor
110539914|NCT00691275|Dermatologic Agents|dermatologic agents|mesh-ancestor
110539915|NCT00691275|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110539916|NCT00691275|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110539917|NCT00691275|Serotonin Agents|serotonin agents|mesh-ancestor
110539918|NCT00691275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110539919|NCT00691275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110539920|NCT00657930|Insulin Detemir|insulin detemir|mesh-list
110539921|NCT00657930|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110539922|NCT00657930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110539923|NCT00655512|Clobetasol|clobetasol|mesh-list
110539924|NCT00655512|Pimecrolimus|pimecrolimus|mesh-list
110539925|NCT00655512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110539926|NCT00655512|Glucocorticoids|glucocorticoids|mesh-ancestor
110539927|NCT00655512|Hormones|hormones|mesh-ancestor
110539928|NCT00655512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110539929|NCT00655512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110539930|NCT00655512|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110539931|NCT00655512|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110539932|NCT00655512|Analgesics|analgesics|mesh-ancestor
110539933|NCT00655512|Sensory System Agents|sensory system agents|mesh-ancestor
110539934|NCT00655512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110539935|NCT00655512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110301537|NCT00284427|Vitamins|vitamins|mesh-ancestor
110539936|NCT00655512|Dermatologic Agents|dermatologic agents|mesh-ancestor
110539937|NCT00655512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110539938|NCT00655512|Immunologic Factors|immunologic factors|mesh-ancestor
110539939|NCT00655512|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110539940|NCT00655512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110539941|NCT00655512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110539942|NCT00644306|Thalidomide|thalidomide|mesh-list
110539943|NCT00644306|Prednisone|prednisone|mesh-list
110539944|NCT00644306|Melphalan|melphalan|mesh-list
110539945|NCT00644306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110539946|NCT00644306|Glucocorticoids|glucocorticoids|mesh-ancestor
110539947|NCT00644306|Hormones|hormones|mesh-ancestor
110539948|NCT00644306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110539949|NCT00644306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110539950|NCT00644306|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110539951|NCT00644306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110539952|NCT00644306|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110539953|NCT00644306|Alkylating Agents|alkylating agents|mesh-ancestor
110539954|NCT00644306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110539955|NCT00644306|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110539956|NCT00644306|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110539957|NCT00644306|Immunologic Factors|immunologic factors|mesh-ancestor
110539958|NCT00644306|Leprostatic Agents|leprostatic agents|mesh-ancestor
110539959|NCT00644306|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110539960|NCT00644306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110539961|NCT00644306|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110539962|NCT00644306|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110539963|NCT00644306|Growth Substances|growth substances|mesh-ancestor
110539964|NCT00644306|Growth Inhibitors|growth inhibitors|mesh-ancestor
110539965|NCT02634528|Insulin|insulin|mesh-list
110280757|NCT00220233|Diuretics|diuretics|mesh-ancestor
110539966|NCT02634528|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110539967|NCT02634528|Insulin, Isophane|insulin, isophane|mesh-list
110539968|NCT02634528|Isophane Insulin, Human|isophane insulin, human|mesh-list
110539969|NCT02634528|Isophane insulin, beef|isophane insulin, beef|mesh-list
110539970|NCT02634528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110539971|NCT02634528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110539972|NCT02816411|Caseins|caseins|mesh-list
110539973|NCT02816411|Chelating Agents|chelating agents|mesh-ancestor
110539974|NCT02816411|Sequestering Agents|sequestering agents|mesh-ancestor
110539975|NCT02816411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110539976|NCT00655590|Sildenafil Citrate|sildenafil citrate|mesh-list
110539977|NCT00655590|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
110539978|NCT00655590|Vasodilator Agents|vasodilator agents|mesh-ancestor
110539979|NCT00655590|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110539980|NCT00655590|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110539981|NCT00655590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110539982|NCT00655590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110539983|NCT00655590|Urological Agents|urological agents|mesh-ancestor
110539984|NCT02794025|Esmolol|esmolol|mesh-list
110176818|NCT05568082|Hormone Antagonists|hormone antagonists|mesh-ancestor
110539985|NCT02794025|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110539986|NCT02794025|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110539987|NCT02794025|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110539988|NCT02794025|Adrenergic Agents|adrenergic agents|mesh-ancestor
110539989|NCT02794025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110539990|NCT02794025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110539991|NCT02794025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110539992|NCT00546481|Epoetin Alfa|epoetin alfa|mesh-list
110539993|NCT00546481|Hematinics|hematinics|mesh-ancestor
110539994|NCT02789813|Valproic Acid|valproic acid|mesh-list
110539995|NCT02789813|Anticonvulsants|anticonvulsants|mesh-ancestor
110539996|NCT02789813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110539997|NCT02789813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110539998|NCT02789813|GABA Agents|gaba agents|mesh-ancestor
110539999|NCT02789813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110540000|NCT02789813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110540001|NCT02789813|Antimanic Agents|antimanic agents|mesh-ancestor
110540002|NCT02789813|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110540003|NCT02789813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110540004|NCT02789813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110540005|NCT02632578|Vaccines|vaccines|mesh-list
110540006|NCT02632578|Immunologic Factors|immunologic factors|mesh-ancestor
110540007|NCT02632578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110540008|NCT04138251|Empagliflozin|empagliflozin|mesh-list
110540009|NCT04138251|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110540010|NCT04138251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110540011|NCT04138251|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110540012|NCT04138251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110540013|NCT00964171|Efavirenz|efavirenz|mesh-list
110540014|NCT00964171|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110540015|NCT00964171|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110540016|NCT00964171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110540017|NCT00964171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110540018|NCT00964171|Antiviral Agents|antiviral agents|mesh-ancestor
110540019|NCT00964171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110540020|NCT00964171|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110540021|NCT00964171|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110540022|NCT00964171|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110540023|NCT00964171|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110540024|NCT00964171|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110540025|NCT00964171|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110540026|NCT04016246|Propofol|propofol|mesh-list
110540027|NCT04016246|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110540028|NCT04016246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110540029|NCT04016246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110540030|NCT04016246|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110540031|NCT04016246|Anesthetics, General|anesthetics, general|mesh-ancestor
110540032|NCT04016246|Anesthetics|anesthetics|mesh-ancestor
110540033|NCT02789501|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110540034|NCT04178876|Ethanol|ethanol|mesh-list
110540035|NCT04178876|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110540036|NCT04178876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110540037|NCT04178876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110540038|NCT04178876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110540040|NCT02789579|Nitrofurantoin|nitrofurantoin|mesh-list
110540041|NCT02789579|Cefuroxime|cefuroxime|mesh-list
110540042|NCT02789579|Cefuroxime axetil|cefuroxime axetil|mesh-list
110540043|NCT02789579|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110540044|NCT02789579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110540045|NCT02789579|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110540046|NCT02789579|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110540047|NCT02789579|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110540048|NCT02789579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110540049|NCT02789579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110540050|NCT02789579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110540051|NCT02789579|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110540052|NCT02789579|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110540053|NCT04233203|Insulin|insulin|mesh-list
110540054|NCT04233203|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110540055|NCT04233203|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110540056|NCT04233203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110540057|NCT00959101|Metformin|metformin|mesh-list
110540058|NCT00959101|Repaglinide|repaglinide|mesh-list
110540060|NCT00959101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110540061|NCT04233359|Anesthetics|anesthetics|mesh-list
110540062|NCT04233359|Anesthetics, Local|anesthetics, local|mesh-list
110540063|NCT04233359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110540064|NCT04233359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110540065|NCT04233359|Sensory System Agents|sensory system agents|mesh-ancestor
110540066|NCT04233359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110540067|NCT00964327|Darunavir|darunavir|mesh-list
110540068|NCT00964327|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110540069|NCT00964327|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110540070|NCT00964327|Protease Inhibitors|protease inhibitors|mesh-ancestor
110540071|NCT00964327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110540072|NCT00964327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110540073|NCT00964327|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110540074|NCT00964327|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110540075|NCT00964327|Antiviral Agents|antiviral agents|mesh-ancestor
110540076|NCT00964327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110540077|NCT05252546|Loperamide|loperamide|mesh-list
110540078|NCT05252546|Antidiarrheals|antidiarrheals|mesh-list
110540079|NCT05252546|Bentonite|bentonite|mesh-list
110540080|NCT05252546|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110540081|NCT05252546|Antidotes|antidotes|mesh-ancestor
110540082|NCT05252546|Protective Agents|protective agents|mesh-ancestor
110540083|NCT05252546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110540084|NCT00644384|Acitretin|acitretin|mesh-list
110540085|NCT00644384|Keratolytic Agents|keratolytic agents|mesh-ancestor
110540086|NCT00644384|Dermatologic Agents|dermatologic agents|mesh-ancestor
110540087|NCT02637648|Sodium Oxybate|sodium oxybate|mesh-list
110540088|NCT02637648|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110540089|NCT02637648|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110540090|NCT02637648|Anesthetics, General|anesthetics, general|mesh-ancestor
110540091|NCT02637648|Anesthetics|anesthetics|mesh-ancestor
110540092|NCT02637648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110540093|NCT02637648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110540094|NCT02815865|Oxytocin|oxytocin|mesh-list
110540095|NCT02815865|Dinoprostone|dinoprostone|mesh-list
110540096|NCT02815865|Oxytocics|oxytocics|mesh-ancestor
110540097|NCT02815865|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110540098|NCT02815865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110540099|NCT02673866|Pregabalin|pregabalin|mesh-list
110540100|NCT02673866|DS-1971a|ds-1971a|mesh-list
110540101|NCT02673866|Analgesics|analgesics|mesh-ancestor
110540102|NCT02673866|Sensory System Agents|sensory system agents|mesh-ancestor
110540103|NCT02673866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110540104|NCT02673866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110540105|NCT02673866|Anticonvulsants|anticonvulsants|mesh-ancestor
110540106|NCT02673866|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110540107|NCT02673866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110540108|NCT02673866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110540109|NCT02673866|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110540110|NCT02673866|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110540111|NCT02673866|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110540112|NCT02673866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110540113|NCT02673866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110540114|NCT02673866|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110540115|NCT02673866|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110540116|NCT00964561|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110540117|NCT00964561|Ciprofloxacin|ciprofloxacin|mesh-list
110540118|NCT00964561|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
110540119|NCT00964561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110540120|NCT00964561|Antitubercular Agents|antitubercular agents|mesh-ancestor
110540121|NCT00964561|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110540122|NCT00964561|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110540123|NCT00964561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110540124|NCT00964561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110540125|NCT00964561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110540126|NCT00964561|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110540127|NCT00964561|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110540128|NCT02793323|Anesthetics|anesthetics|mesh-list
110540129|NCT02793323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110540130|NCT02793323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110540131|NCT00964639|Ropivacaine|ropivacaine|mesh-list
110540132|NCT00964639|Anesthetics, Local|anesthetics, local|mesh-ancestor
110540133|NCT00964639|Anesthetics|anesthetics|mesh-ancestor
110540134|NCT00964639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110540135|NCT00964639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110540136|NCT00964639|Sensory System Agents|sensory system agents|mesh-ancestor
110540137|NCT00964639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110540138|NCT00880620|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
110540139|NCT00880620|Carbidopa|carbidopa|mesh-list
110540140|NCT00880620|Levodopa|levodopa|mesh-list
110540141|NCT00880620|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110540142|NCT00880620|Immunologic Factors|immunologic factors|mesh-ancestor
110540143|NCT00880620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110540144|NCT00880620|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110540145|NCT00880620|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110540146|NCT00880620|Dopamine Agonists|dopamine agonists|mesh-ancestor
110540147|NCT00880620|Dopamine Agents|dopamine agents|mesh-ancestor
110540148|NCT00880620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110540149|NCT00880620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110540150|NCT00880620|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
110540151|NCT00880620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110540152|NCT00959335|Bicalutamide|bicalutamide|mesh-list
110540153|NCT00959335|Androgen Antagonists|androgen antagonists|mesh-ancestor
110540154|NCT00959335|Hormone Antagonists|hormone antagonists|mesh-ancestor
110540155|NCT00959335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110540156|NCT00959335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110540157|NCT00959335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110540158|NCT00644618|Gemcitabine|gemcitabine|mesh-list
110540159|NCT00644618|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110301797|NCT00247988|Docetaxel|docetaxel|mesh-list
110540160|NCT00644618|Antimetabolites|antimetabolites|mesh-ancestor
110540161|NCT00644618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110540162|NCT00644618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110540164|NCT03967847|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110540165|NCT03967847|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110540166|NCT03967847|Analgesics|analgesics|mesh-ancestor
110540167|NCT03967847|Sensory System Agents|sensory system agents|mesh-ancestor
110540168|NCT03967847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110540169|NCT03967847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110540170|NCT03967847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110540171|NCT03967847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110540172|NCT03967847|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110540173|NCT03967847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110540174|NCT03967847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110540175|NCT04175990|Dydrogesterone|dydrogesterone|mesh-list
110540176|NCT04175990|Progestins|progestins|mesh-ancestor
110540177|NCT04175990|Hormones|hormones|mesh-ancestor
110540178|NCT04175990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110540179|NCT04175990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110540180|NCT00959569|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
110540181|NCT00959569|Esmolol|esmolol|mesh-list
110540183|NCT00959569|Adrenergic Agents|adrenergic agents|mesh-ancestor
110540184|NCT00959569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110540185|NCT00959569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110540186|NCT00959569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110540187|NCT00959569|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110187720|NCT05646992|Azathioprine|azathioprine|mesh-list
110540189|NCT00881868|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110540190|NCT00881868|Glucocorticoids|glucocorticoids|mesh-ancestor
110540192|NCT00881868|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110540193|NCT00881868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110540194|NCT04176068|Calcium|calcium|mesh-list
110540195|NCT04176068|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110540196|NCT04176068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110540197|NCT00959725|Infliximab|infliximab|mesh-list
110540198|NCT00959725|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110540199|NCT00959725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110540200|NCT00959725|Dermatologic Agents|dermatologic agents|mesh-ancestor
110540201|NCT00959725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110540202|NCT00959725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110540203|NCT02789189|Gemcitabine|gemcitabine|mesh-list
110540204|NCT02789189|Nedaplatin|nedaplatin|mesh-list
110540205|NCT02789189|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110540206|NCT02789189|Antimetabolites|antimetabolites|mesh-ancestor
110540207|NCT02789189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110540208|NCT02789189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110540209|NCT04234607|Carboplatin|carboplatin|mesh-list
110540210|NCT04234607|Etoposide|etoposide|mesh-list
110540211|NCT04234607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110540212|NCT04234607|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110540213|NCT04234607|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110540214|NCT04234607|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110540215|NCT04234607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110540216|NCT04234607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110540217|NCT03955471|Niraparib|niraparib|mesh-list
110540218|NCT03955471|Dostarlimab|dostarlimab|mesh-list
110540219|NCT03955471|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110540220|NCT03955471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110540221|NCT03955471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110540222|NCT03955471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110540223|NCT02637726|Remifentanil|remifentanil|mesh-list
110540224|NCT02637726|Propofol|propofol|mesh-list
110540225|NCT02637726|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110540226|NCT02637726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110540227|NCT02637726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110540228|NCT02637726|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110540229|NCT02637726|Anesthetics, General|anesthetics, general|mesh-ancestor
110540230|NCT02637726|Anesthetics|anesthetics|mesh-ancestor
110540231|NCT02637726|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110540232|NCT02637726|Narcotics|narcotics|mesh-ancestor
110540233|NCT02637726|Analgesics|analgesics|mesh-ancestor
110540234|NCT02637726|Sensory System Agents|sensory system agents|mesh-ancestor
110540235|NCT02637726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110540236|NCT04161768|Norfloxacin|norfloxacin|mesh-list
110540237|NCT04161768|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110540238|NCT04161768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110540239|NCT04161768|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110540240|NCT04161768|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110540241|NCT04161768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110540242|NCT04161768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110540243|NCT04161768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110540244|NCT04161768|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110540245|NCT04161768|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110540246|NCT02793011|Dexamethasone|dexamethasone|mesh-list
110540247|NCT02793011|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110540248|NCT02793011|Antiemetics|antiemetics|mesh-ancestor
110540249|NCT02793011|Autonomic Agents|autonomic agents|mesh-ancestor
110540250|NCT02793011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110540251|NCT02793011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110540252|NCT02793011|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110540253|NCT02793011|Glucocorticoids|glucocorticoids|mesh-ancestor
110540254|NCT02793011|Hormones|hormones|mesh-ancestor
110540255|NCT02793011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110540256|NCT02793011|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110540257|NCT02793011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110540258|NCT00965107|Thiopental|thiopental|mesh-list
110540259|NCT00965107|Propofol|propofol|mesh-list
110540260|NCT00965107|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110540261|NCT00965107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110540262|NCT00965107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110540263|NCT00965107|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110540264|NCT00965107|Anesthetics, General|anesthetics, general|mesh-ancestor
110540266|NCT00965107|Anticonvulsants|anticonvulsants|mesh-ancestor
110540267|NCT00965107|GABA Modulators|gaba modulators|mesh-ancestor
110540268|NCT00965107|GABA Agents|gaba agents|mesh-ancestor
110540269|NCT00965107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110540270|NCT00965107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110540271|NCT02788877|Aflibercept|aflibercept|mesh-list
110540272|NCT02788877|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110540273|NCT02788877|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110540274|NCT02788877|Growth Substances|growth substances|mesh-ancestor
110540275|NCT02788877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110540276|NCT02788877|Growth Inhibitors|growth inhibitors|mesh-ancestor
110540277|NCT02788877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110540278|NCT00959881|Donepezil|donepezil|mesh-list
110540279|NCT00959881|Begacestat|begacestat|mesh-list
110540280|NCT00959881|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110540281|NCT00959881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110540282|NCT00959881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110540283|NCT00959881|Cholinergic Agents|cholinergic agents|mesh-ancestor
110540284|NCT00959881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110540285|NCT00959881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110540286|NCT00959881|Nootropic Agents|nootropic agents|mesh-ancestor
110540287|NCT00959881|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
110540288|NCT00959959|3-hydroxy-17-(1H-benzimidazole-1-yl)androsta-5,16-diene|3-hydroxy-17-(1h-benzimidazole-1-yl)androsta-5,16-diene|mesh-list
110540289|NCT00959959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110540290|NCT00959959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110540291|NCT03651011|Aflibercept|aflibercept|mesh-list
110540292|NCT03651011|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110540293|NCT03651011|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110540294|NCT03651011|Growth Substances|growth substances|mesh-ancestor
110540295|NCT03651011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110540296|NCT03651011|Growth Inhibitors|growth inhibitors|mesh-ancestor
110540297|NCT03651011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110540298|NCT00880542|Sorafenib|sorafenib|mesh-list
110540299|NCT00880542|Ifosfamide|ifosfamide|mesh-list
110540300|NCT00880542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110540301|NCT00880542|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110540302|NCT00880542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110540303|NCT00880542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110540304|NCT00880542|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110540305|NCT00880542|Alkylating Agents|alkylating agents|mesh-ancestor
110540306|NCT00960037|Vitamin D|vitamin d|mesh-list
110540307|NCT00960037|Cholecalciferol|cholecalciferol|mesh-list
110540308|NCT00960037|Vitamins|vitamins|mesh-ancestor
110540309|NCT00960037|Micronutrients|micronutrients|mesh-ancestor
110540310|NCT00960037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110540311|NCT00960037|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110540312|NCT00960037|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110540313|NCT04161690|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
110540314|NCT04161690|Ropivacaine|ropivacaine|mesh-list
110540315|NCT04161690|Anesthetics, Local|anesthetics, local|mesh-ancestor
110540316|NCT04161690|Anesthetics|anesthetics|mesh-ancestor
110540317|NCT04161690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110540318|NCT04161690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110540319|NCT04161690|Sensory System Agents|sensory system agents|mesh-ancestor
110540320|NCT04161690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110540321|NCT04161690|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110540322|NCT04161690|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110540323|NCT04161690|Analgesics|analgesics|mesh-ancestor
110540324|NCT04161690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110540325|NCT04161690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110540326|NCT00885534|Temozolomide|temozolomide|mesh-list
110540327|NCT00885534|Vinblastine|vinblastine|mesh-list
110540328|NCT00885534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110540329|NCT00885534|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110540330|NCT00885534|Alkylating Agents|alkylating agents|mesh-ancestor
110540331|NCT00885534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110540332|NCT00885534|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110540333|NCT00885534|Tubulin Modulators|tubulin modulators|mesh-ancestor
110540334|NCT00885534|Antimitotic Agents|antimitotic agents|mesh-ancestor
110540335|NCT00885534|Mitosis Modulators|mitosis modulators|mesh-ancestor
110540336|NCT05277038|Clonidine|clonidine|mesh-list
110540337|NCT05277038|Zopiclone|zopiclone|mesh-list
110540338|NCT05277038|Analgesics|analgesics|mesh-ancestor
110540339|NCT05277038|Sensory System Agents|sensory system agents|mesh-ancestor
110540340|NCT05277038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110540341|NCT05277038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110540342|NCT05277038|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110540343|NCT05277038|Sympatholytics|sympatholytics|mesh-ancestor
110540344|NCT05277038|Autonomic Agents|autonomic agents|mesh-ancestor
110540345|NCT05277038|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110540346|NCT05277038|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110540347|NCT05277038|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110540348|NCT05277038|Adrenergic Agents|adrenergic agents|mesh-ancestor
110540349|NCT05277038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110540350|NCT05277038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110540351|NCT05277038|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110540352|NCT05277038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110540353|NCT00960349|Cisplatin|cisplatin|mesh-list
110540354|NCT00960349|Capecitabine|capecitabine|mesh-list
110540355|NCT00960349|Cediranib|cediranib|mesh-list
110540356|NCT00960349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110540357|NCT00960349|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110540358|NCT00960349|Antimetabolites|antimetabolites|mesh-ancestor
110540359|NCT00960349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110540360|NCT00960349|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110540361|NCT00960349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110540362|NCT02670434|Pitavastatin|pitavastatin|mesh-list
110540363|NCT02670434|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110540364|NCT02670434|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110540365|NCT02670434|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110540366|NCT02670434|Antimetabolites|antimetabolites|mesh-ancestor
110540367|NCT02670434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110540368|NCT02670434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110540369|NCT02670434|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110540370|NCT00965653|Folic Acid|folic acid|mesh-list
110540371|NCT00965653|Methotrexate|methotrexate|mesh-list
110540372|NCT00965653|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110540373|NCT00965653|Abortifacient Agents|abortifacient agents|mesh-ancestor
110540374|NCT00965653|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110540375|NCT00965653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110540376|NCT00965653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110540377|NCT00965653|Antimetabolites|antimetabolites|mesh-ancestor
110540378|NCT00965653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110540379|NCT00965653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110540380|NCT00965653|Dermatologic Agents|dermatologic agents|mesh-ancestor
110540381|NCT00965653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110540382|NCT00965653|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110540383|NCT00965653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110540384|NCT00965653|Immunologic Factors|immunologic factors|mesh-ancestor
110540385|NCT00965653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110540386|NCT00965653|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110540387|NCT00965653|Hematinics|hematinics|mesh-ancestor
110540388|NCT00965653|Vitamin B Complex|vitamin b complex|mesh-ancestor
110540389|NCT00965653|Vitamins|vitamins|mesh-ancestor
110540390|NCT00965653|Micronutrients|micronutrients|mesh-ancestor
110540391|NCT00644696|Cefixime|cefixime|mesh-list
110540392|NCT00644696|Cefpodoxime|cefpodoxime|mesh-list
110540393|NCT00644696|Irinotecan|irinotecan|mesh-list
110540394|NCT00644696|Bortezomib|bortezomib|mesh-list
110176852|NCT00135499|Rituximab|rituximab|mesh-list
110540395|NCT00644696|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110540396|NCT00644696|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110540398|NCT00644696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110540399|NCT00644696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110540400|NCT00644696|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110540401|NCT00644696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110540402|NCT00960739|Topotecan|topotecan|mesh-list
110540403|NCT00960739|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
110540404|NCT00960739|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110540405|NCT00960739|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110540407|NCT00960739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110540408|NCT00960739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110540409|NCT00960739|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110540410|NCT00659022|Bevacizumab|bevacizumab|mesh-list
110540411|NCT00659022|Capecitabine|capecitabine|mesh-list
110540412|NCT00659022|Oxaliplatin|oxaliplatin|mesh-list
110540413|NCT00659022|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110540414|NCT00659022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110540415|NCT00659022|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110540416|NCT00659022|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110540417|NCT00659022|Growth Substances|growth substances|mesh-ancestor
110540418|NCT00659022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110540419|NCT00659022|Growth Inhibitors|growth inhibitors|mesh-ancestor
110540420|NCT00659022|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110540421|NCT00659022|Antimetabolites|antimetabolites|mesh-ancestor
110540422|NCT00659022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110540423|NCT02788643|Dimercaprol|dimercaprol|mesh-list
110540424|NCT02788643|Chelating Agents|chelating agents|mesh-ancestor
110540425|NCT02788643|Sequestering Agents|sequestering agents|mesh-ancestor
110540426|NCT02788643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110540427|NCT04175522|Immunoglobulins|immunoglobulins|mesh-list
110540428|NCT04175522|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110540429|NCT04175522|Antibodies|antibodies|mesh-list
110540430|NCT04175522|Immunoglobulin G|immunoglobulin g|mesh-list
110540431|NCT04175522|Immunologic Factors|immunologic factors|mesh-ancestor
110540432|NCT04175522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110540433|NCT00960817|Aspirin|aspirin|mesh-list
110540434|NCT00960817|Dipyridamole|dipyridamole|mesh-list
110540435|NCT00960817|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110540436|NCT00960817|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110540437|NCT00960817|Analgesics|analgesics|mesh-ancestor
110540438|NCT00960817|Sensory System Agents|sensory system agents|mesh-ancestor
110540439|NCT00960817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110540440|NCT00960817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110540441|NCT00960817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110540442|NCT00960817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110540443|NCT00960817|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110540444|NCT00960817|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110540445|NCT00960817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110302076|NCT00249431|Sertraline|sertraline|mesh-list
110540446|NCT00960817|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110540447|NCT00960817|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110540448|NCT00960817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110540449|NCT00960817|Antipyretics|antipyretics|mesh-ancestor
110540450|NCT00960817|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110540451|NCT00960817|Vasodilator Agents|vasodilator agents|mesh-ancestor
110540452|NCT00965809|Dronabinol|dronabinol|mesh-list
110540453|NCT00965809|Hallucinogens|hallucinogens|mesh-ancestor
110540454|NCT00965809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110540455|NCT00965809|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110540456|NCT00965809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110540457|NCT00965809|Analgesics|analgesics|mesh-ancestor
110540458|NCT00965809|Sensory System Agents|sensory system agents|mesh-ancestor
110540459|NCT00965809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110540460|NCT00965809|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
110280898|NCT00190229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110540461|NCT00965809|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110540462|NCT00965809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110540463|NCT00965809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110540464|NCT00965809|Hormones|hormones|mesh-ancestor
110540465|NCT00965809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110540466|NCT00885378|Metformin|metformin|mesh-list
110540467|NCT00885378|Saxagliptin|saxagliptin|mesh-list
110540468|NCT00885378|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110540469|NCT00885378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110540470|NCT00885378|Incretins|incretins|mesh-ancestor
110540471|NCT00885378|Hormones|hormones|mesh-ancestor
110540472|NCT00885378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110540473|NCT00885378|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110540474|NCT00885378|Protease Inhibitors|protease inhibitors|mesh-ancestor
110540475|NCT00885378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110540476|NCT00885378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110540477|NCT04095494|Nitrous Oxide|nitrous oxide|mesh-list
110540478|NCT04095494|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110540479|NCT04095494|Anesthetics, General|anesthetics, general|mesh-ancestor
110540481|NCT04095494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110540482|NCT04095494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110540483|NCT04095494|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110540484|NCT04095494|Analgesics|analgesics|mesh-ancestor
110540485|NCT04095494|Sensory System Agents|sensory system agents|mesh-ancestor
110540486|NCT04095494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110188019|NCT04671966|Estradiol|estradiol|mesh-list
110540487|NCT02537210|Mesalamine|mesalamine|mesh-list
110540488|NCT02537210|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110540489|NCT02537210|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110540490|NCT02537210|Analgesics|analgesics|mesh-ancestor
110540491|NCT02537210|Sensory System Agents|sensory system agents|mesh-ancestor
110540492|NCT02537210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110540493|NCT02537210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110540494|NCT02537210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110540495|NCT02537210|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110540496|NCT01563289|Ibuprofen|ibuprofen|mesh-list
110540497|NCT01563289|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110540498|NCT01563289|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110540499|NCT01563289|Analgesics|analgesics|mesh-ancestor
110540500|NCT01563289|Sensory System Agents|sensory system agents|mesh-ancestor
110540501|NCT01563289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110540502|NCT01563289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110540503|NCT01563289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110540504|NCT01563289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110540505|NCT01563289|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110540506|NCT01563289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110540507|NCT01563289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110540508|NCT00960973|Menatetrenone|menatetrenone|mesh-list
110540509|NCT00960973|Hemostatics|hemostatics|mesh-ancestor
110540510|NCT00960973|Coagulants|coagulants|mesh-ancestor
110540511|NCT04099849|Zinc|zinc|mesh-list
110540512|NCT04099849|Trace Elements|trace elements|mesh-ancestor
110540513|NCT04099849|Micronutrients|micronutrients|mesh-ancestor
110540514|NCT04099849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110540515|NCT00659100|Gabapentin|gabapentin|mesh-list
110540516|NCT00659100|Analgesics|analgesics|mesh-ancestor
110540517|NCT00659100|Sensory System Agents|sensory system agents|mesh-ancestor
110540518|NCT00659100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110540519|NCT00659100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110540520|NCT00659100|Anticonvulsants|anticonvulsants|mesh-ancestor
110540521|NCT00659100|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110540522|NCT00659100|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110302193|NCT00249977|Irinotecan|irinotecan|mesh-list
110540523|NCT00659100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110540524|NCT00659100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110540525|NCT00659100|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110540526|NCT00659100|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110540527|NCT00659100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110540528|NCT00659100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110540529|NCT00659100|Antimanic Agents|antimanic agents|mesh-ancestor
110540530|NCT00659178|Doxorubicin|doxorubicin|mesh-list
110540531|NCT00659178|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110540532|NCT00659178|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110540533|NCT00659178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110540534|NCT00659178|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110540535|NCT00659178|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110540536|NCT00659178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110540537|NCT00659178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110540538|NCT02792621|Acipimox|acipimox|mesh-list
110540539|NCT02792621|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110540540|NCT02792621|Antimetabolites|antimetabolites|mesh-ancestor
110540541|NCT02792621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110540542|NCT02792621|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110540543|NCT04009759|Ketamine|ketamine|mesh-list
110540544|NCT04009759|Morphine|morphine|mesh-list
110540545|NCT04009759|Analgesics|analgesics|mesh-ancestor
110540546|NCT04009759|Sensory System Agents|sensory system agents|mesh-ancestor
110540547|NCT04009759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110540548|NCT04009759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110540549|NCT04009759|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110540550|NCT04009759|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110540551|NCT04009759|Anesthetics, General|anesthetics, general|mesh-ancestor
110540552|NCT04009759|Anesthetics|anesthetics|mesh-ancestor
110540553|NCT04009759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110540554|NCT04009759|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110540555|NCT04009759|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110540556|NCT04009759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110540557|NCT04009759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110540558|NCT04009759|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110540559|NCT04009759|Narcotics|narcotics|mesh-ancestor
110540560|NCT00645086|Clarithromycin|clarithromycin|mesh-list
110540561|NCT00645086|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110540562|NCT00645086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110540563|NCT00645086|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110540564|NCT00645086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110540565|NCT00645086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110540566|NCT00645086|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110540567|NCT00645086|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110540569|NCT05238649|Immunologic Factors|immunologic factors|mesh-ancestor
110540570|NCT05238649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110540571|NCT02792153|Estradiol|estradiol|mesh-list
110540572|NCT02792153|Estrogens|estrogens|mesh-ancestor
110540573|NCT02792153|Hormones|hormones|mesh-ancestor
110540574|NCT02792153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110540575|NCT02792153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110540576|NCT00644540|Vaccines|vaccines|mesh-list
110540577|NCT00644540|Immunologic Factors|immunologic factors|mesh-ancestor
110540578|NCT00644540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110540579|NCT02669732|Firuglipel|firuglipel|mesh-list
110540580|NCT02669732|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110540581|NCT02669732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110540582|NCT05003245|Ranibizumab|ranibizumab|mesh-list
110540583|NCT05003245|Antibodies|antibodies|mesh-list
110540584|NCT05003245|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110540585|NCT05003245|Mitogens|mitogens|mesh-list
110540586|NCT05003245|Endothelial Growth Factors|endothelial growth factors|mesh-list
110540587|NCT05003245|Immunologic Factors|immunologic factors|mesh-ancestor
110540588|NCT05003245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110540589|NCT05003245|Mitosis Modulators|mitosis modulators|mesh-ancestor
110540590|NCT05003245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110540591|NCT05003245|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110540592|NCT05003245|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110540593|NCT05003245|Growth Substances|growth substances|mesh-ancestor
110540594|NCT05003245|Growth Inhibitors|growth inhibitors|mesh-ancestor
110540595|NCT05003245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110540596|NCT05367089|Fluconazole|fluconazole|mesh-list
110540597|NCT05367089|Antifungal Agents|antifungal agents|mesh-ancestor
110540598|NCT05367089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110540599|NCT05367089|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110540600|NCT05367089|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110540601|NCT05367089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110540602|NCT05367089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110540603|NCT05367089|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110540604|NCT05367089|Hormone Antagonists|hormone antagonists|mesh-ancestor
110540605|NCT05367089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110176862|NCT00135499|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110540606|NCT05367089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110540607|NCT05367089|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110540608|NCT05367089|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110540609|NCT02671058|Hydrocortisone|hydrocortisone|mesh-list
110540610|NCT02671058|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
110540611|NCT02671058|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
110540612|NCT02671058|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
110540613|NCT02671058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110540614|NCT02791919|Cytarabine|cytarabine|mesh-list
110540615|NCT02791919|Fludarabine|fludarabine|mesh-list
110540616|NCT02791919|Fludarabine phosphate|fludarabine phosphate|mesh-list
110540617|NCT02791919|Lenograstim|lenograstim|mesh-list
110540618|NCT02791919|Adavosertib|adavosertib|mesh-list
110540619|NCT02791919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110540620|NCT02791919|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110540621|NCT02791919|Antimetabolites|antimetabolites|mesh-ancestor
110540622|NCT02791919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110540623|NCT02791919|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110540624|NCT02791919|Immunologic Factors|immunologic factors|mesh-ancestor
110540625|NCT02791919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110540627|NCT02791919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110540628|NCT02791919|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110540629|NCT02791919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110540630|NCT00966121|Propranolol|propranolol|mesh-list
110540631|NCT00966121|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110540632|NCT00966121|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110540633|NCT00966121|Adrenergic Agents|adrenergic agents|mesh-ancestor
110540634|NCT00966121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110540635|NCT00966121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110540636|NCT00966121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110540637|NCT00966121|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110540638|NCT00966121|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110540640|NCT02537288|Moxifloxacin|moxifloxacin|mesh-list
110540641|NCT02537288|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110540642|NCT02537288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110540643|NCT02537288|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110540644|NCT02537288|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110540645|NCT02537288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110540646|NCT02537288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110540647|NCT02537288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110540648|NCT00659412|Methotrexate|methotrexate|mesh-list
110540649|NCT00659412|Alefacept|alefacept|mesh-list
110540650|NCT00659412|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110540651|NCT00659412|Abortifacient Agents|abortifacient agents|mesh-ancestor
110540652|NCT00659412|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110540653|NCT00659412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110540654|NCT00659412|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110540655|NCT00659412|Antimetabolites|antimetabolites|mesh-ancestor
110540656|NCT00659412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110540657|NCT00659412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110540658|NCT00659412|Dermatologic Agents|dermatologic agents|mesh-ancestor
110540659|NCT00659412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110540660|NCT00659412|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110540661|NCT00659412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110540662|NCT00659412|Immunologic Factors|immunologic factors|mesh-ancestor
110540663|NCT00659412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110540664|NCT00659412|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110176873|NCT00135499|Glucocorticoids|glucocorticoids|mesh-ancestor
110540666|NCT04176224|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110540667|NCT04176224|Antioxidants|antioxidants|mesh-ancestor
110540668|NCT04176224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110540669|NCT04176224|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110540670|NCT04176224|Protective Agents|protective agents|mesh-ancestor
110540671|NCT04176224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110540672|NCT00966199|Antihypertensive Agents|antihypertensive agents|mesh-list
110540673|NCT04158102|Bupivacaine|bupivacaine|mesh-list
110540674|NCT04158102|Anesthetics, Local|anesthetics, local|mesh-ancestor
110540675|NCT04158102|Anesthetics|anesthetics|mesh-ancestor
110540676|NCT04158102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110540677|NCT04158102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110540678|NCT04158102|Sensory System Agents|sensory system agents|mesh-ancestor
110540679|NCT04158102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110540680|NCT02689895|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
110540681|NCT02689895|Antiviral Agents|antiviral agents|mesh-ancestor
110540682|NCT02689895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110540683|NCT00961363|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110540684|NCT00961363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110540685|NCT00961363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110540686|NCT00961363|Incretins|incretins|mesh-ancestor
110540687|NCT00961363|Hormones|hormones|mesh-ancestor
110540688|NCT00961363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110540689|NCT00961363|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110540690|NCT00961363|Protease Inhibitors|protease inhibitors|mesh-ancestor
110540691|NCT00961363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110343807|NCT06022614|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110540692|NCT00961363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110540693|NCT02633202|Cisplatin|cisplatin|mesh-list
110540694|NCT02633202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110540695|NCT00645242|Fluconazole|fluconazole|mesh-list
110540696|NCT00645242|Antifungal Agents|antifungal agents|mesh-ancestor
110540697|NCT00645242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110540698|NCT00645242|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110540699|NCT00645242|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110540700|NCT00645242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110540701|NCT00645242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110540702|NCT00645242|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110540703|NCT00645242|Hormone Antagonists|hormone antagonists|mesh-ancestor
110540704|NCT00645242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110540705|NCT00645242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110540706|NCT00645242|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110540707|NCT00645242|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110540709|NCT00659568|Sirolimus|sirolimus|mesh-list
110540710|NCT00659568|Temsirolimus|temsirolimus|mesh-list
110540711|NCT00659568|MTOR Inhibitors|mtor inhibitors|mesh-list
110540712|NCT00659568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110281001|NCT00213564|Infliximab|infliximab|mesh-list
110540713|NCT00659568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110540714|NCT00659568|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110540715|NCT00659568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110540716|NCT00659568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110540717|NCT00659568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110540718|NCT00659568|Immunologic Factors|immunologic factors|mesh-ancestor
110540719|NCT00659568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110540720|NCT00659568|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110540721|NCT00659568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110540722|NCT00659568|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110540723|NCT00659568|Antifungal Agents|antifungal agents|mesh-ancestor
110540725|NCT00961753|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110540726|NCT00961753|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110540727|NCT00961753|Analgesics|analgesics|mesh-ancestor
110540728|NCT00961753|Sensory System Agents|sensory system agents|mesh-ancestor
110540729|NCT00961753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110540730|NCT00961753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110540731|NCT00961753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110540732|NCT00961753|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110540733|NCT00961753|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110540734|NCT00961753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110540735|NCT00961753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110540736|NCT04232813|Estradiol|estradiol|mesh-list
110540737|NCT04232813|Estrogens|estrogens|mesh-ancestor
110540738|NCT04232813|Hormones|hormones|mesh-ancestor
110540739|NCT04232813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110540740|NCT04232813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110540741|NCT00659958|Zonisamide|zonisamide|mesh-list
110540742|NCT00659958|Anticonvulsants|anticonvulsants|mesh-ancestor
110540743|NCT00659958|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110540744|NCT00659958|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110540745|NCT00659958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110540746|NCT00659958|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110540747|NCT00659958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110540748|NCT00644774|Azithromycin|azithromycin|mesh-list
110540749|NCT00644774|Cefdinir|cefdinir|mesh-list
110540750|NCT00644774|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110540751|NCT00644774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110540752|NCT00545779|Ibandronic Acid|ibandronic acid|mesh-list
110540753|NCT00545779|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110540754|NCT00545779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110540755|NCT00910442|Acetylcysteine|acetylcysteine|mesh-list
110540756|NCT00910442|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110540757|NCT00910442|Antiviral Agents|antiviral agents|mesh-ancestor
110540758|NCT00910442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110540759|NCT00910442|Expectorants|expectorants|mesh-ancestor
110540760|NCT00910442|Respiratory System Agents|respiratory system agents|mesh-ancestor
110540761|NCT00910442|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110540762|NCT00910442|Antioxidants|antioxidants|mesh-ancestor
110540763|NCT00910442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110540764|NCT00910442|Protective Agents|protective agents|mesh-ancestor
110540765|NCT00910442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110540766|NCT00910442|Antidotes|antidotes|mesh-ancestor
110540767|NCT00660036|Etoposide|etoposide|mesh-list
110540768|NCT00660036|Mitoxantrone|mitoxantrone|mesh-list
110540769|NCT00660036|Gemtuzumab|gemtuzumab|mesh-list
110540770|NCT00660036|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110540771|NCT00660036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110540772|NCT00660036|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110540773|NCT00660036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110540774|NCT00660036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110540775|NCT00660036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110540776|NCT00660036|Analgesics|analgesics|mesh-ancestor
110540777|NCT00660036|Sensory System Agents|sensory system agents|mesh-ancestor
110540778|NCT00660036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110540779|NCT00660036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110540780|NCT00660036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110540781|NCT00660036|Immunotoxins|immunotoxins|mesh-ancestor
110540782|NCT00660036|Immunoconjugates|immunoconjugates|mesh-ancestor
110540783|NCT00660036|Immunologic Factors|immunologic factors|mesh-ancestor
110540784|NCT02791373|Gemcitabine|gemcitabine|mesh-list
110540785|NCT02791373|Vinorelbine|vinorelbine|mesh-list
110540786|NCT02791373|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110188316|NCT03589729|Calicheamicins|calicheamicins|mesh-list
110540787|NCT02791373|Antimetabolites|antimetabolites|mesh-ancestor
110540788|NCT02791373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110540789|NCT02791373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110540790|NCT02791373|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110176903|NCT00135811|Cyclosporine|cyclosporine|mesh-list
110176905|NCT00135811|Cyclosporins|cyclosporins|mesh-list
110540791|NCT02791373|Tubulin Modulators|tubulin modulators|mesh-ancestor
110540792|NCT02791373|Antimitotic Agents|antimitotic agents|mesh-ancestor
110540793|NCT02791373|Mitosis Modulators|mitosis modulators|mesh-ancestor
110540795|NCT03102047|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110540796|NCT03102047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110540797|NCT00966745|Milrinone|milrinone|mesh-list
110540798|NCT00966745|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110540799|NCT00966745|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110540800|NCT00966745|Vasodilator Agents|vasodilator agents|mesh-ancestor
110540801|NCT00966745|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110540802|NCT00966745|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110540803|NCT00966745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110540804|NCT00966745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110540805|NCT00966745|Protective Agents|protective agents|mesh-ancestor
110540806|NCT00966745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110540807|NCT02669030|Suvorexant|suvorexant|mesh-list
110540808|NCT02669030|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110540809|NCT02669030|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110540810|NCT02669030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110540811|NCT02669030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110540812|NCT02669030|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
110540813|NCT02669030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110540814|NCT02669030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110540815|NCT02668796|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110540816|NCT02668796|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110540818|NCT02668796|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110540819|NCT02668796|Estrogens|estrogens|mesh-ancestor
110540820|NCT02668796|Hormones|hormones|mesh-ancestor
110540821|NCT02668796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110540822|NCT02668796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110540823|NCT02668796|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110540824|NCT02668796|Contraceptive Agents|contraceptive agents|mesh-ancestor
110540825|NCT02668796|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110540826|NCT02668796|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110540827|NCT00645320|Ziprasidone|ziprasidone|mesh-list
110540828|NCT00645320|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110302441|NCT01640275|Propofol|propofol|mesh-list
110540829|NCT00645320|Serotonin Agents|serotonin agents|mesh-ancestor
110540830|NCT00645320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110540831|NCT00645320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110540832|NCT00645320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110540833|NCT00645320|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110540834|NCT00645320|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110540835|NCT00645320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110540836|NCT00645320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110540837|NCT00645320|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110540838|NCT00645320|Dopamine Agents|dopamine agents|mesh-ancestor
110540839|NCT03938857|Fentanyl|fentanyl|mesh-list
110540840|NCT03938857|Dexmedetomidine|dexmedetomidine|mesh-list
110540841|NCT03938857|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110540842|NCT03938857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110540843|NCT03938857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110540844|NCT03938857|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110540845|NCT03938857|Analgesics|analgesics|mesh-ancestor
110540846|NCT03938857|Sensory System Agents|sensory system agents|mesh-ancestor
110540847|NCT03938857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110540848|NCT03938857|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110540849|NCT03938857|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110540850|NCT03938857|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110540851|NCT03938857|Adrenergic Agents|adrenergic agents|mesh-ancestor
110540852|NCT03938857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110540853|NCT03938857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110540854|NCT03938857|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110540855|NCT03938857|Narcotics|narcotics|mesh-ancestor
110540856|NCT03938857|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110540857|NCT03938857|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110540858|NCT03938857|Anesthetics, General|anesthetics, general|mesh-ancestor
110540859|NCT03938857|Anesthetics|anesthetics|mesh-ancestor
110188392|NCT03338790|Prednisone|prednisone|mesh-list
110540861|NCT04160598|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110540862|NCT04160598|Narcotics|narcotics|mesh-ancestor
110540863|NCT04160598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110540864|NCT04160598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110540865|NCT04160598|Analgesics|analgesics|mesh-ancestor
110540866|NCT04160598|Sensory System Agents|sensory system agents|mesh-ancestor
110540867|NCT04160598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110540868|NCT04160598|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110540869|NCT04160598|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110540870|NCT04160598|Anesthetics, General|anesthetics, general|mesh-ancestor
110540871|NCT04160598|Anesthetics|anesthetics|mesh-ancestor
110540872|NCT00967837|Insulin|insulin|mesh-list
110540873|NCT00967837|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110540874|NCT00967837|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110540875|NCT00967837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110540876|NCT02668016|Atorvastatin|atorvastatin|mesh-list
110540877|NCT02668016|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
110540878|NCT02668016|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110540879|NCT02668016|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110540880|NCT02668016|Antimetabolites|antimetabolites|mesh-ancestor
110540881|NCT02668016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110540882|NCT02668016|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110540883|NCT02668016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110540884|NCT00966901|Nicotine|nicotine|mesh-list
110540885|NCT00966901|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110540886|NCT00966901|Autonomic Agents|autonomic agents|mesh-ancestor
110540887|NCT00966901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110540888|NCT00966901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110540889|NCT00966901|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110540890|NCT00966901|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110540891|NCT00966901|Cholinergic Agents|cholinergic agents|mesh-ancestor
110540892|NCT00966901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110540893|NCT00966901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110540894|NCT02668172|Pasireotide|pasireotide|mesh-list
110540895|NCT02668172|Hormones|hormones|mesh-ancestor
110540896|NCT02668172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110540897|NCT02668172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110540898|NCT00660270|Interferons|interferons|mesh-list
110302553|NCT00280098|Docetaxel|docetaxel|mesh-list
110540899|NCT00660270|Interferon-alpha|interferon-alpha|mesh-list
110540900|NCT00660270|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
110540901|NCT00660270|Gemcitabine|gemcitabine|mesh-list
110540902|NCT00660270|Fluorouracil|fluorouracil|mesh-list
110540903|NCT00660270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110540904|NCT00660270|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110540905|NCT00660270|Antimetabolites|antimetabolites|mesh-ancestor
110540906|NCT00660270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110540907|NCT00660270|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110540908|NCT00660270|Immunologic Factors|immunologic factors|mesh-ancestor
110540909|NCT00660270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110540910|NCT00660270|Antiviral Agents|antiviral agents|mesh-ancestor
110540911|NCT00660270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110540912|NCT04032132|Curcumin|curcumin|mesh-list
110540913|NCT04032132|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110540914|NCT04032132|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110540915|NCT04032132|Analgesics|analgesics|mesh-ancestor
110540916|NCT04032132|Sensory System Agents|sensory system agents|mesh-ancestor
110540917|NCT04032132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110540918|NCT04032132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110540919|NCT04032132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110540920|NCT04032132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110540921|NCT04032132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110540922|NCT04032132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110197463|NCT00219934|Antiviral Agents|antiviral agents|mesh-ancestor
110540923|NCT04032132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110540925|NCT00967057|Methotrexate|methotrexate|mesh-list
110540926|NCT00967057|Vincristine|vincristine|mesh-list
110540927|NCT00967057|Asparaginase|asparaginase|mesh-list
110540928|NCT00967057|Mitoxantrone|mitoxantrone|mesh-list
110540929|NCT00967057|Idarubicin|idarubicin|mesh-list
110540930|NCT00967057|Pegaspargase|pegaspargase|mesh-list
110540931|NCT00967057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110540932|NCT00967057|Antiemetics|antiemetics|mesh-ancestor
110540933|NCT00967057|Autonomic Agents|autonomic agents|mesh-ancestor
110540934|NCT00967057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110540935|NCT00967057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110188468|NCT02899611|Antimanic Agents|antimanic agents|mesh-ancestor
110540936|NCT00967057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110540937|NCT00967057|Glucocorticoids|glucocorticoids|mesh-ancestor
110540938|NCT00967057|Hormones|hormones|mesh-ancestor
110540939|NCT00967057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110540940|NCT00967057|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110540941|NCT00967057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110540942|NCT00967057|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110540943|NCT00967057|Abortifacient Agents|abortifacient agents|mesh-ancestor
110540944|NCT00967057|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110540945|NCT00967057|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110540946|NCT00967057|Antimetabolites|antimetabolites|mesh-ancestor
110540947|NCT00967057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110540948|NCT00967057|Dermatologic Agents|dermatologic agents|mesh-ancestor
110540949|NCT00967057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110540950|NCT00967057|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110540951|NCT00967057|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110540952|NCT00967057|Immunologic Factors|immunologic factors|mesh-ancestor
110540953|NCT00967057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110540954|NCT00967057|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110540955|NCT00967057|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110540956|NCT00967057|Tubulin Modulators|tubulin modulators|mesh-ancestor
110540957|NCT00967057|Antimitotic Agents|antimitotic agents|mesh-ancestor
110540958|NCT00967057|Mitosis Modulators|mitosis modulators|mesh-ancestor
110540959|NCT00967057|Analgesics|analgesics|mesh-ancestor
110540960|NCT00967057|Sensory System Agents|sensory system agents|mesh-ancestor
110540961|NCT00967057|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110540962|NCT00967057|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110540963|NCT00967057|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110540964|NCT02633514|Etoposide|etoposide|mesh-list
110540965|NCT02633514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110540966|NCT02633514|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110540967|NCT02633514|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110540968|NCT02633514|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110540969|NCT02633514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110540970|NCT02633514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110540971|NCT00656214|Lycopene|lycopene|mesh-list
110540972|NCT00656214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110540973|NCT00656214|Antioxidants|antioxidants|mesh-ancestor
110540974|NCT00656214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110540976|NCT00656214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110540977|NCT00656214|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110540978|NCT00656214|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110540979|NCT00656214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110540980|NCT02790671|Firuglipel|firuglipel|mesh-list
110540981|NCT02790671|Itraconazole|itraconazole|mesh-list
110540982|NCT02790671|Antifungal Agents|antifungal agents|mesh-ancestor
110540983|NCT02790671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110540984|NCT02790671|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110540985|NCT02790671|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110540986|NCT02790671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110540987|NCT02790671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110540988|NCT02790671|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110540989|NCT02790671|Hormone Antagonists|hormone antagonists|mesh-ancestor
110540990|NCT02790671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110540992|NCT02790671|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110540993|NCT02790671|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110540994|NCT02668094|Lidocaine|lidocaine|mesh-list
110540995|NCT02668094|Pregabalin|pregabalin|mesh-list
110540996|NCT02668094|Propofol|propofol|mesh-list
110540997|NCT02668094|Anesthetics, Local|anesthetics, local|mesh-ancestor
110540998|NCT02668094|Anesthetics|anesthetics|mesh-ancestor
110540999|NCT02668094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110541000|NCT02668094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110541001|NCT02668094|Sensory System Agents|sensory system agents|mesh-ancestor
110541002|NCT02668094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110541003|NCT02668094|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110541004|NCT02668094|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110541005|NCT02668094|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110541006|NCT02668094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110541007|NCT02668094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110541008|NCT02668094|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110541009|NCT02668094|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110541010|NCT02668094|Anesthetics, General|anesthetics, general|mesh-ancestor
110541011|NCT02668094|Analgesics|analgesics|mesh-ancestor
110541012|NCT02668094|Anticonvulsants|anticonvulsants|mesh-ancestor
110541013|NCT02668094|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110541014|NCT02668094|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110541015|NCT02668094|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110541016|NCT02668094|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110541017|NCT02668094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110541019|NCT00967135|Analgesics|analgesics|mesh-ancestor
110541020|NCT00967135|Sensory System Agents|sensory system agents|mesh-ancestor
110541021|NCT00967135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110541022|NCT00967135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110541023|NCT00967135|Anticonvulsants|anticonvulsants|mesh-ancestor
110541024|NCT00967135|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110541025|NCT00967135|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110541026|NCT00967135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110541027|NCT00967135|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110541028|NCT00967135|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110541029|NCT00967135|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110541030|NCT00967135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110541031|NCT00967135|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110541033|NCT02666768|Interferon-gamma|interferon-gamma|mesh-list
110541034|NCT02666768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110541035|NCT02666768|Antiviral Agents|antiviral agents|mesh-ancestor
110541036|NCT02666768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110541037|NCT00967213|Ranibizumab|ranibizumab|mesh-list
110541038|NCT00967213|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110541039|NCT00967213|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110541040|NCT00967213|Growth Substances|growth substances|mesh-ancestor
110541041|NCT00967213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110541042|NCT00967213|Growth Inhibitors|growth inhibitors|mesh-ancestor
110541043|NCT00967213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110541044|NCT04160676|Ascorbic Acid|ascorbic acid|mesh-list
110541045|NCT04160676|Thiamine|thiamine|mesh-list
110541046|NCT04160676|Hydrocortisone|hydrocortisone|mesh-list
110541047|NCT04160676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110541048|NCT04160676|Antioxidants|antioxidants|mesh-ancestor
110541049|NCT04160676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110541050|NCT04160676|Protective Agents|protective agents|mesh-ancestor
110541051|NCT04160676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110541052|NCT04160676|Vitamins|vitamins|mesh-ancestor
110541053|NCT04160676|Micronutrients|micronutrients|mesh-ancestor
110541054|NCT04160676|Vitamin B Complex|vitamin b complex|mesh-ancestor
110541055|NCT00660426|Gemcitabine|gemcitabine|mesh-list
110541056|NCT00660426|Capecitabine|capecitabine|mesh-list
110541057|NCT00660426|Oxaliplatin|oxaliplatin|mesh-list
110541058|NCT00660426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110541059|NCT00660426|Antimetabolites|antimetabolites|mesh-ancestor
110541060|NCT00660426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110541061|NCT00660426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110541062|NCT00967291|Ifosfamide|ifosfamide|mesh-list
110541063|NCT00967291|Mitomycins|mitomycins|mesh-list
110541064|NCT00967291|Mitomycin|mitomycin|mesh-list
110541065|NCT00967291|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110541066|NCT00967291|Alkylating Agents|alkylating agents|mesh-ancestor
110541067|NCT00967291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110541068|NCT00967291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110541069|NCT00967291|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110541070|NCT00967291|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110541071|NCT00967291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110541072|NCT00645398|Pregabalin|pregabalin|mesh-list
110541073|NCT00645398|Analgesics|analgesics|mesh-ancestor
110541074|NCT00645398|Sensory System Agents|sensory system agents|mesh-ancestor
110541075|NCT00645398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110541076|NCT00645398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110541077|NCT00645398|Anticonvulsants|anticonvulsants|mesh-ancestor
110541078|NCT00645398|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110541079|NCT00645398|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110541080|NCT00645398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110541081|NCT00645398|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110541082|NCT00645398|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110541083|NCT00645398|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110541084|NCT00645398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110541085|NCT00645398|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110541086|NCT00884832|Clonidine|clonidine|mesh-list
110541087|NCT00884832|Analgesics|analgesics|mesh-ancestor
110541088|NCT00884832|Sensory System Agents|sensory system agents|mesh-ancestor
110541089|NCT00884832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110541090|NCT00884832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110541091|NCT00884832|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110541092|NCT00884832|Sympatholytics|sympatholytics|mesh-ancestor
110541093|NCT00884832|Autonomic Agents|autonomic agents|mesh-ancestor
110052797|NCT01482117|Clopidogrel|clopidogrel|mesh-list
110541094|NCT00884832|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110541095|NCT00884832|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110541096|NCT00884832|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110541097|NCT00884832|Adrenergic Agents|adrenergic agents|mesh-ancestor
110541098|NCT00884832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110541099|NCT00884832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110541100|NCT00660582|Leucovorin|leucovorin|mesh-list
110541101|NCT00660582|Folic Acid|folic acid|mesh-list
110541102|NCT00660582|Fluorouracil|fluorouracil|mesh-list
110541103|NCT00660582|Oxaliplatin|oxaliplatin|mesh-list
110541104|NCT00660582|Cetuximab|cetuximab|mesh-list
110541105|NCT00660582|Levoleucovorin|levoleucovorin|mesh-list
110541106|NCT00660582|Antimetabolites|antimetabolites|mesh-ancestor
110541107|NCT00660582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110541108|NCT00660582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110541109|NCT00660582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110541110|NCT00660582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110541111|NCT00660582|Immunologic Factors|immunologic factors|mesh-ancestor
110541112|NCT00660582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110541113|NCT00660582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110541114|NCT00660582|Antidotes|antidotes|mesh-ancestor
110541115|NCT00660582|Protective Agents|protective agents|mesh-ancestor
110541116|NCT00660582|Vitamin B Complex|vitamin b complex|mesh-ancestor
110541117|NCT00660582|Vitamins|vitamins|mesh-ancestor
110541118|NCT00660582|Micronutrients|micronutrients|mesh-ancestor
110541119|NCT00660582|Hematinics|hematinics|mesh-ancestor
110541120|NCT00646802|Progesterone|progesterone|mesh-list
110541121|NCT00646802|Progestins|progestins|mesh-ancestor
110541122|NCT00646802|Hormones|hormones|mesh-ancestor
110541123|NCT00646802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110541124|NCT00646802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110541125|NCT00968383|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
110541126|NCT00968383|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
110541127|NCT00968383|Adrenergic Agents|adrenergic agents|mesh-list
110541128|NCT00968383|Adrenergic Antagonists|adrenergic antagonists|mesh-list
110541129|NCT00968383|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
110541130|NCT00968383|Protease Inhibitors|protease inhibitors|mesh-ancestor
110541131|NCT00968383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110541132|NCT00968383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110541133|NCT00968383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110541134|NCT00968383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110541136|NCT00657228|Anticoagulants|anticoagulants|mesh-ancestor
110541137|NCT00657228|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110541138|NCT00657228|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110541139|NCT00657228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110541140|NCT02666534|Lidocaine|lidocaine|mesh-list
110541141|NCT02666534|Prilocaine|prilocaine|mesh-list
110281119|NCT00220896|Donepezil|donepezil|mesh-list
110541142|NCT02666534|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
110541143|NCT02666534|Aminolevulinic Acid|aminolevulinic acid|mesh-list
110541144|NCT02666534|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
110541145|NCT02666534|Anesthetics, Local|anesthetics, local|mesh-ancestor
110541146|NCT02666534|Anesthetics|anesthetics|mesh-ancestor
110541147|NCT02666534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110541148|NCT02666534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110541149|NCT02666534|Sensory System Agents|sensory system agents|mesh-ancestor
110541150|NCT02666534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110541151|NCT02666534|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110541152|NCT02666534|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110541153|NCT02666534|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110541154|NCT02666534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110541155|NCT02666534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110541156|NCT02666534|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110541157|NCT02666534|Dermatologic Agents|dermatologic agents|mesh-ancestor
110188715|NCT00018902|Fluoxetine|fluoxetine|mesh-list
110541158|NCT02666534|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
110541159|NCT02787473|Docetaxel|docetaxel|mesh-list
110541160|NCT02787473|Pemetrexed|pemetrexed|mesh-list
110541161|NCT02787473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110176953|NCT00135967|Antiemetics|antiemetics|mesh-ancestor
110541162|NCT02787473|Tubulin Modulators|tubulin modulators|mesh-ancestor
110541163|NCT02787473|Antimitotic Agents|antimitotic agents|mesh-ancestor
110541164|NCT02787473|Mitosis Modulators|mitosis modulators|mesh-ancestor
110541165|NCT02787473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110541166|NCT02787473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110541167|NCT02787473|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110541168|NCT02787473|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110541170|NCT00657306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110541171|NCT00967603|Sunitinib|sunitinib|mesh-list
110541172|NCT00967603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110541173|NCT00967603|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110541174|NCT00967603|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110541175|NCT00967603|Growth Substances|growth substances|mesh-ancestor
110541176|NCT00967603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110541177|NCT00967603|Growth Inhibitors|growth inhibitors|mesh-ancestor
110541178|NCT00967603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110541179|NCT00967603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110541180|NCT00967603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110541181|NCT00657384|Tranexamic Acid|tranexamic acid|mesh-list
110541182|NCT00657384|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110541183|NCT00657384|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110541184|NCT00657384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110541185|NCT00657384|Hemostatics|hemostatics|mesh-ancestor
110541186|NCT00657384|Coagulants|coagulants|mesh-ancestor
110541187|NCT00973453|Immunomodulating Agents|immunomodulating agents|mesh-list
110541188|NCT00973453|Immunologic Factors|immunologic factors|mesh-list
110541189|NCT00973453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110541190|NCT00646880|Tolterodine Tartrate|tolterodine tartrate|mesh-list
110541191|NCT00646880|Propiverine|propiverine|mesh-list
110541192|NCT00646880|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110302984|NCT00252668|Dermatologic Agents|dermatologic agents|mesh-ancestor
110541193|NCT00646880|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110541194|NCT00646880|Cholinergic Agents|cholinergic agents|mesh-ancestor
110541195|NCT00646880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110541196|NCT00646880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110541197|NCT00646880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110541198|NCT00646880|Urological Agents|urological agents|mesh-ancestor
110541199|NCT00646880|Parasympatholytics|parasympatholytics|mesh-ancestor
110541201|NCT00646880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110541202|NCT00910598|Glatiramer Acetate|glatiramer acetate|mesh-list
110541203|NCT00910598|(T,G)-A-L|(t,g)-a-l|mesh-list
110541204|NCT00910598|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110541205|NCT00910598|Immunologic Factors|immunologic factors|mesh-ancestor
110541206|NCT00910598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110541207|NCT00910598|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110541208|NCT00910598|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110541209|NCT00968461|Phenethyl isothiocyanate|phenethyl isothiocyanate|mesh-list
110541210|NCT00968461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110541211|NCT00968461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110541212|NCT00968461|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110541213|NCT00968461|Protective Agents|protective agents|mesh-ancestor
110541214|NCT00968461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110541215|NCT00968461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110541216|NCT04157010|Methotrexate|methotrexate|mesh-list
110541217|NCT04157010|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110541218|NCT04157010|Abortifacient Agents|abortifacient agents|mesh-ancestor
110541219|NCT04157010|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110541220|NCT04157010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110541221|NCT04157010|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110541222|NCT04157010|Antimetabolites|antimetabolites|mesh-ancestor
110541223|NCT04157010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110541224|NCT04157010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110541225|NCT04157010|Dermatologic Agents|dermatologic agents|mesh-ancestor
110541226|NCT04157010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110541227|NCT04157010|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110541228|NCT04157010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110541229|NCT04157010|Immunologic Factors|immunologic factors|mesh-ancestor
110541230|NCT04157010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110541231|NCT04157010|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110541233|NCT02632032|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110188770|NCT00019058|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110541234|NCT02632032|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110541235|NCT02632032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110541236|NCT00973609|Folic Acid|folic acid|mesh-list
110541237|NCT00973609|Vitamin B Complex|vitamin b complex|mesh-list
110541238|NCT00973609|Bevacizumab|bevacizumab|mesh-list
110541239|NCT00973609|Fluorouracil|fluorouracil|mesh-list
110541240|NCT00973609|Capecitabine|capecitabine|mesh-list
110541241|NCT00973609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110541242|NCT00973609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110303056|NCT01680796|Hormones|hormones|mesh-ancestor
110541243|NCT00973609|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110541244|NCT00973609|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110541245|NCT00973609|Growth Substances|growth substances|mesh-ancestor
110541246|NCT00973609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110541247|NCT00973609|Growth Inhibitors|growth inhibitors|mesh-ancestor
110541248|NCT00973609|Antimetabolites|antimetabolites|mesh-ancestor
110541249|NCT00973609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110541250|NCT00973609|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110541251|NCT00973609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110541252|NCT00973609|Immunologic Factors|immunologic factors|mesh-ancestor
110541253|NCT00973609|Hematinics|hematinics|mesh-ancestor
110541254|NCT00973609|Vitamins|vitamins|mesh-ancestor
110541255|NCT00973609|Micronutrients|micronutrients|mesh-ancestor
110541256|NCT02537054|Aflibercept|aflibercept|mesh-list
110541257|NCT02537054|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110541258|NCT02537054|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110541259|NCT02537054|Growth Substances|growth substances|mesh-ancestor
110541260|NCT02537054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110541261|NCT02537054|Growth Inhibitors|growth inhibitors|mesh-ancestor
110541262|NCT02537054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110541263|NCT00973687|Dexamethasone|dexamethasone|mesh-list
110541264|NCT00973687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110541265|NCT00973687|Antiemetics|antiemetics|mesh-ancestor
110541266|NCT00973687|Autonomic Agents|autonomic agents|mesh-ancestor
110541267|NCT00973687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110541268|NCT00973687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110541269|NCT00973687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110541270|NCT00973687|Glucocorticoids|glucocorticoids|mesh-ancestor
110541271|NCT00973687|Hormones|hormones|mesh-ancestor
110541272|NCT00973687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110541273|NCT00973687|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110541274|NCT00973687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110541275|NCT02785757|Thrombin|thrombin|mesh-list
110177005|NCT00404053|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110541277|NCT02785757|Coagulants|coagulants|mesh-ancestor
110541278|NCT00645554|Galantamine|galantamine|mesh-list
110541279|NCT00645554|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110541280|NCT00645554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110541281|NCT00645554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110541282|NCT00645554|Cholinergic Agents|cholinergic agents|mesh-ancestor
110541283|NCT00645554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110541284|NCT00645554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110541285|NCT00645554|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110541286|NCT00645554|Autonomic Agents|autonomic agents|mesh-ancestor
110541287|NCT00645554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110541288|NCT00645554|Nootropic Agents|nootropic agents|mesh-ancestor
110541290|NCT02785601|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110541291|NCT02785601|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110541292|NCT02785601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110541293|NCT02785601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110541294|NCT02785601|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110541295|NCT02785601|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110541296|NCT02785601|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110541297|NCT02785601|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110541298|NCT02785601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110541299|NCT02785601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110541300|NCT02785601|Serotonin Agents|serotonin agents|mesh-ancestor
110541301|NCT02785601|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110541302|NCT02785601|Antidepressive Agents|antidepressive agents|mesh-ancestor
110541303|NCT05299567|Azithromycin|azithromycin|mesh-list
110541304|NCT05299567|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110541305|NCT05299567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110541306|NCT00660894|Leucovorin|leucovorin|mesh-list
110541307|NCT00660894|Tegafur|tegafur|mesh-list
110541308|NCT00660894|Calcium|calcium|mesh-list
110541309|NCT00660894|Levoleucovorin|levoleucovorin|mesh-list
110541310|NCT00660894|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110541311|NCT00660894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110541313|NCT00660894|Protective Agents|protective agents|mesh-ancestor
110541314|NCT00660894|Vitamin B Complex|vitamin b complex|mesh-ancestor
110541315|NCT00660894|Vitamins|vitamins|mesh-ancestor
110541316|NCT00660894|Micronutrients|micronutrients|mesh-ancestor
110541317|NCT00660894|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110541318|NCT00660894|Antimetabolites|antimetabolites|mesh-ancestor
110541319|NCT00660894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110541320|NCT00660894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110541321|NCT00660972|Tenofovir|tenofovir|mesh-list
110541322|NCT00660972|Emtricitabine|emtricitabine|mesh-list
110541323|NCT00660972|Raltegravir Potassium|raltegravir potassium|mesh-list
110541324|NCT00660972|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110541325|NCT00660972|Antiviral Agents|antiviral agents|mesh-ancestor
110541326|NCT00660972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110541327|NCT00660972|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110541328|NCT00660972|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110541329|NCT00660972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110541330|NCT00660972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110541331|NCT00660972|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110541332|NCT00660972|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110541333|NCT00660972|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110541334|NCT00660972|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110541335|NCT02667470|Solifenacin Succinate|solifenacin succinate|mesh-list
110541336|NCT02667470|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110541337|NCT02667470|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110541338|NCT02667470|Cholinergic Agents|cholinergic agents|mesh-ancestor
110541339|NCT02667470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110541340|NCT02667470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110541341|NCT02667470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110541342|NCT02667470|Urological Agents|urological agents|mesh-ancestor
110541343|NCT05327699|Ketamine|ketamine|mesh-list
110541344|NCT05327699|Analgesics|analgesics|mesh-ancestor
110541345|NCT05327699|Sensory System Agents|sensory system agents|mesh-ancestor
110541346|NCT05327699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110541347|NCT05327699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110541348|NCT05327699|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110541349|NCT05327699|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110541350|NCT05327699|Anesthetics, General|anesthetics, general|mesh-ancestor
110541351|NCT05327699|Anesthetics|anesthetics|mesh-ancestor
110541352|NCT05327699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110541353|NCT05327699|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110541354|NCT05327699|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110541355|NCT05327699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110541356|NCT05327699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110541357|NCT04157478|Temozolomide|temozolomide|mesh-list
110541358|NCT04157478|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110541359|NCT04157478|Alkylating Agents|alkylating agents|mesh-ancestor
110541360|NCT04157478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110541361|NCT04157478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110541362|NCT00647192|Eplerenone|eplerenone|mesh-list
110541363|NCT00647192|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110541364|NCT00647192|Hormone Antagonists|hormone antagonists|mesh-ancestor
110541365|NCT00647192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110541366|NCT00647192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110177052|NCT00136825|Protective Agents|protective agents|mesh-ancestor
110541367|NCT00647192|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110541368|NCT00647192|Diuretics|diuretics|mesh-ancestor
110541369|NCT00647192|Natriuretic Agents|natriuretic agents|mesh-ancestor
110541370|NCT00647192|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110541371|NCT00661206|Clopidogrel|clopidogrel|mesh-list
110541372|NCT00661206|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110541373|NCT00661206|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110541374|NCT00661206|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110541375|NCT00661206|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110541376|NCT00661206|Purinergic Agents|purinergic agents|mesh-ancestor
110541377|NCT00661206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110541378|NCT00661206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110541379|NCT00661206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110541380|NCT05276960|Cholecalciferol|cholecalciferol|mesh-list
110541381|NCT05276960|Vitamin D|vitamin d|mesh-list
110541382|NCT05276960|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110541383|NCT05276960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110541384|NCT05276960|Vitamins|vitamins|mesh-ancestor
110541385|NCT05276960|Micronutrients|micronutrients|mesh-ancestor
110541386|NCT05276960|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110541387|NCT02787317|Heparin|heparin|mesh-list
110541388|NCT02787317|Bivalirudin|bivalirudin|mesh-list
110541389|NCT02787317|Anticoagulants|anticoagulants|mesh-ancestor
110541390|NCT02787317|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110541391|NCT02787317|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110541392|NCT02787317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110541393|NCT02787317|Antithrombins|antithrombins|mesh-ancestor
110541394|NCT02787317|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110541395|NCT02787317|Protease Inhibitors|protease inhibitors|mesh-ancestor
110541396|NCT02787317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110541397|NCT00645632|Doxorubicin|doxorubicin|mesh-list
110541398|NCT00645632|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110541399|NCT00645632|Methotrexate|methotrexate|mesh-list
110541400|NCT00645632|Ifosfamide|ifosfamide|mesh-list
110541401|NCT00645632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110541402|NCT00645632|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110541403|NCT00645632|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110541404|NCT00645632|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110541405|NCT00645632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110541406|NCT00645632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110541407|NCT00645632|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110541408|NCT00645632|Abortifacient Agents|abortifacient agents|mesh-ancestor
110541409|NCT00645632|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110541410|NCT00645632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110541411|NCT00645632|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110541412|NCT00645632|Antimetabolites|antimetabolites|mesh-ancestor
110541413|NCT00645632|Dermatologic Agents|dermatologic agents|mesh-ancestor
110541414|NCT00645632|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110177082|NCT03968822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110541415|NCT00645632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110541416|NCT00645632|Immunologic Factors|immunologic factors|mesh-ancestor
110541417|NCT00645632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110541418|NCT00645632|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110541419|NCT00645632|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110541420|NCT00645632|Alkylating Agents|alkylating agents|mesh-ancestor
110541422|NCT04156464|Phenobarbital|phenobarbital|mesh-list
110541423|NCT04156464|Anticonvulsants|anticonvulsants|mesh-ancestor
110541424|NCT04156464|Antiemetics|antiemetics|mesh-ancestor
110541425|NCT04156464|Autonomic Agents|autonomic agents|mesh-ancestor
110541426|NCT04156464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110541427|NCT04156464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110541428|NCT04156464|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110541429|NCT04156464|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110541430|NCT04156464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110541431|NCT04156464|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110541432|NCT04156464|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110541433|NCT04156464|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110541434|NCT04156464|GABA Modulators|gaba modulators|mesh-ancestor
110303328|NCT01684072|Vaccines|vaccines|mesh-list
110541435|NCT04156464|GABA Agents|gaba agents|mesh-ancestor
110541436|NCT04156464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110541437|NCT04156464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110541438|NCT04156464|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110541439|NCT04156464|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110541440|NCT04156464|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110541441|NCT04156464|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110541442|NCT04156464|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110541443|NCT02607215|Vinorelbine|vinorelbine|mesh-list
110541444|NCT02607215|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110541445|NCT02607215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110541446|NCT02607215|Tubulin Modulators|tubulin modulators|mesh-ancestor
110541447|NCT02607215|Antimitotic Agents|antimitotic agents|mesh-ancestor
110541448|NCT02607215|Mitosis Modulators|mitosis modulators|mesh-ancestor
110541449|NCT02607215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110541450|NCT00973999|Botulinum Toxins|botulinum toxins|mesh-list
110541451|NCT00973999|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110541452|NCT00973999|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110541453|NCT00973999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110541454|NCT00973999|Cholinergic Agents|cholinergic agents|mesh-ancestor
110541455|NCT00973999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110541456|NCT00973999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110189000|NCT00019838|Fludarabine|fludarabine|mesh-list
110541457|NCT00968929|Streptokinase|streptokinase|mesh-list
110541458|NCT00968929|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110541459|NCT00968929|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110541460|NCT00968929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110541461|NCT00661596|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
110541462|NCT00661596|Vasodilator Agents|vasodilator agents|mesh-ancestor
110541463|NCT00661596|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110541464|NCT00661596|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110541465|NCT00661596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110541466|NCT00661596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110541467|NCT00661596|Urological Agents|urological agents|mesh-ancestor
110541468|NCT00969085|Curcumin|curcumin|mesh-list
110541469|NCT00969085|Turmeric extract|turmeric extract|mesh-list
110541470|NCT00969085|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110541471|NCT00969085|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110541472|NCT00969085|Analgesics|analgesics|mesh-ancestor
110541473|NCT00969085|Sensory System Agents|sensory system agents|mesh-ancestor
110541474|NCT00969085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110541475|NCT00969085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110541476|NCT00969085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110541477|NCT00969085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110541478|NCT00969085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110541479|NCT00969085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110541480|NCT00969085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110541481|NCT00969085|Antioxidants|antioxidants|mesh-ancestor
110541482|NCT00969085|Protective Agents|protective agents|mesh-ancestor
110541483|NCT00974155|Dexetimide|dexetimide|mesh-list
110541484|NCT00974155|Citalopram|citalopram|mesh-list
110541485|NCT00974155|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
110541486|NCT00974155|Escitalopram|escitalopram|mesh-list
110541487|NCT00974155|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110541488|NCT00974155|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110541489|NCT00974155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110303487|NCT01685125|Hormones|hormones|mesh-ancestor
110541490|NCT00974155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110541491|NCT00974155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110541492|NCT00974155|Serotonin Agents|serotonin agents|mesh-ancestor
110541493|NCT00974155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110541494|NCT00974155|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110541495|NCT00974155|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110541496|NCT00974155|Parasympatholytics|parasympatholytics|mesh-ancestor
110541497|NCT00974155|Autonomic Agents|autonomic agents|mesh-ancestor
110541498|NCT00974155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110541499|NCT00974155|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110541500|NCT00974155|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110541501|NCT00974155|Cholinergic Agents|cholinergic agents|mesh-ancestor
110303860|NCT00415064|Dexamethasone|dexamethasone|mesh-list
110541502|NCT00974155|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110304015|NCT00288717|Candesartan|candesartan|mesh-list
110541503|NCT00974155|Antidepressive Agents|antidepressive agents|mesh-ancestor
110304082|NCT01608139|Analgesics|analgesics|mesh-ancestor
110541504|NCT00974155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110304220|NCT01588795|Diuretics|diuretics|mesh-list
110541505|NCT00974155|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110541506|NCT00879996|Buprenorphine|buprenorphine|mesh-list
110541507|NCT00879996|Methadone|methadone|mesh-list
110541508|NCT00879996|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
110541509|NCT00879996|Naloxone|naloxone|mesh-list
110541510|NCT00879996|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110541511|NCT00879996|Narcotics|narcotics|mesh-ancestor
110541512|NCT00879996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110541513|NCT00879996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110541514|NCT00879996|Analgesics|analgesics|mesh-ancestor
110541515|NCT00879996|Sensory System Agents|sensory system agents|mesh-ancestor
110541516|NCT00879996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110282376|NCT00223548|Mesna|mesna|mesh-list
110541517|NCT00879996|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110541518|NCT00879996|Antitussive Agents|antitussive agents|mesh-ancestor
110541519|NCT00879996|Respiratory System Agents|respiratory system agents|mesh-ancestor
110541520|NCT00969163|Testosterone|testosterone|mesh-list
110541521|NCT00969163|Androgens|androgens|mesh-ancestor
110541522|NCT00969163|Hormones|hormones|mesh-ancestor
110541523|NCT00969163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110541524|NCT00969163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110541525|NCT00873093|Leucovorin|leucovorin|mesh-list
110541526|NCT00873093|Cytarabine|cytarabine|mesh-list
110541527|NCT00873093|Prednisone|prednisone|mesh-list
110541528|NCT00873093|Hydrocortisone|hydrocortisone|mesh-list
110541529|NCT00873093|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
110304378|NCT00255710|Mycophenolic Acid|mycophenolic acid|mesh-list
110177120|NCT00137098|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110541530|NCT00873093|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
110541531|NCT00873093|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
110541533|NCT00873093|Doxorubicin|doxorubicin|mesh-list
110541534|NCT00873093|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110541535|NCT00873093|Methotrexate|methotrexate|mesh-list
110541536|NCT00873093|Etoposide|etoposide|mesh-list
110541537|NCT00873093|Vincristine|vincristine|mesh-list
110541538|NCT00873093|Bortezomib|bortezomib|mesh-list
110541539|NCT00873093|Asparaginase|asparaginase|mesh-list
110541540|NCT00873093|Pegaspargase|pegaspargase|mesh-list
110541541|NCT00873093|Etoposide phosphate|etoposide phosphate|mesh-list
110541542|NCT00873093|Levoleucovorin|levoleucovorin|mesh-list
110541543|NCT00873093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110541544|NCT00873093|Immunologic Factors|immunologic factors|mesh-ancestor
110541545|NCT00873093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110541546|NCT00873093|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110541547|NCT00873093|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110541548|NCT00873093|Alkylating Agents|alkylating agents|mesh-ancestor
110541549|NCT00873093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110541550|NCT00873093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110541551|NCT00873093|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110541552|NCT00873093|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110541553|NCT00873093|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110541554|NCT00873093|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110541555|NCT00873093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110541556|NCT00873093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110541557|NCT00873093|Glucocorticoids|glucocorticoids|mesh-ancestor
110541558|NCT00873093|Hormones|hormones|mesh-ancestor
110541559|NCT00873093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110541560|NCT00873093|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110541561|NCT00873093|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110541562|NCT00873093|Abortifacient Agents|abortifacient agents|mesh-ancestor
110541563|NCT00873093|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110541564|NCT00873093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110541565|NCT00873093|Antimetabolites|antimetabolites|mesh-ancestor
110541566|NCT00873093|Dermatologic Agents|dermatologic agents|mesh-ancestor
110541567|NCT00873093|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110541568|NCT00873093|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110541569|NCT00873093|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110541570|NCT00873093|Antiviral Agents|antiviral agents|mesh-ancestor
110541571|NCT00873093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110541572|NCT00873093|Antidotes|antidotes|mesh-ancestor
110541573|NCT00873093|Protective Agents|protective agents|mesh-ancestor
110541574|NCT00873093|Vitamin B Complex|vitamin b complex|mesh-ancestor
110541575|NCT00873093|Vitamins|vitamins|mesh-ancestor
110541576|NCT00873093|Micronutrients|micronutrients|mesh-ancestor
110541577|NCT00873093|Tubulin Modulators|tubulin modulators|mesh-ancestor
110541578|NCT00873093|Antimitotic Agents|antimitotic agents|mesh-ancestor
110541579|NCT00873093|Mitosis Modulators|mitosis modulators|mesh-ancestor
110541580|NCT00969319|Factor VIII|factor viii|mesh-list
110541581|NCT00969319|Coagulants|coagulants|mesh-ancestor
110541582|NCT02784899|Iloprost|iloprost|mesh-list
110541583|NCT02784899|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110541584|NCT02784899|Vasodilator Agents|vasodilator agents|mesh-ancestor
110541585|NCT00974389|Bevacizumab|bevacizumab|mesh-list
110541587|NCT00974389|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110541588|NCT00974389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110541589|NCT00974389|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110304679|NCT02270788|Vitamins|vitamins|mesh-ancestor
110541590|NCT00974389|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110541591|NCT00974389|Growth Substances|growth substances|mesh-ancestor
110541592|NCT00974389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110541593|NCT00974389|Growth Inhibitors|growth inhibitors|mesh-ancestor
110198493|NCT00074178|Hormones|hormones|mesh-ancestor
110541594|NCT00974389|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110541596|NCT00974389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110541597|NCT00969397|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
110541598|NCT00969397|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110541599|NCT00969397|Growth Substances|growth substances|mesh-ancestor
110541600|NCT00969397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110541601|NCT00969397|Growth Inhibitors|growth inhibitors|mesh-ancestor
110541602|NCT00969397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110541603|NCT02783885|Immunomodulating Agents|immunomodulating agents|mesh-list
110541604|NCT02783885|Immunologic Factors|immunologic factors|mesh-ancestor
110541605|NCT02783885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110541606|NCT00647660|Nadolol|nadolol|mesh-list
110541607|NCT00647660|Bendroflumethiazide|bendroflumethiazide|mesh-list
110541608|NCT00647660|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110541609|NCT00647660|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110541610|NCT00647660|Adrenergic Agents|adrenergic agents|mesh-ancestor
110541611|NCT00647660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110541612|NCT00647660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110541613|NCT00647660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110541614|NCT00647660|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110541615|NCT00647660|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110541616|NCT00647660|Sympatholytics|sympatholytics|mesh-ancestor
110541617|NCT00647660|Autonomic Agents|autonomic agents|mesh-ancestor
110541618|NCT00647660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110541619|NCT00647660|Diuretics|diuretics|mesh-ancestor
110541620|NCT00647660|Natriuretic Agents|natriuretic agents|mesh-ancestor
110541621|NCT00647660|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110541622|NCT00647660|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110541623|NCT00634595|Paclitaxel|paclitaxel|mesh-list
110541624|NCT00634595|Cisplatin|cisplatin|mesh-list
110541625|NCT00634595|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110541626|NCT00634595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110541627|NCT00634595|Tubulin Modulators|tubulin modulators|mesh-ancestor
110541628|NCT00634595|Antimitotic Agents|antimitotic agents|mesh-ancestor
110541629|NCT00634595|Mitosis Modulators|mitosis modulators|mesh-ancestor
110541630|NCT00634595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110541631|NCT00647738|Baclofen|baclofen|mesh-list
110541632|NCT00647738|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110541633|NCT00647738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110541634|NCT00647738|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110541635|NCT00647738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110541636|NCT00647738|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
110541637|NCT00647738|GABA Agonists|gaba agonists|mesh-ancestor
110541638|NCT00647738|GABA Agents|gaba agents|mesh-ancestor
110541639|NCT00647738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110541640|NCT00647738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110541641|NCT04008511|Capecitabine|capecitabine|mesh-list
110541642|NCT04008511|Oxaliplatin|oxaliplatin|mesh-list
110541643|NCT04008511|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110541644|NCT04008511|Antimetabolites|antimetabolites|mesh-ancestor
110304690|NCT02270827|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110541645|NCT04008511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110541646|NCT04008511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110541647|NCT00979537|Nisoldipine|nisoldipine|mesh-list
110541648|NCT00979537|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110541649|NCT00979537|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110541650|NCT00979537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110541651|NCT00979537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110541652|NCT00979537|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110541653|NCT00979537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110541654|NCT00979537|Vasodilator Agents|vasodilator agents|mesh-ancestor
110541655|NCT00692055|Naproxen|naproxen|mesh-list
110541656|NCT00692055|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110541657|NCT00692055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110541659|NCT00692055|Sensory System Agents|sensory system agents|mesh-ancestor
110541660|NCT00692055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110541661|NCT00692055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110541662|NCT00692055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110541663|NCT00692055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110541664|NCT00692055|Gout Suppressants|gout suppressants|mesh-ancestor
110541665|NCT00692055|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110541666|NCT00692055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110304709|NCT00290121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110541667|NCT00692055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110541668|NCT04033250|Bisacodyl|bisacodyl|mesh-list
110541669|NCT04033250|Picosulfate sodium|picosulfate sodium|mesh-list
110541670|NCT04033250|Magnesium Oxide|magnesium oxide|mesh-list
110541671|NCT04033250|Sodium Citrate|sodium citrate|mesh-list
110541672|NCT04033250|Citric Acid|citric acid|mesh-list
110541673|NCT04033250|Cathartics|cathartics|mesh-ancestor
110541674|NCT04033250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110541675|NCT04033250|Laxatives|laxatives|mesh-ancestor
110541676|NCT04033250|Anticoagulants|anticoagulants|mesh-ancestor
110541677|NCT04033250|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110541678|NCT04033250|Chelating Agents|chelating agents|mesh-ancestor
110541679|NCT04033250|Sequestering Agents|sequestering agents|mesh-ancestor
110541680|NCT04033250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110541681|NCT04033250|Antacids|antacids|mesh-ancestor
110541682|NCT02624973|Tamoxifen|tamoxifen|mesh-list
110541683|NCT02624973|Cyclophosphamide|cyclophosphamide|mesh-list
110541684|NCT02624973|Docetaxel|docetaxel|mesh-list
110541686|NCT02624973|Letrozole|letrozole|mesh-list
110541687|NCT02624973|Epirubicin|epirubicin|mesh-list
110541688|NCT02624973|Olaparib|olaparib|mesh-list
110541689|NCT02624973|Palbociclib|palbociclib|mesh-list
110541690|NCT02624973|Pertuzumab|pertuzumab|mesh-list
110541691|NCT02624973|Goserelin|goserelin|mesh-list
110541692|NCT02624973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110541693|NCT02624973|Immunologic Factors|immunologic factors|mesh-ancestor
110541694|NCT02624973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110541695|NCT02624973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110541696|NCT02624973|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110304755|NCT02271958|Mifepristone|mifepristone|mesh-list
110541697|NCT02624973|Alkylating Agents|alkylating agents|mesh-ancestor
110541698|NCT02624973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110541699|NCT02624973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110541700|NCT02624973|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110177179|NCT00137566|Antipyretics|antipyretics|mesh-ancestor
110177183|NCT00137761|Docetaxel|docetaxel|mesh-list
110541701|NCT02624973|Tubulin Modulators|tubulin modulators|mesh-ancestor
110541702|NCT02624973|Antimitotic Agents|antimitotic agents|mesh-ancestor
110541703|NCT02624973|Mitosis Modulators|mitosis modulators|mesh-ancestor
110541704|NCT02624973|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110541705|NCT02624973|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110541706|NCT02624973|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110541707|NCT02624973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110541708|NCT02624973|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110541709|NCT02624973|Hormone Antagonists|hormone antagonists|mesh-ancestor
110541710|NCT02624973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110541711|NCT02624973|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110541712|NCT02624973|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110541713|NCT02624973|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110541714|NCT02624973|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110541715|NCT02624973|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110541716|NCT02624973|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110541717|NCT02624973|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110541718|NCT02624973|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110541719|NCT02624973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110541720|NCT00647816|Propranolol|propranolol|mesh-list
110541721|NCT00647816|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110541722|NCT00647816|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110541723|NCT00647816|Adrenergic Agents|adrenergic agents|mesh-ancestor
110541724|NCT00647816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110541725|NCT00647816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110541726|NCT00647816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110541727|NCT00647816|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110541728|NCT00647816|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110541729|NCT00647816|Vasodilator Agents|vasodilator agents|mesh-ancestor
110541730|NCT00647894|Alprazolam|alprazolam|mesh-list
110541731|NCT00647894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110541732|NCT00647894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110541733|NCT00647894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110541734|NCT00647894|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110541735|NCT00647894|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110541736|NCT00647894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110541737|NCT00647894|GABA Modulators|gaba modulators|mesh-ancestor
110541738|NCT00647894|GABA Agents|gaba agents|mesh-ancestor
110541739|NCT00647894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110304848|NCT02272738|Tubulin Modulators|tubulin modulators|mesh-ancestor
110541740|NCT00647894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110541741|NCT02782559|Sildenafil Citrate|sildenafil citrate|mesh-list
110541742|NCT02782559|Vasodilator Agents|vasodilator agents|mesh-ancestor
110541743|NCT02782559|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110541744|NCT02782559|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110541745|NCT02782559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110541746|NCT02782559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110541747|NCT02782559|Urological Agents|urological agents|mesh-ancestor
110541748|NCT00647972|Olanzapine|olanzapine|mesh-list
110541749|NCT00647972|Antiemetics|antiemetics|mesh-ancestor
110541750|NCT00647972|Autonomic Agents|autonomic agents|mesh-ancestor
110541751|NCT00647972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110541752|NCT00647972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110541753|NCT00647972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110541754|NCT00647972|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110541755|NCT00647972|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110541756|NCT00647972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110541757|NCT00647972|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110541758|NCT00647972|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110541759|NCT00647972|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110541760|NCT00647972|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110541761|NCT00647972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110284248|NCT00204347|Risperidone|risperidone|mesh-list
110541762|NCT00647972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110541763|NCT00647972|Serotonin Agents|serotonin agents|mesh-ancestor
110541765|NCT02782403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110541766|NCT02782403|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110541767|NCT02782403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110541768|NCT02782403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110541770|NCT00646178|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110541771|NCT00646178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110541772|NCT00646178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110541773|NCT02624817|Glyburide|glyburide|mesh-list
110541774|NCT02624817|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110541775|NCT02624817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110541776|NCT02664116|Diclofenac|diclofenac|mesh-list
110541777|NCT02664116|Ketorolac|ketorolac|mesh-list
110541778|NCT02664116|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110541779|NCT02664116|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110541780|NCT02664116|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110541781|NCT02664116|Analgesics|analgesics|mesh-ancestor
110541782|NCT02664116|Sensory System Agents|sensory system agents|mesh-ancestor
110541783|NCT02664116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110541784|NCT02664116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110541785|NCT02664116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110541786|NCT02664116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110541787|NCT02664116|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110541788|NCT02664116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110541789|NCT02664116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110541790|NCT00692601|Capsaicin|capsaicin|mesh-list
110541791|NCT00692601|Antipruritics|antipruritics|mesh-ancestor
110541792|NCT00692601|Dermatologic Agents|dermatologic agents|mesh-ancestor
110541793|NCT00692601|Sensory System Agents|sensory system agents|mesh-ancestor
110541794|NCT00692601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110541795|NCT00692601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110541796|NCT02785055|Hydromorphone|hydromorphone|mesh-list
110541797|NCT02785055|Bupivacaine|bupivacaine|mesh-list
110541798|NCT02785055|Anesthetics, Local|anesthetics, local|mesh-ancestor
110541799|NCT02785055|Anesthetics|anesthetics|mesh-ancestor
110541800|NCT02785055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110541801|NCT02785055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110541802|NCT02785055|Sensory System Agents|sensory system agents|mesh-ancestor
110177215|NCT00137995|Glucocorticoids|glucocorticoids|mesh-ancestor
110541803|NCT02785055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110541804|NCT02785055|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110541805|NCT02785055|Narcotics|narcotics|mesh-ancestor
110541806|NCT02785055|Analgesics|analgesics|mesh-ancestor
110541807|NCT02624661|Glycerol|glycerol|mesh-list
110541808|NCT02624661|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
110541809|NCT02624661|Protective Agents|protective agents|mesh-ancestor
110541810|NCT02624661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110541811|NCT00648050|Verapamil|verapamil|mesh-list
110541812|NCT00648050|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110541813|NCT00648050|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110541814|NCT00648050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110541815|NCT00648050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110541816|NCT00648050|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110541817|NCT00648050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110541818|NCT00648050|Vasodilator Agents|vasodilator agents|mesh-ancestor
110541819|NCT00692757|Povidone-Iodine|povidone-iodine|mesh-list
110541820|NCT00692757|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110541821|NCT00692757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110541822|NCT02624505|Albuterol|albuterol|mesh-list
110541823|NCT02624505|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110541824|NCT02624505|Autonomic Agents|autonomic agents|mesh-ancestor
110541825|NCT02624505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110541826|NCT02624505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110541827|NCT02624505|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110541828|NCT02624505|Respiratory System Agents|respiratory system agents|mesh-ancestor
110541829|NCT02624505|Tocolytic Agents|tocolytic agents|mesh-ancestor
110541830|NCT02624505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110541831|NCT02624505|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110541832|NCT02624505|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110541833|NCT02624505|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110541834|NCT02624505|Adrenergic Agents|adrenergic agents|mesh-ancestor
110541835|NCT02624505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110541836|NCT02624505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110541837|NCT00969631|Metformin|metformin|mesh-list
110541838|NCT00969631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110541839|NCT00969631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110541840|NCT02782481|Levodopa|levodopa|mesh-list
110541841|NCT02782481|Carbidopa|carbidopa|mesh-list
110541842|NCT02782481|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110541843|NCT02782481|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110541844|NCT02782481|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110541845|NCT02782481|Dopamine Agents|dopamine agents|mesh-ancestor
110541846|NCT02782481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110541847|NCT02782481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110541848|NCT02782481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110541849|NCT02782481|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
110541850|NCT02782481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110541851|NCT00648128|Clarithromycin|clarithromycin|mesh-list
110541852|NCT00648128|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110541853|NCT00648128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110541854|NCT00648128|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110541855|NCT00648128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110541856|NCT00648128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110541857|NCT00648128|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110177245|NCT00138229|Alkylating Agents|alkylating agents|mesh-ancestor
110541858|NCT00648128|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110541860|NCT05342597|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110541861|NCT05342597|Antioxidants|antioxidants|mesh-ancestor
110541862|NCT05342597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110541863|NCT05342597|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110541864|NCT05342597|Protective Agents|protective agents|mesh-ancestor
110541865|NCT05342597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110541866|NCT02784821|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110541867|NCT02784821|Gentamicins|gentamicins|mesh-list
110541868|NCT02784821|Ampicillin|ampicillin|mesh-list
110541869|NCT02784821|Cefotaxime|cefotaxime|mesh-list
110541870|NCT02784821|Cefoxitin|cefoxitin|mesh-list
110541871|NCT02784821|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
110541872|NCT02784821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110541873|NCT02784821|Antitubercular Agents|antitubercular agents|mesh-ancestor
110541874|NCT02784821|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110541875|NCT02784821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110541876|NCT02784821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110541877|NCT00693069|Clopidogrel|clopidogrel|mesh-list
110541878|NCT00693069|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110541879|NCT00693069|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110541880|NCT00693069|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110541881|NCT00693069|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110541882|NCT00693069|Purinergic Agents|purinergic agents|mesh-ancestor
110541883|NCT00693069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110541884|NCT00693069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110541885|NCT00693069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110541886|NCT04949282|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
110541887|NCT04949282|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110541888|NCT04949282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110541889|NCT00974935|Aluminum Hydroxide|aluminum hydroxide|mesh-list
110541890|NCT00974935|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110541891|NCT00974935|Immunologic Factors|immunologic factors|mesh-ancestor
110541892|NCT00974935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110541893|NCT00974935|Antacids|antacids|mesh-ancestor
110541894|NCT00974935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110541895|NCT00974935|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110541896|NCT00665808|Insulin|insulin|mesh-list
110541897|NCT00665808|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110541898|NCT00665808|Insulin Detemir|insulin detemir|mesh-list
110541899|NCT00665808|Isophane Insulin, Human|isophane insulin, human|mesh-list
110541900|NCT00665808|Insulin, Isophane|insulin, isophane|mesh-list
110541901|NCT00665808|Isophane insulin, beef|isophane insulin, beef|mesh-list
110541902|NCT00665808|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110541903|NCT00665808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110541904|NCT04230083|Dienogest|dienogest|mesh-list
110541905|NCT04230083|Nandrolone|nandrolone|mesh-list
110541906|NCT04230083|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110541907|NCT04230083|Contraceptive Agents|contraceptive agents|mesh-ancestor
110541908|NCT04230083|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110541909|NCT04230083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110541910|NCT04230083|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110541911|NCT04230083|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110541912|NCT04230083|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110541913|NCT04230083|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110541914|NCT04230083|Hormone Antagonists|hormone antagonists|mesh-ancestor
110541915|NCT04230083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110541916|NCT04230083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110541917|NCT04230083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110541918|NCT04230083|Androgens|androgens|mesh-ancestor
110541919|NCT04230083|Hormones|hormones|mesh-ancestor
110541920|NCT04230083|Anabolic Agents|anabolic agents|mesh-ancestor
110541921|NCT00645866|Docetaxel|docetaxel|mesh-list
110541922|NCT00645866|Capecitabine|capecitabine|mesh-list
110541923|NCT00645866|Epirubicin|epirubicin|mesh-list
110541924|NCT00645866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110541925|NCT00645866|Tubulin Modulators|tubulin modulators|mesh-ancestor
110541926|NCT00645866|Antimitotic Agents|antimitotic agents|mesh-ancestor
110541927|NCT00645866|Mitosis Modulators|mitosis modulators|mesh-ancestor
110541928|NCT00645866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110541929|NCT00645866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110541930|NCT00645866|Antimetabolites|antimetabolites|mesh-ancestor
110541931|NCT00645866|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110541932|NCT00645866|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110541933|NCT00645866|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110541934|NCT00645866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110541935|NCT05221151|Pregabalin|pregabalin|mesh-list
110541936|NCT05221151|Ondansetron|ondansetron|mesh-list
110541937|NCT05221151|Melatonin|melatonin|mesh-list
110541938|NCT05221151|Analgesics|analgesics|mesh-ancestor
110541939|NCT05221151|Sensory System Agents|sensory system agents|mesh-ancestor
110541940|NCT05221151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110541941|NCT05221151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110541942|NCT05221151|Anticonvulsants|anticonvulsants|mesh-ancestor
110541943|NCT05221151|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110541944|NCT05221151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110541945|NCT05221151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110541946|NCT05221151|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110541947|NCT05221151|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110541948|NCT05221151|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110541949|NCT05221151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110541950|NCT05221151|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110541951|NCT05221151|Antioxidants|antioxidants|mesh-ancestor
110541952|NCT05221151|Protective Agents|protective agents|mesh-ancestor
110541953|NCT05221151|Antiemetics|antiemetics|mesh-ancestor
110541954|NCT05221151|Autonomic Agents|autonomic agents|mesh-ancestor
110541955|NCT05221151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110541956|NCT05221151|Antipruritics|antipruritics|mesh-ancestor
110541958|NCT05221151|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110541959|NCT05221151|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110541960|NCT05221151|Serotonin Agents|serotonin agents|mesh-ancestor
110541961|NCT05221151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110541962|NCT04008043|Acetaminophen|acetaminophen|mesh-list
110541963|NCT04008043|Dexamethasone|dexamethasone|mesh-list
110541964|NCT04008043|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
110177285|NCT03150771|Dopamine Agonists|dopamine agonists|mesh-ancestor
110541966|NCT04008043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110541967|NCT04008043|Antiemetics|antiemetics|mesh-ancestor
110541968|NCT04008043|Autonomic Agents|autonomic agents|mesh-ancestor
110541969|NCT04008043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110541970|NCT04008043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110541971|NCT04008043|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110541972|NCT04008043|Glucocorticoids|glucocorticoids|mesh-ancestor
110541973|NCT04008043|Hormones|hormones|mesh-ancestor
110541974|NCT04008043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110541975|NCT04008043|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110541976|NCT04008043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110541977|NCT04008043|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110541978|NCT04008043|Analgesics|analgesics|mesh-ancestor
110541979|NCT04008043|Sensory System Agents|sensory system agents|mesh-ancestor
110541980|NCT04008043|Antipyretics|antipyretics|mesh-ancestor
110541981|NCT04008043|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110541982|NCT04008043|Narcotics|narcotics|mesh-ancestor
110541983|NCT04008043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110541984|NCT04008043|Antitussive Agents|antitussive agents|mesh-ancestor
110541985|NCT04008043|Respiratory System Agents|respiratory system agents|mesh-ancestor
110541986|NCT04008043|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110541987|NCT04008043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110541988|NCT02783183|Pregabalin|pregabalin|mesh-list
110541989|NCT02783183|Analgesics|analgesics|mesh-ancestor
110541990|NCT02783183|Sensory System Agents|sensory system agents|mesh-ancestor
110541991|NCT02783183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110541992|NCT02783183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110541993|NCT02783183|Anticonvulsants|anticonvulsants|mesh-ancestor
110541994|NCT02783183|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110541995|NCT02783183|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110541996|NCT02783183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110541997|NCT02783183|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110541998|NCT02783183|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110541999|NCT02783183|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110542000|NCT02783183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110542001|NCT02783183|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110542002|NCT00693381|Mycophenolic Acid|mycophenolic acid|mesh-list
110542003|NCT00693381|Prednisone|prednisone|mesh-list
110542004|NCT00693381|Methylprednisolone|methylprednisolone|mesh-list
110542005|NCT00693381|Tacrolimus|tacrolimus|mesh-list
110542006|NCT00693381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110542007|NCT00693381|Glucocorticoids|glucocorticoids|mesh-ancestor
110542008|NCT00693381|Hormones|hormones|mesh-ancestor
110542009|NCT00693381|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110542010|NCT00693381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110542011|NCT00693381|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110542012|NCT00693381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110542013|NCT00693381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110542014|NCT00693381|Immunologic Factors|immunologic factors|mesh-ancestor
110542015|NCT00693381|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110542016|NCT00693381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110305188|NCT01603030|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110542017|NCT00693381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110542018|NCT00693381|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110542019|NCT00693381|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110542020|NCT00693381|Antitubercular Agents|antitubercular agents|mesh-ancestor
110542021|NCT00693381|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110542022|NCT00693381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110542023|NCT00693381|Antiemetics|antiemetics|mesh-ancestor
110542024|NCT00693381|Autonomic Agents|autonomic agents|mesh-ancestor
110542025|NCT00693381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110542026|NCT00693381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110542027|NCT00693381|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110542028|NCT00693381|Protective Agents|protective agents|mesh-ancestor
110542029|NCT05285891|Ocrelizumab|ocrelizumab|mesh-list
110542030|NCT05285891|Immunologic Factors|immunologic factors|mesh-ancestor
110542031|NCT05285891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110542032|NCT00693615|Vaccines|vaccines|mesh-list
110542033|NCT00693615|Immunologic Factors|immunologic factors|mesh-ancestor
110542034|NCT00693615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110542035|NCT02663960|Citric Acid|citric acid|mesh-list
110542036|NCT02663960|Sodium Citrate|sodium citrate|mesh-list
110542037|NCT02663960|Anticoagulants|anticoagulants|mesh-ancestor
110542038|NCT02663960|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110542039|NCT02663960|Chelating Agents|chelating agents|mesh-ancestor
110542040|NCT02663960|Sequestering Agents|sequestering agents|mesh-ancestor
110305218|NCT00290823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110542041|NCT02663960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110542042|NCT00693771|Insulin Glargine|insulin glargine|mesh-list
110542043|NCT00693771|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110542044|NCT00693771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110542045|NCT00693849|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
110542046|NCT00693849|Sertraline|sertraline|mesh-list
110542047|NCT00693849|Escitalopram|escitalopram|mesh-list
110542048|NCT00693849|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110542049|NCT00693849|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110542050|NCT00693849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110542051|NCT00693849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110542052|NCT00693849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110542053|NCT00693849|Serotonin Agents|serotonin agents|mesh-ancestor
110542054|NCT00693849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110542055|NCT00693849|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110542056|NCT00693849|Antidepressive Agents|antidepressive agents|mesh-ancestor
110542058|NCT00693849|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110542059|NCT00693927|Fludarabine|fludarabine|mesh-list
110189612|NCT00021827|Hormones|hormones|mesh-list
110542060|NCT00693927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110542061|NCT00648362|Glimepiride|glimepiride|mesh-list
110542062|NCT00648362|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110542063|NCT00648362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110542064|NCT00648362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110542065|NCT00648362|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110542066|NCT00648362|Immunologic Factors|immunologic factors|mesh-ancestor
110542068|NCT00648440|Sympathomimetics|sympathomimetics|mesh-ancestor
110542069|NCT00648440|Autonomic Agents|autonomic agents|mesh-ancestor
110542070|NCT00648440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110542071|NCT00648440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110542072|NCT00648440|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110542073|NCT00648440|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110542074|NCT00648440|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110542075|NCT00648440|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110542076|NCT00648440|Adrenergic Agents|adrenergic agents|mesh-ancestor
110542077|NCT00648440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110542078|NCT00648440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110542079|NCT00694005|Sirolimus|sirolimus|mesh-list
110542080|NCT00694005|Paclitaxel|paclitaxel|mesh-list
110542081|NCT00694005|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110177317|NCT03893825|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110177319|NCT03893825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110542082|NCT00694005|Everolimus|everolimus|mesh-list
110542083|NCT00694005|Temsirolimus|temsirolimus|mesh-list
110542084|NCT00694005|MTOR Inhibitors|mtor inhibitors|mesh-list
110542085|NCT00694005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110542086|NCT00694005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110542087|NCT00694005|Tubulin Modulators|tubulin modulators|mesh-ancestor
110542088|NCT00694005|Antimitotic Agents|antimitotic agents|mesh-ancestor
110542089|NCT00694005|Mitosis Modulators|mitosis modulators|mesh-ancestor
110542090|NCT00694005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110542091|NCT00694005|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110542092|NCT00694005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110542093|NCT00694005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110542094|NCT00694005|Immunologic Factors|immunologic factors|mesh-ancestor
110542095|NCT00694005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110542096|NCT00694005|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110542097|NCT00694005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110305294|NCT01603498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110542098|NCT00694005|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110542099|NCT00694005|Antifungal Agents|antifungal agents|mesh-ancestor
110542100|NCT00975325|Yohimbine|yohimbine|mesh-list
110542101|NCT00975325|Mydriatics|mydriatics|mesh-ancestor
110542102|NCT00975325|Autonomic Agents|autonomic agents|mesh-ancestor
110542103|NCT00975325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110542104|NCT00975325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110542105|NCT00975325|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
110542106|NCT00975325|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110542107|NCT00975325|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110542108|NCT00975325|Adrenergic Agents|adrenergic agents|mesh-ancestor
110542109|NCT00975325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110542110|NCT00975325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110542111|NCT00975325|Urological Agents|urological agents|mesh-ancestor
110542112|NCT00910676|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
110542113|NCT00910676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110542114|NCT00648518|Metformin|metformin|mesh-list
110542115|NCT00648518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110542116|NCT00648518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110542117|NCT00648596|Sildenafil Citrate|sildenafil citrate|mesh-list
110542118|NCT00648596|Vasodilator Agents|vasodilator agents|mesh-ancestor
110542119|NCT00648596|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110542120|NCT00648596|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110542121|NCT00648596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110542122|NCT00648596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110542123|NCT00648596|Urological Agents|urological agents|mesh-ancestor
110542125|NCT03921151|Antidepressive Agents|antidepressive agents|mesh-ancestor
110542126|NCT03921151|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110542127|NCT03921151|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110542128|NCT03921151|Histamine Antagonists|histamine antagonists|mesh-ancestor
110542129|NCT03921151|Histamine Agents|histamine agents|mesh-ancestor
110542130|NCT03921151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110542131|NCT03921151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110542132|NCT03921151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110542133|NCT03921151|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110189683|NCT00022139|Antimetabolites|antimetabolites|mesh-ancestor
110542134|NCT03921151|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110542135|NCT03921151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110542136|NCT03921151|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
110542137|NCT03921151|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110542138|NCT03921151|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110542139|NCT03921151|Adrenergic Agents|adrenergic agents|mesh-ancestor
110542140|NCT03921151|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110542141|NCT03921151|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110542142|NCT03921151|Serotonin Agents|serotonin agents|mesh-ancestor
110542143|NCT03921151|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110542144|NCT04570436|Diazepam|diazepam|mesh-list
110542145|NCT04570436|Gabapentin|gabapentin|mesh-list
110542146|NCT04570436|Analgesics|analgesics|mesh-ancestor
110542147|NCT04570436|Sensory System Agents|sensory system agents|mesh-ancestor
110542148|NCT04570436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110542149|NCT04570436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110542150|NCT04570436|Anticonvulsants|anticonvulsants|mesh-ancestor
110542151|NCT04570436|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110542152|NCT04570436|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110542153|NCT04570436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110542154|NCT04570436|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110542155|NCT04570436|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110542156|NCT04570436|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110542157|NCT04570436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110542158|NCT04570436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110542159|NCT04570436|Antimanic Agents|antimanic agents|mesh-ancestor
110542160|NCT04570436|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110542161|NCT04570436|Antiemetics|antiemetics|mesh-ancestor
110542162|NCT04570436|Autonomic Agents|autonomic agents|mesh-ancestor
110542163|NCT04570436|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110542164|NCT04570436|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110542165|NCT04570436|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110542166|NCT04570436|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110542167|NCT04570436|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110542168|NCT04570436|Anesthetics, General|anesthetics, general|mesh-ancestor
110542169|NCT04570436|Anesthetics|anesthetics|mesh-ancestor
110542170|NCT04570436|GABA Modulators|gaba modulators|mesh-ancestor
110542171|NCT04570436|GABA Agents|gaba agents|mesh-ancestor
110542172|NCT05195645|Abatacept|abatacept|mesh-list
110177353|NCT00138970|Antifungal Agents|antifungal agents|mesh-ancestor
110177354|NCT00138970|Dermatologic Agents|dermatologic agents|mesh-ancestor
110542173|NCT05195645|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110542174|NCT05195645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110542175|NCT05195645|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110305381|NCT00258245|Aspirin|aspirin|mesh-list
110542177|NCT05195645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110542178|NCT05195645|Immunologic Factors|immunologic factors|mesh-ancestor
110542179|NCT05195645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110542180|NCT05195645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110542181|NCT04171388|Micronutrients|micronutrients|mesh-list
110542182|NCT04171388|Trace Elements|trace elements|mesh-list
110542183|NCT04171388|Azithromycin|azithromycin|mesh-list
110542184|NCT04171388|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110542185|NCT04171388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110542186|NCT04171388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110542187|NCT00970411|Tivozanib|tivozanib|mesh-list
110542188|NCT00970411|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110542189|NCT00970411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110542190|NCT00970411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110542191|NCT05341193|Bevacizumab|bevacizumab|mesh-list
110542192|NCT05341193|Gemcitabine|gemcitabine|mesh-list
110542193|NCT05341193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110542194|NCT05341193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110542195|NCT05341193|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110542196|NCT05341193|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110542197|NCT05341193|Growth Substances|growth substances|mesh-ancestor
110542198|NCT05341193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110542199|NCT05341193|Growth Inhibitors|growth inhibitors|mesh-ancestor
110542200|NCT05341193|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110542201|NCT05341193|Antimetabolites|antimetabolites|mesh-ancestor
110542202|NCT05341193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110542204|NCT04229459|Cetuximab|cetuximab|mesh-list
110542205|NCT04229459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110284403|NCT00228033|Antacids|antacids|mesh-ancestor
110542206|NCT04229459|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110542207|NCT04229459|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110542208|NCT04229459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110542209|NCT00980239|Bevacizumab|bevacizumab|mesh-list
110542210|NCT00980239|Cetuximab|cetuximab|mesh-list
110177398|NCT00139204|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110542211|NCT00980239|Oxaliplatin|oxaliplatin|mesh-list
110542212|NCT00980239|Irinotecan|irinotecan|mesh-list
110542213|NCT00980239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110542214|NCT00980239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110542215|NCT00980239|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110542216|NCT00980239|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110542217|NCT00980239|Growth Substances|growth substances|mesh-ancestor
110542218|NCT00980239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110542219|NCT00980239|Growth Inhibitors|growth inhibitors|mesh-ancestor
110542220|NCT00980239|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110542221|NCT00980239|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110542222|NCT00980239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110542223|NCT00980239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110542224|NCT02665832|Amlodipine|amlodipine|mesh-list
110542225|NCT02665832|Olmesartan|olmesartan|mesh-list
110542226|NCT02665832|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110542227|NCT02665832|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110542228|NCT02665832|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110542229|NCT02665832|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110542230|NCT02665832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110542231|NCT02665832|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110542232|NCT02665832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110542233|NCT02665832|Vasodilator Agents|vasodilator agents|mesh-ancestor
110542234|NCT02665832|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110284425|NCT00204581|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110542235|NCT02665832|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110542236|NCT02665832|Antimetabolites|antimetabolites|mesh-ancestor
110542237|NCT02665832|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110542238|NCT02665832|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110542239|NCT02665832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110542240|NCT02665832|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110542241|NCT02665832|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110542242|NCT02781467|Cyclophosphamide|cyclophosphamide|mesh-list
110542243|NCT02781467|Fludarabine|fludarabine|mesh-list
110542244|NCT02781467|Interleukin-2|interleukin-2|mesh-list
110542245|NCT02781467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110542246|NCT02781467|Immunologic Factors|immunologic factors|mesh-ancestor
110542247|NCT02781467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110542248|NCT02781467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110542249|NCT02781467|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110542250|NCT02781467|Alkylating Agents|alkylating agents|mesh-ancestor
110542251|NCT02781467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110542252|NCT02781467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110542253|NCT02781467|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110542254|NCT02781467|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110542256|NCT02781467|Sensory System Agents|sensory system agents|mesh-ancestor
110542257|NCT02781467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110542258|NCT00648830|Clarithromycin|clarithromycin|mesh-list
110542259|NCT00648830|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110542260|NCT00648830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110542261|NCT00648830|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110542262|NCT00648830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110542263|NCT00648830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110542264|NCT00648830|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110542265|NCT00648830|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110542266|NCT00970567|Insulin|insulin|mesh-list
110542267|NCT00970567|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110177440|NCT00139516|Nicotine|nicotine|mesh-list
110542268|NCT00970567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110542269|NCT05341817|Letrozole|letrozole|mesh-list
110542270|NCT05341817|Mifepristone|mifepristone|mesh-list
110542271|NCT05341817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110542272|NCT05341817|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110542273|NCT05341817|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110542274|NCT05341817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110542275|NCT05341817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110542276|NCT05341817|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110542277|NCT05341817|Hormone Antagonists|hormone antagonists|mesh-ancestor
110542278|NCT05341817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110542279|NCT05341817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110542280|NCT05341817|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
110542281|NCT05341817|Abortifacient Agents|abortifacient agents|mesh-ancestor
110189849|NCT00049998|Topotecan|topotecan|mesh-list
110542282|NCT05341817|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110542283|NCT05341817|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110542284|NCT05341817|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110542285|NCT05341817|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110542286|NCT05341817|Contraceptive Agents|contraceptive agents|mesh-ancestor
110542287|NCT05341817|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
110542288|NCT05341817|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
110542289|NCT05341817|Luteolytic Agents|luteolytic agents|mesh-ancestor
110542290|NCT05341817|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110542291|NCT05341817|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
110542292|NCT02663570|Melatonin|melatonin|mesh-list
110542293|NCT02663570|Antioxidants|antioxidants|mesh-ancestor
110542294|NCT02663570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110542295|NCT02663570|Protective Agents|protective agents|mesh-ancestor
110542296|NCT02663570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110542297|NCT02663570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110542298|NCT00980473|Timolol|timolol|mesh-list
110542299|NCT00980473|Travoprost|travoprost|mesh-list
110542300|NCT00980473|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110542301|NCT00980473|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110542302|NCT00980473|Adrenergic Agents|adrenergic agents|mesh-ancestor
110542303|NCT00980473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110542304|NCT00980473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110542305|NCT00980473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110542306|NCT00980473|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110542307|NCT00980473|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110542308|NCT02784743|Ivermectin|ivermectin|mesh-list
110542309|NCT02784743|Albendazole|albendazole|mesh-list
110542310|NCT02784743|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110542311|NCT02784743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110542312|NCT02784743|Anthelmintics|anthelmintics|mesh-ancestor
110542313|NCT02784743|Anticestodal Agents|anticestodal agents|mesh-ancestor
110542314|NCT02784743|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110542315|NCT02784743|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110542316|NCT02784743|Tubulin Modulators|tubulin modulators|mesh-ancestor
110542317|NCT02784743|Antimitotic Agents|antimitotic agents|mesh-ancestor
110542318|NCT02784743|Mitosis Modulators|mitosis modulators|mesh-ancestor
110542319|NCT02784743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110542320|NCT02784743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110542321|NCT00980551|Carboplatin|carboplatin|mesh-list
110542322|NCT00980551|Vincristine|vincristine|mesh-list
110542323|NCT00980551|Topotecan|topotecan|mesh-list
110542324|NCT00980551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110542325|NCT00980551|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110542326|NCT00980551|Tubulin Modulators|tubulin modulators|mesh-ancestor
110542327|NCT00980551|Antimitotic Agents|antimitotic agents|mesh-ancestor
110542328|NCT00980551|Mitosis Modulators|mitosis modulators|mesh-ancestor
110542329|NCT00980551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110542330|NCT00980551|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110542331|NCT00980551|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110177453|NCT00139555|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110542332|NCT00980551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110542333|NCT02660060|Pramipexole|pramipexole|mesh-list
110542334|NCT02660060|Antioxidants|antioxidants|mesh-ancestor
110542335|NCT02660060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110542336|NCT02660060|Protective Agents|protective agents|mesh-ancestor
110542337|NCT02660060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110542338|NCT02660060|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110542339|NCT02660060|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110542340|NCT02660060|Dopamine Agonists|dopamine agonists|mesh-ancestor
110542341|NCT02660060|Dopamine Agents|dopamine agents|mesh-ancestor
110542342|NCT02660060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110542343|NCT04008979|Aspirin|aspirin|mesh-list
110542344|NCT04008979|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110542345|NCT04008979|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110542346|NCT04008979|Analgesics|analgesics|mesh-ancestor
110542347|NCT04008979|Sensory System Agents|sensory system agents|mesh-ancestor
110542348|NCT04008979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110542349|NCT04008979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110542350|NCT04008979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110542351|NCT04008979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110542352|NCT04008979|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110542353|NCT04008979|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110542354|NCT04008979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110542355|NCT04008979|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110542356|NCT04008979|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110542358|NCT04008979|Antipyretics|antipyretics|mesh-ancestor
110542359|NCT05263583|Bromides|bromides|mesh-list
110542360|NCT05263583|Anticonvulsants|anticonvulsants|mesh-ancestor
110542361|NCT00970879|Mefloquine|mefloquine|mesh-list
110542362|NCT00970879|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
110542363|NCT00970879|Antimalarials|antimalarials|mesh-ancestor
110542364|NCT00970879|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110542365|NCT00970879|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110542366|NCT00970879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110542367|NCT00970879|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110542368|NCT00970879|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110542369|NCT05340803|Magnesium Sulfate|magnesium sulfate|mesh-list
110542370|NCT05340803|Midazolam|midazolam|mesh-list
110542371|NCT05340803|Dexmedetomidine|dexmedetomidine|mesh-list
110542372|NCT05340803|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110542373|NCT05340803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110542374|NCT05340803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110542375|NCT05340803|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110542376|NCT05340803|Analgesics|analgesics|mesh-ancestor
110542377|NCT05340803|Sensory System Agents|sensory system agents|mesh-ancestor
110542378|NCT05340803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110284560|NCT00231582|Paclitaxel|paclitaxel|mesh-list
110542379|NCT05340803|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110542380|NCT05340803|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110542381|NCT05340803|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110542382|NCT05340803|Adrenergic Agents|adrenergic agents|mesh-ancestor
110542383|NCT05340803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110542384|NCT05340803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110542385|NCT05340803|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110542386|NCT05340803|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110542387|NCT05340803|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110542388|NCT05340803|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110177460|NCT00139555|Protease Inhibitors|protease inhibitors|mesh-ancestor
110542390|NCT05340803|Anesthetics, General|anesthetics, general|mesh-ancestor
110542391|NCT05340803|Anesthetics|anesthetics|mesh-ancestor
110542392|NCT05340803|GABA Modulators|gaba modulators|mesh-ancestor
110542393|NCT05340803|GABA Agents|gaba agents|mesh-ancestor
110542394|NCT05340803|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110542395|NCT05340803|Anticonvulsants|anticonvulsants|mesh-ancestor
110542396|NCT05340803|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110542397|NCT05340803|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110542398|NCT05340803|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110542399|NCT05340803|Tocolytic Agents|tocolytic agents|mesh-ancestor
110542400|NCT05340803|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110542401|NCT02663258|Pembrolizumab|pembrolizumab|mesh-list
110542402|NCT02663258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110542403|NCT02663258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110542404|NCT02663258|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110542405|NCT02663258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110542406|NCT04033172|Fulvestrant|fulvestrant|mesh-list
110542407|NCT04033172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110542408|NCT04033172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110542409|NCT04033172|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110542410|NCT04033172|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110542411|NCT04033172|Hormone Antagonists|hormone antagonists|mesh-ancestor
110542412|NCT04033172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110542413|NCT04033172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110542414|NCT00980707|Fluticasone|fluticasone|mesh-list
110542415|NCT00980707|Xhance|xhance|mesh-list
110542416|NCT00980707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110542417|NCT00980707|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110542418|NCT00980707|Autonomic Agents|autonomic agents|mesh-ancestor
110305527|NCT00271635|Micronutrients|micronutrients|mesh-ancestor
110542419|NCT00980707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110542420|NCT00980707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110542421|NCT00980707|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110542422|NCT00980707|Respiratory System Agents|respiratory system agents|mesh-ancestor
110542423|NCT00980707|Dermatologic Agents|dermatologic agents|mesh-ancestor
110542424|NCT00980707|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110542425|NCT05340725|Dexmedetomidine|dexmedetomidine|mesh-list
110542426|NCT05340725|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110542427|NCT05340725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110542428|NCT05340725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110542429|NCT05340725|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110542430|NCT05340725|Analgesics|analgesics|mesh-ancestor
110542431|NCT05340725|Sensory System Agents|sensory system agents|mesh-ancestor
110542432|NCT05340725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110542433|NCT05340725|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110177480|NCT03844412|Antidepressive Agents|antidepressive agents|mesh-ancestor
110542434|NCT05340725|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110542436|NCT05340725|Adrenergic Agents|adrenergic agents|mesh-ancestor
110542437|NCT05340725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110542438|NCT05340725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110542440|NCT00970957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110542441|NCT00970957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110542442|NCT00970957|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110542443|NCT00970957|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110542444|NCT00970957|Growth Substances|growth substances|mesh-ancestor
110542445|NCT00970957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110542446|NCT00970957|Growth Inhibitors|growth inhibitors|mesh-ancestor
110542447|NCT00976105|Zolpidem|zolpidem|mesh-list
110542448|NCT00976105|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
110542449|NCT00976105|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110542450|NCT00976105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110542451|NCT00976105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110542452|NCT00976105|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
110542453|NCT00976105|GABA Agonists|gaba agonists|mesh-ancestor
110542454|NCT00976105|GABA Agents|gaba agents|mesh-ancestor
110542455|NCT00976105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110542456|NCT00976105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110542457|NCT00976261|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110542458|NCT00976261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110542459|NCT00976261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110542460|NCT00976261|Incretins|incretins|mesh-ancestor
110542461|NCT00976261|Hormones|hormones|mesh-ancestor
110542462|NCT00976261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110542463|NCT00976261|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110542464|NCT00976261|Protease Inhibitors|protease inhibitors|mesh-ancestor
110542465|NCT00976261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110542466|NCT00976261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110542467|NCT02662712|JNJ-56136379|jnj-56136379|mesh-list
110542468|NCT02662712|Antiviral Agents|antiviral agents|mesh-ancestor
110542469|NCT02662712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110542470|NCT00976651|Menotropins|menotropins|mesh-list
110542471|NCT00976651|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110542472|NCT00976651|Fertility Agents|fertility agents|mesh-ancestor
110542473|NCT00976651|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110542474|NCT00976651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110542475|NCT00971581|Ketoprofen|ketoprofen|mesh-list
110542476|NCT00971581|Omeprazole|omeprazole|mesh-list
110542477|NCT00971581|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110542478|NCT00971581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110542479|NCT00971581|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110542480|NCT00971581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110542481|NCT00971581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110542482|NCT00971581|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110542483|NCT00971581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110542484|NCT00971581|Analgesics|analgesics|mesh-ancestor
110542485|NCT00971581|Sensory System Agents|sensory system agents|mesh-ancestor
110542486|NCT00971581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110542487|NCT00971581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110542488|NCT00971581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110542489|NCT00971581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110542490|NCT00971581|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110542491|NCT02662322|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
110177511|NCT03837977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110542492|NCT02662322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110542493|NCT02662322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110542494|NCT00971659|Insulin|insulin|mesh-list
110542495|NCT00971659|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110542496|NCT00971659|Metformin|metformin|mesh-list
110542497|NCT00971659|Insulin Glargine|insulin glargine|mesh-list
110542498|NCT00971659|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110542499|NCT00971659|Exenatide|exenatide|mesh-list
110542500|NCT00971659|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110542501|NCT00971659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110542502|NCT00971659|Incretins|incretins|mesh-ancestor
110542503|NCT00971659|Hormones|hormones|mesh-ancestor
110542504|NCT00971659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110542505|NCT00971659|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110542506|NCT00971659|Protease Inhibitors|protease inhibitors|mesh-ancestor
110542507|NCT00971659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110343808|NCT06022614|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110542508|NCT00971659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110542511|NCT00648986|Dermatologic Agents|dermatologic agents|mesh-ancestor
110542512|NCT00648986|Keratolytic Agents|keratolytic agents|mesh-ancestor
110542513|NCT00971815|Dexetimide|dexetimide|mesh-list
110542514|NCT00971815|Citalopram|citalopram|mesh-list
110542515|NCT00971815|Escitalopram|escitalopram|mesh-list
110542516|NCT00971815|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110542517|NCT00971815|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110542518|NCT00971815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110284618|NCT00231855|Docetaxel|docetaxel|mesh-list
110542519|NCT00971815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110542520|NCT00971815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110542521|NCT00971815|Serotonin Agents|serotonin agents|mesh-ancestor
110542522|NCT00971815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110542523|NCT00971815|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110542524|NCT00971815|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110542525|NCT00971815|Parasympatholytics|parasympatholytics|mesh-ancestor
110542526|NCT00971815|Autonomic Agents|autonomic agents|mesh-ancestor
110542527|NCT00971815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110542528|NCT00971815|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110542529|NCT00971815|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110542530|NCT00971815|Cholinergic Agents|cholinergic agents|mesh-ancestor
110542531|NCT00971815|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110542532|NCT00971815|Antidepressive Agents|antidepressive agents|mesh-ancestor
110542533|NCT00971815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110542534|NCT00981487|Ondansetron|ondansetron|mesh-list
110542535|NCT00981487|Antiemetics|antiemetics|mesh-ancestor
110542536|NCT00981487|Autonomic Agents|autonomic agents|mesh-ancestor
110542537|NCT00981487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110542538|NCT00981487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110542539|NCT00981487|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110542540|NCT00981487|Antipruritics|antipruritics|mesh-ancestor
110542541|NCT00981487|Dermatologic Agents|dermatologic agents|mesh-ancestor
110542542|NCT00981487|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110542543|NCT00981487|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110542544|NCT00981487|Serotonin Agents|serotonin agents|mesh-ancestor
110177528|NCT00404326|GABA Agents|gaba agents|mesh-ancestor
110177529|NCT00404326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110542545|NCT00981487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110312414|NCT00417833|Growth Inhibitors|growth inhibitors|mesh-ancestor
110305596|NCT01332799|Antioxidants|antioxidants|mesh-ancestor
110542546|NCT00981487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110542547|NCT00646568|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
110542548|NCT00646568|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110542549|NCT00646568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110542550|NCT00971893|Methylprednisolone|methylprednisolone|mesh-list
110542551|NCT00971893|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110542552|NCT00971893|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110542553|NCT00971893|Prednisolone|prednisolone|mesh-list
110542554|NCT00971893|Prednisolone acetate|prednisolone acetate|mesh-list
110542555|NCT00971893|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110542556|NCT00971893|Prednisolone phosphate|prednisolone phosphate|mesh-list
110542557|NCT00971893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110542558|NCT00971893|Antiemetics|antiemetics|mesh-ancestor
110542559|NCT00971893|Autonomic Agents|autonomic agents|mesh-ancestor
110542560|NCT00971893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110542561|NCT00971893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110542562|NCT00971893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110542563|NCT00971893|Glucocorticoids|glucocorticoids|mesh-ancestor
110542565|NCT00971893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110542566|NCT00971893|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110542567|NCT00971893|Protective Agents|protective agents|mesh-ancestor
110542568|NCT00971893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110200066|NCT00131755|Diazoxide|diazoxide|mesh-list
110542569|NCT00971893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110542570|NCT02665208|Nicotine|nicotine|mesh-list
110542571|NCT02665208|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110542572|NCT02665208|Autonomic Agents|autonomic agents|mesh-ancestor
110542573|NCT02665208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110542574|NCT02665208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110542575|NCT02665208|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110542576|NCT02665208|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110542577|NCT02665208|Cholinergic Agents|cholinergic agents|mesh-ancestor
110542578|NCT02665208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110542579|NCT02665208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110542580|NCT00977353|Citalopram|citalopram|mesh-list
110542581|NCT00977353|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110542582|NCT00977353|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110542583|NCT00977353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110542584|NCT00977353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110542585|NCT00977353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110542586|NCT00977353|Serotonin Agents|serotonin agents|mesh-ancestor
110542587|NCT00977353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110542588|NCT00977353|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110542589|NCT00977353|Antidepressive Agents|antidepressive agents|mesh-ancestor
110542590|NCT00977353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110542591|NCT00871923|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110542592|NCT00871923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110542593|NCT00871923|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110542594|NCT00871923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110284670|NCT00199004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110542595|NCT00871923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110542596|NCT04170530|Oxaliplatin|oxaliplatin|mesh-list
110542597|NCT04170530|Irinotecan|irinotecan|mesh-list
110542598|NCT04170530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110542599|NCT04170530|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110542600|NCT04170530|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110542601|NCT04170530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110542602|NCT04170530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110542603|NCT02617017|Buspirone|buspirone|mesh-list
110542604|NCT02617017|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110542605|NCT02617017|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110542606|NCT02617017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110542607|NCT02617017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110542608|NCT02617017|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110542609|NCT02617017|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110542610|NCT02617017|Serotonin Agents|serotonin agents|mesh-ancestor
110542611|NCT02617017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110542612|NCT02617017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110542613|NCT02616861|Praliciguat|praliciguat|mesh-list
110542614|NCT02616861|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
110542615|NCT02616861|Enzyme Activators|enzyme activators|mesh-ancestor
110542616|NCT02616861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110542617|NCT02616861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110542618|NCT00981721|Cediranib|cediranib|mesh-list
110542619|NCT00981721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110542620|NCT00981721|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110542621|NCT00981721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110542622|NCT00981721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110542623|NCT04133337|Apatinib|apatinib|mesh-list
110542624|NCT04133337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110542625|NCT04133337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110542626|NCT04133337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110542627|NCT04133337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110542628|NCT04133259|Tenofovir|tenofovir|mesh-list
110542629|NCT04133259|Entecavir|entecavir|mesh-list
110542630|NCT04133259|Antibodies|antibodies|mesh-list
110542631|NCT04133259|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110542632|NCT04133259|Immunologic Factors|immunologic factors|mesh-ancestor
110542633|NCT04133259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110542634|NCT04133259|Antiviral Agents|antiviral agents|mesh-ancestor
110542635|NCT04133259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110542636|NCT04133259|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110542637|NCT04133259|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110542638|NCT04133259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110542639|NCT04133259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110542640|NCT04133259|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110542641|NCT04133259|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110542642|NCT02616315|Naltrexone|naltrexone|mesh-list
110542643|NCT02616315|Bupropion|bupropion|mesh-list
110542644|NCT02616315|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110542645|NCT02616315|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110542646|NCT02616315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110542647|NCT02616315|Sensory System Agents|sensory system agents|mesh-ancestor
110542648|NCT02616315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110542649|NCT02616315|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110542650|NCT02616315|Antidepressive Agents|antidepressive agents|mesh-ancestor
110542651|NCT02616315|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110542652|NCT02616315|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110542653|NCT02616315|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110542654|NCT02616315|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110542655|NCT02616315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110542656|NCT02616315|Dopamine Agents|dopamine agents|mesh-ancestor
110542657|NCT02616315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110177631|NCT00140530|Antimitotic Agents|antimitotic agents|mesh-ancestor
110177647|NCT00140647|Ramipril|ramipril|mesh-list
110542658|NCT02616315|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110542659|NCT02616315|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110542660|NCT02616315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110542661|NCT02779283|Calcium, Dietary|calcium, dietary|mesh-list
110542663|NCT02779283|Folic Acid|folic acid|mesh-list
110542664|NCT02779283|Cytarabine|cytarabine|mesh-list
110542665|NCT02779283|Dexamethasone|dexamethasone|mesh-list
110542666|NCT02779283|Methylprednisolone|methylprednisolone|mesh-list
110542667|NCT02779283|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110542668|NCT02779283|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110542670|NCT02779283|Prednisolone acetate|prednisolone acetate|mesh-list
110542671|NCT02779283|Dexamethasone acetate|dexamethasone acetate|mesh-list
110542672|NCT02779283|Cyclophosphamide|cyclophosphamide|mesh-list
110542673|NCT02779283|Rituximab|rituximab|mesh-list
110542674|NCT02779283|Doxorubicin|doxorubicin|mesh-list
110542675|NCT02779283|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110542676|NCT02779283|Methotrexate|methotrexate|mesh-list
110542677|NCT02779283|Vincristine|vincristine|mesh-list
110542678|NCT02779283|Sorafenib|sorafenib|mesh-list
110542679|NCT02779283|Sunitinib|sunitinib|mesh-list
110542680|NCT02779283|Dasatinib|dasatinib|mesh-list
110542681|NCT02779283|Idarubicin|idarubicin|mesh-list
110542682|NCT02779283|Ponatinib|ponatinib|mesh-list
110542683|NCT02779283|Idelalisib|idelalisib|mesh-list
110542684|NCT02779283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110542685|NCT02779283|Antibodies|antibodies|mesh-list
110542686|NCT02779283|Immunoglobulins|immunoglobulins|mesh-list
110542687|NCT02779283|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110305847|NCT00259805|Rituximab|rituximab|mesh-list
110542688|NCT02779283|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110542689|NCT02779283|Prednisolone phosphate|prednisolone phosphate|mesh-list
110542690|NCT02779283|BB 1101|bb 1101|mesh-list
110542691|NCT02779283|Calcium|calcium|mesh-list
110542692|NCT02779283|Levoleucovorin|levoleucovorin|mesh-list
110542693|NCT02779283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110542694|NCT02779283|Immunologic Factors|immunologic factors|mesh-ancestor
110542695|NCT02779283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110542696|NCT02779283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110542697|NCT02779283|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110542698|NCT02779283|Alkylating Agents|alkylating agents|mesh-ancestor
110542699|NCT02779283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110542700|NCT02779283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110542701|NCT02779283|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110542702|NCT02779283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110542703|NCT02779283|Antiemetics|antiemetics|mesh-ancestor
110542704|NCT02779283|Autonomic Agents|autonomic agents|mesh-ancestor
110542705|NCT02779283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110542706|NCT02779283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110542707|NCT02779283|Glucocorticoids|glucocorticoids|mesh-ancestor
110542708|NCT02779283|Hormones|hormones|mesh-ancestor
110542709|NCT02779283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110542710|NCT02779283|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110542711|NCT02779283|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110542712|NCT02779283|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110542713|NCT02779283|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110542714|NCT02779283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110542715|NCT02779283|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110542716|NCT02779283|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110305877|NCT00272415|Temozolomide|temozolomide|mesh-list
110542717|NCT02779283|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110542718|NCT02779283|Abortifacient Agents|abortifacient agents|mesh-ancestor
110542719|NCT02779283|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110542720|NCT02779283|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110542721|NCT02779283|Antimetabolites|antimetabolites|mesh-ancestor
110542722|NCT02779283|Dermatologic Agents|dermatologic agents|mesh-ancestor
110542723|NCT02779283|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110542724|NCT02779283|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110542725|NCT02779283|Antiviral Agents|antiviral agents|mesh-ancestor
110542726|NCT02779283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110542727|NCT02779283|Antidotes|antidotes|mesh-ancestor
110542728|NCT02779283|Protective Agents|protective agents|mesh-ancestor
110542729|NCT02779283|Vitamin B Complex|vitamin b complex|mesh-ancestor
110542730|NCT02779283|Vitamins|vitamins|mesh-ancestor
110542731|NCT02779283|Micronutrients|micronutrients|mesh-ancestor
110542732|NCT02779283|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110542733|NCT02779283|Tubulin Modulators|tubulin modulators|mesh-ancestor
110542734|NCT02779283|Antimitotic Agents|antimitotic agents|mesh-ancestor
110542735|NCT02779283|Mitosis Modulators|mitosis modulators|mesh-ancestor
110542736|NCT02779283|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110542737|NCT02779283|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110542738|NCT02779283|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110542739|NCT02779283|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110542740|NCT02779283|Growth Substances|growth substances|mesh-ancestor
110542741|NCT02779283|Growth Inhibitors|growth inhibitors|mesh-ancestor
110542742|NCT02779283|Hematinics|hematinics|mesh-ancestor
110542743|NCT02779283|Protease Inhibitors|protease inhibitors|mesh-ancestor
110542744|NCT02616003|Liraglutide|liraglutide|mesh-list
110542745|NCT02616003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110542746|NCT02616003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110542747|NCT02616003|Incretins|incretins|mesh-ancestor
110542748|NCT02616003|Hormones|hormones|mesh-ancestor
110542749|NCT02616003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110542750|NCT02661152|Nimorazole|nimorazole|mesh-list
110542751|NCT02661152|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
110542752|NCT02661152|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110542753|NCT02661152|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110542754|NCT02661152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110542755|NCT00697671|Cyclophosphamide|cyclophosphamide|mesh-list
110542756|NCT00697671|Etoposide|etoposide|mesh-list
110542757|NCT00697671|Interleukin-2|interleukin-2|mesh-list
110542758|NCT00697671|Clofarabine|clofarabine|mesh-list
110542759|NCT00697671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110542760|NCT00697671|Immunologic Factors|immunologic factors|mesh-ancestor
110542761|NCT00697671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110542762|NCT00697671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110542763|NCT00697671|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110542764|NCT00697671|Alkylating Agents|alkylating agents|mesh-ancestor
110542765|NCT00697671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110542766|NCT00697671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110284761|NCT00410774|Antimetabolites|antimetabolites|mesh-ancestor
110542767|NCT00697671|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110542768|NCT00697671|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110542769|NCT00697671|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110542770|NCT00697671|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110542771|NCT00697671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110542772|NCT00697671|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110542773|NCT00697671|Analgesics|analgesics|mesh-ancestor
110542774|NCT00697671|Sensory System Agents|sensory system agents|mesh-ancestor
110177680|NCT00140920|Diclofenac|diclofenac|mesh-list
110542775|NCT00697671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110542776|NCT00697671|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110542777|NCT00697671|Antimetabolites|antimetabolites|mesh-ancestor
110542778|NCT03922945|Topiramate|topiramate|mesh-list
110542779|NCT03922945|Phentermine|phentermine|mesh-list
110542780|NCT03922945|Anticonvulsants|anticonvulsants|mesh-ancestor
110542781|NCT03922945|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110542782|NCT03922945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110343809|NCT06022614|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110542783|NCT03922945|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110542784|NCT03922945|Appetite Depressants|appetite depressants|mesh-ancestor
110542785|NCT03922945|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110542786|NCT03922945|Sympathomimetics|sympathomimetics|mesh-ancestor
110542787|NCT03922945|Autonomic Agents|autonomic agents|mesh-ancestor
110542788|NCT03922945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110542789|NCT03922945|Adrenergic Agents|adrenergic agents|mesh-ancestor
110542790|NCT03922945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110542791|NCT03922945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110542793|NCT04973345|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110542794|NCT04973345|Autonomic Agents|autonomic agents|mesh-ancestor
110542795|NCT04973345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110542796|NCT04973345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110542797|NCT04973345|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110542798|NCT04973345|Respiratory System Agents|respiratory system agents|mesh-ancestor
110542799|NCT04973345|Sympathomimetics|sympathomimetics|mesh-ancestor
110542800|NCT04973345|Tocolytic Agents|tocolytic agents|mesh-ancestor
110542801|NCT04973345|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110542802|NCT04973345|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110542803|NCT04973345|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110542804|NCT04973345|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110542805|NCT04973345|Adrenergic Agents|adrenergic agents|mesh-ancestor
110542806|NCT04973345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110542807|NCT04973345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110542808|NCT05236985|Oxytocin|oxytocin|mesh-list
110542809|NCT05236985|Oxytocics|oxytocics|mesh-ancestor
110542810|NCT05236985|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110542811|NCT05236985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110542812|NCT03922477|Atezolizumab|atezolizumab|mesh-list
110542813|NCT03922477|Magrolimab|magrolimab|mesh-list
110542814|NCT03922477|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110542815|NCT03922477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110542816|NCT03922477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110542817|NCT03922477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110542818|NCT00978211|Octreotide|octreotide|mesh-list
110542819|NCT00978211|Somatostatin|somatostatin|mesh-list
110542820|NCT00978211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110542821|NCT00978211|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110542822|NCT00978211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110542823|NCT00978211|Hormones|hormones|mesh-ancestor
110542824|NCT00978211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110542825|NCT00978211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110542826|NCT00867165|Ezetimibe|ezetimibe|mesh-list
110542827|NCT00867165|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110542828|NCT00867165|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110542829|NCT00867165|Antimetabolites|antimetabolites|mesh-ancestor
110542830|NCT00867165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110542831|NCT00867165|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110542832|NCT00981955|Caffeine|caffeine|mesh-list
110542833|NCT00981955|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110542834|NCT00981955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110542835|NCT00981955|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110542836|NCT00981955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110542837|NCT00981955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110542838|NCT00981955|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110542839|NCT00981955|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110542840|NCT00981955|Purinergic Agents|purinergic agents|mesh-ancestor
110542841|NCT00981955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110542842|NCT00972829|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110542843|NCT00972829|Ezetimibe|ezetimibe|mesh-list
110542844|NCT00972829|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110542845|NCT00972829|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110542846|NCT00972829|Antimetabolites|antimetabolites|mesh-ancestor
110542847|NCT00972829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110542848|NCT00972829|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110542849|NCT00972829|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110542850|NCT00972829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110542851|NCT05037617|Oxytocin|oxytocin|mesh-list
110542852|NCT05037617|Oxytocics|oxytocics|mesh-ancestor
110542853|NCT05037617|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110542854|NCT05037617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110542855|NCT00972907|Nifedipine|nifedipine|mesh-list
110542856|NCT00972907|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110542857|NCT00972907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110542858|NCT00972907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110542859|NCT00972907|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110177730|NCT00141193|Analgesics|analgesics|mesh-ancestor
110542860|NCT00972907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110542861|NCT00972907|Vasodilator Agents|vasodilator agents|mesh-ancestor
110542862|NCT00972907|Tocolytic Agents|tocolytic agents|mesh-ancestor
110542863|NCT00972907|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110542864|NCT04008433|Lidocaine|lidocaine|mesh-list
110542865|NCT04008433|Anesthetics, Local|anesthetics, local|mesh-ancestor
110542866|NCT04008433|Anesthetics|anesthetics|mesh-ancestor
110542867|NCT04008433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110542868|NCT04008433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110542869|NCT04008433|Sensory System Agents|sensory system agents|mesh-ancestor
110542870|NCT04008433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110542871|NCT04008433|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110542872|NCT04008433|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110542873|NCT04008433|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110542874|NCT04008433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110542875|NCT04008433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110542876|NCT04132479|Amoxicillin|amoxicillin|mesh-list
110542877|NCT04132479|Clarithromycin|clarithromycin|mesh-list
110542878|NCT04132479|Tinidazole|tinidazole|mesh-list
110306085|NCT01330459|Anesthetics|anesthetics|mesh-ancestor
110542879|NCT04132479|Rabeprazole|rabeprazole|mesh-list
110542880|NCT04132479|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110542881|NCT04132479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110542882|NCT04132479|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110190450|NCT00052455|Lomustine|lomustine|mesh-list
110542883|NCT04132479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110542884|NCT04132479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110542885|NCT04132479|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110542886|NCT04132479|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110542887|NCT04132479|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110542888|NCT04132479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110542889|NCT04132479|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110542890|NCT04132479|Alkylating Agents|alkylating agents|mesh-ancestor
110542891|NCT04132479|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
110542892|NCT04132479|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110542893|NCT04132479|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110542894|NCT00972985|Lorazepam|lorazepam|mesh-list
110542895|NCT00972985|Methylphenidate|methylphenidate|mesh-list
110542896|NCT00972985|Modafinil|modafinil|mesh-list
110542897|NCT00972985|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110542898|NCT00972985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110306132|NCT00298662|Interferon beta-1b|interferon beta-1b|mesh-list
110542899|NCT00972985|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110542900|NCT00972985|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110542901|NCT00972985|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110542902|NCT00972985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110542903|NCT00972985|Dopamine Agents|dopamine agents|mesh-ancestor
110542904|NCT00972985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110542905|NCT00972985|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
110542906|NCT00972985|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110542907|NCT00972985|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110542908|NCT00972985|Anticonvulsants|anticonvulsants|mesh-ancestor
110542909|NCT00972985|Antiemetics|antiemetics|mesh-ancestor
110542911|NCT00972985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110542912|NCT00972985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110542913|NCT00972985|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110542914|NCT00972985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110542915|NCT00972985|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110542916|NCT00972985|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110542917|NCT00972985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110542918|NCT00972985|GABA Modulators|gaba modulators|mesh-ancestor
110542919|NCT00972985|GABA Agents|gaba agents|mesh-ancestor
110542920|NCT00867087|Rituximab|rituximab|mesh-list
110542935|NCT02778425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110542936|NCT02778425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110542938|NCT02778425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110542939|NCT04228757|Phytoestrogens|phytoestrogens|mesh-list
110542940|NCT04228757|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
110542941|NCT04228757|Estrogens|estrogens|mesh-ancestor
110542942|NCT04228757|Hormones|hormones|mesh-ancestor
110542943|NCT04228757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110542944|NCT04228757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110542945|NCT04227431|Insulin|insulin|mesh-list
110542946|NCT04227431|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110542947|NCT04227431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110542948|NCT04227041|Capecitabine|capecitabine|mesh-list
110542949|NCT04227041|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110542950|NCT04227041|Antimetabolites|antimetabolites|mesh-ancestor
110542951|NCT04227041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110542952|NCT04227041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110542967|NCT00545233|Pioglitazone|pioglitazone|mesh-list
110542969|NCT00545233|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110542970|NCT00545233|Antimetabolites|antimetabolites|mesh-ancestor
110542971|NCT00545233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110542972|NCT00545233|Antiviral Agents|antiviral agents|mesh-ancestor
110542973|NCT00545233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110542974|NCT00545233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110542975|NCT00545233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110542976|NCT02393248|Gemcitabine|gemcitabine|mesh-list
110542977|NCT02393248|Docetaxel|docetaxel|mesh-list
110542978|NCT02393248|Pembrolizumab|pembrolizumab|mesh-list
110542979|NCT02393248|Trastuzumab|trastuzumab|mesh-list
110542980|NCT02393248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110542981|NCT02393248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110542982|NCT02393248|Antimetabolites|antimetabolites|mesh-ancestor
110542983|NCT02393248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110542984|NCT02393248|Tubulin Modulators|tubulin modulators|mesh-ancestor
110542985|NCT02393248|Antimitotic Agents|antimitotic agents|mesh-ancestor
110542986|NCT02393248|Mitosis Modulators|mitosis modulators|mesh-ancestor
110542987|NCT02393248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110542988|NCT02393248|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110542989|NCT00601484|Tanezumab|tanezumab|mesh-list
110542990|NCT00601484|Analgesics|analgesics|mesh-ancestor
110542991|NCT00601484|Sensory System Agents|sensory system agents|mesh-ancestor
110542992|NCT00601484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110542993|NCT00601484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110542994|NCT04228601|Fluzoparib|fluzoparib|mesh-list
110177776|NCT00404404|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110542995|NCT04228601|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110542996|NCT04228601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110542997|NCT04228601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110542998|NCT04228601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110542999|NCT00978601|Analgesics|analgesics|mesh-list
110543000|NCT00978601|Sensory System Agents|sensory system agents|mesh-ancestor
110543001|NCT00978601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110543002|NCT00978601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110543003|NCT00883896|Fezakinumab|fezakinumab|mesh-list
110543004|NCT00883896|Dermatologic Agents|dermatologic agents|mesh-ancestor
110543005|NCT02778191|Carboplatin|carboplatin|mesh-list
110543006|NCT02778191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110543007|NCT05170685|Nivolumab|nivolumab|mesh-list
110543008|NCT05170685|Relatlimab|relatlimab|mesh-list
110543009|NCT05170685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110543010|NCT05170685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110543011|NCT05170685|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110543012|NCT05170685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110543013|NCT02778893|Thalidomide|thalidomide|mesh-list
110543014|NCT02778893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110543015|NCT02778893|Immunologic Factors|immunologic factors|mesh-ancestor
110543016|NCT02778893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110543017|NCT02778893|Leprostatic Agents|leprostatic agents|mesh-ancestor
110543018|NCT02778893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110543019|NCT02778893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110543020|NCT02778893|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110543021|NCT02778893|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110543022|NCT02778893|Growth Substances|growth substances|mesh-ancestor
110543023|NCT02778893|Growth Inhibitors|growth inhibitors|mesh-ancestor
110543024|NCT02778893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110543025|NCT02671864|Hypoglycemic Agents|hypoglycemic agents|mesh-list
110543026|NCT02671864|Incretins|incretins|mesh-list
110543027|NCT02671864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110543028|NCT02671864|Hormones|hormones|mesh-ancestor
110543029|NCT02671864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110543030|NCT00867009|Pemetrexed|pemetrexed|mesh-list
110543031|NCT00867009|Cetuximab|cetuximab|mesh-list
110543032|NCT00867009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110543033|NCT00867009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110543034|NCT00867009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110543035|NCT00867009|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110543036|NCT00867009|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110543037|NCT00867009|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110543038|NCT00666042|Moxifloxacin|moxifloxacin|mesh-list
110543039|NCT00666042|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110543040|NCT00666042|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
110543041|NCT00666042|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110543042|NCT00666042|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110543043|NCT00666042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110543044|NCT00666042|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110543045|NCT00666042|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110543046|NCT00666042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110543047|NCT00666042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110543048|NCT00666042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110543049|NCT00666042|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110543050|NCT00666042|Contraceptive Agents|contraceptive agents|mesh-ancestor
110543051|NCT00666042|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110543052|NCT00666042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110543053|NCT00666042|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110543054|NCT00666042|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110177796|NCT00404482|Antifungal Agents|antifungal agents|mesh-ancestor
110543055|NCT00666042|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110543057|NCT02660840|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
110543058|NCT02660840|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110543059|NCT02660840|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110543060|NCT02660840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110543061|NCT02660840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110543062|NCT02660840|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110543063|NCT02660840|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110543064|NCT02660840|Dopamine Agents|dopamine agents|mesh-ancestor
110543065|NCT02660840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110543066|NCT02660840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110543067|NCT02777801|Entecavir|entecavir|mesh-list
110543068|NCT02777801|Antiviral Agents|antiviral agents|mesh-ancestor
110543069|NCT02777801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110543070|NCT00649064|Ziprasidone|ziprasidone|mesh-list
110543071|NCT00649064|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110543072|NCT00649064|Serotonin Agents|serotonin agents|mesh-ancestor
110543073|NCT00649064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110543074|NCT00649064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110543075|NCT00649064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110543076|NCT00649064|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110543077|NCT00649064|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110543078|NCT00649064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110543079|NCT00649064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110543080|NCT00649064|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110543081|NCT00649064|Dopamine Agents|dopamine agents|mesh-ancestor
110543082|NCT04132713|Capecitabine|capecitabine|mesh-list
110543083|NCT04132713|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110543084|NCT04132713|Antimetabolites|antimetabolites|mesh-ancestor
110284913|NCT00205751|Thalidomide|thalidomide|mesh-list
110543085|NCT04132713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110543086|NCT04132713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110543087|NCT04007341|Dexmedetomidine|dexmedetomidine|mesh-list
110543088|NCT04007341|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110543089|NCT04007341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110543090|NCT04007341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110543091|NCT04007341|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110543092|NCT04007341|Analgesics|analgesics|mesh-ancestor
110543093|NCT04007341|Sensory System Agents|sensory system agents|mesh-ancestor
110543094|NCT04007341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110543095|NCT04007341|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110543096|NCT04007341|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110543097|NCT04007341|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110543098|NCT04007341|Adrenergic Agents|adrenergic agents|mesh-ancestor
110543099|NCT04007341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110543100|NCT04007341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110543101|NCT02656082|Etanercept|etanercept|mesh-list
110543102|NCT02656082|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110543103|NCT02656082|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110543104|NCT02656082|Analgesics|analgesics|mesh-ancestor
110543105|NCT02656082|Sensory System Agents|sensory system agents|mesh-ancestor
110543106|NCT02656082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110543107|NCT02656082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110543108|NCT02656082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110543109|NCT02656082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110543110|NCT02656082|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110543111|NCT02656082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110543112|NCT02656082|Immunologic Factors|immunologic factors|mesh-ancestor
110543113|NCT04132635|Mitogens|mitogens|mesh-list
110543114|NCT04132635|Mitosis Modulators|mitosis modulators|mesh-ancestor
110543115|NCT04132635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110543116|NCT02623504|Carbamazepine|carbamazepine|mesh-list
110543117|NCT02623504|Anticonvulsants|anticonvulsants|mesh-ancestor
110543118|NCT02623504|Antimanic Agents|antimanic agents|mesh-ancestor
110543119|NCT02623504|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110306322|NCT00293436|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110306323|NCT00261872|Methylphenidate|methylphenidate|mesh-list
110543120|NCT02623504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110543121|NCT02623504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110543122|NCT02623504|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110543123|NCT02623504|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110543124|NCT02623504|Analgesics|analgesics|mesh-ancestor
110543125|NCT02623504|Sensory System Agents|sensory system agents|mesh-ancestor
110543126|NCT02623504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110543127|NCT02623504|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110543128|NCT02623504|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110543129|NCT02623504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110543130|NCT02623504|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110543131|NCT02623504|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110306333|NCT00293475|Rituximab|rituximab|mesh-list
110543132|NCT02777723|Hyaluronic Acid|hyaluronic acid|mesh-list
110543133|NCT02777723|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110543134|NCT02777723|Immunologic Factors|immunologic factors|mesh-ancestor
110543135|NCT02777723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110543136|NCT02777723|Viscosupplements|viscosupplements|mesh-ancestor
110543137|NCT02777723|Protective Agents|protective agents|mesh-ancestor
110543138|NCT00601250|Linagliptin|linagliptin|mesh-list
110543139|NCT00601250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110543140|NCT00601250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110543141|NCT00601250|Incretins|incretins|mesh-ancestor
110543142|NCT00601250|Hormones|hormones|mesh-ancestor
110543143|NCT00601250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110543144|NCT00601250|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110543145|NCT00601250|Protease Inhibitors|protease inhibitors|mesh-ancestor
110543146|NCT00601250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110543147|NCT00601250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110543148|NCT04226885|Fentanyl|fentanyl|mesh-list
110543149|NCT04226885|Midazolam|midazolam|mesh-list
110543150|NCT04226885|Dexmedetomidine|dexmedetomidine|mesh-list
110543151|NCT04226885|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110306386|NCT00299013|Antiemetics|antiemetics|mesh-ancestor
110543152|NCT04226885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110543153|NCT04226885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110543154|NCT04226885|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110543155|NCT04226885|Analgesics|analgesics|mesh-ancestor
110543157|NCT04226885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110543158|NCT04226885|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110543159|NCT04226885|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110543160|NCT04226885|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110543161|NCT04226885|Adrenergic Agents|adrenergic agents|mesh-ancestor
110543162|NCT04226885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110543163|NCT04226885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110543164|NCT04226885|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110543165|NCT04226885|Narcotics|narcotics|mesh-ancestor
110543166|NCT04226885|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110543167|NCT04226885|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110543168|NCT04226885|Anesthetics, General|anesthetics, general|mesh-ancestor
110543169|NCT04226885|Anesthetics|anesthetics|mesh-ancestor
110543170|NCT04226885|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110543171|NCT04226885|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110543172|NCT04226885|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110543173|NCT04226885|GABA Modulators|gaba modulators|mesh-ancestor
110543174|NCT04226885|GABA Agents|gaba agents|mesh-ancestor
110543175|NCT00866775|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
110543176|NCT00866775|Anticonvulsants|anticonvulsants|mesh-ancestor
110543177|NCT00866775|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110543178|NCT00866775|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110543179|NCT00866775|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110543180|NCT00866775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110543181|NCT02777411|Vaccines|vaccines|mesh-list
110543182|NCT02777411|Immunologic Factors|immunologic factors|mesh-ancestor
110543183|NCT02777411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110543184|NCT02777489|Perindopril|perindopril|mesh-list
110306410|NCT00299208|Quinine|quinine|mesh-list
110543185|NCT02777489|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110543186|NCT02777489|Protease Inhibitors|protease inhibitors|mesh-ancestor
110543187|NCT02777489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110543188|NCT02777489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110543189|NCT02777489|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110543191|NCT02660762|Dexamethasone|dexamethasone|mesh-list
110543192|NCT02660762|Dexamethasone acetate|dexamethasone acetate|mesh-list
110543193|NCT02660762|Prednisone|prednisone|mesh-list
110543194|NCT02660762|Cyclophosphamide|cyclophosphamide|mesh-list
110543195|NCT02660762|Methotrexate|methotrexate|mesh-list
110543196|NCT02660762|Etoposide|etoposide|mesh-list
110543197|NCT02660762|Vincristine|vincristine|mesh-list
110543198|NCT02660762|Daunorubicin|daunorubicin|mesh-list
110543199|NCT02660762|Mercaptopurine|mercaptopurine|mesh-list
110543200|NCT02660762|Pegaspargase|pegaspargase|mesh-list
110543201|NCT02660762|Thioguanine|thioguanine|mesh-list
110543202|NCT02660762|BB 1101|bb 1101|mesh-list
110543203|NCT02660762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110543204|NCT02660762|Immunologic Factors|immunologic factors|mesh-ancestor
110543205|NCT02660762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110543206|NCT02660762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110543207|NCT02660762|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110543208|NCT02660762|Alkylating Agents|alkylating agents|mesh-ancestor
110543209|NCT02660762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110543210|NCT02660762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110543211|NCT02660762|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110543212|NCT02660762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110543213|NCT02660762|Antiemetics|antiemetics|mesh-ancestor
110543214|NCT02660762|Autonomic Agents|autonomic agents|mesh-ancestor
110543215|NCT02660762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110543216|NCT02660762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110543217|NCT02660762|Glucocorticoids|glucocorticoids|mesh-ancestor
110543219|NCT02660762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110543220|NCT02660762|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110543221|NCT02660762|Protease Inhibitors|protease inhibitors|mesh-ancestor
110543222|NCT02660762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110543223|NCT02660762|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110543224|NCT02660762|Abortifacient Agents|abortifacient agents|mesh-ancestor
110543225|NCT02660762|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110543226|NCT02660762|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110543227|NCT02660762|Antimetabolites|antimetabolites|mesh-ancestor
110543228|NCT02660762|Dermatologic Agents|dermatologic agents|mesh-ancestor
110543229|NCT02660762|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110543230|NCT02660762|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110543231|NCT02660762|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110543232|NCT02660762|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110543233|NCT02660762|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110543234|NCT02660762|Antiviral Agents|antiviral agents|mesh-ancestor
110543235|NCT02660762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110543236|NCT02660762|Tubulin Modulators|tubulin modulators|mesh-ancestor
110543237|NCT02660762|Antimitotic Agents|antimitotic agents|mesh-ancestor
110543238|NCT02660762|Mitosis Modulators|mitosis modulators|mesh-ancestor
110543239|NCT02660762|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110543240|NCT02660684|Cyclosporine|cyclosporine|mesh-list
110543241|NCT02660684|Methotrexate|methotrexate|mesh-list
110543242|NCT02660684|Tacrolimus|tacrolimus|mesh-list
110543243|NCT02660684|Cyclosporins|cyclosporins|mesh-list
110543244|NCT02660684|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110543245|NCT02660684|Abortifacient Agents|abortifacient agents|mesh-ancestor
110543246|NCT02660684|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110543247|NCT02660684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110543248|NCT02660684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110177823|NCT00141427|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110177830|NCT00141544|Estrone|estrone|mesh-list
110543250|NCT02660684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110543251|NCT02660684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110543252|NCT02660684|Dermatologic Agents|dermatologic agents|mesh-ancestor
110543253|NCT02660684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110543254|NCT02660684|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110543255|NCT02660684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110543256|NCT02660684|Immunologic Factors|immunologic factors|mesh-ancestor
110543257|NCT02660684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110543258|NCT02660684|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110543260|NCT02660684|Antifungal Agents|antifungal agents|mesh-ancestor
110543261|NCT02660684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110543262|NCT00982891|Morphine|morphine|mesh-list
110543263|NCT00982891|Hydromorphone|hydromorphone|mesh-list
110543264|NCT00982891|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110543265|NCT00982891|Narcotics|narcotics|mesh-ancestor
110543266|NCT00982891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110543267|NCT00982891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110543268|NCT00982891|Analgesics|analgesics|mesh-ancestor
110543269|NCT00982891|Sensory System Agents|sensory system agents|mesh-ancestor
110543270|NCT00982891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110543271|NCT02615223|Bicalutamide|bicalutamide|mesh-list
110543272|NCT02615223|Hormones|hormones|mesh-list
110543273|NCT02615223|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
110543274|NCT02615223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110543275|NCT02615223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110543276|NCT02615223|Androgen Antagonists|androgen antagonists|mesh-ancestor
110543277|NCT02615223|Hormone Antagonists|hormone antagonists|mesh-ancestor
110285060|NCT00411047|Gefitinib|gefitinib|mesh-list
110543278|NCT02615223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110543279|NCT04132557|Methylphenidate|methylphenidate|mesh-list
110543280|NCT04132557|Amphetamine|amphetamine|mesh-list
110543281|NCT04132557|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
110543282|NCT04132557|Dextroamphetamine|dextroamphetamine|mesh-list
110543283|NCT04132557|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
110543284|NCT04132557|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110543285|NCT04132557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110543286|NCT04132557|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110543287|NCT04132557|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110543288|NCT04132557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110543289|NCT04132557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110543290|NCT04132557|Dopamine Agents|dopamine agents|mesh-ancestor
110543291|NCT04132557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110543292|NCT04132557|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110543293|NCT04132557|Adrenergic Agents|adrenergic agents|mesh-ancestor
110543294|NCT04132557|Sympathomimetics|sympathomimetics|mesh-ancestor
110543295|NCT04132557|Autonomic Agents|autonomic agents|mesh-ancestor
110543296|NCT04132557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110543297|NCT00978913|Cyclophosphamide|cyclophosphamide|mesh-list
110543298|NCT00978913|Vaccines|vaccines|mesh-list
110543299|NCT00978913|Immunologic Factors|immunologic factors|mesh-ancestor
110543300|NCT00978913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110543301|NCT00978913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110543302|NCT00978913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110543303|NCT00978913|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110543304|NCT00978913|Alkylating Agents|alkylating agents|mesh-ancestor
110543305|NCT00978913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110543306|NCT00978913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110543307|NCT00978913|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110543308|NCT04227509|Pembrolizumab|pembrolizumab|mesh-list
110177839|NCT00141544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110543309|NCT04227509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110543310|NCT04227509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110543311|NCT04227509|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110543312|NCT04227509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110543313|NCT02778659|Zolpidem|zolpidem|mesh-list
110543314|NCT02778659|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110543315|NCT02778659|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110543316|NCT02778659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110543317|NCT02778659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110543318|NCT02778659|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
110543319|NCT02778659|GABA Agonists|gaba agonists|mesh-ancestor
110543320|NCT02778659|GABA Agents|gaba agents|mesh-ancestor
110543321|NCT02778659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110543322|NCT02778659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110543323|NCT04072900|Imiquimod|imiquimod|mesh-list
110543324|NCT04072900|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110543325|NCT04072900|Immunologic Factors|immunologic factors|mesh-ancestor
110543326|NCT04072900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110543327|NCT04072900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110543328|NCT04072900|Interferon Inducers|interferon inducers|mesh-ancestor
110543329|NCT00984763|Aluminum Hydroxide|aluminum hydroxide|mesh-list
110543330|NCT00984763|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110543331|NCT00984763|Immunologic Factors|immunologic factors|mesh-ancestor
110190899|NCT00053820|Immunologic Factors|immunologic factors|mesh-ancestor
110543332|NCT00984763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110543333|NCT00984763|Antacids|antacids|mesh-ancestor
110543334|NCT00984763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110543335|NCT00984763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110543336|NCT02578108|Lidocaine|lidocaine|mesh-list
110543337|NCT02578108|Anesthetics, Local|anesthetics, local|mesh-list
110543338|NCT02578108|Anesthetics|anesthetics|mesh-list
110543339|NCT02578108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110343810|NCT06022614|Adrenergic Agents|adrenergic agents|mesh-ancestor
110543340|NCT02578108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110543341|NCT02578108|Sensory System Agents|sensory system agents|mesh-ancestor
110543342|NCT02578108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110543343|NCT02578108|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110543344|NCT02578108|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110543345|NCT02578108|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110543346|NCT02578108|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110543347|NCT02578108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110543348|NCT02776163|Docetaxel|docetaxel|mesh-list
110543349|NCT02776163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110543350|NCT02776163|Tubulin Modulators|tubulin modulators|mesh-ancestor
110543351|NCT02776163|Antimitotic Agents|antimitotic agents|mesh-ancestor
110543352|NCT02776163|Mitosis Modulators|mitosis modulators|mesh-ancestor
110543353|NCT02776163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110543354|NCT05325346|Argatroban|argatroban|mesh-list
110543355|NCT05325346|Antithrombins|antithrombins|mesh-ancestor
110543356|NCT05325346|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110543357|NCT05325346|Protease Inhibitors|protease inhibitors|mesh-ancestor
110543358|NCT05325346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110543359|NCT05325346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110543360|NCT05325346|Anticoagulants|anticoagulants|mesh-ancestor
110543361|NCT05325346|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110543362|NCT00984997|Etoposide|etoposide|mesh-list
110543363|NCT00984997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110543364|NCT00984997|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110543365|NCT00984997|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110543366|NCT00984997|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110543367|NCT00984997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110543368|NCT00984997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110543369|NCT00973219|Interferons|interferons|mesh-list
110543371|NCT00973219|Interferon-alpha|interferon-alpha|mesh-list
110543372|NCT00973219|Interferon alpha-2|interferon alpha-2|mesh-list
110543373|NCT00973219|Adefovir|adefovir|mesh-list
110543374|NCT00973219|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
110543375|NCT00973219|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110543376|NCT00973219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110543377|NCT00973219|Antiviral Agents|antiviral agents|mesh-ancestor
110543378|NCT00973219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110543379|NCT00973219|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110543380|NCT00973219|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110543381|NCT00973219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110543382|NCT00973219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110543383|NCT00973219|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110543384|NCT00973219|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110543385|NCT00973219|Immunologic Factors|immunologic factors|mesh-ancestor
110543386|NCT00973219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110543387|NCT04194125|Edotreotide lutetium LU-177|edotreotide lutetium lu-177|mesh-list
110543388|NCT04194125|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110543389|NCT04194125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110543390|NCT04973891|Metformin|metformin|mesh-list
110543391|NCT04973891|Canagliflozin|canagliflozin|mesh-list
110543392|NCT04973891|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110543393|NCT04973891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110543394|NCT04973891|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110543395|NCT04973891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110543396|NCT00983047|Docetaxel|docetaxel|mesh-list
110543397|NCT00983047|Nimotuzumab|nimotuzumab|mesh-list
110543398|NCT00983047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110543399|NCT00983047|Tubulin Modulators|tubulin modulators|mesh-ancestor
110543400|NCT00983047|Antimitotic Agents|antimitotic agents|mesh-ancestor
110543401|NCT00983047|Mitosis Modulators|mitosis modulators|mesh-ancestor
110543402|NCT00983047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110543403|NCT00983047|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110543404|NCT00983125|Clonidine|clonidine|mesh-list
110543405|NCT00983125|Analgesics|analgesics|mesh-ancestor
110543406|NCT00983125|Sensory System Agents|sensory system agents|mesh-ancestor
110543407|NCT00983125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110543408|NCT00983125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110543409|NCT00983125|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110543410|NCT00983125|Sympatholytics|sympatholytics|mesh-ancestor
110543411|NCT00983125|Autonomic Agents|autonomic agents|mesh-ancestor
110543412|NCT00983125|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110543413|NCT00983125|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110543414|NCT00983125|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110543415|NCT00983125|Adrenergic Agents|adrenergic agents|mesh-ancestor
110177861|NCT00141895|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110543416|NCT00983125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110543417|NCT00983125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110543418|NCT00988039|Raltegravir Potassium|raltegravir potassium|mesh-list
110543419|NCT00988039|Lopinavir|lopinavir|mesh-list
110543420|NCT00988039|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110543421|NCT00988039|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110543422|NCT00988039|Antiviral Agents|antiviral agents|mesh-ancestor
110543423|NCT00988039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110543424|NCT00988039|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110543425|NCT00988039|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110543426|NCT00988039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110543427|NCT00988039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110543428|NCT00988039|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110543429|NCT00988039|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110543430|NCT00988039|Protease Inhibitors|protease inhibitors|mesh-ancestor
110543431|NCT00988039|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110543432|NCT00988039|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110543433|NCT04855513|Metformin|metformin|mesh-list
110543434|NCT04855513|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110543435|NCT04855513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110543436|NCT02775773|Tranexamic Acid|tranexamic acid|mesh-list
110543437|NCT02775773|Oxytocin|oxytocin|mesh-list
110543438|NCT02775773|Oxytocics|oxytocics|mesh-ancestor
110285188|NCT00424710|Ranibizumab|ranibizumab|mesh-list
110543439|NCT02775773|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110543440|NCT02775773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110543441|NCT02775773|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110543442|NCT02775773|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110543443|NCT02775773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110543445|NCT02775773|Coagulants|coagulants|mesh-ancestor
110543447|NCT00983203|Lubricant Eye Drops|lubricant eye drops|mesh-list
110543448|NCT00983203|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110543449|NCT00988195|Doxorubicin|doxorubicin|mesh-list
110543450|NCT00988195|BCT-100|bct-100|mesh-list
110543451|NCT00988195|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110543452|NCT00988195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110543453|NCT00988195|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110543454|NCT00988195|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110543455|NCT00988195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110543456|NCT00988195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110543457|NCT00634985|Eletriptan|eletriptan|mesh-list
110543458|NCT00634985|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110543459|NCT00634985|Serotonin Agents|serotonin agents|mesh-ancestor
110543460|NCT00634985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110543461|NCT00634985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110543462|NCT00634985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110543463|NCT00985387|Solifenacin Succinate|solifenacin succinate|mesh-list
110543464|NCT00985387|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110543465|NCT00985387|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110543466|NCT00985387|Cholinergic Agents|cholinergic agents|mesh-ancestor
110543467|NCT00985387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110543468|NCT00985387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110543469|NCT00985387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110543470|NCT00985387|Urological Agents|urological agents|mesh-ancestor
110543471|NCT02776943|Hyaluronic Acid|hyaluronic acid|mesh-list
110543472|NCT02776943|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110177892|NCT02825979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110543473|NCT02776943|Immunologic Factors|immunologic factors|mesh-ancestor
110543474|NCT02776943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110543475|NCT02776943|Viscosupplements|viscosupplements|mesh-ancestor
110306885|NCT00264680|GABA Agents|gaba agents|mesh-ancestor
110543476|NCT02776943|Protective Agents|protective agents|mesh-ancestor
110543477|NCT04005781|Hydroxychloroquine|hydroxychloroquine|mesh-list
110543478|NCT04005781|Antimalarials|antimalarials|mesh-ancestor
110543479|NCT04005781|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110543480|NCT04005781|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110543481|NCT04005781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110543482|NCT04005781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110543483|NCT04005781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110543484|NCT04005781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110543486|NCT04654351|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110543487|NCT04654351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110543488|NCT04654351|Analgesics|analgesics|mesh-ancestor
110543489|NCT04654351|Sensory System Agents|sensory system agents|mesh-ancestor
110543490|NCT04654351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110543491|NCT04654351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110543492|NCT04654351|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110543493|NCT04654351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110543494|NCT04654351|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
110543495|NCT04654351|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
110543496|NCT04654351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110543497|NCT04654351|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
110543498|NCT04654351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110285258|NCT00413712|Purinergic Agents|purinergic agents|mesh-ancestor
110543499|NCT04654351|Immunologic Factors|immunologic factors|mesh-ancestor
110543500|NCT00582556|Zoledronic Acid|zoledronic acid|mesh-list
110543501|NCT00582556|Leuprolide|leuprolide|mesh-list
110543502|NCT00582556|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110543503|NCT00582556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110543504|NCT00582556|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110543505|NCT00582556|Fertility Agents|fertility agents|mesh-ancestor
110543506|NCT00582556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110543507|NCT00582556|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110543508|NCT00582556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110543510|NCT02776397|Tocopherols|tocopherols|mesh-list
110543511|NCT02776397|alpha-Tocopherol|alpha-tocopherol|mesh-list
110543512|NCT02776397|Vitamins|vitamins|mesh-ancestor
110543513|NCT02776397|Micronutrients|micronutrients|mesh-ancestor
110543514|NCT02776397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110543515|NCT02776397|Antioxidants|antioxidants|mesh-ancestor
110543516|NCT02776397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110543517|NCT02776397|Protective Agents|protective agents|mesh-ancestor
110543518|NCT00985777|Vitamin E|vitamin e|mesh-list
110543519|NCT00985777|Tocopherols|tocopherols|mesh-list
110543520|NCT00985777|Tocotrienols|tocotrienols|mesh-list
110543521|NCT00985777|Vitamins|vitamins|mesh-ancestor
110543522|NCT00985777|Micronutrients|micronutrients|mesh-ancestor
110543523|NCT00985777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110543524|NCT00985777|Antioxidants|antioxidants|mesh-ancestor
110543525|NCT00985777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110543526|NCT00985777|Protective Agents|protective agents|mesh-ancestor
110543527|NCT01563601|Carboplatin|carboplatin|mesh-list
110543529|NCT01563601|Etoposide phosphate|etoposide phosphate|mesh-list
110543530|NCT01563601|Obatoclax|obatoclax|mesh-list
110543531|NCT01563601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110543532|NCT01563601|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110543533|NCT01563601|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110543534|NCT01563601|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110543535|NCT01563601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110543536|NCT01563601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110543537|NCT00988507|Artesunate|artesunate|mesh-list
110543538|NCT00988507|Ferroquine|ferroquine|mesh-list
110543539|NCT00988507|Antimalarials|antimalarials|mesh-ancestor
110543540|NCT00988507|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110543541|NCT00988507|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110543542|NCT00988507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110543543|NCT00988507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110543544|NCT00988507|Antiviral Agents|antiviral agents|mesh-ancestor
110543545|NCT00988507|Schistosomicides|schistosomicides|mesh-ancestor
110543546|NCT00988507|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110543547|NCT00988507|Anthelmintics|anthelmintics|mesh-ancestor
110543548|NCT00985855|Etoposide|etoposide|mesh-list
110543549|NCT00985855|Cetuximab|cetuximab|mesh-list
110543550|NCT00985855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110543551|NCT00985855|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110543552|NCT00985855|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110543553|NCT00985855|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110543554|NCT00985855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110543555|NCT00985855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110543556|NCT00985855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110191139|NCT00054600|Methoxsalen|methoxsalen|mesh-list
110543557|NCT04226105|Insulin|insulin|mesh-list
110543558|NCT04226105|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110543559|NCT04226105|Insulin Aspart|insulin aspart|mesh-list
110543560|NCT04226105|Insulin, Long-Acting|insulin, long-acting|mesh-list
110543561|NCT04226105|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
110543562|NCT04226105|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
110543563|NCT04226105|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110543564|NCT04226105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110543565|NCT02776865|Lidocaine|lidocaine|mesh-list
110543566|NCT02776865|Anesthetics, Local|anesthetics, local|mesh-ancestor
110543567|NCT02776865|Anesthetics|anesthetics|mesh-ancestor
110543568|NCT02776865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110543569|NCT02776865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110543570|NCT02776865|Sensory System Agents|sensory system agents|mesh-ancestor
110543571|NCT02776865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110177937|NCT00142480|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110543572|NCT02776865|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110543573|NCT02776865|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110543574|NCT02776865|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110543575|NCT02776865|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110543576|NCT02776865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110543577|NCT02772653|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
110543578|NCT02772653|Natriuretic Agents|natriuretic agents|mesh-ancestor
110543579|NCT02772653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110543580|NCT00542269|Amlodipine|amlodipine|mesh-list
110543581|NCT00542269|Ramipril|ramipril|mesh-list
110543582|NCT00542269|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110543583|NCT00542269|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110543584|NCT00542269|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110543585|NCT00542269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110543586|NCT00542269|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110543587|NCT00542269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110543588|NCT00542269|Vasodilator Agents|vasodilator agents|mesh-ancestor
110312423|NCT00305292|Modafinil|modafinil|mesh-list
110543589|NCT00542269|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110543590|NCT00542269|Protease Inhibitors|protease inhibitors|mesh-ancestor
110543591|NCT00542269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110543592|NCT02579434|Midazolam|midazolam|mesh-list
110543593|NCT02579434|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110543594|NCT02579434|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110543595|NCT02579434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110543596|NCT02579434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110543597|NCT02579434|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110543598|NCT02579434|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110543599|NCT02579434|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110543600|NCT02579434|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110543601|NCT02579434|Anesthetics, General|anesthetics, general|mesh-ancestor
110543602|NCT02579434|Anesthetics|anesthetics|mesh-ancestor
110543603|NCT02579434|GABA Modulators|gaba modulators|mesh-ancestor
110543604|NCT02579434|GABA Agents|gaba agents|mesh-ancestor
110543605|NCT02579434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110543606|NCT02579434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110543607|NCT00542191|Paclitaxel|paclitaxel|mesh-list
110543608|NCT00542191|Cyclophosphamide|cyclophosphamide|mesh-list
110543609|NCT00542191|Carboplatin|carboplatin|mesh-list
110307040|NCT00265304|Ketoprofen|ketoprofen|mesh-list
110543610|NCT00542191|Doxorubicin|doxorubicin|mesh-list
110543611|NCT00542191|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110543612|NCT00542191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110543613|NCT00542191|Tubulin Modulators|tubulin modulators|mesh-ancestor
110543614|NCT00542191|Antimitotic Agents|antimitotic agents|mesh-ancestor
110543615|NCT00542191|Mitosis Modulators|mitosis modulators|mesh-ancestor
110543616|NCT00542191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110543617|NCT00542191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110543618|NCT00542191|Immunologic Factors|immunologic factors|mesh-ancestor
110543619|NCT00542191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110543620|NCT00542191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110543621|NCT00542191|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110543622|NCT00542191|Alkylating Agents|alkylating agents|mesh-ancestor
110177959|NCT02781792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110543623|NCT00542191|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110543624|NCT00542191|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110543625|NCT00542191|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110543626|NCT00542191|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110543627|NCT00542191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110543628|NCT00600938|Deferasirox|deferasirox|mesh-list
110543629|NCT00600938|Deferoxamine|deferoxamine|mesh-list
110543630|NCT00600938|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110543631|NCT00600938|Chelating Agents|chelating agents|mesh-ancestor
110543632|NCT00600938|Sequestering Agents|sequestering agents|mesh-ancestor
110191206|NCT00055107|Nitazoxanide|nitazoxanide|mesh-list
110543633|NCT00600938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110543635|NCT03061474|Niacinamide|niacinamide|mesh-list
110543636|NCT03061474|Niacin|niacin|mesh-list
110543637|NCT03061474|Nicotinic Acids|nicotinic acids|mesh-list
110543638|NCT03061474|Vitamin B Complex|vitamin b complex|mesh-ancestor
110543639|NCT03061474|Vitamins|vitamins|mesh-ancestor
110543640|NCT03061474|Micronutrients|micronutrients|mesh-ancestor
110543641|NCT03061474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110543642|NCT03061474|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110543643|NCT03061474|Antimetabolites|antimetabolites|mesh-ancestor
110543644|NCT03061474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110543645|NCT03061474|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110543646|NCT03061474|Vasodilator Agents|vasodilator agents|mesh-ancestor
110543647|NCT00988663|Memantine|memantine|mesh-list
110543648|NCT00988663|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110543650|NCT00988663|Dopamine Agents|dopamine agents|mesh-ancestor
110543651|NCT00988663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110543652|NCT00988663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110543653|NCT00988663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110543654|NCT00988663|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110543655|NCT00988663|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110543656|NCT04072198|Leucovorin|leucovorin|mesh-list
110543657|NCT04072198|Bevacizumab|bevacizumab|mesh-list
110543658|NCT04072198|Nivolumab|nivolumab|mesh-list
110543659|NCT04072198|Oxaliplatin|oxaliplatin|mesh-list
110543660|NCT04072198|Irinotecan|irinotecan|mesh-list
110543661|NCT04072198|Fluorouracil|fluorouracil|mesh-list
110543662|NCT04072198|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110543663|NCT04072198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110543664|NCT04072198|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110543665|NCT04072198|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110543666|NCT04072198|Growth Substances|growth substances|mesh-ancestor
110368748|NCT04650555|Hormones|hormones|mesh-ancestor
110543667|NCT04072198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110543668|NCT04072198|Growth Inhibitors|growth inhibitors|mesh-ancestor
110543669|NCT04072198|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110543670|NCT04072198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110543671|NCT04072198|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110543672|NCT04072198|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110543673|NCT04072198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110543674|NCT04072198|Antidotes|antidotes|mesh-ancestor
110543675|NCT04072198|Protective Agents|protective agents|mesh-ancestor
110543676|NCT04072198|Vitamin B Complex|vitamin b complex|mesh-ancestor
110543677|NCT04072198|Vitamins|vitamins|mesh-ancestor
110543678|NCT04072198|Micronutrients|micronutrients|mesh-ancestor
110543679|NCT04072198|Antimetabolites|antimetabolites|mesh-ancestor
110543680|NCT04072198|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110543681|NCT04072198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110543682|NCT04072198|Immunologic Factors|immunologic factors|mesh-ancestor
110543683|NCT02772419|Benralizumab|benralizumab|mesh-list
110543684|NCT02772419|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110543685|NCT02772419|Respiratory System Agents|respiratory system agents|mesh-ancestor
110543686|NCT00543439|Factor VIII|factor viii|mesh-list
110543687|NCT00543439|Coagulants|coagulants|mesh-ancestor
110543688|NCT02772497|Aflibercept|aflibercept|mesh-list
110543689|NCT02772497|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110543690|NCT02772497|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110543691|NCT02772497|Growth Substances|growth substances|mesh-ancestor
110177978|NCT00142948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110543692|NCT02772497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110543693|NCT02772497|Growth Inhibitors|growth inhibitors|mesh-ancestor
110543694|NCT02772497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110543696|NCT00582166|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110543697|NCT00582166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110543698|NCT00582166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110543699|NCT00582166|Immunologic Factors|immunologic factors|mesh-ancestor
110543700|NCT00582166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110543701|NCT00582166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110543702|NCT02775539|Mirabegron|mirabegron|mesh-list
110543703|NCT02775539|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
110543704|NCT02775539|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110543705|NCT02775539|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110543706|NCT02775539|Adrenergic Agents|adrenergic agents|mesh-ancestor
110543707|NCT02775539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110543708|NCT02775539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110543709|NCT02775539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110543710|NCT02775539|Urological Agents|urological agents|mesh-ancestor
110543711|NCT04840459|Bamlanivimab|bamlanivimab|mesh-list
110543712|NCT04840459|Antiviral Agents|antiviral agents|mesh-ancestor
110543713|NCT04840459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110543714|NCT04666961|Tamoxifen|tamoxifen|mesh-list
110543715|NCT04666961|Anastrozole|anastrozole|mesh-list
110543716|NCT04666961|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110543717|NCT04666961|Hormone Antagonists|hormone antagonists|mesh-ancestor
110543718|NCT04666961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110543719|NCT04666961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110543720|NCT04666961|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110543721|NCT04666961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110543722|NCT04666961|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110543723|NCT04666961|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110543724|NCT04666961|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110543725|NCT04666961|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110543726|NCT04666961|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110543727|NCT04666961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110543728|NCT04666961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110543730|NCT04006639|Sensory System Agents|sensory system agents|mesh-ancestor
110543731|NCT04006639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110543732|NCT04006639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110543733|NCT00601172|Dexamethasone|dexamethasone|mesh-list
110543734|NCT00601172|Ondansetron|ondansetron|mesh-list
110543735|NCT00601172|Casopitant|casopitant|mesh-list
110543736|NCT00601172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110543737|NCT00601172|Antiemetics|antiemetics|mesh-ancestor
110543738|NCT00601172|Autonomic Agents|autonomic agents|mesh-ancestor
110543739|NCT00601172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110543740|NCT00601172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110543741|NCT00601172|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110543742|NCT00601172|Glucocorticoids|glucocorticoids|mesh-ancestor
110543743|NCT00601172|Hormones|hormones|mesh-ancestor
110543744|NCT00601172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110543745|NCT00601172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110543746|NCT00601172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110543747|NCT00601172|Antipruritics|antipruritics|mesh-ancestor
110543748|NCT00601172|Dermatologic Agents|dermatologic agents|mesh-ancestor
110543749|NCT00601172|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110543750|NCT00601172|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110543751|NCT00601172|Serotonin Agents|serotonin agents|mesh-ancestor
110543752|NCT00601172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110543753|NCT00601172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110543754|NCT00601172|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110543755|NCT02772107|Temozolomide|temozolomide|mesh-list
110177987|NCT02780427|Sensory System Agents|sensory system agents|mesh-ancestor
110543756|NCT02772107|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110543757|NCT02772107|Alkylating Agents|alkylating agents|mesh-ancestor
110543758|NCT02772107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110543759|NCT02772107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110543760|NCT00986167|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110543761|NCT00986167|Antidepressive Agents|antidepressive agents|mesh-ancestor
110543762|NCT00986167|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110543763|NCT00986167|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110543764|NCT00986167|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110543765|NCT00986167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110543766|NCT00986167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110543767|NCT00988897|Leucovorin|leucovorin|mesh-list
110543768|NCT00988897|Bevacizumab|bevacizumab|mesh-list
110543769|NCT00988897|Fluorouracil|fluorouracil|mesh-list
110543770|NCT00988897|Oxaliplatin|oxaliplatin|mesh-list
110543771|NCT00988897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110543772|NCT00988897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110543773|NCT00988897|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110543774|NCT00988897|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110543775|NCT00988897|Growth Substances|growth substances|mesh-ancestor
110543776|NCT00988897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110543777|NCT00988897|Growth Inhibitors|growth inhibitors|mesh-ancestor
110543778|NCT00988897|Antimetabolites|antimetabolites|mesh-ancestor
110543779|NCT00988897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110543780|NCT00988897|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110543781|NCT00988897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110543782|NCT00988897|Immunologic Factors|immunologic factors|mesh-ancestor
110543783|NCT00988897|Antidotes|antidotes|mesh-ancestor
110543784|NCT00988897|Protective Agents|protective agents|mesh-ancestor
110191364|NCT00027716|Bortezomib|bortezomib|mesh-list
110543785|NCT00988897|Vitamin B Complex|vitamin b complex|mesh-ancestor
110543786|NCT00988897|Vitamins|vitamins|mesh-ancestor
110543787|NCT00988897|Micronutrients|micronutrients|mesh-ancestor
110543788|NCT02775227|Hydrocortisone|hydrocortisone|mesh-list
110543789|NCT02775227|Pasireotide|pasireotide|mesh-list
110543790|NCT02775227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110543791|NCT02775227|Hormones|hormones|mesh-ancestor
110543792|NCT02775227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110543793|NCT02775227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110543794|NCT02875132|Pembrolizumab|pembrolizumab|mesh-list
110543795|NCT02875132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110543796|NCT02875132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110543797|NCT02875132|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110543798|NCT02875132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110543799|NCT00984217|Panitumumab|panitumumab|mesh-list
110543800|NCT00984217|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110543801|NCT00984217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110543802|NCT00989053|Escitalopram|escitalopram|mesh-list
110543803|NCT00989053|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110543804|NCT00989053|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110543805|NCT00989053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110543806|NCT00989053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110543807|NCT00989053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110543808|NCT00989053|Serotonin Agents|serotonin agents|mesh-ancestor
110543809|NCT00989053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110543810|NCT04614493|Temozolomide|temozolomide|mesh-list
110543811|NCT04614493|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110543812|NCT04614493|Alkylating Agents|alkylating agents|mesh-ancestor
110543813|NCT04614493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110543814|NCT04614493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110177995|NCT00142987|Tegaserod|tegaserod|mesh-list
110543815|NCT02841748|Pembrolizumab|pembrolizumab|mesh-list
110543816|NCT02841748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110543817|NCT02841748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110543818|NCT02841748|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110543819|NCT02841748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110543820|NCT04033094|Morphine|morphine|mesh-list
110543821|NCT04033094|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110543822|NCT04033094|Narcotics|narcotics|mesh-ancestor
110543823|NCT04033094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110543824|NCT04033094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110543825|NCT04033094|Analgesics|analgesics|mesh-ancestor
110543826|NCT04033094|Sensory System Agents|sensory system agents|mesh-ancestor
110543827|NCT04033094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110543828|NCT04073758|Dexmedetomidine|dexmedetomidine|mesh-list
110543829|NCT04073758|Remifentanil|remifentanil|mesh-list
110543830|NCT04073758|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110543831|NCT04073758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110368768|NCT04649892|Naltrexone|naltrexone|mesh-list
110543832|NCT04073758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110543833|NCT04073758|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110543834|NCT04073758|Analgesics|analgesics|mesh-ancestor
110543835|NCT04073758|Sensory System Agents|sensory system agents|mesh-ancestor
110543836|NCT04073758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110543837|NCT04073758|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110543838|NCT04073758|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110543839|NCT04073758|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110543840|NCT04073758|Adrenergic Agents|adrenergic agents|mesh-ancestor
110543841|NCT04073758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110543842|NCT04073758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110543843|NCT04073758|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110543844|NCT04073758|Narcotics|narcotics|mesh-ancestor
110543845|NCT02660606|Analgesics, Opioid|analgesics, opioid|mesh-list
110543846|NCT02660606|Narcotics|narcotics|mesh-ancestor
110543847|NCT02660606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110543848|NCT02660606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110543849|NCT02660606|Analgesics|analgesics|mesh-ancestor
110543850|NCT02660606|Sensory System Agents|sensory system agents|mesh-ancestor
110543851|NCT02660606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110543852|NCT00582010|Nitric Oxide|nitric oxide|mesh-list
110543853|NCT00582010|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110543854|NCT00582010|Autonomic Agents|autonomic agents|mesh-ancestor
110543855|NCT00582010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110543856|NCT00582010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110543857|NCT00582010|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110543858|NCT00582010|Respiratory System Agents|respiratory system agents|mesh-ancestor
110543859|NCT00582010|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110543860|NCT00582010|Antioxidants|antioxidants|mesh-ancestor
110543861|NCT00582010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110543862|NCT00582010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110543863|NCT00582010|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
110543864|NCT00582010|Vasodilator Agents|vasodilator agents|mesh-ancestor
110543865|NCT00582010|Gasotransmitters|gasotransmitters|mesh-ancestor
110543866|NCT00582010|Protective Agents|protective agents|mesh-ancestor
110543867|NCT00989209|Botulinum Toxins|botulinum toxins|mesh-list
110543868|NCT00989209|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110543869|NCT00989209|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110543870|NCT00989209|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110543871|NCT00989209|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110543872|NCT00989209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110543873|NCT00989209|Cholinergic Agents|cholinergic agents|mesh-ancestor
110543874|NCT00989209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110543875|NCT00989209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110543876|NCT00989209|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110543877|NCT00989209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110543878|NCT00649922|Adalimumab|adalimumab|mesh-list
110543879|NCT00649922|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110543880|NCT00649922|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110543881|NCT00649922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110543882|NCT00986557|Ganciclovir|ganciclovir|mesh-list
110543883|NCT00986557|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
110543884|NCT00986557|Foscarnet|foscarnet|mesh-list
110543885|NCT00986557|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
110543886|NCT00986557|Alemtuzumab|alemtuzumab|mesh-list
110543887|NCT00986557|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110543888|NCT00986557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110543889|NCT00986557|Antiviral Agents|antiviral agents|mesh-ancestor
110543890|NCT00986557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110543891|NCT00986557|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110543892|NCT00986557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110285393|NCT01089556|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110543893|NCT00986557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110543894|NCT00986557|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110543896|NCT00910754|Abiraterone Acetate|abiraterone acetate|mesh-list
110543897|NCT00910754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110543898|NCT00910754|Glucocorticoids|glucocorticoids|mesh-ancestor
110543899|NCT00910754|Hormones|hormones|mesh-ancestor
110543900|NCT00910754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110543901|NCT00910754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110543902|NCT00910754|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110543903|NCT00910754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110543904|NCT00910754|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110543905|NCT00910754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110543906|NCT00910754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110543907|NCT00910754|Hormone Antagonists|hormone antagonists|mesh-ancestor
110543908|NCT00910754|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110543909|NCT00649376|Fexofenadine|fexofenadine|mesh-list
110543910|NCT00649376|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110543911|NCT00649376|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110543912|NCT00649376|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110543913|NCT00649376|Histamine Antagonists|histamine antagonists|mesh-ancestor
110543914|NCT00649376|Histamine Agents|histamine agents|mesh-ancestor
110543915|NCT00649376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110543916|NCT00649376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110543917|NCT00649376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110543918|NCT02340676|Interleukin-2|interleukin-2|mesh-list
110543919|NCT02340676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110543920|NCT02340676|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110543921|NCT02340676|Analgesics|analgesics|mesh-ancestor
110543922|NCT02340676|Sensory System Agents|sensory system agents|mesh-ancestor
110543923|NCT02340676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110543924|NCT02340676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110543925|NCT00649454|Metformin|metformin|mesh-list
110543926|NCT00649454|Glipizide|glipizide|mesh-list
110543927|NCT00649454|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110543928|NCT00649454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110543929|NCT03920215|Varenicline|varenicline|mesh-list
110543930|NCT03920215|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110543931|NCT03920215|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110543933|NCT03920215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110543934|NCT03920215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110543935|NCT03920215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110543937|NCT02655770|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110543938|NCT02655770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110543939|NCT02655770|Incretins|incretins|mesh-ancestor
110543940|NCT02655770|Hormones|hormones|mesh-ancestor
110543941|NCT02655770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110543942|NCT00986713|Amphotericin B|amphotericin b|mesh-list
110543944|NCT00986713|Amebicides|amebicides|mesh-ancestor
110543945|NCT00986713|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110543946|NCT00986713|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110543947|NCT00986713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110543948|NCT00986713|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110543949|NCT00986713|Antifungal Agents|antifungal agents|mesh-ancestor
110543950|NCT02651870|Amlodipine|amlodipine|mesh-list
110543951|NCT02651870|Candesartan|candesartan|mesh-list
110543952|NCT02651870|Candesartan cilexetil|candesartan cilexetil|mesh-list
110543953|NCT02651870|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110285402|NCT00233376|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110543954|NCT02651870|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110543955|NCT02651870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110543956|NCT02651870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110543957|NCT02651870|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110543958|NCT02651870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110543959|NCT02651870|Vasodilator Agents|vasodilator agents|mesh-ancestor
110543960|NCT02651870|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110543961|NCT02651870|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110543963|NCT02766803|Simvastatin|simvastatin|mesh-list
110543964|NCT02766803|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110543965|NCT02766803|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110543966|NCT02766803|Antimetabolites|antimetabolites|mesh-ancestor
110543967|NCT02766803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110543968|NCT02766803|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110543969|NCT02766803|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110543970|NCT02766803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110543971|NCT02766803|Antioxidants|antioxidants|mesh-ancestor
110543972|NCT02766803|Protective Agents|protective agents|mesh-ancestor
110543973|NCT02766803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110543974|NCT02766803|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110543975|NCT00650468|Mycophenolic Acid|mycophenolic acid|mesh-list
110543976|NCT00650468|Prednisone|prednisone|mesh-list
110543977|NCT00650468|Tacrolimus|tacrolimus|mesh-list
110543978|NCT00650468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110543979|NCT00650468|Glucocorticoids|glucocorticoids|mesh-ancestor
110543980|NCT00650468|Hormones|hormones|mesh-ancestor
110543981|NCT00650468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110543982|NCT00650468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110543983|NCT00650468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110543984|NCT00650468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110543985|NCT00650468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110543986|NCT00650468|Immunologic Factors|immunologic factors|mesh-ancestor
110543987|NCT00650468|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110543988|NCT00650468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110543989|NCT00650468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110543990|NCT00650468|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110543991|NCT00650468|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110543992|NCT00650468|Antitubercular Agents|antitubercular agents|mesh-ancestor
110543993|NCT00650468|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110543994|NCT00650468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110543995|NCT02576080|Imatinib Mesylate|imatinib mesylate|mesh-list
110543996|NCT02576080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110543997|NCT02576080|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110543998|NCT02576080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110543999|NCT02576080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110544000|NCT04006483|Fluorides|fluorides|mesh-list
110544001|NCT04006483|Tin Fluorides|tin fluorides|mesh-list
110544002|NCT04006483|Cariostatic Agents|cariostatic agents|mesh-ancestor
110544003|NCT04006483|Protective Agents|protective agents|mesh-ancestor
110544004|NCT04006483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110544005|NCT02651792|Meperidine|meperidine|mesh-list
110544006|NCT02651792|Ketamine|ketamine|mesh-list
110544007|NCT02651792|Propofol|propofol|mesh-list
110544008|NCT02651792|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110544009|NCT02651792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110544010|NCT02651792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110544011|NCT02651792|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110544012|NCT02651792|Anesthetics, General|anesthetics, general|mesh-ancestor
110544013|NCT02651792|Anesthetics|anesthetics|mesh-ancestor
110544014|NCT02651792|Analgesics|analgesics|mesh-ancestor
110544015|NCT02651792|Sensory System Agents|sensory system agents|mesh-ancestor
110544016|NCT02651792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110544017|NCT02651792|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110544018|NCT02651792|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110544019|NCT02651792|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110544020|NCT02651792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110544021|NCT02651792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110544022|NCT02651792|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110544024|NCT02651792|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110544025|NCT04754815|Paclitaxel|paclitaxel|mesh-list
110544026|NCT04754815|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110544027|NCT04754815|Pembrolizumab|pembrolizumab|mesh-list
110544028|NCT04754815|Pemetrexed|pemetrexed|mesh-list
110544029|NCT04754815|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110544030|NCT04754815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110544031|NCT04754815|Tubulin Modulators|tubulin modulators|mesh-ancestor
110544032|NCT04754815|Antimitotic Agents|antimitotic agents|mesh-ancestor
110544033|NCT04754815|Mitosis Modulators|mitosis modulators|mesh-ancestor
110544034|NCT04754815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110544035|NCT04754815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110544036|NCT04754815|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110544037|NCT04754815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110544038|NCT04754815|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110544039|NCT04754815|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110544040|NCT00649532|Ondansetron|ondansetron|mesh-list
110544041|NCT00649532|Antiemetics|antiemetics|mesh-ancestor
110544042|NCT00649532|Autonomic Agents|autonomic agents|mesh-ancestor
110544043|NCT00649532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110544044|NCT00649532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110544045|NCT00649532|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110544046|NCT00649532|Antipruritics|antipruritics|mesh-ancestor
110544047|NCT00649532|Dermatologic Agents|dermatologic agents|mesh-ancestor
110544048|NCT00649532|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110544049|NCT00649532|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110544050|NCT00649532|Serotonin Agents|serotonin agents|mesh-ancestor
110544051|NCT00649532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110544052|NCT00649532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110544053|NCT02655614|Midazolam|midazolam|mesh-list
110544054|NCT02655614|Caffeine|caffeine|mesh-list
110544055|NCT02655614|Rabeprazole|rabeprazole|mesh-list
110544056|NCT02655614|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110544057|NCT02655614|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110544058|NCT02655614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110544059|NCT02655614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110544060|NCT02655614|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110544061|NCT02655614|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110544062|NCT02655614|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110544063|NCT02655614|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110544064|NCT02655614|Anesthetics, General|anesthetics, general|mesh-ancestor
110544065|NCT02655614|Anesthetics|anesthetics|mesh-ancestor
110544066|NCT02655614|GABA Modulators|gaba modulators|mesh-ancestor
110544067|NCT02655614|GABA Agents|gaba agents|mesh-ancestor
110544068|NCT02655614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110544069|NCT02655614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110544070|NCT02655614|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110544071|NCT02655614|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110544072|NCT02655614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110544073|NCT02655614|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110544074|NCT02655614|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110544075|NCT02655614|Purinergic Agents|purinergic agents|mesh-ancestor
110544076|NCT02655614|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110544077|NCT02655614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110544078|NCT02655614|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110544079|NCT02772029|Apatinib|apatinib|mesh-list
110544080|NCT02772029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110544081|NCT02772029|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110544082|NCT02772029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110544083|NCT02772029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110544084|NCT02766725|Sildenafil Citrate|sildenafil citrate|mesh-list
110544085|NCT02766725|Vasodilator Agents|vasodilator agents|mesh-ancestor
110544086|NCT02766725|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110544087|NCT02766725|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110544088|NCT02766725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110544089|NCT02766725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110544090|NCT02766725|Urological Agents|urological agents|mesh-ancestor
110544091|NCT02658422|Montelukast|montelukast|mesh-list
110544092|NCT02658422|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110544093|NCT02658422|Respiratory System Agents|respiratory system agents|mesh-ancestor
110544094|NCT02658422|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110544095|NCT02658422|Hormone Antagonists|hormone antagonists|mesh-ancestor
110544096|NCT02658422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110544097|NCT02658422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110544098|NCT02658422|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110544099|NCT02658422|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110544100|NCT02658422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110544102|NCT02771795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110285557|NCT01084603|Nicotine|nicotine|mesh-list
110544103|NCT02771795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110544104|NCT02655536|Bevacizumab|bevacizumab|mesh-list
110544105|NCT02655536|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110544106|NCT02655536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110544107|NCT02655536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110544108|NCT02655536|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110544109|NCT02655536|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110544110|NCT02655536|Growth Substances|growth substances|mesh-ancestor
110544111|NCT02655536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110544112|NCT02655536|Growth Inhibitors|growth inhibitors|mesh-ancestor
110544113|NCT02655536|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110544114|NCT02655536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110544115|NCT02655536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110544116|NCT02766647|Lenograstim|lenograstim|mesh-list
110544117|NCT02766647|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110544118|NCT02766647|Immunologic Factors|immunologic factors|mesh-ancestor
110544119|NCT02766647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110544120|NCT02651636|Folic Acid|folic acid|mesh-list
110544121|NCT02651636|Thioctic Acid|thioctic acid|mesh-list
110544122|NCT02651636|Inositol|inositol|mesh-list
110544123|NCT02651636|Hematinics|hematinics|mesh-ancestor
110544124|NCT02651636|Vitamin B Complex|vitamin b complex|mesh-ancestor
110544125|NCT02651636|Vitamins|vitamins|mesh-ancestor
110544126|NCT02651636|Micronutrients|micronutrients|mesh-ancestor
110544127|NCT02651636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110544128|NCT02651636|Antioxidants|antioxidants|mesh-ancestor
110544129|NCT02651636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110544130|NCT02651636|Protective Agents|protective agents|mesh-ancestor
110544131|NCT02774993|Doxycycline|doxycycline|mesh-list
110544132|NCT02774993|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110544133|NCT02774993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110544134|NCT02774993|Antimalarials|antimalarials|mesh-ancestor
110544135|NCT02774993|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110544136|NCT02774993|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110544138|NCT02774837|Telbivudine|telbivudine|mesh-list
110544139|NCT02774837|Antiviral Agents|antiviral agents|mesh-ancestor
110544140|NCT02774837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110544141|NCT02774837|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110544142|NCT02774837|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110544143|NCT02774837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110544144|NCT02774837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110544145|NCT02774837|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110544146|NCT02774837|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110544147|NCT02658188|Gabapentin|gabapentin|mesh-list
110544148|NCT02658188|Analgesics|analgesics|mesh-ancestor
110544149|NCT02658188|Sensory System Agents|sensory system agents|mesh-ancestor
110544150|NCT02658188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110544151|NCT02658188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110544152|NCT02658188|Anticonvulsants|anticonvulsants|mesh-ancestor
110544153|NCT02658188|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110544154|NCT02658188|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110544155|NCT02658188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110544156|NCT02658188|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110544157|NCT02658188|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110544158|NCT02658188|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110544159|NCT02658188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110544160|NCT02658188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110544161|NCT02658188|Antimanic Agents|antimanic agents|mesh-ancestor
110544162|NCT02771717|Budesonide|budesonide|mesh-list
110285800|NCT00234234|Adalimumab|adalimumab|mesh-list
110544163|NCT02771717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110544164|NCT02771717|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110544165|NCT02771717|Autonomic Agents|autonomic agents|mesh-ancestor
110544166|NCT02771717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110544167|NCT02771717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110544168|NCT02771717|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110544169|NCT02771717|Respiratory System Agents|respiratory system agents|mesh-ancestor
110544170|NCT02771717|Glucocorticoids|glucocorticoids|mesh-ancestor
110544171|NCT02771717|Hormones|hormones|mesh-ancestor
110544172|NCT02771717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110544173|NCT02655380|Ketamine|ketamine|mesh-list
110544174|NCT02655380|Remifentanil|remifentanil|mesh-list
110544175|NCT02655380|Analgesics|analgesics|mesh-ancestor
110544176|NCT02655380|Sensory System Agents|sensory system agents|mesh-ancestor
110544177|NCT02655380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110544178|NCT02655380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110544179|NCT02655380|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110544180|NCT02655380|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110544181|NCT02655380|Anesthetics, General|anesthetics, general|mesh-ancestor
110544182|NCT02655380|Anesthetics|anesthetics|mesh-ancestor
110544183|NCT02655380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110544184|NCT02655380|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110544185|NCT02655380|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110544186|NCT02655380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110544187|NCT02655380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110544188|NCT02655380|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110544189|NCT02655380|Narcotics|narcotics|mesh-ancestor
110544190|NCT00580840|Certolizumab Pegol|certolizumab pegol|mesh-list
110544191|NCT00580840|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110544192|NCT00580840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110544193|NCT00580840|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110544194|NCT00580840|Immunologic Factors|immunologic factors|mesh-ancestor
110544195|NCT00580840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110544196|NCT00580840|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110544197|NCT00987103|Tacrolimus|tacrolimus|mesh-list
110544198|NCT00987103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110544199|NCT00987103|Immunologic Factors|immunologic factors|mesh-ancestor
110544200|NCT00987103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110544201|NCT00987103|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110544202|NCT00987103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110544203|NCT00987103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110544204|NCT02655458|Lenalidomide|lenalidomide|mesh-list
110544205|NCT02655458|Elotuzumab|elotuzumab|mesh-list
110544206|NCT02655458|Immunologic Factors|immunologic factors|mesh-ancestor
110544207|NCT02655458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110544208|NCT02655458|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110544209|NCT02655458|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110544210|NCT02655458|Growth Substances|growth substances|mesh-ancestor
110544211|NCT02655458|Growth Inhibitors|growth inhibitors|mesh-ancestor
110544212|NCT02655458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110544213|NCT04006093|Apixaban|apixaban|mesh-list
110544214|NCT04006093|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110544215|NCT04006093|Antithrombins|antithrombins|mesh-ancestor
110544216|NCT04006093|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110544217|NCT04006093|Protease Inhibitors|protease inhibitors|mesh-ancestor
110544218|NCT04006093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110544219|NCT04006093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110544220|NCT04006093|Anticoagulants|anticoagulants|mesh-ancestor
110544221|NCT02766257|Anesthetics|anesthetics|mesh-list
110544222|NCT02766257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110544223|NCT02766257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110544224|NCT04005469|Treprostinil|treprostinil|mesh-list
110544225|NCT04005469|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110544226|NCT02651324|Ketamine|ketamine|mesh-list
110544227|NCT02651324|Analgesics|analgesics|mesh-ancestor
110544228|NCT02651324|Sensory System Agents|sensory system agents|mesh-ancestor
110544229|NCT02651324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110544230|NCT02651324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110544231|NCT02651324|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110544232|NCT02651324|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110191811|NCT00395681|Propofol|propofol|mesh-list
110544233|NCT02651324|Anesthetics, General|anesthetics, general|mesh-ancestor
110544234|NCT02651324|Anesthetics|anesthetics|mesh-ancestor
110544235|NCT02651324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110178084|NCT04726345|Fexofenadine|fexofenadine|mesh-list
110544236|NCT02651324|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110544237|NCT02651324|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110544238|NCT02651324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110544239|NCT02651324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110544240|NCT00662220|Ribavirin|ribavirin|mesh-list
110544241|NCT00662220|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110544242|NCT00662220|Interferon-alpha|interferon-alpha|mesh-list
110544243|NCT00662220|Antimetabolites|antimetabolites|mesh-ancestor
110544244|NCT00662220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110544245|NCT00662220|Antiviral Agents|antiviral agents|mesh-ancestor
110544246|NCT00662220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110544247|NCT00662220|Immunologic Factors|immunologic factors|mesh-ancestor
110544248|NCT00662220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110544249|NCT02575924|Imidacloprid|imidacloprid|mesh-list
110544250|NCT02575924|Cholinergic Agents|cholinergic agents|mesh-ancestor
110544251|NCT02575924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110544252|NCT02575924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110544253|NCT02575924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110544254|NCT02651168|Aflibercept|aflibercept|mesh-list
110544255|NCT02651168|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110544256|NCT02651168|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110544257|NCT02651168|Growth Substances|growth substances|mesh-ancestor
110544258|NCT02651168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110544259|NCT02651168|Growth Inhibitors|growth inhibitors|mesh-ancestor
110544260|NCT02651168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110544261|NCT04073602|Trastuzumab|trastuzumab|mesh-list
110544262|NCT04073602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110544263|NCT04073602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110544264|NCT00650000|Modafinil|modafinil|mesh-list
110544265|NCT00650000|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110544266|NCT00650000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110544267|NCT00650000|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
110544268|NCT00650000|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110544269|NCT00650000|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110544270|NCT00650000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110544271|NCT02630862|Aspirin|aspirin|mesh-list
110544272|NCT02630862|Dipyridamole|dipyridamole|mesh-list
110544273|NCT02630862|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110544274|NCT02630862|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110544275|NCT02630862|Analgesics|analgesics|mesh-ancestor
110544276|NCT02630862|Sensory System Agents|sensory system agents|mesh-ancestor
110544277|NCT02630862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110544278|NCT02630862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110544279|NCT02630862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110544280|NCT02630862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110544281|NCT02630862|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110544282|NCT02630862|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110343811|NCT06022614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110544283|NCT02630862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110544284|NCT02630862|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110544285|NCT02630862|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110544286|NCT02630862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110544287|NCT02630862|Antipyretics|antipyretics|mesh-ancestor
110544288|NCT02630862|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110544289|NCT02630862|Vasodilator Agents|vasodilator agents|mesh-ancestor
110544290|NCT02536430|Ketorolac|ketorolac|mesh-list
110544291|NCT02536430|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
110544292|NCT02536430|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110544293|NCT02536430|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110544294|NCT02536430|Analgesics|analgesics|mesh-ancestor
110544295|NCT02536430|Sensory System Agents|sensory system agents|mesh-ancestor
110544296|NCT02536430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110544297|NCT02536430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110544298|NCT02536430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110544299|NCT02536430|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110544300|NCT02536430|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110544301|NCT02536430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110544302|NCT02536430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110544303|NCT02631174|Antithrombins|antithrombins|mesh-list
110544304|NCT02631174|Antithrombin III|antithrombin iii|mesh-list
110544305|NCT02631174|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110544306|NCT02631174|Protease Inhibitors|protease inhibitors|mesh-ancestor
110191891|NCT00030173|Epothilones|epothilones|mesh-list
110544307|NCT02631174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110544308|NCT02631174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110544309|NCT02631174|Anticoagulants|anticoagulants|mesh-ancestor
110544310|NCT04686929|Abatacept|abatacept|mesh-list
110544311|NCT04686929|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110544312|NCT04686929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110544313|NCT04686929|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110544314|NCT04686929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110544315|NCT04686929|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110544316|NCT04686929|Immunologic Factors|immunologic factors|mesh-ancestor
110544317|NCT04686929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110544318|NCT04686929|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110544319|NCT02765633|Cangrelor|cangrelor|mesh-list
110544320|NCT02765633|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110544321|NCT02765633|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110544322|NCT02765633|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110544323|NCT02765633|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110544324|NCT02765633|Purinergic Agents|purinergic agents|mesh-ancestor
110544325|NCT02765633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110544326|NCT02765633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110544327|NCT02765633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110544328|NCT00581776|Dexamethasone|dexamethasone|mesh-list
110544329|NCT00581776|Cyclophosphamide|cyclophosphamide|mesh-list
110544330|NCT00581776|Rituximab|rituximab|mesh-list
110285972|NCT00234468|Gefitinib|gefitinib|mesh-list
110544331|NCT00581776|Doxorubicin|doxorubicin|mesh-list
110544332|NCT00581776|Vincristine|vincristine|mesh-list
110544333|NCT00581776|Bortezomib|bortezomib|mesh-list
110544334|NCT00581776|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110544335|NCT00581776|Immunologic Factors|immunologic factors|mesh-ancestor
110544336|NCT00581776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110544337|NCT00581776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110544338|NCT00581776|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110544339|NCT00581776|Alkylating Agents|alkylating agents|mesh-ancestor
110544340|NCT00581776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110544341|NCT00581776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110544342|NCT00581776|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110544343|NCT00581776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110544344|NCT00581776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110544345|NCT00581776|Antiemetics|antiemetics|mesh-ancestor
110544346|NCT00581776|Autonomic Agents|autonomic agents|mesh-ancestor
110544347|NCT00581776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110544348|NCT00581776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110544349|NCT00581776|Glucocorticoids|glucocorticoids|mesh-ancestor
110178119|NCT00143689|Lamivudine|lamivudine|mesh-list
110544350|NCT00581776|Hormones|hormones|mesh-ancestor
110544351|NCT00581776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110544352|NCT00581776|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110544353|NCT00581776|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110544354|NCT00581776|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110544355|NCT00581776|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110544356|NCT00581776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110544357|NCT00581776|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110544358|NCT00581776|Tubulin Modulators|tubulin modulators|mesh-ancestor
110544359|NCT00581776|Antimitotic Agents|antimitotic agents|mesh-ancestor
110544360|NCT00581776|Mitosis Modulators|mitosis modulators|mesh-ancestor
110544361|NCT00662454|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110544362|NCT00662454|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110544363|NCT00662454|Levonorgestrel|levonorgestrel|mesh-list
110544364|NCT00662454|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110544365|NCT00662454|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
110544367|NCT00662454|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110544368|NCT00662454|Estrogens|estrogens|mesh-ancestor
110544369|NCT00662454|Hormones|hormones|mesh-ancestor
110544370|NCT00662454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110544371|NCT00662454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110544372|NCT00662454|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110544373|NCT00662454|Contraceptive Agents|contraceptive agents|mesh-ancestor
110544374|NCT00662454|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110544375|NCT00662454|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110544376|NCT00662454|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110544377|NCT00662454|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110544378|NCT00662454|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110544379|NCT00662454|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110191964|NCT00030446|Carboplatin|carboplatin|mesh-list
110544380|NCT04156152|Listerine|listerine|mesh-list
110544381|NCT04156152|Fluorides|fluorides|mesh-list
110544382|NCT04156152|Sodium Fluoride|sodium fluoride|mesh-list
110544383|NCT04156152|Cariostatic Agents|cariostatic agents|mesh-ancestor
110544384|NCT04156152|Protective Agents|protective agents|mesh-ancestor
110544385|NCT04156152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110544386|NCT04156152|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110544387|NCT04156152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110544388|NCT00662610|Naproxen|naproxen|mesh-list
110286041|NCT01084330|Irinotecan|irinotecan|mesh-list
110544389|NCT00662610|Naproxen-n-butyl nitrate|naproxen-n-butyl nitrate|mesh-list
110544390|NCT00662610|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110544391|NCT00662610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110544392|NCT00662610|Analgesics|analgesics|mesh-ancestor
110544393|NCT00662610|Sensory System Agents|sensory system agents|mesh-ancestor
110544394|NCT00662610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110544395|NCT00662610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110544396|NCT00662610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110544397|NCT00662610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110544398|NCT00662610|Gout Suppressants|gout suppressants|mesh-ancestor
110544399|NCT00662610|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110544400|NCT00662610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110544401|NCT00662610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110544402|NCT00662610|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
110544403|NCT04225325|Dolutegravir|dolutegravir|mesh-list
110544404|NCT04225325|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
110544405|NCT04225325|Emtricitabine|emtricitabine|mesh-list
110544406|NCT04225325|Darunavir|darunavir|mesh-list
110544407|NCT04225325|Cobicistat|cobicistat|mesh-list
110544408|NCT04225325|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110544409|NCT04225325|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110544410|NCT04225325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110544411|NCT04225325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110544412|NCT04225325|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110544413|NCT04225325|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110544414|NCT04225325|Antiviral Agents|antiviral agents|mesh-ancestor
110544415|NCT04225325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110544416|NCT04225325|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110544417|NCT04225325|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110544418|NCT04225325|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110544419|NCT04225325|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110544420|NCT04225325|Protease Inhibitors|protease inhibitors|mesh-ancestor
110544421|NCT04225325|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110544422|NCT04225325|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110544423|NCT00649610|Diclofenac|diclofenac|mesh-list
110544424|NCT00649610|Valdecoxib|valdecoxib|mesh-list
110544425|NCT00649610|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110544426|NCT00649610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110544427|NCT00649610|Analgesics|analgesics|mesh-ancestor
110544428|NCT00649610|Sensory System Agents|sensory system agents|mesh-ancestor
110544429|NCT00649610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110544430|NCT00649610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110544431|NCT00649610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110544432|NCT00649610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110544433|NCT00649610|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110544434|NCT00649610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110544435|NCT00649610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110544436|NCT00649610|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110544437|NCT02655146|Triptorelin Pamoate|triptorelin pamoate|mesh-list
110544438|NCT02655146|Progesterone|progesterone|mesh-list
110544439|NCT02655146|Estradiol|estradiol|mesh-list
110544440|NCT02655146|Progestins|progestins|mesh-ancestor
110544441|NCT02655146|Hormones|hormones|mesh-ancestor
110544442|NCT02655146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110286313|NCT02210182|Pentamidine|pentamidine|mesh-list
110544443|NCT02655146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110544444|NCT02655146|Luteolytic Agents|luteolytic agents|mesh-ancestor
110544445|NCT02655146|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110544446|NCT02655146|Contraceptive Agents|contraceptive agents|mesh-ancestor
110544447|NCT02655146|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110544448|NCT02655146|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110544449|NCT02655146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110544450|NCT02655146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110544451|NCT02655146|Estrogens|estrogens|mesh-ancestor
110544452|NCT02774525|Ethanol|ethanol|mesh-list
110544453|NCT02774525|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110544454|NCT02774525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110544455|NCT02774525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110544456|NCT02774525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110544457|NCT04167566|Artemisinins|artemisinins|mesh-list
110544458|NCT04167566|Artemisinin|artemisinin|mesh-list
110544459|NCT04167566|Antimalarials|antimalarials|mesh-ancestor
110544460|NCT04167566|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110544461|NCT04167566|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110178158|NCT00143806|Cyclosporine|cyclosporine|mesh-list
110544462|NCT04167566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110544464|NCT00650624|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110544465|NCT00650624|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110544466|NCT00650624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110544467|NCT00650624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110544468|NCT00650624|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110544469|NCT00650624|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110544470|NCT00650624|Analgesics|analgesics|mesh-ancestor
110544471|NCT00650624|Sensory System Agents|sensory system agents|mesh-ancestor
110544472|NCT00650624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110544473|NCT00650624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110544474|NCT00650624|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110544475|NCT00650624|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110544476|NCT00666354|Methotrexate|methotrexate|mesh-list
110544477|NCT00666354|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110544478|NCT00666354|Abortifacient Agents|abortifacient agents|mesh-ancestor
110544479|NCT00666354|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110544480|NCT00666354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110544481|NCT00666354|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110544482|NCT00666354|Antimetabolites|antimetabolites|mesh-ancestor
110544483|NCT00666354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110544484|NCT00666354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110544485|NCT00666354|Dermatologic Agents|dermatologic agents|mesh-ancestor
110544486|NCT00666354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110544487|NCT00666354|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110544488|NCT00666354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110544489|NCT00666354|Immunologic Factors|immunologic factors|mesh-ancestor
110544490|NCT00666354|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110544491|NCT00666354|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110544492|NCT02536352|Vitamins|vitamins|mesh-list
110544493|NCT02536352|Fluorides|fluorides|mesh-list
110544494|NCT02536352|Micronutrients|micronutrients|mesh-ancestor
110544495|NCT02536352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110544496|NCT02536352|Cariostatic Agents|cariostatic agents|mesh-ancestor
110544497|NCT02536352|Protective Agents|protective agents|mesh-ancestor
110544498|NCT02773979|Chloroquine|chloroquine|mesh-list
110544499|NCT02773979|Amebicides|amebicides|mesh-ancestor
110544500|NCT02773979|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110544501|NCT02773979|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110544502|NCT02773979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110544503|NCT02773979|Antimalarials|antimalarials|mesh-ancestor
110544504|NCT02773979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110544505|NCT00662844|Vitamin D|vitamin d|mesh-list
110544506|NCT00662844|Cholecalciferol|cholecalciferol|mesh-list
110544507|NCT00662844|Vitamins|vitamins|mesh-ancestor
110544508|NCT00662844|Micronutrients|micronutrients|mesh-ancestor
110544509|NCT00662844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110544510|NCT00662844|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110544511|NCT00662844|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110544512|NCT02650544|Mirtazapine|mirtazapine|mesh-list
110544513|NCT02650544|Antidepressive Agents|antidepressive agents|mesh-ancestor
110544514|NCT02650544|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110544515|NCT02650544|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110544516|NCT02650544|Histamine Antagonists|histamine antagonists|mesh-ancestor
110544517|NCT02650544|Histamine Agents|histamine agents|mesh-ancestor
110544518|NCT02650544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110544519|NCT02650544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110544520|NCT02650544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110544521|NCT02650544|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110544522|NCT02650544|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110544523|NCT02650544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110544524|NCT02650544|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
110544525|NCT02650544|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110544526|NCT02650544|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110544527|NCT02650544|Adrenergic Agents|adrenergic agents|mesh-ancestor
110544528|NCT02650544|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110544529|NCT02650544|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110544531|NCT02650544|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110287585|NCT00214370|Analgesics|analgesics|mesh-ancestor
110544533|NCT02650388|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110544534|NCT02650388|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110544535|NCT02650388|Analgesics|analgesics|mesh-ancestor
110544536|NCT02650388|Sensory System Agents|sensory system agents|mesh-ancestor
110544537|NCT02650388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110544538|NCT02650388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110544539|NCT02650388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110544540|NCT02650388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110544541|NCT00883740|Pregabalin|pregabalin|mesh-list
110544542|NCT00883740|Analgesics|analgesics|mesh-ancestor
110544543|NCT00883740|Sensory System Agents|sensory system agents|mesh-ancestor
110544544|NCT00883740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110544545|NCT00883740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110544547|NCT00883740|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110544548|NCT00883740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110544549|NCT00883740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110544550|NCT00883740|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110544551|NCT00883740|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110544552|NCT00883740|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110544553|NCT00883740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110544554|NCT00883740|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110544555|NCT04183712|Gemcitabine|gemcitabine|mesh-list
110544556|NCT04183712|Oxaliplatin|oxaliplatin|mesh-list
110544557|NCT04183712|Afatinib|afatinib|mesh-list
110544558|NCT04183712|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110544559|NCT04183712|Antimetabolites|antimetabolites|mesh-ancestor
110544560|NCT04183712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110544561|NCT04183712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110544562|NCT04183712|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110544563|NCT04183712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110544564|NCT02773199|Bupivacaine|bupivacaine|mesh-list
110544565|NCT02773199|Anesthetics, Local|anesthetics, local|mesh-ancestor
110544566|NCT02773199|Anesthetics|anesthetics|mesh-ancestor
110544567|NCT02773199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110544568|NCT02773199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110544569|NCT02773199|Sensory System Agents|sensory system agents|mesh-ancestor
110544570|NCT02773199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110544571|NCT02654834|Nitrous Oxide|nitrous oxide|mesh-list
110544572|NCT02654834|Anesthetics|anesthetics|mesh-list
110544573|NCT02654834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110544574|NCT02654834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110544575|NCT02654834|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110544576|NCT02654834|Anesthetics, General|anesthetics, general|mesh-ancestor
110544577|NCT02654834|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110544578|NCT02654834|Analgesics|analgesics|mesh-ancestor
110544579|NCT02654834|Sensory System Agents|sensory system agents|mesh-ancestor
110544580|NCT02654834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110544581|NCT00656526|Lidocaine|lidocaine|mesh-list
110544582|NCT00656526|Anesthetics, Local|anesthetics, local|mesh-ancestor
110544583|NCT00656526|Anesthetics|anesthetics|mesh-ancestor
110544584|NCT00656526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110544585|NCT00656526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110544586|NCT00656526|Sensory System Agents|sensory system agents|mesh-ancestor
110544587|NCT00656526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110544588|NCT00656526|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110544589|NCT00656526|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110289572|NCT00412646|Etravirine|etravirine|mesh-list
110544590|NCT00656526|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110544591|NCT00656526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110544592|NCT00656526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110544593|NCT02765009|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110544594|NCT02765009|Furosemide|furosemide|mesh-list
110544595|NCT02765009|Bumetanide|bumetanide|mesh-list
110544596|NCT02765009|Diuretics|diuretics|mesh-list
110544597|NCT02765009|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110544598|NCT02765009|Natriuretic Agents|natriuretic agents|mesh-ancestor
110544599|NCT02765009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110544600|NCT02765009|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110544601|NCT02765009|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110544602|NCT02765009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110544603|NCT02765009|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110544604|NCT02649920|Dinoprostone|dinoprostone|mesh-list
110544605|NCT02649920|Oxytocics|oxytocics|mesh-ancestor
110544606|NCT02649920|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110544607|NCT02649920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110544610|NCT00649688|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110544611|NCT00649688|Diuretics|diuretics|mesh-ancestor
110544612|NCT00649688|Natriuretic Agents|natriuretic agents|mesh-ancestor
110544613|NCT00649688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110544614|NCT00649688|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110544615|NCT00649688|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110544616|NCT00649688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110544617|NCT00649688|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110544619|NCT00649688|Autonomic Agents|autonomic agents|mesh-ancestor
110544620|NCT00649688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110544621|NCT00649688|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110544622|NCT00649688|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110544623|NCT00649688|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110544624|NCT00649688|Adrenergic Agents|adrenergic agents|mesh-ancestor
110544625|NCT00649688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110544626|NCT00667056|Tacrolimus|tacrolimus|mesh-list
110544627|NCT00667056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110544628|NCT00667056|Immunologic Factors|immunologic factors|mesh-ancestor
110544629|NCT00667056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110544630|NCT00667056|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110544631|NCT00667056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110544632|NCT00667056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110544633|NCT02764619|Spironolactone|spironolactone|mesh-list
110291700|NCT04588285|Ambroxol|ambroxol|mesh-list
110544634|NCT02764619|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110544635|NCT02764619|Hormone Antagonists|hormone antagonists|mesh-ancestor
110544636|NCT02764619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110544637|NCT02764619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110544638|NCT02764619|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110544639|NCT02764619|Diuretics|diuretics|mesh-ancestor
110544640|NCT02764619|Natriuretic Agents|natriuretic agents|mesh-ancestor
110544641|NCT04032210|Zinc|zinc|mesh-list
110544642|NCT04032210|Fluorides|fluorides|mesh-list
110544643|NCT04032210|Cariostatic Agents|cariostatic agents|mesh-ancestor
110544644|NCT04032210|Protective Agents|protective agents|mesh-ancestor
110544645|NCT04032210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110544646|NCT04032210|Trace Elements|trace elements|mesh-ancestor
110544647|NCT04032210|Micronutrients|micronutrients|mesh-ancestor
110544648|NCT04223219|Magnesium Sulfate|magnesium sulfate|mesh-list
110544649|NCT04223219|Fentanyl|fentanyl|mesh-list
110544650|NCT04223219|Dexmedetomidine|dexmedetomidine|mesh-list
110544651|NCT04223219|Ketamine|ketamine|mesh-list
110544652|NCT04223219|Propofol|propofol|mesh-list
110544653|NCT04223219|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110544654|NCT04223219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110544655|NCT04223219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110178195|NCT00144157|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110178199|NCT00144196|Tiotropium Bromide|tiotropium bromide|mesh-list
110544656|NCT04223219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110544657|NCT04223219|Analgesics|analgesics|mesh-ancestor
110544658|NCT04223219|Sensory System Agents|sensory system agents|mesh-ancestor
110544659|NCT04223219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110544660|NCT04223219|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110544661|NCT04223219|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110544662|NCT04223219|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110544663|NCT04223219|Adrenergic Agents|adrenergic agents|mesh-ancestor
110544664|NCT04223219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110544665|NCT04223219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110544666|NCT04223219|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110544667|NCT04223219|Anesthetics, General|anesthetics, general|mesh-ancestor
110544668|NCT04223219|Anesthetics|anesthetics|mesh-ancestor
110544669|NCT04223219|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110544670|NCT04223219|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110544671|NCT04223219|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110544672|NCT04223219|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110544673|NCT04223219|Narcotics|narcotics|mesh-ancestor
110544674|NCT04223219|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110544675|NCT04223219|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110544676|NCT04223219|Anticonvulsants|anticonvulsants|mesh-ancestor
110544677|NCT04223219|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110544678|NCT04223219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110544679|NCT04223219|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110192317|NCT00059358|Ribavirin|ribavirin|mesh-list
110544680|NCT04223219|Tocolytic Agents|tocolytic agents|mesh-ancestor
110544681|NCT04223219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110544682|NCT02631252|Hydroxychloroquine|hydroxychloroquine|mesh-list
110544684|NCT02631252|Mitoxantrone|mitoxantrone|mesh-list
110544685|NCT02631252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110544686|NCT02631252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110544687|NCT02631252|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110544688|NCT02631252|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110544689|NCT02631252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110544690|NCT02631252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110544691|NCT02631252|Antimalarials|antimalarials|mesh-ancestor
110544692|NCT02631252|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110544693|NCT02631252|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110294311|NCT00236808|Levofloxacin|levofloxacin|mesh-list
110544694|NCT02631252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110544695|NCT02631252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110544696|NCT02631252|Analgesics|analgesics|mesh-ancestor
110544697|NCT02631252|Sensory System Agents|sensory system agents|mesh-ancestor
110544698|NCT02631252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110544699|NCT02631252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110544700|NCT02631408|Vancomycin|vancomycin|mesh-list
110544701|NCT02631408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110544702|NCT02631408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110544703|NCT02630394|Azithromycin|azithromycin|mesh-list
110544704|NCT02630394|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110544705|NCT02630394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110544706|NCT02771405|Ribavirin|ribavirin|mesh-list
110544707|NCT02771405|Sofosbuvir|sofosbuvir|mesh-list
110544708|NCT02771405|Simeprevir|simeprevir|mesh-list
110544709|NCT02771405|Ledipasvir|ledipasvir|mesh-list
110544710|NCT02771405|Antimetabolites|antimetabolites|mesh-ancestor
110544711|NCT02771405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110544712|NCT02771405|Antiviral Agents|antiviral agents|mesh-ancestor
110544713|NCT02771405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110544714|NCT02771405|Protease Inhibitors|protease inhibitors|mesh-ancestor
110295250|NCT04560049|Silver Nitrate|silver nitrate|mesh-list
110544715|NCT02771405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110544716|NCT00667758|Cetrorelix|cetrorelix|mesh-list
110544717|NCT00667758|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110544719|NCT00667758|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110544720|NCT00667758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110544721|NCT00667758|Hormone Antagonists|hormone antagonists|mesh-ancestor
110544722|NCT00667758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110544723|NCT00542815|Sevelamer|sevelamer|mesh-list
110544724|NCT00542815|Chelating Agents|chelating agents|mesh-ancestor
110544725|NCT00542815|Sequestering Agents|sequestering agents|mesh-ancestor
110544726|NCT00542815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110544727|NCT02762591|Pimavanserin|pimavanserin|mesh-list
110544728|NCT02762591|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110544729|NCT02762591|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110544730|NCT02762591|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110544731|NCT02762591|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110544732|NCT02762591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110544733|NCT02762591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110544734|NCT02762591|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110544735|NCT02762591|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110544736|NCT02762591|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110544737|NCT02762591|Serotonin Agents|serotonin agents|mesh-ancestor
110544738|NCT02762591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110544739|NCT02762591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110544740|NCT02696369|Lidocaine|lidocaine|mesh-list
110544741|NCT02696369|Epinephrine|epinephrine|mesh-list
110544742|NCT02696369|Racepinephrine|racepinephrine|mesh-list
110544743|NCT02696369|Epinephryl borate|epinephryl borate|mesh-list
110544744|NCT02696369|Anesthetics, Local|anesthetics, local|mesh-ancestor
110544745|NCT02696369|Anesthetics|anesthetics|mesh-ancestor
110544746|NCT02696369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110544747|NCT02696369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110544748|NCT02696369|Sensory System Agents|sensory system agents|mesh-ancestor
110544749|NCT02696369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110544750|NCT02696369|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110544751|NCT02696369|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110544752|NCT02696369|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110544753|NCT02696369|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110544754|NCT02696369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110544755|NCT02696369|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110544756|NCT02696369|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110544757|NCT02696369|Adrenergic Agents|adrenergic agents|mesh-ancestor
110544758|NCT02696369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110544759|NCT02696369|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110544760|NCT02696369|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110544761|NCT02696369|Autonomic Agents|autonomic agents|mesh-ancestor
110544762|NCT02696369|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110544763|NCT02696369|Respiratory System Agents|respiratory system agents|mesh-ancestor
110544764|NCT02696369|Mydriatics|mydriatics|mesh-ancestor
110544765|NCT02696369|Sympathomimetics|sympathomimetics|mesh-ancestor
110544766|NCT02696369|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110544767|NCT00663312|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
110544768|NCT00663312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110544769|NCT00663312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110544770|NCT02636088|Cetuximab|cetuximab|mesh-list
110544771|NCT02636088|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110544772|NCT02636088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110544773|NCT02630160|Epinephrine|epinephrine|mesh-list
110544774|NCT02630160|Bupivacaine|bupivacaine|mesh-list
110544775|NCT02630160|Anesthetics, Local|anesthetics, local|mesh-ancestor
110544776|NCT02630160|Anesthetics|anesthetics|mesh-ancestor
110178220|NCT00144352|Antimalarials|antimalarials|mesh-ancestor
110178221|NCT00144352|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110544777|NCT02630160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110544778|NCT02630160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110544779|NCT02630160|Sensory System Agents|sensory system agents|mesh-ancestor
110544780|NCT02630160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110544781|NCT02630160|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110544782|NCT02630160|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110544783|NCT02630160|Adrenergic Agents|adrenergic agents|mesh-ancestor
110544784|NCT02630160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110544785|NCT02630160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110544786|NCT02630160|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110544787|NCT02630160|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110544788|NCT02630160|Autonomic Agents|autonomic agents|mesh-ancestor
110544789|NCT02630160|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110544790|NCT02630160|Respiratory System Agents|respiratory system agents|mesh-ancestor
110544792|NCT02630160|Sympathomimetics|sympathomimetics|mesh-ancestor
110544793|NCT02630160|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110544794|NCT00668304|Moxifloxacin|moxifloxacin|mesh-list
110544795|NCT00668304|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
110544796|NCT00668304|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110544797|NCT00668304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110544798|NCT00668304|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110544799|NCT00668304|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110544800|NCT00668304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110544801|NCT00668304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110544802|NCT00668304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110544803|NCT00668304|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110544804|NCT00668304|Contraceptive Agents|contraceptive agents|mesh-ancestor
110544805|NCT00668304|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110544806|NCT00668304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110544807|NCT00668304|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110544808|NCT00668304|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110544809|NCT00668304|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110544810|NCT00542425|Teriparatide|teriparatide|mesh-list
110544811|NCT00542425|Abaloparatide|abaloparatide|mesh-list
110544812|NCT00542425|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
110544813|NCT00542425|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110544814|NCT00542425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110544815|NCT00542425|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110544817|NCT00668538|Clotrimazole|clotrimazole|mesh-list
110544818|NCT00668538|Antifungal Agents|antifungal agents|mesh-ancestor
110544819|NCT00668538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110544820|NCT00668538|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110544821|NCT00668538|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110544822|NCT00668538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110544823|NCT00668538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110544824|NCT00668538|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110544826|NCT00668538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110544827|NCT00668538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110544828|NCT00668538|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110544829|NCT00668538|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110544830|NCT00668538|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110544831|NCT00668616|Paclitaxel|paclitaxel|mesh-list
110544832|NCT00668616|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110544833|NCT00668616|Cyclophosphamide|cyclophosphamide|mesh-list
110544834|NCT00668616|Epirubicin|epirubicin|mesh-list
110544835|NCT00668616|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110544836|NCT00668616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110544837|NCT00668616|Tubulin Modulators|tubulin modulators|mesh-ancestor
110544838|NCT00668616|Antimitotic Agents|antimitotic agents|mesh-ancestor
110544839|NCT00668616|Mitosis Modulators|mitosis modulators|mesh-ancestor
110544840|NCT00668616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110544841|NCT00668616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110544842|NCT00668616|Immunologic Factors|immunologic factors|mesh-ancestor
110544843|NCT00668616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110544844|NCT00668616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110544845|NCT00668616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110544846|NCT00668616|Alkylating Agents|alkylating agents|mesh-ancestor
110544847|NCT00668616|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110544848|NCT00668616|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110544849|NCT00668616|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110544850|NCT00668616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110544851|NCT00668616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110544852|NCT02763761|Prednisone|prednisone|mesh-list
110544853|NCT02763761|Methylprednisolone|methylprednisolone|mesh-list
110544854|NCT02763761|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110544855|NCT02763761|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110544856|NCT02763761|Prednisolone|prednisolone|mesh-list
110544857|NCT02763761|Prednisolone acetate|prednisolone acetate|mesh-list
110544858|NCT02763761|Infliximab|infliximab|mesh-list
110544859|NCT02763761|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110544860|NCT02763761|Prednisolone phosphate|prednisolone phosphate|mesh-list
110544861|NCT02763761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110544862|NCT02763761|Glucocorticoids|glucocorticoids|mesh-ancestor
110544863|NCT02763761|Hormones|hormones|mesh-ancestor
110544864|NCT02763761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110544865|NCT02763761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110544866|NCT02763761|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110544867|NCT02763761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110544868|NCT02763761|Antiemetics|antiemetics|mesh-ancestor
110544869|NCT02763761|Autonomic Agents|autonomic agents|mesh-ancestor
110544870|NCT02763761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110544871|NCT02763761|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110544872|NCT02763761|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110544873|NCT02763761|Protective Agents|protective agents|mesh-ancestor
110298632|NCT05085496|Atezolizumab|atezolizumab|mesh-list
110544874|NCT02763761|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110544875|NCT02763761|Dermatologic Agents|dermatologic agents|mesh-ancestor
110544876|NCT02763761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110544877|NCT04155918|Allopurinol|allopurinol|mesh-list
110544878|NCT04155918|Febuxostat|febuxostat|mesh-list
110544879|NCT04155918|Antimetabolites|antimetabolites|mesh-ancestor
110544880|NCT04155918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110544881|NCT04155918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110544882|NCT04155918|Gout Suppressants|gout suppressants|mesh-ancestor
110544883|NCT04155918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110544884|NCT04155918|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110544885|NCT04155918|Antioxidants|antioxidants|mesh-ancestor
110544886|NCT04155918|Protective Agents|protective agents|mesh-ancestor
110544887|NCT04155918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110544888|NCT02763839|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
110544889|NCT02763839|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110544890|NCT02763839|Immunologic Factors|immunologic factors|mesh-ancestor
110544891|NCT02763839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110544892|NCT02763839|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110544893|NCT02763839|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110544894|NCT02763839|Dopamine Agonists|dopamine agonists|mesh-ancestor
110544895|NCT02763839|Dopamine Agents|dopamine agents|mesh-ancestor
110544896|NCT02763839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110544897|NCT02763839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110544898|NCT00541099|Bevacizumab|bevacizumab|mesh-list
110544900|NCT00541099|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110544901|NCT00541099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110544902|NCT00541099|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110544903|NCT00541099|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110544905|NCT00541099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110544906|NCT00541099|Growth Inhibitors|growth inhibitors|mesh-ancestor
110544907|NCT00541099|Tubulin Modulators|tubulin modulators|mesh-ancestor
110544908|NCT00541099|Antimitotic Agents|antimitotic agents|mesh-ancestor
110544909|NCT00541099|Mitosis Modulators|mitosis modulators|mesh-ancestor
110544910|NCT00541099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110544912|NCT00580606|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
110544913|NCT00580606|Protective Agents|protective agents|mesh-ancestor
110544914|NCT00580606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110544915|NCT02575768|Adenosine|adenosine|mesh-list
110544916|NCT02575768|Analgesics|analgesics|mesh-ancestor
110544917|NCT02575768|Sensory System Agents|sensory system agents|mesh-ancestor
110544918|NCT02575768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110544919|NCT02575768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110544920|NCT02575768|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110544921|NCT02575768|Vasodilator Agents|vasodilator agents|mesh-ancestor
110299975|NCT02279563|Xhance|xhance|mesh-list
110544922|NCT02575768|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
110544923|NCT02575768|Purinergic Agonists|purinergic agonists|mesh-ancestor
110544924|NCT02575768|Purinergic Agents|purinergic agents|mesh-ancestor
110544925|NCT02575768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110544926|NCT02575768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110544927|NCT00987493|Rituximab|rituximab|mesh-list
110544928|NCT00987493|Lenalidomide|lenalidomide|mesh-list
110544929|NCT00987493|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110544930|NCT00987493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110544931|NCT00987493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110544932|NCT00987493|Immunologic Factors|immunologic factors|mesh-ancestor
110544933|NCT00987493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110544934|NCT00987493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110544935|NCT00987493|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110544936|NCT00987493|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110544937|NCT00987493|Growth Substances|growth substances|mesh-ancestor
110544938|NCT00987493|Growth Inhibitors|growth inhibitors|mesh-ancestor
110544939|NCT00987493|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110544940|NCT00987493|Alkylating Agents|alkylating agents|mesh-ancestor
110544941|NCT00987493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110544942|NCT02579356|Telmisartan|telmisartan|mesh-list
110544943|NCT02579356|Atorvastatin|atorvastatin|mesh-list
110544944|NCT02579356|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110544945|NCT02579356|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110544946|NCT02579356|Antimetabolites|antimetabolites|mesh-ancestor
110544947|NCT02579356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110544948|NCT02579356|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110544949|NCT02579356|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110544950|NCT02579356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110544951|NCT02579356|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110544952|NCT02579356|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110544953|NCT02579356|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110544954|NCT00663624|Insulin Aspart|insulin aspart|mesh-list
110544955|NCT00663624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110300592|NCT02961842|Anesthetics|anesthetics|mesh-ancestor
110544956|NCT00663624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110544958|NCT02577250|Analgesics|analgesics|mesh-ancestor
110544959|NCT02577250|Sensory System Agents|sensory system agents|mesh-ancestor
110544960|NCT02577250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110544961|NCT02577250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110544962|NCT02577250|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110544963|NCT02577250|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110544964|NCT02577250|Anesthetics, General|anesthetics, general|mesh-ancestor
110544965|NCT02577250|Anesthetics|anesthetics|mesh-ancestor
110544966|NCT02577250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110544967|NCT02577250|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110544968|NCT02577250|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110544969|NCT02577250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110544970|NCT02577250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110544971|NCT00668850|Insulin|insulin|mesh-list
110544972|NCT00668850|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110544973|NCT00668850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110544974|NCT00668850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110544975|NCT02762123|Flurbiprofen|flurbiprofen|mesh-list
110544977|NCT02762123|Midazolam|midazolam|mesh-list
110544978|NCT02762123|Omeprazole|omeprazole|mesh-list
110544979|NCT02762123|Montelukast|montelukast|mesh-list
110544981|NCT02762123|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110544982|NCT02762123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110301387|NCT00246155|Cholinergic Agents|cholinergic agents|mesh-ancestor
110544983|NCT02762123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110544984|NCT02762123|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110544985|NCT02762123|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110544986|NCT02762123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110544987|NCT02762123|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110544988|NCT02762123|Anesthetics, General|anesthetics, general|mesh-ancestor
110544989|NCT02762123|Anesthetics|anesthetics|mesh-ancestor
110544990|NCT02762123|GABA Modulators|gaba modulators|mesh-ancestor
110544991|NCT02762123|GABA Agents|gaba agents|mesh-ancestor
110544992|NCT02762123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110544993|NCT02762123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110544994|NCT02762123|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110544995|NCT02762123|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110544996|NCT02762123|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110544997|NCT02762123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110544998|NCT02762123|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110544999|NCT02762123|Respiratory System Agents|respiratory system agents|mesh-ancestor
110545000|NCT02762123|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110545001|NCT02762123|Hormone Antagonists|hormone antagonists|mesh-ancestor
110545002|NCT02762123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110545003|NCT02762123|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110545004|NCT02762123|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110545005|NCT02762123|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110545006|NCT02762123|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110545007|NCT02762123|Protective Agents|protective agents|mesh-ancestor
110545008|NCT02762123|Analgesics|analgesics|mesh-ancestor
110545009|NCT02762123|Sensory System Agents|sensory system agents|mesh-ancestor
110545010|NCT02762123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110545011|NCT02762123|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110545012|NCT02762123|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110545013|NCT02762123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110545014|NCT02762123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110545015|NCT02762123|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110545016|NCT04153734|Paclitaxel|paclitaxel|mesh-list
110545017|NCT04153734|Carboplatin|carboplatin|mesh-list
110545018|NCT04153734|Pembrolizumab|pembrolizumab|mesh-list
110545019|NCT04153734|Pemetrexed|pemetrexed|mesh-list
110545020|NCT04153734|Cisplatin|cisplatin|mesh-list
110545021|NCT04153734|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110545022|NCT04153734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110545023|NCT04153734|Tubulin Modulators|tubulin modulators|mesh-ancestor
110545024|NCT04153734|Antimitotic Agents|antimitotic agents|mesh-ancestor
110545025|NCT04153734|Mitosis Modulators|mitosis modulators|mesh-ancestor
110545026|NCT04153734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110545027|NCT04153734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110545028|NCT04153734|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110545029|NCT04153734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110545030|NCT04153734|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110545031|NCT04153734|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110545032|NCT04073680|Canagliflozin|canagliflozin|mesh-list
110545033|NCT04073680|Serabelisib|serabelisib|mesh-list
110545034|NCT04073680|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110545035|NCT04073680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110545036|NCT04073680|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110545037|NCT04073680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110545038|NCT04073680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110545039|NCT02761577|Acetylcysteine|acetylcysteine|mesh-list
110545040|NCT02761577|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110545041|NCT02761577|Antiviral Agents|antiviral agents|mesh-ancestor
110545042|NCT02761577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110545043|NCT02761577|Expectorants|expectorants|mesh-ancestor
110545044|NCT02761577|Respiratory System Agents|respiratory system agents|mesh-ancestor
110545045|NCT02761577|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110545046|NCT02761577|Antioxidants|antioxidants|mesh-ancestor
110545047|NCT02761577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110545048|NCT02761577|Protective Agents|protective agents|mesh-ancestor
110545049|NCT02761577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110545050|NCT02761577|Antidotes|antidotes|mesh-ancestor
110545051|NCT00579982|Lamotrigine|lamotrigine|mesh-list
110545052|NCT00579982|Anticonvulsants|anticonvulsants|mesh-ancestor
110545053|NCT00579982|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110192631|NCT00032747|Hemostatics|hemostatics|mesh-ancestor
110545054|NCT00579982|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110545055|NCT00579982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110545056|NCT00579982|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110545057|NCT00579982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110545058|NCT00579982|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110545059|NCT00579982|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110545060|NCT00579982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110545061|NCT00579982|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110545062|NCT00579982|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110545063|NCT00596466|Pregabalin|pregabalin|mesh-list
110545064|NCT00596466|Analgesics|analgesics|mesh-ancestor
110545065|NCT00596466|Sensory System Agents|sensory system agents|mesh-ancestor
110545066|NCT00596466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110545067|NCT00596466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110545068|NCT00596466|Anticonvulsants|anticonvulsants|mesh-ancestor
110545069|NCT00596466|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110545070|NCT00596466|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110545071|NCT00596466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110343831|NCT06020755|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110545072|NCT00596466|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110545073|NCT00596466|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110545074|NCT00596466|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110303400|NCT00416910|Analgesics|analgesics|mesh-ancestor
110545075|NCT00596466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110545076|NCT00596466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110545077|NCT02763059|Acetaminophen|acetaminophen|mesh-list
110545078|NCT02763059|Dexamethasone|dexamethasone|mesh-list
110545079|NCT02763059|Ibuprofen|ibuprofen|mesh-list
110545080|NCT02763059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110545081|NCT02763059|Antiemetics|antiemetics|mesh-ancestor
110545082|NCT02763059|Autonomic Agents|autonomic agents|mesh-ancestor
110545083|NCT02763059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110178291|NCT00404833|Chlorambucil|chlorambucil|mesh-list
110303553|NCT00281619|Mycophenolic Acid|mycophenolic acid|mesh-list
110545084|NCT02763059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110545085|NCT02763059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110545086|NCT02763059|Glucocorticoids|glucocorticoids|mesh-ancestor
110545087|NCT02763059|Hormones|hormones|mesh-ancestor
110545088|NCT02763059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110545089|NCT02763059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110545090|NCT02763059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110545091|NCT02763059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110545092|NCT02763059|Analgesics|analgesics|mesh-ancestor
110545093|NCT02763059|Sensory System Agents|sensory system agents|mesh-ancestor
110545094|NCT02763059|Antipyretics|antipyretics|mesh-ancestor
110545095|NCT02763059|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110545096|NCT02763059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110545097|NCT02763059|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110545098|NCT02763059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110545099|NCT02763059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110545100|NCT04222517|Hemostatics|hemostatics|mesh-list
110545101|NCT04222517|Coagulants|coagulants|mesh-ancestor
110545102|NCT00671112|Everolimus|everolimus|mesh-list
110545103|NCT00671112|Bortezomib|bortezomib|mesh-list
110545104|NCT00671112|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110545105|NCT00671112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110545106|NCT00671112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110545107|NCT00671112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110545108|NCT00671112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110545109|NCT00671112|Immunologic Factors|immunologic factors|mesh-ancestor
110545110|NCT00671112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110545111|NCT00671112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110545112|NCT04857385|Hemostatics|hemostatics|mesh-list
110545113|NCT04857385|Coagulants|coagulants|mesh-ancestor
110545114|NCT00664014|Tolvaptan|tolvaptan|mesh-list
110545115|NCT00664014|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
110545116|NCT00664014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110545117|NCT00664014|Natriuretic Agents|natriuretic agents|mesh-ancestor
110545118|NCT00664014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110545119|NCT02696915|Fentanyl|fentanyl|mesh-list
110545120|NCT02696915|Bupivacaine|bupivacaine|mesh-list
110545121|NCT02696915|Anesthetics, Local|anesthetics, local|mesh-ancestor
110545122|NCT02696915|Anesthetics|anesthetics|mesh-ancestor
110307121|NCT00265928|Enzyme Inhibitors|enzyme inhibitors|mesh-list
110545123|NCT02696915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110545124|NCT02696915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110545125|NCT02696915|Sensory System Agents|sensory system agents|mesh-ancestor
110545126|NCT02696915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110545128|NCT02696915|Narcotics|narcotics|mesh-ancestor
110545129|NCT02696915|Analgesics|analgesics|mesh-ancestor
110545130|NCT02696915|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110545131|NCT02696915|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110545132|NCT02696915|Anesthetics, General|anesthetics, general|mesh-ancestor
110545133|NCT00911664|Vitamin D|vitamin d|mesh-list
110545134|NCT00911664|Ergocalciferols|ergocalciferols|mesh-list
110545135|NCT00911664|Cholecalciferol|cholecalciferol|mesh-list
110545136|NCT00911664|Vitamins|vitamins|mesh-list
110545137|NCT00911664|Micronutrients|micronutrients|mesh-ancestor
110545138|NCT00911664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110545139|NCT00911664|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110304188|NCT02273440|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110545140|NCT00911664|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110545141|NCT00664170|Docetaxel|docetaxel|mesh-list
110545142|NCT00664170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110545143|NCT00664170|Tubulin Modulators|tubulin modulators|mesh-ancestor
110545144|NCT00664170|Antimitotic Agents|antimitotic agents|mesh-ancestor
110545145|NCT00664170|Mitosis Modulators|mitosis modulators|mesh-ancestor
110545146|NCT00664170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110545147|NCT02758067|Risperidone|risperidone|mesh-list
110545148|NCT02758067|Brexpiprazole|brexpiprazole|mesh-list
110545149|NCT02758067|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110545150|NCT02758067|Serotonin Agents|serotonin agents|mesh-ancestor
110545151|NCT02758067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110545152|NCT02758067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110545153|NCT02758067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110545154|NCT02758067|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110545155|NCT02758067|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110545156|NCT02758067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110545157|NCT02758067|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110545158|NCT02758067|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110545159|NCT02758067|Dopamine Agents|dopamine agents|mesh-ancestor
110545160|NCT02758067|Dopamine Agonists|dopamine agonists|mesh-ancestor
110545161|NCT00664248|Clindamycin|clindamycin|mesh-list
110545162|NCT00664248|Clindamycin palmitate|clindamycin palmitate|mesh-list
110545163|NCT00664248|Clindamycin phosphate|clindamycin phosphate|mesh-list
110545164|NCT00664248|Benzoyl Peroxide|benzoyl peroxide|mesh-list
110545165|NCT00664248|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110545166|NCT00664248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110545167|NCT00664248|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110305563|NCT01334710|Sorafenib|sorafenib|mesh-list
110545168|NCT00664248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110545169|NCT00664248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110545170|NCT00664248|Dermatologic Agents|dermatologic agents|mesh-ancestor
110545171|NCT00579670|Ziprasidone|ziprasidone|mesh-list
110545172|NCT00579670|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110545173|NCT00579670|Serotonin Agents|serotonin agents|mesh-ancestor
110545174|NCT00579670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110545175|NCT00579670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110545176|NCT00579670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110545177|NCT00579670|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110545178|NCT00579670|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110545179|NCT00579670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110545180|NCT00579670|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110545181|NCT00579670|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110545182|NCT00579670|Dopamine Agents|dopamine agents|mesh-ancestor
110545183|NCT00669786|Menotropins|menotropins|mesh-list
110545184|NCT00669786|Hormones|hormones|mesh-list
110545185|NCT00669786|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
110545186|NCT00669786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110545187|NCT00669786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110545189|NCT00669786|Fertility Agents|fertility agents|mesh-ancestor
110545190|NCT00669786|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110545191|NCT02760953|Epirubicin|epirubicin|mesh-list
110545192|NCT02760953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110545193|NCT02760953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110545194|NCT02760953|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110545195|NCT02760953|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110545196|NCT02760953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110545197|NCT02760953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110545198|NCT02630004|Melatonin|melatonin|mesh-list
110545199|NCT02630004|Antioxidants|antioxidants|mesh-ancestor
110306734|NCT00263978|Defibrotide|defibrotide|mesh-list
110545200|NCT02630004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110545202|NCT02630004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110545203|NCT02630004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110545204|NCT00129922|Paclitaxel|paclitaxel|mesh-list
110545206|NCT00129922|Fluorouracil|fluorouracil|mesh-list
110545207|NCT00129922|Epirubicin|epirubicin|mesh-list
110545208|NCT00129922|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110545209|NCT00129922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110545210|NCT00129922|Tubulin Modulators|tubulin modulators|mesh-ancestor
110545211|NCT00129922|Antimitotic Agents|antimitotic agents|mesh-ancestor
110545212|NCT00129922|Mitosis Modulators|mitosis modulators|mesh-ancestor
110545213|NCT00129922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110545214|NCT00129922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110545215|NCT00129922|Immunologic Factors|immunologic factors|mesh-ancestor
110545216|NCT00129922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110545217|NCT00129922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110545218|NCT00129922|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110545219|NCT00129922|Alkylating Agents|alkylating agents|mesh-ancestor
110545220|NCT00129922|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110545221|NCT00129922|Antimetabolites|antimetabolites|mesh-ancestor
110545222|NCT00129922|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110545223|NCT00129922|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110545224|NCT00129922|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110545225|NCT00129922|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110545226|NCT00129922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110545227|NCT03909295|Valsartan|valsartan|mesh-list
110545228|NCT03909295|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
110545229|NCT03909295|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110545230|NCT03909295|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110545231|NCT03909295|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110545232|NCT03909295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110545233|NCT04153968|Retinol acetate|retinol acetate|mesh-list
110545234|NCT04153968|Protective Agents|protective agents|mesh-ancestor
110545235|NCT04153968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110545236|NCT04153968|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110545237|NCT04153968|Immunologic Factors|immunologic factors|mesh-ancestor
110545238|NCT04153968|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110545239|NCT04153968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110545240|NCT00671424|Remogliflozin etabonate|remogliflozin etabonate|mesh-list
110545241|NCT00671424|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110545242|NCT00671424|Furosemide|furosemide|mesh-list
110545243|NCT00671424|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110545244|NCT00671424|Diuretics|diuretics|mesh-ancestor
110545245|NCT00671424|Natriuretic Agents|natriuretic agents|mesh-ancestor
110545246|NCT00671424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110545247|NCT00671424|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110545248|NCT00671424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110545249|NCT00671424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110545250|NCT00671424|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110545251|NCT00671424|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110545252|NCT00671424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110545253|NCT00599924|Leucovorin|leucovorin|mesh-list
110545254|NCT00599924|Sunitinib|sunitinib|mesh-list
110545255|NCT00599924|Fluorouracil|fluorouracil|mesh-list
110545256|NCT00599924|Oxaliplatin|oxaliplatin|mesh-list
110545257|NCT00599924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110545258|NCT00599924|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110545259|NCT00599924|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110545260|NCT00599924|Growth Substances|growth substances|mesh-ancestor
110545261|NCT00599924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110545262|NCT00599924|Growth Inhibitors|growth inhibitors|mesh-ancestor
110545263|NCT00599924|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110545264|NCT00599924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110545265|NCT00599924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110545266|NCT00599924|Antimetabolites|antimetabolites|mesh-ancestor
110545267|NCT00599924|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110545268|NCT00599924|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110545269|NCT00599924|Immunologic Factors|immunologic factors|mesh-ancestor
110545270|NCT00599924|Antidotes|antidotes|mesh-ancestor
110545271|NCT00599924|Protective Agents|protective agents|mesh-ancestor
110545272|NCT00599924|Vitamin B Complex|vitamin b complex|mesh-ancestor
110545273|NCT00599924|Vitamins|vitamins|mesh-ancestor
110545275|NCT02757209|Fluticasone|fluticasone|mesh-list
110545276|NCT02757209|Xhance|xhance|mesh-list
110545277|NCT02757209|Budesonide|budesonide|mesh-list
110545278|NCT02757209|Formoterol Fumarate|formoterol fumarate|mesh-list
110545279|NCT02757209|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110545280|NCT02757209|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
110545281|NCT02757209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110545282|NCT02757209|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110545283|NCT02757209|Autonomic Agents|autonomic agents|mesh-ancestor
110545284|NCT02757209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110545285|NCT02757209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110545286|NCT02757209|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110545287|NCT02757209|Respiratory System Agents|respiratory system agents|mesh-ancestor
110545288|NCT02757209|Dermatologic Agents|dermatologic agents|mesh-ancestor
110545289|NCT02757209|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110545290|NCT02757209|Glucocorticoids|glucocorticoids|mesh-ancestor
110545291|NCT02757209|Hormones|hormones|mesh-ancestor
110545292|NCT02757209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110545293|NCT02757209|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110545294|NCT02757209|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110545295|NCT02757209|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110545296|NCT02757209|Adrenergic Agents|adrenergic agents|mesh-ancestor
110545297|NCT02757209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110545298|NCT02757209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110545299|NCT00670254|Hydrocortisone|hydrocortisone|mesh-list
110545300|NCT00670254|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110545301|NCT00581542|Moxifloxacin|moxifloxacin|mesh-list
110545302|NCT00581542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110545303|NCT00581542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110545304|NCT00581542|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110368924|NCT04713371|Alkylating Agents|alkylating agents|mesh-ancestor
110545305|NCT00581542|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110545306|NCT00581542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110545307|NCT00581542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110545308|NCT00581542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110545310|NCT05338801|Antipruritics|antipruritics|mesh-ancestor
110545311|NCT05338801|Dermatologic Agents|dermatologic agents|mesh-ancestor
110545312|NCT02757287|Desogestrel|desogestrel|mesh-list
110545313|NCT02757287|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110545314|NCT02757287|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110545315|NCT02757287|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110545316|NCT02757287|Contraceptive Agents|contraceptive agents|mesh-ancestor
110545317|NCT02757287|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110545318|NCT02757287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110545319|NCT02757287|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110545320|NCT02757287|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110545321|NCT02757287|Progestins|progestins|mesh-ancestor
110545322|NCT02757287|Hormones|hormones|mesh-ancestor
110545323|NCT02757287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110545324|NCT02757365|Aspirin|aspirin|mesh-list
110545325|NCT02757365|Levofloxacin|levofloxacin|mesh-list
110545326|NCT02757365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110545327|NCT02757365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110545328|NCT02757365|Analgesics|analgesics|mesh-ancestor
110545329|NCT02757365|Sensory System Agents|sensory system agents|mesh-ancestor
110545330|NCT02757365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110545331|NCT02757365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110545332|NCT02757365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110545333|NCT02757365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110545334|NCT02757365|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110545335|NCT02757365|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110545336|NCT02757365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110545337|NCT02757365|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110545338|NCT02757365|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110545339|NCT02757365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110545340|NCT02757365|Antipyretics|antipyretics|mesh-ancestor
110545341|NCT02757365|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110545342|NCT02757365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110545343|NCT02757365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110369039|NCT00563589|Methotrexate|methotrexate|mesh-list
110545344|NCT02757365|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110545345|NCT02757365|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110545346|NCT02757365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110545347|NCT02757365|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110545348|NCT02757365|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110545350|NCT02649530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110545351|NCT02649530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110545352|NCT02575534|Procainamide|procainamide|mesh-list
110545353|NCT02575534|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110545354|NCT02575534|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110545355|NCT02575534|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110545356|NCT02575534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110545357|NCT02575534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110545358|NCT02757443|Phosphocreatine|phosphocreatine|mesh-list
110545359|NCT02757443|Anesthetics|anesthetics|mesh-list
110545360|NCT02757443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110545361|NCT02757443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110545362|NCT02757443|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110545363|NCT02757443|Protective Agents|protective agents|mesh-ancestor
110545364|NCT04071262|Prednisolone|prednisolone|mesh-list
110545365|NCT04071262|Abiraterone Acetate|abiraterone acetate|mesh-list
110545366|NCT04071262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110545367|NCT04071262|Glucocorticoids|glucocorticoids|mesh-ancestor
110545368|NCT04071262|Hormones|hormones|mesh-ancestor
110545369|NCT04071262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110545370|NCT04071262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110545371|NCT04071262|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110545372|NCT04071262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110545373|NCT04071262|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110545374|NCT04071262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110545375|NCT04071262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110545376|NCT04071262|Hormone Antagonists|hormone antagonists|mesh-ancestor
110545377|NCT04071262|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110545378|NCT04154748|Omeprazole|omeprazole|mesh-list
110545379|NCT04154748|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110545380|NCT04154748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110545381|NCT04154748|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110545382|NCT04154748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110545383|NCT04154748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110545385|NCT02657096|Dental Disinfectants|dental disinfectants|mesh-ancestor
110545386|NCT02657096|Disinfectants|disinfectants|mesh-ancestor
110545387|NCT02657096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110545388|NCT02536742|Fulvestrant|fulvestrant|mesh-list
110545389|NCT02536742|Palbociclib|palbociclib|mesh-list
110545390|NCT02536742|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110545391|NCT02536742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110545392|NCT02536742|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110545393|NCT02536742|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110545394|NCT02536742|Hormone Antagonists|hormone antagonists|mesh-ancestor
110545395|NCT02536742|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110545396|NCT02536742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110545397|NCT02536742|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110545398|NCT02536742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110545399|NCT02536742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110545400|NCT00670410|Fludarabine|fludarabine|mesh-list
110545401|NCT00670410|Busulfan|busulfan|mesh-list
110545402|NCT00670410|Thymoglobulin|thymoglobulin|mesh-list
110545403|NCT00670410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110545404|NCT00670410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110545405|NCT00670410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110545406|NCT00670410|Immunologic Factors|immunologic factors|mesh-ancestor
110545407|NCT00670410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110545408|NCT00670410|Alkylating Agents|alkylating agents|mesh-ancestor
110545409|NCT00670410|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110545410|NCT00670410|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110545411|NCT02756663|Dexamethasone|dexamethasone|mesh-list
110545412|NCT02756663|Panobinostat|panobinostat|mesh-list
110545413|NCT02756663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110545414|NCT02756663|Antiemetics|antiemetics|mesh-ancestor
110545415|NCT02756663|Autonomic Agents|autonomic agents|mesh-ancestor
110545416|NCT02756663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110545417|NCT02756663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110545418|NCT02756663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110545419|NCT02756663|Glucocorticoids|glucocorticoids|mesh-ancestor
110545420|NCT02756663|Hormones|hormones|mesh-ancestor
110560325|NCT02684123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110545421|NCT02756663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110545422|NCT02756663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110545423|NCT02756663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110545424|NCT02756663|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110545425|NCT02756663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110545426|NCT02756663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110545427|NCT02654678|Enalapril|enalapril|mesh-list
110545428|NCT02654678|Enalaprilat|enalaprilat|mesh-list
110545429|NCT02654678|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110545430|NCT02654678|Protease Inhibitors|protease inhibitors|mesh-ancestor
110545431|NCT02654678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110343832|NCT06020755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110545432|NCT02654678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110545433|NCT02654678|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110545434|NCT00670566|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110545436|NCT00670566|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110545437|NCT00670566|Diuretics|diuretics|mesh-ancestor
110164937|NCT00022126|Pegaspargase|pegaspargase|mesh-list
110545438|NCT00670566|Natriuretic Agents|natriuretic agents|mesh-ancestor
110545439|NCT00670566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110545440|NCT00670566|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110545441|NCT00670566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110545442|NCT00670566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110545443|NCT00670566|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110545444|NCT00670566|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110545445|NCT02629848|Paclitaxel|paclitaxel|mesh-list
110545446|NCT02629848|Carboplatin|carboplatin|mesh-list
110545447|NCT02629848|Motesanib diphosphate|motesanib diphosphate|mesh-list
110545448|NCT02629848|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110165003|NCT00388739|Albuterol|albuterol|mesh-list
110545449|NCT02629848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110545450|NCT02629848|Tubulin Modulators|tubulin modulators|mesh-ancestor
110545451|NCT02629848|Antimitotic Agents|antimitotic agents|mesh-ancestor
110545452|NCT02629848|Mitosis Modulators|mitosis modulators|mesh-ancestor
110545453|NCT02629848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110545454|NCT02629848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110545455|NCT02629848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110545456|NCT03912337|Erenumab|erenumab|mesh-list
110545457|NCT03912337|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
110545458|NCT03912337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110545459|NCT03912337|Analgesics|analgesics|mesh-ancestor
110545460|NCT03912337|Sensory System Agents|sensory system agents|mesh-ancestor
110545461|NCT03912337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110545462|NCT03912337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110545463|NCT00650156|Adalimumab|adalimumab|mesh-list
110545464|NCT00650156|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110545465|NCT00650156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110545466|NCT00650156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110545467|NCT02576782|Dexamethasone|dexamethasone|mesh-list
110545468|NCT02576782|Dexamethasone acetate|dexamethasone acetate|mesh-list
110545469|NCT02576782|Bupivacaine|bupivacaine|mesh-list
110545470|NCT02576782|BB 1101|bb 1101|mesh-list
110545471|NCT02576782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110545472|NCT02576782|Antiemetics|antiemetics|mesh-ancestor
110545473|NCT02576782|Autonomic Agents|autonomic agents|mesh-ancestor
110545474|NCT02576782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110545475|NCT02576782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110545476|NCT02576782|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110545477|NCT02576782|Glucocorticoids|glucocorticoids|mesh-ancestor
110545478|NCT02576782|Hormones|hormones|mesh-ancestor
110545479|NCT02576782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110545480|NCT02576782|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110545481|NCT02576782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110545482|NCT02576782|Protease Inhibitors|protease inhibitors|mesh-ancestor
110545483|NCT02576782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110545484|NCT02576782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110545485|NCT02576782|Anesthetics, Local|anesthetics, local|mesh-ancestor
110545487|NCT02576782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110545488|NCT02576782|Sensory System Agents|sensory system agents|mesh-ancestor
110545489|NCT02629770|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110545490|NCT02629770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110545491|NCT02577094|Fludarabine|fludarabine|mesh-list
110545492|NCT02577094|Busulfan|busulfan|mesh-list
110545493|NCT02577094|Epratuzumab|epratuzumab|mesh-list
110545494|NCT02577094|Thymoglobulin|thymoglobulin|mesh-list
110545495|NCT02577094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110545496|NCT02577094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110545497|NCT02577094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110545498|NCT02577094|Immunologic Factors|immunologic factors|mesh-ancestor
110545499|NCT02577094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110545500|NCT02577094|Alkylating Agents|alkylating agents|mesh-ancestor
110193082|NCT00034580|Olanzapine|olanzapine|mesh-list
110545501|NCT02577094|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110545502|NCT02577094|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110545503|NCT02577094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110545505|NCT00649844|Clozapine|clozapine|mesh-list
110545506|NCT00649844|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110545507|NCT00649844|Serotonin Agents|serotonin agents|mesh-ancestor
110545508|NCT00649844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110545509|NCT00649844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110545510|NCT00649844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110545511|NCT00649844|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110545512|NCT00649844|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110545513|NCT00649844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110545514|NCT00649844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110545515|NCT00649844|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110165274|NCT00023335|Isoniazid|isoniazid|mesh-list
110545516|NCT00649844|Dopamine Agents|dopamine agents|mesh-ancestor
110545517|NCT00649844|GABA Antagonists|gaba antagonists|mesh-ancestor
110545518|NCT00649844|GABA Agents|gaba agents|mesh-ancestor
110545519|NCT03912259|Emollients|emollients|mesh-list
110545520|NCT03912259|Dermatologic Agents|dermatologic agents|mesh-ancestor
110545521|NCT02656472|Tranexamic Acid|tranexamic acid|mesh-list
110545522|NCT02656472|Aminocaproic Acid|aminocaproic acid|mesh-list
110545523|NCT02656472|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110545524|NCT02656472|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110380606|NCT01204294|Metformin|metformin|mesh-list
110545525|NCT02656472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110545527|NCT02656472|Coagulants|coagulants|mesh-ancestor
110545528|NCT00665340|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
110545529|NCT00665340|Vasodilator Agents|vasodilator agents|mesh-ancestor
110545530|NCT00665340|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110545531|NCT00665340|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110545532|NCT00665340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110545533|NCT00665340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110545534|NCT00665340|Urological Agents|urological agents|mesh-ancestor
110545535|NCT00665418|Sevoflurane|sevoflurane|mesh-list
110545536|NCT00665418|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110545537|NCT00665418|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110545538|NCT00665418|Anesthetics, General|anesthetics, general|mesh-ancestor
110545539|NCT00665418|Anesthetics|anesthetics|mesh-ancestor
110545540|NCT00665418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110545541|NCT00665418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110545542|NCT04058990|Paclitaxel|paclitaxel|mesh-list
110545543|NCT04058990|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110545544|NCT04058990|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110545545|NCT04058990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110545546|NCT04058990|Tubulin Modulators|tubulin modulators|mesh-ancestor
110545547|NCT04058990|Antimitotic Agents|antimitotic agents|mesh-ancestor
110545548|NCT04058990|Mitosis Modulators|mitosis modulators|mesh-ancestor
110545549|NCT04058990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110545550|NCT00595920|Vaccines|vaccines|mesh-list
110545551|NCT00595920|Immunologic Factors|immunologic factors|mesh-ancestor
110545552|NCT00595920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110545553|NCT02654288|Gemcitabine|gemcitabine|mesh-list
110545554|NCT02654288|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110545555|NCT02654288|Antimetabolites|antimetabolites|mesh-ancestor
110545556|NCT02654288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110545557|NCT02654288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110545558|NCT02649140|Acetic Acid|acetic acid|mesh-list
110545559|NCT02649140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110545560|NCT02649140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110545561|NCT00665496|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
110165373|NCT00000179|Haloperidol|haloperidol|mesh-list
110545562|NCT00665496|Vasodilator Agents|vasodilator agents|mesh-ancestor
110545563|NCT00665496|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110545564|NCT00665496|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110545565|NCT00665496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110560326|NCT00638729|Clonidine|clonidine|mesh-list
110545566|NCT00665496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110545567|NCT00665496|Urological Agents|urological agents|mesh-ancestor
110545570|NCT02653898|Piperaquine|piperaquine|mesh-list
110545571|NCT02653898|Artenimol|artenimol|mesh-list
110545572|NCT02653898|Mefloquine|mefloquine|mesh-list
110545573|NCT02653898|Permethrin|permethrin|mesh-list
110193160|NCT00034736|Levofloxacin|levofloxacin|mesh-list
110545574|NCT02653898|Antimalarials|antimalarials|mesh-ancestor
110545575|NCT02653898|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110545576|NCT02653898|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110545577|NCT02653898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110545578|NCT02653898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110545579|NCT02653898|Antiviral Agents|antiviral agents|mesh-ancestor
110545580|NCT02653898|Schistosomicides|schistosomicides|mesh-ancestor
110545581|NCT02653898|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110545582|NCT02653898|Anthelmintics|anthelmintics|mesh-ancestor
110545583|NCT02653898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110545584|NCT02653898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110545585|NCT02629536|Acetylcysteine|acetylcysteine|mesh-list
110545586|NCT02629536|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110545587|NCT02629536|Antiviral Agents|antiviral agents|mesh-ancestor
110545588|NCT02629536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110545589|NCT02629536|Expectorants|expectorants|mesh-ancestor
110545590|NCT02629536|Respiratory System Agents|respiratory system agents|mesh-ancestor
110545591|NCT02629536|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110545592|NCT02629536|Antioxidants|antioxidants|mesh-ancestor
110545593|NCT02629536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110545594|NCT02629536|Protective Agents|protective agents|mesh-ancestor
110545595|NCT02629536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110545596|NCT02629536|Antidotes|antidotes|mesh-ancestor
110545597|NCT04071106|Betamethasone|betamethasone|mesh-list
110545598|NCT04071106|Calcipotriene|calcipotriene|mesh-list
110545599|NCT04071106|Petrolatum|petrolatum|mesh-list
110545600|NCT04071106|Turmeric extract|turmeric extract|mesh-list
110545601|NCT04071106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110545602|NCT04071106|Glucocorticoids|glucocorticoids|mesh-ancestor
110545603|NCT04071106|Hormones|hormones|mesh-ancestor
110545604|NCT04071106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110545605|NCT04071106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110545606|NCT04071106|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110545607|NCT04071106|Respiratory System Agents|respiratory system agents|mesh-ancestor
110178437|NCT05468671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110545608|NCT04071106|Dermatologic Agents|dermatologic agents|mesh-ancestor
110545609|NCT04071106|Antioxidants|antioxidants|mesh-ancestor
110545610|NCT04071106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110545611|NCT04071106|Protective Agents|protective agents|mesh-ancestor
110545612|NCT04071106|Emollients|emollients|mesh-ancestor
110545613|NCT00670722|Insulin|insulin|mesh-list
110545614|NCT00670722|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110545615|NCT00670722|Insulin Aspart|insulin aspart|mesh-list
110545616|NCT00670722|Insulin, Long-Acting|insulin, long-acting|mesh-list
110545617|NCT00670722|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
110545618|NCT00670722|Insulin Detemir|insulin detemir|mesh-list
110545619|NCT00670722|Biphasic Insulins|biphasic insulins|mesh-list
110545620|NCT00670722|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
110545621|NCT00670722|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110545622|NCT00670722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110545623|NCT02648906|Choline|choline|mesh-list
110545624|NCT02648906|Lipotropic Agents|lipotropic agents|mesh-ancestor
110545625|NCT02648906|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110545626|NCT02648906|Antimetabolites|antimetabolites|mesh-ancestor
110545627|NCT02648906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110545628|NCT02648906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110545629|NCT02648906|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110545630|NCT02648906|Nootropic Agents|nootropic agents|mesh-ancestor
110545631|NCT00670878|Gemcitabine|gemcitabine|mesh-list
110165606|NCT00024310|Folic Acid|folic acid|mesh-list
110545632|NCT00670878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110545633|NCT00670878|Antimetabolites|antimetabolites|mesh-ancestor
110545634|NCT00670878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110545635|NCT00670878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110545636|NCT02760095|Vitamin A|vitamin a|mesh-list
110545637|NCT02760095|Acetic Acid|acetic acid|mesh-list
110545638|NCT02760095|Retinol acetate|retinol acetate|mesh-list
110545639|NCT02760095|Zinc Sulfate|zinc sulfate|mesh-list
110545640|NCT02760095|Vitamins|vitamins|mesh-ancestor
110545641|NCT02760095|Micronutrients|micronutrients|mesh-ancestor
110545642|NCT02760095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110545643|NCT02760095|Protective Agents|protective agents|mesh-ancestor
110545644|NCT02760095|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110545645|NCT02760095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110545647|NCT02760095|Dermatologic Agents|dermatologic agents|mesh-ancestor
110545648|NCT02760095|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110545649|NCT02760095|Immunologic Factors|immunologic factors|mesh-ancestor
110545650|NCT02760095|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110545651|NCT02760095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110545658|NCT02576626|Albuterol|albuterol|mesh-list
110545659|NCT02576626|Ipratropium|ipratropium|mesh-list
110545660|NCT02576626|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110545661|NCT02576626|Autonomic Agents|autonomic agents|mesh-ancestor
110545662|NCT02576626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110545663|NCT02576626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110545664|NCT02576626|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110545665|NCT02576626|Respiratory System Agents|respiratory system agents|mesh-ancestor
110545666|NCT02576626|Tocolytic Agents|tocolytic agents|mesh-ancestor
110545667|NCT02576626|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110545668|NCT02576626|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110545669|NCT02576626|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110545670|NCT02576626|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110545671|NCT02576626|Adrenergic Agents|adrenergic agents|mesh-ancestor
110545672|NCT02576626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110545673|NCT02576626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110545674|NCT02576626|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110545675|NCT02576626|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110545676|NCT02576626|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110545677|NCT02576626|Cholinergic Agents|cholinergic agents|mesh-ancestor
110545678|NCT00877890|Exenatide|exenatide|mesh-list
110545679|NCT00877890|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110545680|NCT00877890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110545681|NCT00877890|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110545682|NCT00877890|Incretins|incretins|mesh-ancestor
110545683|NCT00877890|Hormones|hormones|mesh-ancestor
110165847|NCT00025402|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110545684|NCT00877890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110545685|NCT02648672|BPN14770|bpn14770|mesh-list
110545686|NCT02648672|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
110545687|NCT02648672|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110545688|NCT02648672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110545689|NCT02648672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110545690|NCT04221971|Cyclophosphamide|cyclophosphamide|mesh-list
110545691|NCT04221971|Fludarabine|fludarabine|mesh-list
110545692|NCT04221971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110545693|NCT04221971|Immunologic Factors|immunologic factors|mesh-ancestor
110545694|NCT04221971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110545695|NCT04221971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110545696|NCT04221971|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110545697|NCT04221971|Alkylating Agents|alkylating agents|mesh-ancestor
110545698|NCT04221971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110545699|NCT04221971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110545700|NCT04221971|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110545701|NCT02644694|Dexamethasone|dexamethasone|mesh-list
110545702|NCT02644694|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110545703|NCT02644694|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
110545704|NCT02644694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110545705|NCT02644694|Antiemetics|antiemetics|mesh-ancestor
110545706|NCT02644694|Autonomic Agents|autonomic agents|mesh-ancestor
110545707|NCT02644694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110545708|NCT02644694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110545709|NCT02644694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110545710|NCT02644694|Glucocorticoids|glucocorticoids|mesh-ancestor
110545711|NCT02644694|Hormones|hormones|mesh-ancestor
110343812|NCT06022614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110545712|NCT02644694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110545713|NCT02644694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110545714|NCT02644694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110545715|NCT02644694|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110545717|NCT02653742|Fentanyl|fentanyl|mesh-list
110545718|NCT02653742|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110545719|NCT02653742|Narcotics|narcotics|mesh-ancestor
110545720|NCT02653742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110545722|NCT02653742|Analgesics|analgesics|mesh-ancestor
110545723|NCT02653742|Sensory System Agents|sensory system agents|mesh-ancestor
110545724|NCT02653742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110545725|NCT02653742|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110545726|NCT02653742|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110545727|NCT02653742|Anesthetics, General|anesthetics, general|mesh-ancestor
110545728|NCT02653742|Anesthetics|anesthetics|mesh-ancestor
110545729|NCT02653742|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110545730|NCT02653742|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110545731|NCT02653742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110545732|NCT02653742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110178485|NCT01806948|Antiemetics|antiemetics|mesh-ancestor
110545734|NCT02653742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110545735|NCT02653742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110545736|NCT02755259|Acetazolamide|acetazolamide|mesh-list
110545737|NCT02755259|Anticonvulsants|anticonvulsants|mesh-ancestor
110545738|NCT02755259|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110545739|NCT02755259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110545740|NCT02755259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110545741|NCT02755259|Diuretics|diuretics|mesh-ancestor
110545742|NCT02755259|Natriuretic Agents|natriuretic agents|mesh-ancestor
110545743|NCT02755259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110545744|NCT02575222|Nivolumab|nivolumab|mesh-list
110545745|NCT02575222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110545746|NCT02575222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110545747|NCT02575222|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110545748|NCT02575222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110545749|NCT00680394|Misoprostol|misoprostol|mesh-list
110545750|NCT00680394|Mifepristone|mifepristone|mesh-list
110545751|NCT00680394|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110545752|NCT00680394|Abortifacient Agents|abortifacient agents|mesh-ancestor
110545753|NCT00680394|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110545754|NCT00680394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110545755|NCT00680394|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110165918|NCT00025519|Fludarabine|fludarabine|mesh-list
110545756|NCT00680394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110545757|NCT00680394|Oxytocics|oxytocics|mesh-ancestor
110545758|NCT00680394|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
110545759|NCT00680394|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110545760|NCT00680394|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110545761|NCT00680394|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110545762|NCT00680394|Contraceptive Agents|contraceptive agents|mesh-ancestor
110545763|NCT00680394|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
110165941|NCT00025558|Temozolomide|temozolomide|mesh-list
110545764|NCT00680394|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
110545765|NCT00680394|Hormone Antagonists|hormone antagonists|mesh-ancestor
110545766|NCT00680394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110545767|NCT00680394|Luteolytic Agents|luteolytic agents|mesh-ancestor
110545768|NCT00680394|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110545769|NCT00680394|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
110545770|NCT04724044|Moxifloxacin|moxifloxacin|mesh-list
110545771|NCT04724044|Clarithromycin|clarithromycin|mesh-list
110545772|NCT04724044|Ceftriaxone|ceftriaxone|mesh-list
110545774|NCT04724044|beta-Lactams|beta-lactams|mesh-list
110165990|NCT00025636|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110545775|NCT04724044|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
110545776|NCT04724044|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110545777|NCT04724044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110545778|NCT04724044|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110545779|NCT04724044|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110545780|NCT04724044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110545781|NCT04724044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110545782|NCT04724044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110545783|NCT04724044|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110545784|NCT04724044|Contraceptive Agents|contraceptive agents|mesh-ancestor
110166059|NCT00026143|Interferons|interferons|mesh-list
110545785|NCT04724044|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110545786|NCT04724044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110545787|NCT04724044|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110545788|NCT04724044|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110545789|NCT04724044|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110545790|NCT04724044|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110545791|NCT04724044|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110545792|NCT04724044|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110545794|NCT02768519|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110545795|NCT02768519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110545796|NCT02768519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110545797|NCT00671814|Linezolid|linezolid|mesh-list
110545798|NCT00671814|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110545799|NCT00671814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110545800|NCT00671814|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110166130|NCT00026416|Interferons|interferons|mesh-list
110545801|NCT00671814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110545802|NCT00671814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110545803|NCT02627430|Talazoparib|talazoparib|mesh-list
110545804|NCT02627430|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110545805|NCT02627430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110545806|NCT02627430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110545807|NCT02627430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110545808|NCT02759393|Lansoprazole|lansoprazole|mesh-list
110545809|NCT02759393|Dexlansoprazole|dexlansoprazole|mesh-list
110545810|NCT02759393|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110545811|NCT02759393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110545812|NCT02759393|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110545813|NCT02759393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110545814|NCT02759393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110545815|NCT02576548|MEDI4276|medi4276|mesh-list
110545816|NCT02576548|Immunoconjugates|immunoconjugates|mesh-ancestor
110545817|NCT02576548|Immunologic Factors|immunologic factors|mesh-ancestor
110545818|NCT02576548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110545819|NCT02758925|Cytarabine|cytarabine|mesh-list
110545820|NCT02758925|Rituximab|rituximab|mesh-list
110545821|NCT02758925|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110545822|NCT02758925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110545823|NCT02758925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110545824|NCT02758925|Immunologic Factors|immunologic factors|mesh-ancestor
110545825|NCT02758925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110545826|NCT02758925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110545827|NCT02758925|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110545828|NCT02758925|Antimetabolites|antimetabolites|mesh-ancestor
110545829|NCT02758925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110545830|NCT02758925|Antiviral Agents|antiviral agents|mesh-ancestor
110545831|NCT02758925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110545832|NCT02758925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110545833|NCT02758925|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110545834|NCT02758925|Alkylating Agents|alkylating agents|mesh-ancestor
110545835|NCT00676260|Pioglitazone|pioglitazone|mesh-list
110545836|NCT00676260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110545837|NCT00676260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110545838|NCT00652652|Furosemide|furosemide|mesh-list
110545839|NCT00652652|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
110545840|NCT00652652|Diuretics|diuretics|mesh-ancestor
110545841|NCT00652652|Natriuretic Agents|natriuretic agents|mesh-ancestor
110545842|NCT00652652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110545843|NCT00652652|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110545844|NCT00652652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110545845|NCT00652652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110545846|NCT02768441|Dextroamphetamine|dextroamphetamine|mesh-list
110545847|NCT02768441|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110545848|NCT02768441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110545849|NCT02768441|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110545850|NCT02768441|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110545851|NCT02768441|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110545852|NCT02768441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110545853|NCT02768441|Dopamine Agents|dopamine agents|mesh-ancestor
110545854|NCT02768441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110545856|NCT02644616|Tolvaptan|tolvaptan|mesh-list
110545857|NCT02644616|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
110545858|NCT02644616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110545859|NCT02644616|Natriuretic Agents|natriuretic agents|mesh-ancestor
110545860|NCT02644616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110545861|NCT02644616|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110545862|NCT02644616|Diuretics|diuretics|mesh-ancestor
110545863|NCT02644616|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110545864|NCT02644616|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110545865|NCT02648048|Pirfenidone|pirfenidone|mesh-list
110545866|NCT02648048|Analgesics|analgesics|mesh-ancestor
110545867|NCT02648048|Sensory System Agents|sensory system agents|mesh-ancestor
110545868|NCT02648048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110545869|NCT02648048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110545870|NCT02648048|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110545871|NCT02648048|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110545872|NCT02648048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110545873|NCT02648048|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110545874|NCT02648048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110193452|NCT00035984|Exenatide|exenatide|mesh-list
110545875|NCT00676416|Propofol|propofol|mesh-list
110545876|NCT00676416|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110545877|NCT00676416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110545878|NCT00676416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110545879|NCT00676416|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110545880|NCT00676416|Anesthetics, General|anesthetics, general|mesh-ancestor
110178514|NCT01806792|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110178515|NCT01806792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110178516|NCT01806792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110545882|NCT04150536|Lidocaine|lidocaine|mesh-list
110545883|NCT04150536|Anesthetics, Local|anesthetics, local|mesh-ancestor
110545884|NCT04150536|Anesthetics|anesthetics|mesh-ancestor
110545885|NCT04150536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110545886|NCT04150536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110545887|NCT04150536|Sensory System Agents|sensory system agents|mesh-ancestor
110545888|NCT04150536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110545889|NCT04150536|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110545890|NCT04150536|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110545891|NCT04150536|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110545892|NCT04150536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110545893|NCT04150536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110545894|NCT05167123|Calcium|calcium|mesh-list
110545895|NCT05167123|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110545896|NCT05167123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110166784|NCT00028717|Hormones|hormones|mesh-ancestor
110545897|NCT02644538|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110545898|NCT02644538|Antiviral Agents|antiviral agents|mesh-ancestor
110545899|NCT02644538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110545900|NCT02576314|Sofosbuvir|sofosbuvir|mesh-list
110545901|NCT02576314|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
110545902|NCT02576314|Ledipasvir|ledipasvir|mesh-list
110545903|NCT02576314|Antiviral Agents|antiviral agents|mesh-ancestor
110545904|NCT02576314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110545905|NCT00650234|Metformin|metformin|mesh-list
110545906|NCT00650234|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110545907|NCT00650234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110545908|NCT00680940|Paclitaxel|paclitaxel|mesh-list
110545909|NCT00680940|Cisplatin|cisplatin|mesh-list
110545910|NCT00680940|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110545911|NCT00680940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110545912|NCT00680940|Tubulin Modulators|tubulin modulators|mesh-ancestor
110166851|NCT00028834|Gemcitabine|gemcitabine|mesh-list
110545913|NCT00680940|Antimitotic Agents|antimitotic agents|mesh-ancestor
110545914|NCT00680940|Mitosis Modulators|mitosis modulators|mesh-ancestor
110545915|NCT00680940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110545916|NCT03472885|Eculizumab|eculizumab|mesh-list
110545917|NCT03472885|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
110545918|NCT03472885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110545919|NCT03472885|Immunologic Factors|immunologic factors|mesh-ancestor
110545920|NCT03472885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110545921|NCT02644304|Cabergoline|cabergoline|mesh-list
110178556|NCT01806675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110545922|NCT02644304|Clomiphene|clomiphene|mesh-list
110545923|NCT02644304|Enclomiphene|enclomiphene|mesh-list
110545924|NCT02644304|Zuclomiphene|zuclomiphene|mesh-list
110545925|NCT02644304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110545926|NCT02644304|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110545927|NCT02644304|Hormone Antagonists|hormone antagonists|mesh-ancestor
110545928|NCT02644304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110545929|NCT02644304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110545930|NCT02644304|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110545931|NCT02644304|Fertility Agents|fertility agents|mesh-ancestor
110545932|NCT02644304|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110545933|NCT02644304|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110545934|NCT02644304|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110545935|NCT02644304|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110545936|NCT02644304|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110545937|NCT02644304|Dopamine Agonists|dopamine agonists|mesh-ancestor
110545938|NCT02644304|Dopamine Agents|dopamine agents|mesh-ancestor
110545939|NCT02644304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110545940|NCT00681174|Acetaminophen|acetaminophen|mesh-list
110545941|NCT00681174|Morphine|morphine|mesh-list
110545942|NCT00681174|Remifentanil|remifentanil|mesh-list
110545943|NCT00681174|Oxycodone|oxycodone|mesh-list
110545944|NCT00681174|Propofol|propofol|mesh-list
110545945|NCT00681174|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110545946|NCT00681174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110167250|NCT00030589|Dermatologic Agents|dermatologic agents|mesh-ancestor
110545947|NCT00681174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110545948|NCT00681174|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110545949|NCT00681174|Anesthetics, General|anesthetics, general|mesh-ancestor
110545950|NCT00681174|Anesthetics|anesthetics|mesh-ancestor
110545951|NCT00681174|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110545953|NCT00681174|Analgesics|analgesics|mesh-ancestor
110545954|NCT00681174|Sensory System Agents|sensory system agents|mesh-ancestor
110545955|NCT00681174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110545956|NCT00681174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110545957|NCT00681174|Antipyretics|antipyretics|mesh-ancestor
110545958|NCT02758769|Abatacept|abatacept|mesh-list
110545959|NCT02758769|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110545960|NCT02758769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110545961|NCT02758769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110545962|NCT02758769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110545963|NCT02758769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110545964|NCT02758769|Immunologic Factors|immunologic factors|mesh-ancestor
110545965|NCT02758769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110545966|NCT02758769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110545967|NCT04150146|Rebamipide|rebamipide|mesh-list
110545968|NCT04150146|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110545969|NCT04150146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110545970|NCT04150146|Antioxidants|antioxidants|mesh-ancestor
110545971|NCT04150146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110545972|NCT04150146|Protective Agents|protective agents|mesh-ancestor
110545973|NCT04150146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110545974|NCT04150146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110545975|NCT00652730|Buspirone|buspirone|mesh-list
110545976|NCT00652730|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110545977|NCT00652730|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110545978|NCT00652730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110545979|NCT00652730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110545980|NCT00652730|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110545981|NCT00652730|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110545982|NCT00652730|Serotonin Agents|serotonin agents|mesh-ancestor
110545983|NCT00652730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110545984|NCT00652730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110545986|NCT00652808|Valdecoxib|valdecoxib|mesh-list
110545987|NCT00652808|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110545988|NCT00652808|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110545989|NCT00652808|Analgesics|analgesics|mesh-ancestor
110545990|NCT00652808|Sensory System Agents|sensory system agents|mesh-ancestor
110545991|NCT00652808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110545992|NCT00652808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110545993|NCT00652808|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110545994|NCT00652808|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110545995|NCT00652808|Gout Suppressants|gout suppressants|mesh-ancestor
110545996|NCT00652808|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110545997|NCT00652808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110167623|NCT00000599|Niacin|niacin|mesh-list
110545998|NCT00652808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110545999|NCT00652808|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110546000|NCT00635531|Alprazolam|alprazolam|mesh-list
110546001|NCT00635531|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110546002|NCT00635531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110546003|NCT00635531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110546004|NCT00635531|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110546005|NCT00635531|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110546006|NCT00635531|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110546007|NCT00635531|GABA Modulators|gaba modulators|mesh-ancestor
110546008|NCT00635531|GABA Agents|gaba agents|mesh-ancestor
110546009|NCT00635531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110546010|NCT00635531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110546011|NCT02535156|Risperidone|risperidone|mesh-list
110546012|NCT02535156|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110546013|NCT02535156|Serotonin Agents|serotonin agents|mesh-ancestor
110546014|NCT02535156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110546015|NCT02535156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110546016|NCT02535156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110546017|NCT02535156|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110546018|NCT02535156|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110546019|NCT02535156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110546020|NCT02535156|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110546021|NCT02535156|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110546022|NCT02535156|Dopamine Agents|dopamine agents|mesh-ancestor
110546023|NCT03417895|Apatinib|apatinib|mesh-list
110546024|NCT03417895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110546025|NCT03417895|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110546026|NCT03417895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110546027|NCT03417895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110546028|NCT05299164|Rituximab|rituximab|mesh-list
110546029|NCT05299164|Gemcitabine|gemcitabine|mesh-list
110546030|NCT05299164|Vinorelbine|vinorelbine|mesh-list
110546031|NCT05299164|Mitoxantrone|mitoxantrone|mesh-list
110546032|NCT05299164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110546033|NCT05299164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110546034|NCT05299164|Immunologic Factors|immunologic factors|mesh-ancestor
110546035|NCT05299164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110546036|NCT05299164|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110546037|NCT05299164|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110546038|NCT05299164|Antimetabolites|antimetabolites|mesh-ancestor
110167858|NCT00033358|Estrogens|estrogens|mesh-ancestor
110546039|NCT05299164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110546040|NCT05299164|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110546041|NCT05299164|Tubulin Modulators|tubulin modulators|mesh-ancestor
110546042|NCT05299164|Antimitotic Agents|antimitotic agents|mesh-ancestor
110546043|NCT05299164|Mitosis Modulators|mitosis modulators|mesh-ancestor
110546044|NCT05299164|Analgesics|analgesics|mesh-ancestor
110546045|NCT05299164|Sensory System Agents|sensory system agents|mesh-ancestor
110546046|NCT05299164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110343813|NCT06022588|Butyric Acid|butyric acid|mesh-list
110546047|NCT05299164|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110546048|NCT05299164|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110546049|NCT05299164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110546051|NCT01563835|Bupivacaine|bupivacaine|mesh-list
110546052|NCT01563835|Citric Acid|citric acid|mesh-list
110546053|NCT01563835|Sodium Citrate|sodium citrate|mesh-list
110546054|NCT01563835|Anesthetics, Local|anesthetics, local|mesh-ancestor
110546055|NCT01563835|Anesthetics|anesthetics|mesh-ancestor
110546056|NCT01563835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110546057|NCT01563835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110546058|NCT01563835|Sensory System Agents|sensory system agents|mesh-ancestor
110546059|NCT01563835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110546060|NCT01563835|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110546061|NCT01563835|Narcotics|narcotics|mesh-ancestor
110546062|NCT01563835|Analgesics|analgesics|mesh-ancestor
110546063|NCT01563835|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110546064|NCT01563835|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110546065|NCT01563835|Anesthetics, General|anesthetics, general|mesh-ancestor
110546066|NCT01563835|Anticoagulants|anticoagulants|mesh-ancestor
110546067|NCT01563835|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110546068|NCT01563835|Chelating Agents|chelating agents|mesh-ancestor
110168081|NCT00000665|Foscarnet|foscarnet|mesh-list
110546069|NCT01563835|Sequestering Agents|sequestering agents|mesh-ancestor
110546070|NCT01563835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110546071|NCT02768207|Vemurafenib|vemurafenib|mesh-list
110546072|NCT02768207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110546073|NCT02768207|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110546074|NCT02768207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110546075|NCT02768207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110546076|NCT02653196|Cyclosporine|cyclosporine|mesh-list
110546077|NCT02653196|Mycophenolic Acid|mycophenolic acid|mesh-list
110546078|NCT02653196|Fludarabine|fludarabine|mesh-list
110546080|NCT02653196|Melphalan|melphalan|mesh-list
110546081|NCT02653196|Alemtuzumab|alemtuzumab|mesh-list
110546082|NCT02653196|Thiotepa|thiotepa|mesh-list
110546083|NCT02653196|Tacrolimus|tacrolimus|mesh-list
110546084|NCT02653196|Cyclosporins|cyclosporins|mesh-list
110546085|NCT02653196|Mitogens|mitogens|mesh-list
110546086|NCT02653196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110546087|NCT02653196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110546088|NCT02653196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110546089|NCT02653196|Immunologic Factors|immunologic factors|mesh-ancestor
110546090|NCT02653196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110546091|NCT02653196|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110546092|NCT02653196|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110546093|NCT02653196|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110546095|NCT02653196|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110546096|NCT02653196|Antifungal Agents|antifungal agents|mesh-ancestor
110546097|NCT02653196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110546098|NCT02653196|Dermatologic Agents|dermatologic agents|mesh-ancestor
110546099|NCT02653196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110546100|NCT02653196|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110204028|NCT00162916|Citalopram|citalopram|mesh-list
110546101|NCT02653196|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110546102|NCT02653196|Antitubercular Agents|antitubercular agents|mesh-ancestor
110546103|NCT02653196|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110168339|NCT00000689|Hormones|hormones|mesh-ancestor
110546104|NCT02653196|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110546105|NCT02653196|Alkylating Agents|alkylating agents|mesh-ancestor
110546106|NCT02653196|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110546107|NCT02653196|Mitosis Modulators|mitosis modulators|mesh-ancestor
110546108|NCT02653196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110546109|NCT05135845|Spartalizumab|spartalizumab|mesh-list
110546110|NCT05135845|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110546111|NCT05135845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110546112|NCT05135845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110546113|NCT05135845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110546114|NCT04479436|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
110546115|NCT04479436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110546116|NCT04479436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110546117|NCT00677118|Cisplatin|cisplatin|mesh-list
110546118|NCT00677118|Fluorouracil|fluorouracil|mesh-list
110546119|NCT00677118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110546120|NCT00677118|Antimetabolites|antimetabolites|mesh-ancestor
110546121|NCT00677118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110546122|NCT00677118|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110546123|NCT00677118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110546124|NCT00677118|Immunologic Factors|immunologic factors|mesh-ancestor
110546125|NCT00677118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110546126|NCT02644226|Sevoflurane|sevoflurane|mesh-list
110546127|NCT02644226|Desflurane|desflurane|mesh-list
110546128|NCT02644226|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110546129|NCT02644226|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110546130|NCT02644226|Anesthetics, General|anesthetics, general|mesh-ancestor
110546131|NCT02644226|Anesthetics|anesthetics|mesh-ancestor
110546132|NCT02644226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110546133|NCT02644226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110546134|NCT02753855|Telavancin|telavancin|mesh-list
110546135|NCT02753855|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110546136|NCT02753855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110546137|NCT02758691|Insulin|insulin|mesh-list
110546138|NCT02758691|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110546139|NCT02758691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110546140|NCT00714376|Docetaxel|docetaxel|mesh-list
110546141|NCT00714376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110546142|NCT00714376|Tubulin Modulators|tubulin modulators|mesh-ancestor
110546143|NCT00714376|Antimitotic Agents|antimitotic agents|mesh-ancestor
110546144|NCT00714376|Mitosis Modulators|mitosis modulators|mesh-ancestor
110546145|NCT00714376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110546146|NCT04068766|Bupivacaine|bupivacaine|mesh-list
110546147|NCT04068766|Anesthetics, Local|anesthetics, local|mesh-ancestor
110546148|NCT04068766|Anesthetics|anesthetics|mesh-ancestor
110546149|NCT04068766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110546150|NCT04068766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110546151|NCT04068766|Sensory System Agents|sensory system agents|mesh-ancestor
110546152|NCT04068766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110546153|NCT03267199|Fibrinolytic Agents|fibrinolytic agents|mesh-list
110168830|NCT00036166|Micafungin|micafungin|mesh-list
110546154|NCT03267199|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110178641|NCT04749043|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110546155|NCT03267199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110546157|NCT04725695|Anesthetics, Local|anesthetics, local|mesh-ancestor
110546158|NCT04725695|Anesthetics|anesthetics|mesh-ancestor
110546159|NCT04725695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110546160|NCT04725695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110546161|NCT04725695|Sensory System Agents|sensory system agents|mesh-ancestor
110546162|NCT04725695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110546163|NCT04725695|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110546164|NCT04725695|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110546165|NCT04725695|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110546166|NCT04725695|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110546167|NCT04725695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110546168|NCT04151472|Ubiquinone|ubiquinone|mesh-list
110546169|NCT04151472|Idebenone|idebenone|mesh-list
110546170|NCT04151472|Antioxidants|antioxidants|mesh-ancestor
110546171|NCT04151472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110546172|NCT04151472|Protective Agents|protective agents|mesh-ancestor
110546173|NCT04151472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110546174|NCT04151472|Micronutrients|micronutrients|mesh-ancestor
110546175|NCT04070794|Metformin|metformin|mesh-list
110546176|NCT04070794|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110546177|NCT04070794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110546178|NCT02695901|Chlorhexidine|chlorhexidine|mesh-list
110546179|NCT02695901|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110546180|NCT02695901|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110546181|NCT02695901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110546183|NCT02695901|Dermatologic Agents|dermatologic agents|mesh-ancestor
110546184|NCT00677664|Glatiramer Acetate|glatiramer acetate|mesh-list
110546185|NCT00677664|Mannitol|mannitol|mesh-list
110546186|NCT00677664|(T,G)-A-L|(t,g)-a-l|mesh-list
110546187|NCT00677664|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110546188|NCT00677664|Diuretics|diuretics|mesh-ancestor
110546189|NCT00677664|Natriuretic Agents|natriuretic agents|mesh-ancestor
110546190|NCT00677664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110546191|NCT00677664|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110546192|NCT00677664|Immunologic Factors|immunologic factors|mesh-ancestor
110546193|NCT00677664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110546194|NCT00677664|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110546195|NCT02572492|Dexamethasone|dexamethasone|mesh-list
110546196|NCT02572492|Dexamethasone acetate|dexamethasone acetate|mesh-list
110546197|NCT02572492|Melphalan|melphalan|mesh-list
110546198|NCT02572492|BB 1101|bb 1101|mesh-list
110546199|NCT02572492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110546200|NCT02572492|Antiemetics|antiemetics|mesh-ancestor
110546201|NCT02572492|Autonomic Agents|autonomic agents|mesh-ancestor
110546202|NCT02572492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110546203|NCT02572492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110546204|NCT02572492|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110546205|NCT02572492|Glucocorticoids|glucocorticoids|mesh-ancestor
110546206|NCT02572492|Hormones|hormones|mesh-ancestor
110391697|NCT02872116|Micronutrients|micronutrients|mesh-ancestor
110546207|NCT02572492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110546208|NCT02572492|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110546209|NCT02572492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110546210|NCT02572492|Protease Inhibitors|protease inhibitors|mesh-ancestor
110546211|NCT02572492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110546212|NCT02572492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110546213|NCT02572492|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110391839|NCT01810588|Rituximab|rituximab|mesh-list
110546214|NCT02572492|Alkylating Agents|alkylating agents|mesh-ancestor
110546215|NCT02572492|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110546216|NCT02572492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110546217|NCT02572492|Immunologic Factors|immunologic factors|mesh-ancestor
110546218|NCT02753387|Chlorhexidine|chlorhexidine|mesh-list
110546219|NCT02753387|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110546220|NCT02753387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110546221|NCT02753387|Disinfectants|disinfectants|mesh-ancestor
110546222|NCT00672282|Bicalutamide|bicalutamide|mesh-list
110546223|NCT00672282|Androgen Antagonists|androgen antagonists|mesh-ancestor
110546224|NCT00672282|Hormone Antagonists|hormone antagonists|mesh-ancestor
110546225|NCT00672282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110546226|NCT00672282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110546227|NCT00672282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110546228|NCT02753309|Sirolimus|sirolimus|mesh-list
110546229|NCT02753309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110546230|NCT02753309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110546231|NCT02753309|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110546232|NCT02753309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110546233|NCT02753309|Antifungal Agents|antifungal agents|mesh-ancestor
110546234|NCT02753309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110546235|NCT02753309|Immunologic Factors|immunologic factors|mesh-ancestor
110546236|NCT02753309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110546237|NCT04147728|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
110546238|NCT04147728|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110546239|NCT04147728|Growth Substances|growth substances|mesh-ancestor
110392045|NCT01601730|Serotonin Agents|serotonin agents|mesh-ancestor
110546240|NCT04147728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110546241|NCT04147728|Growth Inhibitors|growth inhibitors|mesh-ancestor
110546242|NCT04147728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110546244|NCT04330690|Dexamethasone|dexamethasone|mesh-list
110546245|NCT04330690|Infliximab|infliximab|mesh-list
110546246|NCT04330690|Imatinib Mesylate|imatinib mesylate|mesh-list
110546247|NCT04330690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110546248|NCT04330690|Antiemetics|antiemetics|mesh-ancestor
110546249|NCT04330690|Autonomic Agents|autonomic agents|mesh-ancestor
110546250|NCT04330690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110546251|NCT04330690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110546252|NCT04330690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110193829|NCT00038090|Dexamethasone|dexamethasone|mesh-list
110546253|NCT04330690|Glucocorticoids|glucocorticoids|mesh-ancestor
110546254|NCT04330690|Hormones|hormones|mesh-ancestor
110546255|NCT04330690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110546256|NCT04330690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110546257|NCT04330690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110546258|NCT04330690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110546259|NCT04330690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110546260|NCT04330690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110546261|NCT04330690|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110546263|NCT04330690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110546264|NCT04330690|Antimalarials|antimalarials|mesh-ancestor
110546265|NCT04330690|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110546266|NCT04330690|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110546267|NCT04330690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110546268|NCT04330690|Antiviral Agents|antiviral agents|mesh-ancestor
110546269|NCT04330690|Schistosomicides|schistosomicides|mesh-ancestor
110546270|NCT04330690|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110546271|NCT04330690|Anthelmintics|anthelmintics|mesh-ancestor
110546272|NCT03083041|Apatinib|apatinib|mesh-list
110546273|NCT03083041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110546274|NCT03083041|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110546275|NCT03083041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110546276|NCT03083041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110546277|NCT00672360|Folic Acid|folic acid|mesh-list
110546278|NCT00672360|Hematinics|hematinics|mesh-ancestor
110546279|NCT00672360|Vitamin B Complex|vitamin b complex|mesh-ancestor
110546280|NCT00672360|Vitamins|vitamins|mesh-ancestor
110546281|NCT00672360|Micronutrients|micronutrients|mesh-ancestor
110546282|NCT00672360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110546283|NCT02628522|Lidocaine|lidocaine|mesh-list
110546284|NCT02628522|Epinephrine|epinephrine|mesh-list
110546285|NCT02628522|Anesthetics, Local|anesthetics, local|mesh-ancestor
110546286|NCT02628522|Anesthetics|anesthetics|mesh-ancestor
110546287|NCT02628522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110546288|NCT02628522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110546289|NCT02628522|Sensory System Agents|sensory system agents|mesh-ancestor
110546290|NCT02628522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110546291|NCT02628522|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110546292|NCT02628522|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110546293|NCT02628522|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110546294|NCT02628522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110546295|NCT02628522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110546296|NCT02628522|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110546297|NCT02628522|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110546298|NCT02628522|Adrenergic Agents|adrenergic agents|mesh-ancestor
110546299|NCT02628522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110546300|NCT02628522|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110546301|NCT02628522|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110546302|NCT02628522|Autonomic Agents|autonomic agents|mesh-ancestor
110546303|NCT02628522|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110546304|NCT02628522|Respiratory System Agents|respiratory system agents|mesh-ancestor
110546305|NCT02628522|Mydriatics|mydriatics|mesh-ancestor
110546306|NCT02628522|Sympathomimetics|sympathomimetics|mesh-ancestor
110546307|NCT02628522|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110546308|NCT02572336|Plasminogen|plasminogen|mesh-list
110546309|NCT02572336|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
110546310|NCT02572336|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110392433|NCT01647659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110546311|NCT02572336|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110392495|NCT01647893|Protease Inhibitors|protease inhibitors|mesh-ancestor
110546312|NCT02572336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110546313|NCT02750969|Lidocaine|lidocaine|mesh-list
110546314|NCT02750969|Anesthetics, Local|anesthetics, local|mesh-ancestor
110546315|NCT02750969|Anesthetics|anesthetics|mesh-ancestor
110546316|NCT02750969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110546317|NCT02750969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110546318|NCT02750969|Sensory System Agents|sensory system agents|mesh-ancestor
110546319|NCT02750969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110546320|NCT02750969|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110546321|NCT02750969|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110546322|NCT02750969|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110546323|NCT02750969|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110546324|NCT02750969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110546326|NCT04067011|Ciprofloxacin|ciprofloxacin|mesh-list
110546327|NCT04067011|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110546328|NCT04067011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110546329|NCT04067011|Antimalarials|antimalarials|mesh-ancestor
110546330|NCT04067011|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110546331|NCT04067011|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110546332|NCT04067011|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110546333|NCT04067011|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110546334|NCT04067011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110546335|NCT04067011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110546336|NCT04067011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110546337|NCT04067011|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110546338|NCT04067011|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110546339|NCT00719056|Ciprofloxacin|ciprofloxacin|mesh-list
110546340|NCT00719056|Lactams|lactams|mesh-list
110546341|NCT00719056|Cephalosporins|cephalosporins|mesh-list
110546342|NCT00719056|Teicoplanin|teicoplanin|mesh-list
110546343|NCT00719056|beta-Lactams|beta-lactams|mesh-list
110546344|NCT00719056|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110546345|NCT00719056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110392787|NCT01609413|Antacids|antacids|mesh-ancestor
110546346|NCT00719056|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110546347|NCT00719056|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110546348|NCT00719056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110546349|NCT00719056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110546350|NCT00719056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110546351|NCT00719056|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110546352|NCT00719056|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110546353|NCT04469699|Aminolevulinic Acid|aminolevulinic acid|mesh-list
110546354|NCT04469699|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110392861|NCT01606878|Cyclophosphamide|cyclophosphamide|mesh-list
110546355|NCT04469699|Dermatologic Agents|dermatologic agents|mesh-ancestor
110546356|NCT03475004|Bevacizumab|bevacizumab|mesh-list
110546357|NCT03475004|Pembrolizumab|pembrolizumab|mesh-list
110546358|NCT03475004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110546359|NCT03475004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110546360|NCT03475004|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110546361|NCT03475004|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110546362|NCT03475004|Growth Substances|growth substances|mesh-ancestor
110546363|NCT03475004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110546364|NCT03475004|Growth Inhibitors|growth inhibitors|mesh-ancestor
110546365|NCT03475004|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110546366|NCT03475004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110546367|NCT02695745|Celecoxib|celecoxib|mesh-list
110546368|NCT02695745|Capsaicin|capsaicin|mesh-list
110546369|NCT02695745|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110546370|NCT02695745|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110546371|NCT02695745|Analgesics|analgesics|mesh-ancestor
110546372|NCT02695745|Sensory System Agents|sensory system agents|mesh-ancestor
110546373|NCT02695745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110546374|NCT02695745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110546375|NCT02695745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110546376|NCT02695745|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110546377|NCT02695745|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110546378|NCT02695745|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110393060|NCT02270424|Hormones|hormones|mesh-ancestor
110546379|NCT02695745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110546380|NCT02695745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110546381|NCT02695745|Antipruritics|antipruritics|mesh-ancestor
110546382|NCT02695745|Dermatologic Agents|dermatologic agents|mesh-ancestor
110546383|NCT00990067|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110546384|NCT00990067|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
110546385|NCT00990067|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110546386|NCT00990067|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110546387|NCT00990067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110546388|NCT00990067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110546389|NCT00990067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110546390|NCT00990067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110546391|NCT00990067|Analgesics|analgesics|mesh-ancestor
110546392|NCT00990067|Sensory System Agents|sensory system agents|mesh-ancestor
110546393|NCT00990067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110546394|NCT00990067|Antidepressive Agents|antidepressive agents|mesh-ancestor
110546395|NCT00990067|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110546396|NCT00990067|Dopamine Agents|dopamine agents|mesh-ancestor
110546397|NCT00990067|Hallucinogens|hallucinogens|mesh-ancestor
110546398|NCT00990067|Serotonin Agents|serotonin agents|mesh-ancestor
110546399|NCT00990067|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110546400|NCT00990067|Adrenergic Agents|adrenergic agents|mesh-ancestor
110546401|NCT00719290|Hyaluronic Acid|hyaluronic acid|mesh-list
110546402|NCT00719290|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110546403|NCT00719290|Immunologic Factors|immunologic factors|mesh-ancestor
110546404|NCT00719290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110546405|NCT00719290|Viscosupplements|viscosupplements|mesh-ancestor
110546406|NCT00719290|Protective Agents|protective agents|mesh-ancestor
110546407|NCT00635921|Ziprasidone|ziprasidone|mesh-list
110546408|NCT00635921|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110546409|NCT00635921|Serotonin Agents|serotonin agents|mesh-ancestor
110546410|NCT00635921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110546411|NCT00635921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110393186|NCT02271360|Dopamine Agents|dopamine agents|mesh-ancestor
110546412|NCT00635921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110546413|NCT00635921|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110546414|NCT00635921|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110546415|NCT00635921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110546416|NCT00635921|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110546417|NCT00635921|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110546418|NCT00635921|Dopamine Agents|dopamine agents|mesh-ancestor
110546419|NCT04166006|Interleukin-2|interleukin-2|mesh-list
110546420|NCT04166006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110546421|NCT04166006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110546422|NCT04166006|Analgesics|analgesics|mesh-ancestor
110546423|NCT04166006|Sensory System Agents|sensory system agents|mesh-ancestor
110546424|NCT04166006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110546425|NCT04166006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110546426|NCT04069858|Entecavir|entecavir|mesh-list
110546427|NCT04069858|Antiviral Agents|antiviral agents|mesh-ancestor
110546428|NCT04069858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110546429|NCT00710086|Remifentanil|remifentanil|mesh-list
110546430|NCT00710086|Hydromorphone|hydromorphone|mesh-list
110546431|NCT00710086|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110546433|NCT00710086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110546434|NCT00710086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110546435|NCT00710086|Analgesics|analgesics|mesh-ancestor
110546436|NCT00710086|Sensory System Agents|sensory system agents|mesh-ancestor
110546437|NCT00710086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110546438|NCT00652886|Oxandrolone|oxandrolone|mesh-list
110546439|NCT00652886|Androgens|androgens|mesh-ancestor
110546440|NCT00652886|Hormones|hormones|mesh-ancestor
110546441|NCT00652886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110546442|NCT00652886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110546444|NCT00539305|Methyltestosterone|methyltestosterone|mesh-list
110546445|NCT00539305|Testosterone|testosterone|mesh-list
110546446|NCT00539305|Testosterone undecanoate|testosterone undecanoate|mesh-list
110546447|NCT00539305|Testosterone enanthate|testosterone enanthate|mesh-list
110546448|NCT00539305|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
110546449|NCT00539305|Androgens|androgens|mesh-ancestor
110546450|NCT00539305|Hormones|hormones|mesh-ancestor
110546451|NCT00539305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110546452|NCT00539305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110546453|NCT00539305|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110546454|NCT00539305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110546455|NCT00539305|Anabolic Agents|anabolic agents|mesh-ancestor
110546456|NCT02643914|Nicotine|nicotine|mesh-list
110546457|NCT02643914|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110546458|NCT02643914|Autonomic Agents|autonomic agents|mesh-ancestor
110546459|NCT02643914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110546460|NCT02643914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110546461|NCT02643914|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110546462|NCT02643914|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110546463|NCT02643914|Cholinergic Agents|cholinergic agents|mesh-ancestor
110546464|NCT02643914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110546465|NCT02643914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110393575|NCT01335009|Antibodies|antibodies|mesh-list
110655641|NCT00425854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110655642|NCT00425698|Epoetin Alfa|epoetin alfa|mesh-list
110546466|NCT00715702|N-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-N-ethyl-2-(4-methanesulfonylphenyl)acetamide|n-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-n-ethyl-2-(4-methanesulfonylphenyl)acetamide|mesh-list
110546467|NCT00715702|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
110546468|NCT00715702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110546469|NCT00715702|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110546470|NCT00715702|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110546471|NCT00715702|Antiviral Agents|antiviral agents|mesh-ancestor
110546472|NCT00715702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110546473|NCT00990223|Eplerenone|eplerenone|mesh-list
110546474|NCT00990223|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110546475|NCT00990223|Hormone Antagonists|hormone antagonists|mesh-ancestor
110546476|NCT00990223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110546477|NCT00990223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110546478|NCT00990223|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110546479|NCT00990223|Diuretics|diuretics|mesh-ancestor
110546480|NCT00990223|Natriuretic Agents|natriuretic agents|mesh-ancestor
110546482|NCT00715780|Insulin|insulin|mesh-list
110546483|NCT00715780|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110546484|NCT00715780|Insulin Aspart|insulin aspart|mesh-list
110546485|NCT00715780|Insulin, Long-Acting|insulin, long-acting|mesh-list
110546486|NCT00715780|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
110546487|NCT00715780|Insulin Detemir|insulin detemir|mesh-list
110546488|NCT00715780|Biphasic Insulins|biphasic insulins|mesh-list
110546489|NCT00715780|Isophane Insulin, Human|isophane insulin, human|mesh-list
110546490|NCT00715780|Insulin, Isophane|insulin, isophane|mesh-list
110546491|NCT00715780|Isophane insulin, beef|isophane insulin, beef|mesh-list
110546492|NCT00715780|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110546493|NCT00715780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110546494|NCT02652884|Betamethasone|betamethasone|mesh-list
110546495|NCT02652884|Betamethasone acetate|betamethasone acetate|mesh-list
110546496|NCT02652884|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110546497|NCT02652884|Glucocorticoids|glucocorticoids|mesh-ancestor
110546498|NCT02652884|Hormones|hormones|mesh-ancestor
110655643|NCT00425698|Hematinics|hematinics|mesh-ancestor
110655644|NCT01037530|Ramipril|ramipril|mesh-list
110546499|NCT02652884|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110546500|NCT02652884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110546501|NCT02652884|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110546502|NCT02652884|Respiratory System Agents|respiratory system agents|mesh-ancestor
110546503|NCT00990301|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110546504|NCT00990301|Moexipril|moexipril|mesh-list
110546505|NCT00990301|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110546506|NCT00990301|Diuretics|diuretics|mesh-ancestor
110546507|NCT00990301|Natriuretic Agents|natriuretic agents|mesh-ancestor
110546508|NCT00990301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110546509|NCT00990301|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110546510|NCT00990301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110546511|NCT00990301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110393993|NCT02893371|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110546512|NCT00990301|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110546513|NCT00990301|Protease Inhibitors|protease inhibitors|mesh-ancestor
110546514|NCT00990301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110546515|NCT00715858|Doxycycline|doxycycline|mesh-list
110546516|NCT00715858|Rifampin|rifampin|mesh-list
110546517|NCT00715858|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110546518|NCT00715858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110546519|NCT00715858|Antimalarials|antimalarials|mesh-ancestor
110546520|NCT00715858|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110546521|NCT00715858|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110546522|NCT00715858|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110394137|NCT02893254|Adalimumab|adalimumab|mesh-list
110546523|NCT00715858|Antitubercular Agents|antitubercular agents|mesh-ancestor
110546524|NCT00715858|Leprostatic Agents|leprostatic agents|mesh-ancestor
110546525|NCT00715858|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110546526|NCT00715858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110546527|NCT00715858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110546528|NCT00715858|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110546529|NCT00715858|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110546530|NCT00715858|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110546531|NCT00715858|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110546532|NCT00715858|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110028010|NCT03407196|Dapagliflozin|dapagliflozin|mesh-list
110546533|NCT00715858|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110546534|NCT02643680|Chlorhexidine|chlorhexidine|mesh-list
110546535|NCT02643680|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110546536|NCT02643680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110546537|NCT02643680|Disinfectants|disinfectants|mesh-ancestor
110546538|NCT04696445|Morphine|morphine|mesh-list
110546539|NCT04696445|Oxycodone|oxycodone|mesh-list
110546540|NCT04696445|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110546541|NCT04696445|Narcotics|narcotics|mesh-ancestor
110546542|NCT04696445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110546543|NCT04696445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110546544|NCT04696445|Analgesics|analgesics|mesh-ancestor
110546545|NCT04696445|Sensory System Agents|sensory system agents|mesh-ancestor
110546546|NCT04696445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110546547|NCT05360953|Clonidine|clonidine|mesh-list
110546549|NCT05360953|Analgesics|analgesics|mesh-ancestor
110546550|NCT05360953|Sensory System Agents|sensory system agents|mesh-ancestor
110546551|NCT05360953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110546552|NCT05360953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110394332|NCT01175824|Insulin Lispro|insulin lispro|mesh-list
110546553|NCT05360953|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110546554|NCT05360953|Sympatholytics|sympatholytics|mesh-ancestor
110546555|NCT05360953|Autonomic Agents|autonomic agents|mesh-ancestor
110194145|NCT00066339|Gefitinib|gefitinib|mesh-list
110546557|NCT05360953|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110546558|NCT05360953|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110546559|NCT05360953|Adrenergic Agents|adrenergic agents|mesh-ancestor
110546560|NCT05360953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110343814|NCT06022588|Histamine Antagonists|histamine antagonists|mesh-ancestor
110546561|NCT05360953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110546562|NCT05360953|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110394461|NCT01601912|Dexetimide|dexetimide|mesh-list
110546563|NCT05360953|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110546564|NCT05360953|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110546565|NCT02647424|Letrozole|letrozole|mesh-list
110546566|NCT02647424|Clomiphene|clomiphene|mesh-list
110546567|NCT02647424|Enclomiphene|enclomiphene|mesh-list
110546568|NCT02647424|Zuclomiphene|zuclomiphene|mesh-list
110546569|NCT02647424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110546570|NCT02647424|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110546571|NCT02647424|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110546572|NCT02647424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110546573|NCT02647424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110546574|NCT02647424|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110546575|NCT02647424|Hormone Antagonists|hormone antagonists|mesh-ancestor
110546576|NCT02647424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110394681|NCT01609205|Adalimumab|adalimumab|mesh-list
110546577|NCT02647424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110546578|NCT02647424|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110546579|NCT02647424|Fertility Agents|fertility agents|mesh-ancestor
110546580|NCT02647424|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110546581|NCT02647424|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110546582|NCT02647424|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110546583|NCT02574754|Warfarin|warfarin|mesh-list
110546584|NCT02574754|Anticoagulants|anticoagulants|mesh-ancestor
110546585|NCT00719602|Ritonavir|ritonavir|mesh-list
110546586|NCT00719602|Lopinavir|lopinavir|mesh-list
110546587|NCT00719602|Lamivudine|lamivudine|mesh-list
110546588|NCT00719602|Zidovudine|zidovudine|mesh-list
110546589|NCT00719602|Nevirapine|nevirapine|mesh-list
110546590|NCT00719602|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110546591|NCT00719602|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110546592|NCT00719602|Protease Inhibitors|protease inhibitors|mesh-ancestor
110546593|NCT00719602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110546594|NCT00719602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110546595|NCT00719602|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110546596|NCT00719602|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110546597|NCT00719602|Antiviral Agents|antiviral agents|mesh-ancestor
110546598|NCT00719602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110546599|NCT00719602|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110546600|NCT00719602|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110546601|NCT00719602|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110546602|NCT00719602|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110546603|NCT00719602|Antimetabolites|antimetabolites|mesh-ancestor
110546604|NCT00719602|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110546605|NCT00719602|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110546606|NCT02652650|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110546607|NCT02652650|Norethindrone|norethindrone|mesh-list
110546608|NCT02652650|Norethindrone Acetate|norethindrone acetate|mesh-list
110546609|NCT02652650|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110546610|NCT02652650|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110546611|NCT02652650|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110546612|NCT02652650|Contraceptive Agents|contraceptive agents|mesh-ancestor
110546613|NCT02652650|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110546614|NCT02652650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110546615|NCT02652650|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110546616|NCT02652650|Estrogens|estrogens|mesh-ancestor
110546617|NCT02652650|Hormones|hormones|mesh-ancestor
110546618|NCT02652650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110546619|NCT02652650|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110546620|NCT02643602|Theophylline|theophylline|mesh-list
110546621|NCT02643602|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110546622|NCT02643602|Autonomic Agents|autonomic agents|mesh-ancestor
110546623|NCT02643602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110546624|NCT02643602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110546625|NCT02643602|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110546626|NCT02643602|Respiratory System Agents|respiratory system agents|mesh-ancestor
110546627|NCT02643602|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110546628|NCT02643602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110546629|NCT02643602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110546630|NCT02643602|Vasodilator Agents|vasodilator agents|mesh-ancestor
110395187|NCT01172938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110546631|NCT02643602|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110546632|NCT02643602|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110546633|NCT02643602|Purinergic Agents|purinergic agents|mesh-ancestor
110546634|NCT02643602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110546635|NCT00710320|Anesthetics|anesthetics|mesh-list
110546636|NCT00710320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110546637|NCT00710320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110546638|NCT00716170|Glucagon|glucagon|mesh-list
110546639|NCT00716170|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
110546640|NCT00716170|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
110546641|NCT00716170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110546642|NCT00716170|Hormones|hormones|mesh-ancestor
110546643|NCT00716170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110546644|NCT00716170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110546645|NCT00716170|Incretins|incretins|mesh-ancestor
110546646|NCT02652806|Epoetin Alfa|epoetin alfa|mesh-list
110546647|NCT02652806|Hematinics|hematinics|mesh-ancestor
110546648|NCT04529135|Dexmedetomidine|dexmedetomidine|mesh-list
110546649|NCT04529135|Remifentanil|remifentanil|mesh-list
110546650|NCT04529135|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110546651|NCT04529135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110546652|NCT04529135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110546653|NCT04529135|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110546654|NCT04529135|Analgesics|analgesics|mesh-ancestor
110546655|NCT04529135|Sensory System Agents|sensory system agents|mesh-ancestor
110546656|NCT04529135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110546657|NCT04529135|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110546658|NCT04529135|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110546659|NCT04529135|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110546660|NCT04529135|Adrenergic Agents|adrenergic agents|mesh-ancestor
110546661|NCT04529135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110546662|NCT04529135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110546663|NCT04529135|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110546664|NCT04529135|Narcotics|narcotics|mesh-ancestor
110546665|NCT02647190|Asparaginase|asparaginase|mesh-list
110546666|NCT02647190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110546667|NCT00653042|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
110546668|NCT00653042|Natriuretic Agents|natriuretic agents|mesh-ancestor
110546669|NCT00653042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110546670|NCT04165850|Ciprofloxacin|ciprofloxacin|mesh-list
110546672|NCT04165850|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110546673|NCT04165850|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110546674|NCT04165850|Analgesics|analgesics|mesh-ancestor
110546675|NCT04165850|Sensory System Agents|sensory system agents|mesh-ancestor
110178801|NCT01805817|Estrogens|estrogens|mesh-ancestor
110546676|NCT04165850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110546677|NCT04165850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110546678|NCT04165850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110546679|NCT04165850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110546680|NCT04165850|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110546681|NCT04165850|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110546682|NCT04165850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110546683|NCT04165850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110546684|NCT04165850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110546685|NCT04165850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110546686|NCT04165850|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110546687|NCT04165850|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110546688|NCT04165850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110546689|NCT04165850|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110546690|NCT04165850|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110546692|NCT00719758|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110546693|NCT00719758|Vasodilator Agents|vasodilator agents|mesh-ancestor
110546694|NCT02647268|Magnesium Sulfate|magnesium sulfate|mesh-list
110546695|NCT02647268|Oxytocin|oxytocin|mesh-list
110546696|NCT02647268|Oxytocics|oxytocics|mesh-ancestor
110546697|NCT02647268|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110546698|NCT02647268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110546699|NCT02647268|Analgesics|analgesics|mesh-ancestor
110546700|NCT02647268|Sensory System Agents|sensory system agents|mesh-ancestor
110546701|NCT02647268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110546702|NCT02647268|Anesthetics|anesthetics|mesh-ancestor
110194289|NCT00070629|Paclitaxel|paclitaxel|mesh-list
110546703|NCT02647268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110546704|NCT02647268|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110546705|NCT02647268|Anticonvulsants|anticonvulsants|mesh-ancestor
110546706|NCT02647268|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110546707|NCT02647268|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110395568|NCT00106184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110546708|NCT02647268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110546709|NCT02647268|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110546710|NCT02647268|Tocolytic Agents|tocolytic agents|mesh-ancestor
110546711|NCT04218149|Bupivacaine|bupivacaine|mesh-list
110546712|NCT04218149|Anesthetics, Local|anesthetics, local|mesh-ancestor
110546713|NCT04218149|Anesthetics|anesthetics|mesh-ancestor
110546714|NCT04218149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110546715|NCT04218149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110546716|NCT04218149|Sensory System Agents|sensory system agents|mesh-ancestor
110546717|NCT04218149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110546718|NCT04032860|Tenofovir|tenofovir|mesh-list
110546719|NCT04032860|Entecavir|entecavir|mesh-list
110546720|NCT04032860|Antiviral Agents|antiviral agents|mesh-ancestor
110546721|NCT04032860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110546722|NCT04032860|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110546723|NCT04032860|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110546724|NCT04032860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110546725|NCT04032860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110546726|NCT04032860|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110546727|NCT04032860|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110546728|NCT00716248|Bucillamine|bucillamine|mesh-list
110546729|NCT00716248|Methotrexate|methotrexate|mesh-list
110546730|NCT00716248|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110546731|NCT00716248|Abortifacient Agents|abortifacient agents|mesh-ancestor
110546732|NCT00716248|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110546733|NCT00716248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110546734|NCT00716248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110546735|NCT00716248|Antimetabolites|antimetabolites|mesh-ancestor
110546736|NCT00716248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110546737|NCT00716248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110178816|NCT01805817|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110546738|NCT00716248|Dermatologic Agents|dermatologic agents|mesh-ancestor
110546739|NCT00716248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110546740|NCT00716248|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110546741|NCT00716248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110546742|NCT00716248|Immunologic Factors|immunologic factors|mesh-ancestor
110546743|NCT00716248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110546744|NCT00716248|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110546745|NCT00716248|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110396122|NCT01171183|Antioxidants|antioxidants|mesh-ancestor
110546746|NCT00716248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110546747|NCT00716248|Analgesics|analgesics|mesh-ancestor
110546748|NCT00716248|Sensory System Agents|sensory system agents|mesh-ancestor
110546749|NCT00716248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110546750|NCT00716248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110546751|NCT00716248|Antioxidants|antioxidants|mesh-ancestor
110546752|NCT00716248|Protective Agents|protective agents|mesh-ancestor
110546753|NCT02643212|Rivaroxaban|rivaroxaban|mesh-list
110546754|NCT02643212|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110546755|NCT02643212|Antithrombins|antithrombins|mesh-ancestor
110546756|NCT02643212|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110546757|NCT02643212|Protease Inhibitors|protease inhibitors|mesh-ancestor
110546758|NCT02643212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110546759|NCT02643212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110546760|NCT02643212|Anticoagulants|anticoagulants|mesh-ancestor
110546761|NCT02642900|Nystatin|nystatin|mesh-list
110546762|NCT02642900|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110546763|NCT02642900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110546764|NCT02642900|Antifungal Agents|antifungal agents|mesh-ancestor
110546765|NCT02642900|Ionophores|ionophores|mesh-ancestor
110546766|NCT02642900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110546767|NCT02642900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110546768|NCT02652728|Enalapril|enalapril|mesh-list
110546769|NCT02652728|Enalaprilat|enalaprilat|mesh-list
110546770|NCT02652728|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110546771|NCT02652728|Protease Inhibitors|protease inhibitors|mesh-ancestor
110546772|NCT02652728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110396327|NCT04328636|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110546773|NCT02652728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110546774|NCT02652728|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110546775|NCT00720148|Bortezomib|bortezomib|mesh-list
110546776|NCT00720148|Sunitinib|sunitinib|mesh-list
110194361|NCT00066846|Antimetabolites|antimetabolites|mesh-ancestor
110546777|NCT00720148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110546778|NCT00720148|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110546779|NCT00720148|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110546780|NCT00720148|Growth Substances|growth substances|mesh-ancestor
110546781|NCT00720148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110546782|NCT00720148|Growth Inhibitors|growth inhibitors|mesh-ancestor
110546783|NCT00720148|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110546784|NCT00720148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110546785|NCT00720148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110546786|NCT00710788|Calcium Carbonate|calcium carbonate|mesh-list
110546787|NCT00710788|Calcium|calcium|mesh-list
110546788|NCT00710788|Sevelamer|sevelamer|mesh-list
110546789|NCT00710788|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110546790|NCT00710788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110546791|NCT00710788|Antacids|antacids|mesh-ancestor
110546792|NCT00710788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110546793|NCT00710788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110546794|NCT00710788|Chelating Agents|chelating agents|mesh-ancestor
110546795|NCT00710788|Sequestering Agents|sequestering agents|mesh-ancestor
110546796|NCT02646800|Micafungin|micafungin|mesh-list
110546797|NCT02646800|Antifungal Agents|antifungal agents|mesh-ancestor
110546798|NCT02646800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110546799|NCT02749409|Parecoxib|parecoxib|mesh-list
110546800|NCT02749409|Morphine|morphine|mesh-list
110396597|NCT00623168|Antimetabolites|antimetabolites|mesh-ancestor
110546801|NCT02749409|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110546802|NCT02749409|Narcotics|narcotics|mesh-ancestor
110546803|NCT02749409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110546804|NCT02749409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110546805|NCT02749409|Analgesics|analgesics|mesh-ancestor
110546806|NCT02749409|Sensory System Agents|sensory system agents|mesh-ancestor
110546807|NCT02749409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110546808|NCT02749409|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110546809|NCT02749409|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110546810|NCT02749409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110546811|NCT02749409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110546812|NCT02749409|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110546813|NCT02749409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110396669|NCT01324388|Metoprolol|metoprolol|mesh-list
110546814|NCT02749409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110546815|NCT02749409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110546816|NCT03449459|Amikacin|amikacin|mesh-list
110546817|NCT03449459|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110546818|NCT03449459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110546819|NCT00653120|Propranolol|propranolol|mesh-list
110546820|NCT00653120|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110546821|NCT00653120|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110546822|NCT00653120|Adrenergic Agents|adrenergic agents|mesh-ancestor
110546823|NCT00653120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110546824|NCT00653120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110560327|NCT00638729|Midazolam|midazolam|mesh-list
110546825|NCT00653120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110546826|NCT00653120|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110546827|NCT00653120|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110546828|NCT00653120|Vasodilator Agents|vasodilator agents|mesh-ancestor
110546829|NCT00678132|Gemcitabine|gemcitabine|mesh-list
110546830|NCT00678132|Olaparib|olaparib|mesh-list
110546831|NCT00678132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110546832|NCT00678132|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110546833|NCT00678132|Antimetabolites|antimetabolites|mesh-ancestor
110546834|NCT00678132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110546835|NCT00678132|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110546836|NCT00678132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110546837|NCT02789345|Osimertinib|osimertinib|mesh-list
110546838|NCT02789345|Ramucirumab|ramucirumab|mesh-list
110546839|NCT02789345|Necitumumab|necitumumab|mesh-list
110397045|NCT01323621|Xhance|xhance|mesh-list
110546840|NCT02789345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110546841|NCT02789345|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110546842|NCT02789345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110546843|NCT02789345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110546844|NCT02789345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110546845|NCT02772965|Methotrexate|methotrexate|mesh-list
110546846|NCT02772965|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110546847|NCT02772965|Abortifacient Agents|abortifacient agents|mesh-ancestor
110546848|NCT02772965|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110397090|NCT01317615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110546849|NCT02772965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110546850|NCT02772965|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110546851|NCT02772965|Antimetabolites|antimetabolites|mesh-ancestor
110546852|NCT02772965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110546853|NCT02772965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110546855|NCT02772965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110546856|NCT02772965|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110546857|NCT02772965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110546858|NCT02772965|Immunologic Factors|immunologic factors|mesh-ancestor
110546859|NCT02772965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110546860|NCT02772965|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110546862|NCT00681720|Antidotes|antidotes|mesh-ancestor
110546863|NCT00681720|Protective Agents|protective agents|mesh-ancestor
110546864|NCT00681720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110546865|NCT00681720|GABA Modulators|gaba modulators|mesh-ancestor
110546866|NCT00681720|GABA Agents|gaba agents|mesh-ancestor
110546867|NCT00681720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110546868|NCT00681720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110546869|NCT00650312|Metformin|metformin|mesh-list
110546870|NCT00650312|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110546871|NCT00650312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110546872|NCT00538681|Pemetrexed|pemetrexed|mesh-list
110546873|NCT00538681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110546874|NCT00538681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110397298|NCT01169350|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110546875|NCT00538681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110546876|NCT00538681|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110546877|NCT00538681|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110546878|NCT00650390|Adalimumab|adalimumab|mesh-list
110546879|NCT00650390|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110546880|NCT00650390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110546881|NCT00650390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110546882|NCT00681876|Bevacizumab|bevacizumab|mesh-list
110546883|NCT00681876|Cetuximab|cetuximab|mesh-list
110546884|NCT00681876|Irinotecan|irinotecan|mesh-list
110546885|NCT00681876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110546886|NCT00681876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110546887|NCT00681876|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110546888|NCT00681876|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110546889|NCT00681876|Growth Substances|growth substances|mesh-ancestor
110546890|NCT00681876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110546891|NCT00681876|Growth Inhibitors|growth inhibitors|mesh-ancestor
110546892|NCT00681876|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110546893|NCT00681876|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110546894|NCT00681876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110546895|NCT00681876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110546896|NCT02226367|Prazosin|prazosin|mesh-list
110397369|NCT01114516|Cefazolin|cefazolin|mesh-list
110546897|NCT02226367|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110546898|NCT02226367|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110546899|NCT02226367|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110546900|NCT02226367|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110546901|NCT02226367|Adrenergic Agents|adrenergic agents|mesh-ancestor
110546902|NCT02226367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110546903|NCT02226367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110546904|NCT02226367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110546905|NCT03885934|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110546906|NCT03885934|Immunologic Factors|immunologic factors|mesh-ancestor
110546907|NCT03885934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110546908|NCT02159989|Aflibercept|aflibercept|mesh-list
110546909|NCT02159989|Endothelial Growth Factors|endothelial growth factors|mesh-list
110546910|NCT02159989|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110546911|NCT02159989|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110546912|NCT02159989|Growth Substances|growth substances|mesh-ancestor
110397493|NCT01077739|Antidotes|antidotes|mesh-ancestor
110546913|NCT02159989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110546914|NCT02159989|Growth Inhibitors|growth inhibitors|mesh-ancestor
110546915|NCT02159989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110546916|NCT02628132|Paclitaxel|paclitaxel|mesh-list
110546917|NCT02628132|Durvalumab|durvalumab|mesh-list
110546918|NCT02628132|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110546919|NCT02628132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110546920|NCT02628132|Tubulin Modulators|tubulin modulators|mesh-ancestor
110546921|NCT02628132|Antimitotic Agents|antimitotic agents|mesh-ancestor
110546922|NCT02628132|Mitosis Modulators|mitosis modulators|mesh-ancestor
110546923|NCT02628132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110546924|NCT02628132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110546925|NCT02695355|Methylphenidate|methylphenidate|mesh-list
110546926|NCT02695355|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110546927|NCT02695355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110546928|NCT02695355|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110546929|NCT02695355|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110546930|NCT02695355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110546931|NCT02695355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110546932|NCT02695355|Dopamine Agents|dopamine agents|mesh-ancestor
110546933|NCT02695355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110546934|NCT02573038|Aflibercept|aflibercept|mesh-list
110546935|NCT02573038|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110546936|NCT02573038|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110397845|NCT04306471|Evolocumab|evolocumab|mesh-list
110546937|NCT02573038|Growth Substances|growth substances|mesh-ancestor
110546938|NCT02573038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110546939|NCT02573038|Growth Inhibitors|growth inhibitors|mesh-ancestor
110546940|NCT02573038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110546941|NCT02159755|Palbociclib|palbociclib|mesh-list
110546942|NCT02159755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110397908|NCT01308567|Hormones|hormones|mesh-ancestor
110546943|NCT02159755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110546944|NCT02159755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110546945|NCT02159755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110546946|NCT01822015|Cytarabine|cytarabine|mesh-list
110546947|NCT01822015|Sirolimus|sirolimus|mesh-list
110546948|NCT01822015|Idarubicin|idarubicin|mesh-list
110397975|NCT01070329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110546949|NCT01822015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110546950|NCT01822015|Antimetabolites|antimetabolites|mesh-ancestor
110546951|NCT01822015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110546952|NCT01822015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110546953|NCT01822015|Antiviral Agents|antiviral agents|mesh-ancestor
110546954|NCT01822015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110546955|NCT01822015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110546956|NCT01822015|Immunologic Factors|immunologic factors|mesh-ancestor
110546957|NCT01822015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110546958|NCT01822015|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110546959|NCT01822015|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110546960|NCT01822015|Antifungal Agents|antifungal agents|mesh-ancestor
110546961|NCT01822015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110546962|NCT01822015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110546963|NCT01822015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110546964|NCT00990535|Octreotide|octreotide|mesh-list
110546965|NCT00990535|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110546966|NCT00990535|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110546967|NCT00990535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110546968|NCT05590897|Anti-Infective Agents|anti-infective agents|mesh-list
110546969|NCT05590897|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110546970|NCT00720304|Docetaxel|docetaxel|mesh-list
110546971|NCT00720304|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110546972|NCT00720304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110398335|NCT00598793|Metformin|metformin|mesh-list
110546973|NCT00720304|Tubulin Modulators|tubulin modulators|mesh-ancestor
110546974|NCT00720304|Antimitotic Agents|antimitotic agents|mesh-ancestor
110546975|NCT00720304|Mitosis Modulators|mitosis modulators|mesh-ancestor
110546976|NCT00720304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110546977|NCT00720304|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110546978|NCT00720304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110546979|NCT00682344|Levobupivacaine|levobupivacaine|mesh-list
110546980|NCT00682344|Anesthetics, Local|anesthetics, local|mesh-ancestor
110546981|NCT00682344|Anesthetics|anesthetics|mesh-ancestor
110546982|NCT00682344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110546983|NCT00682344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110546984|NCT00682344|Sensory System Agents|sensory system agents|mesh-ancestor
110546985|NCT00682344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110546986|NCT00990691|Desipramine|desipramine|mesh-list
110546987|NCT00990691|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110546988|NCT00990691|Antidepressive Agents|antidepressive agents|mesh-ancestor
110546989|NCT00990691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110546990|NCT00990691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110546991|NCT00990691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110546992|NCT00990691|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110398547|NCT05643651|Coagulants|coagulants|mesh-ancestor
110546993|NCT00990691|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110546994|NCT00990691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110546995|NCT00990691|Adrenergic Agents|adrenergic agents|mesh-ancestor
110546996|NCT00990691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110546997|NCT00990691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110546998|NCT00678522|Atorvastatin|atorvastatin|mesh-list
110546999|NCT00678522|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110547000|NCT00678522|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110547001|NCT00678522|Antimetabolites|antimetabolites|mesh-ancestor
110547002|NCT00678522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110547003|NCT00678522|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110398688|NCT02890173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110547004|NCT00678522|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110547005|NCT00678522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110547006|NCT04391855|Dexmedetomidine|dexmedetomidine|mesh-list
110547007|NCT04391855|Tramadol|tramadol|mesh-list
110547008|NCT04391855|Ropivacaine|ropivacaine|mesh-list
110547009|NCT04391855|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110547010|NCT04391855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110547011|NCT04391855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110547012|NCT04391855|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110547013|NCT04391855|Analgesics|analgesics|mesh-ancestor
110547014|NCT04391855|Sensory System Agents|sensory system agents|mesh-ancestor
110547015|NCT04391855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110547016|NCT04391855|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110547017|NCT04391855|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110547018|NCT04391855|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110547019|NCT04391855|Adrenergic Agents|adrenergic agents|mesh-ancestor
110547020|NCT04391855|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110547021|NCT04391855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110547022|NCT04391855|Anesthetics, Local|anesthetics, local|mesh-ancestor
110547023|NCT04391855|Anesthetics|anesthetics|mesh-ancestor
110547024|NCT04391855|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110547025|NCT04391855|Narcotics|narcotics|mesh-ancestor
110547026|NCT00716950|Losartan|losartan|mesh-list
110547027|NCT00716950|Valsartan|valsartan|mesh-list
110547028|NCT00716950|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110547029|NCT00716950|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110547030|NCT00716950|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110547031|NCT00716950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110547032|NCT00716950|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110547033|NCT00711178|Aminolevulinic Acid|aminolevulinic acid|mesh-list
110547034|NCT00711178|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
110547035|NCT00711178|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110547036|NCT00711178|Dermatologic Agents|dermatologic agents|mesh-ancestor
110547037|NCT00678756|Ketoconazole|ketoconazole|mesh-list
110547038|NCT00678756|Antifungal Agents|antifungal agents|mesh-ancestor
110547039|NCT00678756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110547040|NCT00678756|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110547041|NCT00678756|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110547042|NCT00678756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110547043|NCT00678756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110547044|NCT00678756|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110547045|NCT00678756|Hormone Antagonists|hormone antagonists|mesh-ancestor
110547046|NCT00678756|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110547047|NCT00678756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110547048|NCT00678756|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110547049|NCT02748395|Triamcinolone|triamcinolone|mesh-list
110547050|NCT02748395|Lidocaine|lidocaine|mesh-list
110547051|NCT02748395|Anesthetics, Local|anesthetics, local|mesh-ancestor
110547052|NCT02748395|Anesthetics|anesthetics|mesh-ancestor
110547053|NCT02748395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110547054|NCT02748395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110547055|NCT02748395|Sensory System Agents|sensory system agents|mesh-ancestor
110398944|NCT01314911|Oseltamivir|oseltamivir|mesh-list
110547056|NCT02748395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110547057|NCT02748395|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110547058|NCT02748395|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110547059|NCT02748395|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110547060|NCT02748395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110547061|NCT02748395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110547062|NCT02748395|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110547063|NCT02748395|Glucocorticoids|glucocorticoids|mesh-ancestor
110547064|NCT02748395|Hormones|hormones|mesh-ancestor
110547065|NCT02748395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110547066|NCT02629224|Gabapentin|gabapentin|mesh-list
110547067|NCT02629224|Analgesics|analgesics|mesh-ancestor
110547068|NCT02629224|Sensory System Agents|sensory system agents|mesh-ancestor
110547069|NCT02629224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110547070|NCT02629224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110547071|NCT02629224|Anticonvulsants|anticonvulsants|mesh-ancestor
110547072|NCT02629224|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110547073|NCT02629224|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110547074|NCT02629224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110547075|NCT02629224|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110547076|NCT02629224|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110547077|NCT02629224|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110399068|NCT01310777|Brinzolamide|brinzolamide|mesh-list
110547078|NCT02629224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110547079|NCT02629224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110547080|NCT02629224|Antimanic Agents|antimanic agents|mesh-ancestor
110547081|NCT00711256|Sunscreening Agents|sunscreening agents|mesh-list
110547082|NCT00711256|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110547083|NCT00711256|Protective Agents|protective agents|mesh-ancestor
110547084|NCT00711256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110547085|NCT00711256|Dermatologic Agents|dermatologic agents|mesh-ancestor
110547087|NCT04069234|Ticagrelor|ticagrelor|mesh-list
110547088|NCT04069234|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110547089|NCT04069234|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110547090|NCT04069234|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110547091|NCT04069234|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110547092|NCT04069234|Purinergic Agents|purinergic agents|mesh-ancestor
110547093|NCT04069234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110399278|NCT04301557|Immunologic Factors|immunologic factors|mesh-ancestor
110547094|NCT04069234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110547095|NCT04069234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110547096|NCT04374773|Dronabinol|dronabinol|mesh-list
110547097|NCT04374773|Hallucinogens|hallucinogens|mesh-ancestor
110547098|NCT04374773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110547099|NCT04374773|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110547100|NCT04374773|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110547101|NCT04374773|Analgesics|analgesics|mesh-ancestor
110547102|NCT04374773|Sensory System Agents|sensory system agents|mesh-ancestor
110399346|NCT01294683|Niacinamide|niacinamide|mesh-list
110547103|NCT04374773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110178893|NCT01903421|Propofol|propofol|mesh-list
110547104|NCT04374773|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
110547105|NCT04374773|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110547106|NCT04374773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110547107|NCT04374773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110547108|NCT04374773|Hormones|hormones|mesh-ancestor
110560328|NCT00638729|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110547109|NCT04374773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110547110|NCT00720538|Thalidomide|thalidomide|mesh-list
110547111|NCT00720538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110547112|NCT00720538|Immunologic Factors|immunologic factors|mesh-ancestor
110547113|NCT00720538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110547114|NCT00720538|Leprostatic Agents|leprostatic agents|mesh-ancestor
110547115|NCT00720538|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110547116|NCT00720538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110547117|NCT00720538|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110547118|NCT00720538|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110547119|NCT00720538|Growth Substances|growth substances|mesh-ancestor
110547120|NCT00720538|Growth Inhibitors|growth inhibitors|mesh-ancestor
110547121|NCT00720538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110547122|NCT00678990|Heparin|heparin|mesh-list
110547123|NCT00678990|Anticoagulants|anticoagulants|mesh-ancestor
110547124|NCT00678990|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110547125|NCT00678990|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110547126|NCT00678990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110547127|NCT00679068|Bosentan|bosentan|mesh-list
110547128|NCT00679068|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110547129|NCT00679068|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
110547130|NCT00679068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110547131|NCT00679146|Ketoprofen|ketoprofen|mesh-list
110547132|NCT00679146|Colchicine|colchicine|mesh-list
110547133|NCT00679146|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110547134|NCT00679146|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110547135|NCT00679146|Analgesics|analgesics|mesh-ancestor
110547136|NCT00679146|Sensory System Agents|sensory system agents|mesh-ancestor
110547137|NCT00679146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110547138|NCT00679146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110547139|NCT00679146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110547140|NCT00679146|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110547141|NCT00679146|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110547142|NCT00679146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110547143|NCT00679146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110547144|NCT00679146|Gout Suppressants|gout suppressants|mesh-ancestor
110547145|NCT00679146|Tubulin Modulators|tubulin modulators|mesh-ancestor
110547146|NCT00679146|Antimitotic Agents|antimitotic agents|mesh-ancestor
110547147|NCT00679146|Mitosis Modulators|mitosis modulators|mesh-ancestor
110547148|NCT00679146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110547149|NCT00679224|Ambrisentan|ambrisentan|mesh-list
110547150|NCT00679224|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110547151|NCT02748005|Fenugreek seed meal|fenugreek seed meal|mesh-list
110547152|NCT02748005|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110547153|NCT02748005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110547154|NCT00990847|Procaterol|procaterol|mesh-list
110547155|NCT00990847|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110547156|NCT00990847|Autonomic Agents|autonomic agents|mesh-ancestor
110547157|NCT00990847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110547158|NCT00990847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110547159|NCT00990847|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110547160|NCT00990847|Respiratory System Agents|respiratory system agents|mesh-ancestor
110547161|NCT00990847|Sympathomimetics|sympathomimetics|mesh-ancestor
110547162|NCT00990847|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110547163|NCT00990847|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110547164|NCT00990847|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110547165|NCT00990847|Adrenergic Agents|adrenergic agents|mesh-ancestor
110400194|NCT04295317|Capecitabine|capecitabine|mesh-list
110400264|NCT01264965|Analgesics|analgesics|mesh-ancestor
110547166|NCT00990847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110547167|NCT00990847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110400366|NCT01003249|Baclofen|baclofen|mesh-list
110547169|NCT00594516|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110547170|NCT00594516|Narcotics|narcotics|mesh-ancestor
110547171|NCT00594516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110547172|NCT00594516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110547173|NCT00594516|Analgesics|analgesics|mesh-ancestor
110547174|NCT00594516|Sensory System Agents|sensory system agents|mesh-ancestor
110547175|NCT00594516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110547176|NCT00594516|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110547177|NCT00594516|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110400565|NCT04479267|Antiemetics|antiemetics|mesh-ancestor
110547178|NCT00594516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110547179|NCT00594516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110547180|NCT00594516|Adrenergic Agents|adrenergic agents|mesh-ancestor
110547181|NCT00594516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110547182|NCT00682500|Calfactant|calfactant|mesh-list
110547183|NCT00682500|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
110547184|NCT00682500|Respiratory System Agents|respiratory system agents|mesh-ancestor
110547185|NCT00538291|Capecitabine|capecitabine|mesh-list
110547186|NCT00538291|Cetuximab|cetuximab|mesh-list
110547187|NCT00538291|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110547188|NCT00538291|Antimetabolites|antimetabolites|mesh-ancestor
110547189|NCT00538291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110547190|NCT00538291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110547191|NCT00538291|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110547192|NCT00682578|Artesunate|artesunate|mesh-list
110547193|NCT00682578|Chloroquine|chloroquine|mesh-list
110547194|NCT00682578|Pyrimethamine|pyrimethamine|mesh-list
110547195|NCT00682578|Piperaquine|piperaquine|mesh-list
110547196|NCT00682578|Artenimol|artenimol|mesh-list
110547197|NCT00682578|Antimalarials|antimalarials|mesh-ancestor
110547198|NCT00682578|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110547199|NCT00682578|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110547200|NCT00682578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110547201|NCT00682578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110547202|NCT00682578|Antiviral Agents|antiviral agents|mesh-ancestor
110547203|NCT00682578|Schistosomicides|schistosomicides|mesh-ancestor
110547204|NCT00682578|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110547205|NCT00682578|Anthelmintics|anthelmintics|mesh-ancestor
110547206|NCT00682578|Amebicides|amebicides|mesh-ancestor
110547207|NCT00682578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110547208|NCT00682578|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110547209|NCT00682578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110547210|NCT00682578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110547211|NCT00594906|Teriparatide|teriparatide|mesh-list
110401073|NCT01074190|Fentanyl|fentanyl|mesh-list
110547212|NCT00594906|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110547213|NCT00594906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110547214|NCT00594906|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110547215|NCT02745431|Oxytocin|oxytocin|mesh-list
110547216|NCT02745431|Oxytocics|oxytocics|mesh-ancestor
110547217|NCT02745431|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110547218|NCT02745431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110547219|NCT00682656|Azithromycin|azithromycin|mesh-list
110547220|NCT00682656|Meglumine Antimoniate|meglumine antimoniate|mesh-list
110547221|NCT00682656|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110178918|NCT01723839|Rituximab|rituximab|mesh-list
110194818|NCT00202696|Nalmefene|nalmefene|mesh-list
110547222|NCT00682656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110547223|NCT00682656|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110547224|NCT00682656|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110547226|NCT05590117|Fluorouracil|fluorouracil|mesh-list
110547227|NCT05590117|Oxaliplatin|oxaliplatin|mesh-list
110547228|NCT05590117|Pentoxifylline|pentoxifylline|mesh-list
110547229|NCT05590117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110547230|NCT05590117|Antimetabolites|antimetabolites|mesh-ancestor
110547231|NCT05590117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110547232|NCT05590117|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110547233|NCT05590117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110547234|NCT05590117|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110547235|NCT05590117|Immunologic Factors|immunologic factors|mesh-ancestor
110547236|NCT05590117|Antidotes|antidotes|mesh-ancestor
110547237|NCT05590117|Protective Agents|protective agents|mesh-ancestor
110547238|NCT05590117|Vitamin B Complex|vitamin b complex|mesh-ancestor
110547239|NCT05590117|Vitamins|vitamins|mesh-ancestor
110547240|NCT05590117|Micronutrients|micronutrients|mesh-ancestor
110547241|NCT05590117|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110547242|NCT05590117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110547243|NCT05590117|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110547244|NCT05590117|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110547245|NCT05590117|Vasodilator Agents|vasodilator agents|mesh-ancestor
110547246|NCT05590117|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110547247|NCT05590117|Antioxidants|antioxidants|mesh-ancestor
110547248|NCT00636311|Gemcitabine|gemcitabine|mesh-list
110547249|NCT00636311|Bortezomib|bortezomib|mesh-list
110547250|NCT00636311|Vinorelbine|vinorelbine|mesh-list
110547251|NCT00636311|Ifosfamide|ifosfamide|mesh-list
110547252|NCT00636311|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110547253|NCT00636311|Antimetabolites|antimetabolites|mesh-ancestor
110030425|NCT01386255|Baclofen|baclofen|mesh-list
110547254|NCT00636311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110547255|NCT00636311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110547256|NCT00636311|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110547257|NCT00636311|Tubulin Modulators|tubulin modulators|mesh-ancestor
110547258|NCT00636311|Antimitotic Agents|antimitotic agents|mesh-ancestor
110547259|NCT00636311|Mitosis Modulators|mitosis modulators|mesh-ancestor
110401246|NCT01281306|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110547260|NCT00636311|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110547261|NCT00636311|Alkylating Agents|alkylating agents|mesh-ancestor
110547262|NCT00679458|Buprenorphine|buprenorphine|mesh-list
110547263|NCT00679458|Naloxone|naloxone|mesh-list
110547264|NCT00679458|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110547265|NCT00679458|Narcotics|narcotics|mesh-ancestor
110547266|NCT00679458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110547267|NCT00679458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110547268|NCT00679458|Analgesics|analgesics|mesh-ancestor
110547269|NCT00679458|Sensory System Agents|sensory system agents|mesh-ancestor
110401384|NCT01034176|Levofloxacin|levofloxacin|mesh-list
110547270|NCT00679458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110547271|NCT00679458|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110547272|NCT04216511|Autoantibodies|autoantibodies|mesh-list
110547273|NCT04216511|Immunologic Factors|immunologic factors|mesh-ancestor
110547274|NCT04216511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110547275|NCT02747537|Irinotecan|irinotecan|mesh-list
110547276|NCT02747537|Sorafenib|sorafenib|mesh-list
110547277|NCT02747537|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110547278|NCT02747537|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110547279|NCT02747537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110547280|NCT02747537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110547281|NCT02747537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110547282|NCT02747537|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110547283|NCT02747381|Alfacalcidol|alfacalcidol|mesh-list
110547284|NCT02747381|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
110547285|NCT02747381|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110547286|NCT02747381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110547287|NCT02747381|Vitamins|vitamins|mesh-ancestor
110547288|NCT02747381|Micronutrients|micronutrients|mesh-ancestor
110547289|NCT00673218|Omalizumab|omalizumab|mesh-list
110547290|NCT00673218|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110547291|NCT00673218|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110547292|NCT00673218|Respiratory System Agents|respiratory system agents|mesh-ancestor
110547293|NCT00673296|Bevacizumab|bevacizumab|mesh-list
110547294|NCT00673296|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110547295|NCT00673296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110547296|NCT00673296|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110401888|NCT06054529|Vitamins|vitamins|mesh-ancestor
110547297|NCT00673296|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110547298|NCT00673296|Growth Substances|growth substances|mesh-ancestor
110547299|NCT00673296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110547301|NCT04216355|Azacitidine|azacitidine|mesh-list
110547302|NCT04216355|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110547303|NCT04216355|Antimetabolites|antimetabolites|mesh-ancestor
110547304|NCT04216355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110547305|NCT04216355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110547306|NCT04216355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110547307|NCT00683124|Losartan|losartan|mesh-list
110547308|NCT00683124|Nebivolol|nebivolol|mesh-list
110547309|NCT00683124|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110547310|NCT00683124|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110402183|NCT05955924|Niacinamide|niacinamide|mesh-list
110547311|NCT00683124|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110547312|NCT00683124|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110547313|NCT00683124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110547314|NCT00683124|Vasodilator Agents|vasodilator agents|mesh-ancestor
110547315|NCT00683124|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
110547316|NCT00683124|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110547317|NCT00683124|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110547318|NCT00683124|Adrenergic Agents|adrenergic agents|mesh-ancestor
110547319|NCT00683124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110547320|NCT00683124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110547321|NCT02744729|HYNIC-3PRGD(2)|hynic-3prgd(2)|mesh-list
110547322|NCT02744729|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110547323|NCT02744729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110547324|NCT00683202|Aspirin|aspirin|mesh-list
110178978|NCT02993029|Analgesics|analgesics|mesh-ancestor
110547325|NCT00683202|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110547326|NCT00683202|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110547328|NCT00683202|Sensory System Agents|sensory system agents|mesh-ancestor
110547329|NCT00683202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110547330|NCT00683202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110547331|NCT00683202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110547332|NCT00683202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110547333|NCT00683202|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110547334|NCT00683202|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110547335|NCT00683202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110547336|NCT00683202|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110547337|NCT00683202|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110547338|NCT00683202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110547339|NCT00683202|Antipyretics|antipyretics|mesh-ancestor
110547340|NCT00679536|Fludarabine|fludarabine|mesh-list
110547341|NCT00679536|Busulfan|busulfan|mesh-list
110547342|NCT00679536|Thymoglobulin|thymoglobulin|mesh-list
110547343|NCT00679536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110547344|NCT00679536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110547345|NCT00679536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110547346|NCT00679536|Immunologic Factors|immunologic factors|mesh-ancestor
110547347|NCT00679536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110547348|NCT00679536|Alkylating Agents|alkylating agents|mesh-ancestor
110547349|NCT00679536|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110547350|NCT00679536|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110547351|NCT00537979|Ergocalciferols|ergocalciferols|mesh-list
110547352|NCT00537979|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110547353|NCT00537979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110547354|NCT00537979|Vitamins|vitamins|mesh-ancestor
110547355|NCT00537979|Micronutrients|micronutrients|mesh-ancestor
110547356|NCT00537979|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110547357|NCT00679614|Acetaminophen|acetaminophen|mesh-list
110547358|NCT00679614|Tramadol|tramadol|mesh-list
110547359|NCT00679614|Naloxone|naloxone|mesh-list
110547360|NCT00679614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110547361|NCT00679614|Analgesics|analgesics|mesh-ancestor
110547362|NCT00679614|Sensory System Agents|sensory system agents|mesh-ancestor
110547363|NCT00679614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110547364|NCT00679614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110547365|NCT00679614|Antipyretics|antipyretics|mesh-ancestor
110547366|NCT00679614|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110547367|NCT00679614|Narcotics|narcotics|mesh-ancestor
110547368|NCT00679614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110547369|NCT00679614|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110547370|NCT02744417|Bupropion|bupropion|mesh-list
110547371|NCT02744417|Nicotine|nicotine|mesh-list
110547372|NCT02744417|Varenicline|varenicline|mesh-list
110194971|NCT00203788|Risperidone|risperidone|mesh-list
110547373|NCT02744417|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110547374|NCT02744417|Autonomic Agents|autonomic agents|mesh-ancestor
110547375|NCT02744417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110547376|NCT02744417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110547377|NCT02744417|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110547378|NCT02744417|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110547379|NCT02744417|Cholinergic Agents|cholinergic agents|mesh-ancestor
110547380|NCT02744417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110547381|NCT02744417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110547382|NCT02744417|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110547383|NCT02744417|Antidepressive Agents|antidepressive agents|mesh-ancestor
110547384|NCT02744417|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110547385|NCT02744417|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110547386|NCT02744417|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110547387|NCT02744417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110547388|NCT02744417|Dopamine Agents|dopamine agents|mesh-ancestor
110547389|NCT02744417|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110178986|NCT02993029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110403419|NCT04873895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110547390|NCT02744417|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110547391|NCT02744417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110547392|NCT02629146|Fentanyl|fentanyl|mesh-list
110547393|NCT02629146|Midazolam|midazolam|mesh-list
110547394|NCT02629146|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110403638|NCT04448873|Sirolimus|sirolimus|mesh-list
110547395|NCT02629146|Narcotics|narcotics|mesh-ancestor
110547396|NCT02629146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110547397|NCT02629146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110547398|NCT02629146|Analgesics|analgesics|mesh-ancestor
110547399|NCT02629146|Sensory System Agents|sensory system agents|mesh-ancestor
110403835|NCT04277442|Nivolumab|nivolumab|mesh-list
110547400|NCT02629146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110547401|NCT02629146|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110547402|NCT02629146|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110404025|NCT04059224|Trametinib|trametinib|mesh-list
110547403|NCT02629146|Anesthetics, General|anesthetics, general|mesh-ancestor
110547404|NCT02629146|Anesthetics|anesthetics|mesh-ancestor
110547405|NCT02629146|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110547406|NCT02629146|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110547407|NCT02629146|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110547408|NCT02629146|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110547409|NCT02629146|GABA Modulators|gaba modulators|mesh-ancestor
110547410|NCT02629146|GABA Agents|gaba agents|mesh-ancestor
110547411|NCT02629146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110547412|NCT02629146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110547413|NCT02744339|Riociguat|riociguat|mesh-list
110547414|NCT02744339|Enzyme Activators|enzyme activators|mesh-ancestor
110404445|NCT03583710|Cisplatin|cisplatin|mesh-list
110547415|NCT02744339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110547416|NCT00991159|Bococizumab|bococizumab|mesh-list
110547417|NCT00991159|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110547418|NCT00991159|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110547419|NCT00991159|Antimetabolites|antimetabolites|mesh-ancestor
110547420|NCT00991159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110547421|NCT00991159|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110547422|NCT00679770|Tavaborole|tavaborole|mesh-list
110547423|NCT00679770|Antifungal Agents|antifungal agents|mesh-ancestor
110404719|NCT03206047|Poly I-C|poly i-c|mesh-list
110547424|NCT00679770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110547425|NCT02744495|Betamethasone|betamethasone|mesh-list
110547426|NCT02744495|Droperidol|droperidol|mesh-list
110547427|NCT02744495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110547428|NCT02744495|Glucocorticoids|glucocorticoids|mesh-ancestor
110547429|NCT02744495|Hormones|hormones|mesh-ancestor
110547430|NCT02744495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110547431|NCT02744495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110547432|NCT02744495|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110404896|NCT02971501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110547433|NCT02744495|Respiratory System Agents|respiratory system agents|mesh-ancestor
110547434|NCT02744495|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110547435|NCT02744495|Antiemetics|antiemetics|mesh-ancestor
110547436|NCT02744495|Autonomic Agents|autonomic agents|mesh-ancestor
110547437|NCT02744495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110547438|NCT02744495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110547439|NCT02744495|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110547440|NCT02744495|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110547441|NCT02744495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110547442|NCT02744495|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110547443|NCT02744495|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110547444|NCT02744495|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110547445|NCT02744495|Dopamine Agents|dopamine agents|mesh-ancestor
110547446|NCT02744495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110405167|NCT02496663|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110547447|NCT02744495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110547448|NCT00683358|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
110195040|NCT00204061|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110547449|NCT00683358|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110547450|NCT00683358|Immunologic Factors|immunologic factors|mesh-ancestor
110547451|NCT00683358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110547452|NCT00683436|Adipiplon|adipiplon|mesh-list
110547453|NCT00683436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110547454|NCT00683436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110547455|NCT00683436|GABA Agonists|gaba agonists|mesh-ancestor
110547456|NCT00683436|GABA Agents|gaba agents|mesh-ancestor
110547457|NCT00683436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110405240|NCT02298257|Immunoconjugates|immunoconjugates|mesh-list
110547458|NCT00683436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110547459|NCT00683436|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110547460|NCT00683436|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110547461|NCT00683436|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110547462|NCT00989443|Cidofovir|cidofovir|mesh-list
110547463|NCT00989443|Antiviral Agents|antiviral agents|mesh-ancestor
110547464|NCT00989443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110547465|NCT00989443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110547466|NCT00989443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110547467|NCT00683514|Cisplatin|cisplatin|mesh-list
110547468|NCT00683514|Vinorelbine|vinorelbine|mesh-list
110547469|NCT00683514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110547470|NCT00683514|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110547471|NCT00683514|Tubulin Modulators|tubulin modulators|mesh-ancestor
110547472|NCT00683514|Antimitotic Agents|antimitotic agents|mesh-ancestor
110547473|NCT00683514|Mitosis Modulators|mitosis modulators|mesh-ancestor
110547474|NCT00683514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110547475|NCT00683670|Cyclophosphamide|cyclophosphamide|mesh-list
110547476|NCT00683670|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110547477|NCT00683670|Immunologic Factors|immunologic factors|mesh-ancestor
110547478|NCT00683670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110547479|NCT00683670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110547480|NCT00683670|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110547481|NCT00683670|Alkylating Agents|alkylating agents|mesh-ancestor
110547482|NCT00683670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110547483|NCT00683670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110547484|NCT00683670|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110547485|NCT05629325|Buspirone|buspirone|mesh-list
110547486|NCT05629325|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110547487|NCT05629325|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110547488|NCT05629325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110547489|NCT05629325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110547490|NCT05629325|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110547491|NCT05629325|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110547492|NCT05629325|Serotonin Agents|serotonin agents|mesh-ancestor
110547493|NCT05629325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110547494|NCT05629325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110547495|NCT02629380|Hyaluronic Acid|hyaluronic acid|mesh-list
110547496|NCT02629380|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110547497|NCT02629380|Immunologic Factors|immunologic factors|mesh-ancestor
110547498|NCT02629380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110547499|NCT02629380|Viscosupplements|viscosupplements|mesh-ancestor
110405594|NCT00006721|Prednisone|prednisone|mesh-list
110547500|NCT02629380|Protective Agents|protective agents|mesh-ancestor
110547501|NCT02743247|Mycophenolic Acid|mycophenolic acid|mesh-list
110547502|NCT02743247|Tacrolimus|tacrolimus|mesh-list
110547503|NCT02743247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110547504|NCT02743247|Immunologic Factors|immunologic factors|mesh-ancestor
110547505|NCT02743247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110547506|NCT02743247|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110547507|NCT02743247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110547508|NCT02743247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110547509|NCT02743247|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110547510|NCT02743247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110547511|NCT02743247|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110547512|NCT02743247|Antitubercular Agents|antitubercular agents|mesh-ancestor
110547513|NCT02743247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110547514|NCT02743247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110547515|NCT00680160|Tavaborole|tavaborole|mesh-list
110547516|NCT00680160|Antifungal Agents|antifungal agents|mesh-ancestor
110547517|NCT00680160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110547518|NCT00683982|Nitazoxanide|nitazoxanide|mesh-list
110547519|NCT00683982|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110547520|NCT00683982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110547521|NCT02742623|Rivaroxaban|rivaroxaban|mesh-list
110547522|NCT02742623|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110547523|NCT02742623|Antithrombins|antithrombins|mesh-ancestor
110547524|NCT02742623|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110547525|NCT02742623|Protease Inhibitors|protease inhibitors|mesh-ancestor
110547526|NCT02742623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110547527|NCT02742623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110547528|NCT02742623|Anticoagulants|anticoagulants|mesh-ancestor
110547529|NCT00537823|Leucovorin|leucovorin|mesh-list
110547530|NCT00537823|Bevacizumab|bevacizumab|mesh-list
110547531|NCT00537823|Cetuximab|cetuximab|mesh-list
110547532|NCT00537823|Fluorouracil|fluorouracil|mesh-list
110547533|NCT00537823|Oxaliplatin|oxaliplatin|mesh-list
110547534|NCT00537823|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110547535|NCT00537823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110547536|NCT00537823|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110547537|NCT00537823|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110547538|NCT00537823|Growth Substances|growth substances|mesh-ancestor
110547539|NCT00537823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110547540|NCT00537823|Growth Inhibitors|growth inhibitors|mesh-ancestor
110547541|NCT00537823|Antimetabolites|antimetabolites|mesh-ancestor
110547542|NCT00537823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110547543|NCT00537823|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110547544|NCT00537823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110547545|NCT00537823|Immunologic Factors|immunologic factors|mesh-ancestor
110547546|NCT00537823|Antidotes|antidotes|mesh-ancestor
110547547|NCT00537823|Protective Agents|protective agents|mesh-ancestor
110547548|NCT00537823|Vitamin B Complex|vitamin b complex|mesh-ancestor
110547549|NCT00537823|Vitamins|vitamins|mesh-ancestor
110547550|NCT00537823|Micronutrients|micronutrients|mesh-ancestor
110547551|NCT04139928|Magnesium citrate|magnesium citrate|mesh-list
110547552|NCT04139928|Magnesium Oxide|magnesium oxide|mesh-list
110547553|NCT04139928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110547554|NCT04139928|Cathartics|cathartics|mesh-ancestor
110547555|NCT04139928|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110547557|NCT05589025|Eugenol|eugenol|mesh-list
110547558|NCT05589025|Zinc Oxide|zinc oxide|mesh-list
110547559|NCT05589025|Dermatologic Agents|dermatologic agents|mesh-ancestor
110547560|NCT05589025|Sunscreening Agents|sunscreening agents|mesh-ancestor
110547561|NCT05589025|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110547562|NCT05589025|Protective Agents|protective agents|mesh-ancestor
110547563|NCT05589025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110547564|NCT05589025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110547565|NCT02742233|Saxagliptin|saxagliptin|mesh-list
110547566|NCT02742233|Incretins|incretins|mesh-ancestor
110547567|NCT02742233|Hormones|hormones|mesh-ancestor
110547568|NCT02742233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110547569|NCT02742233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110547570|NCT02742233|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110547571|NCT02742233|Protease Inhibitors|protease inhibitors|mesh-ancestor
110547572|NCT02742233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110547573|NCT02742233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110547574|NCT02742233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110547575|NCT00673608|Deferasirox|deferasirox|mesh-list
110547576|NCT00673608|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110547577|NCT00673608|Chelating Agents|chelating agents|mesh-ancestor
110547578|NCT00673608|Sequestering Agents|sequestering agents|mesh-ancestor
110547579|NCT00673608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110547580|NCT00537277|Insulin Aspart|insulin aspart|mesh-list
110547581|NCT00537277|Biphasic Insulins|biphasic insulins|mesh-list
110547582|NCT00537277|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
110547583|NCT00537277|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110547584|NCT00537277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110547586|NCT02742467|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110547587|NCT02742467|Perindopril|perindopril|mesh-list
110547588|NCT02742467|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110547589|NCT02742467|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110547590|NCT02742467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110547591|NCT02742467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110547592|NCT02742467|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110547593|NCT02742467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110547594|NCT02742467|Vasodilator Agents|vasodilator agents|mesh-ancestor
110547595|NCT02742467|Diuretics|diuretics|mesh-ancestor
110547596|NCT02742467|Natriuretic Agents|natriuretic agents|mesh-ancestor
110547597|NCT02742467|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110547598|NCT02742467|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110547599|NCT02742467|Protease Inhibitors|protease inhibitors|mesh-ancestor
110547600|NCT02742467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110547602|NCT00684216|Capecitabine|capecitabine|mesh-list
110547603|NCT00684216|Letrozole|letrozole|mesh-list
110547604|NCT00684216|Anastrozole|anastrozole|mesh-list
110547605|NCT00684216|Exemestane|exemestane|mesh-list
110547606|NCT00684216|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110547607|NCT00684216|Antimetabolites|antimetabolites|mesh-ancestor
110547608|NCT00684216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110547609|NCT00684216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110547610|NCT00684216|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110547611|NCT00684216|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110547612|NCT00684216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110547613|NCT00684216|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110547614|NCT00684216|Hormone Antagonists|hormone antagonists|mesh-ancestor
110547615|NCT00684216|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110547616|NCT00684216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110547617|NCT00684216|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110547618|NCT00684216|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110179041|NCT01466478|Dermatologic Agents|dermatologic agents|mesh-ancestor
110547619|NCT00684216|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110547620|NCT00684216|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110547621|NCT00684450|Protamines|protamines|mesh-list
110547622|NCT00684450|Heparin Antagonists|heparin antagonists|mesh-ancestor
110547623|NCT00684450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110547624|NCT00684450|Coagulants|coagulants|mesh-ancestor
110547625|NCT00684528|Metformin|metformin|mesh-list
110547626|NCT00684528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110547627|NCT00684528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110547628|NCT00684606|Oxytocin|oxytocin|mesh-list
110547629|NCT00684606|Oxytocics|oxytocics|mesh-ancestor
110547630|NCT00684606|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110547631|NCT00684606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110547632|NCT00684372|Leflunomide|leflunomide|mesh-list
110547633|NCT00684372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110547634|NCT00684372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110547635|NCT00684372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110547636|NCT00684372|Immunologic Factors|immunologic factors|mesh-ancestor
110547637|NCT00684372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110547638|NCT00673686|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
110547639|NCT00673686|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110547640|NCT00673686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110547641|NCT04334915|Cenicriviroc|cenicriviroc|mesh-list
110547642|NCT04334915|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
110547643|NCT04334915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110547644|NCT04334915|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110547645|NCT04334915|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110547646|NCT04334915|Antiviral Agents|antiviral agents|mesh-ancestor
110547647|NCT04334915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110547648|NCT00991627|Atropine|atropine|mesh-list
110547649|NCT00991627|Ephedrine|ephedrine|mesh-list
110547650|NCT00991627|Pseudoephedrine|pseudoephedrine|mesh-list
110547651|NCT00991627|Morphine|morphine|mesh-list
110547652|NCT00991627|Bupivacaine|bupivacaine|mesh-list
110547653|NCT00991627|Anesthetics, Local|anesthetics, local|mesh-list
110547654|NCT00991627|Anesthetics|anesthetics|mesh-list
110547655|NCT00991627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110547656|NCT00991627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110547657|NCT00991627|Sensory System Agents|sensory system agents|mesh-ancestor
110547658|NCT00991627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110547659|NCT00991627|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110547660|NCT00991627|Narcotics|narcotics|mesh-ancestor
110547661|NCT00991627|Analgesics|analgesics|mesh-ancestor
110547662|NCT00991627|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110547663|NCT00991627|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110547664|NCT00991627|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110547665|NCT00991627|Autonomic Agents|autonomic agents|mesh-ancestor
110547666|NCT00991627|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110547667|NCT00991627|Respiratory System Agents|respiratory system agents|mesh-ancestor
110547668|NCT00991627|Mydriatics|mydriatics|mesh-ancestor
110547669|NCT00991627|Parasympatholytics|parasympatholytics|mesh-ancestor
110547670|NCT00991627|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110547671|NCT00991627|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110547672|NCT00991627|Cholinergic Agents|cholinergic agents|mesh-ancestor
110547673|NCT00991627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110547674|NCT00991627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110547675|NCT00991627|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110547676|NCT00991627|Sympathomimetics|sympathomimetics|mesh-ancestor
110547678|NCT00991627|Adrenergic Agents|adrenergic agents|mesh-ancestor
110547679|NCT00991627|Nasal Decongestants|nasal decongestants|mesh-ancestor
110547680|NCT03562871|Carboplatin|carboplatin|mesh-list
110547681|NCT03562871|Pembrolizumab|pembrolizumab|mesh-list
110547682|NCT03562871|Pemetrexed|pemetrexed|mesh-list
110547683|NCT03562871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110547684|NCT03562871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110547685|NCT03562871|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110547686|NCT03562871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110547687|NCT03562871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110547688|NCT03562871|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110547689|NCT03562871|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110547690|NCT00690222|Mydriatics|mydriatics|mesh-list
110547691|NCT00690222|Autonomic Agents|autonomic agents|mesh-ancestor
110547692|NCT00690222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110547693|NCT00690222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110547694|NCT02736071|Celecoxib|celecoxib|mesh-list
110547696|NCT02736071|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110547697|NCT02736071|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110547698|NCT02736071|Analgesics|analgesics|mesh-ancestor
110547699|NCT02736071|Sensory System Agents|sensory system agents|mesh-ancestor
110547700|NCT02736071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110547701|NCT02736071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110547702|NCT02736071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110547703|NCT02736071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110547704|NCT02736071|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110547705|NCT02736071|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110547706|NCT02736071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110547707|NCT02736071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110547708|NCT02736071|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110547709|NCT02736071|Narcotics|narcotics|mesh-ancestor
110547710|NCT02736071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110547711|NCT00690300|Docetaxel|docetaxel|mesh-list
110547712|NCT00690300|Oxaliplatin|oxaliplatin|mesh-list
110547713|NCT00690300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110547714|NCT00690300|Tubulin Modulators|tubulin modulators|mesh-ancestor
110547715|NCT00690300|Antimitotic Agents|antimitotic agents|mesh-ancestor
110547716|NCT00690300|Mitosis Modulators|mitosis modulators|mesh-ancestor
110547717|NCT00690300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110547718|NCT02741219|Sufentanil|sufentanil|mesh-list
110547719|NCT02741219|Dexmedetomidine|dexmedetomidine|mesh-list
110547720|NCT02741219|Dsuvia|dsuvia|mesh-list
110547721|NCT02741219|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110547722|NCT02741219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110547723|NCT02741219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110547724|NCT02741219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110547725|NCT02741219|Analgesics|analgesics|mesh-ancestor
110547726|NCT02741219|Sensory System Agents|sensory system agents|mesh-ancestor
110547727|NCT02741219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110547728|NCT02741219|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110547729|NCT02741219|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110547730|NCT02741219|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110547731|NCT02741219|Adrenergic Agents|adrenergic agents|mesh-ancestor
110547732|NCT02741219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110547733|NCT02741219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110547734|NCT02741219|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110547735|NCT02741219|Narcotics|narcotics|mesh-ancestor
110547736|NCT02741219|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110547737|NCT02741219|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110547738|NCT02741219|Anesthetics, General|anesthetics, general|mesh-ancestor
110547739|NCT02741219|Anesthetics|anesthetics|mesh-ancestor
110547740|NCT00690534|Insulin|insulin|mesh-list
110547741|NCT00690534|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110547742|NCT00690534|Nitroprusside|nitroprusside|mesh-list
110547743|NCT00690534|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110547744|NCT00690534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110547745|NCT00690534|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110547746|NCT00690534|Vasodilator Agents|vasodilator agents|mesh-ancestor
110547747|NCT00690534|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
110547748|NCT00690534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110547749|NCT00991705|Atorvastatin|atorvastatin|mesh-list
110547750|NCT00991705|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110547751|NCT00991705|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110547752|NCT00991705|Antimetabolites|antimetabolites|mesh-ancestor
110547753|NCT00991705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110547754|NCT00991705|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110547755|NCT00991705|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110547756|NCT00991705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110547757|NCT02735837|Doxycycline|doxycycline|mesh-list
110547758|NCT02735837|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110547759|NCT02735837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110547760|NCT02735837|Antimalarials|antimalarials|mesh-ancestor
110547761|NCT02735837|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110547762|NCT02735837|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110547763|NCT02625558|Riociguat|riociguat|mesh-list
110547764|NCT02625558|Enzyme Activators|enzyme activators|mesh-ancestor
110547765|NCT02625558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110547766|NCT00685230|Antivenins|antivenins|mesh-list
110547767|NCT00685230|Immunologic Factors|immunologic factors|mesh-ancestor
110547768|NCT00685230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110547769|NCT05455879|Pulmonary Surfactants|pulmonary surfactants|mesh-list
110547770|NCT05455879|Respiratory System Agents|respiratory system agents|mesh-ancestor
110547772|NCT00991783|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110547773|NCT00991783|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110547774|NCT00991783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110547775|NCT00991783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110547776|NCT00991783|Protective Agents|protective agents|mesh-ancestor
110547777|NCT00991783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110547778|NCT00690768|Bevacizumab|bevacizumab|mesh-list
110547779|NCT00690768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110547780|NCT00690768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110547781|NCT00690768|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110547782|NCT00690768|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110547783|NCT00690768|Growth Substances|growth substances|mesh-ancestor
110547784|NCT00690768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110547785|NCT00690768|Growth Inhibitors|growth inhibitors|mesh-ancestor
110547786|NCT00690846|Adalimumab|adalimumab|mesh-list
110547787|NCT00690846|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110547788|NCT00690846|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110547789|NCT00690846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110547790|NCT04683679|Pembrolizumab|pembrolizumab|mesh-list
110547791|NCT04683679|Olaparib|olaparib|mesh-list
110547792|NCT04683679|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110547793|NCT04683679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110547794|NCT04683679|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110547795|NCT04683679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110547796|NCT04683679|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110547797|NCT04683679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110547798|NCT00685464|Abciximab|abciximab|mesh-list
110547799|NCT00685464|Anticoagulants|anticoagulants|mesh-ancestor
110547800|NCT00685464|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110547801|NCT02740829|Glucagon|glucagon|mesh-list
110179108|NCT00009191|Sertraline|sertraline|mesh-list
110547802|NCT02740829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110547803|NCT02740829|Hormones|hormones|mesh-ancestor
110547804|NCT02740829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110547805|NCT02740829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110547806|NCT00685542|Diacerein|diacerein|mesh-list
110547807|NCT00685542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110547808|NCT02741063|Oxytocin|oxytocin|mesh-list
110547809|NCT02741063|Oxytocics|oxytocics|mesh-ancestor
110547810|NCT02741063|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110547811|NCT02741063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110547812|NCT04138836|Itraconazole|itraconazole|mesh-list
110547813|NCT04138836|Midazolam|midazolam|mesh-list
110547814|NCT04138836|Esomeprazole|esomeprazole|mesh-list
110547815|NCT04138836|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110547816|NCT04138836|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110547817|NCT04138836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110547818|NCT04138836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110547819|NCT04138836|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110547820|NCT04138836|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110547821|NCT04138836|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110547822|NCT04138836|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110547823|NCT04138836|Anesthetics, General|anesthetics, general|mesh-ancestor
110547824|NCT04138836|Anesthetics|anesthetics|mesh-ancestor
110547825|NCT04138836|GABA Modulators|gaba modulators|mesh-ancestor
110547826|NCT04138836|GABA Agents|gaba agents|mesh-ancestor
110547827|NCT04138836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110547828|NCT04138836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110547830|NCT04138836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110547831|NCT04138836|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110547832|NCT04138836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110547833|NCT04138836|Antifungal Agents|antifungal agents|mesh-ancestor
110547834|NCT04138836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110547835|NCT04138836|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110547836|NCT04138836|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110547837|NCT04138836|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110547838|NCT04138836|Hormone Antagonists|hormone antagonists|mesh-ancestor
110547839|NCT04138836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110547840|NCT04138836|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110547841|NCT00922584|Sorafenib|sorafenib|mesh-list
110547842|NCT00922584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110547843|NCT00922584|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110547844|NCT00922584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110547845|NCT00922584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110547847|NCT02735603|Naltrexone|naltrexone|mesh-list
110547848|NCT02735603|Bupropion|bupropion|mesh-list
110547849|NCT02735603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110547850|NCT02735603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110547851|NCT02735603|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110547852|NCT02735603|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110547853|NCT02735603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110547854|NCT02735603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110547855|NCT02735603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110547856|NCT02735603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110547857|NCT02735603|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110547858|NCT02735603|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110547859|NCT02735603|Sensory System Agents|sensory system agents|mesh-ancestor
110547860|NCT02735603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110547861|NCT02735603|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110547862|NCT02735603|Antidepressive Agents|antidepressive agents|mesh-ancestor
110547863|NCT02735603|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110547864|NCT02735603|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110547865|NCT02735603|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110547866|NCT02735603|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110547867|NCT02735603|Dopamine Agents|dopamine agents|mesh-ancestor
110547868|NCT02735603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110547869|NCT02735603|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110547870|NCT02735603|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110547871|NCT00685776|Anacetrapib|anacetrapib|mesh-list
110547872|NCT00685776|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110547873|NCT00685776|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110547874|NCT00685776|Antimetabolites|antimetabolites|mesh-ancestor
110547875|NCT00685776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110547876|NCT00685776|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110547877|NCT00685854|Ranibizumab|ranibizumab|mesh-list
110547878|NCT00685854|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110547879|NCT00685854|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110547880|NCT00685854|Growth Substances|growth substances|mesh-ancestor
110547881|NCT00685854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110547882|NCT00685854|Growth Inhibitors|growth inhibitors|mesh-ancestor
110547883|NCT00685854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110547884|NCT04138368|Psychotropic Drugs|psychotropic drugs|mesh-list
110547885|NCT04138290|Antidepressive Agents|antidepressive agents|mesh-list
110547886|NCT04138290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110547887|NCT04003207|Hormones|hormones|mesh-list
110547888|NCT04003207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110547889|NCT04003207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110547890|NCT05295355|Bromides|bromides|mesh-list
110547891|NCT05295355|Tiotropium Bromide|tiotropium bromide|mesh-list
110547892|NCT05295355|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110547893|NCT05295355|Autonomic Agents|autonomic agents|mesh-ancestor
110547894|NCT05295355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110547895|NCT05295355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110547896|NCT05295355|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110547897|NCT05295355|Respiratory System Agents|respiratory system agents|mesh-ancestor
110547898|NCT05295355|Parasympatholytics|parasympatholytics|mesh-ancestor
110547899|NCT05295355|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110547900|NCT05295355|Cholinergic Agents|cholinergic agents|mesh-ancestor
110547901|NCT05295355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110547902|NCT05295355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110547903|NCT05295355|Anticonvulsants|anticonvulsants|mesh-ancestor
110547904|NCT01564303|Acetylcysteine|acetylcysteine|mesh-list
110547905|NCT01564303|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110547906|NCT01564303|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
110547907|NCT01564303|Antiviral Agents|antiviral agents|mesh-ancestor
110547908|NCT01564303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110547909|NCT01564303|Expectorants|expectorants|mesh-ancestor
110547910|NCT01564303|Respiratory System Agents|respiratory system agents|mesh-ancestor
110547911|NCT01564303|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110547912|NCT01564303|Antioxidants|antioxidants|mesh-ancestor
110547913|NCT01564303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110547914|NCT01564303|Protective Agents|protective agents|mesh-ancestor
110547915|NCT01564303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110547917|NCT01564303|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110547918|NCT01564303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110547919|NCT00674232|Misoprostol|misoprostol|mesh-list
110547920|NCT00674232|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110547921|NCT00674232|Abortifacient Agents|abortifacient agents|mesh-ancestor
110547922|NCT00674232|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110547923|NCT00674232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110547924|NCT00674232|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110179129|NCT00009230|Analgesics|analgesics|mesh-ancestor
110547925|NCT00674232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110547926|NCT00674232|Oxytocics|oxytocics|mesh-ancestor
110547927|NCT00674310|Ropinirole|ropinirole|mesh-list
110547928|NCT00674310|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110547929|NCT00674310|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110547930|NCT00674310|Dopamine Agonists|dopamine agonists|mesh-ancestor
110547931|NCT00674310|Dopamine Agents|dopamine agents|mesh-ancestor
110547932|NCT00674310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110547933|NCT00674310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110547934|NCT00674310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110547935|NCT00686010|Dalcetrapib|dalcetrapib|mesh-list
110547936|NCT00686010|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110547937|NCT00686010|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110547938|NCT00686010|Antimetabolites|antimetabolites|mesh-ancestor
110547939|NCT00686010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110547940|NCT00686010|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110547941|NCT05265247|Esomeprazole|esomeprazole|mesh-list
110547942|NCT05265247|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110547943|NCT05265247|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110547944|NCT05265247|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110547945|NCT05265247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110547946|NCT05265247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110547947|NCT03823300|Aflibercept|aflibercept|mesh-list
110547948|NCT03823300|Faricimab|faricimab|mesh-list
110547949|NCT03823300|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110547950|NCT03823300|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110547951|NCT03823300|Growth Substances|growth substances|mesh-ancestor
110547952|NCT03823300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110547953|NCT03823300|Growth Inhibitors|growth inhibitors|mesh-ancestor
110547954|NCT03823300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110547955|NCT00537745|Naltrexone|naltrexone|mesh-list
110031474|NCT01392534|Diuretics|diuretics|mesh-ancestor
110547956|NCT00537745|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110547957|NCT00537745|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110547958|NCT00537745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110547959|NCT00537745|Sensory System Agents|sensory system agents|mesh-ancestor
110547960|NCT00537745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110547961|NCT00686322|Paclitaxel|paclitaxel|mesh-list
110547962|NCT00686322|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110547963|NCT00686322|Cisplatin|cisplatin|mesh-list
110547964|NCT00686322|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110547965|NCT00686322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110547966|NCT00686322|Tubulin Modulators|tubulin modulators|mesh-ancestor
110547967|NCT00686322|Antimitotic Agents|antimitotic agents|mesh-ancestor
110547968|NCT00686322|Mitosis Modulators|mitosis modulators|mesh-ancestor
110547969|NCT00686322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110547970|NCT02734511|Propofol|propofol|mesh-list
110547971|NCT02734511|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110547972|NCT02734511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110547973|NCT02734511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110547974|NCT02734511|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110547975|NCT02734511|Anesthetics, General|anesthetics, general|mesh-ancestor
110547976|NCT02734511|Anesthetics|anesthetics|mesh-ancestor
110547977|NCT04003441|Fexuprazan|fexuprazan|mesh-list
110547978|NCT04003441|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110547979|NCT02739815|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110547980|NCT02739815|Tranexamic Acid|tranexamic acid|mesh-list
110547981|NCT02739815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110547982|NCT02739815|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110547983|NCT02739815|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110547984|NCT02739815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110547985|NCT02739815|Hemostatics|hemostatics|mesh-ancestor
110547986|NCT02739815|Coagulants|coagulants|mesh-ancestor
110547987|NCT00720616|Insulin|insulin|mesh-list
110547988|NCT00720616|Hormones|hormones|mesh-list
110547989|NCT00720616|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110547990|NCT00720616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110547991|NCT00720616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110547992|NCT00720772|Sodium thiosulfate|sodium thiosulfate|mesh-list
110547993|NCT00720772|Antidotes|antidotes|mesh-ancestor
110547994|NCT00720772|Protective Agents|protective agents|mesh-ancestor
110547995|NCT00720772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110547996|NCT00720772|Antioxidants|antioxidants|mesh-ancestor
110547997|NCT00720772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110547998|NCT00720772|Antitubercular Agents|antitubercular agents|mesh-ancestor
110547999|NCT00720772|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110548000|NCT00720772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110548001|NCT00720772|Chelating Agents|chelating agents|mesh-ancestor
110548002|NCT00720772|Sequestering Agents|sequestering agents|mesh-ancestor
110548003|NCT00720850|Lenalidomide|lenalidomide|mesh-list
110548004|NCT00720850|Immunologic Factors|immunologic factors|mesh-ancestor
110548005|NCT00720850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110548006|NCT00720850|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110548007|NCT00720850|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110548008|NCT00720850|Growth Substances|growth substances|mesh-ancestor
110548009|NCT00720850|Growth Inhibitors|growth inhibitors|mesh-ancestor
110548010|NCT00720850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110548011|NCT03785158|Melatonin|melatonin|mesh-list
110548012|NCT03785158|Antioxidants|antioxidants|mesh-ancestor
110548013|NCT03785158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110548014|NCT03785158|Protective Agents|protective agents|mesh-ancestor
110548015|NCT03785158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110548016|NCT03785158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110548017|NCT02739581|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
110548018|NCT02739581|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110548019|NCT02739581|Adrenergic Agents|adrenergic agents|mesh-ancestor
110548020|NCT02739581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110548021|NCT02739581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110179167|NCT00009698|Interleukin-2|interleukin-2|mesh-list
110179170|NCT00009698|Analgesics|analgesics|mesh-ancestor
110548022|NCT02739581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110548023|NCT02733809|Sorafenib|sorafenib|mesh-list
110548024|NCT02733809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110548025|NCT02733809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110548026|NCT02733809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110548027|NCT02733809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110548028|NCT00717340|Paclitaxel|paclitaxel|mesh-list
110548029|NCT00717340|Tivozanib|tivozanib|mesh-list
110548030|NCT00717340|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110548031|NCT00717340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110548032|NCT00717340|Tubulin Modulators|tubulin modulators|mesh-ancestor
110548033|NCT00717340|Antimitotic Agents|antimitotic agents|mesh-ancestor
110548034|NCT00717340|Mitosis Modulators|mitosis modulators|mesh-ancestor
110548035|NCT00717340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110548036|NCT00717340|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110548037|NCT00717340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110548038|NCT02733887|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110548039|NCT02733887|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110548040|NCT02733887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110548041|NCT00874848|Paclitaxel|paclitaxel|mesh-list
110548042|NCT00874848|Carboplatin|carboplatin|mesh-list
110548043|NCT00874848|Cetuximab|cetuximab|mesh-list
110548044|NCT00874848|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110548045|NCT00874848|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110548046|NCT00874848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110548047|NCT00874848|Tubulin Modulators|tubulin modulators|mesh-ancestor
110548048|NCT00874848|Antimitotic Agents|antimitotic agents|mesh-ancestor
110548049|NCT00874848|Mitosis Modulators|mitosis modulators|mesh-ancestor
110548050|NCT00874848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110548051|NCT00874848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110548052|NCT00691236|Zoledronic Acid|zoledronic acid|mesh-list
110548053|NCT00691236|Doxorubicin|doxorubicin|mesh-list
110548054|NCT00691236|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110548056|NCT00691236|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110548057|NCT00691236|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110343815|NCT06022588|Histamine Agents|histamine agents|mesh-ancestor
110548059|NCT00691236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110548060|NCT00691236|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110548061|NCT00691236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110548063|NCT04137978|Diuretics|diuretics|mesh-ancestor
110548064|NCT04137978|Natriuretic Agents|natriuretic agents|mesh-ancestor
110548065|NCT04137978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110548066|NCT04137978|Expectorants|expectorants|mesh-ancestor
110548067|NCT04137978|Respiratory System Agents|respiratory system agents|mesh-ancestor
110548068|NCT00691392|Linezolid|linezolid|mesh-list
110548069|NCT00691392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110548070|NCT00691392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110548071|NCT00691392|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110548072|NCT00691392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110548073|NCT00691392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110548074|NCT02625168|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110548075|NCT02625168|Afatinib|afatinib|mesh-list
110548076|NCT02625168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110548077|NCT02625168|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110548078|NCT02625168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110548079|NCT02625168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110548080|NCT00717730|Vitamins|vitamins|mesh-list
110548081|NCT00717730|Folic Acid|folic acid|mesh-list
110548082|NCT00717730|Hydroxocobalamin|hydroxocobalamin|mesh-list
110548083|NCT00717730|Vitamin B 12|vitamin b 12|mesh-list
110548084|NCT00717730|Vitamin B Complex|vitamin b complex|mesh-list
110548085|NCT00717730|Micronutrients|micronutrients|mesh-ancestor
110548087|NCT00717730|Hematinics|hematinics|mesh-ancestor
110548088|NCT00691470|Warfarin|warfarin|mesh-list
110548089|NCT00691470|Anticoagulants|anticoagulants|mesh-ancestor
110548090|NCT05407597|Icatibant|icatibant|mesh-list
110548091|NCT05407597|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110548092|NCT05407597|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110548093|NCT05407597|Analgesics|analgesics|mesh-ancestor
110548094|NCT05407597|Sensory System Agents|sensory system agents|mesh-ancestor
110548095|NCT05407597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110548096|NCT05407597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110548097|NCT05407597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110548098|NCT05407597|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110548099|NCT05407597|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
110548100|NCT05407597|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
110548101|NCT05407597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110548102|NCT05407597|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
110548103|NCT05407597|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110548104|NCT05407597|Immunologic Factors|immunologic factors|mesh-ancestor
110548105|NCT05407207|Immunologic Factors|immunologic factors|mesh-list
110548106|NCT05407207|Immunomodulating Agents|immunomodulating agents|mesh-list
110548107|NCT05407207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110548108|NCT05493995|Paclitaxel|paclitaxel|mesh-list
110548109|NCT05493995|Gemcitabine|gemcitabine|mesh-list
110548110|NCT05493995|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110548111|NCT05493995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110548112|NCT05493995|Tubulin Modulators|tubulin modulators|mesh-ancestor
110548113|NCT05493995|Antimitotic Agents|antimitotic agents|mesh-ancestor
110548114|NCT05493995|Mitosis Modulators|mitosis modulators|mesh-ancestor
110548115|NCT05493995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110548116|NCT05493995|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110548117|NCT05493995|Antimetabolites|antimetabolites|mesh-ancestor
110548118|NCT00717808|Tranilast|tranilast|mesh-list
110548119|NCT00717808|Anthranilic acid|anthranilic acid|mesh-list
110548120|NCT00717808|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110548121|NCT00717808|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110548122|NCT00717808|Analgesics|analgesics|mesh-ancestor
110548123|NCT00717808|Sensory System Agents|sensory system agents|mesh-ancestor
110548124|NCT00717808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110548125|NCT00717808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110548126|NCT00717808|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110312530|NCT00325962|Verapamil|verapamil|mesh-list
110548128|NCT00717808|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110548129|NCT00717808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110548130|NCT00717808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110548131|NCT00717808|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110548132|NCT00717808|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110548133|NCT00717808|Histamine Antagonists|histamine antagonists|mesh-ancestor
110548134|NCT00717808|Histamine Agents|histamine agents|mesh-ancestor
110548135|NCT00717808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110548136|NCT00717808|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110548137|NCT00717808|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110548138|NCT00717808|Anticonvulsants|anticonvulsants|mesh-ancestor
110548139|NCT02738177|Isosorbide|isosorbide|mesh-list
110548140|NCT02738177|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
110548141|NCT02738177|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
110548142|NCT02738177|Misoprostol|misoprostol|mesh-list
110548143|NCT02738177|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110548144|NCT02738177|Abortifacient Agents|abortifacient agents|mesh-ancestor
110548145|NCT02738177|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110548146|NCT02738177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110548147|NCT02738177|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110548148|NCT02738177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110548149|NCT02738177|Oxytocics|oxytocics|mesh-ancestor
110548150|NCT02738177|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110548151|NCT02738177|Diuretics|diuretics|mesh-ancestor
110548152|NCT02738177|Natriuretic Agents|natriuretic agents|mesh-ancestor
110548153|NCT02738177|Vasodilator Agents|vasodilator agents|mesh-ancestor
110548154|NCT02738177|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
110548155|NCT02738177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110548156|NCT04043806|Ivacaftor|ivacaftor|mesh-list
110548157|NCT04043806|Elexacaftor|elexacaftor|mesh-list
110548158|NCT04043806|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
110548159|NCT04043806|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110548160|NCT04043806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110548161|NCT02737943|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110548162|NCT02737943|Analgesics|analgesics|mesh-list
110548163|NCT02737943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110548164|NCT02737943|Sensory System Agents|sensory system agents|mesh-ancestor
110548165|NCT02737943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110548166|NCT02737943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110548167|NCT05290753|Erythromycin|erythromycin|mesh-list
110548168|NCT05290753|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110548169|NCT05290753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110548170|NCT05290753|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110548171|NCT05290753|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110548172|NCT05290753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110548173|NCT05290753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110548174|NCT02737709|Paclitaxel|paclitaxel|mesh-list
110548175|NCT02737709|Carboplatin|carboplatin|mesh-list
110548176|NCT02737709|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110548177|NCT02737709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110548178|NCT02737709|Tubulin Modulators|tubulin modulators|mesh-ancestor
110548179|NCT02737709|Antimitotic Agents|antimitotic agents|mesh-ancestor
110548180|NCT02737709|Mitosis Modulators|mitosis modulators|mesh-ancestor
110548181|NCT02737709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110548182|NCT02572960|Vitamin D|vitamin d|mesh-list
110548183|NCT02572960|Cholecalciferol|cholecalciferol|mesh-list
110548184|NCT02572960|Valsartan|valsartan|mesh-list
110548185|NCT02572960|Vitamins|vitamins|mesh-ancestor
110548186|NCT02572960|Micronutrients|micronutrients|mesh-ancestor
110548187|NCT02572960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110548188|NCT02572960|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110548189|NCT02572960|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110548190|NCT02572960|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110548191|NCT02572960|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110548192|NCT02572960|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110548193|NCT02572960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110179231|NCT01465815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110548194|NCT04001959|Fluorides|fluorides|mesh-list
110548195|NCT04001959|Cariostatic Agents|cariostatic agents|mesh-ancestor
110548196|NCT04001959|Protective Agents|protective agents|mesh-ancestor
110548197|NCT04001959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110548198|NCT00721240|Montelukast|montelukast|mesh-list
110548199|NCT00721240|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110548200|NCT00721240|Respiratory System Agents|respiratory system agents|mesh-ancestor
110195795|NCT00208273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110548201|NCT00721240|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110548202|NCT00721240|Hormone Antagonists|hormone antagonists|mesh-ancestor
110548203|NCT00721240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110548204|NCT00721240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110548205|NCT00721240|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110548206|NCT00721240|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110548207|NCT00721240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110548208|NCT02737319|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110548209|NCT02737319|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110548210|NCT02737319|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110548211|NCT02737319|Antimetabolites|antimetabolites|mesh-ancestor
110548212|NCT02737319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110548213|NCT02737319|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110548214|NCT02737319|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110548215|NCT02737319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110548216|NCT00721552|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110548218|NCT00721552|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110548219|NCT00721552|Methylprednisolone|methylprednisolone|mesh-list
110548220|NCT00721552|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110548221|NCT00721552|Prednisolone acetate|prednisolone acetate|mesh-list
110548222|NCT00721552|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110548223|NCT00721552|Prednisolone phosphate|prednisolone phosphate|mesh-list
110548224|NCT00721552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110548225|NCT00721552|Glucocorticoids|glucocorticoids|mesh-ancestor
110548227|NCT00721552|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110548228|NCT00721552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110548229|NCT00721552|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110548230|NCT00721552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110548231|NCT00721552|Antiemetics|antiemetics|mesh-ancestor
110548232|NCT00721552|Autonomic Agents|autonomic agents|mesh-ancestor
110548233|NCT00721552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110548234|NCT00721552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110548235|NCT00721552|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110548236|NCT00721552|Protective Agents|protective agents|mesh-ancestor
110548237|NCT00721552|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110548238|NCT00721552|Incretins|incretins|mesh-ancestor
110548239|NCT00721552|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110548240|NCT00721552|Protease Inhibitors|protease inhibitors|mesh-ancestor
110548241|NCT00721552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110548242|NCT00721552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110548243|NCT04069078|Scopolamine|scopolamine|mesh-list
110548244|NCT04069078|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
110548245|NCT04069078|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110548246|NCT04069078|Antiemetics|antiemetics|mesh-ancestor
110548247|NCT04069078|Autonomic Agents|autonomic agents|mesh-ancestor
110548248|NCT04069078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110548249|NCT04069078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110548250|NCT04069078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110548251|NCT04069078|Mydriatics|mydriatics|mesh-ancestor
110548252|NCT04069078|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110548253|NCT04069078|Cholinergic Agents|cholinergic agents|mesh-ancestor
110548254|NCT04069078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110031549|NCT01392833|Hormones|hormones|mesh-ancestor
110548255|NCT04069078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110548256|NCT04069078|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110548257|NCT04069078|Parasympatholytics|parasympatholytics|mesh-ancestor
110548258|NCT02732249|Metronidazole|metronidazole|mesh-list
110548259|NCT02732249|Clarithromycin|clarithromycin|mesh-list
110548260|NCT02732249|Potassium Citrate|potassium citrate|mesh-list
110548261|NCT02732249|Esomeprazole|esomeprazole|mesh-list
110548263|NCT02732249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110548264|NCT02732249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110548265|NCT02732249|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110548266|NCT02732249|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110548267|NCT02732249|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110548268|NCT02732249|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110548269|NCT02732249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110548270|NCT02732249|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110548271|NCT02732249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110548272|NCT02732249|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110548273|NCT02732249|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110548274|NCT02732249|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110548275|NCT02732249|Antacids|antacids|mesh-ancestor
110548276|NCT02732249|Diuretics|diuretics|mesh-ancestor
110548277|NCT02732249|Natriuretic Agents|natriuretic agents|mesh-ancestor
110548278|NCT02732249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110548279|NCT02732249|Expectorants|expectorants|mesh-ancestor
110548280|NCT02732249|Respiratory System Agents|respiratory system agents|mesh-ancestor
110548281|NCT04561063|Sofosbuvir|sofosbuvir|mesh-list
110548282|NCT04561063|Nitazoxanide|nitazoxanide|mesh-list
110548283|NCT04561063|Antiviral Agents|antiviral agents|mesh-ancestor
110548284|NCT04561063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110548285|NCT04561063|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110548286|NCT02732093|Lidocaine|lidocaine|mesh-list
110548287|NCT02732093|Anesthetics, Local|anesthetics, local|mesh-ancestor
110548288|NCT02732093|Anesthetics|anesthetics|mesh-ancestor
110548289|NCT02732093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110548290|NCT02732093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110548291|NCT02732093|Sensory System Agents|sensory system agents|mesh-ancestor
110548292|NCT02732093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110548293|NCT02732093|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110548294|NCT02732093|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110548295|NCT02732093|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110548296|NCT02732093|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110548297|NCT02732093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110548298|NCT00718276|Vitamin D|vitamin d|mesh-list
110548299|NCT00718276|Cholecalciferol|cholecalciferol|mesh-list
110548300|NCT00718276|Vitamins|vitamins|mesh-ancestor
110548301|NCT00718276|Micronutrients|micronutrients|mesh-ancestor
110548302|NCT00718276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110548303|NCT00718276|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110548304|NCT00718276|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110548305|NCT00718354|Cisplatin|cisplatin|mesh-list
110548306|NCT00718354|Carboplatin|carboplatin|mesh-list
110548307|NCT00718354|Fluorouracil|fluorouracil|mesh-list
110548308|NCT00718354|Capecitabine|capecitabine|mesh-list
110548309|NCT00718354|Oxaliplatin|oxaliplatin|mesh-list
110548310|NCT00718354|Epirubicin|epirubicin|mesh-list
110548311|NCT00718354|Enoxaparin|enoxaparin|mesh-list
110548312|NCT00718354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110548313|NCT00718354|Antimetabolites|antimetabolites|mesh-ancestor
110548314|NCT00718354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110548315|NCT00718354|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110548316|NCT00718354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110548317|NCT00718354|Immunologic Factors|immunologic factors|mesh-ancestor
110548318|NCT00718354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110548319|NCT00718354|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110548320|NCT00718354|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110548321|NCT00718354|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110548322|NCT00718354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110548323|NCT00718354|Anticoagulants|anticoagulants|mesh-ancestor
110548325|NCT00718354|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110548327|NCT00536809|Oxaliplatin|oxaliplatin|mesh-list
110548328|NCT00536809|Lapatinib|lapatinib|mesh-list
110548329|NCT00536809|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110548330|NCT00536809|Antimetabolites|antimetabolites|mesh-ancestor
110548331|NCT00536809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110548332|NCT00536809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110548333|NCT00536809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110548334|NCT00536809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110548335|NCT04189601|Complement System Proteins|complement system proteins|mesh-list
110548336|NCT04189601|Immunologic Factors|immunologic factors|mesh-ancestor
110548337|NCT04189601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110548338|NCT04067986|Apatinib|apatinib|mesh-list
110548339|NCT04067986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110548340|NCT04067986|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110548341|NCT04067986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110548342|NCT04067986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110548343|NCT00536731|Budesonide|budesonide|mesh-list
110548344|NCT00536731|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
110548345|NCT00536731|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110548346|NCT00536731|Respiratory System Agents|respiratory system agents|mesh-ancestor
110548347|NCT00536731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110548348|NCT00536731|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110548349|NCT00536731|Autonomic Agents|autonomic agents|mesh-ancestor
110548350|NCT00536731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110548351|NCT00536731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110548352|NCT00536731|Glucocorticoids|glucocorticoids|mesh-ancestor
110548353|NCT00536731|Hormones|hormones|mesh-ancestor
110548354|NCT00536731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110548355|NCT02571712|Timolol|timolol|mesh-list
110548356|NCT02571712|Bimatoprost|bimatoprost|mesh-list
110548357|NCT02571712|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110548358|NCT02571712|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110548359|NCT02571712|Adrenergic Agents|adrenergic agents|mesh-ancestor
110548360|NCT02571712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110548361|NCT02571712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110548362|NCT02571712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110548363|NCT02571712|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110548364|NCT02571712|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110548365|NCT02730845|Dexmedetomidine|dexmedetomidine|mesh-list
110548366|NCT02730845|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110548367|NCT02730845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110548368|NCT02730845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110548369|NCT02730845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110548370|NCT02730845|Analgesics|analgesics|mesh-ancestor
110548371|NCT02730845|Sensory System Agents|sensory system agents|mesh-ancestor
110548372|NCT02730845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110548373|NCT02730845|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110548374|NCT02730845|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110548375|NCT02730845|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110548376|NCT02730845|Adrenergic Agents|adrenergic agents|mesh-ancestor
110548377|NCT02730845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110548378|NCT02730845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110548379|NCT02730689|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110548380|NCT02730689|Ezetimibe|ezetimibe|mesh-list
110548381|NCT02730689|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110548382|NCT02730689|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110548383|NCT02730689|Antimetabolites|antimetabolites|mesh-ancestor
110548384|NCT02730689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110548385|NCT02730689|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110179263|NCT00009971|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110548386|NCT02730689|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110548388|NCT03579316|Olaparib|olaparib|mesh-list
110548389|NCT03579316|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
110548390|NCT03579316|Adavosertib|adavosertib|mesh-list
110548391|NCT03579316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110548392|NCT03579316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110548393|NCT03579316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110548394|NCT02730533|Esomeprazole|esomeprazole|mesh-list
110548395|NCT02730533|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110548396|NCT02730533|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110548397|NCT02730533|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110548398|NCT02730533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110548399|NCT02730533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110548400|NCT00536575|Bortezomib|bortezomib|mesh-list
110548401|NCT00536575|Sorafenib|sorafenib|mesh-list
110548402|NCT00536575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110548403|NCT00536575|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110548404|NCT00536575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110548405|NCT00536575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110548406|NCT00712114|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
110548407|NCT00712114|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110548408|NCT00712114|Immunologic Factors|immunologic factors|mesh-ancestor
110548409|NCT00712114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110548410|NCT03214250|Paclitaxel|paclitaxel|mesh-list
110548411|NCT03214250|Gemcitabine|gemcitabine|mesh-list
110548412|NCT03214250|Nivolumab|nivolumab|mesh-list
110548413|NCT03214250|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110548414|NCT03214250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110548415|NCT03214250|Tubulin Modulators|tubulin modulators|mesh-ancestor
110548416|NCT03214250|Antimitotic Agents|antimitotic agents|mesh-ancestor
110548417|NCT03214250|Mitosis Modulators|mitosis modulators|mesh-ancestor
110548418|NCT03214250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110548419|NCT03214250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110548420|NCT03214250|Antimetabolites|antimetabolites|mesh-ancestor
110548421|NCT03214250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110548422|NCT03214250|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110548423|NCT00722098|Cyclophosphamide|cyclophosphamide|mesh-list
110548425|NCT00722098|Immunologic Factors|immunologic factors|mesh-ancestor
110548426|NCT00722098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110548427|NCT00722098|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110548428|NCT00722098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110548429|NCT00722098|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110548430|NCT00722098|Alkylating Agents|alkylating agents|mesh-ancestor
110548431|NCT00722098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110548432|NCT00722098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110548433|NCT00722098|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110548435|NCT04186871|Branebrutinib|branebrutinib|mesh-list
110548436|NCT04186871|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110548437|NCT04186871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110548438|NCT04186871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110548439|NCT04186871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110548440|NCT04186871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110548441|NCT04186871|Immunologic Factors|immunologic factors|mesh-ancestor
110548442|NCT04186871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110548443|NCT04186871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110548444|NCT04186871|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110548445|NCT04186871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110548446|NCT05245591|Pentosan Sulfuric Polyester|pentosan sulfuric polyester|mesh-list
110548447|NCT05245591|Anticoagulants|anticoagulants|mesh-ancestor
110548448|NCT00992095|Buprenorphine|buprenorphine|mesh-list
110548449|NCT00992095|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110548450|NCT00992095|Narcotics|narcotics|mesh-ancestor
110548451|NCT00992095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110548452|NCT00992095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110548453|NCT00992095|Analgesics|analgesics|mesh-ancestor
110548454|NCT00992095|Sensory System Agents|sensory system agents|mesh-ancestor
110548455|NCT00992095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110548456|NCT00992095|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110548457|NCT00653354|Valdecoxib|valdecoxib|mesh-list
110548458|NCT00653354|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110548459|NCT00653354|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110548460|NCT00653354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110548461|NCT00653354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110548462|NCT00653354|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110548463|NCT00653354|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110548464|NCT00653354|Analgesics|analgesics|mesh-ancestor
110548465|NCT00653354|Sensory System Agents|sensory system agents|mesh-ancestor
110548466|NCT00653354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110548467|NCT00653354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110548468|NCT00653354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110548469|NCT00653354|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110548470|NCT00712504|Docetaxel|docetaxel|mesh-list
110548471|NCT00712504|Sunitinib|sunitinib|mesh-list
110548472|NCT00712504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110548473|NCT00712504|Tubulin Modulators|tubulin modulators|mesh-ancestor
110548474|NCT00712504|Antimitotic Agents|antimitotic agents|mesh-ancestor
110548475|NCT00712504|Mitosis Modulators|mitosis modulators|mesh-ancestor
110548476|NCT00712504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110548477|NCT00712504|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110548478|NCT00712504|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110548479|NCT00712504|Growth Substances|growth substances|mesh-ancestor
110548480|NCT00712504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110548481|NCT00712504|Growth Inhibitors|growth inhibitors|mesh-ancestor
110548482|NCT00712504|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110548483|NCT00712504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110548484|NCT00653510|Insulin|insulin|mesh-list
110548485|NCT00653510|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110548486|NCT00653510|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110548487|NCT00653510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110548488|NCT02694653|Acetaminophen|acetaminophen|mesh-list
110548489|NCT02694653|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110548490|NCT02694653|Analgesics|analgesics|mesh-ancestor
110548491|NCT02694653|Sensory System Agents|sensory system agents|mesh-ancestor
110548492|NCT02694653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110548493|NCT02694653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110548494|NCT02694653|Antipyretics|antipyretics|mesh-ancestor
110548495|NCT00722956|N-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-N-ethyl-2-(4-methanesulfonylphenyl)acetamide|n-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-n-ethyl-2-(4-methanesulfonylphenyl)acetamide|mesh-list
110548496|NCT00722956|Atorvastatin|atorvastatin|mesh-list
110548497|NCT00722956|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110548498|NCT00722956|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110548499|NCT00722956|Antimetabolites|antimetabolites|mesh-ancestor
110548500|NCT00722956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110548501|NCT00722956|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110548502|NCT00722956|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110548503|NCT00722956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110548504|NCT00722956|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
110548505|NCT00722956|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110548506|NCT00722956|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110548507|NCT00722956|Antiviral Agents|antiviral agents|mesh-ancestor
110548508|NCT00722956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110548509|NCT00992173|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
110548510|NCT00992173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110548511|NCT00992173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110548512|NCT00992173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110548513|NCT00992173|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110548514|NCT02729285|Ketorolac|ketorolac|mesh-list
110548515|NCT02729285|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
110548516|NCT02729285|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110548517|NCT02729285|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110548518|NCT02729285|Analgesics|analgesics|mesh-ancestor
110548519|NCT02729285|Sensory System Agents|sensory system agents|mesh-ancestor
110548520|NCT02729285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110548521|NCT02729285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110548522|NCT02729285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110548523|NCT02729285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110548524|NCT02729285|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110548525|NCT02729285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110548526|NCT02729285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110548527|NCT00722176|Risperidone|risperidone|mesh-list
110548528|NCT00722176|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110548529|NCT00722176|Serotonin Agents|serotonin agents|mesh-ancestor
110548530|NCT00722176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110548531|NCT00722176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110548532|NCT00722176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110548533|NCT00722176|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110548534|NCT00722176|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110548535|NCT00722176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110548536|NCT00722176|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110548537|NCT00722176|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110548538|NCT00722176|Dopamine Agents|dopamine agents|mesh-ancestor
110548539|NCT02729441|Ramipril|ramipril|mesh-list
110548540|NCT02729441|Perindopril|perindopril|mesh-list
110548541|NCT02729441|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110548542|NCT02729441|Protease Inhibitors|protease inhibitors|mesh-ancestor
110548543|NCT02729441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110548544|NCT02729441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110548545|NCT02729441|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110548546|NCT00712660|Antipsychotic Agents|antipsychotic agents|mesh-list
110548547|NCT00712660|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110548548|NCT00712660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110548549|NCT00712660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110548550|NCT00712660|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110548551|NCT00636545|Oblimersen|oblimersen|mesh-list
110548552|NCT00636545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110548553|NCT00722488|Pevonedistat|pevonedistat|mesh-list
110548554|NCT00722488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110548555|NCT00722488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110548556|NCT00652106|Timolol|timolol|mesh-list
110548557|NCT00652106|Brimonidine Tartrate|brimonidine tartrate|mesh-list
110548558|NCT00652106|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110548559|NCT00652106|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110548560|NCT00652106|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110548561|NCT00652106|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110548562|NCT00652106|Adrenergic Agents|adrenergic agents|mesh-ancestor
110548563|NCT00652106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110548564|NCT00652106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110548565|NCT00652106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110548566|NCT00652106|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110548567|NCT00652106|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110548568|NCT00652106|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110548569|NCT00652106|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110179300|NCT00010088|Micronutrients|micronutrients|mesh-ancestor
110548570|NCT00652106|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110548573|NCT00723268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110548574|NCT00723268|Glucocorticoids|glucocorticoids|mesh-ancestor
110196173|NCT00209872|Anticonvulsants|anticonvulsants|mesh-ancestor
110548575|NCT00723268|Hormones|hormones|mesh-ancestor
110548576|NCT00723268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110548577|NCT00723268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110548578|NCT00723268|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110548579|NCT00723268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110548580|NCT00723268|Gout Suppressants|gout suppressants|mesh-ancestor
110548581|NCT00723268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110548582|NCT00723268|Tubulin Modulators|tubulin modulators|mesh-ancestor
110548583|NCT00723268|Antimitotic Agents|antimitotic agents|mesh-ancestor
110548584|NCT00723268|Mitosis Modulators|mitosis modulators|mesh-ancestor
110548585|NCT00723268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110548586|NCT00874770|Ribavirin|ribavirin|mesh-list
110548587|NCT00874770|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110548588|NCT00874770|Antimetabolites|antimetabolites|mesh-ancestor
110548589|NCT00874770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110548590|NCT00874770|Antiviral Agents|antiviral agents|mesh-ancestor
110548591|NCT00874770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110548592|NCT00536263|Interferons|interferons|mesh-list
110548593|NCT00536263|Interferon-alpha|interferon-alpha|mesh-list
110548594|NCT00536263|Interferon alpha-2|interferon alpha-2|mesh-list
110548595|NCT00536263|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110548596|NCT00536263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110548597|NCT00536263|Antiviral Agents|antiviral agents|mesh-ancestor
110548598|NCT00536263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110548599|NCT00536263|Immunologic Factors|immunologic factors|mesh-ancestor
110548600|NCT00536263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110548601|NCT00578344|Cyclophosphamide|cyclophosphamide|mesh-list
110548602|NCT00578344|Busulfan|busulfan|mesh-list
110548603|NCT00578344|Alemtuzumab|alemtuzumab|mesh-list
110548604|NCT00578344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110548605|NCT00578344|Immunologic Factors|immunologic factors|mesh-ancestor
110548606|NCT00578344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110548607|NCT00578344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110548608|NCT00578344|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110548609|NCT00578344|Alkylating Agents|alkylating agents|mesh-ancestor
110548610|NCT00578344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110548611|NCT00578344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110548612|NCT00578344|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110548613|NCT00578344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110548614|NCT00653588|Atorvastatin|atorvastatin|mesh-list
110548615|NCT00653588|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110548616|NCT00653588|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110548617|NCT00653588|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110548618|NCT00653588|Antimetabolites|antimetabolites|mesh-ancestor
110548619|NCT00653588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110548620|NCT00653588|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110548621|NCT00653588|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110548622|NCT00653588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110548623|NCT00723346|Asparaginase|asparaginase|mesh-list
110548624|NCT00723346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110548625|NCT02571400|Analgesics, Opioid|analgesics, opioid|mesh-list
110548626|NCT02571400|Analgesics|analgesics|mesh-list
110548627|NCT02571400|Narcotics|narcotics|mesh-ancestor
110548628|NCT02571400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110548629|NCT02571400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110548630|NCT02571400|Sensory System Agents|sensory system agents|mesh-ancestor
110031624|NCT01393288|Lorazepam|lorazepam|mesh-list
110548631|NCT02571400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110548632|NCT02641652|Sertraline|sertraline|mesh-list
110548633|NCT02641652|Antidepressive Agents|antidepressive agents|mesh-ancestor
110548634|NCT02641652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110179311|NCT01465503|Protease Inhibitors|protease inhibitors|mesh-ancestor
110548635|NCT02641652|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110548636|NCT02641652|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110548637|NCT02641652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110548638|NCT02641652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110548639|NCT02641652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110548641|NCT02641652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110548642|NCT02626104|Lactoferrin|lactoferrin|mesh-list
110548643|NCT02626104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110548644|NCT02571166|Valacyclovir|valacyclovir|mesh-list
110548645|NCT02571166|Antiviral Agents|antiviral agents|mesh-ancestor
110548646|NCT02571166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110548647|NCT00686478|Interferons|interferons|mesh-list
110548648|NCT00686478|Interferon-alpha|interferon-alpha|mesh-list
110548649|NCT00686478|Interferon alpha-2|interferon alpha-2|mesh-list
110196260|NCT00210301|Modafinil|modafinil|mesh-list
110548650|NCT00686478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110548651|NCT00686478|Antiviral Agents|antiviral agents|mesh-ancestor
110548652|NCT00686478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110548653|NCT00686478|Immunologic Factors|immunologic factors|mesh-ancestor
110548654|NCT00686478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110548655|NCT00723424|N-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-N-ethyl-2-(4-methanesulfonylphenyl)acetamide|n-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-n-ethyl-2-(4-methanesulfonylphenyl)acetamide|mesh-list
110548656|NCT00723424|Digoxin|digoxin|mesh-list
110548657|NCT00723424|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110548658|NCT00723424|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110548659|NCT00723424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110548660|NCT00723424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110548661|NCT00723424|Protective Agents|protective agents|mesh-ancestor
110548662|NCT00723424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110548663|NCT00723424|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
110548664|NCT00723424|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110548665|NCT00723424|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110548666|NCT00723424|Antiviral Agents|antiviral agents|mesh-ancestor
110548667|NCT00723424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110548668|NCT02641340|Fentanyl|fentanyl|mesh-list
110548669|NCT02641340|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110548670|NCT02641340|Narcotics|narcotics|mesh-ancestor
110548671|NCT02641340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110548672|NCT02641340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110548673|NCT02641340|Analgesics|analgesics|mesh-ancestor
110548674|NCT02641340|Sensory System Agents|sensory system agents|mesh-ancestor
110548675|NCT02641340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110548676|NCT02641340|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110548677|NCT02641340|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110548678|NCT02641340|Anesthetics, General|anesthetics, general|mesh-ancestor
110548679|NCT02641340|Anesthetics|anesthetics|mesh-ancestor
110548680|NCT02625948|Tranexamic Acid|tranexamic acid|mesh-list
110548681|NCT02625948|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110548682|NCT02625948|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110548683|NCT02625948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110548684|NCT02625948|Hemostatics|hemostatics|mesh-ancestor
110548685|NCT02625948|Coagulants|coagulants|mesh-ancestor
110548686|NCT02571556|Dexamethasone|dexamethasone|mesh-list
110548687|NCT02571556|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110548688|NCT02571556|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
110548689|NCT02571556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110548690|NCT02571556|Antiemetics|antiemetics|mesh-ancestor
110548691|NCT02571556|Autonomic Agents|autonomic agents|mesh-ancestor
110548692|NCT02571556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110548693|NCT02571556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110548694|NCT02571556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110548695|NCT02571556|Glucocorticoids|glucocorticoids|mesh-ancestor
110548696|NCT02571556|Hormones|hormones|mesh-ancestor
110548697|NCT02571556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110548698|NCT02571556|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110548699|NCT02571556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110548700|NCT02571556|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110548701|NCT00691548|Cetuximab|cetuximab|mesh-list
110548702|NCT00691548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110548703|NCT00691548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110548704|NCT00712738|Nifedipine|nifedipine|mesh-list
110548705|NCT00712738|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110548706|NCT00712738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110548707|NCT00712738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110548708|NCT00712738|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110548709|NCT00712738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110548710|NCT00712738|Vasodilator Agents|vasodilator agents|mesh-ancestor
110548711|NCT00712738|Tocolytic Agents|tocolytic agents|mesh-ancestor
110548712|NCT00712738|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110548713|NCT00686556|Cyclosporine|cyclosporine|mesh-list
110548714|NCT00686556|Mycophenolic Acid|mycophenolic acid|mesh-list
110548715|NCT00686556|Cyclophosphamide|cyclophosphamide|mesh-list
110548716|NCT00686556|Fludarabine|fludarabine|mesh-list
110548717|NCT00686556|Cyclosporins|cyclosporins|mesh-list
110548718|NCT00686556|Lenograstim|lenograstim|mesh-list
110548719|NCT00686556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110548720|NCT00686556|Immunologic Factors|immunologic factors|mesh-ancestor
110548721|NCT00686556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110548722|NCT00686556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110548723|NCT00686556|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110548724|NCT00686556|Alkylating Agents|alkylating agents|mesh-ancestor
110548725|NCT00686556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110548726|NCT00686556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110548727|NCT00686556|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110548728|NCT00686556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110548729|NCT00686556|Antifungal Agents|antifungal agents|mesh-ancestor
110548730|NCT00686556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110548731|NCT00686556|Dermatologic Agents|dermatologic agents|mesh-ancestor
110548732|NCT00686556|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110548733|NCT00686556|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110548734|NCT00686556|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110548735|NCT00686556|Antitubercular Agents|antitubercular agents|mesh-ancestor
110548736|NCT00686556|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110548737|NCT00686556|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110548739|NCT04070482|Antiviral Agents|antiviral agents|mesh-ancestor
110548740|NCT04070482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110548741|NCT04070482|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110548742|NCT04070482|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110548743|NCT04070482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110179340|NCT01465074|Autonomic Agents|autonomic agents|mesh-ancestor
110179341|NCT01465074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110548744|NCT04070482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110548745|NCT04070482|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110548746|NCT04070482|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110548748|NCT04166786|Methyltestosterone|methyltestosterone|mesh-list
110548749|NCT04166786|Petrolatum|petrolatum|mesh-list
110548750|NCT04166786|Testosterone|testosterone|mesh-list
110548751|NCT04166786|Testosterone undecanoate|testosterone undecanoate|mesh-list
110548752|NCT04166786|Testosterone enanthate|testosterone enanthate|mesh-list
110548753|NCT04166786|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
110548754|NCT04166786|Androgens|androgens|mesh-ancestor
110548755|NCT04166786|Hormones|hormones|mesh-ancestor
110548756|NCT04166786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110548757|NCT04166786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110548758|NCT04166786|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110548759|NCT04166786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110548760|NCT04166786|Anabolic Agents|anabolic agents|mesh-ancestor
110548761|NCT04166786|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110548762|NCT04166786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110548763|NCT04166786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110548764|NCT04166786|Emollients|emollients|mesh-ancestor
110548765|NCT04166786|Dermatologic Agents|dermatologic agents|mesh-ancestor
110548766|NCT02727647|Factor VIII|factor viii|mesh-list
110548767|NCT02727647|Coagulants|coagulants|mesh-ancestor
110548768|NCT00723502|Amoxicillin|amoxicillin|mesh-list
110548769|NCT00723502|Finafloxacin|finafloxacin|mesh-list
110548770|NCT00723502|Fluoroquinolones|fluoroquinolones|mesh-list
110548771|NCT00723502|Esomeprazole|esomeprazole|mesh-list
110548772|NCT00723502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110548773|NCT00723502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110548774|NCT00723502|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110548775|NCT00723502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110548776|NCT00723502|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110548777|NCT00723502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110548778|NCT00723502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110031656|NCT01393548|Ephedrine|ephedrine|mesh-list
110548779|NCT00723502|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110548780|NCT00723502|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110548781|NCT00723502|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110548782|NCT00723502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110548783|NCT00723502|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110548784|NCT02727881|Squalamine|squalamine|mesh-list
110548785|NCT02727881|Ranibizumab|ranibizumab|mesh-list
110548786|NCT02727881|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110548787|NCT02727881|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110548788|NCT02727881|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110548789|NCT02727881|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110548790|NCT02727881|Growth Substances|growth substances|mesh-ancestor
110548791|NCT02727881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110548792|NCT02727881|Growth Inhibitors|growth inhibitors|mesh-ancestor
110548793|NCT02727881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110548794|NCT02727881|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110548795|NCT02727881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110548796|NCT02727881|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110548797|NCT02727881|Protective Agents|protective agents|mesh-ancestor
110548799|NCT01564381|Antioxidants|antioxidants|mesh-ancestor
110548800|NCT01564381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110548801|NCT01564381|Protective Agents|protective agents|mesh-ancestor
110548802|NCT01564381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110548803|NCT01564381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110548804|NCT01564381|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110548805|NCT04164524|Gentamicins|gentamicins|mesh-list
110548806|NCT04164524|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110548807|NCT04164524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110548808|NCT04164524|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110548809|NCT04164524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110548810|NCT04164524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110548811|NCT00723658|Cytarabine|cytarabine|mesh-list
110548812|NCT00723658|Thalidomide|thalidomide|mesh-list
110548813|NCT00723658|Dexamethasone|dexamethasone|mesh-list
110548814|NCT00723658|Cyclophosphamide|cyclophosphamide|mesh-list
110548815|NCT00723658|Melphalan|melphalan|mesh-list
110548816|NCT00723658|Carmustine|carmustine|mesh-list
110548817|NCT00723658|Rituximab|rituximab|mesh-list
110548818|NCT00723658|Doxorubicin|doxorubicin|mesh-list
110548819|NCT00723658|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110548820|NCT00723658|Etoposide|etoposide|mesh-list
110548821|NCT00723658|Bortezomib|bortezomib|mesh-list
110548822|NCT00723658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110548823|NCT00723658|Immunologic Factors|immunologic factors|mesh-ancestor
110548824|NCT00723658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110548825|NCT00723658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110548826|NCT00723658|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110548827|NCT00723658|Alkylating Agents|alkylating agents|mesh-ancestor
110548828|NCT00723658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110548829|NCT00723658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110548830|NCT00723658|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110548831|NCT00723658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110548832|NCT00723658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110548833|NCT00723658|Antiemetics|antiemetics|mesh-ancestor
110548834|NCT00723658|Autonomic Agents|autonomic agents|mesh-ancestor
110548835|NCT00723658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110548836|NCT00723658|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110548837|NCT00723658|Glucocorticoids|glucocorticoids|mesh-ancestor
110548838|NCT00723658|Hormones|hormones|mesh-ancestor
110548839|NCT00723658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110548840|NCT00723658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110548841|NCT00723658|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110548842|NCT00723658|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110548843|NCT00723658|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110548844|NCT00723658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110548845|NCT00723658|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110548846|NCT00723658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110548847|NCT00723658|Antimetabolites|antimetabolites|mesh-ancestor
110548848|NCT00723658|Antiviral Agents|antiviral agents|mesh-ancestor
110548849|NCT00723658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110548850|NCT00723658|Leprostatic Agents|leprostatic agents|mesh-ancestor
110548851|NCT00723658|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110548852|NCT00723658|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110548853|NCT00723658|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110548854|NCT00723658|Growth Substances|growth substances|mesh-ancestor
110548855|NCT00723658|Growth Inhibitors|growth inhibitors|mesh-ancestor
110548856|NCT04139850|Antiviral Agents|antiviral agents|mesh-list
110548857|NCT04139850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110179386|NCT00010361|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110548859|NCT02638142|Diuretics|diuretics|mesh-ancestor
110548860|NCT02638142|Natriuretic Agents|natriuretic agents|mesh-ancestor
110548861|NCT02638142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110548862|NCT02638142|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110548863|NCT02638142|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110548864|NCT02638142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110548865|NCT02727491|Dextromethorphan|dextromethorphan|mesh-list
110548866|NCT02727491|Antitussive Agents|antitussive agents|mesh-ancestor
110548867|NCT02727491|Respiratory System Agents|respiratory system agents|mesh-ancestor
110548868|NCT02727491|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110548869|NCT02727491|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110548870|NCT02727491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110343816|NCT06022588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110548871|NCT02727491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110548872|NCT02727491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110548873|NCT03562195|Albuterol|albuterol|mesh-list
110548874|NCT03562195|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110548875|NCT03562195|Autonomic Agents|autonomic agents|mesh-ancestor
110548876|NCT03562195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110548877|NCT03562195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110548878|NCT03562195|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110548879|NCT03562195|Respiratory System Agents|respiratory system agents|mesh-ancestor
110548880|NCT03562195|Tocolytic Agents|tocolytic agents|mesh-ancestor
110548881|NCT03562195|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110548882|NCT03562195|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110548883|NCT03562195|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110548884|NCT03562195|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110548885|NCT03562195|Adrenergic Agents|adrenergic agents|mesh-ancestor
110548886|NCT03562195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110548887|NCT03562195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110548888|NCT00686868|Ofatumumab|ofatumumab|mesh-list
110548889|NCT00686868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110548890|NCT00992329|Ciprofloxacin|ciprofloxacin|mesh-list
110548891|NCT00992329|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110548892|NCT00992329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110548893|NCT00992329|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110548894|NCT00992329|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110548895|NCT00992329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110548896|NCT00992329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110548897|NCT00992329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110548898|NCT00992329|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110548899|NCT00992329|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110548900|NCT02645864|Irinotecan|irinotecan|mesh-list
110548901|NCT02645864|Apatinib|apatinib|mesh-list
110548902|NCT02645864|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110548903|NCT02645864|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110548904|NCT02645864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110548905|NCT02645864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110548906|NCT02645864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110548907|NCT02645864|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110548908|NCT00674856|Naproxen-n-butyl nitrate|naproxen-n-butyl nitrate|mesh-list
110548909|NCT00674856|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
110179397|NCT01464840|Azithromycin|azithromycin|mesh-list
110548910|NCT00674856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110548911|NCT02574130|Amikacin|amikacin|mesh-list
110548912|NCT02574130|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110548913|NCT02574130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110548914|NCT00652184|Valacyclovir|valacyclovir|mesh-list
110548915|NCT00652184|Sorivudine|sorivudine|mesh-list
110548916|NCT00652184|Antiviral Agents|antiviral agents|mesh-ancestor
110548917|NCT00652184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110548918|NCT00652184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110548919|NCT00652184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110548920|NCT02726867|Lacosamide|lacosamide|mesh-list
110548921|NCT02726867|Ketamine|ketamine|mesh-list
110548922|NCT02726867|Levetiracetam|levetiracetam|mesh-list
110548923|NCT02726867|Phenobarbital|phenobarbital|mesh-list
110548924|NCT02726867|Analgesics|analgesics|mesh-ancestor
110548925|NCT02726867|Sensory System Agents|sensory system agents|mesh-ancestor
110548926|NCT02726867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110052790|NCT01482052|Immunologic Factors|immunologic factors|mesh-ancestor
110548927|NCT02726867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110548928|NCT02726867|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110548929|NCT02726867|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110548930|NCT02726867|Anesthetics, General|anesthetics, general|mesh-ancestor
110548931|NCT02726867|Anesthetics|anesthetics|mesh-ancestor
110548932|NCT02726867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110548933|NCT02726867|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110548934|NCT02726867|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110548935|NCT02726867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110548936|NCT02726867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110548937|NCT02726867|Anticonvulsants|anticonvulsants|mesh-ancestor
110548938|NCT02726867|Nootropic Agents|nootropic agents|mesh-ancestor
110548939|NCT02726867|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110548940|NCT02726867|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110548941|NCT02726867|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110548942|NCT02726867|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110548943|NCT02726867|GABA Modulators|gaba modulators|mesh-ancestor
110548944|NCT02726867|GABA Agents|gaba agents|mesh-ancestor
110548945|NCT02726867|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110548946|NCT02726867|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110548947|NCT02726867|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110548948|NCT00723970|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110548949|NCT00723970|Antidepressive Agents|antidepressive agents|mesh-ancestor
110548950|NCT00723970|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110548951|NCT00723970|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110548952|NCT00723970|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110548953|NCT00723970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110548954|NCT00723970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110548956|NCT00873366|Dextromethorphan|dextromethorphan|mesh-list
110548957|NCT00873366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110548958|NCT00873366|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110548959|NCT00873366|Hormone Antagonists|hormone antagonists|mesh-ancestor
110548960|NCT00873366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110548961|NCT00873366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110548962|NCT00873366|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110548963|NCT00873366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110548964|NCT00873366|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110548965|NCT00873366|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110548966|NCT00873366|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110548967|NCT00873366|Antitussive Agents|antitussive agents|mesh-ancestor
110548968|NCT00873366|Respiratory System Agents|respiratory system agents|mesh-ancestor
110548969|NCT00873366|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110548970|NCT00873366|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110548971|NCT00873366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110548972|NCT00712894|Verapamil|verapamil|mesh-list
110548973|NCT00712894|Diltiazem|diltiazem|mesh-list
110548974|NCT00712894|Nitroglycerin|nitroglycerin|mesh-list
110548975|NCT00712894|Vasodilator Agents|vasodilator agents|mesh-ancestor
110548976|NCT00712894|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110548977|NCT00712894|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110548978|NCT00712894|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110548979|NCT00712894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110548980|NCT00712894|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110548981|NCT00712894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110548982|NCT00712894|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110548983|NCT04164368|Lenalidomide|lenalidomide|mesh-list
110548984|NCT04164368|Immunologic Factors|immunologic factors|mesh-ancestor
110548985|NCT04164368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110548986|NCT04164368|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110548987|NCT04164368|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110548988|NCT04164368|Growth Substances|growth substances|mesh-ancestor
110548989|NCT04164368|Growth Inhibitors|growth inhibitors|mesh-ancestor
110548990|NCT04164368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110548991|NCT02726555|Atorvastatin|atorvastatin|mesh-list
110548992|NCT02726555|Red yeast rice|red yeast rice|mesh-list
110548993|NCT02726555|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110548994|NCT02726555|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110548995|NCT02726555|Antimetabolites|antimetabolites|mesh-ancestor
110548996|NCT02726555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110548997|NCT02726555|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110548998|NCT02726555|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110548999|NCT02726555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110549000|NCT00536107|Docetaxel|docetaxel|mesh-list
110549001|NCT00536107|Gefitinib|gefitinib|mesh-list
110549002|NCT00536107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110549003|NCT00536107|Tubulin Modulators|tubulin modulators|mesh-ancestor
110549004|NCT00536107|Antimitotic Agents|antimitotic agents|mesh-ancestor
110549005|NCT00536107|Mitosis Modulators|mitosis modulators|mesh-ancestor
110560329|NCT00638729|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110549006|NCT00536107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110549007|NCT00536107|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110549008|NCT00536107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110549009|NCT01022138|Cyclophosphamide|cyclophosphamide|mesh-list
110549010|NCT01022138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110549011|NCT01022138|Immunologic Factors|immunologic factors|mesh-ancestor
110549012|NCT01022138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110549013|NCT01022138|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110549014|NCT01022138|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110549015|NCT01022138|Alkylating Agents|alkylating agents|mesh-ancestor
110549016|NCT01022138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110549017|NCT01022138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110549018|NCT01022138|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110549019|NCT00724360|Trastuzumab|trastuzumab|mesh-list
110549020|NCT00724360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110549021|NCT00724360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110549022|NCT02637830|Fluorides|fluorides|mesh-list
110549023|NCT02637830|Fluorides, Topical|fluorides, topical|mesh-list
110549024|NCT02637830|Sodium fluoride topical preparation|sodium fluoride topical preparation|mesh-list
110549025|NCT02637830|Cariostatic Agents|cariostatic agents|mesh-ancestor
110549026|NCT02637830|Protective Agents|protective agents|mesh-ancestor
110549027|NCT02637830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110549029|NCT00687258|Vitamins|vitamins|mesh-ancestor
110549030|NCT00687258|Micronutrients|micronutrients|mesh-ancestor
110549031|NCT00687258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110549032|NCT00687258|Antioxidants|antioxidants|mesh-ancestor
110549033|NCT00687258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110549034|NCT00687258|Protective Agents|protective agents|mesh-ancestor
110549035|NCT04001569|Paclitaxel|paclitaxel|mesh-list
110549036|NCT04001569|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110549037|NCT04001569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110549038|NCT04001569|Tubulin Modulators|tubulin modulators|mesh-ancestor
110549039|NCT04001569|Antimitotic Agents|antimitotic agents|mesh-ancestor
110549040|NCT04001569|Mitosis Modulators|mitosis modulators|mesh-ancestor
110549041|NCT04001569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110549042|NCT00692016|Naproxen|naproxen|mesh-list
110549043|NCT00692016|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110549044|NCT00692016|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110549045|NCT00692016|Analgesics|analgesics|mesh-ancestor
110549046|NCT00692016|Sensory System Agents|sensory system agents|mesh-ancestor
110549047|NCT00692016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110549048|NCT00692016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110549049|NCT00692016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110549050|NCT00692016|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110549051|NCT00692016|Gout Suppressants|gout suppressants|mesh-ancestor
110549052|NCT00692016|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110549053|NCT00692016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110549054|NCT00692016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110549055|NCT03295981|Zoledronic Acid|zoledronic acid|mesh-list
110549056|NCT03295981|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110549057|NCT03295981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110549058|NCT02733107|Etoposide|etoposide|mesh-list
110549059|NCT02733107|Apatinib|apatinib|mesh-list
110549060|NCT02733107|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110549061|NCT02733107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110549062|NCT02733107|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110549063|NCT02733107|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110549064|NCT02733107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110549065|NCT02733107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110549066|NCT02733107|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110549067|NCT00675012|Capecitabine|capecitabine|mesh-list
110549068|NCT00675012|Oxaliplatin|oxaliplatin|mesh-list
110549069|NCT00675012|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110549070|NCT00675012|Antimetabolites|antimetabolites|mesh-ancestor
110549071|NCT00675012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110549072|NCT00675012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110549073|NCT00652262|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
110549074|NCT00652262|Vasodilator Agents|vasodilator agents|mesh-ancestor
110549075|NCT00652262|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110549076|NCT00652262|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110549077|NCT00652262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110549078|NCT00652262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110549079|NCT00652262|Urological Agents|urological agents|mesh-ancestor
110549081|NCT02640794|Clopidogrel|clopidogrel|mesh-list
110549082|NCT02640794|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110549083|NCT02640794|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110549084|NCT02640794|Analgesics|analgesics|mesh-ancestor
110549085|NCT02640794|Sensory System Agents|sensory system agents|mesh-ancestor
110549086|NCT02640794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110549087|NCT02640794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110549088|NCT02640794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110549089|NCT02640794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110549090|NCT02640794|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110549091|NCT02640794|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110549092|NCT02640794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110549093|NCT02640794|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110549094|NCT02640794|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110549095|NCT02640794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110196697|NCT00214318|Antioxidants|antioxidants|mesh-ancestor
110549096|NCT02640794|Antipyretics|antipyretics|mesh-ancestor
110549097|NCT02640794|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110549098|NCT02640794|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110549099|NCT02640794|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110549100|NCT02640794|Purinergic Agents|purinergic agents|mesh-ancestor
110549101|NCT02640794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110549102|NCT00724672|Adalimumab|adalimumab|mesh-list
110549103|NCT00724672|Infliximab|infliximab|mesh-list
110549104|NCT00724672|Etanercept|etanercept|mesh-list
110549105|NCT00724672|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110549106|NCT00724672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110549107|NCT00724672|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110549108|NCT00724672|Dermatologic Agents|dermatologic agents|mesh-ancestor
110549109|NCT00724672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110549110|NCT00724672|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110549111|NCT00724672|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110549112|NCT00724672|Analgesics|analgesics|mesh-ancestor
110549113|NCT00724672|Sensory System Agents|sensory system agents|mesh-ancestor
110549114|NCT00724672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110549115|NCT00724672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110549116|NCT00724672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110549117|NCT00724672|Immunologic Factors|immunologic factors|mesh-ancestor
110549118|NCT02624856|Dexamethasone|dexamethasone|mesh-list
110549119|NCT02624856|Bupivacaine|bupivacaine|mesh-list
110549120|NCT02624856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110549121|NCT02624856|Antiemetics|antiemetics|mesh-ancestor
110549122|NCT02624856|Autonomic Agents|autonomic agents|mesh-ancestor
110549123|NCT02624856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110549124|NCT02624856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110549125|NCT02624856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110549126|NCT02624856|Glucocorticoids|glucocorticoids|mesh-ancestor
110549127|NCT02624856|Hormones|hormones|mesh-ancestor
110549128|NCT02624856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110549129|NCT02624856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110549130|NCT02624856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110549131|NCT02624856|Anesthetics, Local|anesthetics, local|mesh-ancestor
110549132|NCT02624856|Anesthetics|anesthetics|mesh-ancestor
110549133|NCT02624856|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110549134|NCT02624856|Sensory System Agents|sensory system agents|mesh-ancestor
110549135|NCT02646020|Loratadine|loratadine|mesh-list
110549136|NCT02646020|Aprepitant|aprepitant|mesh-list
110549137|NCT02646020|Fosaprepitant|fosaprepitant|mesh-list
110549138|NCT02646020|Desloratadine|desloratadine|mesh-list
110549139|NCT02646020|Antiemetics|antiemetics|mesh-ancestor
110549140|NCT02646020|Autonomic Agents|autonomic agents|mesh-ancestor
110549141|NCT02646020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110549142|NCT02646020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110549143|NCT02646020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110549144|NCT02646020|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110179467|NCT00011297|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110549145|NCT02646020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110549146|NCT02646020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110549147|NCT02646020|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110549148|NCT02646020|Cholinergic Agents|cholinergic agents|mesh-ancestor
110549149|NCT02646020|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110549150|NCT02646020|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110549151|NCT02646020|Histamine Antagonists|histamine antagonists|mesh-ancestor
110549152|NCT02646020|Histamine Agents|histamine agents|mesh-ancestor
110549153|NCT02646020|Antipruritics|antipruritics|mesh-ancestor
110549154|NCT02646020|Dermatologic Agents|dermatologic agents|mesh-ancestor
110549155|NCT02646020|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110549156|NCT02733419|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
110549157|NCT02733419|Enfuvirtide|enfuvirtide|mesh-list
110549158|NCT02733419|Antiviral Agents|antiviral agents|mesh-ancestor
110549159|NCT02733419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110549160|NCT02733419|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110549161|NCT02733419|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110549162|NCT02733419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110549163|NCT02733419|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110549165|NCT00992797|Cholecalciferol|cholecalciferol|mesh-list
110549166|NCT00992797|Vitamins|vitamins|mesh-ancestor
110549167|NCT00992797|Micronutrients|micronutrients|mesh-ancestor
110549168|NCT00992797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110549169|NCT00992797|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110549170|NCT00992797|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110549171|NCT02725541|Trastuzumab|trastuzumab|mesh-list
110549172|NCT02725541|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
110549173|NCT02725541|Maytansine|maytansine|mesh-list
110549174|NCT02725541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110549175|NCT02725541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110549176|NCT02725541|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110549177|NCT02725541|Tubulin Modulators|tubulin modulators|mesh-ancestor
110549178|NCT02725541|Antimitotic Agents|antimitotic agents|mesh-ancestor
110549179|NCT02725541|Mitosis Modulators|mitosis modulators|mesh-ancestor
110549180|NCT02725541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110549181|NCT02725541|Immunotoxins|immunotoxins|mesh-ancestor
110549182|NCT02725541|Immunoconjugates|immunoconjugates|mesh-ancestor
110549183|NCT02725541|Immunologic Factors|immunologic factors|mesh-ancestor
110549184|NCT02725541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110549185|NCT00911066|Azacitidine|azacitidine|mesh-list
110549186|NCT00911066|Pevonedistat|pevonedistat|mesh-list
110549187|NCT00911066|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110549188|NCT00911066|Antimetabolites|antimetabolites|mesh-ancestor
110549189|NCT00911066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110549190|NCT00911066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110549191|NCT00911066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110549192|NCT02733341|Ticagrelor|ticagrelor|mesh-list
110549193|NCT02733341|Cangrelor|cangrelor|mesh-list
110549194|NCT02733341|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110549195|NCT02733341|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110549196|NCT02733341|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110549197|NCT02733341|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110549198|NCT02733341|Purinergic Agents|purinergic agents|mesh-ancestor
110549199|NCT02733341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110549200|NCT02733341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110549201|NCT02733341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110549202|NCT00692172|Alefacept|alefacept|mesh-list
110549203|NCT00692172|Dermatologic Agents|dermatologic agents|mesh-ancestor
110549204|NCT00692172|Immunologic Factors|immunologic factors|mesh-ancestor
110549205|NCT00692172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110549206|NCT00692250|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
110549207|NCT00692250|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110549208|NCT00692250|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110549209|NCT00692250|Antimetabolites|antimetabolites|mesh-ancestor
110549210|NCT00692250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110549211|NCT00692250|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110549212|NCT03675139|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
110549213|NCT03675139|Medroxyprogesterone|medroxyprogesterone|mesh-list
110549214|NCT03675139|Dydrogesterone|dydrogesterone|mesh-list
110549215|NCT03675139|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110549216|NCT03675139|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110549217|NCT03675139|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110549218|NCT03675139|Contraceptive Agents|contraceptive agents|mesh-ancestor
110549219|NCT03675139|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110549220|NCT03675139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110549221|NCT03675139|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110549222|NCT03675139|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110549223|NCT03675139|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110549224|NCT03675139|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110549225|NCT03675139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110549226|NCT03675139|Progestins|progestins|mesh-ancestor
110549227|NCT03675139|Hormones|hormones|mesh-ancestor
110549228|NCT03675139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110549229|NCT02645552|Tranexamic Acid|tranexamic acid|mesh-list
110549230|NCT02645552|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110549231|NCT02645552|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110549232|NCT02645552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110549233|NCT02645552|Hemostatics|hemostatics|mesh-ancestor
110549234|NCT02645552|Coagulants|coagulants|mesh-ancestor
110549235|NCT00692328|Levodopa|levodopa|mesh-list
110549236|NCT00692328|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110549237|NCT00692328|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110549238|NCT00692328|Dopamine Agents|dopamine agents|mesh-ancestor
110549239|NCT00692328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110549240|NCT00692328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110549241|NCT00692328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110549242|NCT03415828|Ethanol|ethanol|mesh-list
110549243|NCT03415828|Prednisolone|prednisolone|mesh-list
110549244|NCT03415828|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110549245|NCT03415828|Methylprednisolone|methylprednisolone|mesh-list
110549246|NCT03415828|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110549247|NCT03415828|Prednisolone acetate|prednisolone acetate|mesh-list
110549248|NCT03415828|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110196847|NCT00041483|Anecortave|anecortave|mesh-list
110549250|NCT03415828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110549251|NCT03415828|Glucocorticoids|glucocorticoids|mesh-ancestor
110549252|NCT03415828|Hormones|hormones|mesh-ancestor
110549253|NCT03415828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110549254|NCT03415828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110549255|NCT03415828|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110549256|NCT03415828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110549257|NCT03415828|Antiemetics|antiemetics|mesh-ancestor
110549258|NCT03415828|Autonomic Agents|autonomic agents|mesh-ancestor
110549259|NCT03415828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110549260|NCT03415828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110549261|NCT03415828|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110549262|NCT03415828|Protective Agents|protective agents|mesh-ancestor
110549263|NCT03415828|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110549264|NCT03415828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110549265|NCT03415828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110549266|NCT00687648|Prednisolone|prednisolone|mesh-list
110549267|NCT00687648|Cyclophosphamide|cyclophosphamide|mesh-list
110549268|NCT00687648|Methotrexate|methotrexate|mesh-list
110549269|NCT00687648|Letrozole|letrozole|mesh-list
110549270|NCT00687648|Anastrozole|anastrozole|mesh-list
110549272|NCT00687648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110549273|NCT00687648|Immunologic Factors|immunologic factors|mesh-ancestor
110549274|NCT00687648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110549275|NCT00687648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110549276|NCT00687648|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110549277|NCT00687648|Alkylating Agents|alkylating agents|mesh-ancestor
110549278|NCT00687648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110549279|NCT00687648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110549280|NCT00687648|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110549281|NCT00687648|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110549282|NCT00687648|Abortifacient Agents|abortifacient agents|mesh-ancestor
110549283|NCT00687648|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110549284|NCT00687648|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110549285|NCT00687648|Antimetabolites|antimetabolites|mesh-ancestor
110549286|NCT00687648|Dermatologic Agents|dermatologic agents|mesh-ancestor
110549287|NCT00687648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110549288|NCT00687648|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110549289|NCT00687648|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110549290|NCT00687648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110549291|NCT00687648|Glucocorticoids|glucocorticoids|mesh-ancestor
110549292|NCT00687648|Hormones|hormones|mesh-ancestor
110179499|NCT00847899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110549293|NCT00687648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110549294|NCT00687648|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110549296|NCT00687648|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110549297|NCT00687648|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110549298|NCT00687648|Hormone Antagonists|hormone antagonists|mesh-ancestor
110549299|NCT00725218|Flurbiprofen|flurbiprofen|mesh-list
110549300|NCT00725218|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
110549301|NCT00725218|Analgesics|analgesics|mesh-ancestor
110549302|NCT00725218|Sensory System Agents|sensory system agents|mesh-ancestor
110549303|NCT00725218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110549304|NCT00725218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110549305|NCT00725218|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110549306|NCT00725218|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110549307|NCT00725218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110549308|NCT00725218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110549309|NCT00725218|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110549310|NCT00725218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110549311|NCT00725218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110549312|NCT02732795|Morphine|morphine|mesh-list
110549313|NCT02732795|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110549314|NCT02732795|Narcotics|narcotics|mesh-ancestor
110549315|NCT02732795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110549316|NCT02732795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110549317|NCT02732795|Analgesics|analgesics|mesh-ancestor
110549318|NCT02732795|Sensory System Agents|sensory system agents|mesh-ancestor
110549319|NCT02732795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110549320|NCT05373004|Empagliflozin|empagliflozin|mesh-list
110549321|NCT05373004|Enalapril|enalapril|mesh-list
110549322|NCT05373004|Enalaprilat|enalaprilat|mesh-list
110549323|NCT05373004|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110549324|NCT05373004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110549325|NCT05373004|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110549326|NCT05373004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110549327|NCT05373004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110549328|NCT05373004|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110549329|NCT05373004|Protease Inhibitors|protease inhibitors|mesh-ancestor
110549330|NCT05373004|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110549331|NCT00655616|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110549332|NCT00655616|Montelukast|montelukast|mesh-list
110549333|NCT00655616|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110549334|NCT00655616|Autonomic Agents|autonomic agents|mesh-ancestor
110549335|NCT00655616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110549336|NCT00655616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110179535|NCT00009932|Paclitaxel|paclitaxel|mesh-list
110549337|NCT00655616|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110549338|NCT00655616|Respiratory System Agents|respiratory system agents|mesh-ancestor
110549339|NCT00655616|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110549340|NCT00655616|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110549341|NCT00655616|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110549342|NCT00655616|Adrenergic Agents|adrenergic agents|mesh-ancestor
110549343|NCT00655616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110549344|NCT00655616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110549345|NCT00655616|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110549346|NCT00655616|Hormone Antagonists|hormone antagonists|mesh-ancestor
110549347|NCT00655616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110549348|NCT00655616|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110549349|NCT00655616|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110549350|NCT00713440|Acetaminophen|acetaminophen|mesh-list
110549351|NCT00713440|Prednisolone|prednisolone|mesh-list
110549352|NCT00713440|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110549353|NCT00713440|Methylprednisolone|methylprednisolone|mesh-list
110549354|NCT00713440|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110549355|NCT00713440|Prednisolone acetate|prednisolone acetate|mesh-list
110549356|NCT00713440|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110549357|NCT00713440|Prednisolone phosphate|prednisolone phosphate|mesh-list
110549358|NCT00713440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110549359|NCT00713440|Glucocorticoids|glucocorticoids|mesh-ancestor
110549360|NCT00713440|Hormones|hormones|mesh-ancestor
110549361|NCT00713440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110549362|NCT00713440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110549363|NCT00713440|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110549364|NCT00713440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110549365|NCT00713440|Antiemetics|antiemetics|mesh-ancestor
110549366|NCT00713440|Autonomic Agents|autonomic agents|mesh-ancestor
110549367|NCT00713440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110549368|NCT00713440|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110549369|NCT00713440|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110549370|NCT00713440|Protective Agents|protective agents|mesh-ancestor
110549371|NCT00713440|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110549372|NCT00713440|Analgesics|analgesics|mesh-ancestor
110549374|NCT00713440|Antipyretics|antipyretics|mesh-ancestor
110549375|NCT00993109|Valsartan|valsartan|mesh-list
110549376|NCT00993109|Nifedipine|nifedipine|mesh-list
110549377|NCT00993109|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110549378|NCT00993109|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110549379|NCT00993109|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110549380|NCT00993109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110549381|NCT00993109|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110549382|NCT00993109|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110549383|NCT00993109|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110549384|NCT00993109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110549385|NCT00993109|Vasodilator Agents|vasodilator agents|mesh-ancestor
110549386|NCT00993109|Tocolytic Agents|tocolytic agents|mesh-ancestor
110549387|NCT00993109|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110549388|NCT02725229|Levobupivacaine|levobupivacaine|mesh-list
110549389|NCT02725229|Anesthetics, Local|anesthetics, local|mesh-ancestor
110549390|NCT02725229|Anesthetics|anesthetics|mesh-ancestor
110549391|NCT02725229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110549392|NCT02725229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110549393|NCT02725229|Sensory System Agents|sensory system agents|mesh-ancestor
110549394|NCT02725229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110549395|NCT00655772|Chlorine dioxide|chlorine dioxide|mesh-list
110549396|NCT00655772|Dental Disinfectants|dental disinfectants|mesh-ancestor
110549397|NCT00655772|Disinfectants|disinfectants|mesh-ancestor
110549399|NCT00675246|Betamethasone|betamethasone|mesh-list
110549400|NCT00675246|Betamethasone acetate phosphate|betamethasone acetate phosphate|mesh-list
110549401|NCT00675246|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110549402|NCT00675246|Glucocorticoids|glucocorticoids|mesh-ancestor
110549403|NCT00675246|Hormones|hormones|mesh-ancestor
110549404|NCT00675246|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110549405|NCT00675246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110549406|NCT00675246|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110549407|NCT00675246|Respiratory System Agents|respiratory system agents|mesh-ancestor
110549408|NCT00675246|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110549409|NCT00675246|Autonomic Agents|autonomic agents|mesh-ancestor
110549410|NCT00675246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110549411|NCT02732405|Grazoprevir|grazoprevir|mesh-list
110549412|NCT02732405|Antiviral Agents|antiviral agents|mesh-ancestor
110549413|NCT02732405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110549414|NCT04001725|Metformin|metformin|mesh-list
110549415|NCT04001725|Dexamethasone|dexamethasone|mesh-list
110549416|NCT04001725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110549417|NCT04001725|Antiemetics|antiemetics|mesh-ancestor
110549418|NCT04001725|Autonomic Agents|autonomic agents|mesh-ancestor
110549419|NCT04001725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110549420|NCT04001725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110549421|NCT04001725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110549422|NCT04001725|Glucocorticoids|glucocorticoids|mesh-ancestor
110549423|NCT04001725|Hormones|hormones|mesh-ancestor
110549424|NCT04001725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110549425|NCT04001725|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110549426|NCT04001725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110549427|NCT04001725|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110549428|NCT00713674|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110549429|NCT00713674|Mupirocin|mupirocin|mesh-list
110549430|NCT00713674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110549431|NCT00713674|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110549432|NCT00713674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110549433|NCT00713674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110549434|NCT00885482|Ritonavir|ritonavir|mesh-list
110549435|NCT00885482|Atazanavir Sulfate|atazanavir sulfate|mesh-list
110549436|NCT00885482|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110549437|NCT00885482|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110549438|NCT00885482|Protease Inhibitors|protease inhibitors|mesh-ancestor
110549439|NCT00885482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110549440|NCT00885482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110549441|NCT00885482|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110549442|NCT00885482|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110549443|NCT00885482|Antiviral Agents|antiviral agents|mesh-ancestor
110549444|NCT00885482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110549445|NCT00885482|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110549446|NCT00885482|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110549447|NCT04139226|CC-11050|cc-11050|mesh-list
110549448|NCT04139226|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
110549449|NCT04139226|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110549450|NCT04139226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110549451|NCT04139226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110549452|NCT05366062|Cyclophosphamide|cyclophosphamide|mesh-list
110549453|NCT05366062|Pembrolizumab|pembrolizumab|mesh-list
110549454|NCT05366062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110549455|NCT05366062|Immunologic Factors|immunologic factors|mesh-ancestor
110549457|NCT05366062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110549458|NCT05366062|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110549459|NCT05366062|Alkylating Agents|alkylating agents|mesh-ancestor
110549460|NCT05366062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110549461|NCT05366062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110549462|NCT05366062|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110549463|NCT05366062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110549464|NCT05366062|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110549465|NCT02645240|Heparin|heparin|mesh-list
110549466|NCT02645240|Calcium heparin|calcium heparin|mesh-list
110549467|NCT02645240|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
110549468|NCT02645240|Tinzaparin|tinzaparin|mesh-list
110549469|NCT02645240|Dalteparin|dalteparin|mesh-list
110549470|NCT02645240|Anticoagulants|anticoagulants|mesh-ancestor
110549471|NCT02645240|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110549472|NCT02645240|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110549473|NCT02645240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110549474|NCT00688194|Letrozole|letrozole|mesh-list
110549475|NCT00688194|Fulvestrant|fulvestrant|mesh-list
110549476|NCT00688194|Lapatinib|lapatinib|mesh-list
110549477|NCT00688194|Anastrozole|anastrozole|mesh-list
110549478|NCT00688194|Exemestane|exemestane|mesh-list
110549479|NCT00688194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110549480|NCT00688194|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110549481|NCT00688194|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110549482|NCT00688194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110549483|NCT00688194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110549484|NCT00688194|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110549485|NCT00688194|Hormone Antagonists|hormone antagonists|mesh-ancestor
110549486|NCT00688194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110179623|NCT00012038|Irofulven|irofulven|mesh-list
110549487|NCT00688194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110549488|NCT00688194|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110549489|NCT00688194|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110549490|NCT00688194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110549491|NCT00653744|Atorvastatin|atorvastatin|mesh-list
110549492|NCT00653744|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110549493|NCT00653744|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110549494|NCT00653744|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110549495|NCT00653744|Antimetabolites|antimetabolites|mesh-ancestor
110549496|NCT00653744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110549497|NCT00653744|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110549498|NCT00653744|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110549499|NCT00653744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110549500|NCT03322267|Cisplatin|cisplatin|mesh-list
110549501|NCT03322267|Pembrolizumab|pembrolizumab|mesh-list
110549502|NCT03322267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110549503|NCT03322267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110549504|NCT03322267|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110549505|NCT03322267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110549506|NCT00652496|Bimatoprost|bimatoprost|mesh-list
110549507|NCT00652496|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110549508|NCT00652496|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110549509|NCT00652496|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110549510|NCT00688272|Ciprofloxacin|ciprofloxacin|mesh-list
110549511|NCT00688272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110549512|NCT00688272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110549513|NCT00688272|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110549514|NCT00688272|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110549515|NCT00688272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110549516|NCT00688272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110549517|NCT00688272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110549518|NCT00688272|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110549519|NCT00688272|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110549520|NCT00993343|Cyclosporine|cyclosporine|mesh-list
110549521|NCT00993343|Sirolimus|sirolimus|mesh-list
110549522|NCT00993343|Methotrexate|methotrexate|mesh-list
110549523|NCT00993343|Tacrolimus|tacrolimus|mesh-list
110549524|NCT00993343|Cyclosporins|cyclosporins|mesh-list
110549525|NCT00993343|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110549526|NCT00993343|Abortifacient Agents|abortifacient agents|mesh-ancestor
110549527|NCT00993343|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110549528|NCT00993343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110549529|NCT00993343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110549530|NCT00993343|Antimetabolites|antimetabolites|mesh-ancestor
110549531|NCT00993343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110549532|NCT00993343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110549533|NCT00993343|Dermatologic Agents|dermatologic agents|mesh-ancestor
110549534|NCT00993343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110549535|NCT00993343|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110549536|NCT00993343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110549537|NCT00993343|Immunologic Factors|immunologic factors|mesh-ancestor
110549538|NCT00993343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110549539|NCT00993343|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110549540|NCT00993343|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110549541|NCT00993343|Antifungal Agents|antifungal agents|mesh-ancestor
110549542|NCT00993343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110549543|NCT00993343|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110549544|NCT00993343|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110549545|NCT02974049|Ivermectin|ivermectin|mesh-list
110549546|NCT02974049|Albendazole|albendazole|mesh-list
110549547|NCT02974049|Diethylcarbamazine|diethylcarbamazine|mesh-list
110549548|NCT02974049|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110549549|NCT02974049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110549550|NCT02974049|Anthelmintics|anthelmintics|mesh-ancestor
110549551|NCT02974049|Anticestodal Agents|anticestodal agents|mesh-ancestor
110549552|NCT02974049|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110549553|NCT02974049|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110549554|NCT02974049|Tubulin Modulators|tubulin modulators|mesh-ancestor
110549555|NCT02974049|Antimitotic Agents|antimitotic agents|mesh-ancestor
110549556|NCT02974049|Mitosis Modulators|mitosis modulators|mesh-ancestor
110549557|NCT02974049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110549558|NCT02974049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110549559|NCT02974049|Filaricides|filaricides|mesh-ancestor
110549560|NCT02974049|Antinematodal Agents|antinematodal agents|mesh-ancestor
110549561|NCT02974049|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
110549562|NCT02974049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110549563|NCT02637284|BPC 157|bpc 157|mesh-list
110549564|NCT02637284|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110549565|NCT02637284|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110549566|NCT04138992|Bevacizumab|bevacizumab|mesh-list
110549567|NCT04138992|Cisplatin|cisplatin|mesh-list
110549568|NCT04138992|Docetaxel|docetaxel|mesh-list
110549569|NCT04138992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110549570|NCT04138992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110549571|NCT04138992|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110549572|NCT04138992|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110549573|NCT04138992|Growth Substances|growth substances|mesh-ancestor
110549574|NCT04138992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110549575|NCT04138992|Growth Inhibitors|growth inhibitors|mesh-ancestor
110549576|NCT04138992|Tubulin Modulators|tubulin modulators|mesh-ancestor
110549577|NCT04138992|Antimitotic Agents|antimitotic agents|mesh-ancestor
110549578|NCT04138992|Mitosis Modulators|mitosis modulators|mesh-ancestor
110549579|NCT04138992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110549580|NCT04137588|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
110549581|NCT04137588|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
110549582|NCT04137588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110549583|NCT04137588|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110549584|NCT04137588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110549585|NCT04137588|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110549586|NCT04137588|Growth Substances|growth substances|mesh-ancestor
110549587|NCT04137588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110549588|NCT04137588|Growth Inhibitors|growth inhibitors|mesh-ancestor
110549590|NCT02721329|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110549591|NCT02721329|Analgesics|analgesics|mesh-ancestor
110549592|NCT02721329|Sensory System Agents|sensory system agents|mesh-ancestor
110549593|NCT02721329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110549594|NCT02721329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110549595|NCT02721329|Antipyretics|antipyretics|mesh-ancestor
110549596|NCT02637128|Artesunate|artesunate|mesh-list
110549597|NCT02637128|Lumefantrine|lumefantrine|mesh-list
110549598|NCT02637128|Artemether|artemether|mesh-list
110549599|NCT02637128|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
110549600|NCT02637128|Amodiaquine|amodiaquine|mesh-list
110549601|NCT02637128|Antimalarials|antimalarials|mesh-ancestor
110549602|NCT02637128|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110549603|NCT02637128|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110549604|NCT02637128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110549605|NCT02637128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110549606|NCT02637128|Antiviral Agents|antiviral agents|mesh-ancestor
110549607|NCT02637128|Schistosomicides|schistosomicides|mesh-ancestor
110549608|NCT02637128|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110549609|NCT02637128|Anthelmintics|anthelmintics|mesh-ancestor
110549610|NCT02624622|Chlorhexidine|chlorhexidine|mesh-list
110549611|NCT02624622|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110549612|NCT02624622|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110549613|NCT02624622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110549614|NCT02624622|Disinfectants|disinfectants|mesh-ancestor
110549615|NCT02624622|Dermatologic Agents|dermatologic agents|mesh-ancestor
110549616|NCT00585247|Imiquimod|imiquimod|mesh-list
110549617|NCT00585247|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110549618|NCT00585247|Immunologic Factors|immunologic factors|mesh-ancestor
110549619|NCT00585247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110549620|NCT00585247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110549621|NCT00585247|Interferon Inducers|interferon inducers|mesh-ancestor
110549622|NCT04002349|Budesonide|budesonide|mesh-list
110197222|NCT00041990|Decitabine|decitabine|mesh-list
110549623|NCT04002349|Levocabastine|levocabastine|mesh-list
110549624|NCT04002349|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110549625|NCT04002349|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110549626|NCT04002349|Autonomic Agents|autonomic agents|mesh-ancestor
110549627|NCT04002349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110549628|NCT04002349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110549629|NCT04002349|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110549630|NCT04002349|Respiratory System Agents|respiratory system agents|mesh-ancestor
110549631|NCT04002349|Glucocorticoids|glucocorticoids|mesh-ancestor
110549632|NCT04002349|Hormones|hormones|mesh-ancestor
110549633|NCT04002349|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110549634|NCT04002349|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110549635|NCT04002349|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110549636|NCT04002349|Histamine Antagonists|histamine antagonists|mesh-ancestor
110549637|NCT04002349|Histamine Agents|histamine agents|mesh-ancestor
110549638|NCT04002349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110549639|NCT04002349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110549640|NCT00688428|Aspirin|aspirin|mesh-list
110549641|NCT00688428|Esomeprazole|esomeprazole|mesh-list
110549642|NCT00688428|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110549643|NCT00688428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110549644|NCT00688428|Analgesics|analgesics|mesh-ancestor
110549645|NCT00688428|Sensory System Agents|sensory system agents|mesh-ancestor
110549646|NCT00688428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110549647|NCT00688428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110549648|NCT00688428|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110549649|NCT00688428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110549650|NCT00688428|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110549651|NCT00688428|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110549652|NCT00688428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110549653|NCT00688428|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110549654|NCT00688428|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110549655|NCT00688428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110549656|NCT00688428|Antipyretics|antipyretics|mesh-ancestor
110549657|NCT00688428|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110549658|NCT00688428|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110549659|NCT00688428|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110549660|NCT02724761|Epinephrine|epinephrine|mesh-list
110549661|NCT02724761|Racepinephrine|racepinephrine|mesh-list
110549662|NCT02724761|Epinephryl borate|epinephryl borate|mesh-list
110549663|NCT02724761|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110549664|NCT02724761|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110549665|NCT02724761|Adrenergic Agents|adrenergic agents|mesh-ancestor
110549666|NCT02724761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110549667|NCT02724761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110549668|NCT02724761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110549669|NCT02724761|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110549670|NCT02724761|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110549671|NCT02724761|Autonomic Agents|autonomic agents|mesh-ancestor
110549672|NCT02724761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110549673|NCT02724761|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110549674|NCT02724761|Respiratory System Agents|respiratory system agents|mesh-ancestor
110549675|NCT02724761|Mydriatics|mydriatics|mesh-ancestor
110549676|NCT02724761|Sympathomimetics|sympathomimetics|mesh-ancestor
110549677|NCT02724761|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110549678|NCT04350190|Apatinib|apatinib|mesh-list
110549679|NCT04350190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110549680|NCT04350190|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110549681|NCT04350190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110549682|NCT04350190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110549683|NCT02721173|Clindamycin|clindamycin|mesh-list
110549684|NCT02721173|Clindamycin palmitate|clindamycin palmitate|mesh-list
110549685|NCT02721173|Clindamycin phosphate|clindamycin phosphate|mesh-list
110549686|NCT02721173|Adapalene|adapalene|mesh-list
110549687|NCT02721173|Tazarotene|tazarotene|mesh-list
110549688|NCT02721173|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110549689|NCT02721173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110549690|NCT02721173|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110549691|NCT02721173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110549692|NCT02721173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110549693|NCT02721173|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110549694|NCT02721173|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110549695|NCT02721173|Analgesics|analgesics|mesh-ancestor
110549696|NCT02721173|Sensory System Agents|sensory system agents|mesh-ancestor
110549697|NCT02721173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110549698|NCT02721173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110549699|NCT02721173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110549700|NCT02721173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110549701|NCT02721173|Dermatologic Agents|dermatologic agents|mesh-ancestor
110549702|NCT02721173|Keratolytic Agents|keratolytic agents|mesh-ancestor
110549704|NCT00713986|Cariostatic Agents|cariostatic agents|mesh-ancestor
110549705|NCT00713986|Protective Agents|protective agents|mesh-ancestor
110549706|NCT00713986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110549707|NCT00993733|Dialysis Solutions|dialysis solutions|mesh-list
110549708|NCT00993733|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110549709|NCT00692640|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110549710|NCT00692640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110549711|NCT00692640|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110549712|NCT00692640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110549713|NCT00692640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110549714|NCT04137432|Oxytocin|oxytocin|mesh-list
110549715|NCT04137432|Oxytocics|oxytocics|mesh-ancestor
110549716|NCT04137432|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110549717|NCT04137432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110549718|NCT00885170|Vitamin D|vitamin d|mesh-list
110549719|NCT00885170|Cholecalciferol|cholecalciferol|mesh-list
110549720|NCT00885170|Calcium|calcium|mesh-list
110549721|NCT00885170|Vitamins|vitamins|mesh-ancestor
110549722|NCT00885170|Micronutrients|micronutrients|mesh-ancestor
110549723|NCT00885170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110549724|NCT00885170|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110549725|NCT00885170|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110549726|NCT05342467|Dinoprostone|dinoprostone|mesh-list
110549727|NCT05342467|Gemeprost|gemeprost|mesh-list
110549729|NCT05342467|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110549730|NCT05342467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110549731|NCT05342467|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110549732|NCT05342467|Abortifacient Agents|abortifacient agents|mesh-ancestor
110549733|NCT02720783|Econazole|econazole|mesh-list
110549734|NCT02720783|Benzydamine|benzydamine|mesh-list
110549735|NCT02720783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110549736|NCT02720783|Antifungal Agents|antifungal agents|mesh-ancestor
110549737|NCT02720783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110549738|NCT02720783|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110549739|NCT02720783|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110549740|NCT02720783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110549741|NCT02720783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110549742|NCT02720783|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110549743|NCT02720783|Hormone Antagonists|hormone antagonists|mesh-ancestor
110549744|NCT02720783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110549745|NCT02720783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110549747|NCT00714064|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110549748|NCT00714064|Pentetic Acid|pentetic acid|mesh-list
110549749|NCT00714064|Immunologic Factors|immunologic factors|mesh-ancestor
110549750|NCT00714064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110549751|NCT00714064|Antidotes|antidotes|mesh-ancestor
110549752|NCT00714064|Protective Agents|protective agents|mesh-ancestor
110549753|NCT00714064|Chelating Agents|chelating agents|mesh-ancestor
110549754|NCT00714064|Sequestering Agents|sequestering agents|mesh-ancestor
110549755|NCT00714064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110549756|NCT00714064|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110549757|NCT00714064|Anticoagulants|anticoagulants|mesh-ancestor
110549758|NCT00714064|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110549759|NCT02720705|Dexmedetomidine|dexmedetomidine|mesh-list
110549760|NCT02720705|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110549761|NCT02720705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110549762|NCT02720705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110549763|NCT02720705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110549764|NCT02720705|Analgesics|analgesics|mesh-ancestor
110549765|NCT02720705|Sensory System Agents|sensory system agents|mesh-ancestor
110549766|NCT02720705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110549767|NCT02720705|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110549768|NCT02720705|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110549769|NCT02720705|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110549770|NCT02720705|Adrenergic Agents|adrenergic agents|mesh-ancestor
110549771|NCT02720705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110549772|NCT02720705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110549773|NCT02720471|Anesthetics|anesthetics|mesh-list
110549774|NCT02720471|Anesthetics, Local|anesthetics, local|mesh-list
110549775|NCT02720471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110549776|NCT02720471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110549777|NCT02720471|Sensory System Agents|sensory system agents|mesh-ancestor
110549778|NCT02720471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110549779|NCT00688818|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110549780|NCT00688818|Antidepressive Agents|antidepressive agents|mesh-ancestor
110549781|NCT00688818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110549782|NCT00688818|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110549783|NCT00688818|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110549784|NCT00688818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110549785|NCT00688818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110549786|NCT00656006|Ribavirin|ribavirin|mesh-list
110179701|NCT00012350|Tipifarnib|tipifarnib|mesh-list
110549787|NCT00656006|Antimetabolites|antimetabolites|mesh-ancestor
110549788|NCT00656006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110549789|NCT00656006|Antiviral Agents|antiviral agents|mesh-ancestor
110549790|NCT00656006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110549791|NCT00688896|Pravastatin|pravastatin|mesh-list
110549792|NCT00688896|Dalcetrapib|dalcetrapib|mesh-list
110549793|NCT00688896|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110549794|NCT00688896|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110549795|NCT00688896|Antimetabolites|antimetabolites|mesh-ancestor
110549796|NCT00688896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110549797|NCT00688896|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110549798|NCT00688896|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110549799|NCT00688896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110549800|NCT02724293|Pregabalin|pregabalin|mesh-list
110549801|NCT02724293|Analgesics|analgesics|mesh-ancestor
110549802|NCT02724293|Sensory System Agents|sensory system agents|mesh-ancestor
110549803|NCT02724293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110549804|NCT02724293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110549805|NCT02724293|Anticonvulsants|anticonvulsants|mesh-ancestor
110549806|NCT02724293|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110549807|NCT02724293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110549808|NCT02724293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110549809|NCT02724293|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110549810|NCT02724293|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110549811|NCT02724293|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110549812|NCT02724293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110549813|NCT02724293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110549814|NCT05092828|Morphine|morphine|mesh-list
110549815|NCT05092828|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110549816|NCT05092828|Narcotics|narcotics|mesh-ancestor
110549817|NCT05092828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110312557|NCT00295100|Tamoxifen|tamoxifen|mesh-list
110549818|NCT05092828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110549819|NCT05092828|Analgesics|analgesics|mesh-ancestor
110549820|NCT05092828|Sensory System Agents|sensory system agents|mesh-ancestor
110549821|NCT05092828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110549822|NCT04137198|Sufentanil|sufentanil|mesh-list
110549823|NCT04137198|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110549824|NCT04137198|Narcotics|narcotics|mesh-ancestor
110549825|NCT04137198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110549826|NCT04137198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110549827|NCT04137198|Analgesics|analgesics|mesh-ancestor
110549828|NCT04137198|Sensory System Agents|sensory system agents|mesh-ancestor
110549829|NCT04137198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110549830|NCT04137198|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110549831|NCT04137198|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110549832|NCT04137198|Anesthetics, General|anesthetics, general|mesh-ancestor
110549833|NCT04137198|Anesthetics|anesthetics|mesh-ancestor
110549834|NCT00995293|Docetaxel|docetaxel|mesh-list
110549835|NCT00995293|Fluorouracil|fluorouracil|mesh-list
110549836|NCT00995293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110549837|NCT00995293|Tubulin Modulators|tubulin modulators|mesh-ancestor
110549838|NCT00995293|Antimitotic Agents|antimitotic agents|mesh-ancestor
110549839|NCT00995293|Mitosis Modulators|mitosis modulators|mesh-ancestor
110549840|NCT00995293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110549841|NCT00995293|Antimetabolites|antimetabolites|mesh-ancestor
110549842|NCT00995293|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110549843|NCT00995293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110549844|NCT00995293|Immunologic Factors|immunologic factors|mesh-ancestor
110549845|NCT00995293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110549846|NCT00692952|Benzalkonium Compounds|benzalkonium compounds|mesh-list
110549847|NCT00692952|Contraceptive Agents|contraceptive agents|mesh-list
110549849|NCT00692952|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110549850|NCT00692952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110549851|NCT00692952|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110549852|NCT00692952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110549853|NCT00692952|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
110549854|NCT00692952|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
110549855|NCT00692952|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110549856|NCT00692952|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110549857|NCT02639858|Docetaxel|docetaxel|mesh-list
110549858|NCT02639858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110549859|NCT02639858|Tubulin Modulators|tubulin modulators|mesh-ancestor
110549860|NCT02639858|Antimitotic Agents|antimitotic agents|mesh-ancestor
110549861|NCT02639858|Mitosis Modulators|mitosis modulators|mesh-ancestor
110549862|NCT02639858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110549864|NCT00689208|Physostigmine|physostigmine|mesh-list
110549865|NCT00689208|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110549866|NCT00689208|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110549867|NCT00689208|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110549868|NCT00689208|Autonomic Agents|autonomic agents|mesh-ancestor
110549869|NCT00689208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110549870|NCT00689208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110549871|NCT00689208|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110549872|NCT00689208|Respiratory System Agents|respiratory system agents|mesh-ancestor
110549873|NCT00689208|Mydriatics|mydriatics|mesh-ancestor
110549874|NCT00689208|Parasympatholytics|parasympatholytics|mesh-ancestor
110549875|NCT00689208|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110549876|NCT00689208|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110549877|NCT00689208|Cholinergic Agents|cholinergic agents|mesh-ancestor
110549878|NCT00689208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110549879|NCT00689208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110549880|NCT00689208|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110549881|NCT00689208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110549882|NCT00689208|Miotics|miotics|mesh-ancestor
110549883|NCT00726466|Ranibizumab|ranibizumab|mesh-list
110549884|NCT00726466|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110549885|NCT00726466|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110549886|NCT00726466|Growth Substances|growth substances|mesh-ancestor
110549887|NCT00726466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110549888|NCT00726466|Growth Inhibitors|growth inhibitors|mesh-ancestor
110549889|NCT00726466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110549890|NCT02694263|Pioglitazone|pioglitazone|mesh-list
110549891|NCT02694263|Glimepiride|glimepiride|mesh-list
110549892|NCT02694263|Canagliflozin|canagliflozin|mesh-list
110549893|NCT02694263|Repaglinide|repaglinide|mesh-list
110549894|NCT02694263|Gliclazide|gliclazide|mesh-list
110549895|NCT02694263|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110549896|NCT02694263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110549897|NCT02694263|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110549898|NCT02694263|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110549899|NCT02694263|Immunologic Factors|immunologic factors|mesh-ancestor
110549900|NCT02694263|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110549901|NCT02694263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110549903|NCT04139070|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110549904|NCT04139070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110549905|NCT00693030|Sirolimus|sirolimus|mesh-list
110549906|NCT00693030|Paclitaxel|paclitaxel|mesh-list
110549907|NCT00693030|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110549908|NCT00693030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110549909|NCT00693030|Tubulin Modulators|tubulin modulators|mesh-ancestor
110549910|NCT00693030|Antimitotic Agents|antimitotic agents|mesh-ancestor
110549911|NCT00693030|Mitosis Modulators|mitosis modulators|mesh-ancestor
110549912|NCT00693030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110549913|NCT00693030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110549914|NCT00693030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110549915|NCT00693030|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110549916|NCT00693030|Antifungal Agents|antifungal agents|mesh-ancestor
110549917|NCT00693030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110549918|NCT00693030|Immunologic Factors|immunologic factors|mesh-ancestor
110549919|NCT00693030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110549920|NCT00653822|Alefacept|alefacept|mesh-list
110549921|NCT00653822|Dermatologic Agents|dermatologic agents|mesh-ancestor
110549922|NCT00653822|Immunologic Factors|immunologic factors|mesh-ancestor
110549923|NCT00653822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110549924|NCT04137276|Vitamins|vitamins|mesh-list
110549925|NCT04137276|Thiamine|thiamine|mesh-list
110549926|NCT04137276|Vitamin B Complex|vitamin b complex|mesh-list
110549927|NCT04137276|Micronutrients|micronutrients|mesh-ancestor
110549928|NCT04137276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110549929|NCT02723981|Vitamins|vitamins|mesh-list
110549931|NCT02723981|Rivaroxaban|rivaroxaban|mesh-list
110549932|NCT02723981|Dabigatran|dabigatran|mesh-list
110549933|NCT02723981|Anticoagulants|anticoagulants|mesh-list
110549934|NCT02723981|Clopidogrel|clopidogrel|mesh-list
110549935|NCT02723981|Micronutrients|micronutrients|mesh-ancestor
110549936|NCT02723981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110549937|NCT02723981|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110549938|NCT02723981|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110549939|NCT02723981|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110549940|NCT02723981|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110549941|NCT02723981|Purinergic Agents|purinergic agents|mesh-ancestor
110549942|NCT02723981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110549943|NCT02723981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110549944|NCT02723981|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110549945|NCT02723981|Antithrombins|antithrombins|mesh-ancestor
110549946|NCT02723981|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110549947|NCT02723981|Protease Inhibitors|protease inhibitors|mesh-ancestor
110549948|NCT02723981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110549949|NCT02723981|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110549950|NCT02723981|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110549951|NCT02723981|Hemostatics|hemostatics|mesh-ancestor
110549952|NCT02723981|Coagulants|coagulants|mesh-ancestor
110549953|NCT00912444|Cyclophosphamide|cyclophosphamide|mesh-list
110549954|NCT00912444|Docetaxel|docetaxel|mesh-list
110549955|NCT00912444|Doxorubicin|doxorubicin|mesh-list
110549956|NCT00912444|Epirubicin|epirubicin|mesh-list
110549957|NCT00912444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110549958|NCT00912444|Immunologic Factors|immunologic factors|mesh-ancestor
110549959|NCT00912444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110549960|NCT00912444|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110549961|NCT00912444|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110549962|NCT00912444|Alkylating Agents|alkylating agents|mesh-ancestor
110549963|NCT00912444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110549964|NCT00912444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110549965|NCT00912444|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110549966|NCT00912444|Tubulin Modulators|tubulin modulators|mesh-ancestor
110549967|NCT00912444|Antimitotic Agents|antimitotic agents|mesh-ancestor
110549968|NCT00912444|Mitosis Modulators|mitosis modulators|mesh-ancestor
110179743|NCT00012467|Amebicides|amebicides|mesh-ancestor
110549969|NCT00912444|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110549970|NCT00912444|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110549971|NCT00912444|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110549973|NCT02644525|Imatinib Mesylate|imatinib mesylate|mesh-list
110549974|NCT02644525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110549975|NCT02644525|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110549976|NCT02644525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110549977|NCT02644525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110549979|NCT00726700|Cyclophosphamide|cyclophosphamide|mesh-list
110549980|NCT00726700|Rituximab|rituximab|mesh-list
110549981|NCT00726700|Doxorubicin|doxorubicin|mesh-list
110549982|NCT00726700|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110549983|NCT00726700|Vincristine|vincristine|mesh-list
110549984|NCT00726700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110549985|NCT00726700|Immunologic Factors|immunologic factors|mesh-ancestor
110549986|NCT00726700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110549987|NCT00726700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110549988|NCT00726700|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110549989|NCT00726700|Alkylating Agents|alkylating agents|mesh-ancestor
110549990|NCT00726700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110549991|NCT00726700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110549992|NCT00726700|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110549993|NCT00726700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110549994|NCT00726700|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110549995|NCT00726700|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110549996|NCT00726700|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110549997|NCT00726700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110549998|NCT00726700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110549999|NCT00726700|Glucocorticoids|glucocorticoids|mesh-ancestor
110550000|NCT00726700|Hormones|hormones|mesh-ancestor
110550001|NCT00726700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110550002|NCT00726700|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110550003|NCT00726700|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110550004|NCT00726700|Tubulin Modulators|tubulin modulators|mesh-ancestor
110550005|NCT00726700|Antimitotic Agents|antimitotic agents|mesh-ancestor
110550006|NCT00726700|Mitosis Modulators|mitosis modulators|mesh-ancestor
110550007|NCT02723903|Fluoxetine|fluoxetine|mesh-list
110550008|NCT02723903|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110550009|NCT02723903|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110550010|NCT02723903|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110550011|NCT02723903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110550012|NCT02723903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110550013|NCT02723903|Serotonin Agents|serotonin agents|mesh-ancestor
110550014|NCT02723903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110550015|NCT02723903|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110550016|NCT02723903|Antidepressive Agents|antidepressive agents|mesh-ancestor
110550017|NCT02723903|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110550018|NCT02723903|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110550019|NCT02723903|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110550020|NCT02723903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110550021|NCT00675714|Nandrolone Decanoate|nandrolone decanoate|mesh-list
110550022|NCT00675714|Itraconazole|itraconazole|mesh-list
110550023|NCT00675714|Fluconazole|fluconazole|mesh-list
110550024|NCT00675714|Ketoconazole|ketoconazole|mesh-list
110550025|NCT00675714|Methyltestosterone|methyltestosterone|mesh-list
110550026|NCT00675714|Propranolol|propranolol|mesh-list
110550027|NCT00675714|Metoprolol|metoprolol|mesh-list
110550028|NCT00675714|Hormones|hormones|mesh-list
110550029|NCT00675714|Testosterone|testosterone|mesh-list
110550030|NCT00675714|Testosterone undecanoate|testosterone undecanoate|mesh-list
110550031|NCT00675714|Testosterone enanthate|testosterone enanthate|mesh-list
110550032|NCT00675714|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
110550033|NCT00675714|Oxandrolone|oxandrolone|mesh-list
110550034|NCT00675714|Nandrolone|nandrolone|mesh-list
110550035|NCT00675714|Nandrolone phenpropionate|nandrolone phenpropionate|mesh-list
110550036|NCT00675714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110550037|NCT00675714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110550038|NCT00675714|Androgens|androgens|mesh-ancestor
110550039|NCT00675714|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110550040|NCT00675714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110550041|NCT00675714|Anabolic Agents|anabolic agents|mesh-ancestor
110550042|NCT00675714|Antifungal Agents|antifungal agents|mesh-ancestor
110550043|NCT00675714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110550044|NCT00675714|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110550045|NCT00675714|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110550046|NCT00675714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110550047|NCT00675714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110550048|NCT00675714|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110550049|NCT00675714|Hormone Antagonists|hormone antagonists|mesh-ancestor
110550050|NCT00675714|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110550051|NCT00675714|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110550052|NCT00675714|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110550053|NCT00675714|Adrenergic Agents|adrenergic agents|mesh-ancestor
110550054|NCT00675714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110550055|NCT00675714|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110550056|NCT00675714|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110550057|NCT00675714|Vasodilator Agents|vasodilator agents|mesh-ancestor
110550058|NCT00675714|Sympatholytics|sympatholytics|mesh-ancestor
110550059|NCT00675714|Autonomic Agents|autonomic agents|mesh-ancestor
110550060|NCT00675714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110550061|NCT00675714|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110550062|NCT00675714|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110550063|NCT00675714|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110550064|NCT00675714|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110550065|NCT00656240|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110550066|NCT00656240|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110550067|NCT00729976|Ibuprofen|ibuprofen|mesh-list
110550068|NCT00729976|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110550069|NCT00729976|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110550070|NCT00729976|Analgesics|analgesics|mesh-ancestor
110550071|NCT00729976|Sensory System Agents|sensory system agents|mesh-ancestor
110550072|NCT00729976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110550073|NCT00729976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110550074|NCT00729976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110550075|NCT00729976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110550076|NCT00729976|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110550077|NCT00729976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110197668|NCT00402259|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110550078|NCT00729976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110550079|NCT00656318|Contraceptive Agents|contraceptive agents|mesh-list
110550080|NCT00656318|Contraceptives, Oral|contraceptives, oral|mesh-list
110550081|NCT00656318|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
110550082|NCT00656318|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110550083|NCT00656318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110550084|NCT00656318|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110550086|NCT02451553|Afatinib|afatinib|mesh-list
110550087|NCT02451553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110550088|NCT02451553|Antimetabolites|antimetabolites|mesh-ancestor
110550089|NCT02451553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110550090|NCT02451553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110550091|NCT02451553|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110550092|NCT02451553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110550093|NCT02636816|Carbetocin|carbetocin|mesh-list
110550094|NCT02636816|Oxytocics|oxytocics|mesh-ancestor
110550095|NCT02636816|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110550096|NCT02636816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110550097|NCT00730054|Clonidine|clonidine|mesh-list
110550098|NCT00730054|Remifentanil|remifentanil|mesh-list
110550099|NCT00730054|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110550100|NCT00730054|Narcotics|narcotics|mesh-ancestor
110550101|NCT00730054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110550102|NCT00730054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110550103|NCT00730054|Analgesics|analgesics|mesh-ancestor
110550104|NCT00730054|Sensory System Agents|sensory system agents|mesh-ancestor
110550105|NCT00730054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110550106|NCT00730054|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110550107|NCT00730054|Sympatholytics|sympatholytics|mesh-ancestor
110550108|NCT00730054|Autonomic Agents|autonomic agents|mesh-ancestor
110550109|NCT00730054|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110550110|NCT00730054|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110550111|NCT00730054|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110550112|NCT00730054|Adrenergic Agents|adrenergic agents|mesh-ancestor
110550113|NCT00730054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110550114|NCT00730054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110550115|NCT00866619|Vaccines|vaccines|mesh-list
110550116|NCT00866619|Immunologic Factors|immunologic factors|mesh-ancestor
110550117|NCT00866619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110550118|NCT00693108|Testosterone|testosterone|mesh-list
110550119|NCT00693108|Androgens|androgens|mesh-ancestor
110550120|NCT00693108|Hormones|hormones|mesh-ancestor
110550121|NCT00693108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110209053|NCT00084591|Capecitabine|capecitabine|mesh-list
110550122|NCT00693108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110550124|NCT00884390|Coagulants|coagulants|mesh-ancestor
110550125|NCT02723669|Acetylcysteine|acetylcysteine|mesh-list
110550126|NCT02723669|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110550127|NCT02723669|Antiviral Agents|antiviral agents|mesh-ancestor
110550128|NCT02723669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110550129|NCT02723669|Expectorants|expectorants|mesh-ancestor
110550130|NCT02723669|Respiratory System Agents|respiratory system agents|mesh-ancestor
110550131|NCT02723669|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110550132|NCT02723669|Antioxidants|antioxidants|mesh-ancestor
110550133|NCT02723669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110550134|NCT02723669|Protective Agents|protective agents|mesh-ancestor
110550135|NCT02723669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110550136|NCT02723669|Antidotes|antidotes|mesh-ancestor
110550137|NCT02719379|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110550138|NCT02719379|Immunologic Factors|immunologic factors|mesh-ancestor
110550139|NCT02719379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110550140|NCT00689442|Atorvastatin|atorvastatin|mesh-list
110550141|NCT00689442|Dalcetrapib|dalcetrapib|mesh-list
110550142|NCT00689442|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110550143|NCT00689442|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110550144|NCT00689442|Antimetabolites|antimetabolites|mesh-ancestor
110550145|NCT00689442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110550146|NCT00689442|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110550147|NCT00689442|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110550148|NCT00689442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110550149|NCT02625636|Glucagon|glucagon|mesh-list
110197755|NCT00122863|Analgesics|analgesics|mesh-ancestor
110550150|NCT02625636|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
110550151|NCT02625636|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110550152|NCT02625636|Hormones|hormones|mesh-ancestor
110550153|NCT02625636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110550154|NCT02625636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110550155|NCT02625636|Incretins|incretins|mesh-ancestor
110550156|NCT03012100|Cyclophosphamide|cyclophosphamide|mesh-list
110550157|NCT03012100|Vaccines|vaccines|mesh-list
110550158|NCT03012100|Sargramostim|sargramostim|mesh-list
110550159|NCT03012100|Immunologic Factors|immunologic factors|mesh-ancestor
110550160|NCT03012100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110550161|NCT03012100|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110550162|NCT03012100|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110550163|NCT03012100|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110550164|NCT03012100|Alkylating Agents|alkylating agents|mesh-ancestor
110550165|NCT03012100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110550166|NCT03012100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110550167|NCT03012100|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110550168|NCT02379247|Paclitaxel|paclitaxel|mesh-list
110550169|NCT02379247|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110550170|NCT02379247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110550171|NCT02379247|Tubulin Modulators|tubulin modulators|mesh-ancestor
110550172|NCT02379247|Antimitotic Agents|antimitotic agents|mesh-ancestor
110550173|NCT02379247|Mitosis Modulators|mitosis modulators|mesh-ancestor
110550174|NCT02379247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110550175|NCT00689520|Vitamin K|vitamin k|mesh-list
110550176|NCT00689520|Tinzaparin|tinzaparin|mesh-list
110550177|NCT00689520|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
110550178|NCT00689520|Dalteparin|dalteparin|mesh-list
110550179|NCT00689520|Acenocoumarol|acenocoumarol|mesh-list
110550180|NCT00689520|Vitamins|vitamins|mesh-ancestor
110550181|NCT00689520|Micronutrients|micronutrients|mesh-ancestor
110550182|NCT00689520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110550183|NCT00689520|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110550184|NCT00689520|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110550185|NCT00689520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110550186|NCT00689520|Hemostatics|hemostatics|mesh-ancestor
110550187|NCT00689520|Coagulants|coagulants|mesh-ancestor
110550188|NCT00689520|Anticoagulants|anticoagulants|mesh-ancestor
110550189|NCT00689520|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110550190|NCT02723279|Tolterodine Tartrate|tolterodine tartrate|mesh-list
110550191|NCT02723279|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110550192|NCT02723279|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110550193|NCT02723279|Cholinergic Agents|cholinergic agents|mesh-ancestor
110179865|NCT00846339|Bupropion|bupropion|mesh-list
110550194|NCT02723279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110550195|NCT02723279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110550196|NCT02723279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110550197|NCT02723279|Urological Agents|urological agents|mesh-ancestor
110550198|NCT02615301|Vitamin D|vitamin d|mesh-list
110550199|NCT02615301|Ergocalciferols|ergocalciferols|mesh-list
110550200|NCT02615301|Cholecalciferol|cholecalciferol|mesh-list
110550201|NCT02615301|Vitamins|vitamins|mesh-list
110550202|NCT02615301|Micronutrients|micronutrients|mesh-ancestor
110550203|NCT02615301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110550204|NCT02615301|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110550205|NCT02615301|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110550207|NCT02570230|Analgesics|analgesics|mesh-ancestor
110550208|NCT02570230|Sensory System Agents|sensory system agents|mesh-ancestor
110550209|NCT02570230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110550210|NCT02570230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110550211|NCT02570230|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110550212|NCT02570230|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110550213|NCT02570230|Anesthetics, General|anesthetics, general|mesh-ancestor
110550214|NCT02570230|Anesthetics|anesthetics|mesh-ancestor
110550215|NCT02570230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110550216|NCT02570230|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110550217|NCT02570230|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110550218|NCT02570230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110550219|NCT02570230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110550220|NCT00693342|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
110550221|NCT00693342|Immunologic Factors|immunologic factors|mesh-ancestor
110550222|NCT00693342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110550223|NCT02718911|Durvalumab|durvalumab|mesh-list
110550224|NCT02718911|Tremelimumab|tremelimumab|mesh-list
110550225|NCT02718911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110550226|NCT02718911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110550227|NCT00697905|Carboplatin|carboplatin|mesh-list
110197812|NCT00077727|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110550228|NCT00697905|Gemcitabine|gemcitabine|mesh-list
110550229|NCT00697905|Fluorouracil|fluorouracil|mesh-list
110550230|NCT00697905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110550231|NCT00697905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110550232|NCT00697905|Antimetabolites|antimetabolites|mesh-ancestor
110550233|NCT00697905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110550234|NCT00697905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110550235|NCT00697905|Immunologic Factors|immunologic factors|mesh-ancestor
110550236|NCT00697905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110550237|NCT02718755|Cytarabine|cytarabine|mesh-list
110550238|NCT02718755|Fludarabine|fludarabine|mesh-list
110550239|NCT02718755|Fludarabine phosphate|fludarabine phosphate|mesh-list
110550240|NCT02718755|Asparaginase|asparaginase|mesh-list
110550241|NCT02718755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110550242|NCT02718755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110550243|NCT02718755|Antimetabolites|antimetabolites|mesh-ancestor
110550244|NCT02718755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110550245|NCT02718755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110550246|NCT02718755|Immunologic Factors|immunologic factors|mesh-ancestor
110550247|NCT02718755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110550248|NCT02718755|Antiviral Agents|antiviral agents|mesh-ancestor
110550249|NCT02718755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110550250|NCT00730210|Parathyroid Hormone|parathyroid hormone|mesh-list
110550251|NCT00730210|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110550252|NCT00730210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110550253|NCT00730288|Vaccines|vaccines|mesh-list
110550254|NCT00730288|Immunologic Factors|immunologic factors|mesh-ancestor
110550255|NCT00730288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110550256|NCT00872898|Memantine|memantine|mesh-list
110550257|NCT00872898|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110550258|NCT00872898|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110550259|NCT00872898|Dopamine Agents|dopamine agents|mesh-ancestor
110550260|NCT00872898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110550261|NCT00872898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110550262|NCT00872898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110550263|NCT00872898|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110550264|NCT00872898|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110550265|NCT02723435|Midostaurin|midostaurin|mesh-list
110550266|NCT02723435|Staurosporine|staurosporine|mesh-list
110550268|NCT02723435|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110550269|NCT02723435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110550270|NCT02723435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110550271|NCT02718677|Factor VIII|factor viii|mesh-list
110550272|NCT02718677|Coagulants|coagulants|mesh-ancestor
110550273|NCT04132011|Morphine|morphine|mesh-list
110550274|NCT04132011|Oxycodone|oxycodone|mesh-list
110550275|NCT04132011|Analgesics, Opioid|analgesics, opioid|mesh-list
110550276|NCT04132011|Hydromorphone|hydromorphone|mesh-list
110550277|NCT04132011|Narcotics|narcotics|mesh-ancestor
110550278|NCT04132011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110550279|NCT04132011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110550280|NCT04132011|Analgesics|analgesics|mesh-ancestor
110550281|NCT04132011|Sensory System Agents|sensory system agents|mesh-ancestor
110550282|NCT04132011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110550283|NCT00693576|Simvastatin|simvastatin|mesh-list
110550284|NCT00693576|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110550285|NCT00693576|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110550286|NCT00693576|Antimetabolites|antimetabolites|mesh-ancestor
110550287|NCT00693576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110550288|NCT00693576|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110550289|NCT00693576|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110550290|NCT00693576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110550291|NCT04116047|Durvalumab|durvalumab|mesh-list
110550292|NCT04116047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110550293|NCT04116047|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110550294|NCT00693732|Escitalopram|escitalopram|mesh-list
110550295|NCT00693732|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110550296|NCT00693732|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110550297|NCT00693732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110550298|NCT00693732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110550299|NCT00693732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110550300|NCT00693732|Serotonin Agents|serotonin agents|mesh-ancestor
110550301|NCT00693732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110550302|NCT00689598|Spironolactone|spironolactone|mesh-list
110550303|NCT00689598|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110550304|NCT00689598|Hormone Antagonists|hormone antagonists|mesh-ancestor
110550305|NCT00689598|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110550306|NCT00689598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110550308|NCT00689598|Diuretics|diuretics|mesh-ancestor
110180033|NCT00276705|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110550309|NCT00689598|Natriuretic Agents|natriuretic agents|mesh-ancestor
110550310|NCT04163354|Listerine|listerine|mesh-list
110550311|NCT04163354|Fluorides|fluorides|mesh-list
110550312|NCT04163354|Sodium Fluoride|sodium fluoride|mesh-list
110550313|NCT04163354|Fluorides, Topical|fluorides, topical|mesh-list
110550314|NCT04163354|Cariostatic Agents|cariostatic agents|mesh-ancestor
110550315|NCT04163354|Protective Agents|protective agents|mesh-ancestor
110550316|NCT04163354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110550317|NCT04163354|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110550318|NCT04163354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110550319|NCT04131621|Nivolumab|nivolumab|mesh-list
110550320|NCT04131621|Ipilimumab|ipilimumab|mesh-list
110550321|NCT04131621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110550322|NCT04131621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110550323|NCT04131621|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110550324|NCT04131621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110550325|NCT00689832|Fluticasone|fluticasone|mesh-list
110550326|NCT00689832|Tacrolimus|tacrolimus|mesh-list
110550327|NCT00689832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110550328|NCT00689832|Immunologic Factors|immunologic factors|mesh-ancestor
110550329|NCT00689832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110550330|NCT00689832|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110550331|NCT00689832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110550332|NCT00689832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110550333|NCT00689832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110550334|NCT00689832|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110550335|NCT00689832|Autonomic Agents|autonomic agents|mesh-ancestor
110550336|NCT00689832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110550337|NCT00689832|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110550338|NCT00689832|Respiratory System Agents|respiratory system agents|mesh-ancestor
110550339|NCT00689832|Dermatologic Agents|dermatologic agents|mesh-ancestor
110550340|NCT00689832|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110550341|NCT02718521|Isosorbide|isosorbide|mesh-list
110550342|NCT02718521|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
110550343|NCT02718521|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
110550344|NCT02718521|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110550345|NCT02718521|Diuretics|diuretics|mesh-ancestor
110550346|NCT02718521|Natriuretic Agents|natriuretic agents|mesh-ancestor
110550347|NCT02718521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110550348|NCT02718521|Vasodilator Agents|vasodilator agents|mesh-ancestor
110550349|NCT02718521|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
110550350|NCT02718521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110550351|NCT02718599|Terlipressin|terlipressin|mesh-list
110550352|NCT02718599|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110550353|NCT02718599|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110550354|NCT00693966|Vaccines|vaccines|mesh-list
110550355|NCT00693966|Immunologic Factors|immunologic factors|mesh-ancestor
110550356|NCT00693966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110550357|NCT00694044|Varenicline|varenicline|mesh-list
110550358|NCT00694044|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110550359|NCT00694044|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110550360|NCT00694044|Cholinergic Agents|cholinergic agents|mesh-ancestor
110032222|NCT01396200|Sirolimus|sirolimus|mesh-list
110550361|NCT00694044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110550362|NCT00694044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110550363|NCT00694044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110550364|NCT02722811|Etanercept|etanercept|mesh-list
110550365|NCT02722811|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110550366|NCT02722811|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110550367|NCT02722811|Analgesics|analgesics|mesh-ancestor
110550368|NCT02722811|Sensory System Agents|sensory system agents|mesh-ancestor
110550369|NCT02722811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110550370|NCT02722811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110550371|NCT02722811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110550372|NCT02722811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110550373|NCT02722811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110550374|NCT02722811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110550375|NCT02722811|Immunologic Factors|immunologic factors|mesh-ancestor
110550376|NCT04136886|Cisplatin|cisplatin|mesh-list
110550377|NCT04136886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110550378|NCT04103645|Vactosertib|vactosertib|mesh-list
110550379|NCT04103645|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110550380|NCT04103645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110550381|NCT04103645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110550383|NCT00534313|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110550384|NCT00534313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110550385|NCT00534313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110550386|NCT00534313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110550387|NCT00534313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110550388|NCT00534313|Immunologic Factors|immunologic factors|mesh-ancestor
110550389|NCT00534313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110550390|NCT00534313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110550391|NCT00694200|Bevacizumab|bevacizumab|mesh-list
110550392|NCT00694200|Vinorelbine|vinorelbine|mesh-list
110550393|NCT00694200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110550394|NCT00694200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110550395|NCT00694200|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110550396|NCT00694200|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110550397|NCT00694200|Growth Substances|growth substances|mesh-ancestor
110550398|NCT00694200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110550399|NCT00694200|Growth Inhibitors|growth inhibitors|mesh-ancestor
110550400|NCT00694200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110550401|NCT00694200|Tubulin Modulators|tubulin modulators|mesh-ancestor
110550402|NCT00694200|Antimitotic Agents|antimitotic agents|mesh-ancestor
110550403|NCT00694200|Mitosis Modulators|mitosis modulators|mesh-ancestor
110550404|NCT00694200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110550405|NCT02722733|Cytarabine|cytarabine|mesh-list
110550406|NCT02722733|Lenograstim|lenograstim|mesh-list
110550407|NCT02722733|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110550408|NCT02722733|Immunologic Factors|immunologic factors|mesh-ancestor
110550409|NCT02722733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110550410|NCT02722733|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110550411|NCT02722733|Antimetabolites|antimetabolites|mesh-ancestor
110550412|NCT02722733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110550413|NCT02722733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110550414|NCT02722733|Antiviral Agents|antiviral agents|mesh-ancestor
110550415|NCT02722733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110550416|NCT02722733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110550438|NCT02617290|Clopidogrel|clopidogrel|mesh-list
110550439|NCT02617290|Ticagrelor|ticagrelor|mesh-list
110550440|NCT02617290|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110550441|NCT02617290|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110550442|NCT02617290|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110550443|NCT02617290|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110550444|NCT02617290|Purinergic Agents|purinergic agents|mesh-ancestor
110550445|NCT02617290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110550446|NCT02617290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110550447|NCT02617290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110550448|NCT02717819|Vitamin D|vitamin d|mesh-list
110550449|NCT02717819|Vitamins|vitamins|mesh-ancestor
110550450|NCT02717819|Micronutrients|micronutrients|mesh-ancestor
110198039|NCT00402415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110550451|NCT02717819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110550452|NCT02717819|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110550453|NCT02007655|Apixaban|apixaban|mesh-list
110550454|NCT02007655|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110550455|NCT02007655|Antithrombins|antithrombins|mesh-ancestor
110180147|NCT00014573|Paclitaxel|paclitaxel|mesh-list
110550456|NCT02007655|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110550457|NCT02007655|Protease Inhibitors|protease inhibitors|mesh-ancestor
110550458|NCT02007655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110550459|NCT02007655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110550460|NCT02007655|Anticoagulants|anticoagulants|mesh-ancestor
110550461|NCT05298462|Antibodies|antibodies|mesh-list
110550462|NCT05298462|Immunologic Factors|immunologic factors|mesh-ancestor
110550463|NCT05298462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110550464|NCT00730366|Chloroquine|chloroquine|mesh-list
110550465|NCT00730366|Pyrimethamine|pyrimethamine|mesh-list
110550466|NCT00730366|Sulfadoxine|sulfadoxine|mesh-list
110550467|NCT00730366|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
110550468|NCT00730366|Amebicides|amebicides|mesh-ancestor
110550469|NCT00730366|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110550470|NCT00730366|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110550471|NCT00730366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110550472|NCT00730366|Antimalarials|antimalarials|mesh-ancestor
110550473|NCT00730366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110550474|NCT00730366|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110550475|NCT00730366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110550476|NCT00730366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110550477|NCT00730366|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110550478|NCT02722343|Tenofovir|tenofovir|mesh-list
110550479|NCT02722343|Emtricitabine|emtricitabine|mesh-list
110550480|NCT02722343|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110550481|NCT02722343|Antiviral Agents|antiviral agents|mesh-ancestor
110550482|NCT02722343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110550483|NCT02722343|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110550484|NCT02722343|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110550485|NCT02722343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110550486|NCT02722343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110550487|NCT02722343|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110180179|NCT00276276|Topotecan|topotecan|mesh-list
110180185|NCT00014651|Vapreotide|vapreotide|mesh-list
110550488|NCT02722343|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110550489|NCT00694590|Plerixafor|plerixafor|mesh-list
110550490|NCT00694590|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110550491|NCT00694590|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110550492|NCT00694590|Antiviral Agents|antiviral agents|mesh-ancestor
110550493|NCT00694590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110550494|NCT00730444|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
110550495|NCT00730444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110550496|NCT00730444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110550497|NCT00730444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110550498|NCT00730444|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110550499|NCT03903406|Dexamethasone|dexamethasone|mesh-list
110550500|NCT03903406|Lenalidomide|lenalidomide|mesh-list
110550501|NCT03903406|Ixazomib|ixazomib|mesh-list
110550502|NCT03903406|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110550503|NCT03903406|Antiemetics|antiemetics|mesh-ancestor
110550504|NCT03903406|Autonomic Agents|autonomic agents|mesh-ancestor
110550505|NCT03903406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110550506|NCT03903406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110550507|NCT03903406|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110550508|NCT03903406|Glucocorticoids|glucocorticoids|mesh-ancestor
110550509|NCT03903406|Hormones|hormones|mesh-ancestor
110550510|NCT03903406|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110550511|NCT03903406|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110550512|NCT03903406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110550513|NCT03903406|Immunologic Factors|immunologic factors|mesh-ancestor
110550514|NCT03903406|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110550515|NCT03903406|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110550516|NCT03903406|Growth Substances|growth substances|mesh-ancestor
110550517|NCT03903406|Growth Inhibitors|growth inhibitors|mesh-ancestor
110550518|NCT03903406|Protease Inhibitors|protease inhibitors|mesh-ancestor
110550519|NCT03903406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110550520|NCT03903406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110550521|NCT00594204|Varenicline|varenicline|mesh-list
110550522|NCT00594204|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110550523|NCT00594204|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110550524|NCT00594204|Cholinergic Agents|cholinergic agents|mesh-ancestor
110550525|NCT00594204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110550526|NCT00594204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110550527|NCT00594204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110550528|NCT00999271|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
110550529|NCT00999271|Hormones|hormones|mesh-list
110550530|NCT00999271|Incretins|incretins|mesh-list
110180219|NCT00276081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110211611|NCT00232024|Tegaserod|tegaserod|mesh-list
110550531|NCT00999271|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110550532|NCT00999271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110550533|NCT00999271|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110550534|NCT02716961|Gemcitabine|gemcitabine|mesh-list
110550535|NCT02716961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110550536|NCT02716961|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110550537|NCT02716961|Antimetabolites|antimetabolites|mesh-ancestor
110550538|NCT02716961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110550539|NCT02704156|Gemcitabine|gemcitabine|mesh-list
110550540|NCT02704156|Pembrolizumab|pembrolizumab|mesh-list
110550541|NCT02704156|Trametinib|trametinib|mesh-list
110550542|NCT02704156|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110550543|NCT02704156|Antimetabolites|antimetabolites|mesh-ancestor
110550544|NCT02704156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110550545|NCT02704156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110550546|NCT02704156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110550547|NCT02704156|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110550548|NCT02704156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110550549|NCT02704156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110550550|NCT00912678|Mycophenolic Acid|mycophenolic acid|mesh-list
110550551|NCT00912678|Tacrolimus|tacrolimus|mesh-list
110550552|NCT00912678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110550553|NCT00912678|Immunologic Factors|immunologic factors|mesh-ancestor
110550554|NCT00912678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110550555|NCT00912678|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110550556|NCT00912678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110550557|NCT00912678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110550558|NCT00912678|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110550559|NCT00912678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110550560|NCT00912678|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110550561|NCT00912678|Antitubercular Agents|antitubercular agents|mesh-ancestor
110550562|NCT00912678|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110550563|NCT00912678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110550564|NCT00995839|Terlipressin|terlipressin|mesh-list
110550565|NCT00995839|Vasopressins|vasopressins|mesh-list
110550566|NCT00995839|Arginine Vasopressin|arginine vasopressin|mesh-list
110550567|NCT00995839|Hemostatics|hemostatics|mesh-ancestor
110550568|NCT00995839|Coagulants|coagulants|mesh-ancestor
110550569|NCT00995839|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110550570|NCT00995839|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
110550571|NCT00995839|Natriuretic Agents|natriuretic agents|mesh-ancestor
110550572|NCT00995839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110550573|NCT00995839|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110550574|NCT00994513|Thioctic Acid|thioctic acid|mesh-list
110550575|NCT00994513|Antioxidants|antioxidants|mesh-ancestor
110550576|NCT00994513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110550577|NCT00994513|Protective Agents|protective agents|mesh-ancestor
110550578|NCT00994513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110550579|NCT00994513|Vitamin B Complex|vitamin b complex|mesh-ancestor
110550580|NCT00994513|Vitamins|vitamins|mesh-ancestor
110550581|NCT00994513|Micronutrients|micronutrients|mesh-ancestor
110550582|NCT02616744|Ibandronic Acid|ibandronic acid|mesh-list
110550583|NCT02616744|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110550584|NCT02616744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110550585|NCT00995917|Vitamin K|vitamin k|mesh-list
110550586|NCT00995917|Vitamins|vitamins|mesh-ancestor
110550587|NCT00995917|Micronutrients|micronutrients|mesh-ancestor
110550588|NCT00995917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110550589|NCT00995917|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110550590|NCT00995917|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110550591|NCT00995917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110550592|NCT00995917|Hemostatics|hemostatics|mesh-ancestor
110550593|NCT00995917|Coagulants|coagulants|mesh-ancestor
110550594|NCT02616822|Resveratrol|resveratrol|mesh-list
110550595|NCT02616822|Antioxidants|antioxidants|mesh-ancestor
110550596|NCT02616822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110550597|NCT02616822|Protective Agents|protective agents|mesh-ancestor
110550598|NCT02616822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110550599|NCT02616822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110550600|NCT02616822|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110550601|NCT00912756|Cilostazol|cilostazol|mesh-list
110550602|NCT00912756|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110550603|NCT00912756|Autonomic Agents|autonomic agents|mesh-ancestor
110550604|NCT00912756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110550605|NCT00912756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110550606|NCT00912756|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110550607|NCT00912756|Respiratory System Agents|respiratory system agents|mesh-ancestor
110550608|NCT00912756|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110550609|NCT00912756|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110550610|NCT00912756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110550611|NCT00912756|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110550612|NCT00912756|Vasodilator Agents|vasodilator agents|mesh-ancestor
110550613|NCT00912756|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110550614|NCT00912756|Protective Agents|protective agents|mesh-ancestor
110550615|NCT00912756|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110550616|NCT00912756|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110550617|NCT00912756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110550618|NCT04426240|Cyclosporine|cyclosporine|mesh-list
110550619|NCT04426240|Cyclosporins|cyclosporins|mesh-list
110550620|NCT04426240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110550621|NCT04426240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110550622|NCT04426240|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110550623|NCT04426240|Immunologic Factors|immunologic factors|mesh-ancestor
110550624|NCT04426240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110550625|NCT04426240|Antifungal Agents|antifungal agents|mesh-ancestor
110550626|NCT04426240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110550627|NCT04426240|Dermatologic Agents|dermatologic agents|mesh-ancestor
110550628|NCT04426240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110550629|NCT04426240|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110550630|NCT00995995|Rosiglitazone|rosiglitazone|mesh-list
110550631|NCT00995995|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110550632|NCT00995995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110550633|NCT00999349|Silymarin|silymarin|mesh-list
110550634|NCT00999349|Antioxidants|antioxidants|mesh-ancestor
110550635|NCT00999349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110550636|NCT00999349|Protective Agents|protective agents|mesh-ancestor
110550637|NCT00999349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110550638|NCT02621112|Imiquimod|imiquimod|mesh-list
110550639|NCT02621112|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110550640|NCT02621112|Immunologic Factors|immunologic factors|mesh-ancestor
110550641|NCT02621112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110550642|NCT02621112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110550643|NCT02621112|Interferon Inducers|interferon inducers|mesh-ancestor
110550644|NCT04000789|Vitamins|vitamins|mesh-list
110550645|NCT04000789|Vitamin E|vitamin e|mesh-list
110550646|NCT04000789|Vitamin A|vitamin a|mesh-list
110550647|NCT04000789|Hyaluronic Acid|hyaluronic acid|mesh-list
110550648|NCT04000789|Micronutrients|micronutrients|mesh-ancestor
110550649|NCT04000789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110550650|NCT04000789|Antioxidants|antioxidants|mesh-ancestor
110550651|NCT04000789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110550652|NCT04000789|Protective Agents|protective agents|mesh-ancestor
110550653|NCT04000789|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110550654|NCT04000789|Immunologic Factors|immunologic factors|mesh-ancestor
110550655|NCT04000789|Viscosupplements|viscosupplements|mesh-ancestor
110550656|NCT00697554|Vaccines|vaccines|mesh-list
110550657|NCT00697554|Immunologic Factors|immunologic factors|mesh-ancestor
110550658|NCT00697554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110550659|NCT00731068|Mitogens|mitogens|mesh-list
110550660|NCT00731068|Mitosis Modulators|mitosis modulators|mesh-ancestor
110550661|NCT00731068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110550662|NCT00866307|Cytarabine|cytarabine|mesh-list
110550663|NCT00866307|Dexamethasone|dexamethasone|mesh-list
110550664|NCT00866307|Dexamethasone acetate|dexamethasone acetate|mesh-list
110550665|NCT00866307|Prednisone|prednisone|mesh-list
110550666|NCT00866307|Cortisone|cortisone|mesh-list
110550667|NCT00866307|Cyclophosphamide|cyclophosphamide|mesh-list
110550668|NCT00866307|Doxorubicin|doxorubicin|mesh-list
110550669|NCT00866307|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110550670|NCT00866307|Methotrexate|methotrexate|mesh-list
110550671|NCT00866307|Vincristine|vincristine|mesh-list
110550672|NCT00866307|Daunorubicin|daunorubicin|mesh-list
110550673|NCT00866307|Asparaginase|asparaginase|mesh-list
110550674|NCT00866307|Mercaptopurine|mercaptopurine|mesh-list
110550675|NCT00866307|Pegaspargase|pegaspargase|mesh-list
110550676|NCT00866307|Thioguanine|thioguanine|mesh-list
110550677|NCT00866307|BB 1101|bb 1101|mesh-list
110550678|NCT00866307|2-Aminopurine|2-aminopurine|mesh-list
110198273|NCT00125983|Ritonavir|ritonavir|mesh-list
110550679|NCT00866307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110550680|NCT00866307|Immunologic Factors|immunologic factors|mesh-ancestor
110550681|NCT00866307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110550682|NCT00866307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110550683|NCT00866307|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110550684|NCT00866307|Alkylating Agents|alkylating agents|mesh-ancestor
110550685|NCT00866307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110550686|NCT00866307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110550687|NCT00866307|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110550688|NCT00866307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110550689|NCT00866307|Antiemetics|antiemetics|mesh-ancestor
110550690|NCT00866307|Autonomic Agents|autonomic agents|mesh-ancestor
110550691|NCT00866307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110180289|NCT00275730|Indomethacin|indomethacin|mesh-list
110550692|NCT00866307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110550693|NCT00866307|Glucocorticoids|glucocorticoids|mesh-ancestor
110550695|NCT00866307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110550696|NCT00866307|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110550697|NCT00866307|Protease Inhibitors|protease inhibitors|mesh-ancestor
110550698|NCT00866307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110550699|NCT00866307|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110550700|NCT00866307|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110550701|NCT00866307|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110550702|NCT00866307|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110550703|NCT00866307|Abortifacient Agents|abortifacient agents|mesh-ancestor
110550704|NCT00866307|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110550705|NCT00866307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110550706|NCT00866307|Antimetabolites|antimetabolites|mesh-ancestor
110550707|NCT00866307|Dermatologic Agents|dermatologic agents|mesh-ancestor
110550708|NCT00866307|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110550709|NCT00866307|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110550710|NCT00866307|Antiviral Agents|antiviral agents|mesh-ancestor
110550711|NCT00866307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110550712|NCT00866307|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110550713|NCT00866307|Tubulin Modulators|tubulin modulators|mesh-ancestor
110550714|NCT00866307|Antimitotic Agents|antimitotic agents|mesh-ancestor
110550715|NCT00866307|Mitosis Modulators|mitosis modulators|mesh-ancestor
110550716|NCT00731146|Anesthetics|anesthetics|mesh-list
110550717|NCT00731146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110550718|NCT00731146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110550719|NCT02716415|Menthol|menthol|mesh-list
110550720|NCT02716415|Petrolatum|petrolatum|mesh-list
110550721|NCT02716415|Zinc Oxide|zinc oxide|mesh-list
110550722|NCT02716415|Antipruritics|antipruritics|mesh-ancestor
110550723|NCT02716415|Dermatologic Agents|dermatologic agents|mesh-ancestor
110550724|NCT02716415|Emollients|emollients|mesh-ancestor
110550725|NCT02716415|Sunscreening Agents|sunscreening agents|mesh-ancestor
110550726|NCT02716415|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110550727|NCT02716415|Protective Agents|protective agents|mesh-ancestor
110550728|NCT02716415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110550729|NCT02616354|Imipenem|imipenem|mesh-list
110550730|NCT02616354|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110550731|NCT02616354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110550732|NCT00731224|Rivastigmine|rivastigmine|mesh-list
110550733|NCT00731224|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110550734|NCT00731224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110550735|NCT00731224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110550736|NCT00731224|Cholinergic Agents|cholinergic agents|mesh-ancestor
110550737|NCT00731224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110550738|NCT00731224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110550739|NCT00731224|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110550740|NCT00731224|Protective Agents|protective agents|mesh-ancestor
110550741|NCT00531427|Buprenorphine|buprenorphine|mesh-list
110550742|NCT00531427|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110550743|NCT00531427|Narcotics|narcotics|mesh-ancestor
110550744|NCT00531427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110550745|NCT00531427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110550746|NCT00531427|Analgesics|analgesics|mesh-ancestor
110550747|NCT00531427|Sensory System Agents|sensory system agents|mesh-ancestor
110550748|NCT00531427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110550749|NCT00531427|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110550750|NCT00731302|Aspirin|aspirin|mesh-list
110550751|NCT00731302|Meloxicam|meloxicam|mesh-list
110550752|NCT00731302|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110550753|NCT00731302|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110550754|NCT00731302|Analgesics|analgesics|mesh-ancestor
110550755|NCT00731302|Sensory System Agents|sensory system agents|mesh-ancestor
110550756|NCT00731302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110550757|NCT00731302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110550758|NCT00731302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110550759|NCT00731302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110180435|NCT00015860|Imatinib Mesylate|imatinib mesylate|mesh-list
110550760|NCT00731302|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110550761|NCT00731302|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110550762|NCT00731302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110550763|NCT00731302|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110550764|NCT00731302|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110550765|NCT00731302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110550767|NCT00731302|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110550768|NCT00871728|Itraconazole|itraconazole|mesh-list
110550769|NCT00871728|Antifungal Agents|antifungal agents|mesh-ancestor
110550770|NCT00871728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110550771|NCT00871728|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110550772|NCT00871728|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110550773|NCT00871728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110550774|NCT00871728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110550775|NCT00871728|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110550776|NCT00871728|Hormone Antagonists|hormone antagonists|mesh-ancestor
110550777|NCT00871728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110550778|NCT00871728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110550779|NCT00871728|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110550780|NCT00731380|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110550781|NCT00731380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110550782|NCT00999427|Povidone-Iodine|povidone-iodine|mesh-list
110550783|NCT00999427|Povidone|povidone|mesh-list
110550784|NCT00999427|Plasma Substitutes|plasma substitutes|mesh-ancestor
110550785|NCT00999427|Blood Substitutes|blood substitutes|mesh-ancestor
110550786|NCT00999427|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110550787|NCT00999427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110550788|NCT04189211|Trastuzumab|trastuzumab|mesh-list
110550789|NCT04189211|Maytansine|maytansine|mesh-list
110550790|NCT04189211|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110550791|NCT04189211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110550792|NCT04189211|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110550793|NCT04189211|Tubulin Modulators|tubulin modulators|mesh-ancestor
110550794|NCT04189211|Antimitotic Agents|antimitotic agents|mesh-ancestor
110550795|NCT04189211|Mitosis Modulators|mitosis modulators|mesh-ancestor
110550796|NCT04189211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110550797|NCT00364780|XL647|xl647|mesh-list
110550798|NCT00364780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110550799|NCT00364780|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110550800|NCT00364780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110550801|NCT00364780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110550802|NCT00868998|Gemcitabine|gemcitabine|mesh-list
110550803|NCT00868998|Capecitabine|capecitabine|mesh-list
110550804|NCT00868998|Docetaxel|docetaxel|mesh-list
110550805|NCT00868998|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110550806|NCT00868998|Antimetabolites|antimetabolites|mesh-ancestor
110550807|NCT00868998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110550808|NCT00868998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110550809|NCT00868998|Tubulin Modulators|tubulin modulators|mesh-ancestor
110550810|NCT00868998|Antimitotic Agents|antimitotic agents|mesh-ancestor
110550811|NCT00868998|Mitosis Modulators|mitosis modulators|mesh-ancestor
110550812|NCT00996151|Testosterone|testosterone|mesh-list
110550813|NCT00996151|Androgens|androgens|mesh-ancestor
110550814|NCT00996151|Hormones|hormones|mesh-ancestor
110550815|NCT00996151|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110550816|NCT00996151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110550817|NCT04131231|Aldesleukin|aldesleukin|mesh-list
110550818|NCT04131231|Methotrexate|methotrexate|mesh-list
110550819|NCT04131231|Interleukin-2|interleukin-2|mesh-list
110550820|NCT04131231|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110550821|NCT04131231|Abortifacient Agents|abortifacient agents|mesh-ancestor
110550822|NCT04131231|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110550823|NCT04131231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110550824|NCT04131231|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110550825|NCT04131231|Antimetabolites|antimetabolites|mesh-ancestor
110550826|NCT04131231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110550827|NCT04131231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110550828|NCT04131231|Dermatologic Agents|dermatologic agents|mesh-ancestor
110550829|NCT04131231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110550830|NCT04131231|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110550831|NCT04131231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110550832|NCT04131231|Immunologic Factors|immunologic factors|mesh-ancestor
110550833|NCT04131231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110550834|NCT04131231|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110550835|NCT04131231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110550836|NCT04131231|Analgesics|analgesics|mesh-ancestor
110550837|NCT04131231|Sensory System Agents|sensory system agents|mesh-ancestor
110550838|NCT04131231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110550839|NCT04131231|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110550840|NCT04131231|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110550841|NCT04131231|Antiviral Agents|antiviral agents|mesh-ancestor
110550842|NCT04131231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110550843|NCT02716259|Fluorides|fluorides|mesh-list
110550844|NCT02716259|Sodium Fluoride|sodium fluoride|mesh-list
110550845|NCT02716259|Cariostatic Agents|cariostatic agents|mesh-ancestor
110550846|NCT02716259|Protective Agents|protective agents|mesh-ancestor
110550847|NCT02716259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110550848|NCT00996229|Resveratrol|resveratrol|mesh-list
110550849|NCT00996229|Antioxidants|antioxidants|mesh-ancestor
110550850|NCT00996229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110550851|NCT00996229|Protective Agents|protective agents|mesh-ancestor
110550852|NCT00996229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110550853|NCT00996229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110550854|NCT00996229|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110550855|NCT02712671|Interferons|interferons|mesh-list
110550856|NCT02712671|Interferon-gamma|interferon-gamma|mesh-list
110550857|NCT02712671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110550858|NCT02712671|Antiviral Agents|antiviral agents|mesh-ancestor
110550859|NCT02712671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110550860|NCT02614833|Paclitaxel|paclitaxel|mesh-list
110550861|NCT02614833|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110550862|NCT02614833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110550863|NCT02614833|Tubulin Modulators|tubulin modulators|mesh-ancestor
110550864|NCT02614833|Antimitotic Agents|antimitotic agents|mesh-ancestor
110550865|NCT02614833|Mitosis Modulators|mitosis modulators|mesh-ancestor
110180495|NCT00275106|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110550866|NCT02614833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110550867|NCT05260957|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
110550868|NCT05260957|Immunoconjugates|immunoconjugates|mesh-ancestor
110550869|NCT05260957|Immunologic Factors|immunologic factors|mesh-ancestor
110550870|NCT05260957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110550871|NCT00999505|Amantadine|amantadine|mesh-list
110550872|NCT00999505|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110550873|NCT00999505|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110550874|NCT00999505|Antiviral Agents|antiviral agents|mesh-ancestor
110550875|NCT00999505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110550876|NCT00999505|Dopamine Agents|dopamine agents|mesh-ancestor
110550877|NCT00999505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110550878|NCT00999505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110550879|NCT00999505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110550880|NCT00999505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110550881|NCT00999505|Analgesics|analgesics|mesh-ancestor
110550882|NCT00999505|Sensory System Agents|sensory system agents|mesh-ancestor
110550883|NCT00999505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110550884|NCT00996385|Oxaliplatin|oxaliplatin|mesh-list
110550885|NCT00996385|Bortezomib|bortezomib|mesh-list
110550886|NCT00996385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110550887|NCT00533845|Bupivacaine|bupivacaine|mesh-list
110550888|NCT00533845|Anesthetics, Local|anesthetics, local|mesh-ancestor
110550889|NCT00533845|Anesthetics|anesthetics|mesh-ancestor
110550890|NCT00533845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110550891|NCT00533845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110550892|NCT00533845|Sensory System Agents|sensory system agents|mesh-ancestor
110550893|NCT00533845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110550894|NCT02752763|Dextrans|dextrans|mesh-list
110550895|NCT02752763|Povidone|povidone|mesh-list
110550896|NCT02752763|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110550897|NCT02752763|Lubricant Eye Drops|lubricant eye drops|mesh-list
110550898|NCT02752763|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110550899|NCT02752763|Plasma Substitutes|plasma substitutes|mesh-ancestor
110550900|NCT02752763|Blood Substitutes|blood substitutes|mesh-ancestor
110550901|NCT02752763|Anticoagulants|anticoagulants|mesh-ancestor
110550902|NCT00857649|Memantine|memantine|mesh-list
110550903|NCT00857649|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110550904|NCT00857649|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110550905|NCT00857649|Dopamine Agents|dopamine agents|mesh-ancestor
110550906|NCT00857649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110550907|NCT00857649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110550908|NCT00857649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110550909|NCT00857649|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110550910|NCT00857649|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110550911|NCT02752841|Vitamin D|vitamin d|mesh-list
110550913|NCT02752841|Micronutrients|micronutrients|mesh-ancestor
110550914|NCT02752841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110550915|NCT02752841|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110550916|NCT03971669|Vaccines|vaccines|mesh-list
110550917|NCT03971669|Immunologic Factors|immunologic factors|mesh-ancestor
110550918|NCT03971669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110550919|NCT02715869|Sevoflurane|sevoflurane|mesh-list
110550920|NCT02715869|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110550921|NCT02715869|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110550922|NCT02715869|Anesthetics, General|anesthetics, general|mesh-ancestor
110550923|NCT02715869|Anesthetics|anesthetics|mesh-ancestor
110550924|NCT02715869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110180520|NCT00275067|Temozolomide|temozolomide|mesh-list
110550925|NCT02715869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110550927|NCT00532441|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110550928|NCT00532441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110550929|NCT00532441|Tubulin Modulators|tubulin modulators|mesh-ancestor
110550930|NCT00532441|Antimitotic Agents|antimitotic agents|mesh-ancestor
110550931|NCT00532441|Mitosis Modulators|mitosis modulators|mesh-ancestor
110550932|NCT00532441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110550933|NCT00532441|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110550934|NCT00532441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110550935|NCT00999739|Vaccines|vaccines|mesh-list
110550936|NCT00999739|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110550937|NCT00999739|Immunologic Factors|immunologic factors|mesh-ancestor
110550938|NCT00999739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110550939|NCT00996463|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
110550940|NCT00996463|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110550941|NCT00996463|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110550942|NCT00996463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110550943|NCT00996463|Schistosomicides|schistosomicides|mesh-ancestor
110550944|NCT00996463|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110550945|NCT00996463|Anthelmintics|anthelmintics|mesh-ancestor
110550946|NCT00999817|Dextromethorphan|dextromethorphan|mesh-list
110550947|NCT00999817|Antitussive Agents|antitussive agents|mesh-ancestor
110550948|NCT00999817|Respiratory System Agents|respiratory system agents|mesh-ancestor
110550949|NCT00999817|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110550950|NCT00999817|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110550951|NCT00999817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110550952|NCT00999817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110550953|NCT00999817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110550954|NCT00857259|Everolimus|everolimus|mesh-list
110550955|NCT00857259|Ranibizumab|ranibizumab|mesh-list
110550956|NCT00857259|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110550957|NCT00857259|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110550958|NCT00857259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110550959|NCT00857259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110550960|NCT00857259|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110550961|NCT00857259|Immunologic Factors|immunologic factors|mesh-ancestor
110550962|NCT00857259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110550963|NCT00857259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110550964|NCT00857259|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110550965|NCT00857259|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110550966|NCT00857259|Growth Substances|growth substances|mesh-ancestor
110550967|NCT00857259|Growth Inhibitors|growth inhibitors|mesh-ancestor
110550968|NCT00868608|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
110550969|NCT00868608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110550970|NCT00868608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110550971|NCT00868608|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110550972|NCT00868608|Immunotoxins|immunotoxins|mesh-ancestor
110550973|NCT00868608|Immunoconjugates|immunoconjugates|mesh-ancestor
110550974|NCT00868608|Immunologic Factors|immunologic factors|mesh-ancestor
110550975|NCT00868608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110550976|NCT04000633|Lidocaine|lidocaine|mesh-list
110550977|NCT04000633|Anesthetics, Local|anesthetics, local|mesh-ancestor
110550978|NCT04000633|Anesthetics|anesthetics|mesh-ancestor
110550979|NCT04000633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110550980|NCT04000633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110550981|NCT04000633|Sensory System Agents|sensory system agents|mesh-ancestor
110550982|NCT04000633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110550983|NCT04000633|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110180536|NCT00015977|Interleukin-12|interleukin-12|mesh-list
110550984|NCT04000633|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110550985|NCT04000633|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110198563|NCT00127114|Analgesics|analgesics|mesh-ancestor
110550987|NCT04000633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110550988|NCT00994825|Simendan|simendan|mesh-list
110550989|NCT00994825|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110550990|NCT00994825|Vasodilator Agents|vasodilator agents|mesh-ancestor
110550991|NCT00994825|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110550992|NCT00994825|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110550993|NCT00994825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110550994|NCT00994825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110550995|NCT00994825|Protective Agents|protective agents|mesh-ancestor
110550996|NCT00994825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110550997|NCT02752529|Tacrolimus|tacrolimus|mesh-list
110550998|NCT02752529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110550999|NCT02752529|Immunologic Factors|immunologic factors|mesh-ancestor
110551000|NCT02752529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110551001|NCT02752529|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110551002|NCT02752529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110551003|NCT02752529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110551004|NCT00856635|Glatiramer Acetate|glatiramer acetate|mesh-list
110551005|NCT00856635|(T,G)-A-L|(t,g)-a-l|mesh-list
110551006|NCT00856635|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110551007|NCT00856635|Immunologic Factors|immunologic factors|mesh-ancestor
110551008|NCT00856635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110551009|NCT00856635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110551010|NCT00856635|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110551011|NCT02620800|Leucovorin|leucovorin|mesh-list
110551012|NCT02620800|Paclitaxel|paclitaxel|mesh-list
110551013|NCT02620800|Bevacizumab|bevacizumab|mesh-list
110551014|NCT02620800|Oxaliplatin|oxaliplatin|mesh-list
110551015|NCT02620800|Calcium|calcium|mesh-list
110551016|NCT02620800|Levoleucovorin|levoleucovorin|mesh-list
110551017|NCT02620800|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110551018|NCT02620800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110551019|NCT02620800|Tubulin Modulators|tubulin modulators|mesh-ancestor
110551020|NCT02620800|Antimitotic Agents|antimitotic agents|mesh-ancestor
110551021|NCT02620800|Mitosis Modulators|mitosis modulators|mesh-ancestor
110551022|NCT02620800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110551023|NCT02620800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110551024|NCT02620800|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110551025|NCT02620800|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110551026|NCT02620800|Growth Substances|growth substances|mesh-ancestor
110551027|NCT02620800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110551028|NCT02620800|Growth Inhibitors|growth inhibitors|mesh-ancestor
110551029|NCT02620800|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110551030|NCT02620800|Antidotes|antidotes|mesh-ancestor
110551031|NCT02620800|Protective Agents|protective agents|mesh-ancestor
110551032|NCT02620800|Vitamin B Complex|vitamin b complex|mesh-ancestor
110551033|NCT02620800|Vitamins|vitamins|mesh-ancestor
110551034|NCT02620800|Micronutrients|micronutrients|mesh-ancestor
110551035|NCT04135014|Midazolam|midazolam|mesh-list
110551036|NCT04135014|Dexmedetomidine|dexmedetomidine|mesh-list
110551037|NCT04135014|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110180551|NCT01678586|Anticonvulsants|anticonvulsants|mesh-ancestor
110551038|NCT04135014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110551039|NCT04135014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110551040|NCT04135014|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110551041|NCT04135014|Analgesics|analgesics|mesh-ancestor
110551042|NCT04135014|Sensory System Agents|sensory system agents|mesh-ancestor
110551043|NCT04135014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110551044|NCT04135014|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110551045|NCT04135014|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110551046|NCT04135014|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110551047|NCT04135014|Adrenergic Agents|adrenergic agents|mesh-ancestor
110551048|NCT04135014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110551049|NCT04135014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110551050|NCT04135014|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110551051|NCT04135014|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110551052|NCT04135014|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110551053|NCT04135014|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110551054|NCT04135014|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110551055|NCT04135014|Anesthetics, General|anesthetics, general|mesh-ancestor
110551056|NCT04135014|Anesthetics|anesthetics|mesh-ancestor
110551057|NCT04135014|GABA Modulators|gaba modulators|mesh-ancestor
110551058|NCT04135014|GABA Agents|gaba agents|mesh-ancestor
110551059|NCT00996697|Budesonide|budesonide|mesh-list
110551060|NCT00996697|Formoterol Fumarate|formoterol fumarate|mesh-list
110551061|NCT00996697|Tiotropium Bromide|tiotropium bromide|mesh-list
110551062|NCT00996697|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
110551063|NCT00996697|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110551064|NCT00996697|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110551065|NCT00996697|Autonomic Agents|autonomic agents|mesh-ancestor
110551066|NCT00996697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110551067|NCT00996697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110551068|NCT00996697|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110551069|NCT00996697|Respiratory System Agents|respiratory system agents|mesh-ancestor
110551070|NCT00996697|Glucocorticoids|glucocorticoids|mesh-ancestor
110551071|NCT00996697|Hormones|hormones|mesh-ancestor
110551072|NCT00996697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110551073|NCT00996697|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110551074|NCT00996697|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110551075|NCT00996697|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110551076|NCT00996697|Adrenergic Agents|adrenergic agents|mesh-ancestor
110551077|NCT00996697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110551078|NCT00996697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110551079|NCT00996697|Parasympatholytics|parasympatholytics|mesh-ancestor
110551080|NCT00996697|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110551081|NCT00996697|Cholinergic Agents|cholinergic agents|mesh-ancestor
110551082|NCT00999973|Mitomycins|mitomycins|mesh-list
110551083|NCT00999973|Mitomycin|mitomycin|mesh-list
110551084|NCT00999973|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110551085|NCT00999973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110551086|NCT00999973|Alkylating Agents|alkylating agents|mesh-ancestor
110551087|NCT00999973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110551088|NCT00999973|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110551089|NCT00999973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110551090|NCT02715947|Methotrexate|methotrexate|mesh-list
110551091|NCT02715947|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110551092|NCT02715947|Abortifacient Agents|abortifacient agents|mesh-ancestor
110551093|NCT02715947|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110551094|NCT02715947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110551095|NCT02715947|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110551096|NCT02715947|Antimetabolites|antimetabolites|mesh-ancestor
110551097|NCT02715947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110180570|NCT01678586|Histamine Agents|histamine agents|mesh-ancestor
110551099|NCT02715947|Dermatologic Agents|dermatologic agents|mesh-ancestor
110551100|NCT02715947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110551101|NCT02715947|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110551102|NCT02715947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110551103|NCT02715947|Immunologic Factors|immunologic factors|mesh-ancestor
110551104|NCT02715947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110551105|NCT02715947|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110551106|NCT00856323|Tenofovir|tenofovir|mesh-list
110551107|NCT00856323|Emtricitabine|emtricitabine|mesh-list
110551108|NCT00856323|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110551109|NCT00856323|Antiviral Agents|antiviral agents|mesh-ancestor
110551110|NCT00856323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110551111|NCT00856323|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110551112|NCT00856323|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110551113|NCT00856323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110551114|NCT00856323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110551115|NCT00856323|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110551116|NCT00856323|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110551117|NCT00856245|Rituximab|rituximab|mesh-list
110551118|NCT00856245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110551119|NCT00856245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110551120|NCT00856245|Immunologic Factors|immunologic factors|mesh-ancestor
110551121|NCT00856245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110551122|NCT00856245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110551123|NCT00855933|Cetylpyridinium|cetylpyridinium|mesh-list
110551124|NCT00855933|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110551125|NCT00855933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110551126|NCT00994903|Simvastatin|simvastatin|mesh-list
110551127|NCT00994903|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110551128|NCT00994903|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110551129|NCT00994903|Antimetabolites|antimetabolites|mesh-ancestor
110551130|NCT00994903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110551131|NCT00994903|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110551132|NCT00994903|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110551133|NCT00994903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110551134|NCT00699777|Risedronic Acid|risedronic acid|mesh-list
110551135|NCT00699777|Etidronic Acid|etidronic acid|mesh-list
110551136|NCT00699777|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110551137|NCT00699777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110551138|NCT00699777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110551139|NCT00699777|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110551140|NCT00699777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110551141|NCT00699777|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110551142|NCT00997009|Paclitaxel|paclitaxel|mesh-list
110551143|NCT00997009|Carboplatin|carboplatin|mesh-list
110551144|NCT00997009|Cetuximab|cetuximab|mesh-list
110551145|NCT00997009|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110551146|NCT00997009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110551147|NCT00997009|Tubulin Modulators|tubulin modulators|mesh-ancestor
110551148|NCT00997009|Antimitotic Agents|antimitotic agents|mesh-ancestor
110551149|NCT00997009|Mitosis Modulators|mitosis modulators|mesh-ancestor
110551150|NCT00997009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110551151|NCT00997009|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110551152|NCT02712125|Isosorbide|isosorbide|mesh-list
110551153|NCT02712125|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
110551154|NCT02712125|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
110551155|NCT02712125|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110551156|NCT02712125|Diuretics|diuretics|mesh-ancestor
110551157|NCT02712125|Natriuretic Agents|natriuretic agents|mesh-ancestor
110551158|NCT02712125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110551159|NCT02712125|Vasodilator Agents|vasodilator agents|mesh-ancestor
110551160|NCT02712125|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
110551161|NCT02712125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110551162|NCT00994981|Magnesium Sulfate|magnesium sulfate|mesh-list
110551163|NCT00994981|Analgesics|analgesics|mesh-ancestor
110551164|NCT00994981|Sensory System Agents|sensory system agents|mesh-ancestor
110551165|NCT00994981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110551166|NCT00994981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110551167|NCT00994981|Anesthetics|anesthetics|mesh-ancestor
110551168|NCT00994981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110551169|NCT00994981|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110551170|NCT00994981|Anticonvulsants|anticonvulsants|mesh-ancestor
110551171|NCT00994981|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110551172|NCT00994981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110551173|NCT00994981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110551174|NCT00994981|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110551175|NCT00994981|Tocolytic Agents|tocolytic agents|mesh-ancestor
110551176|NCT00994981|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110551177|NCT02715479|Dolutegravir|dolutegravir|mesh-list
110551178|NCT02715479|BMS-955176|bms-955176|mesh-list
110551179|NCT02715479|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110551180|NCT02715479|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110551181|NCT02715479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110551182|NCT02715479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110551183|NCT02715479|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110551184|NCT02715479|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110551185|NCT02715479|Antiviral Agents|antiviral agents|mesh-ancestor
110551186|NCT02715479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110551187|NCT01000441|Adalimumab|adalimumab|mesh-list
110551188|NCT01000441|Infliximab|infliximab|mesh-list
110551189|NCT01000441|Etanercept|etanercept|mesh-list
110551190|NCT01000441|Rituximab|rituximab|mesh-list
110551191|NCT01000441|Abatacept|abatacept|mesh-list
110551192|NCT01000441|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110551193|NCT01000441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110551194|NCT01000441|Immunologic Factors|immunologic factors|mesh-ancestor
110551195|NCT01000441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110551196|NCT01000441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110551197|NCT01000441|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110551198|NCT01000441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110551199|NCT01000441|Dermatologic Agents|dermatologic agents|mesh-ancestor
110551200|NCT01000441|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110551201|NCT01000441|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110551202|NCT01000441|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110551203|NCT01000441|Analgesics|analgesics|mesh-ancestor
110551204|NCT01000441|Sensory System Agents|sensory system agents|mesh-ancestor
110551205|NCT01000441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110551206|NCT01000441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110551207|NCT01000441|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110551208|NCT01000441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110551209|NCT00997087|Flumazenil|flumazenil|mesh-list
110551210|NCT00997087|Antidotes|antidotes|mesh-ancestor
110551211|NCT00997087|Protective Agents|protective agents|mesh-ancestor
110551212|NCT00997087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110551213|NCT00997087|GABA Modulators|gaba modulators|mesh-ancestor
110551214|NCT00997087|GABA Agents|gaba agents|mesh-ancestor
110551215|NCT00997087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110551216|NCT00997087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110551217|NCT01000597|Fluticasone|fluticasone|mesh-list
110551219|NCT01000597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110551220|NCT01000597|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110551221|NCT01000597|Autonomic Agents|autonomic agents|mesh-ancestor
110551222|NCT01000597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110551223|NCT01000597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110551224|NCT01000597|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110551225|NCT01000597|Respiratory System Agents|respiratory system agents|mesh-ancestor
110551226|NCT01000597|Dermatologic Agents|dermatologic agents|mesh-ancestor
110551227|NCT01000597|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110551228|NCT02751593|Dexamethasone|dexamethasone|mesh-list
110551229|NCT02751593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110551230|NCT02751593|Antiemetics|antiemetics|mesh-ancestor
110551231|NCT02751593|Autonomic Agents|autonomic agents|mesh-ancestor
110551232|NCT02751593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110551233|NCT02751593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110551234|NCT02751593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110551235|NCT02751593|Glucocorticoids|glucocorticoids|mesh-ancestor
110551236|NCT02751593|Hormones|hormones|mesh-ancestor
110551237|NCT02751593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110551238|NCT02751593|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110551239|NCT02751593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110551240|NCT00997399|Panobinostat|panobinostat|mesh-list
110551241|NCT00997399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110551242|NCT00997399|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110551243|NCT00997399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110551244|NCT00997399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110551245|NCT00997477|Budesonide|budesonide|mesh-list
110551246|NCT00997477|Formoterol Fumarate|formoterol fumarate|mesh-list
110551247|NCT00997477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110551248|NCT00997477|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110551249|NCT00997477|Autonomic Agents|autonomic agents|mesh-ancestor
110551250|NCT00997477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110551251|NCT00997477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110551252|NCT00997477|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110551253|NCT00997477|Respiratory System Agents|respiratory system agents|mesh-ancestor
110551254|NCT00997477|Glucocorticoids|glucocorticoids|mesh-ancestor
110551255|NCT00997477|Hormones|hormones|mesh-ancestor
110551256|NCT00997477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110551257|NCT00997477|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110551258|NCT00997477|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110551259|NCT00997477|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110551260|NCT00997477|Adrenergic Agents|adrenergic agents|mesh-ancestor
110551261|NCT00997477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110551262|NCT00997477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110551263|NCT01000831|Vaccines|vaccines|mesh-list
110551264|NCT01000831|Immunologic Factors|immunologic factors|mesh-ancestor
110551265|NCT01000831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110551266|NCT05170789|Dexamethasone|dexamethasone|mesh-list
110551267|NCT05170789|Elotuzumab|elotuzumab|mesh-list
110551268|NCT05170789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110551269|NCT05170789|Antiemetics|antiemetics|mesh-ancestor
110551270|NCT05170789|Autonomic Agents|autonomic agents|mesh-ancestor
110551271|NCT05170789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110551272|NCT05170789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110551273|NCT05170789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110551274|NCT05170789|Glucocorticoids|glucocorticoids|mesh-ancestor
110551275|NCT05170789|Hormones|hormones|mesh-ancestor
110551276|NCT05170789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110551277|NCT05170789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110551278|NCT05170789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110551279|NCT02693951|Cefotiam|cefotiam|mesh-list
110551280|NCT02693951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110551281|NCT02693951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110551282|NCT00997711|Sirolimus|sirolimus|mesh-list
110551283|NCT00997711|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110198861|NCT00044486|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110551284|NCT00997711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110551285|NCT00997711|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110551286|NCT00997711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110551287|NCT00997711|Antifungal Agents|antifungal agents|mesh-ancestor
110551288|NCT00997711|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110551289|NCT00997711|Immunologic Factors|immunologic factors|mesh-ancestor
110551290|NCT00997711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110551291|NCT01001143|Decitabine|decitabine|mesh-list
110551292|NCT01001143|Bexarotene|bexarotene|mesh-list
110551293|NCT01001143|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110551294|NCT01001143|Antimetabolites|antimetabolites|mesh-ancestor
110551295|NCT01001143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110551296|NCT01001143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110551297|NCT01001143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110551298|NCT02715167|Budesonide|budesonide|mesh-list
110551299|NCT02715167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110551300|NCT02715167|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110551301|NCT02715167|Autonomic Agents|autonomic agents|mesh-ancestor
110551302|NCT02715167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110551303|NCT02715167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110551304|NCT02715167|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110551305|NCT02715167|Respiratory System Agents|respiratory system agents|mesh-ancestor
110551306|NCT02715167|Glucocorticoids|glucocorticoids|mesh-ancestor
110551307|NCT02715167|Hormones|hormones|mesh-ancestor
110551308|NCT02715167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110551309|NCT03885661|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
110551310|NCT03885661|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110551311|NCT03885661|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110551312|NCT02620566|Bupivacaine|bupivacaine|mesh-list
110551313|NCT02620566|Anesthetics, Local|anesthetics, local|mesh-ancestor
110551314|NCT02620566|Anesthetics|anesthetics|mesh-ancestor
110551315|NCT02620566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110551316|NCT02620566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110551317|NCT02620566|Sensory System Agents|sensory system agents|mesh-ancestor
110551318|NCT02620566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110551319|NCT00855465|Riociguat|riociguat|mesh-list
110551320|NCT00855465|Enzyme Activators|enzyme activators|mesh-ancestor
110551321|NCT00855465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110551324|NCT02714699|Bromides|bromides|mesh-list
110551325|NCT02714699|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
110551326|NCT02714699|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110551327|NCT02714699|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110551328|NCT02714699|Analgesics|analgesics|mesh-ancestor
110551329|NCT02714699|Sensory System Agents|sensory system agents|mesh-ancestor
110551330|NCT02714699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110551331|NCT02714699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110551332|NCT02714699|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110551333|NCT02714699|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110551334|NCT02714699|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110551335|NCT02714699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110551336|NCT02714699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110551337|NCT02714699|Anticonvulsants|anticonvulsants|mesh-ancestor
110551338|NCT02714699|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110551339|NCT02714699|Antiemetics|antiemetics|mesh-ancestor
110551340|NCT02714699|Autonomic Agents|autonomic agents|mesh-ancestor
110551341|NCT02714699|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110551342|NCT02714699|Mydriatics|mydriatics|mesh-ancestor
110551343|NCT02714699|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110551344|NCT02714699|Cholinergic Agents|cholinergic agents|mesh-ancestor
110551345|NCT02714699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110551346|NCT02714699|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110551347|NCT02714699|Parasympatholytics|parasympatholytics|mesh-ancestor
110551348|NCT01004419|Fulvestrant|fulvestrant|mesh-list
110551349|NCT01004419|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110551350|NCT01004419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110551351|NCT01004419|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110551352|NCT01004419|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110551353|NCT01004419|Hormone Antagonists|hormone antagonists|mesh-ancestor
110551354|NCT01004419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110551355|NCT01004419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110551356|NCT02714855|Apixaban|apixaban|mesh-list
110551357|NCT02714855|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110551358|NCT02714855|Antithrombins|antithrombins|mesh-ancestor
110551359|NCT02714855|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110551360|NCT02714855|Protease Inhibitors|protease inhibitors|mesh-ancestor
110551361|NCT02714855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110551362|NCT02714855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110551363|NCT02714855|Anticoagulants|anticoagulants|mesh-ancestor
110551365|NCT02712203|Immunologic Factors|immunologic factors|mesh-ancestor
110551366|NCT02712203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110551367|NCT00696930|Edotreotide|edotreotide|mesh-list
110551368|NCT00696930|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110551369|NCT00696930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110551370|NCT00598442|Darbepoetin alfa|darbepoetin alfa|mesh-list
110551371|NCT00598442|Hematinics|hematinics|mesh-ancestor
110551372|NCT02714543|Hydrocortisone|hydrocortisone|mesh-list
110551373|NCT02714543|Hyaluronic Acid|hyaluronic acid|mesh-list
110551374|NCT02714543|Antioxidants|antioxidants|mesh-list
110551375|NCT02714543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110551376|NCT02714543|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110551377|NCT02714543|Immunologic Factors|immunologic factors|mesh-ancestor
110551378|NCT02714543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110551379|NCT02714543|Viscosupplements|viscosupplements|mesh-ancestor
110551380|NCT02714543|Protective Agents|protective agents|mesh-ancestor
110551381|NCT02714543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110551382|NCT02714231|Diclofenac|diclofenac|mesh-list
110551383|NCT02714231|Scopolamine|scopolamine|mesh-list
110551384|NCT02714231|Bromides|bromides|mesh-list
110551385|NCT02714231|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
110551386|NCT02714231|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110551387|NCT02714231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110551388|NCT02714231|Analgesics|analgesics|mesh-ancestor
110551389|NCT02714231|Sensory System Agents|sensory system agents|mesh-ancestor
110551390|NCT02714231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110551391|NCT02714231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110551392|NCT02714231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110551393|NCT02714231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110551394|NCT02714231|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110551395|NCT02714231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110551396|NCT02714231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110551397|NCT02714231|Anticonvulsants|anticonvulsants|mesh-ancestor
110551398|NCT02714231|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110551399|NCT02714231|Antiemetics|antiemetics|mesh-ancestor
110551400|NCT02714231|Autonomic Agents|autonomic agents|mesh-ancestor
110551401|NCT02714231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110551402|NCT02714231|Mydriatics|mydriatics|mesh-ancestor
110551403|NCT02714231|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110551404|NCT02714231|Cholinergic Agents|cholinergic agents|mesh-ancestor
110551405|NCT02714231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110551406|NCT02714231|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110551407|NCT02714231|Parasympatholytics|parasympatholytics|mesh-ancestor
110551408|NCT00855309|Acyclovir|acyclovir|mesh-list
110551409|NCT00855309|Antiviral Agents|antiviral agents|mesh-ancestor
110551410|NCT00855309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110551411|NCT00532129|Rituximab|rituximab|mesh-list
110551412|NCT00532129|Chlorambucil|chlorambucil|mesh-list
110551413|NCT00532129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110551414|NCT00532129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110551415|NCT00532129|Immunologic Factors|immunologic factors|mesh-ancestor
110551416|NCT00532129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110551417|NCT00532129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110551418|NCT00532129|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110551419|NCT00532129|Alkylating Agents|alkylating agents|mesh-ancestor
110551420|NCT00532129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110551421|NCT04163276|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110551422|NCT04163276|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110551423|NCT04163276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110551424|NCT04163588|Metolazone|metolazone|mesh-list
110551425|NCT04163588|Diuretics|diuretics|mesh-list
110551426|NCT04163588|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
110551427|NCT04163588|Natriuretic Agents|natriuretic agents|mesh-ancestor
110551428|NCT04163588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110551429|NCT04163588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110551430|NCT04163588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110551431|NCT04163588|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110551432|NCT04163588|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110551433|NCT05167513|Metformin|metformin|mesh-list
110551434|NCT05167513|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110199022|NCT00044837|Estradiol|estradiol|mesh-list
110551435|NCT05167513|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110551436|NCT05167513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110551438|NCT05167513|Hormones|hormones|mesh-ancestor
110551439|NCT05167513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110551440|NCT05167513|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110551441|NCT05167513|Protease Inhibitors|protease inhibitors|mesh-ancestor
110551442|NCT05167513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110180669|NCT00016172|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110551443|NCT05167513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110551444|NCT00654056|Insulin|insulin|mesh-list
110551445|NCT00654056|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110551446|NCT00654056|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110551447|NCT00654056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110551448|NCT00854373|Hormones|hormones|mesh-list
110551449|NCT00854373|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
110551450|NCT00854373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110551451|NCT00854373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110551452|NCT00611507|Fluorouracil|fluorouracil|mesh-list
110551453|NCT00611507|Oxaliplatin|oxaliplatin|mesh-list
110551454|NCT00611507|Antimetabolites|antimetabolites|mesh-ancestor
110551455|NCT00611507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110551456|NCT00611507|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110551457|NCT00611507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110551458|NCT00611507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110551459|NCT00611507|Immunologic Factors|immunologic factors|mesh-ancestor
110551460|NCT00611507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110551461|NCT01001845|Vitamin E|vitamin e|mesh-list
110551463|NCT01001845|Tocopherols|tocopherols|mesh-list
110551464|NCT01001845|Antioxidants|antioxidants|mesh-ancestor
110551465|NCT01001845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110551466|NCT01001845|Protective Agents|protective agents|mesh-ancestor
110551467|NCT01001845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110551468|NCT01001845|Vitamins|vitamins|mesh-ancestor
110551469|NCT01001845|Micronutrients|micronutrients|mesh-ancestor
110551470|NCT02635334|Montelukast|montelukast|mesh-list
110551471|NCT02635334|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110551472|NCT02635334|Respiratory System Agents|respiratory system agents|mesh-ancestor
110551473|NCT02635334|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110551474|NCT02635334|Hormone Antagonists|hormone antagonists|mesh-ancestor
110551475|NCT02635334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110551476|NCT02635334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110551477|NCT02635334|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110551478|NCT02635334|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110551479|NCT02635334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110551480|NCT00853905|Triamcinolone|triamcinolone|mesh-list
110551481|NCT00853905|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110551482|NCT00853905|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110551483|NCT00853905|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110551484|NCT00853905|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110551485|NCT00853905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110180689|NCT00394368|Dermatologic Agents|dermatologic agents|mesh-ancestor
110551486|NCT00853905|Glucocorticoids|glucocorticoids|mesh-ancestor
110551487|NCT00853905|Hormones|hormones|mesh-ancestor
110551488|NCT00853905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110551489|NCT00853905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110551490|NCT00853905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110551491|NCT00853905|Immunologic Factors|immunologic factors|mesh-ancestor
110551492|NCT00853905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110551493|NCT00853905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110551494|NCT00998101|Carboplatin|carboplatin|mesh-list
110551495|NCT00998101|Cetuximab|cetuximab|mesh-list
110551496|NCT00998101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110551497|NCT00998101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110551499|NCT04234217|Niacinamide|niacinamide|mesh-list
110551500|NCT04234217|Nicotinic Acids|nicotinic acids|mesh-list
110551501|NCT04234217|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110551502|NCT04234217|Antimetabolites|antimetabolites|mesh-ancestor
110551503|NCT04234217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110551504|NCT04234217|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110551505|NCT04234217|Vasodilator Agents|vasodilator agents|mesh-ancestor
110551506|NCT04234217|Vitamin B Complex|vitamin b complex|mesh-ancestor
110551507|NCT04234217|Vitamins|vitamins|mesh-ancestor
110551508|NCT04234217|Micronutrients|micronutrients|mesh-ancestor
110551509|NCT04234217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110551510|NCT01002079|Rifampin|rifampin|mesh-list
110551511|NCT01002079|BMS 708163|bms 708163|mesh-list
110551512|NCT01002079|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110551513|NCT01002079|Antitubercular Agents|antitubercular agents|mesh-ancestor
110551514|NCT01002079|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110551515|NCT01002079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110551516|NCT01002079|Leprostatic Agents|leprostatic agents|mesh-ancestor
110551517|NCT01002079|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110551518|NCT01002079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110551519|NCT01002079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110551520|NCT01002079|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110551521|NCT01002079|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110551522|NCT01002079|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110551523|NCT01002079|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110551524|NCT01002079|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110551525|NCT01002079|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110551526|NCT01002079|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
110551527|NCT02639624|Dialysis Solutions|dialysis solutions|mesh-list
110551528|NCT02639624|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110551529|NCT05429567|Fentanyl|fentanyl|mesh-list
110551530|NCT05429567|Bupivacaine|bupivacaine|mesh-list
110551531|NCT05429567|Anesthetics, Local|anesthetics, local|mesh-ancestor
110551532|NCT05429567|Anesthetics|anesthetics|mesh-ancestor
110551533|NCT05429567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110551534|NCT05429567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110551535|NCT05429567|Sensory System Agents|sensory system agents|mesh-ancestor
110551537|NCT05429567|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110551539|NCT05429567|Analgesics|analgesics|mesh-ancestor
110551540|NCT05429567|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110551541|NCT05429567|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110551542|NCT05429567|Anesthetics, General|anesthetics, general|mesh-ancestor
110551543|NCT00868296|Pantoprazole|pantoprazole|mesh-list
110551544|NCT00868296|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110551545|NCT00868296|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110551546|NCT00868296|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110551547|NCT00868296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110551548|NCT00868296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110551549|NCT01002157|Vitamin K|vitamin k|mesh-list
110551550|NCT01002157|Vitamin K 2|vitamin k 2|mesh-list
110551551|NCT01002157|Menaquinone 7|menaquinone 7|mesh-list
110551552|NCT01002157|Vitamins|vitamins|mesh-ancestor
110551553|NCT01002157|Micronutrients|micronutrients|mesh-ancestor
110551554|NCT01002157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110551555|NCT01002157|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110551556|NCT01002157|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110551557|NCT01002157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110551558|NCT01002157|Hemostatics|hemostatics|mesh-ancestor
110551559|NCT01002157|Coagulants|coagulants|mesh-ancestor
110551560|NCT01004497|Cytarabine|cytarabine|mesh-list
110551561|NCT01004497|Dexamethasone|dexamethasone|mesh-list
110551562|NCT01004497|Dexamethasone acetate|dexamethasone acetate|mesh-list
110551563|NCT01004497|Cyclophosphamide|cyclophosphamide|mesh-list
110551564|NCT01004497|Vincristine|vincristine|mesh-list
110551565|NCT01004497|Daunorubicin|daunorubicin|mesh-list
110551566|NCT01004497|Dasatinib|dasatinib|mesh-list
110551567|NCT01004497|Mitoxantrone|mitoxantrone|mesh-list
110551568|NCT01004497|BB 1101|bb 1101|mesh-list
110551569|NCT01004497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110551570|NCT01004497|Immunologic Factors|immunologic factors|mesh-ancestor
110551571|NCT01004497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110551572|NCT01004497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110551573|NCT01004497|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110551574|NCT01004497|Alkylating Agents|alkylating agents|mesh-ancestor
110551575|NCT01004497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110551576|NCT01004497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110551577|NCT01004497|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110551578|NCT01004497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110551579|NCT01004497|Antiemetics|antiemetics|mesh-ancestor
110551580|NCT01004497|Autonomic Agents|autonomic agents|mesh-ancestor
110551581|NCT01004497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110551582|NCT01004497|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110551583|NCT01004497|Glucocorticoids|glucocorticoids|mesh-ancestor
110551584|NCT01004497|Hormones|hormones|mesh-ancestor
110551585|NCT01004497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110199159|NCT00045149|Aldesleukin|aldesleukin|mesh-list
110551586|NCT01004497|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110551587|NCT01004497|Protease Inhibitors|protease inhibitors|mesh-ancestor
110551588|NCT01004497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110551589|NCT01004497|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110551590|NCT01004497|Antimetabolites|antimetabolites|mesh-ancestor
110551591|NCT01004497|Antiviral Agents|antiviral agents|mesh-ancestor
110551592|NCT01004497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110551593|NCT01004497|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110551594|NCT01004497|Tubulin Modulators|tubulin modulators|mesh-ancestor
110551595|NCT01004497|Antimitotic Agents|antimitotic agents|mesh-ancestor
110551596|NCT01004497|Mitosis Modulators|mitosis modulators|mesh-ancestor
110551597|NCT01004497|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110551598|NCT01004497|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110551599|NCT01004497|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110551600|NCT01004497|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110551601|NCT01004497|Analgesics|analgesics|mesh-ancestor
110551602|NCT01004497|Sensory System Agents|sensory system agents|mesh-ancestor
110551603|NCT02713841|Insulin|insulin|mesh-list
110551604|NCT02713841|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110551605|NCT02713841|Insulin Lispro|insulin lispro|mesh-list
110551606|NCT02713841|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110551607|NCT02713841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110551609|NCT01004575|Chromium|chromium|mesh-list
110551610|NCT01004575|Trace Elements|trace elements|mesh-ancestor
110551611|NCT01004575|Micronutrients|micronutrients|mesh-ancestor
110551612|NCT01004575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110551613|NCT02615730|Paclitaxel|paclitaxel|mesh-list
110551614|NCT02615730|GSK2636771|gsk2636771|mesh-list
110551615|NCT02615730|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110551616|NCT02615730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110551617|NCT02615730|Tubulin Modulators|tubulin modulators|mesh-ancestor
110551618|NCT02615730|Antimitotic Agents|antimitotic agents|mesh-ancestor
110551619|NCT02615730|Mitosis Modulators|mitosis modulators|mesh-ancestor
110551620|NCT02615730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110551621|NCT02615730|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110551622|NCT02615730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110551623|NCT02711891|Loperamide|loperamide|mesh-list
110551624|NCT02711891|Antidiarrheals|antidiarrheals|mesh-list
110551625|NCT02711891|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110551626|NCT02615496|Aflibercept|aflibercept|mesh-list
110551627|NCT02615496|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110551628|NCT02615496|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110551629|NCT02615496|Growth Substances|growth substances|mesh-ancestor
110551630|NCT02615496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110551631|NCT02615496|Growth Inhibitors|growth inhibitors|mesh-ancestor
110551632|NCT02615496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110551634|NCT02714075|Iron|iron|mesh-list
110551635|NCT02714075|Zinc Sulfate|zinc sulfate|mesh-list
110551636|NCT02714075|Zinc Oxide|zinc oxide|mesh-list
110551637|NCT02714075|Citric Acid|citric acid|mesh-list
110551638|NCT02714075|Sodium Citrate|sodium citrate|mesh-list
110551639|NCT02714075|Anticoagulants|anticoagulants|mesh-ancestor
110551640|NCT02714075|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110551641|NCT02714075|Chelating Agents|chelating agents|mesh-ancestor
110551642|NCT02714075|Sequestering Agents|sequestering agents|mesh-ancestor
110551643|NCT02714075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110551644|NCT02714075|Trace Elements|trace elements|mesh-ancestor
110551645|NCT02714075|Micronutrients|micronutrients|mesh-ancestor
110551646|NCT02714075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110551647|NCT02714075|Astringents|astringents|mesh-ancestor
110551648|NCT02714075|Dermatologic Agents|dermatologic agents|mesh-ancestor
110551649|NCT02714075|Sunscreening Agents|sunscreening agents|mesh-ancestor
110551650|NCT02714075|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110551651|NCT02714075|Protective Agents|protective agents|mesh-ancestor
110551652|NCT02636426|Sorafenib|sorafenib|mesh-list
110551653|NCT02636426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110551654|NCT02636426|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110180767|NCT00016367|Gemcitabine|gemcitabine|mesh-list
110551655|NCT02636426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110551656|NCT02636426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110551657|NCT02713763|Sunitinib|sunitinib|mesh-list
110551658|NCT02713763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110551659|NCT02713763|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110551660|NCT02713763|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110551661|NCT02713763|Growth Substances|growth substances|mesh-ancestor
110551662|NCT02713763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110551663|NCT02713763|Growth Inhibitors|growth inhibitors|mesh-ancestor
110551664|NCT02713763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110551665|NCT02713763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110551666|NCT02713763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110551667|NCT00867360|Mifepristone|mifepristone|mesh-list
110551668|NCT00867360|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
110551669|NCT00867360|Abortifacient Agents|abortifacient agents|mesh-ancestor
110551670|NCT00867360|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110551671|NCT00867360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110551672|NCT00867360|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110551673|NCT00867360|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110551674|NCT00867360|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110551675|NCT00867360|Contraceptive Agents|contraceptive agents|mesh-ancestor
110551676|NCT00867360|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
110551677|NCT00867360|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
110551678|NCT00867360|Hormone Antagonists|hormone antagonists|mesh-ancestor
110551679|NCT00867360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110551680|NCT00867360|Luteolytic Agents|luteolytic agents|mesh-ancestor
110551681|NCT00867360|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110551682|NCT00867360|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
110551683|NCT00656552|Escitalopram|escitalopram|mesh-list
110551684|NCT00656552|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110551685|NCT00656552|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110551686|NCT00656552|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110551687|NCT00656552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110551688|NCT00656552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110551689|NCT00656552|Serotonin Agents|serotonin agents|mesh-ancestor
110551690|NCT00656552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110551691|NCT01004809|Dutasteride|dutasteride|mesh-list
110551692|NCT01004809|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
110551693|NCT01004809|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110551694|NCT01004809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110551695|NCT01004809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110551696|NCT01004809|Hormone Antagonists|hormone antagonists|mesh-ancestor
110551697|NCT01004809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110551698|NCT01004809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110551699|NCT00883688|Bevacizumab|bevacizumab|mesh-list
110551700|NCT00883688|Lapatinib|lapatinib|mesh-list
110551701|NCT00883688|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110551702|NCT00883688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110551703|NCT00883688|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110551704|NCT00883688|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110551705|NCT00883688|Growth Substances|growth substances|mesh-ancestor
110551706|NCT00883688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110551707|NCT00883688|Growth Inhibitors|growth inhibitors|mesh-ancestor
110551708|NCT00883688|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110551709|NCT00883688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110180783|NCT00016406|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110551710|NCT00883688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110551711|NCT04191863|Valproic Acid|valproic acid|mesh-list
110551712|NCT04191863|Anticonvulsants|anticonvulsants|mesh-ancestor
110551713|NCT04191863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110551714|NCT04191863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110551715|NCT04191863|GABA Agents|gaba agents|mesh-ancestor
110551716|NCT04191863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110551717|NCT04191863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110551718|NCT04191863|Antimanic Agents|antimanic agents|mesh-ancestor
110551719|NCT04191863|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110551720|NCT04191863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110551721|NCT04191863|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110551722|NCT02636348|Vitamin D|vitamin d|mesh-list
110551723|NCT02636348|Calcium|calcium|mesh-list
110551724|NCT02636348|Vitamins|vitamins|mesh-ancestor
110551725|NCT02636348|Micronutrients|micronutrients|mesh-ancestor
110551726|NCT02636348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110551727|NCT02636348|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110551728|NCT02636348|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110551729|NCT04219865|Edaravone|edaravone|mesh-list
110551730|NCT04219865|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110551731|NCT04219865|Antioxidants|antioxidants|mesh-ancestor
110551732|NCT04219865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110551733|NCT04219865|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110551734|NCT04219865|Protective Agents|protective agents|mesh-ancestor
110551735|NCT04219865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110551736|NCT01002703|Prednisone|prednisone|mesh-list
110551737|NCT01002703|Lenalidomide|lenalidomide|mesh-list
110551738|NCT01002703|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110199309|NCT00403312|Nicotine|nicotine|mesh-list
110551739|NCT01002703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110551740|NCT01002703|Glucocorticoids|glucocorticoids|mesh-ancestor
110551742|NCT01002703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110551743|NCT01002703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110551744|NCT01002703|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110551745|NCT01002703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110551746|NCT01002703|Immunologic Factors|immunologic factors|mesh-ancestor
110551747|NCT01002703|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110551748|NCT01002703|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110551749|NCT01002703|Growth Substances|growth substances|mesh-ancestor
110551750|NCT01002703|Growth Inhibitors|growth inhibitors|mesh-ancestor
110551751|NCT01002703|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110551752|NCT01002703|Alkylating Agents|alkylating agents|mesh-ancestor
110551753|NCT01002703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110551754|NCT02639234|Nivolumab|nivolumab|mesh-list
110551755|NCT02639234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110551756|NCT02639234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110551757|NCT02639234|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110551758|NCT02639234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110551760|NCT00654290|Amiodarone|amiodarone|mesh-list
110551761|NCT00654290|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110551762|NCT00654290|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110551763|NCT00654290|Adrenergic Agents|adrenergic agents|mesh-ancestor
110551764|NCT00654290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110551765|NCT00654290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110551766|NCT00654290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110551767|NCT00654290|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110551768|NCT00654290|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110551769|NCT00654290|Vasodilator Agents|vasodilator agents|mesh-ancestor
110551770|NCT00654290|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
110551771|NCT00654290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110551772|NCT00654290|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110551773|NCT00654290|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110551774|NCT00654290|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110551775|NCT00654290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110551776|NCT00654290|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110551777|NCT00654290|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110551778|NCT00654290|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110551780|NCT02713139|Clotrimazole|clotrimazole|mesh-list
110551781|NCT02713139|Miconazole|miconazole|mesh-list
110551782|NCT02713139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110551783|NCT02713139|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110551784|NCT02713139|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110551785|NCT02713139|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110551786|NCT02713139|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110551787|NCT02713139|Antifungal Agents|antifungal agents|mesh-ancestor
110551788|NCT02713139|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110551789|NCT02713139|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110551790|NCT02713139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110551791|NCT02713139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110551792|NCT02713139|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110551793|NCT02713139|Hormone Antagonists|hormone antagonists|mesh-ancestor
110551794|NCT02713139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110551795|NCT02713139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110551796|NCT02713139|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110551797|NCT02713139|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110551798|NCT01005121|Colchicine|colchicine|mesh-list
110551799|NCT01005121|Gout Suppressants|gout suppressants|mesh-ancestor
110551800|NCT01005121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110551801|NCT01005121|Tubulin Modulators|tubulin modulators|mesh-ancestor
110551802|NCT01005121|Antimitotic Agents|antimitotic agents|mesh-ancestor
110551803|NCT01005121|Mitosis Modulators|mitosis modulators|mesh-ancestor
110551804|NCT01005121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110551805|NCT01005121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110551806|NCT02711579|Celecoxib|celecoxib|mesh-list
110551807|NCT02711579|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110551808|NCT02711579|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110551809|NCT02711579|Analgesics|analgesics|mesh-ancestor
110551810|NCT02711579|Sensory System Agents|sensory system agents|mesh-ancestor
110551811|NCT02711579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110551812|NCT02711579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110551813|NCT02711579|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110551814|NCT02711579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110551815|NCT02711579|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110551816|NCT02711579|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110551817|NCT02711579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110551818|NCT02711579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110551819|NCT00611195|Remifentanil|remifentanil|mesh-list
110551820|NCT00611195|Propofol|propofol|mesh-list
110551821|NCT00611195|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110551822|NCT00611195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110551823|NCT00611195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110551824|NCT00611195|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110551825|NCT00611195|Anesthetics, General|anesthetics, general|mesh-ancestor
110551826|NCT00611195|Anesthetics|anesthetics|mesh-ancestor
110551827|NCT00611195|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110551828|NCT00611195|Narcotics|narcotics|mesh-ancestor
110551829|NCT00611195|Analgesics|analgesics|mesh-ancestor
110551830|NCT00611195|Sensory System Agents|sensory system agents|mesh-ancestor
110551831|NCT00611195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110551832|NCT01008709|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
110551833|NCT01008709|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
110551834|NCT01008709|beta-Endorphin|beta-endorphin|mesh-list
110551835|NCT01008709|Hormones|hormones|mesh-ancestor
110551836|NCT01008709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110551837|NCT01008709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110551838|NCT01008709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110551839|NCT01008709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110551840|NCT02615574|Interferons|interferons|mesh-list
110551841|NCT02615574|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
110551842|NCT02615574|Celecoxib|celecoxib|mesh-list
110551843|NCT02615574|Vaccines|vaccines|mesh-list
110551844|NCT02615574|Immunologic Factors|immunologic factors|mesh-ancestor
110551845|NCT02615574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110551846|NCT02615574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110551847|NCT02615574|Antiviral Agents|antiviral agents|mesh-ancestor
110551848|NCT02615574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110551849|NCT02615574|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110551850|NCT02615574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110551851|NCT02615574|Analgesics|analgesics|mesh-ancestor
110551852|NCT02615574|Sensory System Agents|sensory system agents|mesh-ancestor
110551853|NCT02615574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110551854|NCT02615574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110551855|NCT02615574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110551856|NCT02615574|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110551857|NCT02615574|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110551858|NCT02615574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110551859|NCT02615574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110551860|NCT02708693|Triamcinolone|triamcinolone|mesh-list
110551861|NCT02708693|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110551862|NCT02708693|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110551863|NCT02708693|Lidocaine|lidocaine|mesh-list
110551864|NCT02708693|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110551865|NCT02708693|Anesthetics, Local|anesthetics, local|mesh-ancestor
110551866|NCT02708693|Anesthetics|anesthetics|mesh-ancestor
110551867|NCT02708693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110551868|NCT02708693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110551869|NCT02708693|Sensory System Agents|sensory system agents|mesh-ancestor
110551870|NCT02708693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110551871|NCT02708693|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110551872|NCT02708693|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110551873|NCT02708693|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110551874|NCT02708693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110551875|NCT02708693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110551876|NCT02708693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110551877|NCT02708693|Glucocorticoids|glucocorticoids|mesh-ancestor
110551878|NCT02708693|Hormones|hormones|mesh-ancestor
110551879|NCT02708693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110551880|NCT02708693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110551881|NCT02708693|Immunologic Factors|immunologic factors|mesh-ancestor
110551882|NCT02708693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110551883|NCT02638922|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110551884|NCT02638922|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110551885|NCT02638922|Trisequens|trisequens|mesh-list
110551886|NCT02638922|Norethindrone|norethindrone|mesh-list
110551887|NCT02638922|Estradiol|estradiol|mesh-list
110551888|NCT02638922|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110551889|NCT02638922|Estrogens|estrogens|mesh-ancestor
110551890|NCT02638922|Hormones|hormones|mesh-ancestor
110551891|NCT02638922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110551892|NCT02638922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110551893|NCT02638922|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110551894|NCT02638922|Contraceptive Agents|contraceptive agents|mesh-ancestor
110551895|NCT02638922|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110551896|NCT02638922|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110551897|NCT02638922|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110551898|NCT02638922|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110551899|NCT02638922|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110551901|NCT01005199|Sorafenib|sorafenib|mesh-list
110551902|NCT01005199|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110551903|NCT01005199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110551904|NCT01005199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110551905|NCT01005199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110551906|NCT01005199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110551907|NCT01005199|Immunologic Factors|immunologic factors|mesh-ancestor
110551908|NCT01005199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110551909|NCT01005199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110551910|NCT02711189|Oxytocin|oxytocin|mesh-list
110551911|NCT02711189|Oxytocics|oxytocics|mesh-ancestor
110551912|NCT02711189|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110551913|NCT02711189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110551914|NCT02635802|Lidocaine|lidocaine|mesh-list
110551915|NCT02635802|Midazolam|midazolam|mesh-list
110551916|NCT02635802|Remifentanil|remifentanil|mesh-list
110551917|NCT02635802|Anesthetics, Local|anesthetics, local|mesh-ancestor
110551918|NCT02635802|Anesthetics|anesthetics|mesh-ancestor
110551919|NCT02635802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110551920|NCT02635802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110551921|NCT02635802|Sensory System Agents|sensory system agents|mesh-ancestor
110551922|NCT02635802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110551923|NCT02635802|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110551924|NCT02635802|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110551925|NCT02635802|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110551926|NCT02635802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110551927|NCT02635802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110551928|NCT02635802|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110551929|NCT02635802|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110551930|NCT02635802|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110551931|NCT02635802|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110551932|NCT02635802|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110551933|NCT02635802|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110551934|NCT02635802|Anesthetics, General|anesthetics, general|mesh-ancestor
110551935|NCT02635802|GABA Modulators|gaba modulators|mesh-ancestor
110551936|NCT02635802|GABA Agents|gaba agents|mesh-ancestor
110551937|NCT02635802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110551938|NCT02635802|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110551939|NCT02635802|Narcotics|narcotics|mesh-ancestor
110551940|NCT02635802|Analgesics|analgesics|mesh-ancestor
110551941|NCT00853749|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110551942|NCT00853749|Immunologic Factors|immunologic factors|mesh-ancestor
110551943|NCT00853749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110551944|NCT00657410|Dexamethasone|dexamethasone|mesh-list
110551945|NCT00657410|Prednisone|prednisone|mesh-list
110551946|NCT00657410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110551947|NCT00657410|Antiemetics|antiemetics|mesh-ancestor
110551948|NCT00657410|Autonomic Agents|autonomic agents|mesh-ancestor
110551949|NCT00657410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110551950|NCT00657410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110551951|NCT00657410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110551952|NCT00657410|Glucocorticoids|glucocorticoids|mesh-ancestor
110551953|NCT00657410|Hormones|hormones|mesh-ancestor
110551954|NCT00657410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110551955|NCT00657410|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110551956|NCT00657410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110551957|NCT01009021|Diclofenac|diclofenac|mesh-list
110551958|NCT01009021|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110551959|NCT01009021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110551960|NCT01009021|Analgesics|analgesics|mesh-ancestor
110551961|NCT01009021|Sensory System Agents|sensory system agents|mesh-ancestor
110551962|NCT01009021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110551963|NCT01009021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110551964|NCT01009021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110551965|NCT01009021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110551966|NCT01009021|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110551967|NCT01009021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110551968|NCT01009021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110551969|NCT01005433|Dexmedetomidine|dexmedetomidine|mesh-list
110551970|NCT01005433|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110551971|NCT01005433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110551972|NCT01005433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110551973|NCT01005433|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110551975|NCT01005433|Sensory System Agents|sensory system agents|mesh-ancestor
110551976|NCT01005433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110551977|NCT01005433|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110551978|NCT01005433|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110551979|NCT01005433|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110551980|NCT01005433|Adrenergic Agents|adrenergic agents|mesh-ancestor
110551981|NCT01005433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110551982|NCT01005433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110551983|NCT00654446|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110551984|NCT00654446|Simvastatin|simvastatin|mesh-list
110551985|NCT00654446|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110551986|NCT00654446|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110551987|NCT00654446|Antimetabolites|antimetabolites|mesh-ancestor
110551988|NCT00654446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110551989|NCT00654446|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110551990|NCT00654446|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110551991|NCT00654446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110551992|NCT01003483|Orlistat|orlistat|mesh-list
110551993|NCT01003483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110551994|NCT01003483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110551995|NCT01003483|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110551996|NCT01003483|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110551997|NCT00592839|Estrogens|estrogens|mesh-list
110551998|NCT00592839|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
110551999|NCT00592839|Estrogens, conjugated synthetic A|estrogens, conjugated synthetic a|mesh-list
110552000|NCT00592839|Estrogens, conjugated synthetic B|estrogens, conjugated synthetic b|mesh-list
110552001|NCT00592839|Hormones|hormones|mesh-ancestor
110552002|NCT00592839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110552003|NCT00592839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110552004|NCT01009177|Bosentan|bosentan|mesh-list
110552005|NCT01009177|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110552006|NCT01009177|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
110552007|NCT01009177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110552008|NCT00598832|Adapalene|adapalene|mesh-list
110552009|NCT00598832|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110552010|NCT00598832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110552011|NCT00598832|Analgesics|analgesics|mesh-ancestor
110552012|NCT00598832|Sensory System Agents|sensory system agents|mesh-ancestor
110552013|NCT00598832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110552014|NCT00598832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110552015|NCT00598832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110552016|NCT00598832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110552017|NCT00598832|Dermatologic Agents|dermatologic agents|mesh-ancestor
110552019|NCT01003561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110180838|NCT00016601|Nelfinavir|nelfinavir|mesh-list
110552020|NCT01003561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110552021|NCT02711267|Acyclovir|acyclovir|mesh-list
110552022|NCT02711267|Antiviral Agents|antiviral agents|mesh-ancestor
110552023|NCT02711267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110552024|NCT04219553|Anti-Infective Agents|anti-infective agents|mesh-list
110552025|NCT04219553|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110552026|NCT04459871|Thrombin|thrombin|mesh-list
110552027|NCT04459871|Hemostatics|hemostatics|mesh-ancestor
110552028|NCT04459871|Coagulants|coagulants|mesh-ancestor
110552029|NCT02708459|Morphine|morphine|mesh-list
110552030|NCT02708459|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110552031|NCT02708459|Narcotics|narcotics|mesh-ancestor
110552032|NCT02708459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110552033|NCT02708459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110552034|NCT02708459|Analgesics|analgesics|mesh-ancestor
110552035|NCT02708459|Sensory System Agents|sensory system agents|mesh-ancestor
110552036|NCT02708459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110552037|NCT01005979|Cyclophosphamide|cyclophosphamide|mesh-list
110552039|NCT01005979|Lenalidomide|lenalidomide|mesh-list
110552040|NCT01005979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110552041|NCT01005979|Immunologic Factors|immunologic factors|mesh-ancestor
110552042|NCT01005979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110552043|NCT01005979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110552044|NCT01005979|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110552045|NCT01005979|Alkylating Agents|alkylating agents|mesh-ancestor
110552046|NCT01005979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110552047|NCT01005979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110552048|NCT01005979|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110552049|NCT01005979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110552050|NCT01005979|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110552051|NCT01005979|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110552053|NCT01005979|Growth Inhibitors|growth inhibitors|mesh-ancestor
110552054|NCT00913029|Timolol|timolol|mesh-list
110552055|NCT00913029|Latanoprost|latanoprost|mesh-list
110552056|NCT00913029|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110552057|NCT00913029|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110552058|NCT00913029|Adrenergic Agents|adrenergic agents|mesh-ancestor
110552059|NCT00913029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110552060|NCT00913029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110552061|NCT00913029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110552062|NCT00913029|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110552063|NCT00913029|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110552064|NCT00913029|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110552065|NCT00913029|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110552066|NCT01006057|Insulin|insulin|mesh-list
110552067|NCT01006057|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110552068|NCT01006057|Insulin, Long-Acting|insulin, long-acting|mesh-list
110552069|NCT01006057|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110552070|NCT01006057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110552071|NCT00853125|Sunitinib|sunitinib|mesh-list
110552072|NCT00853125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110552073|NCT00853125|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110552074|NCT00853125|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110552075|NCT00853125|Growth Substances|growth substances|mesh-ancestor
110552076|NCT00853125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110552077|NCT00853125|Growth Inhibitors|growth inhibitors|mesh-ancestor
110552078|NCT00853125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110552079|NCT00853125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110552080|NCT00853125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110552081|NCT02707913|Amlodipine|amlodipine|mesh-list
110552082|NCT02707913|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110552083|NCT02707913|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110552084|NCT02707913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110552085|NCT02707913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110552086|NCT02707913|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110552087|NCT02707913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110552088|NCT02707913|Vasodilator Agents|vasodilator agents|mesh-ancestor
110552089|NCT02710877|Sufentanil|sufentanil|mesh-list
110552090|NCT02710877|Dsuvia|dsuvia|mesh-list
110552091|NCT02710877|Levobupivacaine|levobupivacaine|mesh-list
110552092|NCT02710877|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110552093|NCT02710877|Narcotics|narcotics|mesh-ancestor
110552094|NCT02710877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110552095|NCT02710877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110552096|NCT02710877|Analgesics|analgesics|mesh-ancestor
110552097|NCT02710877|Sensory System Agents|sensory system agents|mesh-ancestor
110552098|NCT02710877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110552100|NCT02710877|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110552101|NCT02710877|Anesthetics, General|anesthetics, general|mesh-ancestor
110552102|NCT02710877|Anesthetics|anesthetics|mesh-ancestor
110552103|NCT02710877|Anesthetics, Local|anesthetics, local|mesh-ancestor
110552104|NCT00530023|Insulin|insulin|mesh-list
110552105|NCT00530023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110552106|NCT00530023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110552107|NCT02707445|Clopidogrel|clopidogrel|mesh-list
110552108|NCT02707445|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110552109|NCT02707445|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110552110|NCT02707445|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110552111|NCT02707445|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110552112|NCT02707445|Purinergic Agents|purinergic agents|mesh-ancestor
110552113|NCT02707445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110552114|NCT02707445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110552115|NCT02707445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110552116|NCT03999775|Calcium, Dietary|calcium, dietary|mesh-list
110552118|NCT03999775|Ergocalciferols|ergocalciferols|mesh-list
110552119|NCT03999775|Cholecalciferol|cholecalciferol|mesh-list
110552120|NCT03999775|Vitamins|vitamins|mesh-list
110552121|NCT03999775|Calcium|calcium|mesh-list
110552122|NCT03999775|Micronutrients|micronutrients|mesh-ancestor
110552123|NCT03999775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110552124|NCT03999775|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110552125|NCT03999775|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110552126|NCT02706977|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
110552127|NCT02706977|Carbidopa|carbidopa|mesh-list
110552128|NCT02706977|Levodopa|levodopa|mesh-list
110552129|NCT02706977|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110552130|NCT02706977|Immunologic Factors|immunologic factors|mesh-ancestor
110552131|NCT02706977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110552132|NCT02706977|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110552133|NCT02706977|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110552134|NCT02706977|Dopamine Agonists|dopamine agonists|mesh-ancestor
110552135|NCT02706977|Dopamine Agents|dopamine agents|mesh-ancestor
110552136|NCT02706977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110552137|NCT02706977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110552138|NCT02706977|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
110552139|NCT02706977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110552140|NCT02707211|Antibodies|antibodies|mesh-list
110552141|NCT02707211|Immunoglobulin M|immunoglobulin m|mesh-list
110552142|NCT02707211|Immunologic Factors|immunologic factors|mesh-ancestor
110552143|NCT02707211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110552144|NCT01006525|Zolpidem|zolpidem|mesh-list
110552145|NCT01006525|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110552146|NCT01006525|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110552147|NCT01006525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110552148|NCT01006525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110552149|NCT01006525|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
110552150|NCT01006525|GABA Agonists|gaba agonists|mesh-ancestor
110552152|NCT01006525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110552153|NCT01006525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110180929|NCT00129363|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110552154|NCT01006681|Vaccines|vaccines|mesh-list
110552155|NCT01006681|MF59 oil emulsion|mf59 oil emulsion|mesh-list
110552156|NCT01006681|Immunologic Factors|immunologic factors|mesh-ancestor
110552157|NCT01006681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110552158|NCT01006681|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110552159|NCT05733403|Norepinephrine|norepinephrine|mesh-list
110552160|NCT05733403|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110552161|NCT05733403|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110552162|NCT05733403|Adrenergic Agents|adrenergic agents|mesh-ancestor
110552163|NCT05733403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110552164|NCT05733403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110552165|NCT05733403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110552166|NCT05733403|Sympathomimetics|sympathomimetics|mesh-ancestor
110552167|NCT05733403|Autonomic Agents|autonomic agents|mesh-ancestor
110552168|NCT05733403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110552169|NCT05733403|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110552170|NCT03893903|Avelumab|avelumab|mesh-list
110552171|NCT03893903|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110552172|NCT03893903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110552173|NCT02706509|Tramadol|tramadol|mesh-list
110552174|NCT02706509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110552175|NCT02706509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110552176|NCT02706509|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110552177|NCT02706509|Narcotics|narcotics|mesh-ancestor
110552178|NCT02706509|Analgesics|analgesics|mesh-ancestor
110552179|NCT02706509|Sensory System Agents|sensory system agents|mesh-ancestor
110552180|NCT02706509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110552181|NCT02710409|Vaccines|vaccines|mesh-list
110552182|NCT02710409|Immunologic Factors|immunologic factors|mesh-ancestor
110199766|NCT00131404|Hormones|hormones|mesh-ancestor
110552183|NCT02710409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110552184|NCT00529087|Bromides|bromides|mesh-list
110552185|NCT00529087|Methylnaltrexone|methylnaltrexone|mesh-list
110552186|NCT00529087|Anticonvulsants|anticonvulsants|mesh-ancestor
110552187|NCT00529087|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110552188|NCT00529087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110552189|NCT00529087|Sensory System Agents|sensory system agents|mesh-ancestor
110552190|NCT00529087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110552191|NCT04318210|Tenofovir|tenofovir|mesh-list
110552192|NCT04318210|Emtricitabine|emtricitabine|mesh-list
110552193|NCT04318210|Antiviral Agents|antiviral agents|mesh-ancestor
110552194|NCT04318210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110552195|NCT04318210|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110552196|NCT04318210|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110552197|NCT04318210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110552198|NCT04318210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110552199|NCT04318210|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110552200|NCT04318210|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110552201|NCT00611663|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110552202|NCT00611663|Immunologic Factors|immunologic factors|mesh-ancestor
110552203|NCT00611663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110552204|NCT00870870|Carboplatin|carboplatin|mesh-list
110552205|NCT00870870|Gemcitabine|gemcitabine|mesh-list
110552206|NCT00870870|Cetuximab|cetuximab|mesh-list
110552207|NCT00870870|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110552208|NCT00870870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110552209|NCT00870870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110552210|NCT00870870|Antimetabolites|antimetabolites|mesh-ancestor
110552211|NCT00870870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110552212|NCT00870870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110552213|NCT00870870|Immunologic Factors|immunologic factors|mesh-ancestor
110552214|NCT00870870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110552215|NCT04120636|Celecoxib|celecoxib|mesh-list
110552216|NCT04120636|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110552217|NCT04120636|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110552218|NCT04120636|Analgesics|analgesics|mesh-ancestor
110552219|NCT04120636|Sensory System Agents|sensory system agents|mesh-ancestor
110552220|NCT04120636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110552221|NCT04120636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110552222|NCT04120636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110552223|NCT04120636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110552224|NCT04120636|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110552225|NCT04120636|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110552226|NCT04120636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110552227|NCT04120636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110552228|NCT00731926|Vitamins|vitamins|mesh-list
110552229|NCT00731926|Vitamin E|vitamin e|mesh-list
110552230|NCT00731926|Micronutrients|micronutrients|mesh-ancestor
110552231|NCT00731926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110552232|NCT00731926|Antioxidants|antioxidants|mesh-ancestor
110552233|NCT00731926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110552234|NCT00731926|Protective Agents|protective agents|mesh-ancestor
110552235|NCT00732082|Gemcitabine|gemcitabine|mesh-list
110552236|NCT00732082|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110552237|NCT00732082|Antimetabolites|antimetabolites|mesh-ancestor
110552238|NCT00732082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110552239|NCT00732082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110552240|NCT00611741|Furosemide|furosemide|mesh-list
110552241|NCT00611741|Diuretics|diuretics|mesh-ancestor
110552242|NCT00611741|Natriuretic Agents|natriuretic agents|mesh-ancestor
110552243|NCT00611741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110552244|NCT00611741|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110552245|NCT00611741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110552246|NCT00611741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110552247|NCT04134468|Gemcitabine|gemcitabine|mesh-list
110552248|NCT04134468|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110552249|NCT04134468|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110552250|NCT04134468|Antimetabolites|antimetabolites|mesh-ancestor
110552251|NCT04134468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110552252|NCT04134468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110552253|NCT02709863|Propofol|propofol|mesh-list
110552254|NCT02709863|Sevoflurane|sevoflurane|mesh-list
110552255|NCT02709863|Desflurane|desflurane|mesh-list
110552256|NCT02709863|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110552257|NCT02709863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110552258|NCT02709863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110552259|NCT02709863|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110552260|NCT02709863|Anesthetics, General|anesthetics, general|mesh-ancestor
110552261|NCT02709863|Anesthetics|anesthetics|mesh-ancestor
110552262|NCT02709863|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110552263|NCT02709863|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110552264|NCT03877237|Dapagliflozin|dapagliflozin|mesh-list
110180972|NCT00017108|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110552265|NCT03877237|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110552266|NCT03877237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110552267|NCT03877237|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110552268|NCT03877237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110552270|NCT02619786|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110552271|NCT02619786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110552272|NCT00697086|Dronedarone|dronedarone|mesh-list
110552273|NCT00697086|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110552274|NCT04066660|Fucoidan|fucoidan|mesh-list
110552275|NCT04066660|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110552276|NCT04066660|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110552277|NCT04066660|Anticoagulants|anticoagulants|mesh-ancestor
110552278|NCT04066660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110552279|NCT00697164|Epoetin Alfa|epoetin alfa|mesh-list
110552280|NCT00697164|Hematinics|hematinics|mesh-ancestor
110552281|NCT00694980|Etrolizumab|etrolizumab|mesh-list
110552282|NCT00694980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110552283|NCT00694980|Immunologic Factors|immunologic factors|mesh-ancestor
110552284|NCT00694980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110552285|NCT00612755|Ribavirin|ribavirin|mesh-list
110552286|NCT00612755|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110552287|NCT00612755|Antimetabolites|antimetabolites|mesh-ancestor
110552288|NCT00612755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110552289|NCT00612755|Antiviral Agents|antiviral agents|mesh-ancestor
110552290|NCT00612755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110552291|NCT04132674|Tenofovir|tenofovir|mesh-list
110552292|NCT04132674|Emtricitabine|emtricitabine|mesh-list
110552293|NCT04132674|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
110552294|NCT04132674|Antiviral Agents|antiviral agents|mesh-ancestor
110552295|NCT04132674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110552296|NCT04132674|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110552297|NCT04132674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110552298|NCT04132674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110552299|NCT04132674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110552300|NCT04132674|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110552301|NCT04132674|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110552302|NCT00612287|Buprenorphine|buprenorphine|mesh-list
110552303|NCT00612287|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110552304|NCT00612287|Narcotics|narcotics|mesh-ancestor
110552305|NCT00612287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110552306|NCT00612287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110552307|NCT00612287|Analgesics|analgesics|mesh-ancestor
110552308|NCT00612287|Sensory System Agents|sensory system agents|mesh-ancestor
110552309|NCT00612287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110552310|NCT00612287|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110552311|NCT00732784|Imatinib Mesylate|imatinib mesylate|mesh-list
110552312|NCT00732784|Calcium Carbonate|calcium carbonate|mesh-list
110552313|NCT00732784|Calcium|calcium|mesh-list
110552314|NCT00732784|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110552315|NCT00732784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110552316|NCT00732784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110552317|NCT00732784|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110552318|NCT00732784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110552319|NCT00732784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110552320|NCT00732784|Antacids|antacids|mesh-ancestor
110552321|NCT00732784|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110552322|NCT04496219|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110552323|NCT04496219|BCG Vaccine|bcg vaccine|mesh-list
110552324|NCT04496219|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110552325|NCT04496219|Immunologic Factors|immunologic factors|mesh-ancestor
110552326|NCT04496219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110552327|NCT02947126|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
110552328|NCT02947126|Pentetic Acid|pentetic acid|mesh-list
110552329|NCT02947126|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110552330|NCT02947126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110552331|NCT02947126|Antidotes|antidotes|mesh-ancestor
110552332|NCT02947126|Protective Agents|protective agents|mesh-ancestor
110552333|NCT02947126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110552334|NCT02947126|Chelating Agents|chelating agents|mesh-ancestor
110552335|NCT02947126|Sequestering Agents|sequestering agents|mesh-ancestor
110552336|NCT02947126|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110552337|NCT04492553|Testosterone|testosterone|mesh-list
110552338|NCT04492553|Androgens|androgens|mesh-ancestor
110552339|NCT04492553|Hormones|hormones|mesh-ancestor
110552340|NCT04492553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110552341|NCT04492553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110552342|NCT00871494|Azithromycin|azithromycin|mesh-list
110552343|NCT00871494|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110552344|NCT00871494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110552345|NCT01007539|Choline|choline|mesh-list
110552346|NCT01007539|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
110552347|NCT01007539|Lipotropic Agents|lipotropic agents|mesh-ancestor
110552348|NCT01007539|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110552349|NCT01007539|Antimetabolites|antimetabolites|mesh-ancestor
110552350|NCT01007539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110552351|NCT01007539|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110552352|NCT01007539|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110552353|NCT01007539|Nootropic Agents|nootropic agents|mesh-ancestor
110552354|NCT04951817|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
110552355|NCT04951817|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110552356|NCT04951817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110552357|NCT04137185|Hormones|hormones|mesh-list
110552358|NCT04137185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110552359|NCT04137185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110552360|NCT00733174|Rosiglitazone|rosiglitazone|mesh-list
110552361|NCT00733174|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110552362|NCT00733174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110552363|NCT00529789|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110552364|NCT00529789|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110552365|NCT00529789|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110552366|NCT00529789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110552367|NCT00529789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110552368|NCT00529789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110552369|NCT00529789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110552370|NCT00529789|Analgesics|analgesics|mesh-ancestor
110552371|NCT00529789|Sensory System Agents|sensory system agents|mesh-ancestor
110552372|NCT00529789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110552373|NCT00529789|Antidepressive Agents|antidepressive agents|mesh-ancestor
110552374|NCT00529789|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110552375|NCT00529789|Dopamine Agents|dopamine agents|mesh-ancestor
110552376|NCT04136028|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
110552377|NCT04136028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110552378|NCT00611819|Interferons|interferons|mesh-list
110552379|NCT00611819|Ribavirin|ribavirin|mesh-list
110552380|NCT00611819|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110552381|NCT00611819|Interferon-alpha|interferon-alpha|mesh-list
110552382|NCT00611819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110552383|NCT00611819|Antiviral Agents|antiviral agents|mesh-ancestor
110552384|NCT00611819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110552385|NCT00611819|Antimetabolites|antimetabolites|mesh-ancestor
110552386|NCT00611819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110181005|NCT00129207|Bortezomib|bortezomib|mesh-list
110552387|NCT00611819|Immunologic Factors|immunologic factors|mesh-ancestor
110552388|NCT00611819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110552390|NCT00577642|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110552391|NCT00577642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110552392|NCT02619162|Letrozole|letrozole|mesh-list
110552393|NCT02619162|Nintedanib|nintedanib|mesh-list
110552394|NCT02619162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110552395|NCT02619162|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110552396|NCT02619162|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110552397|NCT02619162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110552398|NCT02619162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110552399|NCT02619162|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110552400|NCT02619162|Hormone Antagonists|hormone antagonists|mesh-ancestor
110552401|NCT02619162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110552402|NCT02619162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110552403|NCT02619162|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110552404|NCT04018690|Triamcinolone|triamcinolone|mesh-list
110552405|NCT04018690|Ropivacaine|ropivacaine|mesh-list
110552406|NCT04018690|Anesthetics, Local|anesthetics, local|mesh-ancestor
110552407|NCT04018690|Anesthetics|anesthetics|mesh-ancestor
110552408|NCT04018690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110552409|NCT04018690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110552410|NCT04018690|Sensory System Agents|sensory system agents|mesh-ancestor
110552411|NCT04018690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110552412|NCT04018690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110552413|NCT04018690|Glucocorticoids|glucocorticoids|mesh-ancestor
110552415|NCT04018690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110552416|NCT00697866|Vaccines|vaccines|mesh-list
110552417|NCT00697866|Immunologic Factors|immunologic factors|mesh-ancestor
110552418|NCT00697866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110552419|NCT00733564|Lidocaine|lidocaine|mesh-list
110552420|NCT00733564|Propofol|propofol|mesh-list
110552421|NCT00733564|Sevoflurane|sevoflurane|mesh-list
110552422|NCT00733564|Anesthetics, Local|anesthetics, local|mesh-ancestor
110552423|NCT00733564|Anesthetics|anesthetics|mesh-ancestor
110552424|NCT00733564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110552425|NCT00733564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110552426|NCT00733564|Sensory System Agents|sensory system agents|mesh-ancestor
110552427|NCT00733564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110552429|NCT00733564|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110552430|NCT00733564|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110552431|NCT00733564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110552432|NCT00733564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110552433|NCT00733564|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110552434|NCT00733564|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110552435|NCT00733564|Anesthetics, General|anesthetics, general|mesh-ancestor
110552436|NCT00733564|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110552437|NCT00733564|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110552439|NCT00727870|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
110552440|NCT00727870|Protective Agents|protective agents|mesh-ancestor
110552441|NCT00727870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110552442|NCT01007695|Valproic Acid|valproic acid|mesh-list
110552443|NCT01007695|Anticonvulsants|anticonvulsants|mesh-ancestor
110552444|NCT01007695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110552445|NCT01007695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110552446|NCT01007695|GABA Agents|gaba agents|mesh-ancestor
110552447|NCT01007695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110552448|NCT01007695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110552449|NCT01007695|Antimanic Agents|antimanic agents|mesh-ancestor
110552450|NCT01007695|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110552451|NCT01007695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110552452|NCT01007695|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110552453|NCT02709473|Remifentanil|remifentanil|mesh-list
110552454|NCT02709473|Propofol|propofol|mesh-list
110552455|NCT02709473|Rocuronium|rocuronium|mesh-list
110552456|NCT02709473|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110552457|NCT02709473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110552458|NCT02709473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110552459|NCT02709473|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110552460|NCT02709473|Anesthetics, General|anesthetics, general|mesh-ancestor
110552461|NCT02709473|Anesthetics|anesthetics|mesh-ancestor
110552462|NCT02709473|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110552463|NCT02709473|Narcotics|narcotics|mesh-ancestor
110552464|NCT02709473|Analgesics|analgesics|mesh-ancestor
110552465|NCT02709473|Sensory System Agents|sensory system agents|mesh-ancestor
110552466|NCT02709473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110552467|NCT02709473|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110552468|NCT02709473|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110552469|NCT02709473|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110552470|NCT00866658|Lixisenatide|lixisenatide|mesh-list
110552471|NCT00866658|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110552472|NCT00866658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110552473|NCT04942067|Dexamethasone|dexamethasone|mesh-list
110552474|NCT04942067|Dexamethasone acetate|dexamethasone acetate|mesh-list
110552475|NCT04942067|Lenalidomide|lenalidomide|mesh-list
110552476|NCT04942067|Daratumumab|daratumumab|mesh-list
110552477|NCT04942067|Pomalidomide|pomalidomide|mesh-list
110552478|NCT04942067|BB 1101|bb 1101|mesh-list
110552479|NCT04942067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110552480|NCT04942067|Antiemetics|antiemetics|mesh-ancestor
110552481|NCT04942067|Autonomic Agents|autonomic agents|mesh-ancestor
110552482|NCT04942067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110552483|NCT04942067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110552484|NCT04942067|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110552485|NCT04942067|Glucocorticoids|glucocorticoids|mesh-ancestor
110552486|NCT04942067|Hormones|hormones|mesh-ancestor
110552487|NCT04942067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110552488|NCT04942067|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110552489|NCT04942067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110552490|NCT04942067|Protease Inhibitors|protease inhibitors|mesh-ancestor
110552491|NCT04942067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110552492|NCT04942067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110552493|NCT04942067|Immunologic Factors|immunologic factors|mesh-ancestor
110552494|NCT04942067|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110552495|NCT04942067|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110552496|NCT04942067|Growth Substances|growth substances|mesh-ancestor
110552497|NCT04942067|Growth Inhibitors|growth inhibitors|mesh-ancestor
110552498|NCT02615340|Melatonin|melatonin|mesh-list
110552499|NCT02615340|Antioxidants|antioxidants|mesh-ancestor
110552500|NCT02615340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110552501|NCT02615340|Protective Agents|protective agents|mesh-ancestor
110552502|NCT02615340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110552503|NCT02615340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110552504|NCT04899791|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
110552505|NCT04899791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110552506|NCT04899791|Antioxidants|antioxidants|mesh-ancestor
110552507|NCT04899791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110552508|NCT04899791|Protective Agents|protective agents|mesh-ancestor
110552509|NCT04899791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110552510|NCT04899791|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110552511|NCT02615106|Endostar protein|endostar protein|mesh-list
110552512|NCT02615106|Endostatins|endostatins|mesh-list
110552513|NCT02615106|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110181026|NCT00017186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110552514|NCT02615106|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110552516|NCT02615106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110552517|NCT02615106|Growth Inhibitors|growth inhibitors|mesh-ancestor
110552518|NCT02615106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110552519|NCT04930237|Methylnaltrexone|methylnaltrexone|mesh-list
110552521|NCT04930237|Magnesium citrate|magnesium citrate|mesh-list
110552522|NCT04930237|Magnesium Oxide|magnesium oxide|mesh-list
110552523|NCT04930237|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
110552524|NCT04930237|Magnesium Hydroxide|magnesium hydroxide|mesh-list
110552525|NCT04930237|Calcium|calcium|mesh-list
110552526|NCT04930237|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110552527|NCT04930237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110552528|NCT04930237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110552529|NCT04930237|Cathartics|cathartics|mesh-ancestor
110552530|NCT04930237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110552531|NCT04930237|Laxatives|laxatives|mesh-ancestor
110552532|NCT04930237|Antacids|antacids|mesh-ancestor
110552533|NCT04930237|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110552534|NCT04930237|Sensory System Agents|sensory system agents|mesh-ancestor
110552535|NCT04930237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110552536|NCT04930237|Antidiarrheals|antidiarrheals|mesh-ancestor
110552537|NCT02615262|Dexamethasone|dexamethasone|mesh-list
110552538|NCT02615262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110552539|NCT02615262|Antiemetics|antiemetics|mesh-ancestor
110552540|NCT02615262|Autonomic Agents|autonomic agents|mesh-ancestor
110552541|NCT02615262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110552542|NCT02615262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110552543|NCT02615262|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110552544|NCT02615262|Glucocorticoids|glucocorticoids|mesh-ancestor
110552545|NCT02615262|Hormones|hormones|mesh-ancestor
110552546|NCT02615262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110552547|NCT02615262|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110552548|NCT02615262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110552549|NCT00733720|Naltrexone|naltrexone|mesh-list
110552550|NCT00733720|Buprenorphine|buprenorphine|mesh-list
110552551|NCT00733720|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
110552552|NCT00733720|Naloxone|naloxone|mesh-list
110552553|NCT00733720|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110552554|NCT00733720|Narcotics|narcotics|mesh-ancestor
110552555|NCT00733720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110552556|NCT00733720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110552557|NCT00733720|Analgesics|analgesics|mesh-ancestor
110552558|NCT00733720|Sensory System Agents|sensory system agents|mesh-ancestor
110552559|NCT00733720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110552560|NCT00733720|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110552561|NCT00733720|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110552562|NCT04134312|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
110552563|NCT04134312|Antiviral Agents|antiviral agents|mesh-ancestor
110200134|NCT00046943|Atrasentan|atrasentan|mesh-list
110552564|NCT04134312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110552565|NCT02624388|Genistein|genistein|mesh-list
110552566|NCT02624388|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110181036|NCT00017225|Carboplatin|carboplatin|mesh-list
110552567|NCT02624388|Protective Agents|protective agents|mesh-ancestor
110552568|NCT02624388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110552569|NCT02624388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110552570|NCT02624388|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110552571|NCT02624388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110552572|NCT02624388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110552573|NCT02624388|Phytoestrogens|phytoestrogens|mesh-ancestor
110552574|NCT02624388|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
110552575|NCT02624388|Estrogens|estrogens|mesh-ancestor
110552576|NCT02624388|Hormones|hormones|mesh-ancestor
110560330|NCT00638729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110552577|NCT02624388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110552578|NCT00727948|Aspirin|aspirin|mesh-list
110552579|NCT00727948|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110552580|NCT00727948|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110552581|NCT00727948|Analgesics|analgesics|mesh-ancestor
110552582|NCT00727948|Sensory System Agents|sensory system agents|mesh-ancestor
110552583|NCT00727948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110552584|NCT00727948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110552585|NCT00727948|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110552586|NCT00727948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110552587|NCT00727948|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110552588|NCT00727948|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110552589|NCT00727948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110552590|NCT00727948|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110552591|NCT00727948|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110552592|NCT00727948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110552593|NCT00727948|Antipyretics|antipyretics|mesh-ancestor
110552594|NCT01007851|Triptorelin Pamoate|triptorelin pamoate|mesh-list
110552595|NCT01007851|Luteolytic Agents|luteolytic agents|mesh-ancestor
110552596|NCT01007851|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110552597|NCT01007851|Contraceptive Agents|contraceptive agents|mesh-ancestor
110552598|NCT01007851|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110552599|NCT01007851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110552600|NCT01007851|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110552601|NCT01007851|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110552602|NCT01007851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110552603|NCT05580016|Plasminogen|plasminogen|mesh-list
110552604|NCT05580016|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110552605|NCT05580016|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110552606|NCT05580016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110552607|NCT05730673|Leronlimab|leronlimab|mesh-list
110552608|NCT05730673|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110552609|NCT05730673|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110552610|NCT05730673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110552611|NCT05730673|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110552612|NCT05730673|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110552613|NCT05730673|Antiviral Agents|antiviral agents|mesh-ancestor
110552614|NCT05730673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110552615|NCT04134078|Nitric Oxide|nitric oxide|mesh-list
110552616|NCT04134078|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110552617|NCT04134078|Autonomic Agents|autonomic agents|mesh-ancestor
110552618|NCT04134078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110552619|NCT04134078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110552620|NCT04134078|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110552621|NCT04134078|Respiratory System Agents|respiratory system agents|mesh-ancestor
110552622|NCT04134078|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110552623|NCT04134078|Antioxidants|antioxidants|mesh-ancestor
110552624|NCT04134078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110552625|NCT04134078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110552626|NCT04134078|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
110552627|NCT04134078|Vasodilator Agents|vasodilator agents|mesh-ancestor
110552628|NCT04134078|Gasotransmitters|gasotransmitters|mesh-ancestor
110552629|NCT04134078|Protective Agents|protective agents|mesh-ancestor
110552630|NCT03871829|Dexamethasone|dexamethasone|mesh-list
110552631|NCT03871829|Dexamethasone acetate|dexamethasone acetate|mesh-list
110552632|NCT03871829|BB 1101|bb 1101|mesh-list
110552633|NCT03871829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110552634|NCT03871829|Antiemetics|antiemetics|mesh-ancestor
110552635|NCT03871829|Autonomic Agents|autonomic agents|mesh-ancestor
110552636|NCT03871829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110552637|NCT03871829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110552638|NCT03871829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110552639|NCT03871829|Glucocorticoids|glucocorticoids|mesh-ancestor
110552640|NCT03871829|Hormones|hormones|mesh-ancestor
110552641|NCT03871829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110552642|NCT03871829|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110552643|NCT03871829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110552644|NCT03871829|Protease Inhibitors|protease inhibitors|mesh-ancestor
110552645|NCT03871829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110552646|NCT03871829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110552647|NCT00738556|Sirolimus|sirolimus|mesh-list
110552648|NCT00738556|Paclitaxel|paclitaxel|mesh-list
110552649|NCT00738556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110552650|NCT00738556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110552651|NCT00738556|Tubulin Modulators|tubulin modulators|mesh-ancestor
110552652|NCT00738556|Antimitotic Agents|antimitotic agents|mesh-ancestor
110552653|NCT00738556|Mitosis Modulators|mitosis modulators|mesh-ancestor
110552654|NCT00738556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110552655|NCT00738556|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110552656|NCT00738556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110552657|NCT00738556|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110552658|NCT00738556|Antifungal Agents|antifungal agents|mesh-ancestor
110552659|NCT00738556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110552660|NCT00738556|Immunologic Factors|immunologic factors|mesh-ancestor
110552661|NCT00738556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110552662|NCT00597584|Epoetin Alfa|epoetin alfa|mesh-list
110552663|NCT00597584|Hematinics|hematinics|mesh-ancestor
110552664|NCT00529633|Thalidomide|thalidomide|mesh-list
110552665|NCT00529633|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110552666|NCT00529633|Immunologic Factors|immunologic factors|mesh-ancestor
110552667|NCT00529633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110552668|NCT00529633|Leprostatic Agents|leprostatic agents|mesh-ancestor
110552669|NCT00529633|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110552670|NCT00529633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110552671|NCT00529633|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110552672|NCT00529633|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110552673|NCT00529633|Growth Substances|growth substances|mesh-ancestor
110552674|NCT00529633|Growth Inhibitors|growth inhibitors|mesh-ancestor
110552675|NCT00529633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110552676|NCT00697944|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
110552677|NCT00697944|Antifungal Agents|antifungal agents|mesh-ancestor
110552678|NCT00697944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110552679|NCT00697944|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110552680|NCT00697944|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110552681|NCT00657488|Thalidomide|thalidomide|mesh-list
110552682|NCT00657488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110552683|NCT00657488|Immunologic Factors|immunologic factors|mesh-ancestor
110552684|NCT00657488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110552685|NCT00657488|Leprostatic Agents|leprostatic agents|mesh-ancestor
110181074|NCT00128934|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110552686|NCT00657488|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110552687|NCT00657488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110552688|NCT00657488|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110552689|NCT00657488|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110552690|NCT00657488|Growth Substances|growth substances|mesh-ancestor
110552691|NCT00657488|Growth Inhibitors|growth inhibitors|mesh-ancestor
110552692|NCT00657488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110552693|NCT00530335|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
110552694|NCT00530335|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110552695|NCT00530335|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110552696|NCT00530335|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110552697|NCT00530335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110552698|NCT00530335|Adrenergic Agents|adrenergic agents|mesh-ancestor
110552699|NCT00530335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110552700|NCT00530335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110552701|NCT00712270|Risperidone|risperidone|mesh-list
110552702|NCT00712270|Aripiprazole|aripiprazole|mesh-list
110552703|NCT00712270|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110552704|NCT00712270|Serotonin Agents|serotonin agents|mesh-ancestor
110552705|NCT00712270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110552706|NCT00712270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110552707|NCT00712270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110552708|NCT00712270|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110552709|NCT00712270|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110552710|NCT00712270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110552711|NCT00712270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110552712|NCT00712270|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110552713|NCT00712270|Dopamine Agents|dopamine agents|mesh-ancestor
110552714|NCT00712270|Antidepressive Agents|antidepressive agents|mesh-ancestor
110552715|NCT00712270|Dopamine Agonists|dopamine agonists|mesh-ancestor
110552716|NCT00712270|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110552717|NCT00712270|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110552718|NCT00712270|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110552719|NCT00712270|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110552720|NCT03860597|Memantine|memantine|mesh-list
110552721|NCT03860597|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110552722|NCT03860597|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110552723|NCT03860597|Dopamine Agents|dopamine agents|mesh-ancestor
110552724|NCT03860597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110552725|NCT03860597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110552726|NCT03860597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110552727|NCT03860597|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110552728|NCT03860597|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110552729|NCT02614872|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
110552730|NCT02614872|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
110552731|NCT02614872|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110552732|NCT02614872|Protease Inhibitors|protease inhibitors|mesh-ancestor
110552733|NCT02614872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110552734|NCT02614872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110552735|NCT00695604|Fluticasone|fluticasone|mesh-list
110552736|NCT00695604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110552737|NCT00695604|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110552738|NCT00695604|Autonomic Agents|autonomic agents|mesh-ancestor
110552739|NCT00695604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110552740|NCT00695604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110552741|NCT00695604|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110552742|NCT00695604|Respiratory System Agents|respiratory system agents|mesh-ancestor
110552743|NCT00695604|Dermatologic Agents|dermatologic agents|mesh-ancestor
110552744|NCT00695604|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110552746|NCT00654524|Goserelin|goserelin|mesh-list
110552747|NCT00654524|Hormones|hormones|mesh-list
110552748|NCT00654524|Vitamins|vitamins|mesh-ancestor
110552749|NCT00654524|Micronutrients|micronutrients|mesh-ancestor
110552750|NCT00654524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110552751|NCT00654524|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110552752|NCT00654524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110552753|NCT00654524|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110552754|NCT00654524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110552755|NCT05260619|Lenalidomide|lenalidomide|mesh-list
110552756|NCT05260619|Immunologic Factors|immunologic factors|mesh-ancestor
110552757|NCT05260619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110552758|NCT05260619|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110552759|NCT05260619|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110552760|NCT05260619|Growth Substances|growth substances|mesh-ancestor
110552761|NCT05260619|Growth Inhibitors|growth inhibitors|mesh-ancestor
110552762|NCT05260619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110552763|NCT00695682|Infliximab|infliximab|mesh-list
110552764|NCT00695682|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110552765|NCT00695682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110552766|NCT00695682|Dermatologic Agents|dermatologic agents|mesh-ancestor
110552767|NCT00695682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110552768|NCT00695682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110552769|NCT00657566|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110552770|NCT00657566|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
110552771|NCT00657566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110552772|NCT00657566|Antitubercular Agents|antitubercular agents|mesh-ancestor
110552773|NCT03828773|Fluconazole|fluconazole|mesh-list
110552774|NCT03828773|Posaconazole|posaconazole|mesh-list
110552775|NCT03828773|Antifungal Agents|antifungal agents|mesh-ancestor
110552776|NCT03828773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110552777|NCT03828773|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110552778|NCT03828773|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110552779|NCT03828773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110552780|NCT03828773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110552781|NCT03828773|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110552782|NCT03828773|Hormone Antagonists|hormone antagonists|mesh-ancestor
110552783|NCT03828773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110552784|NCT03828773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110552785|NCT03828773|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110552786|NCT03828773|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110552787|NCT03828773|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
110552788|NCT03828773|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110552789|NCT03828773|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110552790|NCT00530257|Methylphenidate|methylphenidate|mesh-list
110552791|NCT00530257|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110552792|NCT00530257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110552793|NCT00530257|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110552794|NCT00530257|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110552795|NCT00530257|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110552796|NCT00530257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110552797|NCT00530257|Dopamine Agents|dopamine agents|mesh-ancestor
110552798|NCT00530257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110552800|NCT00738868|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110552801|NCT00738868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110552802|NCT00657644|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
110552803|NCT00657644|Vasodilator Agents|vasodilator agents|mesh-ancestor
110552804|NCT00657644|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110552805|NCT00657644|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110552806|NCT00657644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110552807|NCT00657644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110552808|NCT00657644|Urological Agents|urological agents|mesh-ancestor
110552810|NCT00869778|Immunologic Factors|immunologic factors|mesh-ancestor
110552811|NCT00869778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110552812|NCT04159610|Glycopyrrolate|glycopyrrolate|mesh-list
110552813|NCT04159610|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110552814|NCT04159610|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110552815|NCT04159610|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110552816|NCT04159610|Cholinergic Agents|cholinergic agents|mesh-ancestor
110552817|NCT04159610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110552818|NCT04159610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110552819|NCT04159610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110552820|NCT04162028|Ketamine|ketamine|mesh-list
110552821|NCT04162028|Analgesics|analgesics|mesh-ancestor
110552822|NCT04162028|Sensory System Agents|sensory system agents|mesh-ancestor
110552823|NCT04162028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110552824|NCT04162028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110552825|NCT04162028|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110552826|NCT04162028|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110552827|NCT04162028|Anesthetics, General|anesthetics, general|mesh-ancestor
110552828|NCT04162028|Anesthetics|anesthetics|mesh-ancestor
110552829|NCT04162028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110552830|NCT04162028|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110552831|NCT04162028|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110552832|NCT04162028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110552833|NCT04162028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110552834|NCT00656786|Vitamin K 3|vitamin k 3|mesh-list
110552835|NCT00656786|Vitamin K|vitamin k|mesh-list
110552836|NCT00656786|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110552837|NCT00656786|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110552838|NCT00656786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110552839|NCT00656786|Hemostatics|hemostatics|mesh-ancestor
110552840|NCT00656786|Coagulants|coagulants|mesh-ancestor
110552841|NCT00656786|Vitamins|vitamins|mesh-ancestor
110552842|NCT00656786|Micronutrients|micronutrients|mesh-ancestor
110552843|NCT00656786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110552844|NCT01008631|Sodium thiosulfate|sodium thiosulfate|mesh-list
110552845|NCT01008631|Antidotes|antidotes|mesh-ancestor
110552846|NCT01008631|Protective Agents|protective agents|mesh-ancestor
110552847|NCT01008631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110552848|NCT01008631|Antioxidants|antioxidants|mesh-ancestor
110552849|NCT01008631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110552850|NCT01008631|Antitubercular Agents|antitubercular agents|mesh-ancestor
110552851|NCT01008631|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110552852|NCT01008631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110552853|NCT01008631|Chelating Agents|chelating agents|mesh-ancestor
110552854|NCT01008631|Sequestering Agents|sequestering agents|mesh-ancestor
110552855|NCT00734890|Bevacizumab|bevacizumab|mesh-list
110552856|NCT00734890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110552857|NCT00734890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110552858|NCT00734890|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110552859|NCT00734890|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110552860|NCT00734890|Growth Substances|growth substances|mesh-ancestor
110552861|NCT00734890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110552862|NCT00734890|Growth Inhibitors|growth inhibitors|mesh-ancestor
110552863|NCT05325190|Granisetron|granisetron|mesh-list
110552864|NCT05325190|Antiemetics|antiemetics|mesh-ancestor
110552865|NCT05325190|Autonomic Agents|autonomic agents|mesh-ancestor
110552866|NCT05325190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110552867|NCT05325190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110552868|NCT05325190|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110552869|NCT05325190|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110552870|NCT05325190|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110552872|NCT05325190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110552873|NCT05325190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110552874|NCT02624310|Droxidopa|droxidopa|mesh-list
110552875|NCT02624310|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110552876|NCT02624310|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110552877|NCT00612521|Adenosine|adenosine|mesh-list
110552878|NCT00612521|Analgesics|analgesics|mesh-ancestor
110552879|NCT00612521|Sensory System Agents|sensory system agents|mesh-ancestor
110552880|NCT00612521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110552881|NCT00612521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110552882|NCT00612521|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110552883|NCT00612521|Vasodilator Agents|vasodilator agents|mesh-ancestor
110552884|NCT00612521|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
110552885|NCT00612521|Purinergic Agonists|purinergic agonists|mesh-ancestor
110552886|NCT00612521|Purinergic Agents|purinergic agents|mesh-ancestor
110552887|NCT00612521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110552888|NCT00612521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110552889|NCT00735124|Gabapentin|gabapentin|mesh-list
110552890|NCT00735124|Analgesics|analgesics|mesh-ancestor
110552891|NCT00735124|Sensory System Agents|sensory system agents|mesh-ancestor
110552892|NCT00735124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110552893|NCT00735124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110552894|NCT00735124|Anticonvulsants|anticonvulsants|mesh-ancestor
110552895|NCT00735124|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110552896|NCT00735124|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110552897|NCT00735124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110552898|NCT00735124|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110552899|NCT00735124|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110552900|NCT00735124|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110552901|NCT00735124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110552902|NCT00735124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110552903|NCT00735124|Antimanic Agents|antimanic agents|mesh-ancestor
110552904|NCT04131348|Botulinum Toxins|botulinum toxins|mesh-list
110552905|NCT04131348|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110552906|NCT04131348|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110552907|NCT04131348|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110552908|NCT04131348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110552909|NCT04131348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110552910|NCT04131348|Cholinergic Agents|cholinergic agents|mesh-ancestor
110552911|NCT04131348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110552912|NCT04131348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110552913|NCT04131348|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110552914|NCT04131348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110552915|NCT04246541|Acetaminophen|acetaminophen|mesh-list
110552916|NCT04246541|Ketorolac|ketorolac|mesh-list
110552917|NCT04246541|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
110552918|NCT04246541|Oxycodone|oxycodone|mesh-list
110552919|NCT04246541|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110552920|NCT04246541|Analgesics|analgesics|mesh-ancestor
110552921|NCT04246541|Sensory System Agents|sensory system agents|mesh-ancestor
110552922|NCT04246541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110552923|NCT04246541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110552924|NCT04246541|Antipyretics|antipyretics|mesh-ancestor
110552925|NCT04246541|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110552926|NCT04246541|Narcotics|narcotics|mesh-ancestor
110552927|NCT04246541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110552928|NCT04246541|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110552929|NCT04246541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110552930|NCT04246541|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110552931|NCT04246541|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110552932|NCT04246541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110552933|NCT04246541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110552934|NCT04902859|Clonidine|clonidine|mesh-list
110552935|NCT04902859|Analgesics|analgesics|mesh-ancestor
110200521|NCT00081042|Paclitaxel|paclitaxel|mesh-list
110552936|NCT04902859|Sensory System Agents|sensory system agents|mesh-ancestor
110552937|NCT04902859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110552938|NCT04902859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110552939|NCT04902859|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110552940|NCT04902859|Sympatholytics|sympatholytics|mesh-ancestor
110552941|NCT04902859|Autonomic Agents|autonomic agents|mesh-ancestor
110312581|NCT00305838|Tamoxifen|tamoxifen|mesh-list
110552942|NCT04902859|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110552943|NCT04902859|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110552944|NCT04902859|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110552945|NCT04902859|Adrenergic Agents|adrenergic agents|mesh-ancestor
110552946|NCT04902859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110552947|NCT04902859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110552948|NCT05227313|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110552949|NCT00711958|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110552950|NCT04180943|Bupivacaine|bupivacaine|mesh-list
110552951|NCT04180943|Anesthetics, Local|anesthetics, local|mesh-ancestor
110552952|NCT04180943|Anesthetics|anesthetics|mesh-ancestor
110552953|NCT04180943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110552954|NCT04180943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110552955|NCT04180943|Sensory System Agents|sensory system agents|mesh-ancestor
110552956|NCT04180943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110552957|NCT05011357|Phenylephrine|phenylephrine|mesh-list
110552958|NCT05011357|Oxymetazoline|oxymetazoline|mesh-list
110552959|NCT05011357|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110552960|NCT05011357|Mydriatics|mydriatics|mesh-ancestor
110552961|NCT05011357|Autonomic Agents|autonomic agents|mesh-ancestor
110552962|NCT05011357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110552963|NCT05011357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110552964|NCT05011357|Sympathomimetics|sympathomimetics|mesh-ancestor
110552965|NCT05011357|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110552966|NCT05011357|Nasal Decongestants|nasal decongestants|mesh-ancestor
110552967|NCT05011357|Respiratory System Agents|respiratory system agents|mesh-ancestor
110552968|NCT05011357|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110552969|NCT05011357|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110552970|NCT05011357|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110552971|NCT05011357|Adrenergic Agents|adrenergic agents|mesh-ancestor
110552972|NCT05011357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110552973|NCT05011357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110552974|NCT05011357|Protective Agents|protective agents|mesh-ancestor
110552975|NCT00711880|Nabiximols|nabiximols|mesh-list
110552976|NCT00711880|Analgesics|analgesics|mesh-ancestor
110552977|NCT00711880|Sensory System Agents|sensory system agents|mesh-ancestor
110552978|NCT00711880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110552979|NCT00711880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110552980|NCT02693483|Povidone-Iodine|povidone-iodine|mesh-list
110552981|NCT02693483|Povidone|povidone|mesh-list
110552982|NCT02693483|Plasma Substitutes|plasma substitutes|mesh-ancestor
110552983|NCT02693483|Blood Substitutes|blood substitutes|mesh-ancestor
110181141|NCT00128700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110552984|NCT02693483|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110552985|NCT02693483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110552987|NCT04873063|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110552988|NCT04873063|Glucocorticoids|glucocorticoids|mesh-ancestor
110552989|NCT04873063|Hormones|hormones|mesh-ancestor
110552990|NCT04873063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110552991|NCT04873063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110552992|NCT04873063|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110552993|NCT04873063|Respiratory System Agents|respiratory system agents|mesh-ancestor
110552994|NCT00739414|Panobinostat|panobinostat|mesh-list
110552995|NCT00739414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110552996|NCT00739414|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110552997|NCT00739414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110552998|NCT00739414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110552999|NCT00612599|Insulin Aspart|insulin aspart|mesh-list
110553000|NCT00612599|Biphasic Insulins|biphasic insulins|mesh-list
110553001|NCT00612599|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110553002|NCT00612599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110553003|NCT00735280|Heparin|heparin|mesh-list
110553004|NCT00735280|Calcium heparin|calcium heparin|mesh-list
110553005|NCT00735280|Anticoagulants|anticoagulants|mesh-ancestor
110553006|NCT00735280|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110553007|NCT00735280|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110553008|NCT00735280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110553009|NCT00612989|Temozolomide|temozolomide|mesh-list
110553010|NCT00612989|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
110553011|NCT00612989|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110553012|NCT00612989|Alkylating Agents|alkylating agents|mesh-ancestor
110553013|NCT00612989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110553014|NCT00612989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110553015|NCT00612989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110553016|NCT04929067|Immunomodulating Agents|immunomodulating agents|mesh-list
110553017|NCT04929067|Immunologic Factors|immunologic factors|mesh-ancestor
110553018|NCT04929067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110553019|NCT05215405|Venetoclax|venetoclax|mesh-list
110553020|NCT05215405|Navitoclax|navitoclax|mesh-list
110553021|NCT05215405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110553022|NCT00613067|Escitalopram|escitalopram|mesh-list
110553023|NCT00613067|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110553024|NCT00613067|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110553025|NCT00613067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110553026|NCT00613067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110553027|NCT00613067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110553028|NCT00613067|Serotonin Agents|serotonin agents|mesh-ancestor
110553029|NCT00613067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110553030|NCT04649489|Bevacizumab|bevacizumab|mesh-list
110553031|NCT04649489|Atezolizumab|atezolizumab|mesh-list
110553032|NCT04649489|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110553033|NCT04649489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110553034|NCT04649489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110553035|NCT04649489|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110553036|NCT04649489|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110553037|NCT04649489|Growth Substances|growth substances|mesh-ancestor
110553038|NCT04649489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110553039|NCT04649489|Growth Inhibitors|growth inhibitors|mesh-ancestor
110553040|NCT04649489|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110553041|NCT04649489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110553042|NCT04649489|Immunologic Factors|immunologic factors|mesh-ancestor
110553043|NCT00613145|Capecitabine|capecitabine|mesh-list
110553044|NCT00613145|Sorafenib|sorafenib|mesh-list
110553045|NCT00613145|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110553047|NCT00613145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110553048|NCT00613145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110553049|NCT00613145|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110553050|NCT00613145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110553051|NCT04570085|Caffeine|caffeine|mesh-list
110553052|NCT04570085|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110553053|NCT04570085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110553054|NCT04570085|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110553055|NCT04570085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110553056|NCT04570085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110553057|NCT04570085|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110553058|NCT04570085|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110553059|NCT04570085|Purinergic Agents|purinergic agents|mesh-ancestor
110553060|NCT04570085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110553061|NCT00529399|Aluminum Hydroxide|aluminum hydroxide|mesh-list
110553062|NCT00529399|Aluminum sulfate|aluminum sulfate|mesh-list
110553063|NCT00529399|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110553064|NCT00529399|Immunologic Factors|immunologic factors|mesh-ancestor
110553065|NCT00529399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110553066|NCT00529399|Antacids|antacids|mesh-ancestor
110553067|NCT00529399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110553068|NCT00529399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110553069|NCT05268419|Ethanol|ethanol|mesh-list
110553070|NCT05268419|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110553071|NCT05268419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110553072|NCT05268419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110553073|NCT05268419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110553074|NCT00852969|Niacin|niacin|mesh-list
110553075|NCT00852969|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110553076|NCT00852969|Antimetabolites|antimetabolites|mesh-ancestor
110553077|NCT00852969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110553078|NCT00852969|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110553079|NCT00852969|Vasodilator Agents|vasodilator agents|mesh-ancestor
110553080|NCT00852969|Vitamin B Complex|vitamin b complex|mesh-ancestor
110553081|NCT00852969|Vitamins|vitamins|mesh-ancestor
110553082|NCT00852969|Micronutrients|micronutrients|mesh-ancestor
110553083|NCT00852969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110553084|NCT00613457|Cytarabine|cytarabine|mesh-list
110553085|NCT00613457|Dexamethasone|dexamethasone|mesh-list
110553086|NCT00613457|Prednisone|prednisone|mesh-list
110553087|NCT00613457|Cyclophosphamide|cyclophosphamide|mesh-list
110553088|NCT00613457|Ifosfamide|ifosfamide|mesh-list
110553089|NCT00613457|Doxorubicin|doxorubicin|mesh-list
110553090|NCT00613457|Methotrexate|methotrexate|mesh-list
110553091|NCT00613457|Etoposide|etoposide|mesh-list
110553092|NCT00613457|Vincristine|vincristine|mesh-list
110553094|NCT00613457|Asparaginase|asparaginase|mesh-list
110553095|NCT00613457|Mercaptopurine|mercaptopurine|mesh-list
110553096|NCT00613457|Thioguanine|thioguanine|mesh-list
110553097|NCT00613457|Vindesine|vindesine|mesh-list
110553098|NCT00613457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110553099|NCT00613457|Immunologic Factors|immunologic factors|mesh-ancestor
110553100|NCT00613457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110553101|NCT00613457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110553102|NCT00613457|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110553103|NCT00613457|Alkylating Agents|alkylating agents|mesh-ancestor
110553104|NCT00613457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110553105|NCT00613457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110553106|NCT00613457|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110553107|NCT00613457|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110553108|NCT00613457|Antiemetics|antiemetics|mesh-ancestor
110553109|NCT00613457|Autonomic Agents|autonomic agents|mesh-ancestor
110553110|NCT00613457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110181179|NCT00017576|Calcitriol|calcitriol|mesh-list
110553111|NCT00613457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110553112|NCT00613457|Glucocorticoids|glucocorticoids|mesh-ancestor
110553113|NCT00613457|Hormones|hormones|mesh-ancestor
110553114|NCT00613457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110553115|NCT00613457|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110553116|NCT00613457|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110553117|NCT00613457|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110553118|NCT00613457|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110553119|NCT00613457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110553120|NCT00613457|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110553121|NCT00613457|Abortifacient Agents|abortifacient agents|mesh-ancestor
110553122|NCT00613457|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110553123|NCT00613457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110553124|NCT00613457|Antimetabolites|antimetabolites|mesh-ancestor
110553125|NCT00613457|Dermatologic Agents|dermatologic agents|mesh-ancestor
110553126|NCT00613457|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110553127|NCT00613457|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110553128|NCT00613457|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110553129|NCT00613457|Antiviral Agents|antiviral agents|mesh-ancestor
110553130|NCT00613457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110553131|NCT00613457|Tubulin Modulators|tubulin modulators|mesh-ancestor
110553132|NCT00613457|Antimitotic Agents|antimitotic agents|mesh-ancestor
110553133|NCT00613457|Mitosis Modulators|mitosis modulators|mesh-ancestor
110553134|NCT04131582|Metformin|metformin|mesh-list
110553135|NCT04131582|Empagliflozin|empagliflozin|mesh-list
110553136|NCT04131582|Linagliptin|linagliptin|mesh-list
110553137|NCT04131582|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110553138|NCT04131582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110553139|NCT04131582|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110553140|NCT04131582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110553141|NCT04131582|Incretins|incretins|mesh-ancestor
110553142|NCT04131582|Hormones|hormones|mesh-ancestor
110553143|NCT04131582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110553144|NCT04131582|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110553145|NCT04131582|Protease Inhibitors|protease inhibitors|mesh-ancestor
110553146|NCT04131582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110553147|NCT00521365|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110553148|NCT00521365|Antidepressive Agents|antidepressive agents|mesh-ancestor
110553149|NCT00521365|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110553150|NCT00521365|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110553151|NCT00521365|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110553152|NCT00521365|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110553153|NCT00521365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110553154|NCT00695994|Carboplatin|carboplatin|mesh-list
110553155|NCT00695994|Gemcitabine|gemcitabine|mesh-list
110553156|NCT00695994|Docetaxel|docetaxel|mesh-list
110553157|NCT00695994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110553158|NCT00695994|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110553159|NCT00695994|Antimetabolites|antimetabolites|mesh-ancestor
110553160|NCT00695994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110553161|NCT00695994|Tubulin Modulators|tubulin modulators|mesh-ancestor
110553162|NCT00695994|Antimitotic Agents|antimitotic agents|mesh-ancestor
110553163|NCT00695994|Mitosis Modulators|mitosis modulators|mesh-ancestor
110553165|NCT00711802|Cloxacillin|cloxacillin|mesh-list
110553166|NCT00711802|Oxacillin|oxacillin|mesh-list
110553167|NCT00711802|Nafcillin|nafcillin|mesh-list
110553168|NCT00711802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110553169|NCT00711802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110553170|NCT00851877|Paclitaxel|paclitaxel|mesh-list
110553171|NCT00851877|Cetuximab|cetuximab|mesh-list
110553172|NCT00851877|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110553173|NCT00851877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110181188|NCT00017576|Vitamins|vitamins|mesh-ancestor
110553174|NCT00851877|Tubulin Modulators|tubulin modulators|mesh-ancestor
110553175|NCT00851877|Antimitotic Agents|antimitotic agents|mesh-ancestor
110553176|NCT00851877|Mitosis Modulators|mitosis modulators|mesh-ancestor
110553177|NCT00851877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110553178|NCT00851877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110553180|NCT00613223|Etoposide phosphate|etoposide phosphate|mesh-list
110553181|NCT00613223|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110553182|NCT00613223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110553183|NCT00613223|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110553184|NCT00613223|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110553185|NCT00613223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110553186|NCT00613223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110553187|NCT00882908|Ribavirin|ribavirin|mesh-list
110553188|NCT00882908|Simeprevir|simeprevir|mesh-list
110553189|NCT00882908|Antimetabolites|antimetabolites|mesh-ancestor
110553190|NCT00882908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110553191|NCT00882908|Antiviral Agents|antiviral agents|mesh-ancestor
110553192|NCT00882908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110553193|NCT00882908|Protease Inhibitors|protease inhibitors|mesh-ancestor
110553194|NCT00882908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110553195|NCT03580967|Vortioxetine|vortioxetine|mesh-list
110553196|NCT03580967|Antidepressive Agents|antidepressive agents|mesh-ancestor
110553197|NCT03580967|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110553198|NCT03580967|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110553199|NCT03580967|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110553200|NCT03580967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110553201|NCT03580967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110553202|NCT03580967|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110553203|NCT03580967|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110553204|NCT03580967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110553205|NCT03580967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110553206|NCT03580967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110553207|NCT03580967|Serotonin Agents|serotonin agents|mesh-ancestor
110553208|NCT03580967|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110553209|NCT03580967|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110553210|NCT03580967|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110553211|NCT03580967|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110553212|NCT00851799|Ritonavir|ritonavir|mesh-list
110553213|NCT00851799|Atazanavir Sulfate|atazanavir sulfate|mesh-list
110553214|NCT00851799|Darunavir|darunavir|mesh-list
110553215|NCT00851799|Tenofovir|tenofovir|mesh-list
110553216|NCT00851799|Emtricitabine|emtricitabine|mesh-list
110553217|NCT00851799|Raltegravir Potassium|raltegravir potassium|mesh-list
110553218|NCT00851799|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110553219|NCT00851799|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110553220|NCT00851799|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110553221|NCT00851799|Protease Inhibitors|protease inhibitors|mesh-ancestor
110553222|NCT00851799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110553223|NCT00851799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110553224|NCT00851799|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110553225|NCT00851799|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110553226|NCT00851799|Antiviral Agents|antiviral agents|mesh-ancestor
110553227|NCT00851799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110553228|NCT00851799|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110553229|NCT00851799|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110553230|NCT00851799|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110553231|NCT00851799|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110553232|NCT00851799|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110216593|NCT00264277|Micronutrients|micronutrients|mesh-ancestor
110553233|NCT00851799|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110553234|NCT00853047|Octreotide|octreotide|mesh-list
110553235|NCT00853047|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110553236|NCT00853047|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110553237|NCT00853047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110553238|NCT04117191|Tryptophan|tryptophan|mesh-list
110553239|NCT04117191|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110553240|NCT04117191|Antidepressive Agents|antidepressive agents|mesh-ancestor
110553241|NCT04117191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110553242|NCT00520975|Paclitaxel|paclitaxel|mesh-list
110553243|NCT00520975|Bevacizumab|bevacizumab|mesh-list
110553244|NCT00520975|Carboplatin|carboplatin|mesh-list
110553245|NCT00520975|Trastuzumab|trastuzumab|mesh-list
110553246|NCT00520975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110553247|NCT00520975|Antibodies|antibodies|mesh-list
110553248|NCT00520975|Immunoglobulins|immunoglobulins|mesh-list
110553249|NCT00520975|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110553250|NCT00520975|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110553251|NCT00520975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110553252|NCT00520975|Tubulin Modulators|tubulin modulators|mesh-ancestor
110553253|NCT00520975|Antimitotic Agents|antimitotic agents|mesh-ancestor
110553254|NCT00520975|Mitosis Modulators|mitosis modulators|mesh-ancestor
110553255|NCT00520975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110553256|NCT00520975|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110553257|NCT00520975|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110553258|NCT00520975|Growth Substances|growth substances|mesh-ancestor
110553259|NCT00520975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110553260|NCT00520975|Growth Inhibitors|growth inhibitors|mesh-ancestor
110553261|NCT00520975|Immunologic Factors|immunologic factors|mesh-ancestor
110553262|NCT00614159|Ketamine|ketamine|mesh-list
110553263|NCT00614159|Propofol|propofol|mesh-list
110553264|NCT00614159|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110553265|NCT00614159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110553266|NCT00614159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110553267|NCT00614159|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110553268|NCT00614159|Anesthetics, General|anesthetics, general|mesh-ancestor
110553269|NCT00614159|Anesthetics|anesthetics|mesh-ancestor
110553270|NCT00614159|Analgesics|analgesics|mesh-ancestor
110553271|NCT00614159|Sensory System Agents|sensory system agents|mesh-ancestor
110553272|NCT00614159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110553273|NCT00614159|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110553274|NCT00614159|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110553275|NCT00614159|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110553276|NCT00614159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110553277|NCT00614159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110553278|NCT05042531|Azacitidine|azacitidine|mesh-list
110553279|NCT05042531|Dasatinib|dasatinib|mesh-list
110553280|NCT05042531|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110553281|NCT05042531|Antimetabolites|antimetabolites|mesh-ancestor
110553282|NCT05042531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110553283|NCT05042531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110553284|NCT05042531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110553285|NCT05042531|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110553286|NCT00851721|Factor VIII|factor viii|mesh-list
110553287|NCT00851721|Anti-inhibitor coagulant complex|anti-inhibitor coagulant complex|mesh-list
110553288|NCT00851721|Coagulants|coagulants|mesh-ancestor
110553289|NCT04071119|Oxytocin|oxytocin|mesh-list
110553290|NCT04071119|Oxytocics|oxytocics|mesh-ancestor
110553291|NCT04071119|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110181207|NCT00017654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110553292|NCT04071119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110553293|NCT02634476|Ethanol|ethanol|mesh-list
110553294|NCT02634476|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110553295|NCT02634476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110553296|NCT02634476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110553297|NCT02634476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110553298|NCT04385303|Lorecivivint|lorecivivint|mesh-list
110553299|NCT04385303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110553300|NCT00654602|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110553301|NCT00654602|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110553302|NCT00654602|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110553303|NCT00654602|Antimetabolites|antimetabolites|mesh-ancestor
110553304|NCT00654602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110553305|NCT00654602|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110553306|NCT00654602|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110553307|NCT00654602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110553308|NCT00740194|Estradiol|estradiol|mesh-list
110553309|NCT00740194|Estrogens|estrogens|mesh-ancestor
110553310|NCT00740194|Hormones|hormones|mesh-ancestor
110553311|NCT00740194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110553312|NCT00740194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110553313|NCT04159142|Paclitaxel|paclitaxel|mesh-list
110553314|NCT04159142|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110553315|NCT04159142|Carboplatin|carboplatin|mesh-list
110553316|NCT04159142|Capecitabine|capecitabine|mesh-list
110553317|NCT04159142|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110553318|NCT04159142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110553319|NCT04159142|Tubulin Modulators|tubulin modulators|mesh-ancestor
110553320|NCT04159142|Antimitotic Agents|antimitotic agents|mesh-ancestor
110553321|NCT04159142|Mitosis Modulators|mitosis modulators|mesh-ancestor
110553322|NCT04159142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110553323|NCT04159142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110553324|NCT04159142|Antimetabolites|antimetabolites|mesh-ancestor
110553325|NCT00654680|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
110553326|NCT00654680|Vasodilator Agents|vasodilator agents|mesh-ancestor
110553327|NCT00654680|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110553328|NCT00654680|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110553329|NCT00654680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110553330|NCT00654680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110553331|NCT00654680|Urological Agents|urological agents|mesh-ancestor
110553332|NCT00520741|Lacosamide|lacosamide|mesh-list
110553333|NCT00520741|Anticonvulsants|anticonvulsants|mesh-ancestor
110553334|NCT00520741|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110553335|NCT00520741|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110553336|NCT00520741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110553337|NCT00520741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110553338|NCT03682289|Durvalumab|durvalumab|mesh-list
110553339|NCT03682289|Olaparib|olaparib|mesh-list
110553340|NCT03682289|Adenosine|adenosine|mesh-list
110553341|NCT03682289|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110553342|NCT03682289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110553343|NCT03682289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110553344|NCT03682289|Immunologic Factors|immunologic factors|mesh-ancestor
110553345|NCT03682289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110553346|NCT03682289|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110553347|NCT03682289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110181224|NCT00394485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110553348|NCT03682289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110553349|NCT03682289|Analgesics|analgesics|mesh-ancestor
110553350|NCT03682289|Sensory System Agents|sensory system agents|mesh-ancestor
110553351|NCT03682289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110553352|NCT03682289|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110553353|NCT03682289|Vasodilator Agents|vasodilator agents|mesh-ancestor
110553354|NCT03682289|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
110553355|NCT03682289|Purinergic Agonists|purinergic agonists|mesh-ancestor
110553356|NCT03682289|Purinergic Agents|purinergic agents|mesh-ancestor
110553357|NCT03682289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110553358|NCT00729118|Lenalidomide|lenalidomide|mesh-list
110553359|NCT00729118|Vorinostat|vorinostat|mesh-list
110553360|NCT00729118|Immunologic Factors|immunologic factors|mesh-ancestor
110553361|NCT00729118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110553362|NCT00729118|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110553363|NCT00729118|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110553364|NCT00729118|Growth Substances|growth substances|mesh-ancestor
110553365|NCT00729118|Growth Inhibitors|growth inhibitors|mesh-ancestor
110553366|NCT00729118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110553367|NCT00729118|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110553369|NCT00729118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110553370|NCT04064632|Darunavir|darunavir|mesh-list
110553371|NCT04064632|Cobicistat|cobicistat|mesh-list
110553372|NCT04064632|Rilpivirine|rilpivirine|mesh-list
110553373|NCT04064632|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
110553374|NCT04064632|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110553375|NCT04064632|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110553376|NCT04064632|Protease Inhibitors|protease inhibitors|mesh-ancestor
110553377|NCT04064632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110553378|NCT04064632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110553379|NCT04064632|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110553380|NCT04064632|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110553381|NCT04064632|Antiviral Agents|antiviral agents|mesh-ancestor
110553382|NCT04064632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110553383|NCT04064632|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110553384|NCT04064632|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110553385|NCT04064632|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110553386|NCT04064632|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110553387|NCT00882518|Chlorpromazine|chlorpromazine|mesh-list
110553388|NCT00882518|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110553389|NCT00882518|Antidepressive Agents|antidepressive agents|mesh-ancestor
110553390|NCT00882518|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110553391|NCT00882518|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110553392|NCT00882518|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110553393|NCT00882518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110553394|NCT00882518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110553395|NCT00882518|Antiemetics|antiemetics|mesh-ancestor
110553396|NCT00882518|Autonomic Agents|autonomic agents|mesh-ancestor
110553397|NCT00882518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110553398|NCT00882518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110553399|NCT00882518|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110553400|NCT00882518|Dopamine Agents|dopamine agents|mesh-ancestor
110553401|NCT00882518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110553402|NCT00882518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110553403|NCT00882362|Aripiprazole|aripiprazole|mesh-list
110553404|NCT00882362|Antidepressive Agents|antidepressive agents|mesh-ancestor
110553405|NCT00882362|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110553406|NCT00882362|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110553407|NCT00882362|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110553408|NCT00882362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110553409|NCT00882362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110553410|NCT00882362|Dopamine Agonists|dopamine agonists|mesh-ancestor
110553411|NCT00882362|Dopamine Agents|dopamine agents|mesh-ancestor
110553412|NCT00882362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110553413|NCT00882362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110553414|NCT00882362|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110553415|NCT00882362|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110553416|NCT00882362|Serotonin Agents|serotonin agents|mesh-ancestor
110553417|NCT00882362|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110553418|NCT00882362|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110553419|NCT00882362|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110553420|NCT00882362|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110553421|NCT00529243|Raltegravir Potassium|raltegravir potassium|mesh-list
110553422|NCT00529243|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110553423|NCT00529243|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110553424|NCT00529243|Antiviral Agents|antiviral agents|mesh-ancestor
110553425|NCT00529243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110553426|NCT00529243|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110553427|NCT00529243|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110553428|NCT00529243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110553429|NCT00529243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110553430|NCT00636935|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110553431|NCT00636935|Clindamycin|clindamycin|mesh-list
110553432|NCT00636935|Clindamycin palmitate|clindamycin palmitate|mesh-list
110553433|NCT00636935|Clindamycin phosphate|clindamycin phosphate|mesh-list
110553435|NCT00636935|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
110553436|NCT00636935|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
110553438|NCT00636935|Trimethoprim|trimethoprim|mesh-list
110553439|NCT00636935|Atovaquone|atovaquone|mesh-list
110553440|NCT00636935|Pentamidine|pentamidine|mesh-list
110553441|NCT00636935|Prednisone|prednisone|mesh-list
110553442|NCT00636935|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110553443|NCT00636935|Glucocorticoids|glucocorticoids|mesh-ancestor
110553444|NCT00636935|Hormones|hormones|mesh-ancestor
110553445|NCT00636935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110553446|NCT00636935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110553447|NCT00636935|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110553448|NCT00636935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110553450|NCT00636935|Antitubercular Agents|antitubercular agents|mesh-ancestor
110553451|NCT00636935|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110553452|NCT00636935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110553453|NCT00636935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110553454|NCT00636935|Antimalarials|antimalarials|mesh-ancestor
110553455|NCT00636935|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110553456|NCT00636935|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110553457|NCT00636935|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110553458|NCT00636935|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110553459|NCT00636935|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110553460|NCT00636935|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
110553461|NCT00636935|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110553462|NCT00636935|Leprostatic Agents|leprostatic agents|mesh-ancestor
110553463|NCT00636935|Antifungal Agents|antifungal agents|mesh-ancestor
110553464|NCT00636935|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
110553465|NCT00654758|Paclitaxel|paclitaxel|mesh-list
110553466|NCT00654758|Carboplatin|carboplatin|mesh-list
110553467|NCT00654758|Volociximab|volociximab|mesh-list
110553468|NCT00654758|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110553469|NCT00654758|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110553470|NCT00654758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110553471|NCT00654758|Tubulin Modulators|tubulin modulators|mesh-ancestor
110553472|NCT00654758|Antimitotic Agents|antimitotic agents|mesh-ancestor
110553473|NCT00654758|Mitosis Modulators|mitosis modulators|mesh-ancestor
110553474|NCT00654758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110553475|NCT00654758|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110553476|NCT00654758|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110553477|NCT00654758|Growth Substances|growth substances|mesh-ancestor
110553478|NCT00654758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110553479|NCT00654758|Growth Inhibitors|growth inhibitors|mesh-ancestor
110553480|NCT00654758|Immunologic Factors|immunologic factors|mesh-ancestor
110553481|NCT00656864|Pioglitazone|pioglitazone|mesh-list
110553482|NCT00656864|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110553483|NCT00656864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110553484|NCT00658268|Clodronic Acid|clodronic acid|mesh-list
110553485|NCT00658268|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110553486|NCT00658268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110553487|NCT00613613|Fenofibrate|fenofibrate|mesh-list
110553488|NCT00613613|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110553489|NCT00613613|Antimetabolites|antimetabolites|mesh-ancestor
110553490|NCT00613613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110553491|NCT00613613|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110553492|NCT04298099|Ropivacaine|ropivacaine|mesh-list
110553493|NCT04298099|Anesthetics, Local|anesthetics, local|mesh-ancestor
110553494|NCT04298099|Anesthetics|anesthetics|mesh-ancestor
110553495|NCT04298099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110553496|NCT04298099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110553497|NCT04298099|Sensory System Agents|sensory system agents|mesh-ancestor
110553498|NCT04298099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110553499|NCT02613195|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110553500|NCT00850395|Maraviroc|maraviroc|mesh-list
110553501|NCT00850395|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110553502|NCT00850395|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110553503|NCT00850395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110553504|NCT00850395|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110553505|NCT00850395|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110553506|NCT00850395|Antiviral Agents|antiviral agents|mesh-ancestor
110553507|NCT00850395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110553508|NCT00850395|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
110553509|NCT04188431|Dexamethasone|dexamethasone|mesh-list
110553510|NCT04188431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110553511|NCT04188431|Antiemetics|antiemetics|mesh-ancestor
110553512|NCT04188431|Autonomic Agents|autonomic agents|mesh-ancestor
110553513|NCT04188431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110181291|NCT00018083|Isoniazid|isoniazid|mesh-list
110553514|NCT04188431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110553515|NCT04188431|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110553516|NCT04188431|Glucocorticoids|glucocorticoids|mesh-ancestor
110553518|NCT04188431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110553519|NCT04188431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110553520|NCT04188431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110553521|NCT03630809|Vaccines|vaccines|mesh-list
110553522|NCT03630809|Immunologic Factors|immunologic factors|mesh-ancestor
110553523|NCT03630809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110553524|NCT00577720|Risedronic Acid|risedronic acid|mesh-list
110553525|NCT00577720|Etidronic Acid|etidronic acid|mesh-list
110553526|NCT00577720|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110553527|NCT00577720|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110553528|NCT00577720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110553529|NCT00577720|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110553530|NCT00577720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110553531|NCT00577720|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110553532|NCT00736294|Ramipril|ramipril|mesh-list
110553533|NCT00736294|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110553534|NCT00736294|Protease Inhibitors|protease inhibitors|mesh-ancestor
110553535|NCT00736294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110553536|NCT00736294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110553537|NCT00736294|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110553538|NCT00512707|Sildenafil Citrate|sildenafil citrate|mesh-list
110553539|NCT00512707|Testosterone|testosterone|mesh-list
110553540|NCT00512707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110553541|NCT00512707|Androgens|androgens|mesh-ancestor
110553543|NCT00512707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110553544|NCT00512707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110553545|NCT00512707|Vasodilator Agents|vasodilator agents|mesh-ancestor
110553546|NCT00512707|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110553547|NCT00512707|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110553548|NCT00512707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110553549|NCT00512707|Urological Agents|urological agents|mesh-ancestor
110553550|NCT00729274|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110553551|NCT03471767|Dextromethorphan|dextromethorphan|mesh-list
110553552|NCT03471767|Bupropion|bupropion|mesh-list
110553553|NCT03471767|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110553554|NCT03471767|Antidepressive Agents|antidepressive agents|mesh-ancestor
110553555|NCT03471767|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110553556|NCT03471767|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110553557|NCT03471767|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110553558|NCT03471767|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110553559|NCT03471767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110553560|NCT03471767|Dopamine Agents|dopamine agents|mesh-ancestor
110553561|NCT03471767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110553562|NCT03471767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110553563|NCT03471767|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110553564|NCT03471767|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110553565|NCT03471767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110553566|NCT03471767|Antitussive Agents|antitussive agents|mesh-ancestor
110553567|NCT03471767|Respiratory System Agents|respiratory system agents|mesh-ancestor
110553568|NCT03471767|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110181305|NCT00018083|Antitubercular Agents|antitubercular agents|mesh-ancestor
110553569|NCT03471767|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110553570|NCT00849693|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110553571|NCT00849693|Fluoxetine|fluoxetine|mesh-list
110553572|NCT00849693|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110553573|NCT00849693|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110553574|NCT00849693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110553575|NCT00849693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110553576|NCT00849693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110553577|NCT00849693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110553578|NCT00849693|Analgesics|analgesics|mesh-ancestor
110553579|NCT00849693|Sensory System Agents|sensory system agents|mesh-ancestor
110553580|NCT00849693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110553581|NCT00849693|Antidepressive Agents|antidepressive agents|mesh-ancestor
110553582|NCT00849693|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110553583|NCT00849693|Dopamine Agents|dopamine agents|mesh-ancestor
110553584|NCT00849693|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110553585|NCT00849693|Serotonin Agents|serotonin agents|mesh-ancestor
110553586|NCT00849693|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110553587|NCT00849693|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110553588|NCT00849693|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110553589|NCT00849693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110553590|NCT00736606|Simvastatin|simvastatin|mesh-list
110553591|NCT00736606|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110553592|NCT00736606|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110553593|NCT00736606|Antimetabolites|antimetabolites|mesh-ancestor
110553594|NCT00736606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110553595|NCT00736606|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110553596|NCT00736606|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110553597|NCT00736606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110553598|NCT00527605|Dutasteride|dutasteride|mesh-list
110553599|NCT00527605|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
110553600|NCT00527605|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110553601|NCT00527605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110553602|NCT00527605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110553603|NCT00527605|Hormone Antagonists|hormone antagonists|mesh-ancestor
110201193|NCT00147979|Heparin|heparin|mesh-list
110553604|NCT00527605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110553605|NCT00527605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110553606|NCT04865939|Gemcitabine|gemcitabine|mesh-list
110553607|NCT04865939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110553608|NCT04865939|Antimetabolites|antimetabolites|mesh-ancestor
110553609|NCT04865939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110553610|NCT04865939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110553611|NCT00741052|Azithromycin|azithromycin|mesh-list
110553612|NCT00741052|Ciprofloxacin|ciprofloxacin|mesh-list
110553613|NCT00741052|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110553614|NCT00741052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110553615|NCT00741052|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110553616|NCT00741052|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110553617|NCT00741052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110553618|NCT00741052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110553619|NCT00741052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110553620|NCT00741052|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110553621|NCT00741052|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110553622|NCT04116411|Valganciclovir|valganciclovir|mesh-list
110553623|NCT04116411|Temozolomide|temozolomide|mesh-list
110553624|NCT04116411|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110553625|NCT04116411|Alkylating Agents|alkylating agents|mesh-ancestor
110553626|NCT04116411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110553627|NCT04116411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110553628|NCT04116411|Antiviral Agents|antiviral agents|mesh-ancestor
110553629|NCT04116411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110553630|NCT00706953|Doxorubicin|doxorubicin|mesh-list
110553631|NCT00706953|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110553632|NCT00706953|Bortezomib|bortezomib|mesh-list
110553633|NCT00706953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110553634|NCT00706953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110553635|NCT00706953|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110553636|NCT00706953|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110553637|NCT00706953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110553638|NCT00706953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110553639|NCT03462017|Sildenafil Citrate|sildenafil citrate|mesh-list
110553640|NCT03462017|Acetylcholine|acetylcholine|mesh-list
110553641|NCT03462017|Vasodilator Agents|vasodilator agents|mesh-ancestor
110553642|NCT03462017|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110553643|NCT03462017|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110553644|NCT03462017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110553645|NCT03462017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110553646|NCT03462017|Urological Agents|urological agents|mesh-ancestor
110553648|NCT03462017|Cholinergic Agents|cholinergic agents|mesh-ancestor
110553649|NCT03462017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110553650|NCT03462017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110553651|NCT00913419|Amitriptyline|amitriptyline|mesh-list
110553652|NCT00913419|Cyclobenzaprine|cyclobenzaprine|mesh-list
110553653|NCT00913419|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110553654|NCT00913419|Antidepressive Agents|antidepressive agents|mesh-ancestor
110553655|NCT00913419|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110553656|NCT00913419|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110553657|NCT00913419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110553658|NCT00913419|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110553659|NCT00913419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110553660|NCT00913419|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110553661|NCT00913419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110553662|NCT00913419|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110553663|NCT00913419|Analgesics|analgesics|mesh-ancestor
110553664|NCT00913419|Sensory System Agents|sensory system agents|mesh-ancestor
110553665|NCT00913419|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110553666|NCT00913419|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110553667|NCT00913419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110553668|NCT00913419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110553669|NCT00913419|Adrenergic Agents|adrenergic agents|mesh-ancestor
110553670|NCT00913419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110553671|NCT00711412|Capecitabine|capecitabine|mesh-list
110553672|NCT00711412|Oxaliplatin|oxaliplatin|mesh-list
110553673|NCT00711412|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110553674|NCT00711412|Antimetabolites|antimetabolites|mesh-ancestor
110553675|NCT00711412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110553676|NCT00711412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110553678|NCT01840007|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110553679|NCT01840007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110553680|NCT03746951|Ropivacaine|ropivacaine|mesh-list
110553681|NCT03746951|Anesthetics, Local|anesthetics, local|mesh-ancestor
110553682|NCT03746951|Anesthetics|anesthetics|mesh-ancestor
110553683|NCT03746951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110553684|NCT03746951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110553685|NCT03746951|Sensory System Agents|sensory system agents|mesh-ancestor
110553686|NCT03746951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110553687|NCT00577408|Naltrexone|naltrexone|mesh-list
110553688|NCT00577408|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110553689|NCT00577408|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110553690|NCT00577408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110553691|NCT00577408|Sensory System Agents|sensory system agents|mesh-ancestor
110553692|NCT00577408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110553693|NCT03391193|Vaccines|vaccines|mesh-list
110553694|NCT03391193|Immunologic Factors|immunologic factors|mesh-ancestor
110553695|NCT03391193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110553696|NCT00741364|Vitamin D|vitamin d|mesh-list
110553697|NCT00741364|Cholecalciferol|cholecalciferol|mesh-list
110553698|NCT00741364|Vitamins|vitamins|mesh-ancestor
110553699|NCT00741364|Micronutrients|micronutrients|mesh-ancestor
110553700|NCT00741364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110553701|NCT00741364|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110553702|NCT00741364|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110553703|NCT03332303|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110553704|NCT03332303|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110553705|NCT03332303|Estradiol|estradiol|mesh-list
110553706|NCT03332303|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110553707|NCT03332303|Estrogens|estrogens|mesh-ancestor
110553708|NCT03332303|Hormones|hormones|mesh-ancestor
110553709|NCT03332303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110553710|NCT03332303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110553711|NCT03332303|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110553712|NCT03332303|Contraceptive Agents|contraceptive agents|mesh-ancestor
110553713|NCT03332303|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110553714|NCT03332303|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110553715|NCT00614471|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110553716|NCT00614471|Interferon-alpha|interferon-alpha|mesh-list
110553717|NCT00614471|Entecavir|entecavir|mesh-list
110553718|NCT00614471|Antiviral Agents|antiviral agents|mesh-ancestor
110553719|NCT00614471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110553720|NCT00614471|Immunologic Factors|immunologic factors|mesh-ancestor
110553721|NCT00614471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110553722|NCT05742256|Sufentanil|sufentanil|mesh-list
110553723|NCT05742256|Oxycodone|oxycodone|mesh-list
110553724|NCT05742256|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110553725|NCT05742256|Narcotics|narcotics|mesh-ancestor
110553726|NCT05742256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110553727|NCT05742256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110553728|NCT05742256|Analgesics|analgesics|mesh-ancestor
110553729|NCT05742256|Sensory System Agents|sensory system agents|mesh-ancestor
110553730|NCT05742256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110553731|NCT05742256|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110553732|NCT05742256|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110553733|NCT05742256|Anesthetics, General|anesthetics, general|mesh-ancestor
110553734|NCT05742256|Anesthetics|anesthetics|mesh-ancestor
110553735|NCT00713596|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
110553736|NCT00713596|Hemostatics|hemostatics|mesh-ancestor
110553737|NCT00713596|Coagulants|coagulants|mesh-ancestor
110553738|NCT00729664|Atezolizumab|atezolizumab|mesh-list
110553739|NCT00729664|BMS-936559|bms-936559|mesh-list
110553740|NCT00729664|Antibodies|antibodies|mesh-list
110553741|NCT00729664|Immunoglobulins|immunoglobulins|mesh-list
110181356|NCT04734353|Ticagrelor|ticagrelor|mesh-list
110553742|NCT00729664|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110553743|NCT00729664|Immunologic Factors|immunologic factors|mesh-ancestor
110553744|NCT00729664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110553745|NCT00729664|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110553746|NCT00729664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110553747|NCT00729664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110553748|NCT00729664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110553749|NCT04229615|Apatinib|apatinib|mesh-list
110553750|NCT04229615|Fluzoparib|fluzoparib|mesh-list
110553751|NCT04229615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110553752|NCT04229615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110553753|NCT04229615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110553754|NCT04229615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110553755|NCT04229615|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110553756|NCT00881894|Rotigotine|rotigotine|mesh-list
110553757|NCT00881894|Dopamine Agonists|dopamine agonists|mesh-ancestor
110553758|NCT00881894|Dopamine Agents|dopamine agents|mesh-ancestor
110033157|NCT04760912|Bromides|bromides|mesh-list
110553759|NCT00881894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110560331|NCT00638729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110553760|NCT00881894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110553761|NCT00881894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110553762|NCT02638376|Riboflavin|riboflavin|mesh-list
110553763|NCT02638376|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110553764|NCT02638376|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110553765|NCT02638376|Vitamin B Complex|vitamin b complex|mesh-ancestor
110553766|NCT02638376|Vitamins|vitamins|mesh-ancestor
110553767|NCT02638376|Micronutrients|micronutrients|mesh-ancestor
110553768|NCT02638376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110181359|NCT04734353|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110553769|NCT02638376|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110553770|NCT02638376|Dermatologic Agents|dermatologic agents|mesh-ancestor
110553771|NCT00827931|Tranexamic Acid|tranexamic acid|mesh-list
110553772|NCT00827931|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110553773|NCT00827931|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110553774|NCT00827931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110553775|NCT00827931|Hemostatics|hemostatics|mesh-ancestor
110553776|NCT00827931|Coagulants|coagulants|mesh-ancestor
110553777|NCT04158674|Simendan|simendan|mesh-list
110553778|NCT04158674|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110553779|NCT04158674|Vasodilator Agents|vasodilator agents|mesh-ancestor
110553780|NCT04158674|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110553781|NCT04158674|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110553782|NCT04158674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110553783|NCT04158674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110553784|NCT04158674|Protective Agents|protective agents|mesh-ancestor
110553785|NCT04158674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110553786|NCT00526669|Capecitabine|capecitabine|mesh-list
110553787|NCT00526669|Lapatinib|lapatinib|mesh-list
110553788|NCT00526669|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110553789|NCT00526669|Antimetabolites|antimetabolites|mesh-ancestor
110553790|NCT00526669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110553791|NCT00526669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110553792|NCT00526669|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110553793|NCT00526669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110553794|NCT03640949|Methylprednisolone|methylprednisolone|mesh-list
110553795|NCT03640949|Vasopressins|vasopressins|mesh-list
110553796|NCT03640949|Arginine Vasopressin|arginine vasopressin|mesh-list
110553797|NCT03640949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110553798|NCT03640949|Antiemetics|antiemetics|mesh-ancestor
110553799|NCT03640949|Autonomic Agents|autonomic agents|mesh-ancestor
110553800|NCT03640949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110553801|NCT03640949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110553802|NCT03640949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110553803|NCT03640949|Glucocorticoids|glucocorticoids|mesh-ancestor
110553804|NCT03640949|Hormones|hormones|mesh-ancestor
110553805|NCT03640949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110553806|NCT03640949|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110553807|NCT03640949|Protective Agents|protective agents|mesh-ancestor
110553808|NCT03640949|Hemostatics|hemostatics|mesh-ancestor
110553809|NCT03640949|Coagulants|coagulants|mesh-ancestor
110553810|NCT03640949|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110553811|NCT03640949|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
110553812|NCT03640949|Natriuretic Agents|natriuretic agents|mesh-ancestor
110553813|NCT00827775|Carvedilol|carvedilol|mesh-list
110553814|NCT00827775|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110553815|NCT00827775|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110553816|NCT00827775|Adrenergic Agents|adrenergic agents|mesh-ancestor
110553817|NCT00827775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110553818|NCT00827775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110553819|NCT00827775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110553820|NCT00827775|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110553821|NCT00827775|Antioxidants|antioxidants|mesh-ancestor
110553822|NCT00827775|Protective Agents|protective agents|mesh-ancestor
110553823|NCT00827775|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110553824|NCT00827775|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110553825|NCT00827775|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110553826|NCT00827775|Vasodilator Agents|vasodilator agents|mesh-ancestor
110553827|NCT00827775|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110553828|NCT00827775|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110201425|NCT00149188|Lanreotide|lanreotide|mesh-list
110553829|NCT02544308|Dexamethasone|dexamethasone|mesh-list
110553830|NCT02544308|Lenalidomide|lenalidomide|mesh-list
110553831|NCT02544308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110553832|NCT02544308|Antiemetics|antiemetics|mesh-ancestor
110553833|NCT02544308|Autonomic Agents|autonomic agents|mesh-ancestor
110553834|NCT02544308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110553835|NCT02544308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110553837|NCT02544308|Glucocorticoids|glucocorticoids|mesh-ancestor
110553838|NCT02544308|Hormones|hormones|mesh-ancestor
110553839|NCT02544308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110553840|NCT02544308|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110553841|NCT02544308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110553842|NCT02544308|Immunologic Factors|immunologic factors|mesh-ancestor
110553843|NCT02544308|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110553844|NCT02544308|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110553845|NCT02544308|Growth Substances|growth substances|mesh-ancestor
110553846|NCT02544308|Growth Inhibitors|growth inhibitors|mesh-ancestor
110553847|NCT00707187|Tadalafil|tadalafil|mesh-list
110553848|NCT00707187|Vasodilator Agents|vasodilator agents|mesh-ancestor
110553849|NCT00707187|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110553850|NCT00707187|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110553851|NCT00707187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110553852|NCT00707187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110553853|NCT00707187|Urological Agents|urological agents|mesh-ancestor
110553854|NCT03998761|Progesterone|progesterone|mesh-list
110553855|NCT03998761|Dydrogesterone|dydrogesterone|mesh-list
110553856|NCT03998761|Progestins|progestins|mesh-ancestor
110553857|NCT03998761|Hormones|hormones|mesh-ancestor
110553858|NCT03998761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110553859|NCT03998761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110553860|NCT00658580|Etoposide|etoposide|mesh-list
110553861|NCT00658580|Etoposide phosphate|etoposide phosphate|mesh-list
110553862|NCT00658580|Epirubicin|epirubicin|mesh-list
110553863|NCT00658580|Ifosfamide|ifosfamide|mesh-list
110553864|NCT00658580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110553865|NCT00658580|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110553866|NCT00658580|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110553867|NCT00658580|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110553868|NCT00658580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110553869|NCT00658580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110553870|NCT00658580|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110553871|NCT00658580|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110553872|NCT00658580|Alkylating Agents|alkylating agents|mesh-ancestor
110553873|NCT00729742|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110553874|NCT00729742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110553875|NCT00729742|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110553876|NCT00729742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110553877|NCT00729742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110553878|NCT03435107|Durvalumab|durvalumab|mesh-list
110553879|NCT03435107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110553880|NCT03435107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110553881|NCT03612791|Atezolizumab|atezolizumab|mesh-list
110553882|NCT03612791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110553883|NCT03612791|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110553884|NCT03612791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110553885|NCT03612791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110553886|NCT00827541|Tigecycline|tigecycline|mesh-list
110553887|NCT00827541|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110553888|NCT00827541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110553889|NCT00827541|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110553890|NCT00827541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110553891|NCT00827541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110553892|NCT03916601|Insulin|insulin|mesh-list
110553893|NCT03916601|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110553894|NCT03916601|Insulin Aspart|insulin aspart|mesh-list
110553895|NCT03916601|Insulin, Long-Acting|insulin, long-acting|mesh-list
110553896|NCT03916601|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
110553897|NCT03916601|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110553898|NCT03916601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110553899|NCT00518323|Paliperidone Palmitate|paliperidone palmitate|mesh-list
110553900|NCT00518323|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110553901|NCT00518323|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110553902|NCT00518323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110553903|NCT00518323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110553904|NCT00518323|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110553905|NCT00518323|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110553906|NCT00518323|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110553907|NCT00518323|Serotonin Agents|serotonin agents|mesh-ancestor
110553908|NCT00518323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110553909|NCT00518323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110553910|NCT00518323|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110553911|NCT00518323|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110553912|NCT00518323|Dopamine Agents|dopamine agents|mesh-ancestor
110553913|NCT00707421|Fluorometholone|fluorometholone|mesh-list
110553914|NCT00707421|Ketorolac|ketorolac|mesh-list
110553915|NCT00707421|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110553916|NCT00707421|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110553917|NCT00707421|Analgesics|analgesics|mesh-ancestor
110553918|NCT00707421|Sensory System Agents|sensory system agents|mesh-ancestor
110553919|NCT00707421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110553920|NCT00707421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110553921|NCT00707421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110553922|NCT00707421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110553923|NCT00707421|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110553924|NCT00707421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110553925|NCT00707421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110553926|NCT00707421|Glucocorticoids|glucocorticoids|mesh-ancestor
110553927|NCT00707421|Hormones|hormones|mesh-ancestor
110553928|NCT00707421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110553929|NCT00707421|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110553930|NCT03570437|Paclitaxel|paclitaxel|mesh-list
110553931|NCT03570437|Olaparib|olaparib|mesh-list
110553932|NCT03570437|Cediranib|cediranib|mesh-list
110553933|NCT03570437|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110553934|NCT03570437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110553935|NCT03570437|Tubulin Modulators|tubulin modulators|mesh-ancestor
110553936|NCT03570437|Antimitotic Agents|antimitotic agents|mesh-ancestor
110553937|NCT03570437|Mitosis Modulators|mitosis modulators|mesh-ancestor
110553938|NCT03570437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110553939|NCT03570437|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110553940|NCT03570437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110553941|NCT03570437|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110553942|NCT00826449|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110553943|NCT00826449|Dasatinib|dasatinib|mesh-list
110553944|NCT00826449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110553945|NCT00826449|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110553946|NCT00826449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110553947|NCT00826449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110553948|NCT03632213|Losartan|losartan|mesh-list
110553949|NCT03632213|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110553950|NCT03632213|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110553951|NCT03632213|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110553952|NCT03632213|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110553953|NCT03632213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110553954|NCT00825825|Citalopram|citalopram|mesh-list
110553955|NCT00825825|Escitalopram|escitalopram|mesh-list
110553956|NCT00825825|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110553957|NCT00825825|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110553958|NCT00825825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110553959|NCT00825825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110553960|NCT00825825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110553961|NCT00825825|Serotonin Agents|serotonin agents|mesh-ancestor
110553962|NCT00825825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110553963|NCT00825825|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110553964|NCT00825825|Antidepressive Agents|antidepressive agents|mesh-ancestor
110553965|NCT00825825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110553966|NCT03802487|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
110553967|NCT03802487|Charcoal|charcoal|mesh-list
110553968|NCT03802487|Antidotes|antidotes|mesh-ancestor
110553969|NCT03802487|Protective Agents|protective agents|mesh-ancestor
110553970|NCT03802487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110553971|NCT03802487|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110553972|NCT03802487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110553973|NCT03802487|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110553974|NCT00880334|Docetaxel|docetaxel|mesh-list
110553975|NCT00880334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110201563|NCT04725448|Paclitaxel|paclitaxel|mesh-list
110033210|NCT04604691|Blinatumomab|blinatumomab|mesh-list
110553976|NCT00880334|Tubulin Modulators|tubulin modulators|mesh-ancestor
110553977|NCT00880334|Antimitotic Agents|antimitotic agents|mesh-ancestor
110553978|NCT00880334|Mitosis Modulators|mitosis modulators|mesh-ancestor
110553979|NCT00880334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110553980|NCT00658892|Antibodies|antibodies|mesh-list
110553981|NCT00658892|Immunologic Factors|immunologic factors|mesh-ancestor
110553982|NCT00658892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110553983|NCT00654914|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
110553984|NCT00654914|Vasodilator Agents|vasodilator agents|mesh-ancestor
110553985|NCT00654914|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110553986|NCT00654914|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110553987|NCT00654914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110553988|NCT00654914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110553989|NCT00654914|Urological Agents|urological agents|mesh-ancestor
110553990|NCT00865566|Vaccines|vaccines|mesh-list
110553991|NCT00865566|Immunologic Factors|immunologic factors|mesh-ancestor
110553992|NCT00865566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110553993|NCT00658970|Tirbanibulin|tirbanibulin|mesh-list
110553994|NCT00658970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110181459|NCT00019344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110181460|NCT00019344|Growth Inhibitors|growth inhibitors|mesh-ancestor
110181461|NCT00019344|Growth Substances|growth substances|mesh-ancestor
110553995|NCT00658970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110553997|NCT00659048|Glucocorticoids|glucocorticoids|mesh-ancestor
110553998|NCT00659048|Hormones|hormones|mesh-ancestor
110553999|NCT00659048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110554000|NCT00659048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110554001|NCT00659048|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110554002|NCT02623920|Rituximab|rituximab|mesh-list
110554003|NCT02623920|Brentuximab Vedotin|brentuximab vedotin|mesh-list
110554004|NCT02623920|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110554005|NCT02623920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110554006|NCT02623920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110554007|NCT02623920|Immunologic Factors|immunologic factors|mesh-ancestor
110554008|NCT02623920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110554009|NCT02623920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110554010|NCT02623920|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110554011|NCT02623920|Alkylating Agents|alkylating agents|mesh-ancestor
110554012|NCT02623920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110554013|NCT02623920|Immunotoxins|immunotoxins|mesh-ancestor
110554014|NCT02623920|Immunoconjugates|immunoconjugates|mesh-ancestor
110554015|NCT00525499|Androgens|androgens|mesh-list
110554016|NCT00525499|Hormones|hormones|mesh-ancestor
110554017|NCT00525499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110554018|NCT00525499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110554019|NCT04576546|Inositol|inositol|mesh-list
110554020|NCT04576546|Vitamin B Complex|vitamin b complex|mesh-ancestor
110554021|NCT04576546|Vitamins|vitamins|mesh-ancestor
110554022|NCT04576546|Micronutrients|micronutrients|mesh-ancestor
110554023|NCT04576546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110554024|NCT02617680|Nitric Oxide|nitric oxide|mesh-list
110554025|NCT02617680|Desflurane|desflurane|mesh-list
110554026|NCT02617680|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110554027|NCT02617680|Autonomic Agents|autonomic agents|mesh-ancestor
110554028|NCT02617680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110554029|NCT02617680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110554030|NCT02617680|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110554031|NCT02617680|Respiratory System Agents|respiratory system agents|mesh-ancestor
110554032|NCT02617680|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110554033|NCT02617680|Antioxidants|antioxidants|mesh-ancestor
110554034|NCT02617680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110554035|NCT02617680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110554036|NCT02617680|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
110554037|NCT02617680|Vasodilator Agents|vasodilator agents|mesh-ancestor
110554038|NCT02617680|Gasotransmitters|gasotransmitters|mesh-ancestor
110554039|NCT02617680|Protective Agents|protective agents|mesh-ancestor
110554040|NCT02617680|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110554041|NCT02617680|Anesthetics, General|anesthetics, general|mesh-ancestor
110554043|NCT02617680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110554044|NCT02568280|Insulin|insulin|mesh-list
110554045|NCT02568280|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110554046|NCT02568280|Insulin Aspart|insulin aspart|mesh-list
110554047|NCT02568280|Insulin, Long-Acting|insulin, long-acting|mesh-list
110554048|NCT02568280|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
110554049|NCT02568280|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110554050|NCT02568280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110554051|NCT00525265|Tolvaptan|tolvaptan|mesh-list
110554052|NCT00525265|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
110554053|NCT00525265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110554054|NCT00525265|Natriuretic Agents|natriuretic agents|mesh-ancestor
110554055|NCT00525265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110554056|NCT04158830|Aspirin|aspirin|mesh-list
110554057|NCT04158830|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110554058|NCT04158830|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110554059|NCT04158830|Analgesics|analgesics|mesh-ancestor
110554060|NCT04158830|Sensory System Agents|sensory system agents|mesh-ancestor
110554061|NCT04158830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110554062|NCT04158830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110554063|NCT04158830|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110554064|NCT04158830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110554065|NCT04158830|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110554066|NCT04158830|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110554067|NCT04158830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110554068|NCT04158830|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110554069|NCT04158830|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110554070|NCT04158830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110554071|NCT04158830|Antipyretics|antipyretics|mesh-ancestor
110554072|NCT00659282|Insulin Aspart|insulin aspart|mesh-list
110554073|NCT00659282|Biphasic Insulins|biphasic insulins|mesh-list
110554074|NCT00659282|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
110554075|NCT00659282|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110554076|NCT00659282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110554077|NCT02617758|Fentanyl|fentanyl|mesh-list
110554078|NCT02617758|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110554079|NCT02617758|Narcotics|narcotics|mesh-ancestor
110554080|NCT02617758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110554081|NCT02617758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110554082|NCT02617758|Analgesics|analgesics|mesh-ancestor
110554083|NCT02617758|Sensory System Agents|sensory system agents|mesh-ancestor
110554084|NCT02617758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110554085|NCT02617758|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110554086|NCT02617758|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110554087|NCT02617758|Anesthetics, General|anesthetics, general|mesh-ancestor
110554088|NCT02617758|Anesthetics|anesthetics|mesh-ancestor
110554089|NCT00737542|Lidocaine|lidocaine|mesh-list
110554090|NCT00737542|Anesthetics, Local|anesthetics, local|mesh-ancestor
110554091|NCT00737542|Anesthetics|anesthetics|mesh-ancestor
110554092|NCT00737542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110554093|NCT00737542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110554094|NCT00737542|Sensory System Agents|sensory system agents|mesh-ancestor
110554095|NCT00737542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110554096|NCT00737542|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110554097|NCT00737542|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110554098|NCT00737542|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110554099|NCT00737542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110554100|NCT00737542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110554101|NCT00865098|Cetuximab|cetuximab|mesh-list
110554102|NCT00865098|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110554103|NCT00865098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110554104|NCT00880100|Pancrelipase|pancrelipase|mesh-list
110554105|NCT00880100|Pancreatin|pancreatin|mesh-list
110554106|NCT00880100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110554107|NCT00729898|Insulin Aspart|insulin aspart|mesh-list
110554108|NCT00729898|Biphasic Insulins|biphasic insulins|mesh-list
110181484|NCT00018551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110554109|NCT00729898|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
110554110|NCT00729898|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110554111|NCT00729898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110554112|NCT00659594|Ciclesonide|ciclesonide|mesh-list
110554113|NCT00659594|Glucocorticoids|glucocorticoids|mesh-ancestor
110554114|NCT00659594|Hormones|hormones|mesh-ancestor
110554115|NCT00659594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110554116|NCT00659594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110554117|NCT00659594|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110554118|NCT05541016|Cisplatin|cisplatin|mesh-list
110554119|NCT05541016|Docetaxel|docetaxel|mesh-list
110554120|NCT05541016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110554121|NCT05541016|Tubulin Modulators|tubulin modulators|mesh-ancestor
110554122|NCT05541016|Antimitotic Agents|antimitotic agents|mesh-ancestor
110554123|NCT05541016|Mitosis Modulators|mitosis modulators|mesh-ancestor
110554124|NCT05541016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110554126|NCT04158050|Antibodies|antibodies|mesh-list
110554127|NCT04158050|Immunologic Factors|immunologic factors|mesh-ancestor
110554128|NCT04158050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110554129|NCT04158050|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110554130|NCT04158050|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110554131|NCT04158050|Respiratory System Agents|respiratory system agents|mesh-ancestor
110554132|NCT00659750|Ciclesonide|ciclesonide|mesh-list
110554133|NCT00659750|Glucocorticoids|glucocorticoids|mesh-ancestor
110554134|NCT00659750|Hormones|hormones|mesh-ancestor
110554135|NCT00659750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110554136|NCT00659750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110554137|NCT00659750|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110554138|NCT00697476|Topotecan|topotecan|mesh-list
110554139|NCT00697476|Vorinostat|vorinostat|mesh-list
110554140|NCT00697476|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110554141|NCT00697476|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110554142|NCT00697476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110554143|NCT00697476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110554144|NCT00697476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110554145|NCT00697476|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110554146|NCT00660062|Dexetimide|dexetimide|mesh-list
110554147|NCT00660062|Citalopram|citalopram|mesh-list
110554148|NCT00660062|Nortriptyline|nortriptyline|mesh-list
110554149|NCT00660062|Escitalopram|escitalopram|mesh-list
110554150|NCT00660062|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110554151|NCT00660062|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110554152|NCT00660062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110554153|NCT00660062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110554154|NCT00660062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110554155|NCT00660062|Serotonin Agents|serotonin agents|mesh-ancestor
110554156|NCT00660062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110554157|NCT00660062|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110554158|NCT00660062|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110554159|NCT00660062|Parasympatholytics|parasympatholytics|mesh-ancestor
110554160|NCT00660062|Autonomic Agents|autonomic agents|mesh-ancestor
110554161|NCT00660062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110554162|NCT00660062|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110554163|NCT00660062|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110181504|NCT00019539|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110554164|NCT00660062|Cholinergic Agents|cholinergic agents|mesh-ancestor
110554165|NCT00660062|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110554166|NCT00660062|Antidepressive Agents|antidepressive agents|mesh-ancestor
110554167|NCT00660062|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110554168|NCT00660062|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110554169|NCT00660062|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110554170|NCT00660062|Adrenergic Agents|adrenergic agents|mesh-ancestor
110554171|NCT04063540|Amiloride|amiloride|mesh-list
110554172|NCT04063540|Diuretics|diuretics|mesh-ancestor
110554173|NCT04063540|Natriuretic Agents|natriuretic agents|mesh-ancestor
110554174|NCT04063540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110554175|NCT04063540|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
110554176|NCT04063540|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110554177|NCT04063540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110554178|NCT04063540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110554179|NCT04063540|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
110554180|NCT04063540|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110554181|NCT04161560|Cetuximab|cetuximab|mesh-list
110554182|NCT04161560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110554183|NCT04161560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110554184|NCT00518011|Gemcitabine|gemcitabine|mesh-list
110554185|NCT00518011|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110554186|NCT00518011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110554187|NCT00518011|Antimetabolites|antimetabolites|mesh-ancestor
110554188|NCT00518011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110554189|NCT00518011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110554190|NCT00518011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110554191|NCT00518011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110554192|NCT00737776|Insulin Aspart|insulin aspart|mesh-list
110554193|NCT00737776|Biphasic Insulins|biphasic insulins|mesh-list
110554194|NCT00737776|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
110554195|NCT00737776|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110554196|NCT00737776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110554198|NCT02633930|Clarithromycin|clarithromycin|mesh-list
110554199|NCT02633930|Lansoprazole|lansoprazole|mesh-list
110554200|NCT02633930|Dexlansoprazole|dexlansoprazole|mesh-list
110554201|NCT02633930|Bismuth|bismuth|mesh-list
110554202|NCT02633930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110554203|NCT02633930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110554204|NCT02633930|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110554205|NCT02633930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110554206|NCT02633930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110554207|NCT02633930|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110554208|NCT02633930|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110554209|NCT02633930|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110554210|NCT02633930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110554211|NCT02633930|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110554212|NCT02633930|Antacids|antacids|mesh-ancestor
110554213|NCT00698334|Rifampin|rifampin|mesh-list
110554214|NCT00698334|Pyrazinamide|pyrazinamide|mesh-list
110554215|NCT00698334|Ethambutol|ethambutol|mesh-list
110554216|NCT00698334|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110554217|NCT00698334|Antitubercular Agents|antitubercular agents|mesh-ancestor
110554218|NCT00698334|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110554219|NCT00698334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110554220|NCT00698334|Leprostatic Agents|leprostatic agents|mesh-ancestor
110554221|NCT00698334|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110554222|NCT00698334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110554223|NCT00698334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110554224|NCT00698334|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110554225|NCT00698334|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110554226|NCT00698334|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110554227|NCT00698334|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110554228|NCT00698334|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110554229|NCT00698334|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110554230|NCT04161482|Furosemide|furosemide|mesh-list
110554231|NCT04161482|Diuretics|diuretics|mesh-ancestor
110554232|NCT04161482|Natriuretic Agents|natriuretic agents|mesh-ancestor
110554233|NCT04161482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110554234|NCT04161482|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110554235|NCT04161482|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110554236|NCT04161482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110554237|NCT02623452|Insulin Lispro|insulin lispro|mesh-list
110554238|NCT02623452|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110554239|NCT02623452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110554240|NCT02633696|Silybin|silybin|mesh-list
110554241|NCT02633696|Silymarin|silymarin|mesh-list
110554242|NCT02633696|Antioxidants|antioxidants|mesh-ancestor
110554243|NCT02633696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110554244|NCT02633696|Protective Agents|protective agents|mesh-ancestor
110554245|NCT02633696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110554246|NCT02633696|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110554247|NCT02633696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110554248|NCT02633852|Aflibercept|aflibercept|mesh-list
110554249|NCT02633852|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110554250|NCT02633852|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110554251|NCT02633852|Growth Substances|growth substances|mesh-ancestor
110554252|NCT02633852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110554253|NCT02633852|Growth Inhibitors|growth inhibitors|mesh-ancestor
110554254|NCT02633852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110554255|NCT02633774|Propafenone|propafenone|mesh-list
110554256|NCT02633774|Apixaban|apixaban|mesh-list
110554257|NCT02633774|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110554258|NCT02633774|Antithrombins|antithrombins|mesh-ancestor
110554259|NCT02633774|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110554260|NCT02633774|Protease Inhibitors|protease inhibitors|mesh-ancestor
110554261|NCT02633774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110554262|NCT02633774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110554263|NCT02633774|Anticoagulants|anticoagulants|mesh-ancestor
110554264|NCT02633774|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110554265|NCT02633774|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110554266|NCT02633774|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110554267|NCT02633774|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110554268|NCT02633618|Neurotropin|neurotropin|mesh-list
110554269|NCT02633618|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110554270|NCT02633618|Immunologic Factors|immunologic factors|mesh-ancestor
110554271|NCT02633618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110554272|NCT02633618|Analgesics|analgesics|mesh-ancestor
110554273|NCT02633618|Sensory System Agents|sensory system agents|mesh-ancestor
110554274|NCT02633618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110554276|NCT00865020|Telmisartan|telmisartan|mesh-list
110554277|NCT00865020|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110554278|NCT00865020|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110554279|NCT00865020|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110554280|NCT00865020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110554281|NCT00517933|Sildenafil Citrate|sildenafil citrate|mesh-list
110554282|NCT00517933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110554283|NCT00517933|Vasodilator Agents|vasodilator agents|mesh-ancestor
110181536|NCT00019734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110554284|NCT00517933|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110554285|NCT00517933|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110554286|NCT00517933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110554287|NCT00517933|Urological Agents|urological agents|mesh-ancestor
110554289|NCT02633384|SMOFlipid|smoflipid|mesh-list
110554290|NCT02633384|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
110554291|NCT02633384|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
110554292|NCT02633384|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110554293|NCT02633384|Cathartics|cathartics|mesh-ancestor
110554294|NCT02633384|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110554295|NCT02633462|Inositol|inositol|mesh-list
110554296|NCT02633462|Vitamin B Complex|vitamin b complex|mesh-ancestor
110554297|NCT02633462|Vitamins|vitamins|mesh-ancestor
110554298|NCT02633462|Micronutrients|micronutrients|mesh-ancestor
110554299|NCT02633462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110554300|NCT02638064|Surgiflo|surgiflo|mesh-list
110554301|NCT02638064|Hemostatics|hemostatics|mesh-ancestor
110554302|NCT02638064|Coagulants|coagulants|mesh-ancestor
110554303|NCT00655148|Vaccines|vaccines|mesh-list
110554304|NCT00655148|Immunologic Factors|immunologic factors|mesh-ancestor
110554305|NCT00655148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110554306|NCT00857766|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
110554307|NCT00857766|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110554308|NCT00857766|Autonomic Agents|autonomic agents|mesh-ancestor
110554309|NCT00857766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110554310|NCT00857766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110554311|NCT00857766|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110554312|NCT00857766|Respiratory System Agents|respiratory system agents|mesh-ancestor
110554313|NCT00857766|Glucocorticoids|glucocorticoids|mesh-ancestor
110554314|NCT00857766|Hormones|hormones|mesh-ancestor
110554315|NCT00857766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110554316|NCT00857766|Sympathomimetics|sympathomimetics|mesh-ancestor
110554317|NCT04161404|Metformin|metformin|mesh-list
110554318|NCT04161404|Andrographolide|andrographolide|mesh-list
110554319|NCT04161404|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110554320|NCT04161404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110554321|NCT04161404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110554322|NCT04161404|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110554323|NCT04161404|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110554324|NCT04161404|Analgesics|analgesics|mesh-ancestor
110554325|NCT04161404|Sensory System Agents|sensory system agents|mesh-ancestor
110554326|NCT04161404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110554327|NCT04161404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110554328|NCT04161404|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110554329|NCT04161404|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110554330|NCT04161404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110554331|NCT04161404|Antiviral Agents|antiviral agents|mesh-ancestor
110554332|NCT04161404|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110554333|NCT00517699|Cytarabine|cytarabine|mesh-list
110554334|NCT00517699|Rituximab|rituximab|mesh-list
110554335|NCT00517699|Methotrexate|methotrexate|mesh-list
110554336|NCT00517699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110554337|NCT00517699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110554338|NCT00517699|Immunologic Factors|immunologic factors|mesh-ancestor
110554339|NCT00517699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110554340|NCT00517699|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110554341|NCT00517699|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110554342|NCT00517699|Abortifacient Agents|abortifacient agents|mesh-ancestor
110554343|NCT00517699|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110554344|NCT00517699|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110554345|NCT00517699|Antimetabolites|antimetabolites|mesh-ancestor
110554346|NCT00517699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110554347|NCT00517699|Dermatologic Agents|dermatologic agents|mesh-ancestor
110554348|NCT00517699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110554349|NCT00517699|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110554350|NCT00517699|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110554351|NCT00517699|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110554352|NCT00517699|Antiviral Agents|antiviral agents|mesh-ancestor
110554353|NCT00517699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110554354|NCT04161014|Nintedanib|nintedanib|mesh-list
110554355|NCT04161014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110554356|NCT04161014|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110554357|NCT04161014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110554358|NCT04161014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110554359|NCT04491643|Megestrol|megestrol|mesh-list
110554360|NCT04491643|Megestrol Acetate|megestrol acetate|mesh-list
110554361|NCT04491643|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110554362|NCT04491643|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110554363|NCT04491643|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110554364|NCT04491643|Antimetabolites|antimetabolites|mesh-ancestor
110554365|NCT04491643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110554366|NCT04491643|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110554367|NCT04491643|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110554368|NCT04491643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110554369|NCT04491643|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110554370|NCT04491643|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110554371|NCT04491643|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110554372|NCT04491643|Contraceptive Agents|contraceptive agents|mesh-ancestor
110554373|NCT04491643|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110554374|NCT04491643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110554375|NCT04491643|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110554376|NCT04491643|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110554377|NCT04491643|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110554378|NCT04491643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110554379|NCT04491643|Appetite Stimulants|appetite stimulants|mesh-ancestor
110554380|NCT04491643|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110554381|NCT00699504|Moxifloxacin|moxifloxacin|mesh-list
110554382|NCT00699504|Cangrelor|cangrelor|mesh-list
110554383|NCT00699504|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110554384|NCT00699504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110554385|NCT00699504|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110554386|NCT00699504|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110554387|NCT00699504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110554388|NCT00699504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110554389|NCT00699504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110554390|NCT00699504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110554391|NCT00699504|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110554392|NCT00699504|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110554393|NCT00699504|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110554394|NCT00699504|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110554395|NCT00699504|Purinergic Agents|purinergic agents|mesh-ancestor
110554396|NCT00699504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110554397|NCT02997605|Prednisone|prednisone|mesh-list
110554398|NCT02997605|Hydrocortisone|hydrocortisone|mesh-list
110554399|NCT02997605|Glucocorticoids|glucocorticoids|mesh-list
110554400|NCT02997605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110554401|NCT02997605|Hormones|hormones|mesh-ancestor
110554402|NCT02997605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110554403|NCT02997605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110554404|NCT02997605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110554405|NCT02997605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110554406|NCT03767543|Insulin Glargine|insulin glargine|mesh-list
110554407|NCT03767543|Lixisenatide|lixisenatide|mesh-list
110554408|NCT03767543|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110181562|NCT00019968|Immunologic Factors|immunologic factors|mesh-ancestor
110554409|NCT03767543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110554410|NCT00857454|Testosterone|testosterone|mesh-list
110554411|NCT00857454|Androgens|androgens|mesh-ancestor
110554412|NCT00857454|Hormones|hormones|mesh-ancestor
110554413|NCT00857454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110554414|NCT00857454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110554415|NCT00660140|Carboplatin|carboplatin|mesh-list
110554416|NCT00660140|Gemcitabine|gemcitabine|mesh-list
110554417|NCT00660140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110554418|NCT00660140|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110554420|NCT00660140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110554421|NCT03760991|Insulin Glargine|insulin glargine|mesh-list
110554422|NCT03760991|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110554423|NCT03760991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110554424|NCT00525031|Interferons|interferons|mesh-list
110554425|NCT00525031|Interferon-alpha|interferon-alpha|mesh-list
110554426|NCT00525031|Interferon alpha-2|interferon alpha-2|mesh-list
110554427|NCT00525031|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110554428|NCT00525031|Temozolomide|temozolomide|mesh-list
110554429|NCT00525031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110554430|NCT00525031|Antiviral Agents|antiviral agents|mesh-ancestor
110554431|NCT00525031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110554432|NCT00525031|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110554433|NCT00525031|Alkylating Agents|alkylating agents|mesh-ancestor
110554434|NCT00525031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110554435|NCT00525031|Immunologic Factors|immunologic factors|mesh-ancestor
110554436|NCT00525031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110554437|NCT00660374|Isophane Insulin, Human|isophane insulin, human|mesh-list
110554438|NCT00660374|Insulin, Isophane|insulin, isophane|mesh-list
110554439|NCT00660374|Isophane insulin, beef|isophane insulin, beef|mesh-list
110554440|NCT00660374|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110554441|NCT00660374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110554442|NCT00524485|Aminolevulinic Acid|aminolevulinic acid|mesh-list
110554443|NCT00524485|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110554444|NCT00524485|Dermatologic Agents|dermatologic agents|mesh-ancestor
110554445|NCT00857220|Eszopiclone|eszopiclone|mesh-list
110554446|NCT00857220|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110554447|NCT00857220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110554448|NCT00857220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110554449|NCT00524173|Tenofovir|tenofovir|mesh-list
110554450|NCT00524173|Emtricitabine|emtricitabine|mesh-list
110554451|NCT00524173|Antiviral Agents|antiviral agents|mesh-ancestor
110554452|NCT00524173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110554453|NCT00524173|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110554454|NCT00524173|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110554455|NCT00524173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110554456|NCT00524173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110554457|NCT00524173|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110554458|NCT00524173|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110554459|NCT02704481|Misoprostol|misoprostol|mesh-list
110554460|NCT02704481|Mifepristone|mifepristone|mesh-list
110554461|NCT02704481|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110554462|NCT02704481|Abortifacient Agents|abortifacient agents|mesh-ancestor
110554463|NCT02704481|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110554464|NCT02704481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110554465|NCT02704481|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110554466|NCT02704481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110554467|NCT02704481|Oxytocics|oxytocics|mesh-ancestor
110554468|NCT02704481|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
110554469|NCT02704481|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110554470|NCT02704481|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110554471|NCT02704481|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110554473|NCT02704481|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
110554474|NCT02704481|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
110554475|NCT02704481|Hormone Antagonists|hormone antagonists|mesh-ancestor
110554476|NCT02704481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110554477|NCT02704481|Luteolytic Agents|luteolytic agents|mesh-ancestor
110554478|NCT02704481|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110554479|NCT02704481|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
110554480|NCT02614482|Fesoterodine|fesoterodine|mesh-list
110554481|NCT02614482|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110554482|NCT02614482|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110554483|NCT02614482|Cholinergic Agents|cholinergic agents|mesh-ancestor
110554484|NCT02614482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110554485|NCT02614482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110554486|NCT02614482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110554487|NCT02614482|Urological Agents|urological agents|mesh-ancestor
110554488|NCT04713709|Naloxone|naloxone|mesh-list
110554489|NCT04713709|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110554490|NCT04713709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110554491|NCT04713709|Sensory System Agents|sensory system agents|mesh-ancestor
110560332|NCT00638729|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110554492|NCT04713709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110554493|NCT00879710|Simvastatin|simvastatin|mesh-list
110554494|NCT00879710|Ezetimibe|ezetimibe|mesh-list
110554495|NCT00879710|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110554496|NCT00879710|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110554497|NCT00879710|Antimetabolites|antimetabolites|mesh-ancestor
110554498|NCT00879710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110202083|NCT00151801|Interferons|interferons|mesh-list
110554500|NCT00879710|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110554501|NCT00879710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110554502|NCT02703857|Cefoxitin|cefoxitin|mesh-list
110554503|NCT02703857|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110554504|NCT02703857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110554505|NCT02623062|Alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|mesh-list
110554506|NCT02623062|Antacids|antacids|mesh-ancestor
110554507|NCT02623062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110554508|NCT02623062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110554510|NCT00597506|Everolimus|everolimus|mesh-list
110554511|NCT00597506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110554512|NCT00597506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110554513|NCT00597506|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110554514|NCT00597506|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110554515|NCT00597506|Growth Substances|growth substances|mesh-ancestor
110554516|NCT00597506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110554517|NCT00597506|Growth Inhibitors|growth inhibitors|mesh-ancestor
110554518|NCT00597506|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110554519|NCT00597506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110554520|NCT00597506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110181594|NCT00020124|Doxorubicin|doxorubicin|mesh-list
110554521|NCT00597506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110554522|NCT00597506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110554523|NCT00597506|Immunologic Factors|immunologic factors|mesh-ancestor
110554524|NCT03393611|Cytarabine|cytarabine|mesh-list
110554525|NCT03393611|Fludarabine|fludarabine|mesh-list
110554526|NCT03393611|Melphalan|melphalan|mesh-list
110554527|NCT03393611|Daunorubicin|daunorubicin|mesh-list
110554528|NCT03393611|Thymoglobulin|thymoglobulin|mesh-list
110554529|NCT03393611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110554530|NCT03393611|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110554531|NCT03393611|Antimetabolites|antimetabolites|mesh-ancestor
110554532|NCT03393611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110554533|NCT03393611|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110554534|NCT03393611|Immunologic Factors|immunologic factors|mesh-ancestor
110554535|NCT03393611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110554536|NCT03393611|Antiviral Agents|antiviral agents|mesh-ancestor
110554537|NCT03393611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110554538|NCT03393611|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110554539|NCT03393611|Alkylating Agents|alkylating agents|mesh-ancestor
110554540|NCT03393611|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110554541|NCT03393611|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110554542|NCT03393611|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110554543|NCT03393611|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110554544|NCT03393611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110554545|NCT04032548|Chlorhexidine|chlorhexidine|mesh-list
110554546|NCT04032548|Propolis|propolis|mesh-list
110554547|NCT04032548|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110554548|NCT04032548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110554549|NCT04032548|Disinfectants|disinfectants|mesh-ancestor
110554550|NCT04032236|Caffeine|caffeine|mesh-list
110554551|NCT04032236|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110554552|NCT04032236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110554553|NCT04032236|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110554554|NCT04032236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110554555|NCT04032236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110554556|NCT04032236|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110554557|NCT04032236|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110554558|NCT04032236|Purinergic Agents|purinergic agents|mesh-ancestor
110554559|NCT04032236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110554560|NCT02313389|Rituximab|rituximab|mesh-list
110181608|NCT05576675|Sufentanil|sufentanil|mesh-list
110554561|NCT02313389|Methotrexate|methotrexate|mesh-list
110554562|NCT02313389|Temozolomide|temozolomide|mesh-list
110554563|NCT02313389|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110554564|NCT02313389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110554565|NCT02313389|Immunologic Factors|immunologic factors|mesh-ancestor
110554566|NCT02313389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110554567|NCT02313389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110554568|NCT02313389|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110554569|NCT02313389|Abortifacient Agents|abortifacient agents|mesh-ancestor
110554570|NCT02313389|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110554571|NCT02313389|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110554572|NCT02313389|Antimetabolites|antimetabolites|mesh-ancestor
110554573|NCT02313389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110554574|NCT02313389|Dermatologic Agents|dermatologic agents|mesh-ancestor
110554575|NCT02313389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110554576|NCT02313389|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110554577|NCT02313389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110554578|NCT02313389|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110554579|NCT02313389|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110554580|NCT02313389|Alkylating Agents|alkylating agents|mesh-ancestor
110554581|NCT00708682|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110554582|NCT00708682|Immunologic Factors|immunologic factors|mesh-ancestor
110554583|NCT00708682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110554584|NCT02632916|Zoledronic Acid|zoledronic acid|mesh-list
110554586|NCT02632916|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110554587|NCT02632916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110554588|NCT00881504|Bevacizumab|bevacizumab|mesh-list
110554589|NCT00881504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110554590|NCT00881504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110554591|NCT00881504|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110554592|NCT00881504|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110554593|NCT00881504|Growth Substances|growth substances|mesh-ancestor
110554594|NCT00881504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110554595|NCT00881504|Growth Inhibitors|growth inhibitors|mesh-ancestor
110554596|NCT00660764|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110554597|NCT00660764|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110554598|NCT00660764|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110554599|NCT00660764|Antimetabolites|antimetabolites|mesh-ancestor
110554600|NCT00660764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110554601|NCT00660764|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110554602|NCT00660764|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110554603|NCT00660764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110554604|NCT02131493|Gemcitabine|gemcitabine|mesh-list
110554605|NCT02131493|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110554606|NCT02131493|Antimetabolites|antimetabolites|mesh-ancestor
110554607|NCT02131493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110554608|NCT02131493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110554609|NCT02096159|Trimethoprim|trimethoprim|mesh-list
110554610|NCT02096159|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
110554611|NCT02096159|Sulfamethoxazole|sulfamethoxazole|mesh-list
110554612|NCT02096159|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110554613|NCT02096159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110554614|NCT02096159|Antimalarials|antimalarials|mesh-ancestor
110554615|NCT02096159|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110554616|NCT02096159|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110554617|NCT02096159|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110554618|NCT02096159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110554619|NCT02096159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110554620|NCT02096159|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110554621|NCT02096159|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
110181647|NCT00020475|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110554622|NCT02096159|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110554623|NCT02096159|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110554625|NCT02632136|Anesthetics, Local|anesthetics, local|mesh-ancestor
110554626|NCT02632136|Anesthetics|anesthetics|mesh-ancestor
110554627|NCT02632136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110554628|NCT02632136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110554629|NCT02632136|Sensory System Agents|sensory system agents|mesh-ancestor
110554630|NCT02632136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110554631|NCT00660920|Ponatinib|ponatinib|mesh-list
110554632|NCT00660920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110554633|NCT00660920|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110554634|NCT00660920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110554635|NCT00660920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110554636|NCT01936831|Vitamin B 6|vitamin b 6|mesh-list
110554638|NCT01936831|Pyridoxine|pyridoxine|mesh-list
110554639|NCT01936831|Isoniazid|isoniazid|mesh-list
110554640|NCT01936831|Vitamins|vitamins|mesh-ancestor
110554641|NCT01936831|Micronutrients|micronutrients|mesh-ancestor
110554642|NCT01936831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110554643|NCT01936831|Vitamin B Complex|vitamin b complex|mesh-ancestor
110554644|NCT01936831|Antitubercular Agents|antitubercular agents|mesh-ancestor
110554645|NCT01936831|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110554646|NCT01936831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110554647|NCT01936831|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
110554648|NCT01936831|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110554649|NCT01936831|Antimetabolites|antimetabolites|mesh-ancestor
110554650|NCT01936831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110554651|NCT01936831|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110554652|NCT00615173|Cyclophosphamide|cyclophosphamide|mesh-list
110554653|NCT00615173|Azathioprine|azathioprine|mesh-list
110554654|NCT00615173|Tacrolimus|tacrolimus|mesh-list
110554655|NCT00615173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110554656|NCT00615173|Immunologic Factors|immunologic factors|mesh-ancestor
110554657|NCT00615173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110554658|NCT00615173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110554659|NCT00615173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110554660|NCT00615173|Alkylating Agents|alkylating agents|mesh-ancestor
110554661|NCT00615173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110554662|NCT00615173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110554663|NCT00615173|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110554664|NCT00615173|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110554665|NCT00615173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110554666|NCT00615173|Antimetabolites|antimetabolites|mesh-ancestor
110554667|NCT00615173|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110554668|NCT00660998|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
110554669|NCT00660998|Vasodilator Agents|vasodilator agents|mesh-ancestor
110554670|NCT00660998|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110554671|NCT00660998|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110554672|NCT00660998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110554673|NCT00660998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110554674|NCT00660998|Urological Agents|urological agents|mesh-ancestor
110554675|NCT00657254|Sorafenib|sorafenib|mesh-list
110554676|NCT00657254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110554677|NCT00657254|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110554678|NCT00657254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110554679|NCT00657254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110554680|NCT01455389|Diphenhydramine|diphenhydramine|mesh-list
110554681|NCT01455389|Promethazine|promethazine|mesh-list
110554682|NCT01455389|Dexamethasone|dexamethasone|mesh-list
110554683|NCT01455389|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110181665|NCT05576324|Ivacaftor|ivacaftor|mesh-list
110554684|NCT01455389|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110554685|NCT01455389|Antiemetics|antiemetics|mesh-ancestor
110554686|NCT01455389|Autonomic Agents|autonomic agents|mesh-ancestor
110554687|NCT01455389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110554688|NCT01455389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110554689|NCT01455389|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110554690|NCT01455389|Glucocorticoids|glucocorticoids|mesh-ancestor
110554691|NCT01455389|Hormones|hormones|mesh-ancestor
110554692|NCT01455389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110554693|NCT01455389|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110554694|NCT01455389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110554695|NCT01455389|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110554696|NCT01455389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110554697|NCT01455389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110554698|NCT01455389|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110554699|NCT01455389|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110554700|NCT01455389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110554701|NCT01455389|Anesthetics, Local|anesthetics, local|mesh-ancestor
110554702|NCT01455389|Anesthetics|anesthetics|mesh-ancestor
110554703|NCT01455389|Sensory System Agents|sensory system agents|mesh-ancestor
110554704|NCT01455389|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110554706|NCT01455389|Histamine Agents|histamine agents|mesh-ancestor
110554707|NCT01455389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110554708|NCT01455389|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110554709|NCT01455389|Antipruritics|antipruritics|mesh-ancestor
110554710|NCT01455389|Dermatologic Agents|dermatologic agents|mesh-ancestor
110554712|NCT00661076|Adefovir|adefovir|mesh-list
110554713|NCT00661076|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
110554714|NCT00661076|Antiviral Agents|antiviral agents|mesh-ancestor
110554715|NCT00661076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110554716|NCT00661076|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110554717|NCT00661076|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110554718|NCT00661076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110554719|NCT00661076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110554720|NCT04215965|Dialysis Solutions|dialysis solutions|mesh-list
110202312|NCT00152815|Vitamin E|vitamin e|mesh-list
110554722|NCT00661700|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
110554723|NCT00661700|Vasodilator Agents|vasodilator agents|mesh-ancestor
110554724|NCT00661700|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110554725|NCT00661700|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110554726|NCT00661700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110554727|NCT00661700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110554728|NCT00661700|Urological Agents|urological agents|mesh-ancestor
110554729|NCT00613769|Metronidazole|metronidazole|mesh-list
110554730|NCT00613769|Trimethoprim|trimethoprim|mesh-list
110554731|NCT00613769|Sulfamethoxazole|sulfamethoxazole|mesh-list
110554732|NCT00613769|Cefuroxime|cefuroxime|mesh-list
110554733|NCT00613769|Cefuroxime axetil|cefuroxime axetil|mesh-list
110554734|NCT00613769|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
110554735|NCT00613769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110554736|NCT00613769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110554737|NCT00613769|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110554738|NCT00613769|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110554739|NCT00613769|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110554740|NCT00613769|Antimalarials|antimalarials|mesh-ancestor
110554741|NCT00613769|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110554742|NCT00613769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110554743|NCT00613769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110554744|NCT00613769|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110554745|NCT00613769|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
110554746|NCT00613769|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110554747|NCT00661154|Bevacizumab|bevacizumab|mesh-list
110554748|NCT00661154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110554749|NCT00661154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110554750|NCT00661154|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110554751|NCT00661154|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110554752|NCT00661154|Growth Substances|growth substances|mesh-ancestor
110554753|NCT00661154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110554754|NCT00661154|Growth Inhibitors|growth inhibitors|mesh-ancestor
110554755|NCT00523705|Escitalopram|escitalopram|mesh-list
110554756|NCT00523705|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110554757|NCT00523705|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110554758|NCT00523705|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110554759|NCT00523705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110554760|NCT00523705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110554761|NCT00523705|Serotonin Agents|serotonin agents|mesh-ancestor
110554762|NCT00523705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110554763|NCT00193427|Carboplatin|carboplatin|mesh-list
110554764|NCT00193427|Gemcitabine|gemcitabine|mesh-list
110554765|NCT00193427|Docetaxel|docetaxel|mesh-list
110554766|NCT00193427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110554767|NCT00193427|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110554768|NCT00193427|Antimetabolites|antimetabolites|mesh-ancestor
110554769|NCT00193427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110554770|NCT00193427|Tubulin Modulators|tubulin modulators|mesh-ancestor
110554772|NCT00193427|Mitosis Modulators|mitosis modulators|mesh-ancestor
110554773|NCT00665678|Paroxetine|paroxetine|mesh-list
110554774|NCT00665678|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110554775|NCT00665678|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110554776|NCT00665678|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110554777|NCT00665678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110554778|NCT00665678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110554779|NCT00665678|Serotonin Agents|serotonin agents|mesh-ancestor
110554780|NCT00665678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110554781|NCT00665678|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110554782|NCT00665678|Antidepressive Agents|antidepressive agents|mesh-ancestor
110554784|NCT00665678|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110554785|NCT00665678|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110554786|NCT00665678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110554787|NCT00523549|Amlodipine|amlodipine|mesh-list
110554788|NCT00523549|Valsartan|valsartan|mesh-list
110554789|NCT00523549|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110554790|NCT00523549|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110554791|NCT00523549|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110554792|NCT00523549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110554793|NCT00523549|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110554794|NCT00523549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110554795|NCT00523549|Vasodilator Agents|vasodilator agents|mesh-ancestor
110094956|NCT01711827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110554796|NCT00523549|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110554797|NCT00523549|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110554798|NCT04215653|Rabeprazole|rabeprazole|mesh-list
110554799|NCT04215653|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110095027|NCT01712295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110554800|NCT04215653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110554801|NCT04215653|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110554802|NCT04215653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110554803|NCT04215653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110554804|NCT02706119|Insulin|insulin|mesh-list
110554805|NCT02706119|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110554806|NCT02706119|Insulin Glargine|insulin glargine|mesh-list
110554807|NCT02706119|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110095182|NCT01713101|Hemostatics|hemostatics|mesh-ancestor
110554808|NCT02706119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110554809|NCT02631668|Ferrous succinate|ferrous succinate|mesh-list
110554810|NCT02631668|Hematinics|hematinics|mesh-ancestor
110554812|NCT00665756|Mitomycin|mitomycin|mesh-list
110554813|NCT00665756|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110554814|NCT00665756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110554815|NCT00665756|Alkylating Agents|alkylating agents|mesh-ancestor
110554816|NCT00665756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110554817|NCT00665756|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110554818|NCT00665756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110554819|NCT00661856|Genistein|genistein|mesh-list
110554820|NCT00661856|Daidzein|daidzein|mesh-list
110554821|NCT00661856|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110554822|NCT00661856|Protective Agents|protective agents|mesh-ancestor
110554823|NCT00661856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110554824|NCT00661856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110554825|NCT00661856|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110554826|NCT00661856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110554827|NCT00661856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110554828|NCT00661856|Phytoestrogens|phytoestrogens|mesh-ancestor
110095463|NCT01714414|Antiviral Agents|antiviral agents|mesh-ancestor
110554829|NCT00661856|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
110554830|NCT00661856|Estrogens|estrogens|mesh-ancestor
110554831|NCT00661856|Hormones|hormones|mesh-ancestor
110554832|NCT00661856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110554833|NCT04215731|Leucovorin|leucovorin|mesh-list
110554834|NCT04215731|Bevacizumab|bevacizumab|mesh-list
110554835|NCT04215731|Fluorouracil|fluorouracil|mesh-list
110554836|NCT04215731|Oxaliplatin|oxaliplatin|mesh-list
110554837|NCT04215731|Irinotecan|irinotecan|mesh-list
110554838|NCT04215731|Levoleucovorin|levoleucovorin|mesh-list
110554839|NCT04215731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110554840|NCT04215731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110554841|NCT04215731|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110554842|NCT04215731|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110554843|NCT04215731|Growth Substances|growth substances|mesh-ancestor
110554844|NCT04215731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110554845|NCT04215731|Growth Inhibitors|growth inhibitors|mesh-ancestor
110554846|NCT04215731|Antimetabolites|antimetabolites|mesh-ancestor
110554847|NCT04215731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110554848|NCT04215731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110095745|NCT01715987|Tenofovir|tenofovir|mesh-list
110554849|NCT04215731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110554850|NCT04215731|Immunologic Factors|immunologic factors|mesh-ancestor
110554851|NCT04215731|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110554852|NCT04215731|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110554853|NCT04215731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110554854|NCT04215731|Antidotes|antidotes|mesh-ancestor
110554855|NCT04215731|Protective Agents|protective agents|mesh-ancestor
110554856|NCT04215731|Vitamin B Complex|vitamin b complex|mesh-ancestor
110554857|NCT04215731|Vitamins|vitamins|mesh-ancestor
110554858|NCT04215731|Micronutrients|micronutrients|mesh-ancestor
110095891|NCT01717222|Lidocaine|lidocaine|mesh-list
110554860|NCT00665834|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110554861|NCT00665834|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110554862|NCT00665834|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110554863|NCT00665834|Antimetabolites|antimetabolites|mesh-ancestor
110554864|NCT00665834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110554865|NCT00665834|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110554866|NCT00665834|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110554867|NCT00665834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110554868|NCT02704013|Oxybutynin|oxybutynin|mesh-list
110554869|NCT02704013|Parasympatholytics|parasympatholytics|mesh-ancestor
110096025|NCT01718093|Metformin|metformin|mesh-list
110554870|NCT02704013|Autonomic Agents|autonomic agents|mesh-ancestor
110554871|NCT02704013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110554872|NCT02704013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110554873|NCT02704013|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110096172|NCT01718626|Tubulin Modulators|tubulin modulators|mesh-ancestor
110554874|NCT02704013|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110554875|NCT02704013|Cholinergic Agents|cholinergic agents|mesh-ancestor
110554876|NCT02704013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110554877|NCT02704013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110554878|NCT02704013|Urological Agents|urological agents|mesh-ancestor
110554879|NCT00665990|Cyclophosphamide|cyclophosphamide|mesh-list
110554880|NCT00665990|Bevacizumab|bevacizumab|mesh-list
110554882|NCT00665990|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110554883|NCT00665990|Immunologic Factors|immunologic factors|mesh-ancestor
110554884|NCT00665990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110554885|NCT00665990|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110554886|NCT00665990|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110554887|NCT00665990|Alkylating Agents|alkylating agents|mesh-ancestor
110554888|NCT00665990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110554889|NCT00665990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110554890|NCT00665990|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110554891|NCT00665990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110554892|NCT00665990|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110554893|NCT00665990|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110554894|NCT00665990|Growth Substances|growth substances|mesh-ancestor
110554895|NCT00665990|Growth Inhibitors|growth inhibitors|mesh-ancestor
110554896|NCT00665990|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110554897|NCT00665990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110554898|NCT00666068|Hormones|hormones|mesh-list
110554899|NCT00666068|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
110096529|NCT01724450|Protective Agents|protective agents|mesh-ancestor
110554900|NCT00666068|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
110554901|NCT00666068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110554902|NCT00666068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110554903|NCT00700102|Bevacizumab|bevacizumab|mesh-list
110554904|NCT00700102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110554905|NCT00700102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110554906|NCT00700102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110554907|NCT00700102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110554908|NCT00700102|Growth Substances|growth substances|mesh-ancestor
110554909|NCT00700102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110554910|NCT00700102|Growth Inhibitors|growth inhibitors|mesh-ancestor
110554911|NCT02705729|Methamphetamine|methamphetamine|mesh-list
110554912|NCT02705729|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110554913|NCT02705729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110554914|NCT02705729|Sympathomimetics|sympathomimetics|mesh-ancestor
110554915|NCT02705729|Autonomic Agents|autonomic agents|mesh-ancestor
110554916|NCT02705729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110554917|NCT02705729|Dopamine Agents|dopamine agents|mesh-ancestor
110554918|NCT02705729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110554919|NCT02705729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110554920|NCT02705729|Adrenergic Agents|adrenergic agents|mesh-ancestor
110554921|NCT02705729|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110554922|NCT02705729|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110554923|NCT02705729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110554924|NCT02705729|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110554925|NCT02705573|Mannitol|mannitol|mesh-list
110554926|NCT02705573|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110554927|NCT02705573|Diuretics|diuretics|mesh-ancestor
110554928|NCT02705573|Natriuretic Agents|natriuretic agents|mesh-ancestor
110554929|NCT02705573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110554930|NCT00613847|Trastuzumab|trastuzumab|mesh-list
110554931|NCT00613847|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
110560333|NCT00638729|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110554932|NCT00613847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110096764|NCT01731067|Analgesics|analgesics|mesh-ancestor
110554933|NCT00613847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110554934|NCT00613847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110554935|NCT00516295|Cyclophosphamide|cyclophosphamide|mesh-list
110554936|NCT00516295|Bevacizumab|bevacizumab|mesh-list
110554937|NCT00516295|Vincristine|vincristine|mesh-list
110554938|NCT00516295|Topotecan|topotecan|mesh-list
110554939|NCT00516295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110554940|NCT00516295|Antibodies|antibodies|mesh-list
110554941|NCT00516295|Immunoglobulins|immunoglobulins|mesh-list
110554942|NCT00516295|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110554943|NCT00516295|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110554944|NCT00516295|Immunologic Factors|immunologic factors|mesh-ancestor
110554945|NCT00516295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110554946|NCT00516295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110554947|NCT00516295|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110554948|NCT00516295|Alkylating Agents|alkylating agents|mesh-ancestor
110554949|NCT00516295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110554950|NCT00516295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110554951|NCT00516295|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110554952|NCT00516295|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110554953|NCT00516295|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110554954|NCT00516295|Growth Substances|growth substances|mesh-ancestor
110554955|NCT00516295|Growth Inhibitors|growth inhibitors|mesh-ancestor
110554956|NCT00516295|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110554957|NCT00516295|Tubulin Modulators|tubulin modulators|mesh-ancestor
110554958|NCT00516295|Antimitotic Agents|antimitotic agents|mesh-ancestor
110554959|NCT00516295|Mitosis Modulators|mitosis modulators|mesh-ancestor
110554960|NCT00516295|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110554961|NCT00516295|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110554962|NCT00516295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110554963|NCT03362099|Bupropion|bupropion|mesh-list
110554964|NCT03362099|Varenicline|varenicline|mesh-list
110554965|NCT03362099|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110554966|NCT03362099|Antidepressive Agents|antidepressive agents|mesh-ancestor
110554967|NCT03362099|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110554968|NCT03362099|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110554969|NCT03362099|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110554970|NCT03362099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110554971|NCT03362099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110554972|NCT03362099|Dopamine Agents|dopamine agents|mesh-ancestor
110554973|NCT03362099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110554974|NCT03362099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110554975|NCT03362099|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110097148|NCT01733589|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110554976|NCT03362099|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110554977|NCT03362099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110554978|NCT03362099|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110554979|NCT03362099|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110554980|NCT03362099|Cholinergic Agents|cholinergic agents|mesh-ancestor
110554981|NCT03861559|Mometasone Furoate|mometasone furoate|mesh-list
110554982|NCT03861559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110554983|NCT03861559|Dermatologic Agents|dermatologic agents|mesh-ancestor
110554984|NCT03861559|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110554985|NCT02705651|Somatostatin|somatostatin|mesh-list
110554986|NCT02705651|Hormones|hormones|mesh-ancestor
110181725|NCT00020943|Levoleucovorin|levoleucovorin|mesh-list
110097361|NCT01735240|Ketoconazole|ketoconazole|mesh-list
110554987|NCT02705651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110554988|NCT02705651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110554989|NCT00738088|Gliclazide|gliclazide|mesh-list
110554990|NCT00738088|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110554991|NCT00738088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110554992|NCT02703233|Nitrous Oxide|nitrous oxide|mesh-list
110554993|NCT02703233|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110554994|NCT02703233|Anesthetics, General|anesthetics, general|mesh-ancestor
110554995|NCT02703233|Anesthetics|anesthetics|mesh-ancestor
110554996|NCT02703233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110554997|NCT02703233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110554998|NCT02703233|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110554999|NCT02703233|Analgesics|analgesics|mesh-ancestor
110555000|NCT02703233|Sensory System Agents|sensory system agents|mesh-ancestor
110555001|NCT02703233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110555002|NCT04062760|Diuretics|diuretics|mesh-list
110555003|NCT04062760|Natriuretic Agents|natriuretic agents|mesh-ancestor
110555004|NCT04062760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110555006|NCT02702843|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110555007|NCT02702843|Anesthetics, General|anesthetics, general|mesh-ancestor
110555008|NCT02702843|Anesthetics|anesthetics|mesh-ancestor
110555009|NCT02702843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110555010|NCT02702843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110555011|NCT00516139|Lamotrigine|lamotrigine|mesh-list
110097635|NCT01737086|Zinc Sulfate|zinc sulfate|mesh-list
110555012|NCT00516139|Anticonvulsants|anticonvulsants|mesh-ancestor
110555013|NCT00516139|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110555014|NCT00516139|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110555015|NCT00516139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110555016|NCT00516139|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110555017|NCT00516139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110555018|NCT00516139|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110555019|NCT00516139|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110555020|NCT00516139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110555021|NCT00516139|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110555022|NCT00516139|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110555023|NCT02704715|Anesthetics|anesthetics|mesh-list
110555024|NCT02704715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110555025|NCT02704715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110555026|NCT00515827|Raltegravir Potassium|raltegravir potassium|mesh-list
110555027|NCT00515827|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110555028|NCT00515827|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110555029|NCT00515827|Antiviral Agents|antiviral agents|mesh-ancestor
110555030|NCT00515827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110555031|NCT00515827|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110555032|NCT00515827|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110555033|NCT00515827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110555034|NCT00515827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110555035|NCT00615875|Naproxen|naproxen|mesh-list
110097985|NCT01739556|Aspirin|aspirin|mesh-list
110555036|NCT00615875|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110555037|NCT00615875|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110555038|NCT00615875|Analgesics|analgesics|mesh-ancestor
110555039|NCT00615875|Sensory System Agents|sensory system agents|mesh-ancestor
110555040|NCT00615875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110098143|NCT01740921|Antipyretics|antipyretics|mesh-ancestor
110555041|NCT00615875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110555042|NCT00615875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110555043|NCT00615875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110555044|NCT00615875|Gout Suppressants|gout suppressants|mesh-ancestor
110555045|NCT00615875|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110555046|NCT00615875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110555047|NCT00615875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110555048|NCT02630888|Memantine|memantine|mesh-list
110555049|NCT02630888|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110555050|NCT02630888|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110555051|NCT02630888|Dopamine Agents|dopamine agents|mesh-ancestor
110555052|NCT02630888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110555053|NCT02630888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110555054|NCT02630888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110555055|NCT02630888|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110555056|NCT02630888|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110555057|NCT00666302|Pimecrolimus|pimecrolimus|mesh-list
110555059|NCT00666302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110555060|NCT00666302|Immunologic Factors|immunologic factors|mesh-ancestor
110098501|NCT01742767|Pemetrexed|pemetrexed|mesh-list
110555061|NCT00666302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110555062|NCT00666302|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110555063|NCT00666302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110555064|NCT00666302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110555065|NCT00666302|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110555066|NCT00666302|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110555067|NCT00666302|Analgesics|analgesics|mesh-ancestor
110555068|NCT00666302|Sensory System Agents|sensory system agents|mesh-ancestor
110555069|NCT00666302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110555070|NCT00666302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110555071|NCT00666302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110555072|NCT00666302|Dermatologic Agents|dermatologic agents|mesh-ancestor
110555073|NCT00671372|Bevacizumab|bevacizumab|mesh-list
110555074|NCT00671372|Cetuximab|cetuximab|mesh-list
110555075|NCT00671372|Irinotecan|irinotecan|mesh-list
110148435|NCT03352765|Rituximab|rituximab|mesh-list
110555076|NCT00671372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110555077|NCT00671372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110555078|NCT00671372|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110560334|NCT00638729|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110555079|NCT00671372|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110148503|NCT00006480|Aldesleukin|aldesleukin|mesh-list
110555080|NCT00671372|Growth Substances|growth substances|mesh-ancestor
110555081|NCT00671372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110555082|NCT00671372|Growth Inhibitors|growth inhibitors|mesh-ancestor
110555083|NCT00671372|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110555084|NCT00671372|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110555085|NCT00671372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110555086|NCT00671372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110555087|NCT00856986|Metformin|metformin|mesh-list
110555088|NCT00856986|Liraglutide|liraglutide|mesh-list
110555089|NCT00856986|Insulin Detemir|insulin detemir|mesh-list
110555090|NCT00856986|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110555091|NCT00856986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110555092|NCT00856986|Incretins|incretins|mesh-ancestor
110555093|NCT00856986|Hormones|hormones|mesh-ancestor
110555094|NCT00856986|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110555095|NCT00666692|Paclitaxel|paclitaxel|mesh-list
110555096|NCT00666692|Bevacizumab|bevacizumab|mesh-list
110555097|NCT00666692|Carboplatin|carboplatin|mesh-list
110555098|NCT00666692|Volociximab|volociximab|mesh-list
110555099|NCT00666692|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110555100|NCT00666692|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110555101|NCT00666692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110555102|NCT00666692|Tubulin Modulators|tubulin modulators|mesh-ancestor
110555103|NCT00666692|Antimitotic Agents|antimitotic agents|mesh-ancestor
110555104|NCT00666692|Mitosis Modulators|mitosis modulators|mesh-ancestor
110555105|NCT00666692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110555106|NCT00666692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110555107|NCT00666692|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110555108|NCT00666692|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110555109|NCT00666692|Growth Substances|growth substances|mesh-ancestor
110555110|NCT00666692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110555111|NCT00666692|Growth Inhibitors|growth inhibitors|mesh-ancestor
110555112|NCT00666692|Immunologic Factors|immunologic factors|mesh-ancestor
110555113|NCT00707746|Mipomersen|mipomersen|mesh-list
110555114|NCT00707746|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110555115|NCT00707746|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110555116|NCT00707746|Antimetabolites|antimetabolites|mesh-ancestor
110555117|NCT00707746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110555118|NCT00707746|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110555119|NCT00666770|Gabapentin|gabapentin|mesh-list
110555120|NCT00666770|Analgesics|analgesics|mesh-ancestor
110555121|NCT00666770|Sensory System Agents|sensory system agents|mesh-ancestor
110555122|NCT00666770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110555123|NCT00666770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110555124|NCT00666770|Anticonvulsants|anticonvulsants|mesh-ancestor
110555125|NCT00666770|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110148772|NCT00006070|Etanercept|etanercept|mesh-list
110555126|NCT00666770|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110555127|NCT00666770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110555128|NCT00666770|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110555129|NCT00666770|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110555130|NCT00666770|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110555131|NCT00666770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110555132|NCT00666770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110555133|NCT00666770|Antimanic Agents|antimanic agents|mesh-ancestor
110555134|NCT04188353|Mannitol|mannitol|mesh-list
110555135|NCT04188353|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110555136|NCT04188353|Diuretics|diuretics|mesh-ancestor
110555137|NCT04188353|Natriuretic Agents|natriuretic agents|mesh-ancestor
110555138|NCT04188353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110555139|NCT03583697|Natriuretic Peptide, C-Type|natriuretic peptide, c-type|mesh-list
110555140|NCT03583697|Natriuretic Agents|natriuretic agents|mesh-ancestor
110555141|NCT03583697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110555142|NCT02630420|Cetuximab|cetuximab|mesh-list
110555143|NCT02630420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110555144|NCT02630420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110555145|NCT00667082|Vorinostat|vorinostat|mesh-list
110555146|NCT00667082|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
110149144|NCT00006235|Carboplatin|carboplatin|mesh-list
110555147|NCT00667082|Proteasome Inhibitors|proteasome inhibitors|mesh-list
110555148|NCT00667082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110555149|NCT00667082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110555150|NCT00667082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110555151|NCT00667082|Protease Inhibitors|protease inhibitors|mesh-ancestor
110555152|NCT05343299|Lidocaine|lidocaine|mesh-list
110555153|NCT05343299|Ropivacaine|ropivacaine|mesh-list
110555155|NCT05343299|Anesthetics, Local|anesthetics, local|mesh-ancestor
110555156|NCT05343299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110555157|NCT05343299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110555158|NCT05343299|Sensory System Agents|sensory system agents|mesh-ancestor
110555159|NCT05343299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110555160|NCT05343299|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110555161|NCT05343299|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110555162|NCT05343299|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110555163|NCT05343299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110555164|NCT05343299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110555165|NCT00667160|Pimecrolimus|pimecrolimus|mesh-list
110555166|NCT00667160|Tacrolimus|tacrolimus|mesh-list
110555167|NCT00667160|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110202757|NCT00406471|Ranibizumab|ranibizumab|mesh-list
110555168|NCT00667160|Immunologic Factors|immunologic factors|mesh-ancestor
110181768|NCT00021060|Antibodies|antibodies|mesh-list
110555169|NCT00667160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110555170|NCT00667160|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110555171|NCT00667160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110555172|NCT00667160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110555173|NCT00667160|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110555174|NCT00667160|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110555175|NCT00667160|Analgesics|analgesics|mesh-ancestor
110149342|NCT00006343|Cytarabine|cytarabine|mesh-list
110555176|NCT00667160|Sensory System Agents|sensory system agents|mesh-ancestor
110555177|NCT00667160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110555178|NCT00667160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110555179|NCT00667160|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110555180|NCT00667160|Dermatologic Agents|dermatologic agents|mesh-ancestor
110555181|NCT02701673|Pyridoxine|pyridoxine|mesh-list
110555182|NCT02701673|Gemcitabine|gemcitabine|mesh-list
110555183|NCT02701673|Azacitidine|azacitidine|mesh-list
110555184|NCT02701673|Melphalan|melphalan|mesh-list
110555185|NCT02701673|Busulfan|busulfan|mesh-list
110555186|NCT02701673|Belinostat|belinostat|mesh-list
110555187|NCT02701673|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110555188|NCT02701673|Antimetabolites|antimetabolites|mesh-ancestor
110555189|NCT02701673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110555190|NCT02701673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110555191|NCT02701673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110555192|NCT02701673|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110555193|NCT02701673|Alkylating Agents|alkylating agents|mesh-ancestor
110555194|NCT02701673|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110555195|NCT02701673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110555196|NCT02701673|Immunologic Factors|immunologic factors|mesh-ancestor
110555197|NCT02701673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110555198|NCT02701673|Vitamin B Complex|vitamin b complex|mesh-ancestor
110555199|NCT02701673|Vitamins|vitamins|mesh-ancestor
110555200|NCT02701673|Micronutrients|micronutrients|mesh-ancestor
110555201|NCT02701673|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110555202|NCT00522379|Rotigotine|rotigotine|mesh-list
110555203|NCT00522379|Dopamine Agonists|dopamine agonists|mesh-ancestor
110555204|NCT00522379|Dopamine Agents|dopamine agents|mesh-ancestor
110555205|NCT00522379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110555206|NCT00522379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110555207|NCT00522379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110555208|NCT00856830|Carboplatin|carboplatin|mesh-list
110555209|NCT00856830|Irinotecan|irinotecan|mesh-list
110555210|NCT00856830|Etoposide|etoposide|mesh-list
110555211|NCT00856830|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110555212|NCT00856830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110555213|NCT00856830|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110555214|NCT00856830|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110555215|NCT00856830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110555216|NCT00856830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110555217|NCT00856830|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110555218|NCT00856830|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110555219|NCT00856830|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110555220|NCT00856830|Alkylating Agents|alkylating agents|mesh-ancestor
110555221|NCT02614404|Piperaquine|piperaquine|mesh-list
110555222|NCT02614404|Artenimol|artenimol|mesh-list
110555223|NCT02614404|Imatinib Mesylate|imatinib mesylate|mesh-list
110555224|NCT02614404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110555225|NCT02614404|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110555226|NCT02614404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110555227|NCT02614404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110555229|NCT02614404|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110555230|NCT02614404|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110555231|NCT02614404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110555232|NCT00522301|Sorafenib|sorafenib|mesh-list
110555233|NCT00522301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110555234|NCT00522301|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110555235|NCT00522301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110555236|NCT00522301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110555237|NCT00662636|Dasatinib|dasatinib|mesh-list
110555238|NCT00662636|Lapatinib|lapatinib|mesh-list
110555239|NCT00662636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110555240|NCT00662636|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110555241|NCT00662636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110555242|NCT00662636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110555243|NCT00506389|Mirtazapine|mirtazapine|mesh-list
110555244|NCT00506389|Antidepressive Agents|antidepressive agents|mesh-ancestor
110555245|NCT00506389|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110555246|NCT00506389|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110555247|NCT00506389|Histamine Antagonists|histamine antagonists|mesh-ancestor
110555248|NCT00506389|Histamine Agents|histamine agents|mesh-ancestor
110555249|NCT00506389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110555250|NCT00506389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110555251|NCT00506389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110555252|NCT00506389|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110555253|NCT00506389|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110555254|NCT00506389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110181814|NCT00020670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110555255|NCT00506389|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
110555256|NCT00506389|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110149877|NCT00008463|Antimetabolites|antimetabolites|mesh-ancestor
110555257|NCT00506389|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110555258|NCT00506389|Adrenergic Agents|adrenergic agents|mesh-ancestor
110555259|NCT00506389|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110555260|NCT00506389|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110555261|NCT00506389|Serotonin Agents|serotonin agents|mesh-ancestor
110555262|NCT00506389|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110555264|NCT00667472|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110555265|NCT00667472|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110555266|NCT00667472|Growth Substances|growth substances|mesh-ancestor
110555267|NCT00667472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110555268|NCT00667472|Growth Inhibitors|growth inhibitors|mesh-ancestor
110555269|NCT00667472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110555271|NCT00662714|Repaglinide|repaglinide|mesh-list
110555272|NCT00662714|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110555273|NCT00662714|Insulin, Short-Acting|insulin, short-acting|mesh-list
110150024|NCT00007813|Etoposide|etoposide|mesh-list
110555274|NCT00662714|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110555275|NCT00662714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110555276|NCT00668018|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
110555277|NCT00668018|Vasodilator Agents|vasodilator agents|mesh-ancestor
110555278|NCT00668018|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110555279|NCT00668018|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110555280|NCT00668018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110150091|NCT00008047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110555281|NCT00668018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110555282|NCT00668018|Urological Agents|urological agents|mesh-ancestor
110555283|NCT00871338|Vaccines|vaccines|mesh-list
110555284|NCT00871338|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110555285|NCT00871338|Immunologic Factors|immunologic factors|mesh-ancestor
110555286|NCT00871338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110555287|NCT04130100|Hyaluronic Acid|hyaluronic acid|mesh-list
110555288|NCT04130100|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110555289|NCT04130100|Immunologic Factors|immunologic factors|mesh-ancestor
110150165|NCT00008242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110555290|NCT04130100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110555291|NCT04130100|Viscosupplements|viscosupplements|mesh-ancestor
110555292|NCT04130100|Protective Agents|protective agents|mesh-ancestor
110555293|NCT00597116|Vinorelbine|vinorelbine|mesh-list
110555294|NCT00597116|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110555295|NCT00597116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110555296|NCT00597116|Tubulin Modulators|tubulin modulators|mesh-ancestor
110555297|NCT00597116|Antimitotic Agents|antimitotic agents|mesh-ancestor
110555298|NCT00597116|Mitosis Modulators|mitosis modulators|mesh-ancestor
110150309|NCT05638633|Corticosterone|corticosterone|mesh-list
110555299|NCT00597116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110555300|NCT00668096|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
110555301|NCT00668096|Vasodilator Agents|vasodilator agents|mesh-ancestor
110555302|NCT00668096|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110555303|NCT00668096|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110555304|NCT00668096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110555305|NCT00668096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110555306|NCT00668096|Urological Agents|urological agents|mesh-ancestor
110555307|NCT00514735|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
110555308|NCT03252587|Deucravacitinib|deucravacitinib|mesh-list
110555309|NCT03252587|Dermatologic Agents|dermatologic agents|mesh-ancestor
110555310|NCT03252587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110555311|NCT03252587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110555312|NCT03252587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110555314|NCT02630264|Endostatins|endostatins|mesh-list
110181848|NCT00021294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110150449|NCT00000187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110555315|NCT02630264|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110555316|NCT02630264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110555317|NCT02630264|Tubulin Modulators|tubulin modulators|mesh-ancestor
110202914|NCT00083538|Etoposide|etoposide|mesh-list
110555318|NCT02630264|Antimitotic Agents|antimitotic agents|mesh-ancestor
110555319|NCT02630264|Mitosis Modulators|mitosis modulators|mesh-ancestor
110555320|NCT02630264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110555321|NCT02630264|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110555322|NCT02630264|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110150589|NCT00000478|Diuretics|diuretics|mesh-ancestor
110555323|NCT02630264|Growth Substances|growth substances|mesh-ancestor
110555324|NCT02630264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110555325|NCT02630264|Growth Inhibitors|growth inhibitors|mesh-ancestor
110555326|NCT00668330|Calcium, Dietary|calcium, dietary|mesh-list
110555327|NCT00668330|Ibandronic Acid|ibandronic acid|mesh-list
110555329|NCT00668330|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
110555330|NCT00668330|Calcium|calcium|mesh-list
110555331|NCT00668330|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110555332|NCT00668330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110555333|NCT00668330|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110555334|NCT00668330|Vitamins|vitamins|mesh-ancestor
110555335|NCT00668330|Micronutrients|micronutrients|mesh-ancestor
110555336|NCT01012687|Perindopril|perindopril|mesh-list
110555337|NCT01012687|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110555338|NCT01012687|Protease Inhibitors|protease inhibitors|mesh-ancestor
110555339|NCT01012687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110555340|NCT01012687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110555341|NCT01012687|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110555342|NCT00662948|Rituximab|rituximab|mesh-list
110555343|NCT00662948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110555344|NCT00662948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110555345|NCT00662948|Immunologic Factors|immunologic factors|mesh-ancestor
110555346|NCT00662948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110555347|NCT00662948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110555348|NCT00511147|Immunoglobulins|immunoglobulins|mesh-list
110555349|NCT00511147|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110555350|NCT00511147|gamma-Globulins|gamma-globulins|mesh-list
110555351|NCT00511147|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110555352|NCT00511147|Immunologic Factors|immunologic factors|mesh-ancestor
110555353|NCT00511147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110555354|NCT00672464|Metformin|metformin|mesh-list
110555355|NCT00672464|Olanzapine|olanzapine|mesh-list
110555356|NCT00672464|Simvastatin|simvastatin|mesh-list
110555357|NCT00672464|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110555358|NCT00672464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110555359|NCT00672464|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110555360|NCT00672464|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110555361|NCT00672464|Antimetabolites|antimetabolites|mesh-ancestor
110555362|NCT00672464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110555363|NCT00672464|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110151084|NCT00000760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110555364|NCT00672464|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110555365|NCT00672464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110555366|NCT00672464|Antiemetics|antiemetics|mesh-ancestor
110555367|NCT00672464|Autonomic Agents|autonomic agents|mesh-ancestor
110555368|NCT00672464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110555369|NCT00672464|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110555370|NCT00672464|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110555371|NCT00672464|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110555372|NCT00672464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110555373|NCT00672464|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110555374|NCT00672464|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110555375|NCT00672464|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110555376|NCT00672464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110555377|NCT00672464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110555378|NCT00672464|Serotonin Agents|serotonin agents|mesh-ancestor
110555379|NCT02701595|Amoxicillin|amoxicillin|mesh-list
110555380|NCT02701595|Vancomycin|vancomycin|mesh-list
110555381|NCT02701595|Gentamicins|gentamicins|mesh-list
110555382|NCT02701595|Ceftriaxone|ceftriaxone|mesh-list
110555383|NCT02701595|Penicillins|penicillins|mesh-list
110555384|NCT02701595|Penicillin G|penicillin g|mesh-list
110555385|NCT02701595|Penicillin G Benzathine|penicillin g benzathine|mesh-list
110151294|NCT00000919|Ritonavir|ritonavir|mesh-list
110555386|NCT02701595|Penicillin G Procaine|penicillin g procaine|mesh-list
110555387|NCT02701595|Netilmicin|netilmicin|mesh-list
110555388|NCT02701595|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110555389|NCT02701595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110555390|NCT02701595|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110202999|NCT00156403|Amlodipine|amlodipine|mesh-list
110555391|NCT02701595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110555392|NCT02701595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110555393|NCT02698553|Bupropion|bupropion|mesh-list
110151451|NCT00000985|Acyclovir|acyclovir|mesh-list
110555394|NCT02698553|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110555395|NCT02698553|Antidepressive Agents|antidepressive agents|mesh-ancestor
110555396|NCT02698553|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110555397|NCT02698553|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110555398|NCT02698553|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110555399|NCT02698553|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110555400|NCT02698553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110555401|NCT02698553|Dopamine Agents|dopamine agents|mesh-ancestor
110555402|NCT02698553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110555403|NCT02698553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110555404|NCT02698553|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110555405|NCT02698553|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110555406|NCT02698553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110555407|NCT00663182|Entecavir|entecavir|mesh-list
110555408|NCT00663182|Antiviral Agents|antiviral agents|mesh-ancestor
110555409|NCT00663182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110555410|NCT00616031|Paclitaxel|paclitaxel|mesh-list
110555411|NCT00616031|Carboplatin|carboplatin|mesh-list
110555412|NCT00616031|Nitroglycerin|nitroglycerin|mesh-list
110555413|NCT00616031|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110555414|NCT00616031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110555415|NCT00616031|Tubulin Modulators|tubulin modulators|mesh-ancestor
110555416|NCT00616031|Antimitotic Agents|antimitotic agents|mesh-ancestor
110555417|NCT00616031|Mitosis Modulators|mitosis modulators|mesh-ancestor
110555418|NCT00616031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110555419|NCT00616031|Vasodilator Agents|vasodilator agents|mesh-ancestor
110555420|NCT04213937|Paclitaxel|paclitaxel|mesh-list
110555421|NCT04213937|Topotecan|topotecan|mesh-list
110151576|NCT00001048|Antiviral Agents|antiviral agents|mesh-ancestor
110555422|NCT04213937|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110555423|NCT04213937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110555424|NCT04213937|Tubulin Modulators|tubulin modulators|mesh-ancestor
110555425|NCT04213937|Antimitotic Agents|antimitotic agents|mesh-ancestor
110555426|NCT04213937|Mitosis Modulators|mitosis modulators|mesh-ancestor
110555427|NCT04213937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110555428|NCT04213937|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110555429|NCT04213937|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110555430|NCT04213937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110555431|NCT02701517|Cyclosporine|cyclosporine|mesh-list
110555432|NCT02701517|Methotrexate|methotrexate|mesh-list
110555433|NCT02701517|Alemtuzumab|alemtuzumab|mesh-list
110555434|NCT02701517|Cyclosporins|cyclosporins|mesh-list
110555435|NCT02701517|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110555436|NCT02701517|Abortifacient Agents|abortifacient agents|mesh-ancestor
110555437|NCT02701517|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110151713|NCT00389272|Acetaminophen|acetaminophen|mesh-list
110555438|NCT02701517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110555439|NCT02701517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110555440|NCT02701517|Antimetabolites|antimetabolites|mesh-ancestor
110555441|NCT02701517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110555442|NCT02701517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110555443|NCT02701517|Dermatologic Agents|dermatologic agents|mesh-ancestor
110555444|NCT02701517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110555445|NCT02701517|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110555446|NCT02701517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110555447|NCT02701517|Immunologic Factors|immunologic factors|mesh-ancestor
110555448|NCT02701517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110555449|NCT02701517|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110555450|NCT02701517|Antifungal Agents|antifungal agents|mesh-ancestor
110555452|NCT02701517|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110555453|NCT02701517|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110555454|NCT02630108|Epirubicin|epirubicin|mesh-list
110555455|NCT02630108|Ethiodized Oil|ethiodized oil|mesh-list
110151789|NCT00001333|Topotecan|topotecan|mesh-list
110555456|NCT02630108|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110555457|NCT02630108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110555458|NCT02630108|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110555459|NCT02630108|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110555460|NCT02630108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110555461|NCT02630108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110555462|NCT00505921|Cytarabine|cytarabine|mesh-list
110555463|NCT00505921|Cyclophosphamide|cyclophosphamide|mesh-list
110555464|NCT00505921|Melphalan|melphalan|mesh-list
110555465|NCT00505921|Carmustine|carmustine|mesh-list
110555466|NCT00505921|Fludarabine|fludarabine|mesh-list
110555467|NCT00505921|Fludarabine phosphate|fludarabine phosphate|mesh-list
110555468|NCT00505921|Etoposide|etoposide|mesh-list
110555469|NCT00505921|Etoposide phosphate|etoposide phosphate|mesh-list
110555470|NCT00505921|Molgramostim|molgramostim|mesh-list
110555472|NCT00505921|Sargramostim|sargramostim|mesh-list
110555473|NCT00505921|Lenograstim|lenograstim|mesh-list
110555474|NCT00505921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110555475|NCT00505921|Immunologic Factors|immunologic factors|mesh-ancestor
110555476|NCT00505921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110555477|NCT00505921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110555478|NCT00505921|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110555479|NCT00505921|Alkylating Agents|alkylating agents|mesh-ancestor
110555480|NCT00505921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110555481|NCT00505921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110555482|NCT00505921|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110555483|NCT00505921|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110555484|NCT00505921|Antimetabolites|antimetabolites|mesh-ancestor
110555485|NCT00505921|Antiviral Agents|antiviral agents|mesh-ancestor
110555486|NCT00505921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110555487|NCT00505921|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110555488|NCT00505921|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110555489|NCT00505921|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110555490|NCT00505921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110555491|NCT00505921|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110555492|NCT00505921|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110555493|NCT00669344|Rivastigmine|rivastigmine|mesh-list
110555494|NCT00669344|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110555495|NCT00669344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110555496|NCT00669344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110181895|NCT00021450|Goserelin|goserelin|mesh-list
110555497|NCT00669344|Cholinergic Agents|cholinergic agents|mesh-ancestor
110555498|NCT00669344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110555499|NCT00669344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110555500|NCT00669344|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110555501|NCT00669344|Protective Agents|protective agents|mesh-ancestor
110555502|NCT02701127|Niacinamide|niacinamide|mesh-list
110555504|NCT02701127|Nicotinic Acids|nicotinic acids|mesh-list
110555505|NCT02701127|Vitamin B Complex|vitamin b complex|mesh-ancestor
110555506|NCT02701127|Vitamins|vitamins|mesh-ancestor
110555507|NCT02701127|Micronutrients|micronutrients|mesh-ancestor
110555508|NCT02701127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110555509|NCT02701127|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110555510|NCT02701127|Antimetabolites|antimetabolites|mesh-ancestor
110555511|NCT02701127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110555512|NCT02701127|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110555513|NCT02701127|Vasodilator Agents|vasodilator agents|mesh-ancestor
110555514|NCT02700893|Atropine|atropine|mesh-list
110555515|NCT02700893|Sufentanil|sufentanil|mesh-list
110555516|NCT02700893|Propofol|propofol|mesh-list
110555517|NCT02700893|Atracurium|atracurium|mesh-list
110555518|NCT02700893|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110555519|NCT02700893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110555520|NCT02700893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110555521|NCT02700893|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110555522|NCT02700893|Anesthetics, General|anesthetics, general|mesh-ancestor
110555523|NCT02700893|Anesthetics|anesthetics|mesh-ancestor
110555524|NCT02700893|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110555525|NCT02700893|Narcotics|narcotics|mesh-ancestor
110555526|NCT02700893|Analgesics|analgesics|mesh-ancestor
110555527|NCT02700893|Sensory System Agents|sensory system agents|mesh-ancestor
110555528|NCT02700893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110555529|NCT02700893|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110555530|NCT02700893|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110555531|NCT02700893|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110555532|NCT02700893|Autonomic Agents|autonomic agents|mesh-ancestor
110555533|NCT02700893|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110555534|NCT02700893|Respiratory System Agents|respiratory system agents|mesh-ancestor
110555535|NCT02700893|Mydriatics|mydriatics|mesh-ancestor
110555536|NCT02700893|Parasympatholytics|parasympatholytics|mesh-ancestor
110555537|NCT02700893|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110555538|NCT02700893|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110555539|NCT02700893|Cholinergic Agents|cholinergic agents|mesh-ancestor
110555540|NCT02700893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110555541|NCT02700893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110555542|NCT02700893|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110555543|NCT02700893|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110555544|NCT02700893|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110555545|NCT02700893|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
110555546|NCT04213781|Sufentanil|sufentanil|mesh-list
110555547|NCT04213781|Propofol|propofol|mesh-list
110555548|NCT04213781|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110555549|NCT04213781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110555550|NCT04213781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110152375|NCT00000504|Flecainide|flecainide|mesh-list
110555551|NCT04213781|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110555552|NCT04213781|Anesthetics, General|anesthetics, general|mesh-ancestor
110555554|NCT04213781|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110555556|NCT04213781|Analgesics|analgesics|mesh-ancestor
110555557|NCT04213781|Sensory System Agents|sensory system agents|mesh-ancestor
110555558|NCT04213781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110555559|NCT04213781|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110555560|NCT00505687|Rotigotine|rotigotine|mesh-list
110555561|NCT00505687|Dopamine Agonists|dopamine agonists|mesh-ancestor
110555562|NCT00505687|Dopamine Agents|dopamine agents|mesh-ancestor
110555563|NCT00505687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110555564|NCT00505687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110555565|NCT00505687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110555566|NCT00669656|Vitamin D|vitamin d|mesh-list
110555567|NCT00669656|Cholecalciferol|cholecalciferol|mesh-list
110555568|NCT00669656|Vitamins|vitamins|mesh-list
110555569|NCT00669656|Vitamin E|vitamin e|mesh-list
110555570|NCT00669656|Tocopherols|tocopherols|mesh-list
110555571|NCT00669656|alpha-Tocopherol|alpha-tocopherol|mesh-list
110555572|NCT00669656|Selenium|selenium|mesh-list
110555573|NCT00669656|Lycopene|lycopene|mesh-list
110555574|NCT00669656|Daidzein|daidzein|mesh-list
110555575|NCT00669656|Micronutrients|micronutrients|mesh-ancestor
110555576|NCT00669656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110152508|NCT00000531|Sympatholytics|sympatholytics|mesh-ancestor
110555577|NCT00669656|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110555578|NCT00669656|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110555579|NCT00669656|Antioxidants|antioxidants|mesh-ancestor
110555580|NCT00669656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110555581|NCT00669656|Protective Agents|protective agents|mesh-ancestor
110555582|NCT00669656|Trace Elements|trace elements|mesh-ancestor
110555583|NCT00669656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110555584|NCT00669656|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110555585|NCT00669656|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110555586|NCT00669656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110555587|NCT00669656|Phytoestrogens|phytoestrogens|mesh-ancestor
110555588|NCT00669656|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
110555589|NCT00669656|Estrogens|estrogens|mesh-ancestor
110555590|NCT00669656|Hormones|hormones|mesh-ancestor
110555591|NCT00669656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110555592|NCT00672776|Paroxetine|paroxetine|mesh-list
110555593|NCT00672776|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110555594|NCT00672776|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110555595|NCT00672776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110555596|NCT00672776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110555597|NCT00672776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110555598|NCT00672776|Serotonin Agents|serotonin agents|mesh-ancestor
110555599|NCT00672776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110555600|NCT00672776|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110555601|NCT00672776|Antidepressive Agents|antidepressive agents|mesh-ancestor
110555602|NCT00672776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110555603|NCT00672776|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110555604|NCT00672776|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110312607|NCT00326352|Propofol|propofol|mesh-list
110555605|NCT00672776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110555606|NCT00616187|Interferons|interferons|mesh-list
110555607|NCT00616187|Interferon-beta|interferon-beta|mesh-list
110555608|NCT00616187|Atorvastatin|atorvastatin|mesh-list
110555609|NCT00616187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110555610|NCT00616187|Antiviral Agents|antiviral agents|mesh-ancestor
110555611|NCT00616187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110555612|NCT00616187|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110555613|NCT00616187|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110555614|NCT00616187|Antimetabolites|antimetabolites|mesh-ancestor
110555615|NCT00616187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110555616|NCT00616187|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110555617|NCT00616187|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110555618|NCT00616187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110555619|NCT00616187|Immunologic Factors|immunologic factors|mesh-ancestor
110555620|NCT00616187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110555621|NCT00663338|Rotigotine|rotigotine|mesh-list
110555622|NCT00663338|Dopamine Agonists|dopamine agonists|mesh-ancestor
110555623|NCT00663338|Dopamine Agents|dopamine agents|mesh-ancestor
110555624|NCT00663338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110555625|NCT00663338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110555626|NCT00663338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110555627|NCT02992015|Gemcitabine|gemcitabine|mesh-list
110555628|NCT02992015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110555629|NCT02992015|Antimetabolites|antimetabolites|mesh-ancestor
110555630|NCT02992015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110555631|NCT02992015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110555632|NCT01009567|Cabergoline|cabergoline|mesh-list
110555633|NCT01009567|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110555634|NCT01009567|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110555635|NCT01009567|Dopamine Agonists|dopamine agonists|mesh-ancestor
110555636|NCT01009567|Dopamine Agents|dopamine agents|mesh-ancestor
110555637|NCT01009567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110555638|NCT01009567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110555639|NCT01009567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110555640|NCT00669812|Cytarabine|cytarabine|mesh-list
110555641|NCT00669812|Prednisolone|prednisolone|mesh-list
110555642|NCT00669812|Cyclophosphamide|cyclophosphamide|mesh-list
110555643|NCT00669812|Melphalan|melphalan|mesh-list
110555644|NCT00669812|Ifosfamide|ifosfamide|mesh-list
110555645|NCT00669812|Carmustine|carmustine|mesh-list
110555646|NCT00669812|Doxorubicin|doxorubicin|mesh-list
110555647|NCT00669812|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110555648|NCT00669812|Methotrexate|methotrexate|mesh-list
110555649|NCT00669812|Etoposide|etoposide|mesh-list
110555650|NCT00669812|Vincristine|vincristine|mesh-list
110555651|NCT00669812|Epirubicin|epirubicin|mesh-list
110555652|NCT00669812|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110555653|NCT00669812|Immunologic Factors|immunologic factors|mesh-ancestor
110555654|NCT00669812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110555655|NCT00669812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110555656|NCT00669812|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110555657|NCT00669812|Alkylating Agents|alkylating agents|mesh-ancestor
110555658|NCT00669812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110555659|NCT00669812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110555660|NCT00669812|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110555661|NCT00669812|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110555662|NCT00669812|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110555663|NCT00669812|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110555664|NCT00669812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110555665|NCT00669812|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110555666|NCT00669812|Abortifacient Agents|abortifacient agents|mesh-ancestor
110555667|NCT00669812|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110555668|NCT00669812|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110555669|NCT00669812|Antimetabolites|antimetabolites|mesh-ancestor
110555670|NCT00669812|Dermatologic Agents|dermatologic agents|mesh-ancestor
110555671|NCT00669812|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110555672|NCT00669812|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110555673|NCT00669812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110555675|NCT00669812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110555676|NCT00669812|Tubulin Modulators|tubulin modulators|mesh-ancestor
110555677|NCT00669812|Antimitotic Agents|antimitotic agents|mesh-ancestor
110555678|NCT00669812|Mitosis Modulators|mitosis modulators|mesh-ancestor
110555679|NCT00669812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110555680|NCT00669812|Glucocorticoids|glucocorticoids|mesh-ancestor
110555681|NCT00669812|Hormones|hormones|mesh-ancestor
110555682|NCT00669812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110555683|NCT00669812|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110555684|NCT02697851|Atazanavir Sulfate|atazanavir sulfate|mesh-list
110555685|NCT02697851|Cobicistat|cobicistat|mesh-list
110555686|NCT02697851|Levonorgestrel|levonorgestrel|mesh-list
110555687|NCT02697851|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110152937|NCT00000708|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110555688|NCT02697851|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
110555689|NCT02697851|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
110555690|NCT02697851|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110555691|NCT02697851|Contraceptive Agents|contraceptive agents|mesh-ancestor
110555692|NCT02697851|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110555693|NCT02697851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110555694|NCT02697851|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110555695|NCT02697851|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110555696|NCT02697851|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110555697|NCT02697851|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110555698|NCT02697851|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110555699|NCT02697851|Protease Inhibitors|protease inhibitors|mesh-ancestor
110555701|NCT02697851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110555702|NCT02697851|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110555703|NCT02697851|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110555704|NCT02697851|Antiviral Agents|antiviral agents|mesh-ancestor
110555705|NCT02697851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110152998|NCT00000741|Methylprednisolone|methylprednisolone|mesh-list
110555706|NCT02697851|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110555707|NCT02697851|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110555708|NCT02697851|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110555709|NCT02697851|Estrogens|estrogens|mesh-ancestor
110555710|NCT02697851|Hormones|hormones|mesh-ancestor
110555711|NCT02697851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110555712|NCT02697851|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110555713|NCT02697851|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
110555714|NCT02697851|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
110555715|NCT02697851|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
110555716|NCT01012843|Amoxicillin|amoxicillin|mesh-list
110555717|NCT01012843|Clavulanic Acid|clavulanic acid|mesh-list
110555718|NCT01012843|Clavulanic Acids|clavulanic acids|mesh-list
110555719|NCT01012843|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
110555720|NCT01012843|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110555721|NCT01012843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110555722|NCT01012843|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110555723|NCT01012843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110555724|NCT01012843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110555725|NCT00669890|Mycophenolic Acid|mycophenolic acid|mesh-list
110555726|NCT00669890|Cyclophosphamide|cyclophosphamide|mesh-list
110555727|NCT00669890|Busulfan|busulfan|mesh-list
110555728|NCT00669890|Methotrexate|methotrexate|mesh-list
110555729|NCT00669890|Gemtuzumab|gemtuzumab|mesh-list
110555730|NCT00669890|Tacrolimus|tacrolimus|mesh-list
110555731|NCT00669890|Thymoglobulin|thymoglobulin|mesh-list
110555732|NCT00669890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110555733|NCT00669890|Immunologic Factors|immunologic factors|mesh-ancestor
110555734|NCT00669890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110555735|NCT00669890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110555736|NCT00669890|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110555737|NCT00669890|Alkylating Agents|alkylating agents|mesh-ancestor
110555738|NCT00669890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110555739|NCT00669890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110555740|NCT00669890|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110555741|NCT00669890|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110555743|NCT00669890|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110555744|NCT00669890|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110555745|NCT00669890|Antimetabolites|antimetabolites|mesh-ancestor
110555746|NCT00669890|Dermatologic Agents|dermatologic agents|mesh-ancestor
110555747|NCT00669890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110555748|NCT00669890|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110555749|NCT00669890|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110555750|NCT00669890|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110555751|NCT00669890|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110555752|NCT00669890|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110555753|NCT00669890|Antitubercular Agents|antitubercular agents|mesh-ancestor
110555754|NCT00669890|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110555755|NCT00669890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110555756|NCT00669890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110555757|NCT00669890|Immunotoxins|immunotoxins|mesh-ancestor
110555758|NCT00669890|Immunoconjugates|immunoconjugates|mesh-ancestor
110555759|NCT02697929|Neostigmine|neostigmine|mesh-list
110555760|NCT02697929|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110555761|NCT02697929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110555762|NCT02697929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110555763|NCT02697929|Cholinergic Agents|cholinergic agents|mesh-ancestor
110555764|NCT02697929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110555765|NCT02697929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110555766|NCT02697929|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110555767|NCT02697929|Autonomic Agents|autonomic agents|mesh-ancestor
110555768|NCT02697929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110555769|NCT00505375|Abatacept|abatacept|mesh-list
110555770|NCT00505375|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110555771|NCT00505375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110555772|NCT00505375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110555773|NCT00505375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110555774|NCT00505375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110555776|NCT00505375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110555777|NCT00505375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110555778|NCT02700347|Pyrazinamide|pyrazinamide|mesh-list
110555779|NCT02700347|Allopurinol|allopurinol|mesh-list
110555780|NCT02700347|Antimetabolites|antimetabolites|mesh-ancestor
110555781|NCT02700347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110555782|NCT02700347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110555783|NCT02700347|Gout Suppressants|gout suppressants|mesh-ancestor
110555784|NCT02700347|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110555785|NCT02700347|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110555786|NCT02700347|Antioxidants|antioxidants|mesh-ancestor
110555787|NCT02700347|Protective Agents|protective agents|mesh-ancestor
110555788|NCT02700347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110555789|NCT02700347|Antitubercular Agents|antitubercular agents|mesh-ancestor
110555790|NCT02700347|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110555791|NCT02700347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110555792|NCT00594932|Mycophenolic Acid|mycophenolic acid|mesh-list
110555793|NCT00594932|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110153251|NCT03539302|Flecainide|flecainide|mesh-list
110555794|NCT00594932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110555795|NCT00594932|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110555796|NCT00594932|Antitubercular Agents|antitubercular agents|mesh-ancestor
110555797|NCT00594932|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110555798|NCT00594932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110555799|NCT00594932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110555800|NCT00594932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110555801|NCT00616889|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110555802|NCT00616889|Antidepressive Agents|antidepressive agents|mesh-ancestor
110555803|NCT00616889|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110555804|NCT00616889|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110555805|NCT00616889|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110555806|NCT00616889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110555807|NCT00616889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110555808|NCT00673088|Ropinirole|ropinirole|mesh-list
110555809|NCT00673088|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110555810|NCT00673088|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110555811|NCT00673088|Dopamine Agonists|dopamine agonists|mesh-ancestor
110555812|NCT00673088|Dopamine Agents|dopamine agents|mesh-ancestor
110555813|NCT00673088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110555814|NCT00673088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110555815|NCT00673088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110555816|NCT00504829|Atorvastatin|atorvastatin|mesh-list
110555817|NCT00504829|Fenofibrate|fenofibrate|mesh-list
110555818|NCT00504829|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110555819|NCT00504829|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110555820|NCT00504829|Antimetabolites|antimetabolites|mesh-ancestor
110555821|NCT00504829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110555822|NCT00504829|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110555823|NCT00504829|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110555824|NCT00504829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110555825|NCT02701205|Etanercept|etanercept|mesh-list
110555826|NCT02701205|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110555827|NCT02701205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110555828|NCT02701205|Analgesics|analgesics|mesh-ancestor
110555829|NCT02701205|Sensory System Agents|sensory system agents|mesh-ancestor
110555830|NCT02701205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110555831|NCT02701205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110555832|NCT02701205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110555833|NCT02701205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110555834|NCT02701205|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110555835|NCT02701205|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110555836|NCT02701205|Immunologic Factors|immunologic factors|mesh-ancestor
110555837|NCT00670436|Paclitaxel|paclitaxel|mesh-list
110555838|NCT00670436|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110555839|NCT00670436|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110555840|NCT00670436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110555841|NCT00670436|Tubulin Modulators|tubulin modulators|mesh-ancestor
110555842|NCT00670436|Antimitotic Agents|antimitotic agents|mesh-ancestor
110555843|NCT00670436|Mitosis Modulators|mitosis modulators|mesh-ancestor
110555844|NCT00670436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110555846|NCT02699879|Analgesics|analgesics|mesh-ancestor
110555847|NCT02699879|Sensory System Agents|sensory system agents|mesh-ancestor
110555848|NCT02699879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110555849|NCT02699879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110555850|NCT02699879|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110555851|NCT02699879|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110555852|NCT02699879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110555853|NCT02699879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110555854|NCT02699879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110555855|NCT02699723|Itraconazole|itraconazole|mesh-list
110555856|NCT02699723|Arsenic Trioxide|arsenic trioxide|mesh-list
110555857|NCT02699723|Antifungal Agents|antifungal agents|mesh-ancestor
110555858|NCT02699723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110555859|NCT02699723|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110555860|NCT02699723|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110555861|NCT02699723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110555862|NCT02699723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110555863|NCT02699723|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110555864|NCT02699723|Hormone Antagonists|hormone antagonists|mesh-ancestor
110555865|NCT02699723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110555866|NCT02699723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110555867|NCT02699723|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110555868|NCT02699723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110555869|NCT02699645|Amlodipine|amlodipine|mesh-list
110555870|NCT02699645|Telmisartan|telmisartan|mesh-list
110555871|NCT02699645|Indapamide|indapamide|mesh-list
110555872|NCT02699645|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110153488|NCT00000966|Leucovorin|leucovorin|mesh-list
110555873|NCT02699645|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110555874|NCT02699645|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110555875|NCT02699645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110555876|NCT02699645|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110555877|NCT02699645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110555878|NCT02699645|Vasodilator Agents|vasodilator agents|mesh-ancestor
110555879|NCT02699645|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110555880|NCT02699645|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110555881|NCT02699645|Diuretics|diuretics|mesh-ancestor
110555882|NCT02699645|Natriuretic Agents|natriuretic agents|mesh-ancestor
110555883|NCT02699645|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110555884|NCT04152434|Erenumab|erenumab|mesh-list
110555885|NCT04152434|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
110555886|NCT04152434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110555887|NCT04152434|Analgesics|analgesics|mesh-ancestor
110555888|NCT04152434|Sensory System Agents|sensory system agents|mesh-ancestor
110153532|NCT00000978|Zalcitabine|zalcitabine|mesh-list
110555889|NCT04152434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110555890|NCT04152434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110555891|NCT00615797|Penicillins|penicillins|mesh-list
110555892|NCT00615797|Penicillin V|penicillin v|mesh-list
110555893|NCT00615797|Haloperidol|haloperidol|mesh-list
110555894|NCT00615797|Haloperidol decanoate|haloperidol decanoate|mesh-list
110555895|NCT00615797|Immunoglobulins|immunoglobulins|mesh-list
110555896|NCT00615797|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110555897|NCT00615797|Antibodies|antibodies|mesh-list
110555898|NCT00615797|gamma-Globulins|gamma-globulins|mesh-list
110555899|NCT00615797|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110555900|NCT00615797|Immunologic Factors|immunologic factors|mesh-ancestor
110555901|NCT00615797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110555902|NCT00615797|Antiemetics|antiemetics|mesh-ancestor
110555904|NCT00615797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110555905|NCT00615797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110555906|NCT00615797|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110555907|NCT00615797|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110555908|NCT00615797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110555909|NCT00615797|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110555910|NCT00615797|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110555911|NCT00615797|Dopamine Agents|dopamine agents|mesh-ancestor
110555912|NCT00615797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110555913|NCT00615797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110555914|NCT00615797|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110555915|NCT00615797|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110555916|NCT00615797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110555917|NCT00705016|Fluorouracil|fluorouracil|mesh-list
110555918|NCT00705016|Cetuximab|cetuximab|mesh-list
110555919|NCT00705016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110555920|NCT00705016|Antimetabolites|antimetabolites|mesh-ancestor
110555921|NCT00705016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110555922|NCT00705016|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110555923|NCT00705016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110555924|NCT00705016|Immunologic Factors|immunologic factors|mesh-ancestor
110555925|NCT00705016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110555926|NCT00705016|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110555927|NCT00595868|Varenicline|varenicline|mesh-list
110555928|NCT00595868|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110555929|NCT00595868|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110555930|NCT00595868|Cholinergic Agents|cholinergic agents|mesh-ancestor
110555931|NCT00595868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110555932|NCT00595868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110555933|NCT00595868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110555934|NCT02699801|Dexmedetomidine|dexmedetomidine|mesh-list
110555935|NCT02699801|Propofol|propofol|mesh-list
110555936|NCT02699801|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110555937|NCT02699801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110555938|NCT02699801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110555939|NCT02699801|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110555940|NCT02699801|Analgesics|analgesics|mesh-ancestor
110555941|NCT02699801|Sensory System Agents|sensory system agents|mesh-ancestor
110555942|NCT02699801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110555943|NCT02699801|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110153720|NCT00005834|Etoposide|etoposide|mesh-list
110555944|NCT02699801|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110555945|NCT02699801|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110555946|NCT02699801|Adrenergic Agents|adrenergic agents|mesh-ancestor
110555947|NCT02699801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110555948|NCT02699801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110555949|NCT02699801|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110555950|NCT02699801|Anesthetics, General|anesthetics, general|mesh-ancestor
110555951|NCT02699801|Anesthetics|anesthetics|mesh-ancestor
110555952|NCT02727907|Interferons|interferons|mesh-list
110555953|NCT02727907|Interferon-beta|interferon-beta|mesh-list
110555954|NCT02727907|Interferon beta-1a|interferon beta-1a|mesh-list
110555955|NCT02727907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110555956|NCT02727907|Antiviral Agents|antiviral agents|mesh-ancestor
110555957|NCT02727907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110555958|NCT02727907|Immunologic Factors|immunologic factors|mesh-ancestor
110555959|NCT02727907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110555960|NCT02727907|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110555961|NCT00663728|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
110555962|NCT00663728|Vasodilator Agents|vasodilator agents|mesh-ancestor
110555963|NCT00663728|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110555964|NCT00663728|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110555965|NCT00663728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110555966|NCT00663728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110555967|NCT00663728|Urological Agents|urological agents|mesh-ancestor
110555968|NCT01009801|Doxorubicin|doxorubicin|mesh-list
110555969|NCT01009801|Everolimus|everolimus|mesh-list
110555970|NCT01009801|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110555971|NCT01009801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110555972|NCT01009801|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110555973|NCT01009801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110555974|NCT01009801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110555975|NCT01009801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110555976|NCT01009801|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110555978|NCT01009801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110555979|NCT01009801|Immunologic Factors|immunologic factors|mesh-ancestor
110555980|NCT01009801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110555981|NCT00617045|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110555982|NCT00617045|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110555983|NCT00617045|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110555984|NCT00617045|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110555985|NCT00617045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110555986|NCT00617045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110555987|NCT00617045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110555988|NCT00617045|Analgesics|analgesics|mesh-ancestor
110555989|NCT00617045|Sensory System Agents|sensory system agents|mesh-ancestor
110555990|NCT00617045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110555991|NCT00617045|Antidepressive Agents|antidepressive agents|mesh-ancestor
110555992|NCT00617045|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110555993|NCT00617045|Dopamine Agents|dopamine agents|mesh-ancestor
110555994|NCT02629718|Paclitaxel|paclitaxel|mesh-list
110555995|NCT02629718|Carboplatin|carboplatin|mesh-list
110555996|NCT02629718|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110555997|NCT02629718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110555999|NCT02629718|Antimitotic Agents|antimitotic agents|mesh-ancestor
110556000|NCT02629718|Mitosis Modulators|mitosis modulators|mesh-ancestor
110556001|NCT02629718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110556002|NCT01009879|Etanercept|etanercept|mesh-list
110556003|NCT01009879|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110153905|NCT00001086|Efavirenz|efavirenz|mesh-list
110556004|NCT01009879|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110556005|NCT01009879|Analgesics|analgesics|mesh-ancestor
110556006|NCT01009879|Sensory System Agents|sensory system agents|mesh-ancestor
110556007|NCT01009879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110556008|NCT01009879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110556009|NCT01009879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110556010|NCT01009879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110556011|NCT01009879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110556012|NCT01009879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110556013|NCT01009879|Immunologic Factors|immunologic factors|mesh-ancestor
110556015|NCT01009957|MTOR Inhibitors|mtor inhibitors|mesh-list
110556016|NCT01009957|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110556017|NCT01009957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110556018|NCT01009957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110556019|NCT01009957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110556020|NCT01009957|Immunologic Factors|immunologic factors|mesh-ancestor
110556021|NCT01009957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110556022|NCT01009957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110556023|NCT04062370|Ranibizumab|ranibizumab|mesh-list
110556024|NCT04062370|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110556025|NCT04062370|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110556026|NCT04062370|Growth Substances|growth substances|mesh-ancestor
110556027|NCT04062370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110556028|NCT04062370|Growth Inhibitors|growth inhibitors|mesh-ancestor
110556029|NCT04062370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110556030|NCT01015183|Zinc Sulfate|zinc sulfate|mesh-list
110556031|NCT01015183|Astringents|astringents|mesh-ancestor
110556032|NCT01015183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110556033|NCT01015183|Dermatologic Agents|dermatologic agents|mesh-ancestor
110556034|NCT00856284|Metformin|metformin|mesh-list
110556035|NCT00856284|Alogliptin|alogliptin|mesh-list
110556036|NCT00856284|Glipizide|glipizide|mesh-list
110556037|NCT00856284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110556038|NCT00856284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110556039|NCT00856284|Incretins|incretins|mesh-ancestor
110556040|NCT00856284|Hormones|hormones|mesh-ancestor
110556041|NCT00856284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110556042|NCT00856284|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110556043|NCT00856284|Protease Inhibitors|protease inhibitors|mesh-ancestor
110556044|NCT00856284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110556045|NCT00856284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110556046|NCT00510289|Sorafenib|sorafenib|mesh-list
110556047|NCT00510289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110556048|NCT00510289|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110556049|NCT00510289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110556050|NCT00510289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110556051|NCT01013155|Perindopril|perindopril|mesh-list
110556052|NCT01013155|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110556053|NCT01013155|Protease Inhibitors|protease inhibitors|mesh-ancestor
110556054|NCT01013155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110556055|NCT01013155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110556056|NCT01013155|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110556057|NCT00663806|Ciprofloxacin|ciprofloxacin|mesh-list
110556058|NCT00663806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110556059|NCT00663806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110556060|NCT00663806|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110556061|NCT00663806|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110556062|NCT00663806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110556063|NCT00663806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110556064|NCT00663806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110556065|NCT00663806|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110556066|NCT00663806|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110556067|NCT01015339|Paclitaxel|paclitaxel|mesh-list
110556068|NCT01015339|Capecitabine|capecitabine|mesh-list
110556069|NCT01015339|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110556070|NCT01015339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110556071|NCT01015339|Tubulin Modulators|tubulin modulators|mesh-ancestor
110556072|NCT01015339|Antimitotic Agents|antimitotic agents|mesh-ancestor
110556073|NCT01015339|Mitosis Modulators|mitosis modulators|mesh-ancestor
110556074|NCT01015339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110556075|NCT01015339|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110556077|NCT05110313|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110556078|NCT05110313|Immunologic Factors|immunologic factors|mesh-ancestor
110556079|NCT05110313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110556081|NCT02622906|Hormones|hormones|mesh-ancestor
110556082|NCT02622906|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110556083|NCT02622906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110556084|NCT00673556|Alefacept|alefacept|mesh-list
110182053|NCT00022425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110182055|NCT00022464|Sirolimus|sirolimus|mesh-list
110556086|NCT00673556|Immunologic Factors|immunologic factors|mesh-ancestor
110556087|NCT00673556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110556088|NCT00675896|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110556089|NCT00675896|Antidepressive Agents|antidepressive agents|mesh-ancestor
110556090|NCT00675896|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110556091|NCT00675896|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110556092|NCT00675896|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110556093|NCT00675896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110556094|NCT00675896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110556095|NCT01015417|Amoxicillin|amoxicillin|mesh-list
110556096|NCT01015417|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
110556097|NCT01015417|Clavulanic Acids|clavulanic acids|mesh-list
110556098|NCT01015417|Clavulanic Acid|clavulanic acid|mesh-list
110556099|NCT01015417|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110556100|NCT01015417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110556101|NCT01015417|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110556102|NCT01015417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110556103|NCT01015417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110556104|NCT04061824|Olmesartan|olmesartan|mesh-list
110556105|NCT04061824|Angiotensin II|angiotensin ii|mesh-list
110556106|NCT04061824|Giapreza|giapreza|mesh-list
110556107|NCT04061824|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110556108|NCT04061824|Angiotensinogen|angiotensinogen|mesh-list
110556109|NCT04061824|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
110556110|NCT04061824|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110556111|NCT04061824|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110556112|NCT04061824|Antimetabolites|antimetabolites|mesh-ancestor
110556113|NCT04061824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110556114|NCT04061824|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110556115|NCT04061824|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110556116|NCT04061824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110556117|NCT04061824|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110556118|NCT04061824|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110556119|NCT04061824|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110556120|NCT04061824|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110556121|NCT04061824|Protease Inhibitors|protease inhibitors|mesh-ancestor
110556122|NCT04212533|Vitamin D|vitamin d|mesh-list
110556123|NCT04212533|Vitamins|vitamins|mesh-ancestor
110556124|NCT04212533|Micronutrients|micronutrients|mesh-ancestor
110556125|NCT04212533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110556126|NCT04212533|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110556127|NCT04155554|Tenofovir|tenofovir|mesh-list
110556128|NCT04155554|Lamivudine|lamivudine|mesh-list
110556129|NCT04155554|Emtricitabine|emtricitabine|mesh-list
110556130|NCT04155554|Dolutegravir|dolutegravir|mesh-list
110556131|NCT04155554|Abacavir|abacavir|mesh-list
110556132|NCT04155554|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
110556133|NCT04155554|Antiviral Agents|antiviral agents|mesh-ancestor
110556134|NCT04155554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110556135|NCT04155554|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110556136|NCT04155554|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110556137|NCT04155554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110556138|NCT04155554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110556139|NCT04155554|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110154166|NCT00009802|Calcitriol|calcitriol|mesh-list
110556140|NCT04155554|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110556141|NCT04155554|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110556142|NCT04155554|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110556143|NCT00663884|Voglibose|voglibose|mesh-list
110556144|NCT00663884|Mitiglinide|mitiglinide|mesh-list
110556145|NCT00663884|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110556146|NCT00663884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110556147|NCT00663884|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
110556148|NCT00663884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110556149|NCT00663884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110556150|NCT00856206|Rilonacept|rilonacept|mesh-list
110556151|NCT00856206|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110556152|NCT03997279|Amoxicillin|amoxicillin|mesh-list
110556153|NCT03997279|Metronidazole|metronidazole|mesh-list
110556154|NCT03997279|Clarithromycin|clarithromycin|mesh-list
110556155|NCT03997279|Rabeprazole|rabeprazole|mesh-list
110556156|NCT03997279|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110556157|NCT03997279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110556158|NCT03997279|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110556159|NCT03997279|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110556160|NCT03997279|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110556161|NCT03997279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110556162|NCT03997279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110556163|NCT03997279|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110556164|NCT03997279|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110556165|NCT03997279|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110556166|NCT03997279|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110556167|NCT03997279|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110556169|NCT00920998|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110556170|NCT00920998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110556171|NCT00920998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110556172|NCT00920998|Cholinergic Agents|cholinergic agents|mesh-ancestor
110556173|NCT00920998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110556174|NCT00920998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110154258|NCT00010036|Carboplatin|carboplatin|mesh-list
110556175|NCT00920998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110556176|NCT00593112|Methylphenidate|methylphenidate|mesh-list
110556177|NCT00593112|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110556178|NCT00593112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110556179|NCT00593112|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110556180|NCT00593112|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110556181|NCT00593112|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110556182|NCT00593112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110556183|NCT00593112|Dopamine Agents|dopamine agents|mesh-ancestor
110556184|NCT00593112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110556185|NCT05323565|Dexamethasone|dexamethasone|mesh-list
110556186|NCT05323565|Dexmedetomidine|dexmedetomidine|mesh-list
110556187|NCT05323565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110556188|NCT05323565|Antiemetics|antiemetics|mesh-ancestor
110556189|NCT05323565|Autonomic Agents|autonomic agents|mesh-ancestor
110556190|NCT05323565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110556191|NCT05323565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110556192|NCT05323565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110556193|NCT05323565|Glucocorticoids|glucocorticoids|mesh-ancestor
110556194|NCT05323565|Hormones|hormones|mesh-ancestor
110556195|NCT05323565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110556196|NCT05323565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110556197|NCT05323565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110556198|NCT05323565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110556199|NCT05323565|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110556200|NCT05323565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110556202|NCT05323565|Analgesics|analgesics|mesh-ancestor
110556203|NCT05323565|Sensory System Agents|sensory system agents|mesh-ancestor
110556204|NCT05323565|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110556205|NCT05323565|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110556206|NCT05323565|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110556207|NCT05323565|Adrenergic Agents|adrenergic agents|mesh-ancestor
110556208|NCT05323565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110556209|NCT01015495|Ranibizumab|ranibizumab|mesh-list
110556210|NCT01015495|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110556211|NCT01015495|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110556212|NCT01015495|Growth Substances|growth substances|mesh-ancestor
110556213|NCT01015495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110556214|NCT01015495|Growth Inhibitors|growth inhibitors|mesh-ancestor
110556215|NCT01015495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110556216|NCT00676286|Choline|choline|mesh-list
110556217|NCT00676286|Lipotropic Agents|lipotropic agents|mesh-ancestor
110556218|NCT00676286|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110203826|NCT00162214|Dasatinib|dasatinib|mesh-list
110556219|NCT00676286|Antimetabolites|antimetabolites|mesh-ancestor
110556220|NCT00676286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110556221|NCT00676286|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110556222|NCT00676286|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110556223|NCT00676286|Nootropic Agents|nootropic agents|mesh-ancestor
110556224|NCT00699894|Ondansetron|ondansetron|mesh-list
110556225|NCT00699894|Aprepitant|aprepitant|mesh-list
110556226|NCT00699894|Antiemetics|antiemetics|mesh-ancestor
110556227|NCT00699894|Autonomic Agents|autonomic agents|mesh-ancestor
110556228|NCT00699894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110556229|NCT00699894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110556230|NCT00699894|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110556231|NCT00699894|Antipruritics|antipruritics|mesh-ancestor
110556232|NCT00699894|Dermatologic Agents|dermatologic agents|mesh-ancestor
110556233|NCT00699894|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110556234|NCT00699894|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110556235|NCT00699894|Serotonin Agents|serotonin agents|mesh-ancestor
110556236|NCT00699894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110556237|NCT00699894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110556238|NCT00699894|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110556239|NCT00664196|Hormones|hormones|mesh-list
110556240|NCT00664196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110556241|NCT00664196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110556242|NCT00616499|Gefitinib|gefitinib|mesh-list
110556243|NCT00616499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110556244|NCT00616499|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110556245|NCT00616499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110556246|NCT00616499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110556247|NCT05317936|Venetoclax|venetoclax|mesh-list
110556248|NCT05317936|Pirtobrutinib|pirtobrutinib|mesh-list
110556249|NCT05317936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110556250|NCT05317936|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110556251|NCT05317936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110556252|NCT05317936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110556253|NCT02614248|Protective Agents|protective agents|mesh-list
110556254|NCT02614248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110556255|NCT00491179|Interferons|interferons|mesh-list
110556256|NCT00491179|Ribavirin|ribavirin|mesh-list
110556257|NCT00491179|Interferon-alpha|interferon-alpha|mesh-list
110556258|NCT00491179|Interferon alpha-2|interferon alpha-2|mesh-list
110556259|NCT00491179|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110556260|NCT00491179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110556261|NCT00491179|Antiviral Agents|antiviral agents|mesh-ancestor
110556262|NCT00491179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110556263|NCT00491179|Antimetabolites|antimetabolites|mesh-ancestor
110556264|NCT00491179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110556265|NCT00491179|Immunologic Factors|immunologic factors|mesh-ancestor
110556266|NCT00491179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110556267|NCT04155476|Nitroglycerin|nitroglycerin|mesh-list
110556268|NCT04155476|Vasodilator Agents|vasodilator agents|mesh-ancestor
110556269|NCT04502095|Levofloxacin|levofloxacin|mesh-list
110556270|NCT04502095|Ofloxacin|ofloxacin|mesh-list
110556271|NCT04502095|Trimethoprim|trimethoprim|mesh-list
110556272|NCT04502095|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
110556273|NCT04502095|Nitrofurantoin|nitrofurantoin|mesh-list
110556274|NCT04502095|Clindamycin|clindamycin|mesh-list
110556275|NCT04502095|Ertapenem|ertapenem|mesh-list
110556276|NCT04502095|Sulfamethoxazole|sulfamethoxazole|mesh-list
110556277|NCT04502095|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110556278|NCT04502095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110556279|NCT04502095|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110556280|NCT04502095|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110556281|NCT04502095|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110556282|NCT04502095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110556283|NCT04502095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110556284|NCT04502095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110556285|NCT04502095|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110556286|NCT04502095|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110556287|NCT04502095|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110556288|NCT04502095|Antimalarials|antimalarials|mesh-ancestor
110556289|NCT04502095|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110556290|NCT04502095|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110556291|NCT04502095|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110556292|NCT04502095|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110556293|NCT04502095|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
110556295|NCT00674102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110556296|NCT00503581|Megestrol|megestrol|mesh-list
110556297|NCT00503581|Megestrol Acetate|megestrol acetate|mesh-list
110556298|NCT00503581|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110556299|NCT00503581|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110556300|NCT00503581|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110556301|NCT00503581|Contraceptive Agents|contraceptive agents|mesh-ancestor
110556302|NCT00503581|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110556303|NCT00503581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110556304|NCT00503581|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110556305|NCT00503581|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110556306|NCT00503581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110556307|NCT00503581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110556308|NCT00503581|Appetite Stimulants|appetite stimulants|mesh-ancestor
110556309|NCT00503581|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110556310|NCT00677144|Capecitabine|capecitabine|mesh-list
110556311|NCT00677144|Oxaliplatin|oxaliplatin|mesh-list
110556312|NCT00677144|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110556313|NCT00677144|Antimetabolites|antimetabolites|mesh-ancestor
110556314|NCT00677144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110556315|NCT00677144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110556316|NCT00703534|Lesogaberan|lesogaberan|mesh-list
110556317|NCT00703534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110556318|NCT00703534|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
110556319|NCT00703534|GABA Agonists|gaba agonists|mesh-ancestor
110556320|NCT00703534|GABA Agents|gaba agents|mesh-ancestor
110556321|NCT00703534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110556322|NCT00703534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110556323|NCT00703534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110556324|NCT00503425|Rituximab|rituximab|mesh-list
110556325|NCT00503425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110556326|NCT00503425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110556327|NCT00503425|Immunologic Factors|immunologic factors|mesh-ancestor
110556328|NCT00503425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110556329|NCT00503425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110556330|NCT00863772|Tanezumab|tanezumab|mesh-list
110556331|NCT00863772|Analgesics|analgesics|mesh-ancestor
110556332|NCT00863772|Sensory System Agents|sensory system agents|mesh-ancestor
110556333|NCT00863772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110556334|NCT00863772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110556335|NCT01010425|Hormones|hormones|mesh-list
110556336|NCT01010425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110556337|NCT01010425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110556338|NCT00677300|Ritonavir|ritonavir|mesh-list
110556339|NCT00677300|Darunavir|darunavir|mesh-list
110556340|NCT00677300|Tenofovir|tenofovir|mesh-list
110556341|NCT00677300|Emtricitabine|emtricitabine|mesh-list
110556342|NCT00677300|Raltegravir Potassium|raltegravir potassium|mesh-list
110556343|NCT00677300|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110556344|NCT00677300|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110556345|NCT00677300|Protease Inhibitors|protease inhibitors|mesh-ancestor
110556346|NCT00677300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110556347|NCT00677300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110556348|NCT00677300|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110556349|NCT00677300|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110556350|NCT00677300|Antiviral Agents|antiviral agents|mesh-ancestor
110556351|NCT00677300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110556352|NCT00677300|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110556353|NCT00677300|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110556354|NCT00677300|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110556355|NCT00677300|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110556356|NCT00677300|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110556357|NCT00677300|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110556358|NCT02628392|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110556359|NCT02628392|Firuglipel|firuglipel|mesh-list
110556360|NCT02628392|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110556361|NCT02628392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110556362|NCT02628392|Incretins|incretins|mesh-ancestor
110556363|NCT02628392|Hormones|hormones|mesh-ancestor
110556364|NCT02628392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110556365|NCT02628392|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110556366|NCT02628392|Protease Inhibitors|protease inhibitors|mesh-ancestor
110556367|NCT02628392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110556368|NCT02628392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110556369|NCT00664586|Masoprocol|masoprocol|mesh-list
110556371|NCT00664586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110556372|NCT00664586|Protective Agents|protective agents|mesh-ancestor
110556373|NCT00664586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110556374|NCT00664586|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
110556375|NCT00664586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110556376|NCT00664586|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110556377|NCT00664586|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110556378|NCT00664586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110556379|NCT00664586|Analgesics|analgesics|mesh-ancestor
110556380|NCT00664586|Sensory System Agents|sensory system agents|mesh-ancestor
110556381|NCT00664586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110556382|NCT00664586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110556383|NCT00664586|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110556384|NCT00502801|Doripenem|doripenem|mesh-list
110556385|NCT00502801|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110556386|NCT00502801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110556387|NCT04154852|Folic Acid|folic acid|mesh-list
110556388|NCT04154852|Adalimumab|adalimumab|mesh-list
110556389|NCT04154852|Methotrexate|methotrexate|mesh-list
110556390|NCT04154852|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110556391|NCT04154852|Abortifacient Agents|abortifacient agents|mesh-ancestor
110556392|NCT04154852|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110556393|NCT04154852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110556394|NCT04154852|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110556395|NCT04154852|Antimetabolites|antimetabolites|mesh-ancestor
110556396|NCT04154852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110556397|NCT04154852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110556398|NCT04154852|Dermatologic Agents|dermatologic agents|mesh-ancestor
110556399|NCT04154852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110556400|NCT04154852|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110556401|NCT04154852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110556402|NCT04154852|Immunologic Factors|immunologic factors|mesh-ancestor
110556403|NCT04154852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110556404|NCT04154852|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110556405|NCT04154852|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110556406|NCT04154852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110556407|NCT04154852|Hematinics|hematinics|mesh-ancestor
110556408|NCT04154852|Vitamin B Complex|vitamin b complex|mesh-ancestor
110556409|NCT04154852|Vitamins|vitamins|mesh-ancestor
110556410|NCT04154852|Micronutrients|micronutrients|mesh-ancestor
110556411|NCT00921154|Ivermectin|ivermectin|mesh-list
110556412|NCT00921154|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110556413|NCT00921154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110556414|NCT01015651|Remifentanil|remifentanil|mesh-list
110556415|NCT01015651|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110556416|NCT01015651|Narcotics|narcotics|mesh-ancestor
110556417|NCT01015651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110556418|NCT01015651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110556419|NCT01015651|Analgesics|analgesics|mesh-ancestor
110556420|NCT01015651|Sensory System Agents|sensory system agents|mesh-ancestor
110556421|NCT01015651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110556422|NCT00674414|Trastuzumab|trastuzumab|mesh-list
110556423|NCT00674414|Everolimus|everolimus|mesh-list
110556424|NCT00674414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110312615|NCT00326352|Narcotics|narcotics|mesh-ancestor
110556425|NCT00674414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110556426|NCT00674414|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110556427|NCT00674414|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110556428|NCT00674414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110556429|NCT00674414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110556430|NCT00674414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110556431|NCT00674414|Immunologic Factors|immunologic factors|mesh-ancestor
110556432|NCT00674414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110556433|NCT05570422|Cisplatin|cisplatin|mesh-list
110556434|NCT05570422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110556435|NCT05272930|Dienogest|dienogest|mesh-list
110556436|NCT05272930|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110556437|NCT05272930|Contraceptive Agents|contraceptive agents|mesh-ancestor
110556438|NCT05272930|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110556439|NCT05272930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110556440|NCT05272930|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110556441|NCT05272930|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110204041|NCT00163072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110556442|NCT05272930|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110556443|NCT05272930|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110556444|NCT05272930|Hormone Antagonists|hormone antagonists|mesh-ancestor
110556445|NCT05272930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110556446|NCT05272930|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110556447|NCT05272930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110556448|NCT00855894|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110556449|NCT00855894|Pertuzumab|pertuzumab|mesh-list
110556450|NCT00855894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110556451|NCT00855894|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110556452|NCT00855894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110182137|NCT00022737|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110556453|NCT00855894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110556454|NCT00855894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110556455|NCT02566096|Morphine|morphine|mesh-list
110556456|NCT02566096|Bupivacaine|bupivacaine|mesh-list
110556457|NCT02566096|Anesthetics, Local|anesthetics, local|mesh-list
110556458|NCT02566096|Anesthetics|anesthetics|mesh-list
110556459|NCT02566096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110556460|NCT02566096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110556461|NCT02566096|Sensory System Agents|sensory system agents|mesh-ancestor
110556462|NCT02566096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110556463|NCT02566096|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110556464|NCT02566096|Narcotics|narcotics|mesh-ancestor
110556465|NCT02566096|Analgesics|analgesics|mesh-ancestor
110556466|NCT02622594|Aminolevulinic Acid|aminolevulinic acid|mesh-list
110556467|NCT02622594|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110556468|NCT02622594|Dermatologic Agents|dermatologic agents|mesh-ancestor
110556469|NCT02628860|Ferric Compounds|ferric compounds|mesh-list
110556470|NCT02628860|Hematinics|hematinics|mesh-ancestor
110556471|NCT00708357|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
110556472|NCT00708357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110556473|NCT00708357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110556474|NCT00855738|Topiramate|topiramate|mesh-list
110556475|NCT00855738|Pregabalin|pregabalin|mesh-list
110556476|NCT00855738|Lamotrigine|lamotrigine|mesh-list
110556477|NCT00855738|Zonisamide|zonisamide|mesh-list
110556478|NCT00855738|Gabapentin|gabapentin|mesh-list
110556479|NCT00855738|Levetiracetam|levetiracetam|mesh-list
110556480|NCT00855738|Tiagabine|tiagabine|mesh-list
110556481|NCT00855738|Analgesics|analgesics|mesh-ancestor
110556482|NCT00855738|Sensory System Agents|sensory system agents|mesh-ancestor
110556483|NCT00855738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110556484|NCT00855738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110556485|NCT00855738|Anticonvulsants|anticonvulsants|mesh-ancestor
110556486|NCT00855738|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110556487|NCT00855738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110556488|NCT00855738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110556489|NCT00855738|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110556490|NCT00855738|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110556491|NCT00855738|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110556492|NCT00855738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110556493|NCT00855738|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110556494|NCT00855738|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110556495|NCT00855738|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110556496|NCT00855738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110556498|NCT00855738|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110556499|NCT00855738|Nootropic Agents|nootropic agents|mesh-ancestor
110556500|NCT00855738|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110556501|NCT00855738|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110556502|NCT00855738|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
110556503|NCT00855738|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110556504|NCT00855738|GABA Agents|gaba agents|mesh-ancestor
110556505|NCT02628002|Regadenoson|regadenoson|mesh-list
110556506|NCT02628002|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
110556507|NCT02628002|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
110556508|NCT02628002|Purinergic Agonists|purinergic agonists|mesh-ancestor
110556509|NCT02628002|Purinergic Agents|purinergic agents|mesh-ancestor
110556510|NCT02628002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110182149|NCT00022737|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110556511|NCT02628002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110556512|NCT02628002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110556513|NCT00665054|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
110556514|NCT00665054|Vasodilator Agents|vasodilator agents|mesh-ancestor
110556515|NCT00665054|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110556516|NCT00665054|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110556517|NCT00665054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110556518|NCT00665054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110204118|NCT00163462|Ciclesonide|ciclesonide|mesh-list
110556519|NCT00665054|Urological Agents|urological agents|mesh-ancestor
110556520|NCT02622672|Coenzyme Q10|coenzyme q10|mesh-list
110556521|NCT02622672|Micronutrients|micronutrients|mesh-ancestor
110556522|NCT02622672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110556523|NCT02622672|Vitamins|vitamins|mesh-ancestor
110556524|NCT04152356|Sorafenib|sorafenib|mesh-list
110556525|NCT04152356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110556526|NCT04152356|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110556527|NCT04152356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110556528|NCT04152356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110556529|NCT04271956|Tislelizumab|tislelizumab|mesh-list
110556530|NCT04271956|Zanubrutinib|zanubrutinib|mesh-list
110556531|NCT04271956|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110556532|NCT04271956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110556533|NCT04271956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110556534|NCT04271956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110556535|NCT04271956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110556536|NCT02628080|Atovaquone|atovaquone|mesh-list
110556537|NCT02628080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110556538|NCT02628080|Antimalarials|antimalarials|mesh-ancestor
110556539|NCT02628080|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110556540|NCT02628080|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110556541|NCT02628080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110556542|NCT02628080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110556543|NCT00678236|Gentamicins|gentamicins|mesh-list
110556544|NCT00678236|Cimetidine|cimetidine|mesh-list
110556545|NCT00678236|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110556546|NCT00678236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110556547|NCT00678236|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110556548|NCT00678236|Histamine Antagonists|histamine antagonists|mesh-ancestor
110556549|NCT00678236|Histamine Agents|histamine agents|mesh-ancestor
110556550|NCT00678236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110556551|NCT00678236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110556552|NCT00678236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110556553|NCT00678236|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110556554|NCT00678236|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110556555|NCT00678236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110556556|NCT00678236|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110556557|NCT00678236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110155353|NCT00016744|Estrogens|estrogens|mesh-ancestor
110556558|NCT00678236|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110556559|NCT00678314|Ropivacaine|ropivacaine|mesh-list
110556560|NCT00678314|Anesthetics, Local|anesthetics, local|mesh-ancestor
110182168|NCT00022893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110556561|NCT00678314|Anesthetics|anesthetics|mesh-ancestor
110556562|NCT00678314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110556563|NCT00678314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110556564|NCT00678314|Sensory System Agents|sensory system agents|mesh-ancestor
110556565|NCT00678314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110556566|NCT02566720|Amantadine|amantadine|mesh-list
110556567|NCT02566720|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110556568|NCT02566720|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110556569|NCT02566720|Antiviral Agents|antiviral agents|mesh-ancestor
110556570|NCT02566720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110556571|NCT02566720|Dopamine Agents|dopamine agents|mesh-ancestor
110556572|NCT02566720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110556573|NCT02566720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110155400|NCT00016978|Antidotes|antidotes|mesh-ancestor
110556574|NCT02566720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110556575|NCT02566720|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110556576|NCT02566720|Analgesics|analgesics|mesh-ancestor
110556577|NCT02566720|Sensory System Agents|sensory system agents|mesh-ancestor
110556578|NCT02566720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110556579|NCT00675194|Capecitabine|capecitabine|mesh-list
110556580|NCT00675194|Irinotecan|irinotecan|mesh-list
110556581|NCT00675194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110556582|NCT00675194|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110556583|NCT00675194|Antimetabolites|antimetabolites|mesh-ancestor
110556584|NCT00675194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110556585|NCT00675194|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110556586|NCT00675194|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110556587|NCT00675194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110556588|NCT00665522|Fentanyl|fentanyl|mesh-list
110155461|NCT00001482|Gabapentin|gabapentin|mesh-list
110556589|NCT00665522|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110556590|NCT00665522|Narcotics|narcotics|mesh-ancestor
110556591|NCT00665522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110556592|NCT00665522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110556593|NCT00665522|Analgesics|analgesics|mesh-ancestor
110556594|NCT00665522|Sensory System Agents|sensory system agents|mesh-ancestor
110556595|NCT00665522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110556596|NCT00665522|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110556597|NCT00665522|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110556599|NCT00665522|Anesthetics|anesthetics|mesh-ancestor
110556600|NCT00675272|Hydrocortisone|hydrocortisone|mesh-list
110556601|NCT00675272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110556602|NCT00678626|Docetaxel|docetaxel|mesh-list
110556603|NCT00678626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110556604|NCT00678626|Tubulin Modulators|tubulin modulators|mesh-ancestor
110556605|NCT00678626|Antimitotic Agents|antimitotic agents|mesh-ancestor
110556606|NCT00678626|Mitosis Modulators|mitosis modulators|mesh-ancestor
110556607|NCT00678626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110556608|NCT00678704|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
110556609|NCT00678704|Vasodilator Agents|vasodilator agents|mesh-ancestor
110556610|NCT00678704|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110556611|NCT00678704|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110556612|NCT00678704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110182211|NCT00023166|Paclitaxel|paclitaxel|mesh-list
110556613|NCT00678704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110556614|NCT00678704|Urological Agents|urological agents|mesh-ancestor
110556615|NCT00678782|Etanercept|etanercept|mesh-list
110556616|NCT00678782|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110556617|NCT00678782|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110556618|NCT00678782|Analgesics|analgesics|mesh-ancestor
110556619|NCT00678782|Sensory System Agents|sensory system agents|mesh-ancestor
110556620|NCT00678782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110556621|NCT00678782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110556622|NCT00678782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110556623|NCT00678782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110556624|NCT00678782|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110556625|NCT00678782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110556626|NCT00678782|Immunologic Factors|immunologic factors|mesh-ancestor
110556627|NCT04707352|Dapagliflozin|dapagliflozin|mesh-list
110556628|NCT04707352|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110556629|NCT04707352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110556630|NCT04707352|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110556631|NCT04707352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110556632|NCT04061200|Empagliflozin|empagliflozin|mesh-list
110556633|NCT04061200|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110556634|NCT04061200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110556635|NCT04061200|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110556636|NCT04061200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110556637|NCT00675350|Homoharringtonine|homoharringtonine|mesh-list
110556638|NCT00675350|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110556639|NCT00675350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110556640|NCT00675350|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110556641|NCT00675350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110556642|NCT00675350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110556644|NCT02565862|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110312619|NCT00419601|Fentanyl|fentanyl|mesh-list
110556645|NCT02565862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110556647|NCT04060888|Dermatologic Agents|dermatologic agents|mesh-ancestor
110556648|NCT00879398|Fesoterodine|fesoterodine|mesh-list
110556649|NCT00879398|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110556650|NCT00879398|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110556651|NCT00879398|Cholinergic Agents|cholinergic agents|mesh-ancestor
110155622|NCT00001524|Thalidomide|thalidomide|mesh-list
110556652|NCT00879398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110556653|NCT00879398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110556654|NCT00879398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110556655|NCT00879398|Urological Agents|urological agents|mesh-ancestor
110556656|NCT00679250|Cetirizine|cetirizine|mesh-list
110556657|NCT00679250|Levocetirizine|levocetirizine|mesh-list
110556658|NCT00679250|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110556659|NCT00679250|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110556660|NCT00679250|Histamine Antagonists|histamine antagonists|mesh-ancestor
110556661|NCT00679250|Histamine Agents|histamine agents|mesh-ancestor
110556662|NCT00679250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110556663|NCT00679250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110556664|NCT00679250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110556665|NCT00679250|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110556666|NCT00696436|Valsartan|valsartan|mesh-list
110556667|NCT00696436|Olmesartan|olmesartan|mesh-list
110556668|NCT00696436|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
110204262|NCT00164359|Anthelmintics|anthelmintics|mesh-ancestor
110556669|NCT00696436|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110556670|NCT00696436|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110556671|NCT00696436|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110182218|NCT00394992|Bevacizumab|bevacizumab|mesh-list
110556672|NCT00696436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110556674|NCT00878072|Antiviral Agents|antiviral agents|mesh-ancestor
110556675|NCT00878072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110556676|NCT00878072|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110556677|NCT00878072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110556678|NCT00878072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110556679|NCT00675740|Rosiglitazone|rosiglitazone|mesh-list
110556680|NCT00675740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110556681|NCT00675740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110556682|NCT03045341|Naltrexone|naltrexone|mesh-list
110556683|NCT03045341|Bupropion|bupropion|mesh-list
110556684|NCT03045341|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110556685|NCT03045341|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110556686|NCT03045341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110556687|NCT03045341|Sensory System Agents|sensory system agents|mesh-ancestor
110556688|NCT03045341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110556689|NCT03045341|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110556690|NCT03045341|Antidepressive Agents|antidepressive agents|mesh-ancestor
110556691|NCT03045341|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110556692|NCT03045341|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110556693|NCT03045341|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110556694|NCT03045341|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110556695|NCT03045341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110556696|NCT03045341|Dopamine Agents|dopamine agents|mesh-ancestor
110556697|NCT03045341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110556698|NCT03045341|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110556699|NCT03045341|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110556700|NCT03045341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110556701|NCT00679484|Candesartan|candesartan|mesh-list
110556702|NCT00679484|Candesartan cilexetil|candesartan cilexetil|mesh-list
110556703|NCT00679484|Olmesartan|olmesartan|mesh-list
110556704|NCT00679484|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
110556705|NCT00679484|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110556706|NCT00679484|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110556707|NCT00679484|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110556708|NCT00679484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110556709|NCT00679640|Candesartan|candesartan|mesh-list
110556710|NCT00679640|Candesartan cilexetil|candesartan cilexetil|mesh-list
110556711|NCT00679640|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110556712|NCT00679640|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110556713|NCT00679640|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110556714|NCT00679640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110556715|NCT00921388|Varenicline|varenicline|mesh-list
110155869|NCT05576194|Hydrogen Peroxide|hydrogen peroxide|mesh-list
110556716|NCT00921388|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110556718|NCT00921388|Cholinergic Agents|cholinergic agents|mesh-ancestor
110556719|NCT00921388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110556720|NCT00921388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110556721|NCT00921388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110556722|NCT04212065|Buprenorphine|buprenorphine|mesh-list
110556723|NCT04212065|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110556724|NCT04212065|Narcotics|narcotics|mesh-ancestor
110182227|NCT00394992|Growth Inhibitors|growth inhibitors|mesh-ancestor
110556725|NCT04212065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110556726|NCT04212065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110556727|NCT04212065|Analgesics|analgesics|mesh-ancestor
110556728|NCT04212065|Sensory System Agents|sensory system agents|mesh-ancestor
110556729|NCT04212065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110556730|NCT04212065|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110556731|NCT02627534|Anti-Infective Agents|anti-infective agents|mesh-list
110556732|NCT02627534|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110556733|NCT02627456|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
110556734|NCT02627456|Antimalarials|antimalarials|mesh-ancestor
110556735|NCT02627456|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110155925|NCT00001656|Autonomic Agents|autonomic agents|mesh-ancestor
110556736|NCT02627456|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110556737|NCT02627456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110556738|NCT00617513|Prucalopride|prucalopride|mesh-list
110556739|NCT00617513|Laxatives|laxatives|mesh-ancestor
110556740|NCT00617513|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110556741|NCT00617513|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
110556742|NCT00617513|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110556744|NCT00617513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110556745|NCT00617513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110556746|NCT00617513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110556747|NCT02627222|Vitamin A|vitamin a|mesh-list
110556748|NCT02627222|Provitamins|provitamins|mesh-list
110556749|NCT02627222|Vitamins|vitamins|mesh-ancestor
110556750|NCT02627222|Micronutrients|micronutrients|mesh-ancestor
110556751|NCT02627222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110556752|NCT00684476|Immunomodulating Agents|immunomodulating agents|mesh-list
110556753|NCT00684476|Immunologic Factors|immunologic factors|mesh-ancestor
110556754|NCT00684476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110556755|NCT00594854|Diclofenac|diclofenac|mesh-list
110556756|NCT00594854|Arthrotec|arthrotec|mesh-list
110556757|NCT00594854|Misoprostol|misoprostol|mesh-list
110556758|NCT00594854|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110556759|NCT00594854|Abortifacient Agents|abortifacient agents|mesh-ancestor
110556760|NCT00594854|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110556761|NCT00594854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110556762|NCT00594854|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110556763|NCT00594854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110556764|NCT00594854|Oxytocics|oxytocics|mesh-ancestor
110556765|NCT00594854|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110556766|NCT00594854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110556767|NCT00594854|Analgesics|analgesics|mesh-ancestor
110556768|NCT00594854|Sensory System Agents|sensory system agents|mesh-ancestor
110556769|NCT00594854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110556770|NCT00594854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110556771|NCT00594854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110556772|NCT00594854|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110556773|NCT00594854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110556774|NCT00594854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110556775|NCT00679718|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110556776|NCT00679718|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110556777|NCT00684632|Fentanyl|fentanyl|mesh-list
110556778|NCT00684632|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110556779|NCT00684632|Narcotics|narcotics|mesh-ancestor
110556780|NCT00684632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110556781|NCT00684632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110556782|NCT00684632|Analgesics|analgesics|mesh-ancestor
110556783|NCT00684632|Sensory System Agents|sensory system agents|mesh-ancestor
110556784|NCT00684632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110556785|NCT00684632|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110556786|NCT00684632|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110556787|NCT00684632|Anesthetics, General|anesthetics, general|mesh-ancestor
110556788|NCT00684632|Anesthetics|anesthetics|mesh-ancestor
110556789|NCT00855582|Tadalafil|tadalafil|mesh-list
110556790|NCT00855582|Vasodilator Agents|vasodilator agents|mesh-ancestor
110556791|NCT00855582|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110556792|NCT00855582|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110556793|NCT00855582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110556794|NCT00855582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110556795|NCT00855582|Urological Agents|urological agents|mesh-ancestor
110556796|NCT00619541|Fluorouracil|fluorouracil|mesh-list
110556798|NCT00619541|Antimetabolites|antimetabolites|mesh-ancestor
110556799|NCT00619541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110556800|NCT00619541|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110556801|NCT00619541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110556802|NCT00619541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110556803|NCT00619541|Immunologic Factors|immunologic factors|mesh-ancestor
110556804|NCT00619541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110556805|NCT00619541|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110556806|NCT00619541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110556807|NCT00680498|Ranibizumab|ranibizumab|mesh-list
110556808|NCT00680498|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110556809|NCT00680498|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110556810|NCT00680498|Growth Substances|growth substances|mesh-ancestor
110556811|NCT00680498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110556812|NCT00680498|Growth Inhibitors|growth inhibitors|mesh-ancestor
110556813|NCT00680498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110556814|NCT00684866|Albuterol|albuterol|mesh-list
110556815|NCT00684866|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110556816|NCT00684866|Autonomic Agents|autonomic agents|mesh-ancestor
110556817|NCT00684866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110156218|NCT00392431|Amiodarone|amiodarone|mesh-list
110556818|NCT00684866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110556819|NCT00684866|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110556820|NCT00684866|Respiratory System Agents|respiratory system agents|mesh-ancestor
110556822|NCT00684866|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110556823|NCT00684866|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110556824|NCT00684866|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110556825|NCT00684866|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110556826|NCT00684866|Adrenergic Agents|adrenergic agents|mesh-ancestor
110556827|NCT00684866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110556828|NCT00684866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110556829|NCT00854724|Puerarin|puerarin|mesh-list
110556830|NCT00854724|Vasodilator Agents|vasodilator agents|mesh-ancestor
110556831|NCT00619697|Insulin|insulin|mesh-list
110556832|NCT00619697|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110556833|NCT00619697|Metformin|metformin|mesh-list
110556834|NCT00619697|Insulin Glargine|insulin glargine|mesh-list
110556835|NCT00619697|Insulin Aspart|insulin aspart|mesh-list
110556836|NCT00619697|Glimepiride|glimepiride|mesh-list
110556837|NCT00619697|Biphasic Insulins|biphasic insulins|mesh-list
110156280|NCT00386984|Octreotide|octreotide|mesh-list
110556838|NCT00619697|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
110556839|NCT00619697|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110556840|NCT00619697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110556841|NCT00619697|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110556842|NCT00619697|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110556843|NCT00619697|Immunologic Factors|immunologic factors|mesh-ancestor
110556844|NCT00680654|Riociguat|riociguat|mesh-list
110556845|NCT00680654|Enzyme Activators|enzyme activators|mesh-ancestor
110556846|NCT00680654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110556847|NCT00680108|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110556848|NCT00680108|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110556849|NCT00680732|Folic Acid|folic acid|mesh-list
110556850|NCT00680732|Micronutrients|micronutrients|mesh-list
110556851|NCT00680732|Trace Elements|trace elements|mesh-list
110556852|NCT00680732|Chloroquine|chloroquine|mesh-list
110556853|NCT00680732|Pyrimethamine|pyrimethamine|mesh-list
110556854|NCT00680732|Hematinics|hematinics|mesh-ancestor
110556855|NCT00680732|Vitamin B Complex|vitamin b complex|mesh-ancestor
110556856|NCT00680732|Vitamins|vitamins|mesh-ancestor
110556857|NCT00680732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110556858|NCT00680732|Amebicides|amebicides|mesh-ancestor
110556859|NCT00680732|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110556860|NCT00680732|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110556861|NCT00680732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110556862|NCT00680732|Antimalarials|antimalarials|mesh-ancestor
110556863|NCT00680732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110556864|NCT00680732|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110556865|NCT00680732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110556866|NCT00680732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110556867|NCT00698932|Saxagliptin|saxagliptin|mesh-list
110556868|NCT00698932|Incretins|incretins|mesh-ancestor
110556869|NCT00698932|Hormones|hormones|mesh-ancestor
110556870|NCT00698932|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110556871|NCT00698932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110556872|NCT00698932|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110556874|NCT00698932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110556875|NCT00698932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110556876|NCT00698932|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110556877|NCT02566252|Cromolyn Sodium|cromolyn sodium|mesh-list
110556878|NCT02566252|Albuterol|albuterol|mesh-list
110556879|NCT02566252|Pam2CSK4 acetate and ODN M362 combination|pam2csk4 acetate and odn m362 combination|mesh-list
110556880|NCT02566252|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110556881|NCT02566252|Autonomic Agents|autonomic agents|mesh-ancestor
110556882|NCT02566252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110556883|NCT02566252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110556884|NCT02566252|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110556885|NCT02566252|Respiratory System Agents|respiratory system agents|mesh-ancestor
110556886|NCT02566252|Tocolytic Agents|tocolytic agents|mesh-ancestor
110556887|NCT02566252|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110156449|NCT00392899|Tegafur|tegafur|mesh-list
110556888|NCT02566252|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110556889|NCT02566252|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110556890|NCT02566252|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110556891|NCT02566252|Adrenergic Agents|adrenergic agents|mesh-ancestor
110556892|NCT02566252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110556893|NCT02566252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110556894|NCT02566252|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
110556895|NCT02566252|Immunologic Factors|immunologic factors|mesh-ancestor
110556896|NCT02566252|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110556897|NCT02566252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110556899|NCT00823719|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110556900|NCT00823719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110556901|NCT00823719|Immunologic Factors|immunologic factors|mesh-ancestor
110556902|NCT00823719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110556903|NCT03953170|Teduglutide|teduglutide|mesh-list
110556904|NCT03953170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110556905|NCT03953170|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110556906|NCT03953170|Protective Agents|protective agents|mesh-ancestor
110156524|NCT05633472|Vitamins|vitamins|mesh-ancestor
110556907|NCT03953170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110556908|NCT00708591|Sirolimus|sirolimus|mesh-list
110556909|NCT00708591|Ketoconazole|ketoconazole|mesh-list
110556910|NCT00708591|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110556911|NCT00708591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110556912|NCT00708591|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110556913|NCT00708591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110556914|NCT00708591|Antifungal Agents|antifungal agents|mesh-ancestor
110182271|NCT00023244|Antifungal Agents|antifungal agents|mesh-ancestor
110556915|NCT00708591|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110556916|NCT00708591|Immunologic Factors|immunologic factors|mesh-ancestor
110556917|NCT00708591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110556918|NCT00708591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110556919|NCT00708591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110556920|NCT00708591|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110156569|NCT03151486|JNJ-55308942|jnj-55308942|mesh-list
110556921|NCT00708591|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110556922|NCT00708591|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110556923|NCT00708591|Hormone Antagonists|hormone antagonists|mesh-ancestor
110556924|NCT00708591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110556925|NCT00708591|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110556926|NCT04595266|Leucovorin|leucovorin|mesh-list
110556927|NCT04595266|Bevacizumab|bevacizumab|mesh-list
110556928|NCT04595266|Fluorouracil|fluorouracil|mesh-list
110556929|NCT04595266|Oxaliplatin|oxaliplatin|mesh-list
110556930|NCT04595266|Irinotecan|irinotecan|mesh-list
110556931|NCT04595266|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110556932|NCT04595266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110556933|NCT04595266|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110556934|NCT04595266|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110556935|NCT04595266|Growth Substances|growth substances|mesh-ancestor
110556936|NCT04595266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110556937|NCT04595266|Growth Inhibitors|growth inhibitors|mesh-ancestor
110556938|NCT04595266|Antimetabolites|antimetabolites|mesh-ancestor
110556939|NCT04595266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110556940|NCT04595266|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110556941|NCT04595266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110556942|NCT04595266|Immunologic Factors|immunologic factors|mesh-ancestor
110556943|NCT04595266|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110556944|NCT04595266|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110556945|NCT04595266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110556946|NCT04595266|Antidotes|antidotes|mesh-ancestor
110556947|NCT04595266|Protective Agents|protective agents|mesh-ancestor
110556948|NCT04595266|Vitamin B Complex|vitamin b complex|mesh-ancestor
110556949|NCT04595266|Vitamins|vitamins|mesh-ancestor
110556950|NCT04595266|Micronutrients|micronutrients|mesh-ancestor
110556951|NCT00708747|Immunoglobulins|immunoglobulins|mesh-list
110556952|NCT00708747|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110556953|NCT00708747|Antibodies|antibodies|mesh-list
110556954|NCT00708747|Immunologic Factors|immunologic factors|mesh-ancestor
110556955|NCT00708747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110556956|NCT00685022|Albuterol|albuterol|mesh-list
110556957|NCT00685022|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110556958|NCT00685022|Autonomic Agents|autonomic agents|mesh-ancestor
110556959|NCT00685022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110556960|NCT00685022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110556961|NCT00685022|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110556962|NCT00685022|Respiratory System Agents|respiratory system agents|mesh-ancestor
110556963|NCT00685022|Tocolytic Agents|tocolytic agents|mesh-ancestor
110556964|NCT00685022|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110556965|NCT00685022|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110556966|NCT00685022|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110556967|NCT00685022|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110556968|NCT00685022|Adrenergic Agents|adrenergic agents|mesh-ancestor
110556969|NCT00685022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110556970|NCT00685022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110556971|NCT03787264|Venetoclax|venetoclax|mesh-list
110556972|NCT03787264|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110556973|NCT03787264|Obinutuzumab|obinutuzumab|mesh-list
110556974|NCT03787264|Acalabrutinib|acalabrutinib|mesh-list
110556975|NCT03787264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110182286|NCT00023244|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110556976|NCT03787264|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110556977|NCT03787264|Alkylating Agents|alkylating agents|mesh-ancestor
110556978|NCT03787264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110556979|NCT03787264|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110556980|NCT00822237|Vaccines|vaccines|mesh-list
110556981|NCT00822237|Immunologic Factors|immunologic factors|mesh-ancestor
110556982|NCT00822237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110556983|NCT00617747|Zolmitriptan|zolmitriptan|mesh-list
110556984|NCT00617747|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110556985|NCT00617747|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110556986|NCT00617747|Serotonin Agents|serotonin agents|mesh-ancestor
110556987|NCT00617747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110556988|NCT00617747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110156887|NCT00387413|Analgesics|analgesics|mesh-ancestor
110556989|NCT00617747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110556990|NCT00685100|Triamcinolone|triamcinolone|mesh-list
110556991|NCT00685100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110556992|NCT00685100|Glucocorticoids|glucocorticoids|mesh-ancestor
110556993|NCT00685100|Hormones|hormones|mesh-ancestor
110556994|NCT00685100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110556995|NCT00685100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110556996|NCT00708903|Moxifloxacin|moxifloxacin|mesh-list
110556997|NCT00708903|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110556998|NCT00708903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110556999|NCT00708903|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110557000|NCT00708903|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110557001|NCT00708903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110557002|NCT00708903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110557003|NCT00708903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110557004|NCT00637091|Irinotecan|irinotecan|mesh-list
110557005|NCT00637091|Cetuximab|cetuximab|mesh-list
110557006|NCT00637091|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110557007|NCT00637091|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110557008|NCT00637091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110557009|NCT00637091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110557010|NCT00637091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110557011|NCT00637091|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110557012|NCT04213391|Sulforaphane|sulforaphane|mesh-list
110156943|NCT04579757|Tislelizumab|tislelizumab|mesh-list
110557013|NCT04213391|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110557014|NCT04213391|Protective Agents|protective agents|mesh-ancestor
110557015|NCT04213391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110557016|NCT04213391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110557017|NCT00709137|Amiloride|amiloride|mesh-list
110557018|NCT00709137|Spironolactone|spironolactone|mesh-list
110557019|NCT00709137|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110557020|NCT00709137|Hormone Antagonists|hormone antagonists|mesh-ancestor
110557021|NCT00709137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110557022|NCT00709137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110557023|NCT00709137|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110557024|NCT00709137|Diuretics|diuretics|mesh-ancestor
110557025|NCT00709137|Natriuretic Agents|natriuretic agents|mesh-ancestor
110557026|NCT00709137|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
110557027|NCT00709137|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110557028|NCT00709137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110557029|NCT00709137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110557030|NCT00709137|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
110557031|NCT04150172|Rebamipide|rebamipide|mesh-list
110557032|NCT04150172|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110557033|NCT04150172|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110557034|NCT04150172|Antioxidants|antioxidants|mesh-ancestor
110557035|NCT04150172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110557036|NCT04150172|Protective Agents|protective agents|mesh-ancestor
110557037|NCT04150172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110557038|NCT04150172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110557039|NCT02325011|Fluconazole|fluconazole|mesh-list
110557040|NCT02325011|Nabiximols|nabiximols|mesh-list
110557041|NCT02325011|Dronabinol|dronabinol|mesh-list
110557042|NCT02325011|Cannabidiol|cannabidiol|mesh-list
110557043|NCT02325011|Antifungal Agents|antifungal agents|mesh-ancestor
110557044|NCT02325011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110557045|NCT02325011|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110557046|NCT02325011|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110557047|NCT02325011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110557048|NCT02325011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110557049|NCT02325011|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110557050|NCT02325011|Hormone Antagonists|hormone antagonists|mesh-ancestor
110557051|NCT02325011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110557052|NCT02325011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110557053|NCT02325011|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110557054|NCT02325011|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110557056|NCT02325011|Sensory System Agents|sensory system agents|mesh-ancestor
110557057|NCT02325011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110557058|NCT02325011|Anticonvulsants|anticonvulsants|mesh-ancestor
110557059|NCT02325011|Hallucinogens|hallucinogens|mesh-ancestor
110557060|NCT02325011|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110557061|NCT02325011|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110557062|NCT02325011|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
110157111|NCT05393505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110557063|NCT02325011|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110557064|NCT02325011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110557065|NCT02325011|Hormones|hormones|mesh-ancestor
110557066|NCT00577096|Thalidomide|thalidomide|mesh-list
110557067|NCT00577096|Dexamethasone|dexamethasone|mesh-list
110557068|NCT00577096|Cyclophosphamide|cyclophosphamide|mesh-list
110557069|NCT00577096|Melphalan|melphalan|mesh-list
110557070|NCT00577096|Cisplatin|cisplatin|mesh-list
110557071|NCT00577096|Doxorubicin|doxorubicin|mesh-list
110557072|NCT00577096|Etoposide|etoposide|mesh-list
110557073|NCT00577096|Vincristine|vincristine|mesh-list
110557074|NCT00577096|Heparin|heparin|mesh-list
110557075|NCT00577096|Calcium heparin|calcium heparin|mesh-list
110557076|NCT00577096|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
110557077|NCT00577096|Tinzaparin|tinzaparin|mesh-list
110557078|NCT00577096|Dalteparin|dalteparin|mesh-list
110557079|NCT00577096|Epoetin Alfa|epoetin alfa|mesh-list
110557080|NCT00577096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110557081|NCT00577096|Immunologic Factors|immunologic factors|mesh-ancestor
110157171|NCT04083950|Analgesics|analgesics|mesh-ancestor
110557082|NCT00577096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110557083|NCT00577096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110557084|NCT00577096|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110557085|NCT00577096|Alkylating Agents|alkylating agents|mesh-ancestor
110557086|NCT00577096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110557087|NCT00577096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110557088|NCT00577096|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110182323|NCT05359172|Hemostatics|hemostatics|mesh-ancestor
110557089|NCT00577096|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110557091|NCT00577096|Autonomic Agents|autonomic agents|mesh-ancestor
110557092|NCT00577096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110557093|NCT00577096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110557094|NCT00577096|Glucocorticoids|glucocorticoids|mesh-ancestor
110557095|NCT00577096|Hormones|hormones|mesh-ancestor
110557096|NCT00577096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110557097|NCT00577096|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110557098|NCT00577096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110557099|NCT00577096|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110557100|NCT00577096|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110557101|NCT00577096|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110557102|NCT00577096|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110557103|NCT00577096|Tubulin Modulators|tubulin modulators|mesh-ancestor
110557104|NCT00577096|Antimitotic Agents|antimitotic agents|mesh-ancestor
110557105|NCT00577096|Mitosis Modulators|mitosis modulators|mesh-ancestor
110557106|NCT00577096|Anticoagulants|anticoagulants|mesh-ancestor
110557107|NCT00577096|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110557108|NCT00577096|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110557109|NCT00577096|Hematinics|hematinics|mesh-ancestor
110557110|NCT00577096|Leprostatic Agents|leprostatic agents|mesh-ancestor
110557111|NCT00577096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110557112|NCT00577096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110557113|NCT00577096|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110557114|NCT00577096|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110557115|NCT00577096|Growth Substances|growth substances|mesh-ancestor
110557116|NCT00577096|Growth Inhibitors|growth inhibitors|mesh-ancestor
110557117|NCT02625506|Tramadol|tramadol|mesh-list
110557118|NCT02625506|Levobupivacaine|levobupivacaine|mesh-list
110557119|NCT02625506|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110557120|NCT02625506|Narcotics|narcotics|mesh-ancestor
110557121|NCT02625506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110557122|NCT02625506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110557123|NCT02625506|Analgesics|analgesics|mesh-ancestor
110557124|NCT02625506|Sensory System Agents|sensory system agents|mesh-ancestor
110557125|NCT02625506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110557126|NCT02625506|Anesthetics, Local|anesthetics, local|mesh-ancestor
110557127|NCT02625506|Anesthetics|anesthetics|mesh-ancestor
110557128|NCT04209959|Nifekalant|nifekalant|mesh-list
110557129|NCT04209959|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110557130|NCT04209803|Minoxidil|minoxidil|mesh-list
110557131|NCT04209803|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110557132|NCT04209803|Vasodilator Agents|vasodilator agents|mesh-ancestor
110557133|NCT02567032|Oxytocin|oxytocin|mesh-list
110557134|NCT02567032|Oxytocics|oxytocics|mesh-ancestor
110557135|NCT02567032|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110557136|NCT02567032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110557137|NCT00618059|Pilocarpine|pilocarpine|mesh-list
110557138|NCT00618059|Miotics|miotics|mesh-ancestor
110557139|NCT00618059|Autonomic Agents|autonomic agents|mesh-ancestor
110557140|NCT00618059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110557141|NCT00618059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110557142|NCT00618059|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
110557143|NCT00618059|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110557144|NCT00618059|Cholinergic Agents|cholinergic agents|mesh-ancestor
110557145|NCT00618059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110557146|NCT00618059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110557147|NCT00863304|Naproxen|naproxen|mesh-list
110557148|NCT00863304|Tanezumab|tanezumab|mesh-list
110557149|NCT00863304|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110557150|NCT00863304|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110557151|NCT00863304|Analgesics|analgesics|mesh-ancestor
110557152|NCT00863304|Sensory System Agents|sensory system agents|mesh-ancestor
110557153|NCT00863304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110557154|NCT00863304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110557155|NCT00863304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110557156|NCT00863304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110557157|NCT00863304|Gout Suppressants|gout suppressants|mesh-ancestor
110557158|NCT00863304|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110557159|NCT00863304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110557160|NCT00863304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110557161|NCT00695110|Methyltestosterone|methyltestosterone|mesh-list
110557162|NCT00695110|Testosterone|testosterone|mesh-list
110557163|NCT00695110|Testosterone undecanoate|testosterone undecanoate|mesh-list
110557164|NCT00695110|Testosterone enanthate|testosterone enanthate|mesh-list
110557165|NCT00695110|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
110557167|NCT00695110|Hormones|hormones|mesh-ancestor
110557168|NCT00695110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110557169|NCT00695110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110557170|NCT00695110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110557171|NCT00695110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110557172|NCT00695110|Anabolic Agents|anabolic agents|mesh-ancestor
110557173|NCT03264352|Amlodipine|amlodipine|mesh-list
110557174|NCT03264352|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110557175|NCT03264352|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110557176|NCT03264352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110557177|NCT03264352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110557178|NCT03264352|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110557179|NCT03264352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110557180|NCT03264352|Vasodilator Agents|vasodilator agents|mesh-ancestor
110557181|NCT04897919|Lumefantrine|lumefantrine|mesh-list
110557182|NCT04897919|Artemether|artemether|mesh-list
110557183|NCT04897919|Piperaquine|piperaquine|mesh-list
110557184|NCT04897919|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
110557185|NCT04897919|Artenimol|artenimol|mesh-list
110557186|NCT04897919|Antimalarials|antimalarials|mesh-ancestor
110557187|NCT04897919|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110557188|NCT04897919|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110557189|NCT04897919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110557190|NCT00594386|Rotigotine|rotigotine|mesh-list
110557191|NCT00594386|Dopamine Agonists|dopamine agonists|mesh-ancestor
110557192|NCT00594386|Dopamine Agents|dopamine agents|mesh-ancestor
110557193|NCT00594386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110557194|NCT00594386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110557195|NCT00594386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110557196|NCT04857671|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110557197|NCT04857671|Botulinum Toxins|botulinum toxins|mesh-list
110557198|NCT04857671|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110557199|NCT04857671|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110557200|NCT04857671|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110557201|NCT04857671|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110557202|NCT04857671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110557203|NCT04857671|Cholinergic Agents|cholinergic agents|mesh-ancestor
110557204|NCT04857671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110557205|NCT04857671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110557206|NCT04857671|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110557207|NCT04857671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110557208|NCT03466450|Temozolomide|temozolomide|mesh-list
110557209|NCT03466450|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110557210|NCT03466450|Alkylating Agents|alkylating agents|mesh-ancestor
110557211|NCT03466450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110557212|NCT03466450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110557213|NCT00690560|Prednisone|prednisone|mesh-list
110557214|NCT00690560|Cyclophosphamide|cyclophosphamide|mesh-list
110557215|NCT00690560|Rituximab|rituximab|mesh-list
110557216|NCT00690560|Doxorubicin|doxorubicin|mesh-list
110557217|NCT00690560|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110557218|NCT00690560|Vincristine|vincristine|mesh-list
110557219|NCT00690560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110557220|NCT00690560|Immunologic Factors|immunologic factors|mesh-ancestor
110557221|NCT00690560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110557222|NCT00690560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110557223|NCT00690560|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110557224|NCT00690560|Alkylating Agents|alkylating agents|mesh-ancestor
110557225|NCT00690560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110557226|NCT00690560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110557227|NCT00690560|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110557228|NCT00690560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110557229|NCT00690560|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110557230|NCT00690560|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110557231|NCT00690560|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110557232|NCT00690560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110557233|NCT00690560|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110557234|NCT00690560|Glucocorticoids|glucocorticoids|mesh-ancestor
110557235|NCT00690560|Hormones|hormones|mesh-ancestor
110557236|NCT00690560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110557237|NCT00690560|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110557238|NCT00690560|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110557239|NCT00690560|Tubulin Modulators|tubulin modulators|mesh-ancestor
110557240|NCT00690560|Antimitotic Agents|antimitotic agents|mesh-ancestor
110557241|NCT00690560|Mitosis Modulators|mitosis modulators|mesh-ancestor
110557242|NCT00742690|Terlipressin|terlipressin|mesh-list
110557243|NCT00742690|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110557244|NCT00742690|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110557245|NCT00742768|Vitamins|vitamins|mesh-list
110557246|NCT00742768|Vitamin K|vitamin k|mesh-list
110557247|NCT00742768|Vitamin K 2|vitamin k 2|mesh-list
110557248|NCT00742768|Micronutrients|micronutrients|mesh-ancestor
110557249|NCT00742768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110557250|NCT00742768|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110557251|NCT00742768|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110557252|NCT00742768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110557253|NCT00742768|Hemostatics|hemostatics|mesh-ancestor
110557254|NCT00742768|Coagulants|coagulants|mesh-ancestor
110557255|NCT00862992|Cariprazine|cariprazine|mesh-list
110557256|NCT00862992|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110557257|NCT00862992|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110557258|NCT00862992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110557259|NCT00862992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110557260|NCT00862992|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110557261|NCT02565316|Sertraline|sertraline|mesh-list
110557262|NCT02565316|Antidepressive Agents|antidepressive agents|mesh-ancestor
110557263|NCT02565316|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110557264|NCT02565316|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110557265|NCT02565316|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110557266|NCT02565316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110557267|NCT02565316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110557268|NCT02565316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110557269|NCT02565316|Serotonin Agents|serotonin agents|mesh-ancestor
110557270|NCT02565316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110557271|NCT00742846|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110557272|NCT00742846|Triamcinolone|triamcinolone|mesh-list
110557273|NCT00742846|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110557274|NCT00742846|Lidocaine|lidocaine|mesh-list
110557275|NCT00742846|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110557276|NCT00742846|Anesthetics, Local|anesthetics, local|mesh-ancestor
110557277|NCT00742846|Anesthetics|anesthetics|mesh-ancestor
110557278|NCT00742846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110557279|NCT00742846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110557280|NCT00742846|Sensory System Agents|sensory system agents|mesh-ancestor
110557281|NCT00742846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110557282|NCT00742846|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110557283|NCT00742846|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110557284|NCT00742846|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110557285|NCT00742846|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110157740|NCT00276055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110557286|NCT00742846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110557287|NCT00742846|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110557288|NCT00742846|Glucocorticoids|glucocorticoids|mesh-ancestor
110557289|NCT00742846|Hormones|hormones|mesh-ancestor
110557290|NCT00742846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110557291|NCT00742846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110557292|NCT00742846|Immunologic Factors|immunologic factors|mesh-ancestor
110557293|NCT00742846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110557294|NCT00690872|Carboplatin|carboplatin|mesh-list
110557295|NCT00690872|Gemcitabine|gemcitabine|mesh-list
110557296|NCT00690872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110557297|NCT00690872|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110557298|NCT00690872|Antimetabolites|antimetabolites|mesh-ancestor
110557299|NCT00690872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110557300|NCT00694096|Sunitinib|sunitinib|mesh-list
110557301|NCT00694096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110557302|NCT00694096|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110557303|NCT00694096|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110557304|NCT00694096|Growth Substances|growth substances|mesh-ancestor
110557305|NCT00694096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110557306|NCT00694096|Growth Inhibitors|growth inhibitors|mesh-ancestor
110557307|NCT00694096|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110557308|NCT00694096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110557309|NCT00694096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110557310|NCT04808531|Oxycodone|oxycodone|mesh-list
110557311|NCT04808531|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110557313|NCT04808531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110557314|NCT04808531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110557315|NCT04808531|Analgesics|analgesics|mesh-ancestor
110557316|NCT04808531|Sensory System Agents|sensory system agents|mesh-ancestor
110557317|NCT04808531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110557318|NCT00690950|Dutasteride|dutasteride|mesh-list
110557319|NCT00690950|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
110557320|NCT00690950|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110557321|NCT00690950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110557322|NCT00690950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110557323|NCT00690950|Hormone Antagonists|hormone antagonists|mesh-ancestor
110557324|NCT00690950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110557325|NCT00690950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110557326|NCT02622126|Atropine|atropine|mesh-list
110557327|NCT02622126|Ephedrine|ephedrine|mesh-list
110557328|NCT02622126|Morphine|morphine|mesh-list
110557329|NCT02622126|Bupivacaine|bupivacaine|mesh-list
110557330|NCT02622126|Anesthetics, Local|anesthetics, local|mesh-ancestor
110557331|NCT02622126|Anesthetics|anesthetics|mesh-ancestor
110557332|NCT02622126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110557333|NCT02622126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110557334|NCT02622126|Sensory System Agents|sensory system agents|mesh-ancestor
110557335|NCT02622126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110557336|NCT02622126|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110557337|NCT02622126|Narcotics|narcotics|mesh-ancestor
110557338|NCT02622126|Analgesics|analgesics|mesh-ancestor
110557339|NCT02622126|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110557340|NCT02622126|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110557341|NCT02622126|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110557342|NCT02622126|Autonomic Agents|autonomic agents|mesh-ancestor
110557343|NCT02622126|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110557344|NCT02622126|Respiratory System Agents|respiratory system agents|mesh-ancestor
110557345|NCT02622126|Mydriatics|mydriatics|mesh-ancestor
110557346|NCT02622126|Parasympatholytics|parasympatholytics|mesh-ancestor
110557347|NCT02622126|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110557348|NCT02622126|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110557349|NCT02622126|Cholinergic Agents|cholinergic agents|mesh-ancestor
110557350|NCT02622126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110557351|NCT02622126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110557352|NCT02622126|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110557353|NCT02622126|Sympathomimetics|sympathomimetics|mesh-ancestor
110557354|NCT02622126|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110557355|NCT02622126|Adrenergic Agents|adrenergic agents|mesh-ancestor
110557356|NCT04140188|Sodium Pertechnetate Tc 99m|sodium pertechnetate tc 99m|mesh-list
110557357|NCT04140188|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110557358|NCT04140188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110557360|NCT00685568|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110557361|NCT00685568|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110557362|NCT00685568|Analgesics|analgesics|mesh-ancestor
110557363|NCT00685568|Sensory System Agents|sensory system agents|mesh-ancestor
110557364|NCT00685568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110557365|NCT00685568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110557366|NCT00685568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110557367|NCT00685568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110157975|NCT03977194|Paclitaxel|paclitaxel|mesh-list
110557368|NCT00685568|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110557369|NCT00685568|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110557370|NCT00685568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110557371|NCT00685568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110557372|NCT02626208|ST 1435|st 1435|mesh-list
110557373|NCT02626208|Contraceptive Agents|contraceptive agents|mesh-list
110557374|NCT02626208|Estradiol|estradiol|mesh-list
110557375|NCT02626208|Estrogens|estrogens|mesh-ancestor
110557376|NCT02626208|Hormones|hormones|mesh-ancestor
110557377|NCT02626208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110557378|NCT02626208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110557379|NCT02626208|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110557380|NCT02626208|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110557381|NCT02626208|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110557382|NCT04210739|Betamethasone|betamethasone|mesh-list
110557383|NCT04210739|Betamethasone Valerate|betamethasone valerate|mesh-list
110557384|NCT04210739|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
110557385|NCT04210739|Betamethasone benzoate|betamethasone benzoate|mesh-list
110557386|NCT04210739|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
110557387|NCT04210739|Glucocorticoids|glucocorticoids|mesh-ancestor
110557389|NCT04210739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110557390|NCT04210739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110557391|NCT04210739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110557392|NCT04210739|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110557393|NCT04210739|Respiratory System Agents|respiratory system agents|mesh-ancestor
110557394|NCT00696540|Albuterol|albuterol|mesh-list
110557395|NCT00696540|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110557396|NCT00696540|Autonomic Agents|autonomic agents|mesh-ancestor
110158092|NCT02395705|Cisplatin|cisplatin|mesh-list
110557397|NCT00696540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110557398|NCT00696540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110557399|NCT00696540|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110557400|NCT00696540|Respiratory System Agents|respiratory system agents|mesh-ancestor
110557401|NCT00696540|Tocolytic Agents|tocolytic agents|mesh-ancestor
110557402|NCT00696540|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110557403|NCT00696540|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110557404|NCT00696540|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110557405|NCT00696540|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110557406|NCT00696540|Adrenergic Agents|adrenergic agents|mesh-ancestor
110557407|NCT00696540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110557408|NCT00696540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110557409|NCT04212845|Dexamethasone|dexamethasone|mesh-list
110557410|NCT04212845|Bupivacaine|bupivacaine|mesh-list
110557411|NCT04212845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110557412|NCT04212845|Antiemetics|antiemetics|mesh-ancestor
110557413|NCT04212845|Autonomic Agents|autonomic agents|mesh-ancestor
110557414|NCT04212845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110557415|NCT04212845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110182386|NCT00023829|Hormones|hormones|mesh-list
110557416|NCT04212845|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110557417|NCT04212845|Glucocorticoids|glucocorticoids|mesh-ancestor
110557418|NCT04212845|Hormones|hormones|mesh-ancestor
110557419|NCT04212845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110557420|NCT04212845|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110557421|NCT04212845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110557422|NCT04212845|Anesthetics, Local|anesthetics, local|mesh-ancestor
110557423|NCT04212845|Anesthetics|anesthetics|mesh-ancestor
110557424|NCT04212845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110557425|NCT04212845|Sensory System Agents|sensory system agents|mesh-ancestor
110557426|NCT00620165|Levetiracetam|levetiracetam|mesh-list
110557427|NCT00620165|Anticonvulsants|anticonvulsants|mesh-ancestor
110557428|NCT00620165|Nootropic Agents|nootropic agents|mesh-ancestor
110557429|NCT00685646|Zoledronic Acid|zoledronic acid|mesh-list
110557430|NCT00685646|Androgen Antagonists|androgen antagonists|mesh-list
110557431|NCT00685646|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110557432|NCT00685646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110557433|NCT00685646|Hormone Antagonists|hormone antagonists|mesh-ancestor
110158213|NCT00084097|Omalizumab|omalizumab|mesh-list
110557434|NCT00685646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110557435|NCT00685958|Enoxaparin|enoxaparin|mesh-list
110557436|NCT00685958|Anticoagulants|anticoagulants|mesh-ancestor
110557437|NCT00685958|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110557438|NCT00685958|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110557439|NCT00685958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110557440|NCT04138472|Lidocaine|lidocaine|mesh-list
110557441|NCT04138472|Fentanyl|fentanyl|mesh-list
110557442|NCT04138472|Dexmedetomidine|dexmedetomidine|mesh-list
110557443|NCT04138472|Anesthetics, Local|anesthetics, local|mesh-ancestor
110557444|NCT04138472|Anesthetics|anesthetics|mesh-ancestor
110557445|NCT04138472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110557446|NCT04138472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110557447|NCT04138472|Sensory System Agents|sensory system agents|mesh-ancestor
110557448|NCT04138472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110557449|NCT04138472|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110557450|NCT04138472|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110557451|NCT04138472|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110557452|NCT04138472|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110557453|NCT04138472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110557454|NCT04138472|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110557455|NCT04138472|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110557456|NCT04138472|Analgesics|analgesics|mesh-ancestor
110557457|NCT04138472|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110557458|NCT04138472|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110557459|NCT04138472|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110557460|NCT04138472|Adrenergic Agents|adrenergic agents|mesh-ancestor
110557461|NCT04138472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110557462|NCT04138472|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110557463|NCT04138472|Narcotics|narcotics|mesh-ancestor
110557464|NCT04138472|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110557465|NCT04138472|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110557466|NCT04138472|Anesthetics, General|anesthetics, general|mesh-ancestor
110557467|NCT00620789|Dexetimide|dexetimide|mesh-list
110557468|NCT00620789|Citalopram|citalopram|mesh-list
110557469|NCT00620789|Antidepressive Agents|antidepressive agents|mesh-list
110557470|NCT00620789|Escitalopram|escitalopram|mesh-list
110557471|NCT00620789|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110557472|NCT00620789|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110557473|NCT00620789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110557474|NCT00620789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110557475|NCT00620789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110557476|NCT00620789|Serotonin Agents|serotonin agents|mesh-ancestor
110557477|NCT00620789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110557478|NCT00620789|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110557479|NCT00620789|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110557480|NCT00620789|Parasympatholytics|parasympatholytics|mesh-ancestor
110557481|NCT00620789|Autonomic Agents|autonomic agents|mesh-ancestor
110557482|NCT00620789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110557483|NCT00620789|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110557484|NCT00620789|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110158393|NCT00400114|Irinotecan|irinotecan|mesh-list
110557485|NCT00620789|Cholinergic Agents|cholinergic agents|mesh-ancestor
110557486|NCT00620789|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110557487|NCT00620789|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110557488|NCT00691184|Terbinafine|terbinafine|mesh-list
110557489|NCT00691184|Antifungal Agents|antifungal agents|mesh-ancestor
110557490|NCT00691184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110557491|NCT00691184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110557492|NCT00691184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110557493|NCT00854100|Cariprazine|cariprazine|mesh-list
110158446|NCT00085345|Ascorbic Acid|ascorbic acid|mesh-list
110557494|NCT00854100|Antidepressive Agents|antidepressive agents|mesh-list
110557495|NCT00854100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110205114|NCT00169156|Glucocorticoids|glucocorticoids|mesh-ancestor
110557496|NCT00854100|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110557497|NCT00854100|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110557498|NCT00854100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110557499|NCT00854100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110557500|NCT00691262|Tacrolimus|tacrolimus|mesh-list
110557501|NCT00691262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110557502|NCT00691262|Immunologic Factors|immunologic factors|mesh-ancestor
110557503|NCT00691262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110557504|NCT00691262|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110557505|NCT00691262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110557506|NCT00691262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110557507|NCT00620867|Ibuprofen|ibuprofen|mesh-list
110557508|NCT00620867|Celecoxib|celecoxib|mesh-list
110557509|NCT00620867|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110557510|NCT00620867|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110557511|NCT00620867|Analgesics|analgesics|mesh-ancestor
110557512|NCT00620867|Sensory System Agents|sensory system agents|mesh-ancestor
110557513|NCT00620867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110557514|NCT00620867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110557515|NCT00620867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110557516|NCT00620867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110557517|NCT00620867|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110557518|NCT00620867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110557519|NCT00620867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110557520|NCT00620867|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110557521|NCT04271917|Acetaminophen|acetaminophen|mesh-list
110557522|NCT04271917|Ibuprofen|ibuprofen|mesh-list
110557523|NCT04271917|Cannabidiol|cannabidiol|mesh-list
110557524|NCT04271917|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110557525|NCT04271917|Analgesics|analgesics|mesh-ancestor
110557526|NCT04271917|Sensory System Agents|sensory system agents|mesh-ancestor
110557527|NCT04271917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110557528|NCT04271917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110557529|NCT04271917|Antipyretics|antipyretics|mesh-ancestor
110557530|NCT04271917|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110557531|NCT04271917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110557532|NCT04271917|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110557533|NCT04271917|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110557534|NCT04271917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110557535|NCT04271917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110557536|NCT04271917|Anticonvulsants|anticonvulsants|mesh-ancestor
110557537|NCT04122222|Vaccines|vaccines|mesh-list
110158641|NCT04784637|Insulin|insulin|mesh-list
110557538|NCT04122222|Immunologic Factors|immunologic factors|mesh-ancestor
110557539|NCT04122222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110557540|NCT00686114|Paclitaxel|paclitaxel|mesh-list
110557541|NCT00686114|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110557542|NCT00686114|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110557543|NCT00686114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110557544|NCT00686114|Tubulin Modulators|tubulin modulators|mesh-ancestor
110557545|NCT00686114|Antimitotic Agents|antimitotic agents|mesh-ancestor
110557546|NCT00686114|Mitosis Modulators|mitosis modulators|mesh-ancestor
110557547|NCT00686114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110557548|NCT00686114|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110557549|NCT00686114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110557550|NCT01015729|Esomeprazole|esomeprazole|mesh-list
110557551|NCT01015729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110557552|NCT01015729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110557553|NCT01015729|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110557554|NCT01015729|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110557555|NCT01015729|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110557556|NCT00698724|Prednisolone acetate|prednisolone acetate|mesh-list
110557557|NCT00698724|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110557558|NCT00698724|Methylprednisolone|methylprednisolone|mesh-list
110557559|NCT00698724|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110557560|NCT00698724|Prednisolone|prednisolone|mesh-list
110557561|NCT00698724|Bromfenac|bromfenac|mesh-list
110557562|NCT00698724|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110557563|NCT00698724|Prednisolone phosphate|prednisolone phosphate|mesh-list
110557564|NCT00698724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110557566|NCT00698724|Autonomic Agents|autonomic agents|mesh-ancestor
110557567|NCT00698724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110557568|NCT00698724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110557569|NCT00698724|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110557570|NCT00698724|Glucocorticoids|glucocorticoids|mesh-ancestor
110557571|NCT00698724|Hormones|hormones|mesh-ancestor
110557572|NCT00698724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110557573|NCT00698724|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110557574|NCT00698724|Protective Agents|protective agents|mesh-ancestor
110557575|NCT00698724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110557576|NCT00698724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110557577|NCT00698724|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110557578|NCT00698724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110557579|NCT00698724|Analgesics|analgesics|mesh-ancestor
110557580|NCT00698724|Sensory System Agents|sensory system agents|mesh-ancestor
110557581|NCT00698724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110557582|NCT00686192|Calcium Carbonate|calcium carbonate|mesh-list
110557583|NCT00686192|Calcium|calcium|mesh-list
110557584|NCT00686192|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110557585|NCT00686192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110557586|NCT00686192|Antacids|antacids|mesh-ancestor
110557587|NCT00686192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110557588|NCT00686192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110557589|NCT04117776|Chlorhexidine|chlorhexidine|mesh-list
110557590|NCT04117776|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110557591|NCT04117776|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110557592|NCT04117776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110557593|NCT04117776|Disinfectants|disinfectants|mesh-ancestor
110557594|NCT04117776|Dermatologic Agents|dermatologic agents|mesh-ancestor
110557595|NCT00922610|Epoetin Alfa|epoetin alfa|mesh-list
110557596|NCT00922610|Hematinics|hematinics|mesh-ancestor
110557597|NCT04117698|Ethambutol|ethambutol|mesh-list
110557598|NCT04117698|Antitubercular Agents|antitubercular agents|mesh-ancestor
110557599|NCT04117698|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110557600|NCT04117698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110557601|NCT04118322|Peppermint oil|peppermint oil|mesh-list
110557602|NCT04118322|Antiemetics|antiemetics|mesh-ancestor
110557603|NCT04118322|Autonomic Agents|autonomic agents|mesh-ancestor
110557604|NCT04118322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110557605|NCT04118322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110557606|NCT04118322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110557607|NCT04118322|Parasympatholytics|parasympatholytics|mesh-ancestor
110557608|NCT00698802|Insulin|insulin|mesh-list
110557609|NCT00698802|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110557610|NCT00698802|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110557611|NCT00698802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110557612|NCT00621647|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110557613|NCT00621647|Antidepressive Agents|antidepressive agents|mesh-ancestor
110557614|NCT00621647|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110557615|NCT00621647|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110557616|NCT00621647|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110557617|NCT00621647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110557618|NCT00621647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110557619|NCT02621970|Cisplatin|cisplatin|mesh-list
110557620|NCT02621970|Docetaxel|docetaxel|mesh-list
110557621|NCT02621970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110557622|NCT02621970|Tubulin Modulators|tubulin modulators|mesh-ancestor
110557623|NCT02621970|Antimitotic Agents|antimitotic agents|mesh-ancestor
110557624|NCT02621970|Mitosis Modulators|mitosis modulators|mesh-ancestor
110557625|NCT02621970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110557626|NCT00820755|Cetuximab|cetuximab|mesh-list
110557627|NCT00820755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110557628|NCT00820755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110557629|NCT00700128|Frovatriptan|frovatriptan|mesh-list
110557630|NCT00700128|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110557631|NCT00700128|Serotonin Agents|serotonin agents|mesh-ancestor
110557632|NCT00700128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110557633|NCT00700128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110557634|NCT00700128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110557635|NCT04662515|Warfarin|warfarin|mesh-list
110557636|NCT04662515|Rivaroxaban|rivaroxaban|mesh-list
110557637|NCT04662515|Dabigatran|dabigatran|mesh-list
110557638|NCT04662515|Apixaban|apixaban|mesh-list
110557639|NCT04662515|Edoxaban|edoxaban|mesh-list
110557640|NCT04662515|Anticoagulants|anticoagulants|mesh-ancestor
110557641|NCT04662515|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110557642|NCT04662515|Antithrombins|antithrombins|mesh-ancestor
110557643|NCT04662515|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110557644|NCT04662515|Protease Inhibitors|protease inhibitors|mesh-ancestor
110205252|NCT00170404|Hematinics|hematinics|mesh-ancestor
110557645|NCT04662515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110557646|NCT04662515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110557647|NCT04660097|Etoposide|etoposide|mesh-list
110557648|NCT04660097|Etoposide phosphate|etoposide phosphate|mesh-list
110557650|NCT04660097|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110557651|NCT04660097|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110557652|NCT04660097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110557653|NCT04660097|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110557654|NCT04660097|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110557655|NCT04660097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110557656|NCT04660097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110557657|NCT04660097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110557658|NCT04660097|Immunologic Factors|immunologic factors|mesh-ancestor
110557659|NCT04660097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110557660|NCT00621101|Sirolimus|sirolimus|mesh-list
110557661|NCT00621101|Temsirolimus|temsirolimus|mesh-list
110557662|NCT00621101|MTOR Inhibitors|mtor inhibitors|mesh-list
110557663|NCT00621101|Ezetimibe|ezetimibe|mesh-list
110557664|NCT00621101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110557665|NCT00621101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110557666|NCT00621101|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110557667|NCT00621101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110557668|NCT00621101|Antifungal Agents|antifungal agents|mesh-ancestor
110557669|NCT00621101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110557670|NCT00621101|Immunologic Factors|immunologic factors|mesh-ancestor
110557671|NCT00621101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110159048|NCT00089050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110557672|NCT00621101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110557673|NCT00621101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110557674|NCT00621101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110557675|NCT00621101|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110557676|NCT00621101|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110557677|NCT00621101|Antimetabolites|antimetabolites|mesh-ancestor
110557678|NCT00621101|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110557680|NCT00709215|Pentostatin|pentostatin|mesh-list
110557681|NCT00709215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110557682|NCT00709215|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
110557683|NCT00709215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110557684|NCT00709215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110557685|NCT00709215|Antifungal Agents|antifungal agents|mesh-ancestor
110557686|NCT00709215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110557687|NCT00699036|Metformin|metformin|mesh-list
110557688|NCT00699036|Rosiglitazone|rosiglitazone|mesh-list
110557689|NCT00699036|Losartan|losartan|mesh-list
110557690|NCT00699036|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110557691|NCT00699036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110557692|NCT00699036|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110557693|NCT00699036|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110557694|NCT00699036|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110557695|NCT00699036|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110557696|NCT00699036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110557697|NCT00709293|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110557698|NCT00709293|Immunologic Factors|immunologic factors|mesh-ancestor
110557699|NCT00709293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110557700|NCT00709293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110557701|NCT00819741|Metformin|metformin|mesh-list
110557702|NCT00819741|Repaglinide|repaglinide|mesh-list
110557703|NCT00819741|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110182402|NCT00023868|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110557704|NCT00819741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110557705|NCT04208555|Terconazole|terconazole|mesh-list
110557706|NCT04208555|Antifungal Agents|antifungal agents|mesh-ancestor
110557707|NCT04208555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110557708|NCT00621725|Cediranib|cediranib|mesh-list
110557709|NCT00621725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110557710|NCT00621725|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110557711|NCT00621725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110557712|NCT00621725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110557713|NCT00862134|Docetaxel|docetaxel|mesh-list
110557714|NCT00862134|Lenograstim|lenograstim|mesh-list
110557715|NCT00862134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110557716|NCT00862134|Tubulin Modulators|tubulin modulators|mesh-ancestor
110557717|NCT00862134|Antimitotic Agents|antimitotic agents|mesh-ancestor
110557718|NCT00862134|Mitosis Modulators|mitosis modulators|mesh-ancestor
110557719|NCT00862134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110557720|NCT00862134|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110557721|NCT00862134|Immunologic Factors|immunologic factors|mesh-ancestor
110557722|NCT00862134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110557723|NCT00700284|Dapivirine|dapivirine|mesh-list
110557724|NCT00700284|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110557725|NCT00700284|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110557726|NCT00700284|Antiviral Agents|antiviral agents|mesh-ancestor
110557727|NCT00700284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110557729|NCT00618527|Interferon-beta|interferon-beta|mesh-list
110557730|NCT00618527|Interferon beta-1a|interferon beta-1a|mesh-list
110557731|NCT00618527|Mycophenolic Acid|mycophenolic acid|mesh-list
110557732|NCT00618527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110557733|NCT00618527|Antiviral Agents|antiviral agents|mesh-ancestor
110557734|NCT00618527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110557735|NCT00618527|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110557736|NCT00618527|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110557737|NCT00618527|Antitubercular Agents|antitubercular agents|mesh-ancestor
110557738|NCT00618527|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110557739|NCT00618527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110557740|NCT00618527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110557741|NCT00618527|Immunologic Factors|immunologic factors|mesh-ancestor
110557742|NCT00618527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110557743|NCT00618527|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110557744|NCT02691533|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
110557745|NCT02691533|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
110557746|NCT02691533|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
110557747|NCT02691533|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110557748|NCT00621881|Naproxen-n-butyl nitrate|naproxen-n-butyl nitrate|mesh-list
110557749|NCT00621881|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
110557750|NCT00621881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110557751|NCT04115982|Cholecalciferol|cholecalciferol|mesh-list
110557752|NCT04115982|Vitamin D|vitamin d|mesh-list
110557753|NCT04115982|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110557754|NCT04115982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110557755|NCT04115982|Vitamins|vitamins|mesh-ancestor
110557756|NCT04115982|Micronutrients|micronutrients|mesh-ancestor
110557757|NCT04115982|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110557758|NCT00622037|Lubricant Eye Drops|lubricant eye drops|mesh-list
110557759|NCT00622037|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110557760|NCT00622037|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110557761|NCT01010581|Folic Acid|folic acid|mesh-list
110557762|NCT01010581|Methotrexate|methotrexate|mesh-list
110557763|NCT01010581|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110557764|NCT01010581|Abortifacient Agents|abortifacient agents|mesh-ancestor
110557765|NCT01010581|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110557766|NCT01010581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110557767|NCT01010581|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110557768|NCT01010581|Antimetabolites|antimetabolites|mesh-ancestor
110557769|NCT01010581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110557770|NCT01010581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110557771|NCT01010581|Dermatologic Agents|dermatologic agents|mesh-ancestor
110557772|NCT01010581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110557773|NCT01010581|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110557774|NCT01010581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110557775|NCT01010581|Immunologic Factors|immunologic factors|mesh-ancestor
110557776|NCT01010581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110557777|NCT01010581|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110557779|NCT01010581|Vitamin B Complex|vitamin b complex|mesh-ancestor
110557780|NCT01010581|Vitamins|vitamins|mesh-ancestor
110557781|NCT01010581|Micronutrients|micronutrients|mesh-ancestor
110557782|NCT04382885|Cariprazine|cariprazine|mesh-list
110557783|NCT04382885|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110557784|NCT04382885|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110557785|NCT04382885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110557786|NCT04382885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110557787|NCT04382885|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110557788|NCT04208945|Colistin|colistin|mesh-list
110557789|NCT04208945|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110557790|NCT04208945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110557791|NCT01016041|Paclitaxel|paclitaxel|mesh-list
110557792|NCT01016041|Everolimus|everolimus|mesh-list
110159489|NCT00091936|Lamivudine|lamivudine|mesh-list
110557793|NCT01016041|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110557794|NCT01016041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110557795|NCT01016041|Tubulin Modulators|tubulin modulators|mesh-ancestor
110557796|NCT01016041|Antimitotic Agents|antimitotic agents|mesh-ancestor
110557797|NCT01016041|Mitosis Modulators|mitosis modulators|mesh-ancestor
110557798|NCT01016041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110557799|NCT01016041|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110557800|NCT01016041|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110557801|NCT01016041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110557802|NCT01016041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110557803|NCT01016041|Immunologic Factors|immunologic factors|mesh-ancestor
110557804|NCT01016041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110557806|NCT00622115|Anticoagulants|anticoagulants|mesh-ancestor
110557807|NCT00622115|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110557808|NCT00622115|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110557809|NCT00622115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110557810|NCT02696837|Rocuronium|rocuronium|mesh-list
110557811|NCT02696837|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110557812|NCT02696837|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110557813|NCT02696837|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110557814|NCT02696837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110557815|NCT02696837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110557816|NCT00490555|Methyltestosterone|methyltestosterone|mesh-list
110557817|NCT00490555|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
110557818|NCT00490555|Medroxyprogesterone|medroxyprogesterone|mesh-list
110557819|NCT00490555|Testosterone|testosterone|mesh-list
110557820|NCT00490555|Testosterone undecanoate|testosterone undecanoate|mesh-list
110557821|NCT00490555|Testosterone enanthate|testosterone enanthate|mesh-list
110557822|NCT00490555|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
110557823|NCT00490555|Dutasteride|dutasteride|mesh-list
110557824|NCT00490555|Androgens|androgens|mesh-ancestor
110557825|NCT00490555|Hormones|hormones|mesh-ancestor
110557826|NCT00490555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110557827|NCT00490555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110557828|NCT00490555|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110557829|NCT00490555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110557830|NCT00490555|Anabolic Agents|anabolic agents|mesh-ancestor
110557831|NCT00490555|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
110557832|NCT00490555|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110557833|NCT00490555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110557834|NCT00490555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110557835|NCT00490555|Hormone Antagonists|hormone antagonists|mesh-ancestor
110557836|NCT00490555|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110159595|NCT00093184|Bivalirudin|bivalirudin|mesh-list
110557837|NCT00490555|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110557838|NCT00490555|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110557839|NCT00490555|Contraceptive Agents|contraceptive agents|mesh-ancestor
110557840|NCT00490555|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110557841|NCT00490555|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110557842|NCT00490555|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110557843|NCT00490555|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110557844|NCT01014247|Moxifloxacin|moxifloxacin|mesh-list
110557845|NCT01014247|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
110557846|NCT01014247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110557847|NCT01014247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110557848|NCT01014247|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110557849|NCT01014247|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110557850|NCT01014247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110557851|NCT01014247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110557852|NCT01014247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110557853|NCT01014247|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110557854|NCT01014247|Contraceptive Agents|contraceptive agents|mesh-ancestor
110557855|NCT01014247|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110557856|NCT01014247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110557857|NCT01014247|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110557858|NCT01014247|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110557859|NCT01014247|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110557860|NCT00049595|Prednisone|prednisone|mesh-list
110557861|NCT00049595|Cyclophosphamide|cyclophosphamide|mesh-list
110557862|NCT00049595|Dacarbazine|dacarbazine|mesh-list
110557863|NCT00049595|Doxorubicin|doxorubicin|mesh-list
110557864|NCT00049595|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110557865|NCT00049595|Etoposide|etoposide|mesh-list
110557866|NCT00049595|Vincristine|vincristine|mesh-list
110557867|NCT00049595|Bleomycin|bleomycin|mesh-list
110557868|NCT00049595|Vinblastine|vinblastine|mesh-list
110557869|NCT00049595|Procarbazine|procarbazine|mesh-list
110557870|NCT00049595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110557871|NCT00049595|Immunologic Factors|immunologic factors|mesh-ancestor
110557872|NCT00049595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110557873|NCT00049595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110205480|NCT00171691|Diclofenac|diclofenac|mesh-list
110557874|NCT00049595|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110557875|NCT00049595|Alkylating Agents|alkylating agents|mesh-ancestor
110557876|NCT00049595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110557877|NCT00049595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110557878|NCT00049595|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110557879|NCT00049595|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110557880|NCT00049595|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110159711|NCT00093925|Clevidipine|clevidipine|mesh-list
110557881|NCT00049595|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110557882|NCT00049595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110557883|NCT00049595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110557884|NCT00049595|Glucocorticoids|glucocorticoids|mesh-ancestor
110557885|NCT00049595|Hormones|hormones|mesh-ancestor
110557886|NCT00049595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110557887|NCT00049595|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110557888|NCT00049595|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110557889|NCT00049595|Tubulin Modulators|tubulin modulators|mesh-ancestor
110557890|NCT00049595|Antimitotic Agents|antimitotic agents|mesh-ancestor
110557891|NCT00049595|Mitosis Modulators|mitosis modulators|mesh-ancestor
110557892|NCT00873860|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110557893|NCT00873860|Immunologic Factors|immunologic factors|mesh-ancestor
110557894|NCT00873860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110557895|NCT03854227|Docetaxel|docetaxel|mesh-list
110557896|NCT03854227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110557897|NCT03854227|Tubulin Modulators|tubulin modulators|mesh-ancestor
110557898|NCT03854227|Antimitotic Agents|antimitotic agents|mesh-ancestor
110557899|NCT03854227|Mitosis Modulators|mitosis modulators|mesh-ancestor
110557900|NCT03854227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110557901|NCT05368961|Anti-Anxiety Agents|anti-anxiety agents|mesh-list
110557902|NCT05368961|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110557903|NCT05368961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110557904|NCT05368961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110557905|NCT05368961|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110557906|NCT02626754|Sunitinib|sunitinib|mesh-list
110557907|NCT02626754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110557908|NCT02626754|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110557909|NCT02626754|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110557910|NCT02626754|Growth Substances|growth substances|mesh-ancestor
110557911|NCT02626754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110557912|NCT02626754|Growth Inhibitors|growth inhibitors|mesh-ancestor
110557913|NCT02626754|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110557914|NCT02626754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110557915|NCT02626754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110557916|NCT00691886|Dexmedetomidine|dexmedetomidine|mesh-list
110557917|NCT00691886|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110557918|NCT00691886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110557919|NCT00691886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110557920|NCT00691886|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110557921|NCT00691886|Analgesics|analgesics|mesh-ancestor
110557922|NCT00691886|Sensory System Agents|sensory system agents|mesh-ancestor
110557923|NCT00691886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110557924|NCT00691886|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110557925|NCT00691886|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110557926|NCT00691886|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110557927|NCT00691886|Adrenergic Agents|adrenergic agents|mesh-ancestor
110557928|NCT00691886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110557929|NCT00691886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110557930|NCT04138004|Lubiprostone|lubiprostone|mesh-list
110557931|NCT04138004|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
110557932|NCT04138004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110557933|NCT04138004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110557934|NCT00621491|Warfarin|warfarin|mesh-list
110557935|NCT00621491|Anticoagulants|anticoagulants|mesh-list
110557936|NCT00622349|Cisplatin|cisplatin|mesh-list
110557937|NCT00622349|Gemcitabine|gemcitabine|mesh-list
110557938|NCT00622349|Docetaxel|docetaxel|mesh-list
110557939|NCT00622349|Ifosfamide|ifosfamide|mesh-list
110557940|NCT00622349|Isophosphamide mustard|isophosphamide mustard|mesh-list
110557941|NCT00622349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110557942|NCT00622349|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110557943|NCT00622349|Antimetabolites|antimetabolites|mesh-ancestor
110557944|NCT00622349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110557945|NCT00622349|Tubulin Modulators|tubulin modulators|mesh-ancestor
110557946|NCT00622349|Antimitotic Agents|antimitotic agents|mesh-ancestor
110557947|NCT00622349|Mitosis Modulators|mitosis modulators|mesh-ancestor
110557948|NCT00622349|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110557949|NCT00622349|Alkylating Agents|alkylating agents|mesh-ancestor
110557950|NCT00686816|Sucrose polyester|sucrose polyester|mesh-list
110557951|NCT00686816|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110557952|NCT00686816|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110557953|NCT00686816|Antimetabolites|antimetabolites|mesh-ancestor
110557954|NCT00686816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110557955|NCT00686816|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110557956|NCT05368181|Methylprednisolone|methylprednisolone|mesh-list
110557957|NCT05368181|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110557958|NCT05368181|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110557959|NCT05368181|Prednisolone|prednisolone|mesh-list
110557960|NCT05368181|Prednisolone acetate|prednisolone acetate|mesh-list
110557961|NCT05368181|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110557962|NCT05368181|Prednisolone phosphate|prednisolone phosphate|mesh-list
110557963|NCT05368181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110557964|NCT05368181|Antiemetics|antiemetics|mesh-ancestor
110557965|NCT05368181|Autonomic Agents|autonomic agents|mesh-ancestor
110557966|NCT05368181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110557967|NCT05368181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110159936|NCT00095329|Sirolimus|sirolimus|mesh-list
110557968|NCT05368181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110557969|NCT05368181|Glucocorticoids|glucocorticoids|mesh-ancestor
110557970|NCT05368181|Hormones|hormones|mesh-ancestor
110557971|NCT05368181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110557972|NCT05368181|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110557973|NCT05368181|Protective Agents|protective agents|mesh-ancestor
110557974|NCT05368181|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110557975|NCT05368181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110557976|NCT05662163|Anesthetics|anesthetics|mesh-list
110557977|NCT05662163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110557978|NCT05662163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110557979|NCT02666105|Exemestane|exemestane|mesh-list
110557980|NCT02666105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110557981|NCT02666105|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110557982|NCT02666105|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110557983|NCT02666105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110557984|NCT02666105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110557985|NCT02666105|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110557986|NCT02666105|Hormone Antagonists|hormone antagonists|mesh-ancestor
110557987|NCT02666105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110557988|NCT02666105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110557989|NCT04138238|Sirolimus|sirolimus|mesh-list
110557990|NCT04138238|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110557991|NCT04138238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110557992|NCT04138238|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110557993|NCT04138238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110557994|NCT04138238|Antifungal Agents|antifungal agents|mesh-ancestor
110557995|NCT04138238|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110557996|NCT04138238|Immunologic Factors|immunologic factors|mesh-ancestor
110557997|NCT04138238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110557998|NCT00622817|Epinephrine|epinephrine|mesh-list
110557999|NCT00622817|Xylometazoline|xylometazoline|mesh-list
110558000|NCT00622817|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110558001|NCT00622817|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110558002|NCT00622817|Adrenergic Agents|adrenergic agents|mesh-ancestor
110558003|NCT00622817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110558004|NCT00622817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110558005|NCT00622817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110558006|NCT00622817|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110558007|NCT00622817|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110558008|NCT00622817|Autonomic Agents|autonomic agents|mesh-ancestor
110558009|NCT00622817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110558010|NCT00622817|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110558011|NCT00622817|Respiratory System Agents|respiratory system agents|mesh-ancestor
110558012|NCT00622817|Mydriatics|mydriatics|mesh-ancestor
110558013|NCT00622817|Sympathomimetics|sympathomimetics|mesh-ancestor
110558014|NCT00622817|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110558015|NCT00622817|Nasal Decongestants|nasal decongestants|mesh-ancestor
110558016|NCT02432417|Chloroquine|chloroquine|mesh-list
110558017|NCT02432417|Amebicides|amebicides|mesh-ancestor
110558018|NCT02432417|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110558019|NCT02432417|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110558020|NCT02432417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110160055|NCT04432428|Sufentanil|sufentanil|mesh-list
110558021|NCT02432417|Antimalarials|antimalarials|mesh-ancestor
110558022|NCT02432417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110558023|NCT00692120|Vitamin D|vitamin d|mesh-list
110558024|NCT00692120|Ergocalciferols|ergocalciferols|mesh-list
110558025|NCT00692120|Cholecalciferol|cholecalciferol|mesh-list
110558026|NCT00692120|Vitamins|vitamins|mesh-list
110558027|NCT00692120|Micronutrients|micronutrients|mesh-ancestor
110558028|NCT00692120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110558029|NCT00692120|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110558030|NCT00692120|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110558031|NCT00819585|Colchicine|colchicine|mesh-list
110558032|NCT00819585|Allopurinol|allopurinol|mesh-list
110558033|NCT00819585|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110558034|NCT00819585|Gout Suppressants|gout suppressants|mesh-ancestor
110558035|NCT00819585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110558036|NCT00819585|Tubulin Modulators|tubulin modulators|mesh-ancestor
110558037|NCT00819585|Antimitotic Agents|antimitotic agents|mesh-ancestor
110558038|NCT00819585|Mitosis Modulators|mitosis modulators|mesh-ancestor
110558039|NCT00819585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110558040|NCT00819585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110558041|NCT00819585|Antimetabolites|antimetabolites|mesh-ancestor
110558042|NCT00819585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110558043|NCT00819585|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110558045|NCT00819585|Protective Agents|protective agents|mesh-ancestor
110558046|NCT00819585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110558047|NCT00819585|Immunologic Factors|immunologic factors|mesh-ancestor
110558048|NCT00687206|Valsartan|valsartan|mesh-list
110558049|NCT00687206|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110558050|NCT00687206|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110558051|NCT00687206|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110160077|NCT00006275|Calcitriol|calcitriol|mesh-list
110558052|NCT00687206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110558053|NCT00687284|Insulin Detemir|insulin detemir|mesh-list
110558054|NCT00687284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110558055|NCT00687284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110558056|NCT02358395|Sorafenib|sorafenib|mesh-list
110558057|NCT02358395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110558058|NCT02358395|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110558059|NCT02358395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110558060|NCT02358395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110558061|NCT00692354|Tosedostat|tosedostat|mesh-list
110558062|NCT00692354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110558063|NCT00692354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110558064|NCT03928847|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
110558065|NCT03928847|Antioxidants|antioxidants|mesh-ancestor
110558066|NCT03928847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110160128|NCT00096343|Paclitaxel|paclitaxel|mesh-list
110558067|NCT03928847|Protective Agents|protective agents|mesh-ancestor
110558068|NCT03928847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110558069|NCT03928847|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
110558070|NCT03928847|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110558071|NCT03928847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110558072|NCT03928847|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110558074|NCT02624726|Fluorouracil|fluorouracil|mesh-list
110558075|NCT02624726|Irinotecan|irinotecan|mesh-list
110558076|NCT02624726|Aflibercept|aflibercept|mesh-list
110558077|NCT02624726|Levoleucovorin|levoleucovorin|mesh-list
110558078|NCT02624726|Antimetabolites|antimetabolites|mesh-ancestor
110558079|NCT02624726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110558080|NCT02624726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110558081|NCT02624726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110558082|NCT02624726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110558083|NCT02624726|Immunologic Factors|immunologic factors|mesh-ancestor
110558084|NCT02624726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110558085|NCT02624726|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110558086|NCT02624726|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110558087|NCT02624726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110558088|NCT02624726|Antidotes|antidotes|mesh-ancestor
110558089|NCT02624726|Protective Agents|protective agents|mesh-ancestor
110558090|NCT02624726|Vitamin B Complex|vitamin b complex|mesh-ancestor
110558091|NCT02624726|Vitamins|vitamins|mesh-ancestor
110558092|NCT02624726|Micronutrients|micronutrients|mesh-ancestor
110558093|NCT02624726|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110558094|NCT02624726|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110558095|NCT02624726|Growth Substances|growth substances|mesh-ancestor
110558096|NCT02624726|Growth Inhibitors|growth inhibitors|mesh-ancestor
110558097|NCT00681746|Flumazenil|flumazenil|mesh-list
110558098|NCT00681746|Antidotes|antidotes|mesh-ancestor
110558099|NCT00681746|Protective Agents|protective agents|mesh-ancestor
110558100|NCT00681746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110558101|NCT00681746|GABA Modulators|gaba modulators|mesh-ancestor
110558102|NCT00681746|GABA Agents|gaba agents|mesh-ancestor
110558103|NCT00681746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110558104|NCT00681746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110558105|NCT04265911|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110558106|NCT04265911|Immunologic Factors|immunologic factors|mesh-ancestor
110558107|NCT04265911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110558108|NCT00819039|Ondansetron|ondansetron|mesh-list
110558109|NCT00819039|Aprepitant|aprepitant|mesh-list
110558110|NCT00819039|Antiemetics|antiemetics|mesh-ancestor
110558111|NCT00819039|Autonomic Agents|autonomic agents|mesh-ancestor
110558112|NCT00819039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110558113|NCT00819039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110558114|NCT00819039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110558115|NCT00819039|Antipruritics|antipruritics|mesh-ancestor
110558116|NCT00819039|Dermatologic Agents|dermatologic agents|mesh-ancestor
110558117|NCT00819039|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110558118|NCT00819039|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110558119|NCT00819039|Serotonin Agents|serotonin agents|mesh-ancestor
110558120|NCT00819039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110558121|NCT00819039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110558122|NCT00819039|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110558123|NCT00692510|Rosiglitazone|rosiglitazone|mesh-list
110558124|NCT00692510|Midazolam|midazolam|mesh-list
110558125|NCT00692510|Caffeine|caffeine|mesh-list
110558126|NCT00692510|Bupropion|bupropion|mesh-list
110558127|NCT00692510|Omeprazole|omeprazole|mesh-list
110558128|NCT00692510|Bilirubin|bilirubin|mesh-list
110558129|NCT00692510|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110558130|NCT00692510|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110558131|NCT00692510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110558132|NCT00692510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110558133|NCT00692510|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110558134|NCT00692510|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110558135|NCT00692510|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110558136|NCT00692510|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110558137|NCT00692510|Anesthetics, General|anesthetics, general|mesh-ancestor
110558139|NCT00692510|GABA Modulators|gaba modulators|mesh-ancestor
110558140|NCT00692510|GABA Agents|gaba agents|mesh-ancestor
110558141|NCT00692510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110558142|NCT00692510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110558143|NCT00692510|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110558144|NCT00692510|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110558145|NCT00692510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110558146|NCT00692510|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110558147|NCT00692510|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110558148|NCT00692510|Purinergic Agents|purinergic agents|mesh-ancestor
110558149|NCT00692510|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110558150|NCT00692510|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110558151|NCT00692510|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110558152|NCT00692510|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110558153|NCT00692510|Antidepressive Agents|antidepressive agents|mesh-ancestor
110558154|NCT00692510|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110558155|NCT00692510|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110558156|NCT00692510|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110558157|NCT00692510|Dopamine Agents|dopamine agents|mesh-ancestor
110558158|NCT00692510|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110558159|NCT00692510|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110558160|NCT00692510|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110558161|NCT00692510|Antioxidants|antioxidants|mesh-ancestor
110558162|NCT00692510|Protective Agents|protective agents|mesh-ancestor
110558163|NCT00500539|Omalizumab|omalizumab|mesh-list
110558164|NCT00500539|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110558165|NCT00500539|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110558166|NCT00500539|Respiratory System Agents|respiratory system agents|mesh-ancestor
110558167|NCT00687518|Epoetin Alfa|epoetin alfa|mesh-list
110558168|NCT00687518|Hematinics|hematinics|mesh-ancestor
110558169|NCT02303795|Warfarin|warfarin|mesh-list
110558170|NCT02303795|Rivaroxaban|rivaroxaban|mesh-list
110558171|NCT02303795|Anticoagulants|anticoagulants|mesh-ancestor
110558172|NCT02303795|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110558173|NCT02303795|Antithrombins|antithrombins|mesh-ancestor
110558174|NCT02303795|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110558175|NCT02303795|Protease Inhibitors|protease inhibitors|mesh-ancestor
110558176|NCT02303795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110558177|NCT02303795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110558178|NCT04187417|Tetracaine|tetracaine|mesh-list
110558179|NCT04187417|Anesthetics, Local|anesthetics, local|mesh-ancestor
110558180|NCT04187417|Anesthetics|anesthetics|mesh-ancestor
110558181|NCT04187417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110558182|NCT04187417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110558184|NCT04187417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110558185|NCT00818883|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110558186|NCT00818883|Chlorthalidone|chlorthalidone|mesh-list
110558187|NCT00818883|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
110558188|NCT00818883|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110558189|NCT00818883|Diuretics|diuretics|mesh-ancestor
110558190|NCT00818883|Natriuretic Agents|natriuretic agents|mesh-ancestor
110558191|NCT00818883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110558192|NCT00818883|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110558193|NCT00818883|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110558194|NCT00818883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110558195|NCT00818883|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110558196|NCT00818883|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110558197|NCT01014481|Tenofovir|tenofovir|mesh-list
110558198|NCT01014481|Lamivudine|lamivudine|mesh-list
110558199|NCT01014481|Efavirenz|efavirenz|mesh-list
110558200|NCT01014481|Antiviral Agents|antiviral agents|mesh-ancestor
110558201|NCT01014481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110558202|NCT01014481|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110558203|NCT01014481|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110558204|NCT01014481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110558205|NCT01014481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110558206|NCT01014481|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110558207|NCT01014481|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110558208|NCT01014481|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110558209|NCT01014481|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110558210|NCT01014481|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110558211|NCT01014481|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110558212|NCT01014481|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110558213|NCT01014481|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110558216|NCT02167763|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110558217|NCT02167763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110558218|NCT02167763|Trace Elements|trace elements|mesh-ancestor
110558219|NCT02167763|Micronutrients|micronutrients|mesh-ancestor
110558220|NCT00508027|Simvastatin|simvastatin|mesh-list
110558221|NCT00508027|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110558222|NCT00508027|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110558223|NCT00508027|Antimetabolites|antimetabolites|mesh-ancestor
110558224|NCT00508027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110558225|NCT00508027|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110558226|NCT00508027|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110558227|NCT00508027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110558228|NCT01986101|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
110558229|NCT01986101|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110558230|NCT01986101|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110558231|NCT01986101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110558232|NCT01986101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110558233|NCT01986101|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110558234|NCT01986101|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
110558235|NCT01986101|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110558236|NCT01986101|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110558237|NCT01986101|Adrenergic Agents|adrenergic agents|mesh-ancestor
110558238|NCT01986101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110558239|NCT01986101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110558240|NCT01986101|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110558241|NCT01986101|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110558242|NCT01986101|Serotonin Agents|serotonin agents|mesh-ancestor
110558243|NCT01986101|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110558244|NCT01986101|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110558245|NCT01986101|Dopamine Agents|dopamine agents|mesh-ancestor
110558246|NCT00500149|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
110558247|NCT00500149|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110558248|NCT00500149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110558249|NCT00500149|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110558250|NCT00500149|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110558251|NCT00500149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110558252|NCT00500149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110558254|NCT00500149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110558255|NCT00681902|Lidocaine|lidocaine|mesh-list
110558256|NCT00681902|Anesthetics, Local|anesthetics, local|mesh-ancestor
110558257|NCT00681902|Anesthetics|anesthetics|mesh-ancestor
110558258|NCT00681902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110558259|NCT00681902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110558260|NCT00681902|Sensory System Agents|sensory system agents|mesh-ancestor
110558261|NCT00681902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110558262|NCT00681902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110558263|NCT00681902|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110558264|NCT00681902|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110558265|NCT00681902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110558266|NCT00681902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110558267|NCT04185857|Olmesartan|olmesartan|mesh-list
110558268|NCT04185857|Canrenone|canrenone|mesh-list
110558269|NCT04185857|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110558270|NCT04185857|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110558271|NCT04185857|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110558272|NCT04185857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110558273|NCT04185857|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110558274|NCT04185857|Hormone Antagonists|hormone antagonists|mesh-ancestor
110558275|NCT04185857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110558276|NCT04185857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110160646|NCT00100594|Lamivudine|lamivudine|mesh-list
110558277|NCT04185857|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110558278|NCT04185857|Diuretics|diuretics|mesh-ancestor
110558279|NCT04185857|Natriuretic Agents|natriuretic agents|mesh-ancestor
110558280|NCT01016509|Insulin|insulin|mesh-list
110558281|NCT01016509|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110558282|NCT01016509|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110558283|NCT01016509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110558284|NCT00639119|Ropinirole|ropinirole|mesh-list
110558285|NCT00639119|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110558286|NCT00639119|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110558287|NCT00639119|Dopamine Agonists|dopamine agonists|mesh-ancestor
110558288|NCT00639119|Dopamine Agents|dopamine agents|mesh-ancestor
110558289|NCT00639119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110558290|NCT00639119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110558291|NCT00639119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110558292|NCT01010893|Vaccines|vaccines|mesh-list
110558293|NCT01010893|Immunologic Factors|immunologic factors|mesh-ancestor
110558294|NCT01010893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110558295|NCT01011127|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110558296|NCT01011127|Pravastatin|pravastatin|mesh-list
110558297|NCT01011127|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110558298|NCT01011127|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110558299|NCT01011127|Antimetabolites|antimetabolites|mesh-ancestor
110558300|NCT01011127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110558301|NCT01011127|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110558302|NCT01011127|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110558303|NCT01011127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110558304|NCT00912548|Tamoxifen|tamoxifen|mesh-list
110558305|NCT00912548|Goserelin|goserelin|mesh-list
110558306|NCT00912548|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110160678|NCT00100750|Gemcitabine|gemcitabine|mesh-list
110558307|NCT00912548|Hormone Antagonists|hormone antagonists|mesh-ancestor
110558308|NCT00912548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110558309|NCT00912548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110558310|NCT00912548|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110558311|NCT00912548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110558312|NCT00912548|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110558313|NCT00912548|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110558314|NCT00912548|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110558315|NCT01016665|Anastrozole|anastrozole|mesh-list
110558316|NCT01016665|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110558317|NCT01016665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110558318|NCT01016665|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110558319|NCT01016665|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110558320|NCT01016665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110558321|NCT01016665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110558322|NCT01016665|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110558323|NCT01016665|Hormone Antagonists|hormone antagonists|mesh-ancestor
110558324|NCT01016665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110558325|NCT01016665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110558326|NCT00681980|Valproic Acid|valproic acid|mesh-list
110558327|NCT00681980|Anticonvulsants|anticonvulsants|mesh-ancestor
110558328|NCT00681980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110558329|NCT00681980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110558330|NCT00681980|GABA Agents|gaba agents|mesh-ancestor
110558331|NCT00681980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110558332|NCT00681980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110558333|NCT00681980|Antimanic Agents|antimanic agents|mesh-ancestor
110558334|NCT00681980|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110558335|NCT00681980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110558336|NCT00681980|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110558337|NCT00692900|Docetaxel|docetaxel|mesh-list
110558338|NCT00692900|Oxaliplatin|oxaliplatin|mesh-list
110558339|NCT00692900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110558340|NCT00692900|Tubulin Modulators|tubulin modulators|mesh-ancestor
110558341|NCT00692900|Antimitotic Agents|antimitotic agents|mesh-ancestor
110558342|NCT00692900|Mitosis Modulators|mitosis modulators|mesh-ancestor
110558343|NCT00692900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110558344|NCT03800381|Rifampin|rifampin|mesh-list
110558345|NCT03800381|Isoniazid|isoniazid|mesh-list
110558346|NCT03800381|Pyrazinamide|pyrazinamide|mesh-list
110558347|NCT03800381|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110558348|NCT03800381|Antitubercular Agents|antitubercular agents|mesh-ancestor
110558349|NCT03800381|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110558350|NCT03800381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110558351|NCT03800381|Leprostatic Agents|leprostatic agents|mesh-ancestor
110558352|NCT03800381|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110558353|NCT03800381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110558354|NCT03800381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110558355|NCT03800381|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110558356|NCT03800381|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110160846|NCT00101335|Analgesics|analgesics|mesh-ancestor
110558357|NCT03800381|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110558358|NCT03800381|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110558359|NCT03800381|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110558360|NCT03800381|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110558361|NCT03800381|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
110558362|NCT03800381|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110558363|NCT03800381|Antimetabolites|antimetabolites|mesh-ancestor
110558364|NCT03800381|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110558366|NCT00489853|Formoterol Fumarate|formoterol fumarate|mesh-list
110558367|NCT00489853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110558368|NCT00489853|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110558369|NCT00489853|Autonomic Agents|autonomic agents|mesh-ancestor
110558370|NCT00489853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110558371|NCT00489853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110558372|NCT00489853|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110558373|NCT00489853|Respiratory System Agents|respiratory system agents|mesh-ancestor
110558374|NCT00489853|Glucocorticoids|glucocorticoids|mesh-ancestor
110558375|NCT00489853|Hormones|hormones|mesh-ancestor
110558376|NCT00489853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110558377|NCT00489853|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110558378|NCT00489853|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110558379|NCT00489853|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110558380|NCT00489853|Adrenergic Agents|adrenergic agents|mesh-ancestor
110558381|NCT00489853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110558382|NCT00489853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110558384|NCT00682136|Anesthetics, Local|anesthetics, local|mesh-ancestor
110558385|NCT00682136|Anesthetics|anesthetics|mesh-ancestor
110558386|NCT00682136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110558387|NCT00682136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110558388|NCT00682136|Sensory System Agents|sensory system agents|mesh-ancestor
110558389|NCT00682136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110558390|NCT00693056|beta-Lactams|beta-lactams|mesh-list
110558391|NCT00693056|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110558392|NCT00693056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110558393|NCT04137302|Hydrocortisone|hydrocortisone|mesh-list
110558394|NCT04137302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110558395|NCT04145336|Indomethacin|indomethacin|mesh-list
110558396|NCT04145336|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110558397|NCT04145336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110558399|NCT04145336|Sensory System Agents|sensory system agents|mesh-ancestor
110558400|NCT04145336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110160904|NCT00101764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110558401|NCT04145336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110558402|NCT04145336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110558403|NCT04145336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110558404|NCT04145336|Gout Suppressants|gout suppressants|mesh-ancestor
110558405|NCT04145336|Tocolytic Agents|tocolytic agents|mesh-ancestor
110558406|NCT04145336|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110558407|NCT04145336|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110558408|NCT04145336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110558409|NCT04145336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110558410|NCT00499681|Letrozole|letrozole|mesh-list
110558411|NCT00499681|Lapatinib|lapatinib|mesh-list
110558412|NCT00499681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110558413|NCT00499681|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110558414|NCT00499681|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110558415|NCT00499681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110558416|NCT00499681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110558417|NCT00499681|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110558418|NCT00499681|Hormone Antagonists|hormone antagonists|mesh-ancestor
110558419|NCT00499681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110558420|NCT00499681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110558421|NCT00499681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110558422|NCT02687009|Niclosamide|niclosamide|mesh-list
110558423|NCT02687009|Anticestodal Agents|anticestodal agents|mesh-ancestor
110558424|NCT02687009|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110558425|NCT02687009|Anthelmintics|anthelmintics|mesh-ancestor
110558426|NCT02687009|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110558427|NCT02687009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110161010|NCT00102778|Ritonavir|ritonavir|mesh-list
110558428|NCT02687009|Antinematodal Agents|antinematodal agents|mesh-ancestor
110558429|NCT00693212|Methylphenidate|methylphenidate|mesh-list
110558430|NCT00693212|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110558431|NCT00693212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110558432|NCT00693212|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110558433|NCT00693212|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110558434|NCT00693212|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110558435|NCT00693212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110558436|NCT00693212|Dopamine Agents|dopamine agents|mesh-ancestor
110558437|NCT00693212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110558438|NCT00688298|Imidacloprid|imidacloprid|mesh-list
110558439|NCT00688298|Cholinergic Agents|cholinergic agents|mesh-ancestor
110558440|NCT00688298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110558441|NCT00688298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110161068|NCT00102973|Doxorubicin|doxorubicin|mesh-list
110558442|NCT00688298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110558444|NCT00499603|Cyclophosphamide|cyclophosphamide|mesh-list
110558445|NCT00499603|Fluorouracil|fluorouracil|mesh-list
110558446|NCT00499603|Epirubicin|epirubicin|mesh-list
110558448|NCT00499603|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110558449|NCT00499603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110558450|NCT00499603|Tubulin Modulators|tubulin modulators|mesh-ancestor
110558451|NCT00499603|Antimitotic Agents|antimitotic agents|mesh-ancestor
110558452|NCT00499603|Mitosis Modulators|mitosis modulators|mesh-ancestor
110558453|NCT00499603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110558454|NCT00499603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110558455|NCT00499603|Immunologic Factors|immunologic factors|mesh-ancestor
110558456|NCT00499603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110558457|NCT00499603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110558458|NCT00499603|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110558459|NCT00499603|Alkylating Agents|alkylating agents|mesh-ancestor
110558460|NCT00499603|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110558461|NCT00499603|Antimetabolites|antimetabolites|mesh-ancestor
110558462|NCT00499603|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110558463|NCT00499603|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110182462|NCT00024297|Warfarin|warfarin|mesh-list
110558464|NCT00499603|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110558465|NCT00499603|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110558466|NCT00499603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110558467|NCT00499603|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110558468|NCT00499603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110558470|NCT01946711|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110206074|NCT00176293|Hormones|hormones|mesh-ancestor
110558471|NCT01946711|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110558472|NCT01946711|Autonomic Agents|autonomic agents|mesh-ancestor
110558473|NCT01946711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110558474|NCT01946711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110558475|NCT01946711|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110558476|NCT01946711|Respiratory System Agents|respiratory system agents|mesh-ancestor
110558477|NCT01946711|Glucocorticoids|glucocorticoids|mesh-ancestor
110558478|NCT01946711|Hormones|hormones|mesh-ancestor
110558479|NCT01946711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110558480|NCT00693446|Sirolimus|sirolimus|mesh-list
110558481|NCT00693446|Tacrolimus|tacrolimus|mesh-list
110558482|NCT00693446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110558483|NCT00693446|Immunologic Factors|immunologic factors|mesh-ancestor
110558484|NCT00693446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110558485|NCT00693446|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110558486|NCT00693446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110558487|NCT00693446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110558488|NCT00693446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110558489|NCT00693446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110558490|NCT00693446|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110558491|NCT00693446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110558492|NCT00693446|Antifungal Agents|antifungal agents|mesh-ancestor
110558493|NCT00693524|Mycophenolic Acid|mycophenolic acid|mesh-list
110558494|NCT00693524|Prednisone|prednisone|mesh-list
110558495|NCT00693524|Tacrolimus|tacrolimus|mesh-list
110558496|NCT00693524|Daclizumab|daclizumab|mesh-list
110558497|NCT00693524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110558498|NCT00693524|Glucocorticoids|glucocorticoids|mesh-ancestor
110558499|NCT00693524|Hormones|hormones|mesh-ancestor
110558500|NCT00693524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110558501|NCT00693524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110558502|NCT00693524|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110558503|NCT00693524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110558504|NCT00693524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110558505|NCT00693524|Immunologic Factors|immunologic factors|mesh-ancestor
110558506|NCT00693524|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110558507|NCT00693524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110558508|NCT00693524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110558509|NCT00693524|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110558510|NCT00693524|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110161321|NCT00006467|Gemcitabine|gemcitabine|mesh-list
110558511|NCT00693524|Antitubercular Agents|antitubercular agents|mesh-ancestor
110558512|NCT00693524|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110558513|NCT00693524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110558514|NCT00693602|Asparaginase|asparaginase|mesh-list
110558515|NCT00693602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110558516|NCT00682214|Vitamin D|vitamin d|mesh-list
110558517|NCT00682214|Cholecalciferol|cholecalciferol|mesh-list
110558518|NCT00682214|Vitamins|vitamins|mesh-ancestor
110558519|NCT00682214|Micronutrients|micronutrients|mesh-ancestor
110558520|NCT00682214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110558521|NCT00682214|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110558522|NCT00682214|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110558523|NCT04137380|Mirikizumab|mirikizumab|mesh-list
110558524|NCT04137380|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110558525|NCT04137380|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110558526|NCT04137380|Analgesics|analgesics|mesh-ancestor
110558527|NCT04137380|Sensory System Agents|sensory system agents|mesh-ancestor
110558528|NCT04137380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110558529|NCT04137380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110558530|NCT04137380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110558532|NCT04137380|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110558533|NCT04137380|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110558534|NCT00693680|Imipramine|imipramine|mesh-list
110558535|NCT00693680|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110558536|NCT00693680|Antidepressive Agents|antidepressive agents|mesh-ancestor
110558537|NCT00693680|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110558538|NCT00693680|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110161381|NCT00105937|Fentanyl|fentanyl|mesh-list
110558539|NCT00693680|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110558540|NCT00693680|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110558541|NCT00693680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110558542|NCT00693680|Adrenergic Agents|adrenergic agents|mesh-ancestor
110558543|NCT00693680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110558544|NCT00693680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110558545|NCT00682292|Thymoglobulin|thymoglobulin|mesh-list
110558546|NCT00682292|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110558547|NCT00682292|Daclizumab|daclizumab|mesh-list
110558548|NCT00682292|Immunologic Factors|immunologic factors|mesh-ancestor
110558549|NCT00682292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110558550|NCT00682292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110558551|NCT00810069|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110558552|NCT00810069|Escitalopram|escitalopram|mesh-list
110558553|NCT00810069|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110558554|NCT00810069|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110558555|NCT00810069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110558556|NCT00810069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110558557|NCT00810069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110558558|NCT00810069|Serotonin Agents|serotonin agents|mesh-ancestor
110558559|NCT00810069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110558560|NCT00810069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110558561|NCT00810069|Antidepressive Agents|antidepressive agents|mesh-ancestor
110558562|NCT00810069|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110558563|NCT00810069|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110558564|NCT00810069|Analgesics|analgesics|mesh-ancestor
110558565|NCT00810069|Sensory System Agents|sensory system agents|mesh-ancestor
110558566|NCT00810069|Dopamine Agents|dopamine agents|mesh-ancestor
110558567|NCT00693758|Adenosine|adenosine|mesh-list
110558568|NCT00693758|Analgesics|analgesics|mesh-ancestor
110558569|NCT00693758|Sensory System Agents|sensory system agents|mesh-ancestor
110558571|NCT00693758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110558572|NCT00693758|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110558573|NCT00693758|Vasodilator Agents|vasodilator agents|mesh-ancestor
110558574|NCT00693758|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
110558575|NCT00693758|Purinergic Agonists|purinergic agonists|mesh-ancestor
110558576|NCT00693758|Purinergic Agents|purinergic agents|mesh-ancestor
110558577|NCT00693758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110558578|NCT00693758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110558579|NCT02625740|Paclitaxel|paclitaxel|mesh-list
110558580|NCT02625740|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110558581|NCT02625740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110558582|NCT02625740|Tubulin Modulators|tubulin modulators|mesh-ancestor
110558583|NCT02625740|Antimitotic Agents|antimitotic agents|mesh-ancestor
110558584|NCT02625740|Mitosis Modulators|mitosis modulators|mesh-ancestor
110558585|NCT02625740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110558586|NCT00688922|Pravastatin|pravastatin|mesh-list
110558587|NCT00688922|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110558588|NCT00688922|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110558589|NCT00688922|Antimetabolites|antimetabolites|mesh-ancestor
110558590|NCT00688922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110558591|NCT00688922|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110558592|NCT00688922|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110558593|NCT00688922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110558594|NCT00694148|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
110558595|NCT00694148|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110558596|NCT00694148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110558597|NCT00694148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110558598|NCT00694148|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110558599|NCT00694148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110558600|NCT00694148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110558601|NCT00694148|Cholinergic Agents|cholinergic agents|mesh-ancestor
110558602|NCT00694148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110558603|NCT02626364|Crenolanib|crenolanib|mesh-list
110558604|NCT02626364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110558605|NCT00694460|Vaccines|vaccines|mesh-list
110558606|NCT00694460|Immunologic Factors|immunologic factors|mesh-ancestor
110558607|NCT00694460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110558608|NCT04776525|Doxorubicin|doxorubicin|mesh-list
110558609|NCT04776525|Ifosfamide|ifosfamide|mesh-list
110558610|NCT04776525|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110558611|NCT04776525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110558612|NCT04776525|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110558613|NCT04776525|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110558614|NCT04776525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110558615|NCT04776525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110558616|NCT04776525|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110558617|NCT04776525|Alkylating Agents|alkylating agents|mesh-ancestor
110558618|NCT00689000|Tosedostat|tosedostat|mesh-list
110558619|NCT00689000|Glycine|glycine|mesh-list
110558620|NCT00689000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110558621|NCT00689000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110558622|NCT00689000|Glycine Agents|glycine agents|mesh-ancestor
110558623|NCT00689000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110558624|NCT00689000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110558625|NCT00489541|Paclitaxel|paclitaxel|mesh-list
110558626|NCT00489541|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110558627|NCT00489541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110558628|NCT00489541|Tubulin Modulators|tubulin modulators|mesh-ancestor
110558629|NCT00489541|Antimitotic Agents|antimitotic agents|mesh-ancestor
110558630|NCT00489541|Mitosis Modulators|mitosis modulators|mesh-ancestor
110558631|NCT00489541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110558632|NCT00689156|Cyclophosphamide|cyclophosphamide|mesh-list
110558633|NCT00689156|Docetaxel|docetaxel|mesh-list
110558634|NCT00689156|Epirubicin|epirubicin|mesh-list
110558635|NCT00689156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110558636|NCT00689156|Immunologic Factors|immunologic factors|mesh-ancestor
110558637|NCT00689156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110558638|NCT00689156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110558639|NCT00689156|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110558640|NCT00689156|Alkylating Agents|alkylating agents|mesh-ancestor
110558641|NCT00689156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110558642|NCT00689156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110558643|NCT00689156|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110558644|NCT00689156|Tubulin Modulators|tubulin modulators|mesh-ancestor
110558645|NCT00689156|Antimitotic Agents|antimitotic agents|mesh-ancestor
110558646|NCT00689156|Mitosis Modulators|mitosis modulators|mesh-ancestor
110558647|NCT00689156|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110558648|NCT00689156|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110558649|NCT00689156|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110558650|NCT00689156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110558651|NCT04773873|Lithium Carbonate|lithium carbonate|mesh-list
110558652|NCT04773873|Antidepressive Agents|antidepressive agents|mesh-ancestor
110558653|NCT04773873|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110558654|NCT04773873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110558655|NCT04773873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110558656|NCT04773873|Antimanic Agents|antimanic agents|mesh-ancestor
110558657|NCT04773873|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110558658|NCT04773873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110161586|NCT00107341|Antimitotic Agents|antimitotic agents|mesh-ancestor
110558659|NCT04773873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110558660|NCT01016821|Oxycodone|oxycodone|mesh-list
110558661|NCT01016821|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110558662|NCT01016821|Narcotics|narcotics|mesh-ancestor
110558663|NCT01016821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110558664|NCT01016821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110558665|NCT01016821|Analgesics|analgesics|mesh-ancestor
110558666|NCT01016821|Sensory System Agents|sensory system agents|mesh-ancestor
110558667|NCT01016821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110558668|NCT01011205|Mycophenolic Acid|mycophenolic acid|mesh-list
110558669|NCT01011205|Methylprednisolone|methylprednisolone|mesh-list
110558670|NCT01011205|Tacrolimus|tacrolimus|mesh-list
110558671|NCT01011205|Basiliximab|basiliximab|mesh-list
110558672|NCT01011205|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110558673|NCT01011205|Immunologic Factors|immunologic factors|mesh-ancestor
110558674|NCT01011205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110558675|NCT01011205|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110558676|NCT01011205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110558677|NCT01011205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110558679|NCT01011205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110558680|NCT01011205|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110558681|NCT01011205|Antitubercular Agents|antitubercular agents|mesh-ancestor
110558682|NCT01011205|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110558683|NCT01011205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110558684|NCT01011205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110558685|NCT01011205|Antiemetics|antiemetics|mesh-ancestor
110558686|NCT01011205|Autonomic Agents|autonomic agents|mesh-ancestor
110558687|NCT01011205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110558688|NCT01011205|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110558689|NCT01011205|Glucocorticoids|glucocorticoids|mesh-ancestor
110558690|NCT01011205|Hormones|hormones|mesh-ancestor
110558691|NCT01011205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110206290|NCT00178828|Sertraline|sertraline|mesh-list
110558692|NCT01011205|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110558693|NCT01011205|Protective Agents|protective agents|mesh-ancestor
110558694|NCT00809835|Galantamine|galantamine|mesh-list
110558695|NCT00809835|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110558697|NCT00809835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110558698|NCT00809835|Cholinergic Agents|cholinergic agents|mesh-ancestor
110558699|NCT00809835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110558700|NCT00809835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110558701|NCT00809835|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110558702|NCT00809835|Autonomic Agents|autonomic agents|mesh-ancestor
110558703|NCT00809835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110558704|NCT00809835|Nootropic Agents|nootropic agents|mesh-ancestor
110558705|NCT01014559|Oxycodone|oxycodone|mesh-list
110558706|NCT01014559|Naloxone|naloxone|mesh-list
110558707|NCT01014559|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110558708|NCT01014559|Narcotics|narcotics|mesh-ancestor
110558709|NCT01014559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110558710|NCT01014559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110558711|NCT01014559|Analgesics|analgesics|mesh-ancestor
110558712|NCT01014559|Sensory System Agents|sensory system agents|mesh-ancestor
110558713|NCT01014559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110558714|NCT01014559|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110558715|NCT00853242|Sevelamer|sevelamer|mesh-list
110558716|NCT00853242|Chelating Agents|chelating agents|mesh-ancestor
110558717|NCT00853242|Sequestering Agents|sequestering agents|mesh-ancestor
110312655|NCT00295685|Antacids|antacids|mesh-list
110558718|NCT00853242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110558719|NCT02609061|Alendronate|alendronate|mesh-list
110558720|NCT02609061|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110558721|NCT02609061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110558722|NCT00848250|Enzyme Inhibitors|enzyme inhibitors|mesh-list
110558723|NCT00848250|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
110558724|NCT00848250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110558725|NCT00848250|Protease Inhibitors|protease inhibitors|mesh-ancestor
110558726|NCT00694694|Azithromycin|azithromycin|mesh-list
110558727|NCT00694694|Artesunate|artesunate|mesh-list
110558728|NCT00694694|Lumefantrine|lumefantrine|mesh-list
110558729|NCT00694694|Artemether|artemether|mesh-list
110558730|NCT00694694|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
110558731|NCT00694694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110558732|NCT00694694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110558733|NCT00694694|Antimalarials|antimalarials|mesh-ancestor
110558734|NCT00694694|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110558735|NCT00694694|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110558736|NCT00694694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110558737|NCT00694694|Antiviral Agents|antiviral agents|mesh-ancestor
110558738|NCT00694694|Schistosomicides|schistosomicides|mesh-ancestor
110558739|NCT00694694|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110558740|NCT00694694|Anthelmintics|anthelmintics|mesh-ancestor
110558741|NCT00700362|Insulin|insulin|mesh-list
110558742|NCT00700362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110558743|NCT00700362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110558744|NCT04136600|Antibodies|antibodies|mesh-list
110558745|NCT04136600|Immunologic Factors|immunologic factors|mesh-ancestor
110558746|NCT04136600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110558747|NCT00809757|Albuterol|albuterol|mesh-list
110558748|NCT00809757|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110558749|NCT00809757|Autonomic Agents|autonomic agents|mesh-ancestor
110558750|NCT00809757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110558751|NCT00809757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110558752|NCT00809757|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110558753|NCT00809757|Respiratory System Agents|respiratory system agents|mesh-ancestor
110558754|NCT00809757|Tocolytic Agents|tocolytic agents|mesh-ancestor
110558755|NCT00809757|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110558756|NCT00809757|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110558757|NCT00809757|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110558758|NCT00809757|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110558759|NCT00809757|Adrenergic Agents|adrenergic agents|mesh-ancestor
110558760|NCT00809757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110558761|NCT00809757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110558762|NCT00594464|Rotigotine|rotigotine|mesh-list
110558763|NCT00594464|Dopamine Agonists|dopamine agonists|mesh-ancestor
110558764|NCT00594464|Dopamine Agents|dopamine agents|mesh-ancestor
110558765|NCT00594464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110558766|NCT00594464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110558767|NCT00594464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110558768|NCT00682760|Botulinum Toxins|botulinum toxins|mesh-list
110558769|NCT00682760|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110558770|NCT00682760|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110558771|NCT00682760|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110558772|NCT00682760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110558773|NCT00682760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110558774|NCT00682760|Cholinergic Agents|cholinergic agents|mesh-ancestor
110558775|NCT00682760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110558776|NCT00682760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110558777|NCT00682760|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110558778|NCT00682760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110558779|NCT05326269|Terbutaline|terbutaline|mesh-list
110558780|NCT05326269|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110558781|NCT05326269|Autonomic Agents|autonomic agents|mesh-ancestor
110558782|NCT05326269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110558783|NCT05326269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110558784|NCT05326269|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110558785|NCT05326269|Respiratory System Agents|respiratory system agents|mesh-ancestor
110558786|NCT05326269|Sympathomimetics|sympathomimetics|mesh-ancestor
110558787|NCT05326269|Tocolytic Agents|tocolytic agents|mesh-ancestor
110558788|NCT05326269|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110558789|NCT05326269|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110558790|NCT05326269|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110558791|NCT05326269|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110558792|NCT05326269|Adrenergic Agents|adrenergic agents|mesh-ancestor
110558793|NCT05326269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110558794|NCT05326269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110558795|NCT02624570|Midostaurin|midostaurin|mesh-list
110558796|NCT02624570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110558797|NCT02624570|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110558798|NCT02624570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110558799|NCT02624570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110558800|NCT04665453|Dexmedetomidine|dexmedetomidine|mesh-list
110558801|NCT04665453|Melatonin|melatonin|mesh-list
110558802|NCT04665453|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110558803|NCT04665453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110558804|NCT04665453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110558805|NCT04665453|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110558806|NCT04665453|Analgesics|analgesics|mesh-ancestor
110558807|NCT04665453|Sensory System Agents|sensory system agents|mesh-ancestor
110558808|NCT04665453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110558809|NCT04665453|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110558810|NCT04665453|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110558811|NCT04665453|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110558812|NCT04665453|Adrenergic Agents|adrenergic agents|mesh-ancestor
110558813|NCT04665453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110558814|NCT04665453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110558815|NCT04665453|Antioxidants|antioxidants|mesh-ancestor
110558816|NCT04665453|Protective Agents|protective agents|mesh-ancestor
110558817|NCT00695240|Bupivacaine|bupivacaine|mesh-list
110558818|NCT00695240|Anesthetics, Local|anesthetics, local|mesh-ancestor
110558819|NCT00695240|Anesthetics|anesthetics|mesh-ancestor
110558820|NCT00695240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110558821|NCT00695240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110558822|NCT00695240|Sensory System Agents|sensory system agents|mesh-ancestor
110558823|NCT00695240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110558824|NCT00689702|Capecitabine|capecitabine|mesh-list
110558825|NCT00689702|Cetuximab|cetuximab|mesh-list
110558826|NCT00689702|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110558827|NCT00689702|Antimetabolites|antimetabolites|mesh-ancestor
110558828|NCT00689702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110558829|NCT00689702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110558830|NCT00689702|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110558831|NCT00689780|Midazolam|midazolam|mesh-list
110558832|NCT00689780|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110558833|NCT00689780|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110558834|NCT00689780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110558835|NCT00689780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110558836|NCT00689780|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110558837|NCT00689780|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110558838|NCT00689780|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110558839|NCT00689780|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110558840|NCT00689780|Anesthetics, General|anesthetics, general|mesh-ancestor
110558841|NCT00689780|Anesthetics|anesthetics|mesh-ancestor
110558842|NCT00689780|GABA Modulators|gaba modulators|mesh-ancestor
110558843|NCT00689780|GABA Agents|gaba agents|mesh-ancestor
110558844|NCT00689780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110558845|NCT00689780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110558846|NCT00689858|Cilostazol|cilostazol|mesh-list
110558847|NCT00689858|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110558848|NCT00689858|Autonomic Agents|autonomic agents|mesh-ancestor
110558849|NCT00689858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110558850|NCT00689858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110558851|NCT00689858|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110558852|NCT00689858|Respiratory System Agents|respiratory system agents|mesh-ancestor
110558853|NCT00689858|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110558854|NCT00689858|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110558855|NCT00689858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110558856|NCT00689858|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110558857|NCT00689858|Vasodilator Agents|vasodilator agents|mesh-ancestor
110558858|NCT00689858|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110558859|NCT00689858|Protective Agents|protective agents|mesh-ancestor
110558860|NCT00689858|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110558861|NCT00689858|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110558862|NCT00689858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110558863|NCT00695630|Flumazenil|flumazenil|mesh-list
110558864|NCT00695630|Antidotes|antidotes|mesh-ancestor
110558865|NCT00695630|Protective Agents|protective agents|mesh-ancestor
110558866|NCT00695630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110558867|NCT00695630|GABA Modulators|gaba modulators|mesh-ancestor
110558868|NCT00695630|GABA Agents|gaba agents|mesh-ancestor
110558869|NCT00695630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110558870|NCT00695630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110558871|NCT01614899|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
110558872|NCT01614899|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110558873|NCT01614899|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110558874|NCT01614899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110558875|NCT01614899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110558876|NCT01614899|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110558877|NCT01614899|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
110558878|NCT01614899|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110558879|NCT01614899|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110558880|NCT01614899|Adrenergic Agents|adrenergic agents|mesh-ancestor
110558881|NCT01614899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110558882|NCT01614899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110182492|NCT00024492|Analgesics|analgesics|mesh-ancestor
110558883|NCT01614899|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110558884|NCT01614899|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110558885|NCT01614899|Serotonin Agents|serotonin agents|mesh-ancestor
110558886|NCT01614899|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110558887|NCT01614899|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110558888|NCT01614899|Dopamine Agents|dopamine agents|mesh-ancestor
110558889|NCT00690014|Probenecid|probenecid|mesh-list
110558890|NCT00690014|Uricosuric Agents|uricosuric agents|mesh-ancestor
110558891|NCT00690014|Gout Suppressants|gout suppressants|mesh-ancestor
110558892|NCT00690014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110558893|NCT00683306|Gefitinib|gefitinib|mesh-list
110558894|NCT00683306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110558895|NCT00683306|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110558896|NCT00683306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110558897|NCT00683306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110558898|NCT01475123|Nicorandil|nicorandil|mesh-list
110558899|NCT01475123|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110558900|NCT01475123|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110558901|NCT01475123|Vasodilator Agents|vasodilator agents|mesh-ancestor
110558902|NCT01475123|Vitamin B Complex|vitamin b complex|mesh-ancestor
110558903|NCT01475123|Vitamins|vitamins|mesh-ancestor
110558904|NCT01475123|Micronutrients|micronutrients|mesh-ancestor
110558905|NCT01475123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110558906|NCT04135898|Bevacizumab|bevacizumab|mesh-list
110558907|NCT04135898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110558908|NCT04135898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110558909|NCT04135898|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110558910|NCT04135898|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110558911|NCT04135898|Growth Substances|growth substances|mesh-ancestor
110558912|NCT04135898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110558913|NCT04135898|Growth Inhibitors|growth inhibitors|mesh-ancestor
110558914|NCT04208399|JNJ-56136379|jnj-56136379|mesh-list
110558915|NCT04208399|Antiviral Agents|antiviral agents|mesh-ancestor
110558916|NCT04208399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110558917|NCT00912392|Carboplatin|carboplatin|mesh-list
110558918|NCT00912392|Etoposide|etoposide|mesh-list
110558919|NCT00912392|Endostar protein|endostar protein|mesh-list
110558920|NCT00912392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110558921|NCT00912392|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110558922|NCT00912392|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110558923|NCT00912392|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110558924|NCT00912392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110558925|NCT00912392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110162238|NCT00401674|Paclitaxel|paclitaxel|mesh-list
110558926|NCT00912392|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110558927|NCT00912392|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110558928|NCT00912392|Growth Substances|growth substances|mesh-ancestor
110558929|NCT00912392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110558930|NCT00912392|Growth Inhibitors|growth inhibitors|mesh-ancestor
110558931|NCT00690170|Ketamine|ketamine|mesh-list
110558932|NCT00690170|Nicotine|nicotine|mesh-list
110558933|NCT00690170|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110558934|NCT00690170|Autonomic Agents|autonomic agents|mesh-ancestor
110558935|NCT00690170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110558936|NCT00690170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110558937|NCT00690170|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110558938|NCT00690170|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110558939|NCT00690170|Cholinergic Agents|cholinergic agents|mesh-ancestor
110558940|NCT00690170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110558941|NCT00690170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110558942|NCT00690170|Analgesics|analgesics|mesh-ancestor
110558943|NCT00690170|Sensory System Agents|sensory system agents|mesh-ancestor
110558944|NCT00690170|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110558945|NCT00690170|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110558946|NCT00690170|Anesthetics, General|anesthetics, general|mesh-ancestor
110558947|NCT00690170|Anesthetics|anesthetics|mesh-ancestor
110558948|NCT00690170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110558949|NCT00690170|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110558950|NCT00690170|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110558951|NCT00689624|Leucovorin|leucovorin|mesh-list
110558952|NCT00689624|Fluorouracil|fluorouracil|mesh-list
110558953|NCT00689624|Oxaliplatin|oxaliplatin|mesh-list
110558954|NCT00689624|Irinotecan|irinotecan|mesh-list
110558955|NCT00689624|Cetuximab|cetuximab|mesh-list
110558956|NCT00689624|Antimetabolites|antimetabolites|mesh-ancestor
110558957|NCT00689624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110558958|NCT00689624|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110558959|NCT00689624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110558960|NCT00689624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110558961|NCT00689624|Immunologic Factors|immunologic factors|mesh-ancestor
110558962|NCT00689624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110558963|NCT00689624|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110558964|NCT00689624|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110558965|NCT00689624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110558967|NCT00689624|Protective Agents|protective agents|mesh-ancestor
110558968|NCT00689624|Vitamin B Complex|vitamin b complex|mesh-ancestor
110558969|NCT00689624|Vitamins|vitamins|mesh-ancestor
110558970|NCT00689624|Micronutrients|micronutrients|mesh-ancestor
110558971|NCT00689624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110558972|NCT00696098|Butyric Acid|butyric acid|mesh-list
110558973|NCT00696098|Histamine Antagonists|histamine antagonists|mesh-ancestor
110558974|NCT00696098|Histamine Agents|histamine agents|mesh-ancestor
110558975|NCT00696098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110558976|NCT00696098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110558977|NCT00696098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110558978|NCT02623478|Insulin Lispro|insulin lispro|mesh-list
110558979|NCT02623478|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110558980|NCT02623478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110558982|NCT00684164|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
110558983|NCT00684164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110558984|NCT00684164|Natriuretic Agents|natriuretic agents|mesh-ancestor
110558985|NCT00684164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110558986|NCT04135508|Adalimumab|adalimumab|mesh-list
110558987|NCT04135508|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110558988|NCT04135508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110558989|NCT04135508|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110558990|NCT02622854|Insulin|insulin|mesh-list
110558991|NCT02622854|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110558992|NCT02622854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110558993|NCT02616770|Perflubron|perflubron|mesh-list
110558994|NCT02616770|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110558995|NCT00499369|Leucovorin|leucovorin|mesh-list
110558996|NCT00499369|Bevacizumab|bevacizumab|mesh-list
110558997|NCT00499369|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110558998|NCT00499369|Cetuximab|cetuximab|mesh-list
110558999|NCT00499369|Fluorouracil|fluorouracil|mesh-list
110559000|NCT00499369|Irinotecan|irinotecan|mesh-list
110559001|NCT00499369|Antibodies|antibodies|mesh-list
110559002|NCT00499369|Immunoglobulins|immunoglobulins|mesh-list
110559003|NCT00499369|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110559004|NCT00499369|Levoleucovorin|levoleucovorin|mesh-list
110559005|NCT00499369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110559006|NCT00499369|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110559007|NCT00499369|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110559008|NCT00499369|Growth Substances|growth substances|mesh-ancestor
110559009|NCT00499369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110559010|NCT00499369|Growth Inhibitors|growth inhibitors|mesh-ancestor
110559011|NCT00499369|Immunologic Factors|immunologic factors|mesh-ancestor
110559012|NCT00499369|Antimetabolites|antimetabolites|mesh-ancestor
110559013|NCT00499369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110559014|NCT00499369|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110559015|NCT00499369|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110559016|NCT00499369|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110559017|NCT00499369|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110559018|NCT00499369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110559019|NCT00499369|Antidotes|antidotes|mesh-ancestor
110559020|NCT00499369|Protective Agents|protective agents|mesh-ancestor
110559021|NCT00499369|Vitamin B Complex|vitamin b complex|mesh-ancestor
110559022|NCT00499369|Vitamins|vitamins|mesh-ancestor
110559023|NCT00499369|Micronutrients|micronutrients|mesh-ancestor
110559024|NCT02616692|Sorafenib|sorafenib|mesh-list
110182514|NCT05080049|Epoetin Alfa|epoetin alfa|mesh-list
110559026|NCT02616692|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110559027|NCT02616692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110559028|NCT02616692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110559029|NCT01014637|Antifungal Agents|antifungal agents|mesh-list
110559030|NCT01014637|Clotrimazole|clotrimazole|mesh-list
110559031|NCT01014637|Miconazole|miconazole|mesh-list
110559032|NCT01014637|Amorolfine|amorolfine|mesh-list
110559033|NCT01014637|Ciclopirox|ciclopirox|mesh-list
110559034|NCT01014637|Keratolytic Agents|keratolytic agents|mesh-list
110559035|NCT01014637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110559036|NCT01014637|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110559037|NCT01014637|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110559038|NCT01014637|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110559039|NCT01014637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110559040|NCT01014637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110559041|NCT01014637|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110559042|NCT01014637|Hormone Antagonists|hormone antagonists|mesh-ancestor
110559043|NCT01014637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110559044|NCT01014637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110559045|NCT01014637|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110559046|NCT01014637|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110559047|NCT01014637|Dermatologic Agents|dermatologic agents|mesh-ancestor
110559049|NCT00696566|Clopidogrel|clopidogrel|mesh-list
110559050|NCT00696566|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110559051|NCT00696566|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110559052|NCT00696566|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110559053|NCT00696566|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110559054|NCT00696566|Purinergic Agents|purinergic agents|mesh-ancestor
110559055|NCT00696566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110559056|NCT00696566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110559057|NCT00696566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110559058|NCT00696566|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110559059|NCT00696566|Antitubercular Agents|antitubercular agents|mesh-ancestor
110559060|NCT00696566|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110559061|NCT00696566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110559062|NCT00696566|Leprostatic Agents|leprostatic agents|mesh-ancestor
110559063|NCT00696566|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110559064|NCT00696566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110559065|NCT00696566|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110559066|NCT00696566|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110559067|NCT00696566|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110559068|NCT00696566|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110559069|NCT00696566|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110559070|NCT00696566|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110559071|NCT01017133|Deoxyglucose|deoxyglucose|mesh-list
110559072|NCT01017133|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110559073|NCT01017133|Fluorides|fluorides|mesh-list
110559074|NCT01017133|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110559075|NCT01017133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110559076|NCT01017133|Cariostatic Agents|cariostatic agents|mesh-ancestor
110559077|NCT01017133|Protective Agents|protective agents|mesh-ancestor
110559078|NCT01017133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110559079|NCT01017133|Antimetabolites|antimetabolites|mesh-ancestor
110559080|NCT01017133|Antiviral Agents|antiviral agents|mesh-ancestor
110559081|NCT01017133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110559082|NCT00869258|Gemcitabine|gemcitabine|mesh-list
110559083|NCT00869258|Capecitabine|capecitabine|mesh-list
110559084|NCT00869258|Docetaxel|docetaxel|mesh-list
110559085|NCT00869258|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110559086|NCT00869258|Antimetabolites|antimetabolites|mesh-ancestor
110559087|NCT00869258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110559088|NCT00869258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110559089|NCT00869258|Tubulin Modulators|tubulin modulators|mesh-ancestor
110559090|NCT00869258|Antimitotic Agents|antimitotic agents|mesh-ancestor
110559091|NCT00869258|Mitosis Modulators|mitosis modulators|mesh-ancestor
110559092|NCT00696644|Teriparatide|teriparatide|mesh-list
110559093|NCT00696644|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110559094|NCT00696644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110559095|NCT00696644|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110559097|NCT01017367|Immunologic Factors|immunologic factors|mesh-ancestor
110559098|NCT01017367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110559099|NCT00696722|Atazanavir Sulfate|atazanavir sulfate|mesh-list
110559100|NCT00696722|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110559101|NCT00696722|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110559102|NCT00696722|Protease Inhibitors|protease inhibitors|mesh-ancestor
110559103|NCT00696722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110559104|NCT00696722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110559105|NCT00696722|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110559106|NCT00696722|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110559107|NCT00696722|Antiviral Agents|antiviral agents|mesh-ancestor
110559108|NCT00696722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110559110|NCT00696956|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110559111|NCT00696956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110559112|NCT00696956|Tubulin Modulators|tubulin modulators|mesh-ancestor
110559113|NCT00696956|Antimitotic Agents|antimitotic agents|mesh-ancestor
110559114|NCT00696956|Mitosis Modulators|mitosis modulators|mesh-ancestor
110559115|NCT00696956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110559116|NCT02616848|Everolimus|everolimus|mesh-list
110559117|NCT02616848|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110559118|NCT02616848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110559119|NCT02616848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110559120|NCT02616848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110559121|NCT02616848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110559122|NCT02616848|Immunologic Factors|immunologic factors|mesh-ancestor
110559123|NCT02616848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110559124|NCT02616848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110559125|NCT02620124|Triptorelin Pamoate|triptorelin pamoate|mesh-list
110559126|NCT02620124|Hormones|hormones|mesh-list
110559127|NCT02620124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110162380|NCT00112645|Hormones|hormones|mesh-ancestor
110559128|NCT02620124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110559129|NCT02620124|Luteolytic Agents|luteolytic agents|mesh-ancestor
110559130|NCT02620124|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110559131|NCT02620124|Contraceptive Agents|contraceptive agents|mesh-ancestor
110559132|NCT02620124|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110559133|NCT02620124|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110559134|NCT02620124|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110559135|NCT02620124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110559136|NCT04134650|Metformin|metformin|mesh-list
110559137|NCT04134650|Linagliptin|linagliptin|mesh-list
110559138|NCT04134650|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110559139|NCT04134650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110559140|NCT04134650|Incretins|incretins|mesh-ancestor
110559141|NCT04134650|Hormones|hormones|mesh-ancestor
110559142|NCT04134650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110559143|NCT04134650|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110559144|NCT04134650|Protease Inhibitors|protease inhibitors|mesh-ancestor
110559145|NCT04134650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110559146|NCT04134650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110559147|NCT00488683|Vaccines|vaccines|mesh-list
110559148|NCT00488683|Immunologic Factors|immunologic factors|mesh-ancestor
110559149|NCT00488683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110559150|NCT02563288|Dexmedetomidine|dexmedetomidine|mesh-list
110559151|NCT02563288|Esmolol|esmolol|mesh-list
110559152|NCT02563288|Adrenergic Agents|adrenergic agents|mesh-list
110559153|NCT02563288|Adrenergic Agonists|adrenergic agonists|mesh-list
110559154|NCT02563288|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-list
110559155|NCT02563288|Adrenergic Antagonists|adrenergic antagonists|mesh-list
110559156|NCT02563288|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110559157|NCT02563288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110312666|NCT00417911|Bortezomib|bortezomib|mesh-list
110559158|NCT02563288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110559159|NCT02563288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110559160|NCT02563288|Analgesics|analgesics|mesh-ancestor
110559161|NCT02563288|Sensory System Agents|sensory system agents|mesh-ancestor
110559162|NCT02563288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110559163|NCT02563288|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110559164|NCT02563288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110559165|NCT02563288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110559166|NCT02563288|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110559167|NCT02563288|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110559168|NCT00711269|Risperidone|risperidone|mesh-list
110559169|NCT00711269|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
110559170|NCT00711269|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110559171|NCT00711269|Serotonin Agents|serotonin agents|mesh-ancestor
110559172|NCT00711269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110559173|NCT00711269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110559174|NCT00711269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110559175|NCT00711269|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110559176|NCT00711269|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110559177|NCT00711269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110559178|NCT00711269|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110559179|NCT00711269|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110559180|NCT00711269|Dopamine Agents|dopamine agents|mesh-ancestor
110559181|NCT00711269|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
110559182|NCT00711269|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110559183|NCT00711269|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110559184|NCT00711269|Adrenergic Agents|adrenergic agents|mesh-ancestor
110559185|NCT00711269|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110559186|NCT00711269|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110559188|NCT01014793|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110559189|NCT01014793|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110559190|NCT01014793|Dopamine Agonists|dopamine agonists|mesh-ancestor
110559191|NCT01014793|Dopamine Agents|dopamine agents|mesh-ancestor
110559192|NCT01014793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110559193|NCT01014793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110559194|NCT01014793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110559195|NCT00286169|Amrubicin|amrubicin|mesh-list
110559196|NCT00286169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110559197|NCT00693472|Propranolol|propranolol|mesh-list
110559198|NCT00693472|Haloperidol|haloperidol|mesh-list
110559199|NCT00693472|Haloperidol decanoate|haloperidol decanoate|mesh-list
110559200|NCT00693472|Cholinergic Antagonists|cholinergic antagonists|mesh-list
110559201|NCT00693472|Antiemetics|antiemetics|mesh-ancestor
110559202|NCT00693472|Autonomic Agents|autonomic agents|mesh-ancestor
110559203|NCT00693472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110559204|NCT00693472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110559205|NCT00693472|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110559206|NCT00693472|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110559207|NCT00693472|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110559208|NCT00693472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110559209|NCT00693472|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110559210|NCT00693472|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110559211|NCT00693472|Dopamine Agents|dopamine agents|mesh-ancestor
110559212|NCT00693472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110559213|NCT00693472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110559214|NCT00693472|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110559215|NCT00693472|Cholinergic Agents|cholinergic agents|mesh-ancestor
110559216|NCT00693472|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110559217|NCT00693472|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110559218|NCT00693472|Adrenergic Agents|adrenergic agents|mesh-ancestor
110559219|NCT00693472|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110559220|NCT00693472|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110559221|NCT00693472|Vasodilator Agents|vasodilator agents|mesh-ancestor
110559222|NCT00498433|Amlodipine|amlodipine|mesh-list
110559223|NCT00498433|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110559224|NCT00498433|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110559225|NCT00498433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110559226|NCT00498433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110559227|NCT00498433|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110559228|NCT00498433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110559229|NCT00498433|Vasodilator Agents|vasodilator agents|mesh-ancestor
110559230|NCT02689583|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110559231|NCT02689583|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
110559232|NCT02689583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110559233|NCT02689583|Antitubercular Agents|antitubercular agents|mesh-ancestor
110559235|NCT00746746|Interferon-alpha|interferon-alpha|mesh-list
110559236|NCT00746746|Interferon alpha-2|interferon alpha-2|mesh-list
110559237|NCT00746746|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110559238|NCT00746746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110559239|NCT00746746|Antiviral Agents|antiviral agents|mesh-ancestor
110559240|NCT00746746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110559241|NCT00746746|Immunologic Factors|immunologic factors|mesh-ancestor
110559242|NCT00746746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110559244|NCT00498355|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110559245|NCT00498355|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110559246|NCT00498355|Growth Substances|growth substances|mesh-ancestor
110559247|NCT00498355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110559248|NCT00498355|Growth Inhibitors|growth inhibitors|mesh-ancestor
110559249|NCT00498355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110559250|NCT04539223|Evolocumab|evolocumab|mesh-list
110559251|NCT04539223|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
110559252|NCT04539223|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110559253|NCT04539223|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110559254|NCT04539223|Antimetabolites|antimetabolites|mesh-ancestor
110559255|NCT04539223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110559256|NCT04539223|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110559257|NCT04539223|Protease Inhibitors|protease inhibitors|mesh-ancestor
110559258|NCT04539223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110559259|NCT04539223|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110559260|NCT01011751|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
110559261|NCT01011751|Leuprolide|leuprolide|mesh-list
110559262|NCT01011751|Flutamide|flutamide|mesh-list
110559263|NCT01011751|Cyproterone Acetate|cyproterone acetate|mesh-list
110559264|NCT01011751|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
110559265|NCT01011751|Medroxyprogesterone|medroxyprogesterone|mesh-list
110559266|NCT01011751|Cyproterone|cyproterone|mesh-list
110559267|NCT01011751|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110559268|NCT01011751|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110559269|NCT01011751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110559270|NCT01011751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110559271|NCT01011751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110559272|NCT01011751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110559273|NCT01011751|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110559274|NCT01011751|Antidepressive Agents|antidepressive agents|mesh-ancestor
110559275|NCT01011751|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110559276|NCT01011751|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110559277|NCT01011751|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110559278|NCT01011751|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110559279|NCT01011751|Contraceptive Agents|contraceptive agents|mesh-ancestor
110559280|NCT01011751|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110559281|NCT01011751|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110559282|NCT01011751|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110559283|NCT01011751|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110559284|NCT01011751|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110559285|NCT01011751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110559286|NCT01011751|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110559287|NCT01011751|Fertility Agents|fertility agents|mesh-ancestor
110559288|NCT01011751|Androgen Antagonists|androgen antagonists|mesh-ancestor
110559289|NCT01011751|Hormone Antagonists|hormone antagonists|mesh-ancestor
110559290|NCT01011751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110559291|NCT02686619|Cyclosporine|cyclosporine|mesh-list
110559292|NCT02686619|Sirolimus|sirolimus|mesh-list
110559293|NCT02686619|Prednisolone|prednisolone|mesh-list
110559294|NCT02686619|Cyclosporins|cyclosporins|mesh-list
110559295|NCT02686619|Daclizumab|daclizumab|mesh-list
110559296|NCT02686619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110559297|NCT02686619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110559298|NCT02686619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110559299|NCT02686619|Immunologic Factors|immunologic factors|mesh-ancestor
110559300|NCT02686619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110559301|NCT02686619|Antifungal Agents|antifungal agents|mesh-ancestor
110559302|NCT02686619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110559303|NCT02686619|Dermatologic Agents|dermatologic agents|mesh-ancestor
110559304|NCT02686619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110559305|NCT02686619|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110559306|NCT02686619|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110559307|NCT02686619|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110559308|NCT02686619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110559309|NCT02686619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110559310|NCT02686619|Glucocorticoids|glucocorticoids|mesh-ancestor
110559311|NCT02686619|Hormones|hormones|mesh-ancestor
110559312|NCT02686619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110559313|NCT02686619|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110559314|NCT00688636|Infliximab|infliximab|mesh-list
110559315|NCT00688636|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110559316|NCT00688636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110559317|NCT00688636|Dermatologic Agents|dermatologic agents|mesh-ancestor
110559318|NCT00688636|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110559319|NCT00688636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110559320|NCT00870740|Daclizumab|daclizumab|mesh-list
110559321|NCT00870740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110559322|NCT00870740|Immunologic Factors|immunologic factors|mesh-ancestor
110559323|NCT00870740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110559324|NCT02686853|Amphotericin B|amphotericin b|mesh-list
110559325|NCT02686853|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
110559326|NCT02686853|Amebicides|amebicides|mesh-ancestor
110559327|NCT02686853|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110559328|NCT02686853|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110559329|NCT02686853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110559330|NCT02686853|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110559331|NCT02686853|Antifungal Agents|antifungal agents|mesh-ancestor
110559332|NCT01017679|Gefitinib|gefitinib|mesh-list
110559333|NCT01017679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110559334|NCT01017679|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110559335|NCT01017679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110559336|NCT01017679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110559337|NCT04130672|Hemostatics|hemostatics|mesh-list
110559338|NCT04130672|Coagulants|coagulants|mesh-ancestor
110559339|NCT00743314|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
110559340|NCT00743314|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110559341|NCT00743314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110559342|NCT02685449|Insulin|insulin|mesh-list
110559343|NCT02685449|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110559344|NCT02685449|Insulin Aspart|insulin aspart|mesh-list
110559345|NCT02685449|Insulin Lispro|insulin lispro|mesh-list
110559346|NCT02685449|Insulin glulisine|insulin glulisine|mesh-list
110559347|NCT02685449|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110559348|NCT02685449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110559349|NCT00697034|Capsaicin|capsaicin|mesh-list
110559350|NCT00697034|Antipruritics|antipruritics|mesh-ancestor
110559351|NCT00697034|Dermatologic Agents|dermatologic agents|mesh-ancestor
110559352|NCT00697034|Sensory System Agents|sensory system agents|mesh-ancestor
110559353|NCT00697034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110559354|NCT00697034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110559355|NCT00506779|Paclitaxel|paclitaxel|mesh-list
110559356|NCT00506779|Imatinib Mesylate|imatinib mesylate|mesh-list
110559357|NCT00506779|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110559358|NCT00506779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110559359|NCT00506779|Tubulin Modulators|tubulin modulators|mesh-ancestor
110559360|NCT00506779|Antimitotic Agents|antimitotic agents|mesh-ancestor
110559361|NCT00506779|Mitosis Modulators|mitosis modulators|mesh-ancestor
110188942|NCT00019565|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110559362|NCT00506779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110559363|NCT00506779|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110559364|NCT00506779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110559365|NCT04185233|Nitrous Oxide|nitrous oxide|mesh-list
110559366|NCT04185233|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110559367|NCT04185233|Anesthetics, General|anesthetics, general|mesh-ancestor
110559368|NCT04185233|Anesthetics|anesthetics|mesh-ancestor
110559369|NCT04185233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110559370|NCT04185233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110559371|NCT04185233|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110559372|NCT04185233|Analgesics|analgesics|mesh-ancestor
110559373|NCT04185233|Sensory System Agents|sensory system agents|mesh-ancestor
110559374|NCT04185233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110559375|NCT04185077|Heparin|heparin|mesh-list
110559376|NCT04185077|Calcium heparin|calcium heparin|mesh-list
110559377|NCT04185077|Bivalirudin|bivalirudin|mesh-list
110559378|NCT04185077|Antithrombins|antithrombins|mesh-list
110559379|NCT04185077|Thrombin|thrombin|mesh-list
110559380|NCT04185077|Anticoagulants|anticoagulants|mesh-ancestor
110559381|NCT04185077|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110559382|NCT04185077|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110559383|NCT04185077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110559384|NCT04185077|Hemostatics|hemostatics|mesh-ancestor
110559385|NCT04185077|Coagulants|coagulants|mesh-ancestor
110559386|NCT04185077|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110559387|NCT04185077|Protease Inhibitors|protease inhibitors|mesh-ancestor
110559388|NCT04185077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110559389|NCT02686385|Acetylcysteine|acetylcysteine|mesh-list
110559390|NCT02686385|Prednisolone|prednisolone|mesh-list
110559391|NCT02686385|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110559392|NCT02686385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110559393|NCT02686385|Glucocorticoids|glucocorticoids|mesh-ancestor
110559394|NCT02686385|Hormones|hormones|mesh-ancestor
110559395|NCT02686385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110559396|NCT02686385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110559397|NCT02686385|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110559398|NCT02686385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110559399|NCT02686385|Protective Agents|protective agents|mesh-ancestor
110559400|NCT02686385|Antiviral Agents|antiviral agents|mesh-ancestor
110559401|NCT02686385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110559402|NCT02686385|Expectorants|expectorants|mesh-ancestor
110559403|NCT02686385|Respiratory System Agents|respiratory system agents|mesh-ancestor
110559404|NCT02686385|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110559405|NCT02686385|Antioxidants|antioxidants|mesh-ancestor
110559406|NCT02686385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110559407|NCT02686385|Antidotes|antidotes|mesh-ancestor
110559408|NCT02686151|Dexamethasone|dexamethasone|mesh-list
110559409|NCT02686151|Letrozole|letrozole|mesh-list
110559410|NCT02686151|Polygeline|polygeline|mesh-list
110559411|NCT02686151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110559412|NCT02686151|Antiemetics|antiemetics|mesh-ancestor
110559413|NCT02686151|Autonomic Agents|autonomic agents|mesh-ancestor
110559414|NCT02686151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110559415|NCT02686151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110559416|NCT02686151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110559417|NCT02686151|Glucocorticoids|glucocorticoids|mesh-ancestor
110559418|NCT02686151|Hormones|hormones|mesh-ancestor
110559419|NCT02686151|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110559420|NCT02686151|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110559421|NCT02686151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110559422|NCT02686151|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110559423|NCT02686151|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110559424|NCT02686151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110559425|NCT02686151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110559426|NCT02686151|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110559427|NCT02686151|Hormone Antagonists|hormone antagonists|mesh-ancestor
110559428|NCT02686151|Plasma Substitutes|plasma substitutes|mesh-ancestor
110559429|NCT02686151|Blood Substitutes|blood substitutes|mesh-ancestor
110559430|NCT00868790|Metformin|metformin|mesh-list
110559431|NCT00868790|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110559432|NCT00868790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110559433|NCT00496483|Tacrolimus|tacrolimus|mesh-list
110559434|NCT00496483|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110559435|NCT00496483|Immunologic Factors|immunologic factors|mesh-ancestor
110559436|NCT00496483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110559437|NCT00496483|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110559438|NCT00496483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110559439|NCT00496483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110559440|NCT02614352|Candesartan|candesartan|mesh-list
110559441|NCT02614352|Candesartan cilexetil|candesartan cilexetil|mesh-list
110559442|NCT02614352|Atorvastatin|atorvastatin|mesh-list
110559443|NCT02614352|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110559444|NCT02614352|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110559445|NCT02614352|Antimetabolites|antimetabolites|mesh-ancestor
110559446|NCT02614352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110559447|NCT02614352|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110559448|NCT02614352|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110559449|NCT02614352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110559450|NCT02614352|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110559451|NCT02614352|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110559452|NCT02614352|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110559454|NCT01018225|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110559455|NCT01018225|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110559456|NCT01018225|Cholinergic Agents|cholinergic agents|mesh-ancestor
110559457|NCT01018225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110559458|NCT01018225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110559459|NCT01018225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110559460|NCT01018225|Urological Agents|urological agents|mesh-ancestor
110559461|NCT03528551|Factor VIII|factor viii|mesh-list
110559462|NCT03528551|Coagulants|coagulants|mesh-ancestor
110559463|NCT02685137|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
110559464|NCT02685137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110559465|NCT02685137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110559466|NCT01012063|Epoetin Alfa|epoetin alfa|mesh-list
110559467|NCT01012063|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
110559468|NCT01012063|Hematinics|hematinics|mesh-ancestor
110559469|NCT00861744|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110559470|NCT00861744|Immunologic Factors|immunologic factors|mesh-ancestor
110559471|NCT00861744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110559472|NCT02685059|Paclitaxel|paclitaxel|mesh-list
110559473|NCT02685059|Cyclophosphamide|cyclophosphamide|mesh-list
110559474|NCT02685059|Durvalumab|durvalumab|mesh-list
110559475|NCT02685059|Epirubicin|epirubicin|mesh-list
110559476|NCT02685059|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110559477|NCT02685059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110559478|NCT02685059|Tubulin Modulators|tubulin modulators|mesh-ancestor
110559479|NCT02685059|Antimitotic Agents|antimitotic agents|mesh-ancestor
110559480|NCT02685059|Mitosis Modulators|mitosis modulators|mesh-ancestor
110559481|NCT02685059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110559482|NCT02685059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110559483|NCT02685059|Immunologic Factors|immunologic factors|mesh-ancestor
110559484|NCT02685059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110559485|NCT02685059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110559486|NCT02685059|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110559487|NCT02685059|Alkylating Agents|alkylating agents|mesh-ancestor
110559488|NCT02685059|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110559489|NCT02685059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110559490|NCT02685059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110559491|NCT02685059|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110559492|NCT02685059|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110559493|NCT02685059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110559495|NCT00603239|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110559496|NCT00603239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110559497|NCT00603239|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110559498|NCT00603239|Incretins|incretins|mesh-ancestor
110559499|NCT00603239|Hormones|hormones|mesh-ancestor
110559500|NCT00603239|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110559501|NCT00699114|Acetaminophen|acetaminophen|mesh-list
110559502|NCT00699114|Ibuprofen|ibuprofen|mesh-list
110559503|NCT00699114|Codeine|codeine|mesh-list
110559504|NCT00699114|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110559505|NCT00699114|Analgesics|analgesics|mesh-ancestor
110559506|NCT00699114|Sensory System Agents|sensory system agents|mesh-ancestor
110559507|NCT00699114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110182548|NCT00025038|Dermatologic Agents|dermatologic agents|mesh-ancestor
110559508|NCT00699114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110559509|NCT00699114|Antipyretics|antipyretics|mesh-ancestor
110559510|NCT00699114|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110559511|NCT00699114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110559512|NCT00699114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110559513|NCT00699114|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110559514|NCT00699114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110559515|NCT00699114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110559516|NCT00699114|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110559517|NCT00699114|Narcotics|narcotics|mesh-ancestor
110559518|NCT00699114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110559519|NCT00699114|Antitussive Agents|antitussive agents|mesh-ancestor
110559520|NCT00699114|Respiratory System Agents|respiratory system agents|mesh-ancestor
110559521|NCT00639587|Cetirizine|cetirizine|mesh-list
110559522|NCT00639587|Ketotifen|ketotifen|mesh-list
110559523|NCT00639587|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110559524|NCT00639587|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110559525|NCT00639587|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110559526|NCT00639587|Histamine Antagonists|histamine antagonists|mesh-ancestor
110559528|NCT00639587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110559529|NCT00639587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110559530|NCT00639587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110559531|NCT00639587|Antipruritics|antipruritics|mesh-ancestor
110559532|NCT00639587|Dermatologic Agents|dermatologic agents|mesh-ancestor
110559533|NCT00700518|Nitroglycerin|nitroglycerin|mesh-list
110559534|NCT00700518|Vasodilator Agents|vasodilator agents|mesh-ancestor
110559536|NCT00852540|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110559537|NCT00852540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110559538|NCT00852540|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110559539|NCT00852540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110559540|NCT00852540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110559541|NCT00701298|Interferons|interferons|mesh-list
110559542|NCT00701298|Interferon-alpha|interferon-alpha|mesh-list
110559543|NCT00701298|Interferon alpha-2|interferon alpha-2|mesh-list
110559544|NCT00701298|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110559545|NCT00701298|Decitabine|decitabine|mesh-list
110559546|NCT00701298|Azacitidine|azacitidine|mesh-list
110559547|NCT00701298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110559548|NCT00701298|Antiviral Agents|antiviral agents|mesh-ancestor
110559549|NCT00701298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110559550|NCT00701298|Immunologic Factors|immunologic factors|mesh-ancestor
110559551|NCT00701298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110559552|NCT00701298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110559553|NCT00701298|Antimetabolites|antimetabolites|mesh-ancestor
110559554|NCT00701298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110559555|NCT00701298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110559556|NCT00860574|Methotrexate|methotrexate|mesh-list
110559557|NCT00860574|Fludarabine phosphate|fludarabine phosphate|mesh-list
110559558|NCT00860574|Fludarabine|fludarabine|mesh-list
110559559|NCT00860574|Treosulfan|treosulfan|mesh-list
110559560|NCT00860574|Tacrolimus|tacrolimus|mesh-list
110559561|NCT00860574|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110559562|NCT00860574|Abortifacient Agents|abortifacient agents|mesh-ancestor
110559563|NCT00860574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110559564|NCT00860574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110559565|NCT00860574|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110559566|NCT00860574|Antimetabolites|antimetabolites|mesh-ancestor
110559567|NCT00860574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110559568|NCT00860574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110559569|NCT00860574|Dermatologic Agents|dermatologic agents|mesh-ancestor
110559570|NCT00860574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110559571|NCT00860574|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110559572|NCT00860574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110559573|NCT00860574|Immunologic Factors|immunologic factors|mesh-ancestor
110559574|NCT00860574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110559575|NCT00860574|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110559576|NCT00860574|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110559577|NCT00860574|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110559578|NCT00860574|Alkylating Agents|alkylating agents|mesh-ancestor
110559579|NCT00496015|Acetaminophen|acetaminophen|mesh-list
110559580|NCT00496015|Vaccines|vaccines|mesh-list
110559581|NCT00496015|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110559582|NCT00496015|Immunologic Factors|immunologic factors|mesh-ancestor
110559583|NCT00496015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110559584|NCT00496015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110559585|NCT00496015|Analgesics|analgesics|mesh-ancestor
110559586|NCT00496015|Sensory System Agents|sensory system agents|mesh-ancestor
110559587|NCT00496015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110559588|NCT00496015|Antipyretics|antipyretics|mesh-ancestor
110559589|NCT01018381|Ethanol|ethanol|mesh-list
110559590|NCT01018381|Entecavir|entecavir|mesh-list
110559591|NCT01018381|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110559592|NCT01018381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110559593|NCT01018381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110559594|NCT01018381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110559595|NCT01018381|Antiviral Agents|antiviral agents|mesh-ancestor
110559596|NCT00487825|Methotrexate|methotrexate|mesh-list
110559597|NCT00487825|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110559598|NCT00487825|Abortifacient Agents|abortifacient agents|mesh-ancestor
110559599|NCT00487825|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110559600|NCT00487825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110559601|NCT00487825|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110559602|NCT00487825|Antimetabolites|antimetabolites|mesh-ancestor
110559603|NCT00487825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110559604|NCT00487825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110559605|NCT00487825|Dermatologic Agents|dermatologic agents|mesh-ancestor
110559606|NCT00487825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110559607|NCT00487825|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110559608|NCT00487825|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110559609|NCT00487825|Immunologic Factors|immunologic factors|mesh-ancestor
110559610|NCT00487825|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110559611|NCT00487825|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110559612|NCT00487747|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110559613|NCT00487747|Antiviral Agents|antiviral agents|mesh-ancestor
110559614|NCT00487747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110559616|NCT01012141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110559617|NCT01012141|Tubulin Modulators|tubulin modulators|mesh-ancestor
110559618|NCT01012141|Antimitotic Agents|antimitotic agents|mesh-ancestor
110559619|NCT01012141|Mitosis Modulators|mitosis modulators|mesh-ancestor
110559620|NCT01012141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110559621|NCT00487435|Tapentadol|tapentadol|mesh-list
110559622|NCT00487435|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110559623|NCT00487435|Narcotics|narcotics|mesh-ancestor
110559624|NCT00487435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110559625|NCT00487435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110559626|NCT00487435|Analgesics|analgesics|mesh-ancestor
110559627|NCT00487435|Sensory System Agents|sensory system agents|mesh-ancestor
110559628|NCT00487435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110559629|NCT00487435|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110559630|NCT00487435|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110559631|NCT00487435|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110559632|NCT00487435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110559633|NCT00487435|Adrenergic Agents|adrenergic agents|mesh-ancestor
110559634|NCT00487435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110559635|NCT00495625|Sunitinib|sunitinib|mesh-list
110559636|NCT00495625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110559637|NCT00495625|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110559638|NCT00495625|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110559639|NCT00495625|Growth Substances|growth substances|mesh-ancestor
110559640|NCT00495625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110559641|NCT00495625|Growth Inhibitors|growth inhibitors|mesh-ancestor
110559642|NCT00495625|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110559643|NCT00495625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110559644|NCT00495625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110559645|NCT00847626|Chlorthalidone|chlorthalidone|mesh-list
110559646|NCT00847626|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
110559647|NCT00847626|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110559648|NCT00847626|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110559649|NCT00847626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110559650|NCT00847626|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110559651|NCT00847626|Diuretics|diuretics|mesh-ancestor
110559652|NCT00847626|Natriuretic Agents|natriuretic agents|mesh-ancestor
110559653|NCT00847626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110559654|NCT00847626|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110559655|NCT00847626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110559656|NCT04115904|Ibuprofen|ibuprofen|mesh-list
110559657|NCT04115904|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110559658|NCT04115904|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110559659|NCT04115904|Analgesics|analgesics|mesh-ancestor
110559660|NCT04115904|Sensory System Agents|sensory system agents|mesh-ancestor
110559661|NCT04115904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110559662|NCT04115904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110559663|NCT04115904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110559664|NCT04115904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110559665|NCT04115904|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110559666|NCT04115904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110559667|NCT04115904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110559668|NCT05297994|Vaccines|vaccines|mesh-list
110559669|NCT05297994|Immunologic Factors|immunologic factors|mesh-ancestor
110559670|NCT05297994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110559671|NCT04116138|Antisecretory factor|antisecretory factor|mesh-list
110559672|NCT04116138|Antidiarrheals|antidiarrheals|mesh-ancestor
110559673|NCT04116138|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110559674|NCT00860262|Amlodipine|amlodipine|mesh-list
110559675|NCT00860262|Telmisartan|telmisartan|mesh-list
110559676|NCT00860262|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
110559677|NCT00860262|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110559678|NCT00860262|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110559680|NCT00860262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110559681|NCT00860262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110559682|NCT00860262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110559683|NCT00860262|Vasodilator Agents|vasodilator agents|mesh-ancestor
110559684|NCT00860262|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110559685|NCT00860262|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110559686|NCT00700830|Insulin Detemir|insulin detemir|mesh-list
110559687|NCT00700830|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110559688|NCT00700830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110559689|NCT00860028|Varenicline|varenicline|mesh-list
110559690|NCT00860028|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110559691|NCT00860028|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110559692|NCT00860028|Cholinergic Agents|cholinergic agents|mesh-ancestor
110559693|NCT00860028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110559694|NCT00860028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110559695|NCT00860028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110559696|NCT00701532|Modafinil|modafinil|mesh-list
110559697|NCT00701532|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110559698|NCT00701532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110559699|NCT00701532|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
110559700|NCT00701532|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110559701|NCT00701532|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110559702|NCT00701532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110559703|NCT00846768|Olodaterol|olodaterol|mesh-list
110559704|NCT00846768|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110559705|NCT00846768|Autonomic Agents|autonomic agents|mesh-ancestor
110559706|NCT00846768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110559707|NCT00846768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110559708|NCT00846768|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110559709|NCT00846768|Respiratory System Agents|respiratory system agents|mesh-ancestor
110559710|NCT00863798|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
110559711|NCT00863798|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110559712|NCT00863798|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110559713|NCT00863798|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110559714|NCT00863798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110559715|NCT00863798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110559716|NCT00863798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110559717|NCT00863798|Antidepressive Agents|antidepressive agents|mesh-ancestor
110559718|NCT00863798|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110559719|NCT00697658|Paliperidone Palmitate|paliperidone palmitate|mesh-list
110559720|NCT00697658|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110559721|NCT00697658|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110559722|NCT00697658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110559723|NCT00697658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110559724|NCT00697658|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110559725|NCT00697658|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110559726|NCT00697658|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110559727|NCT00697658|Serotonin Agents|serotonin agents|mesh-ancestor
110559728|NCT00697658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110559729|NCT00697658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110559730|NCT00697658|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110559731|NCT00697658|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110559732|NCT00697658|Dopamine Agents|dopamine agents|mesh-ancestor
110559734|NCT00699426|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110559735|NCT00699426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110559736|NCT00699426|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110559737|NCT00699426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110559738|NCT00699426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110559740|NCT00593606|Dopamine Agonists|dopamine agonists|mesh-ancestor
110559741|NCT00593606|Dopamine Agents|dopamine agents|mesh-ancestor
110559742|NCT00593606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110559743|NCT00593606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110559744|NCT00593606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110559745|NCT02614118|Acetaminophen|acetaminophen|mesh-list
110559746|NCT02614118|Ketorolac|ketorolac|mesh-list
110559747|NCT02614118|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
110559748|NCT02614118|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110559749|NCT02614118|Analgesics|analgesics|mesh-ancestor
110207344|NCT00186979|Cefixime|cefixime|mesh-list
110559750|NCT02614118|Sensory System Agents|sensory system agents|mesh-ancestor
110559751|NCT02614118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110559752|NCT02614118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110559753|NCT02614118|Antipyretics|antipyretics|mesh-ancestor
110559754|NCT02614118|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110559755|NCT02614118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110559756|NCT02614118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110559757|NCT02614118|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110559758|NCT02614118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110559759|NCT02614118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110559760|NCT04134416|Donepezil|donepezil|mesh-list
110559761|NCT04134416|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110559762|NCT04134416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110559763|NCT04134416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110559764|NCT04134416|Cholinergic Agents|cholinergic agents|mesh-ancestor
110559765|NCT04134416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110559766|NCT04134416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110559768|NCT04134182|Nivolumab|nivolumab|mesh-list
110559769|NCT04134182|Ipilimumab|ipilimumab|mesh-list
110559770|NCT04134182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110559771|NCT04134182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110559772|NCT04134182|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110559773|NCT04134182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110559774|NCT00870584|Omalizumab|omalizumab|mesh-list
110559775|NCT00870584|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110559776|NCT00870584|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110559777|NCT00870584|Respiratory System Agents|respiratory system agents|mesh-ancestor
110559778|NCT02614508|Ofatumumab|ofatumumab|mesh-list
110559780|NCT02614508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110559781|NCT02614508|Immunologic Factors|immunologic factors|mesh-ancestor
110559782|NCT02614508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110559783|NCT02616068|Loxoprofen|loxoprofen|mesh-list
110559784|NCT02616068|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110559785|NCT02616068|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110559786|NCT02616068|Analgesics|analgesics|mesh-ancestor
110559787|NCT02616068|Sensory System Agents|sensory system agents|mesh-ancestor
110559788|NCT02616068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110559789|NCT02616068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110559790|NCT02616068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110559791|NCT02616068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110559792|NCT04127084|Empagliflozin|empagliflozin|mesh-list
110559793|NCT04127084|Canagliflozin|canagliflozin|mesh-list
110559794|NCT04127084|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110559795|NCT04127084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110559796|NCT04127084|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110559797|NCT04127084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110559798|NCT00870194|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110559799|NCT00870194|Exenatide|exenatide|mesh-list
110559800|NCT00870194|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110559801|NCT00870194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110559802|NCT00870194|Incretins|incretins|mesh-ancestor
110559804|NCT00870194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110559805|NCT00870194|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110559806|NCT00870194|Protease Inhibitors|protease inhibitors|mesh-ancestor
110559807|NCT00870194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110559808|NCT00870194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110559809|NCT00870194|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110559810|NCT00690430|Octreotide|octreotide|mesh-list
110559811|NCT00690430|Pasireotide|pasireotide|mesh-list
110559812|NCT00690430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110559813|NCT00690430|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110559814|NCT00690430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110559815|NCT00690430|Hormones|hormones|mesh-ancestor
110559816|NCT00690430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110559817|NCT00690430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110559818|NCT04126304|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110559819|NCT04126304|Azithromycin|azithromycin|mesh-list
110559820|NCT04126304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110559821|NCT02563054|Fluorouracil|fluorouracil|mesh-list
110559822|NCT02563054|Capecitabine|capecitabine|mesh-list
110559823|NCT02563054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110559824|NCT02563054|Antimetabolites|antimetabolites|mesh-ancestor
110559825|NCT02563054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110559826|NCT02563054|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110559827|NCT02563054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110559828|NCT02563054|Immunologic Factors|immunologic factors|mesh-ancestor
110559829|NCT02563054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110559830|NCT02614040|Plasma-lyte 148|plasma-lyte 148|mesh-list
110559831|NCT02614040|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110559832|NCT02614040|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110559833|NCT00743470|Ritonavir|ritonavir|mesh-list
110559834|NCT00743470|Lopinavir|lopinavir|mesh-list
110559835|NCT00743470|Rifabutin|rifabutin|mesh-list
110559836|NCT00743470|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110162615|NCT00113815|Anticonvulsants|anticonvulsants|mesh-ancestor
110559837|NCT00743470|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110559838|NCT00743470|Protease Inhibitors|protease inhibitors|mesh-ancestor
110559839|NCT00743470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110559840|NCT00743470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110559841|NCT00743470|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110559842|NCT00743470|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110559843|NCT00743470|Antiviral Agents|antiviral agents|mesh-ancestor
110559844|NCT00743470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110559845|NCT00743470|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110559846|NCT00743470|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110559847|NCT00743470|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110559848|NCT00743470|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110559849|NCT00743470|Antitubercular Agents|antitubercular agents|mesh-ancestor
110559850|NCT00688324|Acamprosate|acamprosate|mesh-list
110559851|NCT00688324|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110559852|NCT02619578|Remifentanil|remifentanil|mesh-list
110559853|NCT02619578|Propofol|propofol|mesh-list
110559854|NCT02619578|Vecuronium Bromide|vecuronium bromide|mesh-list
110559855|NCT02619578|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110559856|NCT02619578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110559857|NCT02619578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110559858|NCT02619578|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110559859|NCT02619578|Anesthetics, General|anesthetics, general|mesh-ancestor
110559860|NCT02619578|Anesthetics|anesthetics|mesh-ancestor
110559861|NCT02619578|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110559862|NCT02619578|Narcotics|narcotics|mesh-ancestor
110559863|NCT02619578|Analgesics|analgesics|mesh-ancestor
110559864|NCT02619578|Sensory System Agents|sensory system agents|mesh-ancestor
110559865|NCT02619578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110559866|NCT02619578|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110559867|NCT02619578|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110559868|NCT02619578|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110559869|NCT02619578|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
110559870|NCT02619578|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110559871|NCT02619578|Cholinergic Agents|cholinergic agents|mesh-ancestor
110559872|NCT02619578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110559873|NCT02619578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110559874|NCT02615912|Castor Oil|castor oil|mesh-list
110559875|NCT02615912|Cathartics|cathartics|mesh-ancestor
110559876|NCT02615912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110559877|NCT04123652|Lidocaine|lidocaine|mesh-list
110559878|NCT04123652|Ketamine|ketamine|mesh-list
110559879|NCT04123652|Anesthetics, Local|anesthetics, local|mesh-ancestor
110559880|NCT04123652|Anesthetics|anesthetics|mesh-ancestor
110559881|NCT04123652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110559882|NCT04123652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110559883|NCT04123652|Sensory System Agents|sensory system agents|mesh-ancestor
110559884|NCT04123652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110559885|NCT04123652|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110559886|NCT04123652|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110559887|NCT04123652|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110559888|NCT04123652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110559889|NCT04123652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110559890|NCT04123652|Analgesics|analgesics|mesh-ancestor
110559891|NCT04123652|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110559892|NCT04123652|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110559893|NCT04123652|Anesthetics, General|anesthetics, general|mesh-ancestor
110559894|NCT04123652|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110559895|NCT04123652|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110559896|NCT04123652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110559897|NCT00862940|Memantine|memantine|mesh-list
110559898|NCT00862940|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110559899|NCT00862940|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110559900|NCT00862940|Dopamine Agents|dopamine agents|mesh-ancestor
110559901|NCT00862940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110559902|NCT00862940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110559903|NCT00862940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110559904|NCT00862940|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110559905|NCT00862940|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110559906|NCT04122716|Liraglutide|liraglutide|mesh-list
110559907|NCT04122716|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110559908|NCT04122716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110559909|NCT04122716|Incretins|incretins|mesh-ancestor
110559910|NCT04122716|Hormones|hormones|mesh-ancestor
110559911|NCT04122716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110559912|NCT00868166|Riluzole|riluzole|mesh-list
110559913|NCT00868166|Anticonvulsants|anticonvulsants|mesh-ancestor
110559914|NCT00868166|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110559915|NCT00868166|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110559916|NCT00868166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110559917|NCT00868166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110559918|NCT00868166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110182625|NCT00025272|Topotecan|topotecan|mesh-list
110559919|NCT00868166|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110559920|NCT00868166|Protective Agents|protective agents|mesh-ancestor
110559921|NCT00858780|Etanercept|etanercept|mesh-list
110559922|NCT00858780|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110559923|NCT00858780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110559924|NCT00858780|Analgesics|analgesics|mesh-ancestor
110559925|NCT00858780|Sensory System Agents|sensory system agents|mesh-ancestor
110559926|NCT00858780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110559927|NCT00858780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110559928|NCT00858780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110559929|NCT00858780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110559930|NCT00858780|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110559931|NCT00858780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110559932|NCT00858780|Immunologic Factors|immunologic factors|mesh-ancestor
110559933|NCT02619266|Megestrol|megestrol|mesh-list
110559934|NCT02619266|Megestrol Acetate|megestrol acetate|mesh-list
110559935|NCT02619266|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110559936|NCT02619266|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110559937|NCT02619266|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110559938|NCT02619266|Contraceptive Agents|contraceptive agents|mesh-ancestor
110559939|NCT02619266|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110559940|NCT02619266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110559941|NCT02619266|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110559942|NCT02619266|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110559943|NCT02619266|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110559944|NCT02619266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110559945|NCT02619266|Appetite Stimulants|appetite stimulants|mesh-ancestor
110559946|NCT02619266|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110559947|NCT00699062|Montelukast|montelukast|mesh-list
110559948|NCT00699062|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110559949|NCT00699062|Respiratory System Agents|respiratory system agents|mesh-ancestor
110559950|NCT00699062|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110559951|NCT00699062|Hormone Antagonists|hormone antagonists|mesh-ancestor
110559952|NCT00699062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110559953|NCT00699062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110559954|NCT00699062|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110559955|NCT00699062|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110559956|NCT00699062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110559958|NCT02619032|Remifentanil|remifentanil|mesh-list
110559959|NCT02619032|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110559960|NCT02619032|Narcotics|narcotics|mesh-ancestor
110559961|NCT02619032|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110559962|NCT02619032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110559963|NCT02619032|Analgesics|analgesics|mesh-ancestor
110559964|NCT02619032|Sensory System Agents|sensory system agents|mesh-ancestor
110559965|NCT02619032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110559966|NCT02619032|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110559967|NCT02619032|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110559968|NCT02619032|Anesthetics, General|anesthetics, general|mesh-ancestor
110559970|NCT00858234|Bortezomib|bortezomib|mesh-list
110559971|NCT00858234|Vorinostat|vorinostat|mesh-list
110559972|NCT00858234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110559973|NCT00858234|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110559974|NCT00858234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110559975|NCT00858234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110559976|NCT00697814|Clomiphene|clomiphene|mesh-list
110559977|NCT00697814|Enclomiphene|enclomiphene|mesh-list
110559978|NCT00697814|Zuclomiphene|zuclomiphene|mesh-list
110559979|NCT00697814|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110559980|NCT00697814|Hormone Antagonists|hormone antagonists|mesh-ancestor
110559981|NCT00697814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110559982|NCT00697814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110559983|NCT00697814|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110559984|NCT00697814|Fertility Agents|fertility agents|mesh-ancestor
110559985|NCT00697814|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110559986|NCT00697814|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110559987|NCT00697814|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110559988|NCT00862082|Sorafenib|sorafenib|mesh-list
110559989|NCT00862082|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
110559990|NCT00862082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110559991|NCT00862082|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110559992|NCT00862082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110559993|NCT00862082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110559994|NCT00862082|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110559997|NCT00849186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110559998|NCT00849186|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110559999|NCT00849186|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110560000|NCT00849186|Growth Substances|growth substances|mesh-ancestor
110560001|NCT00849186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110560002|NCT00849186|Growth Inhibitors|growth inhibitors|mesh-ancestor
110560003|NCT00849186|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110560004|NCT00849186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110560005|NCT00849186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110560006|NCT00692770|Sorafenib|sorafenib|mesh-list
110560007|NCT00692770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110560008|NCT00692770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110560009|NCT00692770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110560010|NCT00692770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110560011|NCT00867308|Lenalidomide|lenalidomide|mesh-list
110560012|NCT00867308|Immunologic Factors|immunologic factors|mesh-ancestor
110560013|NCT00867308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110560014|NCT00867308|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110560015|NCT00867308|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110560016|NCT00867308|Growth Substances|growth substances|mesh-ancestor
110560017|NCT00867308|Growth Inhibitors|growth inhibitors|mesh-ancestor
110560018|NCT00867308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110560019|NCT02618876|Nalbuphine|nalbuphine|mesh-list
110560020|NCT02618876|Bupivacaine|bupivacaine|mesh-list
110560021|NCT02618876|Anesthetics, Local|anesthetics, local|mesh-ancestor
110560022|NCT02618876|Anesthetics|anesthetics|mesh-ancestor
110560023|NCT02618876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110560024|NCT02618876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110560025|NCT02618876|Sensory System Agents|sensory system agents|mesh-ancestor
110560026|NCT02618876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110560027|NCT02618876|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110560028|NCT02618876|Narcotics|narcotics|mesh-ancestor
110560029|NCT02618876|Analgesics|analgesics|mesh-ancestor
110560030|NCT04119752|Curcumin|curcumin|mesh-list
110560031|NCT04119752|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110560032|NCT04119752|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110560033|NCT04119752|Analgesics|analgesics|mesh-ancestor
110560034|NCT04119752|Sensory System Agents|sensory system agents|mesh-ancestor
110560035|NCT04119752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110560036|NCT04119752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110560037|NCT04119752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110560038|NCT04119752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110560039|NCT04119752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110560040|NCT04119752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110560335|NCT00638729|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110560041|NCT04119752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110560042|NCT00866918|Vitamins|vitamins|mesh-list
110560043|NCT00866918|Vitamin A|vitamin a|mesh-list
110560044|NCT00866918|Cytarabine|cytarabine|mesh-list
110560045|NCT00866918|Methotrexate|methotrexate|mesh-list
110560046|NCT00866918|Mercaptopurine|mercaptopurine|mesh-list
110560047|NCT00866918|Mitoxantrone|mitoxantrone|mesh-list
110560048|NCT00866918|Idarubicin|idarubicin|mesh-list
110560049|NCT00866918|Tretinoin|tretinoin|mesh-list
110560050|NCT00866918|Retinol palmitate|retinol palmitate|mesh-list
110560051|NCT00866918|Arsenic Trioxide|arsenic trioxide|mesh-list
110560052|NCT00866918|Micronutrients|micronutrients|mesh-ancestor
110560053|NCT00866918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110560054|NCT00866918|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110560055|NCT00866918|Abortifacient Agents|abortifacient agents|mesh-ancestor
110560056|NCT00866918|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110560057|NCT00866918|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110560058|NCT00866918|Antimetabolites|antimetabolites|mesh-ancestor
110560059|NCT00866918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110560060|NCT00866918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110560061|NCT00866918|Dermatologic Agents|dermatologic agents|mesh-ancestor
110560062|NCT00866918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110560063|NCT00866918|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110560064|NCT00866918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110560065|NCT00866918|Immunologic Factors|immunologic factors|mesh-ancestor
110560066|NCT00866918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110560067|NCT00866918|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110560068|NCT00866918|Antiviral Agents|antiviral agents|mesh-ancestor
110560069|NCT00866918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110560070|NCT00866918|Analgesics|analgesics|mesh-ancestor
110560071|NCT00866918|Sensory System Agents|sensory system agents|mesh-ancestor
110560072|NCT00866918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110560073|NCT00866918|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110560074|NCT00866918|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110560075|NCT00866918|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110560076|NCT00866918|Keratolytic Agents|keratolytic agents|mesh-ancestor
110560077|NCT00866918|Antioxidants|antioxidants|mesh-ancestor
110560078|NCT00866918|Protective Agents|protective agents|mesh-ancestor
110560079|NCT00866918|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110560081|NCT00861692|Antithrombins|antithrombins|mesh-ancestor
110560082|NCT00861692|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110560083|NCT00861692|Protease Inhibitors|protease inhibitors|mesh-ancestor
110560084|NCT00861692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110560085|NCT00861692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110560086|NCT00861692|Anticoagulants|anticoagulants|mesh-ancestor
110560087|NCT00861692|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110560088|NCT03131765|Poly I-C|poly i-c|mesh-list
110560089|NCT03131765|Antiviral Agents|antiviral agents|mesh-ancestor
110560090|NCT03131765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110560091|NCT03131765|Interferon Inducers|interferon inducers|mesh-ancestor
110560092|NCT03131765|Immunologic Factors|immunologic factors|mesh-ancestor
110560093|NCT03131765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110560094|NCT02689037|Aspirin|aspirin|mesh-list
110560095|NCT02689037|Clopidogrel|clopidogrel|mesh-list
110560096|NCT02689037|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110560097|NCT02689037|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110560098|NCT02689037|Analgesics|analgesics|mesh-ancestor
110560099|NCT02689037|Sensory System Agents|sensory system agents|mesh-ancestor
110560100|NCT02689037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110560101|NCT02689037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110560102|NCT02689037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110560103|NCT02689037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110560104|NCT02689037|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110560105|NCT02689037|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110560106|NCT02689037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110560107|NCT02689037|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110560108|NCT02689037|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110560109|NCT02689037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110560110|NCT02689037|Antipyretics|antipyretics|mesh-ancestor
110560111|NCT02689037|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110560112|NCT02689037|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110560113|NCT02689037|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110560114|NCT02689037|Purinergic Agents|purinergic agents|mesh-ancestor
110560115|NCT02689037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110560116|NCT04184921|Aspirin|aspirin|mesh-list
110560117|NCT04184921|Osimertinib|osimertinib|mesh-list
110560336|NCT00638729|Anesthetics, General|anesthetics, general|mesh-ancestor
110560118|NCT04184921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110560119|NCT04184921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110560120|NCT04184921|Analgesics|analgesics|mesh-ancestor
110560121|NCT04184921|Sensory System Agents|sensory system agents|mesh-ancestor
110560122|NCT04184921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110560123|NCT04184921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110560124|NCT04184921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110560125|NCT04184921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110560126|NCT04184921|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110207735|NCT00189007|Mannitol|mannitol|mesh-list
110560127|NCT04184921|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110560128|NCT04184921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110560129|NCT04184921|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110560130|NCT04184921|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110560131|NCT04184921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110560132|NCT04184921|Antipyretics|antipyretics|mesh-ancestor
110560133|NCT04184921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110560134|NCT04184921|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110560135|NCT00602927|Varenicline|varenicline|mesh-list
110560136|NCT00602927|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110560137|NCT00602927|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110560138|NCT00602927|Cholinergic Agents|cholinergic agents|mesh-ancestor
110560139|NCT00602927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110560140|NCT00602927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110560141|NCT00602927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110560142|NCT00639743|Tenecteplase|tenecteplase|mesh-list
110560143|NCT00639743|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110560144|NCT00639743|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110560145|NCT00639743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110560146|NCT00602537|Lithium Carbonate|lithium carbonate|mesh-list
110560147|NCT00602537|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
110560148|NCT00602537|Antidepressive Agents|antidepressive agents|mesh-ancestor
110560149|NCT00602537|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110560150|NCT00602537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110560151|NCT00602537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110560152|NCT00602537|Antimanic Agents|antimanic agents|mesh-ancestor
110560153|NCT00602537|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110560154|NCT00602537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110560155|NCT00602537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110560156|NCT00602537|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110560157|NCT00602537|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110560158|NCT00602537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110560159|NCT00602537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110560160|NCT00602537|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110560161|NCT02688803|Paclitaxel|paclitaxel|mesh-list
110560162|NCT02688803|Docetaxel|docetaxel|mesh-list
110560163|NCT02688803|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110560164|NCT02688803|Cyclophosphamide|cyclophosphamide|mesh-list
110560165|NCT02688803|Doxorubicin|doxorubicin|mesh-list
110560166|NCT02688803|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110560167|NCT02688803|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110560168|NCT02688803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110560169|NCT02688803|Tubulin Modulators|tubulin modulators|mesh-ancestor
110560170|NCT02688803|Antimitotic Agents|antimitotic agents|mesh-ancestor
110560171|NCT02688803|Mitosis Modulators|mitosis modulators|mesh-ancestor
110560172|NCT02688803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110560173|NCT02688803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110560174|NCT02688803|Immunologic Factors|immunologic factors|mesh-ancestor
110560175|NCT02688803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110560176|NCT02688803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110560177|NCT02688803|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110560178|NCT02688803|Alkylating Agents|alkylating agents|mesh-ancestor
110560179|NCT02688803|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110560180|NCT02688803|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110560181|NCT02688803|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110560182|NCT02688803|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110560183|NCT02688803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110560184|NCT02684669|Naloxone|naloxone|mesh-list
110560185|NCT02684669|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110560186|NCT02684669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110560187|NCT02684669|Sensory System Agents|sensory system agents|mesh-ancestor
110560188|NCT02684669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110560189|NCT02976935|Xenon|xenon|mesh-list
110182636|NCT05023382|Protective Agents|protective agents|mesh-ancestor
110162708|NCT00114478|Tocolytic Agents|tocolytic agents|mesh-ancestor
110560190|NCT02976935|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110560191|NCT02976935|Anesthetics, General|anesthetics, general|mesh-ancestor
110560192|NCT02976935|Anesthetics|anesthetics|mesh-ancestor
110560193|NCT02976935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110560194|NCT02976935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110560195|NCT00861614|Ipilimumab|ipilimumab|mesh-list
110560196|NCT00861614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110560197|NCT00861614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110560198|NCT00861614|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110560199|NCT00861614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110560200|NCT00861380|Vaccines|vaccines|mesh-list
110560201|NCT00861380|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110560202|NCT00861380|Immunologic Factors|immunologic factors|mesh-ancestor
110560203|NCT00861380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110560204|NCT00495391|Ribavirin|ribavirin|mesh-list
110560205|NCT00495391|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110560206|NCT00495391|Nitazoxanide|nitazoxanide|mesh-list
110560207|NCT00495391|Antimetabolites|antimetabolites|mesh-ancestor
110560208|NCT00495391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110560209|NCT00495391|Antiviral Agents|antiviral agents|mesh-ancestor
110560210|NCT00495391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110560211|NCT00495391|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110560212|NCT04378621|Adalimumab|adalimumab|mesh-list
110560213|NCT04378621|Infliximab|infliximab|mesh-list
110560214|NCT04378621|Golimumab|golimumab|mesh-list
110560215|NCT04378621|Certolizumab Pegol|certolizumab pegol|mesh-list
110560216|NCT04378621|Etanercept|etanercept|mesh-list
110560217|NCT04378621|Tofacitinib|tofacitinib|mesh-list
110560218|NCT04378621|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
110560219|NCT04378621|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110560220|NCT04378621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110560221|NCT04378621|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110560222|NCT04378621|Dermatologic Agents|dermatologic agents|mesh-ancestor
110560223|NCT04378621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110560224|NCT04378621|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110560225|NCT04378621|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110560226|NCT04378621|Analgesics|analgesics|mesh-ancestor
110560227|NCT04378621|Sensory System Agents|sensory system agents|mesh-ancestor
110560228|NCT04378621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110560229|NCT04378621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110560230|NCT04378621|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110560231|NCT04378621|Immunologic Factors|immunologic factors|mesh-ancestor
110560232|NCT04378621|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110560233|NCT04378621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110560234|NCT04378621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110560235|NCT00869960|Ritonavir|ritonavir|mesh-list
110560236|NCT00869960|Atazanavir Sulfate|atazanavir sulfate|mesh-list
110560237|NCT00869960|Tenofovir|tenofovir|mesh-list
110560238|NCT00869960|Emtricitabine|emtricitabine|mesh-list
110560239|NCT00869960|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110560240|NCT00869960|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110560241|NCT00869960|Protease Inhibitors|protease inhibitors|mesh-ancestor
110560242|NCT00869960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110560243|NCT00869960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110560244|NCT00869960|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110560245|NCT00869960|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110560246|NCT00869960|Antiviral Agents|antiviral agents|mesh-ancestor
110560247|NCT00869960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110560248|NCT00869960|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110560249|NCT00869960|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110560250|NCT00869960|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110560251|NCT00869960|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110560252|NCT02618564|Sennosides|sennosides|mesh-list
110560253|NCT02618564|Laxatives|laxatives|mesh-ancestor
110560254|NCT02618564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110560255|NCT02615366|Tranexamic Acid|tranexamic acid|mesh-list
110560256|NCT02615366|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110560257|NCT02615366|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110560258|NCT02615366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110560259|NCT02615366|Hemostatics|hemostatics|mesh-ancestor
110560260|NCT02615366|Coagulants|coagulants|mesh-ancestor
110560261|NCT00699296|Panobinostat|panobinostat|mesh-list
110560262|NCT00699296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110560263|NCT00699296|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110560264|NCT00699296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110683018|NCT00904631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110683020|NCT00909077|Dexamethasone acetate|dexamethasone acetate|mesh-list
110683021|NCT00909077|Rituximab|rituximab|mesh-list
110683022|NCT00909077|BB 1101|bb 1101|mesh-list
110683023|NCT00909077|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110683024|NCT00909077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110683025|NCT00909077|Immunologic Factors|immunologic factors|mesh-ancestor
110683026|NCT00909077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110683027|NCT00909077|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110683028|NCT00909077|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110683029|NCT00909077|Antiemetics|antiemetics|mesh-ancestor
110683030|NCT00909077|Autonomic Agents|autonomic agents|mesh-ancestor
110683031|NCT00909077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110683032|NCT00909077|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110683033|NCT00909077|Glucocorticoids|glucocorticoids|mesh-ancestor
110683034|NCT00909077|Hormones|hormones|mesh-ancestor
110683035|NCT00909077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110683036|NCT00909077|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110683037|NCT00909077|Protease Inhibitors|protease inhibitors|mesh-ancestor
110683038|NCT00909077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110683039|NCT00909077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110683040|NCT00904709|Tranexamic Acid|tranexamic acid|mesh-list
110683041|NCT00904709|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110683042|NCT00904709|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110683043|NCT00904709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110683044|NCT00904709|Hemostatics|hemostatics|mesh-ancestor
110683045|NCT00904709|Coagulants|coagulants|mesh-ancestor
110683046|NCT00340834|Interferons|interferons|mesh-list
110683047|NCT00340834|Interferon-beta|interferon-beta|mesh-list
110683048|NCT00340834|Interferon beta-1a|interferon beta-1a|mesh-list
110683049|NCT00340834|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
110683050|NCT00340834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110683051|NCT00340834|Antiviral Agents|antiviral agents|mesh-ancestor
110683052|NCT00340834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110683053|NCT00340834|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
110683054|NCT00340834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110683055|NCT00340834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110683056|NCT00340834|Immunologic Factors|immunologic factors|mesh-ancestor
110683057|NCT00340834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110683058|NCT00340834|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110683059|NCT01057966|Vitamins|vitamins|mesh-list
110683060|NCT01057966|Micronutrients|micronutrients|mesh-ancestor
110683061|NCT01057966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110683062|NCT00603941|Paclitaxel|paclitaxel|mesh-list
110683063|NCT00603941|Efatutazone|efatutazone|mesh-list
110683064|NCT00603941|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110683065|NCT00603941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110683066|NCT00603941|Tubulin Modulators|tubulin modulators|mesh-ancestor
110683067|NCT00603941|Antimitotic Agents|antimitotic agents|mesh-ancestor
110683068|NCT00603941|Mitosis Modulators|mitosis modulators|mesh-ancestor
110683069|NCT00603941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110683070|NCT00340678|Losartan|losartan|mesh-list
110683071|NCT00340678|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110683072|NCT00340678|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110683073|NCT00340678|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110683074|NCT00340678|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110683075|NCT00340678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110683076|NCT01055470|Diclofenac|diclofenac|mesh-list
110683077|NCT01055470|Lornoxicam|lornoxicam|mesh-list
110683078|NCT01055470|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110683079|NCT01055470|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110683080|NCT01055470|Analgesics|analgesics|mesh-ancestor
110683081|NCT01055470|Sensory System Agents|sensory system agents|mesh-ancestor
110683082|NCT01055470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110683083|NCT01055470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110683084|NCT01055470|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110683085|NCT01055470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110683086|NCT01055470|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110683087|NCT01055470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110683088|NCT01055470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110683089|NCT03986008|Liraglutide|liraglutide|mesh-list
110683090|NCT03986008|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110683091|NCT03986008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110683094|NCT03986008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110683095|NCT00909233|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
110683096|NCT00909233|Vasodilator Agents|vasodilator agents|mesh-ancestor
110683097|NCT00909233|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110683098|NCT00909233|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110683099|NCT00909233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110683100|NCT00909233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110162787|NCT00115024|Estradiol|estradiol|mesh-list
110683101|NCT00909233|Urological Agents|urological agents|mesh-ancestor
110683102|NCT00909311|Ritonavir|ritonavir|mesh-list
110683103|NCT00909311|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110683104|NCT00909311|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110683105|NCT00909311|Protease Inhibitors|protease inhibitors|mesh-ancestor
110683106|NCT00909311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110683107|NCT00909311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110683108|NCT00909311|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110683109|NCT00909311|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110683110|NCT00909311|Antiviral Agents|antiviral agents|mesh-ancestor
110683111|NCT00909311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110683112|NCT00909311|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110683113|NCT00909311|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110683114|NCT00907751|Rituximab|rituximab|mesh-list
110683115|NCT00907751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110683116|NCT00907751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110683117|NCT00907751|Immunologic Factors|immunologic factors|mesh-ancestor
110683118|NCT00907751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110683119|NCT00907751|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110683120|NCT00905333|Felodipine|felodipine|mesh-list
110683121|NCT00905333|Candesartan|candesartan|mesh-list
110683122|NCT00905333|Candesartan cilexetil|candesartan cilexetil|mesh-list
110683123|NCT00905333|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110683124|NCT00905333|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110683125|NCT00905333|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110330168|NCT00469664|Guanfacine|guanfacine|mesh-list
110683126|NCT00905333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110683127|NCT00905333|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110683128|NCT00905333|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110683129|NCT00905333|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110683130|NCT00905333|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110683131|NCT00905333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110683132|NCT00905333|Vasodilator Agents|vasodilator agents|mesh-ancestor
110683133|NCT00907829|Lidocaine|lidocaine|mesh-list
110683134|NCT00907829|Anesthetics, Local|anesthetics, local|mesh-ancestor
110683135|NCT00907829|Anesthetics|anesthetics|mesh-ancestor
110683136|NCT00907829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110683137|NCT00907829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110683138|NCT00907829|Sensory System Agents|sensory system agents|mesh-ancestor
110683139|NCT00907829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110683140|NCT00907829|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110683141|NCT00907829|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110683142|NCT00907829|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110683143|NCT00907829|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110683144|NCT00907829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110683145|NCT00336544|Clarithromycin|clarithromycin|mesh-list
110683146|NCT00336544|Cethromycin|cethromycin|mesh-list
110683147|NCT00336544|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110683148|NCT00336544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110683149|NCT00336544|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110683150|NCT00336544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110683151|NCT00336544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110683152|NCT00336544|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110683153|NCT00336544|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110683154|NCT01059058|Fluorides|fluorides|mesh-list
110683155|NCT01059058|Fluorides, Topical|fluorides, topical|mesh-list
110683156|NCT01059058|Cariostatic Agents|cariostatic agents|mesh-ancestor
110683157|NCT01059058|Protective Agents|protective agents|mesh-ancestor
110683158|NCT01059058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110683159|NCT00605033|Buprenorphine|buprenorphine|mesh-list
110683160|NCT00605033|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
110683161|NCT00605033|Naloxone|naloxone|mesh-list
110683162|NCT00605033|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110683163|NCT00605033|Narcotics|narcotics|mesh-ancestor
110683164|NCT00605033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110683165|NCT00605033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110683166|NCT00605033|Analgesics|analgesics|mesh-ancestor
110683167|NCT00605033|Sensory System Agents|sensory system agents|mesh-ancestor
110683168|NCT00605033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110683169|NCT00605033|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110683170|NCT03988114|Aromatase Inhibitors|aromatase inhibitors|mesh-list
110683171|NCT03988114|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110683172|NCT03988114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110683173|NCT03988114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110683174|NCT03988114|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110683175|NCT03988114|Hormone Antagonists|hormone antagonists|mesh-ancestor
110683176|NCT03988114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110683177|NCT03988114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110683178|NCT00905723|Estradiol|estradiol|mesh-list
110683179|NCT00905723|Estrogens|estrogens|mesh-ancestor
110683180|NCT00905723|Hormones|hormones|mesh-ancestor
110683181|NCT00905723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110683182|NCT00905723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110683183|NCT00907985|Lamotrigine|lamotrigine|mesh-list
110683184|NCT00907985|Vofopitant|vofopitant|mesh-list
110683185|NCT00907985|Anticonvulsants|anticonvulsants|mesh-ancestor
110683186|NCT00907985|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110683187|NCT00907985|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110683188|NCT00907985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110683189|NCT00907985|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110683190|NCT00907985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110683191|NCT00907985|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110683192|NCT00907985|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110683193|NCT00907985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110683194|NCT00907985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110683195|NCT00907985|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110683196|NCT00907985|Antiemetics|antiemetics|mesh-ancestor
110683197|NCT00907985|Autonomic Agents|autonomic agents|mesh-ancestor
110330240|NCT03271502|Anesthetics|anesthetics|mesh-list
110683198|NCT00907985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110683200|NCT00907985|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110683201|NCT00907985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110683202|NCT01325194|Cytarabine|cytarabine|mesh-list
110683203|NCT01325194|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110683204|NCT01325194|Antimetabolites|antimetabolites|mesh-ancestor
110683205|NCT01325194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110683206|NCT01325194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110683207|NCT01325194|Antiviral Agents|antiviral agents|mesh-ancestor
110683208|NCT01325194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110683209|NCT01325194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110683210|NCT01325194|Immunologic Factors|immunologic factors|mesh-ancestor
110683211|NCT01325194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110683212|NCT00908219|Bevacizumab|bevacizumab|mesh-list
110683213|NCT00908219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110683214|NCT00908219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110683215|NCT00908219|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110683216|NCT00908219|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110683217|NCT00908219|Growth Substances|growth substances|mesh-ancestor
110683218|NCT00908219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110182644|NCT00025116|Gefitinib|gefitinib|mesh-list
110683219|NCT00908219|Growth Inhibitors|growth inhibitors|mesh-ancestor
110683221|NCT00908297|Coenzyme Q10|coenzyme q10|mesh-list
110683222|NCT00908297|Micronutrients|micronutrients|mesh-ancestor
110683223|NCT00908297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110683224|NCT00908297|Vitamins|vitamins|mesh-ancestor
110683225|NCT00927407|Malathion|malathion|mesh-list
110683226|NCT00927407|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110683227|NCT00927407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110683228|NCT00927407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110683229|NCT00927407|Cholinergic Agents|cholinergic agents|mesh-ancestor
110683230|NCT00927407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110683231|NCT00927407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110683232|NCT00931697|Mefloquine|mefloquine|mesh-list
110683233|NCT00931697|Antimalarials|antimalarials|mesh-ancestor
110683234|NCT00931697|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110683235|NCT00931697|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110683236|NCT00931697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110683237|NCT00927797|Cyclophosphamide|cyclophosphamide|mesh-list
110683238|NCT00927797|Rituximab|rituximab|mesh-list
110683239|NCT00927797|Pentostatin|pentostatin|mesh-list
110683240|NCT00927797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110683241|NCT00927797|Immunologic Factors|immunologic factors|mesh-ancestor
110683242|NCT00927797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110683243|NCT00927797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110683244|NCT00927797|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110683245|NCT00927797|Alkylating Agents|alkylating agents|mesh-ancestor
110683246|NCT00927797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110683247|NCT00927797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110683248|NCT00927797|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110683249|NCT00927797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110683250|NCT00927797|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
110683251|NCT00927797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110683252|NCT00338962|Naltrexone|naltrexone|mesh-list
110683253|NCT00338962|Paroxetine|paroxetine|mesh-list
110683254|NCT00338962|Desipramine|desipramine|mesh-list
110683255|NCT00338962|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110683256|NCT00338962|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110683257|NCT00338962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110683258|NCT00338962|Sensory System Agents|sensory system agents|mesh-ancestor
110683259|NCT00338962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110683260|NCT00338962|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110683261|NCT00338962|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110683262|NCT00338962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110683263|NCT00338962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110683264|NCT00338962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110683265|NCT00338962|Serotonin Agents|serotonin agents|mesh-ancestor
110683266|NCT00338962|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110683267|NCT00338962|Antidepressive Agents|antidepressive agents|mesh-ancestor
110683268|NCT00338962|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110683269|NCT00338962|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110683270|NCT00338962|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110683271|NCT00338962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110683272|NCT00338962|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110683273|NCT00338962|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110683275|NCT00931775|Pindolol|pindolol|mesh-list
110683276|NCT00931775|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110683277|NCT00931775|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110683278|NCT00931775|Adrenergic Agents|adrenergic agents|mesh-ancestor
110683279|NCT00931775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110683280|NCT00931775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110683281|NCT00931775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110683282|NCT00931775|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110683283|NCT00931775|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110683284|NCT00931775|Serotonin Agents|serotonin agents|mesh-ancestor
110683285|NCT00931775|Vasodilator Agents|vasodilator agents|mesh-ancestor
110683286|NCT00927875|Carboplatin|carboplatin|mesh-list
110683287|NCT00927875|Etoposide|etoposide|mesh-list
110683288|NCT00927875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110683289|NCT00927875|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110683290|NCT00927875|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110683292|NCT00927875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110683293|NCT00927875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110683294|NCT00568061|Nitric Oxide|nitric oxide|mesh-list
110683295|NCT00568061|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110683296|NCT00568061|Autonomic Agents|autonomic agents|mesh-ancestor
110683297|NCT00568061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110683298|NCT00568061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110683299|NCT00568061|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110683300|NCT00568061|Respiratory System Agents|respiratory system agents|mesh-ancestor
110683301|NCT00568061|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110683302|NCT00568061|Antioxidants|antioxidants|mesh-ancestor
110683303|NCT00568061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110683304|NCT00568061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110683305|NCT00568061|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
110683306|NCT00568061|Vasodilator Agents|vasodilator agents|mesh-ancestor
110683307|NCT00568061|Gasotransmitters|gasotransmitters|mesh-ancestor
110683308|NCT00568061|Protective Agents|protective agents|mesh-ancestor
110683309|NCT03547427|Acetaminophen|acetaminophen|mesh-list
110683310|NCT03547427|Insulin|insulin|mesh-list
110683311|NCT03547427|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110683313|NCT03547427|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110683314|NCT03547427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110683315|NCT03547427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110683316|NCT03547427|Analgesics|analgesics|mesh-ancestor
110683317|NCT03547427|Sensory System Agents|sensory system agents|mesh-ancestor
110683318|NCT03547427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110683319|NCT03547427|Antipyretics|antipyretics|mesh-ancestor
110683320|NCT00338884|Sunitinib|sunitinib|mesh-list
110683321|NCT00338884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110683322|NCT00338884|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110683323|NCT00338884|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110683324|NCT00338884|Growth Substances|growth substances|mesh-ancestor
110683325|NCT00338884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110683326|NCT00338884|Growth Inhibitors|growth inhibitors|mesh-ancestor
110683327|NCT00338884|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110683328|NCT00338884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110683329|NCT00338884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110683330|NCT03038100|Paclitaxel|paclitaxel|mesh-list
110683331|NCT03038100|Bevacizumab|bevacizumab|mesh-list
110683332|NCT03038100|Carboplatin|carboplatin|mesh-list
110683333|NCT03038100|Atezolizumab|atezolizumab|mesh-list
110683334|NCT03038100|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110683335|NCT03038100|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110683336|NCT03038100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110683337|NCT03038100|Tubulin Modulators|tubulin modulators|mesh-ancestor
110683338|NCT03038100|Antimitotic Agents|antimitotic agents|mesh-ancestor
110683339|NCT03038100|Mitosis Modulators|mitosis modulators|mesh-ancestor
110683340|NCT03038100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110683341|NCT03038100|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110683342|NCT03038100|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110683343|NCT03038100|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110683344|NCT03038100|Growth Substances|growth substances|mesh-ancestor
110683345|NCT03038100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110683346|NCT03038100|Growth Inhibitors|growth inhibitors|mesh-ancestor
110683347|NCT03038100|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110683348|NCT03038100|Immunologic Factors|immunologic factors|mesh-ancestor
110683350|NCT00338728|Imatinib Mesylate|imatinib mesylate|mesh-list
110683351|NCT00338728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110683352|NCT00338728|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110683353|NCT00338728|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110683354|NCT00338728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110683355|NCT00338728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110683356|NCT00338728|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110683357|NCT00338728|Hormone Antagonists|hormone antagonists|mesh-ancestor
110683358|NCT00338728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110683359|NCT00338728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110683360|NCT00338728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110683361|NCT01059136|Spironolactone|spironolactone|mesh-list
110683362|NCT01059136|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110683363|NCT01059136|Hormone Antagonists|hormone antagonists|mesh-ancestor
110683364|NCT01059136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110683365|NCT01059136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110683366|NCT01059136|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110683367|NCT01059136|Diuretics|diuretics|mesh-ancestor
110683368|NCT01059136|Natriuretic Agents|natriuretic agents|mesh-ancestor
110683369|NCT00336856|Irinotecan|irinotecan|mesh-list
110683370|NCT00336856|Cetuximab|cetuximab|mesh-list
110683371|NCT00336856|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110683372|NCT00336856|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110683373|NCT00336856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110683374|NCT00336856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110683375|NCT00336856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110683376|NCT00336856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110683377|NCT00566501|Donepezil|donepezil|mesh-list
110683378|NCT00566501|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110683379|NCT00566501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110683380|NCT00566501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110683381|NCT00566501|Cholinergic Agents|cholinergic agents|mesh-ancestor
110683382|NCT00566501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110683383|NCT00566501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110683384|NCT00566501|Nootropic Agents|nootropic agents|mesh-ancestor
110683386|NCT00504894|Propofol|propofol|mesh-list
110683387|NCT00504894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110683388|NCT00504894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110683389|NCT00504894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110683390|NCT00504894|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110683391|NCT00504894|Anesthetics, General|anesthetics, general|mesh-ancestor
110683392|NCT00504894|Anesthetics|anesthetics|mesh-ancestor
110683393|NCT00504894|Anticonvulsants|anticonvulsants|mesh-ancestor
110683394|NCT00504894|GABA Modulators|gaba modulators|mesh-ancestor
110683395|NCT00504894|GABA Agents|gaba agents|mesh-ancestor
110683396|NCT00504894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110683397|NCT00504894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110683398|NCT00924755|Caffeine|caffeine|mesh-list
110683399|NCT00924755|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110683400|NCT00924755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110683401|NCT00924755|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110683402|NCT00924755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110683403|NCT00924755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110683404|NCT00924755|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110683405|NCT00924755|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110683406|NCT00924755|Purinergic Agents|purinergic agents|mesh-ancestor
110683407|NCT00924755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110683408|NCT01011348|Ubiquinone|ubiquinone|mesh-list
110683409|NCT01011348|Coenzyme Q10|coenzyme q10|mesh-list
110683410|NCT01011348|Micronutrients|micronutrients|mesh-ancestor
110683411|NCT01011348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110683412|NCT01011348|Vitamins|vitamins|mesh-ancestor
110683413|NCT00928655|Acetazolamide|acetazolamide|mesh-list
110683414|NCT00928655|Anticonvulsants|anticonvulsants|mesh-ancestor
110683415|NCT00928655|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110683416|NCT00928655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110683417|NCT00928655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110683418|NCT00928655|Diuretics|diuretics|mesh-ancestor
110683419|NCT00928655|Natriuretic Agents|natriuretic agents|mesh-ancestor
110182670|NCT00025428|Carboplatin|carboplatin|mesh-list
110683420|NCT00928655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110683421|NCT01011426|Bisacodyl|bisacodyl|mesh-list
110683422|NCT01011426|Cathartics|cathartics|mesh-ancestor
110683423|NCT01011426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110683424|NCT01011426|Laxatives|laxatives|mesh-ancestor
110683425|NCT00932555|Factor VIII|factor viii|mesh-list
110683426|NCT00932555|Coagulants|coagulants|mesh-ancestor
110683427|NCT00513240|Epoetin Alfa|epoetin alfa|mesh-list
110683428|NCT00513240|Hematinics|hematinics|mesh-ancestor
110683429|NCT00928811|Basiliximab|basiliximab|mesh-list
110683430|NCT00928811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110683431|NCT00928811|Immunologic Factors|immunologic factors|mesh-ancestor
110683432|NCT00928811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110683433|NCT00932867|Telmisartan|telmisartan|mesh-list
110683434|NCT00932867|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110683435|NCT00932867|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110683436|NCT00932867|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110683437|NCT00932867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110683438|NCT00928967|Interferons|interferons|mesh-list
110683439|NCT00928967|Interferon-beta|interferon-beta|mesh-list
110683440|NCT00928967|Interferon beta-1b|interferon beta-1b|mesh-list
110683441|NCT00928967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110683442|NCT00928967|Antiviral Agents|antiviral agents|mesh-ancestor
110683443|NCT00928967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110683444|NCT00928967|Immunologic Factors|immunologic factors|mesh-ancestor
110683445|NCT00928967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110683446|NCT00928967|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110683447|NCT00933023|Hydrocortisone|hydrocortisone|mesh-list
110683448|NCT00933023|Betamethasone|betamethasone|mesh-list
110683449|NCT00933023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110683450|NCT00933023|Glucocorticoids|glucocorticoids|mesh-ancestor
110683451|NCT00933023|Hormones|hormones|mesh-ancestor
110683452|NCT00933023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110683453|NCT00933023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110683454|NCT00933023|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110683455|NCT00933023|Respiratory System Agents|respiratory system agents|mesh-ancestor
110683456|NCT00933179|Levonorgestrel|levonorgestrel|mesh-list
110683457|NCT00933179|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
110683458|NCT00933179|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
110683459|NCT00933179|Gestodene|gestodene|mesh-list
110683460|NCT00933179|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110683461|NCT00933179|Contraceptive Agents|contraceptive agents|mesh-ancestor
110683462|NCT00933179|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110683463|NCT00933179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110683464|NCT00933179|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110683465|NCT00933179|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110683466|NCT00933179|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110683467|NCT00933179|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110683468|NCT00933179|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110683469|NCT00933179|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
110683470|NCT00933179|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
110683471|NCT00933179|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
110683472|NCT00933179|Progestins|progestins|mesh-ancestor
110683473|NCT00933179|Hormones|hormones|mesh-ancestor
110683474|NCT00933179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110683475|NCT00504348|Tacrolimus|tacrolimus|mesh-list
110683476|NCT00504348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110683477|NCT00504348|Immunologic Factors|immunologic factors|mesh-ancestor
110683478|NCT00504348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110683479|NCT00504348|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110683480|NCT00504348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110683481|NCT00504348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110683482|NCT00929045|Hormones|hormones|mesh-list
110683483|NCT00929045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110683484|NCT00929045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110683485|NCT00925457|Domperidone|domperidone|mesh-list
110683486|NCT00925457|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
110683487|NCT00925457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110683488|NCT00925457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110683489|NCT00925457|Antiemetics|antiemetics|mesh-ancestor
110683490|NCT00925457|Autonomic Agents|autonomic agents|mesh-ancestor
110683491|NCT00925457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110182672|NCT00025428|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110683492|NCT00925457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110683493|NCT00925457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110683494|NCT00925457|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110330532|NCT00501618|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110683495|NCT00925457|Dopamine Agents|dopamine agents|mesh-ancestor
110683496|NCT00925457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110683497|NCT00929279|Abciximab|abciximab|mesh-list
110683498|NCT00929279|Anticoagulants|anticoagulants|mesh-ancestor
110683499|NCT00929279|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110683500|NCT00567593|Rosiglitazone|rosiglitazone|mesh-list
110683501|NCT00567593|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110683502|NCT00567593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110683503|NCT00335764|Sirolimus|sirolimus|mesh-list
110683504|NCT00335764|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110683505|NCT00335764|Sorafenib|sorafenib|mesh-list
110683506|NCT00335764|Temsirolimus|temsirolimus|mesh-list
110683507|NCT00335764|Tipifarnib|tipifarnib|mesh-list
110683508|NCT00335764|MTOR Inhibitors|mtor inhibitors|mesh-list
110683509|NCT00335764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110683510|NCT00335764|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110683511|NCT00335764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110683512|NCT00335764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110683513|NCT00335764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110683514|NCT00335764|Immunologic Factors|immunologic factors|mesh-ancestor
110683515|NCT00335764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110683516|NCT00335764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110683517|NCT00335764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110683518|NCT00335764|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110683519|NCT00335764|Antifungal Agents|antifungal agents|mesh-ancestor
110683520|NCT03743285|Insulin Lispro|insulin lispro|mesh-list
110683521|NCT03743285|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110683522|NCT03743285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110683523|NCT03981484|Thrombin|thrombin|mesh-list
110683524|NCT03981484|Hemostatics|hemostatics|mesh-ancestor
110683525|NCT03981484|Coagulants|coagulants|mesh-ancestor
110683526|NCT00567359|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110683527|NCT00567359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110683528|NCT00567359|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110683529|NCT00567359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110683530|NCT00567359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110683531|NCT01063660|Treosulfan|treosulfan|mesh-list
110683532|NCT01063660|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110683533|NCT01063660|Alkylating Agents|alkylating agents|mesh-ancestor
110683534|NCT01063660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110683535|NCT01063660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110683536|NCT00925847|Lithium Carbonate|lithium carbonate|mesh-list
110683537|NCT00925847|Antidepressive Agents|antidepressive agents|mesh-ancestor
110683538|NCT00925847|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110683539|NCT00925847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110683540|NCT00925847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110683541|NCT00925847|Antimanic Agents|antimanic agents|mesh-ancestor
110683542|NCT00925847|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110683543|NCT00925847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110683544|NCT00925847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110683545|NCT00492726|Moxifloxacin|moxifloxacin|mesh-list
110683546|NCT00492726|Ertapenem|ertapenem|mesh-list
110683547|NCT00492726|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
110683548|NCT00492726|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110683549|NCT00492726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110683550|NCT00492726|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110683551|NCT00492726|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110683552|NCT00492726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110683553|NCT00492726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110683554|NCT00492726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110683555|NCT00492726|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110683556|NCT00492726|Contraceptive Agents|contraceptive agents|mesh-ancestor
110683557|NCT00492726|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110683558|NCT00492726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110683559|NCT00492726|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110162949|NCT00115648|Nevirapine|nevirapine|mesh-list
110683560|NCT00492726|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110683561|NCT00492726|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110683562|NCT00309946|Cediranib|cediranib|mesh-list
110683563|NCT00309946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110683564|NCT00309946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110683565|NCT00309946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110683566|NCT00309946|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110683567|NCT00929591|Tamoxifen|tamoxifen|mesh-list
110683568|NCT00929591|Cyclophosphamide|cyclophosphamide|mesh-list
110683569|NCT00929591|Doxorubicin|doxorubicin|mesh-list
110683570|NCT00929591|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110683571|NCT00929591|Fluorouracil|fluorouracil|mesh-list
110683572|NCT00929591|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110683573|NCT00929591|Immunologic Factors|immunologic factors|mesh-ancestor
110683574|NCT00929591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110683575|NCT00929591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110683576|NCT00929591|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110683577|NCT00929591|Alkylating Agents|alkylating agents|mesh-ancestor
110683578|NCT00929591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110683579|NCT00929591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110683580|NCT00929591|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110683581|NCT00929591|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110683582|NCT00929591|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110683583|NCT00929591|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110683584|NCT00929591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110683585|NCT00929591|Antimetabolites|antimetabolites|mesh-ancestor
110683586|NCT00929591|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110683587|NCT00929591|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110683588|NCT00929591|Hormone Antagonists|hormone antagonists|mesh-ancestor
110683589|NCT00929591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110683590|NCT00929591|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110683591|NCT00929591|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110683592|NCT00929591|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110683593|NCT00929591|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110683594|NCT03997500|Norepinephrine|norepinephrine|mesh-list
110683595|NCT03997500|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110683596|NCT03997500|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110683597|NCT03997500|Adrenergic Agents|adrenergic agents|mesh-ancestor
110683598|NCT03997500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110683599|NCT03997500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110683600|NCT03997500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110683601|NCT03997500|Sympathomimetics|sympathomimetics|mesh-ancestor
110683602|NCT03997500|Autonomic Agents|autonomic agents|mesh-ancestor
110683603|NCT03997500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110683604|NCT03997500|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110683605|NCT01011660|Amlodipine|amlodipine|mesh-list
110683606|NCT01011660|Telmisartan|telmisartan|mesh-list
110683607|NCT01011660|Amiloride|amiloride|mesh-list
110683608|NCT01011660|Simvastatin|simvastatin|mesh-list
110683609|NCT01011660|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110683610|NCT01011660|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110683611|NCT01011660|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110182690|NCT00025428|Antimitotic Agents|antimitotic agents|mesh-ancestor
110683612|NCT01011660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110683613|NCT01011660|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110683614|NCT01011660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110683615|NCT01011660|Vasodilator Agents|vasodilator agents|mesh-ancestor
110683616|NCT01011660|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110683617|NCT01011660|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110683618|NCT01011660|Antimetabolites|antimetabolites|mesh-ancestor
110683619|NCT01011660|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110683620|NCT01011660|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110683621|NCT01011660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110683622|NCT01011660|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110683623|NCT01011660|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110683624|NCT01011660|Diuretics|diuretics|mesh-ancestor
110683625|NCT01011660|Natriuretic Agents|natriuretic agents|mesh-ancestor
110683626|NCT01011660|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
110683627|NCT01011660|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110683628|NCT01011660|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
110683629|NCT01011660|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110683631|NCT01015248|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110683632|NCT01015248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110683633|NCT01015248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110683634|NCT01015248|Immunologic Factors|immunologic factors|mesh-ancestor
110683635|NCT01015248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110683636|NCT01015248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110683637|NCT01015248|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110683638|NCT01015248|Alkylating Agents|alkylating agents|mesh-ancestor
110683639|NCT01015248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110683640|NCT00506922|Methotrexate|methotrexate|mesh-list
110683641|NCT00506922|Pentostatin|pentostatin|mesh-list
110683642|NCT00506922|Tacrolimus|tacrolimus|mesh-list
110683643|NCT00506922|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110683644|NCT00506922|Abortifacient Agents|abortifacient agents|mesh-ancestor
110683645|NCT00506922|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110683646|NCT00506922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110683647|NCT00506922|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110683648|NCT00506922|Antimetabolites|antimetabolites|mesh-ancestor
110683649|NCT00506922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110683650|NCT00506922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110683651|NCT00506922|Dermatologic Agents|dermatologic agents|mesh-ancestor
110683652|NCT00506922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110683653|NCT00506922|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110683654|NCT00506922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110683655|NCT00506922|Immunologic Factors|immunologic factors|mesh-ancestor
110683656|NCT00506922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110683657|NCT00506922|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110683658|NCT00506922|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110683659|NCT00506922|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
110683660|NCT00934193|Gabapentin|gabapentin|mesh-list
110683661|NCT00934193|Analgesics|analgesics|mesh-ancestor
110683662|NCT00934193|Sensory System Agents|sensory system agents|mesh-ancestor
110683663|NCT00934193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110683664|NCT00934193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110683665|NCT00934193|Anticonvulsants|anticonvulsants|mesh-ancestor
110683666|NCT00934193|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110683667|NCT00934193|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110683668|NCT00934193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110683669|NCT00934193|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110683670|NCT00934193|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110683671|NCT00934193|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110683672|NCT00934193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110683673|NCT00934193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110683674|NCT00934193|Antimanic Agents|antimanic agents|mesh-ancestor
110683675|NCT00492024|Moxifloxacin|moxifloxacin|mesh-list
110683676|NCT00492024|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
110683677|NCT00492024|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110683678|NCT00492024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110683679|NCT00492024|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110683680|NCT00492024|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110683682|NCT00492024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110683683|NCT00492024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110683684|NCT00492024|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110683685|NCT00492024|Contraceptive Agents|contraceptive agents|mesh-ancestor
110683686|NCT00492024|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110683687|NCT00492024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110683688|NCT00492024|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110683689|NCT00492024|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110683690|NCT00492024|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110683691|NCT00934427|Nitroglycerin|nitroglycerin|mesh-list
110683692|NCT00934427|Vasodilator Agents|vasodilator agents|mesh-ancestor
110683693|NCT00926315|Calcitriol|calcitriol|mesh-list
110683694|NCT00926315|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110683695|NCT00926315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110683696|NCT00926315|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
110683697|NCT00926315|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110683698|NCT00926315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110683699|NCT00926315|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110683701|NCT00926315|Micronutrients|micronutrients|mesh-ancestor
110683702|NCT00926315|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110683703|NCT01013454|Varenicline|varenicline|mesh-list
110683704|NCT01013454|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110683705|NCT01013454|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110683706|NCT01013454|Cholinergic Agents|cholinergic agents|mesh-ancestor
110683707|NCT01013454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110683708|NCT01013454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110683709|NCT01013454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110683710|NCT00491556|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
110683711|NCT00491556|Antiviral Agents|antiviral agents|mesh-ancestor
110683712|NCT00491556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110683713|NCT00926627|Bosentan|bosentan|mesh-list
110683714|NCT00926627|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110683715|NCT00926627|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
110683716|NCT00926627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110683717|NCT00934739|Thalidomide|thalidomide|mesh-list
110683719|NCT00934739|Celecoxib|celecoxib|mesh-list
110683720|NCT00934739|Cyclophosphamide|cyclophosphamide|mesh-list
110683721|NCT00934739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110683722|NCT00934739|Immunologic Factors|immunologic factors|mesh-ancestor
110683723|NCT00934739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110683724|NCT00934739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110683725|NCT00934739|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110683726|NCT00934739|Alkylating Agents|alkylating agents|mesh-ancestor
110683727|NCT00934739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110683728|NCT00934739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110683729|NCT00934739|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110683730|NCT00934739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110683731|NCT00934739|Antiemetics|antiemetics|mesh-ancestor
110683732|NCT00934739|Autonomic Agents|autonomic agents|mesh-ancestor
110683733|NCT00934739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110683734|NCT00934739|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110683735|NCT00934739|Glucocorticoids|glucocorticoids|mesh-ancestor
110683736|NCT00934739|Hormones|hormones|mesh-ancestor
110683737|NCT00934739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110683738|NCT00934739|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110683739|NCT00934739|Leprostatic Agents|leprostatic agents|mesh-ancestor
110683740|NCT00934739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110683741|NCT00934739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110683742|NCT00934739|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110683743|NCT00934739|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110683744|NCT00934739|Growth Substances|growth substances|mesh-ancestor
110683745|NCT00934739|Growth Inhibitors|growth inhibitors|mesh-ancestor
110683746|NCT00934739|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110683747|NCT00934739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110683749|NCT00934739|Sensory System Agents|sensory system agents|mesh-ancestor
110683750|NCT00934739|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110683751|NCT00934739|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110683752|NCT00934739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110683753|NCT01015482|Midazolam|midazolam|mesh-list
110683754|NCT01015482|Remifentanil|remifentanil|mesh-list
110683755|NCT01015482|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110683756|NCT01015482|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110683757|NCT01015482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110683758|NCT01015482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110683759|NCT01015482|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110683760|NCT01015482|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110683761|NCT01015482|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110683762|NCT01015482|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110683763|NCT01015482|Anesthetics, General|anesthetics, general|mesh-ancestor
110683764|NCT01015482|Anesthetics|anesthetics|mesh-ancestor
110683765|NCT01015482|GABA Modulators|gaba modulators|mesh-ancestor
110683766|NCT01015482|GABA Agents|gaba agents|mesh-ancestor
110683767|NCT01015482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110683768|NCT01015482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110683769|NCT01015482|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110683770|NCT01015482|Narcotics|narcotics|mesh-ancestor
110683771|NCT01015482|Analgesics|analgesics|mesh-ancestor
110683772|NCT01015482|Sensory System Agents|sensory system agents|mesh-ancestor
110683773|NCT01015482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110683774|NCT03760679|Chlorhexidine|chlorhexidine|mesh-list
110683775|NCT03760679|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110683776|NCT03760679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110683777|NCT03760679|Disinfectants|disinfectants|mesh-ancestor
110683778|NCT00934817|Metformin|metformin|mesh-list
110683779|NCT00934817|Glimepiride|glimepiride|mesh-list
110683780|NCT00934817|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110683781|NCT00934817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110683782|NCT00934817|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110683783|NCT00934817|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110683784|NCT00934817|Immunologic Factors|immunologic factors|mesh-ancestor
110683785|NCT01013532|Aspirin|aspirin|mesh-list
110683786|NCT01013532|Cilostazol|cilostazol|mesh-list
110683787|NCT01013532|Probucol|probucol|mesh-list
110683788|NCT01013532|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110683789|NCT01013532|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110683790|NCT01013532|Analgesics|analgesics|mesh-ancestor
110683791|NCT01013532|Sensory System Agents|sensory system agents|mesh-ancestor
110683792|NCT01013532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110683793|NCT01013532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110683794|NCT01013532|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110683795|NCT01013532|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110683796|NCT01013532|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110683797|NCT01013532|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110683798|NCT01013532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110683799|NCT01013532|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110683800|NCT01013532|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110683801|NCT01013532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110683802|NCT01013532|Antipyretics|antipyretics|mesh-ancestor
110683803|NCT01013532|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110683804|NCT01013532|Autonomic Agents|autonomic agents|mesh-ancestor
110683805|NCT01013532|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110683806|NCT01013532|Respiratory System Agents|respiratory system agents|mesh-ancestor
110683807|NCT01013532|Vasodilator Agents|vasodilator agents|mesh-ancestor
110683808|NCT01013532|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110683809|NCT01013532|Protective Agents|protective agents|mesh-ancestor
110683810|NCT01013532|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110683811|NCT01013532|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110683812|NCT01013532|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110683813|NCT01013532|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110683814|NCT01013532|Antimetabolites|antimetabolites|mesh-ancestor
110683815|NCT01013532|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110683816|NCT01013532|Antioxidants|antioxidants|mesh-ancestor
110683817|NCT00926705|Fentanyl|fentanyl|mesh-list
110683818|NCT00926705|Dexmedetomidine|dexmedetomidine|mesh-list
110683819|NCT00926705|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110683820|NCT00926705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110683821|NCT00926705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110683822|NCT00926705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110683823|NCT00926705|Analgesics|analgesics|mesh-ancestor
110683824|NCT00926705|Sensory System Agents|sensory system agents|mesh-ancestor
110683825|NCT00926705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110683826|NCT00926705|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110683827|NCT00926705|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110683829|NCT00926705|Adrenergic Agents|adrenergic agents|mesh-ancestor
110683830|NCT00926705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110683831|NCT00926705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110683832|NCT00926705|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110683833|NCT00926705|Narcotics|narcotics|mesh-ancestor
110683834|NCT00926705|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110683835|NCT00926705|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110683836|NCT00926705|Anesthetics, General|anesthetics, general|mesh-ancestor
110683837|NCT00926705|Anesthetics|anesthetics|mesh-ancestor
110683838|NCT01012284|Bedaquiline|bedaquiline|mesh-list
110683839|NCT01012284|Antitubercular Agents|antitubercular agents|mesh-ancestor
110683840|NCT01012284|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110683841|NCT01012284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110683842|NCT00934973|Mebeverine|mebeverine|mesh-list
110683843|NCT00934973|Alverine|alverine|mesh-list
110683844|NCT00934973|Anticonvulsants|anticonvulsants|mesh-ancestor
110683845|NCT00934973|Parasympatholytics|parasympatholytics|mesh-ancestor
110683846|NCT00934973|Autonomic Agents|autonomic agents|mesh-ancestor
110683847|NCT00934973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110683848|NCT00934973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110683849|NCT00485472|Lacosamide|lacosamide|mesh-list
110683850|NCT00485472|Anticonvulsants|anticonvulsants|mesh-ancestor
110683851|NCT00485472|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110683852|NCT00485472|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110683853|NCT00485472|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110683854|NCT00485472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110683855|NCT00930605|Alemtuzumab|alemtuzumab|mesh-list
110683856|NCT00930605|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110683857|NCT00930605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110683858|NCT01018836|Riluzole|riluzole|mesh-list
110683859|NCT01018836|Anticonvulsants|anticonvulsants|mesh-ancestor
110683860|NCT01018836|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110683861|NCT01018836|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110683862|NCT01018836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110163031|NCT04727671|Menotropins|menotropins|mesh-list
110683863|NCT01018836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110683864|NCT01018836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110683865|NCT01018836|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110683866|NCT01018836|Protective Agents|protective agents|mesh-ancestor
110683867|NCT04015661|Paclitaxel|paclitaxel|mesh-list
110683868|NCT04015661|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110330910|NCT00470561|Antipyretics|antipyretics|mesh-ancestor
110683869|NCT04015661|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110683870|NCT04015661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110683871|NCT04015661|Tubulin Modulators|tubulin modulators|mesh-ancestor
110683872|NCT04015661|Antimitotic Agents|antimitotic agents|mesh-ancestor
110683873|NCT04015661|Mitosis Modulators|mitosis modulators|mesh-ancestor
110683874|NCT04015661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110683875|NCT00491400|Atorvastatin|atorvastatin|mesh-list
110683876|NCT00491400|Fenofibrate|fenofibrate|mesh-list
110683877|NCT00491400|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110683878|NCT00491400|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110683879|NCT00491400|Antimetabolites|antimetabolites|mesh-ancestor
110683880|NCT00491400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110683881|NCT00491400|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110683882|NCT00491400|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110683883|NCT00491400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110683884|NCT00491322|Ergocalciferols|ergocalciferols|mesh-list
110683885|NCT00491322|Vitamin D|vitamin d|mesh-list
110683886|NCT00491322|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110683887|NCT00491322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110683889|NCT00491322|Micronutrients|micronutrients|mesh-ancestor
110683890|NCT00491322|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110683891|NCT00930683|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110683892|NCT00930683|Immunologic Factors|immunologic factors|mesh-ancestor
110683893|NCT00930683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110683894|NCT00930839|Aspirin|aspirin|mesh-list
110683895|NCT00930839|Niacin|niacin|mesh-list
110683896|NCT00930839|Nicotinic Acids|nicotinic acids|mesh-list
110683897|NCT00930839|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110683898|NCT00930839|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110683899|NCT00930839|Analgesics|analgesics|mesh-ancestor
110683900|NCT00930839|Sensory System Agents|sensory system agents|mesh-ancestor
110683901|NCT00930839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110683902|NCT00930839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110683903|NCT00930839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110683904|NCT00930839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110683905|NCT00930839|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110683906|NCT00930839|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110683907|NCT00930839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110683908|NCT00930839|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110683909|NCT00930839|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110683910|NCT00930839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110683912|NCT00930839|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110683913|NCT00930839|Antimetabolites|antimetabolites|mesh-ancestor
110683914|NCT00930839|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110683915|NCT00930839|Vasodilator Agents|vasodilator agents|mesh-ancestor
110683916|NCT00930839|Vitamin B Complex|vitamin b complex|mesh-ancestor
110683917|NCT00930839|Vitamins|vitamins|mesh-ancestor
110683918|NCT00930839|Micronutrients|micronutrients|mesh-ancestor
110683919|NCT01015794|Ephedrine|ephedrine|mesh-list
110683920|NCT01015794|Pseudoephedrine|pseudoephedrine|mesh-list
110683921|NCT01015794|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110683922|NCT01015794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110683923|NCT01015794|Sympathomimetics|sympathomimetics|mesh-ancestor
110683924|NCT01015794|Autonomic Agents|autonomic agents|mesh-ancestor
110683925|NCT01015794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110683926|NCT01015794|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110683927|NCT01015794|Adrenergic Agents|adrenergic agents|mesh-ancestor
110683928|NCT01015794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110683929|NCT01015794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110683930|NCT01015794|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110683931|NCT01015794|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110683932|NCT01015794|Respiratory System Agents|respiratory system agents|mesh-ancestor
110683933|NCT01015794|Nasal Decongestants|nasal decongestants|mesh-ancestor
110683934|NCT00935363|Glyburide|glyburide|mesh-list
110683935|NCT00935363|Rifampin|rifampin|mesh-list
110683936|NCT00935363|Fluconazole|fluconazole|mesh-list
110683937|NCT00935363|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110683938|NCT00935363|Antitubercular Agents|antitubercular agents|mesh-ancestor
110683939|NCT00935363|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110683940|NCT00935363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110683941|NCT00935363|Leprostatic Agents|leprostatic agents|mesh-ancestor
110683942|NCT00935363|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110683943|NCT00935363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110683944|NCT00935363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110683945|NCT00935363|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110683946|NCT00935363|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110683947|NCT00935363|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110683948|NCT00935363|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110683949|NCT00935363|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110683950|NCT00935363|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110683951|NCT00935363|Antifungal Agents|antifungal agents|mesh-ancestor
110683952|NCT00935363|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110182718|NCT00025545|Immunologic Factors|immunologic factors|mesh-ancestor
110683953|NCT00935363|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110683954|NCT00935363|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110683955|NCT00935363|Hormone Antagonists|hormone antagonists|mesh-ancestor
110683956|NCT00935363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110683957|NCT00935363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110683958|NCT00935363|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110683959|NCT00935363|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110683960|NCT00935363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110683962|NCT00930995|Candesartan cilexetil|candesartan cilexetil|mesh-list
110683963|NCT00930995|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110683964|NCT00930995|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110683965|NCT00930995|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110683966|NCT00930995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110683967|NCT00931073|Ketoconazole|ketoconazole|mesh-list
110683968|NCT00931073|Omeprazole|omeprazole|mesh-list
110683969|NCT00931073|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110683970|NCT00931073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110683971|NCT00931073|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110683972|NCT00931073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110683973|NCT00931073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110683974|NCT00931073|Antifungal Agents|antifungal agents|mesh-ancestor
110683975|NCT00931073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110683976|NCT00931073|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110683977|NCT00931073|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110683978|NCT00931073|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110683979|NCT00931073|Hormone Antagonists|hormone antagonists|mesh-ancestor
110683980|NCT00931073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110683981|NCT00931073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110683982|NCT00931073|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110683983|NCT00936689|Doxorubicin|doxorubicin|mesh-list
110683984|NCT00936689|Chlorotrianisene|chlorotrianisene|mesh-list
110683985|NCT00936689|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110683986|NCT00936689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110683987|NCT00936689|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110683988|NCT00936689|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110683989|NCT00936689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110683990|NCT00936689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110683991|NCT00936689|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
110683992|NCT00936689|Estrogens|estrogens|mesh-ancestor
110683994|NCT00936689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110683995|NCT00936689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110683996|NCT00936689|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110683997|NCT01018914|Mycophenolic Acid|mycophenolic acid|mesh-list
110683999|NCT01018914|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110684000|NCT01018914|Immunologic Factors|immunologic factors|mesh-ancestor
110684001|NCT01018914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110684002|NCT01018914|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110684003|NCT01018914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110684004|NCT01018914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110684005|NCT01018914|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110684006|NCT01018914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110684007|NCT01018914|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110684008|NCT01018914|Antitubercular Agents|antitubercular agents|mesh-ancestor
110684009|NCT01018914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110684010|NCT01018914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110684011|NCT01019070|Asunaprevir|asunaprevir|mesh-list
110684012|NCT01019070|Protease Inhibitors|protease inhibitors|mesh-ancestor
110684013|NCT01019070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110684014|NCT01019070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110684015|NCT00936767|Artesunate|artesunate|mesh-list
110331049|NCT00471341|Analgesics|analgesics|mesh-ancestor
110684016|NCT00936767|Mefloquine|mefloquine|mesh-list
110684017|NCT00936767|Antimalarials|antimalarials|mesh-ancestor
110684018|NCT00936767|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110684019|NCT00936767|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110684020|NCT00936767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110684021|NCT00936767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110684022|NCT00936767|Antiviral Agents|antiviral agents|mesh-ancestor
110684023|NCT00936767|Schistosomicides|schistosomicides|mesh-ancestor
110684024|NCT00936767|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110684025|NCT00936767|Anthelmintics|anthelmintics|mesh-ancestor
110684026|NCT00931229|Entecavir|entecavir|mesh-list
110684027|NCT00931229|Antiviral Agents|antiviral agents|mesh-ancestor
110684028|NCT00931229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110684029|NCT00936923|Furosemide|furosemide|mesh-list
110684030|NCT00936923|Diuretics|diuretics|mesh-list
110684031|NCT00936923|Natriuretic Agents|natriuretic agents|mesh-ancestor
110684032|NCT00936923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110684033|NCT00936923|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110684034|NCT00936923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110684035|NCT00936923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110684036|NCT01019382|Gemcitabine|gemcitabine|mesh-list
110684037|NCT01019382|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110684038|NCT01019382|Antimetabolites|antimetabolites|mesh-ancestor
110684039|NCT01019382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110684040|NCT01019382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110684041|NCT00935675|Escitalopram|escitalopram|mesh-list
110684042|NCT00935675|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110163072|NCT00116350|Misoprostol|misoprostol|mesh-list
110684043|NCT00935675|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110684044|NCT00935675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110684045|NCT00935675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110684046|NCT00935675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110684047|NCT00935675|Serotonin Agents|serotonin agents|mesh-ancestor
110684048|NCT00935675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110684049|NCT01016184|Vitamin D|vitamin d|mesh-list
110684050|NCT01016184|Vitamins|vitamins|mesh-ancestor
110684051|NCT01016184|Micronutrients|micronutrients|mesh-ancestor
110684052|NCT01016184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110684053|NCT01016184|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110684054|NCT02567825|Amoxicillin|amoxicillin|mesh-list
110684055|NCT02567825|Ceftriaxone|ceftriaxone|mesh-list
110684056|NCT02567825|Clavulanic Acid|clavulanic acid|mesh-list
110684057|NCT02567825|Clavulanic Acids|clavulanic acids|mesh-list
110684058|NCT02567825|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
110684059|NCT02567825|Ofloxacin|ofloxacin|mesh-list
110684060|NCT02567825|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110684061|NCT02567825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110684062|NCT02567825|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110684063|NCT02567825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110684064|NCT02567825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110684065|NCT02567825|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110684066|NCT02567825|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110684067|NCT02567825|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110684068|NCT02567825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110684069|NCT02567825|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110684070|NCT02567825|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110684071|NCT00490776|Panobinostat|panobinostat|mesh-list
110684072|NCT00490776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110684073|NCT00490776|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110684074|NCT00490776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110684075|NCT00490776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110684076|NCT00566735|Galantamine|galantamine|mesh-list
110684077|NCT00566735|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110684078|NCT00566735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110684079|NCT00566735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110684080|NCT00566735|Cholinergic Agents|cholinergic agents|mesh-ancestor
110684081|NCT00566735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110684082|NCT00566735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110684083|NCT00566735|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110684084|NCT00566735|Autonomic Agents|autonomic agents|mesh-ancestor
110684085|NCT00566735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110684086|NCT00566735|Nootropic Agents|nootropic agents|mesh-ancestor
110684087|NCT00936143|Infliximab|infliximab|mesh-list
110684088|NCT00936143|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110684089|NCT00936143|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110684090|NCT00936143|Dermatologic Agents|dermatologic agents|mesh-ancestor
110684092|NCT00936143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110684093|NCT00937079|Exenatide|exenatide|mesh-list
110684094|NCT00937079|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110684095|NCT00937079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110684096|NCT00937079|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110684097|NCT00937079|Incretins|incretins|mesh-ancestor
110684098|NCT00937079|Hormones|hormones|mesh-ancestor
110684099|NCT00937079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110684100|NCT00566111|Ceftriaxone|ceftriaxone|mesh-list
110684101|NCT00566111|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110684102|NCT00566111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110684103|NCT00937625|Cyclophosphamide|cyclophosphamide|mesh-list
110684104|NCT00937625|Fludarabine|fludarabine|mesh-list
110684105|NCT00937625|Fludarabine phosphate|fludarabine phosphate|mesh-list
110684106|NCT00937625|Interleukin-2|interleukin-2|mesh-list
110684107|NCT00937625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110684108|NCT00937625|Immunologic Factors|immunologic factors|mesh-ancestor
110684109|NCT00937625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110684110|NCT00937625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110684111|NCT00937625|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110684112|NCT00937625|Alkylating Agents|alkylating agents|mesh-ancestor
110684113|NCT00937625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110684114|NCT00937625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110684115|NCT00937625|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110684116|NCT00937625|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110684117|NCT00937625|Antimetabolites|antimetabolites|mesh-ancestor
110684118|NCT00937625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110684119|NCT00937625|Analgesics|analgesics|mesh-ancestor
110684120|NCT00937625|Sensory System Agents|sensory system agents|mesh-ancestor
110560337|NCT00638729|Anesthetics|anesthetics|mesh-ancestor
110684121|NCT00937625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110684122|NCT04014101|Apatinib|apatinib|mesh-list
110684123|NCT04014101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110684124|NCT04014101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110684125|NCT04014101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110684126|NCT04014101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110684127|NCT00936533|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110684128|NCT00936533|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110684129|NCT00936533|Botulinum Toxins|botulinum toxins|mesh-list
110684130|NCT00936533|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110684131|NCT00936533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110684132|NCT00936533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110684133|NCT00936533|Cholinergic Agents|cholinergic agents|mesh-ancestor
110684134|NCT00936533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110684135|NCT00936533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110684136|NCT00936533|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110684137|NCT00936533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110684138|NCT00564629|Acetaminophen|acetaminophen|mesh-list
110684139|NCT00564629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110684140|NCT00564629|Analgesics|analgesics|mesh-ancestor
110684141|NCT00564629|Sensory System Agents|sensory system agents|mesh-ancestor
110684142|NCT00564629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110684143|NCT00564629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110684144|NCT00564629|Antipyretics|antipyretics|mesh-ancestor
110684145|NCT00564395|Insulin|insulin|mesh-list
110684146|NCT00564395|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110684147|NCT00564395|Insulin Detemir|insulin detemir|mesh-list
110684148|NCT00564395|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110684149|NCT00564395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110684150|NCT04013243|Magnesium Sulfate|magnesium sulfate|mesh-list
110684151|NCT04013243|Analgesics|analgesics|mesh-ancestor
110684152|NCT04013243|Sensory System Agents|sensory system agents|mesh-ancestor
110684153|NCT04013243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110182741|NCT00025623|Etoposide|etoposide|mesh-list
110684154|NCT04013243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110684155|NCT04013243|Anesthetics|anesthetics|mesh-ancestor
110684156|NCT04013243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110684157|NCT04013243|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110684158|NCT04013243|Anticonvulsants|anticonvulsants|mesh-ancestor
110684159|NCT04013243|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110684160|NCT04013243|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110684161|NCT04013243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110163109|NCT00116545|Troglitazone|troglitazone|mesh-list
110684162|NCT04013243|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110684163|NCT04013243|Tocolytic Agents|tocolytic agents|mesh-ancestor
110684164|NCT04013243|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110684165|NCT00938171|Anesthetics|anesthetics|mesh-list
110684166|NCT00938171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110684167|NCT00938171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110684168|NCT05280275|Dexamethasone|dexamethasone|mesh-list
110684169|NCT05280275|Lenalidomide|lenalidomide|mesh-list
110684170|NCT05280275|Daratumumab|daratumumab|mesh-list
110684171|NCT05280275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110684172|NCT05280275|Antiemetics|antiemetics|mesh-ancestor
110684173|NCT05280275|Autonomic Agents|autonomic agents|mesh-ancestor
110684174|NCT05280275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110684175|NCT05280275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110684176|NCT05280275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110684177|NCT05280275|Glucocorticoids|glucocorticoids|mesh-ancestor
110684179|NCT05280275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110684180|NCT05280275|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110684181|NCT05280275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110684182|NCT05280275|Immunologic Factors|immunologic factors|mesh-ancestor
110684183|NCT05280275|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110684184|NCT05280275|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110684185|NCT05280275|Growth Substances|growth substances|mesh-ancestor
110684186|NCT05280275|Growth Inhibitors|growth inhibitors|mesh-ancestor
110684187|NCT00939497|Risperidone|risperidone|mesh-list
110684188|NCT00939497|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110684189|NCT00939497|Serotonin Agents|serotonin agents|mesh-ancestor
110684190|NCT00939497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110684191|NCT00939497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110684192|NCT00939497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110684193|NCT00939497|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110684194|NCT00939497|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110684195|NCT00939497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110684197|NCT00939497|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110684198|NCT00939497|Dopamine Agents|dopamine agents|mesh-ancestor
110684199|NCT00502242|Ramipril|ramipril|mesh-list
110684200|NCT00502242|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110684201|NCT00502242|Protease Inhibitors|protease inhibitors|mesh-ancestor
110684202|NCT00502242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110684203|NCT00502242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110684204|NCT00502242|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110684205|NCT00938405|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
110684206|NCT00938405|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110684207|NCT00938405|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110684208|NCT00938405|Antimetabolites|antimetabolites|mesh-ancestor
110684209|NCT00938405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110684210|NCT00938405|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110684211|NCT03045653|Tamoxifen|tamoxifen|mesh-list
110684212|NCT03045653|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110684213|NCT03045653|Hormone Antagonists|hormone antagonists|mesh-ancestor
110684214|NCT03045653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110684215|NCT03045653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110684216|NCT03045653|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110684217|NCT03045653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110684218|NCT03045653|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110684219|NCT03045653|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110684220|NCT03045653|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110684221|NCT02991365|Insulin|insulin|mesh-list
110684222|NCT02991365|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110684223|NCT02991365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110684224|NCT03972137|Nicotine|nicotine|mesh-list
110684225|NCT03972137|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110684226|NCT03972137|Autonomic Agents|autonomic agents|mesh-ancestor
110684227|NCT03972137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110684228|NCT03972137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110684229|NCT03972137|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110684230|NCT03972137|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110684231|NCT03972137|Cholinergic Agents|cholinergic agents|mesh-ancestor
110684232|NCT03972137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110684233|NCT03972137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110684234|NCT00490698|Zoledronic Acid|zoledronic acid|mesh-list
110684235|NCT00490698|Atorvastatin|atorvastatin|mesh-list
110684236|NCT00490698|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110684237|NCT00490698|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110684238|NCT00490698|Antimetabolites|antimetabolites|mesh-ancestor
110684239|NCT00490698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110684240|NCT00490698|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110684241|NCT00490698|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110684243|NCT00490698|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110684244|NCT00490698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110684245|NCT04492254|Enoxaparin|enoxaparin|mesh-list
110684246|NCT04492254|Anticoagulants|anticoagulants|mesh-ancestor
110684247|NCT04492254|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110684248|NCT04492254|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110684249|NCT04492254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110684250|NCT03855228|Mometasone Furoate|mometasone furoate|mesh-list
110684251|NCT03855228|Loratadine|loratadine|mesh-list
110684252|NCT03855228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110684253|NCT03855228|Dermatologic Agents|dermatologic agents|mesh-ancestor
110684254|NCT03855228|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110684255|NCT03855228|Antipruritics|antipruritics|mesh-ancestor
110684256|NCT03855228|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110684257|NCT03855228|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110684258|NCT03855228|Histamine Antagonists|histamine antagonists|mesh-ancestor
110684259|NCT03855228|Histamine Agents|histamine agents|mesh-ancestor
110684260|NCT03855228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110684261|NCT03855228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110684262|NCT03855228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110684263|NCT04013477|Donepezil|donepezil|mesh-list
110684264|NCT04013477|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110684265|NCT04013477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110684266|NCT04013477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110684267|NCT04013477|Cholinergic Agents|cholinergic agents|mesh-ancestor
110684268|NCT04013477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110684269|NCT04013477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110684270|NCT04013477|Nootropic Agents|nootropic agents|mesh-ancestor
110684271|NCT00940667|Losartan|losartan|mesh-list
110684272|NCT00940667|Amlodipine|amlodipine|mesh-list
110684273|NCT00940667|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110684274|NCT00940667|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110684275|NCT00940667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110684276|NCT00940667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110684277|NCT00940667|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110684278|NCT00940667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110684279|NCT00940667|Vasodilator Agents|vasodilator agents|mesh-ancestor
110684280|NCT00940667|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110182755|NCT00025623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110684281|NCT00940667|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110684282|NCT00940667|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110684283|NCT01019772|Vaccines|vaccines|mesh-list
110684284|NCT01019772|Immunologic Factors|immunologic factors|mesh-ancestor
110684285|NCT01019772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110684286|NCT00513500|Amoxicillin|amoxicillin|mesh-list
110684287|NCT00513500|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
110684288|NCT00513500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110684289|NCT00513500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110684290|NCT00513500|Antimalarials|antimalarials|mesh-ancestor
110684291|NCT00513500|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110684292|NCT00513500|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110684293|NCT00511004|Albendazole|albendazole|mesh-list
110684294|NCT00511004|Diethylcarbamazine|diethylcarbamazine|mesh-list
110684295|NCT00511004|Anthelmintics|anthelmintics|mesh-ancestor
110684296|NCT00511004|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110684297|NCT00511004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110684298|NCT00511004|Anticestodal Agents|anticestodal agents|mesh-ancestor
110684299|NCT00511004|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110684300|NCT00511004|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110684301|NCT00511004|Tubulin Modulators|tubulin modulators|mesh-ancestor
110684302|NCT00511004|Antimitotic Agents|antimitotic agents|mesh-ancestor
110684303|NCT00511004|Mitosis Modulators|mitosis modulators|mesh-ancestor
110684304|NCT00511004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110684305|NCT00511004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110684306|NCT00511004|Filaricides|filaricides|mesh-ancestor
110684307|NCT00511004|Antinematodal Agents|antinematodal agents|mesh-ancestor
110684308|NCT00511004|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
110684309|NCT00511004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110684310|NCT02550197|Vaccines|vaccines|mesh-list
110684311|NCT02550197|Immunologic Factors|immunologic factors|mesh-ancestor
110684312|NCT02550197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110684313|NCT00939965|Isotretinoin|isotretinoin|mesh-list
110684314|NCT00939965|Dermatologic Agents|dermatologic agents|mesh-ancestor
110684315|NCT04012541|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
110684317|NCT02877134|Dermatologic Agents|dermatologic agents|mesh-ancestor
110684318|NCT00563381|Bromides|bromides|mesh-list
110684319|NCT00563381|Tiotropium Bromide|tiotropium bromide|mesh-list
110684320|NCT00563381|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110684321|NCT00563381|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110684322|NCT00563381|Autonomic Agents|autonomic agents|mesh-ancestor
110684323|NCT00563381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110684324|NCT00563381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110684325|NCT00563381|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110684326|NCT00563381|Respiratory System Agents|respiratory system agents|mesh-ancestor
110684327|NCT00563381|Parasympatholytics|parasympatholytics|mesh-ancestor
110684328|NCT00563381|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110684329|NCT00563381|Cholinergic Agents|cholinergic agents|mesh-ancestor
110684331|NCT00563381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110163168|NCT02752815|Hormones|hormones|mesh-ancestor
110684332|NCT00563381|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110684333|NCT00563381|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110684334|NCT00563381|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110684335|NCT00563381|Adrenergic Agents|adrenergic agents|mesh-ancestor
110684336|NCT00563381|Anticonvulsants|anticonvulsants|mesh-ancestor
110684337|NCT00512798|Temozolomide|temozolomide|mesh-list
110684338|NCT00512798|Bortezomib|bortezomib|mesh-list
110684339|NCT00512798|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110684340|NCT00512798|Alkylating Agents|alkylating agents|mesh-ancestor
110684341|NCT00512798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110684342|NCT00512798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110684343|NCT00940121|Mirabegron|mirabegron|mesh-list
110684344|NCT00940121|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
110684345|NCT00940121|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110684346|NCT00940121|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110684347|NCT00940121|Adrenergic Agents|adrenergic agents|mesh-ancestor
110684348|NCT00940121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110684349|NCT00940121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110684350|NCT00940121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110684351|NCT00940121|Urological Agents|urological agents|mesh-ancestor
110684352|NCT04012619|Cisplatin|cisplatin|mesh-list
110684353|NCT04012619|Carboplatin|carboplatin|mesh-list
110684354|NCT04012619|Pemetrexed|pemetrexed|mesh-list
110684355|NCT04012619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110684356|NCT04012619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110684357|NCT04012619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110684358|NCT04012619|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110684359|NCT04012619|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110684360|NCT00941057|Calcium, Dietary|calcium, dietary|mesh-list
110684361|NCT00941057|Tetrahydrofolates|tetrahydrofolates|mesh-list
110684362|NCT00941057|Dienogest|dienogest|mesh-list
110684363|NCT00941057|Calcium|calcium|mesh-list
110684364|NCT00941057|Nandrolone|nandrolone|mesh-list
110684365|NCT00941057|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110684366|NCT00941057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110684367|NCT00941057|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110684368|NCT00941057|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110684369|NCT00941057|Contraceptive Agents|contraceptive agents|mesh-ancestor
110684370|NCT00941057|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110684371|NCT00941057|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110684372|NCT00941057|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110684373|NCT00941057|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110684374|NCT00941057|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110684375|NCT00941057|Hormone Antagonists|hormone antagonists|mesh-ancestor
110684376|NCT00941057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110684377|NCT00941057|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110684378|NCT00941057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110684379|NCT00941057|Androgens|androgens|mesh-ancestor
110684380|NCT00941057|Hormones|hormones|mesh-ancestor
110684381|NCT00941057|Anabolic Agents|anabolic agents|mesh-ancestor
110684382|NCT00941057|Vitamin B Complex|vitamin b complex|mesh-ancestor
110684383|NCT00941057|Vitamins|vitamins|mesh-ancestor
110684384|NCT00941057|Micronutrients|micronutrients|mesh-ancestor
110684385|NCT00561821|Mirtazapine|mirtazapine|mesh-list
110684386|NCT00561821|Antidepressive Agents|antidepressive agents|mesh-ancestor
110684387|NCT00561821|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110684388|NCT00561821|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110684389|NCT00561821|Histamine Antagonists|histamine antagonists|mesh-ancestor
110684390|NCT00561821|Histamine Agents|histamine agents|mesh-ancestor
110684391|NCT00561821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110684392|NCT00561821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110684393|NCT00561821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110684394|NCT00561821|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110684395|NCT00561821|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110684396|NCT00561821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110684397|NCT00561821|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
110684398|NCT00561821|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110684399|NCT00561821|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110684400|NCT00561821|Adrenergic Agents|adrenergic agents|mesh-ancestor
110684401|NCT00561821|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110684402|NCT00561821|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110684403|NCT00561821|Serotonin Agents|serotonin agents|mesh-ancestor
110182775|NCT00025740|Anticonvulsants|anticonvulsants|mesh-ancestor
110182776|NCT00025740|GABA Modulators|gaba modulators|mesh-ancestor
110182777|NCT00025740|GABA Agents|gaba agents|mesh-ancestor
110684404|NCT00561821|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110684406|NCT03684044|Antiviral Agents|antiviral agents|mesh-ancestor
110684407|NCT03684044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110684408|NCT03684044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110684409|NCT03684044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110684410|NCT01009502|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
110684411|NCT01009502|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110684412|NCT01009502|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110684413|NCT01009502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110684414|NCT01009502|Schistosomicides|schistosomicides|mesh-ancestor
110684415|NCT01009502|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110684416|NCT01009502|Anthelmintics|anthelmintics|mesh-ancestor
110684417|NCT00335452|Clopidogrel|clopidogrel|mesh-list
110684418|NCT00335452|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110684419|NCT00335452|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110684420|NCT00335452|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110684421|NCT00335452|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110684422|NCT00335452|Purinergic Agents|purinergic agents|mesh-ancestor
110684423|NCT00335452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110684424|NCT00335452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110684425|NCT00335452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110684426|NCT00522548|Mycophenolic Acid|mycophenolic acid|mesh-list
110684427|NCT00522548|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110684428|NCT00522548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110684429|NCT00522548|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110684430|NCT00522548|Antitubercular Agents|antitubercular agents|mesh-ancestor
110684431|NCT00522548|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110684432|NCT00522548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110684433|NCT00522548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110684434|NCT00522548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110684435|NCT00522392|Dexamethasone|dexamethasone|mesh-list
110684436|NCT00522392|Lenalidomide|lenalidomide|mesh-list
110684437|NCT00522392|Bortezomib|bortezomib|mesh-list
110684438|NCT00522392|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110684439|NCT00522392|Antiemetics|antiemetics|mesh-ancestor
110684440|NCT00522392|Autonomic Agents|autonomic agents|mesh-ancestor
110684441|NCT00522392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110684442|NCT00522392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110684443|NCT00522392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110684444|NCT00522392|Glucocorticoids|glucocorticoids|mesh-ancestor
110684445|NCT00522392|Hormones|hormones|mesh-ancestor
110684446|NCT00522392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110684447|NCT00522392|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110684448|NCT00522392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110684449|NCT00522392|Immunologic Factors|immunologic factors|mesh-ancestor
110684450|NCT00522392|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110684452|NCT00522392|Growth Substances|growth substances|mesh-ancestor
110684453|NCT00522392|Growth Inhibitors|growth inhibitors|mesh-ancestor
110684454|NCT01061320|Tocopherols|tocopherols|mesh-list
110684455|NCT01061320|Vitamin E|vitamin e|mesh-list
110684456|NCT01061320|Tocotrienols|tocotrienols|mesh-list
110684457|NCT01061320|alpha-Tocopherol|alpha-tocopherol|mesh-list
110684458|NCT01061320|Vitamins|vitamins|mesh-ancestor
110684459|NCT01061320|Micronutrients|micronutrients|mesh-ancestor
110684460|NCT01061320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110684461|NCT01061320|Antioxidants|antioxidants|mesh-ancestor
110684462|NCT01061320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110684463|NCT01061320|Protective Agents|protective agents|mesh-ancestor
110684464|NCT01012544|Clopidogrel|clopidogrel|mesh-list
110684465|NCT01012544|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110684466|NCT01012544|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110684467|NCT01012544|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110684468|NCT01012544|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110684469|NCT01012544|Purinergic Agents|purinergic agents|mesh-ancestor
110684470|NCT01012544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110684471|NCT01012544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110684472|NCT01012544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110684473|NCT01012700|Poly ICLC|poly iclc|mesh-list
110684474|NCT01012700|Interferon Inducers|interferon inducers|mesh-ancestor
110684475|NCT01012700|Immunologic Factors|immunologic factors|mesh-ancestor
110684476|NCT01012700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110684477|NCT01565720|Moxifloxacin|moxifloxacin|mesh-list
110684478|NCT01565720|Isavuconazole|isavuconazole|mesh-list
110684479|NCT01565720|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110684480|NCT01565720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110684481|NCT01565720|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110684482|NCT01565720|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110684483|NCT01565720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110684484|NCT01565720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110684485|NCT01565720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110684486|NCT01565720|Antifungal Agents|antifungal agents|mesh-ancestor
110684487|NCT00309244|Insulin|insulin|mesh-list
110684488|NCT00309244|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110684489|NCT00309244|Insulin Aspart|insulin aspart|mesh-list
110684490|NCT00309244|Protamines|protamines|mesh-list
110684491|NCT00309244|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110684492|NCT00309244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110684493|NCT00309244|Heparin Antagonists|heparin antagonists|mesh-ancestor
110684494|NCT00309244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110684495|NCT00309244|Coagulants|coagulants|mesh-ancestor
110684496|NCT00483756|Cyclosporine|cyclosporine|mesh-list
110684497|NCT00483756|Cyclosporins|cyclosporins|mesh-list
110684498|NCT00483756|Tofacitinib|tofacitinib|mesh-list
110684499|NCT00483756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110684500|NCT00483756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110684501|NCT00483756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110684502|NCT00483756|Immunologic Factors|immunologic factors|mesh-ancestor
110684503|NCT00483756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110684504|NCT00483756|Antifungal Agents|antifungal agents|mesh-ancestor
110684505|NCT00483756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110684506|NCT00483756|Dermatologic Agents|dermatologic agents|mesh-ancestor
110684507|NCT00483756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110684508|NCT00483756|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110684509|NCT00483756|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
110684510|NCT00483756|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110684511|NCT00309166|Vaccines|vaccines|mesh-list
110684512|NCT00309166|Immunologic Factors|immunologic factors|mesh-ancestor
110684513|NCT00309166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110684514|NCT01063816|Carboplatin|carboplatin|mesh-list
110684515|NCT01063816|Gemcitabine|gemcitabine|mesh-list
110684516|NCT01063816|Veliparib|veliparib|mesh-list
110684517|NCT01063816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110684518|NCT01063816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110684519|NCT01063816|Antimetabolites|antimetabolites|mesh-ancestor
110684520|NCT01063816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110684521|NCT01063816|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110684522|NCT01063816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110684523|NCT00501852|Glycopyrrolate|glycopyrrolate|mesh-list
110684524|NCT00501852|Tiotropium Bromide|tiotropium bromide|mesh-list
110684525|NCT00501852|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110684526|NCT00501852|Autonomic Agents|autonomic agents|mesh-ancestor
110684527|NCT00501852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110684528|NCT00501852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110684529|NCT00501852|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110684530|NCT00501852|Respiratory System Agents|respiratory system agents|mesh-ancestor
110684531|NCT00501852|Parasympatholytics|parasympatholytics|mesh-ancestor
110684532|NCT00501852|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110684533|NCT00501852|Cholinergic Agents|cholinergic agents|mesh-ancestor
110684534|NCT00501852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110684535|NCT00501852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110684536|NCT00501852|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110684537|NCT00501852|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110684538|NCT00482274|Docetaxel|docetaxel|mesh-list
110684539|NCT00482274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110684540|NCT00482274|Tubulin Modulators|tubulin modulators|mesh-ancestor
110684541|NCT00482274|Antimitotic Agents|antimitotic agents|mesh-ancestor
110684542|NCT00482274|Mitosis Modulators|mitosis modulators|mesh-ancestor
110684543|NCT00482274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110684544|NCT00490542|Ziprasidone|ziprasidone|mesh-list
110684545|NCT00490542|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110684546|NCT00490542|Serotonin Agents|serotonin agents|mesh-ancestor
110684547|NCT00490542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110684548|NCT00490542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110684549|NCT00490542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110684550|NCT00490542|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110684551|NCT00490542|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110684552|NCT00490542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110684553|NCT00490542|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110684554|NCT00490542|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110684555|NCT00490542|Dopamine Agents|dopamine agents|mesh-ancestor
110684556|NCT01059604|Naproxen|naproxen|mesh-list
110684557|NCT01059604|Sumatriptan|sumatriptan|mesh-list
110684558|NCT01059604|Naratriptan|naratriptan|mesh-list
110684559|NCT01059604|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110684560|NCT01059604|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110684561|NCT01059604|Analgesics|analgesics|mesh-ancestor
110684562|NCT01059604|Sensory System Agents|sensory system agents|mesh-ancestor
110684563|NCT01059604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110684564|NCT01059604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110684565|NCT01059604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110684566|NCT01059604|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110684567|NCT01059604|Gout Suppressants|gout suppressants|mesh-ancestor
110684568|NCT01059604|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110684569|NCT01059604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110684570|NCT01059604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110684571|NCT01059604|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110163227|NCT00388427|Cetuximab|cetuximab|mesh-list
110684572|NCT01059604|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110684573|NCT01059604|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110684574|NCT01059604|Serotonin Agents|serotonin agents|mesh-ancestor
110684575|NCT01059604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110684576|NCT02532634|Dexamethasone|dexamethasone|mesh-list
110684577|NCT02532634|Dexamethasone acetate|dexamethasone acetate|mesh-list
110684578|NCT02532634|Aprepitant|aprepitant|mesh-list
110684579|NCT02532634|Fosaprepitant|fosaprepitant|mesh-list
110684580|NCT02532634|Palonosetron|palonosetron|mesh-list
110684581|NCT02532634|Ramosetron|ramosetron|mesh-list
110684582|NCT02532634|BB 1101|bb 1101|mesh-list
110684583|NCT02532634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110684584|NCT02532634|Antiemetics|antiemetics|mesh-ancestor
110684585|NCT02532634|Autonomic Agents|autonomic agents|mesh-ancestor
110684586|NCT02532634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110684587|NCT02532634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110684588|NCT02532634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110684589|NCT02532634|Glucocorticoids|glucocorticoids|mesh-ancestor
110684590|NCT02532634|Hormones|hormones|mesh-ancestor
110684591|NCT02532634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110684592|NCT02532634|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110684593|NCT02532634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110684594|NCT02532634|Protease Inhibitors|protease inhibitors|mesh-ancestor
110684595|NCT02532634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110684596|NCT02532634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110684597|NCT02532634|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110684598|NCT02532634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110684599|NCT02532634|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110684600|NCT02532634|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110684601|NCT02532634|Serotonin Agents|serotonin agents|mesh-ancestor
110684602|NCT00501540|Lithium Carbonate|lithium carbonate|mesh-list
110684603|NCT00501540|Antidepressive Agents|antidepressive agents|mesh-ancestor
110684604|NCT00501540|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110684605|NCT00501540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110684606|NCT00501540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110684607|NCT00501540|Antimanic Agents|antimanic agents|mesh-ancestor
110684608|NCT00501540|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110684609|NCT00501540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110684610|NCT00501540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110684611|NCT01014156|Epoprostenol|epoprostenol|mesh-list
110684612|NCT01014156|Tezosentan|tezosentan|mesh-list
110684613|NCT01014156|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110684614|NCT01014156|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110684615|NCT01014156|Vasodilator Agents|vasodilator agents|mesh-ancestor
110684616|NCT00322348|Goserelin|goserelin|mesh-list
110684617|NCT00322348|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110684618|NCT00322348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110684620|NCT01014234|Sirolimus|sirolimus|mesh-list
110684621|NCT01014234|Cyclosporins|cyclosporins|mesh-list
110684622|NCT01014234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110684623|NCT01014234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110684624|NCT01014234|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110684625|NCT01014234|Immunologic Factors|immunologic factors|mesh-ancestor
110684626|NCT01014234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110684627|NCT01014234|Antifungal Agents|antifungal agents|mesh-ancestor
110684628|NCT01014234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110684629|NCT01014234|Dermatologic Agents|dermatologic agents|mesh-ancestor
110684630|NCT01014234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110684631|NCT01014234|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110684632|NCT01014234|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110684633|NCT01014234|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110684634|NCT01014234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110684635|NCT00501228|Lenograstim|lenograstim|mesh-list
110684636|NCT00501228|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110684637|NCT00501228|Immunologic Factors|immunologic factors|mesh-ancestor
110684638|NCT00501228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110684639|NCT00308620|Chloroquine|chloroquine|mesh-list
110684640|NCT00308620|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
110684641|NCT00308620|Amebicides|amebicides|mesh-ancestor
110684642|NCT00308620|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110684643|NCT00308620|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110684644|NCT00308620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110684645|NCT00308620|Antimalarials|antimalarials|mesh-ancestor
110684646|NCT00308620|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110684647|NCT00308620|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110684648|NCT00308620|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110684649|NCT00308620|Analgesics|analgesics|mesh-ancestor
110684650|NCT00308620|Sensory System Agents|sensory system agents|mesh-ancestor
110684651|NCT00308620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110684652|NCT00308620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110684653|NCT00308620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110684654|NCT00308620|Filaricides|filaricides|mesh-ancestor
110684655|NCT00308620|Antinematodal Agents|antinematodal agents|mesh-ancestor
110684656|NCT00308620|Anthelmintics|anthelmintics|mesh-ancestor
110684657|NCT00492752|Sorafenib|sorafenib|mesh-list
110684658|NCT00492752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110684659|NCT00492752|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110684660|NCT00492752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110684661|NCT00492752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110684662|NCT00308308|Insulin|insulin|mesh-list
110684663|NCT00308308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110684664|NCT00308308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110684665|NCT00505934|Levetiracetam|levetiracetam|mesh-list
110684666|NCT00505934|Anticonvulsants|anticonvulsants|mesh-ancestor
110684667|NCT00505934|Nootropic Agents|nootropic agents|mesh-ancestor
110684668|NCT02532790|Prednisone|prednisone|mesh-list
110684669|NCT02532790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110684670|NCT02532790|Glucocorticoids|glucocorticoids|mesh-ancestor
110684671|NCT02532790|Hormones|hormones|mesh-ancestor
110684672|NCT02532790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110684673|NCT02532790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110684674|NCT02532790|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110684675|NCT02532790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110684676|NCT00505778|Mesalamine|mesalamine|mesh-list
110684677|NCT00505778|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110684678|NCT00505778|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110684679|NCT00505778|Analgesics|analgesics|mesh-ancestor
110182807|NCT00026130|Gemcitabine|gemcitabine|mesh-list
110182808|NCT00026130|Fluorouracil|fluorouracil|mesh-list
110182809|NCT00026130|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110684680|NCT00505778|Sensory System Agents|sensory system agents|mesh-ancestor
110684681|NCT00505778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110684682|NCT00505778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110684683|NCT00505778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110684684|NCT00505778|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110684685|NCT00308074|Aripiprazole|aripiprazole|mesh-list
110684686|NCT00308074|Antidepressive Agents|antidepressive agents|mesh-ancestor
110684687|NCT00308074|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110684688|NCT00308074|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110684689|NCT00308074|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110684690|NCT00308074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110684691|NCT00308074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110684692|NCT00308074|Dopamine Agonists|dopamine agonists|mesh-ancestor
110684693|NCT00308074|Dopamine Agents|dopamine agents|mesh-ancestor
110684694|NCT00308074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110684695|NCT00308074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110684696|NCT00308074|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110684697|NCT00308074|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110684698|NCT00308074|Serotonin Agents|serotonin agents|mesh-ancestor
110684699|NCT00308074|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110684700|NCT00308074|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110684701|NCT00308074|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110684702|NCT00308074|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110684703|NCT03997058|Estazolam|estazolam|mesh-list
110684704|NCT03997058|Anticonvulsants|anticonvulsants|mesh-ancestor
110684705|NCT03997058|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110684706|NCT03997058|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110684707|NCT03997058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110684708|NCT03997058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110684709|NCT03997058|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110684710|NCT03997058|GABA Modulators|gaba modulators|mesh-ancestor
110684711|NCT03997058|GABA Agents|gaba agents|mesh-ancestor
110684712|NCT03997058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110684713|NCT03997058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110684714|NCT00500760|Panitumumab|panitumumab|mesh-list
110684715|NCT00500760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110684716|NCT00500760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110684717|NCT01016730|Bortezomib|bortezomib|mesh-list
110684718|NCT01016730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110684719|NCT01012934|Alendronate|alendronate|mesh-list
110684720|NCT01012934|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110684721|NCT01012934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110684722|NCT04334330|Trastuzumab|trastuzumab|mesh-list
110684723|NCT04334330|Fulvestrant|fulvestrant|mesh-list
110684724|NCT04334330|Palbociclib|palbociclib|mesh-list
110684725|NCT04334330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110684726|NCT04334330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110684727|NCT04334330|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110684728|NCT04334330|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110684729|NCT04334330|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110684730|NCT04334330|Hormone Antagonists|hormone antagonists|mesh-ancestor
110684731|NCT04334330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110684732|NCT04334330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110684733|NCT04334330|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110684734|NCT04334330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110684735|NCT04334330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110684736|NCT01015196|Daunorubicin|daunorubicin|mesh-list
110684737|NCT01015196|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110684738|NCT01015196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110684739|NCT01015196|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110163301|NCT00117832|Histamine Agents|histamine agents|mesh-ancestor
110684740|NCT01015196|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110684741|NCT01015196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110684742|NCT01015196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110684743|NCT01009892|Codeine|codeine|mesh-list
110684744|NCT01009892|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110684745|NCT01009892|Narcotics|narcotics|mesh-ancestor
110684746|NCT01009892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110684747|NCT01009892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110684748|NCT01009892|Analgesics|analgesics|mesh-ancestor
110684749|NCT01009892|Sensory System Agents|sensory system agents|mesh-ancestor
110684750|NCT01009892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110684751|NCT01009892|Antitussive Agents|antitussive agents|mesh-ancestor
110684752|NCT01009892|Respiratory System Agents|respiratory system agents|mesh-ancestor
110684753|NCT00307684|Methylphenidate|methylphenidate|mesh-list
110684754|NCT00307684|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110684755|NCT00307684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110684756|NCT00307684|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110684757|NCT00307684|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110684758|NCT00307684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110684759|NCT00307684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110684760|NCT00307684|Dopamine Agents|dopamine agents|mesh-ancestor
110684761|NCT00307684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110684762|NCT00489918|Teriparatide|teriparatide|mesh-list
110684763|NCT00489918|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110684764|NCT00489918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110684765|NCT00489918|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110684766|NCT01061788|Everolimus|everolimus|mesh-list
110684767|NCT01061788|Panitumumab|panitumumab|mesh-list
110684768|NCT01061788|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110684769|NCT01061788|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110684770|NCT01061788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110684771|NCT01061788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110684772|NCT01061788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110684773|NCT01061788|Immunologic Factors|immunologic factors|mesh-ancestor
110684774|NCT01061788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110684775|NCT01061788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110684776|NCT01061788|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110684778|NCT00307294|Doxorubicin|doxorubicin|mesh-list
110684779|NCT00307294|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110684780|NCT00307294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110684781|NCT00307294|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110684782|NCT00307294|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110684783|NCT00307294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110684784|NCT00307294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110684785|NCT00307294|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110684786|NCT00307294|Immunologic Factors|immunologic factors|mesh-ancestor
110684787|NCT00307294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110684788|NCT00307294|Leprostatic Agents|leprostatic agents|mesh-ancestor
110684789|NCT00307294|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110684790|NCT00307294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110684791|NCT00307294|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110684792|NCT00307294|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110684793|NCT00307294|Growth Substances|growth substances|mesh-ancestor
110684795|NCT03981094|Pirfenidone|pirfenidone|mesh-list
110684796|NCT03981094|Analgesics|analgesics|mesh-ancestor
110684797|NCT03981094|Sensory System Agents|sensory system agents|mesh-ancestor
110684798|NCT03981094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110684799|NCT03981094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110684800|NCT03981094|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110684801|NCT03981094|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110684802|NCT03981094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110684803|NCT03981094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110684804|NCT03981094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110684805|NCT03963401|PF-06700841|pf-06700841|mesh-list
110684806|NCT03963401|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110684807|NCT03963401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110684808|NCT03963401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110684809|NCT04410965|Teriflunomide|teriflunomide|mesh-list
110684810|NCT04410965|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110684811|NCT04410965|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110684812|NCT04410965|Analgesics|analgesics|mesh-ancestor
110684813|NCT04410965|Sensory System Agents|sensory system agents|mesh-ancestor
110182811|NCT00026130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110182812|NCT00026130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110182816|NCT00026169|Imatinib Mesylate|imatinib mesylate|mesh-list
110684814|NCT04410965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110684815|NCT04410965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110684816|NCT04410965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110684817|NCT04410965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110684818|NCT04410965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110684819|NCT04410965|Immunologic Factors|immunologic factors|mesh-ancestor
110684820|NCT04012775|Insulin|insulin|mesh-list
110684821|NCT04012775|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110684822|NCT04012775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110684823|NCT04012775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110684824|NCT00944723|Vitamins|vitamins|mesh-list
110684825|NCT00944723|Zinc|zinc|mesh-list
110684826|NCT00944723|Vitamin B Complex|vitamin b complex|mesh-list
110684827|NCT00944723|Zinc Sulfate|zinc sulfate|mesh-list
110684828|NCT00944723|Micronutrients|micronutrients|mesh-ancestor
110684829|NCT00944723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110684830|NCT00944723|Trace Elements|trace elements|mesh-ancestor
110684831|NCT00944723|Astringents|astringents|mesh-ancestor
110684832|NCT00944723|Dermatologic Agents|dermatologic agents|mesh-ancestor
110684833|NCT00944801|Doxorubicin|doxorubicin|mesh-list
110684834|NCT00944801|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110684835|NCT00944801|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110684836|NCT00944801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110684837|NCT00944801|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110684838|NCT00944801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110684839|NCT00944801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110684840|NCT00944801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110684841|NCT01060228|Valproic Acid|valproic acid|mesh-list
110684842|NCT01060228|Paliperidone Palmitate|paliperidone palmitate|mesh-list
110684843|NCT01060228|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110684844|NCT01060228|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110684845|NCT01060228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110684846|NCT01060228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110684847|NCT01060228|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110684848|NCT01060228|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110684849|NCT01060228|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110684850|NCT01060228|Serotonin Agents|serotonin agents|mesh-ancestor
110684851|NCT01060228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110684852|NCT01060228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110684853|NCT01060228|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110684854|NCT01060228|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110684855|NCT01060228|Dopamine Agents|dopamine agents|mesh-ancestor
110684856|NCT01060228|Anticonvulsants|anticonvulsants|mesh-ancestor
110684857|NCT01060228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110684858|NCT01060228|GABA Agents|gaba agents|mesh-ancestor
110684859|NCT01060228|Antimanic Agents|antimanic agents|mesh-ancestor
110684860|NCT00306670|Prednisone|prednisone|mesh-list
110684861|NCT00306670|Rituximab|rituximab|mesh-list
110684862|NCT00306670|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110684863|NCT00306670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110684864|NCT00306670|Immunologic Factors|immunologic factors|mesh-ancestor
110684865|NCT00306670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110684866|NCT00306670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110684867|NCT00306670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110684868|NCT00306670|Glucocorticoids|glucocorticoids|mesh-ancestor
110684869|NCT00306670|Hormones|hormones|mesh-ancestor
110684870|NCT00306670|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110684872|NCT00306592|Natalizumab|natalizumab|mesh-list
110684873|NCT00306592|Immunologic Factors|immunologic factors|mesh-ancestor
110684874|NCT00306592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110684875|NCT00321646|Bevacizumab|bevacizumab|mesh-list
110684876|NCT00321646|Docetaxel|docetaxel|mesh-list
110684877|NCT00321646|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110684878|NCT00321646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110684879|NCT00321646|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110684880|NCT00321646|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110684881|NCT00321646|Growth Substances|growth substances|mesh-ancestor
110684882|NCT00321646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110684883|NCT00321646|Growth Inhibitors|growth inhibitors|mesh-ancestor
110684884|NCT00321646|Tubulin Modulators|tubulin modulators|mesh-ancestor
110684885|NCT00321646|Antimitotic Agents|antimitotic agents|mesh-ancestor
110684886|NCT00321646|Mitosis Modulators|mitosis modulators|mesh-ancestor
110182821|NCT04808414|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110684887|NCT00321646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110684888|NCT00403767|Warfarin|warfarin|mesh-list
110684889|NCT00403767|Rivaroxaban|rivaroxaban|mesh-list
110684890|NCT00403767|Anticoagulants|anticoagulants|mesh-ancestor
110684891|NCT00403767|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110684892|NCT00403767|Antithrombins|antithrombins|mesh-ancestor
110684893|NCT00403767|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110684894|NCT00403767|Protease Inhibitors|protease inhibitors|mesh-ancestor
110684895|NCT00403767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110684896|NCT00403767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110684897|NCT00492284|Dexamethasone|dexamethasone|mesh-list
110684898|NCT00492284|Ranibizumab|ranibizumab|mesh-list
110684899|NCT00492284|Verteporfin|verteporfin|mesh-list
110684900|NCT00492284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110684901|NCT00492284|Antiemetics|antiemetics|mesh-ancestor
110684902|NCT00492284|Autonomic Agents|autonomic agents|mesh-ancestor
110684903|NCT00492284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110684904|NCT00492284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110684905|NCT00492284|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110684906|NCT00492284|Glucocorticoids|glucocorticoids|mesh-ancestor
110684907|NCT00492284|Hormones|hormones|mesh-ancestor
110684908|NCT00492284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110684909|NCT00492284|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110684910|NCT00492284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110684911|NCT00492284|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110684912|NCT00492284|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110684913|NCT00492284|Growth Substances|growth substances|mesh-ancestor
110684914|NCT00492284|Growth Inhibitors|growth inhibitors|mesh-ancestor
110684915|NCT00492284|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110684916|NCT00492284|Dermatologic Agents|dermatologic agents|mesh-ancestor
110684917|NCT01013012|Dexamethasone|dexamethasone|mesh-list
110684918|NCT01013012|Ramosetron|ramosetron|mesh-list
110684919|NCT01013012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110684920|NCT01013012|Antiemetics|antiemetics|mesh-ancestor
110684921|NCT01013012|Autonomic Agents|autonomic agents|mesh-ancestor
110684922|NCT01013012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110684923|NCT01013012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110684924|NCT01013012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110684925|NCT01013012|Glucocorticoids|glucocorticoids|mesh-ancestor
110684926|NCT01013012|Hormones|hormones|mesh-ancestor
110684927|NCT01013012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110684928|NCT01013012|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110684929|NCT01013012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110684930|NCT01013012|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110684931|NCT01013012|Serotonin Agents|serotonin agents|mesh-ancestor
110684932|NCT01013012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110684933|NCT01013012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110684934|NCT01009970|Prednisone|prednisone|mesh-list
110684935|NCT01009970|Cyclophosphamide|cyclophosphamide|mesh-list
110684936|NCT01009970|Rituximab|rituximab|mesh-list
110684937|NCT01009970|Doxorubicin|doxorubicin|mesh-list
110684938|NCT01009970|Vincristine|vincristine|mesh-list
110684939|NCT01009970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110684940|NCT01009970|Immunologic Factors|immunologic factors|mesh-ancestor
110684941|NCT01009970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110684942|NCT01009970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110684943|NCT01009970|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110684944|NCT01009970|Alkylating Agents|alkylating agents|mesh-ancestor
110560338|NCT00638729|GABA Modulators|gaba modulators|mesh-ancestor
110684945|NCT01009970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110684947|NCT01009970|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110684948|NCT01009970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110684949|NCT01009970|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110684950|NCT01009970|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110684951|NCT01009970|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110684952|NCT01009970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110684953|NCT01009970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110684954|NCT01009970|Glucocorticoids|glucocorticoids|mesh-ancestor
110684955|NCT01009970|Hormones|hormones|mesh-ancestor
110684956|NCT01009970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110684957|NCT01009970|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110684958|NCT01009970|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110684959|NCT01009970|Tubulin Modulators|tubulin modulators|mesh-ancestor
110684960|NCT01009970|Antimitotic Agents|antimitotic agents|mesh-ancestor
110684961|NCT01009970|Mitosis Modulators|mitosis modulators|mesh-ancestor
110684962|NCT01015352|Azacitidine|azacitidine|mesh-list
110684963|NCT01015352|Epoetin Alfa|epoetin alfa|mesh-list
110684964|NCT01015352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110684965|NCT01015352|Antimetabolites|antimetabolites|mesh-ancestor
110684966|NCT01015352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110684967|NCT01015352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110684968|NCT01015352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110684969|NCT01015352|Hematinics|hematinics|mesh-ancestor
110684970|NCT03563157|Leucovorin|leucovorin|mesh-list
110684971|NCT03563157|Paclitaxel|paclitaxel|mesh-list
110684972|NCT03563157|Cyclophosphamide|cyclophosphamide|mesh-list
110684973|NCT03563157|Fluorouracil|fluorouracil|mesh-list
110684974|NCT03563157|Capecitabine|capecitabine|mesh-list
110684975|NCT03563157|Oxaliplatin|oxaliplatin|mesh-list
110684976|NCT03563157|Cetuximab|cetuximab|mesh-list
110684977|NCT03563157|Avelumab|avelumab|mesh-list
110684978|NCT03563157|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110684979|NCT03563157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110684980|NCT03563157|Tubulin Modulators|tubulin modulators|mesh-ancestor
110684981|NCT03563157|Antimitotic Agents|antimitotic agents|mesh-ancestor
110684982|NCT03563157|Mitosis Modulators|mitosis modulators|mesh-ancestor
110684983|NCT03563157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110163359|NCT00118222|Ether|ether|mesh-list
110684984|NCT03563157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110684985|NCT03563157|Immunologic Factors|immunologic factors|mesh-ancestor
110684986|NCT03563157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110684987|NCT03563157|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110684988|NCT03563157|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110684989|NCT03563157|Alkylating Agents|alkylating agents|mesh-ancestor
110684990|NCT03563157|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110684991|NCT03563157|Antimetabolites|antimetabolites|mesh-ancestor
110684992|NCT03563157|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110684993|NCT03563157|Antidotes|antidotes|mesh-ancestor
110684994|NCT03563157|Protective Agents|protective agents|mesh-ancestor
110684995|NCT03563157|Vitamin B Complex|vitamin b complex|mesh-ancestor
110684996|NCT03563157|Vitamins|vitamins|mesh-ancestor
110684997|NCT03563157|Micronutrients|micronutrients|mesh-ancestor
110684998|NCT03563157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110684999|NCT01010048|Nifedipine|nifedipine|mesh-list
110685000|NCT01010048|Bromides|bromides|mesh-list
110685001|NCT01010048|Propantheline|propantheline|mesh-list
110685002|NCT01010048|Tamsulosin|tamsulosin|mesh-list
110685003|NCT01010048|Progesterone|progesterone|mesh-list
110685004|NCT01010048|Progestins|progestins|mesh-ancestor
110685005|NCT01010048|Hormones|hormones|mesh-ancestor
110685006|NCT01010048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110685007|NCT01010048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110685008|NCT01010048|Anticonvulsants|anticonvulsants|mesh-ancestor
110685009|NCT01010048|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110685010|NCT01010048|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110685011|NCT01010048|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110685012|NCT01010048|Adrenergic Agents|adrenergic agents|mesh-ancestor
110685013|NCT01010048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110685014|NCT01010048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110685015|NCT01010048|Urological Agents|urological agents|mesh-ancestor
110685016|NCT01010048|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110685017|NCT01010048|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110685018|NCT01010048|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110685019|NCT01010048|Vasodilator Agents|vasodilator agents|mesh-ancestor
110685020|NCT01010048|Tocolytic Agents|tocolytic agents|mesh-ancestor
110685021|NCT01010048|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110685022|NCT01010048|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110685023|NCT01010048|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110685024|NCT01010048|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110685025|NCT01010048|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110685026|NCT01010048|Cholinergic Agents|cholinergic agents|mesh-ancestor
110685028|NCT01589055|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110685029|NCT01589055|Autonomic Agents|autonomic agents|mesh-ancestor
110685030|NCT01589055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110685031|NCT01589055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110685032|NCT01589055|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110685033|NCT01589055|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110685034|NCT01589055|Cholinergic Agents|cholinergic agents|mesh-ancestor
110685035|NCT01589055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110685036|NCT01589055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110685038|NCT00414765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110685039|NCT00414765|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110685040|NCT00414765|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110685041|NCT00414765|Antiviral Agents|antiviral agents|mesh-ancestor
110685042|NCT00414765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110685043|NCT03997292|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
110685044|NCT03997292|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110685045|NCT03997292|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110163366|NCT00118222|Anesthetics|anesthetics|mesh-ancestor
110685046|NCT03997292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110685047|NCT01013402|Insulin|insulin|mesh-list
110685048|NCT01013402|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110685049|NCT01013402|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110685050|NCT01013402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110685051|NCT01013480|Baclofen|baclofen|mesh-list
110685052|NCT01013480|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110685053|NCT01013480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110685054|NCT01013480|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110685055|NCT01013480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110685056|NCT01013480|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
110685057|NCT01013480|GABA Agonists|gaba agonists|mesh-ancestor
110685058|NCT01013480|GABA Agents|gaba agents|mesh-ancestor
110685059|NCT01013480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110685060|NCT01013480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110685061|NCT00500370|Exenatide|exenatide|mesh-list
110685062|NCT00500370|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110685063|NCT00500370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110685064|NCT00500370|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110685065|NCT00500370|Incretins|incretins|mesh-ancestor
110685066|NCT00500370|Hormones|hormones|mesh-ancestor
110685067|NCT00500370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110685068|NCT00320788|Aflibercept|aflibercept|mesh-list
110685069|NCT00320788|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110685070|NCT00320788|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110685071|NCT00320788|Growth Substances|growth substances|mesh-ancestor
110685072|NCT00320788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110685073|NCT00320788|Growth Inhibitors|growth inhibitors|mesh-ancestor
110685074|NCT00320788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110685075|NCT03996486|Lipoprotein-associated coagulation inhibitor|lipoprotein-associated coagulation inhibitor|mesh-list
110685076|NCT03996486|Immunoglobulins|immunoglobulins|mesh-list
110685077|NCT03996486|Immunoglobulin G|immunoglobulin g|mesh-list
110685078|NCT03996486|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110685079|NCT03996486|Myeloma Proteins|myeloma proteins|mesh-list
110685080|NCT03996486|Paraproteins|paraproteins|mesh-list
110685081|NCT03996486|Immunologic Factors|immunologic factors|mesh-ancestor
110685082|NCT03996486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110685083|NCT03996486|Anticoagulants|anticoagulants|mesh-ancestor
110685084|NCT03996486|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110685085|NCT03996486|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110685086|NCT03996486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110685087|NCT03996486|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110685088|NCT03996486|Protease Inhibitors|protease inhibitors|mesh-ancestor
110685089|NCT03996486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110685090|NCT03996486|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110685091|NCT03996486|Antithrombins|antithrombins|mesh-ancestor
110685092|NCT01014468|Bevacizumab|bevacizumab|mesh-list
110685093|NCT01014468|Ranibizumab|ranibizumab|mesh-list
110685094|NCT01014468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110685095|NCT01014468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110182844|NCT00026364|Vitamins|vitamins|mesh-ancestor
110685096|NCT01014468|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110685098|NCT01014468|Growth Substances|growth substances|mesh-ancestor
110685099|NCT01014468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110685100|NCT01014468|Growth Inhibitors|growth inhibitors|mesh-ancestor
110685101|NCT00503984|Prednisone|prednisone|mesh-list
110685102|NCT00503984|Docetaxel|docetaxel|mesh-list
110685103|NCT00503984|Azacitidine|azacitidine|mesh-list
110685104|NCT00503984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110685105|NCT00503984|Tubulin Modulators|tubulin modulators|mesh-ancestor
110685106|NCT00503984|Antimitotic Agents|antimitotic agents|mesh-ancestor
110685107|NCT00503984|Mitosis Modulators|mitosis modulators|mesh-ancestor
110685108|NCT00503984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110685110|NCT00503984|Glucocorticoids|glucocorticoids|mesh-ancestor
110685111|NCT00503984|Hormones|hormones|mesh-ancestor
110685112|NCT00503984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110685113|NCT00503984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110685114|NCT00503984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110685115|NCT00503984|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110685116|NCT00503984|Antimetabolites|antimetabolites|mesh-ancestor
110685117|NCT00503984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110685118|NCT03996564|Acetaminophen|acetaminophen|mesh-list
110685119|NCT03996564|Diclofenac|diclofenac|mesh-list
110685120|NCT03996564|Ketorolac|ketorolac|mesh-list
110685121|NCT03996564|Diazepam|diazepam|mesh-list
110685122|NCT03996564|Hydrocodone|hydrocodone|mesh-list
110685123|NCT03996564|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110685124|NCT03996564|Analgesics|analgesics|mesh-ancestor
110685125|NCT03996564|Sensory System Agents|sensory system agents|mesh-ancestor
110685126|NCT03996564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110685127|NCT03996564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110685128|NCT03996564|Antipyretics|antipyretics|mesh-ancestor
110685129|NCT03996564|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110685130|NCT03996564|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110685131|NCT03996564|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110685132|NCT03996564|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110685133|NCT03996564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110685134|NCT03996564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110685135|NCT03996564|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110685136|NCT03996564|Narcotics|narcotics|mesh-ancestor
110685137|NCT03996564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110685138|NCT03996564|Antitussive Agents|antitussive agents|mesh-ancestor
110685139|NCT03996564|Respiratory System Agents|respiratory system agents|mesh-ancestor
110685140|NCT03996564|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110685141|NCT03996564|Anticonvulsants|anticonvulsants|mesh-ancestor
110685142|NCT03996564|Antiemetics|antiemetics|mesh-ancestor
110685143|NCT03996564|Autonomic Agents|autonomic agents|mesh-ancestor
110685144|NCT03996564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110685145|NCT03996564|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110685146|NCT03996564|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110685147|NCT03996564|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110685148|NCT03996564|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110332184|NCT00480272|Prednisone|prednisone|mesh-list
110685149|NCT03996564|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110685150|NCT03996564|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110685151|NCT03996564|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110685152|NCT03996564|Anesthetics, General|anesthetics, general|mesh-ancestor
110685153|NCT03996564|Anesthetics|anesthetics|mesh-ancestor
110685154|NCT03996564|GABA Modulators|gaba modulators|mesh-ancestor
110685155|NCT03996564|GABA Agents|gaba agents|mesh-ancestor
110685156|NCT03996564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110685157|NCT00565409|Etanercept|etanercept|mesh-list
110685158|NCT00565409|Methotrexate|methotrexate|mesh-list
110685159|NCT00565409|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110685160|NCT00565409|Abortifacient Agents|abortifacient agents|mesh-ancestor
110685161|NCT00565409|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110685162|NCT00565409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110685163|NCT00565409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110685164|NCT00565409|Antimetabolites|antimetabolites|mesh-ancestor
110685165|NCT00565409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110685166|NCT00565409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110685167|NCT00565409|Dermatologic Agents|dermatologic agents|mesh-ancestor
110685168|NCT00565409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110685169|NCT00565409|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110685170|NCT00565409|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110685171|NCT00565409|Immunologic Factors|immunologic factors|mesh-ancestor
110685172|NCT00565409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110685173|NCT00565409|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110685174|NCT00565409|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110685175|NCT00565409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110685177|NCT00565409|Sensory System Agents|sensory system agents|mesh-ancestor
110685178|NCT00565409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110685179|NCT00565409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110685180|NCT00565409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110685181|NCT00394251|Paclitaxel|paclitaxel|mesh-list
110685182|NCT00394251|Cyclophosphamide|cyclophosphamide|mesh-list
110685183|NCT00394251|Bevacizumab|bevacizumab|mesh-list
110685184|NCT00394251|Doxorubicin|doxorubicin|mesh-list
110685185|NCT00394251|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110685186|NCT00394251|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110685187|NCT00394251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110685188|NCT00394251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110685189|NCT00394251|Tubulin Modulators|tubulin modulators|mesh-ancestor
110685190|NCT00394251|Antimitotic Agents|antimitotic agents|mesh-ancestor
110685191|NCT00394251|Mitosis Modulators|mitosis modulators|mesh-ancestor
110685192|NCT00394251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110685193|NCT00394251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110685194|NCT00394251|Immunologic Factors|immunologic factors|mesh-ancestor
110685195|NCT00394251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110685196|NCT00394251|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110685197|NCT00394251|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110685198|NCT00394251|Alkylating Agents|alkylating agents|mesh-ancestor
110685199|NCT00394251|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110685200|NCT00394251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110685201|NCT00394251|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110685202|NCT00394251|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110685203|NCT00394251|Growth Substances|growth substances|mesh-ancestor
110685204|NCT00394251|Growth Inhibitors|growth inhibitors|mesh-ancestor
110685205|NCT00394251|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110685206|NCT00394251|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110685207|NCT00394251|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110685208|NCT00394251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110685209|NCT02532400|Goserelin|goserelin|mesh-list
110685210|NCT02532400|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110685211|NCT02532400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110685212|NCT00394095|Topiramate|topiramate|mesh-list
110685213|NCT00394095|Anticonvulsants|anticonvulsants|mesh-ancestor
110685214|NCT00394095|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110685215|NCT00394095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110685216|NCT00503906|Paclitaxel|paclitaxel|mesh-list
110685217|NCT00503906|Bevacizumab|bevacizumab|mesh-list
110685218|NCT00503906|Gemcitabine|gemcitabine|mesh-list
110685219|NCT00503906|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110685220|NCT00503906|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110685221|NCT00503906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110685222|NCT00503906|Tubulin Modulators|tubulin modulators|mesh-ancestor
110685223|NCT00503906|Antimitotic Agents|antimitotic agents|mesh-ancestor
110685224|NCT00503906|Mitosis Modulators|mitosis modulators|mesh-ancestor
110685225|NCT00503906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110332249|NCT00482222|Vitamins|vitamins|mesh-ancestor
110685226|NCT00503906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110685227|NCT00503906|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110685228|NCT00503906|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110685229|NCT00503906|Growth Substances|growth substances|mesh-ancestor
110685230|NCT00503906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110685231|NCT00503906|Growth Inhibitors|growth inhibitors|mesh-ancestor
110685232|NCT00503906|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110685233|NCT00503906|Antimetabolites|antimetabolites|mesh-ancestor
110685234|NCT00305110|Hydromorphone|hydromorphone|mesh-list
110685235|NCT00305110|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110685236|NCT00305110|Narcotics|narcotics|mesh-ancestor
110685237|NCT00305110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110685238|NCT00305110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110685239|NCT00305110|Analgesics|analgesics|mesh-ancestor
110685240|NCT00305110|Sensory System Agents|sensory system agents|mesh-ancestor
110685241|NCT00305110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110685242|NCT03984760|Sevelamer|sevelamer|mesh-list
110685243|NCT03984760|Chelating Agents|chelating agents|mesh-ancestor
110685244|NCT03984760|Sequestering Agents|sequestering agents|mesh-ancestor
110685245|NCT03984760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110685246|NCT00491894|Glycopyrrolate|glycopyrrolate|mesh-list
110685247|NCT00491894|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110685248|NCT00491894|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110685249|NCT00491894|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110685250|NCT00491894|Cholinergic Agents|cholinergic agents|mesh-ancestor
110685251|NCT00491894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110685252|NCT00491894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110685253|NCT00491894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110685254|NCT01060618|Maraviroc|maraviroc|mesh-list
110685255|NCT01060618|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110685256|NCT01060618|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110685257|NCT01060618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110685258|NCT01060618|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110685259|NCT01060618|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110685260|NCT01060618|Antiviral Agents|antiviral agents|mesh-ancestor
110685261|NCT01060618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110685262|NCT01060618|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
110685263|NCT00491504|Mometasone Furoate|mometasone furoate|mesh-list
110685264|NCT00491504|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110685265|NCT00491504|Dermatologic Agents|dermatologic agents|mesh-ancestor
110685266|NCT00491504|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110685267|NCT00500292|Leucovorin|leucovorin|mesh-list
110685268|NCT00500292|Folic Acid|folic acid|mesh-list
110685269|NCT00500292|Fluorouracil|fluorouracil|mesh-list
110685270|NCT00500292|Oxaliplatin|oxaliplatin|mesh-list
110685271|NCT00500292|Levoleucovorin|levoleucovorin|mesh-list
110685272|NCT00500292|Antimetabolites|antimetabolites|mesh-ancestor
110163429|NCT00118690|Fluticasone|fluticasone|mesh-list
110685273|NCT00500292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110685274|NCT00500292|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110685275|NCT00500292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110685276|NCT00500292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110685277|NCT00500292|Immunologic Factors|immunologic factors|mesh-ancestor
110685278|NCT00500292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110685279|NCT00500292|Antidotes|antidotes|mesh-ancestor
110685280|NCT00500292|Protective Agents|protective agents|mesh-ancestor
110685281|NCT00500292|Vitamin B Complex|vitamin b complex|mesh-ancestor
110685282|NCT00500292|Vitamins|vitamins|mesh-ancestor
110685283|NCT00500292|Micronutrients|micronutrients|mesh-ancestor
110685284|NCT00500292|Hematinics|hematinics|mesh-ancestor
110685285|NCT01013558|Remifentanil|remifentanil|mesh-list
110685286|NCT01013558|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110685287|NCT01013558|Narcotics|narcotics|mesh-ancestor
110685288|NCT01013558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110685289|NCT01013558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110685290|NCT01013558|Analgesics|analgesics|mesh-ancestor
110685291|NCT01013558|Sensory System Agents|sensory system agents|mesh-ancestor
110685292|NCT01013558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110685293|NCT00499746|Tramadol|tramadol|mesh-list
110685294|NCT00499746|Hydromorphone|hydromorphone|mesh-list
110685295|NCT00499746|Methylphenidate|methylphenidate|mesh-list
110685296|NCT00499746|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110685297|NCT00499746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110685298|NCT00499746|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110332330|NCT01311505|Rifampin|rifampin|mesh-list
110685299|NCT00499746|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110685300|NCT00499746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110685301|NCT00499746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110685302|NCT00499746|Dopamine Agents|dopamine agents|mesh-ancestor
110685303|NCT00499746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110685304|NCT00499746|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110685305|NCT00499746|Narcotics|narcotics|mesh-ancestor
110685306|NCT00499746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110685307|NCT00499746|Analgesics|analgesics|mesh-ancestor
110685308|NCT00499746|Sensory System Agents|sensory system agents|mesh-ancestor
110685309|NCT00499746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110685311|NCT01010516|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110685312|NCT01010516|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
110685313|NCT01010516|Fenofibrate|fenofibrate|mesh-list
110685314|NCT01010516|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110685315|NCT01010516|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110685316|NCT01010516|Antimetabolites|antimetabolites|mesh-ancestor
110685317|NCT01010516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110685318|NCT01010516|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110685319|NCT01010516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110685320|NCT01010516|Vasodilator Agents|vasodilator agents|mesh-ancestor
110685321|NCT01010516|Vitamin B Complex|vitamin b complex|mesh-ancestor
110685322|NCT01010516|Vitamins|vitamins|mesh-ancestor
110685323|NCT01010516|Micronutrients|micronutrients|mesh-ancestor
110163468|NCT00118807|Antiviral Agents|antiviral agents|mesh-ancestor
110685324|NCT01010516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110685325|NCT01020162|Gabapentin|gabapentin|mesh-list
110685326|NCT01020162|Amitriptyline|amitriptyline|mesh-list
110685327|NCT01020162|Analgesics|analgesics|mesh-ancestor
110685328|NCT01020162|Sensory System Agents|sensory system agents|mesh-ancestor
110685329|NCT01020162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110685330|NCT01020162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110685331|NCT01020162|Anticonvulsants|anticonvulsants|mesh-ancestor
110685332|NCT01020162|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110685333|NCT01020162|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110685334|NCT01020162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110685335|NCT01020162|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110685336|NCT01020162|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110685337|NCT01020162|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110685338|NCT01020162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110685339|NCT01020162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110685340|NCT01020162|Antimanic Agents|antimanic agents|mesh-ancestor
110685341|NCT01020162|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110685342|NCT01020162|Antidepressive Agents|antidepressive agents|mesh-ancestor
110685343|NCT01020162|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110685344|NCT01020162|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110685345|NCT01020162|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110685346|NCT01020162|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110685347|NCT01020162|Adrenergic Agents|adrenergic agents|mesh-ancestor
110685348|NCT01016886|Bisoprolol|bisoprolol|mesh-list
110685349|NCT01016886|Perindopril|perindopril|mesh-list
110685350|NCT01016886|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110685351|NCT01016886|Sympatholytics|sympatholytics|mesh-ancestor
110685352|NCT01016886|Autonomic Agents|autonomic agents|mesh-ancestor
110685353|NCT01016886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110685354|NCT01016886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110685355|NCT01016886|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110685356|NCT01016886|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110685357|NCT01016886|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110685358|NCT01016886|Adrenergic Agents|adrenergic agents|mesh-ancestor
110685359|NCT01016886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110685360|NCT01016886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110685361|NCT01016886|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110685362|NCT01016886|Protease Inhibitors|protease inhibitors|mesh-ancestor
110685363|NCT01016886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110685364|NCT00499590|Ranibizumab|ranibizumab|mesh-list
110685365|NCT00499590|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110685366|NCT00499590|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110685367|NCT00499590|Growth Substances|growth substances|mesh-ancestor
110685368|NCT00499590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110685369|NCT00499590|Growth Inhibitors|growth inhibitors|mesh-ancestor
110685370|NCT00499590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110685371|NCT00510146|Olanzapine|olanzapine|mesh-list
110685372|NCT00510146|Antiemetics|antiemetics|mesh-ancestor
110685373|NCT00510146|Autonomic Agents|autonomic agents|mesh-ancestor
110685374|NCT00510146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110685375|NCT00510146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110332399|NCT00482456|Nitrous Oxide|nitrous oxide|mesh-list
110685376|NCT00510146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110685377|NCT00510146|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110685378|NCT00510146|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110685379|NCT00510146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110685380|NCT00510146|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110685381|NCT00510146|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110685382|NCT00510146|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110685383|NCT00510146|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110685384|NCT00510146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110685385|NCT00510146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110685386|NCT00510146|Serotonin Agents|serotonin agents|mesh-ancestor
110685388|NCT04250064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110685389|NCT04250064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110685390|NCT04250064|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110685391|NCT04250064|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110685392|NCT04250064|Growth Substances|growth substances|mesh-ancestor
110685393|NCT04250064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110685395|NCT00480636|Dalteparin|dalteparin|mesh-list
110685396|NCT00480636|Tinzaparin|tinzaparin|mesh-list
110685397|NCT00480636|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
110685398|NCT00480636|Anticoagulants|anticoagulants|mesh-ancestor
110685399|NCT00480636|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110685400|NCT00480636|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110685401|NCT00480636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110685402|NCT01017198|Antacids|antacids|mesh-list
110685403|NCT01017198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110685404|NCT01017198|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110685405|NCT00499122|Cyclophosphamide|cyclophosphamide|mesh-list
110685406|NCT00499122|Docetaxel|docetaxel|mesh-list
110685407|NCT00499122|Doxorubicin|doxorubicin|mesh-list
110685408|NCT00499122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110685409|NCT00499122|Immunologic Factors|immunologic factors|mesh-ancestor
110685410|NCT00499122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110685411|NCT00499122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110685412|NCT00499122|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110685413|NCT00499122|Alkylating Agents|alkylating agents|mesh-ancestor
110685414|NCT00499122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110685415|NCT00499122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110685416|NCT00499122|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110685417|NCT00499122|Tubulin Modulators|tubulin modulators|mesh-ancestor
110685418|NCT00499122|Antimitotic Agents|antimitotic agents|mesh-ancestor
110685419|NCT00499122|Mitosis Modulators|mitosis modulators|mesh-ancestor
110685420|NCT00499122|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110685421|NCT00499122|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110685422|NCT00499122|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110685423|NCT00499122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110685424|NCT00393939|Docetaxel|docetaxel|mesh-list
110685425|NCT00393939|Sunitinib|sunitinib|mesh-list
110685426|NCT00393939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110685427|NCT00393939|Tubulin Modulators|tubulin modulators|mesh-ancestor
110685428|NCT00393939|Antimitotic Agents|antimitotic agents|mesh-ancestor
110685429|NCT00393939|Mitosis Modulators|mitosis modulators|mesh-ancestor
110685430|NCT00393939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110685431|NCT00393939|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110685432|NCT00393939|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110685433|NCT00393939|Growth Substances|growth substances|mesh-ancestor
110685434|NCT00393939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110685435|NCT00393939|Growth Inhibitors|growth inhibitors|mesh-ancestor
110685436|NCT00393939|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110685437|NCT00393939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110685438|NCT00488982|Docetaxel|docetaxel|mesh-list
110685439|NCT00488982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110685440|NCT00488982|Tubulin Modulators|tubulin modulators|mesh-ancestor
110685441|NCT00488982|Antimitotic Agents|antimitotic agents|mesh-ancestor
110685442|NCT00488982|Mitosis Modulators|mitosis modulators|mesh-ancestor
110685443|NCT00488982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110685444|NCT00488826|Vaccines|vaccines|mesh-list
110685445|NCT00488826|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110685446|NCT00488826|Immunologic Factors|immunologic factors|mesh-ancestor
110685447|NCT00488826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110332471|NCT00481013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110685448|NCT01017354|Calcifediol|calcifediol|mesh-list
110685449|NCT01017354|Vitamins|vitamins|mesh-ancestor
110685451|NCT01017354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110685452|NCT01017354|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110685453|NCT00393861|Bevacizumab|bevacizumab|mesh-list
110685454|NCT00393861|Oxaliplatin|oxaliplatin|mesh-list
110685455|NCT00393861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110685456|NCT00393861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110685457|NCT00393861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110685458|NCT00393861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110685459|NCT00393861|Growth Substances|growth substances|mesh-ancestor
110685460|NCT00393861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110685461|NCT00393861|Growth Inhibitors|growth inhibitors|mesh-ancestor
110685463|NCT01040559|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110685464|NCT01040559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110685465|NCT01040559|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110685466|NCT01040559|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110685468|NCT01040559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110685469|NCT01020396|Metronidazole|metronidazole|mesh-list
110685470|NCT01020396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110685471|NCT01020396|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110685472|NCT01020396|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110685473|NCT01020396|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110685474|NCT00488592|Molgramostim|molgramostim|mesh-list
110685475|NCT00488592|Sargramostim|sargramostim|mesh-list
110685476|NCT00488592|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
110685477|NCT00488592|Immunologic Factors|immunologic factors|mesh-ancestor
110685478|NCT00488592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110685479|NCT00488592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110685480|NCT00488592|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110685481|NCT00488514|Naproxen|naproxen|mesh-list
110685482|NCT00488514|Sumatriptan|sumatriptan|mesh-list
110685483|NCT00488514|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110685484|NCT00488514|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110685485|NCT00488514|Analgesics|analgesics|mesh-ancestor
110685486|NCT00488514|Sensory System Agents|sensory system agents|mesh-ancestor
110685487|NCT00488514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110685488|NCT00488514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110685489|NCT00488514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110685490|NCT00488514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110685491|NCT00488514|Gout Suppressants|gout suppressants|mesh-ancestor
110685492|NCT00488514|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110685493|NCT00488514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110685494|NCT00488514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110685495|NCT00488514|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110685496|NCT00488514|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110685497|NCT00488514|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110685498|NCT00488514|Serotonin Agents|serotonin agents|mesh-ancestor
110685499|NCT00488514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110685500|NCT00320710|Zoledronic Acid|zoledronic acid|mesh-list
110685501|NCT00320710|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110685502|NCT00320710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110685505|NCT00320398|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110685506|NCT00320398|Antithrombins|antithrombins|mesh-ancestor
110685507|NCT00320398|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110685508|NCT00320398|Protease Inhibitors|protease inhibitors|mesh-ancestor
110685509|NCT00320398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110685510|NCT00320398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110685511|NCT00320398|Anticoagulants|anticoagulants|mesh-ancestor
110685512|NCT00320398|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110685513|NCT00320398|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110685514|NCT00498186|Rotigotine|rotigotine|mesh-list
110685515|NCT00498186|Dopamine Agonists|dopamine agonists|mesh-ancestor
110685516|NCT00498186|Dopamine Agents|dopamine agents|mesh-ancestor
110685517|NCT00498186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110685518|NCT00498186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110685519|NCT00498186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110685520|NCT03984526|Atropine|atropine|mesh-list
110685521|NCT03984526|Ephedrine|ephedrine|mesh-list
110685522|NCT03984526|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110685523|NCT03984526|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110685524|NCT03984526|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110685525|NCT03984526|Autonomic Agents|autonomic agents|mesh-ancestor
110685526|NCT03984526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110685527|NCT03984526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110685528|NCT03984526|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110685529|NCT03984526|Respiratory System Agents|respiratory system agents|mesh-ancestor
110685530|NCT03984526|Mydriatics|mydriatics|mesh-ancestor
110685531|NCT03984526|Parasympatholytics|parasympatholytics|mesh-ancestor
110685532|NCT03984526|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110685533|NCT03984526|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110685534|NCT03984526|Cholinergic Agents|cholinergic agents|mesh-ancestor
110685535|NCT03984526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110685536|NCT03984526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110685537|NCT03984526|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110685538|NCT03984526|Sympathomimetics|sympathomimetics|mesh-ancestor
110685539|NCT03984526|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110685540|NCT03984526|Adrenergic Agents|adrenergic agents|mesh-ancestor
110560265|NCT00699296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110685541|NCT01017666|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3H-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3h-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|mesh-list
110685543|NCT01017666|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110685544|NCT01017666|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110685545|NCT01017666|Purinergic Agents|purinergic agents|mesh-ancestor
110685546|NCT01017666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110685547|NCT01017666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110163552|NCT00120055|Atorvastatin|atorvastatin|mesh-list
110685548|NCT01017666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110685549|NCT01017744|Anesthetics|anesthetics|mesh-list
110685550|NCT01017744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110685551|NCT01017744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110685552|NCT00477594|Mipomersen|mipomersen|mesh-list
110685553|NCT00477594|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110685554|NCT00477594|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110685555|NCT00477594|Antimetabolites|antimetabolites|mesh-ancestor
110685556|NCT00477594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110685557|NCT00477594|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110685558|NCT00304954|Sirolimus|sirolimus|mesh-list
110685559|NCT00304954|Infliximab|infliximab|mesh-list
110685560|NCT00304954|Daclizumab|daclizumab|mesh-list
110685561|NCT00304954|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110685562|NCT00304954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110685563|NCT00304954|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110685564|NCT00304954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110685565|NCT00304954|Antifungal Agents|antifungal agents|mesh-ancestor
110685566|NCT00304954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110685567|NCT00304954|Immunologic Factors|immunologic factors|mesh-ancestor
110685568|NCT00304954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110685569|NCT00304954|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110685570|NCT00304954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110685571|NCT00304954|Dermatologic Agents|dermatologic agents|mesh-ancestor
110685572|NCT00304954|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110685573|NCT00304954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110685574|NCT00475176|Ribavirin|ribavirin|mesh-list
110685575|NCT00475176|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110685576|NCT00475176|Antimetabolites|antimetabolites|mesh-ancestor
110685577|NCT00475176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110685578|NCT00475176|Antiviral Agents|antiviral agents|mesh-ancestor
110685579|NCT00475176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110685580|NCT00393705|Insulin|insulin|mesh-list
110685581|NCT00393705|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110685582|NCT00393705|Insulin Lispro|insulin lispro|mesh-list
110685583|NCT00393705|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110685584|NCT00393705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110685585|NCT00303628|Leucovorin|leucovorin|mesh-list
110685586|NCT00303628|Bevacizumab|bevacizumab|mesh-list
110685587|NCT00303628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110685588|NCT00303628|Fluorouracil|fluorouracil|mesh-list
110685589|NCT00303628|Oxaliplatin|oxaliplatin|mesh-list
110685590|NCT00303628|Antibodies|antibodies|mesh-list
110685591|NCT00303628|Immunoglobulins|immunoglobulins|mesh-list
110685593|NCT00303628|Levoleucovorin|levoleucovorin|mesh-list
110685594|NCT00303628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110685595|NCT00303628|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110685596|NCT00303628|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110332614|NCT01240824|Aminophylline|aminophylline|mesh-list
110685597|NCT00303628|Growth Substances|growth substances|mesh-ancestor
110685598|NCT00303628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110685599|NCT00303628|Growth Inhibitors|growth inhibitors|mesh-ancestor
110685600|NCT00303628|Immunologic Factors|immunologic factors|mesh-ancestor
110685601|NCT00303628|Antimetabolites|antimetabolites|mesh-ancestor
110685602|NCT00303628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110685603|NCT00303628|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110685604|NCT00303628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110685606|NCT00303628|Protective Agents|protective agents|mesh-ancestor
110685607|NCT00303628|Vitamin B Complex|vitamin b complex|mesh-ancestor
110685608|NCT00303628|Vitamins|vitamins|mesh-ancestor
110685609|NCT00303628|Micronutrients|micronutrients|mesh-ancestor
110685610|NCT00414453|Lidocaine|lidocaine|mesh-list
110685611|NCT00414453|Oxycodone|oxycodone|mesh-list
110685612|NCT00414453|Anesthetics, Local|anesthetics, local|mesh-ancestor
110685613|NCT00414453|Anesthetics|anesthetics|mesh-ancestor
110163572|NCT00120172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110685614|NCT00414453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110685615|NCT00414453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110685616|NCT00414453|Sensory System Agents|sensory system agents|mesh-ancestor
110685618|NCT00414453|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110685619|NCT00414453|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110685620|NCT00414453|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110685621|NCT00414453|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110685622|NCT00414453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110685623|NCT00414453|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110685624|NCT00414453|Narcotics|narcotics|mesh-ancestor
110685625|NCT00414453|Analgesics|analgesics|mesh-ancestor
110685626|NCT01037595|Turmeric extract|turmeric extract|mesh-list
110685627|NCT01037595|Antioxidants|antioxidants|mesh-ancestor
110685628|NCT01037595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110685629|NCT01037595|Protective Agents|protective agents|mesh-ancestor
110685630|NCT01037595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110685631|NCT01041027|Paclitaxel|paclitaxel|mesh-list
110685632|NCT01041027|Carboplatin|carboplatin|mesh-list
110685633|NCT01041027|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110685634|NCT01041027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110685635|NCT01041027|Tubulin Modulators|tubulin modulators|mesh-ancestor
110685636|NCT01041027|Antimitotic Agents|antimitotic agents|mesh-ancestor
110685637|NCT01041027|Mitosis Modulators|mitosis modulators|mesh-ancestor
110685638|NCT01041027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110685639|NCT00332488|Insulin|insulin|mesh-list
110685640|NCT00332488|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110685641|NCT00332488|Metformin|metformin|mesh-list
110685642|NCT00332488|Secretagogues|secretagogues|mesh-list
110685643|NCT00332488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110685644|NCT00332488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110685645|NCT00332332|Etanercept|etanercept|mesh-list
110685646|NCT00332332|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110685647|NCT00332332|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110685648|NCT00332332|Analgesics|analgesics|mesh-ancestor
110685649|NCT00332332|Sensory System Agents|sensory system agents|mesh-ancestor
110685650|NCT00332332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110685651|NCT00332332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110685652|NCT00332332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110685653|NCT00332332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110685654|NCT00332332|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110685655|NCT00332332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110685656|NCT00332332|Immunologic Factors|immunologic factors|mesh-ancestor
110685657|NCT00392925|Pramlintide|pramlintide|mesh-list
110685658|NCT00392925|Islet Amyloid Polypeptide|islet amyloid polypeptide|mesh-list
110685659|NCT00392925|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110685660|NCT00392925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110685661|NCT00392925|Appetite Depressants|appetite depressants|mesh-ancestor
110685662|NCT00392925|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110685663|NCT00392925|Amylin Receptor Agonists|amylin receptor agonists|mesh-ancestor
110685664|NCT00392925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110685665|NCT00474786|Sirolimus|sirolimus|mesh-list
110685666|NCT00474786|Sorafenib|sorafenib|mesh-list
110685667|NCT00474786|Temsirolimus|temsirolimus|mesh-list
110685668|NCT00474786|MTOR Inhibitors|mtor inhibitors|mesh-list
110685670|NCT00474786|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110685671|NCT00474786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110685672|NCT00474786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110685673|NCT00474786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110685674|NCT00474786|Immunologic Factors|immunologic factors|mesh-ancestor
110685675|NCT00474786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110685676|NCT00474786|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110685677|NCT00474786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110685678|NCT00474786|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110685680|NCT00392769|Cetuximab|cetuximab|mesh-list
110685681|NCT00392769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110685682|NCT00392769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110685683|NCT01041183|Ramosetron|ramosetron|mesh-list
110685684|NCT01041183|Antiemetics|antiemetics|mesh-ancestor
110685685|NCT01041183|Autonomic Agents|autonomic agents|mesh-ancestor
110685686|NCT01041183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110685687|NCT01041183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110685688|NCT01041183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110685689|NCT01041183|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110685690|NCT01041183|Serotonin Agents|serotonin agents|mesh-ancestor
110685691|NCT01041183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110685692|NCT01041183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110685694|NCT00319696|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110685695|NCT00319696|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
110685696|NCT00319696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110685697|NCT00474630|Naltrexone|naltrexone|mesh-list
110685698|NCT00474630|Bupropion|bupropion|mesh-list
110685699|NCT00474630|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110685700|NCT00474630|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110685701|NCT00474630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110685702|NCT00474630|Sensory System Agents|sensory system agents|mesh-ancestor
110685703|NCT00474630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110685704|NCT00474630|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110685705|NCT00474630|Antidepressive Agents|antidepressive agents|mesh-ancestor
110685706|NCT00474630|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110685707|NCT00474630|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110685708|NCT00474630|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110685709|NCT00474630|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110685710|NCT00474630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110685711|NCT00474630|Dopamine Agents|dopamine agents|mesh-ancestor
110685712|NCT00474630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110685713|NCT00474630|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110685714|NCT00474630|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110685715|NCT00474630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110685716|NCT01064752|Minocycline|minocycline|mesh-list
110685717|NCT01064752|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110685718|NCT01064752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110685719|NCT00392379|Nicotine|nicotine|mesh-list
110685720|NCT00392379|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110685721|NCT00392379|Autonomic Agents|autonomic agents|mesh-ancestor
110685722|NCT00392379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110685723|NCT00392379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110685724|NCT00392379|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110685725|NCT00392379|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110685726|NCT00392379|Cholinergic Agents|cholinergic agents|mesh-ancestor
110685727|NCT00392379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110685728|NCT00392379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110685729|NCT01038063|Lumefantrine|lumefantrine|mesh-list
110685730|NCT01038063|Artemether|artemether|mesh-list
110685731|NCT01038063|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
110685732|NCT01038063|Antimalarials|antimalarials|mesh-ancestor
110685733|NCT01038063|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110685734|NCT01038063|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110685735|NCT01038063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110685736|NCT01043991|Darbepoetin alfa|darbepoetin alfa|mesh-list
110685737|NCT01043991|Hematinics|hematinics|mesh-ancestor
110685738|NCT01020630|Sunitinib|sunitinib|mesh-list
110685739|NCT01020630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110685740|NCT01020630|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110685741|NCT01020630|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110685742|NCT01020630|Growth Substances|growth substances|mesh-ancestor
110685743|NCT01020630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110685744|NCT01020630|Growth Inhibitors|growth inhibitors|mesh-ancestor
110685745|NCT01020630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110685746|NCT01020630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110685747|NCT01020630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110685748|NCT00403455|Paroxetine|paroxetine|mesh-list
110685749|NCT00403455|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110685750|NCT00403455|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110685751|NCT00403455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110685752|NCT00403455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110685753|NCT00403455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110685754|NCT00403455|Serotonin Agents|serotonin agents|mesh-ancestor
110685755|NCT00403455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110685756|NCT00403455|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110685757|NCT00403455|Antidepressive Agents|antidepressive agents|mesh-ancestor
110685758|NCT00403455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110685759|NCT00403455|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110685760|NCT00403455|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110685761|NCT00403455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110685762|NCT00318370|Farletuzumab|farletuzumab|mesh-list
110685763|NCT00318370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110685764|NCT00510068|Everolimus|everolimus|mesh-list
110685765|NCT00510068|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110685766|NCT00510068|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110685767|NCT00510068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110685768|NCT00510068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110685769|NCT00510068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110685770|NCT00510068|Immunologic Factors|immunologic factors|mesh-ancestor
110685771|NCT00510068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110685772|NCT00510068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110685773|NCT00509600|Etanercept|etanercept|mesh-list
110685774|NCT00509600|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110685775|NCT00509600|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110685776|NCT00509600|Analgesics|analgesics|mesh-ancestor
110685777|NCT00509600|Sensory System Agents|sensory system agents|mesh-ancestor
110685778|NCT00509600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110685779|NCT00509600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110685780|NCT00509600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110685781|NCT00509600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110685782|NCT00509600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110685783|NCT00509600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110685784|NCT00509600|Immunologic Factors|immunologic factors|mesh-ancestor
110685785|NCT01014104|Methylprednisolone|methylprednisolone|mesh-list
110685786|NCT01014104|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110685787|NCT01014104|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110685788|NCT01014104|Prednisolone|prednisolone|mesh-list
110685789|NCT01014104|Prednisolone acetate|prednisolone acetate|mesh-list
110685790|NCT01014104|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110685791|NCT01014104|Prednisolone phosphate|prednisolone phosphate|mesh-list
110685792|NCT01014104|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110685793|NCT01014104|Antiemetics|antiemetics|mesh-ancestor
110685794|NCT01014104|Autonomic Agents|autonomic agents|mesh-ancestor
110685795|NCT01014104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110685796|NCT01014104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110685797|NCT01014104|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110685798|NCT01014104|Glucocorticoids|glucocorticoids|mesh-ancestor
110685799|NCT01014104|Hormones|hormones|mesh-ancestor
110163616|NCT04727320|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
110685800|NCT01014104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110685801|NCT01014104|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110685802|NCT01014104|Protective Agents|protective agents|mesh-ancestor
110685803|NCT01014104|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110685804|NCT01014104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110685805|NCT00402987|Celecoxib|celecoxib|mesh-list
110685806|NCT00402987|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110685807|NCT00402987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110685808|NCT00402987|Analgesics|analgesics|mesh-ancestor
110685809|NCT00402987|Sensory System Agents|sensory system agents|mesh-ancestor
110685810|NCT00402987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110685811|NCT00402987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110685812|NCT00402987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110685813|NCT00402987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110685814|NCT00402987|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110685815|NCT00402987|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110685816|NCT00402987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110685817|NCT00402987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110685818|NCT01015664|Sirolimus|sirolimus|mesh-list
110685819|NCT01015664|Cetuximab|cetuximab|mesh-list
110685820|NCT01015664|Temsirolimus|temsirolimus|mesh-list
110685821|NCT01015664|MTOR Inhibitors|mtor inhibitors|mesh-list
110685822|NCT01015664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110685823|NCT01015664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110685824|NCT01015664|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110685825|NCT01015664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110685826|NCT01015664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110685827|NCT01015664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110685828|NCT01015664|Immunologic Factors|immunologic factors|mesh-ancestor
110685829|NCT01015664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110685830|NCT01015664|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110685831|NCT01015664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110685832|NCT01015664|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110685833|NCT01015664|Antifungal Agents|antifungal agents|mesh-ancestor
110685834|NCT00501644|Interferons|interferons|mesh-list
110685835|NCT00501644|Interferon-gamma|interferon-gamma|mesh-list
110685836|NCT00501644|Carboplatin|carboplatin|mesh-list
110685837|NCT00501644|Molgramostim|molgramostim|mesh-list
110685838|NCT00501644|Sargramostim|sargramostim|mesh-list
110685839|NCT00501644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110685841|NCT00501644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110685842|NCT00501644|Immunologic Factors|immunologic factors|mesh-ancestor
110685843|NCT00501644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110685844|NCT01014260|Doxycycline|doxycycline|mesh-list
110685845|NCT01014260|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110685846|NCT01014260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110685847|NCT01014260|Antimalarials|antimalarials|mesh-ancestor
110685848|NCT01014260|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110685849|NCT01014260|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110685850|NCT01010672|Sirolimus|sirolimus|mesh-list
110685851|NCT01010672|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110685852|NCT01010672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110685853|NCT01010672|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110685854|NCT01010672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110685855|NCT01010672|Antifungal Agents|antifungal agents|mesh-ancestor
110685856|NCT01010672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110685857|NCT01010672|Immunologic Factors|immunologic factors|mesh-ancestor
110685858|NCT01010672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110685859|NCT01014338|Fosinopril|fosinopril|mesh-list
110685860|NCT01014338|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110685861|NCT01014338|Protease Inhibitors|protease inhibitors|mesh-ancestor
110685862|NCT01014338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110163631|NCT00391014|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110685863|NCT01014338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110685864|NCT01014338|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110685865|NCT01014416|Tolvaptan|tolvaptan|mesh-list
110685866|NCT01014416|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
110685867|NCT01014416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110685868|NCT01014416|Natriuretic Agents|natriuretic agents|mesh-ancestor
110685869|NCT01014416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110685870|NCT00497796|Ganciclovir|ganciclovir|mesh-list
110685871|NCT00497796|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
110685872|NCT00497796|Maribavir|maribavir|mesh-list
110685873|NCT00497796|Antiviral Agents|antiviral agents|mesh-ancestor
110685874|NCT00497796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110685875|NCT00497796|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110685876|NCT00497796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110685877|NCT00497796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110685878|NCT01017822|Gemcitabine|gemcitabine|mesh-list
110685879|NCT01017822|Capecitabine|capecitabine|mesh-list
110685880|NCT01017822|Conatumumab|conatumumab|mesh-list
110685881|NCT01017822|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110685882|NCT01017822|Antimetabolites|antimetabolites|mesh-ancestor
110685883|NCT01017822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110685885|NCT01017822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110685886|NCT00496782|Maraviroc|maraviroc|mesh-list
110685887|NCT00496782|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110685888|NCT00496782|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110685889|NCT00496782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110685890|NCT00496782|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110685891|NCT00496782|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110685892|NCT00496782|Antiviral Agents|antiviral agents|mesh-ancestor
110685893|NCT00496782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110685894|NCT00496782|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
110685895|NCT01020708|Acetylcysteine|acetylcysteine|mesh-list
110685896|NCT01020708|Aminosalicylic Acid|aminosalicylic acid|mesh-list
110685897|NCT01020708|Mesalamine|mesalamine|mesh-list
110685898|NCT01020708|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110685899|NCT01020708|Antiviral Agents|antiviral agents|mesh-ancestor
110685900|NCT01020708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110685901|NCT01020708|Expectorants|expectorants|mesh-ancestor
110685902|NCT01020708|Respiratory System Agents|respiratory system agents|mesh-ancestor
110685903|NCT01020708|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110685904|NCT01020708|Antioxidants|antioxidants|mesh-ancestor
110685905|NCT01020708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110685906|NCT01020708|Protective Agents|protective agents|mesh-ancestor
110685907|NCT01020708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110685908|NCT01020708|Antidotes|antidotes|mesh-ancestor
110685909|NCT01020708|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110685910|NCT01020708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110685911|NCT01020708|Analgesics|analgesics|mesh-ancestor
110685912|NCT01020708|Sensory System Agents|sensory system agents|mesh-ancestor
110685913|NCT01020708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110685914|NCT01020708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110685915|NCT01020708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110685916|NCT01020708|Antitubercular Agents|antitubercular agents|mesh-ancestor
110685917|NCT01020708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110685918|NCT01020864|Carboplatin|carboplatin|mesh-list
110685919|NCT01020864|Cetuximab|cetuximab|mesh-list
110685920|NCT01020864|Vinorelbine|vinorelbine|mesh-list
110685921|NCT01020864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110685922|NCT01020864|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110685923|NCT01020864|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110685924|NCT01020864|Tubulin Modulators|tubulin modulators|mesh-ancestor
110685925|NCT01020864|Antimitotic Agents|antimitotic agents|mesh-ancestor
110685926|NCT01020864|Mitosis Modulators|mitosis modulators|mesh-ancestor
110685927|NCT01020864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110685928|NCT04428372|Mannitol|mannitol|mesh-list
110685929|NCT04428372|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110685930|NCT04428372|Diuretics|diuretics|mesh-ancestor
110685931|NCT04428372|Natriuretic Agents|natriuretic agents|mesh-ancestor
110685932|NCT04428372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110685933|NCT01014858|Donepezil|donepezil|mesh-list
110685934|NCT01014858|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110685935|NCT01014858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110685936|NCT01014858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110685937|NCT01014858|Cholinergic Agents|cholinergic agents|mesh-ancestor
110685938|NCT01014858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110685939|NCT01014858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110685940|NCT01014858|Nootropic Agents|nootropic agents|mesh-ancestor
110685941|NCT00471276|Sunitinib|sunitinib|mesh-list
110685942|NCT00471276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110685943|NCT00471276|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110685944|NCT00471276|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110685945|NCT00471276|Growth Substances|growth substances|mesh-ancestor
110685946|NCT00471276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110685947|NCT00471276|Growth Inhibitors|growth inhibitors|mesh-ancestor
110685948|NCT00471276|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110685949|NCT00471276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110685950|NCT00471276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110685951|NCT00470262|Pioglitazone|pioglitazone|mesh-list
110685952|NCT00470262|Fenofibrate|fenofibrate|mesh-list
110685953|NCT00470262|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110685954|NCT00470262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110685955|NCT00470262|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110685956|NCT00470262|Antimetabolites|antimetabolites|mesh-ancestor
110685957|NCT00470262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110685958|NCT00470262|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110685959|NCT04034862|Lamivudine|lamivudine|mesh-list
110685960|NCT04034862|Dolutegravir|dolutegravir|mesh-list
110685961|NCT04034862|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110685962|NCT04034862|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110685963|NCT04034862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110685964|NCT04034862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110685965|NCT04034862|Antiviral Agents|antiviral agents|mesh-ancestor
110685966|NCT04034862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110685967|NCT04034862|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110685968|NCT04034862|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110685969|NCT04034862|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110685970|NCT04034862|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110685971|NCT00496470|Budesonide|budesonide|mesh-list
110685972|NCT00496470|Bromides|bromides|mesh-list
110685973|NCT00496470|Formoterol Fumarate|formoterol fumarate|mesh-list
110685974|NCT00496470|Tiotropium Bromide|tiotropium bromide|mesh-list
110685975|NCT00496470|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
110685976|NCT00496470|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110685977|NCT00496470|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110685978|NCT00496470|Autonomic Agents|autonomic agents|mesh-ancestor
110685979|NCT00496470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110685980|NCT00496470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110685981|NCT00496470|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110685982|NCT00496470|Respiratory System Agents|respiratory system agents|mesh-ancestor
110685983|NCT00496470|Glucocorticoids|glucocorticoids|mesh-ancestor
110685985|NCT00496470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110685986|NCT00496470|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110685987|NCT00496470|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110685988|NCT00496470|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110685989|NCT00496470|Adrenergic Agents|adrenergic agents|mesh-ancestor
110685990|NCT00496470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110685991|NCT00496470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110685992|NCT00496470|Parasympatholytics|parasympatholytics|mesh-ancestor
110685993|NCT00496470|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110685994|NCT00496470|Cholinergic Agents|cholinergic agents|mesh-ancestor
110685995|NCT00496470|Anticonvulsants|anticonvulsants|mesh-ancestor
110685996|NCT01021176|Diltiazem|diltiazem|mesh-list
110685997|NCT01021176|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110685998|NCT01021176|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110685999|NCT01021176|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110686000|NCT01021176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110686001|NCT01021176|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110686002|NCT01021176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110686003|NCT01021176|Vasodilator Agents|vasodilator agents|mesh-ancestor
110686004|NCT01018368|Rifampin|rifampin|mesh-list
110686005|NCT01018368|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110686006|NCT01018368|Antitubercular Agents|antitubercular agents|mesh-ancestor
110686007|NCT01018368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110686008|NCT01018368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110686009|NCT01018368|Leprostatic Agents|leprostatic agents|mesh-ancestor
110686010|NCT01018368|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110686011|NCT01018368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110686012|NCT01018368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110686013|NCT01018368|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110686014|NCT01018368|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110686015|NCT01018368|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110686016|NCT01018368|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110686017|NCT01018368|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110686018|NCT01018368|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110686019|NCT00487578|Naratriptan|naratriptan|mesh-list
110686020|NCT00487578|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110686021|NCT00487578|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110686022|NCT00487578|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110686023|NCT00487578|Serotonin Agents|serotonin agents|mesh-ancestor
110686024|NCT00487578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110686025|NCT00487578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110686026|NCT00487578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110686028|NCT00495612|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110686029|NCT00495612|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110686030|NCT00495612|Respiratory System Agents|respiratory system agents|mesh-ancestor
110686031|NCT01021488|Enoxaparin|enoxaparin|mesh-list
110686032|NCT01021488|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110686033|NCT01021488|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110686034|NCT01021488|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110686035|NCT01021488|Antimetabolites|antimetabolites|mesh-ancestor
110686036|NCT01021488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110686037|NCT01021488|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110686038|NCT01021488|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110686039|NCT01021488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110686040|NCT01021488|Anticoagulants|anticoagulants|mesh-ancestor
110686041|NCT01021488|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110686042|NCT01021488|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110686043|NCT00487188|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
110686044|NCT00487188|Enfuvirtide|enfuvirtide|mesh-list
110686045|NCT00487188|Antiviral Agents|antiviral agents|mesh-ancestor
110686046|NCT00487188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110686047|NCT00487188|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110686048|NCT00487188|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110686049|NCT00487188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110686050|NCT00487188|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110686051|NCT00509366|Cisplatin|cisplatin|mesh-list
110686052|NCT00509366|Gemcitabine|gemcitabine|mesh-list
110686053|NCT00509366|Docetaxel|docetaxel|mesh-list
110686054|NCT00509366|Pemetrexed|pemetrexed|mesh-list
110686055|NCT00509366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110686056|NCT00509366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110686057|NCT00509366|Antimetabolites|antimetabolites|mesh-ancestor
110686058|NCT00509366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110686059|NCT00509366|Tubulin Modulators|tubulin modulators|mesh-ancestor
110686060|NCT00509366|Antimitotic Agents|antimitotic agents|mesh-ancestor
110686061|NCT00509366|Mitosis Modulators|mitosis modulators|mesh-ancestor
110686062|NCT00509366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110686063|NCT00509366|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110686064|NCT00509366|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110686065|NCT01016054|Carboplatin|carboplatin|mesh-list
110686066|NCT01016054|Gemcitabine|gemcitabine|mesh-list
110686067|NCT01016054|Doxorubicin|doxorubicin|mesh-list
110686068|NCT01016054|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110686069|NCT01016054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110686070|NCT01016054|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110686071|NCT01016054|Antimetabolites|antimetabolites|mesh-ancestor
110686072|NCT01016054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110686073|NCT01016054|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110686074|NCT01016054|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110686075|NCT01016054|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110686076|NCT01016054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110686077|NCT00500318|Bromides|bromides|mesh-list
110686078|NCT00500318|Anticonvulsants|anticonvulsants|mesh-ancestor
110686079|NCT00499694|Bevacizumab|bevacizumab|mesh-list
110686080|NCT00499694|Satraplatin|satraplatin|mesh-list
110686081|NCT00499694|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110686082|NCT00499694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110686083|NCT00499694|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110686084|NCT00499694|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110686085|NCT00499694|Growth Substances|growth substances|mesh-ancestor
110686086|NCT00499694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110686087|NCT00499694|Growth Inhibitors|growth inhibitors|mesh-ancestor
110686088|NCT00486954|Paclitaxel|paclitaxel|mesh-list
110686089|NCT00486954|Lapatinib|lapatinib|mesh-list
110686090|NCT00486954|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110686091|NCT00486954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110686092|NCT00486954|Tubulin Modulators|tubulin modulators|mesh-ancestor
110686093|NCT00486954|Antimitotic Agents|antimitotic agents|mesh-ancestor
110686094|NCT00486954|Mitosis Modulators|mitosis modulators|mesh-ancestor
110686095|NCT00486954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110686096|NCT00486954|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110686097|NCT00486954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110686099|NCT00494676|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110686100|NCT00494676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110686101|NCT00494676|Sympathomimetics|sympathomimetics|mesh-ancestor
110686102|NCT00494676|Autonomic Agents|autonomic agents|mesh-ancestor
110686103|NCT00494676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110686104|NCT00494676|Dopamine Agents|dopamine agents|mesh-ancestor
110686105|NCT00494676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110163694|NCT00121069|Serotonin Agents|serotonin agents|mesh-ancestor
110686106|NCT00494676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110686107|NCT00494676|Adrenergic Agents|adrenergic agents|mesh-ancestor
110686108|NCT00494676|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110686109|NCT00494676|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110686110|NCT00494676|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110686111|NCT00494676|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110686112|NCT00486720|Vorinostat|vorinostat|mesh-list
110686113|NCT00486720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110686114|NCT00486720|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110686115|NCT00486720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110686116|NCT00486720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110686117|NCT00486330|Ritonavir|ritonavir|mesh-list
110686118|NCT00486330|Tipranavir|tipranavir|mesh-list
110686119|NCT00486330|Buprenorphine|buprenorphine|mesh-list
110686120|NCT00486330|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110686121|NCT00486330|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110686122|NCT00486330|Protease Inhibitors|protease inhibitors|mesh-ancestor
110686123|NCT00486330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110686124|NCT00486330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110686125|NCT00486330|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110686126|NCT00486330|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110686127|NCT00486330|Antiviral Agents|antiviral agents|mesh-ancestor
110686128|NCT00486330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110686129|NCT00486330|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110686130|NCT00486330|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110686131|NCT00486330|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110686132|NCT00486330|Narcotics|narcotics|mesh-ancestor
110686133|NCT00486330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110686135|NCT00486330|Analgesics|analgesics|mesh-ancestor
110686136|NCT00486330|Sensory System Agents|sensory system agents|mesh-ancestor
110686137|NCT00486330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110686138|NCT00486330|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110686139|NCT01021566|Methadone|methadone|mesh-list
110686140|NCT01021566|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110686141|NCT01021566|Narcotics|narcotics|mesh-ancestor
110686142|NCT01021566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110686143|NCT01021566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110686144|NCT01021566|Analgesics|analgesics|mesh-ancestor
110686145|NCT01021566|Sensory System Agents|sensory system agents|mesh-ancestor
110686146|NCT01021566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110686147|NCT01021566|Antitussive Agents|antitussive agents|mesh-ancestor
110686148|NCT01021566|Respiratory System Agents|respiratory system agents|mesh-ancestor
110686149|NCT00494442|Olaparib|olaparib|mesh-list
110686150|NCT00494442|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
110686151|NCT00494442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110686152|NCT00494442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110686153|NCT00494442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110686154|NCT00493974|Zileuton|zileuton|mesh-list
110686155|NCT00493974|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110686156|NCT00493974|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110686157|NCT00493974|Analgesics|analgesics|mesh-ancestor
110686158|NCT00493974|Sensory System Agents|sensory system agents|mesh-ancestor
110686159|NCT00493974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110686160|NCT00493974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110686161|NCT00493974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110686162|NCT00493974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110686163|NCT00493974|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
110686164|NCT00493974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110686165|NCT00493974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110686166|NCT00493974|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110686167|NCT00493974|Hormone Antagonists|hormone antagonists|mesh-ancestor
110686168|NCT00493974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110686169|NCT01018446|Busulfan|busulfan|mesh-list
110686170|NCT01018446|Alkylating Agents|alkylating agents|mesh-ancestor
110686171|NCT01018446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110686172|NCT01018446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110686173|NCT01018446|Immunologic Factors|immunologic factors|mesh-ancestor
110686174|NCT01018446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110686175|NCT01018446|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110686176|NCT01018446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110686177|NCT01018446|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110686178|NCT01018602|Vildagliptin|vildagliptin|mesh-list
110686179|NCT01018602|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110686180|NCT01018602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110686181|NCT01018602|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110686182|NCT01018602|Protease Inhibitors|protease inhibitors|mesh-ancestor
110686183|NCT01018602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110686184|NCT01018602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110686185|NCT01018758|Palonosetron|palonosetron|mesh-list
110686186|NCT01018758|Antiemetics|antiemetics|mesh-ancestor
110686187|NCT01018758|Autonomic Agents|autonomic agents|mesh-ancestor
110686188|NCT01018758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110686189|NCT01018758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110686190|NCT01018758|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110686191|NCT01018758|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110686192|NCT01018758|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110686193|NCT01018758|Serotonin Agents|serotonin agents|mesh-ancestor
110686194|NCT01018758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110686195|NCT01018758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110686196|NCT00469092|Insulin|insulin|mesh-list
110686197|NCT00469092|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110686198|NCT00469092|Metformin|metformin|mesh-list
110686199|NCT00469092|Insulin Glargine|insulin glargine|mesh-list
110686200|NCT00469092|Insulin Aspart|insulin aspart|mesh-list
110686201|NCT00469092|Glimepiride|glimepiride|mesh-list
110686202|NCT00469092|Biphasic Insulins|biphasic insulins|mesh-list
110686203|NCT00469092|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110686204|NCT00469092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110686205|NCT00469092|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110686206|NCT00469092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110686207|NCT00469092|Immunologic Factors|immunologic factors|mesh-ancestor
110686209|NCT00499616|Carboplatin|carboplatin|mesh-list
110686210|NCT00499616|Doxorubicin|doxorubicin|mesh-list
110686211|NCT00499616|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110686212|NCT00499616|Etoposide|etoposide|mesh-list
110686213|NCT00499616|Topotecan|topotecan|mesh-list
110686214|NCT00499616|Isotretinoin|isotretinoin|mesh-list
110686215|NCT00499616|Lenograstim|lenograstim|mesh-list
110686216|NCT00499616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110686217|NCT00499616|Immunologic Factors|immunologic factors|mesh-ancestor
110686218|NCT00499616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110686219|NCT00499616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110686220|NCT00499616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110686221|NCT00499616|Alkylating Agents|alkylating agents|mesh-ancestor
110686222|NCT00499616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110686223|NCT00499616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110686224|NCT00499616|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110686225|NCT00499616|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110686226|NCT00499616|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110686227|NCT00499616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110686228|NCT00499616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110686229|NCT00499616|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110686230|NCT00499616|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110686231|NCT00499616|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110686233|NCT00402597|Rivaroxaban|rivaroxaban|mesh-list
110686234|NCT00402597|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110686235|NCT00402597|Antithrombins|antithrombins|mesh-ancestor
110686236|NCT00402597|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110686237|NCT00402597|Protease Inhibitors|protease inhibitors|mesh-ancestor
110686238|NCT00402597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110686239|NCT00402597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110686241|NCT00469014|Fludarabine|fludarabine|mesh-list
110686242|NCT00469014|Fludarabine phosphate|fludarabine phosphate|mesh-list
110686243|NCT00469014|Busulfan|busulfan|mesh-list
110686244|NCT00469014|Clofarabine|clofarabine|mesh-list
110686245|NCT00469014|Thymoglobulin|thymoglobulin|mesh-list
110686246|NCT00469014|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110686247|NCT00469014|Lenograstim|lenograstim|mesh-list
110686248|NCT00469014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110686249|NCT00469014|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110686250|NCT00469014|Antimetabolites|antimetabolites|mesh-ancestor
110686251|NCT00469014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110686252|NCT00469014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110686253|NCT00469014|Immunologic Factors|immunologic factors|mesh-ancestor
110686254|NCT00469014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110686255|NCT00469014|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110686256|NCT00469014|Alkylating Agents|alkylating agents|mesh-ancestor
110686257|NCT00469014|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110686258|NCT00469014|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110686259|NCT00493038|Amoxicillin|amoxicillin|mesh-list
110686260|NCT00493038|Moxifloxacin|moxifloxacin|mesh-list
110686261|NCT00493038|Clavulanic Acid|clavulanic acid|mesh-list
110686262|NCT00493038|Clavulanic Acids|clavulanic acids|mesh-list
110686263|NCT00493038|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
110686264|NCT00493038|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
110686265|NCT00493038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110686266|NCT00493038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110686267|NCT00493038|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110686268|NCT00493038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110686269|NCT00493038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110686270|NCT00493038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110686271|NCT00493038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110686272|NCT00493038|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110686273|NCT00493038|Contraceptive Agents|contraceptive agents|mesh-ancestor
110686274|NCT00493038|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110686275|NCT00493038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110686276|NCT00493038|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110686277|NCT00493038|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110686278|NCT00493038|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110686279|NCT00493038|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110686280|NCT00392223|Azithromycin|azithromycin|mesh-list
110686281|NCT00392223|Minocycline|minocycline|mesh-list
110686282|NCT00392223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110560266|NCT00494299|Sorafenib|sorafenib|mesh-list
110686283|NCT00392223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110686285|NCT00402285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110686286|NCT00402285|Antioxidants|antioxidants|mesh-ancestor
110686287|NCT00402285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110686288|NCT00402285|Protective Agents|protective agents|mesh-ancestor
110686289|NCT00402285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110686290|NCT00402285|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110686291|NCT00402285|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110686292|NCT00402285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110686293|NCT03747159|Belimumab|belimumab|mesh-list
110686294|NCT03747159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110686295|NCT03747159|Immunologic Factors|immunologic factors|mesh-ancestor
110686296|NCT03747159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110686297|NCT00413283|Carboplatin|carboplatin|mesh-list
110686298|NCT00413283|Gemcitabine|gemcitabine|mesh-list
110686299|NCT00413283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110686300|NCT00413283|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110686301|NCT00413283|Antimetabolites|antimetabolites|mesh-ancestor
110686302|NCT00413283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110686303|NCT00402051|Carboplatin|carboplatin|mesh-list
110686304|NCT00402051|Pemetrexed|pemetrexed|mesh-list
110686305|NCT00402051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110686306|NCT00402051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110686307|NCT00402051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110686308|NCT00402051|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110686309|NCT00402051|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110686310|NCT00401973|Metformin|metformin|mesh-list
110686311|NCT00401973|Amantadine|amantadine|mesh-list
110686312|NCT00401973|Zonisamide|zonisamide|mesh-list
110686313|NCT00401973|Olanzapine|olanzapine|mesh-list
110686314|NCT00401973|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110686315|NCT00401973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110686316|NCT00401973|Antiemetics|antiemetics|mesh-ancestor
110686317|NCT00401973|Autonomic Agents|autonomic agents|mesh-ancestor
110686318|NCT00401973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110686319|NCT00401973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110686320|NCT00401973|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110686321|NCT00401973|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110686322|NCT00401973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110686323|NCT00401973|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110163784|NCT04711096|Bupivacaine|bupivacaine|mesh-list
110686324|NCT00401973|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110686325|NCT00401973|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110686326|NCT00401973|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110686327|NCT00401973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110686328|NCT00401973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110686329|NCT00401973|Serotonin Agents|serotonin agents|mesh-ancestor
110686330|NCT00401973|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110686331|NCT00401973|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110686332|NCT00401973|Antiviral Agents|antiviral agents|mesh-ancestor
110686333|NCT00401973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110686334|NCT00401973|Dopamine Agents|dopamine agents|mesh-ancestor
110686335|NCT00401973|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110686336|NCT00401973|Analgesics|analgesics|mesh-ancestor
110686337|NCT00401973|Sensory System Agents|sensory system agents|mesh-ancestor
110686338|NCT00401973|Anticonvulsants|anticonvulsants|mesh-ancestor
110686339|NCT00401973|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110686340|NCT00401973|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110686341|NCT01038453|Vitamin D|vitamin d|mesh-list
110686342|NCT01038453|Cholecalciferol|cholecalciferol|mesh-list
110686343|NCT01038453|Vitamins|vitamins|mesh-ancestor
110686344|NCT01038453|Micronutrients|micronutrients|mesh-ancestor
110686345|NCT01038453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110686346|NCT01038453|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110686347|NCT01038453|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110686348|NCT00401193|Tranexamic Acid|tranexamic acid|mesh-list
110686349|NCT00401193|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110686350|NCT00401193|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110686351|NCT00401193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110686352|NCT00401193|Hemostatics|hemostatics|mesh-ancestor
110686353|NCT00401193|Coagulants|coagulants|mesh-ancestor
110333375|NCT00485030|Sirolimus|sirolimus|mesh-list
110686354|NCT00400569|Sunitinib|sunitinib|mesh-list
110686355|NCT00400569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110686356|NCT00400569|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110686358|NCT00400569|Growth Substances|growth substances|mesh-ancestor
110686359|NCT00400569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110686360|NCT00400569|Growth Inhibitors|growth inhibitors|mesh-ancestor
110686361|NCT00400569|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110686362|NCT00400569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110686363|NCT00400569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110686364|NCT00413049|Amlodipine|amlodipine|mesh-list
110686365|NCT00413049|Valsartan|valsartan|mesh-list
110686366|NCT00413049|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110686367|NCT00413049|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110686368|NCT00413049|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110686369|NCT00413049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110686370|NCT00413049|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110686371|NCT00413049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110686372|NCT00413049|Vasodilator Agents|vasodilator agents|mesh-ancestor
110686373|NCT00413049|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110686374|NCT00413049|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110686376|NCT03732495|Lenvatinib|lenvatinib|mesh-list
110686377|NCT03732495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110686378|NCT03732495|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110686379|NCT03732495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110686380|NCT03732495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110686381|NCT03732495|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110686382|NCT03732495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110686383|NCT01041729|Atorvastatin|atorvastatin|mesh-list
110686384|NCT01041729|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110686385|NCT01041729|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110686386|NCT01041729|Antimetabolites|antimetabolites|mesh-ancestor
110163806|NCT04705948|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110686387|NCT01041729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110686388|NCT01041729|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110686389|NCT01041729|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110686390|NCT01041729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110686391|NCT01324245|Fenoldopam|fenoldopam|mesh-list
110686392|NCT01324245|Enalaprilat|enalaprilat|mesh-list
110686393|NCT01324245|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110686394|NCT01324245|Vasodilator Agents|vasodilator agents|mesh-ancestor
110686395|NCT01324245|Dopamine Agonists|dopamine agonists|mesh-ancestor
110686396|NCT01324245|Dopamine Agents|dopamine agents|mesh-ancestor
110686397|NCT01324245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110686398|NCT01324245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110686399|NCT01324245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110686400|NCT01324245|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110686401|NCT01324245|Protease Inhibitors|protease inhibitors|mesh-ancestor
110686402|NCT01324245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110686403|NCT00454194|Pemetrexed|pemetrexed|mesh-list
110686404|NCT00454194|Sorafenib|sorafenib|mesh-list
110686405|NCT00454194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110686406|NCT00454194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110686407|NCT00454194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110686408|NCT00454194|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110686409|NCT00454194|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110686410|NCT00454194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110686411|NCT00468546|Methotrexate|methotrexate|mesh-list
110686413|NCT00468546|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110686414|NCT00468546|Abortifacient Agents|abortifacient agents|mesh-ancestor
110686415|NCT00468546|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110686416|NCT00468546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110686417|NCT00468546|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110686418|NCT00468546|Antimetabolites|antimetabolites|mesh-ancestor
110686419|NCT00468546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110686420|NCT00468546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110686421|NCT00468546|Dermatologic Agents|dermatologic agents|mesh-ancestor
110686422|NCT00468546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110686423|NCT00468546|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110686424|NCT00468546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110686425|NCT00468546|Immunologic Factors|immunologic factors|mesh-ancestor
110686426|NCT00468546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110686427|NCT00468546|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110686428|NCT00468546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110686429|NCT00303316|Vaccines|vaccines|mesh-list
110686430|NCT00303316|Immunologic Factors|immunologic factors|mesh-ancestor
110686431|NCT00303316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110686432|NCT01064986|Hydrocortisone|hydrocortisone|mesh-list
110686433|NCT01064986|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
110686434|NCT01064986|Epinephrine|epinephrine|mesh-list
110686435|NCT01064986|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110686436|NCT01064986|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110686437|NCT01064986|Adrenergic Agents|adrenergic agents|mesh-ancestor
110686438|NCT01064986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110686439|NCT01064986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110686440|NCT01064986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110686441|NCT01064986|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110686442|NCT01064986|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110686443|NCT01064986|Autonomic Agents|autonomic agents|mesh-ancestor
110686444|NCT01064986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110686445|NCT01064986|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110163819|NCT00121888|Serotonin Agents|serotonin agents|mesh-ancestor
110686446|NCT01064986|Respiratory System Agents|respiratory system agents|mesh-ancestor
110686447|NCT01064986|Mydriatics|mydriatics|mesh-ancestor
110686448|NCT01064986|Sympathomimetics|sympathomimetics|mesh-ancestor
110686449|NCT01064986|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110686450|NCT01064986|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110686451|NCT00468312|Mometasone Furoate|mometasone furoate|mesh-list
110686452|NCT00468312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110686453|NCT00468312|Dermatologic Agents|dermatologic agents|mesh-ancestor
110686454|NCT00468312|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110686455|NCT03980002|Thalidomide|thalidomide|mesh-list
110686456|NCT03980002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110686457|NCT03980002|Immunologic Factors|immunologic factors|mesh-ancestor
110686458|NCT03980002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110686459|NCT03980002|Leprostatic Agents|leprostatic agents|mesh-ancestor
110686460|NCT03980002|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110686461|NCT03980002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110686462|NCT03980002|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110686463|NCT03980002|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110686464|NCT03980002|Growth Substances|growth substances|mesh-ancestor
110686465|NCT03980002|Growth Inhibitors|growth inhibitors|mesh-ancestor
110686466|NCT03980002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110686468|NCT00331864|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110686469|NCT00331864|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110686470|NCT00331864|Growth Substances|growth substances|mesh-ancestor
110686471|NCT00331864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110686472|NCT00331864|Growth Inhibitors|growth inhibitors|mesh-ancestor
110686473|NCT00331864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110686474|NCT00331630|Paclitaxel|paclitaxel|mesh-list
110686475|NCT00331630|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110686476|NCT00331630|Lapatinib|lapatinib|mesh-list
110686477|NCT00331630|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110686478|NCT00331630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110686479|NCT00331630|Tubulin Modulators|tubulin modulators|mesh-ancestor
110686480|NCT00331630|Antimitotic Agents|antimitotic agents|mesh-ancestor
110686481|NCT00331630|Mitosis Modulators|mitosis modulators|mesh-ancestor
110686482|NCT00331630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110686483|NCT00331630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110686484|NCT00331630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110686485|NCT00331552|Cyclophosphamide|cyclophosphamide|mesh-list
110686486|NCT00331552|Doxorubicin|doxorubicin|mesh-list
110686487|NCT00331552|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110686488|NCT00331552|Trastuzumab|trastuzumab|mesh-list
110686489|NCT00331552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110686491|NCT00331552|Immunoglobulins|immunoglobulins|mesh-list
110686492|NCT00331552|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110686493|NCT00331552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110686494|NCT00331552|Immunologic Factors|immunologic factors|mesh-ancestor
110686495|NCT00331552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110686496|NCT00331552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110686497|NCT00331552|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110686498|NCT00331552|Alkylating Agents|alkylating agents|mesh-ancestor
110686499|NCT00331552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110686500|NCT00331552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110686501|NCT00331552|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110686502|NCT00331552|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110686503|NCT00331552|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110686504|NCT00331552|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110686505|NCT00331552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110686506|NCT04320628|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
110686507|NCT04320628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110686509|NCT00331006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110686510|NCT00331006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110686511|NCT00331006|Immunologic Factors|immunologic factors|mesh-ancestor
110686512|NCT00331006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110686513|NCT00331006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110686514|NCT00302458|Methylphenidate|methylphenidate|mesh-list
110686515|NCT00302458|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110686516|NCT00302458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110686517|NCT00302458|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110686518|NCT00302458|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110686519|NCT00302458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110686520|NCT00302458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110686521|NCT00302458|Dopamine Agents|dopamine agents|mesh-ancestor
110686522|NCT00302458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110686524|NCT00391053|Immunologic Factors|immunologic factors|mesh-ancestor
110686525|NCT00391053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110686526|NCT00317044|Esomeprazole|esomeprazole|mesh-list
110686527|NCT00317044|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110686528|NCT00317044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110686529|NCT00317044|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110686530|NCT00317044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110686531|NCT00317044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110686532|NCT00301834|Cyclosporine|cyclosporine|mesh-list
110686533|NCT00301834|Methylprednisolone|methylprednisolone|mesh-list
110686534|NCT00301834|Methotrexate|methotrexate|mesh-list
110686535|NCT00301834|Fludarabine phosphate|fludarabine phosphate|mesh-list
110686536|NCT00301834|Fludarabine|fludarabine|mesh-list
110686537|NCT00301834|Busulfan|busulfan|mesh-list
110686538|NCT00301834|Alemtuzumab|alemtuzumab|mesh-list
110686539|NCT00301834|Cyclosporins|cyclosporins|mesh-list
110686540|NCT00301834|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110686541|NCT00301834|Abortifacient Agents|abortifacient agents|mesh-ancestor
110686542|NCT00301834|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110686543|NCT00301834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110686544|NCT00301834|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110686545|NCT00301834|Antimetabolites|antimetabolites|mesh-ancestor
110686546|NCT00301834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110686547|NCT00301834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110686548|NCT00301834|Dermatologic Agents|dermatologic agents|mesh-ancestor
110686549|NCT00301834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110686550|NCT00301834|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110686551|NCT00301834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110686552|NCT00301834|Immunologic Factors|immunologic factors|mesh-ancestor
110686553|NCT00301834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110686554|NCT00301834|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110686555|NCT00301834|Antifungal Agents|antifungal agents|mesh-ancestor
110686556|NCT00301834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110686557|NCT00301834|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110686558|NCT00301834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110686559|NCT00301834|Antiemetics|antiemetics|mesh-ancestor
110686560|NCT00301834|Autonomic Agents|autonomic agents|mesh-ancestor
110686561|NCT00301834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110686562|NCT00301834|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110686563|NCT00301834|Glucocorticoids|glucocorticoids|mesh-ancestor
110686564|NCT00301834|Hormones|hormones|mesh-ancestor
110686565|NCT00301834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110686566|NCT00301834|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110686567|NCT00301834|Protective Agents|protective agents|mesh-ancestor
110686568|NCT00301834|Alkylating Agents|alkylating agents|mesh-ancestor
110686569|NCT00301834|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110686570|NCT00301834|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110686571|NCT00301834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110686572|NCT00301366|Protease Inhibitors|protease inhibitors|mesh-list
110686573|NCT00301366|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
110686574|NCT00301366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110333592|NCT00485576|Eculizumab|eculizumab|mesh-list
110686575|NCT00301366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110686576|NCT00301366|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
110686577|NCT00301366|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110686578|NCT00466440|Prednisone|prednisone|mesh-list
110686579|NCT00466440|Docetaxel|docetaxel|mesh-list
110686580|NCT00466440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110686581|NCT00466440|Tubulin Modulators|tubulin modulators|mesh-ancestor
110686582|NCT00466440|Antimitotic Agents|antimitotic agents|mesh-ancestor
110686583|NCT00466440|Mitosis Modulators|mitosis modulators|mesh-ancestor
110686584|NCT00466440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110686585|NCT00466440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110686586|NCT00466440|Glucocorticoids|glucocorticoids|mesh-ancestor
110686587|NCT00466440|Hormones|hormones|mesh-ancestor
110686588|NCT00466440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110686589|NCT00466440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110686590|NCT00466440|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110686591|NCT00465972|Doxepin|doxepin|mesh-list
110686592|NCT00465972|Temazepam|temazepam|mesh-list
110686593|NCT00465972|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110686594|NCT00465972|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110686595|NCT00465972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110686596|NCT00465972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110686597|NCT00465972|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110686598|NCT00465972|Antidepressive Agents|antidepressive agents|mesh-ancestor
110686599|NCT00465972|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110686600|NCT00465972|Histamine Antagonists|histamine antagonists|mesh-ancestor
110686601|NCT00465972|Histamine Agents|histamine agents|mesh-ancestor
110686602|NCT00465972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110686603|NCT00465972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110686604|NCT00465972|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110686605|NCT00465972|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110686606|NCT00465972|GABA Modulators|gaba modulators|mesh-ancestor
110686607|NCT00465972|GABA Agents|gaba agents|mesh-ancestor
110686608|NCT03926754|Mirabegron|mirabegron|mesh-list
110686609|NCT03926754|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
110686610|NCT03926754|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110686611|NCT03926754|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110686612|NCT03926754|Adrenergic Agents|adrenergic agents|mesh-ancestor
110686613|NCT03926754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110686614|NCT03926754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110686615|NCT03926754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110686616|NCT03926754|Urological Agents|urological agents|mesh-ancestor
110686617|NCT00465894|Tolterodine Tartrate|tolterodine tartrate|mesh-list
110686618|NCT00465894|Estradiol|estradiol|mesh-list
110686619|NCT00465894|Estrogens|estrogens|mesh-ancestor
110686620|NCT00465894|Hormones|hormones|mesh-ancestor
110686621|NCT00465894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110686622|NCT00465894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110686623|NCT00465894|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110686624|NCT00465894|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110686625|NCT00465894|Cholinergic Agents|cholinergic agents|mesh-ancestor
110686626|NCT00465894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110686627|NCT00465894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110686628|NCT00465894|Urological Agents|urological agents|mesh-ancestor
110686629|NCT00330460|Denosumab|denosumab|mesh-list
110686630|NCT00330460|Alendronate|alendronate|mesh-list
110686631|NCT00330460|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110686632|NCT00330460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110686633|NCT01062490|Treosulfan|treosulfan|mesh-list
110686634|NCT01062490|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110686635|NCT01062490|Alkylating Agents|alkylating agents|mesh-ancestor
110686636|NCT01062490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110686637|NCT01062490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110686638|NCT00465738|Botulinum Toxins|botulinum toxins|mesh-list
110686639|NCT00465738|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110686640|NCT00465738|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110686641|NCT00465738|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
110686642|NCT00465738|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110686643|NCT00465738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110686644|NCT00465738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110686645|NCT00465738|Cholinergic Agents|cholinergic agents|mesh-ancestor
110686646|NCT00465738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110686647|NCT00465738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110686648|NCT00465738|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110686649|NCT00465738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110686650|NCT00400179|Cisplatin|cisplatin|mesh-list
110686651|NCT00400179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110560267|NCT00494299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110686652|NCT00464568|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|mesh-list
110686653|NCT00464568|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
110686654|NCT00464568|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110686655|NCT00464568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110686656|NCT00464568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110686657|NCT00464490|Dexmedetomidine|dexmedetomidine|mesh-list
110686658|NCT00464490|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110686659|NCT00464490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110686660|NCT00464490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110686661|NCT00464490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110686662|NCT00464490|Analgesics|analgesics|mesh-ancestor
110686663|NCT00464490|Sensory System Agents|sensory system agents|mesh-ancestor
110686664|NCT00464490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110686665|NCT00464490|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110686666|NCT00464490|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110686668|NCT00464490|Adrenergic Agents|adrenergic agents|mesh-ancestor
110686669|NCT00464490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110686670|NCT00464490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110686671|NCT00412893|Voriconazole|voriconazole|mesh-list
110686672|NCT00412893|Isavuconazole|isavuconazole|mesh-list
110686673|NCT00412893|Antifungal Agents|antifungal agents|mesh-ancestor
110686674|NCT00412893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110686675|NCT00412893|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110686676|NCT00412893|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110686677|NCT00412893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110686678|NCT00412893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110686679|NCT00412893|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110686680|NCT00412893|Hormone Antagonists|hormone antagonists|mesh-ancestor
110686681|NCT00412893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110686682|NCT00412893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110686683|NCT00412893|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110686684|NCT00412737|Oseltamivir|oseltamivir|mesh-list
110686685|NCT00412737|Antiviral Agents|antiviral agents|mesh-ancestor
110686686|NCT00412737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110686687|NCT00412737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110686688|NCT00412737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110686689|NCT00508742|Vaccines|vaccines|mesh-list
110686690|NCT00508742|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110686691|NCT00508742|Immunologic Factors|immunologic factors|mesh-ancestor
110686692|NCT00508742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110686693|NCT01041963|Losartan|losartan|mesh-list
110686694|NCT01041963|Enalapril|enalapril|mesh-list
110686695|NCT01041963|Enalaprilat|enalaprilat|mesh-list
110686696|NCT01041963|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110686697|NCT01041963|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110686698|NCT01041963|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110686699|NCT01041963|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110686700|NCT01041963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110686701|NCT01041963|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110686702|NCT01041963|Protease Inhibitors|protease inhibitors|mesh-ancestor
110686703|NCT01041963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110686704|NCT01044225|Cetuximab|cetuximab|mesh-list
110686705|NCT01044225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110686706|NCT01044225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110686707|NCT00508274|Capecitabine|capecitabine|mesh-list
110686708|NCT00508274|Lapatinib|lapatinib|mesh-list
110686709|NCT00508274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110686710|NCT00508274|Antimetabolites|antimetabolites|mesh-ancestor
110686711|NCT00508274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110686712|NCT00508274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110686713|NCT00508274|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110686714|NCT00508274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110686715|NCT01042041|Doxorubicin|doxorubicin|mesh-list
110686716|NCT01042041|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110686717|NCT01042041|Sorafenib|sorafenib|mesh-list
110686718|NCT01042041|Mitomycins|mitomycins|mesh-list
110686719|NCT01042041|Mitomycin|mitomycin|mesh-list
110686720|NCT01042041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110686721|NCT01042041|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110686722|NCT01042041|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110686724|NCT01042041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110686725|NCT01042041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110686726|NCT01042041|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110686727|NCT01042041|Alkylating Agents|alkylating agents|mesh-ancestor
110686728|NCT01042041|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110686729|NCT00499460|Oxycodone|oxycodone|mesh-list
110686730|NCT00499460|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110686731|NCT00499460|Narcotics|narcotics|mesh-ancestor
110686732|NCT00499460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110686733|NCT00499460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110686734|NCT00499460|Analgesics|analgesics|mesh-ancestor
110182936|NCT00027339|Ritonavir|ritonavir|mesh-list
110686735|NCT00499460|Sensory System Agents|sensory system agents|mesh-ancestor
110686736|NCT00499460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110686739|NCT00412113|Atorvastatin|atorvastatin|mesh-list
110686740|NCT00412113|Calcium|calcium|mesh-list
110686741|NCT00412113|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110686742|NCT00412113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110686743|NCT00412113|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110686744|NCT00412113|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110686745|NCT00412113|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110686746|NCT00412113|Antimetabolites|antimetabolites|mesh-ancestor
110686747|NCT00412113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110686748|NCT00412113|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110686749|NCT00412113|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110686750|NCT00412113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110686751|NCT00412113|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110686752|NCT00412113|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110686753|NCT00412113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110686754|NCT00412113|Vasodilator Agents|vasodilator agents|mesh-ancestor
110686755|NCT01014650|Glycine|glycine|mesh-list
110686756|NCT01014650|Glycine Agents|glycine agents|mesh-ancestor
110686757|NCT01014650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110686758|NCT01014650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110686759|NCT01014650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110686760|NCT00411645|Maribavir|maribavir|mesh-list
110686761|NCT00411645|Antiviral Agents|antiviral agents|mesh-ancestor
110686762|NCT00411645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110686763|NCT00490724|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
110686764|NCT00490724|Natriuretic Agents|natriuretic agents|mesh-ancestor
110686765|NCT00490724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110686766|NCT01039155|Oxaliplatin|oxaliplatin|mesh-list
110686767|NCT01039155|Azacitidine|azacitidine|mesh-list
110686768|NCT01039155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110686769|NCT01039155|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110686770|NCT01039155|Antimetabolites|antimetabolites|mesh-ancestor
110686771|NCT01039155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110686772|NCT01039155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110686773|NCT01039233|Bicalutamide|bicalutamide|mesh-list
110686774|NCT01039233|Androgen Antagonists|androgen antagonists|mesh-ancestor
110686775|NCT01039233|Hormone Antagonists|hormone antagonists|mesh-ancestor
110686776|NCT01039233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110686777|NCT01039233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110686778|NCT01039233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110686779|NCT00490646|Docetaxel|docetaxel|mesh-list
110686780|NCT00490646|Trastuzumab|trastuzumab|mesh-list
110686781|NCT00490646|Epothilones|epothilones|mesh-list
110686782|NCT00490646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110686783|NCT00490646|Tubulin Modulators|tubulin modulators|mesh-ancestor
110686784|NCT00490646|Antimitotic Agents|antimitotic agents|mesh-ancestor
110686785|NCT00490646|Mitosis Modulators|mitosis modulators|mesh-ancestor
110686786|NCT00490646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110686787|NCT00490646|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110686788|NCT03992937|Levonorgestrel|levonorgestrel|mesh-list
110686789|NCT03992937|Progesterone|progesterone|mesh-list
110686790|NCT03992937|Progestins|progestins|mesh-ancestor
110686791|NCT03992937|Hormones|hormones|mesh-ancestor
110686792|NCT03992937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110686793|NCT03992937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110686794|NCT03992937|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110333787|NCT00485940|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
110686795|NCT03992937|Contraceptive Agents|contraceptive agents|mesh-ancestor
110686796|NCT03992937|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110686797|NCT03992937|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110686798|NCT03992937|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110686799|NCT03992937|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110686800|NCT01039545|Norfloxacin|norfloxacin|mesh-list
110686802|NCT01039545|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110686804|NCT01039545|Analgesics|analgesics|mesh-ancestor
110686805|NCT01039545|Sensory System Agents|sensory system agents|mesh-ancestor
110686806|NCT01039545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110686807|NCT01039545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110686808|NCT01039545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110686809|NCT01039545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110686810|NCT01039545|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110686811|NCT01039545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110686812|NCT01039545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110686813|NCT01039545|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110686814|NCT01039545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110686815|NCT01039545|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110686816|NCT01039545|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110686817|NCT01039545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110686818|NCT01039545|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110686819|NCT01039545|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110686820|NCT00490568|Rosiglitazone|rosiglitazone|mesh-list
110686821|NCT00490568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110686822|NCT00490568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110686823|NCT00561353|Ribavirin|ribavirin|mesh-list
110686824|NCT00561353|Simeprevir|simeprevir|mesh-list
110686825|NCT00561353|Antimetabolites|antimetabolites|mesh-ancestor
110686826|NCT00561353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110686827|NCT00561353|Antiviral Agents|antiviral agents|mesh-ancestor
110686828|NCT00561353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110686829|NCT00561353|Protease Inhibitors|protease inhibitors|mesh-ancestor
110686830|NCT00561353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110686831|NCT00944957|Efavirenz|efavirenz|mesh-list
110686832|NCT00944957|Raltegravir Potassium|raltegravir potassium|mesh-list
110686833|NCT00944957|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110686834|NCT00944957|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110686835|NCT00944957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110686836|NCT00944957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110686837|NCT00944957|Antiviral Agents|antiviral agents|mesh-ancestor
110686838|NCT00944957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110686839|NCT00944957|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110686840|NCT00944957|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110686841|NCT00944957|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110686842|NCT00944957|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110686843|NCT00944957|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110686844|NCT00944957|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110686845|NCT00944957|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110686846|NCT00944957|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110686847|NCT00944957|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110686848|NCT00944957|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110686849|NCT00945347|Miglustat|miglustat|mesh-list
110686850|NCT00945347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110686851|NCT00945347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110686852|NCT00945347|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110686853|NCT00945347|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110686854|NCT00945347|Antiviral Agents|antiviral agents|mesh-ancestor
110686855|NCT00945347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110686856|NCT00945347|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
110686857|NCT00945347|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110686858|NCT00945347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110686859|NCT00941135|Docetaxel|docetaxel|mesh-list
110686860|NCT00941135|Cetuximab|cetuximab|mesh-list
110686861|NCT00941135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110686862|NCT00941135|Tubulin Modulators|tubulin modulators|mesh-ancestor
110686863|NCT00941135|Antimitotic Agents|antimitotic agents|mesh-ancestor
110686864|NCT00941135|Mitosis Modulators|mitosis modulators|mesh-ancestor
110686865|NCT00941135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110686866|NCT00941135|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110686867|NCT00556439|Abatacept|abatacept|mesh-list
110686868|NCT00556439|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110686869|NCT00556439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110686870|NCT00556439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110686871|NCT00556439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110686872|NCT00556439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110686874|NCT00556439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110686875|NCT00556439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110686876|NCT04012307|Candesartan|candesartan|mesh-list
110686877|NCT04012307|Candesartan cilexetil|candesartan cilexetil|mesh-list
110686878|NCT04012307|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110686879|NCT04012307|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110686880|NCT04012307|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110686881|NCT04012307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110686882|NCT00387465|Azacitidine|azacitidine|mesh-list
110686884|NCT00387465|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
110686885|NCT00387465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110686886|NCT00387465|Antimetabolites|antimetabolites|mesh-ancestor
110686887|NCT00387465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110686888|NCT00387465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110686889|NCT00387465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110686890|NCT01042665|Latanoprost|latanoprost|mesh-list
110686891|NCT01042665|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110686892|NCT01042665|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110686893|NCT00949949|Gemcitabine|gemcitabine|mesh-list
110686895|NCT00949949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110686896|NCT00949949|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110686897|NCT00949949|Antimetabolites|antimetabolites|mesh-ancestor
110163982|NCT00129142|Toremifene|toremifene|mesh-list
110686898|NCT00949949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110686899|NCT00949949|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110686900|NCT00949949|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110686901|NCT00949949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110686902|NCT00949949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110686903|NCT00949949|Immunologic Factors|immunologic factors|mesh-ancestor
110686904|NCT00949949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110686905|NCT00941369|Insulin|insulin|mesh-list
110686906|NCT00941369|Insulin Glargine|insulin glargine|mesh-list
110686907|NCT00941369|Insulin, Isophane|insulin, isophane|mesh-list
110686908|NCT00941369|Isophane Insulin, Human|isophane insulin, human|mesh-list
110686909|NCT00941369|Isophane insulin, beef|isophane insulin, beef|mesh-list
110686910|NCT00941369|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110686911|NCT00941369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110686912|NCT00950027|Povidone-Iodine|povidone-iodine|mesh-list
110686913|NCT00950027|Povidone|povidone|mesh-list
110686914|NCT00950027|Plasma Substitutes|plasma substitutes|mesh-ancestor
110686915|NCT00950027|Blood Substitutes|blood substitutes|mesh-ancestor
110686916|NCT00950027|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110686917|NCT00950027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110686918|NCT00941525|Latanoprost|latanoprost|mesh-list
110686919|NCT00941525|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110686920|NCT00941525|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110686921|NCT00456261|Bevacizumab|bevacizumab|mesh-list
110686922|NCT00456261|Carboplatin|carboplatin|mesh-list
110686923|NCT00456261|Gemcitabine|gemcitabine|mesh-list
110686924|NCT00456261|Pemetrexed|pemetrexed|mesh-list
110686925|NCT00456261|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110686926|NCT00456261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110686927|NCT00456261|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110686928|NCT00456261|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110686929|NCT00456261|Growth Substances|growth substances|mesh-ancestor
110686930|NCT00456261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110686931|NCT00456261|Growth Inhibitors|growth inhibitors|mesh-ancestor
110686932|NCT00456261|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110686933|NCT00456261|Antimetabolites|antimetabolites|mesh-ancestor
110686934|NCT00456261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110686935|NCT00456261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110686936|NCT00456261|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110686937|NCT00456261|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110686938|NCT00386607|Valsartan|valsartan|mesh-list
110686939|NCT00386607|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110686940|NCT00386607|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110686941|NCT00386607|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110686942|NCT00386607|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110686943|NCT00386607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110686945|NCT00386607|Natriuretic Agents|natriuretic agents|mesh-ancestor
110686946|NCT00386607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110686947|NCT00386607|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110686948|NCT00386607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110686949|NCT00410163|Cyclophosphamide|cyclophosphamide|mesh-list
110686951|NCT00410163|Ofatumumab|ofatumumab|mesh-list
110686952|NCT00410163|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110686953|NCT00410163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110686954|NCT00410163|Immunologic Factors|immunologic factors|mesh-ancestor
110686955|NCT00410163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110686956|NCT00410163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110163991|NCT00128947|Mycophenolic Acid|mycophenolic acid|mesh-list
110686957|NCT00410163|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110686958|NCT00410163|Alkylating Agents|alkylating agents|mesh-ancestor
110686959|NCT00410163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110686960|NCT00410163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110686961|NCT00410163|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110686962|NCT03617523|Vaccines|vaccines|mesh-list
110686963|NCT03617523|Immunologic Factors|immunologic factors|mesh-ancestor
110686964|NCT03617523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110686965|NCT00409617|Adalimumab|adalimumab|mesh-list
110686966|NCT00409617|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110686967|NCT00409617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110686968|NCT00409617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110686969|NCT00300274|Cyclosporine|cyclosporine|mesh-list
110686970|NCT00300274|Mycophenolic Acid|mycophenolic acid|mesh-list
110686971|NCT00300274|Everolimus|everolimus|mesh-list
110686972|NCT00300274|Cyclosporins|cyclosporins|mesh-list
110686973|NCT00300274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110686974|NCT00300274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110686975|NCT00300274|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110686976|NCT00300274|Immunologic Factors|immunologic factors|mesh-ancestor
110686977|NCT00300274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110686978|NCT00300274|Antifungal Agents|antifungal agents|mesh-ancestor
110686979|NCT00300274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110686980|NCT00300274|Dermatologic Agents|dermatologic agents|mesh-ancestor
110686981|NCT00300274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110686982|NCT00300274|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110686983|NCT00300274|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110686984|NCT00300274|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110686985|NCT00300274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110686986|NCT00300274|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110686987|NCT00300274|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110686988|NCT00300274|Antitubercular Agents|antitubercular agents|mesh-ancestor
110686989|NCT00300274|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110686990|NCT01043211|Lidocaine|lidocaine|mesh-list
110686991|NCT01043211|Epinephrine|epinephrine|mesh-list
110686992|NCT01043211|Anesthetics, Local|anesthetics, local|mesh-ancestor
110686993|NCT01043211|Anesthetics|anesthetics|mesh-ancestor
110686994|NCT01043211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110686995|NCT01043211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110686996|NCT01043211|Sensory System Agents|sensory system agents|mesh-ancestor
110686997|NCT01043211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110686998|NCT01043211|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110686999|NCT01043211|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110687000|NCT01043211|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110687001|NCT01043211|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110687002|NCT01043211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110687003|NCT01043211|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110687004|NCT01043211|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110687005|NCT01043211|Adrenergic Agents|adrenergic agents|mesh-ancestor
110687006|NCT01043211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110687007|NCT01043211|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110687008|NCT01043211|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110687009|NCT01043211|Autonomic Agents|autonomic agents|mesh-ancestor
110687010|NCT01043211|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110687011|NCT01043211|Respiratory System Agents|respiratory system agents|mesh-ancestor
110687012|NCT01043211|Mydriatics|mydriatics|mesh-ancestor
110687013|NCT01043211|Sympathomimetics|sympathomimetics|mesh-ancestor
110687014|NCT01043211|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110687015|NCT01043445|Glycerol|glycerol|mesh-list
110687016|NCT01043445|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
110687017|NCT01043445|Protective Agents|protective agents|mesh-ancestor
110687018|NCT01043445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110687019|NCT00396591|Aflibercept|aflibercept|mesh-list
110312727|NCT00295997|Cyclophosphamide|cyclophosphamide|mesh-list
110687020|NCT00396591|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110687021|NCT00396591|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110687022|NCT00396591|Growth Substances|growth substances|mesh-ancestor
110687023|NCT00396591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110687024|NCT00396591|Growth Inhibitors|growth inhibitors|mesh-ancestor
110687025|NCT00396591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110687027|NCT00316264|Antiviral Agents|antiviral agents|mesh-ancestor
110687028|NCT00316264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110687029|NCT00385827|Prednisone|prednisone|mesh-list
110687030|NCT00385827|Mitoxantrone|mitoxantrone|mesh-list
110687031|NCT00385827|Siltuximab|siltuximab|mesh-list
110687032|NCT00385827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110687033|NCT00385827|Glucocorticoids|glucocorticoids|mesh-ancestor
110687034|NCT00385827|Hormones|hormones|mesh-ancestor
110687035|NCT00385827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110687036|NCT00385827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110687037|NCT00385827|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110687038|NCT00385827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110687039|NCT00385827|Analgesics|analgesics|mesh-ancestor
110687040|NCT00385827|Sensory System Agents|sensory system agents|mesh-ancestor
110687041|NCT00385827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110687042|NCT00385827|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110687043|NCT00385827|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110687044|NCT00385827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110687045|NCT00385827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110687046|NCT00498602|Saponin QA-21V1|saponin qa-21v1|mesh-list
110687047|NCT00498602|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110687048|NCT00498602|Immunologic Factors|immunologic factors|mesh-ancestor
110687049|NCT00498602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110687050|NCT00507728|Bupropion|bupropion|mesh-list
110687051|NCT00507728|Varenicline|varenicline|mesh-list
110687052|NCT00507728|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110687053|NCT00507728|Antidepressive Agents|antidepressive agents|mesh-ancestor
110687054|NCT00507728|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110687055|NCT00507728|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110687056|NCT00507728|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110687057|NCT00507728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110687058|NCT00507728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110687059|NCT00507728|Dopamine Agents|dopamine agents|mesh-ancestor
110687060|NCT00507728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110687061|NCT00507728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110687062|NCT00507728|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110687063|NCT00507728|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110164027|NCT05638295|Panitumumab|panitumumab|mesh-list
110687064|NCT00507728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110687065|NCT00507728|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110687066|NCT00507728|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110687067|NCT00507728|Cholinergic Agents|cholinergic agents|mesh-ancestor
110687068|NCT00498368|Rituximab|rituximab|mesh-list
110687069|NCT00498368|Angiotensin II|angiotensin ii|mesh-list
110687070|NCT00498368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110687071|NCT00498368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110687072|NCT00498368|Immunologic Factors|immunologic factors|mesh-ancestor
110687073|NCT00498368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110687074|NCT00498368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110182964|NCT00027495|Analgesics|analgesics|mesh-ancestor
110687075|NCT00498368|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110687076|NCT04460066|Paclitaxel|paclitaxel|mesh-list
110687077|NCT04460066|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110687078|NCT04460066|Antibodies|antibodies|mesh-list
110687079|NCT04460066|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110687080|NCT04460066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110687081|NCT04460066|Tubulin Modulators|tubulin modulators|mesh-ancestor
110687082|NCT04460066|Antimitotic Agents|antimitotic agents|mesh-ancestor
110687083|NCT04460066|Mitosis Modulators|mitosis modulators|mesh-ancestor
110687084|NCT04460066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110687085|NCT04460066|Immunologic Factors|immunologic factors|mesh-ancestor
110687086|NCT04460066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110687087|NCT00385671|Pregabalin|pregabalin|mesh-list
110687088|NCT00385671|Gabapentin|gabapentin|mesh-list
110687089|NCT00385671|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110687090|NCT00385671|Analgesics|analgesics|mesh-ancestor
110687091|NCT00385671|Sensory System Agents|sensory system agents|mesh-ancestor
110687092|NCT00385671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110687093|NCT00385671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110687094|NCT00385671|Anticonvulsants|anticonvulsants|mesh-ancestor
110687095|NCT00385671|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110334082|NCT05642845|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110687096|NCT00385671|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110687097|NCT00385671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110687098|NCT00385671|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110687100|NCT00385671|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110687101|NCT00385671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110687102|NCT00385671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110687103|NCT00385671|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110687104|NCT00385671|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110687105|NCT00385671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110687106|NCT00385671|Antimanic Agents|antimanic agents|mesh-ancestor
110687107|NCT00385671|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110687108|NCT00385671|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110687109|NCT00385671|Antidepressive Agents|antidepressive agents|mesh-ancestor
110687110|NCT00385671|Dopamine Agents|dopamine agents|mesh-ancestor
110687111|NCT00497198|Bile Acids and Salts|bile acids and salts|mesh-list
110687112|NCT00497198|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110687113|NCT00496964|Botulinum Toxins|botulinum toxins|mesh-list
110687114|NCT00496964|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110687115|NCT00496964|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110687116|NCT00496964|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110687117|NCT00496964|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110687118|NCT00496964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110687119|NCT00496964|Cholinergic Agents|cholinergic agents|mesh-ancestor
110687120|NCT00496964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110687121|NCT00496964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110687122|NCT00496964|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110687123|NCT00496964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110687125|NCT01011062|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110687126|NCT01011062|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110687127|NCT01011062|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110687128|NCT01011062|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110687129|NCT01011062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110687131|NCT00490490|Lugol's solution|lugol's solution|mesh-list
110687132|NCT00490490|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110687133|NCT00490490|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110687134|NCT00490490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110687135|NCT00490490|Trace Elements|trace elements|mesh-ancestor
110687136|NCT00490490|Micronutrients|micronutrients|mesh-ancestor
110182973|NCT00027534|Metronidazole|metronidazole|mesh-list
110687137|NCT00490490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110687138|NCT00490490|Hemostatics|hemostatics|mesh-ancestor
110687139|NCT00490490|Coagulants|coagulants|mesh-ancestor
110687140|NCT05049980|Mifepristone|mifepristone|mesh-list
110687141|NCT05049980|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
110687142|NCT05049980|Abortifacient Agents|abortifacient agents|mesh-ancestor
110687143|NCT05049980|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110687144|NCT05049980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110687145|NCT05049980|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110687146|NCT05049980|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110687147|NCT05049980|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110687148|NCT05049980|Contraceptive Agents|contraceptive agents|mesh-ancestor
110687149|NCT05049980|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
110687150|NCT05049980|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
110687151|NCT05049980|Hormone Antagonists|hormone antagonists|mesh-ancestor
110687152|NCT05049980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110687153|NCT05049980|Luteolytic Agents|luteolytic agents|mesh-ancestor
110687154|NCT05049980|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110687155|NCT05049980|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
110687156|NCT00385593|Budesonide|budesonide|mesh-list
110687157|NCT00385593|Formoterol Fumarate|formoterol fumarate|mesh-list
110687158|NCT00385593|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
110687159|NCT00385593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110687160|NCT00385593|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110687161|NCT00385593|Autonomic Agents|autonomic agents|mesh-ancestor
110687162|NCT00385593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110687163|NCT00385593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110687164|NCT00385593|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110687165|NCT00385593|Respiratory System Agents|respiratory system agents|mesh-ancestor
110687166|NCT00385593|Glucocorticoids|glucocorticoids|mesh-ancestor
110687167|NCT00385593|Hormones|hormones|mesh-ancestor
110164079|NCT00009048|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110687168|NCT00385593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110687169|NCT00385593|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110687170|NCT00385593|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110687171|NCT00385593|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110687172|NCT00385593|Adrenergic Agents|adrenergic agents|mesh-ancestor
110687173|NCT00385593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110687174|NCT00385593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110687175|NCT01015040|Solifenacin Succinate|solifenacin succinate|mesh-list
110687176|NCT01015040|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110687177|NCT01015040|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110687178|NCT01015040|Cholinergic Agents|cholinergic agents|mesh-ancestor
110687179|NCT01015040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110687180|NCT01015040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110687181|NCT01015040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110687182|NCT01015040|Urological Agents|urological agents|mesh-ancestor
110687183|NCT00495170|Paclitaxel|paclitaxel|mesh-list
110687184|NCT00495170|Carboplatin|carboplatin|mesh-list
110687185|NCT00495170|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110687186|NCT00495170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110687187|NCT00495170|Tubulin Modulators|tubulin modulators|mesh-ancestor
110687188|NCT00495170|Antimitotic Agents|antimitotic agents|mesh-ancestor
110687189|NCT00495170|Mitosis Modulators|mitosis modulators|mesh-ancestor
110687190|NCT00495170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110687191|NCT01011374|Ranibizumab|ranibizumab|mesh-list
110687192|NCT01011374|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110687193|NCT01011374|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110687194|NCT01011374|Growth Substances|growth substances|mesh-ancestor
110687195|NCT01011374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110687196|NCT01011374|Growth Inhibitors|growth inhibitors|mesh-ancestor
110687197|NCT01011374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110687198|NCT00385203|Cediranib|cediranib|mesh-list
110687199|NCT00385203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110687200|NCT00385203|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110687201|NCT00385203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110687202|NCT00385203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110687203|NCT01043601|Formoterol Fumarate|formoterol fumarate|mesh-list
110687204|NCT01043601|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110687205|NCT01043601|Autonomic Agents|autonomic agents|mesh-ancestor
110687206|NCT01043601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110687207|NCT01043601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110687208|NCT01043601|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110687209|NCT01043601|Respiratory System Agents|respiratory system agents|mesh-ancestor
110687210|NCT01043601|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110687211|NCT01043601|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110687212|NCT01043601|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110687213|NCT01043601|Adrenergic Agents|adrenergic agents|mesh-ancestor
110687214|NCT01043601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110687215|NCT01043601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110687216|NCT01043679|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110687217|NCT01043679|Antidepressive Agents|antidepressive agents|mesh-ancestor
110687218|NCT01043679|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110687219|NCT01043679|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110687220|NCT01043679|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110687221|NCT01043679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110687222|NCT01043679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110687223|NCT00408993|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110687224|NCT00408993|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110687225|NCT00408993|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110687226|NCT00408993|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110687227|NCT00408993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110687228|NCT00408993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110687229|NCT00408993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110687230|NCT00408993|Analgesics|analgesics|mesh-ancestor
110687231|NCT00408993|Sensory System Agents|sensory system agents|mesh-ancestor
110687232|NCT00408993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110687233|NCT00408993|Antidepressive Agents|antidepressive agents|mesh-ancestor
110687234|NCT00408993|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110687235|NCT00408993|Dopamine Agents|dopamine agents|mesh-ancestor
110687236|NCT00395967|Plerixafor|plerixafor|mesh-list
110687237|NCT00395967|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110687238|NCT00395967|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110687239|NCT00395967|Antiviral Agents|antiviral agents|mesh-ancestor
110687240|NCT00395967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110687241|NCT00395343|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110687242|NCT00395343|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110687243|NCT00395343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110687244|NCT00395343|Incretins|incretins|mesh-ancestor
110687245|NCT00395343|Hormones|hormones|mesh-ancestor
110687246|NCT00395343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110687247|NCT00395343|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110687248|NCT00395343|Protease Inhibitors|protease inhibitors|mesh-ancestor
110687249|NCT00395343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110687250|NCT00395343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110687251|NCT00560573|Gemcitabine|gemcitabine|mesh-list
110687252|NCT00560573|Pemetrexed|pemetrexed|mesh-list
110687253|NCT00560573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110687254|NCT00560573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110687255|NCT00560573|Antimetabolites|antimetabolites|mesh-ancestor
110687256|NCT00560573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110687257|NCT00560573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110687258|NCT00560573|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110687259|NCT00560573|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110687260|NCT00950105|Semapimod|semapimod|mesh-list
110687261|NCT00950105|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110687262|NCT00950105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110687263|NCT00950105|Analgesics|analgesics|mesh-ancestor
110687264|NCT00950105|Sensory System Agents|sensory system agents|mesh-ancestor
110687265|NCT00950105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110687266|NCT00950105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110687267|NCT00950105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110687268|NCT00950105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110687269|NCT00950105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110687270|NCT00950105|Immunologic Factors|immunologic factors|mesh-ancestor
110687271|NCT00950261|Cisplatin|cisplatin|mesh-list
110687272|NCT00950261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110687273|NCT05280197|Bupivacaine|bupivacaine|mesh-list
110687274|NCT05280197|Anesthetics, Local|anesthetics, local|mesh-ancestor
110687275|NCT05280197|Anesthetics|anesthetics|mesh-ancestor
110687276|NCT05280197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110687277|NCT05280197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110687279|NCT05280197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110687280|NCT00946595|Ritonavir|ritonavir|mesh-list
110687281|NCT00946595|Lopinavir|lopinavir|mesh-list
110687282|NCT00946595|Tenofovir|tenofovir|mesh-list
110687283|NCT00946595|Efavirenz|efavirenz|mesh-list
110687284|NCT00946595|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110687285|NCT00946595|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110687286|NCT00946595|Protease Inhibitors|protease inhibitors|mesh-ancestor
110687287|NCT00946595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110687288|NCT00946595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110687289|NCT00946595|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110687290|NCT00946595|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110687291|NCT00946595|Antiviral Agents|antiviral agents|mesh-ancestor
110687292|NCT00946595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110687293|NCT00946595|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110687294|NCT00946595|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110687295|NCT00946595|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110687296|NCT00946595|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110687297|NCT00946595|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110687298|NCT00946595|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110687299|NCT00946595|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110687300|NCT00946595|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110687301|NCT00946595|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110687302|NCT00494780|Prednisone|prednisone|mesh-list
110687303|NCT00494780|Prednisolone|prednisolone|mesh-list
110687304|NCT00494780|Cyclophosphamide|cyclophosphamide|mesh-list
110687305|NCT00494780|Doxorubicin|doxorubicin|mesh-list
110687306|NCT00494780|Vincristine|vincristine|mesh-list
110687307|NCT00494780|Ofatumumab|ofatumumab|mesh-list
110687308|NCT00494780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110687309|NCT00494780|Immunologic Factors|immunologic factors|mesh-ancestor
110687310|NCT00494780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110687311|NCT00494780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110687312|NCT00494780|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110687313|NCT00494780|Alkylating Agents|alkylating agents|mesh-ancestor
110560339|NCT00638729|GABA Agents|gaba agents|mesh-ancestor
110687314|NCT00494780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110687315|NCT00494780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110687316|NCT00494780|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110687317|NCT00494780|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110687318|NCT00494780|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110687319|NCT00494780|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110687320|NCT00494780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110687321|NCT00494780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110687323|NCT00494780|Hormones|hormones|mesh-ancestor
110687324|NCT00494780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110687325|NCT00494780|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110687326|NCT00494780|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110687327|NCT00494780|Tubulin Modulators|tubulin modulators|mesh-ancestor
110687328|NCT00494780|Antimitotic Agents|antimitotic agents|mesh-ancestor
110687329|NCT00494780|Mitosis Modulators|mitosis modulators|mesh-ancestor
110687330|NCT01011452|Montelukast|montelukast|mesh-list
110687331|NCT01011452|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110687332|NCT01011452|Respiratory System Agents|respiratory system agents|mesh-ancestor
110687333|NCT01011452|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110687334|NCT01011452|Hormone Antagonists|hormone antagonists|mesh-ancestor
110687335|NCT01011452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110687336|NCT01011452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110687337|NCT01011452|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110687338|NCT01011452|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110687339|NCT01011452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110687340|NCT00490022|Dihydrotestosterone|dihydrotestosterone|mesh-list
110687341|NCT00490022|Androgens|androgens|mesh-ancestor
110687342|NCT00490022|Hormones|hormones|mesh-ancestor
110687343|NCT00490022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110687344|NCT00490022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110687346|NCT01011530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110687347|NCT01011530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110687348|NCT00493454|Rituximab|rituximab|mesh-list
110687349|NCT00493454|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110687350|NCT00493454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110687351|NCT00493454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110687352|NCT00493454|Immunologic Factors|immunologic factors|mesh-ancestor
110687353|NCT00493454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110687354|NCT00493454|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110687355|NCT00493220|Ceftriaxone|ceftriaxone|mesh-list
110687356|NCT00493220|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110687357|NCT00493220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110687358|NCT00950339|Omeprazole|omeprazole|mesh-list
110687359|NCT00950339|Pantoprazole|pantoprazole|mesh-list
110687360|NCT00950339|Famotidine|famotidine|mesh-list
110687361|NCT00950339|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110687362|NCT00950339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110687363|NCT00950339|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110687364|NCT00950339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110687365|NCT00950339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110687366|NCT00950339|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110687367|NCT00950339|Histamine Antagonists|histamine antagonists|mesh-ancestor
110687368|NCT00950339|Histamine Agents|histamine agents|mesh-ancestor
110687369|NCT00950339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110687370|NCT00950339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110687371|NCT00950417|Nimotuzumab|nimotuzumab|mesh-list
110687372|NCT00950417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110687373|NCT00950417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110687374|NCT00946673|Vorinostat|vorinostat|mesh-list
110687375|NCT00946673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110687376|NCT00946673|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110687377|NCT00946673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110687378|NCT00946673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110687379|NCT00394953|Darbepoetin alfa|darbepoetin alfa|mesh-list
110687380|NCT00394953|Hematinics|hematinics|mesh-ancestor
110687381|NCT00946751|Levetiracetam|levetiracetam|mesh-list
110687382|NCT00946751|Anticonvulsants|anticonvulsants|mesh-ancestor
110687383|NCT00946751|Nootropic Agents|nootropic agents|mesh-ancestor
110687384|NCT00485732|Vaccines|vaccines|mesh-list
110687385|NCT00485732|Immunologic Factors|immunologic factors|mesh-ancestor
110687386|NCT00485732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110687388|NCT00946829|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110687389|NCT00946829|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110687390|NCT00946829|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110687391|NCT00946829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110687392|NCT00489554|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110687393|NCT00489554|Immunologic Factors|immunologic factors|mesh-ancestor
110687394|NCT00489554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110687395|NCT00408681|Lithium Carbonate|lithium carbonate|mesh-list
110687396|NCT00408681|Antidepressive Agents|antidepressive agents|mesh-ancestor
110687397|NCT00408681|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110687398|NCT00408681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110687399|NCT00408681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110687401|NCT00408681|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110182996|NCT00027573|Antimetabolites|antimetabolites|mesh-ancestor
110687402|NCT00408681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110687403|NCT00408681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110687405|NCT00560417|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110687406|NCT00560417|Insulin Glargine|insulin glargine|mesh-list
110687407|NCT00560417|Insulin Lispro|insulin lispro|mesh-list
110687408|NCT00560417|Protamines|protamines|mesh-list
110687409|NCT00560417|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110687410|NCT00560417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110687411|NCT00560417|Heparin Antagonists|heparin antagonists|mesh-ancestor
110687412|NCT00560417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110687413|NCT00560417|Coagulants|coagulants|mesh-ancestor
110687414|NCT01040091|Tenofovir|tenofovir|mesh-list
110687415|NCT01040091|Emtricitabine|emtricitabine|mesh-list
110687416|NCT01040091|Efavirenz|efavirenz|mesh-list
110687417|NCT01040091|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110687418|NCT01040091|Antiviral Agents|antiviral agents|mesh-ancestor
110687419|NCT01040091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110687420|NCT01040091|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110687421|NCT01040091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110687422|NCT01040091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110687423|NCT01040091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110687424|NCT01040091|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110687425|NCT01040091|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110687426|NCT01040091|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110687427|NCT01040091|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110687428|NCT01040091|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110687429|NCT01040091|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110687430|NCT01040091|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110687431|NCT01040091|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110687432|NCT00946907|Aspirin|aspirin|mesh-list
110687433|NCT00946907|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110687434|NCT00946907|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110687435|NCT00946907|Analgesics|analgesics|mesh-ancestor
110164185|NCT00128323|Antifungal Agents|antifungal agents|mesh-ancestor
110687436|NCT00946907|Sensory System Agents|sensory system agents|mesh-ancestor
110687437|NCT00946907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110687438|NCT00946907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110687439|NCT00946907|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110687440|NCT00946907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110687441|NCT00946907|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110687442|NCT00946907|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110687443|NCT00946907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110687444|NCT00946907|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110687445|NCT00946907|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110687446|NCT00946907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110687447|NCT00946907|Antipyretics|antipyretics|mesh-ancestor
110687448|NCT00942539|Midazolam|midazolam|mesh-list
110687449|NCT00942539|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110687450|NCT00942539|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110687451|NCT00942539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110687452|NCT00942539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110687453|NCT00942539|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110687454|NCT00942539|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110687455|NCT00942539|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110687456|NCT00942539|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110687457|NCT00942539|Anesthetics, General|anesthetics, general|mesh-ancestor
110687458|NCT00942539|Anesthetics|anesthetics|mesh-ancestor
110687459|NCT00942539|GABA Modulators|gaba modulators|mesh-ancestor
110687460|NCT00942539|GABA Agents|gaba agents|mesh-ancestor
110687461|NCT00942539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110687462|NCT00942539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110687463|NCT00947063|Promethazine|promethazine|mesh-list
110687464|NCT00947063|Diphenhydramine|diphenhydramine|mesh-list
110687466|NCT00947063|Dermatologic Agents|dermatologic agents|mesh-ancestor
110687467|NCT00947063|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110687468|NCT00947063|Histamine Antagonists|histamine antagonists|mesh-ancestor
110687469|NCT00947063|Histamine Agents|histamine agents|mesh-ancestor
110687470|NCT00947063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110687471|NCT00947063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110687472|NCT00947063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110687473|NCT00947063|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110687474|NCT00947063|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110687475|NCT00947063|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110687476|NCT00947063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110687477|NCT00947063|Anesthetics, Local|anesthetics, local|mesh-ancestor
110687478|NCT00947063|Anesthetics|anesthetics|mesh-ancestor
110687479|NCT00947063|Sensory System Agents|sensory system agents|mesh-ancestor
110687480|NCT00947063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110687481|NCT00947063|Antiemetics|antiemetics|mesh-ancestor
110687482|NCT00947063|Autonomic Agents|autonomic agents|mesh-ancestor
110687483|NCT00947063|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110687484|NCT00942617|Aspirin|aspirin|mesh-list
110687485|NCT00942617|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110687486|NCT00942617|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110687487|NCT00942617|Analgesics|analgesics|mesh-ancestor
110687488|NCT00942617|Sensory System Agents|sensory system agents|mesh-ancestor
110687489|NCT00942617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110687490|NCT00942617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110687491|NCT00942617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110687492|NCT00942617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110687493|NCT00942617|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110687494|NCT00942617|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110687495|NCT00942617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110687496|NCT00942617|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110687497|NCT00942617|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110687498|NCT00942617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110687499|NCT00942617|Antipyretics|antipyretics|mesh-ancestor
110687500|NCT00345345|Alemtuzumab|alemtuzumab|mesh-list
110687501|NCT00345345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110687502|NCT00345345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110687503|NCT03968159|Pimavanserin|pimavanserin|mesh-list
110687504|NCT03968159|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110687505|NCT03968159|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110687506|NCT03968159|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110687507|NCT03968159|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110687508|NCT03968159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110687509|NCT03968159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110687510|NCT03968159|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110687511|NCT03968159|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110687512|NCT03968159|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110687513|NCT03968159|Serotonin Agents|serotonin agents|mesh-ancestor
110687514|NCT03968159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110687515|NCT03968159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110687516|NCT00947141|Valganciclovir|valganciclovir|mesh-list
110687517|NCT00947141|Ganciclovir|ganciclovir|mesh-list
110687518|NCT00947141|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
110687519|NCT00947141|Foscarnet|foscarnet|mesh-list
110687520|NCT00947141|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
110687521|NCT00947141|Antiviral Agents|antiviral agents|mesh-ancestor
110687522|NCT00947141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110687523|NCT00947141|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110687524|NCT00947141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110687525|NCT00947141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110687526|NCT00947141|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110687527|NCT03966365|Timolol|timolol|mesh-list
110687528|NCT03966365|Brimonidine Tartrate|brimonidine tartrate|mesh-list
110687529|NCT03966365|Dorzolamide|dorzolamide|mesh-list
110687530|NCT03966365|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110687531|NCT03966365|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110687532|NCT03966365|Adrenergic Agents|adrenergic agents|mesh-ancestor
110687533|NCT03966365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110687534|NCT03966365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110312732|NCT00295997|Tacrolimus|tacrolimus|mesh-list
110183024|NCT00027807|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110687535|NCT03966365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110687536|NCT03966365|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110687537|NCT03966365|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110687538|NCT03966365|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110687539|NCT03966365|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110687540|NCT03966365|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110687541|NCT03966365|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110687542|NCT03966365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110687544|NCT00375219|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110687545|NCT00375219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110687546|NCT00375219|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110687547|NCT00375219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110687548|NCT00375219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110687550|NCT03965351|Uricosuric Agents|uricosuric agents|mesh-ancestor
110687551|NCT03965351|Gout Suppressants|gout suppressants|mesh-ancestor
110687552|NCT03965351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110687553|NCT00947375|Lamotrigine|lamotrigine|mesh-list
110687554|NCT00947375|Haloperidol|haloperidol|mesh-list
110687555|NCT00947375|Haloperidol decanoate|haloperidol decanoate|mesh-list
110687556|NCT00947375|Antiemetics|antiemetics|mesh-ancestor
110687557|NCT00947375|Autonomic Agents|autonomic agents|mesh-ancestor
110687558|NCT00947375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110687559|NCT00947375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110687560|NCT00947375|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110687561|NCT00947375|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110687562|NCT00947375|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110687563|NCT00947375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110687564|NCT00947375|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110687565|NCT00947375|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110687566|NCT00947375|Dopamine Agents|dopamine agents|mesh-ancestor
110687567|NCT00947375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110687568|NCT00947375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110687569|NCT00947375|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110687570|NCT00947375|Anticonvulsants|anticonvulsants|mesh-ancestor
110687571|NCT00947375|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110687572|NCT00947375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110687573|NCT00947375|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110687574|NCT00947375|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110687575|NCT00947453|Montelukast|montelukast|mesh-list
110687576|NCT00947453|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110687577|NCT00947453|Respiratory System Agents|respiratory system agents|mesh-ancestor
110687578|NCT00947453|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110687579|NCT00947453|Hormone Antagonists|hormone antagonists|mesh-ancestor
110687580|NCT00947453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110687581|NCT00947453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110687582|NCT00947453|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110687583|NCT00947453|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110687584|NCT00947453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110687585|NCT00942773|Voriconazole|voriconazole|mesh-list
110687586|NCT00942773|Antifungal Agents|antifungal agents|mesh-ancestor
110687587|NCT00942773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110687588|NCT00942773|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110687589|NCT00942773|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110687590|NCT00942773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110687591|NCT00942773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110687592|NCT00942773|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110687593|NCT00942773|Hormone Antagonists|hormone antagonists|mesh-ancestor
110687594|NCT00942773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110687595|NCT00942773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110687596|NCT00942773|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110687597|NCT00374907|Metformin|metformin|mesh-list
110687598|NCT00374907|Saxagliptin|saxagliptin|mesh-list
110687599|NCT00374907|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110687600|NCT00374907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110687601|NCT00374907|Incretins|incretins|mesh-ancestor
110687602|NCT00374907|Hormones|hormones|mesh-ancestor
110687603|NCT00374907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110687604|NCT00374907|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110687605|NCT00374907|Protease Inhibitors|protease inhibitors|mesh-ancestor
110687606|NCT00374907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110687607|NCT00374907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110687608|NCT01045083|Methylphenidate|methylphenidate|mesh-list
110687609|NCT01045083|Escitalopram|escitalopram|mesh-list
110687610|NCT01045083|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110687611|NCT01045083|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110687612|NCT01045083|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110687613|NCT01045083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110687614|NCT01045083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110687615|NCT01045083|Serotonin Agents|serotonin agents|mesh-ancestor
110687616|NCT01045083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110687617|NCT01045083|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110687618|NCT01045083|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110687619|NCT01045083|Dopamine Agents|dopamine agents|mesh-ancestor
110687620|NCT01040325|Vaccines|vaccines|mesh-list
110687621|NCT01040325|Immunologic Factors|immunologic factors|mesh-ancestor
110687622|NCT01040325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110687623|NCT00947843|Aspirin|aspirin|mesh-list
110687624|NCT00947843|Clopidogrel|clopidogrel|mesh-list
110687625|NCT00947843|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110687626|NCT00947843|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110687627|NCT00947843|Analgesics|analgesics|mesh-ancestor
110687628|NCT00947843|Sensory System Agents|sensory system agents|mesh-ancestor
110687629|NCT00947843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110687630|NCT00947843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110687631|NCT00947843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110687632|NCT00947843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110687633|NCT00947843|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110687634|NCT00947843|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110687635|NCT00947843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110687636|NCT00947843|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110687637|NCT00947843|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110687638|NCT00947843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110687639|NCT00947843|Antipyretics|antipyretics|mesh-ancestor
110687640|NCT00947843|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110687641|NCT00947843|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110687642|NCT00947843|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110687643|NCT00947843|Purinergic Agents|purinergic agents|mesh-ancestor
110687644|NCT00947843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110687645|NCT00948077|Isoniazid, pyrazinamide, rifampin drug combination|isoniazid, pyrazinamide, rifampin drug combination|mesh-list
110687646|NCT00948077|Antitubercular Agents|antitubercular agents|mesh-ancestor
110687647|NCT00948077|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110687648|NCT00948077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110687649|NCT00407745|Pregabalin|pregabalin|mesh-list
110687650|NCT00407745|Analgesics|analgesics|mesh-ancestor
110687651|NCT00407745|Sensory System Agents|sensory system agents|mesh-ancestor
110687652|NCT00407745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110687653|NCT00407745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110687654|NCT00407745|Anticonvulsants|anticonvulsants|mesh-ancestor
110687655|NCT00407745|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110687656|NCT00407745|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110687657|NCT00407745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110687658|NCT00407745|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110687659|NCT00407745|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110687660|NCT00407745|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110687661|NCT00407745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110687662|NCT00407745|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110687663|NCT00951431|Esomeprazole|esomeprazole|mesh-list
110687664|NCT00951431|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110687665|NCT00951431|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110687666|NCT00951431|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110687667|NCT00951431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110164325|NCT00009828|Calcium|calcium|mesh-list
110687668|NCT00951431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110687669|NCT00299494|Rituximab|rituximab|mesh-list
110687670|NCT00299494|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
110687671|NCT00299494|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110687672|NCT00299494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110687673|NCT00299494|Immunologic Factors|immunologic factors|mesh-ancestor
110687674|NCT00299494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110687675|NCT00299494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110687676|NCT00299494|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110687677|NCT00299494|Immunotoxins|immunotoxins|mesh-ancestor
110687678|NCT00299494|Immunoconjugates|immunoconjugates|mesh-ancestor
110335442|NCT00503126|Bivalirudin|bivalirudin|mesh-list
110335730|NCT00503594|Alkylating Agents|alkylating agents|mesh-ancestor
110336030|NCT01246037|Sympatholytics|sympatholytics|mesh-ancestor
110336107|NCT02274974|Sensory System Agents|sensory system agents|mesh-ancestor
110336332|NCT00501878|Phenylephrine|phenylephrine|mesh-list
110336558|NCT02952963|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
110337017|NCT01245101|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110337319|NCT01244256|Miconazole|miconazole|mesh-list
110337692|NCT02949765|Iron|iron|mesh-list
110337913|NCT00518427|Insulin Glargine|insulin glargine|mesh-list
110338137|NCT04514081|Decitabine|decitabine|mesh-list
110338206|NCT02955056|Teriparatide|teriparatide|mesh-list
110338806|NCT05146154|Imipenem|imipenem|mesh-list
110338957|NCT00525096|Celecoxib|celecoxib|mesh-list
110339556|NCT02953106|Histamine Antagonists|histamine antagonists|mesh-ancestor
110339706|NCT02953184|Antimitotic Agents|antimitotic agents|mesh-ancestor
110339777|NCT00510263|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110339874|NCT00515736|Zinc|zinc|mesh-list
110340009|NCT00511979|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110340100|NCT00512408|Hormones|hormones|mesh-ancestor
110340232|NCT00530907|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110340383|NCT00531999|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110340459|NCT04695197|Artesunate|artesunate|mesh-list
110340610|NCT05317572|Morphine|morphine|mesh-list
110341149|NCT00520091|Analgesics|analgesics|mesh-ancestor
110341591|NCT02948075|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110341664|NCT02947763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110341818|NCT02930265|Liraglutide|liraglutide|mesh-list
110341894|NCT02929524|Anesthetics|anesthetics|mesh-ancestor
110342118|NCT02946944|Apixaban|apixaban|mesh-list
110342193|NCT00526448|Ribavirin|ribavirin|mesh-list
110342639|NCT02925975|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110343473|NCT06025474|Citalopram|citalopram|mesh-list
110343697|NCT06023459|Analgesics|analgesics|mesh-ancestor
110343779|NCT06022835|Chlorhexidine|chlorhexidine|mesh-list
110344394|NCT05838560|Dasatinib|dasatinib|mesh-list
110344973|NCT05450692|Tubulin Modulators|tubulin modulators|mesh-ancestor
110345868|NCT04895358|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110345942|NCT04879329|Immunoconjugates|immunoconjugates|mesh-ancestor
110346015|NCT04824911|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110346244|NCT04712097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110346847|NCT04301778|Durvalumab|durvalumab|mesh-list
110347448|NCT03866499|Gefitinib|gefitinib|mesh-list
110347600|NCT03752216|Niraparib|niraparib|mesh-list
110347747|NCT03587740|Mitosis Modulators|mitosis modulators|mesh-ancestor
110348229|NCT03109795|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110348835|NCT02101853|Hormones|hormones|mesh-ancestor
110349528|NCT02915796|Lenograstim|lenograstim|mesh-list
110349604|NCT02915055|Narcotics|narcotics|mesh-ancestor
110349830|NCT01290757|Dabigatran|dabigatran|mesh-list
110350065|NCT02936492|Clobetasol|clobetasol|mesh-list
110350367|NCT02935101|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110350970|NCT02921165|Aspirin|aspirin|mesh-list
110351194|NCT01280617|Thymoglobulin|thymoglobulin|mesh-list
110351941|NCT01272193|Insulin|insulin|mesh-list
110352327|NCT01462890|Paclitaxel|paclitaxel|mesh-list
110352478|NCT00596050|Narcotics|narcotics|mesh-ancestor
110353002|NCT01313884|Temozolomide|temozolomide|mesh-list
110353294|NCT05116774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110353666|NCT01229072|Heparin|heparin|mesh-list
110353966|NCT03736616|Cytarabine|cytarabine|mesh-list
110354569|NCT04681937|Glucocorticoids|glucocorticoids|mesh-ancestor
110355745|NCT00552747|Fenofibrate|fenofibrate|mesh-list
110355820|NCT01234402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110355905|NCT01232452|Pemetrexed|pemetrexed|mesh-list
110355967|NCT01231555|Antiviral Agents|antiviral agents|mesh-ancestor
110356199|NCT02469155|Risperidone|risperidone|mesh-list
110357017|NCT00557180|Bromides|bromides|mesh-list
110357164|NCT01207414|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110405654|NCT01030666|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110405655|NCT01030666|Doxycycline|doxycycline|mesh-list
110405656|NCT01030666|Ibuprofen|ibuprofen|mesh-list
110405657|NCT01030666|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110405658|NCT01030666|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110405659|NCT01030666|Analgesics|analgesics|mesh-ancestor
110405660|NCT01030666|Sensory System Agents|sensory system agents|mesh-ancestor
110405661|NCT01030666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110405662|NCT01030666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110405663|NCT01030666|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110405664|NCT01030666|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110405665|NCT01030666|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110405666|NCT01030666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110405667|NCT01030666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110405668|NCT01030666|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110405669|NCT01030666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110405671|NCT01030666|Dermatologic Agents|dermatologic agents|mesh-ancestor
110405672|NCT01030666|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110405673|NCT01030666|Antimalarials|antimalarials|mesh-ancestor
110405674|NCT01030666|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110405675|NCT01030666|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110405676|NCT01023256|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110405677|NCT01023256|Immunologic Factors|immunologic factors|mesh-ancestor
110405678|NCT01023256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110405679|NCT01058668|Cariprazine|cariprazine|mesh-list
110405680|NCT01058668|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110405681|NCT01058668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110405682|NCT01058668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110405683|NCT01058668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110405684|NCT01058668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110405685|NCT00623558|Docetaxel|docetaxel|mesh-list
110405686|NCT00623558|Cetuximab|cetuximab|mesh-list
110405687|NCT00623558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110405688|NCT00623558|Tubulin Modulators|tubulin modulators|mesh-ancestor
110164401|NCT00019669|Aldesleukin|aldesleukin|mesh-list
110405689|NCT00623558|Antimitotic Agents|antimitotic agents|mesh-ancestor
110405690|NCT00623558|Mitosis Modulators|mitosis modulators|mesh-ancestor
110405691|NCT00623558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110405692|NCT00623558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110405693|NCT01301066|Pravastatin|pravastatin|mesh-list
110405694|NCT01301066|Pitavastatin|pitavastatin|mesh-list
110405695|NCT01301066|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110405696|NCT01301066|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110405697|NCT01301066|Antimetabolites|antimetabolites|mesh-ancestor
110405698|NCT01301066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110405699|NCT01301066|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110405700|NCT01301066|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110405701|NCT01301066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110405702|NCT01022398|Vitamin D|vitamin d|mesh-list
110405703|NCT01022398|Cholecalciferol|cholecalciferol|mesh-list
110405704|NCT01022398|Vitamins|vitamins|mesh-ancestor
110405705|NCT01022398|Micronutrients|micronutrients|mesh-ancestor
110405706|NCT01022398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110405707|NCT01022398|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110405708|NCT01022398|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110405709|NCT05642624|Amphotericin B|amphotericin b|mesh-list
110405710|NCT05642624|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
110405711|NCT05642624|Deoxycholic Acid|deoxycholic acid|mesh-list
110405712|NCT05642624|Amebicides|amebicides|mesh-ancestor
110405713|NCT05642624|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110405714|NCT05642624|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110405715|NCT05642624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110405716|NCT05642624|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110405717|NCT05642624|Antifungal Agents|antifungal agents|mesh-ancestor
110405718|NCT05642624|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
110405719|NCT05642624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110405720|NCT04324346|Paclitaxel|paclitaxel|mesh-list
110405721|NCT04324346|Docetaxel|docetaxel|mesh-list
110405722|NCT04324346|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110405723|NCT04324346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110405724|NCT04324346|Tubulin Modulators|tubulin modulators|mesh-ancestor
110405725|NCT04324346|Antimitotic Agents|antimitotic agents|mesh-ancestor
110405726|NCT04324346|Mitosis Modulators|mitosis modulators|mesh-ancestor
110357240|NCT04658732|Gabapentin|gabapentin|mesh-list
110405727|NCT04324346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110405728|NCT04300114|Fluzoparib|fluzoparib|mesh-list
110405729|NCT04300114|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110405730|NCT04300114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110405731|NCT04300114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110405732|NCT04300114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110405733|NCT02890238|Sildenafil Citrate|sildenafil citrate|mesh-list
110405734|NCT02890238|Citric Acid|citric acid|mesh-list
110405735|NCT02890238|Sodium Citrate|sodium citrate|mesh-list
110405736|NCT02890238|Clomiphene|clomiphene|mesh-list
110405737|NCT02890238|Enclomiphene|enclomiphene|mesh-list
110405738|NCT02890238|Zuclomiphene|zuclomiphene|mesh-list
110405739|NCT02890238|Anticoagulants|anticoagulants|mesh-ancestor
110405740|NCT02890238|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110405741|NCT02890238|Chelating Agents|chelating agents|mesh-ancestor
110405742|NCT02890238|Sequestering Agents|sequestering agents|mesh-ancestor
110405743|NCT02890238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110164421|NCT00019825|Decitabine|decitabine|mesh-list
110405744|NCT02890238|Vasodilator Agents|vasodilator agents|mesh-ancestor
110405745|NCT02890238|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110405746|NCT02890238|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110405747|NCT02890238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110405748|NCT02890238|Urological Agents|urological agents|mesh-ancestor
110405749|NCT02890238|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110405750|NCT02890238|Hormone Antagonists|hormone antagonists|mesh-ancestor
110405751|NCT02890238|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110405752|NCT02890238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110405753|NCT02890238|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110405754|NCT02890238|Fertility Agents|fertility agents|mesh-ancestor
110405755|NCT02890238|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110405756|NCT02890238|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110405757|NCT02890238|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110405758|NCT00627796|Lanreotide|lanreotide|mesh-list
110405759|NCT00627796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110405760|NCT01299896|Bupropion|bupropion|mesh-list
110405761|NCT01299896|Nicotine|nicotine|mesh-list
110405762|NCT01299896|Varenicline|varenicline|mesh-list
110405763|NCT01299896|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110405764|NCT01299896|Autonomic Agents|autonomic agents|mesh-ancestor
110405765|NCT01299896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110405766|NCT01299896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110405767|NCT01299896|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110405768|NCT01299896|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110405769|NCT01299896|Cholinergic Agents|cholinergic agents|mesh-ancestor
110405770|NCT01299896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110405771|NCT01299896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110405772|NCT01299896|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110405773|NCT01299896|Antidepressive Agents|antidepressive agents|mesh-ancestor
110405774|NCT01299896|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110405775|NCT01299896|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110405776|NCT01299896|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110405777|NCT01299896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110405778|NCT01299896|Dopamine Agents|dopamine agents|mesh-ancestor
110405779|NCT01299896|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110405780|NCT01299896|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110405781|NCT01299896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110405782|NCT01299584|Remifentanil|remifentanil|mesh-list
110405783|NCT01299584|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110405784|NCT01299584|Narcotics|narcotics|mesh-ancestor
110405785|NCT01299584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110405786|NCT01299584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110405787|NCT01299584|Analgesics|analgesics|mesh-ancestor
110405788|NCT01299584|Sensory System Agents|sensory system agents|mesh-ancestor
110183064|NCT00027924|Cyclosporine|cyclosporine|mesh-list
110405789|NCT01299584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110405790|NCT01236573|Cyclophosphamide|cyclophosphamide|mesh-list
110164457|NCT00019864|Vitamins|vitamins|mesh-ancestor
110405791|NCT01236573|Fludarabine|fludarabine|mesh-list
110405792|NCT01236573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110405793|NCT01236573|Immunologic Factors|immunologic factors|mesh-ancestor
110405794|NCT01236573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110405795|NCT01236573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110405796|NCT01236573|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110405797|NCT01236573|Alkylating Agents|alkylating agents|mesh-ancestor
110405798|NCT01236573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110405799|NCT01236573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110405800|NCT01236573|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110405801|NCT04323228|Antioxidants|antioxidants|mesh-list
110405802|NCT04323228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110357322|NCT00541086|Tamoxifen|tamoxifen|mesh-list
110405803|NCT04323228|Protective Agents|protective agents|mesh-ancestor
110405804|NCT04323228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110405805|NCT04322760|Lidocaine|lidocaine|mesh-list
110405806|NCT04322760|Dexmedetomidine|dexmedetomidine|mesh-list
110405807|NCT04322760|Bupivacaine|bupivacaine|mesh-list
110405808|NCT04322760|Anesthetics, Local|anesthetics, local|mesh-ancestor
110405809|NCT04322760|Anesthetics|anesthetics|mesh-ancestor
110405810|NCT04322760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110405811|NCT04322760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110405812|NCT04322760|Sensory System Agents|sensory system agents|mesh-ancestor
110405813|NCT04322760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110405814|NCT04322760|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110405815|NCT04322760|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110405816|NCT04322760|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110405817|NCT04322760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110405818|NCT04322760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110405819|NCT04322760|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110405820|NCT04322760|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110405821|NCT04322760|Analgesics|analgesics|mesh-ancestor
110405822|NCT04322760|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110405823|NCT04322760|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110405824|NCT04322760|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110405825|NCT04322760|Adrenergic Agents|adrenergic agents|mesh-ancestor
110405826|NCT04322760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110405827|NCT04322214|Cobicistat|cobicistat|mesh-list
110405828|NCT04322214|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110405829|NCT04322214|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110405830|NCT04322214|Antiviral Agents|antiviral agents|mesh-ancestor
110405831|NCT04322214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110405832|NCT04322214|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110405833|NCT04322214|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110405834|NCT04322214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110405835|NCT04322214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110405836|NCT01057810|Ipilimumab|ipilimumab|mesh-list
110405837|NCT01057810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110405838|NCT01057810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110405839|NCT01057810|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110405840|NCT01057810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110405841|NCT01262352|Ivacaftor|ivacaftor|mesh-list
110405842|NCT01262352|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
110405843|NCT01262352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110405844|NCT01262352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110405845|NCT01299272|Serotonin|serotonin|mesh-list
110405846|NCT01299272|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
110405847|NCT01299272|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110405848|NCT01299272|Serotonin Agents|serotonin agents|mesh-ancestor
110405849|NCT01299272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110405850|NCT01299272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110405851|NCT01299272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110405852|NCT01299272|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110405853|NCT01299272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110405854|NCT01299116|Contraceptive Agents|contraceptive agents|mesh-list
110405855|NCT01299116|Etonogestrel|etonogestrel|mesh-list
110405856|NCT01299116|Contraceptives, Oral|contraceptives, oral|mesh-list
110405857|NCT01299116|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110405858|NCT01299116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110405859|NCT01299116|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110405860|NCT01299116|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110405861|NCT04207398|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
110405862|NCT04207398|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110405863|NCT04207398|Adrenergic Agents|adrenergic agents|mesh-ancestor
110405864|NCT04207398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110405865|NCT04207398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110405866|NCT04207398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110405867|NCT01299038|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110405868|NCT01299038|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110405869|NCT01299038|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110405870|NCT01299038|Antimetabolites|antimetabolites|mesh-ancestor
110405871|NCT01299038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110405872|NCT01299038|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110405873|NCT01299038|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110357390|NCT00541164|Vitamins|vitamins|mesh-ancestor
110405874|NCT01299038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110405876|NCT04321278|Hydroxychloroquine|hydroxychloroquine|mesh-list
110405877|NCT04321278|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110405878|NCT04321278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110405879|NCT04321278|Antimalarials|antimalarials|mesh-ancestor
110405880|NCT04321278|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110405881|NCT04321278|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110405882|NCT04321278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110405883|NCT04321278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110405884|NCT04321278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110405885|NCT01261338|Sucrose polyester|sucrose polyester|mesh-list
110405886|NCT01261338|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110405887|NCT01261338|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110405889|NCT01261338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110405890|NCT01261338|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110405891|NCT01260948|Donepezil|donepezil|mesh-list
110405892|NCT01260948|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110405893|NCT01260948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110405894|NCT01260948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110405895|NCT01260948|Cholinergic Agents|cholinergic agents|mesh-ancestor
110405896|NCT01260948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110405897|NCT01260948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110405898|NCT01260948|Nootropic Agents|nootropic agents|mesh-ancestor
110405899|NCT01025284|Lenograstim|lenograstim|mesh-list
110405900|NCT01025284|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110405901|NCT01025284|Immunologic Factors|immunologic factors|mesh-ancestor
110405902|NCT01025284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110405903|NCT02873026|Triamcinolone|triamcinolone|mesh-list
110405904|NCT02873026|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110405905|NCT02873026|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110405906|NCT02873026|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110405907|NCT02873026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110405908|NCT02873026|Glucocorticoids|glucocorticoids|mesh-ancestor
110405909|NCT02873026|Hormones|hormones|mesh-ancestor
110405910|NCT02873026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110405911|NCT02873026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110405912|NCT02873026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110405913|NCT02873026|Immunologic Factors|immunologic factors|mesh-ancestor
110405914|NCT02873026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110405915|NCT02873026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110405916|NCT01056718|Nebivolol|nebivolol|mesh-list
110405917|NCT01056718|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110405918|NCT01056718|Vasodilator Agents|vasodilator agents|mesh-ancestor
110405919|NCT01056718|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
110405920|NCT01056718|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110405921|NCT01056718|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110405922|NCT01056718|Adrenergic Agents|adrenergic agents|mesh-ancestor
110405923|NCT01056718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110405924|NCT01056718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110405925|NCT01056718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110405926|NCT01298570|Leucovorin|leucovorin|mesh-list
110405927|NCT01298570|Fluorouracil|fluorouracil|mesh-list
110405928|NCT01298570|Irinotecan|irinotecan|mesh-list
110405929|NCT01298570|Levoleucovorin|levoleucovorin|mesh-list
110405930|NCT01298570|Antimetabolites|antimetabolites|mesh-ancestor
110405931|NCT01298570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110405932|NCT01298570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110405933|NCT01298570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110405934|NCT01298570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110405935|NCT01298570|Immunologic Factors|immunologic factors|mesh-ancestor
110405936|NCT01298570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110405937|NCT01298570|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110405938|NCT01298570|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110405939|NCT01298570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110405941|NCT01298570|Protective Agents|protective agents|mesh-ancestor
110405942|NCT01298570|Vitamin B Complex|vitamin b complex|mesh-ancestor
110405943|NCT01298570|Vitamins|vitamins|mesh-ancestor
110405944|NCT01298570|Micronutrients|micronutrients|mesh-ancestor
110405945|NCT01259856|Aspirin|aspirin|mesh-list
110405946|NCT01259856|Interferons|interferons|mesh-list
110405947|NCT01259856|Interferon-alpha|interferon-alpha|mesh-list
110405948|NCT01259856|Interferon alpha-2|interferon alpha-2|mesh-list
110405949|NCT01259856|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110405950|NCT01259856|Hydroxyurea|hydroxyurea|mesh-list
110405951|NCT01259856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110405952|NCT01259856|Antiviral Agents|antiviral agents|mesh-ancestor
110405953|NCT01259856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110405954|NCT01259856|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110405955|NCT01259856|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110405957|NCT01259856|Sensory System Agents|sensory system agents|mesh-ancestor
110405958|NCT01259856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110405959|NCT01259856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110405960|NCT01259856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110405961|NCT01259856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110405962|NCT01259856|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110405963|NCT01259856|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110405964|NCT01259856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110405965|NCT01259856|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110405966|NCT01259856|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110405967|NCT01259856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110405968|NCT01259856|Antipyretics|antipyretics|mesh-ancestor
110405969|NCT01259856|Immunologic Factors|immunologic factors|mesh-ancestor
110405970|NCT01259856|Antisickling Agents|antisickling agents|mesh-ancestor
110405971|NCT01259856|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110405972|NCT00624000|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
110405973|NCT00624000|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110405974|NCT00624000|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110405975|NCT00624000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110405976|NCT01259466|Nicotine|nicotine|mesh-list
110405977|NCT01259466|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110405978|NCT01259466|Autonomic Agents|autonomic agents|mesh-ancestor
110405979|NCT01259466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110405980|NCT01259466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110405981|NCT01259466|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110405982|NCT01259466|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110405983|NCT01259466|Cholinergic Agents|cholinergic agents|mesh-ancestor
110405984|NCT01259466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110405985|NCT01259466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110405986|NCT01259388|Lithium Carbonate|lithium carbonate|mesh-list
110405987|NCT01259388|Antidepressive Agents|antidepressive agents|mesh-ancestor
110405988|NCT01259388|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110405989|NCT01259388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110405990|NCT01259388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110405991|NCT01259388|Antimanic Agents|antimanic agents|mesh-ancestor
110405992|NCT01259388|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110183070|NCT00027924|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110183071|NCT00027924|Abortifacient Agents|abortifacient agents|mesh-ancestor
110183072|NCT00027924|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110405993|NCT01259388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110405994|NCT01259388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110405995|NCT05525910|Ritonavir|ritonavir|mesh-list
110405996|NCT05525910|Nirmatrelvir|nirmatrelvir|mesh-list
110405997|NCT05525910|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
110405998|NCT05525910|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110405999|NCT05525910|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110406000|NCT05525910|Protease Inhibitors|protease inhibitors|mesh-ancestor
110406001|NCT05525910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110406002|NCT05525910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110406003|NCT05525910|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110406004|NCT05525910|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110406005|NCT05525910|Antiviral Agents|antiviral agents|mesh-ancestor
110406006|NCT05525910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110406007|NCT05525910|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110406008|NCT05525910|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110406009|NCT00624078|Antivenins|antivenins|mesh-list
110406010|NCT00624078|Immunologic Factors|immunologic factors|mesh-ancestor
110406011|NCT00624078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110406012|NCT05286528|Imatinib Mesylate|imatinib mesylate|mesh-list
110406013|NCT05286528|Dasatinib|dasatinib|mesh-list
110406014|NCT05286528|Ponatinib|ponatinib|mesh-list
110406015|NCT05286528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110406016|NCT05286528|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110406017|NCT05286528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110406018|NCT05286528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110406019|NCT01297244|Tivozanib|tivozanib|mesh-list
110406020|NCT01297244|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110406021|NCT01297244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110406022|NCT01297244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110406023|NCT04554732|Mitogens|mitogens|mesh-list
110357535|NCT00542022|Oxymetazoline|oxymetazoline|mesh-list
110406024|NCT04554732|Mitosis Modulators|mitosis modulators|mesh-ancestor
110406025|NCT04554732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110406026|NCT04481256|Paclitaxel|paclitaxel|mesh-list
110406027|NCT04481256|Carboplatin|carboplatin|mesh-list
110406028|NCT04481256|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110406029|NCT04481256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110406030|NCT04481256|Tubulin Modulators|tubulin modulators|mesh-ancestor
110406031|NCT04481256|Antimitotic Agents|antimitotic agents|mesh-ancestor
110406032|NCT04481256|Mitosis Modulators|mitosis modulators|mesh-ancestor
110406033|NCT04481256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110406035|NCT04387110|Immunologic Factors|immunologic factors|mesh-ancestor
110406036|NCT04387110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110406037|NCT03434418|Osimertinib|osimertinib|mesh-list
110406038|NCT03434418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110406039|NCT03434418|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110406040|NCT03434418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110406041|NCT03434418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110406043|NCT03377478|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
110406044|NCT03377478|Velpatasvir|velpatasvir|mesh-list
110406045|NCT03377478|Antiviral Agents|antiviral agents|mesh-ancestor
110406046|NCT03377478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110406047|NCT03181932|Vancomycin|vancomycin|mesh-list
110406048|NCT03181932|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110406049|NCT03181932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110406050|NCT02583672|Acetylcysteine|acetylcysteine|mesh-list
110406051|NCT02583672|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110406052|NCT02583672|Antiviral Agents|antiviral agents|mesh-ancestor
110406053|NCT02583672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110406054|NCT02583672|Expectorants|expectorants|mesh-ancestor
110406055|NCT02583672|Respiratory System Agents|respiratory system agents|mesh-ancestor
110406056|NCT02583672|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110406057|NCT02583672|Antioxidants|antioxidants|mesh-ancestor
110406058|NCT02583672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110406059|NCT02583672|Protective Agents|protective agents|mesh-ancestor
110406060|NCT02583672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110406061|NCT02583672|Antidotes|antidotes|mesh-ancestor
110406062|NCT02888730|Tobramycin|tobramycin|mesh-list
110406063|NCT02888730|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110406064|NCT02888730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110406065|NCT01598298|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110406066|NCT01598298|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110406067|NCT01598298|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110406068|NCT01598298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110406069|NCT01598298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110406070|NCT01598298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110406071|NCT01598298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110406072|NCT01598298|Analgesics|analgesics|mesh-ancestor
110406073|NCT01598298|Sensory System Agents|sensory system agents|mesh-ancestor
110406074|NCT01598298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110406075|NCT01598298|Antidepressive Agents|antidepressive agents|mesh-ancestor
110406076|NCT01598298|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110406077|NCT01598298|Dopamine Agents|dopamine agents|mesh-ancestor
110406078|NCT02888652|Clopidogrel|clopidogrel|mesh-list
110406079|NCT02888652|Ticagrelor|ticagrelor|mesh-list
110406080|NCT02888652|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
110406081|NCT02888652|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110406082|NCT02888652|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110406083|NCT02888652|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110406084|NCT02888652|Purinergic Agents|purinergic agents|mesh-ancestor
110406085|NCT02888652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110406086|NCT02888652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110406087|NCT02888652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110406088|NCT01235949|Acetaminophen|acetaminophen|mesh-list
110406089|NCT01235949|Ibuprofen|ibuprofen|mesh-list
110406090|NCT01235949|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110406091|NCT01235949|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110406092|NCT01235949|Analgesics|analgesics|mesh-ancestor
110406093|NCT01235949|Sensory System Agents|sensory system agents|mesh-ancestor
110406094|NCT01235949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110406095|NCT01235949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110406096|NCT01235949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110406097|NCT01235949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110406098|NCT01235949|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110406099|NCT01235949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110406100|NCT01235949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110406101|NCT01235949|Antipyretics|antipyretics|mesh-ancestor
110406102|NCT00691158|Pramlintide|pramlintide|mesh-list
110406103|NCT00691158|Islet Amyloid Polypeptide|islet amyloid polypeptide|mesh-list
110406104|NCT00691158|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110406105|NCT00691158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110406106|NCT00691158|Appetite Depressants|appetite depressants|mesh-ancestor
110406107|NCT00691158|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110406108|NCT00691158|Amylin Receptor Agonists|amylin receptor agonists|mesh-ancestor
110406109|NCT00691158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110406111|NCT01235793|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110406112|NCT01235793|Alkylating Agents|alkylating agents|mesh-ancestor
110406113|NCT01235793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110406114|NCT01235793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110406115|NCT05601648|Psilocybin|psilocybin|mesh-list
110406116|NCT05601648|Hallucinogens|hallucinogens|mesh-ancestor
110164567|NCT00020488|Antimetabolites|antimetabolites|mesh-ancestor
110406117|NCT05601648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110406118|NCT05601648|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110406119|NCT01235715|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
110406120|NCT01235715|Hemostatics|hemostatics|mesh-ancestor
110406121|NCT01235715|Coagulants|coagulants|mesh-ancestor
110406122|NCT01235403|Lacosamide|lacosamide|mesh-list
110406123|NCT01235403|Anticonvulsants|anticonvulsants|mesh-ancestor
110406124|NCT01235403|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110406125|NCT01235403|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110406126|NCT01235403|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110406127|NCT01235403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110406128|NCT01024036|Siltuximab|siltuximab|mesh-list
110406129|NCT01024036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110406130|NCT01234467|Rituximab|rituximab|mesh-list
110406131|NCT01234467|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110406132|NCT01234467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110406133|NCT01234467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110406134|NCT01234467|Immunologic Factors|immunologic factors|mesh-ancestor
110406135|NCT01234467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110406136|NCT01234467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110406137|NCT01234467|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110406138|NCT01234467|Alkylating Agents|alkylating agents|mesh-ancestor
110406139|NCT01234467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110406140|NCT01233999|Botulinum Toxins|botulinum toxins|mesh-list
110406141|NCT01233999|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110406142|NCT01233999|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110406143|NCT01233999|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110406144|NCT01233999|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110406145|NCT01233999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110406146|NCT01233999|Cholinergic Agents|cholinergic agents|mesh-ancestor
110406147|NCT01233999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110406148|NCT01233999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110406149|NCT01233999|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110406150|NCT01233999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110406151|NCT01233687|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110406152|NCT01233687|Rilotumumab|rilotumumab|mesh-list
110406153|NCT01233687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110406154|NCT01233687|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110406155|NCT01233687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110406156|NCT01233687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110406157|NCT01233687|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110406158|NCT01233609|Valproic Acid|valproic acid|mesh-list
110406159|NCT01233609|Anticonvulsants|anticonvulsants|mesh-ancestor
110406160|NCT01233609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110406161|NCT01233609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110406162|NCT01233609|GABA Agents|gaba agents|mesh-ancestor
110406163|NCT01233609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110406164|NCT01233609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110406165|NCT01233609|Antimanic Agents|antimanic agents|mesh-ancestor
110406166|NCT01233609|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110406167|NCT01233609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110406168|NCT01233609|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110406169|NCT01232283|Apremilast|apremilast|mesh-list
110406170|NCT01232283|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110406171|NCT01232283|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110406172|NCT01232283|Analgesics|analgesics|mesh-ancestor
110406173|NCT01232283|Sensory System Agents|sensory system agents|mesh-ancestor
110406174|NCT01232283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110406175|NCT01232283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110406176|NCT01232283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110406177|NCT01232283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110406178|NCT01232283|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
110406179|NCT01232283|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110406180|NCT01232283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110406181|NCT01232283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110406183|NCT01232127|Atazanavir Sulfate|atazanavir sulfate|mesh-list
110406184|NCT01232127|Tenofovir|tenofovir|mesh-list
110406185|NCT01232127|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
110406186|NCT01232127|Famotidine|famotidine|mesh-list
110406187|NCT01232127|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110406188|NCT01232127|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110406189|NCT01232127|Protease Inhibitors|protease inhibitors|mesh-ancestor
110406190|NCT01232127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110406191|NCT01232127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110406192|NCT01232127|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110406193|NCT01232127|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110406194|NCT01232127|Antiviral Agents|antiviral agents|mesh-ancestor
110406195|NCT01232127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110406196|NCT01232127|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110406197|NCT01232127|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110406198|NCT01232127|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110406199|NCT01232127|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110406200|NCT01232127|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110406201|NCT01232127|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110406202|NCT01232127|Histamine Antagonists|histamine antagonists|mesh-ancestor
110406203|NCT01232127|Histamine Agents|histamine agents|mesh-ancestor
110406204|NCT01232127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110406205|NCT01232127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110406206|NCT01258608|Sorafenib|sorafenib|mesh-list
110406207|NCT01258608|Mapatumumab|mapatumumab|mesh-list
110406208|NCT01258608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110406209|NCT01258608|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110406210|NCT01258608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110406211|NCT01258608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110406212|NCT01231659|Everolimus|everolimus|mesh-list
110406213|NCT01231659|Letrozole|letrozole|mesh-list
110406214|NCT01231659|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110406215|NCT01231659|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110406216|NCT01231659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110406217|NCT01231659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110406218|NCT01231659|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110406219|NCT01231659|Immunologic Factors|immunologic factors|mesh-ancestor
110406220|NCT01231659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110406221|NCT01231659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110406222|NCT01231659|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110406223|NCT01231659|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110406224|NCT01231659|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110406225|NCT01231659|Hormone Antagonists|hormone antagonists|mesh-ancestor
110406226|NCT01231659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110406227|NCT02875288|Bupivacaine|bupivacaine|mesh-list
110406228|NCT02875288|Anesthetics, Local|anesthetics, local|mesh-ancestor
110406229|NCT02875288|Anesthetics|anesthetics|mesh-ancestor
110406230|NCT02875288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110406231|NCT02875288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110406232|NCT02875288|Sensory System Agents|sensory system agents|mesh-ancestor
110406233|NCT02875288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110406234|NCT01054222|Fesoterodine|fesoterodine|mesh-list
110406235|NCT01054222|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110406236|NCT01054222|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110406238|NCT01054222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110406239|NCT01054222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110406240|NCT01054222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110406241|NCT01054222|Urological Agents|urological agents|mesh-ancestor
110406242|NCT01052428|Metoprolol|metoprolol|mesh-list
110406243|NCT01052428|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110406244|NCT01052428|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110406245|NCT01052428|Sympatholytics|sympatholytics|mesh-ancestor
110406246|NCT01052428|Autonomic Agents|autonomic agents|mesh-ancestor
110406247|NCT01052428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110406248|NCT01052428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110406249|NCT01052428|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110406250|NCT01052428|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110406251|NCT01052428|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110406252|NCT01052428|Adrenergic Agents|adrenergic agents|mesh-ancestor
110406253|NCT01052428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110406254|NCT01052428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110406256|NCT01052272|Candesartan|candesartan|mesh-list
110406257|NCT01052272|Candesartan cilexetil|candesartan cilexetil|mesh-list
110406258|NCT01052272|Ramipril|ramipril|mesh-list
110406259|NCT01052272|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110406260|NCT01052272|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110406261|NCT01052272|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110406262|NCT01052272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110406263|NCT01052272|Antimetabolites|antimetabolites|mesh-ancestor
110406264|NCT01052272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110406265|NCT01052272|Gout Suppressants|gout suppressants|mesh-ancestor
110406266|NCT01052272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110406267|NCT01052272|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110406268|NCT01052272|Antioxidants|antioxidants|mesh-ancestor
110406269|NCT01052272|Protective Agents|protective agents|mesh-ancestor
110406270|NCT01052272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110406271|NCT01052272|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110406272|NCT01052272|Protease Inhibitors|protease inhibitors|mesh-ancestor
110406273|NCT01257204|Interferons|interferons|mesh-list
110406274|NCT01257204|Ribavirin|ribavirin|mesh-list
110406275|NCT01257204|Interferon-alpha|interferon-alpha|mesh-list
110406276|NCT01257204|Interferon alpha-2|interferon alpha-2|mesh-list
110406277|NCT01257204|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110406278|NCT01257204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110406279|NCT01257204|Antiviral Agents|antiviral agents|mesh-ancestor
110406280|NCT01257204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110406281|NCT01257204|Antimetabolites|antimetabolites|mesh-ancestor
110406282|NCT01257204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110406283|NCT01257204|Immunologic Factors|immunologic factors|mesh-ancestor
110406284|NCT01257204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110406285|NCT01231581|Gemcitabine|gemcitabine|mesh-list
110406286|NCT01231581|Trametinib|trametinib|mesh-list
110406287|NCT01231581|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110406288|NCT01231581|Antimetabolites|antimetabolites|mesh-ancestor
110406289|NCT01231581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110406290|NCT01231581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110406291|NCT01231581|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110406292|NCT01231581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110406293|NCT01050634|Exemestane|exemestane|mesh-list
110406294|NCT01050634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110406295|NCT01050634|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110406296|NCT01050634|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110406297|NCT01050634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110406298|NCT01050634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110406299|NCT01050634|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110406300|NCT01050634|Hormone Antagonists|hormone antagonists|mesh-ancestor
110406301|NCT01050634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110406302|NCT01050634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110406303|NCT01020526|Pregabalin|pregabalin|mesh-list
110406304|NCT01020526|Analgesics|analgesics|mesh-ancestor
110406305|NCT01020526|Sensory System Agents|sensory system agents|mesh-ancestor
110406306|NCT01020526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110406307|NCT01020526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110406308|NCT01020526|Anticonvulsants|anticonvulsants|mesh-ancestor
110406309|NCT01020526|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110406310|NCT01020526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110406311|NCT01020526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110406312|NCT01020526|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110406313|NCT01020526|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110406314|NCT01020526|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110406315|NCT01020526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110406316|NCT01020526|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110406317|NCT01020448|Triptorelin Pamoate|triptorelin pamoate|mesh-list
110406318|NCT01020448|Luteolytic Agents|luteolytic agents|mesh-ancestor
110406319|NCT01020448|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110406320|NCT01020448|Contraceptive Agents|contraceptive agents|mesh-ancestor
110357837|NCT02324283|Desflurane|desflurane|mesh-list
110406321|NCT01020448|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110406322|NCT01020448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110406323|NCT01020448|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110406324|NCT01020448|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110406325|NCT01020448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110406326|NCT04286230|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110406327|NCT04286230|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
110406328|NCT04286230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110406329|NCT04286230|Antitubercular Agents|antitubercular agents|mesh-ancestor
110406330|NCT01256658|Lumefantrine|lumefantrine|mesh-list
110406331|NCT01256658|Artemether|artemether|mesh-list
110406332|NCT01256658|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
110406333|NCT01256658|Antimalarials|antimalarials|mesh-ancestor
110406334|NCT01256658|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110406335|NCT01256658|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110406336|NCT01256658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110183101|NCT00027963|Gabapentin|gabapentin|mesh-list
110406337|NCT01256190|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
110406338|NCT01256190|Fibrin Foam|fibrin foam|mesh-list
110406339|NCT01256190|Hemostatics|hemostatics|mesh-ancestor
110406340|NCT01256190|Coagulants|coagulants|mesh-ancestor
110406341|NCT02888574|Oxytocin|oxytocin|mesh-list
110406342|NCT02888574|Oxytocics|oxytocics|mesh-ancestor
110406343|NCT02888574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110406344|NCT02888574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110406345|NCT01231503|Vaccines|vaccines|mesh-list
110406346|NCT01231503|Immunologic Factors|immunologic factors|mesh-ancestor
110406347|NCT01231503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110406348|NCT01228071|Testosterone|testosterone|mesh-list
110406349|NCT01228071|Androgens|androgens|mesh-ancestor
110406350|NCT01228071|Hormones|hormones|mesh-ancestor
110406351|NCT01228071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110406352|NCT01228071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110406353|NCT04319289|Vitamin D|vitamin d|mesh-list
110406354|NCT04319289|Ergocalciferols|ergocalciferols|mesh-list
110406355|NCT04319289|Cholecalciferol|cholecalciferol|mesh-list
110406356|NCT04319289|Vitamins|vitamins|mesh-list
110406357|NCT04319289|Micronutrients|micronutrients|mesh-ancestor
110406358|NCT04319289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110406359|NCT04319289|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110406360|NCT04319289|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110406361|NCT01008475|Irinotecan|irinotecan|mesh-list
110406362|NCT01008475|Cetuximab|cetuximab|mesh-list
110406363|NCT01008475|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110406364|NCT01008475|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110406365|NCT01008475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110406366|NCT01008475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110406367|NCT01008475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110406368|NCT01008475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110406369|NCT01226745|Ceralifimod|ceralifimod|mesh-list
110406370|NCT01226745|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
110406371|NCT01226745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110406372|NCT01226745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110406373|NCT01226745|Immunologic Factors|immunologic factors|mesh-ancestor
110406374|NCT01226745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110406375|NCT01226511|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110406376|NCT01226511|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110406377|NCT01226511|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110406378|NCT01226511|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110406379|NCT01226511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110406380|NCT01226511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110406381|NCT01226511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110406382|NCT01226511|Analgesics|analgesics|mesh-ancestor
110406383|NCT01226511|Sensory System Agents|sensory system agents|mesh-ancestor
110406384|NCT01226511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110406385|NCT01226511|Antidepressive Agents|antidepressive agents|mesh-ancestor
110406386|NCT01226511|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110406387|NCT01226511|Dopamine Agents|dopamine agents|mesh-ancestor
110406388|NCT01226043|Insulin Glargine|insulin glargine|mesh-list
110406389|NCT01226043|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110406390|NCT01226043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110406391|NCT01001377|Cetuximab|cetuximab|mesh-list
110406392|NCT01001377|Panitumumab|panitumumab|mesh-list
110406393|NCT01001377|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110406394|NCT01001377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110406395|NCT01225887|Nintedanib|nintedanib|mesh-list
110406396|NCT01225887|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
110406397|NCT01225887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110164671|NCT00010140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110406398|NCT01225887|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110406399|NCT01225887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110406400|NCT01225887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110406401|NCT01296932|BI 836826|bi 836826|mesh-list
110406402|NCT01296932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110406403|NCT01296932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110406404|NCT01296698|Nicotine|nicotine|mesh-list
110406405|NCT01296698|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110406407|NCT01296698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110406408|NCT01296698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110406409|NCT01296698|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110406410|NCT01296698|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110406411|NCT01296698|Cholinergic Agents|cholinergic agents|mesh-ancestor
110406412|NCT01296698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110406413|NCT01296698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110406414|NCT01001221|Gemcitabine|gemcitabine|mesh-list
110406415|NCT01001221|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110406416|NCT01001221|Antimetabolites|antimetabolites|mesh-ancestor
110406417|NCT01001221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110406418|NCT01001221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110406419|NCT01296152|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
110406420|NCT01296152|Medroxyprogesterone|medroxyprogesterone|mesh-list
110406421|NCT01296152|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110406422|NCT01296152|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110406423|NCT01296152|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110406424|NCT01296152|Contraceptive Agents|contraceptive agents|mesh-ancestor
110406425|NCT01296152|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110406426|NCT01296152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110406427|NCT01296152|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110406428|NCT01296152|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110406429|NCT01296152|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110406430|NCT01296152|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110406431|NCT01296152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110406433|NCT01002547|Vitamin E|vitamin e|mesh-list
110406434|NCT01002547|Tocopherols|tocopherols|mesh-list
110406435|NCT01002547|Tocotrienols|tocotrienols|mesh-list
110406436|NCT01002547|alpha-Tocopherol|alpha-tocopherol|mesh-list
110406437|NCT01002547|Pioglitazone|pioglitazone|mesh-list
110406438|NCT01002547|Micronutrients|micronutrients|mesh-ancestor
110406439|NCT01002547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110406440|NCT01002547|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110406441|NCT01002547|Antioxidants|antioxidants|mesh-ancestor
110406442|NCT01002547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110406443|NCT01002547|Protective Agents|protective agents|mesh-ancestor
110406444|NCT04295161|Abiraterone Acetate|abiraterone acetate|mesh-list
110406445|NCT04295161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110406446|NCT04295161|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110406447|NCT04295161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110406448|NCT04295161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110406449|NCT04295161|Hormone Antagonists|hormone antagonists|mesh-ancestor
110406450|NCT04295161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110406451|NCT04295161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110183116|NCT00395421|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110183117|NCT00395421|Antiviral Agents|antiviral agents|mesh-ancestor
110406452|NCT04295161|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110406453|NCT04325659|Lofexidine|lofexidine|mesh-list
110406454|NCT04325659|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110406455|NCT04325659|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110406456|NCT04325659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110406457|NCT04325659|Sensory System Agents|sensory system agents|mesh-ancestor
110406458|NCT04325659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110406459|NCT04325659|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110406460|NCT04325659|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110406461|NCT04325659|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110406462|NCT04325659|Adrenergic Agents|adrenergic agents|mesh-ancestor
110406463|NCT04325659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110406464|NCT04325659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110406465|NCT01007149|Omalizumab|omalizumab|mesh-list
110406466|NCT01007149|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110406467|NCT01007149|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110406468|NCT01007149|Respiratory System Agents|respiratory system agents|mesh-ancestor
110406469|NCT04433767|Nicotine|nicotine|mesh-list
110406470|NCT04433767|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110406471|NCT04433767|Autonomic Agents|autonomic agents|mesh-ancestor
110406472|NCT04433767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110406473|NCT04433767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110406474|NCT04433767|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110406475|NCT04433767|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110406476|NCT04433767|Cholinergic Agents|cholinergic agents|mesh-ancestor
110406477|NCT04433767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110406478|NCT04433767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110406479|NCT00998335|Insulin|insulin|mesh-list
110406480|NCT00998335|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110406481|NCT00998335|Insulin Aspart|insulin aspart|mesh-list
110406482|NCT00998335|Insulin, Long-Acting|insulin, long-acting|mesh-list
110406483|NCT00998335|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
110406484|NCT00998335|Insulin Detemir|insulin detemir|mesh-list
110406485|NCT00998335|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110406486|NCT00998335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110406487|NCT02871505|Penicillins|penicillins|mesh-list
110406488|NCT02871505|Penicillin G|penicillin g|mesh-list
110406489|NCT02871505|Penicillin G Benzathine|penicillin g benzathine|mesh-list
110406490|NCT02871505|Penicillin G Procaine|penicillin g procaine|mesh-list
110406491|NCT02871505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110406492|NCT02871505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110406493|NCT01294670|Etoposide|etoposide|mesh-list
110406494|NCT01294670|Vorinostat|vorinostat|mesh-list
110406495|NCT01294670|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110406496|NCT01294670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110406497|NCT01294670|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110406498|NCT01294670|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110406499|NCT01294670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110406500|NCT01294670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110183141|NCT03960125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110183142|NCT00395655|Hydralazine|hydralazine|mesh-list
110406501|NCT01294670|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110406503|NCT01006603|Saxagliptin|saxagliptin|mesh-list
110406504|NCT01006603|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110406505|NCT01006603|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110406506|NCT01006603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110164706|NCT00020917|Immunologic Factors|immunologic factors|mesh-ancestor
110406507|NCT01006603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110406508|NCT01006603|Immunologic Factors|immunologic factors|mesh-ancestor
110406509|NCT01006603|Incretins|incretins|mesh-ancestor
110406510|NCT01006603|Hormones|hormones|mesh-ancestor
110406511|NCT01006603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110406512|NCT01006603|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110406513|NCT01006603|Protease Inhibitors|protease inhibitors|mesh-ancestor
110406514|NCT01006603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110406515|NCT01006603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110406516|NCT00997321|Ketamine|ketamine|mesh-list
110406517|NCT00997321|Propofol|propofol|mesh-list
110406518|NCT00997321|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110406519|NCT00997321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110406520|NCT00997321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110406521|NCT00997321|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110406522|NCT00997321|Anesthetics, General|anesthetics, general|mesh-ancestor
110406523|NCT00997321|Anesthetics|anesthetics|mesh-ancestor
110406524|NCT00997321|Analgesics|analgesics|mesh-ancestor
110406525|NCT00997321|Sensory System Agents|sensory system agents|mesh-ancestor
110406526|NCT00997321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110406527|NCT00997321|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110406528|NCT00997321|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110406529|NCT00997321|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110406530|NCT00997321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110406531|NCT00997321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110406532|NCT01294592|Tamsulosin|tamsulosin|mesh-list
110406533|NCT01294592|Dutasteride|dutasteride|mesh-list
110406534|NCT01294592|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110406535|NCT01294592|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110406536|NCT01294592|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110406537|NCT01294592|Adrenergic Agents|adrenergic agents|mesh-ancestor
110406538|NCT01294592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110406539|NCT01294592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110406540|NCT01294592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110406541|NCT01294592|Urological Agents|urological agents|mesh-ancestor
110406542|NCT01294592|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
110406543|NCT01294592|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110406544|NCT01294592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110358061|NCT03456531|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110406545|NCT01294592|Hormone Antagonists|hormone antagonists|mesh-ancestor
110560268|NCT00494299|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110406546|NCT01294592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110406548|NCT00997243|Lintuzumab|lintuzumab|mesh-list
110406549|NCT00997243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110406551|NCT00997243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110406552|NCT00997243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110406553|NCT00997243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110406554|NCT00997243|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110406555|NCT02869321|Fentanyl|fentanyl|mesh-list
110406556|NCT02869321|Morphine|morphine|mesh-list
110406557|NCT02869321|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110406558|NCT02869321|Narcotics|narcotics|mesh-ancestor
110406559|NCT02869321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110406560|NCT02869321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110406561|NCT02869321|Analgesics|analgesics|mesh-ancestor
110164730|NCT00021073|Antimetabolites|antimetabolites|mesh-ancestor
110406562|NCT02869321|Sensory System Agents|sensory system agents|mesh-ancestor
110406563|NCT02869321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110406564|NCT02869321|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110406565|NCT02869321|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110406566|NCT02869321|Anesthetics, General|anesthetics, general|mesh-ancestor
110406567|NCT02869321|Anesthetics|anesthetics|mesh-ancestor
110406568|NCT01294436|Dapagliflozin|dapagliflozin|mesh-list
110406569|NCT01294436|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110406570|NCT01294436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110406571|NCT01294436|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110406572|NCT01294436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110406573|NCT01294358|Gemcitabine|gemcitabine|mesh-list
110406574|NCT01294358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110406575|NCT01294358|Antimetabolites|antimetabolites|mesh-ancestor
110406576|NCT01294358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110406577|NCT01294358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110406578|NCT01224639|Vaccines|vaccines|mesh-list
110406579|NCT01224639|Immunologic Factors|immunologic factors|mesh-ancestor
110406580|NCT01224639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110406581|NCT01293968|Diphenhydramine|diphenhydramine|mesh-list
110406582|NCT01293968|Promethazine|promethazine|mesh-list
110406583|NCT01293968|Ibuprofen|ibuprofen|mesh-list
110406584|NCT01293968|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110406585|NCT01293968|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110406586|NCT01293968|Analgesics|analgesics|mesh-ancestor
110406587|NCT01293968|Sensory System Agents|sensory system agents|mesh-ancestor
110406588|NCT01293968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110406589|NCT01293968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110406590|NCT01293968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110406591|NCT01293968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110406592|NCT01293968|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110406593|NCT01293968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110406594|NCT01293968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110406595|NCT01293968|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110406596|NCT01293968|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110406597|NCT01293968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110406598|NCT01293968|Anesthetics, Local|anesthetics, local|mesh-ancestor
110406599|NCT01293968|Anesthetics|anesthetics|mesh-ancestor
110406600|NCT01293968|Antiemetics|antiemetics|mesh-ancestor
110406601|NCT01293968|Autonomic Agents|autonomic agents|mesh-ancestor
110406602|NCT01293968|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110406603|NCT01293968|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110406604|NCT01293968|Histamine Antagonists|histamine antagonists|mesh-ancestor
110406606|NCT01293968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110406607|NCT01293968|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110406608|NCT01293968|Antipruritics|antipruritics|mesh-ancestor
110406609|NCT01293968|Dermatologic Agents|dermatologic agents|mesh-ancestor
110406610|NCT01293032|Tamoxifen|tamoxifen|mesh-list
110406611|NCT01293032|Aromatase Inhibitors|aromatase inhibitors|mesh-list
110406612|NCT01293032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110406613|NCT01293032|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110406614|NCT01293032|Hormone Antagonists|hormone antagonists|mesh-ancestor
110406615|NCT01293032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110406616|NCT01293032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110406617|NCT01293032|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110406618|NCT01293032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110406619|NCT01293032|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110406620|NCT01293032|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110406621|NCT01293032|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110406622|NCT01293032|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110406623|NCT01293032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110406624|NCT01224171|Vedolizumab|vedolizumab|mesh-list
110406625|NCT01224171|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110406626|NCT01223937|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
110406627|NCT01223937|Hemostatics|hemostatics|mesh-ancestor
110406628|NCT01223937|Coagulants|coagulants|mesh-ancestor
110406629|NCT01223937|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
110406630|NCT01223937|Natriuretic Agents|natriuretic agents|mesh-ancestor
110406631|NCT01223937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110406632|NCT01223235|Bevacizumab|bevacizumab|mesh-list
110406633|NCT01223235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110406634|NCT01223235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110406635|NCT01223235|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110406636|NCT01223235|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110406637|NCT01223235|Growth Substances|growth substances|mesh-ancestor
110406638|NCT01223235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110406639|NCT01223235|Growth Inhibitors|growth inhibitors|mesh-ancestor
110406640|NCT00993967|Idebenone|idebenone|mesh-list
110406641|NCT00993967|Antioxidants|antioxidants|mesh-ancestor
110406642|NCT00993967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110406643|NCT00993967|Protective Agents|protective agents|mesh-ancestor
110406644|NCT00993967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110406645|NCT04204603|CKD-506|ckd-506|mesh-list
110406646|NCT04204603|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110406647|NCT04204603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110406648|NCT04204603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110406649|NCT01222533|Tiotropium Bromide|tiotropium bromide|mesh-list
110406650|NCT01222533|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110406651|NCT01222533|Autonomic Agents|autonomic agents|mesh-ancestor
110406652|NCT01222533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110406653|NCT01222533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110406654|NCT01222533|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110406655|NCT01222533|Respiratory System Agents|respiratory system agents|mesh-ancestor
110406656|NCT01222533|Parasympatholytics|parasympatholytics|mesh-ancestor
110406657|NCT01222533|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110406658|NCT01222533|Cholinergic Agents|cholinergic agents|mesh-ancestor
110406659|NCT01222533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110406660|NCT01222533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110406661|NCT01221753|Carboplatin|carboplatin|mesh-list
110406662|NCT01221753|Docetaxel|docetaxel|mesh-list
110406663|NCT01221753|Fluorouracil|fluorouracil|mesh-list
110406664|NCT01221753|Cetuximab|cetuximab|mesh-list
110406665|NCT01221753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110406666|NCT01221753|Tubulin Modulators|tubulin modulators|mesh-ancestor
110406667|NCT01221753|Antimitotic Agents|antimitotic agents|mesh-ancestor
110406668|NCT01221753|Mitosis Modulators|mitosis modulators|mesh-ancestor
110406669|NCT01221753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110406670|NCT01221753|Antimetabolites|antimetabolites|mesh-ancestor
110183215|NCT03959852|Fentanyl|fentanyl|mesh-list
110406671|NCT01221753|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110406672|NCT01221753|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110406673|NCT01221753|Immunologic Factors|immunologic factors|mesh-ancestor
110406674|NCT01221753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110406675|NCT01221753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110406676|NCT02888223|Factor VIII|factor viii|mesh-list
110406677|NCT02888223|Coagulants|coagulants|mesh-ancestor
110406678|NCT01014988|Zanamivir|zanamivir|mesh-list
110406679|NCT01014988|Antiviral Agents|antiviral agents|mesh-ancestor
110406680|NCT01014988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110406681|NCT01014988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110406682|NCT01014988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110406683|NCT01019980|Acetaminophen|acetaminophen|mesh-list
110406684|NCT01019980|Diclofenac|diclofenac|mesh-list
110406685|NCT01019980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110406686|NCT01019980|Analgesics|analgesics|mesh-ancestor
110406687|NCT01019980|Sensory System Agents|sensory system agents|mesh-ancestor
110406688|NCT01019980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110406689|NCT01019980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110406690|NCT01019980|Antipyretics|antipyretics|mesh-ancestor
110406691|NCT01019980|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110406692|NCT01019980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110406693|NCT01019980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110406694|NCT01019980|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110406695|NCT01019980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110406696|NCT01019980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110406697|NCT00993499|Sirolimus|sirolimus|mesh-list
110406698|NCT00993499|Afatinib|afatinib|mesh-list
110406699|NCT00993499|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110406700|NCT00993499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110406701|NCT00993499|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110406702|NCT00993499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110406703|NCT00993499|Antifungal Agents|antifungal agents|mesh-ancestor
110406704|NCT00993499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110406705|NCT00993499|Immunologic Factors|immunologic factors|mesh-ancestor
110406706|NCT00993499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110406707|NCT00993499|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110406708|NCT00993499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110406709|NCT00993499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110406710|NCT01014442|Mycophenolic Acid|mycophenolic acid|mesh-list
110406711|NCT01014442|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110406712|NCT01014442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110406713|NCT01014442|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110406714|NCT01014442|Antitubercular Agents|antitubercular agents|mesh-ancestor
110406715|NCT01014442|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110406716|NCT01014442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110406717|NCT01014442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110406718|NCT01014442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110406719|NCT00996307|MF59 oil emulsion|mf59 oil emulsion|mesh-list
110406720|NCT00996307|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110406721|NCT00996307|Immunologic Factors|immunologic factors|mesh-ancestor
110406722|NCT00996307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110406723|NCT02869165|Estrogens|estrogens|mesh-list
110406724|NCT02869165|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
110406725|NCT02869165|Hormones|hormones|mesh-ancestor
110406726|NCT02869165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110406727|NCT02869165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110406728|NCT01219959|Icodextrin|icodextrin|mesh-list
110406729|NCT01219959|Dialysis Solutions|dialysis solutions|mesh-ancestor
110406730|NCT01219959|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110406731|NCT00993421|Sibutramine|sibutramine|mesh-list
110406732|NCT00993421|Metoprolol|metoprolol|mesh-list
110406733|NCT00993421|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110406734|NCT00993421|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110406735|NCT00993421|Sympatholytics|sympatholytics|mesh-ancestor
110406736|NCT00993421|Autonomic Agents|autonomic agents|mesh-ancestor
110406737|NCT00993421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110406738|NCT00993421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110406739|NCT00993421|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110406740|NCT00993421|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110406741|NCT00993421|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110406742|NCT00993421|Adrenergic Agents|adrenergic agents|mesh-ancestor
110406743|NCT00993421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110406744|NCT00993421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110406745|NCT00993421|Antidepressive Agents|antidepressive agents|mesh-ancestor
110406746|NCT00993421|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110406747|NCT00993421|Appetite Depressants|appetite depressants|mesh-ancestor
110406748|NCT00993421|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110406749|NCT01014208|Rituximab|rituximab|mesh-list
110406750|NCT01014208|Ofatumumab|ofatumumab|mesh-list
110406751|NCT01014208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110406752|NCT01014208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110406753|NCT01014208|Immunologic Factors|immunologic factors|mesh-ancestor
110406754|NCT01014208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110406755|NCT01014208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110406756|NCT04205578|3-n-butylphthalide|3-n-butylphthalide|mesh-list
110406757|NCT04205578|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110406758|NCT04205578|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110406759|NCT04205578|Protective Agents|protective agents|mesh-ancestor
110406760|NCT04205578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110406761|NCT00991939|Dexamethasone|dexamethasone|mesh-list
110406762|NCT00991939|Prednisone|prednisone|mesh-list
110406763|NCT00991939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110406764|NCT00991939|Antiemetics|antiemetics|mesh-ancestor
110406765|NCT00991939|Autonomic Agents|autonomic agents|mesh-ancestor
110406766|NCT00991939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110560402|NCT02683655|Apatinib|apatinib|mesh-list
110406767|NCT00991939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110406768|NCT00991939|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110406769|NCT00991939|Glucocorticoids|glucocorticoids|mesh-ancestor
110406770|NCT00991939|Hormones|hormones|mesh-ancestor
110406771|NCT00991939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110406772|NCT00991939|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110406773|NCT00991939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110406774|NCT02868385|Praziquantel|praziquantel|mesh-list
110406775|NCT02868385|Anthelmintics|anthelmintics|mesh-ancestor
110406776|NCT02868385|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110406777|NCT02868385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110406778|NCT00993265|Acetylcysteine|acetylcysteine|mesh-list
110406779|NCT00993265|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110406780|NCT00993265|Antiviral Agents|antiviral agents|mesh-ancestor
110406781|NCT00993265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110406782|NCT00993265|Expectorants|expectorants|mesh-ancestor
110406783|NCT00993265|Respiratory System Agents|respiratory system agents|mesh-ancestor
110406784|NCT00993265|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110406785|NCT00993265|Antioxidants|antioxidants|mesh-ancestor
110406786|NCT00993265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110406787|NCT00993265|Protective Agents|protective agents|mesh-ancestor
110406788|NCT00993265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110406789|NCT00993265|Antidotes|antidotes|mesh-ancestor
110406790|NCT00993031|Ritonavir|ritonavir|mesh-list
110406791|NCT00993031|Lopinavir|lopinavir|mesh-list
110406792|NCT00993031|Lamivudine|lamivudine|mesh-list
110406793|NCT00993031|Zidovudine|zidovudine|mesh-list
110406794|NCT00993031|Efavirenz|efavirenz|mesh-list
110406795|NCT00993031|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110406796|NCT00993031|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110406797|NCT00993031|Protease Inhibitors|protease inhibitors|mesh-ancestor
110406798|NCT00993031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110406799|NCT00993031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110406800|NCT00993031|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110406801|NCT00993031|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110406802|NCT00993031|Antiviral Agents|antiviral agents|mesh-ancestor
110406803|NCT00993031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110406804|NCT00993031|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110406805|NCT00993031|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110406806|NCT00993031|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110406807|NCT00993031|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110406808|NCT00993031|Antimetabolites|antimetabolites|mesh-ancestor
110406809|NCT00993031|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110406810|NCT00993031|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110406811|NCT00993031|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110406812|NCT00993031|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110406813|NCT00993031|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110406815|NCT01010776|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110406816|NCT01010776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110406817|NCT01010776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110406818|NCT01010776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110406819|NCT01010776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110406820|NCT01010776|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110406821|NCT01010776|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110406822|NCT01010776|Serotonin Agents|serotonin agents|mesh-ancestor
110406823|NCT01010776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110406824|NCT01010776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110406825|NCT01010776|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110406826|NCT01010776|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110406827|NCT01010776|Dopamine Agents|dopamine agents|mesh-ancestor
110406829|NCT04291729|Ritonavir|ritonavir|mesh-list
110406830|NCT04291729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110406831|NCT04291729|Antiviral Agents|antiviral agents|mesh-ancestor
110406832|NCT04291729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110406833|NCT04291729|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110406834|NCT04291729|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110406835|NCT04291729|Protease Inhibitors|protease inhibitors|mesh-ancestor
110406836|NCT04291729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110406837|NCT04291729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110406838|NCT04291729|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110406839|NCT04291729|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110406840|NCT04291729|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110406841|NCT04291729|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110406842|NCT02868931|Insulin|insulin|mesh-list
110406843|NCT02868931|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110406844|NCT02868931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110406845|NCT01018810|Interleukin-23|interleukin-23|mesh-list
110406846|NCT01018810|Antibodies|antibodies|mesh-list
110406847|NCT01018810|Immunoglobulins|immunoglobulins|mesh-list
110406848|NCT01018810|Immunologic Factors|immunologic factors|mesh-ancestor
110406849|NCT01018810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110406850|NCT01018810|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110406851|NCT01018810|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110406852|NCT01018810|Growth Substances|growth substances|mesh-ancestor
110406853|NCT01018810|Growth Inhibitors|growth inhibitors|mesh-ancestor
110406854|NCT01018810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110406855|NCT02867917|Psyllium|psyllium|mesh-list
110406856|NCT02867917|Cathartics|cathartics|mesh-ancestor
110406857|NCT02867917|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110406858|NCT01018732|Lactitol|lactitol|mesh-list
110406859|NCT01018732|Cathartics|cathartics|mesh-ancestor
110406860|NCT01018732|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110406861|NCT01218867|Aldesleukin|aldesleukin|mesh-list
110406862|NCT01218867|Cyclophosphamide|cyclophosphamide|mesh-list
110406863|NCT01218867|Fludarabine|fludarabine|mesh-list
110406864|NCT01218867|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110406865|NCT01218867|Immunologic Factors|immunologic factors|mesh-ancestor
110406866|NCT01218867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110406867|NCT01218867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110406868|NCT01218867|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110406869|NCT01218867|Alkylating Agents|alkylating agents|mesh-ancestor
110406870|NCT01218867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110406871|NCT01218867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110406872|NCT01218867|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110406873|NCT01218867|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110406874|NCT01218867|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110406875|NCT01218867|Antiviral Agents|antiviral agents|mesh-ancestor
110406876|NCT01218867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110406877|NCT01018264|Solifenacin Succinate|solifenacin succinate|mesh-list
110406878|NCT01018264|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110406879|NCT01018264|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110406880|NCT01018264|Cholinergic Agents|cholinergic agents|mesh-ancestor
110406881|NCT01018264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110406882|NCT01018264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110406883|NCT01018264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110406884|NCT01018264|Urological Agents|urological agents|mesh-ancestor
110406885|NCT01018186|Fluticasone|fluticasone|mesh-list
110406887|NCT01018186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110406888|NCT01018186|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110406889|NCT01018186|Autonomic Agents|autonomic agents|mesh-ancestor
110406890|NCT01018186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110406891|NCT01018186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110406892|NCT01018186|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110406893|NCT01018186|Respiratory System Agents|respiratory system agents|mesh-ancestor
110406894|NCT01018186|Dermatologic Agents|dermatologic agents|mesh-ancestor
110406895|NCT01018186|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110406896|NCT00992407|Risperidone|risperidone|mesh-list
110406897|NCT00992407|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110406898|NCT00992407|Serotonin Agents|serotonin agents|mesh-ancestor
110406899|NCT00992407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110406900|NCT00992407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110406901|NCT00992407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110406902|NCT00992407|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110406903|NCT00992407|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110406904|NCT00992407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110406905|NCT00992407|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110406906|NCT00992407|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110406907|NCT00992407|Dopamine Agents|dopamine agents|mesh-ancestor
110406908|NCT00986245|Ropinirole|ropinirole|mesh-list
110406909|NCT00986245|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110406910|NCT00986245|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110406911|NCT00986245|Dopamine Agonists|dopamine agonists|mesh-ancestor
110406912|NCT00986245|Dopamine Agents|dopamine agents|mesh-ancestor
110406913|NCT00986245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110406914|NCT00986245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110406915|NCT00986245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110406917|NCT00989833|Terbutaline|terbutaline|mesh-list
110406918|NCT00989833|Formoterol Fumarate|formoterol fumarate|mesh-list
110406919|NCT00989833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110358434|NCT05867329|Upadacitinib|upadacitinib|mesh-list
110406920|NCT00989833|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110406921|NCT00989833|Autonomic Agents|autonomic agents|mesh-ancestor
110406922|NCT00989833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110406923|NCT00989833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110406924|NCT00989833|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110406925|NCT00989833|Respiratory System Agents|respiratory system agents|mesh-ancestor
110406926|NCT00989833|Glucocorticoids|glucocorticoids|mesh-ancestor
110406927|NCT00989833|Hormones|hormones|mesh-ancestor
110406928|NCT00989833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110406929|NCT00989833|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110406930|NCT00989833|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110406931|NCT00989833|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110406932|NCT00989833|Adrenergic Agents|adrenergic agents|mesh-ancestor
110406933|NCT00989833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110406934|NCT00989833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110406935|NCT00989833|Sympathomimetics|sympathomimetics|mesh-ancestor
110406936|NCT00989833|Tocolytic Agents|tocolytic agents|mesh-ancestor
110406937|NCT00989833|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110406938|NCT04292119|Crizotinib|crizotinib|mesh-list
110406939|NCT04292119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110406940|NCT04292119|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110406941|NCT04292119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110406942|NCT04292119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110406943|NCT01218477|Dasatinib|dasatinib|mesh-list
110406944|NCT01218477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110406945|NCT01218477|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110406946|NCT01218477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110406947|NCT01218477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110406948|NCT01218009|Albuterol|albuterol|mesh-list
110406949|NCT01218009|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110406950|NCT01218009|Autonomic Agents|autonomic agents|mesh-ancestor
110406951|NCT01218009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110406952|NCT01218009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110406953|NCT01218009|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110406954|NCT01218009|Respiratory System Agents|respiratory system agents|mesh-ancestor
110406955|NCT01218009|Tocolytic Agents|tocolytic agents|mesh-ancestor
110406956|NCT01218009|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110406957|NCT01218009|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110406958|NCT01218009|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110406959|NCT01218009|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110406960|NCT01218009|Adrenergic Agents|adrenergic agents|mesh-ancestor
110406961|NCT01218009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110406962|NCT01218009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110406963|NCT02868151|Ascorbic Acid|ascorbic acid|mesh-list
110406964|NCT02868151|Vitamins|vitamins|mesh-ancestor
110406965|NCT02868151|Micronutrients|micronutrients|mesh-ancestor
110406966|NCT02868151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110406967|NCT02868151|Antioxidants|antioxidants|mesh-ancestor
110406968|NCT02868151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110406969|NCT02868151|Protective Agents|protective agents|mesh-ancestor
110406970|NCT01217307|Metformin|metformin|mesh-list
110406971|NCT01217307|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110406972|NCT01217307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110406973|NCT02868073|Vaccines|vaccines|mesh-list
110406974|NCT02868073|Immunologic Factors|immunologic factors|mesh-ancestor
110406975|NCT02868073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110406976|NCT01013740|Capecitabine|capecitabine|mesh-list
110406977|NCT01013740|Vinorelbine|vinorelbine|mesh-list
110406978|NCT01013740|Lapatinib|lapatinib|mesh-list
110406979|NCT01013740|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110406980|NCT01013740|Antimetabolites|antimetabolites|mesh-ancestor
110406981|NCT01013740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110406982|NCT01013740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110406983|NCT01013740|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110406984|NCT01013740|Tubulin Modulators|tubulin modulators|mesh-ancestor
110406985|NCT01013740|Antimitotic Agents|antimitotic agents|mesh-ancestor
110406986|NCT01013740|Mitosis Modulators|mitosis modulators|mesh-ancestor
110406987|NCT01013740|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110406988|NCT01013740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110406989|NCT01217073|Metformin|metformin|mesh-list
110406990|NCT01217073|Pioglitazone|pioglitazone|mesh-list
110406991|NCT01217073|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110406992|NCT01217073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110406994|NCT00985621|Tanezumab|tanezumab|mesh-list
110406995|NCT00985621|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110406996|NCT00985621|Narcotics|narcotics|mesh-ancestor
110406997|NCT00985621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110406998|NCT00985621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110406999|NCT00985621|Analgesics|analgesics|mesh-ancestor
110407000|NCT00985621|Sensory System Agents|sensory system agents|mesh-ancestor
110560473|NCT02613494|Antiemetics|antiemetics|mesh-ancestor
110407001|NCT00985621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110407002|NCT01215981|Vaccines|vaccines|mesh-list
110407003|NCT01215981|Immunologic Factors|immunologic factors|mesh-ancestor
110407004|NCT01215981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110407005|NCT01215435|Insulin|insulin|mesh-list
110407006|NCT01215435|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110407007|NCT01215435|Insulin Aspart|insulin aspart|mesh-list
110407008|NCT01215435|Insulin, Long-Acting|insulin, long-acting|mesh-list
110407009|NCT01215435|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
110407010|NCT01215435|Biphasic Insulins|biphasic insulins|mesh-list
110407011|NCT01215435|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
110407012|NCT01215435|Insulin, Isophane|insulin, isophane|mesh-list
110407013|NCT01215435|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110407014|NCT01215435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110407015|NCT01215357|Ecopipam|ecopipam|mesh-list
110407016|NCT01215357|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110407017|NCT01215357|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110407018|NCT01215357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110407019|NCT01215357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110407020|NCT01215357|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110407021|NCT01215357|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110407022|NCT01215357|Dopamine Agents|dopamine agents|mesh-ancestor
110407023|NCT01215357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110407024|NCT01215357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110407025|NCT01017874|Pemetrexed|pemetrexed|mesh-list
110407026|NCT01017874|Gefitinib|gefitinib|mesh-list
110407027|NCT01017874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110407028|NCT01017874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110407029|NCT01017874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110407030|NCT01017874|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110407031|NCT01017874|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110407032|NCT01017874|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110407033|NCT00627952|Amlodipine|amlodipine|mesh-list
110407034|NCT00627952|Manidipine|manidipine|mesh-list
110407035|NCT00627952|Delapril|delapril|mesh-list
110407036|NCT00627952|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110407037|NCT00627952|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110407038|NCT00627952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110407039|NCT00627952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110407040|NCT00627952|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110407041|NCT00627952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110407042|NCT00627952|Vasodilator Agents|vasodilator agents|mesh-ancestor
110407043|NCT00627952|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110407044|NCT00627952|Protease Inhibitors|protease inhibitors|mesh-ancestor
110407045|NCT00627952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110407046|NCT01009840|Bortezomib|bortezomib|mesh-list
110407047|NCT01009840|Busulfan|busulfan|mesh-list
110407048|NCT01009840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110407050|NCT01009840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110407051|NCT01009840|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110407052|NCT01009840|Immunologic Factors|immunologic factors|mesh-ancestor
110407053|NCT01009840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110407054|NCT01009840|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110407055|NCT01009840|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110407056|NCT04420936|Benzocaine|benzocaine|mesh-list
110407057|NCT04420936|Anesthetics, Local|anesthetics, local|mesh-ancestor
110407058|NCT04420936|Anesthetics|anesthetics|mesh-ancestor
110407059|NCT04420936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110407060|NCT04420936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110407061|NCT04420936|Sensory System Agents|sensory system agents|mesh-ancestor
110407062|NCT04420936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110407063|NCT02872090|Glycopyrrolate|glycopyrrolate|mesh-list
110407064|NCT02872090|Tiotropium Bromide|tiotropium bromide|mesh-list
110407065|NCT02872090|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110407066|NCT02872090|Autonomic Agents|autonomic agents|mesh-ancestor
110407067|NCT02872090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110407068|NCT02872090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110407069|NCT02872090|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110407070|NCT02872090|Respiratory System Agents|respiratory system agents|mesh-ancestor
110407071|NCT02872090|Parasympatholytics|parasympatholytics|mesh-ancestor
110407072|NCT02872090|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110407073|NCT02872090|Cholinergic Agents|cholinergic agents|mesh-ancestor
110407074|NCT02872090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110407075|NCT02872090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110407076|NCT02872090|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110407077|NCT02872090|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110407078|NCT00982657|Sunitinib|sunitinib|mesh-list
110407079|NCT00982657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110407080|NCT00982657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110407081|NCT00982657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110407082|NCT00982657|Growth Substances|growth substances|mesh-ancestor
110407083|NCT00982657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110407084|NCT00982657|Growth Inhibitors|growth inhibitors|mesh-ancestor
110407085|NCT00982657|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110407086|NCT00982657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110407087|NCT00982657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110407088|NCT02867839|Oxaliplatin|oxaliplatin|mesh-list
110407089|NCT02867839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110407090|NCT02867293|Anesthetics|anesthetics|mesh-list
110407091|NCT02867293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110407092|NCT02867293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110407093|NCT01005316|Mycophenolic Acid|mycophenolic acid|mesh-list
110407094|NCT01005316|Prednisone|prednisone|mesh-list
110407095|NCT01005316|Tacrolimus|tacrolimus|mesh-list
110407096|NCT01005316|Immunoglobulins|immunoglobulins|mesh-list
110407097|NCT01005316|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110407098|NCT01005316|Antibodies|antibodies|mesh-list
110407099|NCT01005316|gamma-Globulins|gamma-globulins|mesh-list
110407100|NCT01005316|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110407101|NCT01005316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110407102|NCT01005316|Glucocorticoids|glucocorticoids|mesh-ancestor
110407103|NCT01005316|Hormones|hormones|mesh-ancestor
110407104|NCT01005316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110407105|NCT01005316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110407106|NCT01005316|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110407107|NCT01005316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110407108|NCT01005316|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110407109|NCT01005316|Immunologic Factors|immunologic factors|mesh-ancestor
110407110|NCT01005316|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110407111|NCT01005316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110407112|NCT01005316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110407113|NCT01005316|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110407114|NCT01005316|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110407115|NCT01005316|Antitubercular Agents|antitubercular agents|mesh-ancestor
110407116|NCT01005316|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110407117|NCT01005316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110407118|NCT00988429|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
110407119|NCT00988429|Anticonvulsants|anticonvulsants|mesh-ancestor
110407120|NCT00988429|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110407121|NCT00988429|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110407122|NCT00988429|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110407123|NCT00988429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110407124|NCT01008904|Magnesium Oxide|magnesium oxide|mesh-list
110407126|NCT01008904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110407127|NCT01008904|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110407128|NCT04290793|Cyclophosphamide|cyclophosphamide|mesh-list
110407129|NCT04290793|Trastuzumab|trastuzumab|mesh-list
110407130|NCT04290793|Epirubicin|epirubicin|mesh-list
110407132|NCT04290793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110407133|NCT04290793|Immunologic Factors|immunologic factors|mesh-ancestor
110407134|NCT04290793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110407135|NCT04290793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110407136|NCT04290793|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110407137|NCT04290793|Alkylating Agents|alkylating agents|mesh-ancestor
110560269|NCT00494299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110407138|NCT04290793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110407139|NCT04290793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110407140|NCT04290793|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110407141|NCT04290793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110407142|NCT04290793|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110407143|NCT04290793|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110407144|NCT04290793|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110407145|NCT04290793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110407147|NCT01004614|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110407148|NCT01004614|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110407149|NCT01004614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110407150|NCT01004614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110407151|NCT01004614|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110407152|NCT01004614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110407153|NCT01004614|Vasodilator Agents|vasodilator agents|mesh-ancestor
110407154|NCT04297462|Oseltamivir|oseltamivir|mesh-list
110407155|NCT04297462|Antiviral Agents|antiviral agents|mesh-ancestor
110407156|NCT04297462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110407157|NCT04297462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110407158|NCT04297462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110407159|NCT00981409|Heparin|heparin|mesh-list
110407160|NCT00981409|Calcium heparin|calcium heparin|mesh-list
110407161|NCT00981409|PENTA|penta|mesh-list
110407162|NCT00981409|Fondaparinux|fondaparinux|mesh-list
110407163|NCT00981409|Anticoagulants|anticoagulants|mesh-ancestor
110407164|NCT00981409|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110407165|NCT00981409|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110407166|NCT00981409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110407167|NCT00981409|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110407168|NCT00981409|Antithrombins|antithrombins|mesh-ancestor
110407169|NCT00981409|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110407170|NCT00981409|Protease Inhibitors|protease inhibitors|mesh-ancestor
110407171|NCT00981409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110407172|NCT04297072|Rivaroxaban|rivaroxaban|mesh-list
110407173|NCT04297072|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110407174|NCT04297072|Antithrombins|antithrombins|mesh-ancestor
110407175|NCT04297072|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110407176|NCT04297072|Protease Inhibitors|protease inhibitors|mesh-ancestor
110407177|NCT04297072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110407178|NCT04297072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110407179|NCT04297072|Anticoagulants|anticoagulants|mesh-ancestor
110407180|NCT01008748|Nicotine|nicotine|mesh-list
110407181|NCT01008748|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110407182|NCT01008748|Autonomic Agents|autonomic agents|mesh-ancestor
110407183|NCT01008748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110407184|NCT01008748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110407185|NCT01008748|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110407186|NCT01008748|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110407187|NCT01008748|Cholinergic Agents|cholinergic agents|mesh-ancestor
110407188|NCT01008748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110183306|NCT03959501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110407189|NCT01008748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110407190|NCT00628732|Cyclophosphamide|cyclophosphamide|mesh-list
110407191|NCT00628732|Topotecan|topotecan|mesh-list
110407192|NCT00628732|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110407193|NCT00628732|Immunologic Factors|immunologic factors|mesh-ancestor
110407194|NCT00628732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110407195|NCT00628732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110407196|NCT00628732|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110407197|NCT00628732|Alkylating Agents|alkylating agents|mesh-ancestor
110407198|NCT00628732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110407199|NCT00628732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110407200|NCT00628732|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110407201|NCT00628732|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110407202|NCT00628732|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110407203|NCT00628732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110407204|NCT04131829|Fluoxetine|fluoxetine|mesh-list
110407205|NCT04131829|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110407206|NCT04131829|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110407207|NCT04131829|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110407208|NCT04131829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110407209|NCT04131829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110407210|NCT04131829|Serotonin Agents|serotonin agents|mesh-ancestor
110407211|NCT04131829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110407212|NCT04131829|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110407213|NCT04131829|Antidepressive Agents|antidepressive agents|mesh-ancestor
110407214|NCT04131829|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110407215|NCT04131829|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110407216|NCT04131829|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110407217|NCT04131829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110407218|NCT04205344|Bupivacaine|bupivacaine|mesh-list
110407219|NCT04205344|Anesthetics, Local|anesthetics, local|mesh-ancestor
110407220|NCT04205344|Anesthetics|anesthetics|mesh-ancestor
110407221|NCT04205344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110407222|NCT04205344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110407223|NCT04205344|Sensory System Agents|sensory system agents|mesh-ancestor
110407224|NCT04205344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110407225|NCT00629317|Aminolevulinic Acid|aminolevulinic acid|mesh-list
110407226|NCT00629317|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
110407227|NCT00629317|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110407228|NCT00629317|Dermatologic Agents|dermatologic agents|mesh-ancestor
110407230|NCT00978757|Analgesics|analgesics|mesh-ancestor
110407231|NCT00978757|Sensory System Agents|sensory system agents|mesh-ancestor
110407232|NCT00978757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110407233|NCT00978757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110407234|NCT00978757|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110407235|NCT00978757|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110407236|NCT00978757|Anesthetics, General|anesthetics, general|mesh-ancestor
110407237|NCT00978757|Anesthetics|anesthetics|mesh-ancestor
110407238|NCT00978757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110407239|NCT00978757|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110407240|NCT00978757|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110407241|NCT00978757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110407242|NCT00978757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110407244|NCT01214421|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
110407245|NCT01214421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110407246|NCT01214421|Natriuretic Agents|natriuretic agents|mesh-ancestor
110407247|NCT01214421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110407248|NCT01214187|Carbon Monoxide|carbon monoxide|mesh-list
110407249|NCT01214187|Antimetabolites|antimetabolites|mesh-ancestor
110407250|NCT01214187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110407251|NCT01214187|Gasotransmitters|gasotransmitters|mesh-ancestor
110407252|NCT01214187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110183311|NCT00028782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110407253|NCT01214187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110407254|NCT02866903|Bevacizumab|bevacizumab|mesh-list
110407255|NCT02866903|Oxaliplatin|oxaliplatin|mesh-list
110407256|NCT02866903|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110407257|NCT02866903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110407258|NCT02866903|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110407259|NCT02866903|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110407260|NCT02866903|Growth Substances|growth substances|mesh-ancestor
110407261|NCT02866903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110407262|NCT02866903|Growth Inhibitors|growth inhibitors|mesh-ancestor
110407263|NCT03945019|Infliximab|infliximab|mesh-list
110407264|NCT03945019|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110407265|NCT03945019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110407266|NCT03945019|Dermatologic Agents|dermatologic agents|mesh-ancestor
110407267|NCT03945019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110407268|NCT03945019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110407269|NCT01003990|Ritonavir|ritonavir|mesh-list
110407270|NCT01003990|Lopinavir|lopinavir|mesh-list
110407271|NCT01003990|Atazanavir Sulfate|atazanavir sulfate|mesh-list
110407272|NCT01003990|Tenofovir|tenofovir|mesh-list
110407273|NCT01003990|Emtricitabine|emtricitabine|mesh-list
110407274|NCT01003990|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110407275|NCT01003990|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110407276|NCT01003990|Protease Inhibitors|protease inhibitors|mesh-ancestor
110407277|NCT01003990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110407278|NCT01003990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110407279|NCT01003990|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110407280|NCT01003990|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110407281|NCT01003990|Antiviral Agents|antiviral agents|mesh-ancestor
110407282|NCT01003990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110407283|NCT01003990|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110407284|NCT01003990|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110407285|NCT01003990|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110407286|NCT01003990|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110407287|NCT01002820|Ganaxolone|ganaxolone|mesh-list
110407288|NCT01002820|Neurosteroids|neurosteroids|mesh-ancestor
110407289|NCT01002820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110560561|NCT00638807|Sensory System Agents|sensory system agents|mesh-ancestor
110407290|NCT01002820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110407291|NCT01002820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110407292|NCT01002820|GABA Modulators|gaba modulators|mesh-ancestor
110407293|NCT01002820|GABA Agents|gaba agents|mesh-ancestor
110407294|NCT01012258|Cetuximab|cetuximab|mesh-list
110407295|NCT01012258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110407296|NCT01012258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110407297|NCT00628810|Leucovorin|leucovorin|mesh-list
110407299|NCT00628810|Fluorouracil|fluorouracil|mesh-list
110407300|NCT00628810|Irinotecan|irinotecan|mesh-list
110407301|NCT00628810|Calcium|calcium|mesh-list
110407302|NCT00628810|Levoleucovorin|levoleucovorin|mesh-list
110407303|NCT00628810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110407304|NCT00628810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110407305|NCT00628810|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110407306|NCT00628810|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110407307|NCT00628810|Growth Substances|growth substances|mesh-ancestor
110407308|NCT00628810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110407309|NCT00628810|Growth Inhibitors|growth inhibitors|mesh-ancestor
110407310|NCT00628810|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110407311|NCT00628810|Antimetabolites|antimetabolites|mesh-ancestor
110407312|NCT00628810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110407313|NCT00628810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110407314|NCT00628810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110407315|NCT00628810|Immunologic Factors|immunologic factors|mesh-ancestor
110407316|NCT00628810|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110407317|NCT00628810|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110407318|NCT00628810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110407319|NCT00628810|Antidotes|antidotes|mesh-ancestor
110407320|NCT00628810|Protective Agents|protective agents|mesh-ancestor
110407321|NCT00628810|Vitamin B Complex|vitamin b complex|mesh-ancestor
110407322|NCT00628810|Vitamins|vitamins|mesh-ancestor
110407323|NCT00628810|Micronutrients|micronutrients|mesh-ancestor
110407324|NCT00975481|Alprazolam|alprazolam|mesh-list
110407325|NCT00975481|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110407326|NCT00975481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110407327|NCT00975481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110407328|NCT00975481|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110407329|NCT00975481|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110407330|NCT00975481|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110407331|NCT00975481|GABA Modulators|gaba modulators|mesh-ancestor
110407332|NCT00975481|GABA Agents|gaba agents|mesh-ancestor
110407333|NCT00975481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110407334|NCT00975481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110407335|NCT01011868|Empagliflozin|empagliflozin|mesh-list
110407336|NCT01011868|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110407337|NCT01011868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110407338|NCT01011868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110407339|NCT01011868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110407340|NCT04290013|Tranexamic Acid|tranexamic acid|mesh-list
110407341|NCT04290013|Norethindrone|norethindrone|mesh-list
110407342|NCT04290013|Norethindrone Acetate|norethindrone acetate|mesh-list
110407343|NCT04290013|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110407344|NCT04290013|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110407345|NCT04290013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110407346|NCT04290013|Hemostatics|hemostatics|mesh-ancestor
110407347|NCT04290013|Coagulants|coagulants|mesh-ancestor
110407348|NCT04290013|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110407349|NCT04290013|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110407350|NCT04290013|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110407351|NCT04290013|Contraceptive Agents|contraceptive agents|mesh-ancestor
110407352|NCT04290013|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110407353|NCT04290013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110407354|NCT04290013|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110407355|NCT04290013|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110407356|NCT04288999|Capecitabine|capecitabine|mesh-list
110407357|NCT04288999|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110407358|NCT04288999|Antimetabolites|antimetabolites|mesh-ancestor
110407359|NCT04288999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110407360|NCT04288999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110407362|NCT01213173|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110407363|NCT01213173|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110407364|NCT01213173|Sympatholytics|sympatholytics|mesh-ancestor
110407365|NCT01213173|Autonomic Agents|autonomic agents|mesh-ancestor
110407366|NCT01213173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110407367|NCT01213173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110407368|NCT01213173|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110407369|NCT01213173|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110407370|NCT01213173|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110407371|NCT01213173|Adrenergic Agents|adrenergic agents|mesh-ancestor
110407372|NCT01213173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110407373|NCT01213173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110407374|NCT04095715|Hemostatics|hemostatics|mesh-list
110407375|NCT04095715|Coagulants|coagulants|mesh-ancestor
110407376|NCT02866435|Potassium phosphate|potassium phosphate|mesh-list
110407377|NCT02866435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110407378|NCT02866435|Cariostatic Agents|cariostatic agents|mesh-ancestor
110407379|NCT02866435|Protective Agents|protective agents|mesh-ancestor
110407380|NCT00973765|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
110407381|NCT00973765|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110407382|NCT00973765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110407383|NCT00973765|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110407384|NCT00973765|Antimalarials|antimalarials|mesh-ancestor
110407385|NCT00973765|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110407386|NCT00973765|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110407387|NCT01211769|Naltrexone|naltrexone|mesh-list
110407388|NCT01211769|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110407389|NCT01211769|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110407390|NCT01211769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110407391|NCT01211769|Sensory System Agents|sensory system agents|mesh-ancestor
110407392|NCT01211769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110407393|NCT04288765|Dexamethasone|dexamethasone|mesh-list
110407394|NCT04288765|Lenalidomide|lenalidomide|mesh-list
110407395|NCT04288765|Daratumumab|daratumumab|mesh-list
110407396|NCT04288765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110407397|NCT04288765|Antiemetics|antiemetics|mesh-ancestor
110407398|NCT04288765|Autonomic Agents|autonomic agents|mesh-ancestor
110407399|NCT04288765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110407401|NCT04288765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110407402|NCT04288765|Glucocorticoids|glucocorticoids|mesh-ancestor
110407403|NCT04288765|Hormones|hormones|mesh-ancestor
110407404|NCT04288765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110407405|NCT04288765|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110407406|NCT04288765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110407407|NCT04288765|Immunologic Factors|immunologic factors|mesh-ancestor
110407408|NCT04288765|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110407409|NCT04288765|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110407410|NCT04288765|Growth Substances|growth substances|mesh-ancestor
110407411|NCT04288765|Growth Inhibitors|growth inhibitors|mesh-ancestor
110407412|NCT01211535|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110407413|NCT02863861|Dexmedetomidine|dexmedetomidine|mesh-list
110407414|NCT02863861|Ketamine|ketamine|mesh-list
110407415|NCT02863861|Propofol|propofol|mesh-list
110407416|NCT02863861|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110407417|NCT02863861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110407418|NCT02863861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110407419|NCT02863861|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110407420|NCT02863861|Analgesics|analgesics|mesh-ancestor
110407421|NCT02863861|Sensory System Agents|sensory system agents|mesh-ancestor
110407422|NCT02863861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110407423|NCT02863861|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110312758|NCT00418067|Sirolimus|sirolimus|mesh-list
110407424|NCT02863861|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110407425|NCT02863861|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110407426|NCT02863861|Adrenergic Agents|adrenergic agents|mesh-ancestor
110407427|NCT02863861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110407428|NCT02863861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110407429|NCT02863861|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110407430|NCT02863861|Anesthetics, General|anesthetics, general|mesh-ancestor
110407431|NCT02863861|Anesthetics|anesthetics|mesh-ancestor
110407432|NCT02863861|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110407433|NCT02863861|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110407434|NCT02863861|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110407435|NCT05406765|Bupivacaine|bupivacaine|mesh-list
110407436|NCT05406765|Anesthetics, Local|anesthetics, local|mesh-ancestor
110407437|NCT05406765|Anesthetics|anesthetics|mesh-ancestor
110407438|NCT05406765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110407439|NCT05406765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110407440|NCT05406765|Sensory System Agents|sensory system agents|mesh-ancestor
110407441|NCT05406765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110407442|NCT01011556|Teriparatide|teriparatide|mesh-list
110407443|NCT01011556|Hormones|hormones|mesh-list
110407444|NCT01011556|Parathyroid Hormone|parathyroid hormone|mesh-list
110407445|NCT01011556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110407446|NCT01011556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110407447|NCT01011556|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110407448|NCT01011556|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110407449|NCT01211145|Oxazolidinones|oxazolidinones|mesh-list
110407450|NCT01211145|Zolmitriptan|zolmitriptan|mesh-list
110407451|NCT01211145|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110407452|NCT01211145|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110407453|NCT01211145|Serotonin Agents|serotonin agents|mesh-ancestor
110407454|NCT01211145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110407455|NCT01211145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110407456|NCT01211145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110407457|NCT01211145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110407458|NCT01211145|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110407459|NCT01211145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110407460|NCT00977665|Rasagiline|rasagiline|mesh-list
110407461|NCT00977665|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
110407462|NCT00977665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110407463|NCT00977665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110407464|NCT00977665|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110407465|NCT00977665|Protective Agents|protective agents|mesh-ancestor
110407466|NCT00977665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110407467|NCT04298008|Durvalumab|durvalumab|mesh-list
110407468|NCT04298008|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110407469|NCT04298008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110407470|NCT00628342|Esomeprazole|esomeprazole|mesh-list
110407471|NCT00628342|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110407472|NCT00628342|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110407473|NCT00628342|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110407474|NCT00628342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110407475|NCT00628342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110407476|NCT01210443|Sitaxsentan|sitaxsentan|mesh-list
110407477|NCT01210443|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
110407478|NCT01210443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110407479|NCT04287361|Clonazepam|clonazepam|mesh-list
110407480|NCT04287361|Anticonvulsants|anticonvulsants|mesh-ancestor
110407481|NCT04287361|GABA Modulators|gaba modulators|mesh-ancestor
110407482|NCT04287361|GABA Agents|gaba agents|mesh-ancestor
110407483|NCT04287361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110407484|NCT04287361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110407485|NCT04287361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110407486|NCT00624429|Budesonide|budesonide|mesh-list
110407487|NCT00624429|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110407488|NCT00624429|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110407489|NCT00624429|Autonomic Agents|autonomic agents|mesh-ancestor
110407490|NCT00624429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110407491|NCT00624429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110407492|NCT00624429|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110407493|NCT00624429|Respiratory System Agents|respiratory system agents|mesh-ancestor
110407494|NCT00624429|Glucocorticoids|glucocorticoids|mesh-ancestor
110407495|NCT00624429|Hormones|hormones|mesh-ancestor
110407496|NCT00624429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110407497|NCT01001572|Amlodipine|amlodipine|mesh-list
110407498|NCT01001572|Valsartan|valsartan|mesh-list
110407499|NCT01001572|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110407500|NCT01001572|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110407501|NCT01001572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110407502|NCT01001572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110407503|NCT01001572|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110407504|NCT01001572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110407505|NCT01001572|Vasodilator Agents|vasodilator agents|mesh-ancestor
110407506|NCT01001572|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110407507|NCT01001572|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110407508|NCT04287205|Dydrogesterone|dydrogesterone|mesh-list
110407509|NCT04287205|Progestins|progestins|mesh-ancestor
110407510|NCT04287205|Hormones|hormones|mesh-ancestor
110407511|NCT04287205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110407512|NCT04287205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110407513|NCT00628576|Heparin|heparin|mesh-list
110407514|NCT00628576|Calcium heparin|calcium heparin|mesh-list
110407515|NCT00628576|Tinzaparin|tinzaparin|mesh-list
110407516|NCT00628576|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
110407517|NCT00628576|Dalteparin|dalteparin|mesh-list
110407518|NCT00628576|Anticoagulants|anticoagulants|mesh-ancestor
110407519|NCT00628576|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110407520|NCT00628576|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110407521|NCT00628576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110407522|NCT01208337|Alemtuzumab|alemtuzumab|mesh-list
110407523|NCT01208337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110407524|NCT01208337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110407525|NCT04370548|Clindamycin|clindamycin|mesh-list
110407526|NCT04370548|Clindamycin palmitate|clindamycin palmitate|mesh-list
110407527|NCT04370548|Clindamycin phosphate|clindamycin phosphate|mesh-list
110407528|NCT04370548|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110407529|NCT04370548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110407530|NCT04370548|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110407531|NCT04370548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110407532|NCT04370548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110407533|NCT01208181|Etoricoxib|etoricoxib|mesh-list
110407534|NCT01208181|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110407535|NCT01208181|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110407536|NCT01208181|Analgesics|analgesics|mesh-ancestor
110407537|NCT01208181|Sensory System Agents|sensory system agents|mesh-ancestor
110407538|NCT01208181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110407539|NCT01208181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110407540|NCT01208181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110407541|NCT01208181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110183328|NCT00028860|Paclitaxel|paclitaxel|mesh-list
110407542|NCT01208181|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110407543|NCT01208181|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110407544|NCT01208181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110560662|NCT03996421|Ferrous fumarate|ferrous fumarate|mesh-list
110407545|NCT01208181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110407546|NCT01208103|Bevacizumab|bevacizumab|mesh-list
110407547|NCT01208103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110407548|NCT01208103|Capecitabine|capecitabine|mesh-list
110407549|NCT01208103|Oxaliplatin|oxaliplatin|mesh-list
110407550|NCT01208103|Endothelial Growth Factors|endothelial growth factors|mesh-list
110407552|NCT01208103|Immunoglobulins|immunoglobulins|mesh-list
110407553|NCT01208103|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110407554|NCT01208103|Immunoglobulin G|immunoglobulin g|mesh-list
110407555|NCT01208103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110407556|NCT01208103|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110407557|NCT01208103|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110407558|NCT01208103|Growth Substances|growth substances|mesh-ancestor
110407559|NCT01208103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110407560|NCT01208103|Growth Inhibitors|growth inhibitors|mesh-ancestor
110407561|NCT01208103|Immunologic Factors|immunologic factors|mesh-ancestor
110407562|NCT01208103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110407563|NCT01208103|Antimetabolites|antimetabolites|mesh-ancestor
110407564|NCT01208103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110407565|NCT01206777|Rituximab|rituximab|mesh-list
110407566|NCT01206777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110407567|NCT01206777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110407568|NCT01206777|Immunologic Factors|immunologic factors|mesh-ancestor
110407569|NCT01206777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110407570|NCT01206777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110407571|NCT01001494|Bromides|bromides|mesh-list
110407572|NCT01001494|Anticonvulsants|anticonvulsants|mesh-ancestor
110407573|NCT01205685|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110407574|NCT01205685|Letrozole|letrozole|mesh-list
110407575|NCT01205685|Goserelin|goserelin|mesh-list
110407576|NCT01205685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110407577|NCT01205685|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110407578|NCT01205685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110407579|NCT01205685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110407580|NCT01205685|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110407581|NCT01205685|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110407582|NCT01205685|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110407583|NCT01205685|Hormone Antagonists|hormone antagonists|mesh-ancestor
110407584|NCT01205685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110407585|NCT01205685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110407586|NCT01205685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110407587|NCT01205529|Procainamide|procainamide|mesh-list
110407588|NCT01205529|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110407589|NCT01205529|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110407590|NCT01205529|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110407591|NCT01205529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110407592|NCT01205529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110407593|NCT04294966|Dronabinol|dronabinol|mesh-list
110407594|NCT04294966|Hallucinogens|hallucinogens|mesh-ancestor
110407595|NCT04294966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110407596|NCT04294966|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110407597|NCT04294966|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110407598|NCT04294966|Analgesics|analgesics|mesh-ancestor
110407599|NCT04294966|Sensory System Agents|sensory system agents|mesh-ancestor
110407600|NCT04294966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110407601|NCT04294966|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
110407602|NCT04294966|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110407603|NCT04294966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110407604|NCT04294966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110407605|NCT04294966|Hormones|hormones|mesh-ancestor
110407606|NCT04294966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110407607|NCT01205451|Botulinum Toxins|botulinum toxins|mesh-list
110407608|NCT01205451|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110407609|NCT01205451|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110407610|NCT01205451|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110407611|NCT01205451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110407612|NCT01205451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110407613|NCT01205451|Cholinergic Agents|cholinergic agents|mesh-ancestor
110407614|NCT01205451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110407615|NCT01205451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110407616|NCT01205451|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110407617|NCT01205451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110407618|NCT04294732|Bupivacaine|bupivacaine|mesh-list
110407619|NCT04294732|Anesthetics, Local|anesthetics, local|mesh-ancestor
110407620|NCT04294732|Anesthetics|anesthetics|mesh-ancestor
110407621|NCT04294732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110407622|NCT04294732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110407623|NCT04294732|Sensory System Agents|sensory system agents|mesh-ancestor
110407624|NCT04294732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110407626|NCT02887677|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110407627|NCT02887677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110407628|NCT02887677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110407629|NCT02887677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110407630|NCT01001104|Dulaglutide|dulaglutide|mesh-list
110407631|NCT01001104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110407632|NCT01001104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110407633|NCT04204954|Ciprofloxacin|ciprofloxacin|mesh-list
110407634|NCT04204954|Tea Tree Oil|tea tree oil|mesh-list
110407635|NCT04204954|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110407636|NCT04204954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110407637|NCT04204954|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110407638|NCT04204954|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110407639|NCT04204954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110407640|NCT04204954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110407641|NCT04204954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110407642|NCT04204954|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110407643|NCT04204954|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110407644|NCT04204954|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110407645|NCT01204671|Vaccines|vaccines|mesh-list
110407646|NCT01204671|Immunologic Factors|immunologic factors|mesh-ancestor
110407647|NCT01204671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110407648|NCT01202955|Tolcapone|tolcapone|mesh-list
110407649|NCT01202955|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110407650|NCT01202955|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110407651|NCT01202955|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
110407652|NCT01202955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110407653|NCT01202955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110407654|NCT01202877|Azacitidine|azacitidine|mesh-list
110407655|NCT01202877|Midostaurin|midostaurin|mesh-list
110407656|NCT01202877|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110407657|NCT01202877|Antimetabolites|antimetabolites|mesh-ancestor
110407658|NCT01202877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110407659|NCT01202877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110407660|NCT01202877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110407661|NCT01202877|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110407662|NCT01202409|Panitumumab|panitumumab|mesh-list
110407663|NCT01202409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110407664|NCT01202409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110407665|NCT01202175|Nebivolol|nebivolol|mesh-list
110407666|NCT01202175|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110407667|NCT01202175|Vasodilator Agents|vasodilator agents|mesh-ancestor
110407668|NCT01202175|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
110407669|NCT01202175|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110407670|NCT01202175|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110407671|NCT01202175|Adrenergic Agents|adrenergic agents|mesh-ancestor
110407672|NCT01202175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110183346|NCT00028899|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110407673|NCT01202175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110407674|NCT01202175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110407675|NCT01201785|Aspirin|aspirin|mesh-list
110407676|NCT01201785|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110407677|NCT01201785|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110407678|NCT01201785|Analgesics|analgesics|mesh-ancestor
110407679|NCT01201785|Sensory System Agents|sensory system agents|mesh-ancestor
110407680|NCT01201785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110407681|NCT01201785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110407682|NCT01201785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110407683|NCT01201785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110407684|NCT01201785|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110407685|NCT01201785|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110407686|NCT01201785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110407687|NCT01201785|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110407688|NCT01201785|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110407689|NCT01201785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110407690|NCT01201785|Antipyretics|antipyretics|mesh-ancestor
110407691|NCT01200069|Ibuprofen|ibuprofen|mesh-list
110407692|NCT01200069|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110407693|NCT01200069|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110407695|NCT01200069|Sensory System Agents|sensory system agents|mesh-ancestor
110407696|NCT01200069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110407697|NCT01200069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110407698|NCT01200069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110407699|NCT01200069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110407700|NCT01200069|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110407701|NCT01200069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110407702|NCT01200069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110407703|NCT01199289|Brodalumab|brodalumab|mesh-list
110407704|NCT01199289|Dermatologic Agents|dermatologic agents|mesh-ancestor
110407705|NCT01199055|Paclitaxel|paclitaxel|mesh-list
110407706|NCT01199055|Carboplatin|carboplatin|mesh-list
110407707|NCT01199055|Efatutazone|efatutazone|mesh-list
110407708|NCT01199055|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110407709|NCT01199055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110407710|NCT01199055|Tubulin Modulators|tubulin modulators|mesh-ancestor
110407711|NCT01199055|Antimitotic Agents|antimitotic agents|mesh-ancestor
110407712|NCT01199055|Mitosis Modulators|mitosis modulators|mesh-ancestor
110407713|NCT01199055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110407715|NCT01198587|Astringents|astringents|mesh-ancestor
110407716|NCT01198587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110407717|NCT01198587|Dermatologic Agents|dermatologic agents|mesh-ancestor
110407718|NCT01198509|Vancomycin|vancomycin|mesh-list
110407719|NCT01198509|Doxycycline|doxycycline|mesh-list
110407720|NCT01198509|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110407721|NCT01198509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110407722|NCT01198509|Antimalarials|antimalarials|mesh-ancestor
110407723|NCT01198509|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110407724|NCT01198509|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110407725|NCT01198275|Amiodarone|amiodarone|mesh-list
110407726|NCT01198275|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110407727|NCT01198275|Vasodilator Agents|vasodilator agents|mesh-ancestor
110407728|NCT01198275|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
110407729|NCT01198275|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110407730|NCT01198275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110407731|NCT01198275|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110407732|NCT01198275|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110407733|NCT01198275|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110407734|NCT01198275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110407735|NCT01198275|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110407736|NCT01198275|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110407737|NCT01198275|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110407738|NCT01197417|Magnesium Sulfate|magnesium sulfate|mesh-list
110407739|NCT01197417|Analgesics|analgesics|mesh-ancestor
110407740|NCT01197417|Sensory System Agents|sensory system agents|mesh-ancestor
110407741|NCT01197417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110407742|NCT01197417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110407743|NCT01197417|Anesthetics|anesthetics|mesh-ancestor
110407744|NCT01197417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110407745|NCT01197417|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110407746|NCT01197417|Anticonvulsants|anticonvulsants|mesh-ancestor
110407747|NCT01197417|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110407748|NCT01197417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110407749|NCT01197417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110407750|NCT01197417|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110407751|NCT01197417|Tocolytic Agents|tocolytic agents|mesh-ancestor
110407752|NCT01197417|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110407753|NCT00977431|Temozolomide|temozolomide|mesh-list
110407754|NCT00977431|Afatinib|afatinib|mesh-list
110407755|NCT00977431|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110407756|NCT00977431|Alkylating Agents|alkylating agents|mesh-ancestor
110407757|NCT00977431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110407759|NCT00977431|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110407760|NCT00977431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110407761|NCT04290169|Botulinum Toxins|botulinum toxins|mesh-list
110407762|NCT04290169|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110407763|NCT04290169|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
110407764|NCT04290169|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110407765|NCT04290169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110407766|NCT04290169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110407767|NCT04290169|Cholinergic Agents|cholinergic agents|mesh-ancestor
110407768|NCT04290169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110407769|NCT04290169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110407770|NCT04290169|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110407771|NCT04290169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110407772|NCT02864095|Epinephrine|epinephrine|mesh-list
110407773|NCT02864095|Tranexamic Acid|tranexamic acid|mesh-list
110407774|NCT02864095|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110407775|NCT02864095|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110407776|NCT02864095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110407777|NCT02864095|Hemostatics|hemostatics|mesh-ancestor
110407778|NCT02864095|Coagulants|coagulants|mesh-ancestor
110407779|NCT02864095|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110407780|NCT02864095|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110407781|NCT02864095|Adrenergic Agents|adrenergic agents|mesh-ancestor
110407782|NCT02864095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110407783|NCT02864095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110407784|NCT02864095|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110407785|NCT02864095|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110407787|NCT02864095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110407788|NCT02864095|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110407789|NCT02864095|Respiratory System Agents|respiratory system agents|mesh-ancestor
110407790|NCT02864095|Mydriatics|mydriatics|mesh-ancestor
110407791|NCT02864095|Sympathomimetics|sympathomimetics|mesh-ancestor
110407792|NCT02864095|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110407793|NCT00977197|Pregabalin|pregabalin|mesh-list
110407794|NCT00977197|Analgesics|analgesics|mesh-ancestor
110407795|NCT00977197|Sensory System Agents|sensory system agents|mesh-ancestor
110407796|NCT00977197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110407797|NCT00977197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110407798|NCT00977197|Anticonvulsants|anticonvulsants|mesh-ancestor
110407799|NCT00977197|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110407800|NCT00977197|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110407801|NCT00977197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110407802|NCT00977197|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110407803|NCT00977197|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110407804|NCT00977197|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110407805|NCT00977197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110407806|NCT00977197|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110407807|NCT04288219|Nifedipine|nifedipine|mesh-list
110407808|NCT04288219|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110407809|NCT04288219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110407810|NCT04288219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110407811|NCT04288219|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110407812|NCT04288219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110407813|NCT04288219|Vasodilator Agents|vasodilator agents|mesh-ancestor
110407814|NCT04288219|Tocolytic Agents|tocolytic agents|mesh-ancestor
110407815|NCT04288219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110407816|NCT00974233|Rituximab|rituximab|mesh-list
110407817|NCT00974233|Lenalidomide|lenalidomide|mesh-list
110560779|NCT02678117|Pregabalin|pregabalin|mesh-list
110407818|NCT00974233|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110407819|NCT00974233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110407820|NCT00974233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110407821|NCT00974233|Immunologic Factors|immunologic factors|mesh-ancestor
110407822|NCT00974233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110407823|NCT00974233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110407824|NCT00974233|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110407825|NCT00974233|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110407826|NCT00974233|Growth Substances|growth substances|mesh-ancestor
110407827|NCT00974233|Growth Inhibitors|growth inhibitors|mesh-ancestor
110407828|NCT00974233|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110407829|NCT00974233|Alkylating Agents|alkylating agents|mesh-ancestor
110407830|NCT00974233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110407831|NCT00972595|Ondansetron|ondansetron|mesh-list
110407832|NCT00972595|Antiemetics|antiemetics|mesh-ancestor
110407833|NCT00972595|Autonomic Agents|autonomic agents|mesh-ancestor
110407834|NCT00972595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110407835|NCT00972595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110407836|NCT00972595|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110407837|NCT00972595|Antipruritics|antipruritics|mesh-ancestor
110407838|NCT00972595|Dermatologic Agents|dermatologic agents|mesh-ancestor
110407839|NCT00972595|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110407840|NCT00972595|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110407841|NCT00972595|Serotonin Agents|serotonin agents|mesh-ancestor
110407842|NCT00972595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110407843|NCT00972595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110407844|NCT01196091|Antimalarials|antimalarials|mesh-list
110407845|NCT01196091|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
110407846|NCT01196091|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
110407847|NCT01196091|Immunosuppressive Agents|immunosuppressive agents|mesh-list
110407848|NCT01196091|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110407849|NCT01196091|Analgesics|analgesics|mesh-ancestor
110407850|NCT01196091|Sensory System Agents|sensory system agents|mesh-ancestor
110407851|NCT01196091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110407852|NCT01196091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110407853|NCT01196091|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110407854|NCT01196091|Immunologic Factors|immunologic factors|mesh-ancestor
110407855|NCT01196091|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110407856|NCT01196091|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110407857|NCT01196091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110407858|NCT00972283|Insulin|insulin|mesh-list
110407859|NCT00972283|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110407861|NCT00972283|Insulin Aspart|insulin aspart|mesh-list
110407862|NCT00972283|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110407863|NCT00972283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110407864|NCT05366049|Acetaminophen|acetaminophen|mesh-list
110407865|NCT05366049|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110407866|NCT05366049|Analgesics|analgesics|mesh-ancestor
110407867|NCT05366049|Sensory System Agents|sensory system agents|mesh-ancestor
110407868|NCT05366049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110407869|NCT05366049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110407870|NCT05366049|Antipyretics|antipyretics|mesh-ancestor
110407871|NCT00969709|Milnacipran|milnacipran|mesh-list
110407872|NCT00969709|Levomilnacipran|levomilnacipran|mesh-list
110407873|NCT00969709|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110407874|NCT00969709|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110407875|NCT00969709|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110407876|NCT00969709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110407877|NCT00969709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110407878|NCT00969709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110407879|NCT00969709|Antidepressive Agents|antidepressive agents|mesh-ancestor
110407880|NCT00969709|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110407881|NCT00969709|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110407882|NCT00969709|Analgesics|analgesics|mesh-ancestor
110407883|NCT00969709|Sensory System Agents|sensory system agents|mesh-ancestor
110407884|NCT00969709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110407886|NCT01193517|Azacitidine|azacitidine|mesh-list
110407887|NCT01193517|Decitabine|decitabine|mesh-list
110407888|NCT01193517|Oxaliplatin|oxaliplatin|mesh-list
110407889|NCT01193517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110407890|NCT01193517|Antimetabolites|antimetabolites|mesh-ancestor
110407891|NCT01193517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110407892|NCT01193517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110359411|NCT03677154|Immunologic Factors|immunologic factors|mesh-ancestor
110407893|NCT01193517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110407894|NCT02863705|Timolol|timolol|mesh-list
110407895|NCT02863705|Brimonidine Tartrate|brimonidine tartrate|mesh-list
110407896|NCT02863705|Bimatoprost|bimatoprost|mesh-list
110407897|NCT02863705|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110407898|NCT02863705|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110407899|NCT02863705|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110407900|NCT02863705|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110407901|NCT02863705|Adrenergic Agents|adrenergic agents|mesh-ancestor
110407902|NCT02863705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110407903|NCT02863705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110407904|NCT02863705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110407905|NCT02863705|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110407906|NCT02863705|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110407907|NCT02863705|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110407908|NCT02863705|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110407909|NCT02863705|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110407910|NCT01193283|Cyclosporine|cyclosporine|mesh-list
110407911|NCT01193283|Cyclophosphamide|cyclophosphamide|mesh-list
110407912|NCT01193283|Cyclosporins|cyclosporins|mesh-list
110407913|NCT01193283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110407914|NCT01193283|Immunologic Factors|immunologic factors|mesh-ancestor
110407915|NCT01193283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110407916|NCT01193283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110407917|NCT01193283|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110407918|NCT01193283|Alkylating Agents|alkylating agents|mesh-ancestor
110407919|NCT01193283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110407920|NCT01193283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110407921|NCT01193283|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110407922|NCT01193283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110407923|NCT01193283|Antifungal Agents|antifungal agents|mesh-ancestor
110407924|NCT01193283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110407925|NCT01193283|Dermatologic Agents|dermatologic agents|mesh-ancestor
110407926|NCT01193283|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110407928|NCT02863471|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110407929|NCT02863471|Antimetabolites|antimetabolites|mesh-ancestor
110407930|NCT02863471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110407931|NCT02863471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110407932|NCT01193127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
110407933|NCT01193127|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110407934|NCT01193127|Mydriatics|mydriatics|mesh-list
110407935|NCT01193127|Autonomic Agents|autonomic agents|mesh-ancestor
110407936|NCT01193127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110407937|NCT01193127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110407938|NCT01192815|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110407939|NCT01192815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110407940|NCT01192815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110407941|NCT01192815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110407942|NCT01192815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110407943|NCT01192191|Fluticasone|fluticasone|mesh-list
110407944|NCT01192191|Xhance|xhance|mesh-list
110407945|NCT01192191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110407946|NCT01192191|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110407947|NCT01192191|Autonomic Agents|autonomic agents|mesh-ancestor
110407948|NCT01192191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110407949|NCT01192191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110407950|NCT01192191|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110407951|NCT01192191|Respiratory System Agents|respiratory system agents|mesh-ancestor
110407952|NCT01192191|Dermatologic Agents|dermatologic agents|mesh-ancestor
110407953|NCT01192191|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110407954|NCT01307267|Rituximab|rituximab|mesh-list
110407956|NCT01307267|Immunoglobulin G|immunoglobulin g|mesh-list
110407957|NCT01307267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110407958|NCT01307267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110407959|NCT01307267|Immunologic Factors|immunologic factors|mesh-ancestor
110407960|NCT01307267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110407961|NCT01307267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110407962|NCT01307111|Misoprostol|misoprostol|mesh-list
110407963|NCT01307111|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110407964|NCT01307111|Abortifacient Agents|abortifacient agents|mesh-ancestor
110407965|NCT01307111|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110407966|NCT01307111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110359491|NCT03530683|Hormones|hormones|mesh-ancestor
110407967|NCT01307111|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110407968|NCT01307111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110407969|NCT01307111|Oxytocics|oxytocics|mesh-ancestor
110407970|NCT01191801|Cytarabine|cytarabine|mesh-list
110407971|NCT01191801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110407972|NCT01191801|Antimetabolites|antimetabolites|mesh-ancestor
110407973|NCT01191801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110407974|NCT01191801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110407975|NCT01191801|Antiviral Agents|antiviral agents|mesh-ancestor
110407976|NCT01191801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110407977|NCT01191801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110407978|NCT01191801|Immunologic Factors|immunologic factors|mesh-ancestor
110407979|NCT01191801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110407980|NCT01306643|Idelalisib|idelalisib|mesh-list
110407981|NCT01306643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110407982|NCT01306643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110407983|NCT01306643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110407984|NCT05656833|Cysteamine|cysteamine|mesh-list
110407985|NCT05656833|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
110407986|NCT05656833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110407987|NCT01306331|Nonoxynol|nonoxynol|mesh-list
110407988|NCT01306331|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
110407989|NCT01306331|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
110407990|NCT01306331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110407991|NCT01306331|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110407992|NCT01306331|Contraceptive Agents|contraceptive agents|mesh-ancestor
110407993|NCT01306331|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110407994|NCT01306331|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110407995|NCT00624663|Rivastigmine|rivastigmine|mesh-list
110407996|NCT00624663|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110407997|NCT00624663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110407998|NCT00624663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110407999|NCT00624663|Cholinergic Agents|cholinergic agents|mesh-ancestor
110408000|NCT00624663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110408001|NCT00624663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110408002|NCT00624663|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110408005|NCT02890823|Vitamin D|vitamin d|mesh-list
110408006|NCT02890823|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110408007|NCT02890823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110408008|NCT02890823|Vitamins|vitamins|mesh-ancestor
110408009|NCT02890823|Micronutrients|micronutrients|mesh-ancestor
110408010|NCT02890823|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110408011|NCT02887443|Midazolam|midazolam|mesh-list
110408012|NCT02887443|Idebenone|idebenone|mesh-list
110408013|NCT02887443|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110408014|NCT02887443|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110408015|NCT02887443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110408016|NCT02887443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110408017|NCT02887443|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110408018|NCT02887443|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110408019|NCT02887443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110408020|NCT02887443|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110408021|NCT02887443|Anesthetics, General|anesthetics, general|mesh-ancestor
110408022|NCT02887443|Anesthetics|anesthetics|mesh-ancestor
110408023|NCT02887443|GABA Modulators|gaba modulators|mesh-ancestor
110408024|NCT02887443|GABA Agents|gaba agents|mesh-ancestor
110408025|NCT02887443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110408026|NCT02887443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110408027|NCT02887443|Antioxidants|antioxidants|mesh-ancestor
110408028|NCT02887443|Protective Agents|protective agents|mesh-ancestor
110408029|NCT05359263|Dapagliflozin|dapagliflozin|mesh-list
110408030|NCT05359263|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110408031|NCT05359263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110408032|NCT05359263|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110408033|NCT05359263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110408034|NCT01305941|Trastuzumab|trastuzumab|mesh-list
110408035|NCT01305941|Everolimus|everolimus|mesh-list
110408036|NCT01305941|Vinorelbine|vinorelbine|mesh-list
110408037|NCT01305941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110408038|NCT01305941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110408039|NCT01305941|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110408040|NCT01305941|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110408041|NCT01305941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110408042|NCT01305941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110408043|NCT01305941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110408045|NCT01305941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110408046|NCT01305941|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110408047|NCT01305941|Tubulin Modulators|tubulin modulators|mesh-ancestor
110408048|NCT01305941|Antimitotic Agents|antimitotic agents|mesh-ancestor
110408049|NCT01305941|Mitosis Modulators|mitosis modulators|mesh-ancestor
110408050|NCT05658549|Acetylcysteine|acetylcysteine|mesh-list
110408051|NCT05658549|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110408052|NCT05658549|Antiviral Agents|antiviral agents|mesh-ancestor
110408053|NCT05658549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110408054|NCT05658549|Expectorants|expectorants|mesh-ancestor
110408055|NCT05658549|Respiratory System Agents|respiratory system agents|mesh-ancestor
110408056|NCT05658549|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110408057|NCT05658549|Antioxidants|antioxidants|mesh-ancestor
110408058|NCT05658549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110408059|NCT05658549|Protective Agents|protective agents|mesh-ancestor
110408060|NCT05658549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110408061|NCT05658549|Antidotes|antidotes|mesh-ancestor
110408062|NCT02887365|Tegafur|tegafur|mesh-list
110408063|NCT02887365|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110408064|NCT02887365|Antimetabolites|antimetabolites|mesh-ancestor
110408065|NCT02887365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110408066|NCT02887365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110408067|NCT05658159|Vitamin D|vitamin d|mesh-list
110408069|NCT05658159|Cholecalciferol|cholecalciferol|mesh-list
110408070|NCT05658159|Vitamins|vitamins|mesh-list
110408071|NCT05658159|Micronutrients|micronutrients|mesh-ancestor
110408072|NCT05658159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110408073|NCT05658159|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110408074|NCT05658159|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110408075|NCT01305239|Exemestane|exemestane|mesh-list
110408076|NCT01305239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110408077|NCT01305239|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110408078|NCT01305239|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110408079|NCT01305239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110408080|NCT01305239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110408081|NCT01305239|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110408082|NCT01305239|Hormone Antagonists|hormone antagonists|mesh-ancestor
110408083|NCT01305239|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110408084|NCT01305239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110408085|NCT04317183|Miconazole|miconazole|mesh-list
110408086|NCT04317183|Antifungal Agents|antifungal agents|mesh-ancestor
110408087|NCT04317183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110408088|NCT04317183|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110408089|NCT04317183|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110408090|NCT04317183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110408091|NCT04317183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110408092|NCT04317183|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110408093|NCT04317183|Hormone Antagonists|hormone antagonists|mesh-ancestor
110408094|NCT04317183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110408095|NCT04317183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110408096|NCT04317183|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110408097|NCT04317183|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110408098|NCT01194219|Apremilast|apremilast|mesh-list
110408099|NCT01194219|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110408100|NCT01194219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110408101|NCT01194219|Analgesics|analgesics|mesh-ancestor
110408102|NCT01194219|Sensory System Agents|sensory system agents|mesh-ancestor
110408103|NCT01194219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110408104|NCT01194219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110408105|NCT01194219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110408106|NCT01194219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110408107|NCT01194219|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
110408108|NCT01194219|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110408109|NCT01194219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110408110|NCT01194219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110408111|NCT01304693|Ranibizumab|ranibizumab|mesh-list
110408112|NCT01304693|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110408113|NCT01304693|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110408114|NCT01304693|Growth Substances|growth substances|mesh-ancestor
110408115|NCT01304693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110408116|NCT01304693|Growth Inhibitors|growth inhibitors|mesh-ancestor
110408117|NCT01304693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110408118|NCT01304147|Ketamine|ketamine|mesh-list
110408119|NCT01304147|Analgesics|analgesics|mesh-ancestor
110408120|NCT01304147|Sensory System Agents|sensory system agents|mesh-ancestor
110408121|NCT01304147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110408122|NCT01304147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110408123|NCT01304147|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110408124|NCT01304147|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110408125|NCT01304147|Anesthetics, General|anesthetics, general|mesh-ancestor
110408126|NCT01304147|Anesthetics|anesthetics|mesh-ancestor
110408127|NCT01304147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110408128|NCT01304147|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110408129|NCT01304147|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110408130|NCT01304147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110408131|NCT01304147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110408132|NCT05661227|Dexmedetomidine|dexmedetomidine|mesh-list
110408133|NCT05661227|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110408134|NCT05661227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110408135|NCT05661227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110408136|NCT05661227|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110408137|NCT05661227|Analgesics|analgesics|mesh-ancestor
110408138|NCT05661227|Sensory System Agents|sensory system agents|mesh-ancestor
110408139|NCT05661227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110408140|NCT05661227|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110408141|NCT05661227|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110408142|NCT05661227|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110408143|NCT05661227|Adrenergic Agents|adrenergic agents|mesh-ancestor
110408144|NCT05661227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110408145|NCT05661227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110408146|NCT01303445|Omeprazole|omeprazole|mesh-list
110408147|NCT01303445|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
110408148|NCT01303445|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110408149|NCT01303445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110408150|NCT01303445|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110408151|NCT01303445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110408152|NCT01303445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110408153|NCT01303445|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110408154|NCT01188681|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110408155|NCT01188681|Immunoglobulin G|immunoglobulin g|mesh-list
110408156|NCT01188681|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110408157|NCT01188681|Alkylating Agents|alkylating agents|mesh-ancestor
110408158|NCT01188681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110408159|NCT01188681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110408160|NCT01188681|Immunologic Factors|immunologic factors|mesh-ancestor
110408161|NCT01188681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110408162|NCT01302899|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110408163|NCT01302899|Ramipril|ramipril|mesh-list
110408164|NCT01302899|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110408165|NCT01302899|Diuretics|diuretics|mesh-ancestor
110408166|NCT01302899|Natriuretic Agents|natriuretic agents|mesh-ancestor
110408167|NCT01302899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110408168|NCT01302899|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110408169|NCT01302899|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110408170|NCT01302899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110408171|NCT01302899|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110408172|NCT01302899|Protease Inhibitors|protease inhibitors|mesh-ancestor
110408173|NCT01302899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110408174|NCT01187901|Sulindac|sulindac|mesh-list
110408175|NCT01187901|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110408176|NCT01187901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110183421|NCT00029523|Antiviral Agents|antiviral agents|mesh-ancestor
110408177|NCT01187901|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110408178|NCT01187901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110408179|NCT01187901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110408180|NCT01187901|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110408181|NCT01187901|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110408182|NCT01187901|Analgesics|analgesics|mesh-ancestor
110408183|NCT01187901|Sensory System Agents|sensory system agents|mesh-ancestor
110560954|NCT02676011|Atropine|atropine|mesh-list
110408184|NCT01187901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110408185|NCT01187901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110408186|NCT01187901|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110408187|NCT01187901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110359707|NCT02385110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110408188|NCT01187901|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110408189|NCT01302119|Tavaborole|tavaborole|mesh-list
110408190|NCT01302119|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110408191|NCT01302119|Antifungal Agents|antifungal agents|mesh-ancestor
110408192|NCT01302119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110408193|NCT05927922|Ibuprofen|ibuprofen|mesh-list
110408194|NCT05927922|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110408195|NCT05927922|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110408196|NCT05927922|Analgesics|analgesics|mesh-ancestor
110408197|NCT05927922|Sensory System Agents|sensory system agents|mesh-ancestor
110408198|NCT05927922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110408199|NCT05927922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110408200|NCT05927922|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110408201|NCT05927922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110408202|NCT05927922|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110408203|NCT05927922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110408204|NCT05927922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110408205|NCT05927857|Trifluridine|trifluridine|mesh-list
110408206|NCT05927857|Ramucirumab|ramucirumab|mesh-list
110408207|NCT05927857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110408208|NCT05927857|Antimetabolites|antimetabolites|mesh-ancestor
110408209|NCT05927857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110408210|NCT05927857|Antiviral Agents|antiviral agents|mesh-ancestor
110408211|NCT05927857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110408212|NCT05927831|Grape Seed Extract|grape seed extract|mesh-list
110408213|NCT05927831|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110408214|NCT05927831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110408215|NCT05927831|Antioxidants|antioxidants|mesh-ancestor
110408216|NCT05927831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110408217|NCT05927831|Protective Agents|protective agents|mesh-ancestor
110408218|NCT05927831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110408219|NCT05927818|Charcoal|charcoal|mesh-list
110408220|NCT05927818|Antidotes|antidotes|mesh-ancestor
110408221|NCT05927818|Protective Agents|protective agents|mesh-ancestor
110408222|NCT05927818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110408223|NCT05927428|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110408224|NCT05927428|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110408225|NCT05927259|Acetylcysteine|acetylcysteine|mesh-list
110408226|NCT05927259|Atropine|atropine|mesh-list
110408227|NCT05927259|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110408228|NCT05927259|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110408229|NCT05927259|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110408230|NCT05927259|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110408231|NCT05927259|Autonomic Agents|autonomic agents|mesh-ancestor
110408232|NCT05927259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110408233|NCT05927259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110408234|NCT05927259|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110408235|NCT05927259|Respiratory System Agents|respiratory system agents|mesh-ancestor
110408236|NCT05927259|Mydriatics|mydriatics|mesh-ancestor
110408237|NCT05927259|Parasympatholytics|parasympatholytics|mesh-ancestor
110408238|NCT05927259|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110408239|NCT05927259|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110408240|NCT05927259|Cholinergic Agents|cholinergic agents|mesh-ancestor
110408241|NCT05927259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110560968|NCT02676011|Cholinergic Agents|cholinergic agents|mesh-ancestor
110408242|NCT05927259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110408243|NCT05927259|Antiviral Agents|antiviral agents|mesh-ancestor
110408244|NCT05927259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110408245|NCT05927259|Expectorants|expectorants|mesh-ancestor
110408246|NCT05927259|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110408247|NCT05927259|Antioxidants|antioxidants|mesh-ancestor
110408248|NCT05927259|Protective Agents|protective agents|mesh-ancestor
110408249|NCT05927259|Antidotes|antidotes|mesh-ancestor
110408250|NCT05927155|Tiotropium Bromide|tiotropium bromide|mesh-list
110408251|NCT05927155|Olodaterol|olodaterol|mesh-list
110408252|NCT05927155|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110408253|NCT05927155|Autonomic Agents|autonomic agents|mesh-ancestor
110408254|NCT05927155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110408255|NCT05927155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110408256|NCT05927155|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110408257|NCT05927155|Respiratory System Agents|respiratory system agents|mesh-ancestor
110408258|NCT05927155|Parasympatholytics|parasympatholytics|mesh-ancestor
110408259|NCT05927155|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110408260|NCT05927155|Cholinergic Agents|cholinergic agents|mesh-ancestor
110408261|NCT05927155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110359788|NCT01789879|Contraceptive Agents|contraceptive agents|mesh-ancestor
110408262|NCT05927155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110408263|NCT05927129|Antidepressive Agents|antidepressive agents|mesh-list
110408264|NCT05927129|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110408265|NCT05926895|Betamethasone|betamethasone|mesh-list
110408266|NCT05926895|Betamethasone Valerate|betamethasone valerate|mesh-list
110408267|NCT05926895|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
110408268|NCT05926895|Betamethasone benzoate|betamethasone benzoate|mesh-list
110408269|NCT05926895|Betamethasone dipropionate, betamethasone sodium phosphate drug combination|betamethasone dipropionate, betamethasone sodium phosphate drug combination|mesh-list
110408270|NCT05926895|Prilocaine|prilocaine|mesh-list
110408271|NCT05926895|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
110408272|NCT05926895|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110408273|NCT05926895|Glucocorticoids|glucocorticoids|mesh-ancestor
110408275|NCT05926895|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110408276|NCT05926895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110408277|NCT05926895|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110408278|NCT05926895|Respiratory System Agents|respiratory system agents|mesh-ancestor
110408279|NCT05926895|Anesthetics, Local|anesthetics, local|mesh-ancestor
110408280|NCT05926895|Anesthetics|anesthetics|mesh-ancestor
110313036|NCT04718714|Propofol|propofol|mesh-list
110560984|NCT02678975|Copper|copper|mesh-list
110408281|NCT05926895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110313100|NCT00298415|Antimetabolites|antimetabolites|mesh-ancestor
110408282|NCT05926895|Sensory System Agents|sensory system agents|mesh-ancestor
110408283|NCT05926895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110408284|NCT05926882|Apremilast|apremilast|mesh-list
110408285|NCT05926882|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110408286|NCT05926882|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110408287|NCT05926882|Analgesics|analgesics|mesh-ancestor
110408288|NCT05926882|Sensory System Agents|sensory system agents|mesh-ancestor
110408289|NCT05926882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110313234|NCT00300131|Everolimus|everolimus|mesh-list
110408290|NCT05926882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110408291|NCT05926882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110408292|NCT05926882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110408293|NCT05926882|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
110313461|NCT00301730|Aldesleukin|aldesleukin|mesh-list
110408294|NCT05926882|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110408295|NCT05926882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110408296|NCT05926882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110313604|NCT00328380|Rifaximin|rifaximin|mesh-list
110408297|NCT05926869|Clindamycin|clindamycin|mesh-list
110408298|NCT05926869|Clindamycin palmitate|clindamycin palmitate|mesh-list
110408299|NCT05926869|Clindamycin phosphate|clindamycin phosphate|mesh-list
110408301|NCT05926869|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110408302|NCT05926869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110313897|NCT00328965|Lacidipine|lacidipine|mesh-list
110408303|NCT05926869|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110408304|NCT05926869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110314032|NCT00304811|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110408305|NCT05926869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110408307|NCT05926869|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110408308|NCT05926869|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110408309|NCT05926869|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110314631|NCT00333996|Hormones|hormones|mesh-ancestor
110314715|NCT00334464|Warfarin|warfarin|mesh-list
110408310|NCT05926869|Leprostatic Agents|leprostatic agents|mesh-ancestor
110408311|NCT05926804|Amoxicillin|amoxicillin|mesh-list
110408312|NCT05926804|Metronidazole|metronidazole|mesh-list
110314989|NCT00336375|Lumefantrine|lumefantrine|mesh-list
110408314|NCT05926804|Lansoprazole|lansoprazole|mesh-list
110408315|NCT05926804|Dexlansoprazole|dexlansoprazole|mesh-list
110408316|NCT05926804|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110408317|NCT05926804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110408318|NCT05926804|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110408319|NCT05926804|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110408320|NCT05926804|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110408321|NCT05926804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110408322|NCT05926804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110408323|NCT05926804|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110408324|NCT05926804|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110315216|NCT00306878|Abatacept|abatacept|mesh-list
110408325|NCT05926804|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110408326|NCT05926804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110408327|NCT05926804|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110408328|NCT05926466|Moxifloxacin|moxifloxacin|mesh-list
110408329|NCT05926466|Bedaquiline|bedaquiline|mesh-list
110315426|NCT00308360|Valproic Acid|valproic acid|mesh-list
110408330|NCT05926466|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110315513|NCT00309218|Hormones|hormones|mesh-ancestor
110408331|NCT05926466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110408332|NCT05926466|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110408333|NCT05926466|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110408334|NCT05926466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110315646|NCT00309881|Cyclophosphamide|cyclophosphamide|mesh-list
110408335|NCT05926466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110408336|NCT05926466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110408337|NCT05926466|Antitubercular Agents|antitubercular agents|mesh-ancestor
110408338|NCT05926271|Clopidogrel|clopidogrel|mesh-list
110315939|NCT00339417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110408339|NCT05926271|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110408340|NCT05926271|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110316109|NCT00343161|Antacids|antacids|mesh-ancestor
110408341|NCT05926271|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110408342|NCT05926271|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110408343|NCT05926271|Purinergic Agents|purinergic agents|mesh-ancestor
110408344|NCT05926271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110408345|NCT05926271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110408346|NCT05926271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110408347|NCT05926258|Chloroprocaine|chloroprocaine|mesh-list
110408348|NCT05926258|Benoxinate|benoxinate|mesh-list
110408349|NCT05926258|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110408350|NCT05926258|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110408351|NCT05926258|Anesthetics, Local|anesthetics, local|mesh-ancestor
110408352|NCT05926258|Anesthetics|anesthetics|mesh-ancestor
110408353|NCT05926258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110408354|NCT05926258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110408355|NCT05926258|Sensory System Agents|sensory system agents|mesh-ancestor
110408356|NCT05926258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110408357|NCT05926245|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110408358|NCT05926206|Folfirinox|folfirinox|mesh-list
110408359|NCT05926206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110408360|NCT05926128|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
110408361|NCT05926128|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110408362|NCT05926128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110408363|NCT05926128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110408365|NCT05924152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110408366|NCT05922176|Immunomodulating Agents|immunomodulating agents|mesh-list
110408367|NCT05922176|Immunologic Factors|immunologic factors|mesh-list
110408368|NCT05922176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110408370|NCT05920798|Vaccines|vaccines|mesh-list
110408371|NCT05920798|Immunologic Factors|immunologic factors|mesh-ancestor
110408372|NCT05920798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110408373|NCT05920798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110408374|NCT05920798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110408375|NCT05920798|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110408376|NCT05920798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110408377|NCT05914467|Teicoplanin|teicoplanin|mesh-list
110408378|NCT05914467|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110408379|NCT05914467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110408380|NCT05880862|Mirabegron|mirabegron|mesh-list
110408381|NCT05880862|Trospium chloride|trospium chloride|mesh-list
110408382|NCT05880862|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
110408383|NCT05880862|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110408384|NCT05880862|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110408385|NCT05880862|Adrenergic Agents|adrenergic agents|mesh-ancestor
110316812|NCT00349401|Ketorolac|ketorolac|mesh-list
110408386|NCT05880862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110408387|NCT05880862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110408388|NCT05880862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110408389|NCT05880862|Urological Agents|urological agents|mesh-ancestor
110317106|NCT00350181|Sirolimus|sirolimus|mesh-list
110408390|NCT05880862|Parasympatholytics|parasympatholytics|mesh-ancestor
110408392|NCT05880862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110317331|NCT00318773|Serotonin Agents|serotonin agents|mesh-ancestor
110408393|NCT05880862|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110317402|NCT00421512|Bevacizumab|bevacizumab|mesh-list
110408394|NCT05880862|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110408395|NCT05880862|Cholinergic Agents|cholinergic agents|mesh-ancestor
110408396|NCT05876182|Vancomycin|vancomycin|mesh-list
110408397|NCT05876182|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110408398|NCT05876182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110408399|NCT05798481|Acetylcysteine|acetylcysteine|mesh-list
110408400|NCT05798481|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110408401|NCT05798481|Antiviral Agents|antiviral agents|mesh-ancestor
110408402|NCT05798481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110408403|NCT05798481|Expectorants|expectorants|mesh-ancestor
110408404|NCT05798481|Respiratory System Agents|respiratory system agents|mesh-ancestor
110408405|NCT05798481|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110408406|NCT05798481|Antioxidants|antioxidants|mesh-ancestor
110408407|NCT05798481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110408408|NCT05798481|Protective Agents|protective agents|mesh-ancestor
110408409|NCT05798481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110408410|NCT05798481|Antidotes|antidotes|mesh-ancestor
110408411|NCT05736341|Midazolam|midazolam|mesh-list
110408412|NCT05736341|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110359936|NCT04648358|Anesthetics|anesthetics|mesh-ancestor
110408413|NCT05736341|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110408414|NCT05736341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110318059|NCT00331851|Metformin|metformin|mesh-list
110318120|NCT00324389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110408415|NCT05736341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110408416|NCT05736341|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110408417|NCT05736341|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110408418|NCT05736341|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110408419|NCT05736341|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110408420|NCT05736341|Anesthetics, General|anesthetics, general|mesh-ancestor
110408422|NCT05736341|GABA Modulators|gaba modulators|mesh-ancestor
110408423|NCT05736341|GABA Agents|gaba agents|mesh-ancestor
110408424|NCT05736341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110408425|NCT05736341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110408426|NCT05691010|Paclitaxel|paclitaxel|mesh-list
110408427|NCT05691010|Carboplatin|carboplatin|mesh-list
110408428|NCT05691010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110408429|NCT05691010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110318565|NCT00426777|Etidronic Acid|etidronic acid|mesh-list
110408430|NCT05691010|Tubulin Modulators|tubulin modulators|mesh-ancestor
110408431|NCT05691010|Antimitotic Agents|antimitotic agents|mesh-ancestor
110408432|NCT05691010|Mitosis Modulators|mitosis modulators|mesh-ancestor
110318779|NCT00425997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110408433|NCT05691010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110408434|NCT05690984|Dexamethasone|dexamethasone|mesh-list
110408435|NCT05690984|Lenalidomide|lenalidomide|mesh-list
110408436|NCT05690984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110408437|NCT05690984|Antiemetics|antiemetics|mesh-ancestor
110408438|NCT05690984|Autonomic Agents|autonomic agents|mesh-ancestor
110408439|NCT05690984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110408440|NCT05690984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110408441|NCT05690984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110408442|NCT05690984|Glucocorticoids|glucocorticoids|mesh-ancestor
110408443|NCT05690984|Hormones|hormones|mesh-ancestor
110319221|NCT00428883|Acetylcysteine|acetylcysteine|mesh-list
110560270|NCT00494299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110408444|NCT05690984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110408445|NCT05690984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110408446|NCT05690984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110408447|NCT05690984|Immunologic Factors|immunologic factors|mesh-ancestor
110408448|NCT05690984|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110560271|NCT05298176|Carboplatin|carboplatin|mesh-list
110408449|NCT05690984|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110408450|NCT05690984|Growth Substances|growth substances|mesh-ancestor
110408451|NCT05690984|Growth Inhibitors|growth inhibitors|mesh-ancestor
110408453|NCT05688332|Glyburide|glyburide|mesh-list
110408454|NCT05688332|Voglibose|voglibose|mesh-list
110408455|NCT05688332|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110408456|NCT05688332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110320027|NCT00331955|Doxorubicin|doxorubicin|mesh-list
110560272|NCT05298176|Pemetrexed|pemetrexed|mesh-list
110408457|NCT05688332|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
110408458|NCT05688332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110560273|NCT05298176|Osimertinib|osimertinib|mesh-list
110408459|NCT05688332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110408460|NCT05642962|Pancrelipase|pancrelipase|mesh-list
110560274|NCT05298176|Afatinib|afatinib|mesh-list
110408461|NCT05642962|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110408462|NCT05641142|Anticoagulants|anticoagulants|mesh-list
110408463|NCT05605509|Gemcitabine|gemcitabine|mesh-list
110408464|NCT05605509|Trastuzumab|trastuzumab|mesh-list
110408465|NCT05605509|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110408466|NCT05605509|Antimetabolites|antimetabolites|mesh-ancestor
110183478|NCT00030030|Protective Agents|protective agents|mesh-ancestor
110408467|NCT05605509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110408468|NCT05605509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110408469|NCT05605509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110408471|NCT05597735|Antiviral Agents|antiviral agents|mesh-ancestor
110408472|NCT05597735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110408473|NCT05589363|Bupivacaine|bupivacaine|mesh-list
110408474|NCT05589363|Anesthetics, Local|anesthetics, local|mesh-ancestor
110408475|NCT05589363|Anesthetics|anesthetics|mesh-ancestor
110408476|NCT05589363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110408477|NCT05589363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110408478|NCT05589363|Sensory System Agents|sensory system agents|mesh-ancestor
110320593|NCT00334685|Pregabalin|pregabalin|mesh-list
110408479|NCT05589363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110408480|NCT05554133|Proflavine|proflavine|mesh-list
110408481|NCT05554133|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110408482|NCT05554133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110408483|NCT05488431|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
110408484|NCT05488431|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110360009|NCT04647773|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110408485|NCT05488431|Antimetabolites|antimetabolites|mesh-ancestor
110408486|NCT05488431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110408487|NCT05488431|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110408488|NCT05488431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110408489|NCT05488431|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110408490|NCT05488431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110321547|NCT00452322|Anabolic Agents|anabolic agents|mesh-ancestor
110408492|NCT05435235|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110408493|NCT05435235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110408494|NCT05435235|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110408495|NCT05435235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110408496|NCT05394337|Atezolizumab|atezolizumab|mesh-list
110321699|NCT00446862|Losartan|losartan|mesh-list
110321764|NCT00343187|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110408497|NCT05394337|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110321914|NCT00344123|Tipranavir|tipranavir|mesh-list
110560275|NCT05298176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110408498|NCT05394337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110408499|NCT05394337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110408500|NCT05394337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110322510|NCT00347828|Moxifloxacin|moxifloxacin|mesh-list
110322579|NCT00455832|Ribavirin|ribavirin|mesh-list
110560276|NCT05298176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110322789|NCT00449514|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110560277|NCT05298176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110323158|NCT00450762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110408522|NCT05382208|Doxycycline|doxycycline|mesh-list
110408523|NCT05382208|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110408524|NCT05382208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110408525|NCT05382208|Antimalarials|antimalarials|mesh-ancestor
110408526|NCT05382208|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110408527|NCT05382208|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110408529|NCT05356936|Cholecalciferol|cholecalciferol|mesh-list
110408530|NCT05356936|Vitamins|vitamins|mesh-list
110408531|NCT05356936|Vitamin K|vitamin k|mesh-list
110408532|NCT05356936|Vitamin K 2|vitamin k 2|mesh-list
110408533|NCT05356936|Micronutrients|micronutrients|mesh-ancestor
110408534|NCT05356936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110408535|NCT05356936|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110408536|NCT05356936|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110408537|NCT05356936|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110323514|NCT00354419|Cyclosporine|cyclosporine|mesh-list
110408538|NCT05356936|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110560278|NCT05298176|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110408539|NCT05356936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110408540|NCT05356936|Hemostatics|hemostatics|mesh-ancestor
110408541|NCT05356936|Coagulants|coagulants|mesh-ancestor
110408542|NCT05354453|Phenethyl isothiocyanate|phenethyl isothiocyanate|mesh-list
110408543|NCT05354453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110560279|NCT05298176|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110560280|NCT05298176|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110408544|NCT05354453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110408545|NCT05354453|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110408546|NCT05354453|Protective Agents|protective agents|mesh-ancestor
110408547|NCT05354453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110408548|NCT05354453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110408549|NCT05111353|Poly ICLC|poly iclc|mesh-list
110408550|NCT05111353|Interferon Inducers|interferon inducers|mesh-ancestor
110408551|NCT05111353|Immunologic Factors|immunologic factors|mesh-ancestor
110408552|NCT05111353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110408553|NCT05053087|Ropivacaine|ropivacaine|mesh-list
110324035|NCT00427583|Imatinib Mesylate|imatinib mesylate|mesh-list
110408554|NCT05053087|Anesthetics, Local|anesthetics, local|mesh-ancestor
110560281|NCT02615288|Vitamin D|vitamin d|mesh-list
110408556|NCT05053087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110408557|NCT05053087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110324180|NCT00460707|Antiemetics|antiemetics|mesh-ancestor
110408558|NCT05053087|Sensory System Agents|sensory system agents|mesh-ancestor
110408559|NCT05053087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110408560|NCT05050942|Octreotide|octreotide|mesh-list
110408561|NCT05050942|Lanreotide|lanreotide|mesh-list
110324401|NCT00430235|Sorafenib|sorafenib|mesh-list
110408562|NCT05050942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110408563|NCT05050942|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110560283|NCT02615288|Vitamins|vitamins|mesh-ancestor
110408564|NCT05050942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110560284|NCT02615288|Micronutrients|micronutrients|mesh-ancestor
110408566|NCT05038982|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110408567|NCT05038982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110408568|NCT05038982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110408570|NCT04983966|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110408571|NCT04983966|Anesthetics, General|anesthetics, general|mesh-ancestor
110408572|NCT04983966|Anesthetics|anesthetics|mesh-ancestor
110324976|NCT04446793|Bevacizumab|bevacizumab|mesh-list
110325084|NCT00463983|Octreotide|octreotide|mesh-list
110408573|NCT04983966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110408574|NCT04983966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110408575|NCT04972942|Daratumumab|daratumumab|mesh-list
110408576|NCT04972942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110408577|NCT04953897|Decitabine|decitabine|mesh-list
110408578|NCT04953897|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
110408579|NCT04953897|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110408580|NCT04953897|Antimetabolites|antimetabolites|mesh-ancestor
110408581|NCT04953897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110408582|NCT04953897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110408583|NCT04953897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110408584|NCT04931017|Metformin|metformin|mesh-list
110408585|NCT04931017|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110408586|NCT04931017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110408587|NCT04917406|Dexamethasone|dexamethasone|mesh-list
110408588|NCT04917406|Lidocaine|lidocaine|mesh-list
110408589|NCT04917406|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110408590|NCT04917406|Antiemetics|antiemetics|mesh-ancestor
110408591|NCT04917406|Autonomic Agents|autonomic agents|mesh-ancestor
110408592|NCT04917406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110408593|NCT04917406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110408594|NCT04917406|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110408595|NCT04917406|Glucocorticoids|glucocorticoids|mesh-ancestor
110408596|NCT04917406|Hormones|hormones|mesh-ancestor
110408597|NCT04917406|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110408598|NCT04917406|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110408599|NCT04917406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110408600|NCT04917406|Anesthetics, Local|anesthetics, local|mesh-ancestor
110408601|NCT04917406|Anesthetics|anesthetics|mesh-ancestor
110408602|NCT04917406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110325165|NCT00472368|Panobinostat|panobinostat|mesh-list
110408603|NCT04917406|Sensory System Agents|sensory system agents|mesh-ancestor
110325241|NCT04702490|Empagliflozin|empagliflozin|mesh-list
110408604|NCT04917406|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110325307|NCT01050062|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110408605|NCT04917406|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110408606|NCT04917406|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110408607|NCT04917406|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110325526|NCT03272412|Progestins|progestins|mesh-ancestor
110408608|NCT04917406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110325619|NCT04697745|Hormones|hormones|mesh-ancestor
110408609|NCT04867785|Dulaglutide|dulaglutide|mesh-list
110325691|NCT00436943|Bupropion|bupropion|mesh-list
110408610|NCT04867785|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110325749|NCT00482079|Incretins|incretins|mesh-ancestor
110325896|NCT04701320|Methamphetamine|methamphetamine|mesh-list
110408621|NCT04761302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
110408622|NCT04706507|Ganciclovir|ganciclovir|mesh-list
110408623|NCT04706507|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
110408624|NCT04706507|Antiviral Agents|antiviral agents|mesh-ancestor
110408625|NCT04706507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110408626|NCT04706507|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110408627|NCT04706507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110408628|NCT04706507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110408629|NCT04691375|Pembrolizumab|pembrolizumab|mesh-list
110408630|NCT04691375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110408631|NCT04691375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110408632|NCT04691375|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110408633|NCT04691375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110408634|NCT04666038|Rituximab|rituximab|mesh-list
110408635|NCT04666038|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110408636|NCT04666038|Idelalisib|idelalisib|mesh-list
110408637|NCT04666038|Pirtobrutinib|pirtobrutinib|mesh-list
110360156|NCT02906514|Plasma Substitutes|plasma substitutes|mesh-ancestor
110408638|NCT04666038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110408639|NCT04666038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110408641|NCT04666038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110408642|NCT04666038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110408643|NCT04666038|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110408644|NCT04666038|Alkylating Agents|alkylating agents|mesh-ancestor
110408645|NCT04666038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110326046|NCT00475293|Panitumumab|panitumumab|mesh-list
110408647|NCT04666038|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110408648|NCT04630158|Lubricant Eye Drops|lubricant eye drops|mesh-list
110408649|NCT04630158|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110408650|NCT04630158|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110408651|NCT04617535|Casirivimab and imdevimab drug combination|casirivimab and imdevimab drug combination|mesh-list
110408652|NCT04617535|Antiviral Agents|antiviral agents|mesh-ancestor
110408653|NCT04617535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110326297|NCT00476424|Efavirenz|efavirenz|mesh-list
110408659|NCT04592913|Durvalumab|durvalumab|mesh-list
110408660|NCT04592913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110326521|NCT00440843|Serotonin Agents|serotonin agents|mesh-ancestor
110408661|NCT04592913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110408662|NCT04511039|Trifluridine|trifluridine|mesh-list
110326724|NCT00442052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110326873|NCT00478374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110560285|NCT02615288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110408664|NCT04511039|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110408665|NCT04511039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110327098|NCT00478959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110408666|NCT04511039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110408667|NCT04511039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110408668|NCT04511039|Antimetabolites|antimetabolites|mesh-ancestor
110408669|NCT04511039|Antiviral Agents|antiviral agents|mesh-ancestor
110408670|NCT04511039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110408671|NCT04466917|Paclitaxel|paclitaxel|mesh-list
110408672|NCT04466917|Bevacizumab|bevacizumab|mesh-list
110408673|NCT04466917|Carboplatin|carboplatin|mesh-list
110408674|NCT04466917|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110408675|NCT04466917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110408676|NCT04466917|Tubulin Modulators|tubulin modulators|mesh-ancestor
110408677|NCT04466917|Antimitotic Agents|antimitotic agents|mesh-ancestor
110408678|NCT04466917|Mitosis Modulators|mitosis modulators|mesh-ancestor
110408679|NCT04466917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110408680|NCT04466917|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110408681|NCT04466917|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110408682|NCT04466917|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110408683|NCT04466917|Growth Substances|growth substances|mesh-ancestor
110408684|NCT04466917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110408685|NCT04466917|Growth Inhibitors|growth inhibitors|mesh-ancestor
110408686|NCT04462471|Vemurafenib|vemurafenib|mesh-list
110408687|NCT04462471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110408688|NCT04462471|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110408689|NCT04462471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110408690|NCT04462471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110408691|NCT04370483|Leflunomide|leflunomide|mesh-list
110408692|NCT04370483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110408693|NCT04370483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110408694|NCT04370483|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110408695|NCT04370483|Immunologic Factors|immunologic factors|mesh-ancestor
110408696|NCT04370483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110408697|NCT04339777|Mycophenolic Acid|mycophenolic acid|mesh-list
110408698|NCT04339777|Cyclophosphamide|cyclophosphamide|mesh-list
110408699|NCT04339777|Busulfan|busulfan|mesh-list
110408700|NCT04339777|Fludarabine|fludarabine|mesh-list
110408701|NCT04339777|Alemtuzumab|alemtuzumab|mesh-list
110408702|NCT04339777|Tacrolimus|tacrolimus|mesh-list
110408703|NCT04339777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110408704|NCT04339777|Immunologic Factors|immunologic factors|mesh-ancestor
110408705|NCT04339777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110408706|NCT04339777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110408707|NCT04339777|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110408708|NCT04339777|Alkylating Agents|alkylating agents|mesh-ancestor
110408709|NCT04339777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110408710|NCT04339777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110408711|NCT04339777|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110408712|NCT04339777|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110408713|NCT04339777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110408714|NCT04339777|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110408715|NCT04339777|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110408716|NCT04339777|Antitubercular Agents|antitubercular agents|mesh-ancestor
110408717|NCT04339777|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110408718|NCT04339777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110408719|NCT04339777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110408720|NCT04337970|Axitinib|axitinib|mesh-list
110408721|NCT04337970|Talazoparib|talazoparib|mesh-list
110408722|NCT04337970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110408723|NCT04337970|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110408724|NCT04337970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110408725|NCT04337970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110408726|NCT04337970|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110408727|NCT04297254|Lenvatinib|lenvatinib|mesh-list
110408728|NCT04297254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110408729|NCT04297254|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110408730|NCT04297254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110327826|NCT00457106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110408731|NCT04297254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110408733|NCT04283656|Lamivudine|lamivudine|mesh-list
110408734|NCT04283656|Spironolactone|spironolactone|mesh-list
110408735|NCT04283656|Estradiol|estradiol|mesh-list
110408736|NCT04283656|Antiviral Agents|antiviral agents|mesh-ancestor
110408737|NCT04283656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110408738|NCT04283656|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110408740|NCT04283656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110408741|NCT04283656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110408742|NCT04283656|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110408743|NCT04283656|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110408745|NCT04283656|Hormones|hormones|mesh-ancestor
110408746|NCT04283656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110408747|NCT04283656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110408748|NCT04283656|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110408749|NCT04283656|Hormone Antagonists|hormone antagonists|mesh-ancestor
110408750|NCT04283656|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110408751|NCT04283656|Diuretics|diuretics|mesh-ancestor
110408752|NCT04283656|Natriuretic Agents|natriuretic agents|mesh-ancestor
110408753|NCT04268277|Rituximab|rituximab|mesh-list
110408754|NCT04268277|Pembrolizumab|pembrolizumab|mesh-list
110408755|NCT04268277|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110408756|NCT04268277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110408757|NCT04268277|Immunologic Factors|immunologic factors|mesh-ancestor
110408758|NCT04268277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110408759|NCT04268277|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110408760|NCT04268277|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110408761|NCT04268277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110408762|NCT04238624|Trametinib|trametinib|mesh-list
110408763|NCT04238624|Dabrafenib|dabrafenib|mesh-list
110408764|NCT04238624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110408765|NCT04238624|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110408766|NCT04238624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110408767|NCT04238624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110408768|NCT04207931|Fluocinonide|fluocinonide|mesh-list
110408769|NCT04207931|Triamcinolone|triamcinolone|mesh-list
110408770|NCT04207931|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110408771|NCT04207931|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110408772|NCT04207931|Betamethasone|betamethasone|mesh-list
110408773|NCT04207931|Betamethasone Valerate|betamethasone valerate|mesh-list
110408774|NCT04207931|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
110408775|NCT04207931|Betamethasone benzoate|betamethasone benzoate|mesh-list
110408776|NCT04207931|Clobetasol|clobetasol|mesh-list
110408777|NCT04207931|Minoxidil|minoxidil|mesh-list
110408778|NCT04207931|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
110408779|NCT04207931|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110408780|NCT04207931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110408781|NCT04207931|Glucocorticoids|glucocorticoids|mesh-ancestor
110408782|NCT04207931|Hormones|hormones|mesh-ancestor
110408783|NCT04207931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110408784|NCT04207931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110408785|NCT04207931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110360312|NCT02905305|Hormones|hormones|mesh-ancestor
110408786|NCT04207931|Immunologic Factors|immunologic factors|mesh-ancestor
110408787|NCT04207931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110408788|NCT04207931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110408789|NCT04207931|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110408790|NCT04207931|Respiratory System Agents|respiratory system agents|mesh-ancestor
110408791|NCT04207931|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110408792|NCT04207931|Vasodilator Agents|vasodilator agents|mesh-ancestor
110408793|NCT04207931|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110408794|NCT04161755|Atezolizumab|atezolizumab|mesh-list
110408795|NCT04161755|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110408796|NCT04161755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110408797|NCT04161755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110408798|NCT04161755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110408799|NCT04153136|Valsartan|valsartan|mesh-list
110408800|NCT04153136|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
110408801|NCT04153136|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110408802|NCT04153136|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110408803|NCT04153136|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110408804|NCT04153136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110408805|NCT04128072|Mogamulizumab|mogamulizumab|mesh-list
110408806|NCT04128072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110408807|NCT04106414|Nivolumab|nivolumab|mesh-list
110408808|NCT04106414|Linrodostat|linrodostat|mesh-list
110408809|NCT04106414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110408810|NCT04106414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110408811|NCT04106414|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110408812|NCT04106414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110408813|NCT04106414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110408814|NCT04063267|Nicotine|nicotine|mesh-list
110408815|NCT04063267|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110408816|NCT04063267|Autonomic Agents|autonomic agents|mesh-ancestor
110408817|NCT04063267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110408818|NCT04063267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110408819|NCT04063267|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110408820|NCT04063267|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110408821|NCT04063267|Cholinergic Agents|cholinergic agents|mesh-ancestor
110408822|NCT04063267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110408823|NCT04063267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110408824|NCT04047914|Anti-Infective Agents|anti-infective agents|mesh-list
110408825|NCT04047914|Mupirocin|mupirocin|mesh-list
110408826|NCT04047914|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110408827|NCT04047914|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110408828|NCT04047914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110408829|NCT04047914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110408830|NCT04042753|Nivolumab|nivolumab|mesh-list
110408831|NCT04042753|Ipilimumab|ipilimumab|mesh-list
110408832|NCT04042753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110408833|NCT04042753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110408834|NCT04042753|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110408835|NCT04042753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110408836|NCT03999710|Durvalumab|durvalumab|mesh-list
110408837|NCT03999710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110408838|NCT03999710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110408839|NCT03995355|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110408840|NCT03995355|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110408841|NCT03945591|Cyclophosphamide|cyclophosphamide|mesh-list
110408842|NCT03945591|Bortezomib|bortezomib|mesh-list
110408843|NCT03945591|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110408844|NCT03945591|Immunologic Factors|immunologic factors|mesh-ancestor
110408845|NCT03945591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110408846|NCT03945591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110408847|NCT03945591|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110408848|NCT03945591|Alkylating Agents|alkylating agents|mesh-ancestor
110408849|NCT03945591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110408850|NCT03945591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110408851|NCT03945591|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110408852|NCT03942211|Selexipag|selexipag|mesh-list
110408853|NCT03942211|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110408854|NCT03933397|Morphine|morphine|mesh-list
110408855|NCT03933397|Hydromorphone|hydromorphone|mesh-list
110408857|NCT03933397|Narcotics|narcotics|mesh-ancestor
110408858|NCT03933397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110408859|NCT03933397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110408860|NCT03933397|Analgesics|analgesics|mesh-ancestor
110408861|NCT03933397|Sensory System Agents|sensory system agents|mesh-ancestor
110561166|NCT02675387|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110408862|NCT03933397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110408863|NCT03925090|Cisplatin|cisplatin|mesh-list
110408864|NCT03925090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110408865|NCT03919266|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110408866|NCT03919266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110408867|NCT03829436|Nivolumab|nivolumab|mesh-list
110408868|NCT03829436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110408869|NCT03829436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110408870|NCT03829436|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110408871|NCT03829436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110408872|NCT03790488|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
110408873|NCT03790488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110408874|NCT03790488|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110408875|NCT03790488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110408876|NCT03775486|Paclitaxel|paclitaxel|mesh-list
110408877|NCT03775486|Cisplatin|cisplatin|mesh-list
110408878|NCT03775486|Carboplatin|carboplatin|mesh-list
110408879|NCT03775486|Gemcitabine|gemcitabine|mesh-list
110408880|NCT03775486|Pemetrexed|pemetrexed|mesh-list
110408881|NCT03775486|Durvalumab|durvalumab|mesh-list
110408882|NCT03775486|Olaparib|olaparib|mesh-list
110408883|NCT03775486|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110408884|NCT03775486|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110408885|NCT03775486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110408886|NCT03775486|Tubulin Modulators|tubulin modulators|mesh-ancestor
110408887|NCT03775486|Antimitotic Agents|antimitotic agents|mesh-ancestor
110408888|NCT03775486|Mitosis Modulators|mitosis modulators|mesh-ancestor
110408889|NCT03775486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110408890|NCT03775486|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110408891|NCT03775486|Antimetabolites|antimetabolites|mesh-ancestor
110408892|NCT03775486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110408893|NCT03775486|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110408894|NCT03775486|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110408895|NCT03775486|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110408896|NCT03775486|Immunologic Factors|immunologic factors|mesh-ancestor
110408897|NCT03775486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110408898|NCT03775486|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110408899|NCT03767257|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
110408900|NCT03767257|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110408901|NCT03767257|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110408902|NCT03767257|Antimetabolites|antimetabolites|mesh-ancestor
110408903|NCT03767257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110408904|NCT03767257|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110408905|NCT03606499|Ustekinumab|ustekinumab|mesh-list
110408906|NCT03606499|Dermatologic Agents|dermatologic agents|mesh-ancestor
110408907|NCT03576690|Atoltivimab, maftivimab, and odesivimab-ebgn drug combination|atoltivimab, maftivimab, and odesivimab-ebgn drug combination|mesh-list
110408908|NCT03576690|Atoltivimab|atoltivimab|mesh-list
110408909|NCT03576690|Odesivimab|odesivimab|mesh-list
110408910|NCT03576690|Maftivimab|maftivimab|mesh-list
110408911|NCT03576690|Antiviral Agents|antiviral agents|mesh-ancestor
110408912|NCT03576690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110408913|NCT03573947|Paclitaxel|paclitaxel|mesh-list
110408914|NCT03573947|Nivolumab|nivolumab|mesh-list
110408915|NCT03573947|Ipilimumab|ipilimumab|mesh-list
110408916|NCT03573947|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110408917|NCT03573947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110408918|NCT03573947|Tubulin Modulators|tubulin modulators|mesh-ancestor
110408919|NCT03573947|Antimitotic Agents|antimitotic agents|mesh-ancestor
110408920|NCT03573947|Mitosis Modulators|mitosis modulators|mesh-ancestor
110408921|NCT03573947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110408922|NCT03573947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110408923|NCT03573947|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110408924|NCT03567642|Etoposide|etoposide|mesh-list
110408925|NCT03567642|Osimertinib|osimertinib|mesh-list
110408926|NCT03567642|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110408927|NCT03567642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110408928|NCT03567642|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110408929|NCT03567642|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110408930|NCT03567642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110408931|NCT03567642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110408932|NCT03567642|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110408933|NCT03532880|Olaparib|olaparib|mesh-list
110408934|NCT03532880|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110360438|NCT04640129|Interferons|interferons|mesh-list
110408935|NCT03532880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110408936|NCT03532880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110408937|NCT03532880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110408938|NCT03520647|Cyclophosphamide|cyclophosphamide|mesh-list
110408939|NCT03520647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110408940|NCT03520647|Immunologic Factors|immunologic factors|mesh-ancestor
110408941|NCT03520647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110408942|NCT03520647|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110408943|NCT03520647|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110408944|NCT03520647|Alkylating Agents|alkylating agents|mesh-ancestor
110408945|NCT03520647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110408946|NCT03520647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110408947|NCT03520647|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110408948|NCT03420508|Ensartinib|ensartinib|mesh-list
110408949|NCT03420508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110408950|NCT03420508|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110408951|NCT03420508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110408952|NCT03420508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110408953|NCT03410875|Obinutuzumab|obinutuzumab|mesh-list
110408954|NCT03410875|Vemurafenib|vemurafenib|mesh-list
110408955|NCT03410875|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110408956|NCT03410875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110408957|NCT03410875|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110408958|NCT03410875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110408959|NCT03410875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110408960|NCT03295240|Rituximab|rituximab|mesh-list
110408961|NCT03295240|Venetoclax|venetoclax|mesh-list
110408962|NCT03295240|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110408963|NCT03295240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110408964|NCT03295240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110408965|NCT03295240|Immunologic Factors|immunologic factors|mesh-ancestor
110408966|NCT03295240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110408967|NCT03295240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110408968|NCT03295240|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110408969|NCT03295240|Alkylating Agents|alkylating agents|mesh-ancestor
110408970|NCT03295240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110408971|NCT03207945|Alirocumab|alirocumab|mesh-list
110408972|NCT03207945|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
110408973|NCT03207945|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110408974|NCT03207945|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110408975|NCT03207945|Antimetabolites|antimetabolites|mesh-ancestor
110408976|NCT03207945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110408977|NCT03207945|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110408978|NCT03207945|Protease Inhibitors|protease inhibitors|mesh-ancestor
110408979|NCT03207945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110408980|NCT03207945|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110408981|NCT03134703|Morphine|morphine|mesh-list
110408982|NCT03134703|Methadone|methadone|mesh-list
110408983|NCT03134703|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110408984|NCT03134703|Narcotics|narcotics|mesh-ancestor
110408985|NCT03134703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110408986|NCT03134703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110408987|NCT03134703|Analgesics|analgesics|mesh-ancestor
110408988|NCT03134703|Sensory System Agents|sensory system agents|mesh-ancestor
110408989|NCT03134703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110408990|NCT03134703|Antitussive Agents|antitussive agents|mesh-ancestor
110408991|NCT03134703|Respiratory System Agents|respiratory system agents|mesh-ancestor
110408992|NCT03118674|Sofosbuvir|sofosbuvir|mesh-list
110408993|NCT03118674|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
110408994|NCT03118674|Ledipasvir|ledipasvir|mesh-list
110408995|NCT03118674|Antiviral Agents|antiviral agents|mesh-ancestor
110408996|NCT03118674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110408997|NCT03085056|Paclitaxel|paclitaxel|mesh-list
110408998|NCT03085056|Trametinib|trametinib|mesh-list
110408999|NCT03085056|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110409000|NCT03085056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110409001|NCT03085056|Tubulin Modulators|tubulin modulators|mesh-ancestor
110409002|NCT03085056|Antimitotic Agents|antimitotic agents|mesh-ancestor
110409003|NCT03085056|Mitosis Modulators|mitosis modulators|mesh-ancestor
110409004|NCT03085056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110409005|NCT03085056|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110409006|NCT03085056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110409007|NCT03069352|Cytarabine|cytarabine|mesh-list
110409008|NCT03069352|Venetoclax|venetoclax|mesh-list
110409009|NCT03069352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110409010|NCT03069352|Antimetabolites|antimetabolites|mesh-ancestor
110409011|NCT03069352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110409012|NCT03069352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110409014|NCT03069352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110409015|NCT03069352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110409016|NCT03069352|Immunologic Factors|immunologic factors|mesh-ancestor
110409017|NCT03069352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110409018|NCT03037437|Hydroxychloroquine|hydroxychloroquine|mesh-list
110409019|NCT03037437|Sorafenib|sorafenib|mesh-list
110409020|NCT03037437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110409021|NCT03037437|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110409022|NCT03037437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110327847|NCT00443508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110409023|NCT03037437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110409024|NCT03037437|Antimalarials|antimalarials|mesh-ancestor
110409025|NCT03037437|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110409026|NCT03037437|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110409027|NCT03037437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110409028|NCT03037437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110409029|NCT03036488|Paclitaxel|paclitaxel|mesh-list
110409030|NCT03036488|Cyclophosphamide|cyclophosphamide|mesh-list
110409031|NCT03036488|Carboplatin|carboplatin|mesh-list
110409032|NCT03036488|Doxorubicin|doxorubicin|mesh-list
110409033|NCT03036488|Pembrolizumab|pembrolizumab|mesh-list
110409034|NCT03036488|Epirubicin|epirubicin|mesh-list
110409035|NCT03036488|Lenograstim|lenograstim|mesh-list
110409036|NCT03036488|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110409037|NCT03036488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110409038|NCT03036488|Tubulin Modulators|tubulin modulators|mesh-ancestor
110409039|NCT03036488|Antimitotic Agents|antimitotic agents|mesh-ancestor
110409040|NCT03036488|Mitosis Modulators|mitosis modulators|mesh-ancestor
110409041|NCT03036488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110409042|NCT03036488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110409043|NCT03036488|Immunologic Factors|immunologic factors|mesh-ancestor
110409044|NCT03036488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110409045|NCT03036488|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110409046|NCT03036488|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110409047|NCT03036488|Alkylating Agents|alkylating agents|mesh-ancestor
110409048|NCT03036488|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110409049|NCT03036488|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110409050|NCT03036488|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110409051|NCT03036488|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110409052|NCT03036488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110409053|NCT03036488|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110409054|NCT03036488|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110409055|NCT03036488|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110409057|NCT03023631|Immunologic Factors|immunologic factors|mesh-ancestor
110409058|NCT03023631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110409059|NCT02993523|Azacitidine|azacitidine|mesh-list
110409060|NCT02993523|Venetoclax|venetoclax|mesh-list
110409061|NCT02993523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110409062|NCT02993523|Antimetabolites|antimetabolites|mesh-ancestor
110409063|NCT02993523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110409064|NCT02993523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110409065|NCT02993523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110409066|NCT02989584|Gemcitabine|gemcitabine|mesh-list
110409067|NCT02989584|Atezolizumab|atezolizumab|mesh-list
110409068|NCT02989584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110409069|NCT02989584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110409070|NCT02989584|Antimetabolites|antimetabolites|mesh-ancestor
110409071|NCT02989584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110409072|NCT02989584|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110409073|NCT02989584|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110409074|NCT02884219|Ibuprofen|ibuprofen|mesh-list
110409075|NCT02884219|Indomethacin|indomethacin|mesh-list
110409076|NCT02884219|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-list
110409077|NCT02884219|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110409078|NCT02884219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110409079|NCT02884219|Analgesics|analgesics|mesh-ancestor
110409080|NCT02884219|Sensory System Agents|sensory system agents|mesh-ancestor
110409081|NCT02884219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110409082|NCT02884219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110409083|NCT02884219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110409084|NCT02884219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110409085|NCT02884219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110360589|NCT01235728|Calcitriol|calcitriol|mesh-list
110409086|NCT02884219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110409087|NCT02884219|Gout Suppressants|gout suppressants|mesh-ancestor
110409088|NCT02884219|Tocolytic Agents|tocolytic agents|mesh-ancestor
110409089|NCT02884219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110409090|NCT02861417|Vidarabine|vidarabine|mesh-list
110409091|NCT02861417|Mycophenolic Acid|mycophenolic acid|mesh-list
110409092|NCT02861417|Cyclophosphamide|cyclophosphamide|mesh-list
110409093|NCT02861417|Busulfan|busulfan|mesh-list
110409094|NCT02861417|Thiotepa|thiotepa|mesh-list
110409095|NCT02861417|Fludarabine|fludarabine|mesh-list
110409096|NCT02861417|Fludarabine phosphate|fludarabine phosphate|mesh-list
110409098|NCT02861417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110409099|NCT02861417|Immunologic Factors|immunologic factors|mesh-ancestor
110409100|NCT02861417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110409101|NCT02861417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110409102|NCT02861417|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110409103|NCT02861417|Alkylating Agents|alkylating agents|mesh-ancestor
110409104|NCT02861417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110409105|NCT02861417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110409106|NCT02861417|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110409107|NCT02861417|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110409108|NCT02861417|Antimetabolites|antimetabolites|mesh-ancestor
110409109|NCT02861417|Antiviral Agents|antiviral agents|mesh-ancestor
110409110|NCT02861417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110409111|NCT02861417|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110409112|NCT02861417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110409113|NCT02861417|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110409114|NCT02861417|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110409115|NCT02861417|Antitubercular Agents|antitubercular agents|mesh-ancestor
110409116|NCT02861417|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110409117|NCT02795429|Spartalizumab|spartalizumab|mesh-list
110409118|NCT02795429|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110409119|NCT02795429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110409120|NCT02795429|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110409121|NCT02795429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110409122|NCT02792114|Cyclophosphamide|cyclophosphamide|mesh-list
110409123|NCT02792114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110409124|NCT02792114|Immunologic Factors|immunologic factors|mesh-ancestor
110409125|NCT02792114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110409126|NCT02792114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110409127|NCT02792114|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110409128|NCT02792114|Alkylating Agents|alkylating agents|mesh-ancestor
110409129|NCT02792114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110409130|NCT02792114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110409131|NCT02792114|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110409132|NCT02783625|Bortezomib|bortezomib|mesh-list
110409133|NCT02783625|Romidepsin|romidepsin|mesh-list
110409134|NCT02783625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110409135|NCT02783625|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110409136|NCT02783625|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110409137|NCT02783625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110409138|NCT02783625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110409139|NCT02752685|Paclitaxel|paclitaxel|mesh-list
110409140|NCT02752685|Pembrolizumab|pembrolizumab|mesh-list
110409141|NCT02752685|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110409142|NCT02752685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110409143|NCT02752685|Tubulin Modulators|tubulin modulators|mesh-ancestor
110409144|NCT02752685|Antimitotic Agents|antimitotic agents|mesh-ancestor
110409145|NCT02752685|Mitosis Modulators|mitosis modulators|mesh-ancestor
110409146|NCT02752685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110409147|NCT02752685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110409148|NCT02752685|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110409149|NCT02632344|Pembrolizumab|pembrolizumab|mesh-list
110409150|NCT02632344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110409151|NCT02632344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110409152|NCT02632344|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110409153|NCT02632344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110409154|NCT02628067|Pembrolizumab|pembrolizumab|mesh-list
110409155|NCT02628067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110409156|NCT02628067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110409157|NCT02628067|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110409158|NCT02628067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110409159|NCT02605486|Palbociclib|palbociclib|mesh-list
110409160|NCT02605486|Bicalutamide|bicalutamide|mesh-list
110409161|NCT02605486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110409162|NCT02605486|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110409163|NCT02605486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110409164|NCT02605486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110409165|NCT02605486|Androgen Antagonists|androgen antagonists|mesh-ancestor
110409166|NCT02605486|Hormone Antagonists|hormone antagonists|mesh-ancestor
110409167|NCT02605486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110327851|NCT00457340|Antimetabolites|antimetabolites|mesh-ancestor
110409168|NCT02605486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110409170|NCT02538198|Immunologic Factors|immunologic factors|mesh-ancestor
110409171|NCT02538198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110409172|NCT02538198|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110409173|NCT02538198|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110409174|NCT02538198|Growth Substances|growth substances|mesh-ancestor
110409175|NCT02538198|Growth Inhibitors|growth inhibitors|mesh-ancestor
110409176|NCT02538198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110409177|NCT02506959|Gemcitabine|gemcitabine|mesh-list
110409178|NCT02506959|Melphalan|melphalan|mesh-list
110409179|NCT02506959|Busulfan|busulfan|mesh-list
110409180|NCT02506959|Mechlorethamine|mechlorethamine|mesh-list
110409181|NCT02506959|Panobinostat|panobinostat|mesh-list
110409182|NCT02506959|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
110409183|NCT02506959|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110409184|NCT02506959|Antimetabolites|antimetabolites|mesh-ancestor
110409185|NCT02506959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110409186|NCT02506959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110409187|NCT02506959|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110409188|NCT02506959|Alkylating Agents|alkylating agents|mesh-ancestor
110409189|NCT02506959|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110409190|NCT02506959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110409191|NCT02506959|Immunologic Factors|immunologic factors|mesh-ancestor
110561276|NCT02673047|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110409192|NCT02506959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110409193|NCT02506959|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110409194|NCT02506959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110409195|NCT02484287|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110409196|NCT02484287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110409197|NCT02477696|Acalabrutinib|acalabrutinib|mesh-list
110409198|NCT02477696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110409200|NCT02471144|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110409201|NCT02471144|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110409202|NCT02471144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110409203|NCT02471144|Analgesics|analgesics|mesh-ancestor
110409204|NCT02471144|Sensory System Agents|sensory system agents|mesh-ancestor
110409205|NCT02471144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110409206|NCT02471144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110409207|NCT02471144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110409208|NCT02471144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110409209|NCT02471144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110409210|NCT02471144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110409211|NCT02471144|Immunologic Factors|immunologic factors|mesh-ancestor
110409212|NCT02470585|Paclitaxel|paclitaxel|mesh-list
110409213|NCT02470585|Carboplatin|carboplatin|mesh-list
110409214|NCT02470585|Veliparib|veliparib|mesh-list
110409215|NCT02470585|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110409216|NCT02470585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110409217|NCT02470585|Tubulin Modulators|tubulin modulators|mesh-ancestor
110409218|NCT02470585|Antimitotic Agents|antimitotic agents|mesh-ancestor
110409219|NCT02470585|Mitosis Modulators|mitosis modulators|mesh-ancestor
110409220|NCT02470585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110409221|NCT02470585|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110409222|NCT02470585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110409223|NCT02341144|Ropivacaine|ropivacaine|mesh-list
110409224|NCT02341144|Anesthetics, Local|anesthetics, local|mesh-ancestor
110409225|NCT02341144|Anesthetics|anesthetics|mesh-ancestor
110409226|NCT02341144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110409227|NCT02341144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110409228|NCT02341144|Sensory System Agents|sensory system agents|mesh-ancestor
110409229|NCT02341144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110409230|NCT02332668|Pembrolizumab|pembrolizumab|mesh-list
110409231|NCT02332668|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110409232|NCT02332668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110409233|NCT02332668|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110409234|NCT02332668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110409236|NCT02213328|Emtricitabine|emtricitabine|mesh-list
110409237|NCT02213328|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110409238|NCT02213328|Antiviral Agents|antiviral agents|mesh-ancestor
110409239|NCT02213328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110409240|NCT02213328|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110409241|NCT02213328|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110409242|NCT02213328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110409243|NCT02213328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110409244|NCT02213328|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110409245|NCT02213328|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110409247|NCT02204241|Cyclophosphamide|cyclophosphamide|mesh-list
110409248|NCT02204241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110409249|NCT02204241|Immunologic Factors|immunologic factors|mesh-ancestor
110409250|NCT02204241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110409251|NCT02204241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110409252|NCT02204241|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110409253|NCT02204241|Alkylating Agents|alkylating agents|mesh-ancestor
110409254|NCT02204241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110409255|NCT02204241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110409256|NCT02204241|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110409257|NCT02204241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110409258|NCT02204241|Antiemetics|antiemetics|mesh-ancestor
110409259|NCT02204241|Autonomic Agents|autonomic agents|mesh-ancestor
110409260|NCT02204241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110409261|NCT02204241|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110409262|NCT02204241|Glucocorticoids|glucocorticoids|mesh-ancestor
110409263|NCT02204241|Hormones|hormones|mesh-ancestor
110409264|NCT02204241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110409265|NCT02204241|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110409266|NCT02185820|Dexamethasone|dexamethasone|mesh-list
110409267|NCT02185820|Pomalidomide|pomalidomide|mesh-list
110409268|NCT02185820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110409269|NCT02185820|Antiemetics|antiemetics|mesh-ancestor
110409270|NCT02185820|Autonomic Agents|autonomic agents|mesh-ancestor
110409271|NCT02185820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110409272|NCT02185820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110409273|NCT02185820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110409274|NCT02185820|Glucocorticoids|glucocorticoids|mesh-ancestor
110409276|NCT02185820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110409277|NCT02185820|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110409278|NCT02185820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110409279|NCT02185820|Immunologic Factors|immunologic factors|mesh-ancestor
110409280|NCT02185820|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110409281|NCT02185820|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110409282|NCT02185820|Growth Substances|growth substances|mesh-ancestor
110409283|NCT02185820|Growth Inhibitors|growth inhibitors|mesh-ancestor
110409284|NCT02150967|Infigratinib|infigratinib|mesh-list
110409285|NCT02150967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110409286|NCT02085408|Cytarabine|cytarabine|mesh-list
110409287|NCT02085408|Decitabine|decitabine|mesh-list
110409288|NCT02085408|Clofarabine|clofarabine|mesh-list
110409289|NCT02085408|Azacitidine|azacitidine|mesh-list
110409290|NCT02085408|Daunorubicin|daunorubicin|mesh-list
110409291|NCT02085408|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110409292|NCT02085408|Antimetabolites|antimetabolites|mesh-ancestor
110409293|NCT02085408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110409294|NCT02085408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110409295|NCT02085408|Antiviral Agents|antiviral agents|mesh-ancestor
110409296|NCT02085408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110409297|NCT02085408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110409298|NCT02085408|Immunologic Factors|immunologic factors|mesh-ancestor
110409299|NCT02085408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110409300|NCT02085408|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110409301|NCT02085408|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110409302|NCT02085408|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110409303|NCT02085408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110409304|NCT02004782|Prednisolone|prednisolone|mesh-list
110409305|NCT02004782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110409306|NCT02004782|Glucocorticoids|glucocorticoids|mesh-ancestor
110409307|NCT02004782|Hormones|hormones|mesh-ancestor
110409308|NCT02004782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110409309|NCT02004782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110409310|NCT02004782|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110409311|NCT02004782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110409312|NCT01908777|Cytarabine|cytarabine|mesh-list
110409313|NCT01908777|Etoposide|etoposide|mesh-list
110409314|NCT01908777|Melphalan|melphalan|mesh-list
110409315|NCT01908777|Carmustine|carmustine|mesh-list
110409316|NCT01908777|Romidepsin|romidepsin|mesh-list
110409317|NCT01908777|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110409318|NCT01908777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110409319|NCT01908777|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110409320|NCT01908777|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110409321|NCT01908777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110409322|NCT01908777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110409323|NCT01908777|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110409324|NCT01908777|Antimetabolites|antimetabolites|mesh-ancestor
110409325|NCT01908777|Antiviral Agents|antiviral agents|mesh-ancestor
110409326|NCT01908777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110409327|NCT01908777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110409328|NCT01908777|Immunologic Factors|immunologic factors|mesh-ancestor
110409329|NCT01908777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110409330|NCT01908777|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110409331|NCT01908777|Alkylating Agents|alkylating agents|mesh-ancestor
110409332|NCT01908777|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110409333|NCT01908777|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110409334|NCT01908777|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110409335|NCT01873326|Paclitaxel|paclitaxel|mesh-list
110409336|NCT01873326|Etoposide|etoposide|mesh-list
110409337|NCT01873326|Ifosfamide|ifosfamide|mesh-list
110409338|NCT01873326|Bleomycin|bleomycin|mesh-list
110409339|NCT01873326|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110409340|NCT01873326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110409341|NCT01873326|Tubulin Modulators|tubulin modulators|mesh-ancestor
110409342|NCT01873326|Antimitotic Agents|antimitotic agents|mesh-ancestor
110409343|NCT01873326|Mitosis Modulators|mitosis modulators|mesh-ancestor
110409344|NCT01873326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110409345|NCT01873326|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110409346|NCT01873326|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110409347|NCT01873326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110409348|NCT01873326|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110409349|NCT01873326|Alkylating Agents|alkylating agents|mesh-ancestor
110409350|NCT01873326|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110409351|NCT01867606|Immunoglobulins|immunoglobulins|mesh-list
110409352|NCT01867606|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110409353|NCT01867606|Antibodies|antibodies|mesh-list
110409354|NCT01867606|Immunologic Factors|immunologic factors|mesh-ancestor
110409355|NCT01867606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110409356|NCT01862315|Dexamethasone|dexamethasone|mesh-list
110409357|NCT01862315|Gemcitabine|gemcitabine|mesh-list
110409358|NCT01862315|Oxaliplatin|oxaliplatin|mesh-list
110409359|NCT01862315|Floxuridine|floxuridine|mesh-list
110409360|NCT01862315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110409361|NCT01862315|Antiemetics|antiemetics|mesh-ancestor
110409362|NCT01862315|Autonomic Agents|autonomic agents|mesh-ancestor
110409363|NCT01862315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110409364|NCT01862315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110409365|NCT01862315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110409366|NCT01862315|Glucocorticoids|glucocorticoids|mesh-ancestor
110409367|NCT01862315|Hormones|hormones|mesh-ancestor
110409368|NCT01862315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110409369|NCT01862315|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110409370|NCT01862315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110409371|NCT01862315|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110409372|NCT01862315|Antimetabolites|antimetabolites|mesh-ancestor
110409373|NCT01862315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110409374|NCT01745588|Clarithromycin|clarithromycin|mesh-list
110409375|NCT01745588|Dexamethasone|dexamethasone|mesh-list
110409376|NCT01745588|Pomalidomide|pomalidomide|mesh-list
110409377|NCT01745588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110409378|NCT01745588|Antiemetics|antiemetics|mesh-ancestor
110409379|NCT01745588|Autonomic Agents|autonomic agents|mesh-ancestor
110409380|NCT01745588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110409381|NCT01745588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110409382|NCT01745588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110409383|NCT01745588|Glucocorticoids|glucocorticoids|mesh-ancestor
110409384|NCT01745588|Hormones|hormones|mesh-ancestor
110561334|NCT00643799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110409385|NCT01745588|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110409386|NCT01745588|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110409387|NCT01745588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110327856|NCT03278379|Avelumab|avelumab|mesh-list
110409388|NCT01745588|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110409389|NCT01745588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110409390|NCT01745588|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110409391|NCT01745588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110409392|NCT01745588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110409393|NCT01745588|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110409394|NCT01745588|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110409395|NCT01745588|Immunologic Factors|immunologic factors|mesh-ancestor
110409396|NCT01745588|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110409397|NCT01745588|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110409398|NCT01745588|Growth Substances|growth substances|mesh-ancestor
110409399|NCT01745588|Growth Inhibitors|growth inhibitors|mesh-ancestor
110409400|NCT01730937|Sorafenib|sorafenib|mesh-list
110409401|NCT01730937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110409402|NCT01730937|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110409403|NCT01730937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110409404|NCT01730937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110409405|NCT01290692|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
110409406|NCT01290692|Immunologic Factors|immunologic factors|mesh-ancestor
110409407|NCT01290692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110409408|NCT00996866|Vitamin D|vitamin d|mesh-list
110409409|NCT00996866|Cholecalciferol|cholecalciferol|mesh-list
110409410|NCT00996866|Vitamins|vitamins|mesh-ancestor
110409411|NCT00996866|Micronutrients|micronutrients|mesh-ancestor
110409412|NCT00996866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110409413|NCT00996866|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110409414|NCT00996866|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110409415|NCT00876993|Bevacizumab|bevacizumab|mesh-list
110409416|NCT00876993|Irinotecan|irinotecan|mesh-list
110409417|NCT00876993|Temozolomide|temozolomide|mesh-list
110409418|NCT00876993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110409419|NCT00876993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110409420|NCT00876993|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110409421|NCT00876993|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110409422|NCT00876993|Growth Substances|growth substances|mesh-ancestor
110409423|NCT00876993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110409424|NCT00876993|Growth Inhibitors|growth inhibitors|mesh-ancestor
110409425|NCT00876993|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110409426|NCT00876993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110409427|NCT00876993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110409428|NCT00876993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110409429|NCT00876993|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110409430|NCT00876993|Alkylating Agents|alkylating agents|mesh-ancestor
110409431|NCT00700882|Dasatinib|dasatinib|mesh-list
110409432|NCT00700882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110409433|NCT00700882|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110409434|NCT00700882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110409435|NCT00700882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110409436|NCT00673309|Insulin|insulin|mesh-list
110409437|NCT00673309|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110409438|NCT00673309|Itraconazole|itraconazole|mesh-list
110409439|NCT00673309|Propranolol|propranolol|mesh-list
110409440|NCT00673309|Hormones|hormones|mesh-list
110561356|NCT02674295|Esketamine|esketamine|mesh-list
110409441|NCT00673309|Oxandrolone|oxandrolone|mesh-list
110409442|NCT00673309|Nandrolone|nandrolone|mesh-list
110409443|NCT00673309|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110409444|NCT00673309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110409445|NCT00673309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110409446|NCT00673309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110409447|NCT00673309|Antifungal Agents|antifungal agents|mesh-ancestor
110409448|NCT00673309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110409449|NCT00673309|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110409450|NCT00673309|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110409451|NCT00673309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110409452|NCT00673309|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110409453|NCT00673309|Hormone Antagonists|hormone antagonists|mesh-ancestor
110409454|NCT00673309|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110409455|NCT00673309|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110409456|NCT00673309|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110409457|NCT00673309|Adrenergic Agents|adrenergic agents|mesh-ancestor
110409458|NCT00673309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110409459|NCT00673309|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110327859|NCT02956538|Thalidomide|thalidomide|mesh-list
110409460|NCT00673309|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110409461|NCT00673309|Vasodilator Agents|vasodilator agents|mesh-ancestor
110409462|NCT00673309|Androgens|androgens|mesh-ancestor
110409463|NCT00673309|Anabolic Agents|anabolic agents|mesh-ancestor
110409464|NCT00666835|Epoetin Alfa|epoetin alfa|mesh-list
110409465|NCT00666835|Hematinics|hematinics|mesh-ancestor
110409467|NCT00600496|Docetaxel|docetaxel|mesh-list
110409468|NCT00600496|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110409469|NCT00600496|Temsirolimus|temsirolimus|mesh-list
110409470|NCT00600496|Dacarbazine|dacarbazine|mesh-list
110409471|NCT00600496|MTOR Inhibitors|mtor inhibitors|mesh-list
110409472|NCT00600496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110409473|NCT00600496|Tubulin Modulators|tubulin modulators|mesh-ancestor
110409474|NCT00600496|Antimitotic Agents|antimitotic agents|mesh-ancestor
110409475|NCT00600496|Mitosis Modulators|mitosis modulators|mesh-ancestor
110409476|NCT00600496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110409477|NCT00600496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110409478|NCT00600496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110409479|NCT00600496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110409480|NCT00600496|Immunologic Factors|immunologic factors|mesh-ancestor
110409481|NCT00600496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110409482|NCT00600496|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110409483|NCT00600496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110409484|NCT00600496|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110409485|NCT00600496|Antifungal Agents|antifungal agents|mesh-ancestor
110409486|NCT00600496|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110409487|NCT00600496|Alkylating Agents|alkylating agents|mesh-ancestor
110409488|NCT00551759|Docetaxel|docetaxel|mesh-list
110409489|NCT00551759|Fluorouracil|fluorouracil|mesh-list
110409490|NCT00551759|Oxaliplatin|oxaliplatin|mesh-list
110409491|NCT00551759|Cetuximab|cetuximab|mesh-list
110409492|NCT00551759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110409493|NCT00551759|Tubulin Modulators|tubulin modulators|mesh-ancestor
110409494|NCT00551759|Antimitotic Agents|antimitotic agents|mesh-ancestor
110409495|NCT00551759|Mitosis Modulators|mitosis modulators|mesh-ancestor
110409496|NCT00551759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110409497|NCT00551759|Antimetabolites|antimetabolites|mesh-ancestor
110409498|NCT00551759|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110409499|NCT00551759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110409500|NCT00551759|Immunologic Factors|immunologic factors|mesh-ancestor
110409501|NCT00551759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110409502|NCT00551759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110409503|NCT00335140|Leucovorin|leucovorin|mesh-list
110409504|NCT00335140|Cytarabine|cytarabine|mesh-list
110409505|NCT00335140|Dexamethasone|dexamethasone|mesh-list
110409506|NCT00335140|Dexamethasone acetate|dexamethasone acetate|mesh-list
110409507|NCT00335140|Rituximab|rituximab|mesh-list
110409508|NCT00335140|Methotrexate|methotrexate|mesh-list
110409509|NCT00335140|Vincristine|vincristine|mesh-list
110409510|NCT00335140|Procarbazine|procarbazine|mesh-list
110409511|NCT00335140|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
110409512|NCT00335140|BB 1101|bb 1101|mesh-list
110409513|NCT00335140|Levoleucovorin|levoleucovorin|mesh-list
110409514|NCT00335140|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110409515|NCT00335140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110409516|NCT00335140|Immunologic Factors|immunologic factors|mesh-ancestor
110409517|NCT00335140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110409518|NCT00335140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110409519|NCT00335140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110409520|NCT00335140|Antiemetics|antiemetics|mesh-ancestor
110409521|NCT00335140|Autonomic Agents|autonomic agents|mesh-ancestor
110409522|NCT00335140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110409523|NCT00335140|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110409524|NCT00335140|Glucocorticoids|glucocorticoids|mesh-ancestor
110409525|NCT00335140|Hormones|hormones|mesh-ancestor
110409526|NCT00335140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110409527|NCT00335140|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110409528|NCT00335140|Protease Inhibitors|protease inhibitors|mesh-ancestor
110409529|NCT00335140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110409530|NCT00335140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110409531|NCT00335140|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110409532|NCT00335140|Abortifacient Agents|abortifacient agents|mesh-ancestor
110409533|NCT00335140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110409534|NCT00335140|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110409535|NCT00335140|Antimetabolites|antimetabolites|mesh-ancestor
110409536|NCT00335140|Dermatologic Agents|dermatologic agents|mesh-ancestor
110409537|NCT00335140|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110409538|NCT00335140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110361041|NCT04633850|Dexamethasone|dexamethasone|mesh-list
110409539|NCT00335140|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110409540|NCT00335140|Antiviral Agents|antiviral agents|mesh-ancestor
110409541|NCT00335140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110409542|NCT00335140|Antidotes|antidotes|mesh-ancestor
110409543|NCT00335140|Protective Agents|protective agents|mesh-ancestor
110409544|NCT00335140|Vitamin B Complex|vitamin b complex|mesh-ancestor
110409545|NCT00335140|Vitamins|vitamins|mesh-ancestor
110409546|NCT00335140|Micronutrients|micronutrients|mesh-ancestor
110409547|NCT00335140|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110409548|NCT00335140|Tubulin Modulators|tubulin modulators|mesh-ancestor
110409549|NCT00335140|Antimitotic Agents|antimitotic agents|mesh-ancestor
110409550|NCT00335140|Mitosis Modulators|mitosis modulators|mesh-ancestor
110409551|NCT00304239|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
110409552|NCT00304239|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110409553|NCT00304239|Dermatologic Agents|dermatologic agents|mesh-ancestor
110409554|NCT00101283|Carboplatin|carboplatin|mesh-list
110409555|NCT00101283|Gemcitabine|gemcitabine|mesh-list
110409556|NCT00101283|Pemetrexed|pemetrexed|mesh-list
110409557|NCT00101283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110409558|NCT00101283|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110409559|NCT00101283|Antimetabolites|antimetabolites|mesh-ancestor
110409560|NCT00101283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110409561|NCT00101283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110409562|NCT00101283|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110409563|NCT00101283|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110409564|NCT01301729|Paclitaxel|paclitaxel|mesh-list
110409565|NCT01301729|Docetaxel|docetaxel|mesh-list
110409566|NCT01301729|Trastuzumab|trastuzumab|mesh-list
110409567|NCT01301729|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110409568|NCT01301729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110409569|NCT01301729|Tubulin Modulators|tubulin modulators|mesh-ancestor
110409570|NCT01301729|Antimitotic Agents|antimitotic agents|mesh-ancestor
110409571|NCT01301729|Mitosis Modulators|mitosis modulators|mesh-ancestor
110409572|NCT01301729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110409573|NCT01301729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110409574|NCT05643677|Irinotecan|irinotecan|mesh-list
110409575|NCT05643677|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110409576|NCT05643677|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110409577|NCT05643677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110409578|NCT05643677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110409579|NCT05643677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110409580|NCT02890589|Chromium|chromium|mesh-list
110409581|NCT02890589|Everolimus|everolimus|mesh-list
110409582|NCT02890589|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110409583|NCT02890589|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110409584|NCT02890589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110409585|NCT02890589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110409586|NCT02890589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110409587|NCT02890589|Immunologic Factors|immunologic factors|mesh-ancestor
110409588|NCT02890589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110409589|NCT02890589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110409590|NCT02890589|Trace Elements|trace elements|mesh-ancestor
110409591|NCT02890589|Micronutrients|micronutrients|mesh-ancestor
110409592|NCT01301027|Pioglitazone|pioglitazone|mesh-list
110409593|NCT01301027|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110409594|NCT01301027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110409595|NCT04207385|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
110409596|NCT04207385|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110409597|NCT04207385|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110409598|NCT04207385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110409599|NCT04207385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110409600|NCT04207385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110409601|NCT04207385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110409602|NCT04207385|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110409603|NCT04207385|Antidepressive Agents|antidepressive agents|mesh-ancestor
110409604|NCT04207385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110409605|NCT05641883|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
110409606|NCT02886897|Antibodies|antibodies|mesh-list
110409607|NCT02886897|Immunologic Factors|immunologic factors|mesh-ancestor
110409608|NCT02886897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110409609|NCT05641649|Valproic Acid|valproic acid|mesh-list
110409611|NCT05641649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110409612|NCT05641649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110409613|NCT05641649|GABA Agents|gaba agents|mesh-ancestor
110409614|NCT05641649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110409615|NCT05641649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110409616|NCT05641649|Antimanic Agents|antimanic agents|mesh-ancestor
110409617|NCT05641649|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110409618|NCT05641649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110409619|NCT05641649|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110409620|NCT01184859|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
110409621|NCT01184859|Hemostatics|hemostatics|mesh-ancestor
110409622|NCT01184859|Coagulants|coagulants|mesh-ancestor
110409623|NCT01184859|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
110409624|NCT01184859|Natriuretic Agents|natriuretic agents|mesh-ancestor
110409625|NCT01184859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110409626|NCT02890511|Paclitaxel|paclitaxel|mesh-list
110409627|NCT02890511|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110409628|NCT02890511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110409629|NCT02890511|Tubulin Modulators|tubulin modulators|mesh-ancestor
110409630|NCT02890511|Antimitotic Agents|antimitotic agents|mesh-ancestor
110409631|NCT02890511|Mitosis Modulators|mitosis modulators|mesh-ancestor
110409632|NCT02890511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110409633|NCT01184079|Vaccines|vaccines|mesh-list
110409634|NCT01184079|Immunologic Factors|immunologic factors|mesh-ancestor
110409635|NCT01184079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110409636|NCT05333289|Vaccines|vaccines|mesh-list
110409637|NCT05333289|Immunologic Factors|immunologic factors|mesh-ancestor
110409638|NCT05333289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110409639|NCT01289990|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110409640|NCT01289990|Empagliflozin|empagliflozin|mesh-list
110409641|NCT01289990|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110561430|NCT00644111|Hydromorphone|hydromorphone|mesh-list
110409642|NCT01289990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110409643|NCT01289990|Incretins|incretins|mesh-ancestor
110409644|NCT01289990|Hormones|hormones|mesh-ancestor
110409645|NCT01289990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110409646|NCT01289990|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110409647|NCT01289990|Protease Inhibitors|protease inhibitors|mesh-ancestor
110409648|NCT01289990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110409649|NCT01289990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110409650|NCT01289990|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110409651|NCT01190007|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
110409652|NCT01190007|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110409653|NCT01190007|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110409654|NCT01190007|Antimetabolites|antimetabolites|mesh-ancestor
110409655|NCT01190007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110409656|NCT01190007|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110409657|NCT01190007|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110409658|NCT01190007|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110409659|NCT01190007|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110409660|NCT01190007|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110409661|NCT01190007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110409662|NCT01190007|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110409663|NCT01190007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110409664|NCT01300247|Cyclophosphamide|cyclophosphamide|mesh-list
110409665|NCT01300247|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110409666|NCT01300247|Fludarabine|fludarabine|mesh-list
110409667|NCT01300247|Obinutuzumab|obinutuzumab|mesh-list
110409668|NCT01300247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110409669|NCT01300247|Immunologic Factors|immunologic factors|mesh-ancestor
110409670|NCT01300247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110409671|NCT01300247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110409672|NCT01300247|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110409673|NCT01300247|Alkylating Agents|alkylating agents|mesh-ancestor
110409674|NCT01300247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110409675|NCT01300247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110409676|NCT01300247|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110409677|NCT01300247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110409678|NCT02890277|Anti-Infective Agents|anti-infective agents|mesh-list
110409679|NCT02890277|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110409680|NCT02890277|Chitosan|chitosan|mesh-list
110409681|NCT02890277|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110409682|NCT02890277|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110409683|NCT02890277|Antimetabolites|antimetabolites|mesh-ancestor
110409684|NCT02890277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110561464|NCT04178057|Growth Substances|growth substances|mesh-ancestor
110409685|NCT02890277|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110409686|NCT02890277|Chelating Agents|chelating agents|mesh-ancestor
110409687|NCT02890277|Sequestering Agents|sequestering agents|mesh-ancestor
110409688|NCT02890277|Hemostatics|hemostatics|mesh-ancestor
110409689|NCT02890277|Coagulants|coagulants|mesh-ancestor
110409690|NCT01289678|Interleukin-2|interleukin-2|mesh-list
110409691|NCT01289678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110409692|NCT01289678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110409693|NCT01289678|Analgesics|analgesics|mesh-ancestor
110409694|NCT01289678|Sensory System Agents|sensory system agents|mesh-ancestor
110409695|NCT01289678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110409696|NCT01289678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110409697|NCT01183221|Oxytocin|oxytocin|mesh-list
110409698|NCT01183221|Oxytocics|oxytocics|mesh-ancestor
110409699|NCT01183221|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110409700|NCT01183221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110409701|NCT01183143|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
110409702|NCT01183143|Hormones|hormones|mesh-ancestor
110409703|NCT01183143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110409704|NCT01183143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110409705|NCT01183065|Folic Acid|folic acid|mesh-list
110409706|NCT01183065|Vitamin B 12|vitamin b 12|mesh-list
110409707|NCT01183065|Hydroxocobalamin|hydroxocobalamin|mesh-list
110409708|NCT01183065|Vitamins|vitamins|mesh-ancestor
110409709|NCT01183065|Micronutrients|micronutrients|mesh-ancestor
110409710|NCT01183065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110409711|NCT01183065|Hematinics|hematinics|mesh-ancestor
110409712|NCT01183065|Vitamin B Complex|vitamin b complex|mesh-ancestor
110409713|NCT01182441|Warfarin|warfarin|mesh-list
110409714|NCT01182441|Anticoagulants|anticoagulants|mesh-ancestor
110409715|NCT01182285|Valproic Acid|valproic acid|mesh-list
110409716|NCT01182285|Anticonvulsants|anticonvulsants|mesh-ancestor
110409717|NCT01182285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110409718|NCT01182285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110409719|NCT01182285|GABA Agents|gaba agents|mesh-ancestor
110409720|NCT01182285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110409721|NCT01182285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110409722|NCT01182285|Antimanic Agents|antimanic agents|mesh-ancestor
110409723|NCT01182285|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110409724|NCT01182285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110409725|NCT01182285|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110409726|NCT04315935|Fentanyl|fentanyl|mesh-list
110409727|NCT04315935|Butorphanol|butorphanol|mesh-list
110409728|NCT04315935|Propofol|propofol|mesh-list
110409729|NCT04315935|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110409730|NCT04315935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110409731|NCT04315935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110409732|NCT04315935|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110409733|NCT04315935|Anesthetics, General|anesthetics, general|mesh-ancestor
110409734|NCT04315935|Anesthetics|anesthetics|mesh-ancestor
110409735|NCT04315935|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110409736|NCT04315935|Narcotics|narcotics|mesh-ancestor
110409737|NCT04315935|Analgesics|analgesics|mesh-ancestor
110409738|NCT04315935|Sensory System Agents|sensory system agents|mesh-ancestor
110409739|NCT04315935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110409740|NCT04315935|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110409741|NCT04315935|Antitussive Agents|antitussive agents|mesh-ancestor
110409742|NCT04315935|Respiratory System Agents|respiratory system agents|mesh-ancestor
110409743|NCT04315935|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110409744|NCT01182207|Drospirenone|drospirenone|mesh-list
110409745|NCT01182207|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110409746|NCT01182207|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110409747|NCT01182207|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110409748|NCT01182207|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
110409749|NCT01182207|Estradiol|estradiol|mesh-list
110409750|NCT01182207|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110409751|NCT01182207|Estrogens|estrogens|mesh-ancestor
110409752|NCT01182207|Hormones|hormones|mesh-ancestor
110409753|NCT01182207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110409754|NCT01182207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110409755|NCT01182207|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110409756|NCT01182207|Contraceptive Agents|contraceptive agents|mesh-ancestor
110409757|NCT01182207|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110409758|NCT01182207|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110409759|NCT01182207|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110409760|NCT01182207|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110409761|NCT01182207|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110409762|NCT01182207|Hormone Antagonists|hormone antagonists|mesh-ancestor
110409763|NCT01182207|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110409764|NCT01182207|Diuretics|diuretics|mesh-ancestor
110409765|NCT01182207|Natriuretic Agents|natriuretic agents|mesh-ancestor
110409766|NCT01181895|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110409767|NCT01181895|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110409768|NCT01181895|Autonomic Agents|autonomic agents|mesh-ancestor
110409769|NCT01181895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110409770|NCT01181895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110409771|NCT01181895|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110409772|NCT01181895|Respiratory System Agents|respiratory system agents|mesh-ancestor
110409773|NCT01181895|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110409774|NCT01181895|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110409775|NCT01181895|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110409776|NCT01181895|Adrenergic Agents|adrenergic agents|mesh-ancestor
110409777|NCT01181895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110409778|NCT01181895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110409779|NCT01181271|Sirolimus|sirolimus|mesh-list
110409780|NCT01181271|Cyclophosphamide|cyclophosphamide|mesh-list
110409781|NCT01181271|Busulfan|busulfan|mesh-list
110409782|NCT01181271|Methotrexate|methotrexate|mesh-list
110409783|NCT01181271|Fludarabine|fludarabine|mesh-list
110409784|NCT01181271|Etoposide|etoposide|mesh-list
110409785|NCT01181271|Tacrolimus|tacrolimus|mesh-list
110409786|NCT01181271|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110409787|NCT01181271|Immunologic Factors|immunologic factors|mesh-ancestor
110409788|NCT01181271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110409789|NCT01181271|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110409790|NCT01181271|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110409791|NCT01181271|Alkylating Agents|alkylating agents|mesh-ancestor
110409792|NCT01181271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110409793|NCT01181271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110409794|NCT01181271|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110409795|NCT01181271|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110409796|NCT01181271|Abortifacient Agents|abortifacient agents|mesh-ancestor
110409797|NCT01181271|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110409798|NCT01181271|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110409799|NCT01181271|Antimetabolites|antimetabolites|mesh-ancestor
110409800|NCT01181271|Dermatologic Agents|dermatologic agents|mesh-ancestor
110409801|NCT01181271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110409802|NCT01181271|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110409803|NCT01181271|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110409804|NCT01181271|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110409805|NCT01181271|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110409806|NCT01181271|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110409807|NCT01181271|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110409808|NCT01181271|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110409809|NCT01181271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110409810|NCT01181271|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110409811|NCT01181271|Antifungal Agents|antifungal agents|mesh-ancestor
110409812|NCT00624741|Pergolide|pergolide|mesh-list
110409813|NCT00624741|Dopamine Agonists|dopamine agonists|mesh-ancestor
110409814|NCT00624741|Dopamine Agents|dopamine agents|mesh-ancestor
110409815|NCT00624741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110409816|NCT00624741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110409817|NCT00624741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110409818|NCT01180647|Naltrexone|naltrexone|mesh-list
110409819|NCT01180647|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110409820|NCT01180647|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110409821|NCT01180647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110409822|NCT01180647|Sensory System Agents|sensory system agents|mesh-ancestor
110409823|NCT01180647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110409825|NCT01178853|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110409826|NCT01178853|Pitavastatin|pitavastatin|mesh-list
110409827|NCT01178853|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110409828|NCT01178853|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110409829|NCT01178853|Antimetabolites|antimetabolites|mesh-ancestor
110409830|NCT01178853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110409831|NCT01178853|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110409832|NCT01178853|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110409833|NCT01178853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110409834|NCT01178853|Anticoagulants|anticoagulants|mesh-ancestor
110409835|NCT04286035|Bupivacaine|bupivacaine|mesh-list
110409836|NCT04286035|Anesthetics, Local|anesthetics, local|mesh-ancestor
110409837|NCT04286035|Anesthetics|anesthetics|mesh-ancestor
110409838|NCT04286035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110409839|NCT04286035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110409840|NCT04286035|Sensory System Agents|sensory system agents|mesh-ancestor
110361347|NCT01221727|Denosumab|denosumab|mesh-list
110409841|NCT04286035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110409842|NCT00629473|Dexamethasone|dexamethasone|mesh-list
110409843|NCT00629473|Proteasome Inhibitors|proteasome inhibitors|mesh-list
110409844|NCT00629473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110409845|NCT00629473|Antiemetics|antiemetics|mesh-ancestor
110409846|NCT00629473|Autonomic Agents|autonomic agents|mesh-ancestor
110409847|NCT00629473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110409848|NCT00629473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110409849|NCT00629473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110409850|NCT00629473|Glucocorticoids|glucocorticoids|mesh-ancestor
110409851|NCT00629473|Hormones|hormones|mesh-ancestor
110409852|NCT00629473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110409853|NCT00629473|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110409854|NCT00629473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110409855|NCT00629473|Protease Inhibitors|protease inhibitors|mesh-ancestor
110409856|NCT00629473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110409857|NCT00629473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110409858|NCT04286503|Ritonavir|ritonavir|mesh-list
110409859|NCT04286503|Lopinavir|lopinavir|mesh-list
110409860|NCT04286503|Chloroquine|chloroquine|mesh-list
110409861|NCT04286503|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
110409862|NCT04286503|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110409863|NCT04286503|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110409864|NCT04286503|Protease Inhibitors|protease inhibitors|mesh-ancestor
110409865|NCT04286503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110409866|NCT04286503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110409867|NCT04286503|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110409868|NCT04286503|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110409869|NCT04286503|Antiviral Agents|antiviral agents|mesh-ancestor
110409870|NCT04286503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110409871|NCT04286503|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110409872|NCT04286503|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110409873|NCT04286503|Amebicides|amebicides|mesh-ancestor
110409874|NCT04286503|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110409875|NCT04286503|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110409876|NCT04286503|Antimalarials|antimalarials|mesh-ancestor
110409877|NCT04286503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110409878|NCT04286503|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110409879|NCT04286503|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110409880|NCT04286503|Analgesics|analgesics|mesh-ancestor
110409881|NCT04286503|Sensory System Agents|sensory system agents|mesh-ancestor
110409882|NCT04286503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110409883|NCT04286503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110409884|NCT04286503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110409885|NCT04286503|Filaricides|filaricides|mesh-ancestor
110409886|NCT04286503|Antinematodal Agents|antinematodal agents|mesh-ancestor
110409887|NCT04286503|Anthelmintics|anthelmintics|mesh-ancestor
110409888|NCT00968617|Darbepoetin alfa|darbepoetin alfa|mesh-list
110409889|NCT00968617|Hematinics|hematinics|mesh-ancestor
110409890|NCT00968539|Vaccines|vaccines|mesh-list
110409891|NCT00968539|Immunologic Factors|immunologic factors|mesh-ancestor
110409892|NCT00968539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110409893|NCT00976573|Paclitaxel|paclitaxel|mesh-list
110409894|NCT00976573|Bevacizumab|bevacizumab|mesh-list
110409895|NCT00976573|Carboplatin|carboplatin|mesh-list
110409896|NCT00976573|Everolimus|everolimus|mesh-list
110327878|NCT00457652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110409897|NCT00976573|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110409898|NCT00976573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110409899|NCT00976573|Tubulin Modulators|tubulin modulators|mesh-ancestor
110409900|NCT00976573|Antimitotic Agents|antimitotic agents|mesh-ancestor
110409901|NCT00976573|Mitosis Modulators|mitosis modulators|mesh-ancestor
110409902|NCT00976573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110409903|NCT00976573|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110409904|NCT00976573|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110409905|NCT00976573|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110409906|NCT00976573|Growth Substances|growth substances|mesh-ancestor
110409907|NCT00976573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110409908|NCT00976573|Growth Inhibitors|growth inhibitors|mesh-ancestor
110409909|NCT00976573|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110409910|NCT00976573|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110409911|NCT00976573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110409912|NCT00976573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110409913|NCT00976573|Immunologic Factors|immunologic factors|mesh-ancestor
110409914|NCT00629863|Fluorouracil|fluorouracil|mesh-list
110409915|NCT00629863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110409916|NCT00629863|Antimetabolites|antimetabolites|mesh-ancestor
110409917|NCT00629863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110409918|NCT00629863|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110409919|NCT00629863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110409920|NCT00629863|Immunologic Factors|immunologic factors|mesh-ancestor
110409921|NCT00629863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110409922|NCT02865733|Treprostinil|treprostinil|mesh-list
110409923|NCT02865733|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110409924|NCT00976495|Dapagliflozin|dapagliflozin|mesh-list
110409925|NCT00976495|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110409926|NCT00976495|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110409927|NCT00976495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110409928|NCT00976495|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110409929|NCT00976495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110409930|NCT00976495|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110409931|NCT00976495|Diuretics|diuretics|mesh-ancestor
110409932|NCT00976495|Natriuretic Agents|natriuretic agents|mesh-ancestor
110409933|NCT00976495|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110409934|NCT00976495|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110409935|NCT00630019|Moxifloxacin|moxifloxacin|mesh-list
110409936|NCT00630019|Levofloxacin|levofloxacin|mesh-list
110409937|NCT00630019|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110409938|NCT00630019|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110409939|NCT00630019|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
110409940|NCT00630019|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110409941|NCT00630019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110409942|NCT00630019|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110409943|NCT00630019|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110409944|NCT00630019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110409945|NCT00630019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110409946|NCT00630019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110409947|NCT00630019|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110409948|NCT00630019|Contraceptive Agents|contraceptive agents|mesh-ancestor
110409949|NCT00630019|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110409950|NCT00630019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110409951|NCT00630019|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110409952|NCT00630019|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110409953|NCT00630019|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110409954|NCT00630019|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110409955|NCT00630019|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110409956|NCT00630019|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110409957|NCT00998296|Nintedanib|nintedanib|mesh-list
110409958|NCT00998296|Afatinib|afatinib|mesh-list
110409959|NCT00998296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110409960|NCT00998296|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110409961|NCT00998296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110409962|NCT00998296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110409963|NCT01178073|Ambrisentan|ambrisentan|mesh-list
110409964|NCT01178073|Tadalafil|tadalafil|mesh-list
110409965|NCT01178073|Vasodilator Agents|vasodilator agents|mesh-ancestor
110409966|NCT01178073|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110409967|NCT01178073|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110409968|NCT01178073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110409969|NCT01178073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110409970|NCT01178073|Urological Agents|urological agents|mesh-ancestor
110409971|NCT01178073|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110409973|NCT00997984|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110409974|NCT00997984|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110409975|NCT00997984|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110409976|NCT00997984|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110409977|NCT00997984|Adrenergic Agents|adrenergic agents|mesh-ancestor
110409978|NCT00997984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110409979|NCT00997984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110409980|NCT00997984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110409981|NCT01177293|Amlodipine|amlodipine|mesh-list
110409982|NCT01177293|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110409983|NCT01177293|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110409984|NCT01177293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110409985|NCT01177293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110409986|NCT01177293|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110409987|NCT01177293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110409988|NCT01177293|Vasodilator Agents|vasodilator agents|mesh-ancestor
110409989|NCT02886429|Dexmedetomidine|dexmedetomidine|mesh-list
110409990|NCT02886429|Bupivacaine|bupivacaine|mesh-list
110409991|NCT02886429|Anesthetics, Local|anesthetics, local|mesh-ancestor
110409992|NCT02886429|Anesthetics|anesthetics|mesh-ancestor
110409993|NCT02886429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110409994|NCT02886429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110409995|NCT02886429|Sensory System Agents|sensory system agents|mesh-ancestor
110409996|NCT02886429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110409997|NCT02886429|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110409998|NCT02886429|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110409999|NCT02886429|Analgesics|analgesics|mesh-ancestor
110410000|NCT02886429|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110410001|NCT02886429|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110410002|NCT02886429|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110410003|NCT02886429|Adrenergic Agents|adrenergic agents|mesh-ancestor
110410004|NCT02886429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110410005|NCT02886429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110410006|NCT01299389|Paliperidone Palmitate|paliperidone palmitate|mesh-list
110410007|NCT01299389|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110410008|NCT01299389|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110410009|NCT01299389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110410010|NCT01299389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110410011|NCT01299389|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110410012|NCT01299389|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110410013|NCT01299389|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110410014|NCT01299389|Serotonin Agents|serotonin agents|mesh-ancestor
110410015|NCT01299389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110410016|NCT01299389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110410017|NCT01299389|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110410018|NCT01299389|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110410019|NCT01299389|Dopamine Agents|dopamine agents|mesh-ancestor
110410020|NCT02886351|Nitrous Oxide|nitrous oxide|mesh-list
110410021|NCT02886351|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110410022|NCT02886351|Anesthetics, General|anesthetics, general|mesh-ancestor
110410023|NCT02886351|Anesthetics|anesthetics|mesh-ancestor
110410024|NCT02886351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110410025|NCT02886351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110410026|NCT02886351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110410027|NCT02886351|Analgesics|analgesics|mesh-ancestor
110410028|NCT02886351|Sensory System Agents|sensory system agents|mesh-ancestor
110410029|NCT02886351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110410030|NCT00976027|Vaccines|vaccines|mesh-list
110410031|NCT00976027|Immunologic Factors|immunologic factors|mesh-ancestor
110410032|NCT00976027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110410033|NCT01298765|Buprenorphine|buprenorphine|mesh-list
110410034|NCT01298765|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110410035|NCT01298765|Narcotics|narcotics|mesh-ancestor
110410036|NCT01298765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110410037|NCT01298765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110410038|NCT01298765|Analgesics|analgesics|mesh-ancestor
110410039|NCT01298765|Sensory System Agents|sensory system agents|mesh-ancestor
110410040|NCT01298765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110410042|NCT04296214|Azacitidine|azacitidine|mesh-list
110410043|NCT04296214|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110410044|NCT04296214|Antimetabolites|antimetabolites|mesh-ancestor
110410045|NCT04296214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110410046|NCT04296214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110410047|NCT04296214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110410048|NCT04296370|Apatinib|apatinib|mesh-list
110410049|NCT04296370|Fluzoparib|fluzoparib|mesh-list
110410050|NCT04296370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110410051|NCT04296370|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110410052|NCT04296370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110410053|NCT04296370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110410054|NCT04296370|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110410055|NCT00997438|Thioctic Acid|thioctic acid|mesh-list
110410056|NCT00997438|Antioxidants|antioxidants|mesh-ancestor
110410057|NCT00997438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110410058|NCT00997438|Protective Agents|protective agents|mesh-ancestor
110410059|NCT00997438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110410060|NCT00997438|Vitamin B Complex|vitamin b complex|mesh-ancestor
110410061|NCT00997438|Vitamins|vitamins|mesh-ancestor
110410062|NCT00997438|Micronutrients|micronutrients|mesh-ancestor
110410063|NCT00997126|Alfentanil|alfentanil|mesh-list
110410064|NCT00997126|Propofol|propofol|mesh-list
110361591|NCT04698941|Paclitaxel|paclitaxel|mesh-list
110410065|NCT00997126|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110410066|NCT00997126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110410067|NCT00997126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110410068|NCT00997126|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110410069|NCT00997126|Anesthetics, General|anesthetics, general|mesh-ancestor
110410070|NCT00997126|Anesthetics|anesthetics|mesh-ancestor
110410071|NCT00997126|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110410072|NCT00997126|Narcotics|narcotics|mesh-ancestor
110410073|NCT00997126|Analgesics|analgesics|mesh-ancestor
110410074|NCT00997126|Sensory System Agents|sensory system agents|mesh-ancestor
110410075|NCT00997126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110410076|NCT01000636|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
110410077|NCT01000636|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110410078|NCT01000636|Dermatologic Agents|dermatologic agents|mesh-ancestor
110410079|NCT04433494|Tamoxifen|tamoxifen|mesh-list
110410080|NCT04433494|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110410081|NCT04433494|Hormone Antagonists|hormone antagonists|mesh-ancestor
110410082|NCT04433494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110410083|NCT04433494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110410084|NCT04433494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110410085|NCT04433494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110410086|NCT04433494|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110410087|NCT04433494|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110410088|NCT04433494|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110410089|NCT01000480|Pemetrexed|pemetrexed|mesh-list
110410090|NCT01000480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110410091|NCT01000480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110410092|NCT01000480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110410093|NCT01000480|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110410094|NCT01000480|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110410095|NCT02862691|Acetaminophen|acetaminophen|mesh-list
110410096|NCT02862691|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
110410097|NCT02862691|Oxycodone|oxycodone|mesh-list
110410098|NCT02862691|Analgesics|analgesics|mesh-list
110410099|NCT02862691|Bupivacaine|bupivacaine|mesh-list
110410100|NCT02862691|Anesthetics, Local|anesthetics, local|mesh-list
110410101|NCT02862691|Anesthetics|anesthetics|mesh-list
110410102|NCT02862691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110410103|NCT02862691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110410104|NCT02862691|Sensory System Agents|sensory system agents|mesh-ancestor
110410105|NCT02862691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110410106|NCT02862691|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110410107|NCT02862691|Antipyretics|antipyretics|mesh-ancestor
110410108|NCT02862691|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110410109|NCT02862691|Narcotics|narcotics|mesh-ancestor
110410110|NCT02862691|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110410111|NCT02862691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110410112|NCT02862691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110410113|NCT00965341|Methyltestosterone|methyltestosterone|mesh-list
110410115|NCT00965341|Testosterone undecanoate|testosterone undecanoate|mesh-list
110410116|NCT00965341|Testosterone enanthate|testosterone enanthate|mesh-list
110410117|NCT00965341|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
110410118|NCT00965341|Androgens|androgens|mesh-ancestor
110410119|NCT00965341|Hormones|hormones|mesh-ancestor
110410120|NCT00965341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110410121|NCT00965341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110410122|NCT00965341|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110410123|NCT00965341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110410124|NCT00965341|Anabolic Agents|anabolic agents|mesh-ancestor
110410125|NCT01175811|Insulin|insulin|mesh-list
110410126|NCT01175811|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110410127|NCT01175811|Insulin Glargine|insulin glargine|mesh-list
110410128|NCT01175811|Insulin Lispro|insulin lispro|mesh-list
110410129|NCT01175811|Insulin, Isophane|insulin, isophane|mesh-list
110410130|NCT01175811|Biphasic Insulins|biphasic insulins|mesh-list
110410131|NCT01175811|Isophane insulin, insulin lispro drug combination 50:50|isophane insulin, insulin lispro drug combination 50:50|mesh-list
110410132|NCT01175811|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110410133|NCT01175811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110410134|NCT00965263|Cocaine|cocaine|mesh-list
110410135|NCT00965263|Anesthetics, Local|anesthetics, local|mesh-ancestor
110410136|NCT00965263|Anesthetics|anesthetics|mesh-ancestor
110410137|NCT00965263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110410138|NCT00965263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110410139|NCT00965263|Sensory System Agents|sensory system agents|mesh-ancestor
110410140|NCT00965263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110410141|NCT00965263|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110410142|NCT00965263|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110410143|NCT00965263|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110410144|NCT00965263|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110410145|NCT00965263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110410146|NCT00965263|Dopamine Agents|dopamine agents|mesh-ancestor
110410147|NCT00965263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110410149|NCT02886195|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110410150|NCT02886195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110410151|NCT02886195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110410152|NCT02886195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110410153|NCT02886195|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110410154|NCT02886195|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110410155|NCT02886195|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110410156|NCT02862769|Lidocaine|lidocaine|mesh-list
110410157|NCT02862769|Anesthetics, Local|anesthetics, local|mesh-ancestor
110410158|NCT02862769|Anesthetics|anesthetics|mesh-ancestor
110410159|NCT02862769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110410160|NCT02862769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110410161|NCT02862769|Sensory System Agents|sensory system agents|mesh-ancestor
110410162|NCT02862769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110410163|NCT02862769|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110410164|NCT02862769|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110410165|NCT02862769|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110410166|NCT02862769|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110410167|NCT02862769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110410168|NCT00965185|Atorvastatin|atorvastatin|mesh-list
110410169|NCT00965185|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110410170|NCT00965185|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110410171|NCT00965185|Antimetabolites|antimetabolites|mesh-ancestor
110410172|NCT00965185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110410173|NCT00965185|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110410174|NCT00965185|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110410175|NCT00965185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110410176|NCT01174563|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110410177|NCT01174563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110410178|NCT01174563|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110410179|NCT01174563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110410180|NCT01174563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110410181|NCT01298531|Etanercept|etanercept|mesh-list
110410182|NCT01298531|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110327887|NCT00457808|Sirolimus|sirolimus|mesh-list
110410183|NCT01298531|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110410184|NCT01298531|Analgesics|analgesics|mesh-ancestor
110410185|NCT01298531|Sensory System Agents|sensory system agents|mesh-ancestor
110410186|NCT01298531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110410187|NCT01298531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110410188|NCT01298531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110410189|NCT01298531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110410190|NCT01298531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110410191|NCT01298531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110410192|NCT01298531|Immunologic Factors|immunologic factors|mesh-ancestor
110410193|NCT02862145|Dexamethasone|dexamethasone|mesh-list
110410194|NCT02862145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110410195|NCT02862145|Antiemetics|antiemetics|mesh-ancestor
110410196|NCT02862145|Autonomic Agents|autonomic agents|mesh-ancestor
110410197|NCT02862145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110410198|NCT02862145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110410199|NCT02862145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110410200|NCT02862145|Glucocorticoids|glucocorticoids|mesh-ancestor
110410201|NCT02862145|Hormones|hormones|mesh-ancestor
110410202|NCT02862145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110410203|NCT02862145|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110410204|NCT02862145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110410205|NCT01174173|Ranolazine|ranolazine|mesh-list
110410206|NCT01174173|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110410207|NCT01174173|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110410208|NCT01174173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110410209|NCT00964795|Aflibercept|aflibercept|mesh-list
110410210|NCT00964795|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110410211|NCT00964795|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110410212|NCT00964795|Growth Substances|growth substances|mesh-ancestor
110410213|NCT00964795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110410214|NCT00964795|Growth Inhibitors|growth inhibitors|mesh-ancestor
110410215|NCT00964795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110410217|NCT01173471|Vitamin B Complex|vitamin b complex|mesh-ancestor
110410218|NCT01173471|Vitamins|vitamins|mesh-ancestor
110410219|NCT01173471|Micronutrients|micronutrients|mesh-ancestor
110410220|NCT01173471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110410221|NCT01172847|Oseltamivir|oseltamivir|mesh-list
110410222|NCT01172847|Rimantadine|rimantadine|mesh-list
110410223|NCT01172847|Antiviral Agents|antiviral agents|mesh-ancestor
110410224|NCT01172847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110410225|NCT01172847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110410226|NCT01172847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110410227|NCT01172847|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110410228|NCT00966355|Octreotide|octreotide|mesh-list
110410229|NCT00966355|Terlipressin|terlipressin|mesh-list
110410230|NCT00966355|Somatostatin|somatostatin|mesh-list
110410231|NCT00966355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110410232|NCT00966355|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110410233|NCT00966355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110410234|NCT00966355|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110410235|NCT00966355|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110410236|NCT00966355|Hormones|hormones|mesh-ancestor
110410237|NCT00966355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110410238|NCT00966355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110410240|NCT01172535|Lopinavir|lopinavir|mesh-list
110410241|NCT01172535|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110410242|NCT01172535|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110410243|NCT01172535|Protease Inhibitors|protease inhibitors|mesh-ancestor
110410244|NCT01172535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110410245|NCT01172535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110410246|NCT01172535|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110410247|NCT01172535|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110410248|NCT01172535|Antiviral Agents|antiviral agents|mesh-ancestor
110410249|NCT01172535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110410250|NCT01172535|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110410251|NCT01172535|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110410252|NCT05160493|Pregabalin|pregabalin|mesh-list
110410253|NCT05160493|Ketamine|ketamine|mesh-list
110410254|NCT05160493|Esketamine|esketamine|mesh-list
110410255|NCT05160493|Analgesics|analgesics|mesh-ancestor
110410256|NCT05160493|Sensory System Agents|sensory system agents|mesh-ancestor
110410257|NCT05160493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110410258|NCT05160493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110410259|NCT05160493|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110410260|NCT05160493|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110410261|NCT05160493|Anesthetics, General|anesthetics, general|mesh-ancestor
110410262|NCT05160493|Anesthetics|anesthetics|mesh-ancestor
110410263|NCT05160493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110410264|NCT05160493|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110410265|NCT05160493|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110410266|NCT05160493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110410267|NCT05160493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110410268|NCT05160493|Anticonvulsants|anticonvulsants|mesh-ancestor
110410269|NCT05160493|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110410270|NCT05160493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110410271|NCT05160493|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110410272|NCT05160493|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110410273|NCT05160493|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110410274|NCT05160493|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110410275|NCT05160493|Antidepressive Agents|antidepressive agents|mesh-ancestor
110410276|NCT00966277|Dalteparin|dalteparin|mesh-list
110410277|NCT00966277|Tinzaparin|tinzaparin|mesh-list
110410278|NCT00966277|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
110410279|NCT00966277|Anticoagulants|anticoagulants|mesh-ancestor
110410280|NCT00966277|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110410281|NCT00966277|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110410282|NCT00966277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110410283|NCT01297517|Brimonidine Tartrate|brimonidine tartrate|mesh-list
110410284|NCT01297517|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110410285|NCT01297517|Brinzolamide|brinzolamide|mesh-list
110410286|NCT01297517|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110410287|NCT01297517|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110410288|NCT01297517|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110410289|NCT01297517|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110410290|NCT01297517|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110410291|NCT01297517|Adrenergic Agents|adrenergic agents|mesh-ancestor
110410292|NCT01297517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110410293|NCT01297517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110410294|NCT01297517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110410295|NCT01297517|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110410296|NCT01297517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110410297|NCT01296347|Ketamine|ketamine|mesh-list
110410298|NCT01296347|Analgesics|analgesics|mesh-ancestor
110410299|NCT01296347|Sensory System Agents|sensory system agents|mesh-ancestor
110410300|NCT01296347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110410301|NCT01296347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110410302|NCT01296347|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110410303|NCT01296347|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110410304|NCT01296347|Anesthetics, General|anesthetics, general|mesh-ancestor
110410305|NCT01296347|Anesthetics|anesthetics|mesh-ancestor
110410306|NCT01296347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110410307|NCT01296347|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110410308|NCT01296347|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110410309|NCT01296347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110410310|NCT01296347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110410311|NCT01296035|Panitumumab|panitumumab|mesh-list
110410312|NCT01296035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110410313|NCT01296035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110410314|NCT01294787|Glycopyrrolate|glycopyrrolate|mesh-list
110410315|NCT01294787|Bromides|bromides|mesh-list
110410316|NCT01294787|Tiotropium Bromide|tiotropium bromide|mesh-list
110410317|NCT01294787|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110410318|NCT01294787|Autonomic Agents|autonomic agents|mesh-ancestor
110410319|NCT01294787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110410320|NCT01294787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110410321|NCT01294787|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110410323|NCT01294787|Parasympatholytics|parasympatholytics|mesh-ancestor
110410324|NCT01294787|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110410325|NCT01294787|Cholinergic Agents|cholinergic agents|mesh-ancestor
110410326|NCT01294787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110410327|NCT01294787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110410328|NCT01294787|Anticonvulsants|anticonvulsants|mesh-ancestor
110410329|NCT01294787|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110410330|NCT01294787|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110410332|NCT01294553|Rosiglitazone|rosiglitazone|mesh-list
110410333|NCT01294553|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110410334|NCT01294553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110410335|NCT04326023|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
110410336|NCT04326023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110410337|NCT04326023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110410338|NCT04326023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110410339|NCT01294397|Denosumab|denosumab|mesh-list
110410340|NCT01294397|Etanercept|etanercept|mesh-list
110410341|NCT01294397|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110410342|NCT01294397|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110410343|NCT01294397|Analgesics|analgesics|mesh-ancestor
110410344|NCT01294397|Sensory System Agents|sensory system agents|mesh-ancestor
110410345|NCT01294397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110410346|NCT01294397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110410347|NCT01294397|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110410348|NCT01294397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110410349|NCT01294397|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110410350|NCT01294397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110410351|NCT01294397|Immunologic Factors|immunologic factors|mesh-ancestor
110410352|NCT01294397|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110410353|NCT01293695|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
110410354|NCT01293695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110410355|NCT01293695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110410356|NCT01293539|Melphalan|melphalan|mesh-list
110410357|NCT01293539|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110410358|NCT01293539|Alkylating Agents|alkylating agents|mesh-ancestor
110410359|NCT01293539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110410360|NCT01293539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110410361|NCT01293539|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110410362|NCT01293539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110410363|NCT01293539|Immunologic Factors|immunologic factors|mesh-ancestor
110410364|NCT01293539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110410365|NCT01292837|Levetiracetam|levetiracetam|mesh-list
110410366|NCT01292837|Anticonvulsants|anticonvulsants|mesh-ancestor
110410367|NCT01292837|Nootropic Agents|nootropic agents|mesh-ancestor
110410368|NCT00965731|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110410369|NCT00965731|Crizotinib|crizotinib|mesh-list
110410370|NCT00965731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110410371|NCT00965731|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110410372|NCT00965731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110410373|NCT00965731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110410374|NCT00630175|Zolpidem|zolpidem|mesh-list
110410375|NCT00630175|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110410376|NCT00630175|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110410377|NCT00630175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110410378|NCT00630175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110410379|NCT00630175|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
110410380|NCT00630175|GABA Agonists|gaba agonists|mesh-ancestor
110410381|NCT00630175|GABA Agents|gaba agents|mesh-ancestor
110410382|NCT00630175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110410383|NCT00630175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110410384|NCT00965575|Melatonin|melatonin|mesh-list
110410385|NCT00965575|Antioxidants|antioxidants|mesh-ancestor
110410386|NCT00965575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110410387|NCT00965575|Protective Agents|protective agents|mesh-ancestor
110410388|NCT00965575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110410389|NCT00965575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110410390|NCT00965497|Escitalopram|escitalopram|mesh-list
110410391|NCT00965497|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110410392|NCT00965497|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110410393|NCT00965497|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110410394|NCT00965497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110410395|NCT00965497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110410396|NCT00965497|Serotonin Agents|serotonin agents|mesh-ancestor
110410397|NCT00965497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110410398|NCT00963937|Sumatriptan|sumatriptan|mesh-list
110410399|NCT00963937|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110410400|NCT00963937|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110410401|NCT00963937|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110410402|NCT00963937|Serotonin Agents|serotonin agents|mesh-ancestor
110410403|NCT00963937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110410404|NCT00963937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110410405|NCT00963937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110410406|NCT01170663|Paclitaxel|paclitaxel|mesh-list
110410407|NCT01170663|Ramucirumab|ramucirumab|mesh-list
110410408|NCT01170663|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110410409|NCT01170663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110410410|NCT01170663|Tubulin Modulators|tubulin modulators|mesh-ancestor
110410411|NCT01170663|Antimitotic Agents|antimitotic agents|mesh-ancestor
110410412|NCT01170663|Mitosis Modulators|mitosis modulators|mesh-ancestor
110410413|NCT01170663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110410414|NCT04315155|Nivolumab|nivolumab|mesh-list
110410415|NCT04315155|Ipilimumab|ipilimumab|mesh-list
110410416|NCT04315155|Belinostat|belinostat|mesh-list
110410417|NCT04315155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110410418|NCT04315155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110561792|NCT00461305|Diuretics|diuretics|mesh-ancestor
110410419|NCT04315155|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110410420|NCT04315155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110410421|NCT04315155|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110410422|NCT04315155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110410423|NCT01170273|Vitamin D|vitamin d|mesh-list
110410424|NCT01170273|Vitamins|vitamins|mesh-ancestor
110410425|NCT01170273|Micronutrients|micronutrients|mesh-ancestor
110410426|NCT01170273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110410427|NCT01170273|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110410428|NCT01170039|Lubiprostone|lubiprostone|mesh-list
110410429|NCT01170039|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
110410430|NCT01170039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110410431|NCT01170039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110410432|NCT01286558|Amlodipine|amlodipine|mesh-list
110410433|NCT01286558|Telmisartan|telmisartan|mesh-list
110410434|NCT01286558|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110410435|NCT01286558|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110410436|NCT01286558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110410437|NCT01286558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110410438|NCT01286558|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110410439|NCT01286558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110410440|NCT01286558|Vasodilator Agents|vasodilator agents|mesh-ancestor
110410441|NCT01286558|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110410442|NCT01286558|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110410444|NCT01169103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110410445|NCT01169103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110410446|NCT01286168|Chlorhexidine|chlorhexidine|mesh-list
110410447|NCT01286168|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110410448|NCT01286168|Sodium Hypochlorite|sodium hypochlorite|mesh-list
110410450|NCT01286168|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110410451|NCT01286168|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110410452|NCT01286168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110410453|NCT01286168|Disinfectants|disinfectants|mesh-ancestor
110410454|NCT01286168|Dermatologic Agents|dermatologic agents|mesh-ancestor
110410455|NCT02889692|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110410456|NCT02889692|Gefitinib|gefitinib|mesh-list
110410457|NCT02889692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110410458|NCT02889692|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110410459|NCT02889692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110410460|NCT02889692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110410461|NCT05569382|Verapamil|verapamil|mesh-list
110410462|NCT05569382|Bisoprolol|bisoprolol|mesh-list
110410463|NCT05569382|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110410464|NCT05569382|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110410465|NCT05569382|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110410466|NCT05569382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110410467|NCT05569382|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110410468|NCT05569382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110410469|NCT05569382|Vasodilator Agents|vasodilator agents|mesh-ancestor
110410470|NCT05569382|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110410471|NCT05569382|Sympatholytics|sympatholytics|mesh-ancestor
110410472|NCT05569382|Autonomic Agents|autonomic agents|mesh-ancestor
110410473|NCT05569382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110410474|NCT05569382|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110410475|NCT05569382|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110410476|NCT05569382|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110410477|NCT05569382|Adrenergic Agents|adrenergic agents|mesh-ancestor
110410478|NCT05569382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110410479|NCT00963547|Trastuzumab|trastuzumab|mesh-list
110410480|NCT00963547|Lapatinib|lapatinib|mesh-list
110410481|NCT00963547|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110410482|NCT00963547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110410483|NCT00963547|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110410484|NCT00963547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110410485|NCT00963547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110410486|NCT01285310|Thalidomide|thalidomide|mesh-list
110410487|NCT01285310|Apremilast|apremilast|mesh-list
110410488|NCT01285310|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110410489|NCT01285310|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110410490|NCT01285310|Analgesics|analgesics|mesh-ancestor
110410491|NCT01285310|Sensory System Agents|sensory system agents|mesh-ancestor
110410492|NCT01285310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110410493|NCT01285310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110410494|NCT01285310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110410495|NCT01285310|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110410496|NCT01285310|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
110410497|NCT01285310|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110410498|NCT01285310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110410499|NCT01285310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110410500|NCT01285310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110410501|NCT01285310|Immunologic Factors|immunologic factors|mesh-ancestor
110410502|NCT01285310|Leprostatic Agents|leprostatic agents|mesh-ancestor
110410503|NCT01285310|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110410504|NCT01285310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110410505|NCT01285310|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110410506|NCT01285310|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110410507|NCT01285310|Growth Substances|growth substances|mesh-ancestor
110410508|NCT01285310|Growth Inhibitors|growth inhibitors|mesh-ancestor
110410509|NCT01285310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110410511|NCT01254630|Immunologic Factors|immunologic factors|mesh-ancestor
110410512|NCT01254630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110410513|NCT01253304|Dulaglutide|dulaglutide|mesh-list
110410514|NCT01253304|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110410515|NCT01253304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110410516|NCT04319484|Lenvatinib|lenvatinib|mesh-list
110410517|NCT04319484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110410518|NCT04319484|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110410519|NCT04319484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110410520|NCT04319484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110410521|NCT01253226|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110410522|NCT01253226|Immunologic Factors|immunologic factors|mesh-ancestor
110410523|NCT01253226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110410524|NCT01252134|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110410525|NCT00624312|Epoetin Alfa|epoetin alfa|mesh-list
110410526|NCT00624312|Hematinics|hematinics|mesh-ancestor
110410527|NCT01250418|Ketamine|ketamine|mesh-list
110410528|NCT01250418|Analgesics|analgesics|mesh-ancestor
110410529|NCT01250418|Sensory System Agents|sensory system agents|mesh-ancestor
110410530|NCT01250418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110410531|NCT01250418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110410532|NCT01250418|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110410533|NCT01250418|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110410534|NCT01250418|Anesthetics, General|anesthetics, general|mesh-ancestor
110410535|NCT01250418|Anesthetics|anesthetics|mesh-ancestor
110410536|NCT01250418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110410537|NCT01250418|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110410538|NCT01250418|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110410539|NCT01250418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110410540|NCT01250418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110410541|NCT01292603|Cyclophosphamide|cyclophosphamide|mesh-list
110410542|NCT01292603|Rituximab|rituximab|mesh-list
110410543|NCT01292603|Fludarabine|fludarabine|mesh-list
110410544|NCT01292603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110410545|NCT01292603|Immunologic Factors|immunologic factors|mesh-ancestor
110410546|NCT01292603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110410547|NCT01292603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110410548|NCT01292603|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110410549|NCT01292603|Alkylating Agents|alkylating agents|mesh-ancestor
110410550|NCT01292603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110410551|NCT01292603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110410552|NCT01292603|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110410553|NCT01292603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110410554|NCT01292057|Aripiprazole|aripiprazole|mesh-list
110410555|NCT01292057|Antidepressive Agents|antidepressive agents|mesh-ancestor
110410556|NCT01292057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110410557|NCT01292057|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110410558|NCT01292057|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110410559|NCT01292057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110410560|NCT01292057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110410561|NCT01292057|Dopamine Agonists|dopamine agonists|mesh-ancestor
110410562|NCT01292057|Dopamine Agents|dopamine agents|mesh-ancestor
110410563|NCT01292057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110410564|NCT01292057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110410565|NCT01292057|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110410566|NCT01292057|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110410567|NCT01292057|Serotonin Agents|serotonin agents|mesh-ancestor
110561861|NCT00646529|Hormones|hormones|mesh-ancestor
110410568|NCT01292057|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110410569|NCT01292057|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110410570|NCT01292057|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110410571|NCT01292057|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110410573|NCT01290887|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110410574|NCT01290887|Respiratory System Agents|respiratory system agents|mesh-ancestor
110410575|NCT01290731|Interferons|interferons|mesh-list
110410576|NCT01290731|Ribavirin|ribavirin|mesh-list
110410577|NCT01290731|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110410578|NCT01290731|Simeprevir|simeprevir|mesh-list
110410579|NCT01290731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110410580|NCT01290731|Antiviral Agents|antiviral agents|mesh-ancestor
110410581|NCT01290731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110410582|NCT01290731|Antimetabolites|antimetabolites|mesh-ancestor
110410583|NCT01290731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110410584|NCT01290731|Protease Inhibitors|protease inhibitors|mesh-ancestor
110410585|NCT01290731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110410586|NCT01290341|Naftifine|naftifine|mesh-list
110410587|NCT01290341|Antifungal Agents|antifungal agents|mesh-ancestor
110410588|NCT01290341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110410589|NCT01290263|Bevacizumab|bevacizumab|mesh-list
110410590|NCT01290263|Trebananib|trebananib|mesh-list
110410591|NCT01290263|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110410592|NCT01290263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110410593|NCT01290263|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110410594|NCT01290263|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110410595|NCT01290263|Growth Substances|growth substances|mesh-ancestor
110410596|NCT01290263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110410597|NCT01290263|Growth Inhibitors|growth inhibitors|mesh-ancestor
110410598|NCT01290029|Cinacalcet|cinacalcet|mesh-list
110410599|NCT01290029|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110410600|NCT01290029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110410601|NCT01290029|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
110410602|NCT01290029|Hormone Antagonists|hormone antagonists|mesh-ancestor
110410603|NCT01290029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110410604|NCT02890199|Lidocaine|lidocaine|mesh-list
110410605|NCT02890199|Bupivacaine|bupivacaine|mesh-list
110410606|NCT02890199|Anesthetics, Local|anesthetics, local|mesh-ancestor
110410607|NCT02890199|Anesthetics|anesthetics|mesh-ancestor
110410608|NCT02890199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110410609|NCT02890199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110410610|NCT02890199|Sensory System Agents|sensory system agents|mesh-ancestor
110410611|NCT02890199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110410612|NCT02890199|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110410613|NCT02890199|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110410614|NCT02890199|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110410615|NCT02890199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110560286|NCT02615288|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110410616|NCT02890199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110410617|NCT01289639|Pioglitazone|pioglitazone|mesh-list
110410618|NCT01289639|Fenofibrate|fenofibrate|mesh-list
110410619|NCT01289639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110410620|NCT01289639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110410621|NCT01289639|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110410622|NCT01289639|Antimetabolites|antimetabolites|mesh-ancestor
110410623|NCT01289639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110410624|NCT01289639|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110410625|NCT01288937|Milnacipran|milnacipran|mesh-list
110410626|NCT01288937|Levomilnacipran|levomilnacipran|mesh-list
110410627|NCT01288937|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110410628|NCT01288937|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110410629|NCT01288937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110410630|NCT01288937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110410631|NCT01288937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110410632|NCT01288937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110410633|NCT01288937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110410634|NCT01288937|Analgesics|analgesics|mesh-ancestor
110410635|NCT01288937|Sensory System Agents|sensory system agents|mesh-ancestor
110410636|NCT01288937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110410637|NCT01288937|Antidepressive Agents|antidepressive agents|mesh-ancestor
110410638|NCT01288937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110410639|NCT01288469|Atorvastatin|atorvastatin|mesh-list
110410641|NCT01288469|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110410642|NCT01288469|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110410643|NCT01288469|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110410644|NCT01288469|Antimetabolites|antimetabolites|mesh-ancestor
110410645|NCT01288469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110410646|NCT01288469|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110410647|NCT01288469|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110410648|NCT01288469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110410650|NCT01288469|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110410651|NCT01288469|Protease Inhibitors|protease inhibitors|mesh-ancestor
110410652|NCT01288469|Immunologic Factors|immunologic factors|mesh-ancestor
110410653|NCT01288469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110410654|NCT01288079|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110410655|NCT01288079|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110410656|NCT01288079|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110410657|NCT01288079|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110410658|NCT01288079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110410659|NCT01288079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110410660|NCT01288079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110410661|NCT01288079|Analgesics|analgesics|mesh-ancestor
110410662|NCT01288079|Sensory System Agents|sensory system agents|mesh-ancestor
110410663|NCT01288079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110410664|NCT01288079|Antidepressive Agents|antidepressive agents|mesh-ancestor
110410665|NCT01288079|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110410666|NCT01288079|Dopamine Agents|dopamine agents|mesh-ancestor
110410667|NCT01287221|Riboflavin|riboflavin|mesh-list
110410668|NCT01287221|Rifampin|rifampin|mesh-list
110410669|NCT01287221|Vitamins|vitamins|mesh-ancestor
110410670|NCT01287221|Micronutrients|micronutrients|mesh-ancestor
110410671|NCT01287221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110410672|NCT01287221|Vitamin B Complex|vitamin b complex|mesh-ancestor
110410673|NCT01287221|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110410674|NCT01287221|Antitubercular Agents|antitubercular agents|mesh-ancestor
110410675|NCT01287221|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110410676|NCT01287221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110410677|NCT01287221|Leprostatic Agents|leprostatic agents|mesh-ancestor
110410678|NCT01287221|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110410679|NCT01287221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110410680|NCT01287221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110410681|NCT01287221|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110410682|NCT01287221|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110410683|NCT01287221|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110410684|NCT01287221|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110410685|NCT01287221|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110410686|NCT01287221|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110410687|NCT01287221|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110410688|NCT01287221|Dermatologic Agents|dermatologic agents|mesh-ancestor
110410689|NCT05660213|Bevacizumab|bevacizumab|mesh-list
110410690|NCT05660213|Atezolizumab|atezolizumab|mesh-list
110410691|NCT05660213|Apatinib|apatinib|mesh-list
110410692|NCT05660213|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110410693|NCT05660213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110410694|NCT05660213|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110410695|NCT05660213|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110410696|NCT05660213|Growth Substances|growth substances|mesh-ancestor
110410697|NCT05660213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110410698|NCT05660213|Growth Inhibitors|growth inhibitors|mesh-ancestor
110410699|NCT05660213|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110410700|NCT05660213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110410701|NCT05660213|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110410702|NCT05660213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110410703|NCT01167153|Amlodipine|amlodipine|mesh-list
110410704|NCT01167153|Valsartan|valsartan|mesh-list
110410705|NCT01167153|Nifedipine|nifedipine|mesh-list
110410706|NCT01167153|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110410707|NCT01167153|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110410708|NCT01167153|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110410709|NCT01167153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110410710|NCT01167153|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110410711|NCT01167153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110410712|NCT01167153|Vasodilator Agents|vasodilator agents|mesh-ancestor
110410713|NCT01167153|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110410714|NCT01167153|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110410715|NCT01167153|Tocolytic Agents|tocolytic agents|mesh-ancestor
110410716|NCT01167153|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110410717|NCT01166763|Vitamin D|vitamin d|mesh-list
110410718|NCT01166763|Cholecalciferol|cholecalciferol|mesh-list
110410719|NCT01166763|Vitamins|vitamins|mesh-ancestor
110410720|NCT01166763|Micronutrients|micronutrients|mesh-ancestor
110410721|NCT01166763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110410722|NCT01166763|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110410723|NCT01166763|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110410725|NCT02885961|Antithrombins|antithrombins|mesh-ancestor
110410726|NCT02885961|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110410727|NCT02885961|Protease Inhibitors|protease inhibitors|mesh-ancestor
110410728|NCT02885961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110410729|NCT02885961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110410730|NCT02885961|Anticoagulants|anticoagulants|mesh-ancestor
110410731|NCT02885727|Durvalumab|durvalumab|mesh-list
110410732|NCT02885727|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110410733|NCT02885727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110410734|NCT00963235|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110410735|NCT00963235|Immunologic Factors|immunologic factors|mesh-ancestor
110410736|NCT00963235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110410737|NCT00630097|Modafinil|modafinil|mesh-list
110410738|NCT00630097|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110410739|NCT00630097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110410740|NCT00630097|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
110410741|NCT00630097|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110410742|NCT00630097|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110410743|NCT00630097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110410744|NCT01165281|Oxycodone|oxycodone|mesh-list
110410745|NCT01165281|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110410746|NCT01165281|Narcotics|narcotics|mesh-ancestor
110410747|NCT01165281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110410748|NCT01165281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110410749|NCT01165281|Analgesics|analgesics|mesh-ancestor
110410750|NCT01165281|Sensory System Agents|sensory system agents|mesh-ancestor
110410751|NCT01165281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110410752|NCT02860897|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
110410753|NCT02860897|Estrogens|estrogens|mesh-ancestor
110410754|NCT02860897|Hormones|hormones|mesh-ancestor
110410755|NCT02860897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110410756|NCT02860897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110410757|NCT02860819|Carboplatin|carboplatin|mesh-list
110410759|NCT02860819|Veliparib|veliparib|mesh-list
110410760|NCT02860819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110410761|NCT02860819|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110410762|NCT02860819|Antimetabolites|antimetabolites|mesh-ancestor
110410763|NCT02860819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110410764|NCT02860819|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110410765|NCT02860819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110410766|NCT04284007|Dexamethasone|dexamethasone|mesh-list
110410767|NCT04284007|Dexamethasone acetate|dexamethasone acetate|mesh-list
110410768|NCT04284007|Levobupivacaine|levobupivacaine|mesh-list
110410769|NCT04284007|BB 1101|bb 1101|mesh-list
110410770|NCT04284007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110410771|NCT04284007|Antiemetics|antiemetics|mesh-ancestor
110410772|NCT04284007|Autonomic Agents|autonomic agents|mesh-ancestor
110410773|NCT04284007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110410774|NCT04284007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110410775|NCT04284007|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110410776|NCT04284007|Glucocorticoids|glucocorticoids|mesh-ancestor
110410777|NCT04284007|Hormones|hormones|mesh-ancestor
110410778|NCT04284007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110410779|NCT04284007|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110410780|NCT04284007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110410781|NCT04284007|Protease Inhibitors|protease inhibitors|mesh-ancestor
110410782|NCT04284007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110410783|NCT04284007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110410784|NCT04284007|Anesthetics, Local|anesthetics, local|mesh-ancestor
110410785|NCT04284007|Anesthetics|anesthetics|mesh-ancestor
110410786|NCT04284007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110410787|NCT04284007|Sensory System Agents|sensory system agents|mesh-ancestor
110410788|NCT01165203|Vaccines|vaccines|mesh-list
110410789|NCT01165203|Immunologic Factors|immunologic factors|mesh-ancestor
110410790|NCT01165203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110410791|NCT00960661|Insulin|insulin|mesh-list
110410792|NCT00960661|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110410793|NCT00960661|Metformin|metformin|mesh-list
110410794|NCT00960661|Exenatide|exenatide|mesh-list
110410795|NCT00960661|Insulin Lispro|insulin lispro|mesh-list
110410796|NCT00960661|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110410797|NCT00960661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110410798|NCT00960661|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110410799|NCT00960661|Incretins|incretins|mesh-ancestor
110410800|NCT00960661|Hormones|hormones|mesh-ancestor
110410801|NCT00960661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110410802|NCT00960193|Colchicine|colchicine|mesh-list
110410803|NCT00960193|Gout Suppressants|gout suppressants|mesh-ancestor
110410804|NCT00960193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110410805|NCT00960193|Tubulin Modulators|tubulin modulators|mesh-ancestor
110410806|NCT00960193|Antimitotic Agents|antimitotic agents|mesh-ancestor
110410807|NCT00960193|Mitosis Modulators|mitosis modulators|mesh-ancestor
110410808|NCT00960193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110410809|NCT00960193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110410810|NCT00960115|Cyclophosphamide|cyclophosphamide|mesh-list
110410811|NCT00960115|Immunologic Factors|immunologic factors|mesh-ancestor
110410812|NCT00960115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110410813|NCT00960115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110410814|NCT00960115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110410815|NCT00960115|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110410816|NCT00960115|Alkylating Agents|alkylating agents|mesh-ancestor
110410817|NCT00960115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110410818|NCT00960115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110410819|NCT00960115|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110410821|NCT00959647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110410822|NCT00959647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110410823|NCT00959647|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110410824|NCT00959647|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110327910|NCT00458042|Treprostinil|treprostinil|mesh-list
110410826|NCT00959647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110410827|NCT00959647|Growth Inhibitors|growth inhibitors|mesh-ancestor
110410828|NCT00957853|Cetuximab|cetuximab|mesh-list
110410829|NCT00957853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110410830|NCT00957853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110410831|NCT02859571|Oxytocin|oxytocin|mesh-list
110410832|NCT02859571|Oxytocics|oxytocics|mesh-ancestor
110410833|NCT02859571|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110410834|NCT02859571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110410835|NCT00956839|Vitamin D|vitamin d|mesh-list
110410836|NCT00956839|Ergocalciferols|ergocalciferols|mesh-list
110410837|NCT00956839|Cholecalciferol|cholecalciferol|mesh-list
110410838|NCT00956839|Vitamins|vitamins|mesh-list
110410839|NCT00956839|Micronutrients|micronutrients|mesh-ancestor
110410840|NCT00956839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110410841|NCT00956839|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110410842|NCT00956839|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110410843|NCT00956293|Cyclosporine|cyclosporine|mesh-list
110410844|NCT00956293|Mycophenolic Acid|mycophenolic acid|mesh-list
110410845|NCT00956293|Everolimus|everolimus|mesh-list
110410846|NCT00956293|Cyclosporins|cyclosporins|mesh-list
110410847|NCT00956293|Basiliximab|basiliximab|mesh-list
110410848|NCT00956293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110410849|NCT00956293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110410850|NCT00956293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110410851|NCT00956293|Immunologic Factors|immunologic factors|mesh-ancestor
110410852|NCT00956293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110410853|NCT00956293|Antifungal Agents|antifungal agents|mesh-ancestor
110410854|NCT00956293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110410855|NCT00956293|Dermatologic Agents|dermatologic agents|mesh-ancestor
110410856|NCT00956293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110410857|NCT00956293|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110410858|NCT00956293|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110410859|NCT00956293|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110410860|NCT00956293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110410861|NCT00956293|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110410862|NCT00956293|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110410863|NCT00956293|Antitubercular Agents|antitubercular agents|mesh-ancestor
110410864|NCT00956293|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110410865|NCT04282291|Morphine|morphine|mesh-list
110410866|NCT04282291|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110410867|NCT04282291|Narcotics|narcotics|mesh-ancestor
110410868|NCT04282291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110410869|NCT04282291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110410870|NCT04282291|Analgesics|analgesics|mesh-ancestor
110410871|NCT04282291|Sensory System Agents|sensory system agents|mesh-ancestor
110410872|NCT04282291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110410873|NCT00955825|Immunomodulating Agents|immunomodulating agents|mesh-list
110410874|NCT00955825|Immunologic Factors|immunologic factors|mesh-ancestor
110410875|NCT00955825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110410876|NCT02859103|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
110410877|NCT02859103|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110410878|NCT02859103|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110410879|NCT02859103|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110410880|NCT02859103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110410881|NCT02859103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110410882|NCT02859103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110410883|NCT02859103|Antidepressive Agents|antidepressive agents|mesh-ancestor
110362405|NCT04798287|Adalimumab|adalimumab|mesh-list
110410884|NCT02859103|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110410885|NCT02869009|Aspirin|aspirin|mesh-list
110410886|NCT02869009|Clopidogrel|clopidogrel|mesh-list
110410887|NCT02869009|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110410888|NCT02869009|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110410889|NCT02869009|Analgesics|analgesics|mesh-ancestor
110410890|NCT02869009|Sensory System Agents|sensory system agents|mesh-ancestor
110410891|NCT02869009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110410892|NCT02869009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110410893|NCT02869009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110410894|NCT02869009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110410895|NCT02869009|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110410896|NCT02869009|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110410897|NCT02869009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110410898|NCT02869009|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110410899|NCT02869009|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110410900|NCT02869009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110410901|NCT02869009|Antipyretics|antipyretics|mesh-ancestor
110410902|NCT02869009|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110410903|NCT02869009|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110410904|NCT02869009|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110410905|NCT02869009|Purinergic Agents|purinergic agents|mesh-ancestor
110410906|NCT02869009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110410907|NCT01164579|Methotrexate|methotrexate|mesh-list
110410908|NCT01164579|Tofacitinib|tofacitinib|mesh-list
110410909|NCT01164579|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110410910|NCT01164579|Abortifacient Agents|abortifacient agents|mesh-ancestor
110410911|NCT01164579|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110410912|NCT01164579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110410913|NCT01164579|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110410914|NCT01164579|Antimetabolites|antimetabolites|mesh-ancestor
110410915|NCT01164579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110410916|NCT01164579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110410917|NCT01164579|Dermatologic Agents|dermatologic agents|mesh-ancestor
110410918|NCT01164579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110410919|NCT01164579|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110410920|NCT01164579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110410921|NCT01164579|Immunologic Factors|immunologic factors|mesh-ancestor
110410922|NCT01164579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110410923|NCT01164579|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110410924|NCT01164579|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
110410925|NCT01164579|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110410926|NCT02859259|Fostemsavir|fostemsavir|mesh-list
110410927|NCT02859259|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110410928|NCT02859259|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110410929|NCT02859259|Antiviral Agents|antiviral agents|mesh-ancestor
110410930|NCT02859259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110410931|NCT02859259|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110410932|NCT02859259|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110562029|NCT02655965|Sympatholytics|sympatholytics|mesh-ancestor
110410933|NCT02859259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110410934|NCT02857777|Esketamine|esketamine|mesh-list
110410935|NCT02857777|Antidepressive Agents|antidepressive agents|mesh-ancestor
110410936|NCT02857777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110410937|NCT00630643|Muromonab-CD3|muromonab-cd3|mesh-list
110410938|NCT00630643|Immunologic Factors|immunologic factors|mesh-ancestor
110410939|NCT00630643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110410940|NCT00630643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110410941|NCT03202849|Vitamin D|vitamin d|mesh-list
110410942|NCT03202849|Ergocalciferols|ergocalciferols|mesh-list
110410943|NCT03202849|Cholecalciferol|cholecalciferol|mesh-list
110410944|NCT03202849|Vitamins|vitamins|mesh-list
110410945|NCT03202849|Micronutrients|micronutrients|mesh-ancestor
110410946|NCT03202849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110410947|NCT03202849|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110410948|NCT03202849|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110410949|NCT04277533|Calcium|calcium|mesh-list
110410950|NCT04277533|Bilirubin|bilirubin|mesh-list
110410951|NCT04277533|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110410952|NCT04277533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110410953|NCT04277533|Antioxidants|antioxidants|mesh-ancestor
110410954|NCT04277533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110410955|NCT04277533|Protective Agents|protective agents|mesh-ancestor
110410956|NCT02445391|Cisplatin|cisplatin|mesh-list
110410957|NCT02445391|Carboplatin|carboplatin|mesh-list
110410958|NCT02445391|Capecitabine|capecitabine|mesh-list
110410959|NCT02445391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110410960|NCT02445391|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110410961|NCT02445391|Antimetabolites|antimetabolites|mesh-ancestor
110410962|NCT02445391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110410963|NCT01246986|Sorafenib|sorafenib|mesh-list
110410964|NCT01246986|Ramucirumab|ramucirumab|mesh-list
110410965|NCT01246986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110410966|NCT01246986|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110410967|NCT01246986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110410968|NCT01246986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110410969|NCT01164501|Empagliflozin|empagliflozin|mesh-list
110410970|NCT01164501|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110410971|NCT01164501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110410972|NCT01164501|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110410973|NCT01164501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110410974|NCT01163721|Ranolazine|ranolazine|mesh-list
110410975|NCT01163721|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110410976|NCT01163721|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110410977|NCT01163721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110410978|NCT00958243|Vaccines|vaccines|mesh-list
110410979|NCT00958243|Immunologic Factors|immunologic factors|mesh-ancestor
110562056|NCT04171193|Isoflurane|isoflurane|mesh-list
110410980|NCT00958243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110410981|NCT01241760|Interferons|interferons|mesh-list
110410982|NCT01241760|Ribavirin|ribavirin|mesh-list
110410983|NCT01241760|Interferon-alpha|interferon-alpha|mesh-list
110410984|NCT01241760|Interferon alpha-2|interferon alpha-2|mesh-list
110410985|NCT01241760|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110410986|NCT01241760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110410987|NCT01241760|Antiviral Agents|antiviral agents|mesh-ancestor
110410988|NCT01241760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110410989|NCT01241760|Antimetabolites|antimetabolites|mesh-ancestor
110410990|NCT01241760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110410991|NCT01241760|Immunologic Factors|immunologic factors|mesh-ancestor
110410992|NCT01241760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110410993|NCT04280263|Caffeine|caffeine|mesh-list
110410994|NCT04280263|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110410995|NCT04280263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110410996|NCT04280263|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110410997|NCT04280263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110410998|NCT04280263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110183794|NCT04711668|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110410999|NCT04280263|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110411000|NCT04280263|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110411001|NCT04280263|Purinergic Agents|purinergic agents|mesh-ancestor
110411002|NCT04280263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110411003|NCT00953329|Alefacept|alefacept|mesh-list
110411004|NCT00953329|Dermatologic Agents|dermatologic agents|mesh-ancestor
110411005|NCT00953329|Immunologic Factors|immunologic factors|mesh-ancestor
110411006|NCT00953329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110411007|NCT02857153|Urapidil|urapidil|mesh-list
110411008|NCT02857153|Phenylephrine|phenylephrine|mesh-list
110411009|NCT02857153|Oxymetazoline|oxymetazoline|mesh-list
110411010|NCT02857153|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110411011|NCT02857153|Mydriatics|mydriatics|mesh-ancestor
110411012|NCT02857153|Autonomic Agents|autonomic agents|mesh-ancestor
110411013|NCT02857153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110411014|NCT02857153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110411015|NCT02857153|Sympathomimetics|sympathomimetics|mesh-ancestor
110411016|NCT02857153|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110411017|NCT02857153|Nasal Decongestants|nasal decongestants|mesh-ancestor
110411018|NCT02857153|Respiratory System Agents|respiratory system agents|mesh-ancestor
110411019|NCT02857153|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110411020|NCT02857153|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110411021|NCT02857153|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110411022|NCT02857153|Adrenergic Agents|adrenergic agents|mesh-ancestor
110411023|NCT02857153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110411024|NCT02857153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110411025|NCT02857153|Protective Agents|protective agents|mesh-ancestor
110411026|NCT02857153|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110411027|NCT02857153|Vasodilator Agents|vasodilator agents|mesh-ancestor
110411028|NCT02857153|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110411029|NCT02857153|Serotonin Agents|serotonin agents|mesh-ancestor
110411030|NCT02857153|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110411031|NCT02857153|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110411032|NCT02857153|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110411033|NCT00953017|Bisacodyl|bisacodyl|mesh-list
110411034|NCT00953017|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
110411035|NCT00953017|Lubiprostone|lubiprostone|mesh-list
110411036|NCT00953017|Cathartics|cathartics|mesh-ancestor
110411037|NCT00953017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110411038|NCT00953017|Laxatives|laxatives|mesh-ancestor
110411039|NCT00953017|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
110411040|NCT00953017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110411041|NCT00953017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110411042|NCT00955357|Lacosamide|lacosamide|mesh-list
110411043|NCT00955357|Anticonvulsants|anticonvulsants|mesh-ancestor
110411044|NCT00955357|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110411045|NCT00955357|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110411046|NCT00955357|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110411047|NCT00955357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110411048|NCT00955279|Golimumab|golimumab|mesh-list
110411049|NCT00955279|Ustekinumab|ustekinumab|mesh-list
110411050|NCT00955279|Dermatologic Agents|dermatologic agents|mesh-ancestor
110411051|NCT00955279|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110411052|NCT00955279|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110411053|NCT00955279|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110411054|NCT00955279|Immunologic Factors|immunologic factors|mesh-ancestor
110411055|NCT00955279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110411056|NCT02857309|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
110411057|NCT02857309|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
110411058|NCT02857309|Mineralocorticoids|mineralocorticoids|mesh-list
110411059|NCT02857309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110411060|NCT02857309|Hormone Antagonists|hormone antagonists|mesh-ancestor
110411061|NCT02857309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110411062|NCT02857309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110411063|NCT02857309|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110411064|NCT02857309|Diuretics|diuretics|mesh-ancestor
110411065|NCT02857309|Natriuretic Agents|natriuretic agents|mesh-ancestor
110411067|NCT04261231|Anesthetics|anesthetics|mesh-list
110411068|NCT04261231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110411069|NCT04261231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110411070|NCT02857465|Dexamethasone|dexamethasone|mesh-list
110411071|NCT02857465|Dexamethasone acetate|dexamethasone acetate|mesh-list
110411072|NCT02857465|Sufentanil|sufentanil|mesh-list
110411073|NCT02857465|Dsuvia|dsuvia|mesh-list
110411074|NCT02857465|Ropivacaine|ropivacaine|mesh-list
110411075|NCT02857465|BB 1101|bb 1101|mesh-list
110411076|NCT02857465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110411077|NCT02857465|Antiemetics|antiemetics|mesh-ancestor
110411078|NCT02857465|Autonomic Agents|autonomic agents|mesh-ancestor
110411079|NCT02857465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110411080|NCT02857465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110411081|NCT02857465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110411082|NCT02857465|Glucocorticoids|glucocorticoids|mesh-ancestor
110411083|NCT02857465|Hormones|hormones|mesh-ancestor
110411084|NCT02857465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110411085|NCT02857465|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110411086|NCT02857465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110411087|NCT02857465|Protease Inhibitors|protease inhibitors|mesh-ancestor
110411088|NCT02857465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110562097|NCT04171349|Adrenergic Agents|adrenergic agents|mesh-ancestor
110411089|NCT02857465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110411090|NCT02857465|Anesthetics, Local|anesthetics, local|mesh-ancestor
110411091|NCT02857465|Anesthetics|anesthetics|mesh-ancestor
110411092|NCT02857465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110411093|NCT02857465|Sensory System Agents|sensory system agents|mesh-ancestor
110411094|NCT02857465|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110411095|NCT02857465|Narcotics|narcotics|mesh-ancestor
110411096|NCT02857465|Analgesics|analgesics|mesh-ancestor
110411097|NCT02857465|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110411098|NCT02857465|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110411099|NCT02857465|Anesthetics, General|anesthetics, general|mesh-ancestor
110411100|NCT04260139|Metronidazole|metronidazole|mesh-list
110411101|NCT04260139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110411102|NCT04260139|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110411103|NCT04260139|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110411104|NCT04260139|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110411105|NCT04206618|Denosumab|denosumab|mesh-list
110411106|NCT04206618|Teriparatide|teriparatide|mesh-list
110411107|NCT04206618|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110411108|NCT04206618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110411109|NCT04206618|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110411110|NCT01239732|Paclitaxel|paclitaxel|mesh-list
110411111|NCT01239732|Bevacizumab|bevacizumab|mesh-list
110411112|NCT01239732|Carboplatin|carboplatin|mesh-list
110411113|NCT01239732|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110411114|NCT01239732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110411115|NCT01239732|Tubulin Modulators|tubulin modulators|mesh-ancestor
110411116|NCT01239732|Antimitotic Agents|antimitotic agents|mesh-ancestor
110411117|NCT01239732|Mitosis Modulators|mitosis modulators|mesh-ancestor
110411118|NCT01239732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110411119|NCT01239732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110411120|NCT01239732|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110411121|NCT01239732|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110411122|NCT01239732|Growth Substances|growth substances|mesh-ancestor
110411123|NCT01239732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110411124|NCT01239732|Growth Inhibitors|growth inhibitors|mesh-ancestor
110411125|NCT02856919|Brimonidine Tartrate|brimonidine tartrate|mesh-list
110411126|NCT02856919|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110411127|NCT02856919|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110411128|NCT02856919|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110411129|NCT02856919|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110411130|NCT02856919|Adrenergic Agents|adrenergic agents|mesh-ancestor
110411131|NCT02856919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110411132|NCT02856919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110411133|NCT02856919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110411134|NCT00947011|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110411135|NCT00947011|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110411136|NCT00947011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110411137|NCT00947011|Incretins|incretins|mesh-ancestor
110411138|NCT00947011|Hormones|hormones|mesh-ancestor
110411139|NCT00947011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110411140|NCT00947011|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110411141|NCT00947011|Protease Inhibitors|protease inhibitors|mesh-ancestor
110411142|NCT00947011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110411143|NCT00947011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110411144|NCT02856685|Mitoxantrone|mitoxantrone|mesh-list
110411145|NCT02856685|Analgesics|analgesics|mesh-ancestor
110411146|NCT02856685|Sensory System Agents|sensory system agents|mesh-ancestor
110411147|NCT02856685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110411148|NCT02856685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110411149|NCT02856685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110411150|NCT02856685|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110411151|NCT02856685|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110411152|NCT02856685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110411153|NCT02856685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110411154|NCT01962415|Fludarabine|fludarabine|mesh-list
110411155|NCT01962415|Melphalan|melphalan|mesh-list
110411156|NCT01962415|Alemtuzumab|alemtuzumab|mesh-list
110411157|NCT01962415|Thiotepa|thiotepa|mesh-list
110411158|NCT01962415|Hydroxyurea|hydroxyurea|mesh-list
110411159|NCT01962415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110411160|NCT01962415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110411161|NCT01962415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110411162|NCT01962415|Immunologic Factors|immunologic factors|mesh-ancestor
110411163|NCT01962415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110411164|NCT01962415|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110411165|NCT01962415|Alkylating Agents|alkylating agents|mesh-ancestor
110411166|NCT01962415|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110411167|NCT01962415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110411168|NCT01962415|Antisickling Agents|antisickling agents|mesh-ancestor
110411169|NCT01962415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110411170|NCT01962415|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110411171|NCT02860663|Vitamin D|vitamin d|mesh-list
110411172|NCT02860663|Ergocalciferols|ergocalciferols|mesh-list
110411173|NCT02860663|Cholecalciferol|cholecalciferol|mesh-list
110411174|NCT02860663|Vitamins|vitamins|mesh-list
110411175|NCT02860663|Micronutrients|micronutrients|mesh-ancestor
110411176|NCT02860663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110411177|NCT02860663|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110411178|NCT02860663|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110411179|NCT02854345|Parathyroid Hormone|parathyroid hormone|mesh-list
110411180|NCT02854345|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110327929|NCT00481182|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110411181|NCT02854345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110411182|NCT01239342|Everolimus|everolimus|mesh-list
110411183|NCT01239342|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110411184|NCT01239342|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110411185|NCT01239342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110411186|NCT01239342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110411187|NCT01239342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110411188|NCT01239342|Immunologic Factors|immunologic factors|mesh-ancestor
110411189|NCT01239342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110411190|NCT01239342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110411191|NCT00946309|Sulforaphane|sulforaphane|mesh-list
110411192|NCT00946309|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110411193|NCT00946309|Protective Agents|protective agents|mesh-ancestor
110411194|NCT00946309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110411195|NCT00946309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110411196|NCT02853799|Insulin|insulin|mesh-list
110411197|NCT02853799|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110411198|NCT02853799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110411199|NCT01236534|Lubiprostone|lubiprostone|mesh-list
110411200|NCT01236534|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
110411201|NCT01236534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110411202|NCT01236534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110411203|NCT01235598|Certolizumab Pegol|certolizumab pegol|mesh-list
110411204|NCT01235598|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110411205|NCT01235598|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110411206|NCT01235598|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110411207|NCT01235598|Immunologic Factors|immunologic factors|mesh-ancestor
110411208|NCT01235598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110411209|NCT01235598|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110411210|NCT01235442|Etanercept|etanercept|mesh-list
110411211|NCT01235442|Clobetasol|clobetasol|mesh-list
110411212|NCT01235442|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110411213|NCT01235442|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110411214|NCT01235442|Analgesics|analgesics|mesh-ancestor
110411215|NCT01235442|Sensory System Agents|sensory system agents|mesh-ancestor
110411216|NCT01235442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110411217|NCT01235442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110411218|NCT01235442|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110411219|NCT01235442|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110411220|NCT01235442|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110411221|NCT01235442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110411222|NCT01235442|Immunologic Factors|immunologic factors|mesh-ancestor
110411223|NCT01235442|Glucocorticoids|glucocorticoids|mesh-ancestor
110411224|NCT01235442|Hormones|hormones|mesh-ancestor
110411225|NCT01235442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110411226|NCT01163253|Tofacitinib|tofacitinib|mesh-list
110411227|NCT01163253|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
110411228|NCT01163253|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110411229|NCT01163253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110411230|NCT01163253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110411231|NCT01162863|Lubiprostone|lubiprostone|mesh-list
110411232|NCT01162863|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
110411233|NCT01162863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110411234|NCT01162863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110411235|NCT05304039|Nitric Oxide|nitric oxide|mesh-list
110411236|NCT05304039|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110411237|NCT05304039|Autonomic Agents|autonomic agents|mesh-ancestor
110411238|NCT05304039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110411239|NCT05304039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110411240|NCT05304039|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110411241|NCT05304039|Respiratory System Agents|respiratory system agents|mesh-ancestor
110411242|NCT05304039|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110411243|NCT05304039|Antioxidants|antioxidants|mesh-ancestor
110411244|NCT05304039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110411245|NCT05304039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110411246|NCT05304039|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
110411247|NCT05304039|Vasodilator Agents|vasodilator agents|mesh-ancestor
110411248|NCT05304039|Gasotransmitters|gasotransmitters|mesh-ancestor
110411249|NCT05304039|Protective Agents|protective agents|mesh-ancestor
110411250|NCT01162473|Caseins|caseins|mesh-list
110411251|NCT01162473|Chelating Agents|chelating agents|mesh-ancestor
110411252|NCT01162473|Sequestering Agents|sequestering agents|mesh-ancestor
110327931|NCT00481182|Antiviral Agents|antiviral agents|mesh-ancestor
110411253|NCT01162473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110411254|NCT01162239|Varenicline|varenicline|mesh-list
110411255|NCT01162239|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110411256|NCT01162239|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110411257|NCT01162239|Cholinergic Agents|cholinergic agents|mesh-ancestor
110411258|NCT01162239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110411259|NCT01162239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110411260|NCT01162239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110411261|NCT01161537|Ivacaftor|ivacaftor|mesh-list
110411262|NCT01161537|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
110411263|NCT01161537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110411264|NCT01161537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110411265|NCT04314297|Durvalumab|durvalumab|mesh-list
110411266|NCT04314297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110411267|NCT04314297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110411268|NCT04124133|Hyaluronic Acid|hyaluronic acid|mesh-list
110411269|NCT04124133|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110411270|NCT04124133|Immunologic Factors|immunologic factors|mesh-ancestor
110411271|NCT04124133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110411272|NCT04124133|Viscosupplements|viscosupplements|mesh-ancestor
110411273|NCT04124133|Protective Agents|protective agents|mesh-ancestor
110411274|NCT01233258|Factor VIII|factor viii|mesh-list
110411275|NCT01233258|Coagulants|coagulants|mesh-ancestor
110411276|NCT01232790|Acetylcysteine|acetylcysteine|mesh-list
110411277|NCT01232790|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110411278|NCT01232790|Antiviral Agents|antiviral agents|mesh-ancestor
110411279|NCT01232790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110411280|NCT01232790|Expectorants|expectorants|mesh-ancestor
110411281|NCT01232790|Respiratory System Agents|respiratory system agents|mesh-ancestor
110411282|NCT01232790|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110411283|NCT01232790|Antioxidants|antioxidants|mesh-ancestor
110411284|NCT01232790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110411285|NCT01232790|Protective Agents|protective agents|mesh-ancestor
110411286|NCT01232790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110411287|NCT01232790|Antidotes|antidotes|mesh-ancestor
110411288|NCT01232556|Rituximab|rituximab|mesh-list
110411289|NCT01232556|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
110411290|NCT01232556|Gemcitabine|gemcitabine|mesh-list
110411291|NCT01232556|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110411292|NCT01232556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110411293|NCT01232556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110411294|NCT01232556|Immunologic Factors|immunologic factors|mesh-ancestor
110411295|NCT01232556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110411297|NCT01232556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110411298|NCT01232556|Antimetabolites|antimetabolites|mesh-ancestor
110411299|NCT01232556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110411300|NCT01232556|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110562195|NCT00649415|Valdecoxib|valdecoxib|mesh-list
110411301|NCT01232556|Alkylating Agents|alkylating agents|mesh-ancestor
110411302|NCT01232556|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110411303|NCT01232556|Immunotoxins|immunotoxins|mesh-ancestor
110411304|NCT01232556|Immunoconjugates|immunoconjugates|mesh-ancestor
110411305|NCT00946153|Lenvatinib|lenvatinib|mesh-list
110411306|NCT00946153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110411307|NCT00946153|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110411308|NCT00946153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110411309|NCT00946153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110411310|NCT01914367|Vaccines|vaccines|mesh-list
110411311|NCT01914367|Immunologic Factors|immunologic factors|mesh-ancestor
110411312|NCT01914367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110411313|NCT01160289|Tadalafil|tadalafil|mesh-list
110411314|NCT01160289|Vasodilator Agents|vasodilator agents|mesh-ancestor
110411315|NCT01160289|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110411316|NCT01160289|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110411317|NCT01160289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110411318|NCT01160289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110411319|NCT01160289|Urological Agents|urological agents|mesh-ancestor
110411320|NCT01159665|Plasminogen|plasminogen|mesh-list
110411321|NCT01159665|Fibrinolysin|fibrinolysin|mesh-list
110411322|NCT01159665|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110411323|NCT01159665|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110411324|NCT01159665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110411326|NCT01158261|Hemostatics|hemostatics|mesh-ancestor
110411327|NCT01158261|Coagulants|coagulants|mesh-ancestor
110411328|NCT01157169|Buprenorphine|buprenorphine|mesh-list
110411329|NCT01157169|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110411330|NCT01157169|Narcotics|narcotics|mesh-ancestor
110411331|NCT01157169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110411332|NCT01157169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110411333|NCT01157169|Analgesics|analgesics|mesh-ancestor
110411334|NCT01157169|Sensory System Agents|sensory system agents|mesh-ancestor
110411335|NCT01157169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110411336|NCT01157169|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110411337|NCT04313907|Clonazepam|clonazepam|mesh-list
110411338|NCT04313907|Anticonvulsants|anticonvulsants|mesh-ancestor
110411339|NCT04313907|GABA Modulators|gaba modulators|mesh-ancestor
110411340|NCT04313907|GABA Agents|gaba agents|mesh-ancestor
110411341|NCT04313907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110411342|NCT04313907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110411343|NCT04313907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110411344|NCT01231620|Oseltamivir|oseltamivir|mesh-list
110411345|NCT01231620|Zanamivir|zanamivir|mesh-list
110411346|NCT01231620|Antiviral Agents|antiviral agents|mesh-ancestor
110411347|NCT01231620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110411348|NCT01231620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110411349|NCT01231620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110411350|NCT01231464|Fluticasone|fluticasone|mesh-list
110411351|NCT01231464|Xhance|xhance|mesh-list
110411352|NCT01231464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110411353|NCT01231464|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110411354|NCT01231464|Autonomic Agents|autonomic agents|mesh-ancestor
110411355|NCT01231464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110411356|NCT01231464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110411357|NCT01231464|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110411358|NCT01231464|Respiratory System Agents|respiratory system agents|mesh-ancestor
110411359|NCT01231464|Dermatologic Agents|dermatologic agents|mesh-ancestor
110411360|NCT01231464|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110411361|NCT01156311|Dimethyl Fumarate|dimethyl fumarate|mesh-list
110411362|NCT01156311|Dermatologic Agents|dermatologic agents|mesh-ancestor
110411363|NCT01156311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110411364|NCT01156311|Immunologic Factors|immunologic factors|mesh-ancestor
110411365|NCT01156311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110411366|NCT04281745|Botulinum Toxins|botulinum toxins|mesh-list
110411367|NCT04281745|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110411368|NCT04281745|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110411369|NCT04281745|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110411370|NCT04281745|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110411371|NCT04281745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110411372|NCT04281745|Cholinergic Agents|cholinergic agents|mesh-ancestor
110411373|NCT04281745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110411374|NCT04281745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110411375|NCT04281745|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110411376|NCT04281745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110411378|NCT01155531|Telenzepine|telenzepine|mesh-list
110411379|NCT01155531|Antidepressive Agents|antidepressive agents|mesh-ancestor
110411380|NCT01155531|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110411381|NCT01155531|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110411382|NCT01155531|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110411383|NCT01155531|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110411384|NCT01155531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110411385|NCT01155531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110411386|NCT01155531|Serotonin Agents|serotonin agents|mesh-ancestor
110411387|NCT01155531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110411388|NCT01155531|Parasympatholytics|parasympatholytics|mesh-ancestor
110411389|NCT01155531|Autonomic Agents|autonomic agents|mesh-ancestor
110411390|NCT01155531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110411391|NCT01155219|Latanoprost|latanoprost|mesh-list
110411392|NCT01155219|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110411393|NCT01155219|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110411394|NCT01098955|Varenicline|varenicline|mesh-list
110411395|NCT01098955|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110411396|NCT01098955|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110411397|NCT01098955|Cholinergic Agents|cholinergic agents|mesh-ancestor
110411398|NCT01098955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110411399|NCT01098955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110411400|NCT01098955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110411401|NCT00631033|Metformin|metformin|mesh-list
110411402|NCT00631033|Diazoxide|diazoxide|mesh-list
110411403|NCT00631033|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110411404|NCT00631033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110411405|NCT00631033|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110411406|NCT00631033|Vasodilator Agents|vasodilator agents|mesh-ancestor
110411407|NCT01155063|Exemestane|exemestane|mesh-list
110411408|NCT01155063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110411409|NCT01155063|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110411410|NCT01155063|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110411411|NCT01155063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110411412|NCT01155063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110411413|NCT01155063|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110411414|NCT01155063|Hormone Antagonists|hormone antagonists|mesh-ancestor
110411415|NCT01155063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110411416|NCT01155063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110411417|NCT01154673|Ritonavir|ritonavir|mesh-list
110411418|NCT01154673|Lopinavir|lopinavir|mesh-list
110411419|NCT01154673|Tenofovir|tenofovir|mesh-list
110411420|NCT01154673|Emtricitabine|emtricitabine|mesh-list
110411421|NCT01154673|Raltegravir Potassium|raltegravir potassium|mesh-list
110411422|NCT01154673|Maraviroc|maraviroc|mesh-list
110411423|NCT01154673|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110411424|NCT01154673|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110411425|NCT01154673|Protease Inhibitors|protease inhibitors|mesh-ancestor
110411426|NCT01154673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110411427|NCT01154673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110411428|NCT01154673|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110411429|NCT01154673|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110411430|NCT01154673|Antiviral Agents|antiviral agents|mesh-ancestor
110411431|NCT01154673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110411432|NCT01154673|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110411433|NCT01154673|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110411434|NCT01154673|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110411435|NCT01154673|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110411436|NCT01154673|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110411437|NCT01154673|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110411438|NCT01154673|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110411439|NCT01154673|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110411440|NCT01154673|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
110411441|NCT02884713|Doxycycline|doxycycline|mesh-list
110411442|NCT02884713|Levofloxacin|levofloxacin|mesh-list
110411443|NCT02884713|Esomeprazole|esomeprazole|mesh-list
110411444|NCT02884713|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110411445|NCT02884713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110411446|NCT02884713|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110411447|NCT02884713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110411448|NCT02884713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110411449|NCT02884713|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110411450|NCT02884713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110411451|NCT02884713|Antimalarials|antimalarials|mesh-ancestor
110411452|NCT02884713|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110411453|NCT02884713|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110411454|NCT02884713|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110411455|NCT02884713|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110411456|NCT02884713|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110411457|NCT02884713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110411458|NCT02884713|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110411459|NCT02884713|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110411460|NCT01154127|Glycopyrrolate|glycopyrrolate|mesh-list
110411461|NCT01154127|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110411462|NCT01154127|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110411463|NCT01154127|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110411464|NCT01154127|Cholinergic Agents|cholinergic agents|mesh-ancestor
110411465|NCT01154127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110411466|NCT01154127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110411467|NCT01154127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110411468|NCT01228734|Leucovorin|leucovorin|mesh-list
110411469|NCT01228734|Folic Acid|folic acid|mesh-list
110411470|NCT01228734|Fluorouracil|fluorouracil|mesh-list
110411471|NCT01228734|Oxaliplatin|oxaliplatin|mesh-list
110411472|NCT01228734|Cetuximab|cetuximab|mesh-list
110411473|NCT01228734|Levoleucovorin|levoleucovorin|mesh-list
110411474|NCT01228734|Antimetabolites|antimetabolites|mesh-ancestor
110411475|NCT01228734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110411476|NCT01228734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110411477|NCT01228734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110411478|NCT01228734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110411479|NCT01228734|Immunologic Factors|immunologic factors|mesh-ancestor
110411480|NCT01228734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110411481|NCT01228734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110411482|NCT01228734|Antidotes|antidotes|mesh-ancestor
110411483|NCT01228734|Protective Agents|protective agents|mesh-ancestor
110411484|NCT01228734|Vitamin B Complex|vitamin b complex|mesh-ancestor
110411485|NCT01228734|Vitamins|vitamins|mesh-ancestor
110411486|NCT01228734|Micronutrients|micronutrients|mesh-ancestor
110411487|NCT01228734|Hematinics|hematinics|mesh-ancestor
110411488|NCT01153971|Rituximab|rituximab|mesh-list
110411489|NCT01153971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110411490|NCT01153971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110411491|NCT01153971|Immunologic Factors|immunologic factors|mesh-ancestor
110411492|NCT01153971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110411493|NCT01153971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110411494|NCT01153893|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110411495|NCT01153893|Immunologic Factors|immunologic factors|mesh-ancestor
110411496|NCT01153893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110411497|NCT00951379|Pioglitazone|pioglitazone|mesh-list
110411498|NCT00951379|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110411499|NCT00951379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110411500|NCT01153815|Botulinum Toxins|botulinum toxins|mesh-list
110411501|NCT01153815|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110411502|NCT01153815|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110411503|NCT01153815|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110411504|NCT01153815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110411505|NCT01153815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110411506|NCT01153815|Cholinergic Agents|cholinergic agents|mesh-ancestor
110411507|NCT01153815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110411508|NCT01153815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110411509|NCT01153815|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110411510|NCT01153815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110411512|NCT01153425|Teriparatide|teriparatide|mesh-list
110411513|NCT01153425|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110411514|NCT01153425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110411515|NCT01153425|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110411516|NCT01153269|Ritonavir|ritonavir|mesh-list
110411517|NCT01153269|Lopinavir|lopinavir|mesh-list
110411518|NCT01153269|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110411519|NCT01153269|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110411520|NCT01153269|Protease Inhibitors|protease inhibitors|mesh-ancestor
110411521|NCT01153269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110411522|NCT01153269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110411523|NCT01153269|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110411524|NCT01153269|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110411525|NCT01153269|Antiviral Agents|antiviral agents|mesh-ancestor
110411526|NCT01153269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110411527|NCT01153269|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110411528|NCT01153269|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110411529|NCT02884635|Methotrexate|methotrexate|mesh-list
110411530|NCT02884635|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110411531|NCT02884635|Abortifacient Agents|abortifacient agents|mesh-ancestor
110411532|NCT02884635|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110411533|NCT02884635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110411534|NCT02884635|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110411535|NCT02884635|Antimetabolites|antimetabolites|mesh-ancestor
110411536|NCT02884635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110411537|NCT02884635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110411538|NCT02884635|Dermatologic Agents|dermatologic agents|mesh-ancestor
110562325|NCT02653703|Ethanol|ethanol|mesh-list
110411539|NCT02884635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110411540|NCT02884635|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110411541|NCT02884635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110411542|NCT02884635|Immunologic Factors|immunologic factors|mesh-ancestor
110411543|NCT02884635|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110411544|NCT02884635|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110411546|NCT02884479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110411547|NCT02884479|Tubulin Modulators|tubulin modulators|mesh-ancestor
110411548|NCT02884479|Antimitotic Agents|antimitotic agents|mesh-ancestor
110411549|NCT02884479|Mitosis Modulators|mitosis modulators|mesh-ancestor
110411550|NCT02884479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110411551|NCT01152021|Dexmedetomidine|dexmedetomidine|mesh-list
110411552|NCT01152021|Propofol|propofol|mesh-list
110411553|NCT01152021|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110411554|NCT01152021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110411555|NCT01152021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110411556|NCT01152021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110411557|NCT01152021|Analgesics|analgesics|mesh-ancestor
110411558|NCT01152021|Sensory System Agents|sensory system agents|mesh-ancestor
110411559|NCT01152021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110411560|NCT01152021|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110411561|NCT01152021|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110411562|NCT01152021|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110411563|NCT01152021|Adrenergic Agents|adrenergic agents|mesh-ancestor
110411564|NCT01152021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110411565|NCT01152021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110411566|NCT01152021|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110411567|NCT01152021|Anesthetics, General|anesthetics, general|mesh-ancestor
110411568|NCT01152021|Anesthetics|anesthetics|mesh-ancestor
110411569|NCT01151085|Voriconazole|voriconazole|mesh-list
110411570|NCT01151085|Antifungal Agents|antifungal agents|mesh-ancestor
110411571|NCT01151085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110411572|NCT01151085|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110411573|NCT01151085|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110411574|NCT01151085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110411575|NCT01151085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110411576|NCT01151085|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110411577|NCT01151085|Hormone Antagonists|hormone antagonists|mesh-ancestor
110411578|NCT01151085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110411579|NCT01151085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110411580|NCT01151085|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110411582|NCT01149369|Antiemetics|antiemetics|mesh-ancestor
110411583|NCT01149369|Autonomic Agents|autonomic agents|mesh-ancestor
110411584|NCT01149369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110411585|NCT01149369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110411586|NCT01149369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110411587|NCT01149369|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110411588|NCT01149369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110411589|NCT01149369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110411590|NCT01740427|Letrozole|letrozole|mesh-list
110411591|NCT01740427|Palbociclib|palbociclib|mesh-list
110411592|NCT01740427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110411593|NCT01740427|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110411594|NCT01740427|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110411595|NCT01740427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110411596|NCT01740427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110411597|NCT01740427|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110411599|NCT01740427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110411600|NCT01740427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110411601|NCT01740427|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110411602|NCT00879931|Methylprednisolone|methylprednisolone|mesh-list
110411603|NCT00879931|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110411604|NCT00879931|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110411605|NCT00879931|Prednisolone|prednisolone|mesh-list
110411606|NCT00879931|Prednisolone acetate|prednisolone acetate|mesh-list
110411607|NCT00879931|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110411608|NCT00879931|Prednisolone phosphate|prednisolone phosphate|mesh-list
110411609|NCT00879931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110411610|NCT00879931|Antiemetics|antiemetics|mesh-ancestor
110411611|NCT00879931|Autonomic Agents|autonomic agents|mesh-ancestor
110327946|NCT00443937|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110411612|NCT00879931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110411613|NCT00879931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110411614|NCT00879931|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110411615|NCT00879931|Glucocorticoids|glucocorticoids|mesh-ancestor
110411616|NCT00879931|Hormones|hormones|mesh-ancestor
110411617|NCT00879931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110411618|NCT00879931|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110411619|NCT00879931|Protective Agents|protective agents|mesh-ancestor
110411620|NCT00879931|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110411621|NCT00879931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110411622|NCT01737619|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110411623|NCT01227564|Saponin QA-21V1|saponin qa-21v1|mesh-list
110411624|NCT01227564|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110411625|NCT01227564|Immunologic Factors|immunologic factors|mesh-ancestor
110411626|NCT01227564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110411627|NCT00739141|Cyclophosphamide|cyclophosphamide|mesh-list
110411628|NCT00739141|Thiotepa|thiotepa|mesh-list
110411630|NCT00739141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110411631|NCT00739141|Immunologic Factors|immunologic factors|mesh-ancestor
110411632|NCT00739141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110411633|NCT00739141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110411634|NCT00739141|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110411635|NCT00739141|Alkylating Agents|alkylating agents|mesh-ancestor
110363164|NCT04675944|Zamicastat|zamicastat|mesh-list
110411636|NCT00739141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110562391|NCT02661893|Rifampin|rifampin|mesh-list
110411637|NCT00739141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110411638|NCT00739141|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110411639|NCT01148979|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
110411640|NCT01148979|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110411641|NCT01148979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110411642|NCT01148979|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110411643|NCT01148979|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110411644|NCT01148979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110411645|NCT01148979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110411646|NCT01148979|Dopamine Agents|dopamine agents|mesh-ancestor
110411647|NCT01148979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110411648|NCT01735825|Paclitaxel|paclitaxel|mesh-list
110411649|NCT01735825|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110411650|NCT01735825|Everolimus|everolimus|mesh-list
110411651|NCT01735825|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110411652|NCT01735825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110411653|NCT01735825|Tubulin Modulators|tubulin modulators|mesh-ancestor
110411654|NCT01735825|Antimitotic Agents|antimitotic agents|mesh-ancestor
110411655|NCT01735825|Mitosis Modulators|mitosis modulators|mesh-ancestor
110411656|NCT01735825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110411657|NCT01735825|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110411658|NCT01735825|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110411659|NCT01735825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110411660|NCT01735825|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110411661|NCT01735825|Immunologic Factors|immunologic factors|mesh-ancestor
110411662|NCT01735825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110411663|NCT01148511|Ranibizumab|ranibizumab|mesh-list
110411664|NCT01148511|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110411665|NCT01148511|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110411666|NCT01148511|Growth Substances|growth substances|mesh-ancestor
110411667|NCT01148511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110411668|NCT01148511|Growth Inhibitors|growth inhibitors|mesh-ancestor
110411669|NCT01148511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110411670|NCT02860117|Ketamine|ketamine|mesh-list
110411671|NCT02860117|Analgesics|analgesics|mesh-ancestor
110411672|NCT02860117|Sensory System Agents|sensory system agents|mesh-ancestor
110411673|NCT02860117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110411674|NCT02860117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110411675|NCT02860117|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110411676|NCT02860117|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110411677|NCT02860117|Anesthetics, General|anesthetics, general|mesh-ancestor
110411678|NCT02860117|Anesthetics|anesthetics|mesh-ancestor
110411679|NCT02860117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110411680|NCT02860117|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110411681|NCT02860117|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110411682|NCT02860117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110411683|NCT02860117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110411685|NCT02853253|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
110411686|NCT02853253|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
110411687|NCT02853253|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110411688|NCT04269187|Theophylline|theophylline|mesh-list
110411689|NCT04269187|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110411690|NCT04269187|Autonomic Agents|autonomic agents|mesh-ancestor
110411691|NCT04269187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110411692|NCT04269187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110562406|NCT00855920|Indomethacin|indomethacin|mesh-list
110411693|NCT04269187|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110411694|NCT04269187|Respiratory System Agents|respiratory system agents|mesh-ancestor
110411695|NCT04269187|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110411696|NCT04269187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110411697|NCT04269187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110411698|NCT04269187|Vasodilator Agents|vasodilator agents|mesh-ancestor
110411699|NCT04269187|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110411700|NCT04269187|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110411701|NCT04269187|Purinergic Agents|purinergic agents|mesh-ancestor
110411702|NCT04269187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110411703|NCT04269109|Analgesics, Opioid|analgesics, opioid|mesh-list
110411704|NCT04269109|Narcotics|narcotics|mesh-ancestor
110411705|NCT04269109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110411706|NCT04269109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110411707|NCT04269109|Analgesics|analgesics|mesh-ancestor
110411708|NCT04269109|Sensory System Agents|sensory system agents|mesh-ancestor
110411709|NCT04269109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110411710|NCT01226472|Mogamulizumab|mogamulizumab|mesh-list
110411711|NCT01226472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110411713|NCT04268563|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110411714|NCT04268563|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110411715|NCT04268563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110411716|NCT04268563|Incretins|incretins|mesh-ancestor
110411717|NCT04268563|Hormones|hormones|mesh-ancestor
110411718|NCT04268563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110411719|NCT04268563|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110411720|NCT04268563|Protease Inhibitors|protease inhibitors|mesh-ancestor
110411721|NCT04268563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110411722|NCT04268563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110411723|NCT01225146|Ranibizumab|ranibizumab|mesh-list
110411724|NCT01225146|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110411725|NCT01225146|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110411726|NCT01225146|Growth Substances|growth substances|mesh-ancestor
110411727|NCT01225146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110411728|NCT01225146|Growth Inhibitors|growth inhibitors|mesh-ancestor
110411729|NCT01225146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110411730|NCT01223196|Pioglitazone|pioglitazone|mesh-list
110411731|NCT01223196|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110411732|NCT01223196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110411733|NCT01222416|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
110411734|NCT01222416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110411735|NCT00950911|Denosumab|denosumab|mesh-list
110411736|NCT00950911|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110411737|NCT00950911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110411738|NCT02855515|Anesthetics|anesthetics|mesh-list
110411739|NCT02855515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110411740|NCT02855515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110411741|NCT04206228|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
110411742|NCT04206228|Hematinics|hematinics|mesh-ancestor
110411743|NCT01218594|Endostatins|endostatins|mesh-list
110411744|NCT01218594|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110411745|NCT01218594|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110411746|NCT01218594|Growth Substances|growth substances|mesh-ancestor
110562422|NCT02657213|Insulin|insulin|mesh-list
110411747|NCT01218594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110411748|NCT01218594|Growth Inhibitors|growth inhibitors|mesh-ancestor
110411749|NCT01218594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110411750|NCT01610557|Bevacizumab|bevacizumab|mesh-list
110411751|NCT01610557|Ranibizumab|ranibizumab|mesh-list
110411752|NCT01610557|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110411753|NCT01610557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110411754|NCT01610557|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110411755|NCT01610557|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110411756|NCT01610557|Growth Substances|growth substances|mesh-ancestor
110411757|NCT01610557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110411758|NCT01610557|Growth Inhibitors|growth inhibitors|mesh-ancestor
110411760|NCT00943735|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110411761|NCT00943735|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110411762|NCT00943735|Cholinergic Agents|cholinergic agents|mesh-ancestor
110411763|NCT00943735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110411764|NCT00943735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110411765|NCT00943735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110411766|NCT00943735|Urological Agents|urological agents|mesh-ancestor
110411768|NCT00943111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110411769|NCT00943111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110411770|NCT01147497|Misoprostol|misoprostol|mesh-list
110411771|NCT01147497|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110411772|NCT01147497|Abortifacient Agents|abortifacient agents|mesh-ancestor
110411773|NCT01147497|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110411774|NCT01147497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110411775|NCT01147497|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110411776|NCT01147497|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110411777|NCT01147497|Oxytocics|oxytocics|mesh-ancestor
110411778|NCT01147341|Certolizumab Pegol|certolizumab pegol|mesh-list
110411779|NCT01147341|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110411780|NCT01147341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110411781|NCT01147341|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110411782|NCT01147341|Immunologic Factors|immunologic factors|mesh-ancestor
110363309|NCT04676997|Paclitaxel|paclitaxel|mesh-list
110411783|NCT01147341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110411784|NCT01147341|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110411785|NCT00950755|Tositumomab I-131|tositumomab i-131|mesh-list
110411786|NCT00950755|Antibodies|antibodies|mesh-list
110411787|NCT00950755|Immunologic Factors|immunologic factors|mesh-ancestor
110411788|NCT00950755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110411789|NCT00950755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110411790|NCT01147107|Efavirenz|efavirenz|mesh-list
110411791|NCT01147107|Raltegravir Potassium|raltegravir potassium|mesh-list
110411792|NCT01147107|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110411793|NCT01147107|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110411794|NCT01147107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110411795|NCT01147107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110411796|NCT01147107|Antiviral Agents|antiviral agents|mesh-ancestor
110411797|NCT01147107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110411798|NCT01147107|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110411799|NCT01147107|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110411800|NCT01147107|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110411801|NCT01147107|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110562437|NCT00650273|Azithromycin|azithromycin|mesh-list
110411802|NCT01147107|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110411803|NCT01147107|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110411804|NCT01147107|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110411805|NCT01147107|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110411806|NCT01147107|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110411807|NCT01147107|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110411808|NCT01146951|Rufinamide|rufinamide|mesh-list
110411809|NCT01146951|Anticonvulsants|anticonvulsants|mesh-ancestor
110183872|NCT03152123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110411810|NCT01146951|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110411811|NCT01146951|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110411812|NCT01146951|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110411813|NCT01146951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110411815|NCT01146873|Lopinavir|lopinavir|mesh-list
110411816|NCT01146873|Abacavir|abacavir|mesh-list
110411817|NCT01146873|Stavudine|stavudine|mesh-list
110411818|NCT01146873|Efavirenz|efavirenz|mesh-list
110411819|NCT01146873|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110411820|NCT01146873|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110411821|NCT01146873|Protease Inhibitors|protease inhibitors|mesh-ancestor
110411822|NCT01146873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110411823|NCT01146873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110411824|NCT01146873|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110411825|NCT01146873|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110411826|NCT01146873|Antiviral Agents|antiviral agents|mesh-ancestor
110411827|NCT01146873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110411828|NCT01146873|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110411829|NCT01146873|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110411830|NCT01146873|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110411831|NCT01146873|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110411832|NCT01146873|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110411833|NCT01146873|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110411834|NCT01146873|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110411835|NCT01146873|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110411836|NCT01146873|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110411837|NCT01146873|Antimetabolites|antimetabolites|mesh-ancestor
110411839|NCT01146795|Bevacizumab|bevacizumab|mesh-list
110411840|NCT01146795|Carboplatin|carboplatin|mesh-list
110411841|NCT01146795|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110411842|NCT01146795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110411843|NCT01146795|Tubulin Modulators|tubulin modulators|mesh-ancestor
110411844|NCT01146795|Antimitotic Agents|antimitotic agents|mesh-ancestor
110411845|NCT01146795|Mitosis Modulators|mitosis modulators|mesh-ancestor
110411846|NCT01146795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110411847|NCT01146795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110411848|NCT01146795|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110411849|NCT01146795|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110411850|NCT01146795|Growth Substances|growth substances|mesh-ancestor
110411851|NCT01146795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110411852|NCT01146795|Growth Inhibitors|growth inhibitors|mesh-ancestor
110411853|NCT01146561|Tanezumab|tanezumab|mesh-list
110411854|NCT01146561|Analgesics|analgesics|mesh-ancestor
110411855|NCT01146561|Sensory System Agents|sensory system agents|mesh-ancestor
110411856|NCT01146561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110411857|NCT01146561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110411858|NCT00942175|Esomeprazole|esomeprazole|mesh-list
110411859|NCT00942175|Omeprazole|omeprazole|mesh-list
110411860|NCT00942175|Lansoprazole|lansoprazole|mesh-list
110411861|NCT00942175|Dexlansoprazole|dexlansoprazole|mesh-list
110411862|NCT00942175|Clopidogrel|clopidogrel|mesh-list
110411863|NCT00942175|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110411864|NCT00942175|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110411865|NCT00942175|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110411866|NCT00942175|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110411867|NCT00942175|Purinergic Agents|purinergic agents|mesh-ancestor
110411868|NCT00942175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110411869|NCT00942175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110411870|NCT00942175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110411871|NCT00942175|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110411872|NCT00942175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110411873|NCT00942175|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110411874|NCT00942175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110411876|NCT01145625|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110411877|NCT01145625|Vasodilator Agents|vasodilator agents|mesh-ancestor
110411878|NCT02852083|Pioglitazone|pioglitazone|mesh-list
110411879|NCT02852083|Clarithromycin|clarithromycin|mesh-list
110411880|NCT02852083|Nivolumab|nivolumab|mesh-list
110411881|NCT02852083|Treosulfan|treosulfan|mesh-list
110411882|NCT02852083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110411883|NCT02852083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110411884|NCT02852083|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110411885|NCT02852083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110411886|NCT02852083|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110411887|NCT02852083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110411888|NCT02852083|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110411889|NCT02852083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110411890|NCT02852083|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110411891|NCT02852083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110411892|NCT02852083|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110411893|NCT02852083|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110411894|NCT02852083|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110411895|NCT02852083|Alkylating Agents|alkylating agents|mesh-ancestor
110411896|NCT00602407|Cilostazol|cilostazol|mesh-list
110411897|NCT00602407|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110411898|NCT00602407|Autonomic Agents|autonomic agents|mesh-ancestor
110327956|NCT00443937|Antitubercular Agents|antitubercular agents|mesh-ancestor
110411899|NCT00602407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110411900|NCT00602407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110411901|NCT00602407|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110411902|NCT00602407|Respiratory System Agents|respiratory system agents|mesh-ancestor
110411903|NCT00602407|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110411904|NCT00602407|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110411905|NCT00602407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110411906|NCT00602407|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110411907|NCT00602407|Vasodilator Agents|vasodilator agents|mesh-ancestor
110411908|NCT00602407|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110411909|NCT00602407|Protective Agents|protective agents|mesh-ancestor
110411910|NCT00602407|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110411911|NCT00602407|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110411912|NCT00602407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110411913|NCT00950599|Saxagliptin|saxagliptin|mesh-list
110411914|NCT00950599|Incretins|incretins|mesh-ancestor
110411915|NCT00950599|Hormones|hormones|mesh-ancestor
110411916|NCT00950599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110411917|NCT00950599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110411918|NCT00950599|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110411919|NCT00950599|Protease Inhibitors|protease inhibitors|mesh-ancestor
110411920|NCT00950599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110411921|NCT00950599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110411922|NCT00950599|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110411923|NCT01143207|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
110411924|NCT01143207|Medroxyprogesterone|medroxyprogesterone|mesh-list
110411925|NCT01143207|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110411926|NCT01143207|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110411927|NCT01143207|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110411928|NCT01143207|Contraceptive Agents|contraceptive agents|mesh-ancestor
110411929|NCT01143207|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110411930|NCT01143207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110411931|NCT01143207|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110411932|NCT01143207|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110411933|NCT01143207|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110411934|NCT01143207|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110411935|NCT01143207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110411937|NCT01143051|Racepinephrine|racepinephrine|mesh-list
110411938|NCT01143051|Epinephryl borate|epinephryl borate|mesh-list
110411939|NCT01143051|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110411940|NCT01143051|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110411941|NCT01143051|Adrenergic Agents|adrenergic agents|mesh-ancestor
110411942|NCT01143051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110411943|NCT01143051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110411944|NCT01143051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110411945|NCT01143051|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110411946|NCT01143051|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110411947|NCT01143051|Autonomic Agents|autonomic agents|mesh-ancestor
110411948|NCT01143051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110411949|NCT01143051|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110411950|NCT01143051|Respiratory System Agents|respiratory system agents|mesh-ancestor
110411951|NCT01143051|Mydriatics|mydriatics|mesh-ancestor
110411952|NCT01143051|Sympathomimetics|sympathomimetics|mesh-ancestor
110411953|NCT01143051|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110411954|NCT05199597|Atropine|atropine|mesh-list
110411955|NCT05199597|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110411956|NCT05199597|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110411957|NCT05199597|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110411958|NCT05199597|Autonomic Agents|autonomic agents|mesh-ancestor
110411959|NCT05199597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110411960|NCT05199597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110411961|NCT05199597|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110411962|NCT05199597|Respiratory System Agents|respiratory system agents|mesh-ancestor
110411963|NCT05199597|Mydriatics|mydriatics|mesh-ancestor
110411964|NCT05199597|Parasympatholytics|parasympatholytics|mesh-ancestor
110411965|NCT05199597|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110411966|NCT05199597|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110411967|NCT05199597|Cholinergic Agents|cholinergic agents|mesh-ancestor
110411968|NCT05199597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110411969|NCT05199597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110411970|NCT01142193|Topiramate|topiramate|mesh-list
110411971|NCT01142193|Anticonvulsants|anticonvulsants|mesh-ancestor
110411972|NCT01142193|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110411973|NCT01142193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110411974|NCT01139775|Pemetrexed|pemetrexed|mesh-list
110411975|NCT01139775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110411976|NCT01139775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110411977|NCT01139775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110411978|NCT01139775|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110411979|NCT01139775|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110411980|NCT01283516|Ceritinib|ceritinib|mesh-list
110411981|NCT01283516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110411982|NCT01283516|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110411983|NCT01283516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110411984|NCT01283516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110411985|NCT01283282|Clopidogrel|clopidogrel|mesh-list
110411986|NCT01283282|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110411987|NCT01283282|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110411988|NCT01283282|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110411989|NCT01283282|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110411990|NCT01283282|Purinergic Agents|purinergic agents|mesh-ancestor
110411991|NCT01283282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110411992|NCT01283282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110411993|NCT01283282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110411994|NCT01282814|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
110411995|NCT01282814|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110411996|NCT01282814|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110411997|NCT01282814|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110411998|NCT01282814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110411999|NCT01282814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110412000|NCT01282814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110412001|NCT01282814|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110412002|NCT01282814|Antidepressive Agents|antidepressive agents|mesh-ancestor
110412003|NCT01282814|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110412004|NCT00941863|Sorafenib|sorafenib|mesh-list
110412005|NCT00941863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110412006|NCT00941863|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110412007|NCT00941863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110412008|NCT00941863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110412009|NCT00602173|Cilostazol|cilostazol|mesh-list
110412010|NCT00602173|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110412011|NCT00602173|Autonomic Agents|autonomic agents|mesh-ancestor
110412012|NCT00602173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110412013|NCT00602173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110412014|NCT00602173|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110412015|NCT00602173|Respiratory System Agents|respiratory system agents|mesh-ancestor
110412016|NCT00602173|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110412017|NCT00602173|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110412018|NCT00602173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110412019|NCT00602173|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110412020|NCT00602173|Vasodilator Agents|vasodilator agents|mesh-ancestor
110412021|NCT00602173|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110412022|NCT00602173|Protective Agents|protective agents|mesh-ancestor
110412023|NCT00602173|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110412024|NCT00602173|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110412025|NCT00602173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110412026|NCT02852239|Dabrafenib|dabrafenib|mesh-list
110412027|NCT02852239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110412028|NCT02852239|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110412029|NCT02852239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110412030|NCT02852239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110412031|NCT01282424|Idelalisib|idelalisib|mesh-list
110412032|NCT01282424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110412033|NCT01282424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110412034|NCT01282424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110412035|NCT00602251|Terbinafine|terbinafine|mesh-list
110412036|NCT00602251|Antifungal Agents|antifungal agents|mesh-ancestor
110412037|NCT00602251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110412038|NCT00602251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110412039|NCT00602251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110412041|NCT01281956|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110412042|NCT01281956|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110412043|NCT01281956|Serotonin Agents|serotonin agents|mesh-ancestor
110412044|NCT01281956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110412045|NCT01281956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110412046|NCT01281956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110412047|NCT01279850|Pregabalin|pregabalin|mesh-list
110412048|NCT01279850|Analgesics|analgesics|mesh-ancestor
110412049|NCT01279850|Sensory System Agents|sensory system agents|mesh-ancestor
110412050|NCT01279850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110412051|NCT01279850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110412052|NCT01279850|Anticonvulsants|anticonvulsants|mesh-ancestor
110412053|NCT01279850|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110412054|NCT01279850|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110412055|NCT01279850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110412056|NCT01279850|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110412057|NCT01279850|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110412058|NCT01279850|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110412059|NCT01279850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110412060|NCT01279850|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110412062|NCT00604357|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110412063|NCT00604357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110412064|NCT00604357|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110412065|NCT00604357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110412066|NCT00604357|Antifungal Agents|antifungal agents|mesh-ancestor
110412067|NCT00604357|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110412068|NCT00604357|Immunologic Factors|immunologic factors|mesh-ancestor
110412069|NCT00604357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110412070|NCT00602719|Zolpidem|zolpidem|mesh-list
110412071|NCT00602719|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110412072|NCT00602719|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110412073|NCT00602719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110412074|NCT00602719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110412075|NCT00602719|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
110412076|NCT00602719|GABA Agonists|gaba agonists|mesh-ancestor
110412077|NCT00602719|GABA Agents|gaba agents|mesh-ancestor
110412078|NCT00602719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110412079|NCT00602719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110412080|NCT00604435|Docetaxel|docetaxel|mesh-list
110412081|NCT00604435|Epirubicin|epirubicin|mesh-list
110412082|NCT00604435|Endostatins|endostatins|mesh-list
110412083|NCT00604435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110412084|NCT00604435|Tubulin Modulators|tubulin modulators|mesh-ancestor
110412085|NCT00604435|Antimitotic Agents|antimitotic agents|mesh-ancestor
110412086|NCT00604435|Mitosis Modulators|mitosis modulators|mesh-ancestor
110412087|NCT00604435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110412088|NCT00604435|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110412089|NCT00604435|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110412090|NCT00604435|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110412091|NCT00604435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110412092|NCT00604435|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110412093|NCT00604435|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110412094|NCT00604435|Growth Substances|growth substances|mesh-ancestor
110412095|NCT00604435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110412096|NCT00604435|Growth Inhibitors|growth inhibitors|mesh-ancestor
110412097|NCT01136967|Lenvatinib|lenvatinib|mesh-list
110412098|NCT01136967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110412099|NCT01136967|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110412100|NCT01136967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110412101|NCT01136967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110412102|NCT01218516|Paclitaxel|paclitaxel|mesh-list
110412103|NCT01218516|Carboplatin|carboplatin|mesh-list
110412104|NCT01218516|Pemetrexed|pemetrexed|mesh-list
110412105|NCT01218516|Farletuzumab|farletuzumab|mesh-list
110412106|NCT01218516|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110412107|NCT01218516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110412108|NCT01218516|Tubulin Modulators|tubulin modulators|mesh-ancestor
110412109|NCT01218516|Antimitotic Agents|antimitotic agents|mesh-ancestor
110412110|NCT01218516|Mitosis Modulators|mitosis modulators|mesh-ancestor
110412111|NCT01218516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110412112|NCT01218516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110412113|NCT01218516|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110412114|NCT01218516|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110412116|NCT00938431|Anticonvulsants|anticonvulsants|mesh-ancestor
110412117|NCT00938431|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110412118|NCT00938431|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110412119|NCT00938431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110412120|NCT00938431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110412121|NCT05381389|Bupivacaine|bupivacaine|mesh-list
110412122|NCT05381389|Anesthetics, Local|anesthetics, local|mesh-ancestor
110412123|NCT05381389|Anesthetics|anesthetics|mesh-ancestor
110412124|NCT05381389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110412125|NCT05381389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110412126|NCT05381389|Sensory System Agents|sensory system agents|mesh-ancestor
110412127|NCT05381389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110412128|NCT00949117|Cyproheptadine|cyproheptadine|mesh-list
110412129|NCT00949117|Antipruritics|antipruritics|mesh-ancestor
110412130|NCT00949117|Dermatologic Agents|dermatologic agents|mesh-ancestor
110412131|NCT00949117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110412132|NCT00949117|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110412133|NCT00949117|Histamine Antagonists|histamine antagonists|mesh-ancestor
110412134|NCT00949117|Histamine Agents|histamine agents|mesh-ancestor
110412135|NCT00949117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110412136|NCT00949117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110412137|NCT00949117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110412138|NCT00949117|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110412139|NCT00949117|Serotonin Agents|serotonin agents|mesh-ancestor
110412140|NCT00949117|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110412141|NCT04312347|Tamoxifen|tamoxifen|mesh-list
110412142|NCT04312347|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110412143|NCT04312347|Hormone Antagonists|hormone antagonists|mesh-ancestor
110412144|NCT04312347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110412145|NCT04312347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110412146|NCT04312347|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110412147|NCT04312347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110412148|NCT04312347|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110412149|NCT04312347|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110412150|NCT04312347|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110363676|NCT04672707|Bromhexine|bromhexine|mesh-list
110412151|NCT00938041|Tositumomab I-131|tositumomab i-131|mesh-list
110412152|NCT00938041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110412154|NCT05379283|Anesthetics, Local|anesthetics, local|mesh-ancestor
110412155|NCT05379283|Anesthetics|anesthetics|mesh-ancestor
110412156|NCT05379283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110412157|NCT05379283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110412158|NCT05379283|Sensory System Agents|sensory system agents|mesh-ancestor
110412159|NCT05379283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110412160|NCT05379283|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110412161|NCT05379283|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110412162|NCT05379283|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110412163|NCT05379283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110412164|NCT05379283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110412165|NCT01218438|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110412166|NCT01218438|Immunoglobulins|immunoglobulins|mesh-list
110412167|NCT01218438|Antibodies|antibodies|mesh-list
110412168|NCT01218438|gamma-Globulins|gamma-globulins|mesh-list
110412169|NCT01218438|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110412170|NCT01218438|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110412171|NCT01218438|Immunoglobulin G|immunoglobulin g|mesh-list
110412172|NCT01218438|Immunologic Factors|immunologic factors|mesh-ancestor
110412173|NCT01218438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110412174|NCT00604591|Tolcapone|tolcapone|mesh-list
110412175|NCT00604591|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110412176|NCT00604591|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110412177|NCT00604591|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
110412178|NCT00604591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110412179|NCT00604591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110412180|NCT02691156|Carbon Monoxide|carbon monoxide|mesh-list
110412181|NCT02691156|Bilirubin|bilirubin|mesh-list
110412182|NCT02691156|Antimetabolites|antimetabolites|mesh-ancestor
110412183|NCT02691156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110412184|NCT02691156|Gasotransmitters|gasotransmitters|mesh-ancestor
110412185|NCT02691156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110412186|NCT02691156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110412187|NCT02691156|Antioxidants|antioxidants|mesh-ancestor
110412188|NCT02691156|Protective Agents|protective agents|mesh-ancestor
110412189|NCT00603031|Glucagon|glucagon|mesh-list
110412190|NCT00603031|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
110412191|NCT00603031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110412192|NCT00603031|Hormones|hormones|mesh-ancestor
110412193|NCT00603031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110412194|NCT00603031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110412195|NCT00603031|Incretins|incretins|mesh-ancestor
110412196|NCT05379049|Adalimumab|adalimumab|mesh-list
110412197|NCT05379049|Infliximab|infliximab|mesh-list
110412198|NCT05379049|Etanercept|etanercept|mesh-list
110412199|NCT05379049|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110412200|NCT05379049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110189737|NCT00049569|Vitamins|vitamins|mesh-ancestor
110412201|NCT05379049|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110412202|NCT05379049|Dermatologic Agents|dermatologic agents|mesh-ancestor
110412203|NCT05379049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110412204|NCT05379049|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110412205|NCT05379049|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110412206|NCT05379049|Analgesics|analgesics|mesh-ancestor
110412207|NCT05379049|Sensory System Agents|sensory system agents|mesh-ancestor
110412208|NCT05379049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110412209|NCT05379049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110412210|NCT05379049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110412211|NCT05379049|Immunologic Factors|immunologic factors|mesh-ancestor
110412212|NCT02851459|Vaccines|vaccines|mesh-list
110412213|NCT02851459|Immunologic Factors|immunologic factors|mesh-ancestor
110412214|NCT02851459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110412215|NCT00603343|Propiverine|propiverine|mesh-list
110412216|NCT00603343|Parasympatholytics|parasympatholytics|mesh-ancestor
110412217|NCT00603343|Autonomic Agents|autonomic agents|mesh-ancestor
110412218|NCT00603343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110412219|NCT00603343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110412220|NCT00603343|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110412221|NCT00603343|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110412222|NCT00603343|Cholinergic Agents|cholinergic agents|mesh-ancestor
110412223|NCT00603343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110412224|NCT00603343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110412225|NCT00603343|Urological Agents|urological agents|mesh-ancestor
110412226|NCT01277510|Cinacalcet|cinacalcet|mesh-list
110412227|NCT01277510|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110412228|NCT01277510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110412229|NCT01277510|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
110412230|NCT01277510|Hormone Antagonists|hormone antagonists|mesh-ancestor
110412231|NCT01277510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110412232|NCT00937495|Bortezomib|bortezomib|mesh-list
110412233|NCT00937495|Vorinostat|vorinostat|mesh-list
110412234|NCT00937495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110412235|NCT00937495|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110412236|NCT00937495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110412237|NCT00937495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110412238|NCT04265833|Calcium|calcium|mesh-list
110412239|NCT04265833|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110412240|NCT04265833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110412241|NCT00606541|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110412242|NCT00606541|Antidepressive Agents|antidepressive agents|mesh-ancestor
110412243|NCT00606541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110412244|NCT00606541|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110412245|NCT00606541|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110412246|NCT00606541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110562735|NCT02648711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110412247|NCT00606541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110412248|NCT00936715|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110412249|NCT00936715|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110412250|NCT00936715|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110412251|NCT00936715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110412252|NCT00936715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110412253|NCT00936715|Antiviral Agents|antiviral agents|mesh-ancestor
110412254|NCT00936715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110412255|NCT00936715|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110412256|NCT00936715|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110412257|NCT05378503|Topiramate|topiramate|mesh-list
110412258|NCT05378503|Phentermine|phentermine|mesh-list
110412259|NCT05378503|Anticonvulsants|anticonvulsants|mesh-ancestor
110412260|NCT05378503|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110412261|NCT05378503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110412262|NCT05378503|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110412263|NCT05378503|Appetite Depressants|appetite depressants|mesh-ancestor
110412264|NCT05378503|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110412265|NCT05378503|Sympathomimetics|sympathomimetics|mesh-ancestor
110412266|NCT05378503|Autonomic Agents|autonomic agents|mesh-ancestor
110412267|NCT05378503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110412268|NCT05378503|Adrenergic Agents|adrenergic agents|mesh-ancestor
110412269|NCT05378503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110412270|NCT05378503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110412271|NCT05378191|Vaccines|vaccines|mesh-list
110412272|NCT05378191|Immunologic Factors|immunologic factors|mesh-ancestor
110412273|NCT05378191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110412274|NCT00605137|Insulin|insulin|mesh-list
110412275|NCT00605137|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110412276|NCT00605137|Insulin Detemir|insulin detemir|mesh-list
110412277|NCT00605137|Isophane Insulin, Human|isophane insulin, human|mesh-list
110412278|NCT00605137|Insulin, Isophane|insulin, isophane|mesh-list
110412279|NCT00605137|Isophane insulin, beef|isophane insulin, beef|mesh-list
110412280|NCT00605137|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110412281|NCT00605137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110412282|NCT00606775|Carvedilol|carvedilol|mesh-list
110412283|NCT00606775|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110412284|NCT00606775|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110412285|NCT00606775|Adrenergic Agents|adrenergic agents|mesh-ancestor
110412286|NCT00606775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110412287|NCT00606775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110412288|NCT00606775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110412289|NCT00606775|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110412290|NCT00606775|Antioxidants|antioxidants|mesh-ancestor
110412291|NCT00606775|Protective Agents|protective agents|mesh-ancestor
110412292|NCT00606775|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110412293|NCT00606775|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110412294|NCT00606775|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110412295|NCT00606775|Vasodilator Agents|vasodilator agents|mesh-ancestor
110412296|NCT00606775|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110412297|NCT00606775|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110412298|NCT00605371|Lamotrigine|lamotrigine|mesh-list
110412299|NCT00605371|Anticonvulsants|anticonvulsants|mesh-list
110412300|NCT00605371|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110412301|NCT00605371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110412302|NCT00605371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110412303|NCT00605371|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110412304|NCT00605371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110412305|NCT00605371|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110412306|NCT00605371|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110412307|NCT00605371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110412308|NCT00605371|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110412309|NCT00605371|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110412310|NCT01267994|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
110412311|NCT01267994|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110412312|NCT02850913|Doxycycline|doxycycline|mesh-list
110412313|NCT02850913|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110412314|NCT02850913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110412315|NCT02850913|Antimalarials|antimalarials|mesh-ancestor
110412316|NCT02850913|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110412317|NCT02850913|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110412318|NCT00934843|Methylprednisolone|methylprednisolone|mesh-list
110412319|NCT00934843|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110412320|NCT00934843|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110412321|NCT00934843|Prednisolone|prednisolone|mesh-list
110412322|NCT00934843|Prednisolone acetate|prednisolone acetate|mesh-list
110412323|NCT00934843|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110412324|NCT00934843|Prednisolone phosphate|prednisolone phosphate|mesh-list
110412325|NCT00934843|Glucocorticoids|glucocorticoids|mesh-list
110412326|NCT00934843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110412327|NCT00934843|Antiemetics|antiemetics|mesh-ancestor
110412328|NCT00934843|Autonomic Agents|autonomic agents|mesh-ancestor
110412329|NCT00934843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110412330|NCT00934843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110412331|NCT00934843|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110412332|NCT00934843|Hormones|hormones|mesh-ancestor
110412333|NCT00934843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110412334|NCT00934843|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110412335|NCT00934843|Protective Agents|protective agents|mesh-ancestor
110412336|NCT00934843|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110412337|NCT00934843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110412338|NCT00605605|Dextromethorphan|dextromethorphan|mesh-list
110412339|NCT00605605|Antitussive Agents|antitussive agents|mesh-ancestor
110412340|NCT00605605|Respiratory System Agents|respiratory system agents|mesh-ancestor
110412341|NCT00605605|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110412342|NCT00605605|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110412343|NCT00605605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110412344|NCT00605605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110412345|NCT00605605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110412346|NCT04267237|Atezolizumab|atezolizumab|mesh-list
110412347|NCT04267237|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110412348|NCT04267237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110412349|NCT04267237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110412350|NCT04267237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110412351|NCT00605995|Simvastatin|simvastatin|mesh-list
110412352|NCT00605995|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110412353|NCT00605995|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110412354|NCT00605995|Antimetabolites|antimetabolites|mesh-ancestor
110412355|NCT00605995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110412356|NCT00605995|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110412357|NCT00605995|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110412358|NCT00605995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110412359|NCT00605683|Cabergoline|cabergoline|mesh-list
110412360|NCT00605683|Pramipexole|pramipexole|mesh-list
110412361|NCT00605683|Ropinirole|ropinirole|mesh-list
110412363|NCT00605683|Lisuride|lisuride|mesh-list
110412364|NCT00605683|Apomorphine|apomorphine|mesh-list
110412365|NCT00605683|Pergolide|pergolide|mesh-list
110412366|NCT00605683|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110412367|NCT00605683|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110412368|NCT00605683|Dopamine Agonists|dopamine agonists|mesh-ancestor
110412369|NCT00605683|Dopamine Agents|dopamine agents|mesh-ancestor
110412370|NCT00605683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110412371|NCT00605683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110412372|NCT00605683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110412373|NCT00605683|Antioxidants|antioxidants|mesh-ancestor
110412374|NCT00605683|Protective Agents|protective agents|mesh-ancestor
110363904|NCT04670913|Apatinib|apatinib|mesh-list
110412375|NCT00605683|Hormone Antagonists|hormone antagonists|mesh-ancestor
110412376|NCT00605683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110412377|NCT00605683|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110412379|NCT00605683|Emetics|emetics|mesh-ancestor
110412380|NCT00605683|Autonomic Agents|autonomic agents|mesh-ancestor
110412381|NCT00605683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110412382|NCT00605683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110412383|NCT01266902|Rilpivirine|rilpivirine|mesh-list
110412384|NCT01266902|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110412385|NCT01266902|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110412386|NCT01266902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110412387|NCT01266902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110412388|NCT01266902|Antiviral Agents|antiviral agents|mesh-ancestor
110412389|NCT01266902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110412390|NCT01266902|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110412391|NCT01266902|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110412392|NCT01266824|Proxymetacaine|proxymetacaine|mesh-list
110412393|NCT01266824|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110412394|NCT01266824|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110412395|NCT01266824|Anesthetics, Local|anesthetics, local|mesh-ancestor
110412396|NCT01266824|Anesthetics|anesthetics|mesh-ancestor
110412397|NCT01266824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110412398|NCT01266824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110412399|NCT01266824|Sensory System Agents|sensory system agents|mesh-ancestor
110412400|NCT01266824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110412401|NCT04253119|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
110412402|NCT04253119|Antiviral Agents|antiviral agents|mesh-ancestor
110412403|NCT04253119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110412404|NCT01266590|Digoxin|digoxin|mesh-list
110412405|NCT01266590|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110412406|NCT01266590|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110412407|NCT01266590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110412408|NCT01266590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110412409|NCT01266590|Protective Agents|protective agents|mesh-ancestor
110412410|NCT01266590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110412411|NCT01265498|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
110412412|NCT01265498|Cathartics|cathartics|mesh-ancestor
110412413|NCT01265498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110412414|NCT00607711|Isophosphamide mustard|isophosphamide mustard|mesh-list
110412415|NCT00607711|Ifosfamide|ifosfamide|mesh-list
110412416|NCT00607711|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110412417|NCT00607711|Alkylating Agents|alkylating agents|mesh-ancestor
110412418|NCT00607711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110412419|NCT00607711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110412420|NCT01263782|Bevacizumab|bevacizumab|mesh-list
110412421|NCT01263782|Carboplatin|carboplatin|mesh-list
110412422|NCT01263782|Pemetrexed|pemetrexed|mesh-list
110412423|NCT01263782|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110412424|NCT01263782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110412425|NCT01263782|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110412426|NCT01263782|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110412427|NCT01263782|Growth Substances|growth substances|mesh-ancestor
110412428|NCT01263782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110412429|NCT01263782|Growth Inhibitors|growth inhibitors|mesh-ancestor
110412430|NCT01263782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110412431|NCT01263782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110412432|NCT01263782|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110412433|NCT01263782|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110412434|NCT01263704|Cyclophosphamide|cyclophosphamide|mesh-list
110412435|NCT01263704|Rituximab|rituximab|mesh-list
110412436|NCT01263704|Fludarabine|fludarabine|mesh-list
110412437|NCT01263704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110412438|NCT01263704|Immunologic Factors|immunologic factors|mesh-ancestor
110412439|NCT01263704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110412440|NCT01263704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110412441|NCT01263704|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110412442|NCT01263704|Alkylating Agents|alkylating agents|mesh-ancestor
110412443|NCT01263704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110412444|NCT01263704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110412445|NCT01263704|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110412446|NCT01263704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110412447|NCT01263470|Alogliptin|alogliptin|mesh-list
110412448|NCT01263470|Voglibose|voglibose|mesh-list
110412449|NCT01263470|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110412450|NCT01263470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110412451|NCT01263470|Incretins|incretins|mesh-ancestor
110412452|NCT01263470|Hormones|hormones|mesh-ancestor
110412453|NCT01263470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110412454|NCT01263470|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110412455|NCT01263470|Protease Inhibitors|protease inhibitors|mesh-ancestor
110412456|NCT01263470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110412457|NCT01263470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110412458|NCT01263470|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
110412459|NCT04322786|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
110412460|NCT04322786|Protease Inhibitors|protease inhibitors|mesh-ancestor
110412461|NCT04322786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110412462|NCT04322786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110412463|NCT04322240|Thioctic Acid|thioctic acid|mesh-list
110412464|NCT04322240|Antioxidants|antioxidants|mesh-ancestor
110412465|NCT04322240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110412466|NCT04322240|Protective Agents|protective agents|mesh-ancestor
110412467|NCT04322240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110412468|NCT04322240|Vitamin B Complex|vitamin b complex|mesh-ancestor
110412469|NCT04322240|Vitamins|vitamins|mesh-ancestor
110412470|NCT04322240|Micronutrients|micronutrients|mesh-ancestor
110327975|NCT00458315|Antimetabolites|antimetabolites|mesh-ancestor
110412471|NCT01262456|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
110412472|NCT01262456|Hemostatics|hemostatics|mesh-ancestor
110412473|NCT01262456|Coagulants|coagulants|mesh-ancestor
110412474|NCT01262456|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
110412475|NCT01262456|Natriuretic Agents|natriuretic agents|mesh-ancestor
110412476|NCT01262456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110412477|NCT04321694|Mogamulizumab|mogamulizumab|mesh-list
110412478|NCT04321694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110412479|NCT04321850|Zinc|zinc|mesh-list
110412480|NCT04321850|Zinc Sulfate|zinc sulfate|mesh-list
110412481|NCT04321850|Trace Elements|trace elements|mesh-ancestor
110412482|NCT04321850|Micronutrients|micronutrients|mesh-ancestor
110412483|NCT04321850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110412484|NCT04321850|Astringents|astringents|mesh-ancestor
110412485|NCT04321850|Dermatologic Agents|dermatologic agents|mesh-ancestor
110412486|NCT04321616|Hydroxychloroquine|hydroxychloroquine|mesh-list
110412487|NCT04321616|Remdesivir|remdesivir|mesh-list
110412488|NCT04321616|Antimalarials|antimalarials|mesh-ancestor
110412489|NCT04321616|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110412490|NCT04321616|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110412491|NCT04321616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110412492|NCT04321616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110412493|NCT04321616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110412494|NCT04321616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110412495|NCT04321616|Antimetabolites|antimetabolites|mesh-ancestor
110412496|NCT04321616|Antiviral Agents|antiviral agents|mesh-ancestor
110412497|NCT00932893|Docetaxel|docetaxel|mesh-list
110412498|NCT00932893|Pemetrexed|pemetrexed|mesh-list
110412499|NCT00932893|Crizotinib|crizotinib|mesh-list
110412500|NCT00932893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110412501|NCT00932893|Tubulin Modulators|tubulin modulators|mesh-ancestor
110412502|NCT00932893|Antimitotic Agents|antimitotic agents|mesh-ancestor
110412503|NCT00932893|Mitosis Modulators|mitosis modulators|mesh-ancestor
110412504|NCT00932893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110412505|NCT00932893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110412506|NCT00932893|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110412507|NCT00932893|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110412508|NCT00932893|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110412509|NCT04321070|Clindamycin|clindamycin|mesh-list
110412510|NCT04321070|Clindamycin palmitate|clindamycin palmitate|mesh-list
110412511|NCT04321070|Clindamycin phosphate|clindamycin phosphate|mesh-list
110412512|NCT04321070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110412513|NCT04321070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110412514|NCT04321070|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110412515|NCT04321070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110412516|NCT04321070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110412517|NCT02889224|Hydrocortisone|hydrocortisone|mesh-list
110412518|NCT02889224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110412519|NCT01260896|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
110412520|NCT01260896|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110412521|NCT01260896|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110412522|NCT01260896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110412523|NCT01260896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110412524|NCT01260896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110412525|NCT01260896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110412526|NCT01260896|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110412527|NCT01260896|Antidepressive Agents|antidepressive agents|mesh-ancestor
110412528|NCT01260896|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110412529|NCT00939523|Lapatinib|lapatinib|mesh-list
110412530|NCT00939523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110412531|NCT00939523|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110412532|NCT00939523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110412533|NCT00939523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110412534|NCT01260584|Clopidogrel|clopidogrel|mesh-list
110412535|NCT01260584|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
110412536|NCT01260584|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110412537|NCT01260584|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110412538|NCT01260584|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110327977|NCT00444015|Dasatinib|dasatinib|mesh-list
110412539|NCT01260584|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110412540|NCT01260584|Purinergic Agents|purinergic agents|mesh-ancestor
110412541|NCT01260584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110412542|NCT01260584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110183959|NCT00031824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110412543|NCT01260584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110412545|NCT00607945|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110412546|NCT00607945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110412547|NCT04262635|Capecitabine|capecitabine|mesh-list
110412548|NCT04262635|Cetuximab|cetuximab|mesh-list
110412549|NCT04262635|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110412550|NCT04262635|Antimetabolites|antimetabolites|mesh-ancestor
110412551|NCT04262635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110412552|NCT04262635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110412553|NCT04262635|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110412554|NCT00608101|Dexamethasone|dexamethasone|mesh-list
110412555|NCT00608101|Fludrocortisone|fludrocortisone|mesh-list
110412556|NCT00608101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110412557|NCT00608101|Antiemetics|antiemetics|mesh-ancestor
110412558|NCT00608101|Autonomic Agents|autonomic agents|mesh-ancestor
110412559|NCT00608101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110412560|NCT00608101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110412561|NCT00608101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110412562|NCT00608101|Glucocorticoids|glucocorticoids|mesh-ancestor
110412563|NCT00608101|Hormones|hormones|mesh-ancestor
110412564|NCT00608101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110412565|NCT00608101|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110412566|NCT00608101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110412567|NCT04264039|Fludarabine|fludarabine|mesh-list
110412568|NCT04264039|Cyclophosphamide|cyclophosphamide|mesh-list
110412569|NCT04264039|Melphalan|melphalan|mesh-list
110412570|NCT04264039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110412571|NCT04264039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110412572|NCT04264039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110412573|NCT04264039|Immunologic Factors|immunologic factors|mesh-ancestor
110412574|NCT04264039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110412575|NCT04264039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110412576|NCT04264039|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110412577|NCT04264039|Alkylating Agents|alkylating agents|mesh-ancestor
110412578|NCT04264039|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110412579|NCT00608179|Glimepiride|glimepiride|mesh-list
110412580|NCT00608179|Glyburide|glyburide|mesh-list
110412581|NCT00608179|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110412582|NCT00608179|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110412583|NCT00608179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110412584|NCT00608179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110412585|NCT00608179|Immunologic Factors|immunologic factors|mesh-ancestor
110412586|NCT00608335|Micafungin|micafungin|mesh-list
110412587|NCT00608335|Antifungal Agents|antifungal agents|mesh-ancestor
110412588|NCT00608335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110412589|NCT00927589|Carboplatin|carboplatin|mesh-list
110412590|NCT00927589|Docetaxel|docetaxel|mesh-list
110412591|NCT00927589|Trastuzumab|trastuzumab|mesh-list
110412592|NCT00927589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110412593|NCT00927589|Tubulin Modulators|tubulin modulators|mesh-ancestor
110412594|NCT00927589|Antimitotic Agents|antimitotic agents|mesh-ancestor
110412595|NCT00927589|Mitosis Modulators|mitosis modulators|mesh-ancestor
110412596|NCT00927589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110412597|NCT00927589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110412598|NCT05938725|Cyclophosphamide|cyclophosphamide|mesh-list
110412599|NCT05938725|Fludarabine|fludarabine|mesh-list
110412600|NCT05938725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110412601|NCT05938725|Immunologic Factors|immunologic factors|mesh-ancestor
110412602|NCT05938725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110412603|NCT05938725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110412604|NCT05938725|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110412605|NCT05938725|Alkylating Agents|alkylating agents|mesh-ancestor
110412606|NCT05938725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110412607|NCT05938725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110412608|NCT05938725|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110412609|NCT05938712|Dapagliflozin|dapagliflozin|mesh-list
110412610|NCT05938712|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110412611|NCT05938712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110412612|NCT05938712|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110412613|NCT05938712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110412614|NCT05938374|Fluzoparib|fluzoparib|mesh-list
110412615|NCT05938374|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110412616|NCT05938374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110412617|NCT05938374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110412618|NCT05938374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110412619|NCT05938140|Ritonavir|ritonavir|mesh-list
110412620|NCT05938140|Nirmatrelvir|nirmatrelvir|mesh-list
110412621|NCT05938140|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
110412622|NCT05938140|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110412623|NCT05938140|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110412624|NCT05938140|Protease Inhibitors|protease inhibitors|mesh-ancestor
110412625|NCT05938140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110412626|NCT05938140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110412627|NCT05938140|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110412628|NCT05938140|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110412629|NCT05938140|Antiviral Agents|antiviral agents|mesh-ancestor
110412630|NCT05938140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110412631|NCT05938140|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110412632|NCT05938140|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110412633|NCT05937880|Leflunomide|leflunomide|mesh-list
110412634|NCT05937880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110412635|NCT05937880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110412636|NCT05937880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110412637|NCT05937880|Immunologic Factors|immunologic factors|mesh-ancestor
110412638|NCT05937880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110412639|NCT05937841|Compound 21|compound 21|mesh-list
110412640|NCT05937841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110412641|NCT05937789|Vitamin D|vitamin d|mesh-list
110412642|NCT05937789|Vitamins|vitamins|mesh-ancestor
110412643|NCT05937789|Micronutrients|micronutrients|mesh-ancestor
110412644|NCT05937789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110412645|NCT05937789|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110412646|NCT05937711|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110412647|NCT05937711|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110562936|NCT02643563|Bupivacaine|bupivacaine|mesh-list
110412648|NCT05937711|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110412649|NCT05937711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110412650|NCT05937711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110412651|NCT05937711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110412652|NCT05937711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110412653|NCT05937711|Analgesics|analgesics|mesh-ancestor
110412654|NCT05937711|Sensory System Agents|sensory system agents|mesh-ancestor
110412655|NCT05937711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110412656|NCT05937711|Antidepressive Agents|antidepressive agents|mesh-ancestor
110412657|NCT05937711|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110412658|NCT05937711|Dopamine Agents|dopamine agents|mesh-ancestor
110412659|NCT05937568|Imetelstat|imetelstat|mesh-list
110183991|NCT00031902|Rituximab|rituximab|mesh-list
110412660|NCT05937568|Motesanib diphosphate|motesanib diphosphate|mesh-list
110412661|NCT05937568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110412662|NCT05937568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110412663|NCT05937568|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110412664|NCT05937490|Leuprolide|leuprolide|mesh-list
110412665|NCT05937490|Dienogest|dienogest|mesh-list
110412666|NCT05937490|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110412667|NCT05937490|Fertility Agents|fertility agents|mesh-ancestor
110412668|NCT05937490|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110412669|NCT05937490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110412670|NCT05937490|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110412671|NCT05937490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110412672|NCT05937490|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110412673|NCT05937490|Contraceptive Agents|contraceptive agents|mesh-ancestor
110364202|NCT00533936|Tubulin Modulators|tubulin modulators|mesh-ancestor
110412674|NCT05937490|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110412675|NCT05937490|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110412676|NCT05937490|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110412677|NCT05937490|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110412678|NCT05937490|Hormone Antagonists|hormone antagonists|mesh-ancestor
110412679|NCT05937490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110412680|NCT05937438|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
110412681|NCT05937438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110412682|NCT05937438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110412683|NCT05937438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110412684|NCT05937191|Leflunomide|leflunomide|mesh-list
110412685|NCT05937191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110412686|NCT05937191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110412687|NCT05937191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110412688|NCT05937191|Immunologic Factors|immunologic factors|mesh-ancestor
110412689|NCT05937191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110412690|NCT05937126|Anti-Infective Agents|anti-infective agents|mesh-list
110412691|NCT05937126|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110412692|NCT05937100|Hyaluronic Acid|hyaluronic acid|mesh-list
110412693|NCT05937100|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110412694|NCT05937100|Immunologic Factors|immunologic factors|mesh-ancestor
110412695|NCT05937100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110412696|NCT05937100|Viscosupplements|viscosupplements|mesh-ancestor
110412697|NCT05937100|Protective Agents|protective agents|mesh-ancestor
110412698|NCT05936853|Anesthetics|anesthetics|mesh-list
110412699|NCT05936853|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110412700|NCT05936853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110412701|NCT05936710|Dialysis Solutions|dialysis solutions|mesh-list
110412702|NCT05936710|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110412703|NCT05936489|Brimonidine Tartrate|brimonidine tartrate|mesh-list
110412705|NCT05936489|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110412706|NCT05936489|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110412707|NCT05936489|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110412708|NCT05936489|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110183999|NCT00031902|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110412709|NCT05936489|Adrenergic Agents|adrenergic agents|mesh-ancestor
110412710|NCT05936489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110412711|NCT05936489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110412712|NCT05936489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110412713|NCT05936489|Miotics|miotics|mesh-ancestor
110412714|NCT05936489|Autonomic Agents|autonomic agents|mesh-ancestor
110412715|NCT05936489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110412716|NCT05936489|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110412717|NCT05936229|Interferons|interferons|mesh-list
110412718|NCT05936229|Interferon-beta|interferon-beta|mesh-list
110412719|NCT05936229|Interferon beta-1a|interferon beta-1a|mesh-list
110412720|NCT05936229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110412721|NCT05936229|Antiviral Agents|antiviral agents|mesh-ancestor
110412722|NCT05936229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110412723|NCT05936229|Immunologic Factors|immunologic factors|mesh-ancestor
110412724|NCT05936229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110412725|NCT05936229|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110412726|NCT05935202|Mitapivat|mitapivat|mesh-list
110412727|NCT05935202|Enzyme Activators|enzyme activators|mesh-ancestor
110412728|NCT05935202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110412729|NCT05935059|Pregabalin|pregabalin|mesh-list
110412730|NCT05935059|Anticonvulsants|anticonvulsants|mesh-list
110412731|NCT05935059|Tianeptine|tianeptine|mesh-list
110412732|NCT05935059|Antidepressive Agents|antidepressive agents|mesh-list
110412733|NCT05935059|Analgesics|analgesics|mesh-ancestor
110412734|NCT05935059|Sensory System Agents|sensory system agents|mesh-ancestor
110412735|NCT05935059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110412736|NCT05935059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110412737|NCT05935059|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110412738|NCT05935059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110412739|NCT05935059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110412740|NCT05935059|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110412741|NCT05935059|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110412742|NCT05935059|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110412743|NCT05935059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110412744|NCT05935059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110412745|NCT05935059|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110412746|NCT05928962|Tremelimumab|tremelimumab|mesh-list
110364275|NCT04168502|Immunotoxins|immunotoxins|mesh-ancestor
110412747|NCT05928962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110412749|NCT05924997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110412750|NCT05924997|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110412751|NCT05924997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110412752|NCT05924997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110412753|NCT05910190|Buprenorphine|buprenorphine|mesh-list
110412754|NCT05910190|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110412755|NCT05910190|Narcotics|narcotics|mesh-ancestor
110412756|NCT05910190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110412757|NCT05910190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110412758|NCT05910190|Analgesics|analgesics|mesh-ancestor
110412759|NCT05910190|Sensory System Agents|sensory system agents|mesh-ancestor
110412760|NCT05910190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110412761|NCT05910190|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110412762|NCT05898919|Neostigmine|neostigmine|mesh-list
110412763|NCT05898919|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110412764|NCT05898919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110412765|NCT05898919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110412766|NCT05898919|Cholinergic Agents|cholinergic agents|mesh-ancestor
110412767|NCT05898919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110412768|NCT05898919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110412769|NCT05898919|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110412770|NCT05898919|Autonomic Agents|autonomic agents|mesh-ancestor
110412771|NCT05898919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110412772|NCT05881291|Alfentanil|alfentanil|mesh-list
110412773|NCT05881291|Propofol|propofol|mesh-list
110412774|NCT05881291|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110412775|NCT05881291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110412776|NCT05881291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110412777|NCT05881291|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110412778|NCT05881291|Anesthetics, General|anesthetics, general|mesh-ancestor
110412779|NCT05881291|Anesthetics|anesthetics|mesh-ancestor
110412780|NCT05881291|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110412781|NCT05881291|Narcotics|narcotics|mesh-ancestor
110412782|NCT05881291|Analgesics|analgesics|mesh-ancestor
110412783|NCT05881291|Sensory System Agents|sensory system agents|mesh-ancestor
110412784|NCT05881291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110412785|NCT05867342|Lidocaine|lidocaine|mesh-list
110412786|NCT05867342|Epinephrine|epinephrine|mesh-list
110412787|NCT05867342|Racepinephrine|racepinephrine|mesh-list
110412788|NCT05867342|Epinephryl borate|epinephryl borate|mesh-list
110412789|NCT05867342|Anesthetics, Local|anesthetics, local|mesh-ancestor
110412790|NCT05867342|Anesthetics|anesthetics|mesh-ancestor
110412791|NCT05867342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110412792|NCT05867342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110412793|NCT05867342|Sensory System Agents|sensory system agents|mesh-ancestor
110412794|NCT05867342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110412795|NCT05867342|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110412796|NCT05867342|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110412797|NCT05867342|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110563008|NCT02643719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110412798|NCT05867342|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110412799|NCT05867342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110412800|NCT05867342|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110412801|NCT05867342|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110412802|NCT05867342|Adrenergic Agents|adrenergic agents|mesh-ancestor
110412803|NCT05867342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110412804|NCT05867342|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110412805|NCT05867342|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110412806|NCT05867342|Autonomic Agents|autonomic agents|mesh-ancestor
110412807|NCT05867342|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110412808|NCT05867342|Respiratory System Agents|respiratory system agents|mesh-ancestor
110412809|NCT05867342|Mydriatics|mydriatics|mesh-ancestor
110412810|NCT05867342|Sympathomimetics|sympathomimetics|mesh-ancestor
110412811|NCT05867342|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110412812|NCT05843448|Pembrolizumab|pembrolizumab|mesh-list
110412813|NCT05843448|Vaccines|vaccines|mesh-list
110412814|NCT05843448|Immunologic Factors|immunologic factors|mesh-ancestor
110412815|NCT05843448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110412816|NCT05843448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110412817|NCT05843448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110412818|NCT05843448|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110412819|NCT05843448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110184052|NCT00032019|Etoposide|etoposide|mesh-list
110412820|NCT05810480|Immunoglobulins|immunoglobulins|mesh-list
110412821|NCT05810480|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110412822|NCT05810480|Antibodies|antibodies|mesh-list
110412823|NCT05810480|Immunoglobulin G|immunoglobulin g|mesh-list
110412824|NCT05810480|Autoantibodies|autoantibodies|mesh-list
110412825|NCT05810480|Immunologic Factors|immunologic factors|mesh-ancestor
110412826|NCT05810480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110412827|NCT05809830|Doxorubicin|doxorubicin|mesh-list
110412828|NCT05809830|LB100|lb100|mesh-list
110412829|NCT05809830|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110412830|NCT05809830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110412831|NCT05809830|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110412832|NCT05809830|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110412833|NCT05809830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110412834|NCT05809830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110412836|NCT05798533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110412837|NCT05798533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110412838|NCT05793632|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110412839|NCT05793632|Antidepressive Agents|antidepressive agents|mesh-ancestor
110412840|NCT05793632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110412841|NCT05793632|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110412842|NCT05793632|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110412843|NCT05793632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110412844|NCT05793632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110412845|NCT05780073|Dasatinib|dasatinib|mesh-list
110412846|NCT05780073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110412847|NCT05780073|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110412848|NCT05780073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110412849|NCT05780073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110412850|NCT05768191|Insulin|insulin|mesh-list
110412851|NCT05768191|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110412852|NCT05768191|Isophane Insulin, Human|isophane insulin, human|mesh-list
110412853|NCT05768191|Insulin, Isophane|insulin, isophane|mesh-list
110412854|NCT05768191|Isophane insulin, beef|isophane insulin, beef|mesh-list
110412855|NCT05768191|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110412856|NCT05768191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110412857|NCT05759481|Propofol|propofol|mesh-list
110412858|NCT05759481|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110412859|NCT05759481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110412860|NCT05759481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110412861|NCT05759481|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110412862|NCT05759481|Anesthetics, General|anesthetics, general|mesh-ancestor
110412863|NCT05759481|Anesthetics|anesthetics|mesh-ancestor
110412864|NCT05677282|Azithromycin|azithromycin|mesh-list
110412865|NCT05677282|Rifaximin|rifaximin|mesh-list
110412866|NCT05677282|Loperamide|loperamide|mesh-list
110412867|NCT05677282|Antidiarrheals|antidiarrheals|mesh-list
110412868|NCT05677282|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110412869|NCT05677282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110412870|NCT05677282|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110412871|NCT05657613|Fluconazole|fluconazole|mesh-list
110412872|NCT05657613|Bosentan|bosentan|mesh-list
110412873|NCT05657613|Antifungal Agents|antifungal agents|mesh-ancestor
110412874|NCT05657613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110412875|NCT05657613|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110412876|NCT05657613|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110412877|NCT05657613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110412878|NCT05657613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110412879|NCT05657613|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110412880|NCT05657613|Hormone Antagonists|hormone antagonists|mesh-ancestor
110412881|NCT05657613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110412882|NCT05657613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110412883|NCT05657613|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110412884|NCT05657613|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110412885|NCT05657613|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110412886|NCT05657613|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
110412887|NCT05635110|Rifampin|rifampin|mesh-list
110412888|NCT05635110|Omeprazole|omeprazole|mesh-list
110412889|NCT05635110|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110412890|NCT05635110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110412891|NCT05635110|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110412892|NCT05635110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110412893|NCT05635110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110412894|NCT05635110|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110412895|NCT05635110|Antitubercular Agents|antitubercular agents|mesh-ancestor
110412896|NCT05635110|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110412897|NCT05635110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110412899|NCT05635110|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110412900|NCT05635110|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110412901|NCT05635110|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110412902|NCT05635110|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110412903|NCT05635110|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110412904|NCT05635110|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110412905|NCT05635110|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110412907|NCT05624281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110412908|NCT05624281|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110412909|NCT05624281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110412910|NCT05624281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110412911|NCT05615025|Propofol|propofol|mesh-list
110412912|NCT05615025|Sevoflurane|sevoflurane|mesh-list
110412913|NCT05615025|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110412914|NCT05615025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110412915|NCT05615025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110412916|NCT05615025|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110412917|NCT05615025|Anesthetics, General|anesthetics, general|mesh-ancestor
110412918|NCT05615025|Anesthetics|anesthetics|mesh-ancestor
110412919|NCT05615025|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110412920|NCT05615025|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110412921|NCT05408065|Triamcinolone|triamcinolone|mesh-list
110412922|NCT05408065|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110412923|NCT05408065|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110412924|NCT05408065|Cortisone|cortisone|mesh-list
110412925|NCT05408065|Hyaluronic Acid|hyaluronic acid|mesh-list
110412926|NCT05408065|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110412927|NCT05408065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110412928|NCT05408065|Glucocorticoids|glucocorticoids|mesh-ancestor
110412929|NCT05408065|Hormones|hormones|mesh-ancestor
110412930|NCT05408065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110412931|NCT05408065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110412932|NCT05408065|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110412933|NCT05408065|Immunologic Factors|immunologic factors|mesh-ancestor
110412934|NCT05408065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110412935|NCT05408065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110412936|NCT05408065|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110412937|NCT05408065|Viscosupplements|viscosupplements|mesh-ancestor
110412938|NCT05408065|Protective Agents|protective agents|mesh-ancestor
110412939|NCT05381753|Sunitinib|sunitinib|mesh-list
110412940|NCT05381753|Imatinib Mesylate|imatinib mesylate|mesh-list
110412941|NCT05381753|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
110412942|NCT05381753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110412943|NCT05381753|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110563098|NCT02642939|Mifepristone|mifepristone|mesh-list
110412944|NCT05381753|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110412945|NCT05381753|Growth Substances|growth substances|mesh-ancestor
110412946|NCT05381753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110412947|NCT05381753|Growth Inhibitors|growth inhibitors|mesh-ancestor
110412948|NCT05381753|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110412949|NCT05381753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110412950|NCT05381753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110412951|NCT05276206|Anesthetics|anesthetics|mesh-list
110412952|NCT05276206|Anesthetics, Local|anesthetics, local|mesh-list
110412953|NCT05276206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110412954|NCT05276206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110412955|NCT05276206|Sensory System Agents|sensory system agents|mesh-ancestor
110412956|NCT05276206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110412957|NCT05246111|Topotecan|topotecan|mesh-list
110412958|NCT05246111|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110412959|NCT05246111|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110412960|NCT05246111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110412961|NCT05246111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110412962|NCT05246111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110412963|NCT05207436|Oxytocin|oxytocin|mesh-list
110412964|NCT05207436|Oxytocics|oxytocics|mesh-ancestor
110412965|NCT05207436|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110412966|NCT05207436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110412967|NCT05183828|Letrozole|letrozole|mesh-list
110412968|NCT05183828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110412969|NCT05183828|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110412970|NCT05183828|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110412971|NCT05183828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110412972|NCT05183828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110412973|NCT05183828|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110412974|NCT05183828|Hormone Antagonists|hormone antagonists|mesh-ancestor
110412975|NCT05183828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110412976|NCT05183828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110412977|NCT05168813|Vaccines|vaccines|mesh-list
110412978|NCT05168813|Immunologic Factors|immunologic factors|mesh-ancestor
110412979|NCT05168813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110412980|NCT05141305|Clopidogrel|clopidogrel|mesh-list
110412981|NCT05141305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110412982|NCT05141305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110412983|NCT05141305|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110412984|NCT05141305|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110412985|NCT05141305|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110412986|NCT05141305|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110412987|NCT05141305|Purinergic Agents|purinergic agents|mesh-ancestor
110412988|NCT05141305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110412989|NCT05138822|Nitrofurantoin|nitrofurantoin|mesh-list
110412990|NCT05138822|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110412991|NCT05138822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110563119|NCT02641301|Analgesics|analgesics|mesh-ancestor
110412992|NCT05138822|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110412993|NCT05090124|Adalimumab|adalimumab|mesh-list
110412994|NCT05090124|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110412995|NCT05090124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110412996|NCT05090124|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110412997|NCT05054842|Metformin|metformin|mesh-list
110412998|NCT05054842|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110412999|NCT05054842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110413000|NCT05022927|Bevacizumab|bevacizumab|mesh-list
110413001|NCT05022927|Atezolizumab|atezolizumab|mesh-list
110413002|NCT05022927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110413003|NCT05022927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110413004|NCT05022927|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110413005|NCT05022927|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110413006|NCT05022927|Growth Substances|growth substances|mesh-ancestor
110413007|NCT05022927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110413008|NCT05022927|Growth Inhibitors|growth inhibitors|mesh-ancestor
110413009|NCT05022927|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110413010|NCT05022927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110413011|NCT04984317|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110413012|NCT04984317|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110413013|NCT04984317|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110413014|NCT04984317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110413015|NCT04984317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110413016|NCT04984317|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110413017|NCT04984317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110413018|NCT04984317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110413019|NCT04984317|Cholinergic Agents|cholinergic agents|mesh-ancestor
110563144|NCT02640833|Venetoclax|venetoclax|mesh-list
110413020|NCT04984317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110413021|NCT04915508|Hormones|hormones|mesh-list
110413022|NCT04915508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110413023|NCT04915508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110413024|NCT04844866|Rituximab|rituximab|mesh-list
110413025|NCT04844866|Gemcitabine|gemcitabine|mesh-list
110413026|NCT04844866|Oxaliplatin|oxaliplatin|mesh-list
110413027|NCT04844866|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110413028|NCT04844866|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110413029|NCT04844866|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
110413030|NCT04844866|Immunoconjugates|immunoconjugates|mesh-list
110413031|NCT04844866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110413032|NCT04844866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110413033|NCT04844866|Immunologic Factors|immunologic factors|mesh-ancestor
110413034|NCT04844866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110413035|NCT04844866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110413036|NCT04844866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110413037|NCT04844866|Antimetabolites|antimetabolites|mesh-ancestor
110413038|NCT04844866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110413039|NCT04844866|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110413040|NCT04844866|Alkylating Agents|alkylating agents|mesh-ancestor
110413042|NCT04793867|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110413043|NCT04793867|Anesthetics, General|anesthetics, general|mesh-ancestor
110364576|NCT04679064|Doxorubicin|doxorubicin|mesh-list
110413044|NCT04793867|Anesthetics|anesthetics|mesh-ancestor
110413045|NCT04793867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110413046|NCT04793867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110413047|NCT04729387|Paclitaxel|paclitaxel|mesh-list
110413048|NCT04729387|Doxorubicin|doxorubicin|mesh-list
110413049|NCT04729387|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110413050|NCT04729387|Olaparib|olaparib|mesh-list
110413051|NCT04729387|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110413052|NCT04729387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110413053|NCT04729387|Tubulin Modulators|tubulin modulators|mesh-ancestor
110413054|NCT04729387|Antimitotic Agents|antimitotic agents|mesh-ancestor
110413055|NCT04729387|Mitosis Modulators|mitosis modulators|mesh-ancestor
110413056|NCT04729387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110413057|NCT04729387|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110413058|NCT04729387|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110413059|NCT04729387|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110413060|NCT04729387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110413061|NCT04729387|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110413062|NCT04616534|Gemcitabine|gemcitabine|mesh-list
110413063|NCT04616534|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110413064|NCT04616534|Antimetabolites|antimetabolites|mesh-ancestor
110413065|NCT04616534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110413066|NCT04616534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110413067|NCT04600921|Ertugliflozin|ertugliflozin|mesh-list
110413068|NCT04600921|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110413069|NCT04600921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110413070|NCT04600921|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110413071|NCT04600921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110413073|NCT04520490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110413074|NCT04520490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110413075|NCT04520490|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110413076|NCT04520490|Incretins|incretins|mesh-ancestor
110413077|NCT04520490|Hormones|hormones|mesh-ancestor
110413078|NCT04520490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110413079|NCT04483778|Pembrolizumab|pembrolizumab|mesh-list
110413080|NCT04483778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110413081|NCT04483778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110184077|NCT03151460|Dopamine|dopamine|mesh-list
110413082|NCT04483778|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110413083|NCT04483778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110413085|NCT04482309|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
110413086|NCT04482309|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110413087|NCT04482309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110413088|NCT04482309|Immunoconjugates|immunoconjugates|mesh-ancestor
110413089|NCT04482309|Immunologic Factors|immunologic factors|mesh-ancestor
110413090|NCT04482309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110413091|NCT04480554|Naltrexone|naltrexone|mesh-list
110413092|NCT04480554|Buprenorphine|buprenorphine|mesh-list
110413093|NCT04480554|Methadone|methadone|mesh-list
110413094|NCT04480554|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
110413095|NCT04480554|Naloxone|naloxone|mesh-list
110413096|NCT04480554|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110413097|NCT04480554|Narcotics|narcotics|mesh-ancestor
110413098|NCT04480554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110413099|NCT04480554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110413100|NCT04480554|Analgesics|analgesics|mesh-ancestor
110413101|NCT04480554|Sensory System Agents|sensory system agents|mesh-ancestor
110413102|NCT04480554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110413103|NCT04480554|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110413104|NCT04480554|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110413105|NCT04480554|Antitussive Agents|antitussive agents|mesh-ancestor
110413106|NCT04480554|Respiratory System Agents|respiratory system agents|mesh-ancestor
110413107|NCT04410042|Tranexamic Acid|tranexamic acid|mesh-list
110413108|NCT04410042|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110413109|NCT04410042|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110413110|NCT04410042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110413112|NCT04410042|Coagulants|coagulants|mesh-ancestor
110413113|NCT04375605|Leucovorin|leucovorin|mesh-list
110413114|NCT04375605|Docetaxel|docetaxel|mesh-list
110413115|NCT04375605|Fluorouracil|fluorouracil|mesh-list
110413116|NCT04375605|Oxaliplatin|oxaliplatin|mesh-list
110413117|NCT04375605|Calcium|calcium|mesh-list
110413118|NCT04375605|Levoleucovorin|levoleucovorin|mesh-list
110364654|NCT04678791|Cisplatin|cisplatin|mesh-list
110413119|NCT04375605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110413120|NCT04375605|Tubulin Modulators|tubulin modulators|mesh-ancestor
110413121|NCT04375605|Antimitotic Agents|antimitotic agents|mesh-ancestor
110413122|NCT04375605|Mitosis Modulators|mitosis modulators|mesh-ancestor
110413123|NCT04375605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110413124|NCT04375605|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110413125|NCT04375605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110413126|NCT04375605|Antimetabolites|antimetabolites|mesh-ancestor
110413127|NCT04375605|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110413128|NCT04375605|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110413129|NCT04375605|Immunologic Factors|immunologic factors|mesh-ancestor
110413130|NCT04375605|Antidotes|antidotes|mesh-ancestor
110413131|NCT04375605|Protective Agents|protective agents|mesh-ancestor
110413132|NCT04375605|Vitamin B Complex|vitamin b complex|mesh-ancestor
110413133|NCT04375605|Vitamins|vitamins|mesh-ancestor
110413134|NCT04375605|Micronutrients|micronutrients|mesh-ancestor
110413135|NCT04268498|Acetaminophen|acetaminophen|mesh-list
110413136|NCT04268498|Diphenhydramine|diphenhydramine|mesh-list
110413137|NCT04268498|Promethazine|promethazine|mesh-list
110413138|NCT04268498|Dexamethasone|dexamethasone|mesh-list
110413139|NCT04268498|Lenalidomide|lenalidomide|mesh-list
110413140|NCT04268498|Bortezomib|bortezomib|mesh-list
110413141|NCT04268498|Daratumumab|daratumumab|mesh-list
110413142|NCT04268498|Montelukast|montelukast|mesh-list
110413143|NCT04268498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110413144|NCT04268498|Antiemetics|antiemetics|mesh-ancestor
110413145|NCT04268498|Autonomic Agents|autonomic agents|mesh-ancestor
110413146|NCT04268498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110413147|NCT04268498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110413148|NCT04268498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110413149|NCT04268498|Glucocorticoids|glucocorticoids|mesh-ancestor
110413151|NCT04268498|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110413152|NCT04268498|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110413153|NCT04268498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110413155|NCT04268498|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110413156|NCT04268498|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110413157|NCT04268498|Growth Substances|growth substances|mesh-ancestor
110413158|NCT04268498|Growth Inhibitors|growth inhibitors|mesh-ancestor
110413159|NCT04268498|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110413160|NCT04268498|Analgesics|analgesics|mesh-ancestor
110413161|NCT04268498|Sensory System Agents|sensory system agents|mesh-ancestor
110413162|NCT04268498|Antipyretics|antipyretics|mesh-ancestor
110413163|NCT04268498|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110413164|NCT04268498|Respiratory System Agents|respiratory system agents|mesh-ancestor
110413165|NCT04268498|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110413166|NCT04268498|Hormone Antagonists|hormone antagonists|mesh-ancestor
110413167|NCT04268498|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110413168|NCT04268498|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110413169|NCT04268498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110413170|NCT04268498|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110413171|NCT04268498|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110413172|NCT04268498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110413173|NCT04268498|Anesthetics, Local|anesthetics, local|mesh-ancestor
110413174|NCT04268498|Anesthetics|anesthetics|mesh-ancestor
110413175|NCT04268498|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110413176|NCT04268498|Histamine Antagonists|histamine antagonists|mesh-ancestor
110413177|NCT04268498|Histamine Agents|histamine agents|mesh-ancestor
110413178|NCT04268498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110413179|NCT04268498|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110413180|NCT04268498|Antipruritics|antipruritics|mesh-ancestor
110413181|NCT04268498|Dermatologic Agents|dermatologic agents|mesh-ancestor
110413182|NCT04220931|Botulinum Toxins|botulinum toxins|mesh-list
110413183|NCT04220931|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110413184|NCT04220931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110413185|NCT04220931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110413186|NCT04220931|Cholinergic Agents|cholinergic agents|mesh-ancestor
110413187|NCT04220931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110413188|NCT04220931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110413189|NCT04194775|Lenvatinib|lenvatinib|mesh-list
110413190|NCT04194775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110413191|NCT04194775|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110413192|NCT04194775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110413193|NCT04194775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110413194|NCT04144023|Molgramostim|molgramostim|mesh-list
110413195|NCT04144023|Vaccines|vaccines|mesh-list
110364730|NCT00557232|Bevacizumab|bevacizumab|mesh-list
110413196|NCT04144023|Sargramostim|sargramostim|mesh-list
110413197|NCT04144023|Immunologic Factors|immunologic factors|mesh-ancestor
110413198|NCT04144023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110413199|NCT04144023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110413200|NCT04098432|Nivolumab|nivolumab|mesh-list
110413201|NCT04098432|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110413202|NCT04098432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110413203|NCT04098432|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110413204|NCT04098432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110413205|NCT04024462|Cyclophosphamide|cyclophosphamide|mesh-list
110413206|NCT04024462|Docetaxel|docetaxel|mesh-list
110413207|NCT04024462|Doxorubicin|doxorubicin|mesh-list
110413208|NCT04024462|Trastuzumab|trastuzumab|mesh-list
110413209|NCT04024462|Pertuzumab|pertuzumab|mesh-list
110413210|NCT04024462|Hormones|hormones|mesh-list
110413211|NCT04024462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110413212|NCT04024462|Immunologic Factors|immunologic factors|mesh-ancestor
110413213|NCT04024462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110413214|NCT04024462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110413215|NCT04024462|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110413216|NCT04024462|Alkylating Agents|alkylating agents|mesh-ancestor
110413217|NCT04024462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110413218|NCT04024462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110413219|NCT04024462|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110413220|NCT04024462|Tubulin Modulators|tubulin modulators|mesh-ancestor
110413221|NCT04024462|Antimitotic Agents|antimitotic agents|mesh-ancestor
110413222|NCT04024462|Mitosis Modulators|mitosis modulators|mesh-ancestor
110563276|NCT00654173|Atorvastatin|atorvastatin|mesh-list
110413223|NCT04024462|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110413224|NCT04024462|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110413225|NCT04024462|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110413226|NCT04024462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110413227|NCT04024462|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110413228|NCT04024462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110413229|NCT04011410|Hydroxychloroquine|hydroxychloroquine|mesh-list
110413230|NCT04011410|Antimalarials|antimalarials|mesh-ancestor
110413231|NCT04011410|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110413232|NCT04011410|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110413233|NCT04011410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110413234|NCT04011410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110413235|NCT04011410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110413236|NCT04011410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110413237|NCT03996850|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
110413238|NCT03996850|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110413239|NCT03996850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110413240|NCT03971409|Doxorubicin|doxorubicin|mesh-list
110413241|NCT03971409|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110413242|NCT03971409|Avelumab|avelumab|mesh-list
110413243|NCT03971409|Camptothecin|camptothecin|mesh-list
110413244|NCT03971409|Antibodies|antibodies|mesh-list
110413245|NCT03971409|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110413246|NCT03971409|Immunoglobulin G|immunoglobulin g|mesh-list
110413247|NCT03971409|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
110413248|NCT03971409|Immunoconjugates|immunoconjugates|mesh-list
110413249|NCT03971409|Immunologic Factors|immunologic factors|mesh-ancestor
110413250|NCT03971409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110413251|NCT03971409|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110413252|NCT03971409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110413253|NCT03971409|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110413254|NCT03971409|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110413255|NCT03971409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110413256|NCT03971409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110413257|NCT03971409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110413258|NCT03971409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110413259|NCT03971409|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110413260|NCT03920007|Trimethoprim|trimethoprim|mesh-list
110413261|NCT03920007|Polymyxins|polymyxins|mesh-list
110413262|NCT03920007|Polymyxin B|polymyxin b|mesh-list
110413263|NCT03920007|Prednisone|prednisone|mesh-list
110413264|NCT03920007|Prednisolone|prednisolone|mesh-list
110413265|NCT03920007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110413266|NCT03920007|Glucocorticoids|glucocorticoids|mesh-ancestor
110413267|NCT03920007|Hormones|hormones|mesh-ancestor
110413268|NCT03920007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110413269|NCT03920007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110413270|NCT03920007|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110184102|NCT03151382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110413271|NCT03920007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110413272|NCT03920007|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110413273|NCT03920007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110413274|NCT03920007|Antimalarials|antimalarials|mesh-ancestor
110413275|NCT03920007|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110413276|NCT03920007|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110413277|NCT03920007|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110413278|NCT03920007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110413279|NCT03920007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110413280|NCT03920007|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110413281|NCT03920007|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
110563297|NCT02645279|GABA Modulators|gaba modulators|mesh-ancestor
110413282|NCT03920007|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110413283|NCT03920007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110413285|NCT03909165|Glycopyrrolate|glycopyrrolate|mesh-list
110413286|NCT03909165|Neostigmine|neostigmine|mesh-list
110413287|NCT03909165|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110413288|NCT03909165|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110413289|NCT03909165|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110413290|NCT03909165|Autonomic Agents|autonomic agents|mesh-ancestor
110413291|NCT03909165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110413292|NCT03909165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110413293|NCT03909165|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110413294|NCT03909165|Respiratory System Agents|respiratory system agents|mesh-ancestor
110413295|NCT03909165|Mydriatics|mydriatics|mesh-ancestor
110413296|NCT03909165|Parasympatholytics|parasympatholytics|mesh-ancestor
110413297|NCT03909165|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110413298|NCT03909165|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110413299|NCT03909165|Cholinergic Agents|cholinergic agents|mesh-ancestor
110413300|NCT03909165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110413301|NCT03909165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110413302|NCT03909165|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110413303|NCT03909165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110413304|NCT03909165|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110413305|NCT03906136|Adalimumab|adalimumab|mesh-list
110413306|NCT03906136|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110413307|NCT03906136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110413308|NCT03906136|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110413309|NCT03875573|Durvalumab|durvalumab|mesh-list
110413310|NCT03875573|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110413311|NCT03875573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110413312|NCT03800524|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
110413313|NCT03800524|Antiviral Agents|antiviral agents|mesh-ancestor
110413314|NCT03800524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110413315|NCT03800524|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
110413316|NCT03800524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110413317|NCT03782207|Atezolizumab|atezolizumab|mesh-list
110413318|NCT03782207|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110413319|NCT03782207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110413320|NCT03782207|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110413321|NCT03782207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110413322|NCT03695744|Dexamethasone|dexamethasone|mesh-list
110413324|NCT03695744|Daratumumab|daratumumab|mesh-list
110413325|NCT03695744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110413326|NCT03695744|Antiemetics|antiemetics|mesh-ancestor
110413327|NCT03695744|Autonomic Agents|autonomic agents|mesh-ancestor
110413328|NCT03695744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110413329|NCT03695744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110413330|NCT03695744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110413331|NCT03695744|Glucocorticoids|glucocorticoids|mesh-ancestor
110413332|NCT03695744|Hormones|hormones|mesh-ancestor
110413333|NCT03695744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110413334|NCT03695744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110413335|NCT03695744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110413336|NCT03690869|Cemiplimab|cemiplimab|mesh-list
110413337|NCT03690869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110413338|NCT03690869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110413339|NCT03637764|Atezolizumab|atezolizumab|mesh-list
110413340|NCT03637764|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110413341|NCT03637764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110413342|NCT03637764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110563313|NCT02562664|Metformin|metformin|mesh-list
110413343|NCT03637764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110413344|NCT03611595|Tretinoin|tretinoin|mesh-list
110413345|NCT03611595|Isotretinoin|isotretinoin|mesh-list
110413346|NCT03611595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110413347|NCT03611595|Keratolytic Agents|keratolytic agents|mesh-ancestor
110413348|NCT03611595|Dermatologic Agents|dermatologic agents|mesh-ancestor
110413349|NCT03481569|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110413350|NCT03481569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110413351|NCT03442556|Carboplatin|carboplatin|mesh-list
110413352|NCT03442556|Docetaxel|docetaxel|mesh-list
110413353|NCT03442556|Rucaparib|rucaparib|mesh-list
110413354|NCT03442556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110413355|NCT03442556|Tubulin Modulators|tubulin modulators|mesh-ancestor
110413356|NCT03442556|Antimitotic Agents|antimitotic agents|mesh-ancestor
110413357|NCT03442556|Mitosis Modulators|mitosis modulators|mesh-ancestor
110413358|NCT03442556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110413359|NCT03442556|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110413360|NCT03442556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110413361|NCT03401853|Rituximab|rituximab|mesh-list
110413362|NCT03401853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110413363|NCT03401853|Pembrolizumab|pembrolizumab|mesh-list
110413364|NCT03401853|Obinutuzumab|obinutuzumab|mesh-list
110413365|NCT03401853|Antibodies|antibodies|mesh-list
110413366|NCT03401853|Immunoglobulins|immunoglobulins|mesh-list
110413367|NCT03401853|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110413368|NCT03401853|Immunologic Factors|immunologic factors|mesh-ancestor
110413369|NCT03401853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110413370|NCT03401853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110413371|NCT03401853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110413372|NCT03401853|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110413373|NCT03401853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110413374|NCT03222076|Nivolumab|nivolumab|mesh-list
110413375|NCT03222076|Ipilimumab|ipilimumab|mesh-list
110413376|NCT03222076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110413377|NCT03222076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110413378|NCT03222076|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110413379|NCT03222076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110413394|NCT02936843|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
110413395|NCT02936843|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110413396|NCT02936843|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110413397|NCT02936843|Analgesics|analgesics|mesh-ancestor
110413398|NCT02936843|Sensory System Agents|sensory system agents|mesh-ancestor
110413399|NCT02936843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110413400|NCT02936843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110413401|NCT02936843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110413402|NCT02936843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110413403|NCT02811861|Pembrolizumab|pembrolizumab|mesh-list
110413404|NCT02811861|Everolimus|everolimus|mesh-list
110413405|NCT02811861|Sunitinib|sunitinib|mesh-list
110413406|NCT02811861|Lenvatinib|lenvatinib|mesh-list
110413407|NCT02811861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110413408|NCT02811861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110413409|NCT02811861|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110413410|NCT02811861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110413411|NCT02811861|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110413412|NCT02811861|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110413413|NCT02811861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110413414|NCT02811861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110413415|NCT02811861|Immunologic Factors|immunologic factors|mesh-ancestor
110413416|NCT02811861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110413418|NCT02811861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110413419|NCT02811861|Growth Substances|growth substances|mesh-ancestor
110413420|NCT02811861|Growth Inhibitors|growth inhibitors|mesh-ancestor
110413421|NCT02744612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110413422|NCT02744612|Brentuximab Vedotin|brentuximab vedotin|mesh-list
110413423|NCT02744612|Antibodies|antibodies|mesh-list
110413424|NCT02744612|Immunoglobulins|immunoglobulins|mesh-list
110413425|NCT02744612|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110413426|NCT02744612|Immunoconjugates|immunoconjugates|mesh-list
110413427|NCT02744612|Immunologic Factors|immunologic factors|mesh-ancestor
110413428|NCT02744612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110413429|NCT02744612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110413430|NCT02744612|Immunotoxins|immunotoxins|mesh-ancestor
110413431|NCT02700451|Acetaminophen|acetaminophen|mesh-list
110413432|NCT02700451|Ketorolac|ketorolac|mesh-list
110413433|NCT02700451|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110413434|NCT02700451|Analgesics|analgesics|mesh-ancestor
110413435|NCT02700451|Sensory System Agents|sensory system agents|mesh-ancestor
110413436|NCT02700451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110413437|NCT02700451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110413438|NCT02700451|Antipyretics|antipyretics|mesh-ancestor
110413439|NCT02700451|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110413440|NCT02700451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110413441|NCT02700451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110413442|NCT02700451|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110413443|NCT02700451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110413444|NCT02700451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110413445|NCT02697344|Acetic Acid|acetic acid|mesh-list
110413446|NCT02697344|Dexamethasone|dexamethasone|mesh-list
110413447|NCT02697344|Dexamethasone acetate|dexamethasone acetate|mesh-list
110413448|NCT02697344|Lenalidomide|lenalidomide|mesh-list
110413449|NCT02697344|Retinol acetate|retinol acetate|mesh-list
110413450|NCT02697344|Gossypol acetic acid|gossypol acetic acid|mesh-list
110413451|NCT02697344|Gossypol|gossypol|mesh-list
110413452|NCT02697344|BB 1101|bb 1101|mesh-list
110413453|NCT02697344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110413454|NCT02697344|Antiemetics|antiemetics|mesh-ancestor
110413455|NCT02697344|Autonomic Agents|autonomic agents|mesh-ancestor
110413456|NCT02697344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110413457|NCT02697344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110413458|NCT02697344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110413459|NCT02697344|Glucocorticoids|glucocorticoids|mesh-ancestor
110413460|NCT02697344|Hormones|hormones|mesh-ancestor
110413461|NCT02697344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110413462|NCT02697344|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110413463|NCT02697344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110413464|NCT02697344|Immunologic Factors|immunologic factors|mesh-ancestor
110413465|NCT02697344|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110413466|NCT02697344|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110413467|NCT02697344|Growth Substances|growth substances|mesh-ancestor
110413468|NCT02697344|Growth Inhibitors|growth inhibitors|mesh-ancestor
110413469|NCT02697344|Protease Inhibitors|protease inhibitors|mesh-ancestor
110413471|NCT02697344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110413472|NCT02697344|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110184144|NCT03150914|Sirolimus|sirolimus|mesh-list
110413474|NCT02697344|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110413475|NCT02697344|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110413476|NCT02697344|Protective Agents|protective agents|mesh-ancestor
110413477|NCT02697344|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110413478|NCT02697344|Contraceptive Agents|contraceptive agents|mesh-ancestor
110413479|NCT02697344|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110413480|NCT02697344|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110413481|NCT02697344|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110413482|NCT02697344|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
110413483|NCT02697344|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
110413484|NCT02667418|Vancomycin|vancomycin|mesh-list
110413485|NCT02667418|Fidaxomicin|fidaxomicin|mesh-list
110413486|NCT02667418|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110413487|NCT02667418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110413488|NCT02623426|Dexamethasone|dexamethasone|mesh-list
110413489|NCT02623426|Methotrexate|methotrexate|mesh-list
110413490|NCT02623426|Ranibizumab|ranibizumab|mesh-list
110413491|NCT02623426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110413492|NCT02623426|Antiemetics|antiemetics|mesh-ancestor
110413493|NCT02623426|Autonomic Agents|autonomic agents|mesh-ancestor
110413494|NCT02623426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110413495|NCT02623426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110413496|NCT02623426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110413497|NCT02623426|Glucocorticoids|glucocorticoids|mesh-ancestor
110365033|NCT02382510|Autonomic Agents|autonomic agents|mesh-ancestor
110413498|NCT02623426|Hormones|hormones|mesh-ancestor
110563394|NCT00848718|Paclitaxel|paclitaxel|mesh-list
110413499|NCT02623426|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110413500|NCT02623426|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110413501|NCT02623426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110413502|NCT02623426|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110413503|NCT02623426|Abortifacient Agents|abortifacient agents|mesh-ancestor
110413504|NCT02623426|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110413505|NCT02623426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110413506|NCT02623426|Antimetabolites|antimetabolites|mesh-ancestor
110413507|NCT02623426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110413508|NCT02623426|Dermatologic Agents|dermatologic agents|mesh-ancestor
110413509|NCT02623426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110413510|NCT02623426|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110413511|NCT02623426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110413512|NCT02623426|Immunologic Factors|immunologic factors|mesh-ancestor
110413513|NCT02623426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110413514|NCT02623426|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110413515|NCT02623426|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110413516|NCT02623426|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110413517|NCT02623426|Growth Substances|growth substances|mesh-ancestor
110413518|NCT02623426|Growth Inhibitors|growth inhibitors|mesh-ancestor
110413520|NCT02580058|Avelumab|avelumab|mesh-list
110413521|NCT02580058|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110413522|NCT02580058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110413523|NCT02580058|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110413524|NCT02580058|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110413525|NCT02580058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110413526|NCT02580058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110413527|NCT02580058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110413528|NCT02539394|Methylprednisolone|methylprednisolone|mesh-list
110413529|NCT02539394|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110413530|NCT02539394|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110413531|NCT02539394|Prednisolone|prednisolone|mesh-list
110413532|NCT02539394|Prednisolone acetate|prednisolone acetate|mesh-list
110413533|NCT02539394|Hemostatics|hemostatics|mesh-list
110413534|NCT02539394|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110413535|NCT02539394|Prednisolone phosphate|prednisolone phosphate|mesh-list
110413536|NCT02539394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110413537|NCT02539394|Antiemetics|antiemetics|mesh-ancestor
110413538|NCT02539394|Autonomic Agents|autonomic agents|mesh-ancestor
110413539|NCT02539394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110413540|NCT02539394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110413541|NCT02539394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110413542|NCT02539394|Glucocorticoids|glucocorticoids|mesh-ancestor
110413543|NCT02539394|Hormones|hormones|mesh-ancestor
110413544|NCT02539394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110413545|NCT02539394|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110413546|NCT02539394|Protective Agents|protective agents|mesh-ancestor
110413547|NCT02539394|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110563418|NCT00883337|Analgesics|analgesics|mesh-ancestor
110413548|NCT02539394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110413549|NCT02539394|Coagulants|coagulants|mesh-ancestor
110413550|NCT02530437|Paclitaxel|paclitaxel|mesh-list
110413551|NCT02530437|Carboplatin|carboplatin|mesh-list
110413552|NCT02530437|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110413553|NCT02530437|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110413554|NCT02530437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110413555|NCT02530437|Tubulin Modulators|tubulin modulators|mesh-ancestor
110413556|NCT02530437|Antimitotic Agents|antimitotic agents|mesh-ancestor
110413557|NCT02530437|Mitosis Modulators|mitosis modulators|mesh-ancestor
110413558|NCT02530437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110413559|NCT02412670|Cisplatin|cisplatin|mesh-list
110413560|NCT02412670|Carboplatin|carboplatin|mesh-list
110413561|NCT02412670|Gemcitabine|gemcitabine|mesh-list
110413562|NCT02412670|Doxorubicin|doxorubicin|mesh-list
110413563|NCT02412670|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110413564|NCT02412670|Methotrexate|methotrexate|mesh-list
110413565|NCT02412670|Vinblastine|vinblastine|mesh-list
110413566|NCT02412670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110413567|NCT02412670|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110413568|NCT02412670|Antimetabolites|antimetabolites|mesh-ancestor
110413569|NCT02412670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110413570|NCT02412670|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110413571|NCT02412670|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110413572|NCT02412670|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110413573|NCT02412670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110413574|NCT02412670|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110184206|NCT00032955|Analgesics|analgesics|mesh-ancestor
110413576|NCT02412670|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110413577|NCT02412670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110413578|NCT02412670|Dermatologic Agents|dermatologic agents|mesh-ancestor
110413579|NCT02412670|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110413580|NCT02412670|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110413581|NCT02412670|Immunologic Factors|immunologic factors|mesh-ancestor
110413582|NCT02412670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110413583|NCT02412670|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110413584|NCT02412670|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110413585|NCT02412670|Tubulin Modulators|tubulin modulators|mesh-ancestor
110413586|NCT02412670|Antimitotic Agents|antimitotic agents|mesh-ancestor
110413587|NCT02412670|Mitosis Modulators|mitosis modulators|mesh-ancestor
110413588|NCT01889199|Flutamide|flutamide|mesh-list
110413589|NCT01889199|Androgen Antagonists|androgen antagonists|mesh-ancestor
110413590|NCT01889199|Hormone Antagonists|hormone antagonists|mesh-ancestor
110413591|NCT01889199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110413592|NCT01889199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110413593|NCT01889199|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110413594|NCT01889199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110413595|NCT01737502|Sirolimus|sirolimus|mesh-list
110413596|NCT01737502|Auranofin|auranofin|mesh-list
110413597|NCT01737502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110413598|NCT01737502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110413599|NCT01737502|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110413600|NCT01737502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110413601|NCT01737502|Antifungal Agents|antifungal agents|mesh-ancestor
110413602|NCT01737502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110413603|NCT01737502|Immunologic Factors|immunologic factors|mesh-ancestor
110413604|NCT01737502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110413605|NCT01737502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110413606|NCT01666080|Fludarabine|fludarabine|mesh-list
110413607|NCT01666080|Busulfan|busulfan|mesh-list
110413608|NCT01666080|Levetiracetam|levetiracetam|mesh-list
110413609|NCT01666080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110413610|NCT01666080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110413611|NCT01666080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110413612|NCT01666080|Immunologic Factors|immunologic factors|mesh-ancestor
110413613|NCT01666080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110413614|NCT01666080|Alkylating Agents|alkylating agents|mesh-ancestor
110413615|NCT01666080|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110413616|NCT01666080|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110413617|NCT01666080|Anticonvulsants|anticonvulsants|mesh-ancestor
110413618|NCT01666080|Nootropic Agents|nootropic agents|mesh-ancestor
110413619|NCT01358877|Paclitaxel|paclitaxel|mesh-list
110413620|NCT01358877|Docetaxel|docetaxel|mesh-list
110413621|NCT01358877|Cyclophosphamide|cyclophosphamide|mesh-list
110413622|NCT01358877|Carboplatin|carboplatin|mesh-list
110413623|NCT01358877|Doxorubicin|doxorubicin|mesh-list
110413624|NCT01358877|Fluorouracil|fluorouracil|mesh-list
110413625|NCT01358877|Trastuzumab|trastuzumab|mesh-list
110413626|NCT01358877|Epirubicin|epirubicin|mesh-list
110413627|NCT01358877|Pertuzumab|pertuzumab|mesh-list
110413628|NCT01358877|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110413629|NCT01358877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110413630|NCT01358877|Tubulin Modulators|tubulin modulators|mesh-ancestor
110413631|NCT01358877|Antimitotic Agents|antimitotic agents|mesh-ancestor
110413632|NCT01358877|Mitosis Modulators|mitosis modulators|mesh-ancestor
110413633|NCT01358877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110413634|NCT01358877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110413635|NCT01358877|Immunologic Factors|immunologic factors|mesh-ancestor
110413636|NCT01358877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110413637|NCT01358877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110413638|NCT01358877|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110413639|NCT01358877|Alkylating Agents|alkylating agents|mesh-ancestor
110184215|NCT03150524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110413640|NCT01358877|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110413641|NCT01358877|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110413642|NCT01358877|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110413643|NCT01358877|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110413644|NCT01358877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110413645|NCT01358877|Antimetabolites|antimetabolites|mesh-ancestor
110413646|NCT01358877|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110413647|NCT01358877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110413648|NCT01084252|Dexamethasone|dexamethasone|mesh-list
110413649|NCT01084252|Dexamethasone acetate|dexamethasone acetate|mesh-list
110413650|NCT01084252|BB 1101|bb 1101|mesh-list
110413651|NCT01084252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110413652|NCT01084252|Antiemetics|antiemetics|mesh-ancestor
110413653|NCT01084252|Autonomic Agents|autonomic agents|mesh-ancestor
110413654|NCT01084252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110413655|NCT01084252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110413656|NCT01084252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110413657|NCT01084252|Glucocorticoids|glucocorticoids|mesh-ancestor
110413658|NCT01084252|Hormones|hormones|mesh-ancestor
110413659|NCT01084252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110413660|NCT01084252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110413661|NCT01084252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110413662|NCT01084252|Protease Inhibitors|protease inhibitors|mesh-ancestor
110413663|NCT01084252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110413664|NCT01084252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110413665|NCT00992238|Flavoxate|flavoxate|mesh-list
110413666|NCT00992238|Parasympatholytics|parasympatholytics|mesh-ancestor
110413667|NCT00992238|Autonomic Agents|autonomic agents|mesh-ancestor
110413668|NCT00992238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110413669|NCT00992238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110413670|NCT00992238|Urological Agents|urological agents|mesh-ancestor
110413671|NCT00858897|Insulin|insulin|mesh-list
110413672|NCT00858897|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110413673|NCT00858897|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110413674|NCT00858897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110413676|NCT05940909|Perindopril|perindopril|mesh-list
110413677|NCT05940909|Indapamide|indapamide|mesh-list
110413678|NCT05940909|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110413679|NCT05940909|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110413680|NCT05940909|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110413681|NCT05940909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110413682|NCT05940909|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110413683|NCT05940909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110413684|NCT05940909|Vasodilator Agents|vasodilator agents|mesh-ancestor
110413685|NCT05940909|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110413686|NCT05940909|Protease Inhibitors|protease inhibitors|mesh-ancestor
110413687|NCT05940909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110413688|NCT05940909|Diuretics|diuretics|mesh-ancestor
110413689|NCT05940909|Natriuretic Agents|natriuretic agents|mesh-ancestor
110413690|NCT05940909|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110413691|NCT05940896|Disitamab vedotin|disitamab vedotin|mesh-list
110413692|NCT05940896|Immunoconjugates|immunoconjugates|mesh-ancestor
110413693|NCT05940896|Immunologic Factors|immunologic factors|mesh-ancestor
110413694|NCT05940896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110413695|NCT05940701|Listerine|listerine|mesh-list
110413696|NCT05940701|Sodium Fluoride|sodium fluoride|mesh-list
110413697|NCT05940701|Cariostatic Agents|cariostatic agents|mesh-ancestor
110413698|NCT05940701|Protective Agents|protective agents|mesh-ancestor
110413699|NCT05940701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110413700|NCT05940701|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110413701|NCT05940701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110413702|NCT05940649|Norepinephrine|norepinephrine|mesh-list
110413703|NCT05940649|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110413704|NCT05940649|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110413705|NCT05940649|Adrenergic Agents|adrenergic agents|mesh-ancestor
110184225|NCT00033033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110184226|NCT00033033|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110184227|NCT00033033|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110413706|NCT05940649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110413707|NCT05940649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110413708|NCT05940649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110413709|NCT05940649|Sympathomimetics|sympathomimetics|mesh-ancestor
110413710|NCT05940649|Autonomic Agents|autonomic agents|mesh-ancestor
110413711|NCT05940649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110413712|NCT05940649|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110413713|NCT05940545|Ribavirin|ribavirin|mesh-list
110413714|NCT05940545|Favipiravir|favipiravir|mesh-list
110413715|NCT05940545|Antimetabolites|antimetabolites|mesh-ancestor
110413716|NCT05940545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110413717|NCT05940545|Antiviral Agents|antiviral agents|mesh-ancestor
110413718|NCT05940545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110413719|NCT05940441|Capecitabine|capecitabine|mesh-list
110413720|NCT05940441|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110413721|NCT05940441|Antimetabolites|antimetabolites|mesh-ancestor
110413722|NCT05940441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110413723|NCT05940441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110413724|NCT05940376|Insulin, Short-Acting|insulin, short-acting|mesh-list
110413725|NCT05940376|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110413726|NCT05940376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110413744|NCT05940285|Technetium tc-99m tetrofosmin|technetium tc-99m tetrofosmin|mesh-list
110413745|NCT05940285|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110413746|NCT05940285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110413747|NCT05940233|Letrozole|letrozole|mesh-list
110413748|NCT05940233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110413749|NCT05940233|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110413750|NCT05940233|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110413751|NCT05940233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110413752|NCT05940233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110413753|NCT05940233|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110413754|NCT05940233|Hormone Antagonists|hormone antagonists|mesh-ancestor
110413755|NCT05940233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110413756|NCT05940233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110413757|NCT05940064|Rituximab|rituximab|mesh-list
110413758|NCT05940064|Zanubrutinib|zanubrutinib|mesh-list
110413759|NCT05940064|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
110413760|NCT05940064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110413761|NCT05940064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110413762|NCT05940064|Immunologic Factors|immunologic factors|mesh-ancestor
110328038|NCT00459407|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
110413763|NCT05940064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110413764|NCT05940064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110413765|NCT05940064|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110413766|NCT05940064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110413767|NCT05940064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110413768|NCT05940064|Immunoconjugates|immunoconjugates|mesh-ancestor
110413769|NCT05940051|Rituximab|rituximab|mesh-list
110413770|NCT05940051|Zanubrutinib|zanubrutinib|mesh-list
110413771|NCT05940051|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
110413772|NCT05940051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110413773|NCT05940051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110413774|NCT05940051|Immunologic Factors|immunologic factors|mesh-ancestor
110413775|NCT05940051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110413776|NCT05940051|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110413777|NCT05940051|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110413778|NCT05940051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110413779|NCT05940051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110413780|NCT05940051|Immunoconjugates|immunoconjugates|mesh-ancestor
110413781|NCT05939882|Atropine|atropine|mesh-list
110413782|NCT05939882|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110413783|NCT05939882|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110413784|NCT05939882|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110413785|NCT05939882|Autonomic Agents|autonomic agents|mesh-ancestor
110413786|NCT05939882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110413787|NCT05939882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110413788|NCT05939882|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110413789|NCT05939882|Respiratory System Agents|respiratory system agents|mesh-ancestor
110413790|NCT05939882|Mydriatics|mydriatics|mesh-ancestor
110413791|NCT05939882|Parasympatholytics|parasympatholytics|mesh-ancestor
110413792|NCT05939882|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110413793|NCT05939882|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110413794|NCT05939882|Cholinergic Agents|cholinergic agents|mesh-ancestor
110413795|NCT05939882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110413796|NCT05939882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110413797|NCT05939817|Triamcinolone|triamcinolone|mesh-list
110413798|NCT05939817|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110413799|NCT05939817|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110413800|NCT05939817|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110413801|NCT05939817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110413802|NCT05939817|Glucocorticoids|glucocorticoids|mesh-ancestor
110413803|NCT05939817|Hormones|hormones|mesh-ancestor
110413804|NCT05939817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110413805|NCT05939817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110413806|NCT05939817|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110413807|NCT05939817|Immunologic Factors|immunologic factors|mesh-ancestor
110413808|NCT05939817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110563483|NCT00741910|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110413809|NCT05939817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110413815|NCT05939726|Vitamins|vitamins|mesh-list
110413816|NCT05939726|Vitamin E|vitamin e|mesh-list
110413817|NCT05939726|Tocopherols|tocopherols|mesh-list
110413819|NCT05939726|alpha-Tocopherol|alpha-tocopherol|mesh-list
110413820|NCT05939726|Carbamide Peroxide|carbamide peroxide|mesh-list
110413821|NCT05939726|Micronutrients|micronutrients|mesh-ancestor
110413822|NCT05939726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110413823|NCT05939726|Antioxidants|antioxidants|mesh-ancestor
110413824|NCT05939726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110413825|NCT05939726|Protective Agents|protective agents|mesh-ancestor
110413826|NCT05939726|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110413827|NCT05939726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110413828|NCT05939648|Vaccines|vaccines|mesh-list
110413829|NCT05939648|Immunologic Factors|immunologic factors|mesh-ancestor
110413830|NCT05939648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110413831|NCT05939284|Cetrorelix|cetrorelix|mesh-list
110413832|NCT05939284|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110413833|NCT05939284|Fertility Agents|fertility agents|mesh-ancestor
110413834|NCT05939284|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110413835|NCT05939284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110413836|NCT05939284|Hormone Antagonists|hormone antagonists|mesh-ancestor
110413837|NCT05939284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110413838|NCT05939180|Cytarabine|cytarabine|mesh-list
110413839|NCT05939180|Azacitidine|azacitidine|mesh-list
110413840|NCT05939180|Daunorubicin|daunorubicin|mesh-list
110413841|NCT05939180|Venetoclax|venetoclax|mesh-list
110413842|NCT05939180|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110413843|NCT05939180|Antimetabolites|antimetabolites|mesh-ancestor
110413844|NCT05939180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110413845|NCT05939180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110413846|NCT05939180|Antiviral Agents|antiviral agents|mesh-ancestor
110413847|NCT05939180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110413848|NCT05939180|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110413849|NCT05939180|Immunologic Factors|immunologic factors|mesh-ancestor
110413850|NCT05939180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110413851|NCT05939180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110413852|NCT05939180|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110413853|NCT05939180|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110413854|NCT05939180|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110413855|NCT05939076|Sotalol|sotalol|mesh-list
110413856|NCT05939076|Flecainide|flecainide|mesh-list
110413857|NCT05939076|Dronedarone|dronedarone|mesh-list
110413858|NCT05939076|Propafenone|propafenone|mesh-list
110413859|NCT05939076|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110413860|NCT05939076|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110184239|NCT00033072|Selegiline|selegiline|mesh-list
110413861|NCT05939076|Adrenergic Agents|adrenergic agents|mesh-ancestor
110413862|NCT05939076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110413863|NCT05939076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110413864|NCT05939076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110413865|NCT05939076|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110413866|NCT05939076|Sympatholytics|sympatholytics|mesh-ancestor
110413867|NCT05939076|Autonomic Agents|autonomic agents|mesh-ancestor
110413868|NCT05939076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110413869|NCT05939076|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110413870|NCT05939076|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110413871|NCT05939076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110413873|NCT05939037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110413874|NCT05939037|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110413875|NCT05939037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110413876|NCT05939037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110413877|NCT05938972|Omalizumab|omalizumab|mesh-list
110413878|NCT05938972|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110413879|NCT05938972|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110413880|NCT05938972|Respiratory System Agents|respiratory system agents|mesh-ancestor
110365410|NCT00542711|Curcumin|curcumin|mesh-list
110413882|NCT05938959|Anesthetics, Local|anesthetics, local|mesh-ancestor
110413883|NCT05938959|Anesthetics|anesthetics|mesh-ancestor
110413884|NCT05938959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110413885|NCT05938959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110413886|NCT05938959|Sensory System Agents|sensory system agents|mesh-ancestor
110413887|NCT05938959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110413888|NCT05938530|Sirolimus|sirolimus|mesh-list
110413889|NCT05938530|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110413890|NCT05938530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110413891|NCT05938530|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110413892|NCT05938530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110413893|NCT05938530|Antifungal Agents|antifungal agents|mesh-ancestor
110413894|NCT05938530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110413895|NCT05938530|Immunologic Factors|immunologic factors|mesh-ancestor
110413896|NCT05938530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110413897|NCT05937282|Lidocaine|lidocaine|mesh-list
110413898|NCT05937282|Dexmedetomidine|dexmedetomidine|mesh-list
110413899|NCT05937282|Propofol|propofol|mesh-list
110413900|NCT05937282|Anesthetics, Local|anesthetics, local|mesh-ancestor
110413901|NCT05937282|Anesthetics|anesthetics|mesh-ancestor
110413902|NCT05937282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110413903|NCT05937282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110413904|NCT05937282|Sensory System Agents|sensory system agents|mesh-ancestor
110413905|NCT05937282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110413906|NCT05937282|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110413907|NCT05937282|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110413908|NCT05937282|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110413909|NCT05937282|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110413910|NCT05937282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110413911|NCT05937282|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110413912|NCT05937282|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110413914|NCT05937282|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110413915|NCT05937282|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110413916|NCT05937282|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110413917|NCT05937282|Adrenergic Agents|adrenergic agents|mesh-ancestor
110413918|NCT05937282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110413919|NCT05937282|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110413920|NCT05937282|Anesthetics, General|anesthetics, general|mesh-ancestor
110413921|NCT05936268|Colchicine|colchicine|mesh-list
110413922|NCT05936268|Gout Suppressants|gout suppressants|mesh-ancestor
110413923|NCT05936268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110413924|NCT05936268|Tubulin Modulators|tubulin modulators|mesh-ancestor
110413925|NCT05936268|Antimitotic Agents|antimitotic agents|mesh-ancestor
110413926|NCT05936268|Mitosis Modulators|mitosis modulators|mesh-ancestor
110184246|NCT00033072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110413927|NCT05936268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110413928|NCT05936268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110413929|NCT05935787|Niacinamide|niacinamide|mesh-list
110413930|NCT05935787|Niacin|niacin|mesh-list
110413931|NCT05935787|Nicotinic Acids|nicotinic acids|mesh-list
110413932|NCT05935787|Riboflavin|riboflavin|mesh-list
110413933|NCT05935787|Vitamin B Complex|vitamin b complex|mesh-ancestor
110413934|NCT05935787|Vitamins|vitamins|mesh-ancestor
110413935|NCT05935787|Micronutrients|micronutrients|mesh-ancestor
110413936|NCT05935787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110413937|NCT05935787|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110413938|NCT05935787|Antimetabolites|antimetabolites|mesh-ancestor
110413939|NCT05935787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110413940|NCT05935787|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110413941|NCT05935787|Vasodilator Agents|vasodilator agents|mesh-ancestor
110413942|NCT05935787|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110413943|NCT05935787|Dermatologic Agents|dermatologic agents|mesh-ancestor
110413945|NCT05933642|Furosemide|furosemide|mesh-list
110413946|NCT05933642|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110413947|NCT05933642|Autonomic Agents|autonomic agents|mesh-ancestor
110413948|NCT05933642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110413949|NCT05933642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110413950|NCT05933642|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110413951|NCT05933642|Respiratory System Agents|respiratory system agents|mesh-ancestor
110413952|NCT05933642|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110413953|NCT05933642|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110413954|NCT05933642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110413955|NCT05933642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110413956|NCT05933642|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110413957|NCT05933642|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110413958|NCT05933642|Purinergic Agents|purinergic agents|mesh-ancestor
110413959|NCT05933642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110413960|NCT05933642|Protective Agents|protective agents|mesh-ancestor
110413961|NCT05933642|Diuretics|diuretics|mesh-ancestor
110413962|NCT05933642|Natriuretic Agents|natriuretic agents|mesh-ancestor
110413963|NCT05933642|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110413964|NCT05933642|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110413965|NCT05932251|Metformin|metformin|mesh-list
110413966|NCT05932251|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110413967|NCT05932251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110413968|NCT05928520|Lidocaine|lidocaine|mesh-list
110413969|NCT05928520|Tramadol|tramadol|mesh-list
110413970|NCT05928520|Anesthetics, Local|anesthetics, local|mesh-ancestor
110413971|NCT05928520|Anesthetics|anesthetics|mesh-ancestor
110413972|NCT05928520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110413973|NCT05928520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110413974|NCT05928520|Sensory System Agents|sensory system agents|mesh-ancestor
110413975|NCT05928520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110413976|NCT05928520|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110413977|NCT05928520|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110413978|NCT05928520|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110413979|NCT05928520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110184247|NCT00033072|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110413980|NCT05928520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110413981|NCT05928520|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110413982|NCT05928520|Narcotics|narcotics|mesh-ancestor
110413983|NCT05928520|Analgesics|analgesics|mesh-ancestor
110413984|NCT05928390|Pasireotide|pasireotide|mesh-list
110413985|NCT05928390|Hormones|hormones|mesh-ancestor
110413986|NCT05928390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110413987|NCT05928390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110413988|NCT05923411|Rabeprazole|rabeprazole|mesh-list
110413989|NCT05923411|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110413990|NCT05923411|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110413991|NCT05923411|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110413992|NCT05923411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110413993|NCT05923411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110413994|NCT05923190|Pembrolizumab|pembrolizumab|mesh-list
110413995|NCT05923190|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110413996|NCT05923190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110413997|NCT05923190|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110413998|NCT05923190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110413999|NCT05919173|Dexmedetomidine|dexmedetomidine|mesh-list
110414000|NCT05919173|Bupivacaine|bupivacaine|mesh-list
110414001|NCT05919173|Anesthetics, Local|anesthetics, local|mesh-ancestor
110414002|NCT05919173|Anesthetics|anesthetics|mesh-ancestor
110414003|NCT05919173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110414004|NCT05919173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110414005|NCT05919173|Sensory System Agents|sensory system agents|mesh-ancestor
110414006|NCT05919173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110414007|NCT05919173|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110414008|NCT05919173|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110414009|NCT05919173|Analgesics|analgesics|mesh-ancestor
110414010|NCT05919173|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110414011|NCT05919173|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110414013|NCT05919173|Adrenergic Agents|adrenergic agents|mesh-ancestor
110414014|NCT05919173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110414015|NCT05919173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110414016|NCT05911776|Dexmedetomidine|dexmedetomidine|mesh-list
110414017|NCT05911776|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110414018|NCT05911776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110414019|NCT05911776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110414020|NCT05911776|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110414021|NCT05911776|Analgesics|analgesics|mesh-ancestor
110414022|NCT05911776|Sensory System Agents|sensory system agents|mesh-ancestor
110414023|NCT05911776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110414024|NCT05911776|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110414025|NCT05911776|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110414026|NCT05911776|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110414027|NCT05911776|Adrenergic Agents|adrenergic agents|mesh-ancestor
110414028|NCT05911776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110414029|NCT05911776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110414030|NCT05908747|Paclitaxel|paclitaxel|mesh-list
110414031|NCT05908747|Gemcitabine|gemcitabine|mesh-list
110414032|NCT05908747|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110414033|NCT05908747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110414034|NCT05908747|Tubulin Modulators|tubulin modulators|mesh-ancestor
110414035|NCT05908747|Antimitotic Agents|antimitotic agents|mesh-ancestor
110414036|NCT05908747|Mitosis Modulators|mitosis modulators|mesh-ancestor
110414037|NCT05908747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110414038|NCT05908747|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110414039|NCT05908747|Antimetabolites|antimetabolites|mesh-ancestor
110414040|NCT05906511|Dronabinol|dronabinol|mesh-list
110414041|NCT05906511|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110414042|NCT05906511|Hallucinogens|hallucinogens|mesh-ancestor
110414043|NCT05906511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110414044|NCT05906511|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110414045|NCT05906511|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110414046|NCT05906511|Analgesics|analgesics|mesh-ancestor
110414047|NCT05906511|Sensory System Agents|sensory system agents|mesh-ancestor
110414048|NCT05906511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110414049|NCT05906511|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
110328050|NCT03278262|Growth Substances|growth substances|mesh-ancestor
110414050|NCT05906511|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110414051|NCT05906511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110414052|NCT05906511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110414053|NCT05906511|Hormones|hormones|mesh-ancestor
110414054|NCT05906511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110414055|NCT05904808|Metolazone|metolazone|mesh-list
110414056|NCT05904808|Furosemide|furosemide|mesh-list
110414057|NCT05904808|Acetazolamide|acetazolamide|mesh-list
110414058|NCT05904808|Magnesium citrate|magnesium citrate|mesh-list
110414059|NCT05904808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110414060|NCT05904808|Diuretics|diuretics|mesh-ancestor
110414061|NCT05904808|Natriuretic Agents|natriuretic agents|mesh-ancestor
110414062|NCT05904808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110414063|NCT05904808|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110414064|NCT05904808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110414065|NCT05904808|Anticonvulsants|anticonvulsants|mesh-ancestor
110414066|NCT05904808|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110414067|NCT05904808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110414068|NCT05904808|Cathartics|cathartics|mesh-ancestor
110414069|NCT05904808|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110414070|NCT05904808|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110414071|NCT05904808|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110414072|NCT05888350|Beclomethasone|beclomethasone|mesh-list
110414073|NCT05888350|Formoterol Fumarate|formoterol fumarate|mesh-list
110414074|NCT05888350|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110414075|NCT05888350|Autonomic Agents|autonomic agents|mesh-ancestor
110414076|NCT05888350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110414077|NCT05888350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110414078|NCT05888350|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110414079|NCT05888350|Respiratory System Agents|respiratory system agents|mesh-ancestor
110414080|NCT05888350|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110414081|NCT05888350|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110414082|NCT05888350|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110414083|NCT05888350|Adrenergic Agents|adrenergic agents|mesh-ancestor
110414084|NCT05888350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110414085|NCT05888350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110414086|NCT05888350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110414087|NCT05888350|Glucocorticoids|glucocorticoids|mesh-ancestor
110414088|NCT05888350|Hormones|hormones|mesh-ancestor
110414089|NCT05888350|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110414090|NCT05881083|Nicotine|nicotine|mesh-list
110414091|NCT05881083|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110414092|NCT05881083|Autonomic Agents|autonomic agents|mesh-ancestor
110414093|NCT05881083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110414094|NCT05881083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110414095|NCT05881083|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110414096|NCT05881083|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110414097|NCT05881083|Cholinergic Agents|cholinergic agents|mesh-ancestor
110414098|NCT05881083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110414099|NCT05881083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110414100|NCT05875961|MF59 oil emulsion|mf59 oil emulsion|mesh-list
110414101|NCT05875961|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110414102|NCT05875961|Immunologic Factors|immunologic factors|mesh-ancestor
110414103|NCT05875961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110414104|NCT05870683|Amoxicillin|amoxicillin|mesh-list
110414105|NCT05870683|Esomeprazole|esomeprazole|mesh-list
110414106|NCT05870683|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110414107|NCT05870683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110414108|NCT05870683|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110414109|NCT05870683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110414110|NCT05870683|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110414111|NCT05870683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110414112|NCT05870683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110414113|NCT05860400|Immunosuppressive Agents|immunosuppressive agents|mesh-list
110414114|NCT05860400|Immunologic Factors|immunologic factors|mesh-ancestor
110563561|NCT00742300|Cyclophosphamide|cyclophosphamide|mesh-list
110414115|NCT05860400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110414116|NCT05854784|Afamelanotide|afamelanotide|mesh-list
110414117|NCT05854784|Dermatologic Agents|dermatologic agents|mesh-ancestor
110414118|NCT05847452|Benralizumab|benralizumab|mesh-list
110414119|NCT05847452|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110414120|NCT05847452|Respiratory System Agents|respiratory system agents|mesh-ancestor
110414122|NCT05833776|Bupivacaine|bupivacaine|mesh-list
110414123|NCT05833776|Anesthetics, Local|anesthetics, local|mesh-ancestor
110414124|NCT05833776|Anesthetics|anesthetics|mesh-ancestor
110414125|NCT05833776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110414126|NCT05833776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110414127|NCT05833776|Sensory System Agents|sensory system agents|mesh-ancestor
110414128|NCT05833776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110414129|NCT05833776|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110414130|NCT05833776|Narcotics|narcotics|mesh-ancestor
110414131|NCT05833776|Analgesics|analgesics|mesh-ancestor
110414132|NCT05833776|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110414133|NCT05833776|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110414134|NCT05833776|Anesthetics, General|anesthetics, general|mesh-ancestor
110414135|NCT05823441|Oxytocin|oxytocin|mesh-list
110414136|NCT05823441|Oxytocics|oxytocics|mesh-ancestor
110414137|NCT05823441|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110414138|NCT05823441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110414139|NCT05821309|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
110414140|NCT05821309|Glycerol|glycerol|mesh-list
110414141|NCT05821309|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
110414142|NCT05821309|Protective Agents|protective agents|mesh-ancestor
110414143|NCT05821309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110414144|NCT05821309|Laxatives|laxatives|mesh-ancestor
110414145|NCT05821309|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110414146|NCT05816616|Xenon|xenon|mesh-list
110414147|NCT05816616|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110414148|NCT05816616|Anesthetics, General|anesthetics, general|mesh-ancestor
110414149|NCT05816616|Anesthetics|anesthetics|mesh-ancestor
110414150|NCT05816616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110414151|NCT05816616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110414152|NCT05792319|Copper|copper|mesh-list
110184308|NCT00033345|Indole-3-carbinol|indole-3-carbinol|mesh-list
110184313|NCT00033423|Rituximab|rituximab|mesh-list
110414153|NCT05792319|Trace Elements|trace elements|mesh-ancestor
110414154|NCT05792319|Micronutrients|micronutrients|mesh-ancestor
110414155|NCT05792319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110414156|NCT05760261|Midazolam|midazolam|mesh-list
110414157|NCT05760261|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110414158|NCT05760261|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110414159|NCT05760261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110414160|NCT05760261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110414161|NCT05760261|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110414162|NCT05760261|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110414163|NCT05760261|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110414164|NCT05760261|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110414165|NCT05760261|Anesthetics, General|anesthetics, general|mesh-ancestor
110414166|NCT05760261|Anesthetics|anesthetics|mesh-ancestor
110414167|NCT05760261|GABA Modulators|gaba modulators|mesh-ancestor
110414168|NCT05760261|GABA Agents|gaba agents|mesh-ancestor
110414169|NCT05760261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110414170|NCT05760261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110414171|NCT05746377|Metoclopramide|metoclopramide|mesh-list
110414172|NCT05746377|Antiemetics|antiemetics|mesh-ancestor
110414173|NCT05746377|Autonomic Agents|autonomic agents|mesh-ancestor
110414174|NCT05746377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110414175|NCT05746377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110414176|NCT05746377|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110414177|NCT05746377|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110414178|NCT05746377|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110414179|NCT05746377|Dopamine Agents|dopamine agents|mesh-ancestor
110414180|NCT05746377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110414181|NCT05746377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110414182|NCT05725798|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110414183|NCT05725798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110414184|NCT05725798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110414185|NCT05725798|Incretins|incretins|mesh-ancestor
110414186|NCT05725798|Hormones|hormones|mesh-ancestor
110414187|NCT05725798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110414188|NCT05725798|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110414189|NCT05725798|Protease Inhibitors|protease inhibitors|mesh-ancestor
110414190|NCT05725798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110414191|NCT05725798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110414192|NCT05708859|Tirzepatide|tirzepatide|mesh-list
110414193|NCT05708859|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110414194|NCT05708859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110414195|NCT05708859|Incretins|incretins|mesh-ancestor
110414196|NCT05708859|Hormones|hormones|mesh-ancestor
110414197|NCT05708859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110414198|NCT05699252|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
110414199|NCT05699252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110414200|NCT05699252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110414201|NCT05655949|Cisplatin|cisplatin|mesh-list
110414202|NCT05655949|Gemcitabine|gemcitabine|mesh-list
110414203|NCT05655949|Durvalumab|durvalumab|mesh-list
110414204|NCT05655949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110414205|NCT05655949|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110414206|NCT05655949|Antimetabolites|antimetabolites|mesh-ancestor
110414207|NCT05655949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110414208|NCT05655949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110414209|NCT05646719|Phentolamine|phentolamine|mesh-list
110414210|NCT05646719|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110414211|NCT05646719|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110414212|NCT05646719|Pilocarpine|pilocarpine|mesh-list
110414214|NCT05646719|Autonomic Agents|autonomic agents|mesh-ancestor
110414215|NCT05646719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110414216|NCT05646719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110414217|NCT05646719|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
110414218|NCT05646719|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110414219|NCT05646719|Cholinergic Agents|cholinergic agents|mesh-ancestor
110414220|NCT05646719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110414221|NCT05646719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110414222|NCT05646719|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110414223|NCT05646719|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110414224|NCT05646719|Adrenergic Agents|adrenergic agents|mesh-ancestor
110414225|NCT05646719|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110414226|NCT05645406|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110414227|NCT05645406|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110414228|NCT05645406|Estradiol|estradiol|mesh-list
110414229|NCT05645406|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110414230|NCT05645406|Estrogens|estrogens|mesh-ancestor
110414231|NCT05645406|Hormones|hormones|mesh-ancestor
110414232|NCT05645406|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110414233|NCT05645406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110414234|NCT05645406|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110414235|NCT05645406|Contraceptive Agents|contraceptive agents|mesh-ancestor
110414236|NCT05645406|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110414237|NCT05645406|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110414238|NCT05645393|Estrogens|estrogens|mesh-list
110414239|NCT05645393|Hormones|hormones|mesh-ancestor
110414240|NCT05645393|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110414241|NCT05645393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110414242|NCT05625594|Cyclophosphamide|cyclophosphamide|mesh-list
110414243|NCT05625594|Fludarabine|fludarabine|mesh-list
110414244|NCT05625594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110414245|NCT05625594|Immunologic Factors|immunologic factors|mesh-ancestor
110414246|NCT05625594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110414247|NCT05625594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110414248|NCT05625594|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110414249|NCT05625594|Alkylating Agents|alkylating agents|mesh-ancestor
110414250|NCT05625594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110414251|NCT05625594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110414252|NCT05625594|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110414253|NCT05618301|Natalizumab|natalizumab|mesh-list
110414254|NCT05618301|Immunologic Factors|immunologic factors|mesh-ancestor
110414255|NCT05618301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110414267|NCT05612074|Nitric Oxide|nitric oxide|mesh-list
110414268|NCT05612074|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110414269|NCT05612074|Autonomic Agents|autonomic agents|mesh-ancestor
110414270|NCT05612074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110414271|NCT05612074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110414272|NCT05612074|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110414273|NCT05612074|Respiratory System Agents|respiratory system agents|mesh-ancestor
110414274|NCT05612074|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110414275|NCT05612074|Antioxidants|antioxidants|mesh-ancestor
110414276|NCT05612074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110414277|NCT05612074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110414278|NCT05612074|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
110184347|NCT00033618|Mitosis Modulators|mitosis modulators|mesh-ancestor
110414279|NCT05612074|Vasodilator Agents|vasodilator agents|mesh-ancestor
110414280|NCT05612074|Gasotransmitters|gasotransmitters|mesh-ancestor
110414281|NCT05612074|Protective Agents|protective agents|mesh-ancestor
110414282|NCT05610085|Levetiracetam|levetiracetam|mesh-list
110414283|NCT05610085|Phenobarbital|phenobarbital|mesh-list
110414284|NCT05610085|Anticonvulsants|anticonvulsants|mesh-ancestor
110414285|NCT05610085|Nootropic Agents|nootropic agents|mesh-ancestor
110414286|NCT05610085|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110414287|NCT05610085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110414288|NCT05610085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110414289|NCT05610085|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110414290|NCT05610085|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110414291|NCT05610085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110414292|NCT05610085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110414293|NCT05610085|GABA Modulators|gaba modulators|mesh-ancestor
110414294|NCT05610085|GABA Agents|gaba agents|mesh-ancestor
110414295|NCT05610085|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110414296|NCT05610085|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110414297|NCT05610085|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110414298|NCT05581589|Camptothecin|camptothecin|mesh-list
110414299|NCT05581589|Irinotecan|irinotecan|mesh-list
110414300|NCT05581589|Immunoconjugates|immunoconjugates|mesh-list
110414301|NCT05581589|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
110414302|NCT05581589|Immunologic Factors|immunologic factors|mesh-ancestor
110414303|NCT05581589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110414304|NCT05581589|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110414305|NCT05581589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110414306|NCT05581589|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110414307|NCT05581589|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110414308|NCT05581589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110414309|NCT05581589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110414324|NCT05554367|Palbociclib|palbociclib|mesh-list
110414325|NCT05554367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110414326|NCT05554367|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110414327|NCT05554367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110414328|NCT05554367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110414329|NCT05549778|Polaprezinc|polaprezinc|mesh-list
110414330|NCT05549778|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110414331|NCT05549778|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110365855|NCT05817474|Hemostatics|hemostatics|mesh-ancestor
110414332|NCT05513924|Fluorouracil|fluorouracil|mesh-list
110414333|NCT05513924|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110414334|NCT05513924|Latanoprost|latanoprost|mesh-list
110414335|NCT05513924|Antimetabolites|antimetabolites|mesh-ancestor
110414336|NCT05513924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110414337|NCT05513924|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110414338|NCT05513924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110414339|NCT05513924|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110414340|NCT05513924|Immunologic Factors|immunologic factors|mesh-ancestor
110414341|NCT05513924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110414342|NCT05513924|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110414344|NCT05505630|Dexmedetomidine|dexmedetomidine|mesh-list
110414345|NCT05505630|Ketamine|ketamine|mesh-list
110414346|NCT05505630|Anesthetics, Dissociative|anesthetics, dissociative|mesh-list
110414347|NCT05505630|Anesthetics|anesthetics|mesh-list
110414348|NCT05505630|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110414349|NCT05505630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110414350|NCT05505630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110414351|NCT05505630|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110414352|NCT05505630|Analgesics|analgesics|mesh-ancestor
110414353|NCT05505630|Sensory System Agents|sensory system agents|mesh-ancestor
110414354|NCT05505630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110414355|NCT05505630|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110563652|NCT00689104|Mirabegron|mirabegron|mesh-list
110414356|NCT05505630|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110414357|NCT05505630|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110414358|NCT05505630|Adrenergic Agents|adrenergic agents|mesh-ancestor
110414359|NCT05505630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110414360|NCT05505630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110414361|NCT05505630|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110414362|NCT05505630|Anesthetics, General|anesthetics, general|mesh-ancestor
110414363|NCT05505630|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110414364|NCT05505630|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110414365|NCT05505630|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110414366|NCT05505630|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110414367|NCT05505630|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110414368|NCT05505630|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110414369|NCT05505630|GABA Modulators|gaba modulators|mesh-ancestor
110414370|NCT05505630|GABA Agents|gaba agents|mesh-ancestor
110414371|NCT05444777|Ketamine|ketamine|mesh-list
110414372|NCT05444777|Analgesics|analgesics|mesh-ancestor
110414373|NCT05444777|Sensory System Agents|sensory system agents|mesh-ancestor
110414374|NCT05444777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110414375|NCT05444777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110414376|NCT05444777|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110414377|NCT05444777|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110414378|NCT05444777|Anesthetics, General|anesthetics, general|mesh-ancestor
110414379|NCT05444777|Anesthetics|anesthetics|mesh-ancestor
110414380|NCT05444777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110414381|NCT05444777|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110414382|NCT05444777|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110414383|NCT05444777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110414384|NCT05444777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110414386|NCT05433961|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110414387|NCT05433961|Anesthetics, General|anesthetics, general|mesh-ancestor
110414388|NCT05433961|Anesthetics|anesthetics|mesh-ancestor
110414389|NCT05433961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110414390|NCT05433961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110414391|NCT05410821|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
110414392|NCT05410821|Chelating Agents|chelating agents|mesh-ancestor
110414393|NCT05410821|Sequestering Agents|sequestering agents|mesh-ancestor
110414394|NCT05410821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110414395|NCT05410418|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
110414396|NCT05410418|Immunoconjugates|immunoconjugates|mesh-ancestor
110414397|NCT05410418|Immunologic Factors|immunologic factors|mesh-ancestor
110414398|NCT05410418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110414400|NCT05402293|Anesthetics, Local|anesthetics, local|mesh-ancestor
110414401|NCT05402293|Anesthetics|anesthetics|mesh-ancestor
110414402|NCT05402293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110414403|NCT05402293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110414404|NCT05402293|Sensory System Agents|sensory system agents|mesh-ancestor
110414405|NCT05402293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110414406|NCT05402293|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110414407|NCT05402293|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110414408|NCT05402293|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110414409|NCT05402293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110414410|NCT05402293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110414411|NCT05355168|Nimotuzumab|nimotuzumab|mesh-list
110414412|NCT05355168|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110414413|NCT05355168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110414414|NCT05348356|Nirogacestat|nirogacestat|mesh-list
110414415|NCT05348356|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
110414416|NCT05348356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110414417|NCT05348356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110414418|NCT05330130|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
110414420|NCT05330130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110414421|NCT05330130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110414422|NCT05323981|Pertuzumab|pertuzumab|mesh-list
110414423|NCT05323981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110414424|NCT05323981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110414425|NCT05317364|Estradiol|estradiol|mesh-list
110414426|NCT05317364|Estrogens|estrogens|mesh-ancestor
110414427|NCT05317364|Hormones|hormones|mesh-ancestor
110414428|NCT05317364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110414429|NCT05317364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110414430|NCT05313243|Pembrolizumab|pembrolizumab|mesh-list
110414431|NCT05313243|Brentuximab Vedotin|brentuximab vedotin|mesh-list
110414432|NCT05313243|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110414433|NCT05313243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110414434|NCT05313243|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110414435|NCT05313243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110414436|NCT05313243|Immunotoxins|immunotoxins|mesh-ancestor
110414437|NCT05313243|Immunoconjugates|immunoconjugates|mesh-ancestor
110414438|NCT05313243|Immunologic Factors|immunologic factors|mesh-ancestor
110414439|NCT05313243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110414440|NCT05313009|Sotorasib|sotorasib|mesh-list
110414441|NCT05313009|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110414442|NCT05313009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110414443|NCT05313009|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110414444|NCT05313009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110414445|NCT05311475|Mometasone Furoate|mometasone furoate|mesh-list
110414446|NCT05311475|Azelastine|azelastine|mesh-list
110414447|NCT05311475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110414448|NCT05311475|Dermatologic Agents|dermatologic agents|mesh-ancestor
110414449|NCT05311475|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110414450|NCT05311475|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110414451|NCT05311475|Autonomic Agents|autonomic agents|mesh-ancestor
110414452|NCT05311475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110414453|NCT05311475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110414454|NCT05311475|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110414455|NCT05311475|Respiratory System Agents|respiratory system agents|mesh-ancestor
110414456|NCT05311475|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
110414457|NCT05311475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110414458|NCT05311475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110414459|NCT05311475|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110414460|NCT05311475|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110414461|NCT05311475|Histamine Antagonists|histamine antagonists|mesh-ancestor
110414462|NCT05311475|Histamine Agents|histamine agents|mesh-ancestor
110414463|NCT05311475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110414464|NCT05311176|Paclitaxel|paclitaxel|mesh-list
110414465|NCT05311176|Pembrolizumab|pembrolizumab|mesh-list
110414466|NCT05311176|Ramucirumab|ramucirumab|mesh-list
110414467|NCT05311176|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110414468|NCT05311176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110414469|NCT05311176|Tubulin Modulators|tubulin modulators|mesh-ancestor
110414470|NCT05311176|Antimitotic Agents|antimitotic agents|mesh-ancestor
110414471|NCT05311176|Mitosis Modulators|mitosis modulators|mesh-ancestor
110414472|NCT05311176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110414473|NCT05311176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110414474|NCT05311176|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110414475|NCT05302817|Xenon|xenon|mesh-list
110414476|NCT05302817|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110414477|NCT05302817|Anesthetics, General|anesthetics, general|mesh-ancestor
110414478|NCT05302817|Anesthetics|anesthetics|mesh-ancestor
110414479|NCT05302817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110414480|NCT05302817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110414481|NCT05289492|Dexamethasone|dexamethasone|mesh-list
110414482|NCT05289492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110414483|NCT05289492|Antiemetics|antiemetics|mesh-ancestor
110414484|NCT05289492|Autonomic Agents|autonomic agents|mesh-ancestor
110414485|NCT05289492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110414486|NCT05289492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110414487|NCT05289492|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110414488|NCT05289492|Glucocorticoids|glucocorticoids|mesh-ancestor
110414489|NCT05289492|Hormones|hormones|mesh-ancestor
110414490|NCT05289492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110414491|NCT05289492|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110414492|NCT05289492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110414493|NCT05260528|Cytarabine|cytarabine|mesh-list
110414494|NCT05260528|Idarubicin|idarubicin|mesh-list
110414495|NCT05260528|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110414496|NCT05260528|Antimetabolites|antimetabolites|mesh-ancestor
110414497|NCT05260528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110414498|NCT05260528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110414499|NCT05260528|Antiviral Agents|antiviral agents|mesh-ancestor
110414500|NCT05260528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110414501|NCT05260528|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110414502|NCT05260528|Immunologic Factors|immunologic factors|mesh-ancestor
110414503|NCT05260528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110414504|NCT05260528|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110414505|NCT05260528|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110414506|NCT05260528|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110414507|NCT05260528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110414509|NCT05255666|Irinotecan|irinotecan|mesh-list
110414510|NCT05255666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110414511|NCT05255666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110414512|NCT05255666|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110414513|NCT05255666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110414514|NCT05255666|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110414515|NCT05255666|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110414516|NCT05255666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110414517|NCT05255146|Nitrous Oxide|nitrous oxide|mesh-list
110414518|NCT05255146|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110414519|NCT05255146|Anesthetics, General|anesthetics, general|mesh-ancestor
110414520|NCT05255146|Anesthetics|anesthetics|mesh-ancestor
110414521|NCT05255146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110414522|NCT05255146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110414523|NCT05255146|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110414524|NCT05255146|Analgesics|analgesics|mesh-ancestor
110414525|NCT05255146|Sensory System Agents|sensory system agents|mesh-ancestor
110414526|NCT05255146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110414527|NCT05254743|Pirtobrutinib|pirtobrutinib|mesh-list
110414528|NCT05254743|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110414529|NCT05254743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110414530|NCT05254743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110414531|NCT05198609|Apatinib|apatinib|mesh-list
110414532|NCT05198609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110414533|NCT05198609|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110414534|NCT05198609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110414535|NCT05198609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110414536|NCT05191004|Fulvestrant|fulvestrant|mesh-list
110414537|NCT05191004|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110414538|NCT05191004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110414539|NCT05191004|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110414540|NCT05191004|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110414541|NCT05191004|Hormone Antagonists|hormone antagonists|mesh-ancestor
110414542|NCT05191004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110414543|NCT05191004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110414544|NCT05185089|Maleic acid|maleic acid|mesh-list
110414545|NCT05185089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110414546|NCT05185089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110414547|NCT05157672|Letrozole|letrozole|mesh-list
110414548|NCT05157672|Nicotine|nicotine|mesh-list
110414549|NCT05157672|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110414550|NCT05157672|Autonomic Agents|autonomic agents|mesh-ancestor
110414551|NCT05157672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110414552|NCT05157672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110414553|NCT05157672|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110366093|NCT04823156|Calcium|calcium|mesh-list
110414554|NCT05157672|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110414555|NCT05157672|Cholinergic Agents|cholinergic agents|mesh-ancestor
110414556|NCT05157672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110414557|NCT05157672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110414558|NCT05157672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110414559|NCT05157672|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110414560|NCT05157672|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110414561|NCT05157672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110414562|NCT05157672|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110414563|NCT05157672|Hormone Antagonists|hormone antagonists|mesh-ancestor
110414564|NCT05157672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110414565|NCT05111145|Ivacaftor|ivacaftor|mesh-list
110414566|NCT05111145|Elexacaftor|elexacaftor|mesh-list
110414567|NCT05111145|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
110414568|NCT05111145|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110414569|NCT05111145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110414570|NCT05090033|Ofatumumab|ofatumumab|mesh-list
110414571|NCT05090033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110414572|NCT05060432|Pembrolizumab|pembrolizumab|mesh-list
110414573|NCT05060432|Dostarlimab|dostarlimab|mesh-list
110414574|NCT05060432|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110414575|NCT05060432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110414576|NCT05060432|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110414577|NCT05060432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110414578|NCT05023980|Rituximab|rituximab|mesh-list
110414579|NCT05023980|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110414580|NCT05023980|Pirtobrutinib|pirtobrutinib|mesh-list
110414581|NCT05023980|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110414582|NCT05023980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110414583|NCT05023980|Immunologic Factors|immunologic factors|mesh-ancestor
110414584|NCT05023980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110414586|NCT05023980|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110414587|NCT05023980|Alkylating Agents|alkylating agents|mesh-ancestor
110414588|NCT05023980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110414589|NCT05023980|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110414590|NCT05023980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110414591|NCT05007522|Ketotifen|ketotifen|mesh-list
110414592|NCT05007522|Indomethacin|indomethacin|mesh-list
110414593|NCT05007522|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110414594|NCT05007522|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110414595|NCT05007522|Analgesics|analgesics|mesh-ancestor
110414596|NCT05007522|Sensory System Agents|sensory system agents|mesh-ancestor
110414597|NCT05007522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110414598|NCT05007522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110414599|NCT05007522|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110414600|NCT05007522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110414601|NCT05007522|Gout Suppressants|gout suppressants|mesh-ancestor
110414602|NCT05007522|Tocolytic Agents|tocolytic agents|mesh-ancestor
110414603|NCT05007522|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110414604|NCT05007522|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110414605|NCT05007522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110328090|NCT00459719|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110414606|NCT05007522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110414607|NCT05007522|Antipruritics|antipruritics|mesh-ancestor
110414608|NCT05007522|Dermatologic Agents|dermatologic agents|mesh-ancestor
110414609|NCT05007522|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110414610|NCT05007522|Histamine Antagonists|histamine antagonists|mesh-ancestor
110414611|NCT05007522|Histamine Agents|histamine agents|mesh-ancestor
110414612|NCT05007522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110414613|NCT05007522|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110414614|NCT05003349|Salicylic Acid|salicylic acid|mesh-list
110414615|NCT05003349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110414616|NCT05003349|Antifungal Agents|antifungal agents|mesh-ancestor
110414617|NCT05003349|Keratolytic Agents|keratolytic agents|mesh-ancestor
110414618|NCT05003349|Dermatologic Agents|dermatologic agents|mesh-ancestor
110414619|NCT04952779|Insulin|insulin|mesh-list
110414620|NCT04952779|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110414621|NCT04952779|Liraglutide|liraglutide|mesh-list
110414622|NCT04952779|Insulin, Long-Acting|insulin, long-acting|mesh-list
110414623|NCT04952779|Xultophy|xultophy|mesh-list
110414624|NCT04952779|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110414625|NCT04952779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110414626|NCT04952779|Incretins|incretins|mesh-ancestor
110414627|NCT04952779|Hormones|hormones|mesh-ancestor
110414628|NCT04952779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110414629|NCT04941573|Xenon|xenon|mesh-list
110414630|NCT04941573|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110414631|NCT04941573|Anesthetics, General|anesthetics, general|mesh-ancestor
110414632|NCT04941573|Anesthetics|anesthetics|mesh-ancestor
110414633|NCT04941573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110414634|NCT04941573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110414635|NCT04926948|Immunomodulating Agents|immunomodulating agents|mesh-list
110414636|NCT04926948|Immunologic Factors|immunologic factors|mesh-ancestor
110414637|NCT04926948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110414638|NCT04900623|Paclitaxel|paclitaxel|mesh-list
110414639|NCT04900623|Cisplatin|cisplatin|mesh-list
110414640|NCT04900623|Carboplatin|carboplatin|mesh-list
110414641|NCT04900623|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110414642|NCT04900623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110414643|NCT04900623|Tubulin Modulators|tubulin modulators|mesh-ancestor
110414644|NCT04900623|Antimitotic Agents|antimitotic agents|mesh-ancestor
110414645|NCT04900623|Mitosis Modulators|mitosis modulators|mesh-ancestor
110414646|NCT04900623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110414647|NCT04899050|Cannabidiol|cannabidiol|mesh-list
110414648|NCT04899050|Anticonvulsants|anticonvulsants|mesh-ancestor
110414649|NCT04808622|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
110414650|NCT04808622|Antioxidants|antioxidants|mesh-ancestor
110414651|NCT04808622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110414652|NCT04808622|Protective Agents|protective agents|mesh-ancestor
110414653|NCT04808622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110414654|NCT04808622|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110414655|NCT04808622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110414656|NCT04783675|Rituximab|rituximab|mesh-list
110414657|NCT04783675|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110414658|NCT04783675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110414659|NCT04783675|Immunologic Factors|immunologic factors|mesh-ancestor
110414660|NCT04783675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110414661|NCT04783675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110414662|NCT04695080|Cladribine|cladribine|mesh-list
110184555|NCT01806857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110414663|NCT04695080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110414664|NCT04695080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110414665|NCT04695080|Immunologic Factors|immunologic factors|mesh-ancestor
110414666|NCT04695080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110414667|NCT04591353|Lidocaine|lidocaine|mesh-list
110563790|NCT00655109|Analgesics|analgesics|mesh-ancestor
110414668|NCT04591353|Anesthetics, Local|anesthetics, local|mesh-ancestor
110414669|NCT04591353|Anesthetics|anesthetics|mesh-ancestor
110414670|NCT04591353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110414671|NCT04591353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110414672|NCT04591353|Sensory System Agents|sensory system agents|mesh-ancestor
110414673|NCT04591353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110414674|NCT04591353|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110414675|NCT04591353|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110414676|NCT04591353|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110414677|NCT04591353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110414678|NCT04591353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110414679|NCT04540211|Paclitaxel|paclitaxel|mesh-list
110328093|NCT00495183|Biperiden|biperiden|mesh-list
110414681|NCT04540211|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110414682|NCT04540211|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110414683|NCT04540211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110414684|NCT04540211|Tubulin Modulators|tubulin modulators|mesh-ancestor
110414685|NCT04540211|Antimitotic Agents|antimitotic agents|mesh-ancestor
110414686|NCT04540211|Mitosis Modulators|mitosis modulators|mesh-ancestor
110414687|NCT04540211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110414688|NCT04540211|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110414689|NCT04540211|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110414690|NCT04540211|Immunologic Factors|immunologic factors|mesh-ancestor
110414691|NCT04540211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110414692|NCT04505774|Dapagliflozin|dapagliflozin|mesh-list
110414693|NCT04505774|Empagliflozin|empagliflozin|mesh-list
110414694|NCT04505774|Canagliflozin|canagliflozin|mesh-list
110414695|NCT04505774|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
110414696|NCT04505774|Ertugliflozin|ertugliflozin|mesh-list
110414697|NCT04505774|Heparin|heparin|mesh-list
110414698|NCT04505774|Calcium heparin|calcium heparin|mesh-list
110414699|NCT04505774|Enoxaparin|enoxaparin|mesh-list
110414700|NCT04505774|Dalteparin|dalteparin|mesh-list
110414701|NCT04505774|Tinzaparin|tinzaparin|mesh-list
110414702|NCT04505774|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
110414703|NCT04505774|Enoxaparin sodium|enoxaparin sodium|mesh-list
110414704|NCT04505774|Clopidogrel|clopidogrel|mesh-list
110414705|NCT04505774|Ticagrelor|ticagrelor|mesh-list
110414706|NCT04505774|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110414707|NCT04505774|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110414708|NCT04505774|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110414710|NCT04505774|Purinergic Agents|purinergic agents|mesh-ancestor
110414711|NCT04505774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110414712|NCT04505774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110414713|NCT04505774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110414714|NCT04505774|Anticoagulants|anticoagulants|mesh-ancestor
110414715|NCT04505774|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110414716|NCT04505774|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110414717|NCT04505774|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110414718|NCT04499950|Bupropion hydrochloride, naltrexone hydrochoride drug combination|bupropion hydrochloride, naltrexone hydrochoride drug combination|mesh-list
110414720|NCT04499950|Bupropion|bupropion|mesh-list
110414721|NCT04499950|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110414722|NCT04499950|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110414723|NCT04499950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110414724|NCT04499950|Sensory System Agents|sensory system agents|mesh-ancestor
110414725|NCT04499950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110414726|NCT04499950|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110414727|NCT04499950|Antidepressive Agents|antidepressive agents|mesh-ancestor
110414728|NCT04499950|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110414729|NCT04499950|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110414730|NCT04499950|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110414731|NCT04499950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110414732|NCT04499950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110414733|NCT04499950|Dopamine Agents|dopamine agents|mesh-ancestor
110414734|NCT04499950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110414735|NCT04499950|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110414736|NCT04499950|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110414737|NCT04499950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110414738|NCT04499950|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110414739|NCT04444492|Ranibizumab|ranibizumab|mesh-list
110414740|NCT04444492|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110414741|NCT04444492|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110414742|NCT04444492|Growth Substances|growth substances|mesh-ancestor
110414743|NCT04444492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110414744|NCT04444492|Growth Inhibitors|growth inhibitors|mesh-ancestor
110414745|NCT04444492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110414746|NCT04402385|Aspirin|aspirin|mesh-list
110414747|NCT04402385|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110414748|NCT04402385|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110414749|NCT04402385|Analgesics|analgesics|mesh-ancestor
110414750|NCT04402385|Sensory System Agents|sensory system agents|mesh-ancestor
110414751|NCT04402385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110414752|NCT04402385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110414753|NCT04402385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110414754|NCT04402385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110414755|NCT04402385|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110414756|NCT04402385|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110414757|NCT04402385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110414758|NCT04402385|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110414759|NCT04402385|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110414760|NCT04402385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110414761|NCT04402385|Antipyretics|antipyretics|mesh-ancestor
110414762|NCT04396730|Cannabidiol|cannabidiol|mesh-list
110414763|NCT04396730|Contraceptive Agents|contraceptive agents|mesh-list
110414764|NCT04396730|Contraceptives, Oral|contraceptives, oral|mesh-list
110184622|NCT01806311|Amlodipine|amlodipine|mesh-list
110414765|NCT04396730|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
110414766|NCT04396730|Anticonvulsants|anticonvulsants|mesh-ancestor
110414767|NCT04396730|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110414768|NCT04396730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110414769|NCT04396730|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110414770|NCT04385368|Durvalumab|durvalumab|mesh-list
110414771|NCT04385368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110414772|NCT04385368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110414773|NCT04378868|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110414774|NCT04378868|Metronidazole|metronidazole|mesh-list
110414775|NCT04378868|Cefuroxime|cefuroxime|mesh-list
110414776|NCT04378868|Cefuroxime axetil|cefuroxime axetil|mesh-list
110414777|NCT04378868|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
110414778|NCT04378868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110414779|NCT04378868|Antitubercular Agents|antitubercular agents|mesh-ancestor
110414780|NCT04378868|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110414781|NCT04378868|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110414782|NCT04300556|Farletuzumab|farletuzumab|mesh-list
110414783|NCT04300556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110414784|NCT04251585|Insulin|insulin|mesh-list
110414785|NCT04251585|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110414786|NCT04251585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110414787|NCT04218357|Probenecid|probenecid|mesh-list
110414788|NCT04218357|Uricosuric Agents|uricosuric agents|mesh-ancestor
110414789|NCT04218357|Gout Suppressants|gout suppressants|mesh-ancestor
110414790|NCT04218357|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110414791|NCT04166877|Magnesium Sulfate|magnesium sulfate|mesh-list
110414792|NCT04166877|Analgesics|analgesics|mesh-ancestor
110414793|NCT04166877|Sensory System Agents|sensory system agents|mesh-ancestor
110414794|NCT04166877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110414795|NCT04166877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110414796|NCT04166877|Anesthetics|anesthetics|mesh-ancestor
110414797|NCT04166877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110414798|NCT04166877|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110414799|NCT04166877|Anticonvulsants|anticonvulsants|mesh-ancestor
110414800|NCT04166877|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110414801|NCT04166877|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110414802|NCT04166877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110414803|NCT04166877|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110414804|NCT04166877|Tocolytic Agents|tocolytic agents|mesh-ancestor
110414805|NCT04166877|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110414806|NCT04164979|Pembrolizumab|pembrolizumab|mesh-list
110414807|NCT04164979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110414808|NCT04164979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110414809|NCT04164979|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110414810|NCT04164979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110414811|NCT04135846|Doxazosin|doxazosin|mesh-list
110414812|NCT04135846|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110414813|NCT04135846|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110414814|NCT04135846|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110414815|NCT04135846|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110414816|NCT04135846|Adrenergic Agents|adrenergic agents|mesh-ancestor
110414817|NCT04135846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110414818|NCT04135846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110414819|NCT04135846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110414820|NCT04117893|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110414821|NCT04117893|Hyaluronic Acid|hyaluronic acid|mesh-list
110414822|NCT04117893|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110414823|NCT04117893|Immunologic Factors|immunologic factors|mesh-ancestor
110414824|NCT04117893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110414826|NCT04117893|Protective Agents|protective agents|mesh-ancestor
110414827|NCT04117893|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110414828|NCT04117893|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110414829|NCT04117893|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110414830|NCT04117893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110414831|NCT04117893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110414832|NCT04117893|Analgesics|analgesics|mesh-ancestor
110414833|NCT04117893|Sensory System Agents|sensory system agents|mesh-ancestor
110414834|NCT04117893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110414835|NCT04117893|Antidepressive Agents|antidepressive agents|mesh-ancestor
110414836|NCT04117893|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110414837|NCT04117893|Dopamine Agents|dopamine agents|mesh-ancestor
110414838|NCT04098003|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110414839|NCT04098003|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110414840|NCT04098003|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110414841|NCT04098003|Antimetabolites|antimetabolites|mesh-ancestor
110414842|NCT04098003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110414843|NCT04098003|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110414844|NCT04098003|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110414845|NCT04098003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110414846|NCT04049851|Ivermectin|ivermectin|mesh-list
110414847|NCT04049851|Moxidectin|moxidectin|mesh-list
110414848|NCT04049851|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110414849|NCT04049851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110414850|NCT04049851|Anthelmintics|anthelmintics|mesh-ancestor
110414851|NCT04049851|Antinematodal Agents|antinematodal agents|mesh-ancestor
110414852|NCT03970954|Interleukin-2|interleukin-2|mesh-list
110414853|NCT03970954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110414854|NCT03970954|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110414855|NCT03970954|Analgesics|analgesics|mesh-ancestor
110414856|NCT03970954|Sensory System Agents|sensory system agents|mesh-ancestor
110414857|NCT03970954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110414858|NCT03970954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110414859|NCT03963375|Cladribine|cladribine|mesh-list
110414860|NCT03963375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110414861|NCT03963375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110184658|NCT00034983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110414862|NCT03963375|Immunologic Factors|immunologic factors|mesh-ancestor
110414863|NCT03963375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110414864|NCT03810105|Durvalumab|durvalumab|mesh-list
110414865|NCT03810105|Olaparib|olaparib|mesh-list
110414866|NCT03810105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110414867|NCT03810105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110414868|NCT03810105|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110414869|NCT03810105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110414870|NCT03810105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110414874|NCT03785210|Vancomycin|vancomycin|mesh-list
110414875|NCT03785210|Nivolumab|nivolumab|mesh-list
110414876|NCT03785210|Tadalafil|tadalafil|mesh-list
110414877|NCT03785210|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110414878|NCT03785210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110414879|NCT03785210|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110414880|NCT03785210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110414881|NCT03785210|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110414882|NCT03785210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110414883|NCT03785210|Vasodilator Agents|vasodilator agents|mesh-ancestor
110414884|NCT03785210|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110414885|NCT03785210|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110414886|NCT03785210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110414887|NCT03785210|Urological Agents|urological agents|mesh-ancestor
110414888|NCT03757689|Pembrolizumab|pembrolizumab|mesh-list
110414889|NCT03757689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110414890|NCT03757689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110414891|NCT03757689|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110414892|NCT03757689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110414893|NCT03750968|Carotenoids|carotenoids|mesh-list
110414894|NCT03750968|Antioxidants|antioxidants|mesh-ancestor
110414895|NCT03750968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110414896|NCT03750968|Protective Agents|protective agents|mesh-ancestor
110414897|NCT03750968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110414899|NCT03735979|Eptifibatide|eptifibatide|mesh-list
110414900|NCT03735979|Antithrombins|antithrombins|mesh-ancestor
110414901|NCT03735979|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110414902|NCT03735979|Protease Inhibitors|protease inhibitors|mesh-ancestor
110414903|NCT03735979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110414904|NCT03735979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110414905|NCT03735979|Anticoagulants|anticoagulants|mesh-ancestor
110414906|NCT03735979|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110414907|NCT03722498|Leucovorin|leucovorin|mesh-list
110414908|NCT03722498|Fluorouracil|fluorouracil|mesh-list
110414909|NCT03722498|Oxaliplatin|oxaliplatin|mesh-list
110414910|NCT03722498|Sorafenib|sorafenib|mesh-list
110414911|NCT03722498|Antimetabolites|antimetabolites|mesh-ancestor
110414912|NCT03722498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110414913|NCT03722498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110414914|NCT03722498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110414915|NCT03722498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110414916|NCT03722498|Immunologic Factors|immunologic factors|mesh-ancestor
110414917|NCT03722498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110414918|NCT03722498|Antidotes|antidotes|mesh-ancestor
110414919|NCT03722498|Protective Agents|protective agents|mesh-ancestor
110414920|NCT03722498|Vitamin B Complex|vitamin b complex|mesh-ancestor
110414921|NCT03722498|Vitamins|vitamins|mesh-ancestor
110414922|NCT03722498|Micronutrients|micronutrients|mesh-ancestor
110414923|NCT03722498|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110414924|NCT03722498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110414925|NCT03710824|Nintedanib|nintedanib|mesh-list
110414926|NCT03710824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110414927|NCT03710824|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110414928|NCT03710824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110414929|NCT03710824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110414931|NCT03648892|Fallypride|fallypride|mesh-list
110414932|NCT03648892|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110414933|NCT03648892|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110414934|NCT03648892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110414935|NCT03648892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110414936|NCT03648892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110414937|NCT03648892|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110414938|NCT03648892|Dopamine Agents|dopamine agents|mesh-ancestor
110414939|NCT03648892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110414940|NCT03648892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110414941|NCT03648892|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110414942|NCT03637543|Nivolumab|nivolumab|mesh-list
110414943|NCT03637543|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110414944|NCT03637543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110414945|NCT03637543|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110414946|NCT03637543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110414947|NCT03626831|Evolocumab|evolocumab|mesh-list
110414948|NCT03626831|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
110414949|NCT03626831|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110414950|NCT03626831|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110414951|NCT03626831|Antimetabolites|antimetabolites|mesh-ancestor
110414952|NCT03626831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110414953|NCT03626831|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110414954|NCT03626831|Protease Inhibitors|protease inhibitors|mesh-ancestor
110414955|NCT03626831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110414956|NCT03626831|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110414957|NCT03619213|Dapagliflozin|dapagliflozin|mesh-list
110414958|NCT03619213|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110414959|NCT03619213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110414960|NCT03619213|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110414961|NCT03619213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110414962|NCT03595059|Paclitaxel|paclitaxel|mesh-list
110414963|NCT03595059|Docetaxel|docetaxel|mesh-list
110414964|NCT03595059|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110414965|NCT03595059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110414966|NCT03595059|Tubulin Modulators|tubulin modulators|mesh-ancestor
110414967|NCT03595059|Antimitotic Agents|antimitotic agents|mesh-ancestor
110414968|NCT03595059|Mitosis Modulators|mitosis modulators|mesh-ancestor
110414969|NCT03595059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110414970|NCT03445949|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
110414971|NCT03342690|Eplerenone|eplerenone|mesh-list
110414972|NCT03342690|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110414973|NCT03342690|Hormone Antagonists|hormone antagonists|mesh-ancestor
110414974|NCT03342690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110414975|NCT03342690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110414976|NCT03342690|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110414977|NCT03342690|Diuretics|diuretics|mesh-ancestor
110414978|NCT03342690|Natriuretic Agents|natriuretic agents|mesh-ancestor
110184703|NCT00035178|Protease Inhibitors|protease inhibitors|mesh-ancestor
110414979|NCT03342690|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110414980|NCT03333616|Nivolumab|nivolumab|mesh-list
110414981|NCT03333616|Ipilimumab|ipilimumab|mesh-list
110414982|NCT03333616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110414983|NCT03333616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110414984|NCT03333616|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110414985|NCT03333616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110414986|NCT03262662|Varenicline|varenicline|mesh-list
110414987|NCT03262662|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110414988|NCT03262662|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110414989|NCT03262662|Cholinergic Agents|cholinergic agents|mesh-ancestor
110414990|NCT03262662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110414991|NCT03262662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110414992|NCT03262662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110414993|NCT03257267|Cemiplimab|cemiplimab|mesh-list
110414994|NCT03257267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110414995|NCT03257267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110414996|NCT03190668|Cefazolin|cefazolin|mesh-list
110414997|NCT03190668|Dialysis Solutions|dialysis solutions|mesh-list
110414998|NCT03190668|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110563910|NCT00750802|GABA Modulators|gaba modulators|mesh-ancestor
110414999|NCT03190668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110415000|NCT03190668|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110415001|NCT03162653|Allopurinol|allopurinol|mesh-list
110415002|NCT03162653|Mannitol|mannitol|mesh-list
110415003|NCT03162653|Antimetabolites|antimetabolites|mesh-ancestor
110415004|NCT03162653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110415005|NCT03162653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110415006|NCT03162653|Gout Suppressants|gout suppressants|mesh-ancestor
110415007|NCT03162653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110415008|NCT03162653|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110415009|NCT03162653|Antioxidants|antioxidants|mesh-ancestor
110415010|NCT03162653|Protective Agents|protective agents|mesh-ancestor
110415011|NCT03162653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110415012|NCT03162653|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110415013|NCT03162653|Diuretics|diuretics|mesh-ancestor
110415014|NCT03162653|Natriuretic Agents|natriuretic agents|mesh-ancestor
110415015|NCT02991456|Ondansetron|ondansetron|mesh-list
110415016|NCT02991456|Rolapitant|rolapitant|mesh-list
110415017|NCT02991456|Antiemetics|antiemetics|mesh-ancestor
110415018|NCT02991456|Autonomic Agents|autonomic agents|mesh-ancestor
110415019|NCT02991456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110415020|NCT02991456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110415021|NCT02991456|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110415022|NCT02991456|Antipruritics|antipruritics|mesh-ancestor
110415023|NCT02991456|Dermatologic Agents|dermatologic agents|mesh-ancestor
110415024|NCT02991456|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110415025|NCT02991456|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110415026|NCT02991456|Serotonin Agents|serotonin agents|mesh-ancestor
110415027|NCT02991456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110415028|NCT02991456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110415029|NCT02991456|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110415030|NCT02867384|Obinutuzumab|obinutuzumab|mesh-list
110415031|NCT02867384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110415032|NCT02867384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110415033|NCT02842827|Tretinoin|tretinoin|mesh-list
110415034|NCT02842827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110415035|NCT02842827|Keratolytic Agents|keratolytic agents|mesh-ancestor
110415036|NCT02842827|Dermatologic Agents|dermatologic agents|mesh-ancestor
110415037|NCT02823821|Dialysis Solutions|dialysis solutions|mesh-list
110415038|NCT02823821|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110415039|NCT02503774|Durvalumab|durvalumab|mesh-list
110415040|NCT02503774|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110415041|NCT02503774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110415042|NCT02432274|Etoposide|etoposide|mesh-list
110415043|NCT02432274|Etoposide phosphate|etoposide phosphate|mesh-list
110415044|NCT02432274|Lenvatinib|lenvatinib|mesh-list
110415045|NCT02432274|Ifosfamide|ifosfamide|mesh-list
110415046|NCT02432274|Isophosphamide mustard|isophosphamide mustard|mesh-list
110415047|NCT02432274|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110415048|NCT02432274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110415049|NCT02432274|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110415050|NCT02432274|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110415051|NCT02432274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110415052|NCT02432274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110415053|NCT02432274|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110415054|NCT02432274|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110415055|NCT02432274|Alkylating Agents|alkylating agents|mesh-ancestor
110415056|NCT02393859|Dexamethasone|dexamethasone|mesh-list
110415057|NCT02393859|Methotrexate|methotrexate|mesh-list
110415058|NCT02393859|Daunorubicin|daunorubicin|mesh-list
110415059|NCT02393859|Asparaginase|asparaginase|mesh-list
110415060|NCT02393859|Ifosfamide|ifosfamide|mesh-list
110415061|NCT02393859|Blinatumomab|blinatumomab|mesh-list
110415062|NCT02393859|Pegaspargase|pegaspargase|mesh-list
110415063|NCT02393859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110415064|NCT02393859|Antiemetics|antiemetics|mesh-ancestor
110415065|NCT02393859|Autonomic Agents|autonomic agents|mesh-ancestor
110415066|NCT02393859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110415067|NCT02393859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110415068|NCT02393859|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110415069|NCT02393859|Glucocorticoids|glucocorticoids|mesh-ancestor
110415070|NCT02393859|Hormones|hormones|mesh-ancestor
110415071|NCT02393859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110415072|NCT02393859|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110415073|NCT02393859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110415074|NCT02393859|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110415075|NCT02393859|Abortifacient Agents|abortifacient agents|mesh-ancestor
110415076|NCT02393859|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110415077|NCT02393859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110415078|NCT02393859|Antimetabolites|antimetabolites|mesh-ancestor
110415079|NCT02393859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110415080|NCT02393859|Dermatologic Agents|dermatologic agents|mesh-ancestor
110415081|NCT02393859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110415082|NCT02393859|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110415083|NCT02393859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110415084|NCT02393859|Immunologic Factors|immunologic factors|mesh-ancestor
110415085|NCT02393859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110415086|NCT02393859|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110415087|NCT02393859|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110415088|NCT02393859|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110415089|NCT02393859|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110415090|NCT02393859|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110415091|NCT02393859|Alkylating Agents|alkylating agents|mesh-ancestor
110415092|NCT02392429|Cytarabine|cytarabine|mesh-list
110415093|NCT02392429|Alovudine|alovudine|mesh-list
110415094|NCT02392429|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110415095|NCT02392429|Antimetabolites|antimetabolites|mesh-ancestor
110415096|NCT02392429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110415097|NCT02392429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110415098|NCT02392429|Antiviral Agents|antiviral agents|mesh-ancestor
110415099|NCT02392429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110415100|NCT02392429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110415101|NCT02392429|Immunologic Factors|immunologic factors|mesh-ancestor
110415102|NCT02392429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110415103|NCT02197234|Osimertinib|osimertinib|mesh-list
110415104|NCT02197234|Simvastatin|simvastatin|mesh-list
110415105|NCT02197234|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110415106|NCT02197234|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110415107|NCT02197234|Antimetabolites|antimetabolites|mesh-ancestor
110415108|NCT02197234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110415109|NCT02197234|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110415110|NCT02197234|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110415111|NCT02197234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110415112|NCT02197234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110415113|NCT02197234|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110415114|NCT02096588|Cyclophosphamide|cyclophosphamide|mesh-list
110415115|NCT02096588|Doxorubicin|doxorubicin|mesh-list
110415116|NCT02096588|Simvastatin|simvastatin|mesh-list
110415117|NCT02096588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110415118|NCT02096588|Immunologic Factors|immunologic factors|mesh-ancestor
110415119|NCT02096588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110415120|NCT02096588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110415121|NCT02096588|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110415122|NCT02096588|Alkylating Agents|alkylating agents|mesh-ancestor
110415123|NCT02096588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110415124|NCT02096588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110415125|NCT02096588|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110415126|NCT02096588|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110415127|NCT02096588|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110415128|NCT02096588|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110415129|NCT02096588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110415130|NCT02096588|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110415131|NCT02096588|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110415132|NCT02096588|Antimetabolites|antimetabolites|mesh-ancestor
110415133|NCT02096588|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110415134|NCT02096588|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110415135|NCT02022982|Palbociclib|palbociclib|mesh-list
110415136|NCT02022982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110415137|NCT02022982|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110415138|NCT02022982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110415139|NCT02022982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110415140|NCT01622335|Nitrous Oxide|nitrous oxide|mesh-list
110415141|NCT01622335|Anesthetics|anesthetics|mesh-ancestor
110415142|NCT01622335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110415143|NCT01622335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110415144|NCT01622335|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110415145|NCT01622335|Anesthetics, General|anesthetics, general|mesh-ancestor
110415146|NCT01622335|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110415147|NCT01622335|Analgesics|analgesics|mesh-ancestor
110184746|NCT00035451|Autonomic Agents|autonomic agents|mesh-ancestor
110415148|NCT01622335|Sensory System Agents|sensory system agents|mesh-ancestor
110415149|NCT01622335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110415151|NCT01359592|Cyclophosphamide|cyclophosphamide|mesh-list
110415152|NCT01359592|Rituximab|rituximab|mesh-list
110415153|NCT01359592|Doxorubicin|doxorubicin|mesh-list
110415154|NCT01359592|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110415155|NCT01359592|Vincristine|vincristine|mesh-list
110415156|NCT01359592|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110415157|NCT01359592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110415158|NCT01359592|Immunologic Factors|immunologic factors|mesh-ancestor
110415159|NCT01359592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110415160|NCT01359592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110415161|NCT01359592|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110415163|NCT01359592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110415164|NCT01359592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110415165|NCT01359592|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110415166|NCT01359592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110415167|NCT01359592|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110415168|NCT01359592|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110415169|NCT01359592|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110415170|NCT01359592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110415171|NCT01359592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110415172|NCT01359592|Glucocorticoids|glucocorticoids|mesh-ancestor
110415173|NCT01359592|Hormones|hormones|mesh-ancestor
110415174|NCT01359592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110415175|NCT01359592|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110415176|NCT01359592|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110415177|NCT01359592|Tubulin Modulators|tubulin modulators|mesh-ancestor
110415178|NCT01359592|Antimitotic Agents|antimitotic agents|mesh-ancestor
110415179|NCT01359592|Mitosis Modulators|mitosis modulators|mesh-ancestor
110415180|NCT01359592|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110415181|NCT01331018|Plerixafor|plerixafor|mesh-list
110415182|NCT01331018|Prednisone|prednisone|mesh-list
110415183|NCT01331018|Methylprednisolone|methylprednisolone|mesh-list
110415184|NCT01331018|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110415185|NCT01331018|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110415186|NCT01331018|Prednisolone|prednisolone|mesh-list
110415187|NCT01331018|Prednisolone acetate|prednisolone acetate|mesh-list
110415188|NCT01331018|Cortisone|cortisone|mesh-list
110415189|NCT01331018|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110415190|NCT01331018|Prednisolone phosphate|prednisolone phosphate|mesh-list
110415191|NCT01331018|Lenograstim|lenograstim|mesh-list
110415192|NCT01331018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110415193|NCT01331018|Glucocorticoids|glucocorticoids|mesh-ancestor
110415194|NCT01331018|Hormones|hormones|mesh-ancestor
110415195|NCT01331018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110415196|NCT01331018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110415197|NCT01331018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110415198|NCT01331018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110415199|NCT01331018|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110415200|NCT01331018|Immunologic Factors|immunologic factors|mesh-ancestor
110415202|NCT01331018|Autonomic Agents|autonomic agents|mesh-ancestor
110415203|NCT01331018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110415204|NCT01331018|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110415205|NCT01331018|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110415206|NCT01331018|Protective Agents|protective agents|mesh-ancestor
110415207|NCT01331018|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110415208|NCT01331018|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110415209|NCT01331018|Antiviral Agents|antiviral agents|mesh-ancestor
110415210|NCT01331018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110415211|NCT00840853|Acetaminophen|acetaminophen|mesh-list
110415212|NCT00840853|Diphenhydramine|diphenhydramine|mesh-list
110415213|NCT00840853|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110415214|NCT00840853|Analgesics|analgesics|mesh-ancestor
110415215|NCT00840853|Sensory System Agents|sensory system agents|mesh-ancestor
110415216|NCT00840853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110415217|NCT00840853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110415218|NCT00840853|Antipyretics|antipyretics|mesh-ancestor
110415219|NCT00840853|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110415220|NCT00840853|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110415221|NCT00840853|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110415222|NCT00840853|Anesthetics, Local|anesthetics, local|mesh-ancestor
110415223|NCT00840853|Anesthetics|anesthetics|mesh-ancestor
110415224|NCT00840853|Antiemetics|antiemetics|mesh-ancestor
110415225|NCT00840853|Autonomic Agents|autonomic agents|mesh-ancestor
110415226|NCT00840853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110415227|NCT00840853|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110415228|NCT00840853|Histamine Antagonists|histamine antagonists|mesh-ancestor
110415229|NCT00840853|Histamine Agents|histamine agents|mesh-ancestor
110415230|NCT00840853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110415231|NCT00840853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110415232|NCT00840853|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110415233|NCT00697073|Idebenone|idebenone|mesh-list
110415234|NCT00697073|Antioxidants|antioxidants|mesh-ancestor
110415235|NCT00697073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110415236|NCT00697073|Protective Agents|protective agents|mesh-ancestor
110415237|NCT00697073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110415238|NCT00656331|Amlodipine|amlodipine|mesh-list
110415239|NCT00656331|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110415240|NCT00656331|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110415241|NCT00656331|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110563976|NCT00880763|Ribavirin|ribavirin|mesh-list
110415242|NCT00656331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110415243|NCT00656331|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110415244|NCT00656331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110415245|NCT00656331|Vasodilator Agents|vasodilator agents|mesh-ancestor
110415246|NCT00653432|Hyaluronic Acid|hyaluronic acid|mesh-list
110415247|NCT00653432|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110415248|NCT00653432|Immunologic Factors|immunologic factors|mesh-ancestor
110415249|NCT00653432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110415250|NCT00653432|Viscosupplements|viscosupplements|mesh-ancestor
110415251|NCT00653432|Protective Agents|protective agents|mesh-ancestor
110415252|NCT00537680|Ubiquinone|ubiquinone|mesh-list
110415253|NCT00537680|Idebenone|idebenone|mesh-list
110415254|NCT00537680|Antioxidants|antioxidants|mesh-ancestor
110415255|NCT00537680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110415256|NCT00537680|Protective Agents|protective agents|mesh-ancestor
110415257|NCT00537680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110415258|NCT00537680|Micronutrients|micronutrients|mesh-ancestor
110415259|NCT00516724|Paclitaxel|paclitaxel|mesh-list
110415260|NCT00516724|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110415261|NCT00516724|Carboplatin|carboplatin|mesh-list
110415262|NCT00516724|Olaparib|olaparib|mesh-list
110415263|NCT00516724|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
110415264|NCT00516724|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110415265|NCT00516724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110415266|NCT00516724|Tubulin Modulators|tubulin modulators|mesh-ancestor
110415267|NCT00516724|Antimitotic Agents|antimitotic agents|mesh-ancestor
110415268|NCT00516724|Mitosis Modulators|mitosis modulators|mesh-ancestor
110415269|NCT00516724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110415270|NCT00516724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110415271|NCT00446043|Adapalene|adapalene|mesh-list
110415272|NCT00446043|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
110415273|NCT00446043|Benzoyl Peroxide|benzoyl peroxide|mesh-list
110415274|NCT00446043|Dermatologic Agents|dermatologic agents|mesh-ancestor
110415275|NCT00446043|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110415276|NCT00446043|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110415277|NCT00446043|Analgesics|analgesics|mesh-ancestor
110415278|NCT00446043|Sensory System Agents|sensory system agents|mesh-ancestor
110415279|NCT00446043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110415280|NCT00446043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110415281|NCT00446043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110415282|NCT00446043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110415283|NCT00400725|Clobetasol|clobetasol|mesh-list
110184791|NCT04732377|Analgesics|analgesics|mesh-ancestor
110415284|NCT00400725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110415285|NCT00400725|Glucocorticoids|glucocorticoids|mesh-ancestor
110415286|NCT00400725|Hormones|hormones|mesh-ancestor
110415287|NCT00400725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110415288|NCT00400725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110415289|NCT00099437|Fulvestrant|fulvestrant|mesh-list
110415290|NCT00099437|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110415291|NCT00099437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110415292|NCT00099437|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110415293|NCT00099437|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110415294|NCT00099437|Hormone Antagonists|hormone antagonists|mesh-ancestor
110415295|NCT00099437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110415296|NCT00099437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110415297|NCT00932113|Folic Acid|folic acid|mesh-list
110415298|NCT00932113|Adalimumab|adalimumab|mesh-list
110415299|NCT00932113|Methotrexate|methotrexate|mesh-list
110415300|NCT00932113|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110415301|NCT00932113|Abortifacient Agents|abortifacient agents|mesh-ancestor
110415302|NCT00932113|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110415303|NCT00932113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110415304|NCT00932113|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110415305|NCT00932113|Antimetabolites|antimetabolites|mesh-ancestor
110415306|NCT00932113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110415307|NCT00932113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110415308|NCT00932113|Dermatologic Agents|dermatologic agents|mesh-ancestor
110415309|NCT00932113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110415310|NCT00932113|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110366832|NCT00547664|Morphine|morphine|mesh-list
110415311|NCT00932113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110415312|NCT00932113|Immunologic Factors|immunologic factors|mesh-ancestor
110415313|NCT00932113|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110415314|NCT00932113|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110415315|NCT00932113|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110415316|NCT00932113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110415317|NCT00932113|Hematinics|hematinics|mesh-ancestor
110415318|NCT00932113|Vitamin B Complex|vitamin b complex|mesh-ancestor
110415319|NCT00932113|Vitamins|vitamins|mesh-ancestor
110415320|NCT00932113|Micronutrients|micronutrients|mesh-ancestor
110415321|NCT00931801|Tenofovir|tenofovir|mesh-list
110415322|NCT00931801|Emtricitabine|emtricitabine|mesh-list
110415323|NCT00931801|Raltegravir Potassium|raltegravir potassium|mesh-list
110415324|NCT00931801|Atazanavir Sulfate|atazanavir sulfate|mesh-list
110328130|NCT00488709|Fludarabine|fludarabine|mesh-list
110415325|NCT00931801|Antiviral Agents|antiviral agents|mesh-ancestor
110415326|NCT00931801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110415327|NCT00931801|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110415328|NCT00931801|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110415329|NCT00931801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110415330|NCT00931801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110415331|NCT00931801|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110415332|NCT00931801|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110415333|NCT00931801|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110415334|NCT00931801|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110415335|NCT00931801|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110415336|NCT00931801|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110415337|NCT00931801|Protease Inhibitors|protease inhibitors|mesh-ancestor
110415338|NCT00931723|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110415339|NCT00931723|Antidepressive Agents|antidepressive agents|mesh-ancestor
110415340|NCT00931723|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110415341|NCT00931723|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110415342|NCT00931723|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110415343|NCT00931723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110415344|NCT00931723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110415345|NCT05025397|Propofol|propofol|mesh-list
110415346|NCT05025397|Sevoflurane|sevoflurane|mesh-list
110415347|NCT05025397|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110415348|NCT05025397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110415349|NCT05025397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110415350|NCT05025397|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110415351|NCT05025397|Anesthetics, General|anesthetics, general|mesh-ancestor
110415352|NCT05025397|Anesthetics|anesthetics|mesh-ancestor
110415353|NCT05025397|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110415354|NCT05025397|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110415355|NCT00608803|Doxorubicin|doxorubicin|mesh-list
110415356|NCT00608803|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110415357|NCT00608803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110415358|NCT00608803|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110415359|NCT00608803|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110415360|NCT00608803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110415361|NCT00608803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110415362|NCT00931255|Sirolimus|sirolimus|mesh-list
110415363|NCT00931255|Tacrolimus|tacrolimus|mesh-list
110415364|NCT00931255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110415365|NCT00931255|Immunologic Factors|immunologic factors|mesh-ancestor
110415366|NCT00931255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110415367|NCT00931255|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110415368|NCT00931255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110415369|NCT00931255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110415370|NCT00931255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110415371|NCT00931255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110415372|NCT00931255|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110415373|NCT00931255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110415374|NCT00931255|Antifungal Agents|antifungal agents|mesh-ancestor
110415375|NCT00609193|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110415376|NCT00609193|Antidepressive Agents|antidepressive agents|mesh-ancestor
110415377|NCT00609193|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110415378|NCT00609193|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110415379|NCT00609193|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110415380|NCT00609193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110415381|NCT00609193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110415382|NCT00930553|Alemtuzumab|alemtuzumab|mesh-list
110415383|NCT00930553|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110415384|NCT00930553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110415385|NCT04262089|Pembrolizumab|pembrolizumab|mesh-list
110415386|NCT04262089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110415387|NCT04262089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110415388|NCT04262089|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110415389|NCT04262089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110415390|NCT00609817|Dexamethasone|dexamethasone|mesh-list
110415391|NCT00609817|Bortezomib|bortezomib|mesh-list
110415392|NCT00609817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110415393|NCT00609817|Antiemetics|antiemetics|mesh-ancestor
110415394|NCT00609817|Autonomic Agents|autonomic agents|mesh-ancestor
110415395|NCT00609817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110415396|NCT00609817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110415397|NCT00609817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110415398|NCT00609817|Glucocorticoids|glucocorticoids|mesh-ancestor
110415399|NCT00609817|Hormones|hormones|mesh-ancestor
110415400|NCT00609817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110415401|NCT00609817|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110415402|NCT00609817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110415403|NCT00929695|Prednisone|prednisone|mesh-list
110415404|NCT00929695|Methylprednisolone|methylprednisolone|mesh-list
110415405|NCT00929695|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110415406|NCT00929695|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110415407|NCT00929695|Prednisolone|prednisolone|mesh-list
110415409|NCT00929695|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110415410|NCT00929695|Prednisolone phosphate|prednisolone phosphate|mesh-list
110415411|NCT00929695|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110415413|NCT00929695|Hormones|hormones|mesh-ancestor
110415414|NCT00929695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110415415|NCT00929695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110415416|NCT00929695|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110415417|NCT00929695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110415418|NCT00929695|Antiemetics|antiemetics|mesh-ancestor
110415419|NCT00929695|Autonomic Agents|autonomic agents|mesh-ancestor
110415420|NCT00929695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110415421|NCT00929695|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110415422|NCT00929695|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110415423|NCT00929695|Protective Agents|protective agents|mesh-ancestor
110415424|NCT00609895|Insulin Glargine|insulin glargine|mesh-list
110415425|NCT00609895|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110415426|NCT00609895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110415427|NCT04261465|Paclitaxel|paclitaxel|mesh-list
110415428|NCT04261465|Carboplatin|carboplatin|mesh-list
110415429|NCT04261465|Olaparib|olaparib|mesh-list
110415430|NCT04261465|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110415431|NCT04261465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110415432|NCT04261465|Tubulin Modulators|tubulin modulators|mesh-ancestor
110415433|NCT04261465|Antimitotic Agents|antimitotic agents|mesh-ancestor
110415434|NCT04261465|Mitosis Modulators|mitosis modulators|mesh-ancestor
110415435|NCT04261465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110415436|NCT04261465|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110415437|NCT04261465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110415438|NCT04260607|Ketamine|ketamine|mesh-list
110415439|NCT04260607|Analgesics|analgesics|mesh-ancestor
110415440|NCT04260607|Sensory System Agents|sensory system agents|mesh-ancestor
110415441|NCT04260607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110415442|NCT04260607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110415443|NCT04260607|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110415444|NCT04260607|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110415445|NCT04260607|Anesthetics, General|anesthetics, general|mesh-ancestor
110415446|NCT04260607|Anesthetics|anesthetics|mesh-ancestor
110415447|NCT04260607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110415448|NCT04260607|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110415449|NCT04260607|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110415450|NCT04260607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110415451|NCT04260607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110415452|NCT00927355|Pioglitazone|pioglitazone|mesh-list
110415453|NCT00927355|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110415454|NCT00927355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110415455|NCT00923845|Sirolimus|sirolimus|mesh-list
110415456|NCT00923845|Cyclophosphamide|cyclophosphamide|mesh-list
110415457|NCT00923845|Pentostatin|pentostatin|mesh-list
110415458|NCT00923845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110415459|NCT00923845|Immunologic Factors|immunologic factors|mesh-ancestor
110415460|NCT00923845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110415461|NCT00923845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110415462|NCT00923845|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110415463|NCT00923845|Alkylating Agents|alkylating agents|mesh-ancestor
110328140|NCT00488709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110415464|NCT00923845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110415465|NCT00923845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110415466|NCT00923845|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110415467|NCT00923845|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110415468|NCT00923845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110415469|NCT00923845|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110415470|NCT00923845|Antifungal Agents|antifungal agents|mesh-ancestor
110415471|NCT00923845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110184817|NCT01805726|Anesthetics|anesthetics|mesh-ancestor
110415472|NCT00923845|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
110415473|NCT05052541|Dronabinol|dronabinol|mesh-list
110415474|NCT05052541|Hallucinogens|hallucinogens|mesh-ancestor
110415475|NCT05052541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110415476|NCT05052541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110415477|NCT05052541|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110415478|NCT05052541|Analgesics|analgesics|mesh-ancestor
110415479|NCT05052541|Sensory System Agents|sensory system agents|mesh-ancestor
110415480|NCT05052541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110415481|NCT05052541|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
110415482|NCT05052541|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110415483|NCT05052541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110415484|NCT05052541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110415485|NCT05052541|Hormones|hormones|mesh-ancestor
110415486|NCT05052541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110415487|NCT04260685|Lidocaine|lidocaine|mesh-list
110415488|NCT04260685|Esmolol|esmolol|mesh-list
110415489|NCT04260685|Anesthetics, Local|anesthetics, local|mesh-ancestor
110415490|NCT04260685|Anesthetics|anesthetics|mesh-ancestor
110415491|NCT04260685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110415492|NCT04260685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110415493|NCT04260685|Sensory System Agents|sensory system agents|mesh-ancestor
110415494|NCT04260685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110415495|NCT04260685|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110415496|NCT04260685|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110415497|NCT04260685|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110415498|NCT04260685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110415499|NCT04260685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110415500|NCT04260685|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110415501|NCT04260685|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110415502|NCT04260685|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110415503|NCT04260685|Adrenergic Agents|adrenergic agents|mesh-ancestor
110415504|NCT04260685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110415505|NCT05052151|Dialysis Solutions|dialysis solutions|mesh-list
110415506|NCT05052151|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110415507|NCT05013463|Hydroxychloroquine|hydroxychloroquine|mesh-list
110415508|NCT05013463|Indapamide|indapamide|mesh-list
110415509|NCT05013463|Antimalarials|antimalarials|mesh-ancestor
110415510|NCT05013463|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110415511|NCT05013463|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110415512|NCT05013463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110415513|NCT05013463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110415514|NCT05013463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110415515|NCT05013463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110415516|NCT05013463|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110415517|NCT05013463|Diuretics|diuretics|mesh-ancestor
110415518|NCT05013463|Natriuretic Agents|natriuretic agents|mesh-ancestor
110415519|NCT05013463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110415520|NCT05013463|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110415521|NCT05013463|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110415522|NCT00922987|Pregabalin|pregabalin|mesh-list
110415523|NCT00922987|Analgesics|analgesics|mesh-ancestor
110415524|NCT00922987|Sensory System Agents|sensory system agents|mesh-ancestor
110415525|NCT00922987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110415526|NCT00922987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110415527|NCT00922987|Anticonvulsants|anticonvulsants|mesh-ancestor
110415528|NCT00922987|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110415529|NCT00922987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110415530|NCT00922987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110415531|NCT00922987|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110415532|NCT00922987|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110415533|NCT00922987|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110328144|NCT00459992|Betahistine|betahistine|mesh-list
110415534|NCT00922987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110367057|NCT00549926|Atorvastatin|atorvastatin|mesh-list
110184832|NCT00035958|Antimetabolites|antimetabolites|mesh-ancestor
110415535|NCT00922987|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110415537|NCT00610909|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110415538|NCT00610909|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110415539|NCT00610909|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110415540|NCT00610909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110415541|NCT00610909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110415542|NCT00610909|Serotonin Agents|serotonin agents|mesh-ancestor
110415543|NCT00610909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110415544|NCT00610909|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110415545|NCT00610909|Antidepressive Agents|antidepressive agents|mesh-ancestor
110415546|NCT00610909|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110415547|NCT00610909|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110415548|NCT00610909|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110415549|NCT00610909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110415550|NCT00927901|Maleic acid|maleic acid|mesh-list
110415551|NCT00927901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110415552|NCT00927901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110415553|NCT04255771|Cisplatin|cisplatin|mesh-list
110415554|NCT04255771|Gemcitabine|gemcitabine|mesh-list
110415555|NCT04255771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110415556|NCT04255771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110415557|NCT04255771|Antimetabolites|antimetabolites|mesh-ancestor
110415558|NCT04255771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110415559|NCT01218204|Atorvastatin|atorvastatin|mesh-list
110415560|NCT01218204|Ezetimibe|ezetimibe|mesh-list
110415561|NCT01218204|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110415562|NCT01218204|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110415563|NCT01218204|Antimetabolites|antimetabolites|mesh-ancestor
110415564|NCT01218204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110415565|NCT01218204|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110415566|NCT01218204|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110415567|NCT01218204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110415568|NCT00926575|Beclomethasone|beclomethasone|mesh-list
110415569|NCT00926575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110415570|NCT00926575|Glucocorticoids|glucocorticoids|mesh-ancestor
110415571|NCT00926575|Hormones|hormones|mesh-ancestor
110415572|NCT00926575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110415573|NCT00926575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110415574|NCT00926575|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110415575|NCT00926575|Respiratory System Agents|respiratory system agents|mesh-ancestor
110415576|NCT05456412|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
110415577|NCT05456412|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110415578|NCT05456412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110415579|NCT05456412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110415580|NCT01217892|Metformin|metformin|mesh-list
110415581|NCT01217892|Dapagliflozin|dapagliflozin|mesh-list
110415582|NCT01217892|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110415583|NCT01217892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110415584|NCT01217892|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110415585|NCT01217892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110415586|NCT01217814|Leucovorin|leucovorin|mesh-list
110415587|NCT01217814|Folic Acid|folic acid|mesh-list
110415588|NCT01217814|Golimumab|golimumab|mesh-list
110415589|NCT01217814|Methotrexate|methotrexate|mesh-list
110564146|NCT00834912|Tramadol|tramadol|mesh-list
110415590|NCT01217814|Levoleucovorin|levoleucovorin|mesh-list
110415591|NCT01217814|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110415592|NCT01217814|Abortifacient Agents|abortifacient agents|mesh-ancestor
110415593|NCT01217814|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110415594|NCT01217814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110415595|NCT01217814|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110415596|NCT01217814|Antimetabolites|antimetabolites|mesh-ancestor
110415597|NCT01217814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110415598|NCT01217814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110415599|NCT01217814|Dermatologic Agents|dermatologic agents|mesh-ancestor
110184843|NCT00035958|Analgesics|analgesics|mesh-ancestor
110415600|NCT01217814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110415602|NCT01217814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110415603|NCT01217814|Immunologic Factors|immunologic factors|mesh-ancestor
110415604|NCT01217814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110415605|NCT01217814|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110415606|NCT01217814|Antidotes|antidotes|mesh-ancestor
110415607|NCT01217814|Protective Agents|protective agents|mesh-ancestor
110415608|NCT01217814|Vitamin B Complex|vitamin b complex|mesh-ancestor
110415610|NCT01217814|Micronutrients|micronutrients|mesh-ancestor
110415611|NCT01217814|Hematinics|hematinics|mesh-ancestor
110415612|NCT01217814|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110415613|NCT01217814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110415614|NCT01217190|Ondansetron|ondansetron|mesh-list
110415615|NCT01217190|Antiemetics|antiemetics|mesh-ancestor
110415616|NCT01217190|Autonomic Agents|autonomic agents|mesh-ancestor
110415617|NCT01217190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110415618|NCT01217190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110415619|NCT01217190|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110415620|NCT01217190|Antipruritics|antipruritics|mesh-ancestor
110415621|NCT01217190|Dermatologic Agents|dermatologic agents|mesh-ancestor
110415622|NCT01217190|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110415623|NCT01217190|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110415624|NCT01217190|Serotonin Agents|serotonin agents|mesh-ancestor
110415625|NCT01217190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110415626|NCT01217190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110415628|NCT01136733|Lenvatinib|lenvatinib|mesh-list
110415629|NCT01136733|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110415630|NCT01136733|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110415631|NCT01136733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110415632|NCT01136733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110415633|NCT01136733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110415634|NCT01136733|Immunologic Factors|immunologic factors|mesh-ancestor
110415635|NCT01136733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110564159|NCT02632331|Gabapentin|gabapentin|mesh-list
110415636|NCT01136733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110415637|NCT05178693|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
110415638|NCT05178693|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
110415639|NCT05178693|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110415640|NCT05178693|Antimetabolites|antimetabolites|mesh-ancestor
110415641|NCT05178693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110415642|NCT05178693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110415643|NCT05178693|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110415644|NCT01136655|Budesonide|budesonide|mesh-list
110415645|NCT01136655|Formoterol Fumarate|formoterol fumarate|mesh-list
110415646|NCT01136655|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
110415647|NCT01136655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110415648|NCT01136655|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110415649|NCT01136655|Autonomic Agents|autonomic agents|mesh-ancestor
110415650|NCT01136655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110415651|NCT01136655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110415652|NCT01136655|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110415653|NCT01136655|Respiratory System Agents|respiratory system agents|mesh-ancestor
110415654|NCT01136655|Glucocorticoids|glucocorticoids|mesh-ancestor
110415655|NCT01136655|Hormones|hormones|mesh-ancestor
110415656|NCT01136655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110415657|NCT01136655|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110415658|NCT01136655|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110415659|NCT01136655|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110415660|NCT01136655|Adrenergic Agents|adrenergic agents|mesh-ancestor
110415661|NCT01136655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110415662|NCT01136655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110415663|NCT01135017|Dronedarone|dronedarone|mesh-list
110415664|NCT01135017|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110415665|NCT01134705|Beclomethasone|beclomethasone|mesh-list
110184847|NCT01805687|Zileuton|zileuton|mesh-list
110415666|NCT01134705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110415667|NCT01134705|Glucocorticoids|glucocorticoids|mesh-ancestor
110415668|NCT01134705|Hormones|hormones|mesh-ancestor
110415669|NCT01134705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110415670|NCT01134705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110415671|NCT01134705|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110415672|NCT01134705|Respiratory System Agents|respiratory system agents|mesh-ancestor
110415673|NCT01134627|Minocycline|minocycline|mesh-list
110415674|NCT01134627|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110415675|NCT01134627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110415676|NCT01134393|Amlodipine|amlodipine|mesh-list
110415677|NCT01134393|Telmisartan|telmisartan|mesh-list
110415678|NCT01134393|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
110415679|NCT01134393|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110415680|NCT01134393|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110415681|NCT01134393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110415682|NCT01134393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110415683|NCT01134393|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110415684|NCT01134393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110415685|NCT01134393|Vasodilator Agents|vasodilator agents|mesh-ancestor
110564193|NCT02632019|Gemcitabine|gemcitabine|mesh-list
110415686|NCT01134393|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110415687|NCT01134393|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110415688|NCT05331469|Insulin|insulin|mesh-list
110415689|NCT05331469|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110415690|NCT05331469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110415691|NCT00922441|Valsartan|valsartan|mesh-list
110415692|NCT00922441|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110415693|NCT00922441|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110415694|NCT00922441|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110415695|NCT00922441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110415696|NCT01217112|Cannabidiol|cannabidiol|mesh-list
110415697|NCT01217112|Anticonvulsants|anticonvulsants|mesh-ancestor
110415698|NCT01216332|Vaccines|vaccines|mesh-list
110415699|NCT01216332|Immunologic Factors|immunologic factors|mesh-ancestor
110415700|NCT01216332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110415701|NCT00922207|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110415702|NCT00922207|Entecavir|entecavir|mesh-list
110415703|NCT00922207|Adefovir|adefovir|mesh-list
110415704|NCT00922207|Antiviral Agents|antiviral agents|mesh-ancestor
110415705|NCT00922207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110415706|NCT00922207|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110415707|NCT00922207|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110415708|NCT00922207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110415709|NCT00922207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110415710|NCT01134315|Calcitriol|calcitriol|mesh-list
110415711|NCT01134315|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110415712|NCT01134315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110415713|NCT01134315|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
110415714|NCT01134315|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110415715|NCT01134315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110415716|NCT01134315|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110415717|NCT01134315|Vitamins|vitamins|mesh-ancestor
110415718|NCT01134315|Micronutrients|micronutrients|mesh-ancestor
110415719|NCT01134315|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110415720|NCT01216176|Anastrozole|anastrozole|mesh-list
110415721|NCT01216176|Saracatinib|saracatinib|mesh-list
110217466|NCT00270088|Epoetin Alfa|epoetin alfa|mesh-list
110415722|NCT01216176|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110415723|NCT01216176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110415724|NCT01216176|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110415725|NCT01216176|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110415726|NCT01216176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110415727|NCT01216176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110415728|NCT01216176|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110415729|NCT01216176|Hormone Antagonists|hormone antagonists|mesh-ancestor
110415730|NCT01216176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110415731|NCT01216176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110415733|NCT01133847|Methylphenidate|methylphenidate|mesh-list
110415734|NCT01133847|Amphetamine|amphetamine|mesh-list
110415735|NCT01133847|Adderall|adderall|mesh-list
110415736|NCT01133847|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
110415737|NCT01133847|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110415738|NCT01133847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110415739|NCT01133847|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110415740|NCT01133847|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110415741|NCT01133847|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110564209|NCT00659321|Nicotine|nicotine|mesh-list
110415742|NCT01133847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110415743|NCT01133847|Dopamine Agents|dopamine agents|mesh-ancestor
110415744|NCT01133847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110415745|NCT01133847|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110415746|NCT01133847|Adrenergic Agents|adrenergic agents|mesh-ancestor
110415747|NCT01133847|Sympathomimetics|sympathomimetics|mesh-ancestor
110415748|NCT01133847|Autonomic Agents|autonomic agents|mesh-ancestor
110415749|NCT01133847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110415750|NCT01133847|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110415751|NCT01133847|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110415752|NCT01133847|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110415753|NCT01133847|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110415755|NCT01133379|Cariostatic Agents|cariostatic agents|mesh-ancestor
110367284|NCT05209412|Ticagrelor|ticagrelor|mesh-list
110415756|NCT01133379|Protective Agents|protective agents|mesh-ancestor
110415757|NCT01133379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110415758|NCT04253353|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110415759|NCT04253353|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110415760|NCT04253353|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110415761|NCT04253353|Antimetabolites|antimetabolites|mesh-ancestor
110415762|NCT04253353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110415763|NCT04253353|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110415764|NCT04253353|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110415765|NCT04253353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110415766|NCT05154669|Nicotine|nicotine|mesh-list
110415767|NCT05154669|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110415768|NCT05154669|Autonomic Agents|autonomic agents|mesh-ancestor
110415769|NCT05154669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110415770|NCT05154669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110415771|NCT05154669|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110415772|NCT05154669|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110415773|NCT05154669|Cholinergic Agents|cholinergic agents|mesh-ancestor
110415774|NCT05154669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110415775|NCT05154669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110415776|NCT00637455|Fexofenadine|fexofenadine|mesh-list
110415777|NCT00637455|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110415778|NCT00637455|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110415779|NCT00637455|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110415780|NCT00637455|Histamine Antagonists|histamine antagonists|mesh-ancestor
110415781|NCT00637455|Histamine Agents|histamine agents|mesh-ancestor
110415782|NCT00637455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110415783|NCT00637455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110415784|NCT00637455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110415785|NCT00919711|Denosumab|denosumab|mesh-list
110415786|NCT00919711|Risedronic Acid|risedronic acid|mesh-list
110415787|NCT00919711|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110415788|NCT00919711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110415789|NCT00919711|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110415790|NCT00919711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110415791|NCT00919711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110415792|NCT00919711|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110415793|NCT01131585|Ranibizumab|ranibizumab|mesh-list
110415794|NCT01131585|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110415795|NCT01131585|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110415796|NCT01131585|Growth Substances|growth substances|mesh-ancestor
110415797|NCT01131585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110415798|NCT01131585|Growth Inhibitors|growth inhibitors|mesh-ancestor
110415799|NCT01131585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110415800|NCT01131507|Pancrelipase|pancrelipase|mesh-list
110415801|NCT01131507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110415802|NCT00919633|Interferons|interferons|mesh-list
110415803|NCT00919633|Ribavirin|ribavirin|mesh-list
110415804|NCT00919633|Interferon-alpha|interferon-alpha|mesh-list
110415805|NCT00919633|Interferon alpha-2|interferon alpha-2|mesh-list
110415806|NCT00919633|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110415807|NCT00919633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110415808|NCT00919633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110415809|NCT00919633|Antiviral Agents|antiviral agents|mesh-ancestor
110415810|NCT00919633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110415811|NCT00919633|Antimetabolites|antimetabolites|mesh-ancestor
110415812|NCT00919633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110415813|NCT00919633|Immunologic Factors|immunologic factors|mesh-ancestor
110415814|NCT00926029|Listerine|listerine|mesh-list
110415815|NCT00926029|Triclosan|triclosan|mesh-list
110415816|NCT00926029|Fluorides|fluorides|mesh-list
110415817|NCT00926029|Sodium Fluoride|sodium fluoride|mesh-list
110415818|NCT00926029|Cariostatic Agents|cariostatic agents|mesh-ancestor
110415819|NCT00926029|Protective Agents|protective agents|mesh-ancestor
110415820|NCT00926029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110415821|NCT00926029|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110415822|NCT00926029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110415823|NCT00926029|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
110415824|NCT00926029|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110415825|NCT00926029|Antimetabolites|antimetabolites|mesh-ancestor
110415826|NCT00926029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110415827|NCT00926029|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110415828|NCT04254835|Chlorhexidine, thymol drug combination|chlorhexidine, thymol drug combination|mesh-list
110415829|NCT04254835|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110415830|NCT04254835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110415831|NCT04254913|Edaravone|edaravone|mesh-list
110415832|NCT04254913|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110415833|NCT04254913|Antioxidants|antioxidants|mesh-ancestor
110415834|NCT04254913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110415835|NCT04254913|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110415836|NCT04254913|Protective Agents|protective agents|mesh-ancestor
110415837|NCT04254913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110415838|NCT01130493|Levodopa|levodopa|mesh-list
110415839|NCT01130493|Carbidopa|carbidopa|mesh-list
110415840|NCT01130493|Entacapone|entacapone|mesh-list
110415841|NCT01130493|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
110415842|NCT01130493|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110415843|NCT01130493|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110415844|NCT01130493|Dopamine Agents|dopamine agents|mesh-ancestor
110415845|NCT01130493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110415846|NCT01130493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110415847|NCT01130493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110415848|NCT01130493|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
110415849|NCT01130493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110415850|NCT01130493|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
110415851|NCT01130493|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110415852|NCT01130493|Immunologic Factors|immunologic factors|mesh-ancestor
110415853|NCT01130493|Dopamine Agonists|dopamine agonists|mesh-ancestor
110415854|NCT01130337|Capecitabine|capecitabine|mesh-list
110415855|NCT01130337|Oxaliplatin|oxaliplatin|mesh-list
110415856|NCT01130337|Trastuzumab|trastuzumab|mesh-list
110415857|NCT01130337|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110415858|NCT01130337|Antimetabolites|antimetabolites|mesh-ancestor
110415859|NCT01130337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110415860|NCT01130337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110415861|NCT01130337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110415862|NCT04901689|Leronlimab|leronlimab|mesh-list
110415863|NCT04901689|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110415864|NCT04901689|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110415865|NCT04901689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110415866|NCT04901689|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110415867|NCT04901689|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110415868|NCT04901689|Antiviral Agents|antiviral agents|mesh-ancestor
110415869|NCT04901689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110415870|NCT04252963|Streptokinase|streptokinase|mesh-list
110415871|NCT04252963|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110415872|NCT04252963|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110415873|NCT04252963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110415874|NCT04258657|Paclitaxel|paclitaxel|mesh-list
110415875|NCT04258657|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110415876|NCT04258657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110415877|NCT04258657|Tubulin Modulators|tubulin modulators|mesh-ancestor
110415878|NCT04258657|Antimitotic Agents|antimitotic agents|mesh-ancestor
110415879|NCT04258657|Mitosis Modulators|mitosis modulators|mesh-ancestor
110415880|NCT04258657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110415882|NCT01130103|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110415883|NCT01130103|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110415884|NCT01130103|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110415885|NCT01130103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110415886|NCT01130103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110415887|NCT01130103|Serotonin Agents|serotonin agents|mesh-ancestor
110415888|NCT01130103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110415889|NCT01130103|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110415890|NCT01130103|Antidepressive Agents|antidepressive agents|mesh-ancestor
110415891|NCT01130103|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110415892|NCT01130103|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110415893|NCT01130103|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110415894|NCT01130103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110415896|NCT04254523|Bupivacaine|bupivacaine|mesh-list
110415897|NCT04254523|Anesthetics, Local|anesthetics, local|mesh-ancestor
110415898|NCT04254523|Anesthetics|anesthetics|mesh-ancestor
110415899|NCT04254523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110415900|NCT04254523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110415901|NCT04254523|Sensory System Agents|sensory system agents|mesh-ancestor
110415902|NCT04254523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110415903|NCT04254523|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110415904|NCT04254523|Narcotics|narcotics|mesh-ancestor
110415906|NCT00625209|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
110415907|NCT00625209|Hydrocortisone|hydrocortisone|mesh-list
110415908|NCT00625209|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
110415909|NCT00625209|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
110415910|NCT00625209|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
110184901|NCT01805453|Losartan|losartan|mesh-list
110415912|NCT00625209|Protein C|protein c|mesh-list
110415913|NCT00625209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110415914|NCT00625209|Anticoagulants|anticoagulants|mesh-ancestor
110415915|NCT00625209|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110415916|NCT00625209|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110415917|NCT00625209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110415918|NCT00625209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110415919|NCT04254601|Erythromycin|erythromycin|mesh-list
110415920|NCT04254601|Erythromycin Estolate|erythromycin estolate|mesh-list
110415921|NCT04254601|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
110415922|NCT04254601|Erythromycin stearate|erythromycin stearate|mesh-list
110415923|NCT04254601|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110415924|NCT04254601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110415925|NCT04254601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110415926|NCT04254601|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110415927|NCT04254601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110415928|NCT04254601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110415929|NCT01129557|Valsartan|valsartan|mesh-list
110415930|NCT01129557|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110415931|NCT01129557|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110415932|NCT01129557|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110415933|NCT01129557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110415934|NCT04254679|Analgesics, Opioid|analgesics, opioid|mesh-list
110415935|NCT04254679|Analgesics|analgesics|mesh-list
110415936|NCT04254679|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
110415937|NCT04254679|Narcotics|narcotics|mesh-ancestor
110415938|NCT04254679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110415939|NCT04254679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110415940|NCT04254679|Sensory System Agents|sensory system agents|mesh-ancestor
110415941|NCT04254679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110415942|NCT01129011|Naproxen|naproxen|mesh-list
110415943|NCT01129011|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110415944|NCT01129011|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110415945|NCT01129011|Analgesics|analgesics|mesh-ancestor
110415946|NCT01129011|Sensory System Agents|sensory system agents|mesh-ancestor
110415947|NCT01129011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110415948|NCT01129011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110415949|NCT01129011|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110415950|NCT01129011|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110415951|NCT01129011|Gout Suppressants|gout suppressants|mesh-ancestor
110415952|NCT01129011|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110415953|NCT01129011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110415954|NCT01129011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110415955|NCT04252885|Ritonavir|ritonavir|mesh-list
110415956|NCT04252885|Lopinavir|lopinavir|mesh-list
110415957|NCT04252885|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110415958|NCT04252885|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110415959|NCT04252885|Protease Inhibitors|protease inhibitors|mesh-ancestor
110415960|NCT04252885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110415961|NCT04252885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110415962|NCT04252885|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110415963|NCT04252885|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110415964|NCT04252885|Antiviral Agents|antiviral agents|mesh-ancestor
110415965|NCT04252885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110415966|NCT04252885|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110415967|NCT04252885|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110415968|NCT04962841|Metformin|metformin|mesh-list
110415969|NCT04962841|Amlodipine|amlodipine|mesh-list
110415970|NCT04962841|Ramipril|ramipril|mesh-list
110415971|NCT04962841|Nebivolol|nebivolol|mesh-list
110415972|NCT04962841|Rivastigmine|rivastigmine|mesh-list
110415973|NCT04962841|Sertraline|sertraline|mesh-list
110415974|NCT04962841|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110415975|NCT04962841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110415976|NCT04962841|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110415977|NCT04962841|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110415978|NCT04962841|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110415979|NCT04962841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110415980|NCT04962841|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110415981|NCT04962841|Vasodilator Agents|vasodilator agents|mesh-ancestor
110415982|NCT04962841|Antidepressive Agents|antidepressive agents|mesh-ancestor
110415983|NCT04962841|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110415984|NCT04962841|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110415985|NCT04962841|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110415986|NCT04962841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110415987|NCT04962841|Serotonin Agents|serotonin agents|mesh-ancestor
110415988|NCT04962841|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110415989|NCT04962841|Protease Inhibitors|protease inhibitors|mesh-ancestor
110415990|NCT04962841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110415991|NCT04962841|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
110415992|NCT04962841|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110415993|NCT04962841|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110415994|NCT04962841|Adrenergic Agents|adrenergic agents|mesh-ancestor
110415995|NCT04962841|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110415996|NCT04962841|Cholinergic Agents|cholinergic agents|mesh-ancestor
110415997|NCT04962841|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110415998|NCT04962841|Protective Agents|protective agents|mesh-ancestor
110415999|NCT00919867|Guanfacine|guanfacine|mesh-list
110416000|NCT00919867|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
110416001|NCT00919867|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110416002|NCT00919867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110416003|NCT00919867|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110416004|NCT00919867|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110416005|NCT00919867|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110416006|NCT00919867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110416007|NCT00919867|Dopamine Agents|dopamine agents|mesh-ancestor
110416008|NCT00919867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110416009|NCT00919867|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110416010|NCT00919867|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110416011|NCT00919867|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110416012|NCT00919867|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110416013|NCT00919867|Adrenergic Agents|adrenergic agents|mesh-ancestor
110416014|NCT04252261|Sulforaphane|sulforaphane|mesh-list
110416015|NCT04252261|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110416016|NCT04252261|Protective Agents|protective agents|mesh-ancestor
110416017|NCT04252261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110184933|NCT00036309|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110416018|NCT04252261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110416019|NCT04251871|Interferons|interferons|mesh-list
110416020|NCT04251871|Ritonavir|ritonavir|mesh-list
110416021|NCT04251871|Lopinavir|lopinavir|mesh-list
110416022|NCT04251871|Interferon-alpha|interferon-alpha|mesh-list
110416023|NCT04251871|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
110416024|NCT04251871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110416025|NCT04251871|Antiviral Agents|antiviral agents|mesh-ancestor
110416026|NCT04251871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110416027|NCT04251871|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110416028|NCT04251871|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110416029|NCT04251871|Protease Inhibitors|protease inhibitors|mesh-ancestor
110416030|NCT04251871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110416031|NCT04251871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110416032|NCT04251871|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110416033|NCT04251871|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110416034|NCT04251871|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110416035|NCT04251871|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110416036|NCT04251871|Immunologic Factors|immunologic factors|mesh-ancestor
110416037|NCT04251871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110416038|NCT01128621|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110416039|NCT01128621|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110416040|NCT01128621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110416041|NCT01128621|Incretins|incretins|mesh-ancestor
110416042|NCT01128621|Hormones|hormones|mesh-ancestor
110416043|NCT01128621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110416044|NCT01128621|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110416045|NCT01128621|Protease Inhibitors|protease inhibitors|mesh-ancestor
110416046|NCT01128621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110416047|NCT01128621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110416048|NCT00918463|Dasatinib|dasatinib|mesh-list
110416049|NCT00918463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110416050|NCT00918463|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110416051|NCT00918463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110184944|NCT00036348|Antidepressive Agents|antidepressive agents|mesh-ancestor
110416052|NCT00918463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110416053|NCT05330065|Bevacizumab|bevacizumab|mesh-list
110416054|NCT05330065|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110416056|NCT05330065|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110416057|NCT05330065|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110416058|NCT05330065|Growth Substances|growth substances|mesh-ancestor
110416059|NCT05330065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110416060|NCT05330065|Growth Inhibitors|growth inhibitors|mesh-ancestor
110416061|NCT01128543|Vinorelbine|vinorelbine|mesh-list
110416062|NCT01128543|Lapatinib|lapatinib|mesh-list
110416063|NCT01128543|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110416064|NCT01128543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110416065|NCT01128543|Tubulin Modulators|tubulin modulators|mesh-ancestor
110416066|NCT01128543|Antimitotic Agents|antimitotic agents|mesh-ancestor
110416067|NCT01128543|Mitosis Modulators|mitosis modulators|mesh-ancestor
110416068|NCT01128543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110416069|NCT01128543|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110416070|NCT01128543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110416071|NCT01128387|Panitumumab|panitumumab|mesh-list
110416072|NCT01128387|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110416073|NCT01128387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110416074|NCT01214850|Vaccines|vaccines|mesh-list
110416075|NCT01214850|Immunologic Factors|immunologic factors|mesh-ancestor
110416076|NCT01214850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110416077|NCT01128153|Saxagliptin|saxagliptin|mesh-list
110184984|NCT00036504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110184990|NCT01466231|Everolimus|everolimus|mesh-list
110416078|NCT01128153|Incretins|incretins|mesh-ancestor
110416079|NCT01128153|Hormones|hormones|mesh-ancestor
110416080|NCT01128153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110416081|NCT01128153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110416082|NCT01128153|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110416083|NCT01128153|Protease Inhibitors|protease inhibitors|mesh-ancestor
110416084|NCT01128153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110416085|NCT01128153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110416086|NCT01128153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110416088|NCT00925015|Cetuximab|cetuximab|mesh-list
110416089|NCT00925015|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110416090|NCT00925015|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110416091|NCT00925015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110416092|NCT00925015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110416093|NCT00925015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110416094|NCT00925015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110416095|NCT00925015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110416096|NCT00925015|Immunologic Factors|immunologic factors|mesh-ancestor
110416097|NCT00925015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110416098|NCT01127763|Carboplatin|carboplatin|mesh-list
110185031|NCT01465919|Antidepressive Agents|antidepressive agents|mesh-ancestor
110185032|NCT01465919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110185033|NCT01465919|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110185034|NCT01465919|Histamine Antagonists|histamine antagonists|mesh-ancestor
110185035|NCT01465919|Histamine Agents|histamine agents|mesh-ancestor
110185036|NCT01465919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110185037|NCT01465919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110185038|NCT01465919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110185039|NCT01465919|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110185040|NCT01465919|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110185041|NCT01465919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110185042|NCT01465919|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
110185043|NCT01465919|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110185044|NCT01465919|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110185045|NCT01465919|Adrenergic Agents|adrenergic agents|mesh-ancestor
110185047|NCT01465919|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110416099|NCT01127763|Everolimus|everolimus|mesh-list
110416100|NCT01127763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110416101|NCT01127763|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110416102|NCT01127763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110416103|NCT01127763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110416104|NCT01127763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110328162|NCT00460148|Ropinirole|ropinirole|mesh-list
110416105|NCT01127763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110416106|NCT01127763|Immunologic Factors|immunologic factors|mesh-ancestor
110416107|NCT01127763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110416108|NCT01127607|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
110416109|NCT01127607|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110416110|NCT01127607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110416111|NCT01127607|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110416112|NCT01127607|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110416113|NCT01127607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110416114|NCT01127607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110416115|NCT01127607|Dopamine Agents|dopamine agents|mesh-ancestor
110416116|NCT01127607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110416117|NCT00924781|Epoetin Alfa|epoetin alfa|mesh-list
110416118|NCT00924781|Hematinics|hematinics|mesh-ancestor
110416119|NCT01127451|Denileukin diftitox|denileukin diftitox|mesh-list
110416120|NCT01127451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110416121|NCT01214616|Vinorelbine|vinorelbine|mesh-list
110416122|NCT01214616|Afatinib|afatinib|mesh-list
110416123|NCT01214616|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110416124|NCT01214616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110416125|NCT01214616|Tubulin Modulators|tubulin modulators|mesh-ancestor
110416126|NCT01214616|Antimitotic Agents|antimitotic agents|mesh-ancestor
110416127|NCT01214616|Mitosis Modulators|mitosis modulators|mesh-ancestor
110416128|NCT01214616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110416129|NCT01214616|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110185066|NCT00036855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110185067|NCT00036855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110185068|NCT00036894|Lenalidomide|lenalidomide|mesh-list
110185069|NCT00036894|Immunologic Factors|immunologic factors|mesh-ancestor
110185070|NCT00036894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110185071|NCT00036894|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110185072|NCT00036894|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110185073|NCT00036894|Growth Substances|growth substances|mesh-ancestor
110185074|NCT00036894|Growth Inhibitors|growth inhibitors|mesh-ancestor
110185075|NCT00036894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110185077|NCT01465685|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
110185078|NCT01465685|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110185079|NCT01465685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110185080|NCT01465685|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110416131|NCT01213836|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110416132|NCT01213836|Antidepressive Agents|antidepressive agents|mesh-ancestor
110416133|NCT01213836|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110416134|NCT01213836|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110416135|NCT01213836|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110416136|NCT01213836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110416137|NCT01213836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110416138|NCT01213524|Nicotine|nicotine|mesh-list
110416139|NCT01213524|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110416140|NCT01213524|Autonomic Agents|autonomic agents|mesh-ancestor
110416141|NCT01213524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110416142|NCT01213524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110416143|NCT01213524|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110416144|NCT01213524|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110416145|NCT01213524|Cholinergic Agents|cholinergic agents|mesh-ancestor
110416146|NCT01213524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110416147|NCT01213524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110416148|NCT01212588|Mifepristone|mifepristone|mesh-list
110564231|NCT00659477|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110416149|NCT01212588|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
110416150|NCT01212588|Abortifacient Agents|abortifacient agents|mesh-ancestor
110416151|NCT01212588|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110416152|NCT01212588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110416153|NCT01212588|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110416154|NCT01212588|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110416155|NCT01212588|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110416156|NCT01212588|Contraceptive Agents|contraceptive agents|mesh-ancestor
110416157|NCT01212588|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
110416158|NCT01212588|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
110416159|NCT01212588|Hormone Antagonists|hormone antagonists|mesh-ancestor
110416160|NCT01212588|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110416161|NCT01212588|Luteolytic Agents|luteolytic agents|mesh-ancestor
110416162|NCT01212588|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110416163|NCT01212588|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
110416164|NCT00918385|Dasatinib|dasatinib|mesh-list
110416165|NCT00918385|Nilutamide|nilutamide|mesh-list
110416166|NCT00918385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110416167|NCT00918385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110416168|NCT00918385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110416169|NCT00918385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110416170|NCT00918385|Androgen Antagonists|androgen antagonists|mesh-ancestor
110416171|NCT00918385|Hormone Antagonists|hormone antagonists|mesh-ancestor
110416172|NCT00918385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110328170|NCT00460226|Lamotrigine|lamotrigine|mesh-list
110416173|NCT00918385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110416175|NCT00637819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110416176|NCT00637819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110416177|NCT00637819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110416178|NCT00637819|Immunologic Factors|immunologic factors|mesh-ancestor
110416179|NCT00637819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110416180|NCT00631501|Doxycycline|doxycycline|mesh-list
110416181|NCT00631501|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110416182|NCT00631501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110416183|NCT00631501|Antimalarials|antimalarials|mesh-ancestor
110416184|NCT00631501|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110416185|NCT00631501|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110416186|NCT04746547|Dolutegravir|dolutegravir|mesh-list
110416187|NCT04746547|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110416188|NCT04746547|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110416189|NCT04746547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110416190|NCT04746547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110416192|NCT04746547|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110416193|NCT04746547|Antiviral Agents|antiviral agents|mesh-ancestor
110416194|NCT04746547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110416195|NCT04782037|Calcium|calcium|mesh-list
110416196|NCT04782037|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110416197|NCT04782037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110416198|NCT00924469|Prednisone|prednisone|mesh-list
110416199|NCT00924469|Leuprolide|leuprolide|mesh-list
110416200|NCT00924469|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110416201|NCT00924469|Glucocorticoids|glucocorticoids|mesh-ancestor
110416203|NCT00924469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110416204|NCT00924469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110416205|NCT00924469|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110416206|NCT00924469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110416207|NCT00924469|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110185108|NCT00037089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110416208|NCT00924469|Fertility Agents|fertility agents|mesh-ancestor
110416209|NCT00924469|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110416210|NCT00631579|Rasburicase|rasburicase|mesh-list
110416211|NCT00631579|Gout Suppressants|gout suppressants|mesh-ancestor
110416212|NCT00631579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110416213|NCT00916357|Insulin|insulin|mesh-list
110416214|NCT00916357|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110416215|NCT00916357|Insulin Lispro|insulin lispro|mesh-list
110416216|NCT00916357|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110416217|NCT00916357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110416218|NCT00916279|Paclitaxel|paclitaxel|mesh-list
110416219|NCT00916279|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110416220|NCT00916279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110416221|NCT00916279|Tubulin Modulators|tubulin modulators|mesh-ancestor
110416222|NCT00916279|Antimitotic Agents|antimitotic agents|mesh-ancestor
110416223|NCT00916279|Mitosis Modulators|mitosis modulators|mesh-ancestor
110416224|NCT00916279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110416225|NCT01209078|Linezolid|linezolid|mesh-list
110416226|NCT01209078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110416227|NCT01209078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110416228|NCT01209078|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110416229|NCT01209078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110416230|NCT01209078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110416231|NCT04318158|Fentanyl|fentanyl|mesh-list
110416232|NCT04318158|Dexmedetomidine|dexmedetomidine|mesh-list
110416233|NCT04318158|Bupivacaine|bupivacaine|mesh-list
110416234|NCT04318158|Anesthetics, Local|anesthetics, local|mesh-ancestor
110416235|NCT04318158|Anesthetics|anesthetics|mesh-ancestor
110416236|NCT04318158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110416237|NCT04318158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110416238|NCT04318158|Sensory System Agents|sensory system agents|mesh-ancestor
110185165|NCT01464983|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110185166|NCT01464983|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110185167|NCT01464983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110185169|NCT00037518|Cinacalcet|cinacalcet|mesh-list
110416239|NCT04318158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110416240|NCT04318158|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110416241|NCT04318158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110416242|NCT04318158|Analgesics|analgesics|mesh-ancestor
110416243|NCT04318158|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110416244|NCT04318158|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110416245|NCT04318158|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110416246|NCT04318158|Adrenergic Agents|adrenergic agents|mesh-ancestor
110416247|NCT04318158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110416248|NCT04318158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110416249|NCT04318158|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110416250|NCT04318158|Narcotics|narcotics|mesh-ancestor
110416251|NCT04318158|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110416252|NCT04318158|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110416253|NCT04318158|Anesthetics, General|anesthetics, general|mesh-ancestor
110416254|NCT01207596|Hydromorphone|hydromorphone|mesh-list
110416255|NCT01207596|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110416256|NCT01207596|Narcotics|narcotics|mesh-ancestor
110416257|NCT01207596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110416258|NCT01207596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110416259|NCT01207596|Analgesics|analgesics|mesh-ancestor
110416260|NCT01207596|Sensory System Agents|sensory system agents|mesh-ancestor
110416261|NCT01207596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110416262|NCT00915343|Hydrocortisone|hydrocortisone|mesh-list
110416263|NCT00915343|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
110416264|NCT00915343|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
110416265|NCT00915343|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
110416266|NCT00915343|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110416267|NCT04203043|Pycnogenols|pycnogenols|mesh-list
110416268|NCT04203043|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110416269|NCT04203043|Immunologic Factors|immunologic factors|mesh-ancestor
110185210|NCT00037635|Hormone Antagonists|hormone antagonists|mesh-ancestor
110185211|NCT00037635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110416270|NCT04203043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110416272|NCT04203043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110416273|NCT04203043|Protective Agents|protective agents|mesh-ancestor
110416274|NCT04203043|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110367818|NCT04625595|Methyldopa|methyldopa|mesh-list
110416275|NCT04435015|Camostat|camostat|mesh-list
110416276|NCT04435015|Protease Inhibitors|protease inhibitors|mesh-ancestor
110416277|NCT04435015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110416278|NCT04435015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110416279|NCT04435015|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
110416280|NCT04435015|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110416281|NCT00631813|Prucalopride|prucalopride|mesh-list
110416282|NCT00631813|Laxatives|laxatives|mesh-ancestor
110416283|NCT00631813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110416284|NCT00631813|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
110416285|NCT00631813|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110416286|NCT00631813|Serotonin Agents|serotonin agents|mesh-ancestor
110416287|NCT00631813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110416288|NCT00631813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110416289|NCT00631813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110416290|NCT04404049|UB-421|ub-421|mesh-list
110416291|NCT04404049|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110416292|NCT04404049|Antiviral Agents|antiviral agents|mesh-ancestor
110416293|NCT04404049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110416294|NCT04911517|Capecitabine|capecitabine|mesh-list
110416295|NCT04911517|Antibodies|antibodies|mesh-list
110416296|NCT04911517|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110416297|NCT04911517|Immunologic Factors|immunologic factors|mesh-ancestor
110416298|NCT04911517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110416299|NCT04911517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110416300|NCT04911517|Antimetabolites|antimetabolites|mesh-ancestor
110185253|NCT00393770|Micronutrients|micronutrients|mesh-ancestor
110185254|NCT00393770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110416301|NCT04911517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110416302|NCT04911517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110416303|NCT00637897|Paclitaxel|paclitaxel|mesh-list
110416304|NCT00637897|Docetaxel|docetaxel|mesh-list
110416305|NCT00637897|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110416306|NCT00637897|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110416307|NCT00637897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110416308|NCT00637897|Tubulin Modulators|tubulin modulators|mesh-ancestor
110416309|NCT00637897|Antimitotic Agents|antimitotic agents|mesh-ancestor
110416310|NCT00637897|Mitosis Modulators|mitosis modulators|mesh-ancestor
110416311|NCT00637897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110416312|NCT03992443|Reteplase|reteplase|mesh-list
110416313|NCT03992443|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110416314|NCT03992443|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110416315|NCT03992443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110416316|NCT04329949|Paclitaxel|paclitaxel|mesh-list
110416317|NCT04329949|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110416318|NCT04329949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110416319|NCT04329949|Tubulin Modulators|tubulin modulators|mesh-ancestor
110416320|NCT04329949|Antimitotic Agents|antimitotic agents|mesh-ancestor
110416321|NCT04329949|Mitosis Modulators|mitosis modulators|mesh-ancestor
110416322|NCT04329949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110416323|NCT04597099|Flutamide|flutamide|mesh-list
110416324|NCT04597099|Estradiol|estradiol|mesh-list
110416325|NCT04597099|Progesterone|progesterone|mesh-list
110416326|NCT04597099|Estrogens|estrogens|mesh-ancestor
110416327|NCT04597099|Hormones|hormones|mesh-ancestor
110416328|NCT04597099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110416329|NCT04597099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110416330|NCT04597099|Progestins|progestins|mesh-ancestor
110416331|NCT04597099|Androgen Antagonists|androgen antagonists|mesh-ancestor
110416332|NCT04597099|Hormone Antagonists|hormone antagonists|mesh-ancestor
110416333|NCT04597099|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110416334|NCT04597099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110416335|NCT04816513|Ustekinumab|ustekinumab|mesh-list
110416336|NCT04816513|Dermatologic Agents|dermatologic agents|mesh-ancestor
110416337|NCT04203511|Paclitaxel|paclitaxel|mesh-list
110416338|NCT04203511|Etoposide|etoposide|mesh-list
110416339|NCT04203511|Carboplatin|carboplatin|mesh-list
110416340|NCT04203511|Pemetrexed|pemetrexed|mesh-list
110416341|NCT04203511|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110416342|NCT04203511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110416343|NCT04203511|Tubulin Modulators|tubulin modulators|mesh-ancestor
110416344|NCT04203511|Antimitotic Agents|antimitotic agents|mesh-ancestor
110416345|NCT04203511|Mitosis Modulators|mitosis modulators|mesh-ancestor
110416346|NCT04203511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110185297|NCT00038259|Antiviral Agents|antiviral agents|mesh-ancestor
110185298|NCT00038259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110185299|NCT00847418|Esketamine|esketamine|mesh-list
110416347|NCT04203511|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110416348|NCT04203511|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110416349|NCT04203511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110416350|NCT04203511|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110416351|NCT04203511|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110416352|NCT03690037|Tranexamic Acid|tranexamic acid|mesh-list
110416353|NCT03690037|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110416354|NCT03690037|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110416355|NCT03690037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110416357|NCT03690037|Coagulants|coagulants|mesh-ancestor
110416358|NCT00910273|Etanercept|etanercept|mesh-list
110416359|NCT00910273|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110416360|NCT00910273|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110416361|NCT00910273|Analgesics|analgesics|mesh-ancestor
110416363|NCT00910273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110416364|NCT00910273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110416365|NCT00910273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110416366|NCT00910273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110416367|NCT00910273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110416368|NCT00910273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110416369|NCT00910273|Immunologic Factors|immunologic factors|mesh-ancestor
110416370|NCT00910039|Sunitinib|sunitinib|mesh-list
110416371|NCT00910039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110416372|NCT00910039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110185326|NCT00396669|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110416373|NCT00910039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110416374|NCT00910039|Growth Substances|growth substances|mesh-ancestor
110416375|NCT00910039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110416376|NCT00910039|Growth Inhibitors|growth inhibitors|mesh-ancestor
110416377|NCT00910039|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110416378|NCT00910039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110416379|NCT00910039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110416381|NCT00909181|Oxybutynin|oxybutynin|mesh-list
110416382|NCT00909181|Parasympatholytics|parasympatholytics|mesh-ancestor
110416383|NCT00909181|Autonomic Agents|autonomic agents|mesh-ancestor
110416384|NCT00909181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110328177|NCT00460226|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110416385|NCT00909181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110416386|NCT00909181|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110416387|NCT00909181|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110416388|NCT00909181|Cholinergic Agents|cholinergic agents|mesh-ancestor
110416389|NCT00909181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110416390|NCT00909181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110416391|NCT00909181|Urological Agents|urological agents|mesh-ancestor
110416392|NCT00909181|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110416393|NCT00909181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110416395|NCT05579665|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110416396|NCT05579665|Immunologic Factors|immunologic factors|mesh-ancestor
110416397|NCT05579665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110416398|NCT05579665|Viscosupplements|viscosupplements|mesh-ancestor
110416399|NCT05579665|Protective Agents|protective agents|mesh-ancestor
110416400|NCT01286987|Talazoparib|talazoparib|mesh-list
110416401|NCT01286987|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110416402|NCT01286987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110416403|NCT01286987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110416404|NCT01286987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110185374|NCT00846950|Lorazepam|lorazepam|mesh-list
110185375|NCT00846950|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
110185376|NCT00846950|Anticonvulsants|anticonvulsants|mesh-ancestor
110185377|NCT00846950|Antiemetics|antiemetics|mesh-ancestor
110416406|NCT01286753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110416407|NCT01286753|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110416408|NCT01286753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110416409|NCT01286753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110416410|NCT01284959|Risperidone|risperidone|mesh-list
110416411|NCT01284959|Paliperidone Palmitate|paliperidone palmitate|mesh-list
110416412|NCT01284959|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110416413|NCT01284959|Serotonin Agents|serotonin agents|mesh-ancestor
110416414|NCT01284959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110185416|NCT00846911|Contraceptive Agents|contraceptive agents|mesh-ancestor
110416415|NCT01284959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110416416|NCT01284959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110416417|NCT01284959|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110416418|NCT01284959|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110416419|NCT01284959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110416420|NCT01284959|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110416421|NCT01284959|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110416422|NCT01284959|Dopamine Agents|dopamine agents|mesh-ancestor
110416423|NCT01284959|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110416424|NCT01284959|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110416425|NCT01283009|Methylprednisolone|methylprednisolone|mesh-list
110416426|NCT01283009|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110367956|NCT00562068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110416427|NCT01283009|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110416429|NCT01283009|Prednisolone acetate|prednisolone acetate|mesh-list
110416430|NCT01283009|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110416431|NCT01283009|Prednisolone phosphate|prednisolone phosphate|mesh-list
110416432|NCT01283009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110416433|NCT01283009|Antiemetics|antiemetics|mesh-ancestor
110416434|NCT01283009|Autonomic Agents|autonomic agents|mesh-ancestor
110416435|NCT01283009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110416436|NCT01283009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110416437|NCT01283009|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110416438|NCT01283009|Glucocorticoids|glucocorticoids|mesh-ancestor
110416439|NCT01283009|Hormones|hormones|mesh-ancestor
110416440|NCT01283009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110416441|NCT01283009|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110185483|NCT00846443|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110185484|NCT00846326|Fluticasone|fluticasone|mesh-list
110185485|NCT00846326|Xhance|xhance|mesh-list
110416442|NCT01283009|Protective Agents|protective agents|mesh-ancestor
110416443|NCT01283009|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110416444|NCT01283009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110416445|NCT01282463|Docetaxel|docetaxel|mesh-list
110416446|NCT01282463|Ramucirumab|ramucirumab|mesh-list
110416447|NCT01282463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110416448|NCT01282463|Tubulin Modulators|tubulin modulators|mesh-ancestor
110416449|NCT01282463|Antimitotic Agents|antimitotic agents|mesh-ancestor
110416450|NCT01282463|Mitosis Modulators|mitosis modulators|mesh-ancestor
110416451|NCT01282463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110416452|NCT01281917|Sirolimus|sirolimus|mesh-list
110416453|NCT01281917|Bortezomib|bortezomib|mesh-list
110416454|NCT01281917|Temsirolimus|temsirolimus|mesh-list
110416455|NCT01281917|MTOR Inhibitors|mtor inhibitors|mesh-list
110416456|NCT01281917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110416457|NCT01281917|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110416458|NCT01281917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110416459|NCT01281917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110416460|NCT01281917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110416461|NCT01281917|Immunologic Factors|immunologic factors|mesh-ancestor
110416462|NCT01281917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110416463|NCT01281917|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110416464|NCT01281917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110416465|NCT01281917|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110416466|NCT01281917|Antifungal Agents|antifungal agents|mesh-ancestor
110416467|NCT01281839|Ribavirin|ribavirin|mesh-list
110416468|NCT01281839|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110416469|NCT01281839|Simeprevir|simeprevir|mesh-list
110416470|NCT01281839|Antimetabolites|antimetabolites|mesh-ancestor
110416471|NCT01281839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110416472|NCT01281839|Antiviral Agents|antiviral agents|mesh-ancestor
110416473|NCT01281839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110416474|NCT01281839|Protease Inhibitors|protease inhibitors|mesh-ancestor
110185530|NCT05116059|Antifungal Agents|antifungal agents|mesh-ancestor
110185531|NCT00845936|Metformin|metformin|mesh-list
110185532|NCT00845936|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110185533|NCT00845936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110416475|NCT01281839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110416477|NCT01280981|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110416478|NCT01280981|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110416479|NCT01280981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110416480|NCT01280981|Hemostatics|hemostatics|mesh-ancestor
110416481|NCT01280981|Coagulants|coagulants|mesh-ancestor
110416482|NCT02889653|Anticoagulants|anticoagulants|mesh-list
110416483|NCT01280591|Naproxen|naproxen|mesh-list
110416484|NCT01280591|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110416485|NCT01280591|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110416486|NCT01280591|Analgesics|analgesics|mesh-ancestor
110416487|NCT01280591|Sensory System Agents|sensory system agents|mesh-ancestor
110416488|NCT01280591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110416489|NCT01280591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110416490|NCT01280591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110416491|NCT01280591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110416492|NCT01280591|Gout Suppressants|gout suppressants|mesh-ancestor
110416493|NCT01280591|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110416494|NCT01280591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110416495|NCT01280591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110416496|NCT04323761|Remdesivir|remdesivir|mesh-list
110416498|NCT04323761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110416499|NCT04323761|Antiviral Agents|antiviral agents|mesh-ancestor
110416500|NCT04323761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110416501|NCT05566223|Aldesleukin|aldesleukin|mesh-list
110416502|NCT05566223|Cyclophosphamide|cyclophosphamide|mesh-list
110416503|NCT05566223|Pembrolizumab|pembrolizumab|mesh-list
110416504|NCT05566223|Fludarabine|fludarabine|mesh-list
110416505|NCT05566223|Interleukin-2|interleukin-2|mesh-list
110416506|NCT05566223|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110416507|NCT05566223|Immunologic Factors|immunologic factors|mesh-ancestor
110416508|NCT05566223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110416509|NCT05566223|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110416510|NCT05566223|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110416511|NCT05566223|Alkylating Agents|alkylating agents|mesh-ancestor
110416512|NCT05566223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110416513|NCT05566223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110416514|NCT05566223|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110185571|NCT00276965|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110217765|NCT00416533|Hormones|hormones|mesh-ancestor
110185586|NCT00396786|Enoxaparin|enoxaparin|mesh-list
110416515|NCT05566223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110416516|NCT05566223|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110416517|NCT05566223|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110416519|NCT05566223|Sensory System Agents|sensory system agents|mesh-ancestor
110416520|NCT05566223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110416521|NCT05566223|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110416522|NCT05566223|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110416523|NCT05566223|Antiviral Agents|antiviral agents|mesh-ancestor
110416524|NCT05566223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110416525|NCT01271933|Pregabalin|pregabalin|mesh-list
110416526|NCT01271933|Analgesics|analgesics|mesh-ancestor
110416527|NCT01271933|Sensory System Agents|sensory system agents|mesh-ancestor
110416528|NCT01271933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110416529|NCT01271933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110416530|NCT01271933|Anticonvulsants|anticonvulsants|mesh-ancestor
110328187|NCT00460382|Ritonavir|ritonavir|mesh-list
110416531|NCT01271933|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110416532|NCT01271933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110416533|NCT01271933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110416534|NCT01271933|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110416535|NCT01271933|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110416536|NCT01271933|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110416537|NCT01271933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110185605|NCT00276848|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110416538|NCT01271933|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110416539|NCT01269125|Leuprolide|leuprolide|mesh-list
110416540|NCT01269125|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110416541|NCT01269125|Fertility Agents|fertility agents|mesh-ancestor
110416542|NCT01269125|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110416543|NCT01269125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110416544|NCT01269125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110416545|NCT01269125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110416546|NCT01268891|Rasagiline|rasagiline|mesh-list
110416547|NCT01268891|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
110416548|NCT01268891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110416549|NCT01268891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110416550|NCT01268891|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110416551|NCT01268891|Protective Agents|protective agents|mesh-ancestor
110416552|NCT01268891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110416553|NCT04323527|Chloroquine|chloroquine|mesh-list
110416554|NCT04323527|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
110416555|NCT04323527|Amebicides|amebicides|mesh-ancestor
110416556|NCT04323527|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110416557|NCT04323527|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110416558|NCT04323527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110416559|NCT04323527|Antimalarials|antimalarials|mesh-ancestor
110416560|NCT04323527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110416561|NCT04323527|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110416562|NCT04323527|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110416563|NCT04323527|Analgesics|analgesics|mesh-ancestor
110416564|NCT04323527|Sensory System Agents|sensory system agents|mesh-ancestor
110416565|NCT04323527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110416566|NCT04323527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110416567|NCT04323527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110416568|NCT04323527|Filaricides|filaricides|mesh-ancestor
110416569|NCT04323527|Antinematodal Agents|antinematodal agents|mesh-ancestor
110416570|NCT04323527|Anthelmintics|anthelmintics|mesh-ancestor
110416571|NCT02889497|Vaccines|vaccines|mesh-list
110416572|NCT02889497|Immunologic Factors|immunologic factors|mesh-ancestor
110416573|NCT02889497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110416574|NCT01266317|Rituximab|rituximab|mesh-list
110416575|NCT01266317|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110416576|NCT01266317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110416577|NCT01266317|Immunologic Factors|immunologic factors|mesh-ancestor
110416578|NCT01266317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110416579|NCT01266317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110416580|NCT01266161|Ibuprofen|ibuprofen|mesh-list
110185720|NCT00276185|Cholinergic Agents|cholinergic agents|mesh-ancestor
110416581|NCT01266161|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110416582|NCT01266161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110416583|NCT01266161|Analgesics|analgesics|mesh-ancestor
110416584|NCT01266161|Sensory System Agents|sensory system agents|mesh-ancestor
110416585|NCT01266161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110416586|NCT01266161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110416587|NCT01266161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110416588|NCT01266161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110416589|NCT01266161|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110416590|NCT01266161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110416591|NCT01266161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110416592|NCT01265849|Indomethacin|indomethacin|mesh-list
110416593|NCT01265849|Cyclophosphamide|cyclophosphamide|mesh-list
110416594|NCT01265849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110416595|NCT01265849|Immunologic Factors|immunologic factors|mesh-ancestor
110416596|NCT01265849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110416597|NCT01265849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110416598|NCT01265849|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110416599|NCT01265849|Alkylating Agents|alkylating agents|mesh-ancestor
110416600|NCT01265849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110416601|NCT01265849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110185761|NCT00276029|Analgesics|analgesics|mesh-ancestor
110185762|NCT00276029|Sensory System Agents|sensory system agents|mesh-ancestor
110185763|NCT00276029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110185765|NCT00276029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110416602|NCT01265849|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110416603|NCT01265849|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110416604|NCT01265849|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110416605|NCT01265849|Analgesics|analgesics|mesh-ancestor
110416606|NCT01265849|Sensory System Agents|sensory system agents|mesh-ancestor
110416607|NCT01265849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110416608|NCT01265849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110416609|NCT01265849|Gout Suppressants|gout suppressants|mesh-ancestor
110416610|NCT01265849|Tocolytic Agents|tocolytic agents|mesh-ancestor
110416611|NCT01265849|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110416612|NCT01265849|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110416613|NCT01265849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110416614|NCT01265615|Cholecalciferol|cholecalciferol|mesh-list
110416615|NCT01265615|Vitamin D|vitamin d|mesh-list
110416616|NCT01265615|Calcitriol|calcitriol|mesh-list
110416617|NCT01265615|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110416618|NCT01265615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110416619|NCT01265615|Vitamins|vitamins|mesh-ancestor
110416620|NCT01265615|Micronutrients|micronutrients|mesh-ancestor
110185808|NCT00397176|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110185809|NCT00397176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110185810|NCT00397176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110416621|NCT01265615|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110416622|NCT01265615|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
110416623|NCT01265615|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110416624|NCT01265615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110416625|NCT01265615|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110416626|NCT01264679|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
110416627|NCT01264679|Hematinics|hematinics|mesh-ancestor
110416628|NCT01264679|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
110416629|NCT01264679|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110416630|NCT01263509|Inositol|inositol|mesh-list
110416631|NCT01263509|Alogliptin|alogliptin|mesh-list
110416632|NCT01263509|Voglibose|voglibose|mesh-list
110416633|NCT01263509|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110416634|NCT01263509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110416635|NCT01263509|Incretins|incretins|mesh-ancestor
110416636|NCT01263509|Hormones|hormones|mesh-ancestor
110416637|NCT01263509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110416638|NCT01263509|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110416639|NCT01263509|Protease Inhibitors|protease inhibitors|mesh-ancestor
110416640|NCT01263509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110416641|NCT01263509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110416642|NCT01263509|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
110416643|NCT01263509|Vitamin B Complex|vitamin b complex|mesh-ancestor
110185866|NCT00275405|Protective Agents|protective agents|mesh-ancestor
110416645|NCT01263509|Micronutrients|micronutrients|mesh-ancestor
110416646|NCT01263197|Phenylethyl Alcohol|phenylethyl alcohol|mesh-list
110416647|NCT01263197|Propranolol|propranolol|mesh-list
110416648|NCT01263197|Albuterol|albuterol|mesh-list
110416649|NCT01263197|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110416650|NCT01263197|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110416651|NCT01263197|Adrenergic Agents|adrenergic agents|mesh-ancestor
110416652|NCT01263197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110416653|NCT01263197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110416654|NCT01263197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110416655|NCT01263197|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110416656|NCT01263197|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110416657|NCT01263197|Vasodilator Agents|vasodilator agents|mesh-ancestor
110416658|NCT01263197|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110416660|NCT01263197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110416661|NCT01263197|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110416662|NCT01263197|Respiratory System Agents|respiratory system agents|mesh-ancestor
110416663|NCT01263197|Tocolytic Agents|tocolytic agents|mesh-ancestor
110416664|NCT01263197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110416665|NCT01263197|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110416666|NCT01263197|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110416667|NCT01263197|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110416668|NCT01263197|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110416669|NCT01263197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110416670|NCT01263197|Disinfectants|disinfectants|mesh-ancestor
110416671|NCT01263119|Warfarin|warfarin|mesh-list
110416672|NCT01263119|Anticoagulants|anticoagulants|mesh-ancestor
110416673|NCT01262651|Nabiximols|nabiximols|mesh-list
110416674|NCT01262651|Analgesics|analgesics|mesh-ancestor
110416675|NCT01262651|Sensory System Agents|sensory system agents|mesh-ancestor
110416676|NCT01262651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110416677|NCT01262651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110416678|NCT01261793|Epratuzumab|epratuzumab|mesh-list
110416679|NCT01261793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110416680|NCT01261793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110416681|NCT04321967|Nitroglycerin|nitroglycerin|mesh-list
110185916|NCT00275093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110416682|NCT04321967|Vasodilator Agents|vasodilator agents|mesh-ancestor
110416684|NCT04321655|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110416685|NCT04321655|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110416686|NCT04321655|Analgesics|analgesics|mesh-ancestor
110416687|NCT04321655|Sensory System Agents|sensory system agents|mesh-ancestor
110416688|NCT04321655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110416689|NCT04321655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110416690|NCT04321655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110416691|NCT04321655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110416692|NCT04321655|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110416693|NCT04321655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110416694|NCT04321655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110416695|NCT05529251|Carboplatin|carboplatin|mesh-list
110416696|NCT05529251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110416697|NCT01261325|Brivaracetam|brivaracetam|mesh-list
110416698|NCT01261325|Anticonvulsants|anticonvulsants|mesh-list
110416699|NCT01260467|Memantine|memantine|mesh-list
110416700|NCT01260467|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110416701|NCT01260467|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110416702|NCT01260467|Dopamine Agents|dopamine agents|mesh-ancestor
110416703|NCT01260467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110416704|NCT01260467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110185956|NCT03208179|Azithromycin|azithromycin|mesh-list
110185957|NCT03208179|Pyrimethamine|pyrimethamine|mesh-list
110185958|NCT03208179|Piperaquine|piperaquine|mesh-list
110185959|NCT03208179|Sulfadoxine|sulfadoxine|mesh-list
110416705|NCT01260467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110416706|NCT01260467|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110416707|NCT01260467|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110416709|NCT01260311|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110416710|NCT01260311|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110416711|NCT01260311|Cholinergic Agents|cholinergic agents|mesh-ancestor
110416712|NCT01260311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110416713|NCT01260311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110416714|NCT01260311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110416715|NCT01260311|Urological Agents|urological agents|mesh-ancestor
110416716|NCT00623987|Warfarin|warfarin|mesh-list
110416717|NCT00623987|Anticoagulants|anticoagulants|mesh-ancestor
110416718|NCT01259375|Amrubicin|amrubicin|mesh-list
110416719|NCT01259375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110416720|NCT05536037|Metformin|metformin|mesh-list
110416721|NCT05536037|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110416722|NCT05536037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110416723|NCT00624143|Voriconazole|voriconazole|mesh-list
110416724|NCT00624143|Amphotericin B|amphotericin b|mesh-list
110186007|NCT00274976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110186008|NCT00274976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110186009|NCT00130403|Risedronic Acid|risedronic acid|mesh-list
110416725|NCT00624143|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
110416726|NCT00624143|Antifungal Agents|antifungal agents|mesh-ancestor
110416727|NCT00624143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110416728|NCT00624143|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110416729|NCT00624143|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110416730|NCT00624143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110416731|NCT00624143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110416732|NCT00624143|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110416733|NCT00624143|Hormone Antagonists|hormone antagonists|mesh-ancestor
110416734|NCT00624143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110416735|NCT00624143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110416736|NCT00624143|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110416737|NCT00624143|Amebicides|amebicides|mesh-ancestor
110416738|NCT00624143|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110416739|NCT00624143|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110416740|NCT00624143|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110416741|NCT05241275|Xenon|xenon|mesh-list
110416742|NCT05241275|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110416743|NCT05241275|Anesthetics, General|anesthetics, general|mesh-ancestor
110416744|NCT05241275|Anesthetics|anesthetics|mesh-ancestor
110416745|NCT05241275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110416746|NCT05241275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110416747|NCT04005287|Pirenzepine|pirenzepine|mesh-list
110416748|NCT04005287|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110328197|NCT00460382|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110416749|NCT04005287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110416750|NCT04005287|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110416751|NCT04005287|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110416752|NCT04005287|Cholinergic Agents|cholinergic agents|mesh-ancestor
110416753|NCT04005287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110416754|NCT04005287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110186061|NCT00130325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110416755|NCT04005287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110416756|NCT04320173|Lidocaine|lidocaine|mesh-list
110416757|NCT04320173|Anesthetics, Local|anesthetics, local|mesh-ancestor
110416758|NCT04320173|Anesthetics|anesthetics|mesh-ancestor
110416759|NCT04320173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110416760|NCT04320173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110416761|NCT04320173|Sensory System Agents|sensory system agents|mesh-ancestor
110416762|NCT04320173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110416763|NCT04320173|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110416764|NCT04320173|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110416765|NCT04320173|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110416766|NCT04320173|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110416767|NCT04320173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110416768|NCT04321733|Amoxicillin|amoxicillin|mesh-list
110416769|NCT04321733|Clavulanic Acid|clavulanic acid|mesh-list
110416770|NCT04321733|Clavulanic Acids|clavulanic acids|mesh-list
110416771|NCT04321733|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
110416772|NCT04321733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110416773|NCT04321733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110416774|NCT04321733|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110416775|NCT04321733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110416776|NCT04321733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110416777|NCT02029001|Everolimus|everolimus|mesh-list
110416778|NCT02029001|Sorafenib|sorafenib|mesh-list
110416779|NCT02029001|Durvalumab|durvalumab|mesh-list
110416780|NCT02029001|Olaparib|olaparib|mesh-list
110416781|NCT02029001|Lapatinib|lapatinib|mesh-list
110416782|NCT02029001|Tremelimumab|tremelimumab|mesh-list
110416783|NCT02029001|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110416784|NCT02029001|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110416785|NCT02029001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110416786|NCT02029001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110416787|NCT02029001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110416788|NCT02029001|Immunologic Factors|immunologic factors|mesh-ancestor
110416789|NCT02029001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110416790|NCT02029001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110416791|NCT02029001|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110416792|NCT02029001|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110416793|NCT01613495|Octreotide|octreotide|mesh-list
110186111|NCT00129818|Famciclovir|famciclovir|mesh-list
110416794|NCT01613495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110416795|NCT01613495|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110416796|NCT01613495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110416797|NCT00694733|Anastrozole|anastrozole|mesh-list
110416798|NCT00694733|Leuprolide|leuprolide|mesh-list
110416799|NCT00694733|Methyltestosterone|methyltestosterone|mesh-list
110416800|NCT00694733|Estradiol|estradiol|mesh-list
110416801|NCT00694733|Estrogens|estrogens|mesh-list
110416802|NCT00694733|Testosterone|testosterone|mesh-list
110416803|NCT00694733|Testosterone undecanoate|testosterone undecanoate|mesh-list
110416804|NCT00694733|Testosterone enanthate|testosterone enanthate|mesh-list
110416805|NCT00694733|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
110416806|NCT00694733|Aromatase Inhibitors|aromatase inhibitors|mesh-list
110368332|NCT02900417|Hormones|hormones|mesh-ancestor
110416807|NCT00694733|Hormones|hormones|mesh-ancestor
110416808|NCT00694733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110416809|NCT00694733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110416810|NCT00694733|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110416811|NCT00694733|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110416812|NCT00694733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110416813|NCT00694733|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110416814|NCT00694733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110416815|NCT00694733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110416816|NCT00694733|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110416817|NCT00694733|Hormone Antagonists|hormone antagonists|mesh-ancestor
110416818|NCT00694733|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110416819|NCT00694733|Fertility Agents|fertility agents|mesh-ancestor
110416820|NCT00694733|Androgens|androgens|mesh-ancestor
110416821|NCT00694733|Anabolic Agents|anabolic agents|mesh-ancestor
110186140|NCT00129233|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110186145|NCT00129233|Vasodilator Agents|vasodilator agents|mesh-ancestor
110416822|NCT01259297|Amlodipine|amlodipine|mesh-list
110416823|NCT01259297|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110416824|NCT01259297|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110416825|NCT01259297|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110416826|NCT01259297|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110416827|NCT01259297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110416828|NCT01259297|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110416829|NCT01259297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110416830|NCT01259297|Vasodilator Agents|vasodilator agents|mesh-ancestor
110416831|NCT01259297|Diuretics|diuretics|mesh-ancestor
110416832|NCT01259297|Natriuretic Agents|natriuretic agents|mesh-ancestor
110416833|NCT01259297|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110416834|NCT01126437|Tiotropium Bromide|tiotropium bromide|mesh-list
110416835|NCT01126437|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110416836|NCT01126437|Autonomic Agents|autonomic agents|mesh-ancestor
110416837|NCT01126437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110416838|NCT01126437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110416839|NCT01126437|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110416840|NCT01126437|Respiratory System Agents|respiratory system agents|mesh-ancestor
110416841|NCT01126437|Parasympatholytics|parasympatholytics|mesh-ancestor
110416842|NCT01126437|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110416843|NCT01126437|Cholinergic Agents|cholinergic agents|mesh-ancestor
110416844|NCT01126437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110186186|NCT00129038|Analgesics|analgesics|mesh-ancestor
110186187|NCT00129038|Sensory System Agents|sensory system agents|mesh-ancestor
110186198|NCT00129038|Antipyretics|antipyretics|mesh-ancestor
110416845|NCT01126437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110416847|NCT01258595|Immunologic Factors|immunologic factors|mesh-ancestor
110416848|NCT01258595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110416849|NCT01257737|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
110416850|NCT01257737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110416851|NCT01126359|Lidocaine|lidocaine|mesh-list
110416852|NCT01126359|Anesthetics, Local|anesthetics, local|mesh-ancestor
110416853|NCT01126359|Anesthetics|anesthetics|mesh-ancestor
110416854|NCT01126359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110416855|NCT01126359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110416856|NCT01126359|Sensory System Agents|sensory system agents|mesh-ancestor
110416857|NCT01126359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110416858|NCT01126359|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110416859|NCT01126359|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110416860|NCT01126359|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110416861|NCT01126359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110416862|NCT01126359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110416863|NCT00637533|Botulinum Toxins|botulinum toxins|mesh-list
110416864|NCT00637533|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110416865|NCT00637533|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110416866|NCT00637533|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110416867|NCT00637533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110416868|NCT00637533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110186237|NCT00128804|Beta Carotene|beta carotene|mesh-list
110416869|NCT00637533|Cholinergic Agents|cholinergic agents|mesh-ancestor
110416870|NCT00637533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110416871|NCT00637533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110416872|NCT00637533|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110416873|NCT00637533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110416874|NCT01125813|Factor VIII|factor viii|mesh-list
110416875|NCT01125813|Coagulants|coagulants|mesh-ancestor
110416877|NCT04311645|Antidotes|antidotes|mesh-ancestor
110416878|NCT04311645|Protective Agents|protective agents|mesh-ancestor
110416879|NCT04311645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110416880|NCT01257581|Tamoxifen|tamoxifen|mesh-list
110416881|NCT01257581|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110416882|NCT01257581|Hormone Antagonists|hormone antagonists|mesh-ancestor
110416883|NCT01257581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110416884|NCT01257581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110416885|NCT01257581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110416886|NCT01257581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110416887|NCT01257581|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110416888|NCT01257581|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110328203|NCT00460382|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110416889|NCT01257581|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110416891|NCT00995566|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
110416892|NCT00995566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110416893|NCT01257425|Triptorelin Pamoate|triptorelin pamoate|mesh-list
110416894|NCT01257425|Luteolytic Agents|luteolytic agents|mesh-ancestor
110416895|NCT01257425|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110416896|NCT01257425|Contraceptive Agents|contraceptive agents|mesh-ancestor
110416897|NCT01257425|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110416898|NCT01257425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110416899|NCT01257425|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110416900|NCT01257425|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110416901|NCT01257425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110416902|NCT00995488|Paclitaxel|paclitaxel|mesh-list
110416903|NCT00995488|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110416904|NCT00995488|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110416905|NCT00995488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110416906|NCT00995488|Tubulin Modulators|tubulin modulators|mesh-ancestor
110416907|NCT00995488|Antimitotic Agents|antimitotic agents|mesh-ancestor
110416908|NCT00995488|Mitosis Modulators|mitosis modulators|mesh-ancestor
110416909|NCT00995488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110416910|NCT04293172|Ticagrelor|ticagrelor|mesh-list
110416911|NCT04293172|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110186288|NCT00128414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110186294|NCT00038493|Temozolomide|temozolomide|mesh-list
110416912|NCT04293172|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110416913|NCT04293172|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110416915|NCT04293172|Purinergic Agents|purinergic agents|mesh-ancestor
110416916|NCT04293172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110416917|NCT04293172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110416918|NCT04293172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110416919|NCT01256879|Cimetidine|cimetidine|mesh-list
110416920|NCT01256879|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110416921|NCT01256879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110416922|NCT01256879|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110416923|NCT01256879|Histamine Antagonists|histamine antagonists|mesh-ancestor
110416924|NCT01256879|Histamine Agents|histamine agents|mesh-ancestor
110416925|NCT01256879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110416926|NCT01256879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110416927|NCT01256879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110416928|NCT01256879|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110186326|NCT00038571|Bortezomib|bortezomib|mesh-list
110416929|NCT01256879|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110416930|NCT01256879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110416932|NCT02869672|Immunologic Factors|immunologic factors|mesh-ancestor
110416933|NCT02869672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110416934|NCT01125189|Interferons|interferons|mesh-list
110416935|NCT01125189|Ribavirin|ribavirin|mesh-list
110416936|NCT01125189|Interferon-alpha|interferon-alpha|mesh-list
110416937|NCT01125189|Interferon alpha-2|interferon alpha-2|mesh-list
110416938|NCT01125189|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110416939|NCT01125189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110416940|NCT01125189|Antiviral Agents|antiviral agents|mesh-ancestor
110416941|NCT01125189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110416942|NCT01125189|Antimetabolites|antimetabolites|mesh-ancestor
110416943|NCT01125189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110416944|NCT01125189|Immunologic Factors|immunologic factors|mesh-ancestor
110416945|NCT01125189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110416946|NCT01256567|Docetaxel|docetaxel|mesh-list
110416947|NCT01256567|Ramucirumab|ramucirumab|mesh-list
110416948|NCT01256567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110416949|NCT01256567|Tubulin Modulators|tubulin modulators|mesh-ancestor
110416950|NCT01256567|Antimitotic Agents|antimitotic agents|mesh-ancestor
110416951|NCT01256567|Mitosis Modulators|mitosis modulators|mesh-ancestor
110416952|NCT01256567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110416953|NCT00996736|Voriconazole|voriconazole|mesh-list
110416954|NCT00996736|Natamycin|natamycin|mesh-list
110416955|NCT00996736|Antifungal Agents|antifungal agents|mesh-ancestor
110416956|NCT00996736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110416957|NCT00996736|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110416958|NCT00996736|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110416959|NCT00996736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110416960|NCT00996736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110416961|NCT00996736|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110416962|NCT00996736|Hormone Antagonists|hormone antagonists|mesh-ancestor
110416963|NCT00996736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110416964|NCT00996736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110416965|NCT00996736|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110416966|NCT00996736|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110416967|NCT00996736|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110416968|NCT00996658|Linagliptin|linagliptin|mesh-list
110416969|NCT00996658|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110416970|NCT00996658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110416971|NCT00996658|Incretins|incretins|mesh-ancestor
110416972|NCT00996658|Hormones|hormones|mesh-ancestor
110416973|NCT00996658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110416974|NCT00996658|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110186438|NCT05736965|Venetoclax|venetoclax|mesh-list
110416975|NCT00996658|Protease Inhibitors|protease inhibitors|mesh-ancestor
110416976|NCT00996658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110416977|NCT00996658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110416978|NCT04310631|Ranibizumab|ranibizumab|mesh-list
110416979|NCT04310631|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110416980|NCT04310631|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110416981|NCT04310631|Growth Substances|growth substances|mesh-ancestor
110416982|NCT04310631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110416983|NCT04310631|Growth Inhibitors|growth inhibitors|mesh-ancestor
110416984|NCT04310631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110416985|NCT01256411|Amlodipine|amlodipine|mesh-list
110416986|NCT01256411|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110416987|NCT01256411|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
110416988|NCT01256411|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110416989|NCT01256411|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110186483|NCT05672225|Analgesics|analgesics|mesh-ancestor
110416990|NCT01256411|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110416991|NCT01256411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110416992|NCT01256411|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110416993|NCT01256411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110416995|NCT01256411|Diuretics|diuretics|mesh-ancestor
110416996|NCT01256411|Natriuretic Agents|natriuretic agents|mesh-ancestor
110186537|NCT05543785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110416997|NCT01256411|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110416998|NCT01256411|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110417000|NCT00996580|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110417001|NCT00996580|Estradiol|estradiol|mesh-list
110417002|NCT00996580|Estrogens|estrogens|mesh-ancestor
110417003|NCT00996580|Hormones|hormones|mesh-ancestor
110417004|NCT00996580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110417005|NCT00996580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110417006|NCT00996580|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110186620|NCT05287425|Povidone|povidone|mesh-list
110417007|NCT00996580|Contraceptive Agents|contraceptive agents|mesh-ancestor
110417008|NCT00996580|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110417009|NCT00996580|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110417010|NCT00996580|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110417011|NCT00996580|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110417012|NCT00996580|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110417013|NCT01124175|Losartan|losartan|mesh-list
110417014|NCT01124175|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110417015|NCT01124175|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110417016|NCT01124175|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110417017|NCT01124175|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110417018|NCT01124175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110417019|NCT01256177|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110417020|NCT01256177|Antidepressive Agents|antidepressive agents|mesh-ancestor
110417021|NCT01256177|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110417022|NCT01256177|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110417023|NCT01256177|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110417024|NCT01256177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110417025|NCT01256177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110417026|NCT02882451|Pinaverium|pinaverium|mesh-list
110417027|NCT02882451|Bromides|bromides|mesh-list
110417028|NCT02882451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110417029|NCT02882451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110417030|NCT02882451|Anticonvulsants|anticonvulsants|mesh-ancestor
110417031|NCT02882451|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110417032|NCT02882451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110417033|NCT02882451|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110417034|NCT02882451|Parasympatholytics|parasympatholytics|mesh-ancestor
110186660|NCT05105919|Analgesics|analgesics|mesh-ancestor
110417035|NCT02882451|Autonomic Agents|autonomic agents|mesh-ancestor
110417036|NCT02882451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110417038|NCT00999544|Aprepitant|aprepitant|mesh-list
110417039|NCT00999544|Fosaprepitant|fosaprepitant|mesh-list
110417040|NCT00999544|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110417041|NCT00999544|Narcotics|narcotics|mesh-ancestor
110417042|NCT00999544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110417043|NCT00999544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110417044|NCT00999544|Analgesics|analgesics|mesh-ancestor
110417045|NCT00999544|Sensory System Agents|sensory system agents|mesh-ancestor
110417046|NCT00999544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110417047|NCT00999544|Antiemetics|antiemetics|mesh-ancestor
110417048|NCT00999544|Autonomic Agents|autonomic agents|mesh-ancestor
110417049|NCT00999544|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110417050|NCT00999544|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110417051|NCT00999544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110417052|NCT00999544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110417053|NCT02869984|Ramosetron|ramosetron|mesh-list
110417054|NCT02869984|Antiemetics|antiemetics|mesh-ancestor
110417055|NCT02869984|Autonomic Agents|autonomic agents|mesh-ancestor
110186704|NCT05022654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110417056|NCT02869984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110417057|NCT02869984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110417058|NCT02869984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110417059|NCT02869984|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110417060|NCT02869984|Serotonin Agents|serotonin agents|mesh-ancestor
110417061|NCT02869984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110417062|NCT02869984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110417063|NCT01124097|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
110417064|NCT01124097|Anticonvulsants|anticonvulsants|mesh-ancestor
110417065|NCT01124097|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110417066|NCT01124097|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110417067|NCT01124097|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110417068|NCT01124097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110417069|NCT01123395|Colchicine|colchicine|mesh-list
110417070|NCT01123395|Gout Suppressants|gout suppressants|mesh-ancestor
110417071|NCT01123395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110417072|NCT01123395|Tubulin Modulators|tubulin modulators|mesh-ancestor
110417073|NCT01123395|Antimitotic Agents|antimitotic agents|mesh-ancestor
110417074|NCT01123395|Mitosis Modulators|mitosis modulators|mesh-ancestor
110417075|NCT01123395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110417076|NCT01123395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110417077|NCT01255787|Vortioxetine|vortioxetine|mesh-list
110417078|NCT01255787|Antidepressive Agents|antidepressive agents|mesh-ancestor
110417079|NCT01255787|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110417080|NCT01255787|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110417081|NCT01255787|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110417082|NCT01255787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110417083|NCT01255787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110417084|NCT01255787|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110417085|NCT01255787|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110417086|NCT01255787|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110417087|NCT01255787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110417088|NCT01255787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110417089|NCT01255787|Serotonin Agents|serotonin agents|mesh-ancestor
110417090|NCT01255787|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110417091|NCT01255787|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110417092|NCT01255787|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110417093|NCT01255787|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110417094|NCT04540835|Calcium|calcium|mesh-list
110417095|NCT04540835|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110417096|NCT04540835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110417097|NCT01255163|Exenatide|exenatide|mesh-list
110417098|NCT01255163|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110417099|NCT01255163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110417101|NCT01255163|Incretins|incretins|mesh-ancestor
110417102|NCT01255163|Hormones|hormones|mesh-ancestor
110417103|NCT01255163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110417104|NCT01123083|Muromonab-CD3|muromonab-cd3|mesh-list
110417105|NCT01123083|Immunologic Factors|immunologic factors|mesh-ancestor
110417106|NCT01123083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110417107|NCT01123083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110417108|NCT02870062|Chlorhexidine|chlorhexidine|mesh-list
110417109|NCT02870062|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110417110|NCT02870062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110417111|NCT02870062|Disinfectants|disinfectants|mesh-ancestor
110417112|NCT01254305|Milnacipran|milnacipran|mesh-list
110417113|NCT01254305|Sertraline|sertraline|mesh-list
110417114|NCT01254305|Fluoxetine|fluoxetine|mesh-list
110417115|NCT01254305|Paroxetine|paroxetine|mesh-list
110417116|NCT01254305|Citalopram|citalopram|mesh-list
110417117|NCT01254305|Levomilnacipran|levomilnacipran|mesh-list
110417118|NCT01254305|Antidepressive Agents|antidepressive agents|mesh-ancestor
110417119|NCT01254305|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110417120|NCT01254305|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110417121|NCT01254305|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110417122|NCT01254305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110417123|NCT01254305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110417124|NCT01254305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110417125|NCT01254305|Serotonin Agents|serotonin agents|mesh-ancestor
110417126|NCT01254305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110417127|NCT01254305|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110417128|NCT01254305|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110417129|NCT01254305|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110417130|NCT01254305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110417131|NCT01254305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110417132|NCT01254305|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110417133|NCT01254305|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110417134|NCT01254305|Analgesics|analgesics|mesh-ancestor
110417135|NCT01254305|Sensory System Agents|sensory system agents|mesh-ancestor
110417136|NCT01122927|Aripiprazole|aripiprazole|mesh-list
110417137|NCT01122927|Antidepressive Agents|antidepressive agents|mesh-ancestor
110417138|NCT01122927|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110417139|NCT01122927|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110417140|NCT01122927|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110417141|NCT01122927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110417142|NCT01122927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110417143|NCT01122927|Dopamine Agonists|dopamine agonists|mesh-ancestor
110417144|NCT01122927|Dopamine Agents|dopamine agents|mesh-ancestor
110417145|NCT01122927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110417146|NCT01122927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110417147|NCT01122927|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110417148|NCT01122927|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110417149|NCT01122927|Serotonin Agents|serotonin agents|mesh-ancestor
110417150|NCT01122927|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110417151|NCT01122927|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110417152|NCT01122927|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110417153|NCT01122927|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110417154|NCT01254227|Deferasirox|deferasirox|mesh-list
110417155|NCT01254227|Deferoxamine|deferoxamine|mesh-list
110417156|NCT01254227|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110417157|NCT01254227|Chelating Agents|chelating agents|mesh-ancestor
110417158|NCT01254227|Sequestering Agents|sequestering agents|mesh-ancestor
110417159|NCT01254227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110417160|NCT01254227|Siderophores|siderophores|mesh-ancestor
110417161|NCT04311255|Anesthetics|anesthetics|mesh-list
110417162|NCT04311255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110417163|NCT04311255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110417164|NCT01122381|Ethosuximide|ethosuximide|mesh-list
110417165|NCT01122381|Anticonvulsants|anticonvulsants|mesh-ancestor
110417166|NCT00996034|Nicotine|nicotine|mesh-list
110417167|NCT00996034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110417168|NCT00996034|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110417169|NCT00996034|Autonomic Agents|autonomic agents|mesh-ancestor
110417170|NCT00996034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110417171|NCT00996034|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110417172|NCT00996034|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110417173|NCT00996034|Cholinergic Agents|cholinergic agents|mesh-ancestor
110417174|NCT00996034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110417175|NCT00996034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110417176|NCT01121991|Hormones|hormones|mesh-list
110417177|NCT01121991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110417178|NCT01121991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110417179|NCT04292236|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
110417180|NCT04292236|Perilla seed oil|perilla seed oil|mesh-list
110417181|NCT04292236|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110417182|NCT04292236|Protective Agents|protective agents|mesh-ancestor
110417183|NCT04292236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110417184|NCT04292236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110417185|NCT01121913|Trazodone|trazodone|mesh-list
110417186|NCT01121913|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110417187|NCT01121913|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110417188|NCT01121913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110417189|NCT01121913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110417190|NCT01121913|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110417191|NCT01121913|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110417192|NCT01121913|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110417193|NCT01121913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110417194|NCT01121913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110417195|NCT01121913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110417196|NCT01121913|Serotonin Agents|serotonin agents|mesh-ancestor
110417197|NCT01121913|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110417198|NCT01121913|Antidepressive Agents|antidepressive agents|mesh-ancestor
110417199|NCT04310943|Paclitaxel|paclitaxel|mesh-list
110417200|NCT04310943|Tislelizumab|tislelizumab|mesh-list
110417201|NCT04310943|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110417202|NCT04310943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110417203|NCT04310943|Tubulin Modulators|tubulin modulators|mesh-ancestor
110417204|NCT04310943|Antimitotic Agents|antimitotic agents|mesh-ancestor
110417205|NCT04310943|Mitosis Modulators|mitosis modulators|mesh-ancestor
110417206|NCT04310943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110417207|NCT04310943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110417208|NCT02868814|Pregabalin|pregabalin|mesh-list
110417209|NCT02868814|Analgesics|analgesics|mesh-ancestor
110417210|NCT02868814|Sensory System Agents|sensory system agents|mesh-ancestor
110417211|NCT02868814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110417212|NCT02868814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110417213|NCT02868814|Anticonvulsants|anticonvulsants|mesh-ancestor
110417214|NCT02868814|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110187023|NCT04300127|Pioglitazone|pioglitazone|mesh-list
110417215|NCT02868814|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110417216|NCT02868814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110417217|NCT02868814|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110417218|NCT02868814|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110417219|NCT02868814|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110417220|NCT02868814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110417221|NCT02868814|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110417222|NCT04292314|Hydroxyurea|hydroxyurea|mesh-list
110417223|NCT04292314|Deferoxamine|deferoxamine|mesh-list
110417224|NCT04292314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110417225|NCT04292314|Antisickling Agents|antisickling agents|mesh-ancestor
110417226|NCT04292314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110417227|NCT04292314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110417228|NCT04292314|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110417229|NCT04292314|Siderophores|siderophores|mesh-ancestor
110417230|NCT04292314|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110417231|NCT04292314|Chelating Agents|chelating agents|mesh-ancestor
110417232|NCT04292314|Sequestering Agents|sequestering agents|mesh-ancestor
110417233|NCT01121757|Lenalidomide|lenalidomide|mesh-list
110417234|NCT01121757|Azacitidine|azacitidine|mesh-list
110417235|NCT01121757|Immunologic Factors|immunologic factors|mesh-ancestor
110417236|NCT01121757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110417237|NCT01121757|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110417238|NCT01121757|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110417239|NCT01121757|Growth Substances|growth substances|mesh-ancestor
110417240|NCT01121757|Growth Inhibitors|growth inhibitors|mesh-ancestor
110417241|NCT01121757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110417242|NCT01121757|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110417244|NCT01121757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110417245|NCT01121757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110417246|NCT04319471|Capecitabine|capecitabine|mesh-list
110417247|NCT04319471|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110417249|NCT04319471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110417250|NCT04319471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110417251|NCT02882217|Histamine|histamine|mesh-list
110417252|NCT02882217|Glutarimide|glutarimide|mesh-list
110417253|NCT02882217|Histamine Agonists|histamine agonists|mesh-ancestor
110417254|NCT02882217|Histamine Agents|histamine agents|mesh-ancestor
110417255|NCT02882217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110417256|NCT02882217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110417257|NCT02882217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110417258|NCT02882217|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110417259|NCT02882217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110417260|NCT01253135|Petrolatum|petrolatum|mesh-list
110417261|NCT01253135|Emollients|emollients|mesh-ancestor
110417262|NCT01253135|Dermatologic Agents|dermatologic agents|mesh-ancestor
110417263|NCT00993616|Carboplatin|carboplatin|mesh-list
110417264|NCT00993616|Belinostat|belinostat|mesh-list
110417265|NCT00993616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110417266|NCT00993616|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110417267|NCT00993616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110417268|NCT00993616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110417269|NCT01120899|Minocycline|minocycline|mesh-list
110417270|NCT01120899|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110417271|NCT01120899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110417272|NCT01120275|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
110417273|NCT01120275|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
110417274|NCT01120275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110417275|NCT01120275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110417276|NCT00991510|Mycophenolic Acid|mycophenolic acid|mesh-list
110417277|NCT00991510|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110417278|NCT00991510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110417279|NCT00991510|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110417280|NCT00991510|Antitubercular Agents|antitubercular agents|mesh-ancestor
110417281|NCT00991510|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110417282|NCT00991510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110417283|NCT00991510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110417284|NCT00991510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110417285|NCT01119963|Castor Oil|castor oil|mesh-list
110417286|NCT01119963|Progesterone|progesterone|mesh-list
110417287|NCT01119963|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
110417288|NCT01119963|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
110417289|NCT01119963|Progestins|progestins|mesh-ancestor
110417290|NCT01119963|Hormones|hormones|mesh-ancestor
110417291|NCT01119963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110417292|NCT01119963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110417293|NCT01119963|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110417294|NCT01119963|Hormone Antagonists|hormone antagonists|mesh-ancestor
110417295|NCT01119963|Cathartics|cathartics|mesh-ancestor
110417296|NCT01119963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110417297|NCT01252667|Cyclosporine|cyclosporine|mesh-list
110417298|NCT01252667|Mycophenolic Acid|mycophenolic acid|mesh-list
110417299|NCT01252667|Clofarabine|clofarabine|mesh-list
110417300|NCT01252667|Cyclosporins|cyclosporins|mesh-list
110417301|NCT01252667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110417302|NCT01252667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110417303|NCT01252667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110417304|NCT01252667|Immunologic Factors|immunologic factors|mesh-ancestor
110417305|NCT01252667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110417306|NCT01252667|Antifungal Agents|antifungal agents|mesh-ancestor
110417307|NCT01252667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110417308|NCT01252667|Dermatologic Agents|dermatologic agents|mesh-ancestor
110417309|NCT01252667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110417310|NCT01252667|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110417311|NCT01252667|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110417312|NCT01252667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110417313|NCT01252667|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110417314|NCT01252667|Antitubercular Agents|antitubercular agents|mesh-ancestor
110417315|NCT01252667|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110417316|NCT01252667|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110417318|NCT02868580|Lamivudine|lamivudine|mesh-list
110417319|NCT02868580|Abacavir|abacavir|mesh-list
110417320|NCT02868580|Dolutegravir|dolutegravir|mesh-list
110417321|NCT02868580|Abacavir, dolutegravir, and lamivudine drug combination|abacavir, dolutegravir, and lamivudine drug combination|mesh-list
110417322|NCT02868580|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110417323|NCT02868580|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110417324|NCT02868580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110417325|NCT02868580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110417326|NCT02868580|Antiviral Agents|antiviral agents|mesh-ancestor
110417327|NCT02868580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110417328|NCT02868580|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110417329|NCT02868580|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110417330|NCT02868580|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110417331|NCT02868580|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110417332|NCT02881749|Mechlorethamine|mechlorethamine|mesh-list
110417333|NCT02881749|Alkylating Agents|alkylating agents|mesh-ancestor
110417334|NCT02881749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110417335|NCT02881749|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110417336|NCT02881749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110417338|NCT01119105|Lefamulin|lefamulin|mesh-list
110417339|NCT01119105|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110417340|NCT01119105|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110417341|NCT01118949|Lacosamide|lacosamide|mesh-list
110417342|NCT01118949|Anticonvulsants|anticonvulsants|mesh-ancestor
110417343|NCT01118949|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110417344|NCT01118949|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110417345|NCT01118949|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110417346|NCT01118949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110417347|NCT01252355|Interferons|interferons|mesh-list
110417348|NCT01252355|Interferon-beta|interferon-beta|mesh-list
110417349|NCT01252355|Teriflunomide|teriflunomide|mesh-list
110417350|NCT01252355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110417351|NCT01252355|Antiviral Agents|antiviral agents|mesh-ancestor
110417352|NCT01252355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110417353|NCT01252355|Immunologic Factors|immunologic factors|mesh-ancestor
110417354|NCT01252355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110417355|NCT01252355|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110417356|NCT01252355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110417357|NCT01252355|Analgesics|analgesics|mesh-ancestor
110417358|NCT01252355|Sensory System Agents|sensory system agents|mesh-ancestor
110417359|NCT01252355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110417360|NCT01252355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110417361|NCT01252355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110417362|NCT01252355|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110417363|NCT01118325|Clopidogrel|clopidogrel|mesh-list
110417364|NCT01118325|Ticagrelor|ticagrelor|mesh-list
110417365|NCT01118325|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110417366|NCT01118325|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110187248|NCT03308578|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110417367|NCT01118325|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110417368|NCT01118325|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110417369|NCT01118325|Purinergic Agents|purinergic agents|mesh-ancestor
110417370|NCT01118325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110417371|NCT01118325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110417372|NCT01118325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110417373|NCT01117857|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110417374|NCT01117857|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110417375|NCT01117857|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110417376|NCT01117857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110417377|NCT01117857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110417378|NCT01117857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110417379|NCT01117857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110417380|NCT01117857|Analgesics|analgesics|mesh-ancestor
110417381|NCT01117857|Sensory System Agents|sensory system agents|mesh-ancestor
110417382|NCT01117857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110187285|NCT03098225|Antiemetics|antiemetics|mesh-ancestor
110417383|NCT01117857|Antidepressive Agents|antidepressive agents|mesh-ancestor
110417384|NCT01117857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110417385|NCT01117857|Dopamine Agents|dopamine agents|mesh-ancestor
110417388|NCT00991276|Analgesics|analgesics|mesh-ancestor
110417389|NCT00991276|Sensory System Agents|sensory system agents|mesh-ancestor
110417390|NCT00991276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110417391|NCT00991276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110417392|NCT00991276|Anticonvulsants|anticonvulsants|mesh-ancestor
110417393|NCT00991276|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110417394|NCT00991276|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110417395|NCT00991276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110417396|NCT00991276|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110417397|NCT00991276|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110417398|NCT00991276|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110417399|NCT00991276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110417400|NCT00991276|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110417401|NCT00991276|Antioxidants|antioxidants|mesh-ancestor
110417402|NCT00991276|Protective Agents|protective agents|mesh-ancestor
110417403|NCT00991276|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110417404|NCT00991276|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110417405|NCT00991276|Dopamine Agonists|dopamine agonists|mesh-ancestor
110417406|NCT00991276|Dopamine Agents|dopamine agents|mesh-ancestor
110417408|NCT02869126|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
110417409|NCT02869126|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110417410|NCT02869126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110417411|NCT00990652|Temozolomide|temozolomide|mesh-list
110417412|NCT00990652|Bortezomib|bortezomib|mesh-list
110417413|NCT00990652|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110417414|NCT00990652|Alkylating Agents|alkylating agents|mesh-ancestor
110417415|NCT00990652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110417416|NCT00990652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110417417|NCT02867878|Adenosine|adenosine|mesh-list
110417418|NCT02867878|Analgesics|analgesics|mesh-ancestor
110417419|NCT02867878|Sensory System Agents|sensory system agents|mesh-ancestor
110417420|NCT02867878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110417421|NCT02867878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110417422|NCT02867878|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110417423|NCT02867878|Vasodilator Agents|vasodilator agents|mesh-ancestor
110417424|NCT02867878|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
110417425|NCT02867878|Purinergic Agonists|purinergic agonists|mesh-ancestor
110417426|NCT02867878|Purinergic Agents|purinergic agents|mesh-ancestor
110417427|NCT02867878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110417428|NCT02867878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110417429|NCT01207440|Ponatinib|ponatinib|mesh-list
110417430|NCT01207440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110417431|NCT01207440|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110417432|NCT01207440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110417433|NCT01207440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110417434|NCT00990184|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
110417435|NCT00990184|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110417436|NCT00990184|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110417437|NCT00990184|Antimetabolites|antimetabolites|mesh-ancestor
110417438|NCT00990184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110417439|NCT00990184|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110417440|NCT00990106|Prazosin|prazosin|mesh-list
110417441|NCT00990106|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110417442|NCT00990106|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110417443|NCT00990106|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110417444|NCT00990106|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110417445|NCT00990106|Adrenergic Agents|adrenergic agents|mesh-ancestor
110417446|NCT00990106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110417447|NCT00990106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110417448|NCT00990106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110417450|NCT02867566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110417451|NCT02867566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110417452|NCT02867566|Immunologic Factors|immunologic factors|mesh-ancestor
110417453|NCT02867566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110417454|NCT02867566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110417455|NCT02867722|Aminolevulinic Acid|aminolevulinic acid|mesh-list
110187446|NCT01604135|Dextrans|dextrans|mesh-list
110417456|NCT02867722|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110417457|NCT02867722|Dermatologic Agents|dermatologic agents|mesh-ancestor
110417459|NCT02867800|Diphenhydramine|diphenhydramine|mesh-list
110417460|NCT02867800|Promethazine|promethazine|mesh-list
110417461|NCT02867800|Cyclosporine|cyclosporine|mesh-list
110417462|NCT02867800|Sirolimus|sirolimus|mesh-list
110417463|NCT02867800|Mycophenolic Acid|mycophenolic acid|mesh-list
110417464|NCT02867800|Methylprednisolone|methylprednisolone|mesh-list
110417465|NCT02867800|Methotrexate|methotrexate|mesh-list
110417466|NCT02867800|Fludarabine|fludarabine|mesh-list
110417467|NCT02867800|Melphalan|melphalan|mesh-list
110417468|NCT02867800|Alemtuzumab|alemtuzumab|mesh-list
110417469|NCT02867800|Abatacept|abatacept|mesh-list
110417470|NCT02867800|Thiotepa|thiotepa|mesh-list
110417471|NCT02867800|Meperidine|meperidine|mesh-list
110417472|NCT02867800|Tacrolimus|tacrolimus|mesh-list
110417473|NCT02867800|Cyclosporins|cyclosporins|mesh-list
110417474|NCT02867800|Thymoglobulin|thymoglobulin|mesh-list
110417475|NCT02867800|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110417476|NCT02867800|Abortifacient Agents|abortifacient agents|mesh-ancestor
110417477|NCT02867800|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110417478|NCT02867800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110417479|NCT02867800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110417480|NCT02867800|Antimetabolites|antimetabolites|mesh-ancestor
110417481|NCT02867800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110417482|NCT02867800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110417483|NCT02867800|Dermatologic Agents|dermatologic agents|mesh-ancestor
110417484|NCT02867800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110417485|NCT02867800|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110417486|NCT02867800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110417487|NCT02867800|Immunologic Factors|immunologic factors|mesh-ancestor
110417488|NCT02867800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110417489|NCT02867800|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110417490|NCT02867800|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110417491|NCT02867800|Antifungal Agents|antifungal agents|mesh-ancestor
110417492|NCT02867800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110417493|NCT02867800|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110417494|NCT02867800|Analgesics|analgesics|mesh-ancestor
110417495|NCT02867800|Sensory System Agents|sensory system agents|mesh-ancestor
110417496|NCT02867800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110417497|NCT02867800|Antipyretics|antipyretics|mesh-ancestor
110417498|NCT02867800|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110417499|NCT02867800|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110417500|NCT02867800|Antitubercular Agents|antitubercular agents|mesh-ancestor
110417501|NCT02867800|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110417502|NCT02867800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110417503|NCT02867800|Antiemetics|antiemetics|mesh-ancestor
110417504|NCT02867800|Autonomic Agents|autonomic agents|mesh-ancestor
110417505|NCT02867800|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110417506|NCT02867800|Glucocorticoids|glucocorticoids|mesh-ancestor
110417507|NCT02867800|Hormones|hormones|mesh-ancestor
110417508|NCT02867800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110417509|NCT02867800|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110417510|NCT02867800|Protective Agents|protective agents|mesh-ancestor
110417511|NCT02867800|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110417512|NCT02867800|Alkylating Agents|alkylating agents|mesh-ancestor
110417513|NCT02867800|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110417514|NCT02867800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110417515|NCT02867800|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110417516|NCT02867800|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110417517|NCT02867800|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110417518|NCT02867800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110417519|NCT02867800|Anesthetics, Local|anesthetics, local|mesh-ancestor
110417520|NCT02867800|Anesthetics|anesthetics|mesh-ancestor
110417521|NCT02867800|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110417522|NCT02867800|Histamine Antagonists|histamine antagonists|mesh-ancestor
110417523|NCT02867800|Histamine Agents|histamine agents|mesh-ancestor
110417524|NCT02867800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110417525|NCT02867800|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110417526|NCT02867800|Antipruritics|antipruritics|mesh-ancestor
110417527|NCT02867800|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110417528|NCT02867800|Narcotics|narcotics|mesh-ancestor
110417529|NCT02867800|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110417530|NCT00629200|Interferons|interferons|mesh-list
110417531|NCT00629200|Interferon-alpha|interferon-alpha|mesh-list
110417532|NCT00629200|Interferon alpha-2|interferon alpha-2|mesh-list
110417533|NCT00629200|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
110417534|NCT00629200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110417535|NCT00629200|Antiviral Agents|antiviral agents|mesh-ancestor
110417536|NCT00629200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110417537|NCT00629200|Immunologic Factors|immunologic factors|mesh-ancestor
110417538|NCT00629200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110417539|NCT00629200|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110417540|NCT00629200|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110417541|NCT00629200|Schistosomicides|schistosomicides|mesh-ancestor
110417542|NCT00629200|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110417543|NCT00629200|Anthelmintics|anthelmintics|mesh-ancestor
110417544|NCT02867176|Ketorolac|ketorolac|mesh-list
110417545|NCT02867176|Gabapentin|gabapentin|mesh-list
110417546|NCT02867176|Analgesics|analgesics|mesh-ancestor
110064511|NCT01527890|Fentanyl|fentanyl|mesh-list
110417547|NCT02867176|Sensory System Agents|sensory system agents|mesh-ancestor
110187589|NCT05771012|Cyclosporine|cyclosporine|mesh-list
110417548|NCT02867176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110417549|NCT02867176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110417550|NCT02867176|Anticonvulsants|anticonvulsants|mesh-ancestor
110417551|NCT02867176|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110417552|NCT02867176|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110417553|NCT02867176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110417554|NCT02867176|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110417555|NCT02867176|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110417556|NCT02867176|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110417557|NCT02867176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110417558|NCT02867176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110417559|NCT02867176|Antimanic Agents|antimanic agents|mesh-ancestor
110417560|NCT02867176|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110417561|NCT02867176|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110417562|NCT02867176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110417563|NCT02867176|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110417564|NCT02867176|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110417565|NCT02867176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110417566|NCT00982228|Insulin|insulin|mesh-list
110417567|NCT00982228|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110417568|NCT00982228|Insulin Glargine|insulin glargine|mesh-list
110417569|NCT00982228|Insulin Aspart|insulin aspart|mesh-list
110417570|NCT00982228|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110417571|NCT00982228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110417572|NCT02867956|Etoposide|etoposide|mesh-list
110417573|NCT02867956|Apatinib|apatinib|mesh-list
110417574|NCT02867956|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110417575|NCT02867956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110417576|NCT02867956|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110417577|NCT02867956|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110417578|NCT02867956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110417579|NCT02867956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110417580|NCT02867956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110417581|NCT04291066|Acetylcysteine|acetylcysteine|mesh-list
110417582|NCT04291066|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110417583|NCT04291066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110417584|NCT04291066|Antiviral Agents|antiviral agents|mesh-ancestor
110417585|NCT04291066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110417586|NCT04291066|Expectorants|expectorants|mesh-ancestor
110417587|NCT04291066|Respiratory System Agents|respiratory system agents|mesh-ancestor
110417588|NCT04291066|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110417589|NCT04291066|Antioxidants|antioxidants|mesh-ancestor
110417590|NCT04291066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110417591|NCT04291066|Protective Agents|protective agents|mesh-ancestor
110417592|NCT04291066|Antidotes|antidotes|mesh-ancestor
110417593|NCT01260350|Sofosbuvir|sofosbuvir|mesh-list
110417594|NCT01260350|Antiviral Agents|antiviral agents|mesh-ancestor
110564245|NCT05863195|Panitumumab|panitumumab|mesh-list
110417595|NCT01260350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110417596|NCT01260194|Trastuzumab|trastuzumab|mesh-list
110417597|NCT01260194|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110417598|NCT01260194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110417599|NCT00629278|Tamoxifen|tamoxifen|mesh-list
110417600|NCT00629278|Docetaxel|docetaxel|mesh-list
110417601|NCT00629278|Cyclophosphamide|cyclophosphamide|mesh-list
110417602|NCT00629278|Doxorubicin|doxorubicin|mesh-list
110417603|NCT00629278|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110417604|NCT00629278|Fluorouracil|fluorouracil|mesh-list
110417605|NCT00629278|Trastuzumab|trastuzumab|mesh-list
110417606|NCT00629278|Epirubicin|epirubicin|mesh-list
110417607|NCT00629278|Hormones|hormones|mesh-list
110417608|NCT00629278|Aromatase Inhibitors|aromatase inhibitors|mesh-list
110417609|NCT00629278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110417610|NCT00629278|Tubulin Modulators|tubulin modulators|mesh-ancestor
110417611|NCT00629278|Antimitotic Agents|antimitotic agents|mesh-ancestor
110417612|NCT00629278|Mitosis Modulators|mitosis modulators|mesh-ancestor
110417613|NCT00629278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110417615|NCT00629278|Immunologic Factors|immunologic factors|mesh-ancestor
110417616|NCT00629278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110417617|NCT00629278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110417618|NCT00629278|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110417619|NCT00629278|Alkylating Agents|alkylating agents|mesh-ancestor
110417620|NCT00629278|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110417621|NCT00629278|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110417622|NCT00629278|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110417623|NCT00629278|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110417624|NCT00629278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110417625|NCT00629278|Antimetabolites|antimetabolites|mesh-ancestor
110417626|NCT00629278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110417627|NCT00629278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110417628|NCT00629278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110417629|NCT00629278|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110417630|NCT00629278|Hormone Antagonists|hormone antagonists|mesh-ancestor
110417631|NCT00629278|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110417632|NCT00629278|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110417633|NCT00629278|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110417634|NCT00629278|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110417635|NCT00629278|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110417636|NCT04207112|Moxifloxacin|moxifloxacin|mesh-list
110417637|NCT04207112|Linezolid|linezolid|mesh-list
110417638|NCT04207112|Bedaquiline|bedaquiline|mesh-list
110417639|NCT04207112|Clofazimine|clofazimine|mesh-list
110417640|NCT04207112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110417641|NCT04207112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110417642|NCT04207112|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110417643|NCT04207112|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110417644|NCT04207112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110417645|NCT04207112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110417646|NCT04207112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110417647|NCT04207112|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110417648|NCT04207112|Antitubercular Agents|antitubercular agents|mesh-ancestor
110417649|NCT04207112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110417650|NCT04207112|Leprostatic Agents|leprostatic agents|mesh-ancestor
110417651|NCT01259492|Methylphenidate|methylphenidate|mesh-list
110417652|NCT01259492|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110417653|NCT01259492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110187794|NCT05408247|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110187795|NCT05408247|Antiviral Agents|antiviral agents|mesh-ancestor
110218155|NCT00075452|Gemcitabine|gemcitabine|mesh-list
110187796|NCT05408247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110417654|NCT01259492|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110417655|NCT01259492|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110417656|NCT01259492|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110417657|NCT01259492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110417659|NCT01259492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110417660|NCT00624026|Memantine|memantine|mesh-list
110417661|NCT00624026|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110417662|NCT00624026|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110417663|NCT00624026|Dopamine Agents|dopamine agents|mesh-ancestor
110417664|NCT00624026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110417665|NCT00624026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110417666|NCT00624026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110417667|NCT00624026|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110417668|NCT00624026|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110417669|NCT05512910|Minocycline|minocycline|mesh-list
110417670|NCT05512910|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110417671|NCT05512910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110417672|NCT02888990|Dasatinib|dasatinib|mesh-list
110417673|NCT02888990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110417674|NCT02888990|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110417675|NCT02888990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110417676|NCT02888990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110417677|NCT05101928|Prednisone|prednisone|mesh-list
110417678|NCT05101928|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110417679|NCT05101928|Glucocorticoids|glucocorticoids|mesh-ancestor
110417680|NCT05101928|Hormones|hormones|mesh-ancestor
110417681|NCT05101928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110417682|NCT05101928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110417684|NCT05101928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110417685|NCT04654052|Clopidogrel|clopidogrel|mesh-list
110417686|NCT04654052|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110417687|NCT04654052|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110417688|NCT04654052|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110417689|NCT04654052|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110417690|NCT04654052|Purinergic Agents|purinergic agents|mesh-ancestor
110417691|NCT04654052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110417692|NCT04654052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110417693|NCT04654052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110417694|NCT05625308|Folic Acid|folic acid|mesh-list
110417695|NCT05625308|Vitamin B 12|vitamin b 12|mesh-list
110417696|NCT05625308|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
110417697|NCT05625308|Hyaluronic Acid|hyaluronic acid|mesh-list
110417698|NCT05625308|Vitamins|vitamins|mesh-ancestor
110417699|NCT05625308|Micronutrients|micronutrients|mesh-ancestor
110417700|NCT05625308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110417701|NCT05625308|Hematinics|hematinics|mesh-ancestor
110417702|NCT05625308|Vitamin B Complex|vitamin b complex|mesh-ancestor
110417703|NCT05625308|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110417704|NCT05625308|Immunologic Factors|immunologic factors|mesh-ancestor
110417705|NCT05625308|Viscosupplements|viscosupplements|mesh-ancestor
110417706|NCT05625308|Protective Agents|protective agents|mesh-ancestor
110417708|NCT05625308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110417709|NCT05625308|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
110417710|NCT05625308|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110417711|NCT05625308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110417712|NCT05625308|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110417713|NCT04291664|Prednisone|prednisone|mesh-list
110417714|NCT04291664|Abiraterone Acetate|abiraterone acetate|mesh-list
110417715|NCT04291664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110417716|NCT04291664|Glucocorticoids|glucocorticoids|mesh-ancestor
110417717|NCT04291664|Hormones|hormones|mesh-ancestor
110417718|NCT04291664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110417719|NCT04291664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110417720|NCT04291664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110417721|NCT04291664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110417722|NCT04291664|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110417723|NCT04291664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110417724|NCT04291664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110417725|NCT04291664|Hormone Antagonists|hormone antagonists|mesh-ancestor
110417726|NCT04291664|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110417727|NCT04187469|Moxifloxacin|moxifloxacin|mesh-list
110417728|NCT04187469|Rifampin|rifampin|mesh-list
110417729|NCT04187469|Isoniazid|isoniazid|mesh-list
110417730|NCT04187469|Pyrazinamide|pyrazinamide|mesh-list
110417731|NCT04187469|Ethambutol|ethambutol|mesh-list
110417732|NCT04187469|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110417733|NCT04187469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110417734|NCT04187469|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110417735|NCT04187469|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110417736|NCT04187469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110417737|NCT04187469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110417738|NCT04187469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110417739|NCT04187469|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110417740|NCT04187469|Antitubercular Agents|antitubercular agents|mesh-ancestor
110417741|NCT04187469|Leprostatic Agents|leprostatic agents|mesh-ancestor
110417742|NCT04187469|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110417743|NCT04187469|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110417744|NCT04187469|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110417745|NCT04187469|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110417746|NCT04187469|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110417747|NCT04187469|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110417748|NCT04187469|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110417749|NCT04187469|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
110417750|NCT04187469|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110417751|NCT04187469|Antimetabolites|antimetabolites|mesh-ancestor
110417752|NCT04187469|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110417753|NCT01116687|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
110417754|NCT01116687|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
110417756|NCT01116687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110417757|NCT02867020|Prednisone|prednisone|mesh-list
110417758|NCT02867020|Goserelin|goserelin|mesh-list
110417759|NCT02867020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110417760|NCT02867020|Glucocorticoids|glucocorticoids|mesh-ancestor
110417761|NCT02867020|Hormones|hormones|mesh-ancestor
110417762|NCT02867020|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110417763|NCT02867020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110417764|NCT02867020|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110417765|NCT02867020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110417766|NCT03817502|Cariprazine|cariprazine|mesh-list
110417767|NCT03817502|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110417768|NCT03817502|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110417769|NCT03817502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110417770|NCT03817502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110417771|NCT03817502|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110417772|NCT04319978|Dexamethasone|dexamethasone|mesh-list
110417773|NCT04319978|Dexamethasone acetate|dexamethasone acetate|mesh-list
110417774|NCT04319978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110417775|NCT04319978|Antiemetics|antiemetics|mesh-ancestor
110417776|NCT04319978|Autonomic Agents|autonomic agents|mesh-ancestor
110417777|NCT04319978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110188144|NCT04437485|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110417778|NCT04319978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110417779|NCT04319978|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110417781|NCT04319978|Hormones|hormones|mesh-ancestor
110417782|NCT04319978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110417783|NCT04319978|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110417784|NCT04319978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110417785|NCT01114737|Verapamil|verapamil|mesh-list
110417786|NCT01114737|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110417787|NCT01114737|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110417788|NCT01114737|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110417789|NCT01114737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110417790|NCT01114737|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110417791|NCT01114737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110417792|NCT01114737|Vasodilator Agents|vasodilator agents|mesh-ancestor
110417793|NCT00624182|Gemcitabine|gemcitabine|mesh-list
110417794|NCT00624182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110417795|NCT00624182|Antimetabolites|antimetabolites|mesh-ancestor
110417796|NCT00624182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110417797|NCT00624182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110417798|NCT00625677|Vaccines|vaccines|mesh-list
110417799|NCT00625677|Immunologic Factors|immunologic factors|mesh-ancestor
110417800|NCT00625677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110417801|NCT00979576|Pemetrexed|pemetrexed|mesh-list
110417802|NCT00979576|Nintedanib|nintedanib|mesh-list
110417803|NCT00979576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110417804|NCT00979576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110417805|NCT00979576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110417806|NCT00979576|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110417807|NCT00979576|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110417808|NCT00979576|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110417809|NCT02867332|Cyclophosphamide|cyclophosphamide|mesh-list
110417810|NCT02867332|Interleukin-2|interleukin-2|mesh-list
110417811|NCT02867332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110417812|NCT02867332|Immunologic Factors|immunologic factors|mesh-ancestor
110417813|NCT02867332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110417814|NCT02867332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110564247|NCT05863195|Oxaliplatin|oxaliplatin|mesh-list
110417815|NCT02867332|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110417816|NCT02867332|Alkylating Agents|alkylating agents|mesh-ancestor
110417817|NCT02867332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110417818|NCT02867332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110417819|NCT02867332|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110417820|NCT02867332|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110417821|NCT02867332|Analgesics|analgesics|mesh-ancestor
110417822|NCT02867332|Sensory System Agents|sensory system agents|mesh-ancestor
110417823|NCT02867332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110417824|NCT02702180|Molgramostim|molgramostim|mesh-list
110417826|NCT02702180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110417827|NCT02702180|Immunologic Factors|immunologic factors|mesh-ancestor
110417828|NCT02702180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110417829|NCT00980980|Chlorhexidine|chlorhexidine|mesh-list
110417830|NCT00980980|Mupirocin|mupirocin|mesh-list
110417831|NCT00980980|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110417832|NCT00980980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110417833|NCT00980980|Disinfectants|disinfectants|mesh-ancestor
110417834|NCT00980980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110417835|NCT00980980|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110417836|NCT00980980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110417837|NCT00980980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110417838|NCT04116502|Interferons|interferons|mesh-list
110417839|NCT04116502|Interferon-alpha|interferon-alpha|mesh-list
110417840|NCT04116502|Interferon alpha-2|interferon alpha-2|mesh-list
110417841|NCT04116502|Hydroxyurea|hydroxyurea|mesh-list
110417842|NCT04116502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110417843|NCT04116502|Antiviral Agents|antiviral agents|mesh-ancestor
110417844|NCT04116502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110417845|NCT04116502|Immunologic Factors|immunologic factors|mesh-ancestor
110417846|NCT04116502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110417847|NCT04116502|Antisickling Agents|antisickling agents|mesh-ancestor
110417848|NCT04116502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110417849|NCT04116502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110417850|NCT04116502|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110417851|NCT04290442|Ropivacaine|ropivacaine|mesh-list
110417852|NCT04290442|Anesthetics, Local|anesthetics, local|mesh-ancestor
110417853|NCT04290442|Anesthetics|anesthetics|mesh-ancestor
110417854|NCT04290442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110417855|NCT04290442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110417856|NCT04290442|Sensory System Agents|sensory system agents|mesh-ancestor
110417857|NCT04290442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110417858|NCT02866786|Metformin|metformin|mesh-list
110417859|NCT02866786|Cyproterone Acetate|cyproterone acetate|mesh-list
110417860|NCT02866786|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110417861|NCT02866786|Estradiol|estradiol|mesh-list
110417862|NCT02866786|Cyproterone|cyproterone|mesh-list
110417863|NCT02866786|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110417864|NCT02866786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110417865|NCT02866786|Estrogens|estrogens|mesh-ancestor
110417866|NCT02866786|Hormones|hormones|mesh-ancestor
110417867|NCT02866786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110417868|NCT02866786|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110417869|NCT02866786|Contraceptive Agents|contraceptive agents|mesh-ancestor
110417870|NCT02866786|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110417871|NCT02866786|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110417872|NCT02866786|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110417873|NCT02866786|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110417874|NCT02866786|Androgen Antagonists|androgen antagonists|mesh-ancestor
110417875|NCT02866786|Hormone Antagonists|hormone antagonists|mesh-ancestor
110417876|NCT02866786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110417877|NCT02866786|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110417878|NCT00979654|Sifalimumab|sifalimumab|mesh-list
110417879|NCT00979654|Immunologic Factors|immunologic factors|mesh-ancestor
110417880|NCT00979654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110417881|NCT00978562|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
110417882|NCT00978562|Hematinics|hematinics|mesh-ancestor
110417883|NCT00978562|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
110417884|NCT00978562|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110417885|NCT04289974|Fulvestrant|fulvestrant|mesh-list
110417886|NCT04289974|Palbociclib|palbociclib|mesh-list
110417887|NCT04289974|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110417888|NCT04289974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110417889|NCT04289974|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110417890|NCT04289974|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110417891|NCT04289974|Hormone Antagonists|hormone antagonists|mesh-ancestor
110417892|NCT04289974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110417893|NCT04289974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110417894|NCT04289974|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110417895|NCT04289974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110417896|NCT04289974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110417897|NCT02865616|Vancomycin|vancomycin|mesh-list
110188393|NCT03338790|Docetaxel|docetaxel|mesh-list
110417899|NCT02865616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110417900|NCT02865460|Coenzyme Q10|coenzyme q10|mesh-list
110417901|NCT02865460|Micronutrients|micronutrients|mesh-ancestor
110417902|NCT02865460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110417904|NCT01206816|Afatinib|afatinib|mesh-list
110417905|NCT01206816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110417906|NCT01206816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110417907|NCT01206816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110417908|NCT01206816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110417909|NCT01259102|Buprenorphine|buprenorphine|mesh-list
110417910|NCT01259102|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110417911|NCT01259102|Narcotics|narcotics|mesh-ancestor
110417912|NCT01259102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110417913|NCT01259102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110417914|NCT01259102|Analgesics|analgesics|mesh-ancestor
110417915|NCT01259102|Sensory System Agents|sensory system agents|mesh-ancestor
110417916|NCT01259102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110417917|NCT01259102|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110417918|NCT00978250|Tetrahydrouridine|tetrahydrouridine|mesh-list
110417919|NCT00978250|Antimetabolites|antimetabolites|mesh-ancestor
110417920|NCT00978250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110417921|NCT01259024|Chlorotrianisene|chlorotrianisene|mesh-list
110417922|NCT01259024|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
110417923|NCT01259024|Estrogens|estrogens|mesh-ancestor
110417924|NCT01259024|Hormones|hormones|mesh-ancestor
110188499|NCT02573831|Oxycodone|oxycodone|mesh-list
110188501|NCT02573831|Narcotics|narcotics|mesh-ancestor
110417925|NCT01259024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110417926|NCT01259024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110417927|NCT01259024|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110417928|NCT01259024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110417929|NCT04319900|Chloroquine|chloroquine|mesh-list
110417930|NCT04319900|Favipiravir|favipiravir|mesh-list
110417931|NCT04319900|Amebicides|amebicides|mesh-ancestor
110417932|NCT04319900|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110417933|NCT04319900|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110417934|NCT04319900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110417935|NCT04319900|Antimalarials|antimalarials|mesh-ancestor
110417936|NCT04319900|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110417937|NCT04319900|Antiviral Agents|antiviral agents|mesh-ancestor
110417938|NCT01257698|Timolol|timolol|mesh-list
110417939|NCT01257698|Dorzolamide|dorzolamide|mesh-list
110417940|NCT01257698|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110417941|NCT01257698|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110417942|NCT01257698|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110417943|NCT01257698|Adrenergic Agents|adrenergic agents|mesh-ancestor
110417944|NCT01257698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110417945|NCT01257698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110417946|NCT01257698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110417947|NCT01257698|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110417948|NCT01257698|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110417949|NCT01257698|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110417950|NCT01257698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110417951|NCT01257698|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110417952|NCT01257542|Dextromethorphan|dextromethorphan|mesh-list
110417953|NCT01257542|Antitussive Agents|antitussive agents|mesh-ancestor
110417954|NCT01257542|Respiratory System Agents|respiratory system agents|mesh-ancestor
110417955|NCT01257542|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110417956|NCT01257542|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110417957|NCT01257542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110417958|NCT01257542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110417959|NCT01257542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110417960|NCT01257230|Tiotropium Bromide|tiotropium bromide|mesh-list
110417961|NCT01257230|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110417962|NCT01257230|Autonomic Agents|autonomic agents|mesh-ancestor
110417963|NCT01257230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110417964|NCT01257230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110417965|NCT01257230|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110417966|NCT01257230|Respiratory System Agents|respiratory system agents|mesh-ancestor
110417967|NCT01257230|Parasympatholytics|parasympatholytics|mesh-ancestor
110417968|NCT01257230|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110417969|NCT01257230|Cholinergic Agents|cholinergic agents|mesh-ancestor
110417970|NCT01257230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110417971|NCT01257230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110417972|NCT01256684|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
110417973|NCT01256684|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110417974|NCT01256684|Immunologic Factors|immunologic factors|mesh-ancestor
110417975|NCT01256684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110417976|NCT01204710|Prednisone|prednisone|mesh-list
110417977|NCT01204710|Mitoxantrone|mitoxantrone|mesh-list
110417978|NCT01204710|Olaratumab|olaratumab|mesh-list
110417979|NCT01204710|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110417980|NCT01204710|Glucocorticoids|glucocorticoids|mesh-ancestor
110417982|NCT01204710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110417983|NCT01204710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110417984|NCT01204710|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110417985|NCT01204710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110417986|NCT01204710|Analgesics|analgesics|mesh-ancestor
110417987|NCT01204710|Sensory System Agents|sensory system agents|mesh-ancestor
110417988|NCT01204710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110417989|NCT01204710|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110417990|NCT01204710|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110417991|NCT01204710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110417992|NCT01204710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110417993|NCT01256450|Buprenorphine|buprenorphine|mesh-list
110417994|NCT01256450|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110417995|NCT01256450|Narcotics|narcotics|mesh-ancestor
110417996|NCT01256450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110417997|NCT01256450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110417998|NCT01256450|Analgesics|analgesics|mesh-ancestor
110417999|NCT01256450|Sensory System Agents|sensory system agents|mesh-ancestor
110418000|NCT01256450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110418001|NCT01256450|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110418002|NCT01204398|Amlodipine|amlodipine|mesh-list
110418003|NCT01204398|Telmisartan|telmisartan|mesh-list
110418004|NCT01204398|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
110418005|NCT01204398|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110418006|NCT01204398|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110418007|NCT01204398|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110418008|NCT01204398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110418009|NCT01204398|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110418010|NCT01204398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110418011|NCT01204398|Vasodilator Agents|vasodilator agents|mesh-ancestor
110418012|NCT01204398|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110418013|NCT01204398|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110418014|NCT01111851|Dexamethasone|dexamethasone|mesh-list
110418015|NCT01111851|Dexamethasone acetate|dexamethasone acetate|mesh-list
110418016|NCT01111851|Ondansetron|ondansetron|mesh-list
110418018|NCT01111851|Fosaprepitant|fosaprepitant|mesh-list
110418019|NCT01111851|BB 1101|bb 1101|mesh-list
110418020|NCT01111851|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110418021|NCT01111851|Antiemetics|antiemetics|mesh-ancestor
110418022|NCT01111851|Autonomic Agents|autonomic agents|mesh-ancestor
110418023|NCT01111851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110418024|NCT01111851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110418025|NCT01111851|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110418026|NCT01111851|Glucocorticoids|glucocorticoids|mesh-ancestor
110418027|NCT01111851|Hormones|hormones|mesh-ancestor
110418028|NCT01111851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110188710|NCT00018863|Dopamine Agents|dopamine agents|mesh-ancestor
110418029|NCT01111851|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110418030|NCT01111851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110418031|NCT01111851|Protease Inhibitors|protease inhibitors|mesh-ancestor
110418032|NCT01111851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110418033|NCT01111851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110418034|NCT01111851|Antipruritics|antipruritics|mesh-ancestor
110418035|NCT01111851|Dermatologic Agents|dermatologic agents|mesh-ancestor
110418036|NCT01111851|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110418037|NCT01111851|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110418038|NCT01111851|Serotonin Agents|serotonin agents|mesh-ancestor
110418039|NCT01111851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110418040|NCT01111851|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110418041|NCT01256294|Tacrolimus|tacrolimus|mesh-list
110418042|NCT01256294|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110418043|NCT01256294|Immunologic Factors|immunologic factors|mesh-ancestor
110418044|NCT01256294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110418045|NCT01256294|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110418047|NCT01256294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110418048|NCT01256060|Oxytocin|oxytocin|mesh-list
110418049|NCT01256060|Oxytocics|oxytocics|mesh-ancestor
110418050|NCT01256060|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110418051|NCT01256060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110418052|NCT01255904|Dexmedetomidine|dexmedetomidine|mesh-list
110418053|NCT01255904|Chloral Hydrate|chloral hydrate|mesh-list
110418054|NCT01255904|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110418055|NCT01255904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110418056|NCT01255904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110418057|NCT01255904|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110418058|NCT01255904|Analgesics|analgesics|mesh-ancestor
110418059|NCT01255904|Sensory System Agents|sensory system agents|mesh-ancestor
110418060|NCT01255904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110418061|NCT01255904|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110418062|NCT01255904|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110418063|NCT01255904|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110418064|NCT01255904|Adrenergic Agents|adrenergic agents|mesh-ancestor
110418065|NCT01255904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110418066|NCT01255904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110418067|NCT01255670|Metronidazole|metronidazole|mesh-list
110418068|NCT01255670|Penicillins|penicillins|mesh-list
110418069|NCT01255670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110418070|NCT01255670|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110418071|NCT01255670|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110418072|NCT01255670|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110418073|NCT01203930|Rituximab|rituximab|mesh-list
110418074|NCT01203930|Idelalisib|idelalisib|mesh-list
110418075|NCT01203930|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110418076|NCT01203930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110418077|NCT01203930|Immunologic Factors|immunologic factors|mesh-ancestor
110418078|NCT01203930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110418079|NCT01203930|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110418080|NCT01203930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110188820|NCT00019175|Aldesleukin|aldesleukin|mesh-list
110418081|NCT01203930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110418084|NCT01254890|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110418085|NCT01254890|Antimetabolites|antimetabolites|mesh-ancestor
110418086|NCT01254890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110418087|NCT01254890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110418088|NCT01254890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110418089|NCT01254890|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110418090|NCT01203852|Metoprolol|metoprolol|mesh-list
110418091|NCT01203852|Chlorthalidone|chlorthalidone|mesh-list
110418092|NCT01203852|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110418093|NCT01203852|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110418094|NCT01203852|Sympatholytics|sympatholytics|mesh-ancestor
110418095|NCT01203852|Autonomic Agents|autonomic agents|mesh-ancestor
110418096|NCT01203852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110418097|NCT01203852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110418098|NCT01203852|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110418099|NCT01203852|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110418100|NCT01203852|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110418101|NCT01203852|Adrenergic Agents|adrenergic agents|mesh-ancestor
110418102|NCT01203852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110418103|NCT01203852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110418104|NCT01203852|Diuretics|diuretics|mesh-ancestor
110418105|NCT01203852|Natriuretic Agents|natriuretic agents|mesh-ancestor
110418106|NCT01203852|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110418107|NCT01203852|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110418108|NCT01203072|Edoxaban|edoxaban|mesh-list
110418109|NCT01203072|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110418110|NCT01203072|Antithrombins|antithrombins|mesh-ancestor
110418111|NCT01203072|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110418112|NCT01203072|Protease Inhibitors|protease inhibitors|mesh-ancestor
110418113|NCT01203072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110418114|NCT01203072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110418115|NCT01203072|Anticoagulants|anticoagulants|mesh-ancestor
110418116|NCT01105377|Azacitidine|azacitidine|mesh-list
110418117|NCT01105377|Entinostat|entinostat|mesh-list
110418118|NCT01105377|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
110418119|NCT01105377|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110418120|NCT01105377|Antimetabolites|antimetabolites|mesh-ancestor
110418121|NCT01105377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110418122|NCT01105377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110418123|NCT01105377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110418124|NCT01105065|Brimonidine Tartrate|brimonidine tartrate|mesh-list
110418125|NCT01105065|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110418126|NCT01105065|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110418127|NCT01105065|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110418128|NCT01105065|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110418129|NCT01105065|Adrenergic Agents|adrenergic agents|mesh-ancestor
110418130|NCT01105065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110418131|NCT01105065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110418132|NCT01105065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110418133|NCT01111539|Aripiprazole|aripiprazole|mesh-list
110418134|NCT01111539|Escitalopram|escitalopram|mesh-list
110418135|NCT01111539|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110418136|NCT01111539|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110418137|NCT01111539|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110418138|NCT01111539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110418139|NCT01111539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110418140|NCT01111539|Serotonin Agents|serotonin agents|mesh-ancestor
110418141|NCT01111539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110418142|NCT01111539|Antidepressive Agents|antidepressive agents|mesh-ancestor
110418143|NCT01111539|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110418144|NCT01111539|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110418145|NCT01111539|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110418146|NCT01111539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110065096|NCT01530620|Urological Agents|urological agents|mesh-ancestor
110418147|NCT01111539|Dopamine Agonists|dopamine agonists|mesh-ancestor
110418148|NCT01111539|Dopamine Agents|dopamine agents|mesh-ancestor
110418149|NCT01111539|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110418150|NCT01111539|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110188889|NCT00019409|Antimetabolites|antimetabolites|mesh-ancestor
110188894|NCT00019409|Antiviral Agents|antiviral agents|mesh-ancestor
110418151|NCT01111539|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110418152|NCT01111539|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110418153|NCT01111539|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110418154|NCT01111539|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110418156|NCT02880345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110418157|NCT02880345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110418158|NCT02880345|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110418159|NCT02880345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110418161|NCT02879955|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
110418162|NCT02879955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110418163|NCT02879955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110418164|NCT02879955|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110418165|NCT02879955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110418166|NCT02880033|Deferiprone|deferiprone|mesh-list
110418167|NCT02880033|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110418168|NCT02880033|Chelating Agents|chelating agents|mesh-ancestor
110418169|NCT02880033|Sequestering Agents|sequestering agents|mesh-ancestor
110418170|NCT02880033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110418171|NCT00625911|Ketamine|ketamine|mesh-list
110418172|NCT00625911|Morphine|morphine|mesh-list
110418173|NCT00625911|Analgesics|analgesics|mesh-ancestor
110418174|NCT00625911|Sensory System Agents|sensory system agents|mesh-ancestor
110418175|NCT00625911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110418176|NCT00625911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110418177|NCT00625911|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110418178|NCT00625911|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110418179|NCT00625911|Anesthetics, General|anesthetics, general|mesh-ancestor
110418180|NCT00625911|Anesthetics|anesthetics|mesh-ancestor
110418181|NCT00625911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110418182|NCT00625911|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110188938|NCT00039351|Tubulin Modulators|tubulin modulators|mesh-ancestor
110418183|NCT00625911|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110418184|NCT00625911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110418185|NCT00625911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110418186|NCT00625911|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110418187|NCT00625911|Narcotics|narcotics|mesh-ancestor
110418188|NCT01111149|Bupropion|bupropion|mesh-list
110418190|NCT01111149|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110418191|NCT01111149|Antidepressive Agents|antidepressive agents|mesh-ancestor
110418192|NCT01111149|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110418193|NCT01111149|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110418194|NCT01111149|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110418195|NCT01111149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110418196|NCT01111149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110418197|NCT01111149|Dopamine Agents|dopamine agents|mesh-ancestor
110418198|NCT01111149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110418199|NCT01111149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110418200|NCT01111149|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110418201|NCT01111149|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110418202|NCT01111149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110418203|NCT01111149|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110418204|NCT01111149|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110418205|NCT01111149|Cholinergic Agents|cholinergic agents|mesh-ancestor
110418207|NCT01254656|Etravirine|etravirine|mesh-list
110418208|NCT01254656|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110418209|NCT01254656|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110418210|NCT01254656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110418211|NCT01254656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110418212|NCT01254656|Antiviral Agents|antiviral agents|mesh-ancestor
110418213|NCT01254656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110418214|NCT01254656|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110418215|NCT01254656|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110418216|NCT01254656|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110418217|NCT01254656|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110418218|NCT01254656|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110418219|NCT01254656|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110418220|NCT01254344|Metronidazole|metronidazole|mesh-list
110418221|NCT01254344|Ceftriaxone|ceftriaxone|mesh-list
110418222|NCT01254344|Ertapenem|ertapenem|mesh-list
110418223|NCT01254344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110418224|NCT01254344|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110418225|NCT01254344|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110418226|NCT01254344|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110418227|NCT05051007|Lidocaine|lidocaine|mesh-list
110418228|NCT05051007|Fentanyl|fentanyl|mesh-list
110418229|NCT05051007|Anesthetics, Local|anesthetics, local|mesh-ancestor
110418230|NCT05051007|Anesthetics|anesthetics|mesh-ancestor
110418231|NCT05051007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110418232|NCT05051007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110418233|NCT05051007|Sensory System Agents|sensory system agents|mesh-ancestor
110418234|NCT05051007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110418235|NCT05051007|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110418236|NCT05051007|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110418237|NCT05051007|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110418238|NCT05051007|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110418239|NCT05051007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110418240|NCT05051007|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110418241|NCT05051007|Narcotics|narcotics|mesh-ancestor
110418242|NCT05051007|Analgesics|analgesics|mesh-ancestor
110418243|NCT05051007|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110418244|NCT05051007|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110418245|NCT05051007|Anesthetics, General|anesthetics, general|mesh-ancestor
110418246|NCT01102803|Cycloserine|cycloserine|mesh-list
110418247|NCT01102803|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110418248|NCT01102803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110418249|NCT01102803|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110418250|NCT01102803|Antitubercular Agents|antitubercular agents|mesh-ancestor
110418251|NCT01102803|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110418252|NCT01102803|Antimetabolites|antimetabolites|mesh-ancestor
110418253|NCT01102803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110418254|NCT01109979|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
110418255|NCT01109979|Drospirenone|drospirenone|mesh-list
110418256|NCT01109979|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110418257|NCT01109979|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110418258|NCT01109979|Medroxyprogesterone|medroxyprogesterone|mesh-list
110418259|NCT01109979|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
110418260|NCT01109979|Estradiol|estradiol|mesh-list
110418261|NCT01109979|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110418262|NCT01109979|Estrogens|estrogens|mesh-ancestor
110418263|NCT01109979|Hormones|hormones|mesh-ancestor
110418264|NCT01109979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110418265|NCT01109979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110418266|NCT01109979|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110418267|NCT01109979|Contraceptive Agents|contraceptive agents|mesh-ancestor
110418268|NCT01109979|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110418269|NCT01109979|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110418270|NCT01109979|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110418271|NCT01109979|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110418272|NCT01109979|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110189136|NCT00020267|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
110418273|NCT01109979|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110418274|NCT01109979|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110418275|NCT01109979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110418276|NCT01109979|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110418277|NCT01109979|Hormone Antagonists|hormone antagonists|mesh-ancestor
110418278|NCT01109979|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110418280|NCT01109979|Natriuretic Agents|natriuretic agents|mesh-ancestor
110418281|NCT01102491|Ramosetron|ramosetron|mesh-list
110418282|NCT01102491|Antiemetics|antiemetics|mesh-ancestor
110418283|NCT01102491|Autonomic Agents|autonomic agents|mesh-ancestor
110418284|NCT01102491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110418285|NCT01102491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110418286|NCT01102491|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110418287|NCT01102491|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110418288|NCT01102491|Serotonin Agents|serotonin agents|mesh-ancestor
110418289|NCT01102491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110418290|NCT01102491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110418291|NCT01108809|Telmisartan|telmisartan|mesh-list
110418292|NCT01108809|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110418293|NCT01108809|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110418294|NCT01108809|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110418295|NCT01108809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110418296|NCT01253408|Dronabinol|dronabinol|mesh-list
110418297|NCT01253408|Hallucinogens|hallucinogens|mesh-ancestor
110418298|NCT01253408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110418299|NCT01253408|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110418300|NCT01253408|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110418301|NCT01253408|Analgesics|analgesics|mesh-ancestor
110418302|NCT01253408|Sensory System Agents|sensory system agents|mesh-ancestor
110418303|NCT01253408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110418304|NCT01253408|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
110418305|NCT01253408|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110418306|NCT01253408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110418307|NCT01253408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110418308|NCT01253408|Hormones|hormones|mesh-ancestor
110418309|NCT01253408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110418311|NCT05506982|Hallucinogens|hallucinogens|mesh-ancestor
110418312|NCT05506982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110418313|NCT05506982|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110418314|NCT02879643|Vincristine|vincristine|mesh-list
110418315|NCT02879643|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110418316|NCT02879643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110418317|NCT02879643|Tubulin Modulators|tubulin modulators|mesh-ancestor
110418318|NCT02879643|Antimitotic Agents|antimitotic agents|mesh-ancestor
110418319|NCT02879643|Mitosis Modulators|mitosis modulators|mesh-ancestor
110418320|NCT02879643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110418321|NCT02879721|Candesartan|candesartan|mesh-list
110418322|NCT02879721|Candesartan cilexetil|candesartan cilexetil|mesh-list
110418323|NCT02879721|Enalapril|enalapril|mesh-list
110418324|NCT02879721|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110418325|NCT02879721|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110418326|NCT02879721|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110418327|NCT02879721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110418328|NCT02879721|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110418329|NCT02879721|Protease Inhibitors|protease inhibitors|mesh-ancestor
110418330|NCT02879721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110418331|NCT01253174|Tetrahydrofolates|tetrahydrofolates|mesh-list
110418332|NCT01253174|Drospirenone|drospirenone|mesh-list
110218383|NCT00279487|Gabapentin|gabapentin|mesh-list
110418333|NCT01253174|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110418334|NCT01253174|Hormone Antagonists|hormone antagonists|mesh-ancestor
110418335|NCT01253174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110418336|NCT01253174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110418337|NCT01253174|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110418338|NCT01253174|Diuretics|diuretics|mesh-ancestor
110418339|NCT01253174|Natriuretic Agents|natriuretic agents|mesh-ancestor
110418340|NCT01253174|Vitamin B Complex|vitamin b complex|mesh-ancestor
110418341|NCT01253174|Vitamins|vitamins|mesh-ancestor
110418342|NCT01253174|Micronutrients|micronutrients|mesh-ancestor
110418343|NCT01108731|Milnacipran|milnacipran|mesh-list
110418344|NCT01108731|Levomilnacipran|levomilnacipran|mesh-list
110418345|NCT01108731|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110418346|NCT01108731|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110418347|NCT01108731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110418348|NCT01108731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110418349|NCT01108731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110418350|NCT01108731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110418351|NCT01108731|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110418352|NCT01108731|Analgesics|analgesics|mesh-ancestor
110418353|NCT01108731|Sensory System Agents|sensory system agents|mesh-ancestor
110418354|NCT01108731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110418355|NCT01108731|Antidepressive Agents|antidepressive agents|mesh-ancestor
110418356|NCT01108731|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110418357|NCT04308525|Analgesics, Opioid|analgesics, opioid|mesh-list
110418358|NCT04308525|Narcotics|narcotics|mesh-ancestor
110418359|NCT04308525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110418360|NCT04308525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110418361|NCT04308525|Analgesics|analgesics|mesh-ancestor
110418362|NCT04308525|Sensory System Agents|sensory system agents|mesh-ancestor
110418363|NCT04308525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110418364|NCT01108341|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110418365|NCT01108341|Ofatumumab|ofatumumab|mesh-list
110418366|NCT01108341|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110418367|NCT01108341|Alkylating Agents|alkylating agents|mesh-ancestor
110418368|NCT01108341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110418369|NCT01108341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110418370|NCT01252940|Emtricitabine, Rilpivirine, Tenofovir Drug Combination|emtricitabine, rilpivirine, tenofovir drug combination|mesh-list
110418371|NCT01252940|Antiviral Agents|antiviral agents|mesh-ancestor
110418372|NCT01252940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110418373|NCT01252940|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110418374|NCT01252940|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110418375|NCT01252940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110418376|NCT01252940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110418377|NCT01252940|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110418378|NCT01252940|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110418379|NCT01252238|Amlodipine|amlodipine|mesh-list
110418380|NCT01252238|Valsartan|valsartan|mesh-list
110418381|NCT01252238|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110418382|NCT01252238|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110418383|NCT01252238|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110418384|NCT01252238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110418385|NCT01252238|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110418386|NCT01252238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110418387|NCT01252238|Vasodilator Agents|vasodilator agents|mesh-ancestor
110418388|NCT01252238|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110418389|NCT01252238|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110418390|NCT01101321|Oxycodone|oxycodone|mesh-list
110418391|NCT01101321|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110418392|NCT01101321|Narcotics|narcotics|mesh-ancestor
110418393|NCT01101321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110418394|NCT01101321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110418395|NCT01101321|Analgesics|analgesics|mesh-ancestor
110418396|NCT01101321|Sensory System Agents|sensory system agents|mesh-ancestor
110418397|NCT01101321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110418398|NCT04309929|Analgesics|analgesics|mesh-list
110418399|NCT04309929|Sensory System Agents|sensory system agents|mesh-ancestor
110418400|NCT04309929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110418401|NCT04309929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110418403|NCT01101165|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110418404|NCT01101165|Narcotics|narcotics|mesh-ancestor
110418405|NCT01101165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110418406|NCT01101165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110418407|NCT01101165|Analgesics|analgesics|mesh-ancestor
110418408|NCT01101165|Sensory System Agents|sensory system agents|mesh-ancestor
110418409|NCT01101165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110418410|NCT01100853|Naltrexone|naltrexone|mesh-list
110418411|NCT01100853|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110418412|NCT01100853|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110418413|NCT01100853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110418414|NCT01100853|Sensory System Agents|sensory system agents|mesh-ancestor
110418415|NCT01100853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110418416|NCT02879097|Paclitaxel|paclitaxel|mesh-list
110418417|NCT02879097|Carboplatin|carboplatin|mesh-list
110418418|NCT02879097|Bevacizumab|bevacizumab|mesh-list
110418419|NCT02879097|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110418420|NCT02879097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110418421|NCT02879097|Tubulin Modulators|tubulin modulators|mesh-ancestor
110418422|NCT02879097|Antimitotic Agents|antimitotic agents|mesh-ancestor
110418423|NCT02879097|Mitosis Modulators|mitosis modulators|mesh-ancestor
110418424|NCT02879097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110418425|NCT02879097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110418426|NCT02879097|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110418427|NCT02879097|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110418428|NCT02879097|Growth Substances|growth substances|mesh-ancestor
110418429|NCT02879097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110418430|NCT02879097|Growth Inhibitors|growth inhibitors|mesh-ancestor
110418431|NCT02878863|Peoniflorin|peoniflorin|mesh-list
110418432|NCT02878863|Silymarin|silymarin|mesh-list
110418433|NCT02878863|Antioxidants|antioxidants|mesh-ancestor
110418434|NCT02878863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110189646|NCT00021983|Immunotoxins|immunotoxins|mesh-list
110418435|NCT02878863|Protective Agents|protective agents|mesh-ancestor
110418436|NCT02878863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110189720|NCT00049569|Hormones|hormones|mesh-ancestor
110418437|NCT02878863|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110418438|NCT02878863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110065398|NCT01532856|Thalidomide|thalidomide|mesh-list
110065399|NCT01532856|Dexamethasone|dexamethasone|mesh-list
110418439|NCT02878863|Analgesics|analgesics|mesh-ancestor
110418440|NCT02878863|Sensory System Agents|sensory system agents|mesh-ancestor
110418441|NCT02878863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110418442|NCT02878863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110418443|NCT02878863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110418444|NCT02881125|Paclitaxel|paclitaxel|mesh-list
110418445|NCT02881125|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110418446|NCT02881125|Nortriptyline|nortriptyline|mesh-list
110418447|NCT02881125|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110418448|NCT02881125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110418449|NCT02881125|Tubulin Modulators|tubulin modulators|mesh-ancestor
110418450|NCT02881125|Antimitotic Agents|antimitotic agents|mesh-ancestor
110418451|NCT02881125|Mitosis Modulators|mitosis modulators|mesh-ancestor
110418452|NCT02881125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110418453|NCT02881125|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110418454|NCT02881125|Antidepressive Agents|antidepressive agents|mesh-ancestor
110418455|NCT02881125|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110418456|NCT02881125|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110418457|NCT02881125|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110418458|NCT02881125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110418459|NCT02881125|Adrenergic Agents|adrenergic agents|mesh-ancestor
110189891|NCT00050271|Acetylcarnitine|acetylcarnitine|mesh-list
110418460|NCT02881125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110046774|NCT04975308|Fulvestrant|fulvestrant|mesh-list
110418461|NCT02881125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110418462|NCT01107405|Loteprednol Etabonate|loteprednol etabonate|mesh-list
110418463|NCT01107405|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110418464|NCT01097577|Pregabalin|pregabalin|mesh-list
110418465|NCT01097577|Analgesics|analgesics|mesh-ancestor
110418466|NCT01097577|Sensory System Agents|sensory system agents|mesh-ancestor
110418467|NCT01097577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110418468|NCT01097577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110418469|NCT01097577|Anticonvulsants|anticonvulsants|mesh-ancestor
110418470|NCT01097577|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110418471|NCT01097577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110328256|NCT00495651|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110418472|NCT01097577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110418473|NCT01097577|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110418474|NCT01097577|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110418475|NCT01097577|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110418476|NCT01097577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110418477|NCT01097577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110418478|NCT01097421|Pramipexole|pramipexole|mesh-list
110418479|NCT01097421|Antioxidants|antioxidants|mesh-ancestor
110190223|NCT00024011|Bortezomib|bortezomib|mesh-list
110418480|NCT01097421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110418481|NCT01097421|Protective Agents|protective agents|mesh-ancestor
110418482|NCT01097421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110418483|NCT01097421|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110418484|NCT01097421|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110418485|NCT01097421|Dopamine Agonists|dopamine agonists|mesh-ancestor
110418486|NCT01097421|Dopamine Agents|dopamine agents|mesh-ancestor
110418487|NCT01097421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110418489|NCT01251614|Methotrexate|methotrexate|mesh-list
110418490|NCT01251614|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110418491|NCT01251614|Abortifacient Agents|abortifacient agents|mesh-ancestor
110190357|NCT00024440|Oblimersen|oblimersen|mesh-list
110418492|NCT01251614|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110418493|NCT01251614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110418494|NCT01251614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110418495|NCT01251614|Antimetabolites|antimetabolites|mesh-ancestor
110418496|NCT01251614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110190493|NCT00052611|Analgesics|analgesics|mesh-ancestor
110418497|NCT01251614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110418498|NCT01251614|Dermatologic Agents|dermatologic agents|mesh-ancestor
110418499|NCT01251614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110418500|NCT01251614|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110418501|NCT01251614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110418502|NCT01251614|Immunologic Factors|immunologic factors|mesh-ancestor
110418503|NCT01251614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110418504|NCT01251614|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110418505|NCT01251614|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110418506|NCT01251614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110418508|NCT01106625|Canagliflozin|canagliflozin|mesh-list
110418509|NCT01106625|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110418510|NCT01106625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110418511|NCT01106625|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110418512|NCT01106625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110418513|NCT01251380|Botulinum Toxins|botulinum toxins|mesh-list
110418514|NCT01251380|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110418515|NCT01251380|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110418516|NCT01251380|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110418517|NCT01251380|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110050381|NCT01466712|Beclomethasone|beclomethasone|mesh-list
110418518|NCT01251380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110418519|NCT01251380|Cholinergic Agents|cholinergic agents|mesh-ancestor
110418520|NCT01251380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110190701|NCT00025220|Thalidomide|thalidomide|mesh-list
110418521|NCT01251380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110418522|NCT01251380|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110418523|NCT01251380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110418524|NCT01251146|Atenolol|atenolol|mesh-list
110418525|NCT01251146|Bisoprolol|bisoprolol|mesh-list
110418526|NCT01251146|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110418527|NCT01251146|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110418528|NCT01251146|Sympatholytics|sympatholytics|mesh-ancestor
110190845|NCT00025649|Busulfan|busulfan|mesh-list
110418529|NCT01251146|Autonomic Agents|autonomic agents|mesh-ancestor
110418530|NCT01251146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110418531|NCT01251146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110418532|NCT01251146|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110418533|NCT01251146|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110418534|NCT01251146|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110418535|NCT01251146|Adrenergic Agents|adrenergic agents|mesh-ancestor
110418536|NCT01251146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110418537|NCT01251146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110418538|NCT02878707|Dexmedetomidine|dexmedetomidine|mesh-list
110418539|NCT02878707|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110418540|NCT02878707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110418541|NCT02878707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110418542|NCT02878707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110418543|NCT02878707|Analgesics|analgesics|mesh-ancestor
110418545|NCT02878707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110418546|NCT02878707|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110418547|NCT02878707|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110418548|NCT02878707|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110418549|NCT02878707|Adrenergic Agents|adrenergic agents|mesh-ancestor
110418550|NCT02878707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110418551|NCT02878707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110418553|NCT01096017|Terbutaline|terbutaline|mesh-list
110418554|NCT01096017|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110418555|NCT01096017|Autonomic Agents|autonomic agents|mesh-ancestor
110418556|NCT01096017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110418557|NCT01096017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110418558|NCT01096017|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110418559|NCT01096017|Respiratory System Agents|respiratory system agents|mesh-ancestor
110418561|NCT01096017|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110418562|NCT01096017|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110418563|NCT01096017|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110418564|NCT01096017|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110191267|NCT00027599|Sargramostim|sargramostim|mesh-list
110418565|NCT01096017|Adrenergic Agents|adrenergic agents|mesh-ancestor
110418566|NCT01096017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110418567|NCT01096017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110418568|NCT01096017|Sympathomimetics|sympathomimetics|mesh-ancestor
110418569|NCT00626223|Folic Acid|folic acid|mesh-list
110418570|NCT00626223|Hematinics|hematinics|mesh-ancestor
110418571|NCT00626223|Vitamin B Complex|vitamin b complex|mesh-ancestor
110418572|NCT00626223|Vitamins|vitamins|mesh-ancestor
110418573|NCT00626223|Micronutrients|micronutrients|mesh-ancestor
110191584|NCT00028691|Chlorambucil|chlorambucil|mesh-list
110418574|NCT00626223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110418575|NCT01106157|Thymoglobulin|thymoglobulin|mesh-list
110418576|NCT01106157|Immunologic Factors|immunologic factors|mesh-ancestor
110418577|NCT01106157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110191731|NCT00029159|Estrogens|estrogens|mesh-list
110418578|NCT01106157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110418579|NCT04828005|Naloxone|naloxone|mesh-list
110418580|NCT04828005|Nalmefene|nalmefene|mesh-list
110418581|NCT04828005|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110418582|NCT04828005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110418583|NCT04828005|Sensory System Agents|sensory system agents|mesh-ancestor
110418584|NCT04828005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110418585|NCT02878161|Prednisone|prednisone|mesh-list
110418586|NCT02878161|Methylprednisolone|methylprednisolone|mesh-list
110418587|NCT02878161|Adalimumab|adalimumab|mesh-list
110418588|NCT02878161|Infliximab|infliximab|mesh-list
110418589|NCT02878161|Etanercept|etanercept|mesh-list
110418590|NCT02878161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
110191951|NCT00057642|Sertraline|sertraline|mesh-list
110418591|NCT02878161|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
110418592|NCT02878161|Methotrexate|methotrexate|mesh-list
110418593|NCT02878161|Glucocorticoids|glucocorticoids|mesh-list
110418594|NCT02878161|Leflunomide|leflunomide|mesh-list
110418595|NCT02878161|Hormones|hormones|mesh-ancestor
110418596|NCT02878161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110192091|NCT00058071|Amifostine|amifostine|mesh-list
110418597|NCT02878161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110418598|NCT02878161|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110418599|NCT02878161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110418600|NCT02878161|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110418601|NCT02878161|Abortifacient Agents|abortifacient agents|mesh-ancestor
110418602|NCT02878161|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110418603|NCT02878161|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110192304|NCT00396344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110418605|NCT02878161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110418606|NCT02878161|Dermatologic Agents|dermatologic agents|mesh-ancestor
110418607|NCT02878161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110418608|NCT02878161|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110418609|NCT02878161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110058261|NCT01511627|Anesthetics|anesthetics|mesh-list
110418610|NCT02878161|Immunologic Factors|immunologic factors|mesh-ancestor
110418611|NCT02878161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110418612|NCT02878161|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110418613|NCT02878161|Antiemetics|antiemetics|mesh-ancestor
110418614|NCT02878161|Autonomic Agents|autonomic agents|mesh-ancestor
110418615|NCT02878161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110418616|NCT02878161|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110418617|NCT02878161|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110192589|NCT00060411|Fluorouracil|fluorouracil|mesh-list
110418619|NCT02878161|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110418620|NCT02878161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110418621|NCT02878161|Analgesics|analgesics|mesh-ancestor
110418622|NCT02878161|Sensory System Agents|sensory system agents|mesh-ancestor
110418623|NCT01093755|Omeprazole|omeprazole|mesh-list
110192772|NCT00033215|S 3304|s 3304|mesh-list
110418624|NCT01093755|Dexlansoprazole|dexlansoprazole|mesh-list
110418625|NCT01093755|Lansoprazole|lansoprazole|mesh-list
110418626|NCT01093755|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110418627|NCT01093755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110418628|NCT01093755|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110418629|NCT01093755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110192878|NCT00033605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110418630|NCT01093755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110418631|NCT01092663|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110418632|NCT01092663|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
110418633|NCT01092663|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110418634|NCT01092663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110418636|NCT01092663|Hormones|hormones|mesh-ancestor
110418637|NCT01092663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110418638|NCT01092663|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110418639|NCT01092663|Protease Inhibitors|protease inhibitors|mesh-ancestor
110418640|NCT01092663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110418641|NCT01092663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110418642|NCT01092663|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110418643|NCT01092663|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110418644|NCT01092663|Antimetabolites|antimetabolites|mesh-ancestor
110418645|NCT01092663|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110418646|NCT01078623|Formoterol Fumarate|formoterol fumarate|mesh-list
110418647|NCT01078623|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110193249|NCT00062244|Oblimersen|oblimersen|mesh-list
110418648|NCT01078623|Autonomic Agents|autonomic agents|mesh-ancestor
110418649|NCT01078623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110418650|NCT01078623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110418651|NCT01078623|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110418652|NCT01078623|Respiratory System Agents|respiratory system agents|mesh-ancestor
110418653|NCT01078623|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110418654|NCT01078623|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110418655|NCT01078623|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110418656|NCT01078623|Adrenergic Agents|adrenergic agents|mesh-ancestor
110418657|NCT01078623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110418658|NCT01078623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110418659|NCT01092507|Vaccines|vaccines|mesh-list
110418660|NCT01092507|Immunologic Factors|immunologic factors|mesh-ancestor
110418661|NCT01092507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110418662|NCT01078545|Leuprolide|leuprolide|mesh-list
110418663|NCT01078545|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110418664|NCT01078545|Fertility Agents|fertility agents|mesh-ancestor
110061251|NCT06005818|Pembrolizumab|pembrolizumab|mesh-list
110418665|NCT01078545|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110418666|NCT01078545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110418667|NCT01078545|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110418668|NCT01078545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110418669|NCT01091259|Bevacizumab|bevacizumab|mesh-list
110418670|NCT01091259|Irinotecan|irinotecan|mesh-list
110418671|NCT01091259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110418672|NCT01091259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110418673|NCT01091259|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110418674|NCT01091259|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110418675|NCT01091259|Growth Substances|growth substances|mesh-ancestor
110193828|NCT00038090|Thalidomide|thalidomide|mesh-list
110418676|NCT01091259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110418677|NCT01091259|Growth Inhibitors|growth inhibitors|mesh-ancestor
110193953|NCT00398853|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110418678|NCT01091259|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110418679|NCT01091259|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110418680|NCT01091259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110418681|NCT01091259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110418682|NCT01078389|Febuxostat|febuxostat|mesh-list
110418683|NCT01078389|Gout Suppressants|gout suppressants|mesh-ancestor
110418684|NCT01078389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110418686|NCT01090323|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110418687|NCT01090323|Chelating Agents|chelating agents|mesh-ancestor
110418688|NCT01090323|Sequestering Agents|sequestering agents|mesh-ancestor
110418689|NCT01090323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110418690|NCT02876991|Listerine|listerine|mesh-list
110418691|NCT02876991|Fluorides|fluorides|mesh-list
110418692|NCT02876991|Sodium Fluoride|sodium fluoride|mesh-list
110418693|NCT02876991|Cariostatic Agents|cariostatic agents|mesh-ancestor
110418694|NCT02876991|Protective Agents|protective agents|mesh-ancestor
110418695|NCT02876991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110418696|NCT02876991|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110418697|NCT02876991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110418698|NCT01201356|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
110418699|NCT01201356|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
110418700|NCT01201356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110418701|NCT01201356|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110418702|NCT01201356|Immunologic Factors|immunologic factors|mesh-ancestor
110418703|NCT01201356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110418704|NCT00637611|Fexofenadine|fexofenadine|mesh-list
110418705|NCT00637611|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110418706|NCT00637611|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110418707|NCT00637611|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110418708|NCT00637611|Histamine Antagonists|histamine antagonists|mesh-ancestor
110418709|NCT00637611|Histamine Agents|histamine agents|mesh-ancestor
110418710|NCT00637611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110418711|NCT00637611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110418712|NCT00637611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110418713|NCT00626535|Esomeprazole|esomeprazole|mesh-list
110418714|NCT00626535|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110418715|NCT00626535|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110418716|NCT00626535|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110418717|NCT00626535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110418718|NCT00626535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110418719|NCT01200810|Bicalutamide|bicalutamide|mesh-list
110418720|NCT01200810|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
110418721|NCT01200810|Androgen Antagonists|androgen antagonists|mesh-ancestor
110418722|NCT01200810|Hormone Antagonists|hormone antagonists|mesh-ancestor
110194731|NCT00144976|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110418723|NCT01200810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110194805|NCT00038597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110418724|NCT01200810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110418725|NCT01200810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110418726|NCT01200810|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
110418727|NCT01200810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110418728|NCT01200810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110418729|NCT01200342|Paclitaxel|paclitaxel|mesh-list
110418730|NCT01200342|Carboplatin|carboplatin|mesh-list
110418731|NCT01200342|Oblimersen|oblimersen|mesh-list
110065704|NCT01534442|Autonomic Agents|autonomic agents|mesh-ancestor
110195003|NCT00203905|Immunologic Factors|immunologic factors|mesh-ancestor
110065705|NCT01534442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110065706|NCT01534442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110065707|NCT01534442|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110418732|NCT01200342|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110418733|NCT01200342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110418734|NCT01200342|Tubulin Modulators|tubulin modulators|mesh-ancestor
110418735|NCT01200342|Antimitotic Agents|antimitotic agents|mesh-ancestor
110418736|NCT01200342|Mitosis Modulators|mitosis modulators|mesh-ancestor
110418737|NCT01200342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110418739|NCT01198548|Cholecalciferol|cholecalciferol|mesh-list
110418741|NCT01198548|Bevacizumab|bevacizumab|mesh-list
110418742|NCT01198548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110418743|NCT01198548|Fluorouracil|fluorouracil|mesh-list
110418744|NCT01198548|Oxaliplatin|oxaliplatin|mesh-list
110418745|NCT01198548|Antibodies|antibodies|mesh-list
110418746|NCT01198548|Immunoglobulins|immunoglobulins|mesh-list
110418747|NCT01198548|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110418748|NCT01198548|Levoleucovorin|levoleucovorin|mesh-list
110418750|NCT01198548|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110418751|NCT01198548|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110418752|NCT01198548|Growth Substances|growth substances|mesh-ancestor
110418753|NCT01198548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110418754|NCT01198548|Growth Inhibitors|growth inhibitors|mesh-ancestor
110418755|NCT01198548|Vitamins|vitamins|mesh-ancestor
110418756|NCT01198548|Micronutrients|micronutrients|mesh-ancestor
110418757|NCT01198548|Immunologic Factors|immunologic factors|mesh-ancestor
110418758|NCT01198548|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110418759|NCT01198548|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110418760|NCT01198548|Antimetabolites|antimetabolites|mesh-ancestor
110195192|NCT00072345|Immunologic Factors|immunologic factors|mesh-ancestor
110418761|NCT01198548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110418762|NCT01198548|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110418763|NCT01198548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110418764|NCT01198548|Antidotes|antidotes|mesh-ancestor
110418765|NCT01198548|Protective Agents|protective agents|mesh-ancestor
110418766|NCT01198548|Vitamin B Complex|vitamin b complex|mesh-ancestor
110418767|NCT00977938|Aspirin|aspirin|mesh-list
110418768|NCT00977938|Clopidogrel|clopidogrel|mesh-list
110418769|NCT00977938|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
110418770|NCT00977938|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110418771|NCT00977938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110418772|NCT00977938|Analgesics|analgesics|mesh-ancestor
110418773|NCT00977938|Sensory System Agents|sensory system agents|mesh-ancestor
110418774|NCT00977938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110418775|NCT00977938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110418776|NCT00977938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110195329|NCT00206167|Hormones|hormones|mesh-ancestor
110418777|NCT00977938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110418778|NCT00977938|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110418779|NCT00977938|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110418780|NCT00977938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110418781|NCT00977938|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110418782|NCT00977938|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110418783|NCT00977938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110418784|NCT00977938|Antipyretics|antipyretics|mesh-ancestor
110418785|NCT00977938|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110418786|NCT00977938|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110418787|NCT00977938|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110418789|NCT00977938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110418790|NCT00977548|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110418791|NCT00977548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110418792|NCT00977548|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110418793|NCT00977548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110195747|NCT00208117|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110418794|NCT00977548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110418795|NCT04290208|Acetaminophen|acetaminophen|mesh-list
110418796|NCT04290208|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110418797|NCT04290208|Analgesics|analgesics|mesh-ancestor
110418798|NCT04290208|Sensory System Agents|sensory system agents|mesh-ancestor
110418799|NCT04290208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110418800|NCT04290208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110418802|NCT03223597|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
110195965|NCT00209014|Growth Substances|growth substances|mesh-ancestor
110418803|NCT03223597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110418805|NCT01090011|Afatinib|afatinib|mesh-list
110418806|NCT01090011|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110418807|NCT01090011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110418808|NCT01090011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110418809|NCT01090011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110418810|NCT01090011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110418812|NCT02877615|GABA-A Receptor Antagonists|gaba-a receptor antagonists|mesh-ancestor
110418813|NCT02877615|GABA Antagonists|gaba antagonists|mesh-ancestor
110418814|NCT02877615|GABA Agents|gaba agents|mesh-ancestor
110418815|NCT02877615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110418816|NCT02877615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110196333|NCT00041327|Glucocorticoids|glucocorticoids|mesh-ancestor
110418817|NCT02877615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110418818|NCT02437279|Nivolumab|nivolumab|mesh-list
110418819|NCT02437279|Ipilimumab|ipilimumab|mesh-list
110418820|NCT02437279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110196558|NCT00073203|Paroxetine|paroxetine|mesh-list
110418822|NCT02437279|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110196626|NCT00213538|Abortifacient Agents|abortifacient agents|mesh-ancestor
110418823|NCT02437279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110418824|NCT01251653|Gemcitabine|gemcitabine|mesh-list
110418825|NCT01251653|Docetaxel|docetaxel|mesh-list
110418826|NCT01251653|Afatinib|afatinib|mesh-list
110418827|NCT01251653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110418828|NCT01251653|Antimetabolites|antimetabolites|mesh-ancestor
110418829|NCT01251653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110418830|NCT01251653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110418831|NCT01251653|Tubulin Modulators|tubulin modulators|mesh-ancestor
110418832|NCT01251653|Antimitotic Agents|antimitotic agents|mesh-ancestor
110418833|NCT01251653|Mitosis Modulators|mitosis modulators|mesh-ancestor
110418834|NCT01251653|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110418835|NCT01251653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110418836|NCT00910663|Mycophenolic Acid|mycophenolic acid|mesh-list
110418837|NCT00910663|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110418838|NCT00910663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110418839|NCT00910663|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110418840|NCT00910663|Antitubercular Agents|antitubercular agents|mesh-ancestor
110418841|NCT00910663|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110418842|NCT00910663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110418843|NCT00910663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110197118|NCT00412126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110418844|NCT00910663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110418845|NCT01077375|Milnacipran|milnacipran|mesh-list
110418846|NCT01077375|Levomilnacipran|levomilnacipran|mesh-list
110197262|NCT00218218|Nicotine|nicotine|mesh-list
110418847|NCT01077375|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110197416|NCT00219778|Mifepristone|mifepristone|mesh-list
110418848|NCT01077375|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110418849|NCT01077375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110418850|NCT01077375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110418851|NCT01077375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110197555|NCT00412633|Sulfamethazine|sulfamethazine|mesh-list
110418852|NCT01077375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110418853|NCT01077375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110418854|NCT01077375|Analgesics|analgesics|mesh-ancestor
110418855|NCT01077375|Sensory System Agents|sensory system agents|mesh-ancestor
110197629|NCT00221026|Methoxsalen|methoxsalen|mesh-list
110418856|NCT01077375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110418857|NCT01077375|Antidepressive Agents|antidepressive agents|mesh-ancestor
110418859|NCT02877771|Insulin|insulin|mesh-list
110197767|NCT00077688|Paclitaxel|paclitaxel|mesh-list
110418860|NCT02877771|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110418861|NCT02877771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110418862|NCT04306653|Betamethasone|betamethasone|mesh-list
110418863|NCT04306653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110418864|NCT04306653|Glucocorticoids|glucocorticoids|mesh-ancestor
110418865|NCT04306653|Hormones|hormones|mesh-ancestor
110197982|NCT02958046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110418866|NCT04306653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110418867|NCT04306653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110418869|NCT04306653|Respiratory System Agents|respiratory system agents|mesh-ancestor
110418870|NCT04306731|Trimethoprim|trimethoprim|mesh-list
110418871|NCT04306731|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110418872|NCT04306731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110418873|NCT04306731|Antimalarials|antimalarials|mesh-ancestor
110418874|NCT04306731|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110418875|NCT04306731|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110418876|NCT04306731|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110418877|NCT04306731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110065853|NCT01535183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110418878|NCT04306731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110418879|NCT04306731|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110418880|NCT04306731|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
110418881|NCT04306731|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110418882|NCT02877537|Albuterol|albuterol|mesh-list
110418883|NCT02877537|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110418884|NCT02877537|Autonomic Agents|autonomic agents|mesh-ancestor
110418885|NCT02877537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110418886|NCT02877537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110418887|NCT02877537|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110418888|NCT02877537|Respiratory System Agents|respiratory system agents|mesh-ancestor
110418889|NCT02877537|Tocolytic Agents|tocolytic agents|mesh-ancestor
110418890|NCT02877537|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110418891|NCT02877537|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110418892|NCT02877537|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110418893|NCT02877537|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110418894|NCT02877537|Adrenergic Agents|adrenergic agents|mesh-ancestor
110418895|NCT02877537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110418896|NCT02877537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110418897|NCT01250873|Sertraline|sertraline|mesh-list
110418898|NCT01250873|Antidepressive Agents|antidepressive agents|mesh-ancestor
110418899|NCT01250873|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110418900|NCT01250873|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110418901|NCT01250873|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110418902|NCT01250873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110418903|NCT01250873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110198548|NCT00127075|Estradiol|estradiol|mesh-list
110418904|NCT01250873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110418905|NCT01250873|Serotonin Agents|serotonin agents|mesh-ancestor
110418906|NCT01250873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110418907|NCT02888327|Oseltamivir|oseltamivir|mesh-list
110418908|NCT02888327|Digoxin|digoxin|mesh-list
110418909|NCT02888327|Midazolam|midazolam|mesh-list
110418910|NCT02888327|Pitavastatin|pitavastatin|mesh-list
110418911|NCT02888327|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110418912|NCT02888327|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110418913|NCT02888327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110418914|NCT02888327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110418916|NCT02888327|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110418917|NCT02888327|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110418918|NCT02888327|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110418919|NCT02888327|Anesthetics, General|anesthetics, general|mesh-ancestor
110418920|NCT02888327|Anesthetics|anesthetics|mesh-ancestor
110418921|NCT02888327|GABA Modulators|gaba modulators|mesh-ancestor
110418922|NCT02888327|GABA Agents|gaba agents|mesh-ancestor
110418923|NCT02888327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110418924|NCT02888327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110418925|NCT02888327|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110418926|NCT02888327|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110418927|NCT02888327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110418928|NCT02888327|Protective Agents|protective agents|mesh-ancestor
110418929|NCT02888327|Antiviral Agents|antiviral agents|mesh-ancestor
110418930|NCT02888327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110418931|NCT02888327|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110418932|NCT02888327|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110418933|NCT02888327|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110418934|NCT02888327|Antimetabolites|antimetabolites|mesh-ancestor
110418935|NCT02888327|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110418936|NCT01248065|Vitamin D|vitamin d|mesh-list
110418937|NCT01248065|Cholecalciferol|cholecalciferol|mesh-list
110418938|NCT01248065|Ciclesonide|ciclesonide|mesh-list
110418939|NCT01248065|Vitamins|vitamins|mesh-ancestor
110418940|NCT01248065|Micronutrients|micronutrients|mesh-ancestor
110418941|NCT01248065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110418942|NCT01248065|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110418943|NCT01248065|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110418944|NCT01248065|Glucocorticoids|glucocorticoids|mesh-ancestor
110418945|NCT01248065|Hormones|hormones|mesh-ancestor
110418946|NCT01248065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110418947|NCT01248065|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110418948|NCT01250756|Vaccines|vaccines|mesh-list
110418949|NCT01250756|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110418950|NCT01250756|Immunologic Factors|immunologic factors|mesh-ancestor
110418951|NCT01250756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110418952|NCT00977470|Hydroxychloroquine|hydroxychloroquine|mesh-list
110418953|NCT00977470|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110418954|NCT00977470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110418955|NCT00977470|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110065926|NCT01535781|Tranexamic Acid|tranexamic acid|mesh-list
110418956|NCT00977470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110418957|NCT00977470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110418958|NCT00977470|Antimalarials|antimalarials|mesh-ancestor
110418959|NCT00977470|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110418960|NCT00977470|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110418961|NCT00977470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110418962|NCT00977470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110418963|NCT02865304|Endostar protein|endostar protein|mesh-list
110418964|NCT02865304|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110418965|NCT02865304|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110418966|NCT02865304|Growth Substances|growth substances|mesh-ancestor
110418967|NCT02865304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110418968|NCT02865304|Growth Inhibitors|growth inhibitors|mesh-ancestor
110418969|NCT02865304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110418971|NCT04075474|Fluorides|fluorides|mesh-list
110418972|NCT04075474|Sodium Fluoride|sodium fluoride|mesh-list
110418973|NCT04075474|Cariostatic Agents|cariostatic agents|mesh-ancestor
110418974|NCT04075474|Protective Agents|protective agents|mesh-ancestor
110418975|NCT04075474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110418976|NCT04075474|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110418977|NCT04075474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110418978|NCT02866396|Pregabalin|pregabalin|mesh-list
110418979|NCT02866396|Analgesics|analgesics|mesh-ancestor
110418981|NCT02866396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110418982|NCT02866396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110418983|NCT02866396|Anticonvulsants|anticonvulsants|mesh-ancestor
110418984|NCT02866396|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110418985|NCT02866396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110418986|NCT02866396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110418987|NCT02866396|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110418988|NCT02866396|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110418989|NCT02866396|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110418990|NCT02866396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110418991|NCT02866396|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110418992|NCT01087203|Tanezumab|tanezumab|mesh-list
110418993|NCT01087203|Analgesics|analgesics|mesh-ancestor
110418994|NCT01087203|Sensory System Agents|sensory system agents|mesh-ancestor
110418995|NCT01087203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110418996|NCT01087203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110418997|NCT01246583|Tofacitinib|tofacitinib|mesh-list
110418998|NCT01246583|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
110418999|NCT01246583|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110419000|NCT01246583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110419001|NCT01246583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110419002|NCT00626613|Risperidone|risperidone|mesh-list
110419003|NCT00626613|Galantamine|galantamine|mesh-list
110419004|NCT00626613|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110419005|NCT00626613|Serotonin Agents|serotonin agents|mesh-ancestor
110419006|NCT00626613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110419007|NCT00626613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110419008|NCT00626613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110419009|NCT00626613|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110419010|NCT00626613|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110419011|NCT00626613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110419012|NCT00626613|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110419013|NCT00626613|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110419014|NCT00626613|Dopamine Agents|dopamine agents|mesh-ancestor
110419015|NCT00626613|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110419016|NCT00626613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110419017|NCT00626613|Cholinergic Agents|cholinergic agents|mesh-ancestor
110419018|NCT00626613|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110419019|NCT00626613|Autonomic Agents|autonomic agents|mesh-ancestor
110419020|NCT00626613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110419021|NCT00626613|Nootropic Agents|nootropic agents|mesh-ancestor
110419022|NCT01080807|Modafinil|modafinil|mesh-list
110419023|NCT01080807|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110419024|NCT01080807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110419025|NCT01080807|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
110419026|NCT01080807|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110419027|NCT01080807|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110419028|NCT01080807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110419029|NCT01079949|Cetrorelix|cetrorelix|mesh-list
110419030|NCT01079949|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
110419031|NCT01079949|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
110419032|NCT01079949|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110419033|NCT01079949|Fertility Agents|fertility agents|mesh-ancestor
110419034|NCT01079949|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110419035|NCT01079949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110419036|NCT01079949|Hormone Antagonists|hormone antagonists|mesh-ancestor
110419037|NCT01079949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110419038|NCT01079949|Hormones|hormones|mesh-ancestor
110419039|NCT00910429|Riociguat|riociguat|mesh-list
110419040|NCT00910429|Enzyme Activators|enzyme activators|mesh-ancestor
110419041|NCT00910429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110419042|NCT03432949|Dexamethasone|dexamethasone|mesh-list
110419043|NCT03432949|Dexamethasone acetate|dexamethasone acetate|mesh-list
110419045|NCT03432949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110419046|NCT03432949|Antiemetics|antiemetics|mesh-ancestor
110419047|NCT03432949|Autonomic Agents|autonomic agents|mesh-ancestor
110419048|NCT03432949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110419049|NCT03432949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110419050|NCT03432949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110419051|NCT03432949|Glucocorticoids|glucocorticoids|mesh-ancestor
110419052|NCT03432949|Hormones|hormones|mesh-ancestor
110419053|NCT03432949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110419054|NCT03432949|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110419055|NCT03432949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110419056|NCT03432949|Protease Inhibitors|protease inhibitors|mesh-ancestor
110419057|NCT03432949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110419058|NCT03432949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110419059|NCT00909727|Ivacaftor|ivacaftor|mesh-list
110419060|NCT00909727|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
110419061|NCT00909727|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110419062|NCT00909727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110419063|NCT00977080|Cinacalcet|cinacalcet|mesh-list
110419064|NCT00977080|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110419065|NCT00977080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110419066|NCT00977080|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
110419067|NCT00977080|Hormone Antagonists|hormone antagonists|mesh-ancestor
110419068|NCT00977080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110419069|NCT04289194|Hydrogen Peroxide|hydrogen peroxide|mesh-list
110419070|NCT04289194|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110419071|NCT04289194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110419072|NCT04083157|Imiquimod|imiquimod|mesh-list
110419073|NCT04083157|Vaccines|vaccines|mesh-list
110419074|NCT04083157|Immunologic Factors|immunologic factors|mesh-ancestor
110419075|NCT04083157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110419076|NCT04083157|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110419077|NCT04083157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110419078|NCT04083157|Interferon Inducers|interferon inducers|mesh-ancestor
110419079|NCT00975286|Metformin|metformin|mesh-list
110419080|NCT00975286|Insulin Glargine|insulin glargine|mesh-list
110419081|NCT00975286|Lixisenatide|lixisenatide|mesh-list
110419082|NCT00975286|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
110419083|NCT00975286|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110419084|NCT00975286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110419085|NCT00907777|Vaccines|vaccines|mesh-list
110419086|NCT00907777|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110419087|NCT00907777|Immunologic Factors|immunologic factors|mesh-ancestor
110419088|NCT00907777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110419089|NCT03741517|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110419090|NCT03741517|Edotreotide|edotreotide|mesh-list
110419091|NCT03741517|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110419092|NCT03741517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110419093|NCT02864758|Vitamin K|vitamin k|mesh-list
110419094|NCT02864758|Rivaroxaban|rivaroxaban|mesh-list
110419095|NCT02864758|Dabigatran|dabigatran|mesh-list
110419096|NCT02864758|Vitamins|vitamins|mesh-ancestor
110419097|NCT02864758|Micronutrients|micronutrients|mesh-ancestor
110419098|NCT02864758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110419099|NCT02864758|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110419100|NCT02864758|Antithrombins|antithrombins|mesh-ancestor
110419101|NCT02864758|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110419102|NCT02864758|Protease Inhibitors|protease inhibitors|mesh-ancestor
110419103|NCT02864758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110419104|NCT02864758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110419105|NCT02864758|Anticoagulants|anticoagulants|mesh-ancestor
110419106|NCT02864758|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110198988|NCT00074841|Azithromycin|azithromycin|mesh-list
110419107|NCT02864758|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110419108|NCT02864758|Hemostatics|hemostatics|mesh-ancestor
110419109|NCT02864758|Coagulants|coagulants|mesh-ancestor
110419110|NCT00908011|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110419111|NCT00908011|Ezetimibe|ezetimibe|mesh-list
110419112|NCT00908011|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110419113|NCT00908011|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110419114|NCT00908011|Antimetabolites|antimetabolites|mesh-ancestor
110419115|NCT00908011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110419116|NCT00908011|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110419117|NCT00908011|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110419118|NCT00908011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110419119|NCT00976456|Bevacizumab|bevacizumab|mesh-list
110419120|NCT00976456|Carboplatin|carboplatin|mesh-list
110419121|NCT00976456|Pemetrexed|pemetrexed|mesh-list
110419122|NCT00976456|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110419123|NCT00976456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110419124|NCT00976456|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110419125|NCT00976456|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110419126|NCT00976456|Growth Substances|growth substances|mesh-ancestor
110419127|NCT00976456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110419128|NCT00976456|Growth Inhibitors|growth inhibitors|mesh-ancestor
110419129|NCT00976456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110419130|NCT00976456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110419131|NCT00976456|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110419132|NCT00976456|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110419133|NCT01243151|Bococizumab|bococizumab|mesh-list
110419134|NCT01243151|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110419135|NCT01243151|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110419136|NCT01243151|Antimetabolites|antimetabolites|mesh-ancestor
110419137|NCT01243151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110419138|NCT01243151|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110419139|NCT00629512|Esomeprazole|esomeprazole|mesh-list
110419140|NCT00629512|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110419141|NCT00629512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110419142|NCT00629512|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110419143|NCT00629512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110419144|NCT00629512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110419145|NCT01711021|Amphetamine|amphetamine|mesh-list
110419146|NCT01711021|Dextroamphetamine|dextroamphetamine|mesh-list
110419147|NCT01711021|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110419148|NCT01711021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110419149|NCT01711021|Sympathomimetics|sympathomimetics|mesh-ancestor
110419150|NCT01711021|Autonomic Agents|autonomic agents|mesh-ancestor
110419151|NCT01711021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110419152|NCT01711021|Dopamine Agents|dopamine agents|mesh-ancestor
110419153|NCT01711021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110419154|NCT01711021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110419155|NCT01711021|Adrenergic Agents|adrenergic agents|mesh-ancestor
110419156|NCT01711021|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110419157|NCT01711021|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110419158|NCT01711021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110419159|NCT01711021|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110419160|NCT05517265|Acalabrutinib|acalabrutinib|mesh-list
110419161|NCT05517265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110419162|NCT02864602|Dexamethasone|dexamethasone|mesh-list
110419164|NCT02864602|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
110419165|NCT02864602|BB 1101|bb 1101|mesh-list
110419166|NCT02864602|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110419167|NCT02864602|Antiemetics|antiemetics|mesh-ancestor
110419168|NCT02864602|Autonomic Agents|autonomic agents|mesh-ancestor
110419169|NCT02864602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110419170|NCT02864602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110419171|NCT02864602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110419172|NCT02864602|Glucocorticoids|glucocorticoids|mesh-ancestor
110419173|NCT02864602|Hormones|hormones|mesh-ancestor
110419174|NCT02864602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110419175|NCT02864602|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110419176|NCT02864602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110419177|NCT02864602|Protease Inhibitors|protease inhibitors|mesh-ancestor
110419178|NCT02864602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110419179|NCT02864602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110419180|NCT00993148|Ritonavir|ritonavir|mesh-list
110419181|NCT00993148|Darunavir|darunavir|mesh-list
110419182|NCT00993148|Maraviroc|maraviroc|mesh-list
110419183|NCT00993148|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110419184|NCT00993148|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110419185|NCT00993148|Protease Inhibitors|protease inhibitors|mesh-ancestor
110419187|NCT00993148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110419188|NCT00993148|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110419189|NCT00993148|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110419190|NCT00993148|Antiviral Agents|antiviral agents|mesh-ancestor
110419191|NCT00993148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110419192|NCT00993148|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110419193|NCT00993148|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110419194|NCT00993148|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110419195|NCT00993148|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110419196|NCT00993148|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
110419197|NCT03401047|Estradiol|estradiol|mesh-list
110419198|NCT03401047|Estrogens|estrogens|mesh-ancestor
110419199|NCT03401047|Hormones|hormones|mesh-ancestor
110419200|NCT03401047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110419201|NCT03401047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110419202|NCT03384589|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110419203|NCT03384589|Immunologic Factors|immunologic factors|mesh-ancestor
110419204|NCT03384589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110419205|NCT03531073|Methotrexate|methotrexate|mesh-list
110419206|NCT03531073|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110419207|NCT03531073|Abortifacient Agents|abortifacient agents|mesh-ancestor
110419208|NCT03531073|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110419209|NCT03531073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110419210|NCT03531073|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110419211|NCT03531073|Antimetabolites|antimetabolites|mesh-ancestor
110419212|NCT03531073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110419213|NCT03531073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110419214|NCT03531073|Dermatologic Agents|dermatologic agents|mesh-ancestor
110419215|NCT03531073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110419216|NCT03531073|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110419217|NCT03531073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110419218|NCT03531073|Immunologic Factors|immunologic factors|mesh-ancestor
110419219|NCT03531073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110419220|NCT03531073|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110419221|NCT00907153|Vitamin D|vitamin d|mesh-list
110419222|NCT00907153|Vitamins|vitamins|mesh-ancestor
110419223|NCT00907153|Micronutrients|micronutrients|mesh-ancestor
110419224|NCT00907153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110419225|NCT00907153|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110419226|NCT00904033|Calcitriol|calcitriol|mesh-list
110419227|NCT00904033|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110419228|NCT00904033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110419229|NCT00904033|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
110419230|NCT00904033|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110419231|NCT00904033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110419232|NCT00904033|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110419233|NCT00904033|Vitamins|vitamins|mesh-ancestor
110419234|NCT00904033|Micronutrients|micronutrients|mesh-ancestor
110419235|NCT00904033|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110419236|NCT05175625|Myeloma Proteins|myeloma proteins|mesh-list
110419237|NCT05175625|Paraproteins|paraproteins|mesh-list
110419238|NCT05175625|Immunologic Factors|immunologic factors|mesh-ancestor
110419239|NCT05175625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110419240|NCT02555839|Thalidomide|thalidomide|mesh-list
110419241|NCT02555839|Dexamethasone|dexamethasone|mesh-list
110419242|NCT02555839|Dexamethasone acetate|dexamethasone acetate|mesh-list
110419243|NCT02555839|Bortezomib|bortezomib|mesh-list
110419244|NCT02555839|Pomalidomide|pomalidomide|mesh-list
110419245|NCT02555839|BB 1101|bb 1101|mesh-list
110419246|NCT02555839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110419247|NCT02555839|Antiemetics|antiemetics|mesh-ancestor
110419248|NCT02555839|Autonomic Agents|autonomic agents|mesh-ancestor
110419249|NCT02555839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110419250|NCT02555839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110419251|NCT02555839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110419252|NCT02555839|Glucocorticoids|glucocorticoids|mesh-ancestor
110419253|NCT02555839|Hormones|hormones|mesh-ancestor
110419254|NCT02555839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110419255|NCT02555839|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110419256|NCT02555839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110419257|NCT02555839|Protease Inhibitors|protease inhibitors|mesh-ancestor
110419258|NCT02555839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110419259|NCT02555839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110419261|NCT02555839|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110419262|NCT02555839|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110419263|NCT02555839|Growth Substances|growth substances|mesh-ancestor
110419264|NCT02555839|Growth Inhibitors|growth inhibitors|mesh-ancestor
110419265|NCT02555839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110419266|NCT02555839|Leprostatic Agents|leprostatic agents|mesh-ancestor
110419267|NCT02555839|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110419268|NCT02555839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110419269|NCT01241591|Etanercept|etanercept|mesh-list
110419270|NCT01241591|Tofacitinib|tofacitinib|mesh-list
110419271|NCT01241591|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110419272|NCT01241591|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110419273|NCT01241591|Analgesics|analgesics|mesh-ancestor
110419274|NCT01241591|Sensory System Agents|sensory system agents|mesh-ancestor
110419275|NCT01241591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110419276|NCT01241591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110419277|NCT01241591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110419278|NCT01241591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110419279|NCT01241591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110419280|NCT01241591|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110419281|NCT01241591|Immunologic Factors|immunologic factors|mesh-ancestor
110419282|NCT01241591|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
110419283|NCT01241591|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110419284|NCT01241591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110419285|NCT01241591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110419286|NCT04319705|Azithromycin|azithromycin|mesh-list
110419287|NCT04319705|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110419288|NCT04319705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110419289|NCT00906373|Sorafenib|sorafenib|mesh-list
110419290|NCT00906373|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110419291|NCT00906373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110419292|NCT00906373|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110419293|NCT00906373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110419294|NCT00906373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110419295|NCT00906373|Immunologic Factors|immunologic factors|mesh-ancestor
110419296|NCT00906373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110419297|NCT02850445|Olanzapine|olanzapine|mesh-list
110419298|NCT02850445|Antiemetics|antiemetics|mesh-ancestor
110419299|NCT02850445|Autonomic Agents|autonomic agents|mesh-ancestor
110419300|NCT02850445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110419301|NCT02850445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110419302|NCT02850445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110419303|NCT02850445|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110419304|NCT02850445|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110419305|NCT02850445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110419306|NCT02850445|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110419307|NCT02850445|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110419308|NCT02850445|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110419309|NCT02850445|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110419310|NCT02850445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110419311|NCT02850445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110419313|NCT04220203|Capecitabine|capecitabine|mesh-list
110419314|NCT04220203|Trastuzumab|trastuzumab|mesh-list
110419315|NCT04220203|Tucatinib|tucatinib|mesh-list
110419316|NCT04220203|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110419317|NCT04220203|Antimetabolites|antimetabolites|mesh-ancestor
110419318|NCT04220203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110419319|NCT04220203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110419320|NCT04220203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110419321|NCT04220203|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110419322|NCT04220203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110419323|NCT02850211|Ibuprofen|ibuprofen|mesh-list
110419324|NCT02850211|Celecoxib|celecoxib|mesh-list
110419325|NCT02850211|Tramadol|tramadol|mesh-list
110419326|NCT02850211|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110419327|NCT02850211|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110419328|NCT02850211|Analgesics|analgesics|mesh-ancestor
110419329|NCT02850211|Sensory System Agents|sensory system agents|mesh-ancestor
110419330|NCT02850211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110419331|NCT02850211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110419332|NCT02850211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110419333|NCT02850211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110419334|NCT02850211|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110419335|NCT02850211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110419336|NCT02850211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110419337|NCT02850211|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110419338|NCT02850211|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110419339|NCT02850211|Narcotics|narcotics|mesh-ancestor
110419340|NCT02850211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110419341|NCT02850289|Interferons|interferons|mesh-list
110419342|NCT02850289|Ribavirin|ribavirin|mesh-list
110419343|NCT02850289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110419344|NCT02850289|Antiviral Agents|antiviral agents|mesh-ancestor
110419345|NCT02850289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110419346|NCT02850289|Antimetabolites|antimetabolites|mesh-ancestor
110419347|NCT02850289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110419348|NCT05331781|Morphine|morphine|mesh-list
110419349|NCT05331781|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110419350|NCT05331781|Narcotics|narcotics|mesh-ancestor
110419351|NCT05331781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110419352|NCT05331781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110419353|NCT05331781|Analgesics|analgesics|mesh-ancestor
110419354|NCT05331781|Sensory System Agents|sensory system agents|mesh-ancestor
110419355|NCT05331781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110419356|NCT04202887|Fentanyl|fentanyl|mesh-list
110419357|NCT04202887|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110419358|NCT04202887|Narcotics|narcotics|mesh-ancestor
110419359|NCT04202887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110419360|NCT04202887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110419361|NCT04202887|Analgesics|analgesics|mesh-ancestor
110419362|NCT04202887|Sensory System Agents|sensory system agents|mesh-ancestor
110419363|NCT04202887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110419364|NCT04202887|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110419365|NCT04202887|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110419366|NCT04202887|Anesthetics, General|anesthetics, general|mesh-ancestor
110419367|NCT04202887|Anesthetics|anesthetics|mesh-ancestor
110419368|NCT05324215|Fentanyl|fentanyl|mesh-list
110419369|NCT05324215|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110419370|NCT05324215|Narcotics|narcotics|mesh-ancestor
110419371|NCT05324215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110419372|NCT05324215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110419373|NCT05324215|Analgesics|analgesics|mesh-ancestor
110419374|NCT05324215|Sensory System Agents|sensory system agents|mesh-ancestor
110419375|NCT05324215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110419376|NCT05324215|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110419377|NCT05324215|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110419378|NCT05324215|Anesthetics, General|anesthetics, general|mesh-ancestor
110419379|NCT05324215|Anesthetics|anesthetics|mesh-ancestor
110419380|NCT00905437|Pregabalin|pregabalin|mesh-list
110419381|NCT00905437|Analgesics|analgesics|mesh-ancestor
110419382|NCT00905437|Sensory System Agents|sensory system agents|mesh-ancestor
110419383|NCT00905437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110419384|NCT00905437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110419385|NCT00905437|Anticonvulsants|anticonvulsants|mesh-ancestor
110419386|NCT00905437|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110419387|NCT00905437|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110419388|NCT00905437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110419389|NCT00905437|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110419390|NCT00905437|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110419391|NCT00905437|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110419392|NCT00905437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110419393|NCT00905437|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110419394|NCT05007691|Salicylic Acid|salicylic acid|mesh-list
110419395|NCT05007691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110419396|NCT05007691|Antifungal Agents|antifungal agents|mesh-ancestor
110419397|NCT05007691|Keratolytic Agents|keratolytic agents|mesh-ancestor
110419398|NCT05007691|Dermatologic Agents|dermatologic agents|mesh-ancestor
110419399|NCT01238861|Benralizumab|benralizumab|mesh-list
110419400|NCT01238861|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110419401|NCT01238861|Respiratory System Agents|respiratory system agents|mesh-ancestor
110419403|NCT02888561|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110419404|NCT02888561|Sympathomimetics|sympathomimetics|mesh-ancestor
110419405|NCT02888561|Autonomic Agents|autonomic agents|mesh-ancestor
110419406|NCT02888561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110419407|NCT02888561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110419408|NCT02888561|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
110419409|NCT02888561|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110419410|NCT02888561|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110419411|NCT02888561|Adrenergic Agents|adrenergic agents|mesh-ancestor
110419412|NCT02888561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110419413|NCT02888561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110419414|NCT02888561|Protective Agents|protective agents|mesh-ancestor
110419415|NCT04319549|Sodium Hypochlorite|sodium hypochlorite|mesh-list
110419417|NCT04319549|Ketorolac|ketorolac|mesh-list
110419418|NCT04319549|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
110419419|NCT04319549|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110419420|NCT04319549|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110419421|NCT04319549|Analgesics|analgesics|mesh-ancestor
110419422|NCT04319549|Sensory System Agents|sensory system agents|mesh-ancestor
110419423|NCT04319549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110419424|NCT04319549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110419425|NCT04319549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110419426|NCT04319549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110419427|NCT04319549|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110419428|NCT04319549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110419429|NCT04319549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110419430|NCT04319549|Disinfectants|disinfectants|mesh-ancestor
110419431|NCT04319549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110419432|NCT00903409|Simvastatin|simvastatin|mesh-list
110419433|NCT00903409|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110419434|NCT00903409|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110419435|NCT00903409|Antimetabolites|antimetabolites|mesh-ancestor
110419436|NCT00903409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110419437|NCT00903409|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110419438|NCT00903409|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110419439|NCT00903409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110419440|NCT01237223|Amlodipine|amlodipine|mesh-list
110419441|NCT01237223|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110419442|NCT01237223|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110419443|NCT01237223|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110419444|NCT01237223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110419445|NCT01237223|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110419446|NCT01237223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110419447|NCT01237223|Vasodilator Agents|vasodilator agents|mesh-ancestor
110419448|NCT01236365|Atorvastatin|atorvastatin|mesh-list
110199155|NCT04162210|Growth Substances|growth substances|mesh-ancestor
110419449|NCT01236365|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110419451|NCT01236365|Antimetabolites|antimetabolites|mesh-ancestor
110419452|NCT01236365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110419453|NCT01236365|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110419454|NCT01236365|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110419455|NCT01236365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110419456|NCT00903331|Macitentan|macitentan|mesh-list
110419457|NCT00903331|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
110419458|NCT00903331|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
110419459|NCT00903331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110419460|NCT00903331|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
110419461|NCT01235741|Pramlintide|pramlintide|mesh-list
110419462|NCT01235741|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110419463|NCT01235741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110419464|NCT02849353|Immunomodulating Agents|immunomodulating agents|mesh-list
110419465|NCT02849353|Immunologic Factors|immunologic factors|mesh-ancestor
110419466|NCT02849353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110419467|NCT01235507|Methotrexate|methotrexate|mesh-list
110419468|NCT01235507|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110419469|NCT01235507|Abortifacient Agents|abortifacient agents|mesh-ancestor
110419470|NCT01235507|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110419471|NCT01235507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110419472|NCT01235507|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110419473|NCT01235507|Antimetabolites|antimetabolites|mesh-ancestor
110419474|NCT01235507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110419475|NCT01235507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110419476|NCT01235507|Dermatologic Agents|dermatologic agents|mesh-ancestor
110419477|NCT01235507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110419478|NCT01235507|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110419479|NCT01235507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110419480|NCT01235507|Immunologic Factors|immunologic factors|mesh-ancestor
110419481|NCT01235507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110419482|NCT01235507|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110419483|NCT01868269|Dexamethasone|dexamethasone|mesh-list
110419484|NCT01868269|Dexamethasone acetate|dexamethasone acetate|mesh-list
110419485|NCT01868269|Cyclophosphamide|cyclophosphamide|mesh-list
110419486|NCT01868269|Rituximab|rituximab|mesh-list
110419487|NCT01868269|BB 1101|bb 1101|mesh-list
110419488|NCT01868269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110419489|NCT01868269|Immunologic Factors|immunologic factors|mesh-ancestor
110419490|NCT01868269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110419491|NCT01868269|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110419492|NCT01868269|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110419493|NCT01868269|Alkylating Agents|alkylating agents|mesh-ancestor
110419494|NCT01868269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110419495|NCT01868269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110419496|NCT01868269|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110419497|NCT01868269|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110419498|NCT01868269|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110419499|NCT01868269|Antiemetics|antiemetics|mesh-ancestor
110419500|NCT01868269|Autonomic Agents|autonomic agents|mesh-ancestor
110419501|NCT01868269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110419502|NCT01868269|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110419503|NCT01868269|Glucocorticoids|glucocorticoids|mesh-ancestor
110419504|NCT01868269|Hormones|hormones|mesh-ancestor
110419505|NCT01868269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110419506|NCT01868269|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110419507|NCT01868269|Protease Inhibitors|protease inhibitors|mesh-ancestor
110419508|NCT01868269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110419509|NCT01235351|Clopidogrel|clopidogrel|mesh-list
110419510|NCT01235351|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110419511|NCT01235351|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110419512|NCT01235351|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110419513|NCT01235351|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110419514|NCT01235351|Purinergic Agents|purinergic agents|mesh-ancestor
110419515|NCT01235351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110419516|NCT01235351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110419517|NCT01235351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110419518|NCT01234883|Plasma-lyte 148|plasma-lyte 148|mesh-list
110419519|NCT01234883|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110419520|NCT01234883|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110419521|NCT01234649|Metformin|metformin|mesh-list
110419522|NCT01234649|Liraglutide|liraglutide|mesh-list
110419523|NCT01234649|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110419524|NCT01234649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110419525|NCT01234649|Incretins|incretins|mesh-ancestor
110419526|NCT01234649|Hormones|hormones|mesh-ancestor
110419527|NCT01234649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110419528|NCT02876679|Cyclosporine|cyclosporine|mesh-list
110419529|NCT02876679|Mycophenolic Acid|mycophenolic acid|mesh-list
110419530|NCT02876679|Cyclophosphamide|cyclophosphamide|mesh-list
110419531|NCT02876679|Cyclosporins|cyclosporins|mesh-list
110419532|NCT02876679|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110419533|NCT02876679|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110419534|NCT02876679|Immunologic Factors|immunologic factors|mesh-ancestor
110419535|NCT02876679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110419536|NCT02876679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110419537|NCT02876679|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110419538|NCT02876679|Alkylating Agents|alkylating agents|mesh-ancestor
110419539|NCT02876679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110419540|NCT02876679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110419541|NCT02876679|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110419542|NCT02876679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110419543|NCT02876679|Antifungal Agents|antifungal agents|mesh-ancestor
110419544|NCT02876679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110419545|NCT02876679|Dermatologic Agents|dermatologic agents|mesh-ancestor
110419546|NCT02876679|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110419547|NCT02876679|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110419548|NCT02876679|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110419549|NCT02876679|Antitubercular Agents|antitubercular agents|mesh-ancestor
110419550|NCT02876679|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110419552|NCT01075815|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
110419553|NCT01075815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110419554|NCT01075815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110419555|NCT01072149|Fluticasone|fluticasone|mesh-list
110419556|NCT01072149|Xhance|xhance|mesh-list
110419557|NCT01072149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110419558|NCT01072149|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110419559|NCT01072149|Autonomic Agents|autonomic agents|mesh-ancestor
110419560|NCT01072149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110419561|NCT01072149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110419562|NCT01072149|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110419563|NCT01072149|Respiratory System Agents|respiratory system agents|mesh-ancestor
110419564|NCT01072149|Dermatologic Agents|dermatologic agents|mesh-ancestor
110419565|NCT01072149|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110419566|NCT04413253|Dexamethasone|dexamethasone|mesh-list
110419567|NCT04413253|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110419568|NCT04413253|Lifitegrast|lifitegrast|mesh-list
110419569|NCT04413253|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110419570|NCT04413253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110419571|NCT04413253|Antiemetics|antiemetics|mesh-ancestor
110419572|NCT04413253|Autonomic Agents|autonomic agents|mesh-ancestor
110419573|NCT04413253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110419574|NCT04413253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110419575|NCT04413253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110419576|NCT04413253|Glucocorticoids|glucocorticoids|mesh-ancestor
110419577|NCT04413253|Hormones|hormones|mesh-ancestor
110419578|NCT04413253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110419579|NCT04413253|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110419580|NCT04413253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110419581|NCT01679119|Prednisolone|prednisolone|mesh-list
110419582|NCT01679119|Cyclophosphamide|cyclophosphamide|mesh-list
110419583|NCT01679119|Rituximab|rituximab|mesh-list
110419584|NCT01679119|Gemcitabine|gemcitabine|mesh-list
110419585|NCT01679119|Vincristine|vincristine|mesh-list
110419586|NCT01679119|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
110419587|NCT01679119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110419588|NCT01679119|Immunologic Factors|immunologic factors|mesh-ancestor
110419589|NCT01679119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110419590|NCT01679119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110419591|NCT01679119|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110419592|NCT01679119|Alkylating Agents|alkylating agents|mesh-ancestor
110369335|NCT04611243|Vaccines|vaccines|mesh-list
110419593|NCT01679119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110419594|NCT01679119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110419595|NCT01679119|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110419596|NCT01679119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110419597|NCT01679119|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110419598|NCT01679119|Antimetabolites|antimetabolites|mesh-ancestor
110419599|NCT01679119|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110419600|NCT01679119|Tubulin Modulators|tubulin modulators|mesh-ancestor
110419601|NCT01679119|Antimitotic Agents|antimitotic agents|mesh-ancestor
110419602|NCT01679119|Mitosis Modulators|mitosis modulators|mesh-ancestor
110419603|NCT01679119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110419604|NCT01679119|Glucocorticoids|glucocorticoids|mesh-ancestor
110419605|NCT01679119|Hormones|hormones|mesh-ancestor
110419606|NCT01679119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110419607|NCT01679119|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110419608|NCT01679119|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110419609|NCT01679119|Immunotoxins|immunotoxins|mesh-ancestor
110419610|NCT01679119|Immunoconjugates|immunoconjugates|mesh-ancestor
110419612|NCT04778787|Digoxin|digoxin|mesh-list
110419613|NCT04778787|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
110419614|NCT04778787|Vasodilator Agents|vasodilator agents|mesh-list
110419615|NCT04778787|Diuretics|diuretics|mesh-list
110419616|NCT04778787|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
110419617|NCT04778787|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110564299|NCT05862753|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110419618|NCT04778787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110419619|NCT04778787|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110419620|NCT04778787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110419621|NCT04778787|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110419622|NCT04778787|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110419623|NCT04778787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110419624|NCT04778787|Protective Agents|protective agents|mesh-ancestor
110419625|NCT04778787|Natriuretic Agents|natriuretic agents|mesh-ancestor
110419626|NCT04778787|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110419627|NCT04304157|Dexmedetomidine|dexmedetomidine|mesh-list
110419628|NCT04304157|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110419629|NCT04304157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110419630|NCT04304157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110419631|NCT04304157|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110419632|NCT04304157|Analgesics|analgesics|mesh-ancestor
110419633|NCT04304157|Sensory System Agents|sensory system agents|mesh-ancestor
110066617|NCT01539473|Tedizolid|tedizolid|mesh-list
110419634|NCT04304157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110369362|NCT04630548|Copper|copper|mesh-list
110419635|NCT04304157|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110419636|NCT04304157|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110419637|NCT04304157|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110419638|NCT04304157|Adrenergic Agents|adrenergic agents|mesh-ancestor
110419639|NCT04304157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110419640|NCT04304157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110419642|NCT04937413|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
110419643|NCT04937413|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110419644|NCT04937413|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110419645|NCT04937413|Antimetabolites|antimetabolites|mesh-ancestor
110419646|NCT04937413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110419647|NCT04937413|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110419648|NCT04937413|Protease Inhibitors|protease inhibitors|mesh-ancestor
110419649|NCT04937413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110419650|NCT04937413|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110419651|NCT02875587|Cabergoline|cabergoline|mesh-list
110419652|NCT02875587|Calcium|calcium|mesh-list
110419653|NCT02875587|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110419654|NCT02875587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110419655|NCT02875587|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110419656|NCT02875587|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110419657|NCT02875587|Dopamine Agonists|dopamine agonists|mesh-ancestor
110419658|NCT02875587|Dopamine Agents|dopamine agents|mesh-ancestor
110419659|NCT02875587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110419660|NCT02875587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110419661|NCT01070979|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110419662|NCT01070979|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110419663|NCT01070979|Estradiol|estradiol|mesh-list
110419664|NCT01070979|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110419665|NCT01070979|Estrogens|estrogens|mesh-list
110419666|NCT01070979|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
110419667|NCT01070979|Hormones|hormones|mesh-ancestor
110419668|NCT01070979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110419669|NCT01070979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110419670|NCT01070979|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110419671|NCT01070979|Contraceptive Agents|contraceptive agents|mesh-ancestor
110419672|NCT01070979|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110419673|NCT01070979|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110419674|NCT01234337|Capecitabine|capecitabine|mesh-list
110419675|NCT01234337|Sorafenib|sorafenib|mesh-list
110419676|NCT01234337|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110419677|NCT01234337|Antimetabolites|antimetabolites|mesh-ancestor
110419678|NCT01234337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110419679|NCT01234337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110419680|NCT01234337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110419681|NCT01234337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110419682|NCT02848963|Ketamine|ketamine|mesh-list
110419684|NCT02848963|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110419685|NCT02848963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110419686|NCT02848963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110419687|NCT02848963|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110419688|NCT02848963|Anesthetics, General|anesthetics, general|mesh-ancestor
110419689|NCT02848963|Anesthetics|anesthetics|mesh-ancestor
110419690|NCT02848963|Analgesics|analgesics|mesh-ancestor
110419691|NCT02848963|Sensory System Agents|sensory system agents|mesh-ancestor
110419692|NCT02848963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110419693|NCT02848963|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110369385|NCT01165138|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110419694|NCT02848963|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110419695|NCT02848963|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110419696|NCT02848963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110419697|NCT02848963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110419698|NCT01070043|Amlodipine|amlodipine|mesh-list
110419699|NCT01070043|Valsartan|valsartan|mesh-list
110419700|NCT01070043|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110419701|NCT01070043|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110419702|NCT01070043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110419703|NCT01070043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110419704|NCT01070043|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110419705|NCT01070043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110419706|NCT01070043|Vasodilator Agents|vasodilator agents|mesh-ancestor
110419707|NCT01070043|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110419708|NCT01070043|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110419709|NCT01074255|Aprepitant|aprepitant|mesh-list
110419710|NCT01074255|Antiemetics|antiemetics|mesh-ancestor
110419711|NCT01074255|Autonomic Agents|autonomic agents|mesh-ancestor
110419712|NCT01074255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110419713|NCT01074255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110419715|NCT01074255|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110419716|NCT01074255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110419717|NCT01074255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110419718|NCT02962063|Paclitaxel|paclitaxel|mesh-list
110419719|NCT02962063|Carboplatin|carboplatin|mesh-list
110419720|NCT02962063|Durvalumab|durvalumab|mesh-list
110419721|NCT02962063|Tremelimumab|tremelimumab|mesh-list
110419722|NCT02962063|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110419723|NCT02962063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110419724|NCT02962063|Tubulin Modulators|tubulin modulators|mesh-ancestor
110419725|NCT02962063|Antimitotic Agents|antimitotic agents|mesh-ancestor
110419726|NCT02962063|Mitosis Modulators|mitosis modulators|mesh-ancestor
110419727|NCT02962063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110419728|NCT02962063|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110419729|NCT01073943|Bisacodyl|bisacodyl|mesh-list
110419730|NCT01073943|Picosulfate sodium|picosulfate sodium|mesh-list
110419731|NCT01073943|Cathartics|cathartics|mesh-ancestor
110419732|NCT01073943|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110419733|NCT01073943|Laxatives|laxatives|mesh-ancestor
110419734|NCT01073865|Goserelin|goserelin|mesh-list
110419735|NCT01073865|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110419736|NCT01073865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110419737|NCT04862065|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
110419739|NCT04862065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110419740|NCT01064635|Letrozole|letrozole|mesh-list
110419741|NCT01064635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110419742|NCT01064635|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110419743|NCT01064635|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110419744|NCT01064635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110419745|NCT01064635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110419746|NCT01064635|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110419747|NCT01064635|Hormone Antagonists|hormone antagonists|mesh-ancestor
110419748|NCT01064635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110419749|NCT01064635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110419750|NCT04697485|Eplerenone|eplerenone|mesh-list
110419751|NCT04697485|Bumetanide|bumetanide|mesh-list
110419752|NCT04697485|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110419753|NCT04697485|Hormone Antagonists|hormone antagonists|mesh-ancestor
110419754|NCT04697485|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110419755|NCT04697485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110419756|NCT04697485|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110419757|NCT04697485|Diuretics|diuretics|mesh-ancestor
110419758|NCT04697485|Natriuretic Agents|natriuretic agents|mesh-ancestor
110419759|NCT04697485|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110419760|NCT04697485|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110419761|NCT04697485|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110419762|NCT04697485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110419763|NCT01073631|Voriconazole|voriconazole|mesh-list
110419764|NCT01073631|Antifungal Agents|antifungal agents|mesh-ancestor
110419765|NCT01073631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110419766|NCT01073631|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110419767|NCT01073631|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110419768|NCT01073631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110419769|NCT01073631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110419770|NCT01073631|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110419771|NCT01073631|Hormone Antagonists|hormone antagonists|mesh-ancestor
110419772|NCT01073631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110419773|NCT01073631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110419774|NCT01073631|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110419775|NCT00626769|Genistein|genistein|mesh-list
110419776|NCT00626769|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110419777|NCT00626769|Protective Agents|protective agents|mesh-ancestor
110419778|NCT00626769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110419779|NCT00626769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110419780|NCT00626769|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110419781|NCT00626769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110419782|NCT00626769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110419783|NCT00626769|Phytoestrogens|phytoestrogens|mesh-ancestor
110419784|NCT00626769|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
110199340|NCT00045539|Calcium|calcium|mesh-list
110419785|NCT00626769|Estrogens|estrogens|mesh-ancestor
110419786|NCT00626769|Hormones|hormones|mesh-ancestor
110419787|NCT00626769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110419788|NCT02875743|Posaconazole|posaconazole|mesh-list
110419789|NCT02875743|Antifungal Agents|antifungal agents|mesh-ancestor
110419790|NCT02875743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110419791|NCT02875743|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
110419792|NCT02875743|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110419793|NCT02875743|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110419794|NCT02875743|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110419795|NCT02875743|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110419796|NCT02875743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110419797|NCT02875743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110419798|NCT02875743|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110419799|NCT02875743|Hormone Antagonists|hormone antagonists|mesh-ancestor
110419800|NCT02875743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110419801|NCT02875743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110419802|NCT01073163|Rituximab|rituximab|mesh-list
110419803|NCT01073163|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110419804|NCT01073163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110419805|NCT01073163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110419806|NCT01073163|Immunologic Factors|immunologic factors|mesh-ancestor
110419807|NCT01073163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110419808|NCT01073163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110419809|NCT01073163|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110419810|NCT01073163|Alkylating Agents|alkylating agents|mesh-ancestor
110419811|NCT01073163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110419812|NCT02875821|Metformin|metformin|mesh-list
110419813|NCT02875821|Pioglitazone|pioglitazone|mesh-list
110419814|NCT02875821|Ipragliflozin|ipragliflozin|mesh-list
110419815|NCT02875821|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110419816|NCT02875821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110419817|NCT02875821|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110419818|NCT02875821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110419819|NCT04304313|Sildenafil Citrate|sildenafil citrate|mesh-list
110419820|NCT04304313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110419821|NCT04304313|Vasodilator Agents|vasodilator agents|mesh-ancestor
110419822|NCT04304313|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110419823|NCT04304313|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110419824|NCT04304313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110419825|NCT04304313|Urological Agents|urological agents|mesh-ancestor
110419826|NCT01072929|Modafinil|modafinil|mesh-list
110419827|NCT01072929|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110419828|NCT01072929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110419829|NCT01072929|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
110419830|NCT01072929|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110419831|NCT01072929|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110419832|NCT01072929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110419833|NCT04305015|Analgesics, Opioid|analgesics, opioid|mesh-list
110419834|NCT04305015|Narcotics|narcotics|mesh-ancestor
110419835|NCT04305015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110419836|NCT04305015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110419837|NCT04305015|Analgesics|analgesics|mesh-ancestor
110419838|NCT04305015|Sensory System Agents|sensory system agents|mesh-ancestor
110419839|NCT04305015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110419840|NCT01231607|Finasteride|finasteride|mesh-list
110419841|NCT01231607|Dutasteride|dutasteride|mesh-list
110419842|NCT01231607|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
110419843|NCT01231607|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110419844|NCT01231607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110419845|NCT01231607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110419846|NCT01231607|Hormone Antagonists|hormone antagonists|mesh-ancestor
110419847|NCT01231607|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110419848|NCT01231607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110419849|NCT01231607|Urological Agents|urological agents|mesh-ancestor
110419850|NCT01231373|Polidocanol|polidocanol|mesh-list
110419851|NCT01231373|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
110066820|NCT01540708|Sympathomimetics|sympathomimetics|mesh-ancestor
110419853|NCT00975130|Golimumab|golimumab|mesh-list
110419854|NCT00975130|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110419855|NCT00975130|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110419856|NCT00975130|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110419857|NCT00975130|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110419858|NCT00975130|Immunologic Factors|immunologic factors|mesh-ancestor
110419859|NCT00975130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110419860|NCT01230827|Golimumab|golimumab|mesh-list
110419861|NCT01230827|Methotrexate|methotrexate|mesh-list
110419862|NCT01230827|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110419863|NCT01230827|Abortifacient Agents|abortifacient agents|mesh-ancestor
110419864|NCT01230827|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110419865|NCT01230827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110419866|NCT01230827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110419867|NCT01230827|Antimetabolites|antimetabolites|mesh-ancestor
110419868|NCT01230827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110419869|NCT01230827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110419870|NCT01230827|Dermatologic Agents|dermatologic agents|mesh-ancestor
110419871|NCT01230827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110419872|NCT01230827|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110419873|NCT01230827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110419874|NCT01230827|Immunologic Factors|immunologic factors|mesh-ancestor
110419875|NCT01230827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110419876|NCT01230827|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110419877|NCT01230827|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110419878|NCT01230827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110419879|NCT01230749|Pioglitazone|pioglitazone|mesh-list
110419880|NCT01230749|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110419881|NCT01230749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110419882|NCT00903175|Everolimus|everolimus|mesh-list
110419883|NCT00903175|Sunitinib|sunitinib|mesh-list
110419884|NCT00903175|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110419885|NCT00903175|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110419886|NCT00903175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110419887|NCT00903175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110419888|NCT00903175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110419889|NCT00903175|Immunologic Factors|immunologic factors|mesh-ancestor
110419890|NCT00903175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110419891|NCT00903175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110419893|NCT00903175|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110419894|NCT00903175|Growth Substances|growth substances|mesh-ancestor
110419895|NCT00903175|Growth Inhibitors|growth inhibitors|mesh-ancestor
110419896|NCT01229735|Topiramate|topiramate|mesh-list
110419897|NCT01229735|Levetiracetam|levetiracetam|mesh-list
110419898|NCT01229735|Anticonvulsants|anticonvulsants|mesh-ancestor
110419899|NCT01229735|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110419900|NCT01229735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110419901|NCT01229735|Nootropic Agents|nootropic agents|mesh-ancestor
110419902|NCT03866200|Resveratrol|resveratrol|mesh-list
110419903|NCT03866200|Antioxidants|antioxidants|mesh-ancestor
110419904|NCT03866200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110419905|NCT03866200|Protective Agents|protective agents|mesh-ancestor
110419906|NCT03866200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110419907|NCT03866200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110419908|NCT03866200|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110419909|NCT02848183|Cytarabine|cytarabine|mesh-list
110419910|NCT02848183|Etoposide|etoposide|mesh-list
110419911|NCT02848183|Mitoxantrone|mitoxantrone|mesh-list
110419912|NCT02848183|Idarubicin|idarubicin|mesh-list
110419913|NCT02848183|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110419914|NCT02848183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110419915|NCT02848183|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110419916|NCT02848183|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110419917|NCT02848183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110419918|NCT02848183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110419919|NCT02848183|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110419921|NCT02848183|Antiviral Agents|antiviral agents|mesh-ancestor
110419922|NCT02848183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110419923|NCT02848183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110419924|NCT02848183|Immunologic Factors|immunologic factors|mesh-ancestor
110419925|NCT02848183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110419926|NCT02848183|Analgesics|analgesics|mesh-ancestor
110419927|NCT02848183|Sensory System Agents|sensory system agents|mesh-ancestor
110419928|NCT02848183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110419929|NCT02848183|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110419931|NCT00974974|Carbidopa|carbidopa|mesh-list
110419932|NCT00974974|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
110419933|NCT00974974|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110419934|NCT00974974|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110419935|NCT00974974|Dopamine Agents|dopamine agents|mesh-ancestor
110419936|NCT00974974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110419937|NCT00974974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110419938|NCT00974974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110419939|NCT00974974|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
110419940|NCT00974974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110419941|NCT00974974|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110419942|NCT00974974|Immunologic Factors|immunologic factors|mesh-ancestor
110419943|NCT00974974|Dopamine Agonists|dopamine agonists|mesh-ancestor
110419944|NCT02848417|Curcumin|curcumin|mesh-list
110419945|NCT02848417|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110419946|NCT02848417|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110419947|NCT02848417|Analgesics|analgesics|mesh-ancestor
110419948|NCT02848417|Sensory System Agents|sensory system agents|mesh-ancestor
110419949|NCT02848417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110419950|NCT02848417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110419951|NCT02848417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110419952|NCT02848417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110419953|NCT02848417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110419954|NCT02848417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110419955|NCT02848417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110419956|NCT02847403|Exenatide|exenatide|mesh-list
110419957|NCT02847403|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110419958|NCT02847403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110419959|NCT02847403|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110419960|NCT02847403|Incretins|incretins|mesh-ancestor
110419961|NCT02847403|Hormones|hormones|mesh-ancestor
110419962|NCT02847403|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110419963|NCT02848339|Aspirin|aspirin|mesh-list
110419964|NCT02848339|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110419965|NCT02848339|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110419967|NCT02848339|Sensory System Agents|sensory system agents|mesh-ancestor
110419968|NCT02848339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110419969|NCT02848339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110419970|NCT02848339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110419971|NCT02848339|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110419972|NCT02848339|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110419973|NCT02848339|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110419974|NCT02848339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110419975|NCT02848339|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110419976|NCT02848339|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110419977|NCT02848339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110419978|NCT02848339|Antipyretics|antipyretics|mesh-ancestor
110419979|NCT02847481|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110419980|NCT02847481|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
110419981|NCT02847481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110419982|NCT02847481|Antitubercular Agents|antitubercular agents|mesh-ancestor
110419983|NCT04216303|Chrysarobin|chrysarobin|mesh-list
110419984|NCT04216303|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110419985|NCT04216303|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110419986|NCT04216303|Analgesics|analgesics|mesh-ancestor
110419987|NCT04216303|Sensory System Agents|sensory system agents|mesh-ancestor
110419988|NCT04216303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110419989|NCT04216303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110419990|NCT04216303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110419991|NCT04216303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110419992|NCT02847013|Bupivacaine|bupivacaine|mesh-list
110419993|NCT02847013|Anesthetics, Local|anesthetics, local|mesh-ancestor
110419994|NCT02847013|Anesthetics|anesthetics|mesh-ancestor
110419995|NCT02847013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110419996|NCT02847013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110419997|NCT02847013|Sensory System Agents|sensory system agents|mesh-ancestor
110419998|NCT02847013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110419999|NCT02847091|Ipragliflozin|ipragliflozin|mesh-list
110420000|NCT02847091|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110420001|NCT02847091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110420002|NCT02847091|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110420003|NCT02847091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110420005|NCT02846935|Tetrahydrouridine|tetrahydrouridine|mesh-list
110420006|NCT02846935|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110420007|NCT02846935|Antimetabolites|antimetabolites|mesh-ancestor
110420008|NCT02846935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110420009|NCT02846935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110420010|NCT02846935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110420011|NCT02844673|Hydroxyurea|hydroxyurea|mesh-list
110420012|NCT02844673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110420013|NCT02844673|Antisickling Agents|antisickling agents|mesh-ancestor
110420014|NCT02844673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110420015|NCT02844673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110420016|NCT02844673|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110420017|NCT00992992|Tositumomab I-131|tositumomab i-131|mesh-list
110420018|NCT00992992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110420019|NCT04201951|Tranexamic Acid|tranexamic acid|mesh-list
110420020|NCT04201951|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110420021|NCT04201951|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110420022|NCT04201951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110420023|NCT04201951|Hemostatics|hemostatics|mesh-ancestor
110420024|NCT04201951|Coagulants|coagulants|mesh-ancestor
110420025|NCT04753723|Gentamicins|gentamicins|mesh-list
110420026|NCT04753723|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110420027|NCT04753723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110420028|NCT04753723|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110420029|NCT04753723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110420030|NCT04753723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110420031|NCT04751851|Oxymetazoline|oxymetazoline|mesh-list
110420032|NCT04751851|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110420033|NCT04751851|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110420034|NCT04751851|Adrenergic Agents|adrenergic agents|mesh-ancestor
110420035|NCT04751851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110328326|NCT00496158|Adefovir|adefovir|mesh-list
110420036|NCT04751851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110420037|NCT04751851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110420038|NCT04751851|Sympathomimetics|sympathomimetics|mesh-ancestor
110420039|NCT04751851|Autonomic Agents|autonomic agents|mesh-ancestor
110420040|NCT04751851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110420041|NCT04751851|Nasal Decongestants|nasal decongestants|mesh-ancestor
110420042|NCT04751851|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110420043|NCT04751851|Respiratory System Agents|respiratory system agents|mesh-ancestor
110420044|NCT02844517|Pancrelipase|pancrelipase|mesh-list
110420045|NCT02844517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110420046|NCT03901729|Furosemide|furosemide|mesh-list
110420047|NCT03901729|Diuretics|diuretics|mesh-ancestor
110420048|NCT03901729|Natriuretic Agents|natriuretic agents|mesh-ancestor
110420049|NCT03901729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110420050|NCT03901729|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110420051|NCT03901729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110420052|NCT03901729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110420053|NCT02846857|Insulin|insulin|mesh-list
110420054|NCT02846857|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110420055|NCT02846857|Glucagon|glucagon|mesh-list
110420056|NCT02846857|Hormones|hormones|mesh-list
110420057|NCT02846857|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110420058|NCT02846857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110420059|NCT02846857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110420060|NCT02846857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110420061|NCT04672525|Rifampin|rifampin|mesh-list
110420062|NCT04672525|Rifabutin|rifabutin|mesh-list
110420063|NCT04672525|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110199441|NCT00045773|Sertraline|sertraline|mesh-list
110420064|NCT04672525|Antitubercular Agents|antitubercular agents|mesh-ancestor
110420065|NCT04672525|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110420066|NCT04672525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110420067|NCT04672525|Leprostatic Agents|leprostatic agents|mesh-ancestor
110420068|NCT04672525|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110420069|NCT04672525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110420070|NCT04672525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110420071|NCT04672525|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110420072|NCT04672525|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110420073|NCT04672525|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110420074|NCT04672525|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110420075|NCT04672525|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110420076|NCT04672525|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110420077|NCT00992446|Cytarabine|cytarabine|mesh-list
110420078|NCT00992446|Rituximab|rituximab|mesh-list
110420079|NCT00992446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110420080|NCT00992446|Etoposide|etoposide|mesh-list
110420081|NCT00992446|Etoposide phosphate|etoposide phosphate|mesh-list
110420082|NCT00992446|Bortezomib|bortezomib|mesh-list
110420083|NCT00992446|Melphalan|melphalan|mesh-list
110420084|NCT00992446|Mechlorethamine|mechlorethamine|mesh-list
110420085|NCT00992446|Vorinostat|vorinostat|mesh-list
110420086|NCT00992446|Carmustine|carmustine|mesh-list
110420087|NCT00992446|Podophyllotoxin|podophyllotoxin|mesh-list
110420088|NCT00992446|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
110420089|NCT00992446|Antibodies|antibodies|mesh-list
110420090|NCT00992446|Immunoglobulins|immunoglobulins|mesh-list
110420091|NCT00992446|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110420092|NCT00992446|Immunologic Factors|immunologic factors|mesh-ancestor
110420093|NCT00992446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110420094|NCT00992446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110420095|NCT00992446|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110420096|NCT00992446|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110420097|NCT00992446|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110420098|NCT00992446|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110420099|NCT00992446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110420100|NCT00992446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110420101|NCT00992446|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110420102|NCT00992446|Antimetabolites|antimetabolites|mesh-ancestor
110420103|NCT00992446|Antiviral Agents|antiviral agents|mesh-ancestor
110420104|NCT00992446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110420105|NCT00992446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110420106|NCT00992446|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110420107|NCT00992446|Alkylating Agents|alkylating agents|mesh-ancestor
110420108|NCT00992446|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110328329|NCT00496158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110420109|NCT00992446|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110420110|NCT00992446|Keratolytic Agents|keratolytic agents|mesh-ancestor
110420111|NCT00992446|Dermatologic Agents|dermatologic agents|mesh-ancestor
110420112|NCT00992446|Tubulin Modulators|tubulin modulators|mesh-ancestor
110420113|NCT00992446|Antimitotic Agents|antimitotic agents|mesh-ancestor
110420114|NCT00992446|Mitosis Modulators|mitosis modulators|mesh-ancestor
110420115|NCT04452565|Atazanavir Sulfate|atazanavir sulfate|mesh-list
110420116|NCT04452565|Dexamethasone|dexamethasone|mesh-list
110420117|NCT04452565|Dexamethasone acetate|dexamethasone acetate|mesh-list
110420118|NCT04452565|BB 1101|bb 1101|mesh-list
110420119|NCT04452565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110420120|NCT04452565|Antiemetics|antiemetics|mesh-ancestor
110420122|NCT04452565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110420123|NCT04452565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110420124|NCT04452565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110420125|NCT04452565|Glucocorticoids|glucocorticoids|mesh-ancestor
110420126|NCT04452565|Hormones|hormones|mesh-ancestor
110420127|NCT04452565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110420128|NCT04452565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110420129|NCT04452565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110420130|NCT04452565|Protease Inhibitors|protease inhibitors|mesh-ancestor
110420131|NCT04452565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110420132|NCT04452565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110420133|NCT04452565|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110420134|NCT04452565|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110420135|NCT04452565|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110420136|NCT04452565|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110420137|NCT04452565|Antiviral Agents|antiviral agents|mesh-ancestor
110420138|NCT04452565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110420139|NCT02863120|Bupivacaine|bupivacaine|mesh-list
110420140|NCT02863120|Ropivacaine|ropivacaine|mesh-list
110420141|NCT02863120|Anesthetics, Local|anesthetics, local|mesh-ancestor
110420142|NCT02863120|Anesthetics|anesthetics|mesh-ancestor
110420143|NCT02863120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110420144|NCT02863120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110420145|NCT02863120|Sensory System Agents|sensory system agents|mesh-ancestor
110420146|NCT02863120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110420147|NCT03823534|Acetaminophen|acetaminophen|mesh-list
110420148|NCT03823534|Ketorolac|ketorolac|mesh-list
110420149|NCT03823534|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
110067124|NCT01542190|Ketorolac|ketorolac|mesh-list
110420150|NCT03823534|Morphine|morphine|mesh-list
110420151|NCT03823534|Oxycodone|oxycodone|mesh-list
110420152|NCT03823534|Hydrocodone|hydrocodone|mesh-list
110420153|NCT03823534|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110420154|NCT03823534|Narcotics|narcotics|mesh-ancestor
110420155|NCT03823534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110420156|NCT03823534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110420157|NCT03823534|Analgesics|analgesics|mesh-ancestor
110420158|NCT03823534|Sensory System Agents|sensory system agents|mesh-ancestor
110420159|NCT03823534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110420160|NCT03823534|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110420161|NCT03823534|Antipyretics|antipyretics|mesh-ancestor
110199474|NCT00079443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110420162|NCT03823534|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110420163|NCT03823534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110420164|NCT03823534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110420165|NCT03823534|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110420166|NCT03823534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110420167|NCT03823534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110420168|NCT03823534|Antitussive Agents|antitussive agents|mesh-ancestor
110420169|NCT03823534|Respiratory System Agents|respiratory system agents|mesh-ancestor
110420170|NCT02846701|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110420171|NCT02846701|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110420172|NCT02846701|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110420173|NCT02846701|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110420174|NCT02846701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110420175|NCT02846701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110420176|NCT02846701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110420177|NCT02846701|Analgesics|analgesics|mesh-ancestor
110420178|NCT02846701|Sensory System Agents|sensory system agents|mesh-ancestor
110420179|NCT02846701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110420180|NCT02846701|Antidepressive Agents|antidepressive agents|mesh-ancestor
110420181|NCT02846701|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110420182|NCT02846701|Dopamine Agents|dopamine agents|mesh-ancestor
110420183|NCT04327063|Ropivacaine|ropivacaine|mesh-list
110420184|NCT04327063|Anesthetics, Local|anesthetics, local|mesh-ancestor
110420185|NCT04327063|Anesthetics|anesthetics|mesh-ancestor
110420186|NCT04327063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110420187|NCT04327063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110420188|NCT04327063|Sensory System Agents|sensory system agents|mesh-ancestor
110420189|NCT04327063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110420190|NCT04565431|Natalizumab|natalizumab|mesh-list
110420191|NCT04565431|Immunologic Factors|immunologic factors|mesh-ancestor
110420192|NCT04565431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110420193|NCT04292704|Clotrimazole|clotrimazole|mesh-list
110420195|NCT04292704|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110420196|NCT04292704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110420197|NCT04292704|Antifungal Agents|antifungal agents|mesh-ancestor
110420198|NCT04292704|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110420199|NCT04292704|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110420200|NCT04292704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110420201|NCT04292704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110199507|NCT00079560|Dronabinol|dronabinol|mesh-list
110420202|NCT04292704|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110420203|NCT04292704|Hormone Antagonists|hormone antagonists|mesh-ancestor
110420204|NCT04292704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110420205|NCT04292704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110420206|NCT04292704|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110420207|NCT04292704|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110420209|NCT05242783|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110420210|NCT05242783|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110420211|NCT03987685|Topotecan|topotecan|mesh-list
110420212|NCT03987685|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110420213|NCT03987685|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110420214|NCT03987685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110420215|NCT03987685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110420216|NCT03987685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110420217|NCT00900757|Palonosetron|palonosetron|mesh-list
110420218|NCT00900757|Antiemetics|antiemetics|mesh-ancestor
110420219|NCT00900757|Autonomic Agents|autonomic agents|mesh-ancestor
110420220|NCT00900757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110420221|NCT00900757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110420222|NCT00900757|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110420223|NCT00900757|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110420224|NCT00900757|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110420225|NCT00900757|Serotonin Agents|serotonin agents|mesh-ancestor
110420226|NCT00900757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110420227|NCT00900757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110420228|NCT04136743|Dexamethasone|dexamethasone|mesh-list
110420229|NCT04136743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110420230|NCT04136743|Antiemetics|antiemetics|mesh-ancestor
110420231|NCT04136743|Autonomic Agents|autonomic agents|mesh-ancestor
110420232|NCT04136743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110420233|NCT04136743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110420234|NCT04136743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110420235|NCT04136743|Glucocorticoids|glucocorticoids|mesh-ancestor
110420236|NCT04136743|Hormones|hormones|mesh-ancestor
110420237|NCT04136743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110420238|NCT04136743|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110420239|NCT04136743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110420240|NCT03931057|Midazolam|midazolam|mesh-list
110420241|NCT03931057|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110420242|NCT03931057|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110420243|NCT03931057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110420244|NCT03931057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110420245|NCT03931057|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110420246|NCT03931057|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110420247|NCT03931057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110420248|NCT03931057|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110420249|NCT03931057|Anesthetics, General|anesthetics, general|mesh-ancestor
110420250|NCT03931057|Anesthetics|anesthetics|mesh-ancestor
110420251|NCT03931057|GABA Modulators|gaba modulators|mesh-ancestor
110420252|NCT03931057|GABA Agents|gaba agents|mesh-ancestor
110420253|NCT03931057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110420254|NCT03931057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110420256|NCT02846155|Antifoaming Agents|antifoaming agents|mesh-ancestor
110420257|NCT02846155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110420258|NCT02846155|Emollients|emollients|mesh-ancestor
110420259|NCT02846155|Dermatologic Agents|dermatologic agents|mesh-ancestor
110420260|NCT02845843|Interferons|interferons|mesh-list
110420261|NCT02845843|Ritonavir|ritonavir|mesh-list
110420262|NCT02845843|Lopinavir|lopinavir|mesh-list
110420263|NCT02845843|Interferon-beta|interferon-beta|mesh-list
110420264|NCT02845843|Interferon beta-1b|interferon beta-1b|mesh-list
110420265|NCT02845843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110420266|NCT02845843|Antiviral Agents|antiviral agents|mesh-ancestor
110420267|NCT02845843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110420268|NCT02845843|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110420269|NCT02845843|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110420270|NCT02845843|Protease Inhibitors|protease inhibitors|mesh-ancestor
110420271|NCT02845843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110420272|NCT02845843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110420273|NCT02845843|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110420274|NCT02845843|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110420275|NCT02845843|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110420276|NCT02845843|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110420277|NCT02845843|Immunologic Factors|immunologic factors|mesh-ancestor
110420278|NCT02845843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110420279|NCT02845843|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110420280|NCT02845999|Cyclophosphamide|cyclophosphamide|mesh-list
110420281|NCT02845999|Fludarabine|fludarabine|mesh-list
110420282|NCT02845999|Cetuximab|cetuximab|mesh-list
110420283|NCT02845999|Interleukin-2|interleukin-2|mesh-list
110420284|NCT02845999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110420285|NCT02845999|Immunologic Factors|immunologic factors|mesh-ancestor
110420286|NCT02845999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110420287|NCT02845999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110420288|NCT02845999|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110420289|NCT02845999|Alkylating Agents|alkylating agents|mesh-ancestor
110420290|NCT02845999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110420291|NCT02845999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110420292|NCT02845999|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110420293|NCT02845999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110420294|NCT02845999|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110420295|NCT02845999|Analgesics|analgesics|mesh-ancestor
110420296|NCT02845999|Sensory System Agents|sensory system agents|mesh-ancestor
110420297|NCT02845999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110420298|NCT05337085|Midazolam|midazolam|mesh-list
110420299|NCT05337085|Dexmedetomidine|dexmedetomidine|mesh-list
110420300|NCT05337085|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110420301|NCT05337085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110420302|NCT05337085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110420303|NCT05337085|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110420304|NCT05337085|Analgesics|analgesics|mesh-ancestor
110199558|NCT00079638|Ezetimibe|ezetimibe|mesh-list
110420305|NCT05337085|Sensory System Agents|sensory system agents|mesh-ancestor
110420306|NCT05337085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110420307|NCT05337085|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110420308|NCT05337085|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110420309|NCT05337085|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110420310|NCT05337085|Adrenergic Agents|adrenergic agents|mesh-ancestor
110420311|NCT05337085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110420312|NCT05337085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110420313|NCT05337085|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110420314|NCT05337085|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110420315|NCT05337085|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110420316|NCT05337085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110420317|NCT05337085|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110420318|NCT05337085|Anesthetics, General|anesthetics, general|mesh-ancestor
110420319|NCT05337085|Anesthetics|anesthetics|mesh-ancestor
110420320|NCT05337085|GABA Modulators|gaba modulators|mesh-ancestor
110420321|NCT05337085|GABA Agents|gaba agents|mesh-ancestor
110420322|NCT02845765|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
110420323|NCT02845765|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110420324|NCT02845765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110420325|NCT02845765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110420326|NCT01723579|Estradiol|estradiol|mesh-list
110420327|NCT01723579|Estrogens|estrogens|mesh-ancestor
110420328|NCT01723579|Hormones|hormones|mesh-ancestor
110420329|NCT01723579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110420330|NCT01723579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110420331|NCT00901927|Rituximab|rituximab|mesh-list
110420332|NCT00901927|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110420333|NCT00901927|Mitoxantrone|mitoxantrone|mesh-list
110420334|NCT00901927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110420335|NCT00901927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110420336|NCT00901927|Immunologic Factors|immunologic factors|mesh-ancestor
110420337|NCT00901927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110420338|NCT00901927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110420339|NCT00901927|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110420340|NCT00901927|Alkylating Agents|alkylating agents|mesh-ancestor
110420341|NCT00901927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110420342|NCT00901927|Analgesics|analgesics|mesh-ancestor
110420343|NCT00901927|Sensory System Agents|sensory system agents|mesh-ancestor
110420344|NCT00901927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110420345|NCT00901927|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110420346|NCT00901927|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110420347|NCT00901927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110420348|NCT05335837|Anesthetics|anesthetics|mesh-list
110420349|NCT05335837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110420350|NCT05335837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110420351|NCT00903721|Mometasone Furoate|mometasone furoate|mesh-list
110420352|NCT00903721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110420353|NCT00903721|Dermatologic Agents|dermatologic agents|mesh-ancestor
110420354|NCT00903721|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110420355|NCT02845219|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
110420356|NCT02845219|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
110420357|NCT02845219|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110420358|NCT02845219|Contraceptive Agents|contraceptive agents|mesh-ancestor
110420359|NCT02845219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110420360|NCT02845219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110420361|NCT02845219|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110420362|NCT02845219|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110420363|NCT02845219|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110420364|NCT02845219|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110420365|NCT02845219|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110420366|NCT02845219|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
110420367|NCT02845219|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
110420368|NCT02845219|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
110420369|NCT00968968|Trastuzumab|trastuzumab|mesh-list
110420371|NCT00968968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110420372|NCT00968968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110420373|NCT00968968|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110420374|NCT00968968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110420375|NCT00968968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110420376|NCT00973102|Estrogens|estrogens|mesh-list
110420377|NCT00973102|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
110420378|NCT00973102|Hormones|hormones|mesh-ancestor
110420379|NCT00973102|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110420380|NCT00973102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110420381|NCT03691090|Paclitaxel|paclitaxel|mesh-list
110420382|NCT03691090|Cisplatin|cisplatin|mesh-list
110420383|NCT03691090|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110420384|NCT03691090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110420385|NCT03691090|Tubulin Modulators|tubulin modulators|mesh-ancestor
110420386|NCT03691090|Antimitotic Agents|antimitotic agents|mesh-ancestor
110420387|NCT03691090|Mitosis Modulators|mitosis modulators|mesh-ancestor
110420388|NCT03691090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110420389|NCT00783211|Fexofenadine|fexofenadine|mesh-list
110420390|NCT00783211|Desloratadine|desloratadine|mesh-list
110420391|NCT00783211|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110420392|NCT00783211|Cholinergic Agents|cholinergic agents|mesh-ancestor
110420393|NCT00783211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110420394|NCT00783211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110199593|NCT00130468|Protective Agents|protective agents|mesh-ancestor
110199594|NCT00130507|Capecitabine|capecitabine|mesh-list
110420395|NCT00783211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110420396|NCT00783211|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110420397|NCT00783211|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110420398|NCT00783211|Histamine Antagonists|histamine antagonists|mesh-ancestor
110420399|NCT00783211|Histamine Agents|histamine agents|mesh-ancestor
110420400|NCT00783211|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110420402|NCT03679546|Vedolizumab|vedolizumab|mesh-list
110420403|NCT03679546|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110420404|NCT03679546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110420405|NCT03679546|Dermatologic Agents|dermatologic agents|mesh-ancestor
110420406|NCT03679546|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110420407|NCT03679546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110420408|NCT00779545|Mometasone Furoate|mometasone furoate|mesh-list
110420409|NCT00779545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110420410|NCT00779545|Dermatologic Agents|dermatologic agents|mesh-ancestor
110420411|NCT00779545|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110420412|NCT02842567|Vitamin E|vitamin e|mesh-list
110420413|NCT02842567|Tocopherols|tocopherols|mesh-list
110420414|NCT02842567|alpha-Tocopherol|alpha-tocopherol|mesh-list
110420415|NCT02842567|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
110420416|NCT02842567|Phenylethyl Alcohol|phenylethyl alcohol|mesh-list
110420417|NCT02842567|Vitamins|vitamins|mesh-ancestor
110420418|NCT02842567|Micronutrients|micronutrients|mesh-ancestor
110420419|NCT02842567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110420420|NCT02842567|Antioxidants|antioxidants|mesh-ancestor
110420421|NCT02842567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110420422|NCT02842567|Protective Agents|protective agents|mesh-ancestor
110420423|NCT02842567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110420424|NCT02842567|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110420425|NCT02842567|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110420426|NCT02842567|Disinfectants|disinfectants|mesh-ancestor
110420427|NCT00705211|Ezetimibe|ezetimibe|mesh-list
110063328|NCT03140423|Mupirocin|mupirocin|mesh-list
110420428|NCT00705211|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110420429|NCT00705211|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110420430|NCT00705211|Antimetabolites|antimetabolites|mesh-ancestor
110420431|NCT00705211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110420432|NCT00705211|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110420433|NCT02839213|Scopolamine|scopolamine|mesh-list
110420434|NCT02839213|Bromides|bromides|mesh-list
110420435|NCT02839213|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
110420436|NCT02839213|Anticonvulsants|anticonvulsants|mesh-ancestor
110420437|NCT02839213|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110420438|NCT02839213|Antiemetics|antiemetics|mesh-ancestor
110420439|NCT02839213|Autonomic Agents|autonomic agents|mesh-ancestor
110420440|NCT02839213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110420441|NCT02839213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110420442|NCT02839213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110420443|NCT02839213|Mydriatics|mydriatics|mesh-ancestor
110420444|NCT02839213|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110420445|NCT02839213|Cholinergic Agents|cholinergic agents|mesh-ancestor
110420446|NCT02839213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110420447|NCT02839213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110420448|NCT02839213|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110420449|NCT02839213|Parasympatholytics|parasympatholytics|mesh-ancestor
110420451|NCT05334043|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110420452|NCT05334043|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110420453|NCT05334043|Analgesics|analgesics|mesh-ancestor
110420454|NCT05334043|Sensory System Agents|sensory system agents|mesh-ancestor
110420455|NCT05334043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110420456|NCT05334043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110420457|NCT05334043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110420458|NCT05334043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110420459|NCT05334043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110420460|NCT05334043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110420461|NCT05334043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110420463|NCT02838823|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110420464|NCT02838823|Immunologic Factors|immunologic factors|mesh-ancestor
110420465|NCT02838823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110420466|NCT00156091|Olanzapine|olanzapine|mesh-list
110420467|NCT00156091|Asenapine|asenapine|mesh-list
110420468|NCT00156091|Antiemetics|antiemetics|mesh-ancestor
110420469|NCT00156091|Autonomic Agents|autonomic agents|mesh-ancestor
110420470|NCT00156091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110420471|NCT00156091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110420472|NCT00156091|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110420473|NCT00156091|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110420474|NCT00156091|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110420475|NCT00156091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110420476|NCT00156091|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110420477|NCT00156091|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110420478|NCT00156091|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110420479|NCT00156091|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110420480|NCT00156091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110420481|NCT00156091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110420482|NCT00156091|Serotonin Agents|serotonin agents|mesh-ancestor
110420483|NCT00140959|Losartan|losartan|mesh-list
110420484|NCT00140959|Atenolol|atenolol|mesh-list
110420485|NCT00140959|Amlodipine|amlodipine|mesh-list
110420486|NCT00140959|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110420487|NCT00140959|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110420488|NCT00140959|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110420489|NCT00140959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110420490|NCT00140959|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110420491|NCT00140959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110420493|NCT00140959|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110420494|NCT00140959|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110420495|NCT00140959|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110420496|NCT00140959|Adrenergic Agents|adrenergic agents|mesh-ancestor
110420497|NCT00140959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110420498|NCT00140959|Autonomic Agents|autonomic agents|mesh-ancestor
110420499|NCT00140959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110420500|NCT00140959|Sympatholytics|sympatholytics|mesh-ancestor
110420501|NCT00140959|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110420502|NCT00140959|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110420503|NCT00140959|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110420504|NCT00095017|Etoricoxib|etoricoxib|mesh-list
110420505|NCT00095017|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110420506|NCT00095017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110420507|NCT00095017|Analgesics|analgesics|mesh-ancestor
110420508|NCT00095017|Sensory System Agents|sensory system agents|mesh-ancestor
110420509|NCT00095017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110420510|NCT00095017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110420511|NCT00095017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110420512|NCT00095017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110420513|NCT00095017|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110420514|NCT00095017|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110420515|NCT00095017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110420516|NCT00095017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110420517|NCT00092755|Ibuprofen|ibuprofen|mesh-list
110420518|NCT00092755|Etoricoxib|etoricoxib|mesh-list
110420519|NCT00092755|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110420520|NCT00092755|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110420521|NCT00092755|Analgesics|analgesics|mesh-ancestor
110420522|NCT00092755|Sensory System Agents|sensory system agents|mesh-ancestor
110420523|NCT00092755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110420524|NCT00092755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110420525|NCT00092755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110420526|NCT00092755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110420527|NCT00092755|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110420528|NCT00092755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110420529|NCT00092755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110420530|NCT00092755|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110420532|NCT00899431|Fludarabine|fludarabine|mesh-list
110420533|NCT00899431|Fludarabine phosphate|fludarabine phosphate|mesh-list
110420534|NCT00899431|Lenalidomide|lenalidomide|mesh-list
110420535|NCT00899431|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110420536|NCT00899431|Allopurinol|allopurinol|mesh-list
110420537|NCT00899431|Thymoglobulin|thymoglobulin|mesh-list
110420538|NCT00899431|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110420539|NCT00899431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110420540|NCT00899431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110420541|NCT00899431|Immunologic Factors|immunologic factors|mesh-ancestor
110420542|NCT00899431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110420543|NCT00899431|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110420544|NCT00899431|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110420545|NCT00899431|Antimetabolites|antimetabolites|mesh-ancestor
110420546|NCT00899431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110420547|NCT00899431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110420548|NCT00899431|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110420549|NCT00899431|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110420550|NCT00899431|Growth Substances|growth substances|mesh-ancestor
110420551|NCT00899431|Growth Inhibitors|growth inhibitors|mesh-ancestor
110420552|NCT00899431|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110420553|NCT00899431|Alkylating Agents|alkylating agents|mesh-ancestor
110420554|NCT00899431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110420555|NCT00899431|Gout Suppressants|gout suppressants|mesh-ancestor
110420556|NCT00899431|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110420557|NCT00899431|Antioxidants|antioxidants|mesh-ancestor
110420558|NCT00899431|Protective Agents|protective agents|mesh-ancestor
110420559|NCT00898807|Citalopram|citalopram|mesh-list
110420560|NCT00898807|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110420561|NCT00898807|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110420562|NCT00898807|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110420563|NCT00898807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110420564|NCT00898807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110420565|NCT00898807|Serotonin Agents|serotonin agents|mesh-ancestor
110420566|NCT00898807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110420567|NCT00898807|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110420568|NCT00898807|Antidepressive Agents|antidepressive agents|mesh-ancestor
110420569|NCT00898807|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110420570|NCT01229267|Vaccines|vaccines|mesh-list
110420571|NCT01229267|Immunologic Factors|immunologic factors|mesh-ancestor
110420572|NCT01229267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110420573|NCT00897715|Rilonacept|rilonacept|mesh-list
110420574|NCT00897715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110420575|NCT01229111|Leucovorin|leucovorin|mesh-list
110420576|NCT01229111|Fluorouracil|fluorouracil|mesh-list
110420577|NCT01229111|Oxaliplatin|oxaliplatin|mesh-list
110420578|NCT01229111|Cediranib|cediranib|mesh-list
110420579|NCT01229111|Calcium|calcium|mesh-list
110420580|NCT01229111|Levoleucovorin|levoleucovorin|mesh-list
110420581|NCT01229111|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110420582|NCT01229111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110420583|NCT01229111|Antimetabolites|antimetabolites|mesh-ancestor
110420584|NCT01229111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110420585|NCT01229111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110420586|NCT01229111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110420587|NCT01229111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110420588|NCT01229111|Immunologic Factors|immunologic factors|mesh-ancestor
110420589|NCT01229111|Antidotes|antidotes|mesh-ancestor
110420590|NCT01229111|Protective Agents|protective agents|mesh-ancestor
110420591|NCT01229111|Vitamin B Complex|vitamin b complex|mesh-ancestor
110420592|NCT01229111|Vitamins|vitamins|mesh-ancestor
110420593|NCT01229111|Micronutrients|micronutrients|mesh-ancestor
110420594|NCT01229111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110420595|NCT01229111|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110420596|NCT02843815|Immunomodulating Agents|immunomodulating agents|mesh-list
110420597|NCT02843815|Immunologic Factors|immunologic factors|mesh-ancestor
110420598|NCT02843815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110420599|NCT01228175|Riboflavin|riboflavin|mesh-list
110420600|NCT01228175|Varenicline|varenicline|mesh-list
110420601|NCT01228175|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110420602|NCT01228175|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110369665|NCT01847573|Halofuginone|halofuginone|mesh-list
110420603|NCT01228175|Cholinergic Agents|cholinergic agents|mesh-ancestor
110420604|NCT01228175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110420605|NCT01228175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110420606|NCT01228175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110420607|NCT01228175|Vitamin B Complex|vitamin b complex|mesh-ancestor
110420609|NCT01228175|Micronutrients|micronutrients|mesh-ancestor
110420610|NCT01228175|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110420611|NCT01228175|Dermatologic Agents|dermatologic agents|mesh-ancestor
110420613|NCT01228019|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110420614|NCT01228019|Antimetabolites|antimetabolites|mesh-ancestor
110420615|NCT01228019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110420616|NCT01228019|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110420617|NCT01228019|Vasodilator Agents|vasodilator agents|mesh-ancestor
110420618|NCT01228019|Vitamin B Complex|vitamin b complex|mesh-ancestor
110420619|NCT01228019|Vitamins|vitamins|mesh-ancestor
110420620|NCT01228019|Micronutrients|micronutrients|mesh-ancestor
110420621|NCT01228019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110420622|NCT01227707|Leucovorin|leucovorin|mesh-list
110420623|NCT01227707|Bevacizumab|bevacizumab|mesh-list
110420624|NCT01227707|Fluorouracil|fluorouracil|mesh-list
110420625|NCT01227707|Capecitabine|capecitabine|mesh-list
110420626|NCT01227707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110420627|NCT01227707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110420628|NCT01227707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110420629|NCT01227707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110420630|NCT01227707|Growth Substances|growth substances|mesh-ancestor
110420631|NCT01227707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110420632|NCT01227707|Growth Inhibitors|growth inhibitors|mesh-ancestor
110420633|NCT01227707|Antimetabolites|antimetabolites|mesh-ancestor
110420634|NCT01227707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110420635|NCT01227707|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110420636|NCT01227707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110420637|NCT01227707|Immunologic Factors|immunologic factors|mesh-ancestor
110420638|NCT01227707|Antidotes|antidotes|mesh-ancestor
110420639|NCT01227707|Protective Agents|protective agents|mesh-ancestor
110420640|NCT01227707|Vitamin B Complex|vitamin b complex|mesh-ancestor
110420641|NCT01227707|Vitamins|vitamins|mesh-ancestor
110420642|NCT01227707|Micronutrients|micronutrients|mesh-ancestor
110420643|NCT00633373|Cyclosporine|cyclosporine|mesh-list
110420644|NCT00633373|Cyclosporins|cyclosporins|mesh-list
110420645|NCT00633373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110420646|NCT00633373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110420647|NCT00633373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110420648|NCT00633373|Immunologic Factors|immunologic factors|mesh-ancestor
110420649|NCT00633373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110420650|NCT00633373|Antifungal Agents|antifungal agents|mesh-ancestor
110420651|NCT00633373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110420652|NCT00633373|Dermatologic Agents|dermatologic agents|mesh-ancestor
110420653|NCT00633373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110420654|NCT00633373|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110420655|NCT05334745|Hyaluronic Acid|hyaluronic acid|mesh-list
110420656|NCT05334745|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110420657|NCT05334745|Immunologic Factors|immunologic factors|mesh-ancestor
110420658|NCT05334745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110420659|NCT05334745|Viscosupplements|viscosupplements|mesh-ancestor
110420660|NCT05334745|Protective Agents|protective agents|mesh-ancestor
110420661|NCT02838589|Exenatide|exenatide|mesh-list
110420662|NCT02838589|Glucagon|glucagon|mesh-list
110420663|NCT02838589|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
110420664|NCT02838589|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110420665|NCT02838589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110420666|NCT02838589|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110420667|NCT02838589|Incretins|incretins|mesh-ancestor
110420668|NCT02838589|Hormones|hormones|mesh-ancestor
110420669|NCT02838589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110420670|NCT02838589|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110420671|NCT02839135|Scopolamine|scopolamine|mesh-list
110420672|NCT02839135|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
110420673|NCT02839135|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110420674|NCT02839135|Antiemetics|antiemetics|mesh-ancestor
110420675|NCT02839135|Autonomic Agents|autonomic agents|mesh-ancestor
110420676|NCT02839135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110420677|NCT02839135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110420678|NCT02839135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110420679|NCT02839135|Mydriatics|mydriatics|mesh-ancestor
110420680|NCT02839135|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110420681|NCT02839135|Cholinergic Agents|cholinergic agents|mesh-ancestor
110420682|NCT02839135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110420683|NCT02839135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110420684|NCT02839135|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110420685|NCT02839135|Parasympatholytics|parasympatholytics|mesh-ancestor
110420686|NCT00895843|Ibuprofen|ibuprofen|mesh-list
110420687|NCT00895843|Epinephrine|epinephrine|mesh-list
110420688|NCT00895843|Bupivacaine|bupivacaine|mesh-list
110420689|NCT00895843|Anesthetics, Local|anesthetics, local|mesh-ancestor
110420690|NCT00895843|Anesthetics|anesthetics|mesh-ancestor
110420691|NCT00895843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110420692|NCT00895843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110420693|NCT00895843|Sensory System Agents|sensory system agents|mesh-ancestor
110420694|NCT00895843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110420695|NCT00895843|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110420696|NCT00895843|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110420697|NCT00895843|Analgesics|analgesics|mesh-ancestor
110420698|NCT00895843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110420699|NCT00895843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110420700|NCT00895843|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110420701|NCT00895843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110420702|NCT00895843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110199986|NCT00132925|Triamcinolone|triamcinolone|mesh-list
110420703|NCT00895843|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110420704|NCT00895843|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110420705|NCT00895843|Adrenergic Agents|adrenergic agents|mesh-ancestor
110420706|NCT00895843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110420707|NCT00895843|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110420708|NCT00895843|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110420709|NCT00895843|Autonomic Agents|autonomic agents|mesh-ancestor
110420710|NCT00895843|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110420711|NCT00895843|Respiratory System Agents|respiratory system agents|mesh-ancestor
110420712|NCT00895843|Mydriatics|mydriatics|mesh-ancestor
110420713|NCT00895843|Sympathomimetics|sympathomimetics|mesh-ancestor
110420714|NCT00895843|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110420715|NCT05333809|Pembrolizumab|pembrolizumab|mesh-list
110420716|NCT05333809|Disitamab vedotin|disitamab vedotin|mesh-list
110420717|NCT05333809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110420718|NCT05333809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110420719|NCT05333809|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110420720|NCT05333809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110420721|NCT05333809|Immunoconjugates|immunoconjugates|mesh-ancestor
110420722|NCT05333809|Immunologic Factors|immunologic factors|mesh-ancestor
110420723|NCT05333809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110420724|NCT05333731|Oxytocin|oxytocin|mesh-list
110420725|NCT05333731|Oxytocics|oxytocics|mesh-ancestor
110420726|NCT05333731|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110420727|NCT05333731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110420728|NCT02843581|Immunomodulating Agents|immunomodulating agents|mesh-list
110420729|NCT02843581|Immunologic Factors|immunologic factors|mesh-ancestor
110420730|NCT02843581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110420731|NCT00895453|Iron|iron|mesh-list
110420732|NCT00895453|Itraconazole|itraconazole|mesh-list
110420733|NCT00895453|Antifungal Agents|antifungal agents|mesh-ancestor
110420734|NCT00895453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110420735|NCT00895453|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110420736|NCT00895453|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110420737|NCT00895453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110420738|NCT00895453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110420739|NCT00895453|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110420740|NCT00895453|Hormone Antagonists|hormone antagonists|mesh-ancestor
110420741|NCT00895453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110369693|NCT04609254|Antipyretics|antipyretics|mesh-ancestor
110420742|NCT00895453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110420743|NCT00895453|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110420745|NCT00895453|Micronutrients|micronutrients|mesh-ancestor
110420746|NCT00893737|Naproxen|naproxen|mesh-list
110420747|NCT00893737|Sumatriptan|sumatriptan|mesh-list
110420748|NCT00893737|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110420749|NCT00893737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110420750|NCT00893737|Analgesics|analgesics|mesh-ancestor
110420751|NCT00893737|Sensory System Agents|sensory system agents|mesh-ancestor
110420752|NCT00893737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110420753|NCT00893737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110420754|NCT00893737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110420755|NCT00893737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110420756|NCT00893737|Gout Suppressants|gout suppressants|mesh-ancestor
110420757|NCT00893737|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110420758|NCT00893737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110420759|NCT00893737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110420760|NCT00893737|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110420761|NCT00893737|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110420762|NCT00893737|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110420763|NCT00893737|Serotonin Agents|serotonin agents|mesh-ancestor
110420764|NCT00893737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110420766|NCT00893113|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110420767|NCT00893113|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110420768|NCT00893113|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110420769|NCT00893113|Adrenergic Agents|adrenergic agents|mesh-ancestor
110420770|NCT00893113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110420771|NCT00893113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110420772|NCT00893113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110420773|NCT00893113|Urological Agents|urological agents|mesh-ancestor
110420774|NCT02840929|Esomeprazole|esomeprazole|mesh-list
110420775|NCT02840929|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110420776|NCT02840929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110420777|NCT02840929|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110420778|NCT02840929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110420779|NCT02840929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110420780|NCT02838121|Zoledronic Acid|zoledronic acid|mesh-list
110420781|NCT02838121|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110420782|NCT02838121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110420783|NCT02837965|Doxycycline|doxycycline|mesh-list
110420784|NCT02837965|Prednisone|prednisone|mesh-list
110420785|NCT02837965|Methotrexate|methotrexate|mesh-list
110420786|NCT02837965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110420787|NCT02837965|Glucocorticoids|glucocorticoids|mesh-ancestor
110420788|NCT02837965|Hormones|hormones|mesh-ancestor
110420789|NCT02837965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110420790|NCT02837965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110420791|NCT02837965|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110420792|NCT02837965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110420793|NCT02837965|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110420794|NCT02837965|Abortifacient Agents|abortifacient agents|mesh-ancestor
110420795|NCT02837965|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110420796|NCT02837965|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110420797|NCT02837965|Antimetabolites|antimetabolites|mesh-ancestor
110420798|NCT02837965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110420799|NCT02837965|Dermatologic Agents|dermatologic agents|mesh-ancestor
110369708|NCT04609293|Apatinib|apatinib|mesh-list
110420800|NCT02837965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110420801|NCT02837965|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110420802|NCT02837965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110420803|NCT02837965|Immunologic Factors|immunologic factors|mesh-ancestor
110420804|NCT02837965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110420805|NCT02837965|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110420806|NCT02837965|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110420807|NCT02837965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110420808|NCT02837965|Antimalarials|antimalarials|mesh-ancestor
110420809|NCT02837965|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110420810|NCT02837965|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110420811|NCT00892957|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
110420813|NCT00892957|Aprotinin|aprotinin|mesh-list
110420814|NCT00892957|Hemostatics|hemostatics|mesh-ancestor
110420815|NCT00892957|Coagulants|coagulants|mesh-ancestor
110420816|NCT00892957|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
110420817|NCT00892957|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110420818|NCT00892957|Protease Inhibitors|protease inhibitors|mesh-ancestor
110420819|NCT00892957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110420820|NCT00892957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110420821|NCT05322733|Cyclophosphamide|cyclophosphamide|mesh-list
110420822|NCT05322733|Fludarabine|fludarabine|mesh-list
110420823|NCT05322733|Obinutuzumab|obinutuzumab|mesh-list
110420824|NCT05322733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110420825|NCT05322733|Immunologic Factors|immunologic factors|mesh-ancestor
110420826|NCT05322733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110420827|NCT05322733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110420828|NCT05322733|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110420829|NCT05322733|Alkylating Agents|alkylating agents|mesh-ancestor
110420830|NCT05322733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110420832|NCT05322733|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110420833|NCT05322733|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110420834|NCT00968812|Metformin|metformin|mesh-list
110420835|NCT00968812|Glimepiride|glimepiride|mesh-list
110420836|NCT00968812|Canagliflozin|canagliflozin|mesh-list
110420837|NCT00968812|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110420838|NCT00968812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110420839|NCT00968812|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110420840|NCT00968812|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110420841|NCT00968812|Immunologic Factors|immunologic factors|mesh-ancestor
110420842|NCT00968812|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110420843|NCT00968812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110420844|NCT02834845|Sevoflurane|sevoflurane|mesh-list
110420845|NCT02834845|Desflurane|desflurane|mesh-list
110420846|NCT02834845|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110420847|NCT02834845|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110420848|NCT02834845|Anesthetics, General|anesthetics, general|mesh-ancestor
110420849|NCT02834845|Anesthetics|anesthetics|mesh-ancestor
110420850|NCT02834845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110420851|NCT02834845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110420852|NCT05197192|Venetoclax|venetoclax|mesh-list
110420853|NCT05197192|Obinutuzumab|obinutuzumab|mesh-list
110420854|NCT05197192|Acalabrutinib|acalabrutinib|mesh-list
110420855|NCT05197192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110420856|NCT05197192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110420857|NCT00992056|Metoprolol|metoprolol|mesh-list
110420858|NCT00992056|Nebivolol|nebivolol|mesh-list
110420859|NCT00992056|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110420860|NCT00992056|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110420861|NCT00992056|Sympatholytics|sympatholytics|mesh-ancestor
110420862|NCT00992056|Autonomic Agents|autonomic agents|mesh-ancestor
110420863|NCT00992056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110420864|NCT00992056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110420865|NCT00992056|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110420866|NCT00992056|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110420867|NCT00992056|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110420868|NCT00992056|Adrenergic Agents|adrenergic agents|mesh-ancestor
110420869|NCT00992056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110420870|NCT00992056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110420871|NCT00992056|Vasodilator Agents|vasodilator agents|mesh-ancestor
110369714|NCT04676789|Antibodies|antibodies|mesh-list
110420872|NCT00992056|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
110420873|NCT00992056|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110420874|NCT00992056|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110420875|NCT00967798|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110420876|NCT00967798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110420877|NCT00967798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110420878|NCT00967798|Incretins|incretins|mesh-ancestor
110420880|NCT00967798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110420881|NCT00967798|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110420882|NCT00967798|Protease Inhibitors|protease inhibitors|mesh-ancestor
110420883|NCT00967798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110420884|NCT00967798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110420885|NCT04248205|Ketamine|ketamine|mesh-list
110420886|NCT04248205|Analgesics|analgesics|mesh-ancestor
110420887|NCT04248205|Sensory System Agents|sensory system agents|mesh-ancestor
110420888|NCT04248205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110420889|NCT04248205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110420890|NCT04248205|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110420891|NCT04248205|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110420892|NCT04248205|Anesthetics, General|anesthetics, general|mesh-ancestor
110420893|NCT04248205|Anesthetics|anesthetics|mesh-ancestor
110420894|NCT04248205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110420895|NCT04248205|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110420896|NCT04248205|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110420897|NCT04248205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110420898|NCT04248205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110420899|NCT02833831|Moxifloxacin|moxifloxacin|mesh-list
110420900|NCT02833831|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110420901|NCT02833831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110420902|NCT02833831|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110420903|NCT02833831|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110420904|NCT02833831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110420905|NCT02833831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110420908|NCT02833987|Rivaroxaban|rivaroxaban|mesh-list
110420909|NCT02833987|Dabigatran|dabigatran|mesh-list
110420910|NCT02833987|Apixaban|apixaban|mesh-list
110420911|NCT02833987|Anticoagulants|anticoagulants|mesh-ancestor
110420912|NCT02833987|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110420913|NCT02833987|Antithrombins|antithrombins|mesh-ancestor
110420914|NCT02833987|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110420915|NCT02833987|Protease Inhibitors|protease inhibitors|mesh-ancestor
110420916|NCT02833987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110420917|NCT02833987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110420918|NCT02837185|Botulinum Toxins|botulinum toxins|mesh-list
110420919|NCT02837185|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110420920|NCT02837185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110420921|NCT02837185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110420922|NCT02837185|Cholinergic Agents|cholinergic agents|mesh-ancestor
110420923|NCT02837185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110420924|NCT02837185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110420925|NCT00965458|Alefacept|alefacept|mesh-list
110420926|NCT00965458|Dermatologic Agents|dermatologic agents|mesh-ancestor
110420927|NCT00965458|Immunologic Factors|immunologic factors|mesh-ancestor
110369718|NCT04676789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110420928|NCT00965458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110420929|NCT04249531|Amikacin|amikacin|mesh-list
110420930|NCT04249531|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110420931|NCT04249531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110420932|NCT02836639|Etoposide|etoposide|mesh-list
110420933|NCT02836639|Busulfan|busulfan|mesh-list
110420934|NCT02836639|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110420935|NCT02836639|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110420936|NCT02836639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110420937|NCT02836639|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110420938|NCT02836639|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110420939|NCT02836639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110420940|NCT02836639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110420941|NCT02836639|Alkylating Agents|alkylating agents|mesh-ancestor
110420942|NCT02836639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110420943|NCT02836639|Immunologic Factors|immunologic factors|mesh-ancestor
110420944|NCT02836639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110420945|NCT02836639|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110420946|NCT02836639|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110420947|NCT00972244|Dapagliflozin|dapagliflozin|mesh-list
110420948|NCT00972244|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110420949|NCT00972244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110420950|NCT00972244|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110420951|NCT00972244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110420952|NCT05333419|Latanoprost|latanoprost|mesh-list
110420953|NCT05333419|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110420954|NCT05333419|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110420955|NCT02836795|Antibodies|antibodies|mesh-list
110420956|NCT02836795|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110420957|NCT02836795|Immunologic Factors|immunologic factors|mesh-ancestor
110420958|NCT02836795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110420959|NCT02836483|Linezolid|linezolid|mesh-list
110420960|NCT02836483|Delpazolid|delpazolid|mesh-list
110420961|NCT02836483|Oxazolidinones|oxazolidinones|mesh-list
110420962|NCT02836483|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110420963|NCT02836483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110420964|NCT02836483|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110420965|NCT02836483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110420966|NCT02836483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110420967|NCT02836171|Itraconazole|itraconazole|mesh-list
110420968|NCT02836171|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
110420969|NCT02836171|Apatinib|apatinib|mesh-list
110420970|NCT02836171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110420971|NCT02836171|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110420972|NCT02836171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110420973|NCT02836171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110420974|NCT02836171|Antifungal Agents|antifungal agents|mesh-ancestor
110420975|NCT02836171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110420976|NCT02836171|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110420977|NCT02836171|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110420978|NCT02836171|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110420979|NCT02836171|Hormone Antagonists|hormone antagonists|mesh-ancestor
110420980|NCT02836171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110420981|NCT02836171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110420982|NCT02836171|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110420984|NCT00971932|Fluorouracil|fluorouracil|mesh-list
110420985|NCT00971932|Cetuximab|cetuximab|mesh-list
110420986|NCT00971932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110420987|NCT00971932|Antimetabolites|antimetabolites|mesh-ancestor
110420988|NCT00971932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110420989|NCT00971932|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110420990|NCT00971932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110420991|NCT00971932|Immunologic Factors|immunologic factors|mesh-ancestor
110420992|NCT00971932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110420993|NCT00971932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110420994|NCT04400929|Molgramostim|molgramostim|mesh-list
110420995|NCT04400929|Sargramostim|sargramostim|mesh-list
110420996|NCT04400929|Immunologic Factors|immunologic factors|mesh-ancestor
110420997|NCT04400929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110420998|NCT04400929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110420999|NCT05170672|Abatacept|abatacept|mesh-list
110421000|NCT05170672|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110421001|NCT05170672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110421002|NCT05170672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110421003|NCT05170672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110421004|NCT05170672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110421005|NCT05170672|Immunologic Factors|immunologic factors|mesh-ancestor
110421006|NCT05170672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110421007|NCT05170672|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110421008|NCT00970684|Bevacizumab|bevacizumab|mesh-list
110421009|NCT00970684|Gemcitabine|gemcitabine|mesh-list
110421010|NCT00970684|Docetaxel|docetaxel|mesh-list
110421011|NCT00970684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110421012|NCT00970684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110421013|NCT00970684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110421014|NCT00970684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110421015|NCT00970684|Growth Substances|growth substances|mesh-ancestor
110421016|NCT00970684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110421017|NCT00970684|Growth Inhibitors|growth inhibitors|mesh-ancestor
110421018|NCT00970684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110421019|NCT00970684|Antimetabolites|antimetabolites|mesh-ancestor
110421020|NCT00970684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110421021|NCT00970684|Tubulin Modulators|tubulin modulators|mesh-ancestor
110421022|NCT00970684|Antimitotic Agents|antimitotic agents|mesh-ancestor
110421023|NCT00970684|Mitosis Modulators|mitosis modulators|mesh-ancestor
110421024|NCT00967330|Bevacizumab|bevacizumab|mesh-list
110421025|NCT00967330|Irinotecan|irinotecan|mesh-list
110421026|NCT00967330|Temozolomide|temozolomide|mesh-list
110421027|NCT00967330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110421028|NCT00967330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110421029|NCT00967330|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110421030|NCT00967330|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110421031|NCT00967330|Growth Substances|growth substances|mesh-ancestor
110421032|NCT00967330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110421033|NCT00967330|Growth Inhibitors|growth inhibitors|mesh-ancestor
110421034|NCT00967330|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110421035|NCT00967330|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110421036|NCT00967330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110421037|NCT00967330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110421038|NCT00967330|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110421039|NCT00967330|Alkylating Agents|alkylating agents|mesh-ancestor
110421040|NCT02863276|Insulin|insulin|mesh-list
110421041|NCT02863276|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110421042|NCT02863276|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110421043|NCT02863276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110421044|NCT04286152|Mirabegron|mirabegron|mesh-list
110421045|NCT04286152|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
110421046|NCT04286152|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110421047|NCT04286152|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110421048|NCT04286152|Adrenergic Agents|adrenergic agents|mesh-ancestor
110421049|NCT04286152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110328367|NCT00591604|Vitamins|vitamins|mesh-ancestor
110421050|NCT04286152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110421051|NCT04286152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110421052|NCT04286152|Urological Agents|urological agents|mesh-ancestor
110421053|NCT00966940|Travoprost|travoprost|mesh-list
110421054|NCT00966940|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110421055|NCT00966940|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110421056|NCT00966940|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110421057|NCT00965848|Doripenem|doripenem|mesh-list
110421058|NCT00965848|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110421059|NCT00965848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110421060|NCT03447574|Ethanol|ethanol|mesh-list
110421061|NCT03447574|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110421062|NCT03447574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110421063|NCT03447574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110421064|NCT03447574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110421065|NCT04284826|Mitomycins|mitomycins|mesh-list
110421066|NCT04284826|Mitomycin|mitomycin|mesh-list
110421067|NCT04284826|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110421068|NCT04284826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110421069|NCT04284826|Alkylating Agents|alkylating agents|mesh-ancestor
110421070|NCT04284826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110421071|NCT04284826|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110421072|NCT04284826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110421073|NCT04285528|Lidocaine|lidocaine|mesh-list
110421074|NCT04285528|Fentanyl|fentanyl|mesh-list
110421075|NCT04285528|Ketamine|ketamine|mesh-list
110421076|NCT04285528|Propofol|propofol|mesh-list
110421077|NCT04285528|Anesthetics, Local|anesthetics, local|mesh-ancestor
110421078|NCT04285528|Anesthetics|anesthetics|mesh-ancestor
110421079|NCT04285528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110421080|NCT04285528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110421081|NCT04285528|Sensory System Agents|sensory system agents|mesh-ancestor
110421082|NCT04285528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110421083|NCT04285528|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110421084|NCT04285528|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110421085|NCT04285528|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110421086|NCT04285528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110421087|NCT04285528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110421088|NCT04285528|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110421089|NCT04285528|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110421090|NCT04285528|Anesthetics, General|anesthetics, general|mesh-ancestor
110421092|NCT04285528|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110421093|NCT04285528|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110421094|NCT04285528|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110421095|NCT04285528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110421096|NCT04285528|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110421097|NCT04285528|Narcotics|narcotics|mesh-ancestor
110421098|NCT04285528|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110421099|NCT00629824|Interferons|interferons|mesh-list
110421100|NCT00629824|Ribavirin|ribavirin|mesh-list
110421101|NCT00629824|Interferon-alpha|interferon-alpha|mesh-list
110421102|NCT00629824|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110421103|NCT00629824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110421104|NCT00629824|Antiviral Agents|antiviral agents|mesh-ancestor
110421105|NCT00629824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110421106|NCT00629824|Antimetabolites|antimetabolites|mesh-ancestor
110421107|NCT00629824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110421108|NCT00629824|Immunologic Factors|immunologic factors|mesh-ancestor
110421109|NCT00629824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110421111|NCT00961636|Niacinamide|niacinamide|mesh-list
110421112|NCT00961636|Nicotinic Acids|nicotinic acids|mesh-list
110421113|NCT00961636|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110421114|NCT00961636|Antimetabolites|antimetabolites|mesh-ancestor
110421115|NCT00961636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110421116|NCT00961636|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110421117|NCT00961636|Vasodilator Agents|vasodilator agents|mesh-ancestor
110421118|NCT00961636|Vitamin B Complex|vitamin b complex|mesh-ancestor
110421119|NCT00961636|Vitamins|vitamins|mesh-ancestor
110421120|NCT00961636|Micronutrients|micronutrients|mesh-ancestor
110421121|NCT00961636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110421122|NCT00964678|Carvedilol|carvedilol|mesh-list
110421123|NCT00964678|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110421124|NCT00964678|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110421126|NCT00964678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110421127|NCT00964678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110068100|NCT01548794|Lidocaine|lidocaine|mesh-list
110421128|NCT00964678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110421129|NCT00964678|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110421130|NCT00964678|Antioxidants|antioxidants|mesh-ancestor
110421131|NCT00964678|Protective Agents|protective agents|mesh-ancestor
110421132|NCT00964678|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110421133|NCT00964678|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110421134|NCT00964678|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110421135|NCT00964678|Vasodilator Agents|vasodilator agents|mesh-ancestor
110421136|NCT00964678|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110421137|NCT00964678|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110421138|NCT00964366|Clindamycin|clindamycin|mesh-list
110421139|NCT00964366|Clindamycin palmitate|clindamycin palmitate|mesh-list
110421140|NCT00964366|Clindamycin phosphate|clindamycin phosphate|mesh-list
110421141|NCT00964366|Dapsone|dapsone|mesh-list
110421142|NCT00964366|Benzoyl Peroxide|benzoyl peroxide|mesh-list
110421143|NCT00964366|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110200209|NCT00047099|Goserelin|goserelin|mesh-list
110421144|NCT00964366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110421145|NCT00964366|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110421146|NCT00964366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110421147|NCT00964366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110421148|NCT00964366|Dermatologic Agents|dermatologic agents|mesh-ancestor
110421149|NCT00964366|Antimalarials|antimalarials|mesh-ancestor
110421150|NCT00964366|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110421151|NCT00964366|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110421152|NCT00964366|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110421153|NCT00964366|Leprostatic Agents|leprostatic agents|mesh-ancestor
110421154|NCT03545464|Prednisone|prednisone|mesh-list
110421155|NCT03545464|Levocetirizine|levocetirizine|mesh-list
110421156|NCT03545464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110421157|NCT03545464|Glucocorticoids|glucocorticoids|mesh-ancestor
110421158|NCT03545464|Hormones|hormones|mesh-ancestor
110421159|NCT03545464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110421160|NCT03545464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110421161|NCT03545464|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110421162|NCT03545464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110421163|NCT03545464|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110421164|NCT03545464|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110421165|NCT03545464|Histamine Antagonists|histamine antagonists|mesh-ancestor
110421166|NCT03545464|Histamine Agents|histamine agents|mesh-ancestor
110421167|NCT03545464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110421168|NCT03545464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110421169|NCT04284514|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110421170|NCT04284514|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110421171|NCT02860936|Lenvatinib|lenvatinib|mesh-list
110421172|NCT02860936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110421173|NCT02860936|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110421174|NCT02860936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110421175|NCT02860936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110421176|NCT00630214|Calcium, Dietary|calcium, dietary|mesh-list
110421177|NCT00630214|Vitamin D|vitamin d|mesh-list
110421178|NCT00630214|Ergocalciferols|ergocalciferols|mesh-list
110421179|NCT00630214|Cholecalciferol|cholecalciferol|mesh-list
110421180|NCT00630214|Vitamins|vitamins|mesh-list
110421181|NCT00630214|Calcium Carbonate|calcium carbonate|mesh-list
110421182|NCT00630214|Calcium|calcium|mesh-list
110421183|NCT00630214|Micronutrients|micronutrients|mesh-ancestor
110421184|NCT00630214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110369767|NCT00564330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110421185|NCT00630214|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110421186|NCT00630214|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110421187|NCT00630214|Antacids|antacids|mesh-ancestor
110421188|NCT00630214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110421189|NCT00630214|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110421190|NCT02860858|Aflibercept|aflibercept|mesh-list
110421191|NCT02860858|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110421192|NCT02860858|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110421193|NCT02860858|Growth Substances|growth substances|mesh-ancestor
110421194|NCT02860858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110421195|NCT02860858|Growth Inhibitors|growth inhibitors|mesh-ancestor
110421196|NCT02860858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110421197|NCT00960076|Metformin|metformin|mesh-list
110421198|NCT00960076|Saxagliptin|saxagliptin|mesh-list
110421199|NCT00960076|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110421200|NCT00960076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110421201|NCT00960076|Incretins|incretins|mesh-ancestor
110421202|NCT00960076|Hormones|hormones|mesh-ancestor
110421203|NCT00960076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110421204|NCT00960076|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110421205|NCT00960076|Protease Inhibitors|protease inhibitors|mesh-ancestor
110421206|NCT00960076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110421207|NCT00960076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110421208|NCT04281082|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
110421209|NCT04281082|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
110421210|NCT04281082|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110421212|NCT04284202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110421213|NCT04284202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110421214|NCT04284202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110421215|NCT04284202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110421216|NCT01227629|Warfarin|warfarin|mesh-list
110421217|NCT01227629|Dabigatran|dabigatran|mesh-list
110421218|NCT01227629|Anticoagulants|anticoagulants|mesh-ancestor
110421219|NCT01227629|Antithrombins|antithrombins|mesh-ancestor
110421220|NCT01227629|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110421221|NCT01227629|Protease Inhibitors|protease inhibitors|mesh-ancestor
110421222|NCT01227629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110421223|NCT01227629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110421224|NCT00963820|Ixazomib|ixazomib|mesh-list
110421225|NCT00963820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110421226|NCT00963820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110421227|NCT00963820|Protease Inhibitors|protease inhibitors|mesh-ancestor
110421228|NCT00963820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110421229|NCT03241186|Nivolumab|nivolumab|mesh-list
110421230|NCT03241186|Ipilimumab|ipilimumab|mesh-list
110421231|NCT03241186|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110421232|NCT03241186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110421233|NCT03241186|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110421234|NCT03241186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110421235|NCT01227395|Azithromycin|azithromycin|mesh-list
110421236|NCT01227395|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110421237|NCT01227395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110421238|NCT03237286|Ketamine|ketamine|mesh-list
110421239|NCT03237286|Analgesics|analgesics|mesh-ancestor
110421240|NCT03237286|Sensory System Agents|sensory system agents|mesh-ancestor
110421241|NCT03237286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110421242|NCT03237286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110421243|NCT03237286|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110421244|NCT03237286|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110421245|NCT03237286|Anesthetics, General|anesthetics, general|mesh-ancestor
110421246|NCT03237286|Anesthetics|anesthetics|mesh-ancestor
110421247|NCT03237286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110421248|NCT03237286|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110421249|NCT03237286|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110421250|NCT03237286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110421251|NCT03237286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110421252|NCT01226459|Minoxidil|minoxidil|mesh-list
110421253|NCT01226459|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110421254|NCT01226459|Vasodilator Agents|vasodilator agents|mesh-ancestor
110421255|NCT01225991|Milnacipran|milnacipran|mesh-list
110421256|NCT01225991|Levomilnacipran|levomilnacipran|mesh-list
110421257|NCT01225991|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110421258|NCT01225991|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110421259|NCT01225991|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110421260|NCT01225991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110421261|NCT01225991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110421262|NCT01225991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110421263|NCT01225991|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110421264|NCT01225991|Analgesics|analgesics|mesh-ancestor
110421265|NCT01225991|Sensory System Agents|sensory system agents|mesh-ancestor
110421266|NCT01225991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110421267|NCT01225991|Antidepressive Agents|antidepressive agents|mesh-ancestor
110421268|NCT01225991|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110421269|NCT04283110|Midazolam|midazolam|mesh-list
110421270|NCT04283110|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110421271|NCT04283110|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110421272|NCT04283110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110421273|NCT04283110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110421274|NCT04283110|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110421275|NCT04283110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110421276|NCT04283110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110421277|NCT04283110|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110421278|NCT04283110|Anesthetics, General|anesthetics, general|mesh-ancestor
110421279|NCT04283110|Anesthetics|anesthetics|mesh-ancestor
110421280|NCT04283110|GABA Modulators|gaba modulators|mesh-ancestor
110421281|NCT04283110|GABA Agents|gaba agents|mesh-ancestor
110421282|NCT04283110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110421283|NCT04283110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110421284|NCT02860780|Prexasertib|prexasertib|mesh-list
110421285|NCT02860780|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110421286|NCT02860780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110421287|NCT02860780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110421288|NCT01225835|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
110421289|NCT01225835|Cetrorelix|cetrorelix|mesh-list
110421290|NCT01225835|Menotropins|menotropins|mesh-list
110421291|NCT01225835|Progesterone|progesterone|mesh-list
110421292|NCT01225835|Progestins|progestins|mesh-ancestor
110421293|NCT01225835|Hormones|hormones|mesh-ancestor
110421294|NCT01225835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110421295|NCT01225835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110200323|NCT00080847|Tubulin Modulators|tubulin modulators|mesh-ancestor
110421296|NCT01225835|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110421297|NCT01225835|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110421298|NCT01225835|Fertility Agents|fertility agents|mesh-ancestor
110421299|NCT01225835|Hormone Antagonists|hormone antagonists|mesh-ancestor
110421300|NCT04282096|Caseins|caseins|mesh-list
110421301|NCT04282096|Chelating Agents|chelating agents|mesh-ancestor
110421302|NCT04282096|Sequestering Agents|sequestering agents|mesh-ancestor
110421303|NCT04282096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110421304|NCT02899000|Doxycycline|doxycycline|mesh-list
110421305|NCT02899000|Adapalene|adapalene|mesh-list
110421306|NCT02899000|Benzoyl Peroxide|benzoyl peroxide|mesh-list
110421307|NCT02899000|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110421308|NCT02899000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110421309|NCT02899000|Antimalarials|antimalarials|mesh-ancestor
110421310|NCT02899000|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110421311|NCT02899000|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110421312|NCT02899000|Dermatologic Agents|dermatologic agents|mesh-ancestor
110421313|NCT02899000|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110421314|NCT02899000|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110421315|NCT02899000|Analgesics|analgesics|mesh-ancestor
110421316|NCT02899000|Sensory System Agents|sensory system agents|mesh-ancestor
110421317|NCT02899000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110421318|NCT02899000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110421319|NCT02899000|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110421320|NCT02899000|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110421321|NCT04281862|Prednisolone|prednisolone|mesh-list
110421322|NCT04281862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110421323|NCT04281862|Glucocorticoids|glucocorticoids|mesh-ancestor
110421324|NCT04281862|Hormones|hormones|mesh-ancestor
110421325|NCT04281862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110421326|NCT04281862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110328392|NCT00461747|Bortezomib|bortezomib|mesh-list
110421327|NCT04281862|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110421328|NCT04281862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110421329|NCT03122002|Clopidogrel|clopidogrel|mesh-list
110421330|NCT03122002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110421331|NCT03122002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110421332|NCT03122002|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110421333|NCT03122002|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110421334|NCT03122002|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110421335|NCT03122002|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110421336|NCT03122002|Purinergic Agents|purinergic agents|mesh-ancestor
110421337|NCT03122002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110421338|NCT02861482|Oxytocin|oxytocin|mesh-list
110421339|NCT02861482|Carboprost tromethamine|carboprost tromethamine|mesh-list
110421340|NCT02861482|Oxytocics|oxytocics|mesh-ancestor
110421341|NCT02861482|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110421342|NCT02861482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110421343|NCT02861716|Fentanyl|fentanyl|mesh-list
110421344|NCT02861716|Dexmedetomidine|dexmedetomidine|mesh-list
110421345|NCT02861716|Bupivacaine|bupivacaine|mesh-list
110421346|NCT02861716|Anesthetics, Local|anesthetics, local|mesh-ancestor
110421347|NCT02861716|Anesthetics|anesthetics|mesh-ancestor
110421348|NCT02861716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110421349|NCT02861716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110421350|NCT02861716|Sensory System Agents|sensory system agents|mesh-ancestor
110421351|NCT02861716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110421352|NCT02861716|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110421353|NCT02861716|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110421354|NCT02861716|Analgesics|analgesics|mesh-ancestor
110421355|NCT02861716|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110421356|NCT02861716|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110421357|NCT02861716|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110421358|NCT02861716|Adrenergic Agents|adrenergic agents|mesh-ancestor
110421359|NCT02861716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110200373|NCT00134212|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110421360|NCT02861716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110421361|NCT02861716|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110421362|NCT02861716|Narcotics|narcotics|mesh-ancestor
110421363|NCT02861716|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110421364|NCT02861716|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110421365|NCT02861716|Anesthetics, General|anesthetics, general|mesh-ancestor
110421366|NCT00960934|Vitamin D|vitamin d|mesh-list
110421367|NCT00960934|Cholecalciferol|cholecalciferol|mesh-list
110421368|NCT00960934|Calcium Carbonate|calcium carbonate|mesh-list
110421369|NCT00960934|Calcium|calcium|mesh-list
110421370|NCT00960934|Vitamins|vitamins|mesh-ancestor
110421371|NCT00960934|Micronutrients|micronutrients|mesh-ancestor
110421372|NCT00960934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110421373|NCT00960934|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110421374|NCT00960934|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110421375|NCT00960934|Antacids|antacids|mesh-ancestor
110421376|NCT00960934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110421377|NCT00960934|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110421378|NCT00892177|Bevacizumab|bevacizumab|mesh-list
110421379|NCT00892177|Dasatinib|dasatinib|mesh-list
110421380|NCT00892177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110421381|NCT00892177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110421382|NCT00892177|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110421383|NCT00892177|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110421384|NCT00892177|Growth Substances|growth substances|mesh-ancestor
110421385|NCT00892177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110421386|NCT00892177|Growth Inhibitors|growth inhibitors|mesh-ancestor
110421387|NCT00892177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110421388|NCT00892177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110421389|NCT00892177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110421390|NCT00962104|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
110421391|NCT00962104|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110421392|NCT00962104|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110421393|NCT00962104|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110421394|NCT00962104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110421395|NCT00962104|Adrenergic Agents|adrenergic agents|mesh-ancestor
110421396|NCT00962104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110421397|NCT00962104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110421399|NCT02821000|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110421400|NCT02821000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110421401|NCT02821000|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110421402|NCT02821000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110421403|NCT02860624|Esomeprazole|esomeprazole|mesh-list
110421404|NCT02860624|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110421405|NCT02860624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110421406|NCT02860624|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110421407|NCT02860624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110421408|NCT02860624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110421409|NCT00892099|Vitamin D|vitamin d|mesh-list
110421410|NCT00892099|Ergocalciferols|ergocalciferols|mesh-list
110421411|NCT00892099|Cholecalciferol|cholecalciferol|mesh-list
110421412|NCT00892099|Vitamins|vitamins|mesh-list
110421413|NCT00892099|Micronutrients|micronutrients|mesh-ancestor
110421414|NCT00892099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110421415|NCT00892099|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110421416|NCT00892099|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110421417|NCT00960856|Fenofibric acid|fenofibric acid|mesh-list
110421418|NCT00960856|Fenofibrate|fenofibrate|mesh-list
110421419|NCT00960856|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110421420|NCT00960856|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110421421|NCT00960856|Antimetabolites|antimetabolites|mesh-ancestor
110421422|NCT00960856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110421423|NCT00960856|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110421424|NCT00958438|Rilonacept|rilonacept|mesh-list
110421425|NCT00958438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110421426|NCT02835469|Menotropins|menotropins|mesh-list
110421427|NCT02835469|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110421428|NCT02835469|Fertility Agents|fertility agents|mesh-ancestor
110421429|NCT02835469|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110068411|NCT01550653|Hormones|hormones|mesh-ancestor
110421430|NCT02835469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110421431|NCT02832973|Ramipril|ramipril|mesh-list
110421433|NCT02832973|Amiloride|amiloride|mesh-list
110421434|NCT02832973|Furosemide|furosemide|mesh-list
110421435|NCT02832973|Spironolactone|spironolactone|mesh-list
110421436|NCT02832973|Diuretics|diuretics|mesh-list
110421437|NCT02832973|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
110421438|NCT02832973|Natriuretic Agents|natriuretic agents|mesh-ancestor
110421439|NCT02832973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110421440|NCT02832973|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110421441|NCT02832973|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110421442|NCT02832973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110421443|NCT02832973|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110421444|NCT02832973|Hormone Antagonists|hormone antagonists|mesh-ancestor
110421445|NCT02832973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110421446|NCT02832973|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110421447|NCT02832973|Protease Inhibitors|protease inhibitors|mesh-ancestor
110421448|NCT02832973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110421449|NCT02832973|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110421450|NCT02832973|Sympatholytics|sympatholytics|mesh-ancestor
110421451|NCT02832973|Autonomic Agents|autonomic agents|mesh-ancestor
110421452|NCT02832973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110421453|NCT02832973|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110421454|NCT02832973|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110421455|NCT02832973|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110421456|NCT02832973|Adrenergic Agents|adrenergic agents|mesh-ancestor
110421457|NCT02832973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110421458|NCT02832973|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
110421459|NCT02832973|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110421460|NCT02832973|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
110421461|NCT02831491|Docetaxel|docetaxel|mesh-list
110421462|NCT02831491|Ramucirumab|ramucirumab|mesh-list
110421463|NCT02831491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110421464|NCT02831491|Tubulin Modulators|tubulin modulators|mesh-ancestor
110421465|NCT02831491|Antimitotic Agents|antimitotic agents|mesh-ancestor
110421466|NCT02831491|Mitosis Modulators|mitosis modulators|mesh-ancestor
110421467|NCT02831491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110421468|NCT02860234|Capecitabine|capecitabine|mesh-list
110421469|NCT02860234|Oxaliplatin|oxaliplatin|mesh-list
110421470|NCT02860234|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110421471|NCT02860234|Antimetabolites|antimetabolites|mesh-ancestor
110421472|NCT02860234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110421473|NCT02860234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110421475|NCT00630370|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
110421476|NCT00630370|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110421477|NCT00630370|Serotonin Agents|serotonin agents|mesh-ancestor
110421478|NCT00630370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110421479|NCT00630370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110421480|NCT00630370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110421481|NCT02835391|Surgiflo|surgiflo|mesh-list
110421482|NCT02835391|Hemostatics|hemostatics|mesh-ancestor
110421483|NCT02835391|Coagulants|coagulants|mesh-ancestor
110421484|NCT02831101|Sufentanil|sufentanil|mesh-list
110421485|NCT02831101|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110421486|NCT02831101|Narcotics|narcotics|mesh-ancestor
110421487|NCT02831101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110421488|NCT02831101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110421489|NCT02831101|Analgesics|analgesics|mesh-ancestor
110421490|NCT02831101|Sensory System Agents|sensory system agents|mesh-ancestor
110421491|NCT02831101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110421492|NCT02831101|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110421493|NCT02831101|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110421494|NCT02831101|Anesthetics, General|anesthetics, general|mesh-ancestor
110421495|NCT02831101|Anesthetics|anesthetics|mesh-ancestor
110421496|NCT04245787|Fluorides|fluorides|mesh-list
110421497|NCT04245787|Cariostatic Agents|cariostatic agents|mesh-ancestor
110421498|NCT04245787|Protective Agents|protective agents|mesh-ancestor
110421499|NCT04245787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110421500|NCT02831179|Capecitabine|capecitabine|mesh-list
110421501|NCT02831179|Temozolomide|temozolomide|mesh-list
110421502|NCT02831179|Veliparib|veliparib|mesh-list
110421503|NCT02831179|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110421504|NCT02831179|Antimetabolites|antimetabolites|mesh-ancestor
110421505|NCT02831179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110421506|NCT02831179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110421507|NCT02831179|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110421508|NCT02831179|Alkylating Agents|alkylating agents|mesh-ancestor
110421509|NCT02831179|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110421510|NCT02831179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110421511|NCT02830789|Calcium, Dietary|calcium, dietary|mesh-list
110421512|NCT02830789|Calcium Carbonate|calcium carbonate|mesh-list
110421513|NCT02830789|Calcium|calcium|mesh-list
110421514|NCT02830789|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110421515|NCT02830789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110421516|NCT02830789|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110421517|NCT02830789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110421518|NCT02830789|Antacids|antacids|mesh-ancestor
110421519|NCT02830789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110421520|NCT04243993|Calcium|calcium|mesh-list
110421521|NCT04243993|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110421522|NCT04243993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110421523|NCT04245319|Acitretin|acitretin|mesh-list
110421524|NCT04245319|Keratolytic Agents|keratolytic agents|mesh-ancestor
110421525|NCT04245319|Dermatologic Agents|dermatologic agents|mesh-ancestor
110421526|NCT02828059|Ropivacaine|ropivacaine|mesh-list
110421527|NCT02828059|Anesthetics, Local|anesthetics, local|mesh-ancestor
110421528|NCT02828059|Anesthetics|anesthetics|mesh-ancestor
110421529|NCT02828059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110200496|NCT00134641|Gemcitabine|gemcitabine|mesh-list
110421530|NCT02828059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110421531|NCT02828059|Sensory System Agents|sensory system agents|mesh-ancestor
110421532|NCT02828059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110421533|NCT02827903|Metformin|metformin|mesh-list
110421535|NCT02827903|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110421536|NCT02827903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110421537|NCT02827903|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110421538|NCT02827903|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110421539|NCT02827903|Antimetabolites|antimetabolites|mesh-ancestor
110421540|NCT02827903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110421541|NCT02827903|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110421542|NCT02827903|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110421543|NCT02827903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110421544|NCT01243424|Glimepiride|glimepiride|mesh-list
110421545|NCT01243424|Linagliptin|linagliptin|mesh-list
110421546|NCT01243424|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110421547|NCT01243424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110421548|NCT01243424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110421549|NCT01243424|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110421550|NCT01243424|Immunologic Factors|immunologic factors|mesh-ancestor
110421551|NCT01243424|Incretins|incretins|mesh-ancestor
110421552|NCT01243424|Hormones|hormones|mesh-ancestor
110421553|NCT01243424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110421554|NCT01243424|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110421555|NCT01243424|Protease Inhibitors|protease inhibitors|mesh-ancestor
110421556|NCT01243424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110421557|NCT01243424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110421558|NCT02831023|Pyrimethamine|pyrimethamine|mesh-list
110421559|NCT02831023|Primaquine|primaquine|mesh-list
110421560|NCT02831023|Piperaquine|piperaquine|mesh-list
110421561|NCT02831023|Sulfadoxine|sulfadoxine|mesh-list
110421562|NCT02831023|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
110421563|NCT02831023|Amodiaquine|amodiaquine|mesh-list
110421564|NCT02831023|Artenimol|artenimol|mesh-list
110421565|NCT02831023|Methylene Blue|methylene blue|mesh-list
110421566|NCT02831023|Antimalarials|antimalarials|mesh-ancestor
110421567|NCT02831023|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110421568|NCT02831023|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110421569|NCT02831023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110421570|NCT02831023|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110421571|NCT02831023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110421572|NCT02831023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110421573|NCT02831023|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110421574|NCT04244695|Dexamethasone|dexamethasone|mesh-list
110421575|NCT04244695|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110421576|NCT04244695|Antiemetics|antiemetics|mesh-ancestor
110421577|NCT04244695|Autonomic Agents|autonomic agents|mesh-ancestor
110421578|NCT04244695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110421579|NCT04244695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110421580|NCT04244695|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110421581|NCT04244695|Glucocorticoids|glucocorticoids|mesh-ancestor
110421582|NCT04244695|Hormones|hormones|mesh-ancestor
110068547|NCT01551511|Hormones|hormones|mesh-ancestor
110421583|NCT04244695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110421584|NCT04244695|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110421585|NCT04244695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110421586|NCT00887809|Bevacizumab|bevacizumab|mesh-list
110421587|NCT00887809|Gemcitabine|gemcitabine|mesh-list
110421588|NCT00887809|Docetaxel|docetaxel|mesh-list
110421589|NCT00887809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110421590|NCT00887809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110421591|NCT00887809|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110421592|NCT00887809|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110421593|NCT00887809|Growth Substances|growth substances|mesh-ancestor
110421594|NCT00887809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110421595|NCT00887809|Growth Inhibitors|growth inhibitors|mesh-ancestor
110421596|NCT00887809|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110421597|NCT00887809|Antimetabolites|antimetabolites|mesh-ancestor
110421598|NCT00887809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110421599|NCT00887809|Tubulin Modulators|tubulin modulators|mesh-ancestor
110421600|NCT00887809|Antimitotic Agents|antimitotic agents|mesh-ancestor
110369806|NCT00564408|Analgesics|analgesics|mesh-ancestor
110421601|NCT00887809|Mitosis Modulators|mitosis modulators|mesh-ancestor
110421602|NCT02827747|Vitamin A|vitamin a|mesh-list
110421603|NCT02827747|Antioxidants|antioxidants|mesh-list
110421604|NCT02827747|Vitamins|vitamins|mesh-ancestor
110421605|NCT02827747|Micronutrients|micronutrients|mesh-ancestor
110421606|NCT02827747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110421607|NCT02827747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110421608|NCT02827747|Protective Agents|protective agents|mesh-ancestor
110421610|NCT04281628|Analgesics|analgesics|mesh-ancestor
110421611|NCT04281628|Sensory System Agents|sensory system agents|mesh-ancestor
110421612|NCT04281628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110421613|NCT04281628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110421614|NCT04281628|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110421615|NCT04281628|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110421616|NCT04281628|Anesthetics, General|anesthetics, general|mesh-ancestor
110421617|NCT04281628|Anesthetics|anesthetics|mesh-ancestor
110421618|NCT04281628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110421619|NCT04281628|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110421620|NCT04281628|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110421621|NCT04281628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110421622|NCT04281628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110421623|NCT00886795|Abatacept|abatacept|mesh-list
110421624|NCT00886795|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110421625|NCT00886795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110421626|NCT00886795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110421627|NCT00886795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110421628|NCT00886795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110421629|NCT00886795|Immunologic Factors|immunologic factors|mesh-ancestor
110421630|NCT00886795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110421631|NCT00886795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110421632|NCT02783482|Immunoglobulins|immunoglobulins|mesh-list
110421633|NCT02783482|gamma-Globulins|gamma-globulins|mesh-list
110421634|NCT02783482|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110421635|NCT02783482|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110421636|NCT02783482|Immunologic Factors|immunologic factors|mesh-ancestor
110421637|NCT02783482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110421638|NCT00953680|Losartan|losartan|mesh-list
110421639|NCT00953680|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110421640|NCT00953680|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110421641|NCT00953680|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110421642|NCT00953680|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110421643|NCT00953680|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110421644|NCT00953680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110421645|NCT00953680|Diuretics|diuretics|mesh-ancestor
110421646|NCT00953680|Natriuretic Agents|natriuretic agents|mesh-ancestor
110421647|NCT00953680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110421648|NCT00953680|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110421649|NCT00953680|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110421650|NCT00890929|Lenalidomide|lenalidomide|mesh-list
110421651|NCT00890929|Azacitidine|azacitidine|mesh-list
110421652|NCT00890929|Immunologic Factors|immunologic factors|mesh-ancestor
110421653|NCT00890929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110421654|NCT00890929|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110421655|NCT00890929|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110421656|NCT00890929|Growth Substances|growth substances|mesh-ancestor
110421658|NCT00890929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110421659|NCT00890929|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110369831|NCT04608981|Diclofenac|diclofenac|mesh-list
110421660|NCT00890929|Antimetabolites|antimetabolites|mesh-ancestor
110421661|NCT00890929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110421662|NCT00890929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110421663|NCT04246567|Fentanyl|fentanyl|mesh-list
110421664|NCT04246567|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110421665|NCT04246567|Narcotics|narcotics|mesh-ancestor
110421666|NCT04246567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110421667|NCT04246567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110421668|NCT04246567|Analgesics|analgesics|mesh-ancestor
110421669|NCT04246567|Sensory System Agents|sensory system agents|mesh-ancestor
110421670|NCT04246567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110421671|NCT04246567|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110421672|NCT04246567|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110421673|NCT04246567|Anesthetics, General|anesthetics, general|mesh-ancestor
110421674|NCT04246567|Anesthetics|anesthetics|mesh-ancestor
110421675|NCT02830243|Sevoflurane|sevoflurane|mesh-list
110421676|NCT02830243|Desflurane|desflurane|mesh-list
110421677|NCT02830243|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110421678|NCT02830243|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110328418|NCT00461825|Mycophenolic Acid|mycophenolic acid|mesh-list
110421679|NCT02830243|Anesthetics, General|anesthetics, general|mesh-ancestor
110421680|NCT02830243|Anesthetics|anesthetics|mesh-ancestor
110421681|NCT02830243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110421682|NCT02830243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110421683|NCT00889603|Donepezil|donepezil|mesh-list
110421684|NCT00889603|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110421685|NCT00889603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110421686|NCT00889603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110421687|NCT00889603|Cholinergic Agents|cholinergic agents|mesh-ancestor
110421688|NCT00889603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110421689|NCT00889603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110421690|NCT00889603|Nootropic Agents|nootropic agents|mesh-ancestor
110421691|NCT02829385|Apatinib|apatinib|mesh-list
110421692|NCT02829385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110421693|NCT02829385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110421694|NCT02829385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110421695|NCT02829385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110421697|NCT02826343|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
110421698|NCT02826343|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110421699|NCT02826343|Anesthetics, General|anesthetics, general|mesh-ancestor
110421700|NCT02826343|Anesthetics|anesthetics|mesh-ancestor
110421701|NCT02826343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110421702|NCT02826343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110421703|NCT02826343|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110421704|NCT02826343|Autonomic Agents|autonomic agents|mesh-ancestor
110421705|NCT02826343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110200550|NCT00134914|Analgesics|analgesics|mesh-ancestor
110421706|NCT02826343|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110421707|NCT02826343|Respiratory System Agents|respiratory system agents|mesh-ancestor
110421708|NCT02826343|Glucocorticoids|glucocorticoids|mesh-ancestor
110421709|NCT02826343|Hormones|hormones|mesh-ancestor
110421710|NCT02826343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110421711|NCT02826343|Sympathomimetics|sympathomimetics|mesh-ancestor
110421712|NCT05660785|Cyclosporine|cyclosporine|mesh-list
110421713|NCT05660785|Cyclosporins|cyclosporins|mesh-list
110421714|NCT05660785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110421715|NCT05660785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110421716|NCT05660785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110421717|NCT05660785|Immunologic Factors|immunologic factors|mesh-ancestor
110421718|NCT05660785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110421719|NCT05660785|Antifungal Agents|antifungal agents|mesh-ancestor
110421720|NCT05660785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110421721|NCT05660785|Dermatologic Agents|dermatologic agents|mesh-ancestor
110421722|NCT05660785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110421723|NCT05660785|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110421724|NCT04246255|Lidocaine|lidocaine|mesh-list
110421725|NCT04246255|Anesthetics, Local|anesthetics, local|mesh-ancestor
110421726|NCT04246255|Anesthetics|anesthetics|mesh-ancestor
110421727|NCT04246255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110421728|NCT04246255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110421729|NCT04246255|Sensory System Agents|sensory system agents|mesh-ancestor
110369833|NCT04608981|Glucocorticoids|glucocorticoids|mesh-ancestor
110421730|NCT04246255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110421731|NCT04246255|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110421732|NCT04246255|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110421733|NCT04246255|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110421734|NCT04246255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110421735|NCT04246255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110421736|NCT02825953|Pulmonary Surfactants|pulmonary surfactants|mesh-list
110421737|NCT02825953|Respiratory System Agents|respiratory system agents|mesh-ancestor
110421738|NCT05217589|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
110421739|NCT05217589|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
110421740|NCT05217589|beta-Endorphin|beta-endorphin|mesh-list
110421741|NCT05217589|Hormones|hormones|mesh-ancestor
110421742|NCT05217589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110421743|NCT05217589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110421744|NCT05217589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110421745|NCT05217589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110421746|NCT05210725|Rivaroxaban|rivaroxaban|mesh-list
110421747|NCT05210725|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110421748|NCT05210725|Antithrombins|antithrombins|mesh-ancestor
110421749|NCT05210725|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110421750|NCT05210725|Protease Inhibitors|protease inhibitors|mesh-ancestor
110421751|NCT05210725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110421752|NCT05210725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110421754|NCT02826031|Hyaluronic Acid|hyaluronic acid|mesh-list
110421755|NCT02826031|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110421756|NCT02826031|Immunologic Factors|immunologic factors|mesh-ancestor
110421757|NCT02826031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110421758|NCT02826031|Viscosupplements|viscosupplements|mesh-ancestor
110421759|NCT02826031|Protective Agents|protective agents|mesh-ancestor
110421760|NCT02829697|Ropivacaine|ropivacaine|mesh-list
110421761|NCT02829697|Anesthetics, Local|anesthetics, local|mesh-ancestor
110421762|NCT02829697|Anesthetics|anesthetics|mesh-ancestor
110421763|NCT02829697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110421764|NCT02829697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110421765|NCT02829697|Sensory System Agents|sensory system agents|mesh-ancestor
110421766|NCT02829697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110421767|NCT02829151|Aspirin|aspirin|mesh-list
110421768|NCT02829151|Cilostazol|cilostazol|mesh-list
110421769|NCT02829151|Clopidogrel|clopidogrel|mesh-list
110421770|NCT02829151|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110421771|NCT02829151|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110421772|NCT02829151|Analgesics|analgesics|mesh-ancestor
110421773|NCT02829151|Sensory System Agents|sensory system agents|mesh-ancestor
110421774|NCT02829151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110421775|NCT02829151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110421776|NCT02829151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110421777|NCT02829151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110421778|NCT02829151|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110421779|NCT02829151|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110421780|NCT02829151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110421781|NCT02829151|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110421782|NCT02829151|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110421783|NCT02829151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110421784|NCT02829151|Antipyretics|antipyretics|mesh-ancestor
110421785|NCT02829151|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110421786|NCT02829151|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110421787|NCT02829151|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110421788|NCT02829151|Purinergic Agents|purinergic agents|mesh-ancestor
110421789|NCT02829151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110421790|NCT02829151|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110421792|NCT02829151|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110421793|NCT02829151|Respiratory System Agents|respiratory system agents|mesh-ancestor
110421794|NCT02829151|Vasodilator Agents|vasodilator agents|mesh-ancestor
110421795|NCT02829151|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110421796|NCT02829151|Protective Agents|protective agents|mesh-ancestor
110421797|NCT02829151|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110421798|NCT02829151|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110421799|NCT02825719|Tranexamic Acid|tranexamic acid|mesh-list
110421800|NCT02825719|Ulipristal acetate|ulipristal acetate|mesh-list
110421801|NCT02825719|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110421802|NCT02825719|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110421803|NCT02825719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110421804|NCT02825719|Hemostatics|hemostatics|mesh-ancestor
110421805|NCT02825719|Coagulants|coagulants|mesh-ancestor
110421806|NCT02825719|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110421807|NCT02825719|Contraceptive Agents|contraceptive agents|mesh-ancestor
110421808|NCT02825719|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110421809|NCT02825719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110421810|NCT02825719|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110421811|NCT04241653|Sevoflurane|sevoflurane|mesh-list
110421812|NCT04241653|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110421813|NCT04241653|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110421814|NCT04241653|Anesthetics, General|anesthetics, general|mesh-ancestor
110421815|NCT04241653|Anesthetics|anesthetics|mesh-ancestor
110421816|NCT04241653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110421817|NCT04241653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110421818|NCT04241731|Cetuximab|cetuximab|mesh-list
110421819|NCT04241731|Raltitrexed|raltitrexed|mesh-list
110421820|NCT04241731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110421821|NCT04241731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110421822|NCT04241731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110421824|NCT04241731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110421825|NCT04241731|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110421826|NCT04241731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110421827|NCT04241887|Anesthetics|anesthetics|mesh-list
110421828|NCT04241887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110421829|NCT04241887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110421830|NCT02825797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110421831|NCT02825797|Antibodies|antibodies|mesh-list
110421832|NCT02825797|Immunoglobulins|immunoglobulins|mesh-list
110421833|NCT02825797|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110421834|NCT02825797|Immunologic Factors|immunologic factors|mesh-ancestor
110421835|NCT02825797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110421836|NCT02825797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110421837|NCT02824315|Simeprevir|simeprevir|mesh-list
110421838|NCT02824315|Odalasvir|odalasvir|mesh-list
110421839|NCT02824315|Antiviral Agents|antiviral agents|mesh-ancestor
110421840|NCT02824315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110421841|NCT02824315|Protease Inhibitors|protease inhibitors|mesh-ancestor
110421842|NCT02824315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110421843|NCT02824315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110421844|NCT04242433|Antiviral Agents|antiviral agents|mesh-list
110421845|NCT04242433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110421846|NCT02823925|Zoledronic Acid|zoledronic acid|mesh-list
110421847|NCT02823925|Pamidronate|pamidronate|mesh-list
110421848|NCT02823925|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110421849|NCT02823925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110421850|NCT04201249|Piroxicam|piroxicam|mesh-list
110421851|NCT04201249|Lidocaine|lidocaine|mesh-list
110421852|NCT04201249|Anesthetics, Local|anesthetics, local|mesh-ancestor
110421853|NCT04201249|Anesthetics|anesthetics|mesh-ancestor
110421854|NCT04201249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110421855|NCT04201249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110421856|NCT04201249|Sensory System Agents|sensory system agents|mesh-ancestor
110421857|NCT04201249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110421858|NCT04201249|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110421859|NCT04201249|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110421860|NCT04201249|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110421861|NCT04201249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110421862|NCT04201249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110421863|NCT04201249|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110421864|NCT04201249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110421865|NCT04201249|Analgesics|analgesics|mesh-ancestor
110421866|NCT04201249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110421867|NCT04201249|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110421868|NCT04201249|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110421869|NCT04201249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110421870|NCT00633685|Fluoxetine|fluoxetine|mesh-list
110421871|NCT00633685|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110421872|NCT00633685|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110421873|NCT00633685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110421874|NCT00633685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110421875|NCT00633685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110421876|NCT00633685|Serotonin Agents|serotonin agents|mesh-ancestor
110421877|NCT00633685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110421878|NCT00633685|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110068848|NCT01554059|Bevacizumab|bevacizumab|mesh-list
110421879|NCT00633685|Antidepressive Agents|antidepressive agents|mesh-ancestor
110421880|NCT00633685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110421881|NCT00633685|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110421882|NCT00633685|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110421883|NCT00633685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110421885|NCT02823691|Lanreotide|lanreotide|mesh-list
110421886|NCT02823691|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110421887|NCT02823691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110421888|NCT02823691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110421889|NCT02825095|Lidocaine|lidocaine|mesh-list
110421890|NCT02825095|Anesthetics, Local|anesthetics, local|mesh-ancestor
110421891|NCT02825095|Anesthetics|anesthetics|mesh-ancestor
110421892|NCT02825095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110421893|NCT02825095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110421894|NCT02825095|Sensory System Agents|sensory system agents|mesh-ancestor
110421895|NCT02825095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110421896|NCT02825095|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110421897|NCT02825095|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110421898|NCT02825095|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110421899|NCT02825095|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110421900|NCT02825095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110421902|NCT04195009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110421903|NCT04195009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110421904|NCT05660083|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
110421905|NCT05660083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110421906|NCT05660083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110421907|NCT02822131|Sevelamer|sevelamer|mesh-list
110421908|NCT02822131|Chelating Agents|chelating agents|mesh-ancestor
110421909|NCT02822131|Sequestering Agents|sequestering agents|mesh-ancestor
110421910|NCT02822131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110421911|NCT04239625|Vitamin A|vitamin a|mesh-list
110421912|NCT04239625|Retinol acetate|retinol acetate|mesh-list
110421913|NCT04239625|Vitamins|vitamins|mesh-ancestor
110421914|NCT04239625|Micronutrients|micronutrients|mesh-ancestor
110421915|NCT04239625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110421916|NCT04239625|Protective Agents|protective agents|mesh-ancestor
110421917|NCT04239625|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110421918|NCT04239625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110421919|NCT04239625|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110421920|NCT04239625|Immunologic Factors|immunologic factors|mesh-ancestor
110421921|NCT02821897|Anesthetics|anesthetics|mesh-list
110421922|NCT02821897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110421923|NCT02821897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110421924|NCT02820493|Vedolizumab|vedolizumab|mesh-list
110421925|NCT02820493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110421926|NCT05659459|Pioglitazone|pioglitazone|mesh-list
110421927|NCT05659459|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110421928|NCT05659459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110421929|NCT02820259|Tacrolimus|tacrolimus|mesh-list
110421930|NCT02820259|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110421931|NCT02820259|Immunologic Factors|immunologic factors|mesh-ancestor
110421932|NCT02820259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110421933|NCT02820259|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110421934|NCT02820259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110369848|NCT01737905|Epinephrine|epinephrine|mesh-list
110421935|NCT02820259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110421937|NCT00633763|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110421938|NCT00633763|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110421939|NCT00633763|Dopamine Agents|dopamine agents|mesh-ancestor
110421940|NCT00633763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110421941|NCT00633763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110421942|NCT00633763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110421944|NCT02820025|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110421945|NCT02820025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110421946|NCT02820025|Respiratory System Agents|respiratory system agents|mesh-ancestor
110421947|NCT02819869|Metformin|metformin|mesh-list
110421948|NCT02819869|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110421949|NCT02819869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110421950|NCT02820883|Vaccines|vaccines|mesh-list
110421951|NCT02820883|Immunologic Factors|immunologic factors|mesh-ancestor
110421952|NCT02820883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110421953|NCT02819089|Dexmedetomidine|dexmedetomidine|mesh-list
110421954|NCT02819089|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110421955|NCT02819089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110421956|NCT02819089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110421957|NCT02819089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110421958|NCT02819089|Analgesics|analgesics|mesh-ancestor
110421959|NCT02819089|Sensory System Agents|sensory system agents|mesh-ancestor
110421960|NCT02819089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110421961|NCT02819089|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110421962|NCT02819089|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110421963|NCT02819089|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110421964|NCT02819089|Adrenergic Agents|adrenergic agents|mesh-ancestor
110421965|NCT02819089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110328426|NCT00461825|Antifungal Agents|antifungal agents|mesh-ancestor
110421966|NCT02819089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110421968|NCT04238923|Gentamicins|gentamicins|mesh-list
110421969|NCT04238923|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110421970|NCT04238923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110421971|NCT04238923|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110421972|NCT04238923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110421973|NCT04238923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110421974|NCT02815657|Valsartan|valsartan|mesh-list
110421975|NCT02815657|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110421976|NCT02815657|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110421977|NCT02815657|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110421978|NCT02815657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110421979|NCT04597333|Dinoprostone|dinoprostone|mesh-list
110421980|NCT04597333|Oxytocics|oxytocics|mesh-ancestor
110421981|NCT04597333|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110421982|NCT04597333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110421983|NCT00957580|Niacinamide|niacinamide|mesh-list
110421984|NCT00957580|Vitamin B Complex|vitamin b complex|mesh-ancestor
110421985|NCT00957580|Vitamins|vitamins|mesh-ancestor
110421986|NCT00957580|Micronutrients|micronutrients|mesh-ancestor
110421987|NCT00957580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110421988|NCT00957424|Nicotine|nicotine|mesh-list
110421989|NCT00957424|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110421990|NCT00957424|Autonomic Agents|autonomic agents|mesh-ancestor
110421991|NCT00957424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110421992|NCT00957424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110421993|NCT00957424|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110421994|NCT00957424|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110421995|NCT00957424|Cholinergic Agents|cholinergic agents|mesh-ancestor
110421996|NCT00957424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110421997|NCT00957424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110421998|NCT02818621|Dexmedetomidine|dexmedetomidine|mesh-list
110421999|NCT02818621|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110200698|NCT00145522|Tibolone|tibolone|mesh-list
110422000|NCT02818621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110422001|NCT02818621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110422002|NCT02818621|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110422004|NCT02818621|Sensory System Agents|sensory system agents|mesh-ancestor
110422005|NCT02818621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110422006|NCT02818621|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110422007|NCT02818621|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110422008|NCT02818621|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110422009|NCT02818621|Adrenergic Agents|adrenergic agents|mesh-ancestor
110422010|NCT02818621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110422011|NCT02818621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110422012|NCT04642651|Dexmedetomidine|dexmedetomidine|mesh-list
110422013|NCT04642651|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110422014|NCT04642651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110422015|NCT04642651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110422016|NCT04642651|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110422017|NCT04642651|Analgesics|analgesics|mesh-ancestor
110422018|NCT04642651|Sensory System Agents|sensory system agents|mesh-ancestor
110422019|NCT04642651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110422020|NCT04642651|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110422021|NCT04642651|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110422022|NCT04642651|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110422023|NCT04642651|Adrenergic Agents|adrenergic agents|mesh-ancestor
110422024|NCT04642651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110422025|NCT04642651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110069000|NCT01555190|Folic Acid|folic acid|mesh-list
110422026|NCT01061151|Ritonavir|ritonavir|mesh-list
110422027|NCT01061151|Lopinavir|lopinavir|mesh-list
110422028|NCT01061151|Tenofovir|tenofovir|mesh-list
110422029|NCT01061151|Lamivudine|lamivudine|mesh-list
110422030|NCT01061151|Emtricitabine|emtricitabine|mesh-list
110422031|NCT01061151|Zidovudine|zidovudine|mesh-list
110422032|NCT01061151|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110422033|NCT01061151|Nevirapine|nevirapine|mesh-list
110422034|NCT01061151|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
110422035|NCT01061151|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110422036|NCT01061151|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110422037|NCT01061151|Protease Inhibitors|protease inhibitors|mesh-ancestor
110422038|NCT01061151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110422039|NCT01061151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110422040|NCT01061151|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110422041|NCT01061151|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110422042|NCT01061151|Antiviral Agents|antiviral agents|mesh-ancestor
110422043|NCT01061151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110422044|NCT01061151|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110422045|NCT01061151|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110422046|NCT01061151|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110422047|NCT01061151|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110422048|NCT01061151|Antimetabolites|antimetabolites|mesh-ancestor
110200714|NCT00081315|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110422049|NCT01061151|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110422050|NCT01061151|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110422051|NCT04472143|Granisetron|granisetron|mesh-list
110422052|NCT04472143|Antiemetics|antiemetics|mesh-ancestor
110422053|NCT04472143|Autonomic Agents|autonomic agents|mesh-ancestor
110422054|NCT04472143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110422055|NCT04472143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110422056|NCT04472143|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110422057|NCT04472143|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110422058|NCT04472143|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110422059|NCT04472143|Serotonin Agents|serotonin agents|mesh-ancestor
110422060|NCT04472143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110422061|NCT04472143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110422062|NCT01241552|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110422063|NCT01241552|Immunologic Factors|immunologic factors|mesh-ancestor
110422064|NCT01241552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110422065|NCT04748523|Mirtazapine|mirtazapine|mesh-list
110422066|NCT04748523|Antidepressive Agents|antidepressive agents|mesh-ancestor
110422067|NCT04748523|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110422068|NCT04748523|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110422069|NCT04748523|Histamine Antagonists|histamine antagonists|mesh-ancestor
110422070|NCT04748523|Histamine Agents|histamine agents|mesh-ancestor
110422071|NCT04748523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110422072|NCT04748523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110422073|NCT04748523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110422074|NCT04748523|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110422075|NCT04748523|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110422076|NCT04748523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110422077|NCT04748523|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
110422078|NCT04748523|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110422079|NCT04748523|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110422080|NCT04748523|Adrenergic Agents|adrenergic agents|mesh-ancestor
110422081|NCT04748523|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110422082|NCT04748523|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110422083|NCT04748523|Serotonin Agents|serotonin agents|mesh-ancestor
110422084|NCT04748523|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110422085|NCT02817217|Valsartan|valsartan|mesh-list
110422086|NCT02817217|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110422087|NCT02817217|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110422088|NCT02817217|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110422089|NCT02817217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110422090|NCT00948922|Fludarabine|fludarabine|mesh-list
110422091|NCT00948922|Bortezomib|bortezomib|mesh-list
110422092|NCT00948922|Melphalan|melphalan|mesh-list
110422093|NCT00948922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110422094|NCT00948922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110422095|NCT00948922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110422096|NCT00948922|Immunologic Factors|immunologic factors|mesh-ancestor
110422097|NCT00948922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110422098|NCT00948922|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110422099|NCT00948922|Alkylating Agents|alkylating agents|mesh-ancestor
110422100|NCT00948922|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110422101|NCT00634309|Candesartan|candesartan|mesh-list
110422102|NCT00634309|Candesartan cilexetil|candesartan cilexetil|mesh-list
110422103|NCT00634309|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110422104|NCT00634309|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110422105|NCT00634309|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110422106|NCT00634309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110422108|NCT01239992|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110422109|NCT01239992|Antimetabolites|antimetabolites|mesh-ancestor
110422110|NCT01239992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110422111|NCT01239992|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110422112|NCT01239992|Vasodilator Agents|vasodilator agents|mesh-ancestor
110422113|NCT01239992|Vitamin B Complex|vitamin b complex|mesh-ancestor
110422114|NCT01239992|Vitamins|vitamins|mesh-ancestor
110422115|NCT01239992|Micronutrients|micronutrients|mesh-ancestor
110422116|NCT01239992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110422117|NCT02816905|Fluorometholone|fluorometholone|mesh-list
110422118|NCT02816905|Dexamethasone|dexamethasone|mesh-list
110422119|NCT02816905|Rimexolone|rimexolone|mesh-list
110422120|NCT02816905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110422121|NCT02816905|Antiemetics|antiemetics|mesh-ancestor
110422122|NCT02816905|Autonomic Agents|autonomic agents|mesh-ancestor
110422123|NCT02816905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110422124|NCT02816905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110422125|NCT02816905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110422126|NCT02816905|Glucocorticoids|glucocorticoids|mesh-ancestor
110422127|NCT02816905|Hormones|hormones|mesh-ancestor
110422128|NCT02816905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110422129|NCT02816905|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110422130|NCT02816905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110422131|NCT02816905|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110422132|NCT01072539|Tigecycline|tigecycline|mesh-list
110422133|NCT01072539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110422134|NCT01072539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110422135|NCT01072539|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110422136|NCT01072539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110422137|NCT01072539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110422138|NCT05654077|Cyclophosphamide|cyclophosphamide|mesh-list
110422139|NCT05654077|Fludarabine|fludarabine|mesh-list
110422140|NCT05654077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110200772|NCT00081471|Hematinics|hematinics|mesh-ancestor
110422141|NCT05654077|Immunologic Factors|immunologic factors|mesh-ancestor
110422142|NCT05654077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110422143|NCT05654077|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110422144|NCT05654077|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110422145|NCT05654077|Alkylating Agents|alkylating agents|mesh-ancestor
110422146|NCT05654077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110422147|NCT05654077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110422148|NCT05654077|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110422149|NCT04303767|Calcium|calcium|mesh-list
110422150|NCT04303767|Caseins|caseins|mesh-list
110422151|NCT04303767|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110422152|NCT04303767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110422153|NCT04303767|Chelating Agents|chelating agents|mesh-ancestor
110422154|NCT04303767|Sequestering Agents|sequestering agents|mesh-ancestor
110422155|NCT04303767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110422156|NCT02874963|Ethanol|ethanol|mesh-list
110422157|NCT02874963|Listerine|listerine|mesh-list
110422158|NCT02874963|Thymol|thymol|mesh-list
110422159|NCT02874963|Eucalyptol|eucalyptol|mesh-list
110422160|NCT02874963|Salicylates|salicylates|mesh-list
110422161|NCT02874963|Methyl salicylate|methyl salicylate|mesh-list
110422162|NCT02874963|Menthol|menthol|mesh-list
110422163|NCT02874963|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110422164|NCT02874963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110422165|NCT02874963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110422166|NCT02874963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110422167|NCT02874963|Antipruritics|antipruritics|mesh-ancestor
110422168|NCT02874963|Dermatologic Agents|dermatologic agents|mesh-ancestor
110422169|NCT02874963|Protective Agents|protective agents|mesh-ancestor
110422170|NCT02874963|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110422171|NCT02874963|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110422172|NCT02874963|Analgesics|analgesics|mesh-ancestor
110422173|NCT02874963|Sensory System Agents|sensory system agents|mesh-ancestor
110422174|NCT02874963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110422175|NCT02874963|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110422176|NCT02874963|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110422177|NCT02874963|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110422178|NCT02874963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110422179|NCT02874963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110422180|NCT02874963|Antifungal Agents|antifungal agents|mesh-ancestor
110422181|NCT02874963|Antitussive Agents|antitussive agents|mesh-ancestor
110422182|NCT02874963|Respiratory System Agents|respiratory system agents|mesh-ancestor
110422183|NCT02874963|Insect Repellents|insect repellents|mesh-ancestor
110422185|NCT02818309|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110422186|NCT02818309|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
110422187|NCT02818309|GABA Agonists|gaba agonists|mesh-ancestor
110422188|NCT02818309|GABA Agents|gaba agents|mesh-ancestor
110422189|NCT02818309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110422190|NCT02818309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110422191|NCT02818309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110422192|NCT01238822|Methylphenidate|methylphenidate|mesh-list
110422193|NCT01238822|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110422194|NCT01238822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110422195|NCT01238822|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110422196|NCT01238822|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110422197|NCT01238822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110422198|NCT01238822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110422199|NCT01238822|Dopamine Agents|dopamine agents|mesh-ancestor
110422200|NCT01238822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110422201|NCT02818387|Midazolam|midazolam|mesh-list
110422202|NCT02818387|Remifentanil|remifentanil|mesh-list
110422203|NCT02818387|Propofol|propofol|mesh-list
110422204|NCT02818387|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110422205|NCT02818387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110422206|NCT02818387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110422207|NCT02818387|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110422208|NCT02818387|Anesthetics, General|anesthetics, general|mesh-ancestor
110422209|NCT02818387|Anesthetics|anesthetics|mesh-ancestor
110422210|NCT02818387|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110422211|NCT02818387|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110422212|NCT02818387|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110422213|NCT02818387|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110422214|NCT02818387|GABA Modulators|gaba modulators|mesh-ancestor
110422215|NCT02818387|GABA Agents|gaba agents|mesh-ancestor
110422216|NCT02818387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110422217|NCT02818387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110422218|NCT02818387|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110422219|NCT02818387|Narcotics|narcotics|mesh-ancestor
110422220|NCT02818387|Analgesics|analgesics|mesh-ancestor
110422221|NCT02818387|Sensory System Agents|sensory system agents|mesh-ancestor
110422222|NCT02818387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110422223|NCT05296629|Doxycycline|doxycycline|mesh-list
110422224|NCT05296629|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110422225|NCT05296629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110422226|NCT05296629|Antimalarials|antimalarials|mesh-ancestor
110422227|NCT05296629|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110422228|NCT05296629|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110422230|NCT01238588|Chelating Agents|chelating agents|mesh-ancestor
110422231|NCT01238588|Sequestering Agents|sequestering agents|mesh-ancestor
110422232|NCT01238588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110422233|NCT00627003|Cabergoline|cabergoline|mesh-list
110422234|NCT00627003|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110422235|NCT00627003|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110422236|NCT00627003|Dopamine Agonists|dopamine agonists|mesh-ancestor
110422237|NCT00627003|Dopamine Agents|dopamine agents|mesh-ancestor
110422238|NCT00627003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110422239|NCT00627003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110422240|NCT00627003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110422241|NCT04238221|Doxofylline|doxofylline|mesh-list
110422242|NCT04238221|Antitussive Agents|antitussive agents|mesh-ancestor
110422243|NCT04238221|Respiratory System Agents|respiratory system agents|mesh-ancestor
110422244|NCT04238221|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110422245|NCT04238221|Autonomic Agents|autonomic agents|mesh-ancestor
110422246|NCT04238221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110422247|NCT04238221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110422248|NCT04238221|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110422249|NCT04238221|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110422250|NCT04238221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110422251|NCT04238221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110422252|NCT01047501|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
110422253|NCT01047501|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110328436|NCT00461825|Antimetabolites|antimetabolites|mesh-ancestor
110422254|NCT01047501|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110422255|NCT01238120|Ibuprofen|ibuprofen|mesh-list
110422256|NCT01238120|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
110422257|NCT01238120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
110422258|NCT01238120|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110422259|NCT01238120|Analgesics|analgesics|mesh-ancestor
110422260|NCT01238120|Sensory System Agents|sensory system agents|mesh-ancestor
110422261|NCT01238120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110422262|NCT01238120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110422263|NCT01238120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110422264|NCT01238120|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110422265|NCT01238120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110422266|NCT01238120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110422267|NCT02816593|Hydrogen Peroxide|hydrogen peroxide|mesh-list
110422268|NCT02816593|Carbamide Peroxide|carbamide peroxide|mesh-list
110422269|NCT02816593|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110422270|NCT02816593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110422271|NCT04237987|Cyclosporine|cyclosporine|mesh-list
110422272|NCT04237987|Aldesleukin|aldesleukin|mesh-list
110422273|NCT04237987|Interleukin-2|interleukin-2|mesh-list
110422274|NCT04237987|Cyclosporins|cyclosporins|mesh-list
110422275|NCT04237987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110422276|NCT04237987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110422277|NCT04237987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110422278|NCT04237987|Immunologic Factors|immunologic factors|mesh-ancestor
110422279|NCT04237987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110422280|NCT04237987|Antifungal Agents|antifungal agents|mesh-ancestor
110422281|NCT04237987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110422282|NCT04237987|Dermatologic Agents|dermatologic agents|mesh-ancestor
110422283|NCT04237987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110422284|NCT04237987|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110422285|NCT04237987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110422286|NCT04237987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110422287|NCT04237987|Analgesics|analgesics|mesh-ancestor
110422288|NCT04237987|Sensory System Agents|sensory system agents|mesh-ancestor
110422289|NCT04237987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110422290|NCT04237987|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110422291|NCT04237987|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110422292|NCT04237987|Antiviral Agents|antiviral agents|mesh-ancestor
110422293|NCT01045707|Insulin|insulin|mesh-list
110422294|NCT01045707|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110422295|NCT01045707|Insulin Glargine|insulin glargine|mesh-list
110422296|NCT01045707|Insulin Aspart|insulin aspart|mesh-list
110422297|NCT01045707|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110422298|NCT01045707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110422299|NCT04533997|Furosemide|furosemide|mesh-list
110422300|NCT04533997|Diuretics|diuretics|mesh-ancestor
110422301|NCT04533997|Natriuretic Agents|natriuretic agents|mesh-ancestor
110422302|NCT04533997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110422303|NCT04533997|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110422304|NCT04533997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110422305|NCT04533997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110422306|NCT02874807|Empagliflozin|empagliflozin|mesh-list
110422307|NCT02874807|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110422308|NCT02874807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110422309|NCT02874807|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110422310|NCT02874807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110422311|NCT01054599|Memantine|memantine|mesh-list
110422312|NCT01054599|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110422313|NCT01054599|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110422314|NCT01054599|Dopamine Agents|dopamine agents|mesh-ancestor
110422315|NCT01054599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110422316|NCT01054599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110422317|NCT01054599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110422318|NCT01054599|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110422319|NCT01054599|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110422320|NCT05635201|Anesthetics|anesthetics|mesh-list
110422321|NCT05635201|Propofol|propofol|mesh-list
110422322|NCT05635201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110422323|NCT05635201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110422324|NCT05635201|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110422325|NCT05635201|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110069299|NCT05840536|Furosemide|furosemide|mesh-list
110422326|NCT05635201|Anesthetics, General|anesthetics, general|mesh-ancestor
110422327|NCT02813863|Metformin|metformin|mesh-list
110422328|NCT02813863|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110200888|NCT00146614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110422329|NCT02813863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110422330|NCT02874729|Dimercaprol|dimercaprol|mesh-list
110422331|NCT02874729|Chelating Agents|chelating agents|mesh-ancestor
110422332|NCT02874729|Sequestering Agents|sequestering agents|mesh-ancestor
110422333|NCT02874729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110422334|NCT04275661|Magnesium Sulfate|magnesium sulfate|mesh-list
110422335|NCT04275661|Ketamine|ketamine|mesh-list
110422336|NCT04275661|Levobupivacaine|levobupivacaine|mesh-list
110422337|NCT04275661|Analgesics|analgesics|mesh-ancestor
110422338|NCT04275661|Sensory System Agents|sensory system agents|mesh-ancestor
110422339|NCT04275661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110422340|NCT04275661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110422341|NCT04275661|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110422342|NCT04275661|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110422343|NCT04275661|Anesthetics, General|anesthetics, general|mesh-ancestor
110422345|NCT04275661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110422346|NCT04275661|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110422347|NCT04275661|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110422348|NCT04275661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110422349|NCT04275661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110422350|NCT04275661|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110422351|NCT04275661|Anticonvulsants|anticonvulsants|mesh-ancestor
110422352|NCT04275661|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110422353|NCT04275661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110422354|NCT04275661|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110422355|NCT04275661|Tocolytic Agents|tocolytic agents|mesh-ancestor
110422356|NCT04275661|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110422357|NCT04275661|Anesthetics, Local|anesthetics, local|mesh-ancestor
110422358|NCT00948766|Rivastigmine|rivastigmine|mesh-list
110422359|NCT00948766|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110422360|NCT00948766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110422361|NCT00948766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110422362|NCT00948766|Cholinergic Agents|cholinergic agents|mesh-ancestor
110422363|NCT00948766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110422364|NCT00948766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110422365|NCT00948766|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110422366|NCT00948766|Protective Agents|protective agents|mesh-ancestor
110422367|NCT01053663|Oseltamivir|oseltamivir|mesh-list
110422368|NCT01053663|Antiviral Agents|antiviral agents|mesh-ancestor
110422369|NCT01053663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110422370|NCT01053663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110422371|NCT01053663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110422372|NCT01235546|Azithromycin|azithromycin|mesh-list
110422373|NCT01235546|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110422374|NCT01235546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110422375|NCT01053429|Ziprasidone|ziprasidone|mesh-list
110422376|NCT01053429|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110422377|NCT01053429|Serotonin Agents|serotonin agents|mesh-ancestor
110422378|NCT01053429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110422379|NCT01053429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110422380|NCT01053429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110422381|NCT01053429|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110422382|NCT01053429|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110422383|NCT01053429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110422384|NCT01053429|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110422385|NCT01053429|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110422386|NCT01053429|Dopamine Agents|dopamine agents|mesh-ancestor
110422387|NCT01233284|Bromides|bromides|mesh-list
110422388|NCT01233284|Tiotropium Bromide|tiotropium bromide|mesh-list
110422389|NCT01233284|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110422390|NCT01233284|Autonomic Agents|autonomic agents|mesh-ancestor
110422391|NCT01233284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110422392|NCT01233284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110422393|NCT01233284|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110422394|NCT01233284|Respiratory System Agents|respiratory system agents|mesh-ancestor
110422395|NCT01233284|Parasympatholytics|parasympatholytics|mesh-ancestor
110422396|NCT01233284|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110422397|NCT01233284|Cholinergic Agents|cholinergic agents|mesh-ancestor
110422398|NCT01233284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110422399|NCT01233284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110422400|NCT01233284|Anticonvulsants|anticonvulsants|mesh-ancestor
110422401|NCT00948688|Vorinostat|vorinostat|mesh-list
110422402|NCT00948688|Fluorouracil|fluorouracil|mesh-list
110422403|NCT00948688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110422404|NCT00948688|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110422405|NCT00948688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110422406|NCT00948688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110422407|NCT00948688|Antimetabolites|antimetabolites|mesh-ancestor
110422408|NCT00948688|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110422409|NCT00948688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110422410|NCT00948688|Immunologic Factors|immunologic factors|mesh-ancestor
110422411|NCT00948688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110422412|NCT01233050|Ethanol|ethanol|mesh-list
110422413|NCT01233050|Chlorhexidine|chlorhexidine|mesh-list
110422414|NCT01233050|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110422415|NCT01233050|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110422416|NCT01233050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110422417|NCT01233050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110422418|NCT01233050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110422419|NCT01233050|Disinfectants|disinfectants|mesh-ancestor
110422420|NCT01233050|Dermatologic Agents|dermatologic agents|mesh-ancestor
110422421|NCT01049217|Pregabalin|pregabalin|mesh-list
110422422|NCT01049217|Analgesics|analgesics|mesh-ancestor
110422423|NCT01049217|Sensory System Agents|sensory system agents|mesh-ancestor
110422424|NCT01049217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110422425|NCT01049217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110422426|NCT01049217|Anticonvulsants|anticonvulsants|mesh-ancestor
110422427|NCT01049217|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110422428|NCT01049217|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110422429|NCT01049217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110422430|NCT01049217|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110422431|NCT01049217|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110422432|NCT01049217|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110422433|NCT01049217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110422434|NCT01049217|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110422435|NCT01232738|Rasagiline|rasagiline|mesh-list
110422436|NCT01232738|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
110422437|NCT01232738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110422438|NCT01232738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110422439|NCT01232738|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110422440|NCT01232738|Protective Agents|protective agents|mesh-ancestor
110422441|NCT01232738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110422442|NCT00957268|Alogliptin|alogliptin|mesh-list
110422443|NCT00957268|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110422444|NCT00957268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110422445|NCT00957268|Incretins|incretins|mesh-ancestor
110422446|NCT00957268|Hormones|hormones|mesh-ancestor
110422447|NCT00957268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110422448|NCT00957268|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110422449|NCT00957268|Protease Inhibitors|protease inhibitors|mesh-ancestor
110422450|NCT00957268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110422451|NCT00957268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110422452|NCT02888444|Varenicline|varenicline|mesh-list
110422453|NCT02888444|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110422454|NCT02888444|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110422455|NCT02888444|Cholinergic Agents|cholinergic agents|mesh-ancestor
110422456|NCT02888444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110422457|NCT02888444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110422458|NCT02888444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110422459|NCT01230788|Rituximab|rituximab|mesh-list
110422460|NCT01230788|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110422461|NCT01230788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110422462|NCT01230788|Immunologic Factors|immunologic factors|mesh-ancestor
110422463|NCT01230788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110422464|NCT01230788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110422465|NCT01230710|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110422466|NCT01230710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110422467|NCT01230710|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110422468|NCT01230710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110422469|NCT01230710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110422471|NCT00627081|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110422472|NCT00627081|Narcotics|narcotics|mesh-ancestor
110422473|NCT00627081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110422474|NCT00627081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110422476|NCT00627081|Sensory System Agents|sensory system agents|mesh-ancestor
110422477|NCT00627081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110422478|NCT02888054|Allopurinol|allopurinol|mesh-list
110422480|NCT02888054|Antimetabolites|antimetabolites|mesh-ancestor
110422481|NCT02888054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110422482|NCT02888054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110422483|NCT02888054|Gout Suppressants|gout suppressants|mesh-ancestor
110422484|NCT02888054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110422485|NCT02888054|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110422486|NCT02888054|Antioxidants|antioxidants|mesh-ancestor
110422487|NCT02888054|Protective Agents|protective agents|mesh-ancestor
110422488|NCT02888054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110422489|NCT02888054|Uricosuric Agents|uricosuric agents|mesh-ancestor
110422490|NCT01040793|Olodaterol|olodaterol|mesh-list
110422491|NCT01040793|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110422492|NCT01040793|Autonomic Agents|autonomic agents|mesh-ancestor
110422493|NCT01040793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110422494|NCT01040793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110422495|NCT01040793|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110422496|NCT01040793|Respiratory System Agents|respiratory system agents|mesh-ancestor
110422497|NCT02811055|Aprepitant|aprepitant|mesh-list
110422498|NCT02811055|Antiemetics|antiemetics|mesh-ancestor
110422499|NCT02811055|Autonomic Agents|autonomic agents|mesh-ancestor
110422500|NCT02811055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110422501|NCT02811055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110422502|NCT02811055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110422503|NCT02811055|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110422504|NCT02811055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110422505|NCT02811055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110422506|NCT04192903|Cisplatin|cisplatin|mesh-list
110422507|NCT04192903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110422508|NCT02810899|Dexmedetomidine|dexmedetomidine|mesh-list
110422509|NCT02810899|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110422510|NCT02810899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110422511|NCT02810899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110422512|NCT02810899|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110422513|NCT02810899|Analgesics|analgesics|mesh-ancestor
110422514|NCT02810899|Sensory System Agents|sensory system agents|mesh-ancestor
110422515|NCT02810899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110422516|NCT02810899|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110422517|NCT02810899|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110422518|NCT02810899|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110422519|NCT02810899|Adrenergic Agents|adrenergic agents|mesh-ancestor
110422520|NCT02810899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110422521|NCT02810899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110422522|NCT04237129|Insulin Aspart|insulin aspart|mesh-list
110422523|NCT04237129|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110422524|NCT04237129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110422525|NCT02810587|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110422526|NCT02810587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110422527|NCT02810275|Leucovorin|leucovorin|mesh-list
110422528|NCT02810275|Folic Acid|folic acid|mesh-list
110422529|NCT02810275|Levoleucovorin|levoleucovorin|mesh-list
110422530|NCT02810275|Antidotes|antidotes|mesh-ancestor
110422531|NCT02810275|Protective Agents|protective agents|mesh-ancestor
110422532|NCT02810275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110422533|NCT02810275|Vitamin B Complex|vitamin b complex|mesh-ancestor
110422534|NCT02810275|Vitamins|vitamins|mesh-ancestor
110422535|NCT02810275|Micronutrients|micronutrients|mesh-ancestor
110422536|NCT02810275|Hematinics|hematinics|mesh-ancestor
110422537|NCT00948064|Azacitidine|azacitidine|mesh-list
110422538|NCT00948064|Vorinostat|vorinostat|mesh-list
110422539|NCT00948064|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110422540|NCT00948064|Antimetabolites|antimetabolites|mesh-ancestor
110422541|NCT00948064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110422542|NCT00948064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110422543|NCT00948064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110422544|NCT00948064|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110422545|NCT02813239|Triptorelin Pamoate|triptorelin pamoate|mesh-list
110422546|NCT02813239|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
110422547|NCT02813239|Luteolytic Agents|luteolytic agents|mesh-ancestor
110069521|NCT05813158|Bupivacaine|bupivacaine|mesh-list
110422548|NCT02813239|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110422549|NCT02813239|Contraceptive Agents|contraceptive agents|mesh-ancestor
110422550|NCT02813239|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110422551|NCT02813239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110422552|NCT02813239|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110422553|NCT02813239|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110422554|NCT02813239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110422555|NCT02858206|Paclitaxel|paclitaxel|mesh-list
110422556|NCT02858206|Nimotuzumab|nimotuzumab|mesh-list
110422557|NCT02858206|Nedaplatin|nedaplatin|mesh-list
110422558|NCT02858206|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110422559|NCT02858206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110422560|NCT02858206|Tubulin Modulators|tubulin modulators|mesh-ancestor
110422561|NCT02858206|Antimitotic Agents|antimitotic agents|mesh-ancestor
110422562|NCT02858206|Mitosis Modulators|mitosis modulators|mesh-ancestor
110422563|NCT02858206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110422564|NCT02858206|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110422565|NCT02815189|Acetaminophen|acetaminophen|mesh-list
110422566|NCT02815189|Ibuprofen|ibuprofen|mesh-list
110422567|NCT02815189|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110422568|NCT02815189|Analgesics|analgesics|mesh-ancestor
110422569|NCT02815189|Sensory System Agents|sensory system agents|mesh-ancestor
110422570|NCT02815189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110422571|NCT02815189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110422572|NCT02815189|Antipyretics|antipyretics|mesh-ancestor
110422573|NCT02815189|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110422574|NCT02815189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110422575|NCT02815189|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110422576|NCT02815189|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110422577|NCT02815189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110422578|NCT02815189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110422579|NCT02809963|Eplerenone|eplerenone|mesh-list
110422580|NCT02809963|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110422581|NCT02809963|Hormone Antagonists|hormone antagonists|mesh-ancestor
110422582|NCT02809963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110422583|NCT02809963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110422584|NCT02809963|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110422585|NCT02809963|Diuretics|diuretics|mesh-ancestor
110422586|NCT02809963|Natriuretic Agents|natriuretic agents|mesh-ancestor
110422587|NCT02809963|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110422588|NCT02815111|Acetaminophen|acetaminophen|mesh-list
110422589|NCT02815111|Lidocaine|lidocaine|mesh-list
110422590|NCT02815111|Ketamine|ketamine|mesh-list
110422591|NCT02815111|Gabapentin|gabapentin|mesh-list
110422592|NCT02815111|Anesthetics, Local|anesthetics, local|mesh-ancestor
110422593|NCT02815111|Anesthetics|anesthetics|mesh-ancestor
110422594|NCT02815111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110422595|NCT02815111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110422596|NCT02815111|Sensory System Agents|sensory system agents|mesh-ancestor
110422597|NCT02815111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110422598|NCT02815111|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110422599|NCT02815111|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110422600|NCT02815111|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110422601|NCT02815111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110422602|NCT02815111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110422603|NCT02815111|Analgesics|analgesics|mesh-ancestor
110422604|NCT02815111|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110422605|NCT02815111|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110422606|NCT02815111|Anesthetics, General|anesthetics, general|mesh-ancestor
110422607|NCT02815111|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110422608|NCT02815111|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110422609|NCT02815111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110422610|NCT02815111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110422611|NCT02815111|Antipyretics|antipyretics|mesh-ancestor
110422613|NCT02815111|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110422614|NCT02815111|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110422615|NCT02815111|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110422616|NCT02815111|Antimanic Agents|antimanic agents|mesh-ancestor
110422617|NCT04236895|Insulin Glargine|insulin glargine|mesh-list
110422618|NCT04236895|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110422619|NCT04236895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110422620|NCT02809729|Cefazolin|cefazolin|mesh-list
110422621|NCT02809729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110422622|NCT02809729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110422623|NCT04303377|Evolocumab|evolocumab|mesh-list
110422624|NCT04303377|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
110422625|NCT04303377|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110422626|NCT04303377|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110422627|NCT04303377|Antimetabolites|antimetabolites|mesh-ancestor
110422628|NCT04303377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110422629|NCT04303377|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110422630|NCT04303377|Protease Inhibitors|protease inhibitors|mesh-ancestor
110422631|NCT04303377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110422632|NCT04303377|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110422633|NCT00953524|Vaccines|vaccines|mesh-list
110422634|NCT00953524|Immunologic Factors|immunologic factors|mesh-ancestor
110422635|NCT00953524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110422636|NCT02809573|Prednisone|prednisone|mesh-list
110422637|NCT02809573|Cyclophosphamide|cyclophosphamide|mesh-list
110422638|NCT02809573|Vincristine|vincristine|mesh-list
110422639|NCT02809573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110422640|NCT02809573|Immunologic Factors|immunologic factors|mesh-ancestor
110422641|NCT02809573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110422642|NCT02809573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110422643|NCT02809573|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110422644|NCT02809573|Alkylating Agents|alkylating agents|mesh-ancestor
110422645|NCT02809573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110422646|NCT02809573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110422647|NCT02809573|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110422648|NCT02809573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110422649|NCT02809573|Glucocorticoids|glucocorticoids|mesh-ancestor
110422650|NCT02809573|Hormones|hormones|mesh-ancestor
110422651|NCT02809573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110422652|NCT02809573|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110422653|NCT02809573|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110422654|NCT02809573|Tubulin Modulators|tubulin modulators|mesh-ancestor
110422655|NCT02809573|Antimitotic Agents|antimitotic agents|mesh-ancestor
110422656|NCT02809573|Mitosis Modulators|mitosis modulators|mesh-ancestor
110422657|NCT04388683|Nitric Oxide|nitric oxide|mesh-list
110422658|NCT04388683|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110422659|NCT04388683|Autonomic Agents|autonomic agents|mesh-ancestor
110422660|NCT04388683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110422661|NCT04388683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110422662|NCT04388683|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110422663|NCT04388683|Respiratory System Agents|respiratory system agents|mesh-ancestor
110422664|NCT04388683|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110422665|NCT04388683|Antioxidants|antioxidants|mesh-ancestor
110422666|NCT04388683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110422667|NCT04388683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110422668|NCT04388683|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
110422669|NCT04388683|Vasodilator Agents|vasodilator agents|mesh-ancestor
110422670|NCT04388683|Gasotransmitters|gasotransmitters|mesh-ancestor
110422671|NCT04388683|Protective Agents|protective agents|mesh-ancestor
110422672|NCT01040403|Bromides|bromides|mesh-list
110422673|NCT01040403|Tiotropium Bromide|tiotropium bromide|mesh-list
110422675|NCT01040403|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110422676|NCT01040403|Autonomic Agents|autonomic agents|mesh-ancestor
110422677|NCT01040403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110422678|NCT01040403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110422679|NCT01040403|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110422680|NCT01040403|Respiratory System Agents|respiratory system agents|mesh-ancestor
110422681|NCT01040403|Parasympatholytics|parasympatholytics|mesh-ancestor
110422682|NCT01040403|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110422683|NCT01040403|Cholinergic Agents|cholinergic agents|mesh-ancestor
110422684|NCT01040403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110422685|NCT01040403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110422686|NCT01040403|Anticonvulsants|anticonvulsants|mesh-ancestor
110422687|NCT00957034|Testosterone|testosterone|mesh-list
110422688|NCT00957034|Androgens|androgens|mesh-ancestor
110422689|NCT00957034|Hormones|hormones|mesh-ancestor
110422690|NCT00957034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110422691|NCT00957034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110422692|NCT02812693|Pembrolizumab|pembrolizumab|mesh-list
110422693|NCT02812693|Imatinib Mesylate|imatinib mesylate|mesh-list
110069667|NCT05301322|Immunologic Factors|immunologic factors|mesh-ancestor
110069668|NCT05301322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110069669|NCT05266807|Vancomycin|vancomycin|mesh-list
110069670|NCT05266807|Fidaxomicin|fidaxomicin|mesh-list
110069671|NCT05266807|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110069672|NCT05266807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110069673|NCT05254418|Dulaglutide|dulaglutide|mesh-list
110069674|NCT05254418|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110069675|NCT05254418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110422694|NCT02812693|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110422695|NCT02812693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110422696|NCT02812693|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110422697|NCT02812693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110422698|NCT02812693|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110422699|NCT02812693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110422700|NCT04270552|Broncho-Vaxom|broncho-vaxom|mesh-list
110422701|NCT04270552|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110422702|NCT04270552|Immunologic Factors|immunologic factors|mesh-ancestor
110422703|NCT04270552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110422704|NCT04237597|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3H),2'-(2H)pyran)-3',4',5'-triol|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3h),2'-(2h)pyran)-3',4',5'-triol|mesh-list
110422705|NCT04237597|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110422706|NCT04237597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110422707|NCT04237597|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110422708|NCT04237597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110422709|NCT02689999|Rabeprazole|rabeprazole|mesh-list
110422710|NCT02689999|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110422711|NCT02689999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110422712|NCT02689999|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110422713|NCT02689999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110422714|NCT02689999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110422715|NCT02809105|Linaclotide|linaclotide|mesh-list
110422716|NCT02809105|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
110422717|NCT02809105|Enzyme Activators|enzyme activators|mesh-ancestor
110201009|NCT00147160|Cisplatin|cisplatin|mesh-list
110422718|NCT02809105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110422719|NCT02809105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110422720|NCT00953056|Vaccines|vaccines|mesh-list
110422721|NCT00953056|Immunologic Factors|immunologic factors|mesh-ancestor
110422722|NCT00953056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110422723|NCT02811289|Mirabegron|mirabegron|mesh-list
110422724|NCT02811289|Glycerol|glycerol|mesh-list
110422725|NCT02811289|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
110422726|NCT02811289|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110422727|NCT02811289|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110422728|NCT02811289|Adrenergic Agents|adrenergic agents|mesh-ancestor
110422729|NCT02811289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110422730|NCT02811289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110422731|NCT02811289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110422732|NCT02811289|Urological Agents|urological agents|mesh-ancestor
110422733|NCT02811289|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
110422734|NCT02811289|Protective Agents|protective agents|mesh-ancestor
110422735|NCT02808949|Dapivirine|dapivirine|mesh-list
110422736|NCT02808949|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110422737|NCT02808949|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110422738|NCT02808949|Antiviral Agents|antiviral agents|mesh-ancestor
110422739|NCT02808949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110422740|NCT04207177|Mycophenolic Acid|mycophenolic acid|mesh-list
110422741|NCT04207177|Tacrolimus|tacrolimus|mesh-list
110422742|NCT04207177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110369927|NCT01858883|Paclitaxel|paclitaxel|mesh-list
110422744|NCT04207177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110422745|NCT04207177|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110422746|NCT04207177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110422747|NCT04207177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110422748|NCT04207177|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110422749|NCT04207177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110422750|NCT04207177|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110422751|NCT04207177|Antitubercular Agents|antitubercular agents|mesh-ancestor
110422752|NCT04207177|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110422753|NCT04207177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110422754|NCT02812147|Droxidopa|droxidopa|mesh-list
110422755|NCT02812147|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110422756|NCT02812147|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110422757|NCT04303065|Dexamethasone|dexamethasone|mesh-list
110422758|NCT04303065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110422759|NCT04303065|Antiemetics|antiemetics|mesh-ancestor
110422760|NCT04303065|Autonomic Agents|autonomic agents|mesh-ancestor
110422761|NCT04303065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110422762|NCT04303065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110422763|NCT04303065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110422764|NCT04303065|Glucocorticoids|glucocorticoids|mesh-ancestor
110422765|NCT04303065|Hormones|hormones|mesh-ancestor
110422766|NCT04303065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110422767|NCT04303065|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110422768|NCT04303065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110422769|NCT02814877|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110422770|NCT02814877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110422771|NCT00952822|Factor VIII|factor viii|mesh-list
110422772|NCT00952822|Coagulants|coagulants|mesh-ancestor
110422773|NCT02854072|Gemcitabine|gemcitabine|mesh-list
110422774|NCT02854072|Capecitabine|capecitabine|mesh-list
110422775|NCT02854072|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110422776|NCT02854072|Antimetabolites|antimetabolites|mesh-ancestor
110422777|NCT02854072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110201031|NCT00147355|Ibuprofen|ibuprofen|mesh-list
110422778|NCT02854072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110422780|NCT02537314|Anesthetics, Local|anesthetics, local|mesh-ancestor
110422781|NCT02537314|Anesthetics|anesthetics|mesh-ancestor
110422782|NCT02537314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110422783|NCT02537314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110422784|NCT02537314|Sensory System Agents|sensory system agents|mesh-ancestor
110422785|NCT02537314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110422787|NCT00631150|Anticonvulsants|anticonvulsants|mesh-ancestor
110422788|NCT00631150|Nootropic Agents|nootropic agents|mesh-ancestor
110422789|NCT04278040|Melphalan|melphalan|mesh-list
110422790|NCT04278040|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110422791|NCT04278040|Alkylating Agents|alkylating agents|mesh-ancestor
110422792|NCT04278040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110422793|NCT04278040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110422794|NCT04278040|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110422795|NCT04278040|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110422796|NCT04278040|Immunologic Factors|immunologic factors|mesh-ancestor
110422797|NCT04278040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110422798|NCT02856724|Dinoprostone|dinoprostone|mesh-list
110422799|NCT02856724|Oxytocics|oxytocics|mesh-ancestor
110422800|NCT02856724|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110422801|NCT02856724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110422802|NCT02808325|Polygeline|polygeline|mesh-list
110422803|NCT02808325|Plasma Substitutes|plasma substitutes|mesh-ancestor
110422804|NCT02808325|Blood Substitutes|blood substitutes|mesh-ancestor
110422805|NCT00955474|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110422806|NCT00955474|Citalopram|citalopram|mesh-list
110422807|NCT00955474|Sertraline|sertraline|mesh-list
110422808|NCT00955474|Escitalopram|escitalopram|mesh-list
110422809|NCT00955474|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110422810|NCT00955474|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110422811|NCT00955474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110422812|NCT00955474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110422813|NCT00955474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110422814|NCT00955474|Serotonin Agents|serotonin agents|mesh-ancestor
110422815|NCT00955474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110422816|NCT00955474|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110422817|NCT00955474|Antidepressive Agents|antidepressive agents|mesh-ancestor
110422818|NCT00955474|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110422819|NCT00955474|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110422820|NCT00955474|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110422821|NCT00955474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110422822|NCT02808247|Ifosfamide|ifosfamide|mesh-list
110422823|NCT02808247|Nintedanib|nintedanib|mesh-list
110422824|NCT02808247|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110422825|NCT02808247|Alkylating Agents|alkylating agents|mesh-ancestor
110422826|NCT02808247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110422827|NCT02808247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110422828|NCT02808247|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110422829|NCT02808247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110422830|NCT02808091|Bortezomib|bortezomib|mesh-list
110422831|NCT02808091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110422832|NCT02811991|Acetaminophen|acetaminophen|mesh-list
110422833|NCT02811991|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110422834|NCT02811991|Analgesics|analgesics|mesh-ancestor
110422835|NCT02811991|Sensory System Agents|sensory system agents|mesh-ancestor
110422836|NCT02811991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110422837|NCT02811991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110422838|NCT02811991|Antipyretics|antipyretics|mesh-ancestor
110422839|NCT04237675|Anesthetics|anesthetics|mesh-list
110422840|NCT04237675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110422841|NCT04237675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110069830|NCT04835129|Elotuzumab|elotuzumab|mesh-list
110422843|NCT05598853|Ipilimumab|ipilimumab|mesh-list
110422844|NCT05598853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110422845|NCT05598853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110422846|NCT05598853|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110422847|NCT05598853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110422848|NCT01229150|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110422849|NCT01229150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110422850|NCT01229150|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110422851|NCT01229150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110422852|NCT01229150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110422853|NCT02804815|Aspirin|aspirin|mesh-list
110422854|NCT02804815|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110422855|NCT02804815|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110422856|NCT02804815|Analgesics|analgesics|mesh-ancestor
110422857|NCT02804815|Sensory System Agents|sensory system agents|mesh-ancestor
110422858|NCT02804815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110422859|NCT02804815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110422860|NCT02804815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110422861|NCT02804815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110422862|NCT02804815|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110422863|NCT02804815|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110422864|NCT02804815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110422865|NCT02804815|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110422866|NCT02804815|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110422867|NCT02804815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110422868|NCT02804815|Antipyretics|antipyretics|mesh-ancestor
110422869|NCT02814409|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
110422870|NCT02814409|Plasminogen|plasminogen|mesh-list
110422871|NCT02814409|Tenecteplase|tenecteplase|mesh-list
110422872|NCT02814409|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110422873|NCT02814409|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110422874|NCT02814409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110422875|NCT01227902|Ezogabine|ezogabine|mesh-list
110422876|NCT01227902|Anticonvulsants|anticonvulsants|mesh-ancestor
110422877|NCT01227902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110422878|NCT01227902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110422879|NCT00946192|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110422880|NCT00946192|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110422881|NCT00946192|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110422882|NCT00946192|Desogestrel|desogestrel|mesh-list
110422883|NCT00946192|Estradiol|estradiol|mesh-list
110422884|NCT00946192|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110422885|NCT00946192|Progesterone|progesterone|mesh-list
110422886|NCT00946192|Estrogens|estrogens|mesh-ancestor
110422887|NCT00946192|Hormones|hormones|mesh-ancestor
110422888|NCT00946192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110422889|NCT00946192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110422890|NCT00946192|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110422891|NCT00946192|Contraceptive Agents|contraceptive agents|mesh-ancestor
110422892|NCT00946192|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110422893|NCT00946192|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110422894|NCT00946192|Progestins|progestins|mesh-ancestor
110422895|NCT00946192|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110422896|NCT00946192|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110422897|NCT00946192|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110422898|NCT01037127|Trametinib|trametinib|mesh-list
110422899|NCT01037127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110422900|NCT01037127|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110422901|NCT01037127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110422902|NCT01037127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110422903|NCT02806999|Insulin|insulin|mesh-list
110422904|NCT02806999|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110422905|NCT02806999|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110422906|NCT02806999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110422907|NCT00946114|Sildenafil Citrate|sildenafil citrate|mesh-list
110422908|NCT00946114|Vasodilator Agents|vasodilator agents|mesh-ancestor
110422909|NCT00946114|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110422910|NCT00946114|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110422911|NCT00946114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110422912|NCT00946114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110422913|NCT00946114|Urological Agents|urological agents|mesh-ancestor
110422914|NCT00627471|Insulin|insulin|mesh-list
110422915|NCT00627471|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110422916|NCT00627471|Insulin Glargine|insulin glargine|mesh-list
110422917|NCT00627471|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110422918|NCT00627471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110422919|NCT04302441|Capecitabine|capecitabine|mesh-list
110422920|NCT04302441|Vinorelbine|vinorelbine|mesh-list
110422921|NCT04302441|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110422922|NCT04302441|Antimetabolites|antimetabolites|mesh-ancestor
110422923|NCT04302441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110422924|NCT04302441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110422925|NCT04302441|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110422926|NCT04302441|Tubulin Modulators|tubulin modulators|mesh-ancestor
110422927|NCT04302441|Antimitotic Agents|antimitotic agents|mesh-ancestor
110422928|NCT04302441|Mitosis Modulators|mitosis modulators|mesh-ancestor
110422929|NCT02800447|Procarbazine|procarbazine|mesh-list
110422930|NCT02800447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110422931|NCT05520619|Paclitaxel|paclitaxel|mesh-list
110422932|NCT05520619|Tislelizumab|tislelizumab|mesh-list
110422933|NCT05520619|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110422935|NCT05520619|Tubulin Modulators|tubulin modulators|mesh-ancestor
110422936|NCT05520619|Antimitotic Agents|antimitotic agents|mesh-ancestor
110422937|NCT05520619|Mitosis Modulators|mitosis modulators|mesh-ancestor
110422938|NCT05520619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110422939|NCT05520619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110422940|NCT01038921|Melatonin|melatonin|mesh-list
110422941|NCT01038921|Antioxidants|antioxidants|mesh-ancestor
110422942|NCT01038921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110422943|NCT01038921|Protective Agents|protective agents|mesh-ancestor
110422944|NCT01038921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110422945|NCT01038921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110422946|NCT02856568|Cisplatin|cisplatin|mesh-list
110422947|NCT02856568|Gemcitabine|gemcitabine|mesh-list
110422948|NCT02856568|Ricolinostat|ricolinostat|mesh-list
110422949|NCT02856568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110422950|NCT02856568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110422951|NCT02856568|Antimetabolites|antimetabolites|mesh-ancestor
110422952|NCT02856568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110422953|NCT02856568|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110422954|NCT02856568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110422956|NCT04081831|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110422957|NCT04081831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110422958|NCT04081831|Analgesics|analgesics|mesh-ancestor
110422959|NCT04081831|Sensory System Agents|sensory system agents|mesh-ancestor
110422960|NCT04081831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110422961|NCT04081831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110422962|NCT04081831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110422963|NCT04081831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110422964|NCT04081831|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110422965|NCT04081831|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110422966|NCT04081831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110422967|NCT04081831|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110422968|NCT04081831|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110422969|NCT04081831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110422970|NCT04081831|Antipyretics|antipyretics|mesh-ancestor
110422971|NCT01081912|Hydrocodone|hydrocodone|mesh-list
110422972|NCT01081912|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110422973|NCT01081912|Narcotics|narcotics|mesh-ancestor
110422974|NCT01081912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110422975|NCT01081912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110422976|NCT01081912|Analgesics|analgesics|mesh-ancestor
110422977|NCT01081912|Sensory System Agents|sensory system agents|mesh-ancestor
110422978|NCT01081912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110422979|NCT01081912|Antitussive Agents|antitussive agents|mesh-ancestor
110422980|NCT01081912|Respiratory System Agents|respiratory system agents|mesh-ancestor
110422981|NCT01038609|Acetaminophen|acetaminophen|mesh-list
110422982|NCT01038609|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
110422984|NCT01038609|Hydrocodone|hydrocodone|mesh-list
110422985|NCT01038609|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110422986|NCT01038609|Narcotics|narcotics|mesh-ancestor
110422987|NCT01038609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110422988|NCT01038609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110422989|NCT01038609|Analgesics|analgesics|mesh-ancestor
110422990|NCT01038609|Sensory System Agents|sensory system agents|mesh-ancestor
110422991|NCT01038609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110422992|NCT01038609|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110422993|NCT01038609|Antipyretics|antipyretics|mesh-ancestor
110422994|NCT01038609|Antitussive Agents|antitussive agents|mesh-ancestor
110422995|NCT01038609|Respiratory System Agents|respiratory system agents|mesh-ancestor
110422996|NCT01038609|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110422997|NCT01038609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110422998|NCT01038609|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110422999|NCT02857582|Metronidazole|metronidazole|mesh-list
110423000|NCT02857582|Vancomycin|vancomycin|mesh-list
110423001|NCT02857582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110423002|NCT02857582|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110423003|NCT02857582|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110423004|NCT02857582|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110423006|NCT04301895|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110423007|NCT04301895|Narcotics|narcotics|mesh-ancestor
110423008|NCT04301895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110423009|NCT04301895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110423010|NCT04301895|Analgesics|analgesics|mesh-ancestor
110423011|NCT04301895|Sensory System Agents|sensory system agents|mesh-ancestor
110423012|NCT04301895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110423013|NCT02853526|Propranolol|propranolol|mesh-list
110423014|NCT02853526|Warfarin|warfarin|mesh-list
110423015|NCT02853526|Anticoagulants|anticoagulants|mesh-ancestor
110423016|NCT02853526|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110423017|NCT02853526|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110423018|NCT02853526|Adrenergic Agents|adrenergic agents|mesh-ancestor
110423019|NCT02853526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110423020|NCT02853526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110423021|NCT02853526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110423022|NCT02853526|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110423023|NCT02853526|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110423024|NCT02853526|Vasodilator Agents|vasodilator agents|mesh-ancestor
110423025|NCT00630682|Dextroamphetamine|dextroamphetamine|mesh-list
110423026|NCT00630682|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110423027|NCT00630682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110423028|NCT00630682|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110423029|NCT00630682|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110423030|NCT00630682|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110423031|NCT00630682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110423032|NCT00630682|Dopamine Agents|dopamine agents|mesh-ancestor
110423033|NCT00630682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110423034|NCT04269460|Bupivacaine|bupivacaine|mesh-list
110423035|NCT04269460|Anesthetics, Local|anesthetics, local|mesh-ancestor
110423036|NCT04269460|Anesthetics|anesthetics|mesh-ancestor
110423037|NCT04269460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110423038|NCT04269460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110423039|NCT04269460|Sensory System Agents|sensory system agents|mesh-ancestor
110423040|NCT04269460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110423041|NCT04236115|Felypressin|felypressin|mesh-list
110423042|NCT04236115|Carticaine|carticaine|mesh-list
110423043|NCT04236115|Anesthetics, Local|anesthetics, local|mesh-ancestor
110423044|NCT04236115|Anesthetics|anesthetics|mesh-ancestor
110423045|NCT04236115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110423046|NCT04236115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110423047|NCT04236115|Sensory System Agents|sensory system agents|mesh-ancestor
110423048|NCT04236115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110423049|NCT04236115|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110423050|NCT02853370|Rituximab|rituximab|mesh-list
110423051|NCT02853370|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110423052|NCT02853370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110423053|NCT02853370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110423054|NCT02853370|Immunologic Factors|immunologic factors|mesh-ancestor
110423055|NCT02853370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110423056|NCT02853370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110423057|NCT02853370|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110423058|NCT02853370|Alkylating Agents|alkylating agents|mesh-ancestor
110423059|NCT02853370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110423060|NCT02690155|Vitamin K|vitamin k|mesh-list
110423061|NCT02690155|Rivaroxaban|rivaroxaban|mesh-list
110423062|NCT02690155|Vitamins|vitamins|mesh-ancestor
110423063|NCT02690155|Micronutrients|micronutrients|mesh-ancestor
110423064|NCT02690155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110423065|NCT02690155|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110423066|NCT02690155|Antithrombins|antithrombins|mesh-ancestor
110423067|NCT02690155|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110070049|NCT04249063|Lidocaine|lidocaine|mesh-list
110423068|NCT02690155|Protease Inhibitors|protease inhibitors|mesh-ancestor
110423069|NCT02690155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110423070|NCT02690155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110423071|NCT02690155|Anticoagulants|anticoagulants|mesh-ancestor
110423072|NCT02690155|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110423073|NCT02690155|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110423074|NCT02690155|Hemostatics|hemostatics|mesh-ancestor
110423075|NCT02690155|Coagulants|coagulants|mesh-ancestor
110423076|NCT02806375|Cyclophosphamide|cyclophosphamide|mesh-list
110423078|NCT02806375|Fludarabine|fludarabine|mesh-list
110370040|NCT00565539|Antiviral Agents|antiviral agents|mesh-ancestor
110423079|NCT02806375|Fludarabine phosphate|fludarabine phosphate|mesh-list
110423080|NCT02806375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110423081|NCT02806375|Immunologic Factors|immunologic factors|mesh-ancestor
110423082|NCT02806375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110423083|NCT02806375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110423084|NCT02806375|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110423085|NCT02806375|Alkylating Agents|alkylating agents|mesh-ancestor
110423086|NCT02806375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110423087|NCT02806375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110423088|NCT02806375|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110423089|NCT02806375|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110423090|NCT02806375|Antimetabolites|antimetabolites|mesh-ancestor
110423091|NCT04273984|Misoprostol|misoprostol|mesh-list
110423092|NCT04273984|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110423093|NCT04273984|Abortifacient Agents|abortifacient agents|mesh-ancestor
110423094|NCT04273984|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110423095|NCT04273984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110423096|NCT04273984|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110423097|NCT04273984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110423098|NCT04273984|Oxytocics|oxytocics|mesh-ancestor
110423099|NCT00943852|Losartan|losartan|mesh-list
110423100|NCT00943852|Isosorbide|isosorbide|mesh-list
110423101|NCT00943852|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
110423102|NCT00943852|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
110423103|NCT00943852|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110423104|NCT00943852|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110423105|NCT00943852|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110423106|NCT00943852|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110423107|NCT00943852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110423108|NCT00943852|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110423109|NCT00943852|Diuretics|diuretics|mesh-ancestor
110423110|NCT00943852|Natriuretic Agents|natriuretic agents|mesh-ancestor
110423111|NCT00943852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110423112|NCT00943852|Vasodilator Agents|vasodilator agents|mesh-ancestor
110423113|NCT00943852|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
110423114|NCT02853136|Fluvoxamine|fluvoxamine|mesh-list
110423115|NCT02853136|BI 409306|bi 409306|mesh-list
110423116|NCT02853136|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110423117|NCT02853136|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110423118|NCT02853136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110423119|NCT02853136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110423120|NCT02853136|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110423121|NCT02853136|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110423122|NCT02853136|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110423123|NCT02853136|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110423124|NCT02853136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110423125|NCT02853136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110423126|NCT02853136|Serotonin Agents|serotonin agents|mesh-ancestor
110423127|NCT02853136|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110423128|NCT02853136|Antidepressive Agents|antidepressive agents|mesh-ancestor
110423129|NCT02853136|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110423130|NCT02853136|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110423131|NCT02853136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110423132|NCT02853136|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110423133|NCT02853136|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110423134|NCT02806141|Colistin|colistin|mesh-list
110423135|NCT02806141|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110423136|NCT02806141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110423137|NCT00952276|Vaccines|vaccines|mesh-list
110423138|NCT00952276|Immunologic Factors|immunologic factors|mesh-ancestor
110423139|NCT00952276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110423140|NCT02805829|Trastuzumab|trastuzumab|mesh-list
110423141|NCT02805829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110423142|NCT02805829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110070130|NCT04175262|Sunitinib|sunitinib|mesh-list
110423143|NCT02856178|Caspofungin|caspofungin|mesh-list
110423144|NCT02856178|Olorofim|olorofim|mesh-list
110423145|NCT02856178|Antifungal Agents|antifungal agents|mesh-ancestor
110423146|NCT02856178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110423147|NCT02856178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110423148|NCT02856178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110423149|NCT02800135|Furosemide|furosemide|mesh-list
110423150|NCT02800135|Diuretics|diuretics|mesh-ancestor
110423151|NCT02800135|Natriuretic Agents|natriuretic agents|mesh-ancestor
110423152|NCT02800135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110423153|NCT02800135|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110423154|NCT02800135|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110423155|NCT02800135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110423156|NCT02799901|Nivolumab|nivolumab|mesh-list
110423157|NCT02799901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110423158|NCT02799901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110423159|NCT02799901|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110423160|NCT02799901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110423161|NCT02802163|Dexamethasone|dexamethasone|mesh-list
110423162|NCT02802163|Lenalidomide|lenalidomide|mesh-list
110423163|NCT02802163|Panobinostat|panobinostat|mesh-list
110423164|NCT02802163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110423165|NCT02802163|Antiemetics|antiemetics|mesh-ancestor
110423166|NCT02802163|Autonomic Agents|autonomic agents|mesh-ancestor
110423167|NCT02802163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110423168|NCT02802163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110423169|NCT02802163|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110423170|NCT02802163|Glucocorticoids|glucocorticoids|mesh-ancestor
110423171|NCT02802163|Hormones|hormones|mesh-ancestor
110423172|NCT02802163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110423173|NCT02802163|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110423174|NCT02802163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110423175|NCT02802163|Immunologic Factors|immunologic factors|mesh-ancestor
110423176|NCT02802163|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110423177|NCT02802163|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110423178|NCT02802163|Growth Substances|growth substances|mesh-ancestor
110423179|NCT02802163|Growth Inhibitors|growth inhibitors|mesh-ancestor
110423180|NCT02802163|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110423181|NCT02802163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110423182|NCT02802163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110423183|NCT02805049|Caspofungin|caspofungin|mesh-list
110423184|NCT02805049|Micafungin|micafungin|mesh-list
110423185|NCT02805049|Echinocandins|echinocandins|mesh-list
110423186|NCT02805049|Antifungal Agents|antifungal agents|mesh-ancestor
110423187|NCT02805049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110423188|NCT02805049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110423189|NCT02805049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110423190|NCT02799589|Dexmedetomidine|dexmedetomidine|mesh-list
110423191|NCT02799589|Remifentanil|remifentanil|mesh-list
110423192|NCT02799589|Ropivacaine|ropivacaine|mesh-list
110423193|NCT02799589|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110423194|NCT02799589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110423195|NCT02799589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110423196|NCT02799589|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110423197|NCT02799589|Analgesics|analgesics|mesh-ancestor
110423198|NCT02799589|Sensory System Agents|sensory system agents|mesh-ancestor
110423199|NCT02799589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110423200|NCT02799589|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110423201|NCT02799589|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110423202|NCT02799589|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110423203|NCT02799589|Adrenergic Agents|adrenergic agents|mesh-ancestor
110423204|NCT02799589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110423205|NCT02799589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110423206|NCT02799589|Anesthetics, Local|anesthetics, local|mesh-ancestor
110423207|NCT02799589|Anesthetics|anesthetics|mesh-ancestor
110423208|NCT02799589|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110423209|NCT02799589|Narcotics|narcotics|mesh-ancestor
110423210|NCT02856100|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
110423211|NCT02856100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110423212|NCT02801383|Interferons|interferons|mesh-list
110423213|NCT02801383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110423214|NCT02801383|Antiviral Agents|antiviral agents|mesh-ancestor
110423215|NCT02801383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110423216|NCT02799355|Interferons|interferons|mesh-list
110423217|NCT02799355|Ribavirin|ribavirin|mesh-list
110423218|NCT02799355|Sofosbuvir|sofosbuvir|mesh-list
110423219|NCT02799355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110423220|NCT02799355|Antiviral Agents|antiviral agents|mesh-ancestor
110423221|NCT02799355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110423222|NCT02799355|Antimetabolites|antimetabolites|mesh-ancestor
110423223|NCT02799355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110423224|NCT02801305|Diltiazem|diltiazem|mesh-list
110423225|NCT02801305|Nitroglycerin|nitroglycerin|mesh-list
110423226|NCT02801305|Petrolatum|petrolatum|mesh-list
110423227|NCT02801305|Vasodilator Agents|vasodilator agents|mesh-ancestor
110423228|NCT02801305|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110423229|NCT02801305|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110423230|NCT02801305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110423231|NCT02801305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110423232|NCT02801305|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110423233|NCT02801305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110423234|NCT02801305|Emollients|emollients|mesh-ancestor
110423235|NCT02801305|Dermatologic Agents|dermatologic agents|mesh-ancestor
110423236|NCT00637975|Pregabalin|pregabalin|mesh-list
110423237|NCT00637975|Oxycodone|oxycodone|mesh-list
110423238|NCT00637975|Analgesics|analgesics|mesh-ancestor
110423239|NCT00637975|Sensory System Agents|sensory system agents|mesh-ancestor
110423240|NCT00637975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110423241|NCT00637975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110423242|NCT00637975|Anticonvulsants|anticonvulsants|mesh-ancestor
110423243|NCT00637975|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110423244|NCT00637975|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110423245|NCT00637975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110423246|NCT00637975|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110423247|NCT00637975|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110423248|NCT00637975|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110423249|NCT00637975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110423250|NCT00637975|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110423251|NCT00637975|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110423252|NCT00637975|Narcotics|narcotics|mesh-ancestor
110423253|NCT02801227|Oxytocin|oxytocin|mesh-list
110423254|NCT02801227|Dinoprostone|dinoprostone|mesh-list
110423255|NCT02801227|Oxytocics|oxytocics|mesh-ancestor
110423256|NCT02801227|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110423257|NCT02801227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110423258|NCT02795299|Folic Acid|folic acid|mesh-list
110423259|NCT02795299|Methotrexate|methotrexate|mesh-list
110201232|NCT00148135|Carboplatin|carboplatin|mesh-list
110423260|NCT02795299|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110423261|NCT02795299|Abortifacient Agents|abortifacient agents|mesh-ancestor
110423262|NCT02795299|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110423263|NCT02795299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110423264|NCT02795299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110423265|NCT02795299|Antimetabolites|antimetabolites|mesh-ancestor
110423266|NCT02795299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110423267|NCT02795299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110423268|NCT02795299|Dermatologic Agents|dermatologic agents|mesh-ancestor
110423269|NCT02795299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110423270|NCT02795299|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110423271|NCT02795299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110423272|NCT02795299|Immunologic Factors|immunologic factors|mesh-ancestor
110423273|NCT02795299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110423274|NCT02795299|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110423275|NCT02795299|Hematinics|hematinics|mesh-ancestor
110423276|NCT02795299|Vitamin B Complex|vitamin b complex|mesh-ancestor
110423277|NCT02795299|Vitamins|vitamins|mesh-ancestor
110423278|NCT02795299|Micronutrients|micronutrients|mesh-ancestor
110423279|NCT02799277|Testosterone|testosterone|mesh-list
110423280|NCT02799277|Androgens|androgens|mesh-ancestor
110423281|NCT02799277|Hormones|hormones|mesh-ancestor
110423282|NCT02799277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110328495|NCT00496704|Gemcitabine|gemcitabine|mesh-list
110423283|NCT02799277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110423284|NCT01198002|Methotrexate|methotrexate|mesh-list
110423285|NCT01198002|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110423286|NCT01198002|Abortifacient Agents|abortifacient agents|mesh-ancestor
110423287|NCT01198002|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110423288|NCT01198002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110423289|NCT01198002|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110423290|NCT01198002|Antimetabolites|antimetabolites|mesh-ancestor
110423291|NCT01198002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110423292|NCT01198002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110423293|NCT01198002|Dermatologic Agents|dermatologic agents|mesh-ancestor
110423294|NCT01198002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110423295|NCT01198002|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110423296|NCT01198002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110423297|NCT01198002|Immunologic Factors|immunologic factors|mesh-ancestor
110423298|NCT01198002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110423299|NCT01198002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110423301|NCT02795065|Bemiparin|bemiparin|mesh-list
110423302|NCT02795065|Anticoagulants|anticoagulants|mesh-ancestor
110423303|NCT02795065|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110423304|NCT02795065|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110423305|NCT02795065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110423306|NCT04233697|Romidepsin|romidepsin|mesh-list
110423307|NCT04233697|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110423308|NCT04233697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110423309|NCT04233697|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110423310|NCT04233697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110423311|NCT04233697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110423312|NCT03826303|Ethanol|ethanol|mesh-list
110423313|NCT03826303|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110423314|NCT03826303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110423315|NCT03826303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110423316|NCT03826303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110423317|NCT02798653|Progesterone|progesterone|mesh-list
110423318|NCT02798653|Progestins|progestins|mesh-ancestor
110423319|NCT02798653|Hormones|hormones|mesh-ancestor
110423320|NCT02798653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110423321|NCT02798653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110423322|NCT03863587|Ramucirumab|ramucirumab|mesh-list
110423323|NCT03863587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110423324|NCT04233463|Budesonide|budesonide|mesh-list
110423325|NCT04233463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110423326|NCT04233463|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110423327|NCT04233463|Autonomic Agents|autonomic agents|mesh-ancestor
110423328|NCT04233463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110423329|NCT04233463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110423330|NCT04233463|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110423331|NCT04233463|Respiratory System Agents|respiratory system agents|mesh-ancestor
110423332|NCT04233463|Glucocorticoids|glucocorticoids|mesh-ancestor
110423333|NCT04233463|Hormones|hormones|mesh-ancestor
110423334|NCT04233463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110423335|NCT02793739|Hyaluronic Acid|hyaluronic acid|mesh-list
110423336|NCT02793739|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110423337|NCT02793739|Immunologic Factors|immunologic factors|mesh-ancestor
110423338|NCT02793739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110423339|NCT02793739|Viscosupplements|viscosupplements|mesh-ancestor
110423340|NCT02793739|Protective Agents|protective agents|mesh-ancestor
110423341|NCT02793505|Metformin|metformin|mesh-list
110423342|NCT02793505|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110423343|NCT02793505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110423344|NCT02793193|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110423345|NCT02793193|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
110423346|NCT02793193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110423347|NCT02793193|Antitubercular Agents|antitubercular agents|mesh-ancestor
110423348|NCT04234321|Mitogens|mitogens|mesh-list
110423349|NCT04234321|Mitosis Modulators|mitosis modulators|mesh-ancestor
110423350|NCT04234321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110423351|NCT02797717|Prednisone|prednisone|mesh-list
110423352|NCT02797717|Cyclophosphamide|cyclophosphamide|mesh-list
110423354|NCT02797717|Doxorubicin|doxorubicin|mesh-list
110423356|NCT02797717|Vincristine|vincristine|mesh-list
110423357|NCT02797717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110423358|NCT02797717|Immunologic Factors|immunologic factors|mesh-ancestor
110423359|NCT02797717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110423360|NCT02797717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110423361|NCT02797717|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110423362|NCT02797717|Alkylating Agents|alkylating agents|mesh-ancestor
110423363|NCT02797717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110423364|NCT02797717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110423365|NCT02797717|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110423366|NCT02797717|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110423367|NCT02797717|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110423368|NCT02797717|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110423369|NCT02797717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110423370|NCT02797717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110423371|NCT02797717|Glucocorticoids|glucocorticoids|mesh-ancestor
110423373|NCT02797717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110423374|NCT02797717|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110423375|NCT02797717|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110423376|NCT02797717|Tubulin Modulators|tubulin modulators|mesh-ancestor
110423377|NCT02797717|Antimitotic Agents|antimitotic agents|mesh-ancestor
110423378|NCT02797717|Mitosis Modulators|mitosis modulators|mesh-ancestor
110423379|NCT04235569|Enoxaparin|enoxaparin|mesh-list
110423380|NCT04235569|Warfarin|warfarin|mesh-list
110423381|NCT04235569|Enoxaparin sodium|enoxaparin sodium|mesh-list
110423382|NCT04235569|Anticoagulants|anticoagulants|mesh-ancestor
110423383|NCT04235569|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110423384|NCT04235569|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110423385|NCT04235569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110423386|NCT01197378|Cysteamine|cysteamine|mesh-list
110423387|NCT01197378|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
110423388|NCT01197378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110423389|NCT02792491|Prednisone|prednisone|mesh-list
110423390|NCT02792491|Cyclophosphamide|cyclophosphamide|mesh-list
110423391|NCT02792491|Rituximab|rituximab|mesh-list
110423392|NCT02792491|Doxorubicin|doxorubicin|mesh-list
110423393|NCT02792491|Vincristine|vincristine|mesh-list
110423394|NCT02792491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110423395|NCT02792491|Immunologic Factors|immunologic factors|mesh-ancestor
110423396|NCT02792491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110423397|NCT02792491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110423398|NCT02792491|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110423399|NCT02792491|Alkylating Agents|alkylating agents|mesh-ancestor
110423400|NCT02792491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110423401|NCT02792491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110423402|NCT02792491|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110423403|NCT02792491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110423404|NCT02792491|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110423405|NCT02792491|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110423406|NCT02792491|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110423407|NCT02792491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110423408|NCT02792491|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110423409|NCT02792491|Glucocorticoids|glucocorticoids|mesh-ancestor
110423410|NCT02792491|Hormones|hormones|mesh-ancestor
110423411|NCT02792491|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110423412|NCT02792491|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110423413|NCT02792491|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110423414|NCT02792491|Tubulin Modulators|tubulin modulators|mesh-ancestor
110423415|NCT02792491|Antimitotic Agents|antimitotic agents|mesh-ancestor
110423416|NCT02792491|Mitosis Modulators|mitosis modulators|mesh-ancestor
110423417|NCT02792803|Latanoprost|latanoprost|mesh-list
110423418|NCT02792803|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110423419|NCT02792803|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110423420|NCT02797249|Aspirin|aspirin|mesh-list
110423421|NCT02797249|Salicylic Acid|salicylic acid|mesh-list
110423422|NCT02797249|Salicylates|salicylates|mesh-list
110423423|NCT02797249|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110423424|NCT02797249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110423426|NCT02797249|Sensory System Agents|sensory system agents|mesh-ancestor
110423427|NCT02797249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110423428|NCT02797249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110423429|NCT02797249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110423430|NCT02797249|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110423431|NCT02797249|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110423432|NCT02797249|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110423433|NCT02797249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110423434|NCT02797249|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110423435|NCT02797249|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110423436|NCT02797249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110423437|NCT02797249|Antipyretics|antipyretics|mesh-ancestor
110423438|NCT02797249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110423439|NCT02797249|Antifungal Agents|antifungal agents|mesh-ancestor
110423440|NCT02797249|Keratolytic Agents|keratolytic agents|mesh-ancestor
110423441|NCT02797249|Dermatologic Agents|dermatologic agents|mesh-ancestor
110423442|NCT02792335|Warfarin|warfarin|mesh-list
110423443|NCT02792335|Rivaroxaban|rivaroxaban|mesh-list
110423444|NCT02792335|Dabigatran|dabigatran|mesh-list
110423445|NCT02792335|Apixaban|apixaban|mesh-list
110423446|NCT02792335|Anticoagulants|anticoagulants|mesh-ancestor
110423447|NCT02792335|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110423449|NCT02792335|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110423450|NCT02792335|Protease Inhibitors|protease inhibitors|mesh-ancestor
110423451|NCT02792335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110423452|NCT02792335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110423453|NCT01197300|Zoledronic Acid|zoledronic acid|mesh-list
110423454|NCT01197300|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110423455|NCT01197300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110423456|NCT04200235|Dexmedetomidine|dexmedetomidine|mesh-list
110423457|NCT04200235|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110423458|NCT04200235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110423459|NCT04200235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110423460|NCT04200235|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110423461|NCT04200235|Analgesics|analgesics|mesh-ancestor
110423462|NCT04200235|Sensory System Agents|sensory system agents|mesh-ancestor
110423463|NCT04200235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110423464|NCT04200235|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110423465|NCT04200235|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110423466|NCT04200235|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110423467|NCT04200235|Adrenergic Agents|adrenergic agents|mesh-ancestor
110423468|NCT04200235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110423469|NCT04200235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110423470|NCT02791243|Finasteride|finasteride|mesh-list
110423471|NCT02791243|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
110423472|NCT02791243|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110423473|NCT02791243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110201320|NCT00148564|Ziprasidone|ziprasidone|mesh-list
110423474|NCT02791243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110423475|NCT02791243|Hormone Antagonists|hormone antagonists|mesh-ancestor
110423476|NCT02791243|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110423477|NCT02791243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110423478|NCT02791243|Urological Agents|urological agents|mesh-ancestor
110423479|NCT02797015|Ozanimod|ozanimod|mesh-list
110423480|NCT02797015|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
110423481|NCT02797015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110423482|NCT02797015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110423483|NCT02797015|Immunologic Factors|immunologic factors|mesh-ancestor
110423484|NCT02797015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110423485|NCT02796547|Levobupivacaine|levobupivacaine|mesh-list
110423486|NCT02796547|Anesthetics, Local|anesthetics, local|mesh-ancestor
110423487|NCT02796547|Anesthetics|anesthetics|mesh-ancestor
110423488|NCT02796547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110370080|NCT01516346|Vasodilator Agents|vasodilator agents|mesh-ancestor
110423489|NCT02796547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110423490|NCT02796547|Sensory System Agents|sensory system agents|mesh-ancestor
110423491|NCT02796547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110423492|NCT01196988|Vaccines|vaccines|mesh-list
110423493|NCT01196988|Immunologic Factors|immunologic factors|mesh-ancestor
110423494|NCT01196988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110423495|NCT02796469|Pentoxifylline|pentoxifylline|mesh-list
110423496|NCT02796469|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110423497|NCT02796469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110423498|NCT02796469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110423499|NCT02796469|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110423500|NCT02796469|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110423501|NCT02796469|Protective Agents|protective agents|mesh-ancestor
110423502|NCT02796469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110423503|NCT02796469|Vasodilator Agents|vasodilator agents|mesh-ancestor
110423504|NCT02796469|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110423505|NCT02796469|Antioxidants|antioxidants|mesh-ancestor
110423506|NCT02796157|Everolimus|everolimus|mesh-list
110423507|NCT02796157|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110423508|NCT02796157|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110423509|NCT02796157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110423510|NCT02796157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110423511|NCT02796157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110423512|NCT02796157|Immunologic Factors|immunologic factors|mesh-ancestor
110423513|NCT02796157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110423514|NCT02796157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110423515|NCT01196052|Trastuzumab|trastuzumab|mesh-list
110423516|NCT01196052|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
110423517|NCT01196052|Maytansine|maytansine|mesh-list
110423518|NCT01196052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110423519|NCT01196052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110423520|NCT01196052|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110423521|NCT01196052|Tubulin Modulators|tubulin modulators|mesh-ancestor
110423522|NCT01196052|Antimitotic Agents|antimitotic agents|mesh-ancestor
110423523|NCT01196052|Mitosis Modulators|mitosis modulators|mesh-ancestor
110423524|NCT01196052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110423526|NCT01196052|Immunoconjugates|immunoconjugates|mesh-ancestor
110423527|NCT01196052|Immunologic Factors|immunologic factors|mesh-ancestor
110423528|NCT01196052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110423529|NCT02689921|Trastuzumab|trastuzumab|mesh-list
110423530|NCT02689921|Pertuzumab|pertuzumab|mesh-list
110423531|NCT02689921|Letrozole|letrozole|mesh-list
110423532|NCT02689921|Anastrozole|anastrozole|mesh-list
110423533|NCT02689921|Leuprolide|leuprolide|mesh-list
110423534|NCT02689921|Exemestane|exemestane|mesh-list
110423535|NCT02689921|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110423536|NCT02689921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110423537|NCT02689921|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110423538|NCT02689921|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110423539|NCT02689921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110423540|NCT02689921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110423541|NCT02689921|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110423542|NCT02689921|Hormone Antagonists|hormone antagonists|mesh-ancestor
110423543|NCT02689921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110423544|NCT02689921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110423545|NCT02689921|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110423546|NCT02689921|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110423547|NCT02689921|Fertility Agents|fertility agents|mesh-ancestor
110423548|NCT02689921|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110423549|NCT03116425|Pantothenic Acid|pantothenic acid|mesh-list
110423550|NCT03116425|Vitamin B Complex|vitamin b complex|mesh-ancestor
110423551|NCT03116425|Vitamins|vitamins|mesh-ancestor
110423552|NCT03116425|Micronutrients|micronutrients|mesh-ancestor
110423553|NCT03116425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110423554|NCT01195662|Dapagliflozin|dapagliflozin|mesh-list
110423555|NCT01195662|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110423556|NCT01195662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110423557|NCT01195662|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110423558|NCT01195662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110423559|NCT02786407|Botulinum Toxins|botulinum toxins|mesh-list
110423560|NCT02786407|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110423561|NCT02786407|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110423562|NCT02786407|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110423563|NCT02786407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110423564|NCT02786407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110423565|NCT02786407|Cholinergic Agents|cholinergic agents|mesh-ancestor
110423566|NCT02786407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110423567|NCT02786407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110423568|NCT02786407|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110423569|NCT02786407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110423570|NCT03028519|Vitamin D|vitamin d|mesh-list
110423571|NCT03028519|Cholecalciferol|cholecalciferol|mesh-list
110423572|NCT03028519|Vitamins|vitamins|mesh-ancestor
110423573|NCT03028519|Micronutrients|micronutrients|mesh-ancestor
110423574|NCT03028519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110423575|NCT03028519|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110423576|NCT03028519|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110423577|NCT02786641|Cisplatin|cisplatin|mesh-list
110423578|NCT02786641|Docetaxel|docetaxel|mesh-list
110423579|NCT02786641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110423580|NCT02786641|Tubulin Modulators|tubulin modulators|mesh-ancestor
110423581|NCT02786641|Antimitotic Agents|antimitotic agents|mesh-ancestor
110423582|NCT02786641|Mitosis Modulators|mitosis modulators|mesh-ancestor
110423583|NCT02786641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110423584|NCT02787967|Beclomethasone|beclomethasone|mesh-list
110423585|NCT02787967|Formoterol Fumarate|formoterol fumarate|mesh-list
110423586|NCT02787967|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110423587|NCT02787967|Autonomic Agents|autonomic agents|mesh-ancestor
110423588|NCT02787967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110423589|NCT02787967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110423590|NCT02787967|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110423591|NCT02787967|Respiratory System Agents|respiratory system agents|mesh-ancestor
110423592|NCT02787967|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110423593|NCT02787967|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110423594|NCT02787967|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110201352|NCT00148681|Paclitaxel|paclitaxel|mesh-list
110423595|NCT02787967|Adrenergic Agents|adrenergic agents|mesh-ancestor
110423596|NCT02787967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110423597|NCT02787967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110423598|NCT02787967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110423599|NCT02787967|Glucocorticoids|glucocorticoids|mesh-ancestor
110423600|NCT02787967|Hormones|hormones|mesh-ancestor
110423601|NCT02787967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110423602|NCT02788123|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
110423603|NCT02788123|Pantoprazole|pantoprazole|mesh-list
110423604|NCT02788123|Bismuth|bismuth|mesh-list
110423605|NCT02788123|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110423606|NCT02788123|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110423607|NCT02788123|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110423608|NCT02788123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110423609|NCT02788123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110423610|NCT02788123|Antacids|antacids|mesh-ancestor
110423611|NCT02788123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110423612|NCT01194804|Eculizumab|eculizumab|mesh-list
110423613|NCT01194804|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
110423614|NCT01194804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110423615|NCT01194804|Immunologic Factors|immunologic factors|mesh-ancestor
110423616|NCT01194804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110423617|NCT02785549|Acetaminophen|acetaminophen|mesh-list
110423618|NCT02785549|Amoxicillin|amoxicillin|mesh-list
110423619|NCT02785549|Clavulanic Acids|clavulanic acids|mesh-list
110423620|NCT02785549|Clavulanic Acid|clavulanic acid|mesh-list
110423621|NCT02785549|Ibuprofen|ibuprofen|mesh-list
110423622|NCT02785549|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110423623|NCT02785549|Analgesics|analgesics|mesh-ancestor
110423624|NCT02785549|Sensory System Agents|sensory system agents|mesh-ancestor
110423625|NCT02785549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110423626|NCT02785549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110423628|NCT02785549|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110423629|NCT02785549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110423630|NCT02785549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110423631|NCT02785549|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110423632|NCT02785549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110423633|NCT02785549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110423634|NCT02785549|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110423635|NCT02785549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110423636|NCT02785549|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110423637|NCT02785705|Vaccines|vaccines|mesh-list
110423638|NCT02785705|Immunologic Factors|immunologic factors|mesh-ancestor
110423639|NCT02785705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110423640|NCT02821507|Sirolimus|sirolimus|mesh-list
110423641|NCT02821507|Cyclophosphamide|cyclophosphamide|mesh-list
110423642|NCT02821507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110423643|NCT02821507|Immunologic Factors|immunologic factors|mesh-ancestor
110423644|NCT02821507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110423645|NCT02821507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110423646|NCT02821507|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110423647|NCT02821507|Alkylating Agents|alkylating agents|mesh-ancestor
110423648|NCT02821507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110423649|NCT02821507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110423650|NCT02821507|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110423651|NCT02821507|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110423652|NCT02821507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110423653|NCT02821507|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110423654|NCT02821507|Antifungal Agents|antifungal agents|mesh-ancestor
110423655|NCT02785393|Doxazosin|doxazosin|mesh-list
110201354|NCT00148681|Cyclophosphamide|cyclophosphamide|mesh-list
110423656|NCT02785393|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110423657|NCT02785393|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110423658|NCT02785393|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110423659|NCT02785393|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110423660|NCT02785393|Adrenergic Agents|adrenergic agents|mesh-ancestor
110423661|NCT02785393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110423662|NCT02785393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110423663|NCT02785393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110423664|NCT02787031|Anesthetics|anesthetics|mesh-list
110423665|NCT02787031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110423666|NCT02787031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110423667|NCT02784223|Choline|choline|mesh-list
110423668|NCT02784223|Lipotropic Agents|lipotropic agents|mesh-ancestor
110423669|NCT02784223|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110423670|NCT02784223|Antimetabolites|antimetabolites|mesh-ancestor
110423671|NCT02784223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110423672|NCT02784223|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110423673|NCT02784223|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110423674|NCT02784223|Nootropic Agents|nootropic agents|mesh-ancestor
110423675|NCT05262751|Nintedanib|nintedanib|mesh-list
110423676|NCT05262751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110423677|NCT05262751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110423678|NCT05262751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110423679|NCT05262751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110423680|NCT04231123|Anesthetics|anesthetics|mesh-list
110423681|NCT04231123|Anesthetics, Local|anesthetics, local|mesh-list
110423682|NCT04231123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110423683|NCT04231123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110423684|NCT04231123|Sensory System Agents|sensory system agents|mesh-ancestor
110423685|NCT04231123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110423686|NCT04231279|Secretin|secretin|mesh-list
110423687|NCT04231279|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110423688|NCT04231279|Hormones|hormones|mesh-ancestor
110423689|NCT04231279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110423690|NCT04231279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110423691|NCT02782273|Ketorolac|ketorolac|mesh-list
110423692|NCT02782273|Morphine|morphine|mesh-list
110423693|NCT02782273|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110423694|NCT02782273|Narcotics|narcotics|mesh-ancestor
110423695|NCT02782273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110423696|NCT02782273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110423697|NCT02782273|Analgesics|analgesics|mesh-ancestor
110201381|NCT00148837|Ribavirin|ribavirin|mesh-list
110423698|NCT02782273|Sensory System Agents|sensory system agents|mesh-ancestor
110423699|NCT02782273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110423700|NCT02782273|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110423701|NCT02782273|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110423702|NCT02782273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110423703|NCT02782273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110423704|NCT02782273|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110423705|NCT02782273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110423706|NCT02782273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110423707|NCT05342389|Apatinib|apatinib|mesh-list
110423708|NCT05342389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110423709|NCT05342389|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110423710|NCT05342389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110423711|NCT05342389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110423712|NCT02268175|Prednisone|prednisone|mesh-list
110423713|NCT02268175|Leuprolide|leuprolide|mesh-list
110423714|NCT02268175|Abiraterone Acetate|abiraterone acetate|mesh-list
110423715|NCT02268175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110423716|NCT02268175|Glucocorticoids|glucocorticoids|mesh-ancestor
110423718|NCT02268175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110423719|NCT02268175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110423720|NCT02268175|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110423721|NCT02268175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110423722|NCT02268175|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110423723|NCT02268175|Fertility Agents|fertility agents|mesh-ancestor
110423724|NCT02268175|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110423725|NCT02268175|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110423726|NCT02268175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110423727|NCT02268175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110423728|NCT02268175|Hormone Antagonists|hormone antagonists|mesh-ancestor
110423729|NCT02268175|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110423730|NCT02783989|4-hydroxyphenylethanol|4-hydroxyphenylethanol|mesh-list
110423731|NCT02783989|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110423732|NCT02783989|Antioxidants|antioxidants|mesh-ancestor
110423733|NCT02783989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110423734|NCT02783989|Protective Agents|protective agents|mesh-ancestor
110423735|NCT02783989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110423736|NCT02782429|Ketamine|ketamine|mesh-list
110423737|NCT02782429|Analgesics|analgesics|mesh-ancestor
110423738|NCT02782429|Sensory System Agents|sensory system agents|mesh-ancestor
110423739|NCT02782429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110423740|NCT02782429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110423741|NCT02782429|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110423742|NCT02782429|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110423743|NCT02782429|Anesthetics, General|anesthetics, general|mesh-ancestor
110423744|NCT02782429|Anesthetics|anesthetics|mesh-ancestor
110423745|NCT02782429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110423746|NCT02782429|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110423747|NCT02782429|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110423748|NCT02782429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110423749|NCT02782429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110423750|NCT04229719|Melatonin|melatonin|mesh-list
110423751|NCT04229719|Antioxidants|antioxidants|mesh-ancestor
110423752|NCT04229719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110423753|NCT04229719|Protective Agents|protective agents|mesh-ancestor
110423754|NCT04229719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110423755|NCT04229719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110423756|NCT01855867|Tenofovir|tenofovir|mesh-list
110423757|NCT01855867|Emtricitabine|emtricitabine|mesh-list
110423758|NCT01855867|Antiviral Agents|antiviral agents|mesh-ancestor
110423759|NCT01855867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110423760|NCT01855867|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110423761|NCT01855867|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110423762|NCT01855867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110423763|NCT01855867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110423764|NCT01855867|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110423765|NCT01855867|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110423766|NCT02689843|Metformin|metformin|mesh-list
110423767|NCT02689843|Pioglitazone|pioglitazone|mesh-list
110423768|NCT02689843|Cyproterone Acetate|cyproterone acetate|mesh-list
110423769|NCT02689843|Spironolactone|spironolactone|mesh-list
110423770|NCT02689843|Cyproterone|cyproterone|mesh-list
110423771|NCT02689843|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110423772|NCT02689843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110423773|NCT02689843|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110423774|NCT02689843|Hormone Antagonists|hormone antagonists|mesh-ancestor
110423775|NCT02689843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110423776|NCT02689843|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110423777|NCT02689843|Diuretics|diuretics|mesh-ancestor
110423778|NCT02689843|Natriuretic Agents|natriuretic agents|mesh-ancestor
110423779|NCT02689843|Androgen Antagonists|androgen antagonists|mesh-ancestor
110423780|NCT02689843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110423781|NCT02689843|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110423782|NCT02689843|Contraceptive Agents|contraceptive agents|mesh-ancestor
110423783|NCT02689843|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110423784|NCT05166577|Valganciclovir|valganciclovir|mesh-list
110423785|NCT05166577|Pembrolizumab|pembrolizumab|mesh-list
110423786|NCT05166577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110423787|NCT05166577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110423788|NCT05166577|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110423789|NCT05166577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110423791|NCT05166577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110423792|NCT05341999|Ibuprofen|ibuprofen|mesh-list
110423793|NCT05341999|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110423794|NCT05341999|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110423795|NCT05341999|Analgesics|analgesics|mesh-ancestor
110423796|NCT05341999|Sensory System Agents|sensory system agents|mesh-ancestor
110423797|NCT05341999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110423798|NCT05341999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110423799|NCT05341999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110423800|NCT05341999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110423801|NCT05341999|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110423802|NCT05341999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110201430|NCT00048776|Cilostazol|cilostazol|mesh-list
110423803|NCT05341999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110423805|NCT02781805|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110423806|NCT02781805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110423807|NCT02781493|Prucalopride|prucalopride|mesh-list
110423808|NCT02781493|Laxatives|laxatives|mesh-ancestor
110423809|NCT02781493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110423810|NCT02781493|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
110423811|NCT02781493|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110423812|NCT02781493|Serotonin Agents|serotonin agents|mesh-ancestor
110423813|NCT02781493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110423814|NCT02781493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110423815|NCT02781493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110423816|NCT02783053|Metformin|metformin|mesh-list
110423817|NCT02783053|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110070800|NCT02525796|Amiloride|amiloride|mesh-list
110423818|NCT02783053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110423820|NCT02781415|Morphine|morphine|mesh-list
110423821|NCT02781415|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110423822|NCT02781415|Narcotics|narcotics|mesh-ancestor
110564381|NCT05861791|Nefopam|nefopam|mesh-list
110423823|NCT02781415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110423824|NCT02781415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110423825|NCT02781415|Analgesics|analgesics|mesh-ancestor
110423826|NCT02781415|Sensory System Agents|sensory system agents|mesh-ancestor
110423827|NCT02781415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110423828|NCT02785003|Acetaminophen|acetaminophen|mesh-list
110423829|NCT02785003|Ketamine|ketamine|mesh-list
110423830|NCT02785003|Morphine|morphine|mesh-list
110423831|NCT02785003|Narcotics|narcotics|mesh-list
110423832|NCT02785003|Alvimopan|alvimopan|mesh-list
110423833|NCT02785003|Analgesics|analgesics|mesh-ancestor
110423834|NCT02785003|Sensory System Agents|sensory system agents|mesh-ancestor
110423835|NCT02785003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110423836|NCT02785003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110423837|NCT02785003|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110423838|NCT02785003|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110423839|NCT02785003|Anesthetics, General|anesthetics, general|mesh-ancestor
110423840|NCT02785003|Anesthetics|anesthetics|mesh-ancestor
110423841|NCT02785003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110423842|NCT02785003|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110423843|NCT02785003|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110423844|NCT02785003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110423845|NCT02785003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110423846|NCT02785003|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110423847|NCT02785003|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110423848|NCT02785003|Antipyretics|antipyretics|mesh-ancestor
110423849|NCT02785003|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110423850|NCT05297617|Aromatase Inhibitors|aromatase inhibitors|mesh-list
110423851|NCT05297617|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110423852|NCT05297617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110423853|NCT05297617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110423854|NCT05297617|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110423855|NCT05297617|Hormone Antagonists|hormone antagonists|mesh-ancestor
110423856|NCT05297617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110423857|NCT05297617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110423858|NCT02782897|Immunoglobulins|immunoglobulins|mesh-list
110423859|NCT02782897|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110423860|NCT02782897|Antibodies|antibodies|mesh-list
110423861|NCT02782897|Immunologic Factors|immunologic factors|mesh-ancestor
110201446|NCT00048776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110423862|NCT02782897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110423864|NCT00638131|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110423865|NCT00638131|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
110423866|NCT00638131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110423867|NCT02780245|Tranexamic Acid|tranexamic acid|mesh-list
110423868|NCT02780245|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110423869|NCT02780245|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110423870|NCT02780245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110423871|NCT02780245|Hemostatics|hemostatics|mesh-ancestor
110423872|NCT02780245|Coagulants|coagulants|mesh-ancestor
110423873|NCT05340985|Vitamin D|vitamin d|mesh-list
110423874|NCT05340985|Ergocalciferols|ergocalciferols|mesh-list
110423875|NCT05340985|Cholecalciferol|cholecalciferol|mesh-list
110423876|NCT05340985|Calcifediol|calcifediol|mesh-list
110423877|NCT05340985|Vitamins|vitamins|mesh-list
110423878|NCT05340985|Dehydrocholesterols|dehydrocholesterols|mesh-list
110423879|NCT05340985|7-dehydrocholesterol|7-dehydrocholesterol|mesh-list
110423880|NCT05340985|Micronutrients|micronutrients|mesh-ancestor
110423881|NCT05340985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110423882|NCT05340985|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110423883|NCT05340985|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110423884|NCT05340985|Provitamins|provitamins|mesh-ancestor
110423885|NCT02784457|Cetrorelix|cetrorelix|mesh-list
110423886|NCT02784457|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110423887|NCT02784457|Fertility Agents|fertility agents|mesh-ancestor
110423888|NCT02784457|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110423889|NCT02784457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110423890|NCT02784457|Hormone Antagonists|hormone antagonists|mesh-ancestor
110423891|NCT02784457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110423892|NCT02780323|Celecoxib|celecoxib|mesh-list
110070877|NCT01734694|Vancomycin|vancomycin|mesh-list
110423893|NCT02780323|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110423894|NCT02780323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110423895|NCT02780323|Analgesics|analgesics|mesh-ancestor
110423896|NCT02780323|Sensory System Agents|sensory system agents|mesh-ancestor
110423897|NCT02780323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110423898|NCT02780323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110423899|NCT02780323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110423900|NCT02780323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110370122|NCT00564603|Dexamethasone|dexamethasone|mesh-list
110423901|NCT02780323|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110423902|NCT02780323|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110423903|NCT02780323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110423904|NCT02780323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110423905|NCT05331859|Insulin|insulin|mesh-list
110423906|NCT05331859|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110423907|NCT05331859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110423908|NCT04229407|Vitamins|vitamins|mesh-list
110423909|NCT04229407|Vitamin B Complex|vitamin b complex|mesh-list
110423910|NCT04229407|Micronutrients|micronutrients|mesh-ancestor
110423911|NCT04229407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110423912|NCT04231435|Metformin|metformin|mesh-list
110423913|NCT04231435|Digoxin|digoxin|mesh-list
110423914|NCT04231435|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110423915|NCT04231435|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110423916|NCT04231435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110423917|NCT04231435|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110423918|NCT04231435|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110423919|NCT04231435|Antimetabolites|antimetabolites|mesh-ancestor
110423920|NCT04231435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110423921|NCT04231435|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110423922|NCT04231435|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110423923|NCT04231435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110201467|NCT00149539|Buprenorphine|buprenorphine|mesh-list
110423924|NCT04231435|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110423925|NCT04231435|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110423926|NCT04231435|Protective Agents|protective agents|mesh-ancestor
110423927|NCT05340439|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
110423928|NCT05340439|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110328534|NCT00497172|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110423929|NCT05340439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110423930|NCT05340439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110423931|NCT05340439|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110423932|NCT05340439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110423933|NCT05340439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110423934|NCT05340439|Cholinergic Agents|cholinergic agents|mesh-ancestor
110423935|NCT05340439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110423936|NCT01194414|Antirheumatic Agents|antirheumatic agents|mesh-list
110423937|NCT02173405|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110423938|NCT02173405|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110423939|NCT02173405|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110423940|NCT02173405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110423941|NCT02173405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110423942|NCT02173405|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110423943|NCT02173405|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110423944|NCT02173405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110423945|NCT02173405|Cholinergic Agents|cholinergic agents|mesh-ancestor
110423946|NCT02173405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110423947|NCT05322031|Aripiprazole|aripiprazole|mesh-list
110423948|NCT05322031|Antidepressive Agents|antidepressive agents|mesh-ancestor
110423949|NCT05322031|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110423950|NCT05322031|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110423951|NCT05322031|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110423952|NCT05322031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110423953|NCT05322031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110423954|NCT05322031|Dopamine Agonists|dopamine agonists|mesh-ancestor
110423955|NCT05322031|Dopamine Agents|dopamine agents|mesh-ancestor
110423956|NCT05322031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110423957|NCT05322031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110423958|NCT05322031|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110423959|NCT05322031|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110423960|NCT05322031|Serotonin Agents|serotonin agents|mesh-ancestor
110423961|NCT05322031|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110423962|NCT05322031|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110423963|NCT05322031|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110423964|NCT05322031|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110423965|NCT02780011|Brentuximab Vedotin|brentuximab vedotin|mesh-list
110423966|NCT02780011|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110423967|NCT02780011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110423968|NCT02780011|Immunotoxins|immunotoxins|mesh-ancestor
110423969|NCT02780011|Immunoconjugates|immunoconjugates|mesh-ancestor
110423970|NCT02780011|Immunologic Factors|immunologic factors|mesh-ancestor
110201474|NCT00149539|Analgesics|analgesics|mesh-ancestor
110423971|NCT02780011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110423972|NCT02780479|Dexamethasone|dexamethasone|mesh-list
110423973|NCT02780479|Prednisone|prednisone|mesh-list
110423974|NCT02780479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110423975|NCT02780479|Antiemetics|antiemetics|mesh-ancestor
110423976|NCT02780479|Autonomic Agents|autonomic agents|mesh-ancestor
110423977|NCT02780479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110423978|NCT02780479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110423979|NCT02780479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110423980|NCT02780479|Glucocorticoids|glucocorticoids|mesh-ancestor
110423981|NCT02780479|Hormones|hormones|mesh-ancestor
110423982|NCT02780479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110423983|NCT02780479|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110423984|NCT02780479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110423985|NCT05252923|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
110423986|NCT05252923|Anticoagulants|anticoagulants|mesh-ancestor
110423987|NCT05252923|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110423988|NCT05252923|Antimetabolites|antimetabolites|mesh-ancestor
110423989|NCT05252923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110423990|NCT05252923|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110423991|NCT05252923|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110423992|NCT05252923|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110423993|NCT05252923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110423994|NCT05252923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110423995|NCT05097079|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
110423996|NCT05097079|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110423997|NCT05097079|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110423998|NCT05097079|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110423999|NCT05097079|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110424000|NCT05097079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110424001|NCT05097079|Cholinergic Agents|cholinergic agents|mesh-ancestor
110424002|NCT05097079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110424003|NCT05097079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110424004|NCT05097079|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110424005|NCT05097079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110424006|NCT02779387|Goserelin|goserelin|mesh-list
110424007|NCT02779387|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110424008|NCT02779387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110424009|NCT04228315|Primaquine|primaquine|mesh-list
110424010|NCT04228315|Antimalarials|antimalarials|mesh-ancestor
110424011|NCT04228315|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110424012|NCT04228315|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110424013|NCT04228315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110424014|NCT04228393|Mercaptopurine|mercaptopurine|mesh-list
110424015|NCT04228393|Antimetabolites|antimetabolites|mesh-ancestor
110424016|NCT04228393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110424017|NCT04228393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110424018|NCT04228393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110424019|NCT04228393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110424020|NCT04228393|Immunologic Factors|immunologic factors|mesh-ancestor
110424021|NCT04228393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110424022|NCT04228393|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110424023|NCT04228393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110424024|NCT02779777|Tipifarnib|tipifarnib|mesh-list
110424025|NCT02779777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110424026|NCT05279833|Sotalol|sotalol|mesh-list
110424027|NCT05279833|Dronedarone|dronedarone|mesh-list
110424028|NCT05279833|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110424029|NCT05279833|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110424030|NCT05279833|Adrenergic Agents|adrenergic agents|mesh-ancestor
110424031|NCT05279833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110424032|NCT05279833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110424033|NCT05279833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110424034|NCT05279833|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110424035|NCT05279833|Sympatholytics|sympatholytics|mesh-ancestor
110424036|NCT05279833|Autonomic Agents|autonomic agents|mesh-ancestor
110201504|NCT00149656|Selenium|selenium|mesh-list
110424037|NCT05279833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110424038|NCT01880359|Nimorazole|nimorazole|mesh-list
110424039|NCT01880359|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
110424040|NCT01880359|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110424041|NCT01880359|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110424042|NCT01880359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110424043|NCT04975555|Siltuximab|siltuximab|mesh-list
110424044|NCT04975555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110424045|NCT05338489|Itraconazole|itraconazole|mesh-list
110424046|NCT05338489|Rifampin|rifampin|mesh-list
110424047|NCT05338489|Antifungal Agents|antifungal agents|mesh-ancestor
110424048|NCT05338489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110424049|NCT05338489|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110424050|NCT05338489|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110424051|NCT05338489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110424052|NCT05338489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110424053|NCT05338489|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110424054|NCT05338489|Hormone Antagonists|hormone antagonists|mesh-ancestor
110424055|NCT05338489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110424056|NCT05338489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110424057|NCT05338489|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110424058|NCT05338489|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110424059|NCT05338489|Antitubercular Agents|antitubercular agents|mesh-ancestor
110424060|NCT05338489|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110424061|NCT05338489|Leprostatic Agents|leprostatic agents|mesh-ancestor
110424062|NCT05338489|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110424063|NCT05338489|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110424064|NCT05338489|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110424065|NCT05338489|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110424066|NCT05338489|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110424067|NCT05338489|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110424068|NCT05338489|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110424069|NCT05266417|Insulin|insulin|mesh-list
110424070|NCT05266417|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110424071|NCT05266417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110424072|NCT02779465|Vitamin D|vitamin d|mesh-list
110424073|NCT02779465|Cholecalciferol|cholecalciferol|mesh-list
110424074|NCT02779465|Vitamins|vitamins|mesh-ancestor
110424075|NCT02779465|Micronutrients|micronutrients|mesh-ancestor
110424076|NCT02779465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110424077|NCT02779465|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110424078|NCT02779465|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110424079|NCT02776189|Midazolam|midazolam|mesh-list
110424080|NCT02776189|Dexmedetomidine|dexmedetomidine|mesh-list
110424081|NCT02776189|Propofol|propofol|mesh-list
110424082|NCT02776189|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110424083|NCT02776189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110424084|NCT02776189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110424085|NCT02776189|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110424086|NCT02776189|Analgesics|analgesics|mesh-ancestor
110424087|NCT02776189|Sensory System Agents|sensory system agents|mesh-ancestor
110424088|NCT02776189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110424089|NCT02776189|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110424090|NCT02776189|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110424091|NCT02776189|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110424092|NCT02776189|Adrenergic Agents|adrenergic agents|mesh-ancestor
110424093|NCT02776189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110424094|NCT02776189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110424095|NCT02776189|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110424096|NCT02776189|Anesthetics, General|anesthetics, general|mesh-ancestor
110424097|NCT02776189|Anesthetics|anesthetics|mesh-ancestor
110424098|NCT02776189|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110370147|NCT00564642|Acetylcysteine|acetylcysteine|mesh-list
110424099|NCT02776189|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110424100|NCT02776189|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110424101|NCT02776189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110424102|NCT02776189|GABA Modulators|gaba modulators|mesh-ancestor
110424103|NCT02776189|GABA Agents|gaba agents|mesh-ancestor
110424104|NCT01194258|Insulin|insulin|mesh-list
110424105|NCT01194258|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110424106|NCT01194258|Insulin Glargine|insulin glargine|mesh-list
110424107|NCT01194258|Insulin Aspart|insulin aspart|mesh-list
110424108|NCT01194258|Insulin Lispro|insulin lispro|mesh-list
110424109|NCT01194258|Insulin glulisine|insulin glulisine|mesh-list
110424110|NCT01194258|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110424111|NCT01194258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110424112|NCT04883437|Obinutuzumab|obinutuzumab|mesh-list
110424113|NCT04883437|Acalabrutinib|acalabrutinib|mesh-list
110424114|NCT04883437|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
110071110|NCT01557335|Aspirin|aspirin|mesh-list
110424115|NCT04883437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110424116|NCT04883437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110424117|NCT04883437|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110424118|NCT04883437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110424119|NCT04883437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110424120|NCT02775877|Letrozole|letrozole|mesh-list
110424121|NCT02775877|Clomiphene|clomiphene|mesh-list
110424122|NCT02775877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110424123|NCT02775877|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110424124|NCT02775877|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110424125|NCT02775877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110424126|NCT02775877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110424127|NCT02775877|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110424128|NCT02775877|Hormone Antagonists|hormone antagonists|mesh-ancestor
110424129|NCT02775877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110424130|NCT02775877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110424131|NCT02775877|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110424132|NCT02775877|Fertility Agents|fertility agents|mesh-ancestor
110424133|NCT02775877|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110424134|NCT02775877|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110424135|NCT02775877|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110424136|NCT02777671|Gliclazide|gliclazide|mesh-list
110424137|NCT02777671|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
110424138|NCT02777671|Anticonvulsants|anticonvulsants|mesh-ancestor
110424139|NCT02777671|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110424140|NCT02777671|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110424141|NCT02777671|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110424142|NCT02777671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110328541|NCT03273296|Azithromycin|azithromycin|mesh-list
110424143|NCT02777671|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110424144|NCT02777671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110424145|NCT02778919|Leuprolide|leuprolide|mesh-list
110424146|NCT02778919|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110424147|NCT02778919|Fertility Agents|fertility agents|mesh-ancestor
110424148|NCT02778919|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110424149|NCT02778919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110424150|NCT02778919|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110424151|NCT02778919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110424152|NCT02779153|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
110424153|NCT02779153|Hormones|hormones|mesh-ancestor
110424154|NCT02779153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110424155|NCT02779153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110424156|NCT04226443|Midazolam|midazolam|mesh-list
110424157|NCT04226443|Remifentanil|remifentanil|mesh-list
110424158|NCT04226443|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110424159|NCT04226443|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110424160|NCT04226443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110424161|NCT04226443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110424162|NCT04226443|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110424163|NCT04226443|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110424164|NCT04226443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110424165|NCT04226443|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110424166|NCT04226443|Anesthetics, General|anesthetics, general|mesh-ancestor
110424167|NCT04226443|Anesthetics|anesthetics|mesh-ancestor
110424168|NCT04226443|GABA Modulators|gaba modulators|mesh-ancestor
110424169|NCT04226443|GABA Agents|gaba agents|mesh-ancestor
110424170|NCT04226443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110424171|NCT04226443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110424172|NCT04226443|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110424173|NCT04226443|Narcotics|narcotics|mesh-ancestor
110424174|NCT04226443|Analgesics|analgesics|mesh-ancestor
110424175|NCT04226443|Sensory System Agents|sensory system agents|mesh-ancestor
110424176|NCT04226443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110424177|NCT02776891|Citric Acid|citric acid|mesh-list
110424178|NCT02776891|Sodium Citrate|sodium citrate|mesh-list
110424179|NCT02776891|Gallium citrate|gallium citrate|mesh-list
110424180|NCT02776891|Anticoagulants|anticoagulants|mesh-ancestor
110424181|NCT02776891|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110424182|NCT02776891|Chelating Agents|chelating agents|mesh-ancestor
110424183|NCT02776891|Sequestering Agents|sequestering agents|mesh-ancestor
110424184|NCT02776891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110424185|NCT02776891|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110424186|NCT02776813|Rituximab|rituximab|mesh-list
110424187|NCT02776813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110424188|NCT02776813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110424189|NCT02776813|Immunologic Factors|immunologic factors|mesh-ancestor
110424190|NCT02776813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110424191|NCT02776813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110424192|NCT05157997|Casirivimab and imdevimab drug combination|casirivimab and imdevimab drug combination|mesh-list
110424193|NCT05157997|Antibodies|antibodies|mesh-list
110424194|NCT05157997|Immunologic Factors|immunologic factors|mesh-ancestor
110424195|NCT05157997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110424196|NCT05157997|Antiviral Agents|antiviral agents|mesh-ancestor
110424197|NCT05157997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110424198|NCT02773147|Pyridoxine|pyridoxine|mesh-list
110424199|NCT02773147|Vitamin B 12|vitamin b 12|mesh-list
110424200|NCT02773147|Hydroxocobalamin|hydroxocobalamin|mesh-list
110424201|NCT02773147|Hematinics|hematinics|mesh-ancestor
110424202|NCT02773147|Vitamin B Complex|vitamin b complex|mesh-ancestor
110424203|NCT02773147|Vitamins|vitamins|mesh-ancestor
110424204|NCT02773147|Micronutrients|micronutrients|mesh-ancestor
110424205|NCT02773147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110424206|NCT02773927|Metformin|metformin|mesh-list
110424207|NCT02773927|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110424208|NCT02773927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110424210|NCT02773459|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110424211|NCT02773459|Antimetabolites|antimetabolites|mesh-ancestor
110424212|NCT02773459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110424213|NCT02773459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110424214|NCT04818229|Moxifloxacin|moxifloxacin|mesh-list
110424215|NCT04818229|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
110424216|NCT04818229|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110424217|NCT04818229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110424218|NCT04818229|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110424219|NCT04818229|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110424220|NCT04818229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110424221|NCT04818229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110424222|NCT04818229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110424223|NCT04818229|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110424224|NCT04818229|Contraceptive Agents|contraceptive agents|mesh-ancestor
110424225|NCT04818229|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110424226|NCT04818229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110424227|NCT04818229|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110424228|NCT04818229|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110424229|NCT04818229|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110424230|NCT04771741|Acetaminophen|acetaminophen|mesh-list
110424231|NCT04771741|Ketorolac|ketorolac|mesh-list
110424232|NCT04771741|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
110424233|NCT04771741|Meloxicam|meloxicam|mesh-list
110424234|NCT04771741|Pregabalin|pregabalin|mesh-list
110424235|NCT04771741|Cyclobenzaprine|cyclobenzaprine|mesh-list
110424236|NCT04771741|Analgesics|analgesics|mesh-ancestor
110424237|NCT04771741|Sensory System Agents|sensory system agents|mesh-ancestor
110424238|NCT04771741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110424239|NCT04771741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110424240|NCT04771741|Anticonvulsants|anticonvulsants|mesh-ancestor
110424241|NCT04771741|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110424242|NCT04771741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110424243|NCT04771741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110424244|NCT04771741|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110424245|NCT04771741|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110424246|NCT04771741|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110424247|NCT04771741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110424248|NCT04771741|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110424249|NCT04771741|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110424250|NCT04771741|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110424251|NCT04771741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110424252|NCT04771741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110424253|NCT04771741|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110424254|NCT04771741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110424255|NCT04771741|Antipyretics|antipyretics|mesh-ancestor
110424256|NCT04771741|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110564392|NCT05861791|Anesthetics|anesthetics|mesh-ancestor
110424257|NCT04771741|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110424258|NCT04771741|Antidepressive Agents|antidepressive agents|mesh-ancestor
110424259|NCT04771741|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110424260|NCT04771741|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110424261|NCT02772601|Metoprolol|metoprolol|mesh-list
110424262|NCT02772601|Midazolam|midazolam|mesh-list
110424263|NCT02772601|Caffeine|caffeine|mesh-list
110424264|NCT02772601|Omeprazole|omeprazole|mesh-list
110424265|NCT02772601|Warfarin|warfarin|mesh-list
110424266|NCT02772601|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110424267|NCT02772601|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110424268|NCT02772601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110424269|NCT02772601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110424270|NCT02772601|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110424271|NCT02772601|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110424272|NCT02772601|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110424273|NCT02772601|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110424274|NCT02772601|Anesthetics, General|anesthetics, general|mesh-ancestor
110424275|NCT02772601|Anesthetics|anesthetics|mesh-ancestor
110424276|NCT02772601|GABA Modulators|gaba modulators|mesh-ancestor
110424277|NCT02772601|GABA Agents|gaba agents|mesh-ancestor
110424278|NCT02772601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110424279|NCT02772601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110424280|NCT02772601|Anticoagulants|anticoagulants|mesh-ancestor
110424281|NCT02772601|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110424282|NCT02772601|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110424283|NCT02772601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110424284|NCT02772601|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110424285|NCT02772601|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110424286|NCT02772601|Purinergic Agents|purinergic agents|mesh-ancestor
110424287|NCT02772601|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110424288|NCT02772601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110328548|NCT00497250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110424290|NCT02772601|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110424291|NCT02772601|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110424292|NCT02772601|Sympatholytics|sympatholytics|mesh-ancestor
110424293|NCT02772601|Autonomic Agents|autonomic agents|mesh-ancestor
110424294|NCT02772601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110424295|NCT02772601|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110424296|NCT02772601|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110424297|NCT02772601|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110424298|NCT02772601|Adrenergic Agents|adrenergic agents|mesh-ancestor
110424299|NCT02772211|Cycloserine|cycloserine|mesh-list
110424300|NCT02772211|Ketamine|ketamine|mesh-list
110424301|NCT02772211|Analgesics|analgesics|mesh-ancestor
110424302|NCT02772211|Sensory System Agents|sensory system agents|mesh-ancestor
110370165|NCT00555386|Micronutrients|micronutrients|mesh-ancestor
110424303|NCT02772211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110424304|NCT02772211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110424305|NCT02772211|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110424306|NCT02772211|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110424308|NCT02772211|Anesthetics|anesthetics|mesh-ancestor
110424309|NCT02772211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110424310|NCT02772211|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110424311|NCT02772211|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110424312|NCT02772211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110424313|NCT02772211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110424314|NCT02772211|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110424315|NCT02772211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110424316|NCT02772211|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110424317|NCT02772211|Antitubercular Agents|antitubercular agents|mesh-ancestor
110424318|NCT02772211|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110424319|NCT02772211|Antimetabolites|antimetabolites|mesh-ancestor
110424320|NCT04225195|Amphotericin B|amphotericin b|mesh-list
110424321|NCT04225195|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
110424322|NCT04225195|Cholesteryl sulfate|cholesteryl sulfate|mesh-list
110424323|NCT04225195|Amebicides|amebicides|mesh-ancestor
110424324|NCT04225195|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110424325|NCT04225195|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110424326|NCT04225195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110424327|NCT04225195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110424328|NCT04225195|Antifungal Agents|antifungal agents|mesh-ancestor
110424329|NCT04225195|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110424330|NCT04225195|Protease Inhibitors|protease inhibitors|mesh-ancestor
110424331|NCT04225195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110424332|NCT04225195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110424333|NCT04225195|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110424334|NCT04225195|Protective Agents|protective agents|mesh-ancestor
110424335|NCT04225195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110424336|NCT04225195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110424337|NCT02771509|Mitogens|mitogens|mesh-list
110424338|NCT02771509|Mitosis Modulators|mitosis modulators|mesh-ancestor
110424339|NCT02771509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110424340|NCT02696941|Metformin|metformin|mesh-list
110424341|NCT02696941|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
110424342|NCT02696941|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110424343|NCT02696941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110424344|NCT02696941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110424345|NCT02767375|Fluorouracil|fluorouracil|mesh-list
110424346|NCT02767375|Oxaliplatin|oxaliplatin|mesh-list
110424347|NCT02767375|Antimetabolites|antimetabolites|mesh-ancestor
110424348|NCT02767375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110424349|NCT02767375|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110424350|NCT02767375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110424351|NCT02767375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110424352|NCT02767375|Immunologic Factors|immunologic factors|mesh-ancestor
110424353|NCT02767375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110424354|NCT02767219|Dexamethasone|dexamethasone|mesh-list
110424355|NCT02767219|Bevacizumab|bevacizumab|mesh-list
110424356|NCT02767219|Fluorouracil|fluorouracil|mesh-list
110424357|NCT02767219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110424358|NCT02767219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110424359|NCT02767219|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110424360|NCT02767219|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110424361|NCT02767219|Growth Substances|growth substances|mesh-ancestor
110424362|NCT02767219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110424363|NCT02767219|Growth Inhibitors|growth inhibitors|mesh-ancestor
110424364|NCT02767219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110424365|NCT02767219|Antiemetics|antiemetics|mesh-ancestor
110424366|NCT02767219|Autonomic Agents|autonomic agents|mesh-ancestor
110424367|NCT02767219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110424368|NCT02767219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110424369|NCT02767219|Glucocorticoids|glucocorticoids|mesh-ancestor
110424370|NCT02767219|Hormones|hormones|mesh-ancestor
110424371|NCT02767219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110424372|NCT02767219|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110424373|NCT02767219|Antimetabolites|antimetabolites|mesh-ancestor
110424374|NCT02767219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110424375|NCT02767219|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110424376|NCT02767219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110424377|NCT02767219|Immunologic Factors|immunologic factors|mesh-ancestor
110424378|NCT02771587|Ethanol|ethanol|mesh-list
110424379|NCT02771587|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110424380|NCT02771587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110424381|NCT02771587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110424382|NCT02771587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110424383|NCT02771743|Cyclophosphamide|cyclophosphamide|mesh-list
110424384|NCT02771743|Ifosfamide|ifosfamide|mesh-list
110424385|NCT02771743|Carboplatin|carboplatin|mesh-list
110424386|NCT02771743|Doxorubicin|doxorubicin|mesh-list
110424387|NCT02771743|Etoposide|etoposide|mesh-list
110424388|NCT02771743|Interleukin-2|interleukin-2|mesh-list
110424389|NCT02771743|Isotretinoin|isotretinoin|mesh-list
110424390|NCT02771743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110424391|NCT02771743|Immunologic Factors|immunologic factors|mesh-ancestor
110424392|NCT02771743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110424393|NCT02771743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110564401|NCT05861713|Antiemetics|antiemetics|mesh-ancestor
110424394|NCT02771743|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110424395|NCT02771743|Alkylating Agents|alkylating agents|mesh-ancestor
110424396|NCT02771743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110424397|NCT02771743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110424398|NCT02771743|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110424399|NCT02771743|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110424400|NCT02771743|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110424401|NCT02771743|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110424402|NCT02771743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110424403|NCT02771743|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110424404|NCT02771743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110424405|NCT02771743|Analgesics|analgesics|mesh-ancestor
110424406|NCT02771743|Sensory System Agents|sensory system agents|mesh-ancestor
110424407|NCT02771743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110424408|NCT02771743|Dermatologic Agents|dermatologic agents|mesh-ancestor
110424409|NCT02762851|Vaccines|vaccines|mesh-list
110424410|NCT02762851|Immunologic Factors|immunologic factors|mesh-ancestor
110424411|NCT02762851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110424412|NCT02767063|Pioglitazone|pioglitazone|mesh-list
110424413|NCT02767063|Avelumab|avelumab|mesh-list
110424414|NCT02767063|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110424415|NCT02767063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110424416|NCT02767063|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110424417|NCT02767063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110424418|NCT04224103|Nitric Oxide|nitric oxide|mesh-list
110424419|NCT04224103|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110424420|NCT04224103|Autonomic Agents|autonomic agents|mesh-ancestor
110424421|NCT04224103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110201627|NCT00150085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110424422|NCT04224103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110424423|NCT04224103|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110424424|NCT04224103|Respiratory System Agents|respiratory system agents|mesh-ancestor
110424425|NCT04224103|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110424427|NCT04224103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110424428|NCT04224103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110370179|NCT04606836|Bupivacaine|bupivacaine|mesh-list
110424429|NCT04224103|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
110424430|NCT04224103|Vasodilator Agents|vasodilator agents|mesh-ancestor
110424431|NCT04224103|Gasotransmitters|gasotransmitters|mesh-ancestor
110424432|NCT04224103|Protective Agents|protective agents|mesh-ancestor
110424433|NCT02766439|Etanercept|etanercept|mesh-list
110328555|NCT00462956|Lapatinib|lapatinib|mesh-list
110424434|NCT02766439|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110424435|NCT02766439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110424436|NCT02766439|Analgesics|analgesics|mesh-ancestor
110424437|NCT02766439|Sensory System Agents|sensory system agents|mesh-ancestor
110424438|NCT02766439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110424439|NCT02766439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110424440|NCT02766439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110424441|NCT02766439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110424442|NCT02766439|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110424443|NCT02766439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110424444|NCT02766439|Immunologic Factors|immunologic factors|mesh-ancestor
110424445|NCT02765971|Picosulfate sodium|picosulfate sodium|mesh-list
110424446|NCT02765971|Cathartics|cathartics|mesh-ancestor
110424447|NCT02765971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110424448|NCT02765815|Ketorolac|ketorolac|mesh-list
110424449|NCT02765815|Epinephrine|epinephrine|mesh-list
110424450|NCT02765815|Racepinephrine|racepinephrine|mesh-list
110424451|NCT02765815|Morphine|morphine|mesh-list
110424452|NCT02765815|Bupivacaine|bupivacaine|mesh-list
110424453|NCT02765815|Epinephryl borate|epinephryl borate|mesh-list
110424454|NCT02765815|Anesthetics, Local|anesthetics, local|mesh-ancestor
110424455|NCT02765815|Anesthetics|anesthetics|mesh-ancestor
110424456|NCT02765815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110424457|NCT02765815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110424458|NCT02765815|Sensory System Agents|sensory system agents|mesh-ancestor
110424459|NCT02765815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110424460|NCT02765815|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110424461|NCT02765815|Narcotics|narcotics|mesh-ancestor
110424462|NCT02765815|Analgesics|analgesics|mesh-ancestor
110424463|NCT02765815|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110424464|NCT02765815|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110424465|NCT02765815|Adrenergic Agents|adrenergic agents|mesh-ancestor
110424466|NCT02765815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110424467|NCT02765815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110424468|NCT02765815|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110424469|NCT02765815|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110424470|NCT02765815|Autonomic Agents|autonomic agents|mesh-ancestor
110424471|NCT02765815|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110201647|NCT00049244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110424472|NCT02765815|Respiratory System Agents|respiratory system agents|mesh-ancestor
110424473|NCT02765815|Mydriatics|mydriatics|mesh-ancestor
110424474|NCT02765815|Sympathomimetics|sympathomimetics|mesh-ancestor
110424475|NCT02765815|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110424476|NCT02765815|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110424477|NCT02765815|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110424478|NCT02765815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110424479|NCT02765815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110424480|NCT02765815|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110424481|NCT02765815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110424482|NCT02765347|Metformin|metformin|mesh-list
110424483|NCT02765347|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110424484|NCT02765347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110424485|NCT02770885|Dulaglutide|dulaglutide|mesh-list
110424486|NCT02770885|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110424487|NCT02770885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110424488|NCT02770651|Everolimus|everolimus|mesh-list
110424489|NCT02770651|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110424490|NCT02770651|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110424491|NCT02770651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110424492|NCT02770651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110424493|NCT02770651|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110424494|NCT02770651|Immunologic Factors|immunologic factors|mesh-ancestor
110424495|NCT02770651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110424496|NCT02770651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110424497|NCT02770729|Moxifloxacin|moxifloxacin|mesh-list
110424498|NCT02770729|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
110424499|NCT02770729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110424500|NCT02770729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110424501|NCT02770729|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110370194|NCT04675619|Pirfenidone|pirfenidone|mesh-list
110424502|NCT02770729|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110424503|NCT02770729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110424504|NCT02770729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110424505|NCT02770729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110424506|NCT02770729|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110424507|NCT02770729|Contraceptive Agents|contraceptive agents|mesh-ancestor
110424508|NCT02770729|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110424509|NCT02770729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110424510|NCT02770729|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110424511|NCT02770729|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110424512|NCT02770729|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110424513|NCT02770105|Caffeine|caffeine|mesh-list
110424514|NCT02770105|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110424515|NCT02770105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110424516|NCT02770105|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110424517|NCT02770105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110424518|NCT02770105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110424519|NCT02770105|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110424520|NCT02770105|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110424521|NCT02770105|Purinergic Agents|purinergic agents|mesh-ancestor
110424522|NCT02770105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110424523|NCT02769793|Levodopa|levodopa|mesh-list
110424524|NCT02769793|Benserazide|benserazide|mesh-list
110424525|NCT02769793|Benserazide, levodopa drug combination|benserazide, levodopa drug combination|mesh-list
110424526|NCT02769793|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110424527|NCT02769793|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110424528|NCT02769793|Dopamine Agents|dopamine agents|mesh-ancestor
110424529|NCT02769793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110424530|NCT02769793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110424531|NCT02769793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110424532|NCT02769793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110424533|NCT02769325|Ketorolac|ketorolac|mesh-list
110424534|NCT02769325|Atropine|atropine|mesh-list
110424535|NCT02769325|Morphine|morphine|mesh-list
110424536|NCT02769325|Propofol|propofol|mesh-list
110424537|NCT02769325|Sevoflurane|sevoflurane|mesh-list
110424538|NCT02769325|Rocuronium|rocuronium|mesh-list
110424539|NCT02769325|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110424540|NCT02769325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110424541|NCT02769325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110424542|NCT02769325|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110424543|NCT02769325|Anesthetics, General|anesthetics, general|mesh-ancestor
110424544|NCT02769325|Anesthetics|anesthetics|mesh-ancestor
110424545|NCT02769325|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110424546|NCT02769325|Narcotics|narcotics|mesh-ancestor
110424547|NCT02769325|Analgesics|analgesics|mesh-ancestor
110424548|NCT02769325|Sensory System Agents|sensory system agents|mesh-ancestor
110424549|NCT02769325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110424550|NCT02769325|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110424551|NCT02769325|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110424552|NCT02769325|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110424553|NCT02769325|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110424554|NCT02769325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110424555|NCT02769325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110424556|NCT02769325|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110424557|NCT02769325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110424558|NCT02769325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110424559|NCT02769325|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110424560|NCT02769325|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110424561|NCT02769325|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110424562|NCT02769325|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110424563|NCT02769325|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110424564|NCT02769325|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110424565|NCT02769325|Autonomic Agents|autonomic agents|mesh-ancestor
110424566|NCT02769325|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110424567|NCT02769325|Respiratory System Agents|respiratory system agents|mesh-ancestor
110424568|NCT02769325|Mydriatics|mydriatics|mesh-ancestor
110424569|NCT02769325|Parasympatholytics|parasympatholytics|mesh-ancestor
110424570|NCT02769325|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110424571|NCT02769325|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110424573|NCT02769325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110424575|NCT02770261|Candesartan cilexetil|candesartan cilexetil|mesh-list
110424576|NCT02770261|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110424577|NCT02770261|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110424578|NCT02770261|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110424579|NCT02770261|Antimetabolites|antimetabolites|mesh-ancestor
110424580|NCT02770261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110424581|NCT02770261|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110424582|NCT02770261|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110424583|NCT02770261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110424584|NCT02770261|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110424585|NCT02770261|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110424586|NCT02770261|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110424587|NCT04224649|Lidocaine|lidocaine|mesh-list
110424588|NCT04224649|Hyaluronic Acid|hyaluronic acid|mesh-list
110424589|NCT04224649|Anesthetics, Local|anesthetics, local|mesh-ancestor
110424590|NCT04224649|Anesthetics|anesthetics|mesh-ancestor
110424591|NCT04224649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110424592|NCT04224649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110424593|NCT04224649|Sensory System Agents|sensory system agents|mesh-ancestor
110424594|NCT04224649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110424595|NCT04224649|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110424596|NCT04224649|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110424597|NCT04224649|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110424598|NCT04224649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110424599|NCT04224649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110424600|NCT04224649|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110424601|NCT04224649|Immunologic Factors|immunologic factors|mesh-ancestor
110424602|NCT04224649|Viscosupplements|viscosupplements|mesh-ancestor
110424603|NCT04224649|Protective Agents|protective agents|mesh-ancestor
110424604|NCT02769169|Ranibizumab|ranibizumab|mesh-list
110424605|NCT02769169|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110424606|NCT02769169|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110424607|NCT02769169|Growth Substances|growth substances|mesh-ancestor
110424608|NCT02769169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110424609|NCT02769169|Growth Inhibitors|growth inhibitors|mesh-ancestor
110424610|NCT02769169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110424611|NCT02769013|Praziquantel|praziquantel|mesh-list
110424612|NCT02769013|Anthelmintics|anthelmintics|mesh-ancestor
110424613|NCT02769013|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110424614|NCT02769013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110424615|NCT02768545|Ezetimibe|ezetimibe|mesh-list
110424616|NCT02768545|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110424617|NCT02768545|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110424618|NCT02768545|Antimetabolites|antimetabolites|mesh-ancestor
110424619|NCT02768545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110424620|NCT02768545|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110424621|NCT02764723|Bupivacaine|bupivacaine|mesh-list
110424622|NCT02764723|Ropivacaine|ropivacaine|mesh-list
110424623|NCT02764723|Anesthetics, Local|anesthetics, local|mesh-ancestor
110424624|NCT02764723|Anesthetics|anesthetics|mesh-ancestor
110424625|NCT02764723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110424626|NCT02764723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110424627|NCT02764723|Sensory System Agents|sensory system agents|mesh-ancestor
110424628|NCT02764723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110424629|NCT04664959|Denosumab|denosumab|mesh-list
110424630|NCT04664959|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110424631|NCT04664959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110424633|NCT00951496|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110424634|NCT00951496|Bevacizumab|bevacizumab|mesh-list
110424635|NCT00951496|Cisplatin|cisplatin|mesh-list
110424636|NCT00951496|Carboplatin|carboplatin|mesh-list
110424637|NCT00951496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110424638|NCT00951496|Endothelial Growth Factors|endothelial growth factors|mesh-list
110424639|NCT00951496|Antibodies|antibodies|mesh-list
110424640|NCT00951496|Immunoglobulins|immunoglobulins|mesh-list
110424641|NCT00951496|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110424642|NCT00951496|Immunoglobulin G|immunoglobulin g|mesh-list
110424643|NCT00951496|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110424644|NCT00951496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110424645|NCT00951496|Tubulin Modulators|tubulin modulators|mesh-ancestor
110424646|NCT00951496|Antimitotic Agents|antimitotic agents|mesh-ancestor
110424647|NCT00951496|Mitosis Modulators|mitosis modulators|mesh-ancestor
110424648|NCT00951496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110424649|NCT00951496|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110424650|NCT00951496|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110424651|NCT00951496|Growth Substances|growth substances|mesh-ancestor
110424652|NCT00951496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110424653|NCT00951496|Growth Inhibitors|growth inhibitors|mesh-ancestor
110424654|NCT00951496|Immunologic Factors|immunologic factors|mesh-ancestor
110424655|NCT02764411|Brimonidine Tartrate|brimonidine tartrate|mesh-list
110424656|NCT02764411|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110424657|NCT02764411|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110424658|NCT02764411|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110424659|NCT02764411|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110424660|NCT02764411|Adrenergic Agents|adrenergic agents|mesh-ancestor
110424661|NCT02764411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110424662|NCT02764411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110424663|NCT02764411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110424664|NCT02768077|Melatonin|melatonin|mesh-list
110424665|NCT02768077|Antioxidants|antioxidants|mesh-ancestor
110424666|NCT02768077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110424667|NCT02768077|Protective Agents|protective agents|mesh-ancestor
110424668|NCT02768077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110424669|NCT02768077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110424670|NCT01193244|Prednisone|prednisone|mesh-list
110424671|NCT01193244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110424672|NCT01193244|Glucocorticoids|glucocorticoids|mesh-ancestor
110424673|NCT01193244|Hormones|hormones|mesh-ancestor
110424674|NCT01193244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110424675|NCT01193244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110424676|NCT01193244|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110424677|NCT01193244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110424678|NCT04224337|Doxorubicin|doxorubicin|mesh-list
110424679|NCT04224337|Durvalumab|durvalumab|mesh-list
110424680|NCT04224337|Ifosfamide|ifosfamide|mesh-list
110424681|NCT04224337|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110424682|NCT04224337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110424683|NCT04224337|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110424684|NCT04224337|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110424685|NCT04224337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110424686|NCT04224337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110424687|NCT04224337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110424688|NCT04224337|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110424689|NCT04224337|Alkylating Agents|alkylating agents|mesh-ancestor
110424690|NCT02764021|Hypoglycemic Agents|hypoglycemic agents|mesh-list
110424691|NCT02764021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110424692|NCT02762617|Tenofovir|tenofovir|mesh-list
110424693|NCT02762617|Antiviral Agents|antiviral agents|mesh-ancestor
110424694|NCT02762617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110424695|NCT02762617|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110424696|NCT02762617|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110424697|NCT02762617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110424698|NCT02762617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110424699|NCT02762617|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110424700|NCT02762617|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110424701|NCT01192152|Metformin|metformin|mesh-list
110424702|NCT01192152|Saxagliptin|saxagliptin|mesh-list
110424703|NCT01192152|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110424704|NCT01192152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110424705|NCT01192152|Incretins|incretins|mesh-ancestor
110424706|NCT01192152|Hormones|hormones|mesh-ancestor
110424707|NCT01192152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110424708|NCT01192152|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110424709|NCT01192152|Protease Inhibitors|protease inhibitors|mesh-ancestor
110424710|NCT01192152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110424711|NCT01192152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110424712|NCT04572451|Nivolumab|nivolumab|mesh-list
110424713|NCT04572451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110424714|NCT04572451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110424715|NCT04572451|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110424716|NCT04572451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110424717|NCT02758249|Propofol|propofol|mesh-list
110424718|NCT02758249|Sevoflurane|sevoflurane|mesh-list
110424719|NCT02758249|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110424720|NCT02758249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110424721|NCT02758249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110424722|NCT02758249|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110424723|NCT02758249|Anesthetics, General|anesthetics, general|mesh-ancestor
110424725|NCT02758249|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110424726|NCT02758249|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110424727|NCT02758405|Fentanyl|fentanyl|mesh-list
110424728|NCT02758405|Bupivacaine|bupivacaine|mesh-list
110424729|NCT02758405|Anesthetics, Local|anesthetics, local|mesh-ancestor
110424730|NCT02758405|Anesthetics|anesthetics|mesh-ancestor
110424731|NCT02758405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110424732|NCT02758405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110424733|NCT02758405|Sensory System Agents|sensory system agents|mesh-ancestor
110424734|NCT02758405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110424735|NCT02758405|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110424736|NCT02758405|Narcotics|narcotics|mesh-ancestor
110424737|NCT02758405|Analgesics|analgesics|mesh-ancestor
110424738|NCT02758405|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110424739|NCT02758405|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110424740|NCT02758405|Anesthetics, General|anesthetics, general|mesh-ancestor
110424741|NCT02758327|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
110424742|NCT02758327|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110424743|NCT02758327|Lubricant Eye Drops|lubricant eye drops|mesh-list
110424744|NCT02758327|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110424745|NCT02758327|Laxatives|laxatives|mesh-ancestor
110424746|NCT02758327|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110424747|NCT02763475|Cyclophosphamide|cyclophosphamide|mesh-list
110424748|NCT02763475|Fludarabine|fludarabine|mesh-list
110424749|NCT02763475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110424750|NCT02763475|Immunologic Factors|immunologic factors|mesh-ancestor
110424751|NCT02763475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110424752|NCT02763475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110424753|NCT02763475|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110424754|NCT02763475|Alkylating Agents|alkylating agents|mesh-ancestor
110424755|NCT02763475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110424756|NCT02763475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110424757|NCT02763475|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110424758|NCT02762383|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110424759|NCT02762383|Antiviral Agents|antiviral agents|mesh-ancestor
110424760|NCT02762383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110424761|NCT02758015|Betaine|betaine|mesh-list
110424762|NCT02758015|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110424763|NCT02758015|Lipotropic Agents|lipotropic agents|mesh-ancestor
110424764|NCT02758015|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110424765|NCT02758015|Antimetabolites|antimetabolites|mesh-ancestor
110424766|NCT02758015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110424767|NCT02758015|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110424768|NCT02757703|Terlipressin|terlipressin|mesh-list
110424769|NCT02757703|Pantoprazole|pantoprazole|mesh-list
110424770|NCT02757703|Somatostatin|somatostatin|mesh-list
110424771|NCT02757703|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110424772|NCT02757703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110424773|NCT02757703|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110424774|NCT02757703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110424775|NCT02757703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110424776|NCT02757703|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110424777|NCT02757703|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110424778|NCT02757703|Hormones|hormones|mesh-ancestor
110424779|NCT02757703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110424780|NCT02757703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110424781|NCT02763007|Pioglitazone|pioglitazone|mesh-list
110424782|NCT02763007|Alogliptin|alogliptin|mesh-list
110424783|NCT02763007|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110424784|NCT02763007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110424785|NCT02763007|Incretins|incretins|mesh-ancestor
110424786|NCT02763007|Hormones|hormones|mesh-ancestor
110424787|NCT02763007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110424788|NCT02763007|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110424789|NCT02763007|Protease Inhibitors|protease inhibitors|mesh-ancestor
110424790|NCT02763007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110424791|NCT02763007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110424792|NCT00635323|Capecitabine|capecitabine|mesh-list
110424793|NCT00635323|Irinotecan|irinotecan|mesh-list
110424794|NCT00635323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110424795|NCT00635323|Antimetabolites|antimetabolites|mesh-ancestor
110424796|NCT00635323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110424797|NCT00635323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110424798|NCT00635323|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110424799|NCT00635323|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110424800|NCT00635323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110424802|NCT01191840|Cefazolin|cefazolin|mesh-list
110424803|NCT01191840|Daptomycin|daptomycin|mesh-list
110424804|NCT01191840|Cloxacillin|cloxacillin|mesh-list
110424805|NCT01191840|Oxacillin|oxacillin|mesh-list
110424806|NCT01191840|Nafcillin|nafcillin|mesh-list
110424807|NCT01191840|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110424808|NCT01191840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110424809|NCT02752555|Antioxidants|antioxidants|mesh-list
110424810|NCT02752555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110424811|NCT02752555|Protective Agents|protective agents|mesh-ancestor
110424812|NCT02752555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110424813|NCT00624546|Lansoprazole|lansoprazole|mesh-list
110424814|NCT00624546|Dexlansoprazole|dexlansoprazole|mesh-list
110424815|NCT00624546|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110424816|NCT00624546|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110424817|NCT00624546|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110424818|NCT00624546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110424819|NCT00624546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110424820|NCT02757469|Drospirenone|drospirenone|mesh-list
110424821|NCT02757469|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110424822|NCT02757469|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
110424823|NCT02757469|Estradiol|estradiol|mesh-list
110424824|NCT02757469|Estrogens|estrogens|mesh-ancestor
110424825|NCT02757469|Hormones|hormones|mesh-ancestor
110424826|NCT02757469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110424827|NCT02757469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110424828|NCT02757469|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110424829|NCT02757469|Contraceptive Agents|contraceptive agents|mesh-ancestor
110424830|NCT02757469|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110424831|NCT02757469|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110424832|NCT02757469|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110424833|NCT02757469|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110424834|NCT02757469|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110424835|NCT02757469|Hormone Antagonists|hormone antagonists|mesh-ancestor
110424836|NCT02757469|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110424837|NCT02757469|Diuretics|diuretics|mesh-ancestor
110424838|NCT02757469|Natriuretic Agents|natriuretic agents|mesh-ancestor
110424839|NCT02757391|Aldesleukin|aldesleukin|mesh-list
110424840|NCT02757391|Cyclophosphamide|cyclophosphamide|mesh-list
110424841|NCT02757391|Pembrolizumab|pembrolizumab|mesh-list
110424842|NCT02757391|Interleukin-2|interleukin-2|mesh-list
110424843|NCT02757391|Immunologic Factors|immunologic factors|mesh-list
110424844|NCT02757391|Immunomodulating Agents|immunomodulating agents|mesh-list
110424845|NCT02757391|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110424846|NCT02757391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110424847|NCT02757391|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110424848|NCT02757391|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110424849|NCT02757391|Alkylating Agents|alkylating agents|mesh-ancestor
110424850|NCT02757391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110424851|NCT02757391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110424852|NCT02757391|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110424853|NCT02757391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110424854|NCT02757391|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110424855|NCT02757391|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110424856|NCT02757391|Analgesics|analgesics|mesh-ancestor
110424857|NCT02757391|Sensory System Agents|sensory system agents|mesh-ancestor
110424858|NCT02757391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110424859|NCT02757391|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110424860|NCT02757391|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110424861|NCT02757391|Antiviral Agents|antiviral agents|mesh-ancestor
110424862|NCT02757391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110424863|NCT04564417|Pembrolizumab|pembrolizumab|mesh-list
110424864|NCT04564417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110424865|NCT04564417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110424866|NCT04564417|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110424867|NCT04564417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110424869|NCT02757079|Antioxidants|antioxidants|mesh-ancestor
110424870|NCT02757079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110424871|NCT02757079|Protective Agents|protective agents|mesh-ancestor
110424872|NCT02757079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110424873|NCT02757079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110424874|NCT02768389|Bevacizumab|bevacizumab|mesh-list
110424875|NCT02768389|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110424876|NCT02768389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110424877|NCT02768389|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110424878|NCT02768389|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110424879|NCT02768389|Growth Substances|growth substances|mesh-ancestor
110424880|NCT02768389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110424881|NCT02768389|Growth Inhibitors|growth inhibitors|mesh-ancestor
110424882|NCT04529005|Angiotensin II|angiotensin ii|mesh-list
110424883|NCT04529005|Giapreza|giapreza|mesh-list
110424884|NCT04529005|Angiotensinogen|angiotensinogen|mesh-list
110424885|NCT04529005|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110424886|NCT04529005|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110424887|NCT04529005|Protease Inhibitors|protease inhibitors|mesh-ancestor
110424888|NCT04529005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110424889|NCT04529005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110424890|NCT05357040|Nitrous Oxide|nitrous oxide|mesh-list
110424891|NCT05357040|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110424892|NCT05357040|Anesthetics, General|anesthetics, general|mesh-ancestor
110424893|NCT05357040|Anesthetics|anesthetics|mesh-ancestor
110424894|NCT05357040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110424895|NCT05357040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110424896|NCT05357040|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110424897|NCT05357040|Analgesics|analgesics|mesh-ancestor
110424898|NCT05357040|Sensory System Agents|sensory system agents|mesh-ancestor
110424899|NCT05357040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110424900|NCT00943072|Aflibercept|aflibercept|mesh-list
110424901|NCT00943072|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110424902|NCT00943072|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110424903|NCT00943072|Growth Substances|growth substances|mesh-ancestor
110424904|NCT00943072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110424905|NCT00943072|Growth Inhibitors|growth inhibitors|mesh-ancestor
110424906|NCT00943072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110424907|NCT04222855|Diltiazem|diltiazem|mesh-list
110424908|NCT04222855|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110424909|NCT04222855|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110424910|NCT04222855|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110424911|NCT04222855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110424912|NCT04222855|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110424913|NCT04222855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110424914|NCT04222855|Vasodilator Agents|vasodilator agents|mesh-ancestor
110424915|NCT00942994|Amlodipine|amlodipine|mesh-list
110424916|NCT00942994|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110370229|NCT04606563|Irbesartan|irbesartan|mesh-list
110424917|NCT00942994|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110424918|NCT00942994|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110424919|NCT00942994|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110424920|NCT00942994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110424921|NCT00942994|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110424922|NCT00942994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110424923|NCT00942994|Vasodilator Agents|vasodilator agents|mesh-ancestor
110424924|NCT00942994|Diuretics|diuretics|mesh-ancestor
110424925|NCT00942994|Natriuretic Agents|natriuretic agents|mesh-ancestor
110201870|NCT00151255|Antimetabolites|antimetabolites|mesh-ancestor
110424926|NCT00942994|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110424928|NCT04268602|Anesthetics, Local|anesthetics, local|mesh-list
110424929|NCT04268602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110424930|NCT04268602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110424931|NCT04268602|Sensory System Agents|sensory system agents|mesh-ancestor
110424932|NCT04268602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110424934|NCT04314336|Keratolytic Agents|keratolytic agents|mesh-ancestor
110424935|NCT04314336|Dermatologic Agents|dermatologic agents|mesh-ancestor
110424936|NCT00624702|Maleic acid|maleic acid|mesh-list
110424937|NCT00624702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110424938|NCT00624702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110424939|NCT02756377|Chlorhexidine|chlorhexidine|mesh-list
110424940|NCT02756377|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110424941|NCT02756377|Cetylpyridinium|cetylpyridinium|mesh-list
110424942|NCT02756377|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110424943|NCT02756377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110424944|NCT02756377|Disinfectants|disinfectants|mesh-ancestor
110424945|NCT02756377|Dermatologic Agents|dermatologic agents|mesh-ancestor
110424946|NCT05378100|Midazolam|midazolam|mesh-list
110424947|NCT05378100|Ketamine|ketamine|mesh-list
110424948|NCT05378100|Analgesics|analgesics|mesh-ancestor
110424949|NCT05378100|Sensory System Agents|sensory system agents|mesh-ancestor
110424950|NCT05378100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110424951|NCT05378100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110424952|NCT05378100|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110424953|NCT05378100|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110424954|NCT05378100|Anesthetics, General|anesthetics, general|mesh-ancestor
110424956|NCT05378100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110424957|NCT05378100|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110424958|NCT05378100|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110424959|NCT05378100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110424960|NCT05378100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110424961|NCT05378100|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110424962|NCT05378100|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110424963|NCT05378100|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110424964|NCT05378100|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110424965|NCT05378100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110424966|NCT05378100|GABA Modulators|gaba modulators|mesh-ancestor
110424967|NCT05378100|GABA Agents|gaba agents|mesh-ancestor
110424968|NCT02752477|Anesthetics|anesthetics|mesh-list
110424969|NCT02752477|Anesthetics, General|anesthetics, general|mesh-list
110424970|NCT02752477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110424971|NCT02752477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110424972|NCT04204096|Vaccines|vaccines|mesh-list
110424973|NCT04204096|Immunologic Factors|immunologic factors|mesh-ancestor
110424974|NCT04204096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110424975|NCT05376852|Decitabine|decitabine|mesh-list
110424976|NCT05376852|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110424977|NCT05376852|Antimetabolites|antimetabolites|mesh-ancestor
110424978|NCT05376852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110424979|NCT05376852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110424980|NCT05376852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110424981|NCT00061282|Clotrimazole|clotrimazole|mesh-list
110424982|NCT00061282|Miconazole|miconazole|mesh-list
110424983|NCT00061282|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110424984|NCT00061282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110370238|NCT00565968|Sorafenib|sorafenib|mesh-list
110424985|NCT00061282|Antifungal Agents|antifungal agents|mesh-ancestor
110424986|NCT00061282|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110424987|NCT00061282|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110424988|NCT00061282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110424989|NCT00061282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110424990|NCT00061282|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110424991|NCT00061282|Hormone Antagonists|hormone antagonists|mesh-ancestor
110424992|NCT00061282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110424993|NCT00061282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110424994|NCT00061282|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110424995|NCT00061282|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110424996|NCT04268524|Miltefosine|miltefosine|mesh-list
110424997|NCT04268524|Antifungal Agents|antifungal agents|mesh-ancestor
110424998|NCT04268524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110424999|NCT04268524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110425000|NCT04268524|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110425001|NCT04268524|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110425002|NCT02855632|Hormones|hormones|mesh-list
110425003|NCT02855632|Progesterone|progesterone|mesh-list
110425004|NCT02855632|Lenograstim|lenograstim|mesh-list
110425005|NCT02855632|Estrogens|estrogens|mesh-list
110425006|NCT02855632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110425007|NCT02855632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110425008|NCT02855632|Progestins|progestins|mesh-ancestor
110425009|NCT02855632|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110425010|NCT02855632|Immunologic Factors|immunologic factors|mesh-ancestor
110425011|NCT04220281|Nitroglycerin|nitroglycerin|mesh-list
110425012|NCT04220281|Propofol|propofol|mesh-list
110425013|NCT04220281|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110425014|NCT04220281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110425015|NCT04220281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110425016|NCT04220281|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110425017|NCT04220281|Anesthetics, General|anesthetics, general|mesh-ancestor
110425018|NCT04220281|Anesthetics|anesthetics|mesh-ancestor
110425019|NCT04220281|Vasodilator Agents|vasodilator agents|mesh-ancestor
110425020|NCT02751619|Lidocaine|lidocaine|mesh-list
110425021|NCT02751619|Anesthetics, Local|anesthetics, local|mesh-ancestor
110425022|NCT02751619|Anesthetics|anesthetics|mesh-ancestor
110425023|NCT02751619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110425024|NCT02751619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110425025|NCT02751619|Sensory System Agents|sensory system agents|mesh-ancestor
110425026|NCT02751619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110425027|NCT02751619|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110425028|NCT02751619|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110425029|NCT02751619|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110425030|NCT02751619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110425031|NCT02751619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110425032|NCT02751541|Sunscreening Agents|sunscreening agents|mesh-list
110425033|NCT02751541|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110425034|NCT02751541|Protective Agents|protective agents|mesh-ancestor
110425035|NCT02751541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110425036|NCT02751541|Dermatologic Agents|dermatologic agents|mesh-ancestor
110425037|NCT02755753|Lansoprazole|lansoprazole|mesh-list
110425038|NCT02755753|Dexlansoprazole|dexlansoprazole|mesh-list
110425039|NCT02755753|Rebamipide|rebamipide|mesh-list
110425040|NCT02755753|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110425041|NCT02755753|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110425042|NCT02755753|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110425043|NCT02755753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110425044|NCT02755753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110425045|NCT02755753|Antioxidants|antioxidants|mesh-ancestor
110425046|NCT02755753|Protective Agents|protective agents|mesh-ancestor
110425047|NCT02755753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110425048|NCT02755909|Anesthetics|anesthetics|mesh-list
110425049|NCT02755909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110425050|NCT02755909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110425051|NCT02761291|Valganciclovir|valganciclovir|mesh-list
110425052|NCT02761291|Gemcitabine|gemcitabine|mesh-list
110425054|NCT02761291|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110425055|NCT02761291|Antimetabolites|antimetabolites|mesh-ancestor
110425056|NCT02761291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110425057|NCT02761291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110425058|NCT02761291|Anticonvulsants|anticonvulsants|mesh-ancestor
110425059|NCT02761291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110425060|NCT02761291|GABA Agents|gaba agents|mesh-ancestor
110425061|NCT02761291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110190094|NCT00023621|Celecoxib|celecoxib|mesh-list
110425062|NCT02761291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110425063|NCT02761291|Antimanic Agents|antimanic agents|mesh-ancestor
110425064|NCT02761291|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110425065|NCT02761291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110425066|NCT02761291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110425067|NCT02761291|Antiviral Agents|antiviral agents|mesh-ancestor
110425068|NCT02761291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110425069|NCT01187550|Hormones|hormones|mesh-list
110425070|NCT01187550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110425071|NCT01187550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110425072|NCT02855866|Acetaminophen|acetaminophen|mesh-list
110425073|NCT02855866|Dexamethasone|dexamethasone|mesh-list
110425074|NCT02855866|Cortisone|cortisone|mesh-list
110425075|NCT02855866|Dexamethasone acetate|dexamethasone acetate|mesh-list
110425076|NCT02855866|BB 1101|bb 1101|mesh-list
110425077|NCT02855866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110425078|NCT02855866|Antiemetics|antiemetics|mesh-ancestor
110425079|NCT02855866|Autonomic Agents|autonomic agents|mesh-ancestor
110425080|NCT02855866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110425081|NCT02855866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110425082|NCT02855866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110425083|NCT02855866|Glucocorticoids|glucocorticoids|mesh-ancestor
110425084|NCT02855866|Hormones|hormones|mesh-ancestor
110425085|NCT02855866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110425086|NCT02855866|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110425087|NCT02855866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110425089|NCT02855866|Analgesics|analgesics|mesh-ancestor
110425090|NCT02855866|Sensory System Agents|sensory system agents|mesh-ancestor
110425091|NCT02855866|Antipyretics|antipyretics|mesh-ancestor
110425092|NCT02855866|Protease Inhibitors|protease inhibitors|mesh-ancestor
110425093|NCT02855866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110425094|NCT02855866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110425095|NCT02751307|Metformin|metformin|mesh-list
110425096|NCT02751307|Clozapine|clozapine|mesh-list
110425097|NCT02751307|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110425098|NCT02751307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110425099|NCT02751307|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110425100|NCT02751307|Serotonin Agents|serotonin agents|mesh-ancestor
110425101|NCT02751307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110425102|NCT02751307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110425103|NCT02751307|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110425104|NCT02751307|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110425105|NCT02751307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110425106|NCT02751307|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110425107|NCT02751307|GABA Antagonists|gaba antagonists|mesh-ancestor
110425108|NCT02751307|GABA Agents|gaba agents|mesh-ancestor
110425109|NCT00638209|Insulin|insulin|mesh-list
110425110|NCT00638209|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110425111|NCT00638209|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110425112|NCT00638209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110425113|NCT05429671|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110425114|NCT05429671|Gentamicins|gentamicins|mesh-list
110425115|NCT05429671|Tobramycin|tobramycin|mesh-list
110425116|NCT05429671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110425117|NCT05429671|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110425118|NCT05429671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110425119|NCT05429671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110425120|NCT01186770|Methylnaltrexone|methylnaltrexone|mesh-list
110425121|NCT01186770|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110425122|NCT01186770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110425123|NCT01186770|Sensory System Agents|sensory system agents|mesh-ancestor
110425124|NCT01186770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110425125|NCT02754817|Liraglutide|liraglutide|mesh-list
110425126|NCT02754817|Xultophy|xultophy|mesh-list
110425127|NCT02754817|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110425128|NCT02754817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110425129|NCT02754817|Incretins|incretins|mesh-ancestor
110425130|NCT02754817|Hormones|hormones|mesh-ancestor
110425131|NCT02754817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110425132|NCT04230031|Daratumumab|daratumumab|mesh-list
110425133|NCT04230031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110425134|NCT01186458|Rituximab|rituximab|mesh-list
110425135|NCT01186458|Fludarabine|fludarabine|mesh-list
110425136|NCT01186458|Bortezomib|bortezomib|mesh-list
110425137|NCT01186458|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110425138|NCT01186458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110425139|NCT01186458|Immunologic Factors|immunologic factors|mesh-ancestor
110425140|NCT01186458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110425141|NCT01186458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110425142|NCT01185366|Everolimus|everolimus|mesh-list
110425143|NCT01185366|Sunitinib|sunitinib|mesh-list
110425144|NCT01185366|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110425145|NCT01185366|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110425146|NCT01185366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110425147|NCT01185366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110425148|NCT01185366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110425149|NCT01185366|Immunologic Factors|immunologic factors|mesh-ancestor
110425150|NCT01185366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110425151|NCT01185366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110425152|NCT01185366|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110425153|NCT01185366|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110425154|NCT01185366|Growth Substances|growth substances|mesh-ancestor
110425155|NCT01185366|Growth Inhibitors|growth inhibitors|mesh-ancestor
110425156|NCT01185288|Adalimumab|adalimumab|mesh-list
110425157|NCT01185288|Methotrexate|methotrexate|mesh-list
110425158|NCT01185288|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110425159|NCT01185288|Abortifacient Agents|abortifacient agents|mesh-ancestor
110425160|NCT01185288|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110425161|NCT01185288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110425162|NCT01185288|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110425163|NCT01185288|Antimetabolites|antimetabolites|mesh-ancestor
110425164|NCT01185288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110425165|NCT01185288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110425166|NCT01185288|Dermatologic Agents|dermatologic agents|mesh-ancestor
110425167|NCT01185288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110425168|NCT01185288|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110425169|NCT01185288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110425170|NCT01185288|Immunologic Factors|immunologic factors|mesh-ancestor
110425171|NCT01185288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110425172|NCT01185288|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110425173|NCT01185288|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110425174|NCT01185288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110425175|NCT01184118|Fluticasone|fluticasone|mesh-list
110425176|NCT01184118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110425177|NCT01184118|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110425178|NCT01184118|Autonomic Agents|autonomic agents|mesh-ancestor
110425179|NCT01184118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110201932|NCT00151489|Pregabalin|pregabalin|mesh-list
110425180|NCT01184118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110425181|NCT01184118|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110425182|NCT01184118|Respiratory System Agents|respiratory system agents|mesh-ancestor
110425183|NCT01184118|Dermatologic Agents|dermatologic agents|mesh-ancestor
110425184|NCT01184118|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110425185|NCT01183884|Tretinoin|tretinoin|mesh-list
110425186|NCT01183884|Isotretinoin|isotretinoin|mesh-list
110425187|NCT01183884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110425188|NCT01183884|Keratolytic Agents|keratolytic agents|mesh-ancestor
110425189|NCT01183884|Dermatologic Agents|dermatologic agents|mesh-ancestor
110425190|NCT05344248|Antibodies|antibodies|mesh-list
110425191|NCT05344248|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110425192|NCT05344248|Immunologic Factors|immunologic factors|mesh-ancestor
110425193|NCT05344248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110425194|NCT01191762|Sevelamer|sevelamer|mesh-list
110425195|NCT01191762|Chelating Agents|chelating agents|mesh-ancestor
110425196|NCT01191762|Sequestering Agents|sequestering agents|mesh-ancestor
110425197|NCT01191762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110425198|NCT04315974|Rivaroxaban|rivaroxaban|mesh-list
110425199|NCT04315974|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110425200|NCT04315974|Antithrombins|antithrombins|mesh-ancestor
110425201|NCT04315974|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110425202|NCT04315974|Protease Inhibitors|protease inhibitors|mesh-ancestor
110425203|NCT04315974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110425204|NCT04315974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110425205|NCT04315974|Anticoagulants|anticoagulants|mesh-ancestor
110425206|NCT01723774|Anastrozole|anastrozole|mesh-list
110425207|NCT01723774|Goserelin|goserelin|mesh-list
110425208|NCT01723774|Palbociclib|palbociclib|mesh-list
110425209|NCT01723774|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110425210|NCT01723774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110425211|NCT01723774|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110425212|NCT01723774|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110425213|NCT01723774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110425214|NCT01723774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110425215|NCT01723774|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110425216|NCT01723774|Hormone Antagonists|hormone antagonists|mesh-ancestor
110425217|NCT01723774|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110425218|NCT01723774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110425219|NCT01723774|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110425220|NCT02855788|Leucovorin|leucovorin|mesh-list
110425221|NCT02855788|Paclitaxel|paclitaxel|mesh-list
110425222|NCT02855788|Oxaliplatin|oxaliplatin|mesh-list
110425223|NCT02855788|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110425224|NCT02855788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110425225|NCT02855788|Tubulin Modulators|tubulin modulators|mesh-ancestor
110425226|NCT02855788|Antimitotic Agents|antimitotic agents|mesh-ancestor
110425227|NCT02855788|Mitosis Modulators|mitosis modulators|mesh-ancestor
110425228|NCT02855788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110425229|NCT02855788|Antidotes|antidotes|mesh-ancestor
110425230|NCT02855788|Protective Agents|protective agents|mesh-ancestor
110425231|NCT02855788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110425232|NCT02855788|Vitamin B Complex|vitamin b complex|mesh-ancestor
110425233|NCT02855788|Vitamins|vitamins|mesh-ancestor
110425234|NCT02855788|Micronutrients|micronutrients|mesh-ancestor
110425235|NCT01190514|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
110425236|NCT01190514|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110425237|NCT01190514|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110425238|NCT01190514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110425239|NCT01190514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110425240|NCT01190514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110425241|NCT01190514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110425242|NCT01190514|Antidepressive Agents|antidepressive agents|mesh-ancestor
110425243|NCT01190514|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110425245|NCT01190436|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110425246|NCT01190436|Sympatholytics|sympatholytics|mesh-ancestor
110425247|NCT01190436|Autonomic Agents|autonomic agents|mesh-ancestor
110425248|NCT01190436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110425249|NCT01190436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110425250|NCT01190436|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110425251|NCT01190436|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110072217|NCT01570478|Autonomic Agents|autonomic agents|mesh-ancestor
110425252|NCT01190436|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110425253|NCT01190436|Adrenergic Agents|adrenergic agents|mesh-ancestor
110425254|NCT01190436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110425255|NCT01190436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110425257|NCT02852122|Lipotropic Agents|lipotropic agents|mesh-ancestor
110425258|NCT02852122|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110425259|NCT02852122|Antimetabolites|antimetabolites|mesh-ancestor
110425260|NCT02852122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110425261|NCT02852122|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110425262|NCT02852122|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110425263|NCT02852122|Nootropic Agents|nootropic agents|mesh-ancestor
110425264|NCT01035255|Enalapril|enalapril|mesh-list
110425265|NCT01035255|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
110425266|NCT01035255|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110425267|NCT01035255|Protease Inhibitors|protease inhibitors|mesh-ancestor
110425268|NCT01035255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110425269|NCT01035255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110425270|NCT01035255|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110425271|NCT01035255|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110425272|NCT00602524|Pilocarpine|pilocarpine|mesh-list
110425273|NCT00602524|Miotics|miotics|mesh-ancestor
110425274|NCT00602524|Autonomic Agents|autonomic agents|mesh-ancestor
110425275|NCT00602524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110425276|NCT00602524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110425277|NCT00602524|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
110425278|NCT00602524|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110425279|NCT00602524|Cholinergic Agents|cholinergic agents|mesh-ancestor
110425280|NCT00602524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110425281|NCT00602524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110425282|NCT01189890|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110425283|NCT01189890|Glimepiride|glimepiride|mesh-list
110425284|NCT01189890|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110425285|NCT01189890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110425286|NCT01189890|Incretins|incretins|mesh-ancestor
110425287|NCT01189890|Hormones|hormones|mesh-ancestor
110425288|NCT01189890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110370316|NCT01161472|Alprazolam|alprazolam|mesh-list
110425289|NCT01189890|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110425290|NCT01189890|Protease Inhibitors|protease inhibitors|mesh-ancestor
110425291|NCT01189890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110425292|NCT01189890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110425293|NCT01189890|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110425294|NCT01189890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110425295|NCT01189890|Immunologic Factors|immunologic factors|mesh-ancestor
110425296|NCT01189812|Lithium Carbonate|lithium carbonate|mesh-list
110425297|NCT01189812|Citalopram|citalopram|mesh-list
110201949|NCT00049790|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110201950|NCT00049790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110201951|NCT00049790|Tubulin Modulators|tubulin modulators|mesh-ancestor
110201952|NCT00049790|Antimitotic Agents|antimitotic agents|mesh-ancestor
110201953|NCT00049790|Mitosis Modulators|mitosis modulators|mesh-ancestor
110201954|NCT00049790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110425298|NCT01189812|Antidepressive Agents|antidepressive agents|mesh-ancestor
110425299|NCT01189812|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110425300|NCT01189812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110425301|NCT01189812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110425302|NCT01189812|Antimanic Agents|antimanic agents|mesh-ancestor
110425303|NCT01189812|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110425304|NCT01189812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110425305|NCT01189812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110328585|NCT00463112|Appetite Depressants|appetite depressants|mesh-ancestor
110425306|NCT01189812|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110425307|NCT01189812|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110425308|NCT01189812|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110425309|NCT01189812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110425310|NCT01189812|Serotonin Agents|serotonin agents|mesh-ancestor
110425311|NCT01189812|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110425313|NCT01189500|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
110425314|NCT01189500|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110425315|NCT01189500|Hormone Antagonists|hormone antagonists|mesh-ancestor
110425316|NCT01189500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110425317|NCT01189500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110425318|NCT01189500|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110425319|NCT01189500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110425320|NCT01189500|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110425321|NCT01189500|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110425322|NCT01189500|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110425323|NCT01189500|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110425324|NCT01189500|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110425325|NCT01189500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110425326|NCT01189500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110425327|NCT01189500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110425328|NCT01189500|Antidepressive Agents|antidepressive agents|mesh-ancestor
110425329|NCT01189500|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110425331|NCT00938860|Tacrolimus|tacrolimus|mesh-list
110425332|NCT00938860|Cyclosporins|cyclosporins|mesh-list
110425333|NCT00938860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110425334|NCT00938860|Immunologic Factors|immunologic factors|mesh-ancestor
110425335|NCT00938860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110425336|NCT00938860|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110425337|NCT00938860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110425338|NCT00938860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110425339|NCT00938860|Antifungal Agents|antifungal agents|mesh-ancestor
110425340|NCT00938860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110425341|NCT00938860|Dermatologic Agents|dermatologic agents|mesh-ancestor
110425342|NCT00938860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110425343|NCT00604396|Insulin|insulin|mesh-list
110425344|NCT00604396|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110425345|NCT00604396|Insulin Detemir|insulin detemir|mesh-list
110425346|NCT00604396|Isophane Insulin, Human|isophane insulin, human|mesh-list
110425347|NCT00604396|Insulin, Isophane|insulin, isophane|mesh-list
110425348|NCT00604396|Isophane insulin, beef|isophane insulin, beef|mesh-list
110425349|NCT00604396|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110425350|NCT00604396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110425352|NCT00938470|Fluorouracil|fluorouracil|mesh-list
110425353|NCT00938470|Capecitabine|capecitabine|mesh-list
110425354|NCT00938470|Oxaliplatin|oxaliplatin|mesh-list
110425355|NCT00938470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110425356|NCT00938470|Tubulin Modulators|tubulin modulators|mesh-ancestor
110425357|NCT00938470|Antimitotic Agents|antimitotic agents|mesh-ancestor
110425358|NCT00938470|Mitosis Modulators|mitosis modulators|mesh-ancestor
110425359|NCT00938470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110425360|NCT00938470|Antimetabolites|antimetabolites|mesh-ancestor
110425361|NCT00938470|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110425362|NCT00938470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110425363|NCT00938470|Immunologic Factors|immunologic factors|mesh-ancestor
110425364|NCT00938470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110425365|NCT00602680|Donepezil|donepezil|mesh-list
110425366|NCT00602680|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110425367|NCT00602680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110425368|NCT00602680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110425369|NCT00602680|Cholinergic Agents|cholinergic agents|mesh-ancestor
110425370|NCT00602680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110425371|NCT00602680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110425372|NCT00602680|Nootropic Agents|nootropic agents|mesh-ancestor
110425373|NCT00938392|Vaccines|vaccines|mesh-list
110425374|NCT00938392|Immunologic Factors|immunologic factors|mesh-ancestor
110425375|NCT00938392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110425376|NCT02851888|Ropivacaine|ropivacaine|mesh-list
110425377|NCT02851888|Anesthetics|anesthetics|mesh-ancestor
110425378|NCT02851888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110425379|NCT02851888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110425380|NCT02851888|Anesthetics, Local|anesthetics, local|mesh-ancestor
110425381|NCT02851888|Sensory System Agents|sensory system agents|mesh-ancestor
110425382|NCT02851888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110425383|NCT05381428|Indomethacin|indomethacin|mesh-list
110425384|NCT05381428|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110425385|NCT05381428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110425386|NCT05381428|Analgesics|analgesics|mesh-ancestor
110425387|NCT05381428|Sensory System Agents|sensory system agents|mesh-ancestor
110425388|NCT05381428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110425389|NCT05381428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110425390|NCT05381428|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110425391|NCT05381428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110425392|NCT05381428|Gout Suppressants|gout suppressants|mesh-ancestor
110425394|NCT05381428|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110425395|NCT05381428|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110425396|NCT05381428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110425397|NCT05381428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110425398|NCT01022853|Nintedanib|nintedanib|mesh-list
110425399|NCT01022853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110425400|NCT01022853|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110425401|NCT01022853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110425402|NCT01022853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110425403|NCT00937768|Leuprolide|leuprolide|mesh-list
110425404|NCT00937768|Goserelin|goserelin|mesh-list
110425405|NCT00937768|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110425406|NCT00937768|Fertility Agents|fertility agents|mesh-ancestor
110425407|NCT00937768|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110425408|NCT00937768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110201991|NCT00406042|Hormones|hormones|mesh-ancestor
110425409|NCT00937768|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110425410|NCT00937768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110425411|NCT00631228|Everolimus|everolimus|mesh-list
110425412|NCT00631228|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110425413|NCT00631228|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110425414|NCT00631228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110425415|NCT00631228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110425416|NCT00631228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110425417|NCT00631228|Immunologic Factors|immunologic factors|mesh-ancestor
110425418|NCT00631228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110425419|NCT00631228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110425420|NCT05381038|Paclitaxel|paclitaxel|mesh-list
110425421|NCT05381038|Docetaxel|docetaxel|mesh-list
110425422|NCT05381038|Irinotecan|irinotecan|mesh-list
110425423|NCT05381038|Azacitidine|azacitidine|mesh-list
110425424|NCT05381038|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110425425|NCT05381038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110425426|NCT05381038|Tubulin Modulators|tubulin modulators|mesh-ancestor
110425427|NCT05381038|Antimitotic Agents|antimitotic agents|mesh-ancestor
110425428|NCT05381038|Mitosis Modulators|mitosis modulators|mesh-ancestor
110425429|NCT05381038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110425430|NCT05381038|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110425431|NCT05381038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110425432|NCT05381038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110425433|NCT05381038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110425434|NCT05381038|Antimetabolites|antimetabolites|mesh-ancestor
110425435|NCT05380960|Fibrin fragment D|fibrin fragment d|mesh-list
110425436|NCT05380960|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110425437|NCT05380960|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110425438|NCT05380960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110425439|NCT05380960|Hemostatics|hemostatics|mesh-ancestor
110425440|NCT05380960|Coagulants|coagulants|mesh-ancestor
110425441|NCT00604630|Epoetin Alfa|epoetin alfa|mesh-list
110425442|NCT00604630|Hematinics|hematinics|mesh-ancestor
110425443|NCT01189266|Vorinostat|vorinostat|mesh-list
110425444|NCT01189266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110425445|NCT01189266|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110425446|NCT01189266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110425447|NCT01189266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110425448|NCT01189032|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110425449|NCT01189032|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110425450|NCT01188798|Methotrexate|methotrexate|mesh-list
110425451|NCT01188798|Pentostatin|pentostatin|mesh-list
110425452|NCT01188798|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110425453|NCT01188798|Abortifacient Agents|abortifacient agents|mesh-ancestor
110425454|NCT01188798|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110425455|NCT01188798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110425456|NCT01188798|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110425457|NCT01188798|Antimetabolites|antimetabolites|mesh-ancestor
110425458|NCT01188798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110425459|NCT01188798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110425460|NCT01188798|Dermatologic Agents|dermatologic agents|mesh-ancestor
110425461|NCT01188798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110425462|NCT01188798|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110425463|NCT01188798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110425464|NCT01188798|Immunologic Factors|immunologic factors|mesh-ancestor
110425465|NCT01188798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110425466|NCT01188798|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110425467|NCT01188798|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
110425468|NCT01183104|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110425469|NCT01183104|Glimepiride|glimepiride|mesh-list
110425470|NCT01183104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110425471|NCT01183104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110425472|NCT01183104|Incretins|incretins|mesh-ancestor
110425473|NCT01183104|Hormones|hormones|mesh-ancestor
110425474|NCT01183104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110425475|NCT01183104|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110425476|NCT01183104|Protease Inhibitors|protease inhibitors|mesh-ancestor
110425477|NCT01183104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110425478|NCT01183104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110425479|NCT01183104|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110425480|NCT01183104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110425481|NCT01183104|Immunologic Factors|immunologic factors|mesh-ancestor
110425482|NCT02885688|Insulin|insulin|mesh-list
110425483|NCT02885688|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110425484|NCT02885688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110425485|NCT00950248|Idebenone|idebenone|mesh-list
110425486|NCT00950248|Antioxidants|antioxidants|mesh-ancestor
110425487|NCT00950248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110425488|NCT00950248|Protective Agents|protective agents|mesh-ancestor
110425489|NCT00950248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110425490|NCT04269928|Epinephrine|epinephrine|mesh-list
110425491|NCT04269928|Racepinephrine|racepinephrine|mesh-list
110425492|NCT04269928|Epinephryl borate|epinephryl borate|mesh-list
110202054|NCT00082602|Autonomic Agents|autonomic agents|mesh-ancestor
110425493|NCT04269928|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110425494|NCT04269928|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110425495|NCT04269928|Adrenergic Agents|adrenergic agents|mesh-ancestor
110425496|NCT04269928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110425497|NCT04269928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110425498|NCT04269928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110425499|NCT04269928|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110425500|NCT04269928|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110425501|NCT04269928|Autonomic Agents|autonomic agents|mesh-ancestor
110425502|NCT04269928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110425503|NCT04269928|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110425504|NCT04269928|Respiratory System Agents|respiratory system agents|mesh-ancestor
110425506|NCT04269928|Sympathomimetics|sympathomimetics|mesh-ancestor
110425507|NCT04269928|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110425508|NCT00950170|Factor VIII|factor viii|mesh-list
110425509|NCT00950170|Coagulants|coagulants|mesh-ancestor
110425510|NCT00604864|Infliximab|infliximab|mesh-list
110425511|NCT00604864|Antibodies|antibodies|mesh-list
110425512|NCT00604864|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110425513|NCT00604864|Immunologic Factors|immunologic factors|mesh-ancestor
110425514|NCT00604864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110425515|NCT00604864|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110425516|NCT00604864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110425517|NCT00604864|Dermatologic Agents|dermatologic agents|mesh-ancestor
110425518|NCT00604864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110425519|NCT00604864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110425520|NCT01227824|Raltegravir Potassium|raltegravir potassium|mesh-list
110425521|NCT01227824|Dolutegravir|dolutegravir|mesh-list
110425522|NCT01227824|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110425523|NCT01227824|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110425524|NCT01227824|Antiviral Agents|antiviral agents|mesh-ancestor
110425525|NCT01227824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110425526|NCT01227824|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110425527|NCT01227824|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110425528|NCT01227824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110425529|NCT01227824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110425530|NCT00949702|Vemurafenib|vemurafenib|mesh-list
110425531|NCT00949702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110425532|NCT00949702|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110425533|NCT00949702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110425534|NCT00949702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110425535|NCT01034631|Everolimus|everolimus|mesh-list
110425536|NCT01034631|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110425537|NCT01034631|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110425538|NCT01034631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110425539|NCT01034631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110425540|NCT01034631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110425541|NCT01034631|Immunologic Factors|immunologic factors|mesh-ancestor
110425542|NCT01034631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110425543|NCT01034631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110425544|NCT01227668|Aripiprazole|aripiprazole|mesh-list
110425545|NCT01227668|Antidepressive Agents|antidepressive agents|mesh-ancestor
110425546|NCT01227668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110425547|NCT01227668|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110425548|NCT01227668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110425549|NCT01227668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110425550|NCT01227668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110425551|NCT01227668|Dopamine Agonists|dopamine agonists|mesh-ancestor
110425552|NCT01227668|Dopamine Agents|dopamine agents|mesh-ancestor
110425553|NCT01227668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110202062|NCT00151567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110425554|NCT01227668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110425555|NCT01227668|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110425556|NCT01227668|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110425557|NCT01227668|Serotonin Agents|serotonin agents|mesh-ancestor
110425558|NCT01227668|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110425559|NCT01227668|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110425560|NCT01227668|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110425561|NCT01227668|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110425563|NCT01227512|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
110425564|NCT01227512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110425565|NCT01227512|Natriuretic Agents|natriuretic agents|mesh-ancestor
110425566|NCT01227512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110425567|NCT01227278|Benralizumab|benralizumab|mesh-list
110425568|NCT01227278|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110425569|NCT01227278|Respiratory System Agents|respiratory system agents|mesh-ancestor
110425571|NCT01227044|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110425572|NCT01227044|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110425573|NCT01227044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110425574|NCT01227044|Sensory System Agents|sensory system agents|mesh-ancestor
110425575|NCT01227044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110425576|NCT01034163|Panobinostat|panobinostat|mesh-list
110425577|NCT01034163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110425578|NCT01034163|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110425579|NCT01034163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110425580|NCT01034163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110425581|NCT01162122|Vaccines|vaccines|mesh-list
110425582|NCT01162122|Immunologic Factors|immunologic factors|mesh-ancestor
110425583|NCT01162122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110425584|NCT01033071|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110425585|NCT01033071|Olmesartan|olmesartan|mesh-list
110425586|NCT01033071|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
110425587|NCT01033071|Chlorthalidone|chlorthalidone|mesh-list
110425588|NCT01033071|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
110425589|NCT01033071|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110425590|NCT01033071|Diuretics|diuretics|mesh-ancestor
110425591|NCT01033071|Natriuretic Agents|natriuretic agents|mesh-ancestor
110425592|NCT01033071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110425593|NCT01033071|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110425594|NCT01033071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110425595|NCT01033071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110425596|NCT01033071|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110425597|NCT01033071|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110425598|NCT01032915|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110425599|NCT01032915|Immunologic Factors|immunologic factors|mesh-ancestor
110425600|NCT01032915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110425601|NCT04589325|Ixekizumab|ixekizumab|mesh-list
110425602|NCT04589325|Dermatologic Agents|dermatologic agents|mesh-ancestor
110425603|NCT01161498|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
110425604|NCT01161498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110425605|NCT01161498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110425606|NCT02873559|Testosterone|testosterone|mesh-list
110425607|NCT02873559|Androgens|androgens|mesh-ancestor
110425608|NCT02873559|Hormones|hormones|mesh-ancestor
110425609|NCT02873559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110425610|NCT02873559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110425611|NCT01029795|Glyburide|glyburide|mesh-list
110425612|NCT01029795|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110425613|NCT01029795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110425614|NCT02885454|Simeprevir|simeprevir|mesh-list
110425615|NCT02885454|Odalasvir|odalasvir|mesh-list
110425616|NCT02885454|Drospirenone|drospirenone|mesh-list
110425617|NCT02885454|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110425618|NCT02885454|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
110425619|NCT02885454|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110425620|NCT02885454|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110425621|NCT02885454|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110425622|NCT02885454|Contraceptive Agents|contraceptive agents|mesh-ancestor
110425623|NCT02885454|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110425624|NCT02885454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110425625|NCT02885454|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110072586|NCT01572181|Busulfan|busulfan|mesh-list
110425626|NCT02885454|Estrogens|estrogens|mesh-ancestor
110425627|NCT02885454|Hormones|hormones|mesh-ancestor
110425628|NCT02885454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110425629|NCT02885454|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110425630|NCT02885454|Hormone Antagonists|hormone antagonists|mesh-ancestor
110425631|NCT02885454|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110425633|NCT02885454|Natriuretic Agents|natriuretic agents|mesh-ancestor
110425634|NCT02885454|Antiviral Agents|antiviral agents|mesh-ancestor
110425635|NCT02885454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110425636|NCT02885454|Protease Inhibitors|protease inhibitors|mesh-ancestor
110425637|NCT02885454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110425638|NCT02885454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110425639|NCT01032837|Oseltamivir|oseltamivir|mesh-list
110425640|NCT01032837|Antiviral Agents|antiviral agents|mesh-ancestor
110425641|NCT01032837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110425642|NCT01032837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110425643|NCT01032837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110425644|NCT01180296|Progesterone|progesterone|mesh-list
110425645|NCT01180296|Progestins|progestins|mesh-ancestor
110425646|NCT01180296|Hormones|hormones|mesh-ancestor
110425647|NCT01180296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110425648|NCT01180296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110425649|NCT01160640|Metronidazole|metronidazole|mesh-list
110425650|NCT01160640|Doxycycline|doxycycline|mesh-list
110425651|NCT01160640|Ceftriaxone|ceftriaxone|mesh-list
110425652|NCT01160640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110425653|NCT01160640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110425654|NCT01160640|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110425655|NCT01160640|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110425656|NCT01160640|Antimalarials|antimalarials|mesh-ancestor
110425657|NCT01160484|Lenalidomide|lenalidomide|mesh-list
110425658|NCT01160484|Bortezomib|bortezomib|mesh-list
110425659|NCT01160484|Immunologic Factors|immunologic factors|mesh-ancestor
110425660|NCT01160484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110425661|NCT01160484|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110425662|NCT01160484|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110425663|NCT01160484|Growth Substances|growth substances|mesh-ancestor
110425664|NCT01160484|Growth Inhibitors|growth inhibitors|mesh-ancestor
110425665|NCT01160484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110425667|NCT01032291|Cetuximab|cetuximab|mesh-list
110425668|NCT01032291|Immunologic Factors|immunologic factors|mesh-ancestor
110425669|NCT01032291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110425670|NCT01032291|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110425671|NCT01032291|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110425672|NCT01032291|Growth Substances|growth substances|mesh-ancestor
110425673|NCT01032291|Growth Inhibitors|growth inhibitors|mesh-ancestor
110425674|NCT01032291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110425675|NCT01032291|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110425676|NCT01159938|Insulin Lispro|insulin lispro|mesh-list
110425677|NCT01159938|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110425678|NCT01159938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110425679|NCT02873871|Hemostatics|hemostatics|mesh-list
110425680|NCT02873871|Coagulants|coagulants|mesh-ancestor
110425681|NCT04301739|Paclitaxel|paclitaxel|mesh-list
110425682|NCT04301739|Cyclophosphamide|cyclophosphamide|mesh-list
110425683|NCT04301739|Carboplatin|carboplatin|mesh-list
110425684|NCT04301739|Doxorubicin|doxorubicin|mesh-list
110425685|NCT04301739|Epirubicin|epirubicin|mesh-list
110425686|NCT04301739|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110425687|NCT04301739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110425688|NCT04301739|Tubulin Modulators|tubulin modulators|mesh-ancestor
110425689|NCT04301739|Antimitotic Agents|antimitotic agents|mesh-ancestor
110425690|NCT04301739|Mitosis Modulators|mitosis modulators|mesh-ancestor
110425691|NCT04301739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110425692|NCT04301739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110425693|NCT04301739|Immunologic Factors|immunologic factors|mesh-ancestor
110425694|NCT04301739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110425695|NCT04301739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110425696|NCT04301739|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110425697|NCT04301739|Alkylating Agents|alkylating agents|mesh-ancestor
110425698|NCT04301739|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110425699|NCT04301739|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110425700|NCT04301739|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110425701|NCT04301739|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110425702|NCT04301739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110425703|NCT04301583|Proanthocyanidin|proanthocyanidin|mesh-list
110425705|NCT04301583|Antioxidants|antioxidants|mesh-ancestor
110425706|NCT04301583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110425707|NCT04301583|Protective Agents|protective agents|mesh-ancestor
110425708|NCT04301583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110425709|NCT04301583|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110425710|NCT04301583|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110425711|NCT04301583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110425712|NCT01021683|Itraconazole|itraconazole|mesh-list
110425713|NCT01021683|Antifungal Agents|antifungal agents|mesh-ancestor
110425714|NCT01021683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110425715|NCT01021683|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110425716|NCT01021683|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110425717|NCT01021683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110425718|NCT01021683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110425719|NCT01021683|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110425720|NCT01021683|Hormone Antagonists|hormone antagonists|mesh-ancestor
110425721|NCT01021683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110425722|NCT01021683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110425723|NCT01021683|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110425724|NCT04625725|Cilgavimab and tixagevimab drug combination|cilgavimab and tixagevimab drug combination|mesh-list
110425725|NCT04625725|Antiviral Agents|antiviral agents|mesh-ancestor
110425726|NCT04625725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110425728|NCT01021215|Zileuton|zileuton|mesh-list
110425729|NCT01021215|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110425730|NCT01021215|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110425731|NCT01021215|Analgesics|analgesics|mesh-ancestor
110425732|NCT01021215|Sensory System Agents|sensory system agents|mesh-ancestor
110425733|NCT01021215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110425734|NCT01021215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110425736|NCT01021215|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110425737|NCT01021215|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110425738|NCT01021215|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110425739|NCT01021215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110425740|NCT01021215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110425741|NCT01021215|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
110425742|NCT01021215|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110425743|NCT01021215|Hormone Antagonists|hormone antagonists|mesh-ancestor
110425744|NCT01021215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110425745|NCT02760979|Denosumab|denosumab|mesh-list
110425746|NCT02760979|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110425747|NCT02760979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110425748|NCT02873325|Antiviral Agents|antiviral agents|mesh-list
110425749|NCT02873325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110425750|NCT02760901|Acetylcysteine|acetylcysteine|mesh-list
110425751|NCT02760901|Mannitol|mannitol|mesh-list
110425752|NCT02760901|Acetazolamide|acetazolamide|mesh-list
110425753|NCT02760901|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110425754|NCT02760901|Antiviral Agents|antiviral agents|mesh-ancestor
110425755|NCT02760901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110425756|NCT02760901|Expectorants|expectorants|mesh-ancestor
110425757|NCT02760901|Respiratory System Agents|respiratory system agents|mesh-ancestor
110425758|NCT02760901|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110425759|NCT02760901|Antioxidants|antioxidants|mesh-ancestor
110425760|NCT02760901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110425761|NCT02760901|Protective Agents|protective agents|mesh-ancestor
110425762|NCT02760901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110425763|NCT02760901|Antidotes|antidotes|mesh-ancestor
110425764|NCT02760901|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110425765|NCT02760901|Diuretics|diuretics|mesh-ancestor
110425766|NCT02760901|Natriuretic Agents|natriuretic agents|mesh-ancestor
110425767|NCT02760901|Anticonvulsants|anticonvulsants|mesh-ancestor
110425768|NCT02760901|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110425769|NCT02760901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110425770|NCT00635713|Fulvestrant|fulvestrant|mesh-list
110425771|NCT00635713|Anastrozole|anastrozole|mesh-list
110425772|NCT00635713|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110425773|NCT00635713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110425774|NCT00635713|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110425776|NCT00635713|Hormone Antagonists|hormone antagonists|mesh-ancestor
110072733|NCT01572688|Melphalan|melphalan|mesh-list
110425777|NCT00635713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110425778|NCT00635713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110425779|NCT00635713|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110425780|NCT00635713|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110425781|NCT00635713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110425782|NCT00635713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110425783|NCT02760823|Thioctic Acid|thioctic acid|mesh-list
110425784|NCT02760823|Antioxidants|antioxidants|mesh-ancestor
110425785|NCT02760823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110425786|NCT02760823|Protective Agents|protective agents|mesh-ancestor
110425787|NCT02760823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110425788|NCT02760823|Vitamin B Complex|vitamin b complex|mesh-ancestor
110425790|NCT02760823|Micronutrients|micronutrients|mesh-ancestor
110425791|NCT01020747|Bevacizumab|bevacizumab|mesh-list
110425792|NCT01020747|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110425793|NCT01020747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110425794|NCT01020747|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110425795|NCT01020747|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110425796|NCT01020747|Growth Substances|growth substances|mesh-ancestor
110425797|NCT01020747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110425798|NCT01020747|Growth Inhibitors|growth inhibitors|mesh-ancestor
110425799|NCT02754739|Pravastatin|pravastatin|mesh-list
110425800|NCT02754739|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110425801|NCT02754739|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110425802|NCT02754739|Antimetabolites|antimetabolites|mesh-ancestor
110425803|NCT02754739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110425804|NCT02754739|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110425805|NCT02754739|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110425806|NCT02754739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110425807|NCT01031979|Yohimbine|yohimbine|mesh-list
110425808|NCT01031979|Mydriatics|mydriatics|mesh-ancestor
110425809|NCT01031979|Autonomic Agents|autonomic agents|mesh-ancestor
110425810|NCT01031979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110425811|NCT01031979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110425812|NCT01031979|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
110425813|NCT01031979|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110425814|NCT01031979|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110425815|NCT01031979|Adrenergic Agents|adrenergic agents|mesh-ancestor
110425816|NCT01031979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110425817|NCT01031979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110425818|NCT01031979|Urological Agents|urological agents|mesh-ancestor
110425819|NCT02753803|Pioglitazone|pioglitazone|mesh-list
110425820|NCT02753803|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110425821|NCT02753803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110425822|NCT04219579|Antithrombins|antithrombins|mesh-list
110425823|NCT04219579|Antithrombin III|antithrombin iii|mesh-list
110425824|NCT04219579|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110425825|NCT04219579|Protease Inhibitors|protease inhibitors|mesh-ancestor
110425826|NCT04219579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110425827|NCT04219579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110425828|NCT04219579|Anticoagulants|anticoagulants|mesh-ancestor
110425829|NCT00635401|Varenicline|varenicline|mesh-list
110425830|NCT00635401|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110425831|NCT00635401|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110425832|NCT00635401|Cholinergic Agents|cholinergic agents|mesh-ancestor
110425833|NCT00635401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110425834|NCT00635401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110425835|NCT00635401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110425836|NCT02753725|Fentanyl|fentanyl|mesh-list
110425837|NCT02753725|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110425838|NCT02753725|Narcotics|narcotics|mesh-ancestor
110425839|NCT02753725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110425840|NCT02753725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110425841|NCT02753725|Analgesics|analgesics|mesh-ancestor
110425842|NCT02753725|Sensory System Agents|sensory system agents|mesh-ancestor
110425843|NCT02753725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110425844|NCT02753725|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110425845|NCT02753725|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110425846|NCT02753725|Anesthetics, General|anesthetics, general|mesh-ancestor
110425847|NCT02753725|Anesthetics|anesthetics|mesh-ancestor
110425848|NCT01020123|Glipizide|glipizide|mesh-list
110425849|NCT01020123|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110425850|NCT01020123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110425851|NCT04300959|Cisplatin|cisplatin|mesh-list
110425852|NCT04300959|Gemcitabine|gemcitabine|mesh-list
110425853|NCT04300959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110425854|NCT04300959|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110425855|NCT04300959|Antimetabolites|antimetabolites|mesh-ancestor
110425856|NCT04300959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110425857|NCT02760355|Ribavirin|ribavirin|mesh-list
110425858|NCT02760355|Sofosbuvir|sofosbuvir|mesh-list
110425859|NCT02760355|Ledipasvir|ledipasvir|mesh-list
110425860|NCT02760355|Antimetabolites|antimetabolites|mesh-ancestor
110425861|NCT02760355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110425862|NCT02760355|Antiviral Agents|antiviral agents|mesh-ancestor
110425863|NCT02760355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110425864|NCT01028391|Metformin|metformin|mesh-list
110425865|NCT01028391|Pioglitazone|pioglitazone|mesh-list
110425866|NCT01028391|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110425867|NCT01028391|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110425868|NCT01028391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110425869|NCT01028391|Incretins|incretins|mesh-ancestor
110425870|NCT01028391|Hormones|hormones|mesh-ancestor
110425871|NCT01028391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110425872|NCT01028391|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110425873|NCT01028391|Protease Inhibitors|protease inhibitors|mesh-ancestor
110425874|NCT01028391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110425875|NCT01028391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110425876|NCT01179672|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110425877|NCT01179672|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110425878|NCT01179672|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110425879|NCT01179672|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110425880|NCT01179672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110425881|NCT01179672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110425882|NCT01179672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110425883|NCT01179672|Analgesics|analgesics|mesh-ancestor
110425884|NCT01179672|Sensory System Agents|sensory system agents|mesh-ancestor
110425885|NCT01179672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110425886|NCT01179672|Antidepressive Agents|antidepressive agents|mesh-ancestor
110425887|NCT01179672|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110425888|NCT01179672|Dopamine Agents|dopamine agents|mesh-ancestor
110425889|NCT04301349|Misoprostol|misoprostol|mesh-list
110425890|NCT04301349|Dinoprostone|dinoprostone|mesh-list
110370461|NCT00560963|Immunologic Factors|immunologic factors|mesh-ancestor
110425891|NCT04301349|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110425892|NCT04301349|Abortifacient Agents|abortifacient agents|mesh-ancestor
110425893|NCT04301349|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110425894|NCT04301349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110425895|NCT04301349|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110425896|NCT04301349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110425897|NCT04301349|Oxytocics|oxytocics|mesh-ancestor
110425898|NCT02753647|Prednisone|prednisone|mesh-list
110425899|NCT02753647|Cyclophosphamide|cyclophosphamide|mesh-list
110425900|NCT02753647|Rituximab|rituximab|mesh-list
110425901|NCT02753647|Doxorubicin|doxorubicin|mesh-list
110425902|NCT02753647|Vincristine|vincristine|mesh-list
110425903|NCT02753647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110425904|NCT02753647|Immunologic Factors|immunologic factors|mesh-ancestor
110425905|NCT02753647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110202173|NCT00152230|Tegafur|tegafur|mesh-list
110425907|NCT02753647|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110425908|NCT02753647|Alkylating Agents|alkylating agents|mesh-ancestor
110425909|NCT02753647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110425910|NCT02753647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110425911|NCT02753647|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110425912|NCT02753647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110425913|NCT02753647|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110425914|NCT02753647|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110425915|NCT02753647|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110425916|NCT02753647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110425917|NCT02753647|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110425918|NCT02753647|Glucocorticoids|glucocorticoids|mesh-ancestor
110425919|NCT02753647|Hormones|hormones|mesh-ancestor
110425920|NCT02753647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110425921|NCT02753647|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110425922|NCT02753647|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110425923|NCT02753647|Tubulin Modulators|tubulin modulators|mesh-ancestor
110425924|NCT02753647|Antimitotic Agents|antimitotic agents|mesh-ancestor
110425925|NCT02753647|Mitosis Modulators|mitosis modulators|mesh-ancestor
110425926|NCT02872389|Sevoflurane|sevoflurane|mesh-list
110425927|NCT02872389|Desflurane|desflurane|mesh-list
110425928|NCT02872389|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110425929|NCT02872389|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110425930|NCT02872389|Anesthetics, General|anesthetics, general|mesh-ancestor
110425931|NCT02872389|Anesthetics|anesthetics|mesh-ancestor
110425932|NCT02872389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110425933|NCT02872389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110425934|NCT01179516|Vortioxetine|vortioxetine|mesh-list
110425935|NCT01179516|Antidepressive Agents|antidepressive agents|mesh-ancestor
110425936|NCT01179516|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110425937|NCT01179516|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110425938|NCT01179516|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110425939|NCT01179516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110425940|NCT01179516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110425941|NCT01179516|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110425942|NCT01179516|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110425943|NCT01179516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110328626|NCT00489840|Hydrocortisone|hydrocortisone|mesh-list
110425944|NCT01179516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110425945|NCT01179516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110425946|NCT01179516|Serotonin Agents|serotonin agents|mesh-ancestor
110425947|NCT01179516|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110425948|NCT01179516|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110425949|NCT01179516|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110425950|NCT01179516|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110425951|NCT00635791|Sorafenib|sorafenib|mesh-list
110425952|NCT00635791|Vorinostat|vorinostat|mesh-list
110425953|NCT00635791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110425954|NCT00635791|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110425955|NCT00635791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110425956|NCT00635791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110425957|NCT00635791|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110425958|NCT02760121|Acetazolamide|acetazolamide|mesh-list
110425959|NCT02760121|Methazolamide|methazolamide|mesh-list
110425960|NCT02760121|Anticonvulsants|anticonvulsants|mesh-ancestor
110425961|NCT02760121|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110425962|NCT02760121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110425963|NCT02760121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110425964|NCT02760121|Diuretics|diuretics|mesh-ancestor
110425965|NCT02760121|Natriuretic Agents|natriuretic agents|mesh-ancestor
110425966|NCT02760121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110425967|NCT05215873|Misoprostol|misoprostol|mesh-list
110425968|NCT05215873|Oxytocin|oxytocin|mesh-list
110425969|NCT05215873|Oxytocics|oxytocics|mesh-ancestor
110425970|NCT05215873|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110425971|NCT05215873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110425972|NCT05215873|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110425973|NCT05215873|Abortifacient Agents|abortifacient agents|mesh-ancestor
110425974|NCT05215873|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110425975|NCT05215873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110425976|NCT02759887|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110425977|NCT02759887|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110425978|NCT02759887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110425979|NCT02750917|Etoricoxib|etoricoxib|mesh-list
110425980|NCT02750917|Lornoxicam|lornoxicam|mesh-list
110425981|NCT02750917|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110425982|NCT02750917|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110425983|NCT02750917|Analgesics|analgesics|mesh-ancestor
110425984|NCT02750917|Sensory System Agents|sensory system agents|mesh-ancestor
110425985|NCT02750917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110425986|NCT02750917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110425987|NCT02750917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110425988|NCT02750917|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110425989|NCT02750917|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110425990|NCT02750917|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110425991|NCT02750917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110425992|NCT02750917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110425993|NCT02750995|Azacitidine|azacitidine|mesh-list
110425994|NCT02750995|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110425995|NCT02750995|Antimetabolites|antimetabolites|mesh-ancestor
110425996|NCT02750995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110425997|NCT02750995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110425998|NCT02750995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110425999|NCT01027845|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110426000|NCT01027845|Immunologic Factors|immunologic factors|mesh-ancestor
110426001|NCT01027845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110426002|NCT04221919|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
110426003|NCT04221919|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110426004|NCT04221919|Adrenergic Agents|adrenergic agents|mesh-ancestor
110426005|NCT04221919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110426006|NCT04221919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110426007|NCT04221919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110426009|NCT04299633|Sevelamer|sevelamer|mesh-list
110426010|NCT04299633|Calcium acetate|calcium acetate|mesh-list
110426011|NCT04299633|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110426012|NCT04299633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110426013|NCT04299633|Chelating Agents|chelating agents|mesh-ancestor
110426014|NCT04299633|Sequestering Agents|sequestering agents|mesh-ancestor
110426015|NCT04299633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110426016|NCT02695459|Everolimus|everolimus|mesh-list
110426017|NCT02695459|Cisplatin|cisplatin|mesh-list
110426018|NCT02695459|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110426019|NCT02695459|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110426020|NCT02695459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110426021|NCT02695459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110426022|NCT02695459|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110426023|NCT02695459|Immunologic Factors|immunologic factors|mesh-ancestor
110426024|NCT02695459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110426025|NCT02695459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110426027|NCT04288713|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
110426028|NCT04288713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110426029|NCT04288713|Immunologic Factors|immunologic factors|mesh-ancestor
110426030|NCT04288713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110426031|NCT05112991|Lenvatinib|lenvatinib|mesh-list
110426032|NCT05112991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110426033|NCT05112991|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110426034|NCT05112991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110426035|NCT05112991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110426036|NCT01030341|Insulin|insulin|mesh-list
110426037|NCT01030341|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110426038|NCT01030341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110426039|NCT01030341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110426040|NCT02750293|Cholecalciferol|cholecalciferol|mesh-list
110426041|NCT02750293|Vitamin D|vitamin d|mesh-list
110426042|NCT02750293|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110426043|NCT02750293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110426044|NCT02750293|Vitamins|vitamins|mesh-ancestor
110426045|NCT02750293|Micronutrients|micronutrients|mesh-ancestor
110426046|NCT02750293|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110426047|NCT04217785|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110426048|NCT04217785|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110426049|NCT01026831|Timolol|timolol|mesh-list
110426050|NCT01026831|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110426051|NCT01026831|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110426052|NCT01026831|Adrenergic Agents|adrenergic agents|mesh-ancestor
110426053|NCT01026831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110426054|NCT01026831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110426055|NCT01026831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110426056|NCT01026831|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110426057|NCT01026831|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110426059|NCT02750137|Anesthetics, Local|anesthetics, local|mesh-ancestor
110426060|NCT02750137|Anesthetics|anesthetics|mesh-ancestor
110426061|NCT02750137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110426062|NCT02750137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110426063|NCT02750137|Sensory System Agents|sensory system agents|mesh-ancestor
110426064|NCT02750137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110426065|NCT02760043|Dexamethasone|dexamethasone|mesh-list
110426066|NCT02760043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110426067|NCT02760043|Antiemetics|antiemetics|mesh-ancestor
110426068|NCT02760043|Autonomic Agents|autonomic agents|mesh-ancestor
110426069|NCT02760043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110426070|NCT02760043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110426071|NCT02760043|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110426072|NCT02760043|Glucocorticoids|glucocorticoids|mesh-ancestor
110426073|NCT02760043|Hormones|hormones|mesh-ancestor
110426074|NCT02760043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110073028|NCT01575626|Anesthetics, General|anesthetics, general|mesh-ancestor
110426075|NCT02760043|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110426076|NCT02760043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110426077|NCT02750059|Tenofovir|tenofovir|mesh-list
110426078|NCT02750059|Lamivudine|lamivudine|mesh-list
110426079|NCT02750059|Efavirenz|efavirenz|mesh-list
110426080|NCT02750059|Telmisartan|telmisartan|mesh-list
110426081|NCT02750059|Antiviral Agents|antiviral agents|mesh-ancestor
110426082|NCT02750059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110426083|NCT02750059|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110426084|NCT02750059|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110426086|NCT02750059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110426087|NCT02750059|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110426088|NCT02750059|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110426089|NCT02750059|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110426090|NCT02750059|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110426091|NCT02750059|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110426092|NCT02750059|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110426093|NCT02750059|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110426094|NCT02750059|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110426095|NCT02750059|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110426096|NCT02750059|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110426097|NCT02750059|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110426098|NCT02749825|Goserelin|goserelin|mesh-list
110426099|NCT02749825|Triptorelin Pamoate|triptorelin pamoate|mesh-list
110426100|NCT02749825|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110426101|NCT02749825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110426102|NCT02749825|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110426103|NCT02749825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110426104|NCT02749825|Luteolytic Agents|luteolytic agents|mesh-ancestor
110426105|NCT02749825|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110426106|NCT02749825|Contraceptive Agents|contraceptive agents|mesh-ancestor
110426107|NCT02749825|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110426108|NCT02759107|Dulaglutide|dulaglutide|mesh-list
110426109|NCT02759107|Tirzepatide|tirzepatide|mesh-list
110426110|NCT02759107|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110426111|NCT02759107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110426112|NCT02759107|Incretins|incretins|mesh-ancestor
110426113|NCT02759107|Hormones|hormones|mesh-ancestor
110426114|NCT02759107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110426115|NCT02758873|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110426116|NCT02758873|Montelukast|montelukast|mesh-list
110426117|NCT02758873|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110426118|NCT02758873|Autonomic Agents|autonomic agents|mesh-ancestor
110202256|NCT00152620|Methylprednisolone|methylprednisolone|mesh-list
110426119|NCT02758873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110426120|NCT02758873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110426121|NCT02758873|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110426122|NCT02758873|Respiratory System Agents|respiratory system agents|mesh-ancestor
110426123|NCT02758873|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110426124|NCT02758873|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110426125|NCT02758873|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110426126|NCT02758873|Adrenergic Agents|adrenergic agents|mesh-ancestor
110426127|NCT02758873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110426128|NCT02758873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110426129|NCT02758873|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110426130|NCT02758873|Hormone Antagonists|hormone antagonists|mesh-ancestor
110426131|NCT02758873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110426132|NCT02758873|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110426133|NCT02758873|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110426135|NCT02749747|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110426136|NCT02749747|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110426137|NCT02749747|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110426138|NCT02749747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110426139|NCT02749747|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110426140|NCT02749747|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110426141|NCT02749747|Dopamine Agents|dopamine agents|mesh-ancestor
110426142|NCT02749747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110426143|NCT02749747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110426144|NCT02749747|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110426145|NCT02749747|Antidepressive Agents|antidepressive agents|mesh-ancestor
110426146|NCT02749591|Botulinum Toxins|botulinum toxins|mesh-list
110426147|NCT02749591|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110426148|NCT02749591|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110426149|NCT02749591|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110426150|NCT02749591|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110426151|NCT02749591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110426152|NCT02749591|Cholinergic Agents|cholinergic agents|mesh-ancestor
110426153|NCT02749591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110426154|NCT02749591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110426155|NCT02749591|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110426156|NCT02749591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110426157|NCT04359979|Tamsulosin|tamsulosin|mesh-list
110426158|NCT04359979|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110426159|NCT04359979|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110426160|NCT04359979|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110426161|NCT04359979|Adrenergic Agents|adrenergic agents|mesh-ancestor
110426162|NCT04359979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110426163|NCT04359979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110426164|NCT04359979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110426165|NCT04359979|Urological Agents|urological agents|mesh-ancestor
110426166|NCT04180813|Linagliptin|linagliptin|mesh-list
110426167|NCT04180813|Acarbose|acarbose|mesh-list
110426168|NCT04180813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110426169|NCT04180813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110426170|NCT04180813|Incretins|incretins|mesh-ancestor
110426171|NCT04180813|Hormones|hormones|mesh-ancestor
110426172|NCT04180813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110426173|NCT04180813|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110426174|NCT04180813|Protease Inhibitors|protease inhibitors|mesh-ancestor
110426175|NCT04180813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110426176|NCT04180813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110426177|NCT04180813|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
110426178|NCT04116775|Pembrolizumab|pembrolizumab|mesh-list
110426179|NCT04116775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110426180|NCT04116775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110426181|NCT04116775|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110426182|NCT04116775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110426183|NCT03913741|Tisotumab vedotin|tisotumab vedotin|mesh-list
110426184|NCT03913741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110426185|NCT03913741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110426186|NCT02749123|Lidocaine|lidocaine|mesh-list
110426187|NCT02749123|Menthol|menthol|mesh-list
110426188|NCT02749123|Anesthetics, Local|anesthetics, local|mesh-ancestor
110426189|NCT02749123|Anesthetics|anesthetics|mesh-ancestor
110426190|NCT02749123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110426191|NCT02749123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110426192|NCT02749123|Sensory System Agents|sensory system agents|mesh-ancestor
110426193|NCT02749123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110426194|NCT02749123|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110426195|NCT02749123|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110426196|NCT02749123|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110426197|NCT02749123|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110426198|NCT02749123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110426199|NCT02749123|Antipruritics|antipruritics|mesh-ancestor
110426200|NCT02749123|Dermatologic Agents|dermatologic agents|mesh-ancestor
110426201|NCT00635557|Carboplatin|carboplatin|mesh-list
110426202|NCT00635557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110426203|NCT02748265|Epoprostenol|epoprostenol|mesh-list
110426204|NCT02748265|Phenylephrine|phenylephrine|mesh-list
110426205|NCT02748265|Oxymetazoline|oxymetazoline|mesh-list
110426206|NCT02748265|Tezosentan|tezosentan|mesh-list
110426207|NCT02748265|Propofol|propofol|mesh-list
110426208|NCT02748265|Sevoflurane|sevoflurane|mesh-list
110426209|NCT02748265|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110426210|NCT02748265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110426211|NCT02748265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110426212|NCT02748265|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110426213|NCT02748265|Anesthetics, General|anesthetics, general|mesh-ancestor
110426214|NCT02748265|Anesthetics|anesthetics|mesh-ancestor
110426215|NCT02748265|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110426216|NCT02748265|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110426217|NCT02748265|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110426218|NCT02748265|Mydriatics|mydriatics|mesh-ancestor
110426219|NCT02748265|Autonomic Agents|autonomic agents|mesh-ancestor
110426220|NCT02748265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110426221|NCT02748265|Sympathomimetics|sympathomimetics|mesh-ancestor
110426222|NCT02748265|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110426223|NCT02748265|Nasal Decongestants|nasal decongestants|mesh-ancestor
110426224|NCT02748265|Respiratory System Agents|respiratory system agents|mesh-ancestor
110426225|NCT02748265|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110426226|NCT02748265|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110426228|NCT02748265|Adrenergic Agents|adrenergic agents|mesh-ancestor
110426229|NCT02748265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110426230|NCT02748265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110426231|NCT02748265|Protective Agents|protective agents|mesh-ancestor
110426232|NCT02748265|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110426233|NCT02748265|Vasodilator Agents|vasodilator agents|mesh-ancestor
110426234|NCT01015833|Doxorubicin|doxorubicin|mesh-list
110426236|NCT01015833|Sorafenib|sorafenib|mesh-list
110426237|NCT01015833|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110426238|NCT01015833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110426239|NCT01015833|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110426240|NCT01015833|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110426241|NCT01015833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110426242|NCT01015833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110426243|NCT01015833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110426244|NCT03523273|Liraglutide|liraglutide|mesh-list
110426245|NCT03523273|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110426246|NCT03523273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110426247|NCT03523273|Incretins|incretins|mesh-ancestor
110426248|NCT03523273|Hormones|hormones|mesh-ancestor
110426249|NCT03523273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110426250|NCT02695381|Etodolac|etodolac|mesh-list
110426251|NCT02695381|Lidocaine|lidocaine|mesh-list
110426252|NCT02695381|Anesthetics, Local|anesthetics, local|mesh-ancestor
110426253|NCT02695381|Anesthetics|anesthetics|mesh-ancestor
110426254|NCT02695381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110426255|NCT02695381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110426256|NCT02695381|Sensory System Agents|sensory system agents|mesh-ancestor
110426257|NCT02695381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110426258|NCT02695381|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110426259|NCT02695381|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110426260|NCT02695381|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110426261|NCT02695381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110426262|NCT02695381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110426263|NCT02695381|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110426264|NCT02695381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110426265|NCT02695381|Analgesics|analgesics|mesh-ancestor
110426266|NCT02695381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110370533|NCT04631315|Glucocorticoids|glucocorticoids|mesh-ancestor
110426267|NCT02695381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110426268|NCT02695381|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110426269|NCT02695381|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110426270|NCT02695381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110426271|NCT02746783|Vaccines|vaccines|mesh-list
110426272|NCT02746783|Immunologic Factors|immunologic factors|mesh-ancestor
110426273|NCT02746783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110426274|NCT02747953|Afatinib|afatinib|mesh-list
110426275|NCT02747953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110426276|NCT02747953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110426277|NCT02747953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110426278|NCT02747953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110426279|NCT02735239|Leucovorin|leucovorin|mesh-list
110426280|NCT02735239|Paclitaxel|paclitaxel|mesh-list
110426281|NCT02735239|Docetaxel|docetaxel|mesh-list
110426282|NCT02735239|Carboplatin|carboplatin|mesh-list
110426283|NCT02735239|Fluorouracil|fluorouracil|mesh-list
110426284|NCT02735239|Capecitabine|capecitabine|mesh-list
110426285|NCT02735239|Oxaliplatin|oxaliplatin|mesh-list
110426286|NCT02735239|Durvalumab|durvalumab|mesh-list
110426287|NCT02735239|Tremelimumab|tremelimumab|mesh-list
110426288|NCT02735239|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110426289|NCT02735239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110426290|NCT02735239|Tubulin Modulators|tubulin modulators|mesh-ancestor
110426291|NCT02735239|Antimitotic Agents|antimitotic agents|mesh-ancestor
110426292|NCT02735239|Mitosis Modulators|mitosis modulators|mesh-ancestor
110426293|NCT02735239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110426294|NCT02735239|Antimetabolites|antimetabolites|mesh-ancestor
110426295|NCT02735239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110426296|NCT02735239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110426297|NCT02735239|Immunologic Factors|immunologic factors|mesh-ancestor
110426298|NCT02735239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110426299|NCT02735239|Antidotes|antidotes|mesh-ancestor
110426300|NCT02735239|Protective Agents|protective agents|mesh-ancestor
110426301|NCT02735239|Vitamin B Complex|vitamin b complex|mesh-ancestor
110426302|NCT02735239|Vitamins|vitamins|mesh-ancestor
110426303|NCT02735239|Micronutrients|micronutrients|mesh-ancestor
110426304|NCT02735239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110426305|NCT02655523|Dexamethasone|dexamethasone|mesh-list
110426306|NCT02655523|Triamcinolone|triamcinolone|mesh-list
110426307|NCT02655523|Bupivacaine|bupivacaine|mesh-list
110426308|NCT02655523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110426309|NCT02655523|Antiemetics|antiemetics|mesh-ancestor
110426310|NCT02655523|Autonomic Agents|autonomic agents|mesh-ancestor
110426311|NCT02655523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110426312|NCT02655523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110426313|NCT02655523|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110426314|NCT02655523|Glucocorticoids|glucocorticoids|mesh-ancestor
110426315|NCT02655523|Hormones|hormones|mesh-ancestor
110426316|NCT02655523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110426317|NCT02655523|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110426318|NCT02655523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110370536|NCT04631315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110426320|NCT02655523|Anesthetics|anesthetics|mesh-ancestor
110426321|NCT02655523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110426322|NCT02655523|Sensory System Agents|sensory system agents|mesh-ancestor
110426323|NCT02644291|Mebendazole|mebendazole|mesh-list
110426324|NCT02644291|Piperazine|piperazine|mesh-list
110426325|NCT02644291|Piperazine citrate|piperazine citrate|mesh-list
110426326|NCT02644291|DMP 777|dmp 777|mesh-list
110426327|NCT02644291|Antinematodal Agents|antinematodal agents|mesh-ancestor
110426328|NCT02644291|Anthelmintics|anthelmintics|mesh-ancestor
110426329|NCT02644291|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110426330|NCT02644291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110426331|NCT02644291|Tubulin Modulators|tubulin modulators|mesh-ancestor
110426332|NCT02644291|Antimitotic Agents|antimitotic agents|mesh-ancestor
110426333|NCT02644291|Mitosis Modulators|mitosis modulators|mesh-ancestor
110426334|NCT02644291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110426335|NCT02644291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110426336|NCT02644291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110426337|NCT01015677|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110426338|NCT01015677|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110426339|NCT01015677|Estradiol|estradiol|mesh-list
110426340|NCT01015677|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110426341|NCT01015677|Estrogens|estrogens|mesh-ancestor
110426342|NCT01015677|Hormones|hormones|mesh-ancestor
110426343|NCT01015677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110426344|NCT01015677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110426345|NCT01015677|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110426346|NCT01015677|Contraceptive Agents|contraceptive agents|mesh-ancestor
110426347|NCT01015677|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110202319|NCT00043719|Vitamin D|vitamin d|mesh-list
110426348|NCT01015677|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110426349|NCT02281981|Curcumin|curcumin|mesh-list
110426350|NCT02281981|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110426351|NCT02281981|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110426352|NCT02281981|Analgesics|analgesics|mesh-ancestor
110426353|NCT02281981|Sensory System Agents|sensory system agents|mesh-ancestor
110426354|NCT02281981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110426355|NCT02281981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110426356|NCT02281981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110426357|NCT02281981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110426358|NCT02281981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110426359|NCT02281981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110426360|NCT02281981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110426361|NCT04297839|Heparin|heparin|mesh-list
110426362|NCT04297839|Calcium heparin|calcium heparin|mesh-list
110426363|NCT04297839|Citric Acid|citric acid|mesh-list
110426364|NCT04297839|Sodium Citrate|sodium citrate|mesh-list
110426365|NCT04297839|Anticoagulants|anticoagulants|mesh-ancestor
110426366|NCT04297839|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110426367|NCT04297839|Chelating Agents|chelating agents|mesh-ancestor
110426368|NCT04297839|Sequestering Agents|sequestering agents|mesh-ancestor
110426369|NCT04297839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110426370|NCT04297839|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110426371|NCT04297839|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110426372|NCT02751151|Aminolevulinic Acid|aminolevulinic acid|mesh-list
110426373|NCT02751151|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110426374|NCT02751151|Dermatologic Agents|dermatologic agents|mesh-ancestor
110426375|NCT04216459|Cholecalciferol|cholecalciferol|mesh-list
110426376|NCT04216459|Vitamin D|vitamin d|mesh-list
110426377|NCT04216459|Thiamine|thiamine|mesh-list
110426379|NCT04216459|Micronutrients|micronutrients|mesh-ancestor
110426380|NCT04216459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110426381|NCT04216459|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110426382|NCT04216459|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110426383|NCT04216459|Vitamin B Complex|vitamin b complex|mesh-ancestor
110426384|NCT04216771|Cytarabine|cytarabine|mesh-list
110426385|NCT04216771|Idarubicin|idarubicin|mesh-list
110426386|NCT04216771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110426387|NCT04216771|Antimetabolites|antimetabolites|mesh-ancestor
110426388|NCT04216771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110426389|NCT04216771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110426390|NCT04216771|Antiviral Agents|antiviral agents|mesh-ancestor
110426391|NCT04216771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110426392|NCT04216771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110426393|NCT04216771|Immunologic Factors|immunologic factors|mesh-ancestor
110426394|NCT04216771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110426395|NCT04216771|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110426396|NCT04216771|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110426397|NCT04216771|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110426398|NCT04216771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110426400|NCT00636259|Androgen Antagonists|androgen antagonists|mesh-ancestor
110426401|NCT00636259|Hormone Antagonists|hormone antagonists|mesh-ancestor
110426402|NCT00636259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110426403|NCT00636259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110426404|NCT00636259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110426405|NCT02736019|Celecoxib|celecoxib|mesh-list
110426406|NCT02736019|Tramadol|tramadol|mesh-list
110426407|NCT02736019|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110426408|NCT02736019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110426409|NCT02736019|Analgesics|analgesics|mesh-ancestor
110426410|NCT02736019|Sensory System Agents|sensory system agents|mesh-ancestor
110426411|NCT02736019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110426412|NCT02736019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110426413|NCT02736019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110426414|NCT02736019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110426415|NCT02736019|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110426416|NCT02736019|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110426417|NCT02736019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110426418|NCT02736019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110426419|NCT02736019|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110426420|NCT02736019|Narcotics|narcotics|mesh-ancestor
110426421|NCT02736019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110426422|NCT04284397|Aspirin|aspirin|mesh-list
110426423|NCT04284397|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110426424|NCT04284397|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110426425|NCT04284397|Analgesics|analgesics|mesh-ancestor
110426426|NCT04284397|Sensory System Agents|sensory system agents|mesh-ancestor
110426427|NCT04284397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110426428|NCT04284397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110426429|NCT04284397|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110426430|NCT04284397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110426431|NCT04284397|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110426432|NCT04284397|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110426433|NCT04284397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110426434|NCT04284397|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110426435|NCT04284397|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110426436|NCT04284397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110426437|NCT04284397|Antipyretics|antipyretics|mesh-ancestor
110426438|NCT05595889|Irinotecan|irinotecan|mesh-list
110426439|NCT05595889|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110426440|NCT05595889|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110426441|NCT05595889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110426442|NCT05595889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110426443|NCT05595889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110426444|NCT02735395|Amoxicillin|amoxicillin|mesh-list
110426445|NCT02735395|Metronidazole|metronidazole|mesh-list
110426446|NCT02735395|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110426447|NCT02735395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110426448|NCT02735395|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110426449|NCT02735395|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110426450|NCT02741947|Levodopa|levodopa|mesh-list
110426451|NCT02741947|Benserazide|benserazide|mesh-list
110426452|NCT02741947|Benserazide, levodopa drug combination|benserazide, levodopa drug combination|mesh-list
110426453|NCT02741947|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110426454|NCT02741947|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110426455|NCT02741947|Dopamine Agents|dopamine agents|mesh-ancestor
110426456|NCT02741947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110426457|NCT02741947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110426458|NCT02741947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110426459|NCT02741947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110426460|NCT02740933|Demeclocycline|demeclocycline|mesh-list
110426461|NCT02740933|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110426462|NCT02740933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110426463|NCT02739685|Everolimus|everolimus|mesh-list
110426464|NCT02739685|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110426465|NCT02739685|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110426466|NCT02739685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110426467|NCT02739685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110426468|NCT02739685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110426469|NCT02739685|Immunologic Factors|immunologic factors|mesh-ancestor
110426470|NCT02739685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110426471|NCT02739685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110426472|NCT02735317|Vitamin B 12|vitamin b 12|mesh-list
110426473|NCT02735317|Hydroxocobalamin|hydroxocobalamin|mesh-list
110426474|NCT02735317|Gentamicins|gentamicins|mesh-list
110426475|NCT02735317|Dexamethasone|dexamethasone|mesh-list
110426476|NCT02735317|Procaine|procaine|mesh-list
110426477|NCT02735317|Vitamins|vitamins|mesh-ancestor
110426478|NCT02735317|Micronutrients|micronutrients|mesh-ancestor
110426479|NCT02735317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110426480|NCT02735317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110426481|NCT02735317|Antiemetics|antiemetics|mesh-ancestor
110202423|NCT00050414|Hormones|hormones|mesh-ancestor
110426482|NCT02735317|Autonomic Agents|autonomic agents|mesh-ancestor
110426483|NCT02735317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110426484|NCT02735317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110426485|NCT02735317|Glucocorticoids|glucocorticoids|mesh-ancestor
110426486|NCT02735317|Hormones|hormones|mesh-ancestor
110426487|NCT02735317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110426488|NCT02735317|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110426489|NCT02735317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110426490|NCT02735317|Vitamin B Complex|vitamin b complex|mesh-ancestor
110426491|NCT02735317|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110426492|NCT02735317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110426493|NCT02735317|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110426494|NCT02735317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110426495|NCT02735317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110426496|NCT02735317|Hematinics|hematinics|mesh-ancestor
110426497|NCT02735317|Anesthetics, Local|anesthetics, local|mesh-ancestor
110426498|NCT02735317|Anesthetics|anesthetics|mesh-ancestor
110426499|NCT02735317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110426500|NCT02735317|Sensory System Agents|sensory system agents|mesh-ancestor
110426501|NCT02739529|genexol-PM|genexol-pm|mesh-list
110426502|NCT02739529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110426503|NCT02739529|Tubulin Modulators|tubulin modulators|mesh-ancestor
110426504|NCT02739529|Antimitotic Agents|antimitotic agents|mesh-ancestor
110426505|NCT02739529|Mitosis Modulators|mitosis modulators|mesh-ancestor
110426506|NCT02739529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110426507|NCT05544721|Ropivacaine|ropivacaine|mesh-list
110426508|NCT05544721|Anesthetics, Local|anesthetics, local|mesh-ancestor
110426509|NCT05544721|Anesthetics|anesthetics|mesh-ancestor
110426510|NCT05544721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110426511|NCT05544721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110426512|NCT05544721|Sensory System Agents|sensory system agents|mesh-ancestor
110426513|NCT05544721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110426514|NCT02738983|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110426515|NCT02738983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110426516|NCT02738983|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110426517|NCT02738983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110426518|NCT02738983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110328653|NCT00490113|Vitamins|vitamins|mesh-ancestor
110426520|NCT02739061|Sertraline|sertraline|mesh-list
110426521|NCT02739061|Antidepressive Agents|antidepressive agents|mesh-ancestor
110426522|NCT02739061|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110426523|NCT02739061|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110426524|NCT02739061|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110426525|NCT02739061|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110426526|NCT02739061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110426527|NCT02739061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110426529|NCT02739061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110426530|NCT02739061|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110426531|NCT02739061|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110426532|NCT02739061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110426533|NCT02739061|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110426534|NCT02739061|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110426535|NCT02739061|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110426536|NCT02739061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110426537|NCT02739061|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110426538|NCT02745925|Ibuprofen|ibuprofen|mesh-list
110426539|NCT02745925|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110426540|NCT02745925|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110426541|NCT02745925|Analgesics|analgesics|mesh-ancestor
110426542|NCT02745925|Sensory System Agents|sensory system agents|mesh-ancestor
110426543|NCT02745925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110426544|NCT02745925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110426545|NCT02745925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110426546|NCT02745925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110426547|NCT02745925|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110426548|NCT02745925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110426549|NCT02745925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110426550|NCT04374253|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110426551|NCT04374253|Immunologic Factors|immunologic factors|mesh-ancestor
110426552|NCT04374253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110426554|NCT02738905|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110426555|NCT02738905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110426556|NCT02738905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110426557|NCT02745691|Gefitinib|gefitinib|mesh-list
110426558|NCT02745691|Crizotinib|crizotinib|mesh-list
110426559|NCT02745691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110426560|NCT02745691|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110426561|NCT02745691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110426562|NCT02745691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110426563|NCT02745769|Ramucirumab|ramucirumab|mesh-list
110426564|NCT02745769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110426565|NCT02734069|Carboplatin|carboplatin|mesh-list
110426566|NCT02734069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110426567|NCT02737813|Bupivacaine|bupivacaine|mesh-list
110426568|NCT02737813|Anesthetics, Local|anesthetics, local|mesh-ancestor
110426569|NCT02737813|Anesthetics|anesthetics|mesh-ancestor
110426570|NCT02737813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110426571|NCT02737813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110426572|NCT02737813|Sensory System Agents|sensory system agents|mesh-ancestor
110426573|NCT02737813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110426574|NCT00636415|Morphine|morphine|mesh-list
110426575|NCT00636415|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110426576|NCT00636415|Narcotics|narcotics|mesh-ancestor
110426577|NCT00636415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110426578|NCT00636415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110426579|NCT00636415|Analgesics|analgesics|mesh-ancestor
110426580|NCT00636415|Sensory System Agents|sensory system agents|mesh-ancestor
110426581|NCT00636415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110426582|NCT02733835|Remifentanil|remifentanil|mesh-list
110426583|NCT02733835|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110426584|NCT02733835|Narcotics|narcotics|mesh-ancestor
110426585|NCT02733835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110426586|NCT02733835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110426587|NCT02733835|Analgesics|analgesics|mesh-ancestor
110426588|NCT02733835|Sensory System Agents|sensory system agents|mesh-ancestor
110426589|NCT02733835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110426590|NCT02737423|Vitamin D|vitamin d|mesh-list
110426591|NCT02737423|Cholecalciferol|cholecalciferol|mesh-list
110426592|NCT02737423|Vitamins|vitamins|mesh-ancestor
110426593|NCT02737423|Micronutrients|micronutrients|mesh-ancestor
110426594|NCT02737423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110426595|NCT02737423|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110426596|NCT02737423|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110426597|NCT02733679|Metformin|metformin|mesh-list
110426598|NCT02733679|Pioglitazone|pioglitazone|mesh-list
110426599|NCT02733679|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110202442|NCT00083109|Antinematodal Agents|antinematodal agents|mesh-ancestor
110426600|NCT02733679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110426601|NCT03289741|Octreotide|octreotide|mesh-list
110426602|NCT03289741|Lanreotide|lanreotide|mesh-list
110426603|NCT03289741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110426604|NCT03289741|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110426605|NCT03289741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110426606|NCT05629429|Olaparib|olaparib|mesh-list
110426607|NCT05629429|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110426608|NCT05629429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110426609|NCT05629429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110426610|NCT05629429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110426611|NCT02744131|Metformin|metformin|mesh-list
110426612|NCT02744131|Cyproterone Acetate|cyproterone acetate|mesh-list
110426613|NCT02744131|Contraceptive Agents|contraceptive agents|mesh-list
110426614|NCT02744131|Contraceptives, Oral|contraceptives, oral|mesh-list
110426615|NCT02744131|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
110426616|NCT02744131|Estradiol|estradiol|mesh-list
110426617|NCT02744131|Cyproterone|cyproterone|mesh-list
110426618|NCT02744131|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110426619|NCT02744131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110426620|NCT02744131|Estrogens|estrogens|mesh-ancestor
110426621|NCT02744131|Hormones|hormones|mesh-ancestor
110426622|NCT02744131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110426623|NCT02744131|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110426624|NCT02744131|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110426625|NCT02744131|Androgen Antagonists|androgen antagonists|mesh-ancestor
110426626|NCT02744131|Hormone Antagonists|hormone antagonists|mesh-ancestor
110426627|NCT02744131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110426628|NCT02744131|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110426629|NCT03326791|Aspirin|aspirin|mesh-list
110426630|NCT03326791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110426631|NCT03326791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110426632|NCT03326791|Analgesics|analgesics|mesh-ancestor
110426633|NCT03326791|Sensory System Agents|sensory system agents|mesh-ancestor
110426634|NCT03326791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110426635|NCT03326791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110426636|NCT03326791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110426637|NCT03326791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110426638|NCT03326791|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110426639|NCT03326791|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110426640|NCT03326791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110426641|NCT03326791|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110426642|NCT03326791|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110426643|NCT03326791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110426644|NCT03326791|Antipyretics|antipyretics|mesh-ancestor
110426645|NCT02743975|Bevacizumab|bevacizumab|mesh-list
110426646|NCT02743975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110426647|NCT02743975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110426648|NCT02743975|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110426649|NCT02743975|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110426650|NCT02743975|Growth Substances|growth substances|mesh-ancestor
110426651|NCT02743975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110426652|NCT02743975|Growth Inhibitors|growth inhibitors|mesh-ancestor
110426653|NCT02743663|Albuterol|albuterol|mesh-list
110426654|NCT02743663|Bronchodilator Agents|bronchodilator agents|mesh-list
110426656|NCT02743663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110426657|NCT02743663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110426658|NCT02743663|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110202465|NCT00153283|Anticonvulsants|anticonvulsants|mesh-ancestor
110426659|NCT02743663|Respiratory System Agents|respiratory system agents|mesh-ancestor
110426660|NCT02743663|Tocolytic Agents|tocolytic agents|mesh-ancestor
110426661|NCT02743663|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110426662|NCT02743663|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110426663|NCT02743663|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110426664|NCT02743663|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110426665|NCT02743663|Adrenergic Agents|adrenergic agents|mesh-ancestor
110426666|NCT02743663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110426667|NCT02743663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110426668|NCT02733445|Dasatinib|dasatinib|mesh-list
110426669|NCT02733445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110426670|NCT02733445|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110426671|NCT02733445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110426672|NCT02733445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110426673|NCT02731105|Clindamycin|clindamycin|mesh-list
110426674|NCT02731105|Clindamycin palmitate|clindamycin palmitate|mesh-list
110426675|NCT02731105|Clindamycin phosphate|clindamycin phosphate|mesh-list
110426676|NCT02731105|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
110426677|NCT02731105|Tretinoin|tretinoin|mesh-list
110426678|NCT02731105|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110426679|NCT02731105|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110426680|NCT02731105|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110426681|NCT02731105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110426682|NCT02731105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110426683|NCT02731105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110426684|NCT02731105|Keratolytic Agents|keratolytic agents|mesh-ancestor
110426685|NCT02731105|Dermatologic Agents|dermatologic agents|mesh-ancestor
110426686|NCT02731105|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110426687|NCT02731105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110426688|NCT02731105|Analgesics|analgesics|mesh-ancestor
110426689|NCT02731105|Sensory System Agents|sensory system agents|mesh-ancestor
110426690|NCT02731105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110426691|NCT02731105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110426692|NCT02731105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110426693|NCT02731105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110426694|NCT02743429|Dinutuximab|dinutuximab|mesh-list
110426695|NCT02743429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110426696|NCT02730949|Folic Acid|folic acid|mesh-list
110426697|NCT02730949|Inositol|inositol|mesh-list
110426698|NCT02730949|Hematinics|hematinics|mesh-ancestor
110426699|NCT02730949|Vitamin B Complex|vitamin b complex|mesh-ancestor
110426700|NCT02730949|Vitamins|vitamins|mesh-ancestor
110426701|NCT02730949|Micronutrients|micronutrients|mesh-ancestor
110426702|NCT02730949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110426703|NCT04205929|Curcumin|curcumin|mesh-list
110426704|NCT04205929|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110426705|NCT04205929|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110426706|NCT04205929|Analgesics|analgesics|mesh-ancestor
110426707|NCT04205929|Sensory System Agents|sensory system agents|mesh-ancestor
110426708|NCT04205929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110426709|NCT04205929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110426710|NCT04205929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110426711|NCT04205929|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110426712|NCT04205929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110426713|NCT04205929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110426714|NCT04205929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110426715|NCT00636493|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
110426716|NCT00636493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110426717|NCT00636493|Glucocorticoids|glucocorticoids|mesh-ancestor
110426718|NCT00636493|Hormones|hormones|mesh-ancestor
110426719|NCT00636493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110426720|NCT00636493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110426722|NCT02730481|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110426723|NCT02730481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110426724|NCT02730481|Tubulin Modulators|tubulin modulators|mesh-ancestor
110426725|NCT02730481|Antimitotic Agents|antimitotic agents|mesh-ancestor
110426726|NCT02730481|Mitosis Modulators|mitosis modulators|mesh-ancestor
110426727|NCT02730481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110426728|NCT02730091|Letrozole|letrozole|mesh-list
110426729|NCT02730091|Vinorelbine|vinorelbine|mesh-list
110426730|NCT02730091|Anastrozole|anastrozole|mesh-list
110426731|NCT02730091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110426732|NCT02730091|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110426733|NCT02730091|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110426734|NCT02730091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110426735|NCT02730091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110426736|NCT02730091|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110426737|NCT02730091|Hormone Antagonists|hormone antagonists|mesh-ancestor
110426738|NCT02730091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110426739|NCT02730091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110426740|NCT02730091|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110426741|NCT02730091|Tubulin Modulators|tubulin modulators|mesh-ancestor
110426742|NCT02730091|Antimitotic Agents|antimitotic agents|mesh-ancestor
110426743|NCT02730091|Mitosis Modulators|mitosis modulators|mesh-ancestor
110426744|NCT02730091|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110426745|NCT02742805|Vitamin D|vitamin d|mesh-list
110426746|NCT02742805|Ergocalciferols|ergocalciferols|mesh-list
110426747|NCT02742805|Cholecalciferol|cholecalciferol|mesh-list
110426748|NCT02742805|Vitamins|vitamins|mesh-list
110426749|NCT02742805|Omalizumab|omalizumab|mesh-list
110426750|NCT02742805|Micronutrients|micronutrients|mesh-ancestor
110426751|NCT02742805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110426752|NCT02742805|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110426753|NCT02742805|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110426754|NCT02742805|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110426755|NCT02742805|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110426756|NCT02742805|Respiratory System Agents|respiratory system agents|mesh-ancestor
110426757|NCT02690389|Flumazenil|flumazenil|mesh-list
110426758|NCT02690389|Antidotes|antidotes|mesh-ancestor
110426759|NCT02690389|Protective Agents|protective agents|mesh-ancestor
110426760|NCT02690389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110426761|NCT02690389|GABA Modulators|gaba modulators|mesh-ancestor
110426763|NCT02690389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110426764|NCT02690389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110426765|NCT02732197|Thiopental|thiopental|mesh-list
110426766|NCT02732197|Anticonvulsants|anticonvulsants|mesh-ancestor
110426767|NCT02732197|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110426768|NCT02732197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110426769|NCT02732197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110426770|NCT02732197|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110426771|NCT02732197|Anesthetics, General|anesthetics, general|mesh-ancestor
110426772|NCT02732197|Anesthetics|anesthetics|mesh-ancestor
110426773|NCT02732197|GABA Modulators|gaba modulators|mesh-ancestor
110426774|NCT02732197|GABA Agents|gaba agents|mesh-ancestor
110426775|NCT02732197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110426776|NCT02732197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110426777|NCT02729935|Parecoxib|parecoxib|mesh-list
110426778|NCT02729935|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110426779|NCT02729935|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110426780|NCT02729935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110426781|NCT02729935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110426782|NCT02729935|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110202497|NCT00083148|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110426783|NCT02729935|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110426785|NCT02729935|Sensory System Agents|sensory system agents|mesh-ancestor
110426786|NCT02729935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110426787|NCT02729935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110426788|NCT02729935|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110426789|NCT02729935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110426790|NCT02729467|Itraconazole|itraconazole|mesh-list
110426791|NCT02729467|Rifampin|rifampin|mesh-list
110426792|NCT02729467|Antifungal Agents|antifungal agents|mesh-ancestor
110426793|NCT02729467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110426794|NCT02729467|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110426795|NCT02729467|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110426796|NCT02729467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110426797|NCT02729467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110426798|NCT02729467|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110426799|NCT02729467|Hormone Antagonists|hormone antagonists|mesh-ancestor
110426800|NCT02729467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110426801|NCT02729467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110426802|NCT02729467|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110426803|NCT02729467|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110426804|NCT02729467|Antitubercular Agents|antitubercular agents|mesh-ancestor
110426805|NCT02729467|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110426806|NCT02729467|Leprostatic Agents|leprostatic agents|mesh-ancestor
110426807|NCT02729467|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110426808|NCT02729467|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110426809|NCT02729467|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110426810|NCT02729467|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110426811|NCT02729467|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110426812|NCT02729467|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110426813|NCT02729467|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110426814|NCT02727205|Rotigotine|rotigotine|mesh-list
110426815|NCT02727205|Dopamine Agonists|dopamine agonists|mesh-ancestor
110426816|NCT02727205|Dopamine Agents|dopamine agents|mesh-ancestor
110426817|NCT02727205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110426818|NCT02727205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110426819|NCT02727205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110426820|NCT02721433|Denosumab|denosumab|mesh-list
110426821|NCT02721433|Zoledronic Acid|zoledronic acid|mesh-list
110426822|NCT02721433|Pamidronate|pamidronate|mesh-list
110426823|NCT02721433|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110202514|NCT00153634|Azithromycin|azithromycin|mesh-list
110426824|NCT02721433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110426825|NCT02721043|Lenalidomide|lenalidomide|mesh-list
110426826|NCT02721043|Vaccines|vaccines|mesh-list
110426827|NCT02721043|Poly ICLC|poly iclc|mesh-list
110426828|NCT02721043|Immunologic Factors|immunologic factors|mesh-ancestor
110426829|NCT02721043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110426830|NCT02721043|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110426831|NCT02721043|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110426832|NCT02721043|Growth Substances|growth substances|mesh-ancestor
110426833|NCT02721043|Growth Inhibitors|growth inhibitors|mesh-ancestor
110426834|NCT02721043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110426835|NCT02721043|Interferon Inducers|interferon inducers|mesh-ancestor
110426836|NCT02728843|Deferiprone|deferiprone|mesh-list
110426837|NCT02728843|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110426838|NCT02728843|Chelating Agents|chelating agents|mesh-ancestor
110426839|NCT02728843|Sequestering Agents|sequestering agents|mesh-ancestor
110426840|NCT02728843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110426841|NCT02726503|Lenvatinib|lenvatinib|mesh-list
110426842|NCT02726503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110426843|NCT02726503|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110426844|NCT02726503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110426845|NCT02726503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110426846|NCT02720965|Anesthetics|anesthetics|mesh-list
110426847|NCT02720965|Anesthetics, Local|anesthetics, local|mesh-list
110426848|NCT02720965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110426849|NCT02720965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110426850|NCT02720965|Sensory System Agents|sensory system agents|mesh-ancestor
110426851|NCT02720965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110426852|NCT02726737|Lidocaine|lidocaine|mesh-list
110426853|NCT02726737|Anesthetics, Local|anesthetics, local|mesh-ancestor
110426854|NCT02726737|Anesthetics|anesthetics|mesh-ancestor
110426855|NCT02726737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110426856|NCT02726737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110426857|NCT02726737|Sensory System Agents|sensory system agents|mesh-ancestor
110426858|NCT02726737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110426859|NCT02726737|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110426860|NCT02726737|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110426861|NCT02726737|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110426862|NCT02726737|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110328681|NCT00466076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110426863|NCT02726737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110426864|NCT02720575|Vitamin D|vitamin d|mesh-list
110426865|NCT02720575|Vitamins|vitamins|mesh-ancestor
110426866|NCT02720575|Micronutrients|micronutrients|mesh-ancestor
110426867|NCT02720575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110426868|NCT02720575|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110426870|NCT02720341|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110426871|NCT02720341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110426872|NCT02720341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110426873|NCT02720341|Cholinergic Agents|cholinergic agents|mesh-ancestor
110426874|NCT02720341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110426875|NCT02720341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110426876|NCT02728453|Empagliflozin|empagliflozin|mesh-list
110426877|NCT02728453|Glimepiride|glimepiride|mesh-list
110426878|NCT02728453|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110426879|NCT02728453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110426880|NCT02728453|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110426881|NCT02728453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110426882|NCT02728453|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110426883|NCT02728453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110426884|NCT02728453|Immunologic Factors|immunologic factors|mesh-ancestor
110426885|NCT02728687|Mannitol|mannitol|mesh-list
110426886|NCT02728687|Menthol|menthol|mesh-list
110426887|NCT02728687|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110426888|NCT02728687|Diuretics|diuretics|mesh-ancestor
110426889|NCT02728687|Natriuretic Agents|natriuretic agents|mesh-ancestor
110426890|NCT02728687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110426891|NCT02728687|Antipruritics|antipruritics|mesh-ancestor
110426892|NCT02728687|Dermatologic Agents|dermatologic agents|mesh-ancestor
110426893|NCT02726269|Ofloxacin|ofloxacin|mesh-list
110426894|NCT02726269|Levofloxacin|levofloxacin|mesh-list
110426895|NCT02726269|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110426896|NCT02726269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110426897|NCT02726269|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110426898|NCT02726269|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110426899|NCT02726269|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110426900|NCT02726269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110426901|NCT02726269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110073858|NCT01583426|Paclitaxel|paclitaxel|mesh-list
110426902|NCT02726269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110426903|NCT02726269|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110426904|NCT02726269|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110426905|NCT02694289|Metformin|metformin|mesh-list
110426906|NCT02694289|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110426907|NCT02694289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110426908|NCT02719795|Ropivacaine|ropivacaine|mesh-list
110426909|NCT02719795|Anesthetics, Local|anesthetics, local|mesh-ancestor
110426910|NCT02719795|Anesthetics|anesthetics|mesh-ancestor
110426911|NCT02719795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110426912|NCT02719795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110426913|NCT02719795|Sensory System Agents|sensory system agents|mesh-ancestor
110426914|NCT02719795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110426915|NCT02726347|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110426916|NCT02726347|Immunologic Factors|immunologic factors|mesh-ancestor
110426917|NCT02726347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110426918|NCT02726035|Naltrexone|naltrexone|mesh-list
110426919|NCT02726035|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110426920|NCT02726035|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110426921|NCT02726035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110564444|NCT05857384|Dronabinol|dronabinol|mesh-list
110426922|NCT02726035|Sensory System Agents|sensory system agents|mesh-ancestor
110426923|NCT02726035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110426924|NCT02719405|Caseins|caseins|mesh-list
110426925|NCT02719405|Chelating Agents|chelating agents|mesh-ancestor
110426926|NCT02719405|Sequestering Agents|sequestering agents|mesh-ancestor
110426927|NCT02719405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110426928|NCT02725255|Albendazole|albendazole|mesh-list
110426929|NCT02725255|Anthelmintics|anthelmintics|mesh-ancestor
110426930|NCT02725255|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110426931|NCT02725255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110426932|NCT02725255|Anticestodal Agents|anticestodal agents|mesh-ancestor
110426933|NCT02725255|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110426934|NCT02725255|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110426935|NCT02725255|Tubulin Modulators|tubulin modulators|mesh-ancestor
110426936|NCT02725255|Antimitotic Agents|antimitotic agents|mesh-ancestor
110426937|NCT02725255|Mitosis Modulators|mitosis modulators|mesh-ancestor
110426938|NCT02725255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110426939|NCT02725255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110426940|NCT02719015|Pembrolizumab|pembrolizumab|mesh-list
110426941|NCT02719015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110426942|NCT02719015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110426943|NCT02719015|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110426944|NCT02719015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110426945|NCT02725489|Durvalumab|durvalumab|mesh-list
110426946|NCT02725489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110426947|NCT02725489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110426948|NCT02718547|Timolol|timolol|mesh-list
110426949|NCT02718547|Brimonidine Tartrate|brimonidine tartrate|mesh-list
110426950|NCT02718547|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110426951|NCT02718547|Brimonidine Tartrate, Timolol Maleate Drug Combination|brimonidine tartrate, timolol maleate drug combination|mesh-list
110426952|NCT02718547|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110426953|NCT02718547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110426954|NCT02718547|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110426955|NCT02718547|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110426957|NCT02718547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110426958|NCT02718547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110426959|NCT02718547|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110426960|NCT02718547|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110426961|NCT02718547|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110426962|NCT02718547|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110426963|NCT02718547|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110426964|NCT02725099|Ticagrelor|ticagrelor|mesh-list
110426965|NCT02725099|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110426966|NCT02725099|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110426967|NCT02725099|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110426968|NCT02725099|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110426969|NCT02725099|Purinergic Agents|purinergic agents|mesh-ancestor
110426970|NCT02725099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110426971|NCT02725099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110426972|NCT02725099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110426973|NCT01225211|Ivacaftor|ivacaftor|mesh-list
110426974|NCT01225211|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
110426975|NCT01225211|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110426976|NCT01225211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110426977|NCT02685709|Octreotide|octreotide|mesh-list
110426978|NCT02685709|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110426979|NCT02685709|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110426980|NCT02685709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110426981|NCT02265367|Milnacipran|milnacipran|mesh-list
110426982|NCT02265367|Levomilnacipran|levomilnacipran|mesh-list
110426983|NCT02265367|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110426984|NCT02265367|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110426985|NCT02265367|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110426986|NCT02265367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110426987|NCT02265367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110426988|NCT02265367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110426989|NCT02265367|Antidepressive Agents|antidepressive agents|mesh-ancestor
110426990|NCT02265367|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110426991|NCT02265367|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110426992|NCT02265367|Analgesics|analgesics|mesh-ancestor
110426993|NCT02265367|Sensory System Agents|sensory system agents|mesh-ancestor
110426994|NCT02265367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110426995|NCT02718469|Vaccines|vaccines|mesh-list
110426996|NCT02718469|Immunologic Factors|immunologic factors|mesh-ancestor
110426997|NCT02718469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110426998|NCT02716285|Peppermint oil|peppermint oil|mesh-list
110426999|NCT02716285|Antiemetics|antiemetics|mesh-ancestor
110427000|NCT02716285|Autonomic Agents|autonomic agents|mesh-ancestor
110427001|NCT02716285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110427002|NCT02716285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110427003|NCT02716285|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110427004|NCT02716285|Parasympatholytics|parasympatholytics|mesh-ancestor
110427005|NCT01224821|Tositumomab I-131|tositumomab i-131|mesh-list
110427007|NCT01224821|Immunologic Factors|immunologic factors|mesh-ancestor
110427008|NCT01224821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110427009|NCT01224821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110427010|NCT02684851|Fibrinolytic Agents|fibrinolytic agents|mesh-list
110427011|NCT02684851|Tranexamic Acid|tranexamic acid|mesh-list
110427012|NCT02684851|Antifibrinolytic Agents|antifibrinolytic agents|mesh-list
110427013|NCT02684851|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110427014|NCT02684851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110427015|NCT02684851|Hemostatics|hemostatics|mesh-ancestor
110427016|NCT02684851|Coagulants|coagulants|mesh-ancestor
110427017|NCT01224431|Lidocaine|lidocaine|mesh-list
110427018|NCT01224431|Anesthetics, Local|anesthetics, local|mesh-ancestor
110427019|NCT01224431|Anesthetics|anesthetics|mesh-ancestor
110427020|NCT01224431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110427021|NCT01224431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110427022|NCT01224431|Sensory System Agents|sensory system agents|mesh-ancestor
110427023|NCT01224431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110427024|NCT01224431|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110427025|NCT01224431|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110427026|NCT01224431|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110427027|NCT01224431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110427028|NCT01224431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110427030|NCT02716129|Nalbuphine|nalbuphine|mesh-list
110427031|NCT02716129|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110427032|NCT02716129|Narcotics|narcotics|mesh-ancestor
110427033|NCT02716129|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110427034|NCT02716129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110427035|NCT02716129|Analgesics|analgesics|mesh-ancestor
110427036|NCT02716129|Sensory System Agents|sensory system agents|mesh-ancestor
110427037|NCT02716129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110427038|NCT02718079|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110427039|NCT02718079|Acetylcysteine|acetylcysteine|mesh-list
110427040|NCT02718079|Mannitol|mannitol|mesh-list
110427041|NCT02718079|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110427042|NCT02718079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110427043|NCT02718079|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110427044|NCT02718079|Diuretics|diuretics|mesh-ancestor
110427045|NCT02718079|Natriuretic Agents|natriuretic agents|mesh-ancestor
110427046|NCT02718079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110427047|NCT02718079|Antiviral Agents|antiviral agents|mesh-ancestor
110427049|NCT02718079|Respiratory System Agents|respiratory system agents|mesh-ancestor
110427050|NCT02718079|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110427051|NCT02718079|Antioxidants|antioxidants|mesh-ancestor
110427052|NCT02718079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110427053|NCT02718079|Protective Agents|protective agents|mesh-ancestor
110427054|NCT02718079|Antidotes|antidotes|mesh-ancestor
110427055|NCT02717923|Capecitabine|capecitabine|mesh-list
110427056|NCT02717923|Cetuximab|cetuximab|mesh-list
110427057|NCT02717923|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110427058|NCT02717923|Antimetabolites|antimetabolites|mesh-ancestor
110427059|NCT02717923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110427060|NCT02717923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110427061|NCT02717923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110427062|NCT02724163|Cytarabine|cytarabine|mesh-list
110427063|NCT02724163|Cyclophosphamide|cyclophosphamide|mesh-list
110427064|NCT02724163|Busulfan|busulfan|mesh-list
110427065|NCT02724163|Fludarabine|fludarabine|mesh-list
110427066|NCT02724163|Daunorubicin|daunorubicin|mesh-list
110427067|NCT02724163|Mitoxantrone|mitoxantrone|mesh-list
110427068|NCT02724163|Gemtuzumab|gemtuzumab|mesh-list
110427069|NCT02724163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110427070|NCT02724163|Immunologic Factors|immunologic factors|mesh-ancestor
110427071|NCT02724163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110427072|NCT02724163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110427073|NCT02724163|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110427074|NCT02724163|Alkylating Agents|alkylating agents|mesh-ancestor
110427075|NCT02724163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110427076|NCT02724163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110427077|NCT02724163|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110427078|NCT02724163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110427079|NCT02724163|Antimetabolites|antimetabolites|mesh-ancestor
110427080|NCT02724163|Antiviral Agents|antiviral agents|mesh-ancestor
110427081|NCT02724163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110427082|NCT02724163|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110427083|NCT02724163|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110427084|NCT02724163|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110427085|NCT02724163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110427086|NCT02724163|Analgesics|analgesics|mesh-ancestor
110427087|NCT02724163|Sensory System Agents|sensory system agents|mesh-ancestor
110427088|NCT02724163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110427089|NCT02724163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110427090|NCT02724163|Immunotoxins|immunotoxins|mesh-ancestor
110427091|NCT02724163|Immunoconjugates|immunoconjugates|mesh-ancestor
110427092|NCT02723461|Oxytocin|oxytocin|mesh-list
110427093|NCT02723461|Oxytocics|oxytocics|mesh-ancestor
110427094|NCT02723461|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110427095|NCT02723461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110427096|NCT02715193|Volagidemab|volagidemab|mesh-list
110427097|NCT02715193|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110427098|NCT02715193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110427099|NCT01223027|Sorafenib|sorafenib|mesh-list
110427100|NCT01223027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110427101|NCT01223027|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110427102|NCT01223027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110427103|NCT01223027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110427104|NCT02714959|Aldesleukin|aldesleukin|mesh-list
110427105|NCT02714959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110427106|NCT02714959|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110427107|NCT02714959|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110427108|NCT02714959|Antiviral Agents|antiviral agents|mesh-ancestor
110427109|NCT02714959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110427110|NCT02714725|Dexmedetomidine|dexmedetomidine|mesh-list
110427111|NCT02714725|Propofol|propofol|mesh-list
110427112|NCT02714725|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110427113|NCT02714725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110427114|NCT02714725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110427115|NCT02714725|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110427117|NCT02714725|Sensory System Agents|sensory system agents|mesh-ancestor
110427118|NCT02714725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110427119|NCT02714725|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110427120|NCT02714725|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110427121|NCT02714725|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110427122|NCT02714725|Adrenergic Agents|adrenergic agents|mesh-ancestor
110427123|NCT02714725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110427124|NCT02714725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110427125|NCT02714725|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110427126|NCT02714725|Anesthetics, General|anesthetics, general|mesh-ancestor
110427127|NCT02714725|Anesthetics|anesthetics|mesh-ancestor
110427128|NCT01015287|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
110427129|NCT01015287|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110427130|NCT02714179|Acetaminophen|acetaminophen|mesh-list
110427131|NCT02714179|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110427132|NCT02714179|Analgesics|analgesics|mesh-ancestor
110427133|NCT02714179|Sensory System Agents|sensory system agents|mesh-ancestor
110427134|NCT02714179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110427135|NCT02714179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110427136|NCT02714179|Antipyretics|antipyretics|mesh-ancestor
110427137|NCT01015131|Alovudine|alovudine|mesh-list
110427138|NCT01015131|Antiviral Agents|antiviral agents|mesh-ancestor
110427139|NCT01015131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110427140|NCT02723383|Baclofen|baclofen|mesh-list
110427141|NCT02723383|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110427142|NCT02723383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110427143|NCT02723383|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110427144|NCT02723383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110427145|NCT02723383|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
110427146|NCT02723383|GABA Agonists|gaba agonists|mesh-ancestor
110427147|NCT02723383|GABA Agents|gaba agents|mesh-ancestor
110427148|NCT02723383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110427149|NCT02723383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110427150|NCT05269537|Ephedrine|ephedrine|mesh-list
110427151|NCT05269537|Fentanyl|fentanyl|mesh-list
110427152|NCT05269537|Bupivacaine|bupivacaine|mesh-list
110427153|NCT05269537|Oxytocin|oxytocin|mesh-list
110427154|NCT05269537|Anesthetics, Local|anesthetics, local|mesh-ancestor
110427155|NCT05269537|Anesthetics|anesthetics|mesh-ancestor
110202630|NCT00154219|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110427156|NCT05269537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110427157|NCT05269537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110427158|NCT05269537|Sensory System Agents|sensory system agents|mesh-ancestor
110427159|NCT05269537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110427160|NCT05269537|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110427161|NCT05269537|Narcotics|narcotics|mesh-ancestor
110427162|NCT05269537|Analgesics|analgesics|mesh-ancestor
110427163|NCT05269537|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110427164|NCT05269537|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110427165|NCT05269537|Anesthetics, General|anesthetics, general|mesh-ancestor
110427166|NCT05269537|Oxytocics|oxytocics|mesh-ancestor
110427167|NCT05269537|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110427168|NCT05269537|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110427169|NCT05269537|Sympathomimetics|sympathomimetics|mesh-ancestor
110427170|NCT05269537|Autonomic Agents|autonomic agents|mesh-ancestor
110427171|NCT05269537|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110427172|NCT05269537|Adrenergic Agents|adrenergic agents|mesh-ancestor
110427173|NCT05269537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110427174|NCT05269537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110427175|NCT01222715|Sirolimus|sirolimus|mesh-list
110427176|NCT01222715|Cyclophosphamide|cyclophosphamide|mesh-list
110427177|NCT01222715|Bevacizumab|bevacizumab|mesh-list
110427178|NCT01222715|Temsirolimus|temsirolimus|mesh-list
110427179|NCT01222715|Vinorelbine|vinorelbine|mesh-list
110427180|NCT01222715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110427181|NCT01222715|MTOR Inhibitors|mtor inhibitors|mesh-list
110427182|NCT01222715|Antibodies|antibodies|mesh-list
110427183|NCT01222715|Immunoglobulins|immunoglobulins|mesh-list
110427184|NCT01222715|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110427185|NCT01222715|Immunoglobulin G|immunoglobulin g|mesh-list
110427186|NCT01222715|Endothelial Growth Factors|endothelial growth factors|mesh-list
110427187|NCT01222715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110427188|NCT01222715|Immunologic Factors|immunologic factors|mesh-ancestor
110427189|NCT01222715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110427190|NCT01222715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110427191|NCT01222715|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110427192|NCT01222715|Alkylating Agents|alkylating agents|mesh-ancestor
110427193|NCT01222715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110427194|NCT01222715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110427195|NCT01222715|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110427196|NCT01222715|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110427197|NCT01222715|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110427198|NCT01222715|Growth Substances|growth substances|mesh-ancestor
110427199|NCT01222715|Growth Inhibitors|growth inhibitors|mesh-ancestor
110427200|NCT01222715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110427201|NCT01222715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110427202|NCT01222715|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110427203|NCT01222715|Antifungal Agents|antifungal agents|mesh-ancestor
110427204|NCT01222715|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110427205|NCT01222715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110427206|NCT01222715|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110427207|NCT01222715|Tubulin Modulators|tubulin modulators|mesh-ancestor
110427208|NCT01222715|Antimitotic Agents|antimitotic agents|mesh-ancestor
110427209|NCT01222715|Mitosis Modulators|mitosis modulators|mesh-ancestor
110427210|NCT02723071|Ocrelizumab|ocrelizumab|mesh-list
110427211|NCT02723071|Immunologic Factors|immunologic factors|mesh-ancestor
110427212|NCT02723071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110427213|NCT02722759|Chrysarobin|chrysarobin|mesh-list
110427214|NCT02722759|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110427215|NCT02722759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110427216|NCT02722759|Analgesics|analgesics|mesh-ancestor
110427217|NCT02722759|Sensory System Agents|sensory system agents|mesh-ancestor
110427218|NCT02722759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110427219|NCT02722759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110427220|NCT02722759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110427221|NCT02722759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110427222|NCT02722447|Rivaroxaban|rivaroxaban|mesh-list
110427223|NCT02722447|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110427224|NCT02722447|Antithrombins|antithrombins|mesh-ancestor
110427225|NCT02722447|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110427226|NCT02722447|Protease Inhibitors|protease inhibitors|mesh-ancestor
110427227|NCT02722447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110427228|NCT02722447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110427229|NCT02722447|Anticoagulants|anticoagulants|mesh-ancestor
110427230|NCT01222403|Vaccines|vaccines|mesh-list
110427231|NCT01222403|MF59 oil emulsion|mf59 oil emulsion|mesh-list
110427232|NCT01222403|Immunologic Factors|immunologic factors|mesh-ancestor
110427233|NCT01222403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110427234|NCT01222403|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110427235|NCT02722369|Hydroxychloroquine|hydroxychloroquine|mesh-list
110427236|NCT02722369|Carboplatin|carboplatin|mesh-list
110427237|NCT02722369|Gemcitabine|gemcitabine|mesh-list
110427239|NCT02722369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110427240|NCT02722369|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110427241|NCT02722369|Antimetabolites|antimetabolites|mesh-ancestor
110202684|NCT00050804|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110427242|NCT02722369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110427243|NCT02722369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110427244|NCT02722369|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110427245|NCT02722369|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110427246|NCT02722369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110427247|NCT02722369|Antimalarials|antimalarials|mesh-ancestor
110427248|NCT02722369|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110427249|NCT02722369|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110427250|NCT02722369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110427251|NCT02722369|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110427252|NCT01222247|Betamethasone|betamethasone|mesh-list
110427253|NCT01222247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110427254|NCT01222247|Glucocorticoids|glucocorticoids|mesh-ancestor
110427256|NCT01222247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110427257|NCT01222247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110427258|NCT01222247|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110427259|NCT01222247|Respiratory System Agents|respiratory system agents|mesh-ancestor
110427260|NCT01014975|Fibrinolysin|fibrinolysin|mesh-list
110427261|NCT01014975|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110427262|NCT01014975|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110427263|NCT01014975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110427264|NCT03982537|Acetylcysteine|acetylcysteine|mesh-list
110427265|NCT03982537|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110427266|NCT03982537|Antiviral Agents|antiviral agents|mesh-ancestor
110427267|NCT03982537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110427268|NCT03982537|Expectorants|expectorants|mesh-ancestor
110427269|NCT03982537|Respiratory System Agents|respiratory system agents|mesh-ancestor
110427270|NCT03982537|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110427271|NCT03982537|Antioxidants|antioxidants|mesh-ancestor
110427272|NCT03982537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110427273|NCT03982537|Protective Agents|protective agents|mesh-ancestor
110427274|NCT03982537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110427275|NCT03982537|Antidotes|antidotes|mesh-ancestor
110427276|NCT05260593|Vitamins|vitamins|mesh-list
110427277|NCT05260593|Hydroxocobalamin|hydroxocobalamin|mesh-list
110427278|NCT05260593|Vitamin B 12|vitamin b 12|mesh-list
110427279|NCT05260593|Vitamin B Complex|vitamin b complex|mesh-list
110427280|NCT05260593|Micronutrients|micronutrients|mesh-ancestor
110427281|NCT05260593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110427282|NCT05260593|Hematinics|hematinics|mesh-ancestor
110427283|NCT02713477|Insulin|insulin|mesh-list
110427284|NCT02713477|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110427285|NCT02713477|Insulin Glargine|insulin glargine|mesh-list
110427286|NCT02713477|Lixisenatide|lixisenatide|mesh-list
110427287|NCT02713477|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110427288|NCT02713477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110427289|NCT01014585|Milnacipran|milnacipran|mesh-list
110427290|NCT01014585|Levomilnacipran|levomilnacipran|mesh-list
110427291|NCT01014585|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110427292|NCT01014585|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110427293|NCT01014585|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110427294|NCT01014585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110427295|NCT01014585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110427296|NCT01014585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110427297|NCT01014585|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110427298|NCT01014585|Analgesics|analgesics|mesh-ancestor
110427299|NCT01014585|Sensory System Agents|sensory system agents|mesh-ancestor
110427300|NCT01014585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110427301|NCT01014585|Antidepressive Agents|antidepressive agents|mesh-ancestor
110427302|NCT01014585|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110427303|NCT00611143|Atorvastatin|atorvastatin|mesh-list
110427304|NCT00611143|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110427305|NCT00611143|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110427306|NCT00611143|Antimetabolites|antimetabolites|mesh-ancestor
110427307|NCT00611143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110427308|NCT00611143|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110427309|NCT00611143|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110427310|NCT00611143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110427312|NCT02712619|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110427313|NCT02712619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110427314|NCT01220609|Epothilones|epothilones|mesh-list
110427315|NCT01220609|Tubulin Modulators|tubulin modulators|mesh-ancestor
110427316|NCT01220609|Antimitotic Agents|antimitotic agents|mesh-ancestor
110427317|NCT01220609|Mitosis Modulators|mitosis modulators|mesh-ancestor
110427318|NCT01220609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110427319|NCT01220609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110427320|NCT02713087|Phenylephrine|phenylephrine|mesh-list
110427321|NCT02713087|Oxymetazoline|oxymetazoline|mesh-list
110427322|NCT02713087|Ephedrine|ephedrine|mesh-list
110427323|NCT02713087|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110427324|NCT02713087|Mydriatics|mydriatics|mesh-ancestor
110427325|NCT02713087|Autonomic Agents|autonomic agents|mesh-ancestor
110202752|NCT00083343|Caspofungin|caspofungin|mesh-list
110427326|NCT02713087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110427327|NCT02713087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110427328|NCT02713087|Sympathomimetics|sympathomimetics|mesh-ancestor
110427329|NCT02713087|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110427330|NCT02713087|Nasal Decongestants|nasal decongestants|mesh-ancestor
110427331|NCT02713087|Respiratory System Agents|respiratory system agents|mesh-ancestor
110427332|NCT02713087|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110427333|NCT02713087|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110427334|NCT02713087|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110427335|NCT02713087|Adrenergic Agents|adrenergic agents|mesh-ancestor
110427336|NCT02713087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110427337|NCT02713087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110427338|NCT02713087|Protective Agents|protective agents|mesh-ancestor
110427339|NCT02713087|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110427340|NCT02722603|Gabapentin|gabapentin|mesh-list
110427341|NCT02722603|Tramadol|tramadol|mesh-list
110427342|NCT02722603|Analgesics|analgesics|mesh-ancestor
110427343|NCT02722603|Sensory System Agents|sensory system agents|mesh-ancestor
110427344|NCT02722603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110427345|NCT02722603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110427346|NCT02722603|Anticonvulsants|anticonvulsants|mesh-ancestor
110427347|NCT02722603|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110427348|NCT02722603|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110427349|NCT02722603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110427350|NCT02722603|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110370871|NCT00561899|Piperaquine|piperaquine|mesh-list
110427351|NCT02722603|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110427352|NCT02722603|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110427353|NCT02722603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110427354|NCT02722603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110427355|NCT02722603|Antimanic Agents|antimanic agents|mesh-ancestor
110427356|NCT02722603|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110427357|NCT02722603|Narcotics|narcotics|mesh-ancestor
110427358|NCT02712697|Prednisone|prednisone|mesh-list
110427359|NCT02712697|Hormones|hormones|mesh-list
110427360|NCT02712697|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110427361|NCT02712697|Glucocorticoids|glucocorticoids|mesh-ancestor
110427362|NCT02712697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110427363|NCT02712697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110427364|NCT02712697|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110427365|NCT02712697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110427366|NCT01220297|Mycophenolic Acid|mycophenolic acid|mesh-list
110427367|NCT01220297|Sirolimus|sirolimus|mesh-list
110427368|NCT01220297|Cyclophosphamide|cyclophosphamide|mesh-list
110427369|NCT01220297|Carmustine|carmustine|mesh-list
110427370|NCT01220297|Etoposide|etoposide|mesh-list
110427371|NCT01220297|Etoposide phosphate|etoposide phosphate|mesh-list
110427372|NCT01220297|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110427373|NCT01220297|Immunologic Factors|immunologic factors|mesh-ancestor
110427374|NCT01220297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110427375|NCT01220297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110427376|NCT01220297|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110202803|NCT00154726|Paclitaxel|paclitaxel|mesh-list
110427377|NCT01220297|Alkylating Agents|alkylating agents|mesh-ancestor
110427378|NCT01220297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110427379|NCT01220297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110427380|NCT01220297|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110427381|NCT01220297|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110427382|NCT01220297|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110427383|NCT01220297|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110427384|NCT01220297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110427385|NCT01220297|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110427386|NCT01220297|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110427387|NCT01220297|Antitubercular Agents|antitubercular agents|mesh-ancestor
110427388|NCT01220297|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110427389|NCT01220297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110427390|NCT01220297|Antifungal Agents|antifungal agents|mesh-ancestor
110427391|NCT02712775|Minocycline|minocycline|mesh-list
110427392|NCT02712775|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110427393|NCT02712775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110427394|NCT04318847|Ondansetron|ondansetron|mesh-list
110427395|NCT04318847|Antiemetics|antiemetics|mesh-ancestor
110427396|NCT04318847|Autonomic Agents|autonomic agents|mesh-ancestor
110427397|NCT04318847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110427398|NCT04318847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110427399|NCT04318847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110427400|NCT04318847|Antipruritics|antipruritics|mesh-ancestor
110427401|NCT04318847|Dermatologic Agents|dermatologic agents|mesh-ancestor
110427402|NCT04318847|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110427403|NCT04318847|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110427404|NCT04318847|Serotonin Agents|serotonin agents|mesh-ancestor
110427405|NCT04318847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110427406|NCT04318847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110427407|NCT02721511|Furosemide|furosemide|mesh-list
110427408|NCT02721511|Diuretics|diuretics|mesh-ancestor
110427409|NCT02721511|Natriuretic Agents|natriuretic agents|mesh-ancestor
110427410|NCT02721511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110427411|NCT02721511|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110427412|NCT02721511|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110427413|NCT02721511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110427414|NCT02712307|Penicillins|penicillins|mesh-list
110427415|NCT02712307|Penicillin V|penicillin v|mesh-list
110427416|NCT02712307|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110427417|NCT02712307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110427418|NCT02708251|Lidocaine|lidocaine|mesh-list
110427419|NCT02708251|Nitroglycerin|nitroglycerin|mesh-list
110427420|NCT02708251|Anesthetics, Local|anesthetics, local|mesh-ancestor
110427421|NCT02708251|Anesthetics|anesthetics|mesh-ancestor
110427422|NCT02708251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110427423|NCT02708251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110427424|NCT02708251|Sensory System Agents|sensory system agents|mesh-ancestor
110427425|NCT02708251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110427426|NCT02708251|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110427427|NCT02708251|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110427428|NCT02708251|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110427429|NCT02708251|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110427430|NCT02708251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110427431|NCT02708251|Vasodilator Agents|vasodilator agents|mesh-ancestor
110427432|NCT02708173|Vaccines|vaccines|mesh-list
110427433|NCT02708173|Immunologic Factors|immunologic factors|mesh-ancestor
110427434|NCT02708173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110427435|NCT00611611|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110427436|NCT00611611|Immunologic Factors|immunologic factors|mesh-ancestor
110427437|NCT00611611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110427438|NCT00612625|Glucagon|glucagon|mesh-list
110427439|NCT00612625|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
110427440|NCT00612625|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110427441|NCT00612625|Hormones|hormones|mesh-ancestor
110427442|NCT00612625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110427443|NCT00612625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110427444|NCT00612625|Incretins|incretins|mesh-ancestor
110427445|NCT02711917|Propofol|propofol|mesh-list
110427446|NCT02711917|Etomidate|etomidate|mesh-list
110427447|NCT02711917|Rocuronium|rocuronium|mesh-list
110427448|NCT02711917|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110427449|NCT02711917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110328699|NCT00490308|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110427450|NCT02711917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110427451|NCT02711917|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110427452|NCT02711917|Anesthetics, General|anesthetics, general|mesh-ancestor
110427453|NCT02711917|Anesthetics|anesthetics|mesh-ancestor
110427454|NCT02711917|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110427455|NCT02711917|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110427456|NCT02711917|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110427457|NCT02711917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110427458|NCT02711449|Methylprednisolone|methylprednisolone|mesh-list
110427459|NCT02711449|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110427460|NCT02711449|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110427461|NCT02711449|Prednisolone|prednisolone|mesh-list
110427462|NCT02711449|Prednisolone acetate|prednisolone acetate|mesh-list
110427463|NCT02711449|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110427464|NCT02711449|Prednisolone phosphate|prednisolone phosphate|mesh-list
110427465|NCT02711449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110427466|NCT02711449|Antiemetics|antiemetics|mesh-ancestor
110427467|NCT02711449|Autonomic Agents|autonomic agents|mesh-ancestor
110427468|NCT02711449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110427469|NCT02711449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110427470|NCT02711449|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110427471|NCT02711449|Glucocorticoids|glucocorticoids|mesh-ancestor
110427472|NCT02711449|Hormones|hormones|mesh-ancestor
110427473|NCT02711449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110427474|NCT02711449|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110427475|NCT02711449|Protective Agents|protective agents|mesh-ancestor
110427476|NCT02711449|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110427477|NCT02711449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110427478|NCT00612079|Sertindole|sertindole|mesh-list
110427479|NCT00612079|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110427480|NCT00612079|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110427481|NCT00612079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110427482|NCT00612079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110427483|NCT00612079|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110427484|NCT00940498|Gedatolisib|gedatolisib|mesh-list
110427485|NCT00940498|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110427486|NCT00940498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110427487|NCT00940498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110427488|NCT03820531|Pancrelipase|pancrelipase|mesh-list
110427489|NCT03820531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110427490|NCT02850718|Sildenafil Citrate|sildenafil citrate|mesh-list
110427491|NCT02850718|Vasodilator Agents|vasodilator agents|mesh-ancestor
110427492|NCT02850718|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110427493|NCT02850718|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110427494|NCT02850718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110427495|NCT02850718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110427496|NCT02850718|Urological Agents|urological agents|mesh-ancestor
110427497|NCT02707393|Cyclosporine|cyclosporine|mesh-list
110427498|NCT02707393|Mycophenolic Acid|mycophenolic acid|mesh-list
110427499|NCT02707393|Fludarabine|fludarabine|mesh-list
110427500|NCT02707393|Melphalan|melphalan|mesh-list
110427502|NCT02707393|Cyclosporins|cyclosporins|mesh-list
110427503|NCT02707393|Thymoglobulin|thymoglobulin|mesh-list
110427504|NCT02707393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110427505|NCT02707393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110427506|NCT02707393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110427507|NCT02707393|Immunologic Factors|immunologic factors|mesh-ancestor
110427508|NCT02707393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110427509|NCT02707393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110427510|NCT02707393|Antifungal Agents|antifungal agents|mesh-ancestor
110427511|NCT02707393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110427512|NCT02707393|Dermatologic Agents|dermatologic agents|mesh-ancestor
110427513|NCT02707393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110427514|NCT02707393|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110427515|NCT02707393|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110427516|NCT02707393|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110427517|NCT02707393|Antitubercular Agents|antitubercular agents|mesh-ancestor
110427518|NCT02707393|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110427519|NCT02707393|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110427520|NCT02707393|Alkylating Agents|alkylating agents|mesh-ancestor
110427521|NCT02707393|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110427522|NCT00940342|Rituximab|rituximab|mesh-list
110427523|NCT00940342|Molgramostim|molgramostim|mesh-list
110427524|NCT00940342|Sargramostim|sargramostim|mesh-list
110427525|NCT00940342|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110427526|NCT00940342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110427527|NCT00940342|Immunologic Factors|immunologic factors|mesh-ancestor
110427528|NCT00940342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110427529|NCT00940342|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110427530|NCT00936910|Amphotericin B|amphotericin b|mesh-list
110427531|NCT00936910|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
110427532|NCT00936910|Amebicides|amebicides|mesh-ancestor
110427533|NCT00936910|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110427534|NCT00936910|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110427535|NCT00936910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110427536|NCT00936910|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110427537|NCT00936910|Antifungal Agents|antifungal agents|mesh-ancestor
110427538|NCT02707315|Gemcitabine|gemcitabine|mesh-list
110427539|NCT02707315|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110427540|NCT02707315|Antimetabolites|antimetabolites|mesh-ancestor
110427541|NCT02707315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110427542|NCT02707315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110427543|NCT00604942|Domperidone|domperidone|mesh-list
110427544|NCT00604942|Esomeprazole|esomeprazole|mesh-list
110427546|NCT00604942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110427547|NCT00604942|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110427548|NCT00604942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110427549|NCT00604942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110427550|NCT00604942|Antiemetics|antiemetics|mesh-ancestor
110427551|NCT00604942|Autonomic Agents|autonomic agents|mesh-ancestor
110427552|NCT00604942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110427553|NCT00604942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110427554|NCT00604942|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110427555|NCT00604942|Dopamine Agents|dopamine agents|mesh-ancestor
110427556|NCT00604942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110202928|NCT00083538|Antiemetics|antiemetics|mesh-ancestor
110427557|NCT02711683|3-n-butylphthalide|3-n-butylphthalide|mesh-list
110427558|NCT02711683|Donepezil|donepezil|mesh-list
110427559|NCT02711683|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110427560|NCT02711683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110427561|NCT02711683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110427562|NCT02711683|Cholinergic Agents|cholinergic agents|mesh-ancestor
110427563|NCT02711683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110427564|NCT02711683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110427565|NCT02711683|Nootropic Agents|nootropic agents|mesh-ancestor
110427566|NCT02711683|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110427567|NCT02711683|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110427568|NCT02711683|Protective Agents|protective agents|mesh-ancestor
110427569|NCT05079061|Misoprostol|misoprostol|mesh-list
110427570|NCT05079061|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110427571|NCT05079061|Abortifacient Agents|abortifacient agents|mesh-ancestor
110427572|NCT05079061|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110427573|NCT05079061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110427574|NCT05079061|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110427575|NCT05079061|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110427576|NCT05079061|Oxytocics|oxytocics|mesh-ancestor
110427577|NCT00605020|Insulin|insulin|mesh-list
110427578|NCT00605020|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110427579|NCT00605020|Insulin Aspart|insulin aspart|mesh-list
110427580|NCT00605020|Insulin, Long-Acting|insulin, long-acting|mesh-list
110427581|NCT00605020|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
110427582|NCT00605020|Insulin Detemir|insulin detemir|mesh-list
110427583|NCT00605020|Biphasic Insulins|biphasic insulins|mesh-list
110427584|NCT00605020|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110427585|NCT00605020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110427586|NCT02707081|Lidocaine|lidocaine|mesh-list
110427587|NCT02707081|Anesthetics, Local|anesthetics, local|mesh-ancestor
110427588|NCT02707081|Anesthetics|anesthetics|mesh-ancestor
110074531|NCT01593332|Rituximab|rituximab|mesh-list
110427589|NCT02707081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110427590|NCT02707081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110427591|NCT02707081|Sensory System Agents|sensory system agents|mesh-ancestor
110427592|NCT02707081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110427593|NCT02707081|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110427594|NCT02707081|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110427595|NCT02707081|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110427596|NCT02707081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110427597|NCT02707081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110427599|NCT00605098|Lopinavir|lopinavir|mesh-list
110427600|NCT00605098|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110427601|NCT00605098|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110427602|NCT00605098|Protease Inhibitors|protease inhibitors|mesh-ancestor
110427603|NCT00605098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110427604|NCT00605098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110427605|NCT00605098|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110427606|NCT00605098|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110427607|NCT00605098|Antiviral Agents|antiviral agents|mesh-ancestor
110427608|NCT00605098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110370928|NCT04601688|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110427609|NCT00605098|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110427610|NCT00605098|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110427611|NCT02711215|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110427612|NCT02711215|Mirtazapine|mirtazapine|mesh-list
110427613|NCT02711215|Citalopram|citalopram|mesh-list
110427614|NCT02711215|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
110427615|NCT02711215|Escitalopram|escitalopram|mesh-list
110427616|NCT02711215|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110427617|NCT02711215|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110427618|NCT02711215|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110427619|NCT02711215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110427620|NCT02711215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110427621|NCT02711215|Serotonin Agents|serotonin agents|mesh-ancestor
110427622|NCT02711215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110427623|NCT02711215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110427624|NCT02711215|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110427625|NCT02711215|Antidepressive Agents|antidepressive agents|mesh-ancestor
110427626|NCT02711215|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110427627|NCT02711215|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110427628|NCT02711215|Analgesics|analgesics|mesh-ancestor
110427629|NCT02711215|Sensory System Agents|sensory system agents|mesh-ancestor
110427630|NCT02711215|Dopamine Agents|dopamine agents|mesh-ancestor
110427631|NCT02711215|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110427632|NCT02711215|Histamine Antagonists|histamine antagonists|mesh-ancestor
110427633|NCT02711215|Histamine Agents|histamine agents|mesh-ancestor
110427634|NCT02711215|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110427635|NCT02711215|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110427636|NCT02711215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110427637|NCT02711215|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
110427638|NCT02711215|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110427639|NCT02711215|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110427640|NCT02711215|Adrenergic Agents|adrenergic agents|mesh-ancestor
110427641|NCT02711215|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110427642|NCT02711215|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110427643|NCT02711215|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110427644|NCT00603772|Tretinoin|tretinoin|mesh-list
110427645|NCT00603772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110427646|NCT00603772|Keratolytic Agents|keratolytic agents|mesh-ancestor
110427647|NCT00603772|Dermatologic Agents|dermatologic agents|mesh-ancestor
110427648|NCT02706769|Acetaminophen|acetaminophen|mesh-list
110427649|NCT02706769|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110427650|NCT02706769|Analgesics|analgesics|mesh-ancestor
110427651|NCT02706769|Sensory System Agents|sensory system agents|mesh-ancestor
110427652|NCT02706769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110427653|NCT02706769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110427654|NCT02706769|Antipyretics|antipyretics|mesh-ancestor
110427655|NCT05044117|Capecitabine|capecitabine|mesh-list
110427656|NCT05044117|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110427657|NCT05044117|Antimetabolites|antimetabolites|mesh-ancestor
110427658|NCT05044117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110427659|NCT05044117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110427660|NCT03961165|Scopolamine|scopolamine|mesh-list
110427661|NCT03961165|Bromides|bromides|mesh-list
110427662|NCT03961165|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
110427664|NCT03961165|Parasympatholytics|parasympatholytics|mesh-ancestor
110427665|NCT03961165|Autonomic Agents|autonomic agents|mesh-ancestor
110427666|NCT03961165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110427667|NCT03961165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110427668|NCT03961165|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110427669|NCT03961165|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110427670|NCT03961165|Cholinergic Agents|cholinergic agents|mesh-ancestor
110427671|NCT03961165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110427672|NCT03961165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110427673|NCT03961165|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110427674|NCT03961165|Antiemetics|antiemetics|mesh-ancestor
110427675|NCT03961165|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110427676|NCT03961165|Mydriatics|mydriatics|mesh-ancestor
110370937|NCT01154218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110427678|NCT02706535|Rifampin|rifampin|mesh-list
110427679|NCT02706535|Antifungal Agents|antifungal agents|mesh-ancestor
110427680|NCT02706535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110427681|NCT02706535|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110427682|NCT02706535|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110427683|NCT02706535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110427684|NCT02706535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110427685|NCT02706535|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110427686|NCT02706535|Hormone Antagonists|hormone antagonists|mesh-ancestor
110427687|NCT02706535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110203023|NCT00044187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110427688|NCT02706535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110427689|NCT02706535|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110427690|NCT02706535|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110427691|NCT02706535|Antitubercular Agents|antitubercular agents|mesh-ancestor
110427692|NCT02706535|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110427693|NCT02706535|Leprostatic Agents|leprostatic agents|mesh-ancestor
110427694|NCT02706535|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110427695|NCT02706535|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110427696|NCT02706535|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110427697|NCT02706535|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110427698|NCT02706535|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110427699|NCT02706535|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110427700|NCT02706535|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110427701|NCT02711059|Parathyroid Hormone|parathyroid hormone|mesh-list
110427702|NCT02711059|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110427703|NCT02711059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110427704|NCT00612157|Eszopiclone|eszopiclone|mesh-list
110427705|NCT00612157|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110427706|NCT00612157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110427707|NCT00612157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110427708|NCT00936598|Zolpidem|zolpidem|mesh-list
110427709|NCT00936598|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110427710|NCT00936598|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110427711|NCT00936598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110427712|NCT00936598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110427713|NCT00936598|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
110427714|NCT00936598|GABA Agonists|gaba agonists|mesh-ancestor
110427715|NCT00936598|GABA Agents|gaba agents|mesh-ancestor
110427716|NCT00936598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110427717|NCT00936598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110427718|NCT01025817|Mycophenolic Acid|mycophenolic acid|mesh-list
110427719|NCT01025817|Everolimus|everolimus|mesh-list
110427720|NCT01025817|Tacrolimus|tacrolimus|mesh-list
110427721|NCT01025817|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110427722|NCT01025817|Immunologic Factors|immunologic factors|mesh-ancestor
110427723|NCT01025817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110427724|NCT01025817|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110427725|NCT01025817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110427726|NCT01025817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110427727|NCT01025817|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110427728|NCT01025817|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110427729|NCT01025817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110427730|NCT01025817|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110427731|NCT01025817|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110427732|NCT01025817|Antitubercular Agents|antitubercular agents|mesh-ancestor
110427733|NCT01025817|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110427734|NCT01025817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110427735|NCT00636883|Gemcitabine|gemcitabine|mesh-list
110427736|NCT00636883|Oxaliplatin|oxaliplatin|mesh-list
110427737|NCT00636883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110427738|NCT00636883|Antimetabolites|antimetabolites|mesh-ancestor
110328709|NCT00490308|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110427739|NCT00636883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110427740|NCT00636883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110427742|NCT00605410|Ipratropium|ipratropium|mesh-list
110427743|NCT00605410|Anticonvulsants|anticonvulsants|mesh-ancestor
110427744|NCT00605410|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110427745|NCT00605410|Autonomic Agents|autonomic agents|mesh-ancestor
110427746|NCT00605410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110427747|NCT00605410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110427748|NCT00605410|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110427749|NCT00605410|Respiratory System Agents|respiratory system agents|mesh-ancestor
110427750|NCT00605410|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110427751|NCT00605410|Cholinergic Agents|cholinergic agents|mesh-ancestor
110427752|NCT00605410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110427753|NCT00605410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110427754|NCT04300881|Eplerenone|eplerenone|mesh-list
110427755|NCT04300881|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110427756|NCT04300881|Hormone Antagonists|hormone antagonists|mesh-ancestor
110427757|NCT04300881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110427758|NCT04300881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110427759|NCT04300881|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110427760|NCT04300881|Diuretics|diuretics|mesh-ancestor
110427761|NCT04300881|Natriuretic Agents|natriuretic agents|mesh-ancestor
110427762|NCT04300881|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110427763|NCT03873493|Venetoclax|venetoclax|mesh-list
110427764|NCT03873493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110427765|NCT00611689|Imatinib Mesylate|imatinib mesylate|mesh-list
110427766|NCT00611689|Vatalanib|vatalanib|mesh-list
110427767|NCT00611689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110427768|NCT00611689|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110427769|NCT00611689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110427770|NCT00611689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110427771|NCT05264077|Midazolam|midazolam|mesh-list
110427772|NCT05264077|Dexmedetomidine|dexmedetomidine|mesh-list
110427773|NCT05264077|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110427774|NCT05264077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110427775|NCT05264077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110427776|NCT05264077|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110427777|NCT05264077|Analgesics|analgesics|mesh-ancestor
110427778|NCT05264077|Sensory System Agents|sensory system agents|mesh-ancestor
110427779|NCT05264077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110427780|NCT05264077|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110427781|NCT05264077|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110427782|NCT05264077|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110427783|NCT05264077|Adrenergic Agents|adrenergic agents|mesh-ancestor
110427784|NCT05264077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110427785|NCT05264077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110203062|NCT00157066|Vitamin D|vitamin d|mesh-list
110427786|NCT05264077|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110427787|NCT05264077|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110427788|NCT05264077|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110427789|NCT05264077|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110427790|NCT05264077|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110427791|NCT05264077|Anesthetics, General|anesthetics, general|mesh-ancestor
110427792|NCT05264077|Anesthetics|anesthetics|mesh-ancestor
110427793|NCT05264077|GABA Modulators|gaba modulators|mesh-ancestor
110427794|NCT05264077|GABA Agents|gaba agents|mesh-ancestor
110427795|NCT00612859|Levetiracetam|levetiracetam|mesh-list
110427796|NCT00612859|Anticonvulsants|anticonvulsants|mesh-ancestor
110427797|NCT00612859|Nootropic Agents|nootropic agents|mesh-ancestor
110427798|NCT03872401|Evolocumab|evolocumab|mesh-list
110427799|NCT03872401|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
110427800|NCT03872401|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110427801|NCT03872401|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110427802|NCT03872401|Antimetabolites|antimetabolites|mesh-ancestor
110427803|NCT03872401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110427804|NCT03872401|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110427805|NCT03872401|Protease Inhibitors|protease inhibitors|mesh-ancestor
110074752|NCT01594346|Micronutrients|micronutrients|mesh-ancestor
110427806|NCT03872401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110427807|NCT03872401|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110427808|NCT01010217|Mycophenolic Acid|mycophenolic acid|mesh-list
110427809|NCT01010217|Cyclophosphamide|cyclophosphamide|mesh-list
110427810|NCT01010217|Melphalan|melphalan|mesh-list
110427811|NCT01010217|Thiotepa|thiotepa|mesh-list
110427812|NCT01010217|Rituximab|rituximab|mesh-list
110427813|NCT01010217|Fludarabine|fludarabine|mesh-list
110427814|NCT01010217|Fludarabine phosphate|fludarabine phosphate|mesh-list
110427815|NCT01010217|Tacrolimus|tacrolimus|mesh-list
110427816|NCT01010217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110427817|NCT01010217|Immunologic Factors|immunologic factors|mesh-ancestor
110427818|NCT01010217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110427819|NCT01010217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110427820|NCT01010217|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110427821|NCT01010217|Alkylating Agents|alkylating agents|mesh-ancestor
110427822|NCT01010217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110427823|NCT01010217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110427824|NCT01010217|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110427825|NCT01010217|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110427826|NCT01010217|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110427827|NCT01010217|Antimetabolites|antimetabolites|mesh-ancestor
110427828|NCT01010217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110427829|NCT01010217|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110427830|NCT01010217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110427831|NCT01010217|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110427832|NCT01010217|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110427833|NCT01010217|Antitubercular Agents|antitubercular agents|mesh-ancestor
110427834|NCT01010217|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110427835|NCT00604006|Spironolactone|spironolactone|mesh-list
110427836|NCT00604006|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110427837|NCT00604006|Hormone Antagonists|hormone antagonists|mesh-ancestor
110427838|NCT00604006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110427839|NCT00604006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110427840|NCT00604006|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110427841|NCT00604006|Diuretics|diuretics|mesh-ancestor
110427842|NCT00604006|Natriuretic Agents|natriuretic agents|mesh-ancestor
110427843|NCT00604084|Ivermectin|ivermectin|mesh-list
110427844|NCT00604084|Permethrin|permethrin|mesh-list
110427845|NCT00604084|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110427846|NCT00604084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110427847|NCT00604084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110427848|NCT00604084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110427849|NCT05379478|Antibodies|antibodies|mesh-list
110427850|NCT05379478|Immunologic Factors|immunologic factors|mesh-ancestor
110427851|NCT05379478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110427852|NCT04267042|Budesonide|budesonide|mesh-list
110427853|NCT04267042|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110427854|NCT04267042|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110427855|NCT04267042|Autonomic Agents|autonomic agents|mesh-ancestor
110427856|NCT04267042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110427857|NCT04267042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110427858|NCT04267042|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110427859|NCT04267042|Respiratory System Agents|respiratory system agents|mesh-ancestor
110427860|NCT04267042|Glucocorticoids|glucocorticoids|mesh-ancestor
110427861|NCT04267042|Hormones|hormones|mesh-ancestor
110427862|NCT04267042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110427863|NCT01217957|Dexamethasone|dexamethasone|mesh-list
110427864|NCT01217957|Lenalidomide|lenalidomide|mesh-list
110427865|NCT01217957|Ixazomib|ixazomib|mesh-list
110427866|NCT01217957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110427867|NCT01217957|Antiemetics|antiemetics|mesh-ancestor
110427868|NCT01217957|Autonomic Agents|autonomic agents|mesh-ancestor
110427869|NCT01217957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110427870|NCT01217957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110427871|NCT01217957|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110427872|NCT01217957|Glucocorticoids|glucocorticoids|mesh-ancestor
110427873|NCT01217957|Hormones|hormones|mesh-ancestor
110427874|NCT01217957|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110427875|NCT01217957|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110427876|NCT01217957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110427877|NCT01217957|Immunologic Factors|immunologic factors|mesh-ancestor
110427878|NCT01217957|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110427879|NCT01217957|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110427880|NCT01217957|Growth Substances|growth substances|mesh-ancestor
110427881|NCT01217957|Growth Inhibitors|growth inhibitors|mesh-ancestor
110427882|NCT01217957|Protease Inhibitors|protease inhibitors|mesh-ancestor
110074825|NCT01594866|Antidepressive Agents|antidepressive agents|mesh-ancestor
110427883|NCT01217957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110427884|NCT01217957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110427885|NCT01217801|Ondansetron|ondansetron|mesh-list
110427886|NCT01217801|Antiemetics|antiemetics|mesh-ancestor
110427887|NCT01217801|Autonomic Agents|autonomic agents|mesh-ancestor
110427888|NCT01217801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110427889|NCT01217801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110427890|NCT01217801|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110427891|NCT01217801|Antipruritics|antipruritics|mesh-ancestor
110427892|NCT01217801|Dermatologic Agents|dermatologic agents|mesh-ancestor
110427893|NCT01217801|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110427894|NCT01217801|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110427895|NCT01217801|Serotonin Agents|serotonin agents|mesh-ancestor
110427896|NCT01217801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110427897|NCT01217801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110427898|NCT00935818|Bupropion|bupropion|mesh-list
110427899|NCT00935818|Varenicline|varenicline|mesh-list
110427900|NCT00935818|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110427901|NCT00935818|Antidepressive Agents|antidepressive agents|mesh-ancestor
110427902|NCT00935818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110427903|NCT00935818|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110427904|NCT00935818|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110427905|NCT00935818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110203101|NCT00406861|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110427906|NCT00935818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110427907|NCT00935818|Dopamine Agents|dopamine agents|mesh-ancestor
110427908|NCT00935818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110427909|NCT00935818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110427910|NCT00935818|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110427911|NCT00935818|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110427912|NCT00935818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110427913|NCT00935818|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110427914|NCT00935818|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110427915|NCT00935818|Cholinergic Agents|cholinergic agents|mesh-ancestor
110427918|NCT02709265|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110427919|NCT02709265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110427920|NCT00611845|Aprotinin|aprotinin|mesh-list
110427921|NCT00611845|Hemostatics|hemostatics|mesh-ancestor
110427922|NCT00611845|Coagulants|coagulants|mesh-ancestor
110427923|NCT00611845|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
110427924|NCT00611845|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110427925|NCT00611845|Protease Inhibitors|protease inhibitors|mesh-ancestor
110427926|NCT00611845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110427927|NCT00611845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110427928|NCT01216163|Acetaminophen|acetaminophen|mesh-list
110427929|NCT01216163|Ibuprofen|ibuprofen|mesh-list
110427930|NCT01216163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110427931|NCT01216163|Analgesics|analgesics|mesh-ancestor
110427932|NCT01216163|Sensory System Agents|sensory system agents|mesh-ancestor
110427933|NCT01216163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110427934|NCT01216163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110427935|NCT01216163|Antipyretics|antipyretics|mesh-ancestor
110427936|NCT01216163|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110427937|NCT01216163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110427938|NCT01216163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110427939|NCT01216163|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110427940|NCT01216163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110427941|NCT01216163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110427942|NCT05260255|Vitamin D|vitamin d|mesh-list
110427943|NCT05260255|Ergocalciferols|ergocalciferols|mesh-list
110427944|NCT05260255|Vitamins|vitamins|mesh-ancestor
110427945|NCT05260255|Micronutrients|micronutrients|mesh-ancestor
110427946|NCT05260255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110427947|NCT05260255|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110427948|NCT05260255|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110427949|NCT00612469|Chlorhexidine|chlorhexidine|mesh-list
110427950|NCT00612469|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110427951|NCT00612469|Listerine|listerine|mesh-list
110427952|NCT00612469|Vancomycin|vancomycin|mesh-list
110427953|NCT00612469|Fluorides|fluorides|mesh-list
110427954|NCT00612469|Sodium Fluoride|sodium fluoride|mesh-list
110427955|NCT00612469|Cariostatic Agents|cariostatic agents|mesh-ancestor
110427956|NCT00612469|Protective Agents|protective agents|mesh-ancestor
110427957|NCT00612469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110427958|NCT00612469|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110427959|NCT00612469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110427960|NCT00612469|Disinfectants|disinfectants|mesh-ancestor
110427961|NCT00612469|Dermatologic Agents|dermatologic agents|mesh-ancestor
110427963|NCT00933244|Vitamin D|vitamin d|mesh-list
110427964|NCT00933244|Ergocalciferols|ergocalciferols|mesh-list
110427965|NCT00933244|Cholecalciferol|cholecalciferol|mesh-list
110427966|NCT00933244|Vitamins|vitamins|mesh-list
110427967|NCT00933244|Micronutrients|micronutrients|mesh-ancestor
110427968|NCT00933244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110427969|NCT00933244|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110427970|NCT00933244|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110427971|NCT02709187|Candesartan|candesartan|mesh-list
110427972|NCT02709187|Candesartan cilexetil|candesartan cilexetil|mesh-list
110427973|NCT02709187|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110427974|NCT02709187|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110427975|NCT02709187|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110427976|NCT02709187|Antimetabolites|antimetabolites|mesh-ancestor
110427977|NCT02709187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110427978|NCT02709187|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110427979|NCT02709187|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110427980|NCT02709187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110427981|NCT02709187|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110427982|NCT02709187|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110427983|NCT02709187|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110427984|NCT00930046|Ropivacaine|ropivacaine|mesh-list
110427985|NCT00930046|Anesthetics, Local|anesthetics, local|mesh-ancestor
110427986|NCT00930046|Anesthetics|anesthetics|mesh-ancestor
110427987|NCT00930046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110427988|NCT00930046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110427989|NCT00930046|Sensory System Agents|sensory system agents|mesh-ancestor
110427990|NCT00930046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110427991|NCT05244031|Analgesics, Opioid|analgesics, opioid|mesh-list
110427992|NCT05244031|Narcotics|narcotics|mesh-ancestor
110427993|NCT05244031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110427994|NCT05244031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110427995|NCT05244031|Analgesics|analgesics|mesh-ancestor
110427996|NCT05244031|Sensory System Agents|sensory system agents|mesh-ancestor
110427997|NCT05244031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110427998|NCT04712071|Ketamine|ketamine|mesh-list
110427999|NCT04712071|Analgesics|analgesics|mesh-ancestor
110428000|NCT04712071|Sensory System Agents|sensory system agents|mesh-ancestor
110428001|NCT04712071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110428002|NCT04712071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110428003|NCT04712071|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110428004|NCT04712071|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110428005|NCT04712071|Anesthetics, General|anesthetics, general|mesh-ancestor
110428006|NCT04712071|Anesthetics|anesthetics|mesh-ancestor
110428007|NCT04712071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110428008|NCT04712071|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110428009|NCT04712071|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110428010|NCT04712071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110428011|NCT04712071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110428012|NCT05151328|Plecanatide|plecanatide|mesh-list
110428013|NCT05151328|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
110428014|NCT05151328|Enzyme Activators|enzyme activators|mesh-ancestor
110428015|NCT05151328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110428016|NCT05151328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110428017|NCT00609388|Tacrolimus|tacrolimus|mesh-list
110428018|NCT00609388|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110203144|NCT00157651|Warfarin|warfarin|mesh-list
110428019|NCT00609388|Immunologic Factors|immunologic factors|mesh-ancestor
110428020|NCT00609388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110428021|NCT00609388|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110428022|NCT00609388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110428023|NCT00609388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110428025|NCT02709031|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110428026|NCT02709031|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110428027|NCT02709031|Diuretics|diuretics|mesh-ancestor
110428028|NCT02709031|Natriuretic Agents|natriuretic agents|mesh-ancestor
110428029|NCT02709031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110428030|NCT05225545|Iron|iron|mesh-list
110428031|NCT05225545|Trace Elements|trace elements|mesh-ancestor
110428032|NCT05225545|Micronutrients|micronutrients|mesh-ancestor
110428033|NCT05225545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110428034|NCT05378932|Melatonin|melatonin|mesh-list
110428035|NCT05378932|Antioxidants|antioxidants|mesh-ancestor
110074965|NCT01595763|Hemostatics|hemostatics|mesh-ancestor
110428036|NCT05378932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110428037|NCT05378932|Protective Agents|protective agents|mesh-ancestor
110428038|NCT05378932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110428039|NCT05378932|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110428040|NCT00612547|Artesunate|artesunate|mesh-list
110428041|NCT00612547|Amodiaquine|amodiaquine|mesh-list
110428042|NCT00612547|Antimalarials|antimalarials|mesh-ancestor
110428043|NCT00612547|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110428044|NCT00612547|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110428045|NCT00612547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110428046|NCT00612547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110428047|NCT00612547|Antiviral Agents|antiviral agents|mesh-ancestor
110428048|NCT00612547|Schistosomicides|schistosomicides|mesh-ancestor
110428049|NCT00612547|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110428050|NCT00612547|Anthelmintics|anthelmintics|mesh-ancestor
110428051|NCT00606268|Micafungin|micafungin|mesh-list
110428052|NCT00606268|Antifungal Agents|antifungal agents|mesh-ancestor
110428053|NCT00606268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110428054|NCT05342857|Aflibercept|aflibercept|mesh-list
110428055|NCT05342857|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110428056|NCT05342857|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110428057|NCT05342857|Growth Substances|growth substances|mesh-ancestor
110428058|NCT05342857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110428059|NCT05342857|Growth Inhibitors|growth inhibitors|mesh-ancestor
110428060|NCT05342857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110428061|NCT04264624|Erythritol|erythritol|mesh-list
110428062|NCT04264624|Vasodilator Agents|vasodilator agents|mesh-ancestor
110428063|NCT04188691|Vaccines|vaccines|mesh-list
110428064|NCT04188691|Immunologic Factors|immunologic factors|mesh-ancestor
110428065|NCT04188691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110428066|NCT01215851|Moxifloxacin|moxifloxacin|mesh-list
110428067|NCT01215851|Pyrazinamide|pyrazinamide|mesh-list
110428068|NCT01215851|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110428069|NCT01215851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110428070|NCT01215851|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110428071|NCT01215851|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110428072|NCT01215851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110428073|NCT01215851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110428074|NCT01215851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110428075|NCT01215851|Antitubercular Agents|antitubercular agents|mesh-ancestor
110428076|NCT00613093|Temozolomide|temozolomide|mesh-list
110428077|NCT00613093|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
110428078|NCT00613093|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110428079|NCT00613093|Alkylating Agents|alkylating agents|mesh-ancestor
110428080|NCT00613093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110428081|NCT00613093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110428082|NCT00613093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110428083|NCT00607750|Mecamylamine|mecamylamine|mesh-list
110428084|NCT00607750|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110428085|NCT00607750|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
110428086|NCT00607750|Autonomic Agents|autonomic agents|mesh-ancestor
110428087|NCT00607750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110428088|NCT00607750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110428089|NCT00607750|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
110428090|NCT00607750|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110428091|NCT00607750|Cholinergic Agents|cholinergic agents|mesh-ancestor
110428092|NCT00607750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110428093|NCT00607750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110428094|NCT00609544|Rilonacept|rilonacept|mesh-list
110428095|NCT00609544|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110428096|NCT04908475|Apremilast|apremilast|mesh-list
110428097|NCT04908475|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110428098|NCT04908475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110428099|NCT04908475|Analgesics|analgesics|mesh-ancestor
110428100|NCT04908475|Sensory System Agents|sensory system agents|mesh-ancestor
110428101|NCT04908475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110428102|NCT04908475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110428103|NCT04908475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110428104|NCT04908475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110428105|NCT04908475|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
110428106|NCT04908475|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110428107|NCT04908475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110428108|NCT04908475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110428109|NCT03513211|Hydroxychloroquine|hydroxychloroquine|mesh-list
110428110|NCT03513211|Itraconazole|itraconazole|mesh-list
110428111|NCT03513211|Antimalarials|antimalarials|mesh-ancestor
110428112|NCT03513211|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110428113|NCT03513211|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110428114|NCT03513211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110428115|NCT03513211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110428116|NCT03513211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110428117|NCT03513211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110428118|NCT03513211|Antifungal Agents|antifungal agents|mesh-ancestor
110428119|NCT03513211|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110428120|NCT03513211|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110428121|NCT03513211|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110428122|NCT03513211|Hormone Antagonists|hormone antagonists|mesh-ancestor
110428123|NCT03513211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110428124|NCT03513211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110428125|NCT03513211|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110428126|NCT04611139|Pembrolizumab|pembrolizumab|mesh-list
110428127|NCT04611139|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110428128|NCT04611139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110428129|NCT04611139|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110428130|NCT04611139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110428131|NCT04570501|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
110428132|NCT04570501|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110428133|NCT04570501|Vasodilator Agents|vasodilator agents|mesh-ancestor
110428134|NCT05198791|Eplerenone|eplerenone|mesh-list
110203176|NCT00157885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110428135|NCT05198791|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110428136|NCT05198791|Hormone Antagonists|hormone antagonists|mesh-ancestor
110428137|NCT05198791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110428138|NCT05198791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110428139|NCT05198791|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110428140|NCT05198791|Diuretics|diuretics|mesh-ancestor
110428141|NCT05198791|Natriuretic Agents|natriuretic agents|mesh-ancestor
110428142|NCT05198791|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110428143|NCT01010061|Rituximab|rituximab|mesh-list
110428144|NCT01010061|Obinutuzumab|obinutuzumab|mesh-list
110428145|NCT01010061|Chlorambucil|chlorambucil|mesh-list
110428146|NCT01010061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110428147|NCT01010061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110428148|NCT01010061|Immunologic Factors|immunologic factors|mesh-ancestor
110428149|NCT01010061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110428150|NCT01010061|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110428151|NCT01010061|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110428152|NCT01010061|Alkylating Agents|alkylating agents|mesh-ancestor
110428153|NCT01010061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110428155|NCT00607984|Thiotepa|thiotepa|mesh-list
110428156|NCT00607984|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110428157|NCT00607984|Alkylating Agents|alkylating agents|mesh-ancestor
110428158|NCT00607984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110428159|NCT00607984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110428160|NCT00607984|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110428161|NCT00607984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110428162|NCT00607984|Immunologic Factors|immunologic factors|mesh-ancestor
110428163|NCT00607984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110428164|NCT00929734|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110428165|NCT00929734|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
110428166|NCT00929734|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110428167|NCT00929734|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110428168|NCT00929734|Antimetabolites|antimetabolites|mesh-ancestor
110428169|NCT00929734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110428170|NCT00929734|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110428171|NCT00929734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110428172|NCT00609856|Insulin Glargine|insulin glargine|mesh-list
110428173|NCT00609856|Pioglitazone|pioglitazone|mesh-list
110428174|NCT00609856|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110428175|NCT00609856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110428176|NCT04527757|Anesthetics|anesthetics|mesh-list
110428177|NCT04527757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110428178|NCT04527757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110428179|NCT00613249|Dapivirine|dapivirine|mesh-list
110428180|NCT00613249|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110428181|NCT00613249|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110428182|NCT00613249|Antiviral Agents|antiviral agents|mesh-ancestor
110428183|NCT00613249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110428184|NCT00613561|Fludarabine|fludarabine|mesh-list
110428185|NCT00613561|Busulfan|busulfan|mesh-list
110428186|NCT00613561|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110428187|NCT00613561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110428188|NCT00613561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110428189|NCT00613561|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110428190|NCT00613561|Immunologic Factors|immunologic factors|mesh-ancestor
110428191|NCT00613561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110428192|NCT00613561|Alkylating Agents|alkylating agents|mesh-ancestor
110428193|NCT00613561|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110428194|NCT00613561|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110428195|NCT01009983|Paclitaxel|paclitaxel|mesh-list
110428196|NCT01009983|Carboplatin|carboplatin|mesh-list
110428198|NCT01009983|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110428199|NCT01009983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110428200|NCT01009983|Tubulin Modulators|tubulin modulators|mesh-ancestor
110428201|NCT01009983|Antimitotic Agents|antimitotic agents|mesh-ancestor
110428202|NCT01009983|Mitosis Modulators|mitosis modulators|mesh-ancestor
110428203|NCT01009983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110428204|NCT01009983|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110428205|NCT04297215|Anti-Infective Agents|anti-infective agents|mesh-list
110428206|NCT04297215|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110428207|NCT04297215|Chitosan|chitosan|mesh-list
110428208|NCT04297215|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110428209|NCT04297215|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110428210|NCT04297215|Antimetabolites|antimetabolites|mesh-ancestor
110428211|NCT04297215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110428212|NCT04297215|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110428213|NCT04297215|Chelating Agents|chelating agents|mesh-ancestor
110428214|NCT04297215|Sequestering Agents|sequestering agents|mesh-ancestor
110428215|NCT04297215|Hemostatics|hemostatics|mesh-ancestor
110428216|NCT04297215|Coagulants|coagulants|mesh-ancestor
110428217|NCT02873091|Sufentanil|sufentanil|mesh-list
110428218|NCT02873091|Ropivacaine|ropivacaine|mesh-list
110428219|NCT02873091|Anesthetics, Local|anesthetics, local|mesh-ancestor
110428220|NCT02873091|Anesthetics|anesthetics|mesh-ancestor
110428221|NCT02873091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110428222|NCT02873091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110428223|NCT02873091|Sensory System Agents|sensory system agents|mesh-ancestor
110428224|NCT02873091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110428225|NCT02873091|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110428226|NCT02873091|Narcotics|narcotics|mesh-ancestor
110428227|NCT02873091|Analgesics|analgesics|mesh-ancestor
110428228|NCT02873091|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110428229|NCT02873091|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110428230|NCT02873091|Anesthetics, General|anesthetics, general|mesh-ancestor
110428231|NCT04298775|Morphine|morphine|mesh-list
110428232|NCT04298775|Anesthetics|anesthetics|mesh-list
110428233|NCT04298775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110428234|NCT04298775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110428235|NCT04298775|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110428236|NCT04298775|Narcotics|narcotics|mesh-ancestor
110428237|NCT04298775|Analgesics|analgesics|mesh-ancestor
110428238|NCT04298775|Sensory System Agents|sensory system agents|mesh-ancestor
110428239|NCT04298775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110428241|NCT01215227|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
110428242|NCT01215227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110428243|NCT01215227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110428244|NCT01215227|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110428245|NCT01215227|Protective Agents|protective agents|mesh-ancestor
110428246|NCT01215227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110428247|NCT01009515|Paclitaxel|paclitaxel|mesh-list
110428248|NCT01009515|Carboplatin|carboplatin|mesh-list
110428249|NCT01009515|Temozolomide|temozolomide|mesh-list
110428250|NCT01009515|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110428251|NCT01009515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110428252|NCT01009515|Tubulin Modulators|tubulin modulators|mesh-ancestor
110428253|NCT01009515|Antimitotic Agents|antimitotic agents|mesh-ancestor
110428254|NCT01009515|Mitosis Modulators|mitosis modulators|mesh-ancestor
110428255|NCT01009515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110428256|NCT01009515|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110428257|NCT01009515|Alkylating Agents|alkylating agents|mesh-ancestor
110428258|NCT04550481|Lisinopril|lisinopril|mesh-list
110428259|NCT04550481|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110428260|NCT04550481|Protease Inhibitors|protease inhibitors|mesh-ancestor
110428261|NCT04550481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110428262|NCT04550481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110075233|NCT01596764|Naloxone|naloxone|mesh-list
110428263|NCT04550481|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110428264|NCT04550481|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110428265|NCT04550481|Protective Agents|protective agents|mesh-ancestor
110428266|NCT04550481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110428267|NCT01214915|Anagrelide|anagrelide|mesh-list
110428268|NCT01214915|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110428269|NCT01214915|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110428270|NCT01214915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110428271|NCT01214915|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110428272|NCT01009203|Sirolimus|sirolimus|mesh-list
110428273|NCT01009203|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110428274|NCT01009203|Temsirolimus|temsirolimus|mesh-list
110428275|NCT01009203|MTOR Inhibitors|mtor inhibitors|mesh-list
110428276|NCT01009203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110428277|NCT01009203|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110428278|NCT01009203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110428279|NCT01009203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110428280|NCT01009203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110428281|NCT01009203|Immunologic Factors|immunologic factors|mesh-ancestor
110428282|NCT01009203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110428283|NCT01009203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110428284|NCT01009203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110428285|NCT01009203|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110428286|NCT01009203|Antifungal Agents|antifungal agents|mesh-ancestor
110428287|NCT01009047|Aripiprazole|aripiprazole|mesh-list
110428288|NCT01009047|Paliperidone Palmitate|paliperidone palmitate|mesh-list
110428289|NCT01009047|Antidepressive Agents|antidepressive agents|mesh-ancestor
110428290|NCT01009047|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110428291|NCT01009047|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110428292|NCT01009047|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110428293|NCT01009047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110428294|NCT01009047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110428295|NCT01009047|Dopamine Agonists|dopamine agonists|mesh-ancestor
110428296|NCT01009047|Dopamine Agents|dopamine agents|mesh-ancestor
110428297|NCT01009047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110428298|NCT01009047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110428299|NCT01009047|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110428300|NCT01009047|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110428301|NCT01009047|Serotonin Agents|serotonin agents|mesh-ancestor
110428302|NCT01009047|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110428303|NCT01009047|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110428304|NCT01009047|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110428305|NCT01009047|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110428306|NCT04205097|Neostigmine|neostigmine|mesh-list
110428307|NCT04205097|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110428308|NCT04205097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110428309|NCT04205097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110428310|NCT04205097|Cholinergic Agents|cholinergic agents|mesh-ancestor
110428311|NCT04205097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110428312|NCT04205097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110428313|NCT04205097|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110428314|NCT04205097|Autonomic Agents|autonomic agents|mesh-ancestor
110428315|NCT04205097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110428316|NCT04205565|Oxiracetam|oxiracetam|mesh-list
110428317|NCT04205565|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110428318|NCT04205565|Nootropic Agents|nootropic agents|mesh-ancestor
110428319|NCT01025193|Belimumab|belimumab|mesh-list
110428320|NCT01025193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110428321|NCT01025193|Immunologic Factors|immunologic factors|mesh-ancestor
110428322|NCT01025193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110428323|NCT01008423|Budesonide|budesonide|mesh-list
110428324|NCT01008423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110428325|NCT01008423|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110428326|NCT01008423|Autonomic Agents|autonomic agents|mesh-ancestor
110428327|NCT01008423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110428328|NCT01008423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110428329|NCT01008423|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110428330|NCT01008423|Respiratory System Agents|respiratory system agents|mesh-ancestor
110428331|NCT01008423|Glucocorticoids|glucocorticoids|mesh-ancestor
110428332|NCT01008423|Hormones|hormones|mesh-ancestor
110428333|NCT01008423|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110428334|NCT04735861|Bevacizumab|bevacizumab|mesh-list
110428335|NCT04735861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110428336|NCT04735861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110428337|NCT04735861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110428338|NCT04735861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110428339|NCT04735861|Growth Substances|growth substances|mesh-ancestor
110428340|NCT04735861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110428341|NCT04735861|Growth Inhibitors|growth inhibitors|mesh-ancestor
110428342|NCT03685747|Vancomycin|vancomycin|mesh-list
110428343|NCT03685747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110428344|NCT03685747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110428345|NCT03586687|Triamcinolone|triamcinolone|mesh-list
110428346|NCT03586687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110428348|NCT03586687|Hormones|hormones|mesh-ancestor
110428349|NCT03586687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110428350|NCT03586687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110428351|NCT01212185|Oxytocin|oxytocin|mesh-list
110428352|NCT01212185|Oxytocics|oxytocics|mesh-ancestor
110428353|NCT01212185|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110428354|NCT01212185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110428355|NCT00613717|Vitamin D|vitamin d|mesh-list
110428356|NCT00613717|Vitamins|vitamins|mesh-list
110428357|NCT00613717|Folic Acid|folic acid|mesh-list
110428358|NCT00613717|Vitamin A|vitamin a|mesh-list
110428359|NCT00613717|Iron|iron|mesh-list
110428360|NCT00613717|Vitamin B Complex|vitamin b complex|mesh-list
110428361|NCT00613717|Retinol palmitate|retinol palmitate|mesh-list
110428362|NCT00613717|Micronutrients|micronutrients|mesh-ancestor
110428363|NCT00613717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110428364|NCT00613717|Trace Elements|trace elements|mesh-ancestor
110428365|NCT00613717|Hematinics|hematinics|mesh-ancestor
110428366|NCT00613717|Antioxidants|antioxidants|mesh-ancestor
110428367|NCT00613717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110428368|NCT00613717|Protective Agents|protective agents|mesh-ancestor
110428369|NCT00613717|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110428370|NCT00613717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110428371|NCT00613717|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110428372|NCT03369301|Immunoglobulins|immunoglobulins|mesh-list
110428373|NCT03369301|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110428374|NCT03369301|Antibodies|antibodies|mesh-list
110428375|NCT03369301|Immunologic Factors|immunologic factors|mesh-ancestor
110428376|NCT03369301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110428377|NCT05345119|Sirolimus|sirolimus|mesh-list
110428378|NCT05345119|Methylprednisolone|methylprednisolone|mesh-list
110428379|NCT05345119|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110428380|NCT05345119|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110428381|NCT05345119|Prednisolone|prednisolone|mesh-list
110428382|NCT05345119|Prednisolone acetate|prednisolone acetate|mesh-list
110428383|NCT05345119|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110428384|NCT05345119|Prednisolone phosphate|prednisolone phosphate|mesh-list
110428385|NCT05345119|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110428386|NCT05345119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110428387|NCT05345119|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110428388|NCT05345119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110428389|NCT05345119|Antifungal Agents|antifungal agents|mesh-ancestor
110428390|NCT05345119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110428391|NCT05345119|Immunologic Factors|immunologic factors|mesh-ancestor
110428392|NCT05345119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110428393|NCT05345119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110428394|NCT05345119|Antiemetics|antiemetics|mesh-ancestor
110428395|NCT05345119|Autonomic Agents|autonomic agents|mesh-ancestor
110428396|NCT05345119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110428397|NCT05345119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110428398|NCT05345119|Glucocorticoids|glucocorticoids|mesh-ancestor
110428399|NCT05345119|Hormones|hormones|mesh-ancestor
110428400|NCT05345119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110428401|NCT05345119|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110428402|NCT05345119|Protective Agents|protective agents|mesh-ancestor
110428403|NCT05345119|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110428404|NCT03529123|Insulin|insulin|mesh-list
110428405|NCT03529123|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110428406|NCT03529123|Metformin|metformin|mesh-list
110428407|NCT03529123|Insulin Glargine|insulin glargine|mesh-list
110428408|NCT03529123|Insulin glulisine|insulin glulisine|mesh-list
110428409|NCT03529123|Lixisenatide|lixisenatide|mesh-list
110428410|NCT03529123|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110428411|NCT03529123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110428412|NCT04074187|Methylprednisolone|methylprednisolone|mesh-list
110428413|NCT04074187|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110428414|NCT04074187|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110428415|NCT04074187|Prednisolone|prednisolone|mesh-list
110428416|NCT04074187|Prednisolone acetate|prednisolone acetate|mesh-list
110428418|NCT04074187|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110428419|NCT04074187|Prednisolone phosphate|prednisolone phosphate|mesh-list
110428420|NCT04074187|Immunosuppressive Agents|immunosuppressive agents|mesh-list
110428421|NCT04074187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110428422|NCT04074187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110428423|NCT04074187|Immunologic Factors|immunologic factors|mesh-ancestor
110428424|NCT04074187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110428425|NCT04074187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110428426|NCT04074187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110428427|NCT04074187|Antiemetics|antiemetics|mesh-ancestor
110428428|NCT04074187|Autonomic Agents|autonomic agents|mesh-ancestor
110428429|NCT04074187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110428430|NCT04074187|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110428432|NCT04074187|Hormones|hormones|mesh-ancestor
110428433|NCT04074187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110428434|NCT04074187|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110428435|NCT04074187|Protective Agents|protective agents|mesh-ancestor
110428436|NCT04074187|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110428437|NCT03128905|Prednisone|prednisone|mesh-list
110428438|NCT03128905|Colchicine|colchicine|mesh-list
110428439|NCT03128905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110428440|NCT03128905|Glucocorticoids|glucocorticoids|mesh-ancestor
110428441|NCT03128905|Hormones|hormones|mesh-ancestor
110428442|NCT03128905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110428443|NCT03128905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110428444|NCT03128905|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110428445|NCT03128905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110428446|NCT03128905|Gout Suppressants|gout suppressants|mesh-ancestor
110428447|NCT03128905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110428448|NCT03128905|Tubulin Modulators|tubulin modulators|mesh-ancestor
110428449|NCT03128905|Antimitotic Agents|antimitotic agents|mesh-ancestor
110428450|NCT03128905|Mitosis Modulators|mitosis modulators|mesh-ancestor
110428451|NCT03128905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110428452|NCT02430181|Interferons|interferons|mesh-list
110428453|NCT02430181|Ritonavir|ritonavir|mesh-list
110428454|NCT02430181|Interferon-alpha|interferon-alpha|mesh-list
110428455|NCT02430181|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110428456|NCT02430181|Lonafarnib|lonafarnib|mesh-list
110428457|NCT02430181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110428458|NCT02430181|Antiviral Agents|antiviral agents|mesh-ancestor
110428459|NCT02430181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110428460|NCT02430181|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110428461|NCT02430181|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110428462|NCT02430181|Protease Inhibitors|protease inhibitors|mesh-ancestor
110428463|NCT02430181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110328737|NCT00497523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110428464|NCT02430181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110428465|NCT02430181|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110428466|NCT02430181|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110428467|NCT02430181|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110428468|NCT02430181|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110428469|NCT02430181|Immunologic Factors|immunologic factors|mesh-ancestor
110428470|NCT02430181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110428471|NCT00614653|Bevacizumab|bevacizumab|mesh-list
110428472|NCT00614653|Capecitabine|capecitabine|mesh-list
110428473|NCT00614653|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110428474|NCT00614653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110428475|NCT00614653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110428476|NCT00614653|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110428477|NCT00614653|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110428478|NCT00614653|Growth Substances|growth substances|mesh-ancestor
110428479|NCT00614653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110428480|NCT00614653|Growth Inhibitors|growth inhibitors|mesh-ancestor
110428481|NCT00614653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110428482|NCT00614653|Antimetabolites|antimetabolites|mesh-ancestor
110428483|NCT00614653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110428484|NCT00614653|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110428485|NCT00614653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110428486|NCT03909451|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
110428487|NCT03909451|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110428488|NCT03909451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110428489|NCT03909451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110428490|NCT03909451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110428491|NCT03463135|Immunomodulating Agents|immunomodulating agents|mesh-list
110428492|NCT03463135|Immunologic Factors|immunologic factors|mesh-ancestor
110428493|NCT03463135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110428495|NCT03596125|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110428496|NCT03596125|Antiviral Agents|antiviral agents|mesh-ancestor
110428497|NCT03596125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110428498|NCT03596125|Expectorants|expectorants|mesh-ancestor
110428499|NCT03596125|Respiratory System Agents|respiratory system agents|mesh-ancestor
110428500|NCT03596125|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110428501|NCT03596125|Antioxidants|antioxidants|mesh-ancestor
110428502|NCT03596125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110428503|NCT03596125|Protective Agents|protective agents|mesh-ancestor
110428504|NCT03596125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110428505|NCT03596125|Antidotes|antidotes|mesh-ancestor
110428506|NCT02118727|Memantine|memantine|mesh-list
110428507|NCT02118727|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110428508|NCT02118727|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110428509|NCT02118727|Dopamine Agents|dopamine agents|mesh-ancestor
110428510|NCT02118727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110428511|NCT02118727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110428512|NCT02118727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110428513|NCT02118727|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110428514|NCT02118727|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110428515|NCT05343637|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
110428516|NCT05343637|Vasodilator Agents|vasodilator agents|mesh-ancestor
110428517|NCT05343637|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110428518|NCT05343637|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110428519|NCT05343637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110428520|NCT05343637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110428521|NCT05343637|Urological Agents|urological agents|mesh-ancestor
110428522|NCT03776227|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
110428523|NCT03776227|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110428524|NCT03776227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110428525|NCT03776227|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110428526|NCT03776227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110428527|NCT00614809|Gefitinib|gefitinib|mesh-list
110428528|NCT00614809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110428529|NCT00614809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110428530|NCT00614809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110428531|NCT00614809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110428532|NCT02964013|Carboplatin|carboplatin|mesh-list
110428533|NCT02964013|Pembrolizumab|pembrolizumab|mesh-list
110428534|NCT02964013|Etoposide|etoposide|mesh-list
110428535|NCT02964013|Pemetrexed|pemetrexed|mesh-list
110428536|NCT02964013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110428537|NCT02964013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110428538|NCT02964013|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110428539|NCT02964013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110428540|NCT02964013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110428541|NCT02964013|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110428542|NCT02964013|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110428543|NCT02964013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110428544|NCT02964013|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110428545|NCT02964013|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110428546|NCT02699437|Antibodies|antibodies|mesh-list
110428547|NCT02699437|Antibodies, Antiphospholipid|antibodies, antiphospholipid|mesh-list
110428548|NCT02699437|Immunologic Factors|immunologic factors|mesh-ancestor
110428549|NCT02699437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110428550|NCT01211483|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110428551|NCT01211483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110428552|NCT01211483|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110428553|NCT01211483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110428554|NCT01211483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110428555|NCT00615823|Atorvastatin|atorvastatin|mesh-list
110428556|NCT00615823|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110428557|NCT00615823|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110428558|NCT00615823|Antimetabolites|antimetabolites|mesh-ancestor
110428559|NCT00615823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110428560|NCT00615823|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110428561|NCT00615823|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110428562|NCT00615823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110428563|NCT02699281|Palmidrol|palmidrol|mesh-list
110428564|NCT02699281|Analgesics|analgesics|mesh-ancestor
110428565|NCT02699281|Sensory System Agents|sensory system agents|mesh-ancestor
110428566|NCT02699281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110428567|NCT02699281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110428568|NCT02699281|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110428569|NCT02699281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110428570|NCT02699281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110428571|NCT02699281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110428572|NCT02699281|Antiviral Agents|antiviral agents|mesh-ancestor
110428573|NCT02699281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110428574|NCT02699281|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
110428575|NCT02699281|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110428576|NCT02699281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110428577|NCT02699281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110428578|NCT02699281|Hormones|hormones|mesh-ancestor
110428579|NCT02699281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110428580|NCT02704507|Triamcinolone|triamcinolone|mesh-list
110428581|NCT02704507|Tretinoin|tretinoin|mesh-list
110428582|NCT02704507|Emollients|emollients|mesh-list
110428583|NCT02704507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110428584|NCT02704507|Glucocorticoids|glucocorticoids|mesh-ancestor
110428585|NCT02704507|Hormones|hormones|mesh-ancestor
110428586|NCT02704507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110428587|NCT02704507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110428588|NCT02704507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110428589|NCT02704507|Keratolytic Agents|keratolytic agents|mesh-ancestor
110428590|NCT02704507|Dermatologic Agents|dermatologic agents|mesh-ancestor
110428591|NCT01210001|Empagliflozin|empagliflozin|mesh-list
110428592|NCT01210001|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110428593|NCT01210001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110428594|NCT01210001|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110428595|NCT01210001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110428596|NCT00624455|Gabapentin|gabapentin|mesh-list
110428597|NCT00624455|Analgesics|analgesics|mesh-ancestor
110428598|NCT00624455|Sensory System Agents|sensory system agents|mesh-ancestor
110428599|NCT00624455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110428600|NCT00624455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110428601|NCT00624455|Anticonvulsants|anticonvulsants|mesh-ancestor
110428602|NCT00624455|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110428603|NCT00624455|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110428604|NCT00624455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110428605|NCT00624455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110428606|NCT00624455|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110428607|NCT00624455|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110428608|NCT00624455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110428609|NCT00624455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110428610|NCT00624455|Antimanic Agents|antimanic agents|mesh-ancestor
110428611|NCT01127659|Testosterone|testosterone|mesh-list
110428612|NCT01127659|Androgens|androgens|mesh-ancestor
110428613|NCT01127659|Hormones|hormones|mesh-ancestor
110428614|NCT01127659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110428615|NCT01127659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110428616|NCT02698969|Atropine|atropine|mesh-list
110428617|NCT02698969|Fentanyl|fentanyl|mesh-list
110428618|NCT02698969|Propofol|propofol|mesh-list
110428619|NCT02698969|Sevoflurane|sevoflurane|mesh-list
110428620|NCT02698969|Rocuronium|rocuronium|mesh-list
110428621|NCT02698969|Neostigmine|neostigmine|mesh-list
110428622|NCT02698969|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110428623|NCT02698969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110428624|NCT02698969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110428625|NCT02698969|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110428626|NCT02698969|Anesthetics, General|anesthetics, general|mesh-ancestor
110428627|NCT02698969|Anesthetics|anesthetics|mesh-ancestor
110428628|NCT02698969|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110428629|NCT02698969|Narcotics|narcotics|mesh-ancestor
110428630|NCT02698969|Analgesics|analgesics|mesh-ancestor
110428631|NCT02698969|Sensory System Agents|sensory system agents|mesh-ancestor
110428632|NCT02698969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110428633|NCT02698969|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110428634|NCT02698969|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110428635|NCT02698969|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110428636|NCT02698969|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110428637|NCT02698969|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110075571|NCT01598168|Protease Inhibitors|protease inhibitors|mesh-ancestor
110203358|NCT02965053|Sevelamer|sevelamer|mesh-list
110428638|NCT02698969|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110428639|NCT02698969|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110428640|NCT02698969|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110428641|NCT02698969|Autonomic Agents|autonomic agents|mesh-ancestor
110428642|NCT02698969|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110428643|NCT02698969|Respiratory System Agents|respiratory system agents|mesh-ancestor
110428644|NCT02698969|Mydriatics|mydriatics|mesh-ancestor
110428645|NCT02698969|Parasympatholytics|parasympatholytics|mesh-ancestor
110428646|NCT02698969|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110428647|NCT02698969|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110428648|NCT02698969|Cholinergic Agents|cholinergic agents|mesh-ancestor
110428649|NCT02698969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110428650|NCT02698969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110428651|NCT02698969|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110428652|NCT02698969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110428653|NCT02698969|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110428654|NCT00848731|Nitric Oxide|nitric oxide|mesh-list
110428655|NCT00848731|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110428656|NCT00848731|Autonomic Agents|autonomic agents|mesh-ancestor
110428657|NCT00848731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110428658|NCT00848731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110428659|NCT00848731|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110428660|NCT00848731|Respiratory System Agents|respiratory system agents|mesh-ancestor
110428661|NCT00848731|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110428662|NCT00848731|Antioxidants|antioxidants|mesh-ancestor
110428663|NCT00848731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110428664|NCT00848731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110428665|NCT00848731|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
110428666|NCT00848731|Vasodilator Agents|vasodilator agents|mesh-ancestor
110428667|NCT00848731|Gasotransmitters|gasotransmitters|mesh-ancestor
110428668|NCT00848731|Protective Agents|protective agents|mesh-ancestor
110428669|NCT01209143|Rosiglitazone|rosiglitazone|mesh-list
110428671|NCT01209143|Norethindrone|norethindrone|mesh-list
110428672|NCT01209143|Norethindrone Acetate|norethindrone acetate|mesh-list
110428674|NCT01209143|Estrogens|estrogens|mesh-ancestor
110428675|NCT01209143|Hormones|hormones|mesh-ancestor
110428676|NCT01209143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110428677|NCT01209143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110428678|NCT01209143|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110428679|NCT01209143|Contraceptive Agents|contraceptive agents|mesh-ancestor
110428680|NCT01209143|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110428681|NCT01209143|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110428682|NCT01209143|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110428683|NCT01209143|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110428684|NCT01209143|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110428685|NCT01209143|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110428686|NCT00454285|Amoxicillin|amoxicillin|mesh-list
110428687|NCT00454285|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110428688|NCT00454285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110428689|NCT00614965|Irinotecan|irinotecan|mesh-list
110428690|NCT00614965|Pemetrexed|pemetrexed|mesh-list
110428691|NCT00614965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110428692|NCT00614965|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110428693|NCT00614965|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110428694|NCT00614965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110428695|NCT00614965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110428696|NCT00614965|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110428697|NCT00614965|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110428698|NCT00405613|Aspirin|aspirin|mesh-list
110428699|NCT00405613|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110428700|NCT00405613|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110428701|NCT00405613|Analgesics|analgesics|mesh-ancestor
110428702|NCT00405613|Sensory System Agents|sensory system agents|mesh-ancestor
110428703|NCT00405613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110428704|NCT00405613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110428705|NCT00405613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110428706|NCT00405613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110428707|NCT00405613|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110428708|NCT00405613|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110428709|NCT00405613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110428710|NCT00405613|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110428711|NCT00405613|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110428712|NCT00405613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110428713|NCT00405613|Antipyretics|antipyretics|mesh-ancestor
110428714|NCT02703961|Cisplatin|cisplatin|mesh-list
110428715|NCT02703961|Docetaxel|docetaxel|mesh-list
110428716|NCT02703961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110428717|NCT02703961|Tubulin Modulators|tubulin modulators|mesh-ancestor
110428718|NCT02703961|Antimitotic Agents|antimitotic agents|mesh-ancestor
110428719|NCT02703961|Mitosis Modulators|mitosis modulators|mesh-ancestor
110428720|NCT02703961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110428721|NCT02703649|Letrozole|letrozole|mesh-list
110428722|NCT02703649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110428723|NCT02703649|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110428724|NCT02703649|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110428725|NCT02703649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110428726|NCT02703649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110428727|NCT02703649|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110428728|NCT02703649|Hormone Antagonists|hormone antagonists|mesh-ancestor
110428729|NCT02703649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110428730|NCT02703649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110428731|NCT02703571|Trametinib|trametinib|mesh-list
110428732|NCT02703571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110428733|NCT02703571|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110428734|NCT02703571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110428735|NCT02703571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110428736|NCT02703415|Tramadol|tramadol|mesh-list
110428737|NCT02703415|Bupivacaine|bupivacaine|mesh-list
110428738|NCT02703415|Anesthetics, Local|anesthetics, local|mesh-ancestor
110428739|NCT02703415|Anesthetics|anesthetics|mesh-ancestor
110428740|NCT02703415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110328753|NCT00463775|Topiramate|topiramate|mesh-list
110428741|NCT02703415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110428742|NCT02703415|Sensory System Agents|sensory system agents|mesh-ancestor
110428743|NCT02703415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110428744|NCT02703415|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110428745|NCT02703415|Narcotics|narcotics|mesh-ancestor
110428746|NCT02703415|Analgesics|analgesics|mesh-ancestor
110428747|NCT02703181|Diketopiperazines|diketopiperazines|mesh-list
110428748|NCT02703181|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110428749|NCT02703181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110428751|NCT04215835|Misoprostol|misoprostol|mesh-list
110428752|NCT04215835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110428753|NCT04215835|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110428754|NCT04215835|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110428755|NCT04215835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110203384|NCT05567718|Anesthetics|anesthetics|mesh-list
110428756|NCT04215835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110428757|NCT04215835|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110428758|NCT04215835|Hormone Antagonists|hormone antagonists|mesh-ancestor
110428759|NCT04215835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110428760|NCT04215835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110428761|NCT04215835|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110428762|NCT04215835|Abortifacient Agents|abortifacient agents|mesh-ancestor
110428763|NCT04215835|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110428764|NCT04215835|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110428765|NCT04215835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110428766|NCT04215835|Oxytocics|oxytocics|mesh-ancestor
110428767|NCT01208207|Naproxen|naproxen|mesh-list
110428768|NCT01208207|Etoricoxib|etoricoxib|mesh-list
110428769|NCT01208207|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110428770|NCT01208207|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110428771|NCT01208207|Analgesics|analgesics|mesh-ancestor
110428772|NCT01208207|Sensory System Agents|sensory system agents|mesh-ancestor
110428773|NCT01208207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110428774|NCT01208207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110428775|NCT01208207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110428776|NCT01208207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110428777|NCT01208207|Gout Suppressants|gout suppressants|mesh-ancestor
110428778|NCT01208207|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110428779|NCT01208207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110428780|NCT01208207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110428781|NCT01208207|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110428782|NCT05420285|Dapagliflozin|dapagliflozin|mesh-list
110428783|NCT05420285|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110428784|NCT05420285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110428785|NCT05420285|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110428786|NCT05420285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110428787|NCT01012713|Calcitriol|calcitriol|mesh-list
110428788|NCT01012713|Clobetasol|clobetasol|mesh-list
110428789|NCT01012713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110428790|NCT01012713|Glucocorticoids|glucocorticoids|mesh-ancestor
110428791|NCT01012713|Hormones|hormones|mesh-ancestor
110428792|NCT01012713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110428793|NCT01012713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110428794|NCT01012713|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110428795|NCT01012713|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
110428796|NCT01012713|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110428797|NCT01012713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110428798|NCT01012713|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110428799|NCT01012713|Vitamins|vitamins|mesh-ancestor
110428800|NCT01012713|Micronutrients|micronutrients|mesh-ancestor
110428801|NCT01012713|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110428802|NCT02698813|Hyaluronic Acid|hyaluronic acid|mesh-list
110428803|NCT02698813|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110428804|NCT02698813|Immunologic Factors|immunologic factors|mesh-ancestor
110428805|NCT02698813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110428806|NCT02698813|Viscosupplements|viscosupplements|mesh-ancestor
110428807|NCT02698813|Protective Agents|protective agents|mesh-ancestor
110428808|NCT02702323|Apatinib|apatinib|mesh-list
110428809|NCT02702323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110428810|NCT02702323|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110428811|NCT02702323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110428812|NCT02702323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110428814|NCT01007253|Xhance|xhance|mesh-list
110428815|NCT01007253|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
110428816|NCT01007253|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110428817|NCT01007253|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110428818|NCT01007253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110428819|NCT01007253|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110428820|NCT01007253|Autonomic Agents|autonomic agents|mesh-ancestor
110428821|NCT01007253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110428822|NCT01007253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110428823|NCT01007253|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110428824|NCT01007253|Respiratory System Agents|respiratory system agents|mesh-ancestor
110428825|NCT01007253|Dermatologic Agents|dermatologic agents|mesh-ancestor
110428826|NCT01007253|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110428827|NCT01007253|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110428828|NCT01007253|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110428829|NCT01007253|Analgesics|analgesics|mesh-ancestor
110428830|NCT01007253|Sensory System Agents|sensory system agents|mesh-ancestor
110428831|NCT01007253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110428832|NCT01007253|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110428833|NCT01007253|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110428834|NCT01007253|Histamine Antagonists|histamine antagonists|mesh-ancestor
110428835|NCT01007253|Histamine Agents|histamine agents|mesh-ancestor
110428836|NCT01007253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110428837|NCT01007253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110428838|NCT02691949|Mycophenolic Acid|mycophenolic acid|mesh-list
110428839|NCT02691949|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110428840|NCT02691949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110428841|NCT02691949|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110428842|NCT02691949|Antitubercular Agents|antitubercular agents|mesh-ancestor
110428843|NCT02691949|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110428844|NCT02691949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110428845|NCT02691949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110428846|NCT02691949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110428847|NCT01006707|Ondansetron|ondansetron|mesh-list
110428848|NCT01006707|Antiemetics|antiemetics|mesh-ancestor
110428849|NCT01006707|Autonomic Agents|autonomic agents|mesh-ancestor
110428850|NCT01006707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110428851|NCT01006707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110428852|NCT01006707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110428853|NCT01006707|Antipruritics|antipruritics|mesh-ancestor
110428854|NCT01006707|Dermatologic Agents|dermatologic agents|mesh-ancestor
110428855|NCT01006707|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110428856|NCT01006707|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110428857|NCT01006707|Serotonin Agents|serotonin agents|mesh-ancestor
110428858|NCT01006707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110428859|NCT01006707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110428860|NCT01006629|Palivizumab|palivizumab|mesh-list
110428861|NCT01006629|Antiviral Agents|antiviral agents|mesh-ancestor
110428862|NCT01006629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110428863|NCT04214977|Anesthetics|anesthetics|mesh-list
110428864|NCT04214977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110428865|NCT04214977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110428867|NCT02701933|Analgesics|analgesics|mesh-ancestor
110428868|NCT02701933|Sensory System Agents|sensory system agents|mesh-ancestor
110428869|NCT02701933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110428870|NCT02701933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110428871|NCT02701933|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110428872|NCT02701933|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110428873|NCT02701933|Anesthetics, General|anesthetics, general|mesh-ancestor
110428874|NCT02701933|Anesthetics|anesthetics|mesh-ancestor
110428875|NCT02701933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110428876|NCT02701933|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110428877|NCT02701933|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110428878|NCT02701933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110428879|NCT02701933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110428880|NCT04295967|Formaldehyde|formaldehyde|mesh-list
110428881|NCT04295967|Disinfectants|disinfectants|mesh-ancestor
110428882|NCT04295967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110428883|NCT01012323|Immunoglobulins|immunoglobulins|mesh-list
110428884|NCT01012323|Immunologic Factors|immunologic factors|mesh-ancestor
110428885|NCT01012323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110428886|NCT02871765|Warfarin|warfarin|mesh-list
110428887|NCT02871765|Anticoagulants|anticoagulants|mesh-ancestor
110428888|NCT02549209|Paclitaxel|paclitaxel|mesh-list
110428889|NCT02549209|Carboplatin|carboplatin|mesh-list
110428890|NCT02549209|Pembrolizumab|pembrolizumab|mesh-list
110428891|NCT02549209|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110428892|NCT02549209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110428893|NCT02549209|Tubulin Modulators|tubulin modulators|mesh-ancestor
110428894|NCT02549209|Antimitotic Agents|antimitotic agents|mesh-ancestor
110428895|NCT02549209|Mitosis Modulators|mitosis modulators|mesh-ancestor
110428896|NCT02549209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110428897|NCT02549209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110428898|NCT02549209|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110428899|NCT02698267|Itraconazole|itraconazole|mesh-list
110428900|NCT02698267|Antifungal Agents|antifungal agents|mesh-ancestor
110428901|NCT02698267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110428902|NCT02698267|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110428903|NCT02698267|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110428904|NCT02698267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110428905|NCT02698267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110428906|NCT02698267|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110428907|NCT02698267|Hormone Antagonists|hormone antagonists|mesh-ancestor
110428908|NCT02698267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110428909|NCT02698267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110428910|NCT02698267|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110428911|NCT01011465|Oxytocin|oxytocin|mesh-list
110428912|NCT01011465|Oxytocics|oxytocics|mesh-ancestor
110428913|NCT01011465|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110428914|NCT01011465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110428915|NCT02494141|Curcumin|curcumin|mesh-list
110428916|NCT02494141|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110428917|NCT02494141|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110428918|NCT02494141|Analgesics|analgesics|mesh-ancestor
110428919|NCT02494141|Sensory System Agents|sensory system agents|mesh-ancestor
110428920|NCT02494141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110428921|NCT02494141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110428922|NCT02494141|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110428923|NCT02494141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110428924|NCT02494141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110428925|NCT02494141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110428926|NCT02494141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110428927|NCT01011309|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
110428928|NCT01011309|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110428929|NCT01011309|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110428930|NCT01011309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110428932|NCT01011309|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110428933|NCT01011309|Anthelmintics|anthelmintics|mesh-ancestor
110428934|NCT04214821|Moxifloxacin|moxifloxacin|mesh-list
110428935|NCT04214821|Levofloxacin|levofloxacin|mesh-list
110428936|NCT04214821|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110428937|NCT04214821|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110428938|NCT04214821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110428939|NCT04214821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110428940|NCT04214821|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110428941|NCT04214821|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110428942|NCT04214821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110428943|NCT04214821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110428944|NCT04214821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110428945|NCT04214821|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110428946|NCT04214821|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110428947|NCT04214821|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110428948|NCT00616213|Lenograstim|lenograstim|mesh-list
110428949|NCT00616213|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110428950|NCT00616213|Immunologic Factors|immunologic factors|mesh-ancestor
110428951|NCT00616213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110428952|NCT00615667|Tacrolimus|tacrolimus|mesh-list
110428953|NCT00615667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110428954|NCT00615667|Immunologic Factors|immunologic factors|mesh-ancestor
110428955|NCT00615667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110428956|NCT00615667|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110428957|NCT00615667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110328759|NCT00466232|Sorafenib|sorafenib|mesh-list
110428958|NCT00615667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110428960|NCT02697955|Bupivacaine|bupivacaine|mesh-list
110428961|NCT02697955|Anesthetics, Local|anesthetics, local|mesh-ancestor
110428962|NCT02697955|Anesthetics|anesthetics|mesh-ancestor
110428963|NCT02697955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110428964|NCT02697955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110428965|NCT02697955|Sensory System Agents|sensory system agents|mesh-ancestor
110428966|NCT02697955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110428967|NCT02697955|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110428968|NCT02697955|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110428969|NCT02697955|Adrenergic Agents|adrenergic agents|mesh-ancestor
110428970|NCT02697955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110428971|NCT02697955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110428972|NCT02697955|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110428973|NCT02697955|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110428974|NCT02697955|Autonomic Agents|autonomic agents|mesh-ancestor
110428975|NCT02697955|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110428976|NCT02697955|Respiratory System Agents|respiratory system agents|mesh-ancestor
110428977|NCT02697955|Mydriatics|mydriatics|mesh-ancestor
110428978|NCT02697955|Sympathomimetics|sympathomimetics|mesh-ancestor
110428979|NCT02697955|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110428980|NCT04294329|Bupivacaine|bupivacaine|mesh-list
110428981|NCT04294329|Anesthetics, Local|anesthetics, local|mesh-ancestor
110428982|NCT04294329|Anesthetics|anesthetics|mesh-ancestor
110428983|NCT04294329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110428984|NCT04294329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110428985|NCT04294329|Sensory System Agents|sensory system agents|mesh-ancestor
110428986|NCT04294329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110428987|NCT02701309|Iron|iron|mesh-list
110428988|NCT02701309|Protoporphyrin IX|protoporphyrin ix|mesh-list
110428989|NCT02701309|Zinc protoporphyrin|zinc protoporphyrin|mesh-list
110428990|NCT02701309|Trace Elements|trace elements|mesh-ancestor
110428991|NCT02701309|Micronutrients|micronutrients|mesh-ancestor
110428992|NCT02701309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110428993|NCT02701309|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110428994|NCT02701309|Dermatologic Agents|dermatologic agents|mesh-ancestor
110428995|NCT02701309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110428996|NCT02701309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110428997|NCT03250507|Bupivacaine|bupivacaine|mesh-list
110428998|NCT03250507|Anesthetics, Local|anesthetics, local|mesh-ancestor
110428999|NCT03250507|Anesthetics|anesthetics|mesh-ancestor
110429000|NCT03250507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110429001|NCT03250507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110429002|NCT03250507|Sensory System Agents|sensory system agents|mesh-ancestor
110429003|NCT03250507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110075948|NCT05344911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110075949|NCT05344911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110075950|NCT05344911|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110075951|NCT05344911|Anesthetics, General|anesthetics, general|mesh-ancestor
110075952|NCT05344911|Anesthetics|anesthetics|mesh-ancestor
110075953|NCT05344911|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110075954|NCT05344911|Narcotics|narcotics|mesh-ancestor
110075955|NCT05344911|Analgesics|analgesics|mesh-ancestor
110075956|NCT05344911|Sensory System Agents|sensory system agents|mesh-ancestor
110429004|NCT00997893|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
110429005|NCT00997893|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110429006|NCT00997893|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110429007|NCT00997893|Medroxyprogesterone|medroxyprogesterone|mesh-list
110429009|NCT00997893|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110429010|NCT00997893|Estrogens|estrogens|mesh-list
110429011|NCT00997893|Phytoestrogens|phytoestrogens|mesh-list
110429012|NCT00997893|Hormones|hormones|mesh-ancestor
110429013|NCT00997893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110429014|NCT00997893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110429015|NCT00997893|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110429016|NCT00997893|Contraceptive Agents|contraceptive agents|mesh-ancestor
110429017|NCT00997893|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110429018|NCT00997893|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110429019|NCT00997893|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110429020|NCT00997893|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110429021|NCT00997893|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110429023|NCT00997893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110429024|NCT00997893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110429025|NCT00997893|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
110429026|NCT02697877|Regadenoson|regadenoson|mesh-list
110429027|NCT02697877|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
110429028|NCT02697877|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
110429029|NCT02697877|Purinergic Agonists|purinergic agonists|mesh-ancestor
110429030|NCT02697877|Purinergic Agents|purinergic agents|mesh-ancestor
110429031|NCT02697877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110429032|NCT02697877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110429033|NCT02697877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110429034|NCT04214665|Thioctic Acid|thioctic acid|mesh-list
110429035|NCT04214665|Antioxidants|antioxidants|mesh-ancestor
110429036|NCT04214665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110429037|NCT04214665|Protective Agents|protective agents|mesh-ancestor
110429038|NCT04214665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110429039|NCT04214665|Vitamin B Complex|vitamin b complex|mesh-ancestor
110429040|NCT04214665|Vitamins|vitamins|mesh-ancestor
110429041|NCT04214665|Micronutrients|micronutrients|mesh-ancestor
110429042|NCT02870673|Triamcinolone|triamcinolone|mesh-list
110429043|NCT02870673|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110429044|NCT02870673|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110429045|NCT02870673|Lidocaine|lidocaine|mesh-list
110429046|NCT02870673|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110429047|NCT02870673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110429048|NCT02870673|Glucocorticoids|glucocorticoids|mesh-ancestor
110429049|NCT02870673|Hormones|hormones|mesh-ancestor
110429050|NCT02870673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110429051|NCT02870673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110429052|NCT02870673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110429053|NCT02870673|Immunologic Factors|immunologic factors|mesh-ancestor
110429054|NCT02870673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110429055|NCT02870673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110429056|NCT02870673|Anesthetics, Local|anesthetics, local|mesh-ancestor
110429057|NCT02870673|Anesthetics|anesthetics|mesh-ancestor
110429058|NCT02870673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110429059|NCT02870673|Sensory System Agents|sensory system agents|mesh-ancestor
110564492|NCT05746897|Pembrolizumab|pembrolizumab|mesh-list
110429060|NCT02870673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110429061|NCT02870673|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110429062|NCT02870673|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110429063|NCT02870673|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110429064|NCT02870673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110429065|NCT00615745|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110429066|NCT00615745|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110429067|NCT00615745|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110429068|NCT00615745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110429069|NCT00615745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110429070|NCT00615745|Antiviral Agents|antiviral agents|mesh-ancestor
110429071|NCT00615745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110429072|NCT00615745|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110429073|NCT00615745|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110429074|NCT05324839|Botulinum Toxins|botulinum toxins|mesh-list
110429075|NCT05324839|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110076024|NCT04873557|Copper|copper|mesh-list
110429076|NCT05324839|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110429077|NCT05324839|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110429078|NCT05324839|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110371168|NCT00562289|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110429079|NCT05324839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110429080|NCT05324839|Cholinergic Agents|cholinergic agents|mesh-ancestor
110429081|NCT05324839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110429082|NCT05324839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110429083|NCT05324839|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110429084|NCT05324839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110429086|NCT02700685|Pycnogenols|pycnogenols|mesh-list
110429087|NCT02700685|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110429088|NCT02700685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110429089|NCT02700685|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110429090|NCT02700685|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110429091|NCT02700685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110429092|NCT02700685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110429093|NCT02700685|Dopamine Agents|dopamine agents|mesh-ancestor
110429094|NCT02700685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110429095|NCT02700685|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110429096|NCT02700685|Immunologic Factors|immunologic factors|mesh-ancestor
110429097|NCT02700685|Antioxidants|antioxidants|mesh-ancestor
110429098|NCT02700685|Protective Agents|protective agents|mesh-ancestor
110429099|NCT02700685|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110429100|NCT02700763|Dabrafenib|dabrafenib|mesh-list
110429101|NCT02700763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110429102|NCT02700763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110429103|NCT02700763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110429104|NCT02700763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110429105|NCT03151681|Propranolol|propranolol|mesh-list
110429106|NCT03151681|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110429107|NCT03151681|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110429108|NCT03151681|Adrenergic Agents|adrenergic agents|mesh-ancestor
110429109|NCT03151681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110429110|NCT03151681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110429111|NCT03151681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110429112|NCT03151681|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110429113|NCT03151681|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110429114|NCT03151681|Vasodilator Agents|vasodilator agents|mesh-ancestor
110429115|NCT04215445|Empagliflozin|empagliflozin|mesh-list
110429116|NCT04215445|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110429117|NCT04215445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110429118|NCT04215445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110429119|NCT04215445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110429120|NCT00951457|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110429121|NCT00951457|Alemtuzumab|alemtuzumab|mesh-list
110429122|NCT00951457|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110429123|NCT00951457|Alkylating Agents|alkylating agents|mesh-ancestor
110429124|NCT00951457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110429125|NCT00951457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110429126|NCT00951457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110429127|NCT02691871|Docetaxel|docetaxel|mesh-list
110429128|NCT02691871|Apatinib|apatinib|mesh-list
110429129|NCT02691871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110429130|NCT02691871|Tubulin Modulators|tubulin modulators|mesh-ancestor
110429131|NCT02691871|Antimitotic Agents|antimitotic agents|mesh-ancestor
110429132|NCT02691871|Mitosis Modulators|mitosis modulators|mesh-ancestor
110429133|NCT02691871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110429134|NCT02691871|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110429135|NCT02691871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110429136|NCT02700217|Remifentanil|remifentanil|mesh-list
110429137|NCT02700217|Heroin|heroin|mesh-list
110429138|NCT02700217|Bupivacaine|bupivacaine|mesh-list
110429139|NCT02700217|Propofol|propofol|mesh-list
110429140|NCT02700217|Anesthetics, Local|anesthetics, local|mesh-ancestor
110429141|NCT02700217|Anesthetics|anesthetics|mesh-ancestor
110429142|NCT02700217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110429143|NCT02700217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110429144|NCT02700217|Sensory System Agents|sensory system agents|mesh-ancestor
110429145|NCT02700217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110429146|NCT02700217|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110429147|NCT02700217|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110429148|NCT02700217|Anesthetics, General|anesthetics, general|mesh-ancestor
110429149|NCT02700217|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110429151|NCT02700217|Analgesics|analgesics|mesh-ancestor
110429152|NCT02699827|Magnesium Sulfate|magnesium sulfate|mesh-list
110429153|NCT02699827|Levobupivacaine|levobupivacaine|mesh-list
110429154|NCT02699827|Analgesics|analgesics|mesh-ancestor
110429155|NCT02699827|Sensory System Agents|sensory system agents|mesh-ancestor
110429156|NCT02699827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110429157|NCT02699827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110429158|NCT02699827|Anesthetics|anesthetics|mesh-ancestor
110429159|NCT02699827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110429160|NCT02699827|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110429161|NCT02699827|Anticonvulsants|anticonvulsants|mesh-ancestor
110429162|NCT02699827|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110429163|NCT02699827|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110429164|NCT02699827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110429165|NCT02699827|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110429166|NCT02699827|Tocolytic Agents|tocolytic agents|mesh-ancestor
110429167|NCT02699827|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110429168|NCT02699827|Anesthetics, Local|anesthetics, local|mesh-ancestor
110429169|NCT02705989|Branebrutinib|branebrutinib|mesh-list
110429170|NCT02705989|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110429171|NCT02705989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110429172|NCT02705989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110429173|NCT02706067|Orlistat|orlistat|mesh-list
110429174|NCT02706067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110429175|NCT02706067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110429176|NCT02706067|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110429177|NCT02706067|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110429178|NCT02939287|Olanzapine|olanzapine|mesh-list
110429179|NCT02939287|Aprepitant|aprepitant|mesh-list
110429180|NCT02939287|Fosaprepitant|fosaprepitant|mesh-list
110429181|NCT02939287|Antiemetics|antiemetics|mesh-ancestor
110429182|NCT02939287|Autonomic Agents|autonomic agents|mesh-ancestor
110429183|NCT02939287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110429184|NCT02939287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110429185|NCT02939287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110429186|NCT02939287|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110429187|NCT02939287|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110429188|NCT02939287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110429189|NCT02939287|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110429190|NCT02939287|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110429191|NCT02939287|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110429192|NCT02939287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110429193|NCT02939287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110429194|NCT02939287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110429195|NCT02939287|Serotonin Agents|serotonin agents|mesh-ancestor
110429196|NCT02939287|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110429197|NCT05323201|Cyclophosphamide|cyclophosphamide|mesh-list
110429198|NCT05323201|Fludarabine|fludarabine|mesh-list
110429199|NCT05323201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110429200|NCT05323201|Immunologic Factors|immunologic factors|mesh-ancestor
110429201|NCT05323201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110429202|NCT05323201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110429203|NCT05323201|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110429204|NCT05323201|Alkylating Agents|alkylating agents|mesh-ancestor
110564494|NCT05746897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110429205|NCT05323201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110429206|NCT05323201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110429207|NCT05323201|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110429208|NCT01208051|Lenalidomide|lenalidomide|mesh-list
110429209|NCT01208051|Cediranib|cediranib|mesh-list
110429210|NCT01208051|Maleic acid|maleic acid|mesh-list
110429211|NCT01208051|Immunologic Factors|immunologic factors|mesh-ancestor
110429212|NCT01208051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110429213|NCT01208051|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110429214|NCT01208051|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110429215|NCT01208051|Growth Substances|growth substances|mesh-ancestor
110429217|NCT01208051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110429218|NCT01208051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110429219|NCT01208051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110429220|NCT01208051|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110429221|NCT05322889|Telmisartan|telmisartan|mesh-list
110429222|NCT05322889|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110429223|NCT05322889|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110429224|NCT05322889|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110429225|NCT05322889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110429226|NCT00616915|Bupropion|bupropion|mesh-list
110429227|NCT00616915|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110429228|NCT00616915|Antidepressive Agents|antidepressive agents|mesh-ancestor
110429229|NCT00616915|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110429230|NCT00616915|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110429231|NCT00616915|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110429232|NCT00616915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110429233|NCT00616915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110429234|NCT00616915|Dopamine Agents|dopamine agents|mesh-ancestor
110429235|NCT00616915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110429236|NCT00616915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110429237|NCT00616915|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110429238|NCT00616915|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110429239|NCT00616915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110429240|NCT05410223|Amoxicillin|amoxicillin|mesh-list
110429241|NCT05410223|Clarithromycin|clarithromycin|mesh-list
110429242|NCT05410223|Doxycycline|doxycycline|mesh-list
110429243|NCT05410223|Furazolidone|furazolidone|mesh-list
110429244|NCT05410223|Bismuth|bismuth|mesh-list
110429245|NCT05410223|Antibodies|antibodies|mesh-list
110429246|NCT05410223|Immunoglobulins|immunoglobulins|mesh-list
110429247|NCT05410223|Immunologic Factors|immunologic factors|mesh-ancestor
110429248|NCT05410223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110429249|NCT05410223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110429250|NCT05410223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110429251|NCT05410223|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110429252|NCT05410223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110429253|NCT05410223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110429254|NCT05410223|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110429255|NCT05410223|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110429256|NCT05410223|Antimalarials|antimalarials|mesh-ancestor
110429257|NCT05410223|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110429258|NCT05410223|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110429259|NCT05410223|Antacids|antacids|mesh-ancestor
110429260|NCT05410223|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110429261|NCT05410223|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110429262|NCT05410223|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110429263|NCT05410223|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
110429264|NCT05410223|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
110429265|NCT01206101|Liraglutide|liraglutide|mesh-list
110429266|NCT01206101|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110429267|NCT01206101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110429268|NCT01206101|Incretins|incretins|mesh-ancestor
110429269|NCT01206101|Hormones|hormones|mesh-ancestor
110429270|NCT01206101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110429271|NCT00997503|Aspirin|aspirin|mesh-list
110429272|NCT00997503|Paclitaxel|paclitaxel|mesh-list
110429273|NCT00997503|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
110429274|NCT00997503|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110429275|NCT00997503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110429276|NCT00997503|Tubulin Modulators|tubulin modulators|mesh-ancestor
110564497|NCT05686564|Choline|choline|mesh-list
110429277|NCT00997503|Antimitotic Agents|antimitotic agents|mesh-ancestor
110429278|NCT00997503|Mitosis Modulators|mitosis modulators|mesh-ancestor
110429279|NCT00997503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110429280|NCT00997503|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110429281|NCT00997503|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110429282|NCT00997503|Analgesics|analgesics|mesh-ancestor
110203529|NCT00160186|Pancreatin|pancreatin|mesh-list
110429283|NCT00997503|Sensory System Agents|sensory system agents|mesh-ancestor
110429284|NCT00997503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110429285|NCT00997503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110429286|NCT00997503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110429287|NCT00997503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110429288|NCT00997503|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110429289|NCT00997503|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110429290|NCT00997503|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110429291|NCT00997503|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110429292|NCT00997503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110429293|NCT00997503|Antipyretics|antipyretics|mesh-ancestor
110429294|NCT02705053|Insulin|insulin|mesh-list
110429295|NCT02705053|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110429296|NCT02705053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110429297|NCT01204775|Metformin|metformin|mesh-list
110429298|NCT01204775|Saxagliptin|saxagliptin|mesh-list
110429299|NCT01204775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110429300|NCT01204775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110429301|NCT01204775|Incretins|incretins|mesh-ancestor
110429302|NCT01204775|Hormones|hormones|mesh-ancestor
110429303|NCT01204775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110429304|NCT01204775|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110429305|NCT01204775|Protease Inhibitors|protease inhibitors|mesh-ancestor
110429306|NCT01204775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110429307|NCT01204775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110429308|NCT02844907|Dexamethasone|dexamethasone|mesh-list
110429309|NCT02844907|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110429310|NCT02844907|Antiemetics|antiemetics|mesh-ancestor
110429311|NCT02844907|Autonomic Agents|autonomic agents|mesh-ancestor
110429312|NCT02844907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110429313|NCT02844907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110429314|NCT02844907|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110429315|NCT02844907|Glucocorticoids|glucocorticoids|mesh-ancestor
110429316|NCT02844907|Hormones|hormones|mesh-ancestor
110429317|NCT02844907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110429318|NCT02844907|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110429319|NCT02844907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110429320|NCT00628719|Amphotericin B|amphotericin b|mesh-list
110429321|NCT00628719|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
110429322|NCT00628719|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
110429323|NCT00628719|Deoxycholic Acid|deoxycholic acid|mesh-list
110429324|NCT00628719|Amebicides|amebicides|mesh-ancestor
110429325|NCT00628719|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110429326|NCT00628719|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110429327|NCT00628719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110429328|NCT00628719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110429329|NCT00628719|Antifungal Agents|antifungal agents|mesh-ancestor
110429330|NCT00628719|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
110429331|NCT00628719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110429332|NCT00616993|Difluprednate|difluprednate|mesh-list
110429333|NCT00616993|Glucocorticoids|glucocorticoids|mesh-ancestor
110429334|NCT00616993|Hormones|hormones|mesh-ancestor
110429335|NCT00616993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110429336|NCT00616993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110429337|NCT02870361|Insulin|insulin|mesh-list
110429338|NCT02870361|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110429339|NCT02870361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110429340|NCT00616681|Oxcarbazepine|oxcarbazepine|mesh-list
110429341|NCT00616681|Anticonvulsants|anticonvulsants|mesh-ancestor
110429342|NCT00616681|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110429343|NCT00616681|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110429344|NCT00616681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110429345|NCT00616681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110429346|NCT00616681|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110429347|NCT00616681|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110429348|NCT00997035|Voriconazole|voriconazole|mesh-list
110429349|NCT00997035|Antifungal Agents|antifungal agents|mesh-ancestor
110429350|NCT00997035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110429351|NCT00997035|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110429352|NCT00997035|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110429353|NCT00997035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110429354|NCT00997035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110429355|NCT00997035|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110429356|NCT00997035|Hormone Antagonists|hormone antagonists|mesh-ancestor
110429357|NCT00997035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110429358|NCT00997035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110429359|NCT00997035|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110429360|NCT01204697|Docetaxel|docetaxel|mesh-list
110429361|NCT01204697|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110429362|NCT01204697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110429363|NCT01204697|Tubulin Modulators|tubulin modulators|mesh-ancestor
110429364|NCT01204697|Antimitotic Agents|antimitotic agents|mesh-ancestor
110429365|NCT01204697|Mitosis Modulators|mitosis modulators|mesh-ancestor
110429366|NCT01204697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110429367|NCT01204697|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110429368|NCT01204697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110429369|NCT01203917|Gefitinib|gefitinib|mesh-list
110429370|NCT01203917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110429371|NCT01203917|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110429373|NCT01203917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110429374|NCT04213495|Anesthetics|anesthetics|mesh-list
110429375|NCT04213495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110429376|NCT04213495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110429377|NCT04318223|Palbociclib|palbociclib|mesh-list
110429378|NCT04318223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110429379|NCT04318223|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110429380|NCT04318223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110429381|NCT04318223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110429382|NCT01202903|Omalizumab|omalizumab|mesh-list
110429383|NCT01202903|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110429384|NCT01202903|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110429385|NCT01202903|Respiratory System Agents|respiratory system agents|mesh-ancestor
110429386|NCT00618631|Carfentanil|carfentanil|mesh-list
110429387|NCT00618631|Nicotine|nicotine|mesh-list
110429388|NCT00618631|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110429389|NCT00618631|Autonomic Agents|autonomic agents|mesh-ancestor
110429390|NCT00618631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110429391|NCT00618631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110429392|NCT00618631|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110429393|NCT00618631|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110429394|NCT00618631|Cholinergic Agents|cholinergic agents|mesh-ancestor
110429395|NCT00618631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110429396|NCT00618631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110429397|NCT00618631|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110429398|NCT00618631|Narcotics|narcotics|mesh-ancestor
110429399|NCT00618631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110429400|NCT00618631|Analgesics|analgesics|mesh-ancestor
110429401|NCT00618631|Sensory System Agents|sensory system agents|mesh-ancestor
110429402|NCT04213573|Fluorides|fluorides|mesh-list
110429403|NCT04213573|Cariostatic Agents|cariostatic agents|mesh-ancestor
110429404|NCT04213573|Protective Agents|protective agents|mesh-ancestor
110429405|NCT04213573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110429406|NCT00620269|Irinotecan|irinotecan|mesh-list
110429407|NCT00620269|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110429408|NCT00620269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110429409|NCT00620269|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110429410|NCT00620269|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110429411|NCT00620269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110429412|NCT00620269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110429413|NCT00620269|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110429414|NCT04212403|Levofloxacin|levofloxacin|mesh-list
110429415|NCT04212403|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110429416|NCT04212403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110429417|NCT04212403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110429418|NCT04212403|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110429419|NCT04212403|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110429420|NCT04212403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110429421|NCT04212403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110429422|NCT04212403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110371195|NCT04313218|Carbetocin|carbetocin|mesh-list
110429423|NCT04212403|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110429424|NCT04212403|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110429426|NCT00637117|Interferon-alpha|interferon-alpha|mesh-list
110429427|NCT00637117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110429428|NCT00637117|Antiviral Agents|antiviral agents|mesh-ancestor
110429429|NCT00637117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110429430|NCT00637117|Immunologic Factors|immunologic factors|mesh-ancestor
110429431|NCT00637117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110429432|NCT02052193|Vemurafenib|vemurafenib|mesh-list
110429433|NCT02052193|Dabrafenib|dabrafenib|mesh-list
110429434|NCT02052193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110429435|NCT02052193|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110429436|NCT02052193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110429437|NCT02052193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110429438|NCT00617695|Zolmitriptan|zolmitriptan|mesh-list
110429439|NCT00617695|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110429440|NCT00617695|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110429441|NCT00617695|Serotonin Agents|serotonin agents|mesh-ancestor
110429442|NCT00617695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110429443|NCT00617695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110429444|NCT00617695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110429445|NCT00619021|Gemcitabine|gemcitabine|mesh-list
110429446|NCT00619021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110429447|NCT00619021|Antimetabolites|antimetabolites|mesh-ancestor
110429448|NCT00619021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110429449|NCT00619021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110429450|NCT00620347|Sunitinib|sunitinib|mesh-list
110429451|NCT00620347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110429452|NCT00620347|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110429453|NCT00620347|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110429454|NCT00620347|Growth Substances|growth substances|mesh-ancestor
110429455|NCT00620347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110429456|NCT00620347|Growth Inhibitors|growth inhibitors|mesh-ancestor
110429457|NCT00620347|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110429458|NCT00620347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110429459|NCT00620347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110429461|NCT04213105|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110429462|NCT04213105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110429463|NCT01887301|Nabiximols|nabiximols|mesh-list
110429464|NCT01887301|Analgesics|analgesics|mesh-ancestor
110429465|NCT01887301|Sensory System Agents|sensory system agents|mesh-ancestor
110429466|NCT01887301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110429467|NCT01887301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110429468|NCT00996801|Vitamin D|vitamin d|mesh-list
110429469|NCT00996801|Cholecalciferol|cholecalciferol|mesh-list
110429470|NCT00996801|Alendronate|alendronate|mesh-list
110429471|NCT00996801|Calcium Carbonate|calcium carbonate|mesh-list
110429472|NCT00996801|Calcium|calcium|mesh-list
110429473|NCT00996801|Vitamins|vitamins|mesh-ancestor
110429474|NCT00996801|Micronutrients|micronutrients|mesh-ancestor
110429475|NCT00996801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110429476|NCT00996801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110429477|NCT00996801|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110429478|NCT00996801|Antacids|antacids|mesh-ancestor
110429479|NCT00996801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110429480|NCT00996801|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110429481|NCT00619333|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
110429482|NCT00619333|Hormones|hormones|mesh-ancestor
110429483|NCT00619333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110429484|NCT00619333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110429485|NCT04924621|Midazolam|midazolam|mesh-list
110429486|NCT04924621|Sufentanil|sufentanil|mesh-list
110429487|NCT04924621|Propofol|propofol|mesh-list
110429488|NCT04924621|Tetracaine|tetracaine|mesh-list
110429489|NCT04924621|Rocuronium|rocuronium|mesh-list
110429490|NCT04924621|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110429491|NCT04924621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110429492|NCT04924621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110429493|NCT04924621|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110429494|NCT04924621|Anesthetics, General|anesthetics, general|mesh-ancestor
110429495|NCT04924621|Anesthetics|anesthetics|mesh-ancestor
110429496|NCT04924621|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110429497|NCT04924621|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110429498|NCT04924621|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110429499|NCT04924621|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110429500|NCT04924621|GABA Modulators|gaba modulators|mesh-ancestor
110429501|NCT04924621|GABA Agents|gaba agents|mesh-ancestor
110429502|NCT04924621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110429503|NCT04924621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110429504|NCT04924621|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110429505|NCT04924621|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110429506|NCT04924621|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110429507|NCT04924621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110429508|NCT04924621|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110429509|NCT04924621|Narcotics|narcotics|mesh-ancestor
110429510|NCT04924621|Analgesics|analgesics|mesh-ancestor
110429511|NCT04924621|Sensory System Agents|sensory system agents|mesh-ancestor
110429512|NCT04924621|Anesthetics, Local|anesthetics, local|mesh-ancestor
110429513|NCT02213497|Paclitaxel|paclitaxel|mesh-list
110429514|NCT02213497|Carboplatin|carboplatin|mesh-list
110429515|NCT02213497|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110429516|NCT02213497|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110429517|NCT02213497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110429518|NCT02213497|Tubulin Modulators|tubulin modulators|mesh-ancestor
110429519|NCT02213497|Antimitotic Agents|antimitotic agents|mesh-ancestor
110429520|NCT02213497|Mitosis Modulators|mitosis modulators|mesh-ancestor
110429521|NCT02213497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110429522|NCT02213497|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110429523|NCT00618163|Meloxicam|meloxicam|mesh-list
110429524|NCT00618163|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110328782|NCT00497562|Narcotics|narcotics|mesh-ancestor
110429525|NCT00618163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110429526|NCT00618163|Analgesics|analgesics|mesh-ancestor
110429527|NCT00618163|Sensory System Agents|sensory system agents|mesh-ancestor
110429528|NCT00618163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110429529|NCT00618163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110429530|NCT00618163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110429531|NCT00618163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110429532|NCT00618163|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110429533|NCT00618163|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110429534|NCT00618163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110429535|NCT00618163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110429536|NCT00618241|Raltegravir Potassium|raltegravir potassium|mesh-list
110429537|NCT00618241|Lamotrigine|lamotrigine|mesh-list
110429538|NCT00618241|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110429539|NCT00618241|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110429540|NCT00618241|Antiviral Agents|antiviral agents|mesh-ancestor
110429541|NCT00618241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110429542|NCT00618241|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110429543|NCT00618241|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110429544|NCT00618241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110429545|NCT00618241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110429546|NCT00618241|Anticonvulsants|anticonvulsants|mesh-ancestor
110429547|NCT00618241|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110429548|NCT00618241|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110429549|NCT00618241|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110429550|NCT00618241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110429551|NCT00618241|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110429552|NCT00618241|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110429553|NCT00618241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110429554|NCT00618241|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110429555|NCT00618241|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110429556|NCT00618397|Ketamine|ketamine|mesh-list
110429557|NCT00618397|Analgesics|analgesics|mesh-ancestor
110429558|NCT00618397|Sensory System Agents|sensory system agents|mesh-ancestor
110429559|NCT00618397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110429560|NCT00618397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110429561|NCT00618397|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110429562|NCT00618397|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110429563|NCT00618397|Anesthetics, General|anesthetics, general|mesh-ancestor
110429564|NCT00618397|Anesthetics|anesthetics|mesh-ancestor
110429565|NCT00618397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110429566|NCT00618397|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110429567|NCT00618397|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110429568|NCT00618397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110429569|NCT00618397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110429570|NCT04211545|Rabeprazole|rabeprazole|mesh-list
110429571|NCT04211545|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110429572|NCT04211545|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110429573|NCT04211545|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110429574|NCT04211545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110429575|NCT04211545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110429576|NCT00620581|Paroxetine|paroxetine|mesh-list
110429577|NCT00620581|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110429578|NCT00620581|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110429579|NCT00620581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110429580|NCT00620581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110429581|NCT00620581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110429582|NCT00620581|Serotonin Agents|serotonin agents|mesh-ancestor
110429583|NCT00620581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110429584|NCT00620581|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110429585|NCT00620581|Antidepressive Agents|antidepressive agents|mesh-ancestor
110429586|NCT00620581|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110429587|NCT00620581|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110429588|NCT00620581|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110429589|NCT00620581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110429591|NCT01000311|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110429592|NCT01000311|Immunologic Factors|immunologic factors|mesh-ancestor
110429593|NCT01000311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110429594|NCT04209439|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
110429595|NCT04209439|Bupivacaine|bupivacaine|mesh-list
110429597|NCT04209439|Anesthetics|anesthetics|mesh-ancestor
110429598|NCT04209439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110429599|NCT04209439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110429600|NCT04209439|Sensory System Agents|sensory system agents|mesh-ancestor
110429601|NCT04209439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110429602|NCT04209439|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110429603|NCT04209439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110429604|NCT04209439|Analgesics|analgesics|mesh-ancestor
110429605|NCT04209439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110429606|NCT04209439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110429607|NCT05228041|Benralizumab|benralizumab|mesh-list
110429608|NCT05228041|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110429609|NCT05228041|Respiratory System Agents|respiratory system agents|mesh-ancestor
110429610|NCT01003899|Afatinib|afatinib|mesh-list
110429611|NCT01003899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110429612|NCT01003899|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110429613|NCT01003899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110429614|NCT01003899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110429615|NCT04160377|Fluvoxamine|fluvoxamine|mesh-list
110429616|NCT04160377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110429617|NCT04160377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110429618|NCT04160377|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110429619|NCT04160377|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110429620|NCT04160377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110429621|NCT04160377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110429622|NCT04160377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110429623|NCT04160377|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110429624|NCT04160377|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110429625|NCT04160377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110429626|NCT04160377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110429627|NCT04160377|Serotonin Agents|serotonin agents|mesh-ancestor
110429628|NCT04160377|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110429629|NCT04160377|Antidepressive Agents|antidepressive agents|mesh-ancestor
110429630|NCT04160377|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110429631|NCT04160377|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110429632|NCT04160377|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110429633|NCT01000155|Vorinostat|vorinostat|mesh-list
110429634|NCT01000155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110429635|NCT01000155|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110429636|NCT01000155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110429637|NCT01000155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110429638|NCT00999921|Tamoxifen|tamoxifen|mesh-list
110429639|NCT00999921|Evening primrose oil|evening primrose oil|mesh-list
110429640|NCT00999921|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110429641|NCT00999921|Hormone Antagonists|hormone antagonists|mesh-ancestor
110429642|NCT00999921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110429643|NCT00999921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110429644|NCT00999921|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110429645|NCT00999921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110203599|NCT00160576|Nootropic Agents|nootropic agents|mesh-ancestor
110429646|NCT00999921|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110429647|NCT00999921|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110429648|NCT00999921|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110429649|NCT00999921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110429650|NCT00999921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110429651|NCT00999921|Analgesics|analgesics|mesh-ancestor
110429652|NCT00999921|Sensory System Agents|sensory system agents|mesh-ancestor
110429653|NCT00999921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110429654|NCT00999921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110429655|NCT00999921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110429656|NCT00999921|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110429657|NCT00999921|Antimetabolites|antimetabolites|mesh-ancestor
110429658|NCT00999921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110429659|NCT00999921|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110429660|NCT00999921|Dermatologic Agents|dermatologic agents|mesh-ancestor
110429661|NCT02869347|Complement C1s|complement c1s|mesh-list
110429662|NCT02869347|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
110429663|NCT02869347|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
110429664|NCT02869347|Immunologic Factors|immunologic factors|mesh-ancestor
110429665|NCT02869347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110429666|NCT02869347|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
110429668|NCT00621673|Factor VIII|factor viii|mesh-list
110429669|NCT00621673|Coagulants|coagulants|mesh-ancestor
110429670|NCT01002573|Acetaminophen|acetaminophen|mesh-list
110429671|NCT01002573|Ibuprofen|ibuprofen|mesh-list
110429672|NCT01002573|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110429673|NCT01002573|Analgesics|analgesics|mesh-ancestor
110429674|NCT01002573|Sensory System Agents|sensory system agents|mesh-ancestor
110429675|NCT01002573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110429676|NCT01002573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110429677|NCT01002573|Antipyretics|antipyretics|mesh-ancestor
110429678|NCT01002573|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110429679|NCT01002573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110429680|NCT01002573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110429681|NCT01002573|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110429682|NCT01002573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110429683|NCT01002573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110429684|NCT00620893|Lubricant Eye Drops|lubricant eye drops|mesh-list
110429685|NCT00620893|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110429686|NCT00620893|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110429687|NCT04293549|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110429688|NCT04293549|Mitogens|mitogens|mesh-list
110429689|NCT04293549|Mitosis Modulators|mitosis modulators|mesh-ancestor
110371226|NCT04590183|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110429690|NCT04293549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110429691|NCT04293549|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110429692|NCT00996333|Gemcitabine|gemcitabine|mesh-list
110429693|NCT00996333|Capecitabine|capecitabine|mesh-list
110429694|NCT00996333|Docetaxel|docetaxel|mesh-list
110429695|NCT00996333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110429696|NCT00996333|Antimetabolites|antimetabolites|mesh-ancestor
110429697|NCT00996333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110429698|NCT00996333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110429699|NCT00996333|Tubulin Modulators|tubulin modulators|mesh-ancestor
110429700|NCT00996333|Antimitotic Agents|antimitotic agents|mesh-ancestor
110429701|NCT00996333|Mitosis Modulators|mitosis modulators|mesh-ancestor
110429702|NCT00621907|Levobupivacaine|levobupivacaine|mesh-list
110429703|NCT00621907|Anesthetics, Local|anesthetics, local|mesh-ancestor
110429704|NCT00621907|Anesthetics|anesthetics|mesh-ancestor
110429705|NCT00621907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110429706|NCT00621907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110429707|NCT00621907|Sensory System Agents|sensory system agents|mesh-ancestor
110429708|NCT00621907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110429709|NCT01349101|Mycophenolic Acid|mycophenolic acid|mesh-list
110429710|NCT01349101|Cyclophosphamide|cyclophosphamide|mesh-list
110429711|NCT01349101|Busulfan|busulfan|mesh-list
110429712|NCT01349101|Fludarabine|fludarabine|mesh-list
110429713|NCT01349101|Fludarabine phosphate|fludarabine phosphate|mesh-list
110429715|NCT01349101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110429716|NCT01349101|Immunologic Factors|immunologic factors|mesh-ancestor
110429717|NCT01349101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110429718|NCT01349101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110429719|NCT01349101|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110429720|NCT01349101|Alkylating Agents|alkylating agents|mesh-ancestor
110429721|NCT01349101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110429722|NCT01349101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110429723|NCT01349101|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110429724|NCT01349101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110429725|NCT01349101|Antimetabolites|antimetabolites|mesh-ancestor
110429726|NCT01349101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110429727|NCT01349101|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110429728|NCT01349101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110429729|NCT01349101|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110429730|NCT01349101|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110429731|NCT01349101|Antitubercular Agents|antitubercular agents|mesh-ancestor
110429732|NCT01349101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110429733|NCT00620971|Bevacizumab|bevacizumab|mesh-list
110429734|NCT00620971|Cisplatin|cisplatin|mesh-list
110429735|NCT00620971|Gemcitabine|gemcitabine|mesh-list
110429736|NCT00620971|Docetaxel|docetaxel|mesh-list
110429737|NCT00620971|Vinorelbine|vinorelbine|mesh-list
110429738|NCT00620971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110429739|NCT00620971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110429740|NCT00620971|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110076699|NCT03476642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110429741|NCT00620971|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110429742|NCT00620971|Growth Substances|growth substances|mesh-ancestor
110429743|NCT00620971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110429744|NCT00620971|Growth Inhibitors|growth inhibitors|mesh-ancestor
110429745|NCT00620971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110429746|NCT00620971|Antimetabolites|antimetabolites|mesh-ancestor
110429747|NCT00620971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110429748|NCT00620971|Tubulin Modulators|tubulin modulators|mesh-ancestor
110429749|NCT00620971|Antimitotic Agents|antimitotic agents|mesh-ancestor
110429750|NCT00620971|Mitosis Modulators|mitosis modulators|mesh-ancestor
110429751|NCT00620971|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110429752|NCT04223661|Dexamethasone|dexamethasone|mesh-list
110429753|NCT04223661|Lenalidomide|lenalidomide|mesh-list
110429754|NCT04223661|Daratumumab|daratumumab|mesh-list
110429755|NCT04223661|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110429756|NCT04223661|Antiemetics|antiemetics|mesh-ancestor
110429757|NCT04223661|Autonomic Agents|autonomic agents|mesh-ancestor
110429758|NCT04223661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110371236|NCT04590183|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110429759|NCT04223661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110429761|NCT04223661|Glucocorticoids|glucocorticoids|mesh-ancestor
110429762|NCT04223661|Hormones|hormones|mesh-ancestor
110429763|NCT04223661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110429764|NCT04223661|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110429765|NCT04223661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110429766|NCT04223661|Immunologic Factors|immunologic factors|mesh-ancestor
110429767|NCT04223661|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110429768|NCT04223661|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110429769|NCT04223661|Growth Substances|growth substances|mesh-ancestor
110429770|NCT04223661|Growth Inhibitors|growth inhibitors|mesh-ancestor
110429771|NCT00622141|Saquinavir|saquinavir|mesh-list
110429772|NCT00622141|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110429773|NCT00622141|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110429774|NCT00622141|Protease Inhibitors|protease inhibitors|mesh-ancestor
110429775|NCT00622141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110429776|NCT00622141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110429777|NCT00622141|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110429778|NCT00622141|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110429779|NCT00622141|Antiviral Agents|antiviral agents|mesh-ancestor
110429780|NCT00622141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110429781|NCT00622141|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110429782|NCT00622141|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110429783|NCT04210765|Clomiphene|clomiphene|mesh-list
110429784|NCT04210765|Enclomiphene|enclomiphene|mesh-list
110429785|NCT04210765|Zuclomiphene|zuclomiphene|mesh-list
110429786|NCT04210765|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110429787|NCT04210765|Hormone Antagonists|hormone antagonists|mesh-ancestor
110429788|NCT04210765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110429789|NCT04210765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110429790|NCT04210765|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110429791|NCT04210765|Fertility Agents|fertility agents|mesh-ancestor
110429792|NCT04210765|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110429793|NCT04210765|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110429794|NCT04210765|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110429795|NCT00621283|Secretin|secretin|mesh-list
110429796|NCT00621283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110429797|NCT00621283|Hormones|hormones|mesh-ancestor
110203675|NCT00044577|Lamivudine|lamivudine|mesh-list
110203676|NCT00044577|Abacavir|abacavir|mesh-list
110429798|NCT00621283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110429799|NCT00621283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110429800|NCT00995709|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110429801|NCT00995709|Immunologic Factors|immunologic factors|mesh-ancestor
110429802|NCT00995709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110429803|NCT05662189|Exenatide|exenatide|mesh-list
110429804|NCT05662189|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110429805|NCT05662189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110429806|NCT05662189|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110429807|NCT05662189|Incretins|incretins|mesh-ancestor
110429808|NCT05662189|Hormones|hormones|mesh-ancestor
110429809|NCT05662189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110429810|NCT00629031|Paromomycin|paromomycin|mesh-list
110429811|NCT00629031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110429812|NCT00629031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110076774|NCT02938442|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110076775|NCT02938442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110076776|NCT02938442|Tubulin Modulators|tubulin modulators|mesh-ancestor
110076777|NCT02938442|Antimitotic Agents|antimitotic agents|mesh-ancestor
110076778|NCT02938442|Mitosis Modulators|mitosis modulators|mesh-ancestor
110429813|NCT00629031|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110429814|NCT00629031|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110429816|NCT00621361|Cediranib|cediranib|mesh-list
110429817|NCT00621361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110429818|NCT00621361|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110429819|NCT00621361|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110429820|NCT00621361|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110429821|NCT00621361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110429822|NCT00621361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110429823|NCT00621361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110429824|NCT04208581|Fluticasone|fluticasone|mesh-list
110429825|NCT04208581|Xhance|xhance|mesh-list
110429826|NCT04208581|Budesonide|budesonide|mesh-list
110429827|NCT04208581|Bromides|bromides|mesh-list
110429828|NCT04208581|Formoterol Fumarate|formoterol fumarate|mesh-list
110429829|NCT04208581|Tiotropium Bromide|tiotropium bromide|mesh-list
110429830|NCT04208581|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110429831|NCT04208581|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
110429832|NCT04208581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110429833|NCT04208581|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110429834|NCT04208581|Autonomic Agents|autonomic agents|mesh-ancestor
110429835|NCT04208581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110429836|NCT04208581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110429837|NCT04208581|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110429838|NCT04208581|Respiratory System Agents|respiratory system agents|mesh-ancestor
110429839|NCT04208581|Dermatologic Agents|dermatologic agents|mesh-ancestor
110429840|NCT04208581|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110429841|NCT04208581|Glucocorticoids|glucocorticoids|mesh-ancestor
110429842|NCT04208581|Hormones|hormones|mesh-ancestor
110429843|NCT04208581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110429844|NCT04208581|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110429845|NCT04208581|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110429846|NCT04208581|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110429847|NCT04208581|Adrenergic Agents|adrenergic agents|mesh-ancestor
110429848|NCT04208581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110429849|NCT04208581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110429850|NCT04208581|Parasympatholytics|parasympatholytics|mesh-ancestor
110429851|NCT04208581|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110429852|NCT04208581|Cholinergic Agents|cholinergic agents|mesh-ancestor
110429853|NCT04208581|Anticonvulsants|anticonvulsants|mesh-ancestor
110429854|NCT05368675|Buprenorphine|buprenorphine|mesh-list
110429855|NCT05368675|Methadone|methadone|mesh-list
110429856|NCT05368675|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
110429857|NCT05368675|Naloxone|naloxone|mesh-list
110429858|NCT05368675|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110429859|NCT05368675|Narcotics|narcotics|mesh-ancestor
110429860|NCT05368675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110429861|NCT05368675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110429862|NCT05368675|Analgesics|analgesics|mesh-ancestor
110429863|NCT05368675|Sensory System Agents|sensory system agents|mesh-ancestor
110429864|NCT05368675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110429865|NCT05368675|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110429866|NCT05368675|Antitussive Agents|antitussive agents|mesh-ancestor
110429867|NCT05368675|Respiratory System Agents|respiratory system agents|mesh-ancestor
110429868|NCT05368051|Capecitabine|capecitabine|mesh-list
110429869|NCT05368051|Antibodies|antibodies|mesh-list
110429870|NCT05368051|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110429871|NCT05368051|Immunologic Factors|immunologic factors|mesh-ancestor
110429872|NCT05368051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110429873|NCT05368051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110429874|NCT05368051|Antimetabolites|antimetabolites|mesh-ancestor
110429875|NCT05368051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110429876|NCT05368051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110429877|NCT02641873|Leucovorin|leucovorin|mesh-list
110429878|NCT02641873|Bevacizumab|bevacizumab|mesh-list
110429879|NCT02641873|Irinotecan|irinotecan|mesh-list
110429880|NCT02641873|Levoleucovorin|levoleucovorin|mesh-list
110429881|NCT02641873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110429882|NCT02641873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110429883|NCT02641873|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110429884|NCT02641873|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110429885|NCT02641873|Growth Substances|growth substances|mesh-ancestor
110429886|NCT02641873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110429887|NCT02641873|Growth Inhibitors|growth inhibitors|mesh-ancestor
110076850|NCT02188121|Losartan|losartan|mesh-list
110429888|NCT02641873|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110429889|NCT02641873|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110429890|NCT02641873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110429891|NCT02641873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110429892|NCT02641873|Antidotes|antidotes|mesh-ancestor
110429893|NCT02641873|Protective Agents|protective agents|mesh-ancestor
110429894|NCT02641873|Vitamin B Complex|vitamin b complex|mesh-ancestor
110429895|NCT02641873|Vitamins|vitamins|mesh-ancestor
110429896|NCT02641873|Micronutrients|micronutrients|mesh-ancestor
110429897|NCT00998985|Grazoprevir|grazoprevir|mesh-list
110429898|NCT00998985|Antiviral Agents|antiviral agents|mesh-ancestor
110429899|NCT00998985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110429900|NCT05240391|Midodrine|midodrine|mesh-list
110429901|NCT05240391|Sympathomimetics|sympathomimetics|mesh-ancestor
110429902|NCT05240391|Autonomic Agents|autonomic agents|mesh-ancestor
110429903|NCT05240391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110429904|NCT05240391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110429905|NCT05240391|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110429906|NCT05240391|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110429907|NCT05240391|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110429908|NCT05240391|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110429909|NCT05240391|Adrenergic Agents|adrenergic agents|mesh-ancestor
110429910|NCT05240391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110429911|NCT05240391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110429912|NCT00628953|Esomeprazole|esomeprazole|mesh-list
110429913|NCT00628953|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110429914|NCT00628953|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110429915|NCT00628953|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110429916|NCT00628953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110429917|NCT00628953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110429918|NCT04294953|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110429919|NCT04294953|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110429920|NCT04294953|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110429921|NCT04294953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110429922|NCT04294953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110429923|NCT04294953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110429924|NCT04294953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110429925|NCT04294953|Analgesics|analgesics|mesh-ancestor
110429926|NCT04294953|Sensory System Agents|sensory system agents|mesh-ancestor
110429927|NCT04294953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110429928|NCT04294953|Antidepressive Agents|antidepressive agents|mesh-ancestor
110429929|NCT04294953|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110429930|NCT04294953|Dopamine Agents|dopamine agents|mesh-ancestor
110429931|NCT02869815|Methylene Blue|methylene blue|mesh-list
110429932|NCT02869815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110429933|NCT02869815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110429934|NCT04293081|Maleic acid|maleic acid|mesh-list
110429935|NCT04293081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110429936|NCT04293081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110429943|NCT02868801|Pregabalin|pregabalin|mesh-list
110429944|NCT02868801|Analgesics|analgesics|mesh-ancestor
110429945|NCT02868801|Sensory System Agents|sensory system agents|mesh-ancestor
110429946|NCT02868801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110429947|NCT02868801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110429948|NCT02868801|Anticonvulsants|anticonvulsants|mesh-ancestor
110429949|NCT02868801|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110429950|NCT02868801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110429951|NCT02868801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110429952|NCT02868801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110429953|NCT02868801|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110429954|NCT02868801|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110429955|NCT02868801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110429956|NCT02868801|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110429957|NCT01002339|Mycophenolic Acid|mycophenolic acid|mesh-list
110429958|NCT01002339|Cyclosporine|cyclosporine|mesh-list
110429959|NCT01002339|Prednisone|prednisone|mesh-list
110429960|NCT01002339|Tacrolimus|tacrolimus|mesh-list
110429961|NCT01002339|Basiliximab|basiliximab|mesh-list
110429962|NCT01002339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110076942|NCT03187769|Olanzapine|olanzapine|mesh-list
110429963|NCT01002339|Immunologic Factors|immunologic factors|mesh-ancestor
110429964|NCT01002339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110429965|NCT01002339|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110429966|NCT01002339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110203740|NCT00044616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110429967|NCT01002339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110429968|NCT01002339|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110429969|NCT01002339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110429970|NCT01002339|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110429971|NCT01002339|Antitubercular Agents|antitubercular agents|mesh-ancestor
110429972|NCT01002339|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110429973|NCT01002339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110429974|NCT01002339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110429975|NCT01002339|Glucocorticoids|glucocorticoids|mesh-ancestor
110429976|NCT01002339|Hormones|hormones|mesh-ancestor
110429977|NCT01002339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110429978|NCT01002339|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110429979|NCT01002339|Antifungal Agents|antifungal agents|mesh-ancestor
110429980|NCT01002339|Dermatologic Agents|dermatologic agents|mesh-ancestor
110429981|NCT01002339|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110429982|NCT01002105|Baclofen|baclofen|mesh-list
110429983|NCT01002105|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110429984|NCT01002105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110429985|NCT01002105|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110429986|NCT01002105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110429987|NCT01002105|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
110429988|NCT01002105|GABA Agonists|gaba agonists|mesh-ancestor
110429989|NCT01002105|GABA Agents|gaba agents|mesh-ancestor
110429990|NCT01002105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110429991|NCT01002105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110429992|NCT02605993|Ravulizumab|ravulizumab|mesh-list
110429993|NCT02605993|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
110429994|NCT02605993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110429995|NCT02605993|Immunologic Factors|immunologic factors|mesh-ancestor
110429996|NCT02605993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110429997|NCT00995085|Pyridoxine|pyridoxine|mesh-list
110429998|NCT00995085|Metadoxine|metadoxine|mesh-list
110429999|NCT00995085|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110430000|NCT00995085|Vitamin B Complex|vitamin b complex|mesh-ancestor
110430001|NCT00995085|Vitamins|vitamins|mesh-ancestor
110430002|NCT00995085|Micronutrients|micronutrients|mesh-ancestor
110430003|NCT00995085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110430004|NCT00603733|Mesalamine|mesalamine|mesh-list
110430005|NCT00603733|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110430006|NCT00603733|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110430007|NCT00603733|Analgesics|analgesics|mesh-ancestor
110430008|NCT00603733|Sensory System Agents|sensory system agents|mesh-ancestor
110430009|NCT00603733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110430010|NCT00603733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110430011|NCT00603733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110430012|NCT00603733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110430013|NCT02471911|Dexamethasone|dexamethasone|mesh-list
110430014|NCT02471911|Rituximab|rituximab|mesh-list
110430015|NCT02471911|Carboplatin|carboplatin|mesh-list
110430016|NCT02471911|Etoposide|etoposide|mesh-list
110430017|NCT02471911|Ifosfamide|ifosfamide|mesh-list
110430018|NCT02471911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110430019|NCT02471911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110430020|NCT02471911|Immunologic Factors|immunologic factors|mesh-ancestor
110430021|NCT02471911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110430022|NCT02471911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110430023|NCT02471911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110430024|NCT02471911|Antiemetics|antiemetics|mesh-ancestor
110430025|NCT02471911|Autonomic Agents|autonomic agents|mesh-ancestor
110430026|NCT02471911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110430027|NCT02471911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110430028|NCT02471911|Glucocorticoids|glucocorticoids|mesh-ancestor
110430029|NCT02471911|Hormones|hormones|mesh-ancestor
110430030|NCT02471911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110430031|NCT02471911|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110430032|NCT02471911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110430033|NCT02471911|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110430034|NCT02471911|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110430035|NCT02471911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110430036|NCT02471911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110430037|NCT02471911|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110430038|NCT02471911|Alkylating Agents|alkylating agents|mesh-ancestor
110430039|NCT00622375|Mesalamine|mesalamine|mesh-list
110430040|NCT00622375|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110430041|NCT00622375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110430042|NCT00622375|Analgesics|analgesics|mesh-ancestor
110430043|NCT00622375|Sensory System Agents|sensory system agents|mesh-ancestor
110430044|NCT00622375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110430045|NCT00622375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110430046|NCT00622375|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110430047|NCT00622375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110430048|NCT02691325|Charcoal|charcoal|mesh-list
110430049|NCT02691325|Nemiralisib|nemiralisib|mesh-list
110430050|NCT02691325|Antidotes|antidotes|mesh-ancestor
110430051|NCT02691325|Protective Agents|protective agents|mesh-ancestor
110430052|NCT02691325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110430053|NCT02691325|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110430054|NCT02691325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110430055|NCT02691325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110430056|NCT01678027|Clarithromycin|clarithromycin|mesh-list
110430057|NCT01678027|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110430058|NCT01678027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110430059|NCT01678027|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110430060|NCT01678027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110430061|NCT01678027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110430062|NCT01678027|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110430063|NCT01678027|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110430064|NCT02697331|Progesterone|progesterone|mesh-list
110430065|NCT02697331|Progestins|progestins|mesh-ancestor
110430066|NCT02697331|Hormones|hormones|mesh-ancestor
110430067|NCT02697331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110430068|NCT02697331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110430069|NCT04278625|Acetaminophen|acetaminophen|mesh-list
110430070|NCT04278625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110430071|NCT04278625|Analgesics|analgesics|mesh-ancestor
110430072|NCT04278625|Sensory System Agents|sensory system agents|mesh-ancestor
110430073|NCT04278625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110430074|NCT04278625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110430075|NCT04278625|Antipyretics|antipyretics|mesh-ancestor
110430076|NCT02689141|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110430077|NCT02689141|Ofatumumab|ofatumumab|mesh-list
110430078|NCT02689141|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110430079|NCT02689141|Alkylating Agents|alkylating agents|mesh-ancestor
110203760|NCT00044694|Exenatide|exenatide|mesh-list
110430080|NCT02689141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110430081|NCT02689141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110430083|NCT00622687|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110430084|NCT00622687|Vasodilator Agents|vasodilator agents|mesh-ancestor
110430085|NCT02691403|Bupivacaine|bupivacaine|mesh-list
110430086|NCT02691403|Levobupivacaine|levobupivacaine|mesh-list
110430087|NCT02691403|Anesthetics, Local|anesthetics, local|mesh-ancestor
110430088|NCT02691403|Anesthetics|anesthetics|mesh-ancestor
110430089|NCT02691403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110430090|NCT02691403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110430091|NCT02691403|Sensory System Agents|sensory system agents|mesh-ancestor
110430092|NCT02691403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110430093|NCT00995007|Carboplatin|carboplatin|mesh-list
110430094|NCT00995007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110430095|NCT00909883|Botulinum Toxins|botulinum toxins|mesh-list
110430096|NCT00909883|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110430097|NCT00909883|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110430098|NCT00909883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110430099|NCT00909883|Cholinergic Agents|cholinergic agents|mesh-ancestor
110430100|NCT00909883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110430101|NCT00909883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110430102|NCT00639925|Gemcitabine|gemcitabine|mesh-list
110430103|NCT00639925|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110430104|NCT00639925|Antimetabolites|antimetabolites|mesh-ancestor
110430105|NCT00639925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110430106|NCT00639925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110430107|NCT00994461|Celecoxib|celecoxib|mesh-list
110430108|NCT00994461|Loxoprofen|loxoprofen|mesh-list
110430109|NCT00994461|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110077076|NCT02652455|Immunologic Factors|immunologic factors|mesh-ancestor
110430110|NCT00994461|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110430111|NCT00994461|Analgesics|analgesics|mesh-ancestor
110430112|NCT00994461|Sensory System Agents|sensory system agents|mesh-ancestor
110430113|NCT00994461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110430114|NCT00994461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110430115|NCT00994461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110430116|NCT00994461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110430117|NCT00994461|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110328848|NCT03272126|Vitamin D|vitamin d|mesh-list
110430118|NCT00994461|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110430119|NCT00994461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110430120|NCT00994461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110430121|NCT00993915|Atorvastatin|atorvastatin|mesh-list
110430122|NCT00993915|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110430123|NCT00993915|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110430124|NCT00993915|Antimetabolites|antimetabolites|mesh-ancestor
110430125|NCT00993915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110430126|NCT00993915|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110430127|NCT00993915|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110430128|NCT00993915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110430129|NCT01202591|Fulvestrant|fulvestrant|mesh-list
110430130|NCT01202591|Exemestane|exemestane|mesh-list
110430131|NCT01202591|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110430132|NCT01202591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110430133|NCT01202591|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110430134|NCT01202591|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110430135|NCT01202591|Hormone Antagonists|hormone antagonists|mesh-ancestor
110430136|NCT01202591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110430137|NCT01202591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110430138|NCT01202591|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110430139|NCT01202591|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110430140|NCT01202591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110430141|NCT01202591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110430142|NCT01202279|Phenylpropanolamine|phenylpropanolamine|mesh-list
110430143|NCT01202279|Pseudoephedrine|pseudoephedrine|mesh-list
110430144|NCT01202279|Guaifenesin|guaifenesin|mesh-list
110430145|NCT01202279|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
110430146|NCT01202279|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110430147|NCT01202279|Autonomic Agents|autonomic agents|mesh-ancestor
110430148|NCT01202279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110430149|NCT01202279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110430150|NCT01202279|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110430151|NCT01202279|Respiratory System Agents|respiratory system agents|mesh-ancestor
110430152|NCT01202279|Nasal Decongestants|nasal decongestants|mesh-ancestor
110430153|NCT01202279|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110430154|NCT01202279|Sympathomimetics|sympathomimetics|mesh-ancestor
110430155|NCT01202279|Adrenergic Agents|adrenergic agents|mesh-ancestor
110430156|NCT01202279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110430157|NCT01202279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110430158|NCT01202279|Expectorants|expectorants|mesh-ancestor
110430159|NCT01202279|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110430160|NCT01202279|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110430161|NCT01202279|Appetite Depressants|appetite depressants|mesh-ancestor
110430162|NCT01202279|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110430163|NCT03877315|Cimetidine|cimetidine|mesh-list
110430164|NCT03877315|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110430165|NCT03877315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110430166|NCT03877315|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110430167|NCT03877315|Histamine Antagonists|histamine antagonists|mesh-ancestor
110430168|NCT03877315|Histamine Agents|histamine agents|mesh-ancestor
110430169|NCT03877315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110430170|NCT03877315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110430171|NCT03877315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110430172|NCT03877315|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110430173|NCT03877315|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110430174|NCT03877315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110430175|NCT02687347|Morphine|morphine|mesh-list
110430176|NCT02687347|Methadone|methadone|mesh-list
110430177|NCT02687347|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110430178|NCT02687347|Narcotics|narcotics|mesh-ancestor
110430179|NCT02687347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110430180|NCT02687347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110430181|NCT02687347|Analgesics|analgesics|mesh-ancestor
110430182|NCT02687347|Sensory System Agents|sensory system agents|mesh-ancestor
110328857|NCT00491049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110430183|NCT02687347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110430184|NCT02687347|Antitussive Agents|antitussive agents|mesh-ancestor
110430185|NCT02687347|Respiratory System Agents|respiratory system agents|mesh-ancestor
110077160|NCT01859026|Mitogens|mitogens|mesh-list
110430187|NCT02687425|Imatinib Mesylate|imatinib mesylate|mesh-list
110430188|NCT02687425|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
110430189|NCT02687425|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110430190|NCT02687425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110430191|NCT02687425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110430192|NCT02687425|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110430193|NCT02687425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110430194|NCT02687425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110430195|NCT02687269|Ranolazine|ranolazine|mesh-list
110430196|NCT02687269|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110430197|NCT02687269|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110430198|NCT02687269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110430199|NCT02689297|Chlorine dioxide|chlorine dioxide|mesh-list
110430200|NCT02689297|Dental Disinfectants|dental disinfectants|mesh-ancestor
110430201|NCT02689297|Disinfectants|disinfectants|mesh-ancestor
110430202|NCT02689297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110430203|NCT04185805|Fexuprazan|fexuprazan|mesh-list
110430204|NCT04185805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110430205|NCT01201811|Azacitidine|azacitidine|mesh-list
110430206|NCT01201811|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110430207|NCT01201811|Antimetabolites|antimetabolites|mesh-ancestor
110430208|NCT01201811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110430209|NCT01201811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110430210|NCT01201811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110430211|NCT04186897|Salicylic Acid|salicylic acid|mesh-list
110430212|NCT04186897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110430213|NCT04186897|Antifungal Agents|antifungal agents|mesh-ancestor
110430214|NCT04186897|Keratolytic Agents|keratolytic agents|mesh-ancestor
110430215|NCT04186897|Dermatologic Agents|dermatologic agents|mesh-ancestor
110430216|NCT05392127|Vitamin K|vitamin k|mesh-list
110430217|NCT05392127|Vitamin K 1|vitamin k 1|mesh-list
110430218|NCT05392127|Repaglinide|repaglinide|mesh-list
110430219|NCT05392127|Midazolam|midazolam|mesh-list
110430220|NCT05392127|Omeprazole|omeprazole|mesh-list
110430221|NCT05392127|Warfarin|warfarin|mesh-list
110430222|NCT05392127|Vitamins|vitamins|mesh-ancestor
110430223|NCT05392127|Micronutrients|micronutrients|mesh-ancestor
110430224|NCT05392127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110430225|NCT05392127|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110430226|NCT05392127|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110430227|NCT05392127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110430228|NCT05392127|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110430229|NCT05392127|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110430230|NCT05392127|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110430231|NCT05392127|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110430232|NCT05392127|Anesthetics, General|anesthetics, general|mesh-ancestor
110430233|NCT05392127|Anesthetics|anesthetics|mesh-ancestor
110430234|NCT05392127|GABA Modulators|gaba modulators|mesh-ancestor
110430235|NCT05392127|GABA Agents|gaba agents|mesh-ancestor
110430236|NCT05392127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110430237|NCT05392127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110430238|NCT05392127|Anticoagulants|anticoagulants|mesh-ancestor
110430239|NCT05392127|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110430241|NCT05392127|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110430242|NCT05392127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110430243|NCT05392127|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110430244|NCT05392127|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110430245|NCT05392127|Hemostatics|hemostatics|mesh-ancestor
110430246|NCT05392127|Coagulants|coagulants|mesh-ancestor
110430247|NCT05392127|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110430248|NCT05378399|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110430249|NCT05378399|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
110430250|NCT05378399|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110430251|NCT05378399|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110430252|NCT05378399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110430253|NCT05378399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110430254|NCT05378399|Antiviral Agents|antiviral agents|mesh-ancestor
110430255|NCT05378399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110430257|NCT05378399|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110430258|NCT04379011|Brivaracetam|brivaracetam|mesh-list
110430259|NCT04379011|Anticonvulsants|anticonvulsants|mesh-ancestor
110430260|NCT02685163|Antioxidants|antioxidants|mesh-list
110430261|NCT02685163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110430262|NCT02685163|Protective Agents|protective agents|mesh-ancestor
110430263|NCT02685163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110430264|NCT00640003|Baclofen|baclofen|mesh-list
110430265|NCT00640003|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110430266|NCT00640003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110430267|NCT00640003|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110430268|NCT00640003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110430269|NCT00640003|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
110430270|NCT00640003|GABA Agonists|gaba agonists|mesh-ancestor
110430271|NCT00640003|GABA Agents|gaba agents|mesh-ancestor
110430272|NCT00640003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110430273|NCT00640003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110430274|NCT01201343|Interferons|interferons|mesh-list
110430275|NCT01201343|Interferon-beta|interferon-beta|mesh-list
110430276|NCT01201343|Interferon beta-1a|interferon beta-1a|mesh-list
110430277|NCT01201343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110430278|NCT01201343|Antiviral Agents|antiviral agents|mesh-ancestor
110430279|NCT01201343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110430280|NCT01201343|Immunologic Factors|immunologic factors|mesh-ancestor
110430281|NCT01201343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110430282|NCT01201343|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110430283|NCT04185649|Capecitabine|capecitabine|mesh-list
110430284|NCT04185649|Lapatinib|lapatinib|mesh-list
110430285|NCT04185649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110430286|NCT04185649|Antimetabolites|antimetabolites|mesh-ancestor
110430287|NCT04185649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110430288|NCT04185649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110430289|NCT04185649|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110430290|NCT04185649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110430291|NCT01201265|Bevacizumab|bevacizumab|mesh-list
110430292|NCT01201265|Carboplatin|carboplatin|mesh-list
110430293|NCT01201265|Gemcitabine|gemcitabine|mesh-list
110430294|NCT01201265|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110430295|NCT01201265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110430296|NCT01201265|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110430297|NCT01201265|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110430298|NCT01201265|Growth Substances|growth substances|mesh-ancestor
110430299|NCT01201265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110430300|NCT01201265|Growth Inhibitors|growth inhibitors|mesh-ancestor
110430301|NCT01201265|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110430302|NCT01201265|Antimetabolites|antimetabolites|mesh-ancestor
110430303|NCT01201265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110430304|NCT04246801|Clobetasol|clobetasol|mesh-list
110430305|NCT04246801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110430306|NCT04246801|Glucocorticoids|glucocorticoids|mesh-ancestor
110430307|NCT04246801|Hormones|hormones|mesh-ancestor
110430308|NCT04246801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110430309|NCT04246801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110430310|NCT00638677|Sorbitol|sorbitol|mesh-list
110430311|NCT00638677|Cathartics|cathartics|mesh-ancestor
110430312|NCT00638677|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110430313|NCT01200485|Allopurinol|allopurinol|mesh-list
110430314|NCT01200485|Rasburicase|rasburicase|mesh-list
110430315|NCT01200485|Antimetabolites|antimetabolites|mesh-ancestor
110430316|NCT01200485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110430317|NCT01200485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110430318|NCT01200485|Gout Suppressants|gout suppressants|mesh-ancestor
110430319|NCT01200485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110430320|NCT01200485|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110430321|NCT01200485|Antioxidants|antioxidants|mesh-ancestor
110430322|NCT01200485|Protective Agents|protective agents|mesh-ancestor
110430323|NCT01200485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110430324|NCT02688907|Adavosertib|adavosertib|mesh-list
110430325|NCT02688907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110430326|NCT02688907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110430327|NCT02686645|Metronidazole|metronidazole|mesh-list
110430328|NCT02686645|Vancomycin|vancomycin|mesh-list
110430329|NCT02686645|Loperamide|loperamide|mesh-list
110430330|NCT02686645|Antidiarrheals|antidiarrheals|mesh-list
110430331|NCT02686645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110430332|NCT02686645|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110430333|NCT02686645|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110430334|NCT02686645|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110430335|NCT02686645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110430336|NCT04318067|Melatonin|melatonin|mesh-list
110430337|NCT04318067|Antioxidants|antioxidants|mesh-ancestor
110430338|NCT04318067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110077327|NCT01604213|Metformin|metformin|mesh-list
110430339|NCT04318067|Protective Agents|protective agents|mesh-ancestor
110430341|NCT04318067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110430342|NCT01200407|Amlodipine|amlodipine|mesh-list
110430343|NCT01200407|Olmesartan|olmesartan|mesh-list
110430344|NCT01200407|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
110430345|NCT01200407|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110430346|NCT01200407|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110430347|NCT01200407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110430348|NCT01200407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110430349|NCT01200407|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110430350|NCT01200407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110430351|NCT01200407|Vasodilator Agents|vasodilator agents|mesh-ancestor
110430352|NCT01200407|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110430353|NCT01200407|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110430354|NCT02685085|Misoprostol|misoprostol|mesh-list
110430355|NCT02685085|Dinoprostone|dinoprostone|mesh-list
110430356|NCT02685085|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110430357|NCT02685085|Abortifacient Agents|abortifacient agents|mesh-ancestor
110430358|NCT02685085|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110430359|NCT02685085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110430360|NCT02685085|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110430361|NCT02685085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110430363|NCT02688595|Anesthetics|anesthetics|mesh-list
110430364|NCT02688595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110430365|NCT02688595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110430366|NCT01200329|Gemcitabine|gemcitabine|mesh-list
110430367|NCT01200329|Melphalan|melphalan|mesh-list
110430368|NCT01200329|Busulfan|busulfan|mesh-list
110430369|NCT01200329|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110430370|NCT01200329|Antimetabolites|antimetabolites|mesh-ancestor
110430371|NCT01200329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110430372|NCT01200329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110430373|NCT01200329|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110430374|NCT01200329|Alkylating Agents|alkylating agents|mesh-ancestor
110564526|NCT05489185|Hemostatics|hemostatics|mesh-ancestor
110430375|NCT01200329|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110430376|NCT01200329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110430377|NCT01200329|Immunologic Factors|immunologic factors|mesh-ancestor
110430378|NCT01200329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110430379|NCT01199939|Ritonavir|ritonavir|mesh-list
110430380|NCT01199939|Darunavir|darunavir|mesh-list
110430381|NCT01199939|Etravirine|etravirine|mesh-list
110430382|NCT01199939|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110430383|NCT01199939|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110430384|NCT01199939|Protease Inhibitors|protease inhibitors|mesh-ancestor
110430385|NCT01199939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110430386|NCT01199939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110430387|NCT01199939|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110430388|NCT01199939|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110430389|NCT01199939|Antiviral Agents|antiviral agents|mesh-ancestor
110430390|NCT01199939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110430391|NCT01199939|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110430392|NCT01199939|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110430393|NCT01199939|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110430394|NCT01199939|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110430395|NCT02688361|Acetylcysteine|acetylcysteine|mesh-list
110430396|NCT02688361|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110430397|NCT02688361|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110430398|NCT02688361|Antiviral Agents|antiviral agents|mesh-ancestor
110430399|NCT02688361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110430400|NCT02688361|Expectorants|expectorants|mesh-ancestor
110430401|NCT02688361|Respiratory System Agents|respiratory system agents|mesh-ancestor
110430402|NCT02688361|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110430403|NCT02688361|Antioxidants|antioxidants|mesh-ancestor
110430404|NCT02688361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110430405|NCT02688361|Protective Agents|protective agents|mesh-ancestor
110430406|NCT02688361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110430407|NCT02688361|Antidotes|antidotes|mesh-ancestor
110430408|NCT01199861|Vaccines|vaccines|mesh-list
110430409|NCT01199861|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
110430410|NCT01199861|Immunologic Factors|immunologic factors|mesh-ancestor
110430411|NCT01199861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110430412|NCT01199861|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
110077372|NCT01606072|Natriuretic Agents|natriuretic agents|mesh-ancestor
110430413|NCT01199861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110430415|NCT03196219|Anti-Infective Agents|anti-infective agents|mesh-list
110430416|NCT03196219|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110430418|NCT00640081|Fluorouracil|fluorouracil|mesh-list
110430419|NCT00640081|Capecitabine|capecitabine|mesh-list
110430420|NCT00640081|Oxaliplatin|oxaliplatin|mesh-list
110430421|NCT00640081|Cetuximab|cetuximab|mesh-list
110430422|NCT00640081|Calcium|calcium|mesh-list
110430423|NCT00640081|Levoleucovorin|levoleucovorin|mesh-list
110430424|NCT00640081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110430425|NCT00640081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110430426|NCT00640081|Antimetabolites|antimetabolites|mesh-ancestor
110430427|NCT00640081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110371320|NCT04621799|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
110430428|NCT00640081|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110430429|NCT00640081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110430430|NCT00640081|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110430431|NCT00640081|Immunologic Factors|immunologic factors|mesh-ancestor
110430432|NCT00640081|Antidotes|antidotes|mesh-ancestor
110430433|NCT00640081|Protective Agents|protective agents|mesh-ancestor
110430434|NCT00640081|Vitamin B Complex|vitamin b complex|mesh-ancestor
110430435|NCT00640081|Vitamins|vitamins|mesh-ancestor
110430436|NCT00640081|Micronutrients|micronutrients|mesh-ancestor
110430437|NCT00640081|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110430438|NCT01199705|Immunoglobulins|immunoglobulins|mesh-list
110430439|NCT01199705|Antibodies|antibodies|mesh-list
110430440|NCT01199705|gamma-Globulins|gamma-globulins|mesh-list
110430441|NCT01199705|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110430442|NCT01199705|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110430443|NCT01199705|Immunologic Factors|immunologic factors|mesh-ancestor
110430444|NCT01199705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110430445|NCT02688127|Tranexamic Acid|tranexamic acid|mesh-list
110430446|NCT02688127|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110430447|NCT02688127|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110328886|NCT03272321|Oxytocin|oxytocin|mesh-list
110430448|NCT02688127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110430449|NCT02688127|Hemostatics|hemostatics|mesh-ancestor
110430450|NCT02688127|Coagulants|coagulants|mesh-ancestor
110430451|NCT04184947|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
110430452|NCT04184947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110430453|NCT04184947|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110430454|NCT04184947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110430456|NCT00638833|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110430457|NCT00638833|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110430458|NCT00638833|Dopamine Agents|dopamine agents|mesh-ancestor
110430459|NCT00638833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110430460|NCT00638833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110430461|NCT00638833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110430462|NCT00638833|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110430463|NCT00638833|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110430464|NCT01198145|Sulfasalazine|sulfasalazine|mesh-list
110430465|NCT01198145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110430466|NCT01198145|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110430467|NCT01198145|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110430468|NCT01198145|Analgesics|analgesics|mesh-ancestor
110430469|NCT01198145|Sensory System Agents|sensory system agents|mesh-ancestor
110430470|NCT01198145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110430471|NCT01198145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110430472|NCT01198145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110430473|NCT01198145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110430474|NCT01198145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110430475|NCT01179048|Liraglutide|liraglutide|mesh-list
110430476|NCT01179048|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110430477|NCT01179048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110430478|NCT01179048|Incretins|incretins|mesh-ancestor
110430479|NCT01179048|Hormones|hormones|mesh-ancestor
110430480|NCT01179048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110430481|NCT00603265|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110430482|NCT00603265|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110430483|NCT00603265|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110430484|NCT00603265|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110430485|NCT00603265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110430486|NCT00603265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110430488|NCT00603265|Analgesics|analgesics|mesh-ancestor
110430489|NCT00603265|Sensory System Agents|sensory system agents|mesh-ancestor
110430490|NCT00603265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110430491|NCT00603265|Antidepressive Agents|antidepressive agents|mesh-ancestor
110430492|NCT00603265|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110430493|NCT00603265|Dopamine Agents|dopamine agents|mesh-ancestor
110430494|NCT02686177|Metformin|metformin|mesh-list
110430495|NCT02686177|Liraglutide|liraglutide|mesh-list
110430496|NCT02686177|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110430497|NCT02686177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110430498|NCT02686177|Incretins|incretins|mesh-ancestor
110430499|NCT02686177|Hormones|hormones|mesh-ancestor
110430500|NCT02686177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110430501|NCT02686021|Dipyrone|dipyrone|mesh-list
110430502|NCT02686021|Ibuprofen|ibuprofen|mesh-list
110430503|NCT02686021|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110430504|NCT02686021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110430505|NCT02686021|Analgesics|analgesics|mesh-ancestor
110430506|NCT02686021|Sensory System Agents|sensory system agents|mesh-ancestor
110430507|NCT02686021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110430508|NCT02686021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110430509|NCT02686021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110430510|NCT02686021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110430511|NCT02686021|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110430512|NCT02686021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110430513|NCT02686021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110430514|NCT02686021|Antipyretics|antipyretics|mesh-ancestor
110430515|NCT01158534|Interferons|interferons|mesh-list
110430516|NCT01158534|Interferon-alpha|interferon-alpha|mesh-list
110430517|NCT01158534|Interferon alpha-2|interferon alpha-2|mesh-list
110430518|NCT01158534|Celecoxib|celecoxib|mesh-list
110430519|NCT01158534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110430520|NCT01158534|Antiviral Agents|antiviral agents|mesh-ancestor
110430521|NCT01158534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110430522|NCT01158534|Immunologic Factors|immunologic factors|mesh-ancestor
110430523|NCT01158534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110430524|NCT01158534|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110430525|NCT01158534|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110430526|NCT01158534|Analgesics|analgesics|mesh-ancestor
110430527|NCT01158534|Sensory System Agents|sensory system agents|mesh-ancestor
110430528|NCT01158534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110430529|NCT01158534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110430530|NCT01158534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110430531|NCT01158534|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110430532|NCT01158534|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110430533|NCT01158534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110430534|NCT01158534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110430535|NCT02687971|Miltefosine|miltefosine|mesh-list
110430536|NCT02687971|Antifungal Agents|antifungal agents|mesh-ancestor
110430537|NCT02687971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110430538|NCT02687971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110430539|NCT02687971|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110430540|NCT02687971|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110430541|NCT05272878|Irbesartan|irbesartan|mesh-list
110430542|NCT05272878|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110430543|NCT05272878|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110430544|NCT05272878|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110430545|NCT05272878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110430546|NCT02683213|Fluoxetine|fluoxetine|mesh-list
110430547|NCT02683213|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110430548|NCT02683213|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110430549|NCT02683213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110430550|NCT02683213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110430551|NCT02683213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110430552|NCT02683213|Serotonin Agents|serotonin agents|mesh-ancestor
110430553|NCT02683213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110430554|NCT02683213|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110430555|NCT02683213|Antidepressive Agents|antidepressive agents|mesh-ancestor
110430556|NCT02683213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110430557|NCT02683213|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110430558|NCT02683213|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110430559|NCT02683213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110430560|NCT04185103|Valsartan|valsartan|mesh-list
110430561|NCT04185103|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
110430562|NCT04185103|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110430563|NCT04185103|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110430564|NCT04185103|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110430565|NCT04185103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110430566|NCT04033939|Propofol|propofol|mesh-list
110430567|NCT04033939|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110430568|NCT04033939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110430569|NCT04033939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110430570|NCT04033939|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110430571|NCT04033939|Anesthetics, General|anesthetics, general|mesh-ancestor
110430572|NCT04033939|Anesthetics|anesthetics|mesh-ancestor
110430573|NCT00639691|Omalizumab|omalizumab|mesh-list
110430574|NCT00639691|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110430575|NCT00639691|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110430576|NCT00639691|Respiratory System Agents|respiratory system agents|mesh-ancestor
110430577|NCT02684071|Cyclophosphamide|cyclophosphamide|mesh-list
110430578|NCT02684071|Methotrexate|methotrexate|mesh-list
110430579|NCT02684071|Topotecan|topotecan|mesh-list
110430580|NCT02684071|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110430581|NCT02684071|Immunologic Factors|immunologic factors|mesh-ancestor
110430582|NCT02684071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110430583|NCT02684071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110430584|NCT02684071|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110430585|NCT02684071|Alkylating Agents|alkylating agents|mesh-ancestor
110430586|NCT02684071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110430587|NCT02684071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110430588|NCT02684071|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110430589|NCT02684071|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110430590|NCT02684071|Abortifacient Agents|abortifacient agents|mesh-ancestor
110430591|NCT02684071|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110430592|NCT02684071|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110430593|NCT02684071|Antimetabolites|antimetabolites|mesh-ancestor
110430594|NCT02684071|Dermatologic Agents|dermatologic agents|mesh-ancestor
110430595|NCT02684071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110430596|NCT02684071|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110430597|NCT02684071|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110430598|NCT02684071|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110430599|NCT02684071|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110430600|NCT00640861|Vaccines|vaccines|mesh-list
110430601|NCT00640861|Sargramostim|sargramostim|mesh-list
110430602|NCT00640861|Freund's Adjuvant|freund's adjuvant|mesh-list
110430603|NCT00640861|Immunologic Factors|immunologic factors|mesh-ancestor
110430604|NCT00640861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110430605|NCT00640861|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110430606|NCT01158222|Sunitinib|sunitinib|mesh-list
110430607|NCT01158222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110430608|NCT01158222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110430609|NCT01158222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110430610|NCT01158222|Growth Substances|growth substances|mesh-ancestor
110430611|NCT01158222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110430612|NCT01158222|Growth Inhibitors|growth inhibitors|mesh-ancestor
110430613|NCT01158222|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110430614|NCT01158222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110430615|NCT01158222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110430616|NCT02684305|Oxytocin|oxytocin|mesh-list
110430617|NCT02684305|Oxytocics|oxytocics|mesh-ancestor
110430618|NCT02684305|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110430619|NCT02684305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110430620|NCT02940769|Methamphetamine|methamphetamine|mesh-list
110371346|NCT01152190|Tadalafil|tadalafil|mesh-list
110430621|NCT02940769|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110430622|NCT02940769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110430624|NCT02940769|Autonomic Agents|autonomic agents|mesh-ancestor
110430625|NCT02940769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110430626|NCT02940769|Dopamine Agents|dopamine agents|mesh-ancestor
110430627|NCT02940769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110430628|NCT02940769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110430629|NCT02940769|Adrenergic Agents|adrenergic agents|mesh-ancestor
110430630|NCT02940769|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110430631|NCT02940769|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110430632|NCT02940769|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110430633|NCT02940769|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110077601|NCT01611480|Imiquimod|imiquimod|mesh-list
110430634|NCT04315584|Deoxyglucose|deoxyglucose|mesh-list
110430635|NCT04315584|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110430636|NCT04315584|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
110430637|NCT04315584|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110430638|NCT04315584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110430639|NCT04315584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110430640|NCT04315584|Antimetabolites|antimetabolites|mesh-ancestor
110430641|NCT04315584|Antiviral Agents|antiviral agents|mesh-ancestor
110430642|NCT04315584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110430643|NCT04315584|Dopamine Agents|dopamine agents|mesh-ancestor
110430644|NCT04315584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110430645|NCT02683291|Mycophenolic Acid|mycophenolic acid|mesh-list
110430646|NCT02683291|Sirolimus|sirolimus|mesh-list
110430647|NCT02683291|Prednisone|prednisone|mesh-list
110430648|NCT02683291|Tacrolimus|tacrolimus|mesh-list
110430649|NCT02683291|Thymoglobulin|thymoglobulin|mesh-list
110430650|NCT02683291|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110430651|NCT02683291|Basiliximab|basiliximab|mesh-list
110430652|NCT02683291|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110430653|NCT02683291|Glucocorticoids|glucocorticoids|mesh-ancestor
110430655|NCT02683291|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110430656|NCT02683291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110430657|NCT02683291|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110430658|NCT02683291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110430659|NCT02683291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110430660|NCT02683291|Immunologic Factors|immunologic factors|mesh-ancestor
110430661|NCT02683291|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110430662|NCT02683291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110430663|NCT02683291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110430664|NCT02683291|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110430665|NCT02683291|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110430666|NCT02683291|Antitubercular Agents|antitubercular agents|mesh-ancestor
110430667|NCT02683291|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110430668|NCT02683291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110430669|NCT02683291|Antifungal Agents|antifungal agents|mesh-ancestor
110430670|NCT02685397|Leuprolide|leuprolide|mesh-list
110430671|NCT02685397|Goserelin|goserelin|mesh-list
110430672|NCT02685397|Triptorelin Pamoate|triptorelin pamoate|mesh-list
110430673|NCT02685397|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110430674|NCT02685397|Fertility Agents|fertility agents|mesh-ancestor
110430675|NCT02685397|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110430676|NCT02685397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110430677|NCT02685397|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110430678|NCT02685397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110430679|NCT02685397|Luteolytic Agents|luteolytic agents|mesh-ancestor
110430680|NCT02685397|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110430681|NCT02685397|Contraceptive Agents|contraceptive agents|mesh-ancestor
110430682|NCT02685397|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110430683|NCT02683837|Remifentanil|remifentanil|mesh-list
110430684|NCT02683837|Sevoflurane|sevoflurane|mesh-list
110430685|NCT02683837|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110430686|NCT02683837|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110430687|NCT02683837|Anesthetics, General|anesthetics, general|mesh-ancestor
110430688|NCT02683837|Anesthetics|anesthetics|mesh-ancestor
110430689|NCT02683837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110371353|NCT04621565|Hydrocortisone|hydrocortisone|mesh-list
110430690|NCT02683837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110430691|NCT02683837|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110430692|NCT02683837|Narcotics|narcotics|mesh-ancestor
110430693|NCT02683837|Analgesics|analgesics|mesh-ancestor
110430694|NCT02683837|Sensory System Agents|sensory system agents|mesh-ancestor
110430695|NCT02683837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110430696|NCT02680951|Cytarabine|cytarabine|mesh-list
110430697|NCT02680951|Fludarabine|fludarabine|mesh-list
110430698|NCT02680951|Dasatinib|dasatinib|mesh-list
110430699|NCT02680951|Idarubicin|idarubicin|mesh-list
110430700|NCT02680951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110430701|NCT02680951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110430702|NCT02680951|Antimetabolites|antimetabolites|mesh-ancestor
110430703|NCT02680951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110430704|NCT02680951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110430705|NCT02680951|Immunologic Factors|immunologic factors|mesh-ancestor
110430706|NCT02680951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110430707|NCT02680951|Antiviral Agents|antiviral agents|mesh-ancestor
110430708|NCT02680951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110430709|NCT02680951|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110430710|NCT02680951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110430711|NCT02680951|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110430713|NCT02680951|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110430714|NCT02680717|Clobetasol|clobetasol|mesh-list
110430715|NCT02680717|Calcipotriene|calcipotriene|mesh-list
110430716|NCT02680717|Tacrolimus|tacrolimus|mesh-list
110430717|NCT02680717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110430718|NCT02680717|Immunologic Factors|immunologic factors|mesh-ancestor
110430719|NCT02680717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110430720|NCT02680717|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110430721|NCT02680717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110430722|NCT02680717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110430724|NCT02680717|Glucocorticoids|glucocorticoids|mesh-ancestor
110430725|NCT02680717|Hormones|hormones|mesh-ancestor
110430726|NCT02680717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110430727|NCT02680717|Dermatologic Agents|dermatologic agents|mesh-ancestor
110430728|NCT02680795|Belinostat|belinostat|mesh-list
110430729|NCT02680795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110430730|NCT02680795|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110430731|NCT02680795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110430732|NCT02680795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110430733|NCT00640237|Calcifediol|calcifediol|mesh-list
110430734|NCT00640237|Vitamins|vitamins|mesh-ancestor
110430735|NCT00640237|Micronutrients|micronutrients|mesh-ancestor
110430736|NCT00640237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110430737|NCT00640237|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110430738|NCT02683759|Curcumin|curcumin|mesh-list
110430739|NCT02683759|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110430740|NCT02683759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110430741|NCT02683759|Analgesics|analgesics|mesh-ancestor
110430742|NCT02683759|Sensory System Agents|sensory system agents|mesh-ancestor
110430743|NCT02683759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110430744|NCT02683759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110430745|NCT02683759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110430746|NCT02683759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110371373|NCT04588935|Bisoprolol|bisoprolol|mesh-list
110430747|NCT02683759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110430748|NCT02683759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110430749|NCT02683759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110430750|NCT04292691|Ropivacaine|ropivacaine|mesh-list
110430751|NCT04292691|Anesthetics, Local|anesthetics, local|mesh-ancestor
110430752|NCT04292691|Anesthetics|anesthetics|mesh-ancestor
110430753|NCT04292691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110430754|NCT04292691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110430755|NCT04292691|Sensory System Agents|sensory system agents|mesh-ancestor
110430756|NCT04292691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110430757|NCT00990249|Busulfan|busulfan|mesh-list
110430758|NCT00990249|Clofarabine|clofarabine|mesh-list
110430759|NCT00990249|Thymoglobulin|thymoglobulin|mesh-list
110430760|NCT00990249|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110430761|NCT00990249|Alkylating Agents|alkylating agents|mesh-ancestor
110430762|NCT00990249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110430763|NCT00990249|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110430764|NCT00990249|Immunologic Factors|immunologic factors|mesh-ancestor
110430765|NCT00990249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110430766|NCT00990249|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110430767|NCT00990249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110430768|NCT00990249|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110430769|NCT00990249|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110430770|NCT00990249|Antimetabolites|antimetabolites|mesh-ancestor
110430771|NCT02846545|Golimumab|golimumab|mesh-list
110430772|NCT02846545|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110430773|NCT02846545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110430774|NCT02846545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110430775|NCT02846545|Immunologic Factors|immunologic factors|mesh-ancestor
110430776|NCT02846545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110430777|NCT04291755|Pembrolizumab|pembrolizumab|mesh-list
110430778|NCT04291755|Nivolumab|nivolumab|mesh-list
110430779|NCT04291755|Ipilimumab|ipilimumab|mesh-list
110430780|NCT04291755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110430781|NCT04291755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110430782|NCT04291755|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110430783|NCT04291755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110430784|NCT04292769|Decitabine|decitabine|mesh-list
110430785|NCT04292769|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110430786|NCT04292769|Antimetabolites|antimetabolites|mesh-ancestor
110328928|NCT00498108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110430787|NCT04292769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110430788|NCT04292769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110430789|NCT04292769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110430790|NCT00640939|Diclofenac|diclofenac|mesh-list
110430791|NCT00640939|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110430792|NCT00640939|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110430793|NCT00640939|Analgesics|analgesics|mesh-ancestor
110430794|NCT00640939|Sensory System Agents|sensory system agents|mesh-ancestor
110430795|NCT00640939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110430796|NCT00640939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110430797|NCT00640939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110430798|NCT00640939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110430799|NCT00640939|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110430800|NCT00640939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110430801|NCT00640939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110430802|NCT05663749|Metformin|metformin|mesh-list
110430803|NCT05663749|Topiramate|topiramate|mesh-list
110430804|NCT05663749|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110430805|NCT05663749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110430806|NCT05663749|Anticonvulsants|anticonvulsants|mesh-ancestor
110430807|NCT02867553|Rituximab|rituximab|mesh-list
110430808|NCT02867553|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110430809|NCT02867553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110430810|NCT02867553|Immunologic Factors|immunologic factors|mesh-ancestor
110430811|NCT02867553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110430812|NCT02867553|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110430813|NCT00909961|Zoledronic Acid|zoledronic acid|mesh-list
110430814|NCT00909961|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110430815|NCT00909961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110430816|NCT00642577|Leucovorin|leucovorin|mesh-list
110430817|NCT00642577|Bevacizumab|bevacizumab|mesh-list
110430818|NCT00642577|Fluorouracil|fluorouracil|mesh-list
110430819|NCT00642577|Irinotecan|irinotecan|mesh-list
110430820|NCT00642577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110430821|NCT00642577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110430822|NCT00642577|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110564532|NCT05458024|Ergocalciferols|ergocalciferols|mesh-list
110430823|NCT00642577|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110430824|NCT00642577|Growth Substances|growth substances|mesh-ancestor
110430825|NCT00642577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110430826|NCT00642577|Growth Inhibitors|growth inhibitors|mesh-ancestor
110430827|NCT00642577|Antimetabolites|antimetabolites|mesh-ancestor
110430828|NCT00642577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110430829|NCT00642577|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110430830|NCT00642577|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110430831|NCT00642577|Immunologic Factors|immunologic factors|mesh-ancestor
110430832|NCT00642577|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110430833|NCT00642577|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110430834|NCT00642577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110430835|NCT00642577|Antidotes|antidotes|mesh-ancestor
110430836|NCT00642577|Protective Agents|protective agents|mesh-ancestor
110430837|NCT00642577|Vitamin B Complex|vitamin b complex|mesh-ancestor
110430838|NCT00642577|Vitamins|vitamins|mesh-ancestor
110430839|NCT00642577|Micronutrients|micronutrients|mesh-ancestor
110430840|NCT02682121|Metformin|metformin|mesh-list
110430841|NCT02682121|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110430842|NCT02682121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110430843|NCT02683603|Imipenem|imipenem|mesh-list
110430844|NCT02683603|Colistin|colistin|mesh-list
110430845|NCT02683603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110430846|NCT02683603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110430847|NCT00641095|Cyclophosphamide|cyclophosphamide|mesh-list
110430848|NCT00641095|Rituximab|rituximab|mesh-list
110430849|NCT00641095|Fludarabine|fludarabine|mesh-list
110430850|NCT00641095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110430851|NCT00641095|Immunologic Factors|immunologic factors|mesh-ancestor
110430852|NCT00641095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110430853|NCT00641095|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110430854|NCT00641095|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110430855|NCT00641095|Alkylating Agents|alkylating agents|mesh-ancestor
110430856|NCT00641095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110430857|NCT00641095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110430858|NCT00641095|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110430859|NCT00641095|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110430860|NCT01196975|Vaccines|vaccines|mesh-list
110430861|NCT01196975|Immunologic Factors|immunologic factors|mesh-ancestor
110430862|NCT01196975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110430863|NCT00992589|Rabeprazole|rabeprazole|mesh-list
110430864|NCT00992589|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110430865|NCT00992589|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110430866|NCT00992589|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110430867|NCT00992589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110430868|NCT00992589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110430869|NCT01196741|Paclitaxel|paclitaxel|mesh-list
110430870|NCT01196741|Saracatinib|saracatinib|mesh-list
110430871|NCT01196741|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110430872|NCT01196741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110430873|NCT01196741|Tubulin Modulators|tubulin modulators|mesh-ancestor
110430874|NCT01196741|Antimitotic Agents|antimitotic agents|mesh-ancestor
110430875|NCT01196741|Mitosis Modulators|mitosis modulators|mesh-ancestor
110430876|NCT01196741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110430877|NCT01196741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110430878|NCT00629187|Temozolomide|temozolomide|mesh-list
110430879|NCT00629187|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110430880|NCT00629187|Alkylating Agents|alkylating agents|mesh-ancestor
110430881|NCT00629187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110430882|NCT00629187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110430883|NCT04291287|Fibrinolytic Agents|fibrinolytic agents|mesh-list
110430884|NCT04291287|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110430885|NCT04291287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110430886|NCT00983385|Tapentadol|tapentadol|mesh-list
110430887|NCT00983385|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110430889|NCT00983385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110430890|NCT00983385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110430891|NCT00983385|Analgesics|analgesics|mesh-ancestor
110430892|NCT00983385|Sensory System Agents|sensory system agents|mesh-ancestor
110430893|NCT00983385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110430894|NCT00983385|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110430895|NCT00983385|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110430896|NCT00983385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110430897|NCT00983385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110430898|NCT00983385|Adrenergic Agents|adrenergic agents|mesh-ancestor
110430899|NCT00983385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110430900|NCT00992511|Vaccines|vaccines|mesh-list
110430901|NCT00992511|Immunologic Factors|immunologic factors|mesh-ancestor
110430902|NCT00992511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110430903|NCT02869035|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110430904|NCT02869035|Escitalopram|escitalopram|mesh-list
110430905|NCT02869035|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110430906|NCT02869035|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110430907|NCT02869035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110430908|NCT02869035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110430909|NCT02869035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110430910|NCT02869035|Serotonin Agents|serotonin agents|mesh-ancestor
110430911|NCT02869035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110430912|NCT02869035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110430913|NCT02869035|Antidepressive Agents|antidepressive agents|mesh-ancestor
110430914|NCT02869035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110430915|NCT02869035|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110430916|NCT02869035|Analgesics|analgesics|mesh-ancestor
110430917|NCT02869035|Sensory System Agents|sensory system agents|mesh-ancestor
110430919|NCT04290819|Caffeine|caffeine|mesh-list
110430920|NCT04290819|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110430921|NCT04290819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110430922|NCT04290819|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110430923|NCT04290819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110430924|NCT04290819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110430925|NCT04290819|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110430926|NCT04290819|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110430927|NCT04290819|Purinergic Agents|purinergic agents|mesh-ancestor
110430928|NCT04290819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110430929|NCT01196429|Sirolimus|sirolimus|mesh-list
110430930|NCT01196429|Paclitaxel|paclitaxel|mesh-list
110430931|NCT01196429|Docetaxel|docetaxel|mesh-list
110430932|NCT01196429|Carboplatin|carboplatin|mesh-list
110430933|NCT01196429|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110430934|NCT01196429|Temsirolimus|temsirolimus|mesh-list
110430935|NCT01196429|MTOR Inhibitors|mtor inhibitors|mesh-list
110430936|NCT01196429|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110430937|NCT01196429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110430938|NCT01196429|Tubulin Modulators|tubulin modulators|mesh-ancestor
110430939|NCT01196429|Antimitotic Agents|antimitotic agents|mesh-ancestor
110430940|NCT01196429|Mitosis Modulators|mitosis modulators|mesh-ancestor
110430941|NCT01196429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110430942|NCT01196429|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110430943|NCT01196429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110430944|NCT01196429|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110430945|NCT01196429|Antifungal Agents|antifungal agents|mesh-ancestor
110430946|NCT01196429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110430947|NCT01196429|Immunologic Factors|immunologic factors|mesh-ancestor
110430948|NCT01196429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110430949|NCT01196429|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110430950|NCT01196429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110430951|NCT01157364|Bimatoprost|bimatoprost|mesh-list
110430952|NCT01157364|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110430953|NCT01195415|Gemcitabine|gemcitabine|mesh-list
110430954|NCT01195415|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110430955|NCT01195415|Antimetabolites|antimetabolites|mesh-ancestor
110430956|NCT01195415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110430957|NCT01195415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110430959|NCT01195103|Midazolam|midazolam|mesh-list
110430960|NCT01195103|Propofol|propofol|mesh-list
110430961|NCT01195103|Fospropofol|fospropofol|mesh-list
110430962|NCT01195103|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110430963|NCT01195103|Narcotics|narcotics|mesh-ancestor
110430964|NCT01195103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110430965|NCT01195103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110430966|NCT01195103|Analgesics|analgesics|mesh-ancestor
110430967|NCT01195103|Sensory System Agents|sensory system agents|mesh-ancestor
110430968|NCT01195103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110430969|NCT01195103|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110430970|NCT01195103|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110204012|NCT00044811|Fexofenadine|fexofenadine|mesh-list
110430971|NCT01195103|Anesthetics, General|anesthetics, general|mesh-ancestor
110430972|NCT01195103|Anesthetics|anesthetics|mesh-ancestor
110430973|NCT01195103|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110564534|NCT05458024|Vitamins|vitamins|mesh-list
110430974|NCT01195103|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110430975|NCT01195103|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110430976|NCT01195103|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110430977|NCT01195103|GABA Modulators|gaba modulators|mesh-ancestor
110430978|NCT01195103|GABA Agents|gaba agents|mesh-ancestor
110430979|NCT01195103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110430980|NCT01195103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110430981|NCT01194869|Paclitaxel|paclitaxel|mesh-list
110430982|NCT01194869|Cisplatin|cisplatin|mesh-list
110430983|NCT01194869|Sorafenib|sorafenib|mesh-list
110430984|NCT01194869|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110430985|NCT01194869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110430986|NCT01194869|Tubulin Modulators|tubulin modulators|mesh-ancestor
110430987|NCT01194869|Antimitotic Agents|antimitotic agents|mesh-ancestor
110430988|NCT01194869|Mitosis Modulators|mitosis modulators|mesh-ancestor
110430989|NCT01194869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110430990|NCT01194869|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110430991|NCT01194869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110430993|NCT01177800|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110430994|NCT01177800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110430995|NCT01177800|Dermatologic Agents|dermatologic agents|mesh-ancestor
110430996|NCT01177800|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110430997|NCT01177800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110430998|NCT01177722|Vaccines|vaccines|mesh-list
110430999|NCT01177722|Immunologic Factors|immunologic factors|mesh-ancestor
110431000|NCT01177722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110431001|NCT02884986|Etoricoxib|etoricoxib|mesh-list
110431002|NCT02884986|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110431003|NCT02884986|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110431004|NCT02884986|Analgesics|analgesics|mesh-ancestor
110431005|NCT02884986|Sensory System Agents|sensory system agents|mesh-ancestor
110431006|NCT02884986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110431007|NCT02884986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110431008|NCT02884986|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110431009|NCT02884986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110431010|NCT02884986|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110431011|NCT02884986|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110431012|NCT02884986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110431013|NCT02884986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110431014|NCT04124562|Nitrous Oxide|nitrous oxide|mesh-list
110431016|NCT04124562|Anesthetics, General|anesthetics, general|mesh-ancestor
110431017|NCT04124562|Anesthetics|anesthetics|mesh-ancestor
110431018|NCT04124562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110431019|NCT04124562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110431020|NCT04124562|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110431021|NCT04124562|Analgesics|analgesics|mesh-ancestor
110431022|NCT04124562|Sensory System Agents|sensory system agents|mesh-ancestor
110431023|NCT04124562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110431024|NCT01177410|Mesalamine|mesalamine|mesh-list
110431025|NCT01177410|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110431026|NCT01177410|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110431027|NCT01177410|Analgesics|analgesics|mesh-ancestor
110431028|NCT01177410|Sensory System Agents|sensory system agents|mesh-ancestor
110431029|NCT01177410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110431030|NCT01177410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110431031|NCT01177410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110431032|NCT01177410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110431033|NCT02884596|Serotonin|serotonin|mesh-list
110431034|NCT02884596|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
110431035|NCT02884596|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110431036|NCT02884596|Serotonin Agents|serotonin agents|mesh-ancestor
110431037|NCT02884596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110431038|NCT02884596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110431039|NCT02884596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110431040|NCT02884596|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110431041|NCT02884596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110431042|NCT04205916|Moxifloxacin|moxifloxacin|mesh-list
110431043|NCT04205916|Dexamethasone|dexamethasone|mesh-list
110431044|NCT04205916|Ketorolac|ketorolac|mesh-list
110431045|NCT04205916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110431046|NCT04205916|Antiemetics|antiemetics|mesh-ancestor
110431047|NCT04205916|Autonomic Agents|autonomic agents|mesh-ancestor
110328964|NCT01243281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110431048|NCT04205916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110431049|NCT04205916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110431050|NCT04205916|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110431052|NCT04205916|Hormones|hormones|mesh-ancestor
110431053|NCT04205916|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110431054|NCT04205916|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110431055|NCT04205916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110431056|NCT04205916|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110431057|NCT04205916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110431058|NCT04205916|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110431059|NCT04205916|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110431060|NCT04205916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110431061|NCT04205916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110431062|NCT04205916|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110431063|NCT04205916|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110431064|NCT04205916|Analgesics|analgesics|mesh-ancestor
110431065|NCT04205916|Sensory System Agents|sensory system agents|mesh-ancestor
110431066|NCT04205916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110431067|NCT04205916|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110431068|NCT01176240|Mannitol|mannitol|mesh-list
110431069|NCT01176240|Droxidopa|droxidopa|mesh-list
110431070|NCT01176240|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110431071|NCT01176240|Diuretics|diuretics|mesh-ancestor
110431072|NCT01176240|Natriuretic Agents|natriuretic agents|mesh-ancestor
110431073|NCT01176240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110431074|NCT01176240|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110431075|NCT01176240|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110431076|NCT01149096|Lenograstim|lenograstim|mesh-list
110431077|NCT01149096|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110431078|NCT01149096|Immunologic Factors|immunologic factors|mesh-ancestor
110431079|NCT01149096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110431080|NCT02867397|Oxaliplatin|oxaliplatin|mesh-list
110431081|NCT02867397|Epirubicin|epirubicin|mesh-list
110431082|NCT02867397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110431083|NCT02867397|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110431084|NCT02867397|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110371407|NCT04649502|Metformin|metformin|mesh-list
110431085|NCT02867397|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110431086|NCT02867397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110431087|NCT02867397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110431088|NCT01175382|Tamsulosin|tamsulosin|mesh-list
110431089|NCT01175382|Tolterodine Tartrate|tolterodine tartrate|mesh-list
110431090|NCT01175382|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110431091|NCT01175382|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110431092|NCT01175382|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110431093|NCT01175382|Adrenergic Agents|adrenergic agents|mesh-ancestor
110431094|NCT01175382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110431095|NCT01175382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110431096|NCT01175382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110431097|NCT01175382|Urological Agents|urological agents|mesh-ancestor
110431098|NCT01175382|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110431099|NCT01175382|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110431100|NCT01175382|Cholinergic Agents|cholinergic agents|mesh-ancestor
110431102|NCT01194245|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110431103|NCT01194245|Insulin Glargine|insulin glargine|mesh-list
110431104|NCT01194245|Insulin Aspart|insulin aspart|mesh-list
110431105|NCT01194245|Insulin Lispro|insulin lispro|mesh-list
110431106|NCT01194245|Insulin glulisine|insulin glulisine|mesh-list
110431107|NCT01194245|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110431108|NCT01194245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110431109|NCT00979407|Vaccines|vaccines|mesh-list
110431110|NCT00979407|Immunologic Factors|immunologic factors|mesh-ancestor
110431111|NCT00979407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110431112|NCT04290429|Teduglutide|teduglutide|mesh-list
110431113|NCT04290429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110431114|NCT04290429|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110431115|NCT04290429|Protective Agents|protective agents|mesh-ancestor
110431116|NCT04290429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110431117|NCT00975975|Basiliximab|basiliximab|mesh-list
110431118|NCT00975975|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110431119|NCT00975975|Immunologic Factors|immunologic factors|mesh-ancestor
110431120|NCT00975975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110431121|NCT01193153|Paliperidone Palmitate|paliperidone palmitate|mesh-list
110431122|NCT01193153|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110431123|NCT01193153|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110431124|NCT01193153|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110431125|NCT01193153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110431126|NCT01193153|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110431127|NCT01193153|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110431128|NCT01193153|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110431129|NCT01193153|Serotonin Agents|serotonin agents|mesh-ancestor
110431130|NCT01193153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110431131|NCT01193153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110431132|NCT01193153|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110431133|NCT01193153|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110431134|NCT01193153|Dopamine Agents|dopamine agents|mesh-ancestor
110431135|NCT02867007|Mogamulizumab|mogamulizumab|mesh-list
110431136|NCT02867007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110431137|NCT04289883|Calcium|calcium|mesh-list
110431138|NCT04289883|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110431139|NCT04289883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110431140|NCT02865369|Asunaprevir|asunaprevir|mesh-list
110431141|NCT02865369|Protease Inhibitors|protease inhibitors|mesh-ancestor
110431142|NCT02865369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110431143|NCT02865369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110431144|NCT01192295|Oxycodone|oxycodone|mesh-list
110431145|NCT01192295|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110431146|NCT01192295|Narcotics|narcotics|mesh-ancestor
110431147|NCT01192295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110431148|NCT01192295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110431149|NCT01192295|Analgesics|analgesics|mesh-ancestor
110431150|NCT01192295|Sensory System Agents|sensory system agents|mesh-ancestor
110371422|NCT00567762|Immunologic Factors|immunologic factors|mesh-ancestor
110431151|NCT01192295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110431153|NCT04289103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110431154|NCT04289103|Immunologic Factors|immunologic factors|mesh-ancestor
110431155|NCT04289103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110431156|NCT01154166|Ropinirole|ropinirole|mesh-list
110431157|NCT01154166|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110431158|NCT01154166|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110431159|NCT01154166|Dopamine Agonists|dopamine agonists|mesh-ancestor
110431160|NCT01154166|Dopamine Agents|dopamine agents|mesh-ancestor
110431161|NCT01154166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110431162|NCT01154166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110431163|NCT01154166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110431164|NCT04290195|Aflibercept|aflibercept|mesh-list
110431165|NCT04290195|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110431166|NCT04290195|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110431167|NCT04290195|Growth Substances|growth substances|mesh-ancestor
110431168|NCT04290195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110431169|NCT04290195|Growth Inhibitors|growth inhibitors|mesh-ancestor
110431170|NCT04290195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110431171|NCT05656703|Anesthetics|anesthetics|mesh-list
110431172|NCT05656703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110431173|NCT05656703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110431174|NCT05656079|Cyclophosphamide|cyclophosphamide|mesh-list
110431175|NCT05656079|Docetaxel|docetaxel|mesh-list
110431176|NCT05656079|Doxorubicin|doxorubicin|mesh-list
110431177|NCT05656079|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110431178|NCT05656079|Trastuzumab|trastuzumab|mesh-list
110431179|NCT05656079|Epirubicin|epirubicin|mesh-list
110431180|NCT05656079|Pertuzumab|pertuzumab|mesh-list
110431181|NCT05656079|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110431182|NCT05656079|Immunologic Factors|immunologic factors|mesh-ancestor
110431183|NCT05656079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110431184|NCT05656079|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110431185|NCT05656079|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110431186|NCT05656079|Alkylating Agents|alkylating agents|mesh-ancestor
110431187|NCT05656079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110431188|NCT05656079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110431189|NCT05656079|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110431190|NCT05656079|Tubulin Modulators|tubulin modulators|mesh-ancestor
110431191|NCT05656079|Antimitotic Agents|antimitotic agents|mesh-ancestor
110431192|NCT05656079|Mitosis Modulators|mitosis modulators|mesh-ancestor
110431193|NCT05656079|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110431194|NCT05656079|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110431195|NCT05656079|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110431196|NCT05656079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110431197|NCT05656079|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110431198|NCT01181921|Galantamine|galantamine|mesh-list
110431199|NCT01181921|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110431200|NCT01181921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110431201|NCT01181921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110431202|NCT01181921|Cholinergic Agents|cholinergic agents|mesh-ancestor
110431203|NCT01181921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110431204|NCT01181921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110431205|NCT01181921|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110431206|NCT01181921|Autonomic Agents|autonomic agents|mesh-ancestor
110371436|NCT04691063|Etoposide|etoposide|mesh-list
110431207|NCT01181921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110431209|NCT00932698|Ixazomib|ixazomib|mesh-list
110431210|NCT00932698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110431211|NCT00932698|Protease Inhibitors|protease inhibitors|mesh-ancestor
110431212|NCT00932698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110431213|NCT00932698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110431214|NCT00978627|Insulin|insulin|mesh-list
110431215|NCT00978627|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110431216|NCT00978627|Insulin Aspart|insulin aspart|mesh-list
110431217|NCT00978627|Insulin, Long-Acting|insulin, long-acting|mesh-list
110431218|NCT00978627|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
110431219|NCT00978627|Insulin Detemir|insulin detemir|mesh-list
110431220|NCT00978627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110431221|NCT00978627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110431222|NCT01181609|Bevacizumab|bevacizumab|mesh-list
110431223|NCT01181609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110431224|NCT01181609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110431225|NCT01181609|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110431226|NCT01181609|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110431227|NCT01181609|Growth Substances|growth substances|mesh-ancestor
110431228|NCT01181609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110431229|NCT01181609|Growth Inhibitors|growth inhibitors|mesh-ancestor
110431230|NCT04261426|Immunoglobulins|immunoglobulins|mesh-list
110431231|NCT04261426|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110431232|NCT04261426|Antibodies|antibodies|mesh-list
110431233|NCT04261426|gamma-Globulins|gamma-globulins|mesh-list
110431234|NCT04261426|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110431235|NCT04261426|Immunologic Factors|immunologic factors|mesh-ancestor
110431236|NCT04261426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110431237|NCT04264078|Fludarabine|fludarabine|mesh-list
110431238|NCT04264078|Cyclophosphamide|cyclophosphamide|mesh-list
110431239|NCT04264078|Melphalan|melphalan|mesh-list
110431240|NCT04264078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110431241|NCT04264078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110431242|NCT04264078|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110431243|NCT04264078|Immunologic Factors|immunologic factors|mesh-ancestor
110431244|NCT04264078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110431245|NCT04264078|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110431246|NCT04264078|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110431247|NCT04264078|Alkylating Agents|alkylating agents|mesh-ancestor
110431248|NCT04264078|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110431249|NCT01153698|Dabigatran|dabigatran|mesh-list
110431250|NCT01153698|Antithrombins|antithrombins|mesh-ancestor
110431251|NCT01153698|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110431252|NCT01153698|Protease Inhibitors|protease inhibitors|mesh-ancestor
110431253|NCT01153698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110431254|NCT01153698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110431255|NCT01153698|Anticoagulants|anticoagulants|mesh-ancestor
110431256|NCT00608218|Ciclesonide|ciclesonide|mesh-list
110431257|NCT00608218|Glucocorticoids|glucocorticoids|mesh-ancestor
110431258|NCT00608218|Hormones|hormones|mesh-ancestor
110431259|NCT00608218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110431260|NCT00608218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110431261|NCT00608218|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110431262|NCT02884050|Topiramate|topiramate|mesh-list
110431263|NCT02884050|Anticonvulsants|anticonvulsants|mesh-ancestor
110431264|NCT02884050|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110431265|NCT02884050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110431266|NCT00609934|Sorafenib|sorafenib|mesh-list
110431267|NCT00609934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110328987|NCT01243359|Sunitinib|sunitinib|mesh-list
110431268|NCT00609934|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110431269|NCT00609934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110431270|NCT00609934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110431271|NCT01147926|Prucalopride|prucalopride|mesh-list
110431272|NCT01147926|Laxatives|laxatives|mesh-ancestor
110431273|NCT01147926|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110564540|NCT05456685|Maytansine|maytansine|mesh-list
110371449|NCT01151215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110431274|NCT01147926|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
110204087|NCT00044889|Clofarabine|clofarabine|mesh-list
110431275|NCT01147926|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110431276|NCT01147926|Serotonin Agents|serotonin agents|mesh-ancestor
110431277|NCT01147926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110431278|NCT01147926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110431279|NCT01147926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110431280|NCT05115136|Diphenhydramine|diphenhydramine|mesh-list
110431281|NCT05115136|Promethazine|promethazine|mesh-list
110431282|NCT05115136|Doxepin|doxepin|mesh-list
110431283|NCT05115136|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110431284|NCT05115136|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110431285|NCT05115136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110431286|NCT05115136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110431287|NCT05115136|Anesthetics, Local|anesthetics, local|mesh-ancestor
110431288|NCT05115136|Anesthetics|anesthetics|mesh-ancestor
110431289|NCT05115136|Sensory System Agents|sensory system agents|mesh-ancestor
110431290|NCT05115136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110431291|NCT05115136|Antiemetics|antiemetics|mesh-ancestor
110431292|NCT05115136|Autonomic Agents|autonomic agents|mesh-ancestor
110431293|NCT05115136|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110431294|NCT05115136|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110431295|NCT05115136|Histamine Antagonists|histamine antagonists|mesh-ancestor
110431296|NCT05115136|Histamine Agents|histamine agents|mesh-ancestor
110431297|NCT05115136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110431298|NCT05115136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110431299|NCT05115136|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110431300|NCT05115136|Antipruritics|antipruritics|mesh-ancestor
110431301|NCT05115136|Dermatologic Agents|dermatologic agents|mesh-ancestor
110431302|NCT05115136|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110431303|NCT05115136|Antidepressive Agents|antidepressive agents|mesh-ancestor
110431304|NCT05115136|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110431305|NCT00608374|Fludarabine|fludarabine|mesh-list
110431306|NCT00608374|Fludarabine phosphate|fludarabine phosphate|mesh-list
110431307|NCT00608374|Chlorambucil|chlorambucil|mesh-list
110431308|NCT00608374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110431309|NCT00608374|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110431310|NCT00608374|Antimetabolites|antimetabolites|mesh-ancestor
110431311|NCT00608374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110431312|NCT00608374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110431313|NCT00608374|Immunologic Factors|immunologic factors|mesh-ancestor
110431314|NCT00608374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110431315|NCT00608374|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110431316|NCT00608374|Alkylating Agents|alkylating agents|mesh-ancestor
110431317|NCT00625014|Haloperidol|haloperidol|mesh-list
110431318|NCT00625014|Haloperidol decanoate|haloperidol decanoate|mesh-list
110431320|NCT00625014|Autonomic Agents|autonomic agents|mesh-ancestor
110431321|NCT00625014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110431322|NCT00625014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110431323|NCT00625014|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110431324|NCT00625014|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110431325|NCT00625014|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110431326|NCT00625014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110431327|NCT00625014|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110431328|NCT00625014|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110431329|NCT00625014|Dopamine Agents|dopamine agents|mesh-ancestor
110431330|NCT00625014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110431331|NCT00625014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110431332|NCT00625014|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110431333|NCT01147848|Fluticasone|fluticasone|mesh-list
110431334|NCT01147848|Xhance|xhance|mesh-list
110431335|NCT01147848|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110431336|NCT01147848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110431337|NCT01147848|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110431338|NCT01147848|Autonomic Agents|autonomic agents|mesh-ancestor
110431339|NCT01147848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110431340|NCT01147848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110431341|NCT01147848|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110431342|NCT01147848|Respiratory System Agents|respiratory system agents|mesh-ancestor
110431343|NCT01147848|Dermatologic Agents|dermatologic agents|mesh-ancestor
110431344|NCT01147848|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110431345|NCT01147848|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110431346|NCT01147848|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110431347|NCT01147848|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110431348|NCT01147848|Adrenergic Agents|adrenergic agents|mesh-ancestor
110431349|NCT01147848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110431350|NCT01147848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110431352|NCT04261270|Oseltamivir|oseltamivir|mesh-list
110431353|NCT04261270|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110431354|NCT04261270|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110431355|NCT04261270|Protease Inhibitors|protease inhibitors|mesh-ancestor
110431356|NCT04261270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110431357|NCT04261270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110431358|NCT04261270|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110431359|NCT04261270|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110431360|NCT04261270|Antiviral Agents|antiviral agents|mesh-ancestor
110431361|NCT04261270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110431362|NCT04261270|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110431363|NCT04261270|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110431364|NCT01152996|Vortioxetine|vortioxetine|mesh-list
110431365|NCT01152996|Antidepressive Agents|antidepressive agents|mesh-ancestor
110431366|NCT01152996|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110431367|NCT01152996|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110431368|NCT01152996|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110431369|NCT01152996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110431370|NCT01152996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110431371|NCT01152996|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110431372|NCT01152996|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110431373|NCT01152996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110431374|NCT01152996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110431375|NCT01152996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110431376|NCT01152996|Serotonin Agents|serotonin agents|mesh-ancestor
110431377|NCT01152996|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110431378|NCT01152996|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110431379|NCT01152996|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110431380|NCT01152996|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110431381|NCT00624936|Azacitidine|azacitidine|mesh-list
110431382|NCT00624936|Bortezomib|bortezomib|mesh-list
110431383|NCT00624936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110431384|NCT00624936|Antimetabolites|antimetabolites|mesh-ancestor
110431385|NCT00624936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110431386|NCT00624936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110431387|NCT00624936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110431388|NCT00979953|Oxycodone|oxycodone|mesh-list
110431389|NCT00979953|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110431390|NCT00979953|Narcotics|narcotics|mesh-ancestor
110431391|NCT00979953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110078390|NCT01616355|Eusol|eusol|mesh-list
110431392|NCT00979953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110431393|NCT00979953|Analgesics|analgesics|mesh-ancestor
110431394|NCT00979953|Sensory System Agents|sensory system agents|mesh-ancestor
110431395|NCT00979953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110431396|NCT01181531|Vitamin D|vitamin d|mesh-list
110431397|NCT01181531|Cinacalcet|cinacalcet|mesh-list
110431399|NCT01181531|Micronutrients|micronutrients|mesh-ancestor
110431400|NCT01181531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110431401|NCT01181531|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110431402|NCT01181531|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110431403|NCT01181531|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
110431404|NCT01181531|Hormone Antagonists|hormone antagonists|mesh-ancestor
110431405|NCT01181531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110431406|NCT01152450|Tiotropium Bromide|tiotropium bromide|mesh-list
110431407|NCT01152450|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110431408|NCT01152450|Autonomic Agents|autonomic agents|mesh-ancestor
110328996|NCT01243359|Growth Inhibitors|growth inhibitors|mesh-ancestor
110431409|NCT01152450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110431410|NCT01152450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110431411|NCT01152450|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110431412|NCT01152450|Respiratory System Agents|respiratory system agents|mesh-ancestor
110431413|NCT01152450|Parasympatholytics|parasympatholytics|mesh-ancestor
110431414|NCT01152450|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110431415|NCT01152450|Cholinergic Agents|cholinergic agents|mesh-ancestor
110431416|NCT01152450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110431417|NCT01152450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110431419|NCT00610246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110431420|NCT00610246|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110431421|NCT00610246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110431422|NCT00610246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110431423|NCT01181141|Enoxaparin|enoxaparin|mesh-list
110431424|NCT01181141|Enoxaparin sodium|enoxaparin sodium|mesh-list
110431426|NCT01181141|Anticoagulants|anticoagulants|mesh-ancestor
110431427|NCT01181141|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110431428|NCT01181141|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110431429|NCT01181141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110431430|NCT01181141|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110431431|NCT01181141|Antithrombins|antithrombins|mesh-ancestor
110431432|NCT01181141|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110431433|NCT01181141|Protease Inhibitors|protease inhibitors|mesh-ancestor
110431434|NCT01181141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110431435|NCT00606814|Docetaxel|docetaxel|mesh-list
110431436|NCT00606814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110431437|NCT00606814|Tubulin Modulators|tubulin modulators|mesh-ancestor
110431438|NCT00606814|Antimitotic Agents|antimitotic agents|mesh-ancestor
110431439|NCT00606814|Mitosis Modulators|mitosis modulators|mesh-ancestor
110431440|NCT00606814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110431441|NCT01173120|Abatacept|abatacept|mesh-list
110431442|NCT01173120|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110431443|NCT01173120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110431444|NCT01173120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110431445|NCT01173120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110431446|NCT01173120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110431447|NCT01173120|Immunologic Factors|immunologic factors|mesh-ancestor
110431448|NCT01173120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110431449|NCT01173120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110431450|NCT00977379|Capecitabine|capecitabine|mesh-list
110431451|NCT00977379|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110431452|NCT00977379|Antimetabolites|antimetabolites|mesh-ancestor
110431453|NCT00977379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110431454|NCT00977379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110431455|NCT04263844|Midazolam|midazolam|mesh-list
110431456|NCT04263844|Dexmedetomidine|dexmedetomidine|mesh-list
110431457|NCT04263844|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110431458|NCT04263844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110431459|NCT04263844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110431460|NCT04263844|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110431461|NCT04263844|Analgesics|analgesics|mesh-ancestor
110431462|NCT04263844|Sensory System Agents|sensory system agents|mesh-ancestor
110431463|NCT04263844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110431464|NCT04263844|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110204123|NCT00163462|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110431465|NCT04263844|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110431466|NCT04263844|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110431467|NCT04263844|Adrenergic Agents|adrenergic agents|mesh-ancestor
110431468|NCT04263844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110431469|NCT04263844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110431470|NCT04263844|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110431471|NCT04263844|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110431472|NCT04263844|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110431473|NCT04263844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110431474|NCT04263844|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110431475|NCT04263844|Anesthetics, General|anesthetics, general|mesh-ancestor
110431477|NCT04263844|GABA Modulators|gaba modulators|mesh-ancestor
110431478|NCT04263844|GABA Agents|gaba agents|mesh-ancestor
110431479|NCT00610324|Chlorhexidine|chlorhexidine|mesh-list
110431480|NCT00610324|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110431481|NCT00610324|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110431482|NCT00610324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110431483|NCT00610324|Disinfectants|disinfectants|mesh-ancestor
110431484|NCT00610324|Dermatologic Agents|dermatologic agents|mesh-ancestor
110431485|NCT02884128|Leucovorin|leucovorin|mesh-list
110431486|NCT02884128|Fluorouracil|fluorouracil|mesh-list
110431487|NCT02884128|Irinotecan|irinotecan|mesh-list
110431488|NCT02884128|Antimetabolites|antimetabolites|mesh-ancestor
110431489|NCT02884128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110431490|NCT02884128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110431491|NCT02884128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110431492|NCT02884128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110431493|NCT02884128|Immunologic Factors|immunologic factors|mesh-ancestor
110431494|NCT02884128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110431495|NCT02884128|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110431496|NCT02884128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110431497|NCT02884128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110431498|NCT02884128|Antidotes|antidotes|mesh-ancestor
110431499|NCT02884128|Protective Agents|protective agents|mesh-ancestor
110431500|NCT02884128|Vitamin B Complex|vitamin b complex|mesh-ancestor
110431501|NCT02884128|Vitamins|vitamins|mesh-ancestor
110431502|NCT02884128|Micronutrients|micronutrients|mesh-ancestor
110431503|NCT00629343|Azacitidine|azacitidine|mesh-list
110431504|NCT00629343|Temozolomide|temozolomide|mesh-list
110431505|NCT00629343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110431506|NCT00629343|Antimetabolites|antimetabolites|mesh-ancestor
110431507|NCT00629343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110431508|NCT00629343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110431509|NCT00629343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110431510|NCT00629343|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110431511|NCT00629343|Alkylating Agents|alkylating agents|mesh-ancestor
110431512|NCT01180049|Sirolimus|sirolimus|mesh-list
110431513|NCT01180049|Temsirolimus|temsirolimus|mesh-list
110431514|NCT01180049|MTOR Inhibitors|mtor inhibitors|mesh-list
110431515|NCT01180049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110431516|NCT01180049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110431517|NCT01180049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110431518|NCT01180049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110431519|NCT01180049|Immunologic Factors|immunologic factors|mesh-ancestor
110431520|NCT01180049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110431521|NCT01180049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110431522|NCT01180049|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110431523|NCT01180049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110431524|NCT01180049|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110431525|NCT01180049|Antifungal Agents|antifungal agents|mesh-ancestor
110431526|NCT01147458|Naproxen|naproxen|mesh-list
110431527|NCT01147458|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110431528|NCT01147458|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110431529|NCT01147458|Analgesics|analgesics|mesh-ancestor
110431530|NCT01147458|Sensory System Agents|sensory system agents|mesh-ancestor
110431531|NCT01147458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110431532|NCT01147458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110431533|NCT01147458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110431534|NCT01147458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110431535|NCT01147458|Gout Suppressants|gout suppressants|mesh-ancestor
110431536|NCT01147458|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110431537|NCT01147458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110431538|NCT01147458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110431539|NCT01172808|Tiotropium Bromide|tiotropium bromide|mesh-list
110078490|NCT01616966|Analgesics|analgesics|mesh-ancestor
110431540|NCT01172808|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110431541|NCT01172808|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110431542|NCT01172808|Autonomic Agents|autonomic agents|mesh-ancestor
110431543|NCT01172808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110431544|NCT01172808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110431545|NCT01172808|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110431546|NCT01172808|Respiratory System Agents|respiratory system agents|mesh-ancestor
110431547|NCT01172808|Parasympatholytics|parasympatholytics|mesh-ancestor
110431548|NCT01172808|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110431549|NCT01172808|Cholinergic Agents|cholinergic agents|mesh-ancestor
110431550|NCT01172808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110431551|NCT01172808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110431552|NCT01172808|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110431553|NCT01172808|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110431554|NCT01172808|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110431555|NCT01172808|Adrenergic Agents|adrenergic agents|mesh-ancestor
110431556|NCT04315194|Clarithromycin|clarithromycin|mesh-list
110431557|NCT04315194|Oseltamivir|oseltamivir|mesh-list
110431558|NCT04315194|Naproxen|naproxen|mesh-list
110431559|NCT04315194|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110431560|NCT04315194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110431561|NCT04315194|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110431562|NCT04315194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110431563|NCT04315194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110431564|NCT04315194|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110431565|NCT04315194|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110431566|NCT04315194|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110431567|NCT04315194|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110431568|NCT04315194|Analgesics|analgesics|mesh-ancestor
110431569|NCT04315194|Sensory System Agents|sensory system agents|mesh-ancestor
110431570|NCT04315194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110431571|NCT04315194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110431572|NCT04315194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110431573|NCT04315194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110431574|NCT04315194|Gout Suppressants|gout suppressants|mesh-ancestor
110204142|NCT00163540|Formaldehyde|formaldehyde|mesh-list
110431575|NCT04315194|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110431576|NCT04315194|Antiviral Agents|antiviral agents|mesh-ancestor
110431577|NCT04066491|Gemcitabine|gemcitabine|mesh-list
110431578|NCT04066491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110431579|NCT04066491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110431580|NCT04066491|Antimetabolites|antimetabolites|mesh-ancestor
110431581|NCT04066491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110431582|NCT01149486|Losartan|losartan|mesh-list
110431583|NCT01149486|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110431584|NCT01149486|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110431585|NCT01149486|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110431586|NCT01149486|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110431587|NCT01149486|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110431588|NCT01149486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110431589|NCT01149486|Diuretics|diuretics|mesh-ancestor
110431590|NCT01149486|Natriuretic Agents|natriuretic agents|mesh-ancestor
110431591|NCT01149486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110431592|NCT01149486|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110431593|NCT01149486|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110431594|NCT00601705|Fluorouracil|fluorouracil|mesh-list
110431595|NCT00601705|Oxaliplatin|oxaliplatin|mesh-list
110431596|NCT00601705|Epirubicin|epirubicin|mesh-list
110431597|NCT00601705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110431598|NCT00601705|Antimetabolites|antimetabolites|mesh-ancestor
110431599|NCT00601705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110431600|NCT00601705|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110431601|NCT00601705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110431602|NCT00601705|Immunologic Factors|immunologic factors|mesh-ancestor
110431603|NCT00601705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110431604|NCT00601705|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110431605|NCT00601705|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110431606|NCT00601705|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110431607|NCT00601705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110431608|NCT00641173|Paroxetine|paroxetine|mesh-list
110431609|NCT00641173|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110431610|NCT00641173|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110431611|NCT00641173|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110431612|NCT00641173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110431613|NCT00641173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110431614|NCT00641173|Serotonin Agents|serotonin agents|mesh-ancestor
110078624|NCT01617707|Midazolam|midazolam|mesh-list
110431615|NCT00641173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110431616|NCT00641173|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110431617|NCT00641173|Antidepressive Agents|antidepressive agents|mesh-ancestor
110371547|NCT00568503|Bromides|bromides|mesh-list
110329005|NCT00498342|Expectorants|expectorants|mesh-ancestor
110431619|NCT00641173|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110431620|NCT00641173|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110431621|NCT00641173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110431622|NCT00929110|Glycopyrrolate|glycopyrrolate|mesh-list
110431623|NCT00929110|Bromides|bromides|mesh-list
110431624|NCT00929110|Tiotropium Bromide|tiotropium bromide|mesh-list
110431625|NCT00929110|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110431626|NCT00929110|Autonomic Agents|autonomic agents|mesh-ancestor
110431627|NCT00929110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110431628|NCT00929110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110431629|NCT00929110|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110431630|NCT00929110|Respiratory System Agents|respiratory system agents|mesh-ancestor
110431631|NCT00929110|Parasympatholytics|parasympatholytics|mesh-ancestor
110431632|NCT00929110|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110431633|NCT00929110|Cholinergic Agents|cholinergic agents|mesh-ancestor
110431634|NCT00929110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110431635|NCT00929110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110431636|NCT00929110|Anticonvulsants|anticonvulsants|mesh-ancestor
110431637|NCT00929110|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110431638|NCT00929110|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110431639|NCT00922519|Listerine|listerine|mesh-list
110431640|NCT00922519|Fluorides|fluorides|mesh-list
110431641|NCT00922519|Sodium Fluoride|sodium fluoride|mesh-list
110431642|NCT00922519|Cariostatic Agents|cariostatic agents|mesh-ancestor
110431643|NCT00922519|Protective Agents|protective agents|mesh-ancestor
110431644|NCT00922519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110431645|NCT00922519|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110431646|NCT00922519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110431647|NCT00640549|Atorvastatin|atorvastatin|mesh-list
110431648|NCT00640549|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110431649|NCT00640549|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110431650|NCT00640549|Antimetabolites|antimetabolites|mesh-ancestor
110431651|NCT00640549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110431652|NCT00640549|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110431653|NCT00640549|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110431654|NCT00640549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110431655|NCT02683369|Iron|iron|mesh-list
110431656|NCT02683369|Trace Elements|trace elements|mesh-ancestor
110431657|NCT02683369|Micronutrients|micronutrients|mesh-ancestor
110431658|NCT02683369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110431659|NCT01147068|Hemagglutinins|hemagglutinins|mesh-list
110431660|NCT01147068|Agglutinins|agglutinins|mesh-ancestor
110431661|NCT01147068|Immunologic Factors|immunologic factors|mesh-ancestor
110371557|NCT00568503|Cholinergic Agents|cholinergic agents|mesh-ancestor
110431662|NCT01147068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110431663|NCT01147068|Coagulants|coagulants|mesh-ancestor
110431664|NCT00640627|Celecoxib|celecoxib|mesh-list
110431665|NCT00640627|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110431666|NCT00640627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110431667|NCT00640627|Analgesics|analgesics|mesh-ancestor
110431668|NCT00640627|Sensory System Agents|sensory system agents|mesh-ancestor
110431669|NCT00640627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110431670|NCT00640627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110431671|NCT00640627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110431672|NCT00640627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110431673|NCT00640627|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110431674|NCT00640627|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110431675|NCT00640627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110431676|NCT00640627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110431677|NCT02681887|Melatonin|melatonin|mesh-list
110431678|NCT02681887|Antioxidants|antioxidants|mesh-ancestor
110431679|NCT02681887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110431680|NCT02681887|Protective Agents|protective agents|mesh-ancestor
110431681|NCT02681887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110431682|NCT02681887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110431683|NCT01134042|Fluticasone|fluticasone|mesh-list
110431684|NCT01134042|Xhance|xhance|mesh-list
110431685|NCT01134042|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110431686|NCT01134042|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110431687|NCT01134042|Autonomic Agents|autonomic agents|mesh-ancestor
110078641|NCT01617733|Hormones|hormones|mesh-ancestor
110431688|NCT01134042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110431689|NCT01134042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110431690|NCT01134042|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110431691|NCT01134042|Respiratory System Agents|respiratory system agents|mesh-ancestor
110431692|NCT01134042|Dermatologic Agents|dermatologic agents|mesh-ancestor
110431693|NCT01134042|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110431695|NCT01179347|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110431696|NCT01179347|Autonomic Agents|autonomic agents|mesh-ancestor
110431697|NCT01179347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110431698|NCT01179347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110431699|NCT01179347|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110431700|NCT01179347|Respiratory System Agents|respiratory system agents|mesh-ancestor
110431701|NCT01179347|Parasympatholytics|parasympatholytics|mesh-ancestor
110431702|NCT01179347|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110431703|NCT01179347|Cholinergic Agents|cholinergic agents|mesh-ancestor
110431704|NCT01179347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110431705|NCT01179347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110431706|NCT01146288|Furosemide|furosemide|mesh-list
110431707|NCT01146288|Acetazolamide|acetazolamide|mesh-list
110431708|NCT01146288|Diuretics|diuretics|mesh-ancestor
110431709|NCT01146288|Natriuretic Agents|natriuretic agents|mesh-ancestor
110431710|NCT01146288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110431711|NCT01146288|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110431712|NCT01146288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110431713|NCT01146288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110431714|NCT01146288|Anticonvulsants|anticonvulsants|mesh-ancestor
110431715|NCT01146288|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110431716|NCT01146288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110431717|NCT01146054|Gemcitabine|gemcitabine|mesh-list
110431718|NCT01146054|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110431719|NCT01146054|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110431720|NCT01146054|Antimetabolites|antimetabolites|mesh-ancestor
110431721|NCT01146054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110431722|NCT01146054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110431723|NCT01146054|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110431725|NCT00640705|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110431726|NCT00640705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110431727|NCT00640705|Analgesics|analgesics|mesh-ancestor
110431728|NCT00640705|Sensory System Agents|sensory system agents|mesh-ancestor
110431729|NCT00640705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110431730|NCT00640705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110431731|NCT00640705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110431732|NCT00640705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110431733|NCT00640705|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110431734|NCT00640705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110431735|NCT00640705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110431736|NCT01145898|Timolol|timolol|mesh-list
110431737|NCT01145898|Dorzolamide|dorzolamide|mesh-list
110431738|NCT01145898|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110431739|NCT01145898|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110431740|NCT01145898|Adrenergic Agents|adrenergic agents|mesh-ancestor
110431741|NCT01145898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110431742|NCT01145898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110431743|NCT01145898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110431744|NCT01145898|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110431745|NCT01145898|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110431746|NCT01145898|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110431747|NCT01145898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110431748|NCT02681653|Atorvastatin|atorvastatin|mesh-list
110431749|NCT02681653|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110431750|NCT02681653|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110431751|NCT02681653|Antimetabolites|antimetabolites|mesh-ancestor
110431752|NCT02681653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110431753|NCT02681653|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110431754|NCT02681653|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110431755|NCT02681653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110431756|NCT04315116|Loperamide|loperamide|mesh-list
110431757|NCT04315116|Antidiarrheals|antidiarrheals|mesh-list
110431758|NCT04315116|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110431759|NCT02883114|Itraconazole|itraconazole|mesh-list
110431760|NCT02883114|Antifungal Agents|antifungal agents|mesh-ancestor
110431761|NCT02883114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110431762|NCT02883114|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110431763|NCT02883114|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110431764|NCT02883114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110431765|NCT02883114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110431766|NCT02883114|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110431767|NCT02883114|Hormone Antagonists|hormone antagonists|mesh-ancestor
110431768|NCT02883114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110431769|NCT02883114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110431770|NCT02883114|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110431772|NCT04183387|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110431773|NCT04183387|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110431774|NCT04183387|Antimetabolites|antimetabolites|mesh-ancestor
110431775|NCT04183387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110431776|NCT04183387|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110431777|NCT04183387|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110431778|NCT04183387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110431779|NCT00625092|Leucovorin|leucovorin|mesh-list
110431780|NCT00625092|Fluorouracil|fluorouracil|mesh-list
110431781|NCT00625092|Oxaliplatin|oxaliplatin|mesh-list
110431782|NCT00625092|Calcium|calcium|mesh-list
110431783|NCT00625092|Levoleucovorin|levoleucovorin|mesh-list
110431784|NCT00625092|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110431785|NCT00625092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110431786|NCT00625092|Antimetabolites|antimetabolites|mesh-ancestor
110431787|NCT00625092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110431788|NCT00625092|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110431789|NCT00625092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110431790|NCT00625092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110431791|NCT00625092|Immunologic Factors|immunologic factors|mesh-ancestor
110431792|NCT00625092|Antidotes|antidotes|mesh-ancestor
110431793|NCT00625092|Protective Agents|protective agents|mesh-ancestor
110431794|NCT00625092|Vitamin B Complex|vitamin b complex|mesh-ancestor
110431795|NCT00625092|Vitamins|vitamins|mesh-ancestor
110431796|NCT00625092|Micronutrients|micronutrients|mesh-ancestor
110431797|NCT00931918|Prednisone|prednisone|mesh-list
110431798|NCT00931918|Cyclophosphamide|cyclophosphamide|mesh-list
110431799|NCT00931918|Rituximab|rituximab|mesh-list
110431800|NCT00931918|Doxorubicin|doxorubicin|mesh-list
110431801|NCT00931918|Vincristine|vincristine|mesh-list
110431802|NCT00931918|Bortezomib|bortezomib|mesh-list
110431803|NCT00931918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110431804|NCT00931918|Immunologic Factors|immunologic factors|mesh-ancestor
110431805|NCT00931918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110431806|NCT00931918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110431807|NCT00931918|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110431808|NCT00931918|Alkylating Agents|alkylating agents|mesh-ancestor
110431809|NCT00931918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110431810|NCT00931918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110431811|NCT00931918|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110431812|NCT00931918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110431813|NCT00931918|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110431814|NCT00931918|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110204210|NCT00164086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110431815|NCT00931918|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110431816|NCT00931918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110431817|NCT00931918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110431818|NCT00931918|Glucocorticoids|glucocorticoids|mesh-ancestor
110431819|NCT00931918|Hormones|hormones|mesh-ancestor
110431820|NCT00931918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110431821|NCT00931918|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110431822|NCT00931918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110431823|NCT00931918|Tubulin Modulators|tubulin modulators|mesh-ancestor
110431824|NCT00931918|Antimitotic Agents|antimitotic agents|mesh-ancestor
110431825|NCT00931918|Mitosis Modulators|mitosis modulators|mesh-ancestor
110431826|NCT04183075|Vitamins|vitamins|mesh-list
110431827|NCT04183075|Ascorbic Acid|ascorbic acid|mesh-list
110431828|NCT04183075|Micronutrients|micronutrients|mesh-ancestor
110431829|NCT04183075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110431830|NCT04183075|Antioxidants|antioxidants|mesh-ancestor
110431831|NCT04183075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110431832|NCT04183075|Protective Agents|protective agents|mesh-ancestor
110431833|NCT02679001|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
110431834|NCT02679001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110431835|NCT02678221|Aspirin|aspirin|mesh-list
110431836|NCT02678221|Sildenafil Citrate|sildenafil citrate|mesh-list
110078786|NCT01618643|Protective Agents|protective agents|mesh-ancestor
110431837|NCT02678221|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110431838|NCT02678221|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110431839|NCT02678221|Analgesics|analgesics|mesh-ancestor
110431840|NCT02678221|Sensory System Agents|sensory system agents|mesh-ancestor
110431841|NCT02678221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110431842|NCT02678221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110431843|NCT02678221|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110431844|NCT02678221|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110431845|NCT02678221|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110431846|NCT02678221|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110431847|NCT02678221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110431848|NCT02678221|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110431849|NCT02678221|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110431850|NCT02678221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110431851|NCT02678221|Antipyretics|antipyretics|mesh-ancestor
110431852|NCT02678221|Vasodilator Agents|vasodilator agents|mesh-ancestor
110431853|NCT02678221|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110431854|NCT02678221|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110431855|NCT02678221|Urological Agents|urological agents|mesh-ancestor
110431857|NCT00641329|Analgesics|analgesics|mesh-ancestor
110431858|NCT00641329|Sensory System Agents|sensory system agents|mesh-ancestor
110564552|NCT05370313|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110431859|NCT00641329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110431860|NCT00641329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110431861|NCT00641329|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110431862|NCT00641329|Sympatholytics|sympatholytics|mesh-ancestor
110431863|NCT00641329|Autonomic Agents|autonomic agents|mesh-ancestor
110431864|NCT00641329|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110431865|NCT00641329|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110431866|NCT00641329|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110431867|NCT00641329|Adrenergic Agents|adrenergic agents|mesh-ancestor
110431868|NCT00641329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110431869|NCT00641329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110431870|NCT01179191|Naltrexone|naltrexone|mesh-list
110431871|NCT01179191|Morphine|morphine|mesh-list
110431872|NCT01179191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110431873|NCT01179191|Narcotics|narcotics|mesh-ancestor
110431874|NCT01179191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110431875|NCT01179191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110431876|NCT01179191|Analgesics|analgesics|mesh-ancestor
110431877|NCT01179191|Sensory System Agents|sensory system agents|mesh-ancestor
110431878|NCT01179191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110431879|NCT01179191|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110431880|NCT01179191|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110431881|NCT00642421|Octreotide|octreotide|mesh-list
110431882|NCT00642421|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110204227|NCT00164242|Nootropic Agents|nootropic agents|mesh-ancestor
110431884|NCT00642421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110431885|NCT00642187|Budesonide|budesonide|mesh-list
110431886|NCT00642187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110431887|NCT00642187|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110431888|NCT00642187|Autonomic Agents|autonomic agents|mesh-ancestor
110431889|NCT00642187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110431890|NCT00642187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110431891|NCT00642187|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110431892|NCT00642187|Respiratory System Agents|respiratory system agents|mesh-ancestor
110431893|NCT00642187|Glucocorticoids|glucocorticoids|mesh-ancestor
110431894|NCT00642187|Hormones|hormones|mesh-ancestor
110431895|NCT00642187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110431896|NCT05663125|Temozolomide|temozolomide|mesh-list
110431897|NCT05663125|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110431898|NCT05663125|Alkylating Agents|alkylating agents|mesh-ancestor
110431899|NCT05663125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110431900|NCT05663125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110431901|NCT01132482|Sildenafil Citrate|sildenafil citrate|mesh-list
110431902|NCT01132482|Vasodilator Agents|vasodilator agents|mesh-ancestor
110431903|NCT01132482|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110431905|NCT01132482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110431906|NCT01132482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110431907|NCT01132482|Urological Agents|urological agents|mesh-ancestor
110431908|NCT02678767|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
110431909|NCT02678767|Hematinics|hematinics|mesh-ancestor
110431910|NCT02678767|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
110431911|NCT02678767|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110431913|NCT00931762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110431914|NCT00931762|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110431915|NCT00931762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110431916|NCT00931762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110431918|NCT00641407|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110431919|NCT00641407|Insulin Glargine|insulin glargine|mesh-list
110431920|NCT00641407|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110431921|NCT00641407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110431922|NCT02677597|Paclitaxel|paclitaxel|mesh-list
110431923|NCT02677597|Cisplatin|cisplatin|mesh-list
110431924|NCT02677597|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110431925|NCT02677597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110431926|NCT02677597|Tubulin Modulators|tubulin modulators|mesh-ancestor
110431927|NCT02677597|Antimitotic Agents|antimitotic agents|mesh-ancestor
110431928|NCT02677597|Mitosis Modulators|mitosis modulators|mesh-ancestor
110431929|NCT02677597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110431930|NCT01132326|Droxidopa|droxidopa|mesh-list
110431931|NCT01132326|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110431932|NCT01132326|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110431933|NCT02681263|Temocillin|temocillin|mesh-list
110431934|NCT02681263|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110431935|NCT02681263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110431936|NCT02677519|Methylphenidate|methylphenidate|mesh-list
110431937|NCT02677519|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110431938|NCT02677519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110431939|NCT02677519|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110431940|NCT02677519|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110431941|NCT02677519|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110431942|NCT02677519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110431943|NCT02677519|Dopamine Agents|dopamine agents|mesh-ancestor
110431944|NCT02677519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110431945|NCT01145508|Metronidazole|metronidazole|mesh-list
110431946|NCT01145508|Prednisone|prednisone|mesh-list
110431947|NCT01145508|Cortisone|cortisone|mesh-list
110431948|NCT01145508|Docetaxel|docetaxel|mesh-list
110431949|NCT01145508|Vaccines|vaccines|mesh-list
110431950|NCT01145508|Immunologic Factors|immunologic factors|mesh-ancestor
110431951|NCT01145508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110431952|NCT01145508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110431953|NCT01145508|Tubulin Modulators|tubulin modulators|mesh-ancestor
110431954|NCT01145508|Antimitotic Agents|antimitotic agents|mesh-ancestor
110431955|NCT01145508|Mitosis Modulators|mitosis modulators|mesh-ancestor
110431956|NCT01145508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110431957|NCT01145508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110431958|NCT01145508|Glucocorticoids|glucocorticoids|mesh-ancestor
110431959|NCT01145508|Hormones|hormones|mesh-ancestor
110431960|NCT01145508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110431961|NCT01145508|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110431962|NCT01145508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110431963|NCT01145508|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110431964|NCT01145508|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110431965|NCT01145508|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110431966|NCT00931528|Tadalafil|tadalafil|mesh-list
110431967|NCT00931528|Vasodilator Agents|vasodilator agents|mesh-ancestor
110431968|NCT00931528|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110431969|NCT00931528|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110431970|NCT00931528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110431971|NCT00931528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110431972|NCT00931528|Urological Agents|urological agents|mesh-ancestor
110431973|NCT04181749|Aspirin|aspirin|mesh-list
110431974|NCT04181749|Atorvastatin|atorvastatin|mesh-list
110431975|NCT04181749|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110431976|NCT04181749|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110371645|NCT04619069|Hormones|hormones|mesh-list
110431977|NCT04181749|Analgesics|analgesics|mesh-ancestor
110431978|NCT04181749|Sensory System Agents|sensory system agents|mesh-ancestor
110431979|NCT04181749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110431980|NCT04181749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110431981|NCT04181749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110431982|NCT04181749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110431983|NCT04181749|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110431984|NCT04181749|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110431985|NCT04181749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110431986|NCT04181749|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110431987|NCT04181749|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110431988|NCT04181749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110431989|NCT04181749|Antipyretics|antipyretics|mesh-ancestor
110431990|NCT04181749|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110431991|NCT04181749|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110431992|NCT04181749|Antimetabolites|antimetabolites|mesh-ancestor
110431993|NCT04181749|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110431994|NCT04181749|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110431995|NCT04312152|Vitamins|vitamins|mesh-list
110431996|NCT04312152|Vitamin E|vitamin e|mesh-list
110431997|NCT04312152|Tocopherols|tocopherols|mesh-list
110431998|NCT04312152|Folic Acid|folic acid|mesh-list
110431999|NCT04312152|Vitamin B Complex|vitamin b complex|mesh-list
110432000|NCT04312152|Micronutrients|micronutrients|mesh-ancestor
110432001|NCT04312152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110432002|NCT04312152|Antioxidants|antioxidants|mesh-ancestor
110432003|NCT04312152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110432004|NCT04312152|Protective Agents|protective agents|mesh-ancestor
110432005|NCT04312152|Hematinics|hematinics|mesh-ancestor
110432006|NCT00975195|Fluticasone|fluticasone|mesh-list
110432007|NCT00975195|Xhance|xhance|mesh-list
110432008|NCT00975195|Tiotropium Bromide|tiotropium bromide|mesh-list
110432009|NCT00975195|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110224110|NCT00314080|Antitoxins|antitoxins|mesh-list
110432010|NCT00975195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110432011|NCT00975195|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110432012|NCT00975195|Autonomic Agents|autonomic agents|mesh-ancestor
110432013|NCT00975195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110432014|NCT00975195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110432015|NCT00975195|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110432016|NCT00975195|Respiratory System Agents|respiratory system agents|mesh-ancestor
110432017|NCT00975195|Dermatologic Agents|dermatologic agents|mesh-ancestor
110432018|NCT00975195|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110432019|NCT00975195|Parasympatholytics|parasympatholytics|mesh-ancestor
110432020|NCT00975195|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110432021|NCT00975195|Cholinergic Agents|cholinergic agents|mesh-ancestor
110432022|NCT00975195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110432023|NCT00975195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110432024|NCT00975195|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110432025|NCT00975195|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110432026|NCT00975195|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110432027|NCT00975195|Adrenergic Agents|adrenergic agents|mesh-ancestor
110432028|NCT00642499|Dronabinol|dronabinol|mesh-list
110432029|NCT00642499|Hallucinogens|hallucinogens|mesh-ancestor
110432030|NCT00642499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110432031|NCT00642499|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110432032|NCT00642499|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110432033|NCT00642499|Analgesics|analgesics|mesh-ancestor
110432034|NCT00642499|Sensory System Agents|sensory system agents|mesh-ancestor
110432035|NCT00642499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110432036|NCT00642499|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
110432037|NCT00642499|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110432038|NCT00642499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110432039|NCT00642499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110432040|NCT00642499|Hormones|hormones|mesh-ancestor
110432041|NCT00642499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110432042|NCT00644215|Mitomycins|mitomycins|mesh-list
110432043|NCT00644215|Mitomycin|mitomycin|mesh-list
110432044|NCT00644215|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110432045|NCT00644215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110432046|NCT00644215|Alkylating Agents|alkylating agents|mesh-ancestor
110432047|NCT00644215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110432048|NCT00644215|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110432049|NCT00644215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110432050|NCT01145352|Etanercept|etanercept|mesh-list
110432051|NCT01145352|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110432052|NCT01145352|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110432054|NCT01145352|Sensory System Agents|sensory system agents|mesh-ancestor
110432055|NCT01145352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110432056|NCT01145352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110432057|NCT01145352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110432058|NCT01145352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110432059|NCT01145352|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110432060|NCT01145352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110432061|NCT01145352|Immunologic Factors|immunologic factors|mesh-ancestor
110432062|NCT01178099|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
110432063|NCT01178099|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110079013|NCT01619891|Vitamin D|vitamin d|mesh-list
110432064|NCT02673463|Spironolactone|spironolactone|mesh-list
110432065|NCT02673463|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110432066|NCT02673463|Hormone Antagonists|hormone antagonists|mesh-ancestor
110432067|NCT02673463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110432068|NCT02673463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110432069|NCT02673463|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110432070|NCT02673463|Diuretics|diuretics|mesh-ancestor
110432071|NCT02673463|Natriuretic Agents|natriuretic agents|mesh-ancestor
110432072|NCT01169532|Vorinostat|vorinostat|mesh-list
110204259|NCT00164359|Antiviral Agents|antiviral agents|mesh-ancestor
110432073|NCT01169532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110432074|NCT01169532|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110432075|NCT01169532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110432076|NCT01169532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110432077|NCT02537353|Epinephrine|epinephrine|mesh-list
110432078|NCT02537353|Racepinephrine|racepinephrine|mesh-list
110432079|NCT02537353|Epinephryl borate|epinephryl borate|mesh-list
110432080|NCT02537353|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110432081|NCT02537353|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110432082|NCT02537353|Adrenergic Agents|adrenergic agents|mesh-ancestor
110432083|NCT02537353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110432084|NCT02537353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110432085|NCT02537353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110432086|NCT02537353|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110432087|NCT02537353|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110432088|NCT02537353|Autonomic Agents|autonomic agents|mesh-ancestor
110432089|NCT02537353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110432090|NCT02537353|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110432091|NCT02537353|Respiratory System Agents|respiratory system agents|mesh-ancestor
110432092|NCT02537353|Mydriatics|mydriatics|mesh-ancestor
110432093|NCT02537353|Sympathomimetics|sympathomimetics|mesh-ancestor
110432094|NCT02537353|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110432095|NCT00643357|Nitrous Oxide|nitrous oxide|mesh-list
110432096|NCT00643357|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110432097|NCT00643357|Anesthetics, General|anesthetics, general|mesh-ancestor
110432098|NCT00643357|Anesthetics|anesthetics|mesh-ancestor
110432099|NCT00643357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110432100|NCT00643357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110432101|NCT00643357|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110432102|NCT00643357|Analgesics|analgesics|mesh-ancestor
110432103|NCT00643357|Sensory System Agents|sensory system agents|mesh-ancestor
110432104|NCT00643357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110432105|NCT01177943|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
110432106|NCT01177943|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110432107|NCT01177943|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110432108|NCT01177943|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110432109|NCT01177943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110432110|NCT01177943|Adrenergic Agents|adrenergic agents|mesh-ancestor
110432111|NCT01177943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110432112|NCT01177943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110432113|NCT04178785|Remifentanil|remifentanil|mesh-list
110432114|NCT04178785|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110432115|NCT04178785|Narcotics|narcotics|mesh-ancestor
110432116|NCT04178785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110432117|NCT04178785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110432118|NCT04178785|Analgesics|analgesics|mesh-ancestor
110432119|NCT04178785|Sensory System Agents|sensory system agents|mesh-ancestor
110432120|NCT04178785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110432121|NCT00928486|Dexamethasone|dexamethasone|mesh-list
110432122|NCT00928486|Lenalidomide|lenalidomide|mesh-list
110432123|NCT00928486|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110432124|NCT00928486|Antiemetics|antiemetics|mesh-ancestor
110432125|NCT00928486|Autonomic Agents|autonomic agents|mesh-ancestor
110432126|NCT00928486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110432127|NCT00928486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110432128|NCT00928486|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110432129|NCT00928486|Glucocorticoids|glucocorticoids|mesh-ancestor
110432131|NCT00928486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110432132|NCT00928486|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110432133|NCT00928486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110432134|NCT00928486|Immunologic Factors|immunologic factors|mesh-ancestor
110432135|NCT00928486|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110432136|NCT00928486|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110432137|NCT00928486|Growth Substances|growth substances|mesh-ancestor
110432138|NCT00928486|Growth Inhibitors|growth inhibitors|mesh-ancestor
110432139|NCT03867357|Goserelin|goserelin|mesh-list
110432140|NCT03867357|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110432141|NCT03867357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110432142|NCT05655221|Mitogens|mitogens|mesh-list
110432143|NCT05655221|Mitosis Modulators|mitosis modulators|mesh-ancestor
110432144|NCT05655221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110432145|NCT00610792|Doxorubicin|doxorubicin|mesh-list
110432146|NCT00610792|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110432147|NCT00610792|Bortezomib|bortezomib|mesh-list
110432148|NCT00610792|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110432149|NCT00610792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110432150|NCT00610792|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110432151|NCT00610792|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110432152|NCT00610792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110432153|NCT00610792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110432154|NCT00610870|Atorvastatin|atorvastatin|mesh-list
110432155|NCT00610870|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110432156|NCT00610870|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110432157|NCT00610870|Antimetabolites|antimetabolites|mesh-ancestor
110432158|NCT00610870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110432159|NCT00610870|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110432160|NCT00610870|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110432161|NCT00610870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110432162|NCT01168596|Rasagiline|rasagiline|mesh-list
110432163|NCT01168596|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
110432164|NCT01168596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110432165|NCT01168596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110432166|NCT01168596|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110432167|NCT01168596|Protective Agents|protective agents|mesh-ancestor
110432168|NCT01168596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110432169|NCT02675647|Heparin|heparin|mesh-list
110432170|NCT02675647|Protamines|protamines|mesh-list
110432171|NCT02675647|Anticoagulants|anticoagulants|mesh-ancestor
110432172|NCT02675647|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110432173|NCT02675647|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110432174|NCT02675647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110432175|NCT02675647|Heparin Antagonists|heparin antagonists|mesh-ancestor
110432176|NCT02675647|Coagulants|coagulants|mesh-ancestor
110432177|NCT05370898|Calcium Carbonate|calcium carbonate|mesh-list
110432178|NCT05370898|Antacids|antacids|mesh-ancestor
110432179|NCT05370898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110432180|NCT05370898|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110432181|NCT00610948|Leucovorin|leucovorin|mesh-list
110432182|NCT00610948|Fluorouracil|fluorouracil|mesh-list
110432183|NCT00610948|Oxaliplatin|oxaliplatin|mesh-list
110432184|NCT00610948|Everolimus|everolimus|mesh-list
110432185|NCT00610948|Panitumumab|panitumumab|mesh-list
110432186|NCT00610948|Calcium|calcium|mesh-list
110432187|NCT00610948|Levoleucovorin|levoleucovorin|mesh-list
110432188|NCT00610948|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110432189|NCT00610948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110432190|NCT00610948|Antimetabolites|antimetabolites|mesh-ancestor
110432191|NCT00610948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110432192|NCT00610948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110432193|NCT00610948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110432194|NCT00610948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110432195|NCT00610948|Immunologic Factors|immunologic factors|mesh-ancestor
110432196|NCT00610948|Antidotes|antidotes|mesh-ancestor
110432197|NCT00610948|Protective Agents|protective agents|mesh-ancestor
110432198|NCT00610948|Vitamin B Complex|vitamin b complex|mesh-ancestor
110432199|NCT00610948|Vitamins|vitamins|mesh-ancestor
110432200|NCT00610948|Micronutrients|micronutrients|mesh-ancestor
110432201|NCT00610948|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110432202|NCT00610948|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110432203|NCT00610948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110432204|NCT00610948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110432205|NCT02675413|Dimethyl Fumarate|dimethyl fumarate|mesh-list
110432206|NCT02675413|Dermatologic Agents|dermatologic agents|mesh-ancestor
110432207|NCT02675413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110432208|NCT02675413|Immunologic Factors|immunologic factors|mesh-ancestor
110432209|NCT02675413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110432210|NCT00928408|Cinacalcet|cinacalcet|mesh-list
110432211|NCT00928408|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110432212|NCT00928408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110432213|NCT00928408|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
110432214|NCT00928408|Hormone Antagonists|hormone antagonists|mesh-ancestor
110432215|NCT00928408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110432216|NCT00928252|Fluorides|fluorides|mesh-list
110432217|NCT00928252|Cariostatic Agents|cariostatic agents|mesh-ancestor
110432218|NCT00928252|Protective Agents|protective agents|mesh-ancestor
110432219|NCT00928252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110432220|NCT02673229|Bacitracin|bacitracin|mesh-list
110432221|NCT02673229|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110432222|NCT02673229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110432223|NCT02673229|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110432224|NCT00644293|Azithromycin|azithromycin|mesh-list
110432225|NCT00644293|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110432226|NCT00644293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110432227|NCT00930982|Ciprofloxacin|ciprofloxacin|mesh-list
110432228|NCT00930982|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110432229|NCT00930982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110432230|NCT00930982|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110432231|NCT00930982|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110432232|NCT00930982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110432233|NCT00930982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110432234|NCT00930982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110432235|NCT00930982|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110432236|NCT00930982|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110432237|NCT01176773|Hyaluronic Acid|hyaluronic acid|mesh-list
110432238|NCT01176773|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110432239|NCT01176773|Immunologic Factors|immunologic factors|mesh-ancestor
110432240|NCT01176773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110432241|NCT01176773|Viscosupplements|viscosupplements|mesh-ancestor
110432242|NCT01176773|Protective Agents|protective agents|mesh-ancestor
110432243|NCT02887625|Insulin|insulin|mesh-list
110432244|NCT02887625|Insulin Glargine|insulin glargine|mesh-list
110432245|NCT02887625|Pioglitazone|pioglitazone|mesh-list
110432246|NCT02887625|Insulin Aspart|insulin aspart|mesh-list
110432247|NCT02887625|Exenatide|exenatide|mesh-list
110432248|NCT02887625|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110432249|NCT02887625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110432250|NCT02887625|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110432251|NCT02887625|Incretins|incretins|mesh-ancestor
110432252|NCT02887625|Hormones|hormones|mesh-ancestor
110204304|NCT00164749|Curcumin|curcumin|mesh-list
110432253|NCT02887625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110432254|NCT02886377|Antibodies|antibodies|mesh-list
110432255|NCT02886377|Immunologic Factors|immunologic factors|mesh-ancestor
110432256|NCT02886377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110432257|NCT02675335|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110432258|NCT02675335|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110432259|NCT02675335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110432260|NCT02675335|Incretins|incretins|mesh-ancestor
110432261|NCT02675335|Hormones|hormones|mesh-ancestor
110432262|NCT02675335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110432263|NCT02675335|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110432264|NCT02675335|Protease Inhibitors|protease inhibitors|mesh-ancestor
110432265|NCT02675335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110432266|NCT02675335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110432267|NCT02675101|Sucrose polyester|sucrose polyester|mesh-list
110432268|NCT02675101|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110432269|NCT02675101|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110432270|NCT02675101|Antimetabolites|antimetabolites|mesh-ancestor
110432271|NCT02675101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110432272|NCT02675101|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110432273|NCT00928018|Cyclosporine|cyclosporine|mesh-list
110432274|NCT00928018|Sirolimus|sirolimus|mesh-list
110432275|NCT00928018|Mycophenolic Acid|mycophenolic acid|mesh-list
110432276|NCT00928018|Methotrexate|methotrexate|mesh-list
110432277|NCT00928018|Tacrolimus|tacrolimus|mesh-list
110432278|NCT00928018|Cyclosporins|cyclosporins|mesh-list
110432279|NCT00928018|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110432280|NCT00928018|Abortifacient Agents|abortifacient agents|mesh-ancestor
110432281|NCT00928018|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110432282|NCT00928018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110432283|NCT00928018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110432284|NCT00928018|Antimetabolites|antimetabolites|mesh-ancestor
110432285|NCT00928018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110432286|NCT00928018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110432287|NCT00928018|Dermatologic Agents|dermatologic agents|mesh-ancestor
110432288|NCT00928018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110432289|NCT00928018|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110432290|NCT00928018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110432291|NCT00928018|Immunologic Factors|immunologic factors|mesh-ancestor
110432292|NCT00928018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110432293|NCT00928018|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110432294|NCT00928018|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110432295|NCT00928018|Antifungal Agents|antifungal agents|mesh-ancestor
110432296|NCT00928018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110432297|NCT00928018|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110432298|NCT00928018|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110432299|NCT00928018|Antitubercular Agents|antitubercular agents|mesh-ancestor
110432300|NCT00928018|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110432301|NCT02672839|Betadex|betadex|mesh-list
110432302|NCT02672839|Sequestering Agents|sequestering agents|mesh-ancestor
110432303|NCT02672839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110432304|NCT00609154|Glucagon|glucagon|mesh-list
110432305|NCT00609154|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
110432306|NCT00609154|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110432307|NCT00609154|Hormones|hormones|mesh-ancestor
110432308|NCT00609154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110432309|NCT00609154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110432311|NCT00910117|Nimotuzumab|nimotuzumab|mesh-list
110432312|NCT00910117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110432313|NCT00910117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110432314|NCT00927862|Warfarin|warfarin|mesh-list
110432315|NCT00927862|Anticoagulants|anticoagulants|mesh-ancestor
110432316|NCT02672527|Dexamethasone|dexamethasone|mesh-list
110432317|NCT02672527|Trabectedin|trabectedin|mesh-list
110432318|NCT02672527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110432319|NCT02672527|Antiemetics|antiemetics|mesh-ancestor
110432320|NCT02672527|Autonomic Agents|autonomic agents|mesh-ancestor
110432321|NCT02672527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110432322|NCT02672527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110432323|NCT02672527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110432324|NCT02672527|Glucocorticoids|glucocorticoids|mesh-ancestor
110432325|NCT02672527|Hormones|hormones|mesh-ancestor
110432326|NCT02672527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110432327|NCT02672527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110432328|NCT02672527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110432329|NCT02672527|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110432330|NCT02672527|Alkylating Agents|alkylating agents|mesh-ancestor
110432331|NCT02672527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110432332|NCT00976989|Docetaxel|docetaxel|mesh-list
110432333|NCT00976989|Trastuzumab|trastuzumab|mesh-list
110432334|NCT00976989|Pertuzumab|pertuzumab|mesh-list
110432335|NCT00976989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110432336|NCT00976989|Tubulin Modulators|tubulin modulators|mesh-ancestor
110432337|NCT00976989|Antimitotic Agents|antimitotic agents|mesh-ancestor
110432338|NCT00976989|Mitosis Modulators|mitosis modulators|mesh-ancestor
110432339|NCT00976989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110432340|NCT00976989|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110432341|NCT05449171|Vitamin D|vitamin d|mesh-list
110432342|NCT05449171|Vitamins|vitamins|mesh-list
110432343|NCT05449171|Thioctic Acid|thioctic acid|mesh-list
110432344|NCT05449171|Vitamin B 6|vitamin b 6|mesh-list
110432345|NCT05449171|Pyridoxal|pyridoxal|mesh-list
110432346|NCT05449171|Pyridoxine|pyridoxine|mesh-list
110432347|NCT05449171|Hyaluronic Acid|hyaluronic acid|mesh-list
110432348|NCT05449171|Micronutrients|micronutrients|mesh-ancestor
110432349|NCT05449171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110432350|NCT05449171|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110432351|NCT05449171|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110432352|NCT05449171|Immunologic Factors|immunologic factors|mesh-ancestor
110432353|NCT05449171|Viscosupplements|viscosupplements|mesh-ancestor
110432354|NCT05449171|Protective Agents|protective agents|mesh-ancestor
110432355|NCT05449171|Vitamin B Complex|vitamin b complex|mesh-ancestor
110432356|NCT05449171|Antioxidants|antioxidants|mesh-ancestor
110432357|NCT05449171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110432358|NCT02675023|Adalimumab|adalimumab|mesh-list
110432359|NCT02675023|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110432360|NCT02675023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110432361|NCT02675023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110432362|NCT00644371|Rituximab|rituximab|mesh-list
110432363|NCT00644371|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110432364|NCT00644371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110432365|NCT00644371|Immunologic Factors|immunologic factors|mesh-ancestor
110432366|NCT00644371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110432367|NCT00644371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110432368|NCT02864199|Ribavirin|ribavirin|mesh-list
110432369|NCT02864199|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110432370|NCT02864199|Antimetabolites|antimetabolites|mesh-ancestor
110432371|NCT02864199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110432373|NCT02864199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110432374|NCT05911126|Celecoxib|celecoxib|mesh-list
110432375|NCT05911126|Scopolamine|scopolamine|mesh-list
110432376|NCT05911126|Bromides|bromides|mesh-list
110432377|NCT05911126|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
110432378|NCT05911126|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110432379|NCT05911126|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110432380|NCT05911126|Analgesics|analgesics|mesh-ancestor
110432381|NCT05911126|Sensory System Agents|sensory system agents|mesh-ancestor
110564561|NCT05368623|Mydriatics|mydriatics|mesh-list
110432382|NCT05911126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110432383|NCT05911126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110432384|NCT05911126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110432385|NCT05911126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110432386|NCT05911126|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110432387|NCT05911126|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110432388|NCT05911126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110432389|NCT05911126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110432390|NCT05911126|Anticonvulsants|anticonvulsants|mesh-ancestor
110432391|NCT05911126|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110432392|NCT05911126|Antiemetics|antiemetics|mesh-ancestor
110432393|NCT05911126|Autonomic Agents|autonomic agents|mesh-ancestor
110432394|NCT05911126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110432395|NCT05911126|Mydriatics|mydriatics|mesh-ancestor
110432396|NCT05911126|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110432397|NCT05911126|Cholinergic Agents|cholinergic agents|mesh-ancestor
110432398|NCT05911126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110432399|NCT05911126|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110432400|NCT05911126|Parasympatholytics|parasympatholytics|mesh-ancestor
110432401|NCT05908526|Suvorexant|suvorexant|mesh-list
110432402|NCT05908526|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110432403|NCT05908526|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110432404|NCT05908526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110432405|NCT05908526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110432406|NCT05908526|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
110432407|NCT05908526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110432408|NCT05908526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110432409|NCT05908513|Acetylcysteine|acetylcysteine|mesh-list
110432410|NCT05908513|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110432411|NCT05908513|Antiviral Agents|antiviral agents|mesh-ancestor
110432412|NCT05908513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110432413|NCT05908513|Expectorants|expectorants|mesh-ancestor
110432414|NCT05908513|Respiratory System Agents|respiratory system agents|mesh-ancestor
110432415|NCT05908513|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110432416|NCT05908513|Antioxidants|antioxidants|mesh-ancestor
110432417|NCT05908513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110432418|NCT05908513|Protective Agents|protective agents|mesh-ancestor
110432419|NCT05908513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110432420|NCT05908513|Antidotes|antidotes|mesh-ancestor
110432421|NCT05908305|Epinephrine|epinephrine|mesh-list
110432422|NCT05908305|Racepinephrine|racepinephrine|mesh-list
110432423|NCT05908305|Anesthetics|anesthetics|mesh-list
110432424|NCT05908305|Mepivacaine|mepivacaine|mesh-list
110432425|NCT05908305|Carticaine|carticaine|mesh-list
110432426|NCT05908305|Epinephryl borate|epinephryl borate|mesh-list
110432427|NCT05908305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110432428|NCT05908305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110432429|NCT05908305|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110432430|NCT05908305|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110432431|NCT05908305|Adrenergic Agents|adrenergic agents|mesh-ancestor
110432432|NCT05908305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110432433|NCT05908305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110204355|NCT00164866|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110204356|NCT00164866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110432434|NCT05908305|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110432435|NCT05908305|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110432437|NCT05908305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110432438|NCT05908305|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110432439|NCT05908305|Respiratory System Agents|respiratory system agents|mesh-ancestor
110432440|NCT05908305|Mydriatics|mydriatics|mesh-ancestor
110432441|NCT05908305|Sympathomimetics|sympathomimetics|mesh-ancestor
110432442|NCT05908305|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110432443|NCT05908305|Anesthetics, Local|anesthetics, local|mesh-ancestor
110432444|NCT05908305|Sensory System Agents|sensory system agents|mesh-ancestor
110432445|NCT02672995|Bevacizumab|bevacizumab|mesh-list
110432446|NCT02672995|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110432447|NCT02672995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110432448|NCT02672995|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110432449|NCT02672995|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110432450|NCT02672995|Growth Substances|growth substances|mesh-ancestor
110432451|NCT02672995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110432452|NCT02672995|Growth Inhibitors|growth inhibitors|mesh-ancestor
110432453|NCT05907902|Aspirin|aspirin|mesh-list
110432454|NCT05907902|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110432456|NCT05907902|Analgesics|analgesics|mesh-ancestor
110432457|NCT05907902|Sensory System Agents|sensory system agents|mesh-ancestor
110432458|NCT05907902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110432459|NCT05907902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110432460|NCT05907902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110432461|NCT05907902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110432462|NCT05907902|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110432463|NCT05907902|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110432464|NCT05907902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110432465|NCT05907902|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110432466|NCT05907902|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110432467|NCT05907902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110432468|NCT05907902|Antipyretics|antipyretics|mesh-ancestor
110432469|NCT05907733|Mitogens|mitogens|mesh-list
110432470|NCT05907733|Mitosis Modulators|mitosis modulators|mesh-ancestor
110432471|NCT05907733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110432472|NCT05907499|Decitabine|decitabine|mesh-list
110432473|NCT05907499|Epoetin Alfa|epoetin alfa|mesh-list
110432474|NCT05907499|Lenograstim|lenograstim|mesh-list
110432475|NCT05907499|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110432476|NCT05907499|Antimetabolites|antimetabolites|mesh-ancestor
110432477|NCT05907499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110432478|NCT05907499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110432479|NCT05907499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110432480|NCT05907499|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110432481|NCT05907499|Immunologic Factors|immunologic factors|mesh-ancestor
110432482|NCT05907499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110432483|NCT05907499|Hematinics|hematinics|mesh-ancestor
110432484|NCT05907486|Cytarabine|cytarabine|mesh-list
110432485|NCT05907486|Acetylcysteine|acetylcysteine|mesh-list
110432486|NCT05907486|Cyclophosphamide|cyclophosphamide|mesh-list
110432487|NCT05907486|Busulfan|busulfan|mesh-list
110432488|NCT05907486|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110432489|NCT05907486|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110432490|NCT05907486|Immunologic Factors|immunologic factors|mesh-ancestor
110432491|NCT05907486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110432492|NCT05907486|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110432493|NCT05907486|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110432494|NCT05907486|Alkylating Agents|alkylating agents|mesh-ancestor
110432495|NCT05907486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110432496|NCT05907486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110432497|NCT05907486|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110432498|NCT05907486|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110432499|NCT05907486|Antimetabolites|antimetabolites|mesh-ancestor
110432500|NCT05907486|Antiviral Agents|antiviral agents|mesh-ancestor
110432501|NCT05907486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110432502|NCT05907486|Expectorants|expectorants|mesh-ancestor
110204364|NCT00165139|Melphalan|melphalan|mesh-list
110432503|NCT05907486|Respiratory System Agents|respiratory system agents|mesh-ancestor
110432504|NCT05907486|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110432505|NCT05907486|Antioxidants|antioxidants|mesh-ancestor
110432506|NCT05907486|Protective Agents|protective agents|mesh-ancestor
110432507|NCT05907486|Antidotes|antidotes|mesh-ancestor
110432508|NCT05906992|Ocrelizumab|ocrelizumab|mesh-list
110432509|NCT05906992|Immunologic Factors|immunologic factors|mesh-ancestor
110432510|NCT05906992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110432511|NCT05906615|Lidocaine|lidocaine|mesh-list
110432512|NCT05906615|Anesthetics, Local|anesthetics, local|mesh-ancestor
110432513|NCT05906615|Anesthetics|anesthetics|mesh-ancestor
110432514|NCT05906615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110432515|NCT05906615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110432516|NCT05906615|Sensory System Agents|sensory system agents|mesh-ancestor
110432517|NCT05906615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110432518|NCT05906615|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110432519|NCT05906615|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110432520|NCT05906615|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110432521|NCT05906615|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110432522|NCT05906615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110432523|NCT05906576|Infliximab|infliximab|mesh-list
110432524|NCT05906576|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110432525|NCT05906576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110432526|NCT05906576|Dermatologic Agents|dermatologic agents|mesh-ancestor
110432527|NCT05906576|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110432528|NCT05906576|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110432529|NCT05906563|Metformin|metformin|mesh-list
110432530|NCT05906563|Melatonin|melatonin|mesh-list
110432531|NCT05906563|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110432532|NCT05906563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110432533|NCT05906563|Antioxidants|antioxidants|mesh-ancestor
110432534|NCT05906563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110432535|NCT05906563|Protective Agents|protective agents|mesh-ancestor
110432536|NCT05906563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110432537|NCT05906524|Bevacizumab|bevacizumab|mesh-list
110432538|NCT05906524|Tislelizumab|tislelizumab|mesh-list
110432539|NCT05906524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110432540|NCT05906524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110432541|NCT05906524|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110432542|NCT05906524|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110432543|NCT05906524|Growth Substances|growth substances|mesh-ancestor
110432544|NCT05906524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110432545|NCT05906524|Growth Inhibitors|growth inhibitors|mesh-ancestor
110432546|NCT05906498|Vitamin E|vitamin e|mesh-list
110432547|NCT05906498|Acetylcysteine|acetylcysteine|mesh-list
110432548|NCT05906498|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110432549|NCT05906498|Vitamins|vitamins|mesh-ancestor
110432550|NCT05906498|Micronutrients|micronutrients|mesh-ancestor
110432551|NCT05906498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110432552|NCT05906498|Antioxidants|antioxidants|mesh-ancestor
110432553|NCT05906498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110432554|NCT05906498|Protective Agents|protective agents|mesh-ancestor
110432555|NCT05906498|Antiviral Agents|antiviral agents|mesh-ancestor
110329057|NCT02893540|Capecitabine|capecitabine|mesh-list
110432556|NCT05906498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110432557|NCT05906498|Expectorants|expectorants|mesh-ancestor
110432558|NCT05906498|Respiratory System Agents|respiratory system agents|mesh-ancestor
110432559|NCT05906498|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110432560|NCT05906498|Antidotes|antidotes|mesh-ancestor
110432561|NCT05901961|Zinc|zinc|mesh-list
110432562|NCT05901961|Zinc Oxide|zinc oxide|mesh-list
110432563|NCT05901961|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110432564|NCT05901961|Trace Elements|trace elements|mesh-ancestor
110432565|NCT05901961|Micronutrients|micronutrients|mesh-ancestor
110432566|NCT05901961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110432567|NCT05901961|Dermatologic Agents|dermatologic agents|mesh-ancestor
110432568|NCT05901961|Sunscreening Agents|sunscreening agents|mesh-ancestor
110432569|NCT05901961|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110432570|NCT05901961|Protective Agents|protective agents|mesh-ancestor
110432571|NCT05892510|Tenecteplase|tenecteplase|mesh-list
110432572|NCT05892510|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110432573|NCT05892510|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110432574|NCT05892510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110432575|NCT05886972|Propofol|propofol|mesh-list
110432576|NCT05886972|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110432577|NCT05886972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110432578|NCT05886972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110432579|NCT05886972|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110432580|NCT05886972|Anesthetics, General|anesthetics, general|mesh-ancestor
110432581|NCT05886972|Anesthetics|anesthetics|mesh-ancestor
110432582|NCT05879835|Heparin|heparin|mesh-list
110432583|NCT05879835|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110432584|NCT05879835|Anticoagulants|anticoagulants|mesh-ancestor
110432585|NCT05879835|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110432586|NCT05879835|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110432587|NCT05879835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110432588|NCT05874401|Topotecan|topotecan|mesh-list
110432589|NCT05874401|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110371712|NCT00569712|Budesonide|budesonide|mesh-list
110432590|NCT05874401|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110432591|NCT05874401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110432592|NCT05874401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110432593|NCT05874401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110432594|NCT05858957|Magnesium Sulfate|magnesium sulfate|mesh-list
110432595|NCT05858957|Analgesics|analgesics|mesh-ancestor
110432596|NCT05858957|Sensory System Agents|sensory system agents|mesh-ancestor
110432597|NCT05858957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110432598|NCT05858957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110432599|NCT05858957|Anesthetics|anesthetics|mesh-ancestor
110432600|NCT05858957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110432601|NCT05858957|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110432602|NCT05858957|Anticonvulsants|anticonvulsants|mesh-ancestor
110432603|NCT05858957|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110432604|NCT05858957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110432605|NCT05858957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110432606|NCT05858957|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110432607|NCT05858957|Tocolytic Agents|tocolytic agents|mesh-ancestor
110432608|NCT05858957|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110432609|NCT05760807|Oxytocin|oxytocin|mesh-list
110432610|NCT05760807|Oxytocics|oxytocics|mesh-ancestor
110432611|NCT05760807|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110432612|NCT05760807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110432613|NCT05754996|Nifuroxazide|nifuroxazide|mesh-list
110432614|NCT05754996|Lactulose|lactulose|mesh-list
110432615|NCT05754996|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110432616|NCT05754996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110432617|NCT05746442|Nicotine|nicotine|mesh-list
110432618|NCT05746442|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110432619|NCT05746442|Autonomic Agents|autonomic agents|mesh-ancestor
110432620|NCT05746442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110432621|NCT05746442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110432622|NCT05746442|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110432623|NCT05746442|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110432624|NCT05746442|Cholinergic Agents|cholinergic agents|mesh-ancestor
110432625|NCT05746442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110432626|NCT05746442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110432627|NCT05736874|Fluticasone|fluticasone|mesh-list
110432629|NCT05736874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110432630|NCT05736874|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110432632|NCT05736874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110432633|NCT05736874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110432634|NCT05736874|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110432635|NCT05736874|Respiratory System Agents|respiratory system agents|mesh-ancestor
110432636|NCT05736874|Dermatologic Agents|dermatologic agents|mesh-ancestor
110432638|NCT05699655|Oxaliplatin|oxaliplatin|mesh-list
110432639|NCT05699655|Apatinib|apatinib|mesh-list
110432640|NCT05699655|Tislelizumab|tislelizumab|mesh-list
110432641|NCT05699655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110432642|NCT05699655|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110432643|NCT05699655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110432644|NCT05699655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110432645|NCT05699655|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110432646|NCT05687500|Glyburide|glyburide|mesh-list
110432647|NCT05687500|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110432648|NCT05687500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110432649|NCT05681611|Rocuronium|rocuronium|mesh-list
110432650|NCT05681611|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110432651|NCT05681611|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110432652|NCT05681611|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110432653|NCT05681611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110432654|NCT05681611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110432655|NCT05675163|Vitamin K|vitamin k|mesh-list
110432656|NCT05675163|Vitamin K 2|vitamin k 2|mesh-list
110432657|NCT05675163|Vitamins|vitamins|mesh-ancestor
110432658|NCT05675163|Micronutrients|micronutrients|mesh-ancestor
110432659|NCT05675163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110432660|NCT05675163|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110432661|NCT05675163|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110432662|NCT05675163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110432663|NCT05675163|Hemostatics|hemostatics|mesh-ancestor
110432664|NCT05675163|Coagulants|coagulants|mesh-ancestor
110432665|NCT05656170|Bupivacaine|bupivacaine|mesh-list
110432666|NCT05656170|Anesthetics, Local|anesthetics, local|mesh-ancestor
110432667|NCT05656170|Anesthetics|anesthetics|mesh-ancestor
110432668|NCT05656170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110432669|NCT05656170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110432670|NCT05656170|Sensory System Agents|sensory system agents|mesh-ancestor
110432671|NCT05656170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110432672|NCT05596786|Rituximab|rituximab|mesh-list
110432673|NCT05596786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110432674|NCT05596786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110432675|NCT05596786|Immunologic Factors|immunologic factors|mesh-ancestor
110432676|NCT05596786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110079617|NCT01623778|Interferons|interferons|mesh-list
110432677|NCT05596786|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110432678|NCT05582707|Pioglitazone|pioglitazone|mesh-list
110432679|NCT05582707|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110432680|NCT05582707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110432681|NCT05564611|Omalizumab|omalizumab|mesh-list
110432682|NCT05564611|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110432683|NCT05564611|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110432684|NCT05564611|Respiratory System Agents|respiratory system agents|mesh-ancestor
110432685|NCT05559164|Atorvastatin|atorvastatin|mesh-list
110432686|NCT05559164|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110432687|NCT05559164|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110432688|NCT05559164|Antimetabolites|antimetabolites|mesh-ancestor
110432689|NCT05559164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110432690|NCT05559164|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110432691|NCT05559164|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110432692|NCT05559164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110432693|NCT05558007|Tadalafil|tadalafil|mesh-list
110432694|NCT05558007|Vasodilator Agents|vasodilator agents|mesh-ancestor
110432695|NCT05558007|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110432696|NCT05558007|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110432697|NCT05558007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110329062|NCT01327573|Eculizumab|eculizumab|mesh-list
110432698|NCT05558007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110432699|NCT05558007|Urological Agents|urological agents|mesh-ancestor
110432700|NCT05553704|Metformin|metformin|mesh-list
110432701|NCT05553704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110432702|NCT05553704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110432703|NCT05553405|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
110432704|NCT05553405|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
110432705|NCT05553405|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
110432706|NCT05553405|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110432707|NCT05536349|Valacyclovir|valacyclovir|mesh-list
110432708|NCT05536349|Venetoclax|venetoclax|mesh-list
110432709|NCT05536349|Obinutuzumab|obinutuzumab|mesh-list
110432710|NCT05536349|Allopurinol|allopurinol|mesh-list
110432711|NCT05536349|Pirtobrutinib|pirtobrutinib|mesh-list
110432712|NCT05536349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110432713|NCT05536349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110432714|NCT05536349|Antimetabolites|antimetabolites|mesh-ancestor
110432715|NCT05536349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110432716|NCT05536349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110432717|NCT05536349|Gout Suppressants|gout suppressants|mesh-ancestor
110432718|NCT05536349|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110432719|NCT05536349|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110432720|NCT05536349|Antioxidants|antioxidants|mesh-ancestor
110432721|NCT05536349|Protective Agents|protective agents|mesh-ancestor
110432722|NCT05536349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110432724|NCT05536349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110432725|NCT05536349|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110432726|NCT05518903|FAPI-46|fapi-46|mesh-list
110432727|NCT05518903|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110432728|NCT05518903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110432729|NCT05487261|Valsartan|valsartan|mesh-list
110432730|NCT05487261|Enalapril|enalapril|mesh-list
110432731|NCT05487261|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
110432732|NCT05487261|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110432733|NCT05487261|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110432734|NCT05487261|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110432735|NCT05487261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110432736|NCT05487261|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110432737|NCT05487261|Protease Inhibitors|protease inhibitors|mesh-ancestor
110432738|NCT05487261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110432739|NCT05479240|Capecitabine|capecitabine|mesh-list
110432740|NCT05479240|Oxaliplatin|oxaliplatin|mesh-list
110432741|NCT05479240|Tislelizumab|tislelizumab|mesh-list
110432742|NCT05479240|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110432743|NCT05479240|Antimetabolites|antimetabolites|mesh-ancestor
110432744|NCT05479240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110432745|NCT05479240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110432746|NCT05479240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110432747|NCT05465941|Irinotecan|irinotecan|mesh-list
110432748|NCT05465941|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110432749|NCT05465941|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110432750|NCT05465941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110432751|NCT05465941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110432752|NCT05465941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110432753|NCT05461573|Drospirenone|drospirenone|mesh-list
110432754|NCT05461573|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110432755|NCT05461573|Hormone Antagonists|hormone antagonists|mesh-ancestor
110432756|NCT05461573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110432757|NCT05461573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110432758|NCT05461573|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110432759|NCT05461573|Diuretics|diuretics|mesh-ancestor
110432760|NCT05461573|Natriuretic Agents|natriuretic agents|mesh-ancestor
110432761|NCT05457972|Estradiol|estradiol|mesh-list
110432762|NCT05457972|Estrogens|estrogens|mesh-ancestor
110432763|NCT05457972|Hormones|hormones|mesh-ancestor
110432764|NCT05457972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110432765|NCT05457972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110432766|NCT05442684|Vaccines|vaccines|mesh-list
110432767|NCT05442684|Immunologic Factors|immunologic factors|mesh-ancestor
110432768|NCT05442684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110432769|NCT05380388|Vaccines|vaccines|mesh-list
110432770|NCT05380388|Immunologic Factors|immunologic factors|mesh-ancestor
110432771|NCT05380388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110432772|NCT05369819|Midazolam|midazolam|mesh-list
110432773|NCT05369819|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110432774|NCT05369819|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110432775|NCT05369819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110432776|NCT05369819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110432777|NCT05369819|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110432778|NCT05369819|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110432779|NCT05369819|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110432780|NCT05369819|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110432781|NCT05369819|Anesthetics, General|anesthetics, general|mesh-ancestor
110432782|NCT05369819|Anesthetics|anesthetics|mesh-ancestor
110432783|NCT05369819|GABA Modulators|gaba modulators|mesh-ancestor
110432784|NCT05369819|GABA Agents|gaba agents|mesh-ancestor
110432785|NCT05369819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110432786|NCT05369819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110432787|NCT05332444|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110432788|NCT05332444|Amoxicillin|amoxicillin|mesh-list
110432789|NCT05332444|Metronidazole|metronidazole|mesh-list
110432790|NCT05332444|Clarithromycin|clarithromycin|mesh-list
110432791|NCT05332444|Levofloxacin|levofloxacin|mesh-list
110432792|NCT05332444|Tetracycline|tetracycline|mesh-list
110432793|NCT05332444|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
110432794|NCT05332444|Rabeprazole|rabeprazole|mesh-list
110432795|NCT05332444|Bismuth|bismuth|mesh-list
110432796|NCT05332444|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
110432797|NCT05332444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110432798|NCT05332444|Antitubercular Agents|antitubercular agents|mesh-ancestor
110432799|NCT05332444|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110432800|NCT05332444|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110432801|NCT05332444|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110432802|NCT05332444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110432803|NCT05332444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110432804|NCT05332444|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110432805|NCT05332444|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110432806|NCT05332444|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110432807|NCT05332444|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110432808|NCT05332444|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110432809|NCT05332444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110432810|NCT05332444|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110432811|NCT05332444|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110432812|NCT05332444|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110432813|NCT05332444|Antacids|antacids|mesh-ancestor
110432814|NCT05290740|Norepinephrine|norepinephrine|mesh-list
110432815|NCT05290740|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110432816|NCT05290740|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110432817|NCT05290740|Adrenergic Agents|adrenergic agents|mesh-ancestor
110432818|NCT05290740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110432819|NCT05290740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110432820|NCT05290740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110432821|NCT05290740|Sympathomimetics|sympathomimetics|mesh-ancestor
110432822|NCT05290740|Autonomic Agents|autonomic agents|mesh-ancestor
110432823|NCT05290740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110432824|NCT05290740|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110079756|NCT01624649|Methylphenidate|methylphenidate|mesh-list
110204420|NCT00165178|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110432825|NCT05234554|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110432826|NCT05234554|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110432827|NCT05212311|Chitosan|chitosan|mesh-list
110432828|NCT05212311|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110432829|NCT05212311|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110432830|NCT05212311|Antimetabolites|antimetabolites|mesh-ancestor
110432831|NCT05212311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110432832|NCT05212311|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110432833|NCT05212311|Chelating Agents|chelating agents|mesh-ancestor
110432834|NCT05212311|Sequestering Agents|sequestering agents|mesh-ancestor
110432835|NCT05212311|Hemostatics|hemostatics|mesh-ancestor
110432836|NCT05212311|Coagulants|coagulants|mesh-ancestor
110432837|NCT05159752|Afamelanotide|afamelanotide|mesh-list
110432838|NCT05159752|Dermatologic Agents|dermatologic agents|mesh-ancestor
110432839|NCT05095116|Fluticasone|fluticasone|mesh-list
110432840|NCT05095116|Xhance|xhance|mesh-list
110432841|NCT05095116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110432842|NCT05095116|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110432843|NCT05095116|Autonomic Agents|autonomic agents|mesh-ancestor
110432844|NCT05095116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110432845|NCT05095116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110432846|NCT05095116|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110432847|NCT05095116|Respiratory System Agents|respiratory system agents|mesh-ancestor
110432848|NCT05095116|Dermatologic Agents|dermatologic agents|mesh-ancestor
110432849|NCT05095116|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110432850|NCT05093322|Gemcitabine|gemcitabine|mesh-list
110432851|NCT05093322|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110432852|NCT05093322|Antimetabolites|antimetabolites|mesh-ancestor
110432853|NCT05093322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110432854|NCT05093322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110432855|NCT05074355|Azacitidine|azacitidine|mesh-list
110432856|NCT05074355|Venetoclax|venetoclax|mesh-list
110432857|NCT05074355|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110432858|NCT05074355|Antimetabolites|antimetabolites|mesh-ancestor
110432859|NCT05074355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110432860|NCT05074355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110432861|NCT05074355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110432862|NCT05006417|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110432863|NCT05006417|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110432864|NCT05006417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110432865|NCT05006417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110432866|NCT05006417|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110432867|NCT05006417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110432868|NCT05006417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110432869|NCT05006417|Cholinergic Agents|cholinergic agents|mesh-ancestor
110432870|NCT05006417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110432871|NCT05001152|Ozanimod|ozanimod|mesh-list
110432872|NCT05001152|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
110432873|NCT05001152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110432874|NCT05001152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110432875|NCT05001152|Immunologic Factors|immunologic factors|mesh-ancestor
110432876|NCT05001152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110432877|NCT04930653|Mogamulizumab|mogamulizumab|mesh-list
110432878|NCT04930653|Immunoglobulins|immunoglobulins|mesh-list
110432879|NCT04930653|Immunoglobulin G|immunoglobulin g|mesh-list
110432880|NCT04930653|Immunologic Factors|immunologic factors|mesh-ancestor
110432881|NCT04930653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110432882|NCT04930653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110432883|NCT04918173|Antithrombin III|antithrombin iii|mesh-list
110432884|NCT04918173|Antithrombins|antithrombins|mesh-ancestor
110432885|NCT04918173|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110432886|NCT04918173|Protease Inhibitors|protease inhibitors|mesh-ancestor
110432887|NCT04918173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110432888|NCT04918173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110432889|NCT04918173|Anticoagulants|anticoagulants|mesh-ancestor
110432890|NCT04889079|Contraceptive Agents|contraceptive agents|mesh-list
110432891|NCT04889079|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110432892|NCT04889079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110432893|NCT04880434|Cyclophosphamide|cyclophosphamide|mesh-list
110432894|NCT04880434|Fludarabine|fludarabine|mesh-list
110432895|NCT04880434|Brexucabtagene autoleucel|brexucabtagene autoleucel|mesh-list
110432896|NCT04880434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110432897|NCT04880434|Immunologic Factors|immunologic factors|mesh-ancestor
110432898|NCT04880434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110432899|NCT04880434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110432900|NCT04880434|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110432901|NCT04880434|Alkylating Agents|alkylating agents|mesh-ancestor
110432902|NCT04880434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110432903|NCT04880434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110432904|NCT04880434|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110432905|NCT04880434|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110432906|NCT04840394|Pembrolizumab|pembrolizumab|mesh-list
110432907|NCT04840394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110432908|NCT04840394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110432909|NCT04840394|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110432910|NCT04840394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110432911|NCT04839549|Fluorometholone|fluorometholone|mesh-list
110432912|NCT04839549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110432913|NCT04839549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110432914|NCT04839549|Glucocorticoids|glucocorticoids|mesh-ancestor
110432915|NCT04839549|Hormones|hormones|mesh-ancestor
110432916|NCT04839549|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110432917|NCT04839549|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110432918|NCT04794569|Tinzaparin|tinzaparin|mesh-list
110432919|NCT04794569|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
110432920|NCT04794569|Dalteparin|dalteparin|mesh-list
110432921|NCT04794569|Rivaroxaban|rivaroxaban|mesh-list
110432922|NCT04794569|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110432923|NCT04794569|Antithrombins|antithrombins|mesh-ancestor
110432924|NCT04794569|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110432925|NCT04794569|Protease Inhibitors|protease inhibitors|mesh-ancestor
110432926|NCT04794569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110432927|NCT04794569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110432928|NCT04794569|Anticoagulants|anticoagulants|mesh-ancestor
110432929|NCT04794569|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110432930|NCT04794569|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110432931|NCT04787042|Pembrolizumab|pembrolizumab|mesh-list
110432932|NCT04787042|Obinutuzumab|obinutuzumab|mesh-list
110432933|NCT04787042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110432934|NCT04787042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110432935|NCT04787042|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110432936|NCT04787042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110432937|NCT04661358|Fenofibrate|fenofibrate|mesh-list
110432938|NCT04661358|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110432939|NCT04661358|Antimetabolites|antimetabolites|mesh-ancestor
110432940|NCT04661358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110432941|NCT04661358|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110432942|NCT04630808|Latanoprost|latanoprost|mesh-list
110432943|NCT04630808|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110432944|NCT04630808|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110432945|NCT04624178|Nivolumab|nivolumab|mesh-list
110432946|NCT04624178|Rucaparib|rucaparib|mesh-list
110432947|NCT04624178|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110432948|NCT04624178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110432949|NCT04624178|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110432950|NCT04624178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110432951|NCT04624178|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110432952|NCT04624178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110432953|NCT04563338|Bevacizumab|bevacizumab|mesh-list
110432954|NCT04563338|Atezolizumab|atezolizumab|mesh-list
110432955|NCT04563338|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110432956|NCT04563338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110432957|NCT04563338|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110432958|NCT04563338|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110432959|NCT04563338|Growth Substances|growth substances|mesh-ancestor
110432960|NCT04563338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110432961|NCT04563338|Growth Inhibitors|growth inhibitors|mesh-ancestor
110432962|NCT04563338|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110432963|NCT04563338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110432964|NCT04524910|Aflibercept|aflibercept|mesh-list
110432965|NCT04524910|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110432966|NCT04524910|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110432967|NCT04524910|Growth Substances|growth substances|mesh-ancestor
110432968|NCT04524910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110432970|NCT04524910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110432971|NCT04410653|Afatinib|afatinib|mesh-list
110432972|NCT04410653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110432973|NCT04410653|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110432974|NCT04410653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110432975|NCT04410653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110432976|NCT04377087|Olaparib|olaparib|mesh-list
110079904|NCT01625871|Lumefantrine|lumefantrine|mesh-list
110432977|NCT04377087|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110432978|NCT04377087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110432979|NCT04377087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110432980|NCT04377087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110432982|NCT04341779|Antiviral Agents|antiviral agents|mesh-ancestor
110432983|NCT04341779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110432984|NCT04341779|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110432985|NCT04341779|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110432986|NCT04341779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110432987|NCT04341779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110432988|NCT04341779|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110432989|NCT04341779|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110432990|NCT04205838|Vidarabine|vidarabine|mesh-list
110432991|NCT04205838|Cyclophosphamide|cyclophosphamide|mesh-list
110432992|NCT04205838|Fludarabine|fludarabine|mesh-list
110432993|NCT04205838|Fludarabine phosphate|fludarabine phosphate|mesh-list
110432994|NCT04205838|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
110204468|NCT00165217|Growth Substances|growth substances|mesh-ancestor
110432995|NCT04205838|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
110432996|NCT04205838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110432997|NCT04205838|Immunologic Factors|immunologic factors|mesh-ancestor
110432998|NCT04205838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110432999|NCT04205838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110433000|NCT04205838|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110433001|NCT04205838|Alkylating Agents|alkylating agents|mesh-ancestor
110433002|NCT04205838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110433003|NCT04205838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110433004|NCT04205838|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110433005|NCT04205838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110433006|NCT04205838|Antimetabolites|antimetabolites|mesh-ancestor
110433007|NCT04205838|Antiviral Agents|antiviral agents|mesh-ancestor
110433008|NCT04205838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110433009|NCT04205838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110433010|NCT04196530|Atezolizumab|atezolizumab|mesh-list
110433011|NCT04196530|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110433012|NCT04196530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110433013|NCT04196530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110433014|NCT04196530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110433015|NCT04170543|Dapagliflozin|dapagliflozin|mesh-list
110433016|NCT04170543|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110433017|NCT04170543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110433018|NCT04170543|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110433019|NCT04170543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110433020|NCT04163016|Certolizumab Pegol|certolizumab pegol|mesh-list
110433021|NCT04163016|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110433022|NCT04163016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110433023|NCT04163016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110433024|NCT04163016|Immunologic Factors|immunologic factors|mesh-ancestor
110433025|NCT04163016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110433026|NCT04163016|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110433027|NCT04147013|Celecoxib|celecoxib|mesh-list
110433028|NCT04147013|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110433029|NCT04147013|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110433030|NCT04147013|Analgesics|analgesics|mesh-ancestor
110433031|NCT04147013|Sensory System Agents|sensory system agents|mesh-ancestor
110433032|NCT04147013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110433033|NCT04147013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110433034|NCT04147013|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110433035|NCT04147013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110433036|NCT04147013|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110433037|NCT04147013|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110433038|NCT04147013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110433039|NCT04147013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110433041|NCT04084717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110433042|NCT04084717|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110433043|NCT04084717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110433044|NCT04084717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110433045|NCT04042701|Pembrolizumab|pembrolizumab|mesh-list
110433046|NCT04042701|Trastuzumab|trastuzumab|mesh-list
110433047|NCT04042701|Camptothecin|camptothecin|mesh-list
110433048|NCT04042701|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
110433049|NCT04042701|Immunoconjugates|immunoconjugates|mesh-list
110433050|NCT04042701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110433051|NCT04042701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110433052|NCT04042701|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110204484|NCT00165334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110433053|NCT04042701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110433054|NCT04042701|Immunologic Factors|immunologic factors|mesh-ancestor
110433055|NCT04042701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110433056|NCT04042701|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110433057|NCT04042701|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110433058|NCT04042701|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110433059|NCT04042701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110433061|NCT04016389|Carboplatin|carboplatin|mesh-list
110433062|NCT04016389|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110433063|NCT04016389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110433064|NCT04016389|Tubulin Modulators|tubulin modulators|mesh-ancestor
110433065|NCT04016389|Antimitotic Agents|antimitotic agents|mesh-ancestor
110433066|NCT04016389|Mitosis Modulators|mitosis modulators|mesh-ancestor
110433067|NCT04016389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110433068|NCT03991819|Pembrolizumab|pembrolizumab|mesh-list
110433069|NCT03991819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110433070|NCT03991819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110433071|NCT03991819|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110433072|NCT03991819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110433073|NCT03919552|Cisplatin|cisplatin|mesh-list
110433074|NCT03919552|Carboplatin|carboplatin|mesh-list
110433075|NCT03919552|Docetaxel|docetaxel|mesh-list
110433076|NCT03919552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110433077|NCT03919552|Tubulin Modulators|tubulin modulators|mesh-ancestor
110433078|NCT03919552|Antimitotic Agents|antimitotic agents|mesh-ancestor
110433079|NCT03919552|Mitosis Modulators|mitosis modulators|mesh-ancestor
110433080|NCT03919552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110433081|NCT03853707|Paclitaxel|paclitaxel|mesh-list
110433082|NCT03853707|Carboplatin|carboplatin|mesh-list
110433083|NCT03853707|Capecitabine|capecitabine|mesh-list
110433084|NCT03853707|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110433085|NCT03853707|Atezolizumab|atezolizumab|mesh-list
110433086|NCT03853707|Ipatasertib|ipatasertib|mesh-list
110433087|NCT03853707|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110433088|NCT03853707|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110433089|NCT03853707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110433090|NCT03853707|Tubulin Modulators|tubulin modulators|mesh-ancestor
110433091|NCT03853707|Antimitotic Agents|antimitotic agents|mesh-ancestor
110433092|NCT03853707|Mitosis Modulators|mitosis modulators|mesh-ancestor
110433093|NCT03853707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110433094|NCT03853707|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110433095|NCT03853707|Antimetabolites|antimetabolites|mesh-ancestor
110433096|NCT03853707|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110433097|NCT03853707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110433098|NCT03853707|Immunologic Factors|immunologic factors|mesh-ancestor
110433099|NCT03853707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110433100|NCT03853707|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110433101|NCT03853707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110433102|NCT03836209|Cytarabine|cytarabine|mesh-list
110433103|NCT03836209|Daunorubicin|daunorubicin|mesh-list
110433104|NCT03836209|Midostaurin|midostaurin|mesh-list
110433105|NCT03836209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110433106|NCT03836209|Antimetabolites|antimetabolites|mesh-ancestor
110433107|NCT03836209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110433108|NCT03836209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110433109|NCT03836209|Antiviral Agents|antiviral agents|mesh-ancestor
110433110|NCT03836209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110433111|NCT03836209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110433112|NCT03836209|Immunologic Factors|immunologic factors|mesh-ancestor
110433113|NCT03836209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110433114|NCT03836209|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110433115|NCT03836209|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110433116|NCT03836209|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110433117|NCT03836209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110433118|NCT03836209|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110433119|NCT03824808|Lidocaine|lidocaine|mesh-list
110433120|NCT03824808|Anesthetics, Local|anesthetics, local|mesh-ancestor
110433121|NCT03824808|Anesthetics|anesthetics|mesh-ancestor
110433122|NCT03824808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110433123|NCT03824808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110080059|NCT01627158|Hormones|hormones|mesh-ancestor
110433124|NCT03824808|Sensory System Agents|sensory system agents|mesh-ancestor
110433125|NCT03824808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110433126|NCT03824808|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110433127|NCT03824808|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110433128|NCT03824808|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110433129|NCT03824808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110433130|NCT03824808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110433131|NCT03758950|Mometasone Furoate|mometasone furoate|mesh-list
110433132|NCT03758950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110433133|NCT03758950|Dermatologic Agents|dermatologic agents|mesh-ancestor
110433134|NCT03758950|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110433135|NCT03749460|Nivolumab|nivolumab|mesh-list
110433136|NCT03749460|Ipilimumab|ipilimumab|mesh-list
110433137|NCT03749460|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110433138|NCT03749460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110433139|NCT03749460|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110433140|NCT03749460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110433141|NCT03711279|Apatinib|apatinib|mesh-list
110433142|NCT03711279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110433143|NCT03711279|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110433144|NCT03711279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110433145|NCT03711279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110433146|NCT03703297|Durvalumab|durvalumab|mesh-list
110433147|NCT03703297|Tremelimumab|tremelimumab|mesh-list
110433148|NCT03703297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110433149|NCT03703297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110433150|NCT03641456|Dexamethasone|dexamethasone|mesh-list
110433151|NCT03641456|Dexamethasone acetate|dexamethasone acetate|mesh-list
110433152|NCT03641456|Lenalidomide|lenalidomide|mesh-list
110433153|NCT03641456|Bortezomib|bortezomib|mesh-list
110433154|NCT03641456|BB 1101|bb 1101|mesh-list
110433155|NCT03641456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110433156|NCT03641456|Antiemetics|antiemetics|mesh-ancestor
110433157|NCT03641456|Autonomic Agents|autonomic agents|mesh-ancestor
110433158|NCT03641456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110433159|NCT03641456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110433160|NCT03641456|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110433161|NCT03641456|Glucocorticoids|glucocorticoids|mesh-ancestor
110433162|NCT03641456|Hormones|hormones|mesh-ancestor
110433163|NCT03641456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110433164|NCT03641456|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110433165|NCT03641456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110433166|NCT03641456|Protease Inhibitors|protease inhibitors|mesh-ancestor
110433167|NCT03641456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110433168|NCT03641456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110433169|NCT03641456|Immunologic Factors|immunologic factors|mesh-ancestor
110433170|NCT03641456|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110433171|NCT03641456|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110433172|NCT03641456|Growth Substances|growth substances|mesh-ancestor
110433173|NCT03641456|Growth Inhibitors|growth inhibitors|mesh-ancestor
110433174|NCT03582176|Ketotifen|ketotifen|mesh-list
110433175|NCT03582176|Antipruritics|antipruritics|mesh-ancestor
110433176|NCT03582176|Dermatologic Agents|dermatologic agents|mesh-ancestor
110433177|NCT03582176|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110433178|NCT03582176|Histamine Antagonists|histamine antagonists|mesh-ancestor
110433179|NCT03582176|Histamine Agents|histamine agents|mesh-ancestor
110433180|NCT03582176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110433181|NCT03582176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110433182|NCT03582176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110433183|NCT03582176|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110433184|NCT03493152|Everolimus|everolimus|mesh-list
110433185|NCT03493152|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110433186|NCT03493152|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110433187|NCT03493152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110433188|NCT03493152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110433189|NCT03493152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110433191|NCT03493152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110433192|NCT03493152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110433193|NCT03492671|Paclitaxel|paclitaxel|mesh-list
110433194|NCT03492671|Gemcitabine|gemcitabine|mesh-list
110433195|NCT03492671|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110433196|NCT03492671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110433197|NCT03492671|Tubulin Modulators|tubulin modulators|mesh-ancestor
110433198|NCT03492671|Antimitotic Agents|antimitotic agents|mesh-ancestor
110433199|NCT03492671|Mitosis Modulators|mitosis modulators|mesh-ancestor
110433200|NCT03492671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110433201|NCT03492671|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110433203|NCT03486301|Pembrolizumab|pembrolizumab|mesh-list
110433204|NCT03486301|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110433205|NCT03486301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110433206|NCT03486301|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110433207|NCT03486301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110433208|NCT03391479|Avelumab|avelumab|mesh-list
110433209|NCT03391479|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110433210|NCT03391479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110433211|NCT03355300|Cannabidiol|cannabidiol|mesh-list
110433212|NCT03355300|Anticonvulsants|anticonvulsants|mesh-ancestor
110433213|NCT03255434|Oxaliplatin|oxaliplatin|mesh-list
110433214|NCT03255434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110433215|NCT03199040|Durvalumab|durvalumab|mesh-list
110433216|NCT03199040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110433217|NCT03199040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110433221|NCT03087903|Grape Seed Extract|grape seed extract|mesh-list
110433222|NCT03087903|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110433223|NCT03087903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110433224|NCT03087903|Antioxidants|antioxidants|mesh-ancestor
110433225|NCT03087903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110433226|NCT03087903|Protective Agents|protective agents|mesh-ancestor
110433227|NCT03087903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110433228|NCT03074045|Drospirenone|drospirenone|mesh-list
110433229|NCT03074045|Levonorgestrel|levonorgestrel|mesh-list
110433230|NCT03074045|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110433231|NCT03074045|Estradiol|estradiol|mesh-list
110433232|NCT03074045|Estrogens|estrogens|mesh-ancestor
110433233|NCT03074045|Hormones|hormones|mesh-ancestor
110433234|NCT03074045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110433235|NCT03074045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110433236|NCT03074045|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110433237|NCT03074045|Contraceptive Agents|contraceptive agents|mesh-ancestor
110433238|NCT03074045|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110433239|NCT03074045|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110433240|NCT03074045|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110433241|NCT03074045|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110433242|NCT03074045|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110433243|NCT03074045|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110433244|NCT03074045|Hormone Antagonists|hormone antagonists|mesh-ancestor
110433245|NCT03074045|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110433246|NCT03074045|Diuretics|diuretics|mesh-ancestor
110433247|NCT03074045|Natriuretic Agents|natriuretic agents|mesh-ancestor
110433248|NCT02948543|Mitomycins|mitomycins|mesh-list
110433249|NCT02948543|Mitomycin|mitomycin|mesh-list
110433250|NCT02948543|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110433251|NCT02948543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110433252|NCT02948543|Alkylating Agents|alkylating agents|mesh-ancestor
110433253|NCT02948543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110433254|NCT02948543|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110433255|NCT02948543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110433256|NCT02901184|Spironolactone|spironolactone|mesh-list
110433257|NCT02901184|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110433258|NCT02901184|Hormone Antagonists|hormone antagonists|mesh-ancestor
110433259|NCT02901184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110433260|NCT02901184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110433261|NCT02901184|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110433262|NCT02901184|Diuretics|diuretics|mesh-ancestor
110433264|NCT02901041|Zonisamide|zonisamide|mesh-list
110433265|NCT02901041|Anticonvulsants|anticonvulsants|mesh-ancestor
110433266|NCT02901041|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110433267|NCT02901041|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110433268|NCT02901041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110433269|NCT02901041|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110433270|NCT02901041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110433271|NCT02840227|Anesthetics|anesthetics|mesh-list
110080199|NCT01627678|Sargramostim|sargramostim|mesh-list
110433272|NCT02840227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110433273|NCT02840227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110433274|NCT02705508|Gemcitabine|gemcitabine|mesh-list
110433275|NCT02705508|Etoposide|etoposide|mesh-list
110433276|NCT02705508|Etoposide phosphate|etoposide phosphate|mesh-list
110433277|NCT02705508|Pegaspargase|pegaspargase|mesh-list
110433278|NCT02705508|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110433279|NCT02705508|Antimetabolites|antimetabolites|mesh-ancestor
110433280|NCT02705508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110433281|NCT02705508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110433282|NCT02705508|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110433283|NCT02705508|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110433284|NCT02705508|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110433285|NCT02705508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110433287|NCT02636322|Cortisone|cortisone|mesh-list
110433288|NCT02636322|Cyclophosphamide|cyclophosphamide|mesh-list
110433289|NCT02636322|Rituximab|rituximab|mesh-list
110433290|NCT02636322|Doxorubicin|doxorubicin|mesh-list
110433291|NCT02636322|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110433292|NCT02636322|Etoposide|etoposide|mesh-list
110433293|NCT02636322|Vincristine|vincristine|mesh-list
110433294|NCT02636322|Lenalidomide|lenalidomide|mesh-list
110433295|NCT02636322|Etoposide phosphate|etoposide phosphate|mesh-list
110433296|NCT02636322|Podophyllotoxin|podophyllotoxin|mesh-list
110433297|NCT02636322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110433298|NCT02636322|Antibodies|antibodies|mesh-list
110433299|NCT02636322|Immunoglobulins|immunoglobulins|mesh-list
110433300|NCT02636322|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110433301|NCT02636322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110433302|NCT02636322|Immunologic Factors|immunologic factors|mesh-ancestor
110433303|NCT02636322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110433304|NCT02636322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110433305|NCT02636322|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110329117|NCT00467012|Paclitaxel|paclitaxel|mesh-list
110433306|NCT02636322|Alkylating Agents|alkylating agents|mesh-ancestor
110433307|NCT02636322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110433308|NCT02636322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110433309|NCT02636322|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110433310|NCT02636322|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110433311|NCT02636322|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110433312|NCT02636322|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110433313|NCT02636322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110433314|NCT02636322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110433315|NCT02636322|Glucocorticoids|glucocorticoids|mesh-ancestor
110433316|NCT02636322|Hormones|hormones|mesh-ancestor
110433317|NCT02636322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110433318|NCT02636322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110433319|NCT02636322|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110433320|NCT02636322|Tubulin Modulators|tubulin modulators|mesh-ancestor
110433321|NCT02636322|Antimitotic Agents|antimitotic agents|mesh-ancestor
110433322|NCT02636322|Mitosis Modulators|mitosis modulators|mesh-ancestor
110433323|NCT02636322|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110433324|NCT02636322|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110433325|NCT02636322|Growth Substances|growth substances|mesh-ancestor
110433326|NCT02636322|Growth Inhibitors|growth inhibitors|mesh-ancestor
110433327|NCT02636322|Keratolytic Agents|keratolytic agents|mesh-ancestor
110433328|NCT02636322|Dermatologic Agents|dermatologic agents|mesh-ancestor
110433329|NCT02547987|Carboplatin|carboplatin|mesh-list
110433330|NCT02547987|Docetaxel|docetaxel|mesh-list
110433331|NCT02547987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110433332|NCT02547987|Tubulin Modulators|tubulin modulators|mesh-ancestor
110433333|NCT02547987|Antimitotic Agents|antimitotic agents|mesh-ancestor
110433334|NCT02547987|Mitosis Modulators|mitosis modulators|mesh-ancestor
110433335|NCT02547987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110433336|NCT02530489|Paclitaxel|paclitaxel|mesh-list
110433337|NCT02530489|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110433338|NCT02530489|Atezolizumab|atezolizumab|mesh-list
110433339|NCT02530489|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110433340|NCT02530489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110204578|NCT00045318|Exatecan|exatecan|mesh-list
110433341|NCT02530489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110433342|NCT02530489|Tubulin Modulators|tubulin modulators|mesh-ancestor
110433343|NCT02530489|Antimitotic Agents|antimitotic agents|mesh-ancestor
110433344|NCT02530489|Mitosis Modulators|mitosis modulators|mesh-ancestor
110433345|NCT02530489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110080282|NCT01628445|Liraglutide|liraglutide|mesh-list
110433346|NCT02530489|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110433347|NCT02530489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110433348|NCT02530489|Immunologic Factors|immunologic factors|mesh-ancestor
110433349|NCT02530489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110433350|NCT02523040|Lenalidomide|lenalidomide|mesh-list
110433351|NCT02523040|Immunologic Factors|immunologic factors|mesh-ancestor
110433352|NCT02523040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110433353|NCT02523040|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110433354|NCT02523040|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110433355|NCT02523040|Growth Substances|growth substances|mesh-ancestor
110433356|NCT02523040|Growth Inhibitors|growth inhibitors|mesh-ancestor
110433357|NCT02523040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110433358|NCT02396043|Cytarabine|cytarabine|mesh-list
110433359|NCT02396043|Dexamethasone|dexamethasone|mesh-list
110433360|NCT02396043|Prednisone|prednisone|mesh-list
110433361|NCT02396043|Cyclophosphamide|cyclophosphamide|mesh-list
110433362|NCT02396043|Methotrexate|methotrexate|mesh-list
110433363|NCT02396043|Vincristine|vincristine|mesh-list
110433364|NCT02396043|Mercaptopurine|mercaptopurine|mesh-list
110433365|NCT02396043|Pegaspargase|pegaspargase|mesh-list
110433366|NCT02396043|Asparaginase|asparaginase|mesh-list
110433367|NCT02396043|Pirarubicin|pirarubicin|mesh-list
110433368|NCT02396043|Doxorubicin|doxorubicin|mesh-list
110433369|NCT02396043|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110433370|NCT02396043|Immunologic Factors|immunologic factors|mesh-ancestor
110433371|NCT02396043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110433372|NCT02396043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110433373|NCT02396043|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110433374|NCT02396043|Alkylating Agents|alkylating agents|mesh-ancestor
110433375|NCT02396043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110433376|NCT02396043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110433377|NCT02396043|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110433378|NCT02396043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110433379|NCT02396043|Antiemetics|antiemetics|mesh-ancestor
110433380|NCT02396043|Autonomic Agents|autonomic agents|mesh-ancestor
110433381|NCT02396043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110433382|NCT02396043|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110433383|NCT02396043|Glucocorticoids|glucocorticoids|mesh-ancestor
110433384|NCT02396043|Hormones|hormones|mesh-ancestor
110433385|NCT02396043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110433386|NCT02396043|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110433387|NCT02396043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110433388|NCT02396043|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110433389|NCT02396043|Abortifacient Agents|abortifacient agents|mesh-ancestor
110433390|NCT02396043|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110433391|NCT02396043|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110433392|NCT02396043|Antimetabolites|antimetabolites|mesh-ancestor
110433393|NCT02396043|Dermatologic Agents|dermatologic agents|mesh-ancestor
110433394|NCT02396043|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110433395|NCT02396043|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110433396|NCT02396043|Antiviral Agents|antiviral agents|mesh-ancestor
110433397|NCT02396043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110433398|NCT02396043|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110433399|NCT02396043|Tubulin Modulators|tubulin modulators|mesh-ancestor
110433400|NCT02396043|Antimitotic Agents|antimitotic agents|mesh-ancestor
110433401|NCT02396043|Mitosis Modulators|mitosis modulators|mesh-ancestor
110433402|NCT02396043|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110433403|NCT02396043|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110433404|NCT02396043|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110433405|NCT02232191|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110433406|NCT02232191|Immunologic Factors|immunologic factors|mesh-ancestor
110433407|NCT02232191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110433408|NCT02097134|Melphalan|melphalan|mesh-list
110433409|NCT02097134|Mechlorethamine|mechlorethamine|mesh-list
110433410|NCT02097134|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
110433411|NCT02097134|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110433412|NCT02097134|Alkylating Agents|alkylating agents|mesh-ancestor
110433413|NCT02097134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110433414|NCT02097134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110433415|NCT02097134|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110433416|NCT02097134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110433417|NCT02097134|Immunologic Factors|immunologic factors|mesh-ancestor
110433418|NCT02097134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110433419|NCT01525966|Paclitaxel|paclitaxel|mesh-list
110433420|NCT01525966|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110433421|NCT01525966|Carboplatin|carboplatin|mesh-list
110433422|NCT01525966|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110433423|NCT01525966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110433424|NCT01525966|Tubulin Modulators|tubulin modulators|mesh-ancestor
110433425|NCT01525966|Antimitotic Agents|antimitotic agents|mesh-ancestor
110433426|NCT01525966|Mitosis Modulators|mitosis modulators|mesh-ancestor
110433427|NCT01525966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110433428|NCT01273610|Trastuzumab|trastuzumab|mesh-list
110433429|NCT01273610|Lapatinib|lapatinib|mesh-list
110433430|NCT01273610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110433431|NCT01273610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110433432|NCT01273610|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110433433|NCT01273610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110433434|NCT01273610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110433435|NCT00999804|Trastuzumab|trastuzumab|mesh-list
110433436|NCT00999804|Letrozole|letrozole|mesh-list
110433437|NCT00999804|Lapatinib|lapatinib|mesh-list
110329136|NCT01327495|Methyltestosterone|methyltestosterone|mesh-list
110433438|NCT00999804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110433439|NCT00999804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110433440|NCT00999804|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110433441|NCT00999804|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110433442|NCT00999804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110433443|NCT00999804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110433444|NCT00999804|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110433445|NCT00999804|Hormone Antagonists|hormone antagonists|mesh-ancestor
110433446|NCT00999804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110433447|NCT00999804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110433448|NCT00999804|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110433449|NCT00544830|Leuprolide|leuprolide|mesh-list
110433450|NCT00544830|Goserelin|goserelin|mesh-list
110433451|NCT00544830|Bicalutamide|bicalutamide|mesh-list
110433452|NCT00544830|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110433453|NCT00544830|Fertility Agents|fertility agents|mesh-ancestor
110433454|NCT00544830|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110433455|NCT00544830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110433456|NCT00544830|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110433457|NCT00544830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110433458|NCT00544830|Androgen Antagonists|androgen antagonists|mesh-ancestor
110433459|NCT00544830|Hormone Antagonists|hormone antagonists|mesh-ancestor
110433460|NCT00544830|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110433461|NCT00130221|Chlorhexidine|chlorhexidine|mesh-list
110433462|NCT00130221|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110433463|NCT00130221|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110433464|NCT00130221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110433465|NCT00130221|Disinfectants|disinfectants|mesh-ancestor
110433466|NCT00130221|Dermatologic Agents|dermatologic agents|mesh-ancestor
110433467|NCT00077129|Paclitaxel|paclitaxel|mesh-list
110433468|NCT00077129|Carboplatin|carboplatin|mesh-list
110433469|NCT00077129|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110433470|NCT00077129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110433471|NCT00077129|Tubulin Modulators|tubulin modulators|mesh-ancestor
110433472|NCT00077129|Antimitotic Agents|antimitotic agents|mesh-ancestor
110433473|NCT00077129|Mitosis Modulators|mitosis modulators|mesh-ancestor
110433474|NCT00077129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110433475|NCT00052884|Melphalan|melphalan|mesh-list
110433476|NCT00052884|Amifostine|amifostine|mesh-list
110433477|NCT00052884|Immunologic Factors|immunologic factors|mesh-ancestor
110433478|NCT00052884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110433479|NCT00052884|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110433480|NCT00052884|Alkylating Agents|alkylating agents|mesh-ancestor
110433481|NCT00052884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110433482|NCT00052884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110433483|NCT00052884|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110433484|NCT00052884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110433485|NCT00052884|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110433486|NCT00052884|Protective Agents|protective agents|mesh-ancestor
110433487|NCT00040807|Docetaxel|docetaxel|mesh-list
110433488|NCT00040807|Irinotecan|irinotecan|mesh-list
110433489|NCT00040807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110433490|NCT00040807|Tubulin Modulators|tubulin modulators|mesh-ancestor
110433491|NCT00040807|Antimitotic Agents|antimitotic agents|mesh-ancestor
110433492|NCT00040807|Mitosis Modulators|mitosis modulators|mesh-ancestor
110433493|NCT00040807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110433494|NCT00040807|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110433495|NCT00040807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110433496|NCT00040807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110433497|NCT00028678|Dalteparin|dalteparin|mesh-list
110433498|NCT00028678|Tinzaparin|tinzaparin|mesh-list
110433499|NCT00028678|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
110080430|NCT01629446|Lofexidine|lofexidine|mesh-list
110433500|NCT00028678|Anticoagulants|anticoagulants|mesh-ancestor
110433501|NCT00028678|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110433502|NCT00028678|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110433503|NCT00028678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110433504|NCT00004223|Gemcitabine|gemcitabine|mesh-list
110433505|NCT00004223|Docetaxel|docetaxel|mesh-list
110433506|NCT00004223|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110433507|NCT00004223|Antimetabolites|antimetabolites|mesh-ancestor
110433508|NCT00004223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110329150|NCT00491634|Treosulfan|treosulfan|mesh-list
110433509|NCT00004223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110433511|NCT00004223|Antimitotic Agents|antimitotic agents|mesh-ancestor
110433512|NCT00004223|Mitosis Modulators|mitosis modulators|mesh-ancestor
110433513|NCT00003764|Cyclophosphamide|cyclophosphamide|mesh-list
110433514|NCT00003764|Fludarabine|fludarabine|mesh-list
110433515|NCT00003764|Fludarabine phosphate|fludarabine phosphate|mesh-list
110433516|NCT00003764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110433517|NCT00003764|Immunologic Factors|immunologic factors|mesh-ancestor
110433518|NCT00003764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110433519|NCT00003764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110433520|NCT00003764|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110433521|NCT00003764|Alkylating Agents|alkylating agents|mesh-ancestor
110433522|NCT00003764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110433523|NCT00003764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110433524|NCT00003764|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110433525|NCT00003764|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110433526|NCT00003764|Antimetabolites|antimetabolites|mesh-ancestor
110433528|NCT00003601|Fenretinide|fenretinide|mesh-list
110433529|NCT00003601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110433530|NCT00003601|Keratolytic Agents|keratolytic agents|mesh-ancestor
110433531|NCT00003601|Dermatologic Agents|dermatologic agents|mesh-ancestor
110433532|NCT00003601|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110433533|NCT00003601|Protective Agents|protective agents|mesh-ancestor
110433534|NCT00003601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110433535|NCT00003266|Methylphenidate|methylphenidate|mesh-list
110433536|NCT00003266|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110433537|NCT00003266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110433538|NCT00003266|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110433539|NCT00003266|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110433540|NCT00003266|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110433541|NCT00003266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110433542|NCT00003266|Dopamine Agents|dopamine agents|mesh-ancestor
110433543|NCT00003266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110433544|NCT00003236|ISIS 5132|isis 5132|mesh-list
110433545|NCT00003236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110433546|NCT00003236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110433547|NCT00003236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110433548|NCT00003057|Octreotide|octreotide|mesh-list
110433549|NCT00003057|Loperamide|loperamide|mesh-list
110433550|NCT00003057|Antidiarrheals|antidiarrheals|mesh-list
110433551|NCT00003057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110433552|NCT00003057|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110433553|NCT00003057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110433554|NCT00002922|Paclitaxel|paclitaxel|mesh-list
110433555|NCT00002922|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110433556|NCT00002922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110433557|NCT00002922|Tubulin Modulators|tubulin modulators|mesh-ancestor
110433558|NCT00002922|Antimitotic Agents|antimitotic agents|mesh-ancestor
110433559|NCT00002922|Mitosis Modulators|mitosis modulators|mesh-ancestor
110433560|NCT00002922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110433561|NCT00002514|Leucovorin|leucovorin|mesh-list
110433562|NCT00002514|Cytarabine|cytarabine|mesh-list
110433563|NCT00002514|Dexamethasone|dexamethasone|mesh-list
110433564|NCT00002514|Prednisone|prednisone|mesh-list
110433565|NCT00002514|Cyclophosphamide|cyclophosphamide|mesh-list
110433566|NCT00002514|Methotrexate|methotrexate|mesh-list
110433567|NCT00002514|Etoposide|etoposide|mesh-list
110433568|NCT00002514|Vincristine|vincristine|mesh-list
110433569|NCT00002514|Imatinib Mesylate|imatinib mesylate|mesh-list
110433570|NCT00002514|Daunorubicin|daunorubicin|mesh-list
110433571|NCT00002514|Asparaginase|asparaginase|mesh-list
110433572|NCT00002514|Mercaptopurine|mercaptopurine|mesh-list
110433573|NCT00002514|Thioguanine|thioguanine|mesh-list
110433574|NCT00002514|Sargramostim|sargramostim|mesh-list
110433575|NCT00002514|Levoleucovorin|levoleucovorin|mesh-list
110433576|NCT00002514|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110433577|NCT00002514|Immunologic Factors|immunologic factors|mesh-ancestor
110433578|NCT00002514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110433579|NCT00002514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110433580|NCT00002514|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110433581|NCT00002514|Alkylating Agents|alkylating agents|mesh-ancestor
110433582|NCT00002514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110433583|NCT00002514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110433584|NCT00002514|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110433585|NCT00002514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110433587|NCT00002514|Autonomic Agents|autonomic agents|mesh-ancestor
110433588|NCT00002514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110433589|NCT00002514|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110433590|NCT00002514|Glucocorticoids|glucocorticoids|mesh-ancestor
110433591|NCT00002514|Hormones|hormones|mesh-ancestor
110433592|NCT00002514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110433593|NCT00002514|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110433594|NCT00002514|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110433595|NCT00002514|Abortifacient Agents|abortifacient agents|mesh-ancestor
110433596|NCT00002514|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110433597|NCT00002514|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110433598|NCT00002514|Antimetabolites|antimetabolites|mesh-ancestor
110433599|NCT00002514|Dermatologic Agents|dermatologic agents|mesh-ancestor
110433600|NCT00002514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110433601|NCT00002514|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110433602|NCT00002514|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110433603|NCT00002514|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110433604|NCT00002514|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110433605|NCT00002514|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110433606|NCT00002514|Antiviral Agents|antiviral agents|mesh-ancestor
110433607|NCT00002514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110433608|NCT00002514|Antidotes|antidotes|mesh-ancestor
110433609|NCT00002514|Protective Agents|protective agents|mesh-ancestor
110433610|NCT00002514|Vitamin B Complex|vitamin b complex|mesh-ancestor
110433611|NCT00002514|Vitamins|vitamins|mesh-ancestor
110433612|NCT00002514|Micronutrients|micronutrients|mesh-ancestor
110433613|NCT00002514|Tubulin Modulators|tubulin modulators|mesh-ancestor
110433614|NCT00002514|Antimitotic Agents|antimitotic agents|mesh-ancestor
110433615|NCT00002514|Mitosis Modulators|mitosis modulators|mesh-ancestor
110433616|NCT00002514|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110433617|NCT00002514|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110433618|NCT00607282|Udenafil|udenafil|mesh-list
110433619|NCT00607282|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110433620|NCT00607282|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110433621|NCT00607282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110433622|NCT00607282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110433623|NCT00927472|Permethrin|permethrin|mesh-list
110433624|NCT00927472|Malathion|malathion|mesh-list
110433625|NCT00927472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110433626|NCT00927472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110433627|NCT00927472|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110433628|NCT00927472|Cholinergic Agents|cholinergic agents|mesh-ancestor
110433629|NCT00927472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110433630|NCT00927472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110433631|NCT00642655|Rituximab|rituximab|mesh-list
110433632|NCT00642655|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110433633|NCT00642655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110433634|NCT00642655|Immunologic Factors|immunologic factors|mesh-ancestor
110433635|NCT00642655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110433636|NCT00642655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110433637|NCT00642733|Gemcitabine|gemcitabine|mesh-list
110433638|NCT00642733|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110433639|NCT00642733|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110433640|NCT00642733|Antimetabolites|antimetabolites|mesh-ancestor
110433641|NCT00642733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110433642|NCT00642733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110433643|NCT00642733|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110433644|NCT00642733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110433645|NCT00927394|Valsartan|valsartan|mesh-list
110433646|NCT00927394|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110433647|NCT00927394|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110433648|NCT00927394|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110433649|NCT00927394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110433650|NCT00643825|Temozolomide|temozolomide|mesh-list
110204657|NCT00054236|Fludarabine|fludarabine|mesh-list
110433651|NCT00643825|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110433652|NCT00643825|Alkylating Agents|alkylating agents|mesh-ancestor
110433653|NCT00643825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110433654|NCT00643825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110433656|NCT04178863|Latanoprost|latanoprost|mesh-list
110433657|NCT04178863|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110433658|NCT04178863|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110433659|NCT04178863|Adrenergic Agents|adrenergic agents|mesh-ancestor
110433660|NCT04178863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110433661|NCT04178863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110433662|NCT04178863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110433663|NCT04178863|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110433664|NCT04178863|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110433665|NCT04178863|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110433666|NCT04178863|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110433668|NCT04264858|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110433669|NCT04264858|Antibodies|antibodies|mesh-list
110433670|NCT04264858|gamma-Globulins|gamma-globulins|mesh-list
110433671|NCT04264858|Immunologic Factors|immunologic factors|mesh-ancestor
110433672|NCT04264858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110433673|NCT00976911|Paclitaxel|paclitaxel|mesh-list
110433674|NCT00976911|Bevacizumab|bevacizumab|mesh-list
110433675|NCT00976911|Doxorubicin|doxorubicin|mesh-list
110433676|NCT00976911|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110433677|NCT00976911|Topotecan|topotecan|mesh-list
110433678|NCT00976911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110433679|NCT00976911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110433680|NCT00976911|Tubulin Modulators|tubulin modulators|mesh-ancestor
110433681|NCT00976911|Antimitotic Agents|antimitotic agents|mesh-ancestor
110433682|NCT00976911|Mitosis Modulators|mitosis modulators|mesh-ancestor
110433683|NCT00976911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110433684|NCT00976911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110433685|NCT00976911|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110433686|NCT00976911|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110433687|NCT00976911|Growth Substances|growth substances|mesh-ancestor
110433688|NCT00976911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110433689|NCT00976911|Growth Inhibitors|growth inhibitors|mesh-ancestor
110433690|NCT00976911|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110433691|NCT00976911|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110433692|NCT00976911|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110433693|NCT00976911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110433694|NCT00976911|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110433695|NCT05336968|Triamcinolone|triamcinolone|mesh-list
110433696|NCT05336968|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110433697|NCT05336968|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110433698|NCT05336968|Ketorolac|ketorolac|mesh-list
110433699|NCT05336968|Ropivacaine|ropivacaine|mesh-list
110433700|NCT05336968|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110433701|NCT05336968|Anesthetics, Local|anesthetics, local|mesh-ancestor
110433702|NCT05336968|Anesthetics|anesthetics|mesh-ancestor
110433703|NCT05336968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110433704|NCT05336968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110433705|NCT05336968|Sensory System Agents|sensory system agents|mesh-ancestor
110433706|NCT05336968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110433707|NCT05336968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110433708|NCT05336968|Glucocorticoids|glucocorticoids|mesh-ancestor
110433709|NCT05336968|Hormones|hormones|mesh-ancestor
110433710|NCT05336968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110433711|NCT05336968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110433712|NCT05336968|Immunologic Factors|immunologic factors|mesh-ancestor
110433713|NCT05336968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110433714|NCT05336968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110433715|NCT05336968|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110433716|NCT05336968|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110433717|NCT05336968|Analgesics|analgesics|mesh-ancestor
110433718|NCT05336968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110433719|NCT05336968|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110433720|NCT02674555|Naquotinib|naquotinib|mesh-list
110433721|NCT02674555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110433722|NCT02674555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110433723|NCT02674555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110433724|NCT02674555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110433725|NCT00934648|Rituximab|rituximab|mesh-list
110433726|NCT00934648|Methotrexate|methotrexate|mesh-list
110433727|NCT00934648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110433728|NCT00934648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110433729|NCT00934648|Immunologic Factors|immunologic factors|mesh-ancestor
110433730|NCT00934648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110433731|NCT00934648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110433732|NCT00934648|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110433733|NCT00934648|Abortifacient Agents|abortifacient agents|mesh-ancestor
110433734|NCT00934648|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110433735|NCT00934648|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110433736|NCT00934648|Antimetabolites|antimetabolites|mesh-ancestor
110433737|NCT00934648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110433738|NCT00934648|Dermatologic Agents|dermatologic agents|mesh-ancestor
110433739|NCT00934648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110433740|NCT00934648|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110433741|NCT00934648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110433742|NCT00934648|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110433743|NCT01175213|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110433744|NCT01175213|gamma-Globulins|gamma-globulins|mesh-list
110433745|NCT01175213|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110433746|NCT01175213|Immunologic Factors|immunologic factors|mesh-ancestor
110433747|NCT01175213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110433748|NCT00644449|Azithromycin|azithromycin|mesh-list
110433749|NCT00644449|Levofloxacin|levofloxacin|mesh-list
110433750|NCT00644449|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110433751|NCT00644449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110433752|NCT00644449|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110433753|NCT00644449|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110433754|NCT00644449|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110433755|NCT00644449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110433756|NCT00644449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110433757|NCT00644449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110433758|NCT00644449|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110433759|NCT00644449|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110433761|NCT04287777|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110433762|NCT04287777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110433763|NCT04287777|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110433764|NCT04287777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110433765|NCT04287777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110433766|NCT04180657|Protein C|protein c|mesh-list
110433767|NCT04180657|Anticoagulants|anticoagulants|mesh-ancestor
110433768|NCT04180657|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110433769|NCT04180657|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110433770|NCT04180657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110433771|NCT00927082|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110433772|NCT00927082|Antiviral Agents|antiviral agents|mesh-ancestor
110433773|NCT00927082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110433774|NCT02674243|Povidone-Iodine|povidone-iodine|mesh-list
110433775|NCT02674243|Povidone|povidone|mesh-list
110433776|NCT02674243|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110433777|NCT02674243|Plasma Substitutes|plasma substitutes|mesh-ancestor
110433778|NCT02674243|Blood Substitutes|blood substitutes|mesh-ancestor
110564607|NCT05221892|Thiamine|thiamine|mesh-list
110433779|NCT02674243|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110433780|NCT02674243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110433781|NCT04256200|Dienogest|dienogest|mesh-list
110433782|NCT04256200|Contraceptive Agents|contraceptive agents|mesh-list
110433783|NCT04256200|Contraceptives, Oral|contraceptives, oral|mesh-list
110433784|NCT04256200|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
110433785|NCT04256200|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110433786|NCT04256200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110433787|NCT04256200|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110433788|NCT04256200|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110433789|NCT04256200|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110433790|NCT04256200|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110433791|NCT04256200|Hormone Antagonists|hormone antagonists|mesh-ancestor
110433792|NCT04256200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110433793|NCT04256200|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110329157|NCT00491634|Immunologic Factors|immunologic factors|mesh-ancestor
110433794|NCT04256200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110433795|NCT02676739|Adderall|adderall|mesh-list
110433796|NCT02676739|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110433797|NCT02676739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110433798|NCT00976677|Paclitaxel|paclitaxel|mesh-list
110433799|NCT00976677|Bevacizumab|bevacizumab|mesh-list
110433800|NCT00976677|Carboplatin|carboplatin|mesh-list
110433801|NCT00976677|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110433802|NCT00976677|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110433803|NCT00976677|Antibodies|antibodies|mesh-list
110433804|NCT00976677|Immunoglobulins|immunoglobulins|mesh-list
110433805|NCT00976677|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110433806|NCT00976677|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110433807|NCT00976677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110433808|NCT00976677|Tubulin Modulators|tubulin modulators|mesh-ancestor
110433809|NCT00976677|Antimitotic Agents|antimitotic agents|mesh-ancestor
110433810|NCT00976677|Mitosis Modulators|mitosis modulators|mesh-ancestor
110433811|NCT00976677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110433812|NCT00976677|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110433813|NCT00976677|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110433814|NCT00976677|Growth Substances|growth substances|mesh-ancestor
110433815|NCT00976677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110433816|NCT00976677|Growth Inhibitors|growth inhibitors|mesh-ancestor
110433817|NCT00976677|Immunologic Factors|immunologic factors|mesh-ancestor
110433818|NCT00976677|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110433819|NCT00976677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110433820|NCT00642967|Epoetin Alfa|epoetin alfa|mesh-list
110433821|NCT00642967|Hematinics|hematinics|mesh-ancestor
110433822|NCT02865993|Povidone-Iodine|povidone-iodine|mesh-list
110433823|NCT02865993|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110433824|NCT02865993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110433825|NCT04287543|Melatonin|melatonin|mesh-list
110433826|NCT04287543|Antioxidants|antioxidants|mesh-ancestor
110433827|NCT04287543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110433828|NCT04287543|Protective Agents|protective agents|mesh-ancestor
110433829|NCT04287543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110433830|NCT04287543|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110433831|NCT04287387|Pioglitazone|pioglitazone|mesh-list
110433832|NCT04287387|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110433833|NCT04287387|Dapagliflozin|dapagliflozin|mesh-list
110433834|NCT04287387|Metformin|metformin|mesh-list
110433835|NCT04287387|Glimepiride|glimepiride|mesh-list
110433836|NCT04287387|Acarbose|acarbose|mesh-list
110433837|NCT04287387|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110433838|NCT04287387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110433840|NCT04287387|Hormones|hormones|mesh-ancestor
110433841|NCT04287387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110433842|NCT04287387|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110433843|NCT04287387|Protease Inhibitors|protease inhibitors|mesh-ancestor
110433844|NCT04287387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110433845|NCT04287387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110204741|NCT00045513|Antimetabolites|antimetabolites|mesh-ancestor
110433846|NCT04287387|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110433847|NCT04287387|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110433848|NCT04287387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110433849|NCT04287387|Immunologic Factors|immunologic factors|mesh-ancestor
110433850|NCT04287387|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
110433851|NCT00644605|Sildenafil Citrate|sildenafil citrate|mesh-list
110433852|NCT00644605|Vasodilator Agents|vasodilator agents|mesh-ancestor
110433853|NCT00644605|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110433854|NCT00644605|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110433855|NCT00644605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110433856|NCT00644605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110433857|NCT00644605|Urological Agents|urological agents|mesh-ancestor
110433858|NCT02865681|Letrozole|letrozole|mesh-list
110433859|NCT02865681|Clomiphene|clomiphene|mesh-list
110433860|NCT02865681|Enclomiphene|enclomiphene|mesh-list
110433861|NCT02865681|Zuclomiphene|zuclomiphene|mesh-list
110433862|NCT02865681|Menotropins|menotropins|mesh-list
110433863|NCT02865681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110433864|NCT02865681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110433865|NCT02865681|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110433866|NCT02865681|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110433867|NCT02865681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110433868|NCT02865681|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110433869|NCT02865681|Hormone Antagonists|hormone antagonists|mesh-ancestor
110433870|NCT02865681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110433871|NCT02865681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110433872|NCT02865681|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110433873|NCT02865681|Fertility Agents|fertility agents|mesh-ancestor
110433874|NCT02865681|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110433875|NCT02865681|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110433876|NCT02865681|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110433877|NCT00644137|Pregabalin|pregabalin|mesh-list
110433878|NCT00644137|Analgesics|analgesics|mesh-ancestor
110433879|NCT00644137|Sensory System Agents|sensory system agents|mesh-ancestor
110433880|NCT00644137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110433881|NCT00644137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110433882|NCT00644137|Anticonvulsants|anticonvulsants|mesh-ancestor
110433883|NCT00644137|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110433884|NCT00644137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110433885|NCT00644137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110433886|NCT00644137|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110433887|NCT00644137|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110433888|NCT00644137|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110433889|NCT00644137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110433890|NCT00644137|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110433891|NCT00910195|Acetaminophen|acetaminophen|mesh-list
110433892|NCT00910195|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110433893|NCT00910195|Analgesics|analgesics|mesh-ancestor
110433894|NCT00910195|Sensory System Agents|sensory system agents|mesh-ancestor
110204774|NCT00054587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110433895|NCT00910195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110371908|NCT00563069|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110433896|NCT00910195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110433898|NCT04176367|Nicergoline|nicergoline|mesh-list
110433899|NCT04176367|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110433900|NCT04176367|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110433901|NCT04176367|Adrenergic Agents|adrenergic agents|mesh-ancestor
110433902|NCT04176367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110433903|NCT04176367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110433904|NCT04176367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110433905|NCT04176367|Vasodilator Agents|vasodilator agents|mesh-ancestor
110433906|NCT04176367|Nootropic Agents|nootropic agents|mesh-ancestor
110433907|NCT04259476|Ketamine|ketamine|mesh-list
110433908|NCT04259476|Analgesics|analgesics|mesh-ancestor
110433909|NCT04259476|Sensory System Agents|sensory system agents|mesh-ancestor
110433910|NCT04259476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110433911|NCT04259476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110433912|NCT04259476|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110433913|NCT04259476|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110433914|NCT04259476|Anesthetics, General|anesthetics, general|mesh-ancestor
110433915|NCT04259476|Anesthetics|anesthetics|mesh-ancestor
110433916|NCT04259476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110433917|NCT04259476|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110433918|NCT04259476|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110433919|NCT04259476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110433920|NCT04259476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110433921|NCT05319574|Tislelizumab|tislelizumab|mesh-list
110433922|NCT05319574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110433923|NCT05319574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110433924|NCT00970281|Olanzapine|olanzapine|mesh-list
110433925|NCT00970281|Antiemetics|antiemetics|mesh-ancestor
110433926|NCT00970281|Autonomic Agents|autonomic agents|mesh-ancestor
110433927|NCT00970281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110433928|NCT00970281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110433929|NCT00970281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110433930|NCT00970281|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110433931|NCT00970281|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110433932|NCT00970281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110433933|NCT00970281|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110204799|NCT00167557|Antiviral Agents|antiviral agents|mesh-ancestor
110433934|NCT00970281|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110433935|NCT00970281|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110433936|NCT00970281|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110433937|NCT00970281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110433938|NCT00970281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110433940|NCT00607438|Paclitaxel|paclitaxel|mesh-list
110433941|NCT00607438|Sorafenib|sorafenib|mesh-list
110433942|NCT00607438|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110433943|NCT00607438|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110433944|NCT00607438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110433945|NCT00607438|Tubulin Modulators|tubulin modulators|mesh-ancestor
110433946|NCT00607438|Antimitotic Agents|antimitotic agents|mesh-ancestor
110433947|NCT00607438|Mitosis Modulators|mitosis modulators|mesh-ancestor
110433948|NCT00607438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110433949|NCT00607438|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110433950|NCT00607438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110080874|NCT01632189|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110433951|NCT00976209|Phenylephrine|phenylephrine|mesh-list
110433952|NCT00976209|Oxymetazoline|oxymetazoline|mesh-list
110433953|NCT00976209|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110433954|NCT00976209|Mydriatics|mydriatics|mesh-ancestor
110433955|NCT00976209|Autonomic Agents|autonomic agents|mesh-ancestor
110433956|NCT00976209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110433957|NCT00976209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110433958|NCT00976209|Sympathomimetics|sympathomimetics|mesh-ancestor
110433959|NCT00976209|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110433960|NCT00976209|Nasal Decongestants|nasal decongestants|mesh-ancestor
110433961|NCT00976209|Respiratory System Agents|respiratory system agents|mesh-ancestor
110433962|NCT00976209|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110433963|NCT00976209|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110433964|NCT00976209|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110433965|NCT00976209|Adrenergic Agents|adrenergic agents|mesh-ancestor
110433966|NCT00976209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110433967|NCT00976209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110433968|NCT00976209|Protective Agents|protective agents|mesh-ancestor
110433970|NCT03746301|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110433971|NCT03746301|Antithrombins|antithrombins|mesh-ancestor
110433972|NCT03746301|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110433973|NCT03746301|Protease Inhibitors|protease inhibitors|mesh-ancestor
110433974|NCT03746301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110433975|NCT03746301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110433976|NCT03746301|Anticoagulants|anticoagulants|mesh-ancestor
110433977|NCT00925990|Ribavirin|ribavirin|mesh-list
110433978|NCT00925990|Antimetabolites|antimetabolites|mesh-ancestor
110433979|NCT00925990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110433980|NCT00925990|Antiviral Agents|antiviral agents|mesh-ancestor
110433981|NCT00925990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110433982|NCT02670655|Lidocaine|lidocaine|mesh-list
110433983|NCT02670655|Prilocaine|prilocaine|mesh-list
110433984|NCT02670655|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
110433985|NCT02670655|Anesthetics, Local|anesthetics, local|mesh-ancestor
110433986|NCT02670655|Anesthetics|anesthetics|mesh-ancestor
110433987|NCT02670655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110433988|NCT02670655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110433989|NCT02670655|Sensory System Agents|sensory system agents|mesh-ancestor
110433990|NCT02670655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110433991|NCT02670655|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110433992|NCT02670655|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110433993|NCT02670655|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110433994|NCT02670655|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110433995|NCT02670655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110433996|NCT02670655|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
110433997|NCT01131078|Bevacizumab|bevacizumab|mesh-list
110433998|NCT01131078|Capecitabine|capecitabine|mesh-list
110433999|NCT01131078|Irinotecan|irinotecan|mesh-list
110434000|NCT01131078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110434001|NCT01131078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110434002|NCT01131078|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110434003|NCT01131078|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110434004|NCT01131078|Growth Substances|growth substances|mesh-ancestor
110434005|NCT01131078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110434006|NCT01131078|Growth Inhibitors|growth inhibitors|mesh-ancestor
110434007|NCT01131078|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110434008|NCT01131078|Antimetabolites|antimetabolites|mesh-ancestor
110434009|NCT01131078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110434010|NCT01131078|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110434011|NCT01131078|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110434013|NCT03709017|Ponatinib|ponatinib|mesh-list
110434014|NCT03709017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110434015|NCT03709017|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110434016|NCT03709017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110434017|NCT03709017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110434018|NCT03695445|Norepinephrine|norepinephrine|mesh-list
110434019|NCT03695445|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110434020|NCT03695445|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110434021|NCT03695445|Adrenergic Agents|adrenergic agents|mesh-ancestor
110434022|NCT03695445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110434023|NCT03695445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110434024|NCT03695445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110434025|NCT03695445|Sympathomimetics|sympathomimetics|mesh-ancestor
110434026|NCT03695445|Autonomic Agents|autonomic agents|mesh-ancestor
110434027|NCT03695445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110434028|NCT03695445|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110434029|NCT04177303|Metformin|metformin|mesh-list
110434030|NCT04177303|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110434031|NCT04177303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110434032|NCT01167426|Glatiramer Acetate|glatiramer acetate|mesh-list
110434033|NCT01167426|(T,G)-A-L|(t,g)-a-l|mesh-list
110434034|NCT01167426|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110434035|NCT01167426|Immunologic Factors|immunologic factors|mesh-ancestor
110434036|NCT01167426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110434037|NCT01167426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110434038|NCT01167426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110434039|NCT02862873|Ondansetron|ondansetron|mesh-list
110434040|NCT02862873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110434041|NCT02862873|Antiemetics|antiemetics|mesh-ancestor
110434042|NCT02862873|Autonomic Agents|autonomic agents|mesh-ancestor
110434043|NCT02862873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110204911|NCT00407407|Carboplatin|carboplatin|mesh-list
110204912|NCT00407407|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110204914|NCT00407446|Sildenafil Citrate|sildenafil citrate|mesh-list
110434044|NCT02862873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110434045|NCT02862873|Antipruritics|antipruritics|mesh-ancestor
110434046|NCT02862873|Dermatologic Agents|dermatologic agents|mesh-ancestor
110434047|NCT02862873|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110434048|NCT02862873|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110434049|NCT02862873|Serotonin Agents|serotonin agents|mesh-ancestor
110434050|NCT02862873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110434051|NCT02862873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110434052|NCT03814005|Paclitaxel|paclitaxel|mesh-list
110434053|NCT03814005|Docetaxel|docetaxel|mesh-list
110434054|NCT03814005|Carboplatin|carboplatin|mesh-list
110434055|NCT03814005|Azacitidine|azacitidine|mesh-list
110434056|NCT03814005|Pevonedistat|pevonedistat|mesh-list
110434057|NCT03814005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110434058|NCT03814005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110434059|NCT03814005|Tubulin Modulators|tubulin modulators|mesh-ancestor
110434060|NCT03814005|Antimitotic Agents|antimitotic agents|mesh-ancestor
110434061|NCT03814005|Mitosis Modulators|mitosis modulators|mesh-ancestor
110434062|NCT03814005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110434063|NCT03814005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110434064|NCT03814005|Antimetabolites|antimetabolites|mesh-ancestor
110434065|NCT03814005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110434066|NCT04016233|Tenofovir|tenofovir|mesh-list
110434067|NCT04016233|Antiviral Agents|antiviral agents|mesh-ancestor
110434068|NCT04016233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110434069|NCT04016233|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110434070|NCT04016233|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110434071|NCT04016233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110434072|NCT04016233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110434073|NCT04016233|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110434074|NCT04016233|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110434075|NCT04033471|Midazolam|midazolam|mesh-list
110434076|NCT04033471|Morphine|morphine|mesh-list
110434077|NCT04033471|Bupivacaine|bupivacaine|mesh-list
110434078|NCT04033471|Anesthetics, Local|anesthetics, local|mesh-ancestor
110434079|NCT04033471|Anesthetics|anesthetics|mesh-ancestor
110434080|NCT04033471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110434081|NCT04033471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110434082|NCT04033471|Sensory System Agents|sensory system agents|mesh-ancestor
110434083|NCT04033471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110434084|NCT04033471|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110434086|NCT04033471|Analgesics|analgesics|mesh-ancestor
110434087|NCT04033471|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110434088|NCT04033471|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110434089|NCT04033471|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110434090|NCT04033471|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110434091|NCT04033471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110434092|NCT04033471|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110434093|NCT04033471|Anesthetics, General|anesthetics, general|mesh-ancestor
110434094|NCT04033471|GABA Modulators|gaba modulators|mesh-ancestor
110434095|NCT04033471|GABA Agents|gaba agents|mesh-ancestor
110434096|NCT04033471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110434097|NCT04033471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110434098|NCT00910351|Ciprofloxacin|ciprofloxacin|mesh-list
110434099|NCT00910351|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110434100|NCT00910351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110434101|NCT00910351|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110434102|NCT00910351|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110434103|NCT00910351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110434104|NCT00910351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110434105|NCT00910351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110434106|NCT00910351|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110434107|NCT00910351|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110434108|NCT04175587|Tretinoin|tretinoin|mesh-list
110434109|NCT04175587|Arsenic Trioxide|arsenic trioxide|mesh-list
110434110|NCT04175587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110434111|NCT04175587|Keratolytic Agents|keratolytic agents|mesh-ancestor
110434112|NCT04175587|Dermatologic Agents|dermatologic agents|mesh-ancestor
110434113|NCT02668159|Vitamin D|vitamin d|mesh-list
110434114|NCT02668159|Ergocalciferols|ergocalciferols|mesh-list
110434115|NCT02668159|Cholecalciferol|cholecalciferol|mesh-list
110434116|NCT02668159|Vitamins|vitamins|mesh-list
110434117|NCT02668159|Micronutrients|micronutrients|mesh-ancestor
110434118|NCT02668159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110434119|NCT02668159|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110434120|NCT02668159|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110434121|NCT02670109|Cyclophosphamide|cyclophosphamide|mesh-list
110434122|NCT02670109|Busulfan|busulfan|mesh-list
110434123|NCT02670109|Carmustine|carmustine|mesh-list
110434124|NCT02670109|Carboplatin|carboplatin|mesh-list
110434125|NCT02670109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110434126|NCT02670109|Immunologic Factors|immunologic factors|mesh-ancestor
110434127|NCT02670109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110434128|NCT02670109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110434129|NCT02670109|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110434130|NCT02670109|Alkylating Agents|alkylating agents|mesh-ancestor
110434131|NCT02670109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110434132|NCT02670109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110434133|NCT02670109|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110434134|NCT00922636|Methylphenidate|methylphenidate|mesh-list
110434135|NCT00922636|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110434136|NCT00922636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110434137|NCT00922636|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110434138|NCT00922636|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110434139|NCT00922636|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110434140|NCT00922636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110434141|NCT00922636|Dopamine Agents|dopamine agents|mesh-ancestor
110434142|NCT00922636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110434143|NCT02667925|Cisplatin|cisplatin|mesh-list
110434144|NCT02667925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110434145|NCT02669719|Carboplatin|carboplatin|mesh-list
110434146|NCT02669719|Pemetrexed|pemetrexed|mesh-list
110434147|NCT02669719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110434148|NCT02669719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110434149|NCT02669719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110434150|NCT02669719|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110434151|NCT02669719|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110434152|NCT00644761|Adefovir|adefovir|mesh-list
110434153|NCT00644761|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
110434154|NCT00644761|Antiviral Agents|antiviral agents|mesh-ancestor
110434155|NCT00644761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110434156|NCT00644761|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110434157|NCT00644761|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110434158|NCT00644761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110434159|NCT00644761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110434160|NCT00645073|Levofloxacin|levofloxacin|mesh-list
110434161|NCT00645073|Cefdinir|cefdinir|mesh-list
110434162|NCT00645073|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110434163|NCT00645073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110434164|NCT00645073|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110434165|NCT00645073|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110434166|NCT00645073|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110434167|NCT00645073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110434168|NCT00645073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110434169|NCT00645073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110434170|NCT00645073|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110434171|NCT00645073|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110434173|NCT04259008|Trace Elements|trace elements|mesh-ancestor
110434174|NCT04259008|Micronutrients|micronutrients|mesh-ancestor
110434175|NCT04259008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110434176|NCT04258930|Calcium|calcium|mesh-list
110434177|NCT04258930|Calcium acetate|calcium acetate|mesh-list
110081105|NCT01634347|Propranolol|propranolol|mesh-list
110434178|NCT04258930|Aluminum sulfate|aluminum sulfate|mesh-list
110434179|NCT04258930|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110434180|NCT04258930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110434181|NCT04258930|Chelating Agents|chelating agents|mesh-ancestor
110434182|NCT04258930|Sequestering Agents|sequestering agents|mesh-ancestor
110434183|NCT04258930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110434184|NCT04258930|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110434185|NCT04258930|Immunologic Factors|immunologic factors|mesh-ancestor
110434186|NCT01175135|Risperidone|risperidone|mesh-list
110434187|NCT01175135|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110434188|NCT01175135|Serotonin Agents|serotonin agents|mesh-ancestor
110434189|NCT01175135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110434190|NCT01175135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110434191|NCT01175135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110434192|NCT01175135|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110434193|NCT01175135|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110434194|NCT01175135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110434195|NCT01175135|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110434196|NCT01175135|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110434197|NCT01175135|Dopamine Agents|dopamine agents|mesh-ancestor
110434198|NCT02669641|Choline|choline|mesh-list
110434199|NCT02669641|Lipotropic Agents|lipotropic agents|mesh-ancestor
110434200|NCT02669641|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110434201|NCT02669641|Antimetabolites|antimetabolites|mesh-ancestor
110434202|NCT02669641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110434203|NCT02669641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110371973|NCT00563225|Insulin Glargine|insulin glargine|mesh-list
110434204|NCT02669641|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110434206|NCT00922480|Losartan|losartan|mesh-list
110434207|NCT00922480|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110434208|NCT00922480|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110434209|NCT00922480|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110434210|NCT00922480|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110434211|NCT00922480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110434212|NCT04963036|Anesthetics|anesthetics|mesh-list
110434213|NCT04963036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110434214|NCT04963036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110434215|NCT00973479|Golimumab|golimumab|mesh-list
110434216|NCT00973479|Methotrexate|methotrexate|mesh-list
110434217|NCT00973479|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110434218|NCT00973479|Abortifacient Agents|abortifacient agents|mesh-ancestor
110434219|NCT00973479|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110434220|NCT00973479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110434221|NCT00973479|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110434222|NCT00973479|Antimetabolites|antimetabolites|mesh-ancestor
110204981|NCT00168766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110434223|NCT00973479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110434224|NCT00973479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110434225|NCT00973479|Dermatologic Agents|dermatologic agents|mesh-ancestor
110434226|NCT00973479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110434227|NCT00973479|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110434228|NCT00973479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110434229|NCT00973479|Immunologic Factors|immunologic factors|mesh-ancestor
110434230|NCT00973479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110434231|NCT00973479|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110434232|NCT00973479|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110434233|NCT00973479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110434234|NCT01174043|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110434235|NCT01174043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110434236|NCT01174043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110434237|NCT01174043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110434238|NCT01174043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110434239|NCT04315493|Maleic acid|maleic acid|mesh-list
110434240|NCT04315493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110434241|NCT04315493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110434242|NCT04173871|Snake venom protein C activator|snake venom protein c activator|mesh-list
110434243|NCT04173871|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110434244|NCT04173871|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110434245|NCT04173871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110434246|NCT02862483|Tadalafil|tadalafil|mesh-list
110434247|NCT02862483|Tamsulosin|tamsulosin|mesh-list
110434248|NCT02862483|Vasodilator Agents|vasodilator agents|mesh-ancestor
110434249|NCT02862483|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110434250|NCT02862483|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110434251|NCT02862483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110434252|NCT02862483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110434253|NCT02862483|Urological Agents|urological agents|mesh-ancestor
110434254|NCT02862483|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110434255|NCT02862483|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110434256|NCT02862483|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110434257|NCT02862483|Adrenergic Agents|adrenergic agents|mesh-ancestor
110434258|NCT02862483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110434259|NCT02862483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110434260|NCT02667535|Isosorbide|isosorbide|mesh-list
110434261|NCT02667535|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
110434262|NCT02667535|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
110434263|NCT02667535|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110434264|NCT02667535|Diuretics|diuretics|mesh-ancestor
110434265|NCT02667535|Natriuretic Agents|natriuretic agents|mesh-ancestor
110434266|NCT02667535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110434267|NCT02667535|Vasodilator Agents|vasodilator agents|mesh-ancestor
110434268|NCT02667535|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
110434269|NCT02667535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110434270|NCT04286841|Immunomodulating Agents|immunomodulating agents|mesh-list
110434271|NCT04286841|Immunologic Factors|immunologic factors|mesh-ancestor
110434272|NCT04286841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110434274|NCT00645151|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110434275|NCT00645151|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110434276|NCT00645151|Antimetabolites|antimetabolites|mesh-ancestor
110434277|NCT00645151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110434278|NCT00645151|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110434279|NCT00645151|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110434280|NCT00645151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110434281|NCT00645229|Ziprasidone|ziprasidone|mesh-list
110434282|NCT00645229|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110434283|NCT00645229|Serotonin Agents|serotonin agents|mesh-ancestor
110434284|NCT00645229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110434285|NCT00645229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110434286|NCT00645229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110204997|NCT00168883|Paclitaxel|paclitaxel|mesh-list
110434287|NCT00645229|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110434288|NCT00645229|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110434289|NCT00645229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110434290|NCT00645229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110434291|NCT00645229|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110434292|NCT00645229|Dopamine Agents|dopamine agents|mesh-ancestor
110434293|NCT01172873|Cycloserine|cycloserine|mesh-list
110434294|NCT01172873|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110434295|NCT01172873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110434296|NCT01172873|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110434297|NCT01172873|Antitubercular Agents|antitubercular agents|mesh-ancestor
110434298|NCT01172873|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110434300|NCT01172873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110434301|NCT02886299|Simvastatin|simvastatin|mesh-list
110434302|NCT02886299|Fenofibrate|fenofibrate|mesh-list
110434303|NCT02886299|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110434304|NCT02886299|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110434305|NCT02886299|Antimetabolites|antimetabolites|mesh-ancestor
110434306|NCT02886299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110434307|NCT02886299|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110434308|NCT02886299|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110434309|NCT02886299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110434310|NCT00925600|Denosumab|denosumab|mesh-list
110434311|NCT00925600|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110434312|NCT00925600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110434313|NCT00645307|Paliperidone Palmitate|paliperidone palmitate|mesh-list
110434314|NCT00645307|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110434315|NCT00645307|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110434316|NCT00645307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110434317|NCT00645307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110434318|NCT00645307|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110434319|NCT00645307|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110434320|NCT00645307|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110434321|NCT00645307|Serotonin Agents|serotonin agents|mesh-ancestor
110434322|NCT00645307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110434323|NCT00645307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110434324|NCT00645307|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110434325|NCT00645307|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110434326|NCT00645307|Dopamine Agents|dopamine agents|mesh-ancestor
110434328|NCT02668861|Budesonide|budesonide|mesh-list
110434329|NCT02668861|Vitamins|vitamins|mesh-ancestor
110434330|NCT02668861|Micronutrients|micronutrients|mesh-ancestor
110434331|NCT02668861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110434332|NCT02668861|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110434333|NCT02668861|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110434334|NCT02668861|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110434335|NCT02668861|Autonomic Agents|autonomic agents|mesh-ancestor
110434336|NCT02668861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110434337|NCT02668861|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110434338|NCT02668861|Respiratory System Agents|respiratory system agents|mesh-ancestor
110434339|NCT02668861|Glucocorticoids|glucocorticoids|mesh-ancestor
110434340|NCT02668861|Hormones|hormones|mesh-ancestor
110434341|NCT02668861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110434342|NCT00968253|Cytarabine|cytarabine|mesh-list
110434343|NCT00968253|Dexamethasone|dexamethasone|mesh-list
110434344|NCT00968253|Methylprednisolone|methylprednisolone|mesh-list
110434345|NCT00968253|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110434346|NCT00968253|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110434347|NCT00968253|Prednisolone|prednisolone|mesh-list
110434348|NCT00968253|Prednisolone acetate|prednisolone acetate|mesh-list
110434349|NCT00968253|Cyclophosphamide|cyclophosphamide|mesh-list
110434350|NCT00968253|Doxorubicin|doxorubicin|mesh-list
110434351|NCT00968253|Methotrexate|methotrexate|mesh-list
110434352|NCT00968253|Vincristine|vincristine|mesh-list
110434353|NCT00968253|Everolimus|everolimus|mesh-list
110434354|NCT00968253|Lenograstim|lenograstim|mesh-list
110434355|NCT00968253|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110434356|NCT00968253|Prednisolone phosphate|prednisolone phosphate|mesh-list
110434357|NCT00968253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110434358|NCT00968253|Immunologic Factors|immunologic factors|mesh-ancestor
110434359|NCT00968253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110434360|NCT00968253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110434361|NCT00968253|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110434362|NCT00968253|Alkylating Agents|alkylating agents|mesh-ancestor
110434363|NCT00968253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110434364|NCT00968253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110434365|NCT00968253|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110434366|NCT00968253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110434367|NCT00968253|Antiemetics|antiemetics|mesh-ancestor
110434368|NCT00968253|Autonomic Agents|autonomic agents|mesh-ancestor
110372037|NCT00571740|Leucovorin|leucovorin|mesh-list
110329189|NCT00592111|Cyclophosphamide|cyclophosphamide|mesh-list
110434369|NCT00968253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110434370|NCT00968253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110434371|NCT00968253|Glucocorticoids|glucocorticoids|mesh-ancestor
110434373|NCT00968253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110434374|NCT00968253|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110434375|NCT00968253|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110434376|NCT00968253|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110434377|NCT00968253|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110434378|NCT00968253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110434379|NCT00968253|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110434380|NCT00968253|Abortifacient Agents|abortifacient agents|mesh-ancestor
110434381|NCT00968253|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110434382|NCT00968253|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110434383|NCT00968253|Antimetabolites|antimetabolites|mesh-ancestor
110434384|NCT00968253|Dermatologic Agents|dermatologic agents|mesh-ancestor
110434385|NCT00968253|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110434386|NCT00968253|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110434387|NCT00968253|Antiviral Agents|antiviral agents|mesh-ancestor
110434388|NCT00968253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110434389|NCT00968253|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110434390|NCT00968253|Tubulin Modulators|tubulin modulators|mesh-ancestor
110434391|NCT00968253|Antimitotic Agents|antimitotic agents|mesh-ancestor
110434392|NCT00968253|Mitosis Modulators|mitosis modulators|mesh-ancestor
110434393|NCT00968253|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110434394|NCT00968253|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110434395|NCT00968253|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110434396|NCT00968253|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110434397|NCT00968253|Protective Agents|protective agents|mesh-ancestor
110434398|NCT00646009|Fluticasone|fluticasone|mesh-list
110434399|NCT00646009|Budesonide|budesonide|mesh-list
110434400|NCT00646009|Albuterol|albuterol|mesh-list
110434401|NCT00646009|Formoterol Fumarate|formoterol fumarate|mesh-list
110434402|NCT00646009|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110434403|NCT00646009|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
110434404|NCT00646009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110434405|NCT00646009|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110434406|NCT00646009|Autonomic Agents|autonomic agents|mesh-ancestor
110434407|NCT00646009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110434408|NCT00646009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110434409|NCT00646009|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110434410|NCT00646009|Respiratory System Agents|respiratory system agents|mesh-ancestor
110434411|NCT00646009|Dermatologic Agents|dermatologic agents|mesh-ancestor
110434412|NCT00646009|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110434413|NCT00646009|Glucocorticoids|glucocorticoids|mesh-ancestor
110434414|NCT00646009|Hormones|hormones|mesh-ancestor
110434415|NCT00646009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110434416|NCT00646009|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110434417|NCT00646009|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110434418|NCT00646009|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110434419|NCT00646009|Adrenergic Agents|adrenergic agents|mesh-ancestor
110434420|NCT00646009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110434421|NCT00646009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110434422|NCT00646009|Tocolytic Agents|tocolytic agents|mesh-ancestor
110434423|NCT00646009|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110434424|NCT00646009|Sympathomimetics|sympathomimetics|mesh-ancestor
110434425|NCT00646087|Ketamine|ketamine|mesh-list
110434426|NCT00646087|Analgesics|analgesics|mesh-ancestor
110434427|NCT00646087|Sensory System Agents|sensory system agents|mesh-ancestor
110434428|NCT00646087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110434429|NCT00646087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110434430|NCT00646087|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110434431|NCT00646087|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110434432|NCT00646087|Anesthetics, General|anesthetics, general|mesh-ancestor
110434433|NCT00646087|Anesthetics|anesthetics|mesh-ancestor
110434434|NCT00646087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110434435|NCT00646087|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110434436|NCT00646087|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110434437|NCT00646087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110372052|NCT00571740|Antimetabolites|antimetabolites|mesh-ancestor
110434438|NCT00646087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110434440|NCT04255576|Calcium|calcium|mesh-list
110434441|NCT04255576|Vitamins|vitamins|mesh-ancestor
110434442|NCT04255576|Micronutrients|micronutrients|mesh-ancestor
110434443|NCT04255576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110434444|NCT04255576|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110434445|NCT04255576|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110434447|NCT04255498|Mifepristone|mifepristone|mesh-list
110434448|NCT04255498|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110434449|NCT04255498|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110434450|NCT04255498|Analgesics|analgesics|mesh-ancestor
110434451|NCT04255498|Sensory System Agents|sensory system agents|mesh-ancestor
110434452|NCT04255498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110434453|NCT04255498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110434454|NCT04255498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110434455|NCT04255498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110434456|NCT04255498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110434457|NCT04255498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110434458|NCT04255498|Immunologic Factors|immunologic factors|mesh-ancestor
110434459|NCT04255498|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
110434460|NCT04255498|Abortifacient Agents|abortifacient agents|mesh-ancestor
110434461|NCT04255498|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110434462|NCT04255498|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110434463|NCT04255498|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110434464|NCT04255498|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110434465|NCT04255498|Contraceptive Agents|contraceptive agents|mesh-ancestor
110434466|NCT04255498|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
110434467|NCT04255498|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
110434468|NCT04255498|Hormone Antagonists|hormone antagonists|mesh-ancestor
110434469|NCT04255498|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110434470|NCT04255498|Luteolytic Agents|luteolytic agents|mesh-ancestor
110434471|NCT04255498|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110434472|NCT04255498|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
110434473|NCT02666209|Dexamethasone|dexamethasone|mesh-list
110434474|NCT02666209|Lenalidomide|lenalidomide|mesh-list
110434475|NCT02666209|Bortezomib|bortezomib|mesh-list
110434476|NCT02666209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110434478|NCT02666209|Autonomic Agents|autonomic agents|mesh-ancestor
110434479|NCT02666209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110434480|NCT02666209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110434481|NCT02666209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110434482|NCT02666209|Glucocorticoids|glucocorticoids|mesh-ancestor
110434483|NCT02666209|Hormones|hormones|mesh-ancestor
110434484|NCT02666209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110434485|NCT02666209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110434486|NCT02666209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110434487|NCT02666209|Immunologic Factors|immunologic factors|mesh-ancestor
110434488|NCT02666209|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110434489|NCT02666209|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110434490|NCT02666209|Growth Substances|growth substances|mesh-ancestor
110434491|NCT02666209|Growth Inhibitors|growth inhibitors|mesh-ancestor
110434492|NCT00964743|Cytarabine|cytarabine|mesh-list
110434493|NCT00964743|Sorafenib|sorafenib|mesh-list
110434494|NCT00964743|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110434495|NCT00964743|Antimetabolites|antimetabolites|mesh-ancestor
110434496|NCT00964743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110434497|NCT00964743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110434498|NCT00964743|Antiviral Agents|antiviral agents|mesh-ancestor
110434499|NCT00964743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110434500|NCT00964743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110434501|NCT00964743|Immunologic Factors|immunologic factors|mesh-ancestor
110434502|NCT00964743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110434503|NCT00964743|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110434504|NCT00964743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110434505|NCT02862327|Dexamethasone|dexamethasone|mesh-list
110434506|NCT02862327|Dexamethasone acetate|dexamethasone acetate|mesh-list
110434507|NCT02862327|Ropivacaine|ropivacaine|mesh-list
110434508|NCT02862327|BB 1101|bb 1101|mesh-list
110434509|NCT02862327|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110434510|NCT02862327|Antiemetics|antiemetics|mesh-ancestor
110434511|NCT02862327|Autonomic Agents|autonomic agents|mesh-ancestor
110434512|NCT02862327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110434513|NCT02862327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110434514|NCT02862327|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110434515|NCT02862327|Glucocorticoids|glucocorticoids|mesh-ancestor
110434516|NCT02862327|Hormones|hormones|mesh-ancestor
110434517|NCT02862327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110434518|NCT02862327|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110434519|NCT02862327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110434520|NCT02862327|Protease Inhibitors|protease inhibitors|mesh-ancestor
110434521|NCT02862327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110205054|NCT00045747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110434522|NCT02862327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110434523|NCT02862327|Anesthetics, Local|anesthetics, local|mesh-ancestor
110434524|NCT02862327|Anesthetics|anesthetics|mesh-ancestor
110434525|NCT02862327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110434526|NCT02862327|Sensory System Agents|sensory system agents|mesh-ancestor
110434527|NCT04945720|Durvalumab|durvalumab|mesh-list
110434528|NCT04945720|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110434529|NCT04945720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110434530|NCT04945720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110434531|NCT04945720|Immunologic Factors|immunologic factors|mesh-ancestor
110434532|NCT04945720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110434533|NCT02666365|Cefazolin|cefazolin|mesh-list
110434534|NCT02666365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110434535|NCT02666365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110434536|NCT02666443|Dexamethasone|dexamethasone|mesh-list
110434537|NCT02666443|Dexamethasone acetate|dexamethasone acetate|mesh-list
110434538|NCT02666443|BB 1101|bb 1101|mesh-list
110434539|NCT02666443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110434540|NCT02666443|Antiemetics|antiemetics|mesh-ancestor
110434541|NCT02666443|Autonomic Agents|autonomic agents|mesh-ancestor
110434542|NCT02666443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110434543|NCT02666443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110434544|NCT02666443|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110434545|NCT02666443|Glucocorticoids|glucocorticoids|mesh-ancestor
110434546|NCT02666443|Hormones|hormones|mesh-ancestor
110434547|NCT02666443|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110434548|NCT02666443|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110434549|NCT02666443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110434550|NCT02666443|Protease Inhibitors|protease inhibitors|mesh-ancestor
110434551|NCT02666443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110081477|NCT01636323|Nicotine|nicotine|mesh-list
110434552|NCT02666443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110434553|NCT01130532|Tadalafil|tadalafil|mesh-list
110434554|NCT01130532|Vasodilator Agents|vasodilator agents|mesh-ancestor
110434555|NCT01130532|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110434556|NCT01130532|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110434557|NCT01130532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110434558|NCT01130532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110434559|NCT01130532|Urological Agents|urological agents|mesh-ancestor
110434560|NCT04258306|Resveratrol|resveratrol|mesh-list
110434561|NCT04258306|Antioxidants|antioxidants|mesh-ancestor
110434562|NCT04258306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110434563|NCT04258306|Protective Agents|protective agents|mesh-ancestor
110434564|NCT04258306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110434565|NCT04258306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110434566|NCT04258306|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110434567|NCT00646711|Valproic Acid|valproic acid|mesh-list
110434568|NCT00646711|Anticonvulsants|anticonvulsants|mesh-ancestor
110434569|NCT00646711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110434570|NCT00646711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110434571|NCT00646711|GABA Agents|gaba agents|mesh-ancestor
110434572|NCT00646711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110434573|NCT00646711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110434574|NCT00646711|Antimanic Agents|antimanic agents|mesh-ancestor
110434575|NCT00646711|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110434576|NCT00646711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110434577|NCT00646711|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110434578|NCT00972777|Besifloxacin|besifloxacin|mesh-list
110434579|NCT00972777|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110434580|NCT00972777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110434581|NCT00972777|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110434582|NCT00972777|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110434583|NCT00972777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110434584|NCT00972777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110434585|NCT00972777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110434586|NCT04254874|Interferons|interferons|mesh-list
110434587|NCT04254874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110434588|NCT04254874|Antiviral Agents|antiviral agents|mesh-ancestor
110434589|NCT04254874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110434590|NCT02667223|Bococizumab|bococizumab|mesh-list
110434591|NCT02667223|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110434592|NCT02667223|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110434593|NCT02667223|Antimetabolites|antimetabolites|mesh-ancestor
110434594|NCT02667223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110434595|NCT02667223|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110434596|NCT00918736|Hyaluronic Acid|hyaluronic acid|mesh-list
110434597|NCT00918736|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110434598|NCT00918736|Immunologic Factors|immunologic factors|mesh-ancestor
110434599|NCT00918736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110434600|NCT00918736|Viscosupplements|viscosupplements|mesh-ancestor
110434601|NCT00918736|Protective Agents|protective agents|mesh-ancestor
110434602|NCT02666053|Fostemsavir|fostemsavir|mesh-list
110434603|NCT02666053|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110434604|NCT02666053|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110434605|NCT02666053|Antiviral Agents|antiviral agents|mesh-ancestor
110434606|NCT02666053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110434607|NCT02666053|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110434608|NCT02666053|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110434609|NCT02666053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110434610|NCT04257838|Meropenem|meropenem|mesh-list
110434611|NCT04257838|Tazobactam|tazobactam|mesh-list
110434612|NCT04257838|Piperacillin|piperacillin|mesh-list
110434613|NCT04257838|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
110434614|NCT04257838|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110434615|NCT04257838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110434616|NCT04257838|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110434617|NCT04257838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110434618|NCT04257838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110434619|NCT01172639|Sulfasalazine|sulfasalazine|mesh-list
110434620|NCT01172639|Prednisone|prednisone|mesh-list
110434621|NCT01172639|Methotrexate|methotrexate|mesh-list
110434622|NCT01172639|Leflunomide|leflunomide|mesh-list
110434623|NCT01172639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110434624|NCT01172639|Glucocorticoids|glucocorticoids|mesh-ancestor
110434625|NCT01172639|Hormones|hormones|mesh-ancestor
110434626|NCT01172639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110434627|NCT01172639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110434628|NCT01172639|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110434629|NCT01172639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110434630|NCT01172639|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110434631|NCT01172639|Abortifacient Agents|abortifacient agents|mesh-ancestor
110434632|NCT01172639|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110434633|NCT01172639|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110434634|NCT01172639|Antimetabolites|antimetabolites|mesh-ancestor
110434635|NCT01172639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110434636|NCT01172639|Dermatologic Agents|dermatologic agents|mesh-ancestor
110434637|NCT01172639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110434638|NCT01172639|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110434639|NCT01172639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110434640|NCT01172639|Immunologic Factors|immunologic factors|mesh-ancestor
110434641|NCT01172639|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110434642|NCT01172639|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110434643|NCT01172639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110434644|NCT01172639|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110434645|NCT01172639|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110434646|NCT01172639|Analgesics|analgesics|mesh-ancestor
110434647|NCT01172639|Sensory System Agents|sensory system agents|mesh-ancestor
110434648|NCT01172639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110329209|NCT00592111|Hormones|hormones|mesh-ancestor
110434649|NCT01172639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110434650|NCT01225562|Ticagrelor|ticagrelor|mesh-list
110434651|NCT01225562|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110434652|NCT01225562|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110434653|NCT01225562|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110434654|NCT01225562|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110434655|NCT01225562|Purinergic Agents|purinergic agents|mesh-ancestor
110434656|NCT01225562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110434657|NCT01225562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110434658|NCT01225562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110434659|NCT00925288|Vaccines|vaccines|mesh-list
110434660|NCT00925288|Immunologic Factors|immunologic factors|mesh-ancestor
110434661|NCT00925288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110434662|NCT01143714|Petrolatum|petrolatum|mesh-list
110434663|NCT01143714|Emollients|emollients|mesh-ancestor
110434664|NCT01143714|Dermatologic Agents|dermatologic agents|mesh-ancestor
110434665|NCT04920682|Iodine|iodine|mesh-list
110434666|NCT04920682|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110434667|NCT04920682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110434668|NCT04920682|Trace Elements|trace elements|mesh-ancestor
110434669|NCT04920682|Micronutrients|micronutrients|mesh-ancestor
110434670|NCT04920682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110434671|NCT04174339|Apatinib|apatinib|mesh-list
110434672|NCT04174339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110434673|NCT04174339|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110434674|NCT04174339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110434675|NCT04174339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110434676|NCT00972543|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110434677|NCT00972543|Immunologic Factors|immunologic factors|mesh-ancestor
110434678|NCT00972543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110434679|NCT00925132|Temozolomide|temozolomide|mesh-list
110434680|NCT00925132|Decitabine|decitabine|mesh-list
110434681|NCT00925132|Panobinostat|panobinostat|mesh-list
110434682|NCT00925132|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110434683|NCT00925132|Alkylating Agents|alkylating agents|mesh-ancestor
110434684|NCT00925132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110434685|NCT00925132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110434686|NCT00925132|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110434687|NCT00925132|Antimetabolites|antimetabolites|mesh-ancestor
110434688|NCT00925132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110434689|NCT00925132|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110434690|NCT02862015|Gemcitabine|gemcitabine|mesh-list
110434691|NCT02862015|Folfirinox|folfirinox|mesh-list
110434692|NCT02862015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110434693|NCT02862015|Antimetabolites|antimetabolites|mesh-ancestor
110434694|NCT02862015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110434695|NCT02862015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110434696|NCT01143402|Temozolomide|temozolomide|mesh-list
110434697|NCT01143402|Dacarbazine|dacarbazine|mesh-list
110434698|NCT01143402|Imidazole|imidazole|mesh-list
110434699|NCT01143402|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110434700|NCT01143402|Alkylating Agents|alkylating agents|mesh-ancestor
110372089|NCT04613726|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110434701|NCT01143402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110434702|NCT01143402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110434704|NCT00646945|Nitrous Oxide|nitrous oxide|mesh-list
110434705|NCT00646945|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110434706|NCT00646945|Anesthetics, General|anesthetics, general|mesh-ancestor
110434707|NCT00646945|Anesthetics|anesthetics|mesh-ancestor
110434708|NCT00646945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110434709|NCT00646945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110434710|NCT00646945|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110434711|NCT00646945|Analgesics|analgesics|mesh-ancestor
110434712|NCT00646945|Sensory System Agents|sensory system agents|mesh-ancestor
110434713|NCT00646945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110434715|NCT00629889|Levetiracetam|levetiracetam|mesh-list
110434716|NCT00629889|Analgesics|analgesics|mesh-ancestor
110434717|NCT00629889|Sensory System Agents|sensory system agents|mesh-ancestor
110434718|NCT00629889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110434719|NCT00629889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110434720|NCT00629889|Anticonvulsants|anticonvulsants|mesh-ancestor
110434721|NCT00629889|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110434722|NCT00629889|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110434723|NCT00629889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110434724|NCT00629889|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110434725|NCT00629889|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110434726|NCT00629889|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110434727|NCT00629889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110434728|NCT00629889|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110434729|NCT00629889|Nootropic Agents|nootropic agents|mesh-ancestor
110434730|NCT03381261|Botulinum Toxins|botulinum toxins|mesh-list
110434731|NCT03381261|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110434732|NCT03381261|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110434733|NCT03381261|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110434734|NCT03381261|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110434735|NCT03381261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110434736|NCT03381261|Cholinergic Agents|cholinergic agents|mesh-ancestor
110434737|NCT03381261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110434738|NCT03381261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110434739|NCT03381261|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110434740|NCT03381261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110434741|NCT00630045|Capecitabine|capecitabine|mesh-list
110434742|NCT00630045|Oxaliplatin|oxaliplatin|mesh-list
110434743|NCT00630045|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110434744|NCT00630045|Antimetabolites|antimetabolites|mesh-ancestor
110434745|NCT00630045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110434746|NCT00630045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110434748|NCT02861859|Antiemetics|antiemetics|mesh-ancestor
110434749|NCT02861859|Autonomic Agents|autonomic agents|mesh-ancestor
110434750|NCT02861859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110434751|NCT02861859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110434752|NCT02861859|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110434753|NCT02861859|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110434754|NCT02861859|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110434755|NCT02861859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110434756|NCT02861859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110434757|NCT02861859|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110434758|NCT02861859|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110434759|NCT02861859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110434760|NCT02861859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110434761|NCT02861859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110434762|NCT02861859|Serotonin Agents|serotonin agents|mesh-ancestor
110434763|NCT00647023|Metformin|metformin|mesh-list
110434764|NCT00647023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110434765|NCT00647023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110434766|NCT00924898|Tenofovir|tenofovir|mesh-list
110434767|NCT00924898|Emtricitabine|emtricitabine|mesh-list
110434768|NCT00924898|Efavirenz|efavirenz|mesh-list
110434769|NCT00924898|Antiviral Agents|antiviral agents|mesh-ancestor
110434770|NCT00924898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110434771|NCT00924898|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110434772|NCT00924898|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110434773|NCT00924898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110434774|NCT00924898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110434775|NCT00924898|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110434776|NCT00924898|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110434777|NCT00924898|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110434778|NCT00924898|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110434779|NCT00924898|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110434780|NCT00924898|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110434781|NCT00924898|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110434782|NCT00924898|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110434784|NCT01167192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110434785|NCT00646321|Budesonide|budesonide|mesh-list
110434786|NCT00646321|Formoterol Fumarate|formoterol fumarate|mesh-list
110434787|NCT00646321|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
110434788|NCT00646321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110434789|NCT00646321|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110434790|NCT00646321|Autonomic Agents|autonomic agents|mesh-ancestor
110434791|NCT00646321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110434792|NCT00646321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110434793|NCT00646321|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110434794|NCT00646321|Respiratory System Agents|respiratory system agents|mesh-ancestor
110434795|NCT00646321|Glucocorticoids|glucocorticoids|mesh-ancestor
110434797|NCT00646321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110434798|NCT00646321|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110434799|NCT00646321|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110434800|NCT00646321|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110434801|NCT00646321|Adrenergic Agents|adrenergic agents|mesh-ancestor
110434802|NCT00646321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110434803|NCT00646321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110434804|NCT00647101|Latanoprost|latanoprost|mesh-list
110434805|NCT00647101|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110434806|NCT00647101|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110434807|NCT01166958|Teriparatide|teriparatide|mesh-list
110434808|NCT01166958|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
110434809|NCT01166958|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110434810|NCT01166958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110434811|NCT01166958|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110434812|NCT01166958|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110434813|NCT01166958|Hormone Antagonists|hormone antagonists|mesh-ancestor
110434814|NCT01166958|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110434815|NCT01166958|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110434816|NCT01166958|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110434817|NCT01170221|Linezolid|linezolid|mesh-list
110434818|NCT01170221|Tedizolid|tedizolid|mesh-list
110434819|NCT01170221|Tedizolid phosphate|tedizolid phosphate|mesh-list
110434820|NCT01170221|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110434821|NCT01170221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110434822|NCT01170221|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110434823|NCT01170221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110434824|NCT01170221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110434825|NCT04254640|Cytarabine|cytarabine|mesh-list
110434827|NCT04254640|Aclarubicin|aclarubicin|mesh-list
110434828|NCT04254640|Lenograstim|lenograstim|mesh-list
110434829|NCT04254640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110434830|NCT04254640|Antimetabolites|antimetabolites|mesh-ancestor
110434831|NCT04254640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110434832|NCT04254640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110434833|NCT04254640|Antiviral Agents|antiviral agents|mesh-ancestor
110434834|NCT04254640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110434835|NCT04254640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110434836|NCT04254640|Immunologic Factors|immunologic factors|mesh-ancestor
110434837|NCT04254640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110434838|NCT04254640|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110434839|NCT04254640|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110434840|NCT04254640|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110434841|NCT04254640|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110434842|NCT04254640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110434844|NCT01166646|Halobetasol|halobetasol|mesh-list
110434845|NCT01166646|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110434846|NCT01166646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110434847|NCT01166646|Glucocorticoids|glucocorticoids|mesh-ancestor
110434848|NCT01166646|Hormones|hormones|mesh-ancestor
110434849|NCT01166646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110434850|NCT01166646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110434851|NCT01129284|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
110434853|NCT01129284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110434854|NCT01129284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110434855|NCT00647257|Losartan|losartan|mesh-list
110434856|NCT00647257|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110434857|NCT00647257|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110434858|NCT00647257|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110434859|NCT00647257|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110434860|NCT00647257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110434861|NCT01166178|Vitamin D|vitamin d|mesh-list
110434862|NCT01166178|Zoledronic Acid|zoledronic acid|mesh-list
110434863|NCT01166178|Calcium|calcium|mesh-list
110434864|NCT01166178|Vitamins|vitamins|mesh-ancestor
110434865|NCT01166178|Micronutrients|micronutrients|mesh-ancestor
110434866|NCT01166178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110434867|NCT01166178|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110434868|NCT01166178|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110434869|NCT00924820|Bevacizumab|bevacizumab|mesh-list
110434870|NCT00924820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110434871|NCT00924820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110434872|NCT00924820|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110434873|NCT00924820|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110434874|NCT00924820|Growth Substances|growth substances|mesh-ancestor
110434875|NCT00924820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110434876|NCT00924820|Growth Inhibitors|growth inhibitors|mesh-ancestor
110434877|NCT01225172|Letrozole|letrozole|mesh-list
110434878|NCT01225172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110434879|NCT01225172|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110434880|NCT01225172|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110434881|NCT01225172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110434882|NCT01225172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110434883|NCT01225172|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110434884|NCT01225172|Hormone Antagonists|hormone antagonists|mesh-ancestor
110434885|NCT01225172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110434886|NCT01225172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110434887|NCT02665039|Carboplatin|carboplatin|mesh-list
110434888|NCT02665039|Gemcitabine|gemcitabine|mesh-list
110434889|NCT02665039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110434890|NCT02665039|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110434891|NCT02665039|Antimetabolites|antimetabolites|mesh-ancestor
110434892|NCT02665039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110434893|NCT00647491|Adalimumab|adalimumab|mesh-list
110434894|NCT00647491|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110434895|NCT00647491|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110434896|NCT00647491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110434897|NCT04252456|Leucovorin|leucovorin|mesh-list
110434898|NCT04252456|Folic Acid|folic acid|mesh-list
110434899|NCT04252456|Fluorouracil|fluorouracil|mesh-list
110434900|NCT04252456|Aflibercept|aflibercept|mesh-list
110434901|NCT04252456|Levoleucovorin|levoleucovorin|mesh-list
110434902|NCT04252456|Antimetabolites|antimetabolites|mesh-ancestor
110434903|NCT04252456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110434904|NCT04252456|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110434905|NCT04252456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110434906|NCT04252456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110434907|NCT04252456|Immunologic Factors|immunologic factors|mesh-ancestor
110434908|NCT04252456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110434909|NCT04252456|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110434910|NCT04252456|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110434911|NCT04252456|Growth Substances|growth substances|mesh-ancestor
110434912|NCT04252456|Growth Inhibitors|growth inhibitors|mesh-ancestor
110434913|NCT04252456|Antidotes|antidotes|mesh-ancestor
110434914|NCT04252456|Protective Agents|protective agents|mesh-ancestor
110434915|NCT04252456|Vitamin B Complex|vitamin b complex|mesh-ancestor
110434916|NCT04252456|Vitamins|vitamins|mesh-ancestor
110434917|NCT04252456|Micronutrients|micronutrients|mesh-ancestor
110434918|NCT04252456|Hematinics|hematinics|mesh-ancestor
110434919|NCT02665351|Peramivir|peramivir|mesh-list
110434920|NCT02665351|Antiviral Agents|antiviral agents|mesh-ancestor
110434921|NCT02665351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110434922|NCT02665351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110434923|NCT02665351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110434924|NCT01222520|Amlodipine|amlodipine|mesh-list
110434925|NCT01222520|Telmisartan|telmisartan|mesh-list
110434926|NCT01222520|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
110434927|NCT01222520|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110434928|NCT01222520|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110434929|NCT01222520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110434930|NCT01222520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110434931|NCT01222520|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110434932|NCT01222520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110434933|NCT01222520|Vasodilator Agents|vasodilator agents|mesh-ancestor
110434934|NCT01222520|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110434935|NCT01222520|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110434936|NCT01221350|Thioctic Acid|thioctic acid|mesh-list
110434937|NCT01221350|Antioxidants|antioxidants|mesh-ancestor
110434938|NCT01221350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110434939|NCT01221350|Protective Agents|protective agents|mesh-ancestor
110434940|NCT01221350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110434941|NCT01221350|Vitamin B Complex|vitamin b complex|mesh-ancestor
110434943|NCT01221350|Micronutrients|micronutrients|mesh-ancestor
110434944|NCT00647647|Terbinafine|terbinafine|mesh-list
110434945|NCT00647647|Antifungal Agents|antifungal agents|mesh-ancestor
110434946|NCT00647647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110434947|NCT00647647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110434948|NCT00647647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110434949|NCT01221272|Ranolazine|ranolazine|mesh-list
110434950|NCT01221272|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110434951|NCT01221272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110434952|NCT01221272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110434953|NCT01220414|Naltrexone|naltrexone|mesh-list
110434954|NCT01220414|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110434955|NCT01220414|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110434956|NCT01220414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110434957|NCT01220414|Sensory System Agents|sensory system agents|mesh-ancestor
110372119|NCT04613180|Montelukast|montelukast|mesh-list
110434958|NCT01220414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110434959|NCT01128894|Liraglutide|liraglutide|mesh-list
110434960|NCT01128894|rGLP-1 protein|rglp-1 protein|mesh-list
110434961|NCT01128894|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110434962|NCT01128894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110434963|NCT01128894|Incretins|incretins|mesh-ancestor
110434964|NCT01128894|Hormones|hormones|mesh-ancestor
110434965|NCT01128894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110434966|NCT01220180|Pregabalin|pregabalin|mesh-list
110434967|NCT01220180|Analgesics|analgesics|mesh-ancestor
110434968|NCT01220180|Sensory System Agents|sensory system agents|mesh-ancestor
110434969|NCT01220180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110434970|NCT01220180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110434971|NCT01220180|Anticonvulsants|anticonvulsants|mesh-ancestor
110434972|NCT01220180|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110434973|NCT01220180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110434974|NCT01220180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110434975|NCT01220180|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110434976|NCT01220180|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110434977|NCT01220180|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110434978|NCT01220180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110434979|NCT01220180|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110434980|NCT01220024|Bupivacaine|bupivacaine|mesh-list
110434981|NCT01220024|Anesthetics, Local|anesthetics, local|mesh-ancestor
110434982|NCT01220024|Anesthetics|anesthetics|mesh-ancestor
110434983|NCT01220024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110434984|NCT01220024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110434985|NCT01220024|Sensory System Agents|sensory system agents|mesh-ancestor
110434986|NCT01220024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110434987|NCT00625248|Anticoagulants|anticoagulants|mesh-list
110434988|NCT00625248|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
110434989|NCT01143090|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
110434990|NCT01143090|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110434991|NCT01143090|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110434992|NCT01143090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110434993|NCT01143090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110434994|NCT01143090|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110434995|NCT01143090|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
110434996|NCT01143090|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110434997|NCT01143090|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110434998|NCT01143090|Adrenergic Agents|adrenergic agents|mesh-ancestor
110434999|NCT01143090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110435000|NCT01143090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110435001|NCT01143090|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110435002|NCT01143090|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110435003|NCT01143090|Serotonin Agents|serotonin agents|mesh-ancestor
110435004|NCT01143090|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110435005|NCT01143090|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110435006|NCT01143090|Dopamine Agents|dopamine agents|mesh-ancestor
110435007|NCT05125146|Trazodone|trazodone|mesh-list
110435008|NCT05125146|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110435009|NCT05125146|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110435010|NCT05125146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110435011|NCT05125146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110435012|NCT05125146|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110435013|NCT05125146|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110435014|NCT05125146|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110435015|NCT05125146|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110435016|NCT05125146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110435017|NCT05125146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110435018|NCT05125146|Serotonin Agents|serotonin agents|mesh-ancestor
110435019|NCT05125146|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110435020|NCT05125146|Antidepressive Agents|antidepressive agents|mesh-ancestor
110435021|NCT01165554|Flutemetamol|flutemetamol|mesh-list
110435022|NCT01165554|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110372133|NCT00571935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110435023|NCT01165554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110435025|NCT01218308|Immunologic Factors|immunologic factors|mesh-ancestor
110435026|NCT01218308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110435027|NCT02887976|Methylprednisolone|methylprednisolone|mesh-list
110435028|NCT02887976|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110435029|NCT02887976|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110435030|NCT02887976|Prednisolone|prednisolone|mesh-list
110435031|NCT02887976|Prednisolone acetate|prednisolone acetate|mesh-list
110435032|NCT02887976|Abiraterone Acetate|abiraterone acetate|mesh-list
110435033|NCT02887976|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110435034|NCT02887976|Prednisolone phosphate|prednisolone phosphate|mesh-list
110435035|NCT02887976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110435036|NCT02887976|Antiemetics|antiemetics|mesh-ancestor
110435037|NCT02887976|Autonomic Agents|autonomic agents|mesh-ancestor
110435038|NCT02887976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110435039|NCT02887976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110435040|NCT02887976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110435041|NCT02887976|Glucocorticoids|glucocorticoids|mesh-ancestor
110435042|NCT02887976|Hormones|hormones|mesh-ancestor
110435043|NCT02887976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110435044|NCT02887976|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110435045|NCT02887976|Protective Agents|protective agents|mesh-ancestor
110435046|NCT02887976|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110435047|NCT02887976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110435048|NCT02887976|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110435049|NCT02887976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110435050|NCT02887976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110435051|NCT02887976|Hormone Antagonists|hormone antagonists|mesh-ancestor
110435052|NCT02887976|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110435053|NCT01165320|Caspofungin|caspofungin|mesh-list
110435054|NCT01165320|Antifungal Agents|antifungal agents|mesh-ancestor
110435055|NCT01165320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110435056|NCT01165320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110435057|NCT01165320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110435058|NCT01217606|Timolol|timolol|mesh-list
110435059|NCT01217606|Brimonidine Tartrate|brimonidine tartrate|mesh-list
110435060|NCT01217606|Bimatoprost|bimatoprost|mesh-list
110229713|NCT00314743|Autonomic Agents|autonomic agents|mesh-ancestor
110435061|NCT01217606|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110435062|NCT01217606|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110435063|NCT01217606|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110435064|NCT01217606|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110435065|NCT01217606|Adrenergic Agents|adrenergic agents|mesh-ancestor
110435066|NCT01217606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110435067|NCT01217606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110435068|NCT01217606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110435069|NCT01217606|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110435070|NCT01217606|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110435071|NCT01217606|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110435072|NCT01217606|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110435073|NCT01217606|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110435074|NCT01128114|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110435075|NCT01128114|Antidepressive Agents|antidepressive agents|mesh-ancestor
110435076|NCT01128114|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110435077|NCT01128114|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110435078|NCT01128114|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110435079|NCT01128114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110435080|NCT01128114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110435082|NCT01217060|Docetaxel|docetaxel|mesh-list
110435083|NCT01217060|Fluorouracil|fluorouracil|mesh-list
110435084|NCT01217060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110435085|NCT01217060|Antiemetics|antiemetics|mesh-ancestor
110435086|NCT01217060|Autonomic Agents|autonomic agents|mesh-ancestor
110435087|NCT01217060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110435088|NCT01217060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110435089|NCT01217060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110435090|NCT01217060|Glucocorticoids|glucocorticoids|mesh-ancestor
110435091|NCT01217060|Hormones|hormones|mesh-ancestor
110435092|NCT01217060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110435093|NCT01217060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110435094|NCT01217060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110435095|NCT01217060|Tubulin Modulators|tubulin modulators|mesh-ancestor
110435096|NCT01217060|Antimitotic Agents|antimitotic agents|mesh-ancestor
110435097|NCT01217060|Mitosis Modulators|mitosis modulators|mesh-ancestor
110435098|NCT01217060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110435099|NCT01217060|Antimetabolites|antimetabolites|mesh-ancestor
110435100|NCT01217060|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110435101|NCT01217060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110435102|NCT01217060|Immunologic Factors|immunologic factors|mesh-ancestor
110435103|NCT01170065|Nintedanib|nintedanib|mesh-list
110435104|NCT01170065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110435105|NCT01170065|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110435106|NCT01170065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110435107|NCT01170065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110435108|NCT02885922|Hypoglycemic Agents|hypoglycemic agents|mesh-list
110435109|NCT02885922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110435110|NCT00966693|Thalidomide|thalidomide|mesh-list
110435111|NCT00966693|Dexamethasone|dexamethasone|mesh-list
110435112|NCT00966693|Dexamethasone acetate|dexamethasone acetate|mesh-list
110435113|NCT00966693|Lenalidomide|lenalidomide|mesh-list
110435114|NCT00966693|Ichthammol|ichthammol|mesh-list
110435115|NCT00966693|BB 1101|bb 1101|mesh-list
110435116|NCT00966693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110435117|NCT00966693|Antiemetics|antiemetics|mesh-ancestor
110435118|NCT00966693|Autonomic Agents|autonomic agents|mesh-ancestor
110435119|NCT00966693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110435120|NCT00966693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110435121|NCT00966693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110435122|NCT00966693|Glucocorticoids|glucocorticoids|mesh-ancestor
110435123|NCT00966693|Hormones|hormones|mesh-ancestor
110435124|NCT00966693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110435125|NCT00966693|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110435126|NCT00966693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110435127|NCT00966693|Immunologic Factors|immunologic factors|mesh-ancestor
110435128|NCT00966693|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110435129|NCT00966693|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110435130|NCT00966693|Growth Substances|growth substances|mesh-ancestor
110435131|NCT00966693|Growth Inhibitors|growth inhibitors|mesh-ancestor
110435132|NCT00966693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110435133|NCT00966693|Leprostatic Agents|leprostatic agents|mesh-ancestor
110435134|NCT00966693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110435135|NCT00966693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110435136|NCT00966693|Protease Inhibitors|protease inhibitors|mesh-ancestor
110435137|NCT00966693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110435138|NCT00966693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110435139|NCT00966693|Dermatologic Agents|dermatologic agents|mesh-ancestor
110435140|NCT01215968|Dulaglutide|dulaglutide|mesh-list
110435141|NCT01215968|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110435142|NCT01215968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110435143|NCT02663713|Clopidogrel|clopidogrel|mesh-list
110435144|NCT02663713|Ticagrelor|ticagrelor|mesh-list
110435145|NCT02663713|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110435146|NCT02663713|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110435147|NCT02663713|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110435149|NCT02663713|Purinergic Agents|purinergic agents|mesh-ancestor
110435150|NCT02663713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110435151|NCT02663713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110435152|NCT02663713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110435153|NCT02664649|Apixaban|apixaban|mesh-list
110435154|NCT02664649|Factor Xa Inhibitors|factor xa inhibitors|mesh-list
110435155|NCT02664649|Anticoagulants|anticoagulants|mesh-list
110435156|NCT02664649|Antithrombins|antithrombins|mesh-ancestor
110435157|NCT02664649|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110564658|NCT04971954|Nicotine|nicotine|mesh-list
110435158|NCT02664649|Protease Inhibitors|protease inhibitors|mesh-ancestor
110435159|NCT02664649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110435160|NCT02664649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110435162|NCT02664493|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110435163|NCT02664493|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110435164|NCT02664493|Prednisolone|prednisolone|mesh-list
110435165|NCT02664493|Prednisolone acetate|prednisolone acetate|mesh-list
110435166|NCT02664493|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110435167|NCT02664493|Prednisolone phosphate|prednisolone phosphate|mesh-list
110435168|NCT02664493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110435169|NCT02664493|Antiemetics|antiemetics|mesh-ancestor
110435170|NCT02664493|Autonomic Agents|autonomic agents|mesh-ancestor
110435171|NCT02664493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110435172|NCT02664493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110435173|NCT02664493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110435174|NCT02664493|Glucocorticoids|glucocorticoids|mesh-ancestor
110435175|NCT02664493|Hormones|hormones|mesh-ancestor
110435176|NCT02664493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110435177|NCT02664493|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110435178|NCT02664493|Protective Agents|protective agents|mesh-ancestor
110435179|NCT02664493|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110435180|NCT02664493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110435181|NCT00963807|Deoxyglucose|deoxyglucose|mesh-list
110435182|NCT00963807|Alovudine|alovudine|mesh-list
110435183|NCT00963807|Dideoxynucleosides|dideoxynucleosides|mesh-list
110435184|NCT00963807|Cisplatin|cisplatin|mesh-list
110435185|NCT00963807|Docetaxel|docetaxel|mesh-list
110435186|NCT00963807|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110435187|NCT00963807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110435188|NCT00963807|Tubulin Modulators|tubulin modulators|mesh-ancestor
110435189|NCT00963807|Antimitotic Agents|antimitotic agents|mesh-ancestor
110435190|NCT00963807|Mitosis Modulators|mitosis modulators|mesh-ancestor
110435191|NCT00963807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110435192|NCT00963807|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110435193|NCT00963807|Antimetabolites|antimetabolites|mesh-ancestor
110435194|NCT00963807|Antiviral Agents|antiviral agents|mesh-ancestor
110435195|NCT00963807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110435196|NCT00963807|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110435197|NCT00963807|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110435198|NCT00963807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110435199|NCT01142466|Interferons|interferons|mesh-list
110435200|NCT01142466|Interferon-beta|interferon-beta|mesh-list
110435201|NCT01142466|Interferon beta-1a|interferon beta-1a|mesh-list
110435202|NCT01142466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110435203|NCT01142466|Antiviral Agents|antiviral agents|mesh-ancestor
110435204|NCT01142466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110435205|NCT01142466|Immunologic Factors|immunologic factors|mesh-ancestor
110435206|NCT01142466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110435207|NCT01142466|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110435208|NCT00648505|Metformin|metformin|mesh-list
110435209|NCT00648505|Glipizide|glipizide|mesh-list
110435210|NCT00648505|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110435211|NCT00648505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110435212|NCT01215734|Vaccines|vaccines|mesh-list
110435213|NCT01215734|Immunologic Factors|immunologic factors|mesh-ancestor
110435214|NCT01215734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110435215|NCT04172311|Levetiracetam|levetiracetam|mesh-list
110435216|NCT04172311|Anticonvulsants|anticonvulsants|mesh-ancestor
110435217|NCT04172311|Nootropic Agents|nootropic agents|mesh-ancestor
110435218|NCT02863185|Atorvastatin|atorvastatin|mesh-list
110435219|NCT02863185|Pitavastatin|pitavastatin|mesh-list
110435220|NCT02863185|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110435221|NCT02863185|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110435222|NCT02863185|Antimetabolites|antimetabolites|mesh-ancestor
110435223|NCT02863185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110082165|NCT01639326|Irinotecan|irinotecan|mesh-list
110435224|NCT02863185|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110435225|NCT02863185|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110435226|NCT02863185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110435227|NCT00647881|Paroxetine|paroxetine|mesh-list
110435228|NCT00647881|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110372157|NCT00568347|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110435229|NCT00647881|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110435230|NCT00647881|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110564659|NCT04971954|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110435231|NCT00647881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110435232|NCT00647881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110435233|NCT00647881|Serotonin Agents|serotonin agents|mesh-ancestor
110435234|NCT00647881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110435235|NCT00647881|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110435236|NCT00647881|Antidepressive Agents|antidepressive agents|mesh-ancestor
110435237|NCT00647881|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110435238|NCT00647881|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110435239|NCT00647881|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110435240|NCT00647881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110435241|NCT04174261|Clopidogrel|clopidogrel|mesh-list
110435242|NCT04174261|Ticagrelor|ticagrelor|mesh-list
110435243|NCT04174261|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110435244|NCT04174261|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110435245|NCT04174261|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110435246|NCT04174261|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110435247|NCT04174261|Purinergic Agents|purinergic agents|mesh-ancestor
110435248|NCT04174261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110435249|NCT04174261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110435250|NCT04174261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110435251|NCT00971997|Isophane insulin, insulin lispro drug combination 50:50|isophane insulin, insulin lispro drug combination 50:50|mesh-list
110435252|NCT00971997|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110435253|NCT00971997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110435254|NCT00910741|Gemcitabine|gemcitabine|mesh-list
110435255|NCT00910741|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110435256|NCT00910741|Antimetabolites|antimetabolites|mesh-ancestor
110435257|NCT00910741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110435258|NCT00910741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110435260|NCT00647959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110435261|NCT00647959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110435262|NCT00647959|Antimalarials|antimalarials|mesh-ancestor
110435263|NCT00647959|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110435264|NCT00647959|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110435265|NCT03602235|Ascorbic Acid|ascorbic acid|mesh-list
110435266|NCT03602235|Melphalan|melphalan|mesh-list
110435267|NCT03602235|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110435268|NCT03602235|Alkylating Agents|alkylating agents|mesh-ancestor
110435269|NCT03602235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110329268|NCT00491790|Hormone Antagonists|hormone antagonists|mesh-ancestor
110435270|NCT03602235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110435271|NCT03602235|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110435272|NCT03602235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110435273|NCT03602235|Immunologic Factors|immunologic factors|mesh-ancestor
110435274|NCT03602235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110435275|NCT03602235|Antioxidants|antioxidants|mesh-ancestor
110435276|NCT03602235|Protective Agents|protective agents|mesh-ancestor
110435277|NCT03602235|Vitamins|vitamins|mesh-ancestor
110435278|NCT03602235|Micronutrients|micronutrients|mesh-ancestor
110435279|NCT00648583|Ondansetron|ondansetron|mesh-list
110435280|NCT00648583|Antiemetics|antiemetics|mesh-ancestor
110435281|NCT00648583|Autonomic Agents|autonomic agents|mesh-ancestor
110435282|NCT00648583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110435283|NCT00648583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110435284|NCT00648583|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110435285|NCT00648583|Antipruritics|antipruritics|mesh-ancestor
110435286|NCT00648583|Dermatologic Agents|dermatologic agents|mesh-ancestor
110435287|NCT00648583|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110435288|NCT00648583|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110435289|NCT00648583|Serotonin Agents|serotonin agents|mesh-ancestor
110435290|NCT00648583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110372164|NCT00568347|Glucocorticoids|glucocorticoids|mesh-ancestor
110435291|NCT00648583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110435292|NCT03809481|Danaparoid|danaparoid|mesh-list
110435293|NCT03809481|Argatroban|argatroban|mesh-list
110435294|NCT03809481|Antithrombins|antithrombins|mesh-ancestor
110435295|NCT03809481|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110435296|NCT03809481|Protease Inhibitors|protease inhibitors|mesh-ancestor
110435297|NCT03809481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110082241|NCT01639898|Lenalidomide|lenalidomide|mesh-list
110435298|NCT03809481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110435299|NCT03809481|Anticoagulants|anticoagulants|mesh-ancestor
110435300|NCT03809481|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110435301|NCT03809481|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110435302|NCT03809481|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110435303|NCT00649129|Oxybutynin|oxybutynin|mesh-list
110435304|NCT00649129|Parasympatholytics|parasympatholytics|mesh-ancestor
110435305|NCT00649129|Autonomic Agents|autonomic agents|mesh-ancestor
110435306|NCT00649129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110435307|NCT00649129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110435308|NCT00649129|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110435309|NCT00649129|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110435310|NCT00649129|Cholinergic Agents|cholinergic agents|mesh-ancestor
110435311|NCT00649129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110435312|NCT00649129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110435313|NCT00649129|Urological Agents|urological agents|mesh-ancestor
110435314|NCT01127646|Methylphenidate|methylphenidate|mesh-list
110435315|NCT01127646|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
110435316|NCT01127646|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110435317|NCT01127646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110435318|NCT01127646|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110435319|NCT01127646|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110435320|NCT01127646|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110435321|NCT01127646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110435322|NCT01127646|Dopamine Agents|dopamine agents|mesh-ancestor
110435323|NCT01127646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110435324|NCT01127646|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110435325|NCT01127646|Adrenergic Agents|adrenergic agents|mesh-ancestor
110435326|NCT02660047|Liraglutide|liraglutide|mesh-list
110435327|NCT02660047|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110435328|NCT02660047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110435329|NCT02660047|Incretins|incretins|mesh-ancestor
110435330|NCT02660047|Hormones|hormones|mesh-ancestor
110435331|NCT02660047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110435332|NCT00648661|Dexetimide|dexetimide|mesh-list
110435333|NCT00648661|Citalopram|citalopram|mesh-list
110435334|NCT00648661|Escitalopram|escitalopram|mesh-list
110435335|NCT00648661|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110435336|NCT00648661|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110435337|NCT00648661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110435338|NCT00648661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110435339|NCT00648661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110435340|NCT00648661|Serotonin Agents|serotonin agents|mesh-ancestor
110435341|NCT00648661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110435342|NCT00648661|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110435343|NCT00648661|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110435344|NCT00648661|Parasympatholytics|parasympatholytics|mesh-ancestor
110435345|NCT00648661|Autonomic Agents|autonomic agents|mesh-ancestor
110435346|NCT00648661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110435347|NCT00648661|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110435348|NCT00648661|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110435349|NCT00648661|Cholinergic Agents|cholinergic agents|mesh-ancestor
110435350|NCT00648661|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110435351|NCT00648661|Antidepressive Agents|antidepressive agents|mesh-ancestor
110435352|NCT00648661|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110435353|NCT05367414|Tea Tree Oil|tea tree oil|mesh-list
110435354|NCT05367414|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110435355|NCT05367414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110435356|NCT04171687|Clopidogrel|clopidogrel|mesh-list
110435357|NCT04171687|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110435358|NCT04171687|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110435359|NCT04171687|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110435360|NCT04171687|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110435361|NCT04171687|Purinergic Agents|purinergic agents|mesh-ancestor
110435362|NCT04171687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110435363|NCT04171687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110435364|NCT04171687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110435365|NCT00648817|Tenofovir|tenofovir|mesh-list
110435366|NCT00648817|Antiviral Agents|antiviral agents|mesh-ancestor
110435367|NCT00648817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110435368|NCT00648817|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110435369|NCT00648817|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110435370|NCT00648817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110435371|NCT00648817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110435373|NCT00648817|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110435375|NCT02663323|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110564663|NCT04971954|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110435376|NCT02663323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110435377|NCT02663323|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110435378|NCT02663323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110435379|NCT02663323|Antifungal Agents|antifungal agents|mesh-ancestor
110435380|NCT02663323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110435381|NCT02663323|Immunologic Factors|immunologic factors|mesh-ancestor
110435382|NCT02663323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110435383|NCT01215188|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110435384|NCT01215188|Immunologic Factors|immunologic factors|mesh-ancestor
110435385|NCT01215188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110435386|NCT04285281|Gabapentin|gabapentin|mesh-list
110435387|NCT04285281|Analgesics|analgesics|mesh-ancestor
110435388|NCT04285281|Sensory System Agents|sensory system agents|mesh-ancestor
110435389|NCT04285281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110435390|NCT04285281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110435391|NCT04285281|Anticonvulsants|anticonvulsants|mesh-ancestor
110435392|NCT04285281|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110435393|NCT04285281|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110435394|NCT04285281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110435395|NCT04285281|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110435396|NCT04285281|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110435397|NCT04285281|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110435398|NCT04285281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110435399|NCT04285281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110435400|NCT04285281|Antimanic Agents|antimanic agents|mesh-ancestor
110435401|NCT02659657|Interleukin-2|interleukin-2|mesh-list
110435402|NCT02659657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110435403|NCT02659657|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110435404|NCT02659657|Analgesics|analgesics|mesh-ancestor
110435405|NCT02659657|Sensory System Agents|sensory system agents|mesh-ancestor
110435406|NCT02659657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110435407|NCT02659657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110435408|NCT02659891|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110435409|NCT02659891|Immunologic Factors|immunologic factors|mesh-ancestor
110435410|NCT02659891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110435412|NCT00648193|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110435413|NCT00648193|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110435414|NCT00648193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110435415|NCT00648193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110435416|NCT00648193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110435418|NCT00648193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110435419|NCT00648193|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110435420|NCT00648193|Antidepressive Agents|antidepressive agents|mesh-ancestor
110435421|NCT00648193|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110435422|NCT00648193|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110435423|NCT00648193|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110435424|NCT00648193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110435425|NCT01215032|Metformin|metformin|mesh-list
110435426|NCT01215032|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110435427|NCT01215032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110435428|NCT02663089|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110435429|NCT02664103|Cyclophosphamide|cyclophosphamide|mesh-list
110435430|NCT02664103|Capecitabine|capecitabine|mesh-list
110435431|NCT02664103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110435432|NCT02664103|Immunologic Factors|immunologic factors|mesh-ancestor
110435433|NCT02664103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110435434|NCT02664103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110435435|NCT02664103|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110435436|NCT02664103|Alkylating Agents|alkylating agents|mesh-ancestor
110435437|NCT02664103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110435438|NCT02664103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110435439|NCT02664103|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110435440|NCT02664103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110435441|NCT02664103|Antimetabolites|antimetabolites|mesh-ancestor
110435442|NCT02662855|Favipiravir|favipiravir|mesh-list
110435443|NCT02662855|Antiviral Agents|antiviral agents|mesh-ancestor
110435444|NCT02662855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110435446|NCT00648271|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110435447|NCT00648271|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110435448|NCT00648271|Sympatholytics|sympatholytics|mesh-ancestor
110435449|NCT00648271|Autonomic Agents|autonomic agents|mesh-ancestor
110435450|NCT00648271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110435451|NCT00648271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110435452|NCT00648271|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110435453|NCT00648271|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110435454|NCT00648271|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110435455|NCT00648271|Adrenergic Agents|adrenergic agents|mesh-ancestor
110435456|NCT00648271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110435457|NCT00648271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110435458|NCT00648349|Rabeprazole|rabeprazole|mesh-list
110435459|NCT00648349|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110435460|NCT00648349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110435461|NCT00648349|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110435462|NCT00648349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110435463|NCT00648349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110435464|NCT00649207|Veliparib|veliparib|mesh-list
110435465|NCT00649207|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110435466|NCT00649207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110435467|NCT00649207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110435468|NCT00649207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110435469|NCT00920686|Sumatriptan|sumatriptan|mesh-list
110435470|NCT00920686|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110205305|NCT00170989|Valsartan|valsartan|mesh-list
110435471|NCT00920686|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110435472|NCT00920686|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110435473|NCT00920686|Serotonin Agents|serotonin agents|mesh-ancestor
110435474|NCT00920686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110435475|NCT00920686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110435476|NCT00920686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110435477|NCT00648427|Paroxetine|paroxetine|mesh-list
110435478|NCT00648427|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110435479|NCT00648427|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110435480|NCT00648427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110435481|NCT00648427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110435483|NCT00648427|Serotonin Agents|serotonin agents|mesh-ancestor
110435484|NCT00648427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110435485|NCT00648427|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110435486|NCT00648427|Antidepressive Agents|antidepressive agents|mesh-ancestor
110435487|NCT00648427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110435488|NCT00648427|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110435489|NCT00648427|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110435490|NCT00648427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110435491|NCT04170751|Vasopressins|vasopressins|mesh-list
110435492|NCT04170751|Arginine Vasopressin|arginine vasopressin|mesh-list
110435493|NCT04170751|Norepinephrine|norepinephrine|mesh-list
110435494|NCT04170751|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110435495|NCT04170751|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110435496|NCT04170751|Adrenergic Agents|adrenergic agents|mesh-ancestor
110435497|NCT04170751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110435498|NCT04170751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110435499|NCT04170751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110435500|NCT04170751|Sympathomimetics|sympathomimetics|mesh-ancestor
110435501|NCT04170751|Autonomic Agents|autonomic agents|mesh-ancestor
110435502|NCT04170751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110435503|NCT04170751|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110435504|NCT04170751|Hemostatics|hemostatics|mesh-ancestor
110435505|NCT04170751|Coagulants|coagulants|mesh-ancestor
110435506|NCT04170751|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
110435507|NCT04170751|Natriuretic Agents|natriuretic agents|mesh-ancestor
110435508|NCT02659033|Ceftriaxone|ceftriaxone|mesh-list
110435509|NCT02659033|Cephalosporins|cephalosporins|mesh-list
110435511|NCT02659033|Cefoxitin|cefoxitin|mesh-list
110435512|NCT02659033|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110435513|NCT02659033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110435514|NCT04170595|Trastuzumab|trastuzumab|mesh-list
110435515|NCT04170595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110435516|NCT04170595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110435517|NCT00648973|Diphenhydramine|diphenhydramine|mesh-list
110435519|NCT00648973|Pseudoephedrine|pseudoephedrine|mesh-list
110435520|NCT00648973|Ephedrine|ephedrine|mesh-list
110435521|NCT00648973|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110435522|NCT00648973|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110435523|NCT00648973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110435524|NCT00648973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110435525|NCT00648973|Anesthetics, Local|anesthetics, local|mesh-ancestor
110435526|NCT00648973|Anesthetics|anesthetics|mesh-ancestor
110435527|NCT00648973|Sensory System Agents|sensory system agents|mesh-ancestor
110205321|NCT00055484|Zonisamide|zonisamide|mesh-list
110435528|NCT00648973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110435529|NCT00648973|Antiemetics|antiemetics|mesh-ancestor
110435530|NCT00648973|Autonomic Agents|autonomic agents|mesh-ancestor
110435531|NCT00648973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110435532|NCT00648973|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110435533|NCT00648973|Histamine Antagonists|histamine antagonists|mesh-ancestor
110435534|NCT00648973|Histamine Agents|histamine agents|mesh-ancestor
110435535|NCT00648973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110435536|NCT00648973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110435537|NCT00648973|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110435538|NCT00648973|Antipruritics|antipruritics|mesh-ancestor
110435539|NCT00648973|Dermatologic Agents|dermatologic agents|mesh-ancestor
110435540|NCT00648973|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110435541|NCT00648973|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110435542|NCT00648973|Respiratory System Agents|respiratory system agents|mesh-ancestor
110435543|NCT00648973|Nasal Decongestants|nasal decongestants|mesh-ancestor
110435544|NCT00648973|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110435545|NCT00648973|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110435546|NCT00648973|Sympathomimetics|sympathomimetics|mesh-ancestor
110435547|NCT00648973|Adrenergic Agents|adrenergic agents|mesh-ancestor
110435548|NCT02662309|Atezolizumab|atezolizumab|mesh-list
110435549|NCT02662309|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110435550|NCT02662309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110435551|NCT02662309|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110435552|NCT02662309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110435553|NCT04032691|Clonidine|clonidine|mesh-list
110435554|NCT04032691|Analgesics|analgesics|mesh-ancestor
110435555|NCT04032691|Sensory System Agents|sensory system agents|mesh-ancestor
110435556|NCT04032691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110435557|NCT04032691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110435558|NCT04032691|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110435559|NCT04032691|Sympatholytics|sympatholytics|mesh-ancestor
110435560|NCT04032691|Autonomic Agents|autonomic agents|mesh-ancestor
110435561|NCT04032691|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110435562|NCT04032691|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110435563|NCT04032691|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110435564|NCT04032691|Adrenergic Agents|adrenergic agents|mesh-ancestor
110435565|NCT04032691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110435566|NCT04032691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110435568|NCT02658799|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110435569|NCT02658799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110435570|NCT02658799|Analgesics|analgesics|mesh-ancestor
110435571|NCT02658799|Sensory System Agents|sensory system agents|mesh-ancestor
110435572|NCT02658799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110435573|NCT02658799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110435574|NCT02658799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110435575|NCT02658799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110435576|NCT02658799|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110435577|NCT02658799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110435578|NCT02658799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110435579|NCT02655757|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110435580|NCT02655757|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110435581|NCT02655757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110435583|NCT02655757|Hormones|hormones|mesh-ancestor
110435584|NCT02655757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110435585|NCT02655757|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110435586|NCT02655757|Protease Inhibitors|protease inhibitors|mesh-ancestor
110435587|NCT02655757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110435588|NCT02655757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110435589|NCT01214720|Bevacizumab|bevacizumab|mesh-list
110435590|NCT01214720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110082564|NCT01650441|Hormones|hormones|mesh-ancestor
110435591|NCT01214720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110435592|NCT01214720|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110435593|NCT01214720|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110435594|NCT01214720|Growth Substances|growth substances|mesh-ancestor
110435595|NCT01214720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110435596|NCT01214720|Growth Inhibitors|growth inhibitors|mesh-ancestor
110435597|NCT02655913|Ascorbic Acid|ascorbic acid|mesh-list
110435598|NCT02655913|Vitamins|vitamins|mesh-ancestor
110435599|NCT02655913|Micronutrients|micronutrients|mesh-ancestor
110435600|NCT02655913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110435601|NCT02655913|Antioxidants|antioxidants|mesh-ancestor
110435602|NCT02655913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110435603|NCT02655913|Protective Agents|protective agents|mesh-ancestor
110435604|NCT00649285|Nitrofurantoin|nitrofurantoin|mesh-list
110435605|NCT00649285|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110435606|NCT00649285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110435607|NCT00649285|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110435608|NCT04169269|Enoxaparin|enoxaparin|mesh-list
110435609|NCT04169269|Rivaroxaban|rivaroxaban|mesh-list
110435610|NCT04169269|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110435611|NCT04169269|Antithrombins|antithrombins|mesh-ancestor
110435612|NCT04169269|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110435613|NCT04169269|Protease Inhibitors|protease inhibitors|mesh-ancestor
110435614|NCT04169269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110435615|NCT04169269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110435616|NCT04169269|Anticoagulants|anticoagulants|mesh-ancestor
110435617|NCT04169269|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110435618|NCT04169269|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110435619|NCT02661373|Cobicistat|cobicistat|mesh-list
110435620|NCT02661373|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110435621|NCT02661373|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110435622|NCT02661373|Antiviral Agents|antiviral agents|mesh-ancestor
110435623|NCT02661373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110435624|NCT02661373|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110435625|NCT02661373|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110435626|NCT02661373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110435627|NCT02661373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110435628|NCT00649051|Metolazone|metolazone|mesh-list
110435629|NCT00649051|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110435630|NCT00649051|Diuretics|diuretics|mesh-ancestor
110435631|NCT00649051|Natriuretic Agents|natriuretic agents|mesh-ancestor
110205363|NCT00055523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110435632|NCT00649051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110435633|NCT00649051|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110435634|NCT00649051|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110435635|NCT00649051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110435636|NCT04168879|Bupivacaine|bupivacaine|mesh-list
110435637|NCT04168879|Anesthetics, Local|anesthetics, local|mesh-ancestor
110435638|NCT04168879|Anesthetics|anesthetics|mesh-ancestor
110435639|NCT04168879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110435640|NCT04168879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110435641|NCT04168879|Sensory System Agents|sensory system agents|mesh-ancestor
110435642|NCT04168879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110435643|NCT00649987|Albuterol|albuterol|mesh-list
110435644|NCT00649987|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110435645|NCT00649987|Autonomic Agents|autonomic agents|mesh-ancestor
110435646|NCT00649987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110435647|NCT00649987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110435648|NCT00649987|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110435649|NCT00649987|Respiratory System Agents|respiratory system agents|mesh-ancestor
110435650|NCT00649987|Tocolytic Agents|tocolytic agents|mesh-ancestor
110435651|NCT00649987|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110435652|NCT00649987|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110435653|NCT00649987|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110435654|NCT00649987|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110435655|NCT00649987|Adrenergic Agents|adrenergic agents|mesh-ancestor
110435656|NCT00649987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110435657|NCT00649987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110435658|NCT01142232|Lenalidomide|lenalidomide|mesh-list
110435659|NCT01142232|Melphalan|melphalan|mesh-list
110435660|NCT01142232|Immunologic Factors|immunologic factors|mesh-ancestor
110435661|NCT01142232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110435662|NCT01142232|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110435663|NCT01142232|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110082631|NCT01650870|Lactulose|lactulose|mesh-list
110435664|NCT01142232|Growth Substances|growth substances|mesh-ancestor
110435665|NCT01142232|Growth Inhibitors|growth inhibitors|mesh-ancestor
110435666|NCT01142232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110435667|NCT01142232|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110435668|NCT01142232|Alkylating Agents|alkylating agents|mesh-ancestor
110564669|NCT04942340|Caffeine|caffeine|mesh-list
110435669|NCT01142232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110435670|NCT01142232|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110435671|NCT01142232|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110435672|NCT02536807|Hyaluronic Acid|hyaluronic acid|mesh-list
110435673|NCT02536807|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110435674|NCT02536807|Immunologic Factors|immunologic factors|mesh-ancestor
110435675|NCT02536807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110435676|NCT02536807|Viscosupplements|viscosupplements|mesh-ancestor
110435677|NCT02536807|Protective Agents|protective agents|mesh-ancestor
110435678|NCT02536495|Docetaxel|docetaxel|mesh-list
110435679|NCT02536495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110435680|NCT02536495|Tubulin Modulators|tubulin modulators|mesh-ancestor
110435681|NCT02536495|Antimitotic Agents|antimitotic agents|mesh-ancestor
110435682|NCT02536495|Mitosis Modulators|mitosis modulators|mesh-ancestor
110205383|NCT00171457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110435683|NCT02536495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110435684|NCT02536417|Melatonin|melatonin|mesh-list
110435685|NCT02536417|Antioxidants|antioxidants|mesh-ancestor
110435686|NCT02536417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110435687|NCT02536417|Protective Agents|protective agents|mesh-ancestor
110435688|NCT02536417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110435689|NCT02536417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110435690|NCT01140906|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110435691|NCT01140906|Vortioxetine|vortioxetine|mesh-list
110435692|NCT01140906|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110435693|NCT01140906|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110435694|NCT01140906|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110435695|NCT01140906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110435696|NCT01140906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110435697|NCT01140906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110435698|NCT01140906|Analgesics|analgesics|mesh-ancestor
110435699|NCT01140906|Sensory System Agents|sensory system agents|mesh-ancestor
110435700|NCT01140906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110435701|NCT01140906|Antidepressive Agents|antidepressive agents|mesh-ancestor
110435702|NCT01140906|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110435703|NCT01140906|Dopamine Agents|dopamine agents|mesh-ancestor
110435704|NCT01140906|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110435705|NCT01140906|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110435706|NCT01140906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110435707|NCT01140906|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110435708|NCT01140906|Serotonin Agents|serotonin agents|mesh-ancestor
110435709|NCT01140906|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110435710|NCT01140906|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110435711|NCT01140906|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110435712|NCT01140906|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110435713|NCT00650065|Cetirizine|cetirizine|mesh-list
110435714|NCT00650065|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110435715|NCT00650065|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110435716|NCT00650065|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110435717|NCT00650065|Histamine Antagonists|histamine antagonists|mesh-ancestor
110435718|NCT00650065|Histamine Agents|histamine agents|mesh-ancestor
110435719|NCT00650065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110435720|NCT00650065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110435721|NCT00650065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110435722|NCT04170439|Chromium|chromium|mesh-list
110435723|NCT04170439|Metformin|metformin|mesh-list
110435724|NCT04170439|Citric Acid|citric acid|mesh-list
110435725|NCT04170439|Sodium Citrate|sodium citrate|mesh-list
110435726|NCT04170439|Clomiphene|clomiphene|mesh-list
110435727|NCT04170439|Enclomiphene|enclomiphene|mesh-list
110435728|NCT04170439|Zuclomiphene|zuclomiphene|mesh-list
110435729|NCT04170439|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110435730|NCT04170439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110435731|NCT04170439|Anticoagulants|anticoagulants|mesh-ancestor
110435732|NCT04170439|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110435733|NCT04170439|Chelating Agents|chelating agents|mesh-ancestor
110435734|NCT04170439|Sequestering Agents|sequestering agents|mesh-ancestor
110435735|NCT04170439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110435736|NCT04170439|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110435737|NCT04170439|Hormone Antagonists|hormone antagonists|mesh-ancestor
110435738|NCT04170439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110435739|NCT04170439|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110435740|NCT04170439|Fertility Agents|fertility agents|mesh-ancestor
110205405|NCT00171496|Dermatologic Agents|dermatologic agents|mesh-ancestor
110205407|NCT00171535|Amlodipine|amlodipine|mesh-list
110435741|NCT04170439|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110435742|NCT04170439|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110435743|NCT04170439|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110435745|NCT04170439|Micronutrients|micronutrients|mesh-ancestor
110435746|NCT00649363|Ondansetron|ondansetron|mesh-list
110435747|NCT00649363|Antiemetics|antiemetics|mesh-ancestor
110435748|NCT00649363|Autonomic Agents|autonomic agents|mesh-ancestor
110435749|NCT00649363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110435750|NCT00649363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110435751|NCT00649363|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110435752|NCT00649363|Antipruritics|antipruritics|mesh-ancestor
110435753|NCT00649363|Dermatologic Agents|dermatologic agents|mesh-ancestor
110435754|NCT00649363|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110435755|NCT00649363|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110435756|NCT00649363|Serotonin Agents|serotonin agents|mesh-ancestor
110435757|NCT00649363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110435758|NCT00649363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110435759|NCT02654743|Sulforaphane|sulforaphane|mesh-list
110435760|NCT02654743|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110435761|NCT02654743|Protective Agents|protective agents|mesh-ancestor
110435762|NCT02654743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110435763|NCT02654743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110435764|NCT04168723|Moxifloxacin|moxifloxacin|mesh-list
110435765|NCT04168723|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
110435766|NCT04168723|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110435767|NCT04168723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110435768|NCT04168723|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110435769|NCT04168723|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110435770|NCT04168723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110329284|NCT00498888|Tolterodine Tartrate|tolterodine tartrate|mesh-list
110435771|NCT04168723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110435772|NCT04168723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110435773|NCT04168723|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110435774|NCT04168723|Contraceptive Agents|contraceptive agents|mesh-ancestor
110435775|NCT04168723|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110435776|NCT04168723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110435777|NCT04168723|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110435778|NCT04168723|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110435779|NCT04168723|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110435780|NCT00649441|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110435781|NCT00649441|Quinapril|quinapril|mesh-list
110435782|NCT00649441|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110435783|NCT00649441|Diuretics|diuretics|mesh-ancestor
110435784|NCT00649441|Natriuretic Agents|natriuretic agents|mesh-ancestor
110435785|NCT00649441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110435786|NCT00649441|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110435787|NCT00649441|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110435788|NCT00649441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110435789|NCT00649441|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110435790|NCT00649441|Protease Inhibitors|protease inhibitors|mesh-ancestor
110435791|NCT00649441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110435792|NCT02654665|Liraglutide|liraglutide|mesh-list
110435793|NCT02654665|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110205419|NCT00171574|Lisinopril|lisinopril|mesh-list
110435794|NCT02654665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110435795|NCT02654665|Incretins|incretins|mesh-ancestor
110435796|NCT02654665|Hormones|hormones|mesh-ancestor
110435797|NCT02654665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110435798|NCT02658721|Diclofenac|diclofenac|mesh-list
110435799|NCT02658721|Lidocaine|lidocaine|mesh-list
110435800|NCT02658721|Atropine|atropine|mesh-list
110435801|NCT02658721|Ephedrine|ephedrine|mesh-list
110435802|NCT02658721|Fentanyl|fentanyl|mesh-list
110435803|NCT02658721|Midazolam|midazolam|mesh-list
110435804|NCT02658721|Tramadol|tramadol|mesh-list
110435805|NCT02658721|Ondansetron|ondansetron|mesh-list
110435806|NCT02658721|Anesthetics, Local|anesthetics, local|mesh-ancestor
110435807|NCT02658721|Anesthetics|anesthetics|mesh-ancestor
110435808|NCT02658721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110435809|NCT02658721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110435810|NCT02658721|Sensory System Agents|sensory system agents|mesh-ancestor
110435811|NCT02658721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110435812|NCT02658721|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110435813|NCT02658721|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110435814|NCT02658721|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110082767|NCT01651520|GABA Agents|gaba agents|mesh-ancestor
110435815|NCT02658721|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110435816|NCT02658721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110435817|NCT02658721|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110435818|NCT02658721|Narcotics|narcotics|mesh-ancestor
110435819|NCT02658721|Analgesics|analgesics|mesh-ancestor
110435820|NCT02658721|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110435821|NCT02658721|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110435822|NCT02658721|Anesthetics, General|anesthetics, general|mesh-ancestor
110435823|NCT02658721|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110435824|NCT02658721|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110435825|NCT02658721|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110435826|NCT02658721|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110435827|NCT02658721|GABA Modulators|gaba modulators|mesh-ancestor
110435828|NCT02658721|GABA Agents|gaba agents|mesh-ancestor
110435829|NCT02658721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110435830|NCT02658721|Antiemetics|antiemetics|mesh-ancestor
110435831|NCT02658721|Autonomic Agents|autonomic agents|mesh-ancestor
110435832|NCT02658721|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110435833|NCT02658721|Antipruritics|antipruritics|mesh-ancestor
110435834|NCT02658721|Dermatologic Agents|dermatologic agents|mesh-ancestor
110435835|NCT02658721|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110435836|NCT02658721|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110435837|NCT02658721|Serotonin Agents|serotonin agents|mesh-ancestor
110435838|NCT02658721|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110435839|NCT02658721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110435840|NCT02658721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110435841|NCT02658721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110435842|NCT02658721|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110435843|NCT02658721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110435844|NCT02658721|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110435845|NCT02658721|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110435846|NCT02658721|Respiratory System Agents|respiratory system agents|mesh-ancestor
110435848|NCT02658721|Parasympatholytics|parasympatholytics|mesh-ancestor
110435849|NCT02658721|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110435850|NCT02658721|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110435851|NCT02658721|Cholinergic Agents|cholinergic agents|mesh-ancestor
110435852|NCT02658721|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110435853|NCT02658721|Sympathomimetics|sympathomimetics|mesh-ancestor
110435854|NCT02658721|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110435855|NCT02658721|Adrenergic Agents|adrenergic agents|mesh-ancestor
110435856|NCT00629967|Interferons|interferons|mesh-list
110435857|NCT00629967|Ribavirin|ribavirin|mesh-list
110435858|NCT00629967|Interferon-alpha|interferon-alpha|mesh-list
110435859|NCT00629967|Interferon alpha-2|interferon alpha-2|mesh-list
110435860|NCT00629967|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110435861|NCT00629967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110435862|NCT00629967|Antiviral Agents|antiviral agents|mesh-ancestor
110435863|NCT00629967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110435864|NCT00629967|Antimetabolites|antimetabolites|mesh-ancestor
110435865|NCT00629967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110435866|NCT00629967|Immunologic Factors|immunologic factors|mesh-ancestor
110435867|NCT00629967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110435868|NCT02654587|Docetaxel|docetaxel|mesh-list
110435869|NCT02654587|Pemetrexed|pemetrexed|mesh-list
110435870|NCT02654587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110435871|NCT02654587|Tubulin Modulators|tubulin modulators|mesh-ancestor
110435872|NCT02654587|Antimitotic Agents|antimitotic agents|mesh-ancestor
110435873|NCT02654587|Mitosis Modulators|mitosis modulators|mesh-ancestor
110435874|NCT02654587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110435875|NCT02654587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110435876|NCT02654587|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110435877|NCT02654587|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110435878|NCT01122264|Sildenafil Citrate|sildenafil citrate|mesh-list
110435879|NCT01122264|Tadalafil|tadalafil|mesh-list
110435880|NCT01122264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110435881|NCT01122264|Vasodilator Agents|vasodilator agents|mesh-ancestor
110435882|NCT01122264|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110435883|NCT01122264|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110435884|NCT01122264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110435885|NCT01122264|Urological Agents|urological agents|mesh-ancestor
110435886|NCT03288675|Serotonin|serotonin|mesh-list
110435887|NCT03288675|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
110435888|NCT03288675|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110435889|NCT03288675|Serotonin Agents|serotonin agents|mesh-ancestor
110435890|NCT03288675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110435891|NCT03288675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110435892|NCT03288675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110435893|NCT03288675|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110435894|NCT03288675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110435895|NCT00920218|Vaccines|vaccines|mesh-list
110435896|NCT00920218|Immunologic Factors|immunologic factors|mesh-ancestor
110435897|NCT00920218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110435898|NCT00649519|Amlodipine|amlodipine|mesh-list
110435899|NCT00649519|Benazepril|benazepril|mesh-list
110435900|NCT00649519|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110435901|NCT00649519|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110435902|NCT00649519|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110435903|NCT00649519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110435904|NCT00649519|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110435905|NCT00649519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110435906|NCT00649519|Vasodilator Agents|vasodilator agents|mesh-ancestor
110205452|NCT00055640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110435907|NCT00649519|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110435908|NCT00649519|Protease Inhibitors|protease inhibitors|mesh-ancestor
110435909|NCT00649519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110435910|NCT00629811|Mitogens|mitogens|mesh-list
110435911|NCT00629811|Mitosis Modulators|mitosis modulators|mesh-ancestor
110435912|NCT00629811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110435914|NCT02652091|Interferon-beta|interferon-beta|mesh-list
110435915|NCT02652091|Interferon beta-1b|interferon beta-1b|mesh-list
110435916|NCT02652091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110435917|NCT02652091|Antiviral Agents|antiviral agents|mesh-ancestor
110435918|NCT02652091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110435919|NCT02652091|Immunologic Factors|immunologic factors|mesh-ancestor
110435920|NCT02652091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110435921|NCT02652091|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110435922|NCT00625560|Lamivudine|lamivudine|mesh-list
110435923|NCT00625560|Entecavir|entecavir|mesh-list
110435924|NCT00625560|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110435925|NCT00625560|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110435926|NCT00625560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110435927|NCT00625560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110435928|NCT00625560|Antiviral Agents|antiviral agents|mesh-ancestor
110435929|NCT00625560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110435930|NCT00625560|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110435931|NCT00625560|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110435932|NCT00650455|Naproxen|naproxen|mesh-list
110435933|NCT00650455|Valdecoxib|valdecoxib|mesh-list
110435934|NCT00650455|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110435935|NCT00650455|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110435936|NCT00650455|Analgesics|analgesics|mesh-ancestor
110435937|NCT00650455|Sensory System Agents|sensory system agents|mesh-ancestor
110435938|NCT00650455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110435939|NCT00650455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110435940|NCT00650455|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110435941|NCT00650455|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110435942|NCT00650455|Gout Suppressants|gout suppressants|mesh-ancestor
110435943|NCT00650455|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110435944|NCT00650455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110435945|NCT00650455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110435946|NCT00650455|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110435947|NCT02654041|Methimazole|methimazole|mesh-list
110435948|NCT02654041|Antithyroid Agents|antithyroid agents|mesh-ancestor
110435949|NCT02654041|Hormone Antagonists|hormone antagonists|mesh-ancestor
110435950|NCT02654041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110435951|NCT02654041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110435952|NCT02658409|Vaccines|vaccines|mesh-list
110435953|NCT02658409|Immunologic Factors|immunologic factors|mesh-ancestor
110435954|NCT02658409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110435955|NCT01121562|Sunitinib|sunitinib|mesh-list
110435956|NCT01121562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110435957|NCT01121562|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110435958|NCT01121562|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110435959|NCT01121562|Growth Substances|growth substances|mesh-ancestor
110435960|NCT01121562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110435961|NCT01121562|Growth Inhibitors|growth inhibitors|mesh-ancestor
110435962|NCT01121562|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110435963|NCT01121562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110205475|NCT00171652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110435964|NCT01121562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110435965|NCT02658253|Aluminum Hydroxide|aluminum hydroxide|mesh-list
110082920|NCT01652326|Anesthetics|anesthetics|mesh-ancestor
110435966|NCT02658253|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110435967|NCT02658253|Immunologic Factors|immunologic factors|mesh-ancestor
110435968|NCT02658253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110435970|NCT02658253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110435971|NCT02658253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110435972|NCT02651623|Moxifloxacin|moxifloxacin|mesh-list
110435973|NCT02651623|Sertraline|sertraline|mesh-list
110435974|NCT02651623|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110435975|NCT02651623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110435976|NCT02651623|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110435977|NCT02651623|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110435978|NCT02651623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110435979|NCT02651623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110435980|NCT02651623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110435981|NCT02651623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110435982|NCT02651623|Antidepressive Agents|antidepressive agents|mesh-ancestor
110435983|NCT02651623|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110372290|NCT00575406|Prednisolone|prednisolone|mesh-list
110435984|NCT02651623|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110435985|NCT02651623|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110435986|NCT02651623|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110435987|NCT02651623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110435988|NCT02651623|Serotonin Agents|serotonin agents|mesh-ancestor
110435989|NCT01121484|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
110435990|NCT01121484|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110435991|NCT01121484|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110435992|NCT01121484|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110435993|NCT01121484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110435994|NCT01121484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110435995|NCT01121484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110435996|NCT01121484|Antidepressive Agents|antidepressive agents|mesh-ancestor
110435997|NCT01121484|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110435999|NCT00650221|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110436000|NCT00650221|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110436001|NCT00650221|Antimetabolites|antimetabolites|mesh-ancestor
110436002|NCT00650221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110436003|NCT00650221|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110436004|NCT00650221|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110436005|NCT00650221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110436006|NCT01169675|Pemetrexed|pemetrexed|mesh-list
110436007|NCT01169675|Afatinib|afatinib|mesh-list
110436008|NCT01169675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110436009|NCT01169675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110436010|NCT01169675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110436011|NCT01169675|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110436012|NCT01169675|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110436013|NCT01169675|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110436014|NCT00650533|Glimepiride|glimepiride|mesh-list
110436015|NCT00650533|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110436016|NCT00650533|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110436017|NCT00650533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110436018|NCT00650533|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110436019|NCT00650533|Immunologic Factors|immunologic factors|mesh-ancestor
110436020|NCT02881866|Furosemide|furosemide|mesh-list
110436021|NCT02881866|Diuretics|diuretics|mesh-ancestor
110436022|NCT02881866|Natriuretic Agents|natriuretic agents|mesh-ancestor
110436023|NCT02881866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110436024|NCT02881866|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110436025|NCT02881866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110436026|NCT02881866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110436027|NCT00924664|Tanezumab|tanezumab|mesh-list
110436028|NCT00924664|Analgesics|analgesics|mesh-ancestor
110436029|NCT00924664|Sensory System Agents|sensory system agents|mesh-ancestor
110436030|NCT00924664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110436031|NCT00924664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110436032|NCT02653651|Lidocaine|lidocaine|mesh-list
110436033|NCT02653651|Ketamine|ketamine|mesh-list
110436034|NCT02653651|Anesthetics, Local|anesthetics, local|mesh-ancestor
110436035|NCT02653651|Anesthetics|anesthetics|mesh-ancestor
110436036|NCT02653651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110436037|NCT02653651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110436038|NCT02653651|Sensory System Agents|sensory system agents|mesh-ancestor
110436039|NCT02653651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110436040|NCT02653651|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110436041|NCT02653651|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110436042|NCT02653651|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110436043|NCT02653651|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110436044|NCT02653651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110436045|NCT02653651|Analgesics|analgesics|mesh-ancestor
110436046|NCT02653651|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110436047|NCT02653651|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110436048|NCT02653651|Anesthetics, General|anesthetics, general|mesh-ancestor
110436049|NCT02653651|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110436050|NCT02653651|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110436051|NCT02653651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110436053|NCT02651311|Fentanyl|fentanyl|mesh-list
110436054|NCT02651311|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110436055|NCT02651311|Narcotics|narcotics|mesh-ancestor
110436056|NCT02651311|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110436057|NCT02651311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110436058|NCT02651311|Analgesics|analgesics|mesh-ancestor
110436059|NCT02651311|Sensory System Agents|sensory system agents|mesh-ancestor
110436060|NCT02651311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110436061|NCT02651311|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110436062|NCT02651311|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110436063|NCT02651311|Anesthetics, General|anesthetics, general|mesh-ancestor
110436064|NCT02651311|Anesthetics|anesthetics|mesh-ancestor
110436065|NCT02651311|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110436066|NCT02651311|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110436067|NCT02651311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110436068|NCT02651311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110436069|NCT02651311|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110436070|NCT02651311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110436071|NCT02651311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110436072|NCT02653261|Tranexamic Acid|tranexamic acid|mesh-list
110436073|NCT02653261|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110436074|NCT02653261|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110436075|NCT02653261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110436076|NCT02653261|Hemostatics|hemostatics|mesh-ancestor
110436077|NCT02653261|Coagulants|coagulants|mesh-ancestor
110436078|NCT02653339|Loratadine|loratadine|mesh-list
110436079|NCT02653339|Antipruritics|antipruritics|mesh-ancestor
110436080|NCT02653339|Dermatologic Agents|dermatologic agents|mesh-ancestor
110436081|NCT02653339|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110436082|NCT02653339|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110436083|NCT02653339|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110436084|NCT02653339|Histamine Antagonists|histamine antagonists|mesh-ancestor
110436085|NCT02653339|Histamine Agents|histamine agents|mesh-ancestor
110436086|NCT02653339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110436087|NCT02653339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110436088|NCT02653339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110436089|NCT00649597|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110436090|NCT00649597|Benazepril|benazepril|mesh-list
110436091|NCT00649597|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110436092|NCT00649597|Diuretics|diuretics|mesh-ancestor
110436093|NCT00649597|Natriuretic Agents|natriuretic agents|mesh-ancestor
110436094|NCT00649597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110436095|NCT00649597|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110436096|NCT00649597|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110436097|NCT00649597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110436098|NCT00649597|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110436099|NCT00649597|Protease Inhibitors|protease inhibitors|mesh-ancestor
110436100|NCT00649597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110436101|NCT02653027|Ivacaftor|ivacaftor|mesh-list
110436102|NCT02653027|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
110436103|NCT02653027|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110436104|NCT02653027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110436105|NCT02652793|Lamivudine|lamivudine|mesh-list
110436106|NCT02652793|Atazanavir Sulfate|atazanavir sulfate|mesh-list
110436107|NCT02652793|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110436108|NCT02652793|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110436109|NCT02652793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110436110|NCT02652793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110083072|NCT01652859|Amphotericin B|amphotericin b|mesh-list
110436111|NCT02652793|Antiviral Agents|antiviral agents|mesh-ancestor
110436112|NCT02652793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110436113|NCT02652793|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110436114|NCT02652793|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110436115|NCT02652793|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110436116|NCT02652793|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110436117|NCT02652793|Protease Inhibitors|protease inhibitors|mesh-ancestor
110436118|NCT00650611|Ziprasidone|ziprasidone|mesh-list
110436119|NCT00650611|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110436120|NCT00650611|Serotonin Agents|serotonin agents|mesh-ancestor
110436121|NCT00650611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110436122|NCT00650611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110329306|NCT00491946|Vincristine|vincristine|mesh-list
110436123|NCT00650611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110436124|NCT00650611|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110436125|NCT00650611|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110436126|NCT00650611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110436127|NCT00650611|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110436128|NCT00650611|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110436129|NCT00650611|Dopamine Agents|dopamine agents|mesh-ancestor
110436130|NCT00600067|Topiramate|topiramate|mesh-list
110436131|NCT00600067|Phentermine|phentermine|mesh-list
110436132|NCT00600067|Anticonvulsants|anticonvulsants|mesh-ancestor
110436133|NCT00600067|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110436134|NCT00600067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110436135|NCT00600067|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110436136|NCT00600067|Appetite Depressants|appetite depressants|mesh-ancestor
110436137|NCT00600067|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110436138|NCT00600067|Sympathomimetics|sympathomimetics|mesh-ancestor
110436139|NCT00600067|Autonomic Agents|autonomic agents|mesh-ancestor
110436140|NCT00600067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110436141|NCT00600067|Adrenergic Agents|adrenergic agents|mesh-ancestor
110436142|NCT00600067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110436143|NCT00600067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110436144|NCT02650609|Methylprednisolone|methylprednisolone|mesh-list
110436145|NCT02650609|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110436146|NCT02650609|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110436147|NCT02650609|Prednisolone|prednisolone|mesh-list
110436148|NCT02650609|Prednisolone acetate|prednisolone acetate|mesh-list
110436149|NCT02650609|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110436150|NCT02650609|Prednisolone phosphate|prednisolone phosphate|mesh-list
110436151|NCT02650609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110436152|NCT02650609|Antiemetics|antiemetics|mesh-ancestor
110436153|NCT02650609|Autonomic Agents|autonomic agents|mesh-ancestor
110436154|NCT02650609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110436155|NCT02650609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110436156|NCT02650609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110436157|NCT02650609|Glucocorticoids|glucocorticoids|mesh-ancestor
110436158|NCT02650609|Hormones|hormones|mesh-ancestor
110436159|NCT02650609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110436160|NCT02650609|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110436161|NCT02650609|Protective Agents|protective agents|mesh-ancestor
110436162|NCT02650609|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110436163|NCT02650609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110436164|NCT02652871|Cytarabine|cytarabine|mesh-list
110436165|NCT02652871|Idarubicin|idarubicin|mesh-list
110436166|NCT02652871|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110436167|NCT02652871|Antimetabolites|antimetabolites|mesh-ancestor
110436168|NCT02652871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110436169|NCT02652871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110436170|NCT02652871|Antiviral Agents|antiviral agents|mesh-ancestor
110436171|NCT02652871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110436172|NCT02652871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110436173|NCT02652871|Immunologic Factors|immunologic factors|mesh-ancestor
110436174|NCT02652871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110436175|NCT02652871|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110436176|NCT02652871|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110205563|NCT00055835|Paclitaxel|paclitaxel|mesh-list
110436177|NCT02652871|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110436178|NCT02652871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110436179|NCT00650299|Alprazolam|alprazolam|mesh-list
110436180|NCT00650299|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110436181|NCT00650299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110436182|NCT00650299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110436183|NCT00650299|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110436184|NCT00650299|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110436185|NCT00650299|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110436186|NCT00650299|GABA Modulators|gaba modulators|mesh-ancestor
110083148|NCT01653171|Expectorants|expectorants|mesh-ancestor
110436188|NCT00650299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110436189|NCT00650299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110436190|NCT04168099|Cefotaxime|cefotaxime|mesh-list
110436191|NCT04168099|Cefoxitin|cefoxitin|mesh-list
110436192|NCT04168099|Gemifloxacin|gemifloxacin|mesh-list
110436193|NCT04168099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110436194|NCT04168099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110436195|NCT04168099|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110436196|NCT04168099|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110436197|NCT04168099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110436198|NCT04168099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110436199|NCT04168099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110436200|NCT04283877|Methylphenidate|methylphenidate|mesh-list
110436201|NCT04283877|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110436202|NCT04283877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110436203|NCT04283877|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110436204|NCT04283877|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110436205|NCT04283877|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110436206|NCT04283877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110436207|NCT04283877|Dopamine Agents|dopamine agents|mesh-ancestor
110436208|NCT04283877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110436209|NCT04283487|Levan|levan|mesh-list
110436210|NCT04283487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110436211|NCT04283331|Proxymetacaine|proxymetacaine|mesh-list
110436212|NCT04283331|Propoxycaine|propoxycaine|mesh-list
110436213|NCT04283331|Anesthetics, Local|anesthetics, local|mesh-ancestor
110436214|NCT04283331|Anesthetics|anesthetics|mesh-ancestor
110436215|NCT04283331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110436216|NCT04283331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110436217|NCT04283331|Sensory System Agents|sensory system agents|mesh-ancestor
110436218|NCT04283331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110436219|NCT02657473|Tobramycin|tobramycin|mesh-list
110436220|NCT02657473|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110436221|NCT02657473|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110436222|NCT02657473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110436223|NCT02652637|Metronidazole|metronidazole|mesh-list
110436224|NCT02652637|Neomycin|neomycin|mesh-list
110436225|NCT02652637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110436226|NCT02652637|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110436227|NCT02652637|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110436228|NCT02652637|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110205574|NCT00172354|Hydrocortisone|hydrocortisone|mesh-list
110436229|NCT02652637|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110436230|NCT02652637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110436231|NCT02652637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110436233|NCT00649675|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110436234|NCT00649675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110436235|NCT00649675|Analgesics|analgesics|mesh-ancestor
110436236|NCT00649675|Sensory System Agents|sensory system agents|mesh-ancestor
110436237|NCT00649675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110436238|NCT00649675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110436239|NCT00649675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110436240|NCT00649675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110436241|NCT00649675|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110436242|NCT00649675|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110436243|NCT00649675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110436244|NCT00649675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110436245|NCT02860923|Exenatide|exenatide|mesh-list
110436246|NCT02860923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110436247|NCT02860923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110436248|NCT02860923|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110436249|NCT02860923|Incretins|incretins|mesh-ancestor
110436250|NCT02860923|Hormones|hormones|mesh-ancestor
110436251|NCT02860923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110436252|NCT01121406|Paclitaxel|paclitaxel|mesh-list
110436253|NCT01121406|Gemcitabine|gemcitabine|mesh-list
110436254|NCT01121406|Doxorubicin|doxorubicin|mesh-list
110436255|NCT01121406|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110436256|NCT01121406|Topotecan|topotecan|mesh-list
110436257|NCT01121406|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110436258|NCT01121406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110436259|NCT01121406|Tubulin Modulators|tubulin modulators|mesh-ancestor
110083235|NCT01653990|Moxifloxacin|moxifloxacin|mesh-list
110436260|NCT01121406|Antimitotic Agents|antimitotic agents|mesh-ancestor
110436261|NCT01121406|Mitosis Modulators|mitosis modulators|mesh-ancestor
110436262|NCT01121406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110436263|NCT01121406|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110436264|NCT01121406|Antimetabolites|antimetabolites|mesh-ancestor
110436266|NCT01121406|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110436267|NCT01121406|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110436268|NCT01121406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110436269|NCT01121406|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110436271|NCT02652325|Cadexomer iodine|cadexomer iodine|mesh-list
110436272|NCT02652325|Povidone-Iodine|povidone-iodine|mesh-list
110436273|NCT02652325|Povidone|povidone|mesh-list
110436274|NCT02652325|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110436275|NCT02652325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110436276|NCT02652325|Trace Elements|trace elements|mesh-ancestor
110436277|NCT02652325|Micronutrients|micronutrients|mesh-ancestor
110436278|NCT02652325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110436279|NCT02652325|Plasma Substitutes|plasma substitutes|mesh-ancestor
110436280|NCT02652325|Blood Substitutes|blood substitutes|mesh-ancestor
110436281|NCT00960687|Fenofibrate|fenofibrate|mesh-list
110436282|NCT00960687|Fenofibric acid|fenofibric acid|mesh-list
110436283|NCT00960687|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110436284|NCT00960687|Antimetabolites|antimetabolites|mesh-ancestor
110436285|NCT00960687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110436286|NCT00960687|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110436287|NCT00960687|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110436288|NCT00920140|Trametinib|trametinib|mesh-list
110436289|NCT00920140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110436290|NCT00920140|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110436291|NCT00920140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110436292|NCT00920140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110436293|NCT01120626|Donepezil|donepezil|mesh-list
110436294|NCT01120626|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110436295|NCT01120626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110436296|NCT01120626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110436297|NCT01120626|Cholinergic Agents|cholinergic agents|mesh-ancestor
110436298|NCT01120626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110436299|NCT01120626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110436300|NCT01120626|Nootropic Agents|nootropic agents|mesh-ancestor
110436301|NCT00650377|Finasteride|finasteride|mesh-list
110436302|NCT00650377|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
110436303|NCT00650377|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110436304|NCT00650377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110436305|NCT00650377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110436306|NCT00650377|Hormone Antagonists|hormone antagonists|mesh-ancestor
110436307|NCT00650377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110436308|NCT00650377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110436309|NCT00650377|Urological Agents|urological agents|mesh-ancestor
110436310|NCT02649751|Roscovitine|roscovitine|mesh-list
110436311|NCT02649751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110436312|NCT02649751|Antiviral Agents|antiviral agents|mesh-ancestor
110436313|NCT02649751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110436314|NCT02649751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110436315|NCT02649751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110436316|NCT02649751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110436317|NCT04252300|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110436318|NCT04252300|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110436319|NCT04252300|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110436320|NCT04252300|Antimetabolites|antimetabolites|mesh-ancestor
110436321|NCT04252300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110436322|NCT04252300|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110436323|NCT04252300|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110436324|NCT04252300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110436325|NCT00924508|Triamcinolone|triamcinolone|mesh-list
110436326|NCT00924508|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110436327|NCT00924508|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110436328|NCT00924508|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110436329|NCT00924508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110436330|NCT00924508|Glucocorticoids|glucocorticoids|mesh-ancestor
110436331|NCT00924508|Hormones|hormones|mesh-ancestor
110436332|NCT00924508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110436333|NCT00924508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110436334|NCT00924508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110083298|NCT01654367|Zoledronic Acid|zoledronic acid|mesh-list
110436335|NCT00924508|Immunologic Factors|immunologic factors|mesh-ancestor
110436336|NCT00924508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110329317|NCT00491946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110436337|NCT00924508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110436339|NCT00650923|Aflibercept|aflibercept|mesh-list
110436340|NCT00650923|Endothelial Growth Factors|endothelial growth factors|mesh-list
110436341|NCT00650923|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110436342|NCT00650923|Alkylating Agents|alkylating agents|mesh-ancestor
110436343|NCT00650923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110436344|NCT00650923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110436345|NCT00650923|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110205614|NCT00055913|Immunologic Factors|immunologic factors|mesh-ancestor
110436346|NCT00650923|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110436348|NCT00650923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110436349|NCT00650923|Growth Inhibitors|growth inhibitors|mesh-ancestor
110436350|NCT00637858|Lycopene|lycopene|mesh-list
110436351|NCT00637858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110436352|NCT00637858|Antioxidants|antioxidants|mesh-ancestor
110436353|NCT00637858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110436354|NCT00637858|Protective Agents|protective agents|mesh-ancestor
110436355|NCT00637858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110436356|NCT00637858|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110436357|NCT00637858|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110436358|NCT00637858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110436359|NCT02657161|Vaccines|vaccines|mesh-list
110436360|NCT02657161|Immunologic Factors|immunologic factors|mesh-ancestor
110436361|NCT02657161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110436362|NCT01139580|Calcipotriene|calcipotriene|mesh-list
110436363|NCT01139580|Dermatologic Agents|dermatologic agents|mesh-ancestor
110436364|NCT04686760|Nitroglycerin|nitroglycerin|mesh-list
110436365|NCT04686760|Vasodilator Agents|vasodilator agents|mesh-ancestor
110436366|NCT04312698|Antihypertensive Agents|antihypertensive agents|mesh-list
110436367|NCT04312698|Hypolipidemic Agents|hypolipidemic agents|mesh-list
110436368|NCT04312698|Antimetabolites|antimetabolites|mesh-ancestor
110436369|NCT04312698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110436370|NCT04312698|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110436371|NCT04251832|Sodium thiosulfate|sodium thiosulfate|mesh-list
110436372|NCT04251832|Antidotes|antidotes|mesh-ancestor
110436373|NCT04251832|Protective Agents|protective agents|mesh-ancestor
110436374|NCT04251832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110436375|NCT04251832|Antioxidants|antioxidants|mesh-ancestor
110436376|NCT04251832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110436377|NCT04251832|Antitubercular Agents|antitubercular agents|mesh-ancestor
110436378|NCT04251832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110436379|NCT04251832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110436380|NCT04251832|Chelating Agents|chelating agents|mesh-ancestor
110436381|NCT04251832|Sequestering Agents|sequestering agents|mesh-ancestor
110436382|NCT02656771|Metronidazole|metronidazole|mesh-list
110436383|NCT02656771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110436384|NCT02656771|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110436385|NCT02656771|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110436386|NCT02656771|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110436387|NCT00917644|Atorvastatin|atorvastatin|mesh-list
110436388|NCT00917644|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110436389|NCT00917644|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110436390|NCT00917644|Antimetabolites|antimetabolites|mesh-ancestor
110436391|NCT00917644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110436392|NCT00917644|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110436393|NCT00917644|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110329319|NCT00491985|Vaccines|vaccines|mesh-list
110436394|NCT00917644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110436396|NCT00625170|Olanzapine|olanzapine|mesh-list
110436397|NCT00625170|Haloperidol decanoate|haloperidol decanoate|mesh-list
110436398|NCT00625170|Antiemetics|antiemetics|mesh-ancestor
110436399|NCT00625170|Autonomic Agents|autonomic agents|mesh-ancestor
110436400|NCT00625170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110436401|NCT00625170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110436402|NCT00625170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110436403|NCT00625170|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110436404|NCT00625170|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110436405|NCT00625170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110436406|NCT00625170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110436407|NCT00625170|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110436408|NCT00625170|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110436409|NCT00625170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110436410|NCT00625170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110436411|NCT00625170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110436412|NCT00625170|Serotonin Agents|serotonin agents|mesh-ancestor
110436413|NCT00625170|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110436414|NCT00625170|Dopamine Agents|dopamine agents|mesh-ancestor
110436415|NCT00625170|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110436416|NCT00599755|Carboplatin|carboplatin|mesh-list
110436417|NCT00599755|Gemcitabine|gemcitabine|mesh-list
110436418|NCT00599755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110436419|NCT00599755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110436420|NCT00599755|Antimetabolites|antimetabolites|mesh-ancestor
110436421|NCT00599755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110436422|NCT04251364|Acetazolamide|acetazolamide|mesh-list
110436423|NCT04251364|Atorvastatin|atorvastatin|mesh-list
110436424|NCT04251364|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110436425|NCT04251364|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110436426|NCT04251364|Antimetabolites|antimetabolites|mesh-ancestor
110436427|NCT04251364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110436428|NCT04251364|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110436429|NCT04251364|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110436430|NCT04251364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110436432|NCT04251364|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110436433|NCT04251364|Diuretics|diuretics|mesh-ancestor
110436434|NCT04251364|Natriuretic Agents|natriuretic agents|mesh-ancestor
110436435|NCT04251364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110436436|NCT04811014|Buprenorphine|buprenorphine|mesh-list
110436437|NCT04811014|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
110436438|NCT04811014|Naloxone|naloxone|mesh-list
110436439|NCT04811014|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110436440|NCT04811014|Narcotics|narcotics|mesh-ancestor
110436441|NCT04811014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110436442|NCT04811014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110436443|NCT04811014|Analgesics|analgesics|mesh-ancestor
110436444|NCT04811014|Sensory System Agents|sensory system agents|mesh-ancestor
110436445|NCT04811014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110436446|NCT04811014|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110436447|NCT02648425|Leucovorin|leucovorin|mesh-list
110436448|NCT02648425|Cisplatin|cisplatin|mesh-list
110436449|NCT02648425|Fluorouracil|fluorouracil|mesh-list
110436450|NCT02648425|Capecitabine|capecitabine|mesh-list
110436451|NCT02648425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110436452|NCT02648425|Antimetabolites|antimetabolites|mesh-ancestor
110436453|NCT02648425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110436454|NCT02648425|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110436455|NCT02648425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110436456|NCT02648425|Immunologic Factors|immunologic factors|mesh-ancestor
110436457|NCT02648425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110436458|NCT02648425|Antidotes|antidotes|mesh-ancestor
110436459|NCT02648425|Protective Agents|protective agents|mesh-ancestor
110436460|NCT02648425|Vitamin B Complex|vitamin b complex|mesh-ancestor
110436461|NCT02648425|Vitamins|vitamins|mesh-ancestor
110436462|NCT02648425|Micronutrients|micronutrients|mesh-ancestor
110436463|NCT02648503|Atropine|atropine|mesh-list
110436464|NCT02648503|Rocuronium|rocuronium|mesh-list
110436465|NCT02648503|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110436466|NCT02648503|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110436467|NCT02648503|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110436468|NCT02648503|Autonomic Agents|autonomic agents|mesh-ancestor
110436469|NCT02648503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110436470|NCT02648503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110436471|NCT02648503|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110436472|NCT02648503|Respiratory System Agents|respiratory system agents|mesh-ancestor
110205643|NCT04631484|Niacin|niacin|mesh-list
110436473|NCT02648503|Mydriatics|mydriatics|mesh-ancestor
110436474|NCT02648503|Parasympatholytics|parasympatholytics|mesh-ancestor
110436475|NCT02648503|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110436476|NCT02648503|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110436477|NCT02648503|Cholinergic Agents|cholinergic agents|mesh-ancestor
110436478|NCT02648503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110436479|NCT02648503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110436480|NCT02648503|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110436481|NCT02648503|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110436482|NCT02648503|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110436483|NCT05253508|Lidocaine|lidocaine|mesh-list
110436484|NCT05253508|Anesthetics, Local|anesthetics, local|mesh-ancestor
110436485|NCT05253508|Anesthetics|anesthetics|mesh-ancestor
110436486|NCT05253508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110436487|NCT05253508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110436488|NCT05253508|Sensory System Agents|sensory system agents|mesh-ancestor
110436489|NCT05253508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110436490|NCT05253508|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110436491|NCT05253508|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110436492|NCT05253508|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110436493|NCT05253508|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110436494|NCT05253508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110436495|NCT04524130|Lidocaine|lidocaine|mesh-list
110436496|NCT04524130|Ketamine|ketamine|mesh-list
110436497|NCT04524130|Anesthetics, Local|anesthetics, local|mesh-ancestor
110436498|NCT04524130|Anesthetics|anesthetics|mesh-ancestor
110436499|NCT04524130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110436500|NCT04524130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110436501|NCT04524130|Sensory System Agents|sensory system agents|mesh-ancestor
110436502|NCT04524130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110436503|NCT04524130|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110436504|NCT04524130|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110436505|NCT04524130|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110436506|NCT04524130|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110436507|NCT04524130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110436508|NCT04524130|Analgesics|analgesics|mesh-ancestor
110436509|NCT04524130|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110436510|NCT04524130|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110436511|NCT04524130|Anesthetics, General|anesthetics, general|mesh-ancestor
110436512|NCT04524130|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110436513|NCT04524130|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110436514|NCT04524130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110436515|NCT00649831|Amoxicillin|amoxicillin|mesh-list
110436516|NCT00649831|Azithromycin|azithromycin|mesh-list
110436517|NCT00649831|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110436518|NCT00649831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110436519|NCT02648659|Amoxicillin|amoxicillin|mesh-list
110436520|NCT02648659|Metronidazole|metronidazole|mesh-list
110436521|NCT02648659|Clarithromycin|clarithromycin|mesh-list
110436522|NCT02648659|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110436523|NCT02648659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110436524|NCT02648659|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110436525|NCT02648659|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110436526|NCT02648659|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110436527|NCT02648659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110436528|NCT02648659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110436529|NCT02648659|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110436530|NCT02648659|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110436531|NCT01125930|Tretinoin|tretinoin|mesh-list
110436533|NCT01125930|Keratolytic Agents|keratolytic agents|mesh-ancestor
110436534|NCT01125930|Dermatologic Agents|dermatologic agents|mesh-ancestor
110436535|NCT02656615|Abiraterone Acetate|abiraterone acetate|mesh-list
110436536|NCT02656615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110436537|NCT02656615|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110436538|NCT02656615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110329340|NCT00492102|Hormone Antagonists|hormone antagonists|mesh-ancestor
110436539|NCT02656615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110436540|NCT02656615|Hormone Antagonists|hormone antagonists|mesh-ancestor
110436541|NCT02656615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110436542|NCT02656615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110436543|NCT02656615|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110436544|NCT00651235|Losartan|losartan|mesh-list
110436545|NCT00651235|Propranolol|propranolol|mesh-list
110436546|NCT00651235|Atenolol|atenolol|mesh-list
110436547|NCT00651235|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110436548|NCT00651235|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110436549|NCT00651235|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110436550|NCT00651235|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110436551|NCT00651235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110436552|NCT00651235|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110436553|NCT00651235|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110436554|NCT00651235|Adrenergic Agents|adrenergic agents|mesh-ancestor
110436555|NCT00651235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110436556|NCT00651235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110436557|NCT00651235|Vasodilator Agents|vasodilator agents|mesh-ancestor
110436558|NCT00651235|Sympatholytics|sympatholytics|mesh-ancestor
110436559|NCT00651235|Autonomic Agents|autonomic agents|mesh-ancestor
110436560|NCT00651235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110436561|NCT00651235|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110436562|NCT04806178|BCG Vaccine|bcg vaccine|mesh-list
110436563|NCT04806178|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110436564|NCT04806178|Immunologic Factors|immunologic factors|mesh-ancestor
110436565|NCT04806178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110436566|NCT04015219|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110436567|NCT04015219|Lifitegrast|lifitegrast|mesh-list
110436568|NCT04015219|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110436569|NCT01137474|Dapagliflozin|dapagliflozin|mesh-list
110436570|NCT01137474|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110436571|NCT01137474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110436572|NCT01137474|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110436573|NCT01137474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110436574|NCT04790188|Nootropic Agents|nootropic agents|mesh-list
110436575|NCT01168973|Docetaxel|docetaxel|mesh-list
110436576|NCT01168973|Ramucirumab|ramucirumab|mesh-list
110436577|NCT01168973|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110436578|NCT01168973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110436579|NCT01168973|Tubulin Modulators|tubulin modulators|mesh-ancestor
110436580|NCT01168973|Antimitotic Agents|antimitotic agents|mesh-ancestor
110436581|NCT01168973|Mitosis Modulators|mitosis modulators|mesh-ancestor
110436582|NCT01168973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110436583|NCT01168973|Immunologic Factors|immunologic factors|mesh-ancestor
110436584|NCT01168973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110436585|NCT00631618|Sunitinib|sunitinib|mesh-list
110436586|NCT00631618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110436587|NCT00631618|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110436588|NCT00631618|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110436589|NCT00631618|Growth Substances|growth substances|mesh-ancestor
110436590|NCT00631618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110436591|NCT00631618|Growth Inhibitors|growth inhibitors|mesh-ancestor
110436592|NCT00631618|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110436593|NCT00631618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110436594|NCT00631618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110436595|NCT04431778|Ethosuximide|ethosuximide|mesh-list
110436596|NCT04431778|Anticonvulsants|anticonvulsants|mesh-ancestor
110436597|NCT04669132|Olanzapine|olanzapine|mesh-list
110436598|NCT04669132|Antiemetics|antiemetics|mesh-ancestor
110436599|NCT04669132|Autonomic Agents|autonomic agents|mesh-ancestor
110436600|NCT04669132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110436601|NCT04669132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110436602|NCT04669132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110436603|NCT04669132|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110436604|NCT04669132|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110436605|NCT04669132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110436606|NCT04669132|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110436607|NCT04669132|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110436608|NCT04669132|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110436609|NCT04669132|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110436610|NCT04669132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110436612|NCT04669132|Serotonin Agents|serotonin agents|mesh-ancestor
110436613|NCT01168349|Epoetin Alfa|epoetin alfa|mesh-list
110436614|NCT01168349|Hematinics|hematinics|mesh-ancestor
110436615|NCT00915772|Metformin|metformin|mesh-list
110436616|NCT00915772|Linagliptin|linagliptin|mesh-list
110436617|NCT00915772|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110436618|NCT00915772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110436619|NCT00915772|Incretins|incretins|mesh-ancestor
110436620|NCT00915772|Hormones|hormones|mesh-ancestor
110436621|NCT00915772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110436622|NCT00915772|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110436623|NCT00915772|Protease Inhibitors|protease inhibitors|mesh-ancestor
110436624|NCT00915772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110436625|NCT00915772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110436626|NCT00632086|Aspirin|aspirin|mesh-list
110436627|NCT00632086|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110436628|NCT00632086|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110436629|NCT00632086|Analgesics|analgesics|mesh-ancestor
110436630|NCT00632086|Sensory System Agents|sensory system agents|mesh-ancestor
110436631|NCT00632086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110436632|NCT00632086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110436633|NCT00632086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110436634|NCT00632086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110436635|NCT00632086|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110436636|NCT00632086|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110436637|NCT00632086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110436638|NCT00632086|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110436639|NCT00632086|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110436640|NCT00632086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110436641|NCT00632086|Antipyretics|antipyretics|mesh-ancestor
110436642|NCT00912964|Mirabegron|mirabegron|mesh-list
110436643|NCT00912964|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
110436644|NCT00912964|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110436645|NCT00912964|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110436646|NCT00912964|Adrenergic Agents|adrenergic agents|mesh-ancestor
110436647|NCT00912964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110436648|NCT00912964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110436649|NCT00912964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110436650|NCT00912964|Urological Agents|urological agents|mesh-ancestor
110436651|NCT02641639|Fosbretabulin|fosbretabulin|mesh-list
110436652|NCT02641639|Combretastatin|combretastatin|mesh-list
110436653|NCT02641639|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110436654|NCT02641639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110436655|NCT02641639|Tubulin Modulators|tubulin modulators|mesh-ancestor
110436656|NCT02641639|Antimitotic Agents|antimitotic agents|mesh-ancestor
110436657|NCT02641639|Mitosis Modulators|mitosis modulators|mesh-ancestor
110436658|NCT02641639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110436659|NCT02647567|Caffeine|caffeine|mesh-list
110436660|NCT02647567|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110436661|NCT02647567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110436662|NCT02647567|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110436663|NCT02647567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110436664|NCT02647567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110436665|NCT02647567|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110436666|NCT02647567|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110436667|NCT02647567|Purinergic Agents|purinergic agents|mesh-ancestor
110436668|NCT02647567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110436669|NCT02647489|Aluminum Hydroxide|aluminum hydroxide|mesh-list
110436670|NCT02647489|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110436671|NCT02647489|Immunologic Factors|immunologic factors|mesh-ancestor
110436672|NCT02647489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110436673|NCT02647489|Antacids|antacids|mesh-ancestor
110436674|NCT02647489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110436675|NCT02647489|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110436676|NCT00910897|Thalidomide|thalidomide|mesh-list
110436677|NCT00910897|Dexamethasone|dexamethasone|mesh-list
110436678|NCT00910897|Dexamethasone acetate|dexamethasone acetate|mesh-list
110436680|NCT00910897|BB 1101|bb 1101|mesh-list
110436681|NCT00910897|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110436682|NCT00910897|Antiemetics|antiemetics|mesh-ancestor
110436683|NCT00910897|Autonomic Agents|autonomic agents|mesh-ancestor
110436684|NCT00910897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110436685|NCT00910897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110436686|NCT00910897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110436687|NCT00910897|Glucocorticoids|glucocorticoids|mesh-ancestor
110436688|NCT00910897|Hormones|hormones|mesh-ancestor
110436689|NCT00910897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110436690|NCT00910897|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110436691|NCT00910897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110436692|NCT00910897|Protease Inhibitors|protease inhibitors|mesh-ancestor
110436693|NCT00910897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110436694|NCT00910897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110436695|NCT00910897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110436696|NCT00910897|Immunologic Factors|immunologic factors|mesh-ancestor
110436697|NCT00910897|Leprostatic Agents|leprostatic agents|mesh-ancestor
110436698|NCT00910897|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110436699|NCT00910897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110436700|NCT00910897|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110436701|NCT00910897|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110436702|NCT00910897|Growth Substances|growth substances|mesh-ancestor
110436703|NCT00910897|Growth Inhibitors|growth inhibitors|mesh-ancestor
110436704|NCT00651547|Budesonide|budesonide|mesh-list
110436705|NCT00651547|Formoterol Fumarate|formoterol fumarate|mesh-list
110436706|NCT00651547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110436707|NCT00651547|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110436708|NCT00651547|Autonomic Agents|autonomic agents|mesh-ancestor
110436709|NCT00651547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110436710|NCT00651547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110436711|NCT00651547|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110436712|NCT00651547|Respiratory System Agents|respiratory system agents|mesh-ancestor
110436713|NCT00651547|Glucocorticoids|glucocorticoids|mesh-ancestor
110436714|NCT00651547|Hormones|hormones|mesh-ancestor
110436715|NCT00651547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110436716|NCT00651547|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110436717|NCT00651547|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110436718|NCT00651547|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110436719|NCT00651547|Adrenergic Agents|adrenergic agents|mesh-ancestor
110436720|NCT00651547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110436721|NCT00651547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110436723|NCT00912808|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110436724|NCT00912808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110436725|NCT00912808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110436726|NCT00912808|Cholinergic Agents|cholinergic agents|mesh-ancestor
110436727|NCT00912808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110436728|NCT00912808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110436729|NCT00912808|Nootropic Agents|nootropic agents|mesh-ancestor
110436730|NCT02647255|Methylprednisolone|methylprednisolone|mesh-list
110436731|NCT02647255|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110436732|NCT02647255|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110436733|NCT02647255|Prednisolone|prednisolone|mesh-list
110436734|NCT02647255|Prednisolone acetate|prednisolone acetate|mesh-list
110436735|NCT02647255|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110436736|NCT02647255|Prednisolone phosphate|prednisolone phosphate|mesh-list
110436737|NCT02647255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110372441|NCT03454217|Oxycodone|oxycodone|mesh-list
110436738|NCT02647255|Antiemetics|antiemetics|mesh-ancestor
110436739|NCT02647255|Autonomic Agents|autonomic agents|mesh-ancestor
110436740|NCT02647255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110436741|NCT02647255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110436742|NCT02647255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110436743|NCT02647255|Glucocorticoids|glucocorticoids|mesh-ancestor
110436744|NCT02647255|Hormones|hormones|mesh-ancestor
110436745|NCT02647255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110436746|NCT02647255|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110436747|NCT02647255|Protective Agents|protective agents|mesh-ancestor
110436748|NCT02647255|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110436749|NCT02647255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110436750|NCT04329442|Tenofovir|tenofovir|mesh-list
110436751|NCT04329442|Emtricitabine|emtricitabine|mesh-list
110436752|NCT04329442|Antiviral Agents|antiviral agents|mesh-ancestor
110436753|NCT04329442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110436754|NCT04329442|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110436755|NCT04329442|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110436756|NCT04329442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110436757|NCT04329442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110436758|NCT04329442|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110436759|NCT04329442|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110436760|NCT04414228|Anesthetics|anesthetics|mesh-list
110436761|NCT04414228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110436762|NCT04414228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110436763|NCT00960531|Saponin QA-21V1|saponin qa-21v1|mesh-list
110436764|NCT00960531|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110436765|NCT00960531|Immunologic Factors|immunologic factors|mesh-ancestor
110436766|NCT00960531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110436767|NCT03017833|Metformin|metformin|mesh-list
110436768|NCT03017833|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110436769|NCT03017833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110436770|NCT02859909|Immunoglobulins|immunoglobulins|mesh-list
110436771|NCT02859909|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110436772|NCT02859909|Immunologic Factors|immunologic factors|mesh-ancestor
110436773|NCT02859909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110436774|NCT00652639|Clonazepam|clonazepam|mesh-list
110436775|NCT00652639|Anticonvulsants|anticonvulsants|mesh-ancestor
110436776|NCT00652639|GABA Modulators|gaba modulators|mesh-ancestor
110436777|NCT00652639|GABA Agents|gaba agents|mesh-ancestor
110436778|NCT00652639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110436779|NCT00652639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110436780|NCT00652639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110436781|NCT02644915|Edaravone|edaravone|mesh-list
110436782|NCT02644915|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110083744|NCT01656330|Anticoagulants|anticoagulants|mesh-ancestor
110436783|NCT02644915|Antioxidants|antioxidants|mesh-ancestor
110205701|NCT00174226|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110436784|NCT02644915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110436785|NCT02644915|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110436786|NCT02644915|Protective Agents|protective agents|mesh-ancestor
110436787|NCT02644915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110436788|NCT00651703|Imiquimod|imiquimod|mesh-list
110436789|NCT00651703|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
110436790|NCT00651703|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110436791|NCT00651703|Immunologic Factors|immunologic factors|mesh-ancestor
110436792|NCT00651703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110436793|NCT00651703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110436794|NCT00651703|Interferon Inducers|interferon inducers|mesh-ancestor
110436795|NCT02964585|Canagliflozin|canagliflozin|mesh-list
110436796|NCT02964585|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110436797|NCT02964585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110436798|NCT02964585|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110436799|NCT02964585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110436800|NCT02640703|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110436801|NCT02640703|Immunologic Factors|immunologic factors|mesh-ancestor
110436802|NCT02640703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110436803|NCT00651781|Bortezomib|bortezomib|mesh-list
110436804|NCT00651781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110436805|NCT00957801|Methylprednisolone|methylprednisolone|mesh-list
110436806|NCT00957801|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110436807|NCT00957801|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110436808|NCT00957801|Prednisolone|prednisolone|mesh-list
110436809|NCT00957801|Prednisolone acetate|prednisolone acetate|mesh-list
110436810|NCT00957801|Methyltestosterone|methyltestosterone|mesh-list
110436811|NCT00957801|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110436812|NCT00957801|Prednisolone phosphate|prednisolone phosphate|mesh-list
110436813|NCT00957801|Testosterone|testosterone|mesh-list
110436814|NCT00957801|Testosterone undecanoate|testosterone undecanoate|mesh-list
110436815|NCT00957801|Testosterone enanthate|testosterone enanthate|mesh-list
110436816|NCT00957801|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
110436817|NCT00957801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110436818|NCT00957801|Antiemetics|antiemetics|mesh-ancestor
110436819|NCT00957801|Autonomic Agents|autonomic agents|mesh-ancestor
110436820|NCT00957801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110436821|NCT00957801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110436822|NCT00957801|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110436823|NCT00957801|Glucocorticoids|glucocorticoids|mesh-ancestor
110436825|NCT00957801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110436826|NCT00957801|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110436827|NCT00957801|Protective Agents|protective agents|mesh-ancestor
110436828|NCT00957801|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110436829|NCT00957801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110436830|NCT00957801|Androgens|androgens|mesh-ancestor
110436831|NCT00957801|Anabolic Agents|anabolic agents|mesh-ancestor
110436832|NCT02640469|Chlorhexidine|chlorhexidine|mesh-list
110436833|NCT02640469|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110436834|NCT02640469|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110436835|NCT02640469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110436836|NCT02640469|Disinfectants|disinfectants|mesh-ancestor
110436837|NCT02640469|Dermatologic Agents|dermatologic agents|mesh-ancestor
110436838|NCT02646709|Ketamine|ketamine|mesh-list
110436839|NCT02646709|Rocuronium|rocuronium|mesh-list
110436840|NCT02646709|Analgesics|analgesics|mesh-ancestor
110436841|NCT02646709|Sensory System Agents|sensory system agents|mesh-ancestor
110436842|NCT02646709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110436843|NCT02646709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110436844|NCT02646709|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110436845|NCT02646709|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110436846|NCT02646709|Anesthetics, General|anesthetics, general|mesh-ancestor
110436847|NCT02646709|Anesthetics|anesthetics|mesh-ancestor
110436848|NCT02646709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110205714|NCT00174304|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110436849|NCT02646709|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110436850|NCT02646709|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110436851|NCT02646709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110436852|NCT02646709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110436853|NCT02646709|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110436854|NCT02646709|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110436855|NCT02646709|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110436856|NCT00651859|Bimatoprost|bimatoprost|mesh-list
110436857|NCT00651859|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110436858|NCT00651859|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110436859|NCT00651859|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110436860|NCT02640313|Choline|choline|mesh-list
110436861|NCT02640313|Lipotropic Agents|lipotropic agents|mesh-ancestor
110436862|NCT02640313|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110436863|NCT02640313|Antimetabolites|antimetabolites|mesh-ancestor
110436864|NCT02640313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110436865|NCT02640313|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110436866|NCT02640313|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110436867|NCT02640313|Nootropic Agents|nootropic agents|mesh-ancestor
110436868|NCT02955823|Dexamethasone|dexamethasone|mesh-list
110436869|NCT02955823|Rituximab|rituximab|mesh-list
110436870|NCT02955823|Lenalidomide|lenalidomide|mesh-list
110436871|NCT02955823|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110436872|NCT02955823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110436873|NCT02955823|Immunologic Factors|immunologic factors|mesh-ancestor
110436874|NCT02955823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110436875|NCT02955823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110436876|NCT02955823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110436877|NCT02955823|Antiemetics|antiemetics|mesh-ancestor
110436878|NCT02955823|Autonomic Agents|autonomic agents|mesh-ancestor
110436879|NCT02955823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110436880|NCT02955823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110436881|NCT02955823|Glucocorticoids|glucocorticoids|mesh-ancestor
110436882|NCT02955823|Hormones|hormones|mesh-ancestor
110436883|NCT02955823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110436884|NCT02955823|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110436885|NCT02955823|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110436886|NCT02955823|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110436887|NCT02955823|Growth Substances|growth substances|mesh-ancestor
110436888|NCT02955823|Growth Inhibitors|growth inhibitors|mesh-ancestor
110436889|NCT02646397|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110436890|NCT02646397|Fosinopril|fosinopril|mesh-list
110436891|NCT02646397|Benidipine|benidipine|mesh-list
110436892|NCT02646397|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110436893|NCT02646397|Diuretics|diuretics|mesh-ancestor
110436894|NCT02646397|Natriuretic Agents|natriuretic agents|mesh-ancestor
110436895|NCT02646397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110436896|NCT02646397|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110436897|NCT02646397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110436898|NCT02646397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110436899|NCT02646397|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110436900|NCT02646397|Protease Inhibitors|protease inhibitors|mesh-ancestor
110436901|NCT02646397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110436902|NCT02646397|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110436903|NCT02646397|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110436904|NCT02646397|Vasodilator Agents|vasodilator agents|mesh-ancestor
110436906|NCT00652795|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110436907|NCT00652795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110436908|NCT00652795|Antimalarials|antimalarials|mesh-ancestor
110436909|NCT00652795|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110436910|NCT00652795|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110436911|NCT00911170|Bevacizumab|bevacizumab|mesh-list
110436912|NCT00911170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110436913|NCT00911170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110436914|NCT00911170|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110436915|NCT00911170|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110436916|NCT00911170|Growth Substances|growth substances|mesh-ancestor
110436917|NCT00911170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110436918|NCT00911170|Growth Inhibitors|growth inhibitors|mesh-ancestor
110436919|NCT00910975|Interferons|interferons|mesh-list
110436920|NCT00910975|Ribavirin|ribavirin|mesh-list
110436921|NCT00910975|Interferon-alpha|interferon-alpha|mesh-list
110436922|NCT00910975|Interferon alpha-2|interferon alpha-2|mesh-list
110436923|NCT00910975|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110436924|NCT00910975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110436925|NCT00910975|Antiviral Agents|antiviral agents|mesh-ancestor
110436926|NCT00910975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110436927|NCT00910975|Antimetabolites|antimetabolites|mesh-ancestor
110436928|NCT00910975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110436929|NCT00910975|Immunologic Factors|immunologic factors|mesh-ancestor
110436930|NCT00910975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110436931|NCT01167881|Glimepiride|glimepiride|mesh-list
110436932|NCT01167881|Empagliflozin|empagliflozin|mesh-list
110436933|NCT01167881|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110436934|NCT01167881|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110436935|NCT01167881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110436936|NCT01167881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110436937|NCT01167881|Immunologic Factors|immunologic factors|mesh-ancestor
110436938|NCT01167881|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110436939|NCT01167881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110436940|NCT02646085|Carbon-11 methionine|carbon-11 methionine|mesh-list
110436941|NCT02646085|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110436942|NCT02646085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110436943|NCT02639767|Pemetrexed|pemetrexed|mesh-list
110436944|NCT02639767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110436945|NCT02639767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110436946|NCT02639767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110436947|NCT02639767|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110436948|NCT02639767|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110436949|NCT04829344|Carticaine|carticaine|mesh-list
110436950|NCT04829344|Anesthetics, Local|anesthetics, local|mesh-ancestor
110436951|NCT04829344|Anesthetics|anesthetics|mesh-ancestor
110436952|NCT04829344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110436953|NCT04829344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110436954|NCT04829344|Sensory System Agents|sensory system agents|mesh-ancestor
110436955|NCT04829344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110436956|NCT00960063|Cyclophosphamide|cyclophosphamide|mesh-list
110436957|NCT00960063|Temozolomide|temozolomide|mesh-list
110436958|NCT00960063|Ifosfamide|ifosfamide|mesh-list
110436959|NCT00960063|Doxorubicin|doxorubicin|mesh-list
110436960|NCT00960063|Irinotecan|irinotecan|mesh-list
110436961|NCT00960063|Etoposide|etoposide|mesh-list
110436962|NCT00960063|Vincristine|vincristine|mesh-list
110436963|NCT00960063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110436964|NCT00960063|Immunologic Factors|immunologic factors|mesh-ancestor
110436965|NCT00960063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110436966|NCT00960063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110436967|NCT00960063|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110436968|NCT00960063|Alkylating Agents|alkylating agents|mesh-ancestor
110436969|NCT00960063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110436970|NCT00960063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110436971|NCT00960063|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110436972|NCT00960063|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110436973|NCT00960063|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110436974|NCT00960063|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110436975|NCT00960063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110436976|NCT00960063|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110436977|NCT00960063|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110436979|NCT00960063|Antimitotic Agents|antimitotic agents|mesh-ancestor
110436980|NCT00960063|Mitosis Modulators|mitosis modulators|mesh-ancestor
110436981|NCT02646319|Sirolimus|sirolimus|mesh-list
110436982|NCT02646319|Temsirolimus|temsirolimus|mesh-list
110436983|NCT02646319|MTOR Inhibitors|mtor inhibitors|mesh-list
110436984|NCT02646319|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110436985|NCT02646319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110436986|NCT02646319|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110436987|NCT02646319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110436988|NCT02646319|Antifungal Agents|antifungal agents|mesh-ancestor
110436989|NCT02646319|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110436990|NCT02646319|Immunologic Factors|immunologic factors|mesh-ancestor
110436991|NCT02646319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110436992|NCT02646319|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110436993|NCT02646319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110436994|NCT02646319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110436995|NCT00653965|Atorvastatin|atorvastatin|mesh-list
110436996|NCT00653965|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110436997|NCT00653965|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110436998|NCT00653965|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110436999|NCT00653965|Antimetabolites|antimetabolites|mesh-ancestor
110437000|NCT00653965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110437001|NCT00653965|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110437002|NCT00653965|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110437003|NCT00653965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110437004|NCT00959907|Botulinum Toxins|botulinum toxins|mesh-list
110437005|NCT00959907|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110437006|NCT00959907|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110083967|NCT01657682|Crenolanib|crenolanib|mesh-list
110437007|NCT00959907|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
110437008|NCT00959907|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110437009|NCT00959907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110437010|NCT00959907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110437011|NCT00959907|Cholinergic Agents|cholinergic agents|mesh-ancestor
110437012|NCT00959907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110437013|NCT00959907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110437014|NCT00959907|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110437015|NCT00959907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110437016|NCT00912340|Trastuzumab|trastuzumab|mesh-list
110437017|NCT00912340|Everolimus|everolimus|mesh-list
110437018|NCT00912340|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110437019|NCT00912340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110437020|NCT00912340|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110437021|NCT00912340|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110437022|NCT00912340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110372526|NCT00576069|Prednisone|prednisone|mesh-list
110437023|NCT00912340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110437024|NCT00912340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110437026|NCT00912340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110437027|NCT01167257|Botulinum Toxins|botulinum toxins|mesh-list
110437028|NCT01167257|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110437029|NCT01167257|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110437030|NCT01167257|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110437031|NCT01167257|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110437032|NCT01167257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110437033|NCT01167257|Cholinergic Agents|cholinergic agents|mesh-ancestor
110437034|NCT01167257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110437035|NCT01167257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110437036|NCT01167257|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110437037|NCT01167257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110437038|NCT01119846|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110437039|NCT01119846|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110437040|NCT01119846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110437041|NCT01119846|Incretins|incretins|mesh-ancestor
110437042|NCT01119846|Hormones|hormones|mesh-ancestor
110437043|NCT01119846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110437044|NCT01119846|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110437045|NCT01119846|Protease Inhibitors|protease inhibitors|mesh-ancestor
110437046|NCT01119846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110437047|NCT01119846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110437048|NCT03775525|Capecitabine|capecitabine|mesh-list
110437049|NCT03775525|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110437050|NCT03775525|Antimetabolites|antimetabolites|mesh-ancestor
110437051|NCT03775525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110437052|NCT03775525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110437053|NCT00654043|Torsemide|torsemide|mesh-list
110437054|NCT00654043|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110437055|NCT00654043|Diuretics|diuretics|mesh-ancestor
110437056|NCT00654043|Natriuretic Agents|natriuretic agents|mesh-ancestor
110437057|NCT00654043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110437058|NCT00654043|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110437059|NCT00654043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110437060|NCT00654043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110437061|NCT04167007|Gemcitabine|gemcitabine|mesh-list
110437062|NCT04167007|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110437063|NCT04167007|Antimetabolites|antimetabolites|mesh-ancestor
110437064|NCT04167007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110437065|NCT04167007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110437066|NCT01167023|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
110437067|NCT01167023|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110437068|NCT00654121|Insulin|insulin|mesh-list
110437069|NCT00654121|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110437070|NCT00654121|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110437071|NCT00654121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110437072|NCT01166945|Amoxicillin|amoxicillin|mesh-list
110437073|NCT01166945|Clavulanic Acid|clavulanic acid|mesh-list
110437074|NCT01166945|Clavulanic Acids|clavulanic acids|mesh-list
110437075|NCT01166945|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
110437076|NCT01166945|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110437077|NCT01166945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110437078|NCT01166945|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110437079|NCT01166945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110437080|NCT01166945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110437081|NCT02639533|Pregabalin|pregabalin|mesh-list
110437082|NCT02639533|Analgesics|analgesics|mesh-ancestor
110437083|NCT02639533|Sensory System Agents|sensory system agents|mesh-ancestor
110437084|NCT02639533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110437085|NCT02639533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110437086|NCT02639533|Anticonvulsants|anticonvulsants|mesh-ancestor
110437087|NCT02639533|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110437088|NCT02639533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110437089|NCT02639533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110437090|NCT02639533|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110437091|NCT02639533|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110437092|NCT02639533|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110437093|NCT02639533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110437094|NCT02639533|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110437095|NCT02639377|Chlorhexidine|chlorhexidine|mesh-list
110437096|NCT02639377|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110437097|NCT02639377|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110437098|NCT02639377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110437099|NCT02639377|Disinfectants|disinfectants|mesh-ancestor
110437100|NCT02639377|Dermatologic Agents|dermatologic agents|mesh-ancestor
110437101|NCT00910000|Carboplatin|carboplatin|mesh-list
110437102|NCT00910000|Gemcitabine|gemcitabine|mesh-list
110437103|NCT00910000|Vorinostat|vorinostat|mesh-list
110437104|NCT00910000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110437105|NCT00910000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110437106|NCT00910000|Antimetabolites|antimetabolites|mesh-ancestor
110437107|NCT00910000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110437108|NCT00910000|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110437109|NCT00910000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110437111|NCT02885909|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110437112|NCT02885909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110437113|NCT05657171|Cyproterone Acetate|cyproterone acetate|mesh-list
110437114|NCT05657171|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110437115|NCT05657171|Estradiol|estradiol|mesh-list
110437116|NCT05657171|Cyproterone|cyproterone|mesh-list
110437117|NCT05657171|Estrogens|estrogens|mesh-ancestor
110437118|NCT05657171|Hormones|hormones|mesh-ancestor
110437119|NCT05657171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110437120|NCT05657171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110437121|NCT05657171|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110437122|NCT05657171|Contraceptive Agents|contraceptive agents|mesh-ancestor
110437123|NCT05657171|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110437124|NCT05657171|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110437125|NCT05657171|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110437126|NCT05657171|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110437127|NCT05657171|Androgen Antagonists|androgen antagonists|mesh-ancestor
110437128|NCT05657171|Hormone Antagonists|hormone antagonists|mesh-ancestor
110437129|NCT05657171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110437130|NCT05657171|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110437131|NCT00652873|Cabergoline|cabergoline|mesh-list
110437132|NCT00652873|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110437133|NCT00652873|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110437134|NCT00652873|Dopamine Agonists|dopamine agonists|mesh-ancestor
110437135|NCT00652873|Dopamine Agents|dopamine agents|mesh-ancestor
110437136|NCT00652873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110437137|NCT00652873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110437138|NCT00652873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110437139|NCT00652171|Lamotrigine|lamotrigine|mesh-list
110437140|NCT00652171|Anticonvulsants|anticonvulsants|mesh-ancestor
110437141|NCT00652171|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110437142|NCT00652171|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110437143|NCT00652171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110437144|NCT00652171|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110437145|NCT00652171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110437146|NCT00652171|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110437147|NCT00652171|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110437148|NCT00652171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110437149|NCT00652171|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110437150|NCT00652171|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110437151|NCT01119768|Esomeprazole|esomeprazole|mesh-list
110437152|NCT01119768|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110437153|NCT01119768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110437154|NCT01119768|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110437155|NCT01119768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110437156|NCT01119768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110437157|NCT01165307|Naproxen|naproxen|mesh-list
110437158|NCT01165307|Levonorgestrel|levonorgestrel|mesh-list
110437159|NCT01165307|Contraceptive Agents|contraceptive agents|mesh-list
110437160|NCT01165307|Contraceptives, Oral|contraceptives, oral|mesh-list
110437161|NCT01165307|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
110437162|NCT01165307|Estradiol|estradiol|mesh-list
110437163|NCT01165307|Estrogens|estrogens|mesh-ancestor
110437164|NCT01165307|Hormones|hormones|mesh-ancestor
110437165|NCT01165307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110437166|NCT01165307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110437167|NCT01165307|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110437168|NCT01165307|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110437169|NCT01165307|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110437170|NCT01165307|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110437171|NCT01165307|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110437172|NCT01165307|Analgesics|analgesics|mesh-ancestor
110437173|NCT01165307|Sensory System Agents|sensory system agents|mesh-ancestor
110437174|NCT01165307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110437175|NCT01165307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110437176|NCT01165307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110437177|NCT01165307|Gout Suppressants|gout suppressants|mesh-ancestor
110437178|NCT01165307|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110437179|NCT01165307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110437180|NCT01165307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110437181|NCT01165307|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110437182|NCT02639143|Clopidogrel|clopidogrel|mesh-list
110437183|NCT02639143|Ticagrelor|ticagrelor|mesh-list
110437184|NCT02639143|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110437185|NCT02639143|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110437186|NCT02639143|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110437187|NCT02639143|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110437188|NCT02639143|Purinergic Agents|purinergic agents|mesh-ancestor
110437189|NCT02639143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110437190|NCT02639143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110437191|NCT02639143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110437192|NCT02644057|Dobutamine|dobutamine|mesh-list
110437193|NCT02644057|Milrinone|milrinone|mesh-list
110437194|NCT02644057|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110437195|NCT02644057|Sympathomimetics|sympathomimetics|mesh-ancestor
110437196|NCT02644057|Autonomic Agents|autonomic agents|mesh-ancestor
110564710|NCT04812548|Azacitidine|azacitidine|mesh-list
110437197|NCT02644057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110437198|NCT02644057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110437199|NCT02644057|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
110437200|NCT02644057|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110437201|NCT02644057|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110437202|NCT02644057|Adrenergic Agents|adrenergic agents|mesh-ancestor
110437203|NCT02644057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110437204|NCT02644057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110437205|NCT02644057|Protective Agents|protective agents|mesh-ancestor
110437206|NCT02644057|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110437207|NCT02644057|Vasodilator Agents|vasodilator agents|mesh-ancestor
110437208|NCT02644057|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110437209|NCT02644057|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110437210|NCT02644057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110437211|NCT00654277|Ondansetron|ondansetron|mesh-list
110437212|NCT00654277|Antiemetics|antiemetics|mesh-ancestor
110437213|NCT00654277|Autonomic Agents|autonomic agents|mesh-ancestor
110437214|NCT00654277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110437215|NCT00654277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110437216|NCT00654277|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110437217|NCT00654277|Antipruritics|antipruritics|mesh-ancestor
110437218|NCT00654277|Dermatologic Agents|dermatologic agents|mesh-ancestor
110437219|NCT00654277|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110437220|NCT00654277|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110437221|NCT00654277|Serotonin Agents|serotonin agents|mesh-ancestor
110437222|NCT00654277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110437223|NCT00654277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110437224|NCT01124838|Prednisone|prednisone|mesh-list
110437225|NCT01124838|Adalimumab|adalimumab|mesh-list
110437226|NCT01124838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110437227|NCT01124838|Glucocorticoids|glucocorticoids|mesh-ancestor
110437228|NCT01124838|Hormones|hormones|mesh-ancestor
110437229|NCT01124838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110437230|NCT01124838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110437231|NCT01124838|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110437233|NCT01124838|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110437234|NCT01124838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110437235|NCT00630435|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
110437236|NCT00630435|Estrogens|estrogens|mesh-ancestor
110437237|NCT00630435|Hormones|hormones|mesh-ancestor
110437238|NCT00630435|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110437239|NCT00630435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110437240|NCT02858193|Carbocysteine|carbocysteine|mesh-list
110437241|NCT02858193|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110437242|NCT02858193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110437243|NCT02858193|Expectorants|expectorants|mesh-ancestor
110437244|NCT02858193|Respiratory System Agents|respiratory system agents|mesh-ancestor
110437245|NCT02581215|Ramucirumab|ramucirumab|mesh-list
110437246|NCT02581215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110437247|NCT04282941|Ibuprofen|ibuprofen|mesh-list
110437248|NCT04282941|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110437249|NCT04282941|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110437250|NCT04282941|Analgesics|analgesics|mesh-ancestor
110437251|NCT04282941|Sensory System Agents|sensory system agents|mesh-ancestor
110437252|NCT04282941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110437253|NCT04282941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110437254|NCT04282941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110437255|NCT04282941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110437256|NCT04282941|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110437257|NCT04282941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110437258|NCT04282941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110437260|NCT00910858|Epoetin Alfa|epoetin alfa|mesh-list
110437261|NCT00910858|Immunologic Factors|immunologic factors|mesh-ancestor
110437262|NCT00910858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110437263|NCT00910858|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110437264|NCT00910858|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110437265|NCT00910858|Growth Substances|growth substances|mesh-ancestor
110437266|NCT00910858|Growth Inhibitors|growth inhibitors|mesh-ancestor
110437267|NCT00910858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110437268|NCT00910858|Hematinics|hematinics|mesh-ancestor
110437269|NCT02567253|Cisplatin|cisplatin|mesh-list
110437270|NCT02567253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110437271|NCT02859285|Estradiol|estradiol|mesh-list
110437272|NCT02859285|Estrogens|estrogens|mesh-ancestor
110437273|NCT02859285|Hormones|hormones|mesh-ancestor
110437274|NCT02859285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110437275|NCT02859285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110437276|NCT04260412|Psyllium|psyllium|mesh-list
110437277|NCT04260412|Cathartics|cathartics|mesh-ancestor
110437278|NCT04260412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110437279|NCT03223155|Nivolumab|nivolumab|mesh-list
110437280|NCT03223155|Ipilimumab|ipilimumab|mesh-list
110437281|NCT03223155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110437282|NCT03223155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110437283|NCT03223155|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110437284|NCT03223155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110437285|NCT04476550|Lenograstim|lenograstim|mesh-list
110437286|NCT04476550|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110437287|NCT04476550|Immunologic Factors|immunologic factors|mesh-ancestor
110205793|NCT00174655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110437288|NCT04476550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110437289|NCT00598975|Irinotecan|irinotecan|mesh-list
110437290|NCT00598975|Cetuximab|cetuximab|mesh-list
110437291|NCT00598975|Etirinotecan pegol|etirinotecan pegol|mesh-list
110437292|NCT00598975|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110437293|NCT00598975|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110437294|NCT00598975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110437295|NCT00598975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110437296|NCT00598975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110437297|NCT00598975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110437298|NCT00598975|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110437300|NCT01124604|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110437301|NCT01124604|Narcotics|narcotics|mesh-ancestor
110437302|NCT01124604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110437303|NCT01124604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110437304|NCT01124604|Analgesics|analgesics|mesh-ancestor
110437305|NCT01124604|Sensory System Agents|sensory system agents|mesh-ancestor
110437306|NCT01124604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110437307|NCT01124604|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110437308|NCT01124604|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110437309|NCT01124604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110437310|NCT01124604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110437311|NCT01124604|Adrenergic Agents|adrenergic agents|mesh-ancestor
110437312|NCT01124604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110437313|NCT00909844|Triptorelin Pamoate|triptorelin pamoate|mesh-list
110437314|NCT00909844|Luteolytic Agents|luteolytic agents|mesh-ancestor
110437315|NCT00909844|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110437316|NCT00909844|Contraceptive Agents|contraceptive agents|mesh-ancestor
110437317|NCT00909844|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110437318|NCT00909844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110437319|NCT00909844|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110437320|NCT00909844|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110437321|NCT00909844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110437322|NCT01124448|TFF1 protein, human|tff1 protein, human|mesh-list
110437323|NCT01124448|Growth Inhibitors|growth inhibitors|mesh-ancestor
110437324|NCT01124448|Growth Substances|growth substances|mesh-ancestor
110437325|NCT01124448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110437327|NCT02638909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110437328|NCT02638909|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110437329|NCT02638909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110437330|NCT02638909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110437331|NCT02643823|Methotrexate|methotrexate|mesh-list
110437332|NCT02643823|Antirheumatic Agents|antirheumatic agents|mesh-list
110437333|NCT02643823|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110437334|NCT02643823|Abortifacient Agents|abortifacient agents|mesh-ancestor
110437335|NCT02643823|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110437336|NCT02643823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110437337|NCT02643823|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110437338|NCT02643823|Antimetabolites|antimetabolites|mesh-ancestor
110437339|NCT02643823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110437340|NCT02643823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110437341|NCT02643823|Dermatologic Agents|dermatologic agents|mesh-ancestor
110437342|NCT02643823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110437343|NCT02643823|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110437344|NCT02643823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110437345|NCT02643823|Immunologic Factors|immunologic factors|mesh-ancestor
110437346|NCT02643823|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110437347|NCT02638831|Ketorolac|ketorolac|mesh-list
110437348|NCT02638831|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
110437349|NCT02638831|Ketoprofen|ketoprofen|mesh-list
110437350|NCT02638831|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110437351|NCT02638831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110437353|NCT02638831|Sensory System Agents|sensory system agents|mesh-ancestor
110437354|NCT02638831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110437355|NCT02638831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110437356|NCT02638831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110437357|NCT02638831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110437358|NCT02638831|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110437359|NCT02638831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110437360|NCT02638831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110437361|NCT01136772|Haloperidol|haloperidol|mesh-list
110437362|NCT01136772|Paliperidone Palmitate|paliperidone palmitate|mesh-list
110437363|NCT01136772|Haloperidol decanoate|haloperidol decanoate|mesh-list
110437364|NCT01136772|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110437365|NCT01136772|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110437366|NCT01136772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110437367|NCT01136772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110437368|NCT01136772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110437369|NCT01136772|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110437370|NCT01136772|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110437371|NCT01136772|Serotonin Agents|serotonin agents|mesh-ancestor
110437372|NCT01136772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110437373|NCT01136772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110437374|NCT01136772|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110437375|NCT01136772|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110437376|NCT01136772|Dopamine Agents|dopamine agents|mesh-ancestor
110437377|NCT01136772|Antiemetics|antiemetics|mesh-ancestor
110437378|NCT01136772|Autonomic Agents|autonomic agents|mesh-ancestor
110437379|NCT01136772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110437380|NCT01136772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110437381|NCT01136772|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110437383|NCT00909532|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
110437384|NCT00909532|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110437385|NCT00909532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110437386|NCT02756845|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
110437387|NCT02756845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110437388|NCT02756845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110437389|NCT01136382|Budesonide|budesonide|mesh-list
110437390|NCT01136382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110437391|NCT01136382|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110437392|NCT01136382|Autonomic Agents|autonomic agents|mesh-ancestor
110437393|NCT01136382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110437394|NCT01136382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110437395|NCT01136382|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110437396|NCT01136382|Respiratory System Agents|respiratory system agents|mesh-ancestor
110437397|NCT01136382|Glucocorticoids|glucocorticoids|mesh-ancestor
110437399|NCT01136382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110437400|NCT03513562|Venetoclax|venetoclax|mesh-list
110437401|NCT03513562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110437402|NCT02731729|Nivolumab|nivolumab|mesh-list
110437403|NCT02731729|Ipilimumab|ipilimumab|mesh-list
110437404|NCT02731729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110437405|NCT02731729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110437406|NCT02731729|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110437407|NCT02731729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110437408|NCT02645461|Palmidrol|palmidrol|mesh-list
110437409|NCT02645461|Riluzole|riluzole|mesh-list
110437410|NCT02645461|Anticonvulsants|anticonvulsants|mesh-ancestor
110437411|NCT02645461|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110437412|NCT02645461|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110437413|NCT02645461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110437414|NCT02645461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110437415|NCT02645461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110437416|NCT02645461|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110437417|NCT02645461|Protective Agents|protective agents|mesh-ancestor
110437418|NCT02645461|Analgesics|analgesics|mesh-ancestor
110437419|NCT02645461|Sensory System Agents|sensory system agents|mesh-ancestor
110437420|NCT02645461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110437421|NCT02645461|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110437422|NCT02645461|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110437423|NCT02645461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110437424|NCT02645461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110437425|NCT02645461|Antiviral Agents|antiviral agents|mesh-ancestor
110437426|NCT02645461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110437427|NCT02645461|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
110437428|NCT02645461|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110437430|NCT02645461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110437431|NCT00654589|Deferasirox|deferasirox|mesh-list
110437432|NCT00654589|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110437433|NCT00654589|Chelating Agents|chelating agents|mesh-ancestor
110437434|NCT00654589|Sequestering Agents|sequestering agents|mesh-ancestor
110437435|NCT00654589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110437436|NCT02645227|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110437437|NCT02645227|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110437438|NCT02645227|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110437439|NCT02645227|Antimetabolites|antimetabolites|mesh-ancestor
110437440|NCT02645227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110437441|NCT02645227|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110437442|NCT02645227|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110437443|NCT02645227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110437444|NCT00652483|Brimonidine Tartrate|brimonidine tartrate|mesh-list
110437445|NCT00652483|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110437446|NCT00652483|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110437447|NCT00652483|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110437448|NCT00652483|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110437449|NCT00652483|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110437450|NCT00652483|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110437451|NCT00652483|Adrenergic Agents|adrenergic agents|mesh-ancestor
110437452|NCT00652483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110437453|NCT00652483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110437454|NCT00652483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110437455|NCT01119066|Cyclophosphamide|cyclophosphamide|mesh-list
110437456|NCT01119066|Melphalan|melphalan|mesh-list
110437457|NCT01119066|Busulfan|busulfan|mesh-list
110437458|NCT01119066|Thiotepa|thiotepa|mesh-list
110437459|NCT01119066|Fludarabine|fludarabine|mesh-list
110437460|NCT01119066|Clofarabine|clofarabine|mesh-list
110437461|NCT01119066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110437462|NCT01119066|Immunologic Factors|immunologic factors|mesh-ancestor
110437463|NCT01119066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110437464|NCT01119066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110437465|NCT01119066|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110437466|NCT01119066|Alkylating Agents|alkylating agents|mesh-ancestor
110437467|NCT01119066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110437468|NCT01119066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110437469|NCT01119066|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110437470|NCT01119066|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110437471|NCT01119066|Antimetabolites|antimetabolites|mesh-ancestor
110437473|NCT00910624|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110437474|NCT00910624|Antimetabolites|antimetabolites|mesh-ancestor
110437475|NCT00910624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110437476|NCT00910624|Antiviral Agents|antiviral agents|mesh-ancestor
110437477|NCT00910624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110437478|NCT00654667|Resveratrol|resveratrol|mesh-list
110437479|NCT00654667|Antioxidants|antioxidants|mesh-ancestor
110437480|NCT00654667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110437481|NCT00654667|Protective Agents|protective agents|mesh-ancestor
110437482|NCT00654667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110437483|NCT00654667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110437484|NCT00654667|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110437485|NCT01123980|Insulin|insulin|mesh-list
110437486|NCT01123980|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110437487|NCT01123980|Metformin|metformin|mesh-list
110437488|NCT01123980|Insulin Glargine|insulin glargine|mesh-list
110437489|NCT01123980|Insulin Aspart|insulin aspart|mesh-list
110437490|NCT01123980|Glimepiride|glimepiride|mesh-list
110437491|NCT01123980|Biphasic Insulins|biphasic insulins|mesh-list
110655645|NCT01037530|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110437492|NCT01123980|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
110437493|NCT01123980|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110437494|NCT01123980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110437495|NCT01123980|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110437496|NCT01123980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110437497|NCT01123980|Immunologic Factors|immunologic factors|mesh-ancestor
110437498|NCT02859129|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
110437499|NCT02859129|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110437500|NCT02859129|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110437501|NCT02859129|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110437502|NCT02859129|Antimetabolites|antimetabolites|mesh-ancestor
110437503|NCT02859129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110437504|NCT02859129|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110437505|NCT02859129|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110437506|NCT02859129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110437507|NCT02859129|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110437509|NCT04164823|Sensory System Agents|sensory system agents|mesh-ancestor
110437510|NCT04164823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110437511|NCT04164823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110437512|NCT02857959|Penicillins|penicillins|mesh-list
110437513|NCT02857959|Penicillin G|penicillin g|mesh-list
110437514|NCT02857959|Penicillin G Benzathine|penicillin g benzathine|mesh-list
110437515|NCT02857959|Penicillin G Procaine|penicillin g procaine|mesh-list
110437516|NCT02857959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110437517|NCT02857959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110437518|NCT02643433|Vaccines|vaccines|mesh-list
110437519|NCT02643433|Immunologic Factors|immunologic factors|mesh-ancestor
110437520|NCT02643433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110437521|NCT00632476|Ascorbic Acid|ascorbic acid|mesh-list
110437522|NCT00632476|Vitamins|vitamins|mesh-ancestor
110437523|NCT00632476|Micronutrients|micronutrients|mesh-ancestor
110437524|NCT00632476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110437525|NCT00632476|Antioxidants|antioxidants|mesh-ancestor
110437526|NCT00632476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110437527|NCT00632476|Protective Agents|protective agents|mesh-ancestor
110437528|NCT04164745|Pembrolizumab|pembrolizumab|mesh-list
110437529|NCT04164745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110437530|NCT04164745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110437531|NCT04164745|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110437532|NCT04164745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110437533|NCT01198522|Gemcitabine|gemcitabine|mesh-list
110437535|NCT01198522|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110437536|NCT01198522|Immunologic Factors|immunologic factors|mesh-ancestor
110437537|NCT01198522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110437538|NCT01198522|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110437539|NCT01198522|Antimetabolites|antimetabolites|mesh-ancestor
110437540|NCT01198522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110437541|NCT01198522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110437542|NCT02638285|Clomiphene|clomiphene|mesh-list
110437543|NCT02638285|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110437544|NCT02638285|Hormone Antagonists|hormone antagonists|mesh-ancestor
110437545|NCT02638285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110437546|NCT02638285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110437547|NCT02638285|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110437548|NCT02638285|Fertility Agents|fertility agents|mesh-ancestor
110437549|NCT02638285|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110437550|NCT02638285|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110437551|NCT02638285|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110437552|NCT01134250|Paclitaxel|paclitaxel|mesh-list
110437553|NCT01134250|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110437554|NCT01134250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110437555|NCT01134250|Tubulin Modulators|tubulin modulators|mesh-ancestor
110437556|NCT01134250|Antimitotic Agents|antimitotic agents|mesh-ancestor
110437558|NCT01134250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110437559|NCT01118520|Amlodipine|amlodipine|mesh-list
110437560|NCT01118520|Perindopril|perindopril|mesh-list
110437561|NCT01118520|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110437562|NCT01118520|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110437563|NCT01118520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110437564|NCT01118520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110437565|NCT01118520|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110437566|NCT01118520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110437567|NCT01118520|Vasodilator Agents|vasodilator agents|mesh-ancestor
110437568|NCT01118520|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110437569|NCT01118520|Protease Inhibitors|protease inhibitors|mesh-ancestor
110437570|NCT01118520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110437571|NCT01135992|Insulin|insulin|mesh-list
110437572|NCT01135992|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110437573|NCT01135992|Insulin Glargine|insulin glargine|mesh-list
110437574|NCT01135992|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110437575|NCT01135992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110437576|NCT03734770|Progesterone|progesterone|mesh-list
110437577|NCT03734770|Progestins|progestins|mesh-ancestor
110437578|NCT03734770|Hormones|hormones|mesh-ancestor
110437579|NCT03734770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110437580|NCT03734770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110437581|NCT00959049|Vaccines|vaccines|mesh-list
110437582|NCT00959049|Immunologic Factors|immunologic factors|mesh-ancestor
110437583|NCT00959049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110437584|NCT00956943|Nicotine|nicotine|mesh-list
110437585|NCT00956943|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110437586|NCT00956943|Autonomic Agents|autonomic agents|mesh-ancestor
110437587|NCT00956943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110437588|NCT00956943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110437589|NCT00956943|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110437590|NCT00956943|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110437591|NCT00956943|Cholinergic Agents|cholinergic agents|mesh-ancestor
110437592|NCT00956943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110437593|NCT00956943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110437594|NCT01135914|Ranibizumab|ranibizumab|mesh-list
110437595|NCT01135914|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110437596|NCT01135914|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110437597|NCT01135914|Growth Substances|growth substances|mesh-ancestor
110437598|NCT01135914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110437599|NCT01135914|Growth Inhibitors|growth inhibitors|mesh-ancestor
110437600|NCT01135914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110437601|NCT00907738|Vorinostat|vorinostat|mesh-list
110437602|NCT00907738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110437603|NCT00907738|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110437604|NCT00907738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110437605|NCT00907738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110437606|NCT02829723|Spartalizumab|spartalizumab|mesh-list
110437607|NCT02829723|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110437608|NCT02829723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110437609|NCT02829723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110437610|NCT02829723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110437611|NCT01123356|Lenalidomide|lenalidomide|mesh-list
110437612|NCT01123356|Ofatumumab|ofatumumab|mesh-list
110437613|NCT01123356|Immunologic Factors|immunologic factors|mesh-ancestor
110437614|NCT01123356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110437615|NCT01123356|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110437616|NCT01123356|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110437617|NCT01123356|Growth Substances|growth substances|mesh-ancestor
110437618|NCT01123356|Growth Inhibitors|growth inhibitors|mesh-ancestor
110437619|NCT01123356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110437620|NCT00630357|Levetiracetam|levetiracetam|mesh-list
110437621|NCT00630357|Anticonvulsants|anticonvulsants|mesh-ancestor
110437622|NCT00630357|Nootropic Agents|nootropic agents|mesh-ancestor
110437623|NCT02858817|Atovaquone|atovaquone|mesh-list
110437624|NCT02858817|Proguanil|proguanil|mesh-list
110437625|NCT02858817|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
110437626|NCT02858817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110437627|NCT02858817|Antimalarials|antimalarials|mesh-ancestor
110437628|NCT02858817|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110437629|NCT02858817|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110437630|NCT02858817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110437631|NCT02858817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110437632|NCT02858817|Antimetabolites|antimetabolites|mesh-ancestor
110437633|NCT02883192|Ondansetron|ondansetron|mesh-list
110437634|NCT02883192|Antiemetics|antiemetics|mesh-ancestor
110437635|NCT02883192|Autonomic Agents|autonomic agents|mesh-ancestor
110437636|NCT02883192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110437637|NCT02883192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110437638|NCT02883192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110437639|NCT02883192|Antipruritics|antipruritics|mesh-ancestor
110437640|NCT02883192|Dermatologic Agents|dermatologic agents|mesh-ancestor
110437641|NCT02883192|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110437642|NCT02883192|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110437643|NCT02883192|Serotonin Agents|serotonin agents|mesh-ancestor
110437644|NCT02883192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110437645|NCT02883192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110437646|NCT00632554|Prednisolone|prednisolone|mesh-list
110437647|NCT00632554|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110437648|NCT00632554|Methylprednisolone|methylprednisolone|mesh-list
110437649|NCT00632554|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110437650|NCT00632554|Prednisolone acetate|prednisolone acetate|mesh-list
110437651|NCT00632554|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110437652|NCT00632554|Prednisolone phosphate|prednisolone phosphate|mesh-list
110437653|NCT00632554|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110437654|NCT00632554|Glucocorticoids|glucocorticoids|mesh-ancestor
110437655|NCT00632554|Hormones|hormones|mesh-ancestor
110437656|NCT00632554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110437657|NCT00632554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110437658|NCT00632554|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110437659|NCT00632554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110437660|NCT00632554|Antiemetics|antiemetics|mesh-ancestor
110437661|NCT00632554|Autonomic Agents|autonomic agents|mesh-ancestor
110437662|NCT00632554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110437663|NCT00632554|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110437664|NCT00632554|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110437665|NCT00632554|Protective Agents|protective agents|mesh-ancestor
110437666|NCT03082209|Bevacizumab|bevacizumab|mesh-list
110437667|NCT03082209|Venetoclax|venetoclax|mesh-list
110437668|NCT03082209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110437669|NCT03082209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110437670|NCT03082209|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110437671|NCT03082209|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110437672|NCT03082209|Growth Substances|growth substances|mesh-ancestor
110437673|NCT03082209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110437674|NCT03082209|Growth Inhibitors|growth inhibitors|mesh-ancestor
110437675|NCT02224144|Vitamin D|vitamin d|mesh-list
110437676|NCT02224144|Cholecalciferol|cholecalciferol|mesh-list
110437677|NCT02224144|Calcitriol|calcitriol|mesh-list
110437678|NCT02224144|Vitamins|vitamins|mesh-ancestor
110437679|NCT02224144|Micronutrients|micronutrients|mesh-ancestor
110437680|NCT02224144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110437681|NCT02224144|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110437682|NCT02224144|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110437684|NCT02224144|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110437685|NCT02224144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110437686|NCT02224144|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110437687|NCT05419180|Stiripentol|stiripentol|mesh-list
110437688|NCT05419180|Anticonvulsants|anticonvulsants|mesh-ancestor
110437689|NCT04280289|Cannabidiol|cannabidiol|mesh-list
110437690|NCT04280289|Anticonvulsants|anticonvulsants|mesh-ancestor
110437691|NCT03302728|Lenalidomide|lenalidomide|mesh-list
110437692|NCT03302728|Brentuximab Vedotin|brentuximab vedotin|mesh-list
110437693|NCT03302728|Immunologic Factors|immunologic factors|mesh-ancestor
110437694|NCT03302728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110437695|NCT03302728|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110437696|NCT03302728|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110437697|NCT03302728|Growth Substances|growth substances|mesh-ancestor
110437698|NCT03302728|Growth Inhibitors|growth inhibitors|mesh-ancestor
110437699|NCT03302728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110437700|NCT03302728|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110437701|NCT03302728|Immunotoxins|immunotoxins|mesh-ancestor
110437702|NCT03302728|Immunoconjugates|immunoconjugates|mesh-ancestor
110437703|NCT03832972|Estrogens|estrogens|mesh-list
110437704|NCT03832972|Hormones|hormones|mesh-ancestor
110437705|NCT03832972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110437706|NCT03832972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110437707|NCT02860299|Heparin|heparin|mesh-list
110437708|NCT02860299|Calcium heparin|calcium heparin|mesh-list
110437709|NCT02860299|Anticoagulants|anticoagulants|mesh-ancestor
110437710|NCT02860299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110437711|NCT02860299|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110437712|NCT02860299|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110437713|NCT02858505|Iron|iron|mesh-list
110437714|NCT02858505|Trace Elements|trace elements|mesh-ancestor
110437715|NCT02858505|Micronutrients|micronutrients|mesh-ancestor
110437716|NCT02858505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110437717|NCT01518556|Idarubicin|idarubicin|mesh-list
110437718|NCT01518556|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110437719|NCT01518556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110437720|NCT01518556|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110437721|NCT01518556|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110437722|NCT01518556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110437723|NCT01518556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110437724|NCT02994069|Cisplatin|cisplatin|mesh-list
110437725|NCT02994069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110437726|NCT02860221|Epinephrine|epinephrine|mesh-list
110437727|NCT02860221|Tranexamic Acid|tranexamic acid|mesh-list
110437728|NCT02860221|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110437729|NCT02860221|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110437730|NCT02860221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110437731|NCT02860221|Hemostatics|hemostatics|mesh-ancestor
110437732|NCT02860221|Coagulants|coagulants|mesh-ancestor
110437733|NCT02860221|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110437734|NCT02860221|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110437735|NCT02860221|Adrenergic Agents|adrenergic agents|mesh-ancestor
110437736|NCT02860221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110437737|NCT02860221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110437738|NCT02860221|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110437739|NCT02860221|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110437740|NCT02860221|Autonomic Agents|autonomic agents|mesh-ancestor
110437741|NCT02860221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110437742|NCT02860221|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110437743|NCT02860221|Respiratory System Agents|respiratory system agents|mesh-ancestor
110437744|NCT02860221|Mydriatics|mydriatics|mesh-ancestor
110437745|NCT02860221|Sympathomimetics|sympathomimetics|mesh-ancestor
110437746|NCT02860221|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110437747|NCT02857569|Nivolumab|nivolumab|mesh-list
110437748|NCT02857569|Ipilimumab|ipilimumab|mesh-list
110437749|NCT02857569|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110437750|NCT02857569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110437751|NCT02857569|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110437752|NCT02857569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110437753|NCT04164355|Tadalafil|tadalafil|mesh-list
110437754|NCT04164355|Vasodilator Agents|vasodilator agents|mesh-ancestor
110437755|NCT04164355|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110437756|NCT04164355|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110437757|NCT04164355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110437758|NCT04164355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110437759|NCT04164355|Urological Agents|urological agents|mesh-ancestor
110437760|NCT01605253|Eszopiclone|eszopiclone|mesh-list
110437761|NCT01605253|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110437762|NCT01605253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110437763|NCT01605253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110437764|NCT00655135|Vedolizumab|vedolizumab|mesh-list
110437765|NCT00655135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110437766|NCT02635867|Calcium, Dietary|calcium, dietary|mesh-list
110437767|NCT02635867|Calcium|calcium|mesh-list
110437768|NCT02635867|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110437769|NCT02635867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110437770|NCT02635867|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110437771|NCT00955305|Paclitaxel|paclitaxel|mesh-list
110437772|NCT00955305|Bevacizumab|bevacizumab|mesh-list
110437773|NCT00955305|Carboplatin|carboplatin|mesh-list
110437774|NCT00955305|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110437775|NCT00955305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110437776|NCT00955305|Tubulin Modulators|tubulin modulators|mesh-ancestor
110437777|NCT00955305|Antimitotic Agents|antimitotic agents|mesh-ancestor
110437778|NCT00955305|Mitosis Modulators|mitosis modulators|mesh-ancestor
110437779|NCT00955305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110437780|NCT00955305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110437781|NCT00955305|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110437782|NCT00955305|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110437783|NCT00955305|Growth Substances|growth substances|mesh-ancestor
110437784|NCT00955305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110437785|NCT00955305|Growth Inhibitors|growth inhibitors|mesh-ancestor
110437786|NCT00656695|Cyclosporine|cyclosporine|mesh-list
110437787|NCT00656695|Cyclosporins|cyclosporins|mesh-list
110437788|NCT00656695|Antifungal Agents|antifungal agents|mesh-ancestor
110437789|NCT00656695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110437790|NCT00656695|Dermatologic Agents|dermatologic agents|mesh-ancestor
110437791|NCT00656695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110437792|NCT00656695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110437793|NCT00656695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110437794|NCT00656695|Immunologic Factors|immunologic factors|mesh-ancestor
110437795|NCT00656695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110437796|NCT00656695|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110437797|NCT00656695|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110437798|NCT04204083|Hyaluronic Acid|hyaluronic acid|mesh-list
110437799|NCT04204083|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110437800|NCT04204083|Immunologic Factors|immunologic factors|mesh-ancestor
110437801|NCT04204083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110437802|NCT04204083|Viscosupplements|viscosupplements|mesh-ancestor
110437803|NCT04204083|Protective Agents|protective agents|mesh-ancestor
110437804|NCT00598585|Sildenafil Citrate|sildenafil citrate|mesh-list
110437805|NCT00598585|Vasodilator Agents|vasodilator agents|mesh-ancestor
110437806|NCT00598585|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110437807|NCT00598585|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110437808|NCT00598585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110437809|NCT00598585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110437810|NCT00598585|Urological Agents|urological agents|mesh-ancestor
110437811|NCT02635243|Glucagon|glucagon|mesh-list
110437812|NCT02635243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110437813|NCT02635243|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110437814|NCT02635243|Hormones|hormones|mesh-ancestor
110437815|NCT02635243|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110437816|NCT00953667|Niacin|niacin|mesh-list
110437817|NCT00953667|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110437818|NCT00953667|Antimetabolites|antimetabolites|mesh-ancestor
110437819|NCT00953667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110437820|NCT00953667|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110437821|NCT00953667|Vasodilator Agents|vasodilator agents|mesh-ancestor
110437822|NCT00953667|Vitamin B Complex|vitamin b complex|mesh-ancestor
110437823|NCT00953667|Vitamins|vitamins|mesh-ancestor
110437824|NCT00953667|Micronutrients|micronutrients|mesh-ancestor
110437825|NCT00953667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110437826|NCT02857491|Ranibizumab|ranibizumab|mesh-list
110437827|NCT02857491|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110437828|NCT02857491|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110437829|NCT02857491|Growth Substances|growth substances|mesh-ancestor
110437830|NCT02857491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110437832|NCT02857491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110437834|NCT00883129|Cyclophosphamide|cyclophosphamide|mesh-list
110437835|NCT00883129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110437836|NCT00883129|Immunologic Factors|immunologic factors|mesh-ancestor
110437837|NCT00883129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110437838|NCT00883129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110437839|NCT00883129|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110437840|NCT00883129|Alkylating Agents|alkylating agents|mesh-ancestor
110437841|NCT00883129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110437842|NCT00883129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110437843|NCT00883129|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110437844|NCT00883129|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110437845|NCT00883129|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110437846|NCT00883129|Antitubercular Agents|antitubercular agents|mesh-ancestor
110437847|NCT00883129|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110437848|NCT00883129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110437849|NCT00883129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110437850|NCT02856867|Leucovorin|leucovorin|mesh-list
110437851|NCT02856867|Fluorouracil|fluorouracil|mesh-list
110437852|NCT02856867|Oxaliplatin|oxaliplatin|mesh-list
110437853|NCT02856867|Nintedanib|nintedanib|mesh-list
110437854|NCT02856867|Antimetabolites|antimetabolites|mesh-ancestor
110437855|NCT02856867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110437856|NCT02856867|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110437857|NCT02856867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110437858|NCT02856867|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110437859|NCT02856867|Immunologic Factors|immunologic factors|mesh-ancestor
110437860|NCT02856867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110437861|NCT02856867|Antidotes|antidotes|mesh-ancestor
110564732|NCT04698525|GABA Agents|gaba agents|mesh-ancestor
110437862|NCT02856867|Protective Agents|protective agents|mesh-ancestor
110437863|NCT02856867|Vitamin B Complex|vitamin b complex|mesh-ancestor
110437864|NCT02856867|Vitamins|vitamins|mesh-ancestor
110437865|NCT02856867|Micronutrients|micronutrients|mesh-ancestor
110437866|NCT02856867|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110437867|NCT02856867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110437868|NCT00630513|Ampicillin|ampicillin|mesh-list
110437869|NCT00630513|Ertapenem|ertapenem|mesh-list
110437870|NCT00630513|Sulbactam|sulbactam|mesh-list
110437871|NCT00630513|Sultamicillin|sultamicillin|mesh-list
110437872|NCT00630513|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110437873|NCT00630513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110437874|NCT00630513|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110437875|NCT00630513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110437876|NCT00630513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110437877|NCT05287360|Apatinib|apatinib|mesh-list
110437878|NCT05287360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110437879|NCT05287360|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110437880|NCT05287360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110437881|NCT05287360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110437882|NCT00954447|Linagliptin|linagliptin|mesh-list
110437883|NCT00954447|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110437884|NCT00954447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110437885|NCT00954447|Incretins|incretins|mesh-ancestor
110437886|NCT00954447|Hormones|hormones|mesh-ancestor
110437887|NCT00954447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110437888|NCT00954447|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110437889|NCT00954447|Protease Inhibitors|protease inhibitors|mesh-ancestor
110437890|NCT00954447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110437891|NCT00954447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110437892|NCT00903760|Decitabine|decitabine|mesh-list
110437893|NCT00903760|Clofarabine|clofarabine|mesh-list
110437894|NCT00903760|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110437895|NCT00903760|Antimetabolites|antimetabolites|mesh-ancestor
110437896|NCT00903760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110437897|NCT00903760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110437898|NCT00903760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110437899|NCT05273554|Pembrolizumab|pembrolizumab|mesh-list
110437900|NCT05273554|Lenvatinib|lenvatinib|mesh-list
110437901|NCT05273554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110437902|NCT05273554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110437903|NCT05273554|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110437904|NCT05273554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110437905|NCT05273554|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110437906|NCT05273554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110437907|NCT05177614|Micronutrients|micronutrients|mesh-list
110437908|NCT05177614|Trace Elements|trace elements|mesh-list
110437909|NCT05177614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110437911|NCT04202536|Antiviral Agents|antiviral agents|mesh-ancestor
110437912|NCT04202536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110437913|NCT04202536|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110437914|NCT04202536|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110437915|NCT04202536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110437916|NCT04202536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110437917|NCT04202536|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110437918|NCT04202536|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110437920|NCT02794402|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110437921|NCT02794402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110437922|NCT02794402|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110437923|NCT02794402|Incretins|incretins|mesh-ancestor
110437924|NCT02794402|Hormones|hormones|mesh-ancestor
110437925|NCT02794402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110437926|NCT00883051|Lasmiditan|lasmiditan|mesh-list
110437927|NCT00883051|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110437928|NCT00883051|Serotonin Agents|serotonin agents|mesh-ancestor
110437929|NCT00883051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110437930|NCT00883051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110437931|NCT00883051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110437932|NCT03395587|Temozolomide|temozolomide|mesh-list
110437933|NCT03395587|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110437934|NCT03395587|Alkylating Agents|alkylating agents|mesh-ancestor
110437935|NCT03395587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110437936|NCT03395587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110437937|NCT00903682|Efavirenz|efavirenz|mesh-list
110437938|NCT00903682|Etravirine|etravirine|mesh-list
110655646|NCT01037530|Protease Inhibitors|protease inhibitors|mesh-ancestor
110437939|NCT00903682|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110437940|NCT00903682|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110437941|NCT00903682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110437942|NCT00903682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110437943|NCT00903682|Antiviral Agents|antiviral agents|mesh-ancestor
110437944|NCT00903682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110437945|NCT00903682|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110437946|NCT00903682|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110437947|NCT00903682|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110437948|NCT00903682|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110437949|NCT00903682|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110437950|NCT00903682|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110437951|NCT00655603|Pancrelipase|pancrelipase|mesh-list
110437952|NCT00655603|Hormones|hormones|mesh-list
110437953|NCT00655603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110437954|NCT00655603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110437955|NCT00655603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110437956|NCT02715466|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110437957|NCT00655681|Pamidronate|pamidronate|mesh-list
110437958|NCT00655681|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110437959|NCT00655681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110437960|NCT04221568|Fentanyl|fentanyl|mesh-list
110437961|NCT04221568|Bupivacaine|bupivacaine|mesh-list
110437962|NCT04221568|Levobupivacaine|levobupivacaine|mesh-list
110437963|NCT04221568|Anesthetics, Local|anesthetics, local|mesh-ancestor
110437964|NCT04221568|Anesthetics|anesthetics|mesh-ancestor
110437965|NCT04221568|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110437966|NCT04221568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110437967|NCT04221568|Sensory System Agents|sensory system agents|mesh-ancestor
110437968|NCT04221568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110437969|NCT04221568|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110437970|NCT04221568|Narcotics|narcotics|mesh-ancestor
110437971|NCT04221568|Analgesics|analgesics|mesh-ancestor
110437972|NCT04221568|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110329403|NCT00492258|Sorafenib|sorafenib|mesh-list
110437973|NCT04221568|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110437974|NCT04221568|Anesthetics, General|anesthetics, general|mesh-ancestor
110437975|NCT01135524|Buprenorphine|buprenorphine|mesh-list
110437976|NCT01135524|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110437977|NCT01135524|Narcotics|narcotics|mesh-ancestor
110437978|NCT01135524|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110437979|NCT01135524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110437980|NCT01135524|Analgesics|analgesics|mesh-ancestor
110437981|NCT01135524|Sensory System Agents|sensory system agents|mesh-ancestor
110437982|NCT01135524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110437983|NCT01135524|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110437984|NCT00948675|Paclitaxel|paclitaxel|mesh-list
110437985|NCT00948675|Bevacizumab|bevacizumab|mesh-list
110437986|NCT00948675|Carboplatin|carboplatin|mesh-list
110437987|NCT00948675|Pemetrexed|pemetrexed|mesh-list
110437988|NCT00948675|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110437989|NCT00948675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110437990|NCT00948675|Tubulin Modulators|tubulin modulators|mesh-ancestor
110437991|NCT00948675|Antimitotic Agents|antimitotic agents|mesh-ancestor
110437992|NCT00948675|Mitosis Modulators|mitosis modulators|mesh-ancestor
110437993|NCT00948675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110437994|NCT00948675|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110437995|NCT00948675|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110437996|NCT00948675|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110437997|NCT00948675|Growth Substances|growth substances|mesh-ancestor
110437998|NCT00948675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110437999|NCT00948675|Growth Inhibitors|growth inhibitors|mesh-ancestor
110438000|NCT00948675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110438001|NCT00948675|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110438002|NCT00948675|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110438003|NCT02642497|Ketamine|ketamine|mesh-list
110438004|NCT02642497|Analgesics|analgesics|mesh-ancestor
110438005|NCT02642497|Sensory System Agents|sensory system agents|mesh-ancestor
110438006|NCT02642497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110438007|NCT02642497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110438008|NCT02642497|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110438009|NCT02642497|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110438010|NCT02642497|Anesthetics, General|anesthetics, general|mesh-ancestor
110438011|NCT02642497|Anesthetics|anesthetics|mesh-ancestor
110655647|NCT01037530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110438012|NCT02642497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110438013|NCT02642497|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110438014|NCT02642497|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110438015|NCT02642497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110438016|NCT02642497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110438017|NCT04273581|Thalidomide|thalidomide|mesh-list
110438018|NCT04273581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110438019|NCT04273581|Immunologic Factors|immunologic factors|mesh-ancestor
110438020|NCT04273581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110438021|NCT04273581|Leprostatic Agents|leprostatic agents|mesh-ancestor
110438022|NCT04273581|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110438023|NCT04273581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110438024|NCT04273581|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110438025|NCT04273581|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110438026|NCT04273581|Growth Substances|growth substances|mesh-ancestor
110438027|NCT04273581|Growth Inhibitors|growth inhibitors|mesh-ancestor
110438028|NCT04273581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110438029|NCT01110408|Amoxicillin|amoxicillin|mesh-list
110438030|NCT01110408|Clavulanic Acid|clavulanic acid|mesh-list
110372645|NCT04596839|Remdesivir|remdesivir|mesh-list
110438031|NCT01110408|Clavulanic Acids|clavulanic acids|mesh-list
110438032|NCT01110408|Cefepime|cefepime|mesh-list
110438033|NCT01110408|Doripenem|doripenem|mesh-list
110438034|NCT01110408|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
110438035|NCT01110408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110438036|NCT01110408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110438037|NCT01110408|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110438038|NCT01110408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110438039|NCT01110408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110438040|NCT00953043|Lubiprostone|lubiprostone|mesh-list
110438041|NCT00953043|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
110438042|NCT00953043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110438043|NCT00953043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110438044|NCT02850484|Budesonide|budesonide|mesh-list
110438045|NCT02850484|Formoterol Fumarate|formoterol fumarate|mesh-list
110438046|NCT02850484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110438047|NCT02850484|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110438048|NCT02850484|Autonomic Agents|autonomic agents|mesh-ancestor
110438049|NCT02850484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110438050|NCT02850484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110438051|NCT02850484|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110438052|NCT02850484|Respiratory System Agents|respiratory system agents|mesh-ancestor
110438053|NCT02850484|Glucocorticoids|glucocorticoids|mesh-ancestor
110438054|NCT02850484|Hormones|hormones|mesh-ancestor
110438055|NCT02850484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110206004|NCT00056654|Leuprolide|leuprolide|mesh-list
110438056|NCT02850484|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110438057|NCT02850484|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110438058|NCT02850484|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110438059|NCT02850484|Adrenergic Agents|adrenergic agents|mesh-ancestor
110438060|NCT02850484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110438061|NCT02850484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110438062|NCT01135134|Mometasone Furoate|mometasone furoate|mesh-list
110438063|NCT01135134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110438064|NCT01135134|Dermatologic Agents|dermatologic agents|mesh-ancestor
110438065|NCT01135134|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110438067|NCT00948441|Heparin|heparin|mesh-list
110438068|NCT00948441|Anticoagulants|anticoagulants|mesh-ancestor
110438069|NCT00948441|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110438070|NCT00948441|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110438071|NCT00948441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110438072|NCT00948441|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110438073|NCT00948441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110438074|NCT00948441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110438075|NCT00948441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110438076|NCT02849782|4-Aminopyridine|4-aminopyridine|mesh-list
110438077|NCT02849782|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
110438078|NCT02849782|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110438079|NCT02849782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110438080|NCT00630903|Methoxsalen|methoxsalen|mesh-list
110438081|NCT00630903|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110438082|NCT00630903|Dermatologic Agents|dermatologic agents|mesh-ancestor
110438083|NCT02883426|Vaccines|vaccines|mesh-list
110438084|NCT02883426|Immunologic Factors|immunologic factors|mesh-ancestor
110438085|NCT02883426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110438086|NCT02849314|Immunomodulating Agents|immunomodulating agents|mesh-list
110438087|NCT02849314|Immunologic Factors|immunologic factors|mesh-ancestor
110438088|NCT02849314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110438089|NCT02849236|Ropivacaine|ropivacaine|mesh-list
110438090|NCT02849236|Anesthetics, Local|anesthetics, local|mesh-ancestor
110438091|NCT02849236|Anesthetics|anesthetics|mesh-ancestor
110438092|NCT02849236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110438093|NCT02849236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110438094|NCT02849236|Sensory System Agents|sensory system agents|mesh-ancestor
110438095|NCT02849236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110438096|NCT02856789|Hemostatics|hemostatics|mesh-list
110438097|NCT02856789|Coagulants|coagulants|mesh-ancestor
110438098|NCT01117350|Metformin|metformin|mesh-list
110438099|NCT01117350|Insulin Glargine|insulin glargine|mesh-list
110438100|NCT01117350|Liraglutide|liraglutide|mesh-list
110438101|NCT01117350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110438102|NCT01117350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110438103|NCT01117350|Incretins|incretins|mesh-ancestor
110438104|NCT01117350|Hormones|hormones|mesh-ancestor
110438105|NCT01117350|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110438106|NCT00952731|Tamoxifen|tamoxifen|mesh-list
110438107|NCT00952731|Afimoxifene|afimoxifene|mesh-list
110438108|NCT00952731|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110438109|NCT00952731|Hormone Antagonists|hormone antagonists|mesh-ancestor
110438110|NCT00952731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110438111|NCT00952731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110438112|NCT00952731|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110438113|NCT00952731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110438114|NCT00952731|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110438115|NCT00952731|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110438116|NCT00952731|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110438117|NCT04202224|Acetaminophen|acetaminophen|mesh-list
110438118|NCT04202224|Ibuprofen|ibuprofen|mesh-list
110438119|NCT04202224|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110438120|NCT04202224|Analgesics|analgesics|mesh-ancestor
110438121|NCT04202224|Sensory System Agents|sensory system agents|mesh-ancestor
110438122|NCT04202224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110438123|NCT04202224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110438125|NCT04202224|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110438126|NCT04202224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110438127|NCT04202224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110438128|NCT04202224|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110438129|NCT04202224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110438130|NCT04202224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110438131|NCT00947427|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110438132|NCT00947427|Immunologic Factors|immunologic factors|mesh-ancestor
110438133|NCT00947427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110438134|NCT02848612|Heparin|heparin|mesh-list
110085088|NCT01664845|Metformin|metformin|mesh-list
110438135|NCT02848612|Calcium heparin|calcium heparin|mesh-list
110438136|NCT02848612|Anticoagulants|anticoagulants|mesh-ancestor
110438137|NCT02848612|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110438138|NCT02848612|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110438139|NCT02848612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110438140|NCT04811404|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
110438141|NCT04811404|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110438142|NCT04811404|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110438143|NCT04235062|Furosemide|furosemide|mesh-list
110438144|NCT04235062|Calcium|calcium|mesh-list
110438145|NCT04235062|Diuretics|diuretics|mesh-list
110438146|NCT04235062|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
110438147|NCT04235062|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110438148|NCT04235062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110438149|NCT04235062|Natriuretic Agents|natriuretic agents|mesh-ancestor
110438150|NCT04235062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110438151|NCT04235062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110438152|NCT02848768|Sunitinib|sunitinib|mesh-list
110438153|NCT02848768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110438154|NCT02848768|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110438155|NCT02848768|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110438156|NCT02848768|Growth Substances|growth substances|mesh-ancestor
110438157|NCT02848768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110438158|NCT02848768|Growth Inhibitors|growth inhibitors|mesh-ancestor
110438159|NCT02848768|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110438160|NCT02848768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110438161|NCT02848768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110438162|NCT02848300|Bimatoprost|bimatoprost|mesh-list
110438163|NCT02848300|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110438164|NCT00953745|Aripiprazole|aripiprazole|mesh-list
110438165|NCT00953745|Escitalopram|escitalopram|mesh-list
110438166|NCT00953745|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110438167|NCT00953745|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110438168|NCT00953745|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110438169|NCT00953745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110438170|NCT00953745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110438171|NCT00953745|Serotonin Agents|serotonin agents|mesh-ancestor
110438172|NCT00953745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110438173|NCT00953745|Antidepressive Agents|antidepressive agents|mesh-ancestor
110438174|NCT00953745|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110438175|NCT00953745|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110438176|NCT00953745|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110438177|NCT00953745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110438178|NCT00953745|Dopamine Agonists|dopamine agonists|mesh-ancestor
110438179|NCT00953745|Dopamine Agents|dopamine agents|mesh-ancestor
110438180|NCT00953745|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110438181|NCT00953745|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110206044|NCT00176020|Niacin|niacin|mesh-list
110438182|NCT00953745|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110438183|NCT00953745|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110438184|NCT00953745|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110438185|NCT00953745|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110438186|NCT04202380|Azithromycin|azithromycin|mesh-list
110438187|NCT04202380|Ampicillin|ampicillin|mesh-list
110438188|NCT04202380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110438189|NCT04202380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110438191|NCT02847442|Opicapone|opicapone|mesh-list
110438192|NCT02847442|Dopa Decarboxylase|dopa decarboxylase|mesh-list
110438193|NCT02847442|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-list
110438194|NCT02847442|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110438195|NCT02847442|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110438196|NCT02847442|Dopamine Agents|dopamine agents|mesh-ancestor
110438197|NCT02847442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110438198|NCT02847442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110438199|NCT02847442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110438200|NCT02847442|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
110438201|NCT02847442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110438202|NCT04736602|Triptorelin Pamoate|triptorelin pamoate|mesh-list
110438203|NCT04736602|Luteolytic Agents|luteolytic agents|mesh-ancestor
110438204|NCT04736602|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110438205|NCT04736602|Contraceptive Agents|contraceptive agents|mesh-ancestor
110438206|NCT04736602|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110438207|NCT04736602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110085177|NCT01665248|Listerine|listerine|mesh-list
110438208|NCT04736602|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110438209|NCT04736602|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110438210|NCT04736602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110438211|NCT01478698|Plasminogen|plasminogen|mesh-list
110438212|NCT01478698|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
110438213|NCT01478698|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110438214|NCT01478698|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110438215|NCT01478698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110438216|NCT01199380|Nicotine|nicotine|mesh-list
110438217|NCT01199380|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110438218|NCT01199380|Autonomic Agents|autonomic agents|mesh-ancestor
110438219|NCT01199380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110438220|NCT01199380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110438221|NCT01199380|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110438222|NCT01199380|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110438223|NCT01199380|Cholinergic Agents|cholinergic agents|mesh-ancestor
110438224|NCT01199380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110438225|NCT01199380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110438226|NCT02847286|Dapivirine|dapivirine|mesh-list
110438227|NCT02847286|Clotrimazole|clotrimazole|mesh-list
110438228|NCT02847286|Miconazole|miconazole|mesh-list
110438229|NCT02847286|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110438230|NCT02847286|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110438231|NCT02847286|Antiviral Agents|antiviral agents|mesh-ancestor
110438232|NCT02847286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110438233|NCT02847286|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110438234|NCT02847286|Antifungal Agents|antifungal agents|mesh-ancestor
110438235|NCT02847286|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110438236|NCT02847286|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110438237|NCT02847286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110438238|NCT02847286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110438239|NCT02847286|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110438240|NCT02847286|Hormone Antagonists|hormone antagonists|mesh-ancestor
110438241|NCT02847286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110438242|NCT02847286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110206049|NCT00176020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110438243|NCT02847286|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110438244|NCT02847286|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110438246|NCT00902668|L 647318|l 647318|mesh-list
110438247|NCT00902668|Dihydromevinolin|dihydromevinolin|mesh-list
110438248|NCT00902668|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110438249|NCT00902668|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110438250|NCT00902668|Antimetabolites|antimetabolites|mesh-ancestor
110438251|NCT00902668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110438252|NCT00902668|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110438253|NCT00902668|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110438254|NCT00902668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110438255|NCT00433420|Paclitaxel|paclitaxel|mesh-list
110438256|NCT00433420|Cyclophosphamide|cyclophosphamide|mesh-list
110438257|NCT00433420|Fluorouracil|fluorouracil|mesh-list
110438258|NCT00433420|Epirubicin|epirubicin|mesh-list
110438259|NCT00433420|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110438260|NCT00433420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110438261|NCT00433420|Tubulin Modulators|tubulin modulators|mesh-ancestor
110438262|NCT00433420|Antimitotic Agents|antimitotic agents|mesh-ancestor
110438263|NCT00433420|Mitosis Modulators|mitosis modulators|mesh-ancestor
110438264|NCT00433420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110438265|NCT00433420|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110438266|NCT00433420|Immunologic Factors|immunologic factors|mesh-ancestor
110438267|NCT00433420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110438268|NCT00433420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110438269|NCT00433420|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110438270|NCT00433420|Alkylating Agents|alkylating agents|mesh-ancestor
110438271|NCT00433420|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110438272|NCT00433420|Antimetabolites|antimetabolites|mesh-ancestor
110438273|NCT00433420|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110438274|NCT00433420|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110438275|NCT00433420|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110438276|NCT00433420|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110438277|NCT00433420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110438278|NCT04202068|Ceftriaxone|ceftriaxone|mesh-list
110438279|NCT04202068|Sulbactam|sulbactam|mesh-list
110438280|NCT04202068|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110438281|NCT04202068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110438282|NCT04202068|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110438283|NCT04202068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110438284|NCT04202068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110438285|NCT02850250|Cefuroxime|cefuroxime|mesh-list
110438286|NCT02850250|Cefuroxime axetil|cefuroxime axetil|mesh-list
110438287|NCT02850250|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110438288|NCT02850250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110438289|NCT05012644|Palbociclib|palbociclib|mesh-list
110438290|NCT05012644|Aromatase Inhibitors|aromatase inhibitors|mesh-list
110438291|NCT05012644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110438292|NCT05012644|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110438293|NCT05012644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110438294|NCT05012644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110438295|NCT05012644|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110438296|NCT05012644|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110438297|NCT05012644|Hormone Antagonists|hormone antagonists|mesh-ancestor
110438298|NCT05012644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110438299|NCT05012644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110438300|NCT02846506|Metformin|metformin|mesh-list
110438301|NCT02846506|Canagliflozin|canagliflozin|mesh-list
110438302|NCT02846506|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110438303|NCT02846506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110372671|NCT00577161|Antimetabolites|antimetabolites|mesh-ancestor
110206062|NCT00176098|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
110438304|NCT02846506|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110438305|NCT02846506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110438306|NCT02846428|Cyclophosphamide|cyclophosphamide|mesh-list
110438307|NCT02846428|Docetaxel|docetaxel|mesh-list
110438308|NCT02846428|Fluorouracil|fluorouracil|mesh-list
110438309|NCT02846428|Capecitabine|capecitabine|mesh-list
110438310|NCT02846428|Epirubicin|epirubicin|mesh-list
110438311|NCT02846428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110438312|NCT02846428|Immunologic Factors|immunologic factors|mesh-ancestor
110438313|NCT02846428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110438314|NCT02846428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110438315|NCT02846428|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110438316|NCT02846428|Alkylating Agents|alkylating agents|mesh-ancestor
110438317|NCT02846428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110438318|NCT02846428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110438319|NCT02846428|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110438320|NCT02846428|Tubulin Modulators|tubulin modulators|mesh-ancestor
110438321|NCT02846428|Antimitotic Agents|antimitotic agents|mesh-ancestor
110438322|NCT02846428|Mitosis Modulators|mitosis modulators|mesh-ancestor
110438323|NCT02846428|Antimetabolites|antimetabolites|mesh-ancestor
110438324|NCT02846428|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110438325|NCT02846428|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110438326|NCT02846428|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110438327|NCT02846428|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110438328|NCT02846428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110438329|NCT02844712|beta-Lactams|beta-lactams|mesh-list
110438330|NCT02844712|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110438331|NCT02844712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110438332|NCT00947349|Interferons|interferons|mesh-list
110438333|NCT00947349|Ribavirin|ribavirin|mesh-list
110438334|NCT00947349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110438335|NCT00947349|Antiviral Agents|antiviral agents|mesh-ancestor
110438336|NCT00947349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110438337|NCT00947349|Antimetabolites|antimetabolites|mesh-ancestor
110438338|NCT00947349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110438339|NCT03425812|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
110438340|NCT03425812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110438341|NCT03425812|Analgesics|analgesics|mesh-ancestor
110438342|NCT03425812|Sensory System Agents|sensory system agents|mesh-ancestor
110438343|NCT03425812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110438344|NCT03425812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110438345|NCT03425812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110438346|NCT03425812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110438347|NCT02845804|Everolimus|everolimus|mesh-list
110438348|NCT02845804|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110438349|NCT02845804|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110438350|NCT02845804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110438351|NCT02845804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110438352|NCT02845804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110438353|NCT02845804|Immunologic Factors|immunologic factors|mesh-ancestor
110438354|NCT02845804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110438355|NCT02845804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110438356|NCT02844634|Tenofovir|tenofovir|mesh-list
110438357|NCT02844634|Emtricitabine|emtricitabine|mesh-list
110085313|NCT01666223|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110438358|NCT02844634|Doxycycline|doxycycline|mesh-list
110438359|NCT02844634|Antiviral Agents|antiviral agents|mesh-ancestor
110438360|NCT02844634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110438361|NCT02844634|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110438362|NCT02844634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110438363|NCT02844634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110438364|NCT02844634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110438366|NCT02844634|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110438367|NCT02844634|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110206075|NCT00176293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110206076|NCT00176293|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110438368|NCT02844634|Antimalarials|antimalarials|mesh-ancestor
110438369|NCT02844634|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110438370|NCT02844634|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110438371|NCT02845648|Cholinergic Antagonists|cholinergic antagonists|mesh-list
110438372|NCT02845648|Cholinergic Agents|cholinergic agents|mesh-ancestor
110438373|NCT02845648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110438374|NCT02845648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110438375|NCT02845648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110438377|NCT00952419|Immunologic Factors|immunologic factors|mesh-ancestor
110438378|NCT00952419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110438379|NCT02844322|Rituximab|rituximab|mesh-list
110438380|NCT02844322|Bortezomib|bortezomib|mesh-list
110438381|NCT02844322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110438382|NCT02844322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110438383|NCT02844322|Immunologic Factors|immunologic factors|mesh-ancestor
110438384|NCT02844322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110438385|NCT02844322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110438386|NCT02845570|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110438387|NCT02845570|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110438388|NCT02845570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110438389|NCT00630981|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110438390|NCT00630981|Escitalopram|escitalopram|mesh-list
110438391|NCT00630981|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110438392|NCT00630981|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110438393|NCT00630981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110438394|NCT00630981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110438395|NCT00630981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110438396|NCT00630981|Serotonin Agents|serotonin agents|mesh-ancestor
110438397|NCT00630981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110438398|NCT00630981|Antidepressive Agents|antidepressive agents|mesh-ancestor
110438399|NCT00630981|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110438400|NCT00630981|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110438401|NCT00630981|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110438402|NCT00630981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110438403|NCT00952341|Dexamethasone|dexamethasone|mesh-list
110438404|NCT00952341|Dexamethasone acetate|dexamethasone acetate|mesh-list
110438405|NCT00952341|Aprepitant|aprepitant|mesh-list
110438406|NCT00952341|Fosaprepitant|fosaprepitant|mesh-list
110438407|NCT00952341|Granisetron|granisetron|mesh-list
110438408|NCT00952341|BB 1101|bb 1101|mesh-list
110438409|NCT00952341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110438410|NCT00952341|Antiemetics|antiemetics|mesh-ancestor
110438411|NCT00952341|Autonomic Agents|autonomic agents|mesh-ancestor
110438412|NCT00952341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110438413|NCT00952341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110438414|NCT00952341|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110438415|NCT00952341|Glucocorticoids|glucocorticoids|mesh-ancestor
110438416|NCT00952341|Hormones|hormones|mesh-ancestor
110438417|NCT00952341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110438418|NCT00952341|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110438419|NCT00952341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110438420|NCT00952341|Protease Inhibitors|protease inhibitors|mesh-ancestor
110438421|NCT00952341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110438422|NCT00952341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110438423|NCT00952341|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110438424|NCT00952341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110438425|NCT00952341|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110438426|NCT00952341|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110438427|NCT00952341|Serotonin Agents|serotonin agents|mesh-ancestor
110438428|NCT02845024|Doxycycline|doxycycline|mesh-list
110438429|NCT02845024|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110438430|NCT02845024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110438431|NCT02845024|Antimalarials|antimalarials|mesh-ancestor
110085390|NCT01666600|Nintedanib|nintedanib|mesh-list
110438432|NCT02845024|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110438434|NCT02853903|Immunomodulating Agents|immunomodulating agents|mesh-list
110438435|NCT02853903|Immunologic Factors|immunologic factors|mesh-ancestor
110438436|NCT02853903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110438438|NCT05242120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110438439|NCT05242120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110438440|NCT01909089|Chloroprocaine|chloroprocaine|mesh-list
110438441|NCT01909089|Anesthetics, Local|anesthetics, local|mesh-ancestor
110438442|NCT01909089|Anesthetics|anesthetics|mesh-ancestor
110438443|NCT01909089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110438444|NCT01909089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110438445|NCT01909089|Sensory System Agents|sensory system agents|mesh-ancestor
110438446|NCT01909089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110438447|NCT02844790|Insulin|insulin|mesh-list
110438448|NCT02844790|Insulin Aspart|insulin aspart|mesh-list
110438449|NCT02844790|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110438450|NCT02844790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110438451|NCT02856243|Antiviral Agents|antiviral agents|mesh-list
110438452|NCT02856243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110438453|NCT04410328|Aspirin|aspirin|mesh-list
110438454|NCT04410328|Dipyridamole|dipyridamole|mesh-list
110438455|NCT04410328|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110438456|NCT04410328|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110438457|NCT04410328|Analgesics|analgesics|mesh-ancestor
110438458|NCT04410328|Sensory System Agents|sensory system agents|mesh-ancestor
110438459|NCT04410328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110438460|NCT04410328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110438461|NCT04410328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110438462|NCT04410328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110438463|NCT04410328|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110438464|NCT04410328|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110438465|NCT04410328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110438466|NCT04410328|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110438467|NCT04410328|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110438468|NCT04410328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110438469|NCT04410328|Antipyretics|antipyretics|mesh-ancestor
110438470|NCT04410328|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110438471|NCT04410328|Vasodilator Agents|vasodilator agents|mesh-ancestor
110438472|NCT02852577|Clonazepam|clonazepam|mesh-list
110438473|NCT02852577|Paroxetine|paroxetine|mesh-list
110438474|NCT02852577|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110438475|NCT02852577|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110438476|NCT02852577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110438477|NCT02852577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110438478|NCT02852577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110438479|NCT02852577|Serotonin Agents|serotonin agents|mesh-ancestor
110438480|NCT02852577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110438481|NCT02852577|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110438482|NCT02852577|Antidepressive Agents|antidepressive agents|mesh-ancestor
110438483|NCT02852577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110438484|NCT02852577|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110438485|NCT02852577|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110438486|NCT02852577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110438487|NCT02852577|Anticonvulsants|anticonvulsants|mesh-ancestor
110438488|NCT02852577|GABA Modulators|gaba modulators|mesh-ancestor
110438489|NCT02852577|GABA Agents|gaba agents|mesh-ancestor
110438490|NCT00902044|Cyclophosphamide|cyclophosphamide|mesh-list
110438491|NCT00902044|Fludarabine|fludarabine|mesh-list
110438492|NCT00902044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110438493|NCT00902044|Immunologic Factors|immunologic factors|mesh-ancestor
110438494|NCT00902044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110438495|NCT00902044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110438496|NCT00902044|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110438497|NCT00902044|Alkylating Agents|alkylating agents|mesh-ancestor
110438498|NCT00902044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110438499|NCT00902044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110438500|NCT00902044|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110438501|NCT04201990|Apatinib|apatinib|mesh-list
110438502|NCT04201990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110438503|NCT04201990|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110438504|NCT04201990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110438505|NCT04201990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110085470|NCT01667263|Tretinoin|tretinoin|mesh-list
110438506|NCT00632866|Hydroxychloroquine|hydroxychloroquine|mesh-list
110438507|NCT00632866|Antimalarials|antimalarials|mesh-ancestor
110438508|NCT00632866|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110438509|NCT00632866|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110438510|NCT00632866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110438511|NCT00632866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110438512|NCT00632866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110438513|NCT00632866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110438514|NCT00901186|Ranibizumab|ranibizumab|mesh-list
110438515|NCT00901186|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110438516|NCT00901186|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110438517|NCT00901186|Growth Substances|growth substances|mesh-ancestor
110438518|NCT00901186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110438519|NCT00901186|Growth Inhibitors|growth inhibitors|mesh-ancestor
110438520|NCT00901186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110438521|NCT05040880|Telmisartan|telmisartan|mesh-list
110438522|NCT05040880|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110438523|NCT05040880|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110438524|NCT05040880|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110438525|NCT05040880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110438526|NCT04073290|Rifaximin|rifaximin|mesh-list
110438527|NCT04073290|Lactulose|lactulose|mesh-list
110438528|NCT04073290|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110438529|NCT04073290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110438530|NCT04073290|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110438531|NCT03936790|Fentanyl|fentanyl|mesh-list
110438532|NCT03936790|Ropivacaine|ropivacaine|mesh-list
110438533|NCT03936790|Anesthetics, Local|anesthetics, local|mesh-ancestor
110438534|NCT03936790|Anesthetics|anesthetics|mesh-ancestor
110438535|NCT03936790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110438536|NCT03936790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110438537|NCT03936790|Sensory System Agents|sensory system agents|mesh-ancestor
110438538|NCT03936790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110438539|NCT03936790|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110438540|NCT03936790|Narcotics|narcotics|mesh-ancestor
110438541|NCT03936790|Analgesics|analgesics|mesh-ancestor
110438542|NCT03936790|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110438543|NCT03936790|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110438544|NCT03936790|Anesthetics, General|anesthetics, general|mesh-ancestor
110438545|NCT04782700|Prednisone|prednisone|mesh-list
110372730|NCT00577668|Melphalan|melphalan|mesh-list
110438547|NCT04782700|Glucocorticoids|glucocorticoids|mesh-ancestor
110438548|NCT04782700|Hormones|hormones|mesh-ancestor
110329422|NCT02955810|Antiemetics|antiemetics|mesh-ancestor
110438549|NCT04782700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110438550|NCT04782700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110438551|NCT04782700|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110438552|NCT04782700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110438553|NCT03711448|Prednisone|prednisone|mesh-list
110438554|NCT03711448|Ustekinumab|ustekinumab|mesh-list
110438555|NCT03711448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110438556|NCT03711448|Glucocorticoids|glucocorticoids|mesh-ancestor
110438557|NCT03711448|Hormones|hormones|mesh-ancestor
110206105|NCT00176449|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110438558|NCT03711448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110438559|NCT03711448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110438560|NCT03711448|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110438561|NCT03711448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110438562|NCT03711448|Dermatologic Agents|dermatologic agents|mesh-ancestor
110438563|NCT00885703|Fluconazole|fluconazole|mesh-list
110438564|NCT00885703|Amphotericin B|amphotericin b|mesh-list
110438565|NCT00885703|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
110438566|NCT00885703|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
110438567|NCT00885703|Deoxycholic Acid|deoxycholic acid|mesh-list
110438568|NCT00885703|Antifungal Agents|antifungal agents|mesh-ancestor
110438569|NCT00885703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110438570|NCT00885703|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110438571|NCT00885703|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110438572|NCT00885703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110438573|NCT00885703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110438574|NCT00885703|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110438575|NCT00885703|Hormone Antagonists|hormone antagonists|mesh-ancestor
110438576|NCT00885703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110438577|NCT00885703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110438578|NCT00885703|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110438579|NCT00885703|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110438580|NCT00885703|Amebicides|amebicides|mesh-ancestor
110438581|NCT00885703|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110438582|NCT00885703|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110438583|NCT00885703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110438584|NCT00885703|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
110438585|NCT00885703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110438586|NCT02642419|Aspirin|aspirin|mesh-list
110438587|NCT02642419|Rivaroxaban|rivaroxaban|mesh-list
110438588|NCT02642419|Clopidogrel|clopidogrel|mesh-list
110438589|NCT02642419|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
110438590|NCT02642419|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
110438591|NCT02642419|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110438592|NCT02642419|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110438593|NCT02642419|Analgesics|analgesics|mesh-ancestor
110438594|NCT02642419|Sensory System Agents|sensory system agents|mesh-ancestor
110438595|NCT02642419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110438596|NCT02642419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110438597|NCT02642419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110438598|NCT02642419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110438599|NCT02642419|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110438600|NCT02642419|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110438601|NCT02642419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110438602|NCT02642419|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110438603|NCT02642419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110438604|NCT02642419|Antipyretics|antipyretics|mesh-ancestor
110438605|NCT02642419|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110438606|NCT02642419|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110438607|NCT02642419|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110438608|NCT02642419|Purinergic Agents|purinergic agents|mesh-ancestor
110438609|NCT02642419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110438610|NCT02642419|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110438611|NCT02642419|Antithrombins|antithrombins|mesh-ancestor
110438612|NCT02642419|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110438613|NCT02642419|Protease Inhibitors|protease inhibitors|mesh-ancestor
110438614|NCT02642419|Anticoagulants|anticoagulants|mesh-ancestor
110438615|NCT00901576|Methylphenidate|methylphenidate|mesh-list
110438616|NCT00901576|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110438617|NCT00901576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110438618|NCT00901576|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110438619|NCT00901576|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110438620|NCT00901576|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110438621|NCT00901576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110438622|NCT00901576|Dopamine Agents|dopamine agents|mesh-ancestor
110438623|NCT00901576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110438624|NCT00655837|Rituximab|rituximab|mesh-list
110438625|NCT00655837|Dacetuzumab|dacetuzumab|mesh-list
110438626|NCT00655837|Gemcitabine|gemcitabine|mesh-list
110438627|NCT00655837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110438628|NCT00655837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110438629|NCT00655837|Immunologic Factors|immunologic factors|mesh-ancestor
110438630|NCT00655837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110438631|NCT00655837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110438632|NCT00655837|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110438633|NCT00655837|Antimetabolites|antimetabolites|mesh-ancestor
110438634|NCT00655837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110438635|NCT00655915|Betamethasone|betamethasone|mesh-list
110438636|NCT00655915|Lidocaine|lidocaine|mesh-list
110438637|NCT00655915|Anesthetics, Local|anesthetics, local|mesh-ancestor
110438638|NCT00655915|Anesthetics|anesthetics|mesh-ancestor
110438639|NCT00655915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110438640|NCT00655915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110438641|NCT00655915|Sensory System Agents|sensory system agents|mesh-ancestor
110438642|NCT00655915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110438643|NCT00655915|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110438644|NCT00655915|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110438645|NCT00655915|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110438646|NCT00655915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110438647|NCT00655915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110438648|NCT00655915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110438649|NCT00655915|Glucocorticoids|glucocorticoids|mesh-ancestor
110438650|NCT00655915|Hormones|hormones|mesh-ancestor
110438651|NCT00655915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110438652|NCT00655915|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110438653|NCT00655915|Respiratory System Agents|respiratory system agents|mesh-ancestor
110438654|NCT02637193|Moxifloxacin|moxifloxacin|mesh-list
110438655|NCT02637193|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
110438656|NCT02637193|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110438657|NCT02637193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110438658|NCT02637193|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110438659|NCT02637193|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110438661|NCT02637193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110438662|NCT02637193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110438663|NCT02637193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110438664|NCT02637193|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110438665|NCT02637193|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110438666|NCT02637193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110438667|NCT02637193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110438668|NCT02637193|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110438669|NCT02637193|Antidepressive Agents|antidepressive agents|mesh-ancestor
110438670|NCT02637193|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110438671|NCT00656773|Sufentanil|sufentanil|mesh-list
110438672|NCT00656773|Morphine|morphine|mesh-list
110438673|NCT00656773|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110438675|NCT00656773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110206132|NCT00176527|Interferon-alpha|interferon-alpha|mesh-list
110438676|NCT00656773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110438677|NCT00656773|Analgesics|analgesics|mesh-ancestor
110438678|NCT00656773|Sensory System Agents|sensory system agents|mesh-ancestor
110438679|NCT00656773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110438680|NCT00656773|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110438681|NCT00656773|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110438682|NCT00656773|Anesthetics, General|anesthetics, general|mesh-ancestor
110438683|NCT00656773|Anesthetics|anesthetics|mesh-ancestor
110438684|NCT00882583|Cisplatin|cisplatin|mesh-list
110438685|NCT00882583|Cetuximab|cetuximab|mesh-list
110438686|NCT00882583|Dasatinib|dasatinib|mesh-list
110438687|NCT00882583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110438688|NCT00882583|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110438689|NCT00882583|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110438690|NCT00882583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110438691|NCT00882583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110438693|NCT04481308|Propofol|propofol|mesh-list
110438694|NCT04481308|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110438695|NCT04481308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110438696|NCT04481308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110438697|NCT04481308|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110438698|NCT04481308|Anesthetics, General|anesthetics, general|mesh-ancestor
110438699|NCT04481308|Anesthetics|anesthetics|mesh-ancestor
110438700|NCT04481308|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110438701|NCT04481308|Narcotics|narcotics|mesh-ancestor
110438702|NCT04481308|Analgesics|analgesics|mesh-ancestor
110438703|NCT04481308|Sensory System Agents|sensory system agents|mesh-ancestor
110438704|NCT04481308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110438705|NCT04481308|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110438706|NCT02634541|Adalimumab|adalimumab|mesh-list
110438707|NCT02634541|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110438708|NCT02634541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110438709|NCT02634541|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110438710|NCT04475848|Midazolam|midazolam|mesh-list
110438711|NCT04475848|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110438712|NCT04475848|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110438713|NCT04475848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110438714|NCT04475848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110438715|NCT04475848|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110438716|NCT04475848|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110438717|NCT04475848|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110438718|NCT04475848|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110438719|NCT04475848|Anesthetics, General|anesthetics, general|mesh-ancestor
110438720|NCT04475848|Anesthetics|anesthetics|mesh-ancestor
110438721|NCT04475848|GABA Modulators|gaba modulators|mesh-ancestor
110438722|NCT04475848|GABA Agents|gaba agents|mesh-ancestor
110438723|NCT04475848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110438724|NCT04475848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110438725|NCT00599521|Adapalene|adapalene|mesh-list
110438726|NCT00599521|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110438727|NCT00599521|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110438728|NCT00599521|Analgesics|analgesics|mesh-ancestor
110438729|NCT00599521|Sensory System Agents|sensory system agents|mesh-ancestor
110085691|NCT01668901|Analgesics|analgesics|mesh-ancestor
110438730|NCT00599521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110438731|NCT00599521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110438733|NCT00599521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110438734|NCT00599521|Dermatologic Agents|dermatologic agents|mesh-ancestor
110438735|NCT04201678|Anesthetics|anesthetics|mesh-list
110438736|NCT04201678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110438737|NCT04201678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110438738|NCT00653341|Insulin|insulin|mesh-list
110438739|NCT00653341|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110438740|NCT00653341|Insulin Glargine|insulin glargine|mesh-list
110438741|NCT00653341|Isophane Insulin, Human|isophane insulin, human|mesh-list
110438742|NCT00653341|Insulin, Isophane|insulin, isophane|mesh-list
110438743|NCT00653341|Isophane insulin, beef|isophane insulin, beef|mesh-list
110438744|NCT00653341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110372756|NCT01147744|Fluticasone|fluticasone|mesh-list
110438745|NCT00653341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110438746|NCT02642263|Carbetocin|carbetocin|mesh-list
110438747|NCT02642263|Oxytocics|oxytocics|mesh-ancestor
110438748|NCT02642263|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110438749|NCT02642263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110438750|NCT00779740|Mometasone Furoate|mometasone furoate|mesh-list
110438751|NCT00779740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110438752|NCT00779740|Dermatologic Agents|dermatologic agents|mesh-ancestor
110438753|NCT00779740|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110438754|NCT02636803|Albendazole|albendazole|mesh-list
110438755|NCT02636803|Oxfendazole|oxfendazole|mesh-list
110438756|NCT02636803|Anthelmintics|anthelmintics|mesh-ancestor
110438757|NCT02636803|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110438758|NCT02636803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110438759|NCT02636803|Anticestodal Agents|anticestodal agents|mesh-ancestor
110438760|NCT02636803|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110438761|NCT02636803|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110438762|NCT02636803|Tubulin Modulators|tubulin modulators|mesh-ancestor
110438763|NCT02636803|Antimitotic Agents|antimitotic agents|mesh-ancestor
110438764|NCT02636803|Mitosis Modulators|mitosis modulators|mesh-ancestor
110438765|NCT02636803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110438766|NCT02636803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110438767|NCT02636803|Antinematodal Agents|antinematodal agents|mesh-ancestor
110438769|NCT02634463|Risperidone|risperidone|mesh-list
110438770|NCT02634463|Aripiprazole|aripiprazole|mesh-list
110438771|NCT02634463|Paliperidone Palmitate|paliperidone palmitate|mesh-list
110438772|NCT02634463|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110438773|NCT02634463|Serotonin Agents|serotonin agents|mesh-ancestor
110438774|NCT02634463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110438775|NCT02634463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110438776|NCT02634463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110438777|NCT02634463|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110438778|NCT02634463|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110438779|NCT02634463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110438780|NCT02634463|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110438781|NCT02634463|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110438782|NCT02634463|Dopamine Agents|dopamine agents|mesh-ancestor
110438783|NCT02634463|Antiemetics|antiemetics|mesh-ancestor
110438784|NCT02634463|Autonomic Agents|autonomic agents|mesh-ancestor
110438785|NCT02634463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110438786|NCT02634463|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110438787|NCT02634463|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110438788|NCT02634463|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110438789|NCT02634463|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110438790|NCT02634463|Antidepressive Agents|antidepressive agents|mesh-ancestor
110438791|NCT02634463|Dopamine Agonists|dopamine agonists|mesh-ancestor
110438792|NCT02634463|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110438793|NCT02634463|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110438794|NCT02634463|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110438795|NCT02634463|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110438796|NCT00882115|Sulforaphane|sulforaphane|mesh-list
110438797|NCT00882115|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110438798|NCT00882115|Protective Agents|protective agents|mesh-ancestor
110438799|NCT00882115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110438800|NCT00882115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110438801|NCT00653419|Buspirone|buspirone|mesh-list
110438802|NCT00653419|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110085768|NCT01669213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110438803|NCT00653419|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110438804|NCT00653419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110438805|NCT00653419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110438806|NCT00653419|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110438807|NCT00653419|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110438808|NCT00653419|Serotonin Agents|serotonin agents|mesh-ancestor
110438809|NCT00653419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110564753|NCT04651439|Lenograstim|lenograstim|mesh-list
110438810|NCT00653419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110438811|NCT00884377|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
110438812|NCT00884377|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110438813|NCT00884377|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110438814|NCT00884377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110438816|NCT00884377|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110438817|NCT00884377|Anthelmintics|anthelmintics|mesh-ancestor
110438818|NCT00656929|Vitamin D|vitamin d|mesh-list
110438819|NCT00656929|Cholecalciferol|cholecalciferol|mesh-list
110438820|NCT00656929|Vitamins|vitamins|mesh-ancestor
110438821|NCT00656929|Micronutrients|micronutrients|mesh-ancestor
110438822|NCT00656929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110438823|NCT00656929|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110438824|NCT00656929|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110438825|NCT00884221|Menotropins|menotropins|mesh-list
110438826|NCT00884221|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110438827|NCT00884221|Fertility Agents|fertility agents|mesh-ancestor
110438828|NCT00884221|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110438829|NCT00884221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110438830|NCT02153632|Amantadine|amantadine|mesh-list
110438831|NCT02153632|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110438832|NCT02153632|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110438833|NCT02153632|Antiviral Agents|antiviral agents|mesh-ancestor
110438834|NCT02153632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110438835|NCT02153632|Dopamine Agents|dopamine agents|mesh-ancestor
110438836|NCT02153632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110438837|NCT02153632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110438838|NCT02153632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110438839|NCT02153632|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110438840|NCT02153632|Analgesics|analgesics|mesh-ancestor
110438841|NCT02153632|Sensory System Agents|sensory system agents|mesh-ancestor
110438842|NCT02153632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110438843|NCT01934452|Sunitinib|sunitinib|mesh-list
110438844|NCT01934452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110438845|NCT01934452|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110438846|NCT01934452|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110438847|NCT01934452|Growth Substances|growth substances|mesh-ancestor
110438848|NCT01934452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110438849|NCT01934452|Growth Inhibitors|growth inhibitors|mesh-ancestor
110206189|NCT00176761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110206190|NCT00176995|Eflornithine|eflornithine|mesh-list
110438850|NCT01934452|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110438851|NCT01934452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110438852|NCT01934452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110438853|NCT03524326|Cetuximab|cetuximab|mesh-list
110438854|NCT03524326|Lenvatinib|lenvatinib|mesh-list
110438855|NCT03524326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110438856|NCT03524326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110438857|NCT03524326|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110438858|NCT03524326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110438859|NCT03524326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110438860|NCT01236430|Atorvastatin|atorvastatin|mesh-list
110438861|NCT01236430|Ezetimibe|ezetimibe|mesh-list
110438862|NCT01236430|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110438863|NCT01236430|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110438864|NCT01236430|Antimetabolites|antimetabolites|mesh-ancestor
110438865|NCT01236430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110438866|NCT01236430|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110438867|NCT01236430|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110438868|NCT01236430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110438869|NCT00726856|Ezetimibe|ezetimibe|mesh-list
110438870|NCT00726856|Fenofibrate|fenofibrate|mesh-list
110438871|NCT00726856|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110438872|NCT00726856|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110438873|NCT00726856|Antimetabolites|antimetabolites|mesh-ancestor
110438874|NCT00726856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110438875|NCT00726856|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110438876|NCT00651274|Ezetimibe|ezetimibe|mesh-list
110438877|NCT00651274|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110438878|NCT00651274|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110438879|NCT00651274|Antimetabolites|antimetabolites|mesh-ancestor
110438880|NCT00651274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110438881|NCT00651274|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110438882|NCT00212836|Olanzapine|olanzapine|mesh-list
110438884|NCT00212836|Antiemetics|antiemetics|mesh-ancestor
110438885|NCT00212836|Autonomic Agents|autonomic agents|mesh-ancestor
110438886|NCT00212836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110438887|NCT00212836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110438888|NCT00212836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110438889|NCT00212836|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110438890|NCT00212836|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110438891|NCT00212836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110438892|NCT00212836|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110438893|NCT00212836|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110438894|NCT00212836|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110438895|NCT00212836|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110438896|NCT00212836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110438897|NCT00212836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110438898|NCT00212836|Serotonin Agents|serotonin agents|mesh-ancestor
110438899|NCT00805324|Desloratadine|desloratadine|mesh-list
110438900|NCT00805324|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110438901|NCT00805324|Cholinergic Agents|cholinergic agents|mesh-ancestor
110438902|NCT00805324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110438903|NCT00805324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110438904|NCT00805324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110438905|NCT00805324|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110438906|NCT00805324|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110438907|NCT00805324|Histamine Antagonists|histamine antagonists|mesh-ancestor
110438909|NCT00157924|Atorvastatin|atorvastatin|mesh-list
110438910|NCT00157924|Simvastatin|simvastatin|mesh-list
110206199|NCT00423527|Levetiracetam|levetiracetam|mesh-list
110438911|NCT00157924|Ezetimibe|ezetimibe|mesh-list
110438912|NCT00157924|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110438913|NCT00157924|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110438914|NCT00157924|Antimetabolites|antimetabolites|mesh-ancestor
110438915|NCT00157924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110438916|NCT00157924|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110438917|NCT00157924|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110438918|NCT00157924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110438919|NCT00794794|Cetirizine|cetirizine|mesh-list
110438920|NCT00794794|Desloratadine|desloratadine|mesh-list
110438921|NCT00794794|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110438922|NCT00794794|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110438923|NCT00794794|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110438924|NCT00794794|Histamine Antagonists|histamine antagonists|mesh-ancestor
110438925|NCT00794794|Histamine Agents|histamine agents|mesh-ancestor
110438926|NCT00794794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110438927|NCT00794794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110438928|NCT00794794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110438929|NCT00794794|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110438930|NCT00794794|Cholinergic Agents|cholinergic agents|mesh-ancestor
110438931|NCT03612466|Plerixafor|plerixafor|mesh-list
110438932|NCT03612466|Calcium Carbonate|calcium carbonate|mesh-list
110438933|NCT03612466|Calcium|calcium|mesh-list
110438934|NCT03612466|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110438935|NCT03612466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110438936|NCT03612466|Antacids|antacids|mesh-ancestor
110438937|NCT03612466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110438938|NCT03612466|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110438939|NCT03612466|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110438940|NCT03612466|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110438941|NCT03612466|Antiviral Agents|antiviral agents|mesh-ancestor
110438942|NCT03612466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110438943|NCT00142558|Indomethacin|indomethacin|mesh-list
110438944|NCT00142558|Etoricoxib|etoricoxib|mesh-list
110438945|NCT00142558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110438946|NCT00142558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110438947|NCT00142558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110438948|NCT00142558|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110438949|NCT00142558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110438950|NCT00142558|Analgesics|analgesics|mesh-ancestor
110438951|NCT00142558|Sensory System Agents|sensory system agents|mesh-ancestor
110438952|NCT00142558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110438953|NCT00142558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110438954|NCT00142558|Gout Suppressants|gout suppressants|mesh-ancestor
110085919|NCT01670812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110438955|NCT00142558|Tocolytic Agents|tocolytic agents|mesh-ancestor
110438956|NCT00142558|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110438957|NCT00142558|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110438958|NCT00142558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110438959|NCT00142558|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110438960|NCT02842294|Bevacizumab|bevacizumab|mesh-list
110438961|NCT02842294|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110438962|NCT02842294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110438963|NCT02842294|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110438964|NCT02842294|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110438965|NCT02842294|Growth Substances|growth substances|mesh-ancestor
110438966|NCT02842294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110438967|NCT02842294|Growth Inhibitors|growth inhibitors|mesh-ancestor
110438969|NCT02841982|Ropivacaine|ropivacaine|mesh-list
110438970|NCT02841982|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110438971|NCT02841982|Narcotics|narcotics|mesh-ancestor
110438972|NCT02841982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110438973|NCT02841982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110438975|NCT02841982|Sensory System Agents|sensory system agents|mesh-ancestor
110438976|NCT02841982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110438977|NCT02841982|Anesthetics, Local|anesthetics, local|mesh-ancestor
110438978|NCT02841982|Anesthetics|anesthetics|mesh-ancestor
110438979|NCT02843698|Dexmedetomidine|dexmedetomidine|mesh-list
110438980|NCT02843698|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110438981|NCT02843698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110438982|NCT02843698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110438983|NCT02843698|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110438984|NCT02843698|Analgesics|analgesics|mesh-ancestor
110438985|NCT02843698|Sensory System Agents|sensory system agents|mesh-ancestor
110438986|NCT02843698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110438987|NCT02843698|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110438988|NCT02843698|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110438989|NCT02843698|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110438990|NCT02843698|Adrenergic Agents|adrenergic agents|mesh-ancestor
110438991|NCT02843698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110438992|NCT02843698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110438993|NCT00690898|Lanreotide|lanreotide|mesh-list
110438994|NCT00690898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110438995|NCT02841202|Contraceptive Agents|contraceptive agents|mesh-list
110438996|NCT02841202|Contraceptives, Oral|contraceptives, oral|mesh-list
110438997|NCT02841202|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
110438998|NCT02841202|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110438999|NCT02841202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110439000|NCT02841202|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110439001|NCT00895414|Doxorubicin|doxorubicin|mesh-list
110439002|NCT00895414|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110439003|NCT00895414|Enalapril|enalapril|mesh-list
110439004|NCT00895414|Enalaprilat|enalaprilat|mesh-list
110439005|NCT00895414|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110439006|NCT00895414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110439007|NCT00895414|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110439008|NCT00895414|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110439009|NCT00895414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110439010|NCT00895414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110439011|NCT00895414|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110439012|NCT00895414|Protease Inhibitors|protease inhibitors|mesh-ancestor
110439013|NCT00895414|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110439014|NCT01822288|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
110439015|NCT01822288|Tibolone|tibolone|mesh-list
110439016|NCT01822288|Medroxyprogesterone|medroxyprogesterone|mesh-list
110439017|NCT01822288|Estradiol|estradiol|mesh-list
110439018|NCT01822288|Estrogens|estrogens|mesh-ancestor
110439019|NCT01822288|Hormones|hormones|mesh-ancestor
110439020|NCT01822288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110439021|NCT01822288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110439022|NCT01822288|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110439023|NCT01822288|Contraceptive Agents|contraceptive agents|mesh-ancestor
110439025|NCT01822288|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110439026|NCT01822288|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110439027|NCT01822288|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110439028|NCT01822288|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110439029|NCT01822288|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110439030|NCT01822288|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110439031|NCT01822288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110439032|NCT01822288|Androgen Antagonists|androgen antagonists|mesh-ancestor
110439033|NCT01822288|Hormone Antagonists|hormone antagonists|mesh-ancestor
110439034|NCT01822288|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110564754|NCT04651439|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110439035|NCT01822288|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110439036|NCT01822288|Anabolic Agents|anabolic agents|mesh-ancestor
110439037|NCT01328626|Venetoclax|venetoclax|mesh-list
110439038|NCT01328626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110439039|NCT02840812|Nemonoxacin|nemonoxacin|mesh-list
110439040|NCT02840812|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110206270|NCT00178048|Serotonin Agents|serotonin agents|mesh-ancestor
110439041|NCT02840812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110439043|NCT01212770|Apremilast|apremilast|mesh-list
110439044|NCT01212770|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110439045|NCT01212770|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110439046|NCT01212770|Analgesics|analgesics|mesh-ancestor
110439047|NCT01212770|Sensory System Agents|sensory system agents|mesh-ancestor
110439048|NCT01212770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110439049|NCT01212770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110439050|NCT01212770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110439051|NCT01212770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110439052|NCT01212770|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
110439053|NCT01212770|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110439054|NCT01212770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110439055|NCT01212770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110439056|NCT01212770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110439057|NCT01212770|Immunologic Factors|immunologic factors|mesh-ancestor
110439058|NCT01212770|Leprostatic Agents|leprostatic agents|mesh-ancestor
110439059|NCT01212770|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110439060|NCT01212770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110439061|NCT01212770|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110439062|NCT01212770|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110439063|NCT01212770|Growth Substances|growth substances|mesh-ancestor
110439064|NCT01212770|Growth Inhibitors|growth inhibitors|mesh-ancestor
110439065|NCT01212770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110439066|NCT05334316|Dexamethasone|dexamethasone|mesh-list
110439067|NCT05334316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110439068|NCT05334316|Antiemetics|antiemetics|mesh-ancestor
110439069|NCT05334316|Autonomic Agents|autonomic agents|mesh-ancestor
110439070|NCT05334316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110439071|NCT05334316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110439072|NCT05334316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110439073|NCT05334316|Glucocorticoids|glucocorticoids|mesh-ancestor
110439074|NCT05334316|Hormones|hormones|mesh-ancestor
110439075|NCT05334316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110439076|NCT05334316|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110439078|NCT00598273|Darbepoetin alfa|darbepoetin alfa|mesh-list
110439079|NCT00598273|Hematinics|hematinics|mesh-ancestor
110439080|NCT02636491|Insulin|insulin|mesh-list
110439081|NCT02636491|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110439082|NCT02636491|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110439083|NCT02636491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110439084|NCT00657007|Belimumab|belimumab|mesh-list
110439085|NCT00657007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110439086|NCT00657007|Immunologic Factors|immunologic factors|mesh-ancestor
110439087|NCT00657007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110439088|NCT04318652|Methylprednisolone|methylprednisolone|mesh-list
110439089|NCT04318652|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110439090|NCT04318652|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110439091|NCT04318652|Prednisolone|prednisolone|mesh-list
110439092|NCT04318652|Prednisolone acetate|prednisolone acetate|mesh-list
110439093|NCT04318652|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110439094|NCT04318652|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110439095|NCT04318652|Prednisolone phosphate|prednisolone phosphate|mesh-list
110439096|NCT04318652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110439097|NCT04318652|Antiemetics|antiemetics|mesh-ancestor
110439098|NCT04318652|Autonomic Agents|autonomic agents|mesh-ancestor
110439099|NCT04318652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110439100|NCT04318652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110206318|NCT00408226|Pemetrexed|pemetrexed|mesh-list
110439101|NCT04318652|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110439102|NCT04318652|Glucocorticoids|glucocorticoids|mesh-ancestor
110439103|NCT04318652|Hormones|hormones|mesh-ancestor
110439104|NCT04318652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110439105|NCT04318652|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110439106|NCT04318652|Protective Agents|protective agents|mesh-ancestor
110439107|NCT04318652|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110439108|NCT04318652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110439109|NCT04318652|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110439110|NCT02633995|Anesthetics|anesthetics|mesh-list
110439111|NCT02633995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110439112|NCT02633995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110439113|NCT02633683|Gabapentin|gabapentin|mesh-list
110439114|NCT02633683|Analgesics|analgesics|mesh-ancestor
110439115|NCT02633683|Sensory System Agents|sensory system agents|mesh-ancestor
110439116|NCT02633683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110439117|NCT02633683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110439118|NCT02633683|Anticonvulsants|anticonvulsants|mesh-ancestor
110439119|NCT02633683|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110439120|NCT02633683|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110439121|NCT02633683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110439122|NCT02633683|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110439123|NCT02633683|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110439124|NCT02633683|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110439125|NCT02633683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110439126|NCT02633683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110439127|NCT02633683|Antimanic Agents|antimanic agents|mesh-ancestor
110439128|NCT01211522|Haloperidol|haloperidol|mesh-list
110439129|NCT01211522|Haloperidol decanoate|haloperidol decanoate|mesh-list
110439130|NCT01211522|Ziprasidone|ziprasidone|mesh-list
110439131|NCT01211522|Antiemetics|antiemetics|mesh-ancestor
110439132|NCT01211522|Autonomic Agents|autonomic agents|mesh-ancestor
110439133|NCT01211522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110439134|NCT01211522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110439135|NCT01211522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110439136|NCT01211522|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110439137|NCT01211522|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110439138|NCT01211522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110439139|NCT01211522|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110439140|NCT01211522|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110439141|NCT01211522|Dopamine Agents|dopamine agents|mesh-ancestor
110439142|NCT01211522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110439143|NCT01211522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110439144|NCT01211522|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110439145|NCT01211522|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110439146|NCT01211522|Serotonin Agents|serotonin agents|mesh-ancestor
110439148|NCT05404724|Antifungal Agents|antifungal agents|mesh-ancestor
110439149|NCT05404724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110439150|NCT05404724|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110439151|NCT05404724|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110439152|NCT05404724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110439153|NCT05404724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110439154|NCT05404724|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110439155|NCT05404724|Hormone Antagonists|hormone antagonists|mesh-ancestor
110329486|NCT01243710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110439156|NCT05404724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110439157|NCT05404724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110439158|NCT05404724|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110439161|NCT03314935|Gemcitabine|gemcitabine|mesh-list
110439162|NCT03314935|Fluorouracil|fluorouracil|mesh-list
110439163|NCT03314935|Oxaliplatin|oxaliplatin|mesh-list
110439164|NCT03314935|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110439165|NCT03314935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110439166|NCT03314935|Tubulin Modulators|tubulin modulators|mesh-ancestor
110439167|NCT03314935|Antimitotic Agents|antimitotic agents|mesh-ancestor
110439168|NCT03314935|Mitosis Modulators|mitosis modulators|mesh-ancestor
110439169|NCT03314935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110439170|NCT03314935|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110439171|NCT03314935|Antimetabolites|antimetabolites|mesh-ancestor
110439172|NCT03314935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110439173|NCT03314935|Immunologic Factors|immunologic factors|mesh-ancestor
110439174|NCT03314935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110439175|NCT03314935|Antidotes|antidotes|mesh-ancestor
110439176|NCT03314935|Protective Agents|protective agents|mesh-ancestor
110439177|NCT03314935|Vitamin B Complex|vitamin b complex|mesh-ancestor
110439178|NCT03314935|Vitamins|vitamins|mesh-ancestor
110439179|NCT03314935|Micronutrients|micronutrients|mesh-ancestor
110439180|NCT02633761|Misoprostol|misoprostol|mesh-list
110439181|NCT02633761|Mifepristone|mifepristone|mesh-list
110439182|NCT02633761|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110439183|NCT02633761|Abortifacient Agents|abortifacient agents|mesh-ancestor
110439184|NCT02633761|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110439185|NCT02633761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110439186|NCT02633761|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110439187|NCT02633761|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110439188|NCT02633761|Oxytocics|oxytocics|mesh-ancestor
110439189|NCT02633761|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
110439190|NCT02633761|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110439191|NCT02633761|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110439192|NCT02633761|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110439193|NCT02633761|Contraceptive Agents|contraceptive agents|mesh-ancestor
110439194|NCT02633761|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
110439195|NCT02633761|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
110439196|NCT02633761|Hormone Antagonists|hormone antagonists|mesh-ancestor
110439197|NCT02633761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110439198|NCT02633761|Luteolytic Agents|luteolytic agents|mesh-ancestor
110439199|NCT02633761|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110439200|NCT02633761|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
110439201|NCT02633839|Carbidopa|carbidopa|mesh-list
110439202|NCT02633839|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110439203|NCT02633839|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110439204|NCT02633839|Dopamine Agents|dopamine agents|mesh-ancestor
110439205|NCT02633839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110439206|NCT02633839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110439207|NCT02633839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110439208|NCT02633839|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
110439209|NCT02633839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110439210|NCT02632903|Zoledronic Acid|zoledronic acid|mesh-list
110206350|NCT00397722|Antidepressive Agents|antidepressive agents|mesh-ancestor
110206351|NCT00397722|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110206352|NCT00397722|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110206353|NCT00397722|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110206354|NCT00397722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110206355|NCT00179023|Trimethaphan|trimethaphan|mesh-list
110206356|NCT00179023|Pseudoephedrine|pseudoephedrine|mesh-list
110372810|NCT01147393|Epratuzumab|epratuzumab|mesh-list
110439211|NCT02632903|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110439212|NCT02632903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110439213|NCT00657397|Methadone|methadone|mesh-list
110439214|NCT00657397|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110439215|NCT00657397|Narcotics|narcotics|mesh-ancestor
110439216|NCT00657397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110439217|NCT00657397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110439218|NCT00657397|Analgesics|analgesics|mesh-ancestor
110439219|NCT00657397|Sensory System Agents|sensory system agents|mesh-ancestor
110439220|NCT00657397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110439221|NCT00657397|Antitussive Agents|antitussive agents|mesh-ancestor
110439222|NCT00657397|Respiratory System Agents|respiratory system agents|mesh-ancestor
110439223|NCT04160611|Midazolam|midazolam|mesh-list
110439224|NCT04160611|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110439225|NCT04160611|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110439226|NCT04160611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110439227|NCT04160611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110439228|NCT04160611|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110439229|NCT04160611|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110439230|NCT04160611|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110439231|NCT04160611|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110439232|NCT04160611|Anesthetics, General|anesthetics, general|mesh-ancestor
110439233|NCT04160611|Anesthetics|anesthetics|mesh-ancestor
110439234|NCT04160611|GABA Modulators|gaba modulators|mesh-ancestor
110439235|NCT04160611|GABA Agents|gaba agents|mesh-ancestor
110439236|NCT04160611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110439237|NCT04160611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110439238|NCT04161001|Amlodipine|amlodipine|mesh-list
110439239|NCT04161001|Olmesartan|olmesartan|mesh-list
110439240|NCT04161001|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
110439241|NCT04161001|Amlodipine Besylate, Olmesartan Medoxomil Drug Combination|amlodipine besylate, olmesartan medoxomil drug combination|mesh-list
110439242|NCT04161001|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110439243|NCT04161001|Ezetimibe|ezetimibe|mesh-list
110439244|NCT04161001|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110439245|NCT04161001|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110439246|NCT04161001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110439247|NCT04161001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110439248|NCT04161001|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110439249|NCT04161001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110439250|NCT04161001|Vasodilator Agents|vasodilator agents|mesh-ancestor
110439251|NCT04161001|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110439252|NCT04161001|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110439253|NCT04161001|Antimetabolites|antimetabolites|mesh-ancestor
110439254|NCT04161001|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110439255|NCT04161001|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110439257|NCT04161001|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110439258|NCT04161001|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110439259|NCT00881569|Efatutazone|efatutazone|mesh-list
110439260|NCT00881569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110439261|NCT00657163|Fluoxetine|fluoxetine|mesh-list
110439262|NCT00657163|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110439263|NCT00657163|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110439264|NCT00657163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110439265|NCT00657163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110439266|NCT00657163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110439267|NCT00657163|Serotonin Agents|serotonin agents|mesh-ancestor
110439268|NCT00657163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110439269|NCT00657163|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110439270|NCT00657163|Antidepressive Agents|antidepressive agents|mesh-ancestor
110439271|NCT00657163|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110439272|NCT00657163|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110439273|NCT00657163|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110439274|NCT00657163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110439275|NCT02636101|Betamethasone|betamethasone|mesh-list
110439276|NCT02636101|Betamethasone Valerate|betamethasone valerate|mesh-list
110439277|NCT02636101|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
110439278|NCT02636101|Betamethasone benzoate|betamethasone benzoate|mesh-list
110439279|NCT02636101|Calcipotriene|calcipotriene|mesh-list
110439280|NCT02636101|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
110439281|NCT02636101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110439282|NCT02636101|Glucocorticoids|glucocorticoids|mesh-ancestor
110439283|NCT02636101|Hormones|hormones|mesh-ancestor
110439284|NCT02636101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110439285|NCT02636101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110439286|NCT02636101|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110439287|NCT02636101|Respiratory System Agents|respiratory system agents|mesh-ancestor
110439288|NCT02636101|Dermatologic Agents|dermatologic agents|mesh-ancestor
110439289|NCT00657475|Heparin|heparin|mesh-list
110439290|NCT00657475|Calcium heparin|calcium heparin|mesh-list
110439291|NCT00657475|Anticoagulants|anticoagulants|mesh-ancestor
110439292|NCT00657475|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110439293|NCT00657475|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110439294|NCT00657475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110439295|NCT00657319|Insulin Aspart|insulin aspart|mesh-list
110439296|NCT00657319|Biphasic Insulins|biphasic insulins|mesh-list
110439297|NCT00657319|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
110439298|NCT00657319|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110439299|NCT00657319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110439300|NCT04159597|Upadacitinib|upadacitinib|mesh-list
110439301|NCT04159597|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
110439302|NCT04159597|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110439303|NCT04159597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110439304|NCT04159597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110439305|NCT04159597|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110439306|NCT00661219|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
110439307|NCT00661219|Vasodilator Agents|vasodilator agents|mesh-ancestor
110439308|NCT00661219|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110439309|NCT00661219|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110439310|NCT00661219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110439311|NCT00661219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110439312|NCT00661219|Urological Agents|urological agents|mesh-ancestor
110439313|NCT00665743|Naproxen|naproxen|mesh-list
110439314|NCT00665743|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110439315|NCT00665743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110439316|NCT00665743|Analgesics|analgesics|mesh-ancestor
110439317|NCT00665743|Sensory System Agents|sensory system agents|mesh-ancestor
110439318|NCT00665743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110439319|NCT00665743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110439320|NCT00665743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110439321|NCT00665743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110439322|NCT00665743|Gout Suppressants|gout suppressants|mesh-ancestor
110439323|NCT00665743|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110439324|NCT00665743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110439325|NCT00665743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110439326|NCT00661297|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
110439327|NCT00661297|Vasodilator Agents|vasodilator agents|mesh-ancestor
110439328|NCT00661297|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110439329|NCT00661297|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110439330|NCT00661297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110439331|NCT00661297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110439332|NCT00661297|Urological Agents|urological agents|mesh-ancestor
110439333|NCT00879775|Sodium Benzoate|sodium benzoate|mesh-list
110439334|NCT00879775|Caffeine|caffeine|mesh-list
110439335|NCT00879775|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110439336|NCT00879775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110439337|NCT00879775|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110439338|NCT00879775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110439339|NCT00879775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110439340|NCT00879775|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110439341|NCT00879775|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110439342|NCT00879775|Purinergic Agents|purinergic agents|mesh-ancestor
110439343|NCT00879775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110439344|NCT00879775|Antifungal Agents|antifungal agents|mesh-ancestor
110439345|NCT00879775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110439346|NCT00894790|Celecoxib|celecoxib|mesh-list
110439347|NCT00894790|Diclofenac|diclofenac|mesh-list
110439348|NCT00894790|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110439349|NCT00894790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110439350|NCT00894790|Analgesics|analgesics|mesh-ancestor
110439351|NCT00894790|Sensory System Agents|sensory system agents|mesh-ancestor
110439352|NCT00894790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110439353|NCT00894790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110439354|NCT00894790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110439355|NCT00894790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110439356|NCT00894790|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110439357|NCT00894790|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110439358|NCT00894790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110439359|NCT00894790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110439360|NCT00665977|Triamcinolone|triamcinolone|mesh-list
110439361|NCT00665977|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110439362|NCT00665977|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110439363|NCT00665977|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110439364|NCT00665977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110439365|NCT00665977|Glucocorticoids|glucocorticoids|mesh-ancestor
110439366|NCT00665977|Hormones|hormones|mesh-ancestor
110439367|NCT00665977|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110439368|NCT00665977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110439369|NCT00665977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110439370|NCT00665977|Immunologic Factors|immunologic factors|mesh-ancestor
110439371|NCT00665977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110439372|NCT00665977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110439373|NCT00666055|Ritonavir|ritonavir|mesh-list
110439374|NCT00666055|Lopinavir|lopinavir|mesh-list
110439375|NCT00666055|Atazanavir Sulfate|atazanavir sulfate|mesh-list
110439376|NCT00666055|Tenofovir|tenofovir|mesh-list
110439377|NCT00666055|Lamivudine|lamivudine|mesh-list
110439378|NCT00666055|Emtricitabine|emtricitabine|mesh-list
110439379|NCT00666055|Zidovudine|zidovudine|mesh-list
110439380|NCT00666055|Raltegravir Potassium|raltegravir potassium|mesh-list
110439381|NCT00666055|Maraviroc|maraviroc|mesh-list
110439382|NCT00666055|Efavirenz|efavirenz|mesh-list
110439383|NCT00666055|Etravirine|etravirine|mesh-list
110439384|NCT00666055|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110439385|NCT00666055|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110439386|NCT00666055|Protease Inhibitors|protease inhibitors|mesh-ancestor
110439387|NCT00666055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110439388|NCT00666055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110439389|NCT00666055|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110439390|NCT00666055|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110439391|NCT00666055|Antiviral Agents|antiviral agents|mesh-ancestor
110439392|NCT00666055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110439393|NCT00666055|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110439394|NCT00666055|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110439395|NCT00666055|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110439396|NCT00666055|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110439397|NCT00666055|Antimetabolites|antimetabolites|mesh-ancestor
110439398|NCT00666055|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110439399|NCT00666055|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110439400|NCT00666055|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110439401|NCT00666055|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110439402|NCT00666055|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110439403|NCT00666055|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110439404|NCT00666055|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110439405|NCT00666055|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110439406|NCT00666055|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110439407|NCT00666055|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
110439408|NCT00661375|Sorafenib|sorafenib|mesh-list
110439409|NCT00661375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110439410|NCT00661375|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110439411|NCT00661375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110439412|NCT00661375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110439413|NCT00911287|Oxymorphone|oxymorphone|mesh-list
110439414|NCT00911287|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110439415|NCT00911287|Narcotics|narcotics|mesh-ancestor
110439416|NCT00911287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110439417|NCT00911287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110439418|NCT00911287|Analgesics|analgesics|mesh-ancestor
110439419|NCT00911287|Sensory System Agents|sensory system agents|mesh-ancestor
110439420|NCT00911287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110439421|NCT00911287|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110439422|NCT04494880|Bupivacaine|bupivacaine|mesh-list
110439423|NCT04494880|Anesthetics, Local|anesthetics, local|mesh-ancestor
110439424|NCT04494880|Anesthetics|anesthetics|mesh-ancestor
110439425|NCT04494880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110439426|NCT04494880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110439427|NCT04494880|Sensory System Agents|sensory system agents|mesh-ancestor
110439428|NCT04494880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110439430|NCT02631031|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110439431|NCT02631031|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110439432|NCT02631031|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110439433|NCT02631031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110439434|NCT02839408|Azithromycin|azithromycin|mesh-list
110439435|NCT02839408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110439436|NCT02839408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110439437|NCT02837614|Acetaminophen|acetaminophen|mesh-list
110439438|NCT02837614|Amoxicillin|amoxicillin|mesh-list
110439439|NCT02837614|Dexamethasone|dexamethasone|mesh-list
110439440|NCT02837614|Dexamethasone acetate|dexamethasone acetate|mesh-list
110439441|NCT02837614|BB 1101|bb 1101|mesh-list
110439442|NCT02837614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110439443|NCT02837614|Antiemetics|antiemetics|mesh-ancestor
110439444|NCT02837614|Autonomic Agents|autonomic agents|mesh-ancestor
110439445|NCT02837614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110439446|NCT02837614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110439447|NCT02837614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110439448|NCT02837614|Glucocorticoids|glucocorticoids|mesh-ancestor
110439449|NCT02837614|Hormones|hormones|mesh-ancestor
110439450|NCT02837614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110439451|NCT02837614|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110439452|NCT02837614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110439453|NCT02837614|Protease Inhibitors|protease inhibitors|mesh-ancestor
110439454|NCT02837614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110439455|NCT02837614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110439456|NCT02837614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110439457|NCT02837614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110439458|NCT02837614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110439459|NCT02837614|Analgesics|analgesics|mesh-ancestor
110206403|NCT00179062|Dopamine Agents|dopamine agents|mesh-ancestor
110439461|NCT02837614|Antipyretics|antipyretics|mesh-ancestor
110439462|NCT02839486|Vancomycin|vancomycin|mesh-list
110439463|NCT02839486|Cefoxitin|cefoxitin|mesh-list
110439464|NCT02839486|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110439465|NCT02839486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110439466|NCT00879229|Ambrisentan|ambrisentan|mesh-list
110439467|NCT00879229|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110439468|NCT04249570|Povidone-Iodine|povidone-iodine|mesh-list
110439469|NCT04249570|Povidone|povidone|mesh-list
110439470|NCT04249570|Plasma Substitutes|plasma substitutes|mesh-ancestor
110439471|NCT04249570|Blood Substitutes|blood substitutes|mesh-ancestor
110439472|NCT04249570|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110439473|NCT04249570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110439474|NCT02837770|Diclofenac|diclofenac|mesh-list
110439475|NCT02837770|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110439476|NCT02837770|Lubricant Eye Drops|lubricant eye drops|mesh-list
110439477|NCT02837770|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110439478|NCT02837770|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110439479|NCT02837770|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110439481|NCT02837770|Sensory System Agents|sensory system agents|mesh-ancestor
110439482|NCT02837770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110439483|NCT02837770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110439484|NCT02837770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110439485|NCT02837770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110439486|NCT02837770|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110439487|NCT02837770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110439488|NCT02837770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110439489|NCT00878995|Methyltestosterone|methyltestosterone|mesh-list
110439490|NCT00878995|Testosterone|testosterone|mesh-list
110439491|NCT00878995|Testosterone undecanoate|testosterone undecanoate|mesh-list
110439492|NCT00878995|Testosterone enanthate|testosterone enanthate|mesh-list
110439493|NCT00878995|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
110439494|NCT00878995|Androgens|androgens|mesh-ancestor
110439495|NCT00878995|Hormones|hormones|mesh-ancestor
110439496|NCT00878995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110439497|NCT00878995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110439498|NCT00878995|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110439499|NCT00878995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110439500|NCT00878995|Anabolic Agents|anabolic agents|mesh-ancestor
110439501|NCT02837146|Methotrexate|methotrexate|mesh-list
110439502|NCT02837146|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110439503|NCT02837146|Abortifacient Agents|abortifacient agents|mesh-ancestor
110439504|NCT02837146|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110439505|NCT02837146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110439506|NCT02837146|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110439507|NCT02837146|Antimetabolites|antimetabolites|mesh-ancestor
110439508|NCT02837146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110439509|NCT02837146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110439510|NCT02837146|Dermatologic Agents|dermatologic agents|mesh-ancestor
110439511|NCT02837146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110439512|NCT02837146|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110439513|NCT02837146|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110439514|NCT02837146|Immunologic Factors|immunologic factors|mesh-ancestor
110439515|NCT02837146|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110439516|NCT02837146|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110439517|NCT00657865|Ramipril|ramipril|mesh-list
110329499|NCT00592930|Olanzapine|olanzapine|mesh-list
110439518|NCT00657865|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110439519|NCT00657865|Protease Inhibitors|protease inhibitors|mesh-ancestor
110439520|NCT00657865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110439521|NCT00657865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110439522|NCT00657865|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110439524|NCT00661765|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110439525|NCT00661765|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110439526|NCT00661765|Cholinergic Agents|cholinergic agents|mesh-ancestor
110439527|NCT00661765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110439528|NCT00661765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110439529|NCT00661765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110439530|NCT00657943|Insulin|insulin|mesh-list
110439531|NCT00657943|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110439532|NCT00657943|Metformin|metformin|mesh-list
110439533|NCT00657943|Insulin Aspart|insulin aspart|mesh-list
110439534|NCT00657943|Insulin, Long-Acting|insulin, long-acting|mesh-list
110439535|NCT00657943|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
110439536|NCT00657943|Insulin Detemir|insulin detemir|mesh-list
110439537|NCT00657943|Protamines|protamines|mesh-list
110439538|NCT00657943|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110439539|NCT00657943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110439540|NCT00657943|Heparin Antagonists|heparin antagonists|mesh-ancestor
110439541|NCT00657943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110439542|NCT00657943|Coagulants|coagulants|mesh-ancestor
110439543|NCT04249804|Magnesium Sulfate|magnesium sulfate|mesh-list
110439544|NCT04249804|Analgesics|analgesics|mesh-ancestor
110439545|NCT04249804|Sensory System Agents|sensory system agents|mesh-ancestor
110439546|NCT04249804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110439547|NCT04249804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110439548|NCT04249804|Anesthetics|anesthetics|mesh-ancestor
110439549|NCT04249804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110439550|NCT04249804|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110439551|NCT04249804|Anticonvulsants|anticonvulsants|mesh-ancestor
110439552|NCT04249804|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110439553|NCT04249804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110439554|NCT04249804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110439555|NCT04249804|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110439556|NCT04249804|Tocolytic Agents|tocolytic agents|mesh-ancestor
110439557|NCT04249804|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110439558|NCT02631109|Methylprednisolone|methylprednisolone|mesh-list
110439559|NCT02631109|Doxorubicin|doxorubicin|mesh-list
110439560|NCT02631109|Etoposide|etoposide|mesh-list
110439561|NCT02631109|Pegaspargase|pegaspargase|mesh-list
110439562|NCT02631109|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110439563|NCT02631109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110439564|NCT02631109|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110439565|NCT02631109|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110439566|NCT02631109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110439567|NCT02631109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110439568|NCT02631109|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110439569|NCT02631109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110439570|NCT02631109|Antiemetics|antiemetics|mesh-ancestor
110439571|NCT02631109|Autonomic Agents|autonomic agents|mesh-ancestor
110439572|NCT02631109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110439573|NCT02631109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110439574|NCT02631109|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110439575|NCT02631109|Glucocorticoids|glucocorticoids|mesh-ancestor
110439576|NCT02631109|Hormones|hormones|mesh-ancestor
110439577|NCT02631109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110439578|NCT02631109|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110439579|NCT02631109|Protective Agents|protective agents|mesh-ancestor
110439580|NCT02630485|Inositol|inositol|mesh-list
110439581|NCT02630485|Letrozole|letrozole|mesh-list
110439582|NCT02630485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110439583|NCT02630485|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110439584|NCT02630485|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110439585|NCT02630485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110439586|NCT02630485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110439587|NCT02630485|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110439588|NCT02630485|Hormone Antagonists|hormone antagonists|mesh-ancestor
110439589|NCT02630485|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110439590|NCT02630485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110206414|NCT00179257|Sertraline|sertraline|mesh-list
110439591|NCT02630485|Vitamin B Complex|vitamin b complex|mesh-ancestor
110439592|NCT02630485|Vitamins|vitamins|mesh-ancestor
110439593|NCT02630485|Micronutrients|micronutrients|mesh-ancestor
110439594|NCT00894556|Sumatriptan|sumatriptan|mesh-list
110439595|NCT00894556|Rizatriptan|rizatriptan|mesh-list
110439596|NCT00894556|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110372864|NCT00578526|Sunitinib|sunitinib|mesh-list
110439597|NCT00894556|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110439598|NCT00894556|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110439599|NCT00894556|Serotonin Agents|serotonin agents|mesh-ancestor
110439600|NCT00894556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110439601|NCT00894556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110439602|NCT00894556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110439603|NCT01210352|Oxymorphone|oxymorphone|mesh-list
110439604|NCT01210352|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110439605|NCT01210352|Narcotics|narcotics|mesh-ancestor
110439606|NCT01210352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110439607|NCT01210352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110439608|NCT01210352|Analgesics|analgesics|mesh-ancestor
110439609|NCT01210352|Sensory System Agents|sensory system agents|mesh-ancestor
110439610|NCT01210352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110439611|NCT01210352|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110439612|NCT04250506|Moxifloxacin|moxifloxacin|mesh-list
110439613|NCT04250506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110439614|NCT04250506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110439615|NCT04250506|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110439616|NCT04250506|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110439617|NCT04250506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110439618|NCT04250506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110439619|NCT04250506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110439620|NCT00662077|Ibandronic Acid|ibandronic acid|mesh-list
110439621|NCT00662077|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110439622|NCT00662077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110439624|NCT00658099|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110439625|NCT00658099|Insulin Detemir|insulin detemir|mesh-list
110439626|NCT00658099|Isophane Insulin, Human|isophane insulin, human|mesh-list
110439627|NCT00658099|Insulin, Isophane|insulin, isophane|mesh-list
110439628|NCT00658099|Isophane insulin, beef|isophane insulin, beef|mesh-list
110439629|NCT00658099|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110439630|NCT00658099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110439631|NCT00658177|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
110439632|NCT00658177|Vasodilator Agents|vasodilator agents|mesh-ancestor
110439633|NCT00658177|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110439634|NCT00658177|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110439635|NCT00658177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110439636|NCT00658177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110439637|NCT00658177|Urological Agents|urological agents|mesh-ancestor
110439638|NCT00658255|Budesonide|budesonide|mesh-list
110439639|NCT00658255|Formoterol Fumarate|formoterol fumarate|mesh-list
110439640|NCT00658255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110439641|NCT00658255|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110439642|NCT00658255|Autonomic Agents|autonomic agents|mesh-ancestor
110439643|NCT00658255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110439644|NCT00658255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110439645|NCT00658255|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110439646|NCT00658255|Respiratory System Agents|respiratory system agents|mesh-ancestor
110439647|NCT00658255|Glucocorticoids|glucocorticoids|mesh-ancestor
110439648|NCT00658255|Hormones|hormones|mesh-ancestor
110439649|NCT00658255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110439650|NCT00658255|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110439651|NCT00658255|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110439652|NCT00658255|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110439653|NCT00658255|Adrenergic Agents|adrenergic agents|mesh-ancestor
110439654|NCT00658255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110439655|NCT00658255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110439656|NCT02836288|Ketamine|ketamine|mesh-list
110439657|NCT02836288|Analgesics|analgesics|mesh-ancestor
110439658|NCT02836288|Sensory System Agents|sensory system agents|mesh-ancestor
110439659|NCT02836288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110439660|NCT02836288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110439661|NCT02836288|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110439662|NCT02836288|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110439663|NCT02836288|Anesthetics, General|anesthetics, general|mesh-ancestor
110439664|NCT02836288|Anesthetics|anesthetics|mesh-ancestor
110439665|NCT02836288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110439666|NCT02836288|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110439667|NCT02836288|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110439668|NCT02836288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110439669|NCT02836288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110439670|NCT00658645|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110439671|NCT00658645|Antidepressive Agents|antidepressive agents|mesh-ancestor
110439672|NCT00658645|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110439673|NCT00658645|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110439674|NCT00658645|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110439675|NCT00658645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110439676|NCT00658645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110439677|NCT01208402|Esmolol|esmolol|mesh-list
110439678|NCT01208402|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110439679|NCT01208402|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110439680|NCT01208402|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110439681|NCT01208402|Adrenergic Agents|adrenergic agents|mesh-ancestor
110439682|NCT01208402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110439683|NCT01208402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110439684|NCT01208402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110439685|NCT01208324|Estrogens|estrogens|mesh-list
110439686|NCT01208324|Hormones|hormones|mesh-ancestor
110439687|NCT01208324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110439688|NCT01208324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110439689|NCT02838940|Cefazolin|cefazolin|mesh-list
110439690|NCT02838940|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110439691|NCT02838940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110439692|NCT02835742|Sargramostim|sargramostim|mesh-list
110439693|NCT02835742|Immunologic Factors|immunologic factors|mesh-ancestor
110439694|NCT02835742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110439695|NCT05326360|Ramosetron|ramosetron|mesh-list
110439696|NCT05326360|Antiemetics|antiemetics|mesh-ancestor
110439697|NCT05326360|Autonomic Agents|autonomic agents|mesh-ancestor
110439698|NCT05326360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110439699|NCT05326360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110439700|NCT05326360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110439701|NCT05326360|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110439702|NCT05326360|Serotonin Agents|serotonin agents|mesh-ancestor
110439703|NCT05326360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110439704|NCT05326360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110439705|NCT00666601|Tedizolid phosphate|tedizolid phosphate|mesh-list
110439706|NCT00666601|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110439707|NCT00666601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110439709|NCT01207388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110439710|NCT02835664|Niacinamide|niacinamide|mesh-list
110439711|NCT02835664|Niacin|niacin|mesh-list
110439712|NCT02835664|Nicotinic Acids|nicotinic acids|mesh-list
110439713|NCT02835664|Vitamin B Complex|vitamin b complex|mesh-ancestor
110439714|NCT02835664|Vitamins|vitamins|mesh-ancestor
110439715|NCT02835664|Micronutrients|micronutrients|mesh-ancestor
110439716|NCT02835664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110439717|NCT02835664|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110439718|NCT02835664|Antimetabolites|antimetabolites|mesh-ancestor
110439719|NCT02835664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110439720|NCT02835664|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110439721|NCT02835664|Vasodilator Agents|vasodilator agents|mesh-ancestor
110439722|NCT02838472|Ascorbic Acid|ascorbic acid|mesh-list
110439723|NCT02838472|Vitamins|vitamins|mesh-ancestor
110439724|NCT02838472|Micronutrients|micronutrients|mesh-ancestor
110439725|NCT02838472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110439726|NCT02838472|Antioxidants|antioxidants|mesh-ancestor
110329503|NCT00592930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110439727|NCT02838472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110439729|NCT00666991|Paclitaxel|paclitaxel|mesh-list
110439730|NCT00666991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110439731|NCT00666991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110439732|NCT00666991|Tubulin Modulators|tubulin modulators|mesh-ancestor
110439733|NCT00666991|Antimitotic Agents|antimitotic agents|mesh-ancestor
110439734|NCT00666991|Mitosis Modulators|mitosis modulators|mesh-ancestor
110439735|NCT00666991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110439736|NCT00667147|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110439737|NCT00667147|Paclitaxel|paclitaxel|mesh-list
110439738|NCT00667147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110439739|NCT00667147|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110439740|NCT00667147|Tubulin Modulators|tubulin modulators|mesh-ancestor
110439741|NCT00667147|Antimitotic Agents|antimitotic agents|mesh-ancestor
110439742|NCT00667147|Mitosis Modulators|mitosis modulators|mesh-ancestor
110439743|NCT00667147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110439744|NCT02835586|Paclitaxel|paclitaxel|mesh-list
110439745|NCT02835586|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110439746|NCT02835586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110439747|NCT02835586|Tubulin Modulators|tubulin modulators|mesh-ancestor
110439748|NCT02835586|Antimitotic Agents|antimitotic agents|mesh-ancestor
110439749|NCT02835586|Mitosis Modulators|mitosis modulators|mesh-ancestor
110439750|NCT02835586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110439751|NCT00667303|Antibodies|antibodies|mesh-list
110439752|NCT00667303|Immunologic Factors|immunologic factors|mesh-ancestor
110439753|NCT00667303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110439754|NCT02838238|Capecitabine|capecitabine|mesh-list
110439755|NCT02838238|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110439756|NCT02838238|Antimetabolites|antimetabolites|mesh-ancestor
110439757|NCT02838238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110439758|NCT02838238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110439759|NCT00667537|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
110439760|NCT00667537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110439761|NCT00667771|Naltrexone|naltrexone|mesh-list
110439762|NCT00667771|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110439763|NCT00667771|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110439764|NCT00667771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110439765|NCT00667771|Sensory System Agents|sensory system agents|mesh-ancestor
110439766|NCT00667771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110439767|NCT01206764|Everolimus|everolimus|mesh-list
110439768|NCT01206764|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110439769|NCT01206764|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110439770|NCT01206764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110439771|NCT01206764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110439772|NCT01206764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110439773|NCT01206764|Immunologic Factors|immunologic factors|mesh-ancestor
110439774|NCT01206764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110439775|NCT01206764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110439776|NCT00667927|Cyclophosphamide|cyclophosphamide|mesh-list
110439777|NCT00667927|Busulfan|busulfan|mesh-list
110439778|NCT00667927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110439779|NCT00667927|Immunologic Factors|immunologic factors|mesh-ancestor
110439780|NCT00667927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110439781|NCT00667927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110439782|NCT00667927|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110439783|NCT00667927|Alkylating Agents|alkylating agents|mesh-ancestor
110439784|NCT00667927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110439785|NCT00667927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110439786|NCT00667927|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110439787|NCT00668005|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
110439788|NCT00668005|Vasodilator Agents|vasodilator agents|mesh-ancestor
110439789|NCT00668005|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110439790|NCT00668005|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110439791|NCT00668005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110439792|NCT00668005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110439793|NCT00668005|Urological Agents|urological agents|mesh-ancestor
110439795|NCT00668239|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110439796|NCT00668239|Glucocorticoids|glucocorticoids|mesh-ancestor
110439797|NCT00668239|Hormones|hormones|mesh-ancestor
110439798|NCT00668239|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110439799|NCT00668239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110439800|NCT02631499|Epirubicin|epirubicin|mesh-list
110439802|NCT02631499|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110439803|NCT02631499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110439804|NCT02631499|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110439805|NCT02631499|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110439806|NCT02631499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110439807|NCT02631499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110439808|NCT00662233|Cyclophosphamide|cyclophosphamide|mesh-list
110439809|NCT00662233|Ifosfamide|ifosfamide|mesh-list
110439810|NCT00662233|Doxorubicin|doxorubicin|mesh-list
110439811|NCT00662233|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110439812|NCT00662233|Etoposide|etoposide|mesh-list
110439813|NCT00662233|Vincristine|vincristine|mesh-list
110439814|NCT00662233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110439815|NCT00662233|Immunologic Factors|immunologic factors|mesh-ancestor
110439816|NCT00662233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110439817|NCT00662233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110439818|NCT00662233|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110439819|NCT00662233|Alkylating Agents|alkylating agents|mesh-ancestor
110439820|NCT00662233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110439821|NCT00662233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110439822|NCT00662233|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110439823|NCT00662233|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110439824|NCT00662233|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110439825|NCT00662233|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110439826|NCT00662233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110439827|NCT00662233|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110439828|NCT00662233|Tubulin Modulators|tubulin modulators|mesh-ancestor
110439829|NCT00662233|Antimitotic Agents|antimitotic agents|mesh-ancestor
110439830|NCT00662233|Mitosis Modulators|mitosis modulators|mesh-ancestor
110439831|NCT00658957|Gentamicins|gentamicins|mesh-list
110439832|NCT00658957|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110439833|NCT00658957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110439834|NCT00658957|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110439835|NCT00658957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110439836|NCT00658957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110439837|NCT00662467|Aspirin|aspirin|mesh-list
110439838|NCT00662467|Warfarin|warfarin|mesh-list
110439839|NCT00662467|Clopidogrel|clopidogrel|mesh-list
110439840|NCT00662467|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110206455|NCT00179608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110206456|NCT00179608|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110206457|NCT00179608|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110206458|NCT00179608|Growth Substances|growth substances|mesh-ancestor
110439841|NCT00662467|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110439843|NCT00662467|Sensory System Agents|sensory system agents|mesh-ancestor
110439844|NCT00662467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110439845|NCT00662467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110439846|NCT00662467|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110439847|NCT00662467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110439848|NCT00662467|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110439849|NCT00662467|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110439850|NCT00662467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110439851|NCT00662467|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110439852|NCT00662467|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110439853|NCT00662467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110439854|NCT00662467|Antipyretics|antipyretics|mesh-ancestor
110439855|NCT00662467|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110439856|NCT00662467|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110439857|NCT00662467|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110439858|NCT00662467|Purinergic Agents|purinergic agents|mesh-ancestor
110439859|NCT00662467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110439860|NCT00662467|Anticoagulants|anticoagulants|mesh-ancestor
110439861|NCT00668941|Vitamin D|vitamin d|mesh-list
110439862|NCT00668941|Cholecalciferol|cholecalciferol|mesh-list
110439863|NCT00668941|Alendronate|alendronate|mesh-list
110439864|NCT00668941|Teriparatide|teriparatide|mesh-list
110439865|NCT00668941|Calcium|calcium|mesh-list
110439866|NCT00668941|Vitamins|vitamins|mesh-ancestor
110439867|NCT00668941|Micronutrients|micronutrients|mesh-ancestor
110439868|NCT00668941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110439869|NCT00668941|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110439870|NCT00668941|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110439871|NCT00894322|Exenatide|exenatide|mesh-list
110439872|NCT00894322|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110439873|NCT00894322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110439874|NCT00894322|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110439875|NCT00894322|Incretins|incretins|mesh-ancestor
110439876|NCT00894322|Hormones|hormones|mesh-ancestor
110439877|NCT00894322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110439878|NCT00633412|Esomeprazole|esomeprazole|mesh-list
110439879|NCT00633412|Ranitidine|ranitidine|mesh-list
110439880|NCT00633412|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
110439881|NCT00633412|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110439882|NCT00633412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110439883|NCT00633412|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110439884|NCT00633412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110439885|NCT00633412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110439886|NCT00633412|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110439887|NCT00633412|Histamine Antagonists|histamine antagonists|mesh-ancestor
110439888|NCT00633412|Histamine Agents|histamine agents|mesh-ancestor
110439889|NCT00633412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110439890|NCT00633412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110439891|NCT00659113|Tegafur|tegafur|mesh-list
110439892|NCT00659113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110439893|NCT00659113|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110439894|NCT00659113|Antimetabolites|antimetabolites|mesh-ancestor
110439895|NCT00659113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110439896|NCT00662779|Formoterol Fumarate|formoterol fumarate|mesh-list
110439897|NCT00662779|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110439898|NCT00662779|Autonomic Agents|autonomic agents|mesh-ancestor
110439899|NCT00662779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110439900|NCT00662779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110439901|NCT00662779|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110439902|NCT00662779|Respiratory System Agents|respiratory system agents|mesh-ancestor
110206476|NCT00179725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110439903|NCT00662779|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110439904|NCT00662779|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110439905|NCT00662779|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110439906|NCT00662779|Adrenergic Agents|adrenergic agents|mesh-ancestor
110439907|NCT00662779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110439908|NCT00662779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110439909|NCT02630095|Nadroparin|nadroparin|mesh-list
110439910|NCT02630095|Warfarin|warfarin|mesh-list
110439911|NCT02630095|Calcium|calcium|mesh-list
110439912|NCT02630095|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110439913|NCT02630095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110439914|NCT02630095|Anticoagulants|anticoagulants|mesh-ancestor
110439915|NCT02630095|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110439916|NCT02630095|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110439917|NCT02630095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110439918|NCT00669487|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110439919|NCT00669487|Lamivudine|lamivudine|mesh-list
110439920|NCT00669487|Stavudine|stavudine|mesh-list
110439921|NCT00669487|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110439922|NCT00669487|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110439923|NCT00669487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110439924|NCT00669487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110439925|NCT00669487|Antiviral Agents|antiviral agents|mesh-ancestor
110439926|NCT00669487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110086899|NCT02931890|Carboplatin|carboplatin|mesh-list
110439927|NCT00669487|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110439928|NCT00669487|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110439929|NCT00669487|Antimetabolites|antimetabolites|mesh-ancestor
110439930|NCT00669565|Bavituximab|bavituximab|mesh-list
110439931|NCT00669565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110439932|NCT00669565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110439933|NCT00669643|Rifampin|rifampin|mesh-list
110439934|NCT00669643|Dapsone|dapsone|mesh-list
110439935|NCT00669643|Clofazimine|clofazimine|mesh-list
110439936|NCT00669643|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110439937|NCT00669643|Antitubercular Agents|antitubercular agents|mesh-ancestor
110439938|NCT00669643|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110439939|NCT00669643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110439940|NCT00669643|Leprostatic Agents|leprostatic agents|mesh-ancestor
110439941|NCT00669643|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110439942|NCT00669643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110329520|NCT01245582|Capecitabine|capecitabine|mesh-list
110439943|NCT00669643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110439945|NCT00669643|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110439946|NCT00669643|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110439947|NCT00669643|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110439948|NCT00669643|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110439949|NCT00669643|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110439950|NCT00669643|Antimalarials|antimalarials|mesh-ancestor
110439951|NCT00669643|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110439952|NCT00669643|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110439953|NCT00669643|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110439954|NCT00669643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110439955|NCT00669721|Heparin|heparin|mesh-list
110439956|NCT00669721|Calcium heparin|calcium heparin|mesh-list
110439957|NCT00669721|Nadroparin|nadroparin|mesh-list
110439958|NCT00669721|Anticoagulants|anticoagulants|mesh-ancestor
110439959|NCT00669721|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110439960|NCT00669721|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110439961|NCT00669721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110439962|NCT00894166|Bupropion|bupropion|mesh-list
110439963|NCT00894166|Nicotine|nicotine|mesh-list
110439964|NCT00894166|Varenicline|varenicline|mesh-list
110439965|NCT00894166|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110439966|NCT00894166|Autonomic Agents|autonomic agents|mesh-ancestor
110206493|NCT00179881|Thalidomide|thalidomide|mesh-list
110439967|NCT00894166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110439968|NCT00894166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110439969|NCT00894166|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110439970|NCT00894166|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110439971|NCT00894166|Cholinergic Agents|cholinergic agents|mesh-ancestor
110439972|NCT00894166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110439973|NCT00894166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110439974|NCT00894166|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110439975|NCT00894166|Antidepressive Agents|antidepressive agents|mesh-ancestor
110439976|NCT00894166|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110439977|NCT00894166|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110439978|NCT00894166|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110439979|NCT00894166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110439980|NCT00894166|Dopamine Agents|dopamine agents|mesh-ancestor
110439981|NCT00894166|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110439982|NCT00894166|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110439983|NCT00894166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110439984|NCT00659503|Ciclesonide|ciclesonide|mesh-list
110439985|NCT00659503|Glucocorticoids|glucocorticoids|mesh-ancestor
110439986|NCT00659503|Hormones|hormones|mesh-ancestor
110439987|NCT00659503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110439988|NCT00659503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110439989|NCT00659503|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110439990|NCT00670345|Tranexamic Acid|tranexamic acid|mesh-list
110439991|NCT00670345|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110439992|NCT00670345|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110439993|NCT00670345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110439994|NCT00670345|Hemostatics|hemostatics|mesh-ancestor
110439995|NCT00670345|Coagulants|coagulants|mesh-ancestor
110439996|NCT04153981|Insulin Glargine|insulin glargine|mesh-list
110439997|NCT04153981|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110439998|NCT04153981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110439999|NCT00670423|Sirolimus|sirolimus|mesh-list
110440000|NCT00670423|Bortezomib|bortezomib|mesh-list
110440001|NCT00670423|Tacrolimus|tacrolimus|mesh-list
110440002|NCT00670423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110440003|NCT00670423|Immunologic Factors|immunologic factors|mesh-ancestor
110440004|NCT00670423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110440005|NCT00670423|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110372912|NCT00567047|Vildagliptin|vildagliptin|mesh-list
110440006|NCT00670423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110440007|NCT00670423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110440008|NCT00670423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110440009|NCT00670423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110440010|NCT00670423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110440011|NCT00670423|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110440012|NCT00670423|Antifungal Agents|antifungal agents|mesh-ancestor
110440013|NCT00659659|Benralizumab|benralizumab|mesh-list
110440014|NCT00659659|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110440015|NCT00659659|Respiratory System Agents|respiratory system agents|mesh-ancestor
110440016|NCT00670501|Vitamin D|vitamin d|mesh-list
110440017|NCT00670501|Teriparatide|teriparatide|mesh-list
110440018|NCT00670501|Calcium|calcium|mesh-list
110440019|NCT00670501|Vitamins|vitamins|mesh-ancestor
110440020|NCT00670501|Micronutrients|micronutrients|mesh-ancestor
110440021|NCT00670501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110440022|NCT00670501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110440023|NCT00670501|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110440024|NCT00663247|Mesalamine|mesalamine|mesh-list
110440025|NCT00663247|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110440026|NCT00663247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110440027|NCT00663247|Analgesics|analgesics|mesh-ancestor
110206506|NCT00179920|Carboplatin|carboplatin|mesh-list
110440028|NCT00663247|Sensory System Agents|sensory system agents|mesh-ancestor
110440029|NCT00663247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110440030|NCT00663247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110440031|NCT00663247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110440032|NCT00663247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110440033|NCT01163747|Methotrexate|methotrexate|mesh-list
110440034|NCT01163747|Vaccines|vaccines|mesh-list
110440035|NCT01163747|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110440036|NCT01163747|Immunologic Factors|immunologic factors|mesh-ancestor
110440037|NCT01163747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110440038|NCT01163747|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110440039|NCT01163747|Abortifacient Agents|abortifacient agents|mesh-ancestor
110440040|NCT01163747|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110440041|NCT01163747|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110440042|NCT01163747|Antimetabolites|antimetabolites|mesh-ancestor
110440043|NCT01163747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110440044|NCT01163747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110440045|NCT01163747|Dermatologic Agents|dermatologic agents|mesh-ancestor
110440046|NCT01163747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110440047|NCT01163747|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110564783|NCT04560660|Midazolam|midazolam|mesh-list
110440048|NCT01163747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110440049|NCT01163747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110440050|NCT01163747|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110440051|NCT00670657|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
110440052|NCT00670657|Antifungal Agents|antifungal agents|mesh-ancestor
110440053|NCT00670657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110440054|NCT00670657|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110440055|NCT00670657|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110440056|NCT05657015|Simvastatin|simvastatin|mesh-list
110440057|NCT05657015|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110440058|NCT05657015|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110440059|NCT05657015|Antimetabolites|antimetabolites|mesh-ancestor
110440060|NCT05657015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110440061|NCT05657015|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110440062|NCT05657015|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110440063|NCT05657015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110440064|NCT02887313|Leucovorin|leucovorin|mesh-list
110440065|NCT02887313|Fluorouracil|fluorouracil|mesh-list
110440066|NCT02887313|Oxaliplatin|oxaliplatin|mesh-list
110440067|NCT02887313|Antimetabolites|antimetabolites|mesh-ancestor
110440068|NCT02887313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110440069|NCT02887313|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110440070|NCT02887313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110440071|NCT02887313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110440072|NCT02887313|Immunologic Factors|immunologic factors|mesh-ancestor
110440073|NCT02887313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110440074|NCT02887313|Antidotes|antidotes|mesh-ancestor
110440075|NCT02887313|Protective Agents|protective agents|mesh-ancestor
110440076|NCT02887313|Vitamin B Complex|vitamin b complex|mesh-ancestor
110440077|NCT02887313|Vitamins|vitamins|mesh-ancestor
110440078|NCT02887313|Micronutrients|micronutrients|mesh-ancestor
110440079|NCT01206140|Sirolimus|sirolimus|mesh-list
110440080|NCT01206140|Temsirolimus|temsirolimus|mesh-list
110440081|NCT01206140|MTOR Inhibitors|mtor inhibitors|mesh-list
110440082|NCT01206140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110440083|NCT01206140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110440084|NCT01206140|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110440085|NCT01206140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110440086|NCT01206140|Antifungal Agents|antifungal agents|mesh-ancestor
110440087|NCT01206140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110440088|NCT01206140|Immunologic Factors|immunologic factors|mesh-ancestor
110206513|NCT00180076|Budesonide|budesonide|mesh-list
110440089|NCT01206140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110440090|NCT01206140|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110440091|NCT01206140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110440092|NCT01206140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110440094|NCT01162421|Methotrexate|methotrexate|mesh-list
110440095|NCT01162421|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110440096|NCT01162421|Abortifacient Agents|abortifacient agents|mesh-ancestor
110440097|NCT01162421|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110440098|NCT01162421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110440099|NCT01162421|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110440100|NCT01162421|Antimetabolites|antimetabolites|mesh-ancestor
110440101|NCT01162421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110440102|NCT01162421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110440103|NCT01162421|Dermatologic Agents|dermatologic agents|mesh-ancestor
110440104|NCT01162421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110440105|NCT01162421|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110440106|NCT01162421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110440107|NCT01162421|Immunologic Factors|immunologic factors|mesh-ancestor
110440108|NCT01162421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110440109|NCT01162421|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110440110|NCT01162421|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110440111|NCT01162421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110440112|NCT02885441|Ketorolac|ketorolac|mesh-list
110440113|NCT02885441|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110440114|NCT02885441|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110440115|NCT02885441|Analgesics|analgesics|mesh-ancestor
110440116|NCT02885441|Sensory System Agents|sensory system agents|mesh-ancestor
110440117|NCT02885441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110440118|NCT02885441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110440119|NCT02885441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110440120|NCT02885441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110440121|NCT02885441|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110440122|NCT02885441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110440123|NCT02885441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110440124|NCT02885597|Methotrexate|methotrexate|mesh-list
110440125|NCT02885597|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110440126|NCT02885597|Abortifacient Agents|abortifacient agents|mesh-ancestor
110440127|NCT02885597|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110440128|NCT02885597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110440129|NCT02885597|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110440130|NCT02885597|Antimetabolites|antimetabolites|mesh-ancestor
110440131|NCT02885597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110440132|NCT02885597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110440133|NCT02885597|Dermatologic Agents|dermatologic agents|mesh-ancestor
110440134|NCT02885597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110440135|NCT02885597|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110440136|NCT02885597|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110440137|NCT02885597|Immunologic Factors|immunologic factors|mesh-ancestor
110440138|NCT02885597|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110440139|NCT02885597|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110440140|NCT01188551|Fentanyl|fentanyl|mesh-list
110440141|NCT01188551|Midazolam|midazolam|mesh-list
110440142|NCT01188551|Dexmedetomidine|dexmedetomidine|mesh-list
110440143|NCT01188551|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110440144|NCT01188551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110440145|NCT01188551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110440146|NCT01188551|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110440147|NCT01188551|Analgesics|analgesics|mesh-ancestor
110440148|NCT01188551|Sensory System Agents|sensory system agents|mesh-ancestor
110440149|NCT01188551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110440150|NCT01188551|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110206527|NCT00180115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110206528|NCT00180115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110206529|NCT00180115|Antiviral Agents|antiviral agents|mesh-ancestor
110206530|NCT00180115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110206531|NCT00180115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110440151|NCT01188551|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110440152|NCT01188551|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110087126|NCT05786820|Immunologic Factors|immunologic factors|mesh-ancestor
110440153|NCT01188551|Adrenergic Agents|adrenergic agents|mesh-ancestor
110440154|NCT01188551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110440155|NCT01188551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110440156|NCT01188551|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110440158|NCT01188551|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110440159|NCT01188551|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110440160|NCT01188551|Anesthetics, General|anesthetics, general|mesh-ancestor
110440161|NCT01188551|Anesthetics|anesthetics|mesh-ancestor
110440162|NCT01188551|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110440163|NCT01188551|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110440164|NCT01188551|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110440165|NCT01188551|GABA Modulators|gaba modulators|mesh-ancestor
110440166|NCT01188551|GABA Agents|gaba agents|mesh-ancestor
110440167|NCT01161407|Calcium Carbonate|calcium carbonate|mesh-list
110440168|NCT01161407|Calcium|calcium|mesh-list
110440169|NCT01161407|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110440170|NCT01161407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110440171|NCT01161407|Antacids|antacids|mesh-ancestor
110440172|NCT01161407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110440173|NCT01161407|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110440174|NCT01161173|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110440175|NCT01161173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110440176|NCT01161173|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110440177|NCT01161173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110440178|NCT01161173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110440179|NCT01159769|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
110440180|NCT01159769|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110440181|NCT01159769|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110440182|NCT01159769|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110440183|NCT01159769|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110440184|NCT01159769|Analgesics|analgesics|mesh-ancestor
110440185|NCT01159769|Sensory System Agents|sensory system agents|mesh-ancestor
110440186|NCT01159769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110440187|NCT01159769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110440188|NCT01159769|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110440189|NCT01159769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110440190|NCT01159769|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110440191|NCT01159769|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110440192|NCT01159769|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110440193|NCT01159769|Histamine Antagonists|histamine antagonists|mesh-ancestor
110440194|NCT01159769|Histamine Agents|histamine agents|mesh-ancestor
110440195|NCT01159769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110440196|NCT01159769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110440197|NCT01185821|Siponimod|siponimod|mesh-list
110440198|NCT01185821|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
110440199|NCT01185821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110440200|NCT01185821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110440201|NCT01185821|Immunologic Factors|immunologic factors|mesh-ancestor
110440202|NCT01185821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110440203|NCT00893464|Ixazomib|ixazomib|mesh-list
110440204|NCT00893464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110440205|NCT00893464|Protease Inhibitors|protease inhibitors|mesh-ancestor
110440206|NCT00893464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110440207|NCT00893464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110440209|NCT00891904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110440210|NCT00891904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110440211|NCT02834260|Dexamethasone|dexamethasone|mesh-list
110440212|NCT02834260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110440213|NCT02834260|Antiemetics|antiemetics|mesh-ancestor
110440214|NCT02834260|Autonomic Agents|autonomic agents|mesh-ancestor
110440215|NCT02834260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110206534|NCT00046527|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110206535|NCT00046527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110206536|NCT00180310|Paclitaxel|paclitaxel|mesh-list
110206537|NCT00180310|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110440216|NCT02834260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110440217|NCT02834260|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110440219|NCT02834260|Hormones|hormones|mesh-ancestor
110440220|NCT02834260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110440221|NCT02834260|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110440222|NCT02834260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110440223|NCT01157351|Olanzapine|olanzapine|mesh-list
110440224|NCT01157351|Risperidone|risperidone|mesh-list
110440226|NCT01157351|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110440227|NCT01157351|Paliperidone Palmitate|paliperidone palmitate|mesh-list
110440228|NCT01157351|Perphenazine|perphenazine|mesh-list
110440229|NCT01157351|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110440230|NCT01157351|Serotonin Agents|serotonin agents|mesh-ancestor
110440231|NCT01157351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110440232|NCT01157351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110440233|NCT01157351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110440234|NCT01157351|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110440235|NCT01157351|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110440236|NCT01157351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110440237|NCT01157351|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110440238|NCT01157351|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110440239|NCT01157351|Dopamine Agents|dopamine agents|mesh-ancestor
110440240|NCT01157351|Antiemetics|antiemetics|mesh-ancestor
110440241|NCT01157351|Autonomic Agents|autonomic agents|mesh-ancestor
110440242|NCT01157351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110440243|NCT01157351|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110440244|NCT01157351|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110440245|NCT01157351|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110440246|NCT01157351|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110440247|NCT01157351|Antidepressive Agents|antidepressive agents|mesh-ancestor
110440248|NCT01157351|Dopamine Agonists|dopamine agonists|mesh-ancestor
110440249|NCT01157351|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110440250|NCT01157351|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110440251|NCT01157351|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110440252|NCT01157351|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110440253|NCT02831686|Dexamethasone|dexamethasone|mesh-list
110440254|NCT02831686|Ixazomib|ixazomib|mesh-list
110440255|NCT02831686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110440256|NCT02831686|Antiemetics|antiemetics|mesh-ancestor
110440257|NCT02831686|Autonomic Agents|autonomic agents|mesh-ancestor
110440258|NCT02831686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110440259|NCT02831686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110440260|NCT02831686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110440261|NCT02831686|Glucocorticoids|glucocorticoids|mesh-ancestor
110440262|NCT02831686|Hormones|hormones|mesh-ancestor
110440263|NCT02831686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110440264|NCT02831686|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110440265|NCT02831686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110440266|NCT02831686|Protease Inhibitors|protease inhibitors|mesh-ancestor
110440267|NCT02831686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110440268|NCT02831686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110440269|NCT00633490|Apatinib|apatinib|mesh-list
110440270|NCT00633490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110440271|NCT00633490|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110440272|NCT00633490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110440273|NCT00633490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110440274|NCT02831374|Anesthetics|anesthetics|mesh-list
110372945|NCT04592081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110440275|NCT02831374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110440276|NCT02831374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110440277|NCT02831218|Aspirin|aspirin|mesh-list
110440278|NCT02831218|Clopidogrel|clopidogrel|mesh-list
110440279|NCT02831218|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110440280|NCT02831218|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110440281|NCT02831218|Analgesics|analgesics|mesh-ancestor
110440282|NCT02831218|Sensory System Agents|sensory system agents|mesh-ancestor
110440283|NCT02831218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110440284|NCT02831218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110440285|NCT02831218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110440286|NCT02831218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110440287|NCT02831218|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110440288|NCT02831218|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110440289|NCT02831218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110329542|NCT00593008|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110440290|NCT02831218|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110440291|NCT02831218|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110440292|NCT02831218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110440294|NCT02831218|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110440295|NCT02831218|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110440296|NCT02831218|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110440297|NCT02831218|Purinergic Agents|purinergic agents|mesh-ancestor
110440298|NCT02831218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110440299|NCT02833480|Fluticasone|fluticasone|mesh-list
110440300|NCT02833480|Budesonide|budesonide|mesh-list
110087278|NCT05118685|Estrogens|estrogens|mesh-list
110440301|NCT02833480|Formoterol Fumarate|formoterol fumarate|mesh-list
110440302|NCT02833480|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110440303|NCT02833480|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110440304|NCT02833480|Autonomic Agents|autonomic agents|mesh-ancestor
110440305|NCT02833480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110440306|NCT02833480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110440307|NCT02833480|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110440308|NCT02833480|Respiratory System Agents|respiratory system agents|mesh-ancestor
110440309|NCT02833480|Dermatologic Agents|dermatologic agents|mesh-ancestor
110440310|NCT02833480|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110440311|NCT02833480|Glucocorticoids|glucocorticoids|mesh-ancestor
110440312|NCT02833480|Hormones|hormones|mesh-ancestor
110440313|NCT02833480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110440314|NCT02833480|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110440315|NCT02833480|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110440316|NCT02833480|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110440317|NCT02833480|Adrenergic Agents|adrenergic agents|mesh-ancestor
110440318|NCT02833480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110440319|NCT02833480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110440320|NCT04201054|Fluconazole|fluconazole|mesh-list
110440321|NCT04201054|Antifungal Agents|antifungal agents|mesh-ancestor
110440322|NCT04201054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110440323|NCT04201054|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110440324|NCT04201054|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110440325|NCT04201054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110440326|NCT04201054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110440327|NCT04201054|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110440328|NCT04201054|Hormone Antagonists|hormone antagonists|mesh-ancestor
110234467|NCT05635370|Cilostazol|cilostazol|mesh-list
110440329|NCT04201054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110440330|NCT04201054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110440331|NCT04201054|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110440332|NCT04201054|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110440333|NCT01157117|Omalizumab|omalizumab|mesh-list
110440334|NCT01157117|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110440335|NCT01157117|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110440336|NCT01157117|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110440337|NCT01157117|Respiratory System Agents|respiratory system agents|mesh-ancestor
110440338|NCT01157117|Immunologic Factors|immunologic factors|mesh-ancestor
110440339|NCT01157117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110440340|NCT00891202|Eliglustat|eliglustat|mesh-list
110440341|NCT00891202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110440342|NCT00891202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110440343|NCT02830906|Ondansetron|ondansetron|mesh-list
110440344|NCT02830906|Ramosetron|ramosetron|mesh-list
110440345|NCT02830906|Antiemetics|antiemetics|mesh-ancestor
110440346|NCT02830906|Autonomic Agents|autonomic agents|mesh-ancestor
110440347|NCT02830906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110440348|NCT02830906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110440349|NCT02830906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110440350|NCT02830906|Antipruritics|antipruritics|mesh-ancestor
110440351|NCT02830906|Dermatologic Agents|dermatologic agents|mesh-ancestor
110440352|NCT02830906|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110440353|NCT02830906|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110440354|NCT02830906|Serotonin Agents|serotonin agents|mesh-ancestor
110440355|NCT02830906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110440356|NCT02830906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110440357|NCT02832778|Tenofovir|tenofovir|mesh-list
110440358|NCT02832778|Lamivudine|lamivudine|mesh-list
110440359|NCT02832778|Emtricitabine|emtricitabine|mesh-list
110440360|NCT02832778|Zidovudine|zidovudine|mesh-list
110440362|NCT02832778|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
110440363|NCT02832778|Isoniazid|isoniazid|mesh-list
110440364|NCT02832778|Antiviral Agents|antiviral agents|mesh-ancestor
110440365|NCT02832778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110440366|NCT02832778|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110440367|NCT02832778|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110440368|NCT02832778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110440369|NCT02832778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110440370|NCT02832778|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110440371|NCT02832778|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110440372|NCT02832778|Antimetabolites|antimetabolites|mesh-ancestor
110440373|NCT02832778|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110440374|NCT02832778|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110440375|NCT02832778|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110440376|NCT02832778|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110440377|NCT02832778|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110440378|NCT02832778|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110440380|NCT02832778|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110440381|NCT02832778|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
110440382|NCT02832778|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110440383|NCT02832778|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110440384|NCT01185509|Trastuzumab|trastuzumab|mesh-list
110440385|NCT01185509|Vinorelbine|vinorelbine|mesh-list
110440386|NCT01185509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110440387|NCT01185509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110440388|NCT01185509|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110440389|NCT01185509|Tubulin Modulators|tubulin modulators|mesh-ancestor
110440390|NCT01185509|Antimitotic Agents|antimitotic agents|mesh-ancestor
110440391|NCT01185509|Mitosis Modulators|mitosis modulators|mesh-ancestor
110372961|NCT04591535|Levodopa|levodopa|mesh-list
110440392|NCT01185509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110440393|NCT04247230|Tetracaine|tetracaine|mesh-list
110440394|NCT04247230|Anesthetics, Local|anesthetics, local|mesh-ancestor
110440395|NCT04247230|Anesthetics|anesthetics|mesh-ancestor
110440396|NCT04247230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110440397|NCT04247230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110440398|NCT04247230|Sensory System Agents|sensory system agents|mesh-ancestor
110440399|NCT04247230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110440400|NCT02832700|Caseins|caseins|mesh-list
110440401|NCT02832700|Chelating Agents|chelating agents|mesh-ancestor
110440402|NCT02832700|Sequestering Agents|sequestering agents|mesh-ancestor
110440403|NCT02832700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110440404|NCT02831842|Bevacizumab|bevacizumab|mesh-list
110440405|NCT02831842|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110440406|NCT02831842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110440407|NCT02831842|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110440408|NCT02831842|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110440409|NCT02831842|Growth Substances|growth substances|mesh-ancestor
110440410|NCT02831842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110440411|NCT02831842|Growth Inhibitors|growth inhibitors|mesh-ancestor
110440412|NCT02830048|Glyburide|glyburide|mesh-list
110440413|NCT02830048|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110440414|NCT02830048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110440415|NCT02830126|Anesthetics|anesthetics|mesh-list
110440416|NCT02830126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110440417|NCT02830126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110440418|NCT02828566|Ketamine|ketamine|mesh-list
110440419|NCT02828566|Analgesics|analgesics|mesh-ancestor
110440420|NCT02828566|Sensory System Agents|sensory system agents|mesh-ancestor
110440421|NCT02828566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110440422|NCT02828566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110440423|NCT02828566|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110440424|NCT02828566|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110440425|NCT02828566|Anesthetics, General|anesthetics, general|mesh-ancestor
110440426|NCT02828566|Anesthetics|anesthetics|mesh-ancestor
110440427|NCT02828566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110440428|NCT02828566|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110440429|NCT02828566|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110440430|NCT02828566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110440431|NCT02828566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110440432|NCT04245046|Amlodipine|amlodipine|mesh-list
110440433|NCT04245046|Candesartan|candesartan|mesh-list
110440434|NCT04245046|Candesartan cilexetil|candesartan cilexetil|mesh-list
110440435|NCT04245046|Atorvastatin|atorvastatin|mesh-list
110440436|NCT04245046|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110440437|NCT04245046|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110440438|NCT04245046|Antimetabolites|antimetabolites|mesh-ancestor
110440439|NCT04245046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110440440|NCT04245046|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110440441|NCT04245046|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110440442|NCT04245046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110440443|NCT04245046|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110440444|NCT04245046|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110440445|NCT04245046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110440446|NCT04245046|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110087427|NCT03959566|Bedaquiline|bedaquiline|mesh-list
110440447|NCT04245046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110440448|NCT04245046|Vasodilator Agents|vasodilator agents|mesh-ancestor
110440449|NCT04245046|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110440450|NCT04245046|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110440451|NCT02828176|Anesthetics|anesthetics|mesh-list
110440452|NCT02828176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110440453|NCT02828176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110440454|NCT00633568|Cisplatin|cisplatin|mesh-list
110440455|NCT00633568|Docetaxel|docetaxel|mesh-list
110440456|NCT00633568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110440457|NCT00633568|Tubulin Modulators|tubulin modulators|mesh-ancestor
110440458|NCT00633568|Antimitotic Agents|antimitotic agents|mesh-ancestor
110206583|NCT00180895|Rituximab|rituximab|mesh-list
110440459|NCT00633568|Mitosis Modulators|mitosis modulators|mesh-ancestor
110440460|NCT00633568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110440461|NCT02829346|Tranexamic Acid|tranexamic acid|mesh-list
110440462|NCT02829346|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110440463|NCT02829346|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110440464|NCT02829346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110440465|NCT02829346|Hemostatics|hemostatics|mesh-ancestor
110440466|NCT02829346|Coagulants|coagulants|mesh-ancestor
110440468|NCT05210764|Anesthetics|anesthetics|mesh-list
110440469|NCT05210764|Propofol|propofol|mesh-list
110440470|NCT05210764|Sevoflurane|sevoflurane|mesh-list
110440471|NCT05210764|Esketamine|esketamine|mesh-list
110440472|NCT05210764|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110440473|NCT05210764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110440474|NCT05210764|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110440475|NCT05210764|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110440476|NCT05210764|Anesthetics, General|anesthetics, general|mesh-ancestor
110440477|NCT05210764|Analgesics|analgesics|mesh-ancestor
110440478|NCT05210764|Sensory System Agents|sensory system agents|mesh-ancestor
110440479|NCT05210764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110440480|NCT05210764|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110440481|NCT05210764|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110440482|NCT05210764|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110440483|NCT05210764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110440484|NCT05210764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110440485|NCT05210764|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110440486|NCT05210764|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110440487|NCT05210764|Antidepressive Agents|antidepressive agents|mesh-ancestor
110440488|NCT05210764|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110440489|NCT00889720|Varenicline|varenicline|mesh-list
110440490|NCT00889720|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110440491|NCT00889720|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110440492|NCT00889720|Cholinergic Agents|cholinergic agents|mesh-ancestor
110440493|NCT00889720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110440494|NCT00889720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110440495|NCT00889720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110440496|NCT01116648|Olaparib|olaparib|mesh-list
110440497|NCT01116648|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
110440498|NCT01116648|Cediranib|cediranib|mesh-list
110440499|NCT01116648|Maleic acid|maleic acid|mesh-list
110440500|NCT01116648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110440501|NCT01116648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110440502|NCT01116648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110440503|NCT01116648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110440504|NCT04243954|Morphine|morphine|mesh-list
110440505|NCT04243954|Hydromorphone|hydromorphone|mesh-list
110440506|NCT04243954|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110440507|NCT04243954|Narcotics|narcotics|mesh-ancestor
110440508|NCT04243954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110440509|NCT04243954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110440510|NCT04243954|Analgesics|analgesics|mesh-ancestor
110440511|NCT04243954|Sensory System Agents|sensory system agents|mesh-ancestor
110440512|NCT04243954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110440513|NCT02827942|Amoxicillin|amoxicillin|mesh-list
110440514|NCT02827942|Metronidazole|metronidazole|mesh-list
110440515|NCT02827942|Clarithromycin|clarithromycin|mesh-list
110440516|NCT02827942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110440517|NCT02827942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110440518|NCT02827942|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110440519|NCT02827942|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110440520|NCT02827942|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110440521|NCT02827942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110440522|NCT02827942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110440523|NCT02827942|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110440524|NCT02827942|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110440526|NCT00889252|Antipruritics|antipruritics|mesh-ancestor
110440527|NCT00889252|Dermatologic Agents|dermatologic agents|mesh-ancestor
110440528|NCT00889252|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110440529|NCT00889252|Histamine Antagonists|histamine antagonists|mesh-ancestor
110440530|NCT00889252|Histamine Agents|histamine agents|mesh-ancestor
110440531|NCT00889252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110440532|NCT00889252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110440533|NCT00889252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110440534|NCT00889252|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110440535|NCT00670813|Modafinil|modafinil|mesh-list
110440536|NCT00670813|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110440537|NCT00670813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110440538|NCT00670813|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
110440539|NCT00670813|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110440540|NCT00670813|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110440541|NCT00670813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110440542|NCT01110330|Ketoconazole|ketoconazole|mesh-list
110440543|NCT01110330|Antifungal Agents|antifungal agents|mesh-ancestor
110440544|NCT01110330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110440545|NCT01110330|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110440546|NCT01110330|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110440547|NCT01110330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110440548|NCT01110330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110440549|NCT01110330|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110440550|NCT01110330|Hormone Antagonists|hormone antagonists|mesh-ancestor
110440551|NCT01110330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110440552|NCT01110330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110440553|NCT01110330|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110440554|NCT00663481|Leucovorin|leucovorin|mesh-list
110440555|NCT00663481|Antidotes|antidotes|mesh-ancestor
110440556|NCT00663481|Protective Agents|protective agents|mesh-ancestor
110440557|NCT00663481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110440558|NCT00663481|Vitamin B Complex|vitamin b complex|mesh-ancestor
110440559|NCT00663481|Vitamins|vitamins|mesh-ancestor
110440560|NCT00663481|Micronutrients|micronutrients|mesh-ancestor
110440561|NCT04308954|Flumazenil|flumazenil|mesh-list
110440562|NCT04308954|Antidotes|antidotes|mesh-ancestor
110440563|NCT04308954|Protective Agents|protective agents|mesh-ancestor
110440564|NCT04308954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110440565|NCT04308954|GABA Modulators|gaba modulators|mesh-ancestor
110440566|NCT04308954|GABA Agents|gaba agents|mesh-ancestor
110440567|NCT04308954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110440568|NCT04308954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110440569|NCT00596947|Mycophenolic Acid|mycophenolic acid|mesh-list
110440570|NCT00596947|Prednisone|prednisone|mesh-list
110440571|NCT00596947|Methylprednisolone|methylprednisolone|mesh-list
110440572|NCT00596947|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110440573|NCT00596947|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110440574|NCT00596947|Prednisolone|prednisolone|mesh-list
110440575|NCT00596947|Prednisolone acetate|prednisolone acetate|mesh-list
110440576|NCT00596947|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110440577|NCT00596947|Prednisolone phosphate|prednisolone phosphate|mesh-list
110440579|NCT00596947|Thymoglobulin|thymoglobulin|mesh-list
110440580|NCT00596947|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110440581|NCT00596947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110440582|NCT00596947|Glucocorticoids|glucocorticoids|mesh-ancestor
110440583|NCT00596947|Hormones|hormones|mesh-ancestor
110440584|NCT00596947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110440585|NCT00596947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110440586|NCT00596947|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110440587|NCT00596947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110440588|NCT00596947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110440589|NCT00596947|Immunologic Factors|immunologic factors|mesh-ancestor
110440590|NCT00596947|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110440591|NCT00596947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110440592|NCT00596947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110440593|NCT00596947|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110440594|NCT00596947|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110440595|NCT00596947|Antitubercular Agents|antitubercular agents|mesh-ancestor
110440596|NCT00596947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110440597|NCT00596947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110440598|NCT00596947|Antiemetics|antiemetics|mesh-ancestor
110440599|NCT00596947|Autonomic Agents|autonomic agents|mesh-ancestor
110440600|NCT00596947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110440601|NCT00596947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110440602|NCT00596947|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110440603|NCT00596947|Protective Agents|protective agents|mesh-ancestor
110440604|NCT04155697|Hand Sanitizers|hand sanitizers|mesh-list
110440605|NCT04155697|Ethanol|ethanol|mesh-list
110440606|NCT04155697|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110440607|NCT04155697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110440608|NCT04155697|Disinfectants|disinfectants|mesh-ancestor
110440609|NCT04155697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110440610|NCT04155697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110440611|NCT00663559|Sunitinib|sunitinib|mesh-list
110440612|NCT00663559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110440613|NCT00663559|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110440614|NCT00663559|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110440615|NCT00663559|Growth Substances|growth substances|mesh-ancestor
110440616|NCT00663559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110440617|NCT00663559|Growth Inhibitors|growth inhibitors|mesh-ancestor
110440618|NCT00663559|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110440619|NCT00663559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110440620|NCT00663559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110440621|NCT04158349|Oxaliplatin|oxaliplatin|mesh-list
110440622|NCT04158349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110440623|NCT00888940|Ecallantide|ecallantide|mesh-list
110440624|NCT00888940|Tranexamic Acid|tranexamic acid|mesh-list
110440625|NCT00888940|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110440626|NCT00888940|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110440627|NCT00888940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110440628|NCT00888940|Hemostatics|hemostatics|mesh-ancestor
110440629|NCT00888940|Coagulants|coagulants|mesh-ancestor
110440630|NCT00888940|Analgesics|analgesics|mesh-ancestor
110440631|NCT00888940|Sensory System Agents|sensory system agents|mesh-ancestor
110440632|NCT00888940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110440633|NCT00888940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110440634|NCT00888940|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110440635|NCT00888940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110440636|NCT00888940|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110440637|NCT00888940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110440638|NCT02826070|Adefovir|adefovir|mesh-list
110440639|NCT02826070|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
110440640|NCT02826070|Telbivudine|telbivudine|mesh-list
110440641|NCT02826070|Antiviral Agents|antiviral agents|mesh-ancestor
110440642|NCT02826070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110440643|NCT02826070|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110440644|NCT02826070|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110440645|NCT02826070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110440646|NCT02826070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110440647|NCT02826226|Bronchodilator Agents|bronchodilator agents|mesh-list
110440648|NCT02826226|Autonomic Agents|autonomic agents|mesh-ancestor
110440649|NCT02826226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110440650|NCT02826226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110440651|NCT02826226|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110440652|NCT02826226|Respiratory System Agents|respiratory system agents|mesh-ancestor
110440653|NCT00671203|Erythromycin|erythromycin|mesh-list
110440654|NCT00671203|Erythromycin Estolate|erythromycin estolate|mesh-list
110440655|NCT00671203|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
110440656|NCT00671203|Erythromycin stearate|erythromycin stearate|mesh-list
110440657|NCT00671203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110440658|NCT00671203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110440659|NCT00671203|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110440660|NCT00671203|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110440661|NCT00671203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110440662|NCT00671203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110440663|NCT04157803|Acetic Acid|acetic acid|mesh-list
110440664|NCT04157803|Retinol acetate|retinol acetate|mesh-list
110440665|NCT04157803|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110440666|NCT04157803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110440667|NCT04157803|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110440668|NCT04157803|Immunologic Factors|immunologic factors|mesh-ancestor
110440669|NCT04157803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110440670|NCT04157803|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110440671|NCT04157803|Protective Agents|protective agents|mesh-ancestor
110440672|NCT04157803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110440673|NCT04157959|Febuxostat|febuxostat|mesh-list
110440674|NCT04157959|Gout Suppressants|gout suppressants|mesh-ancestor
110440675|NCT04157959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110440676|NCT00660283|Temozolomide|temozolomide|mesh-list
110440677|NCT00660283|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110440678|NCT00660283|Alkylating Agents|alkylating agents|mesh-ancestor
110440679|NCT00660283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110440680|NCT00660283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110440681|NCT00663949|Captopril|captopril|mesh-list
110440682|NCT00663949|Pentoxifylline|pentoxifylline|mesh-list
110440683|NCT00663949|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110440684|NCT00663949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110440685|NCT00663949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110440686|NCT00663949|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110440687|NCT00663949|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110440688|NCT00663949|Protective Agents|protective agents|mesh-ancestor
110440689|NCT00663949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110440690|NCT00663949|Vasodilator Agents|vasodilator agents|mesh-ancestor
110440691|NCT00663949|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110440692|NCT00663949|Antioxidants|antioxidants|mesh-ancestor
110440693|NCT00663949|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110440694|NCT00663949|Protease Inhibitors|protease inhibitors|mesh-ancestor
110440695|NCT00663949|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110440696|NCT00888238|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110440697|NCT00888238|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110440698|NCT00888238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110440699|NCT00888238|Incretins|incretins|mesh-ancestor
110440700|NCT00888238|Hormones|hormones|mesh-ancestor
110440701|NCT00888238|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110440702|NCT00888238|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110440703|NCT00888238|Protease Inhibitors|protease inhibitors|mesh-ancestor
110440704|NCT00888238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110440705|NCT00888238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110440706|NCT05660356|Hormones|hormones|mesh-list
110440707|NCT05660356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110440708|NCT05660356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110440709|NCT02825914|Caseins|caseins|mesh-list
110440710|NCT02825914|Chelating Agents|chelating agents|mesh-ancestor
110440711|NCT02825914|Sequestering Agents|sequestering agents|mesh-ancestor
110440712|NCT02825914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110440713|NCT00671281|Tranexamic Acid|tranexamic acid|mesh-list
110440714|NCT00671281|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110440715|NCT00671281|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110329563|NCT00593164|Anticonvulsants|anticonvulsants|mesh-ancestor
110440716|NCT00671281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110440718|NCT00671281|Coagulants|coagulants|mesh-ancestor
110440719|NCT04155229|Acetaminophen|acetaminophen|mesh-list
110440720|NCT04155229|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
110440721|NCT04155229|Oxycodone|oxycodone|mesh-list
110440722|NCT04155229|Hydrocodone|hydrocodone|mesh-list
110440723|NCT04155229|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110440724|NCT04155229|Analgesics|analgesics|mesh-ancestor
110440725|NCT04155229|Sensory System Agents|sensory system agents|mesh-ancestor
110440726|NCT04155229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110440727|NCT04155229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110440728|NCT04155229|Antipyretics|antipyretics|mesh-ancestor
110440729|NCT04155229|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110440730|NCT04155229|Narcotics|narcotics|mesh-ancestor
110440731|NCT04155229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110440732|NCT04155229|Antitussive Agents|antitussive agents|mesh-ancestor
110440733|NCT04155229|Respiratory System Agents|respiratory system agents|mesh-ancestor
110440734|NCT04155229|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110440735|NCT04155229|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110440736|NCT04155229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110440737|NCT00671359|Tedizolid phosphate|tedizolid phosphate|mesh-list
110440738|NCT00671359|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110440739|NCT00671359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110440740|NCT04153201|Hydroxychloroquine|hydroxychloroquine|mesh-list
110440741|NCT04153201|Antimalarials|antimalarials|mesh-list
110440742|NCT04153201|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110440743|NCT04153201|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110440744|NCT04153201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110440745|NCT04153201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110440746|NCT04153201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110440747|NCT04153201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110440749|NCT05660278|Chelating Agents|chelating agents|mesh-ancestor
110440750|NCT05660278|Sequestering Agents|sequestering agents|mesh-ancestor
110440751|NCT05660278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110440752|NCT04153123|Epinephrine|epinephrine|mesh-list
110440753|NCT04153123|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110206655|NCT00181636|Galantamine|galantamine|mesh-list
110440754|NCT04153123|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110440755|NCT04153123|Adrenergic Agents|adrenergic agents|mesh-ancestor
110440756|NCT04153123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110440757|NCT04153123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110440758|NCT04153123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110440759|NCT04153123|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110440760|NCT04153123|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110440761|NCT04153123|Autonomic Agents|autonomic agents|mesh-ancestor
110440762|NCT04153123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110440763|NCT04153123|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110440764|NCT04153123|Respiratory System Agents|respiratory system agents|mesh-ancestor
110440766|NCT04153123|Sympathomimetics|sympathomimetics|mesh-ancestor
110440767|NCT04153123|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110440768|NCT00671593|Phenol|phenol|mesh-list
110440769|NCT00671593|Glycerol|glycerol|mesh-list
110440770|NCT00671593|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
110440771|NCT00671593|Protective Agents|protective agents|mesh-ancestor
110440772|NCT00671593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110440773|NCT00671593|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110440774|NCT00671593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110440775|NCT00671593|Disinfectants|disinfectants|mesh-ancestor
110440776|NCT00671593|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
110440777|NCT00671593|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110440778|NCT01104870|Treprostinil|treprostinil|mesh-list
110440779|NCT01104870|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110440780|NCT02632279|Tryptophan|tryptophan|mesh-list
110440781|NCT02632279|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110440782|NCT02632279|Antidepressive Agents|antidepressive agents|mesh-ancestor
110440783|NCT02632279|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110440784|NCT00664417|Vaccines|vaccines|mesh-list
110440785|NCT00664417|Immunologic Factors|immunologic factors|mesh-ancestor
110440786|NCT00664417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110440787|NCT04031755|Minocycline|minocycline|mesh-list
110440788|NCT04031755|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110440789|NCT04031755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110440790|NCT01104792|Cariprazine|cariprazine|mesh-list
110440791|NCT01104792|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110440792|NCT01104792|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110440793|NCT01104792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110440794|NCT01104792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110440796|NCT01205126|Oxycodone|oxycodone|mesh-list
110440797|NCT01205126|Hydromorphone|hydromorphone|mesh-list
110440798|NCT01205126|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110440799|NCT01205126|Narcotics|narcotics|mesh-ancestor
110440800|NCT01205126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110440801|NCT01205126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110440802|NCT01205126|Analgesics|analgesics|mesh-ancestor
110440803|NCT01205126|Sensory System Agents|sensory system agents|mesh-ancestor
110440804|NCT01205126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110440805|NCT02629627|Metformin|metformin|mesh-list
110440806|NCT02629627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110440807|NCT02629627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110440808|NCT00946647|Azacitidine|azacitidine|mesh-list
110440809|NCT00946647|Panobinostat|panobinostat|mesh-list
110440810|NCT00946647|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110440811|NCT00946647|Antimetabolites|antimetabolites|mesh-ancestor
110440812|NCT00946647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110440813|NCT00946647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110440814|NCT00946647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110440815|NCT00946647|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110440816|NCT05117736|Valsartan|valsartan|mesh-list
110440817|NCT05117736|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
110440818|NCT05117736|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110440819|NCT05117736|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110206665|NCT00181636|Nootropic Agents|nootropic agents|mesh-ancestor
110440820|NCT05117736|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110440821|NCT05117736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110440822|NCT04157491|Antibodies|antibodies|mesh-list
110440823|NCT04157491|Immunologic Factors|immunologic factors|mesh-ancestor
110440824|NCT04157491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110440825|NCT00660751|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110440826|NCT00660751|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110440827|NCT00660751|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110440828|NCT00660751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110440829|NCT00660751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110440830|NCT00660751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110440831|NCT00660751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110440833|NCT00660751|Sensory System Agents|sensory system agents|mesh-ancestor
110440834|NCT00660751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110440835|NCT00660751|Antidepressive Agents|antidepressive agents|mesh-ancestor
110440836|NCT00660751|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110440837|NCT00660751|Dopamine Agents|dopamine agents|mesh-ancestor
110440838|NCT00664963|Sirolimus|sirolimus|mesh-list
110440839|NCT00664963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110440840|NCT00664963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110440841|NCT00664963|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110440842|NCT00664963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110440843|NCT00664963|Antifungal Agents|antifungal agents|mesh-ancestor
110440844|NCT00664963|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110440845|NCT00664963|Immunologic Factors|immunologic factors|mesh-ancestor
110440846|NCT00664963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110440847|NCT00672295|Paclitaxel|paclitaxel|mesh-list
110373051|NCT00567554|Paclitaxel|paclitaxel|mesh-list
110440848|NCT00672295|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110440849|NCT00672295|Carboplatin|carboplatin|mesh-list
110440850|NCT00672295|Dasatinib|dasatinib|mesh-list
110440851|NCT00672295|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110440852|NCT00672295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110440853|NCT00672295|Tubulin Modulators|tubulin modulators|mesh-ancestor
110440854|NCT00672295|Antimitotic Agents|antimitotic agents|mesh-ancestor
110440855|NCT00672295|Mitosis Modulators|mitosis modulators|mesh-ancestor
110440856|NCT00672295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110440857|NCT00672295|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110440858|NCT00672295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110440859|NCT00665041|Quinagolide|quinagolide|mesh-list
110440860|NCT00665041|Dopamine Agonists|dopamine agonists|mesh-ancestor
110440861|NCT00665041|Dopamine Agents|dopamine agents|mesh-ancestor
110440862|NCT00665041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110329570|NCT01316107|Ipragliflozin|ipragliflozin|mesh-list
110440863|NCT00665041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110440864|NCT00665041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110440865|NCT04152655|Coenzyme Q10|coenzyme q10|mesh-list
110440866|NCT04152655|Idebenone|idebenone|mesh-list
110440867|NCT04152655|Micronutrients|micronutrients|mesh-ancestor
110440868|NCT04152655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110440869|NCT04152655|Vitamins|vitamins|mesh-ancestor
110440870|NCT04152655|Antioxidants|antioxidants|mesh-ancestor
110206676|NCT00181675|Nootropic Agents|nootropic agents|mesh-ancestor
110440871|NCT04152655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110440872|NCT04152655|Protective Agents|protective agents|mesh-ancestor
110440873|NCT00665119|Remifentanil|remifentanil|mesh-list
110440874|NCT00665119|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110440875|NCT00665119|Narcotics|narcotics|mesh-ancestor
110440876|NCT00665119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110440877|NCT00665119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110440878|NCT00665119|Analgesics|analgesics|mesh-ancestor
110440879|NCT00665119|Sensory System Agents|sensory system agents|mesh-ancestor
110440880|NCT00665119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110440881|NCT00887224|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
110440882|NCT00887224|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110440883|NCT00887224|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110440884|NCT00887224|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110440885|NCT00887224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110440886|NCT00887224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110440887|NCT00887224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110440888|NCT00887224|Antidepressive Agents|antidepressive agents|mesh-ancestor
110440889|NCT00887224|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110440890|NCT00672763|Calcium, Dietary|calcium, dietary|mesh-list
110440891|NCT00672763|Vitamin D|vitamin d|mesh-list
110440892|NCT00672763|Ergocalciferols|ergocalciferols|mesh-list
110440893|NCT00672763|Cholecalciferol|cholecalciferol|mesh-list
110440894|NCT00672763|Vitamins|vitamins|mesh-list
110440895|NCT00672763|Calcium|calcium|mesh-list
110440896|NCT00672763|Micronutrients|micronutrients|mesh-ancestor
110087873|NCT01690507|Aclacinomycins|aclacinomycins|mesh-list
110440897|NCT00672763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110440898|NCT00672763|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110440899|NCT00672763|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110440900|NCT04154449|Insulin|insulin|mesh-list
110440901|NCT04154449|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110440902|NCT04154449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110440903|NCT00661063|Clonidine|clonidine|mesh-list
110440904|NCT00661063|Ketamine|ketamine|mesh-list
110440905|NCT00661063|Analgesics|analgesics|mesh-ancestor
110440906|NCT00661063|Sensory System Agents|sensory system agents|mesh-ancestor
110440907|NCT00661063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110440908|NCT00661063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110440909|NCT00661063|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110440910|NCT00661063|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110440911|NCT00661063|Anesthetics, General|anesthetics, general|mesh-ancestor
110440912|NCT00661063|Anesthetics|anesthetics|mesh-ancestor
110440913|NCT00661063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110440914|NCT00661063|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110440915|NCT00661063|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110440916|NCT00661063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110373052|NCT00567554|Docetaxel|docetaxel|mesh-list
110440917|NCT00661063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110440918|NCT00661063|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110440919|NCT00661063|Sympatholytics|sympatholytics|mesh-ancestor
110440920|NCT00661063|Autonomic Agents|autonomic agents|mesh-ancestor
110440921|NCT00661063|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110440922|NCT00661063|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110440923|NCT00661063|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110440924|NCT00661063|Adrenergic Agents|adrenergic agents|mesh-ancestor
110440925|NCT00672919|Pioglitazone|pioglitazone|mesh-list
110440926|NCT00672919|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110440927|NCT00672919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110440928|NCT01109316|Insulin|insulin|mesh-list
110440929|NCT01109316|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110440930|NCT01109316|Insulin Aspart|insulin aspart|mesh-list
110440931|NCT01109316|Insulin Lispro|insulin lispro|mesh-list
110440932|NCT01109316|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110440933|NCT01109316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110440934|NCT02825290|Triptorelin Pamoate|triptorelin pamoate|mesh-list
110440935|NCT02825290|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
110206697|NCT00181948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110206698|NCT00181948|Adrenergic Agents|adrenergic agents|mesh-ancestor
110206699|NCT00181948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110440937|NCT02825290|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110440938|NCT02825290|Contraceptive Agents|contraceptive agents|mesh-ancestor
110440939|NCT02825290|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110440940|NCT02825290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110440941|NCT02825290|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110440942|NCT02825290|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110440943|NCT02825290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110440944|NCT00675961|Naltrexone|naltrexone|mesh-list
110440945|NCT00675961|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110440946|NCT00675961|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110440947|NCT00675961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110440948|NCT00675961|Sensory System Agents|sensory system agents|mesh-ancestor
110440949|NCT00675961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110440950|NCT00887068|Azacitidine|azacitidine|mesh-list
110440951|NCT00887068|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110440952|NCT00887068|Antimetabolites|antimetabolites|mesh-ancestor
110440953|NCT00887068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110440954|NCT00887068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110440955|NCT00887068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110440956|NCT00941031|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110440957|NCT00941031|Immunologic Factors|immunologic factors|mesh-ancestor
110440958|NCT00941031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110440959|NCT00886834|Misoprostol|misoprostol|mesh-list
110440960|NCT00886834|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110440961|NCT00886834|Abortifacient Agents|abortifacient agents|mesh-ancestor
110440962|NCT00886834|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110440963|NCT00886834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110440964|NCT00886834|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110440965|NCT00886834|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110440966|NCT00886834|Oxytocics|oxytocics|mesh-ancestor
110440967|NCT00880009|Letrozole|letrozole|mesh-list
110440968|NCT00880009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110440969|NCT00880009|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110440970|NCT00880009|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110440971|NCT00880009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110440972|NCT00880009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110087960|NCT01690767|Lidocaine|lidocaine|mesh-list
110440973|NCT00880009|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110440974|NCT00880009|Hormone Antagonists|hormone antagonists|mesh-ancestor
110440975|NCT00880009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110440976|NCT00880009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110440977|NCT00676039|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
110440979|NCT00676039|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110440980|NCT00676039|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110440981|NCT00676039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110440982|NCT00676039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110440983|NCT00676039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110440984|NCT00676039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110440985|NCT00676039|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110440986|NCT00676039|Antidepressive Agents|antidepressive agents|mesh-ancestor
110440987|NCT00676039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110440988|NCT00676039|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110440989|NCT00676039|Serotonin Agents|serotonin agents|mesh-ancestor
110440990|NCT01104636|Varenicline|varenicline|mesh-list
110206700|NCT00181948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110206701|NCT00181987|Methylphenidate|methylphenidate|mesh-list
110206702|NCT00181987|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110440991|NCT01104636|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110440992|NCT01104636|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110440993|NCT01104636|Cholinergic Agents|cholinergic agents|mesh-ancestor
110440994|NCT01104636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110440995|NCT01104636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110440996|NCT01104636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110440997|NCT04931602|Vitamin D|vitamin d|mesh-list
110440998|NCT04931602|Vitamins|vitamins|mesh-ancestor
110440999|NCT04931602|Micronutrients|micronutrients|mesh-ancestor
110441000|NCT04931602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110441001|NCT04931602|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110441002|NCT04157257|Tenofovir|tenofovir|mesh-list
110441003|NCT04157257|Entecavir|entecavir|mesh-list
110441004|NCT04157257|Antiviral Agents|antiviral agents|mesh-ancestor
110441005|NCT04157257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110441006|NCT04157257|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110441007|NCT04157257|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110441008|NCT04157257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110441009|NCT04157257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110441010|NCT04157257|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110441011|NCT04157257|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110441012|NCT04152889|Docetaxel|docetaxel|mesh-list
110441013|NCT04152889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110441014|NCT04152889|Tubulin Modulators|tubulin modulators|mesh-ancestor
110441015|NCT04152889|Antimitotic Agents|antimitotic agents|mesh-ancestor
110441016|NCT04152889|Mitosis Modulators|mitosis modulators|mesh-ancestor
110441017|NCT04152889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110441018|NCT00602511|Thalidomide|thalidomide|mesh-list
110441019|NCT00602511|Bortezomib|bortezomib|mesh-list
110441020|NCT00602511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110441021|NCT00602511|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110441022|NCT00602511|Immunologic Factors|immunologic factors|mesh-ancestor
110441023|NCT00602511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110441024|NCT00602511|Leprostatic Agents|leprostatic agents|mesh-ancestor
110441025|NCT00602511|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110441026|NCT00602511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110441027|NCT00602511|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110441028|NCT00602511|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110441029|NCT00602511|Growth Substances|growth substances|mesh-ancestor
110441030|NCT00602511|Growth Inhibitors|growth inhibitors|mesh-ancestor
110441031|NCT02826616|Trimetazidine|trimetazidine|mesh-list
110441032|NCT02826616|Vasodilator Agents|vasodilator agents|mesh-ancestor
110441033|NCT00676117|Loxoprofen|loxoprofen|mesh-list
110441034|NCT00676117|Esomeprazole|esomeprazole|mesh-list
110441035|NCT00676117|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110441036|NCT00676117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110441037|NCT00676117|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110441038|NCT00676117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110441039|NCT00676117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110441040|NCT00676117|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110441041|NCT00676117|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110441042|NCT00676117|Analgesics|analgesics|mesh-ancestor
110441043|NCT00676117|Sensory System Agents|sensory system agents|mesh-ancestor
110441044|NCT00676117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110088024|NCT01691001|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110441045|NCT00676117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110441046|NCT00676117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110441047|NCT00676117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110441048|NCT01104558|Bisoprolol|bisoprolol|mesh-list
110441049|NCT01104558|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110441050|NCT01104558|Sympatholytics|sympatholytics|mesh-ancestor
110441051|NCT01104558|Autonomic Agents|autonomic agents|mesh-ancestor
110441052|NCT01104558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110441053|NCT01104558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110441054|NCT01104558|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110441055|NCT01104558|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110441056|NCT01104558|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110441057|NCT01104558|Adrenergic Agents|adrenergic agents|mesh-ancestor
110441058|NCT01104558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110564806|NCT04556526|Antiviral Agents|antiviral agents|mesh-ancestor
110441059|NCT01104558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110441060|NCT00602589|Levofloxacin|levofloxacin|mesh-list
110441062|NCT00602589|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110441063|NCT00602589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110441064|NCT00602589|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110441065|NCT00602589|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110441066|NCT00602589|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110441067|NCT00602589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110441068|NCT00602589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110441069|NCT00602589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110441070|NCT00602589|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110441071|NCT00602589|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110441072|NCT04270071|Nitroglycerin|nitroglycerin|mesh-list
110441073|NCT04270071|Vasodilator Agents|vasodilator agents|mesh-ancestor
110441074|NCT02856087|Remifentanil|remifentanil|mesh-list
110441075|NCT02856087|Naloxone|naloxone|mesh-list
110441076|NCT02856087|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110441077|NCT02856087|Narcotics|narcotics|mesh-ancestor
110329579|NCT05654194|Antimetabolites|antimetabolites|mesh-ancestor
110441078|NCT02856087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110441079|NCT02856087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110441080|NCT02856087|Analgesics|analgesics|mesh-ancestor
110441081|NCT02856087|Sensory System Agents|sensory system agents|mesh-ancestor
110441082|NCT02856087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110441083|NCT02856087|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110441084|NCT00676429|Ziprasidone|ziprasidone|mesh-list
110441085|NCT00676429|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110441086|NCT00676429|Serotonin Agents|serotonin agents|mesh-ancestor
110441087|NCT00676429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110441088|NCT00676429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110441089|NCT00676429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110441090|NCT00676429|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110441091|NCT00676429|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110441092|NCT00676429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110441093|NCT00676429|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110441094|NCT00676429|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110441095|NCT00676429|Dopamine Agents|dopamine agents|mesh-ancestor
110441096|NCT02629315|Formaldehyde|formaldehyde|mesh-list
110441097|NCT02629315|Disinfectants|disinfectants|mesh-ancestor
110441098|NCT02629315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110441099|NCT01204658|Vaccines|vaccines|mesh-list
110441100|NCT01204658|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110441101|NCT01204658|Immunologic Factors|immunologic factors|mesh-ancestor
110441102|NCT01204658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110441103|NCT00951483|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110441104|NCT00951483|Antidepressive Agents|antidepressive agents|mesh-ancestor
110441105|NCT00951483|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110441106|NCT00951483|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110441107|NCT00951483|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110441108|NCT00951483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110441109|NCT00951483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110441110|NCT01104246|Testosterone|testosterone|mesh-list
110441111|NCT01104246|Androgens|androgens|mesh-ancestor
110441112|NCT01104246|Hormones|hormones|mesh-ancestor
110373073|NCT00567554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110206728|NCT00182260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110441113|NCT01104246|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110441114|NCT01104246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110441115|NCT00676741|Insulin|insulin|mesh-list
110441116|NCT00676741|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110441117|NCT00676741|Insulin Aspart|insulin aspart|mesh-list
110441118|NCT00676741|Insulin, Long-Acting|insulin, long-acting|mesh-list
110441119|NCT00676741|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
110441120|NCT00676741|Insulin Detemir|insulin detemir|mesh-list
110441121|NCT00676741|Biphasic Insulins|biphasic insulins|mesh-list
110441122|NCT00676741|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
110441123|NCT00676741|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110441124|NCT00676741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110441125|NCT01103778|Bortezomib|bortezomib|mesh-list
110441126|NCT01103778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110441127|NCT00673621|Albuterol|albuterol|mesh-list
110441128|NCT00673621|Methacholine Chloride|methacholine chloride|mesh-list
110441129|NCT00673621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110441130|NCT00673621|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110441131|NCT00673621|Autonomic Agents|autonomic agents|mesh-ancestor
110441132|NCT00673621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110441133|NCT00673621|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110441134|NCT00673621|Respiratory System Agents|respiratory system agents|mesh-ancestor
110441135|NCT00673621|Tocolytic Agents|tocolytic agents|mesh-ancestor
110441136|NCT00673621|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110441137|NCT00673621|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110441138|NCT00673621|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110441139|NCT00673621|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110441140|NCT00673621|Adrenergic Agents|adrenergic agents|mesh-ancestor
110441141|NCT00673621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110441142|NCT00673621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110441143|NCT00673621|Miotics|miotics|mesh-ancestor
110441144|NCT00673621|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110441145|NCT00673621|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
110441146|NCT00673621|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
110441147|NCT00673621|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110441148|NCT00673621|Cholinergic Agents|cholinergic agents|mesh-ancestor
110441150|NCT02627053|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110441151|NCT02627053|Antithrombins|antithrombins|mesh-ancestor
110441152|NCT02627053|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110441153|NCT02627053|Protease Inhibitors|protease inhibitors|mesh-ancestor
110441154|NCT02627053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110441155|NCT02627053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110441156|NCT02627053|Anticoagulants|anticoagulants|mesh-ancestor
110441157|NCT00945945|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110441158|NCT00945945|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110441159|NCT00945945|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110441160|NCT00945945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110441161|NCT00945945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110441162|NCT00945945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110441163|NCT00945945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110441164|NCT00945945|Analgesics|analgesics|mesh-ancestor
110441165|NCT00945945|Sensory System Agents|sensory system agents|mesh-ancestor
110441166|NCT00945945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110441167|NCT00945945|Antidepressive Agents|antidepressive agents|mesh-ancestor
110441168|NCT00945945|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110441169|NCT00945945|Dopamine Agents|dopamine agents|mesh-ancestor
110441170|NCT01112982|Colchicine|colchicine|mesh-list
110441171|NCT01112982|Febuxostat|febuxostat|mesh-list
110441172|NCT01112982|Gout Suppressants|gout suppressants|mesh-ancestor
110441173|NCT01112982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110441174|NCT01112982|Tubulin Modulators|tubulin modulators|mesh-ancestor
110441175|NCT01112982|Antimitotic Agents|antimitotic agents|mesh-ancestor
110441176|NCT01112982|Mitosis Modulators|mitosis modulators|mesh-ancestor
110441177|NCT01112982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110441178|NCT01112982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110441179|NCT01203878|Imiquimod|imiquimod|mesh-list
110441180|NCT01203878|Aminolevulinic Acid|aminolevulinic acid|mesh-list
110441181|NCT01203878|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110441182|NCT01203878|Immunologic Factors|immunologic factors|mesh-ancestor
110441183|NCT01203878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110441184|NCT01203878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110441185|NCT01203878|Interferon Inducers|interferon inducers|mesh-ancestor
110441186|NCT01203878|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110441187|NCT01203878|Dermatologic Agents|dermatologic agents|mesh-ancestor
110441188|NCT00676819|Insulin|insulin|mesh-list
110441189|NCT00676819|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110441190|NCT00676819|Insulin Aspart|insulin aspart|mesh-list
110441191|NCT00676819|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110441192|NCT00676819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110441193|NCT00625794|Nicotine|nicotine|mesh-list
110441194|NCT00625794|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110441195|NCT00625794|Autonomic Agents|autonomic agents|mesh-ancestor
110441196|NCT00625794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110441197|NCT00625794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110441198|NCT00625794|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110441199|NCT00625794|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110441200|NCT00625794|Cholinergic Agents|cholinergic agents|mesh-ancestor
110441201|NCT00625794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110441202|NCT00625794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110441203|NCT01203098|Enoxaparin|enoxaparin|mesh-list
110441204|NCT01203098|Enoxaparin sodium|enoxaparin sodium|mesh-list
110441205|NCT01203098|Edoxaban|edoxaban|mesh-list
110441206|NCT01203098|Anticoagulants|anticoagulants|mesh-ancestor
110441207|NCT01203098|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110441208|NCT01203098|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110441209|NCT01203098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110441210|NCT01203098|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110441211|NCT01203098|Antithrombins|antithrombins|mesh-ancestor
110441212|NCT01203098|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110441213|NCT01203098|Protease Inhibitors|protease inhibitors|mesh-ancestor
110441214|NCT01203098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110441215|NCT05032794|Bisacodyl|bisacodyl|mesh-list
110441216|NCT05032794|Cathartics|cathartics|mesh-ancestor
110441217|NCT05032794|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110441218|NCT05032794|Laxatives|laxatives|mesh-ancestor
110441219|NCT00945555|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110441220|NCT00945555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110441221|NCT01108458|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110441222|NCT01108458|Pertuzumab|pertuzumab|mesh-list
110441223|NCT01108458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110441224|NCT01108458|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110441225|NCT01108458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110441226|NCT01108458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110441227|NCT01108458|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110441228|NCT04318262|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110441229|NCT04318262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110441230|NCT00680485|Ketoconazole|ketoconazole|mesh-list
110441231|NCT00680485|Antifungal Agents|antifungal agents|mesh-ancestor
110441232|NCT00680485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110441233|NCT00680485|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110441234|NCT00680485|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110441235|NCT00680485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110441236|NCT00680485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110441237|NCT00680485|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110441238|NCT00680485|Hormone Antagonists|hormone antagonists|mesh-ancestor
110441239|NCT00680485|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110441240|NCT00680485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110441241|NCT00680485|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110441242|NCT00680563|Epoetin Alfa|epoetin alfa|mesh-list
110206750|NCT00408655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110206751|NCT00408655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110206752|NCT00408655|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110206757|NCT00182455|Topiramate|topiramate|mesh-list
110441243|NCT00680563|Hematinics|hematinics|mesh-ancestor
110441244|NCT01108068|Lithium Carbonate|lithium carbonate|mesh-list
110441245|NCT01108068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110441246|NCT01108068|Antidepressive Agents|antidepressive agents|mesh-ancestor
110441247|NCT01108068|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110441248|NCT01108068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110441249|NCT01108068|Antimanic Agents|antimanic agents|mesh-ancestor
110441250|NCT01108068|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110441251|NCT01108068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110441252|NCT01108068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110441253|NCT00680641|Simvastatin|simvastatin|mesh-list
110441254|NCT00680641|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110441255|NCT00680641|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110441256|NCT00680641|Antimetabolites|antimetabolites|mesh-ancestor
110441257|NCT00680641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110441258|NCT00680641|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110441259|NCT00680641|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110441260|NCT00680641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110441261|NCT01201850|Bevacizumab|bevacizumab|mesh-list
110441262|NCT01201850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110441263|NCT01201850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110441264|NCT01201850|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110441265|NCT01201850|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110441266|NCT01201850|Growth Substances|growth substances|mesh-ancestor
110441267|NCT01201850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110441268|NCT01201850|Growth Inhibitors|growth inhibitors|mesh-ancestor
110441269|NCT05660122|Fexuprazan|fexuprazan|mesh-list
110441270|NCT05660122|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110441271|NCT04980144|Lubricant Eye Drops|lubricant eye drops|mesh-list
110088246|NCT01693159|Ethyl 2-cyanoacrylate|ethyl 2-cyanoacrylate|mesh-list
110441272|NCT04980144|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110441273|NCT04980144|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110441274|NCT02825056|Morphine|morphine|mesh-list
110441275|NCT02825056|Bupivacaine|bupivacaine|mesh-list
110441276|NCT02825056|Anesthetics, Local|anesthetics, local|mesh-ancestor
110441277|NCT02825056|Anesthetics|anesthetics|mesh-ancestor
110441278|NCT02825056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110441279|NCT02825056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110441280|NCT02825056|Sensory System Agents|sensory system agents|mesh-ancestor
110441281|NCT02825056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110441282|NCT02825056|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110441283|NCT02825056|Narcotics|narcotics|mesh-ancestor
110441284|NCT02825056|Analgesics|analgesics|mesh-ancestor
110441285|NCT02826772|Androgens|androgens|mesh-list
110441286|NCT02826772|Androgen Receptor Antagonists|androgen receptor antagonists|mesh-list
110441287|NCT02826772|Hormones|hormones|mesh-ancestor
110441288|NCT02826772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110441289|NCT02826772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110441290|NCT02826772|Androgen Antagonists|androgen antagonists|mesh-ancestor
110441291|NCT02826772|Hormone Antagonists|hormone antagonists|mesh-ancestor
110441292|NCT00674011|Bevacizumab|bevacizumab|mesh-list
110441293|NCT00674011|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110441294|NCT00674011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110441295|NCT00674011|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110441296|NCT00674011|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110441297|NCT00674011|Growth Substances|growth substances|mesh-ancestor
110441298|NCT00674011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110441299|NCT00674011|Growth Inhibitors|growth inhibitors|mesh-ancestor
110441301|NCT00674089|Vitamins|vitamins|mesh-ancestor
110441302|NCT00674089|Micronutrients|micronutrients|mesh-ancestor
110441303|NCT00674089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110441304|NCT01200992|Mitomycins|mitomycins|mesh-list
110441305|NCT01200992|Mitomycin|mitomycin|mesh-list
110441306|NCT01200992|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110206761|NCT00182494|Metformin|metformin|mesh-list
110441307|NCT01200992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110441308|NCT01200992|Alkylating Agents|alkylating agents|mesh-ancestor
110441309|NCT01200992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110441310|NCT01200992|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110441311|NCT01200992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110441312|NCT02824666|Fallypride|fallypride|mesh-list
110441313|NCT02824666|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110441314|NCT02824666|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110441315|NCT02824666|Dopamine Agents|dopamine agents|mesh-ancestor
110441316|NCT02824666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110441317|NCT02824666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110441318|NCT02824666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110441319|NCT00674167|Docetaxel|docetaxel|mesh-list
110441320|NCT00674167|Capecitabine|capecitabine|mesh-list
110441321|NCT00674167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110441322|NCT00674167|Tubulin Modulators|tubulin modulators|mesh-ancestor
110441323|NCT00674167|Antimitotic Agents|antimitotic agents|mesh-ancestor
110441324|NCT00674167|Mitosis Modulators|mitosis modulators|mesh-ancestor
110441325|NCT00674167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110441326|NCT00674167|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110441327|NCT00674167|Antimetabolites|antimetabolites|mesh-ancestor
110441328|NCT00912145|Alprazolam|alprazolam|mesh-list
110441329|NCT00912145|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110441330|NCT00912145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110441331|NCT00912145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110441332|NCT00912145|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110441333|NCT00912145|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110441334|NCT00912145|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110441335|NCT00912145|GABA Modulators|gaba modulators|mesh-ancestor
110441336|NCT00912145|GABA Agents|gaba agents|mesh-ancestor
110441337|NCT00912145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110441338|NCT00912145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110441339|NCT02824510|Insulin|insulin|mesh-list
110441340|NCT02824510|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110441341|NCT02824510|Insulin Aspart|insulin aspart|mesh-list
110441342|NCT02824510|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110441343|NCT02824510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110441344|NCT00674245|Pantoprazole|pantoprazole|mesh-list
110088321|NCT01693601|Panobinostat|panobinostat|mesh-list
110441345|NCT00674245|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110441346|NCT00674245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110441347|NCT00674245|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110441348|NCT00674245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110441349|NCT00674245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110441350|NCT00878215|Liver Extracts|liver extracts|mesh-list
110441351|NCT00878215|Hematinics|hematinics|mesh-ancestor
110441352|NCT02628847|Sildenafil Citrate|sildenafil citrate|mesh-list
110441353|NCT02628847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110441354|NCT02628847|Vasodilator Agents|vasodilator agents|mesh-ancestor
110441355|NCT02628847|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110441356|NCT02628847|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110441357|NCT02628847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110441358|NCT02628847|Urological Agents|urological agents|mesh-ancestor
110441359|NCT00677443|Capecitabine|capecitabine|mesh-list
110441360|NCT00677443|Oxaliplatin|oxaliplatin|mesh-list
110441361|NCT00677443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110441362|NCT00677443|Antimetabolites|antimetabolites|mesh-ancestor
110441363|NCT00677443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110441364|NCT00677443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110441367|NCT00674557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110441368|NCT00674557|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110441369|NCT00674557|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110441370|NCT00674557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110441371|NCT00674557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110441372|NCT00674557|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110441373|NCT00674557|Hormone Antagonists|hormone antagonists|mesh-ancestor
110441374|NCT00674557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110441375|NCT00674557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110441376|NCT00674557|Chelating Agents|chelating agents|mesh-ancestor
110441377|NCT00674557|Sequestering Agents|sequestering agents|mesh-ancestor
110441378|NCT00674557|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110441379|NCT00674557|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110441380|NCT00674557|Growth Substances|growth substances|mesh-ancestor
110441381|NCT00674557|Growth Inhibitors|growth inhibitors|mesh-ancestor
110441383|NCT00677521|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
110441384|NCT00677521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110441385|NCT00677521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110441386|NCT00677521|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110441387|NCT00677521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110441388|NCT00674713|Ondansetron|ondansetron|mesh-list
110441389|NCT00674713|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110441390|NCT00674713|Antiemetics|antiemetics|mesh-ancestor
110441391|NCT00674713|Autonomic Agents|autonomic agents|mesh-ancestor
110441392|NCT00674713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110441393|NCT00674713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110441394|NCT00674713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110441395|NCT00674713|Antipruritics|antipruritics|mesh-ancestor
110441396|NCT00674713|Dermatologic Agents|dermatologic agents|mesh-ancestor
110441397|NCT00674713|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110441398|NCT00674713|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110441399|NCT00674713|Serotonin Agents|serotonin agents|mesh-ancestor
110441400|NCT00674713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110441401|NCT00674713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110441402|NCT04241380|Heparin|heparin|mesh-list
110441403|NCT04241380|Anticoagulants|anticoagulants|mesh-list
110441404|NCT04241380|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110441405|NCT04241380|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110441406|NCT04241380|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110441407|NCT04241380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110441408|NCT02824354|Nalmefene|nalmefene|mesh-list
110441409|NCT02824354|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110441410|NCT02824354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110441411|NCT02824354|Sensory System Agents|sensory system agents|mesh-ancestor
110441412|NCT02824354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110441413|NCT02823496|Sunscreening Agents|sunscreening agents|mesh-list
110441414|NCT02823496|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110441415|NCT02823496|Protective Agents|protective agents|mesh-ancestor
110441416|NCT02823496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110441417|NCT02823496|Dermatologic Agents|dermatologic agents|mesh-ancestor
110441418|NCT00677755|Misoprostol|misoprostol|mesh-list
110441419|NCT00677755|Mifepristone|mifepristone|mesh-list
110441420|NCT00677755|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110441421|NCT00677755|Abortifacient Agents|abortifacient agents|mesh-ancestor
110441422|NCT00677755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110441423|NCT00677755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110441424|NCT00677755|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110441425|NCT00677755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110441426|NCT00677755|Oxytocics|oxytocics|mesh-ancestor
110441427|NCT00677755|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
110329607|NCT00465452|Dopamine|dopamine|mesh-list
110441428|NCT00677755|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110441429|NCT00677755|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110441430|NCT00677755|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110441431|NCT00677755|Contraceptive Agents|contraceptive agents|mesh-ancestor
110441432|NCT00677755|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
110441433|NCT00677755|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
110441434|NCT00677755|Hormone Antagonists|hormone antagonists|mesh-ancestor
110441435|NCT00677755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110441436|NCT00677755|Luteolytic Agents|luteolytic agents|mesh-ancestor
110441437|NCT00677755|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110441438|NCT00677755|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
110441439|NCT00674947|huB3F6-SPDB-DM4 immunoconjugate|hub3f6-spdb-dm4 immunoconjugate|mesh-list
110441440|NCT00674947|Immunoconjugates|immunoconjugates|mesh-ancestor
110441441|NCT00674947|Immunologic Factors|immunologic factors|mesh-ancestor
110441442|NCT00674947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110441443|NCT02824042|Itraconazole|itraconazole|mesh-list
110441444|NCT02824042|Maytansine|maytansine|mesh-list
110441445|NCT02824042|Anetumab ravtansine|anetumab ravtansine|mesh-list
110441446|NCT02824042|Antifungal Agents|antifungal agents|mesh-ancestor
110441447|NCT02824042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110441448|NCT02824042|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110441449|NCT02824042|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110441450|NCT02824042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110441451|NCT02824042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110441452|NCT02824042|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110441453|NCT02824042|Hormone Antagonists|hormone antagonists|mesh-ancestor
110441454|NCT02824042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110441455|NCT02824042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110441456|NCT02824042|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110441457|NCT02824042|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110441458|NCT02824042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110441459|NCT02824042|Tubulin Modulators|tubulin modulators|mesh-ancestor
110441460|NCT02824042|Antimitotic Agents|antimitotic agents|mesh-ancestor
110441461|NCT02824042|Mitosis Modulators|mitosis modulators|mesh-ancestor
110441462|NCT02824042|Immunoconjugates|immunoconjugates|mesh-ancestor
110441463|NCT02824042|Immunologic Factors|immunologic factors|mesh-ancestor
110441464|NCT00675181|Melatonin|melatonin|mesh-list
110441465|NCT00675181|Antioxidants|antioxidants|mesh-ancestor
110441466|NCT00675181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110441467|NCT00675181|Protective Agents|protective agents|mesh-ancestor
110441468|NCT00675181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110441469|NCT00675181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110441470|NCT04241458|Midazolam|midazolam|mesh-list
110441471|NCT04241458|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110441472|NCT04241458|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110441473|NCT04241458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110441474|NCT04241458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110441475|NCT04241458|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110441476|NCT04241458|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110441477|NCT04241458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110206799|NCT00182650|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110441478|NCT04241458|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110441479|NCT04241458|Anesthetics, General|anesthetics, general|mesh-ancestor
110441480|NCT04241458|Anesthetics|anesthetics|mesh-ancestor
110441481|NCT04241458|GABA Modulators|gaba modulators|mesh-ancestor
110441482|NCT04241458|GABA Agents|gaba agents|mesh-ancestor
110441483|NCT04241458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110441484|NCT04241458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110441485|NCT02823808|Glimepiride|glimepiride|mesh-list
110441486|NCT02823808|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110441487|NCT02823808|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110441488|NCT02823808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110441489|NCT02823808|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110441490|NCT02823808|Immunologic Factors|immunologic factors|mesh-ancestor
110441491|NCT04151719|Bromides|bromides|mesh-list
110441492|NCT04151719|Methylnaltrexone|methylnaltrexone|mesh-list
110441493|NCT04151719|Anticonvulsants|anticonvulsants|mesh-ancestor
110441494|NCT04151719|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110441495|NCT04151719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110441496|NCT04151719|Sensory System Agents|sensory system agents|mesh-ancestor
110441497|NCT04151719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110441498|NCT02822482|Cetuximab|cetuximab|mesh-list
110441499|NCT02822482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110441500|NCT02822482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110441501|NCT00675493|Insulin Aspart|insulin aspart|mesh-list
110441502|NCT00675493|Biphasic Insulins|biphasic insulins|mesh-list
110441503|NCT00675493|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
110441504|NCT00675493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110441505|NCT00675493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110441506|NCT04240834|Aspirin|aspirin|mesh-list
110441507|NCT04240834|Ticagrelor|ticagrelor|mesh-list
110441508|NCT04240834|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110441509|NCT04240834|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110441510|NCT04240834|Analgesics|analgesics|mesh-ancestor
110441511|NCT04240834|Sensory System Agents|sensory system agents|mesh-ancestor
110441512|NCT04240834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110441513|NCT04240834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110441514|NCT04240834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110441515|NCT04240834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110441516|NCT04240834|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110441517|NCT04240834|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110441518|NCT04240834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110441519|NCT04240834|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110441520|NCT04240834|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110441521|NCT04240834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110441522|NCT04240834|Antipyretics|antipyretics|mesh-ancestor
110441523|NCT04240834|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110441524|NCT04240834|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110441525|NCT04240834|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110441526|NCT04240834|Purinergic Agents|purinergic agents|mesh-ancestor
110441527|NCT04240834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110441528|NCT01200758|Prednisone|prednisone|mesh-list
110441529|NCT01200758|Prednisolone|prednisolone|mesh-list
110441530|NCT01200758|Cyclophosphamide|cyclophosphamide|mesh-list
110441531|NCT01200758|Rituximab|rituximab|mesh-list
110441532|NCT01200758|Doxorubicin|doxorubicin|mesh-list
110441533|NCT01200758|Vincristine|vincristine|mesh-list
110441534|NCT01200758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110441535|NCT01200758|Immunologic Factors|immunologic factors|mesh-ancestor
110441536|NCT01200758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110441537|NCT01200758|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110441538|NCT01200758|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110441539|NCT01200758|Alkylating Agents|alkylating agents|mesh-ancestor
110441540|NCT01200758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110441542|NCT01200758|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110441543|NCT01200758|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110441544|NCT01200758|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110441545|NCT01200758|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110441546|NCT01200758|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110441547|NCT01200758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110441548|NCT01200758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110441549|NCT01200758|Glucocorticoids|glucocorticoids|mesh-ancestor
110441550|NCT01200758|Hormones|hormones|mesh-ancestor
110441551|NCT01200758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110441552|NCT01200758|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110441553|NCT01200758|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110441554|NCT01200758|Tubulin Modulators|tubulin modulators|mesh-ancestor
110441555|NCT01200758|Antimitotic Agents|antimitotic agents|mesh-ancestor
110441556|NCT01200758|Mitosis Modulators|mitosis modulators|mesh-ancestor
110441557|NCT02823106|Verapamil|verapamil|mesh-list
110441558|NCT02823106|Choline|choline|mesh-list
110441559|NCT02823106|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
110441560|NCT02823106|Lipotropic Agents|lipotropic agents|mesh-ancestor
110441561|NCT02823106|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110441562|NCT02823106|Antimetabolites|antimetabolites|mesh-ancestor
110441563|NCT02823106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110441564|NCT02823106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110441565|NCT02823106|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110441566|NCT02823106|Nootropic Agents|nootropic agents|mesh-ancestor
110441567|NCT02823106|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110441568|NCT02823106|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110441569|NCT02823106|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110441570|NCT02823106|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110441571|NCT02823106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110441572|NCT02823106|Vasodilator Agents|vasodilator agents|mesh-ancestor
110441574|NCT02821858|Antiviral Agents|antiviral agents|mesh-ancestor
110441575|NCT02821858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110441576|NCT00876343|Aripiprazole|aripiprazole|mesh-list
110441577|NCT00876343|Antidepressive Agents|antidepressive agents|mesh-ancestor
110441578|NCT00876343|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110441579|NCT00876343|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110441580|NCT00876343|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110441581|NCT00876343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110441582|NCT00876343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110441583|NCT00876343|Dopamine Agonists|dopamine agonists|mesh-ancestor
110441584|NCT00876343|Dopamine Agents|dopamine agents|mesh-ancestor
110441585|NCT00876343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110441586|NCT00876343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110441587|NCT00876343|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110441588|NCT00876343|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110441589|NCT00876343|Serotonin Agents|serotonin agents|mesh-ancestor
110441590|NCT00876343|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110441591|NCT00876343|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110441592|NCT00876343|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110441593|NCT00876343|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110441594|NCT02627989|Diflucortolone|diflucortolone|mesh-list
110441595|NCT02627989|Diflucortolone valerate|diflucortolone valerate|mesh-list
110441596|NCT02627989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110441597|NCT02627989|Glucocorticoids|glucocorticoids|mesh-ancestor
110441598|NCT02627989|Hormones|hormones|mesh-ancestor
110441599|NCT02627989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110441600|NCT02627989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110441601|NCT00675649|Golimumab|golimumab|mesh-list
110441602|NCT00675649|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110441603|NCT00675649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110441604|NCT00675649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110441605|NCT00675649|Immunologic Factors|immunologic factors|mesh-ancestor
110441606|NCT00675649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110441607|NCT01107912|Clopidogrel|clopidogrel|mesh-list
110441608|NCT01107912|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
110441609|NCT01107912|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110441610|NCT01107912|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110441611|NCT01107912|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110441612|NCT01107912|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110441613|NCT01107912|Purinergic Agents|purinergic agents|mesh-ancestor
110441614|NCT01107912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110441615|NCT01107912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110441616|NCT01107912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110441618|NCT00678145|Morphine|morphine|mesh-list
110441619|NCT00678145|Naloxone|naloxone|mesh-list
110441620|NCT00678145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110441621|NCT00678145|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110441622|NCT00678145|Narcotics|narcotics|mesh-ancestor
110441623|NCT00678145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110441624|NCT00678145|Analgesics|analgesics|mesh-ancestor
110441625|NCT00678145|Sensory System Agents|sensory system agents|mesh-ancestor
110441626|NCT00678145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110441627|NCT00678145|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110441628|NCT00678145|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110441629|NCT00678145|Adrenergic Agents|adrenergic agents|mesh-ancestor
110441630|NCT00678145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110441631|NCT00678145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110441632|NCT00678145|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110441633|NCT00678145|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110441634|NCT00678145|Autonomic Agents|autonomic agents|mesh-ancestor
110441635|NCT00678145|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110441636|NCT00678145|Respiratory System Agents|respiratory system agents|mesh-ancestor
110441637|NCT00678145|Mydriatics|mydriatics|mesh-ancestor
110441638|NCT00678145|Sympathomimetics|sympathomimetics|mesh-ancestor
110441639|NCT00678145|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110441640|NCT00678145|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110441641|NCT02879916|Levobupivacaine|levobupivacaine|mesh-list
110441642|NCT02879916|Anesthetics, Local|anesthetics, local|mesh-ancestor
110441643|NCT02879916|Anesthetics|anesthetics|mesh-ancestor
110441644|NCT02879916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110441645|NCT02879916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110088622|NCT05294887|Vasodilator Agents|vasodilator agents|mesh-ancestor
110441646|NCT02879916|Sensory System Agents|sensory system agents|mesh-ancestor
110441647|NCT02879916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110441649|NCT02690506|Analgesics|analgesics|mesh-ancestor
110441650|NCT02690506|Sensory System Agents|sensory system agents|mesh-ancestor
110441651|NCT02690506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110441652|NCT02690506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110441653|NCT02690506|Anticonvulsants|anticonvulsants|mesh-ancestor
110441654|NCT02690506|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110441655|NCT02690506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110441656|NCT02690506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110441657|NCT02690506|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110441658|NCT02690506|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110441659|NCT02690506|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110441660|NCT02690506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110441661|NCT02690506|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110441662|NCT04310280|Insulin Glargine|insulin glargine|mesh-list
110441663|NCT04310280|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110441664|NCT04310280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110441665|NCT04239586|Glyburide|glyburide|mesh-list
110441666|NCT04239586|Glipizide|glipizide|mesh-list
110441667|NCT04239586|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110441668|NCT04239586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110441669|NCT02628613|Paclitaxel|paclitaxel|mesh-list
110441670|NCT02628613|Vinorelbine|vinorelbine|mesh-list
110441671|NCT02628613|Epirubicin|epirubicin|mesh-list
110441672|NCT02628613|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110441673|NCT02628613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110441674|NCT02628613|Tubulin Modulators|tubulin modulators|mesh-ancestor
110441675|NCT02628613|Antimitotic Agents|antimitotic agents|mesh-ancestor
110441676|NCT02628613|Mitosis Modulators|mitosis modulators|mesh-ancestor
110441677|NCT02628613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110441678|NCT02628613|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110441679|NCT02628613|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110441680|NCT02628613|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110441681|NCT02628613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110441682|NCT01100034|Etanercept|etanercept|mesh-list
110441683|NCT01100034|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110441684|NCT01100034|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110441685|NCT01100034|Analgesics|analgesics|mesh-ancestor
110441686|NCT01100034|Sensory System Agents|sensory system agents|mesh-ancestor
110441687|NCT01100034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110441688|NCT01100034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110441689|NCT01100034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110441690|NCT01100034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110441691|NCT01100034|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110441692|NCT01100034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110441693|NCT01100034|Immunologic Factors|immunologic factors|mesh-ancestor
110441694|NCT04148833|Paclitaxel|paclitaxel|mesh-list
110441695|NCT04148833|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110441696|NCT04148833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110441697|NCT04148833|Tubulin Modulators|tubulin modulators|mesh-ancestor
110441698|NCT04148833|Antimitotic Agents|antimitotic agents|mesh-ancestor
110441699|NCT04148833|Mitosis Modulators|mitosis modulators|mesh-ancestor
110441700|NCT04148833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110441701|NCT02821546|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110441702|NCT02821468|Acetaminophen|acetaminophen|mesh-list
110441704|NCT02821468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110441705|NCT02821468|Analgesics|analgesics|mesh-ancestor
110441706|NCT02821468|Sensory System Agents|sensory system agents|mesh-ancestor
110441707|NCT02821468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110441708|NCT02821468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110441709|NCT02821468|Antipyretics|antipyretics|mesh-ancestor
110441710|NCT02821468|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110441711|NCT02821468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110441712|NCT02821468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110441713|NCT02821468|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110441714|NCT02821468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110441715|NCT02821468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110441716|NCT04964622|Ibuprofen|ibuprofen|mesh-list
110441717|NCT04964622|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110441718|NCT04964622|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110441719|NCT04964622|Analgesics|analgesics|mesh-ancestor
110088698|NCT05294406|Artenimol|artenimol|mesh-list
110441720|NCT04964622|Sensory System Agents|sensory system agents|mesh-ancestor
110441721|NCT04964622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110441722|NCT04964622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110441723|NCT04964622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110441724|NCT04964622|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110441725|NCT04964622|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110441726|NCT04964622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110441727|NCT04964622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110441728|NCT04769050|Docetaxel|docetaxel|mesh-list
110441729|NCT04769050|Capecitabine|capecitabine|mesh-list
110441730|NCT04769050|Trastuzumab|trastuzumab|mesh-list
110441731|NCT04769050|Pertuzumab|pertuzumab|mesh-list
110441732|NCT04769050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110441733|NCT04769050|Tubulin Modulators|tubulin modulators|mesh-ancestor
110441734|NCT04769050|Antimitotic Agents|antimitotic agents|mesh-ancestor
110441735|NCT04769050|Mitosis Modulators|mitosis modulators|mesh-ancestor
110441736|NCT04769050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110441737|NCT04769050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110441738|NCT04769050|Antimetabolites|antimetabolites|mesh-ancestor
110206856|NCT00183235|Dopamine Agents|dopamine agents|mesh-ancestor
110441739|NCT04769050|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110441741|NCT02821390|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110441742|NCT02821390|Lubricant Eye Drops|lubricant eye drops|mesh-list
110441743|NCT02821390|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110441744|NCT02821390|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110441745|NCT02821390|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110441746|NCT02821390|Analgesics|analgesics|mesh-ancestor
110441747|NCT02821390|Sensory System Agents|sensory system agents|mesh-ancestor
110441748|NCT02821390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110441749|NCT02821390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110441750|NCT02821390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110441751|NCT02821390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110441752|NCT02821312|DA-8010|da-8010|mesh-list
110441753|NCT02821312|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110441754|NCT02821312|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110441755|NCT02821312|Cholinergic Agents|cholinergic agents|mesh-ancestor
110441756|NCT02821312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110441757|NCT02821312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110441758|NCT02821312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110441759|NCT02821156|Nitric Oxide|nitric oxide|mesh-list
110441760|NCT02821156|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110441761|NCT02821156|Autonomic Agents|autonomic agents|mesh-ancestor
110441762|NCT02821156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110441763|NCT02821156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110441764|NCT02821156|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110441765|NCT02821156|Respiratory System Agents|respiratory system agents|mesh-ancestor
110441766|NCT02821156|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110441767|NCT02821156|Antioxidants|antioxidants|mesh-ancestor
110441768|NCT02821156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110441769|NCT02821156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110441770|NCT02821156|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
110441771|NCT02821156|Vasodilator Agents|vasodilator agents|mesh-ancestor
110441772|NCT02821156|Gasotransmitters|gasotransmitters|mesh-ancestor
110441773|NCT02821156|Protective Agents|protective agents|mesh-ancestor
110441774|NCT02820922|Anesthetics|anesthetics|mesh-list
110441775|NCT02820922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110441776|NCT02820922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110441777|NCT00633958|Alovudine|alovudine|mesh-list
110441778|NCT00633958|Antiviral Agents|antiviral agents|mesh-ancestor
110441779|NCT00633958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110441780|NCT02820688|Bupivacaine|bupivacaine|mesh-list
110441781|NCT02820688|Prilocaine|prilocaine|mesh-list
110441782|NCT02820688|Anesthetics, Local|anesthetics, local|mesh-ancestor
110441783|NCT02820688|Anesthetics|anesthetics|mesh-ancestor
110441784|NCT02820688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110441785|NCT02820688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110441786|NCT02820688|Sensory System Agents|sensory system agents|mesh-ancestor
110441787|NCT02820688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110441788|NCT02818816|Brimonidine Tartrate|brimonidine tartrate|mesh-list
110441789|NCT02818816|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
110441790|NCT02818816|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110441791|NCT02818816|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110441792|NCT02818816|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110441793|NCT02818816|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110441794|NCT02818816|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110441795|NCT02818816|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110441796|NCT02818816|Adrenergic Agents|adrenergic agents|mesh-ancestor
110441797|NCT02818816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110441798|NCT02818816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110441799|NCT02818816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110441801|NCT02818816|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110441802|NCT02820610|Magnesium Sulfate|magnesium sulfate|mesh-list
110441803|NCT02820610|Dexmedetomidine|dexmedetomidine|mesh-list
110206860|NCT00183235|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110441804|NCT02820610|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110441805|NCT02820610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110441806|NCT02820610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110441807|NCT02820610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110441808|NCT02820610|Analgesics|analgesics|mesh-ancestor
110441809|NCT02820610|Sensory System Agents|sensory system agents|mesh-ancestor
110441810|NCT02820610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110441811|NCT02820610|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110441812|NCT02820610|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110441813|NCT02820610|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110441814|NCT02820610|Adrenergic Agents|adrenergic agents|mesh-ancestor
110441815|NCT02820610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110441816|NCT02820610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110441817|NCT02820610|Anesthetics|anesthetics|mesh-ancestor
110441818|NCT02820610|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110441819|NCT02820610|Anticonvulsants|anticonvulsants|mesh-ancestor
110441820|NCT02820610|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110441821|NCT02820610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110441822|NCT02820610|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110441823|NCT02820610|Tocolytic Agents|tocolytic agents|mesh-ancestor
110373177|NCT00581685|Pregabalin|pregabalin|mesh-list
110441824|NCT02820610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110441825|NCT04745728|Prednisone|prednisone|mesh-list
110441826|NCT04745728|Cyclophosphamide|cyclophosphamide|mesh-list
110441827|NCT04745728|Rituximab|rituximab|mesh-list
110441828|NCT04745728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110441829|NCT04745728|Immunologic Factors|immunologic factors|mesh-ancestor
110441830|NCT04745728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110441831|NCT04745728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110441832|NCT04745728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110441833|NCT04745728|Alkylating Agents|alkylating agents|mesh-ancestor
110441834|NCT04745728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110441835|NCT04745728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110441836|NCT04745728|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110441837|NCT04745728|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110441838|NCT04745728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110441839|NCT04745728|Glucocorticoids|glucocorticoids|mesh-ancestor
110441840|NCT04745728|Hormones|hormones|mesh-ancestor
110441841|NCT04745728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110441842|NCT04745728|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110441843|NCT02818660|Cosyntropin|cosyntropin|mesh-list
110441844|NCT02818660|Hormones|hormones|mesh-ancestor
110441845|NCT02818660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110441846|NCT02818660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110441847|NCT05659186|Tislelizumab|tislelizumab|mesh-list
110441848|NCT05659186|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110441849|NCT05659186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110441850|NCT01107444|Docetaxel|docetaxel|mesh-list
110441851|NCT01107444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110441852|NCT01107444|Tubulin Modulators|tubulin modulators|mesh-ancestor
110441853|NCT01107444|Antimitotic Agents|antimitotic agents|mesh-ancestor
110441854|NCT01107444|Mitosis Modulators|mitosis modulators|mesh-ancestor
110441855|NCT01107444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110441856|NCT04238806|Desflurane|desflurane|mesh-list
110441857|NCT04238806|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110441858|NCT04238806|Anesthetics, General|anesthetics, general|mesh-ancestor
110441859|NCT04238806|Anesthetics|anesthetics|mesh-ancestor
110441860|NCT04238806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110329618|NCT01379521|Everolimus|everolimus|mesh-list
110441861|NCT04238806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110441862|NCT00876187|Naproxen|naproxen|mesh-list
110441863|NCT00876187|Tanezumab|tanezumab|mesh-list
110441864|NCT00876187|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110441865|NCT00876187|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110441866|NCT00876187|Analgesics|analgesics|mesh-ancestor
110441867|NCT00876187|Sensory System Agents|sensory system agents|mesh-ancestor
110441868|NCT00876187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110441869|NCT00876187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110441870|NCT00876187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110441871|NCT00876187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110441872|NCT00876187|Gout Suppressants|gout suppressants|mesh-ancestor
110441873|NCT00876187|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110441874|NCT00876187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110441875|NCT00876187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110441877|NCT04238884|Antifungal Agents|antifungal agents|mesh-ancestor
110441878|NCT04238884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110441879|NCT04238884|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110441880|NCT04238884|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110441881|NCT04238884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110441882|NCT04238884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110441883|NCT04238884|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110441884|NCT04238884|Hormone Antagonists|hormone antagonists|mesh-ancestor
110441885|NCT04238884|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110441886|NCT04238884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110441887|NCT04238884|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110441888|NCT01102374|Vitamin D|vitamin d|mesh-list
110441889|NCT01102374|Ergocalciferols|ergocalciferols|mesh-list
110441890|NCT01102374|Cholecalciferol|cholecalciferol|mesh-list
110441891|NCT01102374|Vitamins|vitamins|mesh-list
110441892|NCT01102374|Micronutrients|micronutrients|mesh-ancestor
110441893|NCT01102374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110441894|NCT01102374|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110441895|NCT01102374|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110441896|NCT05658640|Cytarabine|cytarabine|mesh-list
110441897|NCT05658640|Dexamethasone|dexamethasone|mesh-list
110441898|NCT05658640|Cyclophosphamide|cyclophosphamide|mesh-list
110441899|NCT05658640|Trametinib|trametinib|mesh-list
110441900|NCT05658640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110441901|NCT05658640|Immunologic Factors|immunologic factors|mesh-ancestor
110441902|NCT05658640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110441903|NCT05658640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110441904|NCT05658640|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110441905|NCT05658640|Alkylating Agents|alkylating agents|mesh-ancestor
110441906|NCT05658640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110441907|NCT05658640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110441908|NCT05658640|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110441909|NCT05658640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110441910|NCT05658640|Antiemetics|antiemetics|mesh-ancestor
110441911|NCT05658640|Autonomic Agents|autonomic agents|mesh-ancestor
110441912|NCT05658640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110441913|NCT05658640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110441914|NCT05658640|Glucocorticoids|glucocorticoids|mesh-ancestor
110441915|NCT05658640|Hormones|hormones|mesh-ancestor
110441916|NCT05658640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110441917|NCT05658640|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110441918|NCT05658640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110441919|NCT05658640|Antimetabolites|antimetabolites|mesh-ancestor
110441920|NCT05658640|Antiviral Agents|antiviral agents|mesh-ancestor
110441921|NCT05658640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110441922|NCT05658640|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110441923|NCT05658640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110441924|NCT02818270|Acetylcysteine|acetylcysteine|mesh-list
110441925|NCT02818270|Albuterol|albuterol|mesh-list
110441926|NCT02818270|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110441927|NCT02818270|Antiviral Agents|antiviral agents|mesh-ancestor
110441928|NCT02818270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110441929|NCT02818270|Expectorants|expectorants|mesh-ancestor
110441930|NCT02818270|Respiratory System Agents|respiratory system agents|mesh-ancestor
110441931|NCT02818270|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110441932|NCT02818270|Antioxidants|antioxidants|mesh-ancestor
110441933|NCT02818270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110441934|NCT02818270|Protective Agents|protective agents|mesh-ancestor
110441935|NCT02818270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110441936|NCT02818270|Antidotes|antidotes|mesh-ancestor
110441937|NCT02818270|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110441938|NCT02818270|Autonomic Agents|autonomic agents|mesh-ancestor
110441939|NCT02818270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110088921|NCT05264584|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110088922|NCT05264584|Antiviral Agents|antiviral agents|mesh-ancestor
110088923|NCT05264584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110088924|NCT05264584|Expectorants|expectorants|mesh-ancestor
110441940|NCT02818270|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110441941|NCT02818270|Tocolytic Agents|tocolytic agents|mesh-ancestor
110441942|NCT02818270|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110441943|NCT02818270|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110441944|NCT02818270|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110441945|NCT02818270|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110441946|NCT02818270|Adrenergic Agents|adrenergic agents|mesh-ancestor
110441947|NCT02818270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110441948|NCT02879760|Pembrolizumab|pembrolizumab|mesh-list
110441949|NCT02879760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110441950|NCT02879760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110441951|NCT02879760|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110441952|NCT02879760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110441953|NCT02818348|Darunavir|darunavir|mesh-list
110441954|NCT02818348|Cobicistat|cobicistat|mesh-list
110441955|NCT02818348|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
110441956|NCT02818348|Etravirine|etravirine|mesh-list
110441957|NCT02818348|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110373199|NCT04588220|Melatonin|melatonin|mesh-list
110441958|NCT02818348|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110441959|NCT02818348|Protease Inhibitors|protease inhibitors|mesh-ancestor
110441960|NCT02818348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110441961|NCT02818348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110441962|NCT02818348|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110441963|NCT02818348|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110441964|NCT02818348|Antiviral Agents|antiviral agents|mesh-ancestor
110441965|NCT02818348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110441966|NCT02818348|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110441967|NCT02818348|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110441968|NCT02818348|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110441969|NCT02818348|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110441970|NCT00634192|Tobramycin|tobramycin|mesh-list
110441971|NCT00634192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110441972|NCT00634192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110441973|NCT00684463|Palonosetron|palonosetron|mesh-list
110441974|NCT00684463|Antiemetics|antiemetics|mesh-ancestor
110441975|NCT00684463|Autonomic Agents|autonomic agents|mesh-ancestor
110441976|NCT00684463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110441977|NCT00684463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110441978|NCT00684463|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110441979|NCT00684463|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110441980|NCT00684463|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110441981|NCT00684463|Serotonin Agents|serotonin agents|mesh-ancestor
110441982|NCT00684463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110441983|NCT00684463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110441984|NCT00678457|Ondansetron|ondansetron|mesh-list
110441985|NCT00678457|Olanzapine|olanzapine|mesh-list
110441986|NCT00678457|Antiemetics|antiemetics|mesh-ancestor
110441987|NCT00678457|Autonomic Agents|autonomic agents|mesh-ancestor
110441988|NCT00678457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110441989|NCT00678457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110441990|NCT00678457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110441991|NCT00678457|Antipruritics|antipruritics|mesh-ancestor
110441992|NCT00678457|Dermatologic Agents|dermatologic agents|mesh-ancestor
110441993|NCT00678457|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110441994|NCT00678457|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110441995|NCT00678457|Serotonin Agents|serotonin agents|mesh-ancestor
110441996|NCT00678457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110441997|NCT00678457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110441998|NCT00678457|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110441999|NCT00678457|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110442000|NCT00678457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110442001|NCT00678457|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110442002|NCT00678457|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110442003|NCT00678457|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110442004|NCT00678457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110442005|NCT00678613|Norfloxacin|norfloxacin|mesh-list
110442006|NCT00678613|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110442007|NCT00678613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110442008|NCT00678613|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110442009|NCT00678613|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110442010|NCT00678613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110442011|NCT00678613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110442012|NCT00678613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110442013|NCT00678613|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110442014|NCT00678613|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110442015|NCT00678769|Sirolimus|sirolimus|mesh-list
110442016|NCT00678769|Temsirolimus|temsirolimus|mesh-list
110442017|NCT00678769|MTOR Inhibitors|mtor inhibitors|mesh-list
110442018|NCT00678769|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110442019|NCT00678769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110442020|NCT00678769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110442021|NCT00678769|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110442022|NCT00678769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110442023|NCT00678769|Antifungal Agents|antifungal agents|mesh-ancestor
110442024|NCT00678769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110442025|NCT00678769|Immunologic Factors|immunologic factors|mesh-ancestor
110442026|NCT00678769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110373207|NCT04586543|Docetaxel|docetaxel|mesh-list
110442027|NCT00678769|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110442028|NCT00678769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110442029|NCT00678769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110442030|NCT04146883|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110442031|NCT04146883|Cephalexin|cephalexin|mesh-list
110442032|NCT04146883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110442033|NCT02817256|Vitamins|vitamins|mesh-list
110442034|NCT02817256|Micronutrients|micronutrients|mesh-ancestor
110442035|NCT02817256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110442036|NCT02817100|Itraconazole|itraconazole|mesh-list
110442037|NCT02817100|Antifungal Agents|antifungal agents|mesh-ancestor
110442038|NCT02817100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110442039|NCT02817100|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110442040|NCT02817100|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110442041|NCT02817100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110442042|NCT02817100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110442043|NCT02817100|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110442044|NCT02817100|Hormone Antagonists|hormone antagonists|mesh-ancestor
110442045|NCT02817100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110442046|NCT02817100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110329636|NCT01371994|Cholinergic Agents|cholinergic agents|mesh-ancestor
110442047|NCT02817100|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110442048|NCT00684853|Bevacizumab|bevacizumab|mesh-list
110442049|NCT00684853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110442050|NCT00684853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110442051|NCT00684853|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110442052|NCT00684853|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110442053|NCT00684853|Growth Substances|growth substances|mesh-ancestor
110442054|NCT00684853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110442055|NCT00684853|Growth Inhibitors|growth inhibitors|mesh-ancestor
110442056|NCT02816476|Daratumumab|daratumumab|mesh-list
110442057|NCT02816476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110442058|NCT04547140|Protease Inhibitors|protease inhibitors|mesh-list
110442059|NCT04547140|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
110206953|NCT00408772|Bevacizumab|bevacizumab|mesh-list
110442060|NCT04547140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110442061|NCT04547140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110442062|NCT04547140|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
110442063|NCT04547140|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110442064|NCT00679159|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110442065|NCT00679159|Immunologic Factors|immunologic factors|mesh-ancestor
110442066|NCT00679159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110442067|NCT00685009|Hormones|hormones|mesh-list
110442068|NCT00685009|Progesterone|progesterone|mesh-list
110442069|NCT00685009|Estrogens|estrogens|mesh-list
110442070|NCT00685009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110442071|NCT00685009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110442072|NCT00685009|Progestins|progestins|mesh-ancestor
110442073|NCT00679237|Metformin|metformin|mesh-list
110442074|NCT00679237|Glimepiride|glimepiride|mesh-list
110442075|NCT00679237|Ezetimibe|ezetimibe|mesh-list
110442076|NCT00679237|Diuretics|diuretics|mesh-list
110442077|NCT00679237|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110442078|NCT00679237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110442079|NCT00679237|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110442080|NCT00679237|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110442081|NCT00679237|Antimetabolites|antimetabolites|mesh-ancestor
110442082|NCT00679237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110442083|NCT00679237|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110442084|NCT00679237|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110442085|NCT00679237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110442086|NCT00679237|Immunologic Factors|immunologic factors|mesh-ancestor
110442087|NCT00679237|Natriuretic Agents|natriuretic agents|mesh-ancestor
110089074|NCT05098041|Rifampin|rifampin|mesh-list
110442088|NCT00681733|Pioglitazone|pioglitazone|mesh-list
110442089|NCT00681733|Pentoxifylline|pentoxifylline|mesh-list
110442090|NCT00681733|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110442091|NCT00681733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110442092|NCT00681733|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110442093|NCT00681733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110442094|NCT00681733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110442095|NCT00681733|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110373211|NCT04586543|Antimitotic Agents|antimitotic agents|mesh-ancestor
110442096|NCT00681733|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110442097|NCT00681733|Protective Agents|protective agents|mesh-ancestor
110442098|NCT00681733|Vasodilator Agents|vasodilator agents|mesh-ancestor
110442099|NCT00681733|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110442100|NCT00681733|Antioxidants|antioxidants|mesh-ancestor
110442101|NCT00679315|Alfuzosin|alfuzosin|mesh-list
110442102|NCT00679315|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110442103|NCT00679315|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110442104|NCT00679315|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110442105|NCT00679315|Adrenergic Agents|adrenergic agents|mesh-ancestor
110442106|NCT00679315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110442107|NCT00679315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110442108|NCT00679315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110442109|NCT00679315|Urological Agents|urological agents|mesh-ancestor
110442110|NCT05652400|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
110442111|NCT05652400|Antiviral Agents|antiviral agents|mesh-ancestor
110442112|NCT05652400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110442113|NCT01098474|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110442114|NCT01098474|Immunologic Factors|immunologic factors|mesh-ancestor
110442115|NCT01098474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110442116|NCT00633802|Risperidone|risperidone|mesh-list
110442117|NCT00633802|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110442118|NCT00633802|Serotonin Agents|serotonin agents|mesh-ancestor
110442119|NCT00633802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110442120|NCT00633802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110442121|NCT00633802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110442122|NCT00633802|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110442123|NCT00633802|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110442124|NCT00633802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110442125|NCT00633802|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110442126|NCT00633802|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110442127|NCT00633802|Dopamine Agents|dopamine agents|mesh-ancestor
110442128|NCT04460248|Rituximab|rituximab|mesh-list
110442129|NCT04460248|Lenalidomide|lenalidomide|mesh-list
110442130|NCT04460248|Zanubrutinib|zanubrutinib|mesh-list
110442131|NCT04460248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110442132|NCT04460248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110442133|NCT04460248|Immunologic Factors|immunologic factors|mesh-ancestor
110442134|NCT04460248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110442135|NCT04460248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110442136|NCT04460248|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110442137|NCT04460248|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110442138|NCT04460248|Growth Substances|growth substances|mesh-ancestor
110442139|NCT04460248|Growth Inhibitors|growth inhibitors|mesh-ancestor
110442140|NCT04460248|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110442141|NCT04460248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110442142|NCT04460248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110442143|NCT05658874|Methenamine|methenamine|mesh-list
110442144|NCT05658874|Methenamine hippurate|methenamine hippurate|mesh-list
110442145|NCT05658874|Methenamine mandelate|methenamine mandelate|mesh-list
110442146|NCT05658874|Gabapentin|gabapentin|mesh-list
110442147|NCT05658874|Amitriptyline|amitriptyline|mesh-list
110442148|NCT05658874|Mirabegron|mirabegron|mesh-list
110442149|NCT05658874|Oxybutynin|oxybutynin|mesh-list
110442150|NCT05658874|Estrogens|estrogens|mesh-list
110442151|NCT05658874|Analgesics|analgesics|mesh-ancestor
110206992|NCT00184015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110442152|NCT05658874|Sensory System Agents|sensory system agents|mesh-ancestor
110442153|NCT05658874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110442154|NCT05658874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110442155|NCT05658874|Anticonvulsants|anticonvulsants|mesh-ancestor
110442156|NCT05658874|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110442157|NCT05658874|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110442158|NCT05658874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110442159|NCT05658874|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110442160|NCT05658874|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110442161|NCT05658874|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110442162|NCT05658874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110442163|NCT05658874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110442164|NCT05658874|Antimanic Agents|antimanic agents|mesh-ancestor
110442166|NCT05658874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110442167|NCT05658874|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
110442168|NCT05658874|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110442169|NCT05658874|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110442170|NCT05658874|Adrenergic Agents|adrenergic agents|mesh-ancestor
110442171|NCT05658874|Urological Agents|urological agents|mesh-ancestor
110442172|NCT05658874|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110442173|NCT05658874|Antidepressive Agents|antidepressive agents|mesh-ancestor
110442174|NCT05658874|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110442175|NCT05658874|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110442176|NCT05658874|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110442177|NCT05658874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110442178|NCT05658874|Parasympatholytics|parasympatholytics|mesh-ancestor
110442179|NCT05658874|Autonomic Agents|autonomic agents|mesh-ancestor
110442180|NCT05658874|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110442181|NCT05658874|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110442182|NCT05658874|Cholinergic Agents|cholinergic agents|mesh-ancestor
110442183|NCT05658874|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110442184|NCT05658874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110442185|NCT05658874|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110442203|NCT04425538|Infliximab|infliximab|mesh-list
110442204|NCT04425538|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110442205|NCT04425538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110442206|NCT04425538|Dermatologic Agents|dermatologic agents|mesh-ancestor
110442207|NCT04425538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110442208|NCT04425538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110442209|NCT02627521|Ticagrelor|ticagrelor|mesh-list
110442210|NCT02627521|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110442211|NCT02627521|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110442212|NCT02627521|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110442213|NCT02627521|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110442214|NCT02627521|Purinergic Agents|purinergic agents|mesh-ancestor
110442215|NCT02627521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110442216|NCT02627521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110442217|NCT02627521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110442218|NCT00681967|Gefitinib|gefitinib|mesh-list
110442219|NCT00681967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110442220|NCT00681967|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110442221|NCT00681967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110442222|NCT00681967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110442223|NCT04239118|Hemostatics|hemostatics|mesh-list
110442224|NCT04239118|Coagulants|coagulants|mesh-ancestor
110442225|NCT04139941|Antibodies|antibodies|mesh-list
110442226|NCT04139941|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
110442227|NCT04139941|Immunologic Factors|immunologic factors|mesh-ancestor
110442228|NCT04139941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110442229|NCT02814994|Respiratory System Agents|respiratory system agents|mesh-list
110442230|NCT00875017|Sevelamer|sevelamer|mesh-list
110442231|NCT00875017|Chelating Agents|chelating agents|mesh-ancestor
110442232|NCT00875017|Sequestering Agents|sequestering agents|mesh-ancestor
110442233|NCT00875017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110442234|NCT00679705|Atosiban|atosiban|mesh-list
110442235|NCT00679705|Ritodrine|ritodrine|mesh-list
110442236|NCT00679705|Hormone Antagonists|hormone antagonists|mesh-ancestor
110442237|NCT00679705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110089223|NCT04835584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110442238|NCT00679705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110442239|NCT00679705|Tocolytic Agents|tocolytic agents|mesh-ancestor
110442240|NCT00679705|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110442241|NCT00679705|Sympathomimetics|sympathomimetics|mesh-ancestor
110442242|NCT00679705|Autonomic Agents|autonomic agents|mesh-ancestor
110442243|NCT00679705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110442244|NCT00679705|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110442245|NCT00679705|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110442246|NCT00679705|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110442247|NCT00679705|Adrenergic Agents|adrenergic agents|mesh-ancestor
110442248|NCT00679705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110373220|NCT04586543|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110442249|NCT00679705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110442251|NCT00685633|Androgen Antagonists|androgen antagonists|mesh-ancestor
110442252|NCT00685633|Hormone Antagonists|hormone antagonists|mesh-ancestor
110442253|NCT00685633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110442254|NCT00685633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110442255|NCT00685633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110442256|NCT04371952|Doxycycline|doxycycline|mesh-list
110442257|NCT04371952|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110442258|NCT04371952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110442259|NCT04371952|Antimalarials|antimalarials|mesh-ancestor
110442260|NCT04371952|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110442261|NCT04371952|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110442262|NCT04329832|Azithromycin|azithromycin|mesh-list
110442263|NCT04329832|Hydroxychloroquine|hydroxychloroquine|mesh-list
110442264|NCT04329832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110442265|NCT04329832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110442266|NCT04329832|Antimalarials|antimalarials|mesh-ancestor
110442267|NCT04329832|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110442268|NCT04329832|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110442269|NCT04329832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110442270|NCT04329832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110442271|NCT04329832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110442273|NCT04237246|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110442274|NCT04237246|Immunologic Factors|immunologic factors|mesh-ancestor
110442275|NCT04237246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110442276|NCT04237246|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110442277|NCT04237246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110442278|NCT04237246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110442279|NCT00680095|Tavaborole|tavaborole|mesh-list
110442280|NCT00680095|Antifungal Agents|antifungal agents|mesh-ancestor
110442281|NCT00680095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110442282|NCT02814058|Zolpidem|zolpidem|mesh-list
110442283|NCT02814058|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110442284|NCT02814058|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110442285|NCT02814058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110442286|NCT02814058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110442287|NCT02814058|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
110442288|NCT02814058|GABA Agonists|gaba agonists|mesh-ancestor
110442289|NCT02814058|GABA Agents|gaba agents|mesh-ancestor
110442290|NCT02814058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110442291|NCT02814058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110442292|NCT00680173|Interferons|interferons|mesh-list
110442293|NCT00680173|Ribavirin|ribavirin|mesh-list
110442294|NCT00680173|Interferon-alpha|interferon-alpha|mesh-list
110442295|NCT00680173|Interferon alpha-2|interferon alpha-2|mesh-list
110442296|NCT00680173|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110442297|NCT00680173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110442298|NCT00680173|Antiviral Agents|antiviral agents|mesh-ancestor
110442299|NCT00680173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110442300|NCT00680173|Antimetabolites|antimetabolites|mesh-ancestor
110442301|NCT00680173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110442302|NCT00680173|Immunologic Factors|immunologic factors|mesh-ancestor
110442303|NCT00680173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110442304|NCT00682279|Topotecan|topotecan|mesh-list
110442305|NCT00682279|Lapatinib|lapatinib|mesh-list
110442306|NCT00682279|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110442307|NCT00682279|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110442308|NCT00682279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110442309|NCT00682279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110442310|NCT00682279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110442311|NCT00682279|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110442312|NCT02811484|Dapagliflozin|dapagliflozin|mesh-list
110442313|NCT02811484|Exenatide|exenatide|mesh-list
110442314|NCT02811484|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110442315|NCT02811484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110442316|NCT02811484|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110442317|NCT02811484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110442318|NCT02811484|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110442319|NCT02811484|Incretins|incretins|mesh-ancestor
110442320|NCT02811484|Hormones|hormones|mesh-ancestor
110442321|NCT02811484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110442322|NCT00686179|Moxifloxacin|moxifloxacin|mesh-list
110442323|NCT00686179|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110442324|NCT00686179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110442325|NCT00686179|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110442326|NCT00686179|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110442327|NCT00686179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110442328|NCT00686179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110442329|NCT00686179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110442330|NCT00922597|Factor VIII|factor viii|mesh-list
110442331|NCT00922597|Coagulants|coagulants|mesh-ancestor
110442332|NCT00874939|Donepezil|donepezil|mesh-list
110442333|NCT00874939|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110442334|NCT00874939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110442335|NCT00874939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110442337|NCT00874939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110442338|NCT00874939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110442339|NCT00874939|Nootropic Agents|nootropic agents|mesh-ancestor
110442340|NCT00634348|Aripiprazole|aripiprazole|mesh-list
110442341|NCT00634348|Ziprasidone|ziprasidone|mesh-list
110442342|NCT00634348|Antidepressive Agents|antidepressive agents|mesh-ancestor
110442343|NCT00634348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110442344|NCT00634348|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110442345|NCT00634348|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110442346|NCT00634348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110442347|NCT00634348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110442348|NCT00634348|Dopamine Agonists|dopamine agonists|mesh-ancestor
110207082|NCT03816774|Simethicone|simethicone|mesh-list
110651642|NCT00933452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110651643|NCT00933452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110651644|NCT00933452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110651645|NCT00933452|Analgesics|analgesics|mesh-ancestor
110651646|NCT00933452|Sensory System Agents|sensory system agents|mesh-ancestor
110651647|NCT00933452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110651648|NCT00933452|Antidepressive Agents|antidepressive agents|mesh-ancestor
110651649|NCT00933452|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110651650|NCT00933452|Dopamine Agents|dopamine agents|mesh-ancestor
110651651|NCT00447694|Deferasirox|deferasirox|mesh-list
110651652|NCT00447694|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110651653|NCT00447694|Chelating Agents|chelating agents|mesh-ancestor
110651654|NCT00447694|Sequestering Agents|sequestering agents|mesh-ancestor
110651655|NCT00447694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110651656|NCT00564278|Antidepressive Agents|antidepressive agents|mesh-list
110651657|NCT00564278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110651658|NCT00447382|Insulin|insulin|mesh-list
110651659|NCT00447382|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110651660|NCT00447382|Insulin Aspart|insulin aspart|mesh-list
110651661|NCT00447382|Insulin Detemir|insulin detemir|mesh-list
110651662|NCT00447382|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110651663|NCT00447382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110651664|NCT00938990|Midazolam|midazolam|mesh-list
110651665|NCT00938990|Etomidate|etomidate|mesh-list
110651666|NCT00938990|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110651667|NCT00938990|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110651668|NCT00938990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110651669|NCT00938990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110651670|NCT00938990|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110651671|NCT00938990|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110651672|NCT00938990|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110651673|NCT00938990|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110651674|NCT00938990|Anesthetics, General|anesthetics, general|mesh-ancestor
110651675|NCT00938990|Anesthetics|anesthetics|mesh-ancestor
110651676|NCT00938990|GABA Modulators|gaba modulators|mesh-ancestor
110651677|NCT00938990|GABA Agents|gaba agents|mesh-ancestor
110651678|NCT00938990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110651679|NCT00938990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110651680|NCT00933998|Vitamin B 12|vitamin b 12|mesh-list
110651681|NCT00933998|Pyridoxal|pyridoxal|mesh-list
110651682|NCT00933998|Pyridoxal Phosphate|pyridoxal phosphate|mesh-list
110651683|NCT00933998|Vitamin B Complex|vitamin b complex|mesh-ancestor
110651684|NCT00933998|Vitamins|vitamins|mesh-ancestor
110651685|NCT00933998|Micronutrients|micronutrients|mesh-ancestor
110651686|NCT00933998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110651687|NCT00447226|Lapatinib|lapatinib|mesh-list
110651688|NCT00447226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110651689|NCT00447226|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110298897|NCT03730649|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110651690|NCT00447226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110651691|NCT00447226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110651692|NCT03360916|Atorvastatin|atorvastatin|mesh-list
110159719|NCT00006239|Tretinoin|tretinoin|mesh-list
110651693|NCT03360916|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110651694|NCT03360916|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110651695|NCT03360916|Antimetabolites|antimetabolites|mesh-ancestor
110651696|NCT03360916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110651697|NCT03360916|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110651698|NCT03360916|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110651699|NCT03360916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110651701|NCT00446992|Antiemetics|antiemetics|mesh-ancestor
110651702|NCT00446992|Autonomic Agents|autonomic agents|mesh-ancestor
110651703|NCT00446992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110651704|NCT00446992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110651705|NCT00446992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110651706|NCT00446992|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110651707|NCT00446992|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110651708|NCT00446992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110651709|NCT00446992|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110651710|NCT00446992|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110651711|NCT00446992|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110651712|NCT00446992|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110651713|NCT00446992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110651714|NCT00446992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110651715|NCT00446992|Serotonin Agents|serotonin agents|mesh-ancestor
110651717|NCT00503139|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110651718|NCT00503139|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110651719|NCT00503139|Analgesics|analgesics|mesh-ancestor
110651720|NCT00503139|Sensory System Agents|sensory system agents|mesh-ancestor
110651721|NCT00503139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110651722|NCT00503139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110651723|NCT00503139|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110651724|NCT00503139|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110651725|NCT00503139|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110651726|NCT00503139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110651727|NCT00503139|Immunologic Factors|immunologic factors|mesh-ancestor
110651728|NCT00577031|Bevacizumab|bevacizumab|mesh-list
110651729|NCT00577031|Oxaliplatin|oxaliplatin|mesh-list
110651730|NCT00577031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110651731|NCT00577031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110651732|NCT00577031|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110651733|NCT00577031|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110651734|NCT00577031|Growth Substances|growth substances|mesh-ancestor
110651735|NCT00577031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110651736|NCT00577031|Growth Inhibitors|growth inhibitors|mesh-ancestor
110651737|NCT00565448|Docetaxel|docetaxel|mesh-list
110651738|NCT00565448|Fluorouracil|fluorouracil|mesh-list
110651739|NCT00565448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110651740|NCT00565448|Tubulin Modulators|tubulin modulators|mesh-ancestor
110651741|NCT00565448|Antimitotic Agents|antimitotic agents|mesh-ancestor
110651742|NCT00565448|Mitosis Modulators|mitosis modulators|mesh-ancestor
110651743|NCT00565448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110651744|NCT00565448|Antimetabolites|antimetabolites|mesh-ancestor
110651745|NCT00565448|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110651746|NCT00565448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110651747|NCT00565448|Immunologic Factors|immunologic factors|mesh-ancestor
110651748|NCT00565448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110651749|NCT01012011|Sorafenib|sorafenib|mesh-list
110651750|NCT01012011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110651751|NCT01012011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110651752|NCT01012011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110651753|NCT01012011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110651754|NCT00934076|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110651755|NCT00934076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110651756|NCT00934076|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110651757|NCT00934076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110651758|NCT00934076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110651759|NCT00934154|Thalidomide|thalidomide|mesh-list
110651760|NCT00934154|Prednisolone|prednisolone|mesh-list
110651761|NCT00934154|Melphalan|melphalan|mesh-list
110651762|NCT00934154|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110651763|NCT00934154|Alkylating Agents|alkylating agents|mesh-ancestor
110298977|NCT03441633|Rivaroxaban|rivaroxaban|mesh-list
110651764|NCT00934154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110651765|NCT00934154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110651766|NCT00934154|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110651767|NCT00934154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110651768|NCT00934154|Immunologic Factors|immunologic factors|mesh-ancestor
110651769|NCT00934154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110651770|NCT00934154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110651772|NCT00934154|Hormones|hormones|mesh-ancestor
110651773|NCT00934154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110651774|NCT00934154|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110651775|NCT00934154|Leprostatic Agents|leprostatic agents|mesh-ancestor
110651776|NCT00934154|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110651777|NCT00934154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110651778|NCT00934154|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110651779|NCT00934154|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110651780|NCT00934154|Growth Substances|growth substances|mesh-ancestor
110651781|NCT00934154|Growth Inhibitors|growth inhibitors|mesh-ancestor
110651782|NCT00446446|Panitumumab|panitumumab|mesh-list
110651783|NCT00446446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110651784|NCT00446446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110651785|NCT05078255|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
110651786|NCT05078255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110651787|NCT05078255|Incretins|incretins|mesh-ancestor
110651788|NCT05078255|Hormones|hormones|mesh-ancestor
110651789|NCT05078255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110651790|NCT05078255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110651791|NCT00939458|Lamotrigine|lamotrigine|mesh-list
110651792|NCT00939458|Anticonvulsants|anticonvulsants|mesh-ancestor
110651793|NCT00939458|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110651794|NCT00939458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110651795|NCT00939458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110651796|NCT00939458|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110651797|NCT00939458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110651798|NCT00939458|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110651799|NCT00939458|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110651800|NCT00939458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110651801|NCT00939458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110651802|NCT00939458|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110651803|NCT02566967|Tofacitinib|tofacitinib|mesh-list
110651804|NCT02566967|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
110651805|NCT02566967|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110651806|NCT02566967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110651807|NCT02566967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110651808|NCT00939068|Telbivudine|telbivudine|mesh-list
110651809|NCT00939068|Antiviral Agents|antiviral agents|mesh-ancestor
110651810|NCT00939068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110651811|NCT00939068|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110651812|NCT00939068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110651813|NCT00939068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110651814|NCT00934232|Busulfan|busulfan|mesh-list
110651815|NCT00934232|Alkylating Agents|alkylating agents|mesh-ancestor
110651816|NCT00934232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110651817|NCT00934232|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110651818|NCT00934232|Immunologic Factors|immunologic factors|mesh-ancestor
110651819|NCT00934232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110651821|NCT00934232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110651822|NCT00934232|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110651823|NCT01013571|Insulin|insulin|mesh-list
110651824|NCT01013571|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110651825|NCT01013571|Insulin Glargine|insulin glargine|mesh-list
110651826|NCT01013571|Insulin glulisine|insulin glulisine|mesh-list
110651827|NCT01013571|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110651828|NCT01013571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110651829|NCT00514449|Valacyclovir|valacyclovir|mesh-list
110651830|NCT00514449|Antiviral Agents|antiviral agents|mesh-ancestor
110651831|NCT00514449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110651832|NCT00492921|Cyclophosphamide|cyclophosphamide|mesh-list
110651833|NCT00492921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110651834|NCT00492921|Immunologic Factors|immunologic factors|mesh-ancestor
110651835|NCT00492921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110651836|NCT00492921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110651837|NCT00492921|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110651838|NCT00492921|Alkylating Agents|alkylating agents|mesh-ancestor
110651839|NCT00492921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110651840|NCT00492921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110651841|NCT00492921|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110651842|NCT00738257|Pamidronate|pamidronate|mesh-list
110651843|NCT00738257|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110651844|NCT00738257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110651845|NCT00738335|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110651846|NCT00738335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110651847|NCT00738335|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110651848|NCT00738335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110651849|NCT00738335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110651850|NCT00502671|Capecitabine|capecitabine|mesh-list
110651851|NCT00502671|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110651852|NCT00502671|Antimetabolites|antimetabolites|mesh-ancestor
110651853|NCT00502671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110651854|NCT00502671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110651855|NCT00738413|Deferasirox|deferasirox|mesh-list
110651856|NCT00738413|Deferoxamine|deferoxamine|mesh-list
110651857|NCT00738413|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110651858|NCT00738413|Chelating Agents|chelating agents|mesh-ancestor
110651859|NCT00738413|Sequestering Agents|sequestering agents|mesh-ancestor
110651860|NCT00738413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110651861|NCT00738413|Siderophores|siderophores|mesh-ancestor
110651862|NCT00697463|Teriparatide|teriparatide|mesh-list
110651863|NCT00697463|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110651864|NCT00697463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110651865|NCT00697463|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110651867|NCT04409795|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110651868|NCT04409795|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110651869|NCT04409795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110651870|NCT04409795|Incretins|incretins|mesh-ancestor
110651871|NCT04409795|Hormones|hormones|mesh-ancestor
110651872|NCT04409795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110651873|NCT04409795|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110651874|NCT04409795|Protease Inhibitors|protease inhibitors|mesh-ancestor
110651875|NCT04409795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110651876|NCT04409795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110651877|NCT00492531|Sildenafil Citrate|sildenafil citrate|mesh-list
110651878|NCT00492531|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
110651879|NCT00492531|Vasodilator Agents|vasodilator agents|mesh-ancestor
110651880|NCT00492531|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110651881|NCT00492531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110651882|NCT00492531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110651883|NCT00492531|Urological Agents|urological agents|mesh-ancestor
110651884|NCT01015209|Acetylcysteine|acetylcysteine|mesh-list
110398220|NCT00597623|Adalimumab|adalimumab|mesh-list
110651886|NCT01015209|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110651887|NCT01015209|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110651888|NCT01015209|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110651889|NCT01015209|Antiviral Agents|antiviral agents|mesh-ancestor
110651890|NCT01015209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110651891|NCT01015209|Expectorants|expectorants|mesh-ancestor
110651892|NCT01015209|Respiratory System Agents|respiratory system agents|mesh-ancestor
110651893|NCT01015209|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110651894|NCT01015209|Antioxidants|antioxidants|mesh-ancestor
110651895|NCT01015209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110651896|NCT01015209|Protective Agents|protective agents|mesh-ancestor
110651897|NCT01015209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110651898|NCT01015209|Antidotes|antidotes|mesh-ancestor
110651899|NCT01015209|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110651900|NCT01015209|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110651901|NCT01015209|Antimetabolites|antimetabolites|mesh-ancestor
110651902|NCT01015209|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110651903|NCT01015209|Chelating Agents|chelating agents|mesh-ancestor
110651904|NCT01015209|Sequestering Agents|sequestering agents|mesh-ancestor
110651905|NCT01015209|Hemostatics|hemostatics|mesh-ancestor
110651906|NCT01015209|Coagulants|coagulants|mesh-ancestor
110651907|NCT04948463|Vancomycin|vancomycin|mesh-list
110651908|NCT04948463|Ciprofloxacin|ciprofloxacin|mesh-list
110651909|NCT04948463|Tazobactam|tazobactam|mesh-list
110651910|NCT04948463|Piperacillin|piperacillin|mesh-list
110651911|NCT04948463|Amikacin|amikacin|mesh-list
110651912|NCT04948463|Ceftazidime|ceftazidime|mesh-list
110651913|NCT04948463|Cefepime|cefepime|mesh-list
110651914|NCT04948463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110651915|NCT04948463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110651916|NCT04948463|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110651917|NCT04948463|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110651918|NCT04948463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110651919|NCT04948463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110651920|NCT04948463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110651921|NCT04948463|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110651922|NCT04948463|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110651923|NCT04948463|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110651924|NCT01080547|Capecitabine|capecitabine|mesh-list
110651925|NCT01080547|Oxaliplatin|oxaliplatin|mesh-list
110651926|NCT01080547|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110651927|NCT01080547|Antimetabolites|antimetabolites|mesh-ancestor
110651928|NCT01080547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110651929|NCT01080547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110651930|NCT04930991|Omeprazole|omeprazole|mesh-list
110651931|NCT04930991|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110651932|NCT04930991|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110651933|NCT04930991|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110651934|NCT04930991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110651935|NCT04930991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110651936|NCT00111241|Letrozole|letrozole|mesh-list
110651937|NCT00111241|Anastrozole|anastrozole|mesh-list
110651938|NCT00111241|Aromatase Inhibitors|aromatase inhibitors|mesh-list
110651939|NCT00111241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110651940|NCT00111241|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110651941|NCT00111241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110651942|NCT00111241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110651943|NCT00111241|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110398229|NCT00598013|Pioglitazone|pioglitazone|mesh-list
110651944|NCT00111241|Hormone Antagonists|hormone antagonists|mesh-ancestor
110651945|NCT00111241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110651946|NCT00111241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110651947|NCT00111241|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110651948|NCT00492297|Sorafenib|sorafenib|mesh-list
110651949|NCT00492297|Dacarbazine|dacarbazine|mesh-list
110651950|NCT00492297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110651951|NCT00492297|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110651952|NCT00492297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110651953|NCT00492297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110651954|NCT00492297|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110651955|NCT00492297|Alkylating Agents|alkylating agents|mesh-ancestor
110651957|NCT00446134|Taribavirin|taribavirin|mesh-list
110651958|NCT00446134|Antimetabolites|antimetabolites|mesh-ancestor
110651959|NCT00446134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110651960|NCT00446134|Antiviral Agents|antiviral agents|mesh-ancestor
110651961|NCT00446134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110651962|NCT00934466|Dextromethorphan|dextromethorphan|mesh-list
110651963|NCT00934466|Antitussive Agents|antitussive agents|mesh-ancestor
110651964|NCT00934466|Respiratory System Agents|respiratory system agents|mesh-ancestor
110651965|NCT00934466|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110651966|NCT00934466|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110651967|NCT00934466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110651968|NCT00934466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110651969|NCT00934466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110651970|NCT00921245|Darifenacin|darifenacin|mesh-list
110651971|NCT00921245|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110651972|NCT00921245|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110651973|NCT00921245|Cholinergic Agents|cholinergic agents|mesh-ancestor
110651974|NCT00921245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110651975|NCT00921245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110651976|NCT00921245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110651977|NCT00921245|Urological Agents|urological agents|mesh-ancestor
110651978|NCT00940238|Dexetimide|dexetimide|mesh-list
110651979|NCT00940238|Citalopram|citalopram|mesh-list
110651980|NCT00940238|Escitalopram|escitalopram|mesh-list
110651981|NCT00940238|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110651982|NCT00940238|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110651983|NCT00940238|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110651984|NCT00940238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110651985|NCT00940238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110651986|NCT00940238|Serotonin Agents|serotonin agents|mesh-ancestor
110651987|NCT00940238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110651988|NCT00940238|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110651989|NCT00940238|Antidepressive Agents|antidepressive agents|mesh-ancestor
110651990|NCT00940238|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110651991|NCT00940238|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110651992|NCT00940238|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110651993|NCT00940238|Parasympatholytics|parasympatholytics|mesh-ancestor
110651994|NCT00940238|Autonomic Agents|autonomic agents|mesh-ancestor
110651995|NCT00940238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110651996|NCT00940238|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110651997|NCT00940238|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110651998|NCT00940238|Cholinergic Agents|cholinergic agents|mesh-ancestor
110651999|NCT04013438|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110652000|NCT04013438|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110652001|NCT04013438|Saw palmetto extract|saw palmetto extract|mesh-list
110652002|NCT04013438|Estradiol|estradiol|mesh-list
110652003|NCT04013438|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110652004|NCT04013438|Estrogens|estrogens|mesh-ancestor
110652005|NCT04013438|Hormones|hormones|mesh-ancestor
110652006|NCT04013438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110652007|NCT04013438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110652008|NCT04013438|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110652009|NCT04013438|Contraceptive Agents|contraceptive agents|mesh-ancestor
110652010|NCT04013438|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110652011|NCT04013438|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110652012|NCT04013438|Urological Agents|urological agents|mesh-ancestor
110652014|NCT02565719|Tenofovir|tenofovir|mesh-list
110652015|NCT02565719|Interferon-alpha|interferon-alpha|mesh-list
110652016|NCT02565719|Interferon alpha-2|interferon alpha-2|mesh-list
110652017|NCT02565719|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110652018|NCT02565719|REP 2139|rep 2139|mesh-list
110652019|NCT02565719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110652020|NCT02565719|Antiviral Agents|antiviral agents|mesh-ancestor
110652021|NCT02565719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110652022|NCT02565719|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110652023|NCT02565719|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110652024|NCT02565719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110652025|NCT02565719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110652026|NCT02565719|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110652027|NCT02565719|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110652028|NCT02565719|Immunologic Factors|immunologic factors|mesh-ancestor
110652029|NCT02565719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110652030|NCT00111007|Paclitaxel|paclitaxel|mesh-list
110652031|NCT00111007|Carboplatin|carboplatin|mesh-list
110652032|NCT00111007|Sorafenib|sorafenib|mesh-list
110652033|NCT00111007|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110652034|NCT00111007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110652035|NCT00111007|Tubulin Modulators|tubulin modulators|mesh-ancestor
110652036|NCT00111007|Antimitotic Agents|antimitotic agents|mesh-ancestor
110652037|NCT00111007|Mitosis Modulators|mitosis modulators|mesh-ancestor
110652038|NCT00111007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110652039|NCT00111007|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110652040|NCT00111007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110652041|NCT00699335|Fentanyl|fentanyl|mesh-list
110652042|NCT00699335|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110652043|NCT00699335|Narcotics|narcotics|mesh-ancestor
110652044|NCT00699335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110652045|NCT00699335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110652046|NCT00699335|Analgesics|analgesics|mesh-ancestor
110159741|NCT00094120|Growth Substances|growth substances|mesh-ancestor
110652047|NCT00699335|Sensory System Agents|sensory system agents|mesh-ancestor
110652048|NCT00699335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110652049|NCT00699335|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110652050|NCT00699335|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110652051|NCT00699335|Anesthetics, General|anesthetics, general|mesh-ancestor
110652052|NCT00699335|Anesthetics|anesthetics|mesh-ancestor
110652053|NCT00939614|Lamotrigine|lamotrigine|mesh-list
110652054|NCT00939614|Anticonvulsants|anticonvulsants|mesh-ancestor
110652055|NCT00939614|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110652056|NCT00939614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110652057|NCT00939614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110652058|NCT00939614|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110652059|NCT00939614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110299274|NCT02217163|Glucocorticoids|glucocorticoids|mesh-ancestor
110652060|NCT00939614|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110652061|NCT00939614|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110652062|NCT00939614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110652064|NCT00939614|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110652065|NCT03962881|Vaccines|vaccines|mesh-list
110652066|NCT03962881|Immunologic Factors|immunologic factors|mesh-ancestor
110652067|NCT03962881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110652068|NCT00935246|Dexetimide|dexetimide|mesh-list
110652069|NCT00935246|Citalopram|citalopram|mesh-list
110652070|NCT00935246|Escitalopram|escitalopram|mesh-list
110652071|NCT00935246|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110652072|NCT00935246|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110652073|NCT00935246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110652074|NCT00935246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110652075|NCT00935246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110652076|NCT00935246|Serotonin Agents|serotonin agents|mesh-ancestor
110398257|NCT04326725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110652077|NCT00935246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110652079|NCT00935246|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110652080|NCT00935246|Parasympatholytics|parasympatholytics|mesh-ancestor
110652081|NCT00935246|Autonomic Agents|autonomic agents|mesh-ancestor
110652082|NCT00935246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110652083|NCT00935246|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110652084|NCT00935246|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110652085|NCT00935246|Cholinergic Agents|cholinergic agents|mesh-ancestor
110652086|NCT00935246|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110652087|NCT00935246|Antidepressive Agents|antidepressive agents|mesh-ancestor
110652088|NCT00935246|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110652089|NCT00935480|Raltegravir Potassium|raltegravir potassium|mesh-list
110652090|NCT00935480|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110652091|NCT00935480|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110652092|NCT00935480|Antiviral Agents|antiviral agents|mesh-ancestor
110652093|NCT00935480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110652094|NCT00935480|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110652095|NCT00935480|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110652096|NCT00935480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110652097|NCT00935480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110652098|NCT00939848|Cisplatin|cisplatin|mesh-list
110652099|NCT00939848|Gemcitabine|gemcitabine|mesh-list
110652100|NCT00939848|Cediranib|cediranib|mesh-list
110652101|NCT00939848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110652102|NCT00939848|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110652103|NCT00939848|Antimetabolites|antimetabolites|mesh-ancestor
110652104|NCT00939848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110652105|NCT00939848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110652106|NCT00939848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110652107|NCT04013048|Fluzoparib|fluzoparib|mesh-list
110652108|NCT04013048|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110652109|NCT04013048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110652110|NCT04013048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110652111|NCT04013048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110652112|NCT00935558|Interleukin-2|interleukin-2|mesh-list
110652113|NCT00935558|Exemestane|exemestane|mesh-list
110652114|NCT00935558|Anastrozole|anastrozole|mesh-list
110652115|NCT00935558|Letrozole|letrozole|mesh-list
110652116|NCT00935558|Lactitol|lactitol|mesh-list
110652117|NCT00935558|Vaccines|vaccines|mesh-list
110652118|NCT00935558|Aromatase Inhibitors|aromatase inhibitors|mesh-list
110652119|NCT00935558|Immunologic Factors|immunologic factors|mesh-ancestor
110652120|NCT00935558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110652121|NCT00935558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110652122|NCT00935558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110652123|NCT00935558|Analgesics|analgesics|mesh-ancestor
110652124|NCT00935558|Sensory System Agents|sensory system agents|mesh-ancestor
110652125|NCT00935558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110652126|NCT00935558|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110652127|NCT00935558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110652128|NCT00935558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110652129|NCT00935558|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110652130|NCT00935558|Hormone Antagonists|hormone antagonists|mesh-ancestor
110652131|NCT00935558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110652132|NCT00935558|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110652133|NCT00935558|Cathartics|cathartics|mesh-ancestor
110652134|NCT00935558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110652135|NCT05280236|Propofol|propofol|mesh-list
110652136|NCT05280236|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110652137|NCT05280236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110299357|NCT00263484|BB 1101|bb 1101|mesh-list
110652138|NCT05280236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110652139|NCT05280236|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110652140|NCT05280236|Anesthetics, General|anesthetics, general|mesh-ancestor
110652141|NCT05280236|Anesthetics|anesthetics|mesh-ancestor
110652142|NCT00940472|Metformin|metformin|mesh-list
110652143|NCT00940472|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110652144|NCT00940472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110652145|NCT00939926|Risperidone|risperidone|mesh-list
110652146|NCT00939926|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110652147|NCT00939926|Serotonin Agents|serotonin agents|mesh-ancestor
110652148|NCT00939926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110652149|NCT00939926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110652150|NCT00939926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110652151|NCT00939926|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110652152|NCT00939926|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110652153|NCT00939926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110652154|NCT00939926|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110652155|NCT00939926|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110652156|NCT00939926|Dopamine Agents|dopamine agents|mesh-ancestor
110652157|NCT00940550|Melatonin|melatonin|mesh-list
110652158|NCT00940550|Zolpidem|zolpidem|mesh-list
110652159|NCT00940550|Temazepam|temazepam|mesh-list
110652160|NCT00940550|Antioxidants|antioxidants|mesh-ancestor
110652161|NCT00940550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110652162|NCT00940550|Protective Agents|protective agents|mesh-ancestor
110652163|NCT00940550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110652164|NCT00940550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110652165|NCT00940550|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110652166|NCT00940550|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110652167|NCT00940550|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
110652168|NCT00940550|GABA Agonists|gaba agonists|mesh-ancestor
110652169|NCT00940550|GABA Agents|gaba agents|mesh-ancestor
110652170|NCT00940550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110652171|NCT00940550|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110652172|NCT00940550|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110652173|NCT00940550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110652174|NCT00940550|GABA Modulators|gaba modulators|mesh-ancestor
110652175|NCT00940628|Orlistat|orlistat|mesh-list
110652176|NCT00940628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110652177|NCT00940628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110652178|NCT00940628|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110652179|NCT00940628|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110652180|NCT00936182|Fluconazole|fluconazole|mesh-list
110652181|NCT00936182|Antifungal Agents|antifungal agents|mesh-ancestor
110652182|NCT00936182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110652183|NCT00936182|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110652184|NCT00936182|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110652185|NCT00936182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110159751|NCT00006245|Growth Inhibitors|growth inhibitors|mesh-ancestor
110652186|NCT00936182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110652187|NCT00936182|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110652188|NCT00936182|Hormone Antagonists|hormone antagonists|mesh-ancestor
110652189|NCT00936182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110652190|NCT00936182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110652191|NCT00936182|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110212363|NCT00236392|Rabeprazole|rabeprazole|mesh-list
110652192|NCT00936182|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110652193|NCT00936260|Alendronate|alendronate|mesh-list
110652194|NCT00936260|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110652195|NCT00936260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110652197|NCT00445978|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110652198|NCT00445978|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110652199|NCT00445978|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110652200|NCT00445978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110652201|NCT00445978|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110652202|NCT00445978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110652203|NCT00445978|Vasodilator Agents|vasodilator agents|mesh-ancestor
110652204|NCT02566733|Remifentanil|remifentanil|mesh-list
110652205|NCT02566733|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110652207|NCT02566733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110652208|NCT02566733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110652209|NCT02566733|Analgesics|analgesics|mesh-ancestor
110652210|NCT02566733|Sensory System Agents|sensory system agents|mesh-ancestor
110652211|NCT02566733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110652212|NCT01028950|Darexaban|darexaban|mesh-list
110652213|NCT01028950|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110652214|NCT01028950|Antithrombins|antithrombins|mesh-ancestor
110652215|NCT01028950|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110652216|NCT01028950|Protease Inhibitors|protease inhibitors|mesh-ancestor
110652217|NCT01028950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110652218|NCT01028950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110652219|NCT01028950|Anticoagulants|anticoagulants|mesh-ancestor
110652221|NCT00940784|Clopidogrel|clopidogrel|mesh-list
110652222|NCT00940784|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110652223|NCT00940784|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110652224|NCT00940784|Analgesics|analgesics|mesh-ancestor
110652225|NCT00940784|Sensory System Agents|sensory system agents|mesh-ancestor
110652226|NCT00940784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110652227|NCT00940784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110652228|NCT00940784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110652229|NCT00940784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110652230|NCT00940784|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110652231|NCT00940784|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110652232|NCT00940784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110652233|NCT00940784|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110652234|NCT00940784|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110652235|NCT00940784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110652236|NCT00940784|Antipyretics|antipyretics|mesh-ancestor
110652237|NCT00940784|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110652238|NCT00940784|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110652239|NCT00940784|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110652240|NCT00940784|Purinergic Agents|purinergic agents|mesh-ancestor
110652241|NCT00940784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110652242|NCT01023490|Vitamin D|vitamin d|mesh-list
110652243|NCT01023490|Vitamins|vitamins|mesh-ancestor
110652244|NCT01023490|Micronutrients|micronutrients|mesh-ancestor
110652245|NCT01023490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110652246|NCT01023490|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110652247|NCT00698009|Cyclophosphamide|cyclophosphamide|mesh-list
110652248|NCT00698009|Fludarabine|fludarabine|mesh-list
110652249|NCT00698009|Fludarabine phosphate|fludarabine phosphate|mesh-list
110652250|NCT00698009|Interleukin-2|interleukin-2|mesh-list
110652251|NCT00698009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110652252|NCT00698009|Immunologic Factors|immunologic factors|mesh-ancestor
110652253|NCT00698009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110652254|NCT00698009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110652255|NCT00698009|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110652256|NCT00698009|Alkylating Agents|alkylating agents|mesh-ancestor
110652257|NCT00698009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110652258|NCT00698009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110652259|NCT00698009|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110652260|NCT00698009|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110652261|NCT00698009|Antimetabolites|antimetabolites|mesh-ancestor
110652262|NCT00698009|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110652263|NCT00698009|Analgesics|analgesics|mesh-ancestor
110652264|NCT00698009|Sensory System Agents|sensory system agents|mesh-ancestor
110652265|NCT00698009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110652266|NCT04648631|Pulmonary Surfactants|pulmonary surfactants|mesh-list
110652267|NCT04648631|Respiratory System Agents|respiratory system agents|mesh-ancestor
110652268|NCT00944606|Vitamin D|vitamin d|mesh-list
110652269|NCT00944606|Vitamins|vitamins|mesh-ancestor
110652270|NCT00944606|Micronutrients|micronutrients|mesh-ancestor
110652271|NCT00944606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110652272|NCT00944606|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110652273|NCT05257655|Analgesics, Opioid|analgesics, opioid|mesh-list
110652274|NCT05257655|Narcotics|narcotics|mesh-ancestor
110652275|NCT05257655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110652276|NCT05257655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110652277|NCT05257655|Analgesics|analgesics|mesh-ancestor
110652278|NCT05257655|Sensory System Agents|sensory system agents|mesh-ancestor
110652279|NCT05257655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110652281|NCT00944684|Antimetabolites|antimetabolites|mesh-ancestor
110652282|NCT00944684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110652283|NCT00944684|Antiviral Agents|antiviral agents|mesh-ancestor
110652284|NCT00944684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110652285|NCT04061057|Lidocaine|lidocaine|mesh-list
110652286|NCT04061057|Anesthetics, Local|anesthetics, local|mesh-ancestor
110652287|NCT04061057|Anesthetics|anesthetics|mesh-ancestor
110652288|NCT04061057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110652289|NCT04061057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110652290|NCT04061057|Sensory System Agents|sensory system agents|mesh-ancestor
110652291|NCT04061057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110652292|NCT04061057|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110652293|NCT04061057|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110652294|NCT04061057|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110652295|NCT04061057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110652296|NCT04061057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110652297|NCT00921167|Bevacizumab|bevacizumab|mesh-list
110652298|NCT00921167|Irinotecan|irinotecan|mesh-list
110652299|NCT00921167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110652300|NCT00921167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110652301|NCT00921167|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110652302|NCT00921167|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110652303|NCT00921167|Growth Substances|growth substances|mesh-ancestor
110652304|NCT00921167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110652305|NCT00921167|Growth Inhibitors|growth inhibitors|mesh-ancestor
110652306|NCT00921167|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110652307|NCT00921167|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110652308|NCT00921167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110652309|NCT00921167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110652310|NCT04061447|Clarithromycin|clarithromycin|mesh-list
110652311|NCT04061447|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110652312|NCT04061447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110652313|NCT04061447|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110652314|NCT04061447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110652315|NCT04061447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110652316|NCT04061447|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110652317|NCT04061447|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110652318|NCT03968978|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110652319|NCT03968978|Immunologic Factors|immunologic factors|mesh-ancestor
110652320|NCT03968978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110652321|NCT05472779|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110652322|NCT05472779|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110652324|NCT05472779|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110652325|NCT05472779|Estrogens|estrogens|mesh-ancestor
110652326|NCT05472779|Hormones|hormones|mesh-ancestor
110652327|NCT05472779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110652328|NCT05472779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110652329|NCT05472779|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110652330|NCT05472779|Contraceptive Agents|contraceptive agents|mesh-ancestor
110652331|NCT05472779|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110652332|NCT05472779|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110652333|NCT02565953|Paclitaxel|paclitaxel|mesh-list
110652334|NCT02565953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110652335|NCT02565953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110652336|NCT02565953|Tubulin Modulators|tubulin modulators|mesh-ancestor
110652337|NCT02565953|Antimitotic Agents|antimitotic agents|mesh-ancestor
110652338|NCT02565953|Mitosis Modulators|mitosis modulators|mesh-ancestor
110652339|NCT02565953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110652340|NCT00562718|Capecitabine|capecitabine|mesh-list
110652341|NCT00562718|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110652342|NCT00562718|Antimetabolites|antimetabolites|mesh-ancestor
110652343|NCT00562718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110652344|NCT00562718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110652345|NCT05222165|Infigratinib|infigratinib|mesh-list
110652346|NCT05222165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110652347|NCT04555811|Rituximab|rituximab|mesh-list
110652348|NCT04555811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110652349|NCT04555811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110652350|NCT04555811|Immunologic Factors|immunologic factors|mesh-ancestor
110652351|NCT04555811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110652352|NCT04555811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110652353|NCT00697619|Zoledronic Acid|zoledronic acid|mesh-list
110652354|NCT00697619|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110652355|NCT00697619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110652356|NCT02566187|Atorvastatin|atorvastatin|mesh-list
110652357|NCT02566187|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110652358|NCT02566187|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110652359|NCT02566187|Antimetabolites|antimetabolites|mesh-ancestor
110652360|NCT02566187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110652361|NCT02566187|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110652362|NCT02566187|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110652363|NCT02566187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110652364|NCT05324891|Fentanyl|fentanyl|mesh-list
110652365|NCT05324891|Dexmedetomidine|dexmedetomidine|mesh-list
110652366|NCT05324891|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110652367|NCT05324891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110652368|NCT05324891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110652369|NCT05324891|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110652370|NCT05324891|Analgesics|analgesics|mesh-ancestor
110652371|NCT05324891|Sensory System Agents|sensory system agents|mesh-ancestor
110652372|NCT05324891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110652373|NCT05324891|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110652374|NCT05324891|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110652375|NCT05324891|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110652376|NCT05324891|Adrenergic Agents|adrenergic agents|mesh-ancestor
110652377|NCT05324891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110652378|NCT05324891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110652379|NCT05324891|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110652380|NCT05324891|Narcotics|narcotics|mesh-ancestor
110652381|NCT05324891|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110652382|NCT05324891|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110207230|NCT00185575|Analgesics|analgesics|mesh-ancestor
110652383|NCT05324891|Anesthetics, General|anesthetics, general|mesh-ancestor
110652384|NCT05324891|Anesthetics|anesthetics|mesh-ancestor
110652385|NCT05451329|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110652386|NCT05451329|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110652387|NCT00445432|Adalimumab|adalimumab|mesh-list
110652388|NCT00445432|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110652389|NCT00445432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110652390|NCT00445432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110652391|NCT03370133|Ustekinumab|ustekinumab|mesh-list
110652392|NCT03370133|Dermatologic Agents|dermatologic agents|mesh-ancestor
110652393|NCT00696137|Fentanyl|fentanyl|mesh-list
110652394|NCT00696137|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110652395|NCT00696137|Narcotics|narcotics|mesh-ancestor
110652396|NCT00696137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110652397|NCT00696137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110652398|NCT00696137|Analgesics|analgesics|mesh-ancestor
110652399|NCT00696137|Sensory System Agents|sensory system agents|mesh-ancestor
110652400|NCT00696137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110652401|NCT00696137|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110652402|NCT00696137|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110652403|NCT00696137|Anesthetics, General|anesthetics, general|mesh-ancestor
110652404|NCT00696137|Anesthetics|anesthetics|mesh-ancestor
110652405|NCT02565641|Gemcitabine|gemcitabine|mesh-list
110652406|NCT02565641|Capecitabine|capecitabine|mesh-list
110652407|NCT02565641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110652408|NCT02565641|Antimetabolites|antimetabolites|mesh-ancestor
110652409|NCT02565641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110652410|NCT02565641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110652411|NCT04036721|Prednisone|prednisone|mesh-list
110652412|NCT04036721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110652413|NCT04036721|Glucocorticoids|glucocorticoids|mesh-ancestor
110652414|NCT04036721|Hormones|hormones|mesh-ancestor
110652415|NCT04036721|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110652416|NCT04036721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110652417|NCT04036721|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110652418|NCT04036721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110652419|NCT00441142|Temozolomide|temozolomide|mesh-list
110652420|NCT00441142|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110652421|NCT00441142|Alkylating Agents|alkylating agents|mesh-ancestor
110652422|NCT00441142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110652423|NCT00441142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110652424|NCT03848416|Ixekizumab|ixekizumab|mesh-list
110652425|NCT03848416|Dermatologic Agents|dermatologic agents|mesh-ancestor
110652426|NCT01029418|Sorafenib|sorafenib|mesh-list
110652427|NCT01029418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110652428|NCT01029418|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110652429|NCT01029418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110652430|NCT01029418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110652431|NCT04060979|Nitric Oxide|nitric oxide|mesh-list
110652432|NCT04060979|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110652433|NCT04060979|Autonomic Agents|autonomic agents|mesh-ancestor
110652434|NCT04060979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110652435|NCT04060979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110652436|NCT04060979|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110652437|NCT04060979|Respiratory System Agents|respiratory system agents|mesh-ancestor
110652438|NCT04060979|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110652439|NCT04060979|Antioxidants|antioxidants|mesh-ancestor
110564899|NCT04138394|Vitamins|vitamins|mesh-ancestor
110652440|NCT04060979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110652441|NCT04060979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110652442|NCT04060979|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
110652443|NCT04060979|Vasodilator Agents|vasodilator agents|mesh-ancestor
110652444|NCT04060979|Gasotransmitters|gasotransmitters|mesh-ancestor
110652445|NCT04060979|Protective Agents|protective agents|mesh-ancestor
110652446|NCT00458302|Darunavir|darunavir|mesh-list
110652447|NCT00458302|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110652448|NCT00458302|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110652449|NCT00458302|Protease Inhibitors|protease inhibitors|mesh-ancestor
110207239|NCT03731832|Ixazomib|ixazomib|mesh-list
110652451|NCT00458302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110652452|NCT00458302|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110652453|NCT00458302|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110652454|NCT00458302|Antiviral Agents|antiviral agents|mesh-ancestor
110652455|NCT00458302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110652456|NCT00444106|Artesunate|artesunate|mesh-list
110652457|NCT00444106|Lumefantrine|lumefantrine|mesh-list
110652458|NCT00444106|Artemether|artemether|mesh-list
110652459|NCT00444106|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
110652460|NCT00444106|Mefloquine|mefloquine|mesh-list
110652461|NCT00444106|Atovaquone|atovaquone|mesh-list
110652462|NCT00444106|Proguanil|proguanil|mesh-list
110652463|NCT00444106|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
110652464|NCT00444106|Antimalarials|antimalarials|mesh-ancestor
110652465|NCT00444106|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110652466|NCT00444106|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110652467|NCT00444106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110652468|NCT00444106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110652469|NCT00444106|Antiviral Agents|antiviral agents|mesh-ancestor
110652470|NCT00444106|Schistosomicides|schistosomicides|mesh-ancestor
110652471|NCT00444106|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110652472|NCT00444106|Anthelmintics|anthelmintics|mesh-ancestor
110652473|NCT00444106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110652474|NCT00444106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110652475|NCT00444106|Antimetabolites|antimetabolites|mesh-ancestor
110652476|NCT00561470|Leucovorin|leucovorin|mesh-list
110652477|NCT00561470|Fluorouracil|fluorouracil|mesh-list
110652478|NCT00561470|Irinotecan|irinotecan|mesh-list
110652479|NCT00561470|Aflibercept|aflibercept|mesh-list
110652480|NCT00561470|Levoleucovorin|levoleucovorin|mesh-list
110398309|NCT00598637|Everolimus|everolimus|mesh-list
110652481|NCT00561470|Antimetabolites|antimetabolites|mesh-ancestor
110652482|NCT00561470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110652483|NCT00561470|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110652484|NCT00561470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110652485|NCT00561470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110652486|NCT00561470|Immunologic Factors|immunologic factors|mesh-ancestor
110652487|NCT00561470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110652488|NCT00561470|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110652489|NCT00561470|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110652490|NCT00561470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110652491|NCT00561470|Antidotes|antidotes|mesh-ancestor
110652492|NCT00561470|Protective Agents|protective agents|mesh-ancestor
110652493|NCT00561470|Vitamin B Complex|vitamin b complex|mesh-ancestor
110652494|NCT00561470|Vitamins|vitamins|mesh-ancestor
110652495|NCT00561470|Micronutrients|micronutrients|mesh-ancestor
110652496|NCT00561470|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110652497|NCT00561470|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110652498|NCT00561470|Growth Substances|growth substances|mesh-ancestor
110652499|NCT00561470|Growth Inhibitors|growth inhibitors|mesh-ancestor
110652500|NCT00443872|Selegiline|selegiline|mesh-list
110652501|NCT00443872|Antidepressive Agents|antidepressive agents|mesh-ancestor
110652502|NCT00443872|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110652503|NCT00443872|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110564914|NCT04095442|Benzocaine|benzocaine|mesh-list
110652504|NCT00443872|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110652505|NCT00443872|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
110652506|NCT00443872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110652507|NCT00443872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110652508|NCT00443872|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110652509|NCT00443872|Protective Agents|protective agents|mesh-ancestor
110652510|NCT00443872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110652511|NCT01323244|Simeprevir|simeprevir|mesh-list
110652512|NCT01323244|Antiviral Agents|antiviral agents|mesh-ancestor
110652513|NCT01323244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110652514|NCT01323244|Protease Inhibitors|protease inhibitors|mesh-ancestor
110652515|NCT01323244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110652516|NCT01323244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110652517|NCT03034642|Dimercaprol|dimercaprol|mesh-list
110652518|NCT03034642|Chelating Agents|chelating agents|mesh-ancestor
110652519|NCT03034642|Sequestering Agents|sequestering agents|mesh-ancestor
110652520|NCT03034642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110652521|NCT03840226|Magnesium Oxide|magnesium oxide|mesh-list
110652522|NCT03840226|Antacids|antacids|mesh-ancestor
110652523|NCT03840226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110652524|NCT03840226|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110652525|NCT03962738|Lasmiditan|lasmiditan|mesh-list
110652526|NCT03962738|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110652527|NCT03962738|Serotonin Agents|serotonin agents|mesh-ancestor
110652528|NCT03962738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110652529|NCT03962738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110652530|NCT03962738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110652531|NCT00561392|Rivastigmine|rivastigmine|mesh-list
110652532|NCT00561392|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110652533|NCT00561392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110652534|NCT00561392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110652535|NCT00561392|Cholinergic Agents|cholinergic agents|mesh-ancestor
110652536|NCT00561392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110652537|NCT00561392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110652538|NCT00561392|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110652539|NCT00561392|Protective Agents|protective agents|mesh-ancestor
110652541|NCT00694109|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110652542|NCT00694109|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110652543|NCT00694109|Antimetabolites|antimetabolites|mesh-ancestor
110652544|NCT00694109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110652545|NCT00694109|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110652546|NCT03070301|Everolimus|everolimus|mesh-list
110652547|NCT03070301|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110652548|NCT03070301|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110652549|NCT03070301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110652550|NCT03070301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110652551|NCT03070301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110652552|NCT03070301|Immunologic Factors|immunologic factors|mesh-ancestor
110652553|NCT03070301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110652554|NCT03070301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110652555|NCT00940862|Adalimumab|adalimumab|mesh-list
110652556|NCT00940862|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110652557|NCT00940862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110652558|NCT00940862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110652559|NCT03068741|Ceftriaxone|ceftriaxone|mesh-list
110652560|NCT03068741|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110652561|NCT03068741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110652562|NCT00561080|Vaccines|vaccines|mesh-list
110652563|NCT00561080|Immunologic Factors|immunologic factors|mesh-ancestor
110652564|NCT00561080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110652565|NCT01307306|Metformin|metformin|mesh-list
110652566|NCT01307306|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110652567|NCT01307306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110652568|NCT00941096|Timolol|timolol|mesh-list
110652569|NCT00941096|Bimatoprost|bimatoprost|mesh-list
110652570|NCT00941096|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110652571|NCT00941096|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110652572|NCT00941096|Adrenergic Agents|adrenergic agents|mesh-ancestor
110652573|NCT00941096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110652574|NCT00941096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110652575|NCT00941096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110652576|NCT00941096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110652577|NCT00941096|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110652578|NCT04012424|Curcumin|curcumin|mesh-list
110652579|NCT04012424|Analgesics|analgesics|mesh-list
110652580|NCT04012424|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110207264|NCT00185887|Terbutaline|terbutaline|mesh-list
110652581|NCT04012424|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110652582|NCT04012424|Sensory System Agents|sensory system agents|mesh-ancestor
110652583|NCT04012424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110652584|NCT04012424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110652585|NCT04012424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110652586|NCT04012424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110652587|NCT04012424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110652588|NCT04012424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110652589|NCT04012424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110652590|NCT00562094|Pantoprazole|pantoprazole|mesh-list
110652591|NCT00562094|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110652592|NCT00562094|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110652593|NCT00562094|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110652594|NCT00562094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110159784|NCT00094432|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110652595|NCT00562094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110652597|NCT03817853|Methylprednisolone|methylprednisolone|mesh-list
110652598|NCT03817853|Prednisolone|prednisolone|mesh-list
110652599|NCT03817853|Cyclophosphamide|cyclophosphamide|mesh-list
110652600|NCT03817853|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110652601|NCT03817853|Doxorubicin|doxorubicin|mesh-list
110652602|NCT03817853|Vincristine|vincristine|mesh-list
110652603|NCT03817853|Obinutuzumab|obinutuzumab|mesh-list
110652604|NCT03817853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110652605|NCT03817853|Immunologic Factors|immunologic factors|mesh-ancestor
110652606|NCT03817853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110652607|NCT03817853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110652608|NCT03817853|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110652609|NCT03817853|Alkylating Agents|alkylating agents|mesh-ancestor
110652610|NCT03817853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110652611|NCT03817853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110652612|NCT03817853|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110652613|NCT03817853|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110652614|NCT03817853|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110652615|NCT03817853|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110652616|NCT03817853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110652617|NCT03817853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110652618|NCT03817853|Glucocorticoids|glucocorticoids|mesh-ancestor
110652619|NCT03817853|Hormones|hormones|mesh-ancestor
110652620|NCT03817853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110652621|NCT03817853|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110652622|NCT03817853|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110652623|NCT03817853|Tubulin Modulators|tubulin modulators|mesh-ancestor
110652624|NCT03817853|Antimitotic Agents|antimitotic agents|mesh-ancestor
110652625|NCT03817853|Mitosis Modulators|mitosis modulators|mesh-ancestor
110652626|NCT03817853|Antiemetics|antiemetics|mesh-ancestor
110652627|NCT03817853|Autonomic Agents|autonomic agents|mesh-ancestor
110652628|NCT03817853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110652629|NCT03817853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110652630|NCT03817853|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110652631|NCT03817853|Protective Agents|protective agents|mesh-ancestor
110652632|NCT03817853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110652633|NCT00944840|Amodiaquine|amodiaquine|mesh-list
110652634|NCT00944840|Antimalarials|antimalarials|mesh-ancestor
110652635|NCT00944840|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110652636|NCT00944840|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110652637|NCT00944840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110652638|NCT00439270|Docetaxel|docetaxel|mesh-list
110652639|NCT00439270|Dasatinib|dasatinib|mesh-list
110652640|NCT00439270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110652641|NCT00439270|Tubulin Modulators|tubulin modulators|mesh-ancestor
110207271|NCT00185887|Sympathomimetics|sympathomimetics|mesh-ancestor
110652642|NCT00439270|Antimitotic Agents|antimitotic agents|mesh-ancestor
110652643|NCT00439270|Mitosis Modulators|mitosis modulators|mesh-ancestor
110652644|NCT00439270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110652645|NCT00439270|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110652646|NCT00439270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110652648|NCT00944918|Anastrozole|anastrozole|mesh-list
110652649|NCT00944918|Exemestane|exemestane|mesh-list
110652650|NCT00944918|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110652651|NCT00944918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110652652|NCT00944918|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110652653|NCT00944918|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110652654|NCT00944918|Hormone Antagonists|hormone antagonists|mesh-ancestor
110652655|NCT00944918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110652656|NCT00944918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110652657|NCT00944918|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110652658|NCT00944918|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110652659|NCT00944918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110652660|NCT00944918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110652661|NCT04012268|Aspirin|aspirin|mesh-list
110652662|NCT04012268|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110652663|NCT04012268|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110652664|NCT04012268|Analgesics|analgesics|mesh-ancestor
110299879|NCT01647646|Hormones|hormones|mesh-ancestor
110652665|NCT04012268|Sensory System Agents|sensory system agents|mesh-ancestor
110652666|NCT04012268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110652667|NCT04012268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110398333|NCT00598793|Insulin|insulin|mesh-list
110652668|NCT04012268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110652669|NCT04012268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110652670|NCT04012268|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110652671|NCT04012268|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110652672|NCT04012268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110652673|NCT04012268|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110652674|NCT04012268|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110652675|NCT04012268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110652676|NCT04012268|Antipyretics|antipyretics|mesh-ancestor
110652677|NCT03995134|Remifentanil|remifentanil|mesh-list
110652678|NCT03995134|Propofol|propofol|mesh-list
110652679|NCT03995134|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110652680|NCT03995134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110652681|NCT03995134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110652682|NCT03995134|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110652683|NCT03995134|Anesthetics, General|anesthetics, general|mesh-ancestor
110652684|NCT03995134|Anesthetics|anesthetics|mesh-ancestor
110652685|NCT03995134|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110652686|NCT03995134|Narcotics|narcotics|mesh-ancestor
110652687|NCT03995134|Analgesics|analgesics|mesh-ancestor
110652688|NCT03995134|Sensory System Agents|sensory system agents|mesh-ancestor
110652689|NCT03995134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110652690|NCT00553280|Pregabalin|pregabalin|mesh-list
110652691|NCT00553280|Analgesics|analgesics|mesh-ancestor
110652692|NCT00553280|Sensory System Agents|sensory system agents|mesh-ancestor
110652693|NCT00553280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110652694|NCT00553280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110652695|NCT00553280|Anticonvulsants|anticonvulsants|mesh-ancestor
110652696|NCT00553280|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110652697|NCT00553280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110652698|NCT00553280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110652699|NCT00553280|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110652700|NCT00553280|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110652701|NCT00553280|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110652702|NCT00553280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110652703|NCT00553280|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110652704|NCT01024192|Zolpidem|zolpidem|mesh-list
110652705|NCT01024192|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110652706|NCT01024192|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110652707|NCT01024192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110652708|NCT01024192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110652709|NCT01024192|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
110652710|NCT01024192|GABA Agonists|gaba agonists|mesh-ancestor
110652711|NCT01024192|GABA Agents|gaba agents|mesh-ancestor
110652712|NCT01024192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110652713|NCT01024192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110652714|NCT01024270|Misoprostol|misoprostol|mesh-list
110652715|NCT01024270|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110652716|NCT01024270|Abortifacient Agents|abortifacient agents|mesh-ancestor
110652717|NCT01024270|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110652718|NCT01024270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110652719|NCT01024270|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110652720|NCT01024270|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110652721|NCT01024270|Oxytocics|oxytocics|mesh-ancestor
110652722|NCT00944996|Citalopram|citalopram|mesh-list
110652723|NCT00944996|Fluoxetine|fluoxetine|mesh-list
110652724|NCT00944996|Paroxetine|paroxetine|mesh-list
110652725|NCT00944996|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
110652726|NCT00944996|Sertraline|sertraline|mesh-list
110652727|NCT00944996|Clomipramine|clomipramine|mesh-list
110652728|NCT00944996|Escitalopram|escitalopram|mesh-list
110652729|NCT00944996|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110398353|NCT01062763|Diuretics|diuretics|mesh-ancestor
110652730|NCT00944996|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110652731|NCT00944996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110652732|NCT00944996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110652733|NCT00944996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110652734|NCT00944996|Serotonin Agents|serotonin agents|mesh-ancestor
110652735|NCT00944996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110652736|NCT00944996|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110652737|NCT00944996|Antidepressive Agents|antidepressive agents|mesh-ancestor
110652738|NCT00944996|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110652739|NCT00944996|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110652740|NCT00944996|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110652741|NCT00944996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110652742|NCT00944996|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110652743|NCT00944996|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110652745|NCT00950066|Irbesartan|irbesartan|mesh-list
110652746|NCT00950066|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110652747|NCT00950066|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110652748|NCT00950066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110652749|NCT00950066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110652750|NCT00950066|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110652751|NCT00950066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110207294|NCT00058682|Anidulafungin|anidulafungin|mesh-list
110652752|NCT00950066|Vasodilator Agents|vasodilator agents|mesh-ancestor
110652753|NCT00950066|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110652754|NCT00950066|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110652755|NCT01031212|Acetic Acid|acetic acid|mesh-list
110652756|NCT01031212|Paclitaxel|paclitaxel|mesh-list
110652757|NCT01031212|Carboplatin|carboplatin|mesh-list
110652758|NCT01031212|Cetuximab|cetuximab|mesh-list
110652759|NCT01031212|Vadimezan|vadimezan|mesh-list
110652760|NCT01031212|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110652761|NCT01031212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110652762|NCT01031212|Tubulin Modulators|tubulin modulators|mesh-ancestor
110652763|NCT01031212|Antimitotic Agents|antimitotic agents|mesh-ancestor
110652764|NCT01031212|Mitosis Modulators|mitosis modulators|mesh-ancestor
110652765|NCT01031212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110652766|NCT01031212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110652767|NCT01031212|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110652768|NCT01031212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110652769|NCT01024348|Acetaminophen|acetaminophen|mesh-list
110652770|NCT01024348|Tramadol|tramadol|mesh-list
110652771|NCT01024348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110652772|NCT01024348|Analgesics|analgesics|mesh-ancestor
110652773|NCT01024348|Sensory System Agents|sensory system agents|mesh-ancestor
110652774|NCT01024348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110652775|NCT01024348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110652776|NCT01024348|Antipyretics|antipyretics|mesh-ancestor
110652777|NCT01024348|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110652778|NCT01024348|Narcotics|narcotics|mesh-ancestor
110652779|NCT01024348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110652780|NCT03994744|Metformin|metformin|mesh-list
110652781|NCT03994744|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
110652782|NCT03994744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110652783|NCT03994744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110652784|NCT03994744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110652785|NCT03994744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110652786|NCT03994744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110652787|NCT00950222|Imipenem|imipenem|mesh-list
110652788|NCT00950222|Amikacin|amikacin|mesh-list
110652789|NCT00950222|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110652790|NCT00950222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110652791|NCT05301530|Docetaxel|docetaxel|mesh-list
110652792|NCT05301530|Trastuzumab|trastuzumab|mesh-list
110652793|NCT05301530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110652794|NCT05301530|Tubulin Modulators|tubulin modulators|mesh-ancestor
110652795|NCT05301530|Antimitotic Agents|antimitotic agents|mesh-ancestor
110652796|NCT05301530|Mitosis Modulators|mitosis modulators|mesh-ancestor
110652797|NCT05301530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110652798|NCT05301530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110652799|NCT00941174|Leucovorin|leucovorin|mesh-list
110652800|NCT00941174|Calcium|calcium|mesh-list
110652801|NCT00941174|Levoleucovorin|levoleucovorin|mesh-list
110652802|NCT00941174|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110652803|NCT00941174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110652804|NCT00941174|Antidotes|antidotes|mesh-ancestor
110652805|NCT00941174|Protective Agents|protective agents|mesh-ancestor
110652806|NCT00941174|Vitamin B Complex|vitamin b complex|mesh-ancestor
110652807|NCT00941174|Vitamins|vitamins|mesh-ancestor
110652808|NCT00941174|Micronutrients|micronutrients|mesh-ancestor
110652809|NCT00440518|Lacosamide|lacosamide|mesh-list
110652810|NCT00440518|Anticonvulsants|anticonvulsants|mesh-ancestor
110652811|NCT00440518|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110652812|NCT00440518|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110652813|NCT00440518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110652814|NCT00440518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110652815|NCT00950534|Insulin Glargine|insulin glargine|mesh-list
110652816|NCT00950534|Hypoglycemic Agents|hypoglycemic agents|mesh-list
110652817|NCT00950534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110652818|NCT00941252|Imiquimod|imiquimod|mesh-list
110652819|NCT00941252|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110652821|NCT00941252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110652822|NCT00941252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110652823|NCT00941252|Interferon Inducers|interferon inducers|mesh-ancestor
110652824|NCT01031368|Cytarabine|cytarabine|mesh-list
110652825|NCT01031368|Clofarabine|clofarabine|mesh-list
110652826|NCT01031368|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110652827|NCT01031368|Antimetabolites|antimetabolites|mesh-ancestor
110652828|NCT01031368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110652829|NCT01031368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110652830|NCT01031368|Antiviral Agents|antiviral agents|mesh-ancestor
110652831|NCT01031368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110652832|NCT01031368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110652833|NCT01031368|Immunologic Factors|immunologic factors|mesh-ancestor
110652834|NCT01031368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110652835|NCT00945308|Eptifibatide|eptifibatide|mesh-list
110652836|NCT00945308|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110652837|NCT03172936|Spartalizumab|spartalizumab|mesh-list
110652838|NCT03172936|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110652839|NCT03172936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110652840|NCT03172936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110652841|NCT03172936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110652842|NCT01030042|Leucovorin|leucovorin|mesh-list
110652843|NCT01030042|Oxaliplatin|oxaliplatin|mesh-list
110652844|NCT01030042|Irinotecan|irinotecan|mesh-list
110652845|NCT01030042|Cetuximab|cetuximab|mesh-list
110652846|NCT01030042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110652847|NCT01030042|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110652848|NCT01030042|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110652849|NCT01030042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110652850|NCT01030042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110652851|NCT01030042|Antidotes|antidotes|mesh-ancestor
110652852|NCT01030042|Protective Agents|protective agents|mesh-ancestor
110652853|NCT01030042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110652854|NCT01030042|Vitamin B Complex|vitamin b complex|mesh-ancestor
110652855|NCT01030042|Vitamins|vitamins|mesh-ancestor
110652856|NCT01030042|Micronutrients|micronutrients|mesh-ancestor
110652857|NCT01030042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110652858|NCT01024504|Bevacizumab|bevacizumab|mesh-list
110652859|NCT01024504|Capecitabine|capecitabine|mesh-list
110652860|NCT01024504|Oxaliplatin|oxaliplatin|mesh-list
110652861|NCT01024504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110652862|NCT01024504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110652863|NCT01024504|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110652864|NCT01024504|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110652865|NCT01024504|Growth Substances|growth substances|mesh-ancestor
110652866|NCT01024504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110398374|NCT01048099|Trastuzumab|trastuzumab|mesh-list
110652867|NCT01024504|Growth Inhibitors|growth inhibitors|mesh-ancestor
110652868|NCT01024504|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110652869|NCT01024504|Antimetabolites|antimetabolites|mesh-ancestor
110652870|NCT01024504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110652871|NCT01030120|Etanercept|etanercept|mesh-list
110652872|NCT01030120|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110652873|NCT01030120|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110652874|NCT01030120|Analgesics|analgesics|mesh-ancestor
110652875|NCT01030120|Sensory System Agents|sensory system agents|mesh-ancestor
110652876|NCT01030120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110652877|NCT01030120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110652878|NCT01030120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110652879|NCT01030120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110652880|NCT01030120|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110652881|NCT01030120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110652882|NCT01030120|Immunologic Factors|immunologic factors|mesh-ancestor
110652883|NCT00951236|Cortisone|cortisone|mesh-list
110652884|NCT00951236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110652885|NCT00945542|Hemostatics|hemostatics|mesh-list
110652886|NCT00945542|Coagulants|coagulants|mesh-ancestor
110652887|NCT00438256|Capecitabine|capecitabine|mesh-list
110652888|NCT00438256|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110652889|NCT00438256|Antimetabolites|antimetabolites|mesh-ancestor
110300091|NCT00240656|Adrenergic Agents|adrenergic agents|mesh-ancestor
110652890|NCT00438256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110652891|NCT00438256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110652892|NCT01031524|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
110652893|NCT01031524|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110652894|NCT01031524|Immunologic Factors|immunologic factors|mesh-ancestor
110652895|NCT01031524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110652896|NCT00945620|Ropivacaine|ropivacaine|mesh-list
110652897|NCT00945620|Anesthetics, Local|anesthetics, local|mesh-ancestor
110652898|NCT00945620|Anesthetics|anesthetics|mesh-ancestor
110652899|NCT00945620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110652900|NCT00945620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110652901|NCT00945620|Sensory System Agents|sensory system agents|mesh-ancestor
110652902|NCT00945620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110652903|NCT01565746|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
110652904|NCT01565746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110652905|NCT01030510|Rocuronium|rocuronium|mesh-list
110652906|NCT01030510|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110652907|NCT01030510|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110652908|NCT01030510|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110652909|NCT01030510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110652910|NCT01030510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110652911|NCT04813822|Miconazole|miconazole|mesh-list
110652912|NCT04813822|Clotrimazole|clotrimazole|mesh-list
110652913|NCT04813822|Bromides|bromides|mesh-list
110652914|NCT04813822|Anticonvulsants|anticonvulsants|mesh-ancestor
110652915|NCT04813822|Antifungal Agents|antifungal agents|mesh-ancestor
110652916|NCT04813822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110652917|NCT04813822|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110652918|NCT04813822|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110652919|NCT04813822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110652920|NCT04813822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110652921|NCT04813822|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110652922|NCT04813822|Hormone Antagonists|hormone antagonists|mesh-ancestor
110652923|NCT04813822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110652924|NCT04813822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110652925|NCT04813822|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110652926|NCT04813822|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110652927|NCT04813822|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110652928|NCT02917564|Triamcinolone|triamcinolone|mesh-list
110652929|NCT02917564|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110652930|NCT02917564|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110652931|NCT02917564|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110652932|NCT02917564|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110652935|NCT02917564|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110652936|NCT02917564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110652937|NCT02917564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110652938|NCT02917564|Immunologic Factors|immunologic factors|mesh-ancestor
110652939|NCT02917564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110652940|NCT02917564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110652941|NCT00952016|Methotrexate|methotrexate|mesh-list
110652942|NCT00952016|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110652943|NCT00952016|Abortifacient Agents|abortifacient agents|mesh-ancestor
110652944|NCT00952016|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110652945|NCT00952016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110652946|NCT00952016|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110652947|NCT00952016|Antimetabolites|antimetabolites|mesh-ancestor
110652948|NCT00952016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110652949|NCT00952016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110652950|NCT00952016|Dermatologic Agents|dermatologic agents|mesh-ancestor
110652951|NCT00952016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110652952|NCT00952016|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110652953|NCT00952016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110652954|NCT00952016|Immunologic Factors|immunologic factors|mesh-ancestor
110652955|NCT00952016|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110652956|NCT00952016|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110652957|NCT00952094|Cinacalcet|cinacalcet|mesh-list
110652958|NCT00952094|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110652959|NCT00952094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110652960|NCT00952094|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
110652961|NCT00952094|Hormone Antagonists|hormone antagonists|mesh-ancestor
110652962|NCT00952094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110652963|NCT00942344|Losartan|losartan|mesh-list
110652964|NCT00942344|Amlodipine|amlodipine|mesh-list
110652965|NCT00942344|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110652966|NCT00942344|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110652967|NCT00942344|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110652968|NCT00942344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110652969|NCT00942344|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110652970|NCT00942344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110652971|NCT00942344|Vasodilator Agents|vasodilator agents|mesh-ancestor
110652972|NCT00942344|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110652973|NCT00942344|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110652974|NCT00942344|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110652976|NCT00946166|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110652977|NCT00946166|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110652978|NCT00946166|Antimetabolites|antimetabolites|mesh-ancestor
110652979|NCT00946166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110652980|NCT00946166|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110652981|NCT00946166|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110652982|NCT00946166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110652983|NCT00952562|Cholecalciferol|cholecalciferol|mesh-list
110652984|NCT00952562|Vitamin D|vitamin d|mesh-list
110652985|NCT00952562|Vitamins|vitamins|mesh-ancestor
110652986|NCT00952562|Micronutrients|micronutrients|mesh-ancestor
110652987|NCT00952562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110652988|NCT00952562|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110159837|NCT00094666|Analgesics|analgesics|mesh-ancestor
110652989|NCT00952562|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110652990|NCT00952640|Vitamin A|vitamin a|mesh-list
110652991|NCT00952640|Vitamins|vitamins|mesh-ancestor
110652992|NCT00952640|Micronutrients|micronutrients|mesh-ancestor
110652993|NCT00952640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110652994|NCT00952796|Moxifloxacin|moxifloxacin|mesh-list
110652995|NCT00952796|Ampicillin|ampicillin|mesh-list
110652996|NCT00952796|Sulbactam|sulbactam|mesh-list
110652997|NCT00952796|Sultamicillin|sultamicillin|mesh-list
110652998|NCT00952796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110652999|NCT00952796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110653000|NCT00952796|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110653001|NCT00952796|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110653002|NCT00952796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110653003|NCT00952796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110653004|NCT00952796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110653005|NCT00952796|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110653006|NCT00952952|Mesalamine|mesalamine|mesh-list
110653007|NCT00952952|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110653008|NCT00952952|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110653009|NCT00952952|Analgesics|analgesics|mesh-ancestor
110653010|NCT00952952|Sensory System Agents|sensory system agents|mesh-ancestor
110653011|NCT00952952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110653012|NCT00952952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110653013|NCT00952952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110653014|NCT00952952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110653015|NCT00953108|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110653016|NCT00953108|Escitalopram|escitalopram|mesh-list
110653017|NCT00953108|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110653018|NCT00953108|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110653019|NCT00953108|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110653020|NCT00953108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110653021|NCT00953108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110653022|NCT00953108|Serotonin Agents|serotonin agents|mesh-ancestor
110653023|NCT00953108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110653024|NCT00953108|Antidepressive Agents|antidepressive agents|mesh-ancestor
110653025|NCT00953108|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110653026|NCT00953108|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110653027|NCT00953108|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110653028|NCT00953108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110653029|NCT00953498|Pioglitazone|pioglitazone|mesh-list
110653030|NCT00953498|Rosiglitazone|rosiglitazone|mesh-list
110653031|NCT00953498|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110653032|NCT00953498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110653033|NCT00943358|Vaccines|vaccines|mesh-list
110653034|NCT00943358|Immunologic Factors|immunologic factors|mesh-ancestor
110653035|NCT00943358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110653036|NCT00120289|Niacin|niacin|mesh-list
110653037|NCT00120289|Simvastatin|simvastatin|mesh-list
110653038|NCT00120289|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110653039|NCT00120289|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110653040|NCT00120289|Antimetabolites|antimetabolites|mesh-ancestor
110653041|NCT00120289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110653042|NCT00120289|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110653043|NCT00120289|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110653044|NCT00120289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110653045|NCT00120289|Vasodilator Agents|vasodilator agents|mesh-ancestor
110653046|NCT00120289|Vitamin B Complex|vitamin b complex|mesh-ancestor
110653048|NCT00120289|Micronutrients|micronutrients|mesh-ancestor
110653049|NCT00120289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110653050|NCT00946556|Valacyclovir|valacyclovir|mesh-list
110653051|NCT00946556|Antiviral Agents|antiviral agents|mesh-ancestor
110653052|NCT00946556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110653053|NCT00943748|Deferiprone|deferiprone|mesh-list
110653054|NCT00943748|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110653055|NCT00943748|Chelating Agents|chelating agents|mesh-ancestor
110653056|NCT00943748|Sequestering Agents|sequestering agents|mesh-ancestor
110653057|NCT00943748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110653058|NCT00946790|Hydroxychloroquine|hydroxychloroquine|mesh-list
110653059|NCT00946790|Antimalarials|antimalarials|mesh-ancestor
110653060|NCT00946790|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110653061|NCT00946790|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110653063|NCT00946790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110653064|NCT00946790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110653065|NCT00946790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110653066|NCT00954200|Ibuprofen|ibuprofen|mesh-list
110653067|NCT00954200|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110653068|NCT00954200|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110653069|NCT00954200|Analgesics|analgesics|mesh-ancestor
110653070|NCT00954200|Sensory System Agents|sensory system agents|mesh-ancestor
110653071|NCT00954200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110653072|NCT00954200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110653073|NCT00954200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110653074|NCT00954200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110653075|NCT00954200|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110653076|NCT00954200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110653077|NCT00954200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110653078|NCT00954278|Sorafenib|sorafenib|mesh-list
110653079|NCT00954278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110653080|NCT00954278|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110653081|NCT00954278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110653082|NCT00954278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110653083|NCT00550446|Adalimumab|adalimumab|mesh-list
110653084|NCT00550446|Tofacitinib|tofacitinib|mesh-list
110653085|NCT00550446|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110653086|NCT00550446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110653087|NCT00550446|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110653088|NCT00550446|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
110653089|NCT00550446|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110653090|NCT00550446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110653091|NCT00550446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110653092|NCT00953472|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
110653093|NCT00953472|Natriuretic Agents|natriuretic agents|mesh-ancestor
110653094|NCT00953472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110653095|NCT00953550|Rocuronium|rocuronium|mesh-list
110653096|NCT00953550|Succinylcholine|succinylcholine|mesh-list
110653097|NCT00953550|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110653098|NCT00953550|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110653099|NCT00953550|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110653100|NCT00953550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110653101|NCT00953550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110653102|NCT00953550|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
110653103|NCT00953628|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
110653104|NCT00953628|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110653105|NCT00953628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110653106|NCT00949026|Sirolimus|sirolimus|mesh-list
110653107|NCT00949026|Temsirolimus|temsirolimus|mesh-list
110653108|NCT00949026|MTOR Inhibitors|mtor inhibitors|mesh-list
110653109|NCT00949026|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110653110|NCT00949026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110653111|NCT00949026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110653112|NCT00949026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110653113|NCT00949026|Immunologic Factors|immunologic factors|mesh-ancestor
110653114|NCT00949026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110653115|NCT00949026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110653116|NCT00949026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110653117|NCT00949026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110653118|NCT00949026|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110653119|NCT00949026|Antifungal Agents|antifungal agents|mesh-ancestor
110653120|NCT00436618|Everolimus|everolimus|mesh-list
110653121|NCT00436618|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110653122|NCT00436618|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110653123|NCT00436618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110653124|NCT00436618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110653125|NCT00436618|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110653126|NCT00436618|Immunologic Factors|immunologic factors|mesh-ancestor
110653127|NCT00436618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110653128|NCT00436618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110653129|NCT01024660|Donepezil|donepezil|mesh-list
110653130|NCT01024660|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110653131|NCT01024660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110653132|NCT01024660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110653133|NCT01024660|Cholinergic Agents|cholinergic agents|mesh-ancestor
110653134|NCT01024660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110653135|NCT01024660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110653136|NCT01024660|Nootropic Agents|nootropic agents|mesh-ancestor
110653137|NCT01751126|Cyclosporine|cyclosporine|mesh-list
110653138|NCT01751126|Cyclosporins|cyclosporins|mesh-list
110653139|NCT01751126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110653140|NCT01751126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110653141|NCT01751126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110653142|NCT01751126|Immunologic Factors|immunologic factors|mesh-ancestor
110653143|NCT01751126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110653144|NCT01751126|Antifungal Agents|antifungal agents|mesh-ancestor
110653145|NCT01751126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110653146|NCT01751126|Dermatologic Agents|dermatologic agents|mesh-ancestor
110653147|NCT01751126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110653148|NCT01751126|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110653149|NCT00943982|Interferons|interferons|mesh-list
110653150|NCT00943982|Interferon-gamma|interferon-gamma|mesh-list
110653151|NCT00943982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110653152|NCT00943982|Antiviral Agents|antiviral agents|mesh-ancestor
110653153|NCT00943982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110653154|NCT00548808|Insulin|insulin|mesh-list
110653155|NCT00548808|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110653156|NCT00548808|Insulin Glargine|insulin glargine|mesh-list
110653157|NCT00548808|Insulin Lispro|insulin lispro|mesh-list
110653158|NCT00548808|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110653159|NCT00548808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110653160|NCT04011878|Mitomycins|mitomycins|mesh-list
110653161|NCT04011878|Mitomycin|mitomycin|mesh-list
110653162|NCT04011878|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110653163|NCT04011878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110653164|NCT04011878|Alkylating Agents|alkylating agents|mesh-ancestor
110653165|NCT04011878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110653166|NCT04011878|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110653167|NCT04011878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110653168|NCT00954096|Nicotine|nicotine|mesh-list
110653169|NCT00954096|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110653170|NCT00954096|Autonomic Agents|autonomic agents|mesh-ancestor
110653171|NCT00954096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110653172|NCT00954096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110653173|NCT00954096|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110653174|NCT00954096|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110653175|NCT00954096|Cholinergic Agents|cholinergic agents|mesh-ancestor
110653176|NCT00954096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110653177|NCT00954096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110653178|NCT00954252|1-(3',4'-dichloro-2-fluoro(1,1'-biphenyl)-4-yl)cyclopropanecarboxylic acid|1-(3',4'-dichloro-2-fluoro(1,1'-biphenyl)-4-yl)cyclopropanecarboxylic acid|mesh-list
110653179|NCT00954252|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
110653180|NCT00954252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110653181|NCT00954252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110653182|NCT00110617|Deferasirox|deferasirox|mesh-list
110653183|NCT00110617|Deferoxamine|deferoxamine|mesh-list
110653184|NCT00110617|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110653185|NCT00110617|Chelating Agents|chelating agents|mesh-ancestor
110653186|NCT00110617|Sequestering Agents|sequestering agents|mesh-ancestor
110653187|NCT00110617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110300394|NCT02218762|Autonomic Agents|autonomic agents|mesh-ancestor
110653188|NCT00110617|Siderophores|siderophores|mesh-ancestor
110653189|NCT00949494|Hylan|hylan|mesh-list
110653190|NCT00949494|Hyaluronic Acid|hyaluronic acid|mesh-list
110653191|NCT00949494|Viscosupplements|viscosupplements|mesh-ancestor
110653192|NCT00949494|Protective Agents|protective agents|mesh-ancestor
110653193|NCT00949494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110653194|NCT00949494|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110653195|NCT00949494|Immunologic Factors|immunologic factors|mesh-ancestor
110653196|NCT00954486|Epoetin Alfa|epoetin alfa|mesh-list
110653197|NCT00954486|Hematinics|hematinics|mesh-ancestor
110653198|NCT00550238|Pimavanserin|pimavanserin|mesh-list
110653199|NCT00550238|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110653200|NCT00550238|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110653201|NCT00550238|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110653202|NCT00550238|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110653203|NCT00550238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110653204|NCT00550238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110653205|NCT00550238|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110653206|NCT00550238|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110653208|NCT00550238|Serotonin Agents|serotonin agents|mesh-ancestor
110653209|NCT00550238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110653210|NCT00550238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110653211|NCT02903680|Dexamethasone|dexamethasone|mesh-list
110653212|NCT02903680|Dexamethasone acetate|dexamethasone acetate|mesh-list
110653213|NCT02903680|BB 1101|bb 1101|mesh-list
110653214|NCT02903680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110653215|NCT02903680|Antiemetics|antiemetics|mesh-ancestor
110653216|NCT02903680|Autonomic Agents|autonomic agents|mesh-ancestor
110653217|NCT02903680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110653218|NCT02903680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110653219|NCT02903680|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110653220|NCT02903680|Glucocorticoids|glucocorticoids|mesh-ancestor
110653221|NCT02903680|Hormones|hormones|mesh-ancestor
110653222|NCT02903680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110653223|NCT02903680|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110653224|NCT02903680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110653225|NCT02903680|Protease Inhibitors|protease inhibitors|mesh-ancestor
110653226|NCT02903680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110653227|NCT02903680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110653228|NCT00946946|Mesalamine|mesalamine|mesh-list
110653229|NCT00946946|Azathioprine|azathioprine|mesh-list
110653230|NCT00946946|Antimetabolites|antimetabolites|mesh-ancestor
110653231|NCT00946946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110653232|NCT00946946|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110653233|NCT00946946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110653234|NCT00946946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110653235|NCT00946946|Immunologic Factors|immunologic factors|mesh-ancestor
110653236|NCT00946946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110653237|NCT00946946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110653238|NCT00946946|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110653239|NCT00946946|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110653240|NCT00946946|Analgesics|analgesics|mesh-ancestor
110653241|NCT00946946|Sensory System Agents|sensory system agents|mesh-ancestor
110653242|NCT00946946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110653243|NCT00946946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110653244|NCT00947024|Glipizide|glipizide|mesh-list
110653245|NCT00947024|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110653246|NCT00947024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110653247|NCT00949572|Vaccines|vaccines|mesh-list
110653248|NCT00949572|Aluminum sulfate|aluminum sulfate|mesh-list
110653249|NCT00949572|Immunologic Factors|immunologic factors|mesh-ancestor
110653250|NCT00949572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110653251|NCT00949572|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110653252|NCT01031992|Tranexamic Acid|tranexamic acid|mesh-list
110653253|NCT01031992|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110653254|NCT01031992|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110653255|NCT01031992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110653256|NCT01031992|Hemostatics|hemostatics|mesh-ancestor
110653257|NCT01031992|Coagulants|coagulants|mesh-ancestor
110653258|NCT00954564|Aromatase Inhibitors|aromatase inhibitors|mesh-list
110653259|NCT00954564|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110653260|NCT00954564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110653261|NCT00954564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110653263|NCT00954564|Hormone Antagonists|hormone antagonists|mesh-ancestor
110300466|NCT04529512|Glucocorticoids|glucocorticoids|mesh-ancestor
110653264|NCT00954564|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110653265|NCT00954564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110653266|NCT00949728|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
110653267|NCT00949728|Hemostatics|hemostatics|mesh-ancestor
110653268|NCT00949728|Coagulants|coagulants|mesh-ancestor
110653269|NCT00954902|Antioxidants|antioxidants|mesh-list
110653270|NCT00954902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110653271|NCT00954902|Protective Agents|protective agents|mesh-ancestor
110653272|NCT00954902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110653273|NCT01034020|Nicotine|nicotine|mesh-list
110653274|NCT01034020|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110653275|NCT01034020|Autonomic Agents|autonomic agents|mesh-ancestor
110653276|NCT01034020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110653277|NCT01034020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110653278|NCT01034020|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110653279|NCT01034020|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110653280|NCT01034020|Cholinergic Agents|cholinergic agents|mesh-ancestor
110653281|NCT01034020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110653282|NCT01034020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110653283|NCT01032148|Panobinostat|panobinostat|mesh-list
110653284|NCT01032148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110653285|NCT01032148|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110653286|NCT01032148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110653287|NCT01032148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110653288|NCT01032304|Erdosteine|erdosteine|mesh-list
110653289|NCT01032304|Expectorants|expectorants|mesh-ancestor
110653290|NCT01032304|Respiratory System Agents|respiratory system agents|mesh-ancestor
110653291|NCT00954642|Paclitaxel|paclitaxel|mesh-list
110653292|NCT00954642|Bevacizumab|bevacizumab|mesh-list
110653293|NCT00954642|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110653294|NCT00954642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110653295|NCT00954642|Tubulin Modulators|tubulin modulators|mesh-ancestor
110653296|NCT00954642|Antimitotic Agents|antimitotic agents|mesh-ancestor
110653297|NCT00954642|Mitosis Modulators|mitosis modulators|mesh-ancestor
110653298|NCT00954642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110653299|NCT00954642|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110653300|NCT00954642|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110653301|NCT00954642|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110653302|NCT00954642|Growth Substances|growth substances|mesh-ancestor
110653303|NCT00954642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110653304|NCT00954642|Growth Inhibitors|growth inhibitors|mesh-ancestor
110653305|NCT00954798|Vaccines|vaccines|mesh-list
110653306|NCT00954798|Immunologic Factors|immunologic factors|mesh-ancestor
110653307|NCT00954798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110653308|NCT00110305|Efavirenz|efavirenz|mesh-list
110653309|NCT00110305|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
110653310|NCT00110305|Rilpivirine|rilpivirine|mesh-list
110653311|NCT00110305|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110653312|NCT00110305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110653313|NCT00110305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110653314|NCT00110305|Antiviral Agents|antiviral agents|mesh-ancestor
110653315|NCT00110305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110653316|NCT00110305|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110653317|NCT00110305|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110653318|NCT00110305|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110653319|NCT00110305|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110653320|NCT00110305|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110653321|NCT00110305|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110653322|NCT00110305|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110653323|NCT00110305|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110653324|NCT00560066|Vaccines|vaccines|mesh-list
110653325|NCT00560066|Immunologic Factors|immunologic factors|mesh-ancestor
110653326|NCT00560066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110653327|NCT00549900|Vaccines|vaccines|mesh-list
110653328|NCT00549900|Immunologic Factors|immunologic factors|mesh-ancestor
110653329|NCT00549900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110653330|NCT00435994|Epinephrine|epinephrine|mesh-list
110653331|NCT00435994|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110653332|NCT00435994|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110653333|NCT00435994|Adrenergic Agents|adrenergic agents|mesh-ancestor
110653334|NCT00435994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110653335|NCT00435994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110653336|NCT00435994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110300546|NCT02219659|Fentanyl|fentanyl|mesh-list
110653337|NCT00435994|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110653338|NCT00435994|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110653339|NCT00435994|Autonomic Agents|autonomic agents|mesh-ancestor
110653340|NCT00435994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110653341|NCT00435994|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110653342|NCT00435994|Respiratory System Agents|respiratory system agents|mesh-ancestor
110653343|NCT00435994|Mydriatics|mydriatics|mesh-ancestor
110653344|NCT00435994|Sympathomimetics|sympathomimetics|mesh-ancestor
110653345|NCT00435994|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110653346|NCT01563120|Metformin|metformin|mesh-list
110653347|NCT01563120|Glyburide|glyburide|mesh-list
110653348|NCT01563120|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110653349|NCT01563120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110653350|NCT00435370|Tropisetron|tropisetron|mesh-list
110653351|NCT00435370|Risperidone|risperidone|mesh-list
110653352|NCT00435370|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110653353|NCT00435370|Serotonin Agents|serotonin agents|mesh-ancestor
110653354|NCT00435370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110653355|NCT00435370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110398479|NCT00601289|Temozolomide|temozolomide|mesh-list
110653356|NCT00435370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110653357|NCT00435370|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110653358|NCT00435370|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110653359|NCT00435370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110653360|NCT00435370|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110653361|NCT00435370|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110653363|NCT00435370|Antiemetics|antiemetics|mesh-ancestor
110653364|NCT00435370|Autonomic Agents|autonomic agents|mesh-ancestor
110653365|NCT00435370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110653366|NCT00435370|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110653367|NCT00435370|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110653368|NCT00096031|Cetuximab|cetuximab|mesh-list
110653369|NCT00096031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110653370|NCT00096031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110653371|NCT00118417|Clonazepam|clonazepam|mesh-list
110653372|NCT00118417|Sertraline|sertraline|mesh-list
110653373|NCT00118417|Antidepressive Agents|antidepressive agents|mesh-ancestor
110653374|NCT00118417|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110653375|NCT00118417|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110653376|NCT00118417|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110653377|NCT00118417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110653378|NCT00118417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110653379|NCT00118417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110653380|NCT00118417|Serotonin Agents|serotonin agents|mesh-ancestor
110653381|NCT00118417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110653382|NCT00118417|Anticonvulsants|anticonvulsants|mesh-ancestor
110653383|NCT00118417|GABA Modulators|gaba modulators|mesh-ancestor
110653384|NCT00118417|GABA Agents|gaba agents|mesh-ancestor
110653385|NCT04293744|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110653386|NCT01079455|Corticosterone|corticosterone|mesh-list
110653387|NCT01079455|Bupivacaine|bupivacaine|mesh-list
110653388|NCT01079455|Hyaluronic Acid|hyaluronic acid|mesh-list
110653389|NCT01079455|Anesthetics, Local|anesthetics, local|mesh-ancestor
110653390|NCT01079455|Anesthetics|anesthetics|mesh-ancestor
110653391|NCT01079455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110653392|NCT01079455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110653393|NCT01079455|Sensory System Agents|sensory system agents|mesh-ancestor
110653394|NCT01079455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110653395|NCT01079455|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110653396|NCT01079455|Immunologic Factors|immunologic factors|mesh-ancestor
110653397|NCT01079455|Viscosupplements|viscosupplements|mesh-ancestor
110653398|NCT01079455|Protective Agents|protective agents|mesh-ancestor
110653399|NCT01079455|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110653400|NCT00549848|Cytarabine|cytarabine|mesh-list
110653401|NCT00549848|Dexamethasone|dexamethasone|mesh-list
110653402|NCT00549848|Dexamethasone acetate|dexamethasone acetate|mesh-list
110653403|NCT00549848|Prednisone|prednisone|mesh-list
110653404|NCT00549848|Prednisolone|prednisolone|mesh-list
110653405|NCT00549848|Cyclophosphamide|cyclophosphamide|mesh-list
110653406|NCT00549848|Doxorubicin|doxorubicin|mesh-list
110653407|NCT00549848|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110653408|NCT00549848|Methotrexate|methotrexate|mesh-list
110653409|NCT00549848|Etoposide|etoposide|mesh-list
110653410|NCT00549848|Etoposide phosphate|etoposide phosphate|mesh-list
110653411|NCT00549848|Vincristine|vincristine|mesh-list
110653412|NCT00549848|Daunorubicin|daunorubicin|mesh-list
110653413|NCT00549848|Asparaginase|asparaginase|mesh-list
110653414|NCT00549848|Dasatinib|dasatinib|mesh-list
110653415|NCT00549848|Mercaptopurine|mercaptopurine|mesh-list
110653416|NCT00549848|Clofarabine|clofarabine|mesh-list
110653417|NCT00549848|Pegaspargase|pegaspargase|mesh-list
110653419|NCT00549848|BB 1101|bb 1101|mesh-list
110653420|NCT00549848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110653421|NCT00549848|Immunologic Factors|immunologic factors|mesh-ancestor
110653422|NCT00549848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110653423|NCT00549848|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110653424|NCT00549848|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110653425|NCT00549848|Alkylating Agents|alkylating agents|mesh-ancestor
110653426|NCT00549848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110653427|NCT00549848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110653428|NCT00549848|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110653429|NCT00549848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110653431|NCT00549848|Autonomic Agents|autonomic agents|mesh-ancestor
110653432|NCT00549848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110653433|NCT00549848|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110653434|NCT00549848|Glucocorticoids|glucocorticoids|mesh-ancestor
110653435|NCT00549848|Hormones|hormones|mesh-ancestor
110653436|NCT00549848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110653437|NCT00549848|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110653438|NCT00549848|Protease Inhibitors|protease inhibitors|mesh-ancestor
110653439|NCT00549848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110653440|NCT00549848|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110207445|NCT00187408|Tinzaparin|tinzaparin|mesh-list
110653441|NCT00549848|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110653442|NCT00549848|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110653443|NCT00549848|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110653444|NCT00549848|Abortifacient Agents|abortifacient agents|mesh-ancestor
110653445|NCT00549848|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110653446|NCT00549848|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110653448|NCT00549848|Dermatologic Agents|dermatologic agents|mesh-ancestor
110653449|NCT00549848|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110653450|NCT00549848|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110653451|NCT00549848|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110653452|NCT00549848|Antiviral Agents|antiviral agents|mesh-ancestor
110653453|NCT00549848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110653454|NCT00549848|Tubulin Modulators|tubulin modulators|mesh-ancestor
110653455|NCT00549848|Antimitotic Agents|antimitotic agents|mesh-ancestor
110653456|NCT00549848|Mitosis Modulators|mitosis modulators|mesh-ancestor
110653457|NCT00549848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110653458|NCT01083589|Docetaxel|docetaxel|mesh-list
110653459|NCT01083589|Imatinib Mesylate|imatinib mesylate|mesh-list
110653460|NCT01083589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110653461|NCT01083589|Tubulin Modulators|tubulin modulators|mesh-ancestor
110653462|NCT01083589|Antimitotic Agents|antimitotic agents|mesh-ancestor
110653463|NCT01083589|Mitosis Modulators|mitosis modulators|mesh-ancestor
110653464|NCT01083589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110653465|NCT01083589|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110653466|NCT01083589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110653467|NCT00949182|Doxorubicin|doxorubicin|mesh-list
110653468|NCT00949182|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110653469|NCT00949182|Mitomycins|mitomycins|mesh-list
110653470|NCT00949182|Mitomycin|mitomycin|mesh-list
110653471|NCT00949182|Sorafenib|sorafenib|mesh-list
110653472|NCT00949182|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110653473|NCT00949182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110653474|NCT00949182|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110653475|NCT00949182|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110653476|NCT00949182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110653477|NCT00949182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110653478|NCT00949182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110398514|NCT05643651|Vitamin K|vitamin k|mesh-list
110653479|NCT00949182|Alkylating Agents|alkylating agents|mesh-ancestor
110653480|NCT00949182|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110653481|NCT00549770|Valsartan|valsartan|mesh-list
110653482|NCT00549770|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
110653483|NCT00549770|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110653484|NCT00549770|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110653485|NCT00549770|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110653486|NCT00549770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110653487|NCT00548184|Trastuzumab|trastuzumab|mesh-list
110653488|NCT00548184|Lapatinib|lapatinib|mesh-list
110653489|NCT00548184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110653490|NCT00548184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110653491|NCT00548184|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110653492|NCT00548184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110653493|NCT00548184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110653494|NCT00454636|Cisplatin|cisplatin|mesh-list
110653495|NCT00454636|Docetaxel|docetaxel|mesh-list
110653496|NCT00454636|Capecitabine|capecitabine|mesh-list
110653497|NCT00454636|Oxaliplatin|oxaliplatin|mesh-list
110653498|NCT00454636|Epirubicin|epirubicin|mesh-list
110653499|NCT00454636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110653500|NCT00454636|Tubulin Modulators|tubulin modulators|mesh-ancestor
110653501|NCT00454636|Antimitotic Agents|antimitotic agents|mesh-ancestor
110653502|NCT00454636|Mitosis Modulators|mitosis modulators|mesh-ancestor
110653503|NCT00454636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110653504|NCT00454636|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110653505|NCT00454636|Antimetabolites|antimetabolites|mesh-ancestor
110653506|NCT00454636|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110653507|NCT00454636|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110653508|NCT00454636|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110653509|NCT00454636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110653510|NCT00427960|Atorvastatin|atorvastatin|mesh-list
110653511|NCT00427960|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110653512|NCT00427960|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110653513|NCT00427960|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110653514|NCT00427960|Antimetabolites|antimetabolites|mesh-ancestor
110653515|NCT00427960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110653516|NCT00427960|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110653517|NCT00427960|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110653518|NCT00427960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110653519|NCT04768686|Pembrolizumab|pembrolizumab|mesh-list
110653520|NCT04768686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110653521|NCT04768686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110653522|NCT04768686|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110653523|NCT04768686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110653524|NCT00955890|Dexrazoxane|dexrazoxane|mesh-list
110653525|NCT00955890|Razoxane|razoxane|mesh-list
110653526|NCT00955890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110653527|NCT00955890|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110653528|NCT00955890|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110653529|NCT00955890|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110653530|NCT00955890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110653531|NCT00955890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110653532|NCT00955890|Protective Agents|protective agents|mesh-ancestor
110653533|NCT00955890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110653534|NCT00955890|Antimitotic Agents|antimitotic agents|mesh-ancestor
110653535|NCT00955890|Mitosis Modulators|mitosis modulators|mesh-ancestor
110653536|NCT00956046|Vaccines|vaccines|mesh-list
110653537|NCT00956046|Immunologic Factors|immunologic factors|mesh-ancestor
110653538|NCT00956046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110653539|NCT00454246|Epoetin Alfa|epoetin alfa|mesh-list
110653540|NCT00454246|Darbepoetin alfa|darbepoetin alfa|mesh-list
110653541|NCT00454246|Hematinics|hematinics|mesh-ancestor
110653542|NCT00434590|Mycophenolic Acid|mycophenolic acid|mesh-list
110653543|NCT00434590|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110653544|NCT00434590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110653545|NCT00434590|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110653546|NCT00434590|Antitubercular Agents|antitubercular agents|mesh-ancestor
110653547|NCT00434590|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110398523|NCT05643651|Analgesics|analgesics|mesh-ancestor
110653548|NCT00434590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110653549|NCT00434590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110653550|NCT00434590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110653551|NCT00956202|Vaccines|vaccines|mesh-list
110653552|NCT00956202|Immunologic Factors|immunologic factors|mesh-ancestor
110653553|NCT00956202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110653554|NCT00695903|Vancomycin|vancomycin|mesh-list
110653555|NCT00695903|Daptomycin|daptomycin|mesh-list
110653556|NCT00695903|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110653557|NCT00695903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110653558|NCT02759861|Sofosbuvir|sofosbuvir|mesh-list
110653559|NCT02759861|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
110653560|NCT02759861|Ledipasvir|ledipasvir|mesh-list
110653561|NCT02759861|Antiviral Agents|antiviral agents|mesh-ancestor
110653562|NCT02759861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110653563|NCT00548262|Voriconazole|voriconazole|mesh-list
110653564|NCT00548262|Anidulafungin|anidulafungin|mesh-list
110653565|NCT00548262|Antifungal Agents|antifungal agents|mesh-ancestor
110653566|NCT00548262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110653567|NCT00548262|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110653568|NCT00548262|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110653569|NCT00548262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110653570|NCT00548262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110653571|NCT00548262|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110653572|NCT00548262|Hormone Antagonists|hormone antagonists|mesh-ancestor
110653573|NCT00548262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110653574|NCT00548262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110653575|NCT00548262|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110653576|NCT02565173|Timolol|timolol|mesh-list
110653577|NCT02565173|Adenosine|adenosine|mesh-list
110653578|NCT02565173|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110653579|NCT02565173|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110653580|NCT02565173|Adrenergic Agents|adrenergic agents|mesh-ancestor
110653581|NCT02565173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110653582|NCT02565173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110653583|NCT02565173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110653584|NCT02565173|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110653585|NCT02565173|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110653586|NCT02565173|Analgesics|analgesics|mesh-ancestor
110653587|NCT02565173|Sensory System Agents|sensory system agents|mesh-ancestor
110653588|NCT02565173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110653589|NCT02565173|Vasodilator Agents|vasodilator agents|mesh-ancestor
110653590|NCT02565173|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
110653591|NCT02565173|Purinergic Agonists|purinergic agonists|mesh-ancestor
110653592|NCT02565173|Purinergic Agents|purinergic agents|mesh-ancestor
110653593|NCT04619082|Tenofovir|tenofovir|mesh-list
110653594|NCT04619082|Antiviral Agents|antiviral agents|mesh-ancestor
110653595|NCT04619082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110653596|NCT04619082|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110653597|NCT04619082|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110653598|NCT04619082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110398527|NCT05643651|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110653599|NCT04619082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110653600|NCT04619082|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110653601|NCT04619082|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110653602|NCT03717623|Posaconazole|posaconazole|mesh-list
110653603|NCT03717623|Antifungal Agents|antifungal agents|mesh-ancestor
110653604|NCT03717623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110653605|NCT03717623|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
110653606|NCT03717623|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110653607|NCT03717623|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110653608|NCT03717623|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110653609|NCT03717623|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110653610|NCT03717623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110653611|NCT03717623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110653612|NCT03717623|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110653613|NCT03717623|Hormone Antagonists|hormone antagonists|mesh-ancestor
110655648|NCT01037530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110653614|NCT03717623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110653615|NCT03717623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110653617|NCT00095173|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110653618|NCT00095173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110653619|NCT00095173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110653620|NCT00095173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110653621|NCT00095173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110653622|NCT00095173|Immunologic Factors|immunologic factors|mesh-ancestor
110653623|NCT00095173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110653624|NCT00095173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110653625|NCT03704753|Ropivacaine|ropivacaine|mesh-list
110653626|NCT03704753|Anesthetics, Local|anesthetics, local|mesh-ancestor
110653627|NCT03704753|Anesthetics|anesthetics|mesh-ancestor
110653628|NCT03704753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110653629|NCT03704753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110653630|NCT03704753|Sensory System Agents|sensory system agents|mesh-ancestor
110653631|NCT03704753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110653632|NCT00690443|Atorvastatin|atorvastatin|mesh-list
110653633|NCT00690443|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110653634|NCT00690443|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110653635|NCT00690443|Antimetabolites|antimetabolites|mesh-ancestor
110653636|NCT00690443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110653637|NCT00690443|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110653638|NCT00690443|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110653639|NCT00690443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110300840|NCT00282945|Metformin|metformin|mesh-list
110653641|NCT03954834|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110653642|NCT03954834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110653643|NCT03954834|Incretins|incretins|mesh-ancestor
110653644|NCT03954834|Hormones|hormones|mesh-ancestor
110653645|NCT03954834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110653646|NCT00693017|Zonisamide|zonisamide|mesh-list
110653647|NCT00693017|Anticonvulsants|anticonvulsants|mesh-ancestor
110159917|NCT00095251|Anticonvulsants|anticonvulsants|mesh-ancestor
110653648|NCT00693017|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110653649|NCT00693017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110653650|NCT00693017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110653651|NCT00693017|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110398563|NCT04303741|Apatinib|apatinib|mesh-list
110653652|NCT00693017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110653653|NCT05299554|Hydrocortisone|hydrocortisone|mesh-list
110653654|NCT05299554|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110653655|NCT00692237|Sildenafil Citrate|sildenafil citrate|mesh-list
110653656|NCT00692237|Vasodilator Agents|vasodilator agents|mesh-ancestor
110653657|NCT00692237|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110653658|NCT00692237|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110653659|NCT00692237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110653660|NCT00692237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110653661|NCT00692237|Urological Agents|urological agents|mesh-ancestor
110653663|NCT00110149|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110653664|NCT00110149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110653665|NCT00110149|Immunologic Factors|immunologic factors|mesh-ancestor
110653666|NCT00110149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110653667|NCT00110149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110653668|NCT01084057|Vorinostat|vorinostat|mesh-list
110653669|NCT01084057|Epothilone B|epothilone b|mesh-list
110653670|NCT01084057|Epothilones|epothilones|mesh-list
110653671|NCT01084057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110653672|NCT01084057|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110653673|NCT01084057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110653674|NCT01084057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110653675|NCT01084057|Tubulin Modulators|tubulin modulators|mesh-ancestor
110653676|NCT01084057|Antimitotic Agents|antimitotic agents|mesh-ancestor
110653677|NCT01084057|Mitosis Modulators|mitosis modulators|mesh-ancestor
110653678|NCT03954444|Phenylephrine|phenylephrine|mesh-list
110653679|NCT03954444|Oxymetazoline|oxymetazoline|mesh-list
110653680|NCT03954444|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110653681|NCT03954444|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110653682|NCT03954444|Adrenergic Agents|adrenergic agents|mesh-ancestor
110653683|NCT03954444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110653684|NCT03954444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110653685|NCT03954444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110653686|NCT03954444|Sympathomimetics|sympathomimetics|mesh-ancestor
110653687|NCT03954444|Autonomic Agents|autonomic agents|mesh-ancestor
110653688|NCT03954444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110653689|NCT03954444|Nasal Decongestants|nasal decongestants|mesh-ancestor
110653690|NCT03954444|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110653691|NCT03954444|Respiratory System Agents|respiratory system agents|mesh-ancestor
110653692|NCT03954444|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110653693|NCT03954444|Mydriatics|mydriatics|mesh-ancestor
110653694|NCT03954444|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110653695|NCT03954444|Protective Agents|protective agents|mesh-ancestor
110653696|NCT03953820|Diazepam|diazepam|mesh-list
110653697|NCT03953820|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110653698|NCT03953820|Anticonvulsants|anticonvulsants|mesh-ancestor
110653699|NCT03953820|Antiemetics|antiemetics|mesh-ancestor
110653700|NCT03953820|Autonomic Agents|autonomic agents|mesh-ancestor
110653701|NCT03953820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110653702|NCT03953820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110653703|NCT03953820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110653704|NCT03953820|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110653705|NCT03953820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110653706|NCT03953820|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110653707|NCT03953820|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110653708|NCT03953820|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110653709|NCT03953820|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110653710|NCT03953820|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110653711|NCT03953820|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110653712|NCT03953820|Anesthetics, General|anesthetics, general|mesh-ancestor
110653713|NCT03953820|Anesthetics|anesthetics|mesh-ancestor
110653714|NCT03953820|GABA Modulators|gaba modulators|mesh-ancestor
110653715|NCT03953820|GABA Agents|gaba agents|mesh-ancestor
110207553|NCT00187993|Hormones|hormones|mesh-list
110653716|NCT03953820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110653717|NCT03953820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110653718|NCT02611037|Gemcitabine|gemcitabine|mesh-list
110653719|NCT02611037|Methotrexate|methotrexate|mesh-list
110653720|NCT02611037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110653721|NCT02611037|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110653722|NCT02611037|Antimetabolites|antimetabolites|mesh-ancestor
110653723|NCT02611037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110653724|NCT02611037|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110653725|NCT02611037|Abortifacient Agents|abortifacient agents|mesh-ancestor
110653726|NCT02611037|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110653727|NCT02611037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110653728|NCT02611037|Dermatologic Agents|dermatologic agents|mesh-ancestor
110653729|NCT02611037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110653730|NCT02611037|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110653731|NCT02611037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110653732|NCT02611037|Immunologic Factors|immunologic factors|mesh-ancestor
110653733|NCT02611037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110653734|NCT02611037|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110653735|NCT03678636|Anti-Infective Agents|anti-infective agents|mesh-list
110653736|NCT03678636|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110653738|NCT04492956|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110653739|NCT04492956|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110653740|NCT04492956|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110653741|NCT04492956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110653742|NCT04492956|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110653743|NCT04492956|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110653744|NCT04492956|Dopamine Agents|dopamine agents|mesh-ancestor
110653745|NCT04492956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110653746|NCT04492956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110653747|NCT01084213|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
110653748|NCT01084213|Antimalarials|antimalarials|mesh-ancestor
110653749|NCT01084213|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110653750|NCT01084213|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110653751|NCT01084213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110653752|NCT00742937|Vitamin A|vitamin a|mesh-list
110653753|NCT00742937|Vitamins|vitamins|mesh-ancestor
110653754|NCT00742937|Micronutrients|micronutrients|mesh-ancestor
110653755|NCT00742937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110653756|NCT00692003|Zonisamide|zonisamide|mesh-list
110653757|NCT00692003|Anticonvulsants|anticonvulsants|mesh-ancestor
110653758|NCT00692003|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110653759|NCT00692003|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110653760|NCT00692003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110653761|NCT00692003|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110653762|NCT00692003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110653763|NCT02564315|Nicotine|nicotine|mesh-list
110653764|NCT02564315|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110653765|NCT02564315|Autonomic Agents|autonomic agents|mesh-ancestor
110653766|NCT02564315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110653767|NCT02564315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110653768|NCT02564315|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110207563|NCT00188071|Antipyretics|antipyretics|mesh-ancestor
110653769|NCT02564315|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110653770|NCT02564315|Cholinergic Agents|cholinergic agents|mesh-ancestor
110653771|NCT02564315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110653772|NCT02564315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110653773|NCT02564237|Vaccines|vaccines|mesh-list
110653774|NCT02564237|Immunologic Factors|immunologic factors|mesh-ancestor
110653775|NCT02564237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110653776|NCT00427648|Lidocaine|lidocaine|mesh-list
110653777|NCT00427648|Anesthetics, Local|anesthetics, local|mesh-ancestor
110653778|NCT00427648|Anesthetics|anesthetics|mesh-ancestor
110653779|NCT00427648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110653780|NCT00427648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110653781|NCT00427648|Sensory System Agents|sensory system agents|mesh-ancestor
110653782|NCT00427648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110653783|NCT00427648|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110653784|NCT00427648|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110653785|NCT00427648|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110653786|NCT00427648|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110301004|NCT00244361|Rituximab|rituximab|mesh-list
110653787|NCT00427648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110653788|NCT02153177|Acetaminophen|acetaminophen|mesh-list
110653789|NCT02153177|Ibuprofen|ibuprofen|mesh-list
110653790|NCT02153177|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
110653791|NCT02153177|Hydrocodone|hydrocodone|mesh-list
110653792|NCT02153177|Oxycodone|oxycodone|mesh-list
110653793|NCT02153177|Omeprazole|omeprazole|mesh-list
110653794|NCT02153177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110653795|NCT02153177|Analgesics|analgesics|mesh-ancestor
110653796|NCT02153177|Sensory System Agents|sensory system agents|mesh-ancestor
110653797|NCT02153177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110653798|NCT02153177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110653799|NCT02153177|Antipyretics|antipyretics|mesh-ancestor
110653800|NCT02153177|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110653801|NCT02153177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110653802|NCT02153177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110653803|NCT02153177|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110653804|NCT02153177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110653805|NCT02153177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110653806|NCT02153177|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110653807|NCT02153177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110653808|NCT02153177|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110653809|NCT02153177|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110653810|NCT02153177|Narcotics|narcotics|mesh-ancestor
110653811|NCT02153177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110653812|NCT02153177|Antitussive Agents|antitussive agents|mesh-ancestor
110653813|NCT02153177|Respiratory System Agents|respiratory system agents|mesh-ancestor
110653814|NCT00743327|Pioglitazone|pioglitazone|mesh-list
110653815|NCT00743327|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110653816|NCT00743327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110653817|NCT02564861|DS-1971a|ds-1971a|mesh-list
110653818|NCT02564861|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110653819|NCT02564861|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110653820|NCT02564861|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110653821|NCT02564861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110653822|NCT00416884|Fludarabine|fludarabine|mesh-list
110653823|NCT00416884|Alemtuzumab|alemtuzumab|mesh-list
110653824|NCT00416884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110653825|NCT00416884|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110653826|NCT03507257|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110653827|NCT03507257|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110653828|NCT03507257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110653829|NCT00555620|Capecitabine|capecitabine|mesh-list
110653830|NCT00555620|Oxaliplatin|oxaliplatin|mesh-list
110653831|NCT00555620|Sunitinib|sunitinib|mesh-list
110653832|NCT00555620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110653833|NCT00555620|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110653835|NCT00555620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110653836|NCT00555620|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110653837|NCT00555620|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110653838|NCT00555620|Growth Substances|growth substances|mesh-ancestor
110653839|NCT00555620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110653840|NCT00555620|Growth Inhibitors|growth inhibitors|mesh-ancestor
110653841|NCT00555620|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110653842|NCT00555620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110653843|NCT00433966|Paclitaxel|paclitaxel|mesh-list
110653844|NCT00433966|Heparin|heparin|mesh-list
110653845|NCT00433966|Calcium heparin|calcium heparin|mesh-list
110653846|NCT00433966|Bivalirudin|bivalirudin|mesh-list
110653847|NCT00433966|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110653848|NCT00433966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110653849|NCT00433966|Tubulin Modulators|tubulin modulators|mesh-ancestor
110653850|NCT00433966|Antimitotic Agents|antimitotic agents|mesh-ancestor
110653851|NCT00433966|Mitosis Modulators|mitosis modulators|mesh-ancestor
110653852|NCT00433966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110653853|NCT00433966|Anticoagulants|anticoagulants|mesh-ancestor
110653854|NCT00433966|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110653855|NCT00433966|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110653857|NCT00433966|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110398590|NCT04303819|Incretins|incretins|mesh-ancestor
110653858|NCT00433966|Protease Inhibitors|protease inhibitors|mesh-ancestor
110653859|NCT00433966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110653860|NCT03463265|Sirolimus|sirolimus|mesh-list
110653861|NCT03463265|Bevacizumab|bevacizumab|mesh-list
110653862|NCT03463265|Temozolomide|temozolomide|mesh-list
110653863|NCT03463265|Temsirolimus|temsirolimus|mesh-list
110653864|NCT03463265|Lomustine|lomustine|mesh-list
110653865|NCT03463265|MTOR Inhibitors|mtor inhibitors|mesh-list
110653866|NCT03463265|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110653867|NCT03463265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110653868|NCT03463265|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110653869|NCT03463265|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110653870|NCT03463265|Growth Substances|growth substances|mesh-ancestor
110653871|NCT03463265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110653872|NCT03463265|Growth Inhibitors|growth inhibitors|mesh-ancestor
110653873|NCT03463265|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110653874|NCT03463265|Alkylating Agents|alkylating agents|mesh-ancestor
110653875|NCT03463265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110653876|NCT03463265|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110653877|NCT03463265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110653878|NCT03463265|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110653879|NCT03463265|Antifungal Agents|antifungal agents|mesh-ancestor
110653880|NCT03463265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110653881|NCT03463265|Immunologic Factors|immunologic factors|mesh-ancestor
110653882|NCT03463265|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110653883|NCT03463265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110653884|NCT00947336|Norfloxacin|norfloxacin|mesh-list
110653885|NCT00947336|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110653886|NCT00947336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110653887|NCT00947336|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110653888|NCT00947336|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110653889|NCT00947336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110653890|NCT00947336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110653891|NCT00947336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110653892|NCT00947336|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110653893|NCT00947336|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110653894|NCT00955214|Paclitaxel|paclitaxel|mesh-list
110653895|NCT00955214|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110207600|NCT00047073|Sirolimus|sirolimus|mesh-list
110653896|NCT00955214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110653897|NCT00955214|Tubulin Modulators|tubulin modulators|mesh-ancestor
110653898|NCT00955214|Antimitotic Agents|antimitotic agents|mesh-ancestor
110653899|NCT00955214|Mitosis Modulators|mitosis modulators|mesh-ancestor
110653900|NCT00955214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110653902|NCT00956462|Ketorolac|ketorolac|mesh-list
110653903|NCT00956462|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
110653904|NCT00956462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110653905|NCT00956462|Antiemetics|antiemetics|mesh-ancestor
110653906|NCT00956462|Autonomic Agents|autonomic agents|mesh-ancestor
110653907|NCT00956462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110653908|NCT00956462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110653909|NCT00956462|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110653910|NCT00956462|Glucocorticoids|glucocorticoids|mesh-ancestor
110653911|NCT00956462|Hormones|hormones|mesh-ancestor
110653912|NCT00956462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110653913|NCT00956462|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110653914|NCT00956462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110653915|NCT00956462|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110653916|NCT00956462|Analgesics|analgesics|mesh-ancestor
110653917|NCT00956462|Sensory System Agents|sensory system agents|mesh-ancestor
110653918|NCT00956462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110653919|NCT00956462|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110653920|NCT00956462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110653921|NCT00956462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110653922|NCT05300360|Adenosine|adenosine|mesh-list
110653923|NCT05300360|Analgesics|analgesics|mesh-ancestor
110653924|NCT05300360|Sensory System Agents|sensory system agents|mesh-ancestor
110653925|NCT05300360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110653926|NCT05300360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110653927|NCT05300360|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110653928|NCT05300360|Vasodilator Agents|vasodilator agents|mesh-ancestor
110653929|NCT05300360|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
110653930|NCT05300360|Purinergic Agonists|purinergic agonists|mesh-ancestor
110653931|NCT05300360|Purinergic Agents|purinergic agents|mesh-ancestor
110653932|NCT05300360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110653933|NCT05300360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110653935|NCT00956696|Anticonvulsants|anticonvulsants|mesh-ancestor
110653936|NCT00956696|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110653937|NCT00956696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110653938|NCT03952650|Chloroquine|chloroquine|mesh-list
110653939|NCT03952650|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
110653940|NCT03952650|Pyrimethamine|pyrimethamine|mesh-list
110653941|NCT03952650|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
110653943|NCT03952650|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110653944|NCT03952650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110653945|NCT03952650|Analgesics|analgesics|mesh-ancestor
110653946|NCT03952650|Sensory System Agents|sensory system agents|mesh-ancestor
110653947|NCT03952650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110653948|NCT03952650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110653949|NCT03952650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110653950|NCT03952650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110653951|NCT03952650|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110653952|NCT03952650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110653953|NCT03952650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110207605|NCT00047073|Antifungal Agents|antifungal agents|mesh-ancestor
110653954|NCT03952650|Amebicides|amebicides|mesh-ancestor
110653955|NCT03952650|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110653956|NCT03952650|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110653957|NCT03952650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110653958|NCT03952650|Antimalarials|antimalarials|mesh-ancestor
110653959|NCT03952650|Filaricides|filaricides|mesh-ancestor
110653960|NCT03952650|Antinematodal Agents|antinematodal agents|mesh-ancestor
110653961|NCT03952650|Anthelmintics|anthelmintics|mesh-ancestor
110653962|NCT03952650|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110653963|NCT00955526|Istradefylline|istradefylline|mesh-list
110653964|NCT00955526|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
110653965|NCT00955526|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110653966|NCT00955526|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110653967|NCT00955526|Purinergic Agents|purinergic agents|mesh-ancestor
110653968|NCT00955526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110653969|NCT00955526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110653970|NCT00955526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110653971|NCT00955604|Rasagiline|rasagiline|mesh-list
110653972|NCT00955604|Antidepressive Agents|antidepressive agents|mesh-list
110653973|NCT00955604|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110653974|NCT00955604|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
110653975|NCT00955604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110653976|NCT00955604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110653977|NCT00955604|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110653978|NCT00955604|Protective Agents|protective agents|mesh-ancestor
110653979|NCT00955604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110653980|NCT03623646|Immunomodulating Agents|immunomodulating agents|mesh-list
110653981|NCT03623646|Immunologic Factors|immunologic factors|mesh-ancestor
110653982|NCT03623646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110653984|NCT00962286|Diuretics|diuretics|mesh-ancestor
110653985|NCT00962286|Natriuretic Agents|natriuretic agents|mesh-ancestor
110653986|NCT00962286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110653987|NCT00962286|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110653988|NCT00962286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110653989|NCT00962286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110653990|NCT00691301|Pemetrexed|pemetrexed|mesh-list
110653991|NCT00691301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110653992|NCT00691301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110653993|NCT00691301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110653994|NCT00691301|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110653995|NCT00691301|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110653996|NCT05277480|Apatinib|apatinib|mesh-list
110653997|NCT05277480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110653998|NCT05277480|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110653999|NCT05277480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110654000|NCT05277480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110654001|NCT00956072|Imatinib Mesylate|imatinib mesylate|mesh-list
110654002|NCT00956072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110654003|NCT00956072|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110654004|NCT00956072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110654005|NCT00956072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110654006|NCT02564003|Oxycodone|oxycodone|mesh-list
110654007|NCT02564003|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110654008|NCT02564003|Narcotics|narcotics|mesh-ancestor
110654009|NCT02564003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110654010|NCT02564003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110654011|NCT02564003|Analgesics|analgesics|mesh-ancestor
110654012|NCT02564003|Sensory System Agents|sensory system agents|mesh-ancestor
110301204|NCT00245141|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110654013|NCT02564003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110654016|NCT00956150|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110654017|NCT00956150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110654018|NCT00956150|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110654019|NCT00923663|Lenalidomide|lenalidomide|mesh-list
110654020|NCT00923663|Immunologic Factors|immunologic factors|mesh-ancestor
110654021|NCT00923663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110654022|NCT00923663|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110654023|NCT00923663|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110654024|NCT00923663|Growth Substances|growth substances|mesh-ancestor
110654025|NCT00923663|Growth Inhibitors|growth inhibitors|mesh-ancestor
110654026|NCT00923663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110654027|NCT00743873|Mitogens|mitogens|mesh-list
110654028|NCT00743873|Mitosis Modulators|mitosis modulators|mesh-ancestor
110654029|NCT00743873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110654030|NCT04011098|Fentanyl|fentanyl|mesh-list
110654031|NCT04011098|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110654032|NCT04011098|Narcotics|narcotics|mesh-ancestor
110654033|NCT04011098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110654034|NCT04011098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110654035|NCT04011098|Analgesics|analgesics|mesh-ancestor
110654036|NCT04011098|Sensory System Agents|sensory system agents|mesh-ancestor
110654037|NCT04011098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110654038|NCT04011098|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110654039|NCT04011098|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110654040|NCT04011098|Anesthetics, General|anesthetics, general|mesh-ancestor
110654041|NCT04011098|Anesthetics|anesthetics|mesh-ancestor
110654042|NCT00927563|Tolcapone|tolcapone|mesh-list
110654043|NCT00927563|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110654044|NCT00927563|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110654045|NCT00927563|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
110654046|NCT00927563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110654047|NCT00927563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110654048|NCT00956306|Udenafil|udenafil|mesh-list
110654049|NCT00956306|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110654050|NCT00956306|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110654051|NCT00956306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110159979|NCT00095641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110654052|NCT00956306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110654053|NCT00775229|Naltrexone|naltrexone|mesh-list
110654054|NCT00775229|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110654055|NCT00775229|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110654056|NCT00775229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110654057|NCT00775229|Sensory System Agents|sensory system agents|mesh-ancestor
110654058|NCT00775229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110654059|NCT00962442|Acetylcysteine|acetylcysteine|mesh-list
110654060|NCT00962442|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110654061|NCT00962442|Antiviral Agents|antiviral agents|mesh-ancestor
110654062|NCT00962442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110654063|NCT00962442|Expectorants|expectorants|mesh-ancestor
110654064|NCT00962442|Respiratory System Agents|respiratory system agents|mesh-ancestor
110654065|NCT00962442|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110654066|NCT00962442|Antioxidants|antioxidants|mesh-ancestor
110654067|NCT00962442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110654068|NCT00962442|Protective Agents|protective agents|mesh-ancestor
110654069|NCT00962442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110654070|NCT00962442|Antidotes|antidotes|mesh-ancestor
110654071|NCT00957320|Sirolimus|sirolimus|mesh-list
110654072|NCT00957320|Asparaginase|asparaginase|mesh-list
110654074|NCT00957320|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110654075|NCT00957320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110654076|NCT00957320|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110654077|NCT00957320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110654078|NCT00957320|Antifungal Agents|antifungal agents|mesh-ancestor
110654079|NCT00957320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110654080|NCT00957320|Immunologic Factors|immunologic factors|mesh-ancestor
110654081|NCT00957320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110654082|NCT00653159|Copper|copper|mesh-list
110654083|NCT00653159|Levonorgestrel|levonorgestrel|mesh-list
110654084|NCT00653159|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110654085|NCT00653159|Contraceptive Agents|contraceptive agents|mesh-ancestor
110301281|NCT00245453|Azithromycin|azithromycin|mesh-list
110654086|NCT00653159|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110654087|NCT00653159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110654088|NCT00653159|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110654089|NCT00653159|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110654090|NCT00653159|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110654091|NCT00653159|Trace Elements|trace elements|mesh-ancestor
110654092|NCT00653159|Micronutrients|micronutrients|mesh-ancestor
110654093|NCT03047070|Lidocaine|lidocaine|mesh-list
110654094|NCT03047070|Anesthetics, Local|anesthetics, local|mesh-ancestor
110654095|NCT03047070|Anesthetics|anesthetics|mesh-ancestor
110654096|NCT03047070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110654097|NCT03047070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110654098|NCT03047070|Sensory System Agents|sensory system agents|mesh-ancestor
110654099|NCT03047070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110654100|NCT03047070|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110654101|NCT03047070|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110654102|NCT03047070|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110654103|NCT03047070|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110654104|NCT03047070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110654105|NCT00948272|Vaccines|vaccines|mesh-list
110654106|NCT00948272|Immunologic Factors|immunologic factors|mesh-ancestor
110654107|NCT00948272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110654108|NCT00957554|Amlodipine|amlodipine|mesh-list
110654109|NCT00957554|Irbesartan|irbesartan|mesh-list
110654110|NCT00957554|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110654111|NCT00957554|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110654112|NCT00957554|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110654113|NCT00957554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110654114|NCT00957554|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110654115|NCT00957554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110159999|NCT04476030|Serotonin Agents|serotonin agents|mesh-ancestor
110654116|NCT00957554|Vasodilator Agents|vasodilator agents|mesh-ancestor
110654117|NCT00957554|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110654118|NCT00957554|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110654119|NCT03024684|Atorvastatin|atorvastatin|mesh-list
110654120|NCT03024684|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110654121|NCT03024684|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110654122|NCT03024684|Antimetabolites|antimetabolites|mesh-ancestor
110565106|NCT03142568|Urological Agents|urological agents|mesh-ancestor
110654123|NCT03024684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110654124|NCT03024684|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110654125|NCT03024684|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110654128|NCT00744107|Trace Elements|trace elements|mesh-ancestor
110654129|NCT00744107|Micronutrients|micronutrients|mesh-ancestor
110654130|NCT00744107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110654131|NCT00117637|Interferons|interferons|mesh-list
110654132|NCT00117637|Sorafenib|sorafenib|mesh-list
110654133|NCT00117637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110654134|NCT00117637|Antiviral Agents|antiviral agents|mesh-ancestor
110654135|NCT00117637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110654136|NCT00117637|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110654137|NCT00117637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110654138|NCT00117637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110654139|NCT00744185|Propranolol|propranolol|mesh-list
110654140|NCT00744185|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110654141|NCT00744185|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110654142|NCT00744185|Adrenergic Agents|adrenergic agents|mesh-ancestor
110654143|NCT00744185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110654144|NCT00744185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110654145|NCT00744185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110654146|NCT00744185|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110654147|NCT00744185|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110654148|NCT00744185|Vasodilator Agents|vasodilator agents|mesh-ancestor
110654149|NCT02897778|Entinostat|entinostat|mesh-list
110654150|NCT02897778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110654151|NCT02897778|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110654152|NCT02897778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110654153|NCT02897778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110654154|NCT01084291|Vaccines|vaccines|mesh-list
110654155|NCT01084291|Immunologic Factors|immunologic factors|mesh-ancestor
110654156|NCT01084291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110654157|NCT00741767|Fluticasone|fluticasone|mesh-list
110654158|NCT00741767|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110654159|NCT00741767|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
110654160|NCT00741767|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110654161|NCT00741767|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110654162|NCT00741767|Autonomic Agents|autonomic agents|mesh-ancestor
110654163|NCT00741767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110654164|NCT00741767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110654165|NCT00741767|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110654166|NCT00741767|Respiratory System Agents|respiratory system agents|mesh-ancestor
110654167|NCT00741767|Dermatologic Agents|dermatologic agents|mesh-ancestor
110654168|NCT00741767|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110654169|NCT00741767|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110654170|NCT00741767|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110654171|NCT00741767|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110654172|NCT00741767|Adrenergic Agents|adrenergic agents|mesh-ancestor
110654173|NCT00741767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110654174|NCT00741767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110654175|NCT00741767|Glucocorticoids|glucocorticoids|mesh-ancestor
110654176|NCT00741767|Hormones|hormones|mesh-ancestor
110654177|NCT00741767|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110654178|NCT00741767|Sympathomimetics|sympathomimetics|mesh-ancestor
110654179|NCT00741845|Metronidazole|metronidazole|mesh-list
110654180|NCT00741845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110654181|NCT00741845|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110654182|NCT00741845|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110654184|NCT00746447|Mesalamine|mesalamine|mesh-list
110654185|NCT00746447|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110654186|NCT00746447|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110654187|NCT00746447|Analgesics|analgesics|mesh-ancestor
110654188|NCT00746447|Sensory System Agents|sensory system agents|mesh-ancestor
110207673|NCT00188773|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110654189|NCT00746447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110654190|NCT00746447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110654191|NCT00746447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110654192|NCT00746447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110654193|NCT00744419|Pantoprazole|pantoprazole|mesh-list
110654194|NCT00744419|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110654195|NCT00744419|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110654196|NCT00744419|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110654197|NCT00744419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110654198|NCT00744419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110654199|NCT00549302|Tadalafil|tadalafil|mesh-list
110654200|NCT00549302|Vasodilator Agents|vasodilator agents|mesh-ancestor
110654201|NCT00549302|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110654202|NCT00549302|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110654203|NCT00549302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110654204|NCT00549302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110654205|NCT00549302|Urological Agents|urological agents|mesh-ancestor
110654206|NCT04277858|Cisplatin|cisplatin|mesh-list
110654207|NCT04277858|Docetaxel|docetaxel|mesh-list
110654208|NCT04277858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110654209|NCT04277858|Tubulin Modulators|tubulin modulators|mesh-ancestor
110654210|NCT04277858|Antimitotic Agents|antimitotic agents|mesh-ancestor
110654211|NCT04277858|Mitosis Modulators|mitosis modulators|mesh-ancestor
110654212|NCT04277858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110654213|NCT00957866|Interferons|interferons|mesh-list
110654214|NCT00957866|Ribavirin|ribavirin|mesh-list
110654215|NCT00957866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110654216|NCT00957866|Antiviral Agents|antiviral agents|mesh-ancestor
110654217|NCT00957866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110654218|NCT00957866|Antimetabolites|antimetabolites|mesh-ancestor
110654219|NCT00957866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110654220|NCT00958022|Carboplatin|carboplatin|mesh-list
110654221|NCT00958022|Etoposide|etoposide|mesh-list
110654222|NCT00958022|Etoposide phosphate|etoposide phosphate|mesh-list
110654223|NCT00958022|Panobinostat|panobinostat|mesh-list
110654224|NCT00958022|Podophyllotoxin|podophyllotoxin|mesh-list
110654225|NCT00958022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110654226|NCT00958022|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110654227|NCT00958022|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110654228|NCT00958022|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110654229|NCT00958022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110654230|NCT00958022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110654231|NCT00958022|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110654232|NCT00958022|Keratolytic Agents|keratolytic agents|mesh-ancestor
110654233|NCT00958022|Dermatologic Agents|dermatologic agents|mesh-ancestor
110654234|NCT00958022|Tubulin Modulators|tubulin modulators|mesh-ancestor
110654235|NCT00958022|Antimitotic Agents|antimitotic agents|mesh-ancestor
110654236|NCT00958022|Mitosis Modulators|mitosis modulators|mesh-ancestor
110654237|NCT00958100|Tenofovir|tenofovir|mesh-list
110301426|NCT00274833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110654239|NCT00958100|Emtricitabine|emtricitabine|mesh-list
110654240|NCT00958100|Raltegravir Potassium|raltegravir potassium|mesh-list
110654241|NCT00958100|Abacavir|abacavir|mesh-list
110654242|NCT00958100|Dideoxynucleosides|dideoxynucleosides|mesh-list
110654243|NCT00958100|Antiviral Agents|antiviral agents|mesh-ancestor
110654244|NCT00958100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110654245|NCT00958100|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110654246|NCT00958100|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110654247|NCT00958100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110654248|NCT00958100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110654249|NCT00958100|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110654250|NCT00958100|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110654251|NCT00958100|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110654252|NCT00958100|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110654253|NCT00958100|Antimetabolites|antimetabolites|mesh-ancestor
110654254|NCT00948584|Insulin|insulin|mesh-list
110654255|NCT00948584|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110654256|NCT00948584|Insulin Glargine|insulin glargine|mesh-list
110654257|NCT00948584|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110654258|NCT00948584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110654259|NCT00948662|Ketoconazole|ketoconazole|mesh-list
110654260|NCT00948662|Antifungal Agents|antifungal agents|mesh-ancestor
110654261|NCT00948662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110654262|NCT00948662|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110654263|NCT00948662|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110654264|NCT00948662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110654265|NCT00948662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110654266|NCT00948662|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110654267|NCT00948662|Hormone Antagonists|hormone antagonists|mesh-ancestor
110654268|NCT00948662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110654269|NCT00948662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110654270|NCT00948662|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110654271|NCT00948740|Vitamin D|vitamin d|mesh-list
110654272|NCT00948740|Ergocalciferols|ergocalciferols|mesh-list
110654273|NCT00948740|Vitamins|vitamins|mesh-ancestor
110654274|NCT00948740|Micronutrients|micronutrients|mesh-ancestor
110654275|NCT00948740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110654276|NCT00948740|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110654277|NCT00948740|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110654278|NCT00108433|Vancomycin|vancomycin|mesh-list
110654279|NCT00108433|Cefazolin|cefazolin|mesh-list
110654280|NCT00108433|Linezolid|linezolid|mesh-list
110654281|NCT00108433|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110654282|NCT00108433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110654283|NCT00108433|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110654284|NCT00108433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110654285|NCT00108433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110654286|NCT01084369|Methyltestosterone|methyltestosterone|mesh-list
110654287|NCT01084369|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
110654288|NCT01084369|Testosterone|testosterone|mesh-list
110654289|NCT01084369|Testosterone undecanoate|testosterone undecanoate|mesh-list
110654290|NCT01084369|Testosterone enanthate|testosterone enanthate|mesh-list
110654291|NCT01084369|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
110654292|NCT01084369|Androgens|androgens|mesh-ancestor
110654293|NCT01084369|Hormones|hormones|mesh-ancestor
110565154|NCT02691923|Aminolevulinic Acid|aminolevulinic acid|mesh-list
110654294|NCT01084369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110654295|NCT01084369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110654296|NCT01084369|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110654297|NCT01084369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110654298|NCT01084369|Anabolic Agents|anabolic agents|mesh-ancestor
110654299|NCT01084369|Vasodilator Agents|vasodilator agents|mesh-ancestor
110654300|NCT01084369|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110654301|NCT01084369|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110654302|NCT01084369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110654303|NCT01084369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110654304|NCT01084369|Urological Agents|urological agents|mesh-ancestor
110654305|NCT00949130|Linezolid|linezolid|mesh-list
110654306|NCT00949130|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110654307|NCT00949130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110654308|NCT00949130|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110654309|NCT00949130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110654310|NCT00949130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110301503|NCT00274911|Alkylating Agents|alkylating agents|mesh-ancestor
110654312|NCT04010318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110654313|NCT04010318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110654314|NCT00108355|Octreotide|octreotide|mesh-list
110654315|NCT00108355|Midodrine|midodrine|mesh-list
110654316|NCT00108355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110654317|NCT00108355|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110654318|NCT00108355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110654319|NCT00108355|Sympathomimetics|sympathomimetics|mesh-ancestor
110654320|NCT00108355|Autonomic Agents|autonomic agents|mesh-ancestor
110654321|NCT00108355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110654322|NCT00108355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110654323|NCT00108355|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110654324|NCT00108355|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110654325|NCT00108355|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110654326|NCT00108355|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110654327|NCT00108355|Adrenergic Agents|adrenergic agents|mesh-ancestor
110654328|NCT00108355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110654329|NCT00108355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110654330|NCT00963222|Vitamin A|vitamin a|mesh-list
110654331|NCT00963222|Vitamins|vitamins|mesh-ancestor
110654332|NCT00963222|Micronutrients|micronutrients|mesh-ancestor
110654333|NCT00963222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110654334|NCT02703584|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
110654335|NCT02703584|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110654336|NCT02703584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110654337|NCT00968682|Trastuzumab|trastuzumab|mesh-list
110654338|NCT00968682|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110654339|NCT00968682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110654340|NCT00968760|Cytarabine|cytarabine|mesh-list
110654341|NCT00968760|Etoposide|etoposide|mesh-list
110654342|NCT00968760|Melphalan|melphalan|mesh-list
110654343|NCT00968760|Interleukin-2|interleukin-2|mesh-list
110654344|NCT00968760|Carmustine|carmustine|mesh-list
110654345|NCT00968760|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110654346|NCT00968760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110654347|NCT00968760|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110654348|NCT00968760|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110654349|NCT00968760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110654350|NCT00968760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110654351|NCT00968760|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110654352|NCT00968760|Antimetabolites|antimetabolites|mesh-ancestor
110654353|NCT00968760|Antiviral Agents|antiviral agents|mesh-ancestor
110654354|NCT00968760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110654355|NCT00968760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110654356|NCT00968760|Immunologic Factors|immunologic factors|mesh-ancestor
110654357|NCT00968760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110654358|NCT00968760|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110654359|NCT00968760|Alkylating Agents|alkylating agents|mesh-ancestor
110654360|NCT00968760|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110654361|NCT00968760|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110654362|NCT00968760|Analgesics|analgesics|mesh-ancestor
110654363|NCT00968760|Sensory System Agents|sensory system agents|mesh-ancestor
110654364|NCT00968760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110654365|NCT02465138|Ketorolac|ketorolac|mesh-list
110654366|NCT02465138|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110654367|NCT02465138|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110654368|NCT02465138|Analgesics|analgesics|mesh-ancestor
110654369|NCT02465138|Sensory System Agents|sensory system agents|mesh-ancestor
110654370|NCT02465138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110654371|NCT02465138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110654372|NCT02465138|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110654373|NCT02465138|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110654374|NCT02465138|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110654375|NCT02465138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110654376|NCT02465138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110654377|NCT00968994|Petrolatum|petrolatum|mesh-list
110654378|NCT00968994|Emollients|emollients|mesh-ancestor
110654379|NCT00968994|Dermatologic Agents|dermatologic agents|mesh-ancestor
110654380|NCT00969072|Dutasteride|dutasteride|mesh-list
110654381|NCT00969072|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
110654382|NCT00969072|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110654383|NCT00969072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110654384|NCT00969072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110654385|NCT00969072|Hormone Antagonists|hormone antagonists|mesh-ancestor
110654386|NCT00969072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110654387|NCT00969072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110654389|NCT00094861|Carboplatin|carboplatin|mesh-list
110654390|NCT00094861|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110654391|NCT00094861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110654392|NCT00094861|Tubulin Modulators|tubulin modulators|mesh-ancestor
110654393|NCT00094861|Antimitotic Agents|antimitotic agents|mesh-ancestor
110654394|NCT00094861|Mitosis Modulators|mitosis modulators|mesh-ancestor
110654395|NCT00094861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110654396|NCT00963534|Rituximab|rituximab|mesh-list
110654397|NCT00963534|Lenalidomide|lenalidomide|mesh-list
110654398|NCT00963534|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110654399|NCT00963534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110654400|NCT00963534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110654401|NCT00963534|Immunologic Factors|immunologic factors|mesh-ancestor
110654402|NCT00963534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110654403|NCT00963534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110654404|NCT00963534|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110654405|NCT00963534|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110654406|NCT00963534|Growth Substances|growth substances|mesh-ancestor
110654407|NCT00963534|Growth Inhibitors|growth inhibitors|mesh-ancestor
110654408|NCT00963534|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110654409|NCT00963534|Alkylating Agents|alkylating agents|mesh-ancestor
110654410|NCT00963534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110654411|NCT00963690|Hemostatics|hemostatics|mesh-list
110654412|NCT00963690|Coagulants|coagulants|mesh-ancestor
110654413|NCT01079767|Sirolimus|sirolimus|mesh-list
110654414|NCT01079767|Temsirolimus|temsirolimus|mesh-list
110654415|NCT01079767|MTOR Inhibitors|mtor inhibitors|mesh-list
110654416|NCT01079767|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110654417|NCT01079767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110654418|NCT01079767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110565190|NCT02578680|Hematinics|hematinics|mesh-ancestor
110654419|NCT01079767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110654420|NCT01079767|Immunologic Factors|immunologic factors|mesh-ancestor
110654421|NCT01079767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110654422|NCT01079767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110654423|NCT01079767|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110654424|NCT01079767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110654425|NCT01079767|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110654426|NCT01079767|Antifungal Agents|antifungal agents|mesh-ancestor
110654427|NCT00969306|Chloroquine|chloroquine|mesh-list
110654428|NCT00969306|Amebicides|amebicides|mesh-ancestor
110654429|NCT00969306|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110654430|NCT00969306|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110654431|NCT00969306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110654432|NCT00969306|Antimalarials|antimalarials|mesh-ancestor
110654433|NCT00969306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110654434|NCT00963768|Canagliflozin|canagliflozin|mesh-list
110654435|NCT00963768|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110654436|NCT00963768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110654437|NCT00963768|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110654438|NCT00963768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110654439|NCT00969462|Doxorubicin|doxorubicin|mesh-list
110654440|NCT00969462|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110654441|NCT00969462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110654442|NCT00969462|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110654443|NCT00969462|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110654444|NCT00969462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110654445|NCT00969462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110654446|NCT00963846|Huperzine A|huperzine a|mesh-list
110654447|NCT00963846|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110654448|NCT00963846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110654449|NCT00963846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110654450|NCT00963846|Cholinergic Agents|cholinergic agents|mesh-ancestor
110654451|NCT00963846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110654452|NCT00963846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110654453|NCT00963846|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110654454|NCT00963846|Protective Agents|protective agents|mesh-ancestor
110654455|NCT00969696|Galantamine|galantamine|mesh-list
110654456|NCT00969696|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110654457|NCT00969696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110654458|NCT00969696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110654459|NCT00969696|Cholinergic Agents|cholinergic agents|mesh-ancestor
110654460|NCT00969696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110654461|NCT00969696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110654462|NCT00969696|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110654464|NCT00969696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110654465|NCT00969696|Nootropic Agents|nootropic agents|mesh-ancestor
110654466|NCT00958854|Thalidomide|thalidomide|mesh-list
110654467|NCT00958854|Cyclophosphamide|cyclophosphamide|mesh-list
110654468|NCT00958854|Fludarabine|fludarabine|mesh-list
110654469|NCT00958854|Fludarabine phosphate|fludarabine phosphate|mesh-list
110654470|NCT00958854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110654471|NCT00958854|Immunologic Factors|immunologic factors|mesh-ancestor
110565196|NCT02385266|Antitubercular Agents|antitubercular agents|mesh-ancestor
110654472|NCT00958854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110654473|NCT00958854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110654474|NCT00958854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110654475|NCT00958854|Alkylating Agents|alkylating agents|mesh-ancestor
110654476|NCT00958854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110654477|NCT00958854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110654478|NCT00958854|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110654479|NCT00958854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110654480|NCT00958854|Antimetabolites|antimetabolites|mesh-ancestor
110654481|NCT00958854|Leprostatic Agents|leprostatic agents|mesh-ancestor
110654482|NCT00958854|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110654483|NCT00958854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110654484|NCT00958854|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110654485|NCT00958854|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110654486|NCT00958854|Growth Substances|growth substances|mesh-ancestor
110654487|NCT00958854|Growth Inhibitors|growth inhibitors|mesh-ancestor
110654488|NCT00964080|Leucovorin|leucovorin|mesh-list
110654489|NCT00964080|Fluorouracil|fluorouracil|mesh-list
110654490|NCT00964080|Oxaliplatin|oxaliplatin|mesh-list
110654491|NCT00964080|Antimetabolites|antimetabolites|mesh-ancestor
110654492|NCT00964080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110654493|NCT00964080|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110654494|NCT00964080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110654495|NCT00964080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110654496|NCT00964080|Immunologic Factors|immunologic factors|mesh-ancestor
110654497|NCT00964080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110654498|NCT00964080|Antidotes|antidotes|mesh-ancestor
110654499|NCT00964080|Protective Agents|protective agents|mesh-ancestor
110654500|NCT00964080|Vitamin B Complex|vitamin b complex|mesh-ancestor
110654501|NCT00964080|Vitamins|vitamins|mesh-ancestor
110654502|NCT00964080|Micronutrients|micronutrients|mesh-ancestor
110654503|NCT00969852|Sertraline|sertraline|mesh-list
110654504|NCT00969852|Antidepressive Agents|antidepressive agents|mesh-ancestor
110654505|NCT00969852|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110654506|NCT00969852|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110654507|NCT00969852|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110654508|NCT00969852|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110654509|NCT00969852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110654510|NCT00969852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110654511|NCT00969852|Serotonin Agents|serotonin agents|mesh-ancestor
110654512|NCT00969852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110654513|NCT00426556|Paclitaxel|paclitaxel|mesh-list
110654514|NCT00426556|Trastuzumab|trastuzumab|mesh-list
110654515|NCT00426556|Everolimus|everolimus|mesh-list
110654516|NCT00426556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110654517|NCT00426556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110654518|NCT00426556|Tubulin Modulators|tubulin modulators|mesh-ancestor
110654519|NCT00426556|Antimitotic Agents|antimitotic agents|mesh-ancestor
110654520|NCT00426556|Mitosis Modulators|mitosis modulators|mesh-ancestor
110654521|NCT00426556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110654522|NCT00426556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110654523|NCT00426556|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110654524|NCT00426556|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110654525|NCT00426556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110654526|NCT00426556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110654527|NCT00426556|Immunologic Factors|immunologic factors|mesh-ancestor
110654528|NCT00426556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110654529|NCT00107653|Ribavirin|ribavirin|mesh-list
110654530|NCT00107653|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110654531|NCT00107653|Interferon-alpha|interferon-alpha|mesh-list
110654532|NCT00107653|Antimetabolites|antimetabolites|mesh-ancestor
110654533|NCT00107653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110654534|NCT00107653|Antiviral Agents|antiviral agents|mesh-ancestor
110301726|NCT00285051|Antipruritics|antipruritics|mesh-ancestor
110654535|NCT00107653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110654536|NCT00107653|Immunologic Factors|immunologic factors|mesh-ancestor
110654537|NCT00107653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110654538|NCT03950856|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110654539|NCT03950856|Immunologic Factors|immunologic factors|mesh-ancestor
110654540|NCT03950856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110654541|NCT00970008|CD59 Antigens|cd59 antigens|mesh-list
110654542|NCT00970008|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
110654543|NCT00970008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110654544|NCT00970008|Immunologic Factors|immunologic factors|mesh-ancestor
110654545|NCT00970008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110654546|NCT00970086|Bupivacaine|bupivacaine|mesh-list
110654547|NCT00970086|Levobupivacaine|levobupivacaine|mesh-list
110654548|NCT00970086|Anesthetics, Local|anesthetics, local|mesh-ancestor
110654549|NCT00970086|Anesthetics|anesthetics|mesh-ancestor
110654550|NCT00970086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110654551|NCT00970086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110654552|NCT00970086|Sensory System Agents|sensory system agents|mesh-ancestor
110654553|NCT00970086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110654554|NCT00689351|Vaccines|vaccines|mesh-list
110654555|NCT00689351|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110654556|NCT00689351|Immunologic Factors|immunologic factors|mesh-ancestor
110654557|NCT00689351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110654558|NCT03950622|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110654559|NCT03950622|Immunologic Factors|immunologic factors|mesh-ancestor
110654560|NCT03950622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110654562|NCT02563847|Tryptophan|tryptophan|mesh-list
110160060|NCT04432428|Analgesics|analgesics|mesh-ancestor
110654563|NCT02563847|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110654564|NCT02563847|Antidepressive Agents|antidepressive agents|mesh-ancestor
110207748|NCT00399945|Tobramycin|tobramycin|mesh-list
110654565|NCT02563847|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110654566|NCT02563847|Vasodilator Agents|vasodilator agents|mesh-ancestor
110654567|NCT00746681|Pregabalin|pregabalin|mesh-list
110654568|NCT00746681|Tolterodine Tartrate|tolterodine tartrate|mesh-list
110654569|NCT00746681|Analgesics|analgesics|mesh-ancestor
110654570|NCT00746681|Sensory System Agents|sensory system agents|mesh-ancestor
110654571|NCT00746681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110654572|NCT00746681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110654573|NCT00746681|Anticonvulsants|anticonvulsants|mesh-ancestor
110654574|NCT00746681|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110654575|NCT00746681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110654576|NCT00746681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110654577|NCT00746681|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110654578|NCT00746681|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110654579|NCT00746681|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110654580|NCT00746681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110654581|NCT00746681|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110654582|NCT00746681|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110654583|NCT00746681|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110654584|NCT00746681|Cholinergic Agents|cholinergic agents|mesh-ancestor
110654585|NCT00746681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110654586|NCT00746681|Urological Agents|urological agents|mesh-ancestor
110654587|NCT00746837|N-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-N-ethyl-2-(4-methanesulfonylphenyl)acetamide|n-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-n-ethyl-2-(4-methanesulfonylphenyl)acetamide|mesh-list
110654588|NCT00746837|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
110654589|NCT00746837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110654590|NCT00746837|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110654591|NCT00746837|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110654592|NCT00746837|Antiviral Agents|antiviral agents|mesh-ancestor
110654593|NCT00746837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110654594|NCT00749099|Pancrelipase|pancrelipase|mesh-list
110654595|NCT00749099|Pancreatin|pancreatin|mesh-list
110654596|NCT00749099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110654597|NCT00959400|Fentanyl|fentanyl|mesh-list
110654598|NCT00959400|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110654599|NCT00959400|Narcotics|narcotics|mesh-ancestor
110654600|NCT00959400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110654601|NCT00959400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110654602|NCT00959400|Analgesics|analgesics|mesh-ancestor
110654603|NCT00959400|Sensory System Agents|sensory system agents|mesh-ancestor
110654604|NCT00959400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110654605|NCT00959400|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110654606|NCT00959400|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110654607|NCT00959400|Anesthetics, General|anesthetics, general|mesh-ancestor
110654608|NCT00959400|Anesthetics|anesthetics|mesh-ancestor
110654609|NCT02563769|Clavulanic Acids|clavulanic acids|mesh-list
110654610|NCT02563769|Clavulanic Acid|clavulanic acid|mesh-list
110654611|NCT02563769|Cocaine|cocaine|mesh-list
110654612|NCT02563769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110654613|NCT02563769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110654614|NCT02563769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110654615|NCT02563769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110654616|NCT02563769|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110654617|NCT02563769|Anesthetics, Local|anesthetics, local|mesh-ancestor
110654618|NCT02563769|Anesthetics|anesthetics|mesh-ancestor
110654619|NCT02563769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110654620|NCT02563769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110398715|NCT05637645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110654621|NCT02563769|Sensory System Agents|sensory system agents|mesh-ancestor
110654622|NCT02563769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110654623|NCT02563769|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110654624|NCT02563769|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110654625|NCT02563769|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110654626|NCT02563769|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110654627|NCT02563769|Dopamine Agents|dopamine agents|mesh-ancestor
110654628|NCT02563769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110654629|NCT00959478|Carbon Monoxide|carbon monoxide|mesh-list
110654630|NCT00959478|Antimetabolites|antimetabolites|mesh-ancestor
110654631|NCT00959478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110654632|NCT00959478|Gasotransmitters|gasotransmitters|mesh-ancestor
110654633|NCT00959478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110654634|NCT00959478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110654636|NCT00964626|Cisplatin|cisplatin|mesh-list
110654637|NCT00964626|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110654638|NCT00964626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110654639|NCT00964626|Tubulin Modulators|tubulin modulators|mesh-ancestor
110654640|NCT00964626|Antimitotic Agents|antimitotic agents|mesh-ancestor
110654641|NCT00964626|Mitosis Modulators|mitosis modulators|mesh-ancestor
110654642|NCT00964626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110654643|NCT02562287|Olanzapine|olanzapine|mesh-list
110654644|NCT02562287|Risperidone|risperidone|mesh-list
110654645|NCT02562287|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110654646|NCT02562287|Clozapine|clozapine|mesh-list
110654647|NCT02562287|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110654648|NCT02562287|Serotonin Agents|serotonin agents|mesh-ancestor
110654649|NCT02562287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110654650|NCT02562287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110654651|NCT02562287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110654652|NCT02562287|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110654653|NCT02562287|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110654654|NCT02562287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110654655|NCT02562287|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110654656|NCT02562287|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110654657|NCT02562287|Dopamine Agents|dopamine agents|mesh-ancestor
110654658|NCT02562287|Antiemetics|antiemetics|mesh-ancestor
110654659|NCT02562287|Autonomic Agents|autonomic agents|mesh-ancestor
110654660|NCT02562287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110654661|NCT02562287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110654662|NCT02562287|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110654663|NCT02562287|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110654664|NCT02562287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110654665|NCT02562287|Antidepressive Agents|antidepressive agents|mesh-ancestor
110654666|NCT02562287|GABA Antagonists|gaba antagonists|mesh-ancestor
110654667|NCT02562287|GABA Agents|gaba agents|mesh-ancestor
110654668|NCT02562053|Fluoxetine|fluoxetine|mesh-list
110654669|NCT02562053|Contraceptive Agents|contraceptive agents|mesh-list
110654670|NCT02562053|Contraceptives, Oral|contraceptives, oral|mesh-list
110654671|NCT02562053|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
110654672|NCT02562053|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110654673|NCT02562053|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110654674|NCT02562053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110654675|NCT02562053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110654676|NCT02562053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110654677|NCT02562053|Serotonin Agents|serotonin agents|mesh-ancestor
110654678|NCT02562053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110654679|NCT02562053|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110654680|NCT02562053|Antidepressive Agents|antidepressive agents|mesh-ancestor
110654681|NCT02562053|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110301874|NCT00278421|Cyclophosphamide|cyclophosphamide|mesh-list
110654682|NCT02562053|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110654683|NCT02562053|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110654684|NCT02562053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110398730|NCT04207515|Anesthetics|anesthetics|mesh-list
110654685|NCT02562053|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110654686|NCT02562053|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110654687|NCT00746993|Contraceptive Agents|contraceptive agents|mesh-list
110654688|NCT00746993|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110654689|NCT00746993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110654690|NCT04060043|Goserelin|goserelin|mesh-list
110654691|NCT04060043|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110654692|NCT04060043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110654693|NCT00553358|Paclitaxel|paclitaxel|mesh-list
110654694|NCT00553358|Trastuzumab|trastuzumab|mesh-list
110654695|NCT00553358|Lapatinib|lapatinib|mesh-list
110654696|NCT00553358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110654697|NCT00553358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110654698|NCT00553358|Tubulin Modulators|tubulin modulators|mesh-ancestor
110654699|NCT00553358|Antimitotic Agents|antimitotic agents|mesh-ancestor
110654700|NCT00553358|Mitosis Modulators|mitosis modulators|mesh-ancestor
110654701|NCT00553358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110654702|NCT00553358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110654703|NCT00553358|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110654704|NCT00553358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110654705|NCT00744809|Moxifloxacin|moxifloxacin|mesh-list
110654706|NCT00744809|Efavirenz|efavirenz|mesh-list
110654707|NCT00744809|Rilpivirine|rilpivirine|mesh-list
110654708|NCT00744809|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110654709|NCT00744809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110654710|NCT00744809|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110654711|NCT00744809|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110654712|NCT00744809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110565267|NCT00660335|Secretin|secretin|mesh-list
110654713|NCT00744809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110654714|NCT00744809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110654715|NCT00744809|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110654716|NCT00744809|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110654717|NCT00744809|Antiviral Agents|antiviral agents|mesh-ancestor
110654718|NCT00744809|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110654719|NCT00744809|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110654720|NCT00744809|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110654721|NCT00744809|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110654722|NCT00744809|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110654723|NCT00744809|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110654724|NCT00744809|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110654725|NCT00744809|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110654726|NCT00744887|Darunavir|darunavir|mesh-list
110654727|NCT00744887|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110654728|NCT00744887|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110654729|NCT00744887|Protease Inhibitors|protease inhibitors|mesh-ancestor
110654730|NCT00744887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110654731|NCT00744887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110654732|NCT00744887|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110654733|NCT00744887|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110654734|NCT00744887|Antiviral Agents|antiviral agents|mesh-ancestor
110398734|NCT01100944|Doxorubicin|doxorubicin|mesh-list
110654735|NCT00744887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110654736|NCT02286830|Zoledronic Acid|zoledronic acid|mesh-list
110654737|NCT02286830|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110654738|NCT02286830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110654739|NCT00749567|Bevacizumab|bevacizumab|mesh-list
110654740|NCT00749567|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110654741|NCT00749567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110654742|NCT00749567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110654743|NCT00749567|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110654744|NCT00749567|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110654745|NCT00749567|Growth Substances|growth substances|mesh-ancestor
110654746|NCT00749567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110654747|NCT00749567|Growth Inhibitors|growth inhibitors|mesh-ancestor
110654748|NCT00749567|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110654749|NCT00749567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110654750|NCT00749567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110654751|NCT04010942|Metformin|metformin|mesh-list
110654752|NCT04010942|Clomiphene|clomiphene|mesh-list
110654753|NCT04010942|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110654754|NCT04010942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110654755|NCT04010942|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110654756|NCT04010942|Hormone Antagonists|hormone antagonists|mesh-ancestor
110654757|NCT04010942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110654758|NCT04010942|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110654759|NCT04010942|Fertility Agents|fertility agents|mesh-ancestor
110654760|NCT04010942|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110654761|NCT04010942|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110654762|NCT04010942|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110654763|NCT00949364|Pomalidomide|pomalidomide|mesh-list
110654764|NCT00949364|Immunologic Factors|immunologic factors|mesh-ancestor
110654765|NCT00949364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110654766|NCT00949364|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110654767|NCT00949364|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110654768|NCT00949364|Growth Substances|growth substances|mesh-ancestor
110654769|NCT00949364|Growth Inhibitors|growth inhibitors|mesh-ancestor
110654770|NCT00949364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110654771|NCT00689117|Clindamycin|clindamycin|mesh-list
110654772|NCT00689117|Clindamycin palmitate|clindamycin palmitate|mesh-list
110654773|NCT00689117|Clindamycin phosphate|clindamycin phosphate|mesh-list
110654774|NCT00689117|Tretinoin|tretinoin|mesh-list
110654775|NCT00689117|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110654776|NCT00689117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110654777|NCT00689117|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110654778|NCT00689117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110654779|NCT00689117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110654780|NCT00689117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110654781|NCT00689117|Keratolytic Agents|keratolytic agents|mesh-ancestor
110654782|NCT00689117|Dermatologic Agents|dermatologic agents|mesh-ancestor
110654783|NCT00949442|Insulin|insulin|mesh-list
110654784|NCT00949442|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110654785|NCT00949442|Insulin Glargine|insulin glargine|mesh-list
110654786|NCT00949442|Glimepiride|glimepiride|mesh-list
110654787|NCT00949442|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110654788|NCT00949442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110654789|NCT00949442|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110654790|NCT00949442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110654791|NCT00949442|Immunologic Factors|immunologic factors|mesh-ancestor
110654792|NCT00749723|Carboplatin|carboplatin|mesh-list
110654793|NCT00749723|Etoposide|etoposide|mesh-list
110654794|NCT00749723|Etoposide phosphate|etoposide phosphate|mesh-list
110654795|NCT00749723|Temozolomide|temozolomide|mesh-list
110654796|NCT00749723|Thiotepa|thiotepa|mesh-list
110654797|NCT00749723|Trofosfamide|trofosfamide|mesh-list
110654798|NCT00749723|Cyclophosphamide|cyclophosphamide|mesh-list
110654799|NCT00749723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110654800|NCT00749723|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110654801|NCT00749723|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110654802|NCT00749723|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110654803|NCT00749723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110654804|NCT00749723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110654805|NCT00749723|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110654806|NCT00749723|Alkylating Agents|alkylating agents|mesh-ancestor
110654807|NCT00749723|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110654808|NCT00749723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110654809|NCT00749723|Immunologic Factors|immunologic factors|mesh-ancestor
110654810|NCT00749723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110654811|NCT00749723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110654812|NCT00547248|Vaccines|vaccines|mesh-list
110654813|NCT00547248|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110654814|NCT00547248|Immunologic Factors|immunologic factors|mesh-ancestor
110654815|NCT00547248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110654816|NCT00688103|Etanercept|etanercept|mesh-list
110654817|NCT00688103|Methotrexate|methotrexate|mesh-list
110654818|NCT00688103|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110654819|NCT00688103|Abortifacient Agents|abortifacient agents|mesh-ancestor
110654820|NCT00688103|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110654821|NCT00688103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110654822|NCT00688103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110654823|NCT00688103|Antimetabolites|antimetabolites|mesh-ancestor
110654824|NCT00688103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110654825|NCT00688103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110654826|NCT00688103|Dermatologic Agents|dermatologic agents|mesh-ancestor
110654827|NCT00688103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110654828|NCT00688103|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110654829|NCT00688103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110654830|NCT00688103|Immunologic Factors|immunologic factors|mesh-ancestor
110654831|NCT00688103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110654832|NCT00688103|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110654833|NCT00688103|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110654834|NCT00688103|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110654835|NCT00688103|Analgesics|analgesics|mesh-ancestor
110654836|NCT00688103|Sensory System Agents|sensory system agents|mesh-ancestor
110654837|NCT00688103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110654838|NCT00688103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110654839|NCT00688103|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110654840|NCT00949598|Tamoxifen|tamoxifen|mesh-list
110654841|NCT00949598|Letrozole|letrozole|mesh-list
110654842|NCT00949598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110654843|NCT00949598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110654844|NCT00949598|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110654845|NCT00949598|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110654846|NCT00949598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110654847|NCT00949598|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110654848|NCT00949598|Hormone Antagonists|hormone antagonists|mesh-ancestor
110654849|NCT00949598|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110654850|NCT00949598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110654851|NCT00949598|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110654852|NCT00949598|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110654853|NCT00949598|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110654854|NCT00949598|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110654855|NCT00964704|Bevacizumab|bevacizumab|mesh-list
110654856|NCT00964704|Trastuzumab|trastuzumab|mesh-list
110654857|NCT00964704|Docetaxel|docetaxel|mesh-list
110654858|NCT00964704|Capecitabine|capecitabine|mesh-list
110654859|NCT00964704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110654860|NCT00964704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110654861|NCT00964704|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110207830|NCT00189787|Tacrolimus|tacrolimus|mesh-list
110654862|NCT00964704|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110654863|NCT00964704|Growth Substances|growth substances|mesh-ancestor
110654864|NCT00964704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110654865|NCT00964704|Growth Inhibitors|growth inhibitors|mesh-ancestor
110654866|NCT00964704|Tubulin Modulators|tubulin modulators|mesh-ancestor
110654867|NCT00964704|Antimitotic Agents|antimitotic agents|mesh-ancestor
110654868|NCT00964704|Mitosis Modulators|mitosis modulators|mesh-ancestor
110654869|NCT00964704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110654870|NCT00964704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110654871|NCT00964704|Antimetabolites|antimetabolites|mesh-ancestor
110654872|NCT00686855|Dexamethasone|dexamethasone|mesh-list
110654873|NCT00686855|Tacrolimus|tacrolimus|mesh-list
110654874|NCT00686855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110654875|NCT00686855|Antiemetics|antiemetics|mesh-ancestor
110654876|NCT00686855|Autonomic Agents|autonomic agents|mesh-ancestor
110654877|NCT00686855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110654878|NCT00686855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110654879|NCT00686855|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110654880|NCT00686855|Glucocorticoids|glucocorticoids|mesh-ancestor
110654881|NCT00686855|Hormones|hormones|mesh-ancestor
110654882|NCT00686855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110654883|NCT00686855|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110654884|NCT00686855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110654885|NCT00686855|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110654886|NCT00686855|Immunologic Factors|immunologic factors|mesh-ancestor
110654887|NCT00686855|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110654888|NCT00686855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110654889|NCT00686855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110654890|NCT00745043|Bronchodilator Agents|bronchodilator agents|mesh-list
110654891|NCT00745043|Autonomic Agents|autonomic agents|mesh-ancestor
110654892|NCT00745043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110654893|NCT00745043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110654894|NCT00745043|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110654895|NCT00745043|Respiratory System Agents|respiratory system agents|mesh-ancestor
110654896|NCT00949832|Calcium, Dietary|calcium, dietary|mesh-list
110654897|NCT00949832|Vitamin D|vitamin d|mesh-list
110160117|NCT00096304|Docetaxel|docetaxel|mesh-list
110654898|NCT00949832|Ergocalciferols|ergocalciferols|mesh-list
110654899|NCT00949832|Cholecalciferol|cholecalciferol|mesh-list
110654900|NCT00949832|Vitamins|vitamins|mesh-list
110654901|NCT00949832|Calcium|calcium|mesh-list
110654902|NCT00949832|Micronutrients|micronutrients|mesh-ancestor
110654903|NCT00949832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110654904|NCT00949832|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110654905|NCT00949832|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110654906|NCT00745199|Cromolyn Sodium|cromolyn sodium|mesh-list
110654907|NCT00745199|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
110654908|NCT00745199|Immunologic Factors|immunologic factors|mesh-ancestor
110654909|NCT00745199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110654910|NCT00745199|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110654911|NCT00745199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110654912|NCT00745199|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110654913|NCT00745199|Respiratory System Agents|respiratory system agents|mesh-ancestor
110654914|NCT00961844|Temozolomide|temozolomide|mesh-list
110654915|NCT00961844|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110654916|NCT00961844|Alkylating Agents|alkylating agents|mesh-ancestor
110654917|NCT00961844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110654918|NCT00961844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110654919|NCT00686777|Interferons|interferons|mesh-list
110654920|NCT00686777|Ribavirin|ribavirin|mesh-list
110654921|NCT00686777|Interferon-alpha|interferon-alpha|mesh-list
110654922|NCT00686777|Interferon alpha-2|interferon alpha-2|mesh-list
110654923|NCT00686777|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110654924|NCT00686777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110654925|NCT00686777|Antiviral Agents|antiviral agents|mesh-ancestor
110654926|NCT00686777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110654927|NCT00686777|Antimetabolites|antimetabolites|mesh-ancestor
110654928|NCT00686777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110654929|NCT00686777|Immunologic Factors|immunologic factors|mesh-ancestor
110654930|NCT00686777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110654931|NCT04009772|Metronidazole|metronidazole|mesh-list
110654932|NCT04009772|Cefepime|cefepime|mesh-list
110654933|NCT04009772|Cefuroxime|cefuroxime|mesh-list
110654934|NCT04009772|Cefuroxime axetil|cefuroxime axetil|mesh-list
110654935|NCT04009772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110654936|NCT04009772|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110654937|NCT04009772|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110654938|NCT04009772|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110654939|NCT00959582|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110654940|NCT00959582|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110654941|NCT00959582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110654942|NCT00962156|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
110654943|NCT00962156|Plasma Substitutes|plasma substitutes|mesh-ancestor
110654944|NCT00962156|Blood Substitutes|blood substitutes|mesh-ancestor
110654945|NCT01563068|Calcipotriene|calcipotriene|mesh-list
110654946|NCT01563068|Dermatologic Agents|dermatologic agents|mesh-ancestor
110654947|NCT00747305|Sunitinib|sunitinib|mesh-list
110654948|NCT00747305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110654949|NCT00747305|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110654950|NCT00747305|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110654951|NCT00747305|Growth Substances|growth substances|mesh-ancestor
110654952|NCT00747305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110654953|NCT00747305|Growth Inhibitors|growth inhibitors|mesh-ancestor
110654954|NCT00747305|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110654955|NCT00747305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110654956|NCT00747305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110654957|NCT05254106|Paclitaxel|paclitaxel|mesh-list
110654958|NCT05254106|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110654959|NCT05254106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110654960|NCT05254106|Tubulin Modulators|tubulin modulators|mesh-ancestor
110654961|NCT05254106|Antimitotic Agents|antimitotic agents|mesh-ancestor
110654962|NCT05254106|Mitosis Modulators|mitosis modulators|mesh-ancestor
110654963|NCT05254106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110654964|NCT00747383|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110654965|NCT00747383|Glimepiride|glimepiride|mesh-list
110654966|NCT00747383|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110654967|NCT00747383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110654968|NCT00747383|Incretins|incretins|mesh-ancestor
110654969|NCT00747383|Hormones|hormones|mesh-ancestor
110654970|NCT00747383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110654971|NCT00747383|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110654972|NCT00747383|Protease Inhibitors|protease inhibitors|mesh-ancestor
110654973|NCT00747383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110654974|NCT00747383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110654975|NCT00747383|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110654976|NCT00747383|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110654977|NCT00747383|Immunologic Factors|immunologic factors|mesh-ancestor
110654978|NCT00106639|Tacrolimus|tacrolimus|mesh-list
110654979|NCT00106639|Tofacitinib|tofacitinib|mesh-list
110654980|NCT00106639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110654981|NCT00106639|Immunologic Factors|immunologic factors|mesh-ancestor
110654982|NCT00106639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110398807|NCT04301479|Hydrocortisone|hydrocortisone|mesh-list
110654983|NCT00106639|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110654984|NCT00106639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110654985|NCT00106639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110654986|NCT00106639|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
110654987|NCT00106639|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110654988|NCT00747539|Interferons|interferons|mesh-list
110654989|NCT00747539|Ribavirin|ribavirin|mesh-list
110654991|NCT00747539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110654992|NCT00747539|Antiviral Agents|antiviral agents|mesh-ancestor
110654993|NCT00747539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110654994|NCT00747539|Antimetabolites|antimetabolites|mesh-ancestor
110654995|NCT00747539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110654996|NCT00747539|Immunologic Factors|immunologic factors|mesh-ancestor
110654997|NCT00747539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110654998|NCT00745433|Metformin|metformin|mesh-list
110654999|NCT00745433|Repaglinide|repaglinide|mesh-list
110655000|NCT00745433|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110655001|NCT00745433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110655002|NCT00962234|Deuterium Oxide|deuterium oxide|mesh-list
110655003|NCT00962234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110655004|NCT00962234|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110655005|NCT00962234|Protective Agents|protective agents|mesh-ancestor
110655006|NCT00962234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110655007|NCT00747695|Rabeprazole|rabeprazole|mesh-list
110655008|NCT00747695|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110655009|NCT00747695|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110655010|NCT00747695|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110655011|NCT00747695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110655012|NCT00747695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110655013|NCT00959972|Nicotine|nicotine|mesh-list
110655014|NCT00959972|Varenicline|varenicline|mesh-list
110655015|NCT00959972|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110655016|NCT00959972|Autonomic Agents|autonomic agents|mesh-ancestor
110655017|NCT00959972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110655018|NCT00959972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110655019|NCT00959972|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110655020|NCT00959972|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110655021|NCT00959972|Cholinergic Agents|cholinergic agents|mesh-ancestor
110655022|NCT00959972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110655023|NCT00959972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110655024|NCT04009616|Chlorhexidine|chlorhexidine|mesh-list
110655025|NCT04009616|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110655026|NCT04009616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110655027|NCT04009616|Disinfectants|disinfectants|mesh-ancestor
110655028|NCT00960284|Gemcitabine|gemcitabine|mesh-list
110655029|NCT00960284|Fluorouracil|fluorouracil|mesh-list
110655030|NCT00960284|Capecitabine|capecitabine|mesh-list
110655031|NCT00960284|Epirubicin|epirubicin|mesh-list
110655032|NCT00960284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110655033|NCT00960284|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110655034|NCT00960284|Antimetabolites|antimetabolites|mesh-ancestor
110655035|NCT00960284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110655036|NCT00960284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110655037|NCT00960284|Immunologic Factors|immunologic factors|mesh-ancestor
110655038|NCT00960284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110655039|NCT00960284|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110655040|NCT00960284|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110655041|NCT00960284|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110655042|NCT00960284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110655044|NCT00105469|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110655045|NCT00105469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110655046|NCT00962312|Capecitabine|capecitabine|mesh-list
110655047|NCT00962312|Lapatinib|lapatinib|mesh-list
110655048|NCT00962312|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110655049|NCT00962312|Antimetabolites|antimetabolites|mesh-ancestor
110655050|NCT00962312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110655051|NCT00962312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110655052|NCT00962312|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110655053|NCT00962312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110655054|NCT00960518|Adefovir|adefovir|mesh-list
110655055|NCT00960518|Antiviral Agents|antiviral agents|mesh-ancestor
110655056|NCT00960518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110655057|NCT00960518|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110655058|NCT00960518|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110655059|NCT00960518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110655060|NCT00960518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110655061|NCT00960830|Mirtazapine|mirtazapine|mesh-list
110655062|NCT00960830|Antidepressive Agents|antidepressive agents|mesh-ancestor
110655063|NCT00960830|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110655064|NCT00960830|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110655065|NCT00960830|Histamine Antagonists|histamine antagonists|mesh-ancestor
110655066|NCT00960830|Histamine Agents|histamine agents|mesh-ancestor
110655067|NCT00960830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110655068|NCT00960830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110655069|NCT00960830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110655070|NCT00960830|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110655071|NCT00960830|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110655072|NCT00960830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110655073|NCT00960830|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
110655074|NCT00960830|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110655075|NCT00960830|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110655076|NCT00960830|Adrenergic Agents|adrenergic agents|mesh-ancestor
110655077|NCT00960830|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110655078|NCT00960830|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110655079|NCT00960830|Serotonin Agents|serotonin agents|mesh-ancestor
110655080|NCT00960830|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110655081|NCT00962624|Vaccines|vaccines|mesh-list
110655082|NCT00962624|Immunologic Factors|immunologic factors|mesh-ancestor
110655083|NCT00962624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110655084|NCT00105235|Cyclosporine|cyclosporine|mesh-list
110655085|NCT00105235|Mycophenolic Acid|mycophenolic acid|mesh-list
110655086|NCT00105235|Alemtuzumab|alemtuzumab|mesh-list
110655087|NCT00105235|Tacrolimus|tacrolimus|mesh-list
110655088|NCT00105235|Cyclosporins|cyclosporins|mesh-list
110655089|NCT00105235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110655090|NCT00105235|Immunologic Factors|immunologic factors|mesh-ancestor
110655091|NCT00105235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110655092|NCT00105235|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110655093|NCT00105235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110655094|NCT00105235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110655095|NCT00105235|Antifungal Agents|antifungal agents|mesh-ancestor
110655096|NCT00105235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110655097|NCT00105235|Dermatologic Agents|dermatologic agents|mesh-ancestor
110655098|NCT00105235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110655099|NCT00105235|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110655100|NCT00105235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110655101|NCT00105235|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110655102|NCT00105235|Antitubercular Agents|antitubercular agents|mesh-ancestor
110655103|NCT00105235|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110655104|NCT00105235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110655106|NCT03962803|Immunologic Factors|immunologic factors|mesh-ancestor
110655107|NCT03962803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110655108|NCT00547118|Rimonabant|rimonabant|mesh-list
110655109|NCT00547118|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110655110|NCT00547118|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
110655111|NCT00547118|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110655112|NCT00547118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110655113|NCT00547118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110655114|NCT00547118|Hormones|hormones|mesh-ancestor
110655115|NCT00547118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110655116|NCT00547118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110655117|NCT00962936|Pidilizumab|pidilizumab|mesh-list
110655118|NCT00962936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110655119|NCT00962936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110655120|NCT01087099|Albendazole|albendazole|mesh-list
110655121|NCT01087099|Anthelmintics|anthelmintics|mesh-ancestor
110655122|NCT01087099|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110655123|NCT01087099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110655124|NCT01087099|Anticestodal Agents|anticestodal agents|mesh-ancestor
110655125|NCT01087099|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110655126|NCT01087099|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110655127|NCT01087099|Tubulin Modulators|tubulin modulators|mesh-ancestor
110655128|NCT01087099|Antimitotic Agents|antimitotic agents|mesh-ancestor
110655129|NCT01087099|Mitosis Modulators|mitosis modulators|mesh-ancestor
110655130|NCT01087099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110655131|NCT01087099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110655132|NCT00686543|Posaconazole|posaconazole|mesh-list
110655133|NCT00686543|Antifungal Agents|antifungal agents|mesh-ancestor
110302329|NCT00250874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110655134|NCT00686543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110655135|NCT00686543|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
110655136|NCT00686543|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110655137|NCT00686543|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110655138|NCT00686543|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110655139|NCT00686543|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110655140|NCT00686543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110655141|NCT00686543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110655142|NCT00686543|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110655143|NCT00686543|Hormone Antagonists|hormone antagonists|mesh-ancestor
110655144|NCT00686543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110655145|NCT00686543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110655146|NCT00750113|Telmisartan|telmisartan|mesh-list
110655147|NCT00750113|Nifedipine|nifedipine|mesh-list
110655148|NCT00750113|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110655149|NCT00750113|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110655150|NCT00750113|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110655151|NCT00750113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110655152|NCT00750113|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110655153|NCT00750113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110655154|NCT00750113|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110655155|NCT00750113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110655156|NCT00750113|Vasodilator Agents|vasodilator agents|mesh-ancestor
110655158|NCT00750113|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110655159|NCT00745511|Bevacizumab|bevacizumab|mesh-list
110655160|NCT00745511|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110655161|NCT00745511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110655162|NCT00745511|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110655163|NCT00745511|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110655164|NCT00745511|Growth Substances|growth substances|mesh-ancestor
110655165|NCT00745511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110655166|NCT00745511|Growth Inhibitors|growth inhibitors|mesh-ancestor
110655167|NCT00545688|Docetaxel|docetaxel|mesh-list
110655168|NCT00545688|Trastuzumab|trastuzumab|mesh-list
110655169|NCT00545688|Pertuzumab|pertuzumab|mesh-list
110655170|NCT00545688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110655171|NCT00545688|Tubulin Modulators|tubulin modulators|mesh-ancestor
110655172|NCT00545688|Antimitotic Agents|antimitotic agents|mesh-ancestor
110655173|NCT00545688|Mitosis Modulators|mitosis modulators|mesh-ancestor
110655174|NCT00545688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110398839|NCT01095094|Lopinavir|lopinavir|mesh-list
110655175|NCT00545688|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110655177|NCT00502203|Carboplatin|carboplatin|mesh-list
110655178|NCT00502203|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110655179|NCT00502203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110655180|NCT00502203|Tubulin Modulators|tubulin modulators|mesh-ancestor
110655181|NCT00502203|Antimitotic Agents|antimitotic agents|mesh-ancestor
110655182|NCT00502203|Mitosis Modulators|mitosis modulators|mesh-ancestor
110655183|NCT00502203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110655184|NCT00546078|Vaccines|vaccines|mesh-list
110655185|NCT00546078|Immunologic Factors|immunologic factors|mesh-ancestor
110655186|NCT00546078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110655187|NCT00967772|Naftopidil|naftopidil|mesh-list
110655188|NCT00967772|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110655189|NCT00967772|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110655190|NCT00967772|Adrenergic Agents|adrenergic agents|mesh-ancestor
110655191|NCT00967772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110655192|NCT00967772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110655193|NCT00967772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110655194|NCT00967772|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110655195|NCT00967772|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110655196|NCT00967772|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110565301|NCT00834366|Analgesics|analgesics|mesh-ancestor
110655197|NCT00967772|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110655198|NCT00967772|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110655199|NCT00967850|Verteporfin|verteporfin|mesh-list
110655200|NCT00967850|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110655201|NCT00967850|Dermatologic Agents|dermatologic agents|mesh-ancestor
110655202|NCT00967928|Everolimus|everolimus|mesh-list
110655203|NCT00967928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110655204|NCT00967928|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110655205|NCT00967928|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110655206|NCT00967928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110302409|NCT00286689|Hormones|hormones|mesh-list
110655207|NCT00967928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110207915|NCT00190294|Mifepristone|mifepristone|mesh-list
110655208|NCT00967928|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110655209|NCT00967928|Immunologic Factors|immunologic factors|mesh-ancestor
110655210|NCT00967928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110655211|NCT00546000|Fluticasone|fluticasone|mesh-list
110655212|NCT00546000|Xhance|xhance|mesh-list
110655213|NCT00546000|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110655214|NCT00546000|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110655215|NCT00546000|Autonomic Agents|autonomic agents|mesh-ancestor
110655216|NCT00546000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110655217|NCT00546000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110655218|NCT00546000|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110655219|NCT00546000|Respiratory System Agents|respiratory system agents|mesh-ancestor
110655220|NCT00546000|Dermatologic Agents|dermatologic agents|mesh-ancestor
110655221|NCT00546000|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110655222|NCT00968006|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110655223|NCT00968006|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110655224|NCT00968006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110655225|NCT00968006|Incretins|incretins|mesh-ancestor
110655226|NCT00968006|Hormones|hormones|mesh-ancestor
110655227|NCT00968006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110655228|NCT00968006|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110655229|NCT00968006|Protease Inhibitors|protease inhibitors|mesh-ancestor
110655230|NCT00968006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110655231|NCT00968006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110655232|NCT00968162|Fludarabine|fludarabine|mesh-list
110655233|NCT00968162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110655234|NCT00968240|Bevacizumab|bevacizumab|mesh-list
110655235|NCT00968240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110655236|NCT00968240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110655237|NCT00968240|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110655238|NCT00968240|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110655239|NCT00968240|Growth Substances|growth substances|mesh-ancestor
110655240|NCT00968240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110655241|NCT00968240|Growth Inhibitors|growth inhibitors|mesh-ancestor
110655242|NCT00501969|Rotigotine|rotigotine|mesh-list
110655243|NCT00501969|Dopamine Agonists|dopamine agonists|mesh-ancestor
110655244|NCT00501969|Dopamine Agents|dopamine agents|mesh-ancestor
110655245|NCT00501969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110655246|NCT00501969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110655247|NCT00501969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110655248|NCT03942042|Ixekizumab|ixekizumab|mesh-list
110655249|NCT03942042|Dermatologic Agents|dermatologic agents|mesh-ancestor
110655250|NCT00968396|Melphalan|melphalan|mesh-list
110655251|NCT00968396|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110655252|NCT00968396|Alkylating Agents|alkylating agents|mesh-ancestor
110655253|NCT00968396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110655254|NCT00968396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110655255|NCT00968396|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110655256|NCT00968396|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110565318|NCT00660725|Gemcitabine|gemcitabine|mesh-list
110655257|NCT00968396|Immunologic Factors|immunologic factors|mesh-ancestor
110655258|NCT00968396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110655259|NCT04008732|Nitroglycerin|nitroglycerin|mesh-list
110655260|NCT04008732|Vasodilator Agents|vasodilator agents|mesh-ancestor
110655261|NCT01013727|Technetium Tc 99m bicisate|technetium tc 99m bicisate|mesh-list
110655262|NCT01013727|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110655263|NCT01013727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110655264|NCT01013805|Leucovorin|leucovorin|mesh-list
110655265|NCT01013805|Fluorouracil|fluorouracil|mesh-list
110655266|NCT01013805|Oxaliplatin|oxaliplatin|mesh-list
110655267|NCT01013805|Antimetabolites|antimetabolites|mesh-ancestor
110655268|NCT01013805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110655269|NCT01013805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110655270|NCT01013805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110655271|NCT01013805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110655272|NCT01013805|Immunologic Factors|immunologic factors|mesh-ancestor
110655273|NCT01013805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110655274|NCT01013805|Antidotes|antidotes|mesh-ancestor
110655275|NCT01013805|Protective Agents|protective agents|mesh-ancestor
110655276|NCT01013805|Vitamin B Complex|vitamin b complex|mesh-ancestor
110655278|NCT01013805|Micronutrients|micronutrients|mesh-ancestor
110655279|NCT00104299|Prednisone|prednisone|mesh-list
110655280|NCT00104299|Methylprednisolone|methylprednisolone|mesh-list
110655281|NCT00104299|Cyclophosphamide|cyclophosphamide|mesh-list
110655282|NCT00104299|Rituximab|rituximab|mesh-list
110655283|NCT00104299|Azathioprine|azathioprine|mesh-list
110655284|NCT00104299|Glucocorticoids|glucocorticoids|mesh-list
110655285|NCT00104299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110655286|NCT00104299|Immunologic Factors|immunologic factors|mesh-ancestor
110655287|NCT00104299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110655288|NCT00104299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110655289|NCT00104299|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110655290|NCT00104299|Alkylating Agents|alkylating agents|mesh-ancestor
110655291|NCT00104299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110655292|NCT00104299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110655293|NCT00104299|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110565331|NCT00844194|Analgesics|analgesics|mesh-ancestor
110655294|NCT00104299|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110655295|NCT00104299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110655296|NCT00104299|Hormones|hormones|mesh-ancestor
110655297|NCT00104299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110655298|NCT00104299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110655299|NCT00104299|Antiemetics|antiemetics|mesh-ancestor
110655300|NCT00104299|Autonomic Agents|autonomic agents|mesh-ancestor
110655301|NCT00104299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110655302|NCT00104299|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110655303|NCT00104299|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110655304|NCT00104299|Protective Agents|protective agents|mesh-ancestor
110655305|NCT00104299|Antimetabolites|antimetabolites|mesh-ancestor
110655306|NCT00104299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110655307|NCT05196308|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
110655308|NCT05196308|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110655309|NCT05196308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110655310|NCT05196308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110655311|NCT05196308|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110655312|NCT05196308|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110655313|NCT05196308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110655314|NCT05196308|Cholinergic Agents|cholinergic agents|mesh-ancestor
110655315|NCT05196308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110655316|NCT00082381|Insulin Glargine|insulin glargine|mesh-list
110655317|NCT00082381|Exenatide|exenatide|mesh-list
110655318|NCT00082381|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110655319|NCT00082381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110655320|NCT00082381|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110655321|NCT00082381|Incretins|incretins|mesh-ancestor
110655322|NCT00082381|Hormones|hormones|mesh-ancestor
110655323|NCT00082381|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110655324|NCT00964106|Rosiglitazone|rosiglitazone|mesh-list
110655325|NCT00964106|Rifampin|rifampin|mesh-list
110655326|NCT00964106|Fluconazole|fluconazole|mesh-list
110655327|NCT00964106|Ketoconazole|ketoconazole|mesh-list
110655328|NCT00964106|Flurbiprofen|flurbiprofen|mesh-list
110655329|NCT00964106|Midazolam|midazolam|mesh-list
110655330|NCT00964106|Dextromethorphan|dextromethorphan|mesh-list
110655331|NCT00964106|Caffeine|caffeine|mesh-list
110655332|NCT00964106|Omeprazole|omeprazole|mesh-list
110655333|NCT00964106|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110655334|NCT00964106|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110655335|NCT00964106|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110655336|NCT00964106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110655337|NCT00964106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110655338|NCT00964106|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110655339|NCT00964106|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110655340|NCT00964106|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110655341|NCT00964106|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110655342|NCT00964106|Anesthetics, General|anesthetics, general|mesh-ancestor
110655343|NCT00964106|Anesthetics|anesthetics|mesh-ancestor
110655344|NCT00964106|GABA Modulators|gaba modulators|mesh-ancestor
110655345|NCT00964106|GABA Agents|gaba agents|mesh-ancestor
110655347|NCT00964106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110655348|NCT00964106|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110655349|NCT00964106|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110655350|NCT00964106|Antimetabolites|antimetabolites|mesh-ancestor
110655351|NCT00964106|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110655352|NCT00964106|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110655353|NCT00964106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110655354|NCT00964106|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110655355|NCT00964106|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110655356|NCT00964106|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110655357|NCT00964106|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110655358|NCT00964106|Purinergic Agents|purinergic agents|mesh-ancestor
110655359|NCT00964106|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110655360|NCT00964106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110655361|NCT00964106|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110655362|NCT00964106|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110655363|NCT00964106|Antitubercular Agents|antitubercular agents|mesh-ancestor
110655364|NCT00964106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110655365|NCT00964106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110655366|NCT00964106|Leprostatic Agents|leprostatic agents|mesh-ancestor
110655367|NCT00964106|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110565481|NCT00913224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110655368|NCT00964106|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110655369|NCT00964106|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110655370|NCT00964106|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110655371|NCT00964106|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110655372|NCT00964106|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110655373|NCT00964106|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110655374|NCT00964106|Antifungal Agents|antifungal agents|mesh-ancestor
110655375|NCT00964106|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110655376|NCT00964106|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110655377|NCT00964106|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110655378|NCT00964106|Hormone Antagonists|hormone antagonists|mesh-ancestor
110655379|NCT00964106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110655380|NCT00964106|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110655381|NCT00964106|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110655382|NCT00964106|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110655383|NCT00964106|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110655384|NCT00964106|Antitussive Agents|antitussive agents|mesh-ancestor
110655385|NCT00964106|Respiratory System Agents|respiratory system agents|mesh-ancestor
110655386|NCT00964106|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110655387|NCT00964106|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110655389|NCT00964106|Sensory System Agents|sensory system agents|mesh-ancestor
110655390|NCT00964106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110655391|NCT00964106|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110655392|NCT00964106|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110655393|NCT00964106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110655394|NCT00964106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110655395|NCT00964106|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110655396|NCT00960336|Doxorubicin|doxorubicin|mesh-list
110655397|NCT00960336|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110655398|NCT00960336|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110655399|NCT00960336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110655400|NCT00960336|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110655401|NCT00960336|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110207955|NCT00190333|Serotonin Agents|serotonin agents|mesh-ancestor
110655402|NCT00960336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110655403|NCT00960336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110655404|NCT00965172|Calcium|calcium|mesh-list
110655405|NCT00965172|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110655406|NCT00965172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110655407|NCT01084837|Bortezomib|bortezomib|mesh-list
110655408|NCT01084837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110655409|NCT00545844|Montelukast|montelukast|mesh-list
110655410|NCT00545844|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110655411|NCT00545844|Respiratory System Agents|respiratory system agents|mesh-ancestor
110655412|NCT00545844|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110655413|NCT00545844|Hormone Antagonists|hormone antagonists|mesh-ancestor
110655414|NCT00545844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110655415|NCT00545844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110655416|NCT00545844|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110655417|NCT00545844|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110655418|NCT00545844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110655419|NCT01084993|Heparin|heparin|mesh-list
110655420|NCT01084993|Bivalirudin|bivalirudin|mesh-list
110655421|NCT01084993|Anticoagulants|anticoagulants|mesh-ancestor
110655422|NCT01084993|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110655423|NCT01084993|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110655424|NCT01084993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110655425|NCT01084993|Antithrombins|antithrombins|mesh-ancestor
110655426|NCT01084993|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110655427|NCT01084993|Protease Inhibitors|protease inhibitors|mesh-ancestor
110655428|NCT01084993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110655429|NCT00492063|Vaccines|vaccines|mesh-list
110302630|NCT00280215|Protease Inhibitors|protease inhibitors|mesh-ancestor
110655430|NCT00492063|Immunologic Factors|immunologic factors|mesh-ancestor
110655431|NCT00492063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110655432|NCT00960492|Temozolomide|temozolomide|mesh-list
110655433|NCT00960492|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110655434|NCT00960492|Alkylating Agents|alkylating agents|mesh-ancestor
110398879|NCT01322009|Antidotes|antidotes|mesh-ancestor
110655435|NCT00960492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110655436|NCT00960492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110655437|NCT00971724|Prednisolone|prednisolone|mesh-list
110655438|NCT00971724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110655439|NCT00971724|Glucocorticoids|glucocorticoids|mesh-ancestor
110655440|NCT00971724|Hormones|hormones|mesh-ancestor
110655441|NCT00971724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110655442|NCT00971724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110655443|NCT00971724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110655444|NCT00971724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110655445|NCT02976909|Paclitaxel|paclitaxel|mesh-list
110655446|NCT02976909|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110655447|NCT02976909|Cisplatin|cisplatin|mesh-list
110655448|NCT02976909|Fluorouracil|fluorouracil|mesh-list
110655449|NCT02976909|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110655450|NCT02976909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110655451|NCT02976909|Tubulin Modulators|tubulin modulators|mesh-ancestor
110655452|NCT02976909|Antimitotic Agents|antimitotic agents|mesh-ancestor
110655453|NCT02976909|Mitosis Modulators|mitosis modulators|mesh-ancestor
110655454|NCT02976909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110655455|NCT02976909|Antimetabolites|antimetabolites|mesh-ancestor
110655456|NCT02976909|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110655457|NCT02976909|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110655458|NCT02976909|Immunologic Factors|immunologic factors|mesh-ancestor
110655459|NCT02976909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110655460|NCT02878083|Adalimumab|adalimumab|mesh-list
110655461|NCT02878083|Vedolizumab|vedolizumab|mesh-list
110655462|NCT02878083|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110655463|NCT02878083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110655464|NCT02878083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110655465|NCT02878083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110655467|NCT00093145|Carboplatin|carboplatin|mesh-list
110655468|NCT00093145|Trastuzumab|trastuzumab|mesh-list
110655469|NCT00093145|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110655470|NCT00093145|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110655471|NCT00093145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110655472|NCT00093145|Tubulin Modulators|tubulin modulators|mesh-ancestor
110565887|NCT04154033|Naltrexone|naltrexone|mesh-list
110655473|NCT00093145|Antimitotic Agents|antimitotic agents|mesh-ancestor
110655474|NCT00093145|Mitosis Modulators|mitosis modulators|mesh-ancestor
110655475|NCT00093145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110655476|NCT00093145|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110655477|NCT00965406|Insulin|insulin|mesh-list
110655478|NCT00965406|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110655479|NCT00965406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110655480|NCT00513357|Melatonin|melatonin|mesh-list
110655481|NCT00513357|Antioxidants|antioxidants|mesh-ancestor
110655482|NCT00513357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110655483|NCT00513357|Protective Agents|protective agents|mesh-ancestor
110655484|NCT00513357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110655485|NCT00513357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110655486|NCT00960960|Paclitaxel|paclitaxel|mesh-list
110655487|NCT00960960|Bevacizumab|bevacizumab|mesh-list
110655488|NCT00960960|Trastuzumab|trastuzumab|mesh-list
110655489|NCT00960960|Letrozole|letrozole|mesh-list
110655490|NCT00960960|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110655491|NCT00960960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110655492|NCT00960960|Tubulin Modulators|tubulin modulators|mesh-ancestor
110655493|NCT00960960|Antimitotic Agents|antimitotic agents|mesh-ancestor
110655494|NCT00960960|Mitosis Modulators|mitosis modulators|mesh-ancestor
110655495|NCT00960960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110655496|NCT00960960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110655497|NCT00960960|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110566063|NCT00911651|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110655498|NCT00960960|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110655499|NCT00960960|Growth Substances|growth substances|mesh-ancestor
110655500|NCT00960960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110655501|NCT00960960|Growth Inhibitors|growth inhibitors|mesh-ancestor
110655502|NCT00960960|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110655503|NCT00960960|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110655504|NCT00960960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110655505|NCT00960960|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110655506|NCT00960960|Hormone Antagonists|hormone antagonists|mesh-ancestor
110655507|NCT00960960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110655509|NCT00965640|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110655510|NCT00965640|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110655511|NCT00965640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110655512|NCT00965640|Cholinergic Agents|cholinergic agents|mesh-ancestor
110655513|NCT00965640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110655514|NCT00965640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110655515|NCT00961038|Ciprofloxacin|ciprofloxacin|mesh-list
110655516|NCT00961038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110566305|NCT00677339|Vitamin D|vitamin d|mesh-list
110655517|NCT00961038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110655518|NCT00961038|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110655519|NCT00961038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110655520|NCT00961038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110655521|NCT00961038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110655522|NCT00961038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110655523|NCT00961038|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110655524|NCT00961038|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110655525|NCT00961194|Ketamine|ketamine|mesh-list
110655526|NCT00961194|Analgesics|analgesics|mesh-ancestor
110655527|NCT00961194|Sensory System Agents|sensory system agents|mesh-ancestor
110655528|NCT00961194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110655529|NCT00961194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110655530|NCT00961194|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110655531|NCT00961194|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110655532|NCT00961194|Anesthetics, General|anesthetics, general|mesh-ancestor
110655533|NCT00961194|Anesthetics|anesthetics|mesh-ancestor
110655534|NCT00961194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110655535|NCT00961194|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110655536|NCT00961194|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110655537|NCT00961194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110655538|NCT00961194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110655539|NCT05279586|Colistin|colistin|mesh-list
110655540|NCT05279586|Lactulose|lactulose|mesh-list
110655541|NCT05279586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110655542|NCT05279586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110655543|NCT05279586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110655544|NCT00965796|Lidocaine|lidocaine|mesh-list
110655545|NCT00965796|Anesthetics, Local|anesthetics, local|mesh-ancestor
110655546|NCT00965796|Anesthetics|anesthetics|mesh-ancestor
110655547|NCT00965796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110655548|NCT00965796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110655549|NCT00965796|Sensory System Agents|sensory system agents|mesh-ancestor
110655550|NCT00965796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110655551|NCT00965796|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110566539|NCT00882557|Daptomycin|daptomycin|mesh-list
110655552|NCT00965796|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110655553|NCT00965796|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110655554|NCT00965796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110655555|NCT00965796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110655556|NCT00415636|Pemetrexed|pemetrexed|mesh-list
110655557|NCT00415636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110655558|NCT00415636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110655559|NCT00415636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110655560|NCT00415636|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110655561|NCT00415636|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110655562|NCT00965874|Magnesium Sulfate|magnesium sulfate|mesh-list
110655563|NCT00965874|Analgesics|analgesics|mesh-ancestor
110655564|NCT00965874|Sensory System Agents|sensory system agents|mesh-ancestor
110655565|NCT00965874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110655566|NCT00965874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110655567|NCT00965874|Anesthetics|anesthetics|mesh-ancestor
110655568|NCT00965874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110655569|NCT00965874|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110655570|NCT00965874|Anticonvulsants|anticonvulsants|mesh-ancestor
110655571|NCT00965874|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110655572|NCT00965874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110655573|NCT00965874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110655574|NCT00965874|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110655575|NCT00965874|Tocolytic Agents|tocolytic agents|mesh-ancestor
110655576|NCT00965874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110655577|NCT00972426|Timolol|timolol|mesh-list
110655579|NCT00972426|Latanoprost|latanoprost|mesh-list
110655580|NCT00972426|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110655581|NCT00972426|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110655582|NCT00972426|Adrenergic Agents|adrenergic agents|mesh-ancestor
110655583|NCT00972426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110655584|NCT00972426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110655585|NCT00972426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110655586|NCT00972426|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110655587|NCT00972426|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110655588|NCT00972426|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110655589|NCT00972426|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110655590|NCT00972426|Sympatholytics|sympatholytics|mesh-ancestor
110655591|NCT00972426|Autonomic Agents|autonomic agents|mesh-ancestor
110655592|NCT00972426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110655593|NCT00972660|Cyclosporine|cyclosporine|mesh-list
110655594|NCT00972660|Mycophenolic Acid|mycophenolic acid|mesh-list
110655595|NCT00972660|Prednisone|prednisone|mesh-list
110655596|NCT00972660|Cyclosporins|cyclosporins|mesh-list
110655597|NCT00972660|Tacrolimus|tacrolimus|mesh-list
110655598|NCT00972660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110655599|NCT00972660|Glucocorticoids|glucocorticoids|mesh-ancestor
110655600|NCT00972660|Hormones|hormones|mesh-ancestor
110655649|NCT01037530|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110655601|NCT00972660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110655602|NCT00972660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110655603|NCT00972660|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110655604|NCT00972660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110655605|NCT00972660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110567085|NCT05941715|Aflibercept|aflibercept|mesh-list
110655606|NCT00972660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110655607|NCT00972660|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110655608|NCT00972660|Immunologic Factors|immunologic factors|mesh-ancestor
110655609|NCT00972660|Antifungal Agents|antifungal agents|mesh-ancestor
110655610|NCT00972660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110655611|NCT00972660|Dermatologic Agents|dermatologic agents|mesh-ancestor
110655612|NCT00972660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110655650|NCT00973050|Bicalutamide|bicalutamide|mesh-list
110655613|NCT00972660|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110655614|NCT00972660|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110655615|NCT00972660|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110655616|NCT00972660|Antitubercular Agents|antitubercular agents|mesh-ancestor
110655617|NCT00972660|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110655618|NCT04008966|Triptorelin Pamoate|triptorelin pamoate|mesh-list
110655619|NCT04008966|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
110208024|NCT00190645|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110655620|NCT04008966|Cetrorelix|cetrorelix|mesh-list
110655621|NCT04008966|Progesterone|progesterone|mesh-list
110655651|NCT00973050|Androgen Antagonists|androgen antagonists|mesh-ancestor
110655653|NCT00973050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110655654|NCT00973050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110655655|NCT00973050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110655656|NCT00973128|Meglumine Antimoniate|meglumine antimoniate|mesh-list
110655657|NCT00973128|Sargramostim|sargramostim|mesh-list
110655658|NCT00973128|Immunologic Factors|immunologic factors|mesh-ancestor
110655659|NCT00973128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110655660|NCT00973128|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110655661|NCT00973128|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110655662|NCT00973128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110655663|NCT00973986|Atorvastatin|atorvastatin|mesh-list
110655664|NCT00973986|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110655665|NCT00973986|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110655666|NCT00973986|Antimetabolites|antimetabolites|mesh-ancestor
110655667|NCT00973986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110655668|NCT00973986|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110655669|NCT00973986|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110655670|NCT00973986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110655672|NCT00966576|Brinzolamide|brinzolamide|mesh-list
110655673|NCT00966576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110655674|NCT00966576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110655675|NCT00966576|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110655676|NCT00966576|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110655677|NCT00966576|Adrenergic Agents|adrenergic agents|mesh-ancestor
110655678|NCT00966576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110655679|NCT00966576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110655680|NCT00966576|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110655681|NCT00966576|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110655682|NCT00966576|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110208035|NCT00190762|Pemetrexed|pemetrexed|mesh-list
110655683|NCT00425308|Cyclosporine|cyclosporine|mesh-list
110655684|NCT00425308|Mycophenolic Acid|mycophenolic acid|mesh-list
110655685|NCT00425308|Everolimus|everolimus|mesh-list
110655686|NCT00425308|Cyclosporins|cyclosporins|mesh-list
110655687|NCT00425308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110655688|NCT00425308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110655689|NCT00425308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110655690|NCT00425308|Immunologic Factors|immunologic factors|mesh-ancestor
110398916|NCT01318811|Heparin|heparin|mesh-list
110655691|NCT00425308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110655692|NCT00425308|Antifungal Agents|antifungal agents|mesh-ancestor
110655693|NCT00425308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110655694|NCT00425308|Dermatologic Agents|dermatologic agents|mesh-ancestor
110655695|NCT00425308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110655696|NCT00425308|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110655697|NCT00425308|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110655698|NCT00425308|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110655699|NCT00425308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110655700|NCT00425308|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110655701|NCT00425308|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110655702|NCT00425308|Antitubercular Agents|antitubercular agents|mesh-ancestor
110655703|NCT00425308|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110655704|NCT04008888|Dexamethasone|dexamethasone|mesh-list
110655705|NCT04008888|Dexamethasone acetate|dexamethasone acetate|mesh-list
110655706|NCT04008888|Fludarabine|fludarabine|mesh-list
110655707|NCT04008888|Melphalan|melphalan|mesh-list
110655708|NCT04008888|BB 1101|bb 1101|mesh-list
110655709|NCT04008888|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110655710|NCT04008888|Antiemetics|antiemetics|mesh-ancestor
110655711|NCT04008888|Autonomic Agents|autonomic agents|mesh-ancestor
110655712|NCT04008888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110655713|NCT04008888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110655714|NCT04008888|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110655715|NCT04008888|Glucocorticoids|glucocorticoids|mesh-ancestor
110655716|NCT04008888|Hormones|hormones|mesh-ancestor
110655717|NCT04008888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110655718|NCT04008888|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110655719|NCT04008888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110655720|NCT04008888|Protease Inhibitors|protease inhibitors|mesh-ancestor
110655721|NCT04008888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110655722|NCT04008888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110655723|NCT04008888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110655724|NCT04008888|Immunologic Factors|immunologic factors|mesh-ancestor
110655725|NCT04008888|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110655726|NCT04008888|Alkylating Agents|alkylating agents|mesh-ancestor
110655727|NCT04008888|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110655728|NCT01033084|Sertraline|sertraline|mesh-list
110655729|NCT01033084|Antidepressive Agents|antidepressive agents|mesh-ancestor
110655730|NCT01033084|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110655731|NCT01033084|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110655732|NCT01033084|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110160248|NCT00097123|Oxytocics|oxytocics|mesh-ancestor
110655733|NCT01033084|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110655734|NCT01033084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110655735|NCT01033084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110655736|NCT01033084|Serotonin Agents|serotonin agents|mesh-ancestor
110655737|NCT01033084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110655738|NCT00979758|Atorvastatin|atorvastatin|mesh-list
110655739|NCT00979758|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110655740|NCT00979758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110655741|NCT00979758|Antimetabolites|antimetabolites|mesh-ancestor
110655742|NCT00979758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110655743|NCT00979758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110655744|NCT00979758|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110655745|NCT00979758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110655746|NCT00545064|Timolol|timolol|mesh-list
110655747|NCT00545064|Dorzolamide|dorzolamide|mesh-list
110655748|NCT00545064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110655749|NCT00545064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110655750|NCT00545064|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110655751|NCT00545064|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110655752|NCT00545064|Adrenergic Agents|adrenergic agents|mesh-ancestor
110655753|NCT00545064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110655754|NCT00545064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110655755|NCT00545064|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110655756|NCT00545064|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110655757|NCT00545064|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110655758|NCT00979836|Calcium Dobesilate|calcium dobesilate|mesh-list
110655759|NCT00979836|Calcium|calcium|mesh-list
110398931|NCT05644691|Emollients|emollients|mesh-list
110655760|NCT00979836|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110655761|NCT00979836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110655762|NCT00979836|Hemostatics|hemostatics|mesh-ancestor
110655763|NCT00979836|Coagulants|coagulants|mesh-ancestor
110655764|NCT01588912|Tenofovir|tenofovir|mesh-list
110655765|NCT01588912|Entecavir|entecavir|mesh-list
110655766|NCT01588912|Telbivudine|telbivudine|mesh-list
110655767|NCT01588912|Antiviral Agents|antiviral agents|mesh-ancestor
110655768|NCT01588912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110655769|NCT01588912|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110655770|NCT01588912|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110655771|NCT01588912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110655772|NCT01588912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110655773|NCT01588912|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110655774|NCT01588912|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110655775|NCT01589068|Nicotine|nicotine|mesh-list
110655776|NCT01589068|Progesterone|progesterone|mesh-list
110655777|NCT01589068|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110655778|NCT01589068|Autonomic Agents|autonomic agents|mesh-ancestor
110655779|NCT01589068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110655780|NCT01589068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110655781|NCT01589068|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110655782|NCT01589068|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110655783|NCT01589068|Cholinergic Agents|cholinergic agents|mesh-ancestor
110655784|NCT01589068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110655785|NCT01589068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110655786|NCT01589068|Progestins|progestins|mesh-ancestor
110655787|NCT01589068|Hormones|hormones|mesh-ancestor
110655788|NCT01589068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110655789|NCT00432562|Vinorelbine|vinorelbine|mesh-list
110655790|NCT00432562|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110655791|NCT00432562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110655792|NCT00432562|Tubulin Modulators|tubulin modulators|mesh-ancestor
110655793|NCT00432562|Antimitotic Agents|antimitotic agents|mesh-ancestor
110655794|NCT00432562|Mitosis Modulators|mitosis modulators|mesh-ancestor
110655795|NCT00432562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110655796|NCT00966966|Gemfibrozil|gemfibrozil|mesh-list
110655797|NCT00966966|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110655798|NCT00966966|Antimetabolites|antimetabolites|mesh-ancestor
110655799|NCT00966966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110655800|NCT00966966|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110655801|NCT00966966|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
110303000|NCT02271997|Trace Elements|trace elements|mesh-ancestor
110655802|NCT00966966|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110655804|NCT00974532|Calcium, Dietary|calcium, dietary|mesh-list
110655805|NCT00974532|Calcium|calcium|mesh-list
110655806|NCT00974532|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110655807|NCT00974532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110655808|NCT00974532|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110655809|NCT00432172|Cyclophosphamide|cyclophosphamide|mesh-list
110655810|NCT00432172|Carboplatin|carboplatin|mesh-list
110655811|NCT00432172|Docetaxel|docetaxel|mesh-list
110655812|NCT00432172|Epirubicin|epirubicin|mesh-list
110655813|NCT00432172|Exemestane|exemestane|mesh-list
110655814|NCT00432172|Goserelin|goserelin|mesh-list
110655815|NCT00432172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110655816|NCT00432172|Immunologic Factors|immunologic factors|mesh-ancestor
110655817|NCT00432172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110655818|NCT00432172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110655819|NCT00432172|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110655820|NCT00432172|Alkylating Agents|alkylating agents|mesh-ancestor
110655821|NCT00432172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110655822|NCT00432172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110655823|NCT00432172|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110655824|NCT00432172|Tubulin Modulators|tubulin modulators|mesh-ancestor
110655825|NCT00432172|Antimitotic Agents|antimitotic agents|mesh-ancestor
110655826|NCT00432172|Mitosis Modulators|mitosis modulators|mesh-ancestor
110655827|NCT00432172|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110655828|NCT00432172|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110655829|NCT00432172|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110655830|NCT00432172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110655831|NCT00432172|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110655832|NCT00432172|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110655833|NCT00432172|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110655834|NCT00432172|Hormone Antagonists|hormone antagonists|mesh-ancestor
110655835|NCT00432172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110655836|NCT00432172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110655837|NCT01034410|Cytarabine|cytarabine|mesh-list
110655838|NCT01034410|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110655839|NCT01034410|Antimetabolites|antimetabolites|mesh-ancestor
110655840|NCT01034410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110655841|NCT01034410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110655842|NCT01034410|Antiviral Agents|antiviral agents|mesh-ancestor
110655843|NCT01034410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110655844|NCT01034410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110655845|NCT01034410|Immunologic Factors|immunologic factors|mesh-ancestor
110655846|NCT01034410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110655847|NCT00415168|Pemetrexed|pemetrexed|mesh-list
110655848|NCT00415168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110655849|NCT00415168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110655850|NCT00415168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110655851|NCT00415168|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110655852|NCT00415168|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110655853|NCT00424762|Rosiglitazone|rosiglitazone|mesh-list
110655854|NCT00424762|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110655855|NCT00424762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110655856|NCT00980304|Rituximab|rituximab|mesh-list
110655857|NCT00980304|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110655858|NCT00980304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110655859|NCT00980304|Immunologic Factors|immunologic factors|mesh-ancestor
110655860|NCT00980304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110655861|NCT00980304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110655862|NCT00974766|Glucocorticoids|glucocorticoids|mesh-list
110655863|NCT00974766|Hormones|hormones|mesh-ancestor
110655864|NCT00974766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110655865|NCT00974766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110655866|NCT00980382|Docetaxel|docetaxel|mesh-list
110208066|NCT00190918|Pemetrexed|pemetrexed|mesh-list
110655867|NCT00980382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110655868|NCT00980382|Tubulin Modulators|tubulin modulators|mesh-ancestor
110655869|NCT00980382|Antimitotic Agents|antimitotic agents|mesh-ancestor
110655870|NCT00980382|Mitosis Modulators|mitosis modulators|mesh-ancestor
110655871|NCT00980382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110655872|NCT00967434|Atorvastatin|atorvastatin|mesh-list
110655873|NCT00967434|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110655874|NCT00967434|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110655875|NCT00967434|Antimetabolites|antimetabolites|mesh-ancestor
110303085|NCT01680913|Anesthetics|anesthetics|mesh-list
110655876|NCT00967434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110655877|NCT00967434|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110655878|NCT00967434|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110655879|NCT00967434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110655880|NCT00967512|Cytarabine|cytarabine|mesh-list
110655881|NCT00967512|Idarubicin|idarubicin|mesh-list
110655882|NCT00967512|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110655883|NCT00967512|Antimetabolites|antimetabolites|mesh-ancestor
110655884|NCT00967512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110655885|NCT00967512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110655886|NCT00967512|Antiviral Agents|antiviral agents|mesh-ancestor
110655887|NCT00967512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110655888|NCT00967512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110655889|NCT00967512|Immunologic Factors|immunologic factors|mesh-ancestor
110655890|NCT00967512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110655891|NCT00967512|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110655892|NCT00967512|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110655893|NCT00967512|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110655894|NCT00967512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110655895|NCT04082910|Infliximab|infliximab|mesh-list
110655896|NCT04082910|Etanercept|etanercept|mesh-list
110655897|NCT04082910|Metoprolol|metoprolol|mesh-list
110655898|NCT04082910|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110655899|NCT04082910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110655900|NCT04082910|Dermatologic Agents|dermatologic agents|mesh-ancestor
110655901|NCT04082910|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110655902|NCT04082910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110655903|NCT04082910|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110655904|NCT04082910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110655905|NCT04082910|Analgesics|analgesics|mesh-ancestor
110655906|NCT04082910|Sensory System Agents|sensory system agents|mesh-ancestor
110655907|NCT04082910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110655908|NCT04082910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110655909|NCT04082910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110655910|NCT04082910|Immunologic Factors|immunologic factors|mesh-ancestor
110655911|NCT04082910|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110655912|NCT04082910|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110655913|NCT04082910|Sympatholytics|sympatholytics|mesh-ancestor
110655914|NCT04082910|Autonomic Agents|autonomic agents|mesh-ancestor
110655915|NCT04082910|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110655916|NCT04082910|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110655917|NCT04082910|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110655918|NCT04082910|Adrenergic Agents|adrenergic agents|mesh-ancestor
110655919|NCT04082910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110655920|NCT04082910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110655922|NCT00975078|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110655923|NCT00975078|Glucocorticoids|glucocorticoids|mesh-ancestor
110655924|NCT00975078|Hormones|hormones|mesh-ancestor
110655925|NCT00975078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110655926|NCT00975078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110655927|NCT00975078|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110655928|NCT00975078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110655929|NCT00980616|Ropivacaine|ropivacaine|mesh-list
110655930|NCT00980616|Anesthetics, Local|anesthetics, local|mesh-ancestor
110655931|NCT00980616|Anesthetics|anesthetics|mesh-ancestor
110655932|NCT00980616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110655933|NCT00980616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110655934|NCT00980616|Sensory System Agents|sensory system agents|mesh-ancestor
110655935|NCT00980616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110655936|NCT00980850|Vaccines|vaccines|mesh-list
110655937|NCT00980850|Immunologic Factors|immunologic factors|mesh-ancestor
110655938|NCT00980850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110655939|NCT00414466|Gabapentin|gabapentin|mesh-list
110655940|NCT00414466|Analgesics|analgesics|mesh-ancestor
110655941|NCT00414466|Sensory System Agents|sensory system agents|mesh-ancestor
110655942|NCT00414466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110655943|NCT00414466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110655945|NCT00414466|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110655946|NCT00414466|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110655947|NCT00414466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110655948|NCT00414466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110655949|NCT00414466|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110655950|NCT00414466|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110655951|NCT00414466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110655952|NCT00414466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110655953|NCT00414466|Antimanic Agents|antimanic agents|mesh-ancestor
110655954|NCT00984750|Acetylcarnitine|acetylcarnitine|mesh-list
110655955|NCT00984750|Simvastatin|simvastatin|mesh-list
110655956|NCT00984750|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110655957|NCT00984750|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110655958|NCT00984750|Antimetabolites|antimetabolites|mesh-ancestor
110655959|NCT00984750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110655960|NCT00984750|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110655961|NCT00984750|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110655962|NCT00984750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110655963|NCT00984750|Vitamin B Complex|vitamin b complex|mesh-ancestor
110655964|NCT00984750|Vitamins|vitamins|mesh-ancestor
110655965|NCT00984750|Micronutrients|micronutrients|mesh-ancestor
110655966|NCT00984750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110655967|NCT00984750|Nootropic Agents|nootropic agents|mesh-ancestor
110655968|NCT00975312|Tretinoin|tretinoin|mesh-list
110655969|NCT00975312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110208112|NCT02922894|Serotonin Agents|serotonin agents|mesh-ancestor
110655970|NCT00975312|Keratolytic Agents|keratolytic agents|mesh-ancestor
110655971|NCT00975312|Dermatologic Agents|dermatologic agents|mesh-ancestor
110655972|NCT00424528|Tiotropium Bromide|tiotropium bromide|mesh-list
110655973|NCT00424528|Formoterol Fumarate|formoterol fumarate|mesh-list
110655974|NCT00424528|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110655975|NCT00424528|Autonomic Agents|autonomic agents|mesh-ancestor
110655976|NCT00424528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110655977|NCT00424528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110655978|NCT00424528|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110655979|NCT00424528|Respiratory System Agents|respiratory system agents|mesh-ancestor
110655980|NCT00424528|Parasympatholytics|parasympatholytics|mesh-ancestor
110655981|NCT00424528|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110655982|NCT00424528|Cholinergic Agents|cholinergic agents|mesh-ancestor
110655983|NCT00424528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110655984|NCT00424528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110655985|NCT00424528|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110655986|NCT00424528|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110655987|NCT00424528|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110655988|NCT00424528|Adrenergic Agents|adrenergic agents|mesh-ancestor
110655989|NCT04974996|Prednisone|prednisone|mesh-list
110655990|NCT04974996|Cyclophosphamide|cyclophosphamide|mesh-list
110655991|NCT04974996|Rituximab|rituximab|mesh-list
110655992|NCT04974996|Doxorubicin|doxorubicin|mesh-list
110655993|NCT04974996|Vincristine|vincristine|mesh-list
110655994|NCT04974996|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
110655995|NCT04974996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110655996|NCT04974996|Immunologic Factors|immunologic factors|mesh-ancestor
110655997|NCT04974996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110655998|NCT04974996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110655999|NCT04974996|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110656000|NCT04974996|Alkylating Agents|alkylating agents|mesh-ancestor
110656001|NCT04974996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110656002|NCT04974996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110656003|NCT04974996|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110656004|NCT04974996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110656005|NCT04974996|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110656006|NCT04974996|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110656007|NCT04974996|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110656009|NCT04974996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110656010|NCT04974996|Glucocorticoids|glucocorticoids|mesh-ancestor
110656011|NCT04974996|Hormones|hormones|mesh-ancestor
110656012|NCT04974996|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110656013|NCT04974996|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110656014|NCT04974996|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110656015|NCT04974996|Tubulin Modulators|tubulin modulators|mesh-ancestor
110656016|NCT04974996|Antimitotic Agents|antimitotic agents|mesh-ancestor
110656017|NCT04974996|Mitosis Modulators|mitosis modulators|mesh-ancestor
110656018|NCT00981006|Mitogens|mitogens|mesh-list
110656019|NCT00981006|Mitosis Modulators|mitosis modulators|mesh-ancestor
110656020|NCT00981006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110656021|NCT00975390|Caffeine|caffeine|mesh-list
110656022|NCT00975390|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110656023|NCT00975390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110656024|NCT00975390|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110656025|NCT00975390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110656026|NCT00975390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110656027|NCT00975390|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110656028|NCT00975390|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110656029|NCT00975390|Purinergic Agents|purinergic agents|mesh-ancestor
110656030|NCT00975390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110656031|NCT00981318|Ritonavir|ritonavir|mesh-list
110656032|NCT00981318|Lopinavir|lopinavir|mesh-list
110656033|NCT00981318|Maraviroc|maraviroc|mesh-list
110656034|NCT00981318|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110656035|NCT00981318|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110656036|NCT00981318|Protease Inhibitors|protease inhibitors|mesh-ancestor
110656037|NCT00981318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110656038|NCT00981318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110656039|NCT00981318|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110656040|NCT00981318|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110656042|NCT00981318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110656043|NCT00981318|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110656044|NCT00981318|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110656045|NCT00981318|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110656046|NCT00981318|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110656047|NCT00981318|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
110656048|NCT00984984|Methylprednisolone|methylprednisolone|mesh-list
110656049|NCT00984984|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110656050|NCT00984984|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110656051|NCT00984984|Prednisolone|prednisolone|mesh-list
110656052|NCT00984984|Prednisolone acetate|prednisolone acetate|mesh-list
110656053|NCT00984984|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110656054|NCT00984984|Prednisolone phosphate|prednisolone phosphate|mesh-list
110656055|NCT00984984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110656056|NCT00984984|Antiemetics|antiemetics|mesh-ancestor
110656057|NCT00984984|Autonomic Agents|autonomic agents|mesh-ancestor
110656058|NCT00984984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110656059|NCT00984984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110656060|NCT00984984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110656061|NCT00984984|Glucocorticoids|glucocorticoids|mesh-ancestor
110656062|NCT00984984|Hormones|hormones|mesh-ancestor
110656063|NCT00984984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110656064|NCT00984984|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110656065|NCT00984984|Protective Agents|protective agents|mesh-ancestor
110656066|NCT00984984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110656067|NCT00984984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110656068|NCT00545532|Oseltamivir|oseltamivir|mesh-list
110656069|NCT00545532|Antiviral Agents|antiviral agents|mesh-ancestor
110656070|NCT00545532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110656071|NCT00545532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110656072|NCT00545532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110656073|NCT00544440|Prednisone|prednisone|mesh-list
110656074|NCT00544440|Abiraterone Acetate|abiraterone acetate|mesh-list
110656075|NCT00544440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110656076|NCT00544440|Glucocorticoids|glucocorticoids|mesh-ancestor
110656077|NCT00544440|Hormones|hormones|mesh-ancestor
110656078|NCT00544440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110656079|NCT00544440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110656080|NCT00544440|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110656081|NCT00544440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110656082|NCT00544440|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110656083|NCT00544440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110656084|NCT00544440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110656085|NCT00544440|Hormone Antagonists|hormone antagonists|mesh-ancestor
110656086|NCT00544440|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110656087|NCT00981708|Dexamethasone|dexamethasone|mesh-list
110656088|NCT00981708|Dexamethasone acetate|dexamethasone acetate|mesh-list
110656089|NCT00981708|Cyclophosphamide|cyclophosphamide|mesh-list
110656090|NCT00981708|Lenalidomide|lenalidomide|mesh-list
110656092|NCT00981708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110656093|NCT00981708|Immunologic Factors|immunologic factors|mesh-ancestor
110656094|NCT00981708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110656095|NCT00981708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110656096|NCT00981708|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110656097|NCT00981708|Alkylating Agents|alkylating agents|mesh-ancestor
110656098|NCT00981708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110656099|NCT00981708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110303308|NCT00287742|Risperidone|risperidone|mesh-list
110656100|NCT00981708|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110656101|NCT00981708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110656103|NCT00981708|Autonomic Agents|autonomic agents|mesh-ancestor
110656104|NCT00981708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110656105|NCT00981708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110656106|NCT00981708|Glucocorticoids|glucocorticoids|mesh-ancestor
110656107|NCT00981708|Hormones|hormones|mesh-ancestor
110656108|NCT00981708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110656109|NCT00981708|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110656110|NCT00981708|Protease Inhibitors|protease inhibitors|mesh-ancestor
110656111|NCT00981708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110656112|NCT00981708|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110656113|NCT00981708|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110656114|NCT00981708|Growth Substances|growth substances|mesh-ancestor
110656115|NCT00981708|Growth Inhibitors|growth inhibitors|mesh-ancestor
110656116|NCT00981786|Timolol|timolol|mesh-list
110656117|NCT00981786|Brimonidine Tartrate|brimonidine tartrate|mesh-list
110656118|NCT00981786|Travoprost|travoprost|mesh-list
110656119|NCT00981786|Brinzolamide|brinzolamide|mesh-list
110656120|NCT00981786|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110656121|NCT00981786|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110656122|NCT00981786|Adrenergic Agents|adrenergic agents|mesh-ancestor
110656123|NCT00981786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110656124|NCT00981786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110656125|NCT00981786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110656126|NCT00981786|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110656127|NCT00981786|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110656128|NCT00981786|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110656129|NCT00981786|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110656130|NCT00981786|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110656131|NCT00981786|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110656132|NCT00981786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110656133|NCT04007562|Hydroxychloroquine|hydroxychloroquine|mesh-list
110656134|NCT04007562|Antimalarials|antimalarials|mesh-ancestor
110656135|NCT04007562|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110656136|NCT04007562|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110656137|NCT04007562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110656138|NCT04007562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110656139|NCT04007562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110656140|NCT04007562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110656141|NCT00985374|Everolimus|everolimus|mesh-list
110656142|NCT00985374|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110656143|NCT00985374|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110656144|NCT00985374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110656145|NCT00985374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110656146|NCT00985374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110656147|NCT00985374|Immunologic Factors|immunologic factors|mesh-ancestor
110656148|NCT00985374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110656149|NCT00985374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110656150|NCT00975936|Ketoconazole|ketoconazole|mesh-list
110656151|NCT00975936|Antifungal Agents|antifungal agents|mesh-ancestor
110656152|NCT00975936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110656153|NCT00975936|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110656154|NCT00975936|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110656155|NCT00975936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110656156|NCT00975936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110656157|NCT00975936|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110656158|NCT00975936|Hormone Antagonists|hormone antagonists|mesh-ancestor
110656159|NCT00975936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110656160|NCT00975936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110656161|NCT00975936|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110656162|NCT00976092|Heparin|heparin|mesh-list
110656163|NCT00976092|Calcium heparin|calcium heparin|mesh-list
110656164|NCT00976092|Bivalirudin|bivalirudin|mesh-list
110656165|NCT00976092|Clopidogrel|clopidogrel|mesh-list
110656166|NCT00976092|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
110656167|NCT00976092|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110656168|NCT00976092|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110656169|NCT00976092|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110656170|NCT00976092|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110656171|NCT00976092|Purinergic Agents|purinergic agents|mesh-ancestor
110656172|NCT00976092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110303380|NCT00416871|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110656173|NCT00976092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110656174|NCT00976092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110656175|NCT00976092|Anticoagulants|anticoagulants|mesh-ancestor
110656176|NCT00976092|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110656177|NCT00976092|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110656178|NCT00976092|Antithrombins|antithrombins|mesh-ancestor
110656179|NCT00976092|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110656180|NCT00976092|Protease Inhibitors|protease inhibitors|mesh-ancestor
110656181|NCT00976092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110656182|NCT00985530|Arsenic Trioxide|arsenic trioxide|mesh-list
110656183|NCT00985530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110656184|NCT04006470|Fluorides|fluorides|mesh-list
110656185|NCT04006470|Tin Fluorides|tin fluorides|mesh-list
110656186|NCT04006470|Cariostatic Agents|cariostatic agents|mesh-ancestor
110656187|NCT04006470|Protective Agents|protective agents|mesh-ancestor
110656188|NCT04006470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110656189|NCT01323712|Vitamin D|vitamin d|mesh-list
110656190|NCT01323712|Cholecalciferol|cholecalciferol|mesh-list
110656191|NCT01323712|Vitamins|vitamins|mesh-ancestor
110656192|NCT01323712|Micronutrients|micronutrients|mesh-ancestor
110656193|NCT01323712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110656194|NCT01323712|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110656195|NCT01323712|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110656196|NCT00981942|Imatinib Mesylate|imatinib mesylate|mesh-list
110656197|NCT00981942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110656198|NCT00981942|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110656199|NCT00981942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110656200|NCT00981942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110656201|NCT03927144|Erenumab|erenumab|mesh-list
110656202|NCT03927144|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
110656203|NCT03927144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110656204|NCT03927144|Analgesics|analgesics|mesh-ancestor
110656205|NCT03927144|Sensory System Agents|sensory system agents|mesh-ancestor
110656206|NCT03927144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110656207|NCT03927144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110656208|NCT00976170|Sorafenib|sorafenib|mesh-list
110656209|NCT00976170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110656210|NCT00976170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110656211|NCT00976170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110656212|NCT00976170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110656213|NCT00982254|Insulin|insulin|mesh-list
110656214|NCT00982254|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110656215|NCT00982254|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110656216|NCT00982254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110656217|NCT00985608|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110656218|NCT00985608|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
110656219|NCT00985608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110656220|NCT00985608|Antitubercular Agents|antitubercular agents|mesh-ancestor
110656221|NCT00976326|Insulin|insulin|mesh-list
110656222|NCT00976326|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110656223|NCT00976326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110656224|NCT00982332|Betamethasone|betamethasone|mesh-list
110656225|NCT00982332|Betamethasone dipropionate, betamethasone sodium phosphate drug combination|betamethasone dipropionate, betamethasone sodium phosphate drug combination|mesh-list
110656226|NCT00982332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110656227|NCT00982332|Glucocorticoids|glucocorticoids|mesh-ancestor
110656229|NCT00982332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110656230|NCT00982332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110656231|NCT00982332|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110656232|NCT00982332|Respiratory System Agents|respiratory system agents|mesh-ancestor
110656233|NCT04007328|Methylprednisolone|methylprednisolone|mesh-list
110656234|NCT04007328|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110656235|NCT04007328|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110656236|NCT04007328|Prednisolone|prednisolone|mesh-list
110656237|NCT04007328|Prednisolone acetate|prednisolone acetate|mesh-list
110656238|NCT04007328|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110656239|NCT04007328|Prednisolone phosphate|prednisolone phosphate|mesh-list
110656240|NCT04007328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110656241|NCT04007328|Antiemetics|antiemetics|mesh-ancestor
110656242|NCT04007328|Autonomic Agents|autonomic agents|mesh-ancestor
110656243|NCT04007328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110656244|NCT04007328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110656245|NCT04007328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110656246|NCT04007328|Glucocorticoids|glucocorticoids|mesh-ancestor
110656247|NCT04007328|Hormones|hormones|mesh-ancestor
110656248|NCT04007328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110656249|NCT04007328|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110656250|NCT04007328|Protective Agents|protective agents|mesh-ancestor
110656251|NCT04007328|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110656252|NCT04007328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110656253|NCT00985920|Tranexamic Acid|tranexamic acid|mesh-list
110656254|NCT00985920|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110656255|NCT00985920|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110656256|NCT00985920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110656257|NCT00985920|Hemostatics|hemostatics|mesh-ancestor
110656258|NCT00985920|Coagulants|coagulants|mesh-ancestor
110656259|NCT00976794|Carbamazepine|carbamazepine|mesh-list
110656260|NCT00976794|Valproic Acid|valproic acid|mesh-list
110656261|NCT00976794|Lithium Carbonate|lithium carbonate|mesh-list
110656262|NCT00976794|Antidepressive Agents|antidepressive agents|mesh-ancestor
110656263|NCT00976794|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110656264|NCT00976794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110656265|NCT00976794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110656266|NCT00976794|Antimanic Agents|antimanic agents|mesh-ancestor
110656267|NCT00976794|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110656268|NCT00976794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110656269|NCT00976794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110656270|NCT00976794|Anticonvulsants|anticonvulsants|mesh-ancestor
110656271|NCT00976794|GABA Agents|gaba agents|mesh-ancestor
110656272|NCT00976794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110656273|NCT00976794|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110656274|NCT00976794|Analgesics|analgesics|mesh-ancestor
110656275|NCT00976794|Sensory System Agents|sensory system agents|mesh-ancestor
110656276|NCT00976794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110656277|NCT00976794|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110399008|NCT01313273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110656278|NCT00976794|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110656279|NCT00976794|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110656280|NCT00976794|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110656281|NCT00985998|Nimotuzumab|nimotuzumab|mesh-list
110656282|NCT00985998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110656283|NCT00985998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110656284|NCT04008186|Metformin|metformin|mesh-list
110656285|NCT04008186|Repaglinide|repaglinide|mesh-list
110656286|NCT04008186|Itraconazole|itraconazole|mesh-list
110656287|NCT04008186|Digoxin|digoxin|mesh-list
110656288|NCT04008186|Verapamil|verapamil|mesh-list
110656289|NCT04008186|Midazolam|midazolam|mesh-list
110656290|NCT04008186|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110656291|NCT04008186|Gemfibrozil|gemfibrozil|mesh-list
110656292|NCT04008186|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110656293|NCT04008186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110160288|NCT00390312|Morphine|morphine|mesh-list
110656294|NCT04008186|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110656295|NCT04008186|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110656296|NCT04008186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110656297|NCT04008186|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110656298|NCT04008186|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110656299|NCT04008186|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110656300|NCT04008186|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110656301|NCT04008186|Anesthetics, General|anesthetics, general|mesh-ancestor
110656302|NCT04008186|Anesthetics|anesthetics|mesh-ancestor
110656303|NCT04008186|GABA Modulators|gaba modulators|mesh-ancestor
110656304|NCT04008186|GABA Agents|gaba agents|mesh-ancestor
110656305|NCT04008186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110656306|NCT04008186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110656307|NCT04008186|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110656308|NCT04008186|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110656309|NCT04008186|Antimetabolites|antimetabolites|mesh-ancestor
110656310|NCT04008186|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110656311|NCT04008186|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110656312|NCT04008186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110656313|NCT04008186|Antifungal Agents|antifungal agents|mesh-ancestor
110656314|NCT04008186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110656315|NCT04008186|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110656316|NCT04008186|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110656317|NCT04008186|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110656318|NCT04008186|Hormone Antagonists|hormone antagonists|mesh-ancestor
110656319|NCT04008186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110656320|NCT04008186|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110656321|NCT04008186|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110656322|NCT04008186|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110656323|NCT04008186|Protective Agents|protective agents|mesh-ancestor
110656324|NCT04008186|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110656325|NCT04008186|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110656326|NCT04008186|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110656327|NCT04008186|Vasodilator Agents|vasodilator agents|mesh-ancestor
110656328|NCT04008186|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
110656329|NCT00982566|Navitoclax|navitoclax|mesh-list
110656330|NCT00982566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110656331|NCT00977028|Lidocaine|lidocaine|mesh-list
110656332|NCT00977028|Epinephrine|epinephrine|mesh-list
110656333|NCT00977028|Racepinephrine|racepinephrine|mesh-list
110656334|NCT00977028|Anesthetics|anesthetics|mesh-list
110656335|NCT00977028|Epinephryl borate|epinephryl borate|mesh-list
110656336|NCT00977028|Anesthetics, Local|anesthetics, local|mesh-ancestor
110656337|NCT00977028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110656338|NCT00977028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110656339|NCT00977028|Sensory System Agents|sensory system agents|mesh-ancestor
110656340|NCT00977028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110656341|NCT00977028|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110656342|NCT00977028|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110656343|NCT00977028|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110656344|NCT00977028|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110656345|NCT00977028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110656346|NCT00977028|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110656347|NCT00977028|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110656348|NCT00977028|Adrenergic Agents|adrenergic agents|mesh-ancestor
110656349|NCT00977028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110656350|NCT00977028|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110656351|NCT00977028|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110656352|NCT00977028|Autonomic Agents|autonomic agents|mesh-ancestor
110656353|NCT00977028|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110656354|NCT00977028|Respiratory System Agents|respiratory system agents|mesh-ancestor
110656355|NCT00977028|Mydriatics|mydriatics|mesh-ancestor
110656356|NCT00977028|Sympathomimetics|sympathomimetics|mesh-ancestor
110656357|NCT00977028|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110656358|NCT00982722|Calcium, Dietary|calcium, dietary|mesh-list
110656359|NCT00982722|Cholecalciferol|cholecalciferol|mesh-list
110656361|NCT00982722|Calcium Carbonate|calcium carbonate|mesh-list
110656363|NCT00982722|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110656364|NCT00982722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110656365|NCT00982722|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110656366|NCT00982722|Vitamins|vitamins|mesh-ancestor
110656367|NCT00982722|Micronutrients|micronutrients|mesh-ancestor
110656368|NCT00982722|Antacids|antacids|mesh-ancestor
110656369|NCT00982722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110656370|NCT00982722|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110656371|NCT00982800|Gabapentin|gabapentin|mesh-list
110656372|NCT00982800|Analgesics|analgesics|mesh-ancestor
110656373|NCT00982800|Sensory System Agents|sensory system agents|mesh-ancestor
110656374|NCT00982800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110656375|NCT00982800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110656376|NCT00982800|Anticonvulsants|anticonvulsants|mesh-ancestor
110656377|NCT00982800|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110656378|NCT00982800|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110656379|NCT00982800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110656380|NCT00982800|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110656381|NCT00982800|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110656382|NCT00982800|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110656383|NCT00982800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110656384|NCT00982800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110656385|NCT00982800|Antimanic Agents|antimanic agents|mesh-ancestor
110656386|NCT00986076|Enoxaparin|enoxaparin|mesh-list
110656387|NCT00986076|Anticoagulants|anticoagulants|mesh-ancestor
110656388|NCT00986076|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110656389|NCT00986076|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110656390|NCT00986076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110656391|NCT00984828|Bortezomib|bortezomib|mesh-list
110656392|NCT00984828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110656393|NCT00983034|Amoxicillin|amoxicillin|mesh-list
110656394|NCT00983034|Clarithromycin|clarithromycin|mesh-list
110656395|NCT00983034|Lansoprazole|lansoprazole|mesh-list
110656396|NCT00983034|Dexlansoprazole|dexlansoprazole|mesh-list
110656397|NCT00983034|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110656398|NCT00983034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110656399|NCT00983034|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110656400|NCT00983034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110656401|NCT00983034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110656402|NCT00983034|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110656403|NCT00983034|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110656404|NCT00983034|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110656405|NCT00983034|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110656406|NCT00983034|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110656407|NCT00983112|Thrombin|thrombin|mesh-list
110656408|NCT00983112|Hemostatics|hemostatics|mesh-ancestor
110656409|NCT00983112|Coagulants|coagulants|mesh-ancestor
110656410|NCT00986466|Vitamin D|vitamin d|mesh-list
110656411|NCT00986466|Ergocalciferols|ergocalciferols|mesh-list
110656412|NCT00986466|Cholecalciferol|cholecalciferol|mesh-list
110656413|NCT00986466|Vitamins|vitamins|mesh-list
110656414|NCT00986466|Micronutrients|micronutrients|mesh-ancestor
110656415|NCT00986466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110656416|NCT00986466|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110656417|NCT00986466|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110656418|NCT00545298|Nitric Oxide|nitric oxide|mesh-list
110656419|NCT00545298|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110656420|NCT00545298|Autonomic Agents|autonomic agents|mesh-ancestor
110656421|NCT00545298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110656422|NCT00545298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110656423|NCT00545298|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110656424|NCT00545298|Respiratory System Agents|respiratory system agents|mesh-ancestor
110656425|NCT00545298|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110656426|NCT00545298|Antioxidants|antioxidants|mesh-ancestor
110656427|NCT00545298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110656428|NCT00545298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110656429|NCT00545298|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
110656430|NCT00545298|Vasodilator Agents|vasodilator agents|mesh-ancestor
110656431|NCT00545298|Gasotransmitters|gasotransmitters|mesh-ancestor
110656432|NCT00545298|Protective Agents|protective agents|mesh-ancestor
110656433|NCT00983268|Capecitabine|capecitabine|mesh-list
110656434|NCT00983268|Vorinostat|vorinostat|mesh-list
110656435|NCT00983268|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110656436|NCT00983268|Antimetabolites|antimetabolites|mesh-ancestor
110656437|NCT00983268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110656438|NCT00983268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110656439|NCT00983268|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110656440|NCT00983268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110656441|NCT00977964|Caseins|caseins|mesh-list
110656442|NCT00977964|Chelating Agents|chelating agents|mesh-ancestor
110656443|NCT00977964|Sequestering Agents|sequestering agents|mesh-ancestor
110656444|NCT00977964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110656445|NCT00983424|Cyclosporine|cyclosporine|mesh-list
110656446|NCT00983424|Paclitaxel|paclitaxel|mesh-list
110656447|NCT00983424|Cyclosporins|cyclosporins|mesh-list
110656448|NCT00983424|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110656449|NCT00983424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110656450|NCT00983424|Tubulin Modulators|tubulin modulators|mesh-ancestor
110656451|NCT00983424|Antimitotic Agents|antimitotic agents|mesh-ancestor
110656452|NCT00983424|Mitosis Modulators|mitosis modulators|mesh-ancestor
110656453|NCT00983424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110656454|NCT00983424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110656455|NCT00983424|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110656456|NCT00983424|Immunologic Factors|immunologic factors|mesh-ancestor
110656457|NCT00983424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110656458|NCT00983424|Antifungal Agents|antifungal agents|mesh-ancestor
110656459|NCT00983424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110656460|NCT00983424|Dermatologic Agents|dermatologic agents|mesh-ancestor
110656461|NCT00983424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110656462|NCT00983424|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110656463|NCT00983736|Tramadol|tramadol|mesh-list
110656464|NCT00983736|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110656465|NCT00983736|Narcotics|narcotics|mesh-ancestor
110656466|NCT00983736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110656467|NCT00983736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110656468|NCT00983736|Analgesics|analgesics|mesh-ancestor
110656469|NCT00983736|Sensory System Agents|sensory system agents|mesh-ancestor
110656470|NCT00983736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110656471|NCT00986778|Lamivudine|lamivudine|mesh-list
110656472|NCT00986778|Adefovir|adefovir|mesh-list
110656473|NCT00986778|Entecavir|entecavir|mesh-list
110303681|NCT00281931|Cyclophosphamide|cyclophosphamide|mesh-list
110656474|NCT00986778|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110208203|NCT02470299|Ketorolac|ketorolac|mesh-list
110656475|NCT00986778|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110656476|NCT00986778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110399034|NCT01312961|Albuterol|albuterol|mesh-list
110656477|NCT00986778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110656478|NCT00986778|Antiviral Agents|antiviral agents|mesh-ancestor
110656479|NCT00986778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110656480|NCT00986778|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110656481|NCT00986778|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110656484|NCT00429364|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110656485|NCT00429364|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110656486|NCT00429364|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110656487|NCT00429364|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110656488|NCT00429364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110656489|NCT00429364|Sympatholytics|sympatholytics|mesh-ancestor
110656490|NCT00429364|Autonomic Agents|autonomic agents|mesh-ancestor
110656491|NCT00429364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110656492|NCT00429364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110656493|NCT00429364|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110656494|NCT00429364|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110656495|NCT00429364|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110656496|NCT00429364|Adrenergic Agents|adrenergic agents|mesh-ancestor
110656497|NCT00429364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110656498|NCT00978354|Furosemide|furosemide|mesh-list
110656499|NCT00978354|Diuretics|diuretics|mesh-ancestor
110656500|NCT00978354|Natriuretic Agents|natriuretic agents|mesh-ancestor
110656501|NCT00978354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110656502|NCT00978354|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110656503|NCT00978354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110656504|NCT00978354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110656505|NCT00984360|Naltrexone|naltrexone|mesh-list
110656506|NCT00984360|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110656507|NCT00984360|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110656508|NCT00984360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110656509|NCT00984360|Sensory System Agents|sensory system agents|mesh-ancestor
110656510|NCT00984360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110656511|NCT00414388|Sorafenib|sorafenib|mesh-list
110160296|NCT00400387|Riboflavin|riboflavin|mesh-list
110656512|NCT00414388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110656513|NCT00414388|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110656514|NCT00414388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110656515|NCT00414388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110656516|NCT00978588|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
110656517|NCT00978588|Plasma Substitutes|plasma substitutes|mesh-ancestor
110656518|NCT00978588|Blood Substitutes|blood substitutes|mesh-ancestor
110656519|NCT01037608|Nabiximols|nabiximols|mesh-list
110656520|NCT01037608|Analgesics|analgesics|mesh-ancestor
110656521|NCT01037608|Sensory System Agents|sensory system agents|mesh-ancestor
110656522|NCT01037608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110656523|NCT01037608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110656524|NCT04006080|Vedolizumab|vedolizumab|mesh-list
110656525|NCT04006080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110656526|NCT00984438|Bevacizumab|bevacizumab|mesh-list
110656527|NCT00984438|Irinotecan|irinotecan|mesh-list
110656528|NCT00984438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110656529|NCT00984438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110656530|NCT00984438|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110656531|NCT00984438|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110656532|NCT00984438|Growth Substances|growth substances|mesh-ancestor
110656533|NCT00984438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110656534|NCT00984438|Growth Inhibitors|growth inhibitors|mesh-ancestor
110656535|NCT00984438|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110656536|NCT00984438|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110656537|NCT00984438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110656538|NCT00984438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110656539|NCT00424372|Pregabalin|pregabalin|mesh-list
110656540|NCT00424372|Analgesics|analgesics|mesh-ancestor
110656541|NCT00424372|Sensory System Agents|sensory system agents|mesh-ancestor
110656542|NCT00424372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110656543|NCT00424372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110656544|NCT00424372|Anticonvulsants|anticonvulsants|mesh-ancestor
110656545|NCT00424372|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110656546|NCT00424372|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110656547|NCT00424372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110656548|NCT00424372|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110303756|NCT01687894|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110656549|NCT00424372|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110656550|NCT00424372|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110656551|NCT00424372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110656552|NCT00424372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110656553|NCT00987168|Octreotide|octreotide|mesh-list
110656554|NCT00987168|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110656555|NCT00987168|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110656556|NCT00987168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110656557|NCT00978978|Fentanyl|fentanyl|mesh-list
110656558|NCT00978978|Midazolam|midazolam|mesh-list
110656559|NCT00978978|Propofol|propofol|mesh-list
110656560|NCT00978978|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110656561|NCT00978978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110656562|NCT00978978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110656563|NCT00978978|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110656564|NCT00978978|Anesthetics, General|anesthetics, general|mesh-ancestor
110656565|NCT00978978|Anesthetics|anesthetics|mesh-ancestor
110656566|NCT00978978|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110656567|NCT00978978|Narcotics|narcotics|mesh-ancestor
110656568|NCT00978978|Analgesics|analgesics|mesh-ancestor
110656569|NCT00978978|Sensory System Agents|sensory system agents|mesh-ancestor
110656570|NCT00978978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110656571|NCT00978978|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110656572|NCT00978978|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110656573|NCT00978978|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110656574|NCT00978978|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110656575|NCT00978978|GABA Modulators|gaba modulators|mesh-ancestor
110656576|NCT00978978|GABA Agents|gaba agents|mesh-ancestor
110656577|NCT00978978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110656578|NCT00978978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110656579|NCT00414310|Decitabine|decitabine|mesh-list
110656580|NCT00414310|Valproic Acid|valproic acid|mesh-list
110656581|NCT00414310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110656582|NCT00414310|Antimetabolites|antimetabolites|mesh-ancestor
110656583|NCT00414310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110656584|NCT00414310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110656585|NCT00414310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110656586|NCT00414310|Anticonvulsants|anticonvulsants|mesh-ancestor
110656587|NCT00414310|GABA Agents|gaba agents|mesh-ancestor
110208223|NCT00191893|Teriparatide|teriparatide|mesh-list
110656589|NCT00414310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110656590|NCT00414310|Antimanic Agents|antimanic agents|mesh-ancestor
110656591|NCT00414310|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110656592|NCT00414310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110656593|NCT00414310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110656594|NCT00542880|Fluticasone|fluticasone|mesh-list
110656595|NCT00542880|Budesonide|budesonide|mesh-list
110656596|NCT00542880|Formoterol Fumarate|formoterol fumarate|mesh-list
110656597|NCT00542880|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110656598|NCT00542880|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
110656599|NCT00542880|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
110656600|NCT00542880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110656601|NCT00542880|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110656602|NCT00542880|Autonomic Agents|autonomic agents|mesh-ancestor
110656603|NCT00542880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110656604|NCT00542880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110656605|NCT00542880|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110656606|NCT00542880|Respiratory System Agents|respiratory system agents|mesh-ancestor
110656607|NCT00542880|Dermatologic Agents|dermatologic agents|mesh-ancestor
110656608|NCT00542880|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110656609|NCT00542880|Glucocorticoids|glucocorticoids|mesh-ancestor
110656610|NCT00542880|Hormones|hormones|mesh-ancestor
110656611|NCT00542880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110656612|NCT00542880|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110656613|NCT00542880|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110656614|NCT00542880|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110656615|NCT00542880|Adrenergic Agents|adrenergic agents|mesh-ancestor
110656616|NCT00542880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110656617|NCT00542880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110656618|NCT00542880|Sympathomimetics|sympathomimetics|mesh-ancestor
110656619|NCT00414076|Letrozole|letrozole|mesh-list
110656620|NCT00414076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110656621|NCT00414076|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110656622|NCT00414076|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110656623|NCT00414076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110656624|NCT00414076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110303833|NCT01600612|Oxytocin|oxytocin|mesh-list
110656625|NCT00414076|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110656626|NCT00414076|Hormone Antagonists|hormone antagonists|mesh-ancestor
110656627|NCT00414076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110656628|NCT00414076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110656629|NCT01033318|Losartan|losartan|mesh-list
110656630|NCT01033318|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110656631|NCT01033318|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110656632|NCT01033318|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110656633|NCT01033318|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110656634|NCT01033318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110656635|NCT01033396|Fexofenadine|fexofenadine|mesh-list
110656636|NCT01033396|Terfenadine|terfenadine|mesh-list
110656637|NCT01033396|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110656638|NCT01033396|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110656639|NCT01033396|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110656640|NCT01033396|Histamine Antagonists|histamine antagonists|mesh-ancestor
110656641|NCT01033396|Histamine Agents|histamine agents|mesh-ancestor
110656642|NCT01033396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110656643|NCT01033396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110656644|NCT01033396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110656645|NCT00979056|Rifaximin|rifaximin|mesh-list
110656646|NCT00979056|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110656647|NCT00979056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110656648|NCT00979056|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110656649|NCT00092677|Simvastatin|simvastatin|mesh-list
110656650|NCT00092677|Ezetimibe|ezetimibe|mesh-list
110656651|NCT00092677|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110656652|NCT00092677|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110656653|NCT00092677|Antimetabolites|antimetabolites|mesh-ancestor
110656654|NCT00092677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110656655|NCT00092677|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110656656|NCT00092677|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110656657|NCT00092677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110656658|NCT00542178|Hypoglycemic Agents|hypoglycemic agents|mesh-list
110656659|NCT00542178|Simvastatin|simvastatin|mesh-list
110656660|NCT00542178|Fenofibrate|fenofibrate|mesh-list
110656661|NCT00542178|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110656662|NCT00542178|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110656663|NCT00542178|Antimetabolites|antimetabolites|mesh-ancestor
110656664|NCT00542178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110656665|NCT00542178|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110656666|NCT00542178|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110656667|NCT00542178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110656668|NCT00542178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110656669|NCT00987636|Zoledronic Acid|zoledronic acid|mesh-list
110656670|NCT00987636|Diphosphonates|diphosphonates|mesh-list
110656671|NCT00987636|Busulfan|busulfan|mesh-list
110656672|NCT00987636|Treosulfan|treosulfan|mesh-list
110656673|NCT00987636|Alkylating Agents|alkylating agents|mesh-ancestor
110656674|NCT00987636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110656675|NCT00987636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110656676|NCT00987636|Immunologic Factors|immunologic factors|mesh-ancestor
110656677|NCT00987636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110656678|NCT00987636|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110656679|NCT00987636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110656680|NCT00987636|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110656681|NCT00987636|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110656682|NCT00424294|Celecoxib|celecoxib|mesh-list
110656683|NCT00424294|Methotrexate|methotrexate|mesh-list
110656684|NCT00424294|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110656685|NCT00424294|Abortifacient Agents|abortifacient agents|mesh-ancestor
110656686|NCT00424294|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110656687|NCT00424294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110656688|NCT00424294|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110656689|NCT00424294|Antimetabolites|antimetabolites|mesh-ancestor
110656690|NCT00424294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110656691|NCT00424294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110656692|NCT00424294|Dermatologic Agents|dermatologic agents|mesh-ancestor
110656693|NCT00424294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110656694|NCT00424294|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110656695|NCT00424294|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110656696|NCT00424294|Immunologic Factors|immunologic factors|mesh-ancestor
110656697|NCT00424294|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110656698|NCT00424294|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110656699|NCT00424294|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110656700|NCT00424294|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110656701|NCT00424294|Analgesics|analgesics|mesh-ancestor
110656702|NCT00424294|Sensory System Agents|sensory system agents|mesh-ancestor
110656703|NCT00424294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110656704|NCT00424294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110656705|NCT00424294|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110656706|NCT00424294|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110656707|NCT00988728|Olanzapine|olanzapine|mesh-list
110656708|NCT00988728|Antiemetics|antiemetics|mesh-ancestor
110656709|NCT00988728|Autonomic Agents|autonomic agents|mesh-ancestor
110656710|NCT00988728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110656711|NCT00988728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110656712|NCT00988728|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110656713|NCT00988728|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110656714|NCT00988728|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110656715|NCT00988728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110656716|NCT00988728|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110656717|NCT00988728|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110656718|NCT00988728|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110656719|NCT00988728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110656720|NCT00988728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110656721|NCT00988728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110656722|NCT00988728|Serotonin Agents|serotonin agents|mesh-ancestor
110656723|NCT00988806|Simendan|simendan|mesh-list
110656724|NCT00988806|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110656725|NCT00988806|Vasodilator Agents|vasodilator agents|mesh-ancestor
110656726|NCT00988806|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110656727|NCT00988806|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110656728|NCT00988806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110656729|NCT00988806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110656730|NCT00988806|Protective Agents|protective agents|mesh-ancestor
110656731|NCT00988806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110656732|NCT04005768|Hydroxychloroquine|hydroxychloroquine|mesh-list
110656733|NCT04005768|Antimalarials|antimalarials|mesh-ancestor
110656734|NCT04005768|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110656735|NCT04005768|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110656736|NCT04005768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110656737|NCT04005768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110656738|NCT04005768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110656739|NCT04005768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110656740|NCT00987792|Moxifloxacin|moxifloxacin|mesh-list
110656741|NCT00987792|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
110656742|NCT00987792|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110656743|NCT00987792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110656744|NCT00987792|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110656745|NCT00987792|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110656746|NCT00987792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110656747|NCT00987792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110656748|NCT00987792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110656749|NCT00987792|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110656750|NCT00987792|Contraceptive Agents|contraceptive agents|mesh-ancestor
110656751|NCT00987792|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110656752|NCT00987792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110656753|NCT00987792|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110656754|NCT00987792|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110656755|NCT00987792|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110656756|NCT00987870|Betamethasone|betamethasone|mesh-list
110656757|NCT00987870|Calcipotriene|calcipotriene|mesh-list
110656758|NCT00987870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110656759|NCT00987870|Glucocorticoids|glucocorticoids|mesh-ancestor
110656760|NCT00987870|Hormones|hormones|mesh-ancestor
110656761|NCT00987870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110656762|NCT00987870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110656763|NCT00987870|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110656764|NCT00987870|Respiratory System Agents|respiratory system agents|mesh-ancestor
110656765|NCT00987870|Dermatologic Agents|dermatologic agents|mesh-ancestor
110656766|NCT00988026|Minocycline|minocycline|mesh-list
110656767|NCT00988026|Lymecycline|lymecycline|mesh-list
110656768|NCT00988026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110656769|NCT00988026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110656770|NCT05578170|Pembrolizumab|pembrolizumab|mesh-list
110656771|NCT05578170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110656772|NCT05578170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110656773|NCT05578170|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110656774|NCT05578170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110656775|NCT00989274|Vaccines|vaccines|mesh-list
110656776|NCT00989274|Immunologic Factors|immunologic factors|mesh-ancestor
110656777|NCT00989274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110656778|NCT03310944|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
110656779|NCT03310944|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110656780|NCT03310944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110656781|NCT03310944|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110656782|NCT03310944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110656783|NCT05712642|Bevacizumab|bevacizumab|mesh-list
110656784|NCT05712642|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110656785|NCT05712642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110656786|NCT05712642|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110656787|NCT05712642|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110656789|NCT05712642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110656790|NCT05712642|Growth Inhibitors|growth inhibitors|mesh-ancestor
110656791|NCT05492682|Cyclophosphamide|cyclophosphamide|mesh-list
110656792|NCT05492682|Pembrolizumab|pembrolizumab|mesh-list
110656793|NCT05492682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110656794|NCT05492682|Immunologic Factors|immunologic factors|mesh-ancestor
110656795|NCT05492682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110656796|NCT05492682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110656797|NCT05492682|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110656798|NCT05492682|Alkylating Agents|alkylating agents|mesh-ancestor
110656799|NCT05492682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110656800|NCT05492682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110656801|NCT05492682|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110656802|NCT05492682|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110656803|NCT05492682|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110656804|NCT01085149|Simvastatin|simvastatin|mesh-list
110656805|NCT01085149|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110656806|NCT01085149|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110656807|NCT01085149|Antimetabolites|antimetabolites|mesh-ancestor
110656808|NCT01085149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110656809|NCT01085149|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110656810|NCT01085149|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110656811|NCT01085149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110656812|NCT04005612|Vitamin D|vitamin d|mesh-list
110656813|NCT04005612|Ergocalciferols|ergocalciferols|mesh-list
110656814|NCT04005612|Cholecalciferol|cholecalciferol|mesh-list
110656815|NCT04005612|Vitamins|vitamins|mesh-list
110656816|NCT04005612|Micronutrients|micronutrients|mesh-ancestor
110656817|NCT04005612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110656818|NCT04005612|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110656819|NCT04005612|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110656820|NCT00413920|Mycophenolic Acid|mycophenolic acid|mesh-list
110656821|NCT00413920|Prednisone|prednisone|mesh-list
110656822|NCT00413920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110656823|NCT00413920|Glucocorticoids|glucocorticoids|mesh-ancestor
110656824|NCT00413920|Hormones|hormones|mesh-ancestor
110656825|NCT00413920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110656826|NCT00413920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110656827|NCT00413920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110656828|NCT00413920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110656829|NCT00413920|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110656830|NCT00413920|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110656831|NCT00413920|Antitubercular Agents|antitubercular agents|mesh-ancestor
110656832|NCT00413920|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110656833|NCT00413920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110656834|NCT00413920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110656835|NCT00413920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110656836|NCT00091819|Vancomycin|vancomycin|mesh-list
110656837|NCT00091819|Telavancin|telavancin|mesh-list
110656838|NCT00091819|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110656839|NCT00091819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110656840|NCT01326871|Gemcitabine|gemcitabine|mesh-list
110656841|NCT01326871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110656842|NCT01326871|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110656843|NCT01326871|Antimetabolites|antimetabolites|mesh-ancestor
110656844|NCT01326871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110656845|NCT01081561|Riboflavin|riboflavin|mesh-list
110656846|NCT01081561|Vitamin B Complex|vitamin b complex|mesh-ancestor
110656847|NCT01081561|Vitamins|vitamins|mesh-ancestor
110656848|NCT01081561|Micronutrients|micronutrients|mesh-ancestor
110656849|NCT01081561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110656850|NCT01081561|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110656851|NCT01081561|Dermatologic Agents|dermatologic agents|mesh-ancestor
110656852|NCT04004754|Miltefosine|miltefosine|mesh-list
110656853|NCT04004754|Antifungal Agents|antifungal agents|mesh-ancestor
110656854|NCT04004754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110399100|NCT01307891|Paclitaxel|paclitaxel|mesh-list
110656855|NCT04004754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110656856|NCT04004754|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110656857|NCT04004754|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110656859|NCT05919797|Bupropion|bupropion|mesh-list
110656860|NCT05919797|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110656861|NCT05919797|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110656862|NCT05919797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110656863|NCT05919797|Sensory System Agents|sensory system agents|mesh-ancestor
110656864|NCT05919797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110656865|NCT05919797|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110656866|NCT05919797|Antidepressive Agents|antidepressive agents|mesh-ancestor
110656867|NCT05919797|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110656868|NCT05919797|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110656869|NCT05919797|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110656870|NCT05919797|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110656871|NCT05919797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110656872|NCT05919797|Dopamine Agents|dopamine agents|mesh-ancestor
110656873|NCT05919797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110656874|NCT05919797|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110656875|NCT05919797|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110656876|NCT05919797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110656877|NCT05919732|Epinephrine|epinephrine|mesh-list
110656878|NCT05919732|Bupivacaine|bupivacaine|mesh-list
110656879|NCT05919732|Anesthetics, Local|anesthetics, local|mesh-ancestor
110656880|NCT05919732|Anesthetics|anesthetics|mesh-ancestor
110656881|NCT05919732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110656882|NCT05919732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110656883|NCT05919732|Sensory System Agents|sensory system agents|mesh-ancestor
110656884|NCT05919732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110656885|NCT05919732|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110656886|NCT05919732|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110656887|NCT05919732|Adrenergic Agents|adrenergic agents|mesh-ancestor
110656888|NCT05919732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110656889|NCT05919732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110656890|NCT05919732|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110656891|NCT05919732|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110656892|NCT05919732|Autonomic Agents|autonomic agents|mesh-ancestor
110656893|NCT05919732|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110656894|NCT05919732|Respiratory System Agents|respiratory system agents|mesh-ancestor
110656895|NCT05919732|Mydriatics|mydriatics|mesh-ancestor
110656896|NCT05919732|Sympathomimetics|sympathomimetics|mesh-ancestor
110656897|NCT05919732|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110656898|NCT05919615|Tranexamic Acid|tranexamic acid|mesh-list
110656899|NCT05919615|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110656900|NCT05919615|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110656901|NCT05919615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110656902|NCT05919615|Hemostatics|hemostatics|mesh-ancestor
110656903|NCT05919615|Coagulants|coagulants|mesh-ancestor
110656904|NCT05919550|Clozapine|clozapine|mesh-list
110656905|NCT05919550|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110656906|NCT05919550|Serotonin Agents|serotonin agents|mesh-ancestor
110656907|NCT05919550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110656908|NCT05919550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110656909|NCT05919550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110656910|NCT05919550|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110656911|NCT05919550|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110656912|NCT05919550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110656913|NCT05919550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110656914|NCT05919550|GABA Antagonists|gaba antagonists|mesh-ancestor
110656915|NCT05919550|GABA Agents|gaba agents|mesh-ancestor
110656917|NCT05919472|Vaccines|vaccines|mesh-list
110656918|NCT05919472|Immunologic Factors|immunologic factors|mesh-ancestor
110656919|NCT05919472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110656920|NCT05919472|Trace Elements|trace elements|mesh-ancestor
110656921|NCT05919472|Micronutrients|micronutrients|mesh-ancestor
110656922|NCT05919407|Amifampridine|amifampridine|mesh-list
110656923|NCT05919407|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
110656924|NCT05919407|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110656925|NCT05919407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110656926|NCT05919407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110656927|NCT05919407|Cholinergic Agents|cholinergic agents|mesh-ancestor
110656928|NCT05919407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110656929|NCT05919407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110656930|NCT05919407|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110656931|NCT05919407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110656932|NCT05919407|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
110656933|NCT05919407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110656934|NCT05919121|Hydrocortisone|hydrocortisone|mesh-list
110656935|NCT05919121|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
110656936|NCT05919121|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
110656937|NCT05919121|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
110656938|NCT05919121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110656940|NCT05919017|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110656941|NCT05919017|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110656942|NCT05919017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110656943|NCT05919017|Sensory System Agents|sensory system agents|mesh-ancestor
110656944|NCT05919017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110656945|NCT05918952|Antibodies|antibodies|mesh-list
110656946|NCT05918952|Immunologic Factors|immunologic factors|mesh-ancestor
110656947|NCT05918952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110656948|NCT05918718|Methotrexate|methotrexate|mesh-list
110656949|NCT05918718|Letrozole|letrozole|mesh-list
110656950|NCT05918718|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110656951|NCT05918718|Abortifacient Agents|abortifacient agents|mesh-ancestor
110656952|NCT05918718|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110656953|NCT05918718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110656954|NCT05918718|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110656955|NCT05918718|Antimetabolites|antimetabolites|mesh-ancestor
110656956|NCT05918718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110656957|NCT05918718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110656958|NCT05918718|Dermatologic Agents|dermatologic agents|mesh-ancestor
110656959|NCT05918718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110656960|NCT05918718|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110656961|NCT05918718|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110656962|NCT05918718|Immunologic Factors|immunologic factors|mesh-ancestor
110656963|NCT05918718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110208302|NCT02968901|Tadalafil|tadalafil|mesh-list
110656964|NCT05918718|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110656965|NCT05918718|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110656966|NCT05918718|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110656967|NCT05918718|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110656968|NCT05918718|Hormone Antagonists|hormone antagonists|mesh-ancestor
110656969|NCT05918718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110656970|NCT05918627|Belumosudil|belumosudil|mesh-list
110656971|NCT05918627|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110656972|NCT05918627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110656973|NCT05918627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110656974|NCT05918614|Belumosudil|belumosudil|mesh-list
110656975|NCT05918614|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110656976|NCT05918614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110656977|NCT05918614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110656978|NCT05918588|Belumosudil|belumosudil|mesh-list
110656979|NCT05918588|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110656980|NCT05918588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110656981|NCT05918588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110656982|NCT05918341|Piracetam|piracetam|mesh-list
110656983|NCT05918341|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110656984|NCT05918341|Protective Agents|protective agents|mesh-ancestor
110656985|NCT05918341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110656986|NCT05918341|Nootropic Agents|nootropic agents|mesh-ancestor
110656987|NCT05918328|Paclitaxel|paclitaxel|mesh-list
110656988|NCT05918328|Docetaxel|docetaxel|mesh-list
110656989|NCT05918328|Carboplatin|carboplatin|mesh-list
110656990|NCT05918328|Trastuzumab|trastuzumab|mesh-list
110656991|NCT05918328|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110656992|NCT05918328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110656993|NCT05918328|Tubulin Modulators|tubulin modulators|mesh-ancestor
110656994|NCT05918328|Antimitotic Agents|antimitotic agents|mesh-ancestor
110656995|NCT05918328|Mitosis Modulators|mitosis modulators|mesh-ancestor
110442349|NCT00634348|Dopamine Agents|dopamine agents|mesh-ancestor
110033831|NCT02578368|Docetaxel|docetaxel|mesh-list
110656996|NCT05918328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110656997|NCT05918328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110656999|NCT05918302|Edotreotide|edotreotide|mesh-list
110657000|NCT05918302|Edotreotide lutetium LU-177|edotreotide lutetium lu-177|mesh-list
110657001|NCT05918302|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110657002|NCT05918302|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110657003|NCT05918302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110657004|NCT05918302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110657005|NCT05918302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110657006|NCT05918302|Immunologic Factors|immunologic factors|mesh-ancestor
110657007|NCT05918302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110657008|NCT05918302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110657009|NCT05918302|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110657011|NCT05918211|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110657012|NCT05918211|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110657013|NCT05918211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110657014|NCT05918211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110657015|NCT05918198|Venetoclax|venetoclax|mesh-list
110657016|NCT05918198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110657017|NCT05918094|Fluorouracil|fluorouracil|mesh-list
110657018|NCT05918094|Antimetabolites|antimetabolites|mesh-ancestor
110657019|NCT05918094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110657020|NCT05918094|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110657021|NCT05918094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110657022|NCT05918094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110657023|NCT05918094|Immunologic Factors|immunologic factors|mesh-ancestor
110657024|NCT05918094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110657025|NCT05918068|Vitamin B 6|vitamin b 6|mesh-list
110657026|NCT05918068|Pyridoxal|pyridoxal|mesh-list
110657027|NCT05918068|Pyridoxine|pyridoxine|mesh-list
110657028|NCT05918068|Metformin|metformin|mesh-list
110657029|NCT05918068|Vitamins|vitamins|mesh-ancestor
110657030|NCT05918068|Micronutrients|micronutrients|mesh-ancestor
110657031|NCT05918068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110657032|NCT05918068|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110657033|NCT05918068|Vitamin B Complex|vitamin b complex|mesh-ancestor
110657034|NCT05917691|Anesthetics|anesthetics|mesh-list
110657035|NCT05917691|Anesthetics, General|anesthetics, general|mesh-list
110657036|NCT05917691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110657037|NCT05917691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110657039|NCT05917522|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110160340|NCT00097825|Zoledronic Acid|zoledronic acid|mesh-list
110657040|NCT05917522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110657041|NCT05917522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110657042|NCT05917522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110657043|NCT05917522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110657044|NCT05917522|Immunologic Factors|immunologic factors|mesh-ancestor
110657045|NCT05917522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110657046|NCT05917522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110657048|NCT05914506|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110657049|NCT05914506|Anesthetics, General|anesthetics, general|mesh-ancestor
110657050|NCT05914506|Anesthetics|anesthetics|mesh-ancestor
110657051|NCT05914506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110657052|NCT05914506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110657053|NCT05913817|Adalimumab|adalimumab|mesh-list
110657054|NCT05913817|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110657055|NCT05913817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110657056|NCT05913817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110657057|NCT05907993|Ibuprofen|ibuprofen|mesh-list
110657058|NCT05907993|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110657059|NCT05907993|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110657060|NCT05907993|Analgesics|analgesics|mesh-ancestor
110657061|NCT05907993|Sensory System Agents|sensory system agents|mesh-ancestor
110657062|NCT05907993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110657063|NCT05907993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110657064|NCT05907993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110657065|NCT05907993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110657066|NCT05907993|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110657067|NCT05907993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110657068|NCT05907993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110657069|NCT05888831|Nivolumab|nivolumab|mesh-list
110657070|NCT05888831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110657071|NCT05888831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110304275|NCT00270153|Enalapril|enalapril|mesh-list
110657072|NCT05888831|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110657073|NCT05888831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110657074|NCT05883241|Diclofenac|diclofenac|mesh-list
110657075|NCT05883241|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110657076|NCT05883241|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110657077|NCT05883241|Analgesics|analgesics|mesh-ancestor
110208978|NCT00048204|Serotonin Agents|serotonin agents|mesh-ancestor
110657078|NCT05883241|Sensory System Agents|sensory system agents|mesh-ancestor
110657079|NCT05883241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110657080|NCT05883241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110657081|NCT05883241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110657082|NCT05883241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110657083|NCT05883241|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110657084|NCT05883241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110657085|NCT05883241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110657086|NCT05882812|Diclofenac|diclofenac|mesh-list
110657087|NCT05882812|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110657088|NCT05882812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110657089|NCT05882812|Analgesics|analgesics|mesh-ancestor
110657090|NCT05882812|Sensory System Agents|sensory system agents|mesh-ancestor
110657091|NCT05882812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110657092|NCT05882812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110657093|NCT05882812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110657094|NCT05882812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110657095|NCT05882812|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110657097|NCT05882812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110657098|NCT05879107|Vaccines|vaccines|mesh-list
110399156|NCT04325009|Atorvastatin|atorvastatin|mesh-list
110657099|NCT05879107|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110657100|NCT05879107|Immunologic Factors|immunologic factors|mesh-ancestor
110657101|NCT05879107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110657103|NCT05874245|Dexmedetomidine|dexmedetomidine|mesh-list
110657104|NCT05874245|Ketamine|ketamine|mesh-list
110209452|NCT00199771|Blood Substitutes|blood substitutes|mesh-ancestor
110657105|NCT05874245|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110657106|NCT05874245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110657107|NCT05874245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110657110|NCT05874245|Sensory System Agents|sensory system agents|mesh-ancestor
110657111|NCT05874245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110657112|NCT05874245|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110657113|NCT05874245|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110657114|NCT05874245|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110657115|NCT05874245|Adrenergic Agents|adrenergic agents|mesh-ancestor
110657116|NCT05874245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110657117|NCT05874245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110657118|NCT05874245|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110657119|NCT05874245|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110657120|NCT05874245|Anesthetics, General|anesthetics, general|mesh-ancestor
110657121|NCT05874245|Anesthetics|anesthetics|mesh-ancestor
110657122|NCT05874245|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110657123|NCT05874245|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110657124|NCT05874245|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110657125|NCT05874245|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110657126|NCT05874245|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110657127|NCT05874245|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110657128|NCT05874245|GABA Modulators|gaba modulators|mesh-ancestor
110657129|NCT05874245|GABA Agents|gaba agents|mesh-ancestor
110657130|NCT05824351|Propolis|propolis|mesh-list
110657131|NCT05824351|Pycnogenols|pycnogenols|mesh-list
110657132|NCT05824351|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110657133|NCT05824351|Immunologic Factors|immunologic factors|mesh-ancestor
110657134|NCT05824351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110657135|NCT05824351|Antioxidants|antioxidants|mesh-ancestor
110657136|NCT05824351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110657137|NCT05824351|Protective Agents|protective agents|mesh-ancestor
110657138|NCT05824351|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110657139|NCT05824351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110657140|NCT05824143|Carbamazepine|carbamazepine|mesh-list
110657141|NCT05824143|Anticonvulsants|anticonvulsants|mesh-ancestor
110657143|NCT05824143|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110210165|NCT00224146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110210238|NCT00224458|Antiviral Agents|antiviral agents|mesh-ancestor
110657144|NCT05824143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110657145|NCT05824143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110304365|NCT00270348|Hormones|hormones|mesh-ancestor
110657146|NCT05824143|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110657147|NCT05824143|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110657148|NCT05824143|Analgesics|analgesics|mesh-ancestor
110657149|NCT05824143|Sensory System Agents|sensory system agents|mesh-ancestor
110657150|NCT05824143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110657151|NCT05824143|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110210310|NCT00224809|Spironolactone|spironolactone|mesh-list
110210311|NCT00224809|Clopidogrel|clopidogrel|mesh-list
110210312|NCT00224809|Enzyme Inhibitors|enzyme inhibitors|mesh-list
110210313|NCT00224809|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
110210314|NCT00224809|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
110657152|NCT05824143|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110657153|NCT05824143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110657154|NCT05824143|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110657155|NCT05824143|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110210380|NCT00413257|Nefopam|nefopam|mesh-list
110657156|NCT05730712|Trastuzumab|trastuzumab|mesh-list
110657157|NCT05730712|Pertuzumab|pertuzumab|mesh-list
110657158|NCT05730712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110657159|NCT05730712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110657160|NCT05687136|Peposertib|peposertib|mesh-list
110657161|NCT05687136|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110657162|NCT05687136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110442350|NCT00634348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110657163|NCT05687136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110657164|NCT05664568|Amoxicillin|amoxicillin|mesh-list
110657165|NCT05664568|Clavulanic Acid|clavulanic acid|mesh-list
110657166|NCT05664568|Clavulanic Acids|clavulanic acids|mesh-list
110657167|NCT05664568|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
110657169|NCT05664568|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110399158|NCT04325009|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110657170|NCT05664568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110657171|NCT05664568|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110657172|NCT05664568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110657173|NCT05664568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110657174|NCT05525858|Bevacizumab|bevacizumab|mesh-list
110210822|NCT00095901|Capecitabine|capecitabine|mesh-list
110657175|NCT05525858|Trastuzumab|trastuzumab|mesh-list
110657176|NCT05525858|Atezolizumab|atezolizumab|mesh-list
110657177|NCT05525858|Pertuzumab|pertuzumab|mesh-list
110657178|NCT05525858|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
110160371|NCT00098137|Olmesartan|olmesartan|mesh-list
110210869|NCT00062972|Donepezil|donepezil|mesh-list
110657179|NCT05525858|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110657180|NCT05525858|Vemurafenib|vemurafenib|mesh-list
110657181|NCT05525858|Maytansine|maytansine|mesh-list
110657182|NCT05525858|Pralsetinib|pralsetinib|mesh-list
110657183|NCT05525858|Entrectinib|entrectinib|mesh-list
110657184|NCT05525858|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110211009|NCT00228046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110657185|NCT05525858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110657186|NCT05525858|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110657187|NCT05525858|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110657188|NCT05525858|Growth Substances|growth substances|mesh-ancestor
110657189|NCT05525858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110657190|NCT05525858|Growth Inhibitors|growth inhibitors|mesh-ancestor
110657191|NCT05525858|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110657192|NCT05525858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110657193|NCT05525858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110657194|NCT05525858|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110657195|NCT05525858|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110657196|NCT05525858|Tubulin Modulators|tubulin modulators|mesh-ancestor
110657197|NCT05525858|Antimitotic Agents|antimitotic agents|mesh-ancestor
110657198|NCT05525858|Mitosis Modulators|mitosis modulators|mesh-ancestor
110657200|NCT05525858|Immunoconjugates|immunoconjugates|mesh-ancestor
110657201|NCT05525858|Immunologic Factors|immunologic factors|mesh-ancestor
110657202|NCT05524584|Fulvestrant|fulvestrant|mesh-list
110657203|NCT05524584|Anastrozole|anastrozole|mesh-list
110657204|NCT05524584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110657205|NCT05524584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110657206|NCT05524584|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110657207|NCT05524584|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110657208|NCT05524584|Hormone Antagonists|hormone antagonists|mesh-ancestor
110657209|NCT05524584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110657210|NCT05524584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110657212|NCT05524584|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110657213|NCT05524584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110211742|NCT00097266|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110657214|NCT05524584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110657215|NCT05498220|Dexamethasone|dexamethasone|mesh-list
110657216|NCT05498220|Rituximab|rituximab|mesh-list
110657217|NCT05498220|Gemcitabine|gemcitabine|mesh-list
110657218|NCT05498220|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
110657219|NCT05498220|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110657220|NCT05498220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110304433|NCT02960919|Ampicillin|ampicillin|mesh-list
110657221|NCT05498220|Immunologic Factors|immunologic factors|mesh-ancestor
110657222|NCT05498220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110657223|NCT05498220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110657224|NCT05498220|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110657225|NCT05498220|Antiemetics|antiemetics|mesh-ancestor
110657226|NCT05498220|Autonomic Agents|autonomic agents|mesh-ancestor
110657227|NCT05498220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110657228|NCT05498220|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110657229|NCT05498220|Glucocorticoids|glucocorticoids|mesh-ancestor
110657230|NCT05498220|Hormones|hormones|mesh-ancestor
110212260|NCT00235261|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110657231|NCT05498220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110657232|NCT05498220|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110657233|NCT05498220|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110657234|NCT05498220|Antimetabolites|antimetabolites|mesh-ancestor
110657235|NCT05498220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110657236|NCT05498220|Immunoconjugates|immunoconjugates|mesh-ancestor
110657237|NCT05494437|Gabapentin|gabapentin|mesh-list
110657238|NCT05494437|Nabilone|nabilone|mesh-list
110657239|NCT05494437|Analgesics|analgesics|mesh-ancestor
110657240|NCT05494437|Sensory System Agents|sensory system agents|mesh-ancestor
110657241|NCT05494437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110657242|NCT05494437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110657243|NCT05494437|Anticonvulsants|anticonvulsants|mesh-ancestor
110657244|NCT05494437|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110657245|NCT05494437|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110657246|NCT05494437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110657247|NCT05494437|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110657248|NCT05494437|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110657249|NCT05494437|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110212703|NCT00237913|Olanzapine|olanzapine|mesh-list
110657250|NCT05494437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110657251|NCT05494437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110657252|NCT05494437|Antimanic Agents|antimanic agents|mesh-ancestor
110657253|NCT05494437|Antiemetics|antiemetics|mesh-ancestor
110657254|NCT05494437|Autonomic Agents|autonomic agents|mesh-ancestor
110657255|NCT05494437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110657267|NCT05405751|Tenofovir|tenofovir|mesh-list
110657268|NCT05405751|Emtricitabine|emtricitabine|mesh-list
110657269|NCT05405751|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
110657270|NCT05405751|Antiviral Agents|antiviral agents|mesh-ancestor
110657271|NCT05405751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110657272|NCT05405751|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110212911|NCT00239161|Levofloxacin|levofloxacin|mesh-list
110657273|NCT05405751|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110657274|NCT05405751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110657275|NCT05405751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110657277|NCT05405751|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110657278|NCT05405309|Olaparib|olaparib|mesh-list
110657279|NCT05405309|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110657280|NCT05405309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110657281|NCT05405309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110657282|NCT05405309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110213197|NCT00240448|Valsartan|valsartan|mesh-list
110657284|NCT05387187|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110657285|NCT05387187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110657286|NCT05387187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110657287|NCT05387187|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110657288|NCT05387187|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110657289|NCT05387187|Protective Agents|protective agents|mesh-ancestor
110657290|NCT05387187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110657291|NCT05387187|Vasodilator Agents|vasodilator agents|mesh-ancestor
110657292|NCT05387187|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110657294|NCT05365893|Hydroxychloroquine|hydroxychloroquine|mesh-list
110657296|NCT05365893|Antimalarials|antimalarials|mesh-ancestor
110657297|NCT05365893|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110657298|NCT05365893|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110657299|NCT05365893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110657300|NCT05365893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110657301|NCT05365893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110657302|NCT05365893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110213406|NCT00098982|Immunologic Factors|immunologic factors|mesh-ancestor
110657303|NCT05365893|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110657304|NCT05365893|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110657305|NCT05365893|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110657306|NCT05365893|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110657307|NCT05364073|Aflutinib|aflutinib|mesh-list
110657309|NCT05364073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110657310|NCT05364073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110657311|NCT05312671|Cisplatin|cisplatin|mesh-list
110657312|NCT05312671|Carboplatin|carboplatin|mesh-list
110657313|NCT05312671|Etoposide|etoposide|mesh-list
110657314|NCT05312671|Atezolizumab|atezolizumab|mesh-list
110657315|NCT05312671|Podophyllotoxin|podophyllotoxin|mesh-list
110657316|NCT05312671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110657317|NCT05312671|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110160382|NCT00098527|Romidepsin|romidepsin|mesh-list
110657318|NCT05312671|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110657319|NCT05312671|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110657321|NCT05312671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110657322|NCT05312671|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110213907|NCT00245245|Factor VIII|factor viii|mesh-list
110657323|NCT05312671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110657324|NCT05312671|Keratolytic Agents|keratolytic agents|mesh-ancestor
110213984|NCT00102843|Vitamins|vitamins|mesh-ancestor
110657325|NCT05312671|Dermatologic Agents|dermatologic agents|mesh-ancestor
110657326|NCT05312671|Tubulin Modulators|tubulin modulators|mesh-ancestor
110214066|NCT00067535|Cocaine|cocaine|mesh-list
110657327|NCT05312671|Antimitotic Agents|antimitotic agents|mesh-ancestor
110657328|NCT05312671|Mitosis Modulators|mitosis modulators|mesh-ancestor
110657329|NCT05254574|Diclofenac|diclofenac|mesh-list
110657330|NCT05254574|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110214141|NCT00424801|Vitamins|vitamins|mesh-ancestor
110657331|NCT05254574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110657332|NCT05254574|Analgesics|analgesics|mesh-ancestor
110657333|NCT05254574|Sensory System Agents|sensory system agents|mesh-ancestor
110657334|NCT05254574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110657335|NCT05254574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110657336|NCT05254574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110657337|NCT05254574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110657338|NCT05254574|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110657339|NCT05254574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110657340|NCT05254574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110657341|NCT05219929|Tetracycline|tetracycline|mesh-list
110657342|NCT05219929|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110657343|NCT05219929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110657344|NCT05219929|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110657345|NCT05219929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110657346|NCT05219929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110657347|NCT05205382|Nicotine|nicotine|mesh-list
110657348|NCT05205382|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110657349|NCT05205382|Autonomic Agents|autonomic agents|mesh-ancestor
110657350|NCT05205382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110657351|NCT05205382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110657352|NCT05205382|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110657353|NCT05205382|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110657354|NCT05205382|Cholinergic Agents|cholinergic agents|mesh-ancestor
110657355|NCT05205382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110657356|NCT05205382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110657357|NCT05198843|Dasatinib|dasatinib|mesh-list
110214198|NCT00400998|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110657358|NCT05198843|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
110657359|NCT05198843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110657360|NCT05198843|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110657361|NCT05198843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110214243|NCT00247663|Letrozole|letrozole|mesh-list
110657362|NCT05198843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110657363|NCT05198843|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110657364|NCT05198843|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110657365|NCT05139225|Daratumumab|daratumumab|mesh-list
110657366|NCT05139225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110657367|NCT05132829|Azithromycin|azithromycin|mesh-list
110657369|NCT05132829|Indomethacin|indomethacin|mesh-list
110214470|NCT00249886|Citalopram|citalopram|mesh-list
110657370|NCT05132829|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110657371|NCT05132829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110657372|NCT05132829|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110657373|NCT05132829|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110657374|NCT05132829|Analgesics|analgesics|mesh-ancestor
110214527|NCT00250120|Rubitecan|rubitecan|mesh-list
110657376|NCT05132829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110657377|NCT05132829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110657378|NCT05132829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110657379|NCT05132829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110657380|NCT05132829|Gout Suppressants|gout suppressants|mesh-ancestor
110657381|NCT05132829|Tocolytic Agents|tocolytic agents|mesh-ancestor
110214600|NCT00068471|Anidulafungin|anidulafungin|mesh-list
110657382|NCT05132829|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110657383|NCT05132829|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110657384|NCT05132829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110657385|NCT05132829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110657386|NCT05117450|Heparin|heparin|mesh-list
110657387|NCT05117450|Anticoagulants|anticoagulants|mesh-ancestor
110657388|NCT05117450|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110657389|NCT05117450|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110214663|NCT00250861|Aldesleukin|aldesleukin|mesh-list
110657390|NCT05117450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110657391|NCT05102669|Antibodies|antibodies|mesh-list
110657392|NCT05102669|Immunologic Factors|immunologic factors|mesh-ancestor
110657393|NCT05102669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110657395|NCT05050448|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110657396|NCT05050448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110657397|NCT05050448|Analgesics|analgesics|mesh-ancestor
110657398|NCT05050448|Sensory System Agents|sensory system agents|mesh-ancestor
110657399|NCT05050448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110657400|NCT05050448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110657401|NCT05050448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110657402|NCT05050448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110657403|NCT05050448|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110657404|NCT05050448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110657405|NCT05050448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110657406|NCT04899388|Fentanyl|fentanyl|mesh-list
110657407|NCT04899388|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110657408|NCT04899388|Narcotics|narcotics|mesh-ancestor
110657409|NCT04899388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110657410|NCT04899388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110657411|NCT04899388|Analgesics|analgesics|mesh-ancestor
110657412|NCT04899388|Sensory System Agents|sensory system agents|mesh-ancestor
110657413|NCT04899388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110657414|NCT04899388|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110657415|NCT04899388|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110657416|NCT04899388|Anesthetics, General|anesthetics, general|mesh-ancestor
110657417|NCT04899388|Anesthetics|anesthetics|mesh-ancestor
110657418|NCT04880785|Lamivudine|lamivudine|mesh-list
110657419|NCT04880785|Dolutegravir|dolutegravir|mesh-list
110657420|NCT04880785|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110657421|NCT04880785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110657422|NCT04880785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110657423|NCT04880785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110657424|NCT04880785|Antiviral Agents|antiviral agents|mesh-ancestor
110657425|NCT04880785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110657426|NCT04880785|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110657427|NCT04880785|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110657428|NCT04880785|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110657429|NCT04880785|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110657430|NCT04874246|Vasopressins|vasopressins|mesh-list
110657431|NCT04874246|Arginine Vasopressin|arginine vasopressin|mesh-list
110657432|NCT04874246|Hemostatics|hemostatics|mesh-ancestor
110657433|NCT04874246|Coagulants|coagulants|mesh-ancestor
110657434|NCT04874246|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110657435|NCT04874246|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
110657436|NCT04874246|Natriuretic Agents|natriuretic agents|mesh-ancestor
110657437|NCT04874246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110657438|NCT04865731|Esomeprazole|esomeprazole|mesh-list
110657439|NCT04865731|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110215297|NCT00254956|Ciclesonide|ciclesonide|mesh-list
110657440|NCT04865731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110657441|NCT04865731|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110657442|NCT04865731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110657443|NCT04865731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110657444|NCT04847466|Pembrolizumab|pembrolizumab|mesh-list
110657445|NCT04847466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110399191|NCT01056289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110657446|NCT04847466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110657447|NCT04847466|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110215427|NCT00100581|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110657448|NCT04847466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110657450|NCT04781088|Pembrolizumab|pembrolizumab|mesh-list
110657451|NCT04781088|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110657453|NCT04781088|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110657454|NCT04781088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110657455|NCT04781088|Tubulin Modulators|tubulin modulators|mesh-ancestor
110657456|NCT04781088|Antimitotic Agents|antimitotic agents|mesh-ancestor
110657457|NCT04781088|Mitosis Modulators|mitosis modulators|mesh-ancestor
110657458|NCT04781088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110657459|NCT04781088|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110657460|NCT04781088|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110657461|NCT04781088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110657462|NCT04781088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110657463|NCT04777006|Amitriptyline|amitriptyline|mesh-list
110657464|NCT04777006|Fluoxetine|fluoxetine|mesh-list
110657465|NCT04777006|Antidepressive Agents|antidepressive agents|mesh-list
110657466|NCT04777006|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110657467|NCT04777006|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110657468|NCT04777006|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110657469|NCT04777006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110657470|NCT04777006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110657471|NCT04777006|Serotonin Agents|serotonin agents|mesh-ancestor
110657472|NCT04777006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110657473|NCT04777006|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110657474|NCT04777006|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110657475|NCT04777006|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110657476|NCT04777006|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110657477|NCT04777006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110657478|NCT04777006|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110657479|NCT04777006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110657480|NCT04777006|Analgesics|analgesics|mesh-ancestor
110657481|NCT04777006|Sensory System Agents|sensory system agents|mesh-ancestor
110657482|NCT04777006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110657483|NCT04777006|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110657484|NCT04777006|Adrenergic Agents|adrenergic agents|mesh-ancestor
110657485|NCT04766086|Vaccines|vaccines|mesh-list
110657486|NCT04766086|Immunologic Factors|immunologic factors|mesh-ancestor
110657487|NCT04766086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110657488|NCT04733547|Furosemide|furosemide|mesh-list
110657489|NCT04733547|Diuretics|diuretics|mesh-ancestor
110657490|NCT04733547|Natriuretic Agents|natriuretic agents|mesh-ancestor
110657491|NCT04733547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110657492|NCT04733547|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110657493|NCT04733547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110657494|NCT04733547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110657495|NCT04717986|Dapagliflozin|dapagliflozin|mesh-list
110657496|NCT04717986|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110657497|NCT04717986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110657498|NCT04717986|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110657499|NCT04717986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110657501|NCT04680910|Anesthetics|anesthetics|mesh-list
110657502|NCT04680910|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110399204|NCT01033825|Ciclesonide|ciclesonide|mesh-list
110657503|NCT04680910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110657504|NCT04680910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110657505|NCT04680910|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110657506|NCT04680910|Anesthetics, General|anesthetics, general|mesh-ancestor
110657507|NCT04678102|PHI-101|phi-101|mesh-list
110657508|NCT04678102|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110657509|NCT04678102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110657510|NCT04678102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110657511|NCT04678102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110657512|NCT04653246|Dexamethasone|dexamethasone|mesh-list
110657513|NCT04653246|Lenalidomide|lenalidomide|mesh-list
110657514|NCT04653246|Bortezomib|bortezomib|mesh-list
110657515|NCT04653246|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110657516|NCT04653246|Antiemetics|antiemetics|mesh-ancestor
110657517|NCT04653246|Autonomic Agents|autonomic agents|mesh-ancestor
110657518|NCT04653246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110657519|NCT04653246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110657520|NCT04653246|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110657521|NCT04653246|Glucocorticoids|glucocorticoids|mesh-ancestor
110657522|NCT04653246|Hormones|hormones|mesh-ancestor
110657523|NCT04653246|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110657524|NCT04653246|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110657525|NCT04653246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110657526|NCT04653246|Immunologic Factors|immunologic factors|mesh-ancestor
110657527|NCT04653246|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110657528|NCT04653246|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110657529|NCT04653246|Growth Substances|growth substances|mesh-ancestor
110657530|NCT04653246|Growth Inhibitors|growth inhibitors|mesh-ancestor
110657531|NCT04643106|Hemostatics|hemostatics|mesh-list
110657532|NCT04643106|Coagulants|coagulants|mesh-ancestor
110657533|NCT04636437|Tenofovir|tenofovir|mesh-list
110657534|NCT04636437|Lamivudine|lamivudine|mesh-list
110657535|NCT04636437|Emtricitabine|emtricitabine|mesh-list
110657536|NCT04636437|Integrase Inhibitors|integrase inhibitors|mesh-list
110657537|NCT04636437|Antiviral Agents|antiviral agents|mesh-ancestor
110657538|NCT04636437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110657539|NCT04636437|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110657540|NCT04636437|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110657541|NCT04636437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110657542|NCT04636437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110657543|NCT04636437|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110657544|NCT04636437|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110657545|NCT04606914|Maytansine|maytansine|mesh-list
110657546|NCT04606914|Mirvetuximab soravtansine|mirvetuximab soravtansine|mesh-list
110657547|NCT04606914|Immunoconjugates|immunoconjugates|mesh-ancestor
110657548|NCT04606914|Immunologic Factors|immunologic factors|mesh-ancestor
110657549|NCT04606914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110657550|NCT04606914|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110657551|NCT04606914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110657552|NCT04606914|Tubulin Modulators|tubulin modulators|mesh-ancestor
110657553|NCT04606914|Antimitotic Agents|antimitotic agents|mesh-ancestor
110657554|NCT04606914|Mitosis Modulators|mitosis modulators|mesh-ancestor
110657555|NCT04606914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110657556|NCT04600648|Insulin|insulin|mesh-list
110657557|NCT04600648|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110657558|NCT04600648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110657559|NCT04564885|Meloxicam|meloxicam|mesh-list
110657560|NCT04564885|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110657561|NCT04564885|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110657562|NCT04564885|Analgesics|analgesics|mesh-ancestor
110657563|NCT04564885|Sensory System Agents|sensory system agents|mesh-ancestor
110657564|NCT04564885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110657565|NCT04564885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110657566|NCT04564885|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110657567|NCT04564885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110657568|NCT04564885|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110657569|NCT04564885|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110657570|NCT04564885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110657571|NCT04564885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110657572|NCT04564157|Paclitaxel|paclitaxel|mesh-list
110657573|NCT04564157|Carboplatin|carboplatin|mesh-list
110657574|NCT04564157|Nivolumab|nivolumab|mesh-list
110657575|NCT04564157|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110657576|NCT04564157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110657577|NCT04564157|Tubulin Modulators|tubulin modulators|mesh-ancestor
110657578|NCT04564157|Antimitotic Agents|antimitotic agents|mesh-ancestor
110657579|NCT04564157|Mitosis Modulators|mitosis modulators|mesh-ancestor
110657580|NCT04564157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110657581|NCT04564157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110657582|NCT04564157|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110657583|NCT04509791|Immunoglobulins|immunoglobulins|mesh-list
110215628|NCT00100776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110657584|NCT04509791|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110657585|NCT04509791|Antibodies|antibodies|mesh-list
110657586|NCT04509791|Thymoglobulin|thymoglobulin|mesh-list
110657587|NCT04509791|Immunologic Factors|immunologic factors|mesh-ancestor
110657588|NCT04509791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110657589|NCT04509791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110657590|NCT04504812|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110657591|NCT04504812|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110657592|NCT04504812|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110657593|NCT04504812|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110657594|NCT04504812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110657595|NCT04504812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110657596|NCT04504812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110657597|NCT04504812|Analgesics|analgesics|mesh-ancestor
110657598|NCT04504812|Sensory System Agents|sensory system agents|mesh-ancestor
110657599|NCT04504812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110657600|NCT04504812|Antidepressive Agents|antidepressive agents|mesh-ancestor
110657601|NCT04504812|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110657602|NCT04504812|Dopamine Agents|dopamine agents|mesh-ancestor
110657603|NCT04497584|Prednisone|prednisone|mesh-list
110657604|NCT04497584|Afatinib|afatinib|mesh-list
110657605|NCT04497584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110657606|NCT04497584|Glucocorticoids|glucocorticoids|mesh-ancestor
110657607|NCT04497584|Hormones|hormones|mesh-ancestor
110657608|NCT04497584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110657609|NCT04497584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110657610|NCT04497584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110657611|NCT04497584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110657612|NCT04497584|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110657613|NCT04497584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110657614|NCT04497584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110657615|NCT04484623|Dexamethasone|dexamethasone|mesh-list
110657616|NCT04484623|Bortezomib|bortezomib|mesh-list
110657617|NCT04484623|Pomalidomide|pomalidomide|mesh-list
110657618|NCT04484623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110657619|NCT04484623|Antiemetics|antiemetics|mesh-ancestor
110657620|NCT04484623|Autonomic Agents|autonomic agents|mesh-ancestor
110657621|NCT04484623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110657622|NCT04484623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110657623|NCT04484623|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110657624|NCT04484623|Glucocorticoids|glucocorticoids|mesh-ancestor
110657625|NCT04484623|Hormones|hormones|mesh-ancestor
110657626|NCT04484623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110657627|NCT04484623|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110657628|NCT04484623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110657629|NCT04484623|Immunologic Factors|immunologic factors|mesh-ancestor
110657630|NCT04484623|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110657631|NCT04484623|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110657632|NCT04484623|Growth Substances|growth substances|mesh-ancestor
110657633|NCT04484623|Growth Inhibitors|growth inhibitors|mesh-ancestor
110657634|NCT04469595|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
110657635|NCT04469595|Aflibercept|aflibercept|mesh-list
110657636|NCT04469595|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110657637|NCT04469595|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110215658|NCT00257023|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110657638|NCT04469595|Growth Substances|growth substances|mesh-ancestor
110657639|NCT04469595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110657640|NCT04469595|Growth Inhibitors|growth inhibitors|mesh-ancestor
110657641|NCT04469595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110657642|NCT04469595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110657643|NCT04469595|Glucocorticoids|glucocorticoids|mesh-ancestor
110657644|NCT04469595|Hormones|hormones|mesh-ancestor
110657645|NCT04469595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110657646|NCT04374877|Pembrolizumab|pembrolizumab|mesh-list
110657647|NCT04374877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110657648|NCT04374877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110657649|NCT04374877|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110657650|NCT04374877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110657651|NCT04250636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110657652|NCT04250636|Antibodies|antibodies|mesh-list
110657653|NCT04250636|Immunoglobulins|immunoglobulins|mesh-list
110657654|NCT04250636|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110657655|NCT04250636|Immunologic Factors|immunologic factors|mesh-ancestor
110657656|NCT04250636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110657657|NCT04250636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110657658|NCT04233749|Tranexamic Acid|tranexamic acid|mesh-list
110657659|NCT04233749|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110657660|NCT04233749|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110657661|NCT04233749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110657662|NCT04233749|Hemostatics|hemostatics|mesh-ancestor
110657663|NCT04233749|Coagulants|coagulants|mesh-ancestor
110657664|NCT04231851|Cytarabine|cytarabine|mesh-list
110657665|NCT04231851|Daunorubicin|daunorubicin|mesh-list
110657666|NCT04231851|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110657667|NCT04231851|Antimetabolites|antimetabolites|mesh-ancestor
110657668|NCT04231851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110657669|NCT04231851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110657670|NCT04231851|Antiviral Agents|antiviral agents|mesh-ancestor
110657671|NCT04231851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110657672|NCT04231851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110657673|NCT04231851|Immunologic Factors|immunologic factors|mesh-ancestor
110657674|NCT04231851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110657675|NCT04231851|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110657676|NCT04231851|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110657677|NCT04231851|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110657678|NCT04231851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110657679|NCT04201561|Selenious Acid|selenious acid|mesh-list
110657680|NCT04201561|Sodium Selenite|sodium selenite|mesh-list
110657681|NCT04201561|Paclitaxel|paclitaxel|mesh-list
110657682|NCT04201561|Carboplatin|carboplatin|mesh-list
110657683|NCT04201561|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110657684|NCT04201561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110657685|NCT04201561|Tubulin Modulators|tubulin modulators|mesh-ancestor
110657686|NCT04201561|Antimitotic Agents|antimitotic agents|mesh-ancestor
110657687|NCT04201561|Mitosis Modulators|mitosis modulators|mesh-ancestor
110657688|NCT04201561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110657689|NCT04201561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110657690|NCT04201561|Trace Elements|trace elements|mesh-ancestor
110657691|NCT04201561|Micronutrients|micronutrients|mesh-ancestor
110657692|NCT04184609|Albuterol|albuterol|mesh-list
110215679|NCT00100854|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110657693|NCT04184609|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110657694|NCT04184609|Autonomic Agents|autonomic agents|mesh-ancestor
110657695|NCT04184609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110657696|NCT04184609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110657697|NCT04184609|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110657698|NCT04184609|Respiratory System Agents|respiratory system agents|mesh-ancestor
110657699|NCT04184609|Tocolytic Agents|tocolytic agents|mesh-ancestor
110657700|NCT04184609|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110657701|NCT04184609|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110657702|NCT04184609|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110399229|NCT02875015|Bupivacaine|bupivacaine|mesh-list
110657703|NCT04184609|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110657704|NCT04184609|Adrenergic Agents|adrenergic agents|mesh-ancestor
110657705|NCT04184609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110657706|NCT04184609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110657707|NCT04162873|Celecoxib|celecoxib|mesh-list
110657708|NCT04162873|Benzenesulfonamide|benzenesulfonamide|mesh-list
110160438|NCT00387920|Sunitinib|sunitinib|mesh-list
110657717|NCT04162873|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110657718|NCT04162873|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110657719|NCT04162873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110657720|NCT04162873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110657721|NCT04162873|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110657722|NCT04061421|Decitabine|decitabine|mesh-list
110657723|NCT04061421|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
110657724|NCT04061421|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110657725|NCT04061421|Antimetabolites|antimetabolites|mesh-ancestor
110657726|NCT04061421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110657727|NCT04061421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110657728|NCT04061421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110657729|NCT04046900|Metronidazole|metronidazole|mesh-list
110657730|NCT04046900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110657731|NCT04046900|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110657732|NCT04046900|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110657733|NCT04046900|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110657734|NCT03989115|Osimertinib|osimertinib|mesh-list
110657735|NCT03989115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110657736|NCT03989115|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110657737|NCT03989115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110657738|NCT03989115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110657739|NCT03971071|Erenumab|erenumab|mesh-list
110657740|NCT03971071|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110657741|NCT03971071|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
110657742|NCT03971071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110657743|NCT03971071|Analgesics|analgesics|mesh-ancestor
110657744|NCT03971071|Sensory System Agents|sensory system agents|mesh-ancestor
110657745|NCT03971071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110657746|NCT03971071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110657747|NCT03971071|Immunologic Factors|immunologic factors|mesh-ancestor
110657756|NCT03937843|Carboplatin|carboplatin|mesh-list
110657757|NCT03937843|Etoposide|etoposide|mesh-list
110657758|NCT03937843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110657759|NCT03937843|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110657760|NCT03937843|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110657761|NCT03937843|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110657762|NCT03937843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110657763|NCT03937843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110657764|NCT03839823|Paclitaxel|paclitaxel|mesh-list
110657765|NCT03839823|Vinorelbine|vinorelbine|mesh-list
110657766|NCT03839823|Docetaxel|docetaxel|mesh-list
110657767|NCT03839823|Gemcitabine|gemcitabine|mesh-list
110657768|NCT03839823|Capecitabine|capecitabine|mesh-list
110657769|NCT03839823|Letrozole|letrozole|mesh-list
110657770|NCT03839823|Anastrozole|anastrozole|mesh-list
110657771|NCT03839823|Goserelin|goserelin|mesh-list
110657772|NCT03839823|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110657773|NCT03839823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110657774|NCT03839823|Tubulin Modulators|tubulin modulators|mesh-ancestor
110657775|NCT03839823|Antimitotic Agents|antimitotic agents|mesh-ancestor
110657776|NCT03839823|Mitosis Modulators|mitosis modulators|mesh-ancestor
110657777|NCT03839823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110657778|NCT03839823|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110657779|NCT03839823|Antimetabolites|antimetabolites|mesh-ancestor
110657780|NCT03839823|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110657781|NCT03839823|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110657782|NCT03839823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110657783|NCT03839823|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110657784|NCT03839823|Hormone Antagonists|hormone antagonists|mesh-ancestor
110657785|NCT03839823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110657786|NCT03839823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110657787|NCT03839823|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110657788|NCT03787680|Olaparib|olaparib|mesh-list
110657789|NCT03787680|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110657790|NCT03787680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110657791|NCT03787680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110657792|NCT03787680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110657793|NCT03743636|Niacinamide|niacinamide|mesh-list
110657794|NCT03743636|Niacin|niacin|mesh-list
110657795|NCT03743636|Nicotinic Acids|nicotinic acids|mesh-list
110657796|NCT03743636|Resveratrol|resveratrol|mesh-list
110657797|NCT03743636|Antioxidants|antioxidants|mesh-ancestor
110657798|NCT03743636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110657799|NCT03743636|Protective Agents|protective agents|mesh-ancestor
110657800|NCT03743636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110657801|NCT03743636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110657802|NCT03743636|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110657803|NCT03743636|Vitamin B Complex|vitamin b complex|mesh-ancestor
110657804|NCT03743636|Vitamins|vitamins|mesh-ancestor
110657805|NCT03743636|Micronutrients|micronutrients|mesh-ancestor
110657806|NCT03743636|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110657807|NCT03743636|Antimetabolites|antimetabolites|mesh-ancestor
110657808|NCT03743636|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110657809|NCT03743636|Vasodilator Agents|vasodilator agents|mesh-ancestor
110657810|NCT03726775|Durvalumab|durvalumab|mesh-list
110657811|NCT03726775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110657812|NCT03726775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110657813|NCT03718039|Aprepitant|aprepitant|mesh-list
110657814|NCT03718039|Antiemetics|antiemetics|mesh-ancestor
110657815|NCT03718039|Autonomic Agents|autonomic agents|mesh-ancestor
110657816|NCT03718039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110657817|NCT03718039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110657818|NCT03718039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110305034|NCT00290628|Hormones|hormones|mesh-ancestor
110657819|NCT03718039|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110657820|NCT03718039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110657821|NCT03718039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110657822|NCT03672292|Voriconazole|voriconazole|mesh-list
110657823|NCT03672292|Ibrexafungerp|ibrexafungerp|mesh-list
110657824|NCT03672292|Antifungal Agents|antifungal agents|mesh-ancestor
110657825|NCT03672292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110657826|NCT03672292|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110657827|NCT03672292|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110657828|NCT03672292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110657829|NCT03672292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110657830|NCT03672292|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110657831|NCT03672292|Hormone Antagonists|hormone antagonists|mesh-ancestor
110657832|NCT03672292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110657833|NCT03672292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110657834|NCT03672292|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110657836|NCT03635164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110657837|NCT03635164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110657838|NCT03602014|Droxidopa|droxidopa|mesh-list
110657839|NCT03602014|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110657840|NCT03602014|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110657841|NCT03559868|Digoxin|digoxin|mesh-list
110657842|NCT03559868|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110657843|NCT03559868|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110657844|NCT03559868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110657845|NCT03559868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110657846|NCT03559868|Protective Agents|protective agents|mesh-ancestor
110160448|NCT00099541|Zoledronic Acid|zoledronic acid|mesh-list
110657847|NCT03559868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110657848|NCT03559192|Aticaprant|aticaprant|mesh-list
110657849|NCT03559192|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110657850|NCT03559192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110657851|NCT03559192|Sensory System Agents|sensory system agents|mesh-ancestor
110657852|NCT03559192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110657853|NCT03552471|Rucaparib|rucaparib|mesh-list
110657854|NCT03552471|Maytansine|maytansine|mesh-list
110657855|NCT03552471|Mirvetuximab soravtansine|mirvetuximab soravtansine|mesh-list
110657856|NCT03552471|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110657857|NCT03552471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110657858|NCT03552471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110657859|NCT03552471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110657860|NCT03552471|Immunoconjugates|immunoconjugates|mesh-ancestor
110657861|NCT03552471|Immunologic Factors|immunologic factors|mesh-ancestor
110657862|NCT03552471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110657863|NCT03552471|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110657864|NCT03552471|Tubulin Modulators|tubulin modulators|mesh-ancestor
110657865|NCT03552471|Antimitotic Agents|antimitotic agents|mesh-ancestor
110657866|NCT03552471|Mitosis Modulators|mitosis modulators|mesh-ancestor
110657867|NCT03533946|Rucaparib|rucaparib|mesh-list
110657868|NCT03533946|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110657869|NCT03533946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110657870|NCT03533946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110657871|NCT03533946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110657872|NCT03523585|Capecitabine|capecitabine|mesh-list
110657873|NCT03523585|Trastuzumab|trastuzumab|mesh-list
110657874|NCT03523585|Lapatinib|lapatinib|mesh-list
110657875|NCT03523585|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
110657876|NCT03523585|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110657877|NCT03523585|Antimetabolites|antimetabolites|mesh-ancestor
110657878|NCT03523585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110657879|NCT03523585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110657880|NCT03523585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110657881|NCT03523585|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110657882|NCT03523585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110657883|NCT03523585|Immunoconjugates|immunoconjugates|mesh-ancestor
110657884|NCT03523585|Immunologic Factors|immunologic factors|mesh-ancestor
110657885|NCT03523585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110657886|NCT03485911|Berotralstat|berotralstat|mesh-list
110657887|NCT03485911|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110657888|NCT03485911|Protease Inhibitors|protease inhibitors|mesh-ancestor
110657889|NCT03485911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110657890|NCT03485911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110657891|NCT03435250|Paclitaxel|paclitaxel|mesh-list
110657892|NCT03435250|Docetaxel|docetaxel|mesh-list
110657893|NCT03435250|Gemcitabine|gemcitabine|mesh-list
110657894|NCT03435250|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110657895|NCT03435250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110657896|NCT03435250|Tubulin Modulators|tubulin modulators|mesh-ancestor
110657897|NCT03435250|Antimitotic Agents|antimitotic agents|mesh-ancestor
110657898|NCT03435250|Mitosis Modulators|mitosis modulators|mesh-ancestor
110657899|NCT03435250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110657900|NCT03435250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110657901|NCT03435250|Antimetabolites|antimetabolites|mesh-ancestor
110657902|NCT03416153|Paclitaxel|paclitaxel|mesh-list
110657903|NCT03416153|Carboplatin|carboplatin|mesh-list
110657904|NCT03416153|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110657905|NCT03416153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110657906|NCT03416153|Tubulin Modulators|tubulin modulators|mesh-ancestor
110657907|NCT03416153|Antimitotic Agents|antimitotic agents|mesh-ancestor
110657908|NCT03416153|Mitosis Modulators|mitosis modulators|mesh-ancestor
110657909|NCT03416153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110657910|NCT03409718|Cimetidine|cimetidine|mesh-list
110657911|NCT03409718|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110657912|NCT03409718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110657913|NCT03409718|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110657914|NCT03409718|Histamine Antagonists|histamine antagonists|mesh-ancestor
110657915|NCT03409718|Histamine Agents|histamine agents|mesh-ancestor
110657916|NCT03409718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110657917|NCT03409718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110657918|NCT03409718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110657919|NCT03409718|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110657920|NCT03409718|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110657921|NCT03409718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110657922|NCT03395314|Midazolam|midazolam|mesh-list
110657923|NCT03395314|Ketamine|ketamine|mesh-list
110657924|NCT03395314|Analgesics|analgesics|mesh-ancestor
110657925|NCT03395314|Sensory System Agents|sensory system agents|mesh-ancestor
110657926|NCT03395314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110657927|NCT03395314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110657928|NCT03395314|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110657929|NCT03395314|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110657930|NCT03395314|Anesthetics, General|anesthetics, general|mesh-ancestor
110657931|NCT03395314|Anesthetics|anesthetics|mesh-ancestor
110657932|NCT03395314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110657933|NCT03395314|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110657934|NCT03395314|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110657935|NCT03395314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110657936|NCT03395314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110657937|NCT03395314|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110657938|NCT03395314|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110657939|NCT03395314|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110657940|NCT03395314|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110657941|NCT03395314|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110657942|NCT03395314|GABA Modulators|gaba modulators|mesh-ancestor
110657943|NCT03395314|GABA Agents|gaba agents|mesh-ancestor
110657944|NCT03386500|Manganese|manganese|mesh-list
110657945|NCT03386500|Trace Elements|trace elements|mesh-ancestor
110657946|NCT03386500|Micronutrients|micronutrients|mesh-ancestor
110657947|NCT03386500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110657948|NCT03293680|Pembrolizumab|pembrolizumab|mesh-list
110657949|NCT03293680|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110657950|NCT03293680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110657951|NCT03293680|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110657952|NCT03293680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110657953|NCT03172975|Albendazole|albendazole|mesh-list
110657954|NCT03172975|Aluminum Hydroxide|aluminum hydroxide|mesh-list
110657955|NCT03172975|Anthelmintics|anthelmintics|mesh-ancestor
110657956|NCT03172975|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110657957|NCT03172975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110657958|NCT03172975|Anticestodal Agents|anticestodal agents|mesh-ancestor
110657959|NCT03172975|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110657960|NCT03172975|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110215734|NCT00070655|Vitamin K|vitamin k|mesh-list
110657961|NCT03172975|Tubulin Modulators|tubulin modulators|mesh-ancestor
110657963|NCT03172975|Mitosis Modulators|mitosis modulators|mesh-ancestor
110657964|NCT03172975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110657965|NCT03172975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110657966|NCT03172975|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110657967|NCT03172975|Immunologic Factors|immunologic factors|mesh-ancestor
110305180|NCT01603030|Antiemetics|antiemetics|mesh-ancestor
110657968|NCT03172975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110657969|NCT03172975|Antacids|antacids|mesh-ancestor
110657970|NCT03172975|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110657971|NCT03073785|Zoledronic Acid|zoledronic acid|mesh-list
110657972|NCT03073785|Fluorouracil|fluorouracil|mesh-list
110657973|NCT03073785|Capecitabine|capecitabine|mesh-list
110657974|NCT03073785|Imidazole|imidazole|mesh-list
110657975|NCT03073785|Antimetabolites|antimetabolites|mesh-ancestor
110657976|NCT03073785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110657977|NCT03073785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110657978|NCT03073785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110657979|NCT03073785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110657980|NCT03073785|Immunologic Factors|immunologic factors|mesh-ancestor
110657981|NCT03073785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110657982|NCT03073785|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110657983|NCT03073785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110657984|NCT03028103|Repaglinide|repaglinide|mesh-list
110657985|NCT03028103|Fluconazole|fluconazole|mesh-list
110657986|NCT03028103|Omeprazole|omeprazole|mesh-list
110657987|NCT03028103|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110657988|NCT03028103|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110657989|NCT03028103|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110657990|NCT03028103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110657991|NCT03028103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110657992|NCT03028103|Antifungal Agents|antifungal agents|mesh-ancestor
110657993|NCT03028103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110657994|NCT03028103|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110657995|NCT03028103|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110657996|NCT03028103|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110657997|NCT03028103|Hormone Antagonists|hormone antagonists|mesh-ancestor
110657998|NCT03028103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110657999|NCT03028103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110658000|NCT03028103|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110658001|NCT03028103|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110658002|NCT03028103|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110658003|NCT03020589|Tacrolimus|tacrolimus|mesh-list
110658004|NCT03020589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110658005|NCT03020589|Immunologic Factors|immunologic factors|mesh-ancestor
110658006|NCT03020589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110658007|NCT03020589|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110658008|NCT03020589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110658009|NCT03020589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110658010|NCT02932475|Metformin|metformin|mesh-list
110658011|NCT02932475|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110658012|NCT02932475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110658013|NCT02919917|Midodrine|midodrine|mesh-list
110658014|NCT02919917|Sympathomimetics|sympathomimetics|mesh-ancestor
110658015|NCT02919917|Autonomic Agents|autonomic agents|mesh-ancestor
110658016|NCT02919917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110658017|NCT02919917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110658018|NCT02919917|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110658019|NCT02919917|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110658020|NCT02919917|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110658021|NCT02919917|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110658022|NCT02919917|Adrenergic Agents|adrenergic agents|mesh-ancestor
110658023|NCT02919917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110658024|NCT02919917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110658025|NCT02893553|Midodrine|midodrine|mesh-list
110658026|NCT02893553|Bromides|bromides|mesh-list
110658027|NCT02893553|Mirabegron|mirabegron|mesh-list
110658028|NCT02893553|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
110658029|NCT02893553|Anticonvulsants|anticonvulsants|mesh-ancestor
110658030|NCT02893553|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
110658031|NCT02893553|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110658032|NCT02893553|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110658033|NCT02893553|Adrenergic Agents|adrenergic agents|mesh-ancestor
110658034|NCT02893553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110658035|NCT02893553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110658036|NCT02893553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110658037|NCT02893553|Urological Agents|urological agents|mesh-ancestor
110658038|NCT02893553|Sympathomimetics|sympathomimetics|mesh-ancestor
110658039|NCT02893553|Autonomic Agents|autonomic agents|mesh-ancestor
110658040|NCT02893553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110658041|NCT02893553|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110658042|NCT02893553|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110658043|NCT02893553|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110658044|NCT02893553|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110658045|NCT02893553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110658046|NCT02893553|Cholinergic Agents|cholinergic agents|mesh-ancestor
110658047|NCT02755272|Carboplatin|carboplatin|mesh-list
110658048|NCT02755272|Gemcitabine|gemcitabine|mesh-list
110658049|NCT02755272|Pembrolizumab|pembrolizumab|mesh-list
110658050|NCT02755272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110658051|NCT02755272|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110658052|NCT02755272|Antimetabolites|antimetabolites|mesh-ancestor
110160460|NCT00006350|Tacrolimus|tacrolimus|mesh-list
110658053|NCT02755272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110658054|NCT02755272|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110658055|NCT02755272|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110658056|NCT02507687|Bimatoprost|bimatoprost|mesh-list
110658057|NCT02507687|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110658058|NCT02321501|Everolimus|everolimus|mesh-list
110658059|NCT02321501|Ceritinib|ceritinib|mesh-list
110658060|NCT02321501|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110658061|NCT02321501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110658062|NCT02321501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110658063|NCT02321501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110658064|NCT02321501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110658065|NCT02321501|Immunologic Factors|immunologic factors|mesh-ancestor
110658066|NCT02321501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110658067|NCT02321501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110658068|NCT02237079|Bazedoxifene|bazedoxifene|mesh-list
110658069|NCT02237079|Estrogens|estrogens|mesh-list
110658070|NCT02237079|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
110658071|NCT02237079|Hormones|hormones|mesh-ancestor
110658072|NCT02237079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110658073|NCT02237079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110658074|NCT02237079|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110658075|NCT02237079|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110658076|NCT02237079|Hormone Antagonists|hormone antagonists|mesh-ancestor
110658077|NCT02237079|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110658078|NCT01992861|Deoxyglucose|deoxyglucose|mesh-list
110658079|NCT01992861|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110658080|NCT01992861|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110658081|NCT01992861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110658082|NCT01992861|Antimetabolites|antimetabolites|mesh-ancestor
110658083|NCT01992861|Antiviral Agents|antiviral agents|mesh-ancestor
110658084|NCT01992861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110658085|NCT01267448|Metformin|metformin|mesh-list
110658086|NCT01267448|Saxagliptin|saxagliptin|mesh-list
110658088|NCT01267448|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110658089|NCT01267448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110658090|NCT01267448|Incretins|incretins|mesh-ancestor
110658091|NCT01267448|Hormones|hormones|mesh-ancestor
110658092|NCT01267448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110658093|NCT01267448|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110658094|NCT01267448|Protease Inhibitors|protease inhibitors|mesh-ancestor
110658095|NCT01267448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110658096|NCT01267448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110658097|NCT01265030|Sirolimus|sirolimus|mesh-list
110658098|NCT01265030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110658099|NCT01265030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110658100|NCT01265030|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110658101|NCT01265030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110658102|NCT01265030|Antifungal Agents|antifungal agents|mesh-ancestor
110658103|NCT01265030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110658104|NCT01265030|Immunologic Factors|immunologic factors|mesh-ancestor
110658105|NCT01265030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110658106|NCT00901511|Sargramostim|sargramostim|mesh-list
110658107|NCT00901511|Immunologic Factors|immunologic factors|mesh-ancestor
110658108|NCT00901511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110658109|NCT00775476|Acetylcysteine|acetylcysteine|mesh-list
110658110|NCT00775476|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110658111|NCT00775476|Antiviral Agents|antiviral agents|mesh-ancestor
110658112|NCT00775476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110658113|NCT00775476|Expectorants|expectorants|mesh-ancestor
110658114|NCT00775476|Respiratory System Agents|respiratory system agents|mesh-ancestor
110658115|NCT00775476|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110658116|NCT00775476|Antioxidants|antioxidants|mesh-ancestor
110305331|NCT00258050|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110658117|NCT00775476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110658118|NCT00775476|Protective Agents|protective agents|mesh-ancestor
110658119|NCT00775476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110658120|NCT00775476|Antidotes|antidotes|mesh-ancestor
110658121|NCT00202813|Anti-Infective Agents|anti-infective agents|mesh-list
110658122|NCT00202813|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110658124|NCT00004180|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110658125|NCT00004180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110658126|NCT00988494|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110658127|NCT00988494|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110658128|NCT00539994|Retapamulin|retapamulin|mesh-list
110658129|NCT00539994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110658130|NCT00539994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110658131|NCT04005222|Selenium|selenium|mesh-list
110658132|NCT04005222|Melatonin|melatonin|mesh-list
110658133|NCT04005222|Antioxidants|antioxidants|mesh-ancestor
110658134|NCT04005222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110658135|NCT04005222|Protective Agents|protective agents|mesh-ancestor
110658136|NCT04005222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110658137|NCT04005222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110658138|NCT04005222|Trace Elements|trace elements|mesh-ancestor
110658139|NCT04005222|Micronutrients|micronutrients|mesh-ancestor
110658140|NCT00098839|Leucovorin|leucovorin|mesh-list
110658141|NCT00098839|Cytarabine|cytarabine|mesh-list
110658142|NCT00098839|Prednisone|prednisone|mesh-list
110658143|NCT00098839|Hydrocortisone|hydrocortisone|mesh-list
110658144|NCT00098839|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
110658145|NCT00098839|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
110658146|NCT00098839|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
110658147|NCT00098839|Cyclophosphamide|cyclophosphamide|mesh-list
110658148|NCT00098839|Doxorubicin|doxorubicin|mesh-list
110658149|NCT00098839|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110658150|NCT00098839|Methotrexate|methotrexate|mesh-list
110658151|NCT00098839|Etoposide|etoposide|mesh-list
110658152|NCT00098839|Vincristine|vincristine|mesh-list
110658153|NCT00098839|Etoposide phosphate|etoposide phosphate|mesh-list
110658154|NCT00098839|Asparaginase|asparaginase|mesh-list
110658155|NCT00098839|Pegaspargase|pegaspargase|mesh-list
110658156|NCT00098839|Epratuzumab|epratuzumab|mesh-list
110658157|NCT00098839|Dexrazoxane|dexrazoxane|mesh-list
110658158|NCT00098839|Razoxane|razoxane|mesh-list
110658159|NCT00098839|Levoleucovorin|levoleucovorin|mesh-list
110658160|NCT00098839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110658161|NCT00098839|Immunologic Factors|immunologic factors|mesh-ancestor
110658162|NCT00098839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110658163|NCT00098839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110658164|NCT00098839|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110658165|NCT00098839|Alkylating Agents|alkylating agents|mesh-ancestor
110658166|NCT00098839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110658167|NCT00098839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110658168|NCT00098839|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110658169|NCT00098839|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110658170|NCT00098839|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110658171|NCT00098839|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110658172|NCT00098839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110658173|NCT00098839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110658174|NCT00098839|Glucocorticoids|glucocorticoids|mesh-ancestor
110658175|NCT00098839|Hormones|hormones|mesh-ancestor
110658176|NCT00098839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110658177|NCT00098839|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110658178|NCT00098839|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110658179|NCT00098839|Abortifacient Agents|abortifacient agents|mesh-ancestor
110658180|NCT00098839|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110658181|NCT00098839|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110658182|NCT00098839|Antimetabolites|antimetabolites|mesh-ancestor
110658183|NCT00098839|Dermatologic Agents|dermatologic agents|mesh-ancestor
110658184|NCT00098839|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110658185|NCT00098839|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110658186|NCT00098839|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110658187|NCT00098839|Antiviral Agents|antiviral agents|mesh-ancestor
110658188|NCT00098839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110658189|NCT00098839|Antidotes|antidotes|mesh-ancestor
110658190|NCT00098839|Protective Agents|protective agents|mesh-ancestor
110658191|NCT00098839|Vitamin B Complex|vitamin b complex|mesh-ancestor
110658192|NCT00098839|Vitamins|vitamins|mesh-ancestor
110658193|NCT00098839|Micronutrients|micronutrients|mesh-ancestor
110658194|NCT00098839|Tubulin Modulators|tubulin modulators|mesh-ancestor
110658195|NCT00098839|Antimitotic Agents|antimitotic agents|mesh-ancestor
110305409|NCT00258245|Analgesics|analgesics|mesh-ancestor
110658196|NCT00098839|Mitosis Modulators|mitosis modulators|mesh-ancestor
110658197|NCT00098839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110160474|NCT00400582|Candesartan|candesartan|mesh-list
110658199|NCT05268744|Micronutrients|micronutrients|mesh-list
110658200|NCT05268744|Trace Elements|trace elements|mesh-list
110658201|NCT05268744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110658202|NCT02531191|Peficitinib|peficitinib|mesh-list
110658203|NCT02531191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110658204|NCT02531191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110658205|NCT02531191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110658206|NCT02531191|Immunologic Factors|immunologic factors|mesh-ancestor
110658207|NCT02531191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110658208|NCT01081639|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
110658210|NCT01081639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110658211|NCT01081639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110658212|NCT01081717|Golimumab|golimumab|mesh-list
110658213|NCT01081717|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110658214|NCT01081717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110658215|NCT01081717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110658216|NCT01081717|Immunologic Factors|immunologic factors|mesh-ancestor
110658217|NCT01081717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110658218|NCT01085383|Aripiprazole|aripiprazole|mesh-list
110658219|NCT01085383|Antidepressive Agents|antidepressive agents|mesh-ancestor
110658220|NCT01085383|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110658221|NCT01085383|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110658222|NCT01085383|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110658223|NCT01085383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110658224|NCT01085383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110658225|NCT01085383|Dopamine Agonists|dopamine agonists|mesh-ancestor
110658226|NCT01085383|Dopamine Agents|dopamine agents|mesh-ancestor
110658227|NCT01085383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110658228|NCT01085383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110658229|NCT01085383|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110658230|NCT01085383|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110658231|NCT01085383|Serotonin Agents|serotonin agents|mesh-ancestor
110658232|NCT01085383|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110658233|NCT01085383|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110658234|NCT01085383|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110658235|NCT01085383|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110658236|NCT00485589|Methotrexate|methotrexate|mesh-list
110658237|NCT00485589|Ocrelizumab|ocrelizumab|mesh-list
110658238|NCT00485589|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110658239|NCT00485589|Abortifacient Agents|abortifacient agents|mesh-ancestor
110658240|NCT00485589|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110658241|NCT00485589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110658242|NCT00485589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110658243|NCT00485589|Antimetabolites|antimetabolites|mesh-ancestor
110658244|NCT00485589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110658245|NCT00485589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110658246|NCT00485589|Dermatologic Agents|dermatologic agents|mesh-ancestor
110658247|NCT00485589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110658248|NCT00485589|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110658249|NCT00485589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110658250|NCT00485589|Immunologic Factors|immunologic factors|mesh-ancestor
110658251|NCT00485589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110658252|NCT00485589|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110658253|NCT00490971|Olanzapine|olanzapine|mesh-list
110658254|NCT00490971|Paliperidone Palmitate|paliperidone palmitate|mesh-list
110658255|NCT00490971|Antiemetics|antiemetics|mesh-ancestor
110658256|NCT00490971|Autonomic Agents|autonomic agents|mesh-ancestor
110658257|NCT00490971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110658258|NCT00490971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110658259|NCT00490971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110658260|NCT00490971|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110658261|NCT00490971|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110658262|NCT00490971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110658263|NCT00490971|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110658264|NCT00490971|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110658265|NCT00490971|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110658266|NCT00490971|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110658267|NCT00490971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110658268|NCT00490971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110658269|NCT00490971|Serotonin Agents|serotonin agents|mesh-ancestor
110658270|NCT00490971|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110658271|NCT00490971|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110658272|NCT00490971|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110658273|NCT00490971|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110658274|NCT00490971|Dopamine Agents|dopamine agents|mesh-ancestor
110658275|NCT04286295|Nicotine|nicotine|mesh-list
110658276|NCT04286295|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110658277|NCT04286295|Autonomic Agents|autonomic agents|mesh-ancestor
110658278|NCT04286295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110658279|NCT04286295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110658280|NCT04286295|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110658281|NCT04286295|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110658282|NCT04286295|Cholinergic Agents|cholinergic agents|mesh-ancestor
110658283|NCT04286295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110658284|NCT04286295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110658285|NCT00750347|Acetaminophen|acetaminophen|mesh-list
110658286|NCT00750347|Rimonabant|rimonabant|mesh-list
110658287|NCT00750347|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110658288|NCT00750347|Analgesics|analgesics|mesh-ancestor
110658289|NCT00750347|Sensory System Agents|sensory system agents|mesh-ancestor
110658290|NCT00750347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110658291|NCT00750347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110658292|NCT00750347|Antipyretics|antipyretics|mesh-ancestor
110658293|NCT00750347|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110658294|NCT00750347|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
110658295|NCT00750347|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110658296|NCT00750347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110658297|NCT00750347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110658298|NCT00750347|Hormones|hormones|mesh-ancestor
110658299|NCT00750347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110658300|NCT00750425|Cediranib|cediranib|mesh-list
110658301|NCT00750425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110658302|NCT00750425|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110658303|NCT00750425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110658304|NCT00750425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110658305|NCT00745589|Sevelamer|sevelamer|mesh-list
110658306|NCT00745589|Chelating Agents|chelating agents|mesh-ancestor
110658307|NCT00745589|Sequestering Agents|sequestering agents|mesh-ancestor
110658308|NCT00745589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110658309|NCT00750581|Indomethacin|indomethacin|mesh-list
110658310|NCT00750581|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110658311|NCT00750581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110658312|NCT00750581|Analgesics|analgesics|mesh-ancestor
110658313|NCT00750581|Sensory System Agents|sensory system agents|mesh-ancestor
110658314|NCT00750581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110215833|NCT00258115|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110658315|NCT00750581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110658316|NCT00750581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110658317|NCT00750581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110658318|NCT00750581|Gout Suppressants|gout suppressants|mesh-ancestor
110658319|NCT00750581|Tocolytic Agents|tocolytic agents|mesh-ancestor
110658320|NCT00750581|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110658321|NCT00750581|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110658322|NCT00750581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110658323|NCT00750581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110658324|NCT00685763|Gemcitabine|gemcitabine|mesh-list
110658325|NCT00685763|Capecitabine|capecitabine|mesh-list
110658326|NCT00685763|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110658327|NCT00685763|Antimetabolites|antimetabolites|mesh-ancestor
110658328|NCT00685763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110658329|NCT00685763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110658330|NCT00098293|Lamivudine|lamivudine|mesh-list
110658331|NCT00098293|Zidovudine|zidovudine|mesh-list
110658332|NCT00098293|Efavirenz|efavirenz|mesh-list
110658333|NCT00098293|Maraviroc|maraviroc|mesh-list
110658334|NCT00098293|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110658335|NCT00098293|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110658336|NCT00098293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110658337|NCT00098293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110658338|NCT00098293|Antiviral Agents|antiviral agents|mesh-ancestor
110658339|NCT00098293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110658340|NCT00098293|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110658341|NCT00098293|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110658342|NCT00098293|Antimetabolites|antimetabolites|mesh-ancestor
110658343|NCT00098293|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110658344|NCT00098293|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110658345|NCT00098293|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110399342|NCT05661045|Anesthetics|anesthetics|mesh-list
110658346|NCT00098293|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110658347|NCT00098293|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110658348|NCT00098293|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110658349|NCT00098293|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110658350|NCT00098293|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110658351|NCT00098293|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
110658352|NCT00923741|Talactoferrin alfa|talactoferrin alfa|mesh-list
110658353|NCT00923741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110658354|NCT00685685|Lovastatin|lovastatin|mesh-list
110658355|NCT00685685|L 647318|l 647318|mesh-list
110658356|NCT00685685|Dihydromevinolin|dihydromevinolin|mesh-list
110658357|NCT00685685|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110658358|NCT00685685|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110658359|NCT00685685|Antimetabolites|antimetabolites|mesh-ancestor
110658360|NCT00685685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110658361|NCT00685685|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110658362|NCT00685685|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110658363|NCT00685685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110658364|NCT01087567|Insulin|insulin|mesh-list
110658365|NCT01087567|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110658366|NCT01087567|Metformin|metformin|mesh-list
110658367|NCT01087567|Pioglitazone|pioglitazone|mesh-list
110658368|NCT01087567|Glimepiride|glimepiride|mesh-list
110658369|NCT01087567|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110658370|NCT01087567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110658371|NCT01087567|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110658372|NCT01087567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110658373|NCT01087567|Immunologic Factors|immunologic factors|mesh-ancestor
110658374|NCT00751049|Timolol|timolol|mesh-list
110658375|NCT00751049|Latanoprost|latanoprost|mesh-list
110658376|NCT00751049|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110658377|NCT00751049|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110658378|NCT00751049|Adrenergic Agents|adrenergic agents|mesh-ancestor
110658379|NCT00751049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110658380|NCT00751049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110658381|NCT00751049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110658382|NCT00751049|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110658383|NCT00751049|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110658384|NCT00751049|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110658385|NCT00751049|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110658387|NCT00500331|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110658388|NCT00500331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110658389|NCT01019109|Cobalt|cobalt|mesh-list
110658390|NCT01019109|Trace Elements|trace elements|mesh-ancestor
110658391|NCT01019109|Micronutrients|micronutrients|mesh-ancestor
110658392|NCT01019109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110658393|NCT00499863|Methylphenidate|methylphenidate|mesh-list
110658394|NCT00499863|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110658395|NCT00499863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110658396|NCT00499863|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110658397|NCT00499863|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110658398|NCT00499863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110658399|NCT00499863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110658400|NCT00499863|Dopamine Agents|dopamine agents|mesh-ancestor
110658401|NCT00499863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110658402|NCT04475835|Heparin|heparin|mesh-list
110658403|NCT04475835|Bivalirudin|bivalirudin|mesh-list
110658404|NCT04475835|Anticoagulants|anticoagulants|mesh-ancestor
110658405|NCT04475835|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110658406|NCT04475835|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110658407|NCT04475835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110399361|NCT01294449|Cytarabine|cytarabine|mesh-list
110658408|NCT04475835|Antithrombins|antithrombins|mesh-ancestor
110658409|NCT04475835|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110658410|NCT04475835|Protease Inhibitors|protease inhibitors|mesh-ancestor
110658411|NCT04475835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110658412|NCT01014507|Goserelin|goserelin|mesh-list
110658413|NCT01014507|Contraceptive Agents|contraceptive agents|mesh-list
110658414|NCT01014507|Contraceptives, Oral|contraceptives, oral|mesh-list
110658415|NCT01014507|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110658416|NCT01014507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110658417|NCT01014507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110658418|NCT01014507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110658419|NCT01014507|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110658420|NCT00097981|Thalidomide|thalidomide|mesh-list
110658421|NCT00097981|Dexamethasone|dexamethasone|mesh-list
110658422|NCT00097981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110658423|NCT00097981|Antiemetics|antiemetics|mesh-ancestor
110658424|NCT00097981|Autonomic Agents|autonomic agents|mesh-ancestor
110658425|NCT00097981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110658426|NCT00097981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110658427|NCT00097981|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110658428|NCT00097981|Glucocorticoids|glucocorticoids|mesh-ancestor
110658429|NCT00097981|Hormones|hormones|mesh-ancestor
110658430|NCT00097981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110658431|NCT00097981|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110658432|NCT00097981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110658433|NCT00097981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110658434|NCT00097981|Immunologic Factors|immunologic factors|mesh-ancestor
110658435|NCT00097981|Leprostatic Agents|leprostatic agents|mesh-ancestor
110658436|NCT00097981|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110658437|NCT00097981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110658438|NCT00097981|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110658439|NCT00097981|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110658440|NCT00097981|Growth Substances|growth substances|mesh-ancestor
110658441|NCT00097981|Growth Inhibitors|growth inhibitors|mesh-ancestor
110658442|NCT01016145|Antipsychotic Agents|antipsychotic agents|mesh-list
110658443|NCT01016145|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110658444|NCT01016145|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110658445|NCT01016145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110658446|NCT01016145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110658447|NCT01016223|Beclomethasone|beclomethasone|mesh-list
110658448|NCT01016223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110658449|NCT01016223|Glucocorticoids|glucocorticoids|mesh-ancestor
110658450|NCT01016223|Hormones|hormones|mesh-ancestor
110658451|NCT01016223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110658452|NCT01016223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110658453|NCT01016223|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110658454|NCT01016223|Respiratory System Agents|respiratory system agents|mesh-ancestor
110658455|NCT04151017|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
110658456|NCT04151017|Hemostatics|hemostatics|mesh-ancestor
110658457|NCT04151017|Coagulants|coagulants|mesh-ancestor
110658458|NCT01019265|Buprenorphine|buprenorphine|mesh-list
110658459|NCT01019265|Tramadol|tramadol|mesh-list
110658460|NCT01019265|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110658461|NCT01019265|Narcotics|narcotics|mesh-ancestor
110658462|NCT01019265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110658463|NCT01019265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110658464|NCT01019265|Analgesics|analgesics|mesh-ancestor
110658465|NCT01019265|Sensory System Agents|sensory system agents|mesh-ancestor
110658466|NCT01019265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110658467|NCT01019265|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110658469|NCT01085617|Cyclophosphamide|cyclophosphamide|mesh-list
110658470|NCT01085617|Melphalan|melphalan|mesh-list
110658471|NCT01085617|Rituximab|rituximab|mesh-list
110658472|NCT01085617|Methotrexate|methotrexate|mesh-list
110658473|NCT01085617|Fludarabine|fludarabine|mesh-list
110658474|NCT01085617|Fludarabine phosphate|fludarabine phosphate|mesh-list
110658475|NCT01085617|Etoposide|etoposide|mesh-list
110658476|NCT01085617|Vincristine|vincristine|mesh-list
110658477|NCT01085617|Imatinib Mesylate|imatinib mesylate|mesh-list
110658478|NCT01085617|Daunorubicin|daunorubicin|mesh-list
110658479|NCT01085617|Mercaptopurine|mercaptopurine|mesh-list
110658480|NCT01085617|Pegaspargase|pegaspargase|mesh-list
110658481|NCT01085617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110160506|NCT00006356|Carboplatin|carboplatin|mesh-list
110658541|NCT01087879|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110658542|NCT01087879|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110658543|NCT01087879|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110658544|NCT01087879|Etonogestrel|etonogestrel|mesh-list
110658545|NCT01087879|Desogestrel|desogestrel|mesh-list
110658547|NCT01087879|Norelgestromin|norelgestromin|mesh-list
110658548|NCT01087879|Contraceptive Agents|contraceptive agents|mesh-list
110658549|NCT01087879|Estradiol|estradiol|mesh-list
110658550|NCT01087879|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110658551|NCT01087879|Estrogens|estrogens|mesh-ancestor
110658552|NCT01087879|Hormones|hormones|mesh-ancestor
110658553|NCT01087879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110658554|NCT01087879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110658555|NCT01087879|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110658556|NCT01087879|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110658557|NCT01087879|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110658558|NCT01087879|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110658559|NCT01087879|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110658560|NCT01087879|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110658561|NCT01087879|Progestins|progestins|mesh-ancestor
110034186|NCT00430040|Carvedilol|carvedilol|mesh-list
110658562|NCT01019421|(2-(6-fluoro-1H-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|(2-(6-fluoro-1h-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|mesh-list
110658563|NCT01019421|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110658564|NCT01019421|Serotonin Agents|serotonin agents|mesh-ancestor
110658565|NCT01019421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110658566|NCT01019421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110215864|NCT00258232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110658567|NCT01019421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110658568|NCT01085695|Rabeprazole|rabeprazole|mesh-list
110658569|NCT01085695|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110658570|NCT01085695|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110658571|NCT01085695|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110658572|NCT01085695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110658573|NCT01085695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110658575|NCT01088035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110658576|NCT01085851|Chlorpheniramine|chlorpheniramine|mesh-list
110658577|NCT01085851|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
110658578|NCT01085851|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110658579|NCT01085851|Histamine Antagonists|histamine antagonists|mesh-ancestor
110658580|NCT01085851|Histamine Agents|histamine agents|mesh-ancestor
110658581|NCT01085851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110658582|NCT01085851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110658583|NCT01085851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110658584|NCT01085851|Antipruritics|antipruritics|mesh-ancestor
110658585|NCT01085851|Dermatologic Agents|dermatologic agents|mesh-ancestor
110160536|NCT04143711|Paclitaxel|paclitaxel|mesh-list
110658586|NCT01085851|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110658587|NCT00751127|Timolol|timolol|mesh-list
110658588|NCT00751127|Latanoprost|latanoprost|mesh-list
110658589|NCT00751127|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110658590|NCT00751127|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110658591|NCT00751127|Adrenergic Agents|adrenergic agents|mesh-ancestor
110658592|NCT00751127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110658593|NCT00751127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110658594|NCT00751127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110658595|NCT00751127|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110658596|NCT00751127|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110658597|NCT00751127|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110658598|NCT00751127|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110658599|NCT00751205|Acetylcarnitine|acetylcarnitine|mesh-list
110658600|NCT00751205|Prednisone|prednisone|mesh-list
110658601|NCT00751205|Prednisolone|prednisolone|mesh-list
110658602|NCT00751205|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110658603|NCT00751205|Methylprednisolone|methylprednisolone|mesh-list
110658604|NCT00751205|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110658605|NCT00751205|Prednisolone acetate|prednisolone acetate|mesh-list
110658606|NCT00751205|Sagopilone|sagopilone|mesh-list
110658607|NCT00751205|Epothilones|epothilones|mesh-list
110658608|NCT00751205|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110658609|NCT00751205|Prednisolone phosphate|prednisolone phosphate|mesh-list
110658610|NCT00751205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110658611|NCT00751205|Glucocorticoids|glucocorticoids|mesh-ancestor
110658612|NCT00751205|Hormones|hormones|mesh-ancestor
110658613|NCT00751205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110658614|NCT00751205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110658615|NCT00751205|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110658616|NCT00751205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110658617|NCT00751205|Antiemetics|antiemetics|mesh-ancestor
110658618|NCT00751205|Autonomic Agents|autonomic agents|mesh-ancestor
110399390|NCT01293123|Tenofovir|tenofovir|mesh-list
110658619|NCT00751205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110658620|NCT00751205|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110658621|NCT00751205|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110658622|NCT00751205|Protective Agents|protective agents|mesh-ancestor
110658623|NCT00751205|Vitamin B Complex|vitamin b complex|mesh-ancestor
110658624|NCT00751205|Vitamins|vitamins|mesh-ancestor
110658625|NCT00751205|Micronutrients|micronutrients|mesh-ancestor
110658626|NCT00751205|Nootropic Agents|nootropic agents|mesh-ancestor
110658627|NCT00751205|Tubulin Modulators|tubulin modulators|mesh-ancestor
110658628|NCT00751205|Antimitotic Agents|antimitotic agents|mesh-ancestor
110658629|NCT00751205|Mitosis Modulators|mitosis modulators|mesh-ancestor
110658630|NCT00751205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110658631|NCT00752063|Capecitabine|capecitabine|mesh-list
110658632|NCT00752063|Oxaliplatin|oxaliplatin|mesh-list
110658633|NCT00752063|Sorafenib|sorafenib|mesh-list
110658634|NCT00752063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110215877|NCT00258271|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110658635|NCT00752063|Antimetabolites|antimetabolites|mesh-ancestor
110658636|NCT00752063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110658637|NCT00752063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110658638|NCT00752063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110658639|NCT00752063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110658640|NCT00752141|Mandelic Acids|mandelic acids|mesh-list
110658641|NCT00752141|Oxybutynin|oxybutynin|mesh-list
110658642|NCT00752141|Parasympatholytics|parasympatholytics|mesh-ancestor
110658643|NCT00752141|Autonomic Agents|autonomic agents|mesh-ancestor
110658644|NCT00752141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110658645|NCT00752141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110658646|NCT00752141|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110305858|NCT00259883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110658647|NCT00752141|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110658648|NCT00752141|Cholinergic Agents|cholinergic agents|mesh-ancestor
110658649|NCT00752141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110658650|NCT00752141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110658651|NCT00752141|Urological Agents|urological agents|mesh-ancestor
110658652|NCT00752141|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110658653|NCT00752141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110658654|NCT00752375|Trimethoprim|trimethoprim|mesh-list
110658655|NCT00752375|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
110658656|NCT00752375|Sulfamethoxazole|sulfamethoxazole|mesh-list
110658657|NCT00752375|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110658658|NCT00752375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110658659|NCT00752375|Antimalarials|antimalarials|mesh-ancestor
110658660|NCT00752375|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110658661|NCT00752375|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110658662|NCT00752375|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110658663|NCT00752375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110658664|NCT00752375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110658665|NCT00752375|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110658666|NCT00752375|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
110658667|NCT00752375|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110658668|NCT00752375|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110658669|NCT00751517|Cyclophosphamide|cyclophosphamide|mesh-list
110658670|NCT00751517|Methotrexate|methotrexate|mesh-list
110658671|NCT00751517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110658672|NCT00751517|Immunologic Factors|immunologic factors|mesh-ancestor
110658673|NCT00751517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110658674|NCT00751517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110658675|NCT00751517|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110658676|NCT00751517|Alkylating Agents|alkylating agents|mesh-ancestor
110658677|NCT00751517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110658678|NCT00751517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110658679|NCT00751517|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110658680|NCT00751517|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110658681|NCT00751517|Abortifacient Agents|abortifacient agents|mesh-ancestor
110658682|NCT00751517|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110658683|NCT00751517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110658684|NCT00751517|Antimetabolites|antimetabolites|mesh-ancestor
110658685|NCT00751517|Dermatologic Agents|dermatologic agents|mesh-ancestor
110658686|NCT00751517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110658687|NCT00751517|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110658688|NCT00751517|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110658689|NCT02561117|Metronidazole|metronidazole|mesh-list
110658690|NCT02561117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110658691|NCT02561117|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110658692|NCT02561117|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110658693|NCT02561117|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110658694|NCT00684515|Aspirin|aspirin|mesh-list
110658695|NCT00684515|Vorapaxar|vorapaxar|mesh-list
110658696|NCT00684515|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110658697|NCT00684515|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110658698|NCT00684515|Analgesics|analgesics|mesh-ancestor
110658699|NCT00684515|Sensory System Agents|sensory system agents|mesh-ancestor
110658700|NCT00684515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110658701|NCT00684515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110658702|NCT00684515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110658703|NCT00684515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110658704|NCT00684515|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110658705|NCT00684515|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110658706|NCT00684515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110658707|NCT00684515|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110658708|NCT00684515|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110658709|NCT00684515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110658710|NCT00684515|Antipyretics|antipyretics|mesh-ancestor
110658711|NCT00751751|Losartan|losartan|mesh-list
110658712|NCT00751751|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110658713|NCT00751751|Olmesartan|olmesartan|mesh-list
110658714|NCT00751751|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
110658715|NCT00751751|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110658716|NCT00751751|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110658717|NCT00751751|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110160551|NCT00006362|Bortezomib|bortezomib|mesh-list
110658718|NCT00751751|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110658719|NCT00751751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110658721|NCT00751751|Natriuretic Agents|natriuretic agents|mesh-ancestor
110305934|NCT00272610|Vitamin A|vitamin a|mesh-list
110658722|NCT00751751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110658723|NCT00751751|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110658724|NCT00751751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110658725|NCT00490815|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
110658726|NCT00490815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110658727|NCT00490815|Glucocorticoids|glucocorticoids|mesh-ancestor
110658728|NCT00490815|Hormones|hormones|mesh-ancestor
110658729|NCT00490815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110658730|NCT00490815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110658731|NCT04453137|Adalimumab|adalimumab|mesh-list
110658732|NCT04453137|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110658733|NCT04453137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110658734|NCT04453137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110658735|NCT03855189|Mometasone Furoate|mometasone furoate|mesh-list
110658736|NCT03855189|Beclomethasone|beclomethasone|mesh-list
110658737|NCT03855189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110658738|NCT03855189|Dermatologic Agents|dermatologic agents|mesh-ancestor
110658739|NCT03855189|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110658740|NCT03855189|Glucocorticoids|glucocorticoids|mesh-ancestor
110658741|NCT03855189|Hormones|hormones|mesh-ancestor
110658742|NCT03855189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110658743|NCT03855189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110658744|NCT03855189|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110658745|NCT03855189|Respiratory System Agents|respiratory system agents|mesh-ancestor
110658747|NCT03853551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110658748|NCT03853551|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110658749|NCT03853551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110658750|NCT03853551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110658751|NCT00423670|Ribavirin|ribavirin|mesh-list
110658752|NCT00423670|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110658753|NCT00423670|Antimetabolites|antimetabolites|mesh-ancestor
110658754|NCT00423670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110658755|NCT00423670|Antiviral Agents|antiviral agents|mesh-ancestor
110658756|NCT00423670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110658757|NCT01019655|Nadroparin|nadroparin|mesh-list
110658758|NCT01019655|Calcium|calcium|mesh-list
110658759|NCT01019655|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110658760|NCT01019655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110658761|NCT01019655|Anticoagulants|anticoagulants|mesh-ancestor
110658762|NCT01019655|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110658763|NCT01019655|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110658764|NCT01019655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110658765|NCT00483717|Ketorolac|ketorolac|mesh-list
110658766|NCT00483717|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
110658767|NCT00483717|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110658768|NCT00483717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110658769|NCT00483717|Analgesics|analgesics|mesh-ancestor
110658770|NCT00483717|Sensory System Agents|sensory system agents|mesh-ancestor
110658771|NCT00483717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110658772|NCT00483717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110658773|NCT00483717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110658774|NCT00483717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110658775|NCT00483717|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110658776|NCT00483717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110658777|NCT00483717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110658778|NCT00406354|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
110658779|NCT00406354|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110658780|NCT00406354|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110658781|NCT00406354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110658782|NCT00406354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110658783|NCT00406354|Adrenergic Agents|adrenergic agents|mesh-ancestor
110658784|NCT00406354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110658785|NCT00406354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110658786|NCT01037842|Mitiglinide|mitiglinide|mesh-list
110658787|NCT01037842|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110658788|NCT01037842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110658790|NCT00483405|Oxaliplatin|oxaliplatin|mesh-list
110658791|NCT00483405|Cetuximab|cetuximab|mesh-list
110658792|NCT00483405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110658793|NCT00483405|Antimetabolites|antimetabolites|mesh-ancestor
110658794|NCT00483405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110658795|NCT00483405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110658796|NCT00483405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110658797|NCT00483327|Megestrol|megestrol|mesh-list
110658798|NCT00483327|Megestrol Acetate|megestrol acetate|mesh-list
110658799|NCT00483327|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110658800|NCT00483327|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110399413|NCT01292187|Katacalcin|katacalcin|mesh-list
110658801|NCT00483327|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110658802|NCT00483327|Contraceptive Agents|contraceptive agents|mesh-ancestor
110658803|NCT00483327|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110658804|NCT00483327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110658805|NCT00483327|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110658806|NCT00483327|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110658807|NCT00483327|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110658808|NCT00483327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110658809|NCT00483327|Appetite Stimulants|appetite stimulants|mesh-ancestor
110658810|NCT00483327|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110658811|NCT00684203|Aspirin|aspirin|mesh-list
110658812|NCT00684203|Clopidogrel|clopidogrel|mesh-list
110658813|NCT00684203|Vorapaxar|vorapaxar|mesh-list
110658814|NCT00684203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110658815|NCT00684203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110658816|NCT00684203|Analgesics|analgesics|mesh-ancestor
110658817|NCT00684203|Sensory System Agents|sensory system agents|mesh-ancestor
110658818|NCT00684203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110658819|NCT00684203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110658820|NCT00684203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110658821|NCT00684203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110658822|NCT00684203|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110658823|NCT00684203|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110658824|NCT00684203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110658825|NCT00684203|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110658826|NCT00684203|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110658827|NCT00684203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110658829|NCT00684203|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110658830|NCT00684203|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110658831|NCT00684203|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110658832|NCT00684203|Purinergic Agents|purinergic agents|mesh-ancestor
110658833|NCT00684203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110658834|NCT00423592|Ambrisentan|ambrisentan|mesh-list
110658835|NCT00423592|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110658836|NCT01037998|Gefitinib|gefitinib|mesh-list
110658837|NCT01037998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110658838|NCT01037998|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110658839|NCT01037998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110658840|NCT01037998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110658841|NCT00751907|Atorvastatin|atorvastatin|mesh-list
110658842|NCT00751907|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110658843|NCT00751907|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110658844|NCT00751907|Antimetabolites|antimetabolites|mesh-ancestor
110658845|NCT00751907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110658846|NCT00751907|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110658847|NCT00751907|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110658848|NCT00751907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110658849|NCT00752843|Mifepristone|mifepristone|mesh-list
110658850|NCT00752843|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
110658851|NCT00752843|Abortifacient Agents|abortifacient agents|mesh-ancestor
110658852|NCT00752843|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110658853|NCT00752843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110658854|NCT00752843|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110658855|NCT00752843|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110658856|NCT00752843|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110658857|NCT00752843|Contraceptive Agents|contraceptive agents|mesh-ancestor
110160558|NCT00099892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110658858|NCT00752843|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
110658859|NCT00752843|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
110658860|NCT00752843|Hormone Antagonists|hormone antagonists|mesh-ancestor
110658861|NCT00752843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110658863|NCT00752843|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110658864|NCT00752843|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
110658866|NCT00752921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110658867|NCT00752921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110658868|NCT00752921|Analgesics|analgesics|mesh-ancestor
110658869|NCT00752921|Sensory System Agents|sensory system agents|mesh-ancestor
110658870|NCT00752921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110658871|NCT00752921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110658872|NCT00752921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110658873|NCT00752921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110658874|NCT00752921|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110658875|NCT00752921|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110658876|NCT00752921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110658877|NCT00752921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110658878|NCT00683657|Saxagliptin|saxagliptin|mesh-list
110658879|NCT00683657|Incretins|incretins|mesh-ancestor
110658880|NCT00683657|Hormones|hormones|mesh-ancestor
110215924|NCT00104910|Cetuximab|cetuximab|mesh-list
110658881|NCT00683657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110658882|NCT00683657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110658883|NCT00683657|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110658884|NCT00683657|Protease Inhibitors|protease inhibitors|mesh-ancestor
110658885|NCT00683657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110658886|NCT00683657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110658887|NCT00683657|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110658888|NCT00755885|Abiraterone Acetate|abiraterone acetate|mesh-list
110658889|NCT00755885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110658890|NCT00755885|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110658891|NCT00755885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110658892|NCT00755885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110658893|NCT00755885|Hormone Antagonists|hormone antagonists|mesh-ancestor
110658894|NCT00755885|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110658895|NCT00755885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110658896|NCT00755885|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110658897|NCT00755963|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110658898|NCT00755963|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110658900|NCT00755963|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110658901|NCT00755963|Progesterone|progesterone|mesh-list
110658902|NCT00755963|Estrogens|estrogens|mesh-ancestor
110658903|NCT00755963|Hormones|hormones|mesh-ancestor
110658904|NCT00755963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110658905|NCT00755963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110658906|NCT00755963|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110658907|NCT00755963|Contraceptive Agents|contraceptive agents|mesh-ancestor
110658908|NCT00755963|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110658909|NCT00755963|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110658910|NCT00755963|Progestins|progestins|mesh-ancestor
110658911|NCT00753311|Rizatriptan|rizatriptan|mesh-list
110658912|NCT00753311|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110658913|NCT00753311|Serotonin Agents|serotonin agents|mesh-ancestor
110658914|NCT00753311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110658915|NCT00753311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110658916|NCT00753311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110658917|NCT00753389|Anesthetics|anesthetics|mesh-list
110658918|NCT00753389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110658919|NCT00753389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110658920|NCT00753467|Interferons|interferons|mesh-list
110658921|NCT00753467|Adefovir|adefovir|mesh-list
110658922|NCT00753467|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
110658923|NCT00753467|Interferon-gamma|interferon-gamma|mesh-list
110658924|NCT00753467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110658925|NCT00753467|Antiviral Agents|antiviral agents|mesh-ancestor
110658926|NCT00753467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110658927|NCT00753467|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110658928|NCT00753467|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110658929|NCT00753467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110658930|NCT00753467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110658932|NCT00482703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110658933|NCT00482703|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110658934|NCT00482703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110658935|NCT00482703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110658936|NCT04052867|Lidocaine|lidocaine|mesh-list
110658937|NCT04052867|Anesthetics, Local|anesthetics, local|mesh-ancestor
110658938|NCT04052867|Anesthetics|anesthetics|mesh-ancestor
110658939|NCT04052867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110658940|NCT04052867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110306159|NCT01330108|Ambrisentan|ambrisentan|mesh-list
110658941|NCT04052867|Sensory System Agents|sensory system agents|mesh-ancestor
110658942|NCT04052867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110658943|NCT04052867|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110658944|NCT04052867|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110658945|NCT04052867|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110658946|NCT04052867|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110658947|NCT04052867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110658948|NCT00482391|Paclitaxel|paclitaxel|mesh-list
110658949|NCT00482391|Cyclophosphamide|cyclophosphamide|mesh-list
110658950|NCT00482391|Doxorubicin|doxorubicin|mesh-list
110658951|NCT00482391|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110658952|NCT00482391|Trastuzumab|trastuzumab|mesh-list
110658953|NCT00482391|Lapatinib|lapatinib|mesh-list
110658954|NCT00482391|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110658955|NCT00482391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110658956|NCT00482391|Tubulin Modulators|tubulin modulators|mesh-ancestor
110658957|NCT00482391|Antimitotic Agents|antimitotic agents|mesh-ancestor
110658958|NCT00482391|Mitosis Modulators|mitosis modulators|mesh-ancestor
110658959|NCT00482391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110658960|NCT00482391|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110658961|NCT00482391|Immunologic Factors|immunologic factors|mesh-ancestor
110658962|NCT00482391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110658963|NCT00482391|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110658964|NCT00482391|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110658965|NCT00482391|Alkylating Agents|alkylating agents|mesh-ancestor
110658966|NCT00482391|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110658967|NCT00482391|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110658968|NCT00482391|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110658969|NCT00482391|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110658970|NCT00482391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110658971|NCT00482391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110658972|NCT00482391|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110658973|NCT00753779|Simvastatin|simvastatin|mesh-list
110658974|NCT00753779|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
110658975|NCT00753779|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110658976|NCT00753779|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110658977|NCT00753779|Antimetabolites|antimetabolites|mesh-ancestor
110658978|NCT00753779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110658979|NCT00753779|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110658980|NCT00753779|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110658981|NCT00753779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110399463|NCT01021423|Lenalidomide|lenalidomide|mesh-list
110658982|NCT00757523|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
110658983|NCT00757523|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110658984|NCT00757523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110658986|NCT00757523|Sensory System Agents|sensory system agents|mesh-ancestor
110658987|NCT00757523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110658988|NCT00757523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110658989|NCT00757523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110658990|NCT00757523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110658991|NCT00757523|Dermatologic Agents|dermatologic agents|mesh-ancestor
110658992|NCT00757679|Milnacipran|milnacipran|mesh-list
110658993|NCT00757679|Levomilnacipran|levomilnacipran|mesh-list
110658994|NCT00757679|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110658995|NCT00757679|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110658996|NCT00757679|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110658997|NCT00757679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110658998|NCT00757679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110658999|NCT00757679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110659000|NCT00757679|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110659001|NCT00757679|Analgesics|analgesics|mesh-ancestor
110659002|NCT00757679|Sensory System Agents|sensory system agents|mesh-ancestor
110659003|NCT00757679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110659004|NCT00757679|Antidepressive Agents|antidepressive agents|mesh-ancestor
110659005|NCT00757679|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110659006|NCT00496587|Bevacizumab|bevacizumab|mesh-list
110659007|NCT00496587|Gemcitabine|gemcitabine|mesh-list
110659008|NCT00496587|Capecitabine|capecitabine|mesh-list
110659009|NCT00496587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110659010|NCT00496587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110659011|NCT00496587|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110659012|NCT00496587|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110659013|NCT00496587|Growth Substances|growth substances|mesh-ancestor
110659014|NCT00496587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110659015|NCT00496587|Growth Inhibitors|growth inhibitors|mesh-ancestor
110659016|NCT00496587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110659017|NCT00496587|Antimetabolites|antimetabolites|mesh-ancestor
110659018|NCT00496587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110659020|NCT00757835|Latanoprost|latanoprost|mesh-list
110659021|NCT00757835|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110659022|NCT00757835|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110659023|NCT00757835|Adrenergic Agents|adrenergic agents|mesh-ancestor
110659024|NCT00757835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110659025|NCT00757835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110659026|NCT00757835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110659027|NCT00757835|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110659028|NCT00757835|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110659029|NCT00757835|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110659030|NCT00757835|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110659031|NCT01038154|Pravastatin|pravastatin|mesh-list
110659032|NCT01038154|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110659033|NCT01038154|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110659034|NCT01038154|Antimetabolites|antimetabolites|mesh-ancestor
110659035|NCT01038154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110659036|NCT01038154|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110659037|NCT01038154|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110659038|NCT01038154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110659039|NCT00405652|Mycophenolic Acid|mycophenolic acid|mesh-list
110659040|NCT00405652|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110659041|NCT00405652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110659042|NCT00405652|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110659043|NCT00405652|Antitubercular Agents|antitubercular agents|mesh-ancestor
110659044|NCT00405652|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110659045|NCT00405652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110659046|NCT00405652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110659047|NCT00405652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110659048|NCT01324180|Metformin|metformin|mesh-list
110659049|NCT01324180|Dexamethasone|dexamethasone|mesh-list
110659050|NCT01324180|Doxorubicin|doxorubicin|mesh-list
110659051|NCT01324180|Vincristine|vincristine|mesh-list
110659052|NCT01324180|Asparaginase|asparaginase|mesh-list
110659053|NCT01324180|Pegaspargase|pegaspargase|mesh-list
110659054|NCT01324180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110659055|NCT01324180|Antiemetics|antiemetics|mesh-ancestor
110659056|NCT01324180|Autonomic Agents|autonomic agents|mesh-ancestor
110659057|NCT01324180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110215965|NCT00259363|Oxaliplatin|oxaliplatin|mesh-list
110659058|NCT01324180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110659059|NCT01324180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110659060|NCT01324180|Glucocorticoids|glucocorticoids|mesh-ancestor
110659062|NCT01324180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110659063|NCT01324180|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110659064|NCT01324180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110659065|NCT01324180|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110659066|NCT01324180|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110659067|NCT01324180|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110659068|NCT01324180|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110659069|NCT01324180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110659070|NCT01324180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110659071|NCT01324180|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110659072|NCT01324180|Tubulin Modulators|tubulin modulators|mesh-ancestor
110659073|NCT01324180|Antimitotic Agents|antimitotic agents|mesh-ancestor
110659074|NCT01324180|Mitosis Modulators|mitosis modulators|mesh-ancestor
110659075|NCT02560649|Tenofovir|tenofovir|mesh-list
110659076|NCT02560649|Lamivudine|lamivudine|mesh-list
110659077|NCT02560649|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110659078|NCT02560649|Interferon-alpha|interferon-alpha|mesh-list
110659079|NCT02560649|Entecavir|entecavir|mesh-list
110659080|NCT02560649|Adefovir|adefovir|mesh-list
110659081|NCT02560649|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
110659082|NCT02560649|Antiviral Agents|antiviral agents|mesh-ancestor
110659083|NCT02560649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110659084|NCT02560649|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110659085|NCT02560649|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110659086|NCT02560649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110659087|NCT02560649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110659088|NCT02560649|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110306306|NCT00298974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110659089|NCT02560649|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110659090|NCT02560649|Immunologic Factors|immunologic factors|mesh-ancestor
110659091|NCT02560649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110659092|NCT00754403|Metformin|metformin|mesh-list
110659093|NCT00754403|Pioglitazone|pioglitazone|mesh-list
110659094|NCT00754403|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110215978|NCT00104988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110659095|NCT00754403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110659096|NCT00758225|Idebenone|idebenone|mesh-list
110659097|NCT00758225|Antioxidants|antioxidants|mesh-ancestor
110659098|NCT00758225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110659099|NCT00758225|Protective Agents|protective agents|mesh-ancestor
110160654|NCT00100594|Antiviral Agents|antiviral agents|mesh-ancestor
110659100|NCT00758225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110659101|NCT02561039|Ibandronic Acid|ibandronic acid|mesh-list
110659102|NCT02561039|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110659103|NCT02561039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110659104|NCT00422734|Tadalafil|tadalafil|mesh-list
110659105|NCT00422734|Vasodilator Agents|vasodilator agents|mesh-ancestor
110659106|NCT00422734|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110659107|NCT00422734|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110659108|NCT00422734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110659109|NCT00422734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110659110|NCT00422734|Urological Agents|urological agents|mesh-ancestor
110659111|NCT00422422|Brivaracetam|brivaracetam|mesh-list
110659112|NCT00422422|Anticonvulsants|anticonvulsants|mesh-ancestor
110659113|NCT00413374|Enoxaparin|enoxaparin|mesh-list
110659114|NCT00413374|Anticoagulants|anticoagulants|mesh-ancestor
110659115|NCT00413374|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110659116|NCT00413374|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110659117|NCT00413374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110659118|NCT00682643|Fluticasone|fluticasone|mesh-list
110659120|NCT00682643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110659121|NCT00682643|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110659122|NCT00682643|Autonomic Agents|autonomic agents|mesh-ancestor
110659123|NCT00682643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110659124|NCT00682643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110659125|NCT00682643|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110659126|NCT00682643|Respiratory System Agents|respiratory system agents|mesh-ancestor
110659127|NCT00682643|Dermatologic Agents|dermatologic agents|mesh-ancestor
110659128|NCT00682643|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110659129|NCT00758381|Sorafenib|sorafenib|mesh-list
110659130|NCT00758381|Cisplatin|cisplatin|mesh-list
110659131|NCT00758381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110659132|NCT00758381|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110659133|NCT00758381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110659134|NCT00758381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110659135|NCT00754871|Dienogest|dienogest|mesh-list
110659136|NCT00754871|Nandrolone|nandrolone|mesh-list
110659137|NCT00754871|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110659138|NCT00754871|Contraceptive Agents|contraceptive agents|mesh-ancestor
110659139|NCT00754871|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110659140|NCT00754871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110659141|NCT00754871|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110659142|NCT00754871|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110659143|NCT00754871|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110659144|NCT00754871|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110659145|NCT00754871|Hormone Antagonists|hormone antagonists|mesh-ancestor
110659146|NCT00754871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110659147|NCT00754871|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110659148|NCT00754871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110659149|NCT00754871|Androgens|androgens|mesh-ancestor
110659150|NCT00754871|Hormones|hormones|mesh-ancestor
110659151|NCT00754871|Anabolic Agents|anabolic agents|mesh-ancestor
110659152|NCT00755027|Rasagiline|rasagiline|mesh-list
110659153|NCT00755027|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
110659154|NCT00755027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110659155|NCT00755027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110659156|NCT00755027|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110659157|NCT00755027|Protective Agents|protective agents|mesh-ancestor
110659158|NCT00755027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110659159|NCT01038388|Dexamethasone|dexamethasone|mesh-list
110659160|NCT01038388|Lenalidomide|lenalidomide|mesh-list
110659162|NCT01038388|Vorinostat|vorinostat|mesh-list
110659163|NCT01038388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110659164|NCT01038388|Antiemetics|antiemetics|mesh-ancestor
110306392|NCT00293514|Thrombin|thrombin|mesh-list
110659165|NCT01038388|Autonomic Agents|autonomic agents|mesh-ancestor
110659166|NCT01038388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110659167|NCT01038388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110659168|NCT01038388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110659169|NCT01038388|Glucocorticoids|glucocorticoids|mesh-ancestor
110659170|NCT01038388|Hormones|hormones|mesh-ancestor
110659171|NCT01038388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110659172|NCT01038388|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110659173|NCT01038388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110659174|NCT01038388|Immunologic Factors|immunologic factors|mesh-ancestor
110659175|NCT01038388|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110659176|NCT01038388|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110659177|NCT01038388|Growth Substances|growth substances|mesh-ancestor
110659178|NCT01038388|Growth Inhibitors|growth inhibitors|mesh-ancestor
110659179|NCT01038388|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110659180|NCT01038388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110659181|NCT01038388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110659182|NCT04050059|Lidocaine|lidocaine|mesh-list
110659183|NCT04050059|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
110659184|NCT04050059|Anesthetics, Local|anesthetics, local|mesh-ancestor
110659185|NCT04050059|Anesthetics|anesthetics|mesh-ancestor
110659186|NCT04050059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110659187|NCT04050059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110659188|NCT04050059|Sensory System Agents|sensory system agents|mesh-ancestor
110659189|NCT04050059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110659190|NCT04050059|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110659191|NCT04050059|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110659192|NCT04050059|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110659193|NCT04050059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110659194|NCT04050059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110659195|NCT04050059|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
110659196|NCT00482001|Donepezil|donepezil|mesh-list
110659197|NCT00482001|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110659198|NCT00482001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110659199|NCT00482001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110659200|NCT00482001|Cholinergic Agents|cholinergic agents|mesh-ancestor
110659201|NCT00482001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110659202|NCT00482001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110659203|NCT00482001|Nootropic Agents|nootropic agents|mesh-ancestor
110659204|NCT00490035|Brivaracetam|brivaracetam|mesh-list
110659205|NCT00490035|Anticonvulsants|anticonvulsants|mesh-ancestor
110659206|NCT00421174|Methylprednisolone|methylprednisolone|mesh-list
110659207|NCT00421174|Etanercept|etanercept|mesh-list
110659208|NCT00421174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110659209|NCT00421174|Antiemetics|antiemetics|mesh-ancestor
110659210|NCT00421174|Autonomic Agents|autonomic agents|mesh-ancestor
110659211|NCT00421174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110659212|NCT00421174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110659213|NCT00421174|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110659214|NCT00421174|Glucocorticoids|glucocorticoids|mesh-ancestor
110659215|NCT00421174|Hormones|hormones|mesh-ancestor
110659216|NCT00421174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110659217|NCT00421174|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110659218|NCT00421174|Protective Agents|protective agents|mesh-ancestor
110659219|NCT00421174|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110659220|NCT00421174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110659221|NCT00421174|Analgesics|analgesics|mesh-ancestor
110659222|NCT00421174|Sensory System Agents|sensory system agents|mesh-ancestor
110659223|NCT00421174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110659224|NCT00421174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110659225|NCT00421174|Immunologic Factors|immunologic factors|mesh-ancestor
110659226|NCT00496197|Fluconazole|fluconazole|mesh-list
110659227|NCT00496197|Voriconazole|voriconazole|mesh-list
110659228|NCT00496197|Anidulafungin|anidulafungin|mesh-list
110659229|NCT00496197|Antifungal Agents|antifungal agents|mesh-ancestor
110659230|NCT00496197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110659231|NCT00496197|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110659232|NCT00496197|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110659233|NCT00496197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110659234|NCT00496197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110659235|NCT00496197|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110659236|NCT00496197|Hormone Antagonists|hormone antagonists|mesh-ancestor
110659237|NCT00496197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110659238|NCT00496197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110659239|NCT00496197|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110659240|NCT00496197|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110659241|NCT00496197|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110659242|NCT03996993|Bicalutamide|bicalutamide|mesh-list
110659243|NCT03996993|Androgen Antagonists|androgen antagonists|mesh-ancestor
110659244|NCT03996993|Hormone Antagonists|hormone antagonists|mesh-ancestor
110659245|NCT03996993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110659246|NCT03996993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110659247|NCT03996993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110659248|NCT01015053|Ropivacaine|ropivacaine|mesh-list
110659249|NCT01015053|Anesthetics, Local|anesthetics, local|mesh-ancestor
110659250|NCT01015053|Anesthetics|anesthetics|mesh-ancestor
110659251|NCT01015053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110659252|NCT01015053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110659253|NCT01015053|Sensory System Agents|sensory system agents|mesh-ancestor
110659254|NCT01015053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110659255|NCT00404092|Caspofungin|caspofungin|mesh-list
110659256|NCT00404092|Antifungal Agents|antifungal agents|mesh-ancestor
110659257|NCT00404092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110659258|NCT00404092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110659259|NCT00404092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110659261|NCT00481767|Immunologic Factors|immunologic factors|mesh-ancestor
110659262|NCT00481767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110659263|NCT00489489|Interferons|interferons|mesh-list
110659264|NCT00489489|Interferon-beta|interferon-beta|mesh-list
110659265|NCT00489489|Teriflunomide|teriflunomide|mesh-list
110659266|NCT00489489|Interferon beta-1b|interferon beta-1b|mesh-list
110659267|NCT00489489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110659268|NCT00489489|Antiviral Agents|antiviral agents|mesh-ancestor
110659269|NCT00489489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110659270|NCT00489489|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110659271|NCT00489489|Immunologic Factors|immunologic factors|mesh-ancestor
110659272|NCT00489489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110659273|NCT00489489|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110659274|NCT00489489|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110659275|NCT00489489|Analgesics|analgesics|mesh-ancestor
110659276|NCT00489489|Sensory System Agents|sensory system agents|mesh-ancestor
110659277|NCT00489489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110659278|NCT00489489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110659279|NCT00489489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110659280|NCT00489489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110659281|NCT00489411|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110659282|NCT00489411|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110659283|NCT00489411|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110659284|NCT00489411|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110659285|NCT00489411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110659286|NCT00489411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110659287|NCT00489411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110659289|NCT00489411|Sensory System Agents|sensory system agents|mesh-ancestor
110659290|NCT00489411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110659291|NCT00489411|Antidepressive Agents|antidepressive agents|mesh-ancestor
110659292|NCT00489411|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110659293|NCT00489411|Dopamine Agents|dopamine agents|mesh-ancestor
110659294|NCT00420784|Interferons|interferons|mesh-list
110659295|NCT00420784|Ribavirin|ribavirin|mesh-list
110659296|NCT00420784|Interferon-alpha|interferon-alpha|mesh-list
110659297|NCT00420784|Interferon alpha-2|interferon alpha-2|mesh-list
110659298|NCT00420784|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110659299|NCT00420784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110659300|NCT00420784|Antiviral Agents|antiviral agents|mesh-ancestor
110659301|NCT00420784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110659302|NCT00420784|Antimetabolites|antimetabolites|mesh-ancestor
110659303|NCT00420784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110659304|NCT00420784|Immunologic Factors|immunologic factors|mesh-ancestor
110659305|NCT00420784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110659306|NCT00420628|Loteprednol Etabonate|loteprednol etabonate|mesh-list
110659307|NCT00420628|Tobramycin|tobramycin|mesh-list
110659308|NCT00420628|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110659309|NCT00420628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110659310|NCT00420628|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110659311|NCT00413218|Voriconazole|voriconazole|mesh-list
110659312|NCT00413218|Caspofungin|caspofungin|mesh-list
110659313|NCT00413218|Isavuconazole|isavuconazole|mesh-list
110306534|NCT00262808|Fluorouracil|fluorouracil|mesh-list
110659314|NCT00413218|Antifungal Agents|antifungal agents|mesh-ancestor
110659315|NCT00413218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110659316|NCT00413218|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110659317|NCT00413218|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110659318|NCT00413218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110659319|NCT00413218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110659320|NCT00413218|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110659321|NCT00413218|Hormone Antagonists|hormone antagonists|mesh-ancestor
110659322|NCT00413218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110659323|NCT00413218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110659324|NCT00413218|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110659325|NCT00494871|Warfarin|warfarin|mesh-list
110659326|NCT00494871|Rivaroxaban|rivaroxaban|mesh-list
110659327|NCT00494871|Anticoagulants|anticoagulants|mesh-ancestor
110659328|NCT00494871|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110659329|NCT00494871|Antithrombins|antithrombins|mesh-ancestor
110659330|NCT00494871|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110659331|NCT00494871|Protease Inhibitors|protease inhibitors|mesh-ancestor
110659332|NCT00494871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110659333|NCT00494871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110659334|NCT00420238|Etanercept|etanercept|mesh-list
110659335|NCT00420238|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110659336|NCT00420238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110659337|NCT00420238|Analgesics|analgesics|mesh-ancestor
110659338|NCT00420238|Sensory System Agents|sensory system agents|mesh-ancestor
110659339|NCT00420238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110659340|NCT00420238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110659341|NCT00420238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110659342|NCT00420238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110659343|NCT00420238|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110659344|NCT00420238|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110659345|NCT00420238|Immunologic Factors|immunologic factors|mesh-ancestor
110659346|NCT00420004|Escitalopram|escitalopram|mesh-list
110659347|NCT00420004|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110659348|NCT00420004|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110659349|NCT00420004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110659350|NCT00420004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110659352|NCT00420004|Serotonin Agents|serotonin agents|mesh-ancestor
110659353|NCT00420004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110659354|NCT00494481|Docetaxel|docetaxel|mesh-list
110659355|NCT00494481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110659356|NCT00494481|Tubulin Modulators|tubulin modulators|mesh-ancestor
110659357|NCT00494481|Antimitotic Agents|antimitotic agents|mesh-ancestor
110659358|NCT00494481|Mitosis Modulators|mitosis modulators|mesh-ancestor
110659359|NCT00494481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110659360|NCT00097591|Clopidogrel|clopidogrel|mesh-list
110659361|NCT00097591|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
110659362|NCT00097591|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110659363|NCT00097591|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110659364|NCT00097591|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110659365|NCT00097591|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110659366|NCT00097591|Purinergic Agents|purinergic agents|mesh-ancestor
110659367|NCT00097591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110659368|NCT00097591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110659369|NCT00097591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110659370|NCT01082029|Lansoprazole|lansoprazole|mesh-list
110659371|NCT01082029|Dexlansoprazole|dexlansoprazole|mesh-list
110659372|NCT01082029|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110659373|NCT01082029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110659374|NCT01082029|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110659375|NCT01082029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110659376|NCT01082029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110659377|NCT00419926|Cyclosporine|cyclosporine|mesh-list
110659378|NCT00419926|Mycophenolic Acid|mycophenolic acid|mesh-list
110659379|NCT00419926|Prednisone|prednisone|mesh-list
110659380|NCT00419926|Cyclosporins|cyclosporins|mesh-list
110659381|NCT00419926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110659382|NCT00419926|Glucocorticoids|glucocorticoids|mesh-ancestor
110659383|NCT00419926|Hormones|hormones|mesh-ancestor
110659384|NCT00419926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110659385|NCT00419926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110306610|NCT00294099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110659386|NCT00419926|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110659387|NCT00419926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110659388|NCT00419926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110659389|NCT00419926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110659390|NCT00419926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110659391|NCT00419926|Immunologic Factors|immunologic factors|mesh-ancestor
110659392|NCT00419926|Antifungal Agents|antifungal agents|mesh-ancestor
110659393|NCT00419926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110659394|NCT00419926|Dermatologic Agents|dermatologic agents|mesh-ancestor
110659395|NCT00419926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110659396|NCT00419926|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110659397|NCT00419926|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110216056|NCT00259792|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110659398|NCT00419926|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110659399|NCT00419926|Antitubercular Agents|antitubercular agents|mesh-ancestor
110659400|NCT00419926|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110659402|NCT00419770|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
110659403|NCT00419770|Deferasirox|deferasirox|mesh-list
110659404|NCT00419770|Amebicides|amebicides|mesh-ancestor
110659405|NCT00419770|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110659406|NCT00419770|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110659407|NCT00419770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110659408|NCT00419770|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110659409|NCT00419770|Antifungal Agents|antifungal agents|mesh-ancestor
110659410|NCT00419770|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110160733|NCT00100945|Gefitinib|gefitinib|mesh-list
110659411|NCT00419770|Chelating Agents|chelating agents|mesh-ancestor
110659412|NCT00419770|Sequestering Agents|sequestering agents|mesh-ancestor
110659413|NCT00419770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110659414|NCT00080119|Isoniazid|isoniazid|mesh-list
110659415|NCT00080119|Trimethoprim|trimethoprim|mesh-list
110659416|NCT00080119|Sulfamethoxazole|sulfamethoxazole|mesh-list
110659417|NCT00080119|Antitubercular Agents|antitubercular agents|mesh-ancestor
110659418|NCT00080119|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110659419|NCT00080119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110659420|NCT00080119|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
110659421|NCT00080119|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110659422|NCT00080119|Antimetabolites|antimetabolites|mesh-ancestor
110659423|NCT00080119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110659424|NCT00080119|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110659425|NCT00080119|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110659426|NCT00080119|Antimalarials|antimalarials|mesh-ancestor
110659427|NCT00080119|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110659428|NCT00080119|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110659429|NCT00080119|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110659430|NCT00080119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110659431|NCT00080119|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110659432|NCT00080119|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
110659433|NCT00080119|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110659434|NCT01034878|Sunitinib|sunitinib|mesh-list
110659435|NCT01034878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110659436|NCT01034878|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110659437|NCT01034878|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110659438|NCT01034878|Growth Substances|growth substances|mesh-ancestor
110659439|NCT01034878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110659440|NCT01034878|Growth Inhibitors|growth inhibitors|mesh-ancestor
110659441|NCT01034878|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110659442|NCT01034878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110659443|NCT01034878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110659444|NCT01082263|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
110659445|NCT01082263|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110659446|NCT01082263|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110659447|NCT01082263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110659448|NCT01082263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110659449|NCT01082263|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110659450|NCT01082263|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
110659451|NCT01082263|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110659452|NCT01082263|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110659453|NCT01082263|Adrenergic Agents|adrenergic agents|mesh-ancestor
110659454|NCT01082263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110659455|NCT01082263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110659456|NCT01082263|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110659457|NCT01082263|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110659458|NCT01082263|Serotonin Agents|serotonin agents|mesh-ancestor
110306689|NCT00263627|Immunologic Factors|immunologic factors|mesh-ancestor
110659459|NCT01082263|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110659460|NCT01082263|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110659461|NCT01082263|Dopamine Agents|dopamine agents|mesh-ancestor
110659462|NCT02208544|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110659463|NCT02208544|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110659464|NCT02208544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110659465|NCT00494091|Sirolimus|sirolimus|mesh-list
110659466|NCT00494091|Temsirolimus|temsirolimus|mesh-list
110659467|NCT00494091|MTOR Inhibitors|mtor inhibitors|mesh-list
110659468|NCT00494091|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110659469|NCT00494091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110659470|NCT00494091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110659471|NCT00494091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110659472|NCT00494091|Immunologic Factors|immunologic factors|mesh-ancestor
110659473|NCT00494091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110659474|NCT00494091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110659475|NCT00494091|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110659476|NCT00494091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110659477|NCT00494091|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110659478|NCT00494091|Antifungal Agents|antifungal agents|mesh-ancestor
110659479|NCT01017159|Immunoglobulins|immunoglobulins|mesh-list
110659480|NCT01017159|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110659481|NCT01017159|Antibodies|antibodies|mesh-list
110659482|NCT01017159|Immunologic Factors|immunologic factors|mesh-ancestor
110659483|NCT01017159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110659484|NCT00494013|Insulin Lispro|insulin lispro|mesh-list
110659485|NCT00494013|Protamines|protamines|mesh-list
110659486|NCT00494013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110659487|NCT00494013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110659488|NCT00494013|Heparin Antagonists|heparin antagonists|mesh-ancestor
110659489|NCT00494013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110659490|NCT00494013|Coagulants|coagulants|mesh-ancestor
110659491|NCT00079339|Tipifarnib|tipifarnib|mesh-list
110659492|NCT00079339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110659493|NCT01088191|Hyaluronic Acid|hyaluronic acid|mesh-list
110659494|NCT01088191|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110659495|NCT01088191|Immunologic Factors|immunologic factors|mesh-ancestor
110659496|NCT01088191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110659497|NCT01088191|Viscosupplements|viscosupplements|mesh-ancestor
110659498|NCT01088191|Protective Agents|protective agents|mesh-ancestor
110659499|NCT01082341|Vaccines|vaccines|mesh-list
110659500|NCT01082341|Immunologic Factors|immunologic factors|mesh-ancestor
110659501|NCT01082341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110659502|NCT00541866|Cytarabine|cytarabine|mesh-list
110659503|NCT00541866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110659504|NCT00541866|Antimetabolites|antimetabolites|mesh-ancestor
110659505|NCT00541866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110659506|NCT00541866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110659507|NCT00541866|Antiviral Agents|antiviral agents|mesh-ancestor
110659508|NCT00541866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110659509|NCT00541866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110659510|NCT00541866|Immunologic Factors|immunologic factors|mesh-ancestor
110659511|NCT00541866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110659512|NCT00493467|Rituximab|rituximab|mesh-list
110659513|NCT00493467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110659514|NCT00493467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110659515|NCT00493467|Immunologic Factors|immunologic factors|mesh-ancestor
110659516|NCT00493467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110659517|NCT00493467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110659518|NCT00090493|Immunomodulating Agents|immunomodulating agents|mesh-list
110659519|NCT00090493|Immunologic Factors|immunologic factors|mesh-ancestor
110659520|NCT00090493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110659521|NCT01088347|Mapatumumab|mapatumumab|mesh-list
110659522|NCT01088347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110659523|NCT04221828|Paclitaxel|paclitaxel|mesh-list
110659524|NCT04221828|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110659525|NCT04221828|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110659526|NCT04221828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110659527|NCT04221828|Tubulin Modulators|tubulin modulators|mesh-ancestor
110659528|NCT04221828|Antimitotic Agents|antimitotic agents|mesh-ancestor
110659529|NCT04221828|Mitosis Modulators|mitosis modulators|mesh-ancestor
110659530|NCT04221828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110659531|NCT04221750|Metformin|metformin|mesh-list
110659532|NCT04221750|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110659533|NCT04221750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110659534|NCT04198428|Analgesics, Opioid|analgesics, opioid|mesh-list
110659535|NCT04198428|Narcotics|narcotics|mesh-ancestor
110659536|NCT04198428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110659537|NCT04198428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110659538|NCT04198428|Analgesics|analgesics|mesh-ancestor
110659539|NCT04198428|Sensory System Agents|sensory system agents|mesh-ancestor
110659540|NCT04198428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110659541|NCT00481065|MF59 oil emulsion|mf59 oil emulsion|mesh-list
110659542|NCT00481065|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110659543|NCT00481065|Immunologic Factors|immunologic factors|mesh-ancestor
110659544|NCT00481065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110659545|NCT01017393|Ketamine|ketamine|mesh-list
110659546|NCT01017393|Analgesics|analgesics|mesh-ancestor
110659547|NCT01017393|Sensory System Agents|sensory system agents|mesh-ancestor
110659548|NCT01017393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110659549|NCT01017393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110659550|NCT01017393|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110659551|NCT01017393|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110659552|NCT01017393|Anesthetics, General|anesthetics, general|mesh-ancestor
110659553|NCT01017393|Anesthetics|anesthetics|mesh-ancestor
110659554|NCT01017393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110659555|NCT01017393|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110659556|NCT01017393|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110659557|NCT01017393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110659558|NCT01017393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110659559|NCT00493311|Acetaminophen|acetaminophen|mesh-list
110659560|NCT00493311|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110659561|NCT00493311|Analgesics|analgesics|mesh-ancestor
110659562|NCT00493311|Sensory System Agents|sensory system agents|mesh-ancestor
110659563|NCT00493311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110659564|NCT00493311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110659565|NCT00493311|Antipyretics|antipyretics|mesh-ancestor
110659566|NCT00571649|Enoxaparin|enoxaparin|mesh-list
110659567|NCT00571649|Rivaroxaban|rivaroxaban|mesh-list
110659568|NCT00571649|Enoxaparin sodium|enoxaparin sodium|mesh-list
110659569|NCT00571649|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110659570|NCT00571649|Antithrombins|antithrombins|mesh-ancestor
110659571|NCT00571649|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110659572|NCT00571649|Protease Inhibitors|protease inhibitors|mesh-ancestor
110659573|NCT00571649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110659574|NCT00571649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110659575|NCT00571649|Anticoagulants|anticoagulants|mesh-ancestor
110659576|NCT00571649|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110659577|NCT00571649|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110659578|NCT00546572|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110659579|NCT00546572|Immunologic Factors|immunologic factors|mesh-ancestor
110659580|NCT00546572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110659581|NCT03917472|Aflibercept|aflibercept|mesh-list
110659582|NCT03917472|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110659583|NCT03917472|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110659584|NCT03917472|Growth Substances|growth substances|mesh-ancestor
110659585|NCT03917472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110659586|NCT03917472|Growth Inhibitors|growth inhibitors|mesh-ancestor
110659587|NCT03917472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110659588|NCT00681863|Pramipexole|pramipexole|mesh-list
110659589|NCT00681863|Antioxidants|antioxidants|mesh-ancestor
110659590|NCT00681863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110659591|NCT00681863|Protective Agents|protective agents|mesh-ancestor
110659592|NCT00681863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110659593|NCT00681863|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110659594|NCT00681863|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110659595|NCT00681863|Dopamine Agonists|dopamine agonists|mesh-ancestor
110659596|NCT00681863|Dopamine Agents|dopamine agents|mesh-ancestor
110659597|NCT00681863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110659598|NCT02559791|Reslizumab|reslizumab|mesh-list
110659599|NCT02559791|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110659600|NCT02559791|Respiratory System Agents|respiratory system agents|mesh-ancestor
110659601|NCT05677620|Propofol|propofol|mesh-list
110659602|NCT05677620|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110399589|NCT01020019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110659603|NCT05677620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110659604|NCT05677620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110659605|NCT05677620|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110659606|NCT05677620|Anesthetics, General|anesthetics, general|mesh-ancestor
110659607|NCT05677620|Anesthetics|anesthetics|mesh-ancestor
110659608|NCT00681629|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110659609|NCT00681629|Antidepressive Agents|antidepressive agents|mesh-ancestor
110659610|NCT00681629|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110659611|NCT00681629|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110659612|NCT00681629|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110659613|NCT00681629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110659614|NCT00681629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110659615|NCT00969176|Acetaminophen|acetaminophen|mesh-list
110659616|NCT00969176|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110659617|NCT00969176|Analgesics|analgesics|mesh-ancestor
110659618|NCT00969176|Sensory System Agents|sensory system agents|mesh-ancestor
110659619|NCT00969176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110659620|NCT00969176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110659621|NCT00969176|Antipyretics|antipyretics|mesh-ancestor
110659622|NCT04503252|Cefazolin|cefazolin|mesh-list
110659623|NCT04503252|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110160753|NCT00101062|Celecoxib|celecoxib|mesh-list
110659624|NCT04503252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110659625|NCT00679367|Dexamethasone|dexamethasone|mesh-list
110659626|NCT00679367|Lenalidomide|lenalidomide|mesh-list
110659627|NCT00679367|Melphalan|melphalan|mesh-list
110659628|NCT00679367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110659629|NCT00679367|Antiemetics|antiemetics|mesh-ancestor
110659630|NCT00679367|Autonomic Agents|autonomic agents|mesh-ancestor
110659631|NCT00679367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110659632|NCT00679367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110659633|NCT00679367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110659634|NCT00679367|Glucocorticoids|glucocorticoids|mesh-ancestor
110659635|NCT00679367|Hormones|hormones|mesh-ancestor
110659636|NCT00679367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110659637|NCT00679367|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110659638|NCT00679367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110659639|NCT00679367|Immunologic Factors|immunologic factors|mesh-ancestor
110659640|NCT00679367|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110659641|NCT00679367|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110659642|NCT00679367|Growth Substances|growth substances|mesh-ancestor
110659643|NCT00679367|Growth Inhibitors|growth inhibitors|mesh-ancestor
110659644|NCT00679367|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110659645|NCT00679367|Alkylating Agents|alkylating agents|mesh-ancestor
110659646|NCT00679367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110659647|NCT00679367|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110659648|NCT00679367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110659649|NCT00969566|Metformin|metformin|mesh-list
110659650|NCT00969566|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110659651|NCT00969566|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110659652|NCT00969566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110659653|NCT00969566|Incretins|incretins|mesh-ancestor
110659654|NCT00969566|Hormones|hormones|mesh-ancestor
110659655|NCT00969566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110659656|NCT00969566|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110659657|NCT00969566|Protease Inhibitors|protease inhibitors|mesh-ancestor
110659658|NCT00969566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110659659|NCT00969566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110659660|NCT00755495|Doxepin|doxepin|mesh-list
110659661|NCT00755495|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110659662|NCT00755495|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110659663|NCT00755495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110659664|NCT00755495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110659665|NCT00755495|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110659666|NCT00755495|Antidepressive Agents|antidepressive agents|mesh-ancestor
110659667|NCT00755495|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110659668|NCT00755495|Histamine Antagonists|histamine antagonists|mesh-ancestor
110659669|NCT00755495|Histamine Agents|histamine agents|mesh-ancestor
110399598|NCT01019317|Fludarabine|fludarabine|mesh-list
110659670|NCT00755495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110659671|NCT00755495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110659672|NCT00964184|Metformin|metformin|mesh-list
110659673|NCT00964184|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110659674|NCT00964184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110659675|NCT00969800|Chlorine dioxide|chlorine dioxide|mesh-list
110659676|NCT00969800|Dental Disinfectants|dental disinfectants|mesh-ancestor
110659677|NCT00969800|Disinfectants|disinfectants|mesh-ancestor
110659678|NCT00969800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110659679|NCT00964262|Exenatide|exenatide|mesh-list
110659680|NCT00964262|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110659681|NCT00964262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110659682|NCT00964262|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110659683|NCT00964262|Incretins|incretins|mesh-ancestor
110659684|NCT00964262|Hormones|hormones|mesh-ancestor
110659685|NCT00964262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110659686|NCT00973778|Capecitabine|capecitabine|mesh-list
110659687|NCT00973778|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110659688|NCT00973778|Antimetabolites|antimetabolites|mesh-ancestor
110659689|NCT00973778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110659690|NCT00973778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110216152|NCT00101205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110659691|NCT05623410|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
110659692|NCT05623410|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110659693|NCT05623410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110659694|NCT05623410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110659695|NCT05623410|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110659696|NCT05623410|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110659697|NCT05623410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110659698|NCT05623410|Cholinergic Agents|cholinergic agents|mesh-ancestor
110659699|NCT05623410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110659701|NCT00964418|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110659703|NCT00964418|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110659704|NCT00964418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110659705|NCT00974012|Valproic Acid|valproic acid|mesh-list
110659706|NCT00974012|Anticonvulsants|anticonvulsants|mesh-ancestor
110659707|NCT00974012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110659708|NCT00974012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110659709|NCT00974012|GABA Agents|gaba agents|mesh-ancestor
110659710|NCT00974012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110659711|NCT00974012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110659712|NCT00974012|Antimanic Agents|antimanic agents|mesh-ancestor
110659713|NCT00974012|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110659714|NCT00974012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110659715|NCT00974012|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110659716|NCT00964574|Insulin|insulin|mesh-list
110659717|NCT00964574|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110659718|NCT00964574|Insulin Glargine|insulin glargine|mesh-list
110659719|NCT00964574|Insulin glulisine|insulin glulisine|mesh-list
110659720|NCT00964574|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110659721|NCT00964574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110659722|NCT00970580|Paclitaxel|paclitaxel|mesh-list
110659723|NCT00970580|Carboplatin|carboplatin|mesh-list
110659724|NCT00970580|Alkylating Agents|alkylating agents|mesh-list
110659725|NCT00970580|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110659726|NCT00970580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110659727|NCT00970580|Tubulin Modulators|tubulin modulators|mesh-ancestor
110659728|NCT00970580|Antimitotic Agents|antimitotic agents|mesh-ancestor
110659729|NCT00970580|Mitosis Modulators|mitosis modulators|mesh-ancestor
110659730|NCT00970580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110659731|NCT00974324|Endostar protein|endostar protein|mesh-list
110659732|NCT00974324|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110659733|NCT00974324|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110659734|NCT00974324|Growth Substances|growth substances|mesh-ancestor
110659735|NCT00974324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110659736|NCT00974324|Growth Inhibitors|growth inhibitors|mesh-ancestor
110659737|NCT00974324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110659739|NCT00545714|Rituximab|rituximab|mesh-list
110659740|NCT00545714|Fludarabine|fludarabine|mesh-list
110659741|NCT00545714|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110659742|NCT00545714|Immunologic Factors|immunologic factors|mesh-ancestor
110659743|NCT00545714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110659744|NCT00545714|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110659745|NCT00545714|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110659746|NCT00545714|Alkylating Agents|alkylating agents|mesh-ancestor
110659747|NCT00545714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110659748|NCT00545714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110659749|NCT00545714|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110659750|NCT00545714|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110659751|NCT00964730|Moxifloxacin|moxifloxacin|mesh-list
110659752|NCT00964730|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110659753|NCT00964730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110659754|NCT00964730|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110659755|NCT00964730|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110659756|NCT00964730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110659757|NCT00964730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110659758|NCT00964730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110659759|NCT00539838|Mycophenolic Acid|mycophenolic acid|mesh-list
110659761|NCT00539838|Methylprednisolone|methylprednisolone|mesh-list
110659762|NCT00539838|Methotrexate|methotrexate|mesh-list
110659763|NCT00539838|Azathioprine|azathioprine|mesh-list
110659764|NCT00539838|Immunosuppressive Agents|immunosuppressive agents|mesh-list
110659766|NCT00539838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110659767|NCT00539838|Glucocorticoids|glucocorticoids|mesh-ancestor
110659768|NCT00539838|Hormones|hormones|mesh-ancestor
110659769|NCT00539838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110659770|NCT00539838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110659771|NCT00539838|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110659772|NCT00539838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110659773|NCT00539838|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110659774|NCT00539838|Abortifacient Agents|abortifacient agents|mesh-ancestor
110659775|NCT00539838|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110659776|NCT00539838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110659777|NCT00539838|Antimetabolites|antimetabolites|mesh-ancestor
110659778|NCT00539838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110659779|NCT00539838|Dermatologic Agents|dermatologic agents|mesh-ancestor
110659780|NCT00539838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110659781|NCT00539838|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110659782|NCT00539838|Immunologic Factors|immunologic factors|mesh-ancestor
110659783|NCT00539838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110659784|NCT00539838|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110659785|NCT00539838|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110659786|NCT00539838|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110659787|NCT00539838|Antitubercular Agents|antitubercular agents|mesh-ancestor
110659788|NCT00539838|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110659789|NCT00539838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110659790|NCT00539838|Antiemetics|antiemetics|mesh-ancestor
110659791|NCT00539838|Autonomic Agents|autonomic agents|mesh-ancestor
110659792|NCT00539838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110659793|NCT00539838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110659794|NCT00539838|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110659795|NCT00539838|Protective Agents|protective agents|mesh-ancestor
110659796|NCT00970892|Warfarin|warfarin|mesh-list
110659797|NCT00970892|Anticoagulants|anticoagulants|mesh-ancestor
110659798|NCT00964808|Oxycodone|oxycodone|mesh-list
110659799|NCT00964808|Buprenorphine|buprenorphine|mesh-list
110659800|NCT00964808|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110659801|NCT00964808|Narcotics|narcotics|mesh-ancestor
110659802|NCT00964808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110659803|NCT00964808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110659804|NCT00964808|Analgesics|analgesics|mesh-ancestor
110659805|NCT00964808|Sensory System Agents|sensory system agents|mesh-ancestor
110659806|NCT00964808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110659807|NCT00964808|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110659808|NCT00970970|Bevacizumab|bevacizumab|mesh-list
110659809|NCT00970970|89Zr-bevacizumab|89zr-bevacizumab|mesh-list
110659810|NCT00970970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110659811|NCT00970970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110659812|NCT00970970|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110659813|NCT00970970|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110659814|NCT00970970|Growth Substances|growth substances|mesh-ancestor
110659815|NCT00970970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110659816|NCT00970970|Growth Inhibitors|growth inhibitors|mesh-ancestor
110659817|NCT00970970|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110659818|NCT00970970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110659819|NCT03765450|Infliximab|infliximab|mesh-list
110659820|NCT03765450|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110659821|NCT03765450|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110659822|NCT03765450|Dermatologic Agents|dermatologic agents|mesh-ancestor
110659823|NCT03765450|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110659824|NCT03765450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110659825|NCT00971126|Thalidomide|thalidomide|mesh-list
110659826|NCT00971126|Sorafenib|sorafenib|mesh-list
110659827|NCT00971126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110659828|NCT00971126|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110659829|NCT00971126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110659830|NCT00971126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110659831|NCT00971126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110659832|NCT00971126|Immunologic Factors|immunologic factors|mesh-ancestor
110659833|NCT00971126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110659834|NCT00971126|Leprostatic Agents|leprostatic agents|mesh-ancestor
110659835|NCT00971126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110659836|NCT00971126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110659837|NCT00971126|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110659838|NCT00971126|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110659839|NCT00971126|Growth Substances|growth substances|mesh-ancestor
110659840|NCT00971126|Growth Inhibitors|growth inhibitors|mesh-ancestor
110659841|NCT00964964|Insulin|insulin|mesh-list
110659842|NCT00964964|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110659843|NCT00964964|Insulin, Long-Acting|insulin, long-acting|mesh-list
110659844|NCT00964964|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110659845|NCT00964964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110659846|NCT00965042|Ceftobiprole|ceftobiprole|mesh-list
110659847|NCT00965042|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
110659848|NCT00965042|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110659849|NCT00965042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110659850|NCT03676764|Azithromycin|azithromycin|mesh-list
110659851|NCT03676764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110659852|NCT03676764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110659853|NCT00974792|Leucovorin|leucovorin|mesh-list
110659854|NCT00974792|Cytarabine|cytarabine|mesh-list
110659855|NCT00974792|Cyclophosphamide|cyclophosphamide|mesh-list
110659856|NCT00974792|Ifosfamide|ifosfamide|mesh-list
110659857|NCT00974792|Rituximab|rituximab|mesh-list
110659858|NCT00974792|Doxorubicin|doxorubicin|mesh-list
110659859|NCT00974792|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110659860|NCT00974792|Methotrexate|methotrexate|mesh-list
110659861|NCT00974792|Etoposide|etoposide|mesh-list
110659862|NCT00974792|Vincristine|vincristine|mesh-list
110659863|NCT00974792|Etoposide phosphate|etoposide phosphate|mesh-list
110659864|NCT00974792|Levoleucovorin|levoleucovorin|mesh-list
110399632|NCT01288443|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
110659865|NCT00974792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110659866|NCT00974792|Immunologic Factors|immunologic factors|mesh-ancestor
110659867|NCT00974792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110659868|NCT00974792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110659869|NCT00974792|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110659870|NCT00974792|Alkylating Agents|alkylating agents|mesh-ancestor
110659871|NCT00974792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110659872|NCT00974792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110659873|NCT00974792|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110659874|NCT00974792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110659875|NCT00974792|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110659876|NCT00974792|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110659877|NCT00974792|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110659878|NCT00974792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110659879|NCT00974792|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110659880|NCT00974792|Abortifacient Agents|abortifacient agents|mesh-ancestor
110659881|NCT00974792|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110659882|NCT00974792|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110659883|NCT00974792|Antimetabolites|antimetabolites|mesh-ancestor
110659884|NCT00974792|Dermatologic Agents|dermatologic agents|mesh-ancestor
110659885|NCT00974792|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110659886|NCT00974792|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110659887|NCT00974792|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110659888|NCT00974792|Antiviral Agents|antiviral agents|mesh-ancestor
110659889|NCT00974792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110659890|NCT00974792|Antidotes|antidotes|mesh-ancestor
110659891|NCT00974792|Protective Agents|protective agents|mesh-ancestor
110659892|NCT00974792|Vitamin B Complex|vitamin b complex|mesh-ancestor
110659894|NCT00974792|Micronutrients|micronutrients|mesh-ancestor
110659895|NCT00974792|Tubulin Modulators|tubulin modulators|mesh-ancestor
110659896|NCT00974792|Antimitotic Agents|antimitotic agents|mesh-ancestor
110659897|NCT00974792|Mitosis Modulators|mitosis modulators|mesh-ancestor
110659898|NCT00965120|Bradykinin|bradykinin|mesh-list
110659899|NCT00965120|Kininogens|kininogens|mesh-list
110659900|NCT00965120|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-list
110659901|NCT00965120|Vasodilator Agents|vasodilator agents|mesh-ancestor
110659902|NCT00965120|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
110659903|NCT00965120|Protease Inhibitors|protease inhibitors|mesh-ancestor
110659904|NCT00965120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110659905|NCT00965120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110659906|NCT00679289|Interferons|interferons|mesh-list
110659907|NCT00679289|Ecromeximab|ecromeximab|mesh-list
110659908|NCT00679289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110659909|NCT00679289|Antiviral Agents|antiviral agents|mesh-ancestor
110160773|NCT00006386|Carmustine|carmustine|mesh-list
110659910|NCT00679289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110659911|NCT00679289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110659912|NCT00679211|Trastuzumab|trastuzumab|mesh-list
110659913|NCT00679211|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
110659914|NCT00679211|Maytansine|maytansine|mesh-list
110659915|NCT00679211|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110659916|NCT00679211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110659917|NCT00679211|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110659918|NCT00679211|Tubulin Modulators|tubulin modulators|mesh-ancestor
110659919|NCT00679211|Antimitotic Agents|antimitotic agents|mesh-ancestor
110659920|NCT00679211|Mitosis Modulators|mitosis modulators|mesh-ancestor
110659921|NCT00679211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110659922|NCT00679211|Immunotoxins|immunotoxins|mesh-ancestor
110659923|NCT00679211|Immunoconjugates|immunoconjugates|mesh-ancestor
110659924|NCT00679211|Immunologic Factors|immunologic factors|mesh-ancestor
110659925|NCT00679211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110659926|NCT00545948|Cisplatin|cisplatin|mesh-list
110659927|NCT00545948|Pemetrexed|pemetrexed|mesh-list
110659928|NCT00545948|Vinorelbine|vinorelbine|mesh-list
110659929|NCT00545948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110659930|NCT00545948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110399646|NCT01287195|Omeprazole|omeprazole|mesh-list
110659931|NCT00545948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110659933|NCT00545948|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110659934|NCT00545948|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110659935|NCT00545948|Tubulin Modulators|tubulin modulators|mesh-ancestor
110659936|NCT00545948|Antimitotic Agents|antimitotic agents|mesh-ancestor
110659937|NCT00545948|Mitosis Modulators|mitosis modulators|mesh-ancestor
110659938|NCT00755573|Pregabalin|pregabalin|mesh-list
110659939|NCT00755573|Analgesics|analgesics|mesh-ancestor
110659940|NCT00755573|Sensory System Agents|sensory system agents|mesh-ancestor
110659941|NCT00755573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110659942|NCT00755573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110659943|NCT00755573|Anticonvulsants|anticonvulsants|mesh-ancestor
110659944|NCT00755573|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110659945|NCT00755573|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110659946|NCT00755573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110659947|NCT00755573|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110659948|NCT00755573|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110659949|NCT00755573|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110659950|NCT00755573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110659951|NCT00755573|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110659952|NCT00975104|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
110659953|NCT00975104|Immunologic Factors|immunologic factors|mesh-ancestor
110659954|NCT00975104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110659955|NCT04008290|Liraglutide|liraglutide|mesh-list
110659956|NCT04008290|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110659957|NCT04008290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110659958|NCT04008290|Incretins|incretins|mesh-ancestor
110659959|NCT04008290|Hormones|hormones|mesh-ancestor
110659960|NCT04008290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110659961|NCT02559167|Cannabidiol|cannabidiol|mesh-list
110659962|NCT02559167|Anticonvulsants|anticonvulsants|mesh-ancestor
110659963|NCT00975182|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110659964|NCT00975182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110659965|NCT00975182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110659966|NCT00975182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110659967|NCT00975182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110659968|NCT05271071|Lidocaine|lidocaine|mesh-list
110659969|NCT05271071|Anesthetics, Local|anesthetics, local|mesh-ancestor
110659970|NCT05271071|Anesthetics|anesthetics|mesh-ancestor
110659971|NCT05271071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110659972|NCT05271071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110659973|NCT05271071|Sensory System Agents|sensory system agents|mesh-ancestor
110659974|NCT05271071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110659975|NCT05271071|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110659976|NCT05271071|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110659977|NCT05271071|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110659978|NCT05271071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110659979|NCT05271071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110659980|NCT00972140|Formoterol Fumarate|formoterol fumarate|mesh-list
110659981|NCT00972140|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110659982|NCT00972140|Autonomic Agents|autonomic agents|mesh-ancestor
110659983|NCT00972140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110659984|NCT00972140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110659985|NCT00972140|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110659986|NCT00972140|Respiratory System Agents|respiratory system agents|mesh-ancestor
110659987|NCT00972140|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110659988|NCT00972140|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110659989|NCT00972140|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110659990|NCT00972140|Adrenergic Agents|adrenergic agents|mesh-ancestor
110659991|NCT00972140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110659992|NCT00972140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110659994|NCT00972218|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110659995|NCT00972218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110399656|NCT01287117|Omalizumab|omalizumab|mesh-list
110659996|NCT00972218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110659997|NCT05230901|Dihydralazine|dihydralazine|mesh-list
110659998|NCT05230901|Spironolactone|spironolactone|mesh-list
110659999|NCT05230901|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110660000|NCT05230901|Hormone Antagonists|hormone antagonists|mesh-ancestor
110660001|NCT05230901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110660002|NCT05230901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110660003|NCT05230901|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110660004|NCT05230901|Diuretics|diuretics|mesh-ancestor
110660005|NCT05230901|Natriuretic Agents|natriuretic agents|mesh-ancestor
110236721|NCT00346957|Hydrocortisone|hydrocortisone|mesh-list
110660006|NCT05230901|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110660008|NCT00972296|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110660009|NCT00972296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110660010|NCT03927950|Bupropion|bupropion|mesh-list
110660011|NCT03927950|Escitalopram|escitalopram|mesh-list
110660012|NCT03927950|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110660013|NCT03927950|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110660014|NCT03927950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110660015|NCT03927950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110660016|NCT03927950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110660017|NCT03927950|Serotonin Agents|serotonin agents|mesh-ancestor
110660018|NCT03927950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110660019|NCT03927950|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110660020|NCT03927950|Antidepressive Agents|antidepressive agents|mesh-ancestor
110660021|NCT03927950|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110660022|NCT03927950|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110660023|NCT03927950|Dopamine Agents|dopamine agents|mesh-ancestor
110660024|NCT03927950|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110660025|NCT03927950|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110660026|NCT03927950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110660027|NCT00972842|Lenalidomide|lenalidomide|mesh-list
110660028|NCT00972842|Vorinostat|vorinostat|mesh-list
110660029|NCT00972842|Immunologic Factors|immunologic factors|mesh-ancestor
110660030|NCT00972842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110660031|NCT00972842|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110660032|NCT00972842|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110660033|NCT00972842|Growth Substances|growth substances|mesh-ancestor
110660034|NCT00972842|Growth Inhibitors|growth inhibitors|mesh-ancestor
110660035|NCT00972842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110660036|NCT00972842|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110660037|NCT00972842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110660038|NCT00972842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110660039|NCT00975494|Sildenafil Citrate|sildenafil citrate|mesh-list
110660040|NCT00975494|Vasodilator Agents|vasodilator agents|mesh-ancestor
110660041|NCT00975494|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110660042|NCT00975494|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110660043|NCT00975494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110660044|NCT00975494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110660046|NCT00975572|Vaccines|vaccines|mesh-list
110660047|NCT00975572|Immunologic Factors|immunologic factors|mesh-ancestor
110660048|NCT00975572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110660049|NCT00965666|Etanercept|etanercept|mesh-list
110660050|NCT00965666|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110660051|NCT00965666|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110660052|NCT00965666|Analgesics|analgesics|mesh-ancestor
110660053|NCT00965666|Sensory System Agents|sensory system agents|mesh-ancestor
110660054|NCT00965666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110660055|NCT00965666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110660056|NCT00965666|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110660057|NCT00965666|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110660058|NCT00965666|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110660059|NCT00965666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110660060|NCT00965666|Immunologic Factors|immunologic factors|mesh-ancestor
110660061|NCT00975728|Antioxidants|antioxidants|mesh-list
110660062|NCT00975728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110660063|NCT00975728|Protective Agents|protective agents|mesh-ancestor
110307276|NCT00295542|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110660064|NCT00975728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110660065|NCT04049747|Bicalutamide|bicalutamide|mesh-list
110660066|NCT04049747|Finasteride|finasteride|mesh-list
110660067|NCT04049747|Androgen Antagonists|androgen antagonists|mesh-ancestor
110660068|NCT04049747|Hormone Antagonists|hormone antagonists|mesh-ancestor
110660069|NCT04049747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110660070|NCT04049747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110660071|NCT04049747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110660072|NCT04049747|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
110660073|NCT04049747|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110660074|NCT04049747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110660075|NCT04049747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110660076|NCT04049747|Urological Agents|urological agents|mesh-ancestor
110660077|NCT00973154|Prednisone|prednisone|mesh-list
110660078|NCT00973154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110660079|NCT00973154|Glucocorticoids|glucocorticoids|mesh-ancestor
110660080|NCT00973154|Hormones|hormones|mesh-ancestor
110660081|NCT00973154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110660082|NCT00973154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110660083|NCT00973154|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110660084|NCT00973154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110660085|NCT00965900|Propranolol|propranolol|mesh-list
110660086|NCT00965900|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
110660087|NCT00965900|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110660088|NCT00965900|Adrenergic Agents|adrenergic agents|mesh-ancestor
110660089|NCT00965900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110660090|NCT00965900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110660091|NCT00965900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110660092|NCT00965900|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110660093|NCT00965900|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110660094|NCT00965900|Vasodilator Agents|vasodilator agents|mesh-ancestor
110660095|NCT00973232|Acetaminophen|acetaminophen|mesh-list
110660096|NCT00973232|Tramadol|tramadol|mesh-list
110660097|NCT00973232|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110660098|NCT00973232|Analgesics|analgesics|mesh-ancestor
110660099|NCT00973232|Sensory System Agents|sensory system agents|mesh-ancestor
110660100|NCT00973232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110660101|NCT00973232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110660102|NCT00973232|Antipyretics|antipyretics|mesh-ancestor
110660103|NCT00973232|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110660104|NCT00973232|Narcotics|narcotics|mesh-ancestor
110660105|NCT00973232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110660106|NCT00973310|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110660107|NCT00973310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110660108|NCT00973310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110660109|NCT00973310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110660110|NCT00973310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110660111|NCT00973388|Moxifloxacin|moxifloxacin|mesh-list
110660112|NCT00973388|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110660113|NCT00973388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110660114|NCT00973388|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110660115|NCT00973388|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110660116|NCT00973388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110660117|NCT00973388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110660118|NCT00973388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110660119|NCT00975962|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
110660120|NCT00975962|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110660121|NCT00975962|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110054093|NCT01489982|Zopiclone|zopiclone|mesh-list
110660122|NCT00975962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110660123|NCT00966056|Mitomycins|mitomycins|mesh-list
110660124|NCT00966056|Mitomycin|mitomycin|mesh-list
110660125|NCT00966056|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110660126|NCT00966056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110660127|NCT00966056|Alkylating Agents|alkylating agents|mesh-ancestor
110660128|NCT00966056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110660129|NCT00966056|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110660130|NCT00966056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110660131|NCT00976040|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
110660132|NCT00976040|Antiviral Agents|antiviral agents|mesh-ancestor
110660133|NCT00976040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110660134|NCT03523728|Venglustat|venglustat|mesh-list
110660135|NCT03523728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110660136|NCT03523728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110660137|NCT00979706|Cyclosporine|cyclosporine|mesh-list
110660138|NCT00979706|Interleukin-2|interleukin-2|mesh-list
110660139|NCT00979706|Cyclosporins|cyclosporins|mesh-list
110660140|NCT00979706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110660141|NCT00979706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110660142|NCT00979706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110660143|NCT00979706|Immunologic Factors|immunologic factors|mesh-ancestor
110660144|NCT00979706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110660145|NCT00979706|Antifungal Agents|antifungal agents|mesh-ancestor
110660146|NCT00979706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110660147|NCT00979706|Dermatologic Agents|dermatologic agents|mesh-ancestor
110660148|NCT00979706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110660149|NCT00979706|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110660150|NCT00979706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110660151|NCT00979706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110660152|NCT00979706|Analgesics|analgesics|mesh-ancestor
110660153|NCT00979706|Sensory System Agents|sensory system agents|mesh-ancestor
110660154|NCT00979706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110660155|NCT00979862|Cediranib|cediranib|mesh-list
110660156|NCT00979862|Maleic acid|maleic acid|mesh-list
110660157|NCT00979862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110660158|NCT00979862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110660159|NCT00979862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110660160|NCT00979862|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110660161|NCT00966290|Warfarin|warfarin|mesh-list
110660162|NCT00966290|Anticoagulants|anticoagulants|mesh-list
110660163|NCT00966290|Acenocoumarol|acenocoumarol|mesh-list
110660164|NCT00966290|Fluindione|fluindione|mesh-list
110660165|NCT00966290|Phenindione|phenindione|mesh-list
110660166|NCT00966368|Insulin|insulin|mesh-list
110660167|NCT00966368|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110660168|NCT00966368|Insulin, Long-Acting|insulin, long-acting|mesh-list
110660169|NCT00966368|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110660170|NCT00966368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110660171|NCT00980408|Cycloserine|cycloserine|mesh-list
110660172|NCT00980408|Memantine|memantine|mesh-list
110660173|NCT00980408|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110660174|NCT00980408|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110660175|NCT00980408|Dopamine Agents|dopamine agents|mesh-ancestor
110660176|NCT00980408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110660177|NCT00980408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110660178|NCT00980408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110660179|NCT00980408|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110660180|NCT00980408|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110660181|NCT00980408|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110660182|NCT00980408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110660183|NCT00980408|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110660184|NCT00980408|Antitubercular Agents|antitubercular agents|mesh-ancestor
110660185|NCT00980408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110660186|NCT00980408|Antimetabolites|antimetabolites|mesh-ancestor
110660187|NCT00980876|Ciprofloxacin|ciprofloxacin|mesh-list
110660188|NCT00980876|Hydrocortisone|hydrocortisone|mesh-list
110660189|NCT00980876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110660190|NCT00980876|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110660191|NCT00980876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110660192|NCT00980876|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110660193|NCT00980876|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110660194|NCT00980876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110660195|NCT00980876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110660196|NCT00980876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110660197|NCT00980876|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110660198|NCT00980876|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110660199|NCT05279040|Ivacaftor|ivacaftor|mesh-list
110660200|NCT05279040|Elexacaftor|elexacaftor|mesh-list
110660201|NCT05279040|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
110660202|NCT05279040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110660203|NCT05279040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110660204|NCT00989898|Insulin|insulin|mesh-list
110660205|NCT00989898|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110660206|NCT00989898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110660207|NCT00990054|Plerixafor|plerixafor|mesh-list
110660208|NCT00990054|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110660209|NCT00990054|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110660210|NCT00990054|Antiviral Agents|antiviral agents|mesh-ancestor
110660211|NCT00990054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110660212|NCT05361408|Zoledronic Acid|zoledronic acid|mesh-list
110660213|NCT05361408|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110660214|NCT05361408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110660215|NCT05590572|Etoposide|etoposide|mesh-list
110660216|NCT05590572|Ifosfamide|ifosfamide|mesh-list
110660217|NCT05590572|Isophosphamide mustard|isophosphamide mustard|mesh-list
110660218|NCT05590572|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110660219|NCT05590572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110660220|NCT05590572|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110660221|NCT05590572|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110660222|NCT05590572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110660223|NCT05590572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110660224|NCT05590572|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110660225|NCT05590572|Alkylating Agents|alkylating agents|mesh-ancestor
110660226|NCT03069378|Pembrolizumab|pembrolizumab|mesh-list
110660227|NCT03069378|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
110660228|NCT03069378|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110660229|NCT03069378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110660230|NCT03069378|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110660231|NCT03069378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110660232|NCT05590416|Adalimumab|adalimumab|mesh-list
110660233|NCT05590416|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110660234|NCT05590416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110660235|NCT05590416|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110660236|NCT00990444|Insulin|insulin|mesh-list
110660237|NCT00990444|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110660238|NCT00990444|Dextrans|dextrans|mesh-list
110660239|NCT00990444|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110660240|NCT00990444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110660241|NCT00990444|Anticoagulants|anticoagulants|mesh-ancestor
110660242|NCT00990444|Plasma Substitutes|plasma substitutes|mesh-ancestor
110660244|NCT00990600|Tenofovir|tenofovir|mesh-list
110660245|NCT00990600|Emtricitabine|emtricitabine|mesh-list
110660246|NCT00990600|Efavirenz|efavirenz|mesh-list
110660247|NCT00990600|Antiviral Agents|antiviral agents|mesh-ancestor
110660248|NCT00990600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110660249|NCT00990600|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110660250|NCT00990600|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110660251|NCT00990600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110660252|NCT00990600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110660253|NCT00990600|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110660254|NCT00990600|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110660255|NCT00990600|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110660256|NCT00990600|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110660257|NCT00990600|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110660258|NCT00990600|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110660259|NCT00990600|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110660260|NCT00990600|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110660262|NCT02897076|Betamethasone Valerate|betamethasone valerate|mesh-list
110660263|NCT02897076|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
110660264|NCT02897076|Betamethasone benzoate|betamethasone benzoate|mesh-list
110660265|NCT02897076|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
110660266|NCT02897076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110660267|NCT02897076|Glucocorticoids|glucocorticoids|mesh-ancestor
110660269|NCT02897076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110660270|NCT02897076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110660271|NCT02897076|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110660272|NCT02897076|Respiratory System Agents|respiratory system agents|mesh-ancestor
110660273|NCT02797548|Aspirin|aspirin|mesh-list
110660274|NCT02797548|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110660275|NCT02797548|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110660276|NCT02797548|Analgesics|analgesics|mesh-ancestor
110660277|NCT02797548|Sensory System Agents|sensory system agents|mesh-ancestor
110660278|NCT02797548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110660279|NCT02797548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110660280|NCT02797548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110660281|NCT02797548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110660282|NCT02797548|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110660283|NCT02797548|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110660284|NCT02797548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110660285|NCT02797548|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110660286|NCT02797548|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110660287|NCT02797548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110660288|NCT02797548|Antipyretics|antipyretics|mesh-ancestor
110660289|NCT00990678|Vitamin D|vitamin d|mesh-list
110098603|NCT01743235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110098604|NCT01743235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110098605|NCT01743235|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110098606|NCT01743235|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110098607|NCT01743235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110098608|NCT01743235|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110098609|NCT01743235|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110098611|NCT01743235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110098612|NCT01743235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110098613|NCT01743300|Sunitinib|sunitinib|mesh-list
110098614|NCT01743300|Midazolam|midazolam|mesh-list
110098615|NCT01743300|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110098616|NCT01743300|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110098617|NCT01743300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110098618|NCT01743300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110098619|NCT01743300|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110098620|NCT01743300|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110098621|NCT01743300|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110098622|NCT01743300|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110098623|NCT01743300|Anesthetics, General|anesthetics, general|mesh-ancestor
110098624|NCT01743300|Anesthetics|anesthetics|mesh-ancestor
110098625|NCT01743300|GABA Modulators|gaba modulators|mesh-ancestor
110098626|NCT01743300|GABA Agents|gaba agents|mesh-ancestor
110098627|NCT01743300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110098628|NCT01743300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110098629|NCT01743300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110098630|NCT01743300|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110098631|NCT01743300|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110098632|NCT01743300|Growth Substances|growth substances|mesh-ancestor
110098633|NCT01743300|Growth Inhibitors|growth inhibitors|mesh-ancestor
110098634|NCT01743300|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110098635|NCT01743300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110098636|NCT01743326|Anesthetics|anesthetics|mesh-list
110399702|NCT01281813|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110098637|NCT01743326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110098639|NCT01743365|Afatinib|afatinib|mesh-list
110098640|NCT01743365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110098641|NCT01743365|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110098642|NCT01743365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110098643|NCT01743365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110098644|NCT01743378|Ropivacaine|ropivacaine|mesh-list
110098645|NCT01743378|Anesthetics, Local|anesthetics, local|mesh-ancestor
110098646|NCT01743378|Anesthetics|anesthetics|mesh-ancestor
110098647|NCT01743378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110098648|NCT01743378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110098649|NCT01743378|Sensory System Agents|sensory system agents|mesh-ancestor
110098650|NCT01743378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110098651|NCT01743456|Anesthetics|anesthetics|mesh-list
110098652|NCT01743456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110098653|NCT01743456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110098654|NCT01743508|Misoprostol|misoprostol|mesh-list
110098655|NCT01743508|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110098656|NCT01743508|Abortifacient Agents|abortifacient agents|mesh-ancestor
110098657|NCT01743508|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110098658|NCT01743508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110098659|NCT01743508|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110098660|NCT01743508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110098661|NCT01743508|Oxytocics|oxytocics|mesh-ancestor
110098662|NCT01743690|Nystatin|nystatin|mesh-list
110098663|NCT01743690|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
110098664|NCT01743690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110098665|NCT01743690|Glucocorticoids|glucocorticoids|mesh-ancestor
110098666|NCT01743690|Hormones|hormones|mesh-ancestor
110098667|NCT01743690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110098668|NCT01743690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110098669|NCT01743690|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110098670|NCT01743690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110098671|NCT01743690|Antifungal Agents|antifungal agents|mesh-ancestor
110098672|NCT01743690|Ionophores|ionophores|mesh-ancestor
110098673|NCT01743690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110098674|NCT01743690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110098675|NCT01743755|Dexamethasone|dexamethasone|mesh-list
110098676|NCT01743755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110098678|NCT01743755|Autonomic Agents|autonomic agents|mesh-ancestor
110098679|NCT01743755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110098680|NCT01743755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110098681|NCT01743755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110098682|NCT01743755|Glucocorticoids|glucocorticoids|mesh-ancestor
110098683|NCT01743755|Hormones|hormones|mesh-ancestor
110098684|NCT01743755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110098685|NCT01743755|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110098686|NCT01743755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110098687|NCT01743794|Ropivacaine|ropivacaine|mesh-list
110160821|NCT00400855|Fluticasone|fluticasone|mesh-list
110098688|NCT01743794|Anesthetics, Local|anesthetics, local|mesh-ancestor
110098689|NCT01743794|Anesthetics|anesthetics|mesh-ancestor
110098690|NCT01743794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110098691|NCT01743794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110098692|NCT01743794|Sensory System Agents|sensory system agents|mesh-ancestor
110098693|NCT01743794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110098694|NCT01743820|Primaquine|primaquine|mesh-list
110098695|NCT01743820|Piperaquine|piperaquine|mesh-list
110098696|NCT01743820|Artenimol|artenimol|mesh-list
110098697|NCT01743820|Antimalarials|antimalarials|mesh-ancestor
110098698|NCT01743820|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110098699|NCT01743820|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110098700|NCT01743820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110098701|NCT01743885|Propranolol|propranolol|mesh-list
110098702|NCT01743885|Acebutolol|acebutolol|mesh-list
110098703|NCT01743885|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110098705|NCT01743885|Adrenergic Agents|adrenergic agents|mesh-ancestor
110098706|NCT01743885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110098707|NCT01743885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110098708|NCT01743885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110098709|NCT01743885|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110098710|NCT01743885|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110098711|NCT01743885|Vasodilator Agents|vasodilator agents|mesh-ancestor
110098712|NCT01743885|Sympathomimetics|sympathomimetics|mesh-ancestor
110098713|NCT01743885|Autonomic Agents|autonomic agents|mesh-ancestor
110098714|NCT01743885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110098715|NCT01743885|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110098716|NCT01743898|Rivaroxaban|rivaroxaban|mesh-list
110098717|NCT01743898|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110098718|NCT01743898|Antithrombins|antithrombins|mesh-ancestor
110098719|NCT01743898|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110098720|NCT01743898|Protease Inhibitors|protease inhibitors|mesh-ancestor
110098721|NCT01743898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110098722|NCT01743898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110098723|NCT01743898|Anticoagulants|anticoagulants|mesh-ancestor
110098724|NCT01743911|Tadalafil|tadalafil|mesh-list
110098725|NCT01743911|Vasodilator Agents|vasodilator agents|mesh-ancestor
110098726|NCT01743911|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110098727|NCT01743911|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110098728|NCT01743911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110098729|NCT01743911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110098730|NCT01743911|Urological Agents|urological agents|mesh-ancestor
110098731|NCT01744106|Pseudoephedrine|pseudoephedrine|mesh-list
110098732|NCT01744106|Ephedrine|ephedrine|mesh-list
110098733|NCT01744106|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110098734|NCT01744106|Autonomic Agents|autonomic agents|mesh-ancestor
110098735|NCT01744106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110098736|NCT01744106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110098737|NCT01744106|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110098738|NCT01744106|Respiratory System Agents|respiratory system agents|mesh-ancestor
110098739|NCT01744106|Nasal Decongestants|nasal decongestants|mesh-ancestor
110098740|NCT01744106|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110098741|NCT01744106|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110098742|NCT01744106|Sympathomimetics|sympathomimetics|mesh-ancestor
110098743|NCT01744106|Adrenergic Agents|adrenergic agents|mesh-ancestor
110098744|NCT01744106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110098745|NCT01744106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110098746|NCT01744184|Midazolam|midazolam|mesh-list
110098747|NCT01744184|Nitrous Oxide|nitrous oxide|mesh-list
110098748|NCT01744184|Entonox|entonox|mesh-list
110098749|NCT01744184|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110098750|NCT01744184|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110098751|NCT01744184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110098752|NCT01744184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110098753|NCT01744184|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110098754|NCT01744184|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110098755|NCT01744184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110098756|NCT01744184|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110098757|NCT01744184|Anesthetics, General|anesthetics, general|mesh-ancestor
110098758|NCT01744184|Anesthetics|anesthetics|mesh-ancestor
110098759|NCT01744184|GABA Modulators|gaba modulators|mesh-ancestor
110098760|NCT01744184|GABA Agents|gaba agents|mesh-ancestor
110098761|NCT01744184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110098762|NCT01744184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110098763|NCT01744184|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110098764|NCT01744184|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110098765|NCT01744184|Analgesics|analgesics|mesh-ancestor
110098766|NCT01744184|Sensory System Agents|sensory system agents|mesh-ancestor
110098767|NCT01744184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110098768|NCT01744184|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
110098769|NCT01744236|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110098770|NCT01744236|Liraglutide|liraglutide|mesh-list
110098772|NCT01744236|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110098773|NCT01744236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110098774|NCT01744236|Incretins|incretins|mesh-ancestor
110098775|NCT01744236|Hormones|hormones|mesh-ancestor
110098776|NCT01744236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110098777|NCT01744236|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110098778|NCT01744236|Protease Inhibitors|protease inhibitors|mesh-ancestor
110098779|NCT01744236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110098780|NCT01744236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110098781|NCT01744236|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110098782|NCT01744249|Axitinib|axitinib|mesh-list
110098783|NCT01744249|Octreotide|octreotide|mesh-list
110098784|NCT01744249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110098785|NCT01744249|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110098786|NCT01744249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110098787|NCT01744249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110098788|NCT01744249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110098789|NCT01744249|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110098790|NCT01744288|Clopidogrel|clopidogrel|mesh-list
110098791|NCT01744288|Ticagrelor|ticagrelor|mesh-list
110098792|NCT01744288|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110098793|NCT01744288|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110098794|NCT01744288|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110098795|NCT01744288|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110098796|NCT01744288|Purinergic Agents|purinergic agents|mesh-ancestor
110098797|NCT01744288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110098798|NCT01744288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110098799|NCT01744288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110098800|NCT01744314|Indomethacin|indomethacin|mesh-list
110098801|NCT01744314|Pantoprazole|pantoprazole|mesh-list
110098802|NCT01744314|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110098803|NCT01744314|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110098804|NCT01744314|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110098805|NCT01744314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110098806|NCT01744314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110098807|NCT01744314|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110098808|NCT01744314|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110098809|NCT01744314|Analgesics|analgesics|mesh-ancestor
110098810|NCT01744314|Sensory System Agents|sensory system agents|mesh-ancestor
110098811|NCT01744314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110098812|NCT01744314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110098813|NCT01744314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110098814|NCT01744314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110098815|NCT01744314|Gout Suppressants|gout suppressants|mesh-ancestor
110098816|NCT01744314|Tocolytic Agents|tocolytic agents|mesh-ancestor
110098817|NCT01744314|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110098818|NCT01744314|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110098819|NCT01744366|Goserelin|goserelin|mesh-list
110098820|NCT01744366|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110098821|NCT01744366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110098822|NCT01744379|Lesinurad|lesinurad|mesh-list
110098823|NCT01744379|Gout Suppressants|gout suppressants|mesh-ancestor
110098824|NCT01744379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110098825|NCT01744379|Uricosuric Agents|uricosuric agents|mesh-ancestor
110098826|NCT01744444|Gabapentin|gabapentin|mesh-list
110098828|NCT01744444|Analgesics|analgesics|mesh-ancestor
110098829|NCT01744444|Sensory System Agents|sensory system agents|mesh-ancestor
110098830|NCT01744444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110098831|NCT01744444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110098833|NCT01744444|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110098834|NCT01744444|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110098835|NCT01744444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110098836|NCT01744444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110098837|NCT01744444|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110098838|NCT01744444|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110098839|NCT01744444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110098840|NCT01744444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110098841|NCT01744444|Antimanic Agents|antimanic agents|mesh-ancestor
110098842|NCT01744444|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110098843|NCT01744444|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110098844|NCT01744444|Dopamine Agents|dopamine agents|mesh-ancestor
110098845|NCT01744470|Tacrolimus|tacrolimus|mesh-list
110098846|NCT01744470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110098847|NCT01744470|Immunologic Factors|immunologic factors|mesh-ancestor
110098848|NCT01744470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110098849|NCT01744470|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110098850|NCT01744470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110098851|NCT01744470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110098852|NCT01744587|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
110098854|NCT01744587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110098855|NCT01744587|Protective Agents|protective agents|mesh-ancestor
110098856|NCT01744587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110098857|NCT01744587|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
110098858|NCT01744587|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110098859|NCT01744587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110098860|NCT01744587|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110098861|NCT01744262|Anesthetics|anesthetics|mesh-list
110098862|NCT01744262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110098863|NCT01744262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110098864|NCT01744756|Bevacizumab|bevacizumab|mesh-list
110098865|NCT01744756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110098866|NCT01744756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110098867|NCT01744756|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110098868|NCT01744756|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110098869|NCT01744756|Growth Substances|growth substances|mesh-ancestor
110098870|NCT01744756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110098871|NCT01744756|Growth Inhibitors|growth inhibitors|mesh-ancestor
110098872|NCT01744873|Bisoprolol|bisoprolol|mesh-list
110098873|NCT01744873|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110098874|NCT01744873|Sympatholytics|sympatholytics|mesh-ancestor
110098875|NCT01744873|Autonomic Agents|autonomic agents|mesh-ancestor
110098876|NCT01744873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110098877|NCT01744873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110098878|NCT01744873|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110098879|NCT01744873|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110098880|NCT01744873|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110098881|NCT01744873|Adrenergic Agents|adrenergic agents|mesh-ancestor
110098882|NCT01744873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110098883|NCT01744873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110098884|NCT01744886|Benzocaine|benzocaine|mesh-list
110098885|NCT01744886|Anesthetics, Local|anesthetics, local|mesh-ancestor
110098886|NCT01744886|Anesthetics|anesthetics|mesh-ancestor
110098887|NCT01744886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110098888|NCT01744886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110098889|NCT01744886|Sensory System Agents|sensory system agents|mesh-ancestor
110098890|NCT01744886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110098891|NCT01744626|Rituximab|rituximab|mesh-list
110098892|NCT01744626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110098893|NCT01744626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110098894|NCT01744626|Immunologic Factors|immunologic factors|mesh-ancestor
110098895|NCT01744626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110098896|NCT01744626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110098897|NCT01744964|Apomorphine|apomorphine|mesh-list
110098898|NCT01744964|Emetics|emetics|mesh-ancestor
110098899|NCT01744964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110098900|NCT01744964|Autonomic Agents|autonomic agents|mesh-ancestor
110098901|NCT01744964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110160843|NCT00101335|Celecoxib|celecoxib|mesh-list
110098903|NCT01744964|Dopamine Agonists|dopamine agonists|mesh-ancestor
110098905|NCT01744964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110098906|NCT01744964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110098907|NCT01745081|Mannitol|mannitol|mesh-list
110098908|NCT01745081|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110098909|NCT01745081|Diuretics|diuretics|mesh-ancestor
110098910|NCT01745081|Natriuretic Agents|natriuretic agents|mesh-ancestor
110098911|NCT01745081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110098912|NCT01745159|Tacrolimus|tacrolimus|mesh-list
110098913|NCT01745159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110098914|NCT01745159|Immunologic Factors|immunologic factors|mesh-ancestor
110098915|NCT01745159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110098916|NCT01745159|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110098917|NCT01745159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110098918|NCT01745159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110098919|NCT01745263|Vitamin D|vitamin d|mesh-list
110098920|NCT01745263|Cholecalciferol|cholecalciferol|mesh-list
110098921|NCT01745263|Vitamins|vitamins|mesh-ancestor
110098922|NCT01745263|Micronutrients|micronutrients|mesh-ancestor
110098923|NCT01745263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110098924|NCT01745263|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110098925|NCT01745263|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110098926|NCT01745302|Gefitinib|gefitinib|mesh-list
110098927|NCT01745302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110098928|NCT01745302|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110098929|NCT01745302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110098930|NCT01745302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110098931|NCT01745328|Amoxicillin|amoxicillin|mesh-list
110098932|NCT01745328|Levofloxacin|levofloxacin|mesh-list
110098933|NCT01745328|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110098934|NCT01745328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110098935|NCT01745328|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110098936|NCT01745328|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110098937|NCT01745328|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110098938|NCT01745328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110098939|NCT01745328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110098940|NCT01745328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110098941|NCT01745328|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110098942|NCT01745328|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110098943|NCT01745549|Insulin|insulin|mesh-list
110098944|NCT01745549|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110098945|NCT01745549|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110098946|NCT01745549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110098947|NCT01745562|Alprazolam|alprazolam|mesh-list
110098948|NCT01745562|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110098949|NCT01745562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110098950|NCT01745562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110098951|NCT01745562|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110098952|NCT01745562|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110098953|NCT01745562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110098954|NCT01745562|GABA Modulators|gaba modulators|mesh-ancestor
110098955|NCT01745562|GABA Agents|gaba agents|mesh-ancestor
110098956|NCT01745562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110098957|NCT01745562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110098958|NCT01745575|Alprazolam|alprazolam|mesh-list
110098959|NCT01745575|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110098960|NCT01745575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110098961|NCT01745575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110098962|NCT01745575|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110098963|NCT01745575|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110098965|NCT01745575|GABA Modulators|gaba modulators|mesh-ancestor
110098966|NCT01745575|GABA Agents|gaba agents|mesh-ancestor
110098967|NCT01745575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110098968|NCT01745575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110098969|NCT01745601|Dexetimide|dexetimide|mesh-list
110098970|NCT01745601|Citalopram|citalopram|mesh-list
110098971|NCT01745601|Escitalopram|escitalopram|mesh-list
110098972|NCT01745601|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110098973|NCT01745601|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110098974|NCT01745601|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110098975|NCT01745601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110098977|NCT01745601|Serotonin Agents|serotonin agents|mesh-ancestor
110098978|NCT01745601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110098979|NCT01745601|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110098980|NCT01745601|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110098981|NCT01745601|Parasympatholytics|parasympatholytics|mesh-ancestor
110098982|NCT01745601|Autonomic Agents|autonomic agents|mesh-ancestor
110098983|NCT01745601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110098984|NCT01745601|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110098985|NCT01745601|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110098986|NCT01745601|Cholinergic Agents|cholinergic agents|mesh-ancestor
110098987|NCT01745601|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110098988|NCT01745601|Antidepressive Agents|antidepressive agents|mesh-ancestor
110098989|NCT01745601|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110098990|NCT01745614|Nimesulide|nimesulide|mesh-list
110098991|NCT01745614|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110098992|NCT01745614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110098993|NCT01745614|Analgesics|analgesics|mesh-ancestor
110098994|NCT01745614|Sensory System Agents|sensory system agents|mesh-ancestor
110098995|NCT01745614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110098997|NCT01745614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110098998|NCT01745614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110098999|NCT01745614|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110099000|NCT01745614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110099001|NCT01745614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110099002|NCT01745640|Dexamethasone|dexamethasone|mesh-list
110099003|NCT01745640|Pomalidomide|pomalidomide|mesh-list
110099004|NCT01745640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110099005|NCT01745640|Antiemetics|antiemetics|mesh-ancestor
110099006|NCT01745640|Autonomic Agents|autonomic agents|mesh-ancestor
110099007|NCT01745640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110099008|NCT01745640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110099009|NCT01745640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110099010|NCT01745640|Glucocorticoids|glucocorticoids|mesh-ancestor
110099011|NCT01745640|Hormones|hormones|mesh-ancestor
110099012|NCT01745640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110099013|NCT01745640|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110099014|NCT01745640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110099015|NCT01745640|Immunologic Factors|immunologic factors|mesh-ancestor
110099016|NCT01745640|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110099017|NCT01745640|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110099018|NCT01745640|Growth Substances|growth substances|mesh-ancestor
110099019|NCT01745640|Growth Inhibitors|growth inhibitors|mesh-ancestor
110099020|NCT01745666|Epinephrine|epinephrine|mesh-list
110099021|NCT01745666|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110216346|NCT00262054|Calcium heparin|calcium heparin|mesh-list
110099022|NCT01745666|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110099023|NCT01745666|Adrenergic Agents|adrenergic agents|mesh-ancestor
110099024|NCT01745666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110399756|NCT01087762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110099025|NCT01745666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110099027|NCT01745666|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110099028|NCT01745666|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110099029|NCT01745666|Autonomic Agents|autonomic agents|mesh-ancestor
110099030|NCT01745666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110099031|NCT01745666|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110099032|NCT01745666|Respiratory System Agents|respiratory system agents|mesh-ancestor
110099033|NCT01745666|Mydriatics|mydriatics|mesh-ancestor
110099034|NCT01745666|Sympathomimetics|sympathomimetics|mesh-ancestor
110099035|NCT01745666|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110099036|NCT01745679|Ceftriaxone|ceftriaxone|mesh-list
110099037|NCT01745679|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110099038|NCT01745679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110099039|NCT01745692|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
110099040|NCT01745692|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110099041|NCT01745692|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110099042|NCT01745692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110099043|NCT01745770|Mesalamine|mesalamine|mesh-list
110099044|NCT01745770|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110099045|NCT01745770|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110099046|NCT01745770|Analgesics|analgesics|mesh-ancestor
110099047|NCT01745770|Sensory System Agents|sensory system agents|mesh-ancestor
110099048|NCT01745770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110099049|NCT01745770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110099050|NCT01745770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110099051|NCT01745770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110099052|NCT01745809|Dimercaprol|dimercaprol|mesh-list
110216359|NCT00262132|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110216360|NCT00262132|Antitubercular Agents|antitubercular agents|mesh-ancestor
110099053|NCT01745809|Chelating Agents|chelating agents|mesh-ancestor
110099054|NCT01745809|Sequestering Agents|sequestering agents|mesh-ancestor
110099055|NCT01745809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110099056|NCT01745835|Bisacodyl|bisacodyl|mesh-list
110099057|NCT01745835|Cathartics|cathartics|mesh-ancestor
110099058|NCT01745835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110099059|NCT01745835|Laxatives|laxatives|mesh-ancestor
110099060|NCT01746199|Pyrimethamine|pyrimethamine|mesh-list
110099061|NCT01746199|Sulfadoxine|sulfadoxine|mesh-list
110099062|NCT01746199|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
110099063|NCT01746199|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
110099064|NCT01746199|Sulfamethoxazole|sulfamethoxazole|mesh-list
110099065|NCT01746199|Antimalarials|antimalarials|mesh-ancestor
110099066|NCT01746199|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110099067|NCT01746199|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110099068|NCT01746199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110099069|NCT01746199|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110099070|NCT01746199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110099071|NCT01746199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110099072|NCT01746199|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110099073|NCT01746199|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110099074|NCT01746251|Afatinib|afatinib|mesh-list
110099075|NCT01746251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110099076|NCT01746251|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110099077|NCT01746251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110099078|NCT01746251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110099079|NCT01746277|Docetaxel|docetaxel|mesh-list
110099080|NCT01746277|Pemetrexed|pemetrexed|mesh-list
110099081|NCT01746277|Gefitinib|gefitinib|mesh-list
110099082|NCT01746277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110099083|NCT01746277|Tubulin Modulators|tubulin modulators|mesh-ancestor
110099084|NCT01746277|Antimitotic Agents|antimitotic agents|mesh-ancestor
110099085|NCT01746277|Mitosis Modulators|mitosis modulators|mesh-ancestor
110099086|NCT01746277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110099087|NCT01746277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110099088|NCT01746277|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110099089|NCT01746277|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110099090|NCT01746277|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110099091|NCT01746485|Treprostinil|treprostinil|mesh-list
110099092|NCT01746485|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110099093|NCT01746563|Ranibizumab|ranibizumab|mesh-list
110099094|NCT01746563|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110099095|NCT01746563|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110099096|NCT01746563|Growth Substances|growth substances|mesh-ancestor
110099097|NCT01746563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110099098|NCT01746563|Growth Inhibitors|growth inhibitors|mesh-ancestor
110099099|NCT01746563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110099100|NCT01746602|Timolol|timolol|mesh-list
110099101|NCT01746602|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110099102|NCT01746602|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110216414|NCT00262405|Prednisone|prednisone|mesh-list
110099103|NCT01746602|Adrenergic Agents|adrenergic agents|mesh-ancestor
110099104|NCT01746602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110099105|NCT01746602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110099106|NCT01746602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110099107|NCT01746602|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110099108|NCT01746602|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110099110|NCT01746641|Propofol|propofol|mesh-list
110099111|NCT01746641|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110099112|NCT01746641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110099113|NCT01746641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110099114|NCT01746641|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110099115|NCT01746641|Anesthetics, General|anesthetics, general|mesh-ancestor
110216428|NCT00262405|Immunologic Factors|immunologic factors|mesh-ancestor
110099117|NCT01746641|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110099118|NCT01746641|Narcotics|narcotics|mesh-ancestor
110099119|NCT01746641|Analgesics|analgesics|mesh-ancestor
110099120|NCT01746641|Sensory System Agents|sensory system agents|mesh-ancestor
110099121|NCT01746641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110099122|NCT01746680|Methotrexate|methotrexate|mesh-list
110099123|NCT01746680|Tacrolimus|tacrolimus|mesh-list
110099124|NCT01746680|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110099125|NCT01746680|Abortifacient Agents|abortifacient agents|mesh-ancestor
110099126|NCT01746680|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110099127|NCT01746680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110099128|NCT01746680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110099129|NCT01746680|Antimetabolites|antimetabolites|mesh-ancestor
110099130|NCT01746680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110216490|NCT00263068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110099132|NCT01746680|Dermatologic Agents|dermatologic agents|mesh-ancestor
110099133|NCT01746680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110099134|NCT01746680|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110099135|NCT01746680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110099136|NCT01746680|Immunologic Factors|immunologic factors|mesh-ancestor
110099137|NCT01746680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110099138|NCT01746680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110099139|NCT01746680|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110216551|NCT00263458|Analgesics|analgesics|mesh-ancestor
110216552|NCT00263458|Sensory System Agents|sensory system agents|mesh-ancestor
110216554|NCT00263458|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110099140|NCT01746719|Etodolac|etodolac|mesh-list
110099141|NCT01746719|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110099142|NCT01746719|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110099143|NCT01746719|Analgesics|analgesics|mesh-ancestor
110099144|NCT01746719|Sensory System Agents|sensory system agents|mesh-ancestor
110099145|NCT01746719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110099146|NCT01746719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110099147|NCT01746719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110099148|NCT01746719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110099149|NCT01746719|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110099150|NCT01746719|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110099151|NCT01746719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110099152|NCT01746719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110099153|NCT01746771|Paclitaxel|paclitaxel|mesh-list
110099154|NCT01746771|Trastuzumab|trastuzumab|mesh-list
110099155|NCT01746771|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110099156|NCT01746771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110099157|NCT01746771|Tubulin Modulators|tubulin modulators|mesh-ancestor
110099158|NCT01746771|Antimitotic Agents|antimitotic agents|mesh-ancestor
110099159|NCT01746771|Mitosis Modulators|mitosis modulators|mesh-ancestor
110099160|NCT01746771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110099161|NCT01746771|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110099162|NCT01746823|Cyclosporine|cyclosporine|mesh-list
110099163|NCT01746823|Cyclosporins|cyclosporins|mesh-list
110099164|NCT01746823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110099165|NCT01746823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110099166|NCT01746823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110099167|NCT01746823|Immunologic Factors|immunologic factors|mesh-ancestor
110099168|NCT01746823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110099169|NCT01746823|Antifungal Agents|antifungal agents|mesh-ancestor
110099170|NCT01746823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110099171|NCT01746823|Dermatologic Agents|dermatologic agents|mesh-ancestor
110099172|NCT01746823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110099173|NCT01746823|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110099174|NCT01746875|Aflibercept|aflibercept|mesh-list
110099175|NCT01746875|Verteporfin|verteporfin|mesh-list
110099176|NCT01746875|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110099177|NCT01746875|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110099178|NCT01746875|Growth Substances|growth substances|mesh-ancestor
110160862|NCT00006401|Nitric Oxide|nitric oxide|mesh-list
110099179|NCT01746875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110099180|NCT01746875|Growth Inhibitors|growth inhibitors|mesh-ancestor
110099181|NCT01746875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110099182|NCT01746875|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110099183|NCT01746875|Dermatologic Agents|dermatologic agents|mesh-ancestor
110099185|NCT01746992|Cyclophosphamide|cyclophosphamide|mesh-list
110099186|NCT01746992|Ifosfamide|ifosfamide|mesh-list
110099187|NCT01746992|Doxorubicin|doxorubicin|mesh-list
110099188|NCT01746992|Methotrexate|methotrexate|mesh-list
110099189|NCT01746992|Etoposide|etoposide|mesh-list
110099190|NCT01746992|Vincristine|vincristine|mesh-list
110099191|NCT01746992|Etoposide phosphate|etoposide phosphate|mesh-list
110099192|NCT01746992|Pirarubicin|pirarubicin|mesh-list
110099193|NCT01746992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110099194|NCT01746992|Immunologic Factors|immunologic factors|mesh-ancestor
110099195|NCT01746992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110099196|NCT01746992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110099197|NCT01746992|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110099198|NCT01746992|Alkylating Agents|alkylating agents|mesh-ancestor
110099199|NCT01746992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110099200|NCT01746992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110099201|NCT01746992|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110099202|NCT01746992|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110099203|NCT01746992|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110099204|NCT01746992|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110099205|NCT01746992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110099206|NCT01746992|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110099207|NCT01746992|Glucocorticoids|glucocorticoids|mesh-ancestor
110099209|NCT01746992|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110099210|NCT01746992|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110099211|NCT01746992|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110099212|NCT01746992|Abortifacient Agents|abortifacient agents|mesh-ancestor
110099213|NCT01746992|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110099214|NCT01746992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110099215|NCT01746992|Antimetabolites|antimetabolites|mesh-ancestor
110099216|NCT01746992|Dermatologic Agents|dermatologic agents|mesh-ancestor
110099217|NCT01746992|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110099218|NCT01746992|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110099219|NCT01746992|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110099220|NCT01746992|Tubulin Modulators|tubulin modulators|mesh-ancestor
110099221|NCT01746992|Antimitotic Agents|antimitotic agents|mesh-ancestor
110099222|NCT01746992|Mitosis Modulators|mitosis modulators|mesh-ancestor
110099224|NCT01747044|Levomilnacipran|levomilnacipran|mesh-list
110099225|NCT01747044|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110099226|NCT01747044|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110099227|NCT01747044|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110099228|NCT01747044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110099229|NCT01747044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110099230|NCT01747044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110099231|NCT01747044|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110099232|NCT01747044|Analgesics|analgesics|mesh-ancestor
110099233|NCT01747044|Sensory System Agents|sensory system agents|mesh-ancestor
110099234|NCT01747044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110099235|NCT01747044|Antidepressive Agents|antidepressive agents|mesh-ancestor
110099236|NCT01747044|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110099237|NCT01747083|Metformin|metformin|mesh-list
110099238|NCT01747083|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110099239|NCT01747083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110099240|NCT01747135|Betadex|betadex|mesh-list
110099241|NCT01747135|Sequestering Agents|sequestering agents|mesh-ancestor
110099242|NCT01747135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110099243|NCT01747148|Radavirsen|radavirsen|mesh-list
110099244|NCT01747148|Antiviral Agents|antiviral agents|mesh-ancestor
110099245|NCT01747148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110099246|NCT01747161|Botulinum Toxins|botulinum toxins|mesh-list
110399819|NCT01081834|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110099247|NCT01747161|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110099248|NCT01747161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110099249|NCT01747161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110099250|NCT01747161|Cholinergic Agents|cholinergic agents|mesh-ancestor
110099251|NCT01747161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110099252|NCT01747161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110099253|NCT01747174|Adenosine|adenosine|mesh-list
110099254|NCT01747174|Nitroprusside|nitroprusside|mesh-list
110099255|NCT01747174|Analgesics|analgesics|mesh-ancestor
110099256|NCT01747174|Sensory System Agents|sensory system agents|mesh-ancestor
110099257|NCT01747174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110099258|NCT01747174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110099259|NCT01747174|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110099260|NCT01747174|Vasodilator Agents|vasodilator agents|mesh-ancestor
110099261|NCT01747174|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
110099262|NCT01747174|Purinergic Agonists|purinergic agonists|mesh-ancestor
110099263|NCT01747174|Purinergic Agents|purinergic agents|mesh-ancestor
110099264|NCT01747174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110099265|NCT01747174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110099266|NCT01747174|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110099267|NCT01747174|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
110099269|NCT01747226|Cariostatic Agents|cariostatic agents|mesh-ancestor
110099270|NCT01747226|Protective Agents|protective agents|mesh-ancestor
110099271|NCT01747226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110099272|NCT01747252|Resveratrol|resveratrol|mesh-list
110099273|NCT01747252|Antioxidants|antioxidants|mesh-ancestor
110099274|NCT01747252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110099275|NCT01747252|Protective Agents|protective agents|mesh-ancestor
110099276|NCT01747252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110099277|NCT01747252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110099278|NCT01747252|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110099279|NCT01747278|Trimethoprim|trimethoprim|mesh-list
110099280|NCT01747278|Sulfamethoxazole|sulfamethoxazole|mesh-list
110099281|NCT01747278|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110099282|NCT01747278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110099283|NCT01747278|Antimalarials|antimalarials|mesh-ancestor
110099284|NCT01747278|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110099285|NCT01747278|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110099286|NCT01747278|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110099287|NCT01747278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110099288|NCT01747278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110099289|NCT01747278|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110099290|NCT01747278|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
110099291|NCT01747278|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110099292|NCT01747564|Mirabegron|mirabegron|mesh-list
110099293|NCT01747564|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
110099294|NCT01747564|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110099295|NCT01747564|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110099296|NCT01747564|Adrenergic Agents|adrenergic agents|mesh-ancestor
110099297|NCT01747564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110099298|NCT01747564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110099299|NCT01747564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110099300|NCT01747564|Urological Agents|urological agents|mesh-ancestor
110099301|NCT01747590|Zolpidem|zolpidem|mesh-list
110099302|NCT01747590|Alprazolam|alprazolam|mesh-list
110099303|NCT01747590|Caffeine|caffeine|mesh-list
110099304|NCT01747590|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110099305|NCT01747590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110099306|NCT01747590|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110099307|NCT01747590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110099308|NCT01747590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110099309|NCT01747590|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110216660|NCT00264628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110099310|NCT01747590|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110099311|NCT01747590|Purinergic Agents|purinergic agents|mesh-ancestor
110099312|NCT01747590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110099313|NCT01747590|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110099314|NCT01747590|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110099315|NCT01747590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110099316|NCT01747590|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
110099317|NCT01747590|GABA Agonists|gaba agonists|mesh-ancestor
110099318|NCT01747590|GABA Agents|gaba agents|mesh-ancestor
110160875|NCT00006401|Gasotransmitters|gasotransmitters|mesh-ancestor
110099319|NCT01747590|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110099320|NCT01747590|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110099321|NCT01747590|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110099322|NCT01747590|GABA Modulators|gaba modulators|mesh-ancestor
110099324|NCT01747616|Chitosan|chitosan|mesh-list
110099325|NCT01747616|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110099326|NCT01747616|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110099327|NCT01747616|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110099328|NCT01747616|Antiviral Agents|antiviral agents|mesh-ancestor
110099329|NCT01747616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110099330|NCT01747616|Expectorants|expectorants|mesh-ancestor
110099331|NCT01747616|Respiratory System Agents|respiratory system agents|mesh-ancestor
110099332|NCT01747616|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110099333|NCT01747616|Antioxidants|antioxidants|mesh-ancestor
110099334|NCT01747616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110099335|NCT01747616|Protective Agents|protective agents|mesh-ancestor
110099336|NCT01747616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110099337|NCT01747616|Antidotes|antidotes|mesh-ancestor
110099338|NCT01747616|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110099339|NCT01747616|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110099340|NCT01747616|Antimetabolites|antimetabolites|mesh-ancestor
110099341|NCT01747616|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110099342|NCT01747616|Chelating Agents|chelating agents|mesh-ancestor
110099343|NCT01747616|Sequestering Agents|sequestering agents|mesh-ancestor
110099344|NCT01747616|Hemostatics|hemostatics|mesh-ancestor
110099345|NCT01747616|Coagulants|coagulants|mesh-ancestor
110099346|NCT01747642|Sorafenib|sorafenib|mesh-list
110099347|NCT01747642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110099348|NCT01747642|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110099349|NCT01747642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110099350|NCT01747642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110099351|NCT01747668|Tocopherols|tocopherols|mesh-list
110099352|NCT01747668|alpha-Tocopherol|alpha-tocopherol|mesh-list
110099353|NCT01747668|Vitamin E|vitamin e|mesh-list
110099354|NCT01747668|Vitamins|vitamins|mesh-ancestor
110099355|NCT01747668|Micronutrients|micronutrients|mesh-ancestor
110099356|NCT01747668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110099357|NCT01747668|Antioxidants|antioxidants|mesh-ancestor
110099358|NCT01747668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110099359|NCT01747668|Protective Agents|protective agents|mesh-ancestor
110099360|NCT01747707|Docetaxel|docetaxel|mesh-list
110099361|NCT01747707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110099362|NCT01747707|Tubulin Modulators|tubulin modulators|mesh-ancestor
110099363|NCT01747707|Antimitotic Agents|antimitotic agents|mesh-ancestor
110099364|NCT01747707|Mitosis Modulators|mitosis modulators|mesh-ancestor
110099365|NCT01747707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110099366|NCT01747720|Vitamin D|vitamin d|mesh-list
110099367|NCT01747720|Cholecalciferol|cholecalciferol|mesh-list
110099368|NCT01747720|Vitamins|vitamins|mesh-ancestor
110099369|NCT01747720|Micronutrients|micronutrients|mesh-ancestor
110099370|NCT01747720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110099371|NCT01747720|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110099372|NCT01747720|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110099373|NCT01747746|Enoxaparin|enoxaparin|mesh-list
110099375|NCT01747746|Rivaroxaban|rivaroxaban|mesh-list
110099376|NCT01747746|Anticoagulants|anticoagulants|mesh-ancestor
110099377|NCT01747746|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110099378|NCT01747746|Antithrombins|antithrombins|mesh-ancestor
110216679|NCT00265135|Siltuximab|siltuximab|mesh-list
110099379|NCT01747746|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110099380|NCT01747746|Protease Inhibitors|protease inhibitors|mesh-ancestor
110099381|NCT01747746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110099382|NCT01747746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110099383|NCT01747746|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110099384|NCT01747746|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110099386|NCT01747798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110099387|NCT01747993|Tamsulosin|tamsulosin|mesh-list
110099388|NCT01747993|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110099389|NCT01747993|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110099390|NCT01747993|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110099391|NCT01747993|Adrenergic Agents|adrenergic agents|mesh-ancestor
110099392|NCT01747993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110099393|NCT01747993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110099394|NCT01747993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110099395|NCT01747993|Urological Agents|urological agents|mesh-ancestor
110099396|NCT01748019|Namitecan|namitecan|mesh-list
110099397|NCT01748019|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110099398|NCT01748019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110099399|NCT01748084|Rituximab|rituximab|mesh-list
110099400|NCT01748084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110099401|NCT01748084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110099402|NCT01748084|Immunologic Factors|immunologic factors|mesh-ancestor
110099403|NCT01748084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110099404|NCT01748084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110099405|NCT01748123|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110099406|NCT01748123|Chlorthalidone|chlorthalidone|mesh-list
110099407|NCT01748123|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110099408|NCT01748123|Diuretics|diuretics|mesh-ancestor
110099409|NCT01748123|Natriuretic Agents|natriuretic agents|mesh-ancestor
110099410|NCT01748123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110099411|NCT01748123|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110099412|NCT01748123|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110099413|NCT01748123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110099414|NCT01748253|Amlodipine|amlodipine|mesh-list
110099415|NCT01748253|Telmisartan|telmisartan|mesh-list
110099416|NCT01748253|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
110099417|NCT01748253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110099418|NCT01748253|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110099419|NCT01748253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110099420|NCT01748253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110099421|NCT01748253|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110099422|NCT01748253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110099423|NCT01748253|Vasodilator Agents|vasodilator agents|mesh-ancestor
110099424|NCT01748253|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110099425|NCT01748253|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110099427|NCT01748279|Formoterol Fumarate|formoterol fumarate|mesh-list
110099428|NCT01748279|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110099429|NCT01748279|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110099430|NCT01748279|Antimetabolites|antimetabolites|mesh-ancestor
110099431|NCT01748279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110216684|NCT00106197|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110216698|NCT00265291|Fluoxetine|fluoxetine|mesh-list
110099432|NCT01748279|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110099433|NCT01748279|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110099434|NCT01748279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110099435|NCT01748279|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110099437|NCT01748279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110099438|NCT01748279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110099439|NCT01748279|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110099440|NCT01748279|Respiratory System Agents|respiratory system agents|mesh-ancestor
110099441|NCT01748279|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110099442|NCT01748279|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110099443|NCT01748279|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110399866|NCT01313676|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110099444|NCT01748279|Adrenergic Agents|adrenergic agents|mesh-ancestor
110099445|NCT01748279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110099446|NCT01748318|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
110099447|NCT01748318|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110099448|NCT01748318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110099449|NCT01748318|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110099450|NCT01748318|Antimalarials|antimalarials|mesh-ancestor
110099451|NCT01748318|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110099452|NCT01748318|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110099454|NCT01748344|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110099455|NCT01748344|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110099456|NCT01748344|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110099457|NCT01748344|Histamine Antagonists|histamine antagonists|mesh-ancestor
110099458|NCT01748344|Histamine Agents|histamine agents|mesh-ancestor
110099459|NCT01748344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110099460|NCT01748344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110099461|NCT01748344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110099462|NCT01748370|Vitamin D|vitamin d|mesh-list
110099463|NCT01748370|Ergocalciferols|ergocalciferols|mesh-list
110099464|NCT01748370|Cholecalciferol|cholecalciferol|mesh-list
110099466|NCT01748370|Micronutrients|micronutrients|mesh-ancestor
110099467|NCT01748370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110099468|NCT01748370|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110099469|NCT01748370|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110099470|NCT01748396|Calcitriol|calcitriol|mesh-list
110099471|NCT01748396|Calcium Carbonate|calcium carbonate|mesh-list
110099472|NCT01748396|Calcium|calcium|mesh-list
110099473|NCT01748396|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110099474|NCT01748396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110099475|NCT01748396|Antacids|antacids|mesh-ancestor
110099476|NCT01748396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110099477|NCT01748396|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110099478|NCT01748396|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
110099479|NCT01748396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110099480|NCT01748396|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110099481|NCT01748396|Vitamins|vitamins|mesh-ancestor
110099482|NCT01748396|Micronutrients|micronutrients|mesh-ancestor
110099483|NCT01748396|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110099484|NCT01748422|Capsaicin|capsaicin|mesh-list
110099485|NCT01748422|Antipruritics|antipruritics|mesh-ancestor
110099486|NCT01748422|Dermatologic Agents|dermatologic agents|mesh-ancestor
110099487|NCT01748422|Sensory System Agents|sensory system agents|mesh-ancestor
110099488|NCT01748422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110099489|NCT01748422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110099491|NCT01748435|Antipruritics|antipruritics|mesh-ancestor
110099492|NCT01748435|Dermatologic Agents|dermatologic agents|mesh-ancestor
110099493|NCT01748435|Sensory System Agents|sensory system agents|mesh-ancestor
110099494|NCT01748435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110099495|NCT01748435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110099496|NCT01748487|Dexamethasone|dexamethasone|mesh-list
110099497|NCT01748487|Dexamethasone acetate|dexamethasone acetate|mesh-list
110099498|NCT01748487|BB 1101|bb 1101|mesh-list
110099499|NCT01748487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110099500|NCT01748487|Antiemetics|antiemetics|mesh-ancestor
110099501|NCT01748487|Autonomic Agents|autonomic agents|mesh-ancestor
110099502|NCT01748487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110099503|NCT01748487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110099504|NCT01748487|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110099505|NCT01748487|Glucocorticoids|glucocorticoids|mesh-ancestor
110099506|NCT01748487|Hormones|hormones|mesh-ancestor
110099507|NCT01748487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110099508|NCT01748487|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110099509|NCT01748487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110099510|NCT01748487|Protease Inhibitors|protease inhibitors|mesh-ancestor
110099511|NCT01748487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110099512|NCT01748487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110099513|NCT01748500|Pantoprazole|pantoprazole|mesh-list
110099514|NCT01748500|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110099515|NCT01748500|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110099516|NCT01748500|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110099517|NCT01748500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110099518|NCT01748500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110099519|NCT01748526|Canagliflozin|canagliflozin|mesh-list
110099520|NCT01748526|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110099521|NCT01748526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110099522|NCT01748526|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110099523|NCT01748526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110099524|NCT01748539|Brodalumab|brodalumab|mesh-list
110099525|NCT01748539|Dermatologic Agents|dermatologic agents|mesh-ancestor
110099526|NCT01748630|Fentanyl|fentanyl|mesh-list
110099527|NCT01748630|Midazolam|midazolam|mesh-list
110099528|NCT01748630|Dexmedetomidine|dexmedetomidine|mesh-list
110099529|NCT01748630|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110099530|NCT01748630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110099531|NCT01748630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110099532|NCT01748630|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110099533|NCT01748630|Analgesics|analgesics|mesh-ancestor
110099534|NCT01748630|Sensory System Agents|sensory system agents|mesh-ancestor
110099535|NCT01748630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110099536|NCT01748630|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110099537|NCT01748630|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110099539|NCT01748630|Adrenergic Agents|adrenergic agents|mesh-ancestor
110099540|NCT01748630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110099541|NCT01748630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110099542|NCT01748630|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110099543|NCT01748630|Narcotics|narcotics|mesh-ancestor
110099544|NCT01748630|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110216736|NCT00265642|Irbesartan|irbesartan|mesh-list
110099545|NCT01748630|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110099546|NCT01748630|Anesthetics, General|anesthetics, general|mesh-ancestor
110099547|NCT01748630|Anesthetics|anesthetics|mesh-ancestor
110099548|NCT01748630|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110099549|NCT01748630|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110099550|NCT01748630|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110099551|NCT01748630|GABA Modulators|gaba modulators|mesh-ancestor
110099552|NCT01748630|GABA Agents|gaba agents|mesh-ancestor
110099553|NCT01748669|Allyl sulfide|allyl sulfide|mesh-list
110099554|NCT01748669|Antioxidants|antioxidants|mesh-ancestor
110099555|NCT01748669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110099556|NCT01748669|Protective Agents|protective agents|mesh-ancestor
110099557|NCT01748669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110099558|NCT01748669|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110099559|NCT01748669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110099560|NCT01748669|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110099561|NCT01748669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110099562|NCT01748721|Antibodies|antibodies|mesh-list
110099563|NCT01748721|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110099564|NCT01748721|Immunologic Factors|immunologic factors|mesh-ancestor
110099565|NCT01748721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110099566|NCT01748747|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
110099567|NCT01748747|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110099568|NCT01748747|Immunologic Factors|immunologic factors|mesh-ancestor
110099569|NCT01748747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110099570|NCT01748773|Capecitabine|capecitabine|mesh-list
110099571|NCT01748773|Oxaliplatin|oxaliplatin|mesh-list
110099572|NCT01748773|Trastuzumab|trastuzumab|mesh-list
110099573|NCT01748773|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110099574|NCT01748773|Antimetabolites|antimetabolites|mesh-ancestor
110099575|NCT01748773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110099576|NCT01748773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110099577|NCT01748773|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110099578|NCT01748838|Mannitol|mannitol|mesh-list
110099579|NCT01748838|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110099580|NCT01748838|Diuretics|diuretics|mesh-ancestor
110099581|NCT01748838|Natriuretic Agents|natriuretic agents|mesh-ancestor
110099582|NCT01748838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110099583|NCT01748929|Albendazole|albendazole|mesh-list
110099584|NCT01748929|Anthelmintics|anthelmintics|mesh-ancestor
110099585|NCT01748929|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110099586|NCT01748929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110099587|NCT01748929|Anticestodal Agents|anticestodal agents|mesh-ancestor
110099588|NCT01748929|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110099589|NCT01748929|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110099590|NCT01748929|Tubulin Modulators|tubulin modulators|mesh-ancestor
110099591|NCT01748929|Antimitotic Agents|antimitotic agents|mesh-ancestor
110099592|NCT01748929|Mitosis Modulators|mitosis modulators|mesh-ancestor
110099593|NCT01748929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110099594|NCT01748929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110099595|NCT01749072|Vinorelbine|vinorelbine|mesh-list
110099596|NCT01749072|Ifosfamide|ifosfamide|mesh-list
110099597|NCT01749072|Gefitinib|gefitinib|mesh-list
110099598|NCT01749072|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110099599|NCT01749072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110099600|NCT01749072|Tubulin Modulators|tubulin modulators|mesh-ancestor
110216740|NCT00265642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110099601|NCT01749072|Antimitotic Agents|antimitotic agents|mesh-ancestor
110099602|NCT01749072|Mitosis Modulators|mitosis modulators|mesh-ancestor
110099603|NCT01749072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110099604|NCT01749072|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110099605|NCT01749072|Alkylating Agents|alkylating agents|mesh-ancestor
110099606|NCT01749072|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110099607|NCT01749072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110099608|NCT01749085|Ketoconazole|ketoconazole|mesh-list
110099609|NCT01749085|Antifungal Agents|antifungal agents|mesh-ancestor
110099610|NCT01749085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110099611|NCT01749085|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110099612|NCT01749085|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110099613|NCT01749085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110099614|NCT01749085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110099615|NCT01749085|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110099616|NCT01749085|Hormone Antagonists|hormone antagonists|mesh-ancestor
110099617|NCT01749085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110099618|NCT01749085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110099619|NCT01749085|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110099620|NCT01749098|Ketamine|ketamine|mesh-list
110099621|NCT01749098|Analgesics|analgesics|mesh-ancestor
110099622|NCT01749098|Sensory System Agents|sensory system agents|mesh-ancestor
110099623|NCT01749098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110099624|NCT01749098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110099625|NCT01749098|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110099626|NCT01749098|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110099627|NCT01749098|Anesthetics, General|anesthetics, general|mesh-ancestor
110099628|NCT01749098|Anesthetics|anesthetics|mesh-ancestor
110099629|NCT01749098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110099630|NCT01749098|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110099631|NCT01749098|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110099632|NCT01749098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110099633|NCT01749098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110099634|NCT01749111|Cyclophosphamide|cyclophosphamide|mesh-list
110099635|NCT01749111|Methotrexate|methotrexate|mesh-list
110099636|NCT01749111|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
110099637|NCT01749111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110099638|NCT01749111|Immunologic Factors|immunologic factors|mesh-ancestor
110399895|NCT01313286|Globalagliatin|globalagliatin|mesh-list
110099640|NCT01749111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110099641|NCT01749111|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110099642|NCT01749111|Alkylating Agents|alkylating agents|mesh-ancestor
110099643|NCT01749111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110099644|NCT01749111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110099645|NCT01749111|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110099646|NCT01749111|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110099647|NCT01749111|Abortifacient Agents|abortifacient agents|mesh-ancestor
110099648|NCT01749111|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110099649|NCT01749111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110099650|NCT01749111|Antimetabolites|antimetabolites|mesh-ancestor
110099651|NCT01749111|Dermatologic Agents|dermatologic agents|mesh-ancestor
110099652|NCT01749111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110099653|NCT01749111|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110099654|NCT01749111|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110099655|NCT01749150|Ritonavir|ritonavir|mesh-list
110099656|NCT01749150|Ribavirin|ribavirin|mesh-list
110099657|NCT01749150|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110099658|NCT01749150|Interferon-alpha|interferon-alpha|mesh-list
110099659|NCT01749150|Lactams|lactams|mesh-list
110099660|NCT01749150|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110099661|NCT01749150|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110099662|NCT01749150|Protease Inhibitors|protease inhibitors|mesh-ancestor
110099663|NCT01749150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110099664|NCT01749150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110099665|NCT01749150|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110099666|NCT01749150|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110099667|NCT01749150|Antiviral Agents|antiviral agents|mesh-ancestor
110099668|NCT01749150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110099669|NCT01749150|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110099670|NCT01749150|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110099671|NCT01749150|Antimetabolites|antimetabolites|mesh-ancestor
110099672|NCT01749150|Immunologic Factors|immunologic factors|mesh-ancestor
110099673|NCT01749150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110099674|NCT01749150|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110099676|NCT01749228|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110099677|NCT01749228|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110099678|NCT01749228|Analgesics|analgesics|mesh-ancestor
110099679|NCT01749228|Sensory System Agents|sensory system agents|mesh-ancestor
110099680|NCT01749228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110099681|NCT01749228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110099682|NCT01749228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110099683|NCT01749228|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110099684|NCT01749228|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110099685|NCT01749228|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110099686|NCT01749228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110099687|NCT01749228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110099688|NCT01749241|Loteprednol Etabonate|loteprednol etabonate|mesh-list
110099689|NCT01749241|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110099690|NCT01749319|Baclofen|baclofen|mesh-list
110099691|NCT01749319|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110099692|NCT01749319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110099693|NCT01749319|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110099694|NCT01749319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110099695|NCT01749319|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
110099696|NCT01749319|GABA Agonists|gaba agonists|mesh-ancestor
110099697|NCT01749319|GABA Agents|gaba agents|mesh-ancestor
110099698|NCT01749319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110099699|NCT01749319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110099700|NCT01749371|Vitamins|vitamins|mesh-list
110099701|NCT01749371|Vitamin E|vitamin e|mesh-list
110099702|NCT01749371|Tocopherols|tocopherols|mesh-list
110099703|NCT01749371|Tocotrienols|tocotrienols|mesh-list
110099704|NCT01749371|alpha-Tocopherol|alpha-tocopherol|mesh-list
110099705|NCT01749371|Micronutrients|micronutrients|mesh-ancestor
110099706|NCT01749371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110099707|NCT01749371|Antioxidants|antioxidants|mesh-ancestor
110099708|NCT01749371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110099709|NCT01749371|Protective Agents|protective agents|mesh-ancestor
110099710|NCT01749384|Bevacizumab|bevacizumab|mesh-list
110099711|NCT01749384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110099712|NCT01749384|Endothelial Growth Factors|endothelial growth factors|mesh-list
110099713|NCT01749384|Antibodies|antibodies|mesh-list
110099714|NCT01749384|Immunoglobulins|immunoglobulins|mesh-list
110099715|NCT01749384|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110099716|NCT01749384|Immunoglobulin G|immunoglobulin g|mesh-list
110099717|NCT01749384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110099718|NCT01749384|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110099719|NCT01749384|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110099720|NCT01749384|Growth Substances|growth substances|mesh-ancestor
110099721|NCT01749384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110099722|NCT01749384|Growth Inhibitors|growth inhibitors|mesh-ancestor
110099723|NCT01749384|Immunologic Factors|immunologic factors|mesh-ancestor
110099725|NCT01749397|Floxuridine|floxuridine|mesh-list
110099726|NCT01749397|Veliparib|veliparib|mesh-list
110099727|NCT01749397|Deoxyuridine|deoxyuridine|mesh-list
110099728|NCT01749397|Antimetabolites|antimetabolites|mesh-ancestor
110099729|NCT01749397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110099730|NCT01749397|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110099731|NCT01749397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110099732|NCT01749397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110099733|NCT01749397|Immunologic Factors|immunologic factors|mesh-ancestor
110099734|NCT01749397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110099735|NCT01749397|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110099736|NCT01749397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110099737|NCT01749423|Botulinum Toxins|botulinum toxins|mesh-list
110099738|NCT01749423|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110099739|NCT01749423|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110099740|NCT01749423|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110099741|NCT01749423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110099742|NCT01749423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110099743|NCT01749423|Cholinergic Agents|cholinergic agents|mesh-ancestor
110099744|NCT01749423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110099745|NCT01749423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110099746|NCT01749423|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110099747|NCT01749423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110099748|NCT01749475|Midazolam|midazolam|mesh-list
110099749|NCT01749475|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110099750|NCT01749475|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110099751|NCT01749475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110099752|NCT01749475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110099753|NCT01749475|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110099754|NCT01749475|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110099755|NCT01749475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110099756|NCT01749475|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110099757|NCT01749475|Anesthetics, General|anesthetics, general|mesh-ancestor
110099759|NCT01749475|GABA Modulators|gaba modulators|mesh-ancestor
110099760|NCT01749475|GABA Agents|gaba agents|mesh-ancestor
110099761|NCT01749475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110099762|NCT01749475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110099763|NCT01749514|Luspatercept|luspatercept|mesh-list
110099764|NCT01749514|Hematinics|hematinics|mesh-ancestor
110099765|NCT01749540|Luspatercept|luspatercept|mesh-list
110099766|NCT01749540|Hematinics|hematinics|mesh-ancestor
110099768|NCT01749566|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110099769|NCT01749566|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110099770|NCT01749566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110099771|NCT01749566|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110099772|NCT01749566|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110099773|NCT01749566|Antiviral Agents|antiviral agents|mesh-ancestor
110099774|NCT01749566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110099775|NCT01749566|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
110099776|NCT01749579|Fentanyl|fentanyl|mesh-list
110099777|NCT01749579|Midazolam|midazolam|mesh-list
110099778|NCT01749579|Propofol|propofol|mesh-list
110099779|NCT01749579|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110099780|NCT01749579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110099782|NCT01749579|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110099783|NCT01749579|Anesthetics, General|anesthetics, general|mesh-ancestor
110099784|NCT01749579|Anesthetics|anesthetics|mesh-ancestor
110099785|NCT01749579|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110099786|NCT01749579|Narcotics|narcotics|mesh-ancestor
110099787|NCT01749579|Analgesics|analgesics|mesh-ancestor
110099788|NCT01749579|Sensory System Agents|sensory system agents|mesh-ancestor
110099789|NCT01749579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110099790|NCT01749579|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110099791|NCT01749579|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110099792|NCT01749579|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110099793|NCT01749579|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110099794|NCT01749579|GABA Modulators|gaba modulators|mesh-ancestor
110099795|NCT01749579|GABA Agents|gaba agents|mesh-ancestor
110099796|NCT01749579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110099797|NCT01749579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110099799|NCT01750060|Naltrexone|naltrexone|mesh-list
110099800|NCT01750060|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110099801|NCT01750060|Narcotics|narcotics|mesh-ancestor
110099802|NCT01750060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110034797|NCT01401803|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110099803|NCT01750060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110099804|NCT01750060|Analgesics|analgesics|mesh-ancestor
110099805|NCT01750060|Sensory System Agents|sensory system agents|mesh-ancestor
110099806|NCT01750060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110099807|NCT01750060|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110099808|NCT01750060|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110099809|NCT01750060|Anesthetics, General|anesthetics, general|mesh-ancestor
110099810|NCT01750060|Anesthetics|anesthetics|mesh-ancestor
110099811|NCT01750060|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110099812|NCT01750060|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110099813|NCT01750099|Lidocaine|lidocaine|mesh-list
110099814|NCT01750099|Epinephrine|epinephrine|mesh-list
110099815|NCT01750099|Fentanyl|fentanyl|mesh-list
110099816|NCT01750099|Bupivacaine|bupivacaine|mesh-list
110099817|NCT01750099|Anesthetics, Local|anesthetics, local|mesh-ancestor
110099818|NCT01750099|Anesthetics|anesthetics|mesh-ancestor
110099819|NCT01750099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110099820|NCT01750099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110099821|NCT01750099|Sensory System Agents|sensory system agents|mesh-ancestor
110099822|NCT01750099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110099823|NCT01750099|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110099824|NCT01750099|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110099825|NCT01750099|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110099826|NCT01750099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110099827|NCT01750099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110099828|NCT01750099|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110099829|NCT01750099|Narcotics|narcotics|mesh-ancestor
110099830|NCT01750099|Analgesics|analgesics|mesh-ancestor
110099831|NCT01750099|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110099832|NCT01750099|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110099833|NCT01750099|Anesthetics, General|anesthetics, general|mesh-ancestor
110099834|NCT01750099|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110099835|NCT01750099|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110099836|NCT01750099|Adrenergic Agents|adrenergic agents|mesh-ancestor
110099837|NCT01750099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110099838|NCT01750099|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110099839|NCT01750099|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110099840|NCT01750099|Autonomic Agents|autonomic agents|mesh-ancestor
110099841|NCT01750099|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110099842|NCT01750099|Respiratory System Agents|respiratory system agents|mesh-ancestor
110099843|NCT01750099|Mydriatics|mydriatics|mesh-ancestor
110099844|NCT01750099|Sympathomimetics|sympathomimetics|mesh-ancestor
110099845|NCT01750099|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110099846|NCT01750359|Curcumin|curcumin|mesh-list
110099847|NCT01750359|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110099848|NCT01750359|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110099849|NCT01750359|Analgesics|analgesics|mesh-ancestor
110099850|NCT01750359|Sensory System Agents|sensory system agents|mesh-ancestor
110099851|NCT01750359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110099852|NCT01750359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110099853|NCT01750359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110099854|NCT01750359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110099855|NCT01750359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110099856|NCT01750359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110099857|NCT01750359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110099858|NCT01750385|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110099859|NCT01750385|Cephalosporins|cephalosporins|mesh-list
110099860|NCT01750385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110099861|NCT01750437|Esomeprazole|esomeprazole|mesh-list
110099862|NCT01750437|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110099863|NCT01750437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110099864|NCT01750437|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110099865|NCT01750437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110099866|NCT01750437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110099867|NCT01750463|Chrysarobin|chrysarobin|mesh-list
110099868|NCT01750463|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110099869|NCT01750463|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110099870|NCT01750463|Analgesics|analgesics|mesh-ancestor
110099871|NCT01750463|Sensory System Agents|sensory system agents|mesh-ancestor
110099872|NCT01750463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110099874|NCT01750463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110099875|NCT01750463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110099876|NCT01750476|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
110099877|NCT01750476|Medroxyprogesterone|medroxyprogesterone|mesh-list
110099878|NCT01750476|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110099880|NCT01750476|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110099881|NCT01750476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110099882|NCT01750476|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110099883|NCT01750476|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110099884|NCT01750476|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110099885|NCT01750476|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110099886|NCT01750476|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110099887|NCT01750476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110099888|NCT01750476|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110099889|NCT01750541|Valproic Acid|valproic acid|mesh-list
110099890|NCT01750541|Haloperidol|haloperidol|mesh-list
110099891|NCT01750541|Haloperidol decanoate|haloperidol decanoate|mesh-list
110099892|NCT01750541|Antiemetics|antiemetics|mesh-ancestor
110099893|NCT01750541|Autonomic Agents|autonomic agents|mesh-ancestor
110099894|NCT01750541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110099895|NCT01750541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110099896|NCT01750541|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110160908|NCT00101803|Vildagliptin|vildagliptin|mesh-list
110099897|NCT01750541|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110099898|NCT01750541|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110099899|NCT01750541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110099900|NCT01750541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110099901|NCT01750541|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110099902|NCT01750541|Dopamine Agents|dopamine agents|mesh-ancestor
110099903|NCT01750541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110099904|NCT01750541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110099905|NCT01750541|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110099906|NCT01750541|Anticonvulsants|anticonvulsants|mesh-ancestor
110099907|NCT01750541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110099908|NCT01750541|GABA Agents|gaba agents|mesh-ancestor
110099909|NCT01750541|Antimanic Agents|antimanic agents|mesh-ancestor
110099910|NCT01750580|Ipilimumab|ipilimumab|mesh-list
110099911|NCT01750580|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110099912|NCT01750580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110099913|NCT01750580|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110099914|NCT01750580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110099915|NCT01750645|Botulinum Toxins|botulinum toxins|mesh-list
110099916|NCT01750645|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110099917|NCT01750645|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110099918|NCT01750645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110099919|NCT01750645|Cholinergic Agents|cholinergic agents|mesh-ancestor
110099920|NCT01750645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110099921|NCT01750645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110099922|NCT01750723|Acetazolamide|acetazolamide|mesh-list
110099923|NCT01750723|Anticonvulsants|anticonvulsants|mesh-ancestor
110099924|NCT01750723|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110099925|NCT01750723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110099926|NCT01750723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110099927|NCT01750723|Diuretics|diuretics|mesh-ancestor
110099928|NCT01750723|Natriuretic Agents|natriuretic agents|mesh-ancestor
110099929|NCT01750723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110099931|NCT01750762|Immunologic Factors|immunologic factors|mesh-ancestor
110099932|NCT01750762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110099933|NCT01750762|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110099934|NCT01750762|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110099935|NCT01750762|Growth Substances|growth substances|mesh-ancestor
110099936|NCT01750762|Growth Inhibitors|growth inhibitors|mesh-ancestor
110099937|NCT01750762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110099938|NCT01750788|Rivaroxaban|rivaroxaban|mesh-list
110099939|NCT01750788|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110099940|NCT01750788|Antithrombins|antithrombins|mesh-ancestor
110099941|NCT01750788|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110099942|NCT01750788|Protease Inhibitors|protease inhibitors|mesh-ancestor
110099943|NCT01750788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110099944|NCT01750788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110099945|NCT01750788|Anticoagulants|anticoagulants|mesh-ancestor
110099946|NCT01750801|Chlorhexidine|chlorhexidine|mesh-list
110099947|NCT01750801|Propolis|propolis|mesh-list
110099948|NCT01750801|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110099949|NCT01750801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110099951|NCT01750866|Prednisone|prednisone|mesh-list
110099952|NCT01750866|Lenograstim|lenograstim|mesh-list
110099953|NCT01750866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110099954|NCT01750866|Glucocorticoids|glucocorticoids|mesh-ancestor
110099955|NCT01750866|Hormones|hormones|mesh-ancestor
110099956|NCT01750866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110099957|NCT01750866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110099958|NCT01750866|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110099959|NCT01750866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110099960|NCT01750866|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110099961|NCT01750866|Immunologic Factors|immunologic factors|mesh-ancestor
110099962|NCT01750983|Lenalidomide|lenalidomide|mesh-list
110099963|NCT01750983|Ipilimumab|ipilimumab|mesh-list
110099964|NCT01750983|Immunologic Factors|immunologic factors|mesh-ancestor
110099965|NCT01750983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110099967|NCT01750983|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110099968|NCT01750983|Growth Substances|growth substances|mesh-ancestor
110099969|NCT01750983|Growth Inhibitors|growth inhibitors|mesh-ancestor
110099970|NCT01750983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110099971|NCT01750983|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110099972|NCT01750983|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110099973|NCT01750983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110099974|NCT01751009|Vitamins|vitamins|mesh-list
110099975|NCT01751009|Vitamin A|vitamin a|mesh-list
110099976|NCT01751009|Retinol palmitate|retinol palmitate|mesh-list
110099977|NCT01751009|Micronutrients|micronutrients|mesh-ancestor
110099978|NCT01751009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110099979|NCT01751009|Antioxidants|antioxidants|mesh-ancestor
110099980|NCT01751009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110099981|NCT01751009|Protective Agents|protective agents|mesh-ancestor
110099982|NCT01751009|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110099983|NCT01751009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110099984|NCT01751074|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110099985|NCT01751074|Darapladib|darapladib|mesh-list
110099986|NCT01751074|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110099987|NCT01751074|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110099988|NCT01751074|Antimetabolites|antimetabolites|mesh-ancestor
110099989|NCT01751074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110099990|NCT01751074|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110099991|NCT01751074|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110099992|NCT01751074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110099993|NCT01751074|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
110099994|NCT01751204|Calcium, Dietary|calcium, dietary|mesh-list
110099995|NCT01751204|Calcium|calcium|mesh-list
110099996|NCT01751204|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110099997|NCT01751204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110216814|NCT00266344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110099998|NCT01751204|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110100000|NCT01751269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110100001|NCT01751269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110100002|NCT01751269|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110100003|NCT01751269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110100004|NCT01751295|Atorvastatin|atorvastatin|mesh-list
110100005|NCT01751295|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110100006|NCT01751295|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110100007|NCT01751295|Antimetabolites|antimetabolites|mesh-ancestor
110100008|NCT01751295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110100009|NCT01751295|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110100010|NCT01751295|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110100011|NCT01751295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110100012|NCT01751321|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110100013|NCT01751321|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110100014|NCT01751321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110100015|NCT01751321|Incretins|incretins|mesh-ancestor
110100016|NCT01751321|Hormones|hormones|mesh-ancestor
110100017|NCT01751321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110100018|NCT01751321|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110100019|NCT01751321|Protease Inhibitors|protease inhibitors|mesh-ancestor
110100021|NCT01751321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110100022|NCT01751347|Lidocaine|lidocaine|mesh-list
110100023|NCT01751347|Bupivacaine|bupivacaine|mesh-list
110100024|NCT01751347|Anesthetics, Local|anesthetics, local|mesh-ancestor
110100025|NCT01751347|Anesthetics|anesthetics|mesh-ancestor
110100026|NCT01751347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110100027|NCT01751347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110100028|NCT01751347|Sensory System Agents|sensory system agents|mesh-ancestor
110100029|NCT01751347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110100030|NCT01751347|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110100031|NCT01751347|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110100032|NCT01751347|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110100033|NCT01751347|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110100034|NCT01751347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110160916|NCT00101842|Pemetrexed|pemetrexed|mesh-list
110100036|NCT01751373|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110100037|NCT01751373|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110100038|NCT01751373|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110100039|NCT01751373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110100040|NCT01751373|Cholinergic Agents|cholinergic agents|mesh-ancestor
110100041|NCT01751373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110100042|NCT01751373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110100043|NCT01751373|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110100044|NCT01751373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110100045|NCT01751763|Sorafenib|sorafenib|mesh-list
110100046|NCT01751763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110100047|NCT01751763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110100048|NCT01751763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110100049|NCT01751763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110100050|NCT01751828|Sertraline|sertraline|mesh-list
110100051|NCT01751828|Antidepressive Agents|antidepressive agents|mesh-ancestor
110100052|NCT01751828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110100053|NCT01751828|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110216825|NCT00266539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110100054|NCT01751828|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110100055|NCT01751828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110100056|NCT01751828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110100058|NCT01751828|Serotonin Agents|serotonin agents|mesh-ancestor
110100059|NCT01751828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110100061|NCT01751854|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110100062|NCT01751854|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110100063|NCT01751854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110100064|NCT01751854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110100065|NCT01751854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110100066|NCT01751854|Serotonin Agents|serotonin agents|mesh-ancestor
110100067|NCT01751854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110100068|NCT01751919|Imatinib Mesylate|imatinib mesylate|mesh-list
110100069|NCT01751919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110100070|NCT01751919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110100071|NCT01751919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110100072|NCT01751919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110100073|NCT01752010|Immunologic Factors|immunologic factors|mesh-list
110100074|NCT01752010|Immunomodulating Agents|immunomodulating agents|mesh-list
110100075|NCT01752010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110100076|NCT01752075|Lenalidomide|lenalidomide|mesh-list
110100077|NCT01752075|Immunologic Factors|immunologic factors|mesh-ancestor
110100078|NCT01752075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110100079|NCT01752075|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110100080|NCT01752075|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110100081|NCT01752075|Growth Substances|growth substances|mesh-ancestor
110100082|NCT01752075|Growth Inhibitors|growth inhibitors|mesh-ancestor
110100083|NCT01752075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110100084|NCT01752153|Silymarin|silymarin|mesh-list
110100085|NCT01752153|Deferoxamine|deferoxamine|mesh-list
110100086|NCT01752153|Antioxidants|antioxidants|mesh-ancestor
110400064|NCT01012219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110100087|NCT01752153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110100088|NCT01752153|Protective Agents|protective agents|mesh-ancestor
110100089|NCT01752153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110100090|NCT01752153|Siderophores|siderophores|mesh-ancestor
110100091|NCT01752153|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110100092|NCT01752153|Chelating Agents|chelating agents|mesh-ancestor
110100093|NCT01752153|Sequestering Agents|sequestering agents|mesh-ancestor
110100094|NCT01752205|Paclitaxel|paclitaxel|mesh-list
110100095|NCT01752205|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110100096|NCT01752205|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110100097|NCT01752205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110100098|NCT01752205|Tubulin Modulators|tubulin modulators|mesh-ancestor
110100099|NCT01752205|Antimitotic Agents|antimitotic agents|mesh-ancestor
110100100|NCT01752205|Mitosis Modulators|mitosis modulators|mesh-ancestor
110100101|NCT01752205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110100102|NCT01752205|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110100103|NCT01752205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110100104|NCT01752244|Alfacalcidol|alfacalcidol|mesh-list
110100105|NCT01752244|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
110100106|NCT01752244|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110100107|NCT01752244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110100108|NCT01752244|Vitamins|vitamins|mesh-ancestor
110100109|NCT01752244|Micronutrients|micronutrients|mesh-ancestor
110100110|NCT01752270|Cyproterone Acetate|cyproterone acetate|mesh-list
110100111|NCT01752270|Cyproterone|cyproterone|mesh-list
110100112|NCT01752270|Cyproterone acetate, ethinyl estradiol drug combination|cyproterone acetate, ethinyl estradiol drug combination|mesh-list
110100113|NCT01752270|Androgen Antagonists|androgen antagonists|mesh-ancestor
110100114|NCT01752270|Hormone Antagonists|hormone antagonists|mesh-ancestor
110100115|NCT01752270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110100116|NCT01752270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110100117|NCT01752270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110100118|NCT01752270|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110100119|NCT01752270|Contraceptive Agents|contraceptive agents|mesh-ancestor
110100120|NCT01752270|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110100121|NCT01752322|Lidocaine|lidocaine|mesh-list
110100122|NCT01752322|Anesthetics, Local|anesthetics, local|mesh-ancestor
110100123|NCT01752322|Anesthetics|anesthetics|mesh-ancestor
110100124|NCT01752322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110100125|NCT01752322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110100126|NCT01752322|Sensory System Agents|sensory system agents|mesh-ancestor
110100127|NCT01752322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110100128|NCT01752322|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110100129|NCT01752322|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110100130|NCT01752322|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110100131|NCT01752322|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110100132|NCT01752322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110100133|NCT01752517|Vinorelbine|vinorelbine|mesh-list
110100134|NCT01752517|Ifosfamide|ifosfamide|mesh-list
110100135|NCT01752517|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110100136|NCT01752517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110100137|NCT01752517|Tubulin Modulators|tubulin modulators|mesh-ancestor
110100138|NCT01752517|Antimitotic Agents|antimitotic agents|mesh-ancestor
110100139|NCT01752517|Mitosis Modulators|mitosis modulators|mesh-ancestor
110100140|NCT01752517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110100141|NCT01752517|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110100142|NCT01752517|Alkylating Agents|alkylating agents|mesh-ancestor
110100143|NCT01752543|Conivaptan|conivaptan|mesh-list
110100144|NCT01752543|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
110100145|NCT01752543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110100146|NCT01752543|Natriuretic Agents|natriuretic agents|mesh-ancestor
110100147|NCT01752543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110100148|NCT01752686|Carboplatin|carboplatin|mesh-list
110100149|NCT01752686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110100150|NCT01752699|Methadone|methadone|mesh-list
110100151|NCT01752699|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110100152|NCT01752699|Narcotics|narcotics|mesh-ancestor
110100153|NCT01752699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110100154|NCT01752699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110100155|NCT01752699|Analgesics|analgesics|mesh-ancestor
110100156|NCT01752699|Sensory System Agents|sensory system agents|mesh-ancestor
110100157|NCT01752699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110100158|NCT01752699|Antitussive Agents|antitussive agents|mesh-ancestor
110100159|NCT01752699|Respiratory System Agents|respiratory system agents|mesh-ancestor
110100160|NCT01752790|Azathioprine|azathioprine|mesh-list
110100161|NCT01752790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110100162|NCT01752790|Antimetabolites|antimetabolites|mesh-ancestor
110100163|NCT01752790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110100164|NCT01752790|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110100165|NCT01752790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110100166|NCT01752790|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110100167|NCT01752790|Immunologic Factors|immunologic factors|mesh-ancestor
110100168|NCT01752790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110100169|NCT01752881|Vaccines|vaccines|mesh-list
110100170|NCT01752881|Immunologic Factors|immunologic factors|mesh-ancestor
110100171|NCT01752881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110100172|NCT01752959|Remifentanil|remifentanil|mesh-list
110100173|NCT01752959|Esmolol|esmolol|mesh-list
110100174|NCT01752959|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110100175|NCT01752959|Narcotics|narcotics|mesh-ancestor
110100176|NCT01752959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110100177|NCT01752959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110100178|NCT01752959|Analgesics|analgesics|mesh-ancestor
110100179|NCT01752959|Sensory System Agents|sensory system agents|mesh-ancestor
110100180|NCT01752959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110100181|NCT01752959|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110100182|NCT01752959|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110100183|NCT01752959|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110100184|NCT01752959|Adrenergic Agents|adrenergic agents|mesh-ancestor
110100185|NCT01752959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110100186|NCT01752959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110100187|NCT01752998|Analgesics, Opioid|analgesics, opioid|mesh-list
110100188|NCT01752998|Narcotics|narcotics|mesh-ancestor
110100189|NCT01752998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110100190|NCT01752998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110100191|NCT01752998|Analgesics|analgesics|mesh-ancestor
110100192|NCT01752998|Sensory System Agents|sensory system agents|mesh-ancestor
110100193|NCT01752998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110100194|NCT01753037|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
110100195|NCT01753037|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110100196|NCT01753037|Immunologic Factors|immunologic factors|mesh-ancestor
110100197|NCT01753037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110100198|NCT01753102|Estradiol|estradiol|mesh-list
110100199|NCT01753102|Estrogens|estrogens|mesh-ancestor
110100200|NCT01753102|Hormones|hormones|mesh-ancestor
110100201|NCT01753102|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110100202|NCT01753102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110100203|NCT01753128|Imipramine|imipramine|mesh-list
110100204|NCT01753128|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110100205|NCT01753128|Antidepressive Agents|antidepressive agents|mesh-ancestor
110100206|NCT01753128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110100207|NCT01753128|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110100208|NCT01753128|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110100209|NCT01753128|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110100210|NCT01753128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110100211|NCT01753128|Adrenergic Agents|adrenergic agents|mesh-ancestor
110100212|NCT01753128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110100213|NCT01753128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110100214|NCT01753154|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110100215|NCT01753349|Botulinum Toxins|botulinum toxins|mesh-list
110100216|NCT01753349|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110100217|NCT01753349|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110100218|NCT01753349|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110100219|NCT01753349|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110100220|NCT01753349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110100221|NCT01753349|Cholinergic Agents|cholinergic agents|mesh-ancestor
110100222|NCT01753349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110100223|NCT01753349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110100224|NCT01753349|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110100225|NCT01753349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110100226|NCT01753375|Vitamin D|vitamin d|mesh-list
110100227|NCT01753375|Cholecalciferol|cholecalciferol|mesh-list
110100228|NCT01753375|Vitamins|vitamins|mesh-ancestor
110100229|NCT01753375|Micronutrients|micronutrients|mesh-ancestor
110100230|NCT01753375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110100231|NCT01753375|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110100232|NCT01753375|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110100233|NCT01753453|Plerixafor|plerixafor|mesh-list
110100234|NCT01753453|Lenograstim|lenograstim|mesh-list
110100235|NCT01753453|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110100236|NCT01753453|Immunologic Factors|immunologic factors|mesh-ancestor
110100237|NCT01753453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110100238|NCT01753453|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110100239|NCT01753453|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110100240|NCT01753453|Antiviral Agents|antiviral agents|mesh-ancestor
110100241|NCT01753453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110100242|NCT01753596|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110100243|NCT01753596|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110100244|NCT01753752|Acetylcysteine|acetylcysteine|mesh-list
110100245|NCT01753752|Chitosan|chitosan|mesh-list
110100246|NCT01753752|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110100247|NCT01753752|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110100248|NCT01753752|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110100250|NCT01753752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110100251|NCT01753752|Expectorants|expectorants|mesh-ancestor
110100252|NCT01753752|Respiratory System Agents|respiratory system agents|mesh-ancestor
110100253|NCT01753752|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110100254|NCT01753752|Antioxidants|antioxidants|mesh-ancestor
110100255|NCT01753752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110100256|NCT01753752|Protective Agents|protective agents|mesh-ancestor
110100257|NCT01753752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110100258|NCT01753752|Antidotes|antidotes|mesh-ancestor
110100259|NCT01753752|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110100260|NCT01753752|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110100261|NCT01753752|Antimetabolites|antimetabolites|mesh-ancestor
110100262|NCT01753752|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110100263|NCT01753752|Chelating Agents|chelating agents|mesh-ancestor
110100264|NCT01753752|Sequestering Agents|sequestering agents|mesh-ancestor
110100265|NCT01753752|Hemostatics|hemostatics|mesh-ancestor
110100266|NCT01753752|Coagulants|coagulants|mesh-ancestor
110100267|NCT01753882|Escitalopram|escitalopram|mesh-list
110100268|NCT01753882|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110100269|NCT01753882|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110100270|NCT01753882|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110100271|NCT01753882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110100272|NCT01753882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110100273|NCT01753882|Serotonin Agents|serotonin agents|mesh-ancestor
110100274|NCT01753882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110100275|NCT01754116|Cabotegravir|cabotegravir|mesh-list
110100276|NCT01754116|Midazolam|midazolam|mesh-list
110100277|NCT01754116|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110100278|NCT01754116|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110100279|NCT01754116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110100280|NCT01754116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110100281|NCT01754116|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110100282|NCT01754116|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110100283|NCT01754116|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110100284|NCT01754116|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110100285|NCT01754116|Anesthetics, General|anesthetics, general|mesh-ancestor
110100286|NCT01754116|Anesthetics|anesthetics|mesh-ancestor
110100287|NCT01754116|GABA Modulators|gaba modulators|mesh-ancestor
110100288|NCT01754116|GABA Agents|gaba agents|mesh-ancestor
110100289|NCT01754116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110100290|NCT01754116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110100291|NCT01754116|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110100292|NCT01754116|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110100293|NCT01754116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110100294|NCT01754116|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110100295|NCT01754116|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110100296|NCT01754116|Antiviral Agents|antiviral agents|mesh-ancestor
110100297|NCT01754116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110100298|NCT01754181|Insulin|insulin|mesh-list
110100299|NCT01754181|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110100300|NCT01754181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110100301|NCT01754220|Montelukast|montelukast|mesh-list
110100302|NCT01754220|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110100303|NCT01754220|Respiratory System Agents|respiratory system agents|mesh-ancestor
110100304|NCT01754220|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110100305|NCT01754220|Hormone Antagonists|hormone antagonists|mesh-ancestor
110100306|NCT01754220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110100307|NCT01754220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110100308|NCT01754220|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110100309|NCT01754220|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110216873|NCT00267319|Glatiramer Acetate|glatiramer acetate|mesh-list
110100310|NCT01754220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110100311|NCT01754285|Octreotide|octreotide|mesh-list
110100312|NCT01754285|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110100313|NCT01754285|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110100314|NCT01754285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110100315|NCT01754324|Methadone|methadone|mesh-list
110100316|NCT01754324|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110100317|NCT01754324|Narcotics|narcotics|mesh-ancestor
110100318|NCT01754324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110100319|NCT01754324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110100321|NCT01754324|Sensory System Agents|sensory system agents|mesh-ancestor
110100322|NCT01754324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110100323|NCT01754324|Antitussive Agents|antitussive agents|mesh-ancestor
110100324|NCT01754324|Respiratory System Agents|respiratory system agents|mesh-ancestor
110100325|NCT01754649|Misoprostol|misoprostol|mesh-list
110100326|NCT01754649|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110100327|NCT01754649|Abortifacient Agents|abortifacient agents|mesh-ancestor
110100328|NCT01754649|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110100329|NCT01754649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110100330|NCT01754649|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110100331|NCT01754649|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110100332|NCT01754649|Oxytocics|oxytocics|mesh-ancestor
110100333|NCT01754701|Iron|iron|mesh-list
110100334|NCT01754701|Trace Elements|trace elements|mesh-ancestor
110100335|NCT01754701|Micronutrients|micronutrients|mesh-ancestor
110400116|NCT01311024|Vaccines|vaccines|mesh-list
110100336|NCT01754701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110100337|NCT01754805|Methotrexate|methotrexate|mesh-list
110100338|NCT01754805|Peficitinib|peficitinib|mesh-list
110100339|NCT01754805|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110100340|NCT01754805|Abortifacient Agents|abortifacient agents|mesh-ancestor
110100341|NCT01754805|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110100342|NCT01754805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110100343|NCT01754805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110100344|NCT01754805|Antimetabolites|antimetabolites|mesh-ancestor
110100345|NCT01754805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110100346|NCT01754805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110100347|NCT01754805|Dermatologic Agents|dermatologic agents|mesh-ancestor
110100348|NCT01754805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110100349|NCT01754805|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110100350|NCT01754805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110100351|NCT01754805|Immunologic Factors|immunologic factors|mesh-ancestor
110100352|NCT01754805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110100353|NCT01754805|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110100355|NCT01754831|Fluorides, Topical|fluorides, topical|mesh-list
110100356|NCT01754831|Cariostatic Agents|cariostatic agents|mesh-ancestor
110100357|NCT01754831|Protective Agents|protective agents|mesh-ancestor
110100358|NCT01754831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110100359|NCT01754844|AZD7624|azd7624|mesh-list
110100360|NCT01754844|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110100361|NCT01754844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110100362|NCT01754844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110100363|NCT01754870|Rituximab|rituximab|mesh-list
110100364|NCT01754870|Lenalidomide|lenalidomide|mesh-list
110100365|NCT01754870|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110100366|NCT01754870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110100367|NCT01754870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110100368|NCT01754870|Immunologic Factors|immunologic factors|mesh-ancestor
110100369|NCT01754870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110100370|NCT01754870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110100371|NCT01754870|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110400124|NCT02871193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110100372|NCT01754870|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110100373|NCT01754870|Growth Substances|growth substances|mesh-ancestor
110100374|NCT01754870|Growth Inhibitors|growth inhibitors|mesh-ancestor
110100375|NCT01754870|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110100376|NCT01754870|Alkylating Agents|alkylating agents|mesh-ancestor
110100377|NCT01754870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110100378|NCT01754883|Lithium Carbonate|lithium carbonate|mesh-list
110100379|NCT01754883|Antidepressive Agents|antidepressive agents|mesh-ancestor
110100380|NCT01754883|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110100381|NCT01754883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110100382|NCT01754883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110100383|NCT01754883|Antimanic Agents|antimanic agents|mesh-ancestor
110100384|NCT01754883|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110100385|NCT01754883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110100386|NCT01754883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110100387|NCT01754961|Vitamin D|vitamin d|mesh-list
110100388|NCT01754961|Ergocalciferols|ergocalciferols|mesh-list
110100389|NCT01754961|Cholecalciferol|cholecalciferol|mesh-list
110100390|NCT01754961|Vitamins|vitamins|mesh-list
110100391|NCT01754961|Micronutrients|micronutrients|mesh-ancestor
110100392|NCT01754961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110100393|NCT01754961|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110100394|NCT01754961|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110100395|NCT01754974|Ribavirin|ribavirin|mesh-list
110100396|NCT01754974|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110100397|NCT01754974|Antimetabolites|antimetabolites|mesh-ancestor
110100398|NCT01754974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110100399|NCT01754974|Antiviral Agents|antiviral agents|mesh-ancestor
110100400|NCT01754974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110100401|NCT01755078|Calcium, Dietary|calcium, dietary|mesh-list
110100402|NCT01755078|Calcium Carbonate|calcium carbonate|mesh-list
110100403|NCT01755078|Calcium|calcium|mesh-list
110100404|NCT01755078|Sevelamer|sevelamer|mesh-list
110100405|NCT01755078|Calcium acetate|calcium acetate|mesh-list
110100406|NCT01755078|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110100407|NCT01755078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110100408|NCT01755078|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110100409|NCT01755078|Antacids|antacids|mesh-ancestor
110100410|NCT01755078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110100411|NCT01755078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110100412|NCT01755078|Chelating Agents|chelating agents|mesh-ancestor
110100413|NCT01755078|Sequestering Agents|sequestering agents|mesh-ancestor
110100414|NCT01755117|Ropivacaine|ropivacaine|mesh-list
110100415|NCT01755117|Anesthetics, Local|anesthetics, local|mesh-ancestor
110100416|NCT01755117|Anesthetics|anesthetics|mesh-ancestor
110100417|NCT01755117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110100418|NCT01755117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110100419|NCT01755117|Sensory System Agents|sensory system agents|mesh-ancestor
110100420|NCT01755117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110100421|NCT01755182|Somatostatin|somatostatin|mesh-list
110100422|NCT01755182|Hormones|hormones|mesh-ancestor
110100423|NCT01755182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110100424|NCT01755182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110100425|NCT01755286|Ciprofloxacin|ciprofloxacin|mesh-list
110100426|NCT01755286|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110100427|NCT01755286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110100428|NCT01755286|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110100429|NCT01755286|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110100430|NCT01755286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110100431|NCT01755286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110100432|NCT01755286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110100433|NCT01755286|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110100434|NCT01755286|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110100435|NCT01755299|Caffeine|caffeine|mesh-list
110400163|NCT01005901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110100436|NCT01755299|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110100437|NCT01755299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110100438|NCT01755299|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110400172|NCT02889549|Purinergic Agents|purinergic agents|mesh-ancestor
110100440|NCT01755299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110100441|NCT01755299|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110100443|NCT01755299|Purinergic Agents|purinergic agents|mesh-ancestor
110100444|NCT01755299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110100446|NCT01755338|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110100447|NCT01755338|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110100448|NCT01755338|Prednisolone|prednisolone|mesh-list
110100449|NCT01755338|Prednisolone acetate|prednisolone acetate|mesh-list
110100450|NCT01755338|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110100451|NCT01755338|Prednisolone phosphate|prednisolone phosphate|mesh-list
110100452|NCT01755338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110100453|NCT01755338|Antiemetics|antiemetics|mesh-ancestor
110100454|NCT01755338|Autonomic Agents|autonomic agents|mesh-ancestor
110100455|NCT01755338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110100456|NCT01755338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110100457|NCT01755338|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110100459|NCT01755338|Hormones|hormones|mesh-ancestor
110100460|NCT01755338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110100461|NCT01755338|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110100462|NCT01755338|Protective Agents|protective agents|mesh-ancestor
110100463|NCT01755338|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110100464|NCT01755338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110100465|NCT01755377|Benzonidazole|benzonidazole|mesh-list
110100466|NCT01755377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110100467|NCT01755377|Immunologic Factors|immunologic factors|mesh-ancestor
110100468|NCT01755377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110100469|NCT01755377|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
110100470|NCT01755377|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110100471|NCT01755377|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110100472|NCT01755377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110100474|NCT01755403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110100475|NCT01755403|Immunologic Factors|immunologic factors|mesh-ancestor
110100476|NCT01755403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110100477|NCT01755403|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
110100478|NCT01755403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110100479|NCT01755403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110100480|NCT01755403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110100481|NCT01755468|Insulin|insulin|mesh-list
110100482|NCT01755468|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110100483|NCT01755468|Metformin|metformin|mesh-list
110100484|NCT01755468|Insulin Glargine|insulin glargine|mesh-list
110100485|NCT01755468|Insulin Lispro|insulin lispro|mesh-list
110100486|NCT01755468|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110100487|NCT01755468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110100488|NCT01755494|Metformin|metformin|mesh-list
110100489|NCT01755494|Saxagliptin|saxagliptin|mesh-list
110100490|NCT01755494|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110100491|NCT01755494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110100492|NCT01755494|Incretins|incretins|mesh-ancestor
110100493|NCT01755494|Hormones|hormones|mesh-ancestor
110100494|NCT01755494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110100495|NCT01755494|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110100496|NCT01755494|Protease Inhibitors|protease inhibitors|mesh-ancestor
110100497|NCT01755494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110100498|NCT01755494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110100499|NCT01755520|Aspirin|aspirin|mesh-list
110100500|NCT01755520|Ticagrelor|ticagrelor|mesh-list
110100501|NCT01755520|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110100502|NCT01755520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110100503|NCT01755520|Analgesics|analgesics|mesh-ancestor
110100504|NCT01755520|Sensory System Agents|sensory system agents|mesh-ancestor
110100505|NCT01755520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110216899|NCT00267553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110100506|NCT01755520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110100507|NCT01755520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110100508|NCT01755520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110100509|NCT01755520|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110100510|NCT01755520|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110100511|NCT01755520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110100512|NCT01755520|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110100513|NCT01755520|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110100514|NCT01755520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110100515|NCT01755520|Antipyretics|antipyretics|mesh-ancestor
110100516|NCT01755520|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110100517|NCT01755520|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110100518|NCT01755520|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110100519|NCT01755520|Purinergic Agents|purinergic agents|mesh-ancestor
110100520|NCT01755520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110100521|NCT01755559|Artesunate|artesunate|mesh-list
110100522|NCT01755559|Lumefantrine|lumefantrine|mesh-list
110100523|NCT01755559|Artemether|artemether|mesh-list
110100524|NCT01755559|Piperaquine|piperaquine|mesh-list
110100525|NCT01755559|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
110100526|NCT01755559|Amodiaquine|amodiaquine|mesh-list
110100527|NCT01755559|Artenimol|artenimol|mesh-list
110100528|NCT01755559|Antimalarials|antimalarials|mesh-ancestor
110100529|NCT01755559|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110160950|NCT00102388|Vildagliptin|vildagliptin|mesh-list
110100530|NCT01755559|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110100531|NCT01755559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110100532|NCT01755559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110100533|NCT01755559|Antiviral Agents|antiviral agents|mesh-ancestor
110100534|NCT01755559|Schistosomicides|schistosomicides|mesh-ancestor
110100535|NCT01755559|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110100536|NCT01755559|Anthelmintics|anthelmintics|mesh-ancestor
110100538|NCT01755572|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110100539|NCT01755572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110100540|NCT01755572|Incretins|incretins|mesh-ancestor
110100541|NCT01755572|Hormones|hormones|mesh-ancestor
110100542|NCT01755572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110100543|NCT01755611|Minocycline|minocycline|mesh-list
110100544|NCT01755611|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110100545|NCT01755611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110100547|NCT01755663|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110100548|NCT01755663|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110100549|NCT01755663|Sympatholytics|sympatholytics|mesh-ancestor
110100550|NCT01755663|Autonomic Agents|autonomic agents|mesh-ancestor
110100551|NCT01755663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110100552|NCT01755663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110100553|NCT01755663|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110100554|NCT01755663|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110100555|NCT01755663|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110100556|NCT01755663|Adrenergic Agents|adrenergic agents|mesh-ancestor
110100557|NCT01755663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110100558|NCT01755663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110100559|NCT01754792|Inositol|inositol|mesh-list
110100560|NCT01754792|Vitamin B Complex|vitamin b complex|mesh-ancestor
110100561|NCT01754792|Vitamins|vitamins|mesh-ancestor
110100562|NCT01754792|Micronutrients|micronutrients|mesh-ancestor
110100563|NCT01754792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110100564|NCT01755676|Orlistat|orlistat|mesh-list
110100565|NCT01755676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110100566|NCT01755676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110100567|NCT01755676|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110100568|NCT01755676|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110100569|NCT01755728|Acetaminophen|acetaminophen|mesh-list
110100570|NCT01755728|Ibuprofen|ibuprofen|mesh-list
110100571|NCT01755728|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110100572|NCT01755728|Analgesics|analgesics|mesh-ancestor
110100573|NCT01755728|Sensory System Agents|sensory system agents|mesh-ancestor
110216913|NCT00106548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110100574|NCT01755728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110100575|NCT01755728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110100577|NCT01755728|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110100578|NCT01755728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110100579|NCT01755728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110100580|NCT01755728|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110100581|NCT01755728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110100582|NCT01755728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110100583|NCT01755845|Paclitaxel|paclitaxel|mesh-list
110100584|NCT01755845|Cisplatin|cisplatin|mesh-list
110100585|NCT01755845|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110100586|NCT01755845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110100587|NCT01755845|Tubulin Modulators|tubulin modulators|mesh-ancestor
110100588|NCT01755845|Antimitotic Agents|antimitotic agents|mesh-ancestor
110100589|NCT01755845|Mitosis Modulators|mitosis modulators|mesh-ancestor
110100590|NCT01755845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110100591|NCT01755871|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
110100592|NCT01755871|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
110100593|NCT01755871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110100594|NCT01755871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110100595|NCT01755871|Immunologic Factors|immunologic factors|mesh-ancestor
110100596|NCT01755871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110100597|NCT01755884|Immunomodulating Agents|immunomodulating agents|mesh-list
110100598|NCT01755884|Immunologic Factors|immunologic factors|mesh-ancestor
110100599|NCT01755884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110100600|NCT01755923|Docetaxel|docetaxel|mesh-list
110100601|NCT01755923|Gefitinib|gefitinib|mesh-list
110100602|NCT01755923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110100603|NCT01755923|Tubulin Modulators|tubulin modulators|mesh-ancestor
110100604|NCT01755923|Antimitotic Agents|antimitotic agents|mesh-ancestor
110100605|NCT01755923|Mitosis Modulators|mitosis modulators|mesh-ancestor
110100606|NCT01755923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110100607|NCT01755923|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110100608|NCT01755923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110100609|NCT01756040|Lactulose|lactulose|mesh-list
110100610|NCT01756040|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110100611|NCT01756040|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110100612|NCT01756105|Insulin|insulin|mesh-list
110100613|NCT01756105|Metformin|metformin|mesh-list
110100614|NCT01756105|Insulin, Isophane|insulin, isophane|mesh-list
110100615|NCT01756105|Isophane Insulin, Human|isophane insulin, human|mesh-list
110100616|NCT01756105|Isophane insulin, beef|isophane insulin, beef|mesh-list
110100617|NCT01756105|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110100618|NCT01756105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110100619|NCT01756131|Cabotegravir|cabotegravir|mesh-list
110100620|NCT01756131|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110100621|NCT01756131|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110100622|NCT01756131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110100623|NCT01756131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110100624|NCT01756131|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110100625|NCT01756131|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110100626|NCT01756131|Antiviral Agents|antiviral agents|mesh-ancestor
110100627|NCT01756131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110100628|NCT01756170|Paclitaxel|paclitaxel|mesh-list
110100629|NCT01756170|Cisplatin|cisplatin|mesh-list
110100630|NCT01756170|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110100631|NCT01756170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110100632|NCT01756170|Tubulin Modulators|tubulin modulators|mesh-ancestor
110100633|NCT01756170|Antimitotic Agents|antimitotic agents|mesh-ancestor
110100634|NCT01756170|Mitosis Modulators|mitosis modulators|mesh-ancestor
110260157|NCT00145301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110100635|NCT01756170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110100637|NCT01756183|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110100638|NCT01756183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110216922|NCT00106548|Immunologic Factors|immunologic factors|mesh-ancestor
110100639|NCT01756183|Tubulin Modulators|tubulin modulators|mesh-ancestor
110100640|NCT01756183|Antimitotic Agents|antimitotic agents|mesh-ancestor
110100641|NCT01756183|Mitosis Modulators|mitosis modulators|mesh-ancestor
110100642|NCT01756183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110100643|NCT01756261|Aflibercept|aflibercept|mesh-list
110100644|NCT01756261|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110100645|NCT01756261|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110100646|NCT01756261|Growth Substances|growth substances|mesh-ancestor
110100647|NCT01756261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110100648|NCT01756261|Growth Inhibitors|growth inhibitors|mesh-ancestor
110100649|NCT01756261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110100650|NCT01756404|Canagliflozin|canagliflozin|mesh-list
110100651|NCT01756404|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110368557|NCT01165216|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110100652|NCT01756404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110100653|NCT01756404|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110100654|NCT01756404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110100656|NCT01756417|Canagliflozin|canagliflozin|mesh-list
110100657|NCT01756417|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110100658|NCT01756417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110100659|NCT01756417|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110100660|NCT01756417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110100661|NCT01756430|Carvedilol|carvedilol|mesh-list
110100662|NCT01756430|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110100663|NCT01756430|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110100664|NCT01756430|Adrenergic Agents|adrenergic agents|mesh-ancestor
110100665|NCT01756430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110100666|NCT01756430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110100667|NCT01756430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110100668|NCT01756430|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110100669|NCT01756430|Antioxidants|antioxidants|mesh-ancestor
110100670|NCT01756430|Protective Agents|protective agents|mesh-ancestor
110100671|NCT01756430|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110100672|NCT01756430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110100673|NCT01756430|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110100674|NCT01756430|Vasodilator Agents|vasodilator agents|mesh-ancestor
110100675|NCT01756430|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110100676|NCT01756430|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110100677|NCT01756443|Lidocaine|lidocaine|mesh-list
110100678|NCT01756443|Epinephrine|epinephrine|mesh-list
110100679|NCT01756443|Racepinephrine|racepinephrine|mesh-list
110100680|NCT01756443|Bupivacaine|bupivacaine|mesh-list
110100681|NCT01756443|Epinephryl borate|epinephryl borate|mesh-list
110100682|NCT01756443|Anesthetics, Local|anesthetics, local|mesh-ancestor
110100683|NCT01756443|Anesthetics|anesthetics|mesh-ancestor
110100684|NCT01756443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110100685|NCT01756443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110216933|NCT00267826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110216934|NCT00425620|Amphotericin B|amphotericin b|mesh-list
110100686|NCT01756443|Sensory System Agents|sensory system agents|mesh-ancestor
110100687|NCT01756443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110100688|NCT01756443|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110100689|NCT01756443|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110100690|NCT01756443|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110100691|NCT01756443|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110100692|NCT01756443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110100693|NCT01756443|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110100694|NCT01756443|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110100695|NCT01756443|Adrenergic Agents|adrenergic agents|mesh-ancestor
110100696|NCT01756443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110100697|NCT01756443|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110100698|NCT01756443|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110100700|NCT01756443|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110100701|NCT01756443|Respiratory System Agents|respiratory system agents|mesh-ancestor
110400277|NCT01264887|Analgesics|analgesics|mesh-ancestor
110100703|NCT01756443|Sympathomimetics|sympathomimetics|mesh-ancestor
110100704|NCT01756443|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110100705|NCT01756495|Moxifloxacin|moxifloxacin|mesh-list
110100706|NCT01756495|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
110100707|NCT01756495|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110100708|NCT01756495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110100709|NCT01756495|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110100710|NCT01756495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110100711|NCT01756495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110100712|NCT01756495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110100713|NCT01756495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110100714|NCT01756495|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110100715|NCT01756495|Contraceptive Agents|contraceptive agents|mesh-ancestor
110100716|NCT01756495|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110100717|NCT01756495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110100718|NCT01756495|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110100719|NCT01756495|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110100720|NCT01756495|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110100721|NCT01756508|Eculizumab|eculizumab|mesh-list
110100722|NCT01756508|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
110100723|NCT01756508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110100724|NCT01756508|Immunologic Factors|immunologic factors|mesh-ancestor
110100725|NCT01756508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110100726|NCT01756521|Moxifloxacin|moxifloxacin|mesh-list
110100727|NCT01756521|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110100728|NCT01756521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110100729|NCT01756521|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110100730|NCT01756521|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110100731|NCT01756521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110100732|NCT01756521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110100733|NCT01756521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110100734|NCT01756547|Potassium Citrate|potassium citrate|mesh-list
110100735|NCT01756547|Diuretics|diuretics|mesh-ancestor
110100736|NCT01756547|Natriuretic Agents|natriuretic agents|mesh-ancestor
110100737|NCT01756547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110100738|NCT01756547|Expectorants|expectorants|mesh-ancestor
110100739|NCT01756547|Respiratory System Agents|respiratory system agents|mesh-ancestor
110100740|NCT01756612|Epoetin Alfa|epoetin alfa|mesh-list
110100742|NCT01756638|Prednisolone|prednisolone|mesh-list
110100743|NCT01756638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110100744|NCT01756638|Glucocorticoids|glucocorticoids|mesh-ancestor
110100745|NCT01756638|Hormones|hormones|mesh-ancestor
110100746|NCT01756638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110100747|NCT01756638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110100748|NCT01756638|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110100749|NCT01756638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110100751|NCT01756651|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110100752|NCT01756651|Narcotics|narcotics|mesh-ancestor
110100753|NCT01756651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110100754|NCT01756651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110100755|NCT01756651|Analgesics|analgesics|mesh-ancestor
110100756|NCT01756651|Sensory System Agents|sensory system agents|mesh-ancestor
110100757|NCT01756651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110100758|NCT01756651|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110100759|NCT01756651|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110100760|NCT01756651|Anesthetics, General|anesthetics, general|mesh-ancestor
110100761|NCT01756651|Anesthetics|anesthetics|mesh-ancestor
110100762|NCT01756664|Sunscreening Agents|sunscreening agents|mesh-list
110100763|NCT01756664|Petrolatum|petrolatum|mesh-list
110100764|NCT01756664|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110100765|NCT01756664|Protective Agents|protective agents|mesh-ancestor
110100766|NCT01756664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110100767|NCT01756664|Dermatologic Agents|dermatologic agents|mesh-ancestor
110100768|NCT01756664|Emollients|emollients|mesh-ancestor
110100769|NCT01756768|Palbociclib|palbociclib|mesh-list
110100770|NCT01756768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110100771|NCT01756768|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110100772|NCT01756768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110100773|NCT01756768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110100774|NCT01756781|Palbociclib|palbociclib|mesh-list
110100775|NCT01756781|Midazolam|midazolam|mesh-list
110100776|NCT01756781|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110100777|NCT01756781|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110100778|NCT01756781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110100779|NCT01756781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110100780|NCT01756781|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110100781|NCT01756781|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110100782|NCT01756781|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110100783|NCT01756781|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110100784|NCT01756781|Anesthetics, General|anesthetics, general|mesh-ancestor
110100785|NCT01756781|Anesthetics|anesthetics|mesh-ancestor
110100786|NCT01756781|GABA Modulators|gaba modulators|mesh-ancestor
110100787|NCT01756781|GABA Agents|gaba agents|mesh-ancestor
110100788|NCT01756781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110100789|NCT01756781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110100790|NCT01756781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110100791|NCT01756781|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110100792|NCT01756781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110100793|NCT01756989|Thalidomide|thalidomide|mesh-list
110100794|NCT01756989|Celecoxib|celecoxib|mesh-list
110100795|NCT01756989|Etoposide|etoposide|mesh-list
110100796|NCT01756989|Etoposide phosphate|etoposide phosphate|mesh-list
110100797|NCT01756989|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110100798|NCT01756989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110100799|NCT01756989|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110100800|NCT01756989|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110100801|NCT01756989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110368558|NCT04652115|Defibrotide|defibrotide|mesh-list
110100802|NCT01756989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110100803|NCT01756989|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110100804|NCT01756989|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110100805|NCT01756989|Analgesics|analgesics|mesh-ancestor
110100806|NCT01756989|Sensory System Agents|sensory system agents|mesh-ancestor
110100807|NCT01756989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110100808|NCT01756989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110100809|NCT01756989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110100810|NCT01756989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110100811|NCT01756989|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110100812|NCT01756989|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110100813|NCT01756989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110100814|NCT01756989|Immunologic Factors|immunologic factors|mesh-ancestor
110100815|NCT01756989|Leprostatic Agents|leprostatic agents|mesh-ancestor
110100816|NCT01756989|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110100817|NCT01756989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110100818|NCT01756989|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110100819|NCT01756989|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110100820|NCT01756989|Growth Substances|growth substances|mesh-ancestor
110100821|NCT01756989|Growth Inhibitors|growth inhibitors|mesh-ancestor
110100823|NCT01757015|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110100824|NCT01757015|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110100825|NCT01757015|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110100826|NCT01757015|Cholinergic Agents|cholinergic agents|mesh-ancestor
110100827|NCT01757015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110100828|NCT01757015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110100829|NCT01757015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110100830|NCT01757106|Sevoflurane|sevoflurane|mesh-list
110100831|NCT01757106|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110100832|NCT01757106|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110100833|NCT01757106|Anesthetics, General|anesthetics, general|mesh-ancestor
110100834|NCT01757106|Anesthetics|anesthetics|mesh-ancestor
110100835|NCT01757106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110100836|NCT01757106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110100838|NCT01757236|Rifampin|rifampin|mesh-list
110100839|NCT01757236|Clindamycin|clindamycin|mesh-list
110100840|NCT01757236|Ceftriaxone|ceftriaxone|mesh-list
110100841|NCT01757236|Linezolid|linezolid|mesh-list
110100842|NCT01757236|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
110100843|NCT01757236|Fluoroquinolones|fluoroquinolones|mesh-list
110100844|NCT01757236|Trimethoprim|trimethoprim|mesh-list
110100845|NCT01757236|Sulfamethoxazole|sulfamethoxazole|mesh-list
110100846|NCT01757236|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110100847|NCT01757236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110100848|NCT01757236|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110100849|NCT01757236|Antitubercular Agents|antitubercular agents|mesh-ancestor
110100850|NCT01757236|Leprostatic Agents|leprostatic agents|mesh-ancestor
110100851|NCT01757236|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110100852|NCT01757236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110100853|NCT01757236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110100854|NCT01757236|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110100855|NCT01757236|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110100856|NCT01757236|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110100857|NCT01757236|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110100858|NCT01757236|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110100859|NCT01757236|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110100860|NCT01757236|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110100861|NCT01757236|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110100862|NCT01757236|Antimalarials|antimalarials|mesh-ancestor
110100863|NCT01757236|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110100864|NCT01757236|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110100865|NCT01757236|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110100866|NCT01757236|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110100867|NCT01757236|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
110100868|NCT01757236|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110100869|NCT01757249|Contraceptive Agents|contraceptive agents|mesh-list
110100870|NCT01757249|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
110100871|NCT01757249|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
110100872|NCT01757249|Contraceptives, Oral|contraceptives, oral|mesh-list
110100873|NCT01757249|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
110100874|NCT01757249|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110100875|NCT01757249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110100876|NCT01757249|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110100877|NCT01757249|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110100878|NCT01757249|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110100879|NCT01757249|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110100880|NCT01757249|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
110100881|NCT01757249|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
110216983|NCT00268216|Fluticasone|fluticasone|mesh-list
110100882|NCT01757249|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
110100883|NCT01757262|Clopidogrel|clopidogrel|mesh-list
110100884|NCT01757262|Ticagrelor|ticagrelor|mesh-list
110100885|NCT01757262|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110100886|NCT01757262|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110100887|NCT01757262|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110100888|NCT01757262|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110100889|NCT01757262|Purinergic Agents|purinergic agents|mesh-ancestor
110100890|NCT01757262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110100891|NCT01757262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110100892|NCT01757262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110100893|NCT01757366|Ginsenoside Rg3|ginsenoside rg3|mesh-list
110100894|NCT01757366|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110100895|NCT01757366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110100896|NCT01757431|Eculizumab|eculizumab|mesh-list
110100897|NCT01757431|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
110100898|NCT01757431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110100899|NCT01757431|Immunologic Factors|immunologic factors|mesh-ancestor
110100900|NCT01757431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110100901|NCT01757457|Abciximab|abciximab|mesh-list
110100902|NCT01757457|Anticoagulants|anticoagulants|mesh-ancestor
110100903|NCT01757457|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110100904|NCT01757574|Alemtuzumab|alemtuzumab|mesh-list
110100905|NCT01757574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110100906|NCT01757574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110100907|NCT01757587|Insulin|insulin|mesh-list
110100908|NCT01757587|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110100909|NCT01757587|Metformin|metformin|mesh-list
110100910|NCT01757587|Vildagliptin|vildagliptin|mesh-list
110100911|NCT01757587|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110100912|NCT01757587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110100913|NCT01757587|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110100915|NCT01757587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110100916|NCT01757587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110100917|NCT01757639|Ipilimumab|ipilimumab|mesh-list
110100918|NCT01757639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110100919|NCT01757639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110100920|NCT01757639|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110100921|NCT01757639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110100922|NCT01757756|Midazolam|midazolam|mesh-list
110100923|NCT01757756|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110100924|NCT01757756|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110100925|NCT01757756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110100926|NCT01757756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110100927|NCT01757756|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110100928|NCT01757756|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110100929|NCT01757756|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110100930|NCT01757756|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110100931|NCT01757756|Anesthetics, General|anesthetics, general|mesh-ancestor
110100932|NCT01757756|Anesthetics|anesthetics|mesh-ancestor
110100933|NCT01757756|GABA Modulators|gaba modulators|mesh-ancestor
110100934|NCT01757756|GABA Agents|gaba agents|mesh-ancestor
110100935|NCT01757756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110100936|NCT01757756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110100937|NCT01757769|Silodosin|silodosin|mesh-list
110100938|NCT01757769|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110100939|NCT01757769|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110100940|NCT01757769|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110100941|NCT01757769|Adrenergic Agents|adrenergic agents|mesh-ancestor
110100942|NCT01757769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110100943|NCT01757769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110100944|NCT01757769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110100945|NCT01757769|Urological Agents|urological agents|mesh-ancestor
110100947|NCT01757795|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110100948|NCT01757795|Protective Agents|protective agents|mesh-ancestor
110100949|NCT01757795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110100950|NCT01757808|Ranolazine|ranolazine|mesh-list
110100951|NCT01757808|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110100952|NCT01757808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110100953|NCT01757808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110100955|NCT01757860|Vitamins|vitamins|mesh-ancestor
110100956|NCT01757860|Micronutrients|micronutrients|mesh-ancestor
110100957|NCT01757860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110100958|NCT01757860|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110100959|NCT01757899|Methylprednisolone|methylprednisolone|mesh-list
110100960|NCT01757899|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110100961|NCT01757899|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110100962|NCT01757899|Prednisolone|prednisolone|mesh-list
110100963|NCT01757899|Prednisolone acetate|prednisolone acetate|mesh-list
110100964|NCT01757899|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110100965|NCT01757899|Prednisolone phosphate|prednisolone phosphate|mesh-list
110100966|NCT01757899|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110100967|NCT01757899|Antiemetics|antiemetics|mesh-ancestor
110100968|NCT01757899|Autonomic Agents|autonomic agents|mesh-ancestor
110100969|NCT01757899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110100970|NCT01757899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110100971|NCT01757899|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110100972|NCT01757899|Glucocorticoids|glucocorticoids|mesh-ancestor
110100973|NCT01757899|Hormones|hormones|mesh-ancestor
110100974|NCT01757899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110100975|NCT01757899|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110100976|NCT01757899|Protective Agents|protective agents|mesh-ancestor
110100977|NCT01757899|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110100978|NCT01757899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110100979|NCT01758029|Methyltestosterone|methyltestosterone|mesh-list
110100980|NCT01758029|Testosterone|testosterone|mesh-list
110100981|NCT01758029|Testosterone undecanoate|testosterone undecanoate|mesh-list
110100982|NCT01758029|Testosterone enanthate|testosterone enanthate|mesh-list
110100983|NCT01758029|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
110100984|NCT01758029|Androgens|androgens|mesh-ancestor
110100985|NCT01758029|Hormones|hormones|mesh-ancestor
110100986|NCT01758029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110100987|NCT01758029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110100988|NCT01758029|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110100989|NCT01758029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110100990|NCT01758029|Anabolic Agents|anabolic agents|mesh-ancestor
110100991|NCT01758094|Testosterone|testosterone|mesh-list
110100992|NCT01758094|Androgens|androgens|mesh-ancestor
110100993|NCT01758094|Hormones|hormones|mesh-ancestor
110100994|NCT01758094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110100995|NCT01758094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110100996|NCT01758107|Cyclosporine|cyclosporine|mesh-list
110100997|NCT01758107|Cyclosporins|cyclosporins|mesh-list
110100998|NCT01758107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110100999|NCT01758107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110101000|NCT01758107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110101001|NCT01758107|Immunologic Factors|immunologic factors|mesh-ancestor
110101002|NCT01758107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110101003|NCT01758107|Antifungal Agents|antifungal agents|mesh-ancestor
110101004|NCT01758107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110101005|NCT01758107|Dermatologic Agents|dermatologic agents|mesh-ancestor
110101006|NCT01758107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110101007|NCT01758107|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110101008|NCT01758120|Prednisone|prednisone|mesh-list
110101009|NCT01758120|Cyclophosphamide|cyclophosphamide|mesh-list
110101010|NCT01758120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110101011|NCT01758120|Immunologic Factors|immunologic factors|mesh-ancestor
110101012|NCT01758120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110101013|NCT01758120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110101014|NCT01758120|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110101015|NCT01758120|Alkylating Agents|alkylating agents|mesh-ancestor
110101016|NCT01758120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110101017|NCT01758120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110160981|NCT00006428|Amitriptyline|amitriptyline|mesh-list
110101019|NCT01758120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110101020|NCT01758120|Glucocorticoids|glucocorticoids|mesh-ancestor
110101021|NCT01758120|Hormones|hormones|mesh-ancestor
110101022|NCT01758120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110101023|NCT01758120|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110101024|NCT01758146|Tamoxifen|tamoxifen|mesh-list
110101025|NCT01758146|Letrozole|letrozole|mesh-list
110101026|NCT01758146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110101027|NCT01758146|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110101028|NCT01758146|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110101029|NCT01758146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110101030|NCT01758146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110101031|NCT01758146|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110101032|NCT01758146|Hormone Antagonists|hormone antagonists|mesh-ancestor
110101033|NCT01758146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110101034|NCT01758146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110101035|NCT01758146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110101036|NCT01758146|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110101037|NCT01758146|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110101038|NCT01758146|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110101039|NCT01758172|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
110101040|NCT01758172|Plasma Substitutes|plasma substitutes|mesh-ancestor
110101041|NCT01758172|Blood Substitutes|blood substitutes|mesh-ancestor
110101042|NCT01758185|Vaccines|vaccines|mesh-list
110101043|NCT01758185|Immunologic Factors|immunologic factors|mesh-ancestor
110101044|NCT01758185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110101045|NCT01758198|Methotrexate|methotrexate|mesh-list
110101046|NCT01758198|Abatacept|abatacept|mesh-list
110101047|NCT01758198|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110101048|NCT01758198|Abortifacient Agents|abortifacient agents|mesh-ancestor
110101049|NCT01758198|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110101050|NCT01758198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110101051|NCT01758198|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110101052|NCT01758198|Antimetabolites|antimetabolites|mesh-ancestor
110101053|NCT01758198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110101054|NCT01758198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110101055|NCT01758198|Dermatologic Agents|dermatologic agents|mesh-ancestor
110101056|NCT01758198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110101057|NCT01758198|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110101058|NCT01758198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110101059|NCT01758198|Immunologic Factors|immunologic factors|mesh-ancestor
110101060|NCT01758198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110101061|NCT01758198|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110101062|NCT01758198|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110101063|NCT01758198|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110101064|NCT01758263|Metoprolol|metoprolol|mesh-list
110101065|NCT01758263|Nebivolol|nebivolol|mesh-list
110101066|NCT01758263|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110101067|NCT01758263|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110101068|NCT01758263|Sympatholytics|sympatholytics|mesh-ancestor
110101069|NCT01758263|Autonomic Agents|autonomic agents|mesh-ancestor
110101070|NCT01758263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110101071|NCT01758263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110101072|NCT01758263|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110101073|NCT01758263|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110101074|NCT01758263|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110101076|NCT01758263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110101077|NCT01758263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110101078|NCT01758263|Vasodilator Agents|vasodilator agents|mesh-ancestor
110101079|NCT01758263|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
110101080|NCT01758263|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110101081|NCT01758263|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110101082|NCT01758367|Decitabine|decitabine|mesh-list
110101083|NCT01758367|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110101084|NCT01758367|Antimetabolites|antimetabolites|mesh-ancestor
110101085|NCT01758367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110101086|NCT01758367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110101087|NCT01758367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110101089|NCT01758380|Vildagliptin|vildagliptin|mesh-list
110101090|NCT01758380|Gliclazide|gliclazide|mesh-list
110101091|NCT01758380|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110101092|NCT01758380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110101093|NCT01758380|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110101094|NCT01758380|Protease Inhibitors|protease inhibitors|mesh-ancestor
110101095|NCT01758380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110101096|NCT01758380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110101097|NCT01758393|Prednisone|prednisone|mesh-list
110101098|NCT01758393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110101099|NCT01758393|Glucocorticoids|glucocorticoids|mesh-ancestor
110101100|NCT01758393|Hormones|hormones|mesh-ancestor
110101101|NCT01758393|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110101102|NCT01758393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110101103|NCT01758393|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110101104|NCT01758393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110101105|NCT01758471|Acarbose|acarbose|mesh-list
110101106|NCT01758471|Glipizide|glipizide|mesh-list
110101107|NCT01758471|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
110101108|NCT01758471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110101109|NCT01758471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110101110|NCT01758471|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110101111|NCT01758471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110101112|NCT01758627|Icodextrin|icodextrin|mesh-list
110101113|NCT01758627|Dialysis Solutions|dialysis solutions|mesh-ancestor
110101114|NCT01758627|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110101115|NCT01758640|Warfarin|warfarin|mesh-list
110101116|NCT01758640|Phenindione|phenindione|mesh-list
110101117|NCT01758640|Anticoagulants|anticoagulants|mesh-ancestor
110101118|NCT01758666|Leucovorin|leucovorin|mesh-list
110101119|NCT01758666|Methotrexate|methotrexate|mesh-list
110101120|NCT01758666|Calcium|calcium|mesh-list
110101121|NCT01758666|Levoleucovorin|levoleucovorin|mesh-list
110101122|NCT01758666|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110101123|NCT01758666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110101124|NCT01758666|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110101125|NCT01758666|Abortifacient Agents|abortifacient agents|mesh-ancestor
110101126|NCT01758666|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110101127|NCT01758666|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110101128|NCT01758666|Antimetabolites|antimetabolites|mesh-ancestor
110101129|NCT01758666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110101130|NCT01758666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110101131|NCT01758666|Dermatologic Agents|dermatologic agents|mesh-ancestor
110101132|NCT01758666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110101133|NCT01758666|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110101134|NCT01758666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110101135|NCT01758666|Immunologic Factors|immunologic factors|mesh-ancestor
110101136|NCT01758666|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110101137|NCT01758666|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110101139|NCT01758666|Protective Agents|protective agents|mesh-ancestor
110101140|NCT01758666|Vitamin B Complex|vitamin b complex|mesh-ancestor
110101141|NCT01758666|Vitamins|vitamins|mesh-ancestor
110101142|NCT01758666|Micronutrients|micronutrients|mesh-ancestor
110101143|NCT01758744|Treprostinil|treprostinil|mesh-list
110101144|NCT01758744|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110101145|NCT01758809|Bupivacaine|bupivacaine|mesh-list
110101146|NCT01758809|Anesthetics, Local|anesthetics, local|mesh-ancestor
110101147|NCT01758809|Anesthetics|anesthetics|mesh-ancestor
110101148|NCT01758809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110101149|NCT01758809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110101150|NCT01758809|Sensory System Agents|sensory system agents|mesh-ancestor
110101151|NCT01758809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110101152|NCT01758835|Calpastatin|calpastatin|mesh-list
110101153|NCT01758835|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
110101154|NCT01758835|Protease Inhibitors|protease inhibitors|mesh-ancestor
110101155|NCT01758835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110101156|NCT01758835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110101157|NCT01758913|Ibuprofen|ibuprofen|mesh-list
110101158|NCT01758913|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110101159|NCT01758913|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110101160|NCT01758913|Analgesics|analgesics|mesh-ancestor
110101161|NCT01758913|Sensory System Agents|sensory system agents|mesh-ancestor
110101162|NCT01758913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110101163|NCT01758913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110101164|NCT01758913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110101165|NCT01758913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110101166|NCT01758913|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110101167|NCT01758913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110101168|NCT01758913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110101169|NCT01758978|Hydrocodone|hydrocodone|mesh-list
110101170|NCT01758978|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110101171|NCT01758978|Narcotics|narcotics|mesh-ancestor
110101172|NCT01758978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110101173|NCT01758978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110101174|NCT01758978|Analgesics|analgesics|mesh-ancestor
110101175|NCT01758978|Sensory System Agents|sensory system agents|mesh-ancestor
110101176|NCT01758978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110101177|NCT01758978|Antitussive Agents|antitussive agents|mesh-ancestor
110101178|NCT01758978|Respiratory System Agents|respiratory system agents|mesh-ancestor
110101179|NCT01759030|Rituximab|rituximab|mesh-list
110101180|NCT01759030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110101181|NCT01759030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110101182|NCT01759030|Immunologic Factors|immunologic factors|mesh-ancestor
110101183|NCT01759030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110101184|NCT01759030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110101185|NCT01759108|Rebamipide|rebamipide|mesh-list
110101186|NCT01759108|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110101187|NCT01759108|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110101188|NCT01759108|Antioxidants|antioxidants|mesh-ancestor
110101189|NCT01759108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110101190|NCT01759108|Protective Agents|protective agents|mesh-ancestor
110101191|NCT01759108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110101192|NCT01759108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110101193|NCT01759394|Maleic acid|maleic acid|mesh-list
110101194|NCT01759394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110101195|NCT01759394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110101196|NCT01759485|Vitamin D|vitamin d|mesh-list
110101197|NCT01759485|Cholecalciferol|cholecalciferol|mesh-list
110101198|NCT01759485|Vitamins|vitamins|mesh-ancestor
110101199|NCT01759485|Micronutrients|micronutrients|mesh-ancestor
110101200|NCT01759485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110101201|NCT01759485|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110101202|NCT01759485|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110101203|NCT01759524|Lidocaine|lidocaine|mesh-list
110101204|NCT01759524|Clonidine|clonidine|mesh-list
110101205|NCT01759524|Bupivacaine|bupivacaine|mesh-list
110101206|NCT01759524|Anesthetics, Local|anesthetics, local|mesh-ancestor
110101207|NCT01759524|Anesthetics|anesthetics|mesh-ancestor
110101208|NCT01759524|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110101209|NCT01759524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110101210|NCT01759524|Sensory System Agents|sensory system agents|mesh-ancestor
110101211|NCT01759524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110101212|NCT01759524|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110101213|NCT01759524|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110101214|NCT01759524|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110101215|NCT01759524|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110101216|NCT01759524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110101217|NCT01759524|Analgesics|analgesics|mesh-ancestor
110101218|NCT01759524|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110101219|NCT01759524|Sympatholytics|sympatholytics|mesh-ancestor
110101220|NCT01759524|Autonomic Agents|autonomic agents|mesh-ancestor
110101221|NCT01759524|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110101222|NCT01759524|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110101223|NCT01759524|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110101224|NCT01759524|Adrenergic Agents|adrenergic agents|mesh-ancestor
110101225|NCT01759524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110101226|NCT01759576|Canagliflozin|canagliflozin|mesh-list
110101227|NCT01759576|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110101228|NCT01759576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110101229|NCT01759576|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110101230|NCT01759576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110101231|NCT01759589|Remifentanil|remifentanil|mesh-list
110101232|NCT01759589|Propofol|propofol|mesh-list
110101233|NCT01759589|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
110101234|NCT01759589|Anesthetics|anesthetics|mesh-list
110101235|NCT01759589|Sevoflurane|sevoflurane|mesh-list
110101236|NCT01759589|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110101237|NCT01759589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110101238|NCT01759589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110101239|NCT01759589|Anesthetics, General|anesthetics, general|mesh-ancestor
110101240|NCT01759589|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110101241|NCT01759589|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110101242|NCT01759589|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110101243|NCT01759589|Narcotics|narcotics|mesh-ancestor
110101244|NCT01759589|Analgesics|analgesics|mesh-ancestor
110101245|NCT01759589|Sensory System Agents|sensory system agents|mesh-ancestor
110101246|NCT01759589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110101247|NCT01759706|Dexamethasone|dexamethasone|mesh-list
110101248|NCT01759706|Sufentanil|sufentanil|mesh-list
110101249|NCT01759706|Diazepam|diazepam|mesh-list
110101250|NCT01759706|Ondansetron|ondansetron|mesh-list
110101251|NCT01759706|Anesthetics|anesthetics|mesh-list
110101252|NCT01759706|Ropivacaine|ropivacaine|mesh-list
110101253|NCT01759706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110101254|NCT01759706|Antiemetics|antiemetics|mesh-ancestor
110101255|NCT01759706|Autonomic Agents|autonomic agents|mesh-ancestor
110101256|NCT01759706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110101257|NCT01759706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110101258|NCT01759706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110101259|NCT01759706|Glucocorticoids|glucocorticoids|mesh-ancestor
110101260|NCT01759706|Hormones|hormones|mesh-ancestor
110101261|NCT01759706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110101262|NCT01759706|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110101264|NCT01759706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110101265|NCT01759706|Antipruritics|antipruritics|mesh-ancestor
110101266|NCT01759706|Dermatologic Agents|dermatologic agents|mesh-ancestor
110101267|NCT01759706|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110101268|NCT01759706|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110101269|NCT01759706|Serotonin Agents|serotonin agents|mesh-ancestor
110101270|NCT01759706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110101271|NCT01759706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110101272|NCT01759706|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110101273|NCT01759706|Narcotics|narcotics|mesh-ancestor
110101274|NCT01759706|Analgesics|analgesics|mesh-ancestor
110101275|NCT01759706|Sensory System Agents|sensory system agents|mesh-ancestor
110101276|NCT01759706|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110101277|NCT01759706|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110101278|NCT01759706|Anesthetics, General|anesthetics, general|mesh-ancestor
110101279|NCT01759706|Anesthetics, Local|anesthetics, local|mesh-ancestor
110101280|NCT01759706|Anticonvulsants|anticonvulsants|mesh-ancestor
110101281|NCT01759706|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110101282|NCT01759706|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110101283|NCT01759706|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110101284|NCT01759706|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110101285|NCT01759706|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110101286|NCT01759706|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110101287|NCT01759706|GABA Modulators|gaba modulators|mesh-ancestor
110101288|NCT01759706|GABA Agents|gaba agents|mesh-ancestor
110101290|NCT01759719|Trace Elements|trace elements|mesh-ancestor
110101291|NCT01759719|Micronutrients|micronutrients|mesh-ancestor
110101292|NCT01759719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110101293|NCT01759732|Cyclophosphamide|cyclophosphamide|mesh-list
110101294|NCT01759732|Fludarabine|fludarabine|mesh-list
110101295|NCT01759732|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110101296|NCT01759732|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110101298|NCT01759732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110101299|NCT01759732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110101300|NCT01759732|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110101301|NCT01759732|Alkylating Agents|alkylating agents|mesh-ancestor
110101302|NCT01759732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110101303|NCT01759732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110101304|NCT01759732|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110101305|NCT01759771|Vitamin D|vitamin d|mesh-list
110101306|NCT01759771|Cholecalciferol|cholecalciferol|mesh-list
110101307|NCT01759771|Vitamins|vitamins|mesh-ancestor
110101308|NCT01759771|Micronutrients|micronutrients|mesh-ancestor
110101309|NCT01759771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110400414|NCT01263015|Antiviral Agents|antiviral agents|mesh-ancestor
110101310|NCT01759771|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110101311|NCT01759771|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110101312|NCT01759810|Vaccines|vaccines|mesh-list
110101313|NCT01759810|Immunologic Factors|immunologic factors|mesh-ancestor
110101314|NCT01759810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110101315|NCT01759875|Ritonavir|ritonavir|mesh-list
110101316|NCT01759875|Atazanavir Sulfate|atazanavir sulfate|mesh-list
110101317|NCT01759875|Rabeprazole|rabeprazole|mesh-list
110101318|NCT01759875|Betaine|betaine|mesh-list
110101319|NCT01759875|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110101320|NCT01759875|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110101321|NCT01759875|Protease Inhibitors|protease inhibitors|mesh-ancestor
110101322|NCT01759875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110101323|NCT01759875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110101324|NCT01759875|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110101325|NCT01759875|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110101326|NCT01759875|Antiviral Agents|antiviral agents|mesh-ancestor
110101327|NCT01759875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110101328|NCT01759875|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110101329|NCT01759875|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110217065|NCT00073697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110101330|NCT01759875|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110101331|NCT01759875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110101332|NCT01759875|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110101333|NCT01759875|Lipotropic Agents|lipotropic agents|mesh-ancestor
110101334|NCT01759875|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110101335|NCT01759875|Antimetabolites|antimetabolites|mesh-ancestor
110101336|NCT01759875|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110101337|NCT01759940|Ropivacaine|ropivacaine|mesh-list
110101338|NCT01759940|Anesthetics, Local|anesthetics, local|mesh-ancestor
110101339|NCT01759940|Anesthetics|anesthetics|mesh-ancestor
110101340|NCT01759940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110101341|NCT01759940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110101342|NCT01759940|Sensory System Agents|sensory system agents|mesh-ancestor
110101343|NCT01759940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110101344|NCT01760018|Desflurane|desflurane|mesh-list
110101345|NCT01760018|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110101346|NCT01760018|Anesthetics, General|anesthetics, general|mesh-ancestor
110101347|NCT01760018|Anesthetics|anesthetics|mesh-ancestor
110101348|NCT01760018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110101349|NCT01760018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110101350|NCT01760096|Cyclosporine|cyclosporine|mesh-list
110101351|NCT01760096|Levamisole|levamisole|mesh-list
110101352|NCT01760096|Cyclosporins|cyclosporins|mesh-list
110101353|NCT01760096|Glucocorticoids|glucocorticoids|mesh-list
110101354|NCT01760096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110101355|NCT01760096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110101356|NCT01760096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110101357|NCT01760096|Immunologic Factors|immunologic factors|mesh-ancestor
110101358|NCT01760096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110101359|NCT01760096|Antifungal Agents|antifungal agents|mesh-ancestor
110101360|NCT01760096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110101361|NCT01760096|Dermatologic Agents|dermatologic agents|mesh-ancestor
110101362|NCT01760096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110101363|NCT01760096|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110101364|NCT01760096|Hormones|hormones|mesh-ancestor
110101365|NCT01760096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110101366|NCT01760096|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110101367|NCT01760096|Antinematodal Agents|antinematodal agents|mesh-ancestor
110101368|NCT01760096|Anthelmintics|anthelmintics|mesh-ancestor
110101369|NCT01760096|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110101370|NCT01760109|Piperacillin|piperacillin|mesh-list
110101371|NCT01760109|Sulbactam|sulbactam|mesh-list
110101372|NCT01760109|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110101373|NCT01760109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110101374|NCT01760109|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110101375|NCT01760109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110101376|NCT01760109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110101377|NCT01760122|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110101378|NCT01760122|Antiviral Agents|antiviral agents|mesh-ancestor
110101379|NCT01760122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110101380|NCT01760148|Interferons|interferons|mesh-list
110101381|NCT01760148|Ribavirin|ribavirin|mesh-list
110101382|NCT01760148|Interferon-alpha|interferon-alpha|mesh-list
110101384|NCT01760148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110101385|NCT01760148|Antiviral Agents|antiviral agents|mesh-ancestor
110101386|NCT01760148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110101387|NCT01760148|Antimetabolites|antimetabolites|mesh-ancestor
110101388|NCT01760148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110101389|NCT01760148|Immunologic Factors|immunologic factors|mesh-ancestor
110101390|NCT01760148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110101391|NCT01760161|Ropivacaine|ropivacaine|mesh-list
110101392|NCT01760161|Anesthetics, Local|anesthetics, local|mesh-ancestor
110101393|NCT01760161|Anesthetics|anesthetics|mesh-ancestor
110101394|NCT01760161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110101395|NCT01760161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110101396|NCT01760161|Sensory System Agents|sensory system agents|mesh-ancestor
110217080|NCT00268372|Fluorouracil|fluorouracil|mesh-list
110101397|NCT01760161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110101398|NCT01760174|Bupivacaine|bupivacaine|mesh-list
110101399|NCT01760174|Ropivacaine|ropivacaine|mesh-list
110101400|NCT01760174|Anesthetics, Local|anesthetics, local|mesh-ancestor
110101401|NCT01760174|Anesthetics|anesthetics|mesh-ancestor
110101402|NCT01760174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110101403|NCT01760174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110101404|NCT01760174|Sensory System Agents|sensory system agents|mesh-ancestor
110101405|NCT01760174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110101406|NCT01760226|Prednisone|prednisone|mesh-list
110101407|NCT01760226|Cyclophosphamide|cyclophosphamide|mesh-list
110101408|NCT01760226|Rituximab|rituximab|mesh-list
110101409|NCT01760226|Doxorubicin|doxorubicin|mesh-list
110101410|NCT01760226|Methotrexate|methotrexate|mesh-list
110101411|NCT01760226|Etoposide|etoposide|mesh-list
110101412|NCT01760226|Vincristine|vincristine|mesh-list
110101413|NCT01760226|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110101414|NCT01760226|Immunologic Factors|immunologic factors|mesh-ancestor
110101415|NCT01760226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110101416|NCT01760226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110101417|NCT01760226|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110101418|NCT01760226|Alkylating Agents|alkylating agents|mesh-ancestor
110101419|NCT01760226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110101420|NCT01760226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110101421|NCT01760226|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110101422|NCT01760226|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110101423|NCT01760226|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110101424|NCT01760226|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110101425|NCT01760226|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110101426|NCT01760226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110101427|NCT01760226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110101428|NCT01760226|Glucocorticoids|glucocorticoids|mesh-ancestor
110101429|NCT01760226|Hormones|hormones|mesh-ancestor
110101430|NCT01760226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110101431|NCT01760226|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110101432|NCT01760226|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110101433|NCT01760226|Abortifacient Agents|abortifacient agents|mesh-ancestor
110101434|NCT01760226|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110101435|NCT01760226|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110101436|NCT01760226|Antimetabolites|antimetabolites|mesh-ancestor
110101437|NCT01760226|Dermatologic Agents|dermatologic agents|mesh-ancestor
110101438|NCT01760226|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110101439|NCT01760226|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110101440|NCT01760226|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110101443|NCT01760226|Mitosis Modulators|mitosis modulators|mesh-ancestor
110101444|NCT01760252|Capecitabine|capecitabine|mesh-list
110101445|NCT01760252|Oxaliplatin|oxaliplatin|mesh-list
110101446|NCT01760252|Irinotecan|irinotecan|mesh-list
110101447|NCT01760252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110101448|NCT01760252|Antimetabolites|antimetabolites|mesh-ancestor
110101449|NCT01760252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110101450|NCT01760252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110101451|NCT01760252|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110101452|NCT01760252|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110101453|NCT01760252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110101454|NCT01760278|Cetrorelix|cetrorelix|mesh-list
110101455|NCT01760278|Hormones|hormones|mesh-list
110101456|NCT01760278|Progesterone|progesterone|mesh-list
110101457|NCT01760278|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
110101458|NCT01760278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110101459|NCT01760278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110101460|NCT01760278|Progestins|progestins|mesh-ancestor
110101461|NCT01760278|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110101462|NCT01760278|Fertility Agents|fertility agents|mesh-ancestor
110101463|NCT01760278|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110101464|NCT01760278|Hormone Antagonists|hormone antagonists|mesh-ancestor
110101465|NCT01760330|Acetaminophen|acetaminophen|mesh-list
110101466|NCT01760330|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110101467|NCT01760330|Analgesics|analgesics|mesh-ancestor
110101468|NCT01760330|Sensory System Agents|sensory system agents|mesh-ancestor
110101469|NCT01760330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110101470|NCT01760330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110101471|NCT01760330|Antipyretics|antipyretics|mesh-ancestor
110101472|NCT01760421|Hydroxychloroquine|hydroxychloroquine|mesh-list
110101473|NCT01760421|Antimalarials|antimalarials|mesh-ancestor
110101474|NCT01760421|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110101475|NCT01760421|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110101476|NCT01760421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110101477|NCT01760421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110368559|NCT04652115|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110101478|NCT01760421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110101479|NCT01760421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110101480|NCT01760460|Oxazolidinones|oxazolidinones|mesh-list
110101481|NCT01760460|Anacetrapib|anacetrapib|mesh-list
110101482|NCT01760460|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110101483|NCT01760460|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110101484|NCT01760460|Antimetabolites|antimetabolites|mesh-ancestor
110101485|NCT01760460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110101486|NCT01760460|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110101487|NCT01760460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110101488|NCT01760460|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110101489|NCT01760460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110101490|NCT01760564|Miglustat|miglustat|mesh-list
110101491|NCT01760564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110101492|NCT01760564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110101493|NCT01760564|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110101494|NCT01760564|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110101495|NCT01760564|Antiviral Agents|antiviral agents|mesh-ancestor
110101496|NCT01760564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110101497|NCT01760564|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
110101498|NCT01760564|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110400448|NCT04321785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110101499|NCT01760564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110101500|NCT01760577|Botulinum Toxins|botulinum toxins|mesh-list
110101501|NCT01760577|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110101502|NCT01760577|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110101503|NCT01760577|Hyaluronic Acid|hyaluronic acid|mesh-list
110101504|NCT01760577|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110101505|NCT01760577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110101506|NCT01760577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110101507|NCT01760577|Cholinergic Agents|cholinergic agents|mesh-ancestor
110101508|NCT01760577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110101509|NCT01760577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110101510|NCT01760577|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110101511|NCT01760577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110101512|NCT01760577|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110101513|NCT01760577|Immunologic Factors|immunologic factors|mesh-ancestor
110101514|NCT01760577|Viscosupplements|viscosupplements|mesh-ancestor
110101515|NCT01760577|Protective Agents|protective agents|mesh-ancestor
110101517|NCT01760642|Ketoconazole|ketoconazole|mesh-list
110101519|NCT01760642|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110101520|NCT01760642|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110101521|NCT01760642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110101522|NCT01760642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110101523|NCT01760642|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110101524|NCT01760642|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110101525|NCT01760642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110101526|NCT01760642|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110101527|NCT01760642|Anesthetics, General|anesthetics, general|mesh-ancestor
110101528|NCT01760642|Anesthetics|anesthetics|mesh-ancestor
110101529|NCT01760642|GABA Modulators|gaba modulators|mesh-ancestor
110101530|NCT01760642|GABA Agents|gaba agents|mesh-ancestor
110101531|NCT01760642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110101532|NCT01760642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110101533|NCT01760642|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110101534|NCT01760642|Antitubercular Agents|antitubercular agents|mesh-ancestor
110101535|NCT01760642|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110101536|NCT01760642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110101537|NCT01760642|Leprostatic Agents|leprostatic agents|mesh-ancestor
110101538|NCT01760642|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110101539|NCT01760642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110101540|NCT01760642|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110101541|NCT01760642|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110101542|NCT01760642|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110101543|NCT01760642|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110101544|NCT01760642|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110101545|NCT01760642|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110101546|NCT01760642|Antifungal Agents|antifungal agents|mesh-ancestor
110101547|NCT01760642|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110101548|NCT01760642|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110101549|NCT01760642|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110101550|NCT01760642|Hormone Antagonists|hormone antagonists|mesh-ancestor
110101551|NCT01760642|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110101552|NCT01760642|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110101553|NCT01760694|Leucovorin|leucovorin|mesh-list
110400466|NCT01261611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110101554|NCT01760694|Oxaliplatin|oxaliplatin|mesh-list
110101555|NCT01760694|Irinotecan|irinotecan|mesh-list
110101556|NCT01760694|Folfirinox|folfirinox|mesh-list
110101557|NCT01760694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110101558|NCT01760694|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110101559|NCT01760694|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110101560|NCT01760694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110101561|NCT01760694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110101562|NCT01760694|Antidotes|antidotes|mesh-ancestor
110101563|NCT01760694|Protective Agents|protective agents|mesh-ancestor
110101564|NCT01760694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110101565|NCT01760694|Vitamin B Complex|vitamin b complex|mesh-ancestor
110101566|NCT01760694|Vitamins|vitamins|mesh-ancestor
110101567|NCT01760694|Micronutrients|micronutrients|mesh-ancestor
110101568|NCT01760746|Bevacizumab|bevacizumab|mesh-list
110101569|NCT01760746|Ranibizumab|ranibizumab|mesh-list
110101570|NCT01760746|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110101571|NCT01760746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110101572|NCT01760746|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110101573|NCT01760746|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110101574|NCT01760746|Growth Substances|growth substances|mesh-ancestor
110101575|NCT01760746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110101576|NCT01760746|Growth Inhibitors|growth inhibitors|mesh-ancestor
110101577|NCT01760798|Teriparatide|teriparatide|mesh-list
110161025|NCT00102778|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110101578|NCT01760798|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110101579|NCT01760798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110101580|NCT01760798|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110101581|NCT01760811|Cetuximab|cetuximab|mesh-list
110101582|NCT01760811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110101583|NCT01760811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110101584|NCT01760824|Amoxicillin|amoxicillin|mesh-list
110101585|NCT01760824|Metronidazole|metronidazole|mesh-list
110101586|NCT01760824|Clarithromycin|clarithromycin|mesh-list
110101587|NCT01760824|Tetracycline|tetracycline|mesh-list
110101588|NCT01760824|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
110101589|NCT01760824|Esomeprazole|esomeprazole|mesh-list
110101590|NCT01760824|Bismuth|bismuth|mesh-list
110101591|NCT01760824|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110101592|NCT01760824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110101593|NCT01760824|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110101594|NCT01760824|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110101595|NCT01760824|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110101596|NCT01760824|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110101597|NCT01760824|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110101598|NCT01760824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110101599|NCT01760824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110101600|NCT01760824|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110101601|NCT01760824|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110101602|NCT01760824|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110101603|NCT01760824|Antacids|antacids|mesh-ancestor
110101604|NCT01760863|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110101605|NCT01760863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110101606|NCT01760967|Dexmedetomidine|dexmedetomidine|mesh-list
110101607|NCT01760967|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110101608|NCT01760967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110101609|NCT01760967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110101610|NCT01760967|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110101611|NCT01760967|Analgesics|analgesics|mesh-ancestor
110101612|NCT01760967|Sensory System Agents|sensory system agents|mesh-ancestor
110101613|NCT01760967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110101614|NCT01760967|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110101615|NCT01760967|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110101616|NCT01760967|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110101617|NCT01760967|Adrenergic Agents|adrenergic agents|mesh-ancestor
110101618|NCT01760967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110101619|NCT01760967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110101620|NCT01760980|Exemestane|exemestane|mesh-list
110101621|NCT01760980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110101622|NCT01760980|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110101623|NCT01760980|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110101624|NCT01760980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110101625|NCT01760980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110101627|NCT01760980|Hormone Antagonists|hormone antagonists|mesh-ancestor
110101628|NCT01760980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110101629|NCT01760980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110101630|NCT01761071|Diclofenac|diclofenac|mesh-list
110101631|NCT01761071|Ketorolac|ketorolac|mesh-list
110101632|NCT01761071|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110101633|NCT01761071|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110101634|NCT01761071|Analgesics|analgesics|mesh-ancestor
110101635|NCT01761071|Sensory System Agents|sensory system agents|mesh-ancestor
110101636|NCT01761071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110101637|NCT01761071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110101638|NCT01761071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110101639|NCT01761071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110101640|NCT01761071|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110101641|NCT01761071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110101642|NCT01761071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110101643|NCT01761110|Buprenorphine|buprenorphine|mesh-list
110101644|NCT01761110|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110101645|NCT01761110|Narcotics|narcotics|mesh-ancestor
110101646|NCT01761110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110101647|NCT01761110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110101648|NCT01761110|Analgesics|analgesics|mesh-ancestor
110101649|NCT01761110|Sensory System Agents|sensory system agents|mesh-ancestor
110101650|NCT01761110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110101651|NCT01761110|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110101652|NCT01761149|Remifentanil|remifentanil|mesh-list
110101653|NCT01761149|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110101654|NCT01761149|Narcotics|narcotics|mesh-ancestor
110101655|NCT01761149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110101656|NCT01761149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110101657|NCT01761149|Analgesics|analgesics|mesh-ancestor
110101658|NCT01761149|Sensory System Agents|sensory system agents|mesh-ancestor
110101659|NCT01761149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110101660|NCT01761201|Levofloxacin|levofloxacin|mesh-list
110101662|NCT01761201|Isoniazid|isoniazid|mesh-list
110101663|NCT01761201|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110101664|NCT01761201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110101665|NCT01761201|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110101666|NCT01761201|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110101667|NCT01761201|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110101668|NCT01761201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110101669|NCT01761201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110101670|NCT01761201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110101671|NCT01761201|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110101672|NCT01761201|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110101673|NCT01761201|Antitubercular Agents|antitubercular agents|mesh-ancestor
110101674|NCT01761201|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
110101675|NCT01761201|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110101676|NCT01761201|Antimetabolites|antimetabolites|mesh-ancestor
110101677|NCT01761201|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110101678|NCT01761214|Amoxicillin|amoxicillin|mesh-list
110101679|NCT01761214|Moxifloxacin|moxifloxacin|mesh-list
110101680|NCT01761214|Ciprofloxacin|ciprofloxacin|mesh-list
110101681|NCT01761214|Clavulanic Acid|clavulanic acid|mesh-list
110101682|NCT01761214|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
110101683|NCT01761214|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-list
110101684|NCT01761214|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110101685|NCT01761214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110101686|NCT01761214|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110101687|NCT01761214|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110101688|NCT01761214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110101689|NCT01761214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110101690|NCT01761214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110101691|NCT01761214|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110101692|NCT01761214|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110101693|NCT01761318|Liraglutide|liraglutide|mesh-list
110101694|NCT01761318|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110101695|NCT01761318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110101696|NCT01761318|Incretins|incretins|mesh-ancestor
110101697|NCT01761318|Hormones|hormones|mesh-ancestor
110101698|NCT01761318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110101699|NCT01761344|Hydrocortisone|hydrocortisone|mesh-list
110101700|NCT01761344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110101701|NCT01761461|Oxaliplatin|oxaliplatin|mesh-list
110101702|NCT01761461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110101703|NCT01761487|Gentamicins|gentamicins|mesh-list
110101704|NCT01761487|Polymyxins|polymyxins|mesh-list
110101705|NCT01761487|Colistin|colistin|mesh-list
110101706|NCT01761487|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110101707|NCT01761487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110101708|NCT01761487|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110101709|NCT01761487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110101710|NCT01761487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110101711|NCT01761513|Esomeprazole|esomeprazole|mesh-list
110101712|NCT01761513|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110101713|NCT01761513|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110101714|NCT01761513|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110101715|NCT01761513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110101716|NCT01761513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110101718|NCT01761526|Dopamine Agonists|dopamine agonists|mesh-ancestor
110101719|NCT01761526|Dopamine Agents|dopamine agents|mesh-ancestor
110101720|NCT01761526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110101721|NCT01761526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110101722|NCT01761526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110101723|NCT01761552|Atropine|atropine|mesh-list
110101724|NCT01761552|Neostigmine|neostigmine|mesh-list
110101725|NCT01761552|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110101726|NCT01761552|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110101727|NCT01761552|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110101728|NCT01761552|Autonomic Agents|autonomic agents|mesh-ancestor
110101729|NCT01761552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110101730|NCT01761552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110101731|NCT01761552|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110101732|NCT01761552|Respiratory System Agents|respiratory system agents|mesh-ancestor
110101733|NCT01761552|Mydriatics|mydriatics|mesh-ancestor
110101734|NCT01761552|Parasympatholytics|parasympatholytics|mesh-ancestor
110101735|NCT01761552|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110101736|NCT01761552|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110101737|NCT01761552|Cholinergic Agents|cholinergic agents|mesh-ancestor
110101738|NCT01761552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110101739|NCT01761552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110101740|NCT01761552|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110101741|NCT01761552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110101742|NCT01761552|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110101743|NCT01761656|Atorvastatin|atorvastatin|mesh-list
110101744|NCT01761656|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110101745|NCT01761656|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110101746|NCT01761656|Antimetabolites|antimetabolites|mesh-ancestor
110101747|NCT01761656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110101748|NCT01761656|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110101749|NCT01761656|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110101750|NCT01761656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110101752|NCT01761669|Vitamins|vitamins|mesh-ancestor
110101753|NCT01761669|Micronutrients|micronutrients|mesh-ancestor
110101754|NCT01761669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110101755|NCT01761669|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110101756|NCT01761916|Clonidine|clonidine|mesh-list
110101757|NCT01761916|Captopril|captopril|mesh-list
110101758|NCT01761916|Analgesics|analgesics|mesh-ancestor
110101759|NCT01761916|Sensory System Agents|sensory system agents|mesh-ancestor
110101760|NCT01761916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110101761|NCT01761916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110101762|NCT01761916|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110101763|NCT01761916|Sympatholytics|sympatholytics|mesh-ancestor
110101764|NCT01761916|Autonomic Agents|autonomic agents|mesh-ancestor
110101765|NCT01761916|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110101766|NCT01761916|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110101767|NCT01761916|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110101768|NCT01761916|Adrenergic Agents|adrenergic agents|mesh-ancestor
110101769|NCT01761916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110101770|NCT01761916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110101771|NCT01761916|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110101772|NCT01761916|Protease Inhibitors|protease inhibitors|mesh-ancestor
110101773|NCT01761916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110101774|NCT01761968|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
110101775|NCT01761968|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110101776|NCT01761968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110101777|NCT01761968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110101779|NCT01761994|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110101780|NCT01761994|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110101781|NCT01761994|Analgesics|analgesics|mesh-ancestor
110101782|NCT01761994|Sensory System Agents|sensory system agents|mesh-ancestor
110101783|NCT01761994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110101784|NCT01761994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110101785|NCT01761994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110101786|NCT01761994|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110101787|NCT01761994|Anticoagulants|anticoagulants|mesh-ancestor
110101788|NCT01761994|Protease Inhibitors|protease inhibitors|mesh-ancestor
110101789|NCT01761994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110101790|NCT01761994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110101791|NCT01761994|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
110101792|NCT01761994|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110101793|NCT01761994|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
110101794|NCT01761994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110101795|NCT01761994|Immunologic Factors|immunologic factors|mesh-ancestor
110101797|NCT01762046|Glipizide|glipizide|mesh-list
110101798|NCT01762046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110101799|NCT01762046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110101800|NCT01762150|Gemcitabine|gemcitabine|mesh-list
110101801|NCT01762150|Sorafenib|sorafenib|mesh-list
110101802|NCT01762150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110101803|NCT01762150|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110101804|NCT01762150|Antimetabolites|antimetabolites|mesh-ancestor
110101805|NCT01762150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110101806|NCT01762150|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110101807|NCT01762150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110101808|NCT01762163|Aspirin|aspirin|mesh-list
110101809|NCT01762163|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110101810|NCT01762163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110101811|NCT01762163|Analgesics|analgesics|mesh-ancestor
110101812|NCT01762163|Sensory System Agents|sensory system agents|mesh-ancestor
110101813|NCT01762163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110101814|NCT01762163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110101815|NCT01762163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110101816|NCT01762163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110101817|NCT01762163|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110101818|NCT01762163|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110101819|NCT01762163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110101820|NCT01762163|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110101821|NCT01762163|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110101822|NCT01762163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110101823|NCT01762163|Antipyretics|antipyretics|mesh-ancestor
110101824|NCT01762202|Cyclophosphamide|cyclophosphamide|mesh-list
110101825|NCT01762202|Fludarabine|fludarabine|mesh-list
110101826|NCT01762202|Ofatumumab|ofatumumab|mesh-list
110101827|NCT01762202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110101828|NCT01762202|Immunologic Factors|immunologic factors|mesh-ancestor
110101829|NCT01762202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110101830|NCT01762202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110101831|NCT01762202|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110101832|NCT01762202|Alkylating Agents|alkylating agents|mesh-ancestor
110101833|NCT01762202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110101834|NCT01762202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110101835|NCT01762202|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110101837|NCT01762306|Diclofenac|diclofenac|mesh-list
110101838|NCT01762306|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110101839|NCT01762306|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110101840|NCT01762306|Analgesics|analgesics|mesh-ancestor
110101841|NCT01762306|Sensory System Agents|sensory system agents|mesh-ancestor
110217163|NCT00268567|Prednisone|prednisone|mesh-list
110101842|NCT01762306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110101843|NCT01762306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110101844|NCT01762306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110101845|NCT01762306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110101846|NCT01762306|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110101847|NCT01762306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110101848|NCT01762306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110101849|NCT01762306|Hematinics|hematinics|mesh-ancestor
110101850|NCT01762306|Vitamin B Complex|vitamin b complex|mesh-ancestor
110101852|NCT01762306|Micronutrients|micronutrients|mesh-ancestor
110101853|NCT01762319|Vitamin B 6|vitamin b 6|mesh-list
110101854|NCT01762319|Pyridoxal|pyridoxal|mesh-list
110101855|NCT01762319|Pyridoxine|pyridoxine|mesh-list
110101856|NCT01762319|Misoprostol|misoprostol|mesh-list
110101857|NCT01762319|Vitamins|vitamins|mesh-ancestor
110101858|NCT01762319|Micronutrients|micronutrients|mesh-ancestor
110101859|NCT01762319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110101860|NCT01762319|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110101861|NCT01762319|Abortifacient Agents|abortifacient agents|mesh-ancestor
110101862|NCT01762319|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110101863|NCT01762319|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110101864|NCT01762319|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110101865|NCT01762319|Oxytocics|oxytocics|mesh-ancestor
110101866|NCT01762319|Vitamin B Complex|vitamin b complex|mesh-ancestor
110101867|NCT01762332|Remifentanil|remifentanil|mesh-list
110101868|NCT01762332|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
110101869|NCT01762332|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110101870|NCT01762332|Narcotics|narcotics|mesh-ancestor
110101871|NCT01762332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110101872|NCT01762332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110101873|NCT01762332|Analgesics|analgesics|mesh-ancestor
110101874|NCT01762332|Sensory System Agents|sensory system agents|mesh-ancestor
110101875|NCT01762332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110101876|NCT01762332|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110101877|NCT01762332|Adrenergic Agents|adrenergic agents|mesh-ancestor
110101878|NCT01762332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110101879|NCT01762332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110101880|NCT01762436|Atenolol|atenolol|mesh-list
110101881|NCT01762436|Bisoprolol|bisoprolol|mesh-list
110217166|NCT00268567|Glucocorticoids|glucocorticoids|mesh-ancestor
110217167|NCT00268567|Hormones|hormones|mesh-ancestor
110217169|NCT00268567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110101882|NCT01762436|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110101883|NCT01762436|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110101885|NCT01762436|Autonomic Agents|autonomic agents|mesh-ancestor
110101886|NCT01762436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110101887|NCT01762436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110101888|NCT01762436|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110101889|NCT01762436|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110101890|NCT01762436|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110101891|NCT01762436|Adrenergic Agents|adrenergic agents|mesh-ancestor
110101892|NCT01762436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110101893|NCT01762436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110101895|NCT01762475|Vasodilator Agents|vasodilator agents|mesh-ancestor
110101896|NCT01762475|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110101897|NCT01762475|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110101898|NCT01762475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110101899|NCT01762475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110101900|NCT01762475|Urological Agents|urological agents|mesh-ancestor
110101901|NCT01762514|Amifostine|amifostine|mesh-list
110101902|NCT01762514|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110101903|NCT01762514|Protective Agents|protective agents|mesh-ancestor
110101904|NCT01762514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110101905|NCT01762540|Prednisolone|prednisolone|mesh-list
110101906|NCT01762540|Calcium|calcium|mesh-list
110101907|NCT01762540|Glucocorticoids|glucocorticoids|mesh-list
110101908|NCT01762540|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110101909|NCT01762540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110101910|NCT01762540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110101911|NCT01762540|Hormones|hormones|mesh-ancestor
110101912|NCT01762540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110101913|NCT01762540|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110101914|NCT01762540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110101915|NCT01762644|Cyclosporine|cyclosporine|mesh-list
110101916|NCT01762644|Omeprazole|omeprazole|mesh-list
110101917|NCT01762644|Cyclosporins|cyclosporins|mesh-list
110101918|NCT01762644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110217199|NCT00106821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110217200|NCT00106821|Anticonvulsants|anticonvulsants|mesh-ancestor
110217206|NCT00268723|Albuterol|albuterol|mesh-list
110101919|NCT01762644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110101920|NCT01762644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110101921|NCT01762644|Immunologic Factors|immunologic factors|mesh-ancestor
110101922|NCT01762644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110101923|NCT01762644|Antifungal Agents|antifungal agents|mesh-ancestor
110101924|NCT01762644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110101925|NCT01762644|Dermatologic Agents|dermatologic agents|mesh-ancestor
110101926|NCT01762644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110101927|NCT01762644|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110101928|NCT01762644|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110101929|NCT01762644|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110101930|NCT01762644|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110101931|NCT01762657|Cyclosporine|cyclosporine|mesh-list
110101932|NCT01762657|Lansoprazole|lansoprazole|mesh-list
110101933|NCT01762657|Dexlansoprazole|dexlansoprazole|mesh-list
110101934|NCT01762657|Cyclosporins|cyclosporins|mesh-list
110101935|NCT01762657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110101936|NCT01762657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110101937|NCT01762657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110101938|NCT01762657|Immunologic Factors|immunologic factors|mesh-ancestor
110101939|NCT01762657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110101940|NCT01762657|Antifungal Agents|antifungal agents|mesh-ancestor
110101941|NCT01762657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110101942|NCT01762657|Dermatologic Agents|dermatologic agents|mesh-ancestor
110101943|NCT01762657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110101944|NCT01762657|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110101945|NCT01762657|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110101946|NCT01762657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110101947|NCT01762657|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110101948|NCT01762670|Metronidazole|metronidazole|mesh-list
110101949|NCT01762670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110101950|NCT01762670|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110101951|NCT01762670|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110101952|NCT01762670|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110101953|NCT01762787|Aspirin|aspirin|mesh-list
110101954|NCT01762787|Prednisolone|prednisolone|mesh-list
110101955|NCT01762787|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110101956|NCT01762787|Methylprednisolone|methylprednisolone|mesh-list
110101957|NCT01762787|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110101958|NCT01762787|Prednisolone acetate|prednisolone acetate|mesh-list
110101959|NCT01762787|Cantharidin|cantharidin|mesh-list
110101960|NCT01762787|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110101961|NCT01762787|Prednisolone phosphate|prednisolone phosphate|mesh-list
110101962|NCT01762787|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110101963|NCT01762787|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110101964|NCT01762787|Analgesics|analgesics|mesh-ancestor
110217236|NCT00268918|Docetaxel|docetaxel|mesh-list
110101965|NCT01762787|Sensory System Agents|sensory system agents|mesh-ancestor
110101966|NCT01762787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110101967|NCT01762787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110101968|NCT01762787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110101969|NCT01762787|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110101970|NCT01762787|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110101971|NCT01762787|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110161089|NCT02697474|Vaccines|vaccines|mesh-list
110101972|NCT01762787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110101973|NCT01762787|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110101974|NCT01762787|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110101975|NCT01762787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110101976|NCT01762787|Antipyretics|antipyretics|mesh-ancestor
110101977|NCT01762787|Glucocorticoids|glucocorticoids|mesh-ancestor
110101978|NCT01762787|Hormones|hormones|mesh-ancestor
110101979|NCT01762787|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110101980|NCT01762787|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110101981|NCT01762787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110101982|NCT01762787|Antiemetics|antiemetics|mesh-ancestor
110101983|NCT01762787|Autonomic Agents|autonomic agents|mesh-ancestor
110101984|NCT01762787|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110101985|NCT01762787|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110101986|NCT01762787|Protective Agents|protective agents|mesh-ancestor
110101987|NCT01762826|Inositol|inositol|mesh-list
110101988|NCT01762826|Vitamin B Complex|vitamin b complex|mesh-ancestor
110101989|NCT01762826|Vitamins|vitamins|mesh-ancestor
110101990|NCT01762826|Micronutrients|micronutrients|mesh-ancestor
110101991|NCT01762826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110101992|NCT01762839|Moxifloxacin|moxifloxacin|mesh-list
110101993|NCT01762839|Oritavancin|oritavancin|mesh-list
110101994|NCT01762839|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110101995|NCT01762839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110101996|NCT01762839|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110101997|NCT01762839|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110101998|NCT01762839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110101999|NCT01762839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110102000|NCT01762839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110102001|NCT01762852|Belimumab|belimumab|mesh-list
110102002|NCT01762852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110102003|NCT01762852|Immunologic Factors|immunologic factors|mesh-ancestor
110102004|NCT01762852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110102005|NCT01762878|Nemiralisib|nemiralisib|mesh-list
110102006|NCT01762878|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110102007|NCT01762878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110400547|NCT04479267|Immunologic Factors|immunologic factors|mesh-ancestor
110102008|NCT01762878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110102009|NCT01762891|Acetaminophen|acetaminophen|mesh-list
110102010|NCT01762891|Celecoxib|celecoxib|mesh-list
110102011|NCT01762891|Rofecoxib|rofecoxib|mesh-list
110217265|NCT00102492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110217283|NCT00074009|Bortezomib|bortezomib|mesh-list
110102012|NCT01762891|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110102013|NCT01762891|Analgesics|analgesics|mesh-ancestor
110102014|NCT01762891|Sensory System Agents|sensory system agents|mesh-ancestor
110102015|NCT01762891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110102016|NCT01762891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110102017|NCT01762891|Antipyretics|antipyretics|mesh-ancestor
110102018|NCT01762891|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110102019|NCT01762891|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110102020|NCT01762891|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110102021|NCT01762891|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110102022|NCT01762891|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110102023|NCT01762891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110102024|NCT01762891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110102025|NCT01762995|Ferrous fumarate|ferrous fumarate|mesh-list
110102026|NCT01762995|Dolutegravir|dolutegravir|mesh-list
110102027|NCT01762995|Calcium Carbonate|calcium carbonate|mesh-list
110102028|NCT01762995|Calcium|calcium|mesh-list
110102029|NCT01762995|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110102030|NCT01762995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110102031|NCT01762995|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110102032|NCT01762995|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110102033|NCT01762995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110102034|NCT01762995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110102035|NCT01762995|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110102036|NCT01762995|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110102037|NCT01762995|Antiviral Agents|antiviral agents|mesh-ancestor
110102038|NCT01762995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110102039|NCT01762995|Antacids|antacids|mesh-ancestor
110102041|NCT01762995|Trace Elements|trace elements|mesh-ancestor
110102042|NCT01762995|Micronutrients|micronutrients|mesh-ancestor
110102043|NCT01763021|Rifampin|rifampin|mesh-list
110102044|NCT01763021|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110102045|NCT01763021|Antitubercular Agents|antitubercular agents|mesh-ancestor
110102046|NCT01763021|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110102047|NCT01763021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110102048|NCT01763021|Leprostatic Agents|leprostatic agents|mesh-ancestor
110102049|NCT01763021|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110102050|NCT01763021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110102051|NCT01763021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110102052|NCT01763021|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110102053|NCT01763021|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110102054|NCT01763021|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110102055|NCT01763021|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110102056|NCT01763021|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110102057|NCT01763021|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110102058|NCT01763281|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
110102059|NCT01763281|Hormones|hormones|mesh-ancestor
110102060|NCT01763281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110102061|NCT01763281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110102062|NCT01763385|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110102063|NCT01763385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110102064|NCT01763385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110102065|NCT01763385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110102066|NCT01763385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110102067|NCT01763437|Tetracycline|tetracycline|mesh-list
110102068|NCT01763437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110102069|NCT01763437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110102070|NCT01763437|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110217290|NCT00269386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110217304|NCT00269542|Vitamin B Complex|vitamin b complex|mesh-list
110102071|NCT01763437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110102072|NCT01763437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110102073|NCT01763450|Bevacizumab|bevacizumab|mesh-list
110102074|NCT01763450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110102075|NCT01763450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110102076|NCT01763450|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110102077|NCT01763450|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110102078|NCT01763450|Growth Substances|growth substances|mesh-ancestor
110102079|NCT01763450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110102080|NCT01763450|Growth Inhibitors|growth inhibitors|mesh-ancestor
110102081|NCT01763463|Fluticasone|fluticasone|mesh-list
110102083|NCT01763463|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110102084|NCT01763463|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
110102085|NCT01763463|Bronchodilator Agents|bronchodilator agents|mesh-list
110102086|NCT01763463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110102087|NCT01763463|Autonomic Agents|autonomic agents|mesh-ancestor
110102088|NCT01763463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110102089|NCT01763463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110102090|NCT01763463|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110102091|NCT01763463|Respiratory System Agents|respiratory system agents|mesh-ancestor
110102092|NCT01763463|Dermatologic Agents|dermatologic agents|mesh-ancestor
110102093|NCT01763463|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110102094|NCT01763463|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110102095|NCT01763463|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110102096|NCT01763463|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110102097|NCT01763463|Adrenergic Agents|adrenergic agents|mesh-ancestor
110102098|NCT01763463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110102099|NCT01763463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110102100|NCT01763463|Glucocorticoids|glucocorticoids|mesh-ancestor
110102101|NCT01763463|Hormones|hormones|mesh-ancestor
110102102|NCT01763463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110102103|NCT01763463|Sympathomimetics|sympathomimetics|mesh-ancestor
110102104|NCT01763476|Paclitaxel|paclitaxel|mesh-list
110102105|NCT01763476|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110102106|NCT01763476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110102107|NCT01763476|Tubulin Modulators|tubulin modulators|mesh-ancestor
110102108|NCT01763476|Antimitotic Agents|antimitotic agents|mesh-ancestor
110102109|NCT01763476|Mitosis Modulators|mitosis modulators|mesh-ancestor
110102110|NCT01763476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110102111|NCT01763541|Anastrozole|anastrozole|mesh-list
110102112|NCT01763541|Leuprolide|leuprolide|mesh-list
110102113|NCT01763541|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110102114|NCT01763541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110102115|NCT01763541|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110102116|NCT01763541|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110102117|NCT01763541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110102118|NCT01763541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110102119|NCT01763541|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110102120|NCT01763541|Hormone Antagonists|hormone antagonists|mesh-ancestor
110102121|NCT01763541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110102122|NCT01763541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110102123|NCT01763541|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110102124|NCT01763541|Fertility Agents|fertility agents|mesh-ancestor
110102125|NCT01763541|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110102126|NCT01763658|Dexamethasone|dexamethasone|mesh-list
110102127|NCT01763658|Prednisolone|prednisolone|mesh-list
110102128|NCT01763658|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110102129|NCT01763658|Immunoglobulins|immunoglobulins|mesh-list
110102130|NCT01763658|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110102131|NCT01763658|gamma-Globulins|gamma-globulins|mesh-list
110102132|NCT01763658|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110102133|NCT01763658|Antioxidants|antioxidants|mesh-list
110102134|NCT01763658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110102135|NCT01763658|Antiemetics|antiemetics|mesh-ancestor
110217357|NCT00269737|Fentanyl|fentanyl|mesh-list
110102136|NCT01763658|Autonomic Agents|autonomic agents|mesh-ancestor
110102137|NCT01763658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110102138|NCT01763658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110102139|NCT01763658|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110102140|NCT01763658|Glucocorticoids|glucocorticoids|mesh-ancestor
110102141|NCT01763658|Hormones|hormones|mesh-ancestor
110102142|NCT01763658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110102143|NCT01763658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110102144|NCT01763658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110102145|NCT01763658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110102146|NCT01763658|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110102147|NCT01763658|Protective Agents|protective agents|mesh-ancestor
110102148|NCT01763658|Immunologic Factors|immunologic factors|mesh-ancestor
110102149|NCT01763710|Paclitaxel|paclitaxel|mesh-list
110102150|NCT01763710|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110102151|NCT01763710|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110102152|NCT01763710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110102153|NCT01763710|Tubulin Modulators|tubulin modulators|mesh-ancestor
110102155|NCT01763710|Mitosis Modulators|mitosis modulators|mesh-ancestor
110102156|NCT01763710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110102157|NCT01763749|Clopidogrel|clopidogrel|mesh-list
110102158|NCT01763749|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110102159|NCT01763749|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110102160|NCT01763749|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110102161|NCT01763749|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110102162|NCT01763749|Purinergic Agents|purinergic agents|mesh-ancestor
110102163|NCT01763749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110102164|NCT01763749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110102165|NCT01763749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110102166|NCT01763788|Gemcitabine|gemcitabine|mesh-list
110102167|NCT01763788|Necitumumab|necitumumab|mesh-list
110102168|NCT01763788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110102169|NCT01763788|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110102170|NCT01763788|Antimetabolites|antimetabolites|mesh-ancestor
110102171|NCT01763788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110102172|NCT01763788|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110102173|NCT01764087|Paclitaxel|paclitaxel|mesh-list
110102174|NCT01764087|Tirbanibulin|tirbanibulin|mesh-list
110102175|NCT01764087|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110102176|NCT01764087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110102177|NCT01764087|Tubulin Modulators|tubulin modulators|mesh-ancestor
110102178|NCT01764087|Antimitotic Agents|antimitotic agents|mesh-ancestor
110102179|NCT01764087|Mitosis Modulators|mitosis modulators|mesh-ancestor
110102180|NCT01764087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110102181|NCT01764087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110102182|NCT01764126|Vaccines|vaccines|mesh-list
110102183|NCT01764126|Immunologic Factors|immunologic factors|mesh-ancestor
110102184|NCT01764126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110102185|NCT01764139|Vitamin D|vitamin d|mesh-list
110102186|NCT01764139|Vitamins|vitamins|mesh-ancestor
110102187|NCT01764139|Micronutrients|micronutrients|mesh-ancestor
110102188|NCT01764139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110102189|NCT01764139|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110102190|NCT01764178|Valsartan|valsartan|mesh-list
110102191|NCT01764178|Pitavastatin|pitavastatin|mesh-list
110102192|NCT01764178|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110102193|NCT01764178|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110102194|NCT01764178|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110102195|NCT01764178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110102196|NCT01764178|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110102197|NCT01764178|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110102198|NCT01764178|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110102199|NCT01764178|Antimetabolites|antimetabolites|mesh-ancestor
110102200|NCT01764178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110102201|NCT01764178|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110102202|NCT01764230|Triptorelin Pamoate|triptorelin pamoate|mesh-list
110102203|NCT01764230|Luteolytic Agents|luteolytic agents|mesh-ancestor
110102204|NCT01764230|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110102205|NCT01764230|Contraceptive Agents|contraceptive agents|mesh-ancestor
110102206|NCT01764230|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110102207|NCT01764230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110102208|NCT01764230|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110102209|NCT01764230|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110102210|NCT01764230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110102211|NCT01764295|Olmesartan|olmesartan|mesh-list
110102212|NCT01764295|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110102213|NCT01764295|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110102214|NCT01764295|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110102215|NCT01764295|Antimetabolites|antimetabolites|mesh-ancestor
110102216|NCT01764295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110217411|NCT00074321|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110217413|NCT00102609|Dexamethasone|dexamethasone|mesh-list
110102217|NCT01764295|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110102218|NCT01764295|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110102219|NCT01764295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110102220|NCT01764295|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110102221|NCT01764295|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110102222|NCT01764295|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110102223|NCT01764451|Simvastatin|simvastatin|mesh-list
110102224|NCT01764451|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110102225|NCT01764451|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110102226|NCT01764451|Antimetabolites|antimetabolites|mesh-ancestor
110102227|NCT01764451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110102228|NCT01764451|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110102229|NCT01764451|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110102230|NCT01764451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110102232|NCT01763424|Niacinamide|niacinamide|mesh-list
110102233|NCT01763424|Niacin|niacin|mesh-list
110102234|NCT01763424|Nicotinic Acids|nicotinic acids|mesh-list
110102235|NCT01763424|Calcipotriene|calcipotriene|mesh-list
110102236|NCT01763424|Vitamin B Complex|vitamin b complex|mesh-ancestor
110102237|NCT01763424|Vitamins|vitamins|mesh-ancestor
110102238|NCT01763424|Micronutrients|micronutrients|mesh-ancestor
110102239|NCT01763424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110102240|NCT01763424|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110102241|NCT01763424|Antimetabolites|antimetabolites|mesh-ancestor
110102242|NCT01763424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110102243|NCT01763424|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110102244|NCT01763424|Vasodilator Agents|vasodilator agents|mesh-ancestor
110102245|NCT01763424|Dermatologic Agents|dermatologic agents|mesh-ancestor
110102246|NCT01763424|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110102247|NCT01763424|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
110102248|NCT01763424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110102249|NCT01763424|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110102250|NCT01763424|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110102252|NCT01764555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110102253|NCT01764555|Analgesics|analgesics|mesh-ancestor
110102254|NCT01764555|Sensory System Agents|sensory system agents|mesh-ancestor
110102255|NCT01764555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110102256|NCT01764555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110102257|NCT01764555|Antipyretics|antipyretics|mesh-ancestor
110102258|NCT01764581|Tacrolimus|tacrolimus|mesh-list
110102259|NCT01764581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110102260|NCT01764581|Immunologic Factors|immunologic factors|mesh-ancestor
110102261|NCT01764581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110102262|NCT01764581|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110102263|NCT01764581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110102264|NCT01764581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110102265|NCT01764672|Methylphenidate|methylphenidate|mesh-list
110102266|NCT01764672|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110102267|NCT01764672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110102268|NCT01764672|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110102269|NCT01764672|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110102270|NCT01764672|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110102271|NCT01764672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110102273|NCT01764672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110102274|NCT01764750|Vancomycin|vancomycin|mesh-list
110102275|NCT01764750|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110217461|NCT00107016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110102276|NCT01764750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110102277|NCT01764828|Gemcitabine|gemcitabine|mesh-list
110102278|NCT01764828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110102279|NCT01764828|Antimetabolites|antimetabolites|mesh-ancestor
110102280|NCT01764828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110102281|NCT01764828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110102282|NCT01764867|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110102283|NCT01764867|Dexetimide|dexetimide|mesh-list
110102284|NCT01764867|Mirtazapine|mirtazapine|mesh-list
110102285|NCT01764867|Fluvoxamine|fluvoxamine|mesh-list
110102286|NCT01764867|Trazodone|trazodone|mesh-list
110102287|NCT01764867|Citalopram|citalopram|mesh-list
110102288|NCT01764867|Bupropion|bupropion|mesh-list
110102289|NCT01764867|Fluoxetine|fluoxetine|mesh-list
110102290|NCT01764867|Paroxetine|paroxetine|mesh-list
110102291|NCT01764867|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
110102292|NCT01764867|Sertraline|sertraline|mesh-list
110102293|NCT01764867|Escitalopram|escitalopram|mesh-list
110102294|NCT01764867|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110102295|NCT01764867|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110102296|NCT01764867|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110102297|NCT01764867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110102298|NCT01764867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110102299|NCT01764867|Serotonin Agents|serotonin agents|mesh-ancestor
110102300|NCT01764867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110102301|NCT01764867|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110102302|NCT01764867|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110102303|NCT01764867|Parasympatholytics|parasympatholytics|mesh-ancestor
110102304|NCT01764867|Autonomic Agents|autonomic agents|mesh-ancestor
110102305|NCT01764867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110102306|NCT01764867|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110102307|NCT01764867|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110102308|NCT01764867|Cholinergic Agents|cholinergic agents|mesh-ancestor
110102309|NCT01764867|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110102310|NCT01764867|Antidepressive Agents|antidepressive agents|mesh-ancestor
110102311|NCT01764867|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110102312|NCT01764867|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110102313|NCT01764867|Dopamine Agents|dopamine agents|mesh-ancestor
110102314|NCT01764867|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110102315|NCT01764867|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110102316|NCT01764867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110102317|NCT01764867|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110102318|NCT01764867|Analgesics|analgesics|mesh-ancestor
110102319|NCT01764867|Sensory System Agents|sensory system agents|mesh-ancestor
110102320|NCT01764867|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110102321|NCT01764867|Histamine Antagonists|histamine antagonists|mesh-ancestor
110102322|NCT01764867|Histamine Agents|histamine agents|mesh-ancestor
110102323|NCT01764867|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110102324|NCT01764867|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110102325|NCT01764867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110102326|NCT01764867|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
110102327|NCT01764867|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110102328|NCT01764867|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110102329|NCT01764867|Adrenergic Agents|adrenergic agents|mesh-ancestor
110102330|NCT01764867|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110102331|NCT01764867|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110102332|NCT01764867|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110102333|NCT01764867|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110102334|NCT01764867|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110102335|NCT01764893|Solifenacin Succinate|solifenacin succinate|mesh-list
110102336|NCT01764893|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110102337|NCT01764893|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110102338|NCT01764893|Cholinergic Agents|cholinergic agents|mesh-ancestor
110102339|NCT01764893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110102340|NCT01764893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110102341|NCT01764893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110102342|NCT01764893|Urological Agents|urological agents|mesh-ancestor
110102343|NCT01765010|Cholecalciferol|cholecalciferol|mesh-list
110102345|NCT01765010|Calcitriol|calcitriol|mesh-list
110102346|NCT01765010|Alfacalcidol|alfacalcidol|mesh-list
110102347|NCT01765010|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
110102348|NCT01765010|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110102349|NCT01765010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110102350|NCT01765010|Vitamins|vitamins|mesh-ancestor
110102351|NCT01765010|Micronutrients|micronutrients|mesh-ancestor
110102352|NCT01765010|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110102353|NCT01765010|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
110102354|NCT01765010|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110102355|NCT01765010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110102356|NCT01765010|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110102357|NCT01765023|Metformin|metformin|mesh-list
110102358|NCT01765023|Atorvastatin|atorvastatin|mesh-list
110102359|NCT01765023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110102360|NCT01765023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110102361|NCT01765023|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110102362|NCT01765023|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110102363|NCT01765023|Antimetabolites|antimetabolites|mesh-ancestor
110102364|NCT01765023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110102365|NCT01765023|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110102366|NCT01765023|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110102367|NCT01765023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110102368|NCT01765088|Temozolomide|temozolomide|mesh-list
110102369|NCT01765088|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110102370|NCT01765088|Alkylating Agents|alkylating agents|mesh-ancestor
110102371|NCT01765088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110102372|NCT01765088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110102373|NCT01765231|Entecavir|entecavir|mesh-list
110102374|NCT01765231|Antiviral Agents|antiviral agents|mesh-ancestor
110102375|NCT01765231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110102376|NCT01765257|Rasagiline|rasagiline|mesh-list
110102377|NCT01765257|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
110102378|NCT01765257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110102379|NCT01765257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110102380|NCT01765257|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110102381|NCT01765257|Protective Agents|protective agents|mesh-ancestor
110102382|NCT01765257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110102383|NCT01765309|Botulinum Toxins|botulinum toxins|mesh-list
110102384|NCT01765309|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110102385|NCT01765309|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110102386|NCT01765309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110102387|NCT01765309|Cholinergic Agents|cholinergic agents|mesh-ancestor
110102388|NCT01765309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110102389|NCT01765309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110102390|NCT01765374|Rituximab|rituximab|mesh-list
110102391|NCT01765374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110102392|NCT01765374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110102393|NCT01765374|Immunologic Factors|immunologic factors|mesh-ancestor
110102394|NCT01765374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110102395|NCT01765374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110102396|NCT01765452|Clopidogrel|clopidogrel|mesh-list
110102397|NCT01765452|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110102398|NCT01765452|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110102399|NCT01765452|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110102400|NCT01765452|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110102401|NCT01765452|Purinergic Agents|purinergic agents|mesh-ancestor
110102402|NCT01765452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110102403|NCT01765452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110102404|NCT01765452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110102405|NCT01765556|Ketoconazole|ketoconazole|mesh-list
110102406|NCT01765556|Vemurafenib|vemurafenib|mesh-list
110102407|NCT01765556|Antifungal Agents|antifungal agents|mesh-ancestor
110102408|NCT01765556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110102409|NCT01765556|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110102410|NCT01765556|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110102411|NCT01765556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110102412|NCT01765556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110102413|NCT01765556|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110102414|NCT01765556|Hormone Antagonists|hormone antagonists|mesh-ancestor
110102415|NCT01765556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110102416|NCT01765556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110102417|NCT01765556|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110102418|NCT01765556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110102419|NCT01765556|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110102420|NCT01765608|Zonisamide|zonisamide|mesh-list
110102421|NCT01765608|Anticonvulsants|anticonvulsants|mesh-ancestor
110102422|NCT01765608|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110102423|NCT01765608|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110102424|NCT01765608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110102425|NCT01765608|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110102426|NCT01765608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110102427|NCT01765738|Minocycline|minocycline|mesh-list
110102428|NCT01765738|Rifampin|rifampin|mesh-list
110102429|NCT01765738|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110102430|NCT01765738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110102431|NCT01765738|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110102432|NCT01765738|Antitubercular Agents|antitubercular agents|mesh-ancestor
110102433|NCT01765738|Leprostatic Agents|leprostatic agents|mesh-ancestor
110102434|NCT01765738|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110102435|NCT01765738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110102436|NCT01765738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110102437|NCT01765738|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110102438|NCT01765738|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110102439|NCT01765738|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110102440|NCT01765738|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110102441|NCT01765738|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110102442|NCT01765738|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110102443|NCT01765790|Antibodies|antibodies|mesh-list
110102444|NCT01765790|Immunoglobulins|immunoglobulins|mesh-list
110102445|NCT01765790|Immunologic Factors|immunologic factors|mesh-ancestor
110102446|NCT01765790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110102447|NCT01765829|Droperidol|droperidol|mesh-list
110102448|NCT01765829|Haloperidol|haloperidol|mesh-list
110102449|NCT01765829|Pimozide|pimozide|mesh-list
110102450|NCT01765829|Olanzapine|olanzapine|mesh-list
110102451|NCT01765829|Chlorpromazine|chlorpromazine|mesh-list
110102452|NCT01765829|Trifluoperazine|trifluoperazine|mesh-list
110102453|NCT01765829|Risperidone|risperidone|mesh-list
110102454|NCT01765829|Aripiprazole|aripiprazole|mesh-list
110102456|NCT01765829|Paliperidone Palmitate|paliperidone palmitate|mesh-list
110102457|NCT01765829|Ziprasidone|ziprasidone|mesh-list
110102458|NCT01765829|Antipsychotic Agents|antipsychotic agents|mesh-list
110102460|NCT01765829|Asenapine|asenapine|mesh-list
110102461|NCT01765829|Amisulpride|amisulpride|mesh-list
110102462|NCT01765829|Perphenazine|perphenazine|mesh-list
110102463|NCT01765829|Sertindole|sertindole|mesh-list
110102464|NCT01765829|Sulpiride|sulpiride|mesh-list
110102465|NCT01765829|Clopenthixol|clopenthixol|mesh-list
110102466|NCT01765829|Clothiapine|clothiapine|mesh-list
110102467|NCT01765829|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110102468|NCT01765829|Serotonin Agents|serotonin agents|mesh-ancestor
110102469|NCT01765829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110217497|NCT00270322|Anesthetics, General|anesthetics, general|mesh-ancestor
110102470|NCT01765829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110102471|NCT01765829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110102472|NCT01765829|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110102473|NCT01765829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110102474|NCT01765829|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110102475|NCT01765829|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110102476|NCT01765829|Dopamine Agents|dopamine agents|mesh-ancestor
110102477|NCT01765829|Antiemetics|antiemetics|mesh-ancestor
110102478|NCT01765829|Autonomic Agents|autonomic agents|mesh-ancestor
110102479|NCT01765829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110102480|NCT01765829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110102481|NCT01765829|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110102482|NCT01765829|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110102483|NCT01765829|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110102484|NCT01765829|Antidepressive Agents|antidepressive agents|mesh-ancestor
110102485|NCT01765829|Dopamine Agonists|dopamine agonists|mesh-ancestor
110102486|NCT01765829|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110102487|NCT01765829|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110102488|NCT01765829|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110102489|NCT01765829|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110102490|NCT01765829|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110102491|NCT01765829|GABA Antagonists|gaba antagonists|mesh-ancestor
110102492|NCT01765829|GABA Agents|gaba agents|mesh-ancestor
110102493|NCT01765829|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110102494|NCT01765829|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110102495|NCT01765842|Rituximab|rituximab|mesh-list
110102496|NCT01765842|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110102497|NCT01765842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110102498|NCT01765842|Immunologic Factors|immunologic factors|mesh-ancestor
110102499|NCT01765842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110102500|NCT01765842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110102501|NCT01765881|Misoprostol|misoprostol|mesh-list
110102502|NCT01765881|Dinoprostone|dinoprostone|mesh-list
110102503|NCT01765881|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110102504|NCT01765881|Abortifacient Agents|abortifacient agents|mesh-ancestor
110102505|NCT01765881|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110102506|NCT01765881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110102507|NCT01765881|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110102508|NCT01765881|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110102509|NCT01765881|Oxytocics|oxytocics|mesh-ancestor
110102510|NCT01765946|Metformin|metformin|mesh-list
110102511|NCT01765946|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110102512|NCT01765946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110102513|NCT01766063|Interferons|interferons|mesh-list
110102514|NCT01766063|Interferon-beta|interferon-beta|mesh-list
110102515|NCT01766063|Interferon beta-1b|interferon beta-1b|mesh-list
110102516|NCT01766063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110102517|NCT01766063|Antiviral Agents|antiviral agents|mesh-ancestor
110102518|NCT01766063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110102519|NCT01766063|Immunologic Factors|immunologic factors|mesh-ancestor
110102520|NCT01766063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110102521|NCT01766063|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110102522|NCT01766089|Dexmedetomidine|dexmedetomidine|mesh-list
110102523|NCT01766089|Remifentanil|remifentanil|mesh-list
110102524|NCT01766089|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110400640|NCT03219177|Analgesics, Opioid|analgesics, opioid|mesh-list
110102525|NCT01766089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110102526|NCT01766089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110102527|NCT01766089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110102528|NCT01766089|Analgesics|analgesics|mesh-ancestor
110102529|NCT01766089|Sensory System Agents|sensory system agents|mesh-ancestor
110102530|NCT01766089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110102531|NCT01766089|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110102532|NCT01766089|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110102533|NCT01766089|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110102534|NCT01766089|Adrenergic Agents|adrenergic agents|mesh-ancestor
110102535|NCT01766089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110102536|NCT01766089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110102537|NCT01766089|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110102538|NCT01766089|Narcotics|narcotics|mesh-ancestor
110102540|NCT01766154|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110102541|NCT01766154|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110102542|NCT01766154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110102543|NCT01766154|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110102544|NCT01766180|Resveratrol|resveratrol|mesh-list
110102545|NCT01766180|Antioxidants|antioxidants|mesh-ancestor
110102546|NCT01766180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110102547|NCT01766180|Protective Agents|protective agents|mesh-ancestor
110102548|NCT01766180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110102549|NCT01766180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110102550|NCT01766180|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110102551|NCT01766258|Carbidopa|carbidopa|mesh-list
110102552|NCT01766258|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110102553|NCT01766258|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110102554|NCT01766258|Dopamine Agents|dopamine agents|mesh-ancestor
110102555|NCT01766258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110102556|NCT01766258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110102557|NCT01766258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110102558|NCT01766258|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
110102559|NCT01766258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110102560|NCT01766323|Modafinil|modafinil|mesh-list
110102561|NCT01766323|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110102562|NCT01766323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110102563|NCT01766323|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
110102564|NCT01766323|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110102565|NCT01766323|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110102566|NCT01766323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110102567|NCT01766375|Cyclosporine|cyclosporine|mesh-list
110102568|NCT01766375|Mycophenolic Acid|mycophenolic acid|mesh-list
110102569|NCT01766375|Methotrexate|methotrexate|mesh-list
110102570|NCT01766375|Cyclosporins|cyclosporins|mesh-list
110102571|NCT01766375|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110102572|NCT01766375|Abortifacient Agents|abortifacient agents|mesh-ancestor
110102573|NCT01766375|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110102574|NCT01766375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110102575|NCT01766375|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110102576|NCT01766375|Antimetabolites|antimetabolites|mesh-ancestor
110102577|NCT01766375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110102578|NCT01766375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110102579|NCT01766375|Dermatologic Agents|dermatologic agents|mesh-ancestor
110102580|NCT01766375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110102581|NCT01766375|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110102582|NCT01766375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110102583|NCT01766375|Immunologic Factors|immunologic factors|mesh-ancestor
110102584|NCT01766375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110102585|NCT01766375|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110102586|NCT01766375|Antifungal Agents|antifungal agents|mesh-ancestor
110102587|NCT01766375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110102588|NCT01766375|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110400647|NCT01302834|Cetuximab|cetuximab|mesh-list
110102590|NCT01766375|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110102591|NCT01766375|Antitubercular Agents|antitubercular agents|mesh-ancestor
110102592|NCT01766375|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110102593|NCT01766414|Complement C1s|complement c1s|mesh-list
110102594|NCT01766414|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
110102595|NCT01766414|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
110102596|NCT01766414|Immunologic Factors|immunologic factors|mesh-ancestor
110102597|NCT01766414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110102598|NCT01766414|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
110102599|NCT01766414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110102600|NCT01766518|Mycophenolic Acid|mycophenolic acid|mesh-list
110102601|NCT01766518|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110102602|NCT01766518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110102603|NCT01766518|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110102604|NCT01766518|Antitubercular Agents|antitubercular agents|mesh-ancestor
110102605|NCT01766518|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110102606|NCT01766518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110102607|NCT01766518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110102608|NCT01766518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110102609|NCT01766583|Lenalidomide|lenalidomide|mesh-list
110102610|NCT01766583|Immunologic Factors|immunologic factors|mesh-ancestor
110102611|NCT01766583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110102612|NCT01766583|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110102613|NCT01766583|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110102614|NCT01766583|Growth Substances|growth substances|mesh-ancestor
110102615|NCT01766583|Growth Inhibitors|growth inhibitors|mesh-ancestor
110102616|NCT01766583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110102617|NCT01766609|Triamcinolone|triamcinolone|mesh-list
110102618|NCT01766609|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110102619|NCT01766609|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110102620|NCT01766609|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110102621|NCT01766609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110102622|NCT01766609|Glucocorticoids|glucocorticoids|mesh-ancestor
110102623|NCT01766609|Hormones|hormones|mesh-ancestor
110102624|NCT01766609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110102625|NCT01766609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110102626|NCT01766609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110102627|NCT01766609|Immunologic Factors|immunologic factors|mesh-ancestor
110102628|NCT01766609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110102629|NCT01766609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110102630|NCT01766830|Immunoglobulin G|immunoglobulin g|mesh-list
110102631|NCT01766830|Immunoglobulin M|immunoglobulin m|mesh-list
110102632|NCT01766830|Immunologic Factors|immunologic factors|mesh-ancestor
110102633|NCT01766830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110102634|NCT01766843|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
110102635|NCT01766843|Charcoal|charcoal|mesh-list
110102636|NCT01766843|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110102637|NCT01766843|Autonomic Agents|autonomic agents|mesh-ancestor
110102638|NCT01766843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110102639|NCT01766843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110102640|NCT01766843|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110102641|NCT01766843|Respiratory System Agents|respiratory system agents|mesh-ancestor
110102642|NCT01766843|Glucocorticoids|glucocorticoids|mesh-ancestor
110102643|NCT01766843|Hormones|hormones|mesh-ancestor
110102644|NCT01766843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110102645|NCT01766843|Sympathomimetics|sympathomimetics|mesh-ancestor
110102646|NCT01766843|Antidotes|antidotes|mesh-ancestor
110102647|NCT01766843|Protective Agents|protective agents|mesh-ancestor
110102648|NCT01766960|Morphine|morphine|mesh-list
110102649|NCT01766960|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110102650|NCT01766960|Narcotics|narcotics|mesh-ancestor
110161157|NCT00103948|Donepezil|donepezil|mesh-list
110102651|NCT01766960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110102652|NCT01766960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110102653|NCT01766960|Analgesics|analgesics|mesh-ancestor
110102654|NCT01766960|Sensory System Agents|sensory system agents|mesh-ancestor
110102655|NCT01766960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110102656|NCT01767025|Oxytocin|oxytocin|mesh-list
110102657|NCT01767025|Oxytocics|oxytocics|mesh-ancestor
110102658|NCT01767025|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110102659|NCT01767025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110102660|NCT01767090|Leuprolide|leuprolide|mesh-list
110102661|NCT01767090|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110102662|NCT01767090|Fertility Agents|fertility agents|mesh-ancestor
110102663|NCT01767090|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110102664|NCT01767090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110102665|NCT01767090|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110102666|NCT01767090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110102667|NCT01767259|Valsartan|valsartan|mesh-list
110102668|NCT01767259|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110102669|NCT01767259|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110102670|NCT01767259|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110102671|NCT01767259|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110102672|NCT01767259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110102673|NCT01767259|Diuretics|diuretics|mesh-ancestor
110102674|NCT01767259|Natriuretic Agents|natriuretic agents|mesh-ancestor
110102675|NCT01767259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110102676|NCT01767259|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110102677|NCT01767259|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110102678|NCT01767272|Fexofenadine|fexofenadine|mesh-list
110102679|NCT01767272|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110102680|NCT01767272|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110102681|NCT01767272|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110102682|NCT01767272|Histamine Antagonists|histamine antagonists|mesh-ancestor
110102683|NCT01767272|Histamine Agents|histamine agents|mesh-ancestor
110102684|NCT01767272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110102685|NCT01767272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110102686|NCT01767272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110102687|NCT01767298|Valsartan|valsartan|mesh-list
110102688|NCT01767298|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110102689|NCT01767298|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110102690|NCT01767298|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110102691|NCT01767298|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110102692|NCT01767298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110102693|NCT01767298|Diuretics|diuretics|mesh-ancestor
110102694|NCT01767298|Natriuretic Agents|natriuretic agents|mesh-ancestor
110102695|NCT01767298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110102696|NCT01767298|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110102697|NCT01767298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110102698|NCT01767363|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
110102699|NCT01767363|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-list
110102700|NCT01767363|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110102701|NCT01767363|Adrenergic Agents|adrenergic agents|mesh-ancestor
110102702|NCT01767363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110102703|NCT01767363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110102704|NCT01767363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110102705|NCT01767363|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110102707|NCT01767363|Hormone Antagonists|hormone antagonists|mesh-ancestor
110102708|NCT01767363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110102709|NCT01767389|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
110102710|NCT01767389|Protease Inhibitors|protease inhibitors|mesh-ancestor
110102711|NCT01767389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110102712|NCT01767389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110161166|NCT00006458|Antibodies|antibodies|mesh-list
110102713|NCT01767389|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110217554|NCT00270751|Minocycline|minocycline|mesh-list
110102714|NCT01767389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110102715|NCT01767402|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110102716|NCT01767402|Immunologic Factors|immunologic factors|mesh-ancestor
110102717|NCT01767402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110102718|NCT01767428|Acetaminophen|acetaminophen|mesh-list
110102719|NCT01767428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110102720|NCT01767428|Analgesics|analgesics|mesh-ancestor
110102721|NCT01767428|Sensory System Agents|sensory system agents|mesh-ancestor
110102722|NCT01767428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110102723|NCT01767428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110102724|NCT01767428|Antipyretics|antipyretics|mesh-ancestor
110102725|NCT01767454|Ipilimumab|ipilimumab|mesh-list
110102726|NCT01767454|Trametinib|trametinib|mesh-list
110102727|NCT01767454|Dabrafenib|dabrafenib|mesh-list
110102728|NCT01767454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110102729|NCT01767454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110102730|NCT01767454|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110102731|NCT01767454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110102732|NCT01767454|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110102733|NCT01767454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110102734|NCT01767532|Cephalexin|cephalexin|mesh-list
110102735|NCT01767532|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110102736|NCT01767532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110102737|NCT01767545|Dexamethasone|dexamethasone|mesh-list
110102738|NCT01767545|Bevacizumab|bevacizumab|mesh-list
110102739|NCT01767545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110102740|NCT01767545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110102741|NCT01767545|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110102742|NCT01767545|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110102743|NCT01767545|Growth Substances|growth substances|mesh-ancestor
110102744|NCT01767545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110102745|NCT01767545|Growth Inhibitors|growth inhibitors|mesh-ancestor
110102746|NCT01767545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110102747|NCT01767545|Antiemetics|antiemetics|mesh-ancestor
110102748|NCT01767545|Autonomic Agents|autonomic agents|mesh-ancestor
110102749|NCT01767545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110102750|NCT01767545|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110102751|NCT01767545|Glucocorticoids|glucocorticoids|mesh-ancestor
110102752|NCT01767545|Hormones|hormones|mesh-ancestor
110102753|NCT01767545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110102754|NCT01767545|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110102755|NCT01767571|Cephalexin|cephalexin|mesh-list
110102756|NCT01767571|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110102757|NCT01767571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110102758|NCT01767584|Cephalexin|cephalexin|mesh-list
110102759|NCT01767584|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110102760|NCT01767584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110102761|NCT01767623|Vemurafenib|vemurafenib|mesh-list
110102762|NCT01767623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110102763|NCT01767623|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110102764|NCT01767623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110102765|NCT01767623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110102766|NCT01767714|Plerixafor|plerixafor|mesh-list
110102767|NCT01767714|Lenograstim|lenograstim|mesh-list
110102768|NCT01767714|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110102769|NCT01767714|Immunologic Factors|immunologic factors|mesh-ancestor
110102770|NCT01767714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110102771|NCT01767714|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110102772|NCT01767714|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110102773|NCT01767714|Antiviral Agents|antiviral agents|mesh-ancestor
110102774|NCT01767714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110102775|NCT01767896|Vaccines|vaccines|mesh-list
110102776|NCT01767896|Immunologic Factors|immunologic factors|mesh-ancestor
110102777|NCT01767896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110102778|NCT01768039|Vitamin D|vitamin d|mesh-list
110102779|NCT01768039|Vitamins|vitamins|mesh-ancestor
110102780|NCT01768039|Micronutrients|micronutrients|mesh-ancestor
110102781|NCT01768039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110102782|NCT01768039|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110102784|NCT01767610|Fenofibrate|fenofibrate|mesh-list
110102785|NCT01767610|Pitavastatin|pitavastatin|mesh-list
110102786|NCT01767610|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110102787|NCT01767610|Antimetabolites|antimetabolites|mesh-ancestor
110102788|NCT01767610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110102789|NCT01767610|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110102790|NCT01767610|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110102791|NCT01767610|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110102792|NCT01767610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110102793|NCT01767610|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110102794|NCT01767610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110102795|NCT01767610|Dermatologic Agents|dermatologic agents|mesh-ancestor
110102796|NCT01767610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110102797|NCT01767610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110102798|NCT01768078|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110102799|NCT01768078|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
110102800|NCT01768078|Betamethasone|betamethasone|mesh-list
110102801|NCT01768078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110102802|NCT01768078|Antitubercular Agents|antitubercular agents|mesh-ancestor
110102803|NCT01768078|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110102804|NCT01768078|Glucocorticoids|glucocorticoids|mesh-ancestor
110102805|NCT01768078|Hormones|hormones|mesh-ancestor
110102806|NCT01768078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110102807|NCT01768078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110102808|NCT01768078|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110102809|NCT01768078|Respiratory System Agents|respiratory system agents|mesh-ancestor
110102810|NCT01768182|Leucovorin|leucovorin|mesh-list
110102811|NCT01768182|Folic Acid|folic acid|mesh-list
110102812|NCT01768182|Levoleucovorin|levoleucovorin|mesh-list
110102813|NCT01768182|Antidotes|antidotes|mesh-ancestor
110102814|NCT01768182|Protective Agents|protective agents|mesh-ancestor
110102815|NCT01768182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110102816|NCT01768182|Vitamin B Complex|vitamin b complex|mesh-ancestor
110102817|NCT01768182|Vitamins|vitamins|mesh-ancestor
110102818|NCT01768182|Micronutrients|micronutrients|mesh-ancestor
110102819|NCT01768182|Hematinics|hematinics|mesh-ancestor
110102820|NCT01768195|Entecavir|entecavir|mesh-list
110102821|NCT01768195|Antiviral Agents|antiviral agents|mesh-ancestor
110102822|NCT01768195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110102823|NCT01768208|Saxagliptin|saxagliptin|mesh-list
110102824|NCT01768208|Incretins|incretins|mesh-ancestor
110102825|NCT01768208|Hormones|hormones|mesh-ancestor
110102826|NCT01768208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110102827|NCT01768208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110102828|NCT01768208|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110102829|NCT01768208|Protease Inhibitors|protease inhibitors|mesh-ancestor
110102830|NCT01768208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110102831|NCT01768208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110102832|NCT01768208|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110102833|NCT01768247|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
110102834|NCT01768247|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110102835|NCT01768247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110102836|NCT01768260|Aspirin|aspirin|mesh-list
110102837|NCT01768260|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110102838|NCT01768260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110102839|NCT01768260|Analgesics|analgesics|mesh-ancestor
110102840|NCT01768260|Sensory System Agents|sensory system agents|mesh-ancestor
110102841|NCT01768260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110102842|NCT01768260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110102843|NCT01768260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110102845|NCT01768260|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110102846|NCT01768260|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110102847|NCT01768260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110102848|NCT01768260|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110102849|NCT01768260|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110102850|NCT01768260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110102851|NCT01768260|Antipyretics|antipyretics|mesh-ancestor
110102852|NCT01768273|Midazolam|midazolam|mesh-list
110102853|NCT01768273|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110102854|NCT01768273|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110400683|NCT02890602|Hormones|hormones|mesh-ancestor
110102855|NCT01768273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110102856|NCT01768273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110102857|NCT01768273|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110102859|NCT01768273|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110102860|NCT01768273|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110102861|NCT01768273|Anesthetics, General|anesthetics, general|mesh-ancestor
110102862|NCT01768273|Anesthetics|anesthetics|mesh-ancestor
110102863|NCT01768273|GABA Modulators|gaba modulators|mesh-ancestor
110102864|NCT01768273|GABA Agents|gaba agents|mesh-ancestor
110102865|NCT01768273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110102866|NCT01768273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110102867|NCT01768299|Misoprostol|misoprostol|mesh-list
110102868|NCT01768299|Mifepristone|mifepristone|mesh-list
110102869|NCT01768299|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110102870|NCT01768299|Abortifacient Agents|abortifacient agents|mesh-ancestor
110102871|NCT01768299|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110102872|NCT01768299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110102873|NCT01768299|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110102874|NCT01768299|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110102875|NCT01768299|Oxytocics|oxytocics|mesh-ancestor
110102876|NCT01768299|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
110102877|NCT01768299|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110102878|NCT01768299|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110102879|NCT01768299|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110102880|NCT01768299|Contraceptive Agents|contraceptive agents|mesh-ancestor
110102881|NCT01768299|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
110102882|NCT01768299|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
110102883|NCT01768299|Hormone Antagonists|hormone antagonists|mesh-ancestor
110102884|NCT01768299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110102885|NCT01768299|Luteolytic Agents|luteolytic agents|mesh-ancestor
110102886|NCT01768299|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110102887|NCT01768299|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
110102888|NCT01768312|Cyclosporine|cyclosporine|mesh-list
110102889|NCT01768312|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110102890|NCT01768312|Cyclosporins|cyclosporins|mesh-list
110102891|NCT01768312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110102892|NCT01768312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110102893|NCT01768312|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110102894|NCT01768312|Immunologic Factors|immunologic factors|mesh-ancestor
110102895|NCT01768312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110102896|NCT01768312|Antifungal Agents|antifungal agents|mesh-ancestor
110102897|NCT01768312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110102898|NCT01768312|Dermatologic Agents|dermatologic agents|mesh-ancestor
110102899|NCT01768312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110102900|NCT01768312|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110102901|NCT01768312|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110102903|NCT01768351|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110102904|NCT01768351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110102905|NCT01768351|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
110102906|NCT01768351|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110102907|NCT01768351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110102909|NCT01768351|Vitamins|vitamins|mesh-ancestor
110102910|NCT01768351|Micronutrients|micronutrients|mesh-ancestor
110102911|NCT01768351|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110102912|NCT01768364|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110400692|NCT01259115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110102913|NCT01768364|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
110102914|NCT01768364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110102915|NCT01768364|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110102916|NCT01768364|Antimalarials|antimalarials|mesh-ancestor
110102917|NCT01768364|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110102918|NCT01768364|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110102919|NCT01768377|Lidocaine|lidocaine|mesh-list
110102920|NCT01768377|Fentanyl|fentanyl|mesh-list
110102921|NCT01768377|Midazolam|midazolam|mesh-list
110102922|NCT01768377|Anesthetics, Local|anesthetics, local|mesh-ancestor
110102923|NCT01768377|Anesthetics|anesthetics|mesh-ancestor
110161185|NCT03879408|Gout Suppressants|gout suppressants|mesh-ancestor
110102924|NCT01768377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110102925|NCT01768377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110102927|NCT01768377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110102928|NCT01768377|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110102929|NCT01768377|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110102930|NCT01768377|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110102931|NCT01768377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110102933|NCT01768377|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110102934|NCT01768377|Narcotics|narcotics|mesh-ancestor
110102935|NCT01768377|Analgesics|analgesics|mesh-ancestor
110102936|NCT01768377|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110102937|NCT01768377|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110102938|NCT01768377|Anesthetics, General|anesthetics, general|mesh-ancestor
110102939|NCT01768377|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110102940|NCT01768377|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110102941|NCT01768377|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110102942|NCT01768377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110102943|NCT01768377|GABA Modulators|gaba modulators|mesh-ancestor
110102944|NCT01768377|GABA Agents|gaba agents|mesh-ancestor
110102945|NCT01768377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110102946|NCT01768390|Fluorides|fluorides|mesh-list
110102947|NCT01768390|Cariostatic Agents|cariostatic agents|mesh-ancestor
110102948|NCT01768390|Protective Agents|protective agents|mesh-ancestor
110102949|NCT01768390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110102950|NCT01768455|Glimepiride|glimepiride|mesh-list
110102951|NCT01768455|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110102952|NCT01768455|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110102953|NCT01768455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110102954|NCT01768455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110102955|NCT01768455|Immunologic Factors|immunologic factors|mesh-ancestor
110102956|NCT01768481|Atorvastatin|atorvastatin|mesh-list
110102957|NCT01768481|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110102958|NCT01768481|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110102959|NCT01768481|Antimetabolites|antimetabolites|mesh-ancestor
110102960|NCT01768481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110102961|NCT01768481|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110102962|NCT01768481|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110102963|NCT01768481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110102964|NCT01768507|Resveratrol|resveratrol|mesh-list
110102965|NCT01768507|Antioxidants|antioxidants|mesh-ancestor
110102966|NCT01768507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110102967|NCT01768507|Protective Agents|protective agents|mesh-ancestor
110400707|NCT01302054|Fesoterodine|fesoterodine|mesh-list
110102968|NCT01768507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110102969|NCT01768507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110102970|NCT01768507|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110102971|NCT01768663|Itraconazole|itraconazole|mesh-list
110102972|NCT01768663|Ciprofloxacin|ciprofloxacin|mesh-list
110102973|NCT01768663|Rifampin|rifampin|mesh-list
110102974|NCT01768663|Ivacaftor|ivacaftor|mesh-list
110102975|NCT01768663|Antifungal Agents|antifungal agents|mesh-ancestor
110102976|NCT01768663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110102977|NCT01768663|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110102978|NCT01768663|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110102979|NCT01768663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110102980|NCT01768663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110102981|NCT01768663|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110102982|NCT01768663|Hormone Antagonists|hormone antagonists|mesh-ancestor
110102983|NCT01768663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110102984|NCT01768663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110102985|NCT01768663|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110102986|NCT01768663|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110102987|NCT01768663|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110102988|NCT01768663|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110102989|NCT01768663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110102990|NCT01768663|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110102991|NCT01768663|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110102992|NCT01768663|Antitubercular Agents|antitubercular agents|mesh-ancestor
110102993|NCT01768663|Leprostatic Agents|leprostatic agents|mesh-ancestor
110161189|NCT03879408|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110102994|NCT01768663|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110102995|NCT01768663|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110102996|NCT01768663|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110102997|NCT01768663|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110102998|NCT01768663|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110102999|NCT01768663|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110103000|NCT01768663|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110103001|NCT01768663|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
110103002|NCT01768663|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110103004|NCT01768741|Hematinics|hematinics|mesh-ancestor
110103005|NCT01768780|Glycopyrrolate|glycopyrrolate|mesh-list
110103006|NCT01768780|Bupivacaine|bupivacaine|mesh-list
110103007|NCT01768780|Cholinergic Antagonists|cholinergic antagonists|mesh-list
110103008|NCT01768780|Anesthetics, Local|anesthetics, local|mesh-ancestor
110103009|NCT01768780|Anesthetics|anesthetics|mesh-ancestor
110103010|NCT01768780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110103011|NCT01768780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110103012|NCT01768780|Sensory System Agents|sensory system agents|mesh-ancestor
110103013|NCT01768780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110103014|NCT01768780|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110103015|NCT01768780|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110103016|NCT01768780|Cholinergic Agents|cholinergic agents|mesh-ancestor
110103017|NCT01768780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110103018|NCT01768780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110103019|NCT01768884|Nitric Oxide|nitric oxide|mesh-list
110103020|NCT01768884|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110103021|NCT01768884|Autonomic Agents|autonomic agents|mesh-ancestor
110103022|NCT01768884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110103023|NCT01768884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110103024|NCT01768884|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110103025|NCT01768884|Respiratory System Agents|respiratory system agents|mesh-ancestor
110103026|NCT01768884|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110103027|NCT01768884|Antioxidants|antioxidants|mesh-ancestor
110103028|NCT01768884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110103029|NCT01768884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110103030|NCT01768884|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
110103031|NCT01768884|Vasodilator Agents|vasodilator agents|mesh-ancestor
110103032|NCT01768884|Gasotransmitters|gasotransmitters|mesh-ancestor
110103033|NCT01768884|Protective Agents|protective agents|mesh-ancestor
110103034|NCT01768897|Thioctic Acid|thioctic acid|mesh-list
110103035|NCT01768897|Cytarabine|cytarabine|mesh-list
110103036|NCT01768897|Mitoxantrone|mitoxantrone|mesh-list
110103037|NCT01768897|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110103038|NCT01768897|Antimetabolites|antimetabolites|mesh-ancestor
110103039|NCT01768897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110103040|NCT01768897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110103041|NCT01768897|Antiviral Agents|antiviral agents|mesh-ancestor
110103042|NCT01768897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110103043|NCT01768897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110103044|NCT01768897|Immunologic Factors|immunologic factors|mesh-ancestor
110103045|NCT01768897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110103046|NCT01768897|Analgesics|analgesics|mesh-ancestor
110103047|NCT01768897|Sensory System Agents|sensory system agents|mesh-ancestor
110103048|NCT01768897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110103049|NCT01768897|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110103050|NCT01768897|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110103051|NCT01768897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110103052|NCT01768897|Antioxidants|antioxidants|mesh-ancestor
110103053|NCT01768897|Protective Agents|protective agents|mesh-ancestor
110103054|NCT01768897|Vitamin B Complex|vitamin b complex|mesh-ancestor
110103055|NCT01768897|Vitamins|vitamins|mesh-ancestor
110103056|NCT01768897|Micronutrients|micronutrients|mesh-ancestor
110103057|NCT01768988|Pregabalin|pregabalin|mesh-list
110103058|NCT01768988|Analgesics|analgesics|mesh-ancestor
110103059|NCT01768988|Sensory System Agents|sensory system agents|mesh-ancestor
110103060|NCT01768988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110103061|NCT01768988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110103062|NCT01768988|Anticonvulsants|anticonvulsants|mesh-ancestor
110103063|NCT01768988|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110103064|NCT01768988|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110103065|NCT01768988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110103066|NCT01768988|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110103067|NCT01768988|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110103068|NCT01768988|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110103069|NCT01768988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110103070|NCT01768988|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110103071|NCT01769040|Rifaximin|rifaximin|mesh-list
110103072|NCT01769040|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110103073|NCT01769040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110103074|NCT01769040|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110103075|NCT01769066|Pemetrexed|pemetrexed|mesh-list
110103076|NCT01769066|Gefitinib|gefitinib|mesh-list
110103077|NCT01769066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110103078|NCT01769066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110400742|NCT01300572|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110103079|NCT01769066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110103080|NCT01769066|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110103081|NCT01769066|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110103082|NCT01769066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110103083|NCT01769079|Isosorbide|isosorbide|mesh-list
110103084|NCT01769079|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110103085|NCT01769079|Diuretics|diuretics|mesh-ancestor
110103086|NCT01769079|Natriuretic Agents|natriuretic agents|mesh-ancestor
110103087|NCT01769079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110103088|NCT01769118|Caffeine|caffeine|mesh-list
110103089|NCT01769118|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110103090|NCT01769118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110103091|NCT01769118|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110103092|NCT01769118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110103093|NCT01769118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110103094|NCT01769118|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110103095|NCT01769118|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110217617|NCT00416377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110103096|NCT01769118|Purinergic Agents|purinergic agents|mesh-ancestor
110103097|NCT01769118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110103098|NCT01769183|Squalamine|squalamine|mesh-list
110103099|NCT01769183|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110103100|NCT01769183|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110103101|NCT01769183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110103102|NCT01769183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110103103|NCT01769183|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110103104|NCT01769183|Protective Agents|protective agents|mesh-ancestor
110103105|NCT01769183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110103106|NCT01769183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110103107|NCT01769183|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110103108|NCT01769183|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110103109|NCT01769183|Growth Substances|growth substances|mesh-ancestor
110103110|NCT01769183|Growth Inhibitors|growth inhibitors|mesh-ancestor
110103111|NCT01769235|Clindamycin|clindamycin|mesh-list
110103112|NCT01769235|Clindamycin palmitate|clindamycin palmitate|mesh-list
110103113|NCT01769235|Clindamycin phosphate|clindamycin phosphate|mesh-list
110103114|NCT01769235|Benzoyl Peroxide|benzoyl peroxide|mesh-list
110103115|NCT01769235|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110103116|NCT01769235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110103117|NCT01769235|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110103118|NCT01769235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110103119|NCT01769235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110103120|NCT01769235|Dermatologic Agents|dermatologic agents|mesh-ancestor
110103122|NCT01769482|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110103123|NCT01769482|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110103124|NCT01769482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110103125|NCT01769482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110103126|NCT01769625|Vitamin D|vitamin d|mesh-list
110103127|NCT01769625|Cholecalciferol|cholecalciferol|mesh-list
110103128|NCT01769625|Celecoxib|celecoxib|mesh-list
110103129|NCT01769625|Vitamins|vitamins|mesh-ancestor
110103130|NCT01769625|Micronutrients|micronutrients|mesh-ancestor
110103131|NCT01769625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110103132|NCT01769625|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110103133|NCT01769625|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110103134|NCT01769625|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110103135|NCT01769625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110103137|NCT01769625|Sensory System Agents|sensory system agents|mesh-ancestor
110103138|NCT01769625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110103139|NCT01769625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110103140|NCT01769625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110103141|NCT01769625|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110103142|NCT01769625|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110103143|NCT01769625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110103144|NCT01769625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110103145|NCT01769651|Methadone|methadone|mesh-list
110103146|NCT01769651|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110103147|NCT01769651|Narcotics|narcotics|mesh-ancestor
110103148|NCT01769651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110400769|NCT01300260|Glucagon|glucagon|mesh-list
110103149|NCT01769651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110103150|NCT01769651|Analgesics|analgesics|mesh-ancestor
110103151|NCT01769651|Sensory System Agents|sensory system agents|mesh-ancestor
110103152|NCT01769651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110103153|NCT01769651|Antitussive Agents|antitussive agents|mesh-ancestor
110103155|NCT01769664|Clindamycin|clindamycin|mesh-list
110103156|NCT01769664|Clindamycin palmitate|clindamycin palmitate|mesh-list
110103157|NCT01769664|Clindamycin phosphate|clindamycin phosphate|mesh-list
110103158|NCT01769664|Benzoyl Peroxide|benzoyl peroxide|mesh-list
110103159|NCT01769664|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110103160|NCT01769664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110103161|NCT01769664|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110103162|NCT01769664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110103163|NCT01769664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110103164|NCT01769664|Dermatologic Agents|dermatologic agents|mesh-ancestor
110103165|NCT01769677|Hydrocodone|hydrocodone|mesh-list
110103166|NCT01769677|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110103167|NCT01769677|Narcotics|narcotics|mesh-ancestor
110103168|NCT01769677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110103169|NCT01769677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110103170|NCT01769677|Analgesics|analgesics|mesh-ancestor
110103171|NCT01769677|Sensory System Agents|sensory system agents|mesh-ancestor
110103172|NCT01769677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110103173|NCT01769677|Antitussive Agents|antitussive agents|mesh-ancestor
110103174|NCT01769677|Respiratory System Agents|respiratory system agents|mesh-ancestor
110103175|NCT01769703|Dabigatran|dabigatran|mesh-list
110103176|NCT01769703|Antithrombins|antithrombins|mesh-ancestor
110103177|NCT01769703|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110103178|NCT01769703|Protease Inhibitors|protease inhibitors|mesh-ancestor
110103179|NCT01769703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110103180|NCT01769703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110103181|NCT01769703|Anticoagulants|anticoagulants|mesh-ancestor
110103182|NCT01769768|Bupropion|bupropion|mesh-list
110103183|NCT01769768|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110103184|NCT01769768|Antidepressive Agents|antidepressive agents|mesh-ancestor
110103185|NCT01769768|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110103186|NCT01769768|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110103187|NCT01769768|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110103188|NCT01769768|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110103189|NCT01769768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110103190|NCT01769768|Dopamine Agents|dopamine agents|mesh-ancestor
110103191|NCT01769768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110103192|NCT01769768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110103193|NCT01769768|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110103194|NCT01769768|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110103195|NCT01769768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110103196|NCT01769781|Anastrozole|anastrozole|mesh-list
110103197|NCT01769781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110103198|NCT01769781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110161210|NCT00388076|Paclitaxel|paclitaxel|mesh-list
110103199|NCT01769781|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110103200|NCT01769781|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110103201|NCT01769781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110103202|NCT01769781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110103203|NCT01769781|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110103204|NCT01769781|Hormone Antagonists|hormone antagonists|mesh-ancestor
110103205|NCT01769781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110103206|NCT01769781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110103207|NCT01769820|Dexamethasone|dexamethasone|mesh-list
110103208|NCT01769820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110103209|NCT01769820|Antiemetics|antiemetics|mesh-ancestor
110103210|NCT01769820|Autonomic Agents|autonomic agents|mesh-ancestor
110103211|NCT01769820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110103212|NCT01769820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110103213|NCT01769820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110103214|NCT01769820|Glucocorticoids|glucocorticoids|mesh-ancestor
110217642|NCT00271336|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110103216|NCT01769820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110103217|NCT01769820|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110103219|NCT01769833|Interferons|interferons|mesh-list
110103220|NCT01769833|Interferon-alpha|interferon-alpha|mesh-list
110103221|NCT01769833|Interferon alpha-2|interferon alpha-2|mesh-list
110103222|NCT01769833|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110103223|NCT01769833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110103224|NCT01769833|Antiviral Agents|antiviral agents|mesh-ancestor
110103225|NCT01769833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110103226|NCT01769833|Immunologic Factors|immunologic factors|mesh-ancestor
110103227|NCT01769833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110103228|NCT01769898|Budesonide|budesonide|mesh-list
110103229|NCT01769898|Theophylline|theophylline|mesh-list
110103230|NCT01769898|Formoterol Fumarate|formoterol fumarate|mesh-list
110103231|NCT01769898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110103232|NCT01769898|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110103233|NCT01769898|Autonomic Agents|autonomic agents|mesh-ancestor
110103234|NCT01769898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110103235|NCT01769898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110103236|NCT01769898|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110103237|NCT01769898|Respiratory System Agents|respiratory system agents|mesh-ancestor
110103238|NCT01769898|Glucocorticoids|glucocorticoids|mesh-ancestor
110103239|NCT01769898|Hormones|hormones|mesh-ancestor
110103240|NCT01769898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110103241|NCT01769898|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110103242|NCT01769898|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110103243|NCT01769898|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110103244|NCT01769898|Adrenergic Agents|adrenergic agents|mesh-ancestor
110103245|NCT01769898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110103246|NCT01769898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110103247|NCT01769898|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110103248|NCT01769898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110103249|NCT01769898|Vasodilator Agents|vasodilator agents|mesh-ancestor
110103250|NCT01769898|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110103251|NCT01769898|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110103252|NCT01769898|Purinergic Agents|purinergic agents|mesh-ancestor
110103253|NCT01769911|Cytarabine|cytarabine|mesh-list
110103254|NCT01769911|Etoposide|etoposide|mesh-list
110103255|NCT01769911|Etoposide phosphate|etoposide phosphate|mesh-list
110103256|NCT01769911|Melphalan|melphalan|mesh-list
110103257|NCT01769911|Carmustine|carmustine|mesh-list
110103258|NCT01769911|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
110103259|NCT01769911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110103260|NCT01769911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110103261|NCT01769911|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110103262|NCT01769911|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110103263|NCT01769911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110103264|NCT01769911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110103265|NCT01769911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110103266|NCT01769911|Antimetabolites|antimetabolites|mesh-ancestor
110103267|NCT01769911|Antiviral Agents|antiviral agents|mesh-ancestor
110103268|NCT01769911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110103269|NCT01769911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110103270|NCT01769911|Immunologic Factors|immunologic factors|mesh-ancestor
110103271|NCT01769911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110103272|NCT01769911|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110103273|NCT01769911|Alkylating Agents|alkylating agents|mesh-ancestor
110103274|NCT01769911|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110103275|NCT01769950|Choline|choline|mesh-list
110103276|NCT01769950|Lipotropic Agents|lipotropic agents|mesh-ancestor
110103277|NCT01769950|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110103278|NCT01769950|Antimetabolites|antimetabolites|mesh-ancestor
110217660|NCT00271414|Anesthetics|anesthetics|mesh-ancestor
110103279|NCT01769950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110103280|NCT01769950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110103281|NCT01769950|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110103282|NCT01769950|Nootropic Agents|nootropic agents|mesh-ancestor
110103283|NCT01770041|Acetaminophen|acetaminophen|mesh-list
110103284|NCT01770041|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110103285|NCT01770041|Analgesics|analgesics|mesh-ancestor
110103286|NCT01770041|Sensory System Agents|sensory system agents|mesh-ancestor
110103287|NCT01770041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110103288|NCT01770041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110103289|NCT01770041|Antipyretics|antipyretics|mesh-ancestor
110103290|NCT01770080|Peppermint oil|peppermint oil|mesh-list
110103291|NCT01770080|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110103292|NCT01770080|Antiemetics|antiemetics|mesh-ancestor
110103293|NCT01770080|Autonomic Agents|autonomic agents|mesh-ancestor
110103294|NCT01770080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110103295|NCT01770080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110103296|NCT01770080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110103297|NCT01770080|Parasympatholytics|parasympatholytics|mesh-ancestor
110103298|NCT01770106|Denosumab|denosumab|mesh-list
110103299|NCT01770106|Alendronate|alendronate|mesh-list
110103300|NCT01770106|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110103301|NCT01770106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110103302|NCT01770132|Gemcitabine|gemcitabine|mesh-list
110103303|NCT01770132|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
110103304|NCT01770132|Hematoporphyrin Derivative|hematoporphyrin derivative|mesh-list
110103306|NCT01770132|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110103307|NCT01770132|Antimetabolites|antimetabolites|mesh-ancestor
110103308|NCT01770132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110103309|NCT01770132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110103310|NCT01770132|Dermatologic Agents|dermatologic agents|mesh-ancestor
110103311|NCT01770132|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110103312|NCT01770171|Paclitaxel|paclitaxel|mesh-list
110103313|NCT01770171|Bevacizumab|bevacizumab|mesh-list
110103314|NCT01770171|Carboplatin|carboplatin|mesh-list
110103315|NCT01770171|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110103316|NCT01770171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110103317|NCT01770171|Tubulin Modulators|tubulin modulators|mesh-ancestor
110103318|NCT01770171|Antimitotic Agents|antimitotic agents|mesh-ancestor
110103319|NCT01770171|Mitosis Modulators|mitosis modulators|mesh-ancestor
110103320|NCT01770171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110103321|NCT01770171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110103322|NCT01770171|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110103323|NCT01770171|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110103324|NCT01770171|Growth Substances|growth substances|mesh-ancestor
110103325|NCT01770171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110103326|NCT01770171|Growth Inhibitors|growth inhibitors|mesh-ancestor
110103327|NCT01770197|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
110103328|NCT01770197|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110103329|NCT01770197|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110103330|NCT01770197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110103331|NCT01770210|Atorvastatin|atorvastatin|mesh-list
110103332|NCT01770210|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110103333|NCT01770210|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110103334|NCT01770210|Antimetabolites|antimetabolites|mesh-ancestor
110103335|NCT01770210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110103336|NCT01770210|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110400797|NCT00637182|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110103337|NCT01770210|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110103338|NCT01770210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110103339|NCT01770223|Ribavirin|ribavirin|mesh-list
110103340|NCT01770223|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110103341|NCT01770223|Antimetabolites|antimetabolites|mesh-ancestor
110161220|NCT00388076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110103342|NCT01770223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110217678|NCT00271804|Bortezomib|bortezomib|mesh-list
110103343|NCT01770223|Antiviral Agents|antiviral agents|mesh-ancestor
110103344|NCT01770223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110103346|NCT01770236|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110103347|NCT01770236|Analgesics|analgesics|mesh-ancestor
110103348|NCT01770236|Sensory System Agents|sensory system agents|mesh-ancestor
110103349|NCT01770236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110103350|NCT01770236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110103351|NCT01770236|Antipyretics|antipyretics|mesh-ancestor
110103352|NCT01770301|Paclitaxel|paclitaxel|mesh-list
110103353|NCT01770301|Bevacizumab|bevacizumab|mesh-list
110103354|NCT01770301|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110103355|NCT01770301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110103356|NCT01770301|Tubulin Modulators|tubulin modulators|mesh-ancestor
110103357|NCT01770301|Antimitotic Agents|antimitotic agents|mesh-ancestor
110103358|NCT01770301|Mitosis Modulators|mitosis modulators|mesh-ancestor
110103359|NCT01770301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110103360|NCT01770301|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110103361|NCT01770301|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110103362|NCT01770301|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110103363|NCT01770301|Growth Substances|growth substances|mesh-ancestor
110103364|NCT01770301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110103365|NCT01770301|Growth Inhibitors|growth inhibitors|mesh-ancestor
110103366|NCT01770444|Cytarabine|cytarabine|mesh-list
110103367|NCT01770444|Thioguanine|thioguanine|mesh-list
110103368|NCT01770444|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110103369|NCT01770444|Antimetabolites|antimetabolites|mesh-ancestor
110103370|NCT01770444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110103371|NCT01770444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110103372|NCT01770444|Antiviral Agents|antiviral agents|mesh-ancestor
110103373|NCT01770444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110103374|NCT01770444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110103375|NCT01770444|Immunologic Factors|immunologic factors|mesh-ancestor
110103376|NCT01770444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110103377|NCT01770470|Chitosan|chitosan|mesh-list
110103379|NCT01770470|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110103380|NCT01770470|Antimetabolites|antimetabolites|mesh-ancestor
110103381|NCT01770470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110103382|NCT01770470|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110103383|NCT01770470|Chelating Agents|chelating agents|mesh-ancestor
110103384|NCT01770470|Sequestering Agents|sequestering agents|mesh-ancestor
110103385|NCT01770470|Hemostatics|hemostatics|mesh-ancestor
110103386|NCT01770470|Coagulants|coagulants|mesh-ancestor
110103387|NCT01770600|Risperidone|risperidone|mesh-list
110103388|NCT01770600|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110103389|NCT01770600|Serotonin Agents|serotonin agents|mesh-ancestor
110103390|NCT01770600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110103391|NCT01770600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110103392|NCT01770600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110103393|NCT01770600|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110103394|NCT01770600|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110400808|NCT01298778|Morphine|morphine|mesh-list
110400809|NCT01298778|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110103395|NCT01770600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110103396|NCT01770600|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110103397|NCT01770600|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110103398|NCT01770600|Dopamine Agents|dopamine agents|mesh-ancestor
110103399|NCT01770769|Cloxacillin|cloxacillin|mesh-list
110103400|NCT01770769|Cephalothin|cephalothin|mesh-list
110103401|NCT01770769|Dalteparin|dalteparin|mesh-list
110103402|NCT01770769|Tinzaparin|tinzaparin|mesh-list
110103403|NCT01770769|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
110103404|NCT01770769|Anticoagulants|anticoagulants|mesh-ancestor
110103405|NCT01770769|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110103406|NCT01770769|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110103407|NCT01770769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110103408|NCT01770769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110103409|NCT01770769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110103410|NCT01770795|Gemcitabine|gemcitabine|mesh-list
110103411|NCT01770795|genexol-PM|genexol-pm|mesh-list
110103412|NCT01770795|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110103413|NCT01770795|Antimetabolites|antimetabolites|mesh-ancestor
110103414|NCT01770795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110103415|NCT01770795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110103416|NCT01770795|Tubulin Modulators|tubulin modulators|mesh-ancestor
110103417|NCT01770795|Antimitotic Agents|antimitotic agents|mesh-ancestor
110103418|NCT01770795|Mitosis Modulators|mitosis modulators|mesh-ancestor
110103419|NCT01770899|Montelukast|montelukast|mesh-list
110103420|NCT01770899|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110103421|NCT01770899|Respiratory System Agents|respiratory system agents|mesh-ancestor
110103422|NCT01770899|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110103423|NCT01770899|Hormone Antagonists|hormone antagonists|mesh-ancestor
110103424|NCT01770899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110103425|NCT01770899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110103426|NCT01770899|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110103427|NCT01770899|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110103428|NCT01770899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110103429|NCT01770964|Pregabalin|pregabalin|mesh-list
110103430|NCT01770964|Analgesics|analgesics|mesh-ancestor
110103431|NCT01770964|Sensory System Agents|sensory system agents|mesh-ancestor
110103432|NCT01770964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110103433|NCT01770964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110103434|NCT01770964|Anticonvulsants|anticonvulsants|mesh-ancestor
110103435|NCT01770964|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110103436|NCT01770964|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110103437|NCT01770964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110103438|NCT01770964|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110103439|NCT01770964|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110103440|NCT01770964|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110103441|NCT01770964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110103442|NCT01770964|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110103443|NCT01771081|Ranibizumab|ranibizumab|mesh-list
110103444|NCT01771081|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110103445|NCT01771081|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110103446|NCT01771081|Growth Substances|growth substances|mesh-ancestor
110103447|NCT01771081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110103448|NCT01771081|Growth Inhibitors|growth inhibitors|mesh-ancestor
110103449|NCT01771081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110103450|NCT01771146|Oxaliplatin|oxaliplatin|mesh-list
110103451|NCT01771146|Irinotecan|irinotecan|mesh-list
110103452|NCT01771146|Folfirinox|folfirinox|mesh-list
110103453|NCT01771146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110103454|NCT01771146|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110103455|NCT01771146|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110103456|NCT01771146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110103457|NCT01771146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110103458|NCT01771185|Metformin|metformin|mesh-list
110103459|NCT01771185|Gliclazide|gliclazide|mesh-list
110103460|NCT01771185|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110103461|NCT01771185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110103462|NCT01771198|Simvastatin|simvastatin|mesh-list
110103463|NCT01771198|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110103464|NCT01771198|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110103465|NCT01771198|Antimetabolites|antimetabolites|mesh-ancestor
110103466|NCT01771198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110103467|NCT01771198|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110103468|NCT01771198|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110103469|NCT01771198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110103470|NCT01771289|Docetaxel|docetaxel|mesh-list
110103471|NCT01771289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110103472|NCT01771289|Tubulin Modulators|tubulin modulators|mesh-ancestor
110103473|NCT01771289|Antimitotic Agents|antimitotic agents|mesh-ancestor
110103474|NCT01771289|Mitosis Modulators|mitosis modulators|mesh-ancestor
110103475|NCT01771289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110103476|NCT01771302|Calcium|calcium|mesh-list
110103477|NCT01771302|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110103478|NCT01771302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110103479|NCT01771328|Hydrocortisone|hydrocortisone|mesh-list
110103480|NCT01771328|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
110103481|NCT01771328|Cortisone|cortisone|mesh-list
110103482|NCT01771328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110103483|NCT01771406|Nebivolol|nebivolol|mesh-list
110103484|NCT01771406|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110103485|NCT01771406|Vasodilator Agents|vasodilator agents|mesh-ancestor
110103486|NCT01771406|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
110103487|NCT01771406|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110103488|NCT01771406|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110103489|NCT01771406|Adrenergic Agents|adrenergic agents|mesh-ancestor
110103490|NCT01771406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110103491|NCT01771406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110103492|NCT01771406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110103493|NCT01771432|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110103494|NCT01771432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110103495|NCT01771445|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
110103496|NCT01771445|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110103498|NCT01771458|Trastuzumab|trastuzumab|mesh-list
110103499|NCT01771458|Everolimus|everolimus|mesh-list
110103500|NCT01771458|Sorafenib|sorafenib|mesh-list
110103501|NCT01771458|Letrozole|letrozole|mesh-list
110103502|NCT01771458|Dasatinib|dasatinib|mesh-list
110103503|NCT01771458|Lapatinib|lapatinib|mesh-list
110103504|NCT01771458|Vemurafenib|vemurafenib|mesh-list
110103505|NCT01771458|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110103506|NCT01771458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110103507|NCT01771458|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110103508|NCT01771458|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110103509|NCT01771458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110103510|NCT01771458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110103511|NCT01771458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110103512|NCT01771458|Immunologic Factors|immunologic factors|mesh-ancestor
110103513|NCT01771458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110103514|NCT01771458|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110103515|NCT01771458|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110103516|NCT01771458|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110103517|NCT01771458|Hormone Antagonists|hormone antagonists|mesh-ancestor
110103518|NCT01771458|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110103519|NCT01771458|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110103520|NCT01771458|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110103521|NCT01771458|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110103522|NCT01771458|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110103523|NCT05318365|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
110103524|NCT05318365|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110103525|NCT05318365|Laxatives|laxatives|mesh-ancestor
110103526|NCT01771783|Enzyme Inhibitors|enzyme inhibitors|mesh-list
110103527|NCT01771783|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
110103528|NCT01771783|Renin Inhibitors|renin inhibitors|mesh-list
110103529|NCT01771783|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
110103530|NCT01771783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110103531|NCT01771783|Protease Inhibitors|protease inhibitors|mesh-ancestor
110103532|NCT01771822|Ibuprofen|ibuprofen|mesh-list
110103533|NCT01771822|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110103534|NCT01771822|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110103535|NCT01771822|Analgesics|analgesics|mesh-ancestor
110103536|NCT01771822|Sensory System Agents|sensory system agents|mesh-ancestor
110103537|NCT01771822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110103538|NCT01771822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110103539|NCT01771822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110103540|NCT01771822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110103541|NCT01771822|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110103542|NCT01771822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110103543|NCT01771822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110103544|NCT01771874|Bupropion|bupropion|mesh-list
110103545|NCT01771874|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
110103546|NCT01771874|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110103547|NCT01771874|Antidepressive Agents|antidepressive agents|mesh-ancestor
110103548|NCT01771874|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110103549|NCT01771874|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110103550|NCT01771874|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110103551|NCT01771874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110103552|NCT01771874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110103553|NCT01771874|Dopamine Agents|dopamine agents|mesh-ancestor
110103554|NCT01771874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110103555|NCT01771874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110103556|NCT01771874|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110103557|NCT01771874|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110103558|NCT01771874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110103559|NCT01771874|Hallucinogens|hallucinogens|mesh-ancestor
110103560|NCT01771874|Serotonin Agents|serotonin agents|mesh-ancestor
110103561|NCT01771874|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110103562|NCT01771874|Adrenergic Agents|adrenergic agents|mesh-ancestor
110103563|NCT01771978|Diltiazem|diltiazem|mesh-list
110103564|NCT01771978|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110103565|NCT01771978|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110103566|NCT01771978|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110103567|NCT01771978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110103568|NCT01771978|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110103569|NCT01771978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110103570|NCT01771978|Vasodilator Agents|vasodilator agents|mesh-ancestor
110103571|NCT01772056|Fluticasone|fluticasone|mesh-list
110103572|NCT01772056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110103573|NCT01772056|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110103574|NCT01772056|Autonomic Agents|autonomic agents|mesh-ancestor
110103575|NCT01772056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110103576|NCT01772056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110103577|NCT01772056|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110103578|NCT01772056|Respiratory System Agents|respiratory system agents|mesh-ancestor
110103579|NCT01772056|Dermatologic Agents|dermatologic agents|mesh-ancestor
110103580|NCT01772056|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110103581|NCT01772212|Terbinafine|terbinafine|mesh-list
110103582|NCT01772212|Antifungal Agents|antifungal agents|mesh-ancestor
110103583|NCT01772212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110103584|NCT01772212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110103585|NCT01772212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110103586|NCT01772238|Amoxicillin|amoxicillin|mesh-list
110103587|NCT01772238|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
110103588|NCT01772238|Clavulanic Acids|clavulanic acids|mesh-list
110103589|NCT01772238|Clavulanic Acid|clavulanic acid|mesh-list
110103590|NCT01772238|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110103591|NCT01772238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110103592|NCT01772238|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110103593|NCT01772238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110103594|NCT01772238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110103595|NCT01772251|Insulin|insulin|mesh-list
110103596|NCT01772251|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110103597|NCT01772251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110103598|NCT01772290|Itraconazole|itraconazole|mesh-list
110103599|NCT01772290|Fluconazole|fluconazole|mesh-list
110103600|NCT01772290|Rabeprazole|rabeprazole|mesh-list
110103601|NCT01772290|Antifungal Agents|antifungal agents|mesh-ancestor
110103602|NCT01772290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110103603|NCT01772290|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110103604|NCT01772290|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110103605|NCT01772290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110103606|NCT01772290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110103607|NCT01772290|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110103608|NCT01772290|Hormone Antagonists|hormone antagonists|mesh-ancestor
110103609|NCT01772290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110103610|NCT01772290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110103611|NCT01772290|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110103612|NCT01772290|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110103613|NCT01772290|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110103614|NCT01772290|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110103615|NCT01772290|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110103616|NCT01772290|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110103617|NCT01772381|Dexamethasone|dexamethasone|mesh-list
110103618|NCT01772381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110103619|NCT01772381|Antiemetics|antiemetics|mesh-ancestor
110103620|NCT01772381|Autonomic Agents|autonomic agents|mesh-ancestor
110103621|NCT01772381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110103622|NCT01772381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110103623|NCT01772381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110103624|NCT01772381|Glucocorticoids|glucocorticoids|mesh-ancestor
110103626|NCT01772381|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110103627|NCT01772381|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110103628|NCT01772381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110103629|NCT01772589|Pyrithione zinc|pyrithione zinc|mesh-list
110103630|NCT01772589|Keratolytic Agents|keratolytic agents|mesh-ancestor
110103631|NCT01772589|Dermatologic Agents|dermatologic agents|mesh-ancestor
110103632|NCT01772615|Ciprofloxacin|ciprofloxacin|mesh-list
110103633|NCT01772615|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110103634|NCT01772615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110103635|NCT01772615|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110103636|NCT01772615|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110103637|NCT01772615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110103638|NCT01772615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110103639|NCT01772615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110103640|NCT01772615|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110103641|NCT01772615|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110103642|NCT01772641|Varenicline|varenicline|mesh-list
110103643|NCT01772641|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110103644|NCT01772641|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110103645|NCT01772641|Cholinergic Agents|cholinergic agents|mesh-ancestor
110103646|NCT01772641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110103647|NCT01772641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110103648|NCT01772641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110103649|NCT01772797|Ceritinib|ceritinib|mesh-list
110103650|NCT01772797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110103651|NCT01772797|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110103652|NCT01772797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110217722|NCT00272584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110103653|NCT01772797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110103654|NCT01772836|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-list
110103655|NCT01772836|Biapenem|biapenem|mesh-list
110103656|NCT01772836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110103657|NCT01772836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110103658|NCT01772836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110103659|NCT01772836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110103660|NCT01772940|Ritonavir|ritonavir|mesh-list
110103661|NCT01772940|Lopinavir|lopinavir|mesh-list
110103662|NCT01772940|Tenofovir|tenofovir|mesh-list
110103663|NCT01772940|Lamivudine|lamivudine|mesh-list
110103664|NCT01772940|Emtricitabine|emtricitabine|mesh-list
110103665|NCT01772940|Zidovudine|zidovudine|mesh-list
110103666|NCT01772940|Nevirapine|nevirapine|mesh-list
110103667|NCT01772940|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110103668|NCT01772940|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110103669|NCT01772940|Protease Inhibitors|protease inhibitors|mesh-ancestor
110103670|NCT01772940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110103671|NCT01772940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110103672|NCT01772940|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110103673|NCT01772940|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110103674|NCT01772940|Antiviral Agents|antiviral agents|mesh-ancestor
110103675|NCT01772940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110103676|NCT01772940|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110103677|NCT01772940|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110103678|NCT01772940|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110103679|NCT01772940|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110103681|NCT01772940|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110103682|NCT01772940|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110103684|NCT01772953|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110103685|NCT01772953|Alkylating Agents|alkylating agents|mesh-ancestor
110103686|NCT01772953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110103687|NCT01772953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110103688|NCT01772979|Trabectedin|trabectedin|mesh-list
110103689|NCT01772979|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110103690|NCT01772979|Alkylating Agents|alkylating agents|mesh-ancestor
110103691|NCT01772979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110103692|NCT01772979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110103693|NCT01773005|Acetaminophen|acetaminophen|mesh-list
110103694|NCT01773005|Ibuprofen|ibuprofen|mesh-list
110103695|NCT01773005|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110103696|NCT01773005|Analgesics|analgesics|mesh-ancestor
110103697|NCT01773005|Sensory System Agents|sensory system agents|mesh-ancestor
110103698|NCT01773005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110103699|NCT01773005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110103700|NCT01773005|Antipyretics|antipyretics|mesh-ancestor
110103701|NCT01773005|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110103702|NCT01773005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110103703|NCT01773005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110103704|NCT01773005|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110103705|NCT01773005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110103706|NCT01773005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110103707|NCT01773044|Lidocaine|lidocaine|mesh-list
110103708|NCT01773044|Anesthetics, Local|anesthetics, local|mesh-ancestor
110103709|NCT01773044|Anesthetics|anesthetics|mesh-ancestor
110400872|NCT04324476|Oxaliplatin|oxaliplatin|mesh-list
110103710|NCT01773044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110035849|NCT01407471|Clobetasol|clobetasol|mesh-list
110103711|NCT01773044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110103712|NCT01773044|Sensory System Agents|sensory system agents|mesh-ancestor
110103713|NCT01773044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110103714|NCT01773044|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110103715|NCT01773044|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110103716|NCT01773044|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110217735|NCT00272701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110103717|NCT01773044|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110103718|NCT01773044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110103721|NCT01773096|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
110103722|NCT01773096|Magnesium Hydroxide|magnesium hydroxide|mesh-list
110103723|NCT01773096|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
110103724|NCT01773096|Cathartics|cathartics|mesh-ancestor
110103725|NCT01773096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110103726|NCT01773096|Laxatives|laxatives|mesh-ancestor
110103727|NCT01773096|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110103728|NCT01773096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110103729|NCT01773096|Sensory System Agents|sensory system agents|mesh-ancestor
110103730|NCT01773096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110103731|NCT01773096|Antacids|antacids|mesh-ancestor
110103732|NCT01773096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110103733|NCT01773096|Antidiarrheals|antidiarrheals|mesh-ancestor
110103734|NCT01773174|Dabigatran|dabigatran|mesh-list
110103735|NCT01773174|Antithrombins|antithrombins|mesh-ancestor
110103736|NCT01773174|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110103737|NCT01773174|Protease Inhibitors|protease inhibitors|mesh-ancestor
110103738|NCT01773174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110103739|NCT01773174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110103740|NCT01773174|Anticoagulants|anticoagulants|mesh-ancestor
110103741|NCT01773408|Cytarabine|cytarabine|mesh-list
110103742|NCT01773408|Daunorubicin|daunorubicin|mesh-list
110103743|NCT01773408|Idarubicin|idarubicin|mesh-list
110103744|NCT01773408|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110103745|NCT01773408|Antimetabolites|antimetabolites|mesh-ancestor
110103746|NCT01773408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110103747|NCT01773408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110103748|NCT01773408|Antiviral Agents|antiviral agents|mesh-ancestor
110103749|NCT01773408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110103750|NCT01773408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110103752|NCT01773408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110103753|NCT01773408|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110103754|NCT01773408|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110103755|NCT01773408|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110103756|NCT01773408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110103757|NCT01773460|Everolimus|everolimus|mesh-list
110103758|NCT01773460|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110103759|NCT01773460|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110103760|NCT01773460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110103761|NCT01773460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110103762|NCT01773460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110103763|NCT01773460|Immunologic Factors|immunologic factors|mesh-ancestor
110103764|NCT01773460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110103765|NCT01773460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110103766|NCT01773512|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110103767|NCT01773512|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110103768|NCT01773512|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110103769|NCT01773512|Antimetabolites|antimetabolites|mesh-ancestor
110103770|NCT01773512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110103771|NCT01773512|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110103772|NCT01773512|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110103773|NCT01773512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110103774|NCT01773538|Rifaximin|rifaximin|mesh-list
110103775|NCT01773538|Lactulose|lactulose|mesh-list
110103776|NCT01773538|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110103777|NCT01773538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110103778|NCT01773538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110103779|NCT01773616|Mycophenolic Acid|mycophenolic acid|mesh-list
110103780|NCT01773616|Prednisolone|prednisolone|mesh-list
110103781|NCT01773616|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110103782|NCT01773616|Methylprednisolone|methylprednisolone|mesh-list
110103783|NCT01773616|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110103784|NCT01773616|Prednisolone acetate|prednisolone acetate|mesh-list
110103785|NCT01773616|Rituximab|rituximab|mesh-list
110103787|NCT01773616|Prednisolone phosphate|prednisolone phosphate|mesh-list
110103788|NCT01773616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110103789|NCT01773616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110103790|NCT01773616|Immunologic Factors|immunologic factors|mesh-ancestor
110103791|NCT01773616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110103792|NCT01773616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110103793|NCT01773616|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110103794|NCT01773616|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110400929|NCT01077076|Omeprazole|omeprazole|mesh-list
110103795|NCT01773616|Antitubercular Agents|antitubercular agents|mesh-ancestor
110103796|NCT01773616|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110103797|NCT01773616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110103798|NCT01773616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110103799|NCT01773616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110103800|NCT01773616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110103802|NCT01773616|Hormones|hormones|mesh-ancestor
110103803|NCT01773616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110103804|NCT01773616|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110103805|NCT01773616|Antiemetics|antiemetics|mesh-ancestor
110103806|NCT01773616|Autonomic Agents|autonomic agents|mesh-ancestor
110103807|NCT01773616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110103808|NCT01773616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110103809|NCT01773616|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110103810|NCT01773616|Protective Agents|protective agents|mesh-ancestor
110103811|NCT01773681|Certolizumab Pegol|certolizumab pegol|mesh-list
110103812|NCT01773681|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110103813|NCT01773681|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110103814|NCT01773681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110103815|NCT01773681|Immunologic Factors|immunologic factors|mesh-ancestor
110103816|NCT01773681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110103817|NCT01773681|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110103818|NCT01773772|Progesterone|progesterone|mesh-list
110103819|NCT01773772|Progestins|progestins|mesh-ancestor
110103820|NCT01773772|Hormones|hormones|mesh-ancestor
110103821|NCT01773772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110103822|NCT01773772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110103823|NCT01773798|Insulin|insulin|mesh-list
110103824|NCT01773798|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110103825|NCT01773798|Insulin Aspart|insulin aspart|mesh-list
110103827|NCT01773798|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
110103828|NCT01773798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110103829|NCT01773798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110103830|NCT01773824|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110103831|NCT01773824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110103832|NCT01773837|Methylphenidate|methylphenidate|mesh-list
110103833|NCT01773837|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110103834|NCT01773837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110103835|NCT01773837|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110103836|NCT01773837|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110103837|NCT01773837|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110103838|NCT01773837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110103839|NCT01773837|Dopamine Agents|dopamine agents|mesh-ancestor
110103840|NCT01773837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110103841|NCT01773876|Micafungin|micafungin|mesh-list
110103842|NCT01773876|Antifungal Agents|antifungal agents|mesh-ancestor
110103843|NCT01773876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110103844|NCT01774370|Dabigatran|dabigatran|mesh-list
110103845|NCT01774370|Antithrombins|antithrombins|mesh-ancestor
110103846|NCT01774370|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110103847|NCT01774370|Protease Inhibitors|protease inhibitors|mesh-ancestor
110103848|NCT01774370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110103849|NCT01774370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110103850|NCT01774370|Anticoagulants|anticoagulants|mesh-ancestor
110103851|NCT01774396|Lidocaine|lidocaine|mesh-list
110103852|NCT01774396|Anesthetics, Local|anesthetics, local|mesh-ancestor
110103853|NCT01774396|Anesthetics|anesthetics|mesh-ancestor
110400950|NCT01253265|Ixekizumab|ixekizumab|mesh-list
110103854|NCT01774396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110103855|NCT01774396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110103856|NCT01774396|Sensory System Agents|sensory system agents|mesh-ancestor
110103857|NCT01774396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110103858|NCT01774396|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110103859|NCT01774396|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110103860|NCT01774396|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110103861|NCT01774396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110103862|NCT01774396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110103863|NCT01774474|Dexamethasone|dexamethasone|mesh-list
110103864|NCT01774474|Dexamethasone acetate|dexamethasone acetate|mesh-list
110103866|NCT01774474|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110103867|NCT01774474|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110103868|NCT01774474|Bromfenac|bromfenac|mesh-list
110103869|NCT01774474|Bevacizumab|bevacizumab|mesh-list
110103870|NCT01774474|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110103871|NCT01774474|BB 1101|bb 1101|mesh-list
110103872|NCT01774474|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110103873|NCT01774474|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110103874|NCT01774474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110103875|NCT01774474|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110103876|NCT01774474|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110103877|NCT01774474|Growth Substances|growth substances|mesh-ancestor
110103878|NCT01774474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110103879|NCT01774474|Growth Inhibitors|growth inhibitors|mesh-ancestor
110103880|NCT01774474|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110103881|NCT01774474|Antiemetics|antiemetics|mesh-ancestor
110103882|NCT01774474|Autonomic Agents|autonomic agents|mesh-ancestor
110103883|NCT01774474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110103884|NCT01774474|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110103885|NCT01774474|Glucocorticoids|glucocorticoids|mesh-ancestor
110103886|NCT01774474|Hormones|hormones|mesh-ancestor
110103887|NCT01774474|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110103888|NCT01774474|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110103889|NCT01774474|Protease Inhibitors|protease inhibitors|mesh-ancestor
110103890|NCT01774474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110103891|NCT01774474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110103892|NCT01774474|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110103893|NCT01774474|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110103894|NCT01774474|Immunologic Factors|immunologic factors|mesh-ancestor
110103895|NCT01774474|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110103896|NCT01774474|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110103897|NCT01774474|Analgesics|analgesics|mesh-ancestor
110103898|NCT01774474|Sensory System Agents|sensory system agents|mesh-ancestor
110103900|NCT01774565|Insulin|insulin|mesh-list
110103901|NCT01774565|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110103902|NCT01774565|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110103903|NCT01774565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110103904|NCT01774812|Ergocalciferols|ergocalciferols|mesh-list
110103905|NCT01774812|Vitamin D|vitamin d|mesh-list
110103906|NCT01774812|Alfacalcidol|alfacalcidol|mesh-list
110103907|NCT01774812|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
110103908|NCT01774812|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110103909|NCT01774812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110103910|NCT01774812|Vitamins|vitamins|mesh-ancestor
110103911|NCT01774812|Micronutrients|micronutrients|mesh-ancestor
110103912|NCT01774812|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110103913|NCT01774838|Clopidogrel|clopidogrel|mesh-list
110103914|NCT01774838|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
110103915|NCT01774838|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110103916|NCT01774838|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110103917|NCT01774838|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110103918|NCT01774838|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110103919|NCT01774838|Purinergic Agents|purinergic agents|mesh-ancestor
110103920|NCT01774838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110103921|NCT01774838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110103922|NCT01774838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110103923|NCT01774864|Udenafil|udenafil|mesh-list
110103924|NCT01774864|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110103925|NCT01774864|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110103926|NCT01774864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110103927|NCT01774864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110103928|NCT01774877|Leflunomide|leflunomide|mesh-list
110103929|NCT01774877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110103930|NCT01774877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110103931|NCT01774877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110103932|NCT01774877|Immunologic Factors|immunologic factors|mesh-ancestor
110161305|NCT00104845|Vaccines|vaccines|mesh-list
110103933|NCT01774877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110103935|NCT01775098|Antimetabolites|antimetabolites|mesh-ancestor
110103936|NCT01775098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110103937|NCT01775098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110103938|NCT01775098|Gout Suppressants|gout suppressants|mesh-ancestor
110103939|NCT01775098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110103940|NCT01775098|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110103941|NCT01775098|Antioxidants|antioxidants|mesh-ancestor
110103942|NCT01775098|Protective Agents|protective agents|mesh-ancestor
110103943|NCT01775098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110103944|NCT01775215|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
110103945|NCT01775215|Natriuretic Agents|natriuretic agents|mesh-ancestor
110103946|NCT01775215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110103947|NCT01775397|Vancomycin|vancomycin|mesh-list
110103948|NCT01775397|Fidaxomicin|fidaxomicin|mesh-list
110103949|NCT01775397|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110103950|NCT01775397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110103951|NCT01775540|Dexamethasone|dexamethasone|mesh-list
110103952|NCT01775540|Lubricant Eye Drops|lubricant eye drops|mesh-list
110103953|NCT01775540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110103954|NCT01775540|Antiemetics|antiemetics|mesh-ancestor
110103955|NCT01775540|Autonomic Agents|autonomic agents|mesh-ancestor
110103956|NCT01775540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110103957|NCT01775540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110103958|NCT01775540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110103959|NCT01775540|Glucocorticoids|glucocorticoids|mesh-ancestor
110103960|NCT01775540|Hormones|hormones|mesh-ancestor
110103961|NCT01775540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110103962|NCT01775540|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110103963|NCT01775540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110103964|NCT01775540|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110103965|NCT01775540|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110103966|NCT01775579|Metformin|metformin|mesh-list
110103967|NCT01775579|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110103968|NCT01775579|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110400988|NCT01292226|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110103969|NCT01775579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110103970|NCT01775579|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110103971|NCT01775579|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110217776|NCT00272896|Vasoactive Intestinal Peptide|vasoactive intestinal peptide|mesh-list
110103973|NCT01775579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110103974|NCT01775579|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110103975|NCT01775579|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110103976|NCT01775579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110103977|NCT01775618|Factor VIII|factor viii|mesh-list
110103978|NCT01775618|Coagulants|coagulants|mesh-ancestor
110103979|NCT01775631|Rituximab|rituximab|mesh-list
110103980|NCT01775631|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110103981|NCT01775631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110103982|NCT01775631|Immunologic Factors|immunologic factors|mesh-ancestor
110103983|NCT01775631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110103984|NCT01775631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110103985|NCT01775761|Moxifloxacin|moxifloxacin|mesh-list
110103986|NCT01775761|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110103987|NCT01775761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110103988|NCT01775761|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110103989|NCT01775761|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110103990|NCT01775761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110103991|NCT01775761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110103992|NCT01775761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110103993|NCT01775839|Aspirin|aspirin|mesh-list
110103994|NCT01775839|Digoxin|digoxin|mesh-list
110103995|NCT01775839|Clopidogrel|clopidogrel|mesh-list
110103996|NCT01775839|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110103997|NCT01775839|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110103998|NCT01775839|Analgesics|analgesics|mesh-ancestor
110103999|NCT01775839|Sensory System Agents|sensory system agents|mesh-ancestor
110104000|NCT01775839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110104001|NCT01775839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110104002|NCT01775839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110104003|NCT01775839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110104004|NCT01775839|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110104005|NCT01775839|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110104006|NCT01775839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110104007|NCT01775839|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110104008|NCT01775839|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110104009|NCT01775839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110104010|NCT01775839|Antipyretics|antipyretics|mesh-ancestor
110104011|NCT01775839|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110104012|NCT01775839|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110104013|NCT01775839|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110104014|NCT01775839|Purinergic Agents|purinergic agents|mesh-ancestor
110104015|NCT01775839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110104016|NCT01775839|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110104017|NCT01775839|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110104018|NCT01775839|Protective Agents|protective agents|mesh-ancestor
110104019|NCT01775891|Flecainide|flecainide|mesh-list
110104020|NCT01775891|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
110104021|NCT01775891|Propafenone|propafenone|mesh-list
110104022|NCT01775891|Pilsicainide|pilsicainide|mesh-list
110104023|NCT01775891|Lidocaine|lidocaine|mesh-list
110104024|NCT01775891|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110104025|NCT01775891|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110104026|NCT01775891|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110104027|NCT01775891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110104028|NCT01775891|Anesthetics, Local|anesthetics, local|mesh-ancestor
110104030|NCT01775891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110104031|NCT01775891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110104032|NCT01775891|Sensory System Agents|sensory system agents|mesh-ancestor
110104033|NCT01775891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110104034|NCT01776047|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
110104035|NCT01776047|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110217792|NCT00273013|Hormone Antagonists|hormone antagonists|mesh-ancestor
110104036|NCT01776203|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
110104037|NCT01776203|Medroxyprogesterone|medroxyprogesterone|mesh-list
110104038|NCT01776203|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110104039|NCT01776203|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110104040|NCT01776203|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110104041|NCT01776203|Contraceptive Agents|contraceptive agents|mesh-ancestor
110104042|NCT01776203|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110104043|NCT01776203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110104044|NCT01776203|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110104045|NCT01776203|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110104046|NCT01776203|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110104047|NCT01776203|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110104048|NCT01776203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110104049|NCT01776320|Alprostadil|alprostadil|mesh-list
110104050|NCT01776320|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110104051|NCT01776320|Vasodilator Agents|vasodilator agents|mesh-ancestor
110104052|NCT01776320|Urological Agents|urological agents|mesh-ancestor
110104053|NCT01776437|Talazoparib|talazoparib|mesh-list
110104054|NCT01776437|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110104055|NCT01776437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110104056|NCT01776437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110104057|NCT01776437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110104058|NCT01776515|Acetaminophen|acetaminophen|mesh-list
110104059|NCT01776515|Tramadol|tramadol|mesh-list
110104060|NCT01776515|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110104061|NCT01776515|Analgesics|analgesics|mesh-ancestor
110104062|NCT01776515|Sensory System Agents|sensory system agents|mesh-ancestor
110104063|NCT01776515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110104064|NCT01776515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110104065|NCT01776515|Antipyretics|antipyretics|mesh-ancestor
110104066|NCT01776515|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110104068|NCT01776515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110104069|NCT01776567|Everolimus|everolimus|mesh-list
110104070|NCT01776567|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110104071|NCT01776567|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110104072|NCT01776567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110104073|NCT01776567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110104074|NCT01776567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110104075|NCT01776567|Immunologic Factors|immunologic factors|mesh-ancestor
110104076|NCT01776567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110104077|NCT01776567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110104078|NCT01776671|Gabapentin|gabapentin|mesh-list
110104079|NCT01776671|Analgesics|analgesics|mesh-ancestor
110104080|NCT01776671|Sensory System Agents|sensory system agents|mesh-ancestor
110104081|NCT01776671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110104082|NCT01776671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110104083|NCT01776671|Anticonvulsants|anticonvulsants|mesh-ancestor
110104084|NCT01776671|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110104085|NCT01776671|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110104086|NCT01776671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110104087|NCT01776671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110104088|NCT01776671|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110104089|NCT01776671|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110104090|NCT01776671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110368560|NCT04652115|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110104091|NCT01776671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110104092|NCT01776671|Antimanic Agents|antimanic agents|mesh-ancestor
110104093|NCT01776684|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110104094|NCT01776684|Gefitinib|gefitinib|mesh-list
110104095|NCT01776684|Afatinib|afatinib|mesh-list
110104096|NCT01776684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110104097|NCT01776684|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110104098|NCT01776684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110104099|NCT01776684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110104101|NCT01776788|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110104102|NCT01776788|Exenatide|exenatide|mesh-list
110104103|NCT01776788|Insulin Lispro|insulin lispro|mesh-list
110104104|NCT01776788|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110104105|NCT01776788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110104106|NCT01776788|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110104107|NCT01776788|Incretins|incretins|mesh-ancestor
110104108|NCT01776788|Hormones|hormones|mesh-ancestor
110104109|NCT01776788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110104110|NCT01776853|Levan|levan|mesh-list
110104111|NCT01776853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110104112|NCT01776970|Nabiximols|nabiximols|mesh-list
110104113|NCT01776970|Analgesics|analgesics|mesh-ancestor
110104114|NCT01776970|Sensory System Agents|sensory system agents|mesh-ancestor
110104115|NCT01776970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110104116|NCT01776970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110104117|NCT01777087|Capsaicin|capsaicin|mesh-list
110104118|NCT01777087|Antipruritics|antipruritics|mesh-ancestor
110104119|NCT01777087|Dermatologic Agents|dermatologic agents|mesh-ancestor
110104120|NCT01777087|Sensory System Agents|sensory system agents|mesh-ancestor
110104121|NCT01777087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110104122|NCT01777087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110104123|NCT01777100|Sufentanil|sufentanil|mesh-list
110104124|NCT01777100|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110104125|NCT01777100|Narcotics|narcotics|mesh-ancestor
110104126|NCT01777100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110104127|NCT01777100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110104128|NCT01777100|Analgesics|analgesics|mesh-ancestor
110104129|NCT01777100|Sensory System Agents|sensory system agents|mesh-ancestor
110104130|NCT01777100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110104131|NCT01777100|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110104132|NCT01777100|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110104133|NCT01777100|Anesthetics, General|anesthetics, general|mesh-ancestor
110104134|NCT01777100|Anesthetics|anesthetics|mesh-ancestor
110104135|NCT01777347|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110104136|NCT01777464|Histamine|histamine|mesh-list
110104137|NCT01777464|Histamine Agonists|histamine agonists|mesh-ancestor
110104138|NCT01777464|Histamine Agents|histamine agents|mesh-ancestor
110104139|NCT01777464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110104140|NCT01777464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110104141|NCT01777464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110104142|NCT01777477|Chloroquine|chloroquine|mesh-list
110104143|NCT01777477|Gemcitabine|gemcitabine|mesh-list
110104144|NCT01777477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110104145|NCT01777477|Antimetabolites|antimetabolites|mesh-ancestor
110401038|NCT04306042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110104146|NCT01777477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110104147|NCT01777477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110104148|NCT01777477|Amebicides|amebicides|mesh-ancestor
110104149|NCT01777477|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110104150|NCT01777477|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110104151|NCT01777477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110104152|NCT01777477|Antimalarials|antimalarials|mesh-ancestor
110104153|NCT01777477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110104154|NCT01777503|Clopidogrel|clopidogrel|mesh-list
110104155|NCT01777503|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
110104156|NCT01777503|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110104157|NCT01777503|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110104158|NCT01777503|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110104159|NCT01777503|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110104160|NCT01777503|Purinergic Agents|purinergic agents|mesh-ancestor
110104161|NCT01777503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110104162|NCT01777503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110104163|NCT01777503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110104164|NCT01777685|Sulpiride|sulpiride|mesh-list
110104165|NCT01777685|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110217811|NCT00107874|Misoprostol|misoprostol|mesh-list
110104166|NCT01777685|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110104167|NCT01777685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110104168|NCT01777685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110104169|NCT01777685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110104170|NCT01777685|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110104171|NCT01777685|Dopamine Agents|dopamine agents|mesh-ancestor
110104172|NCT01777685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110104173|NCT01777685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110104174|NCT01777685|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110104175|NCT01777685|Antidepressive Agents|antidepressive agents|mesh-ancestor
110104176|NCT01777737|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
110104177|NCT01777737|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110104178|NCT01777737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110104179|NCT01777737|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110104180|NCT01777737|Antimalarials|antimalarials|mesh-ancestor
110104181|NCT01777737|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110104182|NCT01777737|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110104183|NCT01777867|Methacholine Chloride|methacholine chloride|mesh-list
110104184|NCT01777867|Miotics|miotics|mesh-ancestor
110104185|NCT01777867|Autonomic Agents|autonomic agents|mesh-ancestor
110104186|NCT01777867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110104187|NCT01777867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110104188|NCT01777867|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110104189|NCT01777867|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
110104190|NCT01777867|Respiratory System Agents|respiratory system agents|mesh-ancestor
110104191|NCT01777867|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
110104192|NCT01777867|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110104193|NCT01777867|Cholinergic Agents|cholinergic agents|mesh-ancestor
110104194|NCT01777867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110104195|NCT01777867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110104196|NCT01777919|Copper|copper|mesh-list
110104197|NCT01777919|Temozolomide|temozolomide|mesh-list
110104198|NCT01777919|Disulfiram|disulfiram|mesh-list
110104199|NCT01777919|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110104200|NCT01777919|Alkylating Agents|alkylating agents|mesh-ancestor
110104201|NCT01777919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110104202|NCT01777919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110104203|NCT01777919|Trace Elements|trace elements|mesh-ancestor
110104204|NCT01777919|Micronutrients|micronutrients|mesh-ancestor
110104205|NCT01777919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110104206|NCT01777919|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110104207|NCT01777919|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
110104208|NCT01777919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110104209|NCT01778075|Acetaminophen|acetaminophen|mesh-list
110104210|NCT01778075|Tramadol|tramadol|mesh-list
110104211|NCT01778075|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110104212|NCT01778075|Analgesics|analgesics|mesh-ancestor
110104213|NCT01778075|Sensory System Agents|sensory system agents|mesh-ancestor
110104214|NCT01778075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110104215|NCT01778075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110104216|NCT01778075|Antipyretics|antipyretics|mesh-ancestor
110104217|NCT01778075|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110104218|NCT01778075|Narcotics|narcotics|mesh-ancestor
110104219|NCT01778075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110104220|NCT01778101|Lansoprazole|lansoprazole|mesh-list
110104221|NCT01778101|Dexlansoprazole|dexlansoprazole|mesh-list
110104222|NCT01778101|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110104223|NCT01778101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110104224|NCT01778101|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110104225|NCT01778101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110104226|NCT01778101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110104227|NCT01778114|Vitamin D|vitamin d|mesh-list
110104228|NCT01778114|Ergocalciferols|ergocalciferols|mesh-list
110217832|NCT00273442|Timolol|timolol|mesh-list
110104229|NCT01778114|Cholecalciferol|cholecalciferol|mesh-list
110104230|NCT01778114|Vitamins|vitamins|mesh-list
110104231|NCT01778114|Micronutrients|micronutrients|mesh-ancestor
110104232|NCT01778114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110104233|NCT01778114|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110104234|NCT01778114|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110104235|NCT01778192|Magnesium citrate|magnesium citrate|mesh-list
110104236|NCT01778192|Picosulfate sodium|picosulfate sodium|mesh-list
110104237|NCT01778192|Citric Acid|citric acid|mesh-list
110104238|NCT01778192|Sodium Citrate|sodium citrate|mesh-list
110104239|NCT01778192|Anticoagulants|anticoagulants|mesh-ancestor
110104240|NCT01778192|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110104241|NCT01778192|Chelating Agents|chelating agents|mesh-ancestor
110104242|NCT01778192|Sequestering Agents|sequestering agents|mesh-ancestor
110104243|NCT01778192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110104244|NCT01778192|Cathartics|cathartics|mesh-ancestor
110104245|NCT01778192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110104246|NCT01778218|Deoxyglucose|deoxyglucose|mesh-list
110104247|NCT01778218|Antimetabolites|antimetabolites|mesh-ancestor
110104248|NCT01778218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110104249|NCT01778218|Antiviral Agents|antiviral agents|mesh-ancestor
110104250|NCT01778218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110104251|NCT01778244|Metformin|metformin|mesh-list
110104252|NCT01778244|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110104253|NCT01778244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110104254|NCT01778283|Dialysis Solutions|dialysis solutions|mesh-list
110104255|NCT01778283|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110104256|NCT01778309|Acetylcysteine|acetylcysteine|mesh-list
110104257|NCT01778309|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110104258|NCT01778309|Antiviral Agents|antiviral agents|mesh-ancestor
110104259|NCT01778309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110104260|NCT01778309|Expectorants|expectorants|mesh-ancestor
110104261|NCT01778309|Respiratory System Agents|respiratory system agents|mesh-ancestor
110104262|NCT01778309|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110104263|NCT01778309|Antioxidants|antioxidants|mesh-ancestor
110104264|NCT01778309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110104265|NCT01778309|Protective Agents|protective agents|mesh-ancestor
110104266|NCT01778309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110104267|NCT01778309|Antidotes|antidotes|mesh-ancestor
110104268|NCT01778400|Ethanol|ethanol|mesh-list
110104269|NCT01778400|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110104270|NCT01778400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110104271|NCT01778400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110104272|NCT01778400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110104273|NCT01778413|Tenofovir|tenofovir|mesh-list
110104274|NCT01778413|Emtricitabine|emtricitabine|mesh-list
110104275|NCT01778413|Efavirenz|efavirenz|mesh-list
110104276|NCT01778413|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110104277|NCT01778413|Antiviral Agents|antiviral agents|mesh-ancestor
110104278|NCT01778413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110104279|NCT01778413|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110104280|NCT01778413|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110104281|NCT01778413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110104282|NCT01778413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110104283|NCT01778413|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110104284|NCT01778413|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110104285|NCT01778413|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110104286|NCT01778413|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110104287|NCT01778413|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110104288|NCT01778413|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110104289|NCT01778413|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110104290|NCT01778413|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110104291|NCT01778647|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
110104292|NCT01778647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110104293|NCT01778686|Pindolol|pindolol|mesh-list
110104294|NCT01778686|Citalopram|citalopram|mesh-list
110104295|NCT01778686|Tryptophan|tryptophan|mesh-list
110104296|NCT01778686|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110104297|NCT01778686|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110104298|NCT01778686|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110217833|NCT00273442|Dorzolamide|dorzolamide|mesh-list
110104299|NCT01778686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110104300|NCT01778686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110104301|NCT01778686|Serotonin Agents|serotonin agents|mesh-ancestor
110104302|NCT01778686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110104303|NCT01778686|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110104304|NCT01778686|Antidepressive Agents|antidepressive agents|mesh-ancestor
110104305|NCT01778686|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110104306|NCT01778686|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110104307|NCT01778686|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110104308|NCT01778686|Adrenergic Agents|adrenergic agents|mesh-ancestor
110104309|NCT01778686|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110104310|NCT01778686|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110104311|NCT01778686|Vasodilator Agents|vasodilator agents|mesh-ancestor
110104313|NCT01778803|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110104314|NCT01778803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110104315|NCT01778803|Tubulin Modulators|tubulin modulators|mesh-ancestor
110104316|NCT01778803|Antimitotic Agents|antimitotic agents|mesh-ancestor
110104317|NCT01778803|Mitosis Modulators|mitosis modulators|mesh-ancestor
110104318|NCT01778803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110104320|NCT01778842|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
110104321|NCT01778842|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110104322|NCT01778842|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110104323|NCT01778842|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110104324|NCT01778842|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110104325|NCT01778842|Purinergic Agents|purinergic agents|mesh-ancestor
110104326|NCT01778842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110104327|NCT01778842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110104328|NCT01778842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110104329|NCT01779089|Minocycline|minocycline|mesh-list
110104330|NCT01779089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110104331|NCT01779089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110104332|NCT01779232|Danazol|danazol|mesh-list
110104333|NCT01779232|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110104334|NCT01779232|Hormone Antagonists|hormone antagonists|mesh-ancestor
110104335|NCT01779232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110104336|NCT01779232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110104337|NCT01779245|Calcium|calcium|mesh-list
110104338|NCT01779245|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110104339|NCT01779245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110104341|NCT01779258|Glycerol|glycerol|mesh-list
110104342|NCT01779258|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
110104343|NCT01779258|Protective Agents|protective agents|mesh-ancestor
110104344|NCT01779258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110104345|NCT01779258|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110104346|NCT01779271|Loxoprofen|loxoprofen|mesh-list
110104347|NCT01779271|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110104348|NCT01779271|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110104350|NCT01779271|Sensory System Agents|sensory system agents|mesh-ancestor
110104351|NCT01779271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110104352|NCT01779271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110104353|NCT01779271|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110161338|NCT00105352|Glucagon|glucagon|mesh-list
110104354|NCT01779271|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110104356|NCT01779284|Travoprost|travoprost|mesh-list
110104357|NCT01779284|Latanoprost|latanoprost|mesh-list
110104358|NCT01779284|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110104359|NCT01779284|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110104360|NCT01779284|Adrenergic Agents|adrenergic agents|mesh-ancestor
110104361|NCT01779284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110104362|NCT01779284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110217837|NCT00273442|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110104363|NCT01779284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110104364|NCT01779284|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110104365|NCT01779284|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110104366|NCT01779284|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110104367|NCT01779284|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110104368|NCT01779362|Metformin|metformin|mesh-list
110104369|NCT01779362|Insulin Glargine|insulin glargine|mesh-list
110104370|NCT01779362|Liraglutide|liraglutide|mesh-list
110104371|NCT01779362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110104372|NCT01779362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110104373|NCT01779362|Incretins|incretins|mesh-ancestor
110104374|NCT01779362|Hormones|hormones|mesh-ancestor
110104375|NCT01779362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110104376|NCT01779401|Aspirin|aspirin|mesh-list
110104377|NCT01779401|Cilostazol|cilostazol|mesh-list
110104378|NCT01779401|Clopidogrel|clopidogrel|mesh-list
110104379|NCT01779401|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110104380|NCT01779401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110104381|NCT01779401|Analgesics|analgesics|mesh-ancestor
110104382|NCT01779401|Sensory System Agents|sensory system agents|mesh-ancestor
110104383|NCT01779401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110104384|NCT01779401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110104385|NCT01779401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110104386|NCT01779401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110104387|NCT01779401|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110104388|NCT01779401|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110104389|NCT01779401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110104390|NCT01779401|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110104391|NCT01779401|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110104392|NCT01779401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110104393|NCT01779401|Antipyretics|antipyretics|mesh-ancestor
110104394|NCT01779401|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110104395|NCT01779401|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110104397|NCT01779401|Purinergic Agents|purinergic agents|mesh-ancestor
110104398|NCT01779401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110104399|NCT01779401|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110104400|NCT01779401|Autonomic Agents|autonomic agents|mesh-ancestor
110104401|NCT01779401|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110104402|NCT01779401|Respiratory System Agents|respiratory system agents|mesh-ancestor
110104403|NCT01779401|Vasodilator Agents|vasodilator agents|mesh-ancestor
110104404|NCT01779401|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110104405|NCT01779401|Protective Agents|protective agents|mesh-ancestor
110104406|NCT01779401|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110104407|NCT01779401|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110104408|NCT01779466|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
110104409|NCT01779466|Hemostatics|hemostatics|mesh-ancestor
110104410|NCT01779466|Coagulants|coagulants|mesh-ancestor
110104411|NCT01779466|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
110104412|NCT01779466|Natriuretic Agents|natriuretic agents|mesh-ancestor
110104413|NCT01779466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110104414|NCT01779479|Paclitaxel|paclitaxel|mesh-list
110104415|NCT01779479|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110104416|NCT01779479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110104417|NCT01779479|Tubulin Modulators|tubulin modulators|mesh-ancestor
110104418|NCT01779479|Antimitotic Agents|antimitotic agents|mesh-ancestor
110104419|NCT01779479|Mitosis Modulators|mitosis modulators|mesh-ancestor
110104420|NCT01779479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110104421|NCT01779492|Oxycodone|oxycodone|mesh-list
110104422|NCT01779492|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110104423|NCT01779492|Narcotics|narcotics|mesh-ancestor
110104424|NCT01779492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110104425|NCT01779492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110104426|NCT01779492|Analgesics|analgesics|mesh-ancestor
110104427|NCT01779492|Sensory System Agents|sensory system agents|mesh-ancestor
110104429|NCT01779518|Interferons|interferons|mesh-list
110104430|NCT01779518|Ribavirin|ribavirin|mesh-list
110104431|NCT01779518|Sofosbuvir|sofosbuvir|mesh-list
110104432|NCT01779518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110104433|NCT01779518|Antiviral Agents|antiviral agents|mesh-ancestor
110104434|NCT01779518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110104435|NCT01779518|Antimetabolites|antimetabolites|mesh-ancestor
110104436|NCT01779518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110104437|NCT01779596|Bosentan|bosentan|mesh-list
110104438|NCT01779596|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110104439|NCT01779596|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
110104440|NCT01779596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110104441|NCT01779609|Bosentan|bosentan|mesh-list
110104442|NCT01779609|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110104443|NCT01779609|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
110104444|NCT01779609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110104445|NCT01779687|Raltegravir Potassium|raltegravir potassium|mesh-list
110104446|NCT01779687|Atorvastatin|atorvastatin|mesh-list
110104447|NCT01779687|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110104448|NCT01779687|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110104449|NCT01779687|Antimetabolites|antimetabolites|mesh-ancestor
110104450|NCT01779687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110104451|NCT01779687|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110104452|NCT01779687|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110104453|NCT01779687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110104454|NCT01779687|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110104455|NCT01779687|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110104456|NCT01779687|Antiviral Agents|antiviral agents|mesh-ancestor
110104457|NCT01779687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110104458|NCT01779687|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110104459|NCT01779687|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110104460|NCT01779830|Zolpidem|zolpidem|mesh-list
110104461|NCT01779830|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110104462|NCT01779830|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110104463|NCT01779830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110104464|NCT01779830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110104465|NCT01779830|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
110104466|NCT01779830|GABA Agonists|gaba agonists|mesh-ancestor
110104467|NCT01779830|GABA Agents|gaba agents|mesh-ancestor
110104468|NCT01779830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110104469|NCT01779830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110104470|NCT01779843|Cytarabine|cytarabine|mesh-list
110104471|NCT01779843|Idarubicin|idarubicin|mesh-list
110104472|NCT01779843|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110104473|NCT01779843|Antimetabolites|antimetabolites|mesh-ancestor
110104474|NCT01779843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110104475|NCT01779843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110104476|NCT01779843|Antiviral Agents|antiviral agents|mesh-ancestor
110104477|NCT01779843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110104478|NCT01779843|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110104479|NCT01779843|Immunologic Factors|immunologic factors|mesh-ancestor
110104480|NCT01779843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110104481|NCT01779843|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110104482|NCT01779843|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110104483|NCT01779843|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110104484|NCT01779843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110104485|NCT01779882|Cyclophosphamide|cyclophosphamide|mesh-list
110104486|NCT01779882|Busulfan|busulfan|mesh-list
110104487|NCT01779882|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110104488|NCT01779882|Immunologic Factors|immunologic factors|mesh-ancestor
110104489|NCT01779882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110104490|NCT01779882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110104491|NCT01779882|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110104492|NCT01779882|Alkylating Agents|alkylating agents|mesh-ancestor
110104493|NCT01779882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110104494|NCT01779882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110104495|NCT01779882|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110104497|NCT01779908|Vitamins|vitamins|mesh-ancestor
110104498|NCT01779908|Micronutrients|micronutrients|mesh-ancestor
110161343|NCT03862950|Metformin|metformin|mesh-list
110104499|NCT01779908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110104500|NCT01779908|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110104502|NCT01779921|Hemostatics|hemostatics|mesh-ancestor
110104503|NCT01779921|Coagulants|coagulants|mesh-ancestor
110104504|NCT01780051|Metformin|metformin|mesh-list
110104505|NCT01780051|Repaglinide|repaglinide|mesh-list
110104506|NCT01780051|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110104507|NCT01780051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110104508|NCT01780181|Gemcitabine|gemcitabine|mesh-list
110104509|NCT01780181|Docetaxel|docetaxel|mesh-list
110104510|NCT01780181|Vinorelbine|vinorelbine|mesh-list
110104511|NCT01780181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110104512|NCT01780181|Antimetabolites|antimetabolites|mesh-ancestor
110104513|NCT01780181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110104514|NCT01780181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110104515|NCT01780181|Tubulin Modulators|tubulin modulators|mesh-ancestor
110104516|NCT01780181|Antimitotic Agents|antimitotic agents|mesh-ancestor
110104517|NCT01780181|Mitosis Modulators|mitosis modulators|mesh-ancestor
110104518|NCT01780181|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110104519|NCT01780233|Fentanyl|fentanyl|mesh-list
110104520|NCT01780233|Naltrexone|naltrexone|mesh-list
110104521|NCT01780233|Citric Acid|citric acid|mesh-list
110104522|NCT01780233|Sodium Citrate|sodium citrate|mesh-list
110104523|NCT01780233|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110104524|NCT01780233|Narcotics|narcotics|mesh-ancestor
110104525|NCT01780233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110104526|NCT01780233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110104527|NCT01780233|Analgesics|analgesics|mesh-ancestor
110104528|NCT01780233|Sensory System Agents|sensory system agents|mesh-ancestor
110104529|NCT01780233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110104530|NCT01780233|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110104531|NCT01780233|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110104532|NCT01780233|Anesthetics, General|anesthetics, general|mesh-ancestor
110104533|NCT01780233|Anesthetics|anesthetics|mesh-ancestor
110104534|NCT01780233|Anticoagulants|anticoagulants|mesh-ancestor
110104535|NCT01780233|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110104536|NCT01780233|Chelating Agents|chelating agents|mesh-ancestor
110104537|NCT01780233|Sequestering Agents|sequestering agents|mesh-ancestor
110104538|NCT01780233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110104539|NCT01780233|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110104540|NCT01780233|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110104541|NCT01780259|Triazolam|triazolam|mesh-list
110104542|NCT01780259|Esketamine|esketamine|mesh-list
110104543|NCT01780259|Antidepressive Agents|antidepressive agents|mesh-ancestor
110104544|NCT01780259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110104545|NCT01780259|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110104546|NCT01780259|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110104547|NCT01780259|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110104548|NCT01780259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110104549|NCT01780259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110104550|NCT01780259|GABA Modulators|gaba modulators|mesh-ancestor
110104551|NCT01780259|GABA Agents|gaba agents|mesh-ancestor
110104552|NCT01780259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110104553|NCT01780259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110104554|NCT01780311|Sotalol|sotalol|mesh-list
110104555|NCT01780311|Flecainide|flecainide|mesh-list
110104556|NCT01780311|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
110104557|NCT01780311|Propafenone|propafenone|mesh-list
110161351|NCT00105547|Analgesics|analgesics|mesh-ancestor
110104558|NCT01780311|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110104559|NCT01780311|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110104560|NCT01780311|Adrenergic Agents|adrenergic agents|mesh-ancestor
110104561|NCT01780311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110104562|NCT01780311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110104563|NCT01780311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110104564|NCT01780311|Sympatholytics|sympatholytics|mesh-ancestor
110104565|NCT01780311|Autonomic Agents|autonomic agents|mesh-ancestor
110104566|NCT01780311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110104567|NCT01780311|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110104568|NCT01780311|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110104569|NCT01780311|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110104570|NCT01780467|Dopamine|dopamine|mesh-list
110104571|NCT01780467|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110104572|NCT01780467|Sympathomimetics|sympathomimetics|mesh-ancestor
110104573|NCT01780467|Autonomic Agents|autonomic agents|mesh-ancestor
110104574|NCT01780467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110104575|NCT01780467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110104576|NCT01780467|Dopamine Agents|dopamine agents|mesh-ancestor
110104577|NCT01780467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110104578|NCT01780467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110104579|NCT01780467|Protective Agents|protective agents|mesh-ancestor
110104581|NCT01780519|Anticonvulsants|anticonvulsants|mesh-ancestor
110104582|NCT01780519|Antiemetics|antiemetics|mesh-ancestor
110104583|NCT01780519|Autonomic Agents|autonomic agents|mesh-ancestor
110104584|NCT01780519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110104585|NCT01780519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110104586|NCT01780519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110104587|NCT01780519|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110104588|NCT01780519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110104589|NCT01780519|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110104590|NCT01780519|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110104591|NCT01780519|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110104592|NCT01780519|GABA Modulators|gaba modulators|mesh-ancestor
110104593|NCT01780519|GABA Agents|gaba agents|mesh-ancestor
110104594|NCT01780519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110104595|NCT01780519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110104596|NCT01780558|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110104597|NCT01780558|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110104598|NCT01780558|Hormones|hormones|mesh-list
110104599|NCT01780558|Estradiol|estradiol|mesh-list
110104600|NCT01780558|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110104601|NCT01780558|Progesterone|progesterone|mesh-list
110104602|NCT01780558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110104603|NCT01780558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110104604|NCT01780558|Estrogens|estrogens|mesh-ancestor
110104605|NCT01780558|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110104606|NCT01780558|Contraceptive Agents|contraceptive agents|mesh-ancestor
110104607|NCT01780558|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110104608|NCT01780558|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110104609|NCT01780558|Progestins|progestins|mesh-ancestor
110104610|NCT01780610|Letrozole|letrozole|mesh-list
110104611|NCT01780610|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110104612|NCT01780610|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110104613|NCT01780610|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
110104614|NCT01780610|Hormones|hormones|mesh-list
110104615|NCT01780610|Estradiol|estradiol|mesh-list
110104616|NCT01780610|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110104617|NCT01780610|Progesterone|progesterone|mesh-list
110104618|NCT01780610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110104619|NCT01780610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110104620|NCT01780610|Estrogens|estrogens|mesh-ancestor
110104621|NCT01780610|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110104622|NCT01780610|Contraceptive Agents|contraceptive agents|mesh-ancestor
110104623|NCT01780610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110104624|NCT01780610|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110104625|NCT01780610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110104626|NCT01780610|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110104627|NCT01780610|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110104628|NCT01780610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110104629|NCT01780610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110104630|NCT01780610|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110104631|NCT01780610|Hormone Antagonists|hormone antagonists|mesh-ancestor
110104632|NCT01780610|Progestins|progestins|mesh-ancestor
110104633|NCT01780740|Atorvastatin|atorvastatin|mesh-list
110104634|NCT01780740|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110104635|NCT01780740|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110104636|NCT01780740|Antimetabolites|antimetabolites|mesh-ancestor
110104637|NCT01780740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110104638|NCT01780740|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110104639|NCT01780740|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110104640|NCT01780740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110104641|NCT01780753|Primaquine|primaquine|mesh-list
110104642|NCT01780753|Antimalarials|antimalarials|mesh-ancestor
110104643|NCT01780753|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110104644|NCT01780753|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110104645|NCT01780753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110104646|NCT01780909|Paromomycin|paromomycin|mesh-list
110104647|NCT01780909|Domperidone|domperidone|mesh-list
110104648|NCT01780909|Loperamide|loperamide|mesh-list
110104649|NCT01780909|Antidiarrheals|antidiarrheals|mesh-list
110104650|NCT01780909|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110104651|NCT01780909|Antiemetics|antiemetics|mesh-ancestor
110104652|NCT01780909|Autonomic Agents|autonomic agents|mesh-ancestor
110104653|NCT01780909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110104654|NCT01780909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110104655|NCT01780909|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110104656|NCT01780909|Dopamine Agents|dopamine agents|mesh-ancestor
110104657|NCT01780909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110104658|NCT01780909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110104659|NCT01780909|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110104660|NCT01780909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110104661|NCT01780909|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110104662|NCT01780909|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110104663|NCT01780948|Everolimus|everolimus|mesh-list
110104664|NCT01780948|Atorvastatin|atorvastatin|mesh-list
110104665|NCT01780948|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110104666|NCT01780948|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110104667|NCT01780948|Antimetabolites|antimetabolites|mesh-ancestor
110104668|NCT01780948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110104669|NCT01780948|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110104670|NCT01780948|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110104671|NCT01780948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110104672|NCT01780948|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110104673|NCT01780948|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110104674|NCT01780948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110104675|NCT01780948|Immunologic Factors|immunologic factors|mesh-ancestor
110104676|NCT01780948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110104677|NCT01780948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110104678|NCT01781052|Iloprost|iloprost|mesh-list
110104679|NCT01781052|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110104680|NCT01781052|Vasodilator Agents|vasodilator agents|mesh-ancestor
110104681|NCT01781273|Ethanol|ethanol|mesh-list
110104682|NCT01781273|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110104683|NCT01781273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110104684|NCT01781273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110104685|NCT01781273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110104686|NCT01781377|Metoclopramide|metoclopramide|mesh-list
110104687|NCT01781377|Propofol|propofol|mesh-list
110104688|NCT01781377|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110104689|NCT01781377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110104690|NCT01781377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110104691|NCT01781377|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110104692|NCT01781377|Anesthetics, General|anesthetics, general|mesh-ancestor
110104693|NCT01781377|Anesthetics|anesthetics|mesh-ancestor
110104694|NCT01781377|Antiemetics|antiemetics|mesh-ancestor
110104695|NCT01781377|Autonomic Agents|autonomic agents|mesh-ancestor
110104696|NCT01781377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110104697|NCT01781377|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110104698|NCT01781377|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110104699|NCT01781377|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110161374|NCT00006476|Antinematodal Agents|antinematodal agents|mesh-ancestor
110104701|NCT01781377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110104702|NCT01781377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110104704|NCT01781442|Temsirolimus|temsirolimus|mesh-list
110104705|NCT01781442|MTOR Inhibitors|mtor inhibitors|mesh-list
110104706|NCT01781442|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110104707|NCT01781442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110104708|NCT01781442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110104709|NCT01781442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110104710|NCT01781442|Immunologic Factors|immunologic factors|mesh-ancestor
110104711|NCT01781442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110104712|NCT01781442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110104713|NCT01781442|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110104714|NCT01781442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110104715|NCT01781442|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110104716|NCT01781442|Antifungal Agents|antifungal agents|mesh-ancestor
110104717|NCT01781507|Cetirizine|cetirizine|mesh-list
110104718|NCT01781507|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110104719|NCT01781507|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110401191|NCT01282476|Immunologic Factors|immunologic factors|mesh-ancestor
110104720|NCT01781507|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110104721|NCT01781507|Histamine Antagonists|histamine antagonists|mesh-ancestor
110104722|NCT01781507|Histamine Agents|histamine agents|mesh-ancestor
110104723|NCT01781507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110104724|NCT01781507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110104725|NCT01781507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110104726|NCT01781663|Petrolatum|petrolatum|mesh-list
110104727|NCT01781663|Emollients|emollients|mesh-ancestor
110104728|NCT01781663|Dermatologic Agents|dermatologic agents|mesh-ancestor
110104729|NCT01781702|Celecoxib|celecoxib|mesh-list
110104730|NCT01781702|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110104731|NCT01781702|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110104732|NCT01781702|Analgesics|analgesics|mesh-ancestor
110104733|NCT01781702|Sensory System Agents|sensory system agents|mesh-ancestor
110104734|NCT01781702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110104735|NCT01781702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110104736|NCT01781702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110104737|NCT01781702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110104738|NCT01781702|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110104739|NCT01781702|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110104740|NCT01781702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110104741|NCT01781702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110104742|NCT01781871|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110104743|NCT01781871|Immunologic Factors|immunologic factors|mesh-ancestor
110104744|NCT01781871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110104745|NCT01781884|gamma-Aminobutyric Acid|gamma-aminobutyric acid|mesh-list
110104746|NCT01781884|GABA Agents|gaba agents|mesh-ancestor
110104747|NCT01781884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110104748|NCT01781884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110104749|NCT01781884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110104750|NCT01781897|Mosapride|mosapride|mesh-list
110104751|NCT01781897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110104752|NCT01781897|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110104753|NCT01781897|Serotonin Agents|serotonin agents|mesh-ancestor
110104754|NCT01781897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110104755|NCT01781897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110104756|NCT01781897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110104757|NCT01781936|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
110104758|NCT01781936|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110104759|NCT01781936|Glucocorticoids|glucocorticoids|mesh-ancestor
110104760|NCT01781936|Hormones|hormones|mesh-ancestor
110104761|NCT01781936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110104762|NCT01781936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110104763|NCT01781988|Carboplatin|carboplatin|mesh-list
110104764|NCT01781988|Gemcitabine|gemcitabine|mesh-list
110104765|NCT01781988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110104766|NCT01781988|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110104768|NCT01781988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110104769|NCT01782001|Vitamins|vitamins|mesh-list
110104770|NCT01782001|Vitamin A|vitamin a|mesh-list
110104771|NCT01782001|Retinol palmitate|retinol palmitate|mesh-list
110104772|NCT01782001|Micronutrients|micronutrients|mesh-ancestor
110104773|NCT01782001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110104774|NCT01782001|Antioxidants|antioxidants|mesh-ancestor
110104775|NCT01782001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110104776|NCT01782001|Protective Agents|protective agents|mesh-ancestor
110104777|NCT01782001|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110104778|NCT01782001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110104779|NCT01782261|Liraglutide|liraglutide|mesh-list
110104780|NCT01782261|Saxagliptin|saxagliptin|mesh-list
110104781|NCT01782261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110104782|NCT01782261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110104783|NCT01782261|Incretins|incretins|mesh-ancestor
110104784|NCT01782261|Hormones|hormones|mesh-ancestor
110104785|NCT01782261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110104786|NCT01782261|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110104787|NCT01782261|Protease Inhibitors|protease inhibitors|mesh-ancestor
110104788|NCT01782261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110104789|NCT01782261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110104790|NCT01782274|Vaccines|vaccines|mesh-list
110104791|NCT01782274|Immunologic Factors|immunologic factors|mesh-ancestor
110104792|NCT01782274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110104793|NCT01782287|Vaccines|vaccines|mesh-list
110104794|NCT01782287|Immunologic Factors|immunologic factors|mesh-ancestor
110104795|NCT01782287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110104796|NCT01782300|Vaccines|vaccines|mesh-list
110104797|NCT01782300|Immunologic Factors|immunologic factors|mesh-ancestor
110104798|NCT01782300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110104799|NCT01782404|Chlorhexidine|chlorhexidine|mesh-list
110104800|NCT01782404|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110104801|NCT01782404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110104802|NCT01782404|Disinfectants|disinfectants|mesh-ancestor
110104803|NCT01782508|Interferons|interferons|mesh-list
110104805|NCT01782508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110104806|NCT01782508|Antiviral Agents|antiviral agents|mesh-ancestor
110104807|NCT01782508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110104808|NCT01782508|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110104809|NCT01782508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110104810|NCT01782508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110104811|NCT01782560|Omeprazole|omeprazole|mesh-list
110104812|NCT01782560|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110104813|NCT01782560|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110104814|NCT01782560|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110104815|NCT01782560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110104816|NCT01782560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110104817|NCT01782573|Chlorhexidine|chlorhexidine|mesh-list
110104818|NCT01782573|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110104819|NCT01782573|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110104820|NCT01782573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110104821|NCT01782573|Disinfectants|disinfectants|mesh-ancestor
110104822|NCT01782573|Dermatologic Agents|dermatologic agents|mesh-ancestor
110104823|NCT01782599|Nicotine|nicotine|mesh-list
110104824|NCT01782599|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110104825|NCT01782599|Autonomic Agents|autonomic agents|mesh-ancestor
110104826|NCT01782599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110104827|NCT01782599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110104828|NCT01782599|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110104829|NCT01782599|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110104830|NCT01782599|Cholinergic Agents|cholinergic agents|mesh-ancestor
110104831|NCT01782599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110104832|NCT01782599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110104833|NCT01782612|Analgesics|analgesics|mesh-list
110401226|NCT04302532|Ubiquinone|ubiquinone|mesh-list
110104834|NCT01782612|Sensory System Agents|sensory system agents|mesh-ancestor
110217911|NCT00274027|Bromides|bromides|mesh-list
110104835|NCT01782612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110104836|NCT01782612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110104838|NCT01782651|Lapatinib|lapatinib|mesh-list
110104839|NCT01782651|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110104840|NCT01782651|Antimetabolites|antimetabolites|mesh-ancestor
110104841|NCT01782651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110104842|NCT01782651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110104843|NCT01782651|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110104844|NCT01782651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110104845|NCT01782781|Epinephrine|epinephrine|mesh-list
110104846|NCT01782781|Ropivacaine|ropivacaine|mesh-list
110104847|NCT01782781|Anesthetics, Local|anesthetics, local|mesh-ancestor
110104848|NCT01782781|Anesthetics|anesthetics|mesh-ancestor
110104849|NCT01782781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110104850|NCT01782781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110104851|NCT01782781|Sensory System Agents|sensory system agents|mesh-ancestor
110104852|NCT01782781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110104853|NCT01782781|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110104854|NCT01782781|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110104855|NCT01782781|Adrenergic Agents|adrenergic agents|mesh-ancestor
110104856|NCT01782781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110104857|NCT01782781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110104858|NCT01782781|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110104859|NCT01782781|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110104860|NCT01782781|Autonomic Agents|autonomic agents|mesh-ancestor
110104861|NCT01782781|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110104862|NCT01782781|Respiratory System Agents|respiratory system agents|mesh-ancestor
110104863|NCT01782781|Mydriatics|mydriatics|mesh-ancestor
110104864|NCT01782781|Sympathomimetics|sympathomimetics|mesh-ancestor
110104865|NCT01782781|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110104866|NCT01782846|Codeine|codeine|mesh-list
110104867|NCT01782846|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110104868|NCT01782846|Narcotics|narcotics|mesh-ancestor
110104869|NCT01782846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110104870|NCT01782846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110104871|NCT01782846|Analgesics|analgesics|mesh-ancestor
110104872|NCT01782846|Sensory System Agents|sensory system agents|mesh-ancestor
110104873|NCT01782846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110104874|NCT01782846|Antitussive Agents|antitussive agents|mesh-ancestor
110104875|NCT01782846|Respiratory System Agents|respiratory system agents|mesh-ancestor
110104876|NCT01782911|Resveratrol|resveratrol|mesh-list
110104877|NCT01782911|Antioxidants|antioxidants|mesh-ancestor
110104878|NCT01782911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110104879|NCT01782911|Protective Agents|protective agents|mesh-ancestor
110104880|NCT01782911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110104881|NCT01782911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110104882|NCT01782911|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110104883|NCT01782924|Brodalumab|brodalumab|mesh-list
110104884|NCT01782924|Dermatologic Agents|dermatologic agents|mesh-ancestor
110104885|NCT01782937|Brodalumab|brodalumab|mesh-list
110104886|NCT01782937|Dermatologic Agents|dermatologic agents|mesh-ancestor
110104887|NCT01782950|Rifampin|rifampin|mesh-list
110104888|NCT01782950|Isoniazid|isoniazid|mesh-list
110104889|NCT01782950|Pyrazinamide|pyrazinamide|mesh-list
110104890|NCT01782950|Ethambutol|ethambutol|mesh-list
110104891|NCT01782950|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110104892|NCT01782950|Antitubercular Agents|antitubercular agents|mesh-ancestor
110104893|NCT01782950|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110104894|NCT01782950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110104895|NCT01782950|Leprostatic Agents|leprostatic agents|mesh-ancestor
110104896|NCT01782950|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110104897|NCT01782950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110104898|NCT01782950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110104899|NCT01782950|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110104900|NCT01782950|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110401236|NCT04302532|Fertility Agents|fertility agents|mesh-ancestor
110104901|NCT01782950|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110104902|NCT01782950|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110104903|NCT01782950|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110104904|NCT01782950|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110104905|NCT01782950|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
110104906|NCT01782950|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110104907|NCT01782950|Antimetabolites|antimetabolites|mesh-ancestor
110104908|NCT01782950|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110104909|NCT01782976|Bevacizumab|bevacizumab|mesh-list
110104910|NCT01782976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110104911|NCT01782976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110104912|NCT01782976|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110104913|NCT01782976|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110104914|NCT01782976|Growth Substances|growth substances|mesh-ancestor
110104915|NCT01782976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110104916|NCT01782976|Growth Inhibitors|growth inhibitors|mesh-ancestor
110104917|NCT01783002|Carbon-11 methionine|carbon-11 methionine|mesh-list
110104918|NCT01783002|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110104919|NCT01783002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110104920|NCT01783106|Hydroxychloroquine|hydroxychloroquine|mesh-list
110104921|NCT01783106|Doxycycline|doxycycline|mesh-list
110104922|NCT01783106|Ciprofloxacin|ciprofloxacin|mesh-list
110104923|NCT01783106|Budesonide|budesonide|mesh-list
110104924|NCT01783106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110104925|NCT01783106|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110104927|NCT01783106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110104928|NCT01783106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110104929|NCT01783106|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110104930|NCT01783106|Respiratory System Agents|respiratory system agents|mesh-ancestor
110104931|NCT01783106|Glucocorticoids|glucocorticoids|mesh-ancestor
110104932|NCT01783106|Hormones|hormones|mesh-ancestor
110104933|NCT01783106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110104934|NCT01783106|Antimalarials|antimalarials|mesh-ancestor
110104935|NCT01783106|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110104936|NCT01783106|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110104937|NCT01783106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110104938|NCT01783106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110104939|NCT01783106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110104940|NCT01783106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110104941|NCT01783106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110104942|NCT01783106|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110104943|NCT01783106|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110104944|NCT01783106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110104945|NCT01783106|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110104946|NCT01783106|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110104947|NCT01783340|Azithromycin|azithromycin|mesh-list
110104948|NCT01783340|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110104949|NCT01783340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110104950|NCT01783379|Micafungin|micafungin|mesh-list
110104951|NCT01783379|Antifungal Agents|antifungal agents|mesh-ancestor
110104952|NCT01783379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110104953|NCT01783431|Poly ICLC|poly iclc|mesh-list
110104954|NCT01783431|Interferon Inducers|interferon inducers|mesh-ancestor
110104955|NCT01783431|Immunologic Factors|immunologic factors|mesh-ancestor
110104956|NCT01783431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110104957|NCT01783587|Docetaxel|docetaxel|mesh-list
110104958|NCT01783587|Afatinib|afatinib|mesh-list
110104959|NCT01783587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110104960|NCT01783587|Tubulin Modulators|tubulin modulators|mesh-ancestor
110104961|NCT01783587|Antimitotic Agents|antimitotic agents|mesh-ancestor
110104962|NCT01783587|Mitosis Modulators|mitosis modulators|mesh-ancestor
110104963|NCT01783587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110104964|NCT01783587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110104965|NCT01783587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110104966|NCT01783717|Exenatide|exenatide|mesh-list
110104967|NCT01783717|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110104968|NCT01783717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110104969|NCT01783717|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110104970|NCT01783717|Incretins|incretins|mesh-ancestor
110104971|NCT01783717|Hormones|hormones|mesh-ancestor
110104972|NCT01783717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110104973|NCT01783756|Capecitabine|capecitabine|mesh-list
110104974|NCT01783756|Everolimus|everolimus|mesh-list
110104975|NCT01783756|Lapatinib|lapatinib|mesh-list
110104976|NCT01783756|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110104977|NCT01783756|Antimetabolites|antimetabolites|mesh-ancestor
110104978|NCT01783756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110104979|NCT01783756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110104980|NCT01783756|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110104981|NCT01783756|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110104982|NCT01783756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110104983|NCT01783756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110104984|NCT01783756|Immunologic Factors|immunologic factors|mesh-ancestor
110104985|NCT01783756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110104986|NCT01783834|Pemetrexed|pemetrexed|mesh-list
110104987|NCT01783834|Gefitinib|gefitinib|mesh-list
110104988|NCT01783834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110104989|NCT01783834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110104990|NCT01783834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110104991|NCT01783834|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110217960|NCT00274144|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110104992|NCT01783834|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110104993|NCT01783834|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110104994|NCT01783925|Aflibercept|aflibercept|mesh-list
110104995|NCT01783925|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110104996|NCT01783925|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110104997|NCT01783925|Growth Substances|growth substances|mesh-ancestor
110104998|NCT01783925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110104999|NCT01783925|Growth Inhibitors|growth inhibitors|mesh-ancestor
110105000|NCT01783925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110105001|NCT01783951|Cisplatin|cisplatin|mesh-list
110105002|NCT01783951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110105004|NCT01783964|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110105005|NCT01783964|Antimetabolites|antimetabolites|mesh-ancestor
110105006|NCT01783964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110105007|NCT01783964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110105008|NCT01783964|Antiviral Agents|antiviral agents|mesh-ancestor
110105009|NCT01783964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110105010|NCT01783964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110105011|NCT01783964|Immunologic Factors|immunologic factors|mesh-ancestor
110105012|NCT01783964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110105013|NCT01783977|Vaccines|vaccines|mesh-list
110105014|NCT01783977|Immunologic Factors|immunologic factors|mesh-ancestor
110105015|NCT01783977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110105016|NCT01784107|Ifosfamide|ifosfamide|mesh-list
110105017|NCT01784107|Belotecan|belotecan|mesh-list
110105018|NCT01784107|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110105019|NCT01784107|Alkylating Agents|alkylating agents|mesh-ancestor
110105020|NCT01784107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110105021|NCT01784107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110105022|NCT01784107|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110105023|NCT01784107|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110105024|NCT01784107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110105025|NCT01784120|Doxorubicin|doxorubicin|mesh-list
110105026|NCT01784120|genexol-PM|genexol-pm|mesh-list
110105027|NCT01784120|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110105028|NCT01784120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110105029|NCT01784120|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110105030|NCT01784120|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110105031|NCT01784120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110105032|NCT01784120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110105033|NCT01784120|Tubulin Modulators|tubulin modulators|mesh-ancestor
110105034|NCT01784120|Antimitotic Agents|antimitotic agents|mesh-ancestor
110105035|NCT01784120|Mitosis Modulators|mitosis modulators|mesh-ancestor
110105036|NCT01784250|Propranolol|propranolol|mesh-list
110105038|NCT01784250|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110105039|NCT01784250|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110105040|NCT01784250|Adrenergic Agents|adrenergic agents|mesh-ancestor
110105041|NCT01784250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110105042|NCT01784250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110105043|NCT01784250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110105044|NCT01784250|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110105045|NCT01784250|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110105046|NCT01784250|Vasodilator Agents|vasodilator agents|mesh-ancestor
110105047|NCT01784250|Analgesics|analgesics|mesh-ancestor
110105048|NCT01784250|Sensory System Agents|sensory system agents|mesh-ancestor
110105049|NCT01784250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110105050|NCT01784250|Sympatholytics|sympatholytics|mesh-ancestor
110105051|NCT01784250|Autonomic Agents|autonomic agents|mesh-ancestor
110105052|NCT01784250|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110105053|NCT01784250|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110105054|NCT01784250|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110105055|NCT01784302|Raltegravir Potassium|raltegravir potassium|mesh-list
110105056|NCT01784302|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110105057|NCT01784302|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110105058|NCT01784302|Antiviral Agents|antiviral agents|mesh-ancestor
110105059|NCT01784302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110105060|NCT01784302|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110105061|NCT01784302|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110105062|NCT01784302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110105063|NCT01784302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110105064|NCT01784315|Chloroquine|chloroquine|mesh-list
110105065|NCT01784315|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
110105066|NCT01784315|Primaquine|primaquine|mesh-list
110105067|NCT01784315|Artemisinins|artemisinins|mesh-list
110105068|NCT01784315|Artemisinin|artemisinin|mesh-list
110105069|NCT01784315|Amebicides|amebicides|mesh-ancestor
110105070|NCT01784315|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110105071|NCT01784315|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110105072|NCT01784315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110105073|NCT01784315|Antimalarials|antimalarials|mesh-ancestor
110105074|NCT01784315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110105075|NCT01784315|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110105076|NCT01784315|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110105077|NCT01784315|Analgesics|analgesics|mesh-ancestor
110105078|NCT01784315|Sensory System Agents|sensory system agents|mesh-ancestor
110105079|NCT01784315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110105080|NCT01784315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110105082|NCT01784315|Filaricides|filaricides|mesh-ancestor
110105083|NCT01784315|Antinematodal Agents|antinematodal agents|mesh-ancestor
110105084|NCT01784315|Anthelmintics|anthelmintics|mesh-ancestor
110105085|NCT01784380|Metformin|metformin|mesh-list
110105086|NCT01784380|Clomiphene|clomiphene|mesh-list
110105087|NCT01784380|Enclomiphene|enclomiphene|mesh-list
110105088|NCT01784380|Zuclomiphene|zuclomiphene|mesh-list
110105089|NCT01784380|Menotropins|menotropins|mesh-list
110105090|NCT01784380|Cyproterone acetate, ethinyl estradiol drug combination|cyproterone acetate, ethinyl estradiol drug combination|mesh-list
110105091|NCT01784380|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110105092|NCT01784380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110105093|NCT01784380|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110105094|NCT01784380|Hormone Antagonists|hormone antagonists|mesh-ancestor
110161435|NCT00106132|Glucocorticoids|glucocorticoids|mesh-ancestor
110161436|NCT00106132|Hormones|hormones|mesh-ancestor
110105095|NCT01784380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110105096|NCT01784380|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110105097|NCT01784380|Fertility Agents|fertility agents|mesh-ancestor
110105098|NCT01784380|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110105099|NCT01784380|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110105100|NCT01784380|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110105101|NCT01784380|Androgen Antagonists|androgen antagonists|mesh-ancestor
110105102|NCT01784445|Ceftazidime|ceftazidime|mesh-list
110105103|NCT01784445|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110105104|NCT01784445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110105105|NCT01784536|Oritavancin|oritavancin|mesh-list
110105106|NCT01784536|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110105107|NCT01784536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110105108|NCT01784549|Gemcitabine|gemcitabine|mesh-list
110105109|NCT01784549|Docetaxel|docetaxel|mesh-list
110105110|NCT01784549|Pemetrexed|pemetrexed|mesh-list
110105111|NCT01784549|Vinorelbine|vinorelbine|mesh-list
110105112|NCT01784549|Gefitinib|gefitinib|mesh-list
110105113|NCT01784549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110105114|NCT01784549|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110105115|NCT01784549|Antimetabolites|antimetabolites|mesh-ancestor
110105116|NCT01784549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110105117|NCT01784549|Tubulin Modulators|tubulin modulators|mesh-ancestor
110105118|NCT01784549|Antimitotic Agents|antimitotic agents|mesh-ancestor
110105119|NCT01784549|Mitosis Modulators|mitosis modulators|mesh-ancestor
110105120|NCT01784549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110105121|NCT01784549|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110105122|NCT01784549|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110105123|NCT01784549|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110217990|NCT00274417|Dutasteride|dutasteride|mesh-list
110105124|NCT01784549|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110105126|NCT01784562|Enzyme Activators|enzyme activators|mesh-ancestor
110105127|NCT01784562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110105128|NCT01784640|Pemetrexed|pemetrexed|mesh-list
110105129|NCT01784640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110105130|NCT01784640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110105131|NCT01784640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110105132|NCT01784640|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110105133|NCT01784640|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110105134|NCT01784718|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
110105135|NCT01784718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110105136|NCT01784900|Catumaxomab|catumaxomab|mesh-list
110105137|NCT01784900|Antibodies, Bispecific|antibodies, bispecific|mesh-list
110105138|NCT01784900|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110105139|NCT01784900|Immunologic Factors|immunologic factors|mesh-ancestor
110105140|NCT01784900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110105141|NCT01784913|Sargramostim|sargramostim|mesh-list
110105142|NCT01784913|Immunologic Factors|immunologic factors|mesh-ancestor
110105143|NCT01784913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110105144|NCT01784978|Everolimus|everolimus|mesh-list
110105145|NCT01784978|Sunitinib|sunitinib|mesh-list
110105146|NCT01784978|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110105147|NCT01784978|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110105148|NCT01784978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110105149|NCT01784978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110105150|NCT01784978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110105151|NCT01784978|Immunologic Factors|immunologic factors|mesh-ancestor
110105152|NCT01784978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110105153|NCT01784978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110105154|NCT01784978|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110105155|NCT01784978|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110105156|NCT01784978|Growth Substances|growth substances|mesh-ancestor
110105157|NCT01784978|Growth Inhibitors|growth inhibitors|mesh-ancestor
110105158|NCT01785004|Vitamin D|vitamin d|mesh-list
110105159|NCT01785004|Cholecalciferol|cholecalciferol|mesh-list
110105160|NCT01785004|Vitamins|vitamins|mesh-ancestor
110105161|NCT01785004|Micronutrients|micronutrients|mesh-ancestor
110105162|NCT01785004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110105163|NCT01785004|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110105164|NCT01785004|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110105165|NCT01785030|Nitrous Oxide|nitrous oxide|mesh-list
110105166|NCT01785030|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110105167|NCT01785030|Anesthetics, General|anesthetics, general|mesh-ancestor
110105168|NCT01785030|Anesthetics|anesthetics|mesh-ancestor
110105169|NCT01785030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110105170|NCT01785030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110105171|NCT01785030|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110105172|NCT01785030|Analgesics|analgesics|mesh-ancestor
110105173|NCT01785030|Sensory System Agents|sensory system agents|mesh-ancestor
110105174|NCT01785030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110105175|NCT01785043|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110105176|NCT01785043|Liraglutide|liraglutide|mesh-list
110105177|NCT01785043|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110105178|NCT01785043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110105179|NCT01785043|Incretins|incretins|mesh-ancestor
110105180|NCT01785043|Hormones|hormones|mesh-ancestor
110105181|NCT01785043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110105182|NCT01785043|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110105183|NCT01785043|Protease Inhibitors|protease inhibitors|mesh-ancestor
110105184|NCT01785043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110105185|NCT01785043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110105186|NCT01785056|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110105187|NCT01785056|Immunologic Factors|immunologic factors|mesh-ancestor
110105188|NCT01785056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110105189|NCT01785108|Vitamin D|vitamin d|mesh-list
110105190|NCT01785108|Ibuprofen|ibuprofen|mesh-list
110105191|NCT01785108|Aluminum sulfate|aluminum sulfate|mesh-list
110105192|NCT01785108|Vitamins|vitamins|mesh-ancestor
110105193|NCT01785108|Micronutrients|micronutrients|mesh-ancestor
110105194|NCT01785108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110105195|NCT01785108|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110105196|NCT01785108|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110105197|NCT01785108|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110105198|NCT01785108|Analgesics|analgesics|mesh-ancestor
110105199|NCT01785108|Sensory System Agents|sensory system agents|mesh-ancestor
110105200|NCT01785108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110105201|NCT01785108|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110105202|NCT01785108|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110105203|NCT01785108|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110105204|NCT01785108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110105205|NCT01785108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110105206|NCT01785108|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110105207|NCT01785108|Immunologic Factors|immunologic factors|mesh-ancestor
110105208|NCT01785290|Haloperidol|haloperidol|mesh-list
110105209|NCT01785290|Haloperidol decanoate|haloperidol decanoate|mesh-list
110105210|NCT01785290|Antiemetics|antiemetics|mesh-ancestor
110105211|NCT01785290|Autonomic Agents|autonomic agents|mesh-ancestor
110105212|NCT01785290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110105213|NCT01785290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110105214|NCT01785290|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110105215|NCT01785290|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110105216|NCT01785290|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110105217|NCT01785290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110105218|NCT01785290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110105219|NCT01785290|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110105220|NCT01785290|Dopamine Agents|dopamine agents|mesh-ancestor
110105221|NCT01785290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110105222|NCT01785290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110105223|NCT01785290|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110105224|NCT01785329|Alirocumab|alirocumab|mesh-list
110105225|NCT01785329|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
110105226|NCT01785329|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110105227|NCT01785329|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110105228|NCT01785329|Antimetabolites|antimetabolites|mesh-ancestor
110105229|NCT01785329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110105230|NCT01785329|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110105231|NCT01785329|Protease Inhibitors|protease inhibitors|mesh-ancestor
110105232|NCT01785329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110105233|NCT01785329|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110105235|NCT01785446|Dexmedetomidine|dexmedetomidine|mesh-list
110105236|NCT01785446|Dsuvia|dsuvia|mesh-list
110105237|NCT01785446|Atracurium|atracurium|mesh-list
110105238|NCT01785446|Cisatracurium|cisatracurium|mesh-list
110105239|NCT01785446|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110105240|NCT01785446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110105241|NCT01785446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110105242|NCT01785446|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110105243|NCT01785446|Analgesics|analgesics|mesh-ancestor
110105244|NCT01785446|Sensory System Agents|sensory system agents|mesh-ancestor
110105245|NCT01785446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110105246|NCT01785446|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110105247|NCT01785446|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110105248|NCT01785446|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110105249|NCT01785446|Adrenergic Agents|adrenergic agents|mesh-ancestor
110105250|NCT01785446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110218007|NCT00274534|Tiotropium Bromide|tiotropium bromide|mesh-list
110105251|NCT01785446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110105252|NCT01785446|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110105253|NCT01785446|Narcotics|narcotics|mesh-ancestor
110105254|NCT01785446|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110105255|NCT01785446|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110105256|NCT01785446|Anesthetics, General|anesthetics, general|mesh-ancestor
110105257|NCT01785446|Anesthetics|anesthetics|mesh-ancestor
110105258|NCT01785446|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110105259|NCT01785446|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110105260|NCT01785446|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110105261|NCT01785446|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
110105262|NCT01785446|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110105263|NCT01785446|Cholinergic Agents|cholinergic agents|mesh-ancestor
110105264|NCT01785589|Adenosine|adenosine|mesh-list
110105265|NCT01785589|Analgesics|analgesics|mesh-ancestor
110105266|NCT01785589|Sensory System Agents|sensory system agents|mesh-ancestor
110105267|NCT01785589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110105268|NCT01785589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110105269|NCT01785589|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110105270|NCT01785589|Vasodilator Agents|vasodilator agents|mesh-ancestor
110105271|NCT01785589|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
110105272|NCT01785589|Purinergic Agonists|purinergic agonists|mesh-ancestor
110105273|NCT01785589|Purinergic Agents|purinergic agents|mesh-ancestor
110105274|NCT01785589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110105275|NCT01785589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110105276|NCT01785641|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110105277|NCT01785641|Ciprofloxacin|ciprofloxacin|mesh-list
110105278|NCT01785641|Gentamicins|gentamicins|mesh-list
110105279|NCT01785641|Cefazolin|cefazolin|mesh-list
110105280|NCT01785641|Ceftazidime|ceftazidime|mesh-list
110105281|NCT01785641|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
110105282|NCT01785641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110105283|NCT01785641|Antitubercular Agents|antitubercular agents|mesh-ancestor
110105284|NCT01785641|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110105285|NCT01785641|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110105286|NCT01785641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110105287|NCT01785641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110105288|NCT01785641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110105289|NCT01785641|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110105290|NCT01785641|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110105291|NCT01785641|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110105292|NCT01785693|Clonidine|clonidine|mesh-list
110105293|NCT01785693|Levobupivacaine|levobupivacaine|mesh-list
110105294|NCT01785693|Analgesics|analgesics|mesh-ancestor
110105295|NCT01785693|Sensory System Agents|sensory system agents|mesh-ancestor
110105296|NCT01785693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110105297|NCT01785693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110105298|NCT01785693|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110105299|NCT01785693|Sympatholytics|sympatholytics|mesh-ancestor
110105300|NCT01785693|Autonomic Agents|autonomic agents|mesh-ancestor
110105301|NCT01785693|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110401288|NCT01037218|Udenafil|udenafil|mesh-list
110105302|NCT01785693|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110105304|NCT01785693|Adrenergic Agents|adrenergic agents|mesh-ancestor
110105305|NCT01785693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110105306|NCT01785693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110105307|NCT01785693|Anesthetics, Local|anesthetics, local|mesh-ancestor
110105308|NCT01785693|Anesthetics|anesthetics|mesh-ancestor
110105309|NCT01785693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110105310|NCT01785797|Silicon|silicon|mesh-list
110105311|NCT01785797|Trace Elements|trace elements|mesh-ancestor
110105312|NCT01785797|Micronutrients|micronutrients|mesh-ancestor
110105313|NCT01785797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110105314|NCT01785836|Dapsone|dapsone|mesh-list
110105315|NCT01785836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110105316|NCT01785836|Antimalarials|antimalarials|mesh-ancestor
110105317|NCT01785836|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110105318|NCT01785836|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110105319|NCT01785836|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110105320|NCT01785836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110105321|NCT01785836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110105322|NCT01785836|Leprostatic Agents|leprostatic agents|mesh-ancestor
110105323|NCT01785836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110105324|NCT01785862|Ibuprofen|ibuprofen|mesh-list
110105325|NCT01785862|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110105326|NCT01785862|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110105327|NCT01785862|Analgesics|analgesics|mesh-ancestor
110105328|NCT01785862|Sensory System Agents|sensory system agents|mesh-ancestor
110105329|NCT01785862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110105330|NCT01785862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110105331|NCT01785862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110105332|NCT01785862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110105333|NCT01785862|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110105334|NCT01785862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110105335|NCT01785862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110105336|NCT01785979|Chloroquine|chloroquine|mesh-list
110105337|NCT01785979|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
110105338|NCT01785979|Prednisone|prednisone|mesh-list
110105339|NCT01785979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110105340|NCT01785979|Glucocorticoids|glucocorticoids|mesh-ancestor
110105342|NCT01785979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110105343|NCT01785979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110105344|NCT01785979|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110105345|NCT01785979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110105346|NCT01785979|Amebicides|amebicides|mesh-ancestor
110105347|NCT01785979|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110105348|NCT01785979|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110105349|NCT01785979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110105350|NCT01785979|Antimalarials|antimalarials|mesh-ancestor
110105351|NCT01785979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110105352|NCT01785979|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110105353|NCT01785979|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110105354|NCT01785979|Analgesics|analgesics|mesh-ancestor
110105355|NCT01785979|Sensory System Agents|sensory system agents|mesh-ancestor
110105356|NCT01785979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110105357|NCT01785979|Filaricides|filaricides|mesh-ancestor
110105358|NCT01785979|Antinematodal Agents|antinematodal agents|mesh-ancestor
110105359|NCT01785979|Anthelmintics|anthelmintics|mesh-ancestor
110105360|NCT01786018|Cyclosporine|cyclosporine|mesh-list
110105361|NCT01786018|Methotrexate|methotrexate|mesh-list
110105362|NCT01786018|Busulfan|busulfan|mesh-list
110105363|NCT01786018|Thiotepa|thiotepa|mesh-list
110105364|NCT01786018|Cyclosporins|cyclosporins|mesh-list
110105365|NCT01786018|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110105366|NCT01786018|Abortifacient Agents|abortifacient agents|mesh-ancestor
110105367|NCT01786018|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110105368|NCT01786018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110105369|NCT01786018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110105370|NCT01786018|Antimetabolites|antimetabolites|mesh-ancestor
110105371|NCT01786018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110105372|NCT01786018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110105373|NCT01786018|Dermatologic Agents|dermatologic agents|mesh-ancestor
110105374|NCT01786018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110105375|NCT01786018|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110105376|NCT01786018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110105377|NCT01786018|Immunologic Factors|immunologic factors|mesh-ancestor
110105378|NCT01786018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110105379|NCT01786018|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110105380|NCT01786018|Antifungal Agents|antifungal agents|mesh-ancestor
110105381|NCT01786018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110105382|NCT01786018|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110105383|NCT01786018|Alkylating Agents|alkylating agents|mesh-ancestor
110105384|NCT01786018|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110105385|NCT01786018|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110105386|NCT01786070|Budesonide|budesonide|mesh-list
110105387|NCT01786070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110105388|NCT01786070|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110105389|NCT01786070|Autonomic Agents|autonomic agents|mesh-ancestor
110105390|NCT01786070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110105391|NCT01786070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110105392|NCT01786070|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110105393|NCT01786070|Respiratory System Agents|respiratory system agents|mesh-ancestor
110105394|NCT01786070|Glucocorticoids|glucocorticoids|mesh-ancestor
110105395|NCT01786070|Hormones|hormones|mesh-ancestor
110105396|NCT01786070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110105397|NCT01786200|Aspirin|aspirin|mesh-list
110105398|NCT01786200|Ibuprofen|ibuprofen|mesh-list
110105399|NCT01786200|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110105400|NCT01786200|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110105401|NCT01786200|Analgesics|analgesics|mesh-ancestor
110105402|NCT01786200|Sensory System Agents|sensory system agents|mesh-ancestor
110105403|NCT01786200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110105404|NCT01786200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110105405|NCT01786200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110105406|NCT01786200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110105407|NCT01786200|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110105408|NCT01786200|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110105409|NCT01786200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110105410|NCT01786200|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110105411|NCT01786200|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110105412|NCT01786200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110105413|NCT01786200|Antipyretics|antipyretics|mesh-ancestor
110105414|NCT01786226|Mifepristone|mifepristone|mesh-list
110105415|NCT01786226|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
110105416|NCT01786226|Abortifacient Agents|abortifacient agents|mesh-ancestor
110105417|NCT01786226|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110105418|NCT01786226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110105419|NCT01786226|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110105420|NCT01786226|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110105421|NCT01786226|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110105422|NCT01786226|Contraceptive Agents|contraceptive agents|mesh-ancestor
110105423|NCT01786226|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
110105424|NCT01786226|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
110105425|NCT01786226|Hormone Antagonists|hormone antagonists|mesh-ancestor
110401314|NCT01269918|Narcotics|narcotics|mesh-ancestor
110105426|NCT01786226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110105427|NCT01786226|Luteolytic Agents|luteolytic agents|mesh-ancestor
110105428|NCT01786226|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110105429|NCT01786226|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
110105430|NCT01786382|Midazolam|midazolam|mesh-list
110105431|NCT01786382|Omeprazole|omeprazole|mesh-list
110105432|NCT01786382|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110105433|NCT01786382|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110105434|NCT01786382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110105435|NCT01786382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110105436|NCT01786382|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110105437|NCT01786382|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110105438|NCT01786382|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110105439|NCT01786382|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110105440|NCT01786382|Anesthetics, General|anesthetics, general|mesh-ancestor
110105441|NCT01786382|Anesthetics|anesthetics|mesh-ancestor
110105442|NCT01786382|GABA Modulators|gaba modulators|mesh-ancestor
110105443|NCT01786382|GABA Agents|gaba agents|mesh-ancestor
110105444|NCT01786382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110105445|NCT01786382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110218034|NCT00274573|Cholinergic Agents|cholinergic agents|mesh-ancestor
110218035|NCT00274573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110105446|NCT01786382|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110105447|NCT01786382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110105448|NCT01786382|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110105449|NCT01786382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110105450|NCT01786395|Isopropyl unoprostone|isopropyl unoprostone|mesh-list
110105451|NCT01786395|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110105452|NCT01786538|Leucovorin|leucovorin|mesh-list
110105453|NCT01786538|Fluorouracil|fluorouracil|mesh-list
110105454|NCT01786538|Oxaliplatin|oxaliplatin|mesh-list
110105455|NCT01786538|Antimetabolites|antimetabolites|mesh-ancestor
110105456|NCT01786538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110105457|NCT01786538|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110105458|NCT01786538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110105459|NCT01786538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110105460|NCT01786538|Immunologic Factors|immunologic factors|mesh-ancestor
110105461|NCT01786538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110105462|NCT01786538|Antidotes|antidotes|mesh-ancestor
110105463|NCT01786538|Protective Agents|protective agents|mesh-ancestor
110105464|NCT01786538|Vitamin B Complex|vitamin b complex|mesh-ancestor
110105465|NCT01786538|Vitamins|vitamins|mesh-ancestor
110105466|NCT01786538|Micronutrients|micronutrients|mesh-ancestor
110105467|NCT01786616|Formoterol Fumarate|formoterol fumarate|mesh-list
110105468|NCT01786616|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110105469|NCT01786616|Autonomic Agents|autonomic agents|mesh-ancestor
110105470|NCT01786616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110105471|NCT01786616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110105472|NCT01786616|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110105473|NCT01786616|Respiratory System Agents|respiratory system agents|mesh-ancestor
110105474|NCT01786616|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110105475|NCT01786616|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110105476|NCT01786616|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110105477|NCT01786616|Adrenergic Agents|adrenergic agents|mesh-ancestor
110105478|NCT01786616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110105479|NCT01786616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110105480|NCT01786655|Epinephrine|epinephrine|mesh-list
110105481|NCT01786655|Bupivacaine|bupivacaine|mesh-list
110105482|NCT01786655|Neosaxitoxin|neosaxitoxin|mesh-list
110105483|NCT01786655|Anesthetics, Local|anesthetics, local|mesh-ancestor
110105484|NCT01786655|Anesthetics|anesthetics|mesh-ancestor
110105485|NCT01786655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110105486|NCT01786655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110105487|NCT01786655|Sensory System Agents|sensory system agents|mesh-ancestor
110105488|NCT01786655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110105489|NCT01786655|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110105490|NCT01786655|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110105491|NCT01786655|Adrenergic Agents|adrenergic agents|mesh-ancestor
110401321|NCT01036594|Antiemetics|antiemetics|mesh-ancestor
110105492|NCT01786655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110105493|NCT01786655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110105494|NCT01786655|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110105495|NCT01786655|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110105496|NCT01786655|Autonomic Agents|autonomic agents|mesh-ancestor
110105497|NCT01786655|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110105498|NCT01786655|Respiratory System Agents|respiratory system agents|mesh-ancestor
110105500|NCT01786655|Sympathomimetics|sympathomimetics|mesh-ancestor
110105501|NCT01786655|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110105502|NCT01786655|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110105503|NCT01786655|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110105504|NCT01786759|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
110218053|NCT00274690|Casopitant|casopitant|mesh-list
110105505|NCT01786759|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
110105506|NCT01786759|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
110105507|NCT01786759|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110105509|NCT01787123|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110105510|NCT01787123|Protective Agents|protective agents|mesh-ancestor
110105511|NCT01787123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110105512|NCT01787123|Nootropic Agents|nootropic agents|mesh-ancestor
110105513|NCT01787136|Dextromethorphan|dextromethorphan|mesh-list
110105514|NCT01787136|Antitussive Agents|antitussive agents|mesh-ancestor
110105515|NCT01787136|Respiratory System Agents|respiratory system agents|mesh-ancestor
110105516|NCT01787136|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110105517|NCT01787136|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110105518|NCT01787136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110105519|NCT01787136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110105520|NCT01787136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110105521|NCT01787344|Botulinum Toxins|botulinum toxins|mesh-list
110105522|NCT01787344|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110105523|NCT01787344|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110105524|NCT01787344|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110105525|NCT01787344|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110105526|NCT01787344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110105527|NCT01787344|Cholinergic Agents|cholinergic agents|mesh-ancestor
110105528|NCT01787344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110105529|NCT01787344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110105530|NCT01787344|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110105531|NCT01787344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110105532|NCT01787357|Canagliflozin|canagliflozin|mesh-list
110105533|NCT01787357|Moxifloxacin|moxifloxacin|mesh-list
110105534|NCT01787357|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110105535|NCT01787357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110105536|NCT01787357|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110105537|NCT01787357|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110105538|NCT01787357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110105539|NCT01787357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110105540|NCT01787357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110105541|NCT01787357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110105542|NCT01787357|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110105543|NCT01787357|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110105544|NCT01787396|Metformin|metformin|mesh-list
110105545|NCT01787396|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110105546|NCT01787396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110105547|NCT01787474|Cytarabine|cytarabine|mesh-list
110105548|NCT01787474|Fludarabine|fludarabine|mesh-list
110105549|NCT01787474|Fludarabine phosphate|fludarabine phosphate|mesh-list
110105550|NCT01787474|Lenograstim|lenograstim|mesh-list
110105551|NCT01787474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110105552|NCT01787474|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110105553|NCT01787474|Antimetabolites|antimetabolites|mesh-ancestor
110105554|NCT01787474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110105555|NCT01787474|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110105556|NCT01787474|Immunologic Factors|immunologic factors|mesh-ancestor
110105557|NCT01787474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110105558|NCT01787474|Antiviral Agents|antiviral agents|mesh-ancestor
110105559|NCT01787474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110105560|NCT01787474|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110105561|NCT01787630|Hyaluronic Acid|hyaluronic acid|mesh-list
110105562|NCT01787630|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110105563|NCT01787630|Immunologic Factors|immunologic factors|mesh-ancestor
110105564|NCT01787630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110105565|NCT01787630|Viscosupplements|viscosupplements|mesh-ancestor
110105566|NCT01787630|Protective Agents|protective agents|mesh-ancestor
110105568|NCT01787669|Bevacizumab|bevacizumab|mesh-list
110105569|NCT01787669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110105570|NCT01787669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110105571|NCT01787669|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110105572|NCT01787669|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110105573|NCT01787669|Growth Substances|growth substances|mesh-ancestor
110105574|NCT01787669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110105575|NCT01787669|Growth Inhibitors|growth inhibitors|mesh-ancestor
110105576|NCT01787669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110105577|NCT01787669|Antiemetics|antiemetics|mesh-ancestor
110105578|NCT01787669|Autonomic Agents|autonomic agents|mesh-ancestor
110105579|NCT01787669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110105580|NCT01787669|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110105581|NCT01787669|Glucocorticoids|glucocorticoids|mesh-ancestor
110105582|NCT01787669|Hormones|hormones|mesh-ancestor
110105583|NCT01787669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110105584|NCT01787669|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110105585|NCT01788007|Imiquimod|imiquimod|mesh-list
110105586|NCT01788007|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110105587|NCT01788007|Immunologic Factors|immunologic factors|mesh-ancestor
110105588|NCT01788007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110105589|NCT01788007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110105590|NCT01788007|Interferon Inducers|interferon inducers|mesh-ancestor
110105591|NCT01788072|Oxytocin|oxytocin|mesh-list
110105592|NCT01788072|Oxytocics|oxytocics|mesh-ancestor
110105593|NCT01788072|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110105594|NCT01788072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110105595|NCT01788176|Zoledronic Acid|zoledronic acid|mesh-list
110105596|NCT01788176|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110105597|NCT01788176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110105598|NCT01788189|Lenalidomide|lenalidomide|mesh-list
110105599|NCT01788189|Immunologic Factors|immunologic factors|mesh-ancestor
110105600|NCT01788189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110105601|NCT01788189|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110105602|NCT01788189|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110105603|NCT01788189|Growth Substances|growth substances|mesh-ancestor
110105604|NCT01788189|Growth Inhibitors|growth inhibitors|mesh-ancestor
110105605|NCT01788189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110105606|NCT01788254|Talinolol|talinolol|mesh-list
110105607|NCT01788254|Torsemide|torsemide|mesh-list
110105608|NCT01788254|Midazolam|midazolam|mesh-list
110105609|NCT01788254|Codeine|codeine|mesh-list
110105610|NCT01788254|Pravastatin|pravastatin|mesh-list
110105611|NCT01788254|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110105612|NCT01788254|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110105613|NCT01788254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110105614|NCT01788254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110105615|NCT01788254|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110105616|NCT01788254|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110105617|NCT01788254|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110105618|NCT01788254|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110105619|NCT01788254|Anesthetics, General|anesthetics, general|mesh-ancestor
110105620|NCT01788254|Anesthetics|anesthetics|mesh-ancestor
110105621|NCT01788254|GABA Modulators|gaba modulators|mesh-ancestor
110105622|NCT01788254|GABA Agents|gaba agents|mesh-ancestor
110105623|NCT01788254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110105624|NCT01788254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110105625|NCT01788254|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110105626|NCT01788254|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110105627|NCT01788254|Antimetabolites|antimetabolites|mesh-ancestor
110105628|NCT01788254|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110105629|NCT01788254|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110105630|NCT01788254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110105631|NCT01788254|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110105632|NCT01788254|Narcotics|narcotics|mesh-ancestor
110105633|NCT01788254|Analgesics|analgesics|mesh-ancestor
110105634|NCT01788254|Sensory System Agents|sensory system agents|mesh-ancestor
110161505|NCT00106561|Irbesartan|irbesartan|mesh-list
110105635|NCT01788254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110105636|NCT01788254|Antitussive Agents|antitussive agents|mesh-ancestor
110105637|NCT01788254|Respiratory System Agents|respiratory system agents|mesh-ancestor
110105638|NCT01788254|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110105639|NCT01788254|Diuretics|diuretics|mesh-ancestor
110105640|NCT01788254|Natriuretic Agents|natriuretic agents|mesh-ancestor
110105641|NCT01788254|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110105642|NCT01788254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110105644|NCT01788254|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110105645|NCT01788254|Adrenergic Agents|adrenergic agents|mesh-ancestor
110105646|NCT01788254|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110105647|NCT01788280|Bevacizumab|bevacizumab|mesh-list
110105648|NCT01788280|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110105649|NCT01788280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110105650|NCT01788280|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110105651|NCT01788280|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110105652|NCT01788280|Growth Substances|growth substances|mesh-ancestor
110105653|NCT01788280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110105654|NCT01788280|Growth Inhibitors|growth inhibitors|mesh-ancestor
110105656|NCT01788332|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110105657|NCT01788332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110105658|NCT01788332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110105659|NCT01788332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110105660|NCT01788371|Lamivudine|lamivudine|mesh-list
110105661|NCT01788371|Telbivudine|telbivudine|mesh-list
110105662|NCT01788371|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110105663|NCT01788371|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110105664|NCT01788371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110105665|NCT01788371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110105666|NCT01788371|Antiviral Agents|antiviral agents|mesh-ancestor
110105667|NCT01788371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110105668|NCT01788371|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110105669|NCT01788371|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110105670|NCT01788384|Clindamycin|clindamycin|mesh-list
110105671|NCT01788384|Clindamycin palmitate|clindamycin palmitate|mesh-list
110105672|NCT01788384|Clindamycin phosphate|clindamycin phosphate|mesh-list
110105673|NCT01788384|Benzoyl Peroxide|benzoyl peroxide|mesh-list
110105674|NCT01788384|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110105675|NCT01788384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110105676|NCT01788384|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110105677|NCT01788384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110105678|NCT01788384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110105679|NCT01788384|Dermatologic Agents|dermatologic agents|mesh-ancestor
110105680|NCT01788462|Tesamorelin|tesamorelin|mesh-list
110105681|NCT01788462|Growth Substances|growth substances|mesh-ancestor
110105682|NCT01788462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110105683|NCT01788501|Cyclosporine|cyclosporine|mesh-list
110105684|NCT01788501|Methotrexate|methotrexate|mesh-list
110105685|NCT01788501|Tacrolimus|tacrolimus|mesh-list
110105686|NCT01788501|Cyclosporins|cyclosporins|mesh-list
110105687|NCT01788501|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110105689|NCT01788501|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110105690|NCT01788501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110105691|NCT01788501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110105692|NCT01788501|Antimetabolites|antimetabolites|mesh-ancestor
110401343|NCT04301908|Antiviral Agents|antiviral agents|mesh-ancestor
110105693|NCT01788501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110105694|NCT01788501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110105695|NCT01788501|Dermatologic Agents|dermatologic agents|mesh-ancestor
110105696|NCT01788501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110105698|NCT01788501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110105699|NCT01788501|Immunologic Factors|immunologic factors|mesh-ancestor
110105700|NCT01788501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110105701|NCT01788501|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110105702|NCT01788501|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110105703|NCT01788501|Antifungal Agents|antifungal agents|mesh-ancestor
110105704|NCT01788501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110105705|NCT01788540|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
110105706|NCT01788540|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
110105707|NCT01788540|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
110105708|NCT01788540|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110105710|NCT01788605|Antiemetics|antiemetics|mesh-ancestor
110105711|NCT01788605|Autonomic Agents|autonomic agents|mesh-ancestor
110105712|NCT01788605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110105713|NCT01788605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110105714|NCT01788605|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110105715|NCT01788605|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110105716|NCT01788605|Serotonin Agents|serotonin agents|mesh-ancestor
110105717|NCT01788605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110105718|NCT01788605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110105719|NCT01788670|Ethanol|ethanol|mesh-list
110105720|NCT01788670|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110105721|NCT01788670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110105722|NCT01788670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110105723|NCT01788670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110105724|NCT01788722|Dienogest|dienogest|mesh-list
110105725|NCT01788722|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110105726|NCT01788722|Contraceptive Agents|contraceptive agents|mesh-ancestor
110105727|NCT01788722|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110105728|NCT01788722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110105729|NCT01788722|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110105730|NCT01788722|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110105731|NCT01788722|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110105732|NCT01788722|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110105733|NCT01788722|Hormone Antagonists|hormone antagonists|mesh-ancestor
110105734|NCT01788722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110105735|NCT01788722|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110105736|NCT01788722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110105737|NCT01788774|Risperidone|risperidone|mesh-list
110105738|NCT01788774|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110105739|NCT01788774|Serotonin Agents|serotonin agents|mesh-ancestor
110105740|NCT01788774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110105741|NCT01788774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110105742|NCT01788774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110105743|NCT01788774|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110105744|NCT01788774|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110105745|NCT01788774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110105746|NCT01788774|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110105747|NCT01788774|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110105748|NCT01788774|Dopamine Agents|dopamine agents|mesh-ancestor
110105749|NCT01788969|Escitalopram|escitalopram|mesh-list
110105750|NCT01788969|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110105751|NCT01788969|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110105752|NCT01788969|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110401356|NCT01268046|Estradiol|estradiol|mesh-list
110105753|NCT01788969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110105754|NCT01788969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110105755|NCT01788969|Serotonin Agents|serotonin agents|mesh-ancestor
110105756|NCT01788969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110105757|NCT01788982|Nintedanib|nintedanib|mesh-list
110105758|NCT01788982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110105759|NCT01788982|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110218100|NCT00277264|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110105761|NCT01788982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110105762|NCT01789086|Liraglutide|liraglutide|mesh-list
110105763|NCT01789086|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110105764|NCT01789086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110105766|NCT01789086|Hormones|hormones|mesh-ancestor
110105767|NCT01789086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110105768|NCT01789099|Sargramostim|sargramostim|mesh-list
110105769|NCT01789099|Immunologic Factors|immunologic factors|mesh-ancestor
110105770|NCT01789099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110105771|NCT01789125|Nicotine|nicotine|mesh-list
110105772|NCT01789125|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110105773|NCT01789125|Autonomic Agents|autonomic agents|mesh-ancestor
110105774|NCT01789125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110105775|NCT01789125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110105776|NCT01789125|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110105777|NCT01789125|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110105778|NCT01789125|Cholinergic Agents|cholinergic agents|mesh-ancestor
110105779|NCT01789125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110105780|NCT01789125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110105781|NCT01789216|Ketorolac|ketorolac|mesh-list
110105782|NCT01789216|Meloxicam|meloxicam|mesh-list
110105783|NCT01789216|Pregabalin|pregabalin|mesh-list
110105784|NCT01789216|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110105785|NCT01789216|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110105786|NCT01789216|Analgesics|analgesics|mesh-ancestor
110105787|NCT01789216|Sensory System Agents|sensory system agents|mesh-ancestor
110105788|NCT01789216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110105789|NCT01789216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110105790|NCT01789216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110105791|NCT01789216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110105792|NCT01789216|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110105793|NCT01789216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110105794|NCT01789216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110105795|NCT01789216|Anticonvulsants|anticonvulsants|mesh-ancestor
110105796|NCT01789216|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110105797|NCT01789216|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110105798|NCT01789216|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110105799|NCT01789216|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110105800|NCT01789216|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110105801|NCT01789216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110105802|NCT01789216|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110105803|NCT01789216|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110105804|NCT01789242|Dexamethasone|dexamethasone|mesh-list
110105805|NCT01789242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110105806|NCT01789242|Antiemetics|antiemetics|mesh-ancestor
110105807|NCT01789242|Autonomic Agents|autonomic agents|mesh-ancestor
110105808|NCT01789242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110105809|NCT01789242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110105810|NCT01789242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110105811|NCT01789242|Glucocorticoids|glucocorticoids|mesh-ancestor
110105812|NCT01789242|Hormones|hormones|mesh-ancestor
110105813|NCT01789242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110105814|NCT01789242|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110105815|NCT01789242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110105816|NCT01789294|Mesalamine|mesalamine|mesh-list
110105817|NCT01789294|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110105818|NCT01789294|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110105819|NCT01789294|Analgesics|analgesics|mesh-ancestor
110105820|NCT01789294|Sensory System Agents|sensory system agents|mesh-ancestor
110105821|NCT01789294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110105822|NCT01789294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110105823|NCT01789294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110105824|NCT01789294|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110105825|NCT01789385|Dexmedetomidine|dexmedetomidine|mesh-list
110105826|NCT01789385|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110105827|NCT01789385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110105828|NCT01789385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110105829|NCT01789385|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110105830|NCT01789385|Analgesics|analgesics|mesh-ancestor
110105831|NCT01789385|Sensory System Agents|sensory system agents|mesh-ancestor
110105832|NCT01789385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110105833|NCT01789385|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110105834|NCT01789385|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110105835|NCT01789385|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110105836|NCT01789385|Adrenergic Agents|adrenergic agents|mesh-ancestor
110105837|NCT01789385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110105838|NCT01789385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110105839|NCT01789437|Dexamethasone|dexamethasone|mesh-list
110105840|NCT01789437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110105841|NCT01789437|Antiemetics|antiemetics|mesh-ancestor
110105842|NCT01789437|Autonomic Agents|autonomic agents|mesh-ancestor
110105843|NCT01789437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110105844|NCT01789437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110105845|NCT01789437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110105846|NCT01789437|Glucocorticoids|glucocorticoids|mesh-ancestor
110105847|NCT01789437|Hormones|hormones|mesh-ancestor
110105848|NCT01789437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110105849|NCT01789437|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110105850|NCT01789437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110105851|NCT01789619|Tacrolimus|tacrolimus|mesh-list
110105852|NCT01789619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110105853|NCT01789619|Immunologic Factors|immunologic factors|mesh-ancestor
110105854|NCT01789619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110105855|NCT01789619|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110105856|NCT01789619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110105857|NCT01789619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110105858|NCT01789710|Bupropion|bupropion|mesh-list
110105859|NCT01789710|Nicotine|nicotine|mesh-list
110105860|NCT01789710|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110105861|NCT01789710|Autonomic Agents|autonomic agents|mesh-ancestor
110105862|NCT01789710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110105863|NCT01789710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110105864|NCT01789710|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110105865|NCT01789710|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110105866|NCT01789710|Cholinergic Agents|cholinergic agents|mesh-ancestor
110105867|NCT01789710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110105868|NCT01789710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110105869|NCT01789710|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110105870|NCT01789710|Antidepressive Agents|antidepressive agents|mesh-ancestor
110105871|NCT01789710|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110105872|NCT01789710|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110105873|NCT01789710|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110105874|NCT01789710|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110105875|NCT01789710|Dopamine Agents|dopamine agents|mesh-ancestor
110105876|NCT01789710|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110105877|NCT01789710|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110105878|NCT01789710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110105879|NCT01789723|Leucovorin|leucovorin|mesh-list
110105880|NCT01789723|Levoleucovorin|levoleucovorin|mesh-list
110105881|NCT01789723|Antidotes|antidotes|mesh-ancestor
110105882|NCT01789723|Protective Agents|protective agents|mesh-ancestor
110105883|NCT01789723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110105884|NCT01789723|Vitamin B Complex|vitamin b complex|mesh-ancestor
110105885|NCT01789723|Vitamins|vitamins|mesh-ancestor
110105886|NCT01789723|Micronutrients|micronutrients|mesh-ancestor
110105887|NCT01789827|Interleukin-2|interleukin-2|mesh-list
110105888|NCT01789827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110105889|NCT01789827|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110105890|NCT01789827|Analgesics|analgesics|mesh-ancestor
110105891|NCT01789827|Sensory System Agents|sensory system agents|mesh-ancestor
110105892|NCT01789827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110105893|NCT01789827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110105894|NCT01789892|Methylprednisolone|methylprednisolone|mesh-list
110161539|NCT00401323|Antimetabolites|antimetabolites|mesh-ancestor
110105895|NCT01789892|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110105896|NCT01789892|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110105898|NCT01789892|Prednisolone acetate|prednisolone acetate|mesh-list
110105899|NCT01789892|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110105900|NCT01789892|Prednisolone phosphate|prednisolone phosphate|mesh-list
110105901|NCT01789892|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110105902|NCT01789892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110105903|NCT01789892|Antiemetics|antiemetics|mesh-ancestor
110105904|NCT01789892|Autonomic Agents|autonomic agents|mesh-ancestor
110105905|NCT01789892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110105906|NCT01789892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110105907|NCT01789892|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110105908|NCT01789892|Glucocorticoids|glucocorticoids|mesh-ancestor
110105909|NCT01789892|Hormones|hormones|mesh-ancestor
110105910|NCT01789892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110105911|NCT01789892|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110105912|NCT01789892|Protective Agents|protective agents|mesh-ancestor
110105913|NCT01789892|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110105914|NCT01789892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110105915|NCT01789892|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110105916|NCT01789892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110105917|NCT01789957|Exenatide|exenatide|mesh-list
110105918|NCT01789957|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110105919|NCT01789957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110105920|NCT01789957|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110105921|NCT01789957|Incretins|incretins|mesh-ancestor
110105922|NCT01789957|Hormones|hormones|mesh-ancestor
110105923|NCT01789957|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110105924|NCT01790854|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
110105925|NCT01790854|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110105926|NCT01792063|Sevoflurane|sevoflurane|mesh-list
110105927|NCT01792063|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110105928|NCT01792063|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110105929|NCT01792063|Anesthetics, General|anesthetics, general|mesh-ancestor
110105930|NCT01792063|Anesthetics|anesthetics|mesh-ancestor
110105931|NCT01792063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110105932|NCT01792063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110105933|NCT01792570|Darunavir|darunavir|mesh-list
110105934|NCT01792570|Rilpivirine|rilpivirine|mesh-list
110105935|NCT01792570|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110105936|NCT01792570|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110105937|NCT01792570|Protease Inhibitors|protease inhibitors|mesh-ancestor
110105939|NCT01792570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110105940|NCT01792570|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110105941|NCT01792570|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110105942|NCT01792570|Antiviral Agents|antiviral agents|mesh-ancestor
110105943|NCT01792570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110105944|NCT01792570|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110105945|NCT01792570|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110105947|NCT01792804|Clindamycin|clindamycin|mesh-list
110105948|NCT01792804|Cefazolin|cefazolin|mesh-list
110105949|NCT01792804|Linezolid|linezolid|mesh-list
110105950|NCT01792804|Daptomycin|daptomycin|mesh-list
110105951|NCT01792804|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
110105952|NCT01792804|Floxacillin|floxacillin|mesh-list
110105953|NCT01792804|Cloxacillin|cloxacillin|mesh-list
110105954|NCT01792804|Trimethoprim|trimethoprim|mesh-list
110105955|NCT01792804|Sulfamethoxazole|sulfamethoxazole|mesh-list
110105956|NCT01792804|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110105957|NCT01792804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110105958|NCT01792804|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110105959|NCT01792804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110105960|NCT01792804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110105961|NCT01792804|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110105962|NCT01792804|Antimalarials|antimalarials|mesh-ancestor
110105963|NCT01792804|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110105964|NCT01792804|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110105965|NCT01792804|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110105966|NCT01792804|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110105967|NCT01792804|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
110105968|NCT01792804|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110105969|NCT01793038|Clomiphene|clomiphene|mesh-list
110105970|NCT01793038|Enclomiphene|enclomiphene|mesh-list
110105971|NCT01793038|Zuclomiphene|zuclomiphene|mesh-list
110105972|NCT01793038|Aromatase Inhibitors|aromatase inhibitors|mesh-list
110105973|NCT01793038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110105974|NCT01793038|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110105975|NCT01793038|Hormone Antagonists|hormone antagonists|mesh-ancestor
110218158|NCT00075452|Antimetabolites|antimetabolites|mesh-ancestor
110218159|NCT00075452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110105976|NCT01793038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110105977|NCT01793038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110105978|NCT01793038|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110105979|NCT01793038|Fertility Agents|fertility agents|mesh-ancestor
110105980|NCT01793038|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110105981|NCT01793038|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110105982|NCT01793038|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110105983|NCT01793038|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110105984|NCT01793038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110105986|NCT01794182|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110105987|NCT01794182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110105988|NCT01794208|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
110105989|NCT01794208|Hormones|hormones|mesh-ancestor
110105990|NCT01794208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110105991|NCT01794208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110105992|NCT01794247|Lidocaine|lidocaine|mesh-list
110105993|NCT01794247|Magnesium Sulfate|magnesium sulfate|mesh-list
110105994|NCT01794247|Fentanyl|fentanyl|mesh-list
110105995|NCT01794247|Anesthetics, Local|anesthetics, local|mesh-ancestor
110105996|NCT01794247|Anesthetics|anesthetics|mesh-ancestor
110105997|NCT01794247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110105998|NCT01794247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110105999|NCT01794247|Sensory System Agents|sensory system agents|mesh-ancestor
110106000|NCT01794247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110106001|NCT01794247|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110106002|NCT01794247|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110106003|NCT01794247|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110106004|NCT01794247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110106005|NCT01794247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110106006|NCT01794247|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110106007|NCT01794247|Narcotics|narcotics|mesh-ancestor
110106008|NCT01794247|Analgesics|analgesics|mesh-ancestor
110106009|NCT01794247|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110106010|NCT01794247|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110106011|NCT01794247|Anesthetics, General|anesthetics, general|mesh-ancestor
110106012|NCT01794247|Anticonvulsants|anticonvulsants|mesh-ancestor
110106013|NCT01794247|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110106014|NCT01794247|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110106015|NCT01794247|Tocolytic Agents|tocolytic agents|mesh-ancestor
110106016|NCT01794247|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110106017|NCT01794429|Exenatide|exenatide|mesh-list
110106018|NCT01794429|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110106019|NCT01794429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110106020|NCT01794429|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110106021|NCT01794429|Incretins|incretins|mesh-ancestor
110106022|NCT01794429|Hormones|hormones|mesh-ancestor
110106023|NCT01794429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110106024|NCT01795248|Liraglutide|liraglutide|mesh-list
110106025|NCT01795248|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110106026|NCT01795248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110106027|NCT01795248|Incretins|incretins|mesh-ancestor
110106028|NCT01795248|Hormones|hormones|mesh-ancestor
110106029|NCT01795248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110106030|NCT01796132|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110106031|NCT01796132|Fluvoxamine|fluvoxamine|mesh-list
110218189|NCT00277654|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110106032|NCT01796132|Citalopram|citalopram|mesh-list
110106033|NCT01796132|Fluoxetine|fluoxetine|mesh-list
110106034|NCT01796132|Paroxetine|paroxetine|mesh-list
110106035|NCT01796132|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
110106036|NCT01796132|Sertraline|sertraline|mesh-list
110106037|NCT01796132|Escitalopram|escitalopram|mesh-list
110106038|NCT01796132|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110106039|NCT01796132|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110106040|NCT01796132|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110401437|NCT01244061|Varenicline|varenicline|mesh-list
110401438|NCT01244061|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110106041|NCT01796132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110106042|NCT01796132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110106043|NCT01796132|Serotonin Agents|serotonin agents|mesh-ancestor
110106044|NCT01796132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110106045|NCT01796132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110106046|NCT01796132|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110106047|NCT01796132|Antidepressive Agents|antidepressive agents|mesh-ancestor
110106048|NCT01796132|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110106049|NCT01796132|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110106050|NCT01796132|Analgesics|analgesics|mesh-ancestor
110106051|NCT01796132|Sensory System Agents|sensory system agents|mesh-ancestor
110106052|NCT01796132|Dopamine Agents|dopamine agents|mesh-ancestor
110106053|NCT01796132|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110106054|NCT01796132|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110106055|NCT01796132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110106056|NCT01796132|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110106057|NCT01796132|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110106058|NCT01796132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110106059|NCT01796132|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110106060|NCT01796132|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110106061|NCT01796418|Beraprost|beraprost|mesh-list
110106062|NCT01796418|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110106063|NCT01796418|Vasodilator Agents|vasodilator agents|mesh-ancestor
110106064|NCT01796522|Nifedipine|nifedipine|mesh-list
110106065|NCT01796522|Progesterone|progesterone|mesh-list
110106066|NCT01796522|Progestins|progestins|mesh-ancestor
110106067|NCT01796522|Hormones|hormones|mesh-ancestor
110106068|NCT01796522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110106069|NCT01796522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110106070|NCT01796522|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110106071|NCT01796522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110106072|NCT01796522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110106073|NCT01796522|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110106074|NCT01796522|Vasodilator Agents|vasodilator agents|mesh-ancestor
110106075|NCT01796522|Tocolytic Agents|tocolytic agents|mesh-ancestor
110106076|NCT01796522|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110106077|NCT01796730|Bambuterol|bambuterol|mesh-list
110106078|NCT01796730|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110106079|NCT01796730|Autonomic Agents|autonomic agents|mesh-ancestor
110106080|NCT01796730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110106081|NCT01796730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110106082|NCT01796730|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110106083|NCT01796730|Respiratory System Agents|respiratory system agents|mesh-ancestor
110106084|NCT01796808|Lidocaine|lidocaine|mesh-list
110106085|NCT01796808|Epinephrine|epinephrine|mesh-list
110106086|NCT01796808|Anesthetics, Local|anesthetics, local|mesh-list
110106087|NCT01796808|Anesthetics|anesthetics|mesh-list
110106088|NCT01796808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110106089|NCT01796808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110106090|NCT01796808|Sensory System Agents|sensory system agents|mesh-ancestor
110218209|NCT00108576|Antimanic Agents|antimanic agents|mesh-ancestor
110106091|NCT01796808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110106092|NCT01796808|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110106093|NCT01796808|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110106094|NCT01796808|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110106095|NCT01796808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110106096|NCT01796808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110106097|NCT01796808|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110106098|NCT01796808|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110106099|NCT01796808|Adrenergic Agents|adrenergic agents|mesh-ancestor
110106100|NCT01796808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110106101|NCT01796808|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110106102|NCT01796808|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110106103|NCT01796808|Autonomic Agents|autonomic agents|mesh-ancestor
110106104|NCT01796808|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110106105|NCT01796808|Respiratory System Agents|respiratory system agents|mesh-ancestor
110106106|NCT01796808|Mydriatics|mydriatics|mesh-ancestor
110106107|NCT01796808|Sympathomimetics|sympathomimetics|mesh-ancestor
110106108|NCT01796808|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110106109|NCT01797289|Fibrin fragment D|fibrin fragment d|mesh-list
110106110|NCT01797289|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110106111|NCT01797289|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110106112|NCT01797289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110106113|NCT01797289|Hemostatics|hemostatics|mesh-ancestor
110106114|NCT01797289|Coagulants|coagulants|mesh-ancestor
110106115|NCT01797718|Letrozole|letrozole|mesh-list
110106116|NCT01797718|Testosterone|testosterone|mesh-list
110106117|NCT01797718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110106118|NCT01797718|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110106119|NCT01797718|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110106120|NCT01797718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110106121|NCT01797718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110106122|NCT01797718|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110106123|NCT01797718|Hormone Antagonists|hormone antagonists|mesh-ancestor
110106124|NCT01797718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110106125|NCT01797718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110106126|NCT01797718|Androgens|androgens|mesh-ancestor
110106127|NCT01797718|Hormones|hormones|mesh-ancestor
110106128|NCT01797796|Capsaicin|capsaicin|mesh-list
110106129|NCT01797796|Antipruritics|antipruritics|mesh-ancestor
110106130|NCT01797796|Dermatologic Agents|dermatologic agents|mesh-ancestor
110106131|NCT01797796|Sensory System Agents|sensory system agents|mesh-ancestor
110106132|NCT01797796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110106133|NCT01797796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110106134|NCT01798108|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
110106135|NCT01798108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110106137|NCT01798446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110106138|NCT01798446|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110106139|NCT01798446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110106140|NCT01798446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110106141|NCT01798680|Vitamin D|vitamin d|mesh-list
110106142|NCT01798680|Cholecalciferol|cholecalciferol|mesh-list
110106143|NCT01798680|Vitamins|vitamins|mesh-ancestor
110106144|NCT01798680|Micronutrients|micronutrients|mesh-ancestor
110106145|NCT01798680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110106146|NCT01798680|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110106147|NCT01798680|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110106148|NCT01798836|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110106149|NCT01798836|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110106150|NCT01798836|Estradiol|estradiol|mesh-list
110106151|NCT01798836|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110106152|NCT01798836|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
110106153|NCT01798836|Estrogens|estrogens|mesh-ancestor
110106154|NCT01798836|Hormones|hormones|mesh-ancestor
110106155|NCT01798836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110106156|NCT01798836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110106157|NCT01798836|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110106158|NCT01798836|Contraceptive Agents|contraceptive agents|mesh-ancestor
110106159|NCT01798836|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110106160|NCT01798836|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110106161|NCT01798901|Decitabine|decitabine|mesh-list
110106162|NCT01798901|Azacitidine|azacitidine|mesh-list
110106163|NCT01798901|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
110106164|NCT01798901|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110106165|NCT01798901|Antimetabolites|antimetabolites|mesh-ancestor
110106166|NCT01798901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110106167|NCT01798901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110106168|NCT01798901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110106170|NCT01799863|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
110106171|NCT01799863|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
110106172|NCT01799863|Lubricant Eye Drops|lubricant eye drops|mesh-list
110106173|NCT01799863|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110106174|NCT01799863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110106175|NCT01799863|Analgesics|analgesics|mesh-ancestor
110106176|NCT01799863|Sensory System Agents|sensory system agents|mesh-ancestor
110106177|NCT01799863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110106178|NCT01799863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110106180|NCT01799863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110106181|NCT01799863|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110106182|NCT01799863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110106183|NCT01799863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110106184|NCT01799863|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110106185|NCT01799863|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110106186|NCT01799863|Laxatives|laxatives|mesh-ancestor
110106187|NCT01799863|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110106188|NCT01800006|Rivaroxaban|rivaroxaban|mesh-list
110106189|NCT01800006|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110106190|NCT01800006|Antithrombins|antithrombins|mesh-ancestor
110106191|NCT01800006|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110106192|NCT01800006|Protease Inhibitors|protease inhibitors|mesh-ancestor
110106193|NCT01800006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110106194|NCT01800006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110106195|NCT01800006|Anticoagulants|anticoagulants|mesh-ancestor
110106196|NCT01800019|Nicotine|nicotine|mesh-list
110106197|NCT01800019|Varenicline|varenicline|mesh-list
110106198|NCT01800019|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110106199|NCT01800019|Autonomic Agents|autonomic agents|mesh-ancestor
110106200|NCT01800019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110106201|NCT01800019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110106202|NCT01800019|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110106203|NCT01800019|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110106204|NCT01800019|Cholinergic Agents|cholinergic agents|mesh-ancestor
110106205|NCT01800019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110106206|NCT01800019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110106207|NCT01800097|Modafinil|modafinil|mesh-list
110106208|NCT01800097|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110106209|NCT01800097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110106210|NCT01800097|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
110106211|NCT01800097|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110106212|NCT01800097|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110106213|NCT01800097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110106215|NCT01800227|Pioglitazone|pioglitazone|mesh-list
110106216|NCT01800227|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110106217|NCT01800227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110106218|NCT01800240|Metformin|metformin|mesh-list
110106219|NCT01800240|Pioglitazone|pioglitazone|mesh-list
110106220|NCT01800240|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110106221|NCT01800240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110106222|NCT01800292|Sildenafil Citrate|sildenafil citrate|mesh-list
110106223|NCT01800292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110106224|NCT01800292|Vasodilator Agents|vasodilator agents|mesh-ancestor
110106225|NCT01800292|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110106226|NCT01800292|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110106227|NCT01800292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110106228|NCT01800292|Urological Agents|urological agents|mesh-ancestor
110106230|NCT01800357|3-(2,2,2-trimethylhydrazine)propionate|3-(2,2,2-trimethylhydrazine)propionate|mesh-list
110106231|NCT01800357|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110106232|NCT01800357|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110106233|NCT01800357|Analgesics|analgesics|mesh-ancestor
110106234|NCT01800357|Sensory System Agents|sensory system agents|mesh-ancestor
110106235|NCT01800357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110106236|NCT01800357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110106237|NCT01800357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110106238|NCT01800357|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110106239|NCT01800357|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110106240|NCT01800357|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110106241|NCT01800357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110106242|NCT01800357|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110106243|NCT01800357|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110106244|NCT01800357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110106246|NCT01800357|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110106247|NCT01800357|Immunologic Factors|immunologic factors|mesh-ancestor
110106248|NCT01800396|Caseins|caseins|mesh-list
110106249|NCT01800396|Chelating Agents|chelating agents|mesh-ancestor
110106250|NCT01800396|Sequestering Agents|sequestering agents|mesh-ancestor
110106251|NCT01800396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110106252|NCT01800422|Progesterone|progesterone|mesh-list
110106253|NCT01800422|Progestins|progestins|mesh-ancestor
110106254|NCT01800422|Hormones|hormones|mesh-ancestor
110106255|NCT01800422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110106256|NCT01800422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110106257|NCT01800435|Tranexamic Acid|tranexamic acid|mesh-list
110106258|NCT01800435|Anti-inhibitor coagulant complex|anti-inhibitor coagulant complex|mesh-list
110106259|NCT01800435|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110106260|NCT01800435|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110106261|NCT01800435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110106262|NCT01800435|Hemostatics|hemostatics|mesh-ancestor
110106263|NCT01800435|Coagulants|coagulants|mesh-ancestor
110106264|NCT01800487|Silymarin|silymarin|mesh-list
110106265|NCT01800487|Antioxidants|antioxidants|mesh-ancestor
110106266|NCT01800487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110106267|NCT01800487|Protective Agents|protective agents|mesh-ancestor
110106268|NCT01800487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110106269|NCT01800526|Acetylcysteine|acetylcysteine|mesh-list
110106270|NCT01800526|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110106271|NCT01800526|Antiviral Agents|antiviral agents|mesh-ancestor
110106272|NCT01800526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110106273|NCT01800526|Expectorants|expectorants|mesh-ancestor
110106274|NCT01800526|Respiratory System Agents|respiratory system agents|mesh-ancestor
110106275|NCT01800526|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110106276|NCT01800526|Antioxidants|antioxidants|mesh-ancestor
110106277|NCT01800526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110106278|NCT01800526|Protective Agents|protective agents|mesh-ancestor
110106279|NCT01800526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110106280|NCT01800526|Antidotes|antidotes|mesh-ancestor
110106281|NCT01800630|Gemcitabine|gemcitabine|mesh-list
110106282|NCT01800630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110106283|NCT01800630|Antimetabolites|antimetabolites|mesh-ancestor
110106284|NCT01800630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110106285|NCT01800630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110106286|NCT01800643|Busulfan|busulfan|mesh-list
110106287|NCT01800643|Alkylating Agents|alkylating agents|mesh-ancestor
110106288|NCT01800643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110106289|NCT01800643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110106290|NCT01800643|Immunologic Factors|immunologic factors|mesh-ancestor
110106291|NCT01800643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110106292|NCT01800643|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110106293|NCT01800643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110106294|NCT01800643|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110106295|NCT01800695|Temozolomide|temozolomide|mesh-list
110106296|NCT01800695|ABT-414|abt-414|mesh-list
110106297|NCT01800695|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110106298|NCT01800695|Alkylating Agents|alkylating agents|mesh-ancestor
110106299|NCT01800695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110106300|NCT01800695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110106301|NCT01800695|Immunoconjugates|immunoconjugates|mesh-ancestor
110106302|NCT01800695|Immunologic Factors|immunologic factors|mesh-ancestor
110106303|NCT01800695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110106304|NCT01800708|Prednisolone|prednisolone|mesh-list
110106305|NCT01800708|Triamcinolone|triamcinolone|mesh-list
110106306|NCT01800708|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110106307|NCT01800708|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110106308|NCT01800708|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110106309|NCT01800708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110106310|NCT01800708|Glucocorticoids|glucocorticoids|mesh-ancestor
110106311|NCT01800708|Hormones|hormones|mesh-ancestor
110106312|NCT01800708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110106313|NCT01800708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110106314|NCT01800708|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110106315|NCT01800708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110106316|NCT01800708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110106317|NCT01800708|Immunologic Factors|immunologic factors|mesh-ancestor
110106318|NCT01800708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110106319|NCT01800708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110106320|NCT01800747|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110106321|NCT01800747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110106322|NCT01800799|Anti-Infective Agents|anti-infective agents|mesh-list
110106323|NCT01800799|Celecoxib|celecoxib|mesh-list
110106324|NCT01800799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
110106325|NCT01800799|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110106326|NCT01800799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110106328|NCT01800799|Sensory System Agents|sensory system agents|mesh-ancestor
110106329|NCT01800799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110106330|NCT01800799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110106331|NCT01800799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110106332|NCT01800799|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110106333|NCT01800799|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110106334|NCT01800799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110106335|NCT01800799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110106336|NCT01800825|Clindamycin|clindamycin|mesh-list
110106337|NCT01800825|Clindamycin palmitate|clindamycin palmitate|mesh-list
110106338|NCT01800825|Clindamycin phosphate|clindamycin phosphate|mesh-list
110106339|NCT01800825|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110106340|NCT01800825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110106341|NCT01800825|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110106342|NCT01800825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110106343|NCT01800825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110106344|NCT01800942|Azithromycin|azithromycin|mesh-list
110106345|NCT01800942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110218262|NCT00278278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110218263|NCT00278278|Antimetabolites|antimetabolites|mesh-ancestor
110106346|NCT01800942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110106347|NCT01801046|Cytarabine|cytarabine|mesh-list
110106348|NCT01801046|Mitoxantrone|mitoxantrone|mesh-list
110106349|NCT01801046|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110106350|NCT01801046|Antimetabolites|antimetabolites|mesh-ancestor
110106351|NCT01801046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110106352|NCT01801046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110106353|NCT01801046|Antiviral Agents|antiviral agents|mesh-ancestor
110106354|NCT01801046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110106355|NCT01801046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110106356|NCT01801046|Immunologic Factors|immunologic factors|mesh-ancestor
110106357|NCT01801046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110106358|NCT01801046|Analgesics|analgesics|mesh-ancestor
110106359|NCT01801046|Sensory System Agents|sensory system agents|mesh-ancestor
110106360|NCT01801046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110106361|NCT01801046|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110106362|NCT01801046|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110106363|NCT01801046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110106364|NCT01801137|Everolimus|everolimus|mesh-list
110106365|NCT01801137|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110106366|NCT01801137|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110106367|NCT01801137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110106368|NCT01801137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110106369|NCT01801137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110106370|NCT01801137|Immunologic Factors|immunologic factors|mesh-ancestor
110106371|NCT01801137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110106372|NCT01801137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110106373|NCT01801163|Sorafenib|sorafenib|mesh-list
110106374|NCT01801163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110106375|NCT01801163|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110106376|NCT01801163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110106377|NCT01801163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110106378|NCT01801228|Eplerenone|eplerenone|mesh-list
110106379|NCT01801228|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110106380|NCT01801228|Hormone Antagonists|hormone antagonists|mesh-ancestor
110106381|NCT01801228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110106382|NCT01801228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110106383|NCT01801228|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110106384|NCT01801228|Diuretics|diuretics|mesh-ancestor
110106385|NCT01801228|Natriuretic Agents|natriuretic agents|mesh-ancestor
110106386|NCT01801228|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110106387|NCT01801410|Misoprostol|misoprostol|mesh-list
110106388|NCT01801410|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110106389|NCT01801410|Abortifacient Agents|abortifacient agents|mesh-ancestor
110106391|NCT01801410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110106392|NCT01801410|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110106393|NCT01801410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110106394|NCT01801410|Oxytocics|oxytocics|mesh-ancestor
110106395|NCT01801423|Hydroxyurea|hydroxyurea|mesh-list
110106396|NCT01801423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110106397|NCT01801423|Antisickling Agents|antisickling agents|mesh-ancestor
110106398|NCT01801423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110106399|NCT01801423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110106400|NCT01801423|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110106401|NCT01801644|Cisplatin|cisplatin|mesh-list
110106402|NCT01801644|Gemcitabine|gemcitabine|mesh-list
110106403|NCT01801644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110106404|NCT01801644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110106405|NCT01801644|Antimetabolites|antimetabolites|mesh-ancestor
110106406|NCT01801644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110106407|NCT01801774|Triamcinolone|triamcinolone|mesh-list
110106408|NCT01801774|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110106409|NCT01801774|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110106410|NCT01801774|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110106411|NCT01801774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110106412|NCT01801774|Glucocorticoids|glucocorticoids|mesh-ancestor
110106413|NCT01801774|Hormones|hormones|mesh-ancestor
110106414|NCT01801774|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110218270|NCT00278278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110106415|NCT01801774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110106416|NCT01801774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110106417|NCT01801774|Immunologic Factors|immunologic factors|mesh-ancestor
110106418|NCT01801774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110106419|NCT01801774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110106420|NCT01802255|Midazolam|midazolam|mesh-list
110106421|NCT01802255|Sevoflurane|sevoflurane|mesh-list
110106422|NCT01802255|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110106423|NCT01802255|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110106424|NCT01802255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110106425|NCT01802255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110106426|NCT01802255|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110106427|NCT01802255|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110106428|NCT01802255|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110106429|NCT01802255|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110106430|NCT01802255|Anesthetics, General|anesthetics, general|mesh-ancestor
110106431|NCT01802255|Anesthetics|anesthetics|mesh-ancestor
110106432|NCT01802255|GABA Modulators|gaba modulators|mesh-ancestor
110106433|NCT01802255|GABA Agents|gaba agents|mesh-ancestor
110106434|NCT01802255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110106435|NCT01802255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110106436|NCT01802255|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110106437|NCT01802255|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110106438|NCT01802268|Sirolimus|sirolimus|mesh-list
110106439|NCT01802268|Tacrolimus|tacrolimus|mesh-list
110106440|NCT01802268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110106441|NCT01802268|Immunologic Factors|immunologic factors|mesh-ancestor
110401567|NCT01264770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110106442|NCT01802268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110106443|NCT01802268|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110106444|NCT01802268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110106445|NCT01802268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110106446|NCT01802268|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110106447|NCT01802268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110106448|NCT01802268|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110106449|NCT01802268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110106450|NCT01802268|Antifungal Agents|antifungal agents|mesh-ancestor
110106451|NCT01802450|Dasatinib|dasatinib|mesh-list
110106452|NCT01802450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110106453|NCT01802450|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110106454|NCT01802450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110106455|NCT01802450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110106457|NCT01802476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110106458|NCT01802476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110106459|NCT01802476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110106460|NCT01802476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110106461|NCT01802489|Amiloride|amiloride|mesh-list
110106462|NCT01802489|Diuretics|diuretics|mesh-ancestor
110106463|NCT01802489|Natriuretic Agents|natriuretic agents|mesh-ancestor
110106464|NCT01802489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110106465|NCT01802489|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
110106466|NCT01802489|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110106467|NCT01802489|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110106468|NCT01802489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110106469|NCT01802489|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
110106470|NCT01802489|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110106471|NCT01802502|Rifampin|rifampin|mesh-list
110218275|NCT00278278|Tubulin Modulators|tubulin modulators|mesh-ancestor
110106472|NCT01802502|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110106473|NCT01802502|Antitubercular Agents|antitubercular agents|mesh-ancestor
110106474|NCT01802502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110106475|NCT01802502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110106476|NCT01802502|Leprostatic Agents|leprostatic agents|mesh-ancestor
110106477|NCT01802502|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110106478|NCT01802502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110106479|NCT01802502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110106480|NCT01802502|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110106481|NCT01802502|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110106482|NCT01802502|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110106483|NCT01802502|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110106484|NCT01802502|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110106485|NCT01802502|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110106486|NCT01802593|Methotrexate|methotrexate|mesh-list
110106487|NCT01802593|Mercaptopurine|mercaptopurine|mesh-list
110106488|NCT01802593|Azathioprine|azathioprine|mesh-list
110106489|NCT01802593|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110106490|NCT01802593|Abortifacient Agents|abortifacient agents|mesh-ancestor
110106491|NCT01802593|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110106492|NCT01802593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110106493|NCT01802593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110106494|NCT01802593|Antimetabolites|antimetabolites|mesh-ancestor
110106495|NCT01802593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110106496|NCT01802593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110106497|NCT01802593|Dermatologic Agents|dermatologic agents|mesh-ancestor
110106498|NCT01802593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110106499|NCT01802593|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110106500|NCT01802593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110106501|NCT01802593|Immunologic Factors|immunologic factors|mesh-ancestor
110106502|NCT01802593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110106503|NCT01802593|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110106504|NCT01802619|Nitric Oxide|nitric oxide|mesh-list
110106505|NCT01802619|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110106506|NCT01802619|Autonomic Agents|autonomic agents|mesh-ancestor
110401583|NCT01032070|Etoposide|etoposide|mesh-list
110106507|NCT01802619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110106508|NCT01802619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110106509|NCT01802619|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110106510|NCT01802619|Respiratory System Agents|respiratory system agents|mesh-ancestor
110106511|NCT01802619|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110106512|NCT01802619|Antioxidants|antioxidants|mesh-ancestor
110106513|NCT01802619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110106514|NCT01802619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110106515|NCT01802619|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
110106516|NCT01802619|Vasodilator Agents|vasodilator agents|mesh-ancestor
110106517|NCT01802619|Gasotransmitters|gasotransmitters|mesh-ancestor
110106518|NCT01802619|Protective Agents|protective agents|mesh-ancestor
110106520|NCT01802645|Folic Acid|folic acid|mesh-list
110106521|NCT01802645|Bevacizumab|bevacizumab|mesh-list
110106522|NCT01802645|Cetuximab|cetuximab|mesh-list
110106523|NCT01802645|Fluorouracil|fluorouracil|mesh-list
110106524|NCT01802645|Oxaliplatin|oxaliplatin|mesh-list
110106525|NCT01802645|Irinotecan|irinotecan|mesh-list
110106526|NCT01802645|Levoleucovorin|levoleucovorin|mesh-list
110106527|NCT01802645|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110106528|NCT01802645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110106529|NCT01802645|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110106530|NCT01802645|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110106531|NCT01802645|Growth Substances|growth substances|mesh-ancestor
110106532|NCT01802645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110106533|NCT01802645|Growth Inhibitors|growth inhibitors|mesh-ancestor
110106534|NCT01802645|Antimetabolites|antimetabolites|mesh-ancestor
110106535|NCT01802645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110106536|NCT01802645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110218292|NCT00278434|Zoledronic Acid|zoledronic acid|mesh-list
110106537|NCT01802645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110106538|NCT01802645|Immunologic Factors|immunologic factors|mesh-ancestor
110106539|NCT01802645|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110106540|NCT01802645|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110106541|NCT01802645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110106542|NCT01802645|Antidotes|antidotes|mesh-ancestor
110106543|NCT01802645|Protective Agents|protective agents|mesh-ancestor
110106544|NCT01802645|Vitamin B Complex|vitamin b complex|mesh-ancestor
110106545|NCT01802645|Vitamins|vitamins|mesh-ancestor
110106546|NCT01802645|Micronutrients|micronutrients|mesh-ancestor
110106547|NCT01802645|Hematinics|hematinics|mesh-ancestor
110106548|NCT01802658|Zoledronic Acid|zoledronic acid|mesh-list
110106549|NCT01802658|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110106550|NCT01802658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110106551|NCT01802684|Aflibercept|aflibercept|mesh-list
110106552|NCT01802684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110106553|NCT01802684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110106554|NCT01802684|Growth Substances|growth substances|mesh-ancestor
110106555|NCT01802684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110106556|NCT01802684|Growth Inhibitors|growth inhibitors|mesh-ancestor
110106557|NCT01802684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110106558|NCT01802814|Epratuzumab|epratuzumab|mesh-list
110106559|NCT01802814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110106560|NCT01802814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110106561|NCT01802892|Plerixafor|plerixafor|mesh-list
110106562|NCT01802892|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110106563|NCT01802892|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110106564|NCT01802892|Antiviral Agents|antiviral agents|mesh-ancestor
110106565|NCT01802892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110106566|NCT01802918|Ritonavir|ritonavir|mesh-list
110106567|NCT01802918|GSK-2838232|gsk-2838232|mesh-list
110106568|NCT01802918|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110106569|NCT01802918|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110106570|NCT01802918|Protease Inhibitors|protease inhibitors|mesh-ancestor
110106571|NCT01802918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110106572|NCT01802918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110106573|NCT01802918|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110106574|NCT01802918|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110106575|NCT01802918|Antiviral Agents|antiviral agents|mesh-ancestor
110106576|NCT01802918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110106577|NCT01802918|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110106578|NCT01802918|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110106579|NCT01802931|Ketoconazole|ketoconazole|mesh-list
110106580|NCT01802931|Antifungal Agents|antifungal agents|mesh-ancestor
110106581|NCT01802931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110106582|NCT01802931|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110106583|NCT01802931|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110106584|NCT01802931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110106585|NCT01802931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110106586|NCT01802931|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110106587|NCT01802931|Hormone Antagonists|hormone antagonists|mesh-ancestor
110106588|NCT01802931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110106589|NCT01802931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110106590|NCT01802931|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110106591|NCT01802944|Insulin|insulin|mesh-list
110106592|NCT01802944|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110106593|NCT01802944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110106594|NCT01802970|Paclitaxel|paclitaxel|mesh-list
110106595|NCT01802970|Vinorelbine|vinorelbine|mesh-list
110106596|NCT01802970|Capecitabine|capecitabine|mesh-list
110106597|NCT01802970|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
110106598|NCT01802970|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110106599|NCT01802970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110218300|NCT00075686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110106600|NCT01802970|Tubulin Modulators|tubulin modulators|mesh-ancestor
110106601|NCT01802970|Antimitotic Agents|antimitotic agents|mesh-ancestor
110106602|NCT01802970|Mitosis Modulators|mitosis modulators|mesh-ancestor
110106603|NCT01802970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110106604|NCT01802970|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110106605|NCT01802970|Antimetabolites|antimetabolites|mesh-ancestor
110106606|NCT01802970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110106607|NCT01803087|Formoterol Fumarate|formoterol fumarate|mesh-list
110106608|NCT01803087|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110106609|NCT01803087|Autonomic Agents|autonomic agents|mesh-ancestor
110106610|NCT01803087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110106611|NCT01803087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110106612|NCT01803087|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110106613|NCT01803087|Respiratory System Agents|respiratory system agents|mesh-ancestor
110106614|NCT01803087|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110106615|NCT01803087|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110106616|NCT01803087|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110106617|NCT01803087|Adrenergic Agents|adrenergic agents|mesh-ancestor
110106618|NCT01803087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110106619|NCT01803087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110106620|NCT01803191|Ciprofloxacin|ciprofloxacin|mesh-list
110106621|NCT01803191|Fosfomycin|fosfomycin|mesh-list
110106622|NCT01803191|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110106623|NCT01803191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110106624|NCT01803191|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110106625|NCT01803191|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110106626|NCT01803191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110106627|NCT01803191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110106628|NCT01803191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110106629|NCT01803191|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110106630|NCT01803191|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110106631|NCT01803321|Rilonacept|rilonacept|mesh-list
110106632|NCT01803321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110106633|NCT01803347|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
110106634|NCT01803347|Hemostatics|hemostatics|mesh-ancestor
110106635|NCT01803347|Coagulants|coagulants|mesh-ancestor
110106636|NCT01803399|Moxifloxacin|moxifloxacin|mesh-list
110106637|NCT01803399|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110106638|NCT01803399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110106639|NCT01803399|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110106640|NCT01803399|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110106641|NCT01803399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110106642|NCT01803399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110106643|NCT01803399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110106644|NCT01803438|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
110106646|NCT01803503|Sunitinib|sunitinib|mesh-list
110106647|NCT01803503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110218313|NCT00278824|Anesthetics|anesthetics|mesh-ancestor
110218314|NCT00278941|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110218315|NCT00278941|Antidepressive Agents|antidepressive agents|mesh-ancestor
110218316|NCT00278941|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110218317|NCT00278941|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110218318|NCT00278941|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110218319|NCT00278941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110218320|NCT00278941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110218321|NCT00279019|Tiotropium Bromide|tiotropium bromide|mesh-list
110218322|NCT00279019|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110218323|NCT00279019|Autonomic Agents|autonomic agents|mesh-ancestor
110106648|NCT01803503|Tubulin Modulators|tubulin modulators|mesh-ancestor
110106649|NCT01803503|Antimitotic Agents|antimitotic agents|mesh-ancestor
110106650|NCT01803503|Mitosis Modulators|mitosis modulators|mesh-ancestor
110106651|NCT01803503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110106652|NCT01803503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110106653|NCT01803503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110106654|NCT01803503|Growth Substances|growth substances|mesh-ancestor
110106655|NCT01803503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110106656|NCT01803503|Growth Inhibitors|growth inhibitors|mesh-ancestor
110106657|NCT01803503|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110106658|NCT01803503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110106659|NCT01803659|Vitamin A|vitamin a|mesh-list
110106660|NCT01803659|Retinol palmitate|retinol palmitate|mesh-list
110106661|NCT01803659|Carotenoids|carotenoids|mesh-list
110106662|NCT01803659|Antioxidants|antioxidants|mesh-ancestor
110106663|NCT01803659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110106664|NCT01803659|Protective Agents|protective agents|mesh-ancestor
110106665|NCT01803659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110106666|NCT01803659|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110106667|NCT01803659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110106668|NCT01803659|Vitamins|vitamins|mesh-ancestor
110106669|NCT01803659|Micronutrients|micronutrients|mesh-ancestor
110106670|NCT01803763|Omalizumab|omalizumab|mesh-list
110106671|NCT01803763|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110106672|NCT01803763|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110106673|NCT01803763|Respiratory System Agents|respiratory system agents|mesh-ancestor
110106674|NCT01803828|Tadalafil|tadalafil|mesh-list
110106675|NCT01803828|Vasodilator Agents|vasodilator agents|mesh-ancestor
110106676|NCT01803828|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110106677|NCT01803828|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110106678|NCT01803828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110106679|NCT01803828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110106680|NCT01803828|Urological Agents|urological agents|mesh-ancestor
110106681|NCT01804127|Rituximab|rituximab|mesh-list
110106682|NCT01804127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110106683|NCT01804127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110106684|NCT01804127|Immunologic Factors|immunologic factors|mesh-ancestor
110106685|NCT01804127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110106686|NCT01804127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110106687|NCT01804205|Magnesium Sulfate|magnesium sulfate|mesh-list
110106688|NCT01804205|Analgesics|analgesics|mesh-ancestor
110106689|NCT01804205|Sensory System Agents|sensory system agents|mesh-ancestor
110106690|NCT01804205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110106691|NCT01804205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110106692|NCT01804205|Anesthetics|anesthetics|mesh-ancestor
110106693|NCT01804205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110106694|NCT01804205|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110106695|NCT01804205|Anticonvulsants|anticonvulsants|mesh-ancestor
110106696|NCT01804205|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110106697|NCT01804205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110106698|NCT01804205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110106699|NCT01804205|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110106700|NCT01804205|Tocolytic Agents|tocolytic agents|mesh-ancestor
110106701|NCT01804205|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110106702|NCT01804218|Nadolol|nadolol|mesh-list
110106703|NCT01804218|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110106704|NCT01804218|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110106705|NCT01804218|Adrenergic Agents|adrenergic agents|mesh-ancestor
110106706|NCT01804218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110106707|NCT01804218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110106708|NCT01804218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110106709|NCT01804218|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110106710|NCT01804218|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110106711|NCT01804218|Sympatholytics|sympatholytics|mesh-ancestor
110106713|NCT01804218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110106714|NCT01804244|Rilpivirine|rilpivirine|mesh-list
110106715|NCT01804244|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110106716|NCT01804244|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110106717|NCT01804244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110106718|NCT01804244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110106719|NCT01804244|Antiviral Agents|antiviral agents|mesh-ancestor
110106720|NCT01804244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110106721|NCT01804244|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110106722|NCT01804244|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110106723|NCT01804335|Trifarotene|trifarotene|mesh-list
110106724|NCT01804335|Dermatologic Agents|dermatologic agents|mesh-ancestor
110106725|NCT01804361|Cyclosporine|cyclosporine|mesh-list
110106726|NCT01804361|Cyclosporins|cyclosporins|mesh-list
110106727|NCT01804361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110106728|NCT01804361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110106729|NCT01804361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110106730|NCT01804361|Immunologic Factors|immunologic factors|mesh-ancestor
110106731|NCT01804361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110106733|NCT01804361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110106734|NCT01804361|Dermatologic Agents|dermatologic agents|mesh-ancestor
110106735|NCT01804361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110106736|NCT01804361|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110106737|NCT01804374|Everolimus|everolimus|mesh-list
110106738|NCT01804374|Sorafenib|sorafenib|mesh-list
110106739|NCT01804374|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110106740|NCT01804374|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110106741|NCT01804374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110106742|NCT01804374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110106743|NCT01804374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110106744|NCT01804374|Immunologic Factors|immunologic factors|mesh-ancestor
110106745|NCT01804374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110106746|NCT01804374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110106747|NCT01804387|Lamivudine|lamivudine|mesh-list
110106749|NCT01804387|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
110106750|NCT01804387|Telbivudine|telbivudine|mesh-list
110106751|NCT01804387|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110106752|NCT01804387|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110106753|NCT01804387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110106754|NCT01804387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110106755|NCT01804387|Antiviral Agents|antiviral agents|mesh-ancestor
110106756|NCT01804387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110106757|NCT01804387|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110106758|NCT01804387|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110106759|NCT01804400|Montelukast|montelukast|mesh-list
110106760|NCT01804400|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110106761|NCT01804400|Respiratory System Agents|respiratory system agents|mesh-ancestor
110106762|NCT01804400|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110106763|NCT01804400|Hormone Antagonists|hormone antagonists|mesh-ancestor
110106764|NCT01804400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110106765|NCT01804400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110106766|NCT01804400|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110106767|NCT01804400|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110106768|NCT01804400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110106769|NCT01804413|Insulin|insulin|mesh-list
110106770|NCT01804413|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110106771|NCT01804413|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110106772|NCT01804413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110106773|NCT01804543|Ranolazine|ranolazine|mesh-list
110106774|NCT01804543|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110106775|NCT01804543|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110106776|NCT01804543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110106777|NCT01804595|Sunscreening Agents|sunscreening agents|mesh-list
110106778|NCT01804595|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110106779|NCT01804595|Protective Agents|protective agents|mesh-ancestor
110106780|NCT01804595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110106781|NCT01804595|Dermatologic Agents|dermatologic agents|mesh-ancestor
110106782|NCT01804712|Rituximab|rituximab|mesh-list
110106783|NCT01804712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110106784|NCT01804712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110106785|NCT01804712|Immunologic Factors|immunologic factors|mesh-ancestor
110106786|NCT01804712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110106787|NCT01804712|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110106788|NCT01804777|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110106789|NCT01804777|Amiloride|amiloride|mesh-list
110106790|NCT01804777|Diuretics|diuretics|mesh-ancestor
110106791|NCT01804777|Natriuretic Agents|natriuretic agents|mesh-ancestor
110106792|NCT01804777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110106793|NCT01804777|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
110106794|NCT01804777|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110106795|NCT01804777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110106796|NCT01804777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110106797|NCT01804777|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
110106798|NCT01804777|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110106799|NCT01804777|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110106800|NCT01804777|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110106801|NCT01804985|Imatinib Mesylate|imatinib mesylate|mesh-list
110106802|NCT01804985|Dasatinib|dasatinib|mesh-list
110106803|NCT01804985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110106804|NCT01804985|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110106805|NCT01804985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110106806|NCT01804985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110106808|NCT01805115|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110106809|NCT01805115|Abortifacient Agents|abortifacient agents|mesh-ancestor
110106810|NCT01805115|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110106811|NCT01805115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110106812|NCT01805115|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110106813|NCT01805115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110106814|NCT01805115|Oxytocics|oxytocics|mesh-ancestor
110106815|NCT01805232|Artesunate|artesunate|mesh-list
110106816|NCT01805232|Quinine|quinine|mesh-list
110106817|NCT01805232|Antimalarials|antimalarials|mesh-ancestor
110106818|NCT01805232|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110106819|NCT01805232|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110106820|NCT01805232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110106821|NCT01805232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110106822|NCT01805232|Antiviral Agents|antiviral agents|mesh-ancestor
110106823|NCT01805232|Schistosomicides|schistosomicides|mesh-ancestor
110106824|NCT01805232|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110106825|NCT01805232|Anthelmintics|anthelmintics|mesh-ancestor
110106826|NCT01805232|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110106827|NCT01805232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110106828|NCT01805232|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110106829|NCT01805232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110106830|NCT01805232|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110106831|NCT01805232|Analgesics|analgesics|mesh-ancestor
110106832|NCT01805232|Sensory System Agents|sensory system agents|mesh-ancestor
110106833|NCT01805258|Efavirenz|efavirenz|mesh-list
110106834|NCT01805258|Nevirapine|nevirapine|mesh-list
110401622|NCT01237587|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110106835|NCT01805258|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110106836|NCT01805258|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110106837|NCT01805258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110106838|NCT01805258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110106839|NCT01805258|Antiviral Agents|antiviral agents|mesh-ancestor
110106840|NCT01805258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110106841|NCT01805258|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110106842|NCT01805258|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110106843|NCT01805258|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110106844|NCT01805258|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110106845|NCT01805258|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110106846|NCT01805258|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110106847|NCT01805258|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110106848|NCT01805258|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110106849|NCT01805310|Magnesium citrate|magnesium citrate|mesh-list
110106851|NCT01805310|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110106852|NCT01805388|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110106853|NCT01805388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110106855|NCT01807741|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110106856|NCT01807741|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110106857|NCT01807741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110106858|NCT01807741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110106859|NCT01807741|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110106860|NCT01807767|Mycophenolic Acid|mycophenolic acid|mesh-list
110106861|NCT01807767|Everolimus|everolimus|mesh-list
110106862|NCT01807767|Tacrolimus|tacrolimus|mesh-list
110106863|NCT01807767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110106864|NCT01807767|Immunologic Factors|immunologic factors|mesh-ancestor
110106865|NCT01807767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110106866|NCT01807767|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110401640|NCT01031446|Paclitaxel|paclitaxel|mesh-list
110106867|NCT01807767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110106868|NCT01807767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110106869|NCT01807767|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110106870|NCT01807767|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110106871|NCT01807767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110106872|NCT01807767|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110106873|NCT01807767|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110106874|NCT01807767|Antitubercular Agents|antitubercular agents|mesh-ancestor
110106875|NCT01807767|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110106876|NCT01807767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110106877|NCT01807832|Capsaicin|capsaicin|mesh-list
110106878|NCT01807832|Antipruritics|antipruritics|mesh-ancestor
110106879|NCT01807832|Dermatologic Agents|dermatologic agents|mesh-ancestor
110106880|NCT01807832|Sensory System Agents|sensory system agents|mesh-ancestor
110106881|NCT01807832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110106882|NCT01807832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110106883|NCT01807910|Choline|choline|mesh-list
110106884|NCT01807910|Lipotropic Agents|lipotropic agents|mesh-ancestor
110106885|NCT01807910|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110106886|NCT01807910|Antimetabolites|antimetabolites|mesh-ancestor
110106887|NCT01807910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110106888|NCT01807910|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110106889|NCT01807910|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110106890|NCT01807910|Nootropic Agents|nootropic agents|mesh-ancestor
110106891|NCT01807962|Lidocaine|lidocaine|mesh-list
110106892|NCT01807962|Anesthetics, Local|anesthetics, local|mesh-ancestor
110106893|NCT01807962|Anesthetics|anesthetics|mesh-ancestor
110106894|NCT01807962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110106895|NCT01807962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110106896|NCT01807962|Sensory System Agents|sensory system agents|mesh-ancestor
110106897|NCT01807962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110106898|NCT01807962|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110106899|NCT01807962|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110106900|NCT01807962|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110106901|NCT01807962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110106902|NCT01807962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110106903|NCT01808014|Nefopam|nefopam|mesh-list
110106904|NCT01808014|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110106905|NCT01808014|Analgesics|analgesics|mesh-ancestor
110106906|NCT01808014|Sensory System Agents|sensory system agents|mesh-ancestor
110106907|NCT01808014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110106908|NCT01808014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110106909|NCT01808131|Lesinurad|lesinurad|mesh-list
110218356|NCT00109044|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110218360|NCT00109044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110106910|NCT01808131|Gout Suppressants|gout suppressants|mesh-ancestor
110106911|NCT01808131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110106912|NCT01808131|Uricosuric Agents|uricosuric agents|mesh-ancestor
110106913|NCT01808300|Thioctic Acid|thioctic acid|mesh-list
110106914|NCT01808300|Pregabalin|pregabalin|mesh-list
110106915|NCT01808300|Analgesics|analgesics|mesh-ancestor
110106916|NCT01808300|Sensory System Agents|sensory system agents|mesh-ancestor
110106917|NCT01808300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110106918|NCT01808300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110106919|NCT01808300|Anticonvulsants|anticonvulsants|mesh-ancestor
110106920|NCT01808300|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110106921|NCT01808300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110106922|NCT01808300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110106923|NCT01808300|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110106924|NCT01808300|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110106925|NCT01808300|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110106926|NCT01808300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110106927|NCT01808300|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110106928|NCT01808300|Antioxidants|antioxidants|mesh-ancestor
110106929|NCT01808300|Protective Agents|protective agents|mesh-ancestor
110106930|NCT01808300|Vitamin B Complex|vitamin b complex|mesh-ancestor
110106931|NCT01808300|Vitamins|vitamins|mesh-ancestor
110106932|NCT01808300|Micronutrients|micronutrients|mesh-ancestor
110106933|NCT01808469|Antibodies|antibodies|mesh-list
110106934|NCT01808469|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110106935|NCT01808469|Immunologic Factors|immunologic factors|mesh-ancestor
110106936|NCT01808469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110106937|NCT01808495|Mitomycins|mitomycins|mesh-list
110106938|NCT01808495|Mitomycin|mitomycin|mesh-list
110106939|NCT01808495|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110106940|NCT01808495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110106941|NCT01808495|Alkylating Agents|alkylating agents|mesh-ancestor
110106942|NCT01808495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110106943|NCT01808495|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110106944|NCT01808495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110106945|NCT01808521|Acetylcysteine|acetylcysteine|mesh-list
110106946|NCT01808521|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110106947|NCT01808521|Antiviral Agents|antiviral agents|mesh-ancestor
110106948|NCT01808521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110106949|NCT01808521|Expectorants|expectorants|mesh-ancestor
110106950|NCT01808521|Respiratory System Agents|respiratory system agents|mesh-ancestor
110106951|NCT01808521|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110106952|NCT01808521|Antioxidants|antioxidants|mesh-ancestor
110106953|NCT01808521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110106954|NCT01808521|Protective Agents|protective agents|mesh-ancestor
110106955|NCT01808521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110106956|NCT01808521|Antidotes|antidotes|mesh-ancestor
110106957|NCT01808586|Dexamethasone|dexamethasone|mesh-list
110106958|NCT01808586|Betamethasone|betamethasone|mesh-list
110106959|NCT01808586|Lidocaine|lidocaine|mesh-list
110106960|NCT01808586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110106961|NCT01808586|Antiemetics|antiemetics|mesh-ancestor
110106962|NCT01808586|Autonomic Agents|autonomic agents|mesh-ancestor
110106963|NCT01808586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110106964|NCT01808586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110106965|NCT01808586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110106966|NCT01808586|Glucocorticoids|glucocorticoids|mesh-ancestor
110106967|NCT01808586|Hormones|hormones|mesh-ancestor
110106968|NCT01808586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110106969|NCT01808586|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110106970|NCT01808586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110106971|NCT01808586|Anesthetics, Local|anesthetics, local|mesh-ancestor
110106972|NCT01808586|Anesthetics|anesthetics|mesh-ancestor
110106973|NCT01808586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110106974|NCT01808586|Sensory System Agents|sensory system agents|mesh-ancestor
110106975|NCT01808586|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110106976|NCT01808586|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110106977|NCT01808586|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110106978|NCT01808586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110106979|NCT01808586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110106980|NCT01808586|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110106981|NCT01808586|Respiratory System Agents|respiratory system agents|mesh-ancestor
110106983|NCT01808638|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110106984|NCT01808638|Antimetabolites|antimetabolites|mesh-ancestor
110106985|NCT01808638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110106986|NCT01808638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110106987|NCT01808768|Alcaftadine|alcaftadine|mesh-list
110106988|NCT01808768|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110106989|NCT01808768|Histamine Antagonists|histamine antagonists|mesh-ancestor
110106990|NCT01808768|Histamine Agents|histamine agents|mesh-ancestor
110106991|NCT01808768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110106992|NCT01808768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110106993|NCT01808768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110106994|NCT01808898|Bupivacaine|bupivacaine|mesh-list
110106995|NCT01808898|Anesthetics, Local|anesthetics, local|mesh-list
110106996|NCT01808898|Mepivacaine|mepivacaine|mesh-list
110106997|NCT01808898|Anesthetics|anesthetics|mesh-list
110106998|NCT01808898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110106999|NCT01808898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110107000|NCT01808898|Sensory System Agents|sensory system agents|mesh-ancestor
110107001|NCT01808898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110107002|NCT01808911|Cyclophosphamide|cyclophosphamide|mesh-list
110107003|NCT01808911|Rituximab|rituximab|mesh-list
110107004|NCT01808911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110107005|NCT01808911|Immunologic Factors|immunologic factors|mesh-ancestor
110107006|NCT01808911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110107007|NCT01808911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110107008|NCT01808911|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110107009|NCT01808911|Alkylating Agents|alkylating agents|mesh-ancestor
110107010|NCT01808911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110107011|NCT01808911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110107012|NCT01808911|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110107013|NCT01808911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110107014|NCT01809158|Minocycline|minocycline|mesh-list
110107015|NCT01809158|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110107016|NCT01809158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110107017|NCT01809171|Vitamin D|vitamin d|mesh-list
110107018|NCT01809171|Cholecalciferol|cholecalciferol|mesh-list
110107019|NCT01809171|Vitamins|vitamins|mesh-ancestor
110107020|NCT01809171|Micronutrients|micronutrients|mesh-ancestor
110107021|NCT01809171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110107022|NCT01809171|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110107023|NCT01809171|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110107024|NCT01809184|Insulin|insulin|mesh-list
110107025|NCT01809184|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110107026|NCT01809184|Insulin Glargine|insulin glargine|mesh-list
110107027|NCT01809184|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110107028|NCT01809184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110107029|NCT01809301|Niacin|niacin|mesh-list
110107030|NCT01809301|Nicotinic Acids|nicotinic acids|mesh-list
110107031|NCT01809301|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110107032|NCT01809301|Antimetabolites|antimetabolites|mesh-ancestor
110107033|NCT01809301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110107034|NCT01809301|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110107035|NCT01809301|Vasodilator Agents|vasodilator agents|mesh-ancestor
110107036|NCT01809301|Vitamin B Complex|vitamin b complex|mesh-ancestor
110107037|NCT01809301|Vitamins|vitamins|mesh-ancestor
110107038|NCT01809301|Micronutrients|micronutrients|mesh-ancestor
110107039|NCT01809301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110107040|NCT01809340|Minocycline|minocycline|mesh-list
110107041|NCT01809340|Ketamine|ketamine|mesh-list
110107042|NCT01809340|Analgesics|analgesics|mesh-ancestor
110107043|NCT01809340|Sensory System Agents|sensory system agents|mesh-ancestor
110107044|NCT01809340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110218378|NCT00075959|Disufenton sodium|disufenton sodium|mesh-list
110107045|NCT01809340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110107046|NCT01809340|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110107047|NCT01809340|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110107048|NCT01809340|Anesthetics, General|anesthetics, general|mesh-ancestor
110107049|NCT01809340|Anesthetics|anesthetics|mesh-ancestor
110107050|NCT01809340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110107051|NCT01809340|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110107052|NCT01809340|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110107053|NCT01809340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110107054|NCT01809340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110107055|NCT01809340|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110107056|NCT01809340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110107058|NCT01809392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110107059|NCT01809392|Antimetabolites|antimetabolites|mesh-ancestor
110107060|NCT01809392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110107061|NCT01809392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110107062|NCT01809392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110107063|NCT01809444|Doxycycline|doxycycline|mesh-list
110107064|NCT01809444|Prednisone|prednisone|mesh-list
110107065|NCT01809444|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110107066|NCT01809444|Glucocorticoids|glucocorticoids|mesh-ancestor
110107067|NCT01809444|Hormones|hormones|mesh-ancestor
110107068|NCT01809444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110107069|NCT01809444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110107070|NCT01809444|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110107071|NCT01809444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110107072|NCT01809444|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110107073|NCT01809444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110107074|NCT01809444|Antimalarials|antimalarials|mesh-ancestor
110107075|NCT01809444|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110107076|NCT01809444|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110107077|NCT01809626|Zolpidem|zolpidem|mesh-list
110107078|NCT01809626|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110107079|NCT01809626|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110107080|NCT01809626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110107081|NCT01809626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110107082|NCT01809626|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
110107083|NCT01809626|GABA Agonists|gaba agonists|mesh-ancestor
110107084|NCT01809626|GABA Agents|gaba agents|mesh-ancestor
110107085|NCT01809626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110107086|NCT01809626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110107087|NCT01809743|Adenosine|adenosine|mesh-list
110107089|NCT01809743|Analgesics|analgesics|mesh-ancestor
110107090|NCT01809743|Sensory System Agents|sensory system agents|mesh-ancestor
110107091|NCT01809743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110107092|NCT01809743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110107093|NCT01809743|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110107094|NCT01809743|Vasodilator Agents|vasodilator agents|mesh-ancestor
110107095|NCT01809743|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
110107096|NCT01809743|Purinergic Agonists|purinergic agonists|mesh-ancestor
110107097|NCT01809743|Purinergic Agents|purinergic agents|mesh-ancestor
110107098|NCT01809743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110107099|NCT01809743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110107100|NCT01809743|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
110107101|NCT01809847|Ofatumumab|ofatumumab|mesh-list
110107102|NCT01809847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110107103|NCT01809860|Sirolimus|sirolimus|mesh-list
110107104|NCT01809860|Isavuconazole|isavuconazole|mesh-list
110107105|NCT01809860|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110107106|NCT01809860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110107107|NCT01809860|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110107108|NCT01809860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110107109|NCT01809860|Antifungal Agents|antifungal agents|mesh-ancestor
110107110|NCT01809860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110107111|NCT01809860|Immunologic Factors|immunologic factors|mesh-ancestor
110107112|NCT01809860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110107113|NCT01809886|Neostigmine|neostigmine|mesh-list
110107114|NCT01809886|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110107115|NCT01809886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110107116|NCT01809886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110107117|NCT01809886|Cholinergic Agents|cholinergic agents|mesh-ancestor
110107118|NCT01809886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110107119|NCT01809886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110107120|NCT01809886|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110107121|NCT01809886|Autonomic Agents|autonomic agents|mesh-ancestor
110107122|NCT01809886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110107123|NCT01809925|Psyllium|psyllium|mesh-list
110107124|NCT01809925|Calcium polycarbophil|calcium polycarbophil|mesh-list
110107126|NCT01809925|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110107127|NCT01809925|Antidiarrheals|antidiarrheals|mesh-ancestor
110107128|NCT01810185|Naltrexone|naltrexone|mesh-list
110107129|NCT01810185|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110107130|NCT01810185|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110107131|NCT01810185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110107132|NCT01810185|Sensory System Agents|sensory system agents|mesh-ancestor
110107133|NCT01810185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110107134|NCT01810237|Dabigatran|dabigatran|mesh-list
110107135|NCT01810237|Antithrombins|antithrombins|mesh-ancestor
110107136|NCT01810237|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110107137|NCT01810237|Protease Inhibitors|protease inhibitors|mesh-ancestor
110107138|NCT01810237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110107139|NCT01810237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110107140|NCT01810237|Anticoagulants|anticoagulants|mesh-ancestor
110107141|NCT01810315|Estradiol|estradiol|mesh-list
110107142|NCT01810315|Estrogens|estrogens|mesh-ancestor
110107143|NCT01810315|Hormones|hormones|mesh-ancestor
110107144|NCT01810315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110401698|NCT01026220|Vincristine|vincristine|mesh-list
110107145|NCT01810315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110107147|NCT01810354|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110107148|NCT01810354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110107149|NCT01810367|Cisplatin|cisplatin|mesh-list
110107150|NCT01810367|Gemcitabine|gemcitabine|mesh-list
110107151|NCT01810367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110107152|NCT01810367|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110107153|NCT01810367|Antimetabolites|antimetabolites|mesh-ancestor
110107154|NCT01810367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110107155|NCT01810393|Trastuzumab|trastuzumab|mesh-list
110107156|NCT01810393|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110107157|NCT01810393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110107158|NCT01810458|Acetaminophen|acetaminophen|mesh-list
110107159|NCT01810458|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
110107160|NCT01810458|Lidocaine|lidocaine|mesh-list
110107161|NCT01810458|Fentanyl|fentanyl|mesh-list
110107162|NCT01810458|Midazolam|midazolam|mesh-list
110107163|NCT01810458|Oxycodone|oxycodone|mesh-list
110107164|NCT01810458|Lorazepam|lorazepam|mesh-list
110107165|NCT01810458|Ondansetron|ondansetron|mesh-list
110107166|NCT01810458|Liver Extracts|liver extracts|mesh-list
110107167|NCT01810458|Anesthetics, Local|anesthetics, local|mesh-ancestor
110107168|NCT01810458|Anesthetics|anesthetics|mesh-ancestor
110107169|NCT01810458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110107170|NCT01810458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110107171|NCT01810458|Sensory System Agents|sensory system agents|mesh-ancestor
110107172|NCT01810458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110107173|NCT01810458|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110107174|NCT01810458|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110107175|NCT01810458|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110107176|NCT01810458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110218394|NCT00279487|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110107177|NCT01810458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110107179|NCT01810458|Narcotics|narcotics|mesh-ancestor
110107180|NCT01810458|Analgesics|analgesics|mesh-ancestor
110107181|NCT01810458|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110107182|NCT01810458|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110107183|NCT01810458|Anesthetics, General|anesthetics, general|mesh-ancestor
110107184|NCT01810458|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110107185|NCT01810458|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110107186|NCT01810458|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110107187|NCT01810458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110107188|NCT01810458|GABA Modulators|gaba modulators|mesh-ancestor
110107189|NCT01810458|GABA Agents|gaba agents|mesh-ancestor
110107190|NCT01810458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110107191|NCT01810458|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110107192|NCT01810458|Antipyretics|antipyretics|mesh-ancestor
110107193|NCT01810458|Hematinics|hematinics|mesh-ancestor
110107194|NCT01810458|Antiemetics|antiemetics|mesh-ancestor
110107195|NCT01810458|Autonomic Agents|autonomic agents|mesh-ancestor
110107196|NCT01810458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110107197|NCT01810458|Antipruritics|antipruritics|mesh-ancestor
110107198|NCT01810458|Dermatologic Agents|dermatologic agents|mesh-ancestor
110107199|NCT01810458|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110107200|NCT01810458|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110107201|NCT01810458|Serotonin Agents|serotonin agents|mesh-ancestor
110107202|NCT01810458|Anticonvulsants|anticonvulsants|mesh-ancestor
110107203|NCT01810458|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110107204|NCT01810458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110107205|NCT01810458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110107206|NCT01810549|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
110107207|NCT01810549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110107208|NCT01810601|Progesterone|progesterone|mesh-list
110107209|NCT01810601|Progestins|progestins|mesh-ancestor
110107210|NCT01810601|Hormones|hormones|mesh-ancestor
110107211|NCT01810601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110107212|NCT01810601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110107213|NCT01810640|Liver Extracts|liver extracts|mesh-list
110107215|NCT01810731|Vaccines|vaccines|mesh-list
110107216|NCT01810731|Immunologic Factors|immunologic factors|mesh-ancestor
110107217|NCT01810731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110107218|NCT01810770|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
110107219|NCT01810770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110107220|NCT01810796|Ranolazine|ranolazine|mesh-list
110107221|NCT01810796|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110107222|NCT01810796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110107223|NCT01810796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110107224|NCT01810809|Hylan|hylan|mesh-list
110107225|NCT01810809|Hyaluronic Acid|hyaluronic acid|mesh-list
110107226|NCT01810809|Viscosupplements|viscosupplements|mesh-ancestor
110107227|NCT01810809|Protective Agents|protective agents|mesh-ancestor
110107228|NCT01810809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110107229|NCT01810809|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110107230|NCT01810809|Immunologic Factors|immunologic factors|mesh-ancestor
110107231|NCT01810848|Hyaluronic Acid|hyaluronic acid|mesh-list
110107232|NCT01810848|Hylan|hylan|mesh-list
110107233|NCT01810848|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110107234|NCT01810848|Immunologic Factors|immunologic factors|mesh-ancestor
110107235|NCT01810848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110107236|NCT01810848|Viscosupplements|viscosupplements|mesh-ancestor
110107237|NCT01810848|Protective Agents|protective agents|mesh-ancestor
110107238|NCT01810887|Ritonavir|ritonavir|mesh-list
110107239|NCT01810887|Darunavir|darunavir|mesh-list
110107240|NCT01810887|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110107241|NCT01810887|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110107242|NCT01810887|Protease Inhibitors|protease inhibitors|mesh-ancestor
110107243|NCT01810887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110107244|NCT01810887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110107245|NCT01810887|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110218405|NCT00279565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110107247|NCT01810887|Antiviral Agents|antiviral agents|mesh-ancestor
110107248|NCT01810887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110107249|NCT01810887|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110107250|NCT01810887|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110107251|NCT01810926|Cyclosporine|cyclosporine|mesh-list
110107252|NCT01810926|Rituximab|rituximab|mesh-list
110107253|NCT01810926|Methotrexate|methotrexate|mesh-list
110107254|NCT01810926|Fludarabine|fludarabine|mesh-list
110107255|NCT01810926|Thiotepa|thiotepa|mesh-list
110107256|NCT01810926|Treosulfan|treosulfan|mesh-list
110107257|NCT01810926|Antibodies|antibodies|mesh-list
110107258|NCT01810926|Cyclosporins|cyclosporins|mesh-list
110107259|NCT01810926|Immunologic Factors|immunologic factors|mesh-ancestor
110107260|NCT01810926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110107261|NCT01810926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110107262|NCT01810926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110107263|NCT01810926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110107264|NCT01810926|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110107265|NCT01810926|Abortifacient Agents|abortifacient agents|mesh-ancestor
110107266|NCT01810926|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110107267|NCT01810926|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110107268|NCT01810926|Antimetabolites|antimetabolites|mesh-ancestor
110107269|NCT01810926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110107270|NCT01810926|Dermatologic Agents|dermatologic agents|mesh-ancestor
110107271|NCT01810926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110107272|NCT01810926|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110107273|NCT01810926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110107274|NCT01810926|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110107275|NCT01810926|Antifungal Agents|antifungal agents|mesh-ancestor
110107276|NCT01810926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110107277|NCT01810926|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110107278|NCT01810926|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110107279|NCT01810926|Alkylating Agents|alkylating agents|mesh-ancestor
110107280|NCT01810926|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110107281|NCT01811056|Mifepristone|mifepristone|mesh-list
110107282|NCT01811056|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
110107283|NCT01811056|Abortifacient Agents|abortifacient agents|mesh-ancestor
110107284|NCT01811056|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110107285|NCT01811056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110107286|NCT01811056|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110107287|NCT01811056|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110107288|NCT01811056|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110107289|NCT01811056|Contraceptive Agents|contraceptive agents|mesh-ancestor
110107290|NCT01811056|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
110107291|NCT01811056|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
110107292|NCT01811056|Hormone Antagonists|hormone antagonists|mesh-ancestor
110107293|NCT01811056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110107294|NCT01811056|Luteolytic Agents|luteolytic agents|mesh-ancestor
110107295|NCT01811056|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110107296|NCT01811056|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
110107297|NCT01811160|Melatonin|melatonin|mesh-list
110107298|NCT01811160|Antioxidants|antioxidants|mesh-ancestor
110107299|NCT01811160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110107300|NCT01811160|Protective Agents|protective agents|mesh-ancestor
110107301|NCT01811160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110107302|NCT01811160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110107303|NCT01811251|Dexamethasone|dexamethasone|mesh-list
110107304|NCT01811251|Pregabalin|pregabalin|mesh-list
110107305|NCT01811251|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110107306|NCT01811251|Antiemetics|antiemetics|mesh-ancestor
110107307|NCT01811251|Autonomic Agents|autonomic agents|mesh-ancestor
110218415|NCT00279565|Analgesics|analgesics|mesh-ancestor
110107308|NCT01811251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110107309|NCT01811251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110107310|NCT01811251|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110107311|NCT01811251|Glucocorticoids|glucocorticoids|mesh-ancestor
110107313|NCT01811251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110107314|NCT01811251|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110107315|NCT01811251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110107316|NCT01811251|Analgesics|analgesics|mesh-ancestor
110107317|NCT01811251|Sensory System Agents|sensory system agents|mesh-ancestor
110107318|NCT01811251|Anticonvulsants|anticonvulsants|mesh-ancestor
110107319|NCT01811251|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110107320|NCT01811251|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110107321|NCT01811251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110107322|NCT01811251|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110107323|NCT01811251|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110107324|NCT01811251|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110107325|NCT01811251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110107326|NCT01811251|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110107327|NCT01811277|Oxaliplatin|oxaliplatin|mesh-list
110107328|NCT01811277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110107329|NCT01811381|Curcumin|curcumin|mesh-list
110107330|NCT01811381|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110107331|NCT01811381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110107332|NCT01811381|Analgesics|analgesics|mesh-ancestor
110107333|NCT01811381|Sensory System Agents|sensory system agents|mesh-ancestor
110107334|NCT01811381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110107335|NCT01811381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110107336|NCT01811381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110107337|NCT01811381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110107338|NCT01811381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110107339|NCT01811381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110107340|NCT01811381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110107341|NCT01811459|Haloperidol|haloperidol|mesh-list
110107342|NCT01811459|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110107343|NCT01811459|Haloperidol decanoate|haloperidol decanoate|mesh-list
110107344|NCT01811459|Antidepressive Agents|antidepressive agents|mesh-ancestor
110107345|NCT01811459|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110107346|NCT01811459|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110107347|NCT01811459|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110107348|NCT01811459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110107349|NCT01811459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110107350|NCT01811459|Antiemetics|antiemetics|mesh-ancestor
110107351|NCT01811459|Autonomic Agents|autonomic agents|mesh-ancestor
110107352|NCT01811459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110107353|NCT01811459|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110107354|NCT01811459|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110107355|NCT01811459|Dopamine Agents|dopamine agents|mesh-ancestor
110107356|NCT01811459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110107357|NCT01811459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110107358|NCT01811459|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110107359|NCT01811615|Ethanol|ethanol|mesh-list
110107360|NCT01811615|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110107361|NCT01811615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110107362|NCT01811615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110107363|NCT01811615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110107364|NCT01811667|Sirolimus|sirolimus|mesh-list
110107365|NCT01811667|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110218427|NCT00109161|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110107366|NCT01811667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110107367|NCT01811667|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110107368|NCT01811667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110107369|NCT01811667|Antifungal Agents|antifungal agents|mesh-ancestor
110107370|NCT01811667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110107371|NCT01811667|Immunologic Factors|immunologic factors|mesh-ancestor
110107372|NCT01811667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110107373|NCT01811810|Androgens|androgens|mesh-list
110107374|NCT01811810|Hormones|hormones|mesh-ancestor
110107375|NCT01811810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110107376|NCT01811810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110107378|NCT01811836|Trace Elements|trace elements|mesh-ancestor
110107379|NCT01811836|Micronutrients|micronutrients|mesh-ancestor
110107380|NCT01811836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110107381|NCT01811849|Insulin|insulin|mesh-list
110107382|NCT01811849|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110107383|NCT01811849|Insulin Lispro|insulin lispro|mesh-list
110107384|NCT01811849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110107385|NCT01811849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110107386|NCT01812018|Gemcitabine|gemcitabine|mesh-list
110107387|NCT01812018|Docetaxel|docetaxel|mesh-list
110107388|NCT01812018|Endostar protein|endostar protein|mesh-list
110107389|NCT01812018|Endostatins|endostatins|mesh-list
110107390|NCT01812018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110107391|NCT01812018|Antimetabolites|antimetabolites|mesh-ancestor
110107392|NCT01812018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110107393|NCT01812018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110107394|NCT01812018|Tubulin Modulators|tubulin modulators|mesh-ancestor
110107395|NCT01812018|Antimitotic Agents|antimitotic agents|mesh-ancestor
110107396|NCT01812018|Mitosis Modulators|mitosis modulators|mesh-ancestor
110107397|NCT01812018|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110107398|NCT01812018|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110107399|NCT01812018|Growth Substances|growth substances|mesh-ancestor
110107400|NCT01812018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110107401|NCT01812018|Growth Inhibitors|growth inhibitors|mesh-ancestor
110107402|NCT01812096|Bortezomib|bortezomib|mesh-list
110107403|NCT01812096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110107404|NCT01812122|Glimepiride|glimepiride|mesh-list
110107405|NCT01812122|Vildagliptin|vildagliptin|mesh-list
110107406|NCT01812122|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110107407|NCT01812122|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110107408|NCT01812122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110107410|NCT01812122|Immunologic Factors|immunologic factors|mesh-ancestor
110107411|NCT01812122|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110107412|NCT01812122|Protease Inhibitors|protease inhibitors|mesh-ancestor
110107413|NCT01812122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110107414|NCT01812122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110107417|NCT01812135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110107418|NCT01812200|Rivaroxaban|rivaroxaban|mesh-list
110107419|NCT01812200|Dabigatran|dabigatran|mesh-list
110107420|NCT01812200|Phenprocoumon|phenprocoumon|mesh-list
110107421|NCT01812200|Ticagrelor|ticagrelor|mesh-list
110107422|NCT01812200|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110107423|NCT01812200|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110107424|NCT01812200|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110107425|NCT01812200|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110107426|NCT01812200|Purinergic Agents|purinergic agents|mesh-ancestor
110107427|NCT01812200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110107428|NCT01812200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110107429|NCT01812200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110107430|NCT01812200|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110107431|NCT01812200|Antithrombins|antithrombins|mesh-ancestor
110107432|NCT01812200|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110107433|NCT01812200|Protease Inhibitors|protease inhibitors|mesh-ancestor
110107434|NCT01812200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110218445|NCT00416728|Valsartan|valsartan|mesh-list
110107435|NCT01812200|Anticoagulants|anticoagulants|mesh-ancestor
110107436|NCT01812239|Progesterone|progesterone|mesh-list
110107437|NCT01812239|Progestins|progestins|mesh-list
110107438|NCT01812239|Hormones|hormones|mesh-ancestor
110107439|NCT01812239|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110107440|NCT01812239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110107441|NCT01812330|Clopidogrel|clopidogrel|mesh-list
110107442|NCT01812330|Ticagrelor|ticagrelor|mesh-list
110107443|NCT01812330|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110107444|NCT01812330|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110107445|NCT01812330|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110107446|NCT01812330|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110107447|NCT01812330|Purinergic Agents|purinergic agents|mesh-ancestor
110107448|NCT01812330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110107449|NCT01812330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110107450|NCT01812330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110107451|NCT01812356|Nitrous Oxide|nitrous oxide|mesh-list
110107452|NCT01812356|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110107453|NCT01812356|Anesthetics, General|anesthetics, general|mesh-ancestor
110107454|NCT01812356|Anesthetics|anesthetics|mesh-ancestor
110107455|NCT01812356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110107456|NCT01812356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110107457|NCT01812356|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110107458|NCT01812356|Analgesics|analgesics|mesh-ancestor
110107459|NCT01812356|Sensory System Agents|sensory system agents|mesh-ancestor
110107460|NCT01812356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110107461|NCT01812369|Gemcitabine|gemcitabine|mesh-list
110107462|NCT01812369|Doxorubicin|doxorubicin|mesh-list
110107463|NCT01812369|Vinblastine|vinblastine|mesh-list
110107464|NCT01812369|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110107465|NCT01812369|Antimetabolites|antimetabolites|mesh-ancestor
110107466|NCT01812369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110107467|NCT01812369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110107468|NCT01812369|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110107469|NCT01812369|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110107470|NCT01812369|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110107471|NCT01812369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110107472|NCT01812369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110107473|NCT01812369|Tubulin Modulators|tubulin modulators|mesh-ancestor
110107474|NCT01812369|Antimitotic Agents|antimitotic agents|mesh-ancestor
110107475|NCT01812369|Mitosis Modulators|mitosis modulators|mesh-ancestor
110107476|NCT01812382|Retapamulin|retapamulin|mesh-list
110107477|NCT01812382|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110107478|NCT01812382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110107479|NCT01812434|Sildenafil Citrate|sildenafil citrate|mesh-list
110107480|NCT01812434|Vasodilator Agents|vasodilator agents|mesh-ancestor
110107481|NCT01812434|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110107482|NCT01812434|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110107483|NCT01812434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110107484|NCT01812434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110107485|NCT01812434|Urological Agents|urological agents|mesh-ancestor
110107486|NCT01812538|Diclofenac|diclofenac|mesh-list
110107487|NCT01812538|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110107488|NCT01812538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110107489|NCT01812538|Analgesics|analgesics|mesh-ancestor
110107490|NCT01812538|Sensory System Agents|sensory system agents|mesh-ancestor
110107491|NCT01812538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110107492|NCT01812538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110107493|NCT01812538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110107494|NCT01812538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110107495|NCT01812538|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110107496|NCT01812538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110107497|NCT01812538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110107498|NCT01812551|Alendronate|alendronate|mesh-list
110107499|NCT01812551|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110107500|NCT01812551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110107501|NCT01812642|N-(1-(3,4-difluorobenzyl)piperidin-4-yl)-6-(trifluoromethyl)pyridazin-3-amine|n-(1-(3,4-difluorobenzyl)piperidin-4-yl)-6-(trifluoromethyl)pyridazin-3-amine|mesh-list
110107502|NCT01812642|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110107503|NCT01812642|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110107504|NCT01812642|Dopamine Agents|dopamine agents|mesh-ancestor
110107505|NCT01812642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110107506|NCT01812642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110107507|NCT01812642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110107508|NCT01812720|Dexamethasone|dexamethasone|mesh-list
110107509|NCT01812720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110107510|NCT01812720|Antiemetics|antiemetics|mesh-ancestor
110107511|NCT01812720|Autonomic Agents|autonomic agents|mesh-ancestor
110107512|NCT01812720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110107513|NCT01812720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110107514|NCT01812720|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110107515|NCT01812720|Glucocorticoids|glucocorticoids|mesh-ancestor
110107517|NCT01812720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110107518|NCT01812720|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110107519|NCT01812720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110107520|NCT01812889|TOL-463|tol-463|mesh-list
110107521|NCT01812889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110107522|NCT01812928|Diclofenac|diclofenac|mesh-list
110107523|NCT01812928|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
110107524|NCT01812928|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
110107525|NCT01812928|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110107526|NCT01812928|Analgesics|analgesics|mesh-ancestor
110107527|NCT01812928|Sensory System Agents|sensory system agents|mesh-ancestor
110107528|NCT01812928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110107529|NCT01812928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110107530|NCT01812928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110107531|NCT01812928|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110107532|NCT01812928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110107533|NCT01812928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110107534|NCT01812954|Cyclosporine|cyclosporine|mesh-list
110107535|NCT01812954|Adalimumab|adalimumab|mesh-list
110107536|NCT01812954|Infliximab|infliximab|mesh-list
110107537|NCT01812954|Etanercept|etanercept|mesh-list
110107538|NCT01812954|Methotrexate|methotrexate|mesh-list
110107539|NCT01812954|Ustekinumab|ustekinumab|mesh-list
110107540|NCT01812954|Acitretin|acitretin|mesh-list
110107541|NCT01812954|Cyclosporins|cyclosporins|mesh-list
110107542|NCT01812954|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110107543|NCT01812954|Abortifacient Agents|abortifacient agents|mesh-ancestor
110107544|NCT01812954|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110107545|NCT01812954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110107546|NCT01812954|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110107547|NCT01812954|Antimetabolites|antimetabolites|mesh-ancestor
110107548|NCT01812954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110107549|NCT01812954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110107550|NCT01812954|Dermatologic Agents|dermatologic agents|mesh-ancestor
110107551|NCT01812954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110107552|NCT01812954|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110107553|NCT01812954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110107554|NCT01812954|Immunologic Factors|immunologic factors|mesh-ancestor
110107555|NCT01812954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110107556|NCT01812954|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110107557|NCT01812954|Antifungal Agents|antifungal agents|mesh-ancestor
110107558|NCT01812954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110107559|NCT01812954|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110107560|NCT01812954|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110218460|NCT00416767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110107561|NCT01812954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110107562|NCT01812954|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110260158|NCT00145301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110107563|NCT01812954|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110107564|NCT01812954|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110107566|NCT01812954|Sensory System Agents|sensory system agents|mesh-ancestor
110107567|NCT01812954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110107568|NCT01812954|Keratolytic Agents|keratolytic agents|mesh-ancestor
110107569|NCT01812967|Caseins|caseins|mesh-list
110107570|NCT01812967|Chelating Agents|chelating agents|mesh-ancestor
110107571|NCT01812967|Sequestering Agents|sequestering agents|mesh-ancestor
110107572|NCT01812967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110107573|NCT01813162|Tenofovir|tenofovir|mesh-list
110107574|NCT01813162|Metronidazole|metronidazole|mesh-list
110107575|NCT01813162|Terconazole|terconazole|mesh-list
110107576|NCT01813162|Contraceptive Agents|contraceptive agents|mesh-list
110107577|NCT01813162|Antiviral Agents|antiviral agents|mesh-ancestor
110107578|NCT01813162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110107579|NCT01813162|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110107580|NCT01813162|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110107581|NCT01813162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110107582|NCT01813162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110107583|NCT01813162|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110107584|NCT01813162|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110107585|NCT01813162|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110107586|NCT01813162|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110107587|NCT01813162|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110107588|NCT01813162|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110107589|NCT01813162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110107590|NCT01813162|Antifungal Agents|antifungal agents|mesh-ancestor
110107591|NCT01813201|Methyltestosterone|methyltestosterone|mesh-list
110107592|NCT01813201|Testosterone|testosterone|mesh-list
110107593|NCT01813201|Testosterone undecanoate|testosterone undecanoate|mesh-list
110107594|NCT01813201|Testosterone enanthate|testosterone enanthate|mesh-list
110107595|NCT01813201|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
110107596|NCT01813201|Androgens|androgens|mesh-ancestor
110107597|NCT01813201|Hormones|hormones|mesh-ancestor
110401776|NCT06055257|Vasodilator Agents|vasodilator agents|mesh-ancestor
110107598|NCT01813201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110107599|NCT01813201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110107600|NCT01813201|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110107601|NCT01813201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110107602|NCT01813201|Anabolic Agents|anabolic agents|mesh-ancestor
110107604|NCT01813240|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110107605|NCT01813240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110107606|NCT01813253|Irinotecan|irinotecan|mesh-list
110107607|NCT01813253|Nimotuzumab|nimotuzumab|mesh-list
110107608|NCT01813253|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110107609|NCT01813253|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110107610|NCT01813253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110107611|NCT01813253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110107612|NCT01813253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110107613|NCT01813253|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110107614|NCT01813318|Acamprosate|acamprosate|mesh-list
110107615|NCT01813318|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110107616|NCT01813448|Fidaxomicin|fidaxomicin|mesh-list
110107617|NCT01813448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110107618|NCT01813448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110107619|NCT01813461|Isavuconazole|isavuconazole|mesh-list
110107620|NCT01813461|Antifungal Agents|antifungal agents|mesh-ancestor
110107621|NCT01813461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110107622|NCT01813487|Entecavir|entecavir|mesh-list
110218478|NCT00076115|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110218480|NCT00076115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110107623|NCT01813487|Antiviral Agents|antiviral agents|mesh-ancestor
110107624|NCT01813487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110107625|NCT01813513|Simeprevir|simeprevir|mesh-list
110107626|NCT01813513|Antiviral Agents|antiviral agents|mesh-ancestor
110107627|NCT01813513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110107628|NCT01813513|Protease Inhibitors|protease inhibitors|mesh-ancestor
110107629|NCT01813513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110107630|NCT01813513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110107631|NCT01813552|Ritonavir|ritonavir|mesh-list
110107632|NCT01813552|Omeprazole|omeprazole|mesh-list
110107633|NCT01813552|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110107634|NCT01813552|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110107635|NCT01813552|Protease Inhibitors|protease inhibitors|mesh-ancestor
110107636|NCT01813552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110107637|NCT01813552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110107638|NCT01813552|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110107639|NCT01813552|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110107640|NCT01813552|Antiviral Agents|antiviral agents|mesh-ancestor
110107641|NCT01813552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110107642|NCT01813552|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110107643|NCT01813552|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110107644|NCT01813552|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110107645|NCT01813552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110107646|NCT01813552|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110107647|NCT01813565|Hyaluronic Acid|hyaluronic acid|mesh-list
110107648|NCT01813565|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110107649|NCT01813565|Immunologic Factors|immunologic factors|mesh-ancestor
110107650|NCT01813565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110107651|NCT01813565|Viscosupplements|viscosupplements|mesh-ancestor
110107652|NCT01813565|Protective Agents|protective agents|mesh-ancestor
110107653|NCT01813591|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
110107654|NCT01813591|Hormones|hormones|mesh-ancestor
110107655|NCT01813591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110107656|NCT01813591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110107657|NCT01813604|Vaccines|vaccines|mesh-list
110107658|NCT01813604|Immunologic Factors|immunologic factors|mesh-ancestor
110107659|NCT01813604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110107660|NCT01813617|Prednisone|prednisone|mesh-list
110107661|NCT01813617|Methotrexate|methotrexate|mesh-list
110107662|NCT01813617|Azathioprine|azathioprine|mesh-list
110107663|NCT01813617|Immunosuppressive Agents|immunosuppressive agents|mesh-list
110107664|NCT01813617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110107665|NCT01813617|Glucocorticoids|glucocorticoids|mesh-ancestor
110107666|NCT01813617|Hormones|hormones|mesh-ancestor
110107667|NCT01813617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110107668|NCT01813617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110107669|NCT01813617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110107670|NCT01813617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110107671|NCT01813617|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110107672|NCT01813617|Abortifacient Agents|abortifacient agents|mesh-ancestor
110107673|NCT01813617|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110107674|NCT01813617|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110107675|NCT01813617|Antimetabolites|antimetabolites|mesh-ancestor
110107676|NCT01813617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110107677|NCT01813617|Dermatologic Agents|dermatologic agents|mesh-ancestor
110107678|NCT01813617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110107679|NCT01813617|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110107680|NCT01813617|Immunologic Factors|immunologic factors|mesh-ancestor
110107681|NCT01813617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110107682|NCT01813617|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110107683|NCT01813643|Risperidone|risperidone|mesh-list
110107684|NCT01813643|Aripiprazole|aripiprazole|mesh-list
110107685|NCT01813643|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110107686|NCT01813643|Serotonin Agents|serotonin agents|mesh-ancestor
110107687|NCT01813643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110107688|NCT01813643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110107689|NCT01813643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110107690|NCT01813643|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110107691|NCT01813643|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110107692|NCT01813643|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110107693|NCT01813643|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110107694|NCT01813643|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110107695|NCT01813643|Dopamine Agents|dopamine agents|mesh-ancestor
110107696|NCT01813643|Antidepressive Agents|antidepressive agents|mesh-ancestor
110107697|NCT01813643|Dopamine Agonists|dopamine agonists|mesh-ancestor
110107698|NCT01813643|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110107699|NCT01813643|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110107700|NCT01813643|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110107701|NCT01813643|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110107702|NCT01813656|Aripiprazole|aripiprazole|mesh-list
110107703|NCT01813656|Antidepressive Agents|antidepressive agents|mesh-ancestor
110107704|NCT01813656|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110107705|NCT01813656|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110107706|NCT01813656|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110107707|NCT01813656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110107708|NCT01813656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110107709|NCT01813656|Dopamine Agonists|dopamine agonists|mesh-ancestor
110107710|NCT01813656|Dopamine Agents|dopamine agents|mesh-ancestor
110107711|NCT01813656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110107712|NCT01813656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110107713|NCT01813656|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110107714|NCT01813656|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110107715|NCT01813656|Serotonin Agents|serotonin agents|mesh-ancestor
110107716|NCT01813656|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110107717|NCT01813656|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110107718|NCT01813656|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110107719|NCT01813656|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110107720|NCT01813773|Aflibercept|aflibercept|mesh-list
110107721|NCT01813773|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110107722|NCT01813773|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110107723|NCT01813773|Growth Substances|growth substances|mesh-ancestor
110107724|NCT01813773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110107725|NCT01813773|Growth Inhibitors|growth inhibitors|mesh-ancestor
110107726|NCT01813773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110107727|NCT01813812|Rebamipide|rebamipide|mesh-list
110107728|NCT01813812|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110107729|NCT01813812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110107730|NCT01813812|Antioxidants|antioxidants|mesh-ancestor
110107731|NCT01813812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110107732|NCT01813812|Protective Agents|protective agents|mesh-ancestor
110107733|NCT01813812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110107734|NCT01813812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110107736|NCT01813955|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110107737|NCT01813955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110107738|NCT01813955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110107739|NCT01813955|Vasodilator Agents|vasodilator agents|mesh-ancestor
110107740|NCT01813955|Urological Agents|urological agents|mesh-ancestor
110107741|NCT01813981|Caffeine|caffeine|mesh-list
110107742|NCT01813981|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110107743|NCT01813981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110107744|NCT01813981|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110107745|NCT01813981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110107746|NCT01813981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110218506|NCT00076232|Acyclovir|acyclovir|mesh-list
110107747|NCT01813981|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110107748|NCT01813981|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110107749|NCT01813981|Purinergic Agents|purinergic agents|mesh-ancestor
110107750|NCT01813981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110107751|NCT01813994|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
110107752|NCT01813994|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110107753|NCT01813994|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110107754|NCT01813994|Antimetabolites|antimetabolites|mesh-ancestor
110107755|NCT01813994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110107756|NCT01813994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110107757|NCT01813994|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110107758|NCT01814059|Sirolimus|sirolimus|mesh-list
110107759|NCT01814059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110107760|NCT01814059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110107761|NCT01814059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110107762|NCT01814059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110107763|NCT01814059|Antifungal Agents|antifungal agents|mesh-ancestor
110107764|NCT01814059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110107765|NCT01814059|Immunologic Factors|immunologic factors|mesh-ancestor
110107766|NCT01814059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110107767|NCT01814085|Escitalopram|escitalopram|mesh-list
110107768|NCT01814085|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110107769|NCT01814085|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110107770|NCT01814085|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110107771|NCT01814085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110107772|NCT01814085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110107773|NCT01814085|Serotonin Agents|serotonin agents|mesh-ancestor
110107774|NCT01814085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110107775|NCT01814098|Escitalopram|escitalopram|mesh-list
110107776|NCT01814098|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110107777|NCT01814098|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110107778|NCT01814098|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110107779|NCT01814098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110107780|NCT01814098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110107781|NCT01814098|Serotonin Agents|serotonin agents|mesh-ancestor
110107782|NCT01814098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110107783|NCT01814163|Paclitaxel|paclitaxel|mesh-list
110107784|NCT01814163|Bevacizumab|bevacizumab|mesh-list
110107785|NCT01814163|Carboplatin|carboplatin|mesh-list
110107786|NCT01814163|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110107787|NCT01814163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110218516|NCT00280423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110218518|NCT00109356|AQ4N|aq4n|mesh-list
110107788|NCT01814163|Tubulin Modulators|tubulin modulators|mesh-ancestor
110107789|NCT01814163|Antimitotic Agents|antimitotic agents|mesh-ancestor
110107790|NCT01814163|Mitosis Modulators|mitosis modulators|mesh-ancestor
110107791|NCT01814163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110107792|NCT01814163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110107793|NCT01814163|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110107794|NCT01814163|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110107795|NCT01814163|Growth Substances|growth substances|mesh-ancestor
110107796|NCT01814163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110107797|NCT01814163|Growth Inhibitors|growth inhibitors|mesh-ancestor
110107798|NCT01814189|Promethazine|promethazine|mesh-list
110107799|NCT01814189|Diphenhydramine|diphenhydramine|mesh-list
110107800|NCT01814189|Sumatriptan|sumatriptan|mesh-list
110107801|NCT01814189|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110107802|NCT01814189|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110107803|NCT01814189|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110107804|NCT01814189|Serotonin Agents|serotonin agents|mesh-ancestor
110107805|NCT01814189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110107806|NCT01814189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110107807|NCT01814189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110107808|NCT01814189|Antipruritics|antipruritics|mesh-ancestor
110107809|NCT01814189|Dermatologic Agents|dermatologic agents|mesh-ancestor
110107810|NCT01814189|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110107811|NCT01814189|Histamine Antagonists|histamine antagonists|mesh-ancestor
110107812|NCT01814189|Histamine Agents|histamine agents|mesh-ancestor
110107813|NCT01814189|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110107814|NCT01814189|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110107815|NCT01814189|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110107816|NCT01814189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110107817|NCT01814189|Anesthetics, Local|anesthetics, local|mesh-ancestor
110107818|NCT01814189|Anesthetics|anesthetics|mesh-ancestor
110107819|NCT01814189|Sensory System Agents|sensory system agents|mesh-ancestor
110107820|NCT01814189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110107821|NCT01814189|Antiemetics|antiemetics|mesh-ancestor
110107822|NCT01814189|Autonomic Agents|autonomic agents|mesh-ancestor
110107823|NCT01814189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110107824|NCT01814319|Probenecid|probenecid|mesh-list
110107825|NCT01814319|Uricosuric Agents|uricosuric agents|mesh-ancestor
110107826|NCT01814319|Gout Suppressants|gout suppressants|mesh-ancestor
110107827|NCT01814319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110107828|NCT01814410|Ethanol|ethanol|mesh-list
110107829|NCT01814410|Nicotine|nicotine|mesh-list
110107830|NCT01814410|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110107831|NCT01814410|Autonomic Agents|autonomic agents|mesh-ancestor
110107832|NCT01814410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110107833|NCT01814410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110107834|NCT01814410|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110107835|NCT01814410|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110107836|NCT01814410|Cholinergic Agents|cholinergic agents|mesh-ancestor
110107837|NCT01814410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110107838|NCT01814410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110107839|NCT01814410|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110107840|NCT01814410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110107841|NCT01814410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110107842|NCT01814423|Chloroquine|chloroquine|mesh-list
110107843|NCT01814423|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
110107844|NCT01814423|Amebicides|amebicides|mesh-ancestor
110107845|NCT01814423|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110107846|NCT01814423|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110107847|NCT01814423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110107848|NCT01814423|Antimalarials|antimalarials|mesh-ancestor
110107849|NCT01814423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110107850|NCT01814423|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110107851|NCT01814423|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110107852|NCT01814423|Analgesics|analgesics|mesh-ancestor
110107853|NCT01814423|Sensory System Agents|sensory system agents|mesh-ancestor
110107854|NCT01814423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110107855|NCT01814423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110107856|NCT01814423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110107857|NCT01814423|Filaricides|filaricides|mesh-ancestor
110107858|NCT01814423|Antinematodal Agents|antinematodal agents|mesh-ancestor
110107859|NCT01814423|Anthelmintics|anthelmintics|mesh-ancestor
110107861|NCT01814449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110107862|NCT01814449|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110107863|NCT01814449|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110107864|NCT01814449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110107865|NCT01814449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110107866|NCT01814449|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110107867|NCT01814449|Hormone Antagonists|hormone antagonists|mesh-ancestor
110107868|NCT01814449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110107869|NCT01814449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110107870|NCT01814475|Vidarabine|vidarabine|mesh-list
110107871|NCT01814475|Fludarabine|fludarabine|mesh-list
110107872|NCT01814475|Fludarabine phosphate|fludarabine phosphate|mesh-list
110107873|NCT01814475|Busulfan|busulfan|mesh-list
110107874|NCT01814475|Thiotepa|thiotepa|mesh-list
110107875|NCT01814475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110107876|NCT01814475|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110107877|NCT01814475|Antimetabolites|antimetabolites|mesh-ancestor
110107878|NCT01814475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110107879|NCT01814475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110107880|NCT01814475|Immunologic Factors|immunologic factors|mesh-ancestor
110107881|NCT01814475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110107882|NCT01814475|Antiviral Agents|antiviral agents|mesh-ancestor
110107883|NCT01814475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110107884|NCT01814475|Alkylating Agents|alkylating agents|mesh-ancestor
110107885|NCT01814475|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110107886|NCT01814475|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110107888|NCT01814501|Fluorouracil|fluorouracil|mesh-list
110107889|NCT01814501|Irinotecan|irinotecan|mesh-list
110107890|NCT01814501|Panitumumab|panitumumab|mesh-list
110107891|NCT01814501|Calcium|calcium|mesh-list
110107892|NCT01814501|Levoleucovorin|levoleucovorin|mesh-list
110107893|NCT01814501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110107894|NCT01814501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110107895|NCT01814501|Antimetabolites|antimetabolites|mesh-ancestor
110107896|NCT01814501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110107897|NCT01814501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110107898|NCT01814501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110107899|NCT01814501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110107900|NCT01814501|Immunologic Factors|immunologic factors|mesh-ancestor
110107901|NCT01814501|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110107902|NCT01814501|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110107903|NCT01814501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110107904|NCT01814501|Antidotes|antidotes|mesh-ancestor
110107905|NCT01814501|Protective Agents|protective agents|mesh-ancestor
110107906|NCT01814501|Vitamin B Complex|vitamin b complex|mesh-ancestor
110107907|NCT01814501|Vitamins|vitamins|mesh-ancestor
110107908|NCT01814501|Micronutrients|micronutrients|mesh-ancestor
110107909|NCT01814501|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110107910|NCT01814514|Timolol|timolol|mesh-list
110107911|NCT01814514|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110107912|NCT01814514|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110218555|NCT00076349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110107913|NCT01814514|Adrenergic Agents|adrenergic agents|mesh-ancestor
110107914|NCT01814514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110107915|NCT01814514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110107916|NCT01814514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110107917|NCT01814514|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110107918|NCT01814514|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110107919|NCT01814618|Budesonide|budesonide|mesh-list
110107920|NCT01814618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110107921|NCT01814618|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110107922|NCT01814618|Autonomic Agents|autonomic agents|mesh-ancestor
110107923|NCT01814618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110107924|NCT01814618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110107925|NCT01814618|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110107926|NCT01814618|Respiratory System Agents|respiratory system agents|mesh-ancestor
110107927|NCT01814618|Glucocorticoids|glucocorticoids|mesh-ancestor
110107928|NCT01814618|Hormones|hormones|mesh-ancestor
110107929|NCT01814618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110107930|NCT01814683|Primaquine|primaquine|mesh-list
110107931|NCT01814683|Antimalarials|antimalarials|mesh-ancestor
110107932|NCT01814683|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110107933|NCT01814683|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110107934|NCT01814683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110107935|NCT01814709|Itraconazole|itraconazole|mesh-list
110107936|NCT01814709|Rifampin|rifampin|mesh-list
110107937|NCT01814709|Antifungal Agents|antifungal agents|mesh-ancestor
110107938|NCT01814709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110107939|NCT01814709|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110107940|NCT01814709|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110107941|NCT01814709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110107942|NCT01814709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110107943|NCT01814709|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110107944|NCT01814709|Hormone Antagonists|hormone antagonists|mesh-ancestor
110107945|NCT01814709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110107946|NCT01814709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110107947|NCT01814709|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110107948|NCT01814709|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110107949|NCT01814709|Antitubercular Agents|antitubercular agents|mesh-ancestor
110107950|NCT01814709|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110107951|NCT01814709|Leprostatic Agents|leprostatic agents|mesh-ancestor
110107952|NCT01814709|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110107953|NCT01814709|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110107954|NCT01814709|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110107955|NCT01814709|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110107956|NCT01814709|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110107957|NCT01814709|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110107958|NCT01814709|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110107959|NCT01814826|Azacitidine|azacitidine|mesh-list
110107960|NCT01814826|Pevonedistat|pevonedistat|mesh-list
110107961|NCT01814826|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110107962|NCT01814826|Antimetabolites|antimetabolites|mesh-ancestor
110107963|NCT01814826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110107964|NCT01814826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110107965|NCT01814826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110107966|NCT01814865|Prednisone|prednisone|mesh-list
110107967|NCT01814865|Anastrozole|anastrozole|mesh-list
110107968|NCT01814865|Abiraterone Acetate|abiraterone acetate|mesh-list
110107969|NCT01814865|Aromatase Inhibitors|aromatase inhibitors|mesh-list
110107970|NCT01814865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110107971|NCT01814865|Glucocorticoids|glucocorticoids|mesh-ancestor
110107972|NCT01814865|Hormones|hormones|mesh-ancestor
110107973|NCT01814865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110107974|NCT01814865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110107975|NCT01814865|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110218571|NCT00280696|Levetiracetam|levetiracetam|mesh-list
110218574|NCT00076388|Docetaxel|docetaxel|mesh-list
110107976|NCT01814865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110107977|NCT01814865|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110107978|NCT01814865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110107979|NCT01814865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110107980|NCT01814865|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110107981|NCT01814865|Hormone Antagonists|hormone antagonists|mesh-ancestor
110107982|NCT01814865|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110107983|NCT01814891|Vitamin A|vitamin a|mesh-list
110107984|NCT01814891|Vitamins|vitamins|mesh-ancestor
110107985|NCT01814891|Micronutrients|micronutrients|mesh-ancestor
110107986|NCT01814891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110107987|NCT01814904|Bile Acids and Salts|bile acids and salts|mesh-list
110107988|NCT01814904|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110107989|NCT01814930|Contraceptive Agents|contraceptive agents|mesh-list
110107990|NCT01814930|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110107991|NCT01814930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110107993|NCT01815021|Calcium Carbonate|calcium carbonate|mesh-list
110107994|NCT01815021|Calcium|calcium|mesh-list
110107995|NCT01815021|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110107996|NCT01815021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110107997|NCT01815021|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110107998|NCT01815021|Antacids|antacids|mesh-ancestor
110107999|NCT01815021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110108000|NCT01815021|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110108001|NCT01815047|Vitamin D|vitamin d|mesh-list
110108002|NCT01815047|Cholecalciferol|cholecalciferol|mesh-list
110108003|NCT01815047|Vitamins|vitamins|mesh-ancestor
110108004|NCT01815047|Micronutrients|micronutrients|mesh-ancestor
110108005|NCT01815047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110108006|NCT01815047|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110108007|NCT01815047|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110108008|NCT01815073|Vaccines|vaccines|mesh-list
110108009|NCT01815073|Immunologic Factors|immunologic factors|mesh-ancestor
110108010|NCT01815073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110108011|NCT01815125|Ondansetron|ondansetron|mesh-list
110108012|NCT01815125|Antiemetics|antiemetics|mesh-ancestor
110108013|NCT01815125|Autonomic Agents|autonomic agents|mesh-ancestor
110108014|NCT01815125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110108015|NCT01815125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110108016|NCT01815125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110108017|NCT01815125|Antipruritics|antipruritics|mesh-ancestor
110108018|NCT01815125|Dermatologic Agents|dermatologic agents|mesh-ancestor
110108019|NCT01815125|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110108020|NCT01815125|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110108021|NCT01815125|Serotonin Agents|serotonin agents|mesh-ancestor
110108022|NCT01815125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110108023|NCT01815125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110108024|NCT01815203|Caffeine|caffeine|mesh-list
110108025|NCT01815203|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110108026|NCT01815203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110108027|NCT01815203|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110108028|NCT01815203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110108029|NCT01815203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110108030|NCT01815203|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110108031|NCT01815203|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110108032|NCT01815203|Purinergic Agents|purinergic agents|mesh-ancestor
110108033|NCT01815203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110108034|NCT01815255|Tenofovir|tenofovir|mesh-list
110108035|NCT01815255|Antiviral Agents|antiviral agents|mesh-ancestor
110108036|NCT01815255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110108037|NCT01815255|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110108038|NCT01815255|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110108039|NCT01815255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110108040|NCT01815255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110108041|NCT01815255|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110108042|NCT01815255|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110108043|NCT01815268|Vaccines|vaccines|mesh-list
110108044|NCT01815268|Immunologic Factors|immunologic factors|mesh-ancestor
110108045|NCT01815268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110108046|NCT01815294|Doxorubicin|doxorubicin|mesh-list
110108047|NCT01815294|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110108048|NCT01815294|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110108049|NCT01815294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110401840|NCT06054919|Vitamin D|vitamin d|mesh-list
110108050|NCT01815294|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110108051|NCT01815294|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110108052|NCT01815294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110108053|NCT01815294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110108054|NCT01815307|Gemcitabine|gemcitabine|mesh-list
110108055|NCT01815307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110108056|NCT01815307|Antimetabolites|antimetabolites|mesh-ancestor
110108057|NCT01815307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110108058|NCT01815307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110108059|NCT01815437|Vitamin D|vitamin d|mesh-list
110108060|NCT01815437|Ergocalciferols|ergocalciferols|mesh-list
110108061|NCT01815437|Cholecalciferol|cholecalciferol|mesh-list
110108062|NCT01815437|Vitamins|vitamins|mesh-list
110108063|NCT01815437|Micronutrients|micronutrients|mesh-ancestor
110108064|NCT01815437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110108065|NCT01815437|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110108066|NCT01815437|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110108067|NCT01815528|Catumaxomab|catumaxomab|mesh-list
110108068|NCT01815528|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110108069|NCT01815541|Teicoplanin|teicoplanin|mesh-list
110108070|NCT01815541|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110108071|NCT01815541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110108072|NCT01815658|Carbon Fiber|carbon fiber|mesh-list
110108073|NCT01815658|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110108074|NCT01815658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110108075|NCT01815723|Dimethyl Fumarate|dimethyl fumarate|mesh-list
110108076|NCT01815723|Dermatologic Agents|dermatologic agents|mesh-ancestor
110108077|NCT01815723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110108078|NCT01815723|Immunologic Factors|immunologic factors|mesh-ancestor
110108079|NCT01815723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110108080|NCT01815892|Furosemide|furosemide|mesh-list
110108081|NCT01815892|Diuretics|diuretics|mesh-ancestor
110108082|NCT01815892|Natriuretic Agents|natriuretic agents|mesh-ancestor
110108083|NCT01815892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110260159|NCT00145301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110108084|NCT01815892|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110108085|NCT01815892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110108086|NCT01815892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110108087|NCT01815944|Ropivacaine|ropivacaine|mesh-list
110108088|NCT01815944|Anesthetics, Local|anesthetics, local|mesh-ancestor
110108089|NCT01815944|Anesthetics|anesthetics|mesh-ancestor
110108090|NCT01815944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110108091|NCT01815944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110108092|NCT01815944|Sensory System Agents|sensory system agents|mesh-ancestor
110108093|NCT01815944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110108094|NCT01816009|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110108095|NCT01816009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110108096|NCT01816035|Trastuzumab|trastuzumab|mesh-list
110108097|NCT01816035|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
110108099|NCT01816035|Immunoconjugates|immunoconjugates|mesh-list
110108100|NCT01816035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110108102|NCT01816035|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110108103|NCT01816035|Tubulin Modulators|tubulin modulators|mesh-ancestor
110108104|NCT01816035|Antimitotic Agents|antimitotic agents|mesh-ancestor
110108105|NCT01816035|Mitosis Modulators|mitosis modulators|mesh-ancestor
110108106|NCT01816035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110108108|NCT01816035|Immunologic Factors|immunologic factors|mesh-ancestor
110108109|NCT01816035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110108111|NCT01816191|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110108112|NCT01816191|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110108113|NCT01816191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110108114|NCT01816191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110108115|NCT01816191|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110108116|NCT01816191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110108117|NCT01816191|Vasodilator Agents|vasodilator agents|mesh-ancestor
110108118|NCT01816321|Ganirelix|ganirelix|mesh-list
110108119|NCT01816321|Hormone Antagonists|hormone antagonists|mesh-ancestor
110108120|NCT01816321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110108121|NCT01816321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110108122|NCT01816334|Methylprednisolone|methylprednisolone|mesh-list
110108123|NCT01816334|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110108124|NCT01816334|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110108125|NCT01816334|Prednisolone|prednisolone|mesh-list
110108126|NCT01816334|Prednisolone acetate|prednisolone acetate|mesh-list
110108127|NCT01816334|Ketoprofen|ketoprofen|mesh-list
110108128|NCT01816334|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110108129|NCT01816334|Prednisolone phosphate|prednisolone phosphate|mesh-list
110108130|NCT01816334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110108131|NCT01816334|Antiemetics|antiemetics|mesh-ancestor
110108132|NCT01816334|Autonomic Agents|autonomic agents|mesh-ancestor
110108133|NCT01816334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110108134|NCT01816334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110108135|NCT01816334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110108136|NCT01816334|Glucocorticoids|glucocorticoids|mesh-ancestor
110108137|NCT01816334|Hormones|hormones|mesh-ancestor
110108138|NCT01816334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110108139|NCT01816334|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110108140|NCT01816334|Protective Agents|protective agents|mesh-ancestor
110108141|NCT01816334|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110108142|NCT01816334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110108143|NCT01816334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110108144|NCT01816334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110108145|NCT01816334|Analgesics|analgesics|mesh-ancestor
110108146|NCT01816334|Sensory System Agents|sensory system agents|mesh-ancestor
110108147|NCT01816334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110108148|NCT01816334|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110108149|NCT01816334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110108150|NCT01816334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110108151|NCT01816412|Paclitaxel|paclitaxel|mesh-list
110108152|NCT01816412|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110108153|NCT01816412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110108154|NCT01816412|Tubulin Modulators|tubulin modulators|mesh-ancestor
110108155|NCT01816412|Antimitotic Agents|antimitotic agents|mesh-ancestor
110108156|NCT01816412|Mitosis Modulators|mitosis modulators|mesh-ancestor
110108157|NCT01816412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110108158|NCT01816490|Silybin|silybin|mesh-list
110108159|NCT01816490|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110260160|NCT00145301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110108160|NCT01816490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110108161|NCT01816490|Protective Agents|protective agents|mesh-ancestor
110108162|NCT01816490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110108164|NCT01816529|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110108165|NCT01816529|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110108166|NCT01816529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110108167|NCT01816529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110108168|NCT01816529|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110108169|NCT01816529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110108170|NCT01816529|Vasodilator Agents|vasodilator agents|mesh-ancestor
110108172|NCT01816555|Vitamins|vitamins|mesh-ancestor
110108173|NCT01816555|Micronutrients|micronutrients|mesh-ancestor
110108174|NCT01816555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110108175|NCT01816555|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110108176|NCT01816581|Morphine|morphine|mesh-list
110108178|NCT01816581|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110108179|NCT01816581|Narcotics|narcotics|mesh-ancestor
110108180|NCT01816581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110108181|NCT01816581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110108182|NCT01816581|Analgesics|analgesics|mesh-ancestor
110108183|NCT01816581|Sensory System Agents|sensory system agents|mesh-ancestor
110108184|NCT01816581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110108185|NCT01816581|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110108186|NCT01816620|Dexamethasone|dexamethasone|mesh-list
110108187|NCT01816620|Lenalidomide|lenalidomide|mesh-list
110108188|NCT01816620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110108189|NCT01816620|Antiemetics|antiemetics|mesh-ancestor
110108190|NCT01816620|Autonomic Agents|autonomic agents|mesh-ancestor
110108191|NCT01816620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110108192|NCT01816620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110108193|NCT01816620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110108194|NCT01816620|Glucocorticoids|glucocorticoids|mesh-ancestor
110108195|NCT01816620|Hormones|hormones|mesh-ancestor
110108196|NCT01816620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110108197|NCT01816620|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110108198|NCT01816620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110108199|NCT01816620|Immunologic Factors|immunologic factors|mesh-ancestor
110108200|NCT01816620|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110108201|NCT01816620|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110108202|NCT01816620|Growth Substances|growth substances|mesh-ancestor
110108203|NCT01816620|Growth Inhibitors|growth inhibitors|mesh-ancestor
110108204|NCT01816646|Cidofovir|cidofovir|mesh-list
110108205|NCT01816646|Probenecid|probenecid|mesh-list
110108206|NCT01816646|Uricosuric Agents|uricosuric agents|mesh-ancestor
110108207|NCT01816646|Gout Suppressants|gout suppressants|mesh-ancestor
110108208|NCT01816646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110108209|NCT01816646|Antiviral Agents|antiviral agents|mesh-ancestor
110108210|NCT01816646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110108211|NCT01816646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110108212|NCT01816646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110108213|NCT01816659|Metformin|metformin|mesh-list
110108214|NCT01816659|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110108215|NCT01816659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110108216|NCT01816789|Buserelin|buserelin|mesh-list
110108217|NCT01816789|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110108218|NCT01816789|Fertility Agents|fertility agents|mesh-ancestor
110108219|NCT01816789|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110108220|NCT01816789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110108221|NCT01816958|Ketamine|ketamine|mesh-list
110108222|NCT01816958|Analgesics|analgesics|mesh-ancestor
110108223|NCT01816958|Sensory System Agents|sensory system agents|mesh-ancestor
110108224|NCT01816958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110108225|NCT01816958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110108226|NCT01816958|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110108227|NCT01816958|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110108228|NCT01816958|Anesthetics, General|anesthetics, general|mesh-ancestor
110108229|NCT01816958|Anesthetics|anesthetics|mesh-ancestor
110108230|NCT01816958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110108231|NCT01816958|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110108232|NCT01816958|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110108233|NCT01816958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110108234|NCT01816958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110108235|NCT01816997|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110108236|NCT01816997|Pravastatin|pravastatin|mesh-list
110108237|NCT01816997|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110108238|NCT01816997|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110108239|NCT01816997|Antimetabolites|antimetabolites|mesh-ancestor
110108240|NCT01816997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110108241|NCT01816997|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110108242|NCT01816997|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110108243|NCT01816997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110108245|NCT01817023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110108246|NCT01817036|Vitamin D|vitamin d|mesh-list
110108247|NCT01817036|Vitamins|vitamins|mesh-ancestor
110108248|NCT01817036|Micronutrients|micronutrients|mesh-ancestor
110108249|NCT01817036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110161962|NCT00110032|Etanidazole|etanidazole|mesh-list
110108250|NCT01817036|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110108252|NCT01817153|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
110108253|NCT01817153|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
110108254|NCT01817153|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
110108255|NCT01817153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110108256|NCT01817218|Anti-Infective Agents|anti-infective agents|mesh-list
110108257|NCT01817218|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110108258|NCT01817257|Heparin|heparin|mesh-list
110108259|NCT01817257|Enoxaparin|enoxaparin|mesh-list
110108260|NCT01817257|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
110108261|NCT01817257|Tinzaparin|tinzaparin|mesh-list
110108262|NCT01817257|Dalteparin|dalteparin|mesh-list
110108263|NCT01817257|Anticoagulants|anticoagulants|mesh-ancestor
110108264|NCT01817257|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110108265|NCT01817257|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110108266|NCT01817257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110108267|NCT01817283|Triptolide|triptolide|mesh-list
110108268|NCT01817283|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
110108269|NCT01817283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110108270|NCT01817283|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110108271|NCT01817283|Contraceptive Agents|contraceptive agents|mesh-ancestor
110108272|NCT01817283|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110108273|NCT01817283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110108274|NCT01817283|Immunologic Factors|immunologic factors|mesh-ancestor
110108275|NCT01817283|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110108276|NCT01817283|Alkylating Agents|alkylating agents|mesh-ancestor
110108277|NCT01817283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110108278|NCT01817283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110108279|NCT01817322|Mycophenolic Acid|mycophenolic acid|mesh-list
110108280|NCT01817322|Methylprednisolone|methylprednisolone|mesh-list
110108281|NCT01817322|Prednisolone|prednisolone|mesh-list
110108282|NCT01817322|Deflazacort|deflazacort|mesh-list
110108283|NCT01817322|Basiliximab|basiliximab|mesh-list
110108284|NCT01817322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110108285|NCT01817322|Antiemetics|antiemetics|mesh-ancestor
110108286|NCT01817322|Autonomic Agents|autonomic agents|mesh-ancestor
110108287|NCT01817322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110108288|NCT01817322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110108289|NCT01817322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110108290|NCT01817322|Glucocorticoids|glucocorticoids|mesh-ancestor
110108291|NCT01817322|Hormones|hormones|mesh-ancestor
110108292|NCT01817322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110108293|NCT01817322|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110108294|NCT01817322|Protective Agents|protective agents|mesh-ancestor
110108295|NCT01817322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110108296|NCT01817322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110108297|NCT01817322|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110108298|NCT01817322|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110108299|NCT01817322|Antitubercular Agents|antitubercular agents|mesh-ancestor
110108300|NCT01817322|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110108301|NCT01817322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110108302|NCT01817322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110108303|NCT01817322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110108304|NCT01817322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110108305|NCT01817322|Immunologic Factors|immunologic factors|mesh-ancestor
110108306|NCT01817348|Lidocaine|lidocaine|mesh-list
110108307|NCT01817348|Anesthetics, Local|anesthetics, local|mesh-ancestor
110108308|NCT01817348|Anesthetics|anesthetics|mesh-ancestor
110108309|NCT01817348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110108310|NCT01817348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110108311|NCT01817348|Sensory System Agents|sensory system agents|mesh-ancestor
110108312|NCT01817348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110108313|NCT01817348|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110108314|NCT01817348|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110108315|NCT01817348|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110108316|NCT01817348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110108317|NCT01817348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110108318|NCT01817400|Aspirin|aspirin|mesh-list
110108319|NCT01817400|Pioglitazone|pioglitazone|mesh-list
110108320|NCT01817400|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
110108321|NCT01817400|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110108322|NCT01817400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110108323|NCT01817400|Analgesics|analgesics|mesh-ancestor
110108324|NCT01817400|Sensory System Agents|sensory system agents|mesh-ancestor
110108325|NCT01817400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110108326|NCT01817400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110108327|NCT01817400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110108328|NCT01817400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110108329|NCT01817400|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110108330|NCT01817400|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110108331|NCT01817400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110108332|NCT01817400|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110108333|NCT01817400|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110108334|NCT01817400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110108335|NCT01817400|Antipyretics|antipyretics|mesh-ancestor
110108336|NCT01817400|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110108337|NCT01817400|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110108338|NCT01817439|Amiodarone|amiodarone|mesh-list
110108339|NCT01817439|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110108340|NCT01817439|Vasodilator Agents|vasodilator agents|mesh-ancestor
110108341|NCT01817439|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
110108342|NCT01817439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110108343|NCT01817439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110108344|NCT01817439|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110108345|NCT01817439|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110108346|NCT01817439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110108347|NCT01817439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110108348|NCT01817439|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110108349|NCT01817439|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110108350|NCT01817439|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110108351|NCT01817699|Vitamin D|vitamin d|mesh-list
110108352|NCT01817699|Cholecalciferol|cholecalciferol|mesh-list
110108353|NCT01817699|Vitamins|vitamins|mesh-ancestor
110108354|NCT01817699|Micronutrients|micronutrients|mesh-ancestor
110108355|NCT01817699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110108356|NCT01817699|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110108357|NCT01817699|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110108358|NCT01817803|Metolazone|metolazone|mesh-list
110108359|NCT01817803|Furosemide|furosemide|mesh-list
110108360|NCT01817803|Spironolactone|spironolactone|mesh-list
110108361|NCT01817803|Diuretics|diuretics|mesh-ancestor
110108362|NCT01817803|Natriuretic Agents|natriuretic agents|mesh-ancestor
110108363|NCT01817803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110401907|NCT06054464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110108364|NCT01817803|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110108365|NCT01817803|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110108366|NCT01817803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110108367|NCT01817803|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110108368|NCT01817803|Hormone Antagonists|hormone antagonists|mesh-ancestor
110108369|NCT01817803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110108370|NCT01817803|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110108371|NCT01817803|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110108372|NCT01817803|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110108373|NCT01817816|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110108374|NCT01817816|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110108375|NCT01817816|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110108376|NCT01817816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110108377|NCT01817816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110108378|NCT01817816|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110108379|NCT01817816|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110108380|NCT01817816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110108381|NCT01817816|Cholinergic Agents|cholinergic agents|mesh-ancestor
110108382|NCT01817816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110108383|NCT01817829|Acetaminophen|acetaminophen|mesh-list
110108384|NCT01817829|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110108385|NCT01817829|Analgesics|analgesics|mesh-ancestor
110108386|NCT01817829|Sensory System Agents|sensory system agents|mesh-ancestor
110161970|NCT00110071|Antibodies|antibodies|mesh-list
110108387|NCT01817829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110108388|NCT01817829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110108390|NCT01817868|Factor VIII|factor viii|mesh-list
110108391|NCT01817868|Coagulants|coagulants|mesh-ancestor
110108392|NCT01817894|Eflornithine|eflornithine|mesh-list
110108393|NCT01817894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110108394|NCT01817894|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
110108395|NCT01817894|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110108396|NCT01817894|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110108397|NCT01817894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110108398|NCT01817894|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
110108399|NCT01817894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110108400|NCT01817894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110108401|NCT01817972|Certolizumab Pegol|certolizumab pegol|mesh-list
110108402|NCT01817972|Azathioprine|azathioprine|mesh-list
110108403|NCT01817972|Antimetabolites|antimetabolites|mesh-ancestor
110108404|NCT01817972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110108405|NCT01817972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110108406|NCT01817972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110108407|NCT01817972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110108408|NCT01817972|Immunologic Factors|immunologic factors|mesh-ancestor
110108409|NCT01817972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110108410|NCT01817972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110108411|NCT01817972|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110108412|NCT01817972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110108413|NCT01817985|Velpatasvir|velpatasvir|mesh-list
110108414|NCT01817985|Antiviral Agents|antiviral agents|mesh-ancestor
110108415|NCT01817985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110108416|NCT01818024|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110108417|NCT01818024|Immunologic Factors|immunologic factors|mesh-ancestor
110108418|NCT01818024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110108419|NCT01818232|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
110108420|NCT01818232|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110108421|NCT01818232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110108422|NCT01818232|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110108423|NCT01818232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110108424|NCT01818648|Exenatide|exenatide|mesh-list
110108425|NCT01818648|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110108426|NCT01818648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110108427|NCT01818648|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110108428|NCT01818648|Incretins|incretins|mesh-ancestor
110108429|NCT01818648|Hormones|hormones|mesh-ancestor
110108430|NCT01818648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110108431|NCT01818713|Doxorubicin|doxorubicin|mesh-list
110108432|NCT01818713|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110108433|NCT01818713|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110108434|NCT01818713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110108435|NCT01818713|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110108436|NCT01818713|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110108437|NCT01818713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110108438|NCT01818713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110108439|NCT01818843|Carbon Monoxide|carbon monoxide|mesh-list
110108440|NCT01818843|Antimetabolites|antimetabolites|mesh-ancestor
110108441|NCT01818843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110108442|NCT01818843|Gasotransmitters|gasotransmitters|mesh-ancestor
110108443|NCT01818843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110108444|NCT01818843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110108445|NCT01818856|Ritonavir|ritonavir|mesh-list
110108446|NCT01818856|Atazanavir Sulfate|atazanavir sulfate|mesh-list
110108447|NCT01818856|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110108448|NCT01818856|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110108449|NCT01818856|Protease Inhibitors|protease inhibitors|mesh-ancestor
110108450|NCT01818856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110108451|NCT01818856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110108452|NCT01818856|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110108453|NCT01818856|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110108454|NCT01818856|Antiviral Agents|antiviral agents|mesh-ancestor
110108455|NCT01818856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110108456|NCT01818856|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110108457|NCT01818856|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110108458|NCT01818869|Adenosine|adenosine|mesh-list
110108459|NCT01818869|Analgesics|analgesics|mesh-ancestor
110108460|NCT01818869|Sensory System Agents|sensory system agents|mesh-ancestor
110108461|NCT01818869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110108462|NCT01818869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110108463|NCT01818869|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110108465|NCT01818869|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
110108466|NCT01818869|Purinergic Agonists|purinergic agonists|mesh-ancestor
110108467|NCT01818869|Purinergic Agents|purinergic agents|mesh-ancestor
110108468|NCT01818869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110108469|NCT01818869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110108470|NCT01818908|Prednisone|prednisone|mesh-list
110108471|NCT01818908|Cyclophosphamide|cyclophosphamide|mesh-list
110108472|NCT01818908|Doxorubicin|doxorubicin|mesh-list
110108473|NCT01818908|Etoposide|etoposide|mesh-list
110108474|NCT01818908|Vincristine|vincristine|mesh-list
110108475|NCT01818908|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110108476|NCT01818908|Immunologic Factors|immunologic factors|mesh-ancestor
110108477|NCT01818908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110108478|NCT01818908|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110108479|NCT01818908|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110108480|NCT01818908|Alkylating Agents|alkylating agents|mesh-ancestor
110108481|NCT01818908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110108482|NCT01818908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110108483|NCT01818908|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110108484|NCT01818908|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110108485|NCT01818908|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110108486|NCT01818908|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110108487|NCT01818908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110108488|NCT01818908|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110108489|NCT01818908|Glucocorticoids|glucocorticoids|mesh-ancestor
110108490|NCT01818908|Hormones|hormones|mesh-ancestor
110108491|NCT01818908|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110108492|NCT01818908|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110108493|NCT01818908|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110108494|NCT01818908|Tubulin Modulators|tubulin modulators|mesh-ancestor
110108495|NCT01818908|Antimitotic Agents|antimitotic agents|mesh-ancestor
110108496|NCT01818908|Mitosis Modulators|mitosis modulators|mesh-ancestor
110108497|NCT01818973|Bevacizumab|bevacizumab|mesh-list
110108498|NCT01818973|Capecitabine|capecitabine|mesh-list
110108499|NCT01818973|Oxaliplatin|oxaliplatin|mesh-list
110108500|NCT01818973|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110108501|NCT01818973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110108502|NCT01818973|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110108503|NCT01818973|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110108504|NCT01818973|Growth Substances|growth substances|mesh-ancestor
110108505|NCT01818973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110108506|NCT01818973|Growth Inhibitors|growth inhibitors|mesh-ancestor
110108507|NCT01818973|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110108508|NCT01818973|Antimetabolites|antimetabolites|mesh-ancestor
110108509|NCT01818973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110108510|NCT01819012|Isoflurane|isoflurane|mesh-list
110108511|NCT01819012|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110108512|NCT01819012|Anesthetics, General|anesthetics, general|mesh-ancestor
110108513|NCT01819012|Anesthetics|anesthetics|mesh-ancestor
110108514|NCT01819012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110108515|NCT01819012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110108516|NCT01819051|Anti-Infective Agents|anti-infective agents|mesh-list
110108517|NCT01819051|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110108518|NCT01819155|Vaccines|vaccines|mesh-list
110108519|NCT01819155|Immunologic Factors|immunologic factors|mesh-ancestor
110161984|NCT00110188|Sirolimus|sirolimus|mesh-list
110108520|NCT01819155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110108522|NCT01819220|Valsartan|valsartan|mesh-list
110108523|NCT01819220|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110108524|NCT01819220|Telmisartan|telmisartan|mesh-list
110108525|NCT01819220|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
110108526|NCT01819220|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
110108527|NCT01819220|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110108528|NCT01819220|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110108529|NCT01819220|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110108530|NCT01819220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110108531|NCT01819220|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110108532|NCT01819220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110108533|NCT01819220|Vasodilator Agents|vasodilator agents|mesh-ancestor
110108534|NCT01819220|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110218690|NCT00281476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110108535|NCT01819220|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110108537|NCT01819220|Natriuretic Agents|natriuretic agents|mesh-ancestor
110108538|NCT01819220|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110108539|NCT01819259|Nicotine|nicotine|mesh-list
110108540|NCT01819259|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110108541|NCT01819259|Autonomic Agents|autonomic agents|mesh-ancestor
110108542|NCT01819259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110108543|NCT01819259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110108544|NCT01819259|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110108545|NCT01819259|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110108546|NCT01819259|Cholinergic Agents|cholinergic agents|mesh-ancestor
110108547|NCT01819259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110108548|NCT01819259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110108549|NCT01819285|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
110108550|NCT01819285|Hormones|hormones|mesh-ancestor
110108551|NCT01819285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110108552|NCT01819285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110108553|NCT01819389|Imatinib Mesylate|imatinib mesylate|mesh-list
110108554|NCT01819389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110108555|NCT01819389|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110108556|NCT01819389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110108557|NCT01819389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110108558|NCT01819402|Pioglitazone|pioglitazone|mesh-list
110108559|NCT01819402|Glimepiride|glimepiride|mesh-list
110108560|NCT01819402|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110108561|NCT01819402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110108562|NCT01819402|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110108563|NCT01819402|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110108564|NCT01819402|Immunologic Factors|immunologic factors|mesh-ancestor
110108565|NCT01819441|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110108566|NCT01819441|Perindopril|perindopril|mesh-list
110108567|NCT01819441|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110108568|NCT01819441|Diuretics|diuretics|mesh-ancestor
110108569|NCT01819441|Natriuretic Agents|natriuretic agents|mesh-ancestor
110108570|NCT01819441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110108571|NCT01819441|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110108572|NCT01819441|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110108573|NCT01819441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110108574|NCT01819441|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110108575|NCT01819441|Protease Inhibitors|protease inhibitors|mesh-ancestor
110108576|NCT01819441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110108577|NCT01819610|Ketorolac|ketorolac|mesh-list
110108578|NCT01819610|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110108579|NCT01819610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110108580|NCT01819610|Analgesics|analgesics|mesh-ancestor
110108581|NCT01819610|Sensory System Agents|sensory system agents|mesh-ancestor
110218697|NCT00416923|Immunologic Factors|immunologic factors|mesh-ancestor
110108582|NCT01819610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110108583|NCT01819610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110108584|NCT01819610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110108585|NCT01819610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110108586|NCT01819610|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110108587|NCT01819610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110108588|NCT01819610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110108589|NCT01819649|Selenium|selenium|mesh-list
110108590|NCT01819649|Antioxidants|antioxidants|mesh-ancestor
110108591|NCT01819649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110108592|NCT01819649|Protective Agents|protective agents|mesh-ancestor
110108593|NCT01819649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110108594|NCT01819649|Trace Elements|trace elements|mesh-ancestor
110108595|NCT01819649|Micronutrients|micronutrients|mesh-ancestor
110108596|NCT01819701|Ubiquinone|ubiquinone|mesh-list
110108597|NCT01819701|Coenzyme Q10|coenzyme q10|mesh-list
110108598|NCT01819701|Micronutrients|micronutrients|mesh-ancestor
110108599|NCT01819701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110108600|NCT01819701|Vitamins|vitamins|mesh-ancestor
110108601|NCT01819779|Amlodipine|amlodipine|mesh-list
110108602|NCT01819779|Valsartan|valsartan|mesh-list
110108603|NCT01819779|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
110108604|NCT01819779|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110108605|NCT01819779|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110108606|NCT01819779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110108607|NCT01819779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110108608|NCT01819779|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110108609|NCT01819779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110108610|NCT01819779|Vasodilator Agents|vasodilator agents|mesh-ancestor
110108611|NCT01819779|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110108612|NCT01819779|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110108613|NCT01819857|Ondansetron|ondansetron|mesh-list
110108614|NCT01819857|Antiemetics|antiemetics|mesh-ancestor
110108615|NCT01819857|Autonomic Agents|autonomic agents|mesh-ancestor
110108616|NCT01819857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110108617|NCT01819857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110108618|NCT01819857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110108619|NCT01819857|Antipruritics|antipruritics|mesh-ancestor
110108620|NCT01819857|Dermatologic Agents|dermatologic agents|mesh-ancestor
110108621|NCT01819857|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110108622|NCT01819857|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110108623|NCT01819857|Serotonin Agents|serotonin agents|mesh-ancestor
110108624|NCT01819857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110108625|NCT01819857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110108627|NCT01819870|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110108628|NCT01819870|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110108629|NCT01819870|Adrenergic Agents|adrenergic agents|mesh-ancestor
110108630|NCT01819870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110108631|NCT01819870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110108632|NCT01819870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110108633|NCT01819870|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110108634|NCT01819870|Antioxidants|antioxidants|mesh-ancestor
110108635|NCT01819870|Protective Agents|protective agents|mesh-ancestor
110108636|NCT01819870|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110108637|NCT01819870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110108638|NCT01819870|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110108639|NCT01819870|Vasodilator Agents|vasodilator agents|mesh-ancestor
110108640|NCT01819870|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110218724|NCT00109824|GABA Agents|gaba agents|mesh-ancestor
110218725|NCT00109824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110108641|NCT01819870|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110108642|NCT01819961|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
110108643|NCT01819961|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
110108644|NCT01819961|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
110108645|NCT01819961|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110108647|NCT01820026|Azithromycin|azithromycin|mesh-list
110108648|NCT01820026|Vancomycin|vancomycin|mesh-list
110108649|NCT01820026|Imipenem|imipenem|mesh-list
110108650|NCT01820026|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
110108651|NCT01820026|Cefotaxime|cefotaxime|mesh-list
110108652|NCT01820026|Cefoxitin|cefoxitin|mesh-list
110108653|NCT01820026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110108654|NCT01820026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110108655|NCT01820026|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110108656|NCT01820026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110108657|NCT01820026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110108658|NCT01820091|Levoleucovorin|levoleucovorin|mesh-list
110108659|NCT01820091|Antidotes|antidotes|mesh-ancestor
110108660|NCT01820091|Protective Agents|protective agents|mesh-ancestor
110108661|NCT01820091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110108662|NCT01820104|Lansoprazole|lansoprazole|mesh-list
110108663|NCT01820104|Dexlansoprazole|dexlansoprazole|mesh-list
110108664|NCT01820104|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110108665|NCT01820104|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110108666|NCT01820104|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110108667|NCT01820104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110108668|NCT01820104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110108669|NCT01820143|Esomeprazole|esomeprazole|mesh-list
110108670|NCT01820143|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110108671|NCT01820143|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110108672|NCT01820143|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110108673|NCT01820143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110108674|NCT01820143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110108675|NCT01820299|Vitamin D|vitamin d|mesh-list
110108676|NCT01820299|Grape Seed Extract|grape seed extract|mesh-list
110108677|NCT01820299|Vitamins|vitamins|mesh-ancestor
110108678|NCT01820299|Micronutrients|micronutrients|mesh-ancestor
110108679|NCT01820299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110108680|NCT01820299|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110108681|NCT01820299|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110108682|NCT01820299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110108683|NCT01820299|Antioxidants|antioxidants|mesh-ancestor
110108684|NCT01820299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110108685|NCT01820299|Protective Agents|protective agents|mesh-ancestor
110108686|NCT01820312|Paclitaxel|paclitaxel|mesh-list
110108687|NCT01820312|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110108688|NCT01820312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110108689|NCT01820312|Tubulin Modulators|tubulin modulators|mesh-ancestor
110108690|NCT01820312|Antimitotic Agents|antimitotic agents|mesh-ancestor
110108691|NCT01820312|Mitosis Modulators|mitosis modulators|mesh-ancestor
110108692|NCT01820312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110108694|NCT01820325|Carboplatin|carboplatin|mesh-list
110108695|NCT01820325|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110108696|NCT01820325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110108697|NCT01820325|Tubulin Modulators|tubulin modulators|mesh-ancestor
110108698|NCT01820325|Antimitotic Agents|antimitotic agents|mesh-ancestor
110108699|NCT01820325|Mitosis Modulators|mitosis modulators|mesh-ancestor
110218738|NCT00109941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110108700|NCT01820325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110108701|NCT01820442|Lofexidine|lofexidine|mesh-list
110108702|NCT01820442|Clonidine|clonidine|mesh-list
110108703|NCT01820442|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110108704|NCT01820442|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110162021|NCT00110578|Aldesleukin|aldesleukin|mesh-list
110108705|NCT01820442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110108706|NCT01820442|Sensory System Agents|sensory system agents|mesh-ancestor
110108707|NCT01820442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110108708|NCT01820442|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110108709|NCT01820442|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110108710|NCT01820442|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110108711|NCT01820442|Adrenergic Agents|adrenergic agents|mesh-ancestor
110108712|NCT01820442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110108713|NCT01820442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110108714|NCT01820442|Analgesics|analgesics|mesh-ancestor
110108715|NCT01820442|Sympatholytics|sympatholytics|mesh-ancestor
110108716|NCT01820442|Autonomic Agents|autonomic agents|mesh-ancestor
110108717|NCT01820455|Chlorhexidine|chlorhexidine|mesh-list
110108718|NCT01820455|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110108719|NCT01820455|Mupirocin|mupirocin|mesh-list
110108720|NCT01820455|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110108721|NCT01820455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110108722|NCT01820455|Disinfectants|disinfectants|mesh-ancestor
110108723|NCT01820455|Dermatologic Agents|dermatologic agents|mesh-ancestor
110108724|NCT01820455|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110108725|NCT01820455|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110108726|NCT01820455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110108727|NCT01820455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110108728|NCT01820624|Tretinoin|tretinoin|mesh-list
110108729|NCT01820624|Lithium Carbonate|lithium carbonate|mesh-list
110108730|NCT01820624|Antidepressive Agents|antidepressive agents|mesh-ancestor
110108731|NCT01820624|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110108732|NCT01820624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110108733|NCT01820624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110108734|NCT01820624|Antimanic Agents|antimanic agents|mesh-ancestor
110108735|NCT01820624|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110108736|NCT01820624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110108737|NCT01820624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110108738|NCT01820624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110108739|NCT01820624|Keratolytic Agents|keratolytic agents|mesh-ancestor
110108740|NCT01820624|Dermatologic Agents|dermatologic agents|mesh-ancestor
110108741|NCT01820767|Ergocalciferols|ergocalciferols|mesh-list
110108742|NCT01820767|Atorvastatin|atorvastatin|mesh-list
110108743|NCT01820767|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110108744|NCT01820767|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110108745|NCT01820767|Antimetabolites|antimetabolites|mesh-ancestor
110108746|NCT01820767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110108747|NCT01820767|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110108748|NCT01820767|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110108749|NCT01820767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110401963|NCT06054100|Colchicine|colchicine|mesh-list
110108750|NCT01820767|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110108751|NCT01820767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110218755|NCT00281710|Methylprednisolone|methylprednisolone|mesh-list
110108753|NCT01820767|Micronutrients|micronutrients|mesh-ancestor
110108754|NCT01820767|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110108755|NCT01820793|Cefoxitin|cefoxitin|mesh-list
110108756|NCT01820793|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110108757|NCT01820793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110108758|NCT01820832|Cholecalciferol|cholecalciferol|mesh-list
110108760|NCT01820832|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110108761|NCT01820832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110108762|NCT01820832|Vitamins|vitamins|mesh-ancestor
110108763|NCT01820832|Micronutrients|micronutrients|mesh-ancestor
110108764|NCT01820832|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110108765|NCT01820832|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
110108766|NCT01820832|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110108767|NCT01820832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110108768|NCT01820832|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110108769|NCT01820897|Trimethoprim|trimethoprim|mesh-list
110108770|NCT01820897|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
110108771|NCT01820897|Sulfamethoxazole|sulfamethoxazole|mesh-list
110108772|NCT01820897|Fosfomycin|fosfomycin|mesh-list
110108773|NCT01820897|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110108774|NCT01820897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110108775|NCT01820897|Antimalarials|antimalarials|mesh-ancestor
110108776|NCT01820897|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110108777|NCT01820897|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110108778|NCT01820897|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110108779|NCT01820897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110108780|NCT01820897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110108782|NCT01820897|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
110108783|NCT01820897|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110108784|NCT01820897|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110108785|NCT01820962|Heparin|heparin|mesh-list
110108786|NCT01820962|Anticoagulants|anticoagulants|mesh-ancestor
110108787|NCT01820962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110108788|NCT01820962|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110108789|NCT01820962|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110108790|NCT01821001|Bromocriptine|bromocriptine|mesh-list
110108791|NCT01821001|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110108792|NCT01821001|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110108793|NCT01821001|Hormone Antagonists|hormone antagonists|mesh-ancestor
110108794|NCT01821001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110108795|NCT01821001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110108796|NCT01821001|Dopamine Agonists|dopamine agonists|mesh-ancestor
110108797|NCT01821001|Dopamine Agents|dopamine agents|mesh-ancestor
110108798|NCT01821001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110108799|NCT01821001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110108800|NCT01821027|Canagliflozin|canagliflozin|mesh-list
110108801|NCT01821027|Simvastatin|simvastatin|mesh-list
110108802|NCT01821027|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110108803|NCT01821027|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110108804|NCT01821027|Antimetabolites|antimetabolites|mesh-ancestor
110108805|NCT01821027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110108806|NCT01821027|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110108807|NCT01821027|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110108808|NCT01821027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110108809|NCT01821027|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110401975|NCT06054035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110108810|NCT01821027|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110108811|NCT01821027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110108812|NCT01821040|Prednisone|prednisone|mesh-list
110108813|NCT01821040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110108814|NCT01821040|Glucocorticoids|glucocorticoids|mesh-ancestor
110108815|NCT01821040|Hormones|hormones|mesh-ancestor
110108816|NCT01821040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110108817|NCT01821040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110108818|NCT01821040|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110108819|NCT01821040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110108820|NCT01821066|Tamoxifen|tamoxifen|mesh-list
110108821|NCT01821066|Palbociclib|palbociclib|mesh-list
110108822|NCT01821066|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110108823|NCT01821066|Hormone Antagonists|hormone antagonists|mesh-ancestor
110108824|NCT01821066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110108825|NCT01821066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110108826|NCT01821066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110108827|NCT01821066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110108828|NCT01821066|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110108829|NCT01821066|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110108830|NCT01821066|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110108831|NCT01821066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110108832|NCT01821066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110108833|NCT01821066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110108834|NCT01821170|Methylphenidate|methylphenidate|mesh-list
110108835|NCT01821170|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110108836|NCT01821170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110108837|NCT01821170|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110108838|NCT01821170|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110108839|NCT01821170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110108840|NCT01821170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110108841|NCT01821170|Dopamine Agents|dopamine agents|mesh-ancestor
110108842|NCT01821170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110108843|NCT01821235|Gabapentin|gabapentin|mesh-list
110108844|NCT01821235|Analgesics|analgesics|mesh-ancestor
110108845|NCT01821235|Sensory System Agents|sensory system agents|mesh-ancestor
110108846|NCT01821235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110108847|NCT01821235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110108848|NCT01821235|Anticonvulsants|anticonvulsants|mesh-ancestor
110108849|NCT01821235|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110108850|NCT01821235|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110108851|NCT01821235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110108852|NCT01821235|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110108853|NCT01821235|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110108854|NCT01821235|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110108855|NCT01821235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110108856|NCT01821235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110108857|NCT01821235|Antimanic Agents|antimanic agents|mesh-ancestor
110108858|NCT01821248|Cisplatin|cisplatin|mesh-list
110108859|NCT01821248|Gemcitabine|gemcitabine|mesh-list
110108860|NCT01821248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110108861|NCT01821248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110108862|NCT01821248|Antimetabolites|antimetabolites|mesh-ancestor
110401989|NCT06053840|Chloral Hydrate|chloral hydrate|mesh-list
110108863|NCT01821248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110108864|NCT01821261|Chlorhexidine|chlorhexidine|mesh-list
110108865|NCT01821261|Fluorides|fluorides|mesh-list
110108866|NCT01821261|Cariostatic Agents|cariostatic agents|mesh-ancestor
110108867|NCT01821261|Protective Agents|protective agents|mesh-ancestor
110108868|NCT01821261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110108869|NCT01821261|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110108870|NCT01821261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110108871|NCT01821261|Disinfectants|disinfectants|mesh-ancestor
110108872|NCT01821274|Diltiazem|diltiazem|mesh-list
110108873|NCT01821274|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110108874|NCT01821274|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110108875|NCT01821274|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110108876|NCT01821274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110108877|NCT01821274|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110108878|NCT01821274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110108879|NCT01821274|Vasodilator Agents|vasodilator agents|mesh-ancestor
110108881|NCT01821404|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110108882|NCT01821404|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110108883|NCT01821404|Antimetabolites|antimetabolites|mesh-ancestor
110108884|NCT01821404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110108885|NCT01821404|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110108886|NCT01821404|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110108887|NCT01821404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110108888|NCT01821430|Pregabalin|pregabalin|mesh-list
110108889|NCT01821430|Analgesics|analgesics|mesh-ancestor
110108890|NCT01821430|Sensory System Agents|sensory system agents|mesh-ancestor
110108891|NCT01821430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110108892|NCT01821430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110108893|NCT01821430|Anticonvulsants|anticonvulsants|mesh-ancestor
110108894|NCT01821430|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110108895|NCT01821430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110108896|NCT01821430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110108897|NCT01821430|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110108898|NCT01821430|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110108899|NCT01821430|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110108900|NCT01821430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110108901|NCT01821430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110108902|NCT01821456|Antiviral Agents|antiviral agents|mesh-list
110108903|NCT01821456|Anti-Infective Agents|anti-infective agents|mesh-list
110108904|NCT01821573|Botulinum Toxins|botulinum toxins|mesh-list
110108905|NCT01821573|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110108906|NCT01821573|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110108907|NCT01821573|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110108908|NCT01821573|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110108909|NCT01821573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110108910|NCT01821573|Cholinergic Agents|cholinergic agents|mesh-ancestor
110108911|NCT01821573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110108912|NCT01821573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110108913|NCT01821573|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110108914|NCT01821573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110108916|NCT01821612|Gemcitabine|gemcitabine|mesh-list
110108917|NCT01821612|Fluorouracil|fluorouracil|mesh-list
110108918|NCT01821612|Capecitabine|capecitabine|mesh-list
110108919|NCT01821612|Oxaliplatin|oxaliplatin|mesh-list
110108920|NCT01821612|Irinotecan|irinotecan|mesh-list
110108921|NCT01821612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110108922|NCT01821612|Antimetabolites|antimetabolites|mesh-ancestor
110108923|NCT01821612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110108924|NCT01821612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110108925|NCT01821612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110108926|NCT01821612|Immunologic Factors|immunologic factors|mesh-ancestor
110108927|NCT01821612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110108928|NCT01821612|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110108929|NCT01821612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110402013|NCT06053489|Anesthetics|anesthetics|mesh-list
110108930|NCT01821612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110108932|NCT01821612|Protective Agents|protective agents|mesh-ancestor
110108933|NCT01821612|Vitamin B Complex|vitamin b complex|mesh-ancestor
110108934|NCT01821612|Vitamins|vitamins|mesh-ancestor
110108935|NCT01821612|Micronutrients|micronutrients|mesh-ancestor
110108936|NCT01821664|Heparin|heparin|mesh-list
110108937|NCT01821664|Anticoagulants|anticoagulants|mesh-ancestor
110108938|NCT01821664|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110108939|NCT01821664|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110108940|NCT01821664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110108941|NCT01821703|Spironolactone|spironolactone|mesh-list
110218794|NCT00281788|Mitosis Modulators|mitosis modulators|mesh-ancestor
110108942|NCT01821703|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110108943|NCT01821703|Hormone Antagonists|hormone antagonists|mesh-ancestor
110108944|NCT01821703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110108945|NCT01821703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110108946|NCT01821703|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110108947|NCT01821703|Diuretics|diuretics|mesh-ancestor
110108948|NCT01821703|Natriuretic Agents|natriuretic agents|mesh-ancestor
110108949|NCT01821846|Liraglutide|liraglutide|mesh-list
110108950|NCT01821846|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110108951|NCT01821846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110108952|NCT01821846|Incretins|incretins|mesh-ancestor
110108953|NCT01821846|Hormones|hormones|mesh-ancestor
110108954|NCT01821846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110108955|NCT01821872|Acetaminophen|acetaminophen|mesh-list
110108956|NCT01821872|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110108957|NCT01821872|Analgesics|analgesics|mesh-ancestor
110108958|NCT01821872|Sensory System Agents|sensory system agents|mesh-ancestor
110108959|NCT01821872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110108960|NCT01821872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110108961|NCT01821872|Antipyretics|antipyretics|mesh-ancestor
110108962|NCT01821989|Lactoferrin|lactoferrin|mesh-list
110108963|NCT01821989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110108964|NCT01822028|Miglustat|miglustat|mesh-list
110108965|NCT01822028|1-Deoxynojirimycin|1-deoxynojirimycin|mesh-list
110108966|NCT01822028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110108967|NCT01822028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110108968|NCT01822028|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110108969|NCT01822028|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110108970|NCT01822028|Antiviral Agents|antiviral agents|mesh-ancestor
110108971|NCT01822028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110108972|NCT01822028|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
110108973|NCT01822028|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110108974|NCT01822028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110108975|NCT01822080|Dienogest|dienogest|mesh-list
110108976|NCT01822080|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110108977|NCT01822080|Contraceptive Agents|contraceptive agents|mesh-ancestor
110108978|NCT01822080|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110108979|NCT01822080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110108980|NCT01822080|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110108981|NCT01822080|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110402014|NCT06053489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110402015|NCT06053489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110056421|NCT01503060|Lidocaine|lidocaine|mesh-list
110402033|NCT06050824|Metronidazole|metronidazole|mesh-list
110402034|NCT06050824|Clarithromycin|clarithromycin|mesh-list
110402035|NCT06050824|Pantoprazole|pantoprazole|mesh-list
110402036|NCT06050824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110402037|NCT06050824|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110108982|NCT01822080|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110108983|NCT01822080|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110108984|NCT01822080|Hormone Antagonists|hormone antagonists|mesh-ancestor
110108985|NCT01822080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110108986|NCT01822080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110108987|NCT01822080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110108988|NCT01822210|Botulinum Toxins|botulinum toxins|mesh-list
110108989|NCT01822210|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110108990|NCT01822210|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110108991|NCT01822210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110108992|NCT01822210|Cholinergic Agents|cholinergic agents|mesh-ancestor
110108993|NCT01822210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110108994|NCT01822210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110108996|NCT01822405|Vitamin E|vitamin e|mesh-list
110108997|NCT01822405|Tocotrienols|tocotrienols|mesh-list
110108998|NCT01822405|alpha-Tocopherol|alpha-tocopherol|mesh-list
110108999|NCT01822405|Pentoxifylline|pentoxifylline|mesh-list
110109000|NCT01822405|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110109001|NCT01822405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110162080|NCT00111046|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110109002|NCT01822405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110109003|NCT01822405|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110109004|NCT01822405|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110109005|NCT01822405|Protective Agents|protective agents|mesh-ancestor
110109006|NCT01822405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110109007|NCT01822405|Vasodilator Agents|vasodilator agents|mesh-ancestor
110109008|NCT01822405|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110109009|NCT01822405|Antioxidants|antioxidants|mesh-ancestor
110109010|NCT01822405|Vitamins|vitamins|mesh-ancestor
110109011|NCT01822405|Micronutrients|micronutrients|mesh-ancestor
110109012|NCT01822418|Agomelatine|agomelatine|mesh-list
110109013|NCT01822418|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110109014|NCT01822418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110109015|NCT01822418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110109016|NCT01822431|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
110109017|NCT01822431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110109018|NCT01822431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110109019|NCT01822431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110109020|NCT01822431|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110109021|NCT01822483|Mycophenolic Acid|mycophenolic acid|mesh-list
110109022|NCT01822483|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110109023|NCT01822483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110109024|NCT01822483|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110109025|NCT01822483|Antitubercular Agents|antitubercular agents|mesh-ancestor
110109026|NCT01822483|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110109027|NCT01822483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110109028|NCT01822483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110109029|NCT01822483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110109030|NCT01822600|Omeprazole|omeprazole|mesh-list
110109031|NCT01822600|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110109032|NCT01822600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110109033|NCT01822600|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110109034|NCT01822600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110109035|NCT01822600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110109036|NCT01822613|Paclitaxel|paclitaxel|mesh-list
110109037|NCT01822613|Docetaxel|docetaxel|mesh-list
110109038|NCT01822613|Irinotecan|irinotecan|mesh-list
110109039|NCT01822613|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110109040|NCT01822613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110109041|NCT01822613|Tubulin Modulators|tubulin modulators|mesh-ancestor
110109042|NCT01822613|Antimitotic Agents|antimitotic agents|mesh-ancestor
110109043|NCT01822613|Mitosis Modulators|mitosis modulators|mesh-ancestor
110109044|NCT01822613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110109045|NCT01822613|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110109046|NCT01822613|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110109047|NCT01822613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110109049|NCT01822639|Enalapril|enalapril|mesh-list
110109050|NCT01822639|Enalaprilat|enalaprilat|mesh-list
110109051|NCT01822639|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110109052|NCT01822639|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110109053|NCT01822639|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110109054|NCT01822639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110109055|NCT01822639|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110109056|NCT01822639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110109057|NCT01822639|Vasodilator Agents|vasodilator agents|mesh-ancestor
110109058|NCT01822639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110109059|NCT01822639|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110109060|NCT01822639|Protease Inhibitors|protease inhibitors|mesh-ancestor
110109061|NCT01822730|Risperidone|risperidone|mesh-list
110109062|NCT01822730|Paliperidone Palmitate|paliperidone palmitate|mesh-list
110109063|NCT01822730|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110109064|NCT01822730|Serotonin Agents|serotonin agents|mesh-ancestor
110109065|NCT01822730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110109066|NCT01822730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110109067|NCT01822730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110109068|NCT01822730|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110109069|NCT01822730|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110109070|NCT01822730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110109071|NCT01822730|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110109072|NCT01822730|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110109073|NCT01822730|Dopamine Agents|dopamine agents|mesh-ancestor
110109074|NCT01822730|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110109075|NCT01822730|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110109076|NCT01822808|Hydralazine|hydralazine|mesh-list
110109078|NCT01822808|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
110109079|NCT01822808|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
110109080|NCT01822808|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110109081|NCT01822808|Diuretics|diuretics|mesh-ancestor
110109082|NCT01822808|Natriuretic Agents|natriuretic agents|mesh-ancestor
110109083|NCT01822808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110109084|NCT01822808|Vasodilator Agents|vasodilator agents|mesh-ancestor
110109085|NCT01822808|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
110109086|NCT01822808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110109087|NCT01822808|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110109088|NCT01822860|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110109089|NCT01822860|Chlorthalidone|chlorthalidone|mesh-list
110109090|NCT01822860|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110109091|NCT01822860|Diuretics|diuretics|mesh-ancestor
110109092|NCT01822860|Natriuretic Agents|natriuretic agents|mesh-ancestor
110109093|NCT01822860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110109094|NCT01822860|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110109095|NCT01822860|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110109096|NCT01822860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110109097|NCT01822951|Cerebrolysin|cerebrolysin|mesh-list
110109098|NCT01822951|Donepezil|donepezil|mesh-list
110109099|NCT01822951|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110109100|NCT01822951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110109101|NCT01822951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110109102|NCT01822951|Cholinergic Agents|cholinergic agents|mesh-ancestor
110109103|NCT01822951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110109104|NCT01822951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110109105|NCT01822951|Nootropic Agents|nootropic agents|mesh-ancestor
110109106|NCT01822951|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110109107|NCT01822951|Protective Agents|protective agents|mesh-ancestor
110109108|NCT01822977|Omeprazole|omeprazole|mesh-list
110109109|NCT01822977|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110109110|NCT01822977|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110109111|NCT01822977|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110109112|NCT01822977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110218844|NCT00110058|Antiviral Agents|antiviral agents|mesh-ancestor
110218845|NCT00110058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110109113|NCT01822977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110109114|NCT01823029|Epoetin Alfa|epoetin alfa|mesh-list
110109115|NCT01823029|Hematinics|hematinics|mesh-ancestor
110109116|NCT01822509|Nivolumab|nivolumab|mesh-list
110109117|NCT01822509|Ipilimumab|ipilimumab|mesh-list
110109118|NCT01822509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110109119|NCT01822509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110109120|NCT01822509|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110109121|NCT01822509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110109122|NCT01823042|Azathioprine|azathioprine|mesh-list
110109123|NCT01823042|Antimetabolites|antimetabolites|mesh-ancestor
110109124|NCT01823042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110109125|NCT01823042|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110109126|NCT01823042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110109127|NCT01823042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110109128|NCT01823042|Immunologic Factors|immunologic factors|mesh-ancestor
110109129|NCT01823042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110109130|NCT01823042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110109131|NCT01823081|Bevacizumab|bevacizumab|mesh-list
110109132|NCT01823081|Fasudil|fasudil|mesh-list
110109133|NCT01823081|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110109134|NCT01823081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110109135|NCT01823081|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110109136|NCT01823081|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110109137|NCT01823081|Growth Substances|growth substances|mesh-ancestor
110109138|NCT01823081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110109139|NCT01823081|Growth Inhibitors|growth inhibitors|mesh-ancestor
110109140|NCT01823081|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110109141|NCT01823081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110109142|NCT01823081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110109143|NCT01823081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110109144|NCT01823081|Vasodilator Agents|vasodilator agents|mesh-ancestor
110109145|NCT01823081|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110109146|NCT01823081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110109147|NCT01823133|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110109148|NCT01823133|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110109149|NCT01823133|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110109150|NCT01823133|Antimetabolites|antimetabolites|mesh-ancestor
110109151|NCT01823133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110109152|NCT01823133|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110109153|NCT01823133|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110109154|NCT01823133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110109155|NCT01823159|Ezogabine|ezogabine|mesh-list
110109156|NCT01823159|Anticonvulsants|anticonvulsants|mesh-ancestor
110109157|NCT01823159|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110109158|NCT01823159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110109159|NCT01823172|Methylene Blue|methylene blue|mesh-list
110109160|NCT01823172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110109161|NCT01823172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110109162|NCT01823185|Clopidogrel|clopidogrel|mesh-list
110109163|NCT01823185|Ticagrelor|ticagrelor|mesh-list
110109164|NCT01823185|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
110109165|NCT01823185|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110109166|NCT01823185|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110109167|NCT01823185|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110109168|NCT01823185|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110109169|NCT01823185|Purinergic Agents|purinergic agents|mesh-ancestor
110109170|NCT01823185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110109171|NCT01823185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110109172|NCT01823185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110109173|NCT01823393|Heparin|heparin|mesh-list
110109174|NCT01823393|Calcium heparin|calcium heparin|mesh-list
110109175|NCT01823393|Anticoagulants|anticoagulants|mesh-ancestor
110109176|NCT01823393|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110109177|NCT01823393|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110109178|NCT01823393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110109179|NCT01823523|Clindamycin|clindamycin|mesh-list
110109180|NCT01823523|Clindamycin palmitate|clindamycin palmitate|mesh-list
110109181|NCT01823523|Clindamycin phosphate|clindamycin phosphate|mesh-list
110109182|NCT01823523|Cefazolin|cefazolin|mesh-list
110109183|NCT01823523|Cephalexin|cephalexin|mesh-list
110109184|NCT01823523|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110109185|NCT01823523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110109186|NCT01823523|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110109187|NCT01823523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110109188|NCT01823523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110402044|NCT06050824|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110402045|NCT06050824|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110402046|NCT06050824|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110402047|NCT06050824|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110109189|NCT01823744|Micronutrients|micronutrients|mesh-list
110109190|NCT01823744|Trace Elements|trace elements|mesh-list
110109193|NCT01823770|Dopamine Agonists|dopamine agonists|mesh-ancestor
110109194|NCT01823770|Dopamine Agents|dopamine agents|mesh-ancestor
110109195|NCT01823770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110109196|NCT01823770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110109197|NCT01823770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110109198|NCT01823809|Adenosine|adenosine|mesh-list
110109199|NCT01823809|Analgesics|analgesics|mesh-ancestor
110109200|NCT01823809|Sensory System Agents|sensory system agents|mesh-ancestor
110109201|NCT01823809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110109202|NCT01823809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110109203|NCT01823809|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110109204|NCT01823809|Vasodilator Agents|vasodilator agents|mesh-ancestor
110109205|NCT01823809|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
110109206|NCT01823809|Purinergic Agonists|purinergic agonists|mesh-ancestor
110109207|NCT01823809|Purinergic Agents|purinergic agents|mesh-ancestor
110109208|NCT01823809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110109209|NCT01823809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110109212|NCT01823848|Dermatologic Agents|dermatologic agents|mesh-ancestor
110109213|NCT01823965|Ranibizumab|ranibizumab|mesh-list
110109214|NCT01823965|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110109215|NCT01823965|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110109216|NCT01823965|Growth Substances|growth substances|mesh-ancestor
110109217|NCT01823965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110109218|NCT01823965|Growth Inhibitors|growth inhibitors|mesh-ancestor
110109219|NCT01823965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110109220|NCT01824056|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110109221|NCT01824056|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110109222|NCT01824056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110109223|NCT01824199|Omeprazole|omeprazole|mesh-list
110109224|NCT01824199|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110109225|NCT01824199|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110109226|NCT01824199|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110109227|NCT01824199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110109228|NCT01824199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110109229|NCT01824225|Aflibercept|aflibercept|mesh-list
110109230|NCT01824225|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110109231|NCT01824225|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110109232|NCT01824225|Growth Substances|growth substances|mesh-ancestor
110109233|NCT01824225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110109234|NCT01824225|Growth Inhibitors|growth inhibitors|mesh-ancestor
110109235|NCT01824225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110109236|NCT01824238|Oxazolidinones|oxazolidinones|mesh-list
110109237|NCT01824238|Anacetrapib|anacetrapib|mesh-list
110109238|NCT01824238|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110109239|NCT01824238|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110109240|NCT01824238|Antimetabolites|antimetabolites|mesh-ancestor
110109241|NCT01824238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110109242|NCT01824238|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110109243|NCT01824238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110109244|NCT01824238|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110109245|NCT01824238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110109246|NCT01824251|Immunoglobulins|immunoglobulins|mesh-list
110109247|NCT01824251|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110109248|NCT01824251|gamma-Globulins|gamma-globulins|mesh-list
110109249|NCT01824251|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110109250|NCT01824251|Immunologic Factors|immunologic factors|mesh-ancestor
110109251|NCT01824251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110109252|NCT01824264|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110109253|NCT01824264|Licogliflozin|licogliflozin|mesh-list
110109254|NCT01824264|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110109255|NCT01824264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110109256|NCT01824264|Incretins|incretins|mesh-ancestor
110109257|NCT01824264|Hormones|hormones|mesh-ancestor
110109258|NCT01824264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110109259|NCT01824264|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110402053|NCT06036823|Insulin|insulin|mesh-list
110402054|NCT06036823|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110109260|NCT01824264|Protease Inhibitors|protease inhibitors|mesh-ancestor
110109261|NCT01824264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110109262|NCT01824264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110109263|NCT01824264|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110109264|NCT01824420|Mandelic Acids|mandelic acids|mesh-list
110109265|NCT01824420|Tolterodine Tartrate|tolterodine tartrate|mesh-list
110109266|NCT01824420|Oxybutynin|oxybutynin|mesh-list
110109267|NCT01824420|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110109268|NCT01824420|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110109269|NCT01824420|Cholinergic Agents|cholinergic agents|mesh-ancestor
110109270|NCT01824420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110109271|NCT01824420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110109272|NCT01824420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110109273|NCT01824420|Urological Agents|urological agents|mesh-ancestor
110109274|NCT01824420|Parasympatholytics|parasympatholytics|mesh-ancestor
110109275|NCT01824420|Autonomic Agents|autonomic agents|mesh-ancestor
110109276|NCT01824420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110109277|NCT01824420|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110109278|NCT01824420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110109280|NCT01824433|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
110109281|NCT01824433|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110109282|NCT01824433|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110109283|NCT01824433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110109284|NCT01824433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110109285|NCT01824433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110109286|NCT01824433|Serotonin Agents|serotonin agents|mesh-ancestor
110109287|NCT01824433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110109288|NCT01824433|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110109289|NCT01824433|Antidepressive Agents|antidepressive agents|mesh-ancestor
110109290|NCT01824433|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110109291|NCT01824433|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110109292|NCT01824433|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110109293|NCT01824433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110109294|NCT01824433|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110109295|NCT01824459|Oxaliplatin|oxaliplatin|mesh-list
110109296|NCT01824459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110109297|NCT01824524|Hydromorphone|hydromorphone|mesh-list
110109298|NCT01824524|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110109299|NCT01824524|Narcotics|narcotics|mesh-ancestor
110218879|NCT00281983|Methotrexate|methotrexate|mesh-list
110109300|NCT01824524|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110109301|NCT01824524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110109302|NCT01824524|Analgesics|analgesics|mesh-ancestor
110109303|NCT01824524|Sensory System Agents|sensory system agents|mesh-ancestor
110109304|NCT01824524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110109305|NCT01824615|Sunitinib|sunitinib|mesh-list
110109306|NCT01824615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110109307|NCT01824615|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110109308|NCT01824615|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110109309|NCT01824615|Growth Substances|growth substances|mesh-ancestor
110109310|NCT01824615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110109311|NCT01824615|Growth Inhibitors|growth inhibitors|mesh-ancestor
110109312|NCT01824615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110109313|NCT01824615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110109314|NCT01824615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110109315|NCT01824758|Lidocaine|lidocaine|mesh-list
110109316|NCT01824758|Rocuronium|rocuronium|mesh-list
110109317|NCT01824758|Esmolol|esmolol|mesh-list
110109318|NCT01824758|Anesthetics, Local|anesthetics, local|mesh-ancestor
110109319|NCT01824758|Anesthetics|anesthetics|mesh-ancestor
110109320|NCT01824758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110109321|NCT01824758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110109322|NCT01824758|Sensory System Agents|sensory system agents|mesh-ancestor
110109323|NCT01824758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110109324|NCT01824758|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110109325|NCT01824758|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110162143|NCT00111319|Bortezomib|bortezomib|mesh-list
110109326|NCT01824758|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110109327|NCT01824758|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110109328|NCT01824758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110109329|NCT01824758|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110109330|NCT01824758|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110109331|NCT01824758|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110109332|NCT01824758|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110109333|NCT01824758|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110109334|NCT01824758|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110109335|NCT01824758|Adrenergic Agents|adrenergic agents|mesh-ancestor
110109336|NCT01824758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110109337|NCT01824888|Anti-Infective Agents|anti-infective agents|mesh-list
110109338|NCT01824888|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110109339|NCT01824927|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110109340|NCT01824927|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110109341|NCT01824992|Interferons|interferons|mesh-list
110109342|NCT01824992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110109343|NCT01824992|Antiviral Agents|antiviral agents|mesh-ancestor
110109344|NCT01824992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110109345|NCT01825031|Azithromycin|azithromycin|mesh-list
110109346|NCT01825031|Isoniazid|isoniazid|mesh-list
110109347|NCT01825031|Raltegravir Potassium|raltegravir potassium|mesh-list
110109348|NCT01825031|Fluconazole|fluconazole|mesh-list
110109349|NCT01825031|Albendazole|albendazole|mesh-list
110109350|NCT01825031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110109351|NCT01825031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110109352|NCT01825031|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110109353|NCT01825031|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110109354|NCT01825031|Antiviral Agents|antiviral agents|mesh-ancestor
110109355|NCT01825031|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110109356|NCT01825031|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110109357|NCT01825031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110109358|NCT01825031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110109359|NCT01825031|Antifungal Agents|antifungal agents|mesh-ancestor
110109360|NCT01825031|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110109361|NCT01825031|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110109362|NCT01825031|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110109363|NCT01825031|Hormone Antagonists|hormone antagonists|mesh-ancestor
110109364|NCT01825031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110109365|NCT01825031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110109366|NCT01825031|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110109367|NCT01825031|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110109368|NCT01825031|Antitubercular Agents|antitubercular agents|mesh-ancestor
110109369|NCT01825031|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
110109370|NCT01825031|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110109371|NCT01825031|Antimetabolites|antimetabolites|mesh-ancestor
110109372|NCT01825031|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110109373|NCT01825031|Anthelmintics|anthelmintics|mesh-ancestor
110109374|NCT01825031|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110109375|NCT01825031|Anticestodal Agents|anticestodal agents|mesh-ancestor
110109376|NCT01825031|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110109377|NCT01825031|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110109378|NCT01825031|Tubulin Modulators|tubulin modulators|mesh-ancestor
110109379|NCT01825031|Antimitotic Agents|antimitotic agents|mesh-ancestor
110109380|NCT01825031|Mitosis Modulators|mitosis modulators|mesh-ancestor
110109381|NCT01825031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110109382|NCT01825044|Cyclosporine|cyclosporine|mesh-list
110109383|NCT01825044|Cyclosporins|cyclosporins|mesh-list
110109384|NCT01825044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110109385|NCT01825044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110109386|NCT01825044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110109387|NCT01825044|Immunologic Factors|immunologic factors|mesh-ancestor
110109388|NCT01825044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110109389|NCT01825044|Antifungal Agents|antifungal agents|mesh-ancestor
110109390|NCT01825044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110109391|NCT01825044|Dermatologic Agents|dermatologic agents|mesh-ancestor
110109392|NCT01825044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110109393|NCT01825044|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110109395|NCT01825083|Analgesics|analgesics|mesh-ancestor
110109396|NCT01825083|Sensory System Agents|sensory system agents|mesh-ancestor
110109397|NCT01825083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110109398|NCT01825083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110109399|NCT01825083|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110109400|NCT01825083|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110109401|NCT01825083|Anesthetics, General|anesthetics, general|mesh-ancestor
110109402|NCT01825083|Anesthetics|anesthetics|mesh-ancestor
110109403|NCT01825083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110109404|NCT01825083|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110109405|NCT01825083|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110109406|NCT01825083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110109407|NCT01825083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110109409|NCT01825109|Immunologic Factors|immunologic factors|mesh-ancestor
110109410|NCT01825109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110109411|NCT01825395|Amifampridine|amifampridine|mesh-list
110109412|NCT01825395|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110109413|NCT01825395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110109414|NCT01825395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110109415|NCT01825395|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
110109416|NCT01825395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110260161|NCT00168870|Gemcitabine|gemcitabine|mesh-list
110109417|NCT01825395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110109418|NCT01825421|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110109419|NCT01825421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110109420|NCT01825447|Naltrexone|naltrexone|mesh-list
110109421|NCT01825447|Oxycodone|oxycodone|mesh-list
110109422|NCT01825447|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110109423|NCT01825447|Narcotics|narcotics|mesh-ancestor
110109424|NCT01825447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110109425|NCT01825447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110109426|NCT01825447|Analgesics|analgesics|mesh-ancestor
110109427|NCT01825447|Sensory System Agents|sensory system agents|mesh-ancestor
110109428|NCT01825447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110109429|NCT01825447|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110109430|NCT01825447|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110109432|NCT01825473|Erythromycin Estolate|erythromycin estolate|mesh-list
110109433|NCT01825473|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
110109434|NCT01825473|Erythromycin stearate|erythromycin stearate|mesh-list
110109436|NCT01825473|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110109437|NCT01825473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110109438|NCT01825473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110109439|NCT01825473|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110109440|NCT01825473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110109441|NCT01825473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110109442|NCT01825473|Anticonvulsants|anticonvulsants|mesh-ancestor
110109443|NCT01825473|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110109444|NCT01825473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110109445|NCT01825473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110109446|NCT01825473|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110109447|NCT01825473|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110109448|NCT01825473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110109449|NCT01825473|GABA Modulators|gaba modulators|mesh-ancestor
110109450|NCT01825473|GABA Agents|gaba agents|mesh-ancestor
110109451|NCT01825473|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110109452|NCT01825473|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110109453|NCT01825473|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110109454|NCT01824043|Ranibizumab|ranibizumab|mesh-list
110109455|NCT01824043|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110109456|NCT01824043|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110109457|NCT01824043|Growth Substances|growth substances|mesh-ancestor
110109458|NCT01824043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110109459|NCT01824043|Growth Inhibitors|growth inhibitors|mesh-ancestor
110109460|NCT01824043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110109462|NCT01825551|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110109463|NCT01825551|Immunologic Factors|immunologic factors|mesh-ancestor
110109464|NCT01825551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110109465|NCT01825590|Dialysis Solutions|dialysis solutions|mesh-list
110109466|NCT01825590|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110109468|NCT01825616|Ergocalciferols|ergocalciferols|mesh-list
110109469|NCT01825616|Vitamins|vitamins|mesh-ancestor
110109470|NCT01825616|Micronutrients|micronutrients|mesh-ancestor
110162153|NCT00111436|Analgesics|analgesics|mesh-ancestor
110109471|NCT01825616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110109472|NCT01825616|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110109473|NCT01825616|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110109474|NCT01825720|Insulin|insulin|mesh-list
110109475|NCT01825720|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110109476|NCT01825720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110109477|NCT01825733|Palonosetron|palonosetron|mesh-list
110109478|NCT01825733|Ramosetron|ramosetron|mesh-list
110109479|NCT01825733|Antiemetics|antiemetics|mesh-ancestor
110109480|NCT01825733|Autonomic Agents|autonomic agents|mesh-ancestor
110109481|NCT01825733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110109482|NCT01825733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110109483|NCT01825733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110109484|NCT01825733|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110109485|NCT01825733|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110109486|NCT01825733|Serotonin Agents|serotonin agents|mesh-ancestor
110109487|NCT01825733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110218908|NCT00281983|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110109488|NCT01825733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110109489|NCT01825850|Irbesartan|irbesartan|mesh-list
110109490|NCT01825850|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110109491|NCT01825850|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110109492|NCT01825850|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110109493|NCT01825850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110109494|NCT01825863|Ropivacaine|ropivacaine|mesh-list
110109495|NCT01825863|Anesthetics, Local|anesthetics, local|mesh-ancestor
110109496|NCT01825863|Anesthetics|anesthetics|mesh-ancestor
110109497|NCT01825863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110109498|NCT01825863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110109499|NCT01825863|Sensory System Agents|sensory system agents|mesh-ancestor
110109500|NCT01825863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110109501|NCT01825902|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110109502|NCT01825902|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110109503|NCT01825902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110109504|NCT01825928|Paliperidone Palmitate|paliperidone palmitate|mesh-list
110109505|NCT01825928|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110109506|NCT01825928|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110109507|NCT01825928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110109508|NCT01825928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110109509|NCT01825928|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110109510|NCT01825928|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110109511|NCT01825928|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110109512|NCT01825928|Serotonin Agents|serotonin agents|mesh-ancestor
110109513|NCT01825928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110109514|NCT01825928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110109515|NCT01825928|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110109516|NCT01825928|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110109517|NCT01825928|Dopamine Agents|dopamine agents|mesh-ancestor
110109518|NCT01825993|Morphine|morphine|mesh-list
110109519|NCT01825993|Bupivacaine|bupivacaine|mesh-list
110109520|NCT01825993|Anesthetics, Local|anesthetics, local|mesh-ancestor
110109521|NCT01825993|Anesthetics|anesthetics|mesh-ancestor
110109522|NCT01825993|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110109523|NCT01825993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110109524|NCT01825993|Sensory System Agents|sensory system agents|mesh-ancestor
110402078|NCT06035874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110109525|NCT01825993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110109526|NCT01825993|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110109527|NCT01825993|Narcotics|narcotics|mesh-ancestor
110109528|NCT01825993|Analgesics|analgesics|mesh-ancestor
110109529|NCT01826149|Propofol|propofol|mesh-list
110109530|NCT01826149|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110109531|NCT01826149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110109532|NCT01826149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110109533|NCT01826149|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110109534|NCT01826149|Anesthetics, General|anesthetics, general|mesh-ancestor
110109535|NCT01826149|Anesthetics|anesthetics|mesh-ancestor
110109536|NCT01826175|Clopidogrel|clopidogrel|mesh-list
110109537|NCT01826175|Ticagrelor|ticagrelor|mesh-list
110109538|NCT01826175|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110109539|NCT01826175|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110109540|NCT01826175|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110109541|NCT01826175|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110109542|NCT01826175|Purinergic Agents|purinergic agents|mesh-ancestor
110109543|NCT01826175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110218923|NCT00282139|Antidepressive Agents|antidepressive agents|mesh-ancestor
110109544|NCT01826175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110109545|NCT01826175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110109546|NCT01826253|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
110109547|NCT01826253|Plasma Substitutes|plasma substitutes|mesh-ancestor
110109548|NCT01826253|Blood Substitutes|blood substitutes|mesh-ancestor
110109549|NCT01826279|Resveratrol|resveratrol|mesh-list
110109550|NCT01826279|Antioxidants|antioxidants|mesh-ancestor
110109551|NCT01826279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110109552|NCT01826279|Protective Agents|protective agents|mesh-ancestor
110109553|NCT01826279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110109554|NCT01826279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110109555|NCT01826279|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110109556|NCT01826396|Irinotecan|irinotecan|mesh-list
110109557|NCT01826396|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110109558|NCT01826396|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110109559|NCT01826396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110109560|NCT01826396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110109561|NCT01826396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110109562|NCT01826526|Taurolidine|taurolidine|mesh-list
110109563|NCT01826526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110109564|NCT01826526|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110109565|NCT01826526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110109566|NCT01826747|Progesterone|progesterone|mesh-list
110109567|NCT01826747|Progestins|progestins|mesh-ancestor
110109568|NCT01826747|Hormones|hormones|mesh-ancestor
110109569|NCT01826747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110109570|NCT01826747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110109571|NCT01826773|Palmitic Acid|palmitic acid|mesh-list
110109572|NCT01826773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110109573|NCT01826773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110109574|NCT01826786|JNJ-42165279|jnj-42165279|mesh-list
110109575|NCT01826786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110109576|NCT01826786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110109577|NCT01826864|Sargramostim|sargramostim|mesh-list
110109578|NCT01826864|Immunologic Factors|immunologic factors|mesh-ancestor
110109579|NCT01826864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110109580|NCT01826916|Ecallantide|ecallantide|mesh-list
110109581|NCT01826916|Analgesics|analgesics|mesh-ancestor
110109582|NCT01826916|Sensory System Agents|sensory system agents|mesh-ancestor
110109583|NCT01826916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110109584|NCT01826916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110109585|NCT01826916|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110402091|NCT06026852|Meropenem|meropenem|mesh-list
110402092|NCT06026852|Tazobactam|tazobactam|mesh-list
110402093|NCT06026852|Piperacillin|piperacillin|mesh-list
110402094|NCT06026852|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
110109586|NCT01826916|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110109587|NCT01826916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110109588|NCT01826916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110109589|NCT01827007|Polygeline|polygeline|mesh-list
110109590|NCT01827007|Plasma Substitutes|plasma substitutes|mesh-ancestor
110109591|NCT01827007|Blood Substitutes|blood substitutes|mesh-ancestor
110109592|NCT01827020|Lidocaine|lidocaine|mesh-list
110109593|NCT01827020|Ketamine|ketamine|mesh-list
110109594|NCT01827020|Anesthetics, Local|anesthetics, local|mesh-ancestor
110109595|NCT01827020|Anesthetics|anesthetics|mesh-ancestor
110162175|NCT00111748|Thalidomide|thalidomide|mesh-list
110109596|NCT01827020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110109597|NCT01827020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110218936|NCT00282139|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110109599|NCT01827020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110109600|NCT01827020|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110109601|NCT01827020|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110109602|NCT01827020|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110109603|NCT01827020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110109604|NCT01827020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110109605|NCT01827020|Analgesics|analgesics|mesh-ancestor
110109606|NCT01827020|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110109607|NCT01827020|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110109608|NCT01827020|Anesthetics, General|anesthetics, general|mesh-ancestor
110109609|NCT01827020|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110109610|NCT01827020|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110109611|NCT01827020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110109612|NCT01827059|Bosentan|bosentan|mesh-list
110109613|NCT01827059|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110109614|NCT01827059|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
110109615|NCT01827059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110109616|NCT01827072|Immunoglobulins|immunoglobulins|mesh-list
110109617|NCT01827072|Immunologic Factors|immunologic factors|mesh-ancestor
110109618|NCT01827072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110109619|NCT01827124|Oxytocin|oxytocin|mesh-list
110109620|NCT01827124|Carbetocin|carbetocin|mesh-list
110109621|NCT01827124|Oxytocics|oxytocics|mesh-ancestor
110109622|NCT01827124|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110109623|NCT01827124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110109624|NCT01827137|Lenalidomide|lenalidomide|mesh-list
110109625|NCT01827137|Molgramostim|molgramostim|mesh-list
110109626|NCT01827137|Sargramostim|sargramostim|mesh-list
110109627|NCT01827137|Immunologic Factors|immunologic factors|mesh-ancestor
110109628|NCT01827137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110109629|NCT01827137|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110109630|NCT01827137|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110109631|NCT01827137|Growth Substances|growth substances|mesh-ancestor
110109632|NCT01827137|Growth Inhibitors|growth inhibitors|mesh-ancestor
110109633|NCT01827137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110109634|NCT01827202|Candesartan|candesartan|mesh-list
110109635|NCT01827202|Candesartan cilexetil|candesartan cilexetil|mesh-list
110109636|NCT01827202|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110109637|NCT01827202|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110109638|NCT01827202|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110109639|NCT01827202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110109640|NCT01827228|HIV Antibodies|hiv antibodies|mesh-list
110109641|NCT01827228|Immunologic Factors|immunologic factors|mesh-ancestor
110109642|NCT01827228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110109643|NCT01827280|Vildagliptin|vildagliptin|mesh-list
110109644|NCT01827280|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110109645|NCT01827280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110109646|NCT01827280|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110109647|NCT01827280|Protease Inhibitors|protease inhibitors|mesh-ancestor
110109649|NCT01827280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110109650|NCT01827293|Promethazine|promethazine|mesh-list
110109651|NCT01827293|Diphenhydramine|diphenhydramine|mesh-list
110109652|NCT01827293|Lorazepam|lorazepam|mesh-list
110109653|NCT01827293|Anticonvulsants|anticonvulsants|mesh-ancestor
110109654|NCT01827293|Antiemetics|antiemetics|mesh-ancestor
110109655|NCT01827293|Autonomic Agents|autonomic agents|mesh-ancestor
110109656|NCT01827293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110109657|NCT01827293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110218950|NCT00110253|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110109658|NCT01827293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110109659|NCT01827293|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110109660|NCT01827293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110109662|NCT01827293|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110162177|NCT00111748|Bortezomib|bortezomib|mesh-list
110109663|NCT01827293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110109664|NCT01827293|GABA Modulators|gaba modulators|mesh-ancestor
110109666|NCT01827293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110109667|NCT01827293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110109668|NCT01827293|Antipruritics|antipruritics|mesh-ancestor
110109669|NCT01827293|Dermatologic Agents|dermatologic agents|mesh-ancestor
110109670|NCT01827293|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110109671|NCT01827293|Histamine Antagonists|histamine antagonists|mesh-ancestor
110109672|NCT01827293|Histamine Agents|histamine agents|mesh-ancestor
110109673|NCT01827293|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110109674|NCT01827293|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110109675|NCT01827293|Anesthetics, Local|anesthetics, local|mesh-ancestor
110109677|NCT01827293|Sensory System Agents|sensory system agents|mesh-ancestor
110109678|NCT01827345|Vitamin D|vitamin d|mesh-list
110109679|NCT01827345|Vitamins|vitamins|mesh-ancestor
110109680|NCT01827345|Micronutrients|micronutrients|mesh-ancestor
110109681|NCT01827345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110109682|NCT01827345|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110109683|NCT01827397|Vaccines|vaccines|mesh-list
110109684|NCT01827397|Immunologic Factors|immunologic factors|mesh-ancestor
110109685|NCT01827397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110109686|NCT01827540|Dolutegravir|dolutegravir|mesh-list
110109687|NCT01827540|Cenicriviroc|cenicriviroc|mesh-list
110109688|NCT01827540|Midazolam|midazolam|mesh-list
110109689|NCT01827540|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110109690|NCT01827540|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110109691|NCT01827540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110109692|NCT01827540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110109693|NCT01827540|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110109694|NCT01827540|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110109695|NCT01827540|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110109696|NCT01827540|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110109697|NCT01827540|Anesthetics, General|anesthetics, general|mesh-ancestor
110109698|NCT01827540|Anesthetics|anesthetics|mesh-ancestor
110109699|NCT01827540|GABA Modulators|gaba modulators|mesh-ancestor
110109700|NCT01827540|GABA Agents|gaba agents|mesh-ancestor
110109701|NCT01827540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110109702|NCT01827540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110109703|NCT01827540|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110109704|NCT01827540|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110109705|NCT01827540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110109706|NCT01827540|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110109707|NCT01827540|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110109708|NCT01827540|Antiviral Agents|antiviral agents|mesh-ancestor
110109709|NCT01827540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110109710|NCT01827540|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
110109711|NCT01827618|Sirolimus|sirolimus|mesh-list
110109712|NCT01827618|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110109713|NCT01827618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110109714|NCT01827618|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110109715|NCT01827618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110109716|NCT01827618|Antifungal Agents|antifungal agents|mesh-ancestor
110109717|NCT01827618|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110109718|NCT01827618|Immunologic Factors|immunologic factors|mesh-ancestor
110109719|NCT01827618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110109720|NCT01827722|Dexamethasone|dexamethasone|mesh-list
110109721|NCT01827722|Dexamethasone acetate|dexamethasone acetate|mesh-list
110109722|NCT01827722|Ranibizumab|ranibizumab|mesh-list
110109723|NCT01827722|BB 1101|bb 1101|mesh-list
110109724|NCT01827722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110109725|NCT01827722|Antiemetics|antiemetics|mesh-ancestor
110109726|NCT01827722|Autonomic Agents|autonomic agents|mesh-ancestor
110402110|NCT06024096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110109727|NCT01827722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110109728|NCT01827722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110109730|NCT01827722|Glucocorticoids|glucocorticoids|mesh-ancestor
110109732|NCT01827722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110109733|NCT01827722|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110109734|NCT01827722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110109735|NCT01827722|Protease Inhibitors|protease inhibitors|mesh-ancestor
110109736|NCT01827722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110109737|NCT01827722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110109738|NCT01827722|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110109739|NCT01827722|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110109740|NCT01827722|Growth Substances|growth substances|mesh-ancestor
110109741|NCT01827722|Growth Inhibitors|growth inhibitors|mesh-ancestor
110109742|NCT01827735|Aldesleukin|aldesleukin|mesh-list
110109743|NCT01827735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110109744|NCT01827735|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110109745|NCT01827735|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110109746|NCT01827735|Antiviral Agents|antiviral agents|mesh-ancestor
110109747|NCT01827735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110109748|NCT01827865|Etodolac|etodolac|mesh-list
110109749|NCT01827865|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110109750|NCT01827865|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110109751|NCT01827865|Analgesics|analgesics|mesh-ancestor
110109752|NCT01827865|Sensory System Agents|sensory system agents|mesh-ancestor
110109753|NCT01827865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110109754|NCT01827865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110109755|NCT01827865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110109756|NCT01827865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110109757|NCT01827865|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110109758|NCT01827865|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110109759|NCT01827865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110109760|NCT01827865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110109761|NCT01827878|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110109762|NCT01827878|Lisinopril|lisinopril|mesh-list
110109763|NCT01827878|Hydrochlorothiazide, lisinopril drug combination|hydrochlorothiazide, lisinopril drug combination|mesh-list
110109764|NCT01827878|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110109765|NCT01827878|Diuretics|diuretics|mesh-ancestor
110109766|NCT01827878|Natriuretic Agents|natriuretic agents|mesh-ancestor
110109767|NCT01827878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110109768|NCT01827878|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110109769|NCT01827878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110109770|NCT01827878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110109771|NCT01827878|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110109772|NCT01827878|Protease Inhibitors|protease inhibitors|mesh-ancestor
110109773|NCT01827878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110109774|NCT01827878|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110109775|NCT01827878|Protective Agents|protective agents|mesh-ancestor
110109776|NCT01828125|Hypoglycemic Agents|hypoglycemic agents|mesh-list
110109777|NCT01828125|Glucagon|glucagon|mesh-list
110218970|NCT00282217|Antifungal Agents|antifungal agents|mesh-ancestor
110109778|NCT01828125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110109779|NCT01828125|Hormones|hormones|mesh-ancestor
110109780|NCT01828125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110109781|NCT01828125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110109782|NCT01828203|Minocycline|minocycline|mesh-list
110109783|NCT01828203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110109784|NCT01828203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110109785|NCT01828294|Immunoglobulins|immunoglobulins|mesh-list
110109786|NCT01828294|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110109787|NCT01828294|Antibodies|antibodies|mesh-list
110109788|NCT01828294|Immunologic Factors|immunologic factors|mesh-ancestor
110109789|NCT01828294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110109790|NCT01828346|Azacitidine|azacitidine|mesh-list
110109791|NCT01828346|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110109792|NCT01828346|Antimetabolites|antimetabolites|mesh-ancestor
110109793|NCT01828346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110109794|NCT01828346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110109795|NCT01828346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110109796|NCT01828359|Losartan|losartan|mesh-list
110109797|NCT01828359|Amlodipine|amlodipine|mesh-list
110109798|NCT01828359|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110109799|NCT01828359|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110109800|NCT01828359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110109801|NCT01828359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110109802|NCT01828359|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110109803|NCT01828359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110109804|NCT01828359|Vasodilator Agents|vasodilator agents|mesh-ancestor
110109805|NCT01828359|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110162188|NCT00111748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110109806|NCT01828359|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110109807|NCT01828359|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110109808|NCT01828385|Magnesium Sulfate|magnesium sulfate|mesh-list
110109809|NCT01828385|Analgesics|analgesics|mesh-ancestor
110109810|NCT01828385|Sensory System Agents|sensory system agents|mesh-ancestor
110109811|NCT01828385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110109812|NCT01828385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110109813|NCT01828385|Anesthetics|anesthetics|mesh-ancestor
110109814|NCT01828385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110109815|NCT01828385|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110109816|NCT01828385|Anticonvulsants|anticonvulsants|mesh-ancestor
110109817|NCT01828385|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110109818|NCT01828385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110109819|NCT01828385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110109820|NCT01828385|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110109821|NCT01828385|Tocolytic Agents|tocolytic agents|mesh-ancestor
110109822|NCT01828385|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110109823|NCT01828437|Pyridoxine|pyridoxine|mesh-list
110109824|NCT01828437|Prednisolone|prednisolone|mesh-list
110109825|NCT01828437|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110109826|NCT01828437|Methylprednisolone|methylprednisolone|mesh-list
110109827|NCT01828437|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110109828|NCT01828437|Prednisolone acetate|prednisolone acetate|mesh-list
110109829|NCT01828437|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110109830|NCT01828437|Prednisolone phosphate|prednisolone phosphate|mesh-list
110109831|NCT01828437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110109832|NCT01828437|Glucocorticoids|glucocorticoids|mesh-ancestor
110109833|NCT01828437|Hormones|hormones|mesh-ancestor
110109834|NCT01828437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110109835|NCT01828437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110109836|NCT01828437|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110109837|NCT01828437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110109838|NCT01828437|Antiemetics|antiemetics|mesh-ancestor
110109839|NCT01828437|Autonomic Agents|autonomic agents|mesh-ancestor
110109840|NCT01828437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110109841|NCT01828437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110109842|NCT01828437|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110109843|NCT01828437|Protective Agents|protective agents|mesh-ancestor
110109844|NCT01828437|Vitamin B Complex|vitamin b complex|mesh-ancestor
110109845|NCT01828437|Vitamins|vitamins|mesh-ancestor
110109846|NCT01828437|Micronutrients|micronutrients|mesh-ancestor
110109847|NCT01828463|Nitisinone|nitisinone|mesh-list
110109848|NCT01828463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110109849|NCT01828463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110109850|NCT01828489|Mitoxantrone|mitoxantrone|mesh-list
110109851|NCT01828489|Analgesics|analgesics|mesh-ancestor
110109852|NCT01828489|Sensory System Agents|sensory system agents|mesh-ancestor
110109853|NCT01828489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110109854|NCT01828489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110109855|NCT01828489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110109856|NCT01828489|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110109857|NCT01828489|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110109858|NCT01828489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110109859|NCT01828489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110109860|NCT01828606|Monensin|monensin|mesh-list
110109861|NCT01828606|Antifungal Agents|antifungal agents|mesh-ancestor
110109862|NCT01828606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110109863|NCT01828606|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110109864|NCT01828606|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110109865|NCT01828606|Coccidiostats|coccidiostats|mesh-ancestor
110109866|NCT01828606|Proton Ionophores|proton ionophores|mesh-ancestor
110109867|NCT01828606|Uncoupling Agents|uncoupling agents|mesh-ancestor
110109868|NCT01828606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110109869|NCT01828606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110109870|NCT01828606|Ionophores|ionophores|mesh-ancestor
110109871|NCT01828606|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110109872|NCT01828606|Sodium Ionophores|sodium ionophores|mesh-ancestor
110109873|NCT01828736|Cisplatin|cisplatin|mesh-list
110109874|NCT01828736|Carboplatin|carboplatin|mesh-list
110109875|NCT01828736|Gemcitabine|gemcitabine|mesh-list
110109876|NCT01828736|Trastuzumab|trastuzumab|mesh-list
110109877|NCT01828736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110109878|NCT01828736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110109879|NCT01828736|Antimetabolites|antimetabolites|mesh-ancestor
110109880|NCT01828736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110109881|NCT01828736|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110109883|NCT01828788|Anesthetics, Local|anesthetics, local|mesh-ancestor
110109884|NCT01828788|Anesthetics|anesthetics|mesh-ancestor
110109885|NCT01828788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110109886|NCT01828788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110109887|NCT01828788|Sensory System Agents|sensory system agents|mesh-ancestor
110109888|NCT01828788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110109889|NCT01828879|Tacrolimus|tacrolimus|mesh-list
110109890|NCT01828879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110109891|NCT01828879|Immunologic Factors|immunologic factors|mesh-ancestor
110109892|NCT01828879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110109893|NCT01828879|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110109894|NCT01828879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110109895|NCT01828879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110109896|NCT01828892|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110109897|NCT01828892|Vancomycin|vancomycin|mesh-list
110109898|NCT01828892|Meropenem|meropenem|mesh-list
110109899|NCT01828892|Ceftazidime|ceftazidime|mesh-list
110109900|NCT01828892|Cefotaxime|cefotaxime|mesh-list
110109901|NCT01828892|Cefoxitin|cefoxitin|mesh-list
110109902|NCT01828892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110109903|NCT01828970|Insulin Aspart|insulin aspart|mesh-list
110109904|NCT01828970|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110109905|NCT01828970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110109906|NCT01829178|Cisplatin|cisplatin|mesh-list
110109907|NCT01829178|Docetaxel|docetaxel|mesh-list
110109908|NCT01829178|Fluorouracil|fluorouracil|mesh-list
110109909|NCT01829178|Silymarin|silymarin|mesh-list
110109910|NCT01829178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110109911|NCT01829178|Tubulin Modulators|tubulin modulators|mesh-ancestor
110109912|NCT01829178|Antimitotic Agents|antimitotic agents|mesh-ancestor
110109913|NCT01829178|Mitosis Modulators|mitosis modulators|mesh-ancestor
110109914|NCT01829178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110109915|NCT01829178|Antimetabolites|antimetabolites|mesh-ancestor
110109916|NCT01829178|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110109917|NCT01829178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110109918|NCT01829178|Immunologic Factors|immunologic factors|mesh-ancestor
110109919|NCT01829178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110109920|NCT01829178|Antioxidants|antioxidants|mesh-ancestor
110109921|NCT01829178|Protective Agents|protective agents|mesh-ancestor
110109922|NCT01829334|Listerine|listerine|mesh-list
110109923|NCT01829334|Fluorides|fluorides|mesh-list
110109924|NCT01829334|Sodium Fluoride|sodium fluoride|mesh-list
110109925|NCT01829334|Fluorides, Topical|fluorides, topical|mesh-list
110109926|NCT01829334|Cariostatic Agents|cariostatic agents|mesh-ancestor
110109927|NCT01829334|Protective Agents|protective agents|mesh-ancestor
110109928|NCT01829334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110109929|NCT01829334|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110109930|NCT01829334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110109931|NCT01829451|Hyaluronic Acid|hyaluronic acid|mesh-list
110109932|NCT01829451|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110109933|NCT01829451|Immunologic Factors|immunologic factors|mesh-ancestor
110109934|NCT01829451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110109935|NCT01829451|Viscosupplements|viscosupplements|mesh-ancestor
110109936|NCT01829451|Protective Agents|protective agents|mesh-ancestor
110109937|NCT01829529|Amoxicillin|amoxicillin|mesh-list
110109938|NCT01829529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110109939|NCT01829529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110109941|NCT01829659|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110109942|NCT01829659|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110109943|NCT01829659|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110109944|NCT01829659|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110109945|NCT01829659|Purinergic Agents|purinergic agents|mesh-ancestor
110162198|NCT00111787|Paclitaxel|paclitaxel|mesh-list
110109946|NCT01829659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110109947|NCT01829659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110109948|NCT01829659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110109949|NCT01829685|Entecavir|entecavir|mesh-list
110109950|NCT01829685|Adefovir|adefovir|mesh-list
110109951|NCT01829685|Antiviral Agents|antiviral agents|mesh-ancestor
110109952|NCT01829685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110109953|NCT01829685|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110109954|NCT01829685|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110109955|NCT01829685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110109956|NCT01829685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110109957|NCT01829698|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
110109958|NCT01829698|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
110109959|NCT01829698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110109960|NCT01829711|Immunotoxin HA22|immunotoxin ha22|mesh-list
110109961|NCT01829711|Protective Agents|protective agents|mesh-list
110109963|NCT01829711|Immunoconjugates|immunoconjugates|mesh-ancestor
110109964|NCT01829711|Immunologic Factors|immunologic factors|mesh-ancestor
110109965|NCT01829711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110109966|NCT01829711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110109968|NCT01829802|Atazanavir Sulfate|atazanavir sulfate|mesh-list
110109969|NCT01829802|Raltegravir Potassium|raltegravir potassium|mesh-list
110109970|NCT01829802|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110109971|NCT01829802|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110109972|NCT01829802|Protease Inhibitors|protease inhibitors|mesh-ancestor
110109973|NCT01829802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110109974|NCT01829802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110109975|NCT01829802|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110109976|NCT01829802|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110109977|NCT01829802|Antiviral Agents|antiviral agents|mesh-ancestor
110109978|NCT01829802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110109979|NCT01829802|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110109980|NCT01829802|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110109981|NCT01829802|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110109982|NCT01829802|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110109983|NCT01829841|Sunitinib|sunitinib|mesh-list
110109984|NCT01829841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110109985|NCT01829841|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110109986|NCT01829841|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110109987|NCT01829841|Growth Substances|growth substances|mesh-ancestor
110109988|NCT01829841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110109989|NCT01829841|Growth Inhibitors|growth inhibitors|mesh-ancestor
110109990|NCT01829841|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110109991|NCT01829841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110109992|NCT01829841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110109993|NCT01829893|Tamsulosin|tamsulosin|mesh-list
110109994|NCT01829893|Finasteride|finasteride|mesh-list
110109995|NCT01829893|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110109996|NCT01829893|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110109997|NCT01829893|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110109998|NCT01829893|Adrenergic Agents|adrenergic agents|mesh-ancestor
110109999|NCT01829893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110110000|NCT01829893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110110001|NCT01829893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110110002|NCT01829893|Urological Agents|urological agents|mesh-ancestor
110110003|NCT01829893|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
110110004|NCT01829893|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110110005|NCT01829893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110110006|NCT01829893|Hormone Antagonists|hormone antagonists|mesh-ancestor
110402132|NCT06021990|Clopidogrel|clopidogrel|mesh-list
110219051|NCT00283309|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110110007|NCT01829893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110110009|NCT01830153|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110110010|NCT01830153|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110110011|NCT01830153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110110012|NCT01830153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110110013|NCT01830153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110110014|NCT01830153|Immunologic Factors|immunologic factors|mesh-ancestor
110110015|NCT01830153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110110016|NCT01830153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110110017|NCT01830244|Paclitaxel|paclitaxel|mesh-list
110110018|NCT01830244|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110110019|NCT01830244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110110020|NCT01830244|Tubulin Modulators|tubulin modulators|mesh-ancestor
110110021|NCT01830244|Antimitotic Agents|antimitotic agents|mesh-ancestor
110110022|NCT01830244|Mitosis Modulators|mitosis modulators|mesh-ancestor
110110023|NCT01830244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110110024|NCT01830270|Paclitaxel|paclitaxel|mesh-list
110110025|NCT01830270|Epirubicin|epirubicin|mesh-list
110110026|NCT01830270|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110110027|NCT01830270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110110028|NCT01830270|Tubulin Modulators|tubulin modulators|mesh-ancestor
110110029|NCT01830270|Antimitotic Agents|antimitotic agents|mesh-ancestor
110110030|NCT01830270|Mitosis Modulators|mitosis modulators|mesh-ancestor
110110031|NCT01830270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110110032|NCT01830270|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110110033|NCT01830270|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110110034|NCT01830270|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110110035|NCT01830270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110110037|NCT01830530|Nifedipine|nifedipine|mesh-list
110110038|NCT01830530|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110110039|NCT01830530|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110110040|NCT01830530|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110110041|NCT01830530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110110042|NCT01830530|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110110043|NCT01830530|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110110044|NCT01830530|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110110045|NCT01830530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110110046|NCT01830530|Vasodilator Agents|vasodilator agents|mesh-ancestor
110110047|NCT01830530|Tocolytic Agents|tocolytic agents|mesh-ancestor
110110048|NCT01830530|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110110049|NCT01830907|Vitamins|vitamins|mesh-list
110110050|NCT01830907|Micronutrients|micronutrients|mesh-ancestor
110110051|NCT01830907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110110052|NCT01831050|Vaccines|vaccines|mesh-list
110110053|NCT01831050|Immunologic Factors|immunologic factors|mesh-ancestor
110110054|NCT01831050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110110055|NCT01831440|Antidepressive Agents|antidepressive agents|mesh-list
110110056|NCT01831440|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110110057|NCT01832311|Ketorolac|ketorolac|mesh-list
110110058|NCT01832311|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110110059|NCT01832311|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110110060|NCT01832311|Analgesics|analgesics|mesh-ancestor
110110061|NCT01832311|Sensory System Agents|sensory system agents|mesh-ancestor
110110062|NCT01832311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110110063|NCT01832311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110402134|NCT06021990|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110402135|NCT06021990|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110402136|NCT06021990|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110402137|NCT06021990|Purinergic Agents|purinergic agents|mesh-ancestor
110402138|NCT06021990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110110064|NCT01832311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110110065|NCT01832311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110110066|NCT01832311|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110110067|NCT01832311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110110068|NCT01832311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110110069|NCT01832350|Quinidine|quinidine|mesh-list
110110070|NCT01832350|Dextromethorphan|dextromethorphan|mesh-list
110110071|NCT01832350|Antitussive Agents|antitussive agents|mesh-ancestor
110110072|NCT01832350|Respiratory System Agents|respiratory system agents|mesh-ancestor
110110073|NCT01832350|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110110074|NCT01832350|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110110075|NCT01832350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110110076|NCT01832350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110110077|NCT01832350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110110078|NCT01832350|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110110079|NCT01832350|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110110080|NCT01832350|Adrenergic Agents|adrenergic agents|mesh-ancestor
110110081|NCT01832350|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110110082|NCT01832350|Antimalarials|antimalarials|mesh-ancestor
110110084|NCT01832350|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110110085|NCT01832350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110110086|NCT01832350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110110087|NCT01832350|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110110088|NCT01832350|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110110089|NCT01832350|Cholinergic Agents|cholinergic agents|mesh-ancestor
110110090|NCT01832350|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110110091|NCT01832350|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110110092|NCT01832350|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110110093|NCT01832350|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110110094|NCT01832350|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110110095|NCT01833221|Lidocaine|lidocaine|mesh-list
110110096|NCT01833221|Anesthetics, Local|anesthetics, local|mesh-ancestor
110110097|NCT01833221|Anesthetics|anesthetics|mesh-ancestor
110110098|NCT01833221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110110099|NCT01833221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110110100|NCT01833221|Sensory System Agents|sensory system agents|mesh-ancestor
110110101|NCT01833221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110110102|NCT01833221|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110110103|NCT01833221|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110110104|NCT01833221|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110110105|NCT01833221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110110106|NCT01833221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110110107|NCT01834820|Dexamethasone|dexamethasone|mesh-list
110110108|NCT01834820|Epinephrine|epinephrine|mesh-list
110110109|NCT01834820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110110110|NCT01834820|Antiemetics|antiemetics|mesh-ancestor
110110111|NCT01834820|Autonomic Agents|autonomic agents|mesh-ancestor
110110112|NCT01834820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110110113|NCT01834820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110110114|NCT01834820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110110115|NCT01834820|Glucocorticoids|glucocorticoids|mesh-ancestor
110110117|NCT01834820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110110118|NCT01834820|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110110119|NCT01834820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110219088|NCT00283660|Zinc Oxide|zinc oxide|mesh-list
110110120|NCT01834820|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110110121|NCT01834820|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110110122|NCT01834820|Adrenergic Agents|adrenergic agents|mesh-ancestor
110110123|NCT01834820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110110124|NCT01834820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110110125|NCT01834820|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110110126|NCT01834820|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110110127|NCT01834820|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110110128|NCT01834820|Respiratory System Agents|respiratory system agents|mesh-ancestor
110110129|NCT01834820|Mydriatics|mydriatics|mesh-ancestor
110110130|NCT01834820|Sympathomimetics|sympathomimetics|mesh-ancestor
110110131|NCT01834820|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110110132|NCT01835197|Abrocitinib|abrocitinib|mesh-list
110110133|NCT01835197|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110110134|NCT01835197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110110135|NCT01835197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110110136|NCT01835418|Amlodipine|amlodipine|mesh-list
110110137|NCT01835418|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110110138|NCT01835418|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110110139|NCT01835418|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110110140|NCT01835418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110110141|NCT01835418|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110110142|NCT01835418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110110143|NCT01835418|Vasodilator Agents|vasodilator agents|mesh-ancestor
110110144|NCT01835678|Linagliptin|linagliptin|mesh-list
110110145|NCT01835678|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110110146|NCT01835678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110110147|NCT01835678|Incretins|incretins|mesh-ancestor
110110148|NCT01835678|Hormones|hormones|mesh-ancestor
110110149|NCT01835678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110110150|NCT01835678|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110110151|NCT01835678|Protease Inhibitors|protease inhibitors|mesh-ancestor
110110152|NCT01835678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110162221|NCT00111943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110110153|NCT01835678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110110154|NCT01836614|Lidocaine|lidocaine|mesh-list
110110155|NCT01836614|Anesthetics, Local|anesthetics, local|mesh-ancestor
110110156|NCT01836614|Anesthetics|anesthetics|mesh-ancestor
110110157|NCT01836614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110110158|NCT01836614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110110159|NCT01836614|Sensory System Agents|sensory system agents|mesh-ancestor
110110160|NCT01836614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110110161|NCT01836614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110110162|NCT01836614|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110110163|NCT01836614|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110110164|NCT01836614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110110165|NCT01836614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110110166|NCT01837251|Bevacizumab|bevacizumab|mesh-list
110110167|NCT01837251|Carboplatin|carboplatin|mesh-list
110110168|NCT01837251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110110169|NCT01837251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110110170|NCT01837251|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110110171|NCT01837251|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110110172|NCT01837251|Growth Substances|growth substances|mesh-ancestor
110110173|NCT01837251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110110174|NCT01837251|Growth Inhibitors|growth inhibitors|mesh-ancestor
110110175|NCT01837290|Midazolam|midazolam|mesh-list
110110176|NCT01837290|Dexmedetomidine|dexmedetomidine|mesh-list
110110177|NCT01837290|Bupivacaine|bupivacaine|mesh-list
110110178|NCT01837290|Anesthetics, Local|anesthetics, local|mesh-ancestor
110110179|NCT01837290|Anesthetics|anesthetics|mesh-ancestor
110110180|NCT01837290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110110181|NCT01837290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110110182|NCT01837290|Sensory System Agents|sensory system agents|mesh-ancestor
110110183|NCT01837290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110110184|NCT01837290|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110110185|NCT01837290|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110110186|NCT01837290|Analgesics|analgesics|mesh-ancestor
110110187|NCT01837290|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110110188|NCT01837290|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110110189|NCT01837290|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110402163|NCT05983354|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110402164|NCT05983354|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110402165|NCT05983354|Dopamine Agents|dopamine agents|mesh-ancestor
110110190|NCT01837290|Adrenergic Agents|adrenergic agents|mesh-ancestor
110110191|NCT01837290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110110192|NCT01837290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110110193|NCT01837290|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110110194|NCT01837290|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110110195|NCT01837290|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110110196|NCT01837290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110110197|NCT01837290|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110110198|NCT01837290|Anesthetics, General|anesthetics, general|mesh-ancestor
110110199|NCT01837290|GABA Modulators|gaba modulators|mesh-ancestor
110110200|NCT01837290|GABA Agents|gaba agents|mesh-ancestor
110110201|NCT01837433|Prednisone|prednisone|mesh-list
110110202|NCT01837433|Glucocorticoids|glucocorticoids|mesh-list
110110203|NCT01837433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110110204|NCT01837433|Hormones|hormones|mesh-ancestor
110110205|NCT01837433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110110206|NCT01837433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110110207|NCT01837433|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110110208|NCT01837433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110110209|NCT01837446|Diphenhydramine|diphenhydramine|mesh-list
110110210|NCT01837446|Promethazine|promethazine|mesh-list
110110211|NCT01837446|Lidocaine|lidocaine|mesh-list
110110212|NCT01837446|Morphine|morphine|mesh-list
110110213|NCT01837446|Aluminum Hydroxide|aluminum hydroxide|mesh-list
110110214|NCT01837446|Aluminum hydroxide, magnesium hydroxide, drug combination|aluminum hydroxide, magnesium hydroxide, drug combination|mesh-list
110110215|NCT01837446|Anesthetics, Local|anesthetics, local|mesh-ancestor
110110216|NCT01837446|Anesthetics|anesthetics|mesh-ancestor
110110217|NCT01837446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110110218|NCT01837446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110110219|NCT01837446|Sensory System Agents|sensory system agents|mesh-ancestor
110110220|NCT01837446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110110221|NCT01837446|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110110222|NCT01837446|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110110223|NCT01837446|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110110224|NCT01837446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110219132|NCT00110448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110110225|NCT01837446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110110226|NCT01837446|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110110227|NCT01837446|Narcotics|narcotics|mesh-ancestor
110110228|NCT01837446|Analgesics|analgesics|mesh-ancestor
110110229|NCT01837446|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110110230|NCT01837446|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110110231|NCT01837446|Antiemetics|antiemetics|mesh-ancestor
110110232|NCT01837446|Autonomic Agents|autonomic agents|mesh-ancestor
110110233|NCT01837446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110110234|NCT01837446|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110110235|NCT01837446|Histamine Antagonists|histamine antagonists|mesh-ancestor
110110236|NCT01837446|Histamine Agents|histamine agents|mesh-ancestor
110110237|NCT01837446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110110238|NCT01837446|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110110239|NCT01837446|Antipruritics|antipruritics|mesh-ancestor
110110240|NCT01837446|Dermatologic Agents|dermatologic agents|mesh-ancestor
110110241|NCT01837446|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110402173|NCT05960708|Omalizumab|omalizumab|mesh-list
110402174|NCT05960708|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110402175|NCT05960708|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110402176|NCT05960708|Respiratory System Agents|respiratory system agents|mesh-ancestor
110402177|NCT05959044|Folic Acid|folic acid|mesh-list
110110243|NCT01837446|Antacids|antacids|mesh-ancestor
110110244|NCT01838850|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
110110245|NCT01838850|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110110246|NCT01838850|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110110247|NCT01838850|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110110248|NCT01838850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110110249|NCT01839344|Acarbose|acarbose|mesh-list
110110250|NCT01839344|Quercetin|quercetin|mesh-list
110110251|NCT01839344|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
110110252|NCT01839344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110110253|NCT01839344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110110254|NCT01839344|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110110255|NCT01839344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110110256|NCT01839344|Antioxidants|antioxidants|mesh-ancestor
110110257|NCT01839344|Protective Agents|protective agents|mesh-ancestor
110110258|NCT01839578|Heparin|heparin|mesh-list
110110259|NCT01839578|Calcium heparin|calcium heparin|mesh-list
110110260|NCT01839578|Anticoagulants|anticoagulants|mesh-ancestor
110110261|NCT01839578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110110262|NCT01839578|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110110263|NCT01839578|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110110264|NCT01839994|Androgens|androgens|mesh-list
110110265|NCT01839994|Hormones|hormones|mesh-ancestor
110110266|NCT01839994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110110267|NCT01839994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110110268|NCT01840189|Hydrocortisone|hydrocortisone|mesh-list
110110269|NCT01840189|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
110110270|NCT01840189|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
110110271|NCT01840189|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
110110272|NCT01840189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110110273|NCT01840254|Dexmedetomidine|dexmedetomidine|mesh-list
110110274|NCT01840254|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110110275|NCT01840254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110110276|NCT01840254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110110277|NCT01840254|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110110278|NCT01840254|Analgesics|analgesics|mesh-ancestor
110110279|NCT01840254|Sensory System Agents|sensory system agents|mesh-ancestor
110110280|NCT01840254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110110281|NCT01840254|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110110282|NCT01840254|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110110283|NCT01840254|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110110284|NCT01840254|Adrenergic Agents|adrenergic agents|mesh-ancestor
110110285|NCT01840254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110110286|NCT01840254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110110287|NCT01840384|Micronutrients|micronutrients|mesh-list
110110288|NCT01840384|Trace Elements|trace elements|mesh-list
110110289|NCT01840384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110110290|NCT01840423|Levodopa|levodopa|mesh-list
110110291|NCT01840423|Carbidopa|carbidopa|mesh-list
110110292|NCT01840423|Entacapone|entacapone|mesh-list
110110293|NCT01840423|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110110294|NCT01840423|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110110295|NCT01840423|Dopamine Agents|dopamine agents|mesh-ancestor
110110296|NCT01840423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110110297|NCT01840423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110110298|NCT01840423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110110299|NCT01840423|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
110110300|NCT01840423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110110301|NCT01840423|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
110110302|NCT01840449|Lanreotide|lanreotide|mesh-list
110110303|NCT01840449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110110304|NCT01840683|Heparin|heparin|mesh-list
110110305|NCT01840683|Anticoagulants|anticoagulants|mesh-ancestor
110110306|NCT01840683|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110110307|NCT01840683|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110110308|NCT01840683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110110309|NCT01840696|Regadenoson|regadenoson|mesh-list
110110310|NCT01840696|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
110110311|NCT01840696|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
110110312|NCT01840696|Purinergic Agonists|purinergic agonists|mesh-ancestor
110110313|NCT01840696|Purinergic Agents|purinergic agents|mesh-ancestor
110110314|NCT01840696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110110315|NCT01840696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110110316|NCT01840696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110110317|NCT01840774|Ketamine|ketamine|mesh-list
110110318|NCT01840774|Analgesics|analgesics|mesh-list
110110319|NCT01840774|Sensory System Agents|sensory system agents|mesh-ancestor
110110320|NCT01840774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110110321|NCT01840774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110110322|NCT01840774|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110110323|NCT01840774|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110110324|NCT01840774|Anesthetics, General|anesthetics, general|mesh-ancestor
110110326|NCT01840774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110110327|NCT01840774|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110110328|NCT01840774|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110110329|NCT01840774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110110330|NCT01840774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110110331|NCT01840800|Ropivacaine|ropivacaine|mesh-list
110110332|NCT01840800|Anesthetics, Local|anesthetics, local|mesh-ancestor
110110333|NCT01840800|Anesthetics|anesthetics|mesh-ancestor
110110334|NCT01840800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110110335|NCT01840800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110110336|NCT01840800|Sensory System Agents|sensory system agents|mesh-ancestor
110110337|NCT01840800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110110338|NCT01840813|Misoprostol|misoprostol|mesh-list
110110339|NCT01840813|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110110341|NCT01840813|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110110342|NCT01840813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110110343|NCT01840813|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110110344|NCT01840813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110110345|NCT01840813|Oxytocics|oxytocics|mesh-ancestor
110110346|NCT01841008|Tacrolimus|tacrolimus|mesh-list
110110347|NCT01841008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110110348|NCT01841008|Immunologic Factors|immunologic factors|mesh-ancestor
110110349|NCT01841008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110110350|NCT01841008|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110110351|NCT01841008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110110352|NCT01841008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110110353|NCT01841099|Mesalamine|mesalamine|mesh-list
110110354|NCT01841099|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110110355|NCT01841099|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110110356|NCT01841099|Analgesics|analgesics|mesh-ancestor
110110357|NCT01841099|Sensory System Agents|sensory system agents|mesh-ancestor
110110358|NCT01841099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110110359|NCT01841099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110110360|NCT01841099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110110361|NCT01841099|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110110362|NCT01841112|BI 409306|bi 409306|mesh-list
110110363|NCT01841112|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110110364|NCT01841112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110110365|NCT01841112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110110366|NCT01841125|Escitalopram|escitalopram|mesh-list
110110367|NCT01841125|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110110368|NCT01841125|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110110369|NCT01841125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110110370|NCT01841125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110110371|NCT01841125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110110372|NCT01841125|Serotonin Agents|serotonin agents|mesh-ancestor
110110373|NCT01841125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110110374|NCT01841164|Montelukast|montelukast|mesh-list
110110375|NCT01841164|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110110376|NCT01841164|Respiratory System Agents|respiratory system agents|mesh-ancestor
110110377|NCT01841164|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110110378|NCT01841164|Hormone Antagonists|hormone antagonists|mesh-ancestor
110110379|NCT01841164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110110380|NCT01841164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110110381|NCT01841164|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110110382|NCT01841164|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110110383|NCT01841164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110110384|NCT01841242|Chlorhexidine|chlorhexidine|mesh-list
110110385|NCT01841242|Povidone-Iodine|povidone-iodine|mesh-list
110110386|NCT01841242|Povidone|povidone|mesh-list
110110387|NCT01841242|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110110388|NCT01841242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110110389|NCT01841242|Disinfectants|disinfectants|mesh-ancestor
110110390|NCT01841242|Plasma Substitutes|plasma substitutes|mesh-ancestor
110110391|NCT01841242|Blood Substitutes|blood substitutes|mesh-ancestor
110110392|NCT01841294|Lidocaine|lidocaine|mesh-list
110110393|NCT01841294|Anesthetics, Local|anesthetics, local|mesh-ancestor
110110394|NCT01841294|Anesthetics|anesthetics|mesh-ancestor
110110395|NCT01841294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110110396|NCT01841294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110110397|NCT01841294|Sensory System Agents|sensory system agents|mesh-ancestor
110110398|NCT01841294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110110399|NCT01841294|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110110400|NCT01841294|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110110401|NCT01841294|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110110402|NCT01841294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110110403|NCT01841294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110110404|NCT01841307|Cromolyn Sodium|cromolyn sodium|mesh-list
110110405|NCT01841307|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
110110407|NCT01841307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110110408|NCT01841307|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110110409|NCT01841307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110110410|NCT01841307|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110110411|NCT01841307|Respiratory System Agents|respiratory system agents|mesh-ancestor
110110412|NCT01841320|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
110110413|NCT01841320|Methadone|methadone|mesh-list
110110414|NCT01841320|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110110415|NCT01841320|Narcotics|narcotics|mesh-ancestor
110110416|NCT01841320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110110417|NCT01841320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110110418|NCT01841320|Analgesics|analgesics|mesh-ancestor
110110419|NCT01841320|Sensory System Agents|sensory system agents|mesh-ancestor
110110420|NCT01841320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110110421|NCT01841320|Antitussive Agents|antitussive agents|mesh-ancestor
110110422|NCT01841320|Respiratory System Agents|respiratory system agents|mesh-ancestor
110110423|NCT01841320|Antiviral Agents|antiviral agents|mesh-ancestor
110110424|NCT01841320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110110425|NCT01841411|Metronidazole|metronidazole|mesh-list
110110426|NCT01841411|Acetylcysteine|acetylcysteine|mesh-list
110110427|NCT01841411|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110110428|NCT01841411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110110429|NCT01841411|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110110430|NCT01841411|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110110431|NCT01841411|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110110432|NCT01841411|Antiviral Agents|antiviral agents|mesh-ancestor
110110433|NCT01841411|Expectorants|expectorants|mesh-ancestor
110110434|NCT01841411|Respiratory System Agents|respiratory system agents|mesh-ancestor
110110435|NCT01841411|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110110436|NCT01841411|Antioxidants|antioxidants|mesh-ancestor
110110437|NCT01841411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110110438|NCT01841411|Protective Agents|protective agents|mesh-ancestor
110110439|NCT01841411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110110440|NCT01841411|Antidotes|antidotes|mesh-ancestor
110110441|NCT01841424|Benzocaine|benzocaine|mesh-list
110110442|NCT01841424|Anesthetics, Local|anesthetics, local|mesh-ancestor
110110443|NCT01841424|Anesthetics|anesthetics|mesh-ancestor
110110444|NCT01841424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110110445|NCT01841424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110110446|NCT01841424|Sensory System Agents|sensory system agents|mesh-ancestor
110237451|NCT00093509|Alkylating Agents|alkylating agents|mesh-ancestor
110110447|NCT01841424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110402210|NCT05943691|Hormones|hormones|mesh-ancestor
110110448|NCT01841463|Vemurafenib|vemurafenib|mesh-list
110110449|NCT01841463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110110450|NCT01841463|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110110451|NCT01841463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110110452|NCT01841463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110110453|NCT01841502|Paroxetine|paroxetine|mesh-list
110110454|NCT01841502|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110110455|NCT01841502|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110110456|NCT01841502|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110110457|NCT01841502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110110458|NCT01841502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110110459|NCT01841502|Serotonin Agents|serotonin agents|mesh-ancestor
110110460|NCT01841502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110110461|NCT01841502|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110110462|NCT01841502|Antidepressive Agents|antidepressive agents|mesh-ancestor
110110463|NCT01841502|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110110464|NCT01841502|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110110465|NCT01841502|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110110466|NCT01841502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110110467|NCT01841515|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
110110468|NCT01841515|Hemostatics|hemostatics|mesh-ancestor
110110469|NCT01841515|Coagulants|coagulants|mesh-ancestor
110110470|NCT01841515|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
110110472|NCT01841515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110110473|NCT01841658|Folic Acid|folic acid|mesh-list
110110474|NCT01841658|Hematinics|hematinics|mesh-ancestor
110110475|NCT01841658|Vitamin B Complex|vitamin b complex|mesh-ancestor
110110476|NCT01841658|Vitamins|vitamins|mesh-ancestor
110110477|NCT01841658|Micronutrients|micronutrients|mesh-ancestor
110110478|NCT01841658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110110479|NCT01841684|Anacetrapib|anacetrapib|mesh-list
110110480|NCT01841684|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110110481|NCT01841684|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110110482|NCT01841684|Antimetabolites|antimetabolites|mesh-ancestor
110110483|NCT01841684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110110484|NCT01841684|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110110485|NCT01841775|Interferons|interferons|mesh-list
110110486|NCT01841775|Ribavirin|ribavirin|mesh-list
110110487|NCT01841775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110110488|NCT01841775|Antiviral Agents|antiviral agents|mesh-ancestor
110110489|NCT01841775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110110490|NCT01841775|Antimetabolites|antimetabolites|mesh-ancestor
110110491|NCT01841775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110110493|NCT01841827|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110110494|NCT01841827|Autonomic Agents|autonomic agents|mesh-ancestor
110110495|NCT01841827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110110496|NCT01841827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110110497|NCT01841827|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110110498|NCT01841827|Respiratory System Agents|respiratory system agents|mesh-ancestor
110110499|NCT01841827|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110110500|NCT01841827|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110110501|NCT01841827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110110502|NCT01841827|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110110503|NCT01841827|Vasodilator Agents|vasodilator agents|mesh-ancestor
110110504|NCT01841827|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110110505|NCT01841827|Protective Agents|protective agents|mesh-ancestor
110110506|NCT01841827|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110110507|NCT01841827|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110110508|NCT01841827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110110509|NCT01841996|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110110510|NCT01842074|Bortezomib|bortezomib|mesh-list
110110511|NCT01842074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110110512|NCT01842087|Iproplatin|iproplatin|mesh-list
110219214|NCT00284947|Basiliximab|basiliximab|mesh-list
110110513|NCT01842087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110110514|NCT01842100|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110110515|NCT01842100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110110516|NCT01842113|Rifaximin|rifaximin|mesh-list
110110517|NCT01842113|Lactulose|lactulose|mesh-list
110110518|NCT01842113|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110110519|NCT01842113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110110520|NCT01842113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110110521|NCT01842139|Poly I-C|poly i-c|mesh-list
110110522|NCT01842139|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
110110523|NCT01842139|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
110110524|NCT01842139|Poly ICLC|poly iclc|mesh-list
110110525|NCT01842139|Basiliximab|basiliximab|mesh-list
110110526|NCT01842139|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110110527|NCT01842139|Immunologic Factors|immunologic factors|mesh-ancestor
110110528|NCT01842139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110110529|NCT01842139|Interferon Inducers|interferon inducers|mesh-ancestor
110110530|NCT01842139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110110531|NCT01842139|Laxatives|laxatives|mesh-ancestor
110110532|NCT01842139|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110110533|NCT01842139|Antiviral Agents|antiviral agents|mesh-ancestor
110260162|NCT00168870|Treosulfan|treosulfan|mesh-list
110110534|NCT01842139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110110535|NCT01842230|Niacin|niacin|mesh-list
110110536|NCT01842230|Amlodipine|amlodipine|mesh-list
110110537|NCT01842230|Telmisartan|telmisartan|mesh-list
110110538|NCT01842230|Atorvastatin|atorvastatin|mesh-list
110110539|NCT01842230|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110110540|NCT01842230|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110110541|NCT01842230|Antimetabolites|antimetabolites|mesh-ancestor
110110542|NCT01842230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110110543|NCT01842230|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110110544|NCT01842230|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110110545|NCT01842230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110110546|NCT01842230|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110110547|NCT01842230|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110110548|NCT01842230|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110110549|NCT01842230|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110110550|NCT01842230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110110551|NCT01842230|Vasodilator Agents|vasodilator agents|mesh-ancestor
110402246|NCT05931575|Fasudil|fasudil|mesh-list
110110552|NCT01842230|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110110553|NCT01842230|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110110554|NCT01842230|Vitamin B Complex|vitamin b complex|mesh-ancestor
110110555|NCT01842230|Vitamins|vitamins|mesh-ancestor
110110556|NCT01842230|Micronutrients|micronutrients|mesh-ancestor
110110557|NCT01842256|Amlodipine|amlodipine|mesh-list
110110558|NCT01842256|Telmisartan|telmisartan|mesh-list
110110559|NCT01842256|Atorvastatin|atorvastatin|mesh-list
110110560|NCT01842256|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110110561|NCT01842256|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110110562|NCT01842256|Antimetabolites|antimetabolites|mesh-ancestor
110110563|NCT01842256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110110564|NCT01842256|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110110565|NCT01842256|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110110566|NCT01842256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110110567|NCT01842256|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110110568|NCT01842256|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110110569|NCT01842256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110110570|NCT01842256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110110571|NCT01842256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110110572|NCT01842256|Vasodilator Agents|vasodilator agents|mesh-ancestor
110110573|NCT01842256|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110110574|NCT01842256|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110110575|NCT01842269|Mycophenolic Acid|mycophenolic acid|mesh-list
110219222|NCT00284947|Antiemetics|antiemetics|mesh-ancestor
110219223|NCT00284947|Autonomic Agents|autonomic agents|mesh-ancestor
110110576|NCT01842269|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110110577|NCT01842269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110110578|NCT01842269|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110110579|NCT01842269|Antitubercular Agents|antitubercular agents|mesh-ancestor
110110580|NCT01842269|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110110581|NCT01842269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110110582|NCT01842269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110110583|NCT01842269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110110584|NCT01842321|Abiraterone Acetate|abiraterone acetate|mesh-list
110110585|NCT01842321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110110586|NCT01842321|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110110587|NCT01842321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110110588|NCT01842321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110110589|NCT01842321|Hormone Antagonists|hormone antagonists|mesh-ancestor
110110590|NCT01842321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110110591|NCT01842321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110110592|NCT01842321|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110110593|NCT01842373|Lidocaine|lidocaine|mesh-list
110110594|NCT01842373|Tetracaine|tetracaine|mesh-list
110110595|NCT01842373|Benzocaine|benzocaine|mesh-list
110110596|NCT01842373|Anesthetics, Local|anesthetics, local|mesh-ancestor
110110597|NCT01842373|Anesthetics|anesthetics|mesh-ancestor
110110598|NCT01842373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110110599|NCT01842373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110110600|NCT01842373|Sensory System Agents|sensory system agents|mesh-ancestor
110110601|NCT01842373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110110602|NCT01842373|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110110603|NCT01842373|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110402262|NCT05931575|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110402263|NCT05931575|Vasodilator Agents|vasodilator agents|mesh-ancestor
110402264|NCT05931575|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110402265|NCT05931575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110402267|NCT05927714|Coagulants|coagulants|mesh-ancestor
110110604|NCT01842373|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110110605|NCT01842373|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110110606|NCT01842373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110110607|NCT01842516|Delpazolid|delpazolid|mesh-list
110110608|NCT01842516|Oxazolidinones|oxazolidinones|mesh-list
110110609|NCT01842516|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110110610|NCT01842516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110110611|NCT01842516|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110110612|NCT01842516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110219235|NCT00110682|Interferon Inducers|interferon inducers|mesh-ancestor
110110613|NCT01842516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110110614|NCT01842529|Botulinum Toxins|botulinum toxins|mesh-list
110110615|NCT01842529|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110110616|NCT01842529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110110617|NCT01842529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110110618|NCT01842529|Cholinergic Agents|cholinergic agents|mesh-ancestor
110110619|NCT01842529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110110620|NCT01842529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110110621|NCT01842893|Fentanyl|fentanyl|mesh-list
110110622|NCT01842893|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110110623|NCT01842893|Narcotics|narcotics|mesh-ancestor
110110624|NCT01842893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110110625|NCT01842893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110110626|NCT01842893|Analgesics|analgesics|mesh-ancestor
110110627|NCT01842893|Sensory System Agents|sensory system agents|mesh-ancestor
110110628|NCT01842893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110110629|NCT01842893|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110110630|NCT01842893|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110110631|NCT01842893|Anesthetics, General|anesthetics, general|mesh-ancestor
110110632|NCT01842893|Anesthetics|anesthetics|mesh-ancestor
110110633|NCT01842932|Bromides|bromides|mesh-list
110110634|NCT01842932|Cholinergic Antagonists|cholinergic antagonists|mesh-list
110110635|NCT01842932|Cimetropium|cimetropium|mesh-list
110110636|NCT01842932|Anticonvulsants|anticonvulsants|mesh-ancestor
110110637|NCT01842932|Cholinergic Agents|cholinergic agents|mesh-ancestor
110110638|NCT01842932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110110639|NCT01842932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110110640|NCT01842932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110110641|NCT01842932|Parasympatholytics|parasympatholytics|mesh-ancestor
110110642|NCT01842932|Autonomic Agents|autonomic agents|mesh-ancestor
110110643|NCT01842932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110110644|NCT01843010|Parecoxib|parecoxib|mesh-list
110110645|NCT01843010|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110110646|NCT01843010|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110110647|NCT01843010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110110648|NCT01843010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110110649|NCT01843010|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110110650|NCT01843010|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110110651|NCT01843010|Analgesics|analgesics|mesh-ancestor
110110652|NCT01843010|Sensory System Agents|sensory system agents|mesh-ancestor
110110653|NCT01843010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110110654|NCT01843010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110110655|NCT01843010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110110656|NCT01843010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110110657|NCT01843075|Liraglutide|liraglutide|mesh-list
110110658|NCT01843075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110110659|NCT01843075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110402296|NCT05907525|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110402297|NCT05907525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110402298|NCT05907525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110402299|NCT05907525|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110402300|NCT05907525|Anesthetics, General|anesthetics, general|mesh-ancestor
110402301|NCT05907525|Anesthetics|anesthetics|mesh-ancestor
110110660|NCT01843075|Incretins|incretins|mesh-ancestor
110110661|NCT01843075|Hormones|hormones|mesh-ancestor
110110662|NCT01843075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110110663|NCT01843088|Mannitol|mannitol|mesh-list
110110664|NCT01843088|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110110665|NCT01843088|Diuretics|diuretics|mesh-ancestor
110110666|NCT01843088|Natriuretic Agents|natriuretic agents|mesh-ancestor
110110667|NCT01843088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110110668|NCT01843127|Exenatide|exenatide|mesh-list
110110669|NCT01843127|Ranolazine|ranolazine|mesh-list
110110670|NCT01843127|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110110671|NCT01843127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110110672|NCT01843127|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110110673|NCT01843127|Incretins|incretins|mesh-ancestor
110110674|NCT01843127|Hormones|hormones|mesh-ancestor
110110675|NCT01843127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110110676|NCT01843127|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110110677|NCT01843127|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110110678|NCT01843127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110110679|NCT01843153|Ropivacaine|ropivacaine|mesh-list
110110680|NCT01843153|Anesthetics, Local|anesthetics, local|mesh-ancestor
110110681|NCT01843153|Anesthetics|anesthetics|mesh-ancestor
110110682|NCT01843153|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110110683|NCT01843153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110110684|NCT01843153|Sensory System Agents|sensory system agents|mesh-ancestor
110110685|NCT01843153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110110686|NCT01843166|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
110110687|NCT01843166|Estrogens|estrogens|mesh-ancestor
110110688|NCT01843166|Hormones|hormones|mesh-ancestor
110110689|NCT01843166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110110690|NCT01843166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110110691|NCT01843179|Cytarabine|cytarabine|mesh-list
110110692|NCT01843179|Sulindac|sulindac|mesh-list
110110693|NCT01843179|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110110694|NCT01843179|Antimetabolites|antimetabolites|mesh-ancestor
110110695|NCT01843179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110110696|NCT01843179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110110698|NCT01843179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110110699|NCT01843179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110110700|NCT01843179|Immunologic Factors|immunologic factors|mesh-ancestor
110110701|NCT01843179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110110702|NCT01843179|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110110703|NCT01843179|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110219292|NCT00285298|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110219307|NCT00077363|Tipifarnib|tipifarnib|mesh-list
110110704|NCT01843179|Analgesics|analgesics|mesh-ancestor
110110705|NCT01843179|Sensory System Agents|sensory system agents|mesh-ancestor
110110706|NCT01843179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110110707|NCT01843179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110110708|NCT01843179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110110709|NCT01843179|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110110710|NCT01843179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110110712|NCT01843257|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110110713|NCT01843257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110110714|NCT01843257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110110715|NCT01843257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110110716|NCT01843296|Magnesium Sulfate|magnesium sulfate|mesh-list
110110717|NCT01843296|Fentanyl|fentanyl|mesh-list
110110718|NCT01843296|Bupivacaine|bupivacaine|mesh-list
110110719|NCT01843296|Anesthetics, Local|anesthetics, local|mesh-ancestor
110402302|NCT05906732|Dofetilide|dofetilide|mesh-list
110402303|NCT05906732|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110402304|NCT05906732|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
110402305|NCT05906732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110402306|NCT05906732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110402307|NCT05900284|Metformin|metformin|mesh-list
110402308|NCT05900284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110402309|NCT05900284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110110720|NCT01843296|Anesthetics|anesthetics|mesh-ancestor
110110721|NCT01843296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110110722|NCT01843296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110110723|NCT01843296|Sensory System Agents|sensory system agents|mesh-ancestor
110110724|NCT01843296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110110725|NCT01843296|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110110726|NCT01843296|Narcotics|narcotics|mesh-ancestor
110110727|NCT01843296|Analgesics|analgesics|mesh-ancestor
110110728|NCT01843296|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110110729|NCT01843296|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110110730|NCT01843296|Anesthetics, General|anesthetics, general|mesh-ancestor
110110731|NCT01843296|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110110732|NCT01843296|Anticonvulsants|anticonvulsants|mesh-ancestor
110110733|NCT01843296|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110110734|NCT01843296|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110110735|NCT01843296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110110736|NCT01843296|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110110737|NCT01843296|Tocolytic Agents|tocolytic agents|mesh-ancestor
110110738|NCT01843296|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110110739|NCT01843309|Spironolactone|spironolactone|mesh-list
110110740|NCT01843309|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110110741|NCT01843309|Hormone Antagonists|hormone antagonists|mesh-ancestor
110110742|NCT01843309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110110743|NCT01843309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110110744|NCT01843309|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110110745|NCT01843309|Diuretics|diuretics|mesh-ancestor
110110746|NCT01843309|Natriuretic Agents|natriuretic agents|mesh-ancestor
110110748|NCT01843439|Vitamin B Complex|vitamin b complex|mesh-ancestor
110110749|NCT01843439|Vitamins|vitamins|mesh-ancestor
110110750|NCT01843439|Micronutrients|micronutrients|mesh-ancestor
110110751|NCT01843439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110402322|NCT05891119|Vitamin K|vitamin k|mesh-list
110402323|NCT05891119|Metoprolol|metoprolol|mesh-list
110402324|NCT05891119|Midazolam|midazolam|mesh-list
110402325|NCT05891119|Caffeine|caffeine|mesh-list
110110752|NCT01843452|Capecitabine|capecitabine|mesh-list
110110753|NCT01843452|Mitomycins|mitomycins|mesh-list
110110754|NCT01843452|Mitomycin|mitomycin|mesh-list
110110755|NCT01843452|Panitumumab|panitumumab|mesh-list
110110756|NCT01843452|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110110757|NCT01843452|Antimetabolites|antimetabolites|mesh-ancestor
110110758|NCT01843452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110110759|NCT01843452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110110760|NCT01843452|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110110761|NCT01843452|Alkylating Agents|alkylating agents|mesh-ancestor
110110762|NCT01843452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110110763|NCT01843452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110110764|NCT01843452|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110110765|NCT01843530|Cortisone|cortisone|mesh-list
110110766|NCT01843530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110110767|NCT01843647|Cisplatin|cisplatin|mesh-list
110110768|NCT01843647|Vinorelbine|vinorelbine|mesh-list
110110769|NCT01843647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110110770|NCT01843647|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110110771|NCT01843647|Tubulin Modulators|tubulin modulators|mesh-ancestor
110110772|NCT01843647|Antimitotic Agents|antimitotic agents|mesh-ancestor
110110773|NCT01843647|Mitosis Modulators|mitosis modulators|mesh-ancestor
110110774|NCT01843647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110110775|NCT01843699|Topiramate|topiramate|mesh-list
110110776|NCT01843699|Anticonvulsants|anticonvulsants|mesh-ancestor
110110777|NCT01843699|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110110778|NCT01843699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110110779|NCT01843725|Capecitabine|capecitabine|mesh-list
110110780|NCT01843725|Aflibercept|aflibercept|mesh-list
110110781|NCT01843725|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110110782|NCT01843725|Antimetabolites|antimetabolites|mesh-ancestor
110110783|NCT01843725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110110784|NCT01843725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110110785|NCT01843725|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110110786|NCT01843725|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110110787|NCT01843725|Growth Substances|growth substances|mesh-ancestor
110162261|NCT00007358|Glucocorticoids|glucocorticoids|mesh-ancestor
110110788|NCT01843725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110110789|NCT01843725|Growth Inhibitors|growth inhibitors|mesh-ancestor
110110790|NCT01843738|Vemurafenib|vemurafenib|mesh-list
110110791|NCT01843738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110110792|NCT01843738|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110110793|NCT01843738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110110794|NCT01843738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110110795|NCT01843829|Paclitaxel|paclitaxel|mesh-list
110110796|NCT01843829|Carboplatin|carboplatin|mesh-list
110219346|NCT00285805|Amiloride|amiloride|mesh-list
110110797|NCT01843829|Capecitabine|capecitabine|mesh-list
110110798|NCT01843829|Oxaliplatin|oxaliplatin|mesh-list
110402364|NCT05891119|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110402365|NCT05891119|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110402366|NCT05891119|Hemostatics|hemostatics|mesh-ancestor
110402367|NCT05891119|Coagulants|coagulants|mesh-ancestor
110402368|NCT05890586|Fluvoxamine|fluvoxamine|mesh-list
110402369|NCT05890586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110110799|NCT01843829|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110110800|NCT01843829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110110801|NCT01843829|Tubulin Modulators|tubulin modulators|mesh-ancestor
110110802|NCT01843829|Antimitotic Agents|antimitotic agents|mesh-ancestor
110110803|NCT01843829|Mitosis Modulators|mitosis modulators|mesh-ancestor
110110804|NCT01843829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110110805|NCT01843829|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110110806|NCT01843829|Antimetabolites|antimetabolites|mesh-ancestor
110110807|NCT01843868|Prednisolone|prednisolone|mesh-list
110110808|NCT01843868|Cyclophosphamide|cyclophosphamide|mesh-list
110110809|NCT01843868|Doxorubicin|doxorubicin|mesh-list
110110810|NCT01843868|Vincristine|vincristine|mesh-list
110110811|NCT01843868|Lorazepam|lorazepam|mesh-list
110110812|NCT01843868|Ondansetron|ondansetron|mesh-list
110110813|NCT01843868|Aprepitant|aprepitant|mesh-list
110110814|NCT01843868|Metoclopramide|metoclopramide|mesh-list
110110815|NCT01843868|Palonosetron|palonosetron|mesh-list
110110816|NCT01843868|Granisetron|granisetron|mesh-list
110110817|NCT01843868|Prochlorperazine|prochlorperazine|mesh-list
110110818|NCT01843868|Tropisetron|tropisetron|mesh-list
110110819|NCT01843868|Antiemetics|antiemetics|mesh-list
110110820|NCT01843868|Emetics|emetics|mesh-list
110110821|NCT01843868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110110822|NCT01843868|Immunologic Factors|immunologic factors|mesh-ancestor
110110823|NCT01843868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110110824|NCT01843868|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110110825|NCT01843868|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110110826|NCT01843868|Alkylating Agents|alkylating agents|mesh-ancestor
110110827|NCT01843868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110110828|NCT01843868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110110829|NCT01843868|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110110830|NCT01843868|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110110831|NCT01843868|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110110832|NCT01843868|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110110833|NCT01843868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110110834|NCT01843868|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110110835|NCT01843868|Tubulin Modulators|tubulin modulators|mesh-ancestor
110110836|NCT01843868|Antimitotic Agents|antimitotic agents|mesh-ancestor
110110837|NCT01843868|Mitosis Modulators|mitosis modulators|mesh-ancestor
110110838|NCT01843868|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110110839|NCT01843868|Glucocorticoids|glucocorticoids|mesh-ancestor
110110840|NCT01843868|Hormones|hormones|mesh-ancestor
110219363|NCT00077441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110219364|NCT00285883|Saquinavir|saquinavir|mesh-list
110219365|NCT00285883|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110110841|NCT01843868|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110110842|NCT01843868|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110110843|NCT01843868|Autonomic Agents|autonomic agents|mesh-ancestor
110110844|NCT01843868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110110845|NCT01843868|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110110846|NCT01843868|Antipruritics|antipruritics|mesh-ancestor
110110847|NCT01843868|Dermatologic Agents|dermatologic agents|mesh-ancestor
110110848|NCT01843868|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110110849|NCT01843868|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110110850|NCT01843868|Serotonin Agents|serotonin agents|mesh-ancestor
110110851|NCT01843868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110110852|NCT01843868|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110110853|NCT01843868|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110110854|NCT01843868|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110110855|NCT01843868|Dopamine Agents|dopamine agents|mesh-ancestor
110110856|NCT01843868|Anticonvulsants|anticonvulsants|mesh-ancestor
110110857|NCT01843868|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110110858|NCT01843868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110110859|NCT01843868|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110110860|NCT01843868|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110110861|NCT01843868|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110110862|NCT01843868|GABA Modulators|gaba modulators|mesh-ancestor
110110863|NCT01843868|GABA Agents|gaba agents|mesh-ancestor
110110864|NCT01843868|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110110866|NCT01843998|Temsirolimus|temsirolimus|mesh-list
110110867|NCT01843998|MTOR Inhibitors|mtor inhibitors|mesh-list
110110868|NCT01843998|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110110869|NCT01843998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110110870|NCT01843998|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110110871|NCT01843998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110110872|NCT01843998|Antifungal Agents|antifungal agents|mesh-ancestor
110110873|NCT01843998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110110874|NCT01843998|Immunologic Factors|immunologic factors|mesh-ancestor
110110875|NCT01843998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110110876|NCT01843998|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110110877|NCT01843998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110110878|NCT01843998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110110879|NCT01844024|Misoprostol|misoprostol|mesh-list
110110880|NCT01844024|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110110881|NCT01844024|Abortifacient Agents|abortifacient agents|mesh-ancestor
110110882|NCT01844024|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110110883|NCT01844024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110110884|NCT01844024|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110110885|NCT01844024|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110110886|NCT01844024|Oxytocics|oxytocics|mesh-ancestor
110110887|NCT01844063|Antiviral Agents|antiviral agents|mesh-list
110110888|NCT01844063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110110889|NCT01844141|Ethanol|ethanol|mesh-list
110110890|NCT01844141|Chlorhexidine|chlorhexidine|mesh-list
110110891|NCT01844141|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110110892|NCT01844141|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110110893|NCT01844141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110110894|NCT01844141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110110895|NCT01844141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110110896|NCT01844141|Disinfectants|disinfectants|mesh-ancestor
110110897|NCT01844141|Dermatologic Agents|dermatologic agents|mesh-ancestor
110110898|NCT01844323|Palbociclib|palbociclib|mesh-list
110110899|NCT01844323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110110900|NCT01844323|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110219391|NCT00286117|Hormone Antagonists|hormone antagonists|mesh-ancestor
110110901|NCT01844323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110110902|NCT01844323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110110903|NCT01844401|Albuterol|albuterol|mesh-list
110110904|NCT01844401|Procaterol|procaterol|mesh-list
110110905|NCT01844401|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110110906|NCT01844401|Autonomic Agents|autonomic agents|mesh-ancestor
110110907|NCT01844401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110110908|NCT01844401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110110909|NCT01844401|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110110910|NCT01844401|Respiratory System Agents|respiratory system agents|mesh-ancestor
110110911|NCT01844401|Tocolytic Agents|tocolytic agents|mesh-ancestor
110110912|NCT01844401|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110110913|NCT01844401|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110110914|NCT01844401|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110110915|NCT01844401|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110110916|NCT01844401|Adrenergic Agents|adrenergic agents|mesh-ancestor
110110917|NCT01844401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110110918|NCT01844401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110110919|NCT01844401|Sympathomimetics|sympathomimetics|mesh-ancestor
110110920|NCT01844427|Memantine|memantine|mesh-list
110110921|NCT01844427|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110110922|NCT01844427|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110110923|NCT01844427|Dopamine Agents|dopamine agents|mesh-ancestor
110110924|NCT01844427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110110925|NCT01844427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110110926|NCT01844427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110110927|NCT01844427|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110110928|NCT01844427|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110110930|NCT01844622|Antiemetics|antiemetics|mesh-ancestor
110110931|NCT01844622|Autonomic Agents|autonomic agents|mesh-ancestor
110110932|NCT01844622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110110933|NCT01844622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110110934|NCT01844622|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110110935|NCT01844622|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110110936|NCT01844622|Dopamine Agents|dopamine agents|mesh-ancestor
110110937|NCT01844622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110110938|NCT01844622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110110939|NCT01844635|Thymoglobulin|thymoglobulin|mesh-list
110110940|NCT01844635|Immunologic Factors|immunologic factors|mesh-ancestor
110110941|NCT01844635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110110942|NCT01844635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110110944|NCT01844648|Mydriatics|mydriatics|mesh-ancestor
110110945|NCT01844648|Autonomic Agents|autonomic agents|mesh-ancestor
110110946|NCT01844648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110110947|NCT01844648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110110948|NCT01844648|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110110949|NCT01844648|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110110950|NCT01844648|Cholinergic Agents|cholinergic agents|mesh-ancestor
110110951|NCT01844648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110110952|NCT01844648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110110953|NCT01844674|Vemurafenib|vemurafenib|mesh-list
110110954|NCT01844674|Tizanidine|tizanidine|mesh-list
110110955|NCT01844674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110110956|NCT01844674|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110110957|NCT01844674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110110958|NCT01844674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110110959|NCT01844674|Analgesics|analgesics|mesh-ancestor
110110960|NCT01844674|Sensory System Agents|sensory system agents|mesh-ancestor
110110961|NCT01844674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110110962|NCT01844674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110110963|NCT01844674|Anticonvulsants|anticonvulsants|mesh-ancestor
110110964|NCT01844674|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110110965|NCT01844674|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110110966|NCT01844674|Parasympatholytics|parasympatholytics|mesh-ancestor
110110967|NCT01844674|Autonomic Agents|autonomic agents|mesh-ancestor
110110968|NCT01844674|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110110969|NCT01844674|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110110970|NCT01844674|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110110971|NCT01844674|Adrenergic Agents|adrenergic agents|mesh-ancestor
110110972|NCT01844674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110110973|NCT01844791|Pentamidine|pentamidine|mesh-list
110110974|NCT01844791|Gemcitabine|gemcitabine|mesh-list
110110975|NCT01844791|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110110976|NCT01844791|Antimetabolites|antimetabolites|mesh-ancestor
110110977|NCT01844791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110110978|NCT01844791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110110979|NCT01844791|Antifungal Agents|antifungal agents|mesh-ancestor
110110980|NCT01844791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110110981|NCT01844791|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110110982|NCT01844791|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110110983|NCT01844791|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
110110985|NCT01844804|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110110986|NCT01844804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110110987|NCT01844804|Dermatologic Agents|dermatologic agents|mesh-ancestor
110110988|NCT01844804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110110989|NCT01844804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110110990|NCT01844869|Homoharringtonine|homoharringtonine|mesh-list
110110991|NCT01844869|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110110992|NCT01844869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110110993|NCT01844869|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110110994|NCT01844869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110110995|NCT01844869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110110996|NCT01844947|Sorafenib|sorafenib|mesh-list
110402416|NCT05866055|GABA Agents|gaba agents|mesh-ancestor
110110998|NCT01844947|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110110999|NCT01844947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110111000|NCT01844947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110111001|NCT01845012|Dialysis Solutions|dialysis solutions|mesh-list
110111002|NCT01845012|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110111004|NCT01845038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110111005|NCT01845038|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110111007|NCT01845038|Adrenergic Agents|adrenergic agents|mesh-ancestor
110111008|NCT01845038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110111009|NCT01845038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110111010|NCT01845038|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110111011|NCT01845038|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110111012|NCT01845064|Kallikreins|kallikreins|mesh-list
110111013|NCT01845064|Coagulants|coagulants|mesh-ancestor
110111014|NCT01845064|Fertility Agents, Male|fertility agents, male|mesh-ancestor
110111015|NCT01845064|Fertility Agents|fertility agents|mesh-ancestor
110111016|NCT01845064|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110111017|NCT01845064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110111018|NCT01845090|Calcium Carbonate|calcium carbonate|mesh-list
110111020|NCT01845090|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110111021|NCT01845090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110111022|NCT01845090|Antacids|antacids|mesh-ancestor
110111023|NCT01845090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110111024|NCT01845090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110111025|NCT01845142|Vitamin D|vitamin d|mesh-list
110111026|NCT01845142|Cholecalciferol|cholecalciferol|mesh-list
110111027|NCT01845142|Vitamins|vitamins|mesh-ancestor
110111028|NCT01845142|Micronutrients|micronutrients|mesh-ancestor
110111029|NCT01845142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110111030|NCT01845142|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110111031|NCT01845142|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110111032|NCT01845194|Metoprolol|metoprolol|mesh-list
110111033|NCT01845194|Talinolol|talinolol|mesh-list
110111034|NCT01845194|Torsemide|torsemide|mesh-list
110111035|NCT01845194|Midazolam|midazolam|mesh-list
110111036|NCT01845194|Codeine|codeine|mesh-list
110111037|NCT01845194|Caffeine|caffeine|mesh-list
110111038|NCT01845194|Pravastatin|pravastatin|mesh-list
110111039|NCT01845194|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110111040|NCT01845194|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110111041|NCT01845194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110111042|NCT01845194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110111043|NCT01845194|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110111044|NCT01845194|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110111045|NCT01845194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110111046|NCT01845194|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110111047|NCT01845194|Anesthetics, General|anesthetics, general|mesh-ancestor
110111048|NCT01845194|Anesthetics|anesthetics|mesh-ancestor
110111049|NCT01845194|GABA Modulators|gaba modulators|mesh-ancestor
110111050|NCT01845194|GABA Agents|gaba agents|mesh-ancestor
110111051|NCT01845194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110111052|NCT01845194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110111053|NCT01845194|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110111054|NCT01845194|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110111055|NCT01845194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110111056|NCT01845194|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110111057|NCT01845194|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110111058|NCT01845194|Purinergic Agents|purinergic agents|mesh-ancestor
110111059|NCT01845194|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110111060|NCT01845194|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110111061|NCT01845194|Sympatholytics|sympatholytics|mesh-ancestor
110111062|NCT01845194|Autonomic Agents|autonomic agents|mesh-ancestor
110111063|NCT01845194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110402426|NCT05864625|Anesthetics|anesthetics|mesh-ancestor
110111064|NCT01845194|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110111065|NCT01845194|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110111066|NCT01845194|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110111067|NCT01845194|Adrenergic Agents|adrenergic agents|mesh-ancestor
110111068|NCT01845194|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110111069|NCT01845194|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110111070|NCT01845194|Antimetabolites|antimetabolites|mesh-ancestor
110111071|NCT01845194|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110111072|NCT01845194|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110111073|NCT01845194|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110111074|NCT01845194|Narcotics|narcotics|mesh-ancestor
110111075|NCT01845194|Analgesics|analgesics|mesh-ancestor
110111076|NCT01845194|Sensory System Agents|sensory system agents|mesh-ancestor
110111077|NCT01845194|Antitussive Agents|antitussive agents|mesh-ancestor
110111078|NCT01845194|Respiratory System Agents|respiratory system agents|mesh-ancestor
110111080|NCT01845194|Natriuretic Agents|natriuretic agents|mesh-ancestor
110111081|NCT01845194|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110111082|NCT01845194|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110111083|NCT01845246|Colistin|colistin|mesh-list
110111084|NCT01845246|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110111085|NCT01845246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110111086|NCT01845259|Liraglutide|liraglutide|mesh-list
110111087|NCT01845259|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110111088|NCT01845259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110111089|NCT01845259|Incretins|incretins|mesh-ancestor
110111090|NCT01845259|Hormones|hormones|mesh-ancestor
110111091|NCT01845259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110111092|NCT01845272|Amlodipine|amlodipine|mesh-list
110111093|NCT01845272|Candesartan|candesartan|mesh-list
110111095|NCT01845272|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110111096|NCT01845272|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110111097|NCT01845272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110111098|NCT01845272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110111099|NCT01845272|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110111100|NCT01845272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110111101|NCT01845272|Vasodilator Agents|vasodilator agents|mesh-ancestor
110111102|NCT01845272|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110111103|NCT01845272|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110111104|NCT01845298|Rifampin|rifampin|mesh-list
110111105|NCT01845298|Rifamycins|rifamycins|mesh-list
110111106|NCT01845298|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110111107|NCT01845298|Antitubercular Agents|antitubercular agents|mesh-ancestor
110111108|NCT01845298|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110111109|NCT01845298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110111110|NCT01845298|Leprostatic Agents|leprostatic agents|mesh-ancestor
110111111|NCT01845298|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110111112|NCT01845298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110111113|NCT01845298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110111114|NCT01845298|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110111115|NCT01845298|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110111116|NCT01845298|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110111117|NCT01845298|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110111118|NCT01845298|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110111119|NCT01845298|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110219464|NCT00111072|Glucocorticoids|glucocorticoids|mesh-ancestor
110111120|NCT01845363|Anti-Infective Agents|anti-infective agents|mesh-list
110111121|NCT01845363|Cefazolin|cefazolin|mesh-list
110111122|NCT01845363|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110111123|NCT01845376|Anesthetics|anesthetics|mesh-list
110111124|NCT01845376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110111125|NCT01845376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110111126|NCT01845428|Pravastatin|pravastatin|mesh-list
110111127|NCT01845428|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110111128|NCT01845428|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110111129|NCT01845428|Antimetabolites|antimetabolites|mesh-ancestor
110111130|NCT01845428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110111131|NCT01845428|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110111132|NCT01845428|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110111133|NCT01845428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110111134|NCT01845493|Sulforaphane|sulforaphane|mesh-list
110111135|NCT01845493|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110111136|NCT01845493|Protective Agents|protective agents|mesh-ancestor
110111137|NCT01845493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110111138|NCT01845493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110111139|NCT01845532|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
110111140|NCT01845532|Anesthetics, Local|anesthetics, local|mesh-ancestor
110111141|NCT01845532|Anesthetics|anesthetics|mesh-ancestor
110111142|NCT01845532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110111143|NCT01845532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110111144|NCT01845532|Sensory System Agents|sensory system agents|mesh-ancestor
110111145|NCT01845532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110111146|NCT01845532|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
110111148|NCT01845558|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110111149|NCT01845558|Immunologic Factors|immunologic factors|mesh-ancestor
110111150|NCT01845558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110111151|NCT01845584|Immunoglobulins|immunoglobulins|mesh-list
110111152|NCT01845584|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110111153|NCT01845584|gamma-Globulins|gamma-globulins|mesh-list
110111154|NCT01845584|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110111155|NCT01845584|Immunologic Factors|immunologic factors|mesh-ancestor
110111156|NCT01845584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110111157|NCT01845610|Manganese|manganese|mesh-list
110111158|NCT01845610|Trace Elements|trace elements|mesh-ancestor
110111159|NCT01845610|Micronutrients|micronutrients|mesh-ancestor
110111160|NCT01845610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110111161|NCT01845675|Temozolomide|temozolomide|mesh-list
110111162|NCT01845675|Dacarbazine|dacarbazine|mesh-list
110111163|NCT01845675|Endostatins|endostatins|mesh-list
110111164|NCT01845675|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110111165|NCT01845675|Alkylating Agents|alkylating agents|mesh-ancestor
110111166|NCT01845675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110111168|NCT01845675|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110111169|NCT01845675|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110111170|NCT01845675|Growth Substances|growth substances|mesh-ancestor
110219493|NCT00286780|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110111171|NCT01845675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110111172|NCT01845675|Growth Inhibitors|growth inhibitors|mesh-ancestor
110111174|NCT01845701|Lumefantrine|lumefantrine|mesh-list
110111175|NCT01845701|Artemether|artemether|mesh-list
110111176|NCT01845701|Piperaquine|piperaquine|mesh-list
110111177|NCT01845701|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
110111178|NCT01845701|Amodiaquine|amodiaquine|mesh-list
110111179|NCT01845701|Artenimol|artenimol|mesh-list
110111180|NCT01845701|Antimalarials|antimalarials|mesh-ancestor
110111181|NCT01845701|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110111182|NCT01845701|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110111183|NCT01845701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110111184|NCT01845701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110111185|NCT01845701|Antiviral Agents|antiviral agents|mesh-ancestor
110111187|NCT01845701|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110111188|NCT01845701|Anthelmintics|anthelmintics|mesh-ancestor
110111189|NCT01845727|Amphotericin B|amphotericin b|mesh-list
110111190|NCT01845727|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
110111191|NCT01845727|Amebicides|amebicides|mesh-ancestor
110111192|NCT01845727|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110111193|NCT01845727|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110111194|NCT01845727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110111195|NCT01845727|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110111196|NCT01845727|Antifungal Agents|antifungal agents|mesh-ancestor
110111197|NCT01845844|Ranibizumab|ranibizumab|mesh-list
110111198|NCT01845844|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110111199|NCT01845844|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110111200|NCT01845844|Growth Substances|growth substances|mesh-ancestor
110111201|NCT01845844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110111202|NCT01845844|Growth Inhibitors|growth inhibitors|mesh-ancestor
110162294|NCT00007436|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110111203|NCT01845844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110111204|NCT01846026|Vitamin D|vitamin d|mesh-list
110111205|NCT01846026|Cholecalciferol|cholecalciferol|mesh-list
110111206|NCT01846026|Vitamins|vitamins|mesh-ancestor
110111207|NCT01846026|Micronutrients|micronutrients|mesh-ancestor
110111208|NCT01846026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110111209|NCT01846026|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110111210|NCT01846026|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110111211|NCT01846117|Vitamin D|vitamin d|mesh-list
110111212|NCT01846117|Secoisolariciresinol|secoisolariciresinol|mesh-list
110111213|NCT01846117|Vitamins|vitamins|mesh-ancestor
110111214|NCT01846117|Micronutrients|micronutrients|mesh-ancestor
110111215|NCT01846117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110111216|NCT01846117|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110111217|NCT01846117|Phytoestrogens|phytoestrogens|mesh-ancestor
110111218|NCT01846117|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
110111219|NCT01846117|Estrogens|estrogens|mesh-ancestor
110111220|NCT01846117|Hormones|hormones|mesh-ancestor
110111221|NCT01846117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110111222|NCT01846143|Poly ICLC|poly iclc|mesh-list
110111223|NCT01846143|Immunologic Factors|immunologic factors|mesh-ancestor
110111224|NCT01846143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110111225|NCT01846143|Interferon Inducers|interferon inducers|mesh-ancestor
110111226|NCT01846273|Ranibizumab|ranibizumab|mesh-list
110111227|NCT01846273|Verteporfin|verteporfin|mesh-list
110111228|NCT01846273|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110111229|NCT01846273|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110111230|NCT01846273|Growth Substances|growth substances|mesh-ancestor
110111231|NCT01846273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110111232|NCT01846273|Growth Inhibitors|growth inhibitors|mesh-ancestor
110111233|NCT01846273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110111234|NCT01846273|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110111235|NCT01846273|Dermatologic Agents|dermatologic agents|mesh-ancestor
110111237|NCT01846325|Vitamins|vitamins|mesh-ancestor
110111238|NCT01846325|Micronutrients|micronutrients|mesh-ancestor
110111239|NCT01846325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110111240|NCT01846325|Antioxidants|antioxidants|mesh-ancestor
110111241|NCT01846325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110111242|NCT01846325|Protective Agents|protective agents|mesh-ancestor
110111243|NCT01846364|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
110111244|NCT01846364|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110111245|NCT01846364|Protective Agents|protective agents|mesh-ancestor
110111246|NCT01846364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110111247|NCT01846364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110402469|NCT05852769|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110402470|NCT05852769|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110111249|NCT01846559|Ticagrelor|ticagrelor|mesh-list
110111250|NCT01846559|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110111251|NCT01846559|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110111252|NCT01846559|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110111253|NCT01846559|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110111254|NCT01846559|Purinergic Agents|purinergic agents|mesh-ancestor
110111255|NCT01846559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110111256|NCT01846559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110111257|NCT01846559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110111258|NCT01846650|Capecitabine|capecitabine|mesh-list
110111259|NCT01846650|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110111260|NCT01846650|Antimetabolites|antimetabolites|mesh-ancestor
110111261|NCT01846650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110111262|NCT01846650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110111263|NCT01846806|Rifaximin|rifaximin|mesh-list
110111264|NCT01846806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110111265|NCT01846806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110111266|NCT01846806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110111267|NCT01846832|Interferons|interferons|mesh-list
110111268|NCT01846832|Ribavirin|ribavirin|mesh-list
110111269|NCT01846832|Interferon-alpha|interferon-alpha|mesh-list
110111270|NCT01846832|Interferon alpha-2|interferon alpha-2|mesh-list
110111271|NCT01846832|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110111272|NCT01846832|Simeprevir|simeprevir|mesh-list
110111273|NCT01846832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110111274|NCT01846832|Antiviral Agents|antiviral agents|mesh-ancestor
110111275|NCT01846832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110111276|NCT01846832|Antimetabolites|antimetabolites|mesh-ancestor
110111277|NCT01846832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110111278|NCT01846832|Immunologic Factors|immunologic factors|mesh-ancestor
110219541|NCT00077753|Enoxaparin|enoxaparin|mesh-list
110111279|NCT01846832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110111280|NCT01846832|Protease Inhibitors|protease inhibitors|mesh-ancestor
110111281|NCT01846832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110111282|NCT01846962|Fluticasone|fluticasone|mesh-list
110111283|NCT01846962|Budesonide|budesonide|mesh-list
110111284|NCT01846962|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110111285|NCT01846962|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110111286|NCT01846962|Autonomic Agents|autonomic agents|mesh-ancestor
110111287|NCT01846962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110111288|NCT01846962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110111289|NCT01846962|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110111290|NCT01846962|Respiratory System Agents|respiratory system agents|mesh-ancestor
110111291|NCT01846962|Dermatologic Agents|dermatologic agents|mesh-ancestor
110111292|NCT01846962|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110111293|NCT01846962|Glucocorticoids|glucocorticoids|mesh-ancestor
110111294|NCT01846962|Hormones|hormones|mesh-ancestor
110111295|NCT01846962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110111296|NCT01846975|Abatacept|abatacept|mesh-list
110111297|NCT01846975|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110111298|NCT01846975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110111299|NCT01846975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110111300|NCT01846975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110111301|NCT01846975|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110402504|NCT05844501|Ondansetron|ondansetron|mesh-list
110111302|NCT01846975|Immunologic Factors|immunologic factors|mesh-ancestor
110111303|NCT01846975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110111304|NCT01846975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110111305|NCT01847144|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110111306|NCT01847144|Gliclazide|gliclazide|mesh-list
110111307|NCT01847144|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
110111309|NCT01847144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110111310|NCT01847144|Incretins|incretins|mesh-ancestor
110111311|NCT01847144|Hormones|hormones|mesh-ancestor
110111312|NCT01847144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110111313|NCT01847144|Protease Inhibitors|protease inhibitors|mesh-ancestor
110111314|NCT01847144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110111315|NCT01847144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110111316|NCT01847157|Anesthetics|anesthetics|mesh-list
110111317|NCT01847157|Prilocaine|prilocaine|mesh-list
110111318|NCT01847157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110111319|NCT01847157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110111320|NCT01847157|Anesthetics, Local|anesthetics, local|mesh-ancestor
110111321|NCT01847157|Sensory System Agents|sensory system agents|mesh-ancestor
110111322|NCT01847157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110111324|NCT01847235|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110111325|NCT01847235|Alkylating Agents|alkylating agents|mesh-ancestor
110111326|NCT01847235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110111327|NCT01847235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110111328|NCT01847339|Bupivacaine|bupivacaine|mesh-list
110111329|NCT01847339|Anesthetics, Local|anesthetics, local|mesh-ancestor
110111330|NCT01847339|Anesthetics|anesthetics|mesh-ancestor
110111331|NCT01847339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110111332|NCT01847339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110111333|NCT01847339|Sensory System Agents|sensory system agents|mesh-ancestor
110111334|NCT01847339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110111335|NCT01847404|Pantoprazole|pantoprazole|mesh-list
110111336|NCT01847404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110111337|NCT01847404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110111338|NCT01847404|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110111339|NCT01847404|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110111340|NCT01847404|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110111341|NCT01847417|Pantoprazole|pantoprazole|mesh-list
110111342|NCT01847417|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110111343|NCT01847417|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110111344|NCT01847417|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110111345|NCT01847417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110111346|NCT01847417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110111347|NCT01847456|Insulin|insulin|mesh-list
110111348|NCT01847456|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110111349|NCT01847456|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110111350|NCT01847456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110111351|NCT01847495|Irinotecan|irinotecan|mesh-list
110111352|NCT01847495|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110111353|NCT01847495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110111354|NCT01847495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110111355|NCT01847495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110111356|NCT01847495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110111357|NCT01847521|Quercetin|quercetin|mesh-list
110111358|NCT01847521|Antioxidants|antioxidants|mesh-ancestor
110111359|NCT01847521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110111360|NCT01847521|Protective Agents|protective agents|mesh-ancestor
110111361|NCT01847521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110111362|NCT01847599|Capecitabine|capecitabine|mesh-list
110111363|NCT01847599|Lapatinib|lapatinib|mesh-list
110111364|NCT01847599|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110111365|NCT01847599|Antimetabolites|antimetabolites|mesh-ancestor
110111366|NCT01847599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110111367|NCT01847599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110111368|NCT01847599|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110111369|NCT01847599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110111370|NCT01847612|Methylene Blue|methylene blue|mesh-list
110111371|NCT01847612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110111372|NCT01847612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110111373|NCT01847664|Rifamycins|rifamycins|mesh-list
110111374|NCT01847664|Rifamycin SV|rifamycin sv|mesh-list
110111375|NCT01847664|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110111376|NCT01847664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110111377|NCT01847664|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110111378|NCT01847677|Paclitaxel|paclitaxel|mesh-list
110111379|NCT01847677|Bevacizumab|bevacizumab|mesh-list
110111380|NCT01847677|Carboplatin|carboplatin|mesh-list
110111381|NCT01847677|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110111383|NCT01847677|Tubulin Modulators|tubulin modulators|mesh-ancestor
110111384|NCT01847677|Antimitotic Agents|antimitotic agents|mesh-ancestor
110111385|NCT01847677|Mitosis Modulators|mitosis modulators|mesh-ancestor
110111386|NCT01847677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110111387|NCT01847677|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110111388|NCT01847677|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110111389|NCT01847677|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110111390|NCT01847677|Growth Substances|growth substances|mesh-ancestor
110111391|NCT01847677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110111392|NCT01847677|Growth Inhibitors|growth inhibitors|mesh-ancestor
110111393|NCT01847690|Hydrocortisone|hydrocortisone|mesh-list
110111394|NCT01847690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110111395|NCT01847768|Methacholine Chloride|methacholine chloride|mesh-list
110111396|NCT01847768|Dimercaprol|dimercaprol|mesh-list
110111397|NCT01847768|Chelating Agents|chelating agents|mesh-ancestor
110111398|NCT01847768|Sequestering Agents|sequestering agents|mesh-ancestor
110111399|NCT01847768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110111400|NCT01847768|Miotics|miotics|mesh-ancestor
110111401|NCT01847768|Autonomic Agents|autonomic agents|mesh-ancestor
110111402|NCT01847768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110111403|NCT01847768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110111404|NCT01847768|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110111405|NCT01847768|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
110111406|NCT01847768|Respiratory System Agents|respiratory system agents|mesh-ancestor
110111407|NCT01847768|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
110111408|NCT01847768|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110111409|NCT01847768|Cholinergic Agents|cholinergic agents|mesh-ancestor
110111410|NCT01847768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110111411|NCT01847781|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110111412|NCT01847781|Immunologic Factors|immunologic factors|mesh-ancestor
110111413|NCT01847781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110111414|NCT01847872|Vaccines|vaccines|mesh-list
110111415|NCT01847872|Immunologic Factors|immunologic factors|mesh-ancestor
110111416|NCT01847872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110111417|NCT01847976|Doxycycline|doxycycline|mesh-list
110111418|NCT01847976|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110111419|NCT01847976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110111420|NCT01847976|Antimalarials|antimalarials|mesh-ancestor
110111421|NCT01847976|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110111422|NCT01847976|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110111423|NCT01848106|Bivalirudin|bivalirudin|mesh-list
110111424|NCT01848106|Antithrombins|antithrombins|mesh-ancestor
110111425|NCT01848106|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110111426|NCT01848106|Protease Inhibitors|protease inhibitors|mesh-ancestor
110111427|NCT01848106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110111428|NCT01848106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110111429|NCT01848106|Anticoagulants|anticoagulants|mesh-ancestor
110111430|NCT01848119|Gabapentin|gabapentin|mesh-list
110111431|NCT01848119|Analgesics|analgesics|mesh-ancestor
110111432|NCT01848119|Sensory System Agents|sensory system agents|mesh-ancestor
110111433|NCT01848119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110111434|NCT01848119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110111435|NCT01848119|Anticonvulsants|anticonvulsants|mesh-ancestor
110111436|NCT01848119|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110111437|NCT01848119|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110111438|NCT01848119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110111439|NCT01848119|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110111440|NCT01848119|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110111441|NCT01848119|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110111442|NCT01848119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110111443|NCT01848119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110111444|NCT01848119|Antimanic Agents|antimanic agents|mesh-ancestor
110111445|NCT01848132|Prednisone|prednisone|mesh-list
110111446|NCT01848132|Cyclophosphamide|cyclophosphamide|mesh-list
110111447|NCT01848132|Rituximab|rituximab|mesh-list
110111448|NCT01848132|Doxorubicin|doxorubicin|mesh-list
110111449|NCT01848132|Vincristine|vincristine|mesh-list
110111450|NCT01848132|Bortezomib|bortezomib|mesh-list
110111451|NCT01848132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110111452|NCT01848132|Immunologic Factors|immunologic factors|mesh-ancestor
110111453|NCT01848132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110111454|NCT01848132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110111455|NCT01848132|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110111456|NCT01848132|Alkylating Agents|alkylating agents|mesh-ancestor
110111457|NCT01848132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110111458|NCT01848132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110111459|NCT01848132|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110111460|NCT01848132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110111461|NCT01848132|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110111462|NCT01848132|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110111463|NCT01848132|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110111464|NCT01848132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110111465|NCT01848132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110111466|NCT01848132|Glucocorticoids|glucocorticoids|mesh-ancestor
110111467|NCT01848132|Hormones|hormones|mesh-ancestor
110111468|NCT01848132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110111469|NCT01848132|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110111470|NCT01848132|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110111471|NCT01848132|Tubulin Modulators|tubulin modulators|mesh-ancestor
110111472|NCT01848132|Antimitotic Agents|antimitotic agents|mesh-ancestor
110219589|NCT00077870|Immunologic Factors|immunologic factors|mesh-ancestor
110219590|NCT00077870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110111473|NCT01848132|Mitosis Modulators|mitosis modulators|mesh-ancestor
110111475|NCT01848197|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110111476|NCT01848197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110111477|NCT01848197|Tubulin Modulators|tubulin modulators|mesh-ancestor
110111478|NCT01848197|Antimitotic Agents|antimitotic agents|mesh-ancestor
110111479|NCT01848197|Mitosis Modulators|mitosis modulators|mesh-ancestor
110111480|NCT01848197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110111481|NCT01848236|Vitamin D|vitamin d|mesh-list
110111482|NCT01848236|Ergocalciferols|ergocalciferols|mesh-list
110111483|NCT01848236|Cholecalciferol|cholecalciferol|mesh-list
110111484|NCT01848236|Vitamins|vitamins|mesh-list
110111485|NCT01848236|Micronutrients|micronutrients|mesh-ancestor
110111486|NCT01848236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110111487|NCT01848236|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110111488|NCT01848236|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110111489|NCT01848262|Pulmonary Surfactants|pulmonary surfactants|mesh-list
110111490|NCT01848262|Respiratory System Agents|respiratory system agents|mesh-ancestor
110111491|NCT01848301|Acetylcholine|acetylcholine|mesh-list
110162323|NCT00007592|Furosemide|furosemide|mesh-list
110111492|NCT01848301|Vasodilator Agents|vasodilator agents|mesh-ancestor
110111493|NCT01848301|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110111494|NCT01848301|Cholinergic Agents|cholinergic agents|mesh-ancestor
110111495|NCT01848301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110111496|NCT01848301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110111497|NCT01848301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110111498|NCT01848340|Cabotegravir|cabotegravir|mesh-list
110111499|NCT01848340|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110111500|NCT01848340|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110111501|NCT01848340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110111502|NCT01848340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110111503|NCT01848340|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110111504|NCT01848340|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110111505|NCT01848340|Antiviral Agents|antiviral agents|mesh-ancestor
110111506|NCT01848340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110111507|NCT01848379|Hypoglycemic Agents|hypoglycemic agents|mesh-list
110111508|NCT01848379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110111509|NCT01848613|Vinorelbine|vinorelbine|mesh-list
110111510|NCT01848613|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110111511|NCT01848613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110111512|NCT01848613|Tubulin Modulators|tubulin modulators|mesh-ancestor
110111513|NCT01848613|Antimitotic Agents|antimitotic agents|mesh-ancestor
110111514|NCT01848613|Mitosis Modulators|mitosis modulators|mesh-ancestor
110111515|NCT01848613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110111516|NCT01848652|Doxorubicin|doxorubicin|mesh-list
110111517|NCT01848652|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110111518|NCT01848652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110111519|NCT01848652|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110111520|NCT01848652|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110111521|NCT01848652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110111522|NCT01848652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110111523|NCT01848665|Indomethacin|indomethacin|mesh-list
110111524|NCT01848665|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110111525|NCT01848665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110111526|NCT01848665|Analgesics|analgesics|mesh-ancestor
110111527|NCT01848665|Sensory System Agents|sensory system agents|mesh-ancestor
110111528|NCT01848665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110111529|NCT01848665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110111530|NCT01848665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110219598|NCT00287170|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110111531|NCT01848665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110111532|NCT01848665|Gout Suppressants|gout suppressants|mesh-ancestor
110111533|NCT01848665|Tocolytic Agents|tocolytic agents|mesh-ancestor
110111534|NCT01848665|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110111535|NCT01848665|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110111536|NCT01848665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110111537|NCT01848665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110111538|NCT01848691|Carbon Monoxide|carbon monoxide|mesh-list
110111539|NCT01848691|Antimetabolites|antimetabolites|mesh-ancestor
110111540|NCT01848691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110111541|NCT01848691|Gasotransmitters|gasotransmitters|mesh-ancestor
110111542|NCT01848691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110111543|NCT01848691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110111545|NCT01848743|Lamivudine|lamivudine|mesh-list
110111546|NCT01848743|Antiviral Agents|antiviral agents|mesh-ancestor
110111547|NCT01848743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110111548|NCT01848743|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110111549|NCT01848743|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110111551|NCT01848743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110111552|NCT01848743|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110111553|NCT01848743|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110111554|NCT01848769|Beclomethasone|beclomethasone|mesh-list
110111555|NCT01848769|Formoterol Fumarate|formoterol fumarate|mesh-list
110111556|NCT01848769|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110111557|NCT01848769|Autonomic Agents|autonomic agents|mesh-ancestor
110111558|NCT01848769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110111559|NCT01848769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110111560|NCT01848769|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110111561|NCT01848769|Respiratory System Agents|respiratory system agents|mesh-ancestor
110111562|NCT01848769|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110111563|NCT01848769|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110111564|NCT01848769|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110111565|NCT01848769|Adrenergic Agents|adrenergic agents|mesh-ancestor
110111566|NCT01848769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110111567|NCT01848769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110111568|NCT01848769|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110111569|NCT01848769|Glucocorticoids|glucocorticoids|mesh-ancestor
110111571|NCT01848769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110111572|NCT01848808|Wobenzym|wobenzym|mesh-list
110111573|NCT01848808|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110111574|NCT01848808|Immunologic Factors|immunologic factors|mesh-ancestor
110111575|NCT01848808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110111576|NCT01848873|Amlodipine|amlodipine|mesh-list
110111577|NCT01848873|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110111578|NCT01848873|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110111579|NCT01848873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110111580|NCT01848873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110111581|NCT01848873|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110111582|NCT01848873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110111583|NCT01848873|Vasodilator Agents|vasodilator agents|mesh-ancestor
110111584|NCT01848925|Hydroxyurea|hydroxyurea|mesh-list
110111585|NCT01848925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110111586|NCT01848925|Antisickling Agents|antisickling agents|mesh-ancestor
110111587|NCT01848925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110111588|NCT01848925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110111589|NCT01848925|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110111590|NCT01849016|Acetylcysteine|acetylcysteine|mesh-list
110111591|NCT01849016|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110111592|NCT01849016|Antiviral Agents|antiviral agents|mesh-ancestor
110111593|NCT01849016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110111594|NCT01849016|Expectorants|expectorants|mesh-ancestor
110111595|NCT01849016|Respiratory System Agents|respiratory system agents|mesh-ancestor
110111596|NCT01849016|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110111597|NCT01849016|Antioxidants|antioxidants|mesh-ancestor
110111598|NCT01849016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110111599|NCT01849016|Protective Agents|protective agents|mesh-ancestor
110111600|NCT01849016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110111601|NCT01849016|Antidotes|antidotes|mesh-ancestor
110111602|NCT01849042|Donepezil|donepezil|mesh-list
110111603|NCT01849042|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110111604|NCT01849042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110111605|NCT01849042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110111606|NCT01849042|Cholinergic Agents|cholinergic agents|mesh-ancestor
110111607|NCT01849042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110111608|NCT01849042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110111609|NCT01849042|Nootropic Agents|nootropic agents|mesh-ancestor
110111610|NCT01849094|Milrinone|milrinone|mesh-list
110111611|NCT01849094|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110111612|NCT01849094|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110111613|NCT01849094|Vasodilator Agents|vasodilator agents|mesh-ancestor
110111614|NCT01849094|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110111615|NCT01849094|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110111616|NCT01849094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110111617|NCT01849094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110111618|NCT01849094|Protective Agents|protective agents|mesh-ancestor
110111619|NCT01849094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110111621|NCT01849211|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110111622|NCT01849211|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110111623|NCT01849211|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110162332|NCT00007631|Tretinoin|tretinoin|mesh-list
110111624|NCT01849211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110111625|NCT01849211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110111626|NCT01849406|Budesonide|budesonide|mesh-list
110111627|NCT01849406|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110111628|NCT01849406|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110111629|NCT01849406|Autonomic Agents|autonomic agents|mesh-ancestor
110111630|NCT01849406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110111631|NCT01849406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110111632|NCT01849406|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110111633|NCT01849406|Respiratory System Agents|respiratory system agents|mesh-ancestor
110111634|NCT01849406|Glucocorticoids|glucocorticoids|mesh-ancestor
110111635|NCT01849406|Hormones|hormones|mesh-ancestor
110111636|NCT01849406|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110111637|NCT01849640|Primaquine|primaquine|mesh-list
110111638|NCT01849640|Piperaquine|piperaquine|mesh-list
110111639|NCT01849640|Antimalarials|antimalarials|mesh-ancestor
110111640|NCT01849640|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110111641|NCT01849640|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110111642|NCT01849640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110111643|NCT01849666|Vemurafenib|vemurafenib|mesh-list
110111644|NCT01849666|Phenprocoumon|phenprocoumon|mesh-list
110111645|NCT01849666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110111646|NCT01849666|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110111647|NCT01849666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110111648|NCT01849666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110111649|NCT01849666|Anticoagulants|anticoagulants|mesh-ancestor
110402530|NCT05822583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110111650|NCT01849757|Plasma-lyte 148|plasma-lyte 148|mesh-list
110111651|NCT01849757|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110111652|NCT01849757|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110111653|NCT01849835|Menthol|menthol|mesh-list
110111654|NCT01849835|Antipruritics|antipruritics|mesh-ancestor
110111655|NCT01849835|Dermatologic Agents|dermatologic agents|mesh-ancestor
110111656|NCT01849861|Methimazole|methimazole|mesh-list
110111657|NCT01849861|Antithyroid Agents|antithyroid agents|mesh-ancestor
110111658|NCT01849861|Hormone Antagonists|hormone antagonists|mesh-ancestor
110111659|NCT01849861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110111660|NCT01849861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110111661|NCT01849926|Amdinocillin|amdinocillin|mesh-list
110111662|NCT01849926|Ibuprofen|ibuprofen|mesh-list
110111663|NCT01849926|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110111664|NCT01849926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110111665|NCT01849926|Analgesics|analgesics|mesh-ancestor
110111666|NCT01849926|Sensory System Agents|sensory system agents|mesh-ancestor
110111667|NCT01849926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110111668|NCT01849926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110111669|NCT01849926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110111670|NCT01849926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110111671|NCT01849926|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110111672|NCT01849926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110111673|NCT01849926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110111674|NCT01849926|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110111675|NCT01849926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110111676|NCT01849926|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110111677|NCT01849939|Immunosuppressive Agents|immunosuppressive agents|mesh-list
110111678|NCT01849939|Immunologic Factors|immunologic factors|mesh-ancestor
110111679|NCT01849939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110111680|NCT01850017|Dexmedetomidine|dexmedetomidine|mesh-list
110111681|NCT01850017|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110111682|NCT01850017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110111683|NCT01850017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110111684|NCT01850017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110111685|NCT01850017|Analgesics|analgesics|mesh-ancestor
110111686|NCT01850017|Sensory System Agents|sensory system agents|mesh-ancestor
110111687|NCT01850017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110111688|NCT01850017|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110111689|NCT01850017|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110111690|NCT01850017|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110111691|NCT01850017|Adrenergic Agents|adrenergic agents|mesh-ancestor
110111692|NCT01850017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110111693|NCT01850017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110111694|NCT01850095|Azelaic acid|azelaic acid|mesh-list
110111696|NCT01850095|Estrogens|estrogens|mesh-ancestor
110111698|NCT01850095|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110111699|NCT01850095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110402541|NCT05809700|Hyaluronic Acid|hyaluronic acid|mesh-list
110402542|NCT05809700|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110402543|NCT05809700|Immunologic Factors|immunologic factors|mesh-ancestor
110402544|NCT05809700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110402545|NCT05809700|Viscosupplements|viscosupplements|mesh-ancestor
110402546|NCT05809700|Protective Agents|protective agents|mesh-ancestor
110402547|NCT05793060|Dexamethasone|dexamethasone|mesh-list
110402548|NCT05793060|Dexamethasone acetate|dexamethasone acetate|mesh-list
110111700|NCT01850095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110111701|NCT01850095|Dermatologic Agents|dermatologic agents|mesh-ancestor
110111702|NCT01850121|Infliximab|infliximab|mesh-list
110111703|NCT01850121|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110111704|NCT01850121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110111705|NCT01850121|Dermatologic Agents|dermatologic agents|mesh-ancestor
110111706|NCT01850121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110111707|NCT01850121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110111708|NCT01850147|Sunitinib|sunitinib|mesh-list
110111709|NCT01850147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110111710|NCT01850147|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110111711|NCT01850147|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110111712|NCT01850147|Growth Substances|growth substances|mesh-ancestor
110111713|NCT01850147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110111714|NCT01850147|Growth Inhibitors|growth inhibitors|mesh-ancestor
110111715|NCT01850147|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110111716|NCT01850147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110111717|NCT01850147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110111718|NCT01850160|Valsartan|valsartan|mesh-list
110111719|NCT01850160|Antihypertensive Agents|antihypertensive agents|mesh-list
110111720|NCT01850160|Chlorthalidone|chlorthalidone|mesh-list
110111721|NCT01850160|Angiotensin II|angiotensin ii|mesh-list
110111722|NCT01850160|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
110111723|NCT01850160|Diuretics|diuretics|mesh-list
110111724|NCT01850160|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
110111725|NCT01850160|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110111726|NCT01850160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110111727|NCT01850160|Natriuretic Agents|natriuretic agents|mesh-ancestor
110111728|NCT01850160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110111729|NCT01850160|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110111730|NCT01850160|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110111731|NCT01850251|Vitamin D|vitamin d|mesh-list
110111732|NCT01850251|Vitamins|vitamins|mesh-ancestor
110111733|NCT01850251|Micronutrients|micronutrients|mesh-ancestor
110111734|NCT01850251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110111735|NCT01850251|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110111736|NCT01850277|Amiodarone|amiodarone|mesh-list
110111737|NCT01850277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110111738|NCT01850277|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110111739|NCT01850277|Vasodilator Agents|vasodilator agents|mesh-ancestor
110111740|NCT01850277|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
110111741|NCT01850277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110111742|NCT01850277|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110111743|NCT01850277|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110111744|NCT01850277|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110111745|NCT01850277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110111746|NCT01850277|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110111747|NCT01850277|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110111748|NCT01850277|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110111749|NCT01850511|Phenylephrine|phenylephrine|mesh-list
110111750|NCT01850511|Oxymetazoline|oxymetazoline|mesh-list
110111751|NCT01850511|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110111752|NCT01850511|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110111753|NCT01850511|Adrenergic Agents|adrenergic agents|mesh-ancestor
110111754|NCT01850511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110111755|NCT01850511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110111756|NCT01850511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110111757|NCT01850511|Sympathomimetics|sympathomimetics|mesh-ancestor
110111758|NCT01850511|Autonomic Agents|autonomic agents|mesh-ancestor
110111759|NCT01850511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110111760|NCT01850511|Nasal Decongestants|nasal decongestants|mesh-ancestor
110111761|NCT01850511|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110111762|NCT01850511|Respiratory System Agents|respiratory system agents|mesh-ancestor
110111763|NCT01850511|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110111764|NCT01850511|Mydriatics|mydriatics|mesh-ancestor
110111765|NCT01850511|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110111766|NCT01850511|Protective Agents|protective agents|mesh-ancestor
110111767|NCT01850628|Paclitaxel|paclitaxel|mesh-list
110111768|NCT01850628|Trastuzumab|trastuzumab|mesh-list
110111770|NCT01850628|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110111771|NCT01850628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110111772|NCT01850628|Tubulin Modulators|tubulin modulators|mesh-ancestor
110111773|NCT01850628|Antimitotic Agents|antimitotic agents|mesh-ancestor
110111774|NCT01850628|Mitosis Modulators|mitosis modulators|mesh-ancestor
110111775|NCT01850628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110111776|NCT01850628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110111777|NCT01850680|Folic Acid|folic acid|mesh-list
110111778|NCT01850680|Methotrexate|methotrexate|mesh-list
110111779|NCT01850680|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110111780|NCT01850680|Abortifacient Agents|abortifacient agents|mesh-ancestor
110111781|NCT01850680|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110111782|NCT01850680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110111783|NCT01850680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110111784|NCT01850680|Antimetabolites|antimetabolites|mesh-ancestor
110111785|NCT01850680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110111786|NCT01850680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110111787|NCT01850680|Dermatologic Agents|dermatologic agents|mesh-ancestor
110111788|NCT01850680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110111789|NCT01850680|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110111790|NCT01850680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110111791|NCT01850680|Immunologic Factors|immunologic factors|mesh-ancestor
110111792|NCT01850680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110111793|NCT01850680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110111794|NCT01850680|Hematinics|hematinics|mesh-ancestor
110111795|NCT01850680|Vitamin B Complex|vitamin b complex|mesh-ancestor
110111796|NCT01850680|Vitamins|vitamins|mesh-ancestor
110111797|NCT01850680|Micronutrients|micronutrients|mesh-ancestor
110111798|NCT01850940|Tolvaptan|tolvaptan|mesh-list
110111799|NCT01850940|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
110111800|NCT01850940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110111801|NCT01850940|Natriuretic Agents|natriuretic agents|mesh-ancestor
110111802|NCT01850940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110111803|NCT01850953|Varenicline|varenicline|mesh-list
110111804|NCT01850953|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110111805|NCT01850953|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110111806|NCT01850953|Cholinergic Agents|cholinergic agents|mesh-ancestor
110111807|NCT01850953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110111808|NCT01850953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110111809|NCT01850953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110111810|NCT01850979|Tacrolimus|tacrolimus|mesh-list
110111811|NCT01850979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110111812|NCT01850979|Immunologic Factors|immunologic factors|mesh-ancestor
110111813|NCT01850979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110111814|NCT01850979|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110111815|NCT01850979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110111816|NCT01850979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110111817|NCT01851005|Dexmedetomidine|dexmedetomidine|mesh-list
110111818|NCT01851005|Remifentanil|remifentanil|mesh-list
110111819|NCT01851005|Anesthetics|anesthetics|mesh-list
110111820|NCT01851005|Propofol|propofol|mesh-list
110111821|NCT01851005|Sevoflurane|sevoflurane|mesh-list
110111822|NCT01851005|Rocuronium|rocuronium|mesh-list
110111823|NCT01851005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110111824|NCT01851005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110111825|NCT01851005|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110111826|NCT01851005|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110111827|NCT01851005|Analgesics|analgesics|mesh-ancestor
110111828|NCT01851005|Sensory System Agents|sensory system agents|mesh-ancestor
110111829|NCT01851005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110111830|NCT01851005|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110111831|NCT01851005|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110111832|NCT01851005|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110111833|NCT01851005|Adrenergic Agents|adrenergic agents|mesh-ancestor
110111834|NCT01851005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110111835|NCT01851005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110111837|NCT01851005|Anesthetics, General|anesthetics, general|mesh-ancestor
110219670|NCT00287326|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110111838|NCT01851005|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110111839|NCT01851005|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110111840|NCT01851005|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110111842|NCT01851005|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110111843|NCT01851005|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110111844|NCT01851005|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110111845|NCT01851148|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-list
110111846|NCT01851148|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110111847|NCT01851148|Serotonin Agents|serotonin agents|mesh-ancestor
110111848|NCT01851148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110111849|NCT01851148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110111850|NCT01851148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110111851|NCT01851200|Brentuximab Vedotin|brentuximab vedotin|mesh-list
110111852|NCT01851200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110111853|NCT01851200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110111854|NCT01851200|Immunotoxins|immunotoxins|mesh-ancestor
110111855|NCT01851200|Immunoconjugates|immunoconjugates|mesh-ancestor
110111856|NCT01851200|Immunologic Factors|immunologic factors|mesh-ancestor
110111857|NCT01851200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110111858|NCT01851265|Olaparib|olaparib|mesh-list
110111859|NCT01851265|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110111860|NCT01851265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110111861|NCT01851265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110111862|NCT01851265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110111863|NCT01851278|Triamcinolone|triamcinolone|mesh-list
110111864|NCT01851278|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110111865|NCT01851278|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110111866|NCT01851278|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110111867|NCT01851278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110111868|NCT01851278|Glucocorticoids|glucocorticoids|mesh-ancestor
110111869|NCT01851278|Hormones|hormones|mesh-ancestor
110111870|NCT01851278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110111871|NCT01851278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110111872|NCT01851278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110111873|NCT01851278|Immunologic Factors|immunologic factors|mesh-ancestor
110111874|NCT01851278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110111875|NCT01851278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110111876|NCT01851408|Sirolimus|sirolimus|mesh-list
110111877|NCT01851408|Sorafenib|sorafenib|mesh-list
110111878|NCT01851408|Temsirolimus|temsirolimus|mesh-list
110111879|NCT01851408|MTOR Inhibitors|mtor inhibitors|mesh-list
110111880|NCT01851408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110111881|NCT01851408|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110111882|NCT01851408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110111883|NCT01851408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110111884|NCT01851408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110111885|NCT01851408|Immunologic Factors|immunologic factors|mesh-ancestor
110111886|NCT01851408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110111887|NCT01851408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110111888|NCT01851408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110111889|NCT01851408|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110111890|NCT01851408|Antifungal Agents|antifungal agents|mesh-ancestor
110111891|NCT01851473|Quinine|quinine|mesh-list
110111892|NCT01851473|Acetazolamide|acetazolamide|mesh-list
110111893|NCT01851473|Cocaine|cocaine|mesh-list
110111894|NCT01851473|Anticonvulsants|anticonvulsants|mesh-ancestor
110111895|NCT01851473|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110111896|NCT01851473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110111897|NCT01851473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110111898|NCT01851473|Diuretics|diuretics|mesh-ancestor
110111899|NCT01851473|Natriuretic Agents|natriuretic agents|mesh-ancestor
110111900|NCT01851473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110111901|NCT01851473|Anesthetics, Local|anesthetics, local|mesh-ancestor
110111902|NCT01851473|Anesthetics|anesthetics|mesh-ancestor
110111903|NCT01851473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110402573|NCT05793060|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110402574|NCT05793060|Adrenergic Agents|adrenergic agents|mesh-ancestor
110402575|NCT05793060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110111904|NCT01851473|Sensory System Agents|sensory system agents|mesh-ancestor
110111905|NCT01851473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110111906|NCT01851473|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110111907|NCT01851473|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110111908|NCT01851473|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110111909|NCT01851473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110111910|NCT01851473|Dopamine Agents|dopamine agents|mesh-ancestor
110111911|NCT01851473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110111912|NCT01851473|Antimalarials|antimalarials|mesh-ancestor
110111913|NCT01851473|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110111914|NCT01851473|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110111915|NCT01851473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110111916|NCT01851473|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110111917|NCT01851473|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110111918|NCT01851473|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110111920|NCT01851486|Clonidine|clonidine|mesh-list
110111921|NCT01851486|Naloxone|naloxone|mesh-list
110111922|NCT01851486|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110111923|NCT01851486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110111924|NCT01851486|Sensory System Agents|sensory system agents|mesh-ancestor
110111925|NCT01851486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110111926|NCT01851486|Analgesics|analgesics|mesh-ancestor
110111927|NCT01851486|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110111928|NCT01851486|Sympatholytics|sympatholytics|mesh-ancestor
110111929|NCT01851486|Autonomic Agents|autonomic agents|mesh-ancestor
110111930|NCT01851486|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110111931|NCT01851486|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110111932|NCT01851486|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110111933|NCT01851486|Adrenergic Agents|adrenergic agents|mesh-ancestor
110111934|NCT01851486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110111935|NCT01851486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110111936|NCT01851512|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
110111937|NCT01851512|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110111938|NCT01851512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110111939|NCT01851551|Rituximab|rituximab|mesh-list
110111940|NCT01851551|Vincristine|vincristine|mesh-list
110111941|NCT01851551|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110111942|NCT01851551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110111943|NCT01851551|Immunologic Factors|immunologic factors|mesh-ancestor
110111944|NCT01851551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110111945|NCT01851551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110111946|NCT01851551|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110111947|NCT01851551|Tubulin Modulators|tubulin modulators|mesh-ancestor
110111948|NCT01851551|Antimitotic Agents|antimitotic agents|mesh-ancestor
110111949|NCT01851551|Mitosis Modulators|mitosis modulators|mesh-ancestor
110111950|NCT01851551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110111951|NCT01851681|Amoxicillin|amoxicillin|mesh-list
110111952|NCT01851681|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110111953|NCT01851681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110111954|NCT01851733|Doxorubicin|doxorubicin|mesh-list
110111955|NCT01851733|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110111956|NCT01851733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110111957|NCT01851733|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110111958|NCT01851733|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110111959|NCT01851733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110111960|NCT01851733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110111961|NCT01851759|Cinepazide|cinepazide|mesh-list
110111962|NCT01851759|Vasodilator Agents|vasodilator agents|mesh-ancestor
110111963|NCT01851824|Vemurafenib|vemurafenib|mesh-list
110111964|NCT01851824|Acenocoumarol|acenocoumarol|mesh-list
110111965|NCT01851824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110111966|NCT01851824|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110111967|NCT01851824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110111968|NCT01851824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110111969|NCT01851824|Anticoagulants|anticoagulants|mesh-ancestor
110111970|NCT01851850|Opicapone|opicapone|mesh-list
110111971|NCT01851850|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
110111972|NCT01851850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110111973|NCT01851850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110111975|NCT01851850|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110111976|NCT01851941|Leucovorin|leucovorin|mesh-list
110111977|NCT01851941|Folic Acid|folic acid|mesh-list
110111978|NCT01851941|Fluorouracil|fluorouracil|mesh-list
110111979|NCT01851941|Oxaliplatin|oxaliplatin|mesh-list
110111980|NCT01851941|Levoleucovorin|levoleucovorin|mesh-list
110111981|NCT01851941|Antimetabolites|antimetabolites|mesh-ancestor
110111982|NCT01851941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110111983|NCT01851941|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110111984|NCT01851941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110111985|NCT01851941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110111986|NCT01851941|Immunologic Factors|immunologic factors|mesh-ancestor
110111987|NCT01851941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110111988|NCT01851941|Antidotes|antidotes|mesh-ancestor
110111989|NCT01851941|Protective Agents|protective agents|mesh-ancestor
110111990|NCT01851941|Vitamin B Complex|vitamin b complex|mesh-ancestor
110111991|NCT01851941|Vitamins|vitamins|mesh-ancestor
110111992|NCT01851941|Micronutrients|micronutrients|mesh-ancestor
110111993|NCT01851941|Hematinics|hematinics|mesh-ancestor
110111994|NCT01851954|Clarithromycin|clarithromycin|mesh-list
110111995|NCT01851954|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110111996|NCT01851954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110111997|NCT01851954|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110111998|NCT01851954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110111999|NCT01851954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110112000|NCT01851954|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110112001|NCT01851954|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110112003|NCT01851980|Diuretics|diuretics|mesh-ancestor
110112004|NCT01851980|Natriuretic Agents|natriuretic agents|mesh-ancestor
110112005|NCT01851980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110112006|NCT01851980|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110112007|NCT01851980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110112008|NCT01851980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110112009|NCT01851993|Ondansetron|ondansetron|mesh-list
110112010|NCT01851993|Antiemetics|antiemetics|mesh-ancestor
110112011|NCT01851993|Autonomic Agents|autonomic agents|mesh-ancestor
110112012|NCT01851993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110112013|NCT01851993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110112014|NCT01851993|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110112015|NCT01851993|Antipruritics|antipruritics|mesh-ancestor
110112016|NCT01851993|Dermatologic Agents|dermatologic agents|mesh-ancestor
110112017|NCT01851993|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110112018|NCT01851993|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110112019|NCT01851993|Serotonin Agents|serotonin agents|mesh-ancestor
110112020|NCT01851993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110112021|NCT01851993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110112022|NCT01852253|Chlorhexidine|chlorhexidine|mesh-list
110112023|NCT01852253|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110112024|NCT01852253|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110112025|NCT01852253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110112026|NCT01852253|Disinfectants|disinfectants|mesh-ancestor
110112027|NCT01852253|Dermatologic Agents|dermatologic agents|mesh-ancestor
110112028|NCT01852266|Vaccines|vaccines|mesh-list
110112029|NCT01852266|Immunologic Factors|immunologic factors|mesh-ancestor
110112030|NCT01852266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110112031|NCT01852318|Fexofenadine|fexofenadine|mesh-list
110112032|NCT01852318|Pregabalin|pregabalin|mesh-list
110112033|NCT01852318|Analgesics|analgesics|mesh-ancestor
110112034|NCT01852318|Sensory System Agents|sensory system agents|mesh-ancestor
110112035|NCT01852318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110112036|NCT01852318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110112037|NCT01852318|Anticonvulsants|anticonvulsants|mesh-ancestor
110112038|NCT01852318|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110112039|NCT01852318|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110112040|NCT01852318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110112041|NCT01852318|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110112042|NCT01852318|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110162375|NCT00112645|Antiemetics|antiemetics|mesh-ancestor
110112043|NCT01852318|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110112044|NCT01852318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110112045|NCT01852318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110112046|NCT01852318|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110112047|NCT01852318|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110112048|NCT01852318|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110112049|NCT01852318|Histamine Antagonists|histamine antagonists|mesh-ancestor
110112050|NCT01852318|Histamine Agents|histamine agents|mesh-ancestor
110112051|NCT01852318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110112052|NCT01852409|Bevacizumab|bevacizumab|mesh-list
110112053|NCT01852409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110112054|NCT01852409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110112055|NCT01852409|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110112056|NCT01852409|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110112057|NCT01852409|Growth Substances|growth substances|mesh-ancestor
110112058|NCT01852409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110112059|NCT01852409|Growth Inhibitors|growth inhibitors|mesh-ancestor
110112060|NCT01852461|Poractant alfa|poractant alfa|mesh-list
110112061|NCT01852461|Beractant|beractant|mesh-list
110112062|NCT01852461|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
110112063|NCT01852461|Respiratory System Agents|respiratory system agents|mesh-ancestor
110112064|NCT01852539|Dexmedetomidine|dexmedetomidine|mesh-list
110112065|NCT01852539|Propofol|propofol|mesh-list
110112066|NCT01852539|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110112067|NCT01852539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110112068|NCT01852539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110112069|NCT01852539|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110112071|NCT01852539|Sensory System Agents|sensory system agents|mesh-ancestor
110112072|NCT01852539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110112073|NCT01852539|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110112074|NCT01852539|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110112075|NCT01852539|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110112076|NCT01852539|Adrenergic Agents|adrenergic agents|mesh-ancestor
110112077|NCT01852539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110112078|NCT01852539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110112079|NCT01852539|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110112080|NCT01852539|Anesthetics, General|anesthetics, general|mesh-ancestor
110112081|NCT01852539|Anesthetics|anesthetics|mesh-ancestor
110112082|NCT01852565|Diltiazem|diltiazem|mesh-list
110112083|NCT01852565|Darapladib|darapladib|mesh-list
110112084|NCT01852565|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110112085|NCT01852565|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110112086|NCT01852565|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110112087|NCT01852565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110112088|NCT01852565|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110112089|NCT01852565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110112090|NCT01852565|Vasodilator Agents|vasodilator agents|mesh-ancestor
110112091|NCT01852565|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
110112092|NCT01852565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110112093|NCT01852604|Interferons|interferons|mesh-list
110112094|NCT01852604|Ritonavir|ritonavir|mesh-list
110112095|NCT01852604|Ribavirin|ribavirin|mesh-list
110112096|NCT01852604|Simeprevir|simeprevir|mesh-list
110112097|NCT01852604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110112098|NCT01852604|Antiviral Agents|antiviral agents|mesh-ancestor
110112099|NCT01852604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110112100|NCT01852604|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110112101|NCT01852604|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110112102|NCT01852604|Protease Inhibitors|protease inhibitors|mesh-ancestor
110112103|NCT01852604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110112104|NCT01852604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110112105|NCT01852604|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110112106|NCT01852604|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110112107|NCT01852604|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110112108|NCT01852604|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110112109|NCT01852604|Antimetabolites|antimetabolites|mesh-ancestor
110112110|NCT01852630|Imipenem|imipenem|mesh-list
110112111|NCT01852630|Cefepime|cefepime|mesh-list
110112112|NCT01852630|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110112113|NCT01852630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110112114|NCT01852786|Contraceptive Agents|contraceptive agents|mesh-list
110112115|NCT01852786|Contraceptives, Oral|contraceptives, oral|mesh-list
110112116|NCT01852786|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
110112117|NCT01852786|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110112118|NCT01852786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110112119|NCT01852786|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110112121|NCT01852903|Ascorbic Acid|ascorbic acid|mesh-list
110112122|NCT01852903|Calcium ascorbate|calcium ascorbate|mesh-list
110112123|NCT01852903|Calcium|calcium|mesh-list
110112124|NCT01852903|Micronutrients|micronutrients|mesh-ancestor
110112125|NCT01852903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110112126|NCT01852903|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110112127|NCT01852903|Antioxidants|antioxidants|mesh-ancestor
110112128|NCT01852903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110112129|NCT01852903|Protective Agents|protective agents|mesh-ancestor
110112130|NCT01852994|Methyltestosterone|methyltestosterone|mesh-list
110112132|NCT01852994|Testosterone undecanoate|testosterone undecanoate|mesh-list
110112133|NCT01852994|Testosterone enanthate|testosterone enanthate|mesh-list
110112134|NCT01852994|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
110112135|NCT01852994|Androgens|androgens|mesh-ancestor
110112136|NCT01852994|Hormones|hormones|mesh-ancestor
110112137|NCT01852994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110112138|NCT01852994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110112139|NCT01852994|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110112140|NCT01852994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110112141|NCT01852994|Anabolic Agents|anabolic agents|mesh-ancestor
110112142|NCT01853111|Aldesleukin|aldesleukin|mesh-list
110112143|NCT01853111|Interleukin-2|interleukin-2|mesh-list
110112144|NCT01853111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110112145|NCT01853111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110112146|NCT01853111|Analgesics|analgesics|mesh-ancestor
110112147|NCT01853111|Sensory System Agents|sensory system agents|mesh-ancestor
110219733|NCT00287794|Anesthetics|anesthetics|mesh-ancestor
110112148|NCT01853111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110112149|NCT01853111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110112151|NCT01853111|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110112152|NCT01853111|Antiviral Agents|antiviral agents|mesh-ancestor
110112153|NCT01853111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110112155|NCT01853306|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110112156|NCT01853306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110112157|NCT01853306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110112158|NCT01853306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110112159|NCT01853423|Sirolimus|sirolimus|mesh-list
110112160|NCT01853423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110112161|NCT01853423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110112162|NCT01853423|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110112163|NCT01853423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110112164|NCT01853423|Antifungal Agents|antifungal agents|mesh-ancestor
110112165|NCT01853423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110112166|NCT01853423|Immunologic Factors|immunologic factors|mesh-ancestor
110112167|NCT01853423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110112168|NCT01853449|Fentanyl|fentanyl|mesh-list
110112169|NCT01853449|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110112170|NCT01853449|Narcotics|narcotics|mesh-ancestor
110112171|NCT01853449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110112172|NCT01853449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110112173|NCT01853449|Analgesics|analgesics|mesh-ancestor
110112174|NCT01853449|Sensory System Agents|sensory system agents|mesh-ancestor
110112175|NCT01853449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110112176|NCT01853449|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110112177|NCT01853449|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110112178|NCT01853449|Anesthetics, General|anesthetics, general|mesh-ancestor
110112179|NCT01853449|Anesthetics|anesthetics|mesh-ancestor
110112180|NCT01853540|Sildenafil Citrate|sildenafil citrate|mesh-list
110112181|NCT01853540|Vasodilator Agents|vasodilator agents|mesh-ancestor
110112182|NCT01853540|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110112183|NCT01853540|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110112184|NCT01853540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110112185|NCT01853540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110112186|NCT01853540|Urological Agents|urological agents|mesh-ancestor
110112187|NCT01853566|Hormones|hormones|mesh-list
110402598|NCT05773092|Osimertinib|osimertinib|mesh-list
110402599|NCT05773092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110402600|NCT05773092|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110112188|NCT01853566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110112189|NCT01853566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110112190|NCT01853709|Bisacodyl|bisacodyl|mesh-list
110112191|NCT01853709|Cathartics|cathartics|mesh-ancestor
110112192|NCT01853709|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110112193|NCT01853709|Laxatives|laxatives|mesh-ancestor
110112194|NCT01853787|Formoterol Fumarate|formoterol fumarate|mesh-list
110112195|NCT01853787|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110112196|NCT01853787|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110112197|NCT01853787|Autonomic Agents|autonomic agents|mesh-ancestor
110112198|NCT01853787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110112199|NCT01853787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110112200|NCT01853787|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110112201|NCT01853787|Respiratory System Agents|respiratory system agents|mesh-ancestor
110112202|NCT01853787|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110112203|NCT01853787|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110112204|NCT01853787|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110112205|NCT01853787|Adrenergic Agents|adrenergic agents|mesh-ancestor
110112206|NCT01853787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110112207|NCT01853787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110112208|NCT01853800|Rivaroxaban|rivaroxaban|mesh-list
110112209|NCT01853800|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110112210|NCT01853800|Antithrombins|antithrombins|mesh-ancestor
110112211|NCT01853800|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110112212|NCT01853800|Protease Inhibitors|protease inhibitors|mesh-ancestor
110112213|NCT01853800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110112214|NCT01853800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110112215|NCT01853800|Anticoagulants|anticoagulants|mesh-ancestor
110112216|NCT01853813|Bevacizumab|bevacizumab|mesh-list
110112217|NCT01853813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110112218|NCT01853813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110112219|NCT01853813|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110112220|NCT01853813|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110112222|NCT01853813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110112223|NCT01853813|Growth Inhibitors|growth inhibitors|mesh-ancestor
110112224|NCT01853852|1-Deoxynojirimycin|1-deoxynojirimycin|mesh-list
110112225|NCT01853852|Antiviral Agents|antiviral agents|mesh-ancestor
110112226|NCT01853852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110112227|NCT01853852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110112228|NCT01853852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110112229|NCT01853956|Alprazolam|alprazolam|mesh-list
110112230|NCT01853956|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110112231|NCT01853956|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110112232|NCT01853956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110112233|NCT01853956|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110112234|NCT01853956|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110112235|NCT01853956|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110112236|NCT01853956|GABA Modulators|gaba modulators|mesh-ancestor
110112237|NCT01853956|GABA Agents|gaba agents|mesh-ancestor
110112238|NCT01853956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110112239|NCT01853956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110112240|NCT01854021|Anesthetics|anesthetics|mesh-list
110112241|NCT01854021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110112242|NCT01854021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110112243|NCT01854073|Scopolamine|scopolamine|mesh-list
110112244|NCT01854073|Bromides|bromides|mesh-list
110112245|NCT01854073|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
110112246|NCT01854073|Anticonvulsants|anticonvulsants|mesh-ancestor
110112247|NCT01854073|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110112248|NCT01854073|Antiemetics|antiemetics|mesh-ancestor
110112249|NCT01854073|Autonomic Agents|autonomic agents|mesh-ancestor
110162397|NCT00007670|Gabapentin|gabapentin|mesh-list
110112250|NCT01854073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110112251|NCT01854073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110112252|NCT01854073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110112253|NCT01854073|Mydriatics|mydriatics|mesh-ancestor
110112254|NCT01854073|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110112255|NCT01854073|Cholinergic Agents|cholinergic agents|mesh-ancestor
110112256|NCT01854073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110112257|NCT01854073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110112258|NCT01854073|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110112259|NCT01854073|Parasympatholytics|parasympatholytics|mesh-ancestor
110112260|NCT01854086|Diphosphonates|diphosphonates|mesh-list
110112261|NCT01854086|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110112262|NCT01854086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110112263|NCT01854203|Cisplatin|cisplatin|mesh-list
110112264|NCT01854203|Gemcitabine|gemcitabine|mesh-list
110112265|NCT01854203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110112266|NCT01854203|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110112267|NCT01854203|Antimetabolites|antimetabolites|mesh-ancestor
110112268|NCT01854203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110112269|NCT01854216|Rotigotine|rotigotine|mesh-list
110112270|NCT01854216|Dopamine Agonists|dopamine agonists|mesh-ancestor
110112271|NCT01854216|Dopamine Agents|dopamine agents|mesh-ancestor
110112272|NCT01854216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110112273|NCT01854216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110112274|NCT01854216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110112275|NCT01854411|Analgesics|analgesics|mesh-list
110112276|NCT01854411|Sensory System Agents|sensory system agents|mesh-ancestor
110112277|NCT01854411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110112278|NCT01854411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110112279|NCT01854424|Dimercaprol|dimercaprol|mesh-list
110112280|NCT01854424|Chelating Agents|chelating agents|mesh-ancestor
110112281|NCT01854424|Sequestering Agents|sequestering agents|mesh-ancestor
110112282|NCT01854424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110112283|NCT01854463|Vitamin D|vitamin d|mesh-list
110112284|NCT01854463|Cholecalciferol|cholecalciferol|mesh-list
110112285|NCT01854463|Vitamins|vitamins|mesh-ancestor
110112286|NCT01854463|Micronutrients|micronutrients|mesh-ancestor
110112287|NCT01854463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110112288|NCT01854463|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110112289|NCT01854463|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110112290|NCT01854476|Tranexamic Acid|tranexamic acid|mesh-list
110112291|NCT01854476|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110112292|NCT01854476|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110112293|NCT01854476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110112294|NCT01854476|Hemostatics|hemostatics|mesh-ancestor
110112295|NCT01854476|Coagulants|coagulants|mesh-ancestor
110112296|NCT01854489|Rifampin|rifampin|mesh-list
110112297|NCT01854489|Buprenorphine|buprenorphine|mesh-list
110112298|NCT01854489|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110112299|NCT01854489|Narcotics|narcotics|mesh-ancestor
110112300|NCT01854489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110112301|NCT01854489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110112302|NCT01854489|Analgesics|analgesics|mesh-ancestor
110112303|NCT01854489|Sensory System Agents|sensory system agents|mesh-ancestor
110112304|NCT01854489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110112305|NCT01854489|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110112306|NCT01854489|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110112307|NCT01854489|Antitubercular Agents|antitubercular agents|mesh-ancestor
110219791|NCT00288379|Budesonide|budesonide|mesh-list
110112308|NCT01854489|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110112309|NCT01854489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110112310|NCT01854489|Leprostatic Agents|leprostatic agents|mesh-ancestor
110112311|NCT01854489|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110112312|NCT01854489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110112313|NCT01854489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110112314|NCT01854489|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110112315|NCT01854489|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110112316|NCT01854489|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110162401|NCT00007670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110112317|NCT01854489|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110112318|NCT01854489|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110112319|NCT01854489|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110402612|NCT05755035|Antibodies|antibodies|mesh-list
110112322|NCT01854502|Protective Agents|protective agents|mesh-ancestor
110112323|NCT01854502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110112324|NCT01854515|Dexamethasone|dexamethasone|mesh-list
110112325|NCT01854515|Budesonide|budesonide|mesh-list
110112326|NCT01854515|Dexamethasone acetate|dexamethasone acetate|mesh-list
110112327|NCT01854515|BB 1101|bb 1101|mesh-list
110112328|NCT01854515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110112329|NCT01854515|Antiemetics|antiemetics|mesh-ancestor
110112330|NCT01854515|Autonomic Agents|autonomic agents|mesh-ancestor
110112331|NCT01854515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110112332|NCT01854515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110112333|NCT01854515|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110112334|NCT01854515|Glucocorticoids|glucocorticoids|mesh-ancestor
110112335|NCT01854515|Hormones|hormones|mesh-ancestor
110112336|NCT01854515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110112337|NCT01854515|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110112338|NCT01854515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110112339|NCT01854515|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110112340|NCT01854515|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110112341|NCT01854515|Respiratory System Agents|respiratory system agents|mesh-ancestor
110112342|NCT01854515|Protease Inhibitors|protease inhibitors|mesh-ancestor
110112343|NCT01854515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110112344|NCT01854515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110112345|NCT01854606|Everolimus|everolimus|mesh-list
110112346|NCT01854606|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110112347|NCT01854606|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110112348|NCT01854606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110112349|NCT01854606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110112350|NCT01854606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110112351|NCT01854606|Immunologic Factors|immunologic factors|mesh-ancestor
110112352|NCT01854606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110112353|NCT01854606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110112354|NCT01854619|Anti-Infective Agents|anti-infective agents|mesh-list
110112355|NCT01854619|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110112356|NCT01854723|Insulin|insulin|mesh-list
110112357|NCT01854723|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110112358|NCT01854723|Insulin Glargine|insulin glargine|mesh-list
110112359|NCT01854723|Insulin, Isophane|insulin, isophane|mesh-list
110112360|NCT01854723|Isophane Insulin, Human|isophane insulin, human|mesh-list
110112361|NCT01854723|Isophane insulin, beef|isophane insulin, beef|mesh-list
110112363|NCT01854723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110112364|NCT01854749|Cisplatin|cisplatin|mesh-list
110112365|NCT01854749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110112366|NCT01854762|Ritonavir|ritonavir|mesh-list
110112367|NCT01854762|Lopinavir|lopinavir|mesh-list
110112368|NCT01854762|Raltegravir Potassium|raltegravir potassium|mesh-list
110112369|NCT01854762|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110112370|NCT01854762|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110112371|NCT01854762|Protease Inhibitors|protease inhibitors|mesh-ancestor
110112372|NCT01854762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110112373|NCT01854762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110112375|NCT01854762|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110112376|NCT01854762|Antiviral Agents|antiviral agents|mesh-ancestor
110112377|NCT01854762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110112378|NCT01854762|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110112379|NCT01854762|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110112380|NCT01854762|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110112381|NCT01854762|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110112382|NCT01854970|Esomeprazole|esomeprazole|mesh-list
110112383|NCT01854970|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110112384|NCT01854970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110112385|NCT01854970|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110112386|NCT01854970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110112387|NCT01854970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110112388|NCT01855009|Calcium, Dietary|calcium, dietary|mesh-list
110112389|NCT01855009|Vitamin D|vitamin d|mesh-list
110112390|NCT01855009|Cholecalciferol|cholecalciferol|mesh-list
110112391|NCT01855009|Calcium Carbonate|calcium carbonate|mesh-list
110112392|NCT01855009|Calcium|calcium|mesh-list
110112393|NCT01855009|Vitamins|vitamins|mesh-ancestor
110112394|NCT01855009|Micronutrients|micronutrients|mesh-ancestor
110402619|NCT05744739|Azacitidine|azacitidine|mesh-list
110112395|NCT01855009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110112396|NCT01855009|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110112397|NCT01855009|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110112398|NCT01855009|Antacids|antacids|mesh-ancestor
110112399|NCT01855009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110112400|NCT01855009|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110112401|NCT01855061|Midazolam|midazolam|mesh-list
110112402|NCT01855061|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110112403|NCT01855061|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110112404|NCT01855061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110112405|NCT01855061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110112406|NCT01855061|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110112407|NCT01855061|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110112408|NCT01855061|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110112409|NCT01855061|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110112410|NCT01855061|Anesthetics, General|anesthetics, general|mesh-ancestor
110112411|NCT01855061|Anesthetics|anesthetics|mesh-ancestor
110112412|NCT01855061|GABA Modulators|gaba modulators|mesh-ancestor
110112413|NCT01855061|GABA Agents|gaba agents|mesh-ancestor
110112414|NCT01855061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110219832|NCT00288535|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110112415|NCT01855061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110112417|NCT01855100|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110112418|NCT01855100|Antithrombins|antithrombins|mesh-ancestor
110112419|NCT01855100|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110112420|NCT01855100|Protease Inhibitors|protease inhibitors|mesh-ancestor
110112421|NCT01855100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110112422|NCT01855100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110112423|NCT01855100|Anticoagulants|anticoagulants|mesh-ancestor
110112424|NCT01855139|Rivaroxaban|rivaroxaban|mesh-list
110112425|NCT01855139|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110112426|NCT01855139|Antithrombins|antithrombins|mesh-ancestor
110112427|NCT01855139|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110112428|NCT01855139|Protease Inhibitors|protease inhibitors|mesh-ancestor
110112429|NCT01855139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110112430|NCT01855139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110112431|NCT01855139|Anticoagulants|anticoagulants|mesh-ancestor
110112432|NCT01855256|Oxybutynin|oxybutynin|mesh-list
110112433|NCT01855256|Parasympatholytics|parasympatholytics|mesh-ancestor
110112435|NCT01855256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110112436|NCT01855256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110112437|NCT01855256|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110112438|NCT01855256|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110112439|NCT01855256|Cholinergic Agents|cholinergic agents|mesh-ancestor
110112440|NCT01855256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110112441|NCT01855256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110112442|NCT01855256|Urological Agents|urological agents|mesh-ancestor
110112443|NCT01855321|Vitamin D|vitamin d|mesh-list
110112444|NCT01855321|Cholecalciferol|cholecalciferol|mesh-list
110112445|NCT01855321|Vitamins|vitamins|mesh-ancestor
110112446|NCT01855321|Micronutrients|micronutrients|mesh-ancestor
110112447|NCT01855321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110112448|NCT01855321|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110112449|NCT01855321|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110112450|NCT01855334|Spironolactone|spironolactone|mesh-list
110112451|NCT01855334|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110112452|NCT01855334|Hormone Antagonists|hormone antagonists|mesh-ancestor
110112453|NCT01855334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110112454|NCT01855334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110112455|NCT01855334|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110112456|NCT01855334|Diuretics|diuretics|mesh-ancestor
110112457|NCT01855334|Natriuretic Agents|natriuretic agents|mesh-ancestor
110112458|NCT01855386|Liver Extracts|liver extracts|mesh-list
110112459|NCT01855386|Hematinics|hematinics|mesh-ancestor
110112461|NCT01855490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110112462|NCT01855490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110112463|NCT01855490|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110112464|NCT01855490|Incretins|incretins|mesh-ancestor
110112466|NCT01855490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110112467|NCT01855516|Heparin|heparin|mesh-list
110112468|NCT01855516|Anticoagulants|anticoagulants|mesh-ancestor
110112469|NCT01855516|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110112470|NCT01855516|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110112471|NCT01855516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110112472|NCT01855529|Ropivacaine|ropivacaine|mesh-list
110112473|NCT01855529|Anesthetics, Local|anesthetics, local|mesh-ancestor
110112474|NCT01855529|Anesthetics|anesthetics|mesh-ancestor
110112475|NCT01855529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110112476|NCT01855529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110112477|NCT01855529|Sensory System Agents|sensory system agents|mesh-ancestor
110112478|NCT01855529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110112479|NCT01855542|Plasma-lyte 148|plasma-lyte 148|mesh-list
110112480|NCT01855542|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110112481|NCT01855542|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110112482|NCT01855555|Propofol|propofol|mesh-list
110112483|NCT01855555|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110112484|NCT01855555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110112485|NCT01855555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110112486|NCT01855555|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110112487|NCT01855555|Anesthetics, General|anesthetics, general|mesh-ancestor
110112488|NCT01855555|Anesthetics|anesthetics|mesh-ancestor
110112489|NCT01855568|Methotrexate|methotrexate|mesh-list
110112490|NCT01855568|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110112491|NCT01855568|Abortifacient Agents|abortifacient agents|mesh-ancestor
110112492|NCT01855568|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110112493|NCT01855568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110112494|NCT01855568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110112495|NCT01855568|Antimetabolites|antimetabolites|mesh-ancestor
110112496|NCT01855568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110112497|NCT01855568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110112498|NCT01855568|Dermatologic Agents|dermatologic agents|mesh-ancestor
110112499|NCT01855568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110112500|NCT01855568|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110112501|NCT01855568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110112502|NCT01855568|Immunologic Factors|immunologic factors|mesh-ancestor
110112503|NCT01855568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110112504|NCT01855568|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110112505|NCT01855581|Ketamine|ketamine|mesh-list
110112506|NCT01855581|Propofol|propofol|mesh-list
110112507|NCT01855581|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110112508|NCT01855581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110112509|NCT01855581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110112510|NCT01855581|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110112511|NCT01855581|Anesthetics, General|anesthetics, general|mesh-ancestor
110112513|NCT01855581|Analgesics|analgesics|mesh-ancestor
110112514|NCT01855581|Sensory System Agents|sensory system agents|mesh-ancestor
110112515|NCT01855581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110112516|NCT01855581|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110112517|NCT01855581|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110112518|NCT01855581|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110112519|NCT01855581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110112520|NCT01855581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110112521|NCT01855594|Lithium Carbonate|lithium carbonate|mesh-list
110112522|NCT01855594|Antidepressive Agents|antidepressive agents|mesh-ancestor
110112523|NCT01855594|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110112524|NCT01855594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110162420|NCT00112879|Ascorbic Acid|ascorbic acid|mesh-list
110112525|NCT01855594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110112527|NCT01855594|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110112528|NCT01855594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110112529|NCT01855594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110112530|NCT01855711|Alosetron|alosetron|mesh-list
110112531|NCT01855711|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110112532|NCT01855711|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110112533|NCT01855711|Serotonin Agents|serotonin agents|mesh-ancestor
110112534|NCT01855711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110402626|NCT05734443|Triptorelin Pamoate|triptorelin pamoate|mesh-list
110112535|NCT01855711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110112536|NCT01855711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110112537|NCT01855724|Gemcitabine|gemcitabine|mesh-list
110112538|NCT01855724|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110112539|NCT01855724|Antimetabolites|antimetabolites|mesh-ancestor
110112540|NCT01855724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110112541|NCT01855724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110112542|NCT01855737|Warfarin|warfarin|mesh-list
110112543|NCT01855737|Anticoagulants|anticoagulants|mesh-ancestor
110112544|NCT01855763|Insulin|insulin|mesh-list
110112545|NCT01855763|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110112546|NCT01855763|Metformin|metformin|mesh-list
110112547|NCT01855763|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110112548|NCT01855763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110112549|NCT01855971|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
110112550|NCT01855971|Antioxidants|antioxidants|mesh-ancestor
110112551|NCT01855971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110112552|NCT01855971|Protective Agents|protective agents|mesh-ancestor
110112553|NCT01855971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110112554|NCT01855971|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
110112555|NCT01855971|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110112556|NCT01855971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110112557|NCT01855971|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110112558|NCT01855984|Tocotrienols|tocotrienols|mesh-list
110112559|NCT01855984|Vitamin E|vitamin e|mesh-list
110112560|NCT01855984|Tocopherols|tocopherols|mesh-list
110112561|NCT01855984|Tocovid|tocovid|mesh-list
110112562|NCT01855984|Antioxidants|antioxidants|mesh-ancestor
110112563|NCT01855984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110112564|NCT01855984|Protective Agents|protective agents|mesh-ancestor
110112565|NCT01855984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110112566|NCT01855984|Vitamins|vitamins|mesh-ancestor
110112567|NCT01855984|Micronutrients|micronutrients|mesh-ancestor
110112568|NCT01856023|Aldesleukin|aldesleukin|mesh-list
110112569|NCT01856023|Ipilimumab|ipilimumab|mesh-list
110112570|NCT01856023|Interleukin-2|interleukin-2|mesh-list
110112571|NCT01856023|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110112572|NCT01856023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110112573|NCT01856023|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110112574|NCT01856023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110112575|NCT01856023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110112576|NCT01856023|Analgesics|analgesics|mesh-ancestor
110112577|NCT01856023|Sensory System Agents|sensory system agents|mesh-ancestor
110219905|NCT00289588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110112578|NCT01856023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110112579|NCT01856023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110112580|NCT01856023|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110112581|NCT01856023|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110112582|NCT01856023|Antiviral Agents|antiviral agents|mesh-ancestor
110112583|NCT01856023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110112584|NCT01856062|Dexamethasone|dexamethasone|mesh-list
110112585|NCT01856062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110112586|NCT01856062|Antiemetics|antiemetics|mesh-ancestor
110112587|NCT01856062|Autonomic Agents|autonomic agents|mesh-ancestor
110112588|NCT01856062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110112589|NCT01856062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110112590|NCT01856062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110112591|NCT01856062|Glucocorticoids|glucocorticoids|mesh-ancestor
110112592|NCT01856062|Hormones|hormones|mesh-ancestor
110112593|NCT01856062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110112594|NCT01856062|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110112595|NCT01856062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110112596|NCT01856101|Dactolisib|dactolisib|mesh-list
110112597|NCT01856101|MTOR Inhibitors|mtor inhibitors|mesh-list
110112598|NCT01856101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110112599|NCT01856101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110112600|NCT01856101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110112601|NCT01856101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110112602|NCT01856101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110112603|NCT01856101|Immunologic Factors|immunologic factors|mesh-ancestor
110112604|NCT01856101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110112605|NCT01856127|Sertraline|sertraline|mesh-list
110112606|NCT01856127|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
110112607|NCT01856127|Antidepressive Agents|antidepressive agents|mesh-ancestor
110112608|NCT01856127|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110112609|NCT01856127|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110112610|NCT01856127|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110112611|NCT01856127|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110112612|NCT01856127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110112613|NCT01856127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110112614|NCT01856127|Serotonin Agents|serotonin agents|mesh-ancestor
110112615|NCT01856127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110112616|NCT01856127|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110112617|NCT01856127|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110112618|NCT01856166|Sufentanil|sufentanil|mesh-list
110112619|NCT01856166|Levobupivacaine|levobupivacaine|mesh-list
110112620|NCT01856166|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110219922|NCT00289861|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110112621|NCT01856166|Narcotics|narcotics|mesh-ancestor
110112622|NCT01856166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110112623|NCT01856166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110112624|NCT01856166|Analgesics|analgesics|mesh-ancestor
110112625|NCT01856166|Sensory System Agents|sensory system agents|mesh-ancestor
110112626|NCT01856166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110112627|NCT01856166|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110112628|NCT01856166|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110112629|NCT01856166|Anesthetics, General|anesthetics, general|mesh-ancestor
110112630|NCT01856166|Anesthetics|anesthetics|mesh-ancestor
110112631|NCT01856166|Anesthetics, Local|anesthetics, local|mesh-ancestor
110112632|NCT01856205|Immunoglobulins|immunoglobulins|mesh-list
110112633|NCT01856205|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110112635|NCT01856205|gamma-Globulins|gamma-globulins|mesh-list
110112636|NCT01856205|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110112637|NCT01856205|Immunologic Factors|immunologic factors|mesh-ancestor
110112638|NCT01856205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110112639|NCT01856348|Vitamin D|vitamin d|mesh-list
110112640|NCT01856348|Vitamins|vitamins|mesh-ancestor
110112641|NCT01856348|Micronutrients|micronutrients|mesh-ancestor
110112642|NCT01856348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110112643|NCT01856348|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110112644|NCT01856374|Sirolimus|sirolimus|mesh-list
110112645|NCT01856374|Everolimus|everolimus|mesh-list
110112646|NCT01856374|Atorvastatin|atorvastatin|mesh-list
110112647|NCT01856374|Pravastatin|pravastatin|mesh-list
110112648|NCT01856374|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110112649|NCT01856374|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110112650|NCT01856374|Antimetabolites|antimetabolites|mesh-ancestor
110112651|NCT01856374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110112652|NCT01856374|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110112653|NCT01856374|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110112654|NCT01856374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110112655|NCT01856374|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110112656|NCT01856374|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110112657|NCT01856374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110112658|NCT01856374|Immunologic Factors|immunologic factors|mesh-ancestor
110112659|NCT01856374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110112660|NCT01856374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110112661|NCT01856374|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110112662|NCT01856374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110112663|NCT01856374|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110112664|NCT01856374|Antifungal Agents|antifungal agents|mesh-ancestor
110112665|NCT01856413|Immunoglobulins|immunoglobulins|mesh-list
110112666|NCT01856413|Immunologic Factors|immunologic factors|mesh-ancestor
110112667|NCT01856413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110112668|NCT01856517|Clonidine|clonidine|mesh-list
110162433|NCT00112879|Hormones|hormones|mesh-ancestor
110112669|NCT01856517|Analgesics|analgesics|mesh-ancestor
110112670|NCT01856517|Sensory System Agents|sensory system agents|mesh-ancestor
110112671|NCT01856517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110112672|NCT01856517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110112673|NCT01856517|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110112674|NCT01856517|Sympatholytics|sympatholytics|mesh-ancestor
110112675|NCT01856517|Autonomic Agents|autonomic agents|mesh-ancestor
110112676|NCT01856517|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110112677|NCT01856517|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110112678|NCT01856517|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110112679|NCT01856517|Adrenergic Agents|adrenergic agents|mesh-ancestor
110112680|NCT01856517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110112681|NCT01856517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110112682|NCT01856556|Glycine|glycine|mesh-list
110112683|NCT01856556|Glycine Agents|glycine agents|mesh-ancestor
110112684|NCT01856556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110112685|NCT01856556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110112686|NCT01856556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110112687|NCT01856621|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
110112688|NCT01856621|Charcoal|charcoal|mesh-list
110112689|NCT01856621|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110112690|NCT01856621|Autonomic Agents|autonomic agents|mesh-ancestor
110112691|NCT01856621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110112692|NCT01856621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110112693|NCT01856621|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110112694|NCT01856621|Respiratory System Agents|respiratory system agents|mesh-ancestor
110112695|NCT01856621|Glucocorticoids|glucocorticoids|mesh-ancestor
110112696|NCT01856621|Hormones|hormones|mesh-ancestor
110112697|NCT01856621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110112698|NCT01856621|Sympathomimetics|sympathomimetics|mesh-ancestor
110112699|NCT01856621|Antidotes|antidotes|mesh-ancestor
110112700|NCT01856621|Protective Agents|protective agents|mesh-ancestor
110112701|NCT01856738|Rivastigmine|rivastigmine|mesh-list
110112702|NCT01856738|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110112703|NCT01856738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110112704|NCT01856738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110112705|NCT01856738|Cholinergic Agents|cholinergic agents|mesh-ancestor
110112706|NCT01856738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110112707|NCT01856738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110112708|NCT01856738|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110112709|NCT01856738|Protective Agents|protective agents|mesh-ancestor
110112710|NCT01856803|Thymoglobulin|thymoglobulin|mesh-list
110112711|NCT01856803|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110112712|NCT01856803|Immunologic Factors|immunologic factors|mesh-ancestor
110112713|NCT01856803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110112714|NCT01856803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110112715|NCT01856946|Vitamin D|vitamin d|mesh-list
110112716|NCT01856946|Cholecalciferol|cholecalciferol|mesh-list
110112717|NCT01856946|Vitamins|vitamins|mesh-ancestor
110112718|NCT01856946|Micronutrients|micronutrients|mesh-ancestor
110112719|NCT01856946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110112720|NCT01856946|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110112721|NCT01856946|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110112722|NCT01856959|Magnesium Sulfate|magnesium sulfate|mesh-list
110112723|NCT01856959|Albuterol|albuterol|mesh-list
110112724|NCT01856959|Analgesics|analgesics|mesh-ancestor
110112725|NCT01856959|Sensory System Agents|sensory system agents|mesh-ancestor
110112726|NCT01856959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110112727|NCT01856959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110112728|NCT01856959|Anesthetics|anesthetics|mesh-ancestor
110112729|NCT01856959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110112730|NCT01856959|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110112731|NCT01856959|Anticonvulsants|anticonvulsants|mesh-ancestor
110112732|NCT01856959|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110112733|NCT01856959|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110112734|NCT01856959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110112735|NCT01856959|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110112736|NCT01856959|Tocolytic Agents|tocolytic agents|mesh-ancestor
110112737|NCT01856959|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110112738|NCT01856959|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110112739|NCT01856959|Autonomic Agents|autonomic agents|mesh-ancestor
110219975|NCT00290602|Methylprednisolone|methylprednisolone|mesh-list
110402646|NCT05715229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110112740|NCT01856959|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110112741|NCT01856959|Respiratory System Agents|respiratory system agents|mesh-ancestor
110112742|NCT01856959|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110112743|NCT01856959|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110112745|NCT01856959|Adrenergic Agents|adrenergic agents|mesh-ancestor
110112746|NCT01856959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110112748|NCT01856985|Mifepristone|mifepristone|mesh-list
110112749|NCT01856985|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110112750|NCT01856985|Abortifacient Agents|abortifacient agents|mesh-ancestor
110112751|NCT01856985|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110112752|NCT01856985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110112754|NCT01856985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110112755|NCT01856985|Oxytocics|oxytocics|mesh-ancestor
110112756|NCT01856985|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
110112757|NCT01856985|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110112758|NCT01856985|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110112759|NCT01856985|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110112760|NCT01856985|Contraceptive Agents|contraceptive agents|mesh-ancestor
110112761|NCT01856985|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
110112762|NCT01856985|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
110112763|NCT01856985|Hormone Antagonists|hormone antagonists|mesh-ancestor
110112764|NCT01856985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110112765|NCT01856985|Luteolytic Agents|luteolytic agents|mesh-ancestor
110112766|NCT01856985|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110112767|NCT01856985|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
110112769|NCT01856998|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110112770|NCT01856998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110112771|NCT01856998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110112772|NCT01856998|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110112773|NCT01856998|Anesthetics, General|anesthetics, general|mesh-ancestor
110112774|NCT01856998|Anesthetics|anesthetics|mesh-ancestor
110112775|NCT01857011|Iron|iron|mesh-list
110112776|NCT01857011|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
110112777|NCT01857011|Teferrol|teferrol|mesh-list
110112778|NCT01857011|Ferric Compounds|ferric compounds|mesh-list
110112779|NCT01857011|Trace Elements|trace elements|mesh-ancestor
110112780|NCT01857011|Micronutrients|micronutrients|mesh-ancestor
110112781|NCT01857011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110112782|NCT01857011|Hematinics|hematinics|mesh-ancestor
110112783|NCT01857024|Sevelamer|sevelamer|mesh-list
110112784|NCT01857024|Chelating Agents|chelating agents|mesh-ancestor
110112785|NCT01857024|Sequestering Agents|sequestering agents|mesh-ancestor
110112786|NCT01857024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110219989|NCT00290602|Hormones|hormones|mesh-ancestor
110112788|NCT01857141|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110112789|NCT01857141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110112790|NCT01857141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110112791|NCT01857141|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110112792|NCT01857141|Analgesics|analgesics|mesh-ancestor
110112793|NCT01857141|Sensory System Agents|sensory system agents|mesh-ancestor
110112794|NCT01857141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110112795|NCT01857141|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110112796|NCT01857141|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110112797|NCT01857141|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110112798|NCT01857141|Adrenergic Agents|adrenergic agents|mesh-ancestor
110112799|NCT01857141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110112800|NCT01857141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110112801|NCT01857154|Calcium, Dietary|calcium, dietary|mesh-list
110112802|NCT01857154|Vitamin D|vitamin d|mesh-list
110112803|NCT01857154|Cholecalciferol|cholecalciferol|mesh-list
110112804|NCT01857154|Calcium Carbonate|calcium carbonate|mesh-list
110112805|NCT01857154|Calcium|calcium|mesh-list
110112806|NCT01857154|Vitamins|vitamins|mesh-ancestor
110112807|NCT01857154|Micronutrients|micronutrients|mesh-ancestor
110112808|NCT01857154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110112809|NCT01857154|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110112810|NCT01857154|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110112812|NCT01857154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110112813|NCT01857154|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110112814|NCT01857193|Everolimus|everolimus|mesh-list
110112815|NCT01857193|Exemestane|exemestane|mesh-list
110112816|NCT01857193|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110112817|NCT01857193|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110112818|NCT01857193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110112819|NCT01857193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110112820|NCT01857193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110112821|NCT01857193|Immunologic Factors|immunologic factors|mesh-ancestor
110112822|NCT01857193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110112823|NCT01857193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110112824|NCT01857193|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110112825|NCT01857193|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110112826|NCT01857193|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110112827|NCT01857193|Hormone Antagonists|hormone antagonists|mesh-ancestor
110112828|NCT01857193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110112829|NCT01857284|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
110112830|NCT01857284|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
110112831|NCT01857284|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
110112832|NCT01857284|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110112833|NCT01857284|Antiviral Agents|antiviral agents|mesh-ancestor
110112834|NCT01857284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110112835|NCT01857349|Ethanol|ethanol|mesh-list
110112836|NCT01857349|Chlorhexidine|chlorhexidine|mesh-list
110112837|NCT01857349|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110112838|NCT01857349|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110112839|NCT01857349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110112840|NCT01857349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110112841|NCT01857349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110112842|NCT01857349|Disinfectants|disinfectants|mesh-ancestor
110112843|NCT01857349|Dermatologic Agents|dermatologic agents|mesh-ancestor
110112844|NCT01857375|Insulin|insulin|mesh-list
110112845|NCT01857375|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110112846|NCT01857375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110112847|NCT01857453|Etoposide|etoposide|mesh-list
110220014|NCT00290641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110220015|NCT00290641|Dermatologic Agents|dermatologic agents|mesh-ancestor
110112848|NCT01857453|Carboplatin|carboplatin|mesh-list
110112849|NCT01857453|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110112850|NCT01857453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110112851|NCT01857453|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110112852|NCT01857453|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110112853|NCT01857453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110112854|NCT01857453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110112855|NCT01857479|Amphotericin B|amphotericin b|mesh-list
110112856|NCT01857479|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
110112857|NCT01857479|Budesonide|budesonide|mesh-list
110112858|NCT01857479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110112859|NCT01857479|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110112860|NCT01857479|Autonomic Agents|autonomic agents|mesh-ancestor
110112861|NCT01857479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110112862|NCT01857479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110112863|NCT01857479|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110112864|NCT01857479|Respiratory System Agents|respiratory system agents|mesh-ancestor
110112865|NCT01857479|Glucocorticoids|glucocorticoids|mesh-ancestor
110112866|NCT01857479|Hormones|hormones|mesh-ancestor
110112867|NCT01857479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110112868|NCT01857479|Amebicides|amebicides|mesh-ancestor
110112869|NCT01857479|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110112870|NCT01857479|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110112871|NCT01857479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110112872|NCT01857479|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110112873|NCT01857479|Antifungal Agents|antifungal agents|mesh-ancestor
110112874|NCT01857544|Aflibercept|aflibercept|mesh-list
110112875|NCT01857544|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110112876|NCT01857544|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110112877|NCT01857544|Growth Substances|growth substances|mesh-ancestor
110112878|NCT01857544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110402666|NCT05707455|Chrysarobin|chrysarobin|mesh-list
110402667|NCT05707455|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110112880|NCT01857544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110112881|NCT01857596|Trazodone|trazodone|mesh-list
110112882|NCT01857596|Bupropion|bupropion|mesh-list
110112883|NCT01857596|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110112884|NCT01857596|Antidepressive Agents|antidepressive agents|mesh-ancestor
110112885|NCT01857596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110112886|NCT01857596|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110112887|NCT01857596|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110112888|NCT01857596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110112889|NCT01857596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110112890|NCT01857596|Dopamine Agents|dopamine agents|mesh-ancestor
110112891|NCT01857596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110112892|NCT01857596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110112893|NCT01857596|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110112894|NCT01857596|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110112895|NCT01857596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110112896|NCT01857596|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110112897|NCT01857596|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110220016|NCT00290641|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110112898|NCT01857596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110112899|NCT01857596|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110112900|NCT01857596|Serotonin Agents|serotonin agents|mesh-ancestor
110112902|NCT01857609|Rabeprazole|rabeprazole|mesh-list
110112903|NCT01857609|Pantoprazole|pantoprazole|mesh-list
110112904|NCT01857609|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110112905|NCT01857609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110112906|NCT01857609|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110112907|NCT01857609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110112908|NCT01857609|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110112909|NCT01857609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110112910|NCT01857609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110112911|NCT01857726|Doxorubicin|doxorubicin|mesh-list
110112912|NCT01857726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110112913|NCT01857726|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110112914|NCT01857726|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110112915|NCT01857726|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110112916|NCT01857726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110112917|NCT01857726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110112918|NCT01857752|Temozolomide|temozolomide|mesh-list
110112919|NCT01857752|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110112920|NCT01857752|Alkylating Agents|alkylating agents|mesh-ancestor
110112921|NCT01857752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110112922|NCT01857752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110112923|NCT01857804|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110112924|NCT01857804|Amoxicillin|amoxicillin|mesh-list
110112925|NCT01857804|Chlorhexidine|chlorhexidine|mesh-list
110112926|NCT01857804|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110112927|NCT01857804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110112928|NCT01857804|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110112929|NCT01857804|Disinfectants|disinfectants|mesh-ancestor
110112930|NCT01857804|Dermatologic Agents|dermatologic agents|mesh-ancestor
110112931|NCT01857817|Etodolac|etodolac|mesh-list
110112932|NCT01857817|Propranolol|propranolol|mesh-list
110112933|NCT01857817|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110112934|NCT01857817|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110112935|NCT01857817|Adrenergic Agents|adrenergic agents|mesh-ancestor
110112936|NCT01857817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110112937|NCT01857817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110112938|NCT01857817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110112939|NCT01857817|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110112940|NCT01857817|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110112941|NCT01857817|Vasodilator Agents|vasodilator agents|mesh-ancestor
110112942|NCT01857817|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110112943|NCT01857817|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110112945|NCT01857817|Sensory System Agents|sensory system agents|mesh-ancestor
110112946|NCT01857817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110112947|NCT01857817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110112948|NCT01857817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110220037|NCT02960815|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110112949|NCT01857817|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110112950|NCT01857817|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110112951|NCT01857817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110112952|NCT01857843|Everolimus|everolimus|mesh-list
110112953|NCT01857843|Simvastatin|simvastatin|mesh-list
110112954|NCT01857843|Ezetimibe|ezetimibe|mesh-list
110112955|NCT01857843|Pravastatin|pravastatin|mesh-list
110112956|NCT01857843|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110112957|NCT01857843|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110112958|NCT01857843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110112959|NCT01857843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110112960|NCT01857843|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110112961|NCT01857843|Immunologic Factors|immunologic factors|mesh-ancestor
110112962|NCT01857843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110112963|NCT01857843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110112964|NCT01857843|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110112965|NCT01857843|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110112966|NCT01857843|Antimetabolites|antimetabolites|mesh-ancestor
110112967|NCT01857843|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110112968|NCT01857843|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110112969|NCT01857856|Eplerenone|eplerenone|mesh-list
110112970|NCT01857856|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110112971|NCT01857856|Hormone Antagonists|hormone antagonists|mesh-ancestor
110112972|NCT01857856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110112973|NCT01857856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110112974|NCT01857856|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110112975|NCT01857856|Diuretics|diuretics|mesh-ancestor
110112976|NCT01857856|Natriuretic Agents|natriuretic agents|mesh-ancestor
110112977|NCT01857856|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110112978|NCT01857895|Exenatide|exenatide|mesh-list
110112980|NCT01857895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110112981|NCT01857895|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110112982|NCT01857895|Incretins|incretins|mesh-ancestor
110112983|NCT01857895|Hormones|hormones|mesh-ancestor
110112984|NCT01857895|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110112985|NCT01857921|Trimetazidine|trimetazidine|mesh-list
110112986|NCT01857921|Atorvastatin|atorvastatin|mesh-list
110112987|NCT01857921|Pravastatin|pravastatin|mesh-list
110112988|NCT01857921|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110112989|NCT01857921|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110112990|NCT01857921|Antimetabolites|antimetabolites|mesh-ancestor
110112991|NCT01857921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110112992|NCT01857921|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110112993|NCT01857921|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110112994|NCT01857921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110112995|NCT01857921|Vasodilator Agents|vasodilator agents|mesh-ancestor
110112996|NCT01857999|Losartan|losartan|mesh-list
110112997|NCT01857999|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110112998|NCT01857999|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110112999|NCT01857999|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110113000|NCT01857999|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110113001|NCT01857999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110113002|NCT01858025|Fluorouracil|fluorouracil|mesh-list
110113003|NCT01858025|Mitomycins|mitomycins|mesh-list
110113004|NCT01858025|Mitomycin|mitomycin|mesh-list
110113005|NCT01858025|Antimetabolites|antimetabolites|mesh-ancestor
110113006|NCT01858025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110113007|NCT01858025|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110113008|NCT01858025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110113009|NCT01858025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110113010|NCT01858025|Immunologic Factors|immunologic factors|mesh-ancestor
110113011|NCT01858025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110113012|NCT01858025|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110113013|NCT01858025|Alkylating Agents|alkylating agents|mesh-ancestor
110113014|NCT01858025|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110113015|NCT01858025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110113016|NCT01858051|Cholecalciferol|cholecalciferol|mesh-list
110113017|NCT01858051|Vitamin D|vitamin d|mesh-list
110113018|NCT01858051|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110113019|NCT01858051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110113020|NCT01858051|Vitamins|vitamins|mesh-ancestor
110113021|NCT01858051|Micronutrients|micronutrients|mesh-ancestor
110113022|NCT01858051|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110113023|NCT01858077|Everolimus|everolimus|mesh-list
110113024|NCT01858077|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110113025|NCT01858077|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110113026|NCT01858077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110113027|NCT01858077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110113028|NCT01858077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110113029|NCT01858077|Immunologic Factors|immunologic factors|mesh-ancestor
110113030|NCT01858077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110113031|NCT01858077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110113032|NCT01858090|Diphenhydramine|diphenhydramine|mesh-list
110113033|NCT01858090|Promethazine|promethazine|mesh-list
110113034|NCT01858090|Diclofenac|diclofenac|mesh-list
110113035|NCT01858090|Atropine|atropine|mesh-list
110113036|NCT01858090|Ephedrine|ephedrine|mesh-list
110113037|NCT01858090|Fentanyl|fentanyl|mesh-list
110113038|NCT01858090|Sufentanil|sufentanil|mesh-list
110113039|NCT01858090|Meperidine|meperidine|mesh-list
110113040|NCT01858090|Metoclopramide|metoclopramide|mesh-list
110113041|NCT01858090|Propofol|propofol|mesh-list
110113042|NCT01858090|Levobupivacaine|levobupivacaine|mesh-list
110113043|NCT01858090|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110113044|NCT01858090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110113045|NCT01858090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110113046|NCT01858090|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110113047|NCT01858090|Anesthetics, General|anesthetics, general|mesh-ancestor
110113048|NCT01858090|Anesthetics|anesthetics|mesh-ancestor
110113049|NCT01858090|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110113050|NCT01858090|Narcotics|narcotics|mesh-ancestor
110113051|NCT01858090|Analgesics|analgesics|mesh-ancestor
110113052|NCT01858090|Sensory System Agents|sensory system agents|mesh-ancestor
110113053|NCT01858090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110113054|NCT01858090|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110113055|NCT01858090|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110113056|NCT01858090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110113057|NCT01858090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110113058|NCT01858090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110113059|NCT01858090|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110113060|NCT01858090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110113061|NCT01858090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110113062|NCT01858090|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110113063|NCT01858090|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110113064|NCT01858090|Autonomic Agents|autonomic agents|mesh-ancestor
110113065|NCT01858090|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110113066|NCT01858090|Respiratory System Agents|respiratory system agents|mesh-ancestor
110113067|NCT01858090|Mydriatics|mydriatics|mesh-ancestor
110113068|NCT01858090|Parasympatholytics|parasympatholytics|mesh-ancestor
110220082|NCT00290914|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110113069|NCT01858090|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110113070|NCT01858090|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110113071|NCT01858090|Cholinergic Agents|cholinergic agents|mesh-ancestor
110113072|NCT01858090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110113073|NCT01858090|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110113074|NCT01858090|Anesthetics, Local|anesthetics, local|mesh-ancestor
110113075|NCT01858090|Antiemetics|antiemetics|mesh-ancestor
110113076|NCT01858090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110113077|NCT01858090|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110113078|NCT01858090|Histamine Antagonists|histamine antagonists|mesh-ancestor
110113079|NCT01858090|Histamine Agents|histamine agents|mesh-ancestor
110113080|NCT01858090|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110113081|NCT01858090|Antipruritics|antipruritics|mesh-ancestor
110113082|NCT01858090|Dermatologic Agents|dermatologic agents|mesh-ancestor
110113083|NCT01858090|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110113084|NCT01858090|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110113085|NCT01858090|Dopamine Agents|dopamine agents|mesh-ancestor
110113086|NCT01858090|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110113087|NCT01858090|Sympathomimetics|sympathomimetics|mesh-ancestor
110113088|NCT01858090|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110113089|NCT01858090|Adrenergic Agents|adrenergic agents|mesh-ancestor
110113090|NCT01858155|Melatonin|melatonin|mesh-list
110113091|NCT01858155|Antioxidants|antioxidants|mesh-ancestor
110113092|NCT01858155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110113093|NCT01858155|Protective Agents|protective agents|mesh-ancestor
110113094|NCT01858155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110113095|NCT01858155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110113097|NCT01858168|Temozolomide|temozolomide|mesh-list
110113098|NCT01858168|Olaparib|olaparib|mesh-list
110113099|NCT01858168|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110113100|NCT01858168|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110113101|NCT01858168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110113102|NCT01858168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110113103|NCT01858168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110113104|NCT01858168|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110113105|NCT01858168|Alkylating Agents|alkylating agents|mesh-ancestor
110113106|NCT01858168|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110113107|NCT01858207|Doxorubicin|doxorubicin|mesh-list
110113108|NCT01858207|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110113109|NCT01858207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110113110|NCT01858207|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110113111|NCT01858207|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110113112|NCT01858207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110113113|NCT01858207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110113114|NCT01858311|Tocotrienols|tocotrienols|mesh-list
110113115|NCT01858311|Vitamin E|vitamin e|mesh-list
110113116|NCT01858311|Tocopherols|tocopherols|mesh-list
110113117|NCT01858311|Antioxidants|antioxidants|mesh-ancestor
110113118|NCT01858311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110113119|NCT01858311|Protective Agents|protective agents|mesh-ancestor
110113120|NCT01858311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110113121|NCT01858311|Vitamins|vitamins|mesh-ancestor
110113122|NCT01858311|Micronutrients|micronutrients|mesh-ancestor
110220096|NCT00291109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110113123|NCT01858402|Acetaminophen|acetaminophen|mesh-list
110113124|NCT01858402|Dipyrone|dipyrone|mesh-list
110113125|NCT01858402|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110113126|NCT01858402|Analgesics|analgesics|mesh-ancestor
110113127|NCT01858402|Sensory System Agents|sensory system agents|mesh-ancestor
110113128|NCT01858402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110113129|NCT01858402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110113130|NCT01858402|Antipyretics|antipyretics|mesh-ancestor
110113131|NCT01858402|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110113133|NCT01858402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110113134|NCT01858441|Abiraterone Acetate|abiraterone acetate|mesh-list
110113135|NCT01858441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110113136|NCT01858441|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110402696|NCT05704725|Growth Inhibitors|growth inhibitors|mesh-ancestor
110402697|NCT05704725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110402698|NCT05660850|Mannitol|mannitol|mesh-list
110402699|NCT05660850|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110402700|NCT05660850|Diuretics|diuretics|mesh-ancestor
110402701|NCT05660850|Natriuretic Agents|natriuretic agents|mesh-ancestor
110402702|NCT05660850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110057083|NCT01506011|Amlodipine|amlodipine|mesh-list
110113137|NCT01858441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110113138|NCT01858441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110113139|NCT01858441|Hormone Antagonists|hormone antagonists|mesh-ancestor
110113140|NCT01858441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110113141|NCT01858441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110113142|NCT01858441|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110113144|NCT01858571|Celecoxib|celecoxib|mesh-list
110113145|NCT01858571|Cyclophosphamide|cyclophosphamide|mesh-list
110113146|NCT01858571|Etoposide|etoposide|mesh-list
110113147|NCT01858571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110113148|NCT01858571|Immunologic Factors|immunologic factors|mesh-ancestor
110113149|NCT01858571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110113150|NCT01858571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110113151|NCT01858571|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110113152|NCT01858571|Alkylating Agents|alkylating agents|mesh-ancestor
110113153|NCT01858571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110113154|NCT01858571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110113155|NCT01858571|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110113156|NCT01858571|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110113157|NCT01858571|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110113158|NCT01858571|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110113159|NCT01858571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110113160|NCT01858571|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110113161|NCT01858571|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110162470|NCT00113113|Rubitecan|rubitecan|mesh-list
110113162|NCT01858571|Analgesics|analgesics|mesh-ancestor
110113163|NCT01858571|Sensory System Agents|sensory system agents|mesh-ancestor
110113164|NCT01858571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110113165|NCT01858571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110113166|NCT01858571|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110113167|NCT01858571|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110113168|NCT01858571|Leprostatic Agents|leprostatic agents|mesh-ancestor
110113169|NCT01858571|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110113170|NCT01858571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110113171|NCT01858571|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110113172|NCT01858571|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110113173|NCT01858571|Growth Substances|growth substances|mesh-ancestor
110113174|NCT01858571|Growth Inhibitors|growth inhibitors|mesh-ancestor
110113175|NCT01858610|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110113176|NCT01858610|Irbesartan|irbesartan|mesh-list
110113177|NCT01858610|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110113178|NCT01858610|Diuretics|diuretics|mesh-ancestor
110113179|NCT01858610|Natriuretic Agents|natriuretic agents|mesh-ancestor
110113180|NCT01858610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110220114|NCT00291148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110220115|NCT00291148|Serotonin Agents|serotonin agents|mesh-ancestor
110220120|NCT00291148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110113181|NCT01858610|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110113182|NCT01858610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110113183|NCT01858610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110113184|NCT01858610|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110113185|NCT01858610|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110113186|NCT01858623|Losartan|losartan|mesh-list
110113187|NCT01858623|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110113188|NCT01858623|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110113189|NCT01858623|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110113190|NCT01858623|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110113191|NCT01858623|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110113192|NCT01858623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110113193|NCT01858623|Diuretics|diuretics|mesh-ancestor
110113194|NCT01858623|Natriuretic Agents|natriuretic agents|mesh-ancestor
110113195|NCT01858623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110113196|NCT01858623|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110113197|NCT01858623|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110113198|NCT01858649|Bevacizumab|bevacizumab|mesh-list
110113199|NCT01858649|Oxaliplatin|oxaliplatin|mesh-list
110113200|NCT01858649|Irinotecan|irinotecan|mesh-list
110113201|NCT01858649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110113202|NCT01858649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110113203|NCT01858649|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110113204|NCT01858649|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110113205|NCT01858649|Growth Substances|growth substances|mesh-ancestor
110113206|NCT01858649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110113207|NCT01858649|Growth Inhibitors|growth inhibitors|mesh-ancestor
110113208|NCT01858649|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110113209|NCT01858649|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110113210|NCT01858649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110113211|NCT01858649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110113213|NCT01858662|Oxaliplatin|oxaliplatin|mesh-list
110113214|NCT01858662|Irinotecan|irinotecan|mesh-list
110113215|NCT01858662|Cetuximab|cetuximab|mesh-list
110113216|NCT01858662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110113217|NCT01858662|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110113218|NCT01858662|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110113219|NCT01858662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110113220|NCT01858662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110113221|NCT01858662|Antidotes|antidotes|mesh-ancestor
110113222|NCT01858662|Protective Agents|protective agents|mesh-ancestor
110113223|NCT01858662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110113224|NCT01858662|Vitamin B Complex|vitamin b complex|mesh-ancestor
110113225|NCT01858662|Vitamins|vitamins|mesh-ancestor
110162476|NCT00007787|Cyclosporine|cyclosporine|mesh-list
110113226|NCT01858662|Micronutrients|micronutrients|mesh-ancestor
110113227|NCT01858662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110113229|NCT01858792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110113230|NCT01858792|Immunologic Factors|immunologic factors|mesh-ancestor
110113231|NCT01858792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110220122|NCT00291382|Xhance|xhance|mesh-list
110113232|NCT01858831|Atovaquone|atovaquone|mesh-list
110113233|NCT01858831|Proguanil|proguanil|mesh-list
110113234|NCT01858831|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
110113235|NCT01858831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110113236|NCT01858831|Antimalarials|antimalarials|mesh-ancestor
110113237|NCT01858831|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110113238|NCT01858831|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110113239|NCT01858831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110113240|NCT01858831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110113241|NCT01858831|Antimetabolites|antimetabolites|mesh-ancestor
110113242|NCT01858870|Lacosamide|lacosamide|mesh-list
110113243|NCT01858870|Anticonvulsants|anticonvulsants|mesh-ancestor
110113244|NCT01858870|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110113245|NCT01858870|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110113246|NCT01858870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110113247|NCT01858870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110113248|NCT01858909|Melatonin|melatonin|mesh-list
110113249|NCT01858909|Antioxidants|antioxidants|mesh-ancestor
110113250|NCT01858909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110113251|NCT01858909|Protective Agents|protective agents|mesh-ancestor
110113252|NCT01858909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110113253|NCT01858909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110113254|NCT01858961|Interferons|interferons|mesh-list
110113255|NCT01858961|Ribavirin|ribavirin|mesh-list
110113256|NCT01858961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110113257|NCT01858961|Antiviral Agents|antiviral agents|mesh-ancestor
110113258|NCT01858961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110113259|NCT01858961|Antimetabolites|antimetabolites|mesh-ancestor
110113260|NCT01858961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110113261|NCT01859234|Bevacizumab|bevacizumab|mesh-list
110113262|NCT01859234|89Zr-bevacizumab|89zr-bevacizumab|mesh-list
110113263|NCT01859234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110113264|NCT01859234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110113265|NCT01859234|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110113266|NCT01859234|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110402724|NCT05628038|Leucovorin|leucovorin|mesh-list
110402725|NCT05628038|Folic Acid|folic acid|mesh-list
110402726|NCT05628038|Fluorouracil|fluorouracil|mesh-list
110402727|NCT05628038|Capecitabine|capecitabine|mesh-list
110402728|NCT05628038|Raltitrexed|raltitrexed|mesh-list
110113267|NCT01859234|Growth Substances|growth substances|mesh-ancestor
110113268|NCT01859234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110113269|NCT01859234|Growth Inhibitors|growth inhibitors|mesh-ancestor
110113270|NCT01859234|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110113271|NCT01859234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110113273|NCT01859377|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110113274|NCT01859377|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110113275|NCT01859377|Analgesics|analgesics|mesh-ancestor
110113276|NCT01859377|Sensory System Agents|sensory system agents|mesh-ancestor
110113277|NCT01859377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110220145|NCT00112476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110220155|NCT00291538|Bortezomib|bortezomib|mesh-list
110113278|NCT01859377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110113279|NCT01859377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110113280|NCT01859377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110113281|NCT01859377|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110113282|NCT01859377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110113283|NCT01859377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110113284|NCT01859455|Atorvastatin|atorvastatin|mesh-list
110113285|NCT01859455|Simvastatin|simvastatin|mesh-list
110113286|NCT01859455|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110113287|NCT01859455|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110113288|NCT01859455|Antimetabolites|antimetabolites|mesh-ancestor
110113289|NCT01859455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110113290|NCT01859455|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110113291|NCT01859455|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110113292|NCT01859455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110113293|NCT01859468|Calcium Carbonate|calcium carbonate|mesh-list
110113294|NCT01859468|Calcium|calcium|mesh-list
110162486|NCT00007787|Antifungal Agents|antifungal agents|mesh-ancestor
110113295|NCT01859468|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110113296|NCT01859468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110113298|NCT01859468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110113299|NCT01859468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110113300|NCT01859481|Eletriptan|eletriptan|mesh-list
110113301|NCT01859481|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110113302|NCT01859481|Serotonin Agents|serotonin agents|mesh-ancestor
110113303|NCT01859481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110113304|NCT01859481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110113305|NCT01859481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110113306|NCT01859585|Ketorolac|ketorolac|mesh-list
110113307|NCT01859585|Parecoxib|parecoxib|mesh-list
110113308|NCT01859585|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110113309|NCT01859585|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110113310|NCT01859585|Analgesics|analgesics|mesh-ancestor
110113311|NCT01859585|Sensory System Agents|sensory system agents|mesh-ancestor
110113312|NCT01859585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110113313|NCT01859585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110113314|NCT01859585|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110113315|NCT01859585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110113316|NCT01859585|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110113317|NCT01859585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110113318|NCT01859585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110113319|NCT01859585|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110113320|NCT01859624|Albuterol|albuterol|mesh-list
110113321|NCT01859624|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110402733|NCT05628038|Immunologic Factors|immunologic factors|mesh-ancestor
110402734|NCT05628038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110113322|NCT01859624|Autonomic Agents|autonomic agents|mesh-ancestor
110113323|NCT01859624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110113324|NCT01859624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110113325|NCT01859624|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110113326|NCT01859624|Respiratory System Agents|respiratory system agents|mesh-ancestor
110113327|NCT01859624|Tocolytic Agents|tocolytic agents|mesh-ancestor
110113328|NCT01859624|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110113329|NCT01859624|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110113330|NCT01859624|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110113331|NCT01859624|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110113332|NCT01859624|Adrenergic Agents|adrenergic agents|mesh-ancestor
110113333|NCT01859624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110113334|NCT01859624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110113335|NCT01859728|Cisplatin|cisplatin|mesh-list
110113336|NCT01859728|Gemcitabine|gemcitabine|mesh-list
110113337|NCT01859728|Irinotecan|irinotecan|mesh-list
110113338|NCT01859728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110113339|NCT01859728|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110113340|NCT01859728|Antimetabolites|antimetabolites|mesh-ancestor
110113341|NCT01859728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110113342|NCT01859728|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110113343|NCT01859728|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110113344|NCT01859728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110113345|NCT01859754|gamma-Globulins|gamma-globulins|mesh-list
110113346|NCT01859754|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110113347|NCT01859754|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110113348|NCT01859754|Immunologic Factors|immunologic factors|mesh-ancestor
110113349|NCT01859754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110113351|NCT01859858|Irinotecan|irinotecan|mesh-list
110113352|NCT01859858|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110113353|NCT01859858|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110113354|NCT01859858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110113355|NCT01859858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110113356|NCT01859858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110113357|NCT01859858|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110113358|NCT01859858|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110113359|NCT01859858|Analgesics|analgesics|mesh-ancestor
110113360|NCT01859858|Sensory System Agents|sensory system agents|mesh-ancestor
110113361|NCT01859858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110113362|NCT01859858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110113363|NCT01859858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110113364|NCT01859858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110113365|NCT01860014|Poractant alfa|poractant alfa|mesh-list
110113366|NCT01860014|Beractant|beractant|mesh-list
110113367|NCT01860014|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
110113368|NCT01860014|Respiratory System Agents|respiratory system agents|mesh-ancestor
110113369|NCT01860066|Fluticasone|fluticasone|mesh-list
110113370|NCT01860066|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110113371|NCT01860066|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
110113372|NCT01860066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110113373|NCT01860066|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110113374|NCT01860066|Autonomic Agents|autonomic agents|mesh-ancestor
110113375|NCT01860066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110113376|NCT01860066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110113377|NCT01860066|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110113378|NCT01860066|Respiratory System Agents|respiratory system agents|mesh-ancestor
110113379|NCT01860066|Dermatologic Agents|dermatologic agents|mesh-ancestor
110113380|NCT01860066|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110113381|NCT01860066|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110113382|NCT01860066|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110113383|NCT01860066|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110113384|NCT01860066|Adrenergic Agents|adrenergic agents|mesh-ancestor
110113385|NCT01860066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110113386|NCT01860066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110113387|NCT01860066|Glucocorticoids|glucocorticoids|mesh-ancestor
110113388|NCT01860066|Hormones|hormones|mesh-ancestor
110113389|NCT01860066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110113390|NCT01860066|Sympathomimetics|sympathomimetics|mesh-ancestor
110113391|NCT01860105|Clopidogrel|clopidogrel|mesh-list
110113392|NCT01860105|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110402755|NCT05625399|Nivolumab|nivolumab|mesh-list
110113393|NCT01860105|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110113394|NCT01860105|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110113395|NCT01860105|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110113396|NCT01860105|Purinergic Agents|purinergic agents|mesh-ancestor
110113397|NCT01860105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110113398|NCT01860105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110220186|NCT00291772|Pramlintide|pramlintide|mesh-list
110113399|NCT01860105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110113400|NCT01860144|Bevacizumab|bevacizumab|mesh-list
110113401|NCT01860144|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110113402|NCT01860144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110113403|NCT01860144|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110113404|NCT01860144|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110113405|NCT01860144|Growth Substances|growth substances|mesh-ancestor
110113406|NCT01860144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110113407|NCT01860144|Growth Inhibitors|growth inhibitors|mesh-ancestor
110113408|NCT01860183|Mycophenolic Acid|mycophenolic acid|mesh-list
110113409|NCT01860183|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110113410|NCT01860183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110113411|NCT01860183|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110113412|NCT01860183|Antitubercular Agents|antitubercular agents|mesh-ancestor
110113413|NCT01860183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110113414|NCT01860183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110113415|NCT01860183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110113416|NCT01860183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110113417|NCT01860196|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110113418|NCT01860196|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110113419|NCT01860196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110113420|NCT01860196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110113421|NCT01860196|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110113422|NCT01860196|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110113423|NCT01860196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110113424|NCT01860196|Cholinergic Agents|cholinergic agents|mesh-ancestor
110113425|NCT01860196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110113426|NCT01860235|Anesthetics|anesthetics|mesh-list
110113428|NCT01860235|Anesthetics, Local|anesthetics, local|mesh-list
110113429|NCT01860235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110113430|NCT01860235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110113431|NCT01860235|Sensory System Agents|sensory system agents|mesh-ancestor
110113432|NCT01860235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110113434|NCT01860300|Clavulanic Acid|clavulanic acid|mesh-list
110113435|NCT01860300|Clavulanic Acids|clavulanic acids|mesh-list
110113436|NCT01860300|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
110113437|NCT01860300|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110113438|NCT01860300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110113439|NCT01860300|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110113440|NCT01860300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110113441|NCT01860300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110113442|NCT01860391|Fluorides|fluorides|mesh-list
110113443|NCT01860391|Cariostatic Agents|cariostatic agents|mesh-ancestor
110113444|NCT01860391|Protective Agents|protective agents|mesh-ancestor
110113445|NCT01860391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110113446|NCT01860417|Mepivacaine|mepivacaine|mesh-list
110113447|NCT01860417|Anesthetics, Local|anesthetics, local|mesh-ancestor
110113448|NCT01860417|Anesthetics|anesthetics|mesh-ancestor
110113449|NCT01860417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110113450|NCT01860417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110113451|NCT01860417|Sensory System Agents|sensory system agents|mesh-ancestor
110113452|NCT01860417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110113453|NCT01860469|Vancomycin|vancomycin|mesh-list
110113454|NCT01860469|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110113455|NCT01860469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110113456|NCT01860482|Rabeprazole|rabeprazole|mesh-list
110113457|NCT01860482|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110113458|NCT01860482|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110113459|NCT01860482|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110113460|NCT01860482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110220196|NCT00291811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110113461|NCT01860482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110113462|NCT01860508|Carboplatin|carboplatin|mesh-list
110113463|NCT01860508|Pemetrexed|pemetrexed|mesh-list
110113464|NCT01860508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110113465|NCT01860508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110113466|NCT01860508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110113467|NCT01860508|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110113468|NCT01860508|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110113469|NCT01860625|Donepezil|donepezil|mesh-list
110113470|NCT01860625|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110113471|NCT01860625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110113472|NCT01860625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110113473|NCT01860625|Cholinergic Agents|cholinergic agents|mesh-ancestor
110113474|NCT01860625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110113475|NCT01860625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110113476|NCT01860625|Nootropic Agents|nootropic agents|mesh-ancestor
110113477|NCT01860638|Bevacizumab|bevacizumab|mesh-list
110113478|NCT01860638|Temozolomide|temozolomide|mesh-list
110113479|NCT01860638|Lomustine|lomustine|mesh-list
110113480|NCT01860638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110113481|NCT01860638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110113482|NCT01860638|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110113483|NCT01860638|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110113484|NCT01860638|Growth Substances|growth substances|mesh-ancestor
110113485|NCT01860638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110113486|NCT01860638|Growth Inhibitors|growth inhibitors|mesh-ancestor
110113487|NCT01860638|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110113488|NCT01860638|Alkylating Agents|alkylating agents|mesh-ancestor
110113489|NCT01860638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110113490|NCT01860664|Hydrocortisone|hydrocortisone|mesh-list
110113491|NCT01860664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110113492|NCT01860690|Methotrexate|methotrexate|mesh-list
110113493|NCT01860690|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110113494|NCT01860690|Abortifacient Agents|abortifacient agents|mesh-ancestor
110113495|NCT01860690|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110113496|NCT01860690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110113497|NCT01860690|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110113498|NCT01860690|Antimetabolites|antimetabolites|mesh-ancestor
110113499|NCT01860690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110113500|NCT01860690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110113501|NCT01860690|Dermatologic Agents|dermatologic agents|mesh-ancestor
110162503|NCT00113503|Azathioprine|azathioprine|mesh-list
110113502|NCT01860690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110113503|NCT01860690|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110113504|NCT01860690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110113505|NCT01860690|Immunologic Factors|immunologic factors|mesh-ancestor
110113506|NCT01860690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110113507|NCT01860690|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110113509|NCT01860716|Antioxidants|antioxidants|mesh-ancestor
110113510|NCT01860716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110113511|NCT01860716|Protective Agents|protective agents|mesh-ancestor
110113512|NCT01860716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110113513|NCT01860716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110113514|NCT01860729|Anacetrapib|anacetrapib|mesh-list
110113515|NCT01860729|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110113516|NCT01860729|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110113517|NCT01860729|Antimetabolites|antimetabolites|mesh-ancestor
110113518|NCT01860729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110113519|NCT01860729|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110220209|NCT00112554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110113521|NCT01860742|Interferon-alpha|interferon-alpha|mesh-list
110113522|NCT01860742|Interferon alpha-2|interferon alpha-2|mesh-list
110113523|NCT01860742|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
110113524|NCT01860742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110113525|NCT01860742|Antiviral Agents|antiviral agents|mesh-ancestor
110113526|NCT01860742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110113527|NCT01860742|Immunologic Factors|immunologic factors|mesh-ancestor
110113528|NCT01860742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110113529|NCT01860742|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110113530|NCT01860742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110113531|NCT01860781|Paliperidone Palmitate|paliperidone palmitate|mesh-list
110113532|NCT01860781|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110113533|NCT01860781|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110113534|NCT01860781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110113535|NCT01860781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110113536|NCT01860781|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110113537|NCT01860781|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110113538|NCT01860781|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110113539|NCT01860781|Serotonin Agents|serotonin agents|mesh-ancestor
110113540|NCT01860781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110113541|NCT01860781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110113542|NCT01860781|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110113543|NCT01860781|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110113544|NCT01860781|Dopamine Agents|dopamine agents|mesh-ancestor
110113545|NCT01860833|Ibuprofen|ibuprofen|mesh-list
110113546|NCT01860833|Celecoxib|celecoxib|mesh-list
110113547|NCT01860833|Diclofenac|diclofenac|mesh-list
110113548|NCT01860833|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110113549|NCT01860833|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110113550|NCT01860833|Analgesics|analgesics|mesh-ancestor
110113551|NCT01860833|Sensory System Agents|sensory system agents|mesh-ancestor
110113552|NCT01860833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110113553|NCT01860833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110113554|NCT01860833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110113555|NCT01860833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110113556|NCT01860833|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110402785|NCT05592951|Autonomic Agents|autonomic agents|mesh-ancestor
110113557|NCT01860833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110113558|NCT01860833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110113559|NCT01860833|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110113560|NCT01860911|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
110113561|NCT01860911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110113562|NCT01860911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110113563|NCT01861015|Vasopressins|vasopressins|mesh-list
110113564|NCT01861015|Arginine Vasopressin|arginine vasopressin|mesh-list
110113565|NCT01861015|Epinephrine|epinephrine|mesh-list
110113566|NCT01861015|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110113567|NCT01861015|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110113568|NCT01861015|Adrenergic Agents|adrenergic agents|mesh-ancestor
110113569|NCT01861015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110113570|NCT01861015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110113571|NCT01861015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110113572|NCT01861015|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110220224|NCT00078689|Immunologic Factors|immunologic factors|mesh-ancestor
110113573|NCT01861015|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110113574|NCT01861015|Autonomic Agents|autonomic agents|mesh-ancestor
110113575|NCT01861015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110113576|NCT01861015|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110113577|NCT01861015|Respiratory System Agents|respiratory system agents|mesh-ancestor
110113578|NCT01861015|Mydriatics|mydriatics|mesh-ancestor
110113579|NCT01861015|Sympathomimetics|sympathomimetics|mesh-ancestor
110113580|NCT01861015|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110113581|NCT01861015|Hemostatics|hemostatics|mesh-ancestor
110113582|NCT01861015|Coagulants|coagulants|mesh-ancestor
110113583|NCT01861015|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
110113584|NCT01861015|Natriuretic Agents|natriuretic agents|mesh-ancestor
110113585|NCT01861041|Bupivacaine|bupivacaine|mesh-list
110113586|NCT01861041|Anesthetics, Local|anesthetics, local|mesh-ancestor
110113587|NCT01861041|Anesthetics|anesthetics|mesh-ancestor
110113588|NCT01861041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110113589|NCT01861041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110113590|NCT01861041|Sensory System Agents|sensory system agents|mesh-ancestor
110113591|NCT01861041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110113592|NCT01861145|Mometasone Furoate|mometasone furoate|mesh-list
110113593|NCT01861145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110113594|NCT01861145|Dermatologic Agents|dermatologic agents|mesh-ancestor
110113595|NCT01861145|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110113596|NCT01861223|Afatinib|afatinib|mesh-list
110113597|NCT01861223|Nimotuzumab|nimotuzumab|mesh-list
110113598|NCT01861223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110113599|NCT01861223|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110113600|NCT01861223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110113601|NCT01861223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110113602|NCT01861223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110113603|NCT01861340|Dexamethasone|dexamethasone|mesh-list
110113604|NCT01861340|Lenalidomide|lenalidomide|mesh-list
110113605|NCT01861340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110113606|NCT01861340|Antiemetics|antiemetics|mesh-ancestor
110113607|NCT01861340|Autonomic Agents|autonomic agents|mesh-ancestor
110113608|NCT01861340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110113609|NCT01861340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110113610|NCT01861340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110113611|NCT01861340|Glucocorticoids|glucocorticoids|mesh-ancestor
110113612|NCT01861340|Hormones|hormones|mesh-ancestor
110113613|NCT01861340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110113614|NCT01861340|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110113615|NCT01861340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110113616|NCT01861340|Immunologic Factors|immunologic factors|mesh-ancestor
110113617|NCT01861340|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110113618|NCT01861340|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110113619|NCT01861340|Growth Substances|growth substances|mesh-ancestor
110113620|NCT01861340|Growth Inhibitors|growth inhibitors|mesh-ancestor
110113621|NCT01861535|Imiquimod|imiquimod|mesh-list
110113622|NCT01861535|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110113623|NCT01861535|Immunologic Factors|immunologic factors|mesh-ancestor
110113624|NCT01861535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110113625|NCT01861535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110113626|NCT01861535|Interferon Inducers|interferon inducers|mesh-ancestor
110113627|NCT01861561|Cyclophosphamide|cyclophosphamide|mesh-list
110113628|NCT01861561|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110113629|NCT01861561|Immunologic Factors|immunologic factors|mesh-ancestor
110113630|NCT01861561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110113631|NCT01861561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110113632|NCT01861561|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110113633|NCT01861561|Alkylating Agents|alkylating agents|mesh-ancestor
110113634|NCT01861561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110113635|NCT01861561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110113636|NCT01861561|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110113637|NCT01861626|Isotretinoin|isotretinoin|mesh-list
110113638|NCT01861626|Dermatologic Agents|dermatologic agents|mesh-ancestor
110113639|NCT01861912|Arsenic Trioxide|arsenic trioxide|mesh-list
110113640|NCT01861912|Ethiodized Oil|ethiodized oil|mesh-list
110113641|NCT01861912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110113642|NCT01861951|Doxorubicin|doxorubicin|mesh-list
110113643|NCT01861951|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110113644|NCT01861951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110113645|NCT01861951|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110113646|NCT01861951|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110113647|NCT01861951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110113648|NCT01861951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110113649|NCT01861990|Valproic Acid|valproic acid|mesh-list
110113650|NCT01861990|Anticonvulsants|anticonvulsants|mesh-ancestor
110113651|NCT01861990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110113652|NCT01861990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110113653|NCT01861990|GABA Agents|gaba agents|mesh-ancestor
110113654|NCT01861990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110113655|NCT01861990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110113656|NCT01861990|Antimanic Agents|antimanic agents|mesh-ancestor
110113657|NCT01861990|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110113658|NCT01861990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110113659|NCT01861990|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110113661|NCT01862003|Folic Acid|folic acid|mesh-list
110113662|NCT01862003|Fluorouracil|fluorouracil|mesh-list
110113663|NCT01862003|Irinotecan|irinotecan|mesh-list
110113664|NCT01862003|Levoleucovorin|levoleucovorin|mesh-list
110113665|NCT01862003|Antimetabolites|antimetabolites|mesh-ancestor
110113666|NCT01862003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110113667|NCT01862003|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110113668|NCT01862003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110113669|NCT01862003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110113670|NCT01862003|Immunologic Factors|immunologic factors|mesh-ancestor
110113671|NCT01862003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110113672|NCT01862003|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110113673|NCT01862003|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110113674|NCT01862003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110113675|NCT01862003|Antidotes|antidotes|mesh-ancestor
110113676|NCT01862003|Protective Agents|protective agents|mesh-ancestor
110113677|NCT01862003|Vitamin B Complex|vitamin b complex|mesh-ancestor
110113678|NCT01862003|Vitamins|vitamins|mesh-ancestor
110113679|NCT01862003|Micronutrients|micronutrients|mesh-ancestor
110113680|NCT01862003|Hematinics|hematinics|mesh-ancestor
110113681|NCT01862081|Paclitaxel|paclitaxel|mesh-list
110113682|NCT01862081|Docetaxel|docetaxel|mesh-list
110113683|NCT01862081|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110113684|NCT01862081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110113685|NCT01862081|Tubulin Modulators|tubulin modulators|mesh-ancestor
110113686|NCT01862081|Antimitotic Agents|antimitotic agents|mesh-ancestor
110113687|NCT01862081|Mitosis Modulators|mitosis modulators|mesh-ancestor
110113688|NCT01862081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110113689|NCT01862120|Interleukin-2|interleukin-2|mesh-list
110113690|NCT01862120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110113691|NCT01862120|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110113692|NCT01862120|Analgesics|analgesics|mesh-ancestor
110113693|NCT01862120|Sensory System Agents|sensory system agents|mesh-ancestor
110113694|NCT01862120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110113695|NCT01862120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110113696|NCT01862263|Vildagliptin|vildagliptin|mesh-list
110113697|NCT01862263|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110113698|NCT01862263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110113699|NCT01862263|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110113700|NCT01862263|Protease Inhibitors|protease inhibitors|mesh-ancestor
110113701|NCT01862263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110113702|NCT01862263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110113703|NCT01862302|Haloperidol|haloperidol|mesh-list
110113704|NCT01862302|Haloperidol decanoate|haloperidol decanoate|mesh-list
110113705|NCT01862302|Antiemetics|antiemetics|mesh-ancestor
110113706|NCT01862302|Autonomic Agents|autonomic agents|mesh-ancestor
110113707|NCT01862302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110113708|NCT01862302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110113709|NCT01862302|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110113710|NCT01862302|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110113711|NCT01862302|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110113712|NCT01862302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110113713|NCT01862302|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110113714|NCT01862302|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110113715|NCT01862302|Dopamine Agents|dopamine agents|mesh-ancestor
110113716|NCT01862302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110113717|NCT01862302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110113718|NCT01862302|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110113719|NCT01862354|Anesthetics|anesthetics|mesh-list
110113720|NCT01862354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110113721|NCT01862354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110113722|NCT01862497|Carvedilol|carvedilol|mesh-list
110113723|NCT01862497|Prazosin|prazosin|mesh-list
110113724|NCT01862497|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110113725|NCT01862497|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110113726|NCT01862497|Adrenergic Agents|adrenergic agents|mesh-ancestor
110113727|NCT01862497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110113728|NCT01862497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110113729|NCT01862497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110113730|NCT01862497|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110113731|NCT01862497|Antioxidants|antioxidants|mesh-ancestor
110113732|NCT01862497|Protective Agents|protective agents|mesh-ancestor
110113733|NCT01862497|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110113734|NCT01862497|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110113735|NCT01862497|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110113736|NCT01862497|Vasodilator Agents|vasodilator agents|mesh-ancestor
110113737|NCT01862497|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110113738|NCT01862497|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110113739|NCT01862523|Capsaicin|capsaicin|mesh-list
110113740|NCT01862523|Antipruritics|antipruritics|mesh-ancestor
110220298|NCT00275041|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110113741|NCT01862523|Dermatologic Agents|dermatologic agents|mesh-ancestor
110113742|NCT01862523|Sensory System Agents|sensory system agents|mesh-ancestor
110113743|NCT01862523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110113744|NCT01862523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110113745|NCT01862835|Anastrozole|anastrozole|mesh-list
110113746|NCT01862835|Testosterone|testosterone|mesh-list
110113747|NCT01862835|Estrogens|estrogens|mesh-list
110113748|NCT01862835|Androgens|androgens|mesh-ancestor
110113749|NCT01862835|Hormones|hormones|mesh-ancestor
110113750|NCT01862835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110113751|NCT01862835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110113752|NCT01862835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110113753|NCT01862835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110113754|NCT01862835|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110113755|NCT01862835|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110113756|NCT01862835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110113757|NCT01862835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110113758|NCT01862835|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110113759|NCT01862835|Hormone Antagonists|hormone antagonists|mesh-ancestor
110113760|NCT01862887|Moxifloxacin|moxifloxacin|mesh-list
110402829|NCT05575180|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110402830|NCT05575180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110113761|NCT01862887|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110113762|NCT01862887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110113763|NCT01862887|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110113764|NCT01862887|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110113765|NCT01862887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110113766|NCT01862887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110113767|NCT01862887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110113768|NCT01862926|Cyclophosphamide|cyclophosphamide|mesh-list
110113769|NCT01862926|Rituximab|rituximab|mesh-list
110113770|NCT01862926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110113771|NCT01862926|Immunologic Factors|immunologic factors|mesh-ancestor
110113772|NCT01862926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110113773|NCT01862926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110113774|NCT01862926|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110113775|NCT01862926|Alkylating Agents|alkylating agents|mesh-ancestor
110113776|NCT01862926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110113777|NCT01862926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110113778|NCT01862926|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110113779|NCT01862926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110113780|NCT01862978|Heparin|heparin|mesh-list
110113781|NCT01862978|Nadroparin|nadroparin|mesh-list
110113782|NCT01862978|Anticoagulants|anticoagulants|mesh-ancestor
110113783|NCT01862978|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110113784|NCT01862978|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110113785|NCT01862978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110113787|NCT01863004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110113788|NCT01863069|Interferons|interferons|mesh-list
110113789|NCT01863069|Interferon-beta|interferon-beta|mesh-list
110113790|NCT01863069|Interferon beta-1a|interferon beta-1a|mesh-list
110113791|NCT01863069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110113792|NCT01863069|Antiviral Agents|antiviral agents|mesh-ancestor
110113793|NCT01863069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110113794|NCT01863069|Immunologic Factors|immunologic factors|mesh-ancestor
110113795|NCT01863069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110113796|NCT01863069|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110113797|NCT01863147|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110113798|NCT01863147|Acarbose|acarbose|mesh-list
110113799|NCT01863147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110113800|NCT01863147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110113801|NCT01863147|Incretins|incretins|mesh-ancestor
110113802|NCT01863147|Hormones|hormones|mesh-ancestor
110113803|NCT01863147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110113804|NCT01863147|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110113805|NCT01863147|Protease Inhibitors|protease inhibitors|mesh-ancestor
110113806|NCT01863147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110113807|NCT01863147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110113808|NCT01863147|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
110113809|NCT01863173|Metoprolol|metoprolol|mesh-list
110113810|NCT01863173|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110113811|NCT01863173|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110113812|NCT01863173|Sympatholytics|sympatholytics|mesh-ancestor
110113813|NCT01863173|Autonomic Agents|autonomic agents|mesh-ancestor
110113814|NCT01863173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110113815|NCT01863173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110113816|NCT01863173|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110113817|NCT01863173|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110113818|NCT01863173|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110113819|NCT01863173|Adrenergic Agents|adrenergic agents|mesh-ancestor
110113820|NCT01863173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110113821|NCT01863173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110113822|NCT01863199|Ranibizumab|ranibizumab|mesh-list
110113823|NCT01863199|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110113824|NCT01863199|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110113825|NCT01863199|Growth Substances|growth substances|mesh-ancestor
110113826|NCT01863199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110113827|NCT01863199|Growth Inhibitors|growth inhibitors|mesh-ancestor
110113828|NCT01863199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110113829|NCT01863225|Atorvastatin|atorvastatin|mesh-list
110113830|NCT01863225|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110113831|NCT01863225|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110113832|NCT01863225|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110113833|NCT01863225|Antimetabolites|antimetabolites|mesh-ancestor
110113834|NCT01863225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110113835|NCT01863225|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110113836|NCT01863225|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110113837|NCT01863225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110113838|NCT01863238|Ivacaftor|ivacaftor|mesh-list
110113839|NCT01863238|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
110113840|NCT01863238|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110113841|NCT01863238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110113842|NCT01863251|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
110113843|NCT01863251|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110113844|NCT01863251|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110113845|NCT01863251|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110113846|NCT01863251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110113847|NCT01863251|Adrenergic Agents|adrenergic agents|mesh-ancestor
110113848|NCT01863251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110113849|NCT01863251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110113850|NCT01863277|Melatonin|melatonin|mesh-list
110113851|NCT01863277|Antioxidants|antioxidants|mesh-ancestor
110113852|NCT01863277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110113853|NCT01863277|Protective Agents|protective agents|mesh-ancestor
110113854|NCT01863277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110113855|NCT01863277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110113856|NCT01863355|Fentanyl|fentanyl|mesh-list
110113857|NCT01863355|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110113858|NCT01863355|Narcotics|narcotics|mesh-ancestor
110113859|NCT01863355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110113860|NCT01863355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110113861|NCT01863355|Analgesics|analgesics|mesh-ancestor
110113862|NCT01863355|Sensory System Agents|sensory system agents|mesh-ancestor
110113863|NCT01863355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110113864|NCT01863355|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110113865|NCT01863355|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110113866|NCT01863355|Anesthetics, General|anesthetics, general|mesh-ancestor
110113867|NCT01863355|Anesthetics|anesthetics|mesh-ancestor
110113868|NCT01863407|Metronidazole|metronidazole|mesh-list
110113869|NCT01863407|Dexamethasone|dexamethasone|mesh-list
110113870|NCT01863407|Allantoin|allantoin|mesh-list
110113871|NCT01863407|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110113872|NCT01863407|Antiemetics|antiemetics|mesh-ancestor
110113873|NCT01863407|Autonomic Agents|autonomic agents|mesh-ancestor
110113874|NCT01863407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110113875|NCT01863407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110113876|NCT01863407|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110113877|NCT01863407|Glucocorticoids|glucocorticoids|mesh-ancestor
110113878|NCT01863407|Hormones|hormones|mesh-ancestor
110113879|NCT01863407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110113880|NCT01863407|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110113881|NCT01863407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110113882|NCT01863407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110113883|NCT01863407|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110113884|NCT01863407|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110113885|NCT01863407|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110113886|NCT01863407|Dermatologic Agents|dermatologic agents|mesh-ancestor
110113887|NCT01863459|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
110113888|NCT01863459|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110113889|NCT01863459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110113890|NCT01863459|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110113891|NCT01863459|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110113892|NCT01863459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110113893|NCT01863459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110113894|NCT01863459|Dopamine Agents|dopamine agents|mesh-ancestor
110113895|NCT01863459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110113896|NCT01863485|Vorolanib|vorolanib|mesh-list
110113897|NCT01863485|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110113898|NCT01863485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110113899|NCT01863485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110113900|NCT01863511|Tolvaptan|tolvaptan|mesh-list
110113901|NCT01863511|Diuretics|diuretics|mesh-list
110113902|NCT01863511|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
110113903|NCT01863511|Natriuretic Agents|natriuretic agents|mesh-ancestor
110113904|NCT01863511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110113905|NCT01863511|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
110113906|NCT01863511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110113907|NCT01863511|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110113908|NCT01863589|Adefovir|adefovir|mesh-list
110113909|NCT01863589|Antiviral Agents|antiviral agents|mesh-ancestor
110113910|NCT01863589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110113911|NCT01863589|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110113912|NCT01863589|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110113913|NCT01863589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110113914|NCT01863589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110162535|NCT00007865|Rituximab|rituximab|mesh-list
110113915|NCT01863602|Lamotrigine|lamotrigine|mesh-list
110113916|NCT01863602|Anticonvulsants|anticonvulsants|mesh-ancestor
110113917|NCT01863602|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110113918|NCT01863602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110113919|NCT01863602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110113920|NCT01863602|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110113921|NCT01863602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110113922|NCT01863602|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110113923|NCT01863602|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110113924|NCT01863602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110113925|NCT01863602|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110113926|NCT01863602|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110113927|NCT01863615|Isotretinoin|isotretinoin|mesh-list
110113928|NCT01863615|Dermatologic Agents|dermatologic agents|mesh-ancestor
110113929|NCT01863641|Calcitriol|calcitriol|mesh-list
110113930|NCT01863641|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110113931|NCT01863641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110113932|NCT01863641|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
110113933|NCT01863641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110113934|NCT01863641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110113935|NCT01863641|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110113936|NCT01863641|Vitamins|vitamins|mesh-ancestor
110113937|NCT01863641|Micronutrients|micronutrients|mesh-ancestor
110113938|NCT01863641|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110113940|NCT01863654|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110113941|NCT01863654|Respiratory System Agents|respiratory system agents|mesh-ancestor
110113942|NCT01863654|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110113943|NCT01863654|Hormone Antagonists|hormone antagonists|mesh-ancestor
110113944|NCT01863654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110113945|NCT01863654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110113946|NCT01863654|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110113947|NCT01863654|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110113948|NCT01863654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110113949|NCT01863706|Misoprostol|misoprostol|mesh-list
110113950|NCT01863706|Oxytocin|oxytocin|mesh-list
110113951|NCT01863706|Oxytocics|oxytocics|mesh-ancestor
110113952|NCT01863706|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110113953|NCT01863706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110113954|NCT01863706|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110113955|NCT01863706|Abortifacient Agents|abortifacient agents|mesh-ancestor
110113956|NCT01863706|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110113957|NCT01863706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110113958|NCT01863719|Colistin|colistin|mesh-list
110113959|NCT01863719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110113960|NCT01863719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110113961|NCT01863810|Pregabalin|pregabalin|mesh-list
110113962|NCT01863810|Analgesics|analgesics|mesh-ancestor
110113963|NCT01863810|Sensory System Agents|sensory system agents|mesh-ancestor
110113964|NCT01863810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110113965|NCT01863810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110113966|NCT01863810|Anticonvulsants|anticonvulsants|mesh-ancestor
110220345|NCT00130312|Antimetabolites|antimetabolites|mesh-ancestor
110113967|NCT01863810|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110113968|NCT01863810|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110113969|NCT01863810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110113970|NCT01863810|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110113971|NCT01863810|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110113972|NCT01863810|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110113973|NCT01863810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110113974|NCT01863810|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110113976|NCT01863823|Tetracycline|tetracycline|mesh-list
110113977|NCT01863823|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110113978|NCT01863823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110113979|NCT01863823|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110113980|NCT01863823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110113981|NCT01863823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110113982|NCT01863888|Teriflunomide|teriflunomide|mesh-list
110113983|NCT01863888|Cholestyramine Resin|cholestyramine resin|mesh-list
110113984|NCT01863888|Charcoal|charcoal|mesh-list
110113985|NCT01863888|Antidotes|antidotes|mesh-ancestor
110113986|NCT01863888|Protective Agents|protective agents|mesh-ancestor
110113987|NCT01863888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110113988|NCT01863888|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110113989|NCT01863888|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110113991|NCT01863888|Sensory System Agents|sensory system agents|mesh-ancestor
110113992|NCT01863888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110113993|NCT01863888|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110113994|NCT01863888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110113995|NCT01863888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110113996|NCT01863888|Immunologic Factors|immunologic factors|mesh-ancestor
110113997|NCT01863888|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110113998|NCT01863888|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110113999|NCT01863888|Antimetabolites|antimetabolites|mesh-ancestor
110402876|NCT05530954|Calcium|calcium|mesh-list
110402877|NCT05530954|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110402878|NCT05530954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110402879|NCT05518929|Propofol|propofol|mesh-list
110402880|NCT05518929|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110402881|NCT05518929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110402882|NCT05518929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110402884|NCT05518929|Anesthetics, General|anesthetics, general|mesh-ancestor
110402885|NCT05518929|Anesthetics|anesthetics|mesh-ancestor
110114000|NCT01863888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110114001|NCT01863888|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110114002|NCT01863914|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110114003|NCT01863914|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110114004|NCT01863914|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110114005|NCT01863914|Antimetabolites|antimetabolites|mesh-ancestor
110114006|NCT01863914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110114007|NCT01863914|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110114008|NCT01863914|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110114009|NCT01863914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110114010|NCT01864057|Thiamine|thiamine|mesh-list
110114011|NCT01864057|Vitamin B Complex|vitamin b complex|mesh-ancestor
110114012|NCT01864057|Vitamins|vitamins|mesh-ancestor
110114013|NCT01864057|Micronutrients|micronutrients|mesh-ancestor
110114014|NCT01864057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110114015|NCT01864070|Everolimus|everolimus|mesh-list
110114016|NCT01864070|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110114017|NCT01864070|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110114018|NCT01864070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110114019|NCT01864070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110220377|NCT00119301|Antidotes|antidotes|mesh-ancestor
110114020|NCT01864070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110114021|NCT01864070|Immunologic Factors|immunologic factors|mesh-ancestor
110114022|NCT01864070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110114023|NCT01864070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110114024|NCT01864083|Fluorides|fluorides|mesh-list
110114025|NCT01864083|Cariostatic Agents|cariostatic agents|mesh-ancestor
110114026|NCT01864083|Protective Agents|protective agents|mesh-ancestor
110114027|NCT01864083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110114028|NCT01864096|Metformin|metformin|mesh-list
110114029|NCT01864096|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110114030|NCT01864096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110402898|NCT05487235|Atezolizumab|atezolizumab|mesh-list
110114032|NCT01864161|Trace Elements|trace elements|mesh-ancestor
110114033|NCT01864161|Micronutrients|micronutrients|mesh-ancestor
110114034|NCT01864161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110114035|NCT01864187|Dexmedetomidine|dexmedetomidine|mesh-list
110114036|NCT01864187|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110114037|NCT01864187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110114038|NCT01864187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110114039|NCT01864187|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110114040|NCT01864187|Analgesics|analgesics|mesh-ancestor
110114041|NCT01864187|Sensory System Agents|sensory system agents|mesh-ancestor
110114042|NCT01864187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110114043|NCT01864187|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110114044|NCT01864187|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110114045|NCT01864187|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110114046|NCT01864187|Adrenergic Agents|adrenergic agents|mesh-ancestor
110114047|NCT01864187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110114048|NCT01864187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110114049|NCT01864213|Tetracaine|tetracaine|mesh-list
110114050|NCT01864213|Anesthetics, Local|anesthetics, local|mesh-ancestor
110114052|NCT01864213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110114053|NCT01864213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110114054|NCT01864213|Sensory System Agents|sensory system agents|mesh-ancestor
110114055|NCT01864213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110114056|NCT01864252|Nitroglycerin|nitroglycerin|mesh-list
110114057|NCT01864252|Vasodilator Agents|vasodilator agents|mesh-ancestor
110114058|NCT01864265|Certolizumab Pegol|certolizumab pegol|mesh-list
110162545|NCT00007865|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110114059|NCT01864265|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110114060|NCT01864265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110114061|NCT01864265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110114062|NCT01864265|Immunologic Factors|immunologic factors|mesh-ancestor
110114063|NCT01864265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110114064|NCT01864265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110114065|NCT01864551|Lamotrigine|lamotrigine|mesh-list
110114066|NCT01864551|Olanzapine|olanzapine|mesh-list
110114067|NCT01864551|Antiemetics|antiemetics|mesh-ancestor
110114068|NCT01864551|Autonomic Agents|autonomic agents|mesh-ancestor
110114069|NCT01864551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110114070|NCT01864551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110114071|NCT01864551|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110114072|NCT01864551|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110114073|NCT01864551|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110114074|NCT01864551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110114075|NCT01864551|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110114076|NCT01864551|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110402994|NCT05422001|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110402995|NCT05422001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110402996|NCT05422001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110403001|NCT05363631|Selenium|selenium|mesh-list
110114077|NCT01864551|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110114078|NCT01864551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110114079|NCT01864551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110114080|NCT01864551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110114081|NCT01864551|Serotonin Agents|serotonin agents|mesh-ancestor
110114082|NCT01864551|Anticonvulsants|anticonvulsants|mesh-ancestor
110114083|NCT01864551|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110220388|NCT00079118|Antimitotic Agents|antimitotic agents|mesh-ancestor
110114084|NCT01864551|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110114085|NCT01864551|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110114086|NCT01864616|Vitamin D|vitamin d|mesh-list
110114087|NCT01864616|Cholecalciferol|cholecalciferol|mesh-list
110114088|NCT01864616|Vitamins|vitamins|mesh-ancestor
110114089|NCT01864616|Micronutrients|micronutrients|mesh-ancestor
110114090|NCT01864616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110114091|NCT01864616|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110114092|NCT01864616|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110114093|NCT01864655|Saracatinib|saracatinib|mesh-list
110114094|NCT01864655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110114095|NCT01864655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110114096|NCT01864655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110114097|NCT01864681|Metformin|metformin|mesh-list
110114098|NCT01864681|Gefitinib|gefitinib|mesh-list
110114099|NCT01864681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110114100|NCT01864681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110114101|NCT01864681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110114102|NCT01864681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110114103|NCT01864681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110114104|NCT01864681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110114105|NCT01864798|Denosumab|denosumab|mesh-list
110114106|NCT01864798|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110114107|NCT01864798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110114109|NCT01864824|Folic Acid|folic acid|mesh-list
110114110|NCT01864824|Vitamin B 12|vitamin b 12|mesh-list
110114111|NCT01864824|Vitamin B 6|vitamin b 6|mesh-list
110114112|NCT01864824|Vitamin B Complex|vitamin b complex|mesh-list
110114113|NCT01864824|Micronutrients|micronutrients|mesh-ancestor
110114114|NCT01864824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110114115|NCT01864824|Hematinics|hematinics|mesh-ancestor
110114116|NCT01864863|Bosentan|bosentan|mesh-list
110114117|NCT01864863|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110114118|NCT01864863|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
110114119|NCT01864863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110114120|NCT01864915|Prucalopride|prucalopride|mesh-list
110114121|NCT01864915|Laxatives|laxatives|mesh-ancestor
110114122|NCT01864915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110114123|NCT01864915|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
110114124|NCT01864915|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110114125|NCT01864915|Serotonin Agents|serotonin agents|mesh-ancestor
110114126|NCT01864915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110162549|NCT00007865|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110114127|NCT01864915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110114128|NCT01864915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110114130|NCT01865175|Trace Elements|trace elements|mesh-ancestor
110114131|NCT01865175|Micronutrients|micronutrients|mesh-ancestor
110114132|NCT01865175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110114133|NCT01865188|Amlodipine|amlodipine|mesh-list
110114134|NCT01865188|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
110114135|NCT01865188|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110114136|NCT01865188|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110114137|NCT01865188|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110403088|NCT05294965|Adrenergic Agents|adrenergic agents|mesh-ancestor
110403089|NCT05294965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110403090|NCT05294965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110403096|NCT05280743|Oxycodone|oxycodone|mesh-list
110403097|NCT05280743|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110403098|NCT05280743|Narcotics|narcotics|mesh-ancestor
110403100|NCT05280743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110220395|NCT00130195|Dexamethasone|dexamethasone|mesh-list
110220396|NCT00130195|Prednisolone|prednisolone|mesh-list
110220397|NCT00130195|Cyclophosphamide|cyclophosphamide|mesh-list
110220398|NCT00130195|Methotrexate|methotrexate|mesh-list
110220399|NCT00130195|Vincristine|vincristine|mesh-list
110220400|NCT00130195|Imatinib Mesylate|imatinib mesylate|mesh-list
110220401|NCT00130195|Daunorubicin|daunorubicin|mesh-list
110220402|NCT00130195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110114138|NCT01865188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110114139|NCT01865188|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110114140|NCT01865188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110114141|NCT01865188|Vasodilator Agents|vasodilator agents|mesh-ancestor
110114142|NCT01865188|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110114145|NCT01865201|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110114146|NCT01865201|Diuretics|diuretics|mesh-ancestor
110114147|NCT01865201|Natriuretic Agents|natriuretic agents|mesh-ancestor
110114148|NCT01865201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110114149|NCT01865201|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110114150|NCT01865201|Antioxidants|antioxidants|mesh-ancestor
110114151|NCT01865201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110114152|NCT01865201|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110114153|NCT01865201|Protective Agents|protective agents|mesh-ancestor
110114154|NCT01865279|Insulin|insulin|mesh-list
110114155|NCT01865279|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110114156|NCT01865279|Insulin, Long-Acting|insulin, long-acting|mesh-list
110114157|NCT01865279|Isophane Insulin, Human|isophane insulin, human|mesh-list
110114158|NCT01865279|Insulin, Isophane|insulin, isophane|mesh-list
110114159|NCT01865279|Isophane insulin, beef|isophane insulin, beef|mesh-list
110114160|NCT01865279|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110114161|NCT01865279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110114162|NCT01865292|Insulin|insulin|mesh-list
110114163|NCT01865292|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110114164|NCT01865292|Insulin Glargine|insulin glargine|mesh-list
110403143|NCT05255913|Fluorides|fluorides|mesh-list
110403144|NCT05255913|Cariostatic Agents|cariostatic agents|mesh-ancestor
110403145|NCT05255913|Protective Agents|protective agents|mesh-ancestor
110403146|NCT05255913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110403147|NCT05247320|Sotalol|sotalol|mesh-list
110403148|NCT05247320|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110403149|NCT05247320|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110403150|NCT05247320|Adrenergic Agents|adrenergic agents|mesh-ancestor
110403151|NCT05247320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110403152|NCT05247320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110403158|NCT05238714|Venglustat|venglustat|mesh-list
110114165|NCT01865292|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110114166|NCT01865292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110114168|NCT01865305|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110114169|NCT01865305|Insulin Aspart|insulin aspart|mesh-list
110114170|NCT01865305|Insulin, Long-Acting|insulin, long-acting|mesh-list
110114171|NCT01865305|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
110114172|NCT01865305|Biphasic Insulins|biphasic insulins|mesh-list
110114173|NCT01865305|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
110114174|NCT01865305|Insulin, Isophane|insulin, isophane|mesh-list
110114175|NCT01865305|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110114176|NCT01865305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110114177|NCT01865318|Insulin|insulin|mesh-list
110114178|NCT01865318|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110114179|NCT01865318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110114180|NCT01865331|Insulin|insulin|mesh-list
110114181|NCT01865331|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110114182|NCT01865331|Insulin Aspart|insulin aspart|mesh-list
110114183|NCT01865331|Insulin, Long-Acting|insulin, long-acting|mesh-list
110114184|NCT01865331|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110114185|NCT01865331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110114186|NCT01865500|Prednisolone|prednisolone|mesh-list
110114187|NCT01865500|Budesonide|budesonide|mesh-list
110114188|NCT01865500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110114189|NCT01865500|Glucocorticoids|glucocorticoids|mesh-ancestor
110114190|NCT01865500|Hormones|hormones|mesh-ancestor
110220403|NCT00130195|Immunologic Factors|immunologic factors|mesh-ancestor
110220404|NCT00130195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110220405|NCT00130195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110220406|NCT00130195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110220408|NCT00130195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110114191|NCT01865500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110114192|NCT01865500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110114193|NCT01865500|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110114194|NCT01865500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110114195|NCT01865500|Autonomic Agents|autonomic agents|mesh-ancestor
110114196|NCT01865500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110114197|NCT01865500|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110114198|NCT01865500|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110114199|NCT01865500|Respiratory System Agents|respiratory system agents|mesh-ancestor
110114200|NCT01865630|Etanercept|etanercept|mesh-list
110114201|NCT01865630|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110114202|NCT01865630|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110114203|NCT01865630|Analgesics|analgesics|mesh-ancestor
110114204|NCT01865630|Sensory System Agents|sensory system agents|mesh-ancestor
110114205|NCT01865630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110114206|NCT01865630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110114207|NCT01865630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110114208|NCT01865630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110114209|NCT01865630|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110114210|NCT01865630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110114211|NCT01865630|Immunologic Factors|immunologic factors|mesh-ancestor
110114212|NCT01865669|Oxytocin|oxytocin|mesh-list
110114213|NCT01865669|Oxytocics|oxytocics|mesh-ancestor
110114214|NCT01865669|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110114215|NCT01865669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110114216|NCT01865721|Entonox|entonox|mesh-list
110114217|NCT01865721|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
110114218|NCT01865721|Anesthetics|anesthetics|mesh-ancestor
110114219|NCT01865721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110114220|NCT01865721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110114221|NCT01865760|Octreotide|octreotide|mesh-list
110114222|NCT01865760|Somatostatin|somatostatin|mesh-list
110114223|NCT01865760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110114224|NCT01865760|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110114225|NCT01865760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110114226|NCT01865760|Hormones|hormones|mesh-ancestor
110114227|NCT01865760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110114228|NCT01865760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110114229|NCT01865916|Ascorbic Acid|ascorbic acid|mesh-list
110114230|NCT01865916|Bisacodyl|bisacodyl|mesh-list
110114231|NCT01865916|Antioxidants|antioxidants|mesh-ancestor
110114232|NCT01865916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110114233|NCT01865916|Protective Agents|protective agents|mesh-ancestor
110114234|NCT01865916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110114235|NCT01865916|Vitamins|vitamins|mesh-ancestor
110114236|NCT01865916|Micronutrients|micronutrients|mesh-ancestor
110114237|NCT01865916|Cathartics|cathartics|mesh-ancestor
110114238|NCT01865916|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110114239|NCT01865916|Laxatives|laxatives|mesh-ancestor
110114240|NCT01865968|Vaccines|vaccines|mesh-list
110114241|NCT01865968|Immunologic Factors|immunologic factors|mesh-ancestor
110114242|NCT01865968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110114243|NCT01866007|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110114244|NCT01866007|Immunologic Factors|immunologic factors|mesh-ancestor
110114245|NCT01866007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110114246|NCT01866059|Methamphetamine|methamphetamine|mesh-list
110114247|NCT01866059|Calcium|calcium|mesh-list
110114248|NCT01866059|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110114249|NCT01866059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110114250|NCT01866059|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110114251|NCT01866059|Sympathomimetics|sympathomimetics|mesh-ancestor
110114252|NCT01866059|Autonomic Agents|autonomic agents|mesh-ancestor
110114253|NCT01866059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110403215|NCT05151263|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110114254|NCT01866059|Dopamine Agents|dopamine agents|mesh-ancestor
110114255|NCT01866059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110114256|NCT01866059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110114257|NCT01866059|Adrenergic Agents|adrenergic agents|mesh-ancestor
110162563|NCT00113737|Serotonin Agents|serotonin agents|mesh-ancestor
110114258|NCT01866059|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110114259|NCT01866059|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110114260|NCT01866059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110114261|NCT01866059|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110114263|NCT01866241|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110114264|NCT01866241|Abortifacient Agents|abortifacient agents|mesh-ancestor
110114265|NCT01866241|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110114266|NCT01866241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110114267|NCT01866241|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110114268|NCT01866241|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110114270|NCT01866254|Morphine|morphine|mesh-list
110114271|NCT01866254|Hydromorphone|hydromorphone|mesh-list
110114272|NCT01866254|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110114273|NCT01866254|Narcotics|narcotics|mesh-ancestor
110114274|NCT01866254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110114275|NCT01866254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110114276|NCT01866254|Analgesics|analgesics|mesh-ancestor
110114277|NCT01866254|Sensory System Agents|sensory system agents|mesh-ancestor
110114278|NCT01866254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110114279|NCT01866267|Maraviroc|maraviroc|mesh-list
110114280|NCT01866267|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110114281|NCT01866267|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110114282|NCT01866267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110114283|NCT01866267|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110114284|NCT01866267|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110114285|NCT01866267|Antiviral Agents|antiviral agents|mesh-ancestor
110114286|NCT01866267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110114287|NCT01866267|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
110114288|NCT01866397|Cidofovir|cidofovir|mesh-list
110114289|NCT01866397|Antiviral Agents|antiviral agents|mesh-ancestor
110114290|NCT01866397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110114291|NCT01866397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110114292|NCT01866397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110114293|NCT01866488|Misoprostol|misoprostol|mesh-list
110114294|NCT01866488|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110114295|NCT01866488|Abortifacient Agents|abortifacient agents|mesh-ancestor
110114296|NCT01866488|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110114297|NCT01866488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110114298|NCT01866488|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110114299|NCT01866488|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110403247|NCT05096195|Calcium, Dietary|calcium, dietary|mesh-list
110403248|NCT05096195|Vitamin D|vitamin d|mesh-list
110403249|NCT05096195|Denosumab|denosumab|mesh-list
110403250|NCT05096195|Calcium|calcium|mesh-list
110403251|NCT05096195|Vitamins|vitamins|mesh-ancestor
110403252|NCT05096195|Micronutrients|micronutrients|mesh-ancestor
110114300|NCT01866488|Oxytocics|oxytocics|mesh-ancestor
110114301|NCT01866514|Lidocaine|lidocaine|mesh-list
110114302|NCT01866514|Anesthetics, Local|anesthetics, local|mesh-ancestor
110114303|NCT01866514|Anesthetics|anesthetics|mesh-ancestor
110220439|NCT00394303|Insulin|insulin|mesh-list
110114304|NCT01866514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110114305|NCT01866514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110114306|NCT01866514|Sensory System Agents|sensory system agents|mesh-ancestor
110114307|NCT01866514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110114308|NCT01866514|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110114309|NCT01866514|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110114310|NCT01866514|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110114311|NCT01866514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110114312|NCT01866514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110114313|NCT01866553|Interferons|interferons|mesh-list
110114314|NCT01866553|Interferon-alpha|interferon-alpha|mesh-list
110114315|NCT01866553|Interferon alpha-2|interferon alpha-2|mesh-list
110114316|NCT01866553|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110114317|NCT01866553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110114318|NCT01866553|Antiviral Agents|antiviral agents|mesh-ancestor
110114319|NCT01866553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110114320|NCT01866553|Immunologic Factors|immunologic factors|mesh-ancestor
110114321|NCT01866553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110114322|NCT01866605|Midazolam|midazolam|mesh-list
110114323|NCT01866605|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110114324|NCT01866605|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110114325|NCT01866605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110114326|NCT01866605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110114328|NCT01866605|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110114329|NCT01866605|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110114330|NCT01866605|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110114331|NCT01866605|Anesthetics, General|anesthetics, general|mesh-ancestor
110114332|NCT01866605|Anesthetics|anesthetics|mesh-ancestor
110114333|NCT01866605|GABA Modulators|gaba modulators|mesh-ancestor
110114334|NCT01866605|GABA Agents|gaba agents|mesh-ancestor
110114335|NCT01866605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110403271|NCT05064280|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110114336|NCT01866605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110114338|NCT01866644|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110114339|NCT01866644|Antiviral Agents|antiviral agents|mesh-ancestor
110114340|NCT01866644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110114341|NCT01866644|Expectorants|expectorants|mesh-ancestor
110114342|NCT01866644|Respiratory System Agents|respiratory system agents|mesh-ancestor
110114343|NCT01866644|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110114344|NCT01866644|Antioxidants|antioxidants|mesh-ancestor
110114345|NCT01866644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110114346|NCT01866644|Protective Agents|protective agents|mesh-ancestor
110114347|NCT01866644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110114348|NCT01866644|Antidotes|antidotes|mesh-ancestor
110114349|NCT01867138|Vancomycin|vancomycin|mesh-list
110114350|NCT01867138|Cefazolin|cefazolin|mesh-list
110114351|NCT01867138|Amikacin|amikacin|mesh-list
110114352|NCT01867138|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110114353|NCT01867138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110114354|NCT01867255|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
110114355|NCT01867255|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110114356|NCT01867255|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110403311|NCT04989283|Immunologic Factors|immunologic factors|mesh-ancestor
110403312|NCT04989283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110403313|NCT04989283|Keratolytic Agents|keratolytic agents|mesh-ancestor
110403314|NCT04989283|Dermatologic Agents|dermatologic agents|mesh-ancestor
110403315|NCT04988841|Nivolumab|nivolumab|mesh-list
110403316|NCT04988841|Ipilimumab|ipilimumab|mesh-list
110403317|NCT04988841|Laxatives|laxatives|mesh-list
110403318|NCT04988841|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110403319|NCT04988841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110403320|NCT04988841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110114365|NCT01867268|Anticonvulsants|anticonvulsants|mesh-ancestor
110114366|NCT01867268|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110114367|NCT01867268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110114368|NCT01867268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110114369|NCT01867268|Diuretics|diuretics|mesh-ancestor
110114370|NCT01867268|Natriuretic Agents|natriuretic agents|mesh-ancestor
110220443|NCT00119340|Mycophenolic Acid|mycophenolic acid|mesh-list
110220444|NCT00119340|Fludarabine|fludarabine|mesh-list
110220445|NCT00119340|Fludarabine phosphate|fludarabine phosphate|mesh-list
110114371|NCT01867268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110114372|NCT01867281|Aspirin|aspirin|mesh-list
110114373|NCT01867281|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110114374|NCT01867281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110114375|NCT01867281|Analgesics|analgesics|mesh-ancestor
110114376|NCT01867281|Sensory System Agents|sensory system agents|mesh-ancestor
110114377|NCT01867281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110114378|NCT01867281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110114379|NCT01867281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110114380|NCT01867281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110114381|NCT01867281|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110114382|NCT01867281|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110114383|NCT01867281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110114384|NCT01867281|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110114385|NCT01867281|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110114386|NCT01867281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110114387|NCT01867281|Antipyretics|antipyretics|mesh-ancestor
110114388|NCT01867463|Aluminum Hydroxide|aluminum hydroxide|mesh-list
110114389|NCT01867463|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110114391|NCT01867463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110114392|NCT01867463|Antacids|antacids|mesh-ancestor
110114393|NCT01867463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110114394|NCT01867463|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110114395|NCT01867502|Metformin|metformin|mesh-list
110403367|NCT04964505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110403368|NCT04939701|Pembrolizumab|pembrolizumab|mesh-list
110403369|NCT04939701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110403370|NCT04939701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110403371|NCT04939701|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110403372|NCT04939701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110403397|NCT04889664|Ketamine|ketamine|mesh-list
110114397|NCT01867502|Glyburide|glyburide|mesh-list
110114398|NCT01867502|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110114399|NCT01867502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110114400|NCT01867502|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110114401|NCT01867502|Protease Inhibitors|protease inhibitors|mesh-ancestor
110114402|NCT01867502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110162576|NCT03272295|Dermatologic Agents|dermatologic agents|mesh-ancestor
110114403|NCT01867502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110114404|NCT01867593|Carbon-11 methionine|carbon-11 methionine|mesh-list
110114405|NCT01867593|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110114406|NCT01867593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110114407|NCT01867645|Immunoglobulins|immunoglobulins|mesh-list
110114408|NCT01867645|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110114410|NCT01867645|gamma-Globulins|gamma-globulins|mesh-list
110114411|NCT01867645|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110114412|NCT01867645|Immunologic Factors|immunologic factors|mesh-ancestor
110114413|NCT01867645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110114414|NCT01867697|Leucovorin|leucovorin|mesh-list
110114415|NCT01867697|Folic Acid|folic acid|mesh-list
110114416|NCT01867697|Oxaliplatin|oxaliplatin|mesh-list
110114417|NCT01867697|Irinotecan|irinotecan|mesh-list
110114418|NCT01867697|Cetuximab|cetuximab|mesh-list
110114419|NCT01867697|Calcium Carbonate|calcium carbonate|mesh-list
110114420|NCT01867697|Levoleucovorin|levoleucovorin|mesh-list
110114421|NCT01867697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110114422|NCT01867697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110114423|NCT01867697|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110114424|NCT01867697|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110403401|NCT04889664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110403402|NCT04889664|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110403403|NCT04889664|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110403404|NCT04889664|Anesthetics, General|anesthetics, general|mesh-ancestor
110403405|NCT04889664|Anesthetics|anesthetics|mesh-ancestor
110403406|NCT04889664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110403407|NCT04889664|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110403408|NCT04889664|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110403409|NCT04889664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110403410|NCT04889664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110403411|NCT04873895|Hydroxychloroquine|hydroxychloroquine|mesh-list
110403412|NCT04873895|Axitinib|axitinib|mesh-list
110403414|NCT04873895|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110114425|NCT01867697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110114426|NCT01867697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110114427|NCT01867697|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110114429|NCT01867697|Protective Agents|protective agents|mesh-ancestor
110114430|NCT01867697|Vitamin B Complex|vitamin b complex|mesh-ancestor
110114431|NCT01867697|Vitamins|vitamins|mesh-ancestor
110114432|NCT01867697|Micronutrients|micronutrients|mesh-ancestor
110114433|NCT01867697|Hematinics|hematinics|mesh-ancestor
110114434|NCT01867697|Antacids|antacids|mesh-ancestor
110114435|NCT01867697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110114436|NCT01867775|Mirtazapine|mirtazapine|mesh-list
110114437|NCT01867775|Antidepressive Agents|antidepressive agents|mesh-ancestor
110114438|NCT01867775|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110114439|NCT01867775|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110114440|NCT01867775|Histamine Antagonists|histamine antagonists|mesh-ancestor
110114441|NCT01867775|Histamine Agents|histamine agents|mesh-ancestor
110114442|NCT01867775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110114443|NCT01867775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110114444|NCT01867775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110114445|NCT01867775|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110114446|NCT01867775|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110114447|NCT01867775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110114448|NCT01867775|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
110114449|NCT01867775|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110114450|NCT01867775|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110114451|NCT01867775|Adrenergic Agents|adrenergic agents|mesh-ancestor
110114452|NCT01867775|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110114453|NCT01867775|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110114454|NCT01867775|Serotonin Agents|serotonin agents|mesh-ancestor
110114455|NCT01867775|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110114456|NCT01867866|Trifluridine|trifluridine|mesh-list
110114457|NCT01867866|Antimetabolites|antimetabolites|mesh-ancestor
110114458|NCT01867866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110114459|NCT01867866|Antiviral Agents|antiviral agents|mesh-ancestor
110114460|NCT01867866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110114461|NCT01867892|Leucovorin|leucovorin|mesh-list
110114462|NCT01867892|Gemcitabine|gemcitabine|mesh-list
110114463|NCT01867892|Fluorouracil|fluorouracil|mesh-list
110403471|NCT04773353|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
110403472|NCT04773353|Hormones|hormones|mesh-ancestor
110403473|NCT04773353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110403474|NCT04773353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110403475|NCT04760288|Pralsetinib|pralsetinib|mesh-list
110403476|NCT04760288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110403477|NCT04742673|Guanfacine|guanfacine|mesh-list
110403478|NCT04742673|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110403479|NCT04742673|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110403480|NCT04742673|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110403481|NCT04742673|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110403482|NCT04742673|Adrenergic Agents|adrenergic agents|mesh-ancestor
110403483|NCT04742673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110114464|NCT01867892|Irinotecan|irinotecan|mesh-list
110114465|NCT01867892|Levoleucovorin|levoleucovorin|mesh-list
110114466|NCT01867892|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110114467|NCT01867892|Antimetabolites|antimetabolites|mesh-ancestor
110114468|NCT01867892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110114469|NCT01867892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110114471|NCT01867892|Immunologic Factors|immunologic factors|mesh-ancestor
110114472|NCT01867892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110114474|NCT01867892|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110114475|NCT01867892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110114476|NCT01867892|Antidotes|antidotes|mesh-ancestor
110114477|NCT01867892|Protective Agents|protective agents|mesh-ancestor
110114478|NCT01867892|Vitamin B Complex|vitamin b complex|mesh-ancestor
110114479|NCT01867892|Vitamins|vitamins|mesh-ancestor
110114480|NCT01867892|Micronutrients|micronutrients|mesh-ancestor
110114481|NCT01868048|Nabiximols|nabiximols|mesh-list
110114482|NCT01868048|Analgesics|analgesics|mesh-ancestor
110114483|NCT01868048|Sensory System Agents|sensory system agents|mesh-ancestor
110114484|NCT01868048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110114485|NCT01868048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110114486|NCT01868113|Fluticasone|fluticasone|mesh-list
110114487|NCT01868113|Xhance|xhance|mesh-list
110114488|NCT01868113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110114489|NCT01868113|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110114490|NCT01868113|Autonomic Agents|autonomic agents|mesh-ancestor
110114491|NCT01868113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110114492|NCT01868113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110114493|NCT01868113|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110114494|NCT01868113|Respiratory System Agents|respiratory system agents|mesh-ancestor
110114495|NCT01868113|Dermatologic Agents|dermatologic agents|mesh-ancestor
110114496|NCT01868113|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110114497|NCT01868126|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110114498|NCT01868126|Latanoprost|latanoprost|mesh-list
110114499|NCT01868126|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110114500|NCT01868191|Thiamine|thiamine|mesh-list
110114501|NCT01868191|Benphothiamine|benphothiamine|mesh-list
110114502|NCT01868191|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110114503|NCT01868191|Immunologic Factors|immunologic factors|mesh-ancestor
110114504|NCT01868191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110114505|NCT01868191|Chelating Agents|chelating agents|mesh-ancestor
110114506|NCT01868191|Sequestering Agents|sequestering agents|mesh-ancestor
110114507|NCT01868191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110114508|NCT01868191|Vitamin B Complex|vitamin b complex|mesh-ancestor
110114509|NCT01868191|Vitamins|vitamins|mesh-ancestor
110114510|NCT01868191|Micronutrients|micronutrients|mesh-ancestor
110114511|NCT01868360|Aflibercept|aflibercept|mesh-list
110114512|NCT01868360|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110114513|NCT01868360|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110114514|NCT01868360|Growth Substances|growth substances|mesh-ancestor
110114515|NCT01868360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110114516|NCT01868360|Growth Inhibitors|growth inhibitors|mesh-ancestor
110114517|NCT01868360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110114518|NCT01868438|Artesunate|artesunate|mesh-list
110114519|NCT01868438|Pyronaridine|pyronaridine|mesh-list
110114520|NCT01868438|Pyronaridine tetraphosphate, artesunate drug combination|pyronaridine tetraphosphate, artesunate drug combination|mesh-list
110114521|NCT01868438|Antimalarials|antimalarials|mesh-ancestor
110114522|NCT01868438|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110114523|NCT01868438|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110114524|NCT01868438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110114525|NCT01868438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110114526|NCT01868438|Antiviral Agents|antiviral agents|mesh-ancestor
110114527|NCT01868438|Schistosomicides|schistosomicides|mesh-ancestor
110114528|NCT01868438|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110114529|NCT01868438|Anthelmintics|anthelmintics|mesh-ancestor
110114530|NCT01868464|BCG Vaccine|bcg vaccine|mesh-list
110114531|NCT01868464|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110114532|NCT01868464|Immunologic Factors|immunologic factors|mesh-ancestor
110114533|NCT01868464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110114534|NCT01868529|Insulin|insulin|mesh-list
110114535|NCT01868529|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110114536|NCT01868529|Insulin Glargine|insulin glargine|mesh-list
110114537|NCT01868529|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110114538|NCT01868529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110114539|NCT01868555|Insulin|insulin|mesh-list
110114540|NCT01868555|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110114541|NCT01868555|Insulin Aspart|insulin aspart|mesh-list
110114542|NCT01868555|Insulin, Long-Acting|insulin, long-acting|mesh-list
110114543|NCT01868555|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
110114544|NCT01868555|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110114545|NCT01868555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110114546|NCT01868568|Insulin|insulin|mesh-list
110114547|NCT01868568|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110114548|NCT01868568|Insulin Aspart|insulin aspart|mesh-list
110114549|NCT01868568|Insulin, Long-Acting|insulin, long-acting|mesh-list
110114550|NCT01868568|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
110114551|NCT01868568|Biphasic Insulins|biphasic insulins|mesh-list
110114552|NCT01868568|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
110114553|NCT01868568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110114554|NCT01868568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110114555|NCT01868581|Insulin|insulin|mesh-list
110114556|NCT01868581|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110114558|NCT01868581|Insulin, Long-Acting|insulin, long-acting|mesh-list
110114559|NCT01868581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110114560|NCT01868581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110114561|NCT01868750|Calcitriol|calcitriol|mesh-list
110114562|NCT01868750|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110114563|NCT01868750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110114564|NCT01868750|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
110114565|NCT01868750|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110114566|NCT01868750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110114567|NCT01868750|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110114568|NCT01868750|Vitamins|vitamins|mesh-ancestor
110114569|NCT01868750|Micronutrients|micronutrients|mesh-ancestor
110114570|NCT01868750|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110114571|NCT01868802|Ketamine|ketamine|mesh-list
110114572|NCT01868802|Analgesics|analgesics|mesh-ancestor
110114573|NCT01868802|Sensory System Agents|sensory system agents|mesh-ancestor
110114574|NCT01868802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110114575|NCT01868802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110114576|NCT01868802|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110114577|NCT01868802|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110114578|NCT01868802|Anesthetics, General|anesthetics, general|mesh-ancestor
110114579|NCT01868802|Anesthetics|anesthetics|mesh-ancestor
110114580|NCT01868802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110114581|NCT01868802|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110114582|NCT01868802|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110114583|NCT01868802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110114584|NCT01868802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110114585|NCT01868906|Temozolomide|temozolomide|mesh-list
110114586|NCT01868906|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110114587|NCT01868906|Alkylating Agents|alkylating agents|mesh-ancestor
110220448|NCT00119340|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110220449|NCT00119340|Antimetabolites|antimetabolites|mesh-ancestor
110220450|NCT00119340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110220452|NCT00119340|Immunologic Factors|immunologic factors|mesh-ancestor
110220464|NCT00130156|Doxazosin|doxazosin|mesh-list
110114588|NCT01868906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110114589|NCT01868906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110114590|NCT01868945|Vitamin D|vitamin d|mesh-list
110114591|NCT01868945|Cholecalciferol|cholecalciferol|mesh-list
110114592|NCT01868945|Calcifediol|calcifediol|mesh-list
110114593|NCT01868945|Vitamins|vitamins|mesh-ancestor
110114594|NCT01868945|Micronutrients|micronutrients|mesh-ancestor
110114595|NCT01868945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110114596|NCT01868945|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110114597|NCT01868945|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110114598|NCT01868984|Paclitaxel|paclitaxel|mesh-list
110114599|NCT01868984|Heparin|heparin|mesh-list
110114600|NCT01868984|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110114601|NCT01868984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110114602|NCT01868984|Tubulin Modulators|tubulin modulators|mesh-ancestor
110403622|NCT04494503|Rituximab|rituximab|mesh-list
110114603|NCT01868984|Antimitotic Agents|antimitotic agents|mesh-ancestor
110114604|NCT01868984|Mitosis Modulators|mitosis modulators|mesh-ancestor
110114605|NCT01868984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110114606|NCT01868984|Anticoagulants|anticoagulants|mesh-ancestor
110114607|NCT01868984|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110114608|NCT01868984|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110114610|NCT01869010|Antiviral Agents|antiviral agents|mesh-ancestor
110114611|NCT01869010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110114612|NCT01869010|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110114613|NCT01869010|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110114614|NCT01869010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110114615|NCT01869010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110114616|NCT01869010|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110114617|NCT01869010|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110114619|NCT01869023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110114620|NCT01869023|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110114621|NCT01869023|Antimetabolites|antimetabolites|mesh-ancestor
110114622|NCT01869023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110114624|NCT01869036|Anesthetics|anesthetics|mesh-list
110114625|NCT01869036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110114626|NCT01869036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110114627|NCT01869036|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110114628|NCT01869036|Narcotics|narcotics|mesh-ancestor
110114629|NCT01869036|Analgesics|analgesics|mesh-ancestor
110114630|NCT01869036|Sensory System Agents|sensory system agents|mesh-ancestor
110114631|NCT01869036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110114632|NCT01869205|Ivermectin|ivermectin|mesh-list
110114633|NCT01869205|Abamectin|abamectin|mesh-list
110114634|NCT01869205|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110114635|NCT01869205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110114636|NCT01869205|Anthelmintics|anthelmintics|mesh-ancestor
110114637|NCT01869257|Triclosan|triclosan|mesh-list
110114638|NCT01869257|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110114639|NCT01869257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110114640|NCT01869257|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
110114641|NCT01869257|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110114642|NCT01869257|Antimetabolites|antimetabolites|mesh-ancestor
110114643|NCT01869257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110114645|NCT01869309|Ticagrelor|ticagrelor|mesh-list
110114646|NCT01869309|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
110114647|NCT01869309|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110403657|NCT04430738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110403658|NCT04430738|Antimetabolites|antimetabolites|mesh-ancestor
110403659|NCT04430738|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110403660|NCT04430738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110403661|NCT04430738|Immunologic Factors|immunologic factors|mesh-ancestor
110403662|NCT04430738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110403663|NCT04430738|Antidotes|antidotes|mesh-ancestor
110403664|NCT04430738|Protective Agents|protective agents|mesh-ancestor
110403665|NCT04430738|Vitamin B Complex|vitamin b complex|mesh-ancestor
110403666|NCT04430738|Vitamins|vitamins|mesh-ancestor
110114648|NCT01869309|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110114649|NCT01869309|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110114650|NCT01869309|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110114651|NCT01869309|Purinergic Agents|purinergic agents|mesh-ancestor
110114652|NCT01869309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110114653|NCT01869309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110114654|NCT01869309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110114655|NCT01869491|Alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|mesh-list
110114657|NCT01869491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110114658|NCT01869491|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110114659|NCT01869556|Oxytocin|oxytocin|mesh-list
110114660|NCT01869556|Carboprost|carboprost|mesh-list
110114661|NCT01869556|Carboprost tromethamine|carboprost tromethamine|mesh-list
110114662|NCT01869556|Ergonovine|ergonovine|mesh-list
110114663|NCT01869556|Oxytocics|oxytocics|mesh-ancestor
110114664|NCT01869556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110114665|NCT01869556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110114666|NCT01869556|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110114667|NCT01869556|Abortifacient Agents|abortifacient agents|mesh-ancestor
110114668|NCT01869569|Pregabalin|pregabalin|mesh-list
110114669|NCT01869569|Analgesics|analgesics|mesh-ancestor
110114670|NCT01869569|Sensory System Agents|sensory system agents|mesh-ancestor
110114671|NCT01869569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110114672|NCT01869569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110114673|NCT01869569|Anticonvulsants|anticonvulsants|mesh-ancestor
110114674|NCT01869569|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110114675|NCT01869569|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110114676|NCT01869569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110403700|NCT04368429|Immunologic Factors|immunologic factors|mesh-ancestor
110403701|NCT04368429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110403702|NCT04356352|Lidocaine|lidocaine|mesh-list
110403703|NCT04356352|Esmolol|esmolol|mesh-list
110403704|NCT04356352|Anesthetics, Local|anesthetics, local|mesh-ancestor
110403705|NCT04356352|Anesthetics|anesthetics|mesh-ancestor
110403706|NCT04356352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110403707|NCT04356352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110403708|NCT04356352|Sensory System Agents|sensory system agents|mesh-ancestor
110403709|NCT04356352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110114677|NCT01869569|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110114678|NCT01869569|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110114679|NCT01869569|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110114680|NCT01869569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110114681|NCT01869569|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110114682|NCT01869621|Metformin|metformin|mesh-list
110114683|NCT01869621|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110114684|NCT01869621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110114685|NCT01869673|Anesthetics|anesthetics|mesh-list
110220494|NCT00079235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110114686|NCT01869673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110114687|NCT01869673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110114688|NCT01869751|Prucalopride|prucalopride|mesh-list
110114689|NCT01869751|Laxatives|laxatives|mesh-ancestor
110114690|NCT01869751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110114691|NCT01869751|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
110114692|NCT01869751|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110114693|NCT01869751|Serotonin Agents|serotonin agents|mesh-ancestor
110114694|NCT01869751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110114695|NCT01869751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110114696|NCT01869751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110114697|NCT01869803|Gemtuzumab|gemtuzumab|mesh-list
110114698|NCT01869803|Calicheamicins|calicheamicins|mesh-list
110114699|NCT01869803|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110114700|NCT01869803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110114701|NCT01869803|Immunotoxins|immunotoxins|mesh-ancestor
110114702|NCT01869803|Immunoconjugates|immunoconjugates|mesh-ancestor
110114703|NCT01869803|Immunologic Factors|immunologic factors|mesh-ancestor
110114704|NCT01869803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110114705|NCT01869803|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110114706|NCT01869881|Sarpogrelate|sarpogrelate|mesh-list
110114707|NCT01869881|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110114708|NCT01869881|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110114709|NCT01869881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110114710|NCT01869881|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110403733|NCT04356326|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110403734|NCT04356326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110403735|NCT04356326|Antipyretics|antipyretics|mesh-ancestor
110403741|NCT04339036|Capecitabine|capecitabine|mesh-list
110403742|NCT04339036|Temozolomide|temozolomide|mesh-list
110403743|NCT04339036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110403744|NCT04339036|Antimetabolites|antimetabolites|mesh-ancestor
110114711|NCT01869881|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110114712|NCT01869881|Serotonin Agents|serotonin agents|mesh-ancestor
110114713|NCT01869881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110114714|NCT01869881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110114715|NCT01869907|Minocycline|minocycline|mesh-list
110114716|NCT01869907|Amitriptyline|amitriptyline|mesh-list
110114717|NCT01869907|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110114718|NCT01869907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110114719|NCT01869907|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110114720|NCT01869907|Antidepressive Agents|antidepressive agents|mesh-ancestor
110114721|NCT01869907|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110114722|NCT01869907|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110114723|NCT01869907|Analgesics|analgesics|mesh-ancestor
110114724|NCT01869907|Sensory System Agents|sensory system agents|mesh-ancestor
110114725|NCT01869907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110114726|NCT01869907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110114727|NCT01869907|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110114728|NCT01869907|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110114729|NCT01869907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110114730|NCT01869907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110114731|NCT01869907|Adrenergic Agents|adrenergic agents|mesh-ancestor
110114732|NCT01869907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110114733|NCT01869946|Ropivacaine|ropivacaine|mesh-list
110114734|NCT01869946|Anesthetics, Local|anesthetics, local|mesh-ancestor
110114735|NCT01869946|Anesthetics|anesthetics|mesh-ancestor
110114736|NCT01869946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110114737|NCT01869946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110114738|NCT01869946|Sensory System Agents|sensory system agents|mesh-ancestor
110114739|NCT01869946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110114740|NCT01870011|Anesthetics|anesthetics|mesh-list
110114741|NCT01870011|Propofol|propofol|mesh-list
110114742|NCT01870011|Desflurane|desflurane|mesh-list
110114743|NCT01870011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110114744|NCT01870011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110114745|NCT01870011|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110114746|NCT01870011|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110114747|NCT01870011|Anesthetics, General|anesthetics, general|mesh-ancestor
110114748|NCT01870011|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110114749|NCT01870024|Fosphenytoin|fosphenytoin|mesh-list
110114750|NCT01870024|Lorazepam|lorazepam|mesh-list
110114751|NCT01870024|Clonazepam|clonazepam|mesh-list
110114752|NCT01870024|Anticonvulsants|anticonvulsants|mesh-ancestor
110114753|NCT01870024|Antiemetics|antiemetics|mesh-ancestor
110114754|NCT01870024|Autonomic Agents|autonomic agents|mesh-ancestor
110114755|NCT01870024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110114756|NCT01870024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110114757|NCT01870024|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110114758|NCT01870024|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110114759|NCT01870024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110114760|NCT01870024|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110114761|NCT01870024|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110114762|NCT01870024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110114763|NCT01870024|GABA Modulators|gaba modulators|mesh-ancestor
110114764|NCT01870024|GABA Agents|gaba agents|mesh-ancestor
110114765|NCT01870024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110114766|NCT01870024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110114767|NCT01870024|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110114768|NCT01870024|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110114769|NCT01870050|Dapsone|dapsone|mesh-list
110114770|NCT01870050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110114771|NCT01870050|Antimalarials|antimalarials|mesh-ancestor
110114772|NCT01870050|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110114773|NCT01870050|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110114774|NCT01870050|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110114775|NCT01870050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110114776|NCT01870050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110114777|NCT01870050|Leprostatic Agents|leprostatic agents|mesh-ancestor
110114778|NCT01870050|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110114779|NCT01870115|Vitamin D|vitamin d|mesh-list
110114780|NCT01870115|Cholecalciferol|cholecalciferol|mesh-list
110114781|NCT01870115|Melatonin|melatonin|mesh-list
110114782|NCT01870115|Vitamins|vitamins|mesh-ancestor
110114783|NCT01870115|Micronutrients|micronutrients|mesh-ancestor
110114784|NCT01870115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110114785|NCT01870115|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110114786|NCT01870115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110403821|NCT04284787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110114787|NCT01870115|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110220517|NCT00129805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110114789|NCT01870115|Protective Agents|protective agents|mesh-ancestor
110114790|NCT01870115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110114791|NCT01870128|Hydroxychloroquine|hydroxychloroquine|mesh-list
110114792|NCT01870128|Sulfasalazine|sulfasalazine|mesh-list
110114793|NCT01870128|Methylprednisolone|methylprednisolone|mesh-list
110114794|NCT01870128|Methotrexate|methotrexate|mesh-list
110114795|NCT01870128|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110114796|NCT01870128|Abortifacient Agents|abortifacient agents|mesh-ancestor
110114797|NCT01870128|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110114798|NCT01870128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110114799|NCT01870128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110114800|NCT01870128|Antimetabolites|antimetabolites|mesh-ancestor
110114801|NCT01870128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110114802|NCT01870128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110114803|NCT01870128|Dermatologic Agents|dermatologic agents|mesh-ancestor
110114804|NCT01870128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110114805|NCT01870128|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110114806|NCT01870128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110114807|NCT01870128|Immunologic Factors|immunologic factors|mesh-ancestor
110114808|NCT01870128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110114809|NCT01870128|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110114810|NCT01870128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110114811|NCT01870128|Antiemetics|antiemetics|mesh-ancestor
110114812|NCT01870128|Autonomic Agents|autonomic agents|mesh-ancestor
110114813|NCT01870128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110114814|NCT01870128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110114815|NCT01870128|Glucocorticoids|glucocorticoids|mesh-ancestor
110114816|NCT01870128|Hormones|hormones|mesh-ancestor
110114817|NCT01870128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110114818|NCT01870128|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110114819|NCT01870128|Protective Agents|protective agents|mesh-ancestor
110114820|NCT01870128|Antimalarials|antimalarials|mesh-ancestor
110403866|NCT04221477|Prednisone|prednisone|mesh-list
110114821|NCT01870128|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110114822|NCT01870128|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110114823|NCT01870128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110114824|NCT01870128|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110114825|NCT01870128|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110114826|NCT01870128|Analgesics|analgesics|mesh-ancestor
110114827|NCT01870128|Sensory System Agents|sensory system agents|mesh-ancestor
110114828|NCT01870167|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
110114829|NCT01870167|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110114830|NCT01870167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110114831|NCT01870167|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110114832|NCT01870167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110114833|NCT01870167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110114834|NCT01870219|Ketamine|ketamine|mesh-list
110114835|NCT01870219|Anesthetics|anesthetics|mesh-list
110114836|NCT01870219|Sevoflurane|sevoflurane|mesh-list
110114837|NCT01870219|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
110114838|NCT01870219|Analgesics|analgesics|mesh-ancestor
110114839|NCT01870219|Sensory System Agents|sensory system agents|mesh-ancestor
110114840|NCT01870219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110114841|NCT01870219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110114842|NCT01870219|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110114844|NCT01870219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110114845|NCT01870219|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110114846|NCT01870219|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110403891|NCT04221477|Anesthetics|anesthetics|mesh-ancestor
110114847|NCT01870219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110114848|NCT01870219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110114849|NCT01870219|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110114850|NCT01870219|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110114851|NCT01870284|Adalimumab|adalimumab|mesh-list
110114852|NCT01870284|Ixekizumab|ixekizumab|mesh-list
110114853|NCT01870284|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110114854|NCT01870284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110114855|NCT01870284|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110114856|NCT01870284|Dermatologic Agents|dermatologic agents|mesh-ancestor
110114857|NCT01870427|Aflibercept|aflibercept|mesh-list
110114858|NCT01870427|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110114859|NCT01870427|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110114860|NCT01870427|Growth Substances|growth substances|mesh-ancestor
110114861|NCT01870427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110114862|NCT01870427|Growth Inhibitors|growth inhibitors|mesh-ancestor
110114863|NCT01870427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110114864|NCT01868880|Bisoprolol|bisoprolol|mesh-list
110114865|NCT01868880|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
110114866|NCT01868880|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110114867|NCT01868880|Adrenergic Agents|adrenergic agents|mesh-ancestor
110114868|NCT01868880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110114869|NCT01868880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110114870|NCT01868880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110114871|NCT01868880|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110114872|NCT01868880|Sympatholytics|sympatholytics|mesh-ancestor
110114873|NCT01868880|Autonomic Agents|autonomic agents|mesh-ancestor
110403937|NCT04214067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110403938|NCT04214067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110403939|NCT04214067|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110403940|NCT04214067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110403941|NCT04206813|Vaccines|vaccines|mesh-list
110403942|NCT04206813|Immunologic Factors|immunologic factors|mesh-ancestor
110403943|NCT04206813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110403944|NCT04197713|Olaparib|olaparib|mesh-list
110114874|NCT01868880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110114875|NCT01868880|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110114876|NCT01870440|Dexamethasone|dexamethasone|mesh-list
110114877|NCT01870440|Dexamethasone acetate|dexamethasone acetate|mesh-list
110114878|NCT01870440|BB 1101|bb 1101|mesh-list
110114879|NCT01870440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110114880|NCT01870440|Antiemetics|antiemetics|mesh-ancestor
110114881|NCT01870440|Autonomic Agents|autonomic agents|mesh-ancestor
110114882|NCT01870440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110114883|NCT01870440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110114884|NCT01870440|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110114885|NCT01870440|Glucocorticoids|glucocorticoids|mesh-ancestor
110114887|NCT01870440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110220571|NCT00119496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110114889|NCT01870440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110114890|NCT01870440|Protease Inhibitors|protease inhibitors|mesh-ancestor
110114891|NCT01870440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110114892|NCT01870440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110114893|NCT01870466|Cilostazol|cilostazol|mesh-list
110114894|NCT01870466|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110114895|NCT01870466|Simvastatin|simvastatin|mesh-list
110114896|NCT01870466|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110114897|NCT01870466|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110114898|NCT01870466|Antimetabolites|antimetabolites|mesh-ancestor
110114899|NCT01870466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110114900|NCT01870466|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110114901|NCT01870466|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110114902|NCT01870466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110403984|NCT04133194|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110403985|NCT04133194|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110403986|NCT04133194|Analgesics|analgesics|mesh-ancestor
110403987|NCT04133194|Sensory System Agents|sensory system agents|mesh-ancestor
110403988|NCT04133194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110403989|NCT04133194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110403990|NCT04133194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110403991|NCT04133194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110403992|NCT04123379|Nivolumab|nivolumab|mesh-list
110403993|NCT04123379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110058349|NCT01511822|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110403994|NCT04123379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110403995|NCT04123379|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110403996|NCT04123379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110404014|NCT04084769|Immunologic Factors|immunologic factors|mesh-ancestor
110114903|NCT01870466|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110114904|NCT01870466|Autonomic Agents|autonomic agents|mesh-ancestor
110114905|NCT01870466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110114906|NCT01870466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110114907|NCT01870466|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110114908|NCT01870466|Respiratory System Agents|respiratory system agents|mesh-ancestor
110114909|NCT01870466|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110114910|NCT01870466|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110114911|NCT01870466|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110114912|NCT01870466|Vasodilator Agents|vasodilator agents|mesh-ancestor
110114913|NCT01870466|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110114914|NCT01870466|Protective Agents|protective agents|mesh-ancestor
110114915|NCT01870466|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110114916|NCT01870466|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110114917|NCT01870492|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
110114918|NCT01870492|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110114919|NCT01870492|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110114920|NCT01870492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110114921|NCT01870635|Ondansetron|ondansetron|mesh-list
110114922|NCT01870635|Antiemetics|antiemetics|mesh-ancestor
110114923|NCT01870635|Autonomic Agents|autonomic agents|mesh-ancestor
110114924|NCT01870635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110114925|NCT01870635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110114926|NCT01870635|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110114927|NCT01870635|Antipruritics|antipruritics|mesh-ancestor
110220592|NCT00298324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110114928|NCT01870635|Dermatologic Agents|dermatologic agents|mesh-ancestor
110114929|NCT01870635|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110114930|NCT01870635|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110114931|NCT01870635|Serotonin Agents|serotonin agents|mesh-ancestor
110404031|NCT04029480|Metformin|metformin|mesh-list
110404039|NCT04022980|Nivolumab|nivolumab|mesh-list
110114932|NCT01870635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110114933|NCT01870635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110114934|NCT01870648|Ondansetron|ondansetron|mesh-list
110114935|NCT01870648|Antiemetics|antiemetics|mesh-ancestor
110114936|NCT01870648|Autonomic Agents|autonomic agents|mesh-ancestor
110114937|NCT01870648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110114938|NCT01870648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110114939|NCT01870648|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110114940|NCT01870648|Antipruritics|antipruritics|mesh-ancestor
110114941|NCT01870648|Dermatologic Agents|dermatologic agents|mesh-ancestor
110114942|NCT01870648|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110114943|NCT01870648|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110114944|NCT01870648|Serotonin Agents|serotonin agents|mesh-ancestor
110114945|NCT01870648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110114946|NCT01870648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110114947|NCT01870674|Prucalopride|prucalopride|mesh-list
110114948|NCT01870674|YH12852|yh12852|mesh-list
110114949|NCT01870674|Laxatives|laxatives|mesh-ancestor
110114950|NCT01870674|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110114951|NCT01870674|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
110114952|NCT01870674|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110114953|NCT01870674|Serotonin Agents|serotonin agents|mesh-ancestor
110114954|NCT01870674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110114955|NCT01870674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110114956|NCT01870674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110114957|NCT01870804|Atorvastatin|atorvastatin|mesh-list
110114958|NCT01870804|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110404085|NCT03918850|Buprenorphine|buprenorphine|mesh-list
110404086|NCT03918850|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110404087|NCT03918850|Narcotics|narcotics|mesh-ancestor
110404088|NCT03918850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110404089|NCT03918850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110404090|NCT03918850|Analgesics|analgesics|mesh-ancestor
110404091|NCT03918850|Sensory System Agents|sensory system agents|mesh-ancestor
110404092|NCT03918850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110114960|NCT01870804|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110114961|NCT01870804|Antimetabolites|antimetabolites|mesh-ancestor
110114962|NCT01870804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110114963|NCT01870804|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110114964|NCT01870804|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110114965|NCT01870804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110114966|NCT01870895|Ramosetron|ramosetron|mesh-list
110114967|NCT01870895|Antiemetics|antiemetics|mesh-ancestor
110114968|NCT01870895|Autonomic Agents|autonomic agents|mesh-ancestor
110114969|NCT01870895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110114970|NCT01870895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110114971|NCT01870895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110114972|NCT01870895|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110114973|NCT01870895|Serotonin Agents|serotonin agents|mesh-ancestor
110114974|NCT01870895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110114975|NCT01870895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110114976|NCT01870908|Tacrolimus|tacrolimus|mesh-list
110114977|NCT01870908|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110114978|NCT01870908|Immunologic Factors|immunologic factors|mesh-ancestor
110114979|NCT01870908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110114980|NCT01870908|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110114981|NCT01870908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110404180|NCT03914300|Nivolumab|nivolumab|mesh-list
110114982|NCT01870908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110114983|NCT01870986|Adalimumab|adalimumab|mesh-list
110114984|NCT01870986|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110114985|NCT01870986|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110114986|NCT01870986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110114987|NCT01871129|Dexmedetomidine|dexmedetomidine|mesh-list
110114988|NCT01871129|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110114989|NCT01871129|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110114990|NCT01871129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110114991|NCT01871129|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110114993|NCT01871129|Sensory System Agents|sensory system agents|mesh-ancestor
110114994|NCT01871129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110114995|NCT01871129|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110114996|NCT01871129|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110114997|NCT01871129|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110114998|NCT01871129|Adrenergic Agents|adrenergic agents|mesh-ancestor
110114999|NCT01871129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110115000|NCT01871129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110115001|NCT01871363|Capecitabine|capecitabine|mesh-list
110115002|NCT01871363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110115003|NCT01871363|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110115004|NCT01871363|Antimetabolites|antimetabolites|mesh-ancestor
110115005|NCT01871363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110115006|NCT01871376|Aflibercept|aflibercept|mesh-list
110115007|NCT01871376|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110115008|NCT01871376|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110115009|NCT01871376|Growth Substances|growth substances|mesh-ancestor
110115010|NCT01871376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110115011|NCT01871376|Growth Inhibitors|growth inhibitors|mesh-ancestor
110115012|NCT01871376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110115014|NCT01871454|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110115015|NCT01871454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110115016|NCT01871454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110115017|NCT01871454|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110115018|NCT01871454|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110115019|NCT01871454|Protective Agents|protective agents|mesh-ancestor
110115020|NCT01871454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110115021|NCT01871454|Vasodilator Agents|vasodilator agents|mesh-ancestor
110115022|NCT01871454|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110115023|NCT01871454|Antioxidants|antioxidants|mesh-ancestor
110115024|NCT01871467|Sargramostim|sargramostim|mesh-list
110115025|NCT01871467|Immunologic Factors|immunologic factors|mesh-ancestor
110115026|NCT01871467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110115028|NCT01871480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110115029|NCT01871480|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110115030|NCT01871480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110115031|NCT01871480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110115032|NCT01871493|Insulin Lispro|insulin lispro|mesh-list
110115033|NCT01871493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110115034|NCT01871493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110404230|NCT03877549|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110404231|NCT03877549|Glucocorticoids|glucocorticoids|mesh-ancestor
110404232|NCT03877549|Hormones|hormones|mesh-ancestor
110404233|NCT03877549|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110404234|NCT03877549|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110404235|NCT03877549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110404245|NCT03868124|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110404246|NCT03868124|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110404247|NCT03868124|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110404248|NCT03854474|Pembrolizumab|pembrolizumab|mesh-list
110404249|NCT03854474|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110404250|NCT03854474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110404251|NCT03854474|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110404252|NCT03854474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110404265|NCT03798678|Dexamethasone|dexamethasone|mesh-list
110404266|NCT03798678|Dexamethasone acetate|dexamethasone acetate|mesh-list
110404267|NCT03798678|Ichthammol|ichthammol|mesh-list
110404268|NCT03798678|BB 1101|bb 1101|mesh-list
110404269|NCT03798678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110115040|NCT01871649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110115041|NCT01871649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110115042|NCT01871649|Antimetabolites|antimetabolites|mesh-ancestor
110115043|NCT01871649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110115044|NCT01871649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110115045|NCT01871649|Dermatologic Agents|dermatologic agents|mesh-ancestor
110115046|NCT01871649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110115047|NCT01871649|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110115048|NCT01871649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110115049|NCT01871649|Immunologic Factors|immunologic factors|mesh-ancestor
110115050|NCT01871649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110115051|NCT01871649|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110404280|NCT03798678|Protease Inhibitors|protease inhibitors|mesh-ancestor
110404281|NCT03798678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110404282|NCT03798678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110404283|NCT03798678|Dermatologic Agents|dermatologic agents|mesh-ancestor
110115052|NCT01871649|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110115053|NCT01871649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110115054|NCT01871662|Interferons|interferons|mesh-list
110115055|NCT01871662|Ribavirin|ribavirin|mesh-list
110115056|NCT01871662|Interferon-alpha|interferon-alpha|mesh-list
110115057|NCT01871662|Interferon alpha-2|interferon alpha-2|mesh-list
110115058|NCT01871662|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110115059|NCT01871662|Silybin|silybin|mesh-list
110115060|NCT01871662|Silymarin|silymarin|mesh-list
110115061|NCT01871662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110115062|NCT01871662|Antiviral Agents|antiviral agents|mesh-ancestor
110115063|NCT01871662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110115064|NCT01871662|Antimetabolites|antimetabolites|mesh-ancestor
110115065|NCT01871662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110115066|NCT01871662|Immunologic Factors|immunologic factors|mesh-ancestor
110115067|NCT01871662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110115069|NCT01871662|Protective Agents|protective agents|mesh-ancestor
110115070|NCT01871662|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110115071|NCT01871675|Rituximab|rituximab|mesh-list
110115072|NCT01871675|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110115073|NCT01871675|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110115074|NCT01871675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110115075|NCT01871675|Immunologic Factors|immunologic factors|mesh-ancestor
110115076|NCT01871675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110220645|NCT00086112|Risperidone|risperidone|mesh-list
110115077|NCT01871675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110115078|NCT01871675|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110115079|NCT01871675|Alkylating Agents|alkylating agents|mesh-ancestor
110115080|NCT01871675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110115081|NCT01871701|Moxifloxacin|moxifloxacin|mesh-list
110115083|NCT01871701|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110115084|NCT01871701|Citalopram|citalopram|mesh-list
110115085|NCT01871701|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
110115086|NCT01871701|Escitalopram|escitalopram|mesh-list
110115087|NCT01871701|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110115088|NCT01871701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110115089|NCT01871701|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110115090|NCT01871701|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110115091|NCT01871701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110115092|NCT01871701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110115093|NCT01871701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110404340|NCT03701321|Dexamethasone|dexamethasone|mesh-list
110115094|NCT01871701|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110115096|NCT01871701|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110115097|NCT01871701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110115098|NCT01871701|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110115099|NCT01871701|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110115100|NCT01871701|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110115101|NCT01871701|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110115102|NCT01871701|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110115103|NCT01871701|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110115104|NCT01871701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110115106|NCT01871701|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110115107|NCT01871701|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110115108|NCT01871701|Parasympatholytics|parasympatholytics|mesh-ancestor
110115109|NCT01871701|Autonomic Agents|autonomic agents|mesh-ancestor
110115110|NCT01871701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110115111|NCT01871701|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110115112|NCT01871701|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110115113|NCT01871701|Cholinergic Agents|cholinergic agents|mesh-ancestor
110115114|NCT01871701|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110115115|NCT01871701|Antidepressive Agents|antidepressive agents|mesh-ancestor
110115116|NCT01871701|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110115117|NCT01871701|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110115118|NCT01871701|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110115119|NCT01871701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110115120|NCT01871740|Folic Acid|folic acid|mesh-list
110115121|NCT01871740|Enalapril|enalapril|mesh-list
110115122|NCT01871740|Enalaprilat|enalaprilat|mesh-list
110115123|NCT01871740|Maleic acid|maleic acid|mesh-list
110115124|NCT01871740|Hematinics|hematinics|mesh-ancestor
110115125|NCT01871740|Vitamin B Complex|vitamin b complex|mesh-ancestor
110115126|NCT01871740|Vitamins|vitamins|mesh-ancestor
110115127|NCT01871740|Micronutrients|micronutrients|mesh-ancestor
110115128|NCT01871740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110404375|NCT03678129|GABA Agents|gaba agents|mesh-ancestor
110404376|NCT03678129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110404377|NCT03678129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110404378|NCT03661684|Prednisone|prednisone|mesh-list
110404380|NCT03661684|Glucocorticoids|glucocorticoids|mesh-ancestor
110404381|NCT03661684|Hormones|hormones|mesh-ancestor
110115129|NCT01871740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110115130|NCT01871740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110115131|NCT01871740|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110115132|NCT01871740|Protease Inhibitors|protease inhibitors|mesh-ancestor
110115133|NCT01871740|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110115134|NCT01871753|Anti-Infective Agents|anti-infective agents|mesh-list
110115136|NCT01871792|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110115137|NCT01871792|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110115138|NCT01871792|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110115139|NCT01871792|Antimetabolites|antimetabolites|mesh-ancestor
110115140|NCT01871792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110115142|NCT01871792|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110115144|NCT01871844|Somatostatin|somatostatin|mesh-list
110115145|NCT01871844|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110115146|NCT01871844|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110115147|NCT01871844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110115148|NCT01871844|Hormones|hormones|mesh-ancestor
110115149|NCT01871844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110115150|NCT01871844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110115151|NCT01871857|Epinephrine|epinephrine|mesh-list
110115152|NCT01871857|Racepinephrine|racepinephrine|mesh-list
110115153|NCT01871857|Epinephryl borate|epinephryl borate|mesh-list
110115154|NCT01871857|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110115155|NCT01871857|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110115156|NCT01871857|Adrenergic Agents|adrenergic agents|mesh-ancestor
110115157|NCT01871857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110115158|NCT01871857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110115159|NCT01871857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110115160|NCT01871857|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110115161|NCT01871857|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110115162|NCT01871857|Autonomic Agents|autonomic agents|mesh-ancestor
110115163|NCT01871857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110115164|NCT01871857|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110115165|NCT01871857|Respiratory System Agents|respiratory system agents|mesh-ancestor
110115166|NCT01871857|Mydriatics|mydriatics|mesh-ancestor
110115167|NCT01871857|Sympathomimetics|sympathomimetics|mesh-ancestor
110115168|NCT01871857|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110115169|NCT01871922|Atropine|atropine|mesh-list
110115170|NCT01871922|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110115171|NCT01871922|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110115172|NCT01871922|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110115173|NCT01871922|Autonomic Agents|autonomic agents|mesh-ancestor
110115174|NCT01871922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110115175|NCT01871922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110115176|NCT01871922|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110115177|NCT01871922|Respiratory System Agents|respiratory system agents|mesh-ancestor
110115178|NCT01871922|Mydriatics|mydriatics|mesh-ancestor
110115179|NCT01871922|Parasympatholytics|parasympatholytics|mesh-ancestor
110220679|NCT00298714|Losartan|losartan|mesh-list
110115180|NCT01871922|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110115181|NCT01871922|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110115182|NCT01871922|Cholinergic Agents|cholinergic agents|mesh-ancestor
110115183|NCT01871922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110115184|NCT01871922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110115186|NCT01871935|Remifentanil|remifentanil|mesh-list
110115187|NCT01871935|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110115188|NCT01871935|Narcotics|narcotics|mesh-ancestor
110115189|NCT01871935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110115190|NCT01871935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110115191|NCT01871935|Analgesics|analgesics|mesh-ancestor
110115192|NCT01871935|Sensory System Agents|sensory system agents|mesh-ancestor
110115193|NCT01871935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110115194|NCT01871935|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110115195|NCT01871935|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110115196|NCT01871935|Anesthetics, General|anesthetics, general|mesh-ancestor
110115197|NCT01871935|Anesthetics|anesthetics|mesh-ancestor
110115198|NCT01871961|Methotrexate|methotrexate|mesh-list
110115199|NCT01871961|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110115200|NCT01871961|Abortifacient Agents|abortifacient agents|mesh-ancestor
110115201|NCT01871961|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110115202|NCT01871961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110115203|NCT01871961|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110115204|NCT01871961|Antimetabolites|antimetabolites|mesh-ancestor
110115205|NCT01871961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110115206|NCT01871961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110115207|NCT01871961|Dermatologic Agents|dermatologic agents|mesh-ancestor
110115208|NCT01871961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110115209|NCT01871961|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110115210|NCT01871961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110115211|NCT01871961|Immunologic Factors|immunologic factors|mesh-ancestor
110115212|NCT01871961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110115213|NCT01871961|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110115214|NCT01871974|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110115215|NCT01871974|Antidepressive Agents|antidepressive agents|mesh-ancestor
110115216|NCT01871974|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110115217|NCT01871974|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110115218|NCT01871974|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110404507|NCT03539744|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110115219|NCT01871974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110115220|NCT01871974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110115222|NCT01871987|Antidepressive Agents|antidepressive agents|mesh-ancestor
110115223|NCT01871987|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110115224|NCT01871987|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110115225|NCT01871987|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110115226|NCT01871987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110115227|NCT01871987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110115229|NCT01872013|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
110115230|NCT01872013|Hormone Antagonists|hormone antagonists|mesh-ancestor
110220702|NCT00298909|Niacinamide|niacinamide|mesh-list
110220703|NCT00298909|Nicotinic Acids|nicotinic acids|mesh-list
110115231|NCT01872013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110115232|NCT01872013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110115234|NCT01872026|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
110115235|NCT01872026|Hormone Antagonists|hormone antagonists|mesh-ancestor
110115236|NCT01872026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110115237|NCT01872026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110115238|NCT01872039|Nicardipine|nicardipine|mesh-list
110115239|NCT01872039|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110115240|NCT01872039|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110115241|NCT01872039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110115242|NCT01872039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110115243|NCT01872039|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110115244|NCT01872039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110115245|NCT01872039|Vasodilator Agents|vasodilator agents|mesh-ancestor
110115246|NCT01871311|Cetuximab|cetuximab|mesh-list
110115247|NCT01871311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110115248|NCT01871311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110115249|NCT01872351|Thioctic Acid|thioctic acid|mesh-list
110115250|NCT01872351|Acetylcarnitine|acetylcarnitine|mesh-list
110115251|NCT01872351|Antioxidants|antioxidants|mesh-ancestor
110220726|NCT00299065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110220727|NCT00299065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110115252|NCT01872351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110115254|NCT01872351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110115255|NCT01872351|Vitamin B Complex|vitamin b complex|mesh-ancestor
110115256|NCT01872351|Vitamins|vitamins|mesh-ancestor
110115257|NCT01872351|Micronutrients|micronutrients|mesh-ancestor
110115258|NCT01872351|Nootropic Agents|nootropic agents|mesh-ancestor
110115259|NCT01872403|Paclitaxel|paclitaxel|mesh-list
110115260|NCT01872403|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110115261|NCT01872403|Carboplatin|carboplatin|mesh-list
110115262|NCT01872403|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110115263|NCT01872403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110115264|NCT01872403|Tubulin Modulators|tubulin modulators|mesh-ancestor
110115265|NCT01872403|Antimitotic Agents|antimitotic agents|mesh-ancestor
110115266|NCT01872403|Mitosis Modulators|mitosis modulators|mesh-ancestor
110115267|NCT01872403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110115268|NCT01872416|Doxorubicin|doxorubicin|mesh-list
110115269|NCT01872416|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110115270|NCT01872416|Ifosfamide|ifosfamide|mesh-list
110115271|NCT01872416|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110115272|NCT01872416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110115273|NCT01872416|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110115274|NCT01872416|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110115275|NCT01872416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110115276|NCT01872416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110115277|NCT01872416|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110115278|NCT01872416|Alkylating Agents|alkylating agents|mesh-ancestor
110115279|NCT01872442|Interferons|interferons|mesh-list
110115280|NCT01872442|Interferon-alpha|interferon-alpha|mesh-list
110115281|NCT01872442|Interferon alpha-2|interferon alpha-2|mesh-list
110115282|NCT01872442|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110115283|NCT01872442|Dasatinib|dasatinib|mesh-list
110115284|NCT01872442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110115285|NCT01872442|Antiviral Agents|antiviral agents|mesh-ancestor
110115286|NCT01872442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110115287|NCT01872442|Immunologic Factors|immunologic factors|mesh-ancestor
110162676|NCT00114400|Pyridoxal|pyridoxal|mesh-list
110115288|NCT01872442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110115289|NCT01872442|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110115290|NCT01872442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110115291|NCT01872442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110115293|NCT01872494|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
110115295|NCT01872494|Palonosetron|palonosetron|mesh-list
110115296|NCT01872494|Ropivacaine|ropivacaine|mesh-list
110115297|NCT01872494|Anesthetics, Local|anesthetics, local|mesh-ancestor
110115298|NCT01872494|Anesthetics|anesthetics|mesh-ancestor
110115299|NCT01872494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110115300|NCT01872494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110115301|NCT01872494|Sensory System Agents|sensory system agents|mesh-ancestor
110115302|NCT01872494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110115303|NCT01872494|Antiemetics|antiemetics|mesh-ancestor
110115304|NCT01872494|Autonomic Agents|autonomic agents|mesh-ancestor
110220783|NCT00299611|Serotonin Agents|serotonin agents|mesh-ancestor
110115305|NCT01872494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110115306|NCT01872494|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110115307|NCT01872494|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110115308|NCT01872494|Serotonin Agents|serotonin agents|mesh-ancestor
110115309|NCT01872494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110115310|NCT01872494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110115311|NCT01872494|Analgesics|analgesics|mesh-ancestor
110115312|NCT01872494|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110115313|NCT01872494|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110115314|NCT01872494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110115315|NCT01872494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110115316|NCT01872494|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110115317|NCT01872494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110115318|NCT01872494|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110115319|NCT01872494|Narcotics|narcotics|mesh-ancestor
110115320|NCT01872494|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110115321|NCT01872494|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110115322|NCT01872546|Adalimumab|adalimumab|mesh-list
110115323|NCT01872546|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110115324|NCT01872546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110115325|NCT01872546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110115326|NCT01872702|Primaquine|primaquine|mesh-list
110115327|NCT01872702|Piperaquine|piperaquine|mesh-list
110115328|NCT01872702|Artenimol|artenimol|mesh-list
110115329|NCT01872702|Antimalarials|antimalarials|mesh-ancestor
110115330|NCT01872702|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110115331|NCT01872702|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110115332|NCT01872702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110115333|NCT01872728|Anesthetics|anesthetics|mesh-list
110115334|NCT01872728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110115335|NCT01872728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110115336|NCT01872754|Remifentanil|remifentanil|mesh-list
110115337|NCT01872754|Propofol|propofol|mesh-list
110115338|NCT01872754|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110115339|NCT01872754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110115340|NCT01872754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110115341|NCT01872754|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110115342|NCT01872754|Anesthetics, General|anesthetics, general|mesh-ancestor
110115343|NCT01872754|Anesthetics|anesthetics|mesh-ancestor
110115344|NCT01872754|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110115345|NCT01872754|Narcotics|narcotics|mesh-ancestor
110115346|NCT01872754|Analgesics|analgesics|mesh-ancestor
110115347|NCT01872754|Sensory System Agents|sensory system agents|mesh-ancestor
110115348|NCT01872754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110115349|NCT01872780|Rosiglitazone|rosiglitazone|mesh-list
110115350|NCT01872780|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110115351|NCT01872780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110115352|NCT01872832|Verinurad|verinurad|mesh-list
110115353|NCT01872832|Gout Suppressants|gout suppressants|mesh-ancestor
110115354|NCT01872832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110115355|NCT01872845|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110115356|NCT01872845|Pravastatin|pravastatin|mesh-list
110404690|NCT03228537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110404691|NCT03228537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110404692|NCT03228537|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110404693|NCT03228537|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110115357|NCT01872845|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110115358|NCT01872845|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110115359|NCT01872845|Antimetabolites|antimetabolites|mesh-ancestor
110115360|NCT01872845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110220813|NCT00299884|Ezetimibe|ezetimibe|mesh-list
110115361|NCT01872845|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110115362|NCT01872845|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110115363|NCT01872845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110115366|NCT01872858|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110115367|NCT01872858|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110115368|NCT01872858|Analgesics|analgesics|mesh-ancestor
110115369|NCT01872858|Sensory System Agents|sensory system agents|mesh-ancestor
110115370|NCT01872858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110115371|NCT01872858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110115372|NCT01872858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110115373|NCT01872858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110115374|NCT01872858|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110115375|NCT01872858|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110115376|NCT01872858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110115377|NCT01872858|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110115378|NCT01872858|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110115379|NCT01872858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110115381|NCT01872858|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110115382|NCT01872858|Autonomic Agents|autonomic agents|mesh-ancestor
110115383|NCT01872858|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110115384|NCT01872858|Respiratory System Agents|respiratory system agents|mesh-ancestor
110115385|NCT01872858|Vasodilator Agents|vasodilator agents|mesh-ancestor
110115386|NCT01872858|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110404725|NCT03206047|Poly ICLC|poly iclc|mesh-list
110115387|NCT01872858|Protective Agents|protective agents|mesh-ancestor
110115388|NCT01872858|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110115389|NCT01872858|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110115391|NCT01872871|Anesthetics|anesthetics|mesh-list
110115392|NCT01872871|Anesthetics, Local|anesthetics, local|mesh-list
110115393|NCT01872871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110115394|NCT01872871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110115395|NCT01872871|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110115396|NCT01872871|Analgesics|analgesics|mesh-ancestor
110115397|NCT01872871|Sensory System Agents|sensory system agents|mesh-ancestor
110115398|NCT01872871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110115399|NCT01872871|Antipyretics|antipyretics|mesh-ancestor
110115400|NCT01872884|Remifentanil|remifentanil|mesh-list
110115401|NCT01872884|Sevoflurane|sevoflurane|mesh-list
110115402|NCT01872884|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110115403|NCT01872884|Narcotics|narcotics|mesh-ancestor
110115404|NCT01872884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110115405|NCT01872884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110115406|NCT01872884|Analgesics|analgesics|mesh-ancestor
110115407|NCT01872884|Sensory System Agents|sensory system agents|mesh-ancestor
110404779|NCT03155100|Dexamethasone|dexamethasone|mesh-list
110404780|NCT03155100|Elotuzumab|elotuzumab|mesh-list
110404781|NCT03155100|Proteasome Inhibitors|proteasome inhibitors|mesh-list
110404782|NCT03155100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110404783|NCT03155100|Antiemetics|antiemetics|mesh-ancestor
110404784|NCT03155100|Autonomic Agents|autonomic agents|mesh-ancestor
110404785|NCT03155100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110404786|NCT03155100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110404787|NCT03155100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110115408|NCT01872884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110115409|NCT01872884|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110115410|NCT01872884|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110115411|NCT01872884|Anesthetics, General|anesthetics, general|mesh-ancestor
110220819|NCT00299884|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110220820|NCT00299884|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110115413|NCT01872897|Alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|mesh-list
110115414|NCT01872897|Antacids|antacids|mesh-ancestor
110115415|NCT01872897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110115416|NCT01872897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110115417|NCT01872923|Bleomycin|bleomycin|mesh-list
110115418|NCT01872923|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110115419|NCT01872923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110115420|NCT01872936|Ribavirin|ribavirin|mesh-list
110115421|NCT01872936|Antimetabolites|antimetabolites|mesh-ancestor
110115422|NCT01872936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110115423|NCT01872936|Antiviral Agents|antiviral agents|mesh-ancestor
110115424|NCT01872936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110115425|NCT01872962|Cisplatin|cisplatin|mesh-list
110115426|NCT01872962|Gemcitabine|gemcitabine|mesh-list
110115427|NCT01872962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110115428|NCT01872962|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110115429|NCT01872962|Antimetabolites|antimetabolites|mesh-ancestor
110115430|NCT01872962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110115431|NCT01872988|Tenofovir|tenofovir|mesh-list
110115432|NCT01872988|Antiviral Agents|antiviral agents|mesh-ancestor
110115433|NCT01872988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110115434|NCT01872988|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110115435|NCT01872988|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110115436|NCT01872988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110115437|NCT01872988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110115438|NCT01872988|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110115439|NCT01872988|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110115440|NCT01873001|Pioglitazone|pioglitazone|mesh-list
110115441|NCT01873001|Abiraterone Acetate|abiraterone acetate|mesh-list
110115442|NCT01873001|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110115443|NCT01873001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110115444|NCT01873001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110115445|NCT01873001|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110115446|NCT01873001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110115447|NCT01873001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110115448|NCT01873001|Hormone Antagonists|hormone antagonists|mesh-ancestor
110115449|NCT01873001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110115450|NCT01873001|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110404826|NCT03060473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110404827|NCT03055013|Nivolumab|nivolumab|mesh-list
110404828|NCT03055013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110404829|NCT03055013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110404830|NCT03055013|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110404831|NCT03055013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110404832|NCT03038672|Nivolumab|nivolumab|mesh-list
110220835|NCT00119652|Serotonin Agents|serotonin agents|mesh-ancestor
110404833|NCT03038672|Immunoglobulins|immunoglobulins|mesh-list
110404834|NCT03038672|Immunoglobulin G|immunoglobulin g|mesh-list
110115452|NCT01873027|Umirolimus|umirolimus|mesh-list
110115453|NCT01873027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110115454|NCT01873027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110115455|NCT01873027|Immunologic Factors|immunologic factors|mesh-ancestor
110115456|NCT01873027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110115457|NCT01873027|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110115458|NCT01873027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110115459|NCT01873027|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110115460|NCT01873027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110115461|NCT01873027|Antifungal Agents|antifungal agents|mesh-ancestor
110115462|NCT01873079|Esomeprazole|esomeprazole|mesh-list
110115463|NCT01873079|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110115464|NCT01873079|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110115465|NCT01873079|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110115466|NCT01873079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110115467|NCT01873079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110115468|NCT05855746|Colchicine|colchicine|mesh-list
110115469|NCT05855746|Gout Suppressants|gout suppressants|mesh-ancestor
110115470|NCT05855746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110115471|NCT05855746|Tubulin Modulators|tubulin modulators|mesh-ancestor
110115472|NCT05855746|Antimitotic Agents|antimitotic agents|mesh-ancestor
110115473|NCT05855746|Mitosis Modulators|mitosis modulators|mesh-ancestor
110115474|NCT05855746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110115475|NCT05855746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110115476|NCT05855629|Inositol|inositol|mesh-list
110115477|NCT05855629|Adapalene|adapalene|mesh-list
110115478|NCT05855629|Benzoyl Peroxide|benzoyl peroxide|mesh-list
110115479|NCT05855629|Dermatologic Agents|dermatologic agents|mesh-ancestor
110115480|NCT05855629|Vitamin B Complex|vitamin b complex|mesh-ancestor
110115481|NCT05855629|Vitamins|vitamins|mesh-ancestor
110115482|NCT05855629|Micronutrients|micronutrients|mesh-ancestor
110404855|NCT03008278|Ramucirumab|ramucirumab|mesh-list
110115483|NCT05855629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110115484|NCT05855629|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110115485|NCT05855629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110115486|NCT05855629|Analgesics|analgesics|mesh-ancestor
110115487|NCT05855629|Sensory System Agents|sensory system agents|mesh-ancestor
110115488|NCT05855629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110115489|NCT05855629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110115490|NCT05855629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110115491|NCT05855616|Chlorhexidine|chlorhexidine|mesh-list
110115492|NCT05855616|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110115493|NCT05855616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110115494|NCT05855616|Disinfectants|disinfectants|mesh-ancestor
110115495|NCT05855590|Tranexamic Acid|tranexamic acid|mesh-list
110115496|NCT05855590|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110162694|NCT00114478|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110115497|NCT05855590|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110115498|NCT05855590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110115499|NCT05855590|Hemostatics|hemostatics|mesh-ancestor
110115500|NCT05855590|Coagulants|coagulants|mesh-ancestor
110115501|NCT05855486|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110115502|NCT05855486|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110115503|NCT05855187|Modafinil|modafinil|mesh-list
110115504|NCT05855187|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110220861|NCT00299962|Immunologic Factors|immunologic factors|mesh-ancestor
110220862|NCT00299962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110115505|NCT05855187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110115506|NCT05855187|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
110115507|NCT05855187|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110115508|NCT05855187|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110115509|NCT05855187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110115510|NCT05855070|Verapamil|verapamil|mesh-list
110115511|NCT05855070|Hyaluronic Acid|hyaluronic acid|mesh-list
110115512|NCT05855070|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110115513|NCT05855070|Immunologic Factors|immunologic factors|mesh-ancestor
110115514|NCT05855070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110404900|NCT02949284|Hormones|hormones|mesh-list
110115521|NCT05855070|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110115522|NCT05855070|Vasodilator Agents|vasodilator agents|mesh-ancestor
110115524|NCT05855018|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110115525|NCT05855018|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110115526|NCT05855018|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110115527|NCT05855018|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110115528|NCT05855018|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110115529|NCT05855018|Autonomic Agents|autonomic agents|mesh-ancestor
110115530|NCT05855018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110115531|NCT05855018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110115532|NCT05855018|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110115533|NCT05855018|Respiratory System Agents|respiratory system agents|mesh-ancestor
110115534|NCT05855018|Mydriatics|mydriatics|mesh-ancestor
110115535|NCT05855018|Parasympatholytics|parasympatholytics|mesh-ancestor
110115536|NCT05855018|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110115537|NCT05855018|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110115538|NCT05855018|Cholinergic Agents|cholinergic agents|mesh-ancestor
110115539|NCT05855018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110115540|NCT05855018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110115547|NCT05854849|Gemcitabine|gemcitabine|mesh-list
110115548|NCT05854849|Apatinib|apatinib|mesh-list
110115549|NCT05854849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110115550|NCT05854849|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110115551|NCT05854849|Antimetabolites|antimetabolites|mesh-ancestor
110115552|NCT05854849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110115553|NCT05854849|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110115554|NCT05854849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110115555|NCT05854667|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
110404940|NCT02912559|Immunologic Factors|immunologic factors|mesh-ancestor
110115556|NCT05854667|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110115557|NCT05854667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110115558|NCT05854667|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110115559|NCT05854667|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110115560|NCT05854667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110115561|NCT05854667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110115562|NCT05854667|Dopamine Agents|dopamine agents|mesh-ancestor
110115563|NCT05854667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110115565|NCT05854537|Bupivacaine|bupivacaine|mesh-list
110115566|NCT05854537|Anesthetics, Local|anesthetics, local|mesh-ancestor
110115567|NCT05854537|Anesthetics|anesthetics|mesh-ancestor
110115568|NCT05854537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110115569|NCT05854537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110115570|NCT05854537|Sensory System Agents|sensory system agents|mesh-ancestor
110115571|NCT05854537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110115572|NCT05854537|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110115573|NCT05854537|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110115574|NCT05854537|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110115575|NCT05854537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110115576|NCT05854537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110115577|NCT05854511|Sofosbuvir|sofosbuvir|mesh-list
110115578|NCT05854511|Antiviral Agents|antiviral agents|mesh-ancestor
110115579|NCT05854511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110115580|NCT05854342|Calcium|calcium|mesh-list
110115581|NCT05854342|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110115582|NCT05854342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110115583|NCT05854225|Thiotepa|thiotepa|mesh-list
110115584|NCT05854225|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110115585|NCT05854225|Alkylating Agents|alkylating agents|mesh-ancestor
110115586|NCT05854225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110115587|NCT05854225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110115588|NCT05854225|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110115589|NCT05854225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110115590|NCT05854225|Immunologic Factors|immunologic factors|mesh-ancestor
110115591|NCT05854225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110115592|NCT05854082|Lidocaine|lidocaine|mesh-list
110115593|NCT05854082|Anesthetics, Local|anesthetics, local|mesh-ancestor
110115594|NCT05854082|Anesthetics|anesthetics|mesh-ancestor
110115595|NCT05854082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110115596|NCT05854082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110115597|NCT05854082|Sensory System Agents|sensory system agents|mesh-ancestor
110115598|NCT05854082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110115599|NCT05854082|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110404972|NCT02849496|Immunologic Factors|immunologic factors|mesh-ancestor
110115600|NCT05854082|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110115601|NCT05854082|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110115602|NCT05854082|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110220919|NCT00300118|Sensory System Agents|sensory system agents|mesh-ancestor
110220920|NCT00300118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110220922|NCT00119730|Fludarabine|fludarabine|mesh-list
110220923|NCT00119730|Mitoxantrone|mitoxantrone|mesh-list
110220924|NCT00119730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110220926|NCT00119730|Immunologic Factors|immunologic factors|mesh-ancestor
110220927|NCT00119730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110220928|NCT00119730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110220930|NCT00119730|Analgesics|analgesics|mesh-ancestor
110115603|NCT05854082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110115605|NCT05853965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110115606|NCT05853718|Tenofovir|tenofovir|mesh-list
110115607|NCT05853718|Antiviral Agents|antiviral agents|mesh-ancestor
110115608|NCT05853718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110115609|NCT05853718|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110115610|NCT05853718|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110115611|NCT05853718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110115612|NCT05853718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110115613|NCT05853718|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110115614|NCT05853718|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110115615|NCT05853627|Propranolol|propranolol|mesh-list
110115616|NCT05853627|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110115617|NCT05853627|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110115618|NCT05853627|Adrenergic Agents|adrenergic agents|mesh-ancestor
110115619|NCT05853627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110115620|NCT05853627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110115621|NCT05853627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110115622|NCT05853627|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110115623|NCT05853627|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110115624|NCT05853627|Vasodilator Agents|vasodilator agents|mesh-ancestor
110115625|NCT05853601|Theophylline|theophylline|mesh-list
110405001|NCT02775851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110405002|NCT02754596|Timolol|timolol|mesh-list
110405003|NCT02754596|Travoprost|travoprost|mesh-list
110405004|NCT02754596|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110405005|NCT02754596|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110405006|NCT02754596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110405007|NCT02754596|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110405008|NCT02754596|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110405009|NCT02754596|Adrenergic Agents|adrenergic agents|mesh-ancestor
110405010|NCT02754596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110405011|NCT02754596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110405012|NCT02754596|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110405013|NCT02754596|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110405014|NCT02744898|Paclitaxel|paclitaxel|mesh-list
110405015|NCT02744898|Carboplatin|carboplatin|mesh-list
110405016|NCT02744898|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110405017|NCT02744898|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110405018|NCT02744898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110405019|NCT02744898|Tubulin Modulators|tubulin modulators|mesh-ancestor
110405020|NCT02744898|Antimitotic Agents|antimitotic agents|mesh-ancestor
110405021|NCT02744898|Mitosis Modulators|mitosis modulators|mesh-ancestor
110405022|NCT02744898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110115626|NCT05853601|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110115627|NCT05853601|Autonomic Agents|autonomic agents|mesh-ancestor
110115628|NCT05853601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110115629|NCT05853601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110220941|NCT00119769|Hormones|hormones|mesh-list
110220942|NCT00119769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110220943|NCT00119769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110220944|NCT00300313|Escitalopram|escitalopram|mesh-list
110220945|NCT00300313|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110220946|NCT00300313|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110220947|NCT00300313|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110220948|NCT00300313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110220949|NCT00300313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110220950|NCT00300313|Serotonin Agents|serotonin agents|mesh-ancestor
110115630|NCT05853601|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110115631|NCT05853601|Respiratory System Agents|respiratory system agents|mesh-ancestor
110115632|NCT05853601|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110115633|NCT05853601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110162706|NCT00114478|Sympathomimetics|sympathomimetics|mesh-ancestor
110115634|NCT05853601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110115635|NCT05853601|Vasodilator Agents|vasodilator agents|mesh-ancestor
110115636|NCT05853601|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110115637|NCT05853601|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110115638|NCT05853601|Purinergic Agents|purinergic agents|mesh-ancestor
110115639|NCT05853601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110115640|NCT05852730|Promethazine|promethazine|mesh-list
110115641|NCT05852730|Diphenhydramine|diphenhydramine|mesh-list
110115642|NCT05852730|Meclizine|meclizine|mesh-list
110115643|NCT05852730|Scopolamine|scopolamine|mesh-list
110115644|NCT05852730|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110115645|NCT05852730|Antiemetics|antiemetics|mesh-ancestor
110115646|NCT05852730|Autonomic Agents|autonomic agents|mesh-ancestor
110115647|NCT05852730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110115648|NCT05852730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110115649|NCT05852730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110115650|NCT05852730|Mydriatics|mydriatics|mesh-ancestor
110115651|NCT05852730|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110115652|NCT05852730|Cholinergic Agents|cholinergic agents|mesh-ancestor
110405054|NCT02685826|Dexamethasone|dexamethasone|mesh-list
110405055|NCT02685826|Lenalidomide|lenalidomide|mesh-list
110115653|NCT05852730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110115654|NCT05852730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110115655|NCT05852730|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110115657|NCT05852730|Dermatologic Agents|dermatologic agents|mesh-ancestor
110115658|NCT05852730|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110115659|NCT05852730|Histamine Antagonists|histamine antagonists|mesh-ancestor
110115660|NCT05852730|Histamine Agents|histamine agents|mesh-ancestor
110115661|NCT05852730|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110115662|NCT05852730|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110115663|NCT05852730|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110115664|NCT05852730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110115665|NCT05852730|Anesthetics, Local|anesthetics, local|mesh-ancestor
110115666|NCT05852730|Anesthetics|anesthetics|mesh-ancestor
110115667|NCT05852730|Sensory System Agents|sensory system agents|mesh-ancestor
110115668|NCT05852041|Fluorides|fluorides|mesh-list
110115669|NCT05852041|Cariostatic Agents|cariostatic agents|mesh-ancestor
110115670|NCT05852041|Protective Agents|protective agents|mesh-ancestor
110115671|NCT05852041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110115672|NCT05845489|Anticoagulants|anticoagulants|mesh-list
110115673|NCT05845489|Clopidogrel|clopidogrel|mesh-list
110115674|NCT05845489|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110115675|NCT05845489|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110115676|NCT05845489|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110115677|NCT05845489|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110115678|NCT05845489|Purinergic Agents|purinergic agents|mesh-ancestor
110115679|NCT05845489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110115680|NCT05845489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110115681|NCT05845489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110115682|NCT05826873|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110115683|NCT05826873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110115684|NCT05823532|Infliximab|infliximab|mesh-list
110115685|NCT05823532|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110115686|NCT05823532|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110115687|NCT05823532|Dermatologic Agents|dermatologic agents|mesh-ancestor
110115688|NCT05823532|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110115689|NCT05823532|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110115691|NCT05815602|Ebastine|ebastine|mesh-list
110115692|NCT05815602|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110115693|NCT05815602|Histamine Antagonists|histamine antagonists|mesh-ancestor
110115694|NCT05815602|Histamine Agents|histamine agents|mesh-ancestor
110115695|NCT05815602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110115696|NCT05815602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110115697|NCT05815602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110115698|NCT05815602|Anticonvulsants|anticonvulsants|mesh-ancestor
110115699|NCT05815602|Parasympatholytics|parasympatholytics|mesh-ancestor
110115700|NCT05815602|Autonomic Agents|autonomic agents|mesh-ancestor
110115701|NCT05815602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110115702|NCT05755737|Ondansetron|ondansetron|mesh-list
110115703|NCT05755737|Antiemetics|antiemetics|mesh-ancestor
110115704|NCT05755737|Autonomic Agents|autonomic agents|mesh-ancestor
110115705|NCT05755737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110162711|NCT00114556|Zoledronic Acid|zoledronic acid|mesh-list
110115706|NCT05755737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110115707|NCT05755737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110115708|NCT05755737|Antipruritics|antipruritics|mesh-ancestor
110115709|NCT05755737|Dermatologic Agents|dermatologic agents|mesh-ancestor
110115710|NCT05755737|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110115711|NCT05755737|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110115712|NCT05755737|Serotonin Agents|serotonin agents|mesh-ancestor
110115713|NCT05755737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110115714|NCT05755737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110115715|NCT05739292|Vaccines|vaccines|mesh-list
110115716|NCT05739292|Immunologic Factors|immunologic factors|mesh-ancestor
110115717|NCT05739292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110115718|NCT05736952|Topotecan|topotecan|mesh-list
110115719|NCT05736952|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110115720|NCT05736952|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110115721|NCT05736952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110115722|NCT05736952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110115723|NCT05736952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110115724|NCT05732506|Edoxaban|edoxaban|mesh-list
110115725|NCT05732506|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110115726|NCT05732506|Antithrombins|antithrombins|mesh-ancestor
110115727|NCT05732506|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110115728|NCT05732506|Protease Inhibitors|protease inhibitors|mesh-ancestor
110115729|NCT05732506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110115730|NCT05732506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110115731|NCT05732506|Anticoagulants|anticoagulants|mesh-ancestor
110115732|NCT05674656|Dolutegravir|dolutegravir|mesh-list
110115733|NCT05674656|Rilpivirine|rilpivirine|mesh-list
110115734|NCT05674656|Dolutegravir, rilpivirine drug combination|dolutegravir, rilpivirine drug combination|mesh-list
110115735|NCT05674656|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110115736|NCT05674656|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110115737|NCT05674656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110115738|NCT05674656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110115739|NCT05674656|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110115740|NCT05674656|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110115742|NCT05674656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110115743|NCT05674656|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110115744|NCT05674656|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110115745|NCT05664789|Acetylcysteine|acetylcysteine|mesh-list
110115746|NCT05664789|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110115747|NCT05664789|Antiviral Agents|antiviral agents|mesh-ancestor
110115748|NCT05664789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110115749|NCT05664789|Expectorants|expectorants|mesh-ancestor
110115750|NCT05664789|Respiratory System Agents|respiratory system agents|mesh-ancestor
110115751|NCT05664789|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110115752|NCT05664789|Antioxidants|antioxidants|mesh-ancestor
110115753|NCT05664789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110115754|NCT05664789|Protective Agents|protective agents|mesh-ancestor
110115755|NCT05664789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110115756|NCT05664789|Antidotes|antidotes|mesh-ancestor
110115757|NCT05656443|Ritonavir|ritonavir|mesh-list
110115758|NCT05656443|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110115759|NCT05656443|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110115760|NCT05656443|Protease Inhibitors|protease inhibitors|mesh-ancestor
110115761|NCT05656443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110115762|NCT05656443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110115763|NCT05656443|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110115764|NCT05656443|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110115765|NCT05656443|Antiviral Agents|antiviral agents|mesh-ancestor
110115766|NCT05656443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110115767|NCT05656443|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110115768|NCT05656443|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110115769|NCT05651633|Lidocaine|lidocaine|mesh-list
110115770|NCT05651633|Anesthetics, Local|anesthetics, local|mesh-ancestor
110115771|NCT05651633|Anesthetics|anesthetics|mesh-ancestor
110115772|NCT05651633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110115773|NCT05651633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110115774|NCT05651633|Sensory System Agents|sensory system agents|mesh-ancestor
110115775|NCT05651633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110115776|NCT05651633|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110115777|NCT05651633|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110115778|NCT05651633|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110115779|NCT05651633|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110115780|NCT05651633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110115781|NCT05648448|Oseltamivir|oseltamivir|mesh-list
110115782|NCT05648448|Favipiravir|favipiravir|mesh-list
110115783|NCT05648448|Zanamivir|zanamivir|mesh-list
110115784|NCT05648448|Molnupiravir|molnupiravir|mesh-list
110115785|NCT05648448|Peramivir|peramivir|mesh-list
110115786|NCT05648448|Baloxavir|baloxavir|mesh-list
110115787|NCT05648448|Laninamivir|laninamivir|mesh-list
110115788|NCT05648448|Antiviral Agents|antiviral agents|mesh-ancestor
110115789|NCT05648448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110115790|NCT05648448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110115791|NCT05648448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110115792|NCT05641064|Dexmedetomidine|dexmedetomidine|mesh-list
110115793|NCT05641064|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110115794|NCT05641064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110115795|NCT05641064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110115796|NCT05641064|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110115797|NCT05641064|Analgesics|analgesics|mesh-ancestor
110115798|NCT05641064|Sensory System Agents|sensory system agents|mesh-ancestor
110115799|NCT05641064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110115800|NCT05641064|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110115801|NCT05641064|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110115802|NCT05641064|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110115803|NCT05641064|Adrenergic Agents|adrenergic agents|mesh-ancestor
110115804|NCT05641064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110115805|NCT05641064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110115806|NCT05634967|Ofatumumab|ofatumumab|mesh-list
110115807|NCT05634967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110115808|NCT05625776|Capsaicin|capsaicin|mesh-list
110115809|NCT05625776|Antipruritics|antipruritics|mesh-ancestor
110115810|NCT05625776|Dermatologic Agents|dermatologic agents|mesh-ancestor
110115811|NCT05625776|Sensory System Agents|sensory system agents|mesh-ancestor
110115812|NCT05625776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110115813|NCT05625776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110115814|NCT05563558|Carboplatin|carboplatin|mesh-list
110115815|NCT05563558|Pembrolizumab|pembrolizumab|mesh-list
110115816|NCT05563558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110115817|NCT05563558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110115818|NCT05563558|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110115819|NCT05563558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110115820|NCT05557838|Durvalumab|durvalumab|mesh-list
110115821|NCT05557838|Tremelimumab|tremelimumab|mesh-list
110115822|NCT05557838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110115823|NCT05557838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110115824|NCT05545735|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110115825|NCT05545735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110115826|NCT05531994|Montelukast|montelukast|mesh-list
110115827|NCT05531994|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110115828|NCT05531994|Respiratory System Agents|respiratory system agents|mesh-ancestor
110115829|NCT05531994|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110115830|NCT05531994|Hormone Antagonists|hormone antagonists|mesh-ancestor
110115831|NCT05531994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110115832|NCT05531994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110115833|NCT05531994|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110115834|NCT05531994|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110115835|NCT05531994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110115836|NCT05528718|Midazolam|midazolam|mesh-list
110115837|NCT05528718|Nitrous Oxide|nitrous oxide|mesh-list
110115838|NCT05528718|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110115839|NCT05528718|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110115840|NCT05528718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110115841|NCT05528718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110115842|NCT05528718|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110115843|NCT05528718|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110115844|NCT05528718|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110115845|NCT05528718|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110115846|NCT05528718|Anesthetics, General|anesthetics, general|mesh-ancestor
110115848|NCT05528718|GABA Modulators|gaba modulators|mesh-ancestor
110115849|NCT05528718|GABA Agents|gaba agents|mesh-ancestor
110115850|NCT05528718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110115851|NCT05528718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110115852|NCT05528718|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110115853|NCT05528718|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110115854|NCT05528718|Analgesics|analgesics|mesh-ancestor
110115855|NCT05528718|Sensory System Agents|sensory system agents|mesh-ancestor
110115856|NCT05528718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110115857|NCT05528198|Montelukast|montelukast|mesh-list
110115858|NCT05528198|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110115859|NCT05528198|Respiratory System Agents|respiratory system agents|mesh-ancestor
110115860|NCT05528198|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110115861|NCT05528198|Hormone Antagonists|hormone antagonists|mesh-ancestor
110115862|NCT05528198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110115863|NCT05528198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110115864|NCT05528198|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110115865|NCT05528198|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110115866|NCT05528198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110115867|NCT05514899|Dronabinol|dronabinol|mesh-list
110115868|NCT05514899|Cannabidiol|cannabidiol|mesh-list
110115869|NCT05514899|Anticonvulsants|anticonvulsants|mesh-ancestor
110115870|NCT05514899|Hallucinogens|hallucinogens|mesh-ancestor
110115871|NCT05514899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110115872|NCT05514899|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110115874|NCT05514899|Analgesics|analgesics|mesh-ancestor
110115875|NCT05514899|Sensory System Agents|sensory system agents|mesh-ancestor
110115876|NCT05514899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110115877|NCT05514899|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
110220991|NCT00086268|Docetaxel|docetaxel|mesh-list
110115878|NCT05514899|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110115879|NCT05514899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110115880|NCT05514899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110115881|NCT05514899|Hormones|hormones|mesh-ancestor
110115882|NCT05514899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110115883|NCT05458401|Trastuzumab|trastuzumab|mesh-list
110115884|NCT05458401|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
110115885|NCT05458401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110115886|NCT05458401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110115887|NCT05458401|Immunoconjugates|immunoconjugates|mesh-ancestor
110115888|NCT05458401|Immunologic Factors|immunologic factors|mesh-ancestor
110115889|NCT05458401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110115891|NCT05458375|Estrogens|estrogens|mesh-ancestor
110115892|NCT05458375|Hormones|hormones|mesh-ancestor
110115893|NCT05458375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110115894|NCT05458375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110115895|NCT05420584|Tislelizumab|tislelizumab|mesh-list
110115896|NCT05420584|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110115897|NCT05420584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110115898|NCT05416580|Metformin|metformin|mesh-list
110115899|NCT05416580|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
110115900|NCT05416580|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110115901|NCT05416580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110115902|NCT05416580|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
110115903|NCT05416580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110115904|NCT05413980|Moxifloxacin|moxifloxacin|mesh-list
110115905|NCT05413980|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110115906|NCT05413980|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
110115907|NCT05413980|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110115908|NCT05413980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110115909|NCT05413980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110115910|NCT05413980|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110115911|NCT05413980|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110115912|NCT05413980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110115913|NCT05413980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110115914|NCT05413980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110115915|NCT05413980|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110115916|NCT05413980|Contraceptive Agents|contraceptive agents|mesh-ancestor
110115917|NCT05413980|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110115918|NCT05413980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110115919|NCT05413980|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110115920|NCT05413980|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110115921|NCT05413980|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110115922|NCT05413551|Isoniazid|isoniazid|mesh-list
110115923|NCT05413551|Antitubercular Agents|antitubercular agents|mesh-ancestor
110115924|NCT05413551|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110115925|NCT05413551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110115926|NCT05413551|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
110115927|NCT05413551|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110115928|NCT05413551|Antimetabolites|antimetabolites|mesh-ancestor
110115929|NCT05413551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110115930|NCT05413551|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110115931|NCT05385406|Acetic Acid|acetic acid|mesh-list
110115932|NCT05385406|Retinol acetate|retinol acetate|mesh-list
110115933|NCT05385406|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110115934|NCT05385406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110115935|NCT05385406|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110115936|NCT05385406|Immunologic Factors|immunologic factors|mesh-ancestor
110115937|NCT05385406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110115938|NCT05385406|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110115939|NCT05385406|Protective Agents|protective agents|mesh-ancestor
110115940|NCT05385406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110221004|NCT00300586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110115941|NCT05375760|Cilgavimab and tixagevimab drug combination|cilgavimab and tixagevimab drug combination|mesh-list
110115942|NCT05375760|Antiviral Agents|antiviral agents|mesh-ancestor
110115943|NCT05375760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110115944|NCT05357547|Buspirone|buspirone|mesh-list
110115945|NCT05357547|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110115946|NCT05357547|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110115947|NCT05357547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110115948|NCT05357547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110115949|NCT05357547|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110115950|NCT05357547|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110115951|NCT05357547|Serotonin Agents|serotonin agents|mesh-ancestor
110115952|NCT05357547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110115953|NCT05357547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110115954|NCT05344833|Lenalidomide|lenalidomide|mesh-list
110115955|NCT05344833|Immunologic Factors|immunologic factors|mesh-ancestor
110115956|NCT05344833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110115957|NCT05344833|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110115958|NCT05344833|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110115959|NCT05344833|Growth Substances|growth substances|mesh-ancestor
110115960|NCT05344833|Growth Inhibitors|growth inhibitors|mesh-ancestor
110115961|NCT05344833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110115962|NCT05323838|Complement System Proteins|complement system proteins|mesh-list
110115978|NCT05302999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110115996|NCT05265806|Oxytocin|oxytocin|mesh-list
110115997|NCT05265806|Oxytocics|oxytocics|mesh-ancestor
110115998|NCT05265806|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110405270|NCT02224781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110405271|NCT02224781|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110405272|NCT02224781|Antioxidants|antioxidants|mesh-ancestor
110405273|NCT02196181|Trametinib|trametinib|mesh-list
110405274|NCT02196181|Dabrafenib|dabrafenib|mesh-list
110405275|NCT02196181|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
110405276|NCT02196181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110405277|NCT02196181|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110405278|NCT02196181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110405279|NCT02196181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110405280|NCT02196181|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
110405281|NCT02196181|Protective Agents|protective agents|mesh-ancestor
110405282|NCT02196181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110405283|NCT02196181|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110405284|NCT02196181|Antioxidants|antioxidants|mesh-ancestor
110405309|NCT02193282|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110405310|NCT02193282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110405311|NCT02193282|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110405312|NCT02193282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110405313|NCT02193282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110405314|NCT02095132|Irinotecan|irinotecan|mesh-list
110405315|NCT02095132|Camptothecin|camptothecin|mesh-list
110115999|NCT05265806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110116001|NCT05252585|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110116002|NCT05252585|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110116003|NCT05252585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110116004|NCT05252585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110116005|NCT05252585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110116006|NCT05252585|Immunologic Factors|immunologic factors|mesh-ancestor
110116007|NCT05252585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110116009|NCT05242419|Huperzine A|huperzine a|mesh-list
110116010|NCT05242419|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110116011|NCT05242419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110116012|NCT05242419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110116013|NCT05242419|Cholinergic Agents|cholinergic agents|mesh-ancestor
110116014|NCT05242419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110116015|NCT05242419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110116016|NCT05242419|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110116017|NCT05242419|Protective Agents|protective agents|mesh-ancestor
110116018|NCT05232227|Primaquine|primaquine|mesh-list
110116019|NCT05232227|Antimalarials|antimalarials|mesh-ancestor
110116020|NCT05232227|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110116021|NCT05232227|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110116022|NCT05232227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110116023|NCT05225363|Cyclophosphamide|cyclophosphamide|mesh-list
110116024|NCT05225363|Fludarabine|fludarabine|mesh-list
110116025|NCT05225363|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110116026|NCT05225363|Immunologic Factors|immunologic factors|mesh-ancestor
110116027|NCT05225363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110116028|NCT05225363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110116029|NCT05225363|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110116030|NCT05225363|Alkylating Agents|alkylating agents|mesh-ancestor
110116031|NCT05225363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110116032|NCT05225363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110116033|NCT05225363|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110116034|NCT05221229|Liraglutide|liraglutide|mesh-list
110116035|NCT05221229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110116036|NCT05221229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110116037|NCT05221229|Incretins|incretins|mesh-ancestor
110116039|NCT05221229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110116040|NCT05216432|Fulvestrant|fulvestrant|mesh-list
110116041|NCT05216432|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110116042|NCT05216432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110116043|NCT05216432|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110116044|NCT05216432|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110116045|NCT05216432|Hormone Antagonists|hormone antagonists|mesh-ancestor
110116046|NCT05216432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110116047|NCT05216432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110116048|NCT05184842|Decitabine|decitabine|mesh-list
110116049|NCT05184842|Venetoclax|venetoclax|mesh-list
110116050|NCT05184842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110116051|NCT05184842|Antimetabolites|antimetabolites|mesh-ancestor
110116052|NCT05184842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110116053|NCT05184842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110116054|NCT05184842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110116055|NCT05139420|Topiramate|topiramate|mesh-list
110116056|NCT05139420|Phentermine|phentermine|mesh-list
110116057|NCT05139420|Anticonvulsants|anticonvulsants|mesh-ancestor
110116058|NCT05139420|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110116059|NCT05139420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110116060|NCT05139420|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110116061|NCT05139420|Appetite Depressants|appetite depressants|mesh-ancestor
110116062|NCT05139420|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110116063|NCT05139420|Sympathomimetics|sympathomimetics|mesh-ancestor
110116064|NCT05139420|Autonomic Agents|autonomic agents|mesh-ancestor
110116065|NCT05139420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110116066|NCT05139420|Adrenergic Agents|adrenergic agents|mesh-ancestor
110116067|NCT05139420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110116068|NCT05139420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110116069|NCT05135650|Sotrovimab|sotrovimab|mesh-list
110116070|NCT05135650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110116071|NCT05135650|Antibodies|antibodies|mesh-list
110116072|NCT05135650|Immunoglobulins|immunoglobulins|mesh-list
110116073|NCT05135650|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110405364|NCT02003222|Muromonab-CD3|muromonab-cd3|mesh-list
110116074|NCT05135650|Immunologic Factors|immunologic factors|mesh-ancestor
110116075|NCT05135650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110116076|NCT05135650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110116077|NCT05135650|Antiviral Agents|antiviral agents|mesh-ancestor
110116078|NCT05135650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110116079|NCT05073822|Mycophenolic Acid|mycophenolic acid|mesh-list
110116080|NCT05073822|Tacrolimus|tacrolimus|mesh-list
110116081|NCT05073822|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110116082|NCT05073822|Immunologic Factors|immunologic factors|mesh-ancestor
110116083|NCT05073822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110116084|NCT05073822|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110116085|NCT05073822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110116086|NCT05073822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110116087|NCT05073822|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110116088|NCT05073822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110116089|NCT05073822|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110116090|NCT05073822|Antitubercular Agents|antitubercular agents|mesh-ancestor
110116091|NCT05073822|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110116092|NCT05073822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110116093|NCT05047952|Vortioxetine|vortioxetine|mesh-list
110116094|NCT05047952|Antidepressive Agents|antidepressive agents|mesh-ancestor
110116095|NCT05047952|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110116096|NCT05047952|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110116097|NCT05047952|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110116098|NCT05047952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110116099|NCT05047952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110116100|NCT05047952|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110116101|NCT05047952|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110116102|NCT05047952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110116103|NCT05047952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110221050|NCT00418249|Protective Agents|protective agents|mesh-ancestor
110116104|NCT05047952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110116105|NCT05047952|Serotonin Agents|serotonin agents|mesh-ancestor
110116106|NCT05047952|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110116107|NCT05047952|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110116108|NCT05047952|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110116109|NCT05047952|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110116110|NCT05001828|Azacitidine|azacitidine|mesh-list
110116111|NCT05001828|Venetoclax|venetoclax|mesh-list
110116113|NCT05001828|Antimetabolites|antimetabolites|mesh-ancestor
110116114|NCT05001828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110116115|NCT05001828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110116116|NCT05001828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110116117|NCT04965454|Choline|choline|mesh-list
110116118|NCT04965454|Lipotropic Agents|lipotropic agents|mesh-ancestor
110116119|NCT04965454|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110116120|NCT04965454|Antimetabolites|antimetabolites|mesh-ancestor
110116121|NCT04965454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110116122|NCT04965454|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110116123|NCT04965454|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110116124|NCT04965454|Nootropic Agents|nootropic agents|mesh-ancestor
110116125|NCT04957615|Nivolumab|nivolumab|mesh-list
110116126|NCT04957615|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110116127|NCT04957615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110116128|NCT04957615|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110116129|NCT04957615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110116130|NCT04933552|Siponimod|siponimod|mesh-list
110116131|NCT04933552|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
110116132|NCT04933552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110116133|NCT04933552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110116134|NCT04933552|Immunologic Factors|immunologic factors|mesh-ancestor
110116135|NCT04933552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110116136|NCT04917484|Octreotide|octreotide|mesh-list
110116137|NCT04917484|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
110116138|NCT04917484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110116139|NCT04917484|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110405441|NCT01913730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110116140|NCT04917484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110116141|NCT04917484|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110116142|NCT04917484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110116143|NCT04916613|Androgens|androgens|mesh-list
110116144|NCT04916613|Hormones|hormones|mesh-ancestor
110162745|NCT00008060|Leucovorin|leucovorin|mesh-list
110116145|NCT04916613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110116146|NCT04916613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110116147|NCT04893525|Buprenorphine|buprenorphine|mesh-list
110116148|NCT04893525|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
110116150|NCT04893525|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110116151|NCT04893525|Narcotics|narcotics|mesh-ancestor
110116152|NCT04893525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110116153|NCT04893525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110116154|NCT04893525|Analgesics|analgesics|mesh-ancestor
110116155|NCT04893525|Sensory System Agents|sensory system agents|mesh-ancestor
110116156|NCT04893525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110116157|NCT04893525|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110116158|NCT04865848|Anesthetics|anesthetics|mesh-list
110116159|NCT04865848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110116160|NCT04865848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110116162|NCT04859322|Somatostatin|somatostatin|mesh-list
110116163|NCT04859322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110116164|NCT04859322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110221075|NCT00301171|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110221083|NCT00301210|Tramadol|tramadol|mesh-list
110116165|NCT04859322|Hormones|hormones|mesh-ancestor
110116166|NCT04859322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110116167|NCT04839666|Propofol|propofol|mesh-list
110116168|NCT04839666|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110116169|NCT04839666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110116170|NCT04839666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110116171|NCT04839666|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110116173|NCT04839666|Anesthetics|anesthetics|mesh-ancestor
110116174|NCT04804007|Etoposide|etoposide|mesh-list
110116175|NCT04804007|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110116176|NCT04804007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110116177|NCT04804007|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110116178|NCT04804007|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110116179|NCT04804007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110116180|NCT04804007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110116181|NCT04788667|Erenumab|erenumab|mesh-list
110116182|NCT04788667|Botulinum Toxins|botulinum toxins|mesh-list
110116183|NCT04788667|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110116184|NCT04788667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110116185|NCT04788667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110116186|NCT04788667|Cholinergic Agents|cholinergic agents|mesh-ancestor
110116187|NCT04788667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110116188|NCT04788667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110116189|NCT04788667|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
110116190|NCT04788667|Analgesics|analgesics|mesh-ancestor
110116191|NCT04788667|Sensory System Agents|sensory system agents|mesh-ancestor
110116192|NCT04788667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110116193|NCT04782180|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
110116194|NCT04782180|Antiviral Agents|antiviral agents|mesh-ancestor
110116195|NCT04782180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110116196|NCT04782180|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110116197|NCT04782180|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110116198|NCT04782180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110116199|NCT04782180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110405532|NCT01273441|Amoxicillin|amoxicillin|mesh-list
110116201|NCT04782180|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110116202|NCT04757584|Propranolol|propranolol|mesh-list
110116203|NCT04757584|Metoprolol|metoprolol|mesh-list
110116204|NCT04757584|Atenolol|atenolol|mesh-list
110116205|NCT04757584|Sotalol|sotalol|mesh-list
110116206|NCT04757584|Nadolol|nadolol|mesh-list
110116207|NCT04757584|Acebutolol|acebutolol|mesh-list
110116208|NCT04757584|Carvedilol|carvedilol|mesh-list
110116209|NCT04757584|Nebivolol|nebivolol|mesh-list
110116210|NCT04757584|Bisoprolol|bisoprolol|mesh-list
110116211|NCT04757584|Labetalol|labetalol|mesh-list
110116212|NCT04757584|Pindolol|pindolol|mesh-list
110116213|NCT04757584|Betaxolol|betaxolol|mesh-list
110116214|NCT04757584|Penbutolol|penbutolol|mesh-list
110116215|NCT04757584|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
110116216|NCT04757584|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110116217|NCT04757584|Adrenergic Agents|adrenergic agents|mesh-ancestor
110116218|NCT04757584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110116219|NCT04757584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110116220|NCT04757584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110116221|NCT04757584|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110116222|NCT04757584|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110116223|NCT04757584|Vasodilator Agents|vasodilator agents|mesh-ancestor
110116226|NCT04757584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110116227|NCT04757584|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110116228|NCT04757584|Antioxidants|antioxidants|mesh-ancestor
110116229|NCT04757584|Protective Agents|protective agents|mesh-ancestor
110116230|NCT04757584|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110116231|NCT04757584|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110116232|NCT04757584|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110116233|NCT04757584|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110116234|NCT04757584|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110116235|NCT04757584|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
110116236|NCT04757584|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110116237|NCT04757584|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110116238|NCT04757584|Sympathomimetics|sympathomimetics|mesh-ancestor
110116239|NCT04757584|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110116240|NCT04757584|Serotonin Agents|serotonin agents|mesh-ancestor
110116241|NCT04756791|Anesthetics|anesthetics|mesh-list
110116242|NCT04756791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110116243|NCT04756791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110116244|NCT04752475|Furosemide|furosemide|mesh-list
110116245|NCT04752475|Diuretics|diuretics|mesh-ancestor
110116246|NCT04752475|Natriuretic Agents|natriuretic agents|mesh-ancestor
110405621|NCT00006721|Mitosis Modulators|mitosis modulators|mesh-ancestor
110116247|NCT04752475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110116248|NCT04752475|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110116249|NCT04752475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110116250|NCT04752475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110116251|NCT04720326|Tacrolimus|tacrolimus|mesh-list
110116252|NCT04720326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110116253|NCT04720326|Immunologic Factors|immunologic factors|mesh-ancestor
110116254|NCT04720326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110116255|NCT04720326|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110116256|NCT04720326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110116257|NCT04720326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110116258|NCT04717362|Methyltestosterone|methyltestosterone|mesh-list
110116259|NCT04717362|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
110116260|NCT04717362|Testosterone|testosterone|mesh-list
110116261|NCT04717362|Testosterone undecanoate|testosterone undecanoate|mesh-list
110116262|NCT04717362|Testosterone enanthate|testosterone enanthate|mesh-list
110116263|NCT04717362|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110116264|NCT04717362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110116265|NCT04717362|Anabolic Agents|anabolic agents|mesh-ancestor
110116266|NCT04717362|Hormones|hormones|mesh-ancestor
110116267|NCT04717362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110116268|NCT04717362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110116269|NCT04717362|Androgens|androgens|mesh-ancestor
110116270|NCT04708054|Fludarabine|fludarabine|mesh-list
110116271|NCT04708054|Fludarabine phosphate|fludarabine phosphate|mesh-list
110116272|NCT04708054|Busulfan|busulfan|mesh-list
110116273|NCT04708054|Venetoclax|venetoclax|mesh-list
110116274|NCT04708054|Thiotepa|thiotepa|mesh-list
110116275|NCT04708054|Cladribine|cladribine|mesh-list
110116276|NCT04708054|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
110116277|NCT04708054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110116278|NCT04708054|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110116279|NCT04708054|Antimetabolites|antimetabolites|mesh-ancestor
110116280|NCT04708054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110116281|NCT04708054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110116282|NCT04708054|Immunologic Factors|immunologic factors|mesh-ancestor
110116283|NCT04708054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110116284|NCT04708054|Alkylating Agents|alkylating agents|mesh-ancestor
110116285|NCT04708054|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110116286|NCT04708054|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110116289|NCT04700826|Edoxaban|edoxaban|mesh-list
110116290|NCT04700826|Dabigatran|dabigatran|mesh-list
110116291|NCT04700826|Anticoagulants|anticoagulants|mesh-list
110116292|NCT04700826|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110116293|NCT04700826|Antithrombins|antithrombins|mesh-ancestor
110116294|NCT04700826|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110116295|NCT04700826|Protease Inhibitors|protease inhibitors|mesh-ancestor
110116296|NCT04700826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110116297|NCT04700826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110116298|NCT04648033|Atovaquone|atovaquone|mesh-list
110116299|NCT04648033|Cisplatin|cisplatin|mesh-list
110116301|NCT04648033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110116302|NCT04648033|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110116303|NCT04648033|Tubulin Modulators|tubulin modulators|mesh-ancestor
110116304|NCT04648033|Antimitotic Agents|antimitotic agents|mesh-ancestor
110116305|NCT04648033|Mitosis Modulators|mitosis modulators|mesh-ancestor
110116306|NCT04648033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110116307|NCT04648033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110116308|NCT04648033|Antimalarials|antimalarials|mesh-ancestor
110116309|NCT04648033|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110116310|NCT04648033|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110116311|NCT04648033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110116312|NCT04604782|Regadenoson|regadenoson|mesh-list
110116313|NCT04604782|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
110116314|NCT04604782|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
110116315|NCT04604782|Purinergic Agonists|purinergic agonists|mesh-ancestor
110116316|NCT04604782|Purinergic Agents|purinergic agents|mesh-ancestor
110116317|NCT04604782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110116318|NCT04604782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110116319|NCT04604782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110116320|NCT04549207|Denosumab|denosumab|mesh-list
110116321|NCT04549207|Zoledronic Acid|zoledronic acid|mesh-list
110116322|NCT04549207|Pamidronate|pamidronate|mesh-list
110116323|NCT04549207|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110116324|NCT04549207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110116325|NCT04319328|Ciprofloxacin|ciprofloxacin|mesh-list
110116326|NCT04319328|Cefazolin|cefazolin|mesh-list
110116327|NCT04319328|Ceftazidime|ceftazidime|mesh-list
110116328|NCT04319328|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110116329|NCT04319328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110116330|NCT04319328|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110116331|NCT04319328|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110116332|NCT04319328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110116333|NCT04319328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110116334|NCT04319328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110116335|NCT04319328|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110116336|NCT04319328|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110116337|NCT04306315|Brodalumab|brodalumab|mesh-list
110116338|NCT04306315|Dermatologic Agents|dermatologic agents|mesh-ancestor
110116339|NCT04267926|Ubiquinone|ubiquinone|mesh-list
110116340|NCT04267926|Micronutrients|micronutrients|mesh-ancestor
110116341|NCT04267926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110116342|NCT04255160|Estradiol|estradiol|mesh-list
110116343|NCT04255160|Estrogens|estrogens|mesh-ancestor
110116344|NCT04255160|Hormones|hormones|mesh-ancestor
110116345|NCT04255160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110116346|NCT04255160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110116347|NCT04098718|Prednisolone|prednisolone|mesh-list
110116348|NCT04098718|Benralizumab|benralizumab|mesh-list
110116349|NCT04098718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110116350|NCT04098718|Glucocorticoids|glucocorticoids|mesh-ancestor
110116351|NCT04098718|Hormones|hormones|mesh-ancestor
110116352|NCT04098718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110116353|NCT04098718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110116354|NCT04098718|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110116355|NCT04098718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110116356|NCT04098718|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110116357|NCT04098718|Respiratory System Agents|respiratory system agents|mesh-ancestor
110116358|NCT04097730|Riboflavin|riboflavin|mesh-list
110162765|NCT00008060|Vitamins|vitamins|mesh-ancestor
110116359|NCT04097730|Moxifloxacin|moxifloxacin|mesh-list
110116360|NCT04097730|Difluprednate|difluprednate|mesh-list
110116361|NCT04097730|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110116362|NCT04097730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110116363|NCT04097730|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110116364|NCT04097730|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110116365|NCT04097730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110116366|NCT04097730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110116367|NCT04097730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110116368|NCT04097730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110116369|NCT04097730|Vitamin B Complex|vitamin b complex|mesh-ancestor
110116371|NCT04097730|Micronutrients|micronutrients|mesh-ancestor
110116372|NCT04097730|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110116373|NCT04097730|Dermatologic Agents|dermatologic agents|mesh-ancestor
110116374|NCT04097730|Glucocorticoids|glucocorticoids|mesh-ancestor
110116375|NCT04097730|Hormones|hormones|mesh-ancestor
110116376|NCT04097730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110116377|NCT04092387|Nicotine|nicotine|mesh-list
110116378|NCT04092387|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110116379|NCT04092387|Autonomic Agents|autonomic agents|mesh-ancestor
110116380|NCT04092387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110116381|NCT04092387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110116382|NCT04092387|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110116383|NCT04092387|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110116384|NCT04092387|Cholinergic Agents|cholinergic agents|mesh-ancestor
110116385|NCT04092387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110116386|NCT04092387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110116387|NCT04074330|Rituximab|rituximab|mesh-list
110221119|NCT00301405|Growth Inhibitors|growth inhibitors|mesh-ancestor
110221120|NCT00301405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110116388|NCT04074330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110116389|NCT04074330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110116390|NCT04074330|Immunologic Factors|immunologic factors|mesh-ancestor
110116391|NCT04074330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110116392|NCT04074330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110116393|NCT04062656|Leucovorin|leucovorin|mesh-list
110116394|NCT04062656|Folic Acid|folic acid|mesh-list
110116395|NCT04062656|Docetaxel|docetaxel|mesh-list
110116396|NCT04062656|Fluorouracil|fluorouracil|mesh-list
110116397|NCT04062656|Oxaliplatin|oxaliplatin|mesh-list
110116398|NCT04062656|Nivolumab|nivolumab|mesh-list
110116399|NCT04062656|Relatlimab|relatlimab|mesh-list
110116400|NCT04062656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110116401|NCT04062656|Tubulin Modulators|tubulin modulators|mesh-ancestor
110116402|NCT04062656|Antimitotic Agents|antimitotic agents|mesh-ancestor
110116403|NCT04062656|Mitosis Modulators|mitosis modulators|mesh-ancestor
110116404|NCT04062656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110116405|NCT04062656|Antimetabolites|antimetabolites|mesh-ancestor
110116406|NCT04062656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110116407|NCT04062656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110116408|NCT04062656|Immunologic Factors|immunologic factors|mesh-ancestor
110116409|NCT04062656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110116410|NCT04062656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110116411|NCT04062656|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110116412|NCT04062656|Antidotes|antidotes|mesh-ancestor
110116413|NCT04062656|Protective Agents|protective agents|mesh-ancestor
110116414|NCT04062656|Vitamin B Complex|vitamin b complex|mesh-ancestor
110116415|NCT04062656|Vitamins|vitamins|mesh-ancestor
110116417|NCT04062656|Hematinics|hematinics|mesh-ancestor
110116418|NCT04041050|Celecoxib|celecoxib|mesh-list
110116419|NCT04041050|Navitoclax|navitoclax|mesh-list
110116420|NCT04041050|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110116421|NCT04041050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110116422|NCT04041050|Analgesics|analgesics|mesh-ancestor
110116423|NCT04041050|Sensory System Agents|sensory system agents|mesh-ancestor
110116424|NCT04041050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110116425|NCT04041050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110116426|NCT04041050|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110116427|NCT04041050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110116428|NCT04041050|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110116429|NCT04041050|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110116430|NCT04041050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110116431|NCT04041050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110162769|NCT00114868|Retinol palmitate|retinol palmitate|mesh-list
110116432|NCT04041050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110116433|NCT04018313|Omalizumab|omalizumab|mesh-list
110116434|NCT04018313|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110116435|NCT04018313|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110221158|NCT00080444|Antiemetics|antiemetics|mesh-ancestor
110116436|NCT04018313|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110116437|NCT04018313|Respiratory System Agents|respiratory system agents|mesh-ancestor
110116438|NCT04018313|Immunologic Factors|immunologic factors|mesh-ancestor
110116439|NCT04018313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110116440|NCT03976518|Atezolizumab|atezolizumab|mesh-list
110116441|NCT03976518|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110116442|NCT03976518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110116443|NCT03976518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110116444|NCT03976518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110116445|NCT03973203|Niacin|niacin|mesh-list
110116446|NCT03973203|Nicotinic Acids|nicotinic acids|mesh-list
110116447|NCT03973203|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110116448|NCT03973203|Antimetabolites|antimetabolites|mesh-ancestor
110116449|NCT03973203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110116450|NCT03973203|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110116451|NCT03973203|Vasodilator Agents|vasodilator agents|mesh-ancestor
110116452|NCT03973203|Vitamin B Complex|vitamin b complex|mesh-ancestor
110116453|NCT03973203|Vitamins|vitamins|mesh-ancestor
110116454|NCT03973203|Micronutrients|micronutrients|mesh-ancestor
110116455|NCT03973203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110116456|NCT03916926|Fluorides|fluorides|mesh-list
110116457|NCT03916926|Fluorides, Topical|fluorides, topical|mesh-list
110116458|NCT03916926|Cariostatic Agents|cariostatic agents|mesh-ancestor
110116459|NCT03916926|Protective Agents|protective agents|mesh-ancestor
110116460|NCT03916926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110116461|NCT03899857|Pembrolizumab|pembrolizumab|mesh-list
110116462|NCT03899857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110116463|NCT03899857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110116464|NCT03899857|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110116465|NCT03899857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110116466|NCT03879694|Octreotide|octreotide|mesh-list
110116467|NCT03879694|Sargramostim|sargramostim|mesh-list
110116468|NCT03879694|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
110116469|NCT03879694|Freund's Adjuvant|freund's adjuvant|mesh-list
110116470|NCT03879694|Immunologic Factors|immunologic factors|mesh-ancestor
110116471|NCT03879694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110116472|NCT03879694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110116473|NCT03879694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110116474|NCT03879694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110116475|NCT03879694|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110116476|NCT03871491|Azithromycin|azithromycin|mesh-list
110116477|NCT03871491|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110116478|NCT03871491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110116479|NCT03840967|Niraparib|niraparib|mesh-list
110116480|NCT03840967|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110116481|NCT03840967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110116482|NCT03840967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110116483|NCT03840967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110116484|NCT03839914|Vancomycin|vancomycin|mesh-list
110116485|NCT03839914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110116486|NCT03839914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110116487|NCT03838263|Cisplatin|cisplatin|mesh-list
110116488|NCT03838263|Nivolumab|nivolumab|mesh-list
110116489|NCT03838263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110116490|NCT03838263|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110116491|NCT03838263|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110116492|NCT03838263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110116493|NCT03801642|Dapagliflozin|dapagliflozin|mesh-list
110116494|NCT03801642|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110116495|NCT03801642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110116496|NCT03801642|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110116497|NCT03801642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110116499|NCT03792490|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110116500|NCT03792490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110116501|NCT03792490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110162774|NCT00114868|Protective Agents|protective agents|mesh-ancestor
110116502|NCT03792490|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110116503|NCT03792490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110116504|NCT03792490|Vasodilator Agents|vasodilator agents|mesh-ancestor
110116505|NCT03792490|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110116506|NCT03792490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110116508|NCT03783429|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110116509|NCT03783429|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110116510|NCT03783429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110116511|NCT03783429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110116512|NCT03783429|Protective Agents|protective agents|mesh-ancestor
110116513|NCT03783429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110116514|NCT03770338|Teriparatide|teriparatide|mesh-list
110116515|NCT03770338|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110116516|NCT03770338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110116517|NCT03770338|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110116518|NCT03721653|Leucovorin|leucovorin|mesh-list
110116519|NCT03721653|Bevacizumab|bevacizumab|mesh-list
110116520|NCT03721653|Atezolizumab|atezolizumab|mesh-list
110116521|NCT03721653|Fluorouracil|fluorouracil|mesh-list
110116522|NCT03721653|Oxaliplatin|oxaliplatin|mesh-list
110116523|NCT03721653|Irinotecan|irinotecan|mesh-list
110116524|NCT03721653|Levoleucovorin|levoleucovorin|mesh-list
110116525|NCT03721653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110116526|NCT03721653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110116527|NCT03721653|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110116528|NCT03721653|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110116529|NCT03721653|Growth Substances|growth substances|mesh-ancestor
110116530|NCT03721653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110116531|NCT03721653|Growth Inhibitors|growth inhibitors|mesh-ancestor
110116532|NCT03721653|Antimetabolites|antimetabolites|mesh-ancestor
110116533|NCT03721653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110116534|NCT03721653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110116535|NCT03721653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110116536|NCT03721653|Immunologic Factors|immunologic factors|mesh-ancestor
110116537|NCT03721653|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110116538|NCT03721653|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110116539|NCT03721653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110116541|NCT03721653|Protective Agents|protective agents|mesh-ancestor
110116542|NCT03721653|Vitamin B Complex|vitamin b complex|mesh-ancestor
110116543|NCT03721653|Vitamins|vitamins|mesh-ancestor
110116544|NCT03721653|Micronutrients|micronutrients|mesh-ancestor
110116545|NCT03721653|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110116546|NCT03713645|Tacrolimus|tacrolimus|mesh-list
110116547|NCT03713645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110116548|NCT03713645|Immunologic Factors|immunologic factors|mesh-ancestor
110116549|NCT03713645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110116550|NCT03713645|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110116551|NCT03713645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110116552|NCT03713645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110116553|NCT03705507|Dexamethasone|dexamethasone|mesh-list
110116554|NCT03705507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110116555|NCT03705507|Antiemetics|antiemetics|mesh-ancestor
110116556|NCT03705507|Autonomic Agents|autonomic agents|mesh-ancestor
110116557|NCT03705507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110116558|NCT03705507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110116559|NCT03705507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110116560|NCT03705507|Glucocorticoids|glucocorticoids|mesh-ancestor
110116561|NCT03705507|Hormones|hormones|mesh-ancestor
110221202|NCT00292279|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
110116562|NCT03705507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110116563|NCT03705507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110116564|NCT03705507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110116565|NCT03664687|Zoledronic Acid|zoledronic acid|mesh-list
110116567|NCT03664687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110116568|NCT03663504|Metronidazole|metronidazole|mesh-list
110116569|NCT03663504|Neomycin|neomycin|mesh-list
110116570|NCT03663504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110116571|NCT03663504|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110116572|NCT03663504|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110116573|NCT03663504|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110116574|NCT03663504|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110116575|NCT03663504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110116576|NCT03663504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110116577|NCT03654066|Botulinum Toxins|botulinum toxins|mesh-list
110116578|NCT03654066|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110116579|NCT03654066|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110116580|NCT03654066|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110116581|NCT03654066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110116582|NCT03654066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110116583|NCT03654066|Cholinergic Agents|cholinergic agents|mesh-ancestor
110116584|NCT03654066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110116585|NCT03654066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110116586|NCT03654066|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110116587|NCT03654066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110116588|NCT03582488|Corticosterone|corticosterone|mesh-list
110116589|NCT03582488|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110116590|NCT03553810|Valsartan|valsartan|mesh-list
110116591|NCT03553810|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
110116592|NCT03553810|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110116593|NCT03553810|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110116594|NCT03553810|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110116595|NCT03553810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110116596|NCT03404596|Nicotine|nicotine|mesh-list
110116597|NCT03404596|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110116598|NCT03404596|Autonomic Agents|autonomic agents|mesh-ancestor
110116599|NCT03404596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110116600|NCT03404596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110116601|NCT03404596|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110116603|NCT03404596|Cholinergic Agents|cholinergic agents|mesh-ancestor
110116604|NCT03404596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110260163|NCT00168870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110116605|NCT03404596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110116606|NCT03340220|Itraconazole|itraconazole|mesh-list
110116607|NCT03340220|Antifungal Agents|antifungal agents|mesh-ancestor
110116608|NCT03340220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110116609|NCT03340220|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110116610|NCT03340220|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110116611|NCT03340220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110116612|NCT03340220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110116613|NCT03340220|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110116614|NCT03340220|Hormone Antagonists|hormone antagonists|mesh-ancestor
110116615|NCT03340220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110116616|NCT03340220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110116617|NCT03340220|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110221210|NCT00080522|Efavirenz|efavirenz|mesh-list
110116618|NCT03317158|Gemcitabine|gemcitabine|mesh-list
110116619|NCT03317158|Docetaxel|docetaxel|mesh-list
110116620|NCT03317158|Durvalumab|durvalumab|mesh-list
110116621|NCT03317158|Tremelimumab|tremelimumab|mesh-list
110116622|NCT03317158|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110116623|NCT03317158|BCG Vaccine|bcg vaccine|mesh-list
110116624|NCT03317158|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110116625|NCT03317158|Antimetabolites|antimetabolites|mesh-ancestor
110116626|NCT03317158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110116627|NCT03317158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110116628|NCT03317158|Tubulin Modulators|tubulin modulators|mesh-ancestor
110116629|NCT03317158|Antimitotic Agents|antimitotic agents|mesh-ancestor
110116630|NCT03317158|Mitosis Modulators|mitosis modulators|mesh-ancestor
110116631|NCT03317158|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110116632|NCT03317158|Immunologic Factors|immunologic factors|mesh-ancestor
110116633|NCT03317158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110116634|NCT03317158|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110116635|NCT03202316|Atezolizumab|atezolizumab|mesh-list
110116636|NCT03202316|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110116637|NCT03202316|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110116638|NCT03202316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110116639|NCT03202316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110116640|NCT03202316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110116641|NCT03202316|Immunologic Factors|immunologic factors|mesh-ancestor
110116642|NCT03202316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110116644|NCT03147859|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110116646|NCT03131219|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
110116647|NCT03131219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110116648|NCT03131219|Immunologic Factors|immunologic factors|mesh-ancestor
110116649|NCT03131219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110116650|NCT02914613|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110116651|NCT02914613|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110116652|NCT02783092|Cannabidiol|cannabidiol|mesh-list
110116653|NCT02783092|Anticonvulsants|anticonvulsants|mesh-ancestor
110116654|NCT02713945|Simvastatin|simvastatin|mesh-list
110116655|NCT02713945|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110116656|NCT02713945|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110116657|NCT02713945|Antimetabolites|antimetabolites|mesh-ancestor
110116658|NCT02713945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110116659|NCT02713945|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110116660|NCT02713945|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110116661|NCT02713945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110116662|NCT02685605|Temozolomide|temozolomide|mesh-list
110116663|NCT02685605|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110116664|NCT02685605|Alkylating Agents|alkylating agents|mesh-ancestor
110116665|NCT02685605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110116666|NCT02685605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110116667|NCT02664935|Docetaxel|docetaxel|mesh-list
110116668|NCT02664935|Durvalumab|durvalumab|mesh-list
110116669|NCT02664935|Palbociclib|palbociclib|mesh-list
110116670|NCT02664935|Osimertinib|osimertinib|mesh-list
110116671|NCT02664935|Crizotinib|crizotinib|mesh-list
110116672|NCT02664935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110116673|NCT02664935|Tubulin Modulators|tubulin modulators|mesh-ancestor
110116674|NCT02664935|Antimitotic Agents|antimitotic agents|mesh-ancestor
110116675|NCT02664935|Mitosis Modulators|mitosis modulators|mesh-ancestor
110116676|NCT02664935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110116677|NCT02664935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110221231|NCT00086775|Alemtuzumab|alemtuzumab|mesh-list
110116678|NCT02664935|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110116679|NCT02664935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110116680|NCT02586207|Cisplatin|cisplatin|mesh-list
110116681|NCT02586207|Pembrolizumab|pembrolizumab|mesh-list
110116682|NCT02586207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110116683|NCT02586207|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110116684|NCT02586207|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110116685|NCT02586207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110116686|NCT02573324|Temozolomide|temozolomide|mesh-list
110116687|NCT02573324|ABT-414|abt-414|mesh-list
110116688|NCT02573324|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110116689|NCT02573324|Alkylating Agents|alkylating agents|mesh-ancestor
110116690|NCT02573324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110116691|NCT02573324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110116692|NCT02573324|Immunoconjugates|immunoconjugates|mesh-ancestor
110116693|NCT02573324|Immunologic Factors|immunologic factors|mesh-ancestor
110116694|NCT02573324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110116695|NCT02553642|Nivolumab|nivolumab|mesh-list
110116696|NCT02553642|Ipilimumab|ipilimumab|mesh-list
110116697|NCT02553642|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110116698|NCT02553642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110116699|NCT02553642|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110116700|NCT02553642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110116701|NCT02523092|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
110116703|NCT02523092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110116704|NCT02523092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110116705|NCT02450773|Furosemide|furosemide|mesh-list
110116706|NCT02450773|Diuretics|diuretics|mesh-ancestor
110116707|NCT02450773|Natriuretic Agents|natriuretic agents|mesh-ancestor
110116708|NCT02450773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110116709|NCT02450773|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110162792|NCT00008177|Iodine|iodine|mesh-list
110116710|NCT02450773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110116711|NCT02450773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110116712|NCT02445248|Tisagenlecleucel|tisagenlecleucel|mesh-list
110116713|NCT02445248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110116714|NCT02445248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110116716|NCT02412566|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
110116717|NCT02412566|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
110221240|NCT00086775|Antimetabolites|antimetabolites|mesh-ancestor
110116718|NCT02412566|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110116720|NCT02397226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110116721|NCT02397226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110116722|NCT02296684|Cisplatin|cisplatin|mesh-list
110116723|NCT02296684|Pembrolizumab|pembrolizumab|mesh-list
110116724|NCT02296684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110116725|NCT02296684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110116726|NCT02296684|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110116727|NCT02296684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110116728|NCT01939275|Copper|copper|mesh-list
110116729|NCT01939275|Trastuzumab|trastuzumab|mesh-list
110116730|NCT01939275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110116731|NCT01939275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110116732|NCT01939275|Trace Elements|trace elements|mesh-ancestor
110116733|NCT01939275|Micronutrients|micronutrients|mesh-ancestor
110116734|NCT01939275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110116735|NCT01900574|Golimumab|golimumab|mesh-list
110116736|NCT01900574|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110116737|NCT01900574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110116738|NCT01900574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110116739|NCT01900574|Immunologic Factors|immunologic factors|mesh-ancestor
110116740|NCT01900574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110116741|NCT01342367|Bicalutamide|bicalutamide|mesh-list
110116742|NCT01342367|Finasteride|finasteride|mesh-list
110116743|NCT01342367|Dutasteride|dutasteride|mesh-list
110116744|NCT01342367|Androgen Antagonists|androgen antagonists|mesh-ancestor
110116745|NCT01342367|Hormone Antagonists|hormone antagonists|mesh-ancestor
110116746|NCT01342367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110116747|NCT01342367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110116748|NCT01342367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110116749|NCT01342367|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
110116750|NCT01342367|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110116751|NCT01342367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110116752|NCT01342367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110116753|NCT01342367|Urological Agents|urological agents|mesh-ancestor
110116755|NCT01185171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110116756|NCT01185171|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110116757|NCT01185171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110116758|NCT01185171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110116759|NCT00896493|Cyclosporine|cyclosporine|mesh-list
110116760|NCT00896493|Cyclosporins|cyclosporins|mesh-list
110116761|NCT00896493|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110116762|NCT00896493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110116763|NCT00896493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110116764|NCT00896493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110116765|NCT00896493|Immunologic Factors|immunologic factors|mesh-ancestor
110116766|NCT00896493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110116767|NCT00896493|Antifungal Agents|antifungal agents|mesh-ancestor
110116768|NCT00896493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110116769|NCT00896493|Dermatologic Agents|dermatologic agents|mesh-ancestor
110116770|NCT00896493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110116771|NCT00896493|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110116772|NCT00790010|Bevacizumab|bevacizumab|mesh-list
110116773|NCT00790010|Ipilimumab|ipilimumab|mesh-list
110116774|NCT00790010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110116775|NCT00790010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110116776|NCT00790010|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110116777|NCT00790010|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110116778|NCT00790010|Growth Substances|growth substances|mesh-ancestor
110116779|NCT00790010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110162798|NCT00008177|Antibodies|antibodies|mesh-list
110116780|NCT00790010|Growth Inhibitors|growth inhibitors|mesh-ancestor
110116781|NCT00790010|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110116782|NCT00790010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110116783|NCT00444093|Antidiarrheals|antidiarrheals|mesh-list
110116784|NCT00444093|Loperamide|loperamide|mesh-list
110116785|NCT00444093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110116786|NCT00408005|Calcium, Dietary|calcium, dietary|mesh-list
110116787|NCT00408005|Leucovorin|leucovorin|mesh-list
110116788|NCT00408005|Folic Acid|folic acid|mesh-list
110116789|NCT00408005|Cytarabine|cytarabine|mesh-list
110116790|NCT00408005|6-methoxypurine arabinoside|6-methoxypurine arabinoside|mesh-list
110116791|NCT00408005|Dexamethasone|dexamethasone|mesh-list
110116792|NCT00408005|Dexamethasone acetate|dexamethasone acetate|mesh-list
110116793|NCT00408005|Prednisone|prednisone|mesh-list
110116794|NCT00408005|Cortisone|cortisone|mesh-list
110116795|NCT00408005|Cyclophosphamide|cyclophosphamide|mesh-list
110116796|NCT00408005|Doxorubicin|doxorubicin|mesh-list
110116797|NCT00408005|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110116798|NCT00408005|Methotrexate|methotrexate|mesh-list
110116799|NCT00408005|Vincristine|vincristine|mesh-list
110116801|NCT00408005|Asparaginase|asparaginase|mesh-list
110116802|NCT00408005|Mercaptopurine|mercaptopurine|mesh-list
110116803|NCT00408005|Pegaspargase|pegaspargase|mesh-list
110116804|NCT00408005|Thioguanine|thioguanine|mesh-list
110116805|NCT00408005|BB 1101|bb 1101|mesh-list
110116806|NCT00408005|Calcium|calcium|mesh-list
110116807|NCT00408005|2-Aminopurine|2-aminopurine|mesh-list
110116808|NCT00408005|Levoleucovorin|levoleucovorin|mesh-list
110116809|NCT00408005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110116810|NCT00408005|Immunologic Factors|immunologic factors|mesh-ancestor
110116811|NCT00408005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110116812|NCT00408005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110116813|NCT00408005|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110116814|NCT00408005|Alkylating Agents|alkylating agents|mesh-ancestor
110116815|NCT00408005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110116816|NCT00408005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110116817|NCT00408005|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110116818|NCT00408005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110116819|NCT00408005|Antiemetics|antiemetics|mesh-ancestor
110116820|NCT00408005|Autonomic Agents|autonomic agents|mesh-ancestor
110116821|NCT00408005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110116822|NCT00408005|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110116823|NCT00408005|Glucocorticoids|glucocorticoids|mesh-ancestor
110116824|NCT00408005|Hormones|hormones|mesh-ancestor
110116825|NCT00408005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110116826|NCT00408005|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110116827|NCT00408005|Protease Inhibitors|protease inhibitors|mesh-ancestor
110116828|NCT00408005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110116829|NCT00408005|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110116830|NCT00408005|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110116831|NCT00408005|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110061983|NCT05296577|Vinorelbine|vinorelbine|mesh-list
110116832|NCT00408005|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110116833|NCT00408005|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110116834|NCT00408005|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110116835|NCT00408005|Abortifacient Agents|abortifacient agents|mesh-ancestor
110116836|NCT00408005|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110116837|NCT00408005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110116838|NCT00408005|Antimetabolites|antimetabolites|mesh-ancestor
110116839|NCT00408005|Dermatologic Agents|dermatologic agents|mesh-ancestor
110116840|NCT00408005|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110116841|NCT00408005|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110116842|NCT00408005|Antiviral Agents|antiviral agents|mesh-ancestor
110116843|NCT00408005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110116844|NCT00408005|Antidotes|antidotes|mesh-ancestor
110116845|NCT00408005|Protective Agents|protective agents|mesh-ancestor
110116846|NCT00408005|Vitamin B Complex|vitamin b complex|mesh-ancestor
110116847|NCT00408005|Vitamins|vitamins|mesh-ancestor
110116848|NCT00408005|Micronutrients|micronutrients|mesh-ancestor
110116849|NCT00408005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110116850|NCT00408005|Tubulin Modulators|tubulin modulators|mesh-ancestor
110116851|NCT00408005|Antimitotic Agents|antimitotic agents|mesh-ancestor
110116852|NCT00408005|Mitosis Modulators|mitosis modulators|mesh-ancestor
110116853|NCT00408005|Hematinics|hematinics|mesh-ancestor
110116854|NCT00003042|Tamoxifen|tamoxifen|mesh-list
110116855|NCT00003042|Paclitaxel|paclitaxel|mesh-list
110116856|NCT00003042|Cyclophosphamide|cyclophosphamide|mesh-list
110116857|NCT00003042|Doxorubicin|doxorubicin|mesh-list
110116858|NCT00003042|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110116859|NCT00003042|Melphalan|melphalan|mesh-list
110116860|NCT00003042|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110116861|NCT00003042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110116862|NCT00003042|Tubulin Modulators|tubulin modulators|mesh-ancestor
110116863|NCT00003042|Antimitotic Agents|antimitotic agents|mesh-ancestor
110116864|NCT00003042|Mitosis Modulators|mitosis modulators|mesh-ancestor
110116865|NCT00003042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110116866|NCT00003042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110116867|NCT00003042|Immunologic Factors|immunologic factors|mesh-ancestor
110116868|NCT00003042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110116869|NCT00003042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110116870|NCT00003042|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110116871|NCT00003042|Alkylating Agents|alkylating agents|mesh-ancestor
110116872|NCT00003042|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110116873|NCT00003042|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110116874|NCT00003042|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110116875|NCT00003042|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110116876|NCT00003042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110116877|NCT00003042|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110116878|NCT00003042|Hormone Antagonists|hormone antagonists|mesh-ancestor
110116879|NCT00003042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110116880|NCT00003042|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110116881|NCT00003042|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110116882|NCT00003042|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110116883|NCT00003042|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110116885|NCT01873144|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110116886|NCT01873144|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110116887|NCT01873144|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110116888|NCT01873144|Adrenergic Agents|adrenergic agents|mesh-ancestor
110116889|NCT01873144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110116890|NCT01873144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110116891|NCT01873144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110116892|NCT01873144|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110116893|NCT01873144|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110116894|NCT01873144|Autonomic Agents|autonomic agents|mesh-ancestor
110116895|NCT01873144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110116896|NCT01873144|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110116897|NCT01873144|Respiratory System Agents|respiratory system agents|mesh-ancestor
110116898|NCT01873144|Mydriatics|mydriatics|mesh-ancestor
110116899|NCT01873144|Sympathomimetics|sympathomimetics|mesh-ancestor
110116900|NCT01873144|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110116902|NCT01873157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110116903|NCT01873222|Sirolimus|sirolimus|mesh-list
110116904|NCT01873222|Umirolimus|umirolimus|mesh-list
110116905|NCT01873222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110116906|NCT01873222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110116907|NCT01873222|Immunologic Factors|immunologic factors|mesh-ancestor
110116908|NCT01873222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110116909|NCT01873222|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110116910|NCT01873222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110116911|NCT01873222|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110116912|NCT01873222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110116913|NCT01873222|Antifungal Agents|antifungal agents|mesh-ancestor
110116914|NCT01873313|Ropivacaine|ropivacaine|mesh-list
110116915|NCT01873313|Anesthetics, Local|anesthetics, local|mesh-ancestor
110116916|NCT01873313|Anesthetics|anesthetics|mesh-ancestor
110116917|NCT01873313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110116918|NCT01873313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110116919|NCT01873313|Sensory System Agents|sensory system agents|mesh-ancestor
110116920|NCT01873313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110116921|NCT01873339|Midazolam|midazolam|mesh-list
110116922|NCT01873339|Darapladib|darapladib|mesh-list
110116923|NCT01873339|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110116924|NCT01873339|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110116925|NCT01873339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110116926|NCT01873339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110116928|NCT01873339|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110116929|NCT01873339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110116930|NCT01873339|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110116931|NCT01873339|Anesthetics, General|anesthetics, general|mesh-ancestor
110116932|NCT01873339|Anesthetics|anesthetics|mesh-ancestor
110116933|NCT01873339|GABA Modulators|gaba modulators|mesh-ancestor
110116934|NCT01873339|GABA Agents|gaba agents|mesh-ancestor
110116935|NCT01873339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110116936|NCT01873339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110116937|NCT01873339|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
110116938|NCT01873339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110116939|NCT01873378|Triptorelin Pamoate|triptorelin pamoate|mesh-list
110116940|NCT01873378|Luteolytic Agents|luteolytic agents|mesh-ancestor
110116941|NCT01873378|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110116942|NCT01873378|Contraceptive Agents|contraceptive agents|mesh-ancestor
110116943|NCT01873378|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110116944|NCT01873378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110116945|NCT01873378|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110116946|NCT01873378|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110116948|NCT01873430|Melatonin|melatonin|mesh-list
110116949|NCT01873430|Antioxidants|antioxidants|mesh-ancestor
110116950|NCT01873430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110116951|NCT01873430|Protective Agents|protective agents|mesh-ancestor
110116952|NCT01873430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110116953|NCT01873430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110116954|NCT01873443|Folic Acid|folic acid|mesh-list
110116955|NCT01873443|Rituximab|rituximab|mesh-list
110116956|NCT01873443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110116957|NCT01873443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110116958|NCT01873443|Immunologic Factors|immunologic factors|mesh-ancestor
110116959|NCT01873443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110116960|NCT01873443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110116961|NCT01873443|Hematinics|hematinics|mesh-ancestor
110116962|NCT01873443|Vitamin B Complex|vitamin b complex|mesh-ancestor
110116963|NCT01873443|Vitamins|vitamins|mesh-ancestor
110116964|NCT01873443|Micronutrients|micronutrients|mesh-ancestor
110116965|NCT01873573|Triamcinolone|triamcinolone|mesh-list
110116966|NCT01873573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110116967|NCT01873573|Glucocorticoids|glucocorticoids|mesh-ancestor
110116968|NCT01873573|Hormones|hormones|mesh-ancestor
110116969|NCT01873573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110116970|NCT01873573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110116971|NCT01873690|Ciprofloxacin|ciprofloxacin|mesh-list
110116972|NCT01873690|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110116973|NCT01873690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110116974|NCT01873690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110116975|NCT01873690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110116976|NCT01873690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110116977|NCT01873690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110116978|NCT01873690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110116979|NCT01873690|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110116980|NCT01873690|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110116981|NCT01873768|Tranexamic Acid|tranexamic acid|mesh-list
110116982|NCT01873768|Aminocaproic Acid|aminocaproic acid|mesh-list
110116983|NCT01873768|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110116984|NCT01873768|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110116985|NCT01873768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110116988|NCT01873807|Cyclophosphamide|cyclophosphamide|mesh-list
110116989|NCT01873807|Etoposide|etoposide|mesh-list
110116990|NCT01873807|Idarubicin|idarubicin|mesh-list
110116991|NCT01873807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110116992|NCT01873807|Immunologic Factors|immunologic factors|mesh-ancestor
110116993|NCT01873807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110116994|NCT01873807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110116995|NCT01873807|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110116996|NCT01873807|Alkylating Agents|alkylating agents|mesh-ancestor
110116997|NCT01873807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110116998|NCT01873807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110116999|NCT01873807|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110117000|NCT01873807|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110117001|NCT01873807|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110117002|NCT01873807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110117003|NCT01873807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110117004|NCT01873807|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110117005|NCT01873820|Ascorbic Acid|ascorbic acid|mesh-list
110117006|NCT01873820|Calcium ascorbate|calcium ascorbate|mesh-list
110117007|NCT01873820|Calcium|calcium|mesh-list
110117008|NCT01873820|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110117009|NCT01873820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110117010|NCT01873820|Antioxidants|antioxidants|mesh-ancestor
110117011|NCT01873820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110117012|NCT01873820|Protective Agents|protective agents|mesh-ancestor
110117013|NCT01873820|Vitamins|vitamins|mesh-ancestor
110117014|NCT01873820|Micronutrients|micronutrients|mesh-ancestor
110117015|NCT01873833|Cyclophosphamide|cyclophosphamide|mesh-list
110117016|NCT01873833|Capecitabine|capecitabine|mesh-list
110117017|NCT01873833|Trastuzumab|trastuzumab|mesh-list
110117018|NCT01873833|Lapatinib|lapatinib|mesh-list
110117019|NCT01873833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110117020|NCT01873833|Immunologic Factors|immunologic factors|mesh-ancestor
110117021|NCT01873833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110117022|NCT01873833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110117023|NCT01873833|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110117024|NCT01873833|Alkylating Agents|alkylating agents|mesh-ancestor
110117025|NCT01873833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110117026|NCT01873833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110117027|NCT01873833|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110117028|NCT01873833|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110117029|NCT01873833|Antimetabolites|antimetabolites|mesh-ancestor
110117030|NCT01873833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110117031|NCT01873833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110221311|NCT00086970|Ifosfamide|ifosfamide|mesh-list
110117032|NCT01873833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110117033|NCT01873885|VIP-ELP fusion molecule PB1046|vip-elp fusion molecule pb1046|mesh-list
110117034|NCT01873885|Vasodilator Agents|vasodilator agents|mesh-ancestor
110117036|NCT01874002|Temsirolimus|temsirolimus|mesh-list
110117037|NCT01874002|MTOR Inhibitors|mtor inhibitors|mesh-list
110117038|NCT01874002|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110117039|NCT01874002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110117040|NCT01874002|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110117041|NCT01874002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110117042|NCT01874002|Antifungal Agents|antifungal agents|mesh-ancestor
110117043|NCT01874002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110117044|NCT01874002|Immunologic Factors|immunologic factors|mesh-ancestor
110117045|NCT01874002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110117046|NCT01874002|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110117048|NCT01874002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110117049|NCT01874028|Trientine|trientine|mesh-list
110117050|NCT01874028|Chelating Agents|chelating agents|mesh-ancestor
110117051|NCT01874028|Sequestering Agents|sequestering agents|mesh-ancestor
110117052|NCT01874028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110117053|NCT01874041|Salicylic Acid|salicylic acid|mesh-list
110117054|NCT01874041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110117055|NCT01874041|Antifungal Agents|antifungal agents|mesh-ancestor
110117056|NCT01874041|Keratolytic Agents|keratolytic agents|mesh-ancestor
110117057|NCT01874041|Dermatologic Agents|dermatologic agents|mesh-ancestor
110117058|NCT01874080|Metformin|metformin|mesh-list
110117059|NCT01874080|Saxagliptin|saxagliptin|mesh-list
110117060|NCT01874080|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110117061|NCT01874080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110117062|NCT01874080|Incretins|incretins|mesh-ancestor
110117063|NCT01874080|Hormones|hormones|mesh-ancestor
110117064|NCT01874080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110117065|NCT01874080|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110117066|NCT01874080|Protease Inhibitors|protease inhibitors|mesh-ancestor
110117067|NCT01874080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110117068|NCT01874080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110117070|NCT01874171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110117071|NCT01874171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110117072|NCT01874236|Bupivacaine|bupivacaine|mesh-list
110117073|NCT01874236|Anesthetics, Local|anesthetics, local|mesh-ancestor
110117074|NCT01874236|Anesthetics|anesthetics|mesh-ancestor
110117075|NCT01874236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110117076|NCT01874236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110117077|NCT01874236|Sensory System Agents|sensory system agents|mesh-ancestor
110117078|NCT01874236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110117079|NCT01874314|Moxifloxacin|moxifloxacin|mesh-list
110117080|NCT01874314|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110117081|NCT01874314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110117082|NCT01874314|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110117083|NCT01874314|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110117084|NCT01874314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110117085|NCT01874314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110117086|NCT01874314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110117087|NCT01874470|Antihypertensive Agents|antihypertensive agents|mesh-list
110117088|NCT01874470|Diuretics|diuretics|mesh-list
110117089|NCT01874470|Natriuretic Agents|natriuretic agents|mesh-ancestor
110117090|NCT01874470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110117091|NCT01874561|Moxifloxacin|moxifloxacin|mesh-list
110117092|NCT01874561|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110117093|NCT01874561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110117094|NCT01874561|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110117096|NCT01874561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110117097|NCT01874561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110117098|NCT01874561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110117099|NCT01874574|Triamcinolone|triamcinolone|mesh-list
110117100|NCT01874574|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110117101|NCT01874574|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110117102|NCT01874574|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110117103|NCT01874574|Hylan|hylan|mesh-list
110117104|NCT01874574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110117105|NCT01874574|Glucocorticoids|glucocorticoids|mesh-ancestor
110117106|NCT01874574|Hormones|hormones|mesh-ancestor
110117107|NCT01874574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110117108|NCT01874574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110117109|NCT01874574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110117110|NCT01874574|Immunologic Factors|immunologic factors|mesh-ancestor
110117111|NCT01874574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110117112|NCT01874574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110117113|NCT01874574|Viscosupplements|viscosupplements|mesh-ancestor
110117114|NCT01874574|Protective Agents|protective agents|mesh-ancestor
110117115|NCT01874639|Hemostatics|hemostatics|mesh-list
110117116|NCT01874639|Coagulants|coagulants|mesh-ancestor
110117117|NCT01874678|Cisplatin|cisplatin|mesh-list
110117118|NCT01874678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110117119|NCT01874717|Midazolam|midazolam|mesh-list
110117120|NCT01874717|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110117121|NCT01874717|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110162826|NCT00115102|Fentanyl|fentanyl|mesh-list
110117123|NCT01874717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110117124|NCT01874717|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110117125|NCT01874717|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110117126|NCT01874717|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110117127|NCT01874717|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110117128|NCT01874717|Anesthetics, General|anesthetics, general|mesh-ancestor
110117129|NCT01874717|Anesthetics|anesthetics|mesh-ancestor
110117130|NCT01874717|GABA Modulators|gaba modulators|mesh-ancestor
110117131|NCT01874717|GABA Agents|gaba agents|mesh-ancestor
110117132|NCT01874717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110117133|NCT01874717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110117134|NCT01874730|Anesthetics|anesthetics|mesh-list
110117135|NCT01874730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110117136|NCT01874730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110117137|NCT01874743|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110117138|NCT01874743|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110117139|NCT01874743|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110117140|NCT01874743|Antimetabolites|antimetabolites|mesh-ancestor
110117141|NCT01874743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110117142|NCT01874743|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110117143|NCT01874743|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110117144|NCT01874743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110117146|NCT01874847|Antioxidants|antioxidants|mesh-ancestor
110117147|NCT01874847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110117148|NCT01874847|Protective Agents|protective agents|mesh-ancestor
110117149|NCT01874847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110117150|NCT01874847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110117151|NCT01874964|Methadone|methadone|mesh-list
110117152|NCT01874964|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110117153|NCT01874964|Narcotics|narcotics|mesh-ancestor
110117154|NCT01874964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110117155|NCT01874964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110117156|NCT01874964|Analgesics|analgesics|mesh-ancestor
110117157|NCT01874964|Sensory System Agents|sensory system agents|mesh-ancestor
110117158|NCT01874964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110117159|NCT01874964|Antitussive Agents|antitussive agents|mesh-ancestor
110117160|NCT01874964|Respiratory System Agents|respiratory system agents|mesh-ancestor
110117161|NCT01875107|Insulin|insulin|mesh-list
110117162|NCT01875107|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110117163|NCT01875107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110117164|NCT01875172|Bupropion|bupropion|mesh-list
110117165|NCT01875172|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110117166|NCT01875172|Antidepressive Agents|antidepressive agents|mesh-ancestor
110117167|NCT01875172|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110117168|NCT01875172|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110117169|NCT01875172|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110117170|NCT01875172|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110117171|NCT01875172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110117172|NCT01875172|Dopamine Agents|dopamine agents|mesh-ancestor
110117173|NCT01875172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110117174|NCT01875172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110117175|NCT01875172|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110117176|NCT01875172|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110117177|NCT01875172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110117178|NCT01875185|Aspirin|aspirin|mesh-list
110117179|NCT01875185|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110117180|NCT01875185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110117181|NCT01875185|Analgesics|analgesics|mesh-ancestor
110117182|NCT01875185|Sensory System Agents|sensory system agents|mesh-ancestor
110117183|NCT01875185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110117184|NCT01875185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110117185|NCT01875185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110117186|NCT01875185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110117187|NCT01875185|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110117188|NCT01875185|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110117189|NCT01875185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110117190|NCT01875185|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110117191|NCT01875185|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110117192|NCT01875185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110117193|NCT01875185|Antipyretics|antipyretics|mesh-ancestor
110117195|NCT01875224|Tacrolimus|tacrolimus|mesh-list
110117196|NCT01875224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110117197|NCT01875224|Immunologic Factors|immunologic factors|mesh-ancestor
110117198|NCT01875224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110117199|NCT01875224|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110117200|NCT01875224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110117201|NCT01875224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110117202|NCT01875224|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110117203|NCT01875224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110117205|NCT01875224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110117206|NCT01875263|Levofloxacin|levofloxacin|mesh-list
110117207|NCT01875263|Cloxacillin|cloxacillin|mesh-list
110117208|NCT01875263|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110117209|NCT01875263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110117210|NCT01875263|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110117211|NCT01875263|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110117212|NCT01875263|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110117213|NCT01875263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110117214|NCT01875263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110117215|NCT01875263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110117216|NCT01875263|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110117217|NCT01875263|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110237907|NCT00095927|Paclitaxel|paclitaxel|mesh-list
110117219|NCT01875653|Sargramostim|sargramostim|mesh-list
110117220|NCT01875653|Immunologic Factors|immunologic factors|mesh-ancestor
110117221|NCT01875653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110117223|NCT01875666|Trastuzumab|trastuzumab|mesh-list
110117224|NCT01875666|Pertuzumab|pertuzumab|mesh-list
110117225|NCT01875666|Lapatinib|lapatinib|mesh-list
110117226|NCT01875666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110117227|NCT01875666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110117228|NCT01875666|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110117229|NCT01875666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110117230|NCT01875666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110117231|NCT01875705|Ravoxertinib|ravoxertinib|mesh-list
110117232|NCT01875705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110117233|NCT01875705|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110117234|NCT01875705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110117235|NCT01875705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110117236|NCT01875757|Vitamin D|vitamin d|mesh-list
110117237|NCT01875757|Cholecalciferol|cholecalciferol|mesh-list
110117238|NCT01875757|Vitamins|vitamins|mesh-ancestor
110117239|NCT01875757|Micronutrients|micronutrients|mesh-ancestor
110117240|NCT01875757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110117241|NCT01875757|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110117242|NCT01875757|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110117243|NCT01875822|Curcumin|curcumin|mesh-list
110117244|NCT01875822|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110117245|NCT01875822|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110117246|NCT01875822|Analgesics|analgesics|mesh-ancestor
110117247|NCT01875822|Sensory System Agents|sensory system agents|mesh-ancestor
110117248|NCT01875822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110117249|NCT01875822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110117250|NCT01875822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110117251|NCT01875822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110117252|NCT01875822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110117253|NCT01875822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110162853|NCT00115219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110117254|NCT01875822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110117255|NCT01875926|Gontivimab|gontivimab|mesh-list
110117256|NCT01875926|Antiviral Agents|antiviral agents|mesh-ancestor
110117257|NCT01875926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110117258|NCT01875939|Levonadifloxacin|levonadifloxacin|mesh-list
110117259|NCT01875939|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110117260|NCT01875939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110117261|NCT01875939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110117262|NCT01875939|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110117263|NCT01875939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110117264|NCT01875952|Isoniazid|isoniazid|mesh-list
110117265|NCT01875952|Antitubercular Agents|antitubercular agents|mesh-ancestor
110117266|NCT01875952|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110117267|NCT01875952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110117268|NCT01875952|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
110117269|NCT01875952|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110117270|NCT01875952|Antimetabolites|antimetabolites|mesh-ancestor
110117271|NCT01875952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110117272|NCT01875952|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110117273|NCT01876004|Methotrexate|methotrexate|mesh-list
110117274|NCT01876004|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110117275|NCT01876004|Abortifacient Agents|abortifacient agents|mesh-ancestor
110117276|NCT01876004|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110117277|NCT01876004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110117278|NCT01876004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110117279|NCT01876004|Antimetabolites|antimetabolites|mesh-ancestor
110117280|NCT01876004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110117281|NCT01876004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110117282|NCT01876004|Dermatologic Agents|dermatologic agents|mesh-ancestor
110117283|NCT01876004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110117284|NCT01876004|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110117285|NCT01876004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110117286|NCT01876004|Immunologic Factors|immunologic factors|mesh-ancestor
110117287|NCT01876004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110117288|NCT01876004|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110117289|NCT01876108|Amoxicillin|amoxicillin|mesh-list
110117290|NCT01876108|Azithromycin|azithromycin|mesh-list
110117291|NCT01876108|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
110117293|NCT01876108|Bismuth|bismuth|mesh-list
110117294|NCT01876108|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110117295|NCT01876108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110117296|NCT01876108|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110117297|NCT01876108|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110117298|NCT01876108|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110117299|NCT01876108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110117300|NCT01876108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110117301|NCT01876108|Antacids|antacids|mesh-ancestor
110117302|NCT01876121|Celecoxib|celecoxib|mesh-list
110117303|NCT01876121|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110117304|NCT01876121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110117305|NCT01876121|Analgesics|analgesics|mesh-ancestor
110117306|NCT01876121|Sensory System Agents|sensory system agents|mesh-ancestor
110117307|NCT01876121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110117308|NCT01876121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110117309|NCT01876121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110117310|NCT01876121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110117311|NCT01876121|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110117312|NCT01876121|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110117313|NCT01876121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110117314|NCT01876121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110117315|NCT01876186|Solifenacin Succinate|solifenacin succinate|mesh-list
110117316|NCT01876186|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110117317|NCT01876186|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110117318|NCT01876186|Cholinergic Agents|cholinergic agents|mesh-ancestor
110117319|NCT01876186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110117320|NCT01876186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110117321|NCT01876186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110117322|NCT01876186|Urological Agents|urological agents|mesh-ancestor
110221395|NCT00306358|Vitamins|vitamins|mesh-ancestor
110117324|NCT01876290|Ondansetron|ondansetron|mesh-list
110117325|NCT01876290|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110117326|NCT01876290|Antiemetics|antiemetics|mesh-ancestor
110117327|NCT01876290|Autonomic Agents|autonomic agents|mesh-ancestor
110117328|NCT01876290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110117329|NCT01876290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110117330|NCT01876290|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110117331|NCT01876290|Glucocorticoids|glucocorticoids|mesh-ancestor
110117332|NCT01876290|Hormones|hormones|mesh-ancestor
110117333|NCT01876290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110117334|NCT01876290|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110117335|NCT01876290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110117336|NCT01876290|Antipruritics|antipruritics|mesh-ancestor
110117337|NCT01876290|Dermatologic Agents|dermatologic agents|mesh-ancestor
110117338|NCT01876290|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110117339|NCT01876290|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110117340|NCT01876290|Serotonin Agents|serotonin agents|mesh-ancestor
110117341|NCT01876290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110117342|NCT01876290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110117343|NCT01876316|Moxifloxacin|moxifloxacin|mesh-list
110117344|NCT01876316|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110117345|NCT01876316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110117346|NCT01876316|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110117347|NCT01876316|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110117348|NCT01876316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110117349|NCT01876316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110117350|NCT01876316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110117352|NCT01876433|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
110117353|NCT01876433|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110117354|NCT01876433|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110117355|NCT01876433|Adrenergic Agents|adrenergic agents|mesh-ancestor
110117356|NCT01876433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110117357|NCT01876433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110117358|NCT01876433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110117359|NCT01876433|Urological Agents|urological agents|mesh-ancestor
110117361|NCT01876550|Calcium|calcium|mesh-list
110117362|NCT01876550|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110117363|NCT01876550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110117364|NCT01876550|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110117365|NCT01876550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110117366|NCT01876550|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110117367|NCT01876550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110117368|NCT01876550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110117369|NCT01876563|Vitamin D|vitamin d|mesh-list
110117370|NCT01876563|Vitamins|vitamins|mesh-ancestor
110117371|NCT01876563|Micronutrients|micronutrients|mesh-ancestor
110117372|NCT01876563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110117373|NCT01876563|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110117374|NCT01876615|Diclofenac|diclofenac|mesh-list
110117375|NCT01876615|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110117376|NCT01876615|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110117377|NCT01876615|Analgesics|analgesics|mesh-ancestor
110221411|NCT00418600|Vitamins|vitamins|mesh-ancestor
110117378|NCT01876615|Sensory System Agents|sensory system agents|mesh-ancestor
110117379|NCT01876615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110117380|NCT01876615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110117381|NCT01876615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110117382|NCT01876615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110117383|NCT01876615|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110117384|NCT01876615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110117385|NCT01876615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110117386|NCT01876641|Decitabine|decitabine|mesh-list
110117387|NCT01876641|Vemurafenib|vemurafenib|mesh-list
110117388|NCT01876641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110117389|NCT01876641|Antimetabolites|antimetabolites|mesh-ancestor
110117390|NCT01876641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110117391|NCT01876641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110117392|NCT01876641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110117393|NCT01876641|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110117394|NCT01876797|Ticagrelor|ticagrelor|mesh-list
110117395|NCT01876797|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
110117396|NCT01876797|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110117397|NCT01876797|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110117398|NCT01876797|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110117399|NCT01876797|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110117400|NCT01876797|Purinergic Agents|purinergic agents|mesh-ancestor
110117401|NCT01876797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110117402|NCT01876797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110117403|NCT01876797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110117404|NCT01876849|Exenatide|exenatide|mesh-list
110117405|NCT01876849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110117406|NCT01876849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110117407|NCT01876849|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110117408|NCT01876849|Incretins|incretins|mesh-ancestor
110117409|NCT01876849|Hormones|hormones|mesh-ancestor
110117410|NCT01876849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110117411|NCT01876862|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
110117412|NCT01876862|Antiviral Agents|antiviral agents|mesh-ancestor
110117413|NCT01876862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110117414|NCT01876966|Ritonavir|ritonavir|mesh-list
110117415|NCT01876966|Darunavir|darunavir|mesh-list
110117416|NCT01876966|Lumefantrine|lumefantrine|mesh-list
110117417|NCT01876966|Artemether|artemether|mesh-list
110117418|NCT01876966|Etravirine|etravirine|mesh-list
110117419|NCT01876966|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
110117420|NCT01876966|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110117421|NCT01876966|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110117422|NCT01876966|Protease Inhibitors|protease inhibitors|mesh-ancestor
110117423|NCT01876966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110117424|NCT01876966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110117425|NCT01876966|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110117426|NCT01876966|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110117427|NCT01876966|Antiviral Agents|antiviral agents|mesh-ancestor
110117428|NCT01876966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110117429|NCT01876966|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110117430|NCT01876966|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110117431|NCT01876966|Antimalarials|antimalarials|mesh-ancestor
110117432|NCT01876966|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110117433|NCT01876966|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110117434|NCT01876966|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110117435|NCT01876966|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110117437|NCT01877122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110117438|NCT01877122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110117439|NCT01877122|Analgesics|analgesics|mesh-ancestor
110221439|NCT00080951|Antidotes|antidotes|mesh-ancestor
110117441|NCT01877122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110117442|NCT01877122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110117443|NCT01877122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110117444|NCT01877122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110117445|NCT01877122|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110162887|NCT00115492|Fluticasone|fluticasone|mesh-list
110117446|NCT01877122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110117447|NCT01877122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110117449|NCT01877226|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110117450|NCT01877226|Narcotics|narcotics|mesh-ancestor
110117451|NCT01877226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110117452|NCT01877226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110117453|NCT01877226|Analgesics|analgesics|mesh-ancestor
110117454|NCT01877226|Sensory System Agents|sensory system agents|mesh-ancestor
110117455|NCT01877226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110117456|NCT01877226|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110117457|NCT01877226|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110117458|NCT01877226|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110117459|NCT01877226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110117460|NCT01877226|Adrenergic Agents|adrenergic agents|mesh-ancestor
110117461|NCT01877226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110117462|NCT01877356|Anesthetics|anesthetics|mesh-list
110117463|NCT01877356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110117464|NCT01877356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110117465|NCT01877512|Hormones|hormones|mesh-list
110117466|NCT01877512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110117467|NCT01877512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110117468|NCT01877577|Vitamin D|vitamin d|mesh-list
110117469|NCT01877577|Ergocalciferols|ergocalciferols|mesh-list
110117470|NCT01877577|Cholecalciferol|cholecalciferol|mesh-list
110117471|NCT01877577|Vitamins|vitamins|mesh-list
110117472|NCT01877577|Micronutrients|micronutrients|mesh-ancestor
110117473|NCT01877577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110117474|NCT01877577|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110117475|NCT01877577|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110117476|NCT01877590|Thioctic Acid|thioctic acid|mesh-list
110117477|NCT01877590|Antioxidants|antioxidants|mesh-ancestor
110117478|NCT01877590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110117479|NCT01877590|Protective Agents|protective agents|mesh-ancestor
110117480|NCT01877590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110117481|NCT01877590|Vitamin B Complex|vitamin b complex|mesh-ancestor
110117483|NCT01877590|Micronutrients|micronutrients|mesh-ancestor
110117484|NCT01877746|Prednisone|prednisone|mesh-list
110117485|NCT01877746|Azathioprine|azathioprine|mesh-list
110117486|NCT01877746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110117487|NCT01877746|Glucocorticoids|glucocorticoids|mesh-ancestor
110117488|NCT01877746|Hormones|hormones|mesh-ancestor
110117489|NCT01877746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110117490|NCT01877746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110117491|NCT01877746|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110117492|NCT01877746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110117493|NCT01877746|Antimetabolites|antimetabolites|mesh-ancestor
110117494|NCT01877746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110117495|NCT01877746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110117496|NCT01877746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110117497|NCT01877746|Immunologic Factors|immunologic factors|mesh-ancestor
110117498|NCT01877746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110117499|NCT01877811|Agerafenib|agerafenib|mesh-list
110117500|NCT01877811|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110117501|NCT01877811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110117502|NCT01877811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110117503|NCT01877889|Dapagliflozin|dapagliflozin|mesh-list
110117504|NCT01877889|Canagliflozin|canagliflozin|mesh-list
110117505|NCT01877889|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110117506|NCT01877889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110117507|NCT01877889|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110117508|NCT01877889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110117510|NCT01877954|Xhance|xhance|mesh-list
110117511|NCT01877954|Beclomethasone|beclomethasone|mesh-list
110117512|NCT01877954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110117513|NCT01877954|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110117514|NCT01877954|Autonomic Agents|autonomic agents|mesh-ancestor
110117515|NCT01877954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110117516|NCT01877954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110117517|NCT01877954|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110117518|NCT01877954|Respiratory System Agents|respiratory system agents|mesh-ancestor
110117519|NCT01877954|Dermatologic Agents|dermatologic agents|mesh-ancestor
110117520|NCT01877954|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110117521|NCT01877954|Glucocorticoids|glucocorticoids|mesh-ancestor
110117522|NCT01877954|Hormones|hormones|mesh-ancestor
110117523|NCT01877954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110117524|NCT01878136|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
110117525|NCT01878136|Plasminogen|plasminogen|mesh-list
110117526|NCT01878136|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110117527|NCT01878136|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110117528|NCT01878136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110117529|NCT01878188|BCG Vaccine|bcg vaccine|mesh-list
110117530|NCT01878188|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110117531|NCT01878188|Immunologic Factors|immunologic factors|mesh-ancestor
110117532|NCT01878188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110117533|NCT01878201|Valsartan|valsartan|mesh-list
110117534|NCT01878201|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110117535|NCT01878201|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110117536|NCT01878201|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110117537|NCT01878201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110117538|NCT01878227|Fenofibrate|fenofibrate|mesh-list
110117539|NCT01878227|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110117540|NCT01878227|Antimetabolites|antimetabolites|mesh-ancestor
110117541|NCT01878227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110117543|NCT01878318|Methotrexate|methotrexate|mesh-list
110117544|NCT01878318|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110117545|NCT01878318|Abortifacient Agents|abortifacient agents|mesh-ancestor
110117546|NCT01878318|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110117547|NCT01878318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110117548|NCT01878318|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110117549|NCT01878318|Antimetabolites|antimetabolites|mesh-ancestor
110117550|NCT01878318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110117551|NCT01878318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110117552|NCT01878318|Dermatologic Agents|dermatologic agents|mesh-ancestor
110117553|NCT01878318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110117554|NCT01878318|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110117555|NCT01878318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110117556|NCT01878318|Immunologic Factors|immunologic factors|mesh-ancestor
110117557|NCT01878318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110117558|NCT01878318|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110117559|NCT01878357|Primaquine|primaquine|mesh-list
110117560|NCT01878357|Piperaquine|piperaquine|mesh-list
110117561|NCT01878357|Artenimol|artenimol|mesh-list
110117562|NCT01878357|Antimalarials|antimalarials|mesh-ancestor
110117563|NCT01878357|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110117564|NCT01878357|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110117565|NCT01878357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110117566|NCT01878422|Leucovorin|leucovorin|mesh-list
110117567|NCT01878422|Bevacizumab|bevacizumab|mesh-list
110117568|NCT01878422|Cetuximab|cetuximab|mesh-list
110117569|NCT01878422|Fluorouracil|fluorouracil|mesh-list
110117570|NCT01878422|Oxaliplatin|oxaliplatin|mesh-list
110117571|NCT01878422|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110117572|NCT01878422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110117573|NCT01878422|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110117574|NCT01878422|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110117575|NCT01878422|Growth Substances|growth substances|mesh-ancestor
110117576|NCT01878422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110117577|NCT01878422|Growth Inhibitors|growth inhibitors|mesh-ancestor
110117578|NCT01878422|Antimetabolites|antimetabolites|mesh-ancestor
110117579|NCT01878422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110117580|NCT01878422|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110117581|NCT01878422|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110117582|NCT01878422|Immunologic Factors|immunologic factors|mesh-ancestor
110117583|NCT01878422|Antidotes|antidotes|mesh-ancestor
110117584|NCT01878422|Protective Agents|protective agents|mesh-ancestor
110117585|NCT01878422|Vitamin B Complex|vitamin b complex|mesh-ancestor
110117586|NCT01878422|Vitamins|vitamins|mesh-ancestor
110117587|NCT01878422|Micronutrients|micronutrients|mesh-ancestor
110117588|NCT01878513|Risperidone|risperidone|mesh-list
110117589|NCT01878513|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110117590|NCT01878513|Serotonin Agents|serotonin agents|mesh-ancestor
110117591|NCT01878513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110117592|NCT01878513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110117593|NCT01878513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110117594|NCT01878513|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110117595|NCT01878513|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110117596|NCT01878513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110117597|NCT01878513|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110117598|NCT01878513|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110117599|NCT01878513|Dopamine Agents|dopamine agents|mesh-ancestor
110117601|NCT01878578|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
110117603|NCT01878578|Anticonvulsants|anticonvulsants|mesh-ancestor
110117604|NCT01878578|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110117605|NCT01878578|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110117606|NCT01878578|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110117607|NCT01878578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110117608|NCT01878578|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110117609|NCT01878578|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110117610|NCT01878643|Vancomycin|vancomycin|mesh-list
110117611|NCT01878643|Gentamicins|gentamicins|mesh-list
110117612|NCT01878643|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110117613|NCT01878643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110117614|NCT01878643|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110117615|NCT01878643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110117616|NCT01878643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110117618|NCT01878695|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110117619|NCT01878695|Antiviral Agents|antiviral agents|mesh-ancestor
110117620|NCT01878695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110117621|NCT01878695|Expectorants|expectorants|mesh-ancestor
110117622|NCT01878695|Respiratory System Agents|respiratory system agents|mesh-ancestor
110117623|NCT01878695|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110117624|NCT01878695|Antioxidants|antioxidants|mesh-ancestor
110117625|NCT01878695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110117626|NCT01878695|Protective Agents|protective agents|mesh-ancestor
110117627|NCT01878695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110117628|NCT01878695|Antidotes|antidotes|mesh-ancestor
110117629|NCT01878708|Dexamethasone|dexamethasone|mesh-list
110117630|NCT01878708|Dexamethasone acetate|dexamethasone acetate|mesh-list
110117631|NCT01878708|Asparaginase|asparaginase|mesh-list
110117632|NCT01878708|Pegaspargase|pegaspargase|mesh-list
110117634|NCT01878708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110117635|NCT01878708|Antiemetics|antiemetics|mesh-ancestor
110117636|NCT01878708|Autonomic Agents|autonomic agents|mesh-ancestor
110117637|NCT01878708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110117638|NCT01878708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110117639|NCT01878708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110117640|NCT01878708|Glucocorticoids|glucocorticoids|mesh-ancestor
110117641|NCT01878708|Hormones|hormones|mesh-ancestor
110117642|NCT01878708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110117643|NCT01878708|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110117644|NCT01878708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110117645|NCT01878708|Protease Inhibitors|protease inhibitors|mesh-ancestor
110117646|NCT01878708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110117647|NCT01878708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110117648|NCT01878734|Micronutrients|micronutrients|mesh-list
110117649|NCT01878734|Trace Elements|trace elements|mesh-list
110117650|NCT01878734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110117651|NCT01878864|Lidocaine|lidocaine|mesh-list
110117652|NCT01878864|Bupivacaine|bupivacaine|mesh-list
110117653|NCT01878864|Anesthetics, Local|anesthetics, local|mesh-ancestor
110117654|NCT01878864|Anesthetics|anesthetics|mesh-ancestor
110117655|NCT01878864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110117656|NCT01878864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110117657|NCT01878864|Sensory System Agents|sensory system agents|mesh-ancestor
110162901|NCT00115492|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110221512|NCT00301912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110117658|NCT01878864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110117659|NCT01878864|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110117660|NCT01878864|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110117661|NCT01878864|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110117662|NCT01878864|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110117663|NCT01878864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110117664|NCT01878942|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
110117665|NCT01878942|Hallucinogens|hallucinogens|mesh-ancestor
110117666|NCT01878942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110117667|NCT01878942|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110117668|NCT01878942|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110117669|NCT01878942|Serotonin Agents|serotonin agents|mesh-ancestor
110117670|NCT01878942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110117671|NCT01878942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110117672|NCT01878942|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110117673|NCT01879007|Gemifloxacin|gemifloxacin|mesh-list
110117674|NCT01879007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110117675|NCT01879007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110117676|NCT01879007|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110117677|NCT01879007|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110117678|NCT01879007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110117679|NCT01879007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110117680|NCT01879007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110117681|NCT01879033|Insulin|insulin|mesh-list
110117682|NCT01879033|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110117683|NCT01879033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110117684|NCT01879202|Methylphenidate|methylphenidate|mesh-list
110117685|NCT01879202|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110117686|NCT01879202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110117687|NCT01879202|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110117688|NCT01879202|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110117689|NCT01879202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110117690|NCT01879202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110117691|NCT01879202|Dopamine Agents|dopamine agents|mesh-ancestor
110117692|NCT01879202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110117694|NCT01879293|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110117695|NCT01879293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110117696|NCT01879358|Sirolimus|sirolimus|mesh-list
110117697|NCT01879358|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110117698|NCT01879358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110117699|NCT01879358|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110117700|NCT01879358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110117701|NCT01879358|Antifungal Agents|antifungal agents|mesh-ancestor
110117702|NCT01879358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110117703|NCT01879358|Immunologic Factors|immunologic factors|mesh-ancestor
110117704|NCT01879358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110117705|NCT01879423|Lamotrigine|lamotrigine|mesh-list
110117706|NCT01879423|Anticonvulsants|anticonvulsants|mesh-list
110117707|NCT01879423|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110117708|NCT01879423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110117709|NCT01879423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110117710|NCT01879423|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110117711|NCT01879423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110117712|NCT01879423|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110117713|NCT01879423|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110117714|NCT01879423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110117715|NCT01879423|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110117716|NCT01879423|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110117718|NCT01879488|Pentetic Acid|pentetic acid|mesh-list
110117719|NCT01879488|Antidotes|antidotes|mesh-ancestor
110117720|NCT01879488|Protective Agents|protective agents|mesh-ancestor
110117721|NCT01879488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110117722|NCT01879488|Chelating Agents|chelating agents|mesh-ancestor
110117723|NCT01879488|Sequestering Agents|sequestering agents|mesh-ancestor
110117724|NCT01879488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110117725|NCT01879488|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110117726|NCT01879488|Anticoagulants|anticoagulants|mesh-ancestor
110117727|NCT01879488|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110117729|NCT01879514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110117730|NCT01879514|Glucocorticoids|glucocorticoids|mesh-ancestor
110117732|NCT01879514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110117733|NCT01879514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110117734|NCT01879514|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110117735|NCT01879514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110117736|NCT01879527|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110117737|NCT01879527|Amiloride|amiloride|mesh-list
110117738|NCT01879527|Amiloride, hydrochlorothiazide drug combination|amiloride, hydrochlorothiazide drug combination|mesh-list
110117739|NCT01879527|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110117740|NCT01879527|Diuretics|diuretics|mesh-ancestor
110117741|NCT01879527|Natriuretic Agents|natriuretic agents|mesh-ancestor
110117742|NCT01879527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110117743|NCT01879527|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110117744|NCT01879527|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110117745|NCT01879527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110117746|NCT01879527|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
110117747|NCT01879527|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110117748|NCT01879527|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
110117749|NCT01879527|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110117750|NCT01879605|Bisacodyl|bisacodyl|mesh-list
110117751|NCT01879605|Sorbitol|sorbitol|mesh-list
110117752|NCT01879605|Cathartics|cathartics|mesh-ancestor
110117753|NCT01879605|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110117754|NCT01879605|Laxatives|laxatives|mesh-ancestor
110117755|NCT01879748|Rasagiline|rasagiline|mesh-list
110117756|NCT01879748|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
110117757|NCT01879748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110117758|NCT01879748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110117759|NCT01879748|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110117760|NCT01879748|Protective Agents|protective agents|mesh-ancestor
110117761|NCT01879748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110117762|NCT01879917|Liraglutide|liraglutide|mesh-list
110117763|NCT01879917|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110117764|NCT01879917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110117767|NCT01879917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110117768|NCT01879930|Doxycycline|doxycycline|mesh-list
110117769|NCT01879930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110117770|NCT01879930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110221546|NCT00301990|Aldesleukin|aldesleukin|mesh-list
110117772|NCT01879930|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110117773|NCT01879930|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110117774|NCT01880112|Cefazolin|cefazolin|mesh-list
110117775|NCT01880112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110117776|NCT01880112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110117777|NCT01880125|Acetaminophen|acetaminophen|mesh-list
110117778|NCT01880125|Tramadol|tramadol|mesh-list
110117779|NCT01880125|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110117780|NCT01880125|Analgesics|analgesics|mesh-ancestor
110117781|NCT01880125|Sensory System Agents|sensory system agents|mesh-ancestor
110117782|NCT01880125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110117783|NCT01880125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110117784|NCT01880125|Antipyretics|antipyretics|mesh-ancestor
110117785|NCT01880125|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110117786|NCT01880125|Narcotics|narcotics|mesh-ancestor
110117787|NCT01880125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110117788|NCT01880138|Anesthetics|anesthetics|mesh-list
110117789|NCT01880138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110117790|NCT01880138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110117791|NCT01880216|Enoxaparin|enoxaparin|mesh-list
110117792|NCT01880216|Enoxaparin sodium|enoxaparin sodium|mesh-list
110117793|NCT01880216|Bemiparin|bemiparin|mesh-list
110117794|NCT01880216|Anticoagulants|anticoagulants|mesh-ancestor
110117795|NCT01880216|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110117796|NCT01880216|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110117797|NCT01880216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110117798|NCT01880307|Prednisolone|prednisolone|mesh-list
110117799|NCT01880307|Infliximab|infliximab|mesh-list
110117800|NCT01880307|Azathioprine|azathioprine|mesh-list
110117801|NCT01880307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110117802|NCT01880307|Glucocorticoids|glucocorticoids|mesh-ancestor
110117803|NCT01880307|Hormones|hormones|mesh-ancestor
110117804|NCT01880307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110117805|NCT01880307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110117806|NCT01880307|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110117807|NCT01880307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110117808|NCT01880307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110117809|NCT01880307|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110117810|NCT01880307|Dermatologic Agents|dermatologic agents|mesh-ancestor
110117811|NCT01880307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110117812|NCT01880307|Antimetabolites|antimetabolites|mesh-ancestor
110117813|NCT01880307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110117814|NCT01880307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110117815|NCT01880307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110117816|NCT01880307|Immunologic Factors|immunologic factors|mesh-ancestor
110117817|NCT01880346|Vitamin D|vitamin d|mesh-list
110117818|NCT01880346|Ergocalciferols|ergocalciferols|mesh-list
110117819|NCT01880346|Cholecalciferol|cholecalciferol|mesh-list
110117820|NCT01880346|Vitamins|vitamins|mesh-list
110117821|NCT01880346|Micronutrients|micronutrients|mesh-ancestor
110117822|NCT01880346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110117823|NCT01880346|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110117824|NCT01880346|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110117825|NCT01880372|Thioctic Acid|thioctic acid|mesh-list
110117826|NCT01880372|Antioxidants|antioxidants|mesh-ancestor
110117827|NCT01880372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110117828|NCT01880372|Protective Agents|protective agents|mesh-ancestor
110117829|NCT01880372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110117830|NCT01880372|Vitamin B Complex|vitamin b complex|mesh-ancestor
110117831|NCT01880372|Vitamins|vitamins|mesh-ancestor
110117832|NCT01880372|Micronutrients|micronutrients|mesh-ancestor
110117833|NCT01880385|Cyclophosphamide|cyclophosphamide|mesh-list
110117834|NCT01880385|Bevacizumab|bevacizumab|mesh-list
110117835|NCT01880385|Docetaxel|docetaxel|mesh-list
110117836|NCT01880385|Fluorouracil|fluorouracil|mesh-list
110117837|NCT01880385|Trastuzumab|trastuzumab|mesh-list
110117838|NCT01880385|Epirubicin|epirubicin|mesh-list
110117839|NCT01880385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110117840|NCT01880385|Immunologic Factors|immunologic factors|mesh-ancestor
110117841|NCT01880385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110117842|NCT01880385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110117843|NCT01880385|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110117844|NCT01880385|Alkylating Agents|alkylating agents|mesh-ancestor
110117845|NCT01880385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110117846|NCT01880385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110117847|NCT01880385|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110117848|NCT01880385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110117849|NCT01880385|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110117850|NCT01880385|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110117851|NCT01880385|Growth Substances|growth substances|mesh-ancestor
110117852|NCT01880385|Growth Inhibitors|growth inhibitors|mesh-ancestor
110117853|NCT01880385|Tubulin Modulators|tubulin modulators|mesh-ancestor
110117854|NCT01880385|Antimitotic Agents|antimitotic agents|mesh-ancestor
110117855|NCT01880385|Mitosis Modulators|mitosis modulators|mesh-ancestor
110117857|NCT01880385|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110117858|NCT01880385|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110117859|NCT01880385|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110117860|NCT01880385|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110117861|NCT01880385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110117862|NCT01880463|Vitamin D|vitamin d|mesh-list
110117863|NCT01880463|Ergocalciferols|ergocalciferols|mesh-list
110117864|NCT01880463|Cholecalciferol|cholecalciferol|mesh-list
110117865|NCT01880463|Vitamins|vitamins|mesh-list
110117866|NCT01880463|Micronutrients|micronutrients|mesh-ancestor
110117867|NCT01880463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110117868|NCT01880463|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110117869|NCT01880463|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110117870|NCT01880619|Tamsulosin|tamsulosin|mesh-list
110117871|NCT01880619|Solifenacin Succinate|solifenacin succinate|mesh-list
110117872|NCT01880619|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110117873|NCT01880619|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110117874|NCT01880619|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110117875|NCT01880619|Adrenergic Agents|adrenergic agents|mesh-ancestor
110117876|NCT01880619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110117877|NCT01880619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110117878|NCT01880619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110117879|NCT01880619|Urological Agents|urological agents|mesh-ancestor
110117880|NCT01880619|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110117881|NCT01880619|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110117882|NCT01880619|Cholinergic Agents|cholinergic agents|mesh-ancestor
110117883|NCT01880658|Capecitabine|capecitabine|mesh-list
110117884|NCT01880658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110117885|NCT01880658|Antimetabolites|antimetabolites|mesh-ancestor
110117886|NCT01880658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110117887|NCT01880658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110117889|NCT01880749|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110117890|NCT01880749|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110117891|NCT01880749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110117892|NCT01880749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110117893|NCT01880749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110117895|NCT01880749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110117896|NCT01880749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110117897|NCT01880775|Bupivacaine|bupivacaine|mesh-list
110117898|NCT01880775|Prilocaine|prilocaine|mesh-list
110117899|NCT01880775|Anesthetics, Local|anesthetics, local|mesh-ancestor
110117900|NCT01880775|Anesthetics|anesthetics|mesh-ancestor
110117901|NCT01880775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110117902|NCT01880775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110117903|NCT01880775|Sensory System Agents|sensory system agents|mesh-ancestor
110117904|NCT01880775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110117905|NCT01879241|Rasagiline|rasagiline|mesh-list
110117906|NCT01879241|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
110117907|NCT01879241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110117908|NCT01879241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110117909|NCT01879241|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110117910|NCT01879241|Protective Agents|protective agents|mesh-ancestor
110117911|NCT01879241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110117912|NCT01880931|Remifentanil|remifentanil|mesh-list
110117913|NCT01880931|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110117914|NCT01880931|Narcotics|narcotics|mesh-ancestor
110117915|NCT01880931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110117916|NCT01880931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110117917|NCT01880931|Analgesics|analgesics|mesh-ancestor
110117918|NCT01880931|Sensory System Agents|sensory system agents|mesh-ancestor
110117919|NCT01880931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110117921|NCT01881074|Triclosan|triclosan|mesh-list
110117922|NCT01881074|Sodium Fluoride|sodium fluoride|mesh-list
110117923|NCT01881074|Cariostatic Agents|cariostatic agents|mesh-ancestor
110117924|NCT01881074|Protective Agents|protective agents|mesh-ancestor
110117925|NCT01881074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110117926|NCT01881074|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110117927|NCT01881074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110117928|NCT01881074|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
110117929|NCT01881074|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110117930|NCT01881074|Antimetabolites|antimetabolites|mesh-ancestor
110117931|NCT01881074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110117932|NCT01881074|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110117934|NCT01881100|Fluorides|fluorides|mesh-list
110117935|NCT01881100|Fluorides, Topical|fluorides, topical|mesh-list
110117936|NCT01881100|Sodium Fluoride|sodium fluoride|mesh-list
110117937|NCT01881100|Sodium fluoride topical preparation|sodium fluoride topical preparation|mesh-list
110117938|NCT01881100|Cariostatic Agents|cariostatic agents|mesh-ancestor
110117939|NCT01881100|Protective Agents|protective agents|mesh-ancestor
110117940|NCT01881100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110117941|NCT01881100|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110117942|NCT01881100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110117943|NCT01881347|Resveratrol|resveratrol|mesh-list
110117944|NCT01881347|Antioxidants|antioxidants|mesh-ancestor
110117945|NCT01881347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110117946|NCT01881347|Protective Agents|protective agents|mesh-ancestor
110117947|NCT01881347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110117948|NCT01881347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110117949|NCT01881347|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110117950|NCT01881464|Adalimumab|adalimumab|mesh-list
110117951|NCT01881464|Infliximab|infliximab|mesh-list
110117952|NCT01881464|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110117953|NCT01881464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110117954|NCT01881464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110117955|NCT01881464|Dermatologic Agents|dermatologic agents|mesh-ancestor
110221595|NCT00302341|Sulfamethoxazole|sulfamethoxazole|mesh-list
110117956|NCT01881464|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110117958|NCT01881503|Blood Substitutes|blood substitutes|mesh-ancestor
110117959|NCT01881568|Tranexamic Acid|tranexamic acid|mesh-list
110117960|NCT01881568|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110117961|NCT01881568|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110117962|NCT01881568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110117963|NCT01881568|Hemostatics|hemostatics|mesh-ancestor
110117964|NCT01881568|Coagulants|coagulants|mesh-ancestor
110117965|NCT01881919|Quercetin|quercetin|mesh-list
110117966|NCT01881919|Antioxidants|antioxidants|mesh-ancestor
110117967|NCT01881919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110117968|NCT01881919|Protective Agents|protective agents|mesh-ancestor
110117969|NCT01881919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110117970|NCT01881971|Calcium|calcium|mesh-list
110117971|NCT01881971|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110117972|NCT01881971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110117973|NCT01881997|Fentanyl|fentanyl|mesh-list
110117974|NCT01881997|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110117975|NCT01881997|Narcotics|narcotics|mesh-ancestor
110117976|NCT01881997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110117977|NCT01881997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110117978|NCT01881997|Analgesics|analgesics|mesh-ancestor
110117979|NCT01881997|Sensory System Agents|sensory system agents|mesh-ancestor
110117980|NCT01881997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110117981|NCT01881997|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110117982|NCT01881997|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110117983|NCT01881997|Anesthetics, General|anesthetics, general|mesh-ancestor
110117984|NCT01881997|Anesthetics|anesthetics|mesh-ancestor
110117985|NCT01882010|Sargramostim|sargramostim|mesh-list
110117986|NCT01882010|Immunologic Factors|immunologic factors|mesh-ancestor
110117987|NCT01882010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110117988|NCT01882075|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
110117989|NCT01882075|Plasma Substitutes|plasma substitutes|mesh-ancestor
110117990|NCT01882075|Blood Substitutes|blood substitutes|mesh-ancestor
110117991|NCT01882127|Dexamethasone|dexamethasone|mesh-list
110117992|NCT01882127|Tretinoin|tretinoin|mesh-list
110117993|NCT01882127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110117994|NCT01882127|Antiemetics|antiemetics|mesh-ancestor
110117995|NCT01882127|Autonomic Agents|autonomic agents|mesh-ancestor
110117996|NCT01882127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110117997|NCT01882127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110117998|NCT01882127|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110117999|NCT01882127|Glucocorticoids|glucocorticoids|mesh-ancestor
110118001|NCT01882127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110118002|NCT01882127|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110118003|NCT01882127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110118004|NCT01882127|Keratolytic Agents|keratolytic agents|mesh-ancestor
110118005|NCT01882127|Dermatologic Agents|dermatologic agents|mesh-ancestor
110118006|NCT01882179|Canrenoic Acid|canrenoic acid|mesh-list
110118007|NCT01882179|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
110118008|NCT01882179|Mineralocorticoids|mineralocorticoids|mesh-list
110118009|NCT01882179|Hormone Antagonists|hormone antagonists|mesh-ancestor
110118010|NCT01882179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110118011|NCT01882179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110221625|NCT00302536|Tacrolimus|tacrolimus|mesh-list
110118012|NCT01882179|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110118013|NCT01882179|Diuretics|diuretics|mesh-ancestor
110118014|NCT01882179|Natriuretic Agents|natriuretic agents|mesh-ancestor
110118016|NCT01882296|Pantoprazole|pantoprazole|mesh-list
110118017|NCT01882296|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110118018|NCT01882296|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110118019|NCT01882296|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110118020|NCT01882296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110118021|NCT01882296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110118022|NCT01882322|Tacrolimus|tacrolimus|mesh-list
110118023|NCT01882322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110118024|NCT01882322|Immunologic Factors|immunologic factors|mesh-ancestor
110118025|NCT01882322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110118026|NCT01882322|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110118027|NCT01882322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110118028|NCT01882322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110118029|NCT01882361|Naltrexone|naltrexone|mesh-list
110118030|NCT01882361|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110118031|NCT01882361|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110118032|NCT01882361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110118033|NCT01882361|Sensory System Agents|sensory system agents|mesh-ancestor
110118034|NCT01882361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110118035|NCT01882374|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
110118036|NCT01882374|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110118037|NCT01882374|Vasodilator Agents|vasodilator agents|mesh-ancestor
110118038|NCT01882387|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
110118039|NCT01882387|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110118040|NCT01882387|Vasodilator Agents|vasodilator agents|mesh-ancestor
110118041|NCT01882400|Alendronate|alendronate|mesh-list
110118042|NCT01882400|Risedronic Acid|risedronic acid|mesh-list
110118043|NCT01882400|Diphosphonates|diphosphonates|mesh-list
110118044|NCT01882400|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110118045|NCT01882400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110118046|NCT01882400|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110118047|NCT01882400|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110118048|NCT01882400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110118049|NCT01882400|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110118050|NCT01882530|Acetaminophen|acetaminophen|mesh-list
110118051|NCT01882530|Ketoprofen|ketoprofen|mesh-list
110118052|NCT01882530|Morphine|morphine|mesh-list
110118053|NCT01882530|Nefopam|nefopam|mesh-list
110118054|NCT01882530|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110118055|NCT01882530|Narcotics|narcotics|mesh-ancestor
110118056|NCT01882530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110118057|NCT01882530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110118058|NCT01882530|Analgesics|analgesics|mesh-ancestor
110118059|NCT01882530|Sensory System Agents|sensory system agents|mesh-ancestor
110118060|NCT01882530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110118061|NCT01882530|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110118062|NCT01882530|Antipyretics|antipyretics|mesh-ancestor
110118063|NCT01882530|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110118064|NCT01882530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110118065|NCT01882530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110118066|NCT01882530|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110118067|NCT01882530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110118068|NCT01882530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110118069|NCT01882556|Botulinum Toxins|botulinum toxins|mesh-list
110118070|NCT01882556|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110118071|NCT01882556|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110118072|NCT01882556|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110118073|NCT01882556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110118074|NCT01882556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110118075|NCT01882556|Cholinergic Agents|cholinergic agents|mesh-ancestor
110118076|NCT01882556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110118077|NCT01882556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110118078|NCT01882556|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110118079|NCT01882556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110118080|NCT01882920|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110118081|NCT01883011|Piracetam|piracetam|mesh-list
110118082|NCT01883011|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110118083|NCT01883011|Protective Agents|protective agents|mesh-ancestor
110118084|NCT01883011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110118085|NCT01883011|Nootropic Agents|nootropic agents|mesh-ancestor
110118086|NCT01883102|Capsaicin|capsaicin|mesh-list
110118087|NCT01883102|Antipruritics|antipruritics|mesh-ancestor
110118088|NCT01883102|Dermatologic Agents|dermatologic agents|mesh-ancestor
110118089|NCT01883102|Sensory System Agents|sensory system agents|mesh-ancestor
110118090|NCT01883102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110118091|NCT01883102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110118092|NCT01883167|Febuxostat|febuxostat|mesh-list
110118093|NCT01883167|Verinurad|verinurad|mesh-list
110118094|NCT01883167|Gout Suppressants|gout suppressants|mesh-ancestor
110118095|NCT01883167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110118096|NCT01883193|Micronutrients|micronutrients|mesh-list
110118097|NCT01883193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110118098|NCT01883232|Lidocaine|lidocaine|mesh-list
110118099|NCT01883232|Epinephrine|epinephrine|mesh-list
110118100|NCT01883232|Anesthetics, Local|anesthetics, local|mesh-ancestor
110118101|NCT01883232|Anesthetics|anesthetics|mesh-ancestor
110118102|NCT01883232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110118103|NCT01883232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110118104|NCT01883232|Sensory System Agents|sensory system agents|mesh-ancestor
110118105|NCT01883232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110118106|NCT01883232|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110118107|NCT01883232|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110118108|NCT01883232|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110118109|NCT01883232|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110118110|NCT01883232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110118111|NCT01883232|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110118112|NCT01883232|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110118113|NCT01883232|Adrenergic Agents|adrenergic agents|mesh-ancestor
110118114|NCT01883232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110118115|NCT01883232|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110118116|NCT01883232|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110118117|NCT01883232|Autonomic Agents|autonomic agents|mesh-ancestor
110118118|NCT01883232|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110118119|NCT01883232|Respiratory System Agents|respiratory system agents|mesh-ancestor
110118120|NCT01883232|Mydriatics|mydriatics|mesh-ancestor
110118121|NCT01883232|Sympathomimetics|sympathomimetics|mesh-ancestor
110118122|NCT01883232|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110118123|NCT01883323|Aldesleukin|aldesleukin|mesh-list
110118124|NCT01883323|Cyclophosphamide|cyclophosphamide|mesh-list
110118125|NCT01883323|Fludarabine|fludarabine|mesh-list
110118126|NCT01883323|Interleukin-2|interleukin-2|mesh-list
110118127|NCT01883323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110118128|NCT01883323|Immunologic Factors|immunologic factors|mesh-ancestor
110118129|NCT01883323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110118130|NCT01883323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110118131|NCT01883323|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110118132|NCT01883323|Alkylating Agents|alkylating agents|mesh-ancestor
110118133|NCT01883323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110118134|NCT01883323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110118135|NCT01883323|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110118136|NCT01883323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110118137|NCT01883323|Analgesics|analgesics|mesh-ancestor
110118138|NCT01883323|Sensory System Agents|sensory system agents|mesh-ancestor
110118139|NCT01883323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110118140|NCT01883323|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110118141|NCT01883323|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110118142|NCT01883323|Antiviral Agents|antiviral agents|mesh-ancestor
110162948|NCT00115648|Zidovudine|zidovudine|mesh-list
110118143|NCT01883323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110118145|NCT01883505|Carbidopa|carbidopa|mesh-list
110118146|NCT01883505|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110118147|NCT01883505|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110118148|NCT01883505|Dopamine Agents|dopamine agents|mesh-ancestor
110118149|NCT01883505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110118150|NCT01883505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110118151|NCT01883505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110118152|NCT01883505|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
110118153|NCT01883505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110118154|NCT01883518|Vaccines|vaccines|mesh-list
110118155|NCT01883518|Immunologic Factors|immunologic factors|mesh-ancestor
110118156|NCT01883518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110118157|NCT01883531|Mannitol|mannitol|mesh-list
110118158|NCT01883531|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110118159|NCT01883531|Diuretics|diuretics|mesh-ancestor
110118160|NCT01883531|Natriuretic Agents|natriuretic agents|mesh-ancestor
110118161|NCT01883531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110118162|NCT01883596|Chlorhexidine|chlorhexidine|mesh-list
110118163|NCT01883596|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110118164|NCT01883596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110118165|NCT01883596|Disinfectants|disinfectants|mesh-ancestor
110118166|NCT01883869|Ticagrelor|ticagrelor|mesh-list
110118167|NCT01883869|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110118168|NCT01883869|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110118169|NCT01883869|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110118170|NCT01883869|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110118171|NCT01883869|Purinergic Agents|purinergic agents|mesh-ancestor
110118172|NCT01883869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110118173|NCT01883869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110118174|NCT01883869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110118175|NCT01883882|Analgesics, Opioid|analgesics, opioid|mesh-list
110118176|NCT01883882|Narcotics|narcotics|mesh-ancestor
110118177|NCT01883882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110118178|NCT01883882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110118179|NCT01883882|Analgesics|analgesics|mesh-ancestor
110118180|NCT01883882|Sensory System Agents|sensory system agents|mesh-ancestor
110118181|NCT01883882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110118182|NCT01883921|Immunoglobulins|immunoglobulins|mesh-list
110118183|NCT01883921|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110118185|NCT01883921|Immunologic Factors|immunologic factors|mesh-ancestor
110118186|NCT01883921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110118187|NCT01884038|Treprostinil|treprostinil|mesh-list
110118188|NCT01884038|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110118189|NCT01884116|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
110118191|NCT01884116|Antipruritics|antipruritics|mesh-ancestor
110118192|NCT01884116|Dermatologic Agents|dermatologic agents|mesh-ancestor
110118193|NCT01884116|Sensory System Agents|sensory system agents|mesh-ancestor
110118194|NCT01884116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110118195|NCT01884116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110118196|NCT01884116|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110118197|NCT01884116|Analgesics|analgesics|mesh-ancestor
110118198|NCT01884116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110221656|NCT00120237|Oxytocics|oxytocics|mesh-ancestor
110118200|NCT01884168|Immunomodulating Agents|immunomodulating agents|mesh-list
110118201|NCT01884168|Immunologic Factors|immunologic factors|mesh-ancestor
110118202|NCT01884168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110118203|NCT01884272|Naproxen|naproxen|mesh-list
110118204|NCT01884272|Indomethacin|indomethacin|mesh-list
110118205|NCT01884272|Lesinurad|lesinurad|mesh-list
110118206|NCT01884272|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110118207|NCT01884272|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110118208|NCT01884272|Analgesics|analgesics|mesh-ancestor
110118209|NCT01884272|Sensory System Agents|sensory system agents|mesh-ancestor
110118210|NCT01884272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110118211|NCT01884272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110118212|NCT01884272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110118213|NCT01884272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110118214|NCT01884272|Gout Suppressants|gout suppressants|mesh-ancestor
110118215|NCT01884272|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110118216|NCT01884272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110162952|NCT00115648|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110118217|NCT01884272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110118218|NCT01884272|Tocolytic Agents|tocolytic agents|mesh-ancestor
110118219|NCT01884272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110118220|NCT01884272|Uricosuric Agents|uricosuric agents|mesh-ancestor
110118221|NCT01884285|Abiraterone Acetate|abiraterone acetate|mesh-list
110118222|NCT01884285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110118223|NCT01884285|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110118224|NCT01884285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110118225|NCT01884285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110118226|NCT01884285|Hormone Antagonists|hormone antagonists|mesh-ancestor
110118227|NCT01884285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110118228|NCT01884285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110118229|NCT01884285|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110118231|NCT01884298|Remifentanil|remifentanil|mesh-list
110118232|NCT01884298|Anesthetics, Local|anesthetics, local|mesh-ancestor
110118233|NCT01884298|Anesthetics|anesthetics|mesh-ancestor
110118234|NCT01884298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110118235|NCT01884298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110118236|NCT01884298|Sensory System Agents|sensory system agents|mesh-ancestor
110118237|NCT01884298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110118238|NCT01884298|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110118239|NCT01884298|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110118240|NCT01884298|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110118241|NCT01884298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110118242|NCT01884298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110118243|NCT01884298|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110118244|NCT01884298|Narcotics|narcotics|mesh-ancestor
110118245|NCT01884298|Analgesics|analgesics|mesh-ancestor
110118246|NCT01884402|Ribavirin|ribavirin|mesh-list
110118247|NCT01884402|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110118248|NCT01884402|Antimetabolites|antimetabolites|mesh-ancestor
110118249|NCT01884402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110118250|NCT01884402|Antiviral Agents|antiviral agents|mesh-ancestor
110118251|NCT01884402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110118252|NCT01884415|Vaccines|vaccines|mesh-list
110118253|NCT01884415|Immunologic Factors|immunologic factors|mesh-ancestor
110118254|NCT01884415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110118255|NCT01884428|Prednisolone|prednisolone|mesh-list
110118256|NCT01884428|Gemcitabine|gemcitabine|mesh-list
110118257|NCT01884428|Vinorelbine|vinorelbine|mesh-list
110118258|NCT01884428|Ifosfamide|ifosfamide|mesh-list
110118259|NCT01884428|Panobinostat|panobinostat|mesh-list
110118260|NCT01884428|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110118261|NCT01884428|Antimetabolites|antimetabolites|mesh-ancestor
110118262|NCT01884428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110118264|NCT01884428|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110118265|NCT01884428|Glucocorticoids|glucocorticoids|mesh-ancestor
110118266|NCT01884428|Hormones|hormones|mesh-ancestor
110118267|NCT01884428|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110118268|NCT01884428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110118269|NCT01884428|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110118270|NCT01884428|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110118271|NCT01884428|Tubulin Modulators|tubulin modulators|mesh-ancestor
110118272|NCT01884428|Antimitotic Agents|antimitotic agents|mesh-ancestor
110118273|NCT01884428|Mitosis Modulators|mitosis modulators|mesh-ancestor
110118274|NCT01884428|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110118275|NCT01884428|Alkylating Agents|alkylating agents|mesh-ancestor
110118276|NCT01884428|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110118277|NCT01884428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110118278|NCT01884441|Gemcitabine|gemcitabine|mesh-list
110118279|NCT01884441|Vinorelbine|vinorelbine|mesh-list
110118280|NCT01884441|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110118281|NCT01884441|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110118282|NCT01884441|Antimetabolites|antimetabolites|mesh-ancestor
110162954|NCT00115648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110118283|NCT01884441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110118284|NCT01884441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110118285|NCT01884441|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110118286|NCT01884441|Tubulin Modulators|tubulin modulators|mesh-ancestor
110118287|NCT01884441|Antimitotic Agents|antimitotic agents|mesh-ancestor
110118288|NCT01884441|Mitosis Modulators|mitosis modulators|mesh-ancestor
110118289|NCT01884441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110118290|NCT01884441|Alkylating Agents|alkylating agents|mesh-ancestor
110118291|NCT01884467|Gentamicins|gentamicins|mesh-list
110118292|NCT01884467|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110118293|NCT01884467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110118294|NCT01884467|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110118295|NCT01884467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110118296|NCT01884467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110118298|NCT01884506|Ascorbic Acid|ascorbic acid|mesh-list
110118299|NCT01884506|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110118300|NCT01884506|Trace Elements|trace elements|mesh-ancestor
110118301|NCT01884506|Micronutrients|micronutrients|mesh-ancestor
110118302|NCT01884506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110118303|NCT01884506|Antioxidants|antioxidants|mesh-ancestor
110118304|NCT01884506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110118305|NCT01884506|Protective Agents|protective agents|mesh-ancestor
110118306|NCT01884506|Vitamins|vitamins|mesh-ancestor
110118307|NCT01884558|Metformin|metformin|mesh-list
110118308|NCT01884558|Isavuconazole|isavuconazole|mesh-list
110118309|NCT01884558|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110118310|NCT01884558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110118311|NCT01884558|Antifungal Agents|antifungal agents|mesh-ancestor
110221675|NCT00418288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110118312|NCT01884558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110118313|NCT01884623|Methotrexate|methotrexate|mesh-list
110118314|NCT01884623|Cetuximab|cetuximab|mesh-list
110118315|NCT01884623|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110118316|NCT01884623|Abortifacient Agents|abortifacient agents|mesh-ancestor
110118317|NCT01884623|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110118318|NCT01884623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110118319|NCT01884623|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110118320|NCT01884623|Antimetabolites|antimetabolites|mesh-ancestor
110118321|NCT01884623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110118322|NCT01884623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110118323|NCT01884623|Dermatologic Agents|dermatologic agents|mesh-ancestor
110118324|NCT01884623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110118325|NCT01884623|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110118326|NCT01884623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110118327|NCT01884623|Immunologic Factors|immunologic factors|mesh-ancestor
110118328|NCT01884623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110118329|NCT01884623|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110118330|NCT01884623|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110118331|NCT01884636|Isavuconazole|isavuconazole|mesh-list
110118332|NCT01884636|Methotrexate|methotrexate|mesh-list
110118333|NCT01884636|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110118334|NCT01884636|Abortifacient Agents|abortifacient agents|mesh-ancestor
110118335|NCT01884636|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110118336|NCT01884636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110118337|NCT01884636|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110118339|NCT01884636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110118340|NCT01884636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110118341|NCT01884636|Dermatologic Agents|dermatologic agents|mesh-ancestor
110118342|NCT01884636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110118343|NCT01884636|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110118344|NCT01884636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110118345|NCT01884636|Immunologic Factors|immunologic factors|mesh-ancestor
110118346|NCT01884636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110118347|NCT01884636|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110118348|NCT01884636|Antifungal Agents|antifungal agents|mesh-ancestor
110118349|NCT01884636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110118350|NCT01884857|Metoprolol|metoprolol|mesh-list
110118351|NCT01884857|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110118352|NCT01884857|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110118353|NCT01884857|Sympatholytics|sympatholytics|mesh-ancestor
110118354|NCT01884857|Autonomic Agents|autonomic agents|mesh-ancestor
110118355|NCT01884857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110118356|NCT01884857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110118357|NCT01884857|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110118358|NCT01884857|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110118359|NCT01884857|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110221700|NCT00418366|Protease Inhibitors|protease inhibitors|mesh-ancestor
110221701|NCT00418366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110118360|NCT01884857|Adrenergic Agents|adrenergic agents|mesh-ancestor
110118361|NCT01884857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110118362|NCT01884857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110118364|NCT01884896|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110118365|NCT01884896|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110118366|NCT01884896|Sympatholytics|sympatholytics|mesh-ancestor
110118367|NCT01884896|Autonomic Agents|autonomic agents|mesh-ancestor
110118368|NCT01884896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110118369|NCT01884896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110118370|NCT01884896|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110118371|NCT01884896|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110118372|NCT01884896|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110118373|NCT01884896|Adrenergic Agents|adrenergic agents|mesh-ancestor
110118374|NCT01884896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110118375|NCT01884896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110118377|NCT01884909|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110118378|NCT01884909|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110118379|NCT01884909|Sympatholytics|sympatholytics|mesh-ancestor
110118380|NCT01884909|Autonomic Agents|autonomic agents|mesh-ancestor
110118381|NCT01884909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110118382|NCT01884909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110118383|NCT01884909|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110118384|NCT01884909|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110118385|NCT01884909|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110118386|NCT01884909|Adrenergic Agents|adrenergic agents|mesh-ancestor
110118387|NCT01884909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110118388|NCT01884909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110118389|NCT01884935|Natalizumab|natalizumab|mesh-list
110118390|NCT01884935|Immunologic Factors|immunologic factors|mesh-ancestor
110118391|NCT01884935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110118392|NCT01885013|Metformin|metformin|mesh-list
110118393|NCT01885013|Cyclophosphamide|cyclophosphamide|mesh-list
110118394|NCT01885013|Doxorubicin|doxorubicin|mesh-list
110118395|NCT01885013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110118396|NCT01885013|Immunologic Factors|immunologic factors|mesh-ancestor
110118397|NCT01885013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110118398|NCT01885013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110118399|NCT01885013|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110118400|NCT01885013|Alkylating Agents|alkylating agents|mesh-ancestor
110118401|NCT01885013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110118402|NCT01885013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110118403|NCT01885013|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110118404|NCT01885013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110118405|NCT01885013|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110118406|NCT01885013|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110118407|NCT01885013|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110118408|NCT01885013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110118409|NCT01885091|Kinetin|kinetin|mesh-list
110118410|NCT01885091|Plant Growth Regulators|plant growth regulators|mesh-ancestor
110118411|NCT01885091|Growth Substances|growth substances|mesh-ancestor
110118412|NCT01885091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110118413|NCT01885338|Acetylcysteine|acetylcysteine|mesh-list
110162969|NCT00008294|Antiemetics|antiemetics|mesh-ancestor
110118414|NCT01885338|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110118415|NCT01885338|Antiviral Agents|antiviral agents|mesh-ancestor
110118416|NCT01885338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110118417|NCT01885338|Expectorants|expectorants|mesh-ancestor
110118418|NCT01885338|Respiratory System Agents|respiratory system agents|mesh-ancestor
110118419|NCT01885338|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110118420|NCT01885338|Antioxidants|antioxidants|mesh-ancestor
110118421|NCT01885338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110118422|NCT01885338|Protective Agents|protective agents|mesh-ancestor
110118423|NCT01885338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110118424|NCT01885338|Antidotes|antidotes|mesh-ancestor
110118425|NCT01885364|Remifentanil|remifentanil|mesh-list
110118426|NCT01885364|Propofol|propofol|mesh-list
110118427|NCT01885364|Esmolol|esmolol|mesh-list
110118428|NCT01885364|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110118429|NCT01885364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110118430|NCT01885364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110118431|NCT01885364|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110118432|NCT01885364|Anesthetics, General|anesthetics, general|mesh-ancestor
110118433|NCT01885364|Anesthetics|anesthetics|mesh-ancestor
110118434|NCT01885364|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110118435|NCT01885364|Narcotics|narcotics|mesh-ancestor
110118436|NCT01885364|Analgesics|analgesics|mesh-ancestor
110118437|NCT01885364|Sensory System Agents|sensory system agents|mesh-ancestor
110118438|NCT01885364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110118439|NCT01885364|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110221755|NCT00303004|Vasodilator Agents|vasodilator agents|mesh-ancestor
110221756|NCT00303004|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110118440|NCT01885364|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110118441|NCT01885364|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110118442|NCT01885364|Adrenergic Agents|adrenergic agents|mesh-ancestor
110118443|NCT01885364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110118444|NCT01885364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110118445|NCT01885481|Dexamethasone|dexamethasone|mesh-list
110118446|NCT01885481|Dexamethasone acetate|dexamethasone acetate|mesh-list
110118447|NCT01885481|Betamethasone|betamethasone|mesh-list
110118448|NCT01885481|Betamethasone Valerate|betamethasone valerate|mesh-list
110118449|NCT01885481|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
110118450|NCT01885481|Betamethasone benzoate|betamethasone benzoate|mesh-list
110118451|NCT01885481|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
110118452|NCT01885481|BB 1101|bb 1101|mesh-list
110118453|NCT01885481|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110118454|NCT01885481|Antiemetics|antiemetics|mesh-ancestor
110118455|NCT01885481|Autonomic Agents|autonomic agents|mesh-ancestor
110118456|NCT01885481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110118457|NCT01885481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110118458|NCT01885481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110118459|NCT01885481|Glucocorticoids|glucocorticoids|mesh-ancestor
110118460|NCT01885481|Hormones|hormones|mesh-ancestor
110118461|NCT01885481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110118462|NCT01885481|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110118463|NCT01885481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110118464|NCT01885481|Protease Inhibitors|protease inhibitors|mesh-ancestor
110118465|NCT01885481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110118466|NCT01885481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110118467|NCT01885481|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110118468|NCT01885481|Respiratory System Agents|respiratory system agents|mesh-ancestor
110118469|NCT01885585|Apixaban|apixaban|mesh-list
110118470|NCT01885585|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110118471|NCT01885585|Antithrombins|antithrombins|mesh-ancestor
110118472|NCT01885585|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110118473|NCT01885585|Protease Inhibitors|protease inhibitors|mesh-ancestor
110118474|NCT01885585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110118475|NCT01885585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110118476|NCT01885585|Anticoagulants|anticoagulants|mesh-ancestor
110118477|NCT01885598|Apixaban|apixaban|mesh-list
110118478|NCT01885598|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110118479|NCT01885598|Antithrombins|antithrombins|mesh-ancestor
110118480|NCT01885598|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110118481|NCT01885598|Protease Inhibitors|protease inhibitors|mesh-ancestor
110118482|NCT01885598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110118483|NCT01885598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110118484|NCT01885598|Anticoagulants|anticoagulants|mesh-ancestor
110118485|NCT01885715|Neostigmine|neostigmine|mesh-list
110118486|NCT01885715|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110118487|NCT01885715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110118488|NCT01885715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110118489|NCT01885715|Cholinergic Agents|cholinergic agents|mesh-ancestor
110118490|NCT01885715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110118491|NCT01885715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110118492|NCT01885715|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110118493|NCT01885715|Autonomic Agents|autonomic agents|mesh-ancestor
110118494|NCT01885715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110118496|NCT01885988|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110118497|NCT01885988|Vasodilator Agents|vasodilator agents|mesh-ancestor
110118498|NCT01885988|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
110118499|NCT01885988|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110118500|NCT01885988|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110118501|NCT01885988|Adrenergic Agents|adrenergic agents|mesh-ancestor
110118502|NCT01885988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110118503|NCT01885988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110118504|NCT01885988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110118505|NCT01886001|Chlorhexidine|chlorhexidine|mesh-list
110118506|NCT01886001|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110118507|NCT01886001|Povidone-Iodine|povidone-iodine|mesh-list
110118508|NCT01886001|Povidone|povidone|mesh-list
110118509|NCT01886001|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110118510|NCT01886001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110118511|NCT01886001|Disinfectants|disinfectants|mesh-ancestor
110118512|NCT01886001|Dermatologic Agents|dermatologic agents|mesh-ancestor
110118513|NCT01886001|Plasma Substitutes|plasma substitutes|mesh-ancestor
110118514|NCT01886001|Blood Substitutes|blood substitutes|mesh-ancestor
110118515|NCT01886014|Oxytocin|oxytocin|mesh-list
110118516|NCT01886014|Oxytocics|oxytocics|mesh-ancestor
110118517|NCT01886014|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110118518|NCT01886014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110118519|NCT01886053|Ertapenem|ertapenem|mesh-list
110118520|NCT01886053|beta-Lactams|beta-lactams|mesh-list
110118521|NCT01886053|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110118522|NCT01886053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110118523|NCT01886079|Dexmedetomidine|dexmedetomidine|mesh-list
110221823|NCT00303433|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110118525|NCT01886079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110118526|NCT01886079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110118527|NCT01886079|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110118529|NCT01886079|Sensory System Agents|sensory system agents|mesh-ancestor
110118530|NCT01886079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110118531|NCT01886079|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110118532|NCT01886079|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110118533|NCT01886079|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110118534|NCT01886079|Adrenergic Agents|adrenergic agents|mesh-ancestor
110118535|NCT01886079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110118536|NCT01886079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110118537|NCT01886196|Ibuprofen|ibuprofen|mesh-list
110118538|NCT01886196|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
110118539|NCT01886196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
110118540|NCT01886196|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110118541|NCT01886196|Analgesics|analgesics|mesh-ancestor
110118542|NCT01886196|Sensory System Agents|sensory system agents|mesh-ancestor
110118543|NCT01886196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110118544|NCT01886196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110118545|NCT01886196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110118546|NCT01886196|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110118547|NCT01886196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110118548|NCT01886196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110118549|NCT01886209|Prednisone|prednisone|mesh-list
110118550|NCT01886209|Methylprednisolone|methylprednisolone|mesh-list
110118551|NCT01886209|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110118552|NCT01886209|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110118553|NCT01886209|Prednisolone|prednisolone|mesh-list
110118554|NCT01886209|Prednisolone acetate|prednisolone acetate|mesh-list
110118555|NCT01886209|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110118556|NCT01886209|Prednisolone phosphate|prednisolone phosphate|mesh-list
110118557|NCT01886209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110118558|NCT01886209|Glucocorticoids|glucocorticoids|mesh-ancestor
110118559|NCT01886209|Hormones|hormones|mesh-ancestor
110118560|NCT01886209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110118561|NCT01886209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110118562|NCT01886209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110118563|NCT01886209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110118565|NCT01886209|Autonomic Agents|autonomic agents|mesh-ancestor
110118566|NCT01886209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110118567|NCT01886209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110118568|NCT01886209|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110118569|NCT01886209|Protective Agents|protective agents|mesh-ancestor
110118570|NCT01886248|Antithrombins|antithrombins|mesh-list
110118571|NCT01886248|Antithrombin III|antithrombin iii|mesh-list
110118572|NCT01886248|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110118573|NCT01886248|Protease Inhibitors|protease inhibitors|mesh-ancestor
110118574|NCT01886248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110118575|NCT01886248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110118576|NCT01886248|Anticoagulants|anticoagulants|mesh-ancestor
110118577|NCT01886352|Levobupivacaine|levobupivacaine|mesh-list
110118578|NCT01886352|Anesthetics, Local|anesthetics, local|mesh-ancestor
110118579|NCT01886352|Anesthetics|anesthetics|mesh-ancestor
110118580|NCT01886352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110118581|NCT01886352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110118582|NCT01886352|Sensory System Agents|sensory system agents|mesh-ancestor
110118583|NCT01886352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110118584|NCT01886365|Insulin|insulin|mesh-list
110118585|NCT01886365|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110118586|NCT01886365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110118587|NCT01886404|Efavirenz|efavirenz|mesh-list
110118588|NCT01886404|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110118589|NCT01886404|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110118590|NCT01886404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110118591|NCT01886404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110118592|NCT01886404|Antiviral Agents|antiviral agents|mesh-ancestor
110118593|NCT01886404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110118594|NCT01886404|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110118595|NCT01886404|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110118596|NCT01886404|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110118597|NCT01886404|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110118598|NCT01886404|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110118599|NCT01886404|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110118600|NCT01886443|Tocopherols|tocopherols|mesh-list
110118601|NCT01886443|Vitamin E|vitamin e|mesh-list
110118602|NCT01886443|alpha-Tocopherol|alpha-tocopherol|mesh-list
110118603|NCT01886443|Infliximab|infliximab|mesh-list
110118604|NCT01886443|Epoprostenol|epoprostenol|mesh-list
110118605|NCT01886443|Tezosentan|tezosentan|mesh-list
110118606|NCT01886443|Melatonin|melatonin|mesh-list
110118607|NCT01886443|Antithrombins|antithrombins|mesh-list
110118608|NCT01886443|Antithrombin III|antithrombin iii|mesh-list
110118609|NCT01886443|Epoetin Alfa|epoetin alfa|mesh-list
110118610|NCT01886443|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
110118611|NCT01886443|Antioxidants|antioxidants|mesh-ancestor
110118612|NCT01886443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110118613|NCT01886443|Protective Agents|protective agents|mesh-ancestor
110118614|NCT01886443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110118615|NCT01886443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110118616|NCT01886443|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110118617|NCT01886443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110118618|NCT01886443|Dermatologic Agents|dermatologic agents|mesh-ancestor
110118619|NCT01886443|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110118620|NCT01886443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110118621|NCT01886443|Hematinics|hematinics|mesh-ancestor
110118622|NCT01886443|Vitamins|vitamins|mesh-ancestor
110118623|NCT01886443|Micronutrients|micronutrients|mesh-ancestor
110118624|NCT01886443|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110118625|NCT01886443|Protease Inhibitors|protease inhibitors|mesh-ancestor
110118626|NCT01886443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110118628|NCT01886443|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110118629|NCT01886443|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110118630|NCT01886443|Vasodilator Agents|vasodilator agents|mesh-ancestor
110118631|NCT01886443|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
110118632|NCT01886443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110118633|NCT01886443|Immunologic Factors|immunologic factors|mesh-ancestor
110118634|NCT01886534|Diuretics|diuretics|mesh-list
110118635|NCT01886534|Natriuretic Agents|natriuretic agents|mesh-ancestor
110118636|NCT01886534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110118637|NCT01886560|Doxycycline|doxycycline|mesh-list
110118638|NCT01886560|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110118639|NCT01886560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110118640|NCT01886560|Antimalarials|antimalarials|mesh-ancestor
110118641|NCT01886560|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110118642|NCT01886560|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110118643|NCT01886573|Azacitidine|azacitidine|mesh-list
110118644|NCT01886573|Entinostat|entinostat|mesh-list
110118645|NCT01886573|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
110118646|NCT01886573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110118647|NCT01886573|Antimetabolites|antimetabolites|mesh-ancestor
110118648|NCT01886573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110118649|NCT01886573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110118650|NCT01886573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110118651|NCT01886599|Asunaprevir|asunaprevir|mesh-list
110118652|NCT01886599|Protease Inhibitors|protease inhibitors|mesh-ancestor
110118653|NCT01886599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110118654|NCT01886599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110118655|NCT01886638|Abacavir|abacavir|mesh-list
110118656|NCT01886638|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110118657|NCT01886638|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110118658|NCT01886638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110118659|NCT01886638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110118660|NCT01886638|Antiviral Agents|antiviral agents|mesh-ancestor
110118661|NCT01886638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110118662|NCT01886638|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110118663|NCT01886638|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110118664|NCT01886664|Sevoflurane|sevoflurane|mesh-list
110118666|NCT01886664|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110118667|NCT01886664|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110118668|NCT01886664|Anesthetics, General|anesthetics, general|mesh-ancestor
110118669|NCT01886664|Anesthetics|anesthetics|mesh-ancestor
110118670|NCT01886664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110118671|NCT01886664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110118672|NCT01886768|Anesthetics|anesthetics|mesh-list
110118673|NCT01886768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110118674|NCT01886768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110118675|NCT01887119|Eplerenone|eplerenone|mesh-list
110118676|NCT01887119|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110118677|NCT01887119|Hormone Antagonists|hormone antagonists|mesh-ancestor
110221956|NCT00081926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110221958|NCT00304135|Gemcitabine|gemcitabine|mesh-list
110118678|NCT01887119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110118679|NCT01887119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110118680|NCT01887119|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110118681|NCT01887119|Diuretics|diuretics|mesh-ancestor
110118682|NCT01887119|Natriuretic Agents|natriuretic agents|mesh-ancestor
110118683|NCT01887119|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110118684|NCT01887158|Bisacodyl|bisacodyl|mesh-list
110118685|NCT01887158|Cathartics|cathartics|mesh-ancestor
110118686|NCT01887158|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110118687|NCT01887158|Laxatives|laxatives|mesh-ancestor
110118688|NCT01887184|Dexmedetomidine|dexmedetomidine|mesh-list
110118689|NCT01887184|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110118690|NCT01887184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110118691|NCT01887184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110118692|NCT01887184|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110118694|NCT01887184|Sensory System Agents|sensory system agents|mesh-ancestor
110118695|NCT01887184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110118696|NCT01887184|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110118697|NCT01887184|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110118698|NCT01887184|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110118699|NCT01887184|Adrenergic Agents|adrenergic agents|mesh-ancestor
110118700|NCT01887184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110118701|NCT01887184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110118702|NCT01887197|Mannitol|mannitol|mesh-list
110118703|NCT01887197|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110118704|NCT01887197|Diuretics|diuretics|mesh-ancestor
110118705|NCT01887197|Natriuretic Agents|natriuretic agents|mesh-ancestor
110118706|NCT01887197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110118707|NCT01887223|Timolol|timolol|mesh-list
110118708|NCT01887223|Brimonidine Tartrate|brimonidine tartrate|mesh-list
110118709|NCT01887223|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110118710|NCT01887223|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110118711|NCT01887223|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110118712|NCT01887223|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110118714|NCT01887223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110118715|NCT01887223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110118716|NCT01887223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110118717|NCT01887223|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110118718|NCT01887223|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110118719|NCT01887223|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110118720|NCT01887249|Metronidazole|metronidazole|mesh-list
110118721|NCT01887249|Clarithromycin|clarithromycin|mesh-list
110118722|NCT01887249|Esomeprazole|esomeprazole|mesh-list
110118723|NCT01887249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110118724|NCT01887249|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110118725|NCT01887249|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110118726|NCT01887249|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110118727|NCT01887249|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110118728|NCT01887249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110118729|NCT01887249|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110118730|NCT01887249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110118731|NCT01887249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110118732|NCT01887249|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110118733|NCT01887249|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110118734|NCT01887249|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110118735|NCT01887275|Interferons|interferons|mesh-list
110118736|NCT01887275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110118737|NCT01887275|Antiviral Agents|antiviral agents|mesh-ancestor
110118738|NCT01887275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110118739|NCT01887340|Carboplatin|carboplatin|mesh-list
110118740|NCT01887340|Etoposide|etoposide|mesh-list
110118741|NCT01887340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110118742|NCT01887340|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110118743|NCT01887340|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110118744|NCT01887340|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110118745|NCT01887340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110118746|NCT01887340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110118747|NCT01887379|Furosemide|furosemide|mesh-list
110118748|NCT01887379|Diuretics|diuretics|mesh-ancestor
110118749|NCT01887379|Natriuretic Agents|natriuretic agents|mesh-ancestor
110118750|NCT01887379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110118751|NCT01887379|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110118752|NCT01887379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110118753|NCT01887379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110118754|NCT01887405|Epinephrine|epinephrine|mesh-list
110118755|NCT01887405|Racepinephrine|racepinephrine|mesh-list
110118756|NCT01887405|Epinephryl borate|epinephryl borate|mesh-list
110118757|NCT01887405|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110118758|NCT01887405|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110118759|NCT01887405|Adrenergic Agents|adrenergic agents|mesh-ancestor
110118760|NCT01887405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110118761|NCT01887405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110118762|NCT01887405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110118763|NCT01887405|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110118764|NCT01887405|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110118765|NCT01887405|Autonomic Agents|autonomic agents|mesh-ancestor
110118766|NCT01887405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110118767|NCT01887405|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110118768|NCT01887405|Respiratory System Agents|respiratory system agents|mesh-ancestor
110118769|NCT01887405|Mydriatics|mydriatics|mesh-ancestor
110222043|NCT00304681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110118771|NCT01887405|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110118772|NCT01887457|Voriconazole|voriconazole|mesh-list
110118773|NCT01887457|Antifungal Agents|antifungal agents|mesh-ancestor
110118774|NCT01887457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110118775|NCT01887457|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110118776|NCT01887457|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110118777|NCT01887457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110118778|NCT01887457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110118780|NCT01887457|Hormone Antagonists|hormone antagonists|mesh-ancestor
110118781|NCT01887457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110118782|NCT01887457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110118783|NCT01887457|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110118785|NCT01887561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110118786|NCT01887561|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110118787|NCT01887561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110118788|NCT01887561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110118790|NCT01887613|Analgesics|analgesics|mesh-ancestor
110118791|NCT01887613|Sensory System Agents|sensory system agents|mesh-ancestor
110118792|NCT01887613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110118793|NCT01887613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110118794|NCT01887613|Anticonvulsants|anticonvulsants|mesh-ancestor
110118795|NCT01887613|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110118796|NCT01887613|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110118797|NCT01887613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110118798|NCT01887613|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110118799|NCT01887613|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110118800|NCT01887613|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110118801|NCT01887613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110118802|NCT01887613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110118803|NCT01887613|Antimanic Agents|antimanic agents|mesh-ancestor
110118804|NCT01887626|Ticagrelor|ticagrelor|mesh-list
110222066|NCT00082199|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110118805|NCT01887626|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110118806|NCT01887626|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110118807|NCT01887626|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110118808|NCT01887626|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110118809|NCT01887626|Purinergic Agents|purinergic agents|mesh-ancestor
110118810|NCT01887626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110118811|NCT01887626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110118812|NCT01887626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110118813|NCT01887691|Eszopiclone|eszopiclone|mesh-list
110118814|NCT01887691|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110118815|NCT01887691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110118816|NCT01887691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110118817|NCT01887704|Aspirin|aspirin|mesh-list
110118818|NCT01887704|Sirolimus|sirolimus|mesh-list
110118819|NCT01887704|Paclitaxel|paclitaxel|mesh-list
110118820|NCT01887704|Everolimus|everolimus|mesh-list
110118821|NCT01887704|Clopidogrel|clopidogrel|mesh-list
110118822|NCT01887704|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110118823|NCT01887704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110118824|NCT01887704|Tubulin Modulators|tubulin modulators|mesh-ancestor
110118825|NCT01887704|Antimitotic Agents|antimitotic agents|mesh-ancestor
110118826|NCT01887704|Mitosis Modulators|mitosis modulators|mesh-ancestor
110118827|NCT01887704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110118828|NCT01887704|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110118829|NCT01887704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110118830|NCT01887704|Analgesics|analgesics|mesh-ancestor
110118831|NCT01887704|Sensory System Agents|sensory system agents|mesh-ancestor
110118832|NCT01887704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110118833|NCT01887704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110118834|NCT01887704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110118835|NCT01887704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110118836|NCT01887704|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110118837|NCT01887704|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110118838|NCT01887704|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110118839|NCT01887704|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110118840|NCT01887704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110118841|NCT01887704|Antipyretics|antipyretics|mesh-ancestor
110118842|NCT01887704|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110222104|NCT00304993|Vasodilator Agents|vasodilator agents|mesh-ancestor
110118843|NCT01887704|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110118844|NCT01887704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110118845|NCT01887704|Immunologic Factors|immunologic factors|mesh-ancestor
110118846|NCT01887704|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110118847|NCT01887704|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110118848|NCT01887704|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110118849|NCT01887704|Purinergic Agents|purinergic agents|mesh-ancestor
110118850|NCT01887704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110118851|NCT01887704|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110118852|NCT01887704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110118853|NCT01887704|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110118854|NCT01887704|Antifungal Agents|antifungal agents|mesh-ancestor
110118855|NCT01887743|Pantoprazole|pantoprazole|mesh-list
110118856|NCT01887743|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110118857|NCT01887743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110118858|NCT01887743|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110118859|NCT01887743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110118860|NCT01887743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110118861|NCT01887795|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110118862|NCT01887795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110118863|NCT01887795|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110118864|NCT01887795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110118865|NCT01887795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110118866|NCT01887821|Chloroquine|chloroquine|mesh-list
110118867|NCT01887821|Piperaquine|piperaquine|mesh-list
110118868|NCT01887821|Artenimol|artenimol|mesh-list
110118869|NCT01887821|Amebicides|amebicides|mesh-ancestor
110118870|NCT01887821|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110118871|NCT01887821|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110118872|NCT01887821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110118873|NCT01887821|Antimalarials|antimalarials|mesh-ancestor
110118874|NCT01887821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110118875|NCT01887847|Nicotine|nicotine|mesh-list
110118876|NCT01887847|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110118877|NCT01887847|Autonomic Agents|autonomic agents|mesh-ancestor
110118878|NCT01887847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110118879|NCT01887847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110118880|NCT01887847|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110118881|NCT01887847|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110118882|NCT01887847|Cholinergic Agents|cholinergic agents|mesh-ancestor
110118883|NCT01887847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110222140|NCT00305422|Serotonin Agents|serotonin agents|mesh-ancestor
110118884|NCT01887847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110118885|NCT01887873|Hyaluronic Acid|hyaluronic acid|mesh-list
110118886|NCT01887873|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110118887|NCT01887873|Immunologic Factors|immunologic factors|mesh-ancestor
110118888|NCT01887873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110118889|NCT01887873|Viscosupplements|viscosupplements|mesh-ancestor
110118891|NCT01887951|Tramadol|tramadol|mesh-list
110118892|NCT01887951|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110118893|NCT01887951|Narcotics|narcotics|mesh-ancestor
110118894|NCT01887951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110118895|NCT01887951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110118896|NCT01887951|Analgesics|analgesics|mesh-ancestor
110118897|NCT01887951|Sensory System Agents|sensory system agents|mesh-ancestor
110118898|NCT01887951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110118899|NCT01888042|Everolimus|everolimus|mesh-list
110118900|NCT01888042|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110118901|NCT01888042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110118902|NCT01888042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110118903|NCT01888042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110118904|NCT01888042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110118905|NCT01888042|Immunologic Factors|immunologic factors|mesh-ancestor
110118906|NCT01888042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110118907|NCT01888042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110118908|NCT01888107|Risperidone|risperidone|mesh-list
110118909|NCT01888107|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110118910|NCT01888107|Serotonin Agents|serotonin agents|mesh-ancestor
110118911|NCT01888107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110118912|NCT01888107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110118913|NCT01888107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110118914|NCT01888107|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110118915|NCT01888107|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110118916|NCT01888107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110118917|NCT01888107|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110118918|NCT01888107|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110118920|NCT01888120|Ziconotide|ziconotide|mesh-list
110118921|NCT01888120|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110118922|NCT01888120|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110118923|NCT01888120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110118924|NCT01888120|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110118925|NCT01888120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110118926|NCT01888120|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110118927|NCT01888120|Protective Agents|protective agents|mesh-ancestor
110118928|NCT01888120|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110118929|NCT01888120|Analgesics|analgesics|mesh-ancestor
110118930|NCT01888120|Sensory System Agents|sensory system agents|mesh-ancestor
110118931|NCT01888120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110118932|NCT01888224|Isotretinoin|isotretinoin|mesh-list
110118933|NCT01888224|Dermatologic Agents|dermatologic agents|mesh-ancestor
110118934|NCT01888250|Lamotrigine|lamotrigine|mesh-list
110118935|NCT01888250|Anticonvulsants|anticonvulsants|mesh-ancestor
110118936|NCT01888250|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110118937|NCT01888250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110118938|NCT01888250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110118939|NCT01888250|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110118940|NCT01888250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110118941|NCT01888250|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110118942|NCT01888250|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110118943|NCT01888250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110118944|NCT01888250|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110118945|NCT01888250|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110118947|NCT01888263|Anticonvulsants|anticonvulsants|mesh-ancestor
110118948|NCT01888263|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110118949|NCT01888263|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110118950|NCT01888263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110118951|NCT01888263|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110118952|NCT01888263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110118953|NCT01888263|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110118954|NCT01888263|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110118955|NCT01888263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110118956|NCT01888263|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110118957|NCT01888263|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110118958|NCT01888289|Isotretinoin|isotretinoin|mesh-list
110118959|NCT01888289|Dermatologic Agents|dermatologic agents|mesh-ancestor
110118961|NCT01888302|Cisplatin|cisplatin|mesh-list
110118962|NCT01888302|Gemcitabine|gemcitabine|mesh-list
110118963|NCT01888302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110118964|NCT01888302|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110118965|NCT01888302|Antimetabolites|antimetabolites|mesh-ancestor
110118966|NCT01888302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110118967|NCT01888302|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110118968|NCT01888302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110118969|NCT01888302|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110118970|NCT01888302|Antifungal Agents|antifungal agents|mesh-ancestor
110118971|NCT01888302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110118972|NCT01888302|Immunologic Factors|immunologic factors|mesh-ancestor
110118973|NCT01888302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110118974|NCT01888328|Isotretinoin|isotretinoin|mesh-list
110118975|NCT01888328|Dermatologic Agents|dermatologic agents|mesh-ancestor
110118976|NCT01888341|Isotretinoin|isotretinoin|mesh-list
110118977|NCT01888341|Dermatologic Agents|dermatologic agents|mesh-ancestor
110118978|NCT01888354|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
110118979|NCT01888354|Hormones|hormones|mesh-ancestor
110118980|NCT01888354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110118981|NCT01888354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110118982|NCT01888393|Ivacaftor|ivacaftor|mesh-list
110222264|NCT00306826|Pioglitazone|pioglitazone|mesh-list
110118983|NCT01888393|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
110118984|NCT01888393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110118985|NCT01888393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110118986|NCT01888445|Darbepoetin alfa|darbepoetin alfa|mesh-list
110118987|NCT01888445|Hematinics|hematinics|mesh-ancestor
110118989|NCT01888458|Antifungal Agents|antifungal agents|mesh-ancestor
110118990|NCT01888458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110118991|NCT01888536|Pregabalin|pregabalin|mesh-list
110118992|NCT01888536|Alprostadil|alprostadil|mesh-list
110118993|NCT01888536|Analgesics|analgesics|mesh-ancestor
110118994|NCT01888536|Sensory System Agents|sensory system agents|mesh-ancestor
110118995|NCT01888536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110118996|NCT01888536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110118997|NCT01888536|Anticonvulsants|anticonvulsants|mesh-ancestor
110118998|NCT01888536|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110118999|NCT01888536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110119000|NCT01888536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110119001|NCT01888536|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110119002|NCT01888536|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110119003|NCT01888536|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110119004|NCT01888536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110119005|NCT01888536|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110119006|NCT01888536|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110119007|NCT01888536|Vasodilator Agents|vasodilator agents|mesh-ancestor
110119008|NCT01888536|Urological Agents|urological agents|mesh-ancestor
110119009|NCT01888562|Ponatinib|ponatinib|mesh-list
110119010|NCT01888562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110119011|NCT01888562|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110119012|NCT01888562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110119013|NCT01888562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110119014|NCT01888575|Aspirin|aspirin|mesh-list
110119015|NCT01888575|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110119016|NCT01888575|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110119017|NCT01888575|Analgesics|analgesics|mesh-ancestor
110119018|NCT01888575|Sensory System Agents|sensory system agents|mesh-ancestor
110119019|NCT01888575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110119020|NCT01888575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110119021|NCT01888575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110119022|NCT01888575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110119023|NCT01888575|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110119024|NCT01888575|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110119025|NCT01888575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110119026|NCT01888575|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110119027|NCT01888575|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110119028|NCT01888575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110119029|NCT01888575|Antipyretics|antipyretics|mesh-ancestor
110119030|NCT01888718|Fexofenadine|fexofenadine|mesh-list
110119031|NCT01888718|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110119032|NCT01888718|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110119033|NCT01888718|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110119034|NCT01888718|Histamine Antagonists|histamine antagonists|mesh-ancestor
110119035|NCT01888718|Histamine Agents|histamine agents|mesh-ancestor
110119036|NCT01888718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110119037|NCT01888718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110119038|NCT01888718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110119039|NCT01888731|Lamotrigine|lamotrigine|mesh-list
110119040|NCT01888731|Anticonvulsants|anticonvulsants|mesh-ancestor
110222345|NCT00120744|Antipruritics|antipruritics|mesh-ancestor
110119042|NCT01888731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110119043|NCT01888731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110119044|NCT01888731|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110119045|NCT01888731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110119046|NCT01888731|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110119047|NCT01888731|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110119048|NCT01888731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110119049|NCT01888731|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110119050|NCT01888731|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110119051|NCT01888744|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
110119052|NCT01888744|Cetrorelix|cetrorelix|mesh-list
110119053|NCT01888744|Progesterone|progesterone|mesh-list
110119054|NCT01888744|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
110119055|NCT01888744|Ganirelix|ganirelix|mesh-list
110119056|NCT01888744|Progestins|progestins|mesh-ancestor
110119057|NCT01888744|Hormones|hormones|mesh-ancestor
110119058|NCT01888744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110119059|NCT01888744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110119060|NCT01888744|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110119061|NCT01888744|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110119062|NCT01888744|Fertility Agents|fertility agents|mesh-ancestor
110119063|NCT01888744|Hormone Antagonists|hormone antagonists|mesh-ancestor
110119064|NCT01888757|Lamotrigine|lamotrigine|mesh-list
110119065|NCT01888757|Anticonvulsants|anticonvulsants|mesh-ancestor
110119066|NCT01888757|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110119067|NCT01888757|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110119068|NCT01888757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110119069|NCT01888757|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110119070|NCT01888757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110119071|NCT01888757|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110119072|NCT01888757|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110119073|NCT01888757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110119074|NCT01888757|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110119075|NCT01888757|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110119076|NCT01888796|Linagliptin|linagliptin|mesh-list
110119077|NCT01888796|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110119078|NCT01888796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110119079|NCT01888796|Incretins|incretins|mesh-ancestor
110119080|NCT01888796|Hormones|hormones|mesh-ancestor
110119081|NCT01888796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110119082|NCT01888796|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110119083|NCT01888796|Protease Inhibitors|protease inhibitors|mesh-ancestor
110119084|NCT01888796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110119085|NCT01888796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110119086|NCT01888822|Ciprofloxacin|ciprofloxacin|mesh-list
110119087|NCT01888822|Ampicillin|ampicillin|mesh-list
110119088|NCT01888822|Sulbactam|sulbactam|mesh-list
110119089|NCT01888822|Sultamicillin|sultamicillin|mesh-list
110119090|NCT01888822|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110119091|NCT01888822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110119092|NCT01888822|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110119093|NCT01888822|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110119094|NCT01888822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110119095|NCT01888822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110119096|NCT01888822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110119097|NCT01888822|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110119098|NCT01888822|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110119099|NCT01888822|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110119100|NCT01888835|Mirtazapine|mirtazapine|mesh-list
110119101|NCT01888835|Antidepressive Agents|antidepressive agents|mesh-ancestor
110119103|NCT01888835|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110119104|NCT01888835|Histamine Antagonists|histamine antagonists|mesh-ancestor
110119106|NCT01888835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110119107|NCT01888835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110119108|NCT01888835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110119109|NCT01888835|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110119110|NCT01888835|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110119111|NCT01888835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110119112|NCT01888835|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
110119113|NCT01888835|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110119114|NCT01888835|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110119115|NCT01888835|Adrenergic Agents|adrenergic agents|mesh-ancestor
110119116|NCT01888835|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110119117|NCT01888835|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110119118|NCT01888835|Serotonin Agents|serotonin agents|mesh-ancestor
110119119|NCT01888835|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110119120|NCT01888861|Thioctic Acid|thioctic acid|mesh-list
110119121|NCT01888861|Antioxidants|antioxidants|mesh-ancestor
110119122|NCT01888861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110119123|NCT01888861|Protective Agents|protective agents|mesh-ancestor
110119124|NCT01888861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110119125|NCT01888861|Vitamin B Complex|vitamin b complex|mesh-ancestor
110119126|NCT01888861|Vitamins|vitamins|mesh-ancestor
110119127|NCT01888861|Micronutrients|micronutrients|mesh-ancestor
110119128|NCT01888978|Leucovorin|leucovorin|mesh-list
110119129|NCT01888978|Gemcitabine|gemcitabine|mesh-list
110119130|NCT01888978|Fluorouracil|fluorouracil|mesh-list
110119131|NCT01888978|Docetaxel|docetaxel|mesh-list
110119132|NCT01888978|Oxaliplatin|oxaliplatin|mesh-list
110119133|NCT01888978|Irinotecan|irinotecan|mesh-list
110119134|NCT01888978|Levoleucovorin|levoleucovorin|mesh-list
110222492|NCT00120861|Interferons|interferons|mesh-list
110119135|NCT01888978|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110119136|NCT01888978|Antimetabolites|antimetabolites|mesh-ancestor
110119137|NCT01888978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110119138|NCT01888978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110119139|NCT01888978|Tubulin Modulators|tubulin modulators|mesh-ancestor
110119140|NCT01888978|Antimitotic Agents|antimitotic agents|mesh-ancestor
110119141|NCT01888978|Mitosis Modulators|mitosis modulators|mesh-ancestor
110119142|NCT01888978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110119143|NCT01888978|Immunologic Factors|immunologic factors|mesh-ancestor
110119144|NCT01888978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110119145|NCT01888978|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110119146|NCT01888978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110119147|NCT01888978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110119148|NCT01888978|Antidotes|antidotes|mesh-ancestor
110119149|NCT01888978|Protective Agents|protective agents|mesh-ancestor
110119150|NCT01888978|Vitamin B Complex|vitamin b complex|mesh-ancestor
110119152|NCT01888978|Micronutrients|micronutrients|mesh-ancestor
110119153|NCT01889004|Dexmedetomidine|dexmedetomidine|mesh-list
110119154|NCT01889004|Propofol|propofol|mesh-list
110119155|NCT01889004|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110119156|NCT01889004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110119157|NCT01889004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110119158|NCT01889004|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110119159|NCT01889004|Analgesics|analgesics|mesh-ancestor
110119160|NCT01889004|Sensory System Agents|sensory system agents|mesh-ancestor
110119161|NCT01889004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110119162|NCT01889004|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110119163|NCT01889004|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110119164|NCT01889004|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110119165|NCT01889004|Adrenergic Agents|adrenergic agents|mesh-ancestor
110119166|NCT01889004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110119167|NCT01889004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110119168|NCT01889004|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110119169|NCT01889004|Anesthetics, General|anesthetics, general|mesh-ancestor
110119170|NCT01889004|Anesthetics|anesthetics|mesh-ancestor
110119171|NCT01889056|Epoetin Alfa|epoetin alfa|mesh-list
110119172|NCT01889056|Hematinics|hematinics|mesh-ancestor
110119173|NCT01889095|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
110119174|NCT01889095|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110119175|NCT01889095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110119176|NCT01889134|Alendronate|alendronate|mesh-list
110119177|NCT01889134|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110119178|NCT01889134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110119180|NCT01889173|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110119181|NCT01889173|Antidepressive Agents|antidepressive agents|mesh-ancestor
110119182|NCT01889173|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110119183|NCT01889173|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110119184|NCT01889173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110119185|NCT01889173|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110119186|NCT01889173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110119187|NCT01889173|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110119188|NCT01889173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110119189|NCT01889212|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110119190|NCT01889212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110119191|NCT01889212|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110119192|NCT01889212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110119193|NCT01889212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110119194|NCT01889290|Methylnaltrexone|methylnaltrexone|mesh-list
110119195|NCT01889290|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110119196|NCT01889290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110119197|NCT01889290|Sensory System Agents|sensory system agents|mesh-ancestor
110119198|NCT01889290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110119199|NCT01889368|Grape Seed Extract|grape seed extract|mesh-list
110119200|NCT01889368|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110119201|NCT01889368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110119202|NCT01889368|Antioxidants|antioxidants|mesh-ancestor
110119203|NCT01889368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110119204|NCT01889368|Protective Agents|protective agents|mesh-ancestor
110119205|NCT01889368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110119206|NCT01889407|Idarubicin|idarubicin|mesh-list
110119207|NCT01889407|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110119208|NCT01889407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110119209|NCT01889407|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110119210|NCT01889407|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110119211|NCT01889407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110119212|NCT01889407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110119213|NCT01889433|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110119214|NCT01889433|Antiviral Agents|antiviral agents|mesh-ancestor
110119215|NCT01889433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110119216|NCT01889446|Calcium|calcium|mesh-list
110119217|NCT01889446|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110119218|NCT01889446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110119219|NCT01889498|Acetazolamide|acetazolamide|mesh-list
110119220|NCT01889498|Anticonvulsants|anticonvulsants|mesh-ancestor
110119221|NCT01889498|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110119222|NCT01889498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110119223|NCT01889498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110119224|NCT01889498|Diuretics|diuretics|mesh-ancestor
110119225|NCT01889498|Natriuretic Agents|natriuretic agents|mesh-ancestor
110119226|NCT01889498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110119227|NCT01889576|Magnesium Oxide|magnesium oxide|mesh-list
110119228|NCT01889576|Antacids|antacids|mesh-ancestor
110119229|NCT01889576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110119230|NCT01889576|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110119231|NCT01889680|Leucovorin|leucovorin|mesh-list
110119232|NCT01889680|Fluorouracil|fluorouracil|mesh-list
110119233|NCT01889680|Oxaliplatin|oxaliplatin|mesh-list
110119234|NCT01889680|Aflibercept|aflibercept|mesh-list
110119235|NCT01889680|Levoleucovorin|levoleucovorin|mesh-list
110119236|NCT01889680|Antimetabolites|antimetabolites|mesh-ancestor
110119237|NCT01889680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110119238|NCT01889680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110119239|NCT01889680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110119240|NCT01889680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110119241|NCT01889680|Immunologic Factors|immunologic factors|mesh-ancestor
110119242|NCT01889680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110119243|NCT01889680|Antidotes|antidotes|mesh-ancestor
110119244|NCT01889680|Protective Agents|protective agents|mesh-ancestor
110119245|NCT01889680|Vitamin B Complex|vitamin b complex|mesh-ancestor
110119246|NCT01889680|Vitamins|vitamins|mesh-ancestor
110119247|NCT01889680|Micronutrients|micronutrients|mesh-ancestor
110119248|NCT01889680|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110119249|NCT01889680|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110163196|NCT00117013|Topotecan|topotecan|mesh-list
110119250|NCT01889680|Growth Substances|growth substances|mesh-ancestor
110119251|NCT01889680|Growth Inhibitors|growth inhibitors|mesh-ancestor
110119252|NCT01889758|Tacrolimus|tacrolimus|mesh-list
110119253|NCT01889758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110119254|NCT01889758|Immunologic Factors|immunologic factors|mesh-ancestor
110119255|NCT01889758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110119256|NCT01889758|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110119257|NCT01889758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110119258|NCT01889758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110119259|NCT01889771|Nicotine|nicotine|mesh-list
110119260|NCT01889771|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110119261|NCT01889771|Autonomic Agents|autonomic agents|mesh-ancestor
110119262|NCT01889771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110119263|NCT01889771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110119264|NCT01889771|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110119265|NCT01889771|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110119266|NCT01889771|Cholinergic Agents|cholinergic agents|mesh-ancestor
110119267|NCT01889771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110119268|NCT01889771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110222587|NCT00308971|Vitamin E|vitamin e|mesh-list
110119269|NCT01889849|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110119270|NCT01889849|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110119271|NCT01889849|Antiviral Agents|antiviral agents|mesh-ancestor
110119272|NCT01889849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110119273|NCT01889914|Insulin|insulin|mesh-list
110119274|NCT01889914|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110119275|NCT01889914|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110119276|NCT01889914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110119277|NCT01889966|Sildenafil Citrate|sildenafil citrate|mesh-list
110119278|NCT01889966|Vasodilator Agents|vasodilator agents|mesh-ancestor
110119279|NCT01889966|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110119280|NCT01889966|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110119281|NCT01889966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110119282|NCT01889966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110119283|NCT01889966|Urological Agents|urological agents|mesh-ancestor
110119284|NCT01889979|Tramadol|tramadol|mesh-list
110119285|NCT01889979|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110119286|NCT01889979|Narcotics|narcotics|mesh-ancestor
110119287|NCT01889979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110119288|NCT01889979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110119289|NCT01889979|Analgesics|analgesics|mesh-ancestor
110119290|NCT01889979|Sensory System Agents|sensory system agents|mesh-ancestor
110119291|NCT01889979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110119292|NCT01890538|Dimenhydrinate|dimenhydrinate|mesh-list
110119293|NCT01890538|Piracetam|piracetam|mesh-list
110119294|NCT01890538|Antiemetics|antiemetics|mesh-ancestor
110119295|NCT01890538|Autonomic Agents|autonomic agents|mesh-ancestor
110119296|NCT01890538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110119297|NCT01890538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110119298|NCT01890538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110119299|NCT01890538|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110119300|NCT01890538|Histamine Antagonists|histamine antagonists|mesh-ancestor
110119301|NCT01890538|Histamine Agents|histamine agents|mesh-ancestor
110119302|NCT01890538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110119303|NCT01890538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110119304|NCT01890538|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110119305|NCT01890538|Protective Agents|protective agents|mesh-ancestor
110119306|NCT01890538|Nootropic Agents|nootropic agents|mesh-ancestor
110119307|NCT01891292|Acetylcysteine|acetylcysteine|mesh-list
110119308|NCT01891292|Enalapril|enalapril|mesh-list
110119309|NCT01891292|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110119310|NCT01891292|Antiviral Agents|antiviral agents|mesh-ancestor
110119311|NCT01891292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110119312|NCT01891292|Expectorants|expectorants|mesh-ancestor
110119313|NCT01891292|Respiratory System Agents|respiratory system agents|mesh-ancestor
110119314|NCT01891292|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110119315|NCT01891292|Antioxidants|antioxidants|mesh-ancestor
110119316|NCT01891292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110119317|NCT01891292|Protective Agents|protective agents|mesh-ancestor
110119318|NCT01891292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110119319|NCT01891292|Antidotes|antidotes|mesh-ancestor
110119320|NCT01891292|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110119321|NCT01891292|Protease Inhibitors|protease inhibitors|mesh-ancestor
110119322|NCT01891292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110119323|NCT01891292|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110119324|NCT01891487|Bimatoprost|bimatoprost|mesh-list
110119325|NCT01891487|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110119326|NCT01891981|Immunotoxin HA22|immunotoxin ha22|mesh-list
110119327|NCT01891981|Immunotoxins|immunotoxins|mesh-ancestor
110119328|NCT01891981|Immunoconjugates|immunoconjugates|mesh-ancestor
110119329|NCT01891981|Immunologic Factors|immunologic factors|mesh-ancestor
110119330|NCT01891981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110119331|NCT01891981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110222628|NCT00309205|Dapivirine|dapivirine|mesh-list
110119333|NCT01892319|Hypoglycemic Agents|hypoglycemic agents|mesh-list
110119334|NCT01892319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110119335|NCT01893229|Oxcarbazepine|oxcarbazepine|mesh-list
110119336|NCT01893229|Valproic Acid|valproic acid|mesh-list
110119337|NCT01893229|Olanzapine|olanzapine|mesh-list
110119338|NCT01893229|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110119339|NCT01893229|Ziprasidone|ziprasidone|mesh-list
110119340|NCT01893229|Lithium Carbonate|lithium carbonate|mesh-list
110119341|NCT01893229|Antiemetics|antiemetics|mesh-ancestor
110119342|NCT01893229|Autonomic Agents|autonomic agents|mesh-ancestor
110119343|NCT01893229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110119344|NCT01893229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110119345|NCT01893229|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110119346|NCT01893229|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110119347|NCT01893229|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110119348|NCT01893229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110119349|NCT01893229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110119350|NCT01893229|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110119351|NCT01893229|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110119352|NCT01893229|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110260164|NCT00168870|Antimetabolites|antimetabolites|mesh-ancestor
110119353|NCT01893229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110119354|NCT01893229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110119355|NCT01893229|Serotonin Agents|serotonin agents|mesh-ancestor
110119356|NCT01893229|Antidepressive Agents|antidepressive agents|mesh-ancestor
110119357|NCT01893229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110119358|NCT01893229|Antimanic Agents|antimanic agents|mesh-ancestor
110119359|NCT01893229|Anticonvulsants|anticonvulsants|mesh-ancestor
110119360|NCT01893229|GABA Agents|gaba agents|mesh-ancestor
110119361|NCT01893229|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110119362|NCT01893229|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110119363|NCT01893229|Dopamine Agents|dopamine agents|mesh-ancestor
110119364|NCT01893229|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110119365|NCT01893229|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110119366|NCT01893229|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110119367|NCT01893229|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110119368|NCT01894269|Lamivudine|lamivudine|mesh-list
110119369|NCT01894269|Entecavir|entecavir|mesh-list
110119370|NCT01894269|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110119371|NCT01894269|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110119372|NCT01894269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110119373|NCT01894269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110119374|NCT01894269|Antiviral Agents|antiviral agents|mesh-ancestor
110163222|NCT00117208|Diuretics|diuretics|mesh-ancestor
110119375|NCT01894269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110119376|NCT01894269|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110119377|NCT01894269|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110119378|NCT01894789|Clopidogrel|clopidogrel|mesh-list
110119379|NCT01894789|Ticagrelor|ticagrelor|mesh-list
110119380|NCT01894789|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110119381|NCT01894789|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110119382|NCT01894789|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110119383|NCT01894789|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110119384|NCT01894789|Purinergic Agents|purinergic agents|mesh-ancestor
110119385|NCT01894789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110119386|NCT01894789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110222633|NCT00309283|Somatostatin|somatostatin|mesh-list
110119387|NCT01894789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110119389|NCT01894815|Citalopram|citalopram|mesh-list
110119390|NCT01894815|Escitalopram|escitalopram|mesh-list
110119391|NCT01894815|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110119392|NCT01894815|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110119393|NCT01894815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110119394|NCT01894815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110119395|NCT01894815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110119396|NCT01894815|Serotonin Agents|serotonin agents|mesh-ancestor
110119397|NCT01894815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110119398|NCT01894815|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110119399|NCT01894815|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110119400|NCT01894815|Parasympatholytics|parasympatholytics|mesh-ancestor
110119401|NCT01894815|Autonomic Agents|autonomic agents|mesh-ancestor
110119402|NCT01894815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110119403|NCT01894815|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110119404|NCT01894815|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110119405|NCT01894815|Cholinergic Agents|cholinergic agents|mesh-ancestor
110119406|NCT01894815|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110119407|NCT01894815|Antidepressive Agents|antidepressive agents|mesh-ancestor
110119408|NCT01894815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110119409|NCT01895049|Mycophenolic Acid|mycophenolic acid|mesh-list
110119410|NCT01895049|Prednisone|prednisone|mesh-list
110119411|NCT01895049|Everolimus|everolimus|mesh-list
110119412|NCT01895049|Tacrolimus|tacrolimus|mesh-list
110119413|NCT01895049|Thymoglobulin|thymoglobulin|mesh-list
110119414|NCT01895049|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110119415|NCT01895049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110119416|NCT01895049|Glucocorticoids|glucocorticoids|mesh-ancestor
110119417|NCT01895049|Hormones|hormones|mesh-ancestor
110119418|NCT01895049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110119419|NCT01895049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110119420|NCT01895049|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110119421|NCT01895049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110119422|NCT01895049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110119423|NCT01895049|Immunologic Factors|immunologic factors|mesh-ancestor
110119424|NCT01895049|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110119425|NCT01895049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110119426|NCT01895049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110119427|NCT01895049|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110119428|NCT01895049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110119429|NCT01895049|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110119430|NCT01895049|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110119431|NCT01895049|Antitubercular Agents|antitubercular agents|mesh-ancestor
110119432|NCT01895049|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110163232|NCT00388427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110119434|NCT01896622|Ritonavir|ritonavir|mesh-list
110119435|NCT01896622|Cobicistat|cobicistat|mesh-list
110119436|NCT01896622|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110119437|NCT01896622|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110119438|NCT01896622|Protease Inhibitors|protease inhibitors|mesh-ancestor
110119439|NCT01896622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110119440|NCT01896622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110119441|NCT01896622|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110119442|NCT01896622|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110119443|NCT01896622|Antiviral Agents|antiviral agents|mesh-ancestor
110119444|NCT01896622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110119445|NCT01896622|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110119446|NCT01896622|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110119447|NCT01897051|Rifaximin|rifaximin|mesh-list
110119448|NCT01897051|Propranolol|propranolol|mesh-list
110119449|NCT01897051|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110119450|NCT01897051|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110119452|NCT01897051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110119453|NCT01897051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110119454|NCT01897051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110119455|NCT01897051|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110119456|NCT01897051|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110119457|NCT01897051|Vasodilator Agents|vasodilator agents|mesh-ancestor
110119458|NCT01897051|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110119459|NCT01897051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110119460|NCT01897051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110119461|NCT01897740|Sildenafil Citrate|sildenafil citrate|mesh-list
110119462|NCT01897740|Vasodilator Agents|vasodilator agents|mesh-ancestor
110119463|NCT01897740|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110119464|NCT01897740|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110119465|NCT01897740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110119466|NCT01897740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110119467|NCT01897740|Urological Agents|urological agents|mesh-ancestor
110119468|NCT01897753|Hormones|hormones|mesh-list
110119469|NCT01897753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110119470|NCT01897753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110119471|NCT01898065|Misonidazole|misonidazole|mesh-list
110119472|NCT01898065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110119473|NCT01898065|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110119474|NCT01898065|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110119475|NCT01898065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110119476|NCT01898221|Ethanol|ethanol|mesh-list
110119477|NCT01898221|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110119478|NCT01898221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110119479|NCT01898221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110119480|NCT01898221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110119481|NCT01898338|Daptomycin|daptomycin|mesh-list
110119482|NCT01898338|Fosfomycin|fosfomycin|mesh-list
110119483|NCT01898338|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110119484|NCT01898338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110119485|NCT01899105|Ivacaftor|ivacaftor|mesh-list
110119486|NCT01899105|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
110119487|NCT01899105|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110119488|NCT01899105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110119489|NCT01900015|Efavirenz|efavirenz|mesh-list
110119490|NCT01900015|Raltegravir Potassium|raltegravir potassium|mesh-list
110119491|NCT01900015|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110119492|NCT01900015|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110119493|NCT01900015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110119494|NCT01900015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110119495|NCT01900015|Antiviral Agents|antiviral agents|mesh-ancestor
110119496|NCT01900015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110119497|NCT01900015|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110119499|NCT01900015|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110119500|NCT01900015|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110119501|NCT01900015|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110119502|NCT01900015|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110119503|NCT01900015|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110119504|NCT01900015|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110119505|NCT01900015|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110119506|NCT01900015|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110119507|NCT01900028|Itraconazole|itraconazole|mesh-list
110119508|NCT01900028|Olaparib|olaparib|mesh-list
110119509|NCT01900028|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110119510|NCT01900028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110119511|NCT01900028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110119512|NCT01900028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110119513|NCT01900028|Antifungal Agents|antifungal agents|mesh-ancestor
110119514|NCT01900028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110119515|NCT01900028|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110119516|NCT01900028|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110119517|NCT01900028|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110119518|NCT01900028|Hormone Antagonists|hormone antagonists|mesh-ancestor
110119519|NCT01900028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110119520|NCT01900028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110119521|NCT01900028|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110119523|NCT01900041|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110119524|NCT01900041|Vasodilator Agents|vasodilator agents|mesh-ancestor
110119525|NCT01900093|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
110119526|NCT01900093|Hormones|hormones|mesh-ancestor
110119527|NCT01900093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110119528|NCT01900093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110119529|NCT01900106|Ritonavir|ritonavir|mesh-list
110119530|NCT01900106|Darunavir|darunavir|mesh-list
110119531|NCT01900106|Lamivudine|lamivudine|mesh-list
110119532|NCT01900106|Raltegravir Potassium|raltegravir potassium|mesh-list
110119533|NCT01900106|Abacavir|abacavir|mesh-list
110119534|NCT01900106|Dideoxynucleosides|dideoxynucleosides|mesh-list
110119535|NCT01900106|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110119536|NCT01900106|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110119537|NCT01900106|Protease Inhibitors|protease inhibitors|mesh-ancestor
110119538|NCT01900106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110119539|NCT01900106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110119540|NCT01900106|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110119541|NCT01900106|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110119542|NCT01900106|Antiviral Agents|antiviral agents|mesh-ancestor
110119543|NCT01900106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110119544|NCT01900106|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110119545|NCT01900106|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110119546|NCT01900106|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110119547|NCT01900106|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110119548|NCT01900106|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110119549|NCT01900106|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110119550|NCT01900106|Antimetabolites|antimetabolites|mesh-ancestor
110119552|NCT01900158|Gemcitabine|gemcitabine|mesh-list
110119553|NCT01900158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110119554|NCT01900158|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110119555|NCT01900158|Antimetabolites|antimetabolites|mesh-ancestor
110119556|NCT01900158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110119557|NCT01900197|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
110119558|NCT01900197|Hematinics|hematinics|mesh-ancestor
110119559|NCT01900301|Scopolamine|scopolamine|mesh-list
110119560|NCT01900301|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
110119561|NCT01900301|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110119562|NCT01900301|Antiemetics|antiemetics|mesh-ancestor
110119563|NCT01900301|Autonomic Agents|autonomic agents|mesh-ancestor
110119564|NCT01900301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110119565|NCT01900301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110119566|NCT01900301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110119567|NCT01900301|Mydriatics|mydriatics|mesh-ancestor
110119568|NCT01900301|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110119569|NCT01900301|Cholinergic Agents|cholinergic agents|mesh-ancestor
110119570|NCT01900301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110119571|NCT01900301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110119572|NCT01900301|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110119573|NCT01900301|Parasympatholytics|parasympatholytics|mesh-ancestor
110119574|NCT01900327|Gemcitabine|gemcitabine|mesh-list
110119575|NCT01900327|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110119576|NCT01900327|Antimetabolites|antimetabolites|mesh-ancestor
110119577|NCT01900327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110119578|NCT01900327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110119579|NCT01900405|Dexmedetomidine|dexmedetomidine|mesh-list
110119580|NCT01900405|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110119581|NCT01900405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110119582|NCT01900405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110119583|NCT01900405|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110119584|NCT01900405|Analgesics|analgesics|mesh-ancestor
110119585|NCT01900405|Sensory System Agents|sensory system agents|mesh-ancestor
110119586|NCT01900405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110119587|NCT01900405|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110119588|NCT01900405|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110119589|NCT01900405|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110119590|NCT01900405|Adrenergic Agents|adrenergic agents|mesh-ancestor
110119591|NCT01900405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110163292|NCT00117832|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110119592|NCT01900405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110119594|NCT01900496|Brentuximab Vedotin|brentuximab vedotin|mesh-list
110119595|NCT01900496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110119596|NCT01900496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110119597|NCT01900496|Immunologic Factors|immunologic factors|mesh-ancestor
110119598|NCT01900496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110119599|NCT01900496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110119600|NCT01900496|Immunotoxins|immunotoxins|mesh-ancestor
110119601|NCT01900496|Immunoconjugates|immunoconjugates|mesh-ancestor
110119602|NCT01900509|Dexamethasone|dexamethasone|mesh-list
110119603|NCT01900509|Etoposide|etoposide|mesh-list
110119604|NCT01900509|Etoposide phosphate|etoposide phosphate|mesh-list
110119605|NCT01900509|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110119606|NCT01900509|Clofarabine|clofarabine|mesh-list
110119607|NCT01900509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110119608|NCT01900509|Antiemetics|antiemetics|mesh-ancestor
110119609|NCT01900509|Autonomic Agents|autonomic agents|mesh-ancestor
110119610|NCT01900509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110119611|NCT01900509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110119612|NCT01900509|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110119613|NCT01900509|Glucocorticoids|glucocorticoids|mesh-ancestor
110119615|NCT01900509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110119616|NCT01900509|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110119617|NCT01900509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110119618|NCT01900509|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110119619|NCT01900509|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110119620|NCT01900509|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110119621|NCT01900509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110119622|NCT01900509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110119623|NCT01900509|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110119624|NCT01900509|Alkylating Agents|alkylating agents|mesh-ancestor
110119625|NCT01900509|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110119626|NCT01900509|Antimetabolites|antimetabolites|mesh-ancestor
110119627|NCT01900587|Tapentadol|tapentadol|mesh-list
110119628|NCT01900587|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110119629|NCT01900587|Narcotics|narcotics|mesh-ancestor
110119630|NCT01900587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110119631|NCT01900587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110119632|NCT01900587|Analgesics|analgesics|mesh-ancestor
110119633|NCT01900587|Sensory System Agents|sensory system agents|mesh-ancestor
110119634|NCT01900587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110119635|NCT01900587|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110119636|NCT01900587|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110119637|NCT01900587|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110119638|NCT01900587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110119639|NCT01900587|Adrenergic Agents|adrenergic agents|mesh-ancestor
110119640|NCT01900587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110119641|NCT01900639|Aspirin|aspirin|mesh-list
110119642|NCT01900639|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110119643|NCT01900639|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110119644|NCT01900639|Analgesics|analgesics|mesh-ancestor
110222687|NCT00309517|Leucovorin|leucovorin|mesh-list
110119645|NCT01900639|Sensory System Agents|sensory system agents|mesh-ancestor
110119646|NCT01900639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110119647|NCT01900639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110119648|NCT01900639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110119649|NCT01900639|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110119650|NCT01900639|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110163314|NCT00118066|Calcitriol|calcitriol|mesh-list
110119651|NCT01900639|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110119652|NCT01900639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110119653|NCT01900639|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110119654|NCT01900639|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110119655|NCT01900639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110119656|NCT01900639|Antipyretics|antipyretics|mesh-ancestor
110119657|NCT01900717|Leucovorin|leucovorin|mesh-list
110119658|NCT01900717|Bevacizumab|bevacizumab|mesh-list
110119659|NCT01900717|Fluorouracil|fluorouracil|mesh-list
110119660|NCT01900717|Oxaliplatin|oxaliplatin|mesh-list
110119661|NCT01900717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110119662|NCT01900717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110119663|NCT01900717|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110119664|NCT01900717|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110119665|NCT01900717|Growth Substances|growth substances|mesh-ancestor
110119666|NCT01900717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110119667|NCT01900717|Growth Inhibitors|growth inhibitors|mesh-ancestor
110119668|NCT01900717|Antimetabolites|antimetabolites|mesh-ancestor
110119669|NCT01900717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110119670|NCT01900717|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110119671|NCT01900717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110119672|NCT01900717|Immunologic Factors|immunologic factors|mesh-ancestor
110119673|NCT01900717|Antidotes|antidotes|mesh-ancestor
110119674|NCT01900717|Protective Agents|protective agents|mesh-ancestor
110119675|NCT01900717|Vitamin B Complex|vitamin b complex|mesh-ancestor
110119676|NCT01900717|Vitamins|vitamins|mesh-ancestor
110119677|NCT01900717|Micronutrients|micronutrients|mesh-ancestor
110119678|NCT01900795|Ibuprofen|ibuprofen|mesh-list
110119679|NCT01900795|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110119680|NCT01900795|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110119681|NCT01900795|Analgesics|analgesics|mesh-ancestor
110119682|NCT01900795|Sensory System Agents|sensory system agents|mesh-ancestor
110119683|NCT01900795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110119684|NCT01900795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110119685|NCT01900795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110119686|NCT01900795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110119687|NCT01900795|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110119688|NCT01900795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110119689|NCT01900795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110119690|NCT01900860|Vitamin D|vitamin d|mesh-list
110119691|NCT01900860|Ergocalciferols|ergocalciferols|mesh-list
110119692|NCT01900860|Cholecalciferol|cholecalciferol|mesh-list
110119693|NCT01900860|Vitamins|vitamins|mesh-list
110119694|NCT01900860|Micronutrients|micronutrients|mesh-ancestor
110119695|NCT01900860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110119696|NCT01900860|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110119697|NCT01900860|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110119698|NCT01900886|Ribavirin|ribavirin|mesh-list
110222689|NCT00309517|Antidotes|antidotes|mesh-ancestor
110119699|NCT01900886|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110119700|NCT01900886|Antimetabolites|antimetabolites|mesh-ancestor
110119701|NCT01900886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110119702|NCT01900886|Antiviral Agents|antiviral agents|mesh-ancestor
110119703|NCT01900886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110119705|NCT01900938|Propofol|propofol|mesh-list
110119706|NCT01900938|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110119707|NCT01900938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110119708|NCT01900938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110119709|NCT01900938|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110119710|NCT01900938|Anesthetics, General|anesthetics, general|mesh-ancestor
110119711|NCT01900938|Anesthetics|anesthetics|mesh-ancestor
110119712|NCT01900938|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110119713|NCT01900938|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110119714|NCT01900938|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110119715|NCT01900938|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110119716|NCT01900938|GABA Modulators|gaba modulators|mesh-ancestor
110119717|NCT01900938|GABA Agents|gaba agents|mesh-ancestor
110119718|NCT01900938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110119719|NCT01900938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110119720|NCT01900951|Temozolomide|temozolomide|mesh-list
110119721|NCT01900951|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110119722|NCT01900951|Alkylating Agents|alkylating agents|mesh-ancestor
110119723|NCT01900951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110119724|NCT01900951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110119726|NCT01901003|Anticonvulsants|anticonvulsants|mesh-ancestor
110119727|NCT01901003|Antiemetics|antiemetics|mesh-ancestor
110119728|NCT01901003|Autonomic Agents|autonomic agents|mesh-ancestor
110119729|NCT01901003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110119730|NCT01901003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110119731|NCT01901003|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110119732|NCT01901003|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110119733|NCT01901003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110119734|NCT01901003|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110119735|NCT01901003|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110119736|NCT01901003|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110119737|NCT01901003|GABA Modulators|gaba modulators|mesh-ancestor
110119738|NCT01901003|GABA Agents|gaba agents|mesh-ancestor
110119739|NCT01901003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110119740|NCT01901003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110119741|NCT01901120|Mirabegron|mirabegron|mesh-list
110119742|NCT01901120|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
110119743|NCT01901120|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110119744|NCT01901120|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110119745|NCT01901120|Adrenergic Agents|adrenergic agents|mesh-ancestor
110119746|NCT01901120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110119747|NCT01901120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110119748|NCT01901120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110119749|NCT01901120|Urological Agents|urological agents|mesh-ancestor
110119750|NCT01901172|Posaconazole|posaconazole|mesh-list
110119751|NCT01901172|Antifungal Agents|antifungal agents|mesh-ancestor
110119752|NCT01901172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110119753|NCT01901172|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
110119754|NCT01901172|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110119755|NCT01901172|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110119756|NCT01901172|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110119757|NCT01901172|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110222710|NCT00121017|Antiviral Agents|antiviral agents|mesh-ancestor
110119758|NCT01901172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110119759|NCT01901172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110119760|NCT01901172|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110119762|NCT01901172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110119763|NCT01901172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110119764|NCT01901198|Interferons|interferons|mesh-list
110119765|NCT01901198|Interferon-alpha|interferon-alpha|mesh-list
110119766|NCT01901198|Interferon alpha-2|interferon alpha-2|mesh-list
110119767|NCT01901198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110119768|NCT01901198|Antiviral Agents|antiviral agents|mesh-ancestor
110119769|NCT01901198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110119770|NCT01901198|Immunologic Factors|immunologic factors|mesh-ancestor
110119771|NCT01901198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110119773|NCT01901276|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110119774|NCT01901276|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110119775|NCT01901276|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110119776|NCT01901276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110119777|NCT01901276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110119778|NCT01901380|Caseins|caseins|mesh-list
110119779|NCT01901380|Chelating Agents|chelating agents|mesh-ancestor
110119780|NCT01901380|Sequestering Agents|sequestering agents|mesh-ancestor
110119781|NCT01901380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110119782|NCT01901432|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
110119783|NCT01901432|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110119784|NCT01901432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110119785|NCT01901432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110119786|NCT01901471|Cyclosporine|cyclosporine|mesh-list
110119787|NCT01901471|Cyclosporins|cyclosporins|mesh-list
110119788|NCT01901471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110119789|NCT01901471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110119790|NCT01901471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110119791|NCT01901471|Immunologic Factors|immunologic factors|mesh-ancestor
110119792|NCT01901471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110119793|NCT01901471|Antifungal Agents|antifungal agents|mesh-ancestor
110119794|NCT01901471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110119795|NCT01901471|Dermatologic Agents|dermatologic agents|mesh-ancestor
110119796|NCT01901471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110119797|NCT01901471|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110119798|NCT01901484|Praziquantel|praziquantel|mesh-list
110119799|NCT01901484|Anthelmintics|anthelmintics|mesh-ancestor
110119800|NCT01901484|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110119801|NCT01901484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110119802|NCT01901549|Metoprolol|metoprolol|mesh-list
110119803|NCT01901549|Lisinopril|lisinopril|mesh-list
110119804|NCT01901549|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110119805|NCT01901549|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110119806|NCT01901549|Sympatholytics|sympatholytics|mesh-ancestor
110119807|NCT01901549|Autonomic Agents|autonomic agents|mesh-ancestor
110119808|NCT01901549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110119809|NCT01901549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110119810|NCT01901549|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110119811|NCT01901549|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110119812|NCT01901549|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110119813|NCT01901549|Adrenergic Agents|adrenergic agents|mesh-ancestor
110119814|NCT01901549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110119815|NCT01901549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110119816|NCT01901549|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110119817|NCT01901549|Protease Inhibitors|protease inhibitors|mesh-ancestor
110119818|NCT01901549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110119819|NCT01901549|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110119820|NCT01901549|Protective Agents|protective agents|mesh-ancestor
110119821|NCT01901601|Anesthetics|anesthetics|mesh-list
110119822|NCT01901601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110119823|NCT01901601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110119824|NCT01901640|Udenafil|udenafil|mesh-list
110119825|NCT01901640|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110119826|NCT01901640|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110119827|NCT01901640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110119828|NCT01901640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110119829|NCT01901666|Hormones|hormones|mesh-list
110119830|NCT01901666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110119831|NCT01901666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110119832|NCT01901692|Sorafenib|sorafenib|mesh-list
110119833|NCT01901692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110119834|NCT01901692|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110119835|NCT01901692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110119836|NCT01901692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110119837|NCT01902017|Ketotifen|ketotifen|mesh-list
110119838|NCT01902017|Antipruritics|antipruritics|mesh-ancestor
110119839|NCT01902017|Dermatologic Agents|dermatologic agents|mesh-ancestor
110119840|NCT01902017|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110119841|NCT01902017|Histamine Antagonists|histamine antagonists|mesh-ancestor
110119842|NCT01902017|Histamine Agents|histamine agents|mesh-ancestor
110119843|NCT01902017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110119844|NCT01902017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110119845|NCT01902017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110119846|NCT01902017|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110119847|NCT01902108|Clonidine|clonidine|mesh-list
110119848|NCT01902108|Bupivacaine|bupivacaine|mesh-list
110119849|NCT01902108|Anesthetics, Local|anesthetics, local|mesh-ancestor
110119850|NCT01902108|Anesthetics|anesthetics|mesh-ancestor
110119851|NCT01902108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110119852|NCT01902108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110119853|NCT01902108|Sensory System Agents|sensory system agents|mesh-ancestor
110119854|NCT01902108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110119855|NCT01902108|Analgesics|analgesics|mesh-ancestor
110119856|NCT01902108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110119857|NCT01902108|Sympatholytics|sympatholytics|mesh-ancestor
110119858|NCT01902108|Autonomic Agents|autonomic agents|mesh-ancestor
110119859|NCT01902108|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110119860|NCT01902108|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110119861|NCT01902108|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110119862|NCT01902108|Adrenergic Agents|adrenergic agents|mesh-ancestor
110119863|NCT01902108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110119864|NCT01902108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110119865|NCT01902121|Insulin|insulin|mesh-list
110119866|NCT01902121|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110119867|NCT01902121|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110119868|NCT01902121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110119869|NCT01902160|Sirolimus|sirolimus|mesh-list
110119870|NCT01902160|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110119871|NCT01902160|Brentuximab Vedotin|brentuximab vedotin|mesh-list
110119872|NCT01902160|Temsirolimus|temsirolimus|mesh-list
110119873|NCT01902160|MTOR Inhibitors|mtor inhibitors|mesh-list
110119874|NCT01902160|Antibodies|antibodies|mesh-list
110119875|NCT01902160|Immunoglobulins|immunoglobulins|mesh-list
110119876|NCT01902160|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110119877|NCT01902160|Immunoconjugates|immunoconjugates|mesh-list
110119878|NCT01902160|Immunologic Factors|immunologic factors|mesh-ancestor
110119879|NCT01902160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110119880|NCT01902160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110119881|NCT01902160|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110119882|NCT01902160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110119883|NCT01902160|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110119884|NCT01902160|Antifungal Agents|antifungal agents|mesh-ancestor
110119885|NCT01902160|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110119886|NCT01902160|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110119887|NCT01902160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110119888|NCT01902160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110119889|NCT01902160|Immunotoxins|immunotoxins|mesh-ancestor
110119891|NCT01902186|Atazanavir Sulfate|atazanavir sulfate|mesh-list
110119892|NCT01902186|Tenofovir|tenofovir|mesh-list
110119893|NCT01902186|Emtricitabine|emtricitabine|mesh-list
110119894|NCT01902186|Raltegravir Potassium|raltegravir potassium|mesh-list
110119895|NCT01902186|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110119896|NCT01902186|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110119897|NCT01902186|Protease Inhibitors|protease inhibitors|mesh-ancestor
110119898|NCT01902186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110119899|NCT01902186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110119900|NCT01902186|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110119901|NCT01902186|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110119902|NCT01902186|Antiviral Agents|antiviral agents|mesh-ancestor
110119903|NCT01902186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110119904|NCT01902186|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110119905|NCT01902186|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110119906|NCT01902186|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110119907|NCT01902186|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110119908|NCT01902186|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110119909|NCT01902186|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110119910|NCT01901861|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110119911|NCT01901861|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110119912|NCT01901861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110119914|NCT01901861|Hormones|hormones|mesh-ancestor
110119915|NCT01901861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110119916|NCT01901861|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110119917|NCT01901861|Protease Inhibitors|protease inhibitors|mesh-ancestor
110119918|NCT01901861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110119919|NCT01901861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110119920|NCT01902225|Doxorubicin|doxorubicin|mesh-list
110119921|NCT01902225|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110119922|NCT01902225|Romidepsin|romidepsin|mesh-list
110119923|NCT01902225|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110119924|NCT01902225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110119925|NCT01902225|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110119926|NCT01902225|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110119927|NCT01902225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110119928|NCT01902225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110119929|NCT01902225|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110119930|NCT01902238|Ethanol|ethanol|mesh-list
110119931|NCT01902238|Ethiodized Oil|ethiodized oil|mesh-list
110222755|NCT00309634|Vaccines|vaccines|mesh-list
110119932|NCT01902238|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110119933|NCT01902238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110119934|NCT01902238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110119935|NCT01902238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110119936|NCT01902238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110119937|NCT01902342|Oseltamivir|oseltamivir|mesh-list
110119938|NCT01902342|Antiviral Agents|antiviral agents|mesh-ancestor
110119939|NCT01902342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110119940|NCT01902342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110119941|NCT01902342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110119942|NCT01902446|Chlorhexidine|chlorhexidine|mesh-list
110119943|NCT01902446|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110119944|NCT01902446|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110119945|NCT01902446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110119946|NCT01902446|Disinfectants|disinfectants|mesh-ancestor
110119947|NCT01902446|Dermatologic Agents|dermatologic agents|mesh-ancestor
110119948|NCT01902485|Contraceptive Agents|contraceptive agents|mesh-list
110119949|NCT01902485|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110119950|NCT01902485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110119951|NCT01902498|Aspirin|aspirin|mesh-list
110119952|NCT01902498|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110119953|NCT01902498|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110119954|NCT01902498|Analgesics|analgesics|mesh-ancestor
110119955|NCT01902498|Sensory System Agents|sensory system agents|mesh-ancestor
110119956|NCT01902498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110119957|NCT01902498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110119958|NCT01902498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110119959|NCT01902498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110119960|NCT01902498|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110119961|NCT01902498|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110119962|NCT01902498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110119963|NCT01902498|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110119964|NCT01902498|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110119965|NCT01902498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110119966|NCT01902498|Antipyretics|antipyretics|mesh-ancestor
110119967|NCT01902511|Epoetin Alfa|epoetin alfa|mesh-list
110119968|NCT01902511|Lenograstim|lenograstim|mesh-list
110119969|NCT01902511|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110119970|NCT01902511|Immunologic Factors|immunologic factors|mesh-ancestor
110119971|NCT01902511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110119972|NCT01902511|Hematinics|hematinics|mesh-ancestor
110119973|NCT01902524|Fentanyl|fentanyl|mesh-list
110119974|NCT01902524|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110119975|NCT01902524|Narcotics|narcotics|mesh-ancestor
110119976|NCT01902524|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110119977|NCT01902524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110119978|NCT01902524|Analgesics|analgesics|mesh-ancestor
110119979|NCT01902524|Sensory System Agents|sensory system agents|mesh-ancestor
110119980|NCT01902524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110119982|NCT01902524|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110119983|NCT01902524|Anesthetics, General|anesthetics, general|mesh-ancestor
110119984|NCT01902524|Anesthetics|anesthetics|mesh-ancestor
110119985|NCT01902537|Prucalopride|prucalopride|mesh-list
110119986|NCT01902537|Laxatives|laxatives|mesh-ancestor
110119987|NCT01902537|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110119988|NCT01902537|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
110119989|NCT01902537|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110119990|NCT01902537|Serotonin Agents|serotonin agents|mesh-ancestor
110119991|NCT01902537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110119992|NCT01902537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110119993|NCT01902537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110119994|NCT01902550|Metoprolol|metoprolol|mesh-list
110119995|NCT01902550|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110119996|NCT01902550|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110119997|NCT01902550|Sympatholytics|sympatholytics|mesh-ancestor
110119998|NCT01902550|Autonomic Agents|autonomic agents|mesh-ancestor
110119999|NCT01902550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110120000|NCT01902550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110120001|NCT01902550|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110120002|NCT01902550|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110120003|NCT01902550|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110120004|NCT01902550|Adrenergic Agents|adrenergic agents|mesh-ancestor
110120005|NCT01902550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110120006|NCT01902550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110120007|NCT01902641|Rocuronium|rocuronium|mesh-list
110120008|NCT01902641|Succinylcholine|succinylcholine|mesh-list
110120009|NCT01902641|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110120010|NCT01902641|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110120011|NCT01902641|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110120012|NCT01902641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110120013|NCT01902641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110120014|NCT01902641|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
110120015|NCT01902771|Imiquimod|imiquimod|mesh-list
110120016|NCT01902771|Vaccines|vaccines|mesh-list
110120017|NCT01902771|Immunologic Factors|immunologic factors|mesh-ancestor
110120018|NCT01902771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110120019|NCT01902771|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110120020|NCT01902771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110120021|NCT01902771|Interferon Inducers|interferon inducers|mesh-ancestor
110120022|NCT01902810|Propranolol|propranolol|mesh-list
110120023|NCT01902810|Metoprolol|metoprolol|mesh-list
110120024|NCT01902810|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110120025|NCT01902810|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110120026|NCT01902810|Adrenergic Agents|adrenergic agents|mesh-ancestor
110120027|NCT01902810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110120028|NCT01902810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110120029|NCT01902810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110120030|NCT01902810|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110120031|NCT01902810|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110120032|NCT01902810|Vasodilator Agents|vasodilator agents|mesh-ancestor
110120033|NCT01902810|Sympatholytics|sympatholytics|mesh-ancestor
110120034|NCT01902810|Autonomic Agents|autonomic agents|mesh-ancestor
110120035|NCT01902810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110120036|NCT01902810|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110120037|NCT01902862|Rituximab|rituximab|mesh-list
110120038|NCT01902862|Bortezomib|bortezomib|mesh-list
110120039|NCT01902862|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110120040|NCT01902862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110120041|NCT01902862|Immunologic Factors|immunologic factors|mesh-ancestor
110120042|NCT01902862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110120043|NCT01902862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110120044|NCT01902875|Paclitaxel|paclitaxel|mesh-list
110120045|NCT01902875|Cisplatin|cisplatin|mesh-list
110120046|NCT01902875|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110120047|NCT01902875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110120048|NCT01902875|Tubulin Modulators|tubulin modulators|mesh-ancestor
110120049|NCT01902875|Antimitotic Agents|antimitotic agents|mesh-ancestor
110120050|NCT01902875|Mitosis Modulators|mitosis modulators|mesh-ancestor
110120051|NCT01902875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110222799|NCT00310141|Nicotine|nicotine|mesh-list
110120053|NCT01903018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110120054|NCT01903057|Azithromycin|azithromycin|mesh-list
110120055|NCT01903057|Ivermectin|ivermectin|mesh-list
110120056|NCT01903057|Albendazole|albendazole|mesh-list
110120057|NCT01903057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110120058|NCT01903057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110120059|NCT01903057|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110120061|NCT01903057|Anticestodal Agents|anticestodal agents|mesh-ancestor
110120062|NCT01903057|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110120063|NCT01903057|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110120064|NCT01903057|Tubulin Modulators|tubulin modulators|mesh-ancestor
110120065|NCT01903057|Antimitotic Agents|antimitotic agents|mesh-ancestor
110120066|NCT01903057|Mitosis Modulators|mitosis modulators|mesh-ancestor
110120067|NCT01903057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110120068|NCT01903057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110120069|NCT01903070|Linagliptin|linagliptin|mesh-list
110120070|NCT01903070|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110120071|NCT01903070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110120072|NCT01903070|Incretins|incretins|mesh-ancestor
110120073|NCT01903070|Hormones|hormones|mesh-ancestor
110120074|NCT01903070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110120075|NCT01903070|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110120076|NCT01903070|Protease Inhibitors|protease inhibitors|mesh-ancestor
110120077|NCT01903070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110120078|NCT01903070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110120079|NCT01903083|Gemcitabine|gemcitabine|mesh-list
110120080|NCT01903083|Tadalafil|tadalafil|mesh-list
110120081|NCT01903083|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110120082|NCT01903083|Antimetabolites|antimetabolites|mesh-ancestor
110120083|NCT01903083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110120084|NCT01903083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110120085|NCT01903083|Vasodilator Agents|vasodilator agents|mesh-ancestor
110120086|NCT01903083|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110120087|NCT01903083|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110120088|NCT01903083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110120089|NCT01903083|Urological Agents|urological agents|mesh-ancestor
110120090|NCT01903096|Antidepressive Agents|antidepressive agents|mesh-list
110120091|NCT01903096|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110120092|NCT01903109|Cevimeline|cevimeline|mesh-list
110120093|NCT01903109|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110120094|NCT01903109|Autonomic Agents|autonomic agents|mesh-ancestor
110120095|NCT01903109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110120096|NCT01903109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110120097|NCT01903109|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
110120098|NCT01903109|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110120099|NCT01903109|Cholinergic Agents|cholinergic agents|mesh-ancestor
110120100|NCT01903109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110120101|NCT01903109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110120102|NCT01903122|Cevimeline|cevimeline|mesh-list
110120103|NCT01903122|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110120104|NCT01903122|Autonomic Agents|autonomic agents|mesh-ancestor
110120105|NCT01903122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110120106|NCT01903122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110120107|NCT01903122|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
110120108|NCT01903122|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110120109|NCT01903122|Cholinergic Agents|cholinergic agents|mesh-ancestor
110120110|NCT01903122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110120111|NCT01903122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110120112|NCT01903200|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110120113|NCT01903200|Antidepressive Agents|antidepressive agents|mesh-ancestor
110120114|NCT01903200|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110120115|NCT01903200|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110120116|NCT01903200|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110120117|NCT01903200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110222815|NCT00083681|Thalidomide|thalidomide|mesh-list
110120118|NCT01903200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110120119|NCT01903278|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110120120|NCT01903278|Antiviral Agents|antiviral agents|mesh-ancestor
110120121|NCT01903278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110120122|NCT01903291|Dimethyl Fumarate|dimethyl fumarate|mesh-list
110120123|NCT01903291|Dermatologic Agents|dermatologic agents|mesh-ancestor
110120124|NCT01903291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110120125|NCT01903291|Immunologic Factors|immunologic factors|mesh-ancestor
110120126|NCT01903291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110120127|NCT01903681|Melatonin|melatonin|mesh-list
110120128|NCT01903681|Antioxidants|antioxidants|mesh-ancestor
110120129|NCT01903681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110120130|NCT01903681|Protective Agents|protective agents|mesh-ancestor
110120131|NCT01903681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110120132|NCT01903681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110120133|NCT01903694|Sorafenib|sorafenib|mesh-list
110120134|NCT01903694|Pravastatin|pravastatin|mesh-list
110120135|NCT01903694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110120136|NCT01903694|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110120137|NCT01903694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110120138|NCT01903694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110120139|NCT01903694|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110120140|NCT01903694|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110120141|NCT01903694|Antimetabolites|antimetabolites|mesh-ancestor
110120142|NCT01903694|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110120143|NCT01903694|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110120144|NCT01903785|Albuterol|albuterol|mesh-list
110120145|NCT01903785|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110120146|NCT01903785|Autonomic Agents|autonomic agents|mesh-ancestor
110120147|NCT01903785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110120148|NCT01903785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110120149|NCT01903785|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110120150|NCT01903785|Respiratory System Agents|respiratory system agents|mesh-ancestor
110120151|NCT01903785|Tocolytic Agents|tocolytic agents|mesh-ancestor
110120152|NCT01903785|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110120153|NCT01903785|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110120154|NCT01903785|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110120155|NCT01903785|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110120156|NCT01903785|Adrenergic Agents|adrenergic agents|mesh-ancestor
110120157|NCT01903785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110120158|NCT01903785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110120159|NCT01903824|Modafinil|modafinil|mesh-list
110120160|NCT01903824|Donepezil|donepezil|mesh-list
110120161|NCT01903824|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110120162|NCT01903824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110120163|NCT01903824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110120164|NCT01903824|Cholinergic Agents|cholinergic agents|mesh-ancestor
110120165|NCT01903824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110120166|NCT01903824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110163478|NCT00118963|Metformin|metformin|mesh-list
110120167|NCT01903824|Nootropic Agents|nootropic agents|mesh-ancestor
110120168|NCT01903824|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110120169|NCT01903824|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
110120170|NCT01903824|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110120171|NCT01903824|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110120172|NCT01904045|Tacrolimus|tacrolimus|mesh-list
110120173|NCT01904045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110120174|NCT01904045|Immunologic Factors|immunologic factors|mesh-ancestor
110120175|NCT01904045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110120176|NCT01904045|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110120177|NCT01904045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110120178|NCT01904045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110120179|NCT01904097|Pregabalin|pregabalin|mesh-list
110120180|NCT01904097|Analgesics|analgesics|mesh-ancestor
110120181|NCT01904097|Sensory System Agents|sensory system agents|mesh-ancestor
110120182|NCT01904097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110120183|NCT01904097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110120184|NCT01904097|Anticonvulsants|anticonvulsants|mesh-ancestor
110120185|NCT01904097|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110120186|NCT01904097|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110120187|NCT01904097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110120188|NCT01904097|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110120190|NCT01904097|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110120191|NCT01904097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110120192|NCT01904097|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110120193|NCT01904110|Cholecalciferol|cholecalciferol|mesh-list
110120194|NCT01904110|Vitamin D|vitamin d|mesh-list
110120195|NCT01904110|Risedronic Acid|risedronic acid|mesh-list
110120196|NCT01904110|Etidronic Acid|etidronic acid|mesh-list
110120197|NCT01904110|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110120198|NCT01904110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110120199|NCT01904110|Vitamins|vitamins|mesh-ancestor
110120200|NCT01904110|Micronutrients|micronutrients|mesh-ancestor
110120201|NCT01904110|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110120202|NCT01904110|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110120203|NCT01904110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110120204|NCT01904110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110120205|NCT01904162|Finafloxacin|finafloxacin|mesh-list
110120206|NCT01904162|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110120207|NCT01904162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110120208|NCT01904162|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110120209|NCT01904162|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110120210|NCT01904162|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110120211|NCT01904162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110120212|NCT01904162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110120213|NCT01904162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110120215|NCT01904214|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
110120216|NCT01904214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110120217|NCT01904214|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110120218|NCT01904214|Immunologic Factors|immunologic factors|mesh-ancestor
110120219|NCT01904214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110120220|NCT01904253|Topotecan|topotecan|mesh-list
110120221|NCT01904253|Amrubicin|amrubicin|mesh-list
110120222|NCT01904253|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110120223|NCT01904253|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110120224|NCT01904253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110120225|NCT01904253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110120226|NCT01904253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110120227|NCT01904357|Cefazolin|cefazolin|mesh-list
110120228|NCT01904357|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110120229|NCT01904357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110120230|NCT01904487|Tiagabine|tiagabine|mesh-list
110120231|NCT01904487|Flumazenil|flumazenil|mesh-list
110120232|NCT01904487|Antidotes|antidotes|mesh-ancestor
110120233|NCT01904487|Protective Agents|protective agents|mesh-ancestor
110120234|NCT01904487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110120235|NCT01904487|GABA Modulators|gaba modulators|mesh-ancestor
110120236|NCT01904487|GABA Agents|gaba agents|mesh-ancestor
110120237|NCT01904487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110120238|NCT01904487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110120239|NCT01904487|Anticonvulsants|anticonvulsants|mesh-ancestor
110120240|NCT01904487|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
110120241|NCT01904487|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110120242|NCT01904487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110120243|NCT01904500|Cefazolin|cefazolin|mesh-list
110120244|NCT01904500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110120245|NCT01904500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110120246|NCT01904539|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
110120247|NCT01904539|Cathartics|cathartics|mesh-ancestor
110120248|NCT01904539|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110120249|NCT01904591|Vitamin E|vitamin e|mesh-list
110120250|NCT01904591|Selenium|selenium|mesh-list
110120251|NCT01904591|Vitamins|vitamins|mesh-ancestor
110120252|NCT01904591|Micronutrients|micronutrients|mesh-ancestor
110120253|NCT01904591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110120254|NCT01904591|Antioxidants|antioxidants|mesh-ancestor
110120255|NCT01904591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110120256|NCT01904591|Protective Agents|protective agents|mesh-ancestor
110120257|NCT01904591|Trace Elements|trace elements|mesh-ancestor
110120258|NCT01904643|Cytarabine|cytarabine|mesh-list
110120259|NCT01904643|Etoposide|etoposide|mesh-list
110120260|NCT01904643|Mitoxantrone|mitoxantrone|mesh-list
110120261|NCT01904643|Lenalidomide|lenalidomide|mesh-list
110120262|NCT01904643|Etoposide phosphate|etoposide phosphate|mesh-list
110120263|NCT01904643|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110120264|NCT01904643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110120265|NCT01904643|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110120266|NCT01904643|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110120267|NCT01904643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110120268|NCT01904643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110120269|NCT01904643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110120270|NCT01904643|Antimetabolites|antimetabolites|mesh-ancestor
110120271|NCT01904643|Antiviral Agents|antiviral agents|mesh-ancestor
110120272|NCT01904643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110120273|NCT01904643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110120274|NCT01904643|Immunologic Factors|immunologic factors|mesh-ancestor
110120275|NCT01904643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110120276|NCT01904643|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110120277|NCT01904643|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110120278|NCT01904643|Growth Substances|growth substances|mesh-ancestor
110120279|NCT01904643|Growth Inhibitors|growth inhibitors|mesh-ancestor
110120280|NCT01904643|Analgesics|analgesics|mesh-ancestor
110120282|NCT01904643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110120283|NCT01904682|ON 01910|on 01910|mesh-list
110120284|NCT01904682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110120285|NCT01904682|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110120286|NCT01904682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110120287|NCT01904682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110120288|NCT01904695|Antihypertensive Agents|antihypertensive agents|mesh-list
110120289|NCT01904695|Diuretics|diuretics|mesh-list
110120290|NCT01904695|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
110120291|NCT01904695|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
110120292|NCT01904695|Natriuretic Agents|natriuretic agents|mesh-ancestor
110120293|NCT01904695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110120294|NCT01904695|Protease Inhibitors|protease inhibitors|mesh-ancestor
110120295|NCT01904695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110120296|NCT01904695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110120297|NCT01904695|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110120298|NCT01904734|Clomiphene|clomiphene|mesh-list
110120299|NCT01904734|Enclomiphene|enclomiphene|mesh-list
110120300|NCT01904734|Zuclomiphene|zuclomiphene|mesh-list
110120301|NCT01904734|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110120302|NCT01904734|Hormone Antagonists|hormone antagonists|mesh-ancestor
110120303|NCT01904734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110120304|NCT01904734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110120305|NCT01904734|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110120306|NCT01904734|Fertility Agents|fertility agents|mesh-ancestor
110120307|NCT01904734|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110120308|NCT01904734|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110120309|NCT01904734|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110120310|NCT01904747|Palbociclib|palbociclib|mesh-list
110120311|NCT01904747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110120312|NCT01904747|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110120313|NCT01904747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110120314|NCT01904747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110120315|NCT01904786|Melatonin|melatonin|mesh-list
110120316|NCT01904786|Antioxidants|antioxidants|mesh-ancestor
110120317|NCT01904786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110120318|NCT01904786|Protective Agents|protective agents|mesh-ancestor
110120319|NCT01904786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110120320|NCT01904786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110120321|NCT01904981|Atenolol|atenolol|mesh-list
110120323|NCT01904981|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
110120324|NCT01904981|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
110120325|NCT01904981|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110120326|NCT01904981|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110120327|NCT01904981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110120328|NCT01904981|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110120329|NCT01904981|Adrenergic Agents|adrenergic agents|mesh-ancestor
110120330|NCT01904981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110120331|NCT01904981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110222888|NCT05568602|Hormones|hormones|mesh-ancestor
110222889|NCT05568602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110120332|NCT01904981|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110120333|NCT01904981|Sympatholytics|sympatholytics|mesh-ancestor
110120334|NCT01904981|Autonomic Agents|autonomic agents|mesh-ancestor
110120335|NCT01904981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110120336|NCT01904981|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110120337|NCT01904994|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
110120338|NCT01904994|Antiviral Agents|antiviral agents|mesh-ancestor
110120339|NCT01904994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110120341|NCT01905059|Lopinavir|lopinavir|mesh-list
110120342|NCT01905059|Darunavir|darunavir|mesh-list
110120343|NCT01905059|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
110120344|NCT01905059|Protease Inhibitors|protease inhibitors|mesh-list
110120345|NCT01905059|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110120346|NCT01905059|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110120347|NCT01905059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110120348|NCT01905059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110120349|NCT01905059|Antiviral Agents|antiviral agents|mesh-ancestor
110120350|NCT01905059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110120351|NCT01905059|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110120352|NCT01905059|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110120353|NCT01905059|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110120354|NCT01905059|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110120355|NCT01905059|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110120356|NCT01905137|Botulinum Toxins|botulinum toxins|mesh-list
110120357|NCT01905137|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110120358|NCT01905137|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110120359|NCT01905137|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110120360|NCT01905137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110120361|NCT01905137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110120362|NCT01905137|Cholinergic Agents|cholinergic agents|mesh-ancestor
110120363|NCT01905137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110120364|NCT01905137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110120365|NCT01905137|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110120366|NCT01905137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110120368|NCT01905150|Ascorbic Acid|ascorbic acid|mesh-list
110120369|NCT01905150|Gemcitabine|gemcitabine|mesh-list
110120370|NCT01905150|Fluorouracil|fluorouracil|mesh-list
110120371|NCT01905150|Docetaxel|docetaxel|mesh-list
110120372|NCT01905150|Oxaliplatin|oxaliplatin|mesh-list
110120373|NCT01905150|Irinotecan|irinotecan|mesh-list
110120374|NCT01905150|Mitomycins|mitomycins|mesh-list
110120375|NCT01905150|Mitomycin|mitomycin|mesh-list
110120376|NCT01905150|Levoleucovorin|levoleucovorin|mesh-list
110120377|NCT01905150|Vitamins|vitamins|mesh-ancestor
110120378|NCT01905150|Micronutrients|micronutrients|mesh-ancestor
110120379|NCT01905150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110120380|NCT01905150|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110120382|NCT01905150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110120383|NCT01905150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110120384|NCT01905150|Tubulin Modulators|tubulin modulators|mesh-ancestor
110120385|NCT01905150|Antimitotic Agents|antimitotic agents|mesh-ancestor
110120386|NCT01905150|Mitosis Modulators|mitosis modulators|mesh-ancestor
110120387|NCT01905150|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110120388|NCT01905150|Immunologic Factors|immunologic factors|mesh-ancestor
110120389|NCT01905150|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110120390|NCT01905150|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110120391|NCT01905150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110120393|NCT01905150|Protective Agents|protective agents|mesh-ancestor
110120394|NCT01905150|Vitamin B Complex|vitamin b complex|mesh-ancestor
110120395|NCT01905150|Antioxidants|antioxidants|mesh-ancestor
110120396|NCT01905150|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110120397|NCT01905150|Alkylating Agents|alkylating agents|mesh-ancestor
110120398|NCT01905150|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110120399|NCT01905215|Vaccines|vaccines|mesh-list
110120400|NCT01905215|Immunologic Factors|immunologic factors|mesh-ancestor
110120401|NCT01905215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110120402|NCT01905371|Amphetamine|amphetamine|mesh-list
110120403|NCT01905371|Dextroamphetamine|dextroamphetamine|mesh-list
110120404|NCT01905371|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110120405|NCT01905371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110120406|NCT01905371|Sympathomimetics|sympathomimetics|mesh-ancestor
110120407|NCT01905371|Autonomic Agents|autonomic agents|mesh-ancestor
110120408|NCT01905371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110120409|NCT01905371|Dopamine Agents|dopamine agents|mesh-ancestor
110120410|NCT01905371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110120411|NCT01905371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110120413|NCT01905371|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110120414|NCT01905371|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110120415|NCT01905371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110120416|NCT01905371|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110120417|NCT01905501|Anesthetics|anesthetics|mesh-list
110120418|NCT01905501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110120419|NCT01905501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110120420|NCT01905566|Clopidogrel|clopidogrel|mesh-list
110120421|NCT01905566|Ticagrelor|ticagrelor|mesh-list
110120422|NCT01905566|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110120423|NCT01905566|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110120424|NCT01905566|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110120425|NCT01905566|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110120426|NCT01905566|Purinergic Agents|purinergic agents|mesh-ancestor
110120427|NCT01905566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110120428|NCT01905566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110120429|NCT01905566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110120430|NCT01905618|Nicotine|nicotine|mesh-list
110120431|NCT01905618|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110120432|NCT01905618|Autonomic Agents|autonomic agents|mesh-ancestor
110120433|NCT01905618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110120434|NCT01905618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110120435|NCT01905618|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110120436|NCT01905618|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110120437|NCT01905618|Cholinergic Agents|cholinergic agents|mesh-ancestor
110120438|NCT01905618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110120439|NCT01905618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110120440|NCT01905696|Acetylcysteine|acetylcysteine|mesh-list
110120441|NCT01905696|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110120442|NCT01905696|Antiviral Agents|antiviral agents|mesh-ancestor
110120443|NCT01905696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110120444|NCT01905696|Expectorants|expectorants|mesh-ancestor
110120445|NCT01905696|Respiratory System Agents|respiratory system agents|mesh-ancestor
110120446|NCT01905696|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110120447|NCT01905696|Antioxidants|antioxidants|mesh-ancestor
110120448|NCT01905696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110120450|NCT01905696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110120451|NCT01905696|Antidotes|antidotes|mesh-ancestor
110120452|NCT01905774|Deferasirox|deferasirox|mesh-list
110120453|NCT01905774|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110120454|NCT01905774|Chelating Agents|chelating agents|mesh-ancestor
110120455|NCT01905774|Sequestering Agents|sequestering agents|mesh-ancestor
110120456|NCT01905774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110120458|NCT01905904|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110120459|NCT01905904|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110120460|NCT01905904|Anesthetics, General|anesthetics, general|mesh-ancestor
110120461|NCT01905904|Anesthetics|anesthetics|mesh-ancestor
110120462|NCT01905904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110120463|NCT01905904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110120464|NCT01906073|Fentanyl|fentanyl|mesh-list
110120465|NCT01906073|Morphine|morphine|mesh-list
110120466|NCT01906073|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110120467|NCT01906073|Narcotics|narcotics|mesh-ancestor
110120468|NCT01906073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110120469|NCT01906073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110120470|NCT01906073|Analgesics|analgesics|mesh-ancestor
110120471|NCT01906073|Sensory System Agents|sensory system agents|mesh-ancestor
110120472|NCT01906073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110120473|NCT01906073|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110120474|NCT01906073|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110120475|NCT01906073|Anesthetics, General|anesthetics, general|mesh-ancestor
110120476|NCT01906073|Anesthetics|anesthetics|mesh-ancestor
110120477|NCT01906125|Palbociclib|palbociclib|mesh-list
110120478|NCT01906125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110120479|NCT01906125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110120480|NCT01906125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110120481|NCT01906125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110120482|NCT01906216|Sorafenib|sorafenib|mesh-list
110120483|NCT01906216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110120484|NCT01906216|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110120485|NCT01906216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110120486|NCT01906216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110120487|NCT01906242|Chlorhexidine|chlorhexidine|mesh-list
110120488|NCT01906242|Sodium Hypochlorite|sodium hypochlorite|mesh-list
110120489|NCT01906242|Eusol|eusol|mesh-list
110120490|NCT01906242|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110120491|NCT01906242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110120492|NCT01906242|Disinfectants|disinfectants|mesh-ancestor
110120493|NCT01906294|Hypoglycemic Agents|hypoglycemic agents|mesh-list
110120494|NCT01906294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110120495|NCT01906307|Angiotensin II|angiotensin ii|mesh-list
110120496|NCT01906307|Giapreza|giapreza|mesh-list
110120497|NCT01906307|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110120498|NCT01906411|Dopamine|dopamine|mesh-list
110120499|NCT01906411|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110120500|NCT01906411|Sympathomimetics|sympathomimetics|mesh-ancestor
110120501|NCT01906411|Autonomic Agents|autonomic agents|mesh-ancestor
110120502|NCT01906411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110120503|NCT01906411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110120504|NCT01906411|Dopamine Agents|dopamine agents|mesh-ancestor
110120505|NCT01906411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110120506|NCT01906411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110120507|NCT01906411|Protective Agents|protective agents|mesh-ancestor
110120509|NCT01906450|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110120510|NCT01906450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110120511|NCT01906528|Mivacurium|mivacurium|mesh-list
110120512|NCT01906528|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110120513|NCT01906528|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110163582|NCT00402181|Siltuximab|siltuximab|mesh-list
110120514|NCT01906528|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110120515|NCT01906528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110120516|NCT01906528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110120517|NCT01906580|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110120518|NCT01906580|Entecavir|entecavir|mesh-list
110120519|NCT01906580|Antiviral Agents|antiviral agents|mesh-ancestor
110120520|NCT01906580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110120521|NCT01906632|Immunomodulating Agents|immunomodulating agents|mesh-list
110120522|NCT01906632|Immunologic Factors|immunologic factors|mesh-ancestor
110120523|NCT01906632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110120524|NCT01906671|Mercaptopurine|mercaptopurine|mesh-list
110120525|NCT01906671|Antimetabolites|antimetabolites|mesh-ancestor
110120526|NCT01906671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110120527|NCT01906671|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110120528|NCT01906671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110120529|NCT01906671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110120530|NCT01906671|Immunologic Factors|immunologic factors|mesh-ancestor
110120531|NCT01906671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110120532|NCT01906671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110120533|NCT01906671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110120535|NCT01906749|Gout Suppressants|gout suppressants|mesh-ancestor
110120536|NCT01906749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110120537|NCT01906749|Tubulin Modulators|tubulin modulators|mesh-ancestor
110120538|NCT01906749|Antimitotic Agents|antimitotic agents|mesh-ancestor
110120539|NCT01906749|Mitosis Modulators|mitosis modulators|mesh-ancestor
110120540|NCT01906749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110120541|NCT01906749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110120542|NCT01906762|Acetaminophen|acetaminophen|mesh-list
110120543|NCT01906762|Morphine|morphine|mesh-list
110120544|NCT01906762|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110120545|NCT01906762|Narcotics|narcotics|mesh-ancestor
110120546|NCT01906762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110120547|NCT01906762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110120548|NCT01906762|Analgesics|analgesics|mesh-ancestor
110120549|NCT01906762|Sensory System Agents|sensory system agents|mesh-ancestor
110120550|NCT01906762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110120551|NCT01906762|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110120552|NCT01906762|Antipyretics|antipyretics|mesh-ancestor
110120553|NCT01906788|Lumefantrine|lumefantrine|mesh-list
110120554|NCT01906788|Artemether|artemether|mesh-list
110120555|NCT01906788|Primaquine|primaquine|mesh-list
110120556|NCT01906788|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
110120557|NCT01906788|Antimalarials|antimalarials|mesh-ancestor
110120558|NCT01906788|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110120559|NCT01906788|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110120560|NCT01906788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110120561|NCT01906801|Diacerein|diacerein|mesh-list
110120562|NCT01906801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110120563|NCT01906879|Bismuth|bismuth|mesh-list
110120564|NCT01906879|Antacids|antacids|mesh-ancestor
110120565|NCT01906879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110120566|NCT01906879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110120567|NCT01906944|Triamcinolone|triamcinolone|mesh-list
110120568|NCT01906944|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110120569|NCT01906944|Bupivacaine|bupivacaine|mesh-list
110120570|NCT01906944|Anesthetics, Local|anesthetics, local|mesh-ancestor
110120571|NCT01906944|Anesthetics|anesthetics|mesh-ancestor
110120572|NCT01906944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110120573|NCT01906944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110120574|NCT01906944|Sensory System Agents|sensory system agents|mesh-ancestor
110120575|NCT01906944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110120576|NCT01906944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110120577|NCT01906944|Glucocorticoids|glucocorticoids|mesh-ancestor
110120578|NCT01906944|Hormones|hormones|mesh-ancestor
110120579|NCT01906944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110120580|NCT01906944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110120581|NCT01906944|Immunologic Factors|immunologic factors|mesh-ancestor
110120582|NCT01907048|Rivaroxaban|rivaroxaban|mesh-list
110120583|NCT01907048|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110120584|NCT01907048|Antithrombins|antithrombins|mesh-ancestor
110120585|NCT01907048|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110120586|NCT01907048|Protease Inhibitors|protease inhibitors|mesh-ancestor
110120587|NCT01907048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110120588|NCT01907048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110120589|NCT01907048|Anticoagulants|anticoagulants|mesh-ancestor
110120590|NCT01907061|Acetylcysteine|acetylcysteine|mesh-list
110120591|NCT01907061|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110120592|NCT01907061|Antiviral Agents|antiviral agents|mesh-ancestor
110120593|NCT01907061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110120594|NCT01907061|Expectorants|expectorants|mesh-ancestor
110120595|NCT01907061|Respiratory System Agents|respiratory system agents|mesh-ancestor
110120596|NCT01907061|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110120597|NCT01907061|Antioxidants|antioxidants|mesh-ancestor
110120598|NCT01907061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110120599|NCT01907061|Protective Agents|protective agents|mesh-ancestor
110120600|NCT01907061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110120601|NCT01907061|Antidotes|antidotes|mesh-ancestor
110120602|NCT01907074|Cholic Acids|cholic acids|mesh-list
110120603|NCT01907074|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110120605|NCT01907165|Temozolomide|temozolomide|mesh-list
110120606|NCT01907165|Disulfiram|disulfiram|mesh-list
110120607|NCT01907165|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110120608|NCT01907165|Alkylating Agents|alkylating agents|mesh-ancestor
110120609|NCT01907165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110120610|NCT01907165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110120611|NCT01907165|Trace Elements|trace elements|mesh-ancestor
110120612|NCT01907165|Micronutrients|micronutrients|mesh-ancestor
110120613|NCT01907165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110120614|NCT01907165|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110120615|NCT01907165|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
110120616|NCT01907165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110120617|NCT01907204|Methylprednisolone|methylprednisolone|mesh-list
110120618|NCT01907204|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110120619|NCT01907204|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110120620|NCT01907204|Prednisolone|prednisolone|mesh-list
110120621|NCT01907204|Prednisolone acetate|prednisolone acetate|mesh-list
110120623|NCT01907204|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110120624|NCT01907204|Prednisolone phosphate|prednisolone phosphate|mesh-list
110120625|NCT01907204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110120626|NCT01907204|Antiemetics|antiemetics|mesh-ancestor
110120627|NCT01907204|Autonomic Agents|autonomic agents|mesh-ancestor
110120628|NCT01907204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110120629|NCT01907204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110222976|NCT00121329|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110120630|NCT01907204|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110120631|NCT01907204|Glucocorticoids|glucocorticoids|mesh-ancestor
110120633|NCT01907204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110120634|NCT01907204|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110120635|NCT01907204|Protective Agents|protective agents|mesh-ancestor
110120636|NCT01907204|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110120637|NCT01907204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110120638|NCT01907204|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110120639|NCT01907204|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110163622|NCT00120484|Hydroxocobalamin|hydroxocobalamin|mesh-list
110120640|NCT01907204|Respiratory System Agents|respiratory system agents|mesh-ancestor
110120641|NCT01907230|Entecavir|entecavir|mesh-list
110120642|NCT01907230|Antiviral Agents|antiviral agents|mesh-ancestor
110120643|NCT01907230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110120644|NCT01907308|Docetaxel|docetaxel|mesh-list
110120645|NCT01907308|Trebananib|trebananib|mesh-list
110120646|NCT01907308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110120647|NCT01907308|Tubulin Modulators|tubulin modulators|mesh-ancestor
110120648|NCT01907308|Antimitotic Agents|antimitotic agents|mesh-ancestor
110120649|NCT01907308|Mitosis Modulators|mitosis modulators|mesh-ancestor
110120650|NCT01907308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110120651|NCT01907308|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110120652|NCT01907308|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110120653|NCT01907308|Growth Substances|growth substances|mesh-ancestor
110120654|NCT01907308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110120655|NCT01907308|Growth Inhibitors|growth inhibitors|mesh-ancestor
110120656|NCT01907373|Probenecid|probenecid|mesh-list
110120657|NCT01907373|Olmesartan|olmesartan|mesh-list
110120658|NCT01907373|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
110120659|NCT01907373|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110120660|NCT01907373|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110120661|NCT01907373|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110120662|NCT01907373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110120663|NCT01907373|Uricosuric Agents|uricosuric agents|mesh-ancestor
110120664|NCT01907373|Gout Suppressants|gout suppressants|mesh-ancestor
110120665|NCT01907373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110120666|NCT01907529|Cyclophosphamide|cyclophosphamide|mesh-list
110120667|NCT01907529|Docetaxel|docetaxel|mesh-list
110120668|NCT01907529|Epirubicin|epirubicin|mesh-list
110120669|NCT01907529|Endostar protein|endostar protein|mesh-list
110120670|NCT01907529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110120671|NCT01907529|Immunologic Factors|immunologic factors|mesh-ancestor
110120672|NCT01907529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110222995|NCT00311116|Protective Agents|protective agents|mesh-ancestor
110120674|NCT01907529|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110120675|NCT01907529|Alkylating Agents|alkylating agents|mesh-ancestor
110120676|NCT01907529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110120677|NCT01907529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110120678|NCT01907529|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110120679|NCT01907529|Tubulin Modulators|tubulin modulators|mesh-ancestor
110120680|NCT01907529|Antimitotic Agents|antimitotic agents|mesh-ancestor
110120681|NCT01907529|Mitosis Modulators|mitosis modulators|mesh-ancestor
110120682|NCT01907529|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110120683|NCT01907529|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110120684|NCT01907529|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110120685|NCT01907529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110120686|NCT01907529|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110120687|NCT01907529|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110120688|NCT01907529|Growth Substances|growth substances|mesh-ancestor
110120689|NCT01907529|Growth Inhibitors|growth inhibitors|mesh-ancestor
110120690|NCT01907594|Cycloserine|cycloserine|mesh-list
110120691|NCT01907594|Nicotine|nicotine|mesh-list
110120692|NCT01907594|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110120693|NCT01907594|Autonomic Agents|autonomic agents|mesh-ancestor
110120694|NCT01907594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110120695|NCT01907594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110120696|NCT01907594|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110120697|NCT01907594|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110120698|NCT01907594|Cholinergic Agents|cholinergic agents|mesh-ancestor
110120699|NCT01907594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110120700|NCT01907594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110120701|NCT01907594|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110120702|NCT01907594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110120703|NCT01907594|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110120704|NCT01907594|Antitubercular Agents|antitubercular agents|mesh-ancestor
110120705|NCT01907594|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110120706|NCT01907594|Antimetabolites|antimetabolites|mesh-ancestor
110120707|NCT01907633|Domperidone|domperidone|mesh-list
110120708|NCT01907633|Antiemetics|antiemetics|mesh-ancestor
110120709|NCT01907633|Autonomic Agents|autonomic agents|mesh-ancestor
110120710|NCT01907633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110120711|NCT01907633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110120712|NCT01907633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110120713|NCT01907633|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110120714|NCT01907633|Dopamine Agents|dopamine agents|mesh-ancestor
110120715|NCT01907633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110120716|NCT01907633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110120717|NCT01907685|Docetaxel|docetaxel|mesh-list
110120718|NCT01907685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110120719|NCT01907685|Tubulin Modulators|tubulin modulators|mesh-ancestor
110120720|NCT01907685|Antimitotic Agents|antimitotic agents|mesh-ancestor
110120721|NCT01907685|Mitosis Modulators|mitosis modulators|mesh-ancestor
110120722|NCT01907685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110120724|NCT01907724|Antiviral Agents|antiviral agents|mesh-ancestor
110120725|NCT01907724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110120726|NCT01907724|Protease Inhibitors|protease inhibitors|mesh-ancestor
110120727|NCT01907724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110120728|NCT01907724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110120729|NCT01907776|Arbekacin|arbekacin|mesh-list
110120730|NCT01907776|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110120731|NCT01907776|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110120732|NCT01907776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110120733|NCT01907802|Dabrafenib|dabrafenib|mesh-list
110120734|NCT01907802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110120735|NCT01907802|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110120736|NCT01907802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110120737|NCT01907802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110120738|NCT01907867|Finafloxacin|finafloxacin|mesh-list
110120739|NCT01907867|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110120740|NCT01907867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110120741|NCT01907867|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110120742|NCT01907867|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110120743|NCT01907867|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110120744|NCT01907867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110120745|NCT01907867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110120746|NCT01907867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110120748|NCT01907880|Pamidronate|pamidronate|mesh-list
110120749|NCT01907880|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110120750|NCT01907880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110120751|NCT01907984|Diclofenac|diclofenac|mesh-list
110120752|NCT01907984|Midazolam|midazolam|mesh-list
110120753|NCT01907984|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110120754|NCT01907984|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110120755|NCT01907984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110120756|NCT01907984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110120757|NCT01907984|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110120758|NCT01907984|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110120759|NCT01907984|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110120760|NCT01907984|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110120761|NCT01907984|Anesthetics, General|anesthetics, general|mesh-ancestor
110120762|NCT01907984|Anesthetics|anesthetics|mesh-ancestor
110120763|NCT01907984|GABA Modulators|gaba modulators|mesh-ancestor
110120764|NCT01907984|GABA Agents|gaba agents|mesh-ancestor
110120765|NCT01907984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110120766|NCT01907984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110120767|NCT01907984|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110120768|NCT01907984|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110120769|NCT01907984|Analgesics|analgesics|mesh-ancestor
110120770|NCT01907984|Sensory System Agents|sensory system agents|mesh-ancestor
110120771|NCT01907984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110120772|NCT01907984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110120773|NCT01907984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110120774|NCT01907984|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110120775|NCT01907984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110120776|NCT01907997|Lidocaine|lidocaine|mesh-list
110120777|NCT01907997|Anesthetics, Local|anesthetics, local|mesh-ancestor
110120778|NCT01907997|Anesthetics|anesthetics|mesh-ancestor
110120779|NCT01907997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110120780|NCT01907997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110120781|NCT01907997|Sensory System Agents|sensory system agents|mesh-ancestor
110120782|NCT01907997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110120783|NCT01907997|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110120784|NCT01907997|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110120785|NCT01907997|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110120786|NCT01907997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110120787|NCT01907997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110120788|NCT01908075|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
110120789|NCT01908075|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110120790|NCT01908075|Autonomic Agents|autonomic agents|mesh-ancestor
110120791|NCT01908075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110120792|NCT01908075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110120793|NCT01908075|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110120794|NCT01908075|Respiratory System Agents|respiratory system agents|mesh-ancestor
110120795|NCT01908075|Glucocorticoids|glucocorticoids|mesh-ancestor
110120796|NCT01908075|Hormones|hormones|mesh-ancestor
110120797|NCT01908075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110120798|NCT01908075|Sympathomimetics|sympathomimetics|mesh-ancestor
110120799|NCT01908114|Vaccines|vaccines|mesh-list
110120800|NCT01908114|Immunologic Factors|immunologic factors|mesh-ancestor
110120801|NCT01908114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110120802|NCT01908257|Lesinurad|lesinurad|mesh-list
110120803|NCT01908257|Ranitidine|ranitidine|mesh-list
110120804|NCT01908257|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
110120805|NCT01908257|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110120806|NCT01908257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110120807|NCT01908257|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110120808|NCT01908257|Histamine Antagonists|histamine antagonists|mesh-ancestor
110120809|NCT01908257|Histamine Agents|histamine agents|mesh-ancestor
110120810|NCT01908257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110120811|NCT01908257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110120812|NCT01908257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110120813|NCT01908257|Gout Suppressants|gout suppressants|mesh-ancestor
110120814|NCT01908257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110120815|NCT01908257|Uricosuric Agents|uricosuric agents|mesh-ancestor
110120816|NCT01908283|Vaccines|vaccines|mesh-list
110120817|NCT01908283|Immunologic Factors|immunologic factors|mesh-ancestor
110120818|NCT01908283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110120819|NCT01908296|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110120820|NCT01908296|Fluvoxamine|fluvoxamine|mesh-list
110120821|NCT01908296|Antidepressive Agents|antidepressive agents|mesh-ancestor
110163663|NCT00120757|Alendronate|alendronate|mesh-list
110120822|NCT01908296|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110120823|NCT01908296|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110120824|NCT01908296|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110120825|NCT01908296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110120826|NCT01908296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110120827|NCT01908296|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110120828|NCT01908296|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110120829|NCT01908296|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110120830|NCT01908296|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110120831|NCT01908296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110120832|NCT01908296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110120833|NCT01908296|Serotonin Agents|serotonin agents|mesh-ancestor
110120834|NCT01908296|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110120835|NCT01908296|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110120836|NCT01908296|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110120837|NCT01908296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110120838|NCT01908296|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110120839|NCT01908322|Sorafenib|sorafenib|mesh-list
110120840|NCT01908322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110120841|NCT01908322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110120842|NCT01908322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110223065|NCT00089037|Dermatologic Agents|dermatologic agents|mesh-ancestor
110120843|NCT01908322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110120844|NCT01908335|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110120845|NCT01908335|Interferon-alpha|interferon-alpha|mesh-list
110120846|NCT01908335|Antiviral Agents|antiviral agents|mesh-ancestor
110120847|NCT01908335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110120848|NCT01908335|Immunologic Factors|immunologic factors|mesh-ancestor
110120849|NCT01908335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110120850|NCT01908348|Erythritol|erythritol|mesh-list
110120851|NCT01908348|Vasodilator Agents|vasodilator agents|mesh-ancestor
110120852|NCT01908387|Azacitidine|azacitidine|mesh-list
110120853|NCT01908387|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110120854|NCT01908387|Antimetabolites|antimetabolites|mesh-ancestor
110120855|NCT01908387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110120856|NCT01908387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110120857|NCT01908387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110120858|NCT01908452|Pyridoxine|pyridoxine|mesh-list
110120859|NCT01908452|Vitamin B Complex|vitamin b complex|mesh-ancestor
110120860|NCT01908452|Vitamins|vitamins|mesh-ancestor
110120861|NCT01908452|Micronutrients|micronutrients|mesh-ancestor
110120862|NCT01908452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110120863|NCT01908478|Gemcitabine|gemcitabine|mesh-list
110120864|NCT01908478|Veliparib|veliparib|mesh-list
110120865|NCT01908478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110120866|NCT01908478|Antimetabolites|antimetabolites|mesh-ancestor
110120867|NCT01908478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110120868|NCT01908478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110120869|NCT01908478|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110120870|NCT01908478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110120872|NCT01908556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110120873|NCT01908556|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110120874|NCT01908556|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110120875|NCT01908556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110120876|NCT01908556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110120877|NCT01908556|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110120878|NCT01908556|Hormone Antagonists|hormone antagonists|mesh-ancestor
110120879|NCT01908556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110120880|NCT01908556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110120881|NCT01908621|Cytarabine|cytarabine|mesh-list
110120882|NCT01908621|Lenograstim|lenograstim|mesh-list
110120883|NCT01908621|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110120884|NCT01908621|Immunologic Factors|immunologic factors|mesh-ancestor
110120885|NCT01908621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110120886|NCT01908621|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110120887|NCT01908621|Antimetabolites|antimetabolites|mesh-ancestor
110120888|NCT01908621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110120889|NCT01908621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110120890|NCT01908621|Antiviral Agents|antiviral agents|mesh-ancestor
110163671|NCT00120796|Antiviral Agents|antiviral agents|mesh-ancestor
110120891|NCT01908621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110120892|NCT01908621|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110120893|NCT01908660|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
110120895|NCT01908660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110120896|NCT01908894|Insulin Lispro|insulin lispro|mesh-list
110120897|NCT01908894|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110120898|NCT01908894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110120899|NCT01909037|Curcumin|curcumin|mesh-list
110120900|NCT01909037|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110120901|NCT01909037|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110120902|NCT01909037|Analgesics|analgesics|mesh-ancestor
110120903|NCT01909037|Sensory System Agents|sensory system agents|mesh-ancestor
110120904|NCT01909037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110120905|NCT01909037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110120906|NCT01909037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110120907|NCT01909037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110120908|NCT01909037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110120909|NCT01909037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110120910|NCT01909037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110120911|NCT01909063|Vitamin D|vitamin d|mesh-list
110120912|NCT01909063|Ergocalciferols|ergocalciferols|mesh-list
110120913|NCT01909063|Cholecalciferol|cholecalciferol|mesh-list
110120914|NCT01909063|Vitamins|vitamins|mesh-list
110120915|NCT01909063|Vitamin E|vitamin e|mesh-list
110120916|NCT01909063|Vitamin A|vitamin a|mesh-list
110120917|NCT01909063|Micronutrients|micronutrients|mesh-ancestor
110120918|NCT01909063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110120919|NCT01909063|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110120920|NCT01909063|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110120921|NCT01909063|Antioxidants|antioxidants|mesh-ancestor
110120922|NCT01909063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110120923|NCT01909063|Protective Agents|protective agents|mesh-ancestor
110120924|NCT01909115|Vitamin D|vitamin d|mesh-list
110120925|NCT01909115|Ergocalciferols|ergocalciferols|mesh-list
110120926|NCT01909115|Cholecalciferol|cholecalciferol|mesh-list
110120927|NCT01909115|Vitamins|vitamins|mesh-list
110120928|NCT01909115|Micronutrients|micronutrients|mesh-ancestor
110120929|NCT01909115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110120930|NCT01909115|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110120931|NCT01909115|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110120932|NCT01909219|Magnesium citrate|magnesium citrate|mesh-list
110120933|NCT01909219|Picosulfate sodium|picosulfate sodium|mesh-list
110120934|NCT01909219|Cathartics|cathartics|mesh-ancestor
110120935|NCT01909219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110120936|NCT01909557|Acetylcarnitine|acetylcarnitine|mesh-list
110120937|NCT01909557|Vitamin B Complex|vitamin b complex|mesh-ancestor
110120939|NCT01909557|Micronutrients|micronutrients|mesh-ancestor
110120940|NCT01909557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110120941|NCT01909557|Nootropic Agents|nootropic agents|mesh-ancestor
110120942|NCT01909622|Vitamin D|vitamin d|mesh-list
110120943|NCT01909622|Ergocalciferols|ergocalciferols|mesh-list
110120944|NCT01909622|Cholecalciferol|cholecalciferol|mesh-list
110120945|NCT01909622|Vitamins|vitamins|mesh-list
110120946|NCT01909622|Micronutrients|micronutrients|mesh-ancestor
110120947|NCT01909622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110120948|NCT01909622|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110120949|NCT01909622|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110120950|NCT01909661|Caseins|caseins|mesh-list
110120951|NCT01909661|Chelating Agents|chelating agents|mesh-ancestor
110120952|NCT01909661|Sequestering Agents|sequestering agents|mesh-ancestor
110120953|NCT01909661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110120954|NCT01909752|Cyclophosphamide|cyclophosphamide|mesh-list
110120955|NCT01909752|Imiquimod|imiquimod|mesh-list
110120956|NCT01909752|Vaccines|vaccines|mesh-list
110120957|NCT01909752|Immunologic Factors|immunologic factors|mesh-ancestor
110120958|NCT01909752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110120959|NCT01909752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110120960|NCT01909752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110120961|NCT01909752|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110120962|NCT01909752|Alkylating Agents|alkylating agents|mesh-ancestor
110120963|NCT01909752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110120964|NCT01909752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110120965|NCT01909752|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110120966|NCT01909752|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110120967|NCT01909752|Interferon Inducers|interferon inducers|mesh-ancestor
110120968|NCT01909830|Gemcitabine|gemcitabine|mesh-list
110120969|NCT01909830|Pemetrexed|pemetrexed|mesh-list
110120970|NCT01909830|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110120971|NCT01909830|Antimetabolites|antimetabolites|mesh-ancestor
110223088|NCT00311818|Insulin Glargine|insulin glargine|mesh-list
110223091|NCT00121407|Verteporfin|verteporfin|mesh-list
110120972|NCT01909830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110120973|NCT01909830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110120974|NCT01909830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110120975|NCT01909830|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110120976|NCT01909830|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110120977|NCT01909843|Gontivimab|gontivimab|mesh-list
110120978|NCT01909843|Antiviral Agents|antiviral agents|mesh-ancestor
110120979|NCT01909843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110120980|NCT01909856|Dexamethasone|dexamethasone|mesh-list
110120981|NCT01909856|Palonosetron|palonosetron|mesh-list
110120982|NCT01909856|Granisetron|granisetron|mesh-list
110120983|NCT01909856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110120984|NCT01909856|Antiemetics|antiemetics|mesh-ancestor
110120985|NCT01909856|Autonomic Agents|autonomic agents|mesh-ancestor
110120986|NCT01909856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110120987|NCT01909856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110120988|NCT01909856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110120989|NCT01909856|Glucocorticoids|glucocorticoids|mesh-ancestor
110120990|NCT01909856|Hormones|hormones|mesh-ancestor
110120991|NCT01909856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110120992|NCT01909856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110120993|NCT01909856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110120994|NCT01909856|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110120995|NCT01909856|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110120996|NCT01909856|Serotonin Agents|serotonin agents|mesh-ancestor
110120997|NCT01909856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110120998|NCT01909856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110120999|NCT01910077|Tacrolimus|tacrolimus|mesh-list
110121000|NCT01910077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110121001|NCT01910077|Immunologic Factors|immunologic factors|mesh-ancestor
110121002|NCT01910077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110121003|NCT01910077|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110121004|NCT01910077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110121005|NCT01910077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110121006|NCT01910090|Flurbiprofen|flurbiprofen|mesh-list
110121007|NCT01910090|Famotidine|famotidine|mesh-list
110121008|NCT01910090|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110121009|NCT01910090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110121010|NCT01910090|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110121011|NCT01910090|Histamine Antagonists|histamine antagonists|mesh-ancestor
110121012|NCT01910090|Histamine Agents|histamine agents|mesh-ancestor
110121013|NCT01910090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110121014|NCT01910090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110121015|NCT01910090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110121016|NCT01910090|Analgesics|analgesics|mesh-ancestor
110121017|NCT01910090|Sensory System Agents|sensory system agents|mesh-ancestor
110121018|NCT01910090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110121019|NCT01910090|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110121020|NCT01910090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110121021|NCT01910090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110121022|NCT01910090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110121023|NCT01910090|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110121024|NCT01910090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110121025|NCT01910142|Vitamin K|vitamin k|mesh-list
110121026|NCT01910142|Calcium|calcium|mesh-list
110121027|NCT01910142|Vitamins|vitamins|mesh-ancestor
110121028|NCT01910142|Micronutrients|micronutrients|mesh-ancestor
110121029|NCT01910142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110121030|NCT01910142|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110121031|NCT01910142|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110121032|NCT01910142|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110223103|NCT00121446|Enoxaparin|enoxaparin|mesh-list
110163679|NCT00120913|Contraceptives, Oral|contraceptives, oral|mesh-list
110121033|NCT01910142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110121035|NCT01910142|Coagulants|coagulants|mesh-ancestor
110121036|NCT01910155|Ciprofloxacin|ciprofloxacin|mesh-list
110121037|NCT01910155|Dexamethasone|dexamethasone|mesh-list
110121038|NCT01910155|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110121039|NCT01910155|Antiemetics|antiemetics|mesh-ancestor
110121040|NCT01910155|Autonomic Agents|autonomic agents|mesh-ancestor
110121041|NCT01910155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110121042|NCT01910155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110121043|NCT01910155|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110121044|NCT01910155|Glucocorticoids|glucocorticoids|mesh-ancestor
110121045|NCT01910155|Hormones|hormones|mesh-ancestor
110121046|NCT01910155|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110121047|NCT01910155|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110121048|NCT01910155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110121049|NCT01910155|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110121050|NCT01910155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110121051|NCT01910155|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110121052|NCT01910155|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110121053|NCT01910155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110121054|NCT01910155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110121055|NCT01910155|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110121056|NCT01910155|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110121057|NCT01910194|Insulin Glargine|insulin glargine|mesh-list
110121058|NCT01910194|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110121059|NCT01910194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110121060|NCT01910246|Metformin|metformin|mesh-list
110121061|NCT01910246|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110121062|NCT01910246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110121063|NCT01910259|Amiloride|amiloride|mesh-list
110121064|NCT01910259|Riluzole|riluzole|mesh-list
110121065|NCT01910259|Fluoxetine|fluoxetine|mesh-list
110121066|NCT01910259|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110121067|NCT01910259|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110121068|NCT01910259|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110121069|NCT01910259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110121070|NCT01910259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110121071|NCT01910259|Serotonin Agents|serotonin agents|mesh-ancestor
110121072|NCT01910259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110121073|NCT01910259|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110121074|NCT01910259|Antidepressive Agents|antidepressive agents|mesh-ancestor
110121075|NCT01910259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110121076|NCT01910259|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110121077|NCT01910259|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110121078|NCT01910259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110121079|NCT01910259|Anticonvulsants|anticonvulsants|mesh-ancestor
110121080|NCT01910259|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110121081|NCT01910259|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110121082|NCT01910259|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110121083|NCT01910259|Protective Agents|protective agents|mesh-ancestor
110121084|NCT01910259|Diuretics|diuretics|mesh-ancestor
110121085|NCT01910259|Natriuretic Agents|natriuretic agents|mesh-ancestor
110121086|NCT01910259|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
110121087|NCT01910259|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110223118|NCT00311974|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110121088|NCT01910259|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
110121089|NCT01910259|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110121090|NCT01910285|Sufentanil|sufentanil|mesh-list
110121091|NCT01910285|Dsuvia|dsuvia|mesh-list
110121092|NCT01910285|Remifentanil|remifentanil|mesh-list
110121093|NCT01910285|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110121094|NCT01910285|Narcotics|narcotics|mesh-ancestor
110121095|NCT01910285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110121096|NCT01910285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110121097|NCT01910285|Analgesics|analgesics|mesh-ancestor
110121098|NCT01910285|Sensory System Agents|sensory system agents|mesh-ancestor
110121099|NCT01910285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110121101|NCT01910285|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110121102|NCT01910285|Anesthetics, General|anesthetics, general|mesh-ancestor
110121103|NCT01910285|Anesthetics|anesthetics|mesh-ancestor
110121104|NCT01910363|Botulinum Toxins|botulinum toxins|mesh-list
110121105|NCT01910363|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110121106|NCT01910363|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110121107|NCT01910363|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110121108|NCT01910363|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110121109|NCT01910363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110121110|NCT01910363|Cholinergic Agents|cholinergic agents|mesh-ancestor
110121111|NCT01910363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110121112|NCT01910363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110121113|NCT01910363|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110121114|NCT01910363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110121116|NCT01910415|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
110121117|NCT01910415|Ivacaftor|ivacaftor|mesh-list
110121118|NCT01910415|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110121119|NCT01910415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110121120|NCT01910415|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110121121|NCT01910415|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110121122|NCT01910415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110121123|NCT01910415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110121124|NCT01910415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110121125|NCT01910415|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110121126|NCT01910415|Contraceptive Agents|contraceptive agents|mesh-ancestor
110121127|NCT01910415|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110121128|NCT01910415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110121129|NCT01910415|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110121130|NCT01910415|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110121131|NCT01910415|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110121132|NCT01910415|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
110121133|NCT01910415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110121134|NCT01910428|Asparaginase|asparaginase|mesh-list
110121135|NCT01910428|Eryaspase|eryaspase|mesh-list
110121136|NCT01910428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110121137|NCT01910480|Ketoconazole|ketoconazole|mesh-list
110121138|NCT01910480|Antifungal Agents|antifungal agents|mesh-ancestor
110121139|NCT01910480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110121140|NCT01910480|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110121141|NCT01910480|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110121142|NCT01910480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110121143|NCT01910480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110121144|NCT01910480|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110121145|NCT01910480|Hormone Antagonists|hormone antagonists|mesh-ancestor
110121146|NCT01910480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110121147|NCT01910480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110121148|NCT01910480|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110121149|NCT01910506|Verinurad|verinurad|mesh-list
110121150|NCT01910506|Gout Suppressants|gout suppressants|mesh-ancestor
110121151|NCT01910506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110121152|NCT01910532|Clevidipine|clevidipine|mesh-list
110121153|NCT01910532|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110121154|NCT01910532|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110121155|NCT01910532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110223135|NCT00121524|Autonomic Agents|autonomic agents|mesh-ancestor
110121156|NCT01910532|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110121157|NCT01910532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110121159|NCT01910545|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110121160|NCT01910545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110121161|NCT01910545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110121162|NCT01910610|Bevacizumab|bevacizumab|mesh-list
110121163|NCT01910610|Cetuximab|cetuximab|mesh-list
110121164|NCT01910610|Panitumumab|panitumumab|mesh-list
110121165|NCT01910610|Irinotecan|irinotecan|mesh-list
110121166|NCT01910610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110121167|NCT01910610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110121168|NCT01910610|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110121169|NCT01910610|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110121170|NCT01910610|Growth Substances|growth substances|mesh-ancestor
110121171|NCT01910610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110121172|NCT01910610|Growth Inhibitors|growth inhibitors|mesh-ancestor
110121173|NCT01910610|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110121174|NCT01910610|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110121175|NCT01910610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110121176|NCT01910610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110121177|NCT01910766|Ubiquinone|ubiquinone|mesh-list
110121178|NCT01910766|Coenzyme Q10|coenzyme q10|mesh-list
110121179|NCT01910766|Clomiphene|clomiphene|mesh-list
110121180|NCT01910766|Enclomiphene|enclomiphene|mesh-list
110121181|NCT01910766|Zuclomiphene|zuclomiphene|mesh-list
110121182|NCT01910766|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110121184|NCT01910766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110121185|NCT01910766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110121186|NCT01910766|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110121187|NCT01910766|Fertility Agents|fertility agents|mesh-ancestor
110121188|NCT01910766|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110121189|NCT01910766|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110121190|NCT01910766|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110121191|NCT01910766|Micronutrients|micronutrients|mesh-ancestor
110121192|NCT01910766|Vitamins|vitamins|mesh-ancestor
110121193|NCT01910844|Cyclophosphamide|cyclophosphamide|mesh-list
110121194|NCT01910844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110121195|NCT01910844|Immunologic Factors|immunologic factors|mesh-ancestor
110121196|NCT01910844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110121197|NCT01910844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110121198|NCT01910844|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110121199|NCT01910844|Alkylating Agents|alkylating agents|mesh-ancestor
110121200|NCT01910844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110121201|NCT01910844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110121202|NCT01910844|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110121204|NCT01910870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110121205|NCT01910870|Immunologic Factors|immunologic factors|mesh-ancestor
110121206|NCT01910870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110121207|NCT01910870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110121208|NCT01910870|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110121209|NCT01910870|Alkylating Agents|alkylating agents|mesh-ancestor
110121210|NCT01910870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110121211|NCT01910870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110121212|NCT01910870|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110121214|NCT01910883|Fluoroquinolones|fluoroquinolones|mesh-list
110121215|NCT01910883|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110121216|NCT01910883|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110121217|NCT01910883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110121218|NCT01910883|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110121219|NCT01910883|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110121220|NCT01910883|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110121221|NCT01910883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110121222|NCT01910883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110121223|NCT01910883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110121224|NCT01910883|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110121226|NCT01910987|Dexamethasone acetate|dexamethasone acetate|mesh-list
110121228|NCT01910987|BB 1101|bb 1101|mesh-list
110121229|NCT01910987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110121230|NCT01910987|Antiemetics|antiemetics|mesh-ancestor
110121231|NCT01910987|Autonomic Agents|autonomic agents|mesh-ancestor
110121232|NCT01910987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110121233|NCT01910987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110121234|NCT01910987|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110121235|NCT01910987|Glucocorticoids|glucocorticoids|mesh-ancestor
110121236|NCT01910987|Hormones|hormones|mesh-ancestor
110121237|NCT01910987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110121238|NCT01910987|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110121239|NCT01910987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110121240|NCT01910987|Protease Inhibitors|protease inhibitors|mesh-ancestor
110121241|NCT01910987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110121242|NCT01910987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110121243|NCT01911195|Isoflurane|isoflurane|mesh-list
110121244|NCT01911195|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110121245|NCT01911195|Anesthetics, General|anesthetics, general|mesh-ancestor
110121246|NCT01911195|Anesthetics|anesthetics|mesh-ancestor
110121247|NCT01911195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110121248|NCT01911195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110121249|NCT01911234|Freund's Adjuvant|freund's adjuvant|mesh-list
110121250|NCT01911234|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110121251|NCT01911234|Immunologic Factors|immunologic factors|mesh-ancestor
110121252|NCT01911234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110121253|NCT01911247|Metformin|metformin|mesh-list
110121254|NCT01911247|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110121255|NCT01911247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110121256|NCT01911299|Choline|choline|mesh-list
110121257|NCT01911299|Glycerol|glycerol|mesh-list
110121259|NCT01911299|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110121260|NCT01911299|Antimetabolites|antimetabolites|mesh-ancestor
110121261|NCT01911299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110121262|NCT01911299|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110121263|NCT01911299|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110121264|NCT01911299|Nootropic Agents|nootropic agents|mesh-ancestor
110121265|NCT01911299|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
110121266|NCT01911299|Protective Agents|protective agents|mesh-ancestor
110121267|NCT01911299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110121268|NCT01911325|Docetaxel|docetaxel|mesh-list
110121269|NCT01911325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110121270|NCT01911325|Tubulin Modulators|tubulin modulators|mesh-ancestor
110121271|NCT01911325|Antimitotic Agents|antimitotic agents|mesh-ancestor
110121272|NCT01911325|Mitosis Modulators|mitosis modulators|mesh-ancestor
110121273|NCT01911325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110121274|NCT01911364|Tiotropium Bromide|tiotropium bromide|mesh-list
110121275|NCT01911364|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110121276|NCT01911364|Autonomic Agents|autonomic agents|mesh-ancestor
110121277|NCT01911364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110121278|NCT01911364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110121279|NCT01911364|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110121280|NCT01911364|Respiratory System Agents|respiratory system agents|mesh-ancestor
110121281|NCT01911364|Parasympatholytics|parasympatholytics|mesh-ancestor
110121282|NCT01911364|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110121283|NCT01911364|Cholinergic Agents|cholinergic agents|mesh-ancestor
110121284|NCT01911364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110121285|NCT01911364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110121286|NCT01911377|Botulinum Toxins|botulinum toxins|mesh-list
110121287|NCT01911377|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110121288|NCT01911377|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110121289|NCT01911377|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110121290|NCT01911377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110121291|NCT01911377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110121292|NCT01911377|Cholinergic Agents|cholinergic agents|mesh-ancestor
110121293|NCT01911377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110121294|NCT01911377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110121295|NCT01911377|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110121296|NCT01911377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110121297|NCT01911455|Acamprosate|acamprosate|mesh-list
110121298|NCT01911455|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110121299|NCT01911468|Metformin|metformin|mesh-list
110121300|NCT01911468|Liraglutide|liraglutide|mesh-list
110121301|NCT01911468|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110121302|NCT01911468|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110121303|NCT01911468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110121305|NCT01911468|Hormones|hormones|mesh-ancestor
110121306|NCT01911468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110121307|NCT01911494|Magnesium Sulfate|magnesium sulfate|mesh-list
110121308|NCT01911494|Methyldopa|methyldopa|mesh-list
110121309|NCT01911494|Analgesics|analgesics|mesh-ancestor
110121310|NCT01911494|Sensory System Agents|sensory system agents|mesh-ancestor
110121311|NCT01911494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110121312|NCT01911494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110121313|NCT01911494|Anesthetics|anesthetics|mesh-ancestor
110121314|NCT01911494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110121315|NCT01911494|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110121316|NCT01911494|Anticonvulsants|anticonvulsants|mesh-ancestor
110121317|NCT01911494|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110121318|NCT01911494|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110121319|NCT01911494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110121320|NCT01911494|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110121321|NCT01911494|Tocolytic Agents|tocolytic agents|mesh-ancestor
110121322|NCT01911494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110121323|NCT01911494|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110121324|NCT01911494|Sympatholytics|sympatholytics|mesh-ancestor
110121325|NCT01911494|Autonomic Agents|autonomic agents|mesh-ancestor
110121326|NCT01911494|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110121327|NCT01911494|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110121328|NCT01911494|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110121329|NCT01911494|Adrenergic Agents|adrenergic agents|mesh-ancestor
110121330|NCT01911494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110121331|NCT01911507|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110121332|NCT01911507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110121333|NCT01911507|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110121335|NCT01911507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110121336|NCT01911598|Paclitaxel|paclitaxel|mesh-list
110121337|NCT01911598|Carboplatin|carboplatin|mesh-list
110121338|NCT01911598|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110121339|NCT01911598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110121340|NCT01911598|Tubulin Modulators|tubulin modulators|mesh-ancestor
110121341|NCT01911598|Antimitotic Agents|antimitotic agents|mesh-ancestor
110121342|NCT01911598|Mitosis Modulators|mitosis modulators|mesh-ancestor
110163749|NCT00121420|Dermatologic Agents|dermatologic agents|mesh-ancestor
110121343|NCT01911598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110121344|NCT01911624|Enoxaparin|enoxaparin|mesh-list
110121345|NCT01911624|Dabigatran|dabigatran|mesh-list
110121347|NCT01911624|Thrombin|thrombin|mesh-list
110121348|NCT01911624|Anticoagulants|anticoagulants|mesh-ancestor
110121349|NCT01911624|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110121350|NCT01911624|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110121351|NCT01911624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110121352|NCT01911624|Antithrombins|antithrombins|mesh-ancestor
110121353|NCT01911624|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110121354|NCT01911624|Protease Inhibitors|protease inhibitors|mesh-ancestor
110121355|NCT01911624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110121356|NCT01911624|Hemostatics|hemostatics|mesh-ancestor
110121357|NCT01911624|Coagulants|coagulants|mesh-ancestor
110121358|NCT01911624|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110121359|NCT01911728|Pioglitazone|pioglitazone|mesh-list
110121360|NCT01911728|Midazolam|midazolam|mesh-list
110121361|NCT01911728|Omeprazole|omeprazole|mesh-list
110121362|NCT01911728|Warfarin|warfarin|mesh-list
110121363|NCT01911728|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110121364|NCT01911728|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110121365|NCT01911728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110121366|NCT01911728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110121367|NCT01911728|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110121368|NCT01911728|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110121369|NCT01911728|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110121370|NCT01911728|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110121371|NCT01911728|Anesthetics, General|anesthetics, general|mesh-ancestor
110121372|NCT01911728|Anesthetics|anesthetics|mesh-ancestor
110121373|NCT01911728|GABA Modulators|gaba modulators|mesh-ancestor
110121374|NCT01911728|GABA Agents|gaba agents|mesh-ancestor
110121375|NCT01911728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110121376|NCT01911728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110121377|NCT01911728|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110121378|NCT01911728|Anticoagulants|anticoagulants|mesh-ancestor
110121379|NCT01911728|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110121380|NCT01911728|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110121381|NCT01911728|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110121382|NCT01911728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110121383|NCT01911949|Epinephrine|epinephrine|mesh-list
110121384|NCT01911949|Bupivacaine|bupivacaine|mesh-list
110121385|NCT01911949|Anesthetics, Local|anesthetics, local|mesh-ancestor
110121386|NCT01911949|Anesthetics|anesthetics|mesh-ancestor
110121387|NCT01911949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110121388|NCT01911949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110121389|NCT01911949|Sensory System Agents|sensory system agents|mesh-ancestor
110121390|NCT01911949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110121391|NCT01911949|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110121392|NCT01911949|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110121393|NCT01911949|Adrenergic Agents|adrenergic agents|mesh-ancestor
110121394|NCT01911949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110121395|NCT01911949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110121396|NCT01911949|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110121397|NCT01911949|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110121398|NCT01911949|Autonomic Agents|autonomic agents|mesh-ancestor
110121399|NCT01911949|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110121400|NCT01911949|Respiratory System Agents|respiratory system agents|mesh-ancestor
110121401|NCT01911949|Mydriatics|mydriatics|mesh-ancestor
110121402|NCT01911949|Sympathomimetics|sympathomimetics|mesh-ancestor
110121403|NCT01911949|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110121404|NCT01911975|Lacosamide|lacosamide|mesh-list
110121405|NCT01911975|Anticonvulsants|anticonvulsants|mesh-ancestor
110121406|NCT01911975|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110121407|NCT01911975|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110121408|NCT01911975|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110260212|NCT00530413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110121409|NCT01911975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110121411|NCT01912053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110121412|NCT01912053|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110121413|NCT01912053|Antimetabolites|antimetabolites|mesh-ancestor
110163753|NCT00121459|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110121414|NCT01912053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110121416|NCT01912066|Misoprostol|misoprostol|mesh-list
110121417|NCT01912066|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110121418|NCT01912066|Abortifacient Agents|abortifacient agents|mesh-ancestor
110121419|NCT01912066|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110121420|NCT01912066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110121421|NCT01912066|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110121422|NCT01912066|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110121423|NCT01912066|Oxytocics|oxytocics|mesh-ancestor
110121424|NCT01912066|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110121425|NCT01912066|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110121426|NCT01912066|Analgesics|analgesics|mesh-ancestor
110121427|NCT01912066|Sensory System Agents|sensory system agents|mesh-ancestor
110121428|NCT01912066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110121429|NCT01912066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110121430|NCT01912066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110121431|NCT01912118|Remifentanil|remifentanil|mesh-list
110121432|NCT01912118|Propofol|propofol|mesh-list
110121433|NCT01912118|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110121434|NCT01912118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110121435|NCT01912118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110121436|NCT01912118|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110121437|NCT01912118|Anesthetics, General|anesthetics, general|mesh-ancestor
110121438|NCT01912118|Anesthetics|anesthetics|mesh-ancestor
110121439|NCT01912118|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110121440|NCT01912118|Narcotics|narcotics|mesh-ancestor
110121441|NCT01912118|Analgesics|analgesics|mesh-ancestor
110121442|NCT01912118|Sensory System Agents|sensory system agents|mesh-ancestor
110121443|NCT01912118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110121444|NCT01912261|Iron|iron|mesh-list
110121445|NCT01912261|Trace Elements|trace elements|mesh-ancestor
110121446|NCT01912261|Micronutrients|micronutrients|mesh-ancestor
110121447|NCT01912261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110121448|NCT01912378|Oxytocin|oxytocin|mesh-list
110121449|NCT01912378|Oxytocics|oxytocics|mesh-ancestor
110121450|NCT01912378|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110121451|NCT01912378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110121452|NCT01912391|Selegiline|selegiline|mesh-list
110121453|NCT01912391|Antidepressive Agents|antidepressive agents|mesh-ancestor
110121454|NCT01912391|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110121455|NCT01912391|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110121456|NCT01912391|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110121457|NCT01912391|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
110121458|NCT01912391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110121459|NCT01912391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110121460|NCT01912391|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110121461|NCT01912391|Protective Agents|protective agents|mesh-ancestor
110121462|NCT01912391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110121464|NCT01912443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110121465|NCT01912443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110121466|NCT01912443|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110121467|NCT01912443|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110121468|NCT01912443|Growth Substances|growth substances|mesh-ancestor
110121469|NCT01912443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110121470|NCT01912443|Growth Inhibitors|growth inhibitors|mesh-ancestor
110121471|NCT01912534|Valsartan|valsartan|mesh-list
110121472|NCT01912534|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110121473|NCT01912534|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110121474|NCT01912534|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110121475|NCT01912534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110121476|NCT01912573|Naloxone|naloxone|mesh-list
110121477|NCT01912573|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110121478|NCT01912573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110121479|NCT01912573|Sensory System Agents|sensory system agents|mesh-ancestor
110121480|NCT01912573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110121481|NCT01912586|Sildenafil Citrate|sildenafil citrate|mesh-list
110121482|NCT01912586|Vasodilator Agents|vasodilator agents|mesh-ancestor
110121483|NCT01912586|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110121484|NCT01912586|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110121485|NCT01912586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110121486|NCT01912586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110121487|NCT01912586|Urological Agents|urological agents|mesh-ancestor
110121488|NCT01912638|Hyaluronic Acid|hyaluronic acid|mesh-list
110121489|NCT01912638|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110121490|NCT01912638|Immunologic Factors|immunologic factors|mesh-ancestor
110121491|NCT01912638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110121492|NCT01912638|Viscosupplements|viscosupplements|mesh-ancestor
110121493|NCT01912638|Protective Agents|protective agents|mesh-ancestor
110121495|NCT01912677|Methyldopa|methyldopa|mesh-list
110121496|NCT01912677|Nifedipine|nifedipine|mesh-list
110121497|NCT01912677|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110121498|NCT01912677|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110121499|NCT01912677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110121500|NCT01912677|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110121501|NCT01912677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110121502|NCT01912677|Vasodilator Agents|vasodilator agents|mesh-ancestor
110121503|NCT01912677|Tocolytic Agents|tocolytic agents|mesh-ancestor
110121504|NCT01912677|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110121505|NCT01912677|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110121506|NCT01912677|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110121507|NCT01912677|Adrenergic Agents|adrenergic agents|mesh-ancestor
110121508|NCT01912677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110121509|NCT01912677|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110121510|NCT01912677|Sympathomimetics|sympathomimetics|mesh-ancestor
110121511|NCT01912677|Autonomic Agents|autonomic agents|mesh-ancestor
110121512|NCT01912677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110121513|NCT01912677|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110121514|NCT01912677|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110121515|NCT01912677|Sympatholytics|sympatholytics|mesh-ancestor
110121516|NCT01912677|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110121517|NCT01912677|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110121518|NCT01912677|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110121519|NCT01912755|Lidocaine|lidocaine|mesh-list
110121520|NCT01912755|Epinephrine|epinephrine|mesh-list
110121521|NCT01912755|Racepinephrine|racepinephrine|mesh-list
110121522|NCT01912755|Carticaine|carticaine|mesh-list
110121524|NCT01912755|Anesthetics, Local|anesthetics, local|mesh-ancestor
110121525|NCT01912755|Anesthetics|anesthetics|mesh-ancestor
110121526|NCT01912755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110121527|NCT01912755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110121528|NCT01912755|Sensory System Agents|sensory system agents|mesh-ancestor
110121529|NCT01912755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110121530|NCT01912755|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110121531|NCT01912755|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110121532|NCT01912755|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110121533|NCT01912755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110121534|NCT01912755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110121535|NCT01912755|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110121536|NCT01912755|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110121537|NCT01912755|Adrenergic Agents|adrenergic agents|mesh-ancestor
110121538|NCT01912755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110121539|NCT01912755|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110121540|NCT01912755|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110121541|NCT01912755|Autonomic Agents|autonomic agents|mesh-ancestor
110121542|NCT01912755|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110121543|NCT01912755|Respiratory System Agents|respiratory system agents|mesh-ancestor
110121544|NCT01912755|Mydriatics|mydriatics|mesh-ancestor
110121545|NCT01912755|Sympathomimetics|sympathomimetics|mesh-ancestor
110121546|NCT01912755|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110121547|NCT01912820|Quercetin|quercetin|mesh-list
110121548|NCT01912820|Antioxidants|antioxidants|mesh-ancestor
110121549|NCT01912820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110121550|NCT01912820|Protective Agents|protective agents|mesh-ancestor
110121551|NCT01912820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110121553|NCT01912898|Ergocalciferols|ergocalciferols|mesh-list
110121554|NCT01912898|Cholecalciferol|cholecalciferol|mesh-list
110121555|NCT01912898|Vitamins|vitamins|mesh-list
110121556|NCT01912898|Micronutrients|micronutrients|mesh-ancestor
110121557|NCT01912898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110121558|NCT01912898|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110121559|NCT01912898|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110121560|NCT01912976|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
110121561|NCT01912976|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110121562|NCT01912976|Dermatologic Agents|dermatologic agents|mesh-ancestor
110260165|NCT00168870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110121563|NCT01913002|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
110121565|NCT01913002|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110121566|NCT01913002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110121567|NCT01913002|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110121568|NCT01913002|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110121569|NCT01913002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110121570|NCT01913002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110121571|NCT01913002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110121572|NCT01913002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110121573|NCT01913002|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110121574|NCT01913002|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110121575|NCT01913015|Abiraterone Acetate|abiraterone acetate|mesh-list
110121576|NCT01913015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110121577|NCT01913015|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110121578|NCT01913015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110121579|NCT01913015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110121580|NCT01913015|Hormone Antagonists|hormone antagonists|mesh-ancestor
110121581|NCT01913015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110121582|NCT01913015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110121583|NCT01913015|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110121584|NCT01913054|Fentanyl|fentanyl|mesh-list
110121585|NCT01913054|Propofol|propofol|mesh-list
110121586|NCT01913054|Etomidate|etomidate|mesh-list
110121587|NCT01913054|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110121588|NCT01913054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110121589|NCT01913054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110121590|NCT01913054|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110121591|NCT01913054|Anesthetics, General|anesthetics, general|mesh-ancestor
110121592|NCT01913054|Anesthetics|anesthetics|mesh-ancestor
110121593|NCT01913054|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110121594|NCT01913054|Narcotics|narcotics|mesh-ancestor
110121595|NCT01913054|Analgesics|analgesics|mesh-ancestor
110121596|NCT01913054|Sensory System Agents|sensory system agents|mesh-ancestor
110121597|NCT01913054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110121598|NCT01913054|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110121599|NCT01913106|Valacyclovir|valacyclovir|mesh-list
110121600|NCT01913106|Antiviral Agents|antiviral agents|mesh-ancestor
110121601|NCT01913106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110121603|NCT01913119|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110121604|NCT01913119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110121605|NCT01913119|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110121606|NCT01913119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110121607|NCT01913119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110121608|NCT01913379|Itraconazole|itraconazole|mesh-list
110121609|NCT01913379|Gemfibrozil|gemfibrozil|mesh-list
110121610|NCT01913379|Antifungal Agents|antifungal agents|mesh-ancestor
110121611|NCT01913379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110121612|NCT01913379|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110121613|NCT01913379|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110121614|NCT01913379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110121615|NCT01913379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110121616|NCT01913379|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110121617|NCT01913379|Hormone Antagonists|hormone antagonists|mesh-ancestor
110121618|NCT01913379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110121619|NCT01913379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110121620|NCT01913379|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110121621|NCT01913379|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110121622|NCT01913379|Antimetabolites|antimetabolites|mesh-ancestor
110121623|NCT01913379|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110121624|NCT01913379|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
110121625|NCT01913431|Entecavir|entecavir|mesh-list
110121626|NCT01913431|Antiviral Agents|antiviral agents|mesh-ancestor
110121627|NCT01913431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110121628|NCT01913444|Antithrombins|antithrombins|mesh-list
110121629|NCT01913444|Antithrombin III|antithrombin iii|mesh-list
110121630|NCT01913444|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110121631|NCT01913444|Protease Inhibitors|protease inhibitors|mesh-ancestor
110121632|NCT01913444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110121633|NCT01913444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110121634|NCT01913444|Anticoagulants|anticoagulants|mesh-ancestor
110121636|NCT01913691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110121637|NCT01913691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110121638|NCT01913691|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110121639|NCT01913691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110121640|NCT01913808|Iron|iron|mesh-list
110121641|NCT01913808|Glycine|glycine|mesh-list
110121642|NCT01913808|Trace Elements|trace elements|mesh-ancestor
110121643|NCT01913808|Micronutrients|micronutrients|mesh-ancestor
110121644|NCT01913808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110121645|NCT01913808|Glycine Agents|glycine agents|mesh-ancestor
110121646|NCT01913808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110121647|NCT01913808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110121648|NCT01913834|Teriparatide|teriparatide|mesh-list
110121649|NCT01913834|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110121650|NCT01913834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110121651|NCT01913834|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110121653|NCT01913847|Vasodilator Agents|vasodilator agents|mesh-ancestor
110121654|NCT01913847|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110121655|NCT01913847|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110121656|NCT01913847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110121657|NCT01913847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110121658|NCT01913847|Urological Agents|urological agents|mesh-ancestor
110121659|NCT01913860|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110121660|NCT01913860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110121661|NCT01913964|Acetylcarnitine|acetylcarnitine|mesh-list
110121662|NCT01913964|Vitamin B Complex|vitamin b complex|mesh-ancestor
110121663|NCT01913964|Vitamins|vitamins|mesh-ancestor
110121664|NCT01913964|Micronutrients|micronutrients|mesh-ancestor
110121665|NCT01913964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110121666|NCT01913964|Nootropic Agents|nootropic agents|mesh-ancestor
110121667|NCT01913990|Dexamethasone|dexamethasone|mesh-list
110121668|NCT01913990|Ondansetron|ondansetron|mesh-list
110121669|NCT01913990|Aprepitant|aprepitant|mesh-list
110121670|NCT01913990|Antiemetics|antiemetics|mesh-list
110121671|NCT01913990|Emetics|emetics|mesh-list
110121672|NCT01913990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110121673|NCT01913990|Autonomic Agents|autonomic agents|mesh-ancestor
110121674|NCT01913990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110121675|NCT01913990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110121676|NCT01913990|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110121677|NCT01913990|Glucocorticoids|glucocorticoids|mesh-ancestor
110121678|NCT01913990|Hormones|hormones|mesh-ancestor
110121679|NCT01913990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110121680|NCT01913990|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110121681|NCT01913990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110121682|NCT01913990|Antipruritics|antipruritics|mesh-ancestor
110121683|NCT01913990|Dermatologic Agents|dermatologic agents|mesh-ancestor
110121684|NCT01913990|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110121685|NCT01913990|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110121686|NCT01913990|Serotonin Agents|serotonin agents|mesh-ancestor
110121687|NCT01913990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110121688|NCT01913990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110121689|NCT01913990|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110121690|NCT01914042|Morphine|morphine|mesh-list
110121691|NCT01914042|Milnacipran|milnacipran|mesh-list
110121692|NCT01914042|Levomilnacipran|levomilnacipran|mesh-list
110121693|NCT01914042|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110121694|NCT01914042|Narcotics|narcotics|mesh-ancestor
110121695|NCT01914042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110121696|NCT01914042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110121697|NCT01914042|Analgesics|analgesics|mesh-ancestor
110121698|NCT01914042|Sensory System Agents|sensory system agents|mesh-ancestor
110121699|NCT01914042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110121700|NCT01914042|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110121701|NCT01914042|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110121702|NCT01914042|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110121703|NCT01914042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110121704|NCT01914042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110121705|NCT01914042|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110121706|NCT01914042|Antidepressive Agents|antidepressive agents|mesh-ancestor
110121707|NCT01914042|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110121708|NCT01914081|Resveratrol|resveratrol|mesh-list
110121709|NCT01914081|Antioxidants|antioxidants|mesh-ancestor
110121710|NCT01914081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110121711|NCT01914081|Protective Agents|protective agents|mesh-ancestor
110223259|NCT00121563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110121712|NCT01914081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110121713|NCT01914081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110121714|NCT01914081|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110121716|NCT01914133|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
110121717|NCT01914133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110121718|NCT01914133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110121719|NCT01914133|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110121720|NCT01914133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110121721|NCT01914146|Insulin|insulin|mesh-list
110121722|NCT01914146|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110121723|NCT01914146|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110121724|NCT01914146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110121725|NCT01914211|Tranexamic Acid|tranexamic acid|mesh-list
110121726|NCT01914211|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110121727|NCT01914211|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110121728|NCT01914211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110121729|NCT01914211|Hemostatics|hemostatics|mesh-ancestor
110121730|NCT01914211|Coagulants|coagulants|mesh-ancestor
110121731|NCT01914237|Castor Oil|castor oil|mesh-list
110121732|NCT01914237|Cathartics|cathartics|mesh-ancestor
110121733|NCT01914237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110121734|NCT01914250|Analgesics|analgesics|mesh-list
110121735|NCT01914250|Tetracaine|tetracaine|mesh-list
110121736|NCT01914250|Sensory System Agents|sensory system agents|mesh-ancestor
110121737|NCT01914250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110121738|NCT01914250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110121739|NCT01914250|Anesthetics, Local|anesthetics, local|mesh-ancestor
110121740|NCT01914250|Anesthetics|anesthetics|mesh-ancestor
110121741|NCT01914250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110121742|NCT01914380|Aflibercept|aflibercept|mesh-list
110121743|NCT01914380|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110121744|NCT01914380|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110121745|NCT01914380|Growth Substances|growth substances|mesh-ancestor
110121746|NCT01914380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110121747|NCT01914380|Growth Inhibitors|growth inhibitors|mesh-ancestor
110121748|NCT01914380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110121749|NCT01914419|Oxytocin|oxytocin|mesh-list
110121750|NCT01914419|Oxytocics|oxytocics|mesh-ancestor
110121751|NCT01914419|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110121752|NCT01914419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110121753|NCT01914432|Telmisartan|telmisartan|mesh-list
110121754|NCT01914432|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110121755|NCT01914432|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110121756|NCT01914432|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110121757|NCT01914432|Antimetabolites|antimetabolites|mesh-ancestor
110121758|NCT01914432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110121759|NCT01914432|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110121760|NCT01914432|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110121761|NCT01914432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110121762|NCT01914432|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110121763|NCT01914432|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110121764|NCT01914432|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110121765|NCT01914562|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
110121766|NCT01914562|Cathartics|cathartics|mesh-ancestor
110121767|NCT01914562|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110121768|NCT01914627|Salicylic Acid|salicylic acid|mesh-list
110121769|NCT01914627|Salicylates|salicylates|mesh-list
110121770|NCT01914627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110121771|NCT01914627|Antifungal Agents|antifungal agents|mesh-ancestor
110121772|NCT01914627|Keratolytic Agents|keratolytic agents|mesh-ancestor
110121773|NCT01914627|Dermatologic Agents|dermatologic agents|mesh-ancestor
110121774|NCT01914627|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110121775|NCT01914627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110121777|NCT01914627|Sensory System Agents|sensory system agents|mesh-ancestor
110121778|NCT01914627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110223277|NCT00121563|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110121779|NCT01914627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110121780|NCT01914627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110121781|NCT01914627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110121782|NCT01914627|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110121783|NCT01914627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110121784|NCT01914627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110121785|NCT01914692|Somatostatin|somatostatin|mesh-list
110121787|NCT01914692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110121788|NCT01914692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110121789|NCT01914718|Rituximab|rituximab|mesh-list
110121790|NCT01914718|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110121791|NCT01914718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110121792|NCT01914718|Immunologic Factors|immunologic factors|mesh-ancestor
110121793|NCT01914718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110121794|NCT01914718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110121795|NCT01914744|Lamivudine|lamivudine|mesh-list
110121796|NCT01914744|Entecavir|entecavir|mesh-list
110121797|NCT01914744|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110121798|NCT01914744|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110121799|NCT01914744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110121800|NCT01914744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110121801|NCT01914744|Antiviral Agents|antiviral agents|mesh-ancestor
110121802|NCT01914744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110121803|NCT01914744|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110121804|NCT01914744|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110121805|NCT01914770|Belimumab|belimumab|mesh-list
110121806|NCT01914770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110121807|NCT01914770|Immunologic Factors|immunologic factors|mesh-ancestor
110121808|NCT01914770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110121809|NCT01914822|Methylphenidate|methylphenidate|mesh-list
110121810|NCT01914822|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110121811|NCT01914822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110121812|NCT01914822|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110121813|NCT01914822|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110121814|NCT01914822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110121815|NCT01914822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110121816|NCT01914822|Dopamine Agents|dopamine agents|mesh-ancestor
110121817|NCT01914822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110121818|NCT01914900|Docetaxel|docetaxel|mesh-list
110121819|NCT01914900|Fluorouracil|fluorouracil|mesh-list
110121820|NCT01914900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110121821|NCT01914900|Tubulin Modulators|tubulin modulators|mesh-ancestor
110121822|NCT01914900|Antimitotic Agents|antimitotic agents|mesh-ancestor
110121823|NCT01914900|Mitosis Modulators|mitosis modulators|mesh-ancestor
110121824|NCT01914900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110121826|NCT01914900|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110121827|NCT01914900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110121828|NCT01914900|Immunologic Factors|immunologic factors|mesh-ancestor
110121829|NCT01914900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110121830|NCT01914939|Oxytocin|oxytocin|mesh-list
110121831|NCT01914939|Oxytocics|oxytocics|mesh-ancestor
110121832|NCT01914939|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110121833|NCT01914939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110121834|NCT01914965|Bupropion|bupropion|mesh-list
110121835|NCT01914965|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110223283|NCT00121563|Anesthetics|anesthetics|mesh-ancestor
110121836|NCT01914965|Antidepressive Agents|antidepressive agents|mesh-ancestor
110121837|NCT01914965|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110121838|NCT01914965|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110121839|NCT01914965|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110121840|NCT01914965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110121841|NCT01914965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110121842|NCT01914965|Dopamine Agents|dopamine agents|mesh-ancestor
110121843|NCT01914965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110121844|NCT01914965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110121845|NCT01914965|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110121846|NCT01914965|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110121847|NCT01914965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110121849|NCT01915069|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110121850|NCT01915069|Autonomic Agents|autonomic agents|mesh-ancestor
110121851|NCT01915069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110121852|NCT01915069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110121853|NCT01915069|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110121854|NCT01915069|Respiratory System Agents|respiratory system agents|mesh-ancestor
110121855|NCT01915069|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110121856|NCT01915069|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110121857|NCT01915069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110121858|NCT01915069|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110121859|NCT01915069|Vasodilator Agents|vasodilator agents|mesh-ancestor
110121860|NCT01915069|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110121861|NCT01915069|Protective Agents|protective agents|mesh-ancestor
110121862|NCT01915069|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110121863|NCT01915069|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110121864|NCT01915069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110121865|NCT01915082|Azithromycin|azithromycin|mesh-list
110121866|NCT01915082|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110121867|NCT01915082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110121868|NCT01915134|Cisplatin|cisplatin|mesh-list
110121869|NCT01915134|Gemcitabine|gemcitabine|mesh-list
110121870|NCT01915134|Endostatins|endostatins|mesh-list
110121871|NCT01915134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110121872|NCT01915134|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110121873|NCT01915134|Antimetabolites|antimetabolites|mesh-ancestor
110121874|NCT01915134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110121875|NCT01915134|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110121876|NCT01915134|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110121877|NCT01915134|Growth Substances|growth substances|mesh-ancestor
110121878|NCT01915134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110121879|NCT01915134|Growth Inhibitors|growth inhibitors|mesh-ancestor
110121880|NCT01915186|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
110121881|NCT01915186|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110121882|NCT01915186|Immunologic Factors|immunologic factors|mesh-ancestor
110121883|NCT01915186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110121885|NCT01915264|Acarbose|acarbose|mesh-list
110121886|NCT01915264|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110121887|NCT01915264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110121888|NCT01915264|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
110121889|NCT01915264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110121890|NCT01915264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110121891|NCT01915277|Dexmedetomidine|dexmedetomidine|mesh-list
110121892|NCT01915277|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110121893|NCT01915277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110121894|NCT01915277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110121895|NCT01915277|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110121896|NCT01915277|Analgesics|analgesics|mesh-ancestor
110121897|NCT01915277|Sensory System Agents|sensory system agents|mesh-ancestor
110121898|NCT01915277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110121899|NCT01915277|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110121900|NCT01915277|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110121901|NCT01915277|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110121902|NCT01915277|Adrenergic Agents|adrenergic agents|mesh-ancestor
110121903|NCT01915277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110121904|NCT01915277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110121905|NCT01915459|Botulinum Toxins|botulinum toxins|mesh-list
110121906|NCT01915459|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110121907|NCT01915459|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110121908|NCT01915459|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110121909|NCT01915459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110121910|NCT01915459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110121911|NCT01915459|Cholinergic Agents|cholinergic agents|mesh-ancestor
110121912|NCT01915459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110121913|NCT01915459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110121914|NCT01915459|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110121915|NCT01915459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110121916|NCT01915472|Irinotecan|irinotecan|mesh-list
110121917|NCT01915472|Labetuzumab|labetuzumab|mesh-list
110121918|NCT01915472|Immunoconjugates|immunoconjugates|mesh-list
110121919|NCT01915472|Immunologic Factors|immunologic factors|mesh-ancestor
110121920|NCT01915472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110121921|NCT01915472|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110121922|NCT01915472|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110121923|NCT01915472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110121924|NCT01915472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110121925|NCT01915472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110121926|NCT01915472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110121927|NCT01915537|Infliximab|infliximab|mesh-list
110121928|NCT01915537|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110121929|NCT01915537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110121930|NCT01915537|Dermatologic Agents|dermatologic agents|mesh-ancestor
110121931|NCT01915537|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110223334|NCT00293527|Interferon alpha-2|interferon alpha-2|mesh-list
110121932|NCT01915537|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110121934|NCT01915550|Metformin|metformin|mesh-list
110121935|NCT01915550|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110121936|NCT01915550|Insulin, pork; isophane insulin, pork drug combination 30:70|insulin, pork; isophane insulin, pork drug combination 30:70|mesh-list
110121937|NCT01915550|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110121938|NCT01915550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110121939|NCT01915602|Sorafenib|sorafenib|mesh-list
110121940|NCT01915602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110121941|NCT01915602|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110121942|NCT01915602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110121943|NCT01915602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110121944|NCT01915758|Clindamycin|clindamycin|mesh-list
110121945|NCT01915758|Clindamycin palmitate|clindamycin palmitate|mesh-list
110121946|NCT01915758|Clindamycin phosphate|clindamycin phosphate|mesh-list
110121947|NCT01915758|Tretinoin|tretinoin|mesh-list
110121948|NCT01915758|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110121949|NCT01915758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110121950|NCT01915758|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110121951|NCT01915758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110121952|NCT01915758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110121953|NCT01915758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110121954|NCT01915758|Keratolytic Agents|keratolytic agents|mesh-ancestor
110121955|NCT01915758|Dermatologic Agents|dermatologic agents|mesh-ancestor
110121956|NCT01915901|Dimethyl Fumarate|dimethyl fumarate|mesh-list
110121957|NCT01915901|Bismuth|bismuth|mesh-list
110121958|NCT01915901|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
110121959|NCT01915901|Antacids|antacids|mesh-ancestor
110121960|NCT01915901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110121961|NCT01915901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110121962|NCT01915901|Dermatologic Agents|dermatologic agents|mesh-ancestor
110121963|NCT01915901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110121964|NCT01915901|Immunologic Factors|immunologic factors|mesh-ancestor
110121965|NCT01915901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110121966|NCT01915901|Antidiarrheals|antidiarrheals|mesh-ancestor
110121967|NCT01915979|Betamethasone|betamethasone|mesh-list
110121968|NCT01915979|Mitogens|mitogens|mesh-list
110121969|NCT01915979|Mitosis Modulators|mitosis modulators|mesh-ancestor
110121970|NCT01915979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110121971|NCT01915979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110121972|NCT01915979|Glucocorticoids|glucocorticoids|mesh-ancestor
110121973|NCT01915979|Hormones|hormones|mesh-ancestor
110121974|NCT01915979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110121975|NCT01915979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110121976|NCT01915979|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110121977|NCT01915979|Respiratory System Agents|respiratory system agents|mesh-ancestor
110121978|NCT01916057|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110121979|NCT01916057|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110121980|NCT01916057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110121981|NCT01916174|Insulin|insulin|mesh-list
110121982|NCT01916174|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110121983|NCT01916174|Liraglutide|liraglutide|mesh-list
110121984|NCT01916174|Insulin, Long-Acting|insulin, long-acting|mesh-list
110121985|NCT01916174|Xultophy|xultophy|mesh-list
110121986|NCT01916174|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110121987|NCT01916174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110121988|NCT01916174|Incretins|incretins|mesh-ancestor
110121989|NCT01916174|Hormones|hormones|mesh-ancestor
110121990|NCT01916174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110121991|NCT01916187|Imetelstat|imetelstat|mesh-list
110121992|NCT01916187|Motesanib diphosphate|motesanib diphosphate|mesh-list
110121993|NCT01916187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110121994|NCT01916187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110121996|NCT01916200|Paroxetine|paroxetine|mesh-list
110121997|NCT01916200|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110121998|NCT01916200|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110121999|NCT01916200|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110122000|NCT01916200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110122001|NCT01916200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110122002|NCT01916200|Serotonin Agents|serotonin agents|mesh-ancestor
110122003|NCT01916200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110122004|NCT01916200|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110122005|NCT01916200|Antidepressive Agents|antidepressive agents|mesh-ancestor
110122006|NCT01916200|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110122007|NCT01916200|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110122008|NCT01916200|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110122009|NCT01916200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110122010|NCT01916213|Hyaluronic Acid|hyaluronic acid|mesh-list
110122011|NCT01916213|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110122012|NCT01916213|Immunologic Factors|immunologic factors|mesh-ancestor
110122013|NCT01916213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110122014|NCT01916213|Viscosupplements|viscosupplements|mesh-ancestor
110122015|NCT01916213|Protective Agents|protective agents|mesh-ancestor
110122016|NCT01916252|Dexamethasone|dexamethasone|mesh-list
110122017|NCT01916252|Dexamethasone acetate|dexamethasone acetate|mesh-list
110122018|NCT01916252|Lenalidomide|lenalidomide|mesh-list
110122019|NCT01916252|Bortezomib|bortezomib|mesh-list
110122020|NCT01916252|Melphalan|melphalan|mesh-list
110122021|NCT01916252|Busulfan|busulfan|mesh-list
110122022|NCT01916252|BB 1101|bb 1101|mesh-list
110122023|NCT01916252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110122024|NCT01916252|Antiemetics|antiemetics|mesh-ancestor
110122025|NCT01916252|Autonomic Agents|autonomic agents|mesh-ancestor
110122026|NCT01916252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110122027|NCT01916252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110122028|NCT01916252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110122030|NCT01916252|Hormones|hormones|mesh-ancestor
110122031|NCT01916252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110122032|NCT01916252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110122033|NCT01916252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110122034|NCT01916252|Immunologic Factors|immunologic factors|mesh-ancestor
110122035|NCT01916252|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110122036|NCT01916252|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110122037|NCT01916252|Growth Substances|growth substances|mesh-ancestor
110122038|NCT01916252|Growth Inhibitors|growth inhibitors|mesh-ancestor
110122039|NCT01916252|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110122040|NCT01916252|Alkylating Agents|alkylating agents|mesh-ancestor
110122041|NCT01916252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110122042|NCT01916252|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110122043|NCT01916252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110122044|NCT01916252|Protease Inhibitors|protease inhibitors|mesh-ancestor
110122045|NCT01916252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110122046|NCT01916265|Glucagon|glucagon|mesh-list
110122047|NCT01916265|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110122048|NCT01916265|Hormones|hormones|mesh-ancestor
110122049|NCT01916265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110122050|NCT01916265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110122051|NCT01916382|Nitisinone|nitisinone|mesh-list
110122052|NCT01916382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110122053|NCT01916382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110122054|NCT01916395|Sumatriptan|sumatriptan|mesh-list
110122055|NCT01916395|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110122056|NCT01916395|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110122057|NCT01916395|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110122058|NCT01916395|Serotonin Agents|serotonin agents|mesh-ancestor
110122059|NCT01916395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110122060|NCT01916395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110122061|NCT01916395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110122062|NCT01916408|Wobenzym|wobenzym|mesh-list
110122063|NCT01916408|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110122064|NCT01916408|Immunologic Factors|immunologic factors|mesh-ancestor
110122065|NCT01916408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110122066|NCT01916447|Bevacizumab|bevacizumab|mesh-list
110122067|NCT01916447|Irinotecan|irinotecan|mesh-list
110122068|NCT01916447|Camptothecin|camptothecin|mesh-list
110122069|NCT01916447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110122071|NCT01916447|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110122072|NCT01916447|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110122073|NCT01916447|Growth Substances|growth substances|mesh-ancestor
110122074|NCT01916447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110122075|NCT01916447|Growth Inhibitors|growth inhibitors|mesh-ancestor
110122076|NCT01916447|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110122077|NCT01916447|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110122078|NCT01916447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110122079|NCT01916447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110122080|NCT01916447|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110122081|NCT01916577|Plerixafor|plerixafor|mesh-list
110122082|NCT01916577|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110122083|NCT01916577|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110122084|NCT01916577|Antiviral Agents|antiviral agents|mesh-ancestor
110122085|NCT01916577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110122086|NCT01916642|Lidocaine|lidocaine|mesh-list
110122087|NCT01916642|Etomidate|etomidate|mesh-list
110122088|NCT01916642|Anesthetics, Local|anesthetics, local|mesh-ancestor
110122089|NCT01916642|Anesthetics|anesthetics|mesh-ancestor
110122090|NCT01916642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110122091|NCT01916642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110122092|NCT01916642|Sensory System Agents|sensory system agents|mesh-ancestor
110122093|NCT01916642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110122094|NCT01916642|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110122095|NCT01916642|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110122096|NCT01916642|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110122097|NCT01916642|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110122098|NCT01916642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110122099|NCT01916642|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110122100|NCT01916642|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110122101|NCT01916642|Anesthetics, General|anesthetics, general|mesh-ancestor
110122102|NCT01916707|Enoxaparin|enoxaparin|mesh-list
110122103|NCT01916707|Anticoagulants|anticoagulants|mesh-ancestor
110122104|NCT01916707|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110122105|NCT01916707|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110122106|NCT01916707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110122107|NCT01916720|Darapladib|darapladib|mesh-list
110122108|NCT01916720|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
110122109|NCT01916720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110122110|NCT01916720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110122111|NCT01916733|Insulin|insulin|mesh-list
110122112|NCT01916733|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110122113|NCT01916733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110122114|NCT01916785|Dasatinib|dasatinib|mesh-list
110122115|NCT01916785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110122116|NCT01916785|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110122117|NCT01916785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110122118|NCT01916785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110122119|NCT01916798|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
110122120|NCT01916798|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
110122121|NCT01916798|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
110223374|NCT00423969|Escitalopram|escitalopram|mesh-list
110223379|NCT00423969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110122122|NCT01916798|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110368561|NCT04652115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110122123|NCT01916850|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
110122124|NCT01916850|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110122125|NCT01916850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110122126|NCT01916850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110122127|NCT01916850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110122129|NCT01916863|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
110122130|NCT01916863|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110122131|NCT01916863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110122132|NCT01916863|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110122133|NCT01916863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110122134|NCT01916902|Ticagrelor|ticagrelor|mesh-list
110122135|NCT01916902|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110122136|NCT01916902|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110122137|NCT01916902|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110122138|NCT01916902|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110122139|NCT01916902|Purinergic Agents|purinergic agents|mesh-ancestor
110122140|NCT01916902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110122141|NCT01916902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110122142|NCT01916902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110122143|NCT01916915|Tramadol|tramadol|mesh-list
110122144|NCT01916915|Levobupivacaine|levobupivacaine|mesh-list
110122145|NCT01916915|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110122146|NCT01916915|Narcotics|narcotics|mesh-ancestor
110122147|NCT01916915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110122148|NCT01916915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110122149|NCT01916915|Analgesics|analgesics|mesh-ancestor
110122150|NCT01916915|Sensory System Agents|sensory system agents|mesh-ancestor
110122151|NCT01916915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110122152|NCT01916915|Anesthetics, Local|anesthetics, local|mesh-ancestor
110122153|NCT01916915|Anesthetics|anesthetics|mesh-ancestor
110122154|NCT01916954|Lumefantrine|lumefantrine|mesh-list
110122155|NCT01916954|Artemether|artemether|mesh-list
110122156|NCT01916954|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
110122157|NCT01916954|Antimalarials|antimalarials|mesh-ancestor
110122158|NCT01916954|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110122159|NCT01916954|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110122160|NCT01916954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110122162|NCT01917019|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
110122163|NCT01917019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110122164|NCT01917019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110122165|NCT01917032|Folic Acid|folic acid|mesh-list
110122166|NCT01917032|Vitamin A|vitamin a|mesh-list
110122167|NCT01917032|Micronutrients|micronutrients|mesh-list
110122168|NCT01917032|Trace Elements|trace elements|mesh-list
110122169|NCT01917032|Tretinoin|tretinoin|mesh-list
110122170|NCT01917032|Vitamins|vitamins|mesh-ancestor
110122171|NCT01917032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110122172|NCT01917032|Hematinics|hematinics|mesh-ancestor
110122173|NCT01917032|Vitamin B Complex|vitamin b complex|mesh-ancestor
110122174|NCT01917032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110122175|NCT01917032|Keratolytic Agents|keratolytic agents|mesh-ancestor
110122176|NCT01917032|Dermatologic Agents|dermatologic agents|mesh-ancestor
110122177|NCT01917045|Sufentanil|sufentanil|mesh-list
110122178|NCT01917045|Morphine|morphine|mesh-list
110122179|NCT01917045|Dsuvia|dsuvia|mesh-list
110122180|NCT01917045|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110122181|NCT01917045|Narcotics|narcotics|mesh-ancestor
110122182|NCT01917045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110122183|NCT01917045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110122184|NCT01917045|Analgesics|analgesics|mesh-ancestor
110122185|NCT01917045|Sensory System Agents|sensory system agents|mesh-ancestor
110122186|NCT01917045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110122187|NCT01917045|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110122188|NCT01917045|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110122189|NCT01917045|Anesthetics, General|anesthetics, general|mesh-ancestor
110122190|NCT01917045|Anesthetics|anesthetics|mesh-ancestor
110122191|NCT01917058|Abatacept|abatacept|mesh-list
110122192|NCT01917058|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110122193|NCT01917058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110122194|NCT01917058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110122195|NCT01917058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110122196|NCT01917058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110122198|NCT01917058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110122199|NCT01917058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110122200|NCT01917097|Dexmedetomidine|dexmedetomidine|mesh-list
110122201|NCT01917097|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110122202|NCT01917097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110122203|NCT01917097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110122204|NCT01917097|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110122205|NCT01917097|Analgesics|analgesics|mesh-ancestor
110122206|NCT01917097|Sensory System Agents|sensory system agents|mesh-ancestor
110122207|NCT01917097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110122208|NCT01917097|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110122209|NCT01917097|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110122210|NCT01917097|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110122211|NCT01917097|Adrenergic Agents|adrenergic agents|mesh-ancestor
110122212|NCT01917097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110122213|NCT01917097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110122214|NCT01917149|Metoprolol|metoprolol|mesh-list
110122215|NCT01917149|Valsartan|valsartan|mesh-list
110122216|NCT01917149|Benazepril|benazepril|mesh-list
110122217|NCT01917149|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110122218|NCT01917149|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110122219|NCT01917149|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110122220|NCT01917149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110122221|NCT01917149|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110122222|NCT01917149|Sympatholytics|sympatholytics|mesh-ancestor
110122223|NCT01917149|Autonomic Agents|autonomic agents|mesh-ancestor
110122224|NCT01917149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110122225|NCT01917149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110122226|NCT01917149|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110122227|NCT01917149|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110122228|NCT01917149|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110163827|NCT00121966|Insulin|insulin|mesh-list
110122229|NCT01917149|Adrenergic Agents|adrenergic agents|mesh-ancestor
110122230|NCT01917149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110122231|NCT01917149|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110122232|NCT01917149|Protease Inhibitors|protease inhibitors|mesh-ancestor
110122233|NCT01917149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110122234|NCT01917279|Docetaxel|docetaxel|mesh-list
110122235|NCT01917279|Capecitabine|capecitabine|mesh-list
110122236|NCT01917279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110122237|NCT01917279|Tubulin Modulators|tubulin modulators|mesh-ancestor
110122238|NCT01917279|Antimitotic Agents|antimitotic agents|mesh-ancestor
110122239|NCT01917279|Mitosis Modulators|mitosis modulators|mesh-ancestor
110122240|NCT01917279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110122241|NCT01917279|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110122242|NCT01917279|Antimetabolites|antimetabolites|mesh-ancestor
110122243|NCT01917318|Iloperidone|iloperidone|mesh-list
110122244|NCT01917318|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110122245|NCT01917318|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110122246|NCT01917318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110122247|NCT01917318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110122248|NCT01917318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110122249|NCT01917331|Beclomethasone|beclomethasone|mesh-list
110122250|NCT01917331|Glycopyrrolate|glycopyrrolate|mesh-list
110122251|NCT01917331|Formoterol Fumarate|formoterol fumarate|mesh-list
110122252|NCT01917331|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110122253|NCT01917331|Autonomic Agents|autonomic agents|mesh-ancestor
110122254|NCT01917331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110122255|NCT01917331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110122256|NCT01917331|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110122257|NCT01917331|Respiratory System Agents|respiratory system agents|mesh-ancestor
110122258|NCT01917331|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110122259|NCT01917331|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110122260|NCT01917331|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110122261|NCT01917331|Adrenergic Agents|adrenergic agents|mesh-ancestor
110122262|NCT01917331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110122263|NCT01917331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110122264|NCT01917331|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110122265|NCT01917331|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110122266|NCT01917331|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110122267|NCT01917331|Cholinergic Agents|cholinergic agents|mesh-ancestor
110122268|NCT01917331|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110122269|NCT01917331|Glucocorticoids|glucocorticoids|mesh-ancestor
110122271|NCT01917331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110122273|NCT01917448|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110122274|NCT01917448|Narcotics|narcotics|mesh-ancestor
110122275|NCT01917448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110122276|NCT01917448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110122277|NCT01917448|Analgesics|analgesics|mesh-ancestor
110122278|NCT01917448|Sensory System Agents|sensory system agents|mesh-ancestor
110122279|NCT01917448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110122280|NCT01917578|Paclitaxel|paclitaxel|mesh-list
110122281|NCT01917578|Docetaxel|docetaxel|mesh-list
110122282|NCT01917578|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110122283|NCT01917578|Cyclophosphamide|cyclophosphamide|mesh-list
110122284|NCT01917578|Carboplatin|carboplatin|mesh-list
110122285|NCT01917578|Doxorubicin|doxorubicin|mesh-list
110122286|NCT01917578|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110122287|NCT01917578|Fluorouracil|fluorouracil|mesh-list
110122288|NCT01917578|Trastuzumab|trastuzumab|mesh-list
110122289|NCT01917578|Epirubicin|epirubicin|mesh-list
110122290|NCT01917578|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110122291|NCT01917578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110122292|NCT01917578|Tubulin Modulators|tubulin modulators|mesh-ancestor
110122293|NCT01917578|Antimitotic Agents|antimitotic agents|mesh-ancestor
110122294|NCT01917578|Mitosis Modulators|mitosis modulators|mesh-ancestor
110122295|NCT01917578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110122296|NCT01917578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110122297|NCT01917578|Immunologic Factors|immunologic factors|mesh-ancestor
110122298|NCT01917578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110122299|NCT01917578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110122300|NCT01917578|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110122301|NCT01917578|Alkylating Agents|alkylating agents|mesh-ancestor
110122302|NCT01917578|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110122303|NCT01917578|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110122304|NCT01917578|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110122305|NCT01917578|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110122306|NCT01917578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110122307|NCT01917578|Antimetabolites|antimetabolites|mesh-ancestor
110122308|NCT01917578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110122309|NCT01917578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110122311|NCT01917617|Gemcitabine|gemcitabine|mesh-list
110122312|NCT01917617|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110122313|NCT01917617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110122314|NCT01917617|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110122316|NCT01917617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110122317|NCT01917708|Abatacept|abatacept|mesh-list
110122318|NCT01917708|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110122319|NCT01917708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110122320|NCT01917708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110122321|NCT01917708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110122322|NCT01917708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110122323|NCT01917708|Immunologic Factors|immunologic factors|mesh-ancestor
110122324|NCT01917708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110122325|NCT01917708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110122326|NCT01917721|Doxycycline|doxycycline|mesh-list
110122327|NCT01917721|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110122328|NCT01917721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110122329|NCT01917721|Antimalarials|antimalarials|mesh-ancestor
110122330|NCT01917721|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110122331|NCT01917721|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110122332|NCT01917799|Aspirin|aspirin|mesh-list
110122333|NCT01917799|Heparin|heparin|mesh-list
110122334|NCT01917799|Enoxaparin|enoxaparin|mesh-list
110122335|NCT01917799|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110122336|NCT01917799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110122337|NCT01917799|Analgesics|analgesics|mesh-ancestor
110122338|NCT01917799|Sensory System Agents|sensory system agents|mesh-ancestor
110122339|NCT01917799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110122340|NCT01917799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110122341|NCT01917799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110122342|NCT01917799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110122343|NCT01917799|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110122344|NCT01917799|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110122345|NCT01917799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110122346|NCT01917799|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110122347|NCT01917799|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110122348|NCT01917799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110122349|NCT01917799|Antipyretics|antipyretics|mesh-ancestor
110122350|NCT01917799|Anticoagulants|anticoagulants|mesh-ancestor
110122351|NCT01917890|Curcumin|curcumin|mesh-list
110122352|NCT01917890|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110122353|NCT01917890|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110122354|NCT01917890|Analgesics|analgesics|mesh-ancestor
110122355|NCT01917890|Sensory System Agents|sensory system agents|mesh-ancestor
110122356|NCT01917890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110122357|NCT01917890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110122358|NCT01917890|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110122359|NCT01917890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110122360|NCT01917890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110122361|NCT01917890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110122362|NCT01917890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110122365|NCT01918098|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110122367|NCT01918098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110122368|NCT01918098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110122369|NCT01918098|Analgesics|analgesics|mesh-ancestor
110122370|NCT01918098|Sensory System Agents|sensory system agents|mesh-ancestor
110122371|NCT01918098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110122372|NCT01918098|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110122373|NCT01918111|Adenosine|adenosine|mesh-list
110122374|NCT01918111|Analgesics|analgesics|mesh-ancestor
110122375|NCT01918111|Sensory System Agents|sensory system agents|mesh-ancestor
110122376|NCT01918111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110122377|NCT01918111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110122378|NCT01918111|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110122379|NCT01918111|Vasodilator Agents|vasodilator agents|mesh-ancestor
110122380|NCT01918111|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
110122381|NCT01918111|Purinergic Agonists|purinergic agonists|mesh-ancestor
110122382|NCT01918111|Purinergic Agents|purinergic agents|mesh-ancestor
110122383|NCT01918111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110122384|NCT01918111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110122385|NCT01918124|Paclitaxel|paclitaxel|mesh-list
110122386|NCT01918124|Cyclophosphamide|cyclophosphamide|mesh-list
110122387|NCT01918124|Cisplatin|cisplatin|mesh-list
110122388|NCT01918124|Carboplatin|carboplatin|mesh-list
110122389|NCT01918124|Doxorubicin|doxorubicin|mesh-list
110122390|NCT01918124|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110122391|NCT01918124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110122392|NCT01918124|Tubulin Modulators|tubulin modulators|mesh-ancestor
110122393|NCT01918124|Antimitotic Agents|antimitotic agents|mesh-ancestor
110122394|NCT01918124|Mitosis Modulators|mitosis modulators|mesh-ancestor
110122395|NCT01918124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110122396|NCT01918124|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110122397|NCT01918124|Immunologic Factors|immunologic factors|mesh-ancestor
110122398|NCT01918124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110122399|NCT01918124|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110122400|NCT01918124|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110122401|NCT01918124|Alkylating Agents|alkylating agents|mesh-ancestor
110122402|NCT01918124|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110122403|NCT01918124|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110122404|NCT01918124|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110122405|NCT01918124|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110122406|NCT01918124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110122408|NCT01918150|Chromium|chromium|mesh-list
110122409|NCT01918150|Trace Elements|trace elements|mesh-ancestor
110122410|NCT01918150|Micronutrients|micronutrients|mesh-ancestor
110122411|NCT01918150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110122412|NCT01918176|Palbociclib|palbociclib|mesh-list
110122413|NCT01918176|Rabeprazole|rabeprazole|mesh-list
110122414|NCT01918176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110122415|NCT01918176|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110122416|NCT01918176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110122417|NCT01918176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110122418|NCT01918176|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110122419|NCT01918176|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110122420|NCT01918176|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110122421|NCT01918241|Lenograstim|lenograstim|mesh-list
110122422|NCT01918241|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110122423|NCT01918241|Immunologic Factors|immunologic factors|mesh-ancestor
110122424|NCT01918241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110122425|NCT01918254|Paclitaxel|paclitaxel|mesh-list
110122426|NCT01918254|Pertuzumab|pertuzumab|mesh-list
110122427|NCT01918254|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110122428|NCT01918254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110122429|NCT01918254|Tubulin Modulators|tubulin modulators|mesh-ancestor
110122430|NCT01918254|Antimitotic Agents|antimitotic agents|mesh-ancestor
110122431|NCT01918254|Mitosis Modulators|mitosis modulators|mesh-ancestor
110122432|NCT01918254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110122433|NCT01918254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110122434|NCT01918358|Valsartan|valsartan|mesh-list
110122435|NCT01918358|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110122436|NCT01918358|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110122437|NCT01918358|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110122438|NCT01918358|Antimetabolites|antimetabolites|mesh-ancestor
110122439|NCT01918358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110122440|NCT01918358|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110122441|NCT01918358|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110122442|NCT01918358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110163846|NCT02013492|Propranolol|propranolol|mesh-list
110122443|NCT01918358|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110122444|NCT01918358|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110122445|NCT01918358|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110122446|NCT01918384|Arbekacin|arbekacin|mesh-list
110122447|NCT01918384|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110122448|NCT01918384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110122449|NCT01918475|Carbetocin|carbetocin|mesh-list
110122450|NCT01918475|Oxytocics|oxytocics|mesh-ancestor
110122451|NCT01918475|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110122452|NCT01918475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110122453|NCT01918488|Amiloride|amiloride|mesh-list
110122454|NCT01918488|Triamterene|triamterene|mesh-list
110122455|NCT01918488|Diuretics|diuretics|mesh-ancestor
110122456|NCT01918488|Natriuretic Agents|natriuretic agents|mesh-ancestor
110122457|NCT01918488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110122458|NCT01918488|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
110122459|NCT01918488|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110122460|NCT01918488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110122461|NCT01918488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110122462|NCT01918488|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
110122463|NCT01918488|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110122464|NCT01918514|Magnesium Sulfate|magnesium sulfate|mesh-list
110122465|NCT01918514|Analgesics|analgesics|mesh-ancestor
110122466|NCT01918514|Sensory System Agents|sensory system agents|mesh-ancestor
110122467|NCT01918514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110122468|NCT01918514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110122469|NCT01918514|Anesthetics|anesthetics|mesh-ancestor
110122470|NCT01918514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110122471|NCT01918514|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110122472|NCT01918514|Anticonvulsants|anticonvulsants|mesh-ancestor
110122473|NCT01918514|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110122474|NCT01918514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110122475|NCT01918514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110122476|NCT01918514|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110122477|NCT01918514|Tocolytic Agents|tocolytic agents|mesh-ancestor
110122478|NCT01918514|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110122479|NCT01918631|Tenofovir|tenofovir|mesh-list
110122480|NCT01918631|Entecavir|entecavir|mesh-list
110122481|NCT01918631|Antiviral Agents|antiviral agents|mesh-ancestor
110122482|NCT01918631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110122483|NCT01918631|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110122484|NCT01918631|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110122485|NCT01918631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110122486|NCT01918631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110122487|NCT01918631|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110122488|NCT01918631|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110122489|NCT01918709|Valsartan|valsartan|mesh-list
110122490|NCT01918709|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110122491|NCT01918709|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110122492|NCT01918709|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110122493|NCT01918709|Antimetabolites|antimetabolites|mesh-ancestor
110122494|NCT01918709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110122495|NCT01918709|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110122496|NCT01918709|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110122497|NCT01918709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110122498|NCT01918709|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110122499|NCT01918709|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110122500|NCT01918709|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110122501|NCT01918813|Vancomycin|vancomycin|mesh-list
110122502|NCT01918813|Mupirocin|mupirocin|mesh-list
110122503|NCT01918813|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110122504|NCT01918813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110122505|NCT01918813|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110122506|NCT01918813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110122507|NCT01918813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110122508|NCT01918852|Bevacizumab|bevacizumab|mesh-list
110122509|NCT01918852|Capecitabine|capecitabine|mesh-list
110122510|NCT01918852|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110122511|NCT01918852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110122512|NCT01918852|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110122513|NCT01918852|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110122514|NCT01918852|Growth Substances|growth substances|mesh-ancestor
110122515|NCT01918852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110122516|NCT01918852|Growth Inhibitors|growth inhibitors|mesh-ancestor
110122517|NCT01918852|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110122518|NCT01918852|Antimetabolites|antimetabolites|mesh-ancestor
110122519|NCT01918852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110122521|NCT01918865|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110122522|NCT01918865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110122523|NCT01918878|Aflibercept|aflibercept|mesh-list
110122524|NCT01918878|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110122525|NCT01918878|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110122526|NCT01918878|Growth Substances|growth substances|mesh-ancestor
110122527|NCT01918878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110122528|NCT01918878|Growth Inhibitors|growth inhibitors|mesh-ancestor
110122529|NCT01918878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110122530|NCT01918904|Sodium thiosulfate|sodium thiosulfate|mesh-list
110122531|NCT01918904|Antidotes|antidotes|mesh-ancestor
110223478|NCT00294463|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110223479|NCT00294463|Contraceptive Agents|contraceptive agents|mesh-ancestor
110223480|NCT00294463|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110223481|NCT00294463|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110223482|NCT00294463|Progestins|progestins|mesh-ancestor
110223483|NCT00294463|Androgen Antagonists|androgen antagonists|mesh-ancestor
110238902|NCT00098540|Sorafenib|sorafenib|mesh-list
110122532|NCT01918904|Protective Agents|protective agents|mesh-ancestor
110122533|NCT01918904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110122534|NCT01918904|Antioxidants|antioxidants|mesh-ancestor
110122535|NCT01918904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110122536|NCT01918904|Antitubercular Agents|antitubercular agents|mesh-ancestor
110122537|NCT01918904|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110122538|NCT01918904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110122539|NCT01918904|Chelating Agents|chelating agents|mesh-ancestor
110122540|NCT01918904|Sequestering Agents|sequestering agents|mesh-ancestor
110122541|NCT01918917|Dexmedetomidine|dexmedetomidine|mesh-list
110122542|NCT01918917|Morphine|morphine|mesh-list
110122543|NCT01918917|Levobupivacaine|levobupivacaine|mesh-list
110122544|NCT01918917|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110122545|NCT01918917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110122546|NCT01918917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110122547|NCT01918917|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110122548|NCT01918917|Analgesics|analgesics|mesh-ancestor
110122549|NCT01918917|Sensory System Agents|sensory system agents|mesh-ancestor
110122550|NCT01918917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110122551|NCT01918917|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110122552|NCT01918917|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110122553|NCT01918917|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110122554|NCT01918917|Adrenergic Agents|adrenergic agents|mesh-ancestor
110122555|NCT01918917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110122556|NCT01918917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110122557|NCT01918917|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110122558|NCT01918917|Narcotics|narcotics|mesh-ancestor
110122559|NCT01918917|Anesthetics, Local|anesthetics, local|mesh-ancestor
110122560|NCT01918917|Anesthetics|anesthetics|mesh-ancestor
110122561|NCT01918995|Regadenoson|regadenoson|mesh-list
110122562|NCT01918995|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
110122563|NCT01918995|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
110122564|NCT01918995|Purinergic Agonists|purinergic agonists|mesh-ancestor
110122565|NCT01918995|Purinergic Agents|purinergic agents|mesh-ancestor
110122566|NCT01918995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110122567|NCT01918995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110122568|NCT01918995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110122569|NCT01919008|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110122570|NCT01919008|Antidepressive Agents|antidepressive agents|mesh-ancestor
110122571|NCT01919008|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110122572|NCT01919008|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110122573|NCT01919008|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110122574|NCT01919008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110122575|NCT01919008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110122576|NCT01919047|Mirabegron|mirabegron|mesh-list
110122577|NCT01919047|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
110122578|NCT01919047|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110122579|NCT01919047|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110122580|NCT01919047|Adrenergic Agents|adrenergic agents|mesh-ancestor
110122581|NCT01919047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110122582|NCT01919047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110122583|NCT01919047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110122584|NCT01919047|Urological Agents|urological agents|mesh-ancestor
110122585|NCT01919203|Remifentanil|remifentanil|mesh-list
110122586|NCT01919203|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110122587|NCT01919203|Narcotics|narcotics|mesh-ancestor
110122588|NCT01919203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110122589|NCT01919203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110122590|NCT01919203|Analgesics|analgesics|mesh-ancestor
110122591|NCT01919203|Sensory System Agents|sensory system agents|mesh-ancestor
110122592|NCT01919203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110122593|NCT01919255|Picosulfate sodium|picosulfate sodium|mesh-list
110122594|NCT01919255|Sodium sulfate|sodium sulfate|mesh-list
110122595|NCT01919255|Magnesium Oxide|magnesium oxide|mesh-list
110122596|NCT01919255|Sodium Citrate|sodium citrate|mesh-list
110122597|NCT01919255|Citric Acid|citric acid|mesh-list
110122598|NCT01919255|Anticoagulants|anticoagulants|mesh-ancestor
110122599|NCT01919255|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110122600|NCT01919255|Chelating Agents|chelating agents|mesh-ancestor
110122601|NCT01919255|Sequestering Agents|sequestering agents|mesh-ancestor
110122602|NCT01919255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110122603|NCT01919255|Cathartics|cathartics|mesh-ancestor
110122604|NCT01919255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110122605|NCT01919255|Antacids|antacids|mesh-ancestor
110122606|NCT01919294|Methyltestosterone|methyltestosterone|mesh-list
110122607|NCT01919294|Testosterone|testosterone|mesh-list
110122608|NCT01919294|Testosterone undecanoate|testosterone undecanoate|mesh-list
110122609|NCT01919294|Testosterone enanthate|testosterone enanthate|mesh-list
110122610|NCT01919294|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
110122611|NCT01919294|Androgens|androgens|mesh-ancestor
110122613|NCT01919294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110122614|NCT01919294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110122615|NCT01919294|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110122616|NCT01919294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110122617|NCT01919294|Anabolic Agents|anabolic agents|mesh-ancestor
110122618|NCT01919346|Eculizumab|eculizumab|mesh-list
110122619|NCT01919346|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
110122620|NCT01919346|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110122621|NCT01919346|Immunologic Factors|immunologic factors|mesh-ancestor
110122622|NCT01919346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110122623|NCT01919424|Methacholine Chloride|methacholine chloride|mesh-list
110122624|NCT01919424|Miotics|miotics|mesh-ancestor
110122625|NCT01919424|Autonomic Agents|autonomic agents|mesh-ancestor
110122626|NCT01919424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110122627|NCT01919424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110122628|NCT01919424|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110122629|NCT01919424|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
110122630|NCT01919424|Respiratory System Agents|respiratory system agents|mesh-ancestor
110122631|NCT01919424|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
110122632|NCT01919424|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110122633|NCT01919424|Cholinergic Agents|cholinergic agents|mesh-ancestor
110122634|NCT01919424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110122635|NCT01919424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110122636|NCT01919593|Chlorhexidine|chlorhexidine|mesh-list
110122637|NCT01919593|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110122638|NCT01919593|Povidone-Iodine|povidone-iodine|mesh-list
110122639|NCT01919593|Povidone|povidone|mesh-list
110122640|NCT01919593|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110122641|NCT01919593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110122642|NCT01919593|Disinfectants|disinfectants|mesh-ancestor
110122643|NCT01919593|Dermatologic Agents|dermatologic agents|mesh-ancestor
110122644|NCT01919593|Plasma Substitutes|plasma substitutes|mesh-ancestor
110122645|NCT01919593|Blood Substitutes|blood substitutes|mesh-ancestor
110122646|NCT01919788|Insulin|insulin|mesh-list
110122647|NCT01919788|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110122648|NCT01919788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110122649|NCT01919879|Cetuximab|cetuximab|mesh-list
110122650|NCT01919879|Afatinib|afatinib|mesh-list
110122651|NCT01919879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110122652|NCT01919879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110122653|NCT01919879|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110122654|NCT01919879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110122655|NCT01919879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110122656|NCT01919892|Lithium Carbonate|lithium carbonate|mesh-list
110122657|NCT01919892|Antidepressive Agents|antidepressive agents|mesh-ancestor
110122658|NCT01919892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110122659|NCT01919892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110122660|NCT01919892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110122661|NCT01919892|Antimanic Agents|antimanic agents|mesh-ancestor
110122662|NCT01919892|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110122663|NCT01919892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110122664|NCT01919892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110122665|NCT01919905|Vitamin D|vitamin d|mesh-list
110122666|NCT01919905|Vitamins|vitamins|mesh-ancestor
110122667|NCT01919905|Micronutrients|micronutrients|mesh-ancestor
110122668|NCT01919905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110122669|NCT01919905|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110122671|NCT01919918|Analgesics|analgesics|mesh-ancestor
110122672|NCT01919918|Sensory System Agents|sensory system agents|mesh-ancestor
110122673|NCT01919918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110122674|NCT01919918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110122675|NCT01919918|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110122676|NCT01919918|Vasodilator Agents|vasodilator agents|mesh-ancestor
110122677|NCT01919918|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
110122678|NCT01919918|Purinergic Agonists|purinergic agonists|mesh-ancestor
110122679|NCT01919918|Purinergic Agents|purinergic agents|mesh-ancestor
110122680|NCT01919918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110122681|NCT01919918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110122682|NCT01920022|Contraceptive Agents|contraceptive agents|mesh-list
110122684|NCT01920022|Etonogestrel|etonogestrel|mesh-list
110122685|NCT01920022|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110122686|NCT01920022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110122687|NCT01920022|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
110122688|NCT01920022|Abortifacient Agents|abortifacient agents|mesh-ancestor
110122689|NCT01920022|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110122690|NCT01920022|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110122691|NCT01920022|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110122692|NCT01920022|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
110122693|NCT01920022|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
110122694|NCT01920022|Hormone Antagonists|hormone antagonists|mesh-ancestor
110122695|NCT01920022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110122696|NCT01920022|Luteolytic Agents|luteolytic agents|mesh-ancestor
110122697|NCT01920022|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110122698|NCT01920022|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
110122699|NCT01920074|Nitroglycerin|nitroglycerin|mesh-list
110122700|NCT01920074|Vasodilator Agents|vasodilator agents|mesh-ancestor
110122701|NCT01920516|Melphalan|melphalan|mesh-list
110122702|NCT01920516|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110122703|NCT01920516|Alkylating Agents|alkylating agents|mesh-ancestor
110122704|NCT01920516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110122705|NCT01920516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110122706|NCT01920516|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110122707|NCT01920516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110122708|NCT01920516|Immunologic Factors|immunologic factors|mesh-ancestor
110122709|NCT01920516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110122710|NCT01920984|Bevacizumab|bevacizumab|mesh-list
110122711|NCT01920984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110122712|NCT01920984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110122713|NCT01920984|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110122714|NCT01920984|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110122715|NCT01920984|Growth Substances|growth substances|mesh-ancestor
110122716|NCT01920984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110122717|NCT01920984|Growth Inhibitors|growth inhibitors|mesh-ancestor
110122719|NCT01921374|Interferons|interferons|mesh-list
110122720|NCT01921374|Interferon-gamma|interferon-gamma|mesh-list
110122721|NCT01921374|Interleukin-2|interleukin-2|mesh-list
110122722|NCT01921374|Interleukin-4|interleukin-4|mesh-list
110122723|NCT01921374|Dinoprostone|dinoprostone|mesh-list
110122724|NCT01921374|Hormones|hormones|mesh-list
110122725|NCT01921374|Estradiol|estradiol|mesh-list
110122727|NCT01921374|Progesterone|progesterone|mesh-list
110122728|NCT01921374|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
110122729|NCT01921374|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
110122730|NCT01921374|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
110122731|NCT01921374|Immunoglobulins|immunoglobulins|mesh-list
110122732|NCT01921374|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110122733|NCT01921374|Antibodies|antibodies|mesh-list
110122734|NCT01921374|Immunoglobulin G|immunoglobulin g|mesh-list
110122735|NCT01921374|Complement System Proteins|complement system proteins|mesh-list
110122736|NCT01921374|Immunoglobulin A|immunoglobulin a|mesh-list
110122737|NCT01921374|Immunoglobulin M|immunoglobulin m|mesh-list
110122738|NCT01921374|beta-Endorphin|beta-endorphin|mesh-list
110122739|NCT01921374|Uric Acid|uric acid|mesh-list
110122740|NCT01921374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110122741|NCT01921374|Vitamins|vitamins|mesh-ancestor
110122742|NCT01921374|Micronutrients|micronutrients|mesh-ancestor
110122743|NCT01921374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110122745|NCT01921374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110122746|NCT01921374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110122747|NCT01921374|Estrogens|estrogens|mesh-ancestor
110122748|NCT01921374|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110122749|NCT01921374|Immunologic Factors|immunologic factors|mesh-ancestor
110122750|NCT01921374|Androgens|androgens|mesh-ancestor
110122751|NCT01921374|Progestins|progestins|mesh-ancestor
110122752|NCT01921374|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110122753|NCT01921374|Analgesics|analgesics|mesh-ancestor
110122754|NCT01921374|Sensory System Agents|sensory system agents|mesh-ancestor
110122755|NCT01921374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110122756|NCT01921374|Vitamin B Complex|vitamin b complex|mesh-ancestor
110122757|NCT01921374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110122758|NCT01921374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110122759|NCT01921374|Antioxidants|antioxidants|mesh-ancestor
110122760|NCT01921374|Protective Agents|protective agents|mesh-ancestor
110122761|NCT01921374|Oxytocics|oxytocics|mesh-ancestor
110122762|NCT01921374|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110122763|NCT01921374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110122765|NCT01921972|Galantamine|galantamine|mesh-list
110122766|NCT01921972|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110122767|NCT01921972|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110122768|NCT01921972|Dopamine Agents|dopamine agents|mesh-ancestor
110122769|NCT01921972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110122770|NCT01921972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110122771|NCT01921972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110122772|NCT01921972|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110122773|NCT01921972|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110122774|NCT01921972|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110122775|NCT01921972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110122776|NCT01921972|Cholinergic Agents|cholinergic agents|mesh-ancestor
110122777|NCT01921972|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110122778|NCT01921972|Autonomic Agents|autonomic agents|mesh-ancestor
110122779|NCT01921972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110122780|NCT01921972|Nootropic Agents|nootropic agents|mesh-ancestor
110122781|NCT01923454|Acetazolamide|acetazolamide|mesh-list
110122782|NCT01923454|Anticonvulsants|anticonvulsants|mesh-ancestor
110122783|NCT01923454|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110122784|NCT01923454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110122785|NCT01923454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110122786|NCT01923454|Diuretics|diuretics|mesh-ancestor
110122787|NCT01923454|Natriuretic Agents|natriuretic agents|mesh-ancestor
110122788|NCT01923454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110122789|NCT01923935|Melphalan|melphalan|mesh-list
110122790|NCT01923935|Busulfan|busulfan|mesh-list
110122791|NCT01923935|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110122792|NCT01923935|Alkylating Agents|alkylating agents|mesh-ancestor
110122793|NCT01923935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110122794|NCT01923935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110122795|NCT01923935|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110122796|NCT01923935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110122797|NCT01923935|Immunologic Factors|immunologic factors|mesh-ancestor
110122798|NCT01923935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110122799|NCT01923974|Melatonin|melatonin|mesh-list
110122800|NCT01923974|Antioxidants|antioxidants|mesh-ancestor
110122801|NCT01923974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110122802|NCT01923974|Protective Agents|protective agents|mesh-ancestor
110122803|NCT01923974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110122804|NCT01923974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110122805|NCT01924013|Vitamin D|vitamin d|mesh-list
110122806|NCT01924013|Cholecalciferol|cholecalciferol|mesh-list
110122807|NCT01924013|Vitamins|vitamins|mesh-ancestor
110122808|NCT01924013|Micronutrients|micronutrients|mesh-ancestor
110122809|NCT01924013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110122810|NCT01924013|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110122811|NCT01924013|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110122812|NCT01924676|Oxycodone|oxycodone|mesh-list
110122813|NCT01924676|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110122814|NCT01924676|Narcotics|narcotics|mesh-ancestor
110122815|NCT01924676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110122816|NCT01924676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110122817|NCT01924676|Analgesics|analgesics|mesh-ancestor
110122818|NCT01924676|Sensory System Agents|sensory system agents|mesh-ancestor
110122819|NCT01924676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110122820|NCT01925066|Vancomycin|vancomycin|mesh-list
110122821|NCT01925066|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110122822|NCT01925066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110122823|NCT01927640|Cocaine|cocaine|mesh-list
110122824|NCT01927640|Dexmedetomidine|dexmedetomidine|mesh-list
110122825|NCT01927640|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110122826|NCT01927640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110122827|NCT01927640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110122828|NCT01927640|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110122829|NCT01927640|Analgesics|analgesics|mesh-ancestor
110122830|NCT01927640|Sensory System Agents|sensory system agents|mesh-ancestor
110122831|NCT01927640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110122832|NCT01927640|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110122833|NCT01927640|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110122834|NCT01927640|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110122835|NCT01927640|Adrenergic Agents|adrenergic agents|mesh-ancestor
110122836|NCT01927640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110122837|NCT01927640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110122838|NCT01927640|Anesthetics, Local|anesthetics, local|mesh-ancestor
110122839|NCT01927640|Anesthetics|anesthetics|mesh-ancestor
110122840|NCT01927640|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110122841|NCT01927640|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110122842|NCT01927640|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110122843|NCT01927640|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110122844|NCT01927640|Dopamine Agents|dopamine agents|mesh-ancestor
110122845|NCT01927679|Vitamin E|vitamin e|mesh-list
110122846|NCT01927679|Antioxidants|antioxidants|mesh-list
110122847|NCT01927679|Vitamins|vitamins|mesh-ancestor
110122848|NCT01927679|Micronutrients|micronutrients|mesh-ancestor
110122849|NCT01927679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110122850|NCT01927679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110122851|NCT01927679|Protective Agents|protective agents|mesh-ancestor
110122852|NCT01927965|14-O-phosphonooxymethyltriptolide disodium salt|14-o-phosphonooxymethyltriptolide disodium salt|mesh-list
110122853|NCT01927965|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110122854|NCT01927965|Alkylating Agents|alkylating agents|mesh-ancestor
110122855|NCT01927965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110122856|NCT01927965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110122857|NCT01928407|Atazanavir Sulfate|atazanavir sulfate|mesh-list
110122858|NCT01928407|Darunavir|darunavir|mesh-list
110122859|NCT01928407|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110122860|NCT01928407|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110122861|NCT01928407|Protease Inhibitors|protease inhibitors|mesh-ancestor
110122862|NCT01928407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110122863|NCT01928407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110122864|NCT01928407|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110122865|NCT01928407|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110122866|NCT01928407|Antiviral Agents|antiviral agents|mesh-ancestor
110122867|NCT01928407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110122868|NCT01928875|Anesthetics|anesthetics|mesh-list
110122869|NCT01928875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110122870|NCT01928875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110122871|NCT01929486|Mogamulizumab|mogamulizumab|mesh-list
110122872|NCT01929486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110122873|NCT01929590|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
110122874|NCT01929590|Laxatives|laxatives|mesh-ancestor
110122875|NCT01929590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110122877|NCT01930019|Etomidate|etomidate|mesh-list
110122878|NCT01930019|Anesthetics|anesthetics|mesh-ancestor
110122879|NCT01930019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110122880|NCT01930019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110122881|NCT01930019|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110122882|NCT01930019|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110122883|NCT01930019|Anesthetics, General|anesthetics, general|mesh-ancestor
110122884|NCT01930019|Anticonvulsants|anticonvulsants|mesh-ancestor
110122885|NCT01930019|GABA Modulators|gaba modulators|mesh-ancestor
110122886|NCT01930019|GABA Agents|gaba agents|mesh-ancestor
110122887|NCT01930019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110122888|NCT01930019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110122889|NCT01930201|Anesthetics|anesthetics|mesh-list
110122890|NCT01930201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110122891|NCT01930201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110122892|NCT01930292|Paclitaxel|paclitaxel|mesh-list
110122893|NCT01930292|Carboplatin|carboplatin|mesh-list
110122894|NCT01930292|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110122895|NCT01930292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110122896|NCT01930292|Tubulin Modulators|tubulin modulators|mesh-ancestor
110122898|NCT01930292|Mitosis Modulators|mitosis modulators|mesh-ancestor
110122899|NCT01930292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110122900|NCT01930318|Parecoxib|parecoxib|mesh-list
110122901|NCT01930318|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110122902|NCT01930318|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110122903|NCT01930318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110122904|NCT01930318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110122905|NCT01930318|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110122906|NCT01930318|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110122907|NCT01930318|Analgesics|analgesics|mesh-ancestor
110122908|NCT01930318|Sensory System Agents|sensory system agents|mesh-ancestor
110122909|NCT01930318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110122910|NCT01930318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110122911|NCT01930318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110122912|NCT01930318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110122914|NCT01930331|Artenimol|artenimol|mesh-list
110122915|NCT01930331|Artemisinins|artemisinins|mesh-list
110122916|NCT01930331|Artemisinin|artemisinin|mesh-list
110122917|NCT01930331|Antimalarials|antimalarials|mesh-ancestor
110122918|NCT01930331|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110122919|NCT01930331|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110122920|NCT01930331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110122921|NCT01930370|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110122922|NCT01930370|Hemodialysis Solutions|hemodialysis solutions|mesh-list
110122923|NCT01930370|Dialysis Solutions|dialysis solutions|mesh-ancestor
110122924|NCT01930396|Heparin|heparin|mesh-list
110122925|NCT01930396|Calcium heparin|calcium heparin|mesh-list
110122926|NCT01930396|Tinzaparin|tinzaparin|mesh-list
110122927|NCT01930396|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
110122928|NCT01930396|Dalteparin|dalteparin|mesh-list
110122929|NCT01930396|Anticoagulants|anticoagulants|mesh-ancestor
110122930|NCT01930396|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110122931|NCT01930396|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110122932|NCT01930396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110122933|NCT01930461|Immunomodulating Agents|immunomodulating agents|mesh-list
110122934|NCT01930461|Immunologic Factors|immunologic factors|mesh-list
110122935|NCT01930461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110122936|NCT01930552|Leucovorin|leucovorin|mesh-list
110122937|NCT01930552|Fluorouracil|fluorouracil|mesh-list
110122938|NCT01930552|Irinotecan|irinotecan|mesh-list
110122939|NCT01930552|Aflibercept|aflibercept|mesh-list
110122940|NCT01930552|Antimetabolites|antimetabolites|mesh-ancestor
110122941|NCT01930552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110122942|NCT01930552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110122943|NCT01930552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110122944|NCT01930552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110122945|NCT01930552|Immunologic Factors|immunologic factors|mesh-ancestor
110122946|NCT01930552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110122947|NCT01930552|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110122948|NCT01930552|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110122949|NCT01930552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110122950|NCT01930552|Antidotes|antidotes|mesh-ancestor
110122951|NCT01930552|Protective Agents|protective agents|mesh-ancestor
110122952|NCT01930552|Vitamin B Complex|vitamin b complex|mesh-ancestor
110122953|NCT01930552|Vitamins|vitamins|mesh-ancestor
110122954|NCT01930552|Micronutrients|micronutrients|mesh-ancestor
110122955|NCT01930552|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110122956|NCT01930552|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110122957|NCT01930552|Growth Substances|growth substances|mesh-ancestor
110122958|NCT01930552|Growth Inhibitors|growth inhibitors|mesh-ancestor
110122959|NCT01930591|Clopidogrel|clopidogrel|mesh-list
110122960|NCT01930591|Ticagrelor|ticagrelor|mesh-list
110122961|NCT01930591|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110122962|NCT01930591|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110122963|NCT01930591|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110122964|NCT01930591|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110122965|NCT01930591|Purinergic Agents|purinergic agents|mesh-ancestor
110122966|NCT01930591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110122967|NCT01930591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110122968|NCT01930591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110122969|NCT01930604|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
110122970|NCT01930604|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110122971|NCT01930604|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110122972|NCT01930604|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110122973|NCT01930604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110223582|NCT00294931|Irinotecan|irinotecan|mesh-list
110122974|NCT01930604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110122975|NCT01930604|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110122976|NCT01930604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110122977|NCT01930604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110122978|NCT01930604|Cholinergic Agents|cholinergic agents|mesh-ancestor
110122979|NCT01930604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110122980|NCT01930604|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110122981|NCT01930682|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
110122982|NCT01930682|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110122983|NCT01930682|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110122984|NCT01930682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110122985|NCT01930708|Dimethyl Fumarate|dimethyl fumarate|mesh-list
110122986|NCT01930708|Dermatologic Agents|dermatologic agents|mesh-ancestor
110122987|NCT01930708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110122988|NCT01930708|Immunologic Factors|immunologic factors|mesh-ancestor
110122989|NCT01930708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110122991|NCT01930734|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110122992|NCT01930734|Sympathomimetics|sympathomimetics|mesh-ancestor
110122993|NCT01930734|Autonomic Agents|autonomic agents|mesh-ancestor
110122994|NCT01930734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110122995|NCT01930734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110122996|NCT01930734|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
110122997|NCT01930734|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110122998|NCT01930734|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110122999|NCT01930734|Adrenergic Agents|adrenergic agents|mesh-ancestor
110123000|NCT01930734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110123001|NCT01930734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110123003|NCT01930773|Clopidogrel|clopidogrel|mesh-list
110123004|NCT01930773|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110123005|NCT01930773|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110123006|NCT01930773|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110123007|NCT01930773|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110123008|NCT01930773|Purinergic Agents|purinergic agents|mesh-ancestor
110123009|NCT01930773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110123010|NCT01930773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110123011|NCT01930773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110123012|NCT01930786|Botulinum Toxins|botulinum toxins|mesh-list
110123013|NCT01930786|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110123014|NCT01930786|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110123015|NCT01930786|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110123016|NCT01930786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110123017|NCT01930786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110123018|NCT01930786|Cholinergic Agents|cholinergic agents|mesh-ancestor
110123019|NCT01930786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110123020|NCT01930786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110123021|NCT01930786|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110123022|NCT01930786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110123024|NCT01930812|Fluorides|fluorides|mesh-list
110123025|NCT01930812|Sodium Fluoride|sodium fluoride|mesh-list
110123026|NCT01930812|Technetium Tc 99m Medronate|technetium tc 99m medronate|mesh-list
110123027|NCT01930812|Cariostatic Agents|cariostatic agents|mesh-ancestor
110123028|NCT01930812|Protective Agents|protective agents|mesh-ancestor
110123029|NCT01930812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110123030|NCT01930812|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110123031|NCT01930812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110223596|NCT02958423|Serotonin Agents|serotonin agents|mesh-ancestor
110123032|NCT01930812|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110123033|NCT01930812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110123035|NCT01930864|Irinotecan|irinotecan|mesh-list
110123036|NCT01930864|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110123037|NCT01930864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110123038|NCT01930864|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110123039|NCT01930864|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110123040|NCT01930864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110123041|NCT01930864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110123042|NCT01930864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110123043|NCT01930877|Lidocaine|lidocaine|mesh-list
110123044|NCT01930877|Anesthetics, Local|anesthetics, local|mesh-ancestor
110123045|NCT01930877|Anesthetics|anesthetics|mesh-ancestor
110123046|NCT01930877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110123047|NCT01930877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110123048|NCT01930877|Sensory System Agents|sensory system agents|mesh-ancestor
110123049|NCT01930877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110123050|NCT01930877|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110123051|NCT01930877|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110123052|NCT01930877|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110123053|NCT01930877|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110123054|NCT01930877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110123055|NCT01930916|Anticoagulants|anticoagulants|mesh-list
110123056|NCT01930916|Antibodies|antibodies|mesh-list
110123057|NCT01930916|Antibodies, Antiphospholipid|antibodies, antiphospholipid|mesh-list
110123058|NCT01930916|Lupus Coagulation Inhibitor|lupus coagulation inhibitor|mesh-list
110123059|NCT01930916|Immunologic Factors|immunologic factors|mesh-ancestor
110123060|NCT01930916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110123061|NCT01931085|Triclabendazole|triclabendazole|mesh-list
110123062|NCT01931085|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110123063|NCT01931085|Anthelmintics|anthelmintics|mesh-ancestor
110123065|NCT01931085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110123066|NCT01931098|Topotecan|topotecan|mesh-list
110123067|NCT01931098|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110123068|NCT01931098|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110123069|NCT01931098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110123070|NCT01931098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110123071|NCT01931098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110123072|NCT01931137|Insulin|insulin|mesh-list
110123073|NCT01931137|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110123074|NCT01931137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110123075|NCT01931189|Infliximab|infliximab|mesh-list
110123076|NCT01931189|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110123077|NCT01931189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110123078|NCT01931189|Dermatologic Agents|dermatologic agents|mesh-ancestor
110123079|NCT01931189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110123080|NCT01931189|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110123081|NCT01931215|Clonidine|clonidine|mesh-list
110123082|NCT01931215|Morphine|morphine|mesh-list
110123083|NCT01931215|Ropivacaine|ropivacaine|mesh-list
110123084|NCT01931215|Anesthetics|anesthetics|mesh-ancestor
110123085|NCT01931215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110123086|NCT01931215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110123087|NCT01931215|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110123088|NCT01931215|Narcotics|narcotics|mesh-ancestor
110123089|NCT01931215|Analgesics|analgesics|mesh-ancestor
110123090|NCT01931215|Sensory System Agents|sensory system agents|mesh-ancestor
110123091|NCT01931215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110123092|NCT01931215|Anesthetics, Local|anesthetics, local|mesh-ancestor
110123093|NCT01931215|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110123094|NCT01931215|Sympatholytics|sympatholytics|mesh-ancestor
110123095|NCT01931215|Autonomic Agents|autonomic agents|mesh-ancestor
110223600|NCT00295165|Sargramostim|sargramostim|mesh-list
110123096|NCT01931215|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110123097|NCT01931215|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110123098|NCT01931215|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110123099|NCT01931215|Adrenergic Agents|adrenergic agents|mesh-ancestor
110123100|NCT01931215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110123101|NCT01931215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110123102|NCT01931293|Folic Acid|folic acid|mesh-list
110123103|NCT01931293|Vitamin B Complex|vitamin b complex|mesh-list
110123104|NCT01931293|Vitamins|vitamins|mesh-ancestor
110123106|NCT01931293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110123107|NCT01931293|Hematinics|hematinics|mesh-ancestor
110123108|NCT01931306|Afatinib|afatinib|mesh-list
110123109|NCT01931306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110123110|NCT01931306|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110123111|NCT01931306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110123112|NCT01931306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110123113|NCT01931319|Baclofen|baclofen|mesh-list
110123114|NCT01931319|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110123115|NCT01931319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110123116|NCT01931319|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110123117|NCT01931319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110123118|NCT01931319|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
110123119|NCT01931319|GABA Agonists|gaba agonists|mesh-ancestor
110123120|NCT01931319|GABA Agents|gaba agents|mesh-ancestor
110123121|NCT01931319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110123122|NCT01931319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110123123|NCT01931332|Heroin|heroin|mesh-list
110123124|NCT01931332|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110123126|NCT01931332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110123127|NCT01931332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110123128|NCT01931332|Analgesics|analgesics|mesh-ancestor
110123129|NCT01931332|Sensory System Agents|sensory system agents|mesh-ancestor
110123130|NCT01931332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110123131|NCT01931384|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
110123132|NCT01931384|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110123133|NCT01931384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110123134|NCT01931410|Misoprostol|misoprostol|mesh-list
110123135|NCT01931410|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110123136|NCT01931410|Abortifacient Agents|abortifacient agents|mesh-ancestor
110123137|NCT01931410|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110123138|NCT01931410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110123139|NCT01931410|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110123140|NCT01931410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110123141|NCT01931410|Oxytocics|oxytocics|mesh-ancestor
110123142|NCT01931501|Montelukast|montelukast|mesh-list
110123143|NCT01931501|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110123144|NCT01931501|Respiratory System Agents|respiratory system agents|mesh-ancestor
110123145|NCT01931501|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110123146|NCT01931501|Hormone Antagonists|hormone antagonists|mesh-ancestor
110123147|NCT01931501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110123148|NCT01931501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110123149|NCT01931501|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110123150|NCT01931501|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110123151|NCT01931501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110123152|NCT01931514|Montelukast|montelukast|mesh-list
110123153|NCT01931514|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110123154|NCT01931514|Respiratory System Agents|respiratory system agents|mesh-ancestor
110123155|NCT01931514|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110123156|NCT01931514|Hormone Antagonists|hormone antagonists|mesh-ancestor
110123157|NCT01931514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110123158|NCT01931514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110123159|NCT01931514|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110123160|NCT01931514|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110123161|NCT01931514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110123162|NCT01931592|Gentamicins|gentamicins|mesh-list
110123163|NCT01931592|Colistin|colistin|mesh-list
110123164|NCT01931592|Fosfomycin|fosfomycin|mesh-list
110123165|NCT01931592|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110123166|NCT01931592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110123167|NCT01931592|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110123168|NCT01931592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110123169|NCT01931592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110123170|NCT01931657|Mifepristone|mifepristone|mesh-list
110123171|NCT01931657|Levonorgestrel|levonorgestrel|mesh-list
110123172|NCT01931657|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
110123173|NCT01931657|Abortifacient Agents|abortifacient agents|mesh-ancestor
110123174|NCT01931657|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110123175|NCT01931657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110123176|NCT01931657|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110123177|NCT01931657|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110123178|NCT01931657|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110123179|NCT01931657|Contraceptive Agents|contraceptive agents|mesh-ancestor
110123180|NCT01931657|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
110123181|NCT01931657|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
110123182|NCT01931657|Hormone Antagonists|hormone antagonists|mesh-ancestor
110123183|NCT01931657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110123184|NCT01931657|Luteolytic Agents|luteolytic agents|mesh-ancestor
110123185|NCT01931657|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110123186|NCT01931657|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
110123187|NCT01931683|Remifentanil|remifentanil|mesh-list
110123188|NCT01931683|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110123189|NCT01931683|Narcotics|narcotics|mesh-ancestor
110123190|NCT01931683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110123191|NCT01931683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110123192|NCT01931683|Analgesics|analgesics|mesh-ancestor
110123193|NCT01931683|Sensory System Agents|sensory system agents|mesh-ancestor
110123194|NCT01931683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110123195|NCT01931787|Thioctic Acid|thioctic acid|mesh-list
110123196|NCT01931787|Antioxidants|antioxidants|mesh-ancestor
110123197|NCT01931787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110123199|NCT01931787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110123200|NCT01931787|Vitamin B Complex|vitamin b complex|mesh-ancestor
110123201|NCT01931787|Vitamins|vitamins|mesh-ancestor
110123202|NCT01931787|Micronutrients|micronutrients|mesh-ancestor
110123203|NCT01931982|Liraglutide|liraglutide|mesh-list
110123204|NCT01931982|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110123205|NCT01931982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110123206|NCT01931982|Incretins|incretins|mesh-ancestor
110123207|NCT01931982|Hormones|hormones|mesh-ancestor
110123208|NCT01931982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110123209|NCT01932151|Terlipressin|terlipressin|mesh-list
110123210|NCT01932151|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110123211|NCT01932151|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110123212|NCT01932177|Everolimus|everolimus|mesh-list
110123213|NCT01932177|Sorafenib|sorafenib|mesh-list
110123214|NCT01932177|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110123215|NCT01932177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110123216|NCT01932177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110123217|NCT01932177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110123218|NCT01932177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110123219|NCT01932177|Immunologic Factors|immunologic factors|mesh-ancestor
110123220|NCT01932177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110123221|NCT01932177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110123222|NCT01932203|Aspirin|aspirin|mesh-list
110123223|NCT01932203|Cilostazol|cilostazol|mesh-list
110123224|NCT01932203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110123225|NCT01932203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110223625|NCT00089622|Dopamine Agonists|dopamine agonists|mesh-ancestor
110123227|NCT01932203|Sensory System Agents|sensory system agents|mesh-ancestor
110123228|NCT01932203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110123229|NCT01932203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110123230|NCT01932203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110123231|NCT01932203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110123232|NCT01932203|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110123233|NCT01932203|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110123234|NCT01932203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110123235|NCT01932203|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110123236|NCT01932203|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110123237|NCT01932203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110123238|NCT01932203|Antipyretics|antipyretics|mesh-ancestor
110123239|NCT01932203|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110123240|NCT01932203|Autonomic Agents|autonomic agents|mesh-ancestor
110123241|NCT01932203|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110123242|NCT01932203|Respiratory System Agents|respiratory system agents|mesh-ancestor
110123243|NCT01932203|Vasodilator Agents|vasodilator agents|mesh-ancestor
110123244|NCT01932203|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110123245|NCT01932203|Protective Agents|protective agents|mesh-ancestor
110123246|NCT01932203|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110123247|NCT01932203|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110123248|NCT01932229|Afatinib|afatinib|mesh-list
110123249|NCT01932229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110123250|NCT01932229|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110123251|NCT01932229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110123252|NCT01932229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110123253|NCT01932268|Rifampin|rifampin|mesh-list
110123254|NCT01932268|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110123255|NCT01932268|Antitubercular Agents|antitubercular agents|mesh-ancestor
110123256|NCT01932268|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110123257|NCT01932268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110123258|NCT01932268|Leprostatic Agents|leprostatic agents|mesh-ancestor
110123259|NCT01932268|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110123260|NCT01932268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110123261|NCT01932268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110123262|NCT01932268|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110123263|NCT01932268|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110123264|NCT01932268|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110123265|NCT01932268|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110123266|NCT01932268|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110123267|NCT01932268|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110123268|NCT01932320|Ketoconazole|ketoconazole|mesh-list
110123269|NCT01932320|Antifungal Agents|antifungal agents|mesh-ancestor
110123270|NCT01932320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110123271|NCT01932320|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110123272|NCT01932320|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110123273|NCT01932320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110123274|NCT01932320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110123275|NCT01932320|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110123276|NCT01932320|Hormone Antagonists|hormone antagonists|mesh-ancestor
110123277|NCT01932320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110123278|NCT01932320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110123279|NCT01932320|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110123280|NCT01932372|Etanercept|etanercept|mesh-list
110123281|NCT01932372|Antirheumatic Agents|antirheumatic agents|mesh-list
110123282|NCT01932372|Tofacitinib|tofacitinib|mesh-list
110123283|NCT01932372|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110223645|NCT00295672|Vinorelbine|vinorelbine|mesh-list
110123284|NCT01932372|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110123285|NCT01932372|Analgesics|analgesics|mesh-ancestor
110123286|NCT01932372|Sensory System Agents|sensory system agents|mesh-ancestor
110123287|NCT01932372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110123288|NCT01932372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110123289|NCT01932372|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110123290|NCT01932372|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110123291|NCT01932372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110123292|NCT01932372|Immunologic Factors|immunologic factors|mesh-ancestor
110123293|NCT01932372|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
110123294|NCT01932372|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110123295|NCT01932372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110123296|NCT01932372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110123297|NCT01932385|Sorafenib|sorafenib|mesh-list
110123298|NCT01932385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110123299|NCT01932385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110123300|NCT01932385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110123301|NCT01932385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110123302|NCT01932424|Propofol|propofol|mesh-list
110123303|NCT01932424|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110123304|NCT01932424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110123305|NCT01932424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110123306|NCT01932424|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110123307|NCT01932424|Anesthetics, General|anesthetics, general|mesh-ancestor
110123308|NCT01932424|Anesthetics|anesthetics|mesh-ancestor
110123309|NCT01932450|Antihypertensive Agents|antihypertensive agents|mesh-list
110123310|NCT01932502|Clobazam|clobazam|mesh-list
110123311|NCT01932502|Anticonvulsants|anticonvulsants|mesh-ancestor
110123312|NCT01932502|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110123313|NCT01932502|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110123314|NCT01932502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110123315|NCT01932502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110123316|NCT01932502|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110123317|NCT01932502|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
110123318|NCT01932502|GABA Agonists|gaba agonists|mesh-ancestor
110123319|NCT01932502|GABA Agents|gaba agents|mesh-ancestor
110123320|NCT01932502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110123321|NCT01932502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110123322|NCT01932541|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
110123323|NCT01932541|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110123324|NCT01932541|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110123325|NCT01932541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110123326|NCT01932541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110123327|NCT01932541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110123328|NCT01932541|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
110123329|NCT01932541|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110123330|NCT01932541|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110123331|NCT01932541|Adrenergic Agents|adrenergic agents|mesh-ancestor
110123332|NCT01932541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110123333|NCT01932541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110123334|NCT01932541|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110123335|NCT01932541|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110123336|NCT01932541|Serotonin Agents|serotonin agents|mesh-ancestor
110123337|NCT01932541|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110123338|NCT01932541|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110123339|NCT01932541|Dopamine Agents|dopamine agents|mesh-ancestor
110123340|NCT01932554|Ibuprofen|ibuprofen|mesh-list
110123341|NCT01932554|Fentanyl|fentanyl|mesh-list
110123342|NCT01932554|Morphine|morphine|mesh-list
110123343|NCT01932554|Hydromorphone|hydromorphone|mesh-list
110123344|NCT01932554|Narcotics|narcotics|mesh-list
110123345|NCT01932554|Abciximab|abciximab|mesh-list
110123346|NCT01932554|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110123347|NCT01932554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110123348|NCT01932554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110123349|NCT01932554|Analgesics|analgesics|mesh-ancestor
110123350|NCT01932554|Sensory System Agents|sensory system agents|mesh-ancestor
110123351|NCT01932554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110123352|NCT01932554|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110123353|NCT01932554|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110123354|NCT01932554|Anesthetics, General|anesthetics, general|mesh-ancestor
110123355|NCT01932554|Anesthetics|anesthetics|mesh-ancestor
110123356|NCT01932554|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110123357|NCT01932554|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110123358|NCT01932554|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110123359|NCT01932554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110123360|NCT01932554|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110123361|NCT01932554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110123362|NCT01932554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110123363|NCT01932554|Anticoagulants|anticoagulants|mesh-ancestor
110123364|NCT01932554|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110123365|NCT01932580|Docetaxel|docetaxel|mesh-list
110123366|NCT01932580|Fluorouracil|fluorouracil|mesh-list
110123367|NCT01932580|Oxaliplatin|oxaliplatin|mesh-list
110123368|NCT01932580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110123369|NCT01932580|Tubulin Modulators|tubulin modulators|mesh-ancestor
110123370|NCT01932580|Antimitotic Agents|antimitotic agents|mesh-ancestor
110123371|NCT01932580|Mitosis Modulators|mitosis modulators|mesh-ancestor
110123372|NCT01932580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110123373|NCT01932580|Antimetabolites|antimetabolites|mesh-ancestor
110123374|NCT01932580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110123375|NCT01932580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110123376|NCT01932580|Immunologic Factors|immunologic factors|mesh-ancestor
110123377|NCT01932580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110123378|NCT01932918|Ketorolac|ketorolac|mesh-list
110123379|NCT01932918|Morphine|morphine|mesh-list
110123380|NCT01932918|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110123381|NCT01932918|Narcotics|narcotics|mesh-ancestor
110123382|NCT01932918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110123383|NCT01932918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110123384|NCT01932918|Analgesics|analgesics|mesh-ancestor
110123385|NCT01932918|Sensory System Agents|sensory system agents|mesh-ancestor
110123386|NCT01932918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110123387|NCT01932918|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110123388|NCT01932918|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110123389|NCT01932918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110123390|NCT01932918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110123391|NCT01932918|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110123392|NCT01932918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110123393|NCT01932918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110123394|NCT01932931|Vitamin D|vitamin d|mesh-list
110123395|NCT01932931|Cholecalciferol|cholecalciferol|mesh-list
110123396|NCT01932931|Vitamins|vitamins|mesh-ancestor
110123397|NCT01932931|Micronutrients|micronutrients|mesh-ancestor
110123398|NCT01932931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110123399|NCT01932931|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110123400|NCT01932931|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110123401|NCT01933022|Leuprolide|leuprolide|mesh-list
110123402|NCT01933022|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110123403|NCT01933022|Fertility Agents|fertility agents|mesh-ancestor
110123404|NCT01933022|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110123405|NCT01933022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110123406|NCT01933022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110123407|NCT01933022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110123408|NCT01933061|Paclitaxel|paclitaxel|mesh-list
110123409|NCT01933061|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110123410|NCT01933061|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110123411|NCT01933061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110123412|NCT01933061|Tubulin Modulators|tubulin modulators|mesh-ancestor
110123413|NCT01933061|Antimitotic Agents|antimitotic agents|mesh-ancestor
110123414|NCT01933061|Mitosis Modulators|mitosis modulators|mesh-ancestor
110123415|NCT01933061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110123416|NCT01933152|Ranibizumab|ranibizumab|mesh-list
110123417|NCT01933152|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110123418|NCT01933152|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110123419|NCT01933152|Growth Substances|growth substances|mesh-ancestor
110123420|NCT01933152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110123421|NCT01933152|Growth Inhibitors|growth inhibitors|mesh-ancestor
110123422|NCT01933152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110123424|NCT01933347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110123425|NCT01933347|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110123426|NCT01933347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110123427|NCT01933347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110123428|NCT01933360|Misoprostol|misoprostol|mesh-list
110123429|NCT01933360|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110123430|NCT01933360|Abortifacient Agents|abortifacient agents|mesh-ancestor
110123431|NCT01933360|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110123432|NCT01933360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110123433|NCT01933360|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110123434|NCT01933360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110123435|NCT01933360|Oxytocics|oxytocics|mesh-ancestor
110123436|NCT01933412|Vaccines|vaccines|mesh-list
110123437|NCT01933412|Immunologic Factors|immunologic factors|mesh-ancestor
110123438|NCT01933412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110123439|NCT01933490|Insulin Aspart|insulin aspart|mesh-list
110123440|NCT01933490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110123441|NCT01933490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110123442|NCT01933503|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
110123443|NCT01933503|Cathartics|cathartics|mesh-ancestor
110123444|NCT01933503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110123445|NCT01933516|Rituximab|rituximab|mesh-list
110123446|NCT01933516|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110123447|NCT01933516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110123448|NCT01933516|Immunologic Factors|immunologic factors|mesh-ancestor
110123449|NCT01933516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110123450|NCT01933516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110123451|NCT01933542|Morphine|morphine|mesh-list
110123452|NCT01933542|Chlorzoxazone|chlorzoxazone|mesh-list
110123453|NCT01933542|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110123454|NCT01933542|Narcotics|narcotics|mesh-ancestor
110123455|NCT01933542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110123456|NCT01933542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110123457|NCT01933542|Analgesics|analgesics|mesh-ancestor
110123458|NCT01933542|Sensory System Agents|sensory system agents|mesh-ancestor
110123459|NCT01933542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110123460|NCT01933542|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110123461|NCT01933542|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110123462|NCT01933568|Cisplatin|cisplatin|mesh-list
110123463|NCT01933568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110123465|NCT01933698|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110123466|NCT01933698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110123467|NCT01933711|Rituximab|rituximab|mesh-list
110123468|NCT01933711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110123469|NCT01933711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110123470|NCT01933711|Immunologic Factors|immunologic factors|mesh-ancestor
110223675|NCT00418054|Nitazoxanide|nitazoxanide|mesh-list
110123472|NCT01933711|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110123473|NCT01933906|Interferons|interferons|mesh-list
110123474|NCT01933906|Interferon-alpha|interferon-alpha|mesh-list
110123475|NCT01933906|Interferon alpha-2|interferon alpha-2|mesh-list
110123476|NCT01933906|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110123477|NCT01933906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110123478|NCT01933906|Antiviral Agents|antiviral agents|mesh-ancestor
110123479|NCT01933906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110123480|NCT01933906|Immunologic Factors|immunologic factors|mesh-ancestor
110123481|NCT01933906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110123482|NCT01933945|Sorafenib|sorafenib|mesh-list
110123483|NCT01933945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110123484|NCT01933945|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110123486|NCT01933945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110123487|NCT01933971|Lenograstim|lenograstim|mesh-list
110123488|NCT01933971|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110123489|NCT01933971|Immunologic Factors|immunologic factors|mesh-ancestor
110123490|NCT01933971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110123491|NCT01933997|Pyridoxine|pyridoxine|mesh-list
110123492|NCT01933997|Metadoxine|metadoxine|mesh-list
110123493|NCT01933997|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110123494|NCT01933997|Vitamin B Complex|vitamin b complex|mesh-ancestor
110123495|NCT01933997|Vitamins|vitamins|mesh-ancestor
110123497|NCT01933997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110123498|NCT01934023|Varenicline|varenicline|mesh-list
110123499|NCT01934023|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110123500|NCT01934023|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110123501|NCT01934023|Cholinergic Agents|cholinergic agents|mesh-ancestor
110123502|NCT01934023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110123503|NCT01934023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110123504|NCT01934023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110123505|NCT01934049|Anesthetics|anesthetics|mesh-list
110123506|NCT01934049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110123507|NCT01934049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110123508|NCT01934088|Fentanyl|fentanyl|mesh-list
110123509|NCT01934088|Midazolam|midazolam|mesh-list
110123510|NCT01934088|Propofol|propofol|mesh-list
110123511|NCT01934088|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110123512|NCT01934088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110123513|NCT01934088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110123514|NCT01934088|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110123515|NCT01934088|Anesthetics, General|anesthetics, general|mesh-ancestor
110123516|NCT01934088|Anesthetics|anesthetics|mesh-ancestor
110123517|NCT01934088|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110123518|NCT01934088|Narcotics|narcotics|mesh-ancestor
110123519|NCT01934088|Analgesics|analgesics|mesh-ancestor
110123520|NCT01934088|Sensory System Agents|sensory system agents|mesh-ancestor
110123521|NCT01934088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110123522|NCT01934088|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110123523|NCT01934088|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110123524|NCT01934088|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110123525|NCT01934088|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110123526|NCT01934088|GABA Modulators|gaba modulators|mesh-ancestor
110123527|NCT01934088|GABA Agents|gaba agents|mesh-ancestor
110123528|NCT01934088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110123529|NCT01934088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110123530|NCT01934127|Vaccines|vaccines|mesh-list
110123533|NCT01934166|Nalmefene|nalmefene|mesh-list
110123534|NCT01934166|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110123535|NCT01934166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110123536|NCT01934166|Sensory System Agents|sensory system agents|mesh-ancestor
110123537|NCT01934166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110123538|NCT01934205|Gepotidacin|gepotidacin|mesh-list
110123539|NCT01934205|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110123541|NCT01934205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110123542|NCT01934205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110123543|NCT01934361|Carboplatin|carboplatin|mesh-list
110123544|NCT01934361|Lomustine|lomustine|mesh-list
110123545|NCT01934361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110123546|NCT01934361|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110123547|NCT01934361|Alkylating Agents|alkylating agents|mesh-ancestor
110123548|NCT01934361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110123549|NCT01934569|Losartan|losartan|mesh-list
110123550|NCT01934569|Midazolam|midazolam|mesh-list
110123551|NCT01934569|Caffeine|caffeine|mesh-list
110123552|NCT01934569|Omeprazole|omeprazole|mesh-list
110123553|NCT01934569|Pravastatin|pravastatin|mesh-list
110123554|NCT01934569|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110123555|NCT01934569|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110123556|NCT01934569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110123558|NCT01934569|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110123559|NCT01934569|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110123560|NCT01934569|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110123561|NCT01934569|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110123562|NCT01934569|Anesthetics, General|anesthetics, general|mesh-ancestor
110123563|NCT01934569|Anesthetics|anesthetics|mesh-ancestor
110123564|NCT01934569|GABA Modulators|gaba modulators|mesh-ancestor
110123565|NCT01934569|GABA Agents|gaba agents|mesh-ancestor
110123566|NCT01934569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110123567|NCT01934569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110123568|NCT01934569|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110123569|NCT01934569|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110123570|NCT01934569|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110123571|NCT01934569|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110123572|NCT01934569|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110123573|NCT01934569|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110123574|NCT01934569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110123575|NCT01934569|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110123576|NCT01934569|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110123577|NCT01934569|Purinergic Agents|purinergic agents|mesh-ancestor
110123578|NCT01934569|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110123579|NCT01934569|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110123580|NCT01934569|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110123581|NCT01934569|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110123582|NCT01934569|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110123584|NCT01934569|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110123585|NCT01934569|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110123586|NCT01934634|Paclitaxel|paclitaxel|mesh-list
110123587|NCT01934634|Gemcitabine|gemcitabine|mesh-list
110123588|NCT01934634|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110123589|NCT01934634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110123590|NCT01934634|Tubulin Modulators|tubulin modulators|mesh-ancestor
110123591|NCT01934634|Antimitotic Agents|antimitotic agents|mesh-ancestor
110123592|NCT01934634|Mitosis Modulators|mitosis modulators|mesh-ancestor
110123593|NCT01934634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110123594|NCT01934634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110123595|NCT01934634|Antimetabolites|antimetabolites|mesh-ancestor
110123597|NCT01934712|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110123598|NCT01934712|Insulin Aspart|insulin aspart|mesh-list
110123599|NCT01934712|Insulin, Long-Acting|insulin, long-acting|mesh-list
110123600|NCT01934712|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
110123601|NCT01934712|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110123602|NCT01934712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110123603|NCT01934777|Vitamin E|vitamin e|mesh-list
110123604|NCT01934777|Choline|choline|mesh-list
110123605|NCT01934777|Vitamins|vitamins|mesh-ancestor
110123606|NCT01934777|Micronutrients|micronutrients|mesh-ancestor
110123607|NCT01934777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110123609|NCT01934777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110123610|NCT01934777|Protective Agents|protective agents|mesh-ancestor
110123611|NCT01934777|Lipotropic Agents|lipotropic agents|mesh-ancestor
110123612|NCT01934777|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110123613|NCT01934777|Antimetabolites|antimetabolites|mesh-ancestor
110123614|NCT01934777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110123615|NCT01934777|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110123616|NCT01934777|Nootropic Agents|nootropic agents|mesh-ancestor
110123617|NCT01934816|Liraglutide|liraglutide|mesh-list
110123618|NCT01934816|Exenatide|exenatide|mesh-list
110123619|NCT01934816|Glucagon|glucagon|mesh-list
110123620|NCT01934816|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
110123621|NCT01934816|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110123622|NCT01934816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110123623|NCT01934816|Incretins|incretins|mesh-ancestor
110123624|NCT01934816|Hormones|hormones|mesh-ancestor
110123625|NCT01934816|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110123626|NCT01934816|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110123627|NCT01934816|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110123628|NCT01934829|Sorafenib|sorafenib|mesh-list
110123629|NCT01934829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110123630|NCT01934829|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110123631|NCT01934829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110123632|NCT01934829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110123633|NCT01934933|Celecoxib|celecoxib|mesh-list
110123634|NCT01934933|Etanercept|etanercept|mesh-list
110123635|NCT01934933|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110123636|NCT01934933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110123637|NCT01934933|Analgesics|analgesics|mesh-ancestor
110123638|NCT01934933|Sensory System Agents|sensory system agents|mesh-ancestor
110123639|NCT01934933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110123640|NCT01934933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110123641|NCT01934933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110123642|NCT01934933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110123643|NCT01934933|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110123644|NCT01934933|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110123645|NCT01934933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110123646|NCT01934933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110123647|NCT01934933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110123648|NCT01934933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110123649|NCT01934933|Immunologic Factors|immunologic factors|mesh-ancestor
110123650|NCT01935063|Lidocaine|lidocaine|mesh-list
110123651|NCT01935063|Anesthetics, Local|anesthetics, local|mesh-ancestor
110123652|NCT01935063|Anesthetics|anesthetics|mesh-ancestor
110123653|NCT01935063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110123654|NCT01935063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110123655|NCT01935063|Sensory System Agents|sensory system agents|mesh-ancestor
110123656|NCT01935063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110123657|NCT01935063|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110123658|NCT01935063|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110123659|NCT01935063|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110123660|NCT01935063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110123661|NCT01935063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110123662|NCT01935115|Ketamine|ketamine|mesh-list
110123663|NCT01935115|Propofol|propofol|mesh-list
110123664|NCT01935115|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110123665|NCT01935115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110123666|NCT01935115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110223715|NCT00296023|Tacrolimus|tacrolimus|mesh-list
110123667|NCT01935115|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110123668|NCT01935115|Anesthetics, General|anesthetics, general|mesh-ancestor
110123669|NCT01935115|Anesthetics|anesthetics|mesh-ancestor
110123670|NCT01935115|Analgesics|analgesics|mesh-ancestor
110123671|NCT01935115|Sensory System Agents|sensory system agents|mesh-ancestor
110123672|NCT01935115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110123673|NCT01935115|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110123674|NCT01935115|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110123675|NCT01935115|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110123676|NCT01935115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110123677|NCT01935115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110123678|NCT01935141|Triiodobenzoic Acids|triiodobenzoic acids|mesh-list
110123679|NCT01935141|Plant Growth Regulators|plant growth regulators|mesh-ancestor
110123680|NCT01935141|Growth Substances|growth substances|mesh-ancestor
110123681|NCT01935141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110123682|NCT01935193|Acetylsalicylic acid lysinate|acetylsalicylic acid lysinate|mesh-list
110123683|NCT01935193|Analgesics|analgesics|mesh-ancestor
110123684|NCT01935193|Sensory System Agents|sensory system agents|mesh-ancestor
110123685|NCT01935193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110123686|NCT01935193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110123687|NCT01935193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110123688|NCT01935193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110123689|NCT01935193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110123690|NCT01935193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110123691|NCT01935193|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110123692|NCT01935193|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110123693|NCT01935193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110123694|NCT01935193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110123695|NCT01935206|Naloxone|naloxone|mesh-list
110123696|NCT01935206|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110163951|NCT05637164|Sympathomimetics|sympathomimetics|mesh-ancestor
110123697|NCT01935206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110123698|NCT01935206|Sensory System Agents|sensory system agents|mesh-ancestor
110123699|NCT01935206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110123700|NCT01935310|Imiquimod|imiquimod|mesh-list
110123701|NCT01935310|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110123702|NCT01935310|Immunologic Factors|immunologic factors|mesh-ancestor
110123703|NCT01935310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110123704|NCT01935310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110123705|NCT01935310|Interferon Inducers|interferon inducers|mesh-ancestor
110123706|NCT01935492|Paclitaxel|paclitaxel|mesh-list
110123707|NCT01935492|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110123708|NCT01935492|Bevacizumab|bevacizumab|mesh-list
110123709|NCT01935492|Doxorubicin|doxorubicin|mesh-list
110123710|NCT01935492|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110123711|NCT01935492|Capecitabine|capecitabine|mesh-list
110123712|NCT01935492|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110123713|NCT01935492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110123714|NCT01935492|Tubulin Modulators|tubulin modulators|mesh-ancestor
110123715|NCT01935492|Antimitotic Agents|antimitotic agents|mesh-ancestor
110123716|NCT01935492|Mitosis Modulators|mitosis modulators|mesh-ancestor
110123717|NCT01935492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110123718|NCT01935492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110123719|NCT01935492|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110123720|NCT01935492|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110123721|NCT01935492|Growth Substances|growth substances|mesh-ancestor
110123722|NCT01935492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110123724|NCT01935492|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110123725|NCT01935492|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110123726|NCT01935492|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110123727|NCT01935492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110123728|NCT01935492|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110123729|NCT01935492|Antimetabolites|antimetabolites|mesh-ancestor
110123730|NCT01935505|Bupropion|bupropion|mesh-list
110123731|NCT01935505|Nicotine|nicotine|mesh-list
110123732|NCT01935505|Varenicline|varenicline|mesh-list
110123733|NCT01935505|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110123734|NCT01935505|Autonomic Agents|autonomic agents|mesh-ancestor
110123735|NCT01935505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110123736|NCT01935505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110123737|NCT01935505|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110123738|NCT01935505|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110123739|NCT01935505|Cholinergic Agents|cholinergic agents|mesh-ancestor
110123740|NCT01935505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110123741|NCT01935505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110123742|NCT01935505|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110123743|NCT01935505|Antidepressive Agents|antidepressive agents|mesh-ancestor
110123744|NCT01935505|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110123745|NCT01935505|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110123746|NCT01935505|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110123747|NCT01935505|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110123748|NCT01935505|Dopamine Agents|dopamine agents|mesh-ancestor
110123749|NCT01935505|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110123750|NCT01935505|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110123751|NCT01935505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110123753|NCT01935518|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110123754|NCT01935518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110123755|NCT01935518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110123756|NCT01935518|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110123757|NCT01935518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110123758|NCT01935518|Vasodilator Agents|vasodilator agents|mesh-ancestor
110123759|NCT01935518|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110123760|NCT01935518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110123761|NCT01935531|Diclofenac|diclofenac|mesh-list
110123762|NCT01935531|Hyaluronic Acid|hyaluronic acid|mesh-list
110123763|NCT01935531|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110123764|NCT01935531|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110123765|NCT01935531|Analgesics|analgesics|mesh-ancestor
110123766|NCT01935531|Sensory System Agents|sensory system agents|mesh-ancestor
110123767|NCT01935531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110123768|NCT01935531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110123769|NCT01935531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110123770|NCT01935531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110123771|NCT01935531|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110123772|NCT01935531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110123773|NCT01935531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110123774|NCT01935531|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110123775|NCT01935531|Immunologic Factors|immunologic factors|mesh-ancestor
110123776|NCT01935531|Viscosupplements|viscosupplements|mesh-ancestor
110123777|NCT01935531|Protective Agents|protective agents|mesh-ancestor
110123778|NCT01935544|Botulinum Toxins|botulinum toxins|mesh-list
110123779|NCT01935544|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110123780|NCT01935544|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110123781|NCT01935544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110123782|NCT01935544|Cholinergic Agents|cholinergic agents|mesh-ancestor
110123783|NCT01935544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110123784|NCT01935544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110123785|NCT01935557|Heparin|heparin|mesh-list
110123786|NCT01935557|Calcium heparin|calcium heparin|mesh-list
110123787|NCT01935557|Anticoagulants|anticoagulants|mesh-ancestor
110123788|NCT01935557|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110123790|NCT01935557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110123791|NCT01935596|Ropivacaine|ropivacaine|mesh-list
110123792|NCT01935596|Levobupivacaine|levobupivacaine|mesh-list
110123793|NCT01935596|Anesthetics, Local|anesthetics, local|mesh-ancestor
110123794|NCT01935596|Anesthetics|anesthetics|mesh-ancestor
110123795|NCT01935596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110123796|NCT01935596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110123797|NCT01935596|Sensory System Agents|sensory system agents|mesh-ancestor
110123798|NCT01935596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110123799|NCT01935648|Ropivacaine|ropivacaine|mesh-list
110123800|NCT01935648|Anesthetics, Local|anesthetics, local|mesh-ancestor
110123801|NCT01935648|Anesthetics|anesthetics|mesh-ancestor
110123802|NCT01935648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110123803|NCT01935648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110123804|NCT01935648|Sensory System Agents|sensory system agents|mesh-ancestor
110123805|NCT01935648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110123806|NCT01935674|Ritonavir|ritonavir|mesh-list
110123807|NCT01935674|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110123808|NCT01935674|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110123809|NCT01935674|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110123810|NCT01935674|Protease Inhibitors|protease inhibitors|mesh-ancestor
110123811|NCT01935674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110123812|NCT01935674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110123813|NCT01935674|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110123814|NCT01935674|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110123815|NCT01935674|Antiviral Agents|antiviral agents|mesh-ancestor
110163978|NCT00129181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110123816|NCT01935674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110123817|NCT01935674|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110123818|NCT01935674|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110123819|NCT01935674|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110123820|NCT01935674|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110123821|NCT01935674|Antimetabolites|antimetabolites|mesh-ancestor
110123822|NCT01935674|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110123823|NCT01935674|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110123825|NCT01935713|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110123826|NCT01935713|Autonomic Agents|autonomic agents|mesh-ancestor
110123827|NCT01935713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110123828|NCT01935713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110123829|NCT01935713|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110123830|NCT01935713|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110123831|NCT01935713|Cholinergic Agents|cholinergic agents|mesh-ancestor
110123832|NCT01935713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110123833|NCT01935713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110123834|NCT01935804|Metformin|metformin|mesh-list
110123835|NCT01935804|Pioglitazone|pioglitazone|mesh-list
110123836|NCT01935804|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110123837|NCT01935804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110123838|NCT01935817|Vitamin E|vitamin e|mesh-list
110123839|NCT01935817|Silybin|silybin|mesh-list
110123840|NCT01935817|Vitamins|vitamins|mesh-ancestor
110123841|NCT01935817|Micronutrients|micronutrients|mesh-ancestor
110123842|NCT01935817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110123843|NCT01935817|Antioxidants|antioxidants|mesh-ancestor
110123844|NCT01935817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110123845|NCT01935817|Protective Agents|protective agents|mesh-ancestor
110123846|NCT01935817|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110123847|NCT01935817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110123849|NCT01935830|Efavirenz|efavirenz|mesh-list
110123850|NCT01935830|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110123851|NCT01935830|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110123852|NCT01935830|Protease Inhibitors|protease inhibitors|mesh-ancestor
110123853|NCT01935830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110123854|NCT01935830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110123855|NCT01935830|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110123856|NCT01935830|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110123857|NCT01935830|Antiviral Agents|antiviral agents|mesh-ancestor
110123858|NCT01935830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110123859|NCT01935830|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110123860|NCT01935830|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110123861|NCT01935830|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110123862|NCT01935830|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110123863|NCT01935830|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110123864|NCT01935830|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110123865|NCT01935830|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110123866|NCT01935830|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110123867|NCT01935830|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110123869|NCT01935869|Emollients|emollients|mesh-ancestor
110123870|NCT01935869|Dermatologic Agents|dermatologic agents|mesh-ancestor
110123871|NCT01935882|Lumefantrine|lumefantrine|mesh-list
110123872|NCT01935882|Artemether|artemether|mesh-list
110123873|NCT01935882|Primaquine|primaquine|mesh-list
110123874|NCT01935882|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
110123875|NCT01935882|Antimalarials|antimalarials|mesh-ancestor
110123876|NCT01935882|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110123877|NCT01935882|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110123878|NCT01935882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110123879|NCT01935908|Levetiracetam|levetiracetam|mesh-list
110123880|NCT01935908|Anticonvulsants|anticonvulsants|mesh-ancestor
110123881|NCT01935908|Nootropic Agents|nootropic agents|mesh-ancestor
110123882|NCT01935973|Trametinib|trametinib|mesh-list
110123883|NCT01935973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110123884|NCT01935973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110123886|NCT01935973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110123887|NCT01936012|Lisinopril|lisinopril|mesh-list
110123888|NCT01936012|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110123889|NCT01936012|Protease Inhibitors|protease inhibitors|mesh-ancestor
110123890|NCT01936012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110123891|NCT01936012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110123892|NCT01936012|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110123893|NCT01936012|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110123894|NCT01936012|Protective Agents|protective agents|mesh-ancestor
110123895|NCT01936012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110123896|NCT01936025|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110123897|NCT01936025|Dextromethorphan|dextromethorphan|mesh-list
110123898|NCT01936025|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110123899|NCT01936025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110123900|NCT01936025|Incretins|incretins|mesh-ancestor
110123901|NCT01936025|Hormones|hormones|mesh-ancestor
110123902|NCT01936025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110123903|NCT01936025|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110123904|NCT01936025|Protease Inhibitors|protease inhibitors|mesh-ancestor
110123905|NCT01936025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110123906|NCT01936025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110123907|NCT01936025|Antitussive Agents|antitussive agents|mesh-ancestor
110123908|NCT01936025|Respiratory System Agents|respiratory system agents|mesh-ancestor
110123909|NCT01936025|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110123910|NCT01936025|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110123911|NCT01936025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110223772|NCT00089856|Docetaxel|docetaxel|mesh-list
110123913|NCT01936064|Epirubicin|epirubicin|mesh-list
110123914|NCT01936064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110123915|NCT01936064|Immunologic Factors|immunologic factors|mesh-ancestor
110123916|NCT01936064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110123917|NCT01936064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110123918|NCT01936064|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110123919|NCT01936064|Alkylating Agents|alkylating agents|mesh-ancestor
110123920|NCT01936064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110123921|NCT01936064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110123922|NCT01936064|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110123923|NCT01936064|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110123924|NCT01936064|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110123925|NCT01936064|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110123926|NCT01936064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110123928|NCT01936090|Melphalan|melphalan|mesh-list
110123929|NCT01936090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110123930|NCT01936090|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110123931|NCT01936090|Alkylating Agents|alkylating agents|mesh-ancestor
110123932|NCT01936090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110123933|NCT01936090|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110123934|NCT01936090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110123935|NCT01936090|Immunologic Factors|immunologic factors|mesh-ancestor
110123936|NCT01936090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110123937|NCT01936103|Atorvastatin|atorvastatin|mesh-list
110123938|NCT01936103|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110123939|NCT01936103|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110123940|NCT01936103|Antimetabolites|antimetabolites|mesh-ancestor
110123941|NCT01936103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110123942|NCT01936103|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110123943|NCT01936103|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110123944|NCT01936103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110123945|NCT01936129|Glatiramer Acetate|glatiramer acetate|mesh-list
110123946|NCT01936129|(T,G)-A-L|(t,g)-a-l|mesh-list
110123947|NCT01936129|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110123948|NCT01936129|Immunologic Factors|immunologic factors|mesh-ancestor
110123949|NCT01936129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110123950|NCT01936129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110123951|NCT01936129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110123952|NCT01936220|Antipsychotic Agents|antipsychotic agents|mesh-list
110123953|NCT01936220|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110123954|NCT01936220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110123955|NCT01936220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110123956|NCT01936220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110123957|NCT01936233|Aspirin|aspirin|mesh-list
110123958|NCT01936233|Lamivudine|lamivudine|mesh-list
110123959|NCT01936233|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110123960|NCT01936233|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110123961|NCT01936233|Analgesics|analgesics|mesh-ancestor
110123962|NCT01936233|Sensory System Agents|sensory system agents|mesh-ancestor
110123963|NCT01936233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110123964|NCT01936233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110123965|NCT01936233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110123966|NCT01936233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110123967|NCT01936233|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110123968|NCT01936233|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110123969|NCT01936233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110123970|NCT01936233|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110123971|NCT01936233|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110123972|NCT01936233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110123973|NCT01936233|Antipyretics|antipyretics|mesh-ancestor
110123974|NCT01936233|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110123975|NCT01936233|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110123976|NCT01936233|Antiviral Agents|antiviral agents|mesh-ancestor
110123977|NCT01936233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110123978|NCT01936233|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110123979|NCT01936233|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110123981|NCT01936285|Gout Suppressants|gout suppressants|mesh-ancestor
110123982|NCT01936285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110123983|NCT01936285|Tubulin Modulators|tubulin modulators|mesh-ancestor
110123984|NCT01936285|Antimitotic Agents|antimitotic agents|mesh-ancestor
110123985|NCT01936285|Mitosis Modulators|mitosis modulators|mesh-ancestor
110123986|NCT01936285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110123987|NCT01936285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110123988|NCT01936350|Sildenafil Citrate|sildenafil citrate|mesh-list
110123989|NCT01936350|Vasodilator Agents|vasodilator agents|mesh-ancestor
110123990|NCT01936350|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110123991|NCT01936350|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110123992|NCT01936350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110123993|NCT01936350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110123994|NCT01936350|Urological Agents|urological agents|mesh-ancestor
110123995|NCT01936545|Propofol|propofol|mesh-list
110123996|NCT01936545|Desflurane|desflurane|mesh-list
110123997|NCT01936545|Liver Extracts|liver extracts|mesh-list
110123998|NCT01936545|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110123999|NCT01936545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110124000|NCT01936545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110124001|NCT01936545|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110124002|NCT01936545|Anesthetics, General|anesthetics, general|mesh-ancestor
110124003|NCT01936545|Anesthetics|anesthetics|mesh-ancestor
110124004|NCT01936545|Hematinics|hematinics|mesh-ancestor
110124005|NCT01936545|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110124006|NCT01936636|Fentanyl|fentanyl|mesh-list
110124007|NCT01936636|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110124008|NCT01936636|Narcotics|narcotics|mesh-ancestor
110124009|NCT01936636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110124010|NCT01936636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110124011|NCT01936636|Analgesics|analgesics|mesh-ancestor
110124012|NCT01936636|Sensory System Agents|sensory system agents|mesh-ancestor
110124013|NCT01936636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110124014|NCT01936636|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110124015|NCT01936636|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110124016|NCT01936636|Anesthetics, General|anesthetics, general|mesh-ancestor
110124017|NCT01936636|Anesthetics|anesthetics|mesh-ancestor
110124018|NCT01936805|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110124019|NCT01936805|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110124021|NCT01936805|Antimetabolites|antimetabolites|mesh-ancestor
110124022|NCT01936805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110124023|NCT01936805|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110124024|NCT01936805|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110124025|NCT01936805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110124026|NCT01936961|Antibodies|antibodies|mesh-list
110124027|NCT01936961|Immunologic Factors|immunologic factors|mesh-ancestor
110124028|NCT01936961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110124029|NCT01937013|Oxytocin|oxytocin|mesh-list
110124030|NCT01937013|Oxytocics|oxytocics|mesh-ancestor
110124031|NCT01937013|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110124032|NCT01937013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110124033|NCT01937078|Famotidine|famotidine|mesh-list
110124034|NCT01937078|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110124035|NCT01937078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110124036|NCT01937078|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110124037|NCT01937078|Histamine Antagonists|histamine antagonists|mesh-ancestor
110124038|NCT01937078|Histamine Agents|histamine agents|mesh-ancestor
110124039|NCT01937078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110124040|NCT01937078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110124041|NCT01937078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110124042|NCT01937104|Remifentanil|remifentanil|mesh-list
110124043|NCT01937104|Desflurane|desflurane|mesh-list
110124044|NCT01937104|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110124045|NCT01937104|Narcotics|narcotics|mesh-ancestor
110124046|NCT01937104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110124047|NCT01937104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110124048|NCT01937104|Analgesics|analgesics|mesh-ancestor
110124049|NCT01937104|Sensory System Agents|sensory system agents|mesh-ancestor
110124050|NCT01937104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110124051|NCT01937104|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110124052|NCT01937104|Anesthetics, General|anesthetics, general|mesh-ancestor
110124053|NCT01937104|Anesthetics|anesthetics|mesh-ancestor
110124054|NCT01937169|Levodopa|levodopa|mesh-list
110124055|NCT01937169|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110124056|NCT01937169|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110124057|NCT01937169|Dopamine Agents|dopamine agents|mesh-ancestor
110124058|NCT01937169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110124059|NCT01937169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110124060|NCT01937169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110124061|NCT01937182|Citalopram|citalopram|mesh-list
110124062|NCT01937182|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
110124063|NCT01937182|Serotonin|serotonin|mesh-list
110124064|NCT01937182|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110124065|NCT01937182|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110124066|NCT01937182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110124067|NCT01937182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110124068|NCT01937182|Serotonin Agents|serotonin agents|mesh-ancestor
110124069|NCT01937182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110124070|NCT01937182|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110124071|NCT01937182|Antidepressive Agents|antidepressive agents|mesh-ancestor
110124072|NCT01937182|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110124073|NCT01937182|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110124074|NCT01937234|Metoclopramide|metoclopramide|mesh-list
110124075|NCT01937234|Antiemetics|antiemetics|mesh-ancestor
110124076|NCT01937234|Autonomic Agents|autonomic agents|mesh-ancestor
110124077|NCT01937234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110124078|NCT01937234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110124079|NCT01937234|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110124080|NCT01937234|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110124081|NCT01937234|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110124082|NCT01937234|Dopamine Agents|dopamine agents|mesh-ancestor
110124083|NCT01937234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110124084|NCT01937234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110124086|NCT01937325|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
110124087|NCT01937325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110164002|NCT00819780|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110124088|NCT01937325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110124089|NCT01937338|AZD7624|azd7624|mesh-list
110223813|NCT00296530|Glucocorticoids|glucocorticoids|mesh-ancestor
110124091|NCT01937338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110124092|NCT01937338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110124093|NCT01937442|Thalidomide|thalidomide|mesh-list
110124094|NCT01937442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110124095|NCT01937442|Immunologic Factors|immunologic factors|mesh-ancestor
110124096|NCT01937442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110124097|NCT01937442|Leprostatic Agents|leprostatic agents|mesh-ancestor
110124098|NCT01937442|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110124099|NCT01937442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110124100|NCT01937442|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110124101|NCT01937442|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110124102|NCT01937442|Growth Substances|growth substances|mesh-ancestor
110124103|NCT01937442|Growth Inhibitors|growth inhibitors|mesh-ancestor
110124104|NCT01937442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110124105|NCT01937494|Benzyl Alcohol|benzyl alcohol|mesh-list
110124106|NCT01937494|Histamine|histamine|mesh-list
110124107|NCT01937494|Histamine Agonists|histamine agonists|mesh-ancestor
110124108|NCT01937494|Histamine Agents|histamine agents|mesh-ancestor
110124109|NCT01937494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110124110|NCT01937494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110124111|NCT01937494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110124112|NCT01937494|Anesthetics, Local|anesthetics, local|mesh-ancestor
110124113|NCT01937494|Anesthetics|anesthetics|mesh-ancestor
110124114|NCT01937494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110124115|NCT01937494|Sensory System Agents|sensory system agents|mesh-ancestor
110124116|NCT01937494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110124118|NCT01937611|Dexmedetomidine|dexmedetomidine|mesh-list
110124119|NCT01937611|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110124120|NCT01937611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110124121|NCT01937611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110124122|NCT01937611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110124123|NCT01937611|Analgesics|analgesics|mesh-ancestor
110124124|NCT01937611|Sensory System Agents|sensory system agents|mesh-ancestor
110124125|NCT01937611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110124126|NCT01937611|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110124127|NCT01937611|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110124128|NCT01937611|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110124129|NCT01937611|Adrenergic Agents|adrenergic agents|mesh-ancestor
110124130|NCT01937611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110124131|NCT01937611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110124132|NCT01937611|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110124133|NCT01937611|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110124134|NCT01937611|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110124135|NCT01937611|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110124136|NCT01937611|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110124137|NCT01937611|Anesthetics, General|anesthetics, general|mesh-ancestor
110124138|NCT01937611|Anesthetics|anesthetics|mesh-ancestor
110124139|NCT01937611|GABA Modulators|gaba modulators|mesh-ancestor
110124140|NCT01937611|GABA Agents|gaba agents|mesh-ancestor
110124141|NCT01937650|Metronidazole|metronidazole|mesh-list
110124142|NCT01937650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110124143|NCT01937650|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110124144|NCT01937650|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110124145|NCT01937650|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110124146|NCT01937728|Interferons|interferons|mesh-list
110124148|NCT01937728|Interferon-alpha|interferon-alpha|mesh-list
110124149|NCT01937728|Interferon alpha-2|interferon alpha-2|mesh-list
110124150|NCT01937728|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110124151|NCT01937728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110124152|NCT01937728|Antiviral Agents|antiviral agents|mesh-ancestor
110124153|NCT01937728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110124154|NCT01937728|Antimetabolites|antimetabolites|mesh-ancestor
110124155|NCT01937728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110124156|NCT01937728|Immunologic Factors|immunologic factors|mesh-ancestor
110124157|NCT01937728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110124158|NCT01937754|Nitric Oxide|nitric oxide|mesh-list
110124159|NCT01937754|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110124160|NCT01937754|Autonomic Agents|autonomic agents|mesh-ancestor
110124161|NCT01937754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110124162|NCT01937754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110124163|NCT01937754|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110124164|NCT01937754|Respiratory System Agents|respiratory system agents|mesh-ancestor
110124165|NCT01937754|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110124166|NCT01937754|Antioxidants|antioxidants|mesh-ancestor
110124167|NCT01937754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110124168|NCT01937754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110124169|NCT01937754|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
110124170|NCT01937754|Vasodilator Agents|vasodilator agents|mesh-ancestor
110124171|NCT01937754|Gasotransmitters|gasotransmitters|mesh-ancestor
110124172|NCT01937754|Protective Agents|protective agents|mesh-ancestor
110124174|NCT01937767|Remifentanil|remifentanil|mesh-list
110124175|NCT01937767|Propofol|propofol|mesh-list
110124176|NCT01937767|Sevoflurane|sevoflurane|mesh-list
110124177|NCT01937767|Rocuronium|rocuronium|mesh-list
110124178|NCT01937767|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110124179|NCT01937767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110124180|NCT01937767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110124181|NCT01937767|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110124182|NCT01937767|Anesthetics, General|anesthetics, general|mesh-ancestor
110124183|NCT01937767|Anesthetics|anesthetics|mesh-ancestor
110124184|NCT01937767|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110124185|NCT01937767|Narcotics|narcotics|mesh-ancestor
110124186|NCT01937767|Analgesics|analgesics|mesh-ancestor
110124187|NCT01937767|Sensory System Agents|sensory system agents|mesh-ancestor
110124188|NCT01937767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110124189|NCT01937767|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110124190|NCT01937767|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110124191|NCT01937767|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110124192|NCT01937767|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110124193|NCT01937767|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110124195|NCT01937806|Tenofovir|tenofovir|mesh-list
110124196|NCT01937806|Antiviral Agents|antiviral agents|mesh-ancestor
110124197|NCT01937806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110124198|NCT01937806|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110124199|NCT01937806|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110124200|NCT01937806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110124201|NCT01937806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110124202|NCT01937806|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110124203|NCT01937806|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110124204|NCT01937832|Ertapenem|ertapenem|mesh-list
110124205|NCT01937832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110124206|NCT01937832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110124207|NCT01938092|Diazepam|diazepam|mesh-list
110124208|NCT01938092|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110124209|NCT01938092|Anticonvulsants|anticonvulsants|mesh-ancestor
110124210|NCT01938092|Antiemetics|antiemetics|mesh-ancestor
110124211|NCT01938092|Autonomic Agents|autonomic agents|mesh-ancestor
110124212|NCT01938092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110124213|NCT01938092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110124214|NCT01938092|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110124215|NCT01938092|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110124216|NCT01938092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110164023|NCT00128752|Provitamins|provitamins|mesh-ancestor
110124217|NCT01938092|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110124219|NCT01938092|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110223840|NCT00296608|Antimetabolites|antimetabolites|mesh-ancestor
110223841|NCT00296608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110223842|NCT00296608|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110124220|NCT01938092|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110124221|NCT01938092|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110124222|NCT01938092|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110124223|NCT01938092|Anesthetics, General|anesthetics, general|mesh-ancestor
110124224|NCT01938092|Anesthetics|anesthetics|mesh-ancestor
110124225|NCT01938092|GABA Modulators|gaba modulators|mesh-ancestor
110124226|NCT01938092|GABA Agents|gaba agents|mesh-ancestor
110124227|NCT01938092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110124228|NCT01938092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110124229|NCT01938105|Nimotuzumab|nimotuzumab|mesh-list
110124230|NCT01938105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110124231|NCT01938105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110124232|NCT01938144|Acetaminophen|acetaminophen|mesh-list
110124233|NCT01938144|Ibuprofen|ibuprofen|mesh-list
110124234|NCT01938144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110124235|NCT01938144|Analgesics|analgesics|mesh-ancestor
110124236|NCT01938144|Sensory System Agents|sensory system agents|mesh-ancestor
110124237|NCT01938144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110124238|NCT01938144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110124239|NCT01938144|Antipyretics|antipyretics|mesh-ancestor
110124240|NCT01938144|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110124241|NCT01938144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110124242|NCT01938144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110124243|NCT01938144|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110124244|NCT01938144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110124245|NCT01938144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110124246|NCT01938183|Metronidazole|metronidazole|mesh-list
110124247|NCT01938183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110124248|NCT01938183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110124249|NCT01938183|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110124250|NCT01938183|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110124251|NCT01938235|Exenatide|exenatide|mesh-list
110124252|NCT01938235|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110124253|NCT01938235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110124254|NCT01938235|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110124255|NCT01938235|Incretins|incretins|mesh-ancestor
110124256|NCT01938235|Hormones|hormones|mesh-ancestor
110124257|NCT01938235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110124258|NCT01938300|Magnesium Sulfate|magnesium sulfate|mesh-list
110124259|NCT01938300|Analgesics|analgesics|mesh-ancestor
110124260|NCT01938300|Sensory System Agents|sensory system agents|mesh-ancestor
110124261|NCT01938300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110124262|NCT01938300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110124263|NCT01938300|Anesthetics|anesthetics|mesh-ancestor
110124264|NCT01938300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110124265|NCT01938300|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110124266|NCT01938300|Anticonvulsants|anticonvulsants|mesh-ancestor
110124267|NCT01938300|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110124268|NCT01938300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110124269|NCT01938300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110124270|NCT01938300|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110124271|NCT01938300|Tocolytic Agents|tocolytic agents|mesh-ancestor
110124272|NCT01938300|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110124273|NCT01938417|Tobramycin|tobramycin|mesh-list
110164037|NCT00063414|Alicaforsen|alicaforsen|mesh-list
110124274|NCT01938417|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110124275|NCT01938417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110124276|NCT01938443|Trametinib|trametinib|mesh-list
110124277|NCT01938443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110124278|NCT01938443|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110124279|NCT01938443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110124280|NCT01938443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110124281|NCT01938456|Docetaxel|docetaxel|mesh-list
110223847|NCT00296608|Protective Agents|protective agents|mesh-ancestor
110223848|NCT00296608|Vitamin B Complex|vitamin b complex|mesh-ancestor
110124283|NCT01938456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110124284|NCT01938456|Tubulin Modulators|tubulin modulators|mesh-ancestor
110124285|NCT01938456|Antimitotic Agents|antimitotic agents|mesh-ancestor
110124286|NCT01938456|Mitosis Modulators|mitosis modulators|mesh-ancestor
110124287|NCT01938456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110124288|NCT01938456|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110124289|NCT01938456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110124291|NCT01938508|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110124292|NCT01938508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110124293|NCT01938612|Durvalumab|durvalumab|mesh-list
110124294|NCT01938612|Tremelimumab|tremelimumab|mesh-list
110124295|NCT01938612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110124296|NCT01938612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110124297|NCT01938729|Dexamethasone|dexamethasone|mesh-list
110124298|NCT01938729|Gemcitabine|gemcitabine|mesh-list
110124299|NCT01938729|Floxuridine|floxuridine|mesh-list
110124300|NCT01938729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110124301|NCT01938729|Antiemetics|antiemetics|mesh-ancestor
110124302|NCT01938729|Autonomic Agents|autonomic agents|mesh-ancestor
110124303|NCT01938729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110124304|NCT01938729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110124305|NCT01938729|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110124307|NCT01938729|Hormones|hormones|mesh-ancestor
110124308|NCT01938729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110124309|NCT01938729|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110124310|NCT01938729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110124311|NCT01938729|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110124312|NCT01938729|Antimetabolites|antimetabolites|mesh-ancestor
110124313|NCT01938729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110124314|NCT01938755|Levobupivacaine|levobupivacaine|mesh-list
110124315|NCT01938755|Anesthetics, Local|anesthetics, local|mesh-ancestor
110124316|NCT01938755|Anesthetics|anesthetics|mesh-ancestor
110124317|NCT01938755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110124318|NCT01938755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110124319|NCT01938755|Sensory System Agents|sensory system agents|mesh-ancestor
110124320|NCT01938755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110124321|NCT01938781|Entecavir|entecavir|mesh-list
110124322|NCT01938781|Antiviral Agents|antiviral agents|mesh-ancestor
110124323|NCT01938781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110124324|NCT01938820|Entecavir|entecavir|mesh-list
110124325|NCT01938820|Antiviral Agents|antiviral agents|mesh-ancestor
110124326|NCT01938820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110124327|NCT01938859|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110124328|NCT01938859|Antidepressive Agents|antidepressive agents|mesh-ancestor
110124329|NCT01938859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110124330|NCT01938859|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110124331|NCT01938859|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110124332|NCT01938859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110124333|NCT01938859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110124334|NCT01938872|Paclitaxel|paclitaxel|mesh-list
110124335|NCT01938872|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110124336|NCT01938872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110124337|NCT01938872|Tubulin Modulators|tubulin modulators|mesh-ancestor
110124338|NCT01938872|Antimitotic Agents|antimitotic agents|mesh-ancestor
110124339|NCT01938872|Mitosis Modulators|mitosis modulators|mesh-ancestor
110124340|NCT01938872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110124341|NCT01938911|Oxytocin|oxytocin|mesh-list
110124342|NCT01938911|Oxytocics|oxytocics|mesh-ancestor
110124343|NCT01938911|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110124344|NCT01938911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110124346|NCT01939054|Capecitabine|capecitabine|mesh-list
110124347|NCT01939054|Nimotuzumab|nimotuzumab|mesh-list
110124348|NCT01939054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110124349|NCT01939054|Tubulin Modulators|tubulin modulators|mesh-ancestor
110124350|NCT01939054|Antimitotic Agents|antimitotic agents|mesh-ancestor
110124351|NCT01939054|Mitosis Modulators|mitosis modulators|mesh-ancestor
110124352|NCT01939054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110124353|NCT01939054|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110124354|NCT01939054|Antimetabolites|antimetabolites|mesh-ancestor
110124355|NCT01939054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110124356|NCT01939093|Thiamine|thiamine|mesh-list
110124357|NCT01939093|Cinnarizine|cinnarizine|mesh-list
110124358|NCT01939093|Diazepam|diazepam|mesh-list
110124359|NCT01939093|Vitamins|vitamins|mesh-ancestor
110124360|NCT01939093|Micronutrients|micronutrients|mesh-ancestor
110124361|NCT01939093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110124362|NCT01939093|Vitamin B Complex|vitamin b complex|mesh-ancestor
110124363|NCT01939093|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110124364|NCT01939093|Anticonvulsants|anticonvulsants|mesh-ancestor
110124365|NCT01939093|Antiemetics|antiemetics|mesh-ancestor
110124366|NCT01939093|Autonomic Agents|autonomic agents|mesh-ancestor
110124367|NCT01939093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110124368|NCT01939093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110124369|NCT01939093|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110124370|NCT01939093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110124371|NCT01939093|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110124372|NCT01939093|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110124373|NCT01939093|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110124374|NCT01939093|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110124375|NCT01939093|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110124376|NCT01939093|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110124377|NCT01939093|Anesthetics, General|anesthetics, general|mesh-ancestor
110124378|NCT01939093|Anesthetics|anesthetics|mesh-ancestor
110124379|NCT01939093|GABA Modulators|gaba modulators|mesh-ancestor
110124380|NCT01939093|GABA Agents|gaba agents|mesh-ancestor
110124381|NCT01939093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110124382|NCT01939093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110124383|NCT01939093|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110124384|NCT01939093|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110124385|NCT01939093|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110124386|NCT01939093|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110124387|NCT01939093|Histamine Antagonists|histamine antagonists|mesh-ancestor
110124388|NCT01939093|Histamine Agents|histamine agents|mesh-ancestor
110124389|NCT01939171|Thymoglobulin|thymoglobulin|mesh-list
110124390|NCT01939171|Immunologic Factors|immunologic factors|mesh-ancestor
110124391|NCT01939171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110124392|NCT01939171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110124393|NCT01939327|Rituximab|rituximab|mesh-list
110124394|NCT01939327|Lenalidomide|lenalidomide|mesh-list
110124395|NCT01939327|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110124396|NCT01939327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110124397|NCT01939327|Immunologic Factors|immunologic factors|mesh-ancestor
110124398|NCT01939327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110124399|NCT01939327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110124400|NCT01939327|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110124401|NCT01939327|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110124402|NCT01939327|Growth Substances|growth substances|mesh-ancestor
110124403|NCT01939327|Growth Inhibitors|growth inhibitors|mesh-ancestor
110124404|NCT01939379|Acetaminophen|acetaminophen|mesh-list
110124405|NCT01939379|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
110124406|NCT01939379|Morphine|morphine|mesh-list
110124407|NCT01939379|Oxycodone|oxycodone|mesh-list
110124408|NCT01939379|Analgesics|analgesics|mesh-list
110124409|NCT01939379|Ropivacaine|ropivacaine|mesh-list
110124410|NCT01939379|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110124411|NCT01939379|Narcotics|narcotics|mesh-ancestor
110124412|NCT01939379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110164054|NCT00009009|Immunosuppressive Agents|immunosuppressive agents|mesh-list
110124413|NCT01939379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110124414|NCT01939379|Sensory System Agents|sensory system agents|mesh-ancestor
110124415|NCT01939379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110124416|NCT01939379|Anesthetics, Local|anesthetics, local|mesh-ancestor
110124417|NCT01939379|Anesthetics|anesthetics|mesh-ancestor
110124418|NCT01939379|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110124419|NCT01939379|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110124420|NCT01939379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110124421|NCT01939379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110124422|NCT01939379|Antipyretics|antipyretics|mesh-ancestor
110124423|NCT01939418|Gemcitabine|gemcitabine|mesh-list
110124424|NCT01939418|Everolimus|everolimus|mesh-list
110124425|NCT01939418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110124426|NCT01939418|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110124427|NCT01939418|Antimetabolites|antimetabolites|mesh-ancestor
110124428|NCT01939418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110124429|NCT01939418|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110124430|NCT01939418|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110124431|NCT01939418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110124432|NCT01939418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110124433|NCT01939418|Immunologic Factors|immunologic factors|mesh-ancestor
110124434|NCT01939418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110124435|NCT01939444|Naloxone|naloxone|mesh-list
110124436|NCT01939444|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110124437|NCT01939444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110124438|NCT01939444|Sensory System Agents|sensory system agents|mesh-ancestor
110124439|NCT01939444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110124440|NCT01939457|Misoprostol|misoprostol|mesh-list
110124441|NCT01939457|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110124442|NCT01939457|Abortifacient Agents|abortifacient agents|mesh-ancestor
110124443|NCT01939457|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110124444|NCT01939457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110124445|NCT01939457|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110124446|NCT01939457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110124447|NCT01939457|Oxytocics|oxytocics|mesh-ancestor
110124448|NCT01939483|Irinotecan|irinotecan|mesh-list
110124449|NCT01939483|Camptothecin|camptothecin|mesh-list
110124450|NCT01939483|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110124451|NCT01939483|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110124452|NCT01939483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110124453|NCT01939483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110124454|NCT01939483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110124455|NCT01939483|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110124456|NCT01939509|Atenolol|atenolol|mesh-list
110124457|NCT01939509|Bisoprolol|bisoprolol|mesh-list
110124458|NCT01939509|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110124459|NCT01939509|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110124460|NCT01939509|Sympatholytics|sympatholytics|mesh-ancestor
110124461|NCT01939509|Autonomic Agents|autonomic agents|mesh-ancestor
110124462|NCT01939509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110124463|NCT01939509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110124464|NCT01939509|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110124465|NCT01939509|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110124466|NCT01939509|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110124467|NCT01939509|Adrenergic Agents|adrenergic agents|mesh-ancestor
110124468|NCT01939509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110124469|NCT01939509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110124470|NCT01939522|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110124471|NCT01939522|Immunologic Factors|immunologic factors|mesh-ancestor
110124472|NCT01939522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110124473|NCT01939561|Lamotrigine|lamotrigine|mesh-list
110124474|NCT01939561|Anticonvulsants|anticonvulsants|mesh-ancestor
110124475|NCT01939561|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110124476|NCT01939561|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110124477|NCT01939561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110124478|NCT01939561|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110124479|NCT01939561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110124480|NCT01939561|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110124481|NCT01939561|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110124482|NCT01939561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110124483|NCT01939561|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110124484|NCT01939561|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110124485|NCT01939574|Bevacizumab|bevacizumab|mesh-list
110124486|NCT01939574|Temozolomide|temozolomide|mesh-list
110124487|NCT01939574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110124488|NCT01939574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110124489|NCT01939574|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110124490|NCT01939574|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110124491|NCT01939574|Growth Substances|growth substances|mesh-ancestor
110124492|NCT01939574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110124493|NCT01939574|Growth Inhibitors|growth inhibitors|mesh-ancestor
110124494|NCT01939574|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110124495|NCT01939574|Alkylating Agents|alkylating agents|mesh-ancestor
110124496|NCT01939574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110124497|NCT01939639|Oxytocin|oxytocin|mesh-list
110124498|NCT01939639|Oxytocics|oxytocics|mesh-ancestor
110124499|NCT01939639|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110124500|NCT01939639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110124501|NCT01939691|Prednisolone|prednisolone|mesh-list
110124502|NCT01939691|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110124503|NCT01939691|Methylprednisolone|methylprednisolone|mesh-list
110124504|NCT01939691|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110124505|NCT01939691|Prednisolone acetate|prednisolone acetate|mesh-list
110124506|NCT01939691|Nepafenac|nepafenac|mesh-list
110124507|NCT01939691|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110124508|NCT01939691|Prednisolone phosphate|prednisolone phosphate|mesh-list
110124509|NCT01939691|Difluprednate|difluprednate|mesh-list
110124510|NCT01939691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110124511|NCT01939691|Glucocorticoids|glucocorticoids|mesh-ancestor
110124512|NCT01939691|Hormones|hormones|mesh-ancestor
110124513|NCT01939691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110124514|NCT01939691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110124515|NCT01939691|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110124516|NCT01939691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110124517|NCT01939691|Antiemetics|antiemetics|mesh-ancestor
110124518|NCT01939691|Autonomic Agents|autonomic agents|mesh-ancestor
110124519|NCT01939691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110124520|NCT01939691|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110124521|NCT01939691|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110124522|NCT01939691|Protective Agents|protective agents|mesh-ancestor
110124523|NCT01939691|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110124524|NCT01939691|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110124525|NCT01939691|Analgesics|analgesics|mesh-ancestor
110124526|NCT01939691|Sensory System Agents|sensory system agents|mesh-ancestor
110124527|NCT01939691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110124528|NCT01939730|Rituximab|rituximab|mesh-list
110124529|NCT01939730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110124530|NCT01939730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110124531|NCT01939730|Immunologic Factors|immunologic factors|mesh-ancestor
110124532|NCT01939730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110124533|NCT01939730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110124535|NCT01939743|Lidocaine|lidocaine|mesh-list
110124536|NCT01939743|Anesthetics, Local|anesthetics, local|mesh-ancestor
110124537|NCT01939743|Anesthetics|anesthetics|mesh-ancestor
110124538|NCT01939743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110124539|NCT01939743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110124540|NCT01939743|Sensory System Agents|sensory system agents|mesh-ancestor
110223899|NCT00297349|Topiramate|topiramate|mesh-list
110124541|NCT01939743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110124542|NCT01939743|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110124543|NCT01939743|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110124544|NCT01939743|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110124545|NCT01939743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110124546|NCT01939743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110124547|NCT01939743|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110124550|NCT01939743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110124551|NCT01939743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110124552|NCT01939743|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110124553|NCT01939743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110124554|NCT01939834|Insulin|insulin|mesh-list
110124555|NCT01939834|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110124556|NCT01939834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110124557|NCT01939886|Artesunate|artesunate|mesh-list
110124558|NCT01939886|Lumefantrine|lumefantrine|mesh-list
110124559|NCT01939886|Artemether|artemether|mesh-list
110124560|NCT01939886|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
110124561|NCT01939886|Mefloquine|mefloquine|mesh-list
110124562|NCT01939886|Antimalarials|antimalarials|mesh-ancestor
110124563|NCT01939886|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110124564|NCT01939886|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110124565|NCT01939886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110124566|NCT01939886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110124567|NCT01939886|Antiviral Agents|antiviral agents|mesh-ancestor
110124568|NCT01939886|Schistosomicides|schistosomicides|mesh-ancestor
110124569|NCT01939886|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110124570|NCT01939886|Anthelmintics|anthelmintics|mesh-ancestor
110124571|NCT01939912|Adenosine|adenosine|mesh-list
110124572|NCT01939912|Analgesics|analgesics|mesh-ancestor
110124573|NCT01939912|Sensory System Agents|sensory system agents|mesh-ancestor
110124574|NCT01939912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110124575|NCT01939912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110124576|NCT01939912|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110124577|NCT01939912|Vasodilator Agents|vasodilator agents|mesh-ancestor
110124578|NCT01939912|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
110124579|NCT01939912|Purinergic Agonists|purinergic agonists|mesh-ancestor
110124580|NCT01939912|Purinergic Agents|purinergic agents|mesh-ancestor
110124581|NCT01939912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110124582|NCT01939912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110124583|NCT01939990|Nebivolol|nebivolol|mesh-list
110124584|NCT01939990|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110124585|NCT01939990|Vasodilator Agents|vasodilator agents|mesh-ancestor
110124586|NCT01939990|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
110124587|NCT01939990|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110124588|NCT01939990|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110124589|NCT01939990|Adrenergic Agents|adrenergic agents|mesh-ancestor
110124590|NCT01939990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110124591|NCT01939990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110124592|NCT01939990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110124593|NCT01940081|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
110124594|NCT01940081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110124595|NCT01940081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110124596|NCT01940081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110124597|NCT01940081|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110124598|NCT01940172|Conatumumab|conatumumab|mesh-list
110124599|NCT01940172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110124600|NCT01940172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110124601|NCT01940224|Pregabalin|pregabalin|mesh-list
110124602|NCT01940224|Morphine|morphine|mesh-list
110124603|NCT01940224|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110124604|NCT01940224|Narcotics|narcotics|mesh-ancestor
110124605|NCT01940224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110124606|NCT01940224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110124607|NCT01940224|Analgesics|analgesics|mesh-ancestor
110124608|NCT01940224|Sensory System Agents|sensory system agents|mesh-ancestor
110124609|NCT01940224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110124610|NCT01940224|Anticonvulsants|anticonvulsants|mesh-ancestor
110124611|NCT01940224|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110124612|NCT01940224|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110124613|NCT01940224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110124614|NCT01940224|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110124615|NCT01940224|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110124616|NCT01940224|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110124617|NCT01940224|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110124618|NCT01940250|Magnesium Sulfate|magnesium sulfate|mesh-list
110124619|NCT01940250|Analgesics|analgesics|mesh-ancestor
110124620|NCT01940250|Sensory System Agents|sensory system agents|mesh-ancestor
110124621|NCT01940250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110124622|NCT01940250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110124623|NCT01940250|Anesthetics|anesthetics|mesh-ancestor
110124624|NCT01940250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110124625|NCT01940250|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110124626|NCT01940250|Anticonvulsants|anticonvulsants|mesh-ancestor
110124627|NCT01940250|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110124628|NCT01940250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110124629|NCT01940250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110124630|NCT01940250|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110124631|NCT01940250|Tocolytic Agents|tocolytic agents|mesh-ancestor
110124632|NCT01940250|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110124633|NCT01940393|Cetirizine|cetirizine|mesh-list
110124634|NCT01940393|Fexofenadine|fexofenadine|mesh-list
110124635|NCT01940393|Desloratadine|desloratadine|mesh-list
110124636|NCT01940393|Ebastine|ebastine|mesh-list
110124637|NCT01940393|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110124638|NCT01940393|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110124639|NCT01940393|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110124640|NCT01940393|Histamine Antagonists|histamine antagonists|mesh-ancestor
110124641|NCT01940393|Histamine Agents|histamine agents|mesh-ancestor
110124642|NCT01940393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110124643|NCT01940393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110124644|NCT01940393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110124645|NCT01940393|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110124646|NCT01940393|Cholinergic Agents|cholinergic agents|mesh-ancestor
110124647|NCT01940419|Tranexamic Acid|tranexamic acid|mesh-list
110124648|NCT01940419|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110124649|NCT01940419|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110124650|NCT01940419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110124651|NCT01940419|Hemostatics|hemostatics|mesh-ancestor
110124652|NCT01940419|Coagulants|coagulants|mesh-ancestor
110124653|NCT01940536|Tranexamic Acid|tranexamic acid|mesh-list
110124654|NCT01940536|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110242430|NCT00110045|Caspofungin|caspofungin|mesh-list
110124655|NCT01940536|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110124656|NCT01940536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110124657|NCT01940536|Hemostatics|hemostatics|mesh-ancestor
110124658|NCT01940536|Coagulants|coagulants|mesh-ancestor
110124659|NCT01940601|Lenograstim|lenograstim|mesh-list
110124660|NCT01940601|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110124661|NCT01940601|Immunologic Factors|immunologic factors|mesh-ancestor
110124662|NCT01940601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110124663|NCT01940627|Ubiquinone|ubiquinone|mesh-list
110124664|NCT01940627|Coenzyme Q10|coenzyme q10|mesh-list
110124665|NCT01940627|Micronutrients|micronutrients|mesh-ancestor
110124666|NCT01940627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110124667|NCT01940627|Vitamins|vitamins|mesh-ancestor
110124668|NCT01940653|Estradiol|estradiol|mesh-list
110124669|NCT01940653|Progesterone|progesterone|mesh-list
110124670|NCT01940653|Estrogens|estrogens|mesh-ancestor
110124671|NCT01940653|Hormones|hormones|mesh-ancestor
110124672|NCT01940653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110124673|NCT01940653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110124674|NCT01940653|Progestins|progestins|mesh-ancestor
110124675|NCT01940692|Tranexamic Acid|tranexamic acid|mesh-list
110124676|NCT01940692|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110124677|NCT01940692|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110124678|NCT01940692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110124679|NCT01940692|Hemostatics|hemostatics|mesh-ancestor
110124680|NCT01940692|Coagulants|coagulants|mesh-ancestor
110124681|NCT01940718|Methyltestosterone|methyltestosterone|mesh-list
110124682|NCT01940718|Testosterone|testosterone|mesh-list
110124683|NCT01940718|Testosterone undecanoate|testosterone undecanoate|mesh-list
110124684|NCT01940718|Testosterone enanthate|testosterone enanthate|mesh-list
110124685|NCT01940718|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
110124686|NCT01940718|Androgens|androgens|mesh-ancestor
110124688|NCT01940718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110124689|NCT01940718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110124690|NCT01940718|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110124691|NCT01940718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110124692|NCT01940718|Anabolic Agents|anabolic agents|mesh-ancestor
110124693|NCT01940796|Brentuximab Vedotin|brentuximab vedotin|mesh-list
110124694|NCT01940796|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110124695|NCT01940796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110124696|NCT01940796|Immunotoxins|immunotoxins|mesh-ancestor
110124697|NCT01940796|Immunoconjugates|immunoconjugates|mesh-ancestor
110124698|NCT01940796|Immunologic Factors|immunologic factors|mesh-ancestor
110124699|NCT01940796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110124700|NCT01940952|Donepezil|donepezil|mesh-list
110124701|NCT01940952|Udenafil|udenafil|mesh-list
110124702|NCT01940952|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110124703|NCT01940952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110124704|NCT01940952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110124705|NCT01940952|Cholinergic Agents|cholinergic agents|mesh-ancestor
110124706|NCT01940952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110124707|NCT01940952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110124708|NCT01940952|Nootropic Agents|nootropic agents|mesh-ancestor
110124709|NCT01940952|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110124710|NCT01940952|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110124711|NCT01940965|Lixisenatide|lixisenatide|mesh-list
110124712|NCT01940965|Biguanides|biguanides|mesh-list
110124713|NCT01940965|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110124714|NCT01940965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110124715|NCT01940978|Cyproheptadine|cyproheptadine|mesh-list
110124716|NCT01940978|Methylphenidate|methylphenidate|mesh-list
110124717|NCT01940978|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110124718|NCT01940978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110124719|NCT01940978|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110124720|NCT01940978|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110124721|NCT01940978|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110124722|NCT01940978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110124723|NCT01940978|Dopamine Agents|dopamine agents|mesh-ancestor
110124724|NCT01940978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110124725|NCT01940978|Antipruritics|antipruritics|mesh-ancestor
110124726|NCT01940978|Dermatologic Agents|dermatologic agents|mesh-ancestor
110124727|NCT01940978|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110124728|NCT01940978|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110124729|NCT01940978|Histamine Antagonists|histamine antagonists|mesh-ancestor
110124730|NCT01940978|Histamine Agents|histamine agents|mesh-ancestor
110124731|NCT01940978|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110124732|NCT01940978|Serotonin Agents|serotonin agents|mesh-ancestor
110124733|NCT01940978|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110124734|NCT01941004|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
110124735|NCT01941004|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
110124736|NCT01941004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110124737|NCT01941004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110124738|NCT01941004|Immunologic Factors|immunologic factors|mesh-ancestor
110124739|NCT01941004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110124740|NCT01941056|Vaccines|vaccines|mesh-list
110124741|NCT01941056|Immunologic Factors|immunologic factors|mesh-ancestor
110124742|NCT01941056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110124743|NCT01941134|Levonorgestrel|levonorgestrel|mesh-list
110124744|NCT01941134|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110124745|NCT01941134|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
110124746|NCT01941134|Contraceptive Agents|contraceptive agents|mesh-list
110124747|NCT01941134|Contraceptives, Oral|contraceptives, oral|mesh-list
110124748|NCT01941134|Estradiol|estradiol|mesh-list
110124749|NCT01941134|Estrogens|estrogens|mesh-ancestor
110124750|NCT01941134|Hormones|hormones|mesh-ancestor
110124751|NCT01941134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110124752|NCT01941134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110124753|NCT01941134|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110124754|NCT01941134|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110124755|NCT01941134|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110124756|NCT01941134|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110124757|NCT01941134|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110124758|NCT01941134|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110124759|NCT01941173|Leucovorin|leucovorin|mesh-list
110124760|NCT01941173|Fluorouracil|fluorouracil|mesh-list
110124761|NCT01941173|Irinotecan|irinotecan|mesh-list
110124762|NCT01941173|Aflibercept|aflibercept|mesh-list
110124763|NCT01941173|Calcium|calcium|mesh-list
110124764|NCT01941173|Levoleucovorin|levoleucovorin|mesh-list
110124765|NCT01941173|Endothelial Growth Factors|endothelial growth factors|mesh-list
110124766|NCT01941173|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110124767|NCT01941173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110124768|NCT01941173|Antimetabolites|antimetabolites|mesh-ancestor
110124769|NCT01941173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110124770|NCT01941173|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110124771|NCT01941173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110124772|NCT01941173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110124773|NCT01941173|Immunologic Factors|immunologic factors|mesh-ancestor
110124775|NCT01941173|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110124776|NCT01941173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110124777|NCT01941173|Antidotes|antidotes|mesh-ancestor
110124778|NCT01941173|Protective Agents|protective agents|mesh-ancestor
110124779|NCT01941173|Vitamin B Complex|vitamin b complex|mesh-ancestor
110124780|NCT01941173|Vitamins|vitamins|mesh-ancestor
110124781|NCT01941173|Micronutrients|micronutrients|mesh-ancestor
110124782|NCT01941173|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110124783|NCT01941173|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110124784|NCT01941173|Growth Substances|growth substances|mesh-ancestor
110124785|NCT01941173|Growth Inhibitors|growth inhibitors|mesh-ancestor
110124786|NCT01941199|Metformin|metformin|mesh-list
110124787|NCT01941199|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110124788|NCT01941199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110124789|NCT01941225|Iloprost|iloprost|mesh-list
110124790|NCT01941225|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110124791|NCT01941225|Vasodilator Agents|vasodilator agents|mesh-ancestor
110124792|NCT01941264|Lumefantrine|lumefantrine|mesh-list
110124793|NCT01941264|Artemether|artemether|mesh-list
110124794|NCT01941264|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
110124795|NCT01941264|Antimalarials|antimalarials|mesh-ancestor
110124796|NCT01941264|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110124797|NCT01941264|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110124798|NCT01941264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110124799|NCT01941316|Irinotecan|irinotecan|mesh-list
110124800|NCT01941316|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110124801|NCT01941316|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110124802|NCT01941316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110124803|NCT01941316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110124804|NCT01941316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110124805|NCT01941329|Ranibizumab|ranibizumab|mesh-list
110124806|NCT01941329|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110124807|NCT01941329|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110124808|NCT01941329|Growth Substances|growth substances|mesh-ancestor
110124809|NCT01941329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110124810|NCT01941329|Growth Inhibitors|growth inhibitors|mesh-ancestor
110124811|NCT01941329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110124812|NCT01941407|Bevacizumab|bevacizumab|mesh-list
110124813|NCT01941407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110124814|NCT01941407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110124815|NCT01941407|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110124816|NCT01941407|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110124817|NCT01941407|Growth Substances|growth substances|mesh-ancestor
110223961|NCT00090207|Ondansetron|ondansetron|mesh-list
110223962|NCT00090207|Aprepitant|aprepitant|mesh-list
110223963|NCT00090207|Antiemetics|antiemetics|mesh-ancestor
110124820|NCT01941524|Poractant alfa|poractant alfa|mesh-list
110124821|NCT01941524|Beractant|beractant|mesh-list
110124822|NCT01941524|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
110124823|NCT01941524|Respiratory System Agents|respiratory system agents|mesh-ancestor
110124824|NCT01941576|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
110124825|NCT01941576|Natriuretic Agents|natriuretic agents|mesh-ancestor
110124826|NCT01941576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110124827|NCT01941602|Enoxaparin|enoxaparin|mesh-list
110124828|NCT01941602|Anticoagulants|anticoagulants|mesh-ancestor
110124829|NCT01941602|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110124830|NCT01941602|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110124831|NCT01941602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110124832|NCT01941732|Sildenafil Citrate|sildenafil citrate|mesh-list
110124833|NCT01941732|Vasodilator Agents|vasodilator agents|mesh-ancestor
110124834|NCT01941732|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110124835|NCT01941732|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110124836|NCT01941732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110124837|NCT01941732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110124838|NCT01941732|Urological Agents|urological agents|mesh-ancestor
110124840|NCT01941758|Immunologic Factors|immunologic factors|mesh-ancestor
110124841|NCT01941758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110124842|NCT01941771|Capecitabine|capecitabine|mesh-list
110124843|NCT01941771|Vinorelbine|vinorelbine|mesh-list
110124844|NCT01941771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110124845|NCT01941771|Antimetabolites|antimetabolites|mesh-ancestor
110124846|NCT01941771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110124847|NCT01941771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110124848|NCT01941771|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110124849|NCT01941771|Tubulin Modulators|tubulin modulators|mesh-ancestor
110124850|NCT01941771|Antimitotic Agents|antimitotic agents|mesh-ancestor
110124851|NCT01941771|Mitosis Modulators|mitosis modulators|mesh-ancestor
110124852|NCT01941810|Lactoferrin|lactoferrin|mesh-list
110124853|NCT01941810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110124855|NCT01941888|Propofol|propofol|mesh-list
110124856|NCT01941888|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110124857|NCT01941888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110124858|NCT01941888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110124859|NCT01941888|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110124860|NCT01941888|Anesthetics, General|anesthetics, general|mesh-ancestor
110124861|NCT01941888|Anesthetics|anesthetics|mesh-ancestor
110124862|NCT01941888|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110124863|NCT01941888|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110124864|NCT01941888|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110124865|NCT01941888|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110124866|NCT01941888|GABA Modulators|gaba modulators|mesh-ancestor
110124867|NCT01941888|GABA Agents|gaba agents|mesh-ancestor
110124868|NCT01941888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110124869|NCT01941888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110124870|NCT01941901|Calcium, Dietary|calcium, dietary|mesh-list
110124871|NCT01941901|Bleomycin|bleomycin|mesh-list
110124872|NCT01941901|Calcium|calcium|mesh-list
110124873|NCT01941901|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110124874|NCT01941901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110124875|NCT01941901|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110124876|NCT01941901|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110124877|NCT01941901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110124879|NCT01941914|Calcium|calcium|mesh-list
110164119|NCT00394459|Anesthetics|anesthetics|mesh-list
110124880|NCT01941914|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110124881|NCT01941914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110124882|NCT01941914|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110124884|NCT01941953|Fluorouracil|fluorouracil|mesh-list
110124885|NCT01941953|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110124886|NCT01941953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110124887|NCT01941953|Antimetabolites|antimetabolites|mesh-ancestor
110124888|NCT01941953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110124889|NCT01941953|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110124890|NCT01941953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110124891|NCT01941953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110124892|NCT01941953|Immunologic Factors|immunologic factors|mesh-ancestor
110124893|NCT01941966|Capecitabine|capecitabine|mesh-list
110124894|NCT01941966|Mitomycins|mitomycins|mesh-list
110124895|NCT01941966|Mitomycin|mitomycin|mesh-list
110124896|NCT01941966|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110124897|NCT01941966|Antimetabolites|antimetabolites|mesh-ancestor
110124898|NCT01941966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110124899|NCT01941966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110124900|NCT01941966|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110124901|NCT01941966|Alkylating Agents|alkylating agents|mesh-ancestor
110124902|NCT01941966|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110124903|NCT01941966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110124904|NCT01941979|Leucovorin|leucovorin|mesh-list
110124905|NCT01941979|Capecitabine|capecitabine|mesh-list
110124906|NCT01941979|Oxaliplatin|oxaliplatin|mesh-list
110124907|NCT01941979|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110124908|NCT01941979|Antimetabolites|antimetabolites|mesh-ancestor
110224027|NCT00122226|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110124909|NCT01941979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110124910|NCT01941979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110124911|NCT01941979|Antidotes|antidotes|mesh-ancestor
110124912|NCT01941979|Protective Agents|protective agents|mesh-ancestor
110124913|NCT01941979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110124914|NCT01941979|Vitamin B Complex|vitamin b complex|mesh-ancestor
110124915|NCT01941979|Vitamins|vitamins|mesh-ancestor
110124916|NCT01941979|Micronutrients|micronutrients|mesh-ancestor
110124917|NCT01942070|Everolimus|everolimus|mesh-list
110124918|NCT01942070|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110124919|NCT01942070|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110124920|NCT01942070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110124921|NCT01942070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110124922|NCT01942070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110124923|NCT01942070|Immunologic Factors|immunologic factors|mesh-ancestor
110124924|NCT01942070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110124925|NCT01942070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110124926|NCT01942109|Torsemide|torsemide|mesh-list
110124927|NCT01942109|Furosemide|furosemide|mesh-list
110124928|NCT01942109|Diuretics|diuretics|mesh-ancestor
110124929|NCT01942109|Natriuretic Agents|natriuretic agents|mesh-ancestor
110124930|NCT01942109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110164128|NCT00394537|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110124931|NCT01942109|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110124932|NCT01942109|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110124933|NCT01942109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110124934|NCT01942109|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110124935|NCT01942174|Methotrexate|methotrexate|mesh-list
110124936|NCT01942174|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110124937|NCT01942174|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110124938|NCT01942174|Abortifacient Agents|abortifacient agents|mesh-ancestor
110124939|NCT01942174|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110124940|NCT01942174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110124941|NCT01942174|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110124942|NCT01942174|Antimetabolites|antimetabolites|mesh-ancestor
110124943|NCT01942174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110124944|NCT01942174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110124945|NCT01942174|Dermatologic Agents|dermatologic agents|mesh-ancestor
110124946|NCT01942174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110124947|NCT01942174|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110124948|NCT01942174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110124949|NCT01942174|Immunologic Factors|immunologic factors|mesh-ancestor
110124950|NCT01942174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110224060|NCT00298168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110124951|NCT01942174|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110124952|NCT01942187|Aripiprazole|aripiprazole|mesh-list
110124954|NCT01942187|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110124955|NCT01942187|Antidepressive Agents|antidepressive agents|mesh-ancestor
110124956|NCT01942187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110124957|NCT01942187|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110124958|NCT01942187|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110124959|NCT01942187|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110124960|NCT01942187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110124961|NCT01942187|Dopamine Agents|dopamine agents|mesh-ancestor
110124962|NCT01942187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110124963|NCT01942187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110124964|NCT01942187|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110124965|NCT01942187|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110124966|NCT01942187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110124967|NCT01942187|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110124968|NCT01942187|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110124969|NCT01942187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110124970|NCT01942187|Dopamine Agonists|dopamine agonists|mesh-ancestor
110124971|NCT01942187|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110124972|NCT01942187|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110124973|NCT01942187|Serotonin Agents|serotonin agents|mesh-ancestor
110124974|NCT01942187|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110124975|NCT01942187|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110124976|NCT01942187|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110124977|NCT01942187|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110124978|NCT01942291|Niacin|niacin|mesh-list
110124979|NCT01942291|Nicotinic Acids|nicotinic acids|mesh-list
110124980|NCT01942291|Vitamins|vitamins|mesh-ancestor
110124981|NCT01942291|Micronutrients|micronutrients|mesh-ancestor
110124982|NCT01942291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110124983|NCT01942291|Vitamin B Complex|vitamin b complex|mesh-ancestor
110124984|NCT01942291|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110124985|NCT01942291|Antimetabolites|antimetabolites|mesh-ancestor
110124986|NCT01942291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110124987|NCT01942291|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110124988|NCT01942291|Vasodilator Agents|vasodilator agents|mesh-ancestor
110124989|NCT01942304|Calcium|calcium|mesh-list
110124990|NCT01942304|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110124991|NCT01942304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110124993|NCT01942343|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110124994|NCT01942343|Antiemetics|antiemetics|mesh-ancestor
110124995|NCT01942343|Autonomic Agents|autonomic agents|mesh-ancestor
110124996|NCT01942343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110124997|NCT01942343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110124998|NCT01942343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110124999|NCT01942343|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110125000|NCT01942343|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110125001|NCT01942343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110125003|NCT01942343|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110125004|NCT01942343|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110125005|NCT01942343|Dopamine Agents|dopamine agents|mesh-ancestor
110125006|NCT01942343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110125007|NCT01942343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110125008|NCT01942369|Triptorelin Pamoate|triptorelin pamoate|mesh-list
110125009|NCT01942369|Luteolytic Agents|luteolytic agents|mesh-ancestor
110125010|NCT01942369|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110125011|NCT01942369|Contraceptive Agents|contraceptive agents|mesh-ancestor
110125012|NCT01942369|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110125013|NCT01942369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110125014|NCT01942369|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110125015|NCT01942369|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110125016|NCT01942369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110125017|NCT01942382|Paliperidone Palmitate|paliperidone palmitate|mesh-list
110125018|NCT01942382|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110125019|NCT01942382|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110125020|NCT01942382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110125021|NCT01942382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110125022|NCT01942382|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110125023|NCT01942382|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110125024|NCT01942382|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110125025|NCT01942382|Serotonin Agents|serotonin agents|mesh-ancestor
110125026|NCT01942382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110125027|NCT01942382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110125028|NCT01942382|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110125029|NCT01942382|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110125030|NCT01942382|Dopamine Agents|dopamine agents|mesh-ancestor
110125031|NCT01942447|Vancomycin|vancomycin|mesh-list
110125032|NCT01942447|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110125033|NCT01942447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110125034|NCT01942460|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
110125035|NCT01942460|Hematinics|hematinics|mesh-ancestor
110125036|NCT01942460|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
110125037|NCT01942460|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110125038|NCT01942551|Tadalafil|tadalafil|mesh-list
110125039|NCT01942551|Dutasteride|dutasteride|mesh-list
110125040|NCT01942551|Vasodilator Agents|vasodilator agents|mesh-ancestor
110125041|NCT01942551|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110125042|NCT01942551|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110125043|NCT01942551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110125044|NCT01942551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110125045|NCT01942551|Urological Agents|urological agents|mesh-ancestor
110125046|NCT01942551|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
110125047|NCT01942551|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110125048|NCT01942551|Hormone Antagonists|hormone antagonists|mesh-ancestor
110125049|NCT01942551|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110125050|NCT01942551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110125051|NCT01942577|Protective Agents|protective agents|mesh-list
110125052|NCT01942577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110125053|NCT01942681|Propiverine|propiverine|mesh-list
110125054|NCT01942681|Parasympatholytics|parasympatholytics|mesh-ancestor
110125055|NCT01942681|Autonomic Agents|autonomic agents|mesh-ancestor
110125056|NCT01942681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110125057|NCT01942681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110125058|NCT01942681|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110125059|NCT01942681|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110125060|NCT01942681|Cholinergic Agents|cholinergic agents|mesh-ancestor
110125061|NCT01942681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110125062|NCT01942681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110125063|NCT01942681|Urological Agents|urological agents|mesh-ancestor
110125064|NCT01942889|Antioxidants|antioxidants|mesh-list
110125065|NCT01942889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110125066|NCT01942889|Protective Agents|protective agents|mesh-ancestor
110125067|NCT01942889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110125068|NCT01943019|Linagliptin|linagliptin|mesh-list
110125069|NCT01943019|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110125070|NCT01943019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110125071|NCT01943019|Incretins|incretins|mesh-ancestor
110125073|NCT01943019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110125074|NCT01943019|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110125076|NCT01943019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110125077|NCT01943019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110125078|NCT01943058|Megestrol|megestrol|mesh-list
110125079|NCT01943058|Megestrol Acetate|megestrol acetate|mesh-list
110125080|NCT01943058|Levonorgestrel|levonorgestrel|mesh-list
110125081|NCT01943058|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110125082|NCT01943058|Contraceptive Agents|contraceptive agents|mesh-ancestor
110125083|NCT01943058|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110125084|NCT01943058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110125085|NCT01943058|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110125086|NCT01943058|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110125087|NCT01943058|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110125088|NCT01943058|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110125089|NCT01943058|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110125090|NCT01943058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110125091|NCT01943058|Appetite Stimulants|appetite stimulants|mesh-ancestor
110125092|NCT01943058|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110125093|NCT01943136|Mupirocin|mupirocin|mesh-list
110125094|NCT01943136|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110125095|NCT01943136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110125096|NCT01943136|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110125097|NCT01943136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110125098|NCT01943136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110125099|NCT01943188|Cyclophosphamide|cyclophosphamide|mesh-list
110125100|NCT01943188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110125101|NCT01943188|Immunologic Factors|immunologic factors|mesh-ancestor
110125102|NCT01943188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110125103|NCT01943188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110125104|NCT01943188|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110125105|NCT01943188|Alkylating Agents|alkylating agents|mesh-ancestor
110125106|NCT01943188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110125107|NCT01943188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110125108|NCT01943188|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110125109|NCT01943240|Ropivacaine|ropivacaine|mesh-list
110125110|NCT01943240|Anesthetics, Local|anesthetics, local|mesh-ancestor
110125111|NCT01943240|Anesthetics|anesthetics|mesh-ancestor
110125112|NCT01943240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110125113|NCT01943240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110125114|NCT01943240|Sensory System Agents|sensory system agents|mesh-ancestor
110125115|NCT01943240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110125116|NCT01943305|Vaccines|vaccines|mesh-list
110125117|NCT01943305|Immunologic Factors|immunologic factors|mesh-ancestor
110125118|NCT01943305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110125119|NCT01943409|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
110125120|NCT01943409|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
110125121|NCT01943409|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
110125122|NCT01943409|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110125123|NCT01943422|Interferons|interferons|mesh-list
110125124|NCT01943422|Interferon-alpha|interferon-alpha|mesh-list
110125125|NCT01943422|Interferon alpha-2|interferon alpha-2|mesh-list
110125126|NCT01943422|Vemurafenib|vemurafenib|mesh-list
110125127|NCT01943422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110125128|NCT01943422|Antiviral Agents|antiviral agents|mesh-ancestor
110125129|NCT01943422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110243725|NCT00352144|Eszopiclone|eszopiclone|mesh-list
110125130|NCT01943422|Immunologic Factors|immunologic factors|mesh-ancestor
110125131|NCT01943422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110125132|NCT01943422|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110125133|NCT01943422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110125134|NCT01943422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110125136|NCT01943487|Tamsulosin|tamsulosin|mesh-list
110125137|NCT01943487|Solifenacin Succinate|solifenacin succinate|mesh-list
110125138|NCT01943487|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110125139|NCT01943487|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110125140|NCT01943487|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110125141|NCT01943487|Adrenergic Agents|adrenergic agents|mesh-ancestor
110125142|NCT01943487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110125143|NCT01943487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110125144|NCT01943487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110125145|NCT01943487|Urological Agents|urological agents|mesh-ancestor
110125146|NCT01943487|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110125148|NCT01943487|Cholinergic Agents|cholinergic agents|mesh-ancestor
110125149|NCT01943487|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110125150|NCT01943487|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110125151|NCT01943487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110125152|NCT01943487|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110125153|NCT01943487|Vasodilator Agents|vasodilator agents|mesh-ancestor
110125154|NCT01943526|Natalizumab|natalizumab|mesh-list
110125155|NCT01943526|Immunologic Factors|immunologic factors|mesh-ancestor
110125156|NCT01943526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110125157|NCT01943617|Entecavir|entecavir|mesh-list
110125158|NCT01943617|Antiviral Agents|antiviral agents|mesh-ancestor
110125159|NCT01943617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110125160|NCT01943630|Ammonium trichloro(dioxoethylene-O,O'-)tellurate|ammonium trichloro(dioxoethylene-o,o'-)tellurate|mesh-list
110125161|NCT01943630|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110125162|NCT01943630|Immunologic Factors|immunologic factors|mesh-ancestor
110125163|NCT01943630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110125164|NCT01943630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110125165|NCT01943630|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110125166|NCT01943630|Protective Agents|protective agents|mesh-ancestor
110125167|NCT01943630|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110125168|NCT01943630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110125169|NCT01943630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110125170|NCT01943630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110125171|NCT01943630|Antiviral Agents|antiviral agents|mesh-ancestor
110125172|NCT01943630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110125173|NCT01943760|Tramadol|tramadol|mesh-list
110125174|NCT01943760|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110125175|NCT01943760|Narcotics|narcotics|mesh-ancestor
110125176|NCT01943760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110125177|NCT01943760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110125178|NCT01943760|Analgesics|analgesics|mesh-ancestor
110125179|NCT01943760|Sensory System Agents|sensory system agents|mesh-ancestor
110125180|NCT01943760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110125181|NCT01943786|Cetuximab|cetuximab|mesh-list
110125182|NCT01943786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110125183|NCT01943786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110125184|NCT01943812|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110125185|NCT01943812|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110125186|NCT01943812|Estradiol|estradiol|mesh-list
110125187|NCT01943812|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110125188|NCT01943812|Progesterone|progesterone|mesh-list
110125189|NCT01943812|Estrogens|estrogens|mesh-ancestor
110125190|NCT01943812|Hormones|hormones|mesh-ancestor
110125191|NCT01943812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110125192|NCT01943812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110125193|NCT01943812|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110125194|NCT01943812|Contraceptive Agents|contraceptive agents|mesh-ancestor
110125195|NCT01943812|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110125196|NCT01943812|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110125197|NCT01943812|Progestins|progestins|mesh-ancestor
110125198|NCT01943877|Propolis|propolis|mesh-list
110125199|NCT01943877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110125200|NCT01943942|Montelukast|montelukast|mesh-list
110125201|NCT01943942|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110125202|NCT01943942|Respiratory System Agents|respiratory system agents|mesh-ancestor
110125203|NCT01943942|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110125204|NCT01943942|Hormone Antagonists|hormone antagonists|mesh-ancestor
110164167|NCT00128440|Parasympatholytics|parasympatholytics|mesh-ancestor
110125205|NCT01943942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110125206|NCT01943942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110125207|NCT01943942|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110125208|NCT01943942|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110125209|NCT01943942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110125210|NCT01944033|Terbutaline|terbutaline|mesh-list
110125211|NCT01944033|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110125212|NCT01944033|Autonomic Agents|autonomic agents|mesh-ancestor
110125213|NCT01944033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110125214|NCT01944033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110125215|NCT01944033|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110125216|NCT01944033|Respiratory System Agents|respiratory system agents|mesh-ancestor
110125217|NCT01944033|Sympathomimetics|sympathomimetics|mesh-ancestor
110125218|NCT01944033|Tocolytic Agents|tocolytic agents|mesh-ancestor
110125219|NCT01944033|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110125220|NCT01944033|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110125221|NCT01944033|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110125222|NCT01944033|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110125223|NCT01944033|Adrenergic Agents|adrenergic agents|mesh-ancestor
110125224|NCT01944033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110125225|NCT01944033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110125226|NCT01944085|Acetaminophen|acetaminophen|mesh-list
110125227|NCT01944085|Ascorbic Acid|ascorbic acid|mesh-list
110125228|NCT01944085|Ibuprofen|ibuprofen|mesh-list
110125229|NCT01944085|Vitamins|vitamins|mesh-ancestor
110125230|NCT01944085|Micronutrients|micronutrients|mesh-ancestor
110125231|NCT01944085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110125232|NCT01944085|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110125233|NCT01944085|Analgesics|analgesics|mesh-ancestor
110125234|NCT01944085|Sensory System Agents|sensory system agents|mesh-ancestor
110125235|NCT01944085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110125236|NCT01944085|Antipyretics|antipyretics|mesh-ancestor
110125237|NCT01944085|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110125238|NCT01944085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110125239|NCT01944085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110125240|NCT01944085|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110125241|NCT01944085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110125242|NCT01944085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110125243|NCT01944085|Antioxidants|antioxidants|mesh-ancestor
110125244|NCT01944085|Protective Agents|protective agents|mesh-ancestor
110125245|NCT01944176|Simvastatin|simvastatin|mesh-list
110224151|NCT00322699|Trioxsalen|trioxsalen|mesh-list
110125246|NCT01944176|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110125247|NCT01944176|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110125248|NCT01944176|Antimetabolites|antimetabolites|mesh-ancestor
110125249|NCT01944176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110125250|NCT01944176|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110125251|NCT01944176|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110125252|NCT01944176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110125253|NCT01944189|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
110125254|NCT01944189|Antimalarials|antimalarials|mesh-ancestor
110125255|NCT01944189|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110125256|NCT01944189|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110125257|NCT01944189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110125258|NCT01944215|Caffeine|caffeine|mesh-list
110125259|NCT01944215|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110125260|NCT01944215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110125261|NCT01944215|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110125262|NCT01944215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110125263|NCT01944215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110125264|NCT01944215|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110125265|NCT01944215|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110125266|NCT01944215|Purinergic Agents|purinergic agents|mesh-ancestor
110125267|NCT01944215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110125268|NCT01944384|Spironolactone|spironolactone|mesh-list
110164169|NCT00128440|Cholinergic Agents|cholinergic agents|mesh-ancestor
110125269|NCT01944384|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110125270|NCT01944384|Hormone Antagonists|hormone antagonists|mesh-ancestor
110125271|NCT01944384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110125272|NCT01944384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110125273|NCT01944384|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110125274|NCT01944384|Diuretics|diuretics|mesh-ancestor
110125275|NCT01944384|Natriuretic Agents|natriuretic agents|mesh-ancestor
110125276|NCT01944410|Mitogens|mitogens|mesh-list
110125277|NCT01944410|Mitosis Modulators|mitosis modulators|mesh-ancestor
110125278|NCT01944410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110125279|NCT01944436|Rivastigmine|rivastigmine|mesh-list
110125280|NCT01944436|Donepezil|donepezil|mesh-list
110125281|NCT01944436|Galantamine|galantamine|mesh-list
110125282|NCT01944436|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
110125283|NCT01944436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110125284|NCT01944436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110125285|NCT01944436|Cholinergic Agents|cholinergic agents|mesh-ancestor
110125286|NCT01944436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110125287|NCT01944436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110125288|NCT01944436|Nootropic Agents|nootropic agents|mesh-ancestor
110125289|NCT01944436|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110125290|NCT01944436|Autonomic Agents|autonomic agents|mesh-ancestor
110125291|NCT01944436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110125292|NCT01944436|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110125293|NCT01944436|Protective Agents|protective agents|mesh-ancestor
110125294|NCT01944618|Dapagliflozin|dapagliflozin|mesh-list
110125295|NCT01944618|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110125296|NCT01944618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110125297|NCT01944618|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110125298|NCT01944618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110125299|NCT01944657|Antidepressive Agents|antidepressive agents|mesh-list
110125300|NCT01944657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110125301|NCT01944683|Midazolam|midazolam|mesh-list
110125302|NCT01944683|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110125303|NCT01944683|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110125304|NCT01944683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110125305|NCT01944683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110125306|NCT01944683|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110125307|NCT01944683|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110125308|NCT01944683|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110125309|NCT01944683|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110125310|NCT01944683|Anesthetics, General|anesthetics, general|mesh-ancestor
110125311|NCT01944683|Anesthetics|anesthetics|mesh-ancestor
110125312|NCT01944683|GABA Modulators|gaba modulators|mesh-ancestor
110125313|NCT01944683|GABA Agents|gaba agents|mesh-ancestor
110125314|NCT01944683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110125315|NCT01944683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110125317|NCT01944735|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110125318|NCT01944735|Diuretics|diuretics|mesh-ancestor
110125319|NCT01944735|Natriuretic Agents|natriuretic agents|mesh-ancestor
110125320|NCT01944735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110125321|NCT01944852|Icodextrin|icodextrin|mesh-list
110125322|NCT01944852|Dialysis Solutions|dialysis solutions|mesh-ancestor
110125323|NCT01944852|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110125324|NCT01945021|Crizotinib|crizotinib|mesh-list
110125325|NCT01945021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110125326|NCT01945021|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110125327|NCT01945021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110125328|NCT01945021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110125329|NCT01945047|Midazolam|midazolam|mesh-list
110125330|NCT01945047|Ketamine|ketamine|mesh-list
110125331|NCT01945047|Analgesics|analgesics|mesh-ancestor
110125332|NCT01945047|Sensory System Agents|sensory system agents|mesh-ancestor
110125333|NCT01945047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110125334|NCT01945047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110125335|NCT01945047|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110125336|NCT01945047|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110125337|NCT01945047|Anesthetics, General|anesthetics, general|mesh-ancestor
110125338|NCT01945047|Anesthetics|anesthetics|mesh-ancestor
110164178|NCT00128401|Antimetabolites|antimetabolites|mesh-ancestor
110125339|NCT01945047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110125340|NCT01945047|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110125341|NCT01945047|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110125342|NCT01945047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110125343|NCT01945047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110125344|NCT01945047|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110125345|NCT01945047|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110125346|NCT01945047|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110125347|NCT01945047|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110125348|NCT01945047|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110125349|NCT01945047|GABA Modulators|gaba modulators|mesh-ancestor
110125351|NCT01945099|Insulin|insulin|mesh-list
110125352|NCT01945099|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110125353|NCT01945099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110125354|NCT01945268|Vaccines|vaccines|mesh-list
110125355|NCT01945268|Immunologic Factors|immunologic factors|mesh-ancestor
110125356|NCT01945268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110125357|NCT01945437|Magnesium Sulfate|magnesium sulfate|mesh-list
110125358|NCT01945437|Analgesics|analgesics|mesh-ancestor
110125359|NCT01945437|Sensory System Agents|sensory system agents|mesh-ancestor
110125360|NCT01945437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110125361|NCT01945437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110125363|NCT01945437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110125364|NCT01945437|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110125365|NCT01945437|Anticonvulsants|anticonvulsants|mesh-ancestor
110125366|NCT01945437|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110224181|NCT00323011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110125367|NCT01945437|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110125368|NCT01945437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110125369|NCT01945437|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110125370|NCT01945437|Tocolytic Agents|tocolytic agents|mesh-ancestor
110125371|NCT01945437|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110125372|NCT01945450|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110125373|NCT01945450|Clindamycin|clindamycin|mesh-list
110125374|NCT01945450|Clindamycin palmitate|clindamycin palmitate|mesh-list
110125375|NCT01945450|Clindamycin phosphate|clindamycin phosphate|mesh-list
110125376|NCT01945450|Gentamicins|gentamicins|mesh-list
110125378|NCT01945450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110125379|NCT01945450|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110125380|NCT01945450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110125381|NCT01945450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110125382|NCT01945476|Midazolam|midazolam|mesh-list
110125383|NCT01945476|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110125384|NCT01945476|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110125385|NCT01945476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110125386|NCT01945476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110125387|NCT01945476|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110125388|NCT01945476|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110125389|NCT01945476|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110125390|NCT01945476|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110125391|NCT01945476|Anesthetics, General|anesthetics, general|mesh-ancestor
110125392|NCT01945476|Anesthetics|anesthetics|mesh-ancestor
110125393|NCT01945476|GABA Modulators|gaba modulators|mesh-ancestor
110125394|NCT01945476|GABA Agents|gaba agents|mesh-ancestor
110125395|NCT01945476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110125396|NCT01945476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110125397|NCT01945528|Lidocaine|lidocaine|mesh-list
110125398|NCT01945528|Anesthetics, Local|anesthetics, local|mesh-list
110125399|NCT01945528|Anesthetics|anesthetics|mesh-list
110125400|NCT01945528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110125401|NCT01945528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110125402|NCT01945528|Sensory System Agents|sensory system agents|mesh-ancestor
110125403|NCT01945528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110125404|NCT01945528|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110125405|NCT01945528|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110125406|NCT01945528|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110125407|NCT01945528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110125408|NCT01945528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110125409|NCT01945554|Bupivacaine|bupivacaine|mesh-list
110125410|NCT01945554|Anesthetics, Local|anesthetics, local|mesh-ancestor
110125411|NCT01945554|Anesthetics|anesthetics|mesh-ancestor
110125412|NCT01945554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110125413|NCT01945554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110125414|NCT01945554|Sensory System Agents|sensory system agents|mesh-ancestor
110125415|NCT01945554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110125416|NCT01945684|Botulinum Toxins|botulinum toxins|mesh-list
110125417|NCT01945684|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110125418|NCT01945684|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110125419|NCT01945684|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110125420|NCT01945684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110125421|NCT01945684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110125422|NCT01945684|Cholinergic Agents|cholinergic agents|mesh-ancestor
110125423|NCT01945684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110125424|NCT01945684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110125425|NCT01945684|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110125426|NCT01945684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110125427|NCT01945736|Methadone|methadone|mesh-list
110125428|NCT01945736|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110125429|NCT01945736|Narcotics|narcotics|mesh-ancestor
110125430|NCT01945736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110125431|NCT01945736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110125432|NCT01945736|Analgesics|analgesics|mesh-ancestor
110125433|NCT01945736|Sensory System Agents|sensory system agents|mesh-ancestor
110125434|NCT01945736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110125435|NCT01945736|Antitussive Agents|antitussive agents|mesh-ancestor
110125436|NCT01945736|Respiratory System Agents|respiratory system agents|mesh-ancestor
110125437|NCT01945788|Teriparatide|teriparatide|mesh-list
110125438|NCT01945788|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110125439|NCT01945788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110125440|NCT01945788|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110125441|NCT01945801|Furosemide|furosemide|mesh-list
110125442|NCT01945801|Spironolactone|spironolactone|mesh-list
110125443|NCT01945801|Diuretics|diuretics|mesh-ancestor
110125444|NCT01945801|Natriuretic Agents|natriuretic agents|mesh-ancestor
110125445|NCT01945801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110125446|NCT01945801|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110125447|NCT01945801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110125448|NCT01945801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110125449|NCT01945801|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110125450|NCT01945801|Hormone Antagonists|hormone antagonists|mesh-ancestor
110125451|NCT01945801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110125452|NCT01945801|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110125453|NCT05410626|Methylphenidate|methylphenidate|mesh-list
110125454|NCT05410626|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110125455|NCT05410626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110125456|NCT05410626|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110125457|NCT05410626|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110125458|NCT05410626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110125459|NCT05410626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110125460|NCT05410626|Dopamine Agents|dopamine agents|mesh-ancestor
110125461|NCT05410626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110125462|NCT05410535|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
110125463|NCT05410535|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
110125464|NCT05410535|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110125465|NCT05410483|Docetaxel|docetaxel|mesh-list
110125466|NCT05410483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110125467|NCT05410483|Tubulin Modulators|tubulin modulators|mesh-ancestor
110125468|NCT05410483|Antimitotic Agents|antimitotic agents|mesh-ancestor
110125469|NCT05410483|Mitosis Modulators|mitosis modulators|mesh-ancestor
110125470|NCT05410483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110125471|NCT05410314|Inositol|inositol|mesh-list
110125472|NCT05410314|Vitamin B Complex|vitamin b complex|mesh-ancestor
110125473|NCT05410314|Vitamins|vitamins|mesh-ancestor
110125474|NCT05410314|Micronutrients|micronutrients|mesh-ancestor
110125475|NCT05410314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110125476|NCT05410275|Rivaroxaban|rivaroxaban|mesh-list
110125477|NCT05410275|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110125478|NCT05410275|Antithrombins|antithrombins|mesh-ancestor
110125479|NCT05410275|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110125480|NCT05410275|Protease Inhibitors|protease inhibitors|mesh-ancestor
110125481|NCT05410275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110125482|NCT05410275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110125483|NCT05410275|Anticoagulants|anticoagulants|mesh-ancestor
110125484|NCT05410093|Vitamin E|vitamin e|mesh-list
110125485|NCT05410093|Tocopherols|tocopherols|mesh-list
110125486|NCT05410093|Resveratrol|resveratrol|mesh-list
110125487|NCT05410093|Vitamins|vitamins|mesh-ancestor
110125488|NCT05410093|Micronutrients|micronutrients|mesh-ancestor
110125489|NCT05410093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110125490|NCT05410093|Antioxidants|antioxidants|mesh-ancestor
110125491|NCT05410093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110125492|NCT05410093|Protective Agents|protective agents|mesh-ancestor
110125493|NCT05410093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110125494|NCT05410093|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110125495|NCT05409820|Anesthetics|anesthetics|mesh-list
110125496|NCT05409820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110125497|NCT05409820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110125498|NCT05409339|Mannitol|mannitol|mesh-list
110125499|NCT05409339|Caffeine|caffeine|mesh-list
110125500|NCT05409339|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110125501|NCT05409339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110125502|NCT05409339|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110125503|NCT05409339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110125504|NCT05409339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110125505|NCT05409339|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110125506|NCT05409339|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110125507|NCT05409339|Purinergic Agents|purinergic agents|mesh-ancestor
110125508|NCT05409339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110125509|NCT05409339|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110125510|NCT05409339|Diuretics|diuretics|mesh-ancestor
110125511|NCT05409339|Natriuretic Agents|natriuretic agents|mesh-ancestor
110125512|NCT05155527|Ivermectin|ivermectin|mesh-list
110125513|NCT05155527|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110125514|NCT05155527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110125515|NCT05151146|Metformin|metformin|mesh-list
110125516|NCT05151146|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110125517|NCT05151146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110125518|NCT05068063|Bupivacaine|bupivacaine|mesh-list
110125519|NCT05068063|Anesthetics, Local|anesthetics, local|mesh-ancestor
110125520|NCT05068063|Anesthetics|anesthetics|mesh-ancestor
110125521|NCT05068063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110125522|NCT05068063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110125523|NCT05068063|Sensory System Agents|sensory system agents|mesh-ancestor
110125524|NCT05068063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110125525|NCT04967378|Psychotropic Drugs|psychotropic drugs|mesh-list
110125526|NCT04946396|Dexmedetomidine|dexmedetomidine|mesh-list
110125527|NCT04946396|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110125528|NCT04946396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110125529|NCT04946396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110125530|NCT04946396|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110125531|NCT04946396|Analgesics|analgesics|mesh-ancestor
110125532|NCT04946396|Sensory System Agents|sensory system agents|mesh-ancestor
110125533|NCT04946396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110224241|NCT00323323|Glucocorticoids|glucocorticoids|mesh-ancestor
110125534|NCT04946396|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110125535|NCT04946396|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110125536|NCT04946396|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110125537|NCT04946396|Adrenergic Agents|adrenergic agents|mesh-ancestor
110125538|NCT04946396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110125539|NCT04946396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110125540|NCT04908657|Sildenafil Citrate|sildenafil citrate|mesh-list
110125541|NCT04908657|Vasodilator Agents|vasodilator agents|mesh-ancestor
110125542|NCT04908657|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110125543|NCT04908657|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110125544|NCT04908657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110125545|NCT04908657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110125546|NCT04908657|Urological Agents|urological agents|mesh-ancestor
110125548|NCT04887389|Fluorides|fluorides|mesh-list
110125549|NCT04887389|Sodium Fluoride|sodium fluoride|mesh-list
110125550|NCT04887389|Fluorides, Topical|fluorides, topical|mesh-list
110125551|NCT04887389|Cariostatic Agents|cariostatic agents|mesh-ancestor
110125552|NCT04887389|Protective Agents|protective agents|mesh-ancestor
110125553|NCT04887389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110125554|NCT04887389|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110125555|NCT04887389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110125556|NCT04773392|Mycophenolic Acid|mycophenolic acid|mesh-list
110125557|NCT04773392|Prednisone|prednisone|mesh-list
110125558|NCT04773392|Methylprednisolone|methylprednisolone|mesh-list
110125559|NCT04773392|Azathioprine|azathioprine|mesh-list
110125560|NCT04773392|Tacrolimus|tacrolimus|mesh-list
110125561|NCT04773392|Thymoglobulin|thymoglobulin|mesh-list
110125562|NCT04773392|Basiliximab|basiliximab|mesh-list
110125563|NCT04773392|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110125564|NCT04773392|Antimetabolites|antimetabolites|mesh-list
110125565|NCT04773392|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110125566|NCT04773392|Glucocorticoids|glucocorticoids|mesh-ancestor
110125567|NCT04773392|Hormones|hormones|mesh-ancestor
110125568|NCT04773392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110125569|NCT04773392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110125570|NCT04773392|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110125571|NCT04773392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110125572|NCT04773392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110125573|NCT04773392|Immunologic Factors|immunologic factors|mesh-ancestor
110125574|NCT04773392|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110125575|NCT04773392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110125576|NCT04773392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110125577|NCT04773392|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110125578|NCT04773392|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110125579|NCT04773392|Antitubercular Agents|antitubercular agents|mesh-ancestor
110125580|NCT04773392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110125581|NCT04773392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110125582|NCT04773392|Antiemetics|antiemetics|mesh-ancestor
110125583|NCT04773392|Autonomic Agents|autonomic agents|mesh-ancestor
110125584|NCT04773392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110125585|NCT04773392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110125586|NCT04773392|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110125587|NCT04773392|Protective Agents|protective agents|mesh-ancestor
110125588|NCT04773392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110125589|NCT04773392|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110224257|NCT00312598|Aripiprazole|aripiprazole|mesh-list
110125590|NCT04724655|Mineral Oil|mineral oil|mesh-list
110125591|NCT04724655|Emollients|emollients|mesh-ancestor
110125592|NCT04724655|Dermatologic Agents|dermatologic agents|mesh-ancestor
110125594|NCT04722835|Dimercaprol|dimercaprol|mesh-list
110125595|NCT04722835|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110125596|NCT04722835|Autonomic Agents|autonomic agents|mesh-ancestor
110125597|NCT04722835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110125598|NCT04722835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110125599|NCT04722835|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110125600|NCT04722835|Respiratory System Agents|respiratory system agents|mesh-ancestor
110125601|NCT04722835|Tocolytic Agents|tocolytic agents|mesh-ancestor
110125602|NCT04722835|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110125603|NCT04722835|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110125604|NCT04722835|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110164212|NCT00018733|Desipramine|desipramine|mesh-list
110125605|NCT04722835|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110125606|NCT04722835|Adrenergic Agents|adrenergic agents|mesh-ancestor
110125607|NCT04722835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110125608|NCT04722835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110125609|NCT04722835|Chelating Agents|chelating agents|mesh-ancestor
110125610|NCT04722835|Sequestering Agents|sequestering agents|mesh-ancestor
110125612|NCT04487990|Calcium heparin|calcium heparin|mesh-list
110125613|NCT04487990|Anticoagulants|anticoagulants|mesh-ancestor
110125614|NCT04487990|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110125615|NCT04487990|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110125616|NCT04487990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110125617|NCT04476979|Dexamethasone|dexamethasone|mesh-list
110125618|NCT04476979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110125619|NCT04476979|Antiemetics|antiemetics|mesh-ancestor
110125620|NCT04476979|Autonomic Agents|autonomic agents|mesh-ancestor
110125621|NCT04476979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110125622|NCT04476979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110125623|NCT04476979|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110125624|NCT04476979|Glucocorticoids|glucocorticoids|mesh-ancestor
110125625|NCT04476979|Hormones|hormones|mesh-ancestor
110125626|NCT04476979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110125627|NCT04476979|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110125628|NCT04476979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110125629|NCT04411953|Haloperidol|haloperidol|mesh-list
110125630|NCT04411953|Benztropine|benztropine|mesh-list
110125631|NCT04411953|Haloperidol decanoate|haloperidol decanoate|mesh-list
110125632|NCT04411953|Antiemetics|antiemetics|mesh-ancestor
110125633|NCT04411953|Autonomic Agents|autonomic agents|mesh-ancestor
110125634|NCT04411953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110125635|NCT04411953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110125636|NCT04411953|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110125637|NCT04411953|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110125638|NCT04411953|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110125639|NCT04411953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110125640|NCT04411953|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110125641|NCT04411953|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110125642|NCT04411953|Dopamine Agents|dopamine agents|mesh-ancestor
110125643|NCT04411953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110125644|NCT04411953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110125645|NCT04411953|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110125646|NCT04411953|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110125647|NCT04411953|Parasympatholytics|parasympatholytics|mesh-ancestor
110125648|NCT04411953|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110125649|NCT04411953|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110125650|NCT04411953|Cholinergic Agents|cholinergic agents|mesh-ancestor
110125651|NCT04411953|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110125652|NCT04411953|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110224275|NCT00312754|Atazanavir Sulfate|atazanavir sulfate|mesh-list
110125653|NCT04411953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110125654|NCT04411940|Haloperidol|haloperidol|mesh-list
110125655|NCT04411940|Benztropine|benztropine|mesh-list
110125656|NCT04411940|Haloperidol decanoate|haloperidol decanoate|mesh-list
110125657|NCT04411940|Antiemetics|antiemetics|mesh-ancestor
110125658|NCT04411940|Autonomic Agents|autonomic agents|mesh-ancestor
110125659|NCT04411940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110125660|NCT04411940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110125661|NCT04411940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110125662|NCT04411940|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110125663|NCT04411940|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110125664|NCT04411940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110125665|NCT04411940|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110125666|NCT04411940|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110125668|NCT04411940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110125669|NCT04411940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110125670|NCT04411940|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110125671|NCT04411940|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110125672|NCT04411940|Parasympatholytics|parasympatholytics|mesh-ancestor
110125673|NCT04411940|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110125674|NCT04411940|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110125675|NCT04411940|Cholinergic Agents|cholinergic agents|mesh-ancestor
110125676|NCT04411940|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110125677|NCT04411940|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110125678|NCT04411940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110125679|NCT04035109|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
110125680|NCT04035109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110125681|NCT04030429|Crizotinib|crizotinib|mesh-list
110125682|NCT04030429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110125683|NCT04030429|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110125684|NCT04030429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110125685|NCT04030429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110125686|NCT03970694|Capecitabine|capecitabine|mesh-list
110125687|NCT03970694|Oxaliplatin|oxaliplatin|mesh-list
110125688|NCT03970694|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110125689|NCT03970694|Antimetabolites|antimetabolites|mesh-ancestor
110125690|NCT03970694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110125691|NCT03970694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110125692|NCT03941132|Ustekinumab|ustekinumab|mesh-list
110125693|NCT03941132|Dermatologic Agents|dermatologic agents|mesh-ancestor
110125694|NCT03873246|Varenicline|varenicline|mesh-list
110125695|NCT03873246|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110125696|NCT03873246|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110125697|NCT03873246|Cholinergic Agents|cholinergic agents|mesh-ancestor
110125698|NCT03873246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110125699|NCT03873246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110125700|NCT03873246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110125701|NCT03714880|Mifepristone|mifepristone|mesh-list
110125702|NCT03714880|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
110125703|NCT03714880|Abortifacient Agents|abortifacient agents|mesh-ancestor
110125704|NCT03714880|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110125705|NCT03714880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110125706|NCT03714880|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110125707|NCT03714880|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110125708|NCT03714880|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110125709|NCT03714880|Contraceptive Agents|contraceptive agents|mesh-ancestor
110125710|NCT03714880|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
110125711|NCT03714880|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
110125712|NCT03714880|Hormone Antagonists|hormone antagonists|mesh-ancestor
110125713|NCT03714880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110125714|NCT03714880|Luteolytic Agents|luteolytic agents|mesh-ancestor
110125715|NCT03714880|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110125716|NCT03714880|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
110125717|NCT03619850|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
110125718|NCT03619850|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
110125719|NCT03619850|Hematinics|hematinics|mesh-ancestor
110125720|NCT03619850|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
110125721|NCT03619850|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110125722|NCT03559686|Certolizumab Pegol|certolizumab pegol|mesh-list
110125723|NCT03559686|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110125724|NCT03559686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110125725|NCT03559686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110125726|NCT03559686|Immunologic Factors|immunologic factors|mesh-ancestor
110125727|NCT03559686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110125728|NCT03559686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110164232|NCT00018850|Nicotine|nicotine|mesh-list
110125729|NCT03559660|Certolizumab Pegol|certolizumab pegol|mesh-list
110125730|NCT03559660|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110125731|NCT03559660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110125732|NCT03559660|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110125733|NCT03559660|Immunologic Factors|immunologic factors|mesh-ancestor
110125734|NCT03559660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110125735|NCT03559660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110125736|NCT03532516|Brivaracetam|brivaracetam|mesh-list
110125737|NCT03532516|Anticonvulsants|anticonvulsants|mesh-ancestor
110125738|NCT03333005|Antifungal Agents|antifungal agents|mesh-list
110125739|NCT03333005|Clotrimazole|clotrimazole|mesh-list
110125740|NCT03333005|Miconazole|miconazole|mesh-list
110125741|NCT03333005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110125742|NCT03333005|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110125743|NCT03333005|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110125744|NCT03333005|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110125745|NCT03333005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110125746|NCT03333005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110125747|NCT03333005|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110125748|NCT03333005|Hormone Antagonists|hormone antagonists|mesh-ancestor
110125749|NCT03333005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110125750|NCT03333005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110125751|NCT03333005|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110125752|NCT03333005|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110125753|NCT03148366|Levofloxacin|levofloxacin|mesh-list
110125754|NCT03148366|Bismuth|bismuth|mesh-list
110125755|NCT03148366|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110125756|NCT03148366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110125757|NCT03148366|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110125758|NCT03148366|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110125759|NCT03148366|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110125760|NCT03148366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110125761|NCT03148366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110125762|NCT03148366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110125763|NCT03148366|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110125764|NCT03148366|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110125765|NCT03148366|Antacids|antacids|mesh-ancestor
110125766|NCT03148366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110125767|NCT03122496|Durvalumab|durvalumab|mesh-list
110125768|NCT03122496|Tremelimumab|tremelimumab|mesh-list
110125769|NCT03122496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110125770|NCT03122496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110125771|NCT03073694|Melphalan|melphalan|mesh-list
110125772|NCT03073694|Mitomycins|mitomycins|mesh-list
110125773|NCT03073694|Mitomycin|mitomycin|mesh-list
110125774|NCT03073694|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110125775|NCT03073694|Alkylating Agents|alkylating agents|mesh-ancestor
110125776|NCT03073694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110125777|NCT03073694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110125778|NCT03073694|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110125779|NCT03073694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110125780|NCT03073694|Immunologic Factors|immunologic factors|mesh-ancestor
110125781|NCT03073694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110125782|NCT03073694|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110125783|NCT03073694|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110125784|NCT03073694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110125785|NCT03069703|Rituximab|rituximab|mesh-list
110125786|NCT03069703|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110125787|NCT03069703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110125788|NCT03069703|Immunologic Factors|immunologic factors|mesh-ancestor
110125789|NCT03069703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110125790|NCT03069703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110125791|NCT02862548|Antiviral Agents|antiviral agents|mesh-list
110125792|NCT02862548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110125793|NCT02818738|Levamisole|levamisole|mesh-list
110125794|NCT02818738|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110125795|NCT02818738|Immunologic Factors|immunologic factors|mesh-ancestor
110125796|NCT02818738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110125797|NCT02818738|Antinematodal Agents|antinematodal agents|mesh-ancestor
110125798|NCT02818738|Anthelmintics|anthelmintics|mesh-ancestor
110125799|NCT02818738|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110125800|NCT02818738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110125801|NCT02818738|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110125803|NCT02335099|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110125804|NCT02335099|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110125805|NCT02335099|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110125806|NCT02335099|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110125807|NCT02335099|Purinergic Agents|purinergic agents|mesh-ancestor
110125808|NCT02335099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110125809|NCT02335099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110125810|NCT02335099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110125812|NCT02330562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110125813|NCT02330562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110125814|NCT02330562|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110125815|NCT02330562|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110224333|NCT06003283|Rituximab|rituximab|mesh-list
110125816|NCT02330562|Growth Substances|growth substances|mesh-ancestor
110125817|NCT02330562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110125818|NCT02330562|Growth Inhibitors|growth inhibitors|mesh-ancestor
110125819|NCT02053363|Tranexamic Acid|tranexamic acid|mesh-list
110125820|NCT02053363|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110125821|NCT02053363|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110125822|NCT02053363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110125823|NCT02053363|Hemostatics|hemostatics|mesh-ancestor
110125824|NCT02053363|Coagulants|coagulants|mesh-ancestor
110125825|NCT01100775|Galantamine|galantamine|mesh-list
110125826|NCT01100775|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110125827|NCT01100775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110125828|NCT01100775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110125829|NCT01100775|Cholinergic Agents|cholinergic agents|mesh-ancestor
110125830|NCT01100775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110125831|NCT01100775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110125832|NCT01100775|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110125833|NCT01100775|Autonomic Agents|autonomic agents|mesh-ancestor
110125834|NCT01100775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110125835|NCT01100775|Nootropic Agents|nootropic agents|mesh-ancestor
110125836|NCT00504712|Testosterone|testosterone|mesh-list
110125837|NCT00504712|Androgens|androgens|mesh-ancestor
110125839|NCT00504712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110125840|NCT00504712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110125841|NCT05413200|Isotretinoin|isotretinoin|mesh-list
110125842|NCT05413200|Dermatologic Agents|dermatologic agents|mesh-ancestor
110125843|NCT05412589|Apatinib|apatinib|mesh-list
110125844|NCT05412589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110125845|NCT05412589|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110125846|NCT05412589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110125847|NCT05412589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110125848|NCT05412576|Lidocaine|lidocaine|mesh-list
110125849|NCT05412576|Anesthetics, Local|anesthetics, local|mesh-ancestor
110125850|NCT05412576|Anesthetics|anesthetics|mesh-ancestor
110125851|NCT05412576|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110125852|NCT05412576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110125853|NCT05412576|Sensory System Agents|sensory system agents|mesh-ancestor
110125854|NCT05412576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110125855|NCT05412576|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110125856|NCT05412576|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110125857|NCT05412576|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110125858|NCT05412576|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110125859|NCT05412576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110125860|NCT05412472|Avasopasem manganese|avasopasem manganese|mesh-list
110125861|NCT05412472|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110125862|NCT05412472|Antioxidants|antioxidants|mesh-ancestor
110125863|NCT05412472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110125864|NCT05412472|Protective Agents|protective agents|mesh-ancestor
110125865|NCT05412472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110125866|NCT05412147|Vitamins|vitamins|mesh-list
110125867|NCT05412147|Micronutrients|micronutrients|mesh-ancestor
110125868|NCT05412147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110125869|NCT05411900|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
110125870|NCT05411900|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110125871|NCT05411900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110125872|NCT05411900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110125873|NCT05411900|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110125874|NCT05411900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110125875|NCT05411900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110125876|NCT05411900|Cholinergic Agents|cholinergic agents|mesh-ancestor
110125877|NCT05411900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110125878|NCT05411757|Bevacizumab|bevacizumab|mesh-list
110125879|NCT05411757|Lenvatinib|lenvatinib|mesh-list
110125880|NCT05411757|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110125881|NCT05411757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110125883|NCT05411757|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110125884|NCT05411757|Growth Substances|growth substances|mesh-ancestor
110125885|NCT05411757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110125886|NCT05411757|Growth Inhibitors|growth inhibitors|mesh-ancestor
110125887|NCT05411757|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110125888|NCT05411757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110260166|NCT00168870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110125889|NCT05411757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110125890|NCT05411666|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110125892|NCT05411276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110125893|NCT05411276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110125894|NCT05396781|Proflavine|proflavine|mesh-list
110125895|NCT05396781|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110125896|NCT05396781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110125897|NCT05303038|Bevacizumab|bevacizumab|mesh-list
110125898|NCT05303038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110125899|NCT05303038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110125900|NCT05303038|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110125901|NCT05303038|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110125902|NCT05303038|Growth Substances|growth substances|mesh-ancestor
110125903|NCT05303038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110125904|NCT05303038|Growth Inhibitors|growth inhibitors|mesh-ancestor
110125905|NCT05275894|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110125906|NCT05275894|Metronidazole|metronidazole|mesh-list
110125907|NCT05275894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110125908|NCT05275894|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110125909|NCT05275894|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110125910|NCT05077800|Losartan|losartan|mesh-list
110125911|NCT05077800|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110125912|NCT05077800|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110125913|NCT05077800|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110125914|NCT05077800|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110125915|NCT05077800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110125916|NCT05042674|Ergothioneine|ergothioneine|mesh-list
110125917|NCT05042674|Antioxidants|antioxidants|mesh-ancestor
110125918|NCT05042674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110125919|NCT05042674|Protective Agents|protective agents|mesh-ancestor
110125920|NCT05042674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110125921|NCT04927585|Vaccines|vaccines|mesh-list
110125922|NCT04927585|Immunologic Factors|immunologic factors|mesh-ancestor
110125923|NCT04927585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110125924|NCT04917055|Dexamethasone|dexamethasone|mesh-list
110125925|NCT04917055|Epinephrine|epinephrine|mesh-list
110125926|NCT04917055|Ropivacaine|ropivacaine|mesh-list
110125927|NCT04917055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110125928|NCT04917055|Antiemetics|antiemetics|mesh-ancestor
110125929|NCT04917055|Autonomic Agents|autonomic agents|mesh-ancestor
110125930|NCT04917055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110125931|NCT04917055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110125932|NCT04917055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110125933|NCT04917055|Glucocorticoids|glucocorticoids|mesh-ancestor
110125934|NCT04917055|Hormones|hormones|mesh-ancestor
110125935|NCT04917055|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110125936|NCT04917055|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110125937|NCT04917055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110125938|NCT04917055|Anesthetics, Local|anesthetics, local|mesh-ancestor
110125939|NCT04917055|Anesthetics|anesthetics|mesh-ancestor
110125940|NCT04917055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110125941|NCT04917055|Sensory System Agents|sensory system agents|mesh-ancestor
110125942|NCT04917055|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110125943|NCT04917055|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110125944|NCT04917055|Adrenergic Agents|adrenergic agents|mesh-ancestor
110125945|NCT04917055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110125946|NCT04917055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110125947|NCT04917055|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110125948|NCT04917055|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110125949|NCT04917055|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110125950|NCT04917055|Respiratory System Agents|respiratory system agents|mesh-ancestor
110125951|NCT04917055|Mydriatics|mydriatics|mesh-ancestor
110125952|NCT04917055|Sympathomimetics|sympathomimetics|mesh-ancestor
110125953|NCT04917055|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110125954|NCT04898478|Analgesics, Opioid|analgesics, opioid|mesh-list
110125955|NCT04898478|Narcotics|narcotics|mesh-ancestor
110125956|NCT04898478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110125957|NCT04898478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110125959|NCT04898478|Sensory System Agents|sensory system agents|mesh-ancestor
110125960|NCT04898478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110125961|NCT04725864|Progesterone|progesterone|mesh-list
110125962|NCT04725864|Progestins|progestins|mesh-ancestor
110125963|NCT04725864|Hormones|hormones|mesh-ancestor
110125964|NCT04725864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110125965|NCT04725864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110125966|NCT04721821|Tofacitinib|tofacitinib|mesh-list
110125967|NCT04721821|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
110125968|NCT04721821|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110125969|NCT04721821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110125970|NCT04721821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110125971|NCT04655391|Decitabine|decitabine|mesh-list
110125972|NCT04655391|Venetoclax|venetoclax|mesh-list
110125973|NCT04655391|Ivosidenib|ivosidenib|mesh-list
110125974|NCT04655391|Maleic acid|maleic acid|mesh-list
110125975|NCT04655391|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110125976|NCT04655391|Antimetabolites|antimetabolites|mesh-ancestor
110125977|NCT04655391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110125978|NCT04655391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110125979|NCT04655391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110125980|NCT04609098|Piperaquine|piperaquine|mesh-list
110125981|NCT04609098|Artenimol|artenimol|mesh-list
110125982|NCT04609098|Tafenoquine|tafenoquine|mesh-list
110125983|NCT04609098|Antimalarials|antimalarials|mesh-ancestor
110125984|NCT04609098|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110125985|NCT04609098|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110125986|NCT04609098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110125987|NCT04605614|Copper|copper|mesh-list
110125988|NCT04605614|Pembrolizumab|pembrolizumab|mesh-list
110125989|NCT04605614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110125990|NCT04605614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110125991|NCT04605614|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110125992|NCT04605614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110125993|NCT04605614|Trace Elements|trace elements|mesh-ancestor
110125994|NCT04605614|Micronutrients|micronutrients|mesh-ancestor
110125995|NCT04605614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110125996|NCT04475016|Paclitaxel|paclitaxel|mesh-list
110125997|NCT04475016|Ifosfamide|ifosfamide|mesh-list
110125998|NCT04475016|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110125999|NCT04475016|Nimotuzumab|nimotuzumab|mesh-list
110126000|NCT04475016|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110126001|NCT04475016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110126002|NCT04475016|Tubulin Modulators|tubulin modulators|mesh-ancestor
110126003|NCT04475016|Antimitotic Agents|antimitotic agents|mesh-ancestor
110126004|NCT04475016|Mitosis Modulators|mitosis modulators|mesh-ancestor
110126005|NCT04475016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110126006|NCT04475016|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110126007|NCT04475016|Alkylating Agents|alkylating agents|mesh-ancestor
110126008|NCT04475016|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110126009|NCT04321551|Letrozole|letrozole|mesh-list
110126010|NCT04321551|Methyltestosterone|methyltestosterone|mesh-list
110126011|NCT04321551|Testosterone|testosterone|mesh-list
110126012|NCT04321551|Testosterone undecanoate|testosterone undecanoate|mesh-list
110126013|NCT04321551|Testosterone enanthate|testosterone enanthate|mesh-list
110126014|NCT04321551|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
110126015|NCT04321551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110126016|NCT04321551|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110126017|NCT04321551|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110126018|NCT04321551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110126019|NCT04321551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110126020|NCT04321551|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110126021|NCT04321551|Hormone Antagonists|hormone antagonists|mesh-ancestor
110126022|NCT04321551|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110126023|NCT04321551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110126024|NCT04321551|Androgens|androgens|mesh-ancestor
110126025|NCT04321551|Hormones|hormones|mesh-ancestor
110126026|NCT04321551|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110126027|NCT04321551|Anabolic Agents|anabolic agents|mesh-ancestor
110126028|NCT04174781|Immunomodulating Agents|immunomodulating agents|mesh-list
110126029|NCT04174781|Immunologic Factors|immunologic factors|mesh-ancestor
110126030|NCT04174781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110126031|NCT04074460|Propofol|propofol|mesh-list
110126032|NCT04074460|Sevoflurane|sevoflurane|mesh-list
110126033|NCT04074460|Desflurane|desflurane|mesh-list
110126034|NCT04074460|Isoflurane|isoflurane|mesh-list
110126035|NCT04074460|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110126036|NCT04074460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110126037|NCT04074460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110126038|NCT04074460|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110126039|NCT04074460|Anesthetics, General|anesthetics, general|mesh-ancestor
110126040|NCT04074460|Anesthetics|anesthetics|mesh-ancestor
110126041|NCT04074460|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110126042|NCT04074460|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110126043|NCT03817125|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110126044|NCT03817125|Vancomycin|vancomycin|mesh-list
110126045|NCT03817125|Nivolumab|nivolumab|mesh-list
110126046|NCT03817125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110126047|NCT03817125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110126048|NCT03817125|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110126049|NCT03817125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110126050|NCT03817125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110126051|NCT03703102|KHK4083|khk4083|mesh-list
110126052|NCT03703102|Dermatologic Agents|dermatologic agents|mesh-ancestor
110126053|NCT03581370|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
110126054|NCT03581370|Cephalosporins|cephalosporins|mesh-list
110126055|NCT03581370|Penicillanic Acid|penicillanic acid|mesh-list
110126056|NCT03581370|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110126057|NCT03581370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110126058|NCT03581370|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110126059|NCT03581370|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110126060|NCT03581370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110126061|NCT03581370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110126062|NCT03568604|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
110126063|NCT03568604|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110126064|NCT03568604|Immunologic Factors|immunologic factors|mesh-ancestor
110126065|NCT03568604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110126067|NCT03539055|Antithrombins|antithrombins|mesh-ancestor
110126068|NCT03539055|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110126069|NCT03539055|Protease Inhibitors|protease inhibitors|mesh-ancestor
110126070|NCT03539055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110126071|NCT03539055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110126072|NCT03539055|Anticoagulants|anticoagulants|mesh-ancestor
110126073|NCT03485534|Tenofovir|tenofovir|mesh-list
110126074|NCT03485534|Antiviral Agents|antiviral agents|mesh-ancestor
110126075|NCT03485534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110126076|NCT03485534|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110126077|NCT03485534|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110126078|NCT03485534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110126079|NCT03485534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110126080|NCT03485534|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110126081|NCT03485534|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110126082|NCT03427736|Ketorolac|ketorolac|mesh-list
110126083|NCT03427736|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
110126084|NCT03427736|Ketamine|ketamine|mesh-list
110126085|NCT03427736|Morphine|morphine|mesh-list
110126086|NCT03427736|Oxycodone|oxycodone|mesh-list
110126087|NCT03427736|Hydromorphone|hydromorphone|mesh-list
110126088|NCT03427736|Analgesics|analgesics|mesh-ancestor
110126089|NCT03427736|Sensory System Agents|sensory system agents|mesh-ancestor
110126090|NCT03427736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110126091|NCT03427736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110126092|NCT03427736|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110126093|NCT03427736|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110126094|NCT03427736|Anesthetics, General|anesthetics, general|mesh-ancestor
110126095|NCT03427736|Anesthetics|anesthetics|mesh-ancestor
110126096|NCT03427736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110126097|NCT03427736|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110126098|NCT03427736|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110126099|NCT03427736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110126100|NCT03427736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110126101|NCT03427736|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110126102|NCT03427736|Narcotics|narcotics|mesh-ancestor
110126103|NCT03427736|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110126104|NCT03427736|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110126105|NCT03427736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110126106|NCT03427736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110126107|NCT03427736|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110126108|NCT03427736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110126109|NCT03395704|Hepcidins|hepcidins|mesh-list
110126110|NCT03395704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110126111|NCT03246503|Bilirubin|bilirubin|mesh-list
110126112|NCT03246503|Antioxidants|antioxidants|mesh-ancestor
110126113|NCT03246503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110126114|NCT03246503|Protective Agents|protective agents|mesh-ancestor
110126115|NCT03246503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110126116|NCT03091881|Granisetron|granisetron|mesh-list
110126117|NCT03091881|Antiemetics|antiemetics|mesh-ancestor
110126118|NCT03091881|Autonomic Agents|autonomic agents|mesh-ancestor
110126119|NCT03091881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110224406|NCT06002477|Cholinergic Agents|cholinergic agents|mesh-ancestor
110126120|NCT03091881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110126121|NCT03091881|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110126122|NCT03091881|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110126123|NCT03091881|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110126124|NCT03091881|Serotonin Agents|serotonin agents|mesh-ancestor
110126125|NCT03091881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110126126|NCT03091881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110126127|NCT02864368|Temozolomide|temozolomide|mesh-list
110126128|NCT02864368|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110126129|NCT02864368|Alkylating Agents|alkylating agents|mesh-ancestor
110126130|NCT02864368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110126131|NCT02864368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110126132|NCT02856698|Midazolam|midazolam|mesh-list
110126133|NCT02856698|Morphine|morphine|mesh-list
110126134|NCT02856698|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110126135|NCT02856698|Narcotics|narcotics|mesh-ancestor
110126136|NCT02856698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110126137|NCT02856698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110126138|NCT02856698|Analgesics|analgesics|mesh-ancestor
110126139|NCT02856698|Sensory System Agents|sensory system agents|mesh-ancestor
110126140|NCT02856698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110126141|NCT02856698|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110126142|NCT02856698|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110126143|NCT02856698|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110126144|NCT02856698|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110126145|NCT02856698|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110126146|NCT02856698|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110126147|NCT02856698|Anesthetics, General|anesthetics, general|mesh-ancestor
110126148|NCT02856698|Anesthetics|anesthetics|mesh-ancestor
110126149|NCT02856698|GABA Modulators|gaba modulators|mesh-ancestor
110126150|NCT02856698|GABA Agents|gaba agents|mesh-ancestor
110126151|NCT02856698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110126152|NCT02856698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110126153|NCT02793375|Montelukast|montelukast|mesh-list
110126154|NCT02793375|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110126155|NCT02793375|Respiratory System Agents|respiratory system agents|mesh-ancestor
110126156|NCT02793375|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110126157|NCT02793375|Hormone Antagonists|hormone antagonists|mesh-ancestor
110126158|NCT02793375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110126159|NCT02793375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110126160|NCT02793375|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110126161|NCT02793375|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110126162|NCT02793375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110126163|NCT02625610|Leucovorin|leucovorin|mesh-list
110126164|NCT02625610|Fluorouracil|fluorouracil|mesh-list
110126165|NCT02625610|Capecitabine|capecitabine|mesh-list
110126166|NCT02625610|Oxaliplatin|oxaliplatin|mesh-list
110126167|NCT02625610|Avelumab|avelumab|mesh-list
110126168|NCT02625610|Levoleucovorin|levoleucovorin|mesh-list
110126169|NCT02625610|Antimetabolites|antimetabolites|mesh-ancestor
110126170|NCT02625610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110126171|NCT02625610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110126172|NCT02625610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110126173|NCT02625610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110126174|NCT02625610|Immunologic Factors|immunologic factors|mesh-ancestor
110126175|NCT02625610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110126176|NCT02625610|Antidotes|antidotes|mesh-ancestor
110126177|NCT02625610|Protective Agents|protective agents|mesh-ancestor
110126178|NCT02625610|Vitamin B Complex|vitamin b complex|mesh-ancestor
110126179|NCT02625610|Vitamins|vitamins|mesh-ancestor
110126180|NCT02625610|Micronutrients|micronutrients|mesh-ancestor
110126181|NCT02625610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110126182|NCT02515591|Dimercaprol|dimercaprol|mesh-list
110126183|NCT02515591|Chelating Agents|chelating agents|mesh-ancestor
110126184|NCT02515591|Sequestering Agents|sequestering agents|mesh-ancestor
110126185|NCT02515591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110126186|NCT02514447|Topotecan|topotecan|mesh-list
110126187|NCT02514447|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110126188|NCT02514447|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110126189|NCT02514447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110126190|NCT02514447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110126191|NCT02514447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110126192|NCT02257346|Lidocaine|lidocaine|mesh-list
110126193|NCT02257346|Anesthetics, Local|anesthetics, local|mesh-ancestor
110126194|NCT02257346|Anesthetics|anesthetics|mesh-ancestor
110126195|NCT02257346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110126196|NCT02257346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110126197|NCT02257346|Sensory System Agents|sensory system agents|mesh-ancestor
110126198|NCT02257346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110126199|NCT02257346|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110126200|NCT02257346|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110126201|NCT02257346|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110126202|NCT02257346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110126203|NCT02257346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110126204|NCT02167477|Pyrithione zinc|pyrithione zinc|mesh-list
110126205|NCT02167477|Keratolytic Agents|keratolytic agents|mesh-ancestor
110126206|NCT02167477|Dermatologic Agents|dermatologic agents|mesh-ancestor
110126207|NCT00712322|Darifenacin|darifenacin|mesh-list
110126208|NCT00712322|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110126209|NCT00712322|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110126210|NCT00712322|Cholinergic Agents|cholinergic agents|mesh-ancestor
110126211|NCT00712322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110126212|NCT00712322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110126213|NCT00712322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110126214|NCT00712322|Urological Agents|urological agents|mesh-ancestor
110126215|NCT00323856|Factor VIII|factor viii|mesh-list
110126216|NCT00323856|Coagulants|coagulants|mesh-ancestor
110126217|NCT05415150|Fibrinolytic Agents|fibrinolytic agents|mesh-list
110126218|NCT05415150|Eptifibatide|eptifibatide|mesh-list
110126219|NCT05415150|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110126220|NCT05415150|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110126221|NCT05415150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110126222|NCT05414942|Analgesics, Opioid|analgesics, opioid|mesh-list
110126223|NCT05414942|Narcotics|narcotics|mesh-ancestor
110126224|NCT05414942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110126225|NCT05414942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110126226|NCT05414942|Analgesics|analgesics|mesh-ancestor
110126227|NCT05414942|Sensory System Agents|sensory system agents|mesh-ancestor
110126228|NCT05414942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110126229|NCT05414721|Anesthetics|anesthetics|mesh-list
110126230|NCT05414721|Desflurane|desflurane|mesh-list
110224454|NCT06001762|Tamoxifen|tamoxifen|mesh-list
110126231|NCT05414721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110126232|NCT05414721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110126233|NCT05414721|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110126234|NCT05414721|Anesthetics, General|anesthetics, general|mesh-ancestor
110126235|NCT05414669|Allopurinol|allopurinol|mesh-list
110126236|NCT05414669|Antimetabolites|antimetabolites|mesh-ancestor
110126237|NCT05414669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110126238|NCT05414669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110126239|NCT05414669|Gout Suppressants|gout suppressants|mesh-ancestor
110126240|NCT05414669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110126241|NCT05414669|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110126242|NCT05414669|Antioxidants|antioxidants|mesh-ancestor
110126243|NCT05414669|Protective Agents|protective agents|mesh-ancestor
110126244|NCT05414669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110126245|NCT05414474|Ascorbic Acid|ascorbic acid|mesh-list
110126246|NCT05414474|Antioxidants|antioxidants|mesh-ancestor
110126247|NCT05414474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110126248|NCT05414474|Protective Agents|protective agents|mesh-ancestor
110126249|NCT05414474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110126250|NCT05414474|Vitamins|vitamins|mesh-ancestor
110126251|NCT05414474|Micronutrients|micronutrients|mesh-ancestor
110126252|NCT05414292|Sirolimus|sirolimus|mesh-list
110126253|NCT05414292|Temsirolimus|temsirolimus|mesh-list
110126254|NCT05414292|MTOR Inhibitors|mtor inhibitors|mesh-list
110126255|NCT05414292|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110126256|NCT05414292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110126257|NCT05414292|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110126258|NCT05414292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110126259|NCT05414292|Antifungal Agents|antifungal agents|mesh-ancestor
110126260|NCT05414292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110126261|NCT05414292|Immunologic Factors|immunologic factors|mesh-ancestor
110126262|NCT05414292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110126263|NCT05414292|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110126264|NCT05414292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110126265|NCT05414292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110126267|NCT05414149|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110126268|NCT05414149|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110126269|NCT05414149|Growth Substances|growth substances|mesh-ancestor
110126270|NCT05414149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110126271|NCT05414149|Growth Inhibitors|growth inhibitors|mesh-ancestor
110126272|NCT05414149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110126273|NCT05413902|Acetaminophen|acetaminophen|mesh-list
110126274|NCT05413902|Methylprednisolone|methylprednisolone|mesh-list
110126275|NCT05413902|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
110126276|NCT05413902|Lidocaine|lidocaine|mesh-list
110126277|NCT05413902|Epinephrine|epinephrine|mesh-list
110126278|NCT05413902|Morphine|morphine|mesh-list
110126279|NCT05413902|Narcotics|narcotics|mesh-list
110126280|NCT05413902|Gabapentin|gabapentin|mesh-list
110126281|NCT05413902|Orphenadrine|orphenadrine|mesh-list
110126282|NCT05413902|Bupivacaine|bupivacaine|mesh-list
110126283|NCT05413902|Anesthetics, Local|anesthetics, local|mesh-ancestor
110126284|NCT05413902|Anesthetics|anesthetics|mesh-ancestor
110126285|NCT05413902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110126286|NCT05413902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110126287|NCT05413902|Sensory System Agents|sensory system agents|mesh-ancestor
110126288|NCT05413902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110126289|NCT05413902|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110126290|NCT05413902|Analgesics|analgesics|mesh-ancestor
110126291|NCT05413902|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110126292|NCT05413902|Antipyretics|antipyretics|mesh-ancestor
110126293|NCT05413902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110126294|NCT05413902|Antiemetics|antiemetics|mesh-ancestor
110126295|NCT05413902|Autonomic Agents|autonomic agents|mesh-ancestor
110126296|NCT05413902|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110126297|NCT05413902|Glucocorticoids|glucocorticoids|mesh-ancestor
110126298|NCT05413902|Hormones|hormones|mesh-ancestor
110126299|NCT05413902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110126300|NCT05413902|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110126301|NCT05413902|Protective Agents|protective agents|mesh-ancestor
110126302|NCT05413902|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110126303|NCT05413902|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110126304|NCT05413902|Adrenergic Agents|adrenergic agents|mesh-ancestor
110126305|NCT05413902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110126306|NCT05413902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110126307|NCT05413902|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110126308|NCT05413902|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110126309|NCT05413902|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110126310|NCT05413902|Respiratory System Agents|respiratory system agents|mesh-ancestor
110126311|NCT05413902|Mydriatics|mydriatics|mesh-ancestor
110126312|NCT05413902|Sympathomimetics|sympathomimetics|mesh-ancestor
110126313|NCT05413902|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110126314|NCT05413902|Anticonvulsants|anticonvulsants|mesh-ancestor
110126315|NCT05413902|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110126316|NCT05413902|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110126317|NCT05413902|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110126318|NCT05413902|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110126319|NCT05413902|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110126320|NCT05413902|Antimanic Agents|antimanic agents|mesh-ancestor
110126321|NCT05413902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110126322|NCT05413902|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110126323|NCT05413902|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110126324|NCT05413902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110126325|NCT05413902|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110126326|NCT05413902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110126327|NCT05413902|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110126328|NCT05413902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110126329|NCT05413902|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110126330|NCT05413902|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110126331|NCT05413902|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110126332|NCT05413902|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110126333|NCT05413902|Parasympatholytics|parasympatholytics|mesh-ancestor
110126334|NCT05413902|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110126335|NCT05413902|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110126336|NCT05413902|Cholinergic Agents|cholinergic agents|mesh-ancestor
110126337|NCT05413902|Cytochrome P-450 CYP2B6 Inhibitors|cytochrome p-450 cyp2b6 inhibitors|mesh-ancestor
110126338|NCT05413902|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110126340|NCT05413746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110126341|NCT05413746|Protective Agents|protective agents|mesh-ancestor
110126342|NCT05413746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110126343|NCT05409365|Antibodies|antibodies|mesh-list
110126344|NCT05409365|Immunoglobulins|immunoglobulins|mesh-list
110126345|NCT05409365|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110126346|NCT05409365|Immunologic Factors|immunologic factors|mesh-ancestor
110126347|NCT05409365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110126348|NCT05397587|Vaccines|vaccines|mesh-list
110126349|NCT05397587|Immunologic Factors|immunologic factors|mesh-ancestor
110126350|NCT05397587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110126351|NCT05378880|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110126352|NCT05378880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110126353|NCT05352178|Ascorbic Acid|ascorbic acid|mesh-list
110126354|NCT05352178|Methyltestosterone|methyltestosterone|mesh-list
110126355|NCT05352178|Androgens|androgens|mesh-list
110126356|NCT05352178|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
110126357|NCT05352178|Hormones|hormones|mesh-ancestor
110126358|NCT05352178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110126359|NCT05352178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110126360|NCT05352178|Antioxidants|antioxidants|mesh-ancestor
110126361|NCT05352178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110126362|NCT05352178|Protective Agents|protective agents|mesh-ancestor
110126363|NCT05352178|Vitamins|vitamins|mesh-ancestor
110126364|NCT05352178|Micronutrients|micronutrients|mesh-ancestor
110126365|NCT05352178|Estrogens|estrogens|mesh-ancestor
110126366|NCT05352178|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110126367|NCT05352178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110126368|NCT05352178|Anabolic Agents|anabolic agents|mesh-ancestor
110126369|NCT05328141|Ascorbic Acid|ascorbic acid|mesh-list
110126370|NCT05328141|Antioxidants|antioxidants|mesh-ancestor
110126371|NCT05328141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110126372|NCT05328141|Protective Agents|protective agents|mesh-ancestor
110126373|NCT05328141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110126374|NCT05328141|Vitamins|vitamins|mesh-ancestor
110126375|NCT05328141|Micronutrients|micronutrients|mesh-ancestor
110126376|NCT05310916|Dapagliflozin|dapagliflozin|mesh-list
110126377|NCT05310916|Hypoglycemic Agents|hypoglycemic agents|mesh-list
110126378|NCT05310916|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110126379|NCT05310916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110126380|NCT05310916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110126382|NCT05251493|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
110126383|NCT05251493|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
110126384|NCT05251493|Trace Elements|trace elements|mesh-ancestor
110126385|NCT05251493|Micronutrients|micronutrients|mesh-ancestor
110126386|NCT05251493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110126387|NCT05251493|Hematinics|hematinics|mesh-ancestor
110126388|NCT05233709|Fesoterodine|fesoterodine|mesh-list
110126389|NCT05233709|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110126390|NCT05233709|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110126391|NCT05233709|Cholinergic Agents|cholinergic agents|mesh-ancestor
110126392|NCT05233709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110126393|NCT05233709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110126394|NCT05233709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110126395|NCT05233709|Urological Agents|urological agents|mesh-ancestor
110126396|NCT05173896|Tadalafil|tadalafil|mesh-list
110126397|NCT05173896|Vasodilator Agents|vasodilator agents|mesh-ancestor
110126398|NCT05173896|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110126399|NCT05173896|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110126400|NCT05173896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110126401|NCT05173896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110126402|NCT05173896|Urological Agents|urological agents|mesh-ancestor
110126403|NCT05150236|Nivolumab|nivolumab|mesh-list
110126404|NCT05150236|Ipilimumab|ipilimumab|mesh-list
110126405|NCT05150236|177Lu-PSMA-617|177lu-psma-617|mesh-list
110126406|NCT05150236|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110126407|NCT05150236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110126408|NCT05150236|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110126409|NCT05150236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110126410|NCT05150236|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110126411|NCT05111821|Deferiprone|deferiprone|mesh-list
110126412|NCT05111821|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110126413|NCT05111821|Chelating Agents|chelating agents|mesh-ancestor
110126414|NCT05111821|Sequestering Agents|sequestering agents|mesh-ancestor
110126415|NCT05111821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110126417|NCT05105282|Anesthetics, Local|anesthetics, local|mesh-list
110126418|NCT05105282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110126419|NCT05105282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110126420|NCT05105282|Sensory System Agents|sensory system agents|mesh-ancestor
110126421|NCT05105282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110126422|NCT05005455|Bevacizumab|bevacizumab|mesh-list
110126423|NCT05005455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110126424|NCT05005455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110126425|NCT05005455|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110126426|NCT05005455|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110126427|NCT05005455|Growth Substances|growth substances|mesh-ancestor
110126428|NCT05005455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110126429|NCT05005455|Growth Inhibitors|growth inhibitors|mesh-ancestor
110126430|NCT04742010|Zoledronic Acid|zoledronic acid|mesh-list
110126431|NCT04742010|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110126432|NCT04742010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110126433|NCT04641234|Aflibercept|aflibercept|mesh-list
110126434|NCT04641234|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110126435|NCT04641234|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110126436|NCT04641234|Growth Substances|growth substances|mesh-ancestor
110126437|NCT04641234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110126438|NCT04641234|Growth Inhibitors|growth inhibitors|mesh-ancestor
110126439|NCT04641234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110126440|NCT04636034|Anesthetics|anesthetics|mesh-list
110126441|NCT04636034|Anesthetics, Local|anesthetics, local|mesh-list
110126442|NCT04636034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110126443|NCT04636034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110126444|NCT04636034|Sensory System Agents|sensory system agents|mesh-ancestor
110126445|NCT04636034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110126446|NCT04524663|Camostat|camostat|mesh-list
110126447|NCT04524663|Protease Inhibitors|protease inhibitors|mesh-ancestor
110126449|NCT04524663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110126450|NCT04524663|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
110126451|NCT04524663|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110126452|NCT04435795|Ciclesonide|ciclesonide|mesh-list
110126453|NCT04435795|Glucocorticoids|glucocorticoids|mesh-ancestor
110126454|NCT04435795|Hormones|hormones|mesh-ancestor
110126455|NCT04435795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110126456|NCT04435795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110126457|NCT04435795|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110126458|NCT04350593|Dapagliflozin|dapagliflozin|mesh-list
110126459|NCT04350593|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110126460|NCT04350593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110126461|NCT04350593|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110126462|NCT04350593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110126463|NCT04222283|Emtricitabine|emtricitabine|mesh-list
110126464|NCT04222283|Antiviral Agents|antiviral agents|mesh-ancestor
110126465|NCT04222283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110126466|NCT04222283|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110126467|NCT04222283|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110126468|NCT04222283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110126469|NCT04222283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110126470|NCT04222283|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110126471|NCT04222283|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110126472|NCT04070352|Fidaxomicin|fidaxomicin|mesh-list
110126473|NCT04070352|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110126474|NCT04070352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110126475|NCT04065152|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
110126476|NCT04065152|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110126477|NCT04065152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110126478|NCT03962998|Lactulose|lactulose|mesh-list
110126479|NCT03962998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110126480|NCT03859635|Bupivacaine|bupivacaine|mesh-list
110126481|NCT03859635|Anesthetics, Local|anesthetics, local|mesh-ancestor
110126482|NCT03859635|Anesthetics|anesthetics|mesh-ancestor
110126483|NCT03859635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110126484|NCT03859635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110126485|NCT03859635|Sensory System Agents|sensory system agents|mesh-ancestor
110126486|NCT03859635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110126487|NCT03783013|Lycopene|lycopene|mesh-list
110126488|NCT03783013|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110126489|NCT03783013|Antioxidants|antioxidants|mesh-ancestor
110126490|NCT03783013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110126491|NCT03783013|Protective Agents|protective agents|mesh-ancestor
110126492|NCT03783013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110126493|NCT03783013|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110126494|NCT03783013|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110126495|NCT03783013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110126496|NCT03726229|Cholic Acids|cholic acids|mesh-list
110126497|NCT03726229|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110126498|NCT03712228|Antibodies|antibodies|mesh-list
110126499|NCT03712228|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110126500|NCT03712228|Immunologic Factors|immunologic factors|mesh-ancestor
110126501|NCT03712228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110126502|NCT03626922|Folic Acid|folic acid|mesh-list
110126503|NCT03626922|Vitamin B 12|vitamin b 12|mesh-list
110126504|NCT03626922|Dexamethasone|dexamethasone|mesh-list
110126505|NCT03626922|Pembrolizumab|pembrolizumab|mesh-list
110126506|NCT03626922|Oxaliplatin|oxaliplatin|mesh-list
110126507|NCT03626922|Pemetrexed|pemetrexed|mesh-list
110126508|NCT03626922|Vitamins|vitamins|mesh-ancestor
110126509|NCT03626922|Micronutrients|micronutrients|mesh-ancestor
110126510|NCT03626922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110126511|NCT03626922|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110126512|NCT03626922|Antiemetics|antiemetics|mesh-ancestor
110126513|NCT03626922|Autonomic Agents|autonomic agents|mesh-ancestor
110126514|NCT03626922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110126515|NCT03626922|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110126516|NCT03626922|Glucocorticoids|glucocorticoids|mesh-ancestor
110126517|NCT03626922|Hormones|hormones|mesh-ancestor
110126518|NCT03626922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110126519|NCT03626922|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110126520|NCT03626922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110126521|NCT03626922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110126522|NCT03626922|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110126523|NCT03626922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110126524|NCT03626922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110126525|NCT03626922|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110126526|NCT03626922|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110126527|NCT03626922|Hematinics|hematinics|mesh-ancestor
110126528|NCT03626922|Vitamin B Complex|vitamin b complex|mesh-ancestor
110126529|NCT03600818|Prednisone|prednisone|mesh-list
110126530|NCT03600818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110126531|NCT03600818|Glucocorticoids|glucocorticoids|mesh-ancestor
110126532|NCT03600818|Hormones|hormones|mesh-ancestor
110126533|NCT03600818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110126534|NCT03600818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110126535|NCT03600818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110126536|NCT03600818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110126537|NCT03578276|Gatifloxacin|gatifloxacin|mesh-list
110126538|NCT03578276|Prednisolone|prednisolone|mesh-list
110126539|NCT03578276|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110126540|NCT03578276|Methylprednisolone|methylprednisolone|mesh-list
110126541|NCT03578276|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110126542|NCT03578276|Prednisolone acetate|prednisolone acetate|mesh-list
110126543|NCT03578276|Bromfenac|bromfenac|mesh-list
110126544|NCT03578276|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110126545|NCT03578276|Prednisolone phosphate|prednisolone phosphate|mesh-list
110126546|NCT03578276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110126547|NCT03578276|Glucocorticoids|glucocorticoids|mesh-ancestor
110126548|NCT03578276|Hormones|hormones|mesh-ancestor
110126549|NCT03578276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110126550|NCT03578276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110126551|NCT03578276|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110126552|NCT03578276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110126553|NCT03578276|Antiemetics|antiemetics|mesh-ancestor
110126554|NCT03578276|Autonomic Agents|autonomic agents|mesh-ancestor
110126555|NCT03578276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110126556|NCT03578276|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110126557|NCT03578276|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110126558|NCT03578276|Protective Agents|protective agents|mesh-ancestor
110126559|NCT03578276|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110126560|NCT03578276|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110126562|NCT03578276|Sensory System Agents|sensory system agents|mesh-ancestor
110126563|NCT03578276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110126564|NCT03578276|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110126565|NCT03578276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110126567|NCT03578276|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110126568|NCT03578276|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110126569|NCT03578276|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110126570|NCT03578276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110126571|NCT03578276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110126572|NCT03491267|Tretinoin|tretinoin|mesh-list
110126573|NCT03491267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110126574|NCT03491267|Keratolytic Agents|keratolytic agents|mesh-ancestor
110126575|NCT03491267|Dermatologic Agents|dermatologic agents|mesh-ancestor
110126576|NCT03174184|Amoxicillin|amoxicillin|mesh-list
110126577|NCT03174184|Rifampin|rifampin|mesh-list
110126578|NCT03174184|Meropenem|meropenem|mesh-list
110126579|NCT03174184|Clavulanic Acid|clavulanic acid|mesh-list
110126581|NCT03174184|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
110126582|NCT03174184|Rifamycins|rifamycins|mesh-list
110126583|NCT03174184|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110126584|NCT03174184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110126585|NCT03174184|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110126586|NCT03174184|Antitubercular Agents|antitubercular agents|mesh-ancestor
110126587|NCT03174184|Leprostatic Agents|leprostatic agents|mesh-ancestor
110126588|NCT03174184|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110126589|NCT03174184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110126590|NCT03174184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110126591|NCT03174184|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110126592|NCT03174184|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110126593|NCT03174184|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110126594|NCT03174184|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110126595|NCT03174184|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110126596|NCT03174184|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110126597|NCT03174184|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110126598|NCT03052933|Gemcitabine|gemcitabine|mesh-list
110126599|NCT03052933|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110126600|NCT03052933|Antimetabolites|antimetabolites|mesh-ancestor
110126601|NCT03052933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110126602|NCT03052933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110126603|NCT02959697|Lidocaine|lidocaine|mesh-list
110126604|NCT02959697|Anesthetics, Local|anesthetics, local|mesh-ancestor
110126605|NCT02959697|Anesthetics|anesthetics|mesh-ancestor
110126606|NCT02959697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110126607|NCT02959697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110126608|NCT02959697|Sensory System Agents|sensory system agents|mesh-ancestor
110126609|NCT02959697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110126610|NCT02959697|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110126611|NCT02959697|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110126612|NCT02959697|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110126613|NCT02959697|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110126614|NCT02959697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110126616|NCT02900560|Azacitidine|azacitidine|mesh-list
110126618|NCT02900560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110126619|NCT02900560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110126620|NCT02900560|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110126621|NCT02900560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110126622|NCT02900560|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110126623|NCT02900560|Antimetabolites|antimetabolites|mesh-ancestor
110126624|NCT02900560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110126625|NCT02877550|Venetoclax|venetoclax|mesh-list
110126626|NCT02877550|Obinutuzumab|obinutuzumab|mesh-list
110126627|NCT02877550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110126628|NCT02877550|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110126629|NCT02775812|Pembrolizumab|pembrolizumab|mesh-list
110126630|NCT02775812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110126631|NCT02775812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110126632|NCT02775812|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110126633|NCT02775812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110126634|NCT02679170|Crizotinib|crizotinib|mesh-list
110126635|NCT02679170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110126636|NCT02679170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110126637|NCT02679170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110126638|NCT02679170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110126640|NCT02518009|Androgens|androgens|mesh-list
110126641|NCT02518009|Hormones|hormones|mesh-ancestor
110126642|NCT02518009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110126643|NCT02518009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110126644|NCT02238496|Sirolimus|sirolimus|mesh-list
110126645|NCT02238496|Temsirolimus|temsirolimus|mesh-list
110126646|NCT02238496|MTOR Inhibitors|mtor inhibitors|mesh-list
110126647|NCT02238496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110126648|NCT02238496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110126649|NCT02238496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110126650|NCT02238496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110126651|NCT02238496|Immunologic Factors|immunologic factors|mesh-ancestor
110126652|NCT02238496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110126653|NCT02238496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110126654|NCT02238496|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110126655|NCT02238496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110126656|NCT02238496|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110126657|NCT02238496|Antifungal Agents|antifungal agents|mesh-ancestor
110126658|NCT02034110|Trametinib|trametinib|mesh-list
110126659|NCT02034110|Dabrafenib|dabrafenib|mesh-list
110126660|NCT02034110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110126661|NCT02034110|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110126662|NCT02034110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110126663|NCT02034110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110126664|NCT01968213|Rucaparib|rucaparib|mesh-list
110126665|NCT01968213|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110126666|NCT01968213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110126667|NCT01968213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110164517|NCT00020332|Tubulin Modulators|tubulin modulators|mesh-ancestor
110126668|NCT01968213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110126669|NCT01498458|Capecitabine|capecitabine|mesh-list
110126670|NCT01498458|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110126671|NCT01498458|Antimetabolites|antimetabolites|mesh-ancestor
110126672|NCT01498458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110126673|NCT01498458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110126674|NCT01427712|Pancrelipase|pancrelipase|mesh-list
110126675|NCT01427712|Pancreatin|pancreatin|mesh-list
110126676|NCT01427712|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110126677|NCT01369147|Clevidipine|clevidipine|mesh-list
110126678|NCT01369147|Propofol|propofol|mesh-list
110126679|NCT01369147|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110126680|NCT01369147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110126681|NCT01369147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110126682|NCT01369147|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110126683|NCT01369147|Anesthetics, General|anesthetics, general|mesh-ancestor
110126684|NCT01369147|Anesthetics|anesthetics|mesh-ancestor
110126685|NCT01369147|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110126686|NCT01369147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110126687|NCT01369147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110126688|NCT01369147|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110126689|NCT01197066|Certolizumab Pegol|certolizumab pegol|mesh-list
110126690|NCT01197066|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110126691|NCT01197066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110126692|NCT01197066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110126693|NCT01197066|Immunologic Factors|immunologic factors|mesh-ancestor
110126694|NCT01197066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110126695|NCT01197066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110126696|NCT01945840|Hormones|hormones|mesh-list
110126697|NCT01945840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110126698|NCT01945840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110126699|NCT01945879|Heparin|heparin|mesh-list
110126700|NCT01945879|Enoxaparin|enoxaparin|mesh-list
110126701|NCT01945879|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
110126702|NCT01945879|Tinzaparin|tinzaparin|mesh-list
110126703|NCT01945879|Dalteparin|dalteparin|mesh-list
110126704|NCT01945879|Anticoagulants|anticoagulants|mesh-ancestor
110126705|NCT01945879|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110126706|NCT01945879|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110126707|NCT01945879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110126708|NCT01945892|Dexamethasone|dexamethasone|mesh-list
110126709|NCT01945892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110126710|NCT01945892|Antiemetics|antiemetics|mesh-ancestor
110126711|NCT01945892|Autonomic Agents|autonomic agents|mesh-ancestor
110126712|NCT01945892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110126713|NCT01945892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110126714|NCT01945892|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110126715|NCT01945892|Glucocorticoids|glucocorticoids|mesh-ancestor
110126716|NCT01945892|Hormones|hormones|mesh-ancestor
110126717|NCT01945892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110126718|NCT01945892|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110126719|NCT01945892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110126720|NCT01945957|Oxytocin|oxytocin|mesh-list
110126721|NCT01945957|Oxytocics|oxytocics|mesh-ancestor
110126722|NCT01945957|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110126723|NCT01945957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110126724|NCT01945983|Norepinephrine|norepinephrine|mesh-list
110126725|NCT01945983|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110126726|NCT01945983|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110126727|NCT01945983|Adrenergic Agents|adrenergic agents|mesh-ancestor
110126728|NCT01945983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110126729|NCT01945983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110126730|NCT01945983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110126731|NCT01945983|Sympathomimetics|sympathomimetics|mesh-ancestor
110126732|NCT01945983|Autonomic Agents|autonomic agents|mesh-ancestor
110126733|NCT01945983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110126734|NCT01945983|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110126736|NCT01946009|Antiviral Agents|antiviral agents|mesh-ancestor
110126737|NCT01946009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110126738|NCT01946009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110126739|NCT01946009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110126740|NCT01946035|Doxazosin|doxazosin|mesh-list
110126741|NCT01946035|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110126742|NCT01946035|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110126743|NCT01946035|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110126744|NCT01946035|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110126745|NCT01946035|Adrenergic Agents|adrenergic agents|mesh-ancestor
110126746|NCT01946035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110126747|NCT01946035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110126748|NCT01946035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110126750|NCT01946061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110126751|NCT01946256|Amoxicillin|amoxicillin|mesh-list
110126752|NCT01946256|Erythromycin|erythromycin|mesh-list
110126753|NCT01946256|Erythromycin Estolate|erythromycin estolate|mesh-list
110126754|NCT01946256|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
110126755|NCT01946256|Erythromycin stearate|erythromycin stearate|mesh-list
110126756|NCT01946256|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110126757|NCT01946256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110126758|NCT01946256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110126759|NCT01946256|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110126760|NCT01946256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110126761|NCT01946256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110126762|NCT01946295|Famotidine|famotidine|mesh-list
110126763|NCT01946295|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110126764|NCT01946295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110126765|NCT01946295|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110126766|NCT01946295|Histamine Antagonists|histamine antagonists|mesh-ancestor
110126767|NCT01946295|Histamine Agents|histamine agents|mesh-ancestor
110126768|NCT01946295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110126769|NCT01946295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110126770|NCT01946295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110126771|NCT01946386|Betamethasone|betamethasone|mesh-list
110126772|NCT01946386|Betamethasone Valerate|betamethasone valerate|mesh-list
110126773|NCT01946386|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
110126774|NCT01946386|Betamethasone benzoate|betamethasone benzoate|mesh-list
110126775|NCT01946386|Clobetasol|clobetasol|mesh-list
110126776|NCT01946386|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
110126777|NCT01946386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110126778|NCT01946386|Glucocorticoids|glucocorticoids|mesh-ancestor
110126779|NCT01946386|Hormones|hormones|mesh-ancestor
110126780|NCT01946386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110126781|NCT01946386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110126782|NCT01946386|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110126783|NCT01946386|Respiratory System Agents|respiratory system agents|mesh-ancestor
110126784|NCT01946399|Dexamethasone|dexamethasone|mesh-list
110126785|NCT01946399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110126786|NCT01946399|Antiemetics|antiemetics|mesh-ancestor
110126787|NCT01946399|Autonomic Agents|autonomic agents|mesh-ancestor
110126788|NCT01946399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110126789|NCT01946399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110126791|NCT01946399|Glucocorticoids|glucocorticoids|mesh-ancestor
110126792|NCT01946399|Hormones|hormones|mesh-ancestor
110126793|NCT01946399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110126794|NCT01946399|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110126795|NCT01946399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110126796|NCT01946555|Fentanyl|fentanyl|mesh-list
110126797|NCT01946555|Morphine|morphine|mesh-list
110126798|NCT01946555|Oxycodone|oxycodone|mesh-list
110126799|NCT01946555|Buprenorphine|buprenorphine|mesh-list
110126800|NCT01946555|Methadone|methadone|mesh-list
110126801|NCT01946555|Hydromorphone|hydromorphone|mesh-list
110126802|NCT01946555|Tapentadol|tapentadol|mesh-list
110126803|NCT01946555|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110126804|NCT01946555|Narcotics|narcotics|mesh-ancestor
110126805|NCT01946555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110126806|NCT01946555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110126807|NCT01946555|Analgesics|analgesics|mesh-ancestor
110126808|NCT01946555|Sensory System Agents|sensory system agents|mesh-ancestor
110126809|NCT01946555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110126810|NCT01946555|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110126811|NCT01946555|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110126812|NCT01946555|Anesthetics, General|anesthetics, general|mesh-ancestor
110126813|NCT01946555|Anesthetics|anesthetics|mesh-ancestor
110126814|NCT01946555|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110126815|NCT01946555|Antitussive Agents|antitussive agents|mesh-ancestor
110126816|NCT01946555|Respiratory System Agents|respiratory system agents|mesh-ancestor
110126817|NCT01946555|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110126818|NCT01946555|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110126819|NCT01946555|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110126820|NCT01946555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110126821|NCT01946555|Adrenergic Agents|adrenergic agents|mesh-ancestor
110126822|NCT01946555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110126823|NCT01946568|Dalbavancin|dalbavancin|mesh-list
110126824|NCT01946568|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110126825|NCT01946568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110126826|NCT01946594|Acetaminophen|acetaminophen|mesh-list
110126827|NCT01946594|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110126828|NCT01946594|Analgesics|analgesics|mesh-ancestor
110126829|NCT01946594|Sensory System Agents|sensory system agents|mesh-ancestor
110126830|NCT01946594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110126831|NCT01946594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110126832|NCT01946594|Antipyretics|antipyretics|mesh-ancestor
110126833|NCT01946607|Citalopram|citalopram|mesh-list
110126834|NCT01946607|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110126835|NCT01946607|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110126836|NCT01946607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110126837|NCT01946607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110126838|NCT01946607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110126839|NCT01946607|Serotonin Agents|serotonin agents|mesh-ancestor
110126840|NCT01946607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110126841|NCT01946607|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110126842|NCT01946607|Antidepressive Agents|antidepressive agents|mesh-ancestor
110126843|NCT01946607|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110126844|NCT01946620|Formoterol Fumarate|formoterol fumarate|mesh-list
110126845|NCT01946620|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110126846|NCT01946620|Autonomic Agents|autonomic agents|mesh-ancestor
110126847|NCT01946620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110126848|NCT01946620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110126849|NCT01946620|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110126850|NCT01946620|Respiratory System Agents|respiratory system agents|mesh-ancestor
110126851|NCT01946620|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110126852|NCT01946620|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110126853|NCT01946620|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110126854|NCT01946620|Adrenergic Agents|adrenergic agents|mesh-ancestor
110126855|NCT01946620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110164549|NCT00020449|Immunologic Factors|immunologic factors|mesh-ancestor
110126856|NCT01946620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110126857|NCT01946906|Rifaximin|rifaximin|mesh-list
110126858|NCT01946906|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110126859|NCT01946906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110126860|NCT01946906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110126861|NCT01946971|Lansoprazole|lansoprazole|mesh-list
110126862|NCT01946971|Dexlansoprazole|dexlansoprazole|mesh-list
110126863|NCT01946971|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110126864|NCT01946971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110126865|NCT01946971|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110126866|NCT01946971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110368562|NCT04652115|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110126867|NCT01946971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110126868|NCT01946984|Diclofenac|diclofenac|mesh-list
110126869|NCT01946984|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
110126870|NCT01946984|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110126871|NCT01946984|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110126872|NCT01946984|Analgesics|analgesics|mesh-ancestor
110126873|NCT01946984|Sensory System Agents|sensory system agents|mesh-ancestor
110126874|NCT01946984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110126875|NCT01946984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110126876|NCT01946984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110126877|NCT01946984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110126878|NCT01946984|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110126879|NCT01946984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110126880|NCT01946984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110126881|NCT01947010|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110126882|NCT01947010|Immunologic Factors|immunologic factors|mesh-ancestor
110126883|NCT01947010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110126884|NCT01947062|Cyclophosphamide|cyclophosphamide|mesh-list
110126885|NCT01947062|Cisplatin|cisplatin|mesh-list
110126886|NCT01947062|Etoposide|etoposide|mesh-list
110126887|NCT01947062|Etoposide phosphate|etoposide phosphate|mesh-list
110126888|NCT01947062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110126889|NCT01947062|Immunologic Factors|immunologic factors|mesh-ancestor
110126890|NCT01947062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110126891|NCT01947062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110126892|NCT01947062|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110126893|NCT01947062|Alkylating Agents|alkylating agents|mesh-ancestor
110126894|NCT01947062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110126895|NCT01947062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110126896|NCT01947062|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110126897|NCT01947062|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110126898|NCT01947062|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110126899|NCT01947062|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110126900|NCT01947062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110126901|NCT01947114|Ketamine|ketamine|mesh-list
110126902|NCT01947114|Remifentanil|remifentanil|mesh-list
110126904|NCT01947114|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110126905|NCT01947114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110126906|NCT01947114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110126907|NCT01947114|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110126908|NCT01947114|Anesthetics, General|anesthetics, general|mesh-ancestor
110126910|NCT01947114|Analgesics|analgesics|mesh-ancestor
110126911|NCT01947114|Sensory System Agents|sensory system agents|mesh-ancestor
110126912|NCT01947114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110126913|NCT01947114|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110224589|NCT06001047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110224593|NCT06000917|Carboplatin|carboplatin|mesh-list
110126914|NCT01947114|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110126915|NCT01947114|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110126916|NCT01947114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110126917|NCT01947114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110126918|NCT01947114|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110126919|NCT01947114|Narcotics|narcotics|mesh-ancestor
110126920|NCT01947192|Chlorhexidine|chlorhexidine|mesh-list
110126921|NCT01947192|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110126922|NCT01947192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110126923|NCT01947192|Disinfectants|disinfectants|mesh-ancestor
110126924|NCT01947205|Acetaminophen|acetaminophen|mesh-list
110126925|NCT01947205|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
110126926|NCT01947205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110126927|NCT01947205|Analgesics|analgesics|mesh-ancestor
110126928|NCT01947205|Sensory System Agents|sensory system agents|mesh-ancestor
110126929|NCT01947205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110126930|NCT01947205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110126931|NCT01947205|Antipyretics|antipyretics|mesh-ancestor
110126932|NCT01947205|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110126933|NCT01947205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110126934|NCT01947205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110126935|NCT01947309|Lenalidomide|lenalidomide|mesh-list
110126936|NCT01947309|Immunologic Factors|immunologic factors|mesh-ancestor
110126937|NCT01947309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110126938|NCT01947309|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110126939|NCT01947309|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110126940|NCT01947309|Growth Substances|growth substances|mesh-ancestor
110126941|NCT01947309|Growth Inhibitors|growth inhibitors|mesh-ancestor
110126942|NCT01947309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110126943|NCT01947465|Vaccines|vaccines|mesh-list
110126944|NCT01947465|Immunologic Factors|immunologic factors|mesh-ancestor
110126945|NCT01947465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110126946|NCT01947556|Insulin Aspart|insulin aspart|mesh-list
110126947|NCT01947556|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110126948|NCT01947556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110126949|NCT01947608|Ceritinib|ceritinib|mesh-list
110126950|NCT01947608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110126951|NCT01947608|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110126952|NCT01947608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110126953|NCT01947608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110126954|NCT01947660|Anesthetics|anesthetics|mesh-list
110126955|NCT01947660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110126956|NCT01947660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110126957|NCT01947699|Glyburide|glyburide|mesh-list
110126958|NCT01947699|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110126959|NCT01947699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110126960|NCT01947777|Rifampin|rifampin|mesh-list
110126961|NCT01947777|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110126962|NCT01947777|Antitubercular Agents|antitubercular agents|mesh-ancestor
110126963|NCT01947777|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110126964|NCT01947777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110126965|NCT01947777|Leprostatic Agents|leprostatic agents|mesh-ancestor
110126966|NCT01947777|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110126967|NCT01947777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110126968|NCT01947777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110126969|NCT01947777|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110126970|NCT01947777|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110126971|NCT01947777|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110126972|NCT01947777|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110126973|NCT01947777|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110126974|NCT01947777|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110126975|NCT01947790|Metformin|metformin|mesh-list
110126976|NCT01947790|Pioglitazone|pioglitazone|mesh-list
110126977|NCT01947790|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110126978|NCT01947790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110126979|NCT01947803|Paliperidone Palmitate|paliperidone palmitate|mesh-list
110126980|NCT01947803|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110126981|NCT01947803|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110126982|NCT01947803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110126983|NCT01947803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110126984|NCT01947803|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110126985|NCT01947803|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110126986|NCT01947803|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110126987|NCT01947803|Serotonin Agents|serotonin agents|mesh-ancestor
110126988|NCT01947803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110126989|NCT01947803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110126990|NCT01947803|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110126991|NCT01947803|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110126992|NCT01947803|Dopamine Agents|dopamine agents|mesh-ancestor
110126994|NCT01947920|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110126995|NCT01947920|Narcotics|narcotics|mesh-ancestor
110126996|NCT01947920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110126997|NCT01947920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110126998|NCT01947920|Analgesics|analgesics|mesh-ancestor
110126999|NCT01947920|Sensory System Agents|sensory system agents|mesh-ancestor
110127000|NCT01947920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110127001|NCT01947933|Mirikizumab|mirikizumab|mesh-list
110127002|NCT01947933|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110127003|NCT01947933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110127004|NCT01947933|Analgesics|analgesics|mesh-ancestor
110127005|NCT01947933|Sensory System Agents|sensory system agents|mesh-ancestor
110127006|NCT01947933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110127007|NCT01947933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110127008|NCT01947933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110127009|NCT01947933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110127010|NCT01947933|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110127011|NCT01947933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110127012|NCT01947959|Rivaroxaban|rivaroxaban|mesh-list
110127013|NCT01947959|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110127014|NCT01947959|Antithrombins|antithrombins|mesh-ancestor
110127015|NCT01947959|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110127016|NCT01947959|Protease Inhibitors|protease inhibitors|mesh-ancestor
110127017|NCT01947959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110127018|NCT01947959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110127019|NCT01947959|Anticoagulants|anticoagulants|mesh-ancestor
110127020|NCT01947985|Rivaroxaban|rivaroxaban|mesh-list
110127021|NCT01947985|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110127022|NCT01947985|Antithrombins|antithrombins|mesh-ancestor
110127023|NCT01947985|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110127024|NCT01947985|Protease Inhibitors|protease inhibitors|mesh-ancestor
110127025|NCT01947985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110127026|NCT01947985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110127027|NCT01947985|Anticoagulants|anticoagulants|mesh-ancestor
110127028|NCT01947998|Warfarin|warfarin|mesh-list
110127029|NCT01947998|Rivaroxaban|rivaroxaban|mesh-list
110127030|NCT01947998|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
110127031|NCT01947998|Anticoagulants|anticoagulants|mesh-ancestor
110127032|NCT01947998|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110127033|NCT01947998|Antithrombins|antithrombins|mesh-ancestor
110127034|NCT01947998|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110127035|NCT01947998|Protease Inhibitors|protease inhibitors|mesh-ancestor
110127036|NCT01947998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110224633|NCT06000657|Entecavir|entecavir|mesh-list
110127037|NCT01947998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110127038|NCT01948011|Racecadotril|racecadotril|mesh-list
110127039|NCT01948011|Thiorphan|thiorphan|mesh-list
110127040|NCT01948011|Antidiarrheals|antidiarrheals|mesh-ancestor
110127041|NCT01948011|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110127042|NCT01948011|Protease Inhibitors|protease inhibitors|mesh-ancestor
110127043|NCT01948011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110127044|NCT01948011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110127045|NCT01948024|Asenapine|asenapine|mesh-list
110127046|NCT01948024|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110127047|NCT01948024|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110127048|NCT01948024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110127049|NCT01948024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110127050|NCT01948024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110127052|NCT01948115|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110127053|NCT01948115|Anesthetics, General|anesthetics, general|mesh-ancestor
110127054|NCT01948115|Anesthetics|anesthetics|mesh-ancestor
110127055|NCT01948115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110127056|NCT01948115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110127057|NCT01948115|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110127058|NCT01948115|Analgesics|analgesics|mesh-ancestor
110127059|NCT01948115|Sensory System Agents|sensory system agents|mesh-ancestor
110127060|NCT01948115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110127061|NCT01948128|Vitamin D|vitamin d|mesh-list
110127062|NCT01948128|Ergocalciferols|ergocalciferols|mesh-list
110127063|NCT01948128|Cholecalciferol|cholecalciferol|mesh-list
110127064|NCT01948128|Vitamins|vitamins|mesh-list
110127065|NCT01948128|Micronutrients|micronutrients|mesh-ancestor
110127066|NCT01948128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110127067|NCT01948128|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110127068|NCT01948128|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110127069|NCT01948232|Perindopril|perindopril|mesh-list
110127070|NCT01948232|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110127071|NCT01948232|Protease Inhibitors|protease inhibitors|mesh-ancestor
110127072|NCT01948232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110127073|NCT01948232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110127074|NCT01948232|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110127075|NCT01948336|Dexmedetomidine|dexmedetomidine|mesh-list
110127076|NCT01948336|Ketamine|ketamine|mesh-list
110127077|NCT01948336|Propofol|propofol|mesh-list
110127078|NCT01948336|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110127079|NCT01948336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110127080|NCT01948336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110127081|NCT01948336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110127082|NCT01948336|Analgesics|analgesics|mesh-ancestor
110127083|NCT01948336|Sensory System Agents|sensory system agents|mesh-ancestor
110127084|NCT01948336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110127085|NCT01948336|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110127086|NCT01948336|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110127087|NCT01948336|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110127089|NCT01948336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110127090|NCT01948336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110127091|NCT01948336|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110127092|NCT01948336|Anesthetics, General|anesthetics, general|mesh-ancestor
110127093|NCT01948336|Anesthetics|anesthetics|mesh-ancestor
110127094|NCT01948336|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110127095|NCT01948336|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110127096|NCT01948336|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110127097|NCT01948362|Sulforaphane|sulforaphane|mesh-list
110127098|NCT01948362|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110127099|NCT01948362|Protective Agents|protective agents|mesh-ancestor
110127100|NCT01948362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110127101|NCT01948362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110127102|NCT01948401|Prednisolone|prednisolone|mesh-list
110127103|NCT01948401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110127104|NCT01948401|Glucocorticoids|glucocorticoids|mesh-ancestor
110127105|NCT01948401|Hormones|hormones|mesh-ancestor
110127106|NCT01948401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110127107|NCT01948401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110127108|NCT01948401|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110127109|NCT01948401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110127110|NCT01948583|Hyaluronic Acid|hyaluronic acid|mesh-list
110127111|NCT01948583|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110127112|NCT01948583|Immunologic Factors|immunologic factors|mesh-ancestor
110127113|NCT01948583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110127114|NCT01948583|Viscosupplements|viscosupplements|mesh-ancestor
110127115|NCT01948583|Protective Agents|protective agents|mesh-ancestor
110127116|NCT01948648|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
110127117|NCT01948648|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110127118|NCT01948648|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110127119|NCT01948648|Antimetabolites|antimetabolites|mesh-ancestor
110127120|NCT01948648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110127121|NCT01948648|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110127122|NCT01948765|Propofol|propofol|mesh-list
110127123|NCT01948765|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110127124|NCT01948765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110127125|NCT01948765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110127126|NCT01948765|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110127127|NCT01948765|Anesthetics, General|anesthetics, general|mesh-ancestor
110127128|NCT01948765|Anesthetics|anesthetics|mesh-ancestor
110127129|NCT01948804|Letrozole|letrozole|mesh-list
110127130|NCT01948804|Clomiphene|clomiphene|mesh-list
110127131|NCT01948804|Cetrorelix|cetrorelix|mesh-list
110127132|NCT01948804|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
110127133|NCT01948804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110127134|NCT01948804|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110127135|NCT01948804|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110127136|NCT01948804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110127137|NCT01948804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110127138|NCT01948804|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110127139|NCT01948804|Hormone Antagonists|hormone antagonists|mesh-ancestor
110127140|NCT01948804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110127141|NCT01948804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110127142|NCT01948804|Hormones|hormones|mesh-ancestor
110127143|NCT01948804|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110127144|NCT01948804|Fertility Agents|fertility agents|mesh-ancestor
110127145|NCT01948804|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110127146|NCT01948804|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110127147|NCT01948804|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110127148|NCT01948817|Deferasirox|deferasirox|mesh-list
110127149|NCT01948817|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110127150|NCT01948817|Chelating Agents|chelating agents|mesh-ancestor
110127151|NCT01948817|Sequestering Agents|sequestering agents|mesh-ancestor
110127152|NCT01948817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110127153|NCT01948895|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
110127154|NCT01948895|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110224662|NCT06000137|Anesthetics|anesthetics|mesh-ancestor
110127155|NCT01948895|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110127156|NCT01948895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110127157|NCT01948895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110127158|NCT01948895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110127159|NCT01948895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110127161|NCT01948895|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110127163|NCT01948921|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110127164|NCT01948921|Narcotics|narcotics|mesh-ancestor
110127165|NCT01948921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110127166|NCT01948921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110127167|NCT01948921|Analgesics|analgesics|mesh-ancestor
110127168|NCT01948921|Sensory System Agents|sensory system agents|mesh-ancestor
110127169|NCT01948921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110127170|NCT01948921|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110127172|NCT01948960|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110127173|NCT01948960|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110127174|NCT01948960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110127175|NCT01948960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110127176|NCT01948960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110127177|NCT01948960|Immunologic Factors|immunologic factors|mesh-ancestor
110127178|NCT01948960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110127179|NCT01948960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110127181|NCT01948999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110127182|NCT01948999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110127183|NCT01949038|Alprazolam|alprazolam|mesh-list
110127184|NCT01949038|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110127185|NCT01949038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110127186|NCT01949038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110127187|NCT01949038|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110127188|NCT01949038|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110127189|NCT01949038|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110127190|NCT01949038|GABA Modulators|gaba modulators|mesh-ancestor
110127191|NCT01949038|GABA Agents|gaba agents|mesh-ancestor
110127192|NCT01949038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110127193|NCT01949038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110127194|NCT01949064|Salicylic Acid|salicylic acid|mesh-list
110127195|NCT01949064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110127196|NCT01949064|Antifungal Agents|antifungal agents|mesh-ancestor
110127197|NCT01949064|Keratolytic Agents|keratolytic agents|mesh-ancestor
110127198|NCT01949064|Dermatologic Agents|dermatologic agents|mesh-ancestor
110127199|NCT01949129|Cyclophosphamide|cyclophosphamide|mesh-list
110127200|NCT01949129|Busulfan|busulfan|mesh-list
110127201|NCT01949129|Thiotepa|thiotepa|mesh-list
110127202|NCT01949129|Treosulfan|treosulfan|mesh-list
110127203|NCT01949129|Fludarabine|fludarabine|mesh-list
110127204|NCT01949129|Etoposide|etoposide|mesh-list
110127205|NCT01949129|Thymoglobulin|thymoglobulin|mesh-list
110127206|NCT01949129|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110127207|NCT01949129|Immunoglobulins|immunoglobulins|mesh-list
110127208|NCT01949129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110127209|NCT01949129|Immunologic Factors|immunologic factors|mesh-ancestor
110127210|NCT01949129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110127211|NCT01949129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110127212|NCT01949129|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110127213|NCT01949129|Alkylating Agents|alkylating agents|mesh-ancestor
110127214|NCT01949129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110127215|NCT01949129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110127216|NCT01949129|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110127217|NCT01949129|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110127218|NCT01949129|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110127219|NCT01949129|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110127220|NCT01949129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110127221|NCT01949168|Ribavirin|ribavirin|mesh-list
110127222|NCT01949168|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110127223|NCT01949168|Antimetabolites|antimetabolites|mesh-ancestor
110127224|NCT01949168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110127225|NCT01949168|Antiviral Agents|antiviral agents|mesh-ancestor
110127226|NCT01949168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110127229|NCT01949233|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110127230|NCT01949233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110127231|NCT01949233|Antimalarials|antimalarials|mesh-ancestor
110127232|NCT01949233|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110127233|NCT01949233|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110127234|NCT01949233|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110127235|NCT01949233|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110127236|NCT01949233|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110127237|NCT01949233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110127238|NCT01949363|Cefixime|cefixime|mesh-list
110127239|NCT01949363|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110127240|NCT01949363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110127241|NCT01949454|Fluorometholone|fluorometholone|mesh-list
110127242|NCT01949454|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110127243|NCT01949454|Lubricant Eye Drops|lubricant eye drops|mesh-list
110127244|NCT01949454|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110127245|NCT01949454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110127246|NCT01949454|Glucocorticoids|glucocorticoids|mesh-ancestor
110127247|NCT01949454|Hormones|hormones|mesh-ancestor
110127248|NCT01949454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110127249|NCT01949454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110127250|NCT01949454|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110127251|NCT01949519|Lycopene|lycopene|mesh-list
110127252|NCT01949519|Docetaxel|docetaxel|mesh-list
110127253|NCT01949519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110127254|NCT01949519|Tubulin Modulators|tubulin modulators|mesh-ancestor
110127255|NCT01949519|Antimitotic Agents|antimitotic agents|mesh-ancestor
110127256|NCT01949519|Mitosis Modulators|mitosis modulators|mesh-ancestor
110127257|NCT01949519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110127258|NCT01949519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110127259|NCT01949519|Antioxidants|antioxidants|mesh-ancestor
110127260|NCT01949519|Protective Agents|protective agents|mesh-ancestor
110127261|NCT01949519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110127262|NCT01949519|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110127263|NCT01949519|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110127264|NCT01949571|Mirtazapine|mirtazapine|mesh-list
110127265|NCT01949571|Antidepressive Agents|antidepressive agents|mesh-ancestor
110127266|NCT01949571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110127267|NCT01949571|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110127268|NCT01949571|Histamine Antagonists|histamine antagonists|mesh-ancestor
110127269|NCT01949571|Histamine Agents|histamine agents|mesh-ancestor
110127270|NCT01949571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110127271|NCT01949571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110127272|NCT01949571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110127273|NCT01949571|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110127274|NCT01949571|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110127275|NCT01949571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110127276|NCT01949571|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
110127277|NCT01949571|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110127278|NCT01949571|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110127279|NCT01949571|Adrenergic Agents|adrenergic agents|mesh-ancestor
110127280|NCT01949571|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110127281|NCT01949571|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110127282|NCT01949571|Serotonin Agents|serotonin agents|mesh-ancestor
110224693|NCT05999994|Alkylating Agents|alkylating agents|mesh-ancestor
110127283|NCT01949571|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110127285|NCT01949675|Immunologic Factors|immunologic factors|mesh-ancestor
110127286|NCT01949675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110127287|NCT01949766|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
110127288|NCT01949766|Glycerol|glycerol|mesh-list
110127289|NCT01949766|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
110127290|NCT01949766|Protective Agents|protective agents|mesh-ancestor
110127291|NCT01949766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110127292|NCT01949766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110127293|NCT01948245|Taurolidine|taurolidine|mesh-list
110127294|NCT01948245|Heparin|heparin|mesh-list
110127295|NCT01948245|Calcium heparin|calcium heparin|mesh-list
110127296|NCT01948245|Anticoagulants|anticoagulants|mesh-ancestor
110127297|NCT01948245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110127298|NCT01948245|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110127299|NCT01948245|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110127300|NCT01948245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110127301|NCT01948245|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110127302|NCT01948245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110127303|NCT01949805|Interferon alpha-2|interferon alpha-2|mesh-list
110127304|NCT01949805|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110127305|NCT01949805|Hydroxyurea|hydroxyurea|mesh-list
110127306|NCT01949805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110127307|NCT01949805|Antisickling Agents|antisickling agents|mesh-ancestor
110127308|NCT01949805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110127309|NCT01949805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110127310|NCT01949805|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110127311|NCT01949805|Antiviral Agents|antiviral agents|mesh-ancestor
110127312|NCT01949805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110127313|NCT01949818|Prednisone|prednisone|mesh-list
110127314|NCT01949818|Prednisolone|prednisolone|mesh-list
110127315|NCT01949818|Cyclophosphamide|cyclophosphamide|mesh-list
110127316|NCT01949818|Doxorubicin|doxorubicin|mesh-list
110127317|NCT01949818|Vincristine|vincristine|mesh-list
110127318|NCT01949818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110127319|NCT01949818|Immunologic Factors|immunologic factors|mesh-ancestor
110127320|NCT01949818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110127321|NCT01949818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110127322|NCT01949818|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110127323|NCT01949818|Alkylating Agents|alkylating agents|mesh-ancestor
110127324|NCT01949818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110127325|NCT01949818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110127326|NCT01949818|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110127327|NCT01949818|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110127328|NCT01949818|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110127329|NCT01949818|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110127330|NCT01949818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110127331|NCT01949818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110127332|NCT01949818|Glucocorticoids|glucocorticoids|mesh-ancestor
110127333|NCT01949818|Hormones|hormones|mesh-ancestor
110224705|NCT05999994|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110127334|NCT01949818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110127335|NCT01949818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110127336|NCT01949818|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110127337|NCT01949818|Tubulin Modulators|tubulin modulators|mesh-ancestor
110127338|NCT01949818|Antimitotic Agents|antimitotic agents|mesh-ancestor
110127339|NCT01949818|Mitosis Modulators|mitosis modulators|mesh-ancestor
110127340|NCT01949857|Vaccines|vaccines|mesh-list
110127341|NCT01949857|Immunologic Factors|immunologic factors|mesh-ancestor
110127342|NCT01949857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110127343|NCT01949909|Aluminum sulfate|aluminum sulfate|mesh-list
110127345|NCT01949909|Immunologic Factors|immunologic factors|mesh-ancestor
110127346|NCT01949909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110127347|NCT01949935|Mupirocin|mupirocin|mesh-list
110127348|NCT01949935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110127349|NCT01949935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110127350|NCT01949935|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110127351|NCT01949935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110127352|NCT01949935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110127353|NCT01949948|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
110127354|NCT01949948|Tenecteplase|tenecteplase|mesh-list
110127355|NCT01949948|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110127356|NCT01949948|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110127357|NCT01949948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110127358|NCT01950000|Fentanyl|fentanyl|mesh-list
110127359|NCT01950000|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110127360|NCT01950000|Narcotics|narcotics|mesh-ancestor
110127361|NCT01950000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110127362|NCT01950000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110127363|NCT01950000|Analgesics|analgesics|mesh-ancestor
110127364|NCT01950000|Sensory System Agents|sensory system agents|mesh-ancestor
110127365|NCT01950000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110127366|NCT01950000|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110127367|NCT01950000|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110127368|NCT01950000|Anesthetics, General|anesthetics, general|mesh-ancestor
110127369|NCT01950000|Anesthetics|anesthetics|mesh-ancestor
110127370|NCT01950182|Tamoxifen|tamoxifen|mesh-list
110127371|NCT01950182|Gemcitabine|gemcitabine|mesh-list
110127372|NCT01950182|Capecitabine|capecitabine|mesh-list
110127373|NCT01950182|Trastuzumab|trastuzumab|mesh-list
110127374|NCT01950182|Vinorelbine|vinorelbine|mesh-list
110127375|NCT01950182|Aromatase Inhibitors|aromatase inhibitors|mesh-list
110127376|NCT01950182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110127377|NCT01950182|Antimetabolites|antimetabolites|mesh-ancestor
110127378|NCT01950182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110127379|NCT01950182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110127380|NCT01950182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110127381|NCT01950182|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110127382|NCT01950182|Tubulin Modulators|tubulin modulators|mesh-ancestor
110127383|NCT01950182|Antimitotic Agents|antimitotic agents|mesh-ancestor
110127384|NCT01950182|Mitosis Modulators|mitosis modulators|mesh-ancestor
110127385|NCT01950182|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110127386|NCT01950182|Hormone Antagonists|hormone antagonists|mesh-ancestor
110127387|NCT01950182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110127388|NCT01950182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110127389|NCT01950182|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110127390|NCT01950182|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110127391|NCT01950182|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110127392|NCT01950182|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110127393|NCT01950182|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110127394|NCT01950182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110127395|NCT01950195|Ipilimumab|ipilimumab|mesh-list
110127396|NCT01950195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110127397|NCT01950195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110127398|NCT01950195|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110127399|NCT01950195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110127400|NCT01950416|Clopidogrel|clopidogrel|mesh-list
110127401|NCT01950416|Ticagrelor|ticagrelor|mesh-list
110127402|NCT01950416|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110127403|NCT01950416|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110127404|NCT01950416|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110127405|NCT01950416|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110127406|NCT01950416|Purinergic Agents|purinergic agents|mesh-ancestor
110127407|NCT01950416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110127408|NCT01950416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110127409|NCT01950416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110127410|NCT01950481|Ceritinib|ceritinib|mesh-list
110127411|NCT01950481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110127412|NCT01950481|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110127413|NCT01950481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110127414|NCT01950481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110127415|NCT01950494|Hand Sanitizers|hand sanitizers|mesh-list
110127416|NCT01950494|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110127417|NCT01950494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110127418|NCT01950494|Disinfectants|disinfectants|mesh-ancestor
110127419|NCT01950507|Fluconazole|fluconazole|mesh-list
110127420|NCT01950507|Voriconazole|voriconazole|mesh-list
110127422|NCT01950507|Budesonide|budesonide|mesh-list
110127423|NCT01950507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110127424|NCT01950507|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110127425|NCT01950507|Autonomic Agents|autonomic agents|mesh-ancestor
110127426|NCT01950507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110127427|NCT01950507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110127428|NCT01950507|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110127429|NCT01950507|Respiratory System Agents|respiratory system agents|mesh-ancestor
110127430|NCT01950507|Glucocorticoids|glucocorticoids|mesh-ancestor
110127431|NCT01950507|Hormones|hormones|mesh-ancestor
110127432|NCT01950507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110127433|NCT01950507|Antifungal Agents|antifungal agents|mesh-ancestor
110127434|NCT01950507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110127435|NCT01950507|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110127436|NCT01950507|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110127437|NCT01950507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110127438|NCT01950507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110127439|NCT01950507|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110127440|NCT01950507|Hormone Antagonists|hormone antagonists|mesh-ancestor
110127441|NCT01950507|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110127442|NCT01950507|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110127443|NCT01950507|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110127444|NCT01950546|Fluorides|fluorides|mesh-list
110127445|NCT01950546|Cariostatic Agents|cariostatic agents|mesh-ancestor
110127446|NCT01950546|Protective Agents|protective agents|mesh-ancestor
110127447|NCT01950546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110127448|NCT01950585|Hydroxyurea|hydroxyurea|mesh-list
110127449|NCT01950585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110127450|NCT01950585|Antisickling Agents|antisickling agents|mesh-ancestor
110127451|NCT01950585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110127452|NCT01950585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110127453|NCT01950585|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110127454|NCT01950611|Bortezomib|bortezomib|mesh-list
110127455|NCT01950611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110127457|NCT01950689|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
110127458|NCT01950689|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110127459|NCT01950689|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110127460|NCT01950689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110127461|NCT01950793|Triamcinolone|triamcinolone|mesh-list
110127462|NCT01950793|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110127463|NCT01950793|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110127464|NCT01950793|Hyaluronic Acid|hyaluronic acid|mesh-list
110127465|NCT01950793|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110127466|NCT01950793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110127467|NCT01950793|Glucocorticoids|glucocorticoids|mesh-ancestor
110127468|NCT01950793|Hormones|hormones|mesh-ancestor
110127469|NCT01950793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110127470|NCT01950793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110127471|NCT01950793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110127472|NCT01950793|Immunologic Factors|immunologic factors|mesh-ancestor
110127473|NCT01950793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110127474|NCT01950793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110127475|NCT01950793|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110127476|NCT01950793|Viscosupplements|viscosupplements|mesh-ancestor
110127477|NCT01950793|Protective Agents|protective agents|mesh-ancestor
110127478|NCT01950884|Ezetimibe|ezetimibe|mesh-list
110127479|NCT01950884|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110127480|NCT01950884|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110127481|NCT01950884|Antimetabolites|antimetabolites|mesh-ancestor
110127482|NCT01950884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110164680|NCT00020878|Celecoxib|celecoxib|mesh-list
110127483|NCT01950884|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110127484|NCT01950923|Sildenafil Citrate|sildenafil citrate|mesh-list
110127485|NCT01950923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110127486|NCT01950923|Vasodilator Agents|vasodilator agents|mesh-ancestor
110127487|NCT01950923|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110127488|NCT01950923|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110127489|NCT01950923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110127490|NCT01950923|Urological Agents|urological agents|mesh-ancestor
110127491|NCT01950949|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
110127492|NCT01950949|Plasma Substitutes|plasma substitutes|mesh-ancestor
110127493|NCT01950949|Blood Substitutes|blood substitutes|mesh-ancestor
110127494|NCT01951001|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
110127495|NCT01951001|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110127496|NCT01951027|Lenograstim|lenograstim|mesh-list
110127497|NCT01951027|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110127498|NCT01951027|Immunologic Factors|immunologic factors|mesh-ancestor
110127499|NCT01951027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110127500|NCT01951053|Citalopram|citalopram|mesh-list
110127501|NCT01951053|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110127502|NCT01951053|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110127503|NCT01951053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110127504|NCT01951053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110127505|NCT01951053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110127506|NCT01951053|Serotonin Agents|serotonin agents|mesh-ancestor
110127507|NCT01951053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110127508|NCT01951053|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110127509|NCT01951053|Antidepressive Agents|antidepressive agents|mesh-ancestor
110127510|NCT01951053|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110127512|NCT01951079|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110127513|NCT01951079|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110127514|NCT01951079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110127515|NCT01951079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110127516|NCT01951079|Protective Agents|protective agents|mesh-ancestor
110127517|NCT01951079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110127518|NCT01951144|Lorazepam|lorazepam|mesh-list
110127519|NCT01951144|PF-06372865|pf-06372865|mesh-list
110127520|NCT01951144|Anticonvulsants|anticonvulsants|mesh-ancestor
110127521|NCT01951144|Antiemetics|antiemetics|mesh-ancestor
110127522|NCT01951144|Autonomic Agents|autonomic agents|mesh-ancestor
110127523|NCT01951144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110127524|NCT01951144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110127525|NCT01951144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110127526|NCT01951144|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110127527|NCT01951144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110127528|NCT01951144|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110127529|NCT01951144|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110127530|NCT01951144|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110127531|NCT01951144|GABA Modulators|gaba modulators|mesh-ancestor
110127532|NCT01951144|GABA Agents|gaba agents|mesh-ancestor
110127533|NCT01951144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110127534|NCT01951144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110127535|NCT01951209|Rifaximin|rifaximin|mesh-list
110127536|NCT01951209|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110127537|NCT01951209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110127538|NCT01951209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110127539|NCT01951404|Allopurinol|allopurinol|mesh-list
110127540|NCT01951404|Antimetabolites|antimetabolites|mesh-ancestor
110368563|NCT04618107|Anesthetics|anesthetics|mesh-list
110127541|NCT01951404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110127542|NCT01951404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110127543|NCT01951404|Gout Suppressants|gout suppressants|mesh-ancestor
110127544|NCT01951404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110127545|NCT01951404|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110127546|NCT01951404|Antioxidants|antioxidants|mesh-ancestor
110127547|NCT01951404|Protective Agents|protective agents|mesh-ancestor
110127548|NCT01951404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110127549|NCT01951430|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110127550|NCT01951430|Cephalosporins|cephalosporins|mesh-list
110127551|NCT01951430|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
110127552|NCT01951430|Itraconazole|itraconazole|mesh-list
110127553|NCT01951430|Fluconazole|fluconazole|mesh-list
110127554|NCT01951430|Posaconazole|posaconazole|mesh-list
110224814|NCT05999383|Autonomic Agents|autonomic agents|mesh-ancestor
110127555|NCT01951430|Antifungal Agents|antifungal agents|mesh-list
110127556|NCT01951430|Clotrimazole|clotrimazole|mesh-list
110127558|NCT01951430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110127559|NCT01951430|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110127560|NCT01951430|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110127561|NCT01951430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110127562|NCT01951430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110127563|NCT01951430|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110127564|NCT01951430|Hormone Antagonists|hormone antagonists|mesh-ancestor
110127565|NCT01951430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110127566|NCT01951430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110127567|NCT01951430|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110127568|NCT01951430|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110127569|NCT01951430|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110127570|NCT01951430|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
110127571|NCT01951430|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110127572|NCT01951430|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110127573|NCT01951430|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110127574|NCT01951430|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110127575|NCT01951430|Antimalarials|antimalarials|mesh-ancestor
110127576|NCT01951482|Bevacizumab|bevacizumab|mesh-list
110127577|NCT01951482|Cisplatin|cisplatin|mesh-list
110127578|NCT01951482|Pemetrexed|pemetrexed|mesh-list
110127579|NCT01951482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110127580|NCT01951482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110127581|NCT01951482|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110127582|NCT01951482|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110127583|NCT01951482|Growth Substances|growth substances|mesh-ancestor
110127584|NCT01951482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110127585|NCT01951482|Growth Inhibitors|growth inhibitors|mesh-ancestor
110127586|NCT01951482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110127587|NCT01951482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110127588|NCT01951482|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110127589|NCT01951482|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110127590|NCT01951508|Methylphenidate|methylphenidate|mesh-list
110127591|NCT01951508|Modafinil|modafinil|mesh-list
110127592|NCT01951508|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110127593|NCT01951508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110127594|NCT01951508|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110127595|NCT01951508|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110127596|NCT01951508|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110127597|NCT01951508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110127598|NCT01951508|Dopamine Agents|dopamine agents|mesh-ancestor
110127599|NCT01951508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110127600|NCT01951508|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
110127601|NCT01951508|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110127602|NCT01951508|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110127603|NCT01951560|Valproic Acid|valproic acid|mesh-list
110127604|NCT01951560|Anticonvulsants|anticonvulsants|mesh-ancestor
110127605|NCT01951560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110127606|NCT01951560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110127607|NCT01951560|GABA Agents|gaba agents|mesh-ancestor
110127608|NCT01951560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110127609|NCT01951560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110127611|NCT01951560|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110127612|NCT01951560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110127613|NCT01951560|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110127614|NCT01951599|Osimertinib|osimertinib|mesh-list
110127615|NCT01951599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110127616|NCT01951599|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110127617|NCT01951599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110127618|NCT01951599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110127619|NCT01951677|Aluminum Hydroxide|aluminum hydroxide|mesh-list
110127620|NCT01951677|Immunologic Factors|immunologic factors|mesh-ancestor
110127621|NCT01951677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110127622|NCT01951677|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110127623|NCT01951677|Antacids|antacids|mesh-ancestor
110127624|NCT01951677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110127625|NCT01951677|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110127626|NCT01951729|Atropine|atropine|mesh-list
110127627|NCT01951729|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110127628|NCT01951729|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110127629|NCT01951729|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110127630|NCT01951729|Autonomic Agents|autonomic agents|mesh-ancestor
110127631|NCT01951729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110127632|NCT01951729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110127633|NCT01951729|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110127634|NCT01951729|Respiratory System Agents|respiratory system agents|mesh-ancestor
110127635|NCT01951729|Mydriatics|mydriatics|mesh-ancestor
110127636|NCT01951729|Parasympatholytics|parasympatholytics|mesh-ancestor
110127637|NCT01951729|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110127638|NCT01951729|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110127639|NCT01951729|Cholinergic Agents|cholinergic agents|mesh-ancestor
110127640|NCT01951729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110127641|NCT01951729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110127642|NCT01951846|Nintedanib|nintedanib|mesh-list
110127643|NCT01951846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110127644|NCT01951846|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110127645|NCT01951846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110127646|NCT01951846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110127647|NCT01951872|Caffeine|caffeine|mesh-list
110127648|NCT01951872|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110127649|NCT01951872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110127650|NCT01951872|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110127651|NCT01951872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110127652|NCT01951872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110127653|NCT01951872|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110127654|NCT01951872|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110127655|NCT01951872|Purinergic Agents|purinergic agents|mesh-ancestor
110127656|NCT01951872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110127658|NCT01951898|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110127659|NCT01951898|Respiratory System Agents|respiratory system agents|mesh-ancestor
110127660|NCT01951898|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110127661|NCT01951898|Hormone Antagonists|hormone antagonists|mesh-ancestor
110127662|NCT01951898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110127663|NCT01951898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110127664|NCT01951898|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110127665|NCT01951898|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110127666|NCT01951898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110127667|NCT01951911|Ketamine|ketamine|mesh-list
110127668|NCT01951911|Analgesics|analgesics|mesh-ancestor
110127669|NCT01951911|Sensory System Agents|sensory system agents|mesh-ancestor
110127670|NCT01951911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110127671|NCT01951911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110127672|NCT01951911|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110127673|NCT01951911|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110127674|NCT01951911|Anesthetics, General|anesthetics, general|mesh-ancestor
110127676|NCT01951911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110127677|NCT01951911|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110127678|NCT01951911|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110127679|NCT01951911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110127680|NCT01951911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110127681|NCT01951924|Immunoglobulins|immunoglobulins|mesh-list
110127682|NCT01951924|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110127683|NCT01951924|Antibodies|antibodies|mesh-list
110127684|NCT01951924|Immunoglobulin G|immunoglobulin g|mesh-list
110127685|NCT01951924|Immunologic Factors|immunologic factors|mesh-ancestor
110127686|NCT01951924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110127687|NCT01952314|Naftopidil|naftopidil|mesh-list
110127688|NCT01952314|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110127689|NCT01952314|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110127690|NCT01952314|Adrenergic Agents|adrenergic agents|mesh-ancestor
110127691|NCT01952314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110127692|NCT01952314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110127693|NCT01952314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110127694|NCT01952314|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110127695|NCT01952314|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110127696|NCT01952314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110127697|NCT01952314|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110127698|NCT01952314|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110127699|NCT01952561|Dapivirine|dapivirine|mesh-list
110127700|NCT01952561|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110127701|NCT01952561|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110127703|NCT01952561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110127704|NCT01952626|Ondansetron|ondansetron|mesh-list
110127705|NCT01952626|Palonosetron|palonosetron|mesh-list
110127706|NCT01952626|Antiemetics|antiemetics|mesh-ancestor
110127707|NCT01952626|Autonomic Agents|autonomic agents|mesh-ancestor
110127708|NCT01952626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110127709|NCT01952626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110127710|NCT01952626|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110127711|NCT01952626|Antipruritics|antipruritics|mesh-ancestor
110127712|NCT01952626|Dermatologic Agents|dermatologic agents|mesh-ancestor
110127713|NCT01952626|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110127714|NCT01952626|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110127715|NCT01952626|Serotonin Agents|serotonin agents|mesh-ancestor
110127716|NCT01952626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110127717|NCT01952626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110127718|NCT01952652|Naproxen|naproxen|mesh-list
110127719|NCT01952652|Codeine|codeine|mesh-list
110127720|NCT01952652|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110127721|NCT01952652|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110127722|NCT01952652|Analgesics|analgesics|mesh-ancestor
110127723|NCT01952652|Sensory System Agents|sensory system agents|mesh-ancestor
110127724|NCT01952652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110127725|NCT01952652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110127726|NCT01952652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110127727|NCT01952652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110127728|NCT01952652|Gout Suppressants|gout suppressants|mesh-ancestor
110127729|NCT01952652|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110127730|NCT01952652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110127731|NCT01952652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110127732|NCT01952652|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110127733|NCT01952652|Narcotics|narcotics|mesh-ancestor
110127734|NCT01952652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110127735|NCT01952652|Antitussive Agents|antitussive agents|mesh-ancestor
110127736|NCT01952652|Respiratory System Agents|respiratory system agents|mesh-ancestor
110127737|NCT01952756|Cilostazol|cilostazol|mesh-list
110127738|NCT01952756|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110127739|NCT01952756|Autonomic Agents|autonomic agents|mesh-ancestor
110127740|NCT01952756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110127741|NCT01952756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110127742|NCT01952756|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110127743|NCT01952756|Respiratory System Agents|respiratory system agents|mesh-ancestor
110127744|NCT01952756|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110127745|NCT01952756|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110127746|NCT01952756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110127747|NCT01952756|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110127748|NCT01952756|Vasodilator Agents|vasodilator agents|mesh-ancestor
110127749|NCT01952756|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110127750|NCT01952756|Protective Agents|protective agents|mesh-ancestor
110127751|NCT01952756|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110127752|NCT01952756|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110127753|NCT01952756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110127754|NCT01952769|Pidilizumab|pidilizumab|mesh-list
110127755|NCT01952769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110127756|NCT01952769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110127758|NCT05876598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110127759|NCT05876585|Ondansetron|ondansetron|mesh-list
110127760|NCT05876585|Metoclopramide|metoclopramide|mesh-list
110127761|NCT05876585|Antiemetics|antiemetics|mesh-ancestor
110127762|NCT05876585|Autonomic Agents|autonomic agents|mesh-ancestor
110127763|NCT05876585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110127764|NCT05876585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110127765|NCT05876585|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110127766|NCT05876585|Antipruritics|antipruritics|mesh-ancestor
110127767|NCT05876585|Dermatologic Agents|dermatologic agents|mesh-ancestor
110127768|NCT05876585|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110127769|NCT05876585|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110224893|NCT05998642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110127771|NCT05876585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110127772|NCT05876585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110127773|NCT05876585|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110127774|NCT05876585|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110127775|NCT05876585|Dopamine Agents|dopamine agents|mesh-ancestor
110127776|NCT05876481|Psilocybin|psilocybin|mesh-list
110127777|NCT05876481|Hallucinogens|hallucinogens|mesh-ancestor
110127778|NCT05876481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110127779|NCT05876481|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110127780|NCT05876390|Acetaminophen|acetaminophen|mesh-list
110127781|NCT05876390|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110127782|NCT05876390|Analgesics|analgesics|mesh-ancestor
110127783|NCT05876390|Sensory System Agents|sensory system agents|mesh-ancestor
110127784|NCT05876390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110127785|NCT05876390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110127786|NCT05876390|Antipyretics|antipyretics|mesh-ancestor
110127787|NCT05876195|Aluminum Hydroxide|aluminum hydroxide|mesh-list
110127788|NCT05876195|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
110127789|NCT05876195|Freund's Adjuvant|freund's adjuvant|mesh-list
110127790|NCT05876195|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
110127791|NCT05876195|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110127792|NCT05876195|Immunologic Factors|immunologic factors|mesh-ancestor
110127793|NCT05876195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110127794|NCT05876195|Antacids|antacids|mesh-ancestor
110127795|NCT05876195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110127796|NCT05876195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110127797|NCT05876169|Salicylic Acid|salicylic acid|mesh-list
110127798|NCT05876169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110127799|NCT05876169|Antifungal Agents|antifungal agents|mesh-ancestor
110127800|NCT05876169|Keratolytic Agents|keratolytic agents|mesh-ancestor
110127801|NCT05876169|Dermatologic Agents|dermatologic agents|mesh-ancestor
110127802|NCT05876039|Remifentanil|remifentanil|mesh-list
110127803|NCT05876039|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110127804|NCT05876039|Narcotics|narcotics|mesh-ancestor
110127805|NCT05876039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110127806|NCT05876039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110127807|NCT05876039|Analgesics|analgesics|mesh-ancestor
110127808|NCT05876039|Sensory System Agents|sensory system agents|mesh-ancestor
110127809|NCT05876039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110127810|NCT05875948|Terlipressin|terlipressin|mesh-list
110127811|NCT05875948|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110127812|NCT05875948|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110127813|NCT05875714|Apremilast|apremilast|mesh-list
110127814|NCT05875714|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110127815|NCT05875714|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110127816|NCT05875714|Analgesics|analgesics|mesh-ancestor
110127817|NCT05875714|Sensory System Agents|sensory system agents|mesh-ancestor
110127818|NCT05875714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110127819|NCT05875714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110127820|NCT05875714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110127821|NCT05875714|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110127822|NCT05875714|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
110127823|NCT05875714|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110127824|NCT05875714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110127825|NCT05875714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110127826|NCT05875701|Vaccines|vaccines|mesh-list
110127827|NCT05875701|Immunologic Factors|immunologic factors|mesh-ancestor
110127828|NCT05875701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110127829|NCT05875675|Pioglitazone|pioglitazone|mesh-list
110127830|NCT05875675|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110127831|NCT05875675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110127832|NCT05875610|Gabapentin|gabapentin|mesh-list
110127833|NCT05875610|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
110127834|NCT05875610|Analgesics|analgesics|mesh-ancestor
110127835|NCT05875610|Sensory System Agents|sensory system agents|mesh-ancestor
110127836|NCT05875610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110127837|NCT05875610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110127838|NCT05875610|Anticonvulsants|anticonvulsants|mesh-ancestor
110127839|NCT05875610|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110127840|NCT05875610|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110127841|NCT05875610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110127842|NCT05875610|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110127843|NCT05875610|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110127844|NCT05875610|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110127845|NCT05875610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110127846|NCT05875610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110127847|NCT05875610|Antimanic Agents|antimanic agents|mesh-ancestor
110127848|NCT05875610|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110127849|NCT05875610|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110127850|NCT05875610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110127851|NCT05875610|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110127852|NCT05875610|Antidepressive Agents|antidepressive agents|mesh-ancestor
110127854|NCT05875571|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110127855|NCT05875571|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110127857|NCT05875571|Sensory System Agents|sensory system agents|mesh-ancestor
110127858|NCT05875571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110127859|NCT05875571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110127860|NCT05875571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110127861|NCT05875571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110127862|NCT05875571|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110127863|NCT05875571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110127864|NCT05875571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110127866|NCT05875519|Mepivacaine|mepivacaine|mesh-list
110127867|NCT05875519|Anesthetics|anesthetics|mesh-ancestor
110127868|NCT05875519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110127869|NCT05875519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110127870|NCT05875519|Anesthetics, Local|anesthetics, local|mesh-ancestor
110127871|NCT05875519|Sensory System Agents|sensory system agents|mesh-ancestor
110127872|NCT05875519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110127873|NCT05875519|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110127874|NCT05875428|Mitoxantrone|mitoxantrone|mesh-list
110127875|NCT05875428|Analgesics|analgesics|mesh-ancestor
110127876|NCT05875428|Sensory System Agents|sensory system agents|mesh-ancestor
110127877|NCT05875428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110127878|NCT05875428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110127879|NCT05875428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110127880|NCT05875428|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110127881|NCT05875428|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110127882|NCT05875428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110127883|NCT05875428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110127884|NCT05875285|Methotrexate|methotrexate|mesh-list
110127885|NCT05875285|Coal Tar|coal tar|mesh-list
110127886|NCT05875285|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110127887|NCT05875285|Abortifacient Agents|abortifacient agents|mesh-ancestor
110127888|NCT05875285|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110224925|NCT05998551|Narcotics|narcotics|mesh-ancestor
110127889|NCT05875285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110127890|NCT05875285|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110127892|NCT05875285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110127894|NCT05875285|Dermatologic Agents|dermatologic agents|mesh-ancestor
110127895|NCT05875285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110127896|NCT05875285|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110127897|NCT05875285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110127898|NCT05875285|Immunologic Factors|immunologic factors|mesh-ancestor
110127899|NCT05875285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110127900|NCT05875285|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110127901|NCT05875285|Keratolytic Agents|keratolytic agents|mesh-ancestor
110127902|NCT05874921|Mitomycins|mitomycins|mesh-list
110127903|NCT05874921|Mitomycin|mitomycin|mesh-list
110127904|NCT05874921|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110127905|NCT05874921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110127906|NCT05874921|Alkylating Agents|alkylating agents|mesh-ancestor
110127907|NCT05874921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110127908|NCT05874921|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110127909|NCT05874921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110127911|NCT05874882|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110127912|NCT05874882|Resveratrol|resveratrol|mesh-list
110127913|NCT05874882|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110127914|NCT05874882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110127915|NCT05874882|Disinfectants|disinfectants|mesh-ancestor
110127916|NCT05874882|Dermatologic Agents|dermatologic agents|mesh-ancestor
110127917|NCT05874882|Antioxidants|antioxidants|mesh-ancestor
110127918|NCT05874882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110127919|NCT05874882|Protective Agents|protective agents|mesh-ancestor
110127920|NCT05874882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110127921|NCT05874882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110127922|NCT05874882|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110127923|NCT05874778|Prednisone|prednisone|mesh-list
110127924|NCT05874778|Cyclophosphamide|cyclophosphamide|mesh-list
110127925|NCT05874778|Vincristine|vincristine|mesh-list
110127926|NCT05874778|Rituximab|rituximab|mesh-list
110127927|NCT05874778|Doxorubicin|doxorubicin|mesh-list
110127928|NCT05874778|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110127929|NCT05874778|Immunologic Factors|immunologic factors|mesh-ancestor
110127930|NCT05874778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110127931|NCT05874778|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110127932|NCT05874778|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110127933|NCT05874778|Alkylating Agents|alkylating agents|mesh-ancestor
110127934|NCT05874778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110127935|NCT05874778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110127936|NCT05874778|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110127937|NCT05874778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110127938|NCT05874778|Glucocorticoids|glucocorticoids|mesh-ancestor
110127939|NCT05874778|Hormones|hormones|mesh-ancestor
110127940|NCT05874778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110127941|NCT05874778|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110127942|NCT05874778|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110127943|NCT05874778|Tubulin Modulators|tubulin modulators|mesh-ancestor
110127944|NCT05874778|Antimitotic Agents|antimitotic agents|mesh-ancestor
110127945|NCT05874778|Mitosis Modulators|mitosis modulators|mesh-ancestor
110127946|NCT05874778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110127947|NCT05874778|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110127948|NCT05874778|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110127949|NCT05874778|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110127950|NCT05874778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110127952|NCT05874700|Glycine|glycine|mesh-list
110127953|NCT05874700|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110127954|NCT05874700|Protease Inhibitors|protease inhibitors|mesh-ancestor
110127955|NCT05874700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110127956|NCT05874700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110127957|NCT05874700|Glycine Agents|glycine agents|mesh-ancestor
110127958|NCT05874700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110127959|NCT05874700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110127960|NCT05874674|Nafamostat|nafamostat|mesh-list
110127961|NCT05874674|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110127962|NCT05874674|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110127963|NCT05874674|Analgesics|analgesics|mesh-ancestor
110127964|NCT05874674|Sensory System Agents|sensory system agents|mesh-ancestor
110127965|NCT05874674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110127966|NCT05874674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110127967|NCT05874674|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110127968|NCT05874674|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110127969|NCT05874674|Anticoagulants|anticoagulants|mesh-ancestor
110127970|NCT05874674|Protease Inhibitors|protease inhibitors|mesh-ancestor
110127971|NCT05874674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110127972|NCT05874674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110127973|NCT05874674|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
110127974|NCT05874674|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110127975|NCT05874674|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
110127976|NCT05874674|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110127977|NCT05874674|Immunologic Factors|immunologic factors|mesh-ancestor
110127978|NCT05874583|Tranexamic Acid|tranexamic acid|mesh-list
110127979|NCT05874583|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110127980|NCT05874583|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110127981|NCT05874583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110127982|NCT05874583|Hemostatics|hemostatics|mesh-ancestor
110127983|NCT05874583|Coagulants|coagulants|mesh-ancestor
110127984|NCT05874544|Amoxicillin|amoxicillin|mesh-list
110127985|NCT05874544|Metronidazole|metronidazole|mesh-list
110127986|NCT05874544|Tetracycline|tetracycline|mesh-list
110127987|NCT05874544|Rifabutin|rifabutin|mesh-list
110127988|NCT05874544|Potassium Citrate|potassium citrate|mesh-list
110127989|NCT05874544|Bismuth|bismuth|mesh-list
110127990|NCT05874544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110127991|NCT05874544|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110127992|NCT05874544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110127993|NCT05874544|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110127994|NCT05874544|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110127995|NCT05874544|Antacids|antacids|mesh-ancestor
110127996|NCT05874544|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110127997|NCT05874544|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110127998|NCT05874544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110127999|NCT05874544|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110128000|NCT05874544|Antitubercular Agents|antitubercular agents|mesh-ancestor
110128001|NCT05874544|Diuretics|diuretics|mesh-ancestor
110128002|NCT05874544|Natriuretic Agents|natriuretic agents|mesh-ancestor
110128003|NCT05874544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110128004|NCT05874544|Expectorants|expectorants|mesh-ancestor
110128005|NCT05874544|Respiratory System Agents|respiratory system agents|mesh-ancestor
110128006|NCT05874518|Letrozole|letrozole|mesh-list
110128007|NCT05874518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110128008|NCT05874518|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110128009|NCT05874518|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110128010|NCT05874518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110224950|NCT05998421|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110128011|NCT05874518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110128012|NCT05874518|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110128013|NCT05874518|Hormone Antagonists|hormone antagonists|mesh-ancestor
110128014|NCT05874518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110128015|NCT05874518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110128016|NCT05874505|Adalimumab|adalimumab|mesh-list
110128017|NCT05874505|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110128018|NCT05874505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110128019|NCT05874505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110128020|NCT05872789|Diazepam|diazepam|mesh-list
110128021|NCT05872789|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110128022|NCT05872789|Anticonvulsants|anticonvulsants|mesh-ancestor
110128023|NCT05872789|Antiemetics|antiemetics|mesh-ancestor
110128024|NCT05872789|Autonomic Agents|autonomic agents|mesh-ancestor
110128025|NCT05872789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110128026|NCT05872789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110128027|NCT05872789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110128028|NCT05872789|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110128029|NCT05872789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110128030|NCT05872789|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110128031|NCT05872789|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110128032|NCT05872789|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110164798|NCT00021463|Dideoxynucleosides|dideoxynucleosides|mesh-list
110128033|NCT05872789|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110128034|NCT05872789|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110128035|NCT05872789|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110128036|NCT05872789|Anesthetics, General|anesthetics, general|mesh-ancestor
110128037|NCT05872789|Anesthetics|anesthetics|mesh-ancestor
110128038|NCT05872789|GABA Modulators|gaba modulators|mesh-ancestor
110128039|NCT05872789|GABA Agents|gaba agents|mesh-ancestor
110128040|NCT05872789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110128041|NCT05872789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110128042|NCT05872412|Paclitaxel|paclitaxel|mesh-list
110128043|NCT05872412|Cyclophosphamide|cyclophosphamide|mesh-list
110128044|NCT05872412|Carboplatin|carboplatin|mesh-list
110128045|NCT05872412|Doxorubicin|doxorubicin|mesh-list
110128046|NCT05872412|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110128047|NCT05872412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110128048|NCT05872412|Tubulin Modulators|tubulin modulators|mesh-ancestor
110128049|NCT05872412|Antimitotic Agents|antimitotic agents|mesh-ancestor
110128050|NCT05872412|Mitosis Modulators|mitosis modulators|mesh-ancestor
110128051|NCT05872412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110128052|NCT05872412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110128053|NCT05872412|Immunologic Factors|immunologic factors|mesh-ancestor
110128054|NCT05872412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110128055|NCT05872412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110128056|NCT05872412|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110128057|NCT05872412|Alkylating Agents|alkylating agents|mesh-ancestor
110128058|NCT05872412|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110128059|NCT05872412|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110128060|NCT05872412|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110128061|NCT05872412|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110128062|NCT05872412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110128063|NCT05871476|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110128064|NCT05871476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110128066|NCT05860439|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
110128067|NCT05860439|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110128068|NCT05823675|Methylprednisolone|methylprednisolone|mesh-list
110128069|NCT05823675|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110250964|NCT00141141|Simvastatin|simvastatin|mesh-list
110128070|NCT05823675|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110128071|NCT05823675|Prednisolone|prednisolone|mesh-list
110128072|NCT05823675|Prednisolone acetate|prednisolone acetate|mesh-list
110128073|NCT05823675|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110128074|NCT05823675|Prednisolone phosphate|prednisolone phosphate|mesh-list
110128075|NCT05823675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110128076|NCT05823675|Antiemetics|antiemetics|mesh-ancestor
110128077|NCT05823675|Autonomic Agents|autonomic agents|mesh-ancestor
110128078|NCT05823675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110128079|NCT05823675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110128080|NCT05823675|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110128081|NCT05823675|Glucocorticoids|glucocorticoids|mesh-ancestor
110128083|NCT05823675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110128084|NCT05823675|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110128085|NCT05823675|Protective Agents|protective agents|mesh-ancestor
110128086|NCT05823675|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110128087|NCT05823675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110128089|NCT05874869|Artenimol|artenimol|mesh-list
110128090|NCT05874869|Antimalarials|antimalarials|mesh-ancestor
110128091|NCT05874869|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110128092|NCT05874869|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110128093|NCT05874869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110128094|NCT05818735|Escitalopram|escitalopram|mesh-list
110128095|NCT05818735|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110052993|NCT01483729|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110128096|NCT05818735|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110128097|NCT05818735|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110128098|NCT05818735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110128099|NCT05818735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110128100|NCT05818735|Serotonin Agents|serotonin agents|mesh-ancestor
110128101|NCT05818735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110128102|NCT05799820|Bevacizumab|bevacizumab|mesh-list
110128103|NCT05799820|Capecitabine|capecitabine|mesh-list
110128104|NCT05799820|Oxaliplatin|oxaliplatin|mesh-list
110224986|NCT05998096|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110128105|NCT05799820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110128106|NCT05799820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110128118|NCT05790161|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110128120|NCT05790161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110128121|NCT05790161|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110128122|NCT05790161|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110128123|NCT05790161|Purinergic Agents|purinergic agents|mesh-ancestor
110128124|NCT05790161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110128125|NCT05786040|Rituximab|rituximab|mesh-list
110128126|NCT05786040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110128127|NCT05786040|Antibodies|antibodies|mesh-list
110128128|NCT05786040|Immunoglobulins|immunoglobulins|mesh-list
110128129|NCT05786040|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110128130|NCT05786040|Immunologic Factors|immunologic factors|mesh-ancestor
110128131|NCT05786040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110128132|NCT05786040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110128133|NCT05786040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110128134|NCT05775809|Serotonin|serotonin|mesh-list
110128135|NCT05775809|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
110128136|NCT05775809|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110128137|NCT05775809|Serotonin Agents|serotonin agents|mesh-ancestor
110128138|NCT05775809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110128155|NCT05701527|Pembrolizumab|pembrolizumab|mesh-list
110128156|NCT05701527|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110128157|NCT05701527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110128158|NCT05701527|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110128159|NCT05701527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110128160|NCT05698407|Sufentanil|sufentanil|mesh-list
110128161|NCT05698407|Dexmedetomidine|dexmedetomidine|mesh-list
110128163|NCT05698407|Ropivacaine|ropivacaine|mesh-list
110128164|NCT05698407|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110128165|NCT05698407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110128166|NCT05698407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110128167|NCT05698407|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110128168|NCT05698407|Analgesics|analgesics|mesh-ancestor
110128169|NCT05698407|Sensory System Agents|sensory system agents|mesh-ancestor
110128170|NCT05698407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110128171|NCT05698407|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110128172|NCT05698407|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110128173|NCT05698407|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110128174|NCT05698407|Adrenergic Agents|adrenergic agents|mesh-ancestor
110128175|NCT05698407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110128176|NCT05698407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110128177|NCT05698407|Anesthetics, Local|anesthetics, local|mesh-ancestor
110128178|NCT05698407|Anesthetics|anesthetics|mesh-ancestor
110128179|NCT05698407|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110128180|NCT05698407|Narcotics|narcotics|mesh-ancestor
110128181|NCT05698407|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110128182|NCT05698407|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110128183|NCT05698407|Anesthetics, General|anesthetics, general|mesh-ancestor
110128184|NCT05671315|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110128185|NCT05671315|Antiviral Agents|antiviral agents|mesh-ancestor
110128186|NCT05671315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110128187|NCT05641467|Methamphetamine|methamphetamine|mesh-list
110128188|NCT05641467|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110128189|NCT05641467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110128190|NCT05641467|Sympathomimetics|sympathomimetics|mesh-ancestor
110128191|NCT05641467|Autonomic Agents|autonomic agents|mesh-ancestor
110128192|NCT05641467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110128193|NCT05641467|Dopamine Agents|dopamine agents|mesh-ancestor
110128194|NCT05641467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110128195|NCT05641467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110128196|NCT05641467|Adrenergic Agents|adrenergic agents|mesh-ancestor
110128197|NCT05641467|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110128198|NCT05641467|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110128199|NCT05641467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110128207|NCT05574712|Abiraterone Acetate|abiraterone acetate|mesh-list
110128208|NCT05574712|Belzutifan|belzutifan|mesh-list
110128209|NCT05574712|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110128210|NCT05574712|Fertility Agents|fertility agents|mesh-ancestor
110128211|NCT05574712|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110128212|NCT05574712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110128219|NCT05574712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110128220|NCT05574712|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110128222|NCT05510063|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110128223|NCT05510063|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110128224|NCT05510063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110128225|NCT05508815|Methotrexate|methotrexate|mesh-list
110128226|NCT05508815|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110128227|NCT05508815|Abortifacient Agents|abortifacient agents|mesh-ancestor
110128228|NCT05508815|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110128229|NCT05508815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110128230|NCT05508815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110128231|NCT05508815|Antimetabolites|antimetabolites|mesh-ancestor
110128232|NCT05508815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110128233|NCT05508815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110128234|NCT05508815|Dermatologic Agents|dermatologic agents|mesh-ancestor
110128235|NCT05508815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110128236|NCT05508815|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110128237|NCT05508815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110128238|NCT05508815|Immunologic Factors|immunologic factors|mesh-ancestor
110128239|NCT05508815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110128240|NCT05508815|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110128241|NCT05500508|Eflornithine|eflornithine|mesh-list
110128242|NCT05500508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110128243|NCT05500508|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
110128244|NCT05500508|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110128245|NCT05500508|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110128246|NCT05500508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110128247|NCT05500508|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
110128248|NCT05500508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110128249|NCT05500508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110128250|NCT05463861|Lemborexant|lemborexant|mesh-list
110128251|NCT05463861|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
110128252|NCT05463861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110128253|NCT05463861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110128254|NCT05463861|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110128255|NCT05463861|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110225034|NCT05997524|Antimetabolites|antimetabolites|mesh-ancestor
110225035|NCT05997524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110128258|NCT05346588|Propofol|propofol|mesh-list
110128259|NCT05346588|Anesthetics|anesthetics|mesh-list
110128260|NCT05346588|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110128261|NCT05346588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110128262|NCT05346588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110128263|NCT05346588|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110128264|NCT05346588|Anesthetics, General|anesthetics, general|mesh-ancestor
110128272|NCT05323708|Denosumab|denosumab|mesh-list
110128273|NCT05323708|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110128274|NCT05323708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110128275|NCT05312645|Diclofenac|diclofenac|mesh-list
110128276|NCT05312645|Petrolatum|petrolatum|mesh-list
110128277|NCT05312645|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110128278|NCT05312645|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110128279|NCT05312645|Analgesics|analgesics|mesh-ancestor
110128280|NCT05312645|Sensory System Agents|sensory system agents|mesh-ancestor
110128281|NCT05312645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110128282|NCT05312645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110128283|NCT05312645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110128284|NCT05312645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110128285|NCT05312645|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110128286|NCT05312645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110128287|NCT05312645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110128289|NCT05312645|Dermatologic Agents|dermatologic agents|mesh-ancestor
110128290|NCT05285566|Lidocaine|lidocaine|mesh-list
110128291|NCT05285566|Bupivacaine|bupivacaine|mesh-list
110128292|NCT05285566|Anesthetics, Local|anesthetics, local|mesh-ancestor
110128293|NCT05285566|Anesthetics|anesthetics|mesh-ancestor
110128294|NCT05285566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110128295|NCT05285566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110128296|NCT05285566|Sensory System Agents|sensory system agents|mesh-ancestor
110128297|NCT05285566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110128298|NCT05285566|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110128299|NCT05285566|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110128300|NCT05285566|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110128301|NCT05285566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110128302|NCT05285566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110128304|NCT05184712|Pemetrexed|pemetrexed|mesh-list
110128305|NCT05184712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110128306|NCT05184712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110128307|NCT05184712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110128308|NCT05184712|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110128309|NCT05184712|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110128310|NCT05129722|Empagliflozin|empagliflozin|mesh-list
110128311|NCT05129722|Eplerenone|eplerenone|mesh-list
110128312|NCT05129722|Bumetanide|bumetanide|mesh-list
110128313|NCT05129722|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110128314|NCT05129722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110128315|NCT05129722|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110128316|NCT05129722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110128317|NCT05129722|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110128318|NCT05129722|Hormone Antagonists|hormone antagonists|mesh-ancestor
110128319|NCT05129722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110128320|NCT05129722|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110128321|NCT05129722|Diuretics|diuretics|mesh-ancestor
110128322|NCT05129722|Natriuretic Agents|natriuretic agents|mesh-ancestor
110128323|NCT05129722|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110128324|NCT05129722|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110128325|NCT05129722|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110128326|NCT05044962|Rilpivirine|rilpivirine|mesh-list
110128327|NCT05044962|Cabotegravir|cabotegravir|mesh-list
110128328|NCT05044962|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
110128329|NCT05044962|Levonorgestrel|levonorgestrel|mesh-list
110128330|NCT05044962|Medroxyprogesterone|medroxyprogesterone|mesh-list
110128331|NCT05044962|Etonogestrel|etonogestrel|mesh-list
110128332|NCT05044962|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110128333|NCT05044962|Contraceptive Agents|contraceptive agents|mesh-ancestor
110128334|NCT05044962|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110128335|NCT05044962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110128336|NCT05044962|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110128337|NCT05044962|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110128338|NCT05044962|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110128339|NCT05044962|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110128340|NCT05044962|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110128341|NCT05044962|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110128342|NCT05044962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110128343|NCT05044962|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110128344|NCT05044962|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110128345|NCT05044962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110128346|NCT05044962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110128347|NCT05044962|Antiviral Agents|antiviral agents|mesh-ancestor
110128348|NCT05044962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110128349|NCT05044962|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110128350|NCT05044962|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110128351|NCT05044962|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110128352|NCT05044962|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110128353|NCT05041101|Halichondrin B|halichondrin b|mesh-list
110128354|NCT05041101|Tubulin Modulators|tubulin modulators|mesh-ancestor
110128355|NCT05041101|Antimitotic Agents|antimitotic agents|mesh-ancestor
110128356|NCT05041101|Mitosis Modulators|mitosis modulators|mesh-ancestor
110128357|NCT05041101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110128358|NCT05041101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110128359|NCT05027919|Lofexidine|lofexidine|mesh-list
110128360|NCT05027919|Clonidine|clonidine|mesh-list
110128361|NCT05027919|Morphine|morphine|mesh-list
110128362|NCT05027919|Naloxone|naloxone|mesh-list
110128363|NCT05027919|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110128364|NCT05027919|Narcotics|narcotics|mesh-ancestor
110128365|NCT05027919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110128366|NCT05027919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110128368|NCT05027919|Sensory System Agents|sensory system agents|mesh-ancestor
110128369|NCT05027919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110128370|NCT05027919|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110128371|NCT05027919|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110128372|NCT05027919|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110128373|NCT05027919|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110128374|NCT05027919|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110128376|NCT05027919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110128377|NCT05027919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110128378|NCT05027919|Sympatholytics|sympatholytics|mesh-ancestor
110128379|NCT05027919|Autonomic Agents|autonomic agents|mesh-ancestor
110128380|NCT04994431|Tamsulosin|tamsulosin|mesh-list
110128381|NCT04994431|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110128382|NCT04994431|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110128383|NCT04994431|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110128384|NCT04994431|Adrenergic Agents|adrenergic agents|mesh-ancestor
110128385|NCT04994431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110128386|NCT04994431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110128388|NCT04994431|Urological Agents|urological agents|mesh-ancestor
110128389|NCT04985760|Aluminum Hydroxide|aluminum hydroxide|mesh-list
110128390|NCT04985760|Vaccines|vaccines|mesh-list
110128391|NCT04985760|Aluminum sulfate|aluminum sulfate|mesh-list
110128392|NCT04985760|Immunologic Factors|immunologic factors|mesh-ancestor
110128393|NCT04985760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110128394|NCT04985760|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110128395|NCT04985760|Antacids|antacids|mesh-ancestor
110128396|NCT04985760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110128397|NCT04985760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110128398|NCT04966546|Memantine|memantine|mesh-list
110128399|NCT04966546|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110128400|NCT04966546|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110128401|NCT04966546|Dopamine Agents|dopamine agents|mesh-ancestor
110128402|NCT04966546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110128403|NCT04966546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110128404|NCT04966546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110128405|NCT04966546|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110128406|NCT04966546|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110128407|NCT04912063|Azacitidine|azacitidine|mesh-list
110128408|NCT04912063|Venetoclax|venetoclax|mesh-list
110128409|NCT04912063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110128410|NCT04912063|Antimetabolites|antimetabolites|mesh-ancestor
110128411|NCT04912063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110128412|NCT04912063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110128413|NCT04912063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110128414|NCT04853446|Dexamethasone|dexamethasone|mesh-list
110128415|NCT04853446|Dexamethasone acetate|dexamethasone acetate|mesh-list
110128416|NCT04853446|BB 1101|bb 1101|mesh-list
110128417|NCT04853446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110128418|NCT04853446|Antiemetics|antiemetics|mesh-ancestor
110128419|NCT04853446|Autonomic Agents|autonomic agents|mesh-ancestor
110128420|NCT04853446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110128421|NCT04853446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110128422|NCT04853446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110128423|NCT04853446|Glucocorticoids|glucocorticoids|mesh-ancestor
110128424|NCT04853446|Hormones|hormones|mesh-ancestor
110128425|NCT04853446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110128426|NCT04853446|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110128427|NCT04853446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110128428|NCT04853446|Protease Inhibitors|protease inhibitors|mesh-ancestor
110128429|NCT04853446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110128430|NCT04853446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110128431|NCT04846231|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110128432|NCT04846231|Red yeast rice|red yeast rice|mesh-list
110128433|NCT04846231|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110128434|NCT04846231|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110128436|NCT04846231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110128437|NCT04846231|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110225083|NCT05997303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110128438|NCT04846231|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110128439|NCT04846231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110128440|NCT04756401|Dexamethasone|dexamethasone|mesh-list
110128441|NCT04756401|Dexamethasone acetate|dexamethasone acetate|mesh-list
110128442|NCT04756401|Daratumumab|daratumumab|mesh-list
110128444|NCT04756401|BB 1101|bb 1101|mesh-list
110128445|NCT04756401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110128446|NCT04756401|Antiemetics|antiemetics|mesh-ancestor
110128447|NCT04756401|Autonomic Agents|autonomic agents|mesh-ancestor
110128448|NCT04756401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110128449|NCT04756401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110128450|NCT04756401|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110128452|NCT04756401|Hormones|hormones|mesh-ancestor
110128453|NCT04756401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110128454|NCT04756401|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110128455|NCT04756401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110128456|NCT04756401|Protease Inhibitors|protease inhibitors|mesh-ancestor
110128457|NCT04756401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110128458|NCT04756401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110128459|NCT04756401|Dermatologic Agents|dermatologic agents|mesh-ancestor
110128460|NCT04705428|Fluorides|fluorides|mesh-list
110128461|NCT04705428|Cariostatic Agents|cariostatic agents|mesh-ancestor
110128462|NCT04705428|Protective Agents|protective agents|mesh-ancestor
110128463|NCT04705428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110128464|NCT04664933|Neuroprotective Agents|neuroprotective agents|mesh-list
110128465|NCT04664933|Protective Agents|protective agents|mesh-ancestor
110128466|NCT04664933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110128467|NCT04660760|Trifluridine|trifluridine|mesh-list
110128468|NCT04660760|Paclitaxel|paclitaxel|mesh-list
110128469|NCT04660760|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110128470|NCT04660760|Ramucirumab|ramucirumab|mesh-list
110128471|NCT04660760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110128472|NCT04660760|Antibodies|antibodies|mesh-list
110128473|NCT04660760|Immunoglobulins|immunoglobulins|mesh-list
110128474|NCT04660760|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110128475|NCT04660760|Lexatumumab|lexatumumab|mesh-list
110128476|NCT04660760|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110128477|NCT04660760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110128478|NCT04660760|Tubulin Modulators|tubulin modulators|mesh-ancestor
110128479|NCT04660760|Antimitotic Agents|antimitotic agents|mesh-ancestor
110128480|NCT04660760|Mitosis Modulators|mitosis modulators|mesh-ancestor
110128481|NCT04660760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110128482|NCT04660760|Immunologic Factors|immunologic factors|mesh-ancestor
110128483|NCT04660760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110128484|NCT04660760|Antimetabolites|antimetabolites|mesh-ancestor
110128485|NCT04660760|Antiviral Agents|antiviral agents|mesh-ancestor
110128486|NCT04660760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110128487|NCT04650698|Tranexamic Acid|tranexamic acid|mesh-list
110128488|NCT04650698|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110128489|NCT04650698|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110128490|NCT04650698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110128491|NCT04650698|Hemostatics|hemostatics|mesh-ancestor
110128492|NCT04650698|Coagulants|coagulants|mesh-ancestor
110128493|NCT04507217|Carboplatin|carboplatin|mesh-list
110128495|NCT04507217|Tislelizumab|tislelizumab|mesh-list
110128496|NCT04507217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110128497|NCT04507217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110128498|NCT04507217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110128500|NCT04507217|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110128501|NCT04507217|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110128503|NCT04495452|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110128504|NCT04495452|Narcotics|narcotics|mesh-ancestor
110128505|NCT04495452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110128506|NCT04495452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110128507|NCT04495452|Analgesics|analgesics|mesh-ancestor
110128508|NCT04495452|Sensory System Agents|sensory system agents|mesh-ancestor
110128509|NCT04495452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110128510|NCT04495452|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110128511|NCT04495452|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110128512|NCT04495452|Anesthetics, General|anesthetics, general|mesh-ancestor
110128514|NCT04447846|Cannabidiol|cannabidiol|mesh-list
110128515|NCT04447846|Anticonvulsants|anticonvulsants|mesh-ancestor
110128516|NCT04405245|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110128517|NCT04405245|Latanoprost|latanoprost|mesh-list
110128518|NCT04405245|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110128519|NCT04335968|Melatonin|melatonin|mesh-list
110128520|NCT04335968|Antioxidants|antioxidants|mesh-ancestor
110128521|NCT04335968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110128522|NCT04335968|Protective Agents|protective agents|mesh-ancestor
110128523|NCT04335968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110128524|NCT04335968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110128525|NCT04262024|Cabergoline|cabergoline|mesh-list
110128526|NCT04262024|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110128527|NCT04262024|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110128529|NCT04262024|Dopamine Agents|dopamine agents|mesh-ancestor
110128530|NCT04262024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110128531|NCT04262024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110128532|NCT04262024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110128533|NCT04237103|Methotrexate|methotrexate|mesh-list
110128534|NCT04237103|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110128535|NCT04237103|Abortifacient Agents|abortifacient agents|mesh-ancestor
110128536|NCT04237103|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110128537|NCT04237103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110128538|NCT04237103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110128539|NCT04237103|Antimetabolites|antimetabolites|mesh-ancestor
110128540|NCT04237103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110128541|NCT04237103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110128542|NCT04237103|Dermatologic Agents|dermatologic agents|mesh-ancestor
110128543|NCT04237103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110128544|NCT04237103|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110128545|NCT04237103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110128547|NCT04237103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110128548|NCT04237103|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110128549|NCT04226690|Dronabinol|dronabinol|mesh-list
110128550|NCT04226690|Hallucinogens|hallucinogens|mesh-ancestor
110128551|NCT04226690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110128552|NCT04226690|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110128553|NCT04226690|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110128554|NCT04226690|Analgesics|analgesics|mesh-ancestor
110128555|NCT04226690|Sensory System Agents|sensory system agents|mesh-ancestor
110128556|NCT04226690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110128557|NCT04226690|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
110128558|NCT04226690|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110128559|NCT04226690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110128560|NCT04226690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110128561|NCT04226690|Hormones|hormones|mesh-ancestor
110225131|NCT05997017|Sirolimus|sirolimus|mesh-list
110128562|NCT04226690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110128563|NCT04201964|Tenecteplase|tenecteplase|mesh-list
110128564|NCT04201964|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110128565|NCT04201964|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110128566|NCT04201964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110128568|NCT04198805|Vitamin E|vitamin e|mesh-list
110128569|NCT04198805|Tocopherols|tocopherols|mesh-list
110128570|NCT04198805|Tocotrienols|tocotrienols|mesh-list
110128571|NCT04198805|alpha-Tocopherol|alpha-tocopherol|mesh-list
110128572|NCT04198805|Micronutrients|micronutrients|mesh-ancestor
110128573|NCT04198805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110128574|NCT04198805|Antioxidants|antioxidants|mesh-ancestor
110128575|NCT04198805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110128576|NCT04198805|Protective Agents|protective agents|mesh-ancestor
110128577|NCT04179890|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110128578|NCT04179890|Gefitinib|gefitinib|mesh-list
110128579|NCT04179890|Osimertinib|osimertinib|mesh-list
110128580|NCT04179890|Afatinib|afatinib|mesh-list
110128581|NCT04179890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110128582|NCT04179890|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110128583|NCT04179890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110128584|NCT04179890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110128585|NCT04166331|Dobutamine|dobutamine|mesh-list
110128586|NCT04166331|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110128587|NCT04166331|Sympathomimetics|sympathomimetics|mesh-ancestor
110128588|NCT04166331|Autonomic Agents|autonomic agents|mesh-ancestor
110128589|NCT04166331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110128590|NCT04166331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110128591|NCT04166331|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
110128592|NCT04166331|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110128593|NCT04166331|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110128594|NCT04166331|Adrenergic Agents|adrenergic agents|mesh-ancestor
110128595|NCT04166331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110128596|NCT04166331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110128597|NCT04166331|Protective Agents|protective agents|mesh-ancestor
110128598|NCT04084210|Nicotine|nicotine|mesh-list
110128599|NCT04084210|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110128600|NCT04084210|Autonomic Agents|autonomic agents|mesh-ancestor
110128601|NCT04084210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110128602|NCT04084210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110128603|NCT04084210|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110128604|NCT04084210|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110128605|NCT04084210|Cholinergic Agents|cholinergic agents|mesh-ancestor
110128606|NCT04084210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110128607|NCT04084210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110128609|NCT04030026|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110128610|NCT04030026|Narcotics|narcotics|mesh-ancestor
110128611|NCT04030026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110128612|NCT04030026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110128613|NCT04030026|Analgesics|analgesics|mesh-ancestor
110128614|NCT04030026|Sensory System Agents|sensory system agents|mesh-ancestor
110128615|NCT04030026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110128617|NCT04006210|Carbidopa|carbidopa|mesh-list
110128618|NCT04006210|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110128619|NCT04006210|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110128620|NCT04006210|Dopamine Agents|dopamine agents|mesh-ancestor
110128621|NCT04006210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110128622|NCT04006210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110128623|NCT04006210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110128624|NCT04006210|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
110128625|NCT04006210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110128626|NCT03927274|Topotecan|topotecan|mesh-list
110128627|NCT03927274|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110128628|NCT03927274|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110128629|NCT03927274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110128630|NCT03927274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110128631|NCT03927274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110128632|NCT03923699|Anesthetics|anesthetics|mesh-list
110128633|NCT03923699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110128634|NCT03923699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110128635|NCT03883880|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
110128636|NCT03883880|Capsaicin|capsaicin|mesh-list
110128637|NCT03883880|Antipruritics|antipruritics|mesh-ancestor
110128638|NCT03883880|Dermatologic Agents|dermatologic agents|mesh-ancestor
110128639|NCT03883880|Sensory System Agents|sensory system agents|mesh-ancestor
110128640|NCT03883880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110128641|NCT03883880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110128642|NCT03883880|Antioxidants|antioxidants|mesh-ancestor
110128643|NCT03883880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110128644|NCT03883880|Protective Agents|protective agents|mesh-ancestor
110128645|NCT03883880|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
110128646|NCT03883880|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110128647|NCT03883880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110128648|NCT03883880|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110128649|NCT03801369|Durvalumab|durvalumab|mesh-list
110128650|NCT03801369|Olaparib|olaparib|mesh-list
110128651|NCT03801369|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
110128652|NCT03801369|Immunoglobulins|immunoglobulins|mesh-list
110128653|NCT03801369|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110128654|NCT03801369|Immunoglobulin G|immunoglobulin g|mesh-list
110128655|NCT03801369|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110128656|NCT03801369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110128657|NCT03801369|Immunologic Factors|immunologic factors|mesh-ancestor
110128658|NCT03801369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110128659|NCT03801369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110128660|NCT03801369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110128662|NCT03649659|Cariostatic Agents|cariostatic agents|mesh-ancestor
110128663|NCT03649659|Protective Agents|protective agents|mesh-ancestor
110128664|NCT03649659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110128665|NCT03620981|Brexpiprazole|brexpiprazole|mesh-list
110128666|NCT03620981|Serotonin Agents|serotonin agents|mesh-ancestor
110128667|NCT03620981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110128668|NCT03620981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110128669|NCT03620981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110128670|NCT03620981|Dopamine Agonists|dopamine agonists|mesh-ancestor
110128671|NCT03620981|Dopamine Agents|dopamine agents|mesh-ancestor
110128672|NCT03563716|Atezolizumab|atezolizumab|mesh-list
110128673|NCT03563716|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110128674|NCT03563716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110128675|NCT03563716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110128676|NCT03563716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110128678|NCT03543969|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110128679|NCT03543969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110128680|NCT03543969|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110128681|NCT03543969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110128682|NCT03493048|Leucovorin|leucovorin|mesh-list
110128683|NCT03493048|Fluorouracil|fluorouracil|mesh-list
110128684|NCT03493048|Oxaliplatin|oxaliplatin|mesh-list
110128685|NCT03493048|Irinotecan|irinotecan|mesh-list
110128686|NCT03493048|Cetuximab|cetuximab|mesh-list
110128687|NCT03493048|Antimetabolites|antimetabolites|mesh-ancestor
110128688|NCT03493048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110128689|NCT03493048|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110128690|NCT03493048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110128691|NCT03493048|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110128692|NCT03493048|Immunologic Factors|immunologic factors|mesh-ancestor
110128693|NCT03493048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110128694|NCT03493048|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110128695|NCT03493048|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110128696|NCT03493048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110128697|NCT03493048|Antidotes|antidotes|mesh-ancestor
110128698|NCT03493048|Protective Agents|protective agents|mesh-ancestor
110128699|NCT03493048|Vitamin B Complex|vitamin b complex|mesh-ancestor
110128700|NCT03493048|Vitamins|vitamins|mesh-ancestor
110128701|NCT03493048|Micronutrients|micronutrients|mesh-ancestor
110128702|NCT03493048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110128703|NCT03486106|Propofol|propofol|mesh-list
110128704|NCT03486106|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110128705|NCT03486106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110128706|NCT03486106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110128707|NCT03486106|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110128708|NCT03486106|Anesthetics, General|anesthetics, general|mesh-ancestor
110128709|NCT03486106|Anesthetics|anesthetics|mesh-ancestor
110128710|NCT03434275|Meloxicam|meloxicam|mesh-list
110128711|NCT03434275|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110128712|NCT03434275|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110128714|NCT03434275|Sensory System Agents|sensory system agents|mesh-ancestor
110128715|NCT03434275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110128716|NCT03434275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110128717|NCT03434275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110128718|NCT03434275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110128719|NCT03434275|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110128720|NCT03434275|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110128721|NCT03434275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110128722|NCT03434275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110128723|NCT03354013|Calcium|calcium|mesh-list
110128724|NCT03354013|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110128725|NCT03354013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110128726|NCT03348423|Fentanyl|fentanyl|mesh-list
110128727|NCT03348423|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110128728|NCT03348423|Narcotics|narcotics|mesh-ancestor
110128729|NCT03348423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110128730|NCT03348423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110128731|NCT03348423|Analgesics|analgesics|mesh-ancestor
110128732|NCT03348423|Sensory System Agents|sensory system agents|mesh-ancestor
110128733|NCT03348423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110225158|NCT05996484|Antimitotic Agents|antimitotic agents|mesh-ancestor
110128734|NCT03348423|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110128735|NCT03348423|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110128736|NCT03348423|Anesthetics, General|anesthetics, general|mesh-ancestor
110128737|NCT03348423|Anesthetics|anesthetics|mesh-ancestor
110128738|NCT03337087|Calcium, Dietary|calcium, dietary|mesh-list
110128739|NCT03337087|Leucovorin|leucovorin|mesh-list
110128740|NCT03337087|Folic Acid|folic acid|mesh-list
110128741|NCT03337087|Fluorouracil|fluorouracil|mesh-list
110128742|NCT03337087|Irinotecan|irinotecan|mesh-list
110128743|NCT03337087|Rucaparib|rucaparib|mesh-list
110128744|NCT03337087|Calcium|calcium|mesh-list
110128745|NCT03337087|Levoleucovorin|levoleucovorin|mesh-list
110128746|NCT03337087|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110128747|NCT03337087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110128748|NCT03337087|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110128749|NCT03337087|Antimetabolites|antimetabolites|mesh-ancestor
110128750|NCT03337087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110128751|NCT03337087|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110128752|NCT03337087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110128768|NCT03262935|Lapatinib|lapatinib|mesh-list
110128769|NCT03262935|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110128770|NCT03262935|Antimetabolites|antimetabolites|mesh-ancestor
110128771|NCT03262935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110128772|NCT03262935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110128773|NCT03262935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110128774|NCT03262935|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110128775|NCT03262935|Tubulin Modulators|tubulin modulators|mesh-ancestor
110128776|NCT03262935|Antimitotic Agents|antimitotic agents|mesh-ancestor
110128777|NCT03262935|Mitosis Modulators|mitosis modulators|mesh-ancestor
110128778|NCT03262935|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110128779|NCT03262935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110128780|NCT03262142|Ciprofloxacin|ciprofloxacin|mesh-list
110128781|NCT03262142|Tazobactam|tazobactam|mesh-list
110128782|NCT03262142|Piperacillin|piperacillin|mesh-list
110128783|NCT03262142|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
110128784|NCT03262142|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110128785|NCT03262142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110128786|NCT03262142|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110128787|NCT03262142|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110128788|NCT03262142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110128789|NCT03262142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110128790|NCT03262142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110128791|NCT03262142|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110128792|NCT03262142|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110128793|NCT03262142|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110128794|NCT03150810|Temozolomide|temozolomide|mesh-list
110128795|NCT03150810|Pamiparib|pamiparib|mesh-list
110128796|NCT03150810|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110128797|NCT03150810|Alkylating Agents|alkylating agents|mesh-ancestor
110128798|NCT03150810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110128799|NCT03150810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110128800|NCT03150810|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110128801|NCT03150810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110128802|NCT03117998|Volagidemab|volagidemab|mesh-list
110128803|NCT03117998|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110128804|NCT03117998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110128890|NCT02766335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110128891|NCT02766335|Tubulin Modulators|tubulin modulators|mesh-ancestor
110128892|NCT02766335|Antimitotic Agents|antimitotic agents|mesh-ancestor
110128893|NCT02766335|Mitosis Modulators|mitosis modulators|mesh-ancestor
110128894|NCT02766335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110225195|NCT05996224|Hyaluronic Acid|hyaluronic acid|mesh-list
110128895|NCT02766335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110128896|NCT02766335|Immunologic Factors|immunologic factors|mesh-ancestor
110128897|NCT02766335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110128898|NCT02739711|polysaccharide-K|polysaccharide-k|mesh-list
110128899|NCT02739711|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110128900|NCT02739711|Immunologic Factors|immunologic factors|mesh-ancestor
110128901|NCT02739711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110128902|NCT02739711|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110128903|NCT02739711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110128904|NCT02739711|Antiviral Agents|antiviral agents|mesh-ancestor
110128905|NCT02739711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110128906|NCT02739711|Interferon Inducers|interferon inducers|mesh-ancestor
110128907|NCT02739711|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110128908|NCT02739711|Protective Agents|protective agents|mesh-ancestor
110128909|NCT02607423|Deoxyglucose|deoxyglucose|mesh-list
110128910|NCT02607423|Cisplatin|cisplatin|mesh-list
110128911|NCT02607423|Gemcitabine|gemcitabine|mesh-list
110128912|NCT02607423|Docetaxel|docetaxel|mesh-list
110128913|NCT02607423|Pemetrexed|pemetrexed|mesh-list
110128914|NCT02607423|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110128915|NCT02607423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110128916|NCT02607423|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110128917|NCT02607423|Antimetabolites|antimetabolites|mesh-ancestor
110128918|NCT02607423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110128919|NCT02607423|Tubulin Modulators|tubulin modulators|mesh-ancestor
110128920|NCT02607423|Antimitotic Agents|antimitotic agents|mesh-ancestor
110128921|NCT02607423|Mitosis Modulators|mitosis modulators|mesh-ancestor
110128922|NCT02607423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110128923|NCT02607423|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110128924|NCT02607423|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110128925|NCT02607423|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110128926|NCT02607423|Antiviral Agents|antiviral agents|mesh-ancestor
110128927|NCT02607423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110128928|NCT02577523|Levodopa|levodopa|mesh-list
110128929|NCT02577523|Carbidopa|carbidopa|mesh-list
110128930|NCT02577523|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110128931|NCT02577523|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110128932|NCT02577523|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110128933|NCT02577523|Dopamine Agents|dopamine agents|mesh-ancestor
110128934|NCT02577523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110128935|NCT02577523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110128936|NCT02577523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110128937|NCT02577523|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
110128938|NCT02577523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110128939|NCT02499328|Durvalumab|durvalumab|mesh-list
110128940|NCT02499328|Tremelimumab|tremelimumab|mesh-list
110128941|NCT02499328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110128942|NCT02499328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110128943|NCT02388906|Nivolumab|nivolumab|mesh-list
110128944|NCT02388906|Ipilimumab|ipilimumab|mesh-list
110128945|NCT02388906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110128946|NCT02388906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110128947|NCT02388906|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110128948|NCT02388906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110128949|NCT02344810|Leucovorin|leucovorin|mesh-list
110128950|NCT02344810|Fluorouracil|fluorouracil|mesh-list
110164882|NCT00388661|Melatonin|melatonin|mesh-list
110128953|NCT02344810|Levoleucovorin|levoleucovorin|mesh-list
110128954|NCT02344810|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110128955|NCT02344810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110128956|NCT02344810|Antimetabolites|antimetabolites|mesh-ancestor
110128957|NCT02344810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110128958|NCT02344810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110128959|NCT02344810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110225209|NCT05996185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110128960|NCT02344810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110128961|NCT02344810|Immunologic Factors|immunologic factors|mesh-ancestor
110128962|NCT02344810|Antidotes|antidotes|mesh-ancestor
110128963|NCT02344810|Protective Agents|protective agents|mesh-ancestor
110128964|NCT02344810|Vitamin B Complex|vitamin b complex|mesh-ancestor
110128966|NCT02344810|Micronutrients|micronutrients|mesh-ancestor
110128967|NCT02333565|Everolimus|everolimus|mesh-list
110128969|NCT02333565|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110128970|NCT02333565|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110128971|NCT02333565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110128972|NCT02333565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110128973|NCT02333565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110128974|NCT02333565|Immunologic Factors|immunologic factors|mesh-ancestor
110128975|NCT02333565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110128976|NCT02333565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110128977|NCT02333565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110128978|NCT02333565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110128979|NCT02278185|Leuprolide|leuprolide|mesh-list
110128980|NCT02278185|Goserelin|goserelin|mesh-list
110128981|NCT02278185|Triptorelin Pamoate|triptorelin pamoate|mesh-list
110128982|NCT02278185|Tryptophan|tryptophan|mesh-list
110128983|NCT02278185|Androgens|androgens|mesh-list
110128984|NCT02278185|Hormones|hormones|mesh-ancestor
110128985|NCT02278185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110128986|NCT02278185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110128987|NCT02278185|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110128988|NCT02278185|Fertility Agents|fertility agents|mesh-ancestor
110128989|NCT02278185|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110128990|NCT02278185|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110128991|NCT02278185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110128992|NCT02278185|Luteolytic Agents|luteolytic agents|mesh-ancestor
110128993|NCT02278185|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110128994|NCT02278185|Contraceptive Agents|contraceptive agents|mesh-ancestor
110128995|NCT02278185|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110128996|NCT02278185|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110128997|NCT02278185|Antidepressive Agents|antidepressive agents|mesh-ancestor
110128998|NCT02278185|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110128999|NCT02177695|Gemcitabine|gemcitabine|mesh-list
110129000|NCT02177695|Doxorubicin|doxorubicin|mesh-list
110129001|NCT02177695|Methotrexate|methotrexate|mesh-list
110129002|NCT02177695|Vinblastine|vinblastine|mesh-list
110129003|NCT02177695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110129004|NCT02177695|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110129005|NCT02177695|Antimetabolites|antimetabolites|mesh-ancestor
110129006|NCT02177695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110129007|NCT02177695|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110129008|NCT02177695|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110129009|NCT02177695|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110129010|NCT02177695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110129011|NCT02177695|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110129012|NCT02177695|Abortifacient Agents|abortifacient agents|mesh-ancestor
110129013|NCT02177695|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110129014|NCT02177695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110129015|NCT02177695|Dermatologic Agents|dermatologic agents|mesh-ancestor
110129016|NCT02177695|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110129017|NCT02177695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110129018|NCT02177695|Immunologic Factors|immunologic factors|mesh-ancestor
110129019|NCT02177695|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110129020|NCT02177695|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110129021|NCT02177695|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110129022|NCT02177695|Tubulin Modulators|tubulin modulators|mesh-ancestor
110129023|NCT02177695|Antimitotic Agents|antimitotic agents|mesh-ancestor
110129024|NCT02177695|Mitosis Modulators|mitosis modulators|mesh-ancestor
110129025|NCT02106572|Viscum album peptide|viscum album peptide|mesh-list
110129027|NCT02106572|Mitomycin|mitomycin|mesh-list
110129028|NCT02106572|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110129029|NCT02106572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110129030|NCT02106572|Alkylating Agents|alkylating agents|mesh-ancestor
110129031|NCT02106572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110129032|NCT02106572|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110129033|NCT02106572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110129034|NCT02106572|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110129035|NCT02106572|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110129036|NCT02106572|Antiviral Agents|antiviral agents|mesh-ancestor
110129037|NCT02106572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110129038|NCT02096601|Levodopa|levodopa|mesh-list
110129039|NCT02096601|Carbidopa|carbidopa|mesh-list
110129040|NCT02096601|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110129041|NCT02096601|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110129042|NCT02096601|Dopamine Agents|dopamine agents|mesh-ancestor
110129043|NCT02096601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110129044|NCT02096601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110129045|NCT02096601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110129046|NCT02096601|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
110129047|NCT02096601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110129048|NCT01840566|Cytarabine|cytarabine|mesh-list
110129049|NCT01840566|Etoposide|etoposide|mesh-list
110129050|NCT01840566|Melphalan|melphalan|mesh-list
110129051|NCT01840566|Carmustine|carmustine|mesh-list
110129052|NCT01840566|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110129053|NCT01840566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110129054|NCT01840566|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110129055|NCT01840566|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110129056|NCT01840566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110129057|NCT01840566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110129058|NCT01840566|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110129059|NCT01840566|Antimetabolites|antimetabolites|mesh-ancestor
110129060|NCT01840566|Antiviral Agents|antiviral agents|mesh-ancestor
110129061|NCT01840566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110129062|NCT01840566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110129063|NCT01840566|Immunologic Factors|immunologic factors|mesh-ancestor
110129064|NCT01840566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110129065|NCT01840566|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110129066|NCT01840566|Alkylating Agents|alkylating agents|mesh-ancestor
110129067|NCT01840566|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110129068|NCT01725802|Levodopa|levodopa|mesh-list
110129069|NCT01725802|Carbidopa|carbidopa|mesh-list
110129070|NCT01725802|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110164923|NCT00388700|Vitamins|vitamins|mesh-ancestor
110129072|NCT01725802|Dopamine Agents|dopamine agents|mesh-ancestor
110129073|NCT01725802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110129074|NCT01725802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110129075|NCT01725802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110129076|NCT01725802|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
110129077|NCT01725802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110129078|NCT01719237|Ropivacaine|ropivacaine|mesh-list
110129079|NCT01719237|Chloroprocaine|chloroprocaine|mesh-list
110129080|NCT01719237|Anesthetics, Local|anesthetics, local|mesh-ancestor
110129081|NCT01719237|Anesthetics|anesthetics|mesh-ancestor
110129082|NCT01719237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110129083|NCT01719237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110129084|NCT01719237|Sensory System Agents|sensory system agents|mesh-ancestor
110129085|NCT01719237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110129086|NCT01257594|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110129087|NCT01257594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110129088|NCT01257594|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110129089|NCT01257594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110129090|NCT01257594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110129091|NCT01004731|Carboplatin|carboplatin|mesh-list
110129092|NCT01004731|Gemcitabine|gemcitabine|mesh-list
110129093|NCT01004731|Cetuximab|cetuximab|mesh-list
110129094|NCT01004731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110129095|NCT01004731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110129096|NCT01004731|Antimetabolites|antimetabolites|mesh-ancestor
110129097|NCT01004731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110129098|NCT01004731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110129099|NCT00771017|Leuprolide|leuprolide|mesh-list
110129100|NCT00771017|Goserelin|goserelin|mesh-list
110129101|NCT00771017|Bicalutamide|bicalutamide|mesh-list
110129102|NCT00771017|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110129103|NCT00771017|Fertility Agents|fertility agents|mesh-ancestor
110129104|NCT00771017|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110129105|NCT00771017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110129106|NCT00771017|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110129107|NCT00771017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110129108|NCT00771017|Androgen Antagonists|androgen antagonists|mesh-ancestor
110129109|NCT00771017|Hormone Antagonists|hormone antagonists|mesh-ancestor
110129110|NCT00771017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110129111|NCT00499291|Paclitaxel|paclitaxel|mesh-list
110129112|NCT00499291|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110129113|NCT00499291|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110129114|NCT00499291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110129115|NCT00499291|Tubulin Modulators|tubulin modulators|mesh-ancestor
110129116|NCT00499291|Antimitotic Agents|antimitotic agents|mesh-ancestor
110129117|NCT00499291|Mitosis Modulators|mitosis modulators|mesh-ancestor
110129118|NCT00499291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110129119|NCT00318903|Docetaxel|docetaxel|mesh-list
110129120|NCT00318903|Irinotecan|irinotecan|mesh-list
110129121|NCT00318903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110129122|NCT00318903|Tubulin Modulators|tubulin modulators|mesh-ancestor
110129123|NCT00318903|Antimitotic Agents|antimitotic agents|mesh-ancestor
110129124|NCT00318903|Mitosis Modulators|mitosis modulators|mesh-ancestor
110129125|NCT00318903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110129126|NCT00318903|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110129127|NCT00318903|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110129128|NCT00318903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110129129|NCT00129090|Rituximab|rituximab|mesh-list
110129130|NCT00129090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110129131|NCT00129090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110129132|NCT00129090|Immunologic Factors|immunologic factors|mesh-ancestor
110129133|NCT00129090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110129134|NCT00129090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110129135|NCT01952886|Ondansetron|ondansetron|mesh-list
110129136|NCT01952886|Granisetron|granisetron|mesh-list
110129137|NCT01952886|Antiemetics|antiemetics|mesh-ancestor
110164930|NCT00022126|Doxorubicin|doxorubicin|mesh-list
110129138|NCT01952886|Autonomic Agents|autonomic agents|mesh-ancestor
110129139|NCT01952886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110129140|NCT01952886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110129141|NCT01952886|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110129142|NCT01952886|Antipruritics|antipruritics|mesh-ancestor
110129143|NCT01952886|Dermatologic Agents|dermatologic agents|mesh-ancestor
110129144|NCT01952886|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110129145|NCT01952886|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110129146|NCT01952886|Serotonin Agents|serotonin agents|mesh-ancestor
110129147|NCT01952886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110129148|NCT01952886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110129149|NCT01952951|Fluorouracil|fluorouracil|mesh-list
110129150|NCT01952951|Capecitabine|capecitabine|mesh-list
110129152|NCT01952951|Antimetabolites|antimetabolites|mesh-ancestor
110129153|NCT01952951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110129154|NCT01952951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110129155|NCT01952951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110129156|NCT01952951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110129157|NCT01952951|Immunologic Factors|immunologic factors|mesh-ancestor
110129158|NCT01952951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110129159|NCT01953107|Ferrous fumarate|ferrous fumarate|mesh-list
110129160|NCT01953107|Trace Elements|trace elements|mesh-ancestor
110129161|NCT01953107|Micronutrients|micronutrients|mesh-ancestor
110129162|NCT01953107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110129163|NCT01953172|Tocotrienols|tocotrienols|mesh-list
110129164|NCT01953172|Tocotrienol, alpha|tocotrienol, alpha|mesh-list
110129165|NCT01953172|Antioxidants|antioxidants|mesh-ancestor
110129166|NCT01953172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110129167|NCT01953172|Protective Agents|protective agents|mesh-ancestor
110129168|NCT01953172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110129169|NCT01953172|Vitamins|vitamins|mesh-ancestor
110129170|NCT01953172|Micronutrients|micronutrients|mesh-ancestor
110129171|NCT01953367|Tobramycin|tobramycin|mesh-list
110129172|NCT01953367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110129173|NCT01953367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110129174|NCT01953406|Fluorouracil|fluorouracil|mesh-list
110129175|NCT01953406|Mitomycins|mitomycins|mesh-list
110129176|NCT01953406|Mitomycin|mitomycin|mesh-list
110129177|NCT01953406|Antimetabolites|antimetabolites|mesh-ancestor
110129178|NCT01953406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110129179|NCT01953406|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110129180|NCT01953406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110129181|NCT01953406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110129182|NCT01953406|Immunologic Factors|immunologic factors|mesh-ancestor
110129183|NCT01953406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110129184|NCT01953406|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110129185|NCT01953406|Alkylating Agents|alkylating agents|mesh-ancestor
110129186|NCT01953406|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110129187|NCT01953406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110129188|NCT01953419|Pemetrexed|pemetrexed|mesh-list
110129189|NCT01953419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110129190|NCT01953419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110129191|NCT01953419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110129192|NCT01953419|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110129193|NCT01953419|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110129194|NCT01953445|Paclitaxel|paclitaxel|mesh-list
110129195|NCT01953445|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110129196|NCT01953445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110129197|NCT01953445|Tubulin Modulators|tubulin modulators|mesh-ancestor
110129198|NCT01953445|Antimitotic Agents|antimitotic agents|mesh-ancestor
110129199|NCT01953445|Mitosis Modulators|mitosis modulators|mesh-ancestor
110129200|NCT01953445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110129201|NCT01953536|Folic Acid|folic acid|mesh-list
110129202|NCT01953536|Paclitaxel|paclitaxel|mesh-list
110129203|NCT01953536|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110129204|NCT01953536|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110129205|NCT01953536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110129206|NCT01953536|Tubulin Modulators|tubulin modulators|mesh-ancestor
110129207|NCT01953536|Antimitotic Agents|antimitotic agents|mesh-ancestor
110129208|NCT01953536|Mitosis Modulators|mitosis modulators|mesh-ancestor
110129209|NCT01953536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110129210|NCT01953536|Hematinics|hematinics|mesh-ancestor
110129211|NCT01953536|Vitamin B Complex|vitamin b complex|mesh-ancestor
110129213|NCT01953536|Micronutrients|micronutrients|mesh-ancestor
110129214|NCT01953536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110129215|NCT01953679|Ulipristal acetate|ulipristal acetate|mesh-list
110129216|NCT01953679|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110129217|NCT01953679|Contraceptive Agents|contraceptive agents|mesh-ancestor
110129218|NCT01953679|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110129219|NCT01953679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110129220|NCT01953679|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110129221|NCT01953731|Rifampin|rifampin|mesh-list
110129222|NCT01953731|Palbociclib|palbociclib|mesh-list
110129223|NCT01953731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110129224|NCT01953731|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110129225|NCT01953731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110129226|NCT01953731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110129227|NCT01953731|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110129228|NCT01953731|Antitubercular Agents|antitubercular agents|mesh-ancestor
110129229|NCT01953731|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110129230|NCT01953731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110129231|NCT01953731|Leprostatic Agents|leprostatic agents|mesh-ancestor
110129232|NCT01953731|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110129233|NCT01953731|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110129234|NCT01953731|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110129235|NCT01953731|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110129236|NCT01953731|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110129237|NCT01953731|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110129238|NCT01953731|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110129239|NCT01953744|Fluconazole|fluconazole|mesh-list
110129240|NCT01953744|Meglumine Antimoniate|meglumine antimoniate|mesh-list
110129241|NCT01953744|Antifungal Agents|antifungal agents|mesh-ancestor
110129242|NCT01953744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110129243|NCT01953744|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110129244|NCT01953744|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110129245|NCT01953744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110129246|NCT01953744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110129247|NCT01953744|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110129248|NCT01953744|Hormone Antagonists|hormone antagonists|mesh-ancestor
110129249|NCT01953744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110129250|NCT01953744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110129251|NCT01953744|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110129252|NCT01953744|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110129253|NCT01953744|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110129254|NCT01953744|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110129255|NCT01953757|Vitamins|vitamins|mesh-list
110129256|NCT01953757|Hydroxocobalamin|hydroxocobalamin|mesh-list
110129257|NCT01953757|Vitamin B 12|vitamin b 12|mesh-list
110129258|NCT01953757|Vitamin B Complex|vitamin b complex|mesh-list
110129259|NCT01953757|Micronutrients|micronutrients|mesh-ancestor
110129260|NCT01953757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110129261|NCT01953757|Hematinics|hematinics|mesh-ancestor
110129262|NCT01953770|Cytarabine|cytarabine|mesh-list
110129263|NCT01953770|Prednisone|prednisone|mesh-list
110129264|NCT01953770|Methotrexate|methotrexate|mesh-list
110129265|NCT01953770|Daunorubicin|daunorubicin|mesh-list
110129266|NCT01953770|Asparaginase|asparaginase|mesh-list
110129267|NCT01953770|Pegaspargase|pegaspargase|mesh-list
110129268|NCT01953770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110129269|NCT01953770|Glucocorticoids|glucocorticoids|mesh-ancestor
110129270|NCT01953770|Hormones|hormones|mesh-ancestor
110129271|NCT01953770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110129272|NCT01953770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110129273|NCT01953770|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110129274|NCT01953770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110129275|NCT01953770|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110129276|NCT01953770|Abortifacient Agents|abortifacient agents|mesh-ancestor
110129277|NCT01953770|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110129278|NCT01953770|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110129280|NCT01953770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110225277|NCT05995119|Apixaban|apixaban|mesh-list
110129281|NCT01953770|Dermatologic Agents|dermatologic agents|mesh-ancestor
110129282|NCT01953770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110129283|NCT01953770|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110129284|NCT01953770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110129285|NCT01953770|Immunologic Factors|immunologic factors|mesh-ancestor
110129286|NCT01953770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110129287|NCT01953770|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110129288|NCT01953770|Antiviral Agents|antiviral agents|mesh-ancestor
110129289|NCT01953770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110129290|NCT01953770|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110129291|NCT01953770|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110129292|NCT01953770|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110129293|NCT01953796|Clomiphene|clomiphene|mesh-list
110129294|NCT01953796|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110129295|NCT01953796|Hormone Antagonists|hormone antagonists|mesh-ancestor
110129296|NCT01953796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110129297|NCT01953796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110129298|NCT01953796|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110129299|NCT01953796|Fertility Agents|fertility agents|mesh-ancestor
110129300|NCT01953796|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110129301|NCT01953796|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110129302|NCT01953796|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110129303|NCT01953835|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110129304|NCT01953835|Simvastatin|simvastatin|mesh-list
110129305|NCT01953835|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110129306|NCT01953835|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110129307|NCT01953835|Antimetabolites|antimetabolites|mesh-ancestor
110129308|NCT01953835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110129309|NCT01953835|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110129310|NCT01953835|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110129311|NCT01953835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110129312|NCT01953848|Tamsulosin|tamsulosin|mesh-list
110129313|NCT01953848|Solifenacin Succinate|solifenacin succinate|mesh-list
110129314|NCT01953848|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110129315|NCT01953848|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110129316|NCT01953848|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110129317|NCT01953848|Adrenergic Agents|adrenergic agents|mesh-ancestor
110129318|NCT01953848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110129319|NCT01953848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110129320|NCT01953848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110129321|NCT01953848|Urological Agents|urological agents|mesh-ancestor
110129322|NCT01953848|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110129323|NCT01953848|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110129324|NCT01953848|Cholinergic Agents|cholinergic agents|mesh-ancestor
110129325|NCT01953887|Tamsulosin|tamsulosin|mesh-list
110129326|NCT01953887|Solifenacin Succinate|solifenacin succinate|mesh-list
110129327|NCT01953887|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110129328|NCT01953887|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110129329|NCT01953887|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110129330|NCT01953887|Adrenergic Agents|adrenergic agents|mesh-ancestor
110129331|NCT01953887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110129332|NCT01953887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110129333|NCT01953887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110225285|NCT05994534|Acetylcysteine|acetylcysteine|mesh-list
110129334|NCT01953887|Urological Agents|urological agents|mesh-ancestor
110129335|NCT01953887|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110129336|NCT01953887|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110129337|NCT01953887|Cholinergic Agents|cholinergic agents|mesh-ancestor
110129339|NCT01953952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110129340|NCT01953978|Acetaminophen|acetaminophen|mesh-list
110129341|NCT01953978|Dexamethasone|dexamethasone|mesh-list
110129342|NCT01953978|Ibuprofen|ibuprofen|mesh-list
110129343|NCT01953978|Morphine|morphine|mesh-list
110129344|NCT01953978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110129345|NCT01953978|Antiemetics|antiemetics|mesh-ancestor
110129346|NCT01953978|Autonomic Agents|autonomic agents|mesh-ancestor
110129347|NCT01953978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110129348|NCT01953978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110129349|NCT01953978|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110129350|NCT01953978|Glucocorticoids|glucocorticoids|mesh-ancestor
110129351|NCT01953978|Hormones|hormones|mesh-ancestor
110129352|NCT01953978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110129353|NCT01953978|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110129354|NCT01953978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110129355|NCT01953978|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110129356|NCT01953978|Narcotics|narcotics|mesh-ancestor
110129357|NCT01953978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110129358|NCT01953978|Analgesics|analgesics|mesh-ancestor
110129359|NCT01953978|Sensory System Agents|sensory system agents|mesh-ancestor
110129360|NCT01953978|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110129361|NCT01953978|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110129362|NCT01953978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110129363|NCT01953978|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110129364|NCT01953978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110129365|NCT01953978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110129366|NCT01953978|Antipyretics|antipyretics|mesh-ancestor
110129367|NCT01954030|Bevacizumab|bevacizumab|mesh-list
110129368|NCT01954030|Carboxyamido-triazole|carboxyamido-triazole|mesh-list
110129369|NCT01954030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110129370|NCT01954030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110129371|NCT01954030|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110129372|NCT01954030|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110129373|NCT01954030|Growth Substances|growth substances|mesh-ancestor
110129374|NCT01954030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110129375|NCT01954030|Growth Inhibitors|growth inhibitors|mesh-ancestor
110129376|NCT01954030|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110129377|NCT01954030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110129378|NCT01954030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110129379|NCT01954030|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110129380|NCT01954043|Rifampin|rifampin|mesh-list
110129381|NCT01954043|Dabrafenib|dabrafenib|mesh-list
110129382|NCT01954043|Rabeprazole|rabeprazole|mesh-list
110129383|NCT01954043|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110129384|NCT01954043|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110129385|NCT01954043|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110129386|NCT01954043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110129387|NCT01954043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110129388|NCT01954043|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110129389|NCT01954043|Antitubercular Agents|antitubercular agents|mesh-ancestor
110225293|NCT05994534|Antioxidants|antioxidants|mesh-ancestor
110129390|NCT01954043|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110129391|NCT01954043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110129392|NCT01954043|Leprostatic Agents|leprostatic agents|mesh-ancestor
110129393|NCT01954043|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110129394|NCT01954043|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110129395|NCT01954043|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110129396|NCT01954043|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110129397|NCT01954043|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110129398|NCT01954043|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110129399|NCT01954043|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110129400|NCT01954043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110129401|NCT01954043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110129402|NCT01954108|Hyaluronic Acid|hyaluronic acid|mesh-list
110129403|NCT01954108|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110129404|NCT01954108|Immunologic Factors|immunologic factors|mesh-ancestor
110129405|NCT01954108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110129406|NCT01954108|Viscosupplements|viscosupplements|mesh-ancestor
110129407|NCT01954108|Protective Agents|protective agents|mesh-ancestor
110129408|NCT01954186|Oxytocin|oxytocin|mesh-list
110129409|NCT01954186|Oxytocics|oxytocics|mesh-ancestor
110129410|NCT01954186|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110129411|NCT01954186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110129412|NCT01954238|Rivaroxaban|rivaroxaban|mesh-list
110129413|NCT01954238|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110129414|NCT01954238|Antithrombins|antithrombins|mesh-ancestor
110129415|NCT01954238|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110129416|NCT01954238|Protease Inhibitors|protease inhibitors|mesh-ancestor
110129417|NCT01954238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110129418|NCT01954238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110129419|NCT01954238|Anticoagulants|anticoagulants|mesh-ancestor
110129420|NCT01954290|Mannitol|mannitol|mesh-list
110129421|NCT01954290|Conivaptan|conivaptan|mesh-list
110129422|NCT01954290|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110129423|NCT01954290|Diuretics|diuretics|mesh-ancestor
110129424|NCT01954290|Natriuretic Agents|natriuretic agents|mesh-ancestor
110129425|NCT01954290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110129426|NCT01954290|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
110129427|NCT01954290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110129428|NCT01954355|Paclitaxel|paclitaxel|mesh-list
110129429|NCT01954355|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110129430|NCT01954355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110129431|NCT01954355|Tubulin Modulators|tubulin modulators|mesh-ancestor
110129432|NCT01954355|Antimitotic Agents|antimitotic agents|mesh-ancestor
110129433|NCT01954355|Mitosis Modulators|mitosis modulators|mesh-ancestor
110129434|NCT01954355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110129436|NCT01954368|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110129437|NCT01954368|Narcotics|narcotics|mesh-ancestor
110129438|NCT01954368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110129439|NCT01954368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110129440|NCT01954368|Analgesics|analgesics|mesh-ancestor
110129441|NCT01954368|Sensory System Agents|sensory system agents|mesh-ancestor
110129442|NCT01954368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110129443|NCT01954368|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110129444|NCT01954368|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110225312|NCT05993039|Narcotics|narcotics|mesh-ancestor
110129445|NCT01954368|Anesthetics, General|anesthetics, general|mesh-ancestor
110129446|NCT01954368|Anesthetics|anesthetics|mesh-ancestor
110129447|NCT01954693|Everolimus|everolimus|mesh-list
110129448|NCT01954693|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110129449|NCT01954693|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110129450|NCT01954693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110129451|NCT01954693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110129452|NCT01954693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110129453|NCT01954693|Immunologic Factors|immunologic factors|mesh-ancestor
110129454|NCT01954693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110129455|NCT01954693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110129456|NCT01954732|Metformin|metformin|mesh-list
110129457|NCT01954732|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110129458|NCT01954732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110129459|NCT01954784|Cyclosporine|cyclosporine|mesh-list
110129460|NCT01954784|Mycophenolic Acid|mycophenolic acid|mesh-list
110129461|NCT01954784|Fludarabine|fludarabine|mesh-list
110129462|NCT01954784|Fludarabine phosphate|fludarabine phosphate|mesh-list
110129463|NCT01954784|Lenalidomide|lenalidomide|mesh-list
110129464|NCT01954784|Bortezomib|bortezomib|mesh-list
110129465|NCT01954784|Cyclosporins|cyclosporins|mesh-list
110129466|NCT01954784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110129467|NCT01954784|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110129468|NCT01954784|Antimetabolites|antimetabolites|mesh-ancestor
110129469|NCT01954784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110129470|NCT01954784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110129471|NCT01954784|Immunologic Factors|immunologic factors|mesh-ancestor
110129472|NCT01954784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110129473|NCT01954784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110129474|NCT01954784|Antifungal Agents|antifungal agents|mesh-ancestor
110129475|NCT01954784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110129476|NCT01954784|Dermatologic Agents|dermatologic agents|mesh-ancestor
110129477|NCT01954784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110129478|NCT01954784|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110129479|NCT01954784|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110129480|NCT01954784|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110129481|NCT01954784|Growth Substances|growth substances|mesh-ancestor
110129482|NCT01954784|Growth Inhibitors|growth inhibitors|mesh-ancestor
110129483|NCT01954784|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110129484|NCT01954784|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110129485|NCT01954784|Antitubercular Agents|antitubercular agents|mesh-ancestor
110129486|NCT01954784|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110129487|NCT01954914|Plerixafor|plerixafor|mesh-list
110129488|NCT01954914|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110129489|NCT01954914|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110129490|NCT01954914|Antiviral Agents|antiviral agents|mesh-ancestor
110129491|NCT01954914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110129492|NCT01954992|Fluorouracil|fluorouracil|mesh-list
110129493|NCT01954992|Antimetabolites|antimetabolites|mesh-ancestor
110129494|NCT01954992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110129495|NCT01954992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110129496|NCT01954992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110129497|NCT01954992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110129498|NCT01954992|Immunologic Factors|immunologic factors|mesh-ancestor
110129499|NCT01954992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110129500|NCT01955057|Carbon Monoxide|carbon monoxide|mesh-list
110129502|NCT01955057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110129503|NCT01955057|Gasotransmitters|gasotransmitters|mesh-ancestor
110129504|NCT01955057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110129505|NCT01955057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110129506|NCT01955070|Ketamine|ketamine|mesh-list
110129507|NCT01955070|Analgesics|analgesics|mesh-ancestor
110129508|NCT01955070|Sensory System Agents|sensory system agents|mesh-ancestor
110129509|NCT01955070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110253515|NCT00162786|Dermatologic Agents|dermatologic agents|mesh-ancestor
110129510|NCT01955070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110129511|NCT01955070|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110129512|NCT01955070|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110129513|NCT01955070|Anesthetics, General|anesthetics, general|mesh-ancestor
110129514|NCT01955070|Anesthetics|anesthetics|mesh-ancestor
110129515|NCT01955070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110129516|NCT01955070|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110129517|NCT01955070|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110129518|NCT01955070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110129519|NCT01955070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110129520|NCT01955135|Ketamine|ketamine|mesh-list
110129521|NCT01955135|Propofol|propofol|mesh-list
110129522|NCT01955135|Sevoflurane|sevoflurane|mesh-list
110129523|NCT01955135|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110129524|NCT01955135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110129525|NCT01955135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110129526|NCT01955135|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110129527|NCT01955135|Anesthetics, General|anesthetics, general|mesh-ancestor
110129528|NCT01955135|Anesthetics|anesthetics|mesh-ancestor
110129529|NCT01955135|Analgesics|analgesics|mesh-ancestor
110129530|NCT01955135|Sensory System Agents|sensory system agents|mesh-ancestor
110129531|NCT01955135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110129532|NCT01955135|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110164970|NCT00022126|Antiviral Agents|antiviral agents|mesh-ancestor
110129533|NCT01955135|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110129534|NCT01955135|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110129535|NCT01955135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110129536|NCT01955135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110129537|NCT01955135|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110129538|NCT01955135|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110129539|NCT01955174|Botulinum Toxins|botulinum toxins|mesh-list
110129540|NCT01955174|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110129541|NCT01955174|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110129542|NCT01955174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110129543|NCT01955174|Cholinergic Agents|cholinergic agents|mesh-ancestor
110129544|NCT01955174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110129545|NCT01955174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110129546|NCT01955187|Methylprednisolone|methylprednisolone|mesh-list
110129547|NCT01955187|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110129548|NCT01955187|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110129549|NCT01955187|Prednisolone|prednisolone|mesh-list
110129550|NCT01955187|Prednisolone acetate|prednisolone acetate|mesh-list
110129551|NCT01955187|Cyclophosphamide|cyclophosphamide|mesh-list
110129554|NCT01955187|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110129555|NCT01955187|Prednisolone phosphate|prednisolone phosphate|mesh-list
110129556|NCT01955187|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110129557|NCT01955187|Immunologic Factors|immunologic factors|mesh-ancestor
110129558|NCT01955187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110129559|NCT01955187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110129560|NCT01955187|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110129561|NCT01955187|Alkylating Agents|alkylating agents|mesh-ancestor
110129562|NCT01955187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110129563|NCT01955187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110129564|NCT01955187|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110129565|NCT01955187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110129566|NCT01955187|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110129567|NCT01955187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110129568|NCT01955187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110129570|NCT01955187|Autonomic Agents|autonomic agents|mesh-ancestor
110129571|NCT01955187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110129572|NCT01955187|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110129573|NCT01955187|Glucocorticoids|glucocorticoids|mesh-ancestor
110129574|NCT01955187|Hormones|hormones|mesh-ancestor
110129575|NCT01955187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110129576|NCT01955187|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110129577|NCT01955187|Protective Agents|protective agents|mesh-ancestor
110129578|NCT01955187|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110129579|NCT01955200|Cilostazol|cilostazol|mesh-list
110129580|NCT01955200|Clopidogrel|clopidogrel|mesh-list
110129581|NCT01955200|Ticagrelor|ticagrelor|mesh-list
110129582|NCT01955200|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110129583|NCT01955200|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110129584|NCT01955200|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110129586|NCT01955200|Purinergic Agents|purinergic agents|mesh-ancestor
110129587|NCT01955200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110129588|NCT01955200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110129589|NCT01955200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110129590|NCT01955200|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110129591|NCT01955200|Autonomic Agents|autonomic agents|mesh-ancestor
110129592|NCT01955200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110129593|NCT01955200|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110129594|NCT01955200|Respiratory System Agents|respiratory system agents|mesh-ancestor
110129595|NCT01955200|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110129596|NCT01955200|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110129597|NCT01955200|Vasodilator Agents|vasodilator agents|mesh-ancestor
110129598|NCT01955200|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110129599|NCT01955200|Protective Agents|protective agents|mesh-ancestor
110129600|NCT01955200|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110129601|NCT01955200|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110129602|NCT01955200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110129603|NCT01955213|Methylnaltrexone|methylnaltrexone|mesh-list
110129604|NCT01955213|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110129605|NCT01955213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110129606|NCT01955213|Sensory System Agents|sensory system agents|mesh-ancestor
110129607|NCT01955213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110129608|NCT01955252|Azithromycin|azithromycin|mesh-list
110129609|NCT01955252|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110129610|NCT01955252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110129611|NCT01955317|Chlorhexidine|chlorhexidine|mesh-list
110129612|NCT01955317|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110129613|NCT01955317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110129614|NCT01955317|Disinfectants|disinfectants|mesh-ancestor
110129615|NCT01955408|Cholinergic Antagonists|cholinergic antagonists|mesh-list
110129616|NCT01955408|Cholinergic Agents|cholinergic agents|mesh-ancestor
110129617|NCT01955408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110129618|NCT01955408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110129619|NCT01955408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110129620|NCT01955421|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110129621|NCT01955421|Gefitinib|gefitinib|mesh-list
110129622|NCT01955421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110129623|NCT01955421|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110129624|NCT01955421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110129625|NCT01955421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110129626|NCT01955577|Vitamin D|vitamin d|mesh-list
110129627|NCT01955577|Cholecalciferol|cholecalciferol|mesh-list
110129628|NCT01955577|Vitamins|vitamins|mesh-ancestor
110129629|NCT01955577|Micronutrients|micronutrients|mesh-ancestor
110129630|NCT01955577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110129631|NCT01955577|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110129632|NCT01955577|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110129633|NCT01955642|Clopidogrel|clopidogrel|mesh-list
110129634|NCT01955642|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110129635|NCT01955642|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110129636|NCT01955642|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110129637|NCT01955642|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110129638|NCT01955642|Purinergic Agents|purinergic agents|mesh-ancestor
110129639|NCT01955642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110129640|NCT01955642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110129641|NCT01955642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110129642|NCT01955655|Baclofen|baclofen|mesh-list
110129643|NCT01955655|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110129644|NCT01955655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110129645|NCT01955655|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110129646|NCT01955655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110129647|NCT01955655|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
110129648|NCT01955655|GABA Agonists|gaba agonists|mesh-ancestor
110129649|NCT01955655|GABA Agents|gaba agents|mesh-ancestor
110129650|NCT01955655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110129651|NCT01955655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110129652|NCT01955694|Eplerenone|eplerenone|mesh-list
110129653|NCT01955694|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110129654|NCT01955694|Hormone Antagonists|hormone antagonists|mesh-ancestor
110129655|NCT01955694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110129656|NCT01955694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110129657|NCT01955694|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110129659|NCT01955694|Natriuretic Agents|natriuretic agents|mesh-ancestor
110129660|NCT01955694|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110129661|NCT01955759|Amiodarone|amiodarone|mesh-list
110129662|NCT01955759|Bisoprolol|bisoprolol|mesh-list
110129663|NCT01955759|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110129664|NCT01955759|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
110129665|NCT01955759|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110129666|NCT01955759|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110129667|NCT01955759|Antimetabolites|antimetabolites|mesh-ancestor
110129668|NCT01955759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110129669|NCT01955759|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110129670|NCT01955759|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110129671|NCT01955759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110129672|NCT01955759|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110129673|NCT01955759|Adrenergic Agents|adrenergic agents|mesh-ancestor
110129674|NCT01955759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110129675|NCT01955759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110129676|NCT01955759|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110129677|NCT01955759|Vasodilator Agents|vasodilator agents|mesh-ancestor
110129678|NCT01955759|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
110129679|NCT01955759|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110129680|NCT01955759|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110129681|NCT01955759|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110129682|NCT01955759|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110129683|NCT01955759|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110129684|NCT01955759|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110129685|NCT01955759|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110129686|NCT01955759|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110129687|NCT01955759|Sympatholytics|sympatholytics|mesh-ancestor
110129688|NCT01955759|Autonomic Agents|autonomic agents|mesh-ancestor
110129689|NCT01955759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110129690|NCT01955759|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110129691|NCT01955824|Lidocaine|lidocaine|mesh-list
110129692|NCT01955824|Anesthetics, Local|anesthetics, local|mesh-ancestor
110129693|NCT01955824|Anesthetics|anesthetics|mesh-ancestor
110129694|NCT01955824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110129695|NCT01955824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110129696|NCT01955824|Sensory System Agents|sensory system agents|mesh-ancestor
110129697|NCT01955824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110129698|NCT01955824|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110129699|NCT01955824|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110129700|NCT01955824|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110129701|NCT01955824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110129702|NCT01955824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110129703|NCT01955967|Lidocaine|lidocaine|mesh-list
110129704|NCT01955967|Anesthetics, Local|anesthetics, local|mesh-ancestor
110129705|NCT01955967|Anesthetics|anesthetics|mesh-ancestor
110129706|NCT01955967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110129707|NCT01955967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110129708|NCT01955967|Sensory System Agents|sensory system agents|mesh-ancestor
110129709|NCT01955967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110129710|NCT01955967|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110129711|NCT01955967|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110129712|NCT01955967|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110129713|NCT01955967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110129714|NCT01955967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110129715|NCT01956006|Milrinone|milrinone|mesh-list
110129716|NCT01956006|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110129717|NCT01956006|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110129718|NCT01956006|Vasodilator Agents|vasodilator agents|mesh-ancestor
110129719|NCT01956006|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110129720|NCT01956006|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110129721|NCT01956006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110129722|NCT01956006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110129723|NCT01956006|Protective Agents|protective agents|mesh-ancestor
110129724|NCT01956006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110129726|NCT01956201|Fenofibrate|fenofibrate|mesh-list
110129727|NCT01956201|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110129728|NCT01956201|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110129729|NCT01956201|Antimetabolites|antimetabolites|mesh-ancestor
110129730|NCT01956201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110129731|NCT01956201|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110129732|NCT01956201|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110129733|NCT01956201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110129734|NCT01956305|Metformin|metformin|mesh-list
110129735|NCT01956305|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110129736|NCT01956305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110129737|NCT01956474|Riboflavin|riboflavin|mesh-list
110129738|NCT01956474|Vitamin B Complex|vitamin b complex|mesh-ancestor
110129739|NCT01956474|Vitamins|vitamins|mesh-ancestor
110129740|NCT01956474|Micronutrients|micronutrients|mesh-ancestor
110129741|NCT01956474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110129742|NCT01956474|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110129743|NCT01956474|Dermatologic Agents|dermatologic agents|mesh-ancestor
110129744|NCT01956487|Propafenone|propafenone|mesh-list
110129745|NCT01956487|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110129746|NCT01956487|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110129747|NCT01956487|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110129748|NCT01956487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110129749|NCT01956487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110129750|NCT01956591|Oxybutynin|oxybutynin|mesh-list
110129751|NCT01956591|Parasympatholytics|parasympatholytics|mesh-ancestor
110129752|NCT01956591|Autonomic Agents|autonomic agents|mesh-ancestor
110129753|NCT01956591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110129754|NCT01956591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110129755|NCT01956591|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110129756|NCT01956591|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110129757|NCT01956591|Cholinergic Agents|cholinergic agents|mesh-ancestor
110129758|NCT01956591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110129759|NCT01956591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110129760|NCT01956591|Urological Agents|urological agents|mesh-ancestor
110129761|NCT01956604|Clonidine|clonidine|mesh-list
110129762|NCT01956604|Analgesics|analgesics|mesh-ancestor
110129763|NCT01956604|Sensory System Agents|sensory system agents|mesh-ancestor
110129764|NCT01956604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110129765|NCT01956604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110129766|NCT01956604|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110129767|NCT01956604|Sympatholytics|sympatholytics|mesh-ancestor
110129768|NCT01956604|Autonomic Agents|autonomic agents|mesh-ancestor
110129769|NCT01956604|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110129770|NCT01956604|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110129771|NCT01956604|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110129772|NCT01956604|Adrenergic Agents|adrenergic agents|mesh-ancestor
110129773|NCT01956604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110129774|NCT01956604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110129776|NCT01956695|Lenalidomide|lenalidomide|mesh-list
110129777|NCT01956695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110129778|NCT01956695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110129779|NCT01956695|Immunologic Factors|immunologic factors|mesh-ancestor
110129780|NCT01956695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110129781|NCT01956695|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110129782|NCT01956695|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110129783|NCT01956695|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110129784|NCT01956695|Growth Substances|growth substances|mesh-ancestor
110129785|NCT01956695|Growth Inhibitors|growth inhibitors|mesh-ancestor
110129786|NCT01956734|Temozolomide|temozolomide|mesh-list
110129787|NCT01956734|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110129788|NCT01956734|Alkylating Agents|alkylating agents|mesh-ancestor
110129789|NCT01956734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110129790|NCT01956734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110129791|NCT01956786|Amlodipine|amlodipine|mesh-list
110129792|NCT01956786|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110129793|NCT01956786|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110129794|NCT01956786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110129795|NCT01956786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110129796|NCT01956786|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110129797|NCT01956786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110129799|NCT01956864|Vitamin D|vitamin d|mesh-list
110129800|NCT01956864|Vitamins|vitamins|mesh-ancestor
110129801|NCT01956864|Micronutrients|micronutrients|mesh-ancestor
110129802|NCT01956864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110129803|NCT01956864|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110129804|NCT01956929|Metformin|metformin|mesh-list
110129805|NCT01956929|Lactulose|lactulose|mesh-list
110129806|NCT01956929|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110129807|NCT01956929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110129808|NCT01956929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110129810|NCT01956955|Enoxaparin|enoxaparin|mesh-list
110129811|NCT01956955|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
110129812|NCT01956955|Calcium heparin|calcium heparin|mesh-list
110129813|NCT01956955|Anticoagulants|anticoagulants|mesh-ancestor
110129814|NCT01956955|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110129815|NCT01956955|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110129816|NCT01956955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110129817|NCT01956981|Magnesium Sulfate|magnesium sulfate|mesh-list
110129818|NCT01956981|Dexmedetomidine|dexmedetomidine|mesh-list
110129819|NCT01956981|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110129820|NCT01956981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110129821|NCT01956981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110129822|NCT01956981|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110129824|NCT01956981|Sensory System Agents|sensory system agents|mesh-ancestor
110129825|NCT01956981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110129826|NCT01956981|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110129827|NCT01956981|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110129828|NCT01956981|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110129829|NCT01956981|Adrenergic Agents|adrenergic agents|mesh-ancestor
110129830|NCT01956981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110129831|NCT01956981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110129832|NCT01956981|Anesthetics|anesthetics|mesh-ancestor
110129833|NCT01956981|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110129834|NCT01956981|Anticonvulsants|anticonvulsants|mesh-ancestor
110129835|NCT01956981|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110129836|NCT01956981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110129837|NCT01956981|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110129838|NCT01956981|Tocolytic Agents|tocolytic agents|mesh-ancestor
110129839|NCT01956981|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110129840|NCT01957007|Docetaxel|docetaxel|mesh-list
110129841|NCT01957007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110129842|NCT01957007|Tubulin Modulators|tubulin modulators|mesh-ancestor
110129843|NCT01957007|Antimitotic Agents|antimitotic agents|mesh-ancestor
110129844|NCT01957007|Mitosis Modulators|mitosis modulators|mesh-ancestor
110129845|NCT01957007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110129846|NCT01957046|Laxatives|laxatives|mesh-list
110129847|NCT01957046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110129848|NCT01957189|Tamsulosin|tamsulosin|mesh-list
110129849|NCT01957189|Dutasteride|dutasteride|mesh-list
110129850|NCT01957189|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110129851|NCT01957189|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110129852|NCT01957189|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110129853|NCT01957189|Adrenergic Agents|adrenergic agents|mesh-ancestor
110129854|NCT01957189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110129855|NCT01957189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110129856|NCT01957189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110129857|NCT01957189|Urological Agents|urological agents|mesh-ancestor
110129858|NCT01957189|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
110129859|NCT01957189|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110129860|NCT01957189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110129861|NCT01957189|Hormone Antagonists|hormone antagonists|mesh-ancestor
110129862|NCT01957189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110129863|NCT01957293|Albuterol|albuterol|mesh-list
110129864|NCT01957293|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110129865|NCT01957293|Autonomic Agents|autonomic agents|mesh-ancestor
110129866|NCT01957293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110129867|NCT01957293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110129868|NCT01957293|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110129869|NCT01957293|Respiratory System Agents|respiratory system agents|mesh-ancestor
110129870|NCT01957293|Tocolytic Agents|tocolytic agents|mesh-ancestor
110129871|NCT01957293|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110129872|NCT01957293|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110129873|NCT01957293|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110129874|NCT01957293|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110129875|NCT01957293|Adrenergic Agents|adrenergic agents|mesh-ancestor
110129876|NCT01957293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110129877|NCT01957293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110129878|NCT01957319|Vitamin E|vitamin e|mesh-list
110129879|NCT01957319|Silybin|silybin|mesh-list
110129880|NCT01957319|Vitamins|vitamins|mesh-ancestor
110129881|NCT01957319|Micronutrients|micronutrients|mesh-ancestor
110129882|NCT01957319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110129883|NCT01957319|Antioxidants|antioxidants|mesh-ancestor
110129884|NCT01957319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110129885|NCT01957319|Protective Agents|protective agents|mesh-ancestor
110129886|NCT01957319|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110129887|NCT01957319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110129888|NCT01957436|Docetaxel|docetaxel|mesh-list
110129889|NCT01957436|Abiraterone Acetate|abiraterone acetate|mesh-list
110129890|NCT01957436|Androgens|androgens|mesh-list
110129891|NCT01957436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110129892|NCT01957436|Tubulin Modulators|tubulin modulators|mesh-ancestor
110129893|NCT01957436|Antimitotic Agents|antimitotic agents|mesh-ancestor
110129894|NCT01957436|Mitosis Modulators|mitosis modulators|mesh-ancestor
110129895|NCT01957436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110129896|NCT01957436|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110129897|NCT01957436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110129898|NCT01957436|Hormone Antagonists|hormone antagonists|mesh-ancestor
110129899|NCT01957436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110129900|NCT01957436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110129901|NCT01957436|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110129902|NCT01957436|Hormones|hormones|mesh-ancestor
110129903|NCT01957449|Propranolol|propranolol|mesh-list
110129904|NCT01957449|Metoprolol|metoprolol|mesh-list
110129905|NCT01957449|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110129906|NCT01957449|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110129907|NCT01957449|Adrenergic Agents|adrenergic agents|mesh-ancestor
110129908|NCT01957449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110129909|NCT01957449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110129910|NCT01957449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110129911|NCT01957449|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110129912|NCT01957449|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110129913|NCT01957449|Vasodilator Agents|vasodilator agents|mesh-ancestor
110129915|NCT01957449|Autonomic Agents|autonomic agents|mesh-ancestor
110129916|NCT01957449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110129917|NCT01957449|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110129918|NCT01957540|Ticagrelor|ticagrelor|mesh-list
110129919|NCT01957540|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
110129920|NCT01957540|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110129921|NCT01957540|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110129922|NCT01957540|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110129923|NCT01957540|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110129924|NCT01957540|Purinergic Agents|purinergic agents|mesh-ancestor
110129925|NCT01957540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110129926|NCT01957540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110129927|NCT01957540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110129928|NCT01957631|Methylprednisolone|methylprednisolone|mesh-list
110129929|NCT01957631|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110129930|NCT01957631|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110129931|NCT01957631|Prednisolone|prednisolone|mesh-list
110129932|NCT01957631|Prednisolone acetate|prednisolone acetate|mesh-list
110129933|NCT01957631|Bupivacaine|bupivacaine|mesh-list
110129934|NCT01957631|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110129935|NCT01957631|Prednisolone phosphate|prednisolone phosphate|mesh-list
110129936|NCT01957631|Anesthetics, Local|anesthetics, local|mesh-ancestor
110129937|NCT01957631|Anesthetics|anesthetics|mesh-ancestor
110129938|NCT01957631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110129939|NCT01957631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110129940|NCT01957631|Sensory System Agents|sensory system agents|mesh-ancestor
110129941|NCT01957631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110129942|NCT01957631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110129943|NCT01957631|Antiemetics|antiemetics|mesh-ancestor
110129944|NCT01957631|Autonomic Agents|autonomic agents|mesh-ancestor
110129945|NCT01957631|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110129946|NCT01957631|Glucocorticoids|glucocorticoids|mesh-ancestor
110129947|NCT01957631|Hormones|hormones|mesh-ancestor
110129948|NCT01957631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110129949|NCT01957631|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110129950|NCT01957631|Protective Agents|protective agents|mesh-ancestor
110129951|NCT01957631|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110129952|NCT01957631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110129953|NCT01957839|Cabergoline|cabergoline|mesh-list
110129954|NCT01957839|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110129955|NCT01957839|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110129956|NCT01957839|Dopamine Agonists|dopamine agonists|mesh-ancestor
110129957|NCT01957839|Dopamine Agents|dopamine agents|mesh-ancestor
110129958|NCT01957839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110129959|NCT01957839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110129960|NCT01957839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110129961|NCT01957852|Thrombin|thrombin|mesh-list
110129962|NCT01957852|Hemostatics|hemostatics|mesh-ancestor
110129963|NCT01957852|Coagulants|coagulants|mesh-ancestor
110129964|NCT01957943|SMOFlipid|smoflipid|mesh-list
110129965|NCT01957943|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
110129966|NCT01957943|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
110129967|NCT01957943|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110129968|NCT01957995|Docetaxel|docetaxel|mesh-list
110129969|NCT01957995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110129970|NCT01957995|Tubulin Modulators|tubulin modulators|mesh-ancestor
110129971|NCT01957995|Antimitotic Agents|antimitotic agents|mesh-ancestor
110129972|NCT01957995|Mitosis Modulators|mitosis modulators|mesh-ancestor
110129973|NCT01957995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110129974|NCT01958138|Propofol|propofol|mesh-list
110129975|NCT01958138|Isoflurane|isoflurane|mesh-list
110129976|NCT01958138|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110129977|NCT01958138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110129978|NCT01958138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110129979|NCT01958138|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110129980|NCT01958138|Anesthetics, General|anesthetics, general|mesh-ancestor
110129981|NCT01958138|Anesthetics|anesthetics|mesh-ancestor
110129982|NCT01958138|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110129983|NCT01958216|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
110129984|NCT01958216|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
110129985|NCT01958216|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
110129986|NCT01958216|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110129987|NCT01958372|Etoposide|etoposide|mesh-list
110129988|NCT01958372|Pemetrexed|pemetrexed|mesh-list
110129989|NCT01958372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110129990|NCT01958372|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110129991|NCT01958372|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110129992|NCT01958372|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110129993|NCT01958372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110129994|NCT01958372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110129995|NCT01958372|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110129996|NCT01958372|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110129997|NCT01958580|Gemcitabine|gemcitabine|mesh-list
110129998|NCT01958580|Docetaxel|docetaxel|mesh-list
110129999|NCT01958580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110130000|NCT01958580|Antimetabolites|antimetabolites|mesh-ancestor
110130001|NCT01958580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110130002|NCT01958580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110130003|NCT01958580|Tubulin Modulators|tubulin modulators|mesh-ancestor
110130004|NCT01958580|Antimitotic Agents|antimitotic agents|mesh-ancestor
110130005|NCT01958580|Mitosis Modulators|mitosis modulators|mesh-ancestor
110130007|NCT01958684|Levonorgestrel|levonorgestrel|mesh-list
110130008|NCT01958684|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110343860|NCT06016738|Letrozole|letrozole|mesh-list
110130009|NCT01958684|Contraceptive Agents|contraceptive agents|mesh-ancestor
110130010|NCT01958684|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110130011|NCT01958684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110130012|NCT01958684|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110130013|NCT01958684|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110130014|NCT01958684|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110130015|NCT01958684|Trace Elements|trace elements|mesh-ancestor
110130016|NCT01958684|Micronutrients|micronutrients|mesh-ancestor
110130017|NCT01958775|Glucagon|glucagon|mesh-list
110165027|NCT00022321|Immunotoxins|immunotoxins|mesh-ancestor
110130018|NCT01958775|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
110130019|NCT01958775|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110130021|NCT01958775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110130022|NCT01958775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110130023|NCT01958775|Incretins|incretins|mesh-ancestor
110130024|NCT01958814|Albuterol|albuterol|mesh-list
110130025|NCT01958814|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110130026|NCT01958814|Autonomic Agents|autonomic agents|mesh-ancestor
110130027|NCT01958814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110130028|NCT01958814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110130029|NCT01958814|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110130030|NCT01958814|Respiratory System Agents|respiratory system agents|mesh-ancestor
110130031|NCT01958814|Tocolytic Agents|tocolytic agents|mesh-ancestor
110130032|NCT01958814|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110130033|NCT01958814|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110130034|NCT01958814|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110130035|NCT01958814|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110130036|NCT01958814|Adrenergic Agents|adrenergic agents|mesh-ancestor
110130037|NCT01958814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110130038|NCT01958814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110130039|NCT01958866|Acetaminophen|acetaminophen|mesh-list
110130040|NCT01958866|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110130041|NCT01958866|Analgesics|analgesics|mesh-ancestor
110130042|NCT01958866|Sensory System Agents|sensory system agents|mesh-ancestor
110130043|NCT01958866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110130044|NCT01958866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110130045|NCT01958866|Antipyretics|antipyretics|mesh-ancestor
110130046|NCT01958905|Lumefantrine|lumefantrine|mesh-list
110130047|NCT01958905|Artemether|artemether|mesh-list
110130048|NCT01958905|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
110130049|NCT01958905|Antimalarials|antimalarials|mesh-ancestor
110130050|NCT01958905|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110130051|NCT01958905|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110130052|NCT01958905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110130053|NCT01958944|Nitric Oxide|nitric oxide|mesh-list
110130054|NCT01958944|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110130055|NCT01958944|Autonomic Agents|autonomic agents|mesh-ancestor
110130056|NCT01958944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110130057|NCT01958944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110130058|NCT01958944|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110130059|NCT01958944|Respiratory System Agents|respiratory system agents|mesh-ancestor
110130060|NCT01958944|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110130061|NCT01958944|Antioxidants|antioxidants|mesh-ancestor
110130062|NCT01958944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110130063|NCT01958944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110130064|NCT01958944|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
110130065|NCT01958944|Vasodilator Agents|vasodilator agents|mesh-ancestor
110130066|NCT01958944|Gasotransmitters|gasotransmitters|mesh-ancestor
110130067|NCT01958944|Protective Agents|protective agents|mesh-ancestor
110130068|NCT01958996|Idarubicin|idarubicin|mesh-list
110130069|NCT01958996|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110130070|NCT01958996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110130071|NCT01958996|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110130072|NCT01958996|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110130073|NCT01958996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110130074|NCT01958996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110130075|NCT01959022|Doxazosin|doxazosin|mesh-list
110130076|NCT01959022|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110130077|NCT01959022|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110130078|NCT01959022|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110130079|NCT01959022|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110130080|NCT01959022|Adrenergic Agents|adrenergic agents|mesh-ancestor
110130081|NCT01959022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110130082|NCT01959022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110130083|NCT01959022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110130084|NCT01959061|Oxaliplatin|oxaliplatin|mesh-list
110130085|NCT01959061|Ethiodized Oil|ethiodized oil|mesh-list
110130086|NCT01959061|Raltitrexed|raltitrexed|mesh-list
110130087|NCT01959061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110130088|NCT01959061|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110130089|NCT01959061|Antimetabolites|antimetabolites|mesh-ancestor
110130090|NCT01959061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110130091|NCT01959061|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110130092|NCT01959061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110130093|NCT01959074|Aceclofenac|aceclofenac|mesh-list
110130095|NCT01959074|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110130096|NCT01959074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110130097|NCT01959074|Analgesics|analgesics|mesh-ancestor
110130098|NCT01959074|Sensory System Agents|sensory system agents|mesh-ancestor
110130099|NCT01959074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110130100|NCT01959074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110130101|NCT01959074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110130102|NCT01959074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110130103|NCT01959074|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110130104|NCT01959074|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110130105|NCT01959074|Adrenergic Agents|adrenergic agents|mesh-ancestor
110130106|NCT01959074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110130107|NCT01959074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110130108|NCT01959074|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110130109|NCT01959074|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110130110|NCT01959074|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110130111|NCT01959074|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110130112|NCT01959074|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110130113|NCT01959100|Azithromycin|azithromycin|mesh-list
110130114|NCT01959100|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110130115|NCT01959100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110130116|NCT01959152|Imidacloprid|imidacloprid|mesh-list
110130117|NCT01959152|Cholinergic Agents|cholinergic agents|mesh-ancestor
110130118|NCT01959152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110343886|NCT06016218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110130119|NCT01959152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110130120|NCT01959152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110130121|NCT01959191|Aspirin|aspirin|mesh-list
110130122|NCT01959191|Clopidogrel|clopidogrel|mesh-list
110130123|NCT01959191|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110130124|NCT01959191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110130125|NCT01959191|Analgesics|analgesics|mesh-ancestor
110130126|NCT01959191|Sensory System Agents|sensory system agents|mesh-ancestor
110130127|NCT01959191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110130128|NCT01959191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110130129|NCT01959191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110130130|NCT01959191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110130131|NCT01959191|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110130132|NCT01959191|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110130133|NCT01959191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110130134|NCT01959191|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110130135|NCT01959191|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110130136|NCT01959191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110130137|NCT01959191|Antipyretics|antipyretics|mesh-ancestor
110130138|NCT01959191|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110130139|NCT01959191|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110130140|NCT01959191|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110130141|NCT01959191|Purinergic Agents|purinergic agents|mesh-ancestor
110130142|NCT01959191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110130143|NCT01959386|Trastuzumab|trastuzumab|mesh-list
110130144|NCT01959386|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110130145|NCT01959386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110130146|NCT01959399|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110130147|NCT01959399|Peficitinib|peficitinib|mesh-list
110130148|NCT01959399|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110130149|NCT01959399|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110130150|NCT01959399|Antimetabolites|antimetabolites|mesh-ancestor
110130151|NCT01959399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110130152|NCT01959399|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110130153|NCT01959399|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110130154|NCT01959399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110130155|NCT01959399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110130156|NCT01959399|Immunologic Factors|immunologic factors|mesh-ancestor
110130157|NCT01959399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110130158|NCT01959438|Selenious Acid|selenious acid|mesh-list
110130159|NCT01959438|Sodium Selenite|sodium selenite|mesh-list
110130160|NCT01959438|Trace Elements|trace elements|mesh-ancestor
110130161|NCT01959438|Micronutrients|micronutrients|mesh-ancestor
110130162|NCT01959438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110130163|NCT01959451|Clopidogrel|clopidogrel|mesh-list
110130164|NCT01959451|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
110130165|NCT01959451|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110130166|NCT01959451|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110130167|NCT01959451|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110130168|NCT01959451|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110130169|NCT01959451|Purinergic Agents|purinergic agents|mesh-ancestor
110130170|NCT01959451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110130171|NCT01959451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110130172|NCT01959451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110130173|NCT01959477|Cyclophosphamide|cyclophosphamide|mesh-list
110130174|NCT01959477|Busulfan|busulfan|mesh-list
110130175|NCT01959477|Etoposide|etoposide|mesh-list
110130176|NCT01959477|Etoposide phosphate|etoposide phosphate|mesh-list
110130177|NCT01959477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110130178|NCT01959477|Immunologic Factors|immunologic factors|mesh-ancestor
110130179|NCT01959477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110130180|NCT01959477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110130181|NCT01959477|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110130182|NCT01959477|Alkylating Agents|alkylating agents|mesh-ancestor
110130183|NCT01959477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110130184|NCT01959477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110130185|NCT01959477|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110130186|NCT01959477|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110130187|NCT01959477|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110130188|NCT01959477|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110130189|NCT01959477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110130190|NCT01959828|Nitric Oxide|nitric oxide|mesh-list
110130191|NCT01959828|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110130192|NCT01959828|Autonomic Agents|autonomic agents|mesh-ancestor
110130193|NCT01959828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110130194|NCT01959828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110130195|NCT01959828|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110130196|NCT01959828|Respiratory System Agents|respiratory system agents|mesh-ancestor
110130197|NCT01959828|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110130198|NCT01959828|Antioxidants|antioxidants|mesh-ancestor
110130199|NCT01959828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110130200|NCT01959828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110130201|NCT01959828|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
110130202|NCT01959828|Vasodilator Agents|vasodilator agents|mesh-ancestor
110130204|NCT01959828|Protective Agents|protective agents|mesh-ancestor
110130205|NCT01959854|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
110130206|NCT01959854|Laxatives|laxatives|mesh-ancestor
110130207|NCT01959854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110130208|NCT01959971|Alirocumab|alirocumab|mesh-list
110130209|NCT01959971|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
110130210|NCT01959971|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110130211|NCT01959971|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110130212|NCT01959971|Antimetabolites|antimetabolites|mesh-ancestor
110130213|NCT01959971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110130214|NCT01959971|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110130215|NCT01959971|Protease Inhibitors|protease inhibitors|mesh-ancestor
110130216|NCT01959971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110130217|NCT01959971|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110130218|NCT01960023|Cetuximab|cetuximab|mesh-list
110130219|NCT01960023|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110130220|NCT01960023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110130221|NCT01960049|Ropivacaine|ropivacaine|mesh-list
110130222|NCT01960049|Anesthetics, Local|anesthetics, local|mesh-ancestor
110130223|NCT01960049|Anesthetics|anesthetics|mesh-ancestor
110130224|NCT01960049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110130225|NCT01960049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110130226|NCT01960049|Sensory System Agents|sensory system agents|mesh-ancestor
110130227|NCT01960049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110130228|NCT01960153|Tadalafil|tadalafil|mesh-list
110130229|NCT01960153|Vasodilator Agents|vasodilator agents|mesh-ancestor
110130230|NCT01960153|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110130231|NCT01960153|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110130232|NCT01960153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110130233|NCT01960153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110130234|NCT01960153|Urological Agents|urological agents|mesh-ancestor
110130235|NCT01960179|Lixisenatide|lixisenatide|mesh-list
110130236|NCT01960179|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110130237|NCT01960179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110130238|NCT01960205|Metformin|metformin|mesh-list
110130239|NCT01960205|Saxagliptin|saxagliptin|mesh-list
110130240|NCT01960205|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110130241|NCT01960205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110130243|NCT01960205|Hormones|hormones|mesh-ancestor
110130244|NCT01960205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110130245|NCT01960205|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110130246|NCT01960205|Protease Inhibitors|protease inhibitors|mesh-ancestor
110130247|NCT01960205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110130248|NCT01960205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110130249|NCT01960283|Methotrexate|methotrexate|mesh-list
110130250|NCT01960283|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110130251|NCT01960283|Abortifacient Agents|abortifacient agents|mesh-ancestor
110130252|NCT01960283|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110130253|NCT01960283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110130254|NCT01960283|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110130255|NCT01960283|Antimetabolites|antimetabolites|mesh-ancestor
110130256|NCT01960283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110130257|NCT01960283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110130258|NCT01960283|Dermatologic Agents|dermatologic agents|mesh-ancestor
110130259|NCT01960283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110130260|NCT01960283|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110130261|NCT01960283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110130262|NCT01960283|Immunologic Factors|immunologic factors|mesh-ancestor
110130263|NCT01960283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110130264|NCT01960283|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110130266|NCT01960426|Infliximab|infliximab|mesh-list
110130267|NCT01960426|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110130268|NCT01960426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110130269|NCT01960426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110130270|NCT01960426|Dermatologic Agents|dermatologic agents|mesh-ancestor
110130271|NCT01960426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110130272|NCT01960543|Fentanyl|fentanyl|mesh-list
110130273|NCT01960543|Bupivacaine|bupivacaine|mesh-list
110130274|NCT01960543|Levobupivacaine|levobupivacaine|mesh-list
110130275|NCT01960543|Anesthetics, Local|anesthetics, local|mesh-ancestor
110130276|NCT01960543|Anesthetics|anesthetics|mesh-ancestor
110130277|NCT01960543|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110130278|NCT01960543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110130279|NCT01960543|Sensory System Agents|sensory system agents|mesh-ancestor
110130280|NCT01960543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110130281|NCT01960543|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110130282|NCT01960543|Narcotics|narcotics|mesh-ancestor
110130283|NCT01960543|Analgesics|analgesics|mesh-ancestor
110130284|NCT01960543|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110130285|NCT01960543|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110130286|NCT01960543|Anesthetics, General|anesthetics, general|mesh-ancestor
110130287|NCT01960569|Hirudins|hirudins|mesh-list
110130288|NCT01960569|Antithrombins|antithrombins|mesh-ancestor
110130289|NCT01960569|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110130290|NCT01960569|Protease Inhibitors|protease inhibitors|mesh-ancestor
110130291|NCT01960569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110130292|NCT01960569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110130293|NCT01960569|Anticoagulants|anticoagulants|mesh-ancestor
110130294|NCT01960569|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110130295|NCT01960569|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110130296|NCT01960595|Fentanyl|fentanyl|mesh-list
110130297|NCT01960595|Bupivacaine|bupivacaine|mesh-list
110130298|NCT01960595|Anesthetics, Local|anesthetics, local|mesh-ancestor
110130299|NCT01960595|Anesthetics|anesthetics|mesh-ancestor
110130300|NCT01960595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110130301|NCT01960595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110130302|NCT01960595|Sensory System Agents|sensory system agents|mesh-ancestor
110130303|NCT01960595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110130304|NCT01960595|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110343938|NCT06012734|LB100|lb100|mesh-list
110130305|NCT01960595|Narcotics|narcotics|mesh-ancestor
110130306|NCT01960595|Analgesics|analgesics|mesh-ancestor
110130307|NCT01960595|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110130308|NCT01960595|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110130309|NCT01960595|Anesthetics, General|anesthetics, general|mesh-ancestor
110130310|NCT01960647|Paclitaxel|paclitaxel|mesh-list
110130311|NCT01960647|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110130312|NCT01960647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110130313|NCT01960647|Tubulin Modulators|tubulin modulators|mesh-ancestor
110130314|NCT01960647|Antimitotic Agents|antimitotic agents|mesh-ancestor
110130315|NCT01960647|Mitosis Modulators|mitosis modulators|mesh-ancestor
110130316|NCT01960647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110130317|NCT01960764|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110130318|NCT01960764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110130319|NCT01960829|Everolimus|everolimus|mesh-list
110130320|NCT01960829|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110130321|NCT01960829|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110130322|NCT01960829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110130323|NCT01960829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110130324|NCT01960829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110130325|NCT01960829|Immunologic Factors|immunologic factors|mesh-ancestor
110130326|NCT01960829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110130327|NCT01960829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110130328|NCT01961154|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
110130329|NCT01961154|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
110130330|NCT01961154|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110130331|NCT01961154|Respiratory System Agents|respiratory system agents|mesh-ancestor
110130332|NCT01961154|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110130333|NCT01961154|Autonomic Agents|autonomic agents|mesh-ancestor
110130334|NCT01961154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110130335|NCT01961154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110130336|NCT01961154|Glucocorticoids|glucocorticoids|mesh-ancestor
110130337|NCT01961154|Hormones|hormones|mesh-ancestor
110130338|NCT01961154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110130339|NCT01961154|Sympathomimetics|sympathomimetics|mesh-ancestor
110130340|NCT01961180|Escitalopram|escitalopram|mesh-list
110130341|NCT01961180|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110130342|NCT01961180|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110130343|NCT01961180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110130344|NCT01961180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110130345|NCT01961180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110130346|NCT01961180|Serotonin Agents|serotonin agents|mesh-ancestor
110130347|NCT01961180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110130349|NCT01961193|Trace Elements|trace elements|mesh-ancestor
110130350|NCT01961193|Micronutrients|micronutrients|mesh-ancestor
110130351|NCT01961193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110130352|NCT01961219|Anesthetics|anesthetics|mesh-list
110130353|NCT01961219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110130354|NCT01961219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110130355|NCT01961336|Testosterone|testosterone|mesh-list
110130356|NCT01961336|Androgens|androgens|mesh-ancestor
110130357|NCT01961336|Hormones|hormones|mesh-ancestor
110130358|NCT01961336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110130359|NCT01961336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110130360|NCT01961388|Metformin|metformin|mesh-list
110130361|NCT01961388|Acarbose|acarbose|mesh-list
110130363|NCT01961388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110130364|NCT01961388|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
110130365|NCT01961388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110130366|NCT01961388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110130367|NCT01961414|Aflibercept|aflibercept|mesh-list
110130368|NCT01961414|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110130369|NCT01961414|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110130370|NCT01961414|Growth Substances|growth substances|mesh-ancestor
110130371|NCT01961414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110130372|NCT01961414|Growth Inhibitors|growth inhibitors|mesh-ancestor
110130373|NCT01961414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110130374|NCT01961453|Isosorbide|isosorbide|mesh-list
110130375|NCT01961453|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
110130376|NCT01961453|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
110130377|NCT01961453|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110130378|NCT01961453|Diuretics|diuretics|mesh-ancestor
110130379|NCT01961453|Natriuretic Agents|natriuretic agents|mesh-ancestor
110130380|NCT01961453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110130381|NCT01961453|Vasodilator Agents|vasodilator agents|mesh-ancestor
110130382|NCT01961453|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
110130383|NCT01961453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110130384|NCT01961635|Cimetidine|cimetidine|mesh-list
110130385|NCT01961635|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110130386|NCT01961635|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110130387|NCT01961635|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110130388|NCT01961635|Histamine Antagonists|histamine antagonists|mesh-ancestor
110130389|NCT01961635|Histamine Agents|histamine agents|mesh-ancestor
110130390|NCT01961635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110130391|NCT01961635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110130392|NCT01961635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110130393|NCT01961635|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110130394|NCT01961635|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110130396|NCT01961739|Lidocaine|lidocaine|mesh-list
110130397|NCT01961739|Anesthetics, Local|anesthetics, local|mesh-ancestor
110130398|NCT01961739|Anesthetics|anesthetics|mesh-ancestor
110130399|NCT01961739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110130400|NCT01961739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110130401|NCT01961739|Sensory System Agents|sensory system agents|mesh-ancestor
110130402|NCT01961739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110130403|NCT01961739|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110130404|NCT01961739|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110130405|NCT01961739|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110130406|NCT01961739|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110130407|NCT01961739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110130408|NCT01961752|Triamcinolone|triamcinolone|mesh-list
110130409|NCT01961752|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110130410|NCT01961752|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110130411|NCT01961752|Bupivacaine|bupivacaine|mesh-list
110130412|NCT01961752|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110130413|NCT01961752|Anesthetics, Local|anesthetics, local|mesh-ancestor
110130414|NCT01961752|Anesthetics|anesthetics|mesh-ancestor
110130415|NCT01961752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110130416|NCT01961752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110130417|NCT01961752|Sensory System Agents|sensory system agents|mesh-ancestor
110130418|NCT01961752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110130419|NCT01961752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110130420|NCT01961752|Glucocorticoids|glucocorticoids|mesh-ancestor
110130421|NCT01961752|Hormones|hormones|mesh-ancestor
110130422|NCT01961752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110130423|NCT01961752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110130424|NCT01961752|Immunologic Factors|immunologic factors|mesh-ancestor
110130425|NCT01961752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110130426|NCT01961752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110130427|NCT01961830|Arbekacin|arbekacin|mesh-list
110130428|NCT01961830|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110130429|NCT01961830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110130430|NCT01961843|Prednisone|prednisone|mesh-list
110130431|NCT01961843|Abiraterone Acetate|abiraterone acetate|mesh-list
110130432|NCT01961843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110130433|NCT01961843|Glucocorticoids|glucocorticoids|mesh-ancestor
110130434|NCT01961843|Hormones|hormones|mesh-ancestor
110130435|NCT01961843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110130436|NCT01961843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110130437|NCT01961843|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110130438|NCT01961843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110130439|NCT01961843|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110130440|NCT01961843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110130441|NCT01961843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110130442|NCT01961843|Hormone Antagonists|hormone antagonists|mesh-ancestor
110130443|NCT01961843|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110130444|NCT01961856|Clopidogrel|clopidogrel|mesh-list
110130445|NCT01961856|Ticagrelor|ticagrelor|mesh-list
110130446|NCT01961856|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110130447|NCT01961856|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110130448|NCT01961856|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110130449|NCT01961856|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110130450|NCT01961856|Purinergic Agents|purinergic agents|mesh-ancestor
110130451|NCT01961856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110130452|NCT01961856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110130453|NCT01961856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110130454|NCT01961947|Vaccines|vaccines|mesh-list
110130455|NCT01961947|Immunologic Factors|immunologic factors|mesh-ancestor
110130456|NCT01961947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110130457|NCT01962116|Heparin|heparin|mesh-list
110130458|NCT01962116|Calcium heparin|calcium heparin|mesh-list
110130459|NCT01962116|Anticoagulants|anticoagulants|mesh-ancestor
110130460|NCT01962116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110130461|NCT01962116|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110130462|NCT01962116|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110130464|NCT01962181|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110130465|NCT01962181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110130466|NCT01962181|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110130467|NCT01962181|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110130468|NCT01962181|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110130469|NCT01962181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110130470|NCT01962181|Dopamine Agents|dopamine agents|mesh-ancestor
110130471|NCT01962181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110130472|NCT01962285|Propofol|propofol|mesh-list
110130473|NCT01962285|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110130474|NCT01962285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110130475|NCT01962285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110130476|NCT01962285|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110130477|NCT01962285|Anesthetics, General|anesthetics, general|mesh-ancestor
110130478|NCT01962285|Anesthetics|anesthetics|mesh-ancestor
110130479|NCT01962363|Tocotrienols|tocotrienols|mesh-list
110130480|NCT01962363|Tocotrienol, alpha|tocotrienol, alpha|mesh-list
110130481|NCT01962363|Antioxidants|antioxidants|mesh-ancestor
110130482|NCT01962363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110130483|NCT01962363|Protective Agents|protective agents|mesh-ancestor
110130484|NCT01962363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110130485|NCT01962363|Vitamins|vitamins|mesh-ancestor
110130486|NCT01962363|Micronutrients|micronutrients|mesh-ancestor
110130487|NCT01962376|Bevacizumab|bevacizumab|mesh-list
110130488|NCT01962376|Capecitabine|capecitabine|mesh-list
110130489|NCT01962376|Oxaliplatin|oxaliplatin|mesh-list
110130490|NCT01962376|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110130491|NCT01962376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110130492|NCT01962376|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110130493|NCT01962376|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110130494|NCT01962376|Growth Substances|growth substances|mesh-ancestor
110130495|NCT01962376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110130496|NCT01962376|Growth Inhibitors|growth inhibitors|mesh-ancestor
110130497|NCT01962376|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110130498|NCT01962376|Antimetabolites|antimetabolites|mesh-ancestor
110130499|NCT01962376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110130500|NCT01962454|Methyltestosterone|methyltestosterone|mesh-list
110130501|NCT01962454|Testosterone|testosterone|mesh-list
110165069|NCT00010686|Hormones|hormones|mesh-ancestor
110130502|NCT01962454|Testosterone undecanoate|testosterone undecanoate|mesh-list
110130503|NCT01962454|Testosterone enanthate|testosterone enanthate|mesh-list
110130504|NCT01962454|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
110130505|NCT01962454|Androgens|androgens|mesh-ancestor
110130506|NCT01962454|Hormones|hormones|mesh-ancestor
110130507|NCT01962454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110130508|NCT01962454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110130509|NCT01962454|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110130510|NCT01962454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110130511|NCT01962454|Anabolic Agents|anabolic agents|mesh-ancestor
110130512|NCT01962571|Epoetin Alfa|epoetin alfa|mesh-list
110130513|NCT01962571|Hematinics|hematinics|mesh-ancestor
110130514|NCT01962831|Dinoprostone|dinoprostone|mesh-list
110130515|NCT01962831|Oxytocics|oxytocics|mesh-ancestor
110130516|NCT01962831|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110130517|NCT01962831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110130518|NCT01963039|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
110130519|NCT01963039|Vasodilator Agents|vasodilator agents|mesh-ancestor
110130520|NCT01963039|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
110130521|NCT01963039|Protective Agents|protective agents|mesh-ancestor
110130522|NCT01963039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110130523|NCT01963182|Irinotecan|irinotecan|mesh-list
110130524|NCT01963182|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110130525|NCT01963182|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110130526|NCT01963182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110130527|NCT01963182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110130528|NCT01963182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110130529|NCT01963221|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110130530|NCT01963221|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110130531|NCT01963221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110130532|NCT01963299|Clonidine|clonidine|mesh-list
110130533|NCT01963299|Ropivacaine|ropivacaine|mesh-list
110130534|NCT01963299|Anesthetics, Local|anesthetics, local|mesh-ancestor
110130535|NCT01963299|Anesthetics|anesthetics|mesh-ancestor
110130536|NCT01963299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110130537|NCT01963299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110130538|NCT01963299|Sensory System Agents|sensory system agents|mesh-ancestor
110130539|NCT01963299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110130540|NCT01963299|Analgesics|analgesics|mesh-ancestor
110130541|NCT01963299|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110130542|NCT01963299|Sympatholytics|sympatholytics|mesh-ancestor
110130543|NCT01963299|Autonomic Agents|autonomic agents|mesh-ancestor
110130544|NCT01963299|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110130545|NCT01963299|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110130546|NCT01963299|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110130547|NCT01963299|Adrenergic Agents|adrenergic agents|mesh-ancestor
110130548|NCT01963299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110130549|NCT01963299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110130550|NCT01963325|Paclitaxel|paclitaxel|mesh-list
110130551|NCT01963325|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110130552|NCT01963325|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110130553|NCT01963325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110130554|NCT01963325|Tubulin Modulators|tubulin modulators|mesh-ancestor
110130555|NCT01963325|Antimitotic Agents|antimitotic agents|mesh-ancestor
110130556|NCT01963325|Mitosis Modulators|mitosis modulators|mesh-ancestor
110130557|NCT01963325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110130559|NCT01963390|Androgens|androgens|mesh-ancestor
110130560|NCT01963390|Hormones|hormones|mesh-ancestor
110130561|NCT01963390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110130562|NCT01963390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110130563|NCT01963416|Micronutrients|micronutrients|mesh-list
110130564|NCT01963416|Trace Elements|trace elements|mesh-list
110130565|NCT01963416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110130566|NCT01963442|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
110130567|NCT01963442|Lactams|lactams|mesh-list
110130568|NCT01963442|beta-Lactams|beta-lactams|mesh-list
110130569|NCT01963442|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110130570|NCT01963442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110130571|NCT01963442|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110130572|NCT01963442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110130573|NCT01963442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110130575|NCT01963546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110130576|NCT01963546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110130577|NCT01963546|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110130578|NCT01963546|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110130579|NCT01963546|Analgesics|analgesics|mesh-ancestor
110130580|NCT01963546|Sensory System Agents|sensory system agents|mesh-ancestor
110130581|NCT01963546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110130582|NCT01963546|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110130583|NCT01963546|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110130584|NCT01963546|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110130585|NCT01963546|Adrenergic Agents|adrenergic agents|mesh-ancestor
110130586|NCT01963546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110130587|NCT01963546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110130588|NCT01963559|Lidocaine|lidocaine|mesh-list
110130589|NCT01963559|Prilocaine|prilocaine|mesh-list
110130590|NCT01963559|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
110130591|NCT01963559|Anesthetics, Local|anesthetics, local|mesh-ancestor
110130592|NCT01963559|Anesthetics|anesthetics|mesh-ancestor
110130593|NCT01963559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110130594|NCT01963559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110130595|NCT01963559|Sensory System Agents|sensory system agents|mesh-ancestor
110130596|NCT01963559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110130597|NCT01963559|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110130598|NCT01963559|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110130599|NCT01963559|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110130600|NCT01963559|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110130601|NCT01963559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110130602|NCT01963559|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
110130603|NCT01963663|Metformin|metformin|mesh-list
110130604|NCT01963663|Pioglitazone|pioglitazone|mesh-list
110130605|NCT01963663|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110130606|NCT01963663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110130607|NCT01963702|Capecitabine|capecitabine|mesh-list
110130608|NCT01963702|Oxaliplatin|oxaliplatin|mesh-list
110130609|NCT01963702|Docetaxel|docetaxel|mesh-list
110130610|NCT01963702|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110130611|NCT01963702|Antimetabolites|antimetabolites|mesh-ancestor
110130612|NCT01963702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110130613|NCT01963702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110130614|NCT01963702|Tubulin Modulators|tubulin modulators|mesh-ancestor
110130615|NCT01963702|Antimitotic Agents|antimitotic agents|mesh-ancestor
110130616|NCT01963702|Mitosis Modulators|mitosis modulators|mesh-ancestor
110130617|NCT01963741|Histamine|histamine|mesh-list
110130618|NCT01963741|Histamine Agonists|histamine agonists|mesh-ancestor
110130620|NCT01963741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110130621|NCT01963741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110130622|NCT01963741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110130623|NCT01963754|Epinephrine|epinephrine|mesh-list
110130624|NCT01963754|Racepinephrine|racepinephrine|mesh-list
110130625|NCT01963754|Anesthetics|anesthetics|mesh-list
110130626|NCT01963754|Carticaine|carticaine|mesh-list
110130627|NCT01963754|Epinephryl borate|epinephryl borate|mesh-list
110130628|NCT01963754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110130629|NCT01963754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110130630|NCT01963754|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110130631|NCT01963754|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110130632|NCT01963754|Adrenergic Agents|adrenergic agents|mesh-ancestor
110130633|NCT01963754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110130634|NCT01963754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110130635|NCT01963754|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110130636|NCT01963754|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110130637|NCT01963754|Autonomic Agents|autonomic agents|mesh-ancestor
110130638|NCT01963754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110130639|NCT01963754|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110130640|NCT01963754|Respiratory System Agents|respiratory system agents|mesh-ancestor
110130641|NCT01963754|Mydriatics|mydriatics|mesh-ancestor
110130642|NCT01963754|Sympathomimetics|sympathomimetics|mesh-ancestor
110130643|NCT01963754|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110130644|NCT01963754|Anesthetics, Local|anesthetics, local|mesh-ancestor
110130645|NCT01963754|Sensory System Agents|sensory system agents|mesh-ancestor
110130647|NCT01963832|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110130648|NCT01963832|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110130649|NCT01963832|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110130650|NCT01963832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110130651|NCT01963832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110130652|NCT01963832|Serotonin Agents|serotonin agents|mesh-ancestor
110130653|NCT01963832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110130654|NCT01963832|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110130655|NCT01963832|Antidepressive Agents|antidepressive agents|mesh-ancestor
110130656|NCT01963832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110130657|NCT01963832|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110130658|NCT01963832|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110130659|NCT01963832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110130660|NCT01963910|Mannitol|mannitol|mesh-list
110130661|NCT01963910|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110130662|NCT01963910|Diuretics|diuretics|mesh-ancestor
110130663|NCT01963910|Natriuretic Agents|natriuretic agents|mesh-ancestor
110130664|NCT01963910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110130665|NCT01963962|Copper|copper|mesh-list
110130666|NCT01963962|Levonorgestrel|levonorgestrel|mesh-list
110130667|NCT01963962|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110130668|NCT01963962|Contraceptive Agents|contraceptive agents|mesh-ancestor
110130669|NCT01963962|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110130670|NCT01963962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110130671|NCT01963962|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110130672|NCT01963962|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110130673|NCT01963962|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110130674|NCT01963962|Trace Elements|trace elements|mesh-ancestor
110130675|NCT01963962|Micronutrients|micronutrients|mesh-ancestor
110130676|NCT01964001|Vitamins|vitamins|mesh-list
110130677|NCT01964001|Coenzyme Q10|coenzyme q10|mesh-list
110130678|NCT01964001|Vitamin B 6|vitamin b 6|mesh-list
110130679|NCT01964001|Pyridoxal|pyridoxal|mesh-list
110130680|NCT01964001|Pyridoxine|pyridoxine|mesh-list
110130681|NCT01964001|Vitamin B Complex|vitamin b complex|mesh-list
110130682|NCT01964001|Ubiquinone|ubiquinone|mesh-list
110130683|NCT01964001|Micronutrients|micronutrients|mesh-ancestor
110130684|NCT01964001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110130685|NCT01964027|Irinotecan|irinotecan|mesh-list
110130686|NCT01964027|Epirubicin|epirubicin|mesh-list
110130687|NCT01964027|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110130688|NCT01964027|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110130689|NCT01964027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110130690|NCT01964027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110130691|NCT01964027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110130692|NCT01964027|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110130693|NCT01964027|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110130694|NCT01964040|Dexmedetomidine|dexmedetomidine|mesh-list
110130695|NCT01964040|Bupivacaine|bupivacaine|mesh-list
110130696|NCT01964040|Anesthetics, Local|anesthetics, local|mesh-ancestor
110130697|NCT01964040|Anesthetics|anesthetics|mesh-ancestor
110130698|NCT01964040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110130699|NCT01964040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110130700|NCT01964040|Sensory System Agents|sensory system agents|mesh-ancestor
110130701|NCT01964040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110130702|NCT01964040|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110130703|NCT01964040|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110130704|NCT01964040|Analgesics|analgesics|mesh-ancestor
110130705|NCT01964040|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110130706|NCT01964040|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110130707|NCT01964040|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110130708|NCT01964040|Adrenergic Agents|adrenergic agents|mesh-ancestor
110130709|NCT01964040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110130710|NCT01964040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110130711|NCT01964079|Losartan|losartan|mesh-list
110130712|NCT01964079|Amlodipine|amlodipine|mesh-list
110130713|NCT01964079|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110130714|NCT01964079|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110130715|NCT01964079|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110130716|NCT01964079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110130717|NCT01964079|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110130718|NCT01964079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110130719|NCT01964079|Vasodilator Agents|vasodilator agents|mesh-ancestor
110130720|NCT01964079|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110130721|NCT01964079|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110130722|NCT01964079|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110130723|NCT01964157|Ceritinib|ceritinib|mesh-list
110130724|NCT01964157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110130725|NCT01964157|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110130726|NCT01964157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110344024|NCT05943496|Obinutuzumab|obinutuzumab|mesh-list
110130727|NCT01964157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110130728|NCT01964170|Goserelin|goserelin|mesh-list
110130729|NCT01964170|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110130730|NCT01964170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110130731|NCT01964183|Mirabegron|mirabegron|mesh-list
110130732|NCT01964183|Tolterodine Tartrate|tolterodine tartrate|mesh-list
110130733|NCT01964183|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
110130734|NCT01964183|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110130735|NCT01964183|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110130736|NCT01964183|Adrenergic Agents|adrenergic agents|mesh-ancestor
110130737|NCT01964183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110130738|NCT01964183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110130739|NCT01964183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110130740|NCT01964183|Urological Agents|urological agents|mesh-ancestor
110130741|NCT01964183|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110130742|NCT01964183|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110130743|NCT01964183|Cholinergic Agents|cholinergic agents|mesh-ancestor
110130744|NCT01964248|Lidocaine|lidocaine|mesh-list
110130745|NCT01964248|Prilocaine|prilocaine|mesh-list
110130746|NCT01964248|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
110130747|NCT01964248|Anesthetics, Local|anesthetics, local|mesh-ancestor
110130748|NCT01964248|Anesthetics|anesthetics|mesh-ancestor
110130749|NCT01964248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110130750|NCT01964248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110130751|NCT01964248|Sensory System Agents|sensory system agents|mesh-ancestor
110130752|NCT01964248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110130753|NCT01964248|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110130754|NCT01964248|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110130755|NCT01964248|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110130756|NCT01964248|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110130757|NCT01964248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110130758|NCT01964248|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
110130759|NCT01964287|Leucovorin|leucovorin|mesh-list
110130760|NCT01964287|Paclitaxel|paclitaxel|mesh-list
110130761|NCT01964287|Gemcitabine|gemcitabine|mesh-list
110130762|NCT01964287|Oxaliplatin|oxaliplatin|mesh-list
110130763|NCT01964287|Irinotecan|irinotecan|mesh-list
110130764|NCT01964287|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110130765|NCT01964287|Folfirinox|folfirinox|mesh-list
110130766|NCT01964287|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110130767|NCT01964287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110130768|NCT01964287|Tubulin Modulators|tubulin modulators|mesh-ancestor
110130769|NCT01964287|Antimitotic Agents|antimitotic agents|mesh-ancestor
110130770|NCT01964287|Mitosis Modulators|mitosis modulators|mesh-ancestor
110130771|NCT01964287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110130772|NCT01964287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110130773|NCT01964287|Antimetabolites|antimetabolites|mesh-ancestor
110130774|NCT01964287|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110130775|NCT01964287|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110130776|NCT01964287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110130777|NCT01964287|Antidotes|antidotes|mesh-ancestor
110130778|NCT01964287|Protective Agents|protective agents|mesh-ancestor
110130779|NCT01964287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110130780|NCT01964287|Vitamin B Complex|vitamin b complex|mesh-ancestor
110130781|NCT01964287|Vitamins|vitamins|mesh-ancestor
110130783|NCT01964365|Fenofibric acid|fenofibric acid|mesh-list
110130784|NCT01964365|Fenofibrate|fenofibrate|mesh-list
110344050|NCT05930197|Bismuth|bismuth|mesh-list
110130785|NCT01964365|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110130786|NCT01964365|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110130787|NCT01964365|Antimetabolites|antimetabolites|mesh-ancestor
110130788|NCT01964365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110130789|NCT01964365|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110130790|NCT01964391|Paclitaxel|paclitaxel|mesh-list
110130791|NCT01964391|Docetaxel|docetaxel|mesh-list
110130792|NCT01964391|Cyclophosphamide|cyclophosphamide|mesh-list
110130793|NCT01964391|Carboplatin|carboplatin|mesh-list
110130794|NCT01964391|Doxorubicin|doxorubicin|mesh-list
110130795|NCT01964391|Trastuzumab|trastuzumab|mesh-list
110130796|NCT01964391|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110130797|NCT01964391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110130798|NCT01964391|Tubulin Modulators|tubulin modulators|mesh-ancestor
110130799|NCT01964391|Antimitotic Agents|antimitotic agents|mesh-ancestor
110130800|NCT01964391|Mitosis Modulators|mitosis modulators|mesh-ancestor
110130801|NCT01964391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110130802|NCT01964391|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110130803|NCT01964391|Immunologic Factors|immunologic factors|mesh-ancestor
110130804|NCT01964391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110130805|NCT01964391|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110130806|NCT01964391|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110130807|NCT01964391|Alkylating Agents|alkylating agents|mesh-ancestor
110130808|NCT01964391|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110130809|NCT01964391|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110130810|NCT01964391|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110130811|NCT01964391|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110130812|NCT01964391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110130813|NCT01964391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110130814|NCT01964404|Dronabinol|dronabinol|mesh-list
110130815|NCT01964404|Hallucinogens|hallucinogens|mesh-ancestor
110130816|NCT01964404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110130817|NCT01964404|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110130818|NCT01964404|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110130819|NCT01964404|Analgesics|analgesics|mesh-ancestor
110130820|NCT01964404|Sensory System Agents|sensory system agents|mesh-ancestor
110130821|NCT01964404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110130822|NCT01964404|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
110130823|NCT01964404|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110130824|NCT01964404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110130825|NCT01964404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110130826|NCT01964404|Hormones|hormones|mesh-ancestor
110130827|NCT01964404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110130828|NCT01964534|Gemcitabine|gemcitabine|mesh-list
110130829|NCT01964534|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110130830|NCT01964534|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110130831|NCT01964534|Antimetabolites|antimetabolites|mesh-ancestor
110130832|NCT01964534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110130833|NCT01964534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110130834|NCT01964573|Rotigotine|rotigotine|mesh-list
110130835|NCT01964573|Dopamine Agonists|dopamine agonists|mesh-ancestor
110130836|NCT01964573|Dopamine Agents|dopamine agents|mesh-ancestor
110130837|NCT01964573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110130838|NCT01964573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110130839|NCT01964573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110130841|NCT01964586|Epinephrine|epinephrine|mesh-list
110130842|NCT01964586|Racepinephrine|racepinephrine|mesh-list
110130843|NCT01964586|Dexmedetomidine|dexmedetomidine|mesh-list
110130844|NCT01964586|Epinephryl borate|epinephryl borate|mesh-list
110130845|NCT01964586|Anesthetics, Local|anesthetics, local|mesh-ancestor
110130846|NCT01964586|Anesthetics|anesthetics|mesh-ancestor
110130847|NCT01964586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110130848|NCT01964586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110130849|NCT01964586|Sensory System Agents|sensory system agents|mesh-ancestor
110130850|NCT01964586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110130851|NCT01964586|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110165092|NCT00000146|Glucocorticoids|glucocorticoids|mesh-ancestor
110130852|NCT01964586|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110130853|NCT01964586|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110130854|NCT01964586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110130855|NCT01964586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110130856|NCT01964586|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110130857|NCT01964586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110130859|NCT01964586|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110130860|NCT01964586|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110130861|NCT01964586|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110130862|NCT01964586|Adrenergic Agents|adrenergic agents|mesh-ancestor
110130863|NCT01964586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110130864|NCT01964586|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110130865|NCT01964586|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110130866|NCT01964586|Autonomic Agents|autonomic agents|mesh-ancestor
110130867|NCT01964586|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110130868|NCT01964586|Respiratory System Agents|respiratory system agents|mesh-ancestor
110130869|NCT01964586|Mydriatics|mydriatics|mesh-ancestor
110130870|NCT01964586|Sympathomimetics|sympathomimetics|mesh-ancestor
110130871|NCT01964586|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110130872|NCT01964651|JNJ-42165279|jnj-42165279|mesh-list
110130873|NCT01964651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110130874|NCT01964651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110130875|NCT01964781|Epinephrine|epinephrine|mesh-list
110130876|NCT01964781|Racepinephrine|racepinephrine|mesh-list
110130877|NCT01964781|Bupivacaine|bupivacaine|mesh-list
110130878|NCT01964781|Tranexamic Acid|tranexamic acid|mesh-list
110130879|NCT01964781|Epinephryl borate|epinephryl borate|mesh-list
110130880|NCT01964781|Anesthetics, Local|anesthetics, local|mesh-ancestor
110130881|NCT01964781|Anesthetics|anesthetics|mesh-ancestor
110130882|NCT01964781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110130883|NCT01964781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110130884|NCT01964781|Sensory System Agents|sensory system agents|mesh-ancestor
110130885|NCT01964781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110130886|NCT01964781|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110130887|NCT01964781|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110130888|NCT01964781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110130889|NCT01964781|Hemostatics|hemostatics|mesh-ancestor
110130890|NCT01964781|Coagulants|coagulants|mesh-ancestor
110130891|NCT01964781|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110130892|NCT01964781|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110130893|NCT01964781|Adrenergic Agents|adrenergic agents|mesh-ancestor
110130894|NCT01964781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110130895|NCT01964781|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110130896|NCT01964781|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110130897|NCT01964781|Autonomic Agents|autonomic agents|mesh-ancestor
110130898|NCT01964781|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110130899|NCT01964781|Respiratory System Agents|respiratory system agents|mesh-ancestor
110130900|NCT01964781|Mydriatics|mydriatics|mesh-ancestor
110130901|NCT01964781|Sympathomimetics|sympathomimetics|mesh-ancestor
110130902|NCT01964781|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110130903|NCT01964846|Curcumin|curcumin|mesh-list
110130904|NCT01964846|Resveratrol|resveratrol|mesh-list
110130905|NCT01964846|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110130906|NCT01964846|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110130907|NCT01964846|Analgesics|analgesics|mesh-ancestor
110130908|NCT01964846|Sensory System Agents|sensory system agents|mesh-ancestor
110130909|NCT01964846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110130910|NCT01964846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110130911|NCT01964846|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110130913|NCT01964846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110130914|NCT01964846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110130915|NCT01964846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110130917|NCT01964846|Protective Agents|protective agents|mesh-ancestor
110130918|NCT01964846|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110130919|NCT01964911|Ropivacaine|ropivacaine|mesh-list
110130920|NCT01964911|Anesthetics, Local|anesthetics, local|mesh-ancestor
110130921|NCT01964911|Anesthetics|anesthetics|mesh-ancestor
110130922|NCT01964911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110130923|NCT01964911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110130924|NCT01964911|Sensory System Agents|sensory system agents|mesh-ancestor
110130925|NCT01964911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110130926|NCT01965041|Aflibercept|aflibercept|mesh-list
110130927|NCT01965041|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110130928|NCT01965041|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110130929|NCT01965041|Growth Substances|growth substances|mesh-ancestor
110130930|NCT01965041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110130931|NCT01965041|Growth Inhibitors|growth inhibitors|mesh-ancestor
110130932|NCT01965041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110130934|NCT01965080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110130935|NCT01965080|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110130936|NCT01965080|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110130937|NCT01965080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110130938|NCT01965080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110130939|NCT01965080|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110130940|NCT01965080|Hormone Antagonists|hormone antagonists|mesh-ancestor
110130941|NCT01965080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110130942|NCT01965080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110130943|NCT01965275|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110130944|NCT01965275|Gefitinib|gefitinib|mesh-list
110130945|NCT01965275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110130946|NCT01965275|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110130947|NCT01965275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110130948|NCT01965275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110130949|NCT01965301|Diphenhydramine|diphenhydramine|mesh-list
110130950|NCT01965301|Promethazine|promethazine|mesh-list
110130951|NCT01965301|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110130952|NCT01965301|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110130953|NCT01965301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110130954|NCT01965301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110130955|NCT01965301|Anesthetics, Local|anesthetics, local|mesh-ancestor
110130956|NCT01965301|Anesthetics|anesthetics|mesh-ancestor
110130957|NCT01965301|Sensory System Agents|sensory system agents|mesh-ancestor
110130958|NCT01965301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110130959|NCT01965301|Antiemetics|antiemetics|mesh-ancestor
110130960|NCT01965301|Autonomic Agents|autonomic agents|mesh-ancestor
110130961|NCT01965301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110130962|NCT01965301|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110130963|NCT01965301|Histamine Antagonists|histamine antagonists|mesh-ancestor
110130964|NCT01965301|Histamine Agents|histamine agents|mesh-ancestor
110130965|NCT01965301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110130966|NCT01965301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110130967|NCT01965301|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110130968|NCT01965301|Antipruritics|antipruritics|mesh-ancestor
110130969|NCT01965301|Dermatologic Agents|dermatologic agents|mesh-ancestor
110130970|NCT01965353|Dexamethasone|dexamethasone|mesh-list
110130971|NCT01965353|Lenalidomide|lenalidomide|mesh-list
110130972|NCT01965353|Bortezomib|bortezomib|mesh-list
110130973|NCT01965353|Panobinostat|panobinostat|mesh-list
110130974|NCT01965353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110130975|NCT01965353|Antiemetics|antiemetics|mesh-ancestor
110344087|NCT05919537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110130976|NCT01965353|Autonomic Agents|autonomic agents|mesh-ancestor
110130977|NCT01965353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110344094|NCT05917275|Amlodipine|amlodipine|mesh-list
110130978|NCT01965353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110130979|NCT01965353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110130980|NCT01965353|Glucocorticoids|glucocorticoids|mesh-ancestor
110130982|NCT01965353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110130983|NCT01965353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110130984|NCT01965353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110130985|NCT01965353|Immunologic Factors|immunologic factors|mesh-ancestor
110130986|NCT01965353|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110130987|NCT01965353|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110130988|NCT01965353|Growth Substances|growth substances|mesh-ancestor
110130989|NCT01965353|Growth Inhibitors|growth inhibitors|mesh-ancestor
110130990|NCT01965353|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110130991|NCT01965353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110130992|NCT01965353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110130993|NCT01965522|Vitamin D|vitamin d|mesh-list
110130994|NCT01965522|Ergocalciferols|ergocalciferols|mesh-list
110130995|NCT01965522|Cholecalciferol|cholecalciferol|mesh-list
110130996|NCT01965522|Vitamins|vitamins|mesh-list
110130997|NCT01965522|Melatonin|melatonin|mesh-list
110130998|NCT01965522|Micronutrients|micronutrients|mesh-ancestor
110130999|NCT01965522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110131000|NCT01965522|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110131001|NCT01965522|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110131002|NCT01965522|Antioxidants|antioxidants|mesh-ancestor
110131003|NCT01965522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110131004|NCT01965522|Protective Agents|protective agents|mesh-ancestor
110131005|NCT01965522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110131006|NCT01965587|Levonorgestrel|levonorgestrel|mesh-list
110131007|NCT01965587|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110131008|NCT01965587|Contraceptive Agents|contraceptive agents|mesh-ancestor
110131009|NCT01965587|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110131010|NCT01965587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110131011|NCT01965587|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110131012|NCT01965587|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110131013|NCT01965587|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110131014|NCT01965626|Oseltamivir|oseltamivir|mesh-list
110131015|NCT01965626|Dexamethasone|dexamethasone|mesh-list
110131016|NCT01965626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110131017|NCT01965626|Antiemetics|antiemetics|mesh-ancestor
110131018|NCT01965626|Autonomic Agents|autonomic agents|mesh-ancestor
110131019|NCT01965626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110131020|NCT01965626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110131021|NCT01965626|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110131022|NCT01965626|Glucocorticoids|glucocorticoids|mesh-ancestor
110131023|NCT01965626|Hormones|hormones|mesh-ancestor
110131024|NCT01965626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110131025|NCT01965626|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110131026|NCT01965626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110131027|NCT01965626|Antiviral Agents|antiviral agents|mesh-ancestor
110131028|NCT01965626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110131029|NCT01965626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110131030|NCT01965626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110131031|NCT01965730|Aminocaproic Acid|aminocaproic acid|mesh-list
110131032|NCT01965730|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110131033|NCT01965730|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110131034|NCT01965730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110131036|NCT01965730|Coagulants|coagulants|mesh-ancestor
110131037|NCT01965405|Bupropion|bupropion|mesh-list
110131038|NCT01965405|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110131039|NCT01965405|Antidepressive Agents|antidepressive agents|mesh-ancestor
110131040|NCT01965405|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110131041|NCT01965405|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110131042|NCT01965405|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110131043|NCT01965405|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110131044|NCT01965405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110131045|NCT01965405|Dopamine Agents|dopamine agents|mesh-ancestor
110131046|NCT01965405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110131047|NCT01965405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110131048|NCT01965405|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110131049|NCT01965405|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110131050|NCT01965405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110131051|NCT01965925|Modafinil|modafinil|mesh-list
110131052|NCT01965925|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110131053|NCT01965925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110131054|NCT01965925|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
110131055|NCT01965925|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110131056|NCT01965925|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110131057|NCT01965925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110131058|NCT01965977|Bortezomib|bortezomib|mesh-list
110131059|NCT01965977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110131060|NCT01966055|Solithromycin|solithromycin|mesh-list
110131061|NCT01966055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110131062|NCT01966055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110131064|NCT01966133|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110131065|NCT01966133|Ethiodized Oil|ethiodized oil|mesh-list
110131066|NCT01966133|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110131067|NCT01966133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110131068|NCT01966133|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110131069|NCT01966133|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110131070|NCT01966133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110131071|NCT01966133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110131072|NCT01966172|Acetaminophen|acetaminophen|mesh-list
110131073|NCT01966172|Ibuprofen|ibuprofen|mesh-list
110131074|NCT01966172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
110131075|NCT01966172|Morphine|morphine|mesh-list
110131076|NCT01966172|Gabapentin|gabapentin|mesh-list
110131077|NCT01966172|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110131078|NCT01966172|Narcotics|narcotics|mesh-ancestor
110131079|NCT01966172|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110131080|NCT01966172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110131081|NCT01966172|Analgesics|analgesics|mesh-ancestor
110131082|NCT01966172|Sensory System Agents|sensory system agents|mesh-ancestor
110131083|NCT01966172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110131084|NCT01966172|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110131085|NCT01966172|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110131086|NCT01966172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110131087|NCT01966172|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110131088|NCT01966172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110131089|NCT01966172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110131090|NCT01966172|Antipyretics|antipyretics|mesh-ancestor
110131091|NCT01966172|Anticonvulsants|anticonvulsants|mesh-ancestor
110131092|NCT01966172|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110131093|NCT01966172|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110131094|NCT01966172|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110131095|NCT01966172|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110131096|NCT01966172|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110131097|NCT01966172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110131098|NCT01966172|Antimanic Agents|antimanic agents|mesh-ancestor
110131099|NCT01966276|Methylphenidate|methylphenidate|mesh-list
110131100|NCT01966276|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110131101|NCT01966276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110131102|NCT01966276|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110131103|NCT01966276|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110131104|NCT01966276|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110131105|NCT01966276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110131106|NCT01966276|Dopamine Agents|dopamine agents|mesh-ancestor
110131107|NCT01966276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110131108|NCT01966289|Cyclophosphamide|cyclophosphamide|mesh-list
110131110|NCT01966289|Immunologic Factors|immunologic factors|mesh-ancestor
110131111|NCT01966289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110131112|NCT01966289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110131113|NCT01966289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110131114|NCT01966289|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110131115|NCT01966289|Alkylating Agents|alkylating agents|mesh-ancestor
110131116|NCT01966289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110131117|NCT01966289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110131118|NCT01966289|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110131119|NCT01966302|Beraprost|beraprost|mesh-list
110131120|NCT01966302|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110131121|NCT01966302|Vasodilator Agents|vasodilator agents|mesh-ancestor
110131122|NCT01966341|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110131123|NCT01966341|Laxatives|laxatives|mesh-list
110131124|NCT01966341|Parasympatholytics|parasympatholytics|mesh-list
110131125|NCT01966341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110131126|NCT01966341|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110131127|NCT01966341|Autonomic Agents|autonomic agents|mesh-ancestor
110131128|NCT01966341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110131129|NCT01966341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110131130|NCT01966484|Succinylcholine|succinylcholine|mesh-list
110131131|NCT01966484|Mivacurium|mivacurium|mesh-list
110131132|NCT01966484|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
110131133|NCT01966484|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110131134|NCT01966484|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110131135|NCT01966484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110131136|NCT01966484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110131137|NCT01966484|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110131138|NCT01966575|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
110131139|NCT01966575|Medroxyprogesterone|medroxyprogesterone|mesh-list
110131141|NCT01966575|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110131142|NCT01966575|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110131143|NCT01966575|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110131144|NCT01966575|Contraceptive Agents|contraceptive agents|mesh-ancestor
110131145|NCT01966575|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110131146|NCT01966575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110131147|NCT01966575|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110131148|NCT01966575|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110131149|NCT01966575|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110131150|NCT01966575|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110131151|NCT01966575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110131152|NCT01966575|Hormones|hormones|mesh-ancestor
110131153|NCT01966575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110131154|NCT01966627|Liver Extracts|liver extracts|mesh-list
110131155|NCT01966627|Hematinics|hematinics|mesh-ancestor
110131156|NCT01966653|Fosfomycin|fosfomycin|mesh-list
110131157|NCT01966653|Nitrofurantoin|nitrofurantoin|mesh-list
110131158|NCT01966653|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110131159|NCT01966653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110131160|NCT01966653|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110131161|NCT01966692|Fluticasone|fluticasone|mesh-list
110131162|NCT01966692|Xhance|xhance|mesh-list
110131163|NCT01966692|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110131164|NCT01966692|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110131165|NCT01966692|Autonomic Agents|autonomic agents|mesh-ancestor
110131166|NCT01966692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110131167|NCT01966692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110131168|NCT01966692|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110131169|NCT01966692|Respiratory System Agents|respiratory system agents|mesh-ancestor
110131170|NCT01966692|Dermatologic Agents|dermatologic agents|mesh-ancestor
110131171|NCT01966692|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110131172|NCT01966783|Budesonide|budesonide|mesh-list
110131173|NCT01966783|Mesalamine|mesalamine|mesh-list
110131174|NCT01966783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110131175|NCT01966783|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110131176|NCT01966783|Autonomic Agents|autonomic agents|mesh-ancestor
110131177|NCT01966783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110131178|NCT01966783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110131179|NCT01966783|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110131180|NCT01966783|Respiratory System Agents|respiratory system agents|mesh-ancestor
110131181|NCT01966783|Glucocorticoids|glucocorticoids|mesh-ancestor
110131182|NCT01966783|Hormones|hormones|mesh-ancestor
110131183|NCT01966783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110131184|NCT01966783|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110131185|NCT01966783|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110131186|NCT01966783|Analgesics|analgesics|mesh-ancestor
110131187|NCT01966783|Sensory System Agents|sensory system agents|mesh-ancestor
110131188|NCT01966783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110131189|NCT01966822|Ritonavir|ritonavir|mesh-list
110131190|NCT01966822|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
110131191|NCT01966822|Dolutegravir|dolutegravir|mesh-list
110131192|NCT01966822|Protease Inhibitors|protease inhibitors|mesh-list
110131193|NCT01966822|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110131194|NCT01966822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110131195|NCT01966822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110131196|NCT01966822|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110131197|NCT01966822|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110131198|NCT01966822|Antiviral Agents|antiviral agents|mesh-ancestor
110131199|NCT01966822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110165199|NCT00023218|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110131200|NCT01966822|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110131201|NCT01966822|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110131202|NCT01966822|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110131204|NCT01966913|Bevacizumab|bevacizumab|mesh-list
110131205|NCT01966913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110131206|NCT01966913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110131207|NCT01966913|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110131208|NCT01966913|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110131209|NCT01966913|Growth Substances|growth substances|mesh-ancestor
110131210|NCT01966913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110131211|NCT01966913|Growth Inhibitors|growth inhibitors|mesh-ancestor
110131213|NCT01967017|Anesthetics, Local|anesthetics, local|mesh-ancestor
110131214|NCT01967017|Anesthetics|anesthetics|mesh-ancestor
110131215|NCT01967017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110131216|NCT01967017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110131217|NCT01967017|Sensory System Agents|sensory system agents|mesh-ancestor
110131218|NCT01967017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110131219|NCT01967017|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110131220|NCT01967017|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110131221|NCT01967017|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110131222|NCT01967017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110131223|NCT01967017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110131224|NCT01967095|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110131225|NCT01967095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110131226|NCT01967095|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110131227|NCT01967095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110131228|NCT01967095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110131229|NCT01967199|Paclitaxel|paclitaxel|mesh-list
110131230|NCT01967199|Everolimus|everolimus|mesh-list
110131231|NCT01967199|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110131232|NCT01967199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110131233|NCT01967199|Tubulin Modulators|tubulin modulators|mesh-ancestor
110131234|NCT01967199|Antimitotic Agents|antimitotic agents|mesh-ancestor
110131235|NCT01967199|Mitosis Modulators|mitosis modulators|mesh-ancestor
110131236|NCT01967199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110131237|NCT01967199|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110131238|NCT01967199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110131239|NCT01967199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110131240|NCT01967199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110131241|NCT01967199|Immunologic Factors|immunologic factors|mesh-ancestor
110131242|NCT01967199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110131243|NCT01967251|Udenafil|udenafil|mesh-list
110131244|NCT01967251|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110131245|NCT01967251|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110131246|NCT01967251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110131247|NCT01967251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110131248|NCT01967264|Udenafil|udenafil|mesh-list
110131249|NCT01967264|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110131250|NCT01967264|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110131251|NCT01967264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110131252|NCT01967264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110131253|NCT01967368|Vaccines|vaccines|mesh-list
110131254|NCT01967368|Immunologic Factors|immunologic factors|mesh-ancestor
110131255|NCT01967368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110131256|NCT01967381|Methamphetamine|methamphetamine|mesh-list
110131257|NCT01967381|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110131258|NCT01967381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110131259|NCT01967381|Sympathomimetics|sympathomimetics|mesh-ancestor
110131260|NCT01967381|Autonomic Agents|autonomic agents|mesh-ancestor
110131261|NCT01967381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110131262|NCT01967381|Dopamine Agents|dopamine agents|mesh-ancestor
110131263|NCT01967381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110131264|NCT01967381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110131265|NCT01967381|Adrenergic Agents|adrenergic agents|mesh-ancestor
110131266|NCT01967381|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110131267|NCT01967381|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110131268|NCT01967381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110131269|NCT01967381|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110131270|NCT01967459|Cholecalciferol|cholecalciferol|mesh-list
110344153|NCT05906836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110131271|NCT01967459|Vitamin D|vitamin d|mesh-list
110131272|NCT01967459|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110131273|NCT01967459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110131274|NCT01967459|Vitamins|vitamins|mesh-ancestor
110131275|NCT01967459|Micronutrients|micronutrients|mesh-ancestor
110131276|NCT01967459|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110131277|NCT01967472|Artesunate|artesunate|mesh-list
110131278|NCT01967472|Lumefantrine|lumefantrine|mesh-list
110131279|NCT01967472|Artemether|artemether|mesh-list
110131280|NCT01967472|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
110131281|NCT01967472|Amodiaquine|amodiaquine|mesh-list
110131282|NCT01967472|Antimalarials|antimalarials|mesh-ancestor
110131283|NCT01967472|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110131284|NCT01967472|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110131285|NCT01967472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110131286|NCT01967472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110131287|NCT01967472|Antiviral Agents|antiviral agents|mesh-ancestor
110131288|NCT01967472|Schistosomicides|schistosomicides|mesh-ancestor
110131289|NCT01967472|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110131290|NCT01967472|Anthelmintics|anthelmintics|mesh-ancestor
110131291|NCT01967498|Montelukast|montelukast|mesh-list
110131292|NCT01967498|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110131293|NCT01967498|Respiratory System Agents|respiratory system agents|mesh-ancestor
110131294|NCT01967498|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110131295|NCT01967498|Hormone Antagonists|hormone antagonists|mesh-ancestor
110131296|NCT01967498|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110131297|NCT01967498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110131298|NCT01967498|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110131299|NCT01967498|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110131300|NCT01967498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110131301|NCT01967524|Ropivacaine|ropivacaine|mesh-list
110131302|NCT01967524|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110131303|NCT01967524|Botulinum Toxins|botulinum toxins|mesh-list
110131304|NCT01967524|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110131305|NCT01967524|Anesthetics, Local|anesthetics, local|mesh-ancestor
110131306|NCT01967524|Anesthetics|anesthetics|mesh-ancestor
110131307|NCT01967524|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110131308|NCT01967524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110131309|NCT01967524|Sensory System Agents|sensory system agents|mesh-ancestor
110131310|NCT01967524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110131311|NCT01967524|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110131312|NCT01967524|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110131313|NCT01967524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110131314|NCT01967524|Cholinergic Agents|cholinergic agents|mesh-ancestor
110131315|NCT01967524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110131316|NCT01967524|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110131317|NCT01967758|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110131318|NCT01967758|Amoxicillin|amoxicillin|mesh-list
110131319|NCT01967758|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
110131320|NCT01967758|Trimethoprim|trimethoprim|mesh-list
110131321|NCT01967758|Sulfamethoxazole|sulfamethoxazole|mesh-list
110131322|NCT01967758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110131323|NCT01967758|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110131324|NCT01967758|Antimalarials|antimalarials|mesh-ancestor
110131325|NCT01967758|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110131326|NCT01967758|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110131327|NCT01967758|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110131328|NCT01967758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110131329|NCT01967758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110131330|NCT01967758|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110165209|NCT00023218|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110131331|NCT01967758|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
110131332|NCT01967758|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110131333|NCT01967758|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110131334|NCT01967823|Aldesleukin|aldesleukin|mesh-list
110131335|NCT01967823|Cyclophosphamide|cyclophosphamide|mesh-list
110131337|NCT01967823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110131338|NCT01967823|Immunologic Factors|immunologic factors|mesh-ancestor
110131339|NCT01967823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110131340|NCT01967823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110131341|NCT01967823|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110131342|NCT01967823|Alkylating Agents|alkylating agents|mesh-ancestor
110131343|NCT01967823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110131344|NCT01967823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110131345|NCT01967823|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110131346|NCT01967823|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110131347|NCT01967823|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110131348|NCT01967823|Antiviral Agents|antiviral agents|mesh-ancestor
110131349|NCT01967823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110131350|NCT01967875|Docetaxel|docetaxel|mesh-list
110131351|NCT01967875|Capecitabine|capecitabine|mesh-list
110131352|NCT01967875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110131353|NCT01967875|Tubulin Modulators|tubulin modulators|mesh-ancestor
110131354|NCT01967875|Antimitotic Agents|antimitotic agents|mesh-ancestor
110131355|NCT01967875|Mitosis Modulators|mitosis modulators|mesh-ancestor
110131356|NCT01967875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110131357|NCT01967875|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110131358|NCT01967875|Antimetabolites|antimetabolites|mesh-ancestor
110131360|NCT01967927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110131361|NCT01967927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110131362|NCT01967979|Itraconazole|itraconazole|mesh-list
110131364|NCT01967979|Antifungal Agents|antifungal agents|mesh-ancestor
110131365|NCT01967979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110131366|NCT01967979|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110131367|NCT01967979|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110131368|NCT01967979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110131369|NCT01967979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110131370|NCT01967979|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110131371|NCT01967979|Hormone Antagonists|hormone antagonists|mesh-ancestor
110131372|NCT01967979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110131373|NCT01967979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110131374|NCT01967979|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110131375|NCT01967979|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110131376|NCT01967979|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110131377|NCT01967979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110131378|NCT01967979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110131379|NCT01967979|Serotonin Agents|serotonin agents|mesh-ancestor
110131380|NCT01967979|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110131381|NCT01967979|Antidepressive Agents|antidepressive agents|mesh-ancestor
110131382|NCT01967979|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110131383|NCT01967979|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110131385|NCT01968005|Lidocaine|lidocaine|mesh-list
110131386|NCT01968005|Anesthetics, Local|anesthetics, local|mesh-ancestor
110131387|NCT01968005|Anesthetics|anesthetics|mesh-ancestor
110131388|NCT01968005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110131389|NCT01968005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110131390|NCT01968005|Sensory System Agents|sensory system agents|mesh-ancestor
110131391|NCT01968005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110131392|NCT01968005|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110131393|NCT01968005|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110131394|NCT01968005|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110131395|NCT01968005|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110131396|NCT01968005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110344189|NCT05891171|Leucovorin|leucovorin|mesh-list
110131397|NCT01968005|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110131398|NCT01968005|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110131399|NCT01968005|Analgesics|analgesics|mesh-ancestor
110131400|NCT01968005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110131401|NCT01968005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110131402|NCT01968005|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110131403|NCT01968005|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110131404|NCT01968005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110131405|NCT01968018|Acetaminophen|acetaminophen|mesh-list
110131406|NCT01968018|Tramadol|tramadol|mesh-list
110131407|NCT01968018|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110131408|NCT01968018|Analgesics|analgesics|mesh-ancestor
110131409|NCT01968018|Sensory System Agents|sensory system agents|mesh-ancestor
110131410|NCT01968018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110131411|NCT01968018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110131412|NCT01968018|Antipyretics|antipyretics|mesh-ancestor
110131413|NCT01968018|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110131414|NCT01968018|Narcotics|narcotics|mesh-ancestor
110131415|NCT01968018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110131416|NCT01968044|Linagliptin|linagliptin|mesh-list
110131417|NCT01968044|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110131418|NCT01968044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110131419|NCT01968044|Incretins|incretins|mesh-ancestor
110131420|NCT01968044|Hormones|hormones|mesh-ancestor
110131421|NCT01968044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110131422|NCT01968044|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110131423|NCT01968044|Protease Inhibitors|protease inhibitors|mesh-ancestor
110131424|NCT01968044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110131425|NCT01968044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110131426|NCT01968083|Vaccines|vaccines|mesh-list
110131427|NCT01968083|Immunologic Factors|immunologic factors|mesh-ancestor
110131428|NCT01968083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110131429|NCT01968161|Asenapine|asenapine|mesh-list
110131430|NCT01968161|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110131431|NCT01968161|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110131432|NCT01968161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110131434|NCT01968161|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110131435|NCT01968239|Ranibizumab|ranibizumab|mesh-list
110131436|NCT01968239|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110131437|NCT01968239|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110131438|NCT01968239|Growth Substances|growth substances|mesh-ancestor
110131439|NCT01968239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110131440|NCT01968239|Growth Inhibitors|growth inhibitors|mesh-ancestor
110131441|NCT01968239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110131442|NCT01968395|Caspofungin|caspofungin|mesh-list
110131443|NCT01968395|Antifungal Agents|antifungal agents|mesh-ancestor
110131444|NCT01968395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110131445|NCT01968395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110131446|NCT01968395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110131447|NCT01968486|Ranibizumab|ranibizumab|mesh-list
110131448|NCT01968486|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110131449|NCT01968486|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110131450|NCT01968486|Growth Substances|growth substances|mesh-ancestor
110131451|NCT01968486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110131452|NCT01968486|Growth Inhibitors|growth inhibitors|mesh-ancestor
110131453|NCT01968486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110131454|NCT01968564|Curcumin|curcumin|mesh-list
110131455|NCT01968564|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110131456|NCT01968564|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110131457|NCT01968564|Analgesics|analgesics|mesh-ancestor
110131458|NCT01968564|Sensory System Agents|sensory system agents|mesh-ancestor
110131459|NCT01968564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110131460|NCT01968564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110131461|NCT01968564|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110131462|NCT01968564|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110131463|NCT01968564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110131464|NCT01968564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110131465|NCT01968564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110131466|NCT01968577|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110131467|NCT01968577|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110131468|NCT01968577|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110131469|NCT01968577|Antimetabolites|antimetabolites|mesh-ancestor
110131470|NCT01968577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110131471|NCT01968577|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110131472|NCT01968577|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110131473|NCT01968577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110131474|NCT01968616|Ranibizumab|ranibizumab|mesh-list
110131475|NCT01968616|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110131476|NCT01968616|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110131477|NCT01968616|Growth Substances|growth substances|mesh-ancestor
110131478|NCT01968616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110131479|NCT01968616|Growth Inhibitors|growth inhibitors|mesh-ancestor
110131480|NCT01968616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110131481|NCT01968655|Factor VIII|factor viii|mesh-list
110131482|NCT01968655|Coagulants|coagulants|mesh-ancestor
110131483|NCT01968759|Ramipril|ramipril|mesh-list
110131484|NCT01968759|Irbesartan|irbesartan|mesh-list
110131485|NCT01968759|Sevelamer|sevelamer|mesh-list
110131486|NCT01968759|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110131487|NCT01968759|Protease Inhibitors|protease inhibitors|mesh-ancestor
110131488|NCT01968759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110131489|NCT01968759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110131490|NCT01968759|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110131491|NCT01968759|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110131492|NCT01968759|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110131493|NCT01968759|Chelating Agents|chelating agents|mesh-ancestor
110131494|NCT01968759|Sequestering Agents|sequestering agents|mesh-ancestor
110131495|NCT01968798|Aspirin|aspirin|mesh-list
110131496|NCT01968798|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110131497|NCT01968798|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110131498|NCT01968798|Analgesics|analgesics|mesh-ancestor
110131499|NCT01968798|Sensory System Agents|sensory system agents|mesh-ancestor
110131500|NCT01968798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110131501|NCT01968798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110131502|NCT01968798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110131503|NCT01968798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110131504|NCT01968798|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110131505|NCT01968798|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110131506|NCT01968798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110131507|NCT01968798|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110131508|NCT01968798|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110131509|NCT01968798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110131510|NCT01968798|Antipyretics|antipyretics|mesh-ancestor
110131511|NCT01968850|Vitamin D|vitamin d|mesh-list
110131512|NCT01968850|Alendronate|alendronate|mesh-list
110131513|NCT01968850|Vitamins|vitamins|mesh-ancestor
110131514|NCT01968850|Micronutrients|micronutrients|mesh-ancestor
110131515|NCT01968850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110131516|NCT01968850|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110131517|NCT01968915|Paclitaxel|paclitaxel|mesh-list
110131518|NCT01968915|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110131519|NCT01968915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110131520|NCT01968915|Tubulin Modulators|tubulin modulators|mesh-ancestor
110131521|NCT01968915|Antimitotic Agents|antimitotic agents|mesh-ancestor
110131522|NCT01968915|Mitosis Modulators|mitosis modulators|mesh-ancestor
110131523|NCT01968915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110131524|NCT01969006|Bupivacaine|bupivacaine|mesh-list
110131525|NCT01969006|Anesthetics, Local|anesthetics, local|mesh-ancestor
110131526|NCT01969006|Anesthetics|anesthetics|mesh-ancestor
110131527|NCT01969006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110131528|NCT01969006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110131529|NCT01969006|Sensory System Agents|sensory system agents|mesh-ancestor
110131530|NCT01969006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110131531|NCT01969019|Prednisone|prednisone|mesh-list
110131532|NCT01969019|Methylprednisolone|methylprednisolone|mesh-list
110131533|NCT01969019|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110131534|NCT01969019|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110131535|NCT01969019|Prednisolone|prednisolone|mesh-list
110131536|NCT01969019|Prednisolone acetate|prednisolone acetate|mesh-list
110131537|NCT01969019|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110131538|NCT01969019|Prednisolone phosphate|prednisolone phosphate|mesh-list
110131539|NCT01969019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110131542|NCT01969019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110131543|NCT01969019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110131544|NCT01969019|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110131545|NCT01969019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110131546|NCT01969019|Antiemetics|antiemetics|mesh-ancestor
110131547|NCT01969019|Autonomic Agents|autonomic agents|mesh-ancestor
110131548|NCT01969019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110131549|NCT01969019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110131550|NCT01969019|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110131551|NCT01969019|Protective Agents|protective agents|mesh-ancestor
110131552|NCT01969032|Paclitaxel|paclitaxel|mesh-list
110131553|NCT01969032|Doxorubicin|doxorubicin|mesh-list
110131554|NCT01969032|Capecitabine|capecitabine|mesh-list
110131555|NCT01969032|Cyclophosphamide|cyclophosphamide|mesh-list
110131556|NCT01969032|Carboplatin|carboplatin|mesh-list
110131557|NCT01969032|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110131558|NCT01969032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110131559|NCT01969032|Tubulin Modulators|tubulin modulators|mesh-ancestor
110131560|NCT01969032|Antimitotic Agents|antimitotic agents|mesh-ancestor
110131561|NCT01969032|Mitosis Modulators|mitosis modulators|mesh-ancestor
110131562|NCT01969032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110131563|NCT01969032|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110131564|NCT01969032|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110131565|NCT01969032|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110131566|NCT01969032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110131567|NCT01969032|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110131568|NCT01969032|Antimetabolites|antimetabolites|mesh-ancestor
110131569|NCT01969032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110131570|NCT01969032|Immunologic Factors|immunologic factors|mesh-ancestor
110131571|NCT01969032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110131572|NCT01969032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110344239|NCT05890638|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110131573|NCT01969032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110131574|NCT01969032|Alkylating Agents|alkylating agents|mesh-ancestor
110131575|NCT01969032|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110131576|NCT01969071|Simendan|simendan|mesh-list
110131577|NCT01969071|Dobutamine|dobutamine|mesh-list
110131578|NCT01969071|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110131579|NCT01969071|Vasodilator Agents|vasodilator agents|mesh-ancestor
110131580|NCT01969071|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110131581|NCT01969071|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110131582|NCT01969071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110131583|NCT01969071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110131584|NCT01969071|Protective Agents|protective agents|mesh-ancestor
110131585|NCT01969071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110131586|NCT01969071|Sympathomimetics|sympathomimetics|mesh-ancestor
110131587|NCT01969071|Autonomic Agents|autonomic agents|mesh-ancestor
110131588|NCT01969071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110131589|NCT01969071|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
110131590|NCT01969071|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110131591|NCT01969071|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110131592|NCT01969071|Adrenergic Agents|adrenergic agents|mesh-ancestor
110131593|NCT01969071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110131595|NCT01969149|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110131596|NCT01969149|Exenatide|exenatide|mesh-list
110131597|NCT01969149|Insulin Lispro|insulin lispro|mesh-list
110131598|NCT01969149|Incretins|incretins|mesh-list
110131599|NCT01969149|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110131600|NCT01969149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110131601|NCT01969149|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110131602|NCT01969149|Hormones|hormones|mesh-ancestor
110131603|NCT01969149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110131604|NCT01969318|Metformin|metformin|mesh-list
110131605|NCT01969318|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110131606|NCT01969318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110131607|NCT01969357|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110131608|NCT01969357|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110131609|NCT01969357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110131610|NCT01969357|Incretins|incretins|mesh-ancestor
110131611|NCT01969357|Hormones|hormones|mesh-ancestor
110131612|NCT01969357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110131613|NCT01969357|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110131614|NCT01969357|Protease Inhibitors|protease inhibitors|mesh-ancestor
110131615|NCT01969357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110131616|NCT01969357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110131617|NCT01969617|Naltrexone|naltrexone|mesh-list
110131618|NCT01969617|Nalmefene|nalmefene|mesh-list
110131619|NCT01969617|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110131620|NCT01969617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110131621|NCT01969617|Sensory System Agents|sensory system agents|mesh-ancestor
110131622|NCT01969617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110131623|NCT01969617|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110131624|NCT01969656|Calcitriol|calcitriol|mesh-list
110131625|NCT01969656|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110131626|NCT01969656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110131627|NCT01969656|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
110131628|NCT01969656|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110131629|NCT01969656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110131630|NCT01969656|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110131631|NCT01969656|Vitamins|vitamins|mesh-ancestor
110131632|NCT01969656|Micronutrients|micronutrients|mesh-ancestor
110131633|NCT01969656|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110131634|NCT01969669|Ketoconazole|ketoconazole|mesh-list
110131635|NCT01969669|Venetoclax|venetoclax|mesh-list
110131637|NCT01969669|Antifungal Agents|antifungal agents|mesh-ancestor
110131638|NCT01969669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110131639|NCT01969669|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110131640|NCT01969669|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110131641|NCT01969669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110131642|NCT01969669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110131643|NCT01969669|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110131644|NCT01969669|Hormone Antagonists|hormone antagonists|mesh-ancestor
110131645|NCT01969669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110131646|NCT01969669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110131647|NCT01969669|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110131648|NCT01969682|Rifampin|rifampin|mesh-list
110131649|NCT01969682|Venetoclax|venetoclax|mesh-list
110131650|NCT01969682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110131651|NCT01969682|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110131652|NCT01969682|Antitubercular Agents|antitubercular agents|mesh-ancestor
110131653|NCT01969682|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110131654|NCT01969682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110131655|NCT01969682|Leprostatic Agents|leprostatic agents|mesh-ancestor
110131656|NCT01969682|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110131657|NCT01969682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110131658|NCT01969682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110131659|NCT01969682|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110131660|NCT01969682|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110131661|NCT01969682|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110131662|NCT01969682|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110131663|NCT01969682|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110131664|NCT01969682|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110131666|NCT01969695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110131667|NCT01969773|Botulinum Toxins|botulinum toxins|mesh-list
110131668|NCT01969773|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110131669|NCT01969773|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110131670|NCT01969773|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110131671|NCT01969773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110131672|NCT01969773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110131674|NCT01969773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110131675|NCT01969773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110131676|NCT01969773|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110131677|NCT01969773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110131678|NCT01969877|Cetuximab|cetuximab|mesh-list
110131679|NCT01969877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110131680|NCT01969877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110131681|NCT01969903|Dexmedetomidine|dexmedetomidine|mesh-list
110131682|NCT01969903|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110131683|NCT01969903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110131684|NCT01969903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110131685|NCT01969903|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110131686|NCT01969903|Analgesics|analgesics|mesh-ancestor
110131687|NCT01969903|Sensory System Agents|sensory system agents|mesh-ancestor
110131688|NCT01969903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110131689|NCT01969903|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110131690|NCT01969903|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110131691|NCT01969903|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110131692|NCT01969903|Adrenergic Agents|adrenergic agents|mesh-ancestor
110131693|NCT01969903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110131694|NCT01969903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110131695|NCT01969942|Melphalan|melphalan|mesh-list
110131696|NCT01969942|Busulfan|busulfan|mesh-list
110131697|NCT01969942|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110131698|NCT01969942|Alkylating Agents|alkylating agents|mesh-ancestor
110131699|NCT01969942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110131700|NCT01969942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110131701|NCT01969942|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110131702|NCT01969942|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110131703|NCT01969942|Immunologic Factors|immunologic factors|mesh-ancestor
110131704|NCT01969942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110131705|NCT01969955|Paclitaxel|paclitaxel|mesh-list
110131706|NCT01969955|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110131707|NCT01969955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110131708|NCT01969955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110131709|NCT01969955|Tubulin Modulators|tubulin modulators|mesh-ancestor
110131710|NCT01969955|Antimitotic Agents|antimitotic agents|mesh-ancestor
110131711|NCT01969955|Mitosis Modulators|mitosis modulators|mesh-ancestor
110131712|NCT01969955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110131713|NCT01970046|Metformin|metformin|mesh-list
110131714|NCT01970046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110131715|NCT01970046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110131716|NCT01970059|Metoprolol|metoprolol|mesh-list
110131717|NCT01970059|Carvedilol|carvedilol|mesh-list
110131718|NCT01970059|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110131719|NCT01970059|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110131720|NCT01970059|Sympatholytics|sympatholytics|mesh-ancestor
110131721|NCT01970059|Autonomic Agents|autonomic agents|mesh-ancestor
110131722|NCT01970059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110131723|NCT01970059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110131724|NCT01970059|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110131725|NCT01970059|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110131726|NCT01970059|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110131727|NCT01970059|Adrenergic Agents|adrenergic agents|mesh-ancestor
110131728|NCT01970059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110131729|NCT01970059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110131730|NCT01970059|Antioxidants|antioxidants|mesh-ancestor
110131731|NCT01970059|Protective Agents|protective agents|mesh-ancestor
110131732|NCT01970059|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110131733|NCT01970059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110131734|NCT01970059|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110131735|NCT01970059|Vasodilator Agents|vasodilator agents|mesh-ancestor
110131736|NCT01970059|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110131737|NCT01970059|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110131739|NCT01970072|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110131740|NCT01970072|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110131741|NCT01970072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110131742|NCT01970072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110131743|NCT01970072|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110131744|NCT01970072|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110131745|NCT01970072|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110131746|NCT01970072|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110131747|NCT01970072|Anesthetics, General|anesthetics, general|mesh-ancestor
110131748|NCT01970072|Anesthetics|anesthetics|mesh-ancestor
110131749|NCT01970072|GABA Modulators|gaba modulators|mesh-ancestor
110131750|NCT01970072|GABA Agents|gaba agents|mesh-ancestor
110131751|NCT01970072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110131752|NCT01970072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110131753|NCT01970202|Enoxaparin|enoxaparin|mesh-list
110131754|NCT01970202|Enoxaparin sodium|enoxaparin sodium|mesh-list
110131756|NCT01970202|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110131757|NCT01970202|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110131758|NCT01970202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110131759|NCT01970215|Atorvastatin|atorvastatin|mesh-list
110131760|NCT01970215|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110131761|NCT01970215|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110131762|NCT01970215|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110131763|NCT01970215|Antimetabolites|antimetabolites|mesh-ancestor
110131764|NCT01970215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110131765|NCT01970215|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110131766|NCT01970215|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110131767|NCT01970215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110131768|NCT01970280|Enoxaparin|enoxaparin|mesh-list
110131769|NCT01970280|Anticoagulants|anticoagulants|mesh-ancestor
110131770|NCT01970280|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110131771|NCT01970280|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110131772|NCT01970280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110131773|NCT01970358|Poly ICLC|poly iclc|mesh-list
110131774|NCT01970358|Interferon Inducers|interferon inducers|mesh-ancestor
110131775|NCT01970358|Immunologic Factors|immunologic factors|mesh-ancestor
110131776|NCT01970358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110131777|NCT01970449|Vaccines|vaccines|mesh-list
110131778|NCT01970449|Immunologic Factors|immunologic factors|mesh-ancestor
110131779|NCT01970449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110131780|NCT01970553|Gemcitabine|gemcitabine|mesh-list
110131781|NCT01970553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110131782|NCT01970553|Antimetabolites|antimetabolites|mesh-ancestor
110131783|NCT01970553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110131784|NCT01970553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110131785|NCT01970579|Paclitaxel|paclitaxel|mesh-list
110131786|NCT01970579|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110131787|NCT01970579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110131788|NCT01970579|Tubulin Modulators|tubulin modulators|mesh-ancestor
110131789|NCT01970579|Antimitotic Agents|antimitotic agents|mesh-ancestor
110131790|NCT01970579|Mitosis Modulators|mitosis modulators|mesh-ancestor
110131791|NCT01970579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110131792|NCT01970748|Propranolol|propranolol|mesh-list
110131793|NCT01970748|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110131794|NCT01970748|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110131795|NCT01970748|Adrenergic Agents|adrenergic agents|mesh-ancestor
110131796|NCT01970748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110131797|NCT01970748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110131798|NCT01970748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110131799|NCT01970748|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110131800|NCT01970748|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110131801|NCT01970748|Vasodilator Agents|vasodilator agents|mesh-ancestor
110131802|NCT01970800|Hormones|hormones|mesh-list
110131803|NCT01970800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110131804|NCT01970800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110131806|NCT01970904|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110131807|NCT01970904|Antimetabolites|antimetabolites|mesh-ancestor
110131808|NCT01970904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110131809|NCT01970904|Antiviral Agents|antiviral agents|mesh-ancestor
110131810|NCT01970904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110131811|NCT01970917|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110131812|NCT01970917|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110131815|NCT01971034|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110131816|NCT01971034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110131817|NCT01971034|Tubulin Modulators|tubulin modulators|mesh-ancestor
110131818|NCT01971034|Antimitotic Agents|antimitotic agents|mesh-ancestor
110131819|NCT01971034|Mitosis Modulators|mitosis modulators|mesh-ancestor
110131820|NCT01971034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110131821|NCT01971034|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110131822|NCT01971034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110131823|NCT01971047|Insulin|insulin|mesh-list
110131824|NCT01971047|Insulin Lispro|insulin lispro|mesh-list
110131825|NCT01971047|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110131826|NCT01971047|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110131827|NCT01971047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110131828|NCT01971190|Aflibercept|aflibercept|mesh-list
110131829|NCT01971190|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110131830|NCT01971190|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110131831|NCT01971190|Growth Substances|growth substances|mesh-ancestor
110131832|NCT01971190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110131833|NCT01971190|Growth Inhibitors|growth inhibitors|mesh-ancestor
110131834|NCT01971190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110131835|NCT01971242|Exenatide|exenatide|mesh-list
110131836|NCT01971242|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110131837|NCT01971242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110131838|NCT01971242|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110131839|NCT01971242|Incretins|incretins|mesh-ancestor
110131840|NCT01971242|Hormones|hormones|mesh-ancestor
110131841|NCT01971242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110131842|NCT01971268|Cimetidine|cimetidine|mesh-list
110131843|NCT01971268|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110131844|NCT01971268|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110131845|NCT01971268|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110131846|NCT01971268|Histamine Antagonists|histamine antagonists|mesh-ancestor
110131847|NCT01971268|Histamine Agents|histamine agents|mesh-ancestor
110131848|NCT01971268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110131849|NCT01971268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110131850|NCT01971268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110131851|NCT01971268|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110131852|NCT01971268|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110131853|NCT01971268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110131854|NCT01971281|Paclitaxel|paclitaxel|mesh-list
110131855|NCT01971281|Gemcitabine|gemcitabine|mesh-list
110131856|NCT01971281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110131857|NCT01971281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110131858|NCT01971281|Tubulin Modulators|tubulin modulators|mesh-ancestor
110131859|NCT01971281|Antimitotic Agents|antimitotic agents|mesh-ancestor
110131860|NCT01971281|Mitosis Modulators|mitosis modulators|mesh-ancestor
110131861|NCT01971281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110131862|NCT01971281|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110131863|NCT01971281|Antimetabolites|antimetabolites|mesh-ancestor
110131864|NCT01971411|Calcium, Dietary|calcium, dietary|mesh-list
110131865|NCT01971411|Vitamin D|vitamin d|mesh-list
110131866|NCT01971411|Ergocalciferols|ergocalciferols|mesh-list
110131867|NCT01971411|Cholecalciferol|cholecalciferol|mesh-list
110131868|NCT01971411|Vitamins|vitamins|mesh-list
110131869|NCT01971411|Calcium|calcium|mesh-list
110131870|NCT01971411|Micronutrients|micronutrients|mesh-ancestor
110131871|NCT01971411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110165271|NCT00023296|Vasodilator Agents|vasodilator agents|mesh-ancestor
110131872|NCT01971411|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110131873|NCT01971411|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110131874|NCT01971424|Magnesium Oxide|magnesium oxide|mesh-list
110131875|NCT01971424|Antacids|antacids|mesh-ancestor
110131876|NCT01971424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110131877|NCT01971424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110131878|NCT01971450|Iloprost|iloprost|mesh-list
110131879|NCT01971450|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110131880|NCT01971450|Vasodilator Agents|vasodilator agents|mesh-ancestor
110131882|NCT01971515|Trastuzumab|trastuzumab|mesh-list
110131883|NCT01971515|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110131884|NCT01971515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110131885|NCT01971515|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110131886|NCT01971515|Hormone Antagonists|hormone antagonists|mesh-ancestor
110131887|NCT01971515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110131888|NCT01971515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110131889|NCT01971515|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110131890|NCT01971515|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110131891|NCT01971515|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110131892|NCT01971515|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110131893|NCT01971606|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110131894|NCT01971606|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110131895|NCT01971606|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110131896|NCT01971606|Antimetabolites|antimetabolites|mesh-ancestor
110131897|NCT01971606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110131898|NCT01971606|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110131899|NCT01971606|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110131900|NCT01971606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110131901|NCT01971632|Oxycodone|oxycodone|mesh-list
110131902|NCT01971632|Naloxone|naloxone|mesh-list
110131903|NCT01971632|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110131904|NCT01971632|Narcotics|narcotics|mesh-ancestor
110131905|NCT01971632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110131906|NCT01971632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110131907|NCT01971632|Analgesics|analgesics|mesh-ancestor
110131908|NCT01971632|Sensory System Agents|sensory system agents|mesh-ancestor
110131909|NCT01971632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110131910|NCT01971632|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110131911|NCT01971658|Thalidomide|thalidomide|mesh-list
110131912|NCT01971658|Dexamethasone|dexamethasone|mesh-list
110131913|NCT01971658|Cyclophosphamide|cyclophosphamide|mesh-list
110131914|NCT01971658|Bortezomib|bortezomib|mesh-list
110131915|NCT01971658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110131916|NCT01971658|Immunologic Factors|immunologic factors|mesh-ancestor
110131917|NCT01971658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110131918|NCT01971658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110131919|NCT01971658|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110131920|NCT01971658|Alkylating Agents|alkylating agents|mesh-ancestor
110131921|NCT01971658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110131922|NCT01971658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110131923|NCT01971658|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110131924|NCT01971658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110131925|NCT01971658|Antiemetics|antiemetics|mesh-ancestor
110131926|NCT01971658|Autonomic Agents|autonomic agents|mesh-ancestor
110131927|NCT01971658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110131928|NCT01971658|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110131929|NCT01971658|Glucocorticoids|glucocorticoids|mesh-ancestor
110131930|NCT01971658|Hormones|hormones|mesh-ancestor
110131931|NCT01971658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110131932|NCT01971658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110131933|NCT01971658|Leprostatic Agents|leprostatic agents|mesh-ancestor
110131934|NCT01971658|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110131935|NCT01971658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110131936|NCT01971658|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110131937|NCT01971658|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110131938|NCT01971658|Growth Substances|growth substances|mesh-ancestor
110131940|NCT01971684|Mycophenolic Acid|mycophenolic acid|mesh-list
110131941|NCT01971684|Sirolimus|sirolimus|mesh-list
110131942|NCT01971684|Mercaptopurine|mercaptopurine|mesh-list
110131943|NCT01971684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110131944|NCT01971684|Immunologic Factors|immunologic factors|mesh-ancestor
110131945|NCT01971684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110131946|NCT01971684|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110131947|NCT01971684|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110131948|NCT01971684|Antitubercular Agents|antitubercular agents|mesh-ancestor
110131949|NCT01971684|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110131950|NCT01971684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110131951|NCT01971684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110131952|NCT01971684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110131953|NCT01971684|Antifungal Agents|antifungal agents|mesh-ancestor
110131954|NCT01971684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110131956|NCT01971684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110131957|NCT01971684|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110131958|NCT01971801|Vitamin D|vitamin d|mesh-list
110131959|NCT01971801|Cholecalciferol|cholecalciferol|mesh-list
110131960|NCT01971801|Vitamins|vitamins|mesh-ancestor
110131961|NCT01971801|Micronutrients|micronutrients|mesh-ancestor
110131962|NCT01971801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110131963|NCT01971801|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110131964|NCT01971801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110131965|NCT01971814|Infliximab|infliximab|mesh-list
110131966|NCT01971814|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110131967|NCT01971814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110131968|NCT01971814|Dermatologic Agents|dermatologic agents|mesh-ancestor
110131969|NCT01971814|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110131970|NCT01971814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110131971|NCT01971918|Antibodies|antibodies|mesh-list
110131972|NCT01971918|Immunologic Factors|immunologic factors|mesh-ancestor
110131973|NCT01971918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110131974|NCT01972113|Vitamins|vitamins|mesh-list
110131975|NCT01972113|Vitamin K|vitamin k|mesh-list
110131976|NCT01972113|Vitamin K 2|vitamin k 2|mesh-list
110131977|NCT01972113|Menaquinone 7|menaquinone 7|mesh-list
110131978|NCT01972113|Micronutrients|micronutrients|mesh-ancestor
110131979|NCT01972113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110131980|NCT01972113|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110131981|NCT01972113|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110131982|NCT01972113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110131983|NCT01972113|Hemostatics|hemostatics|mesh-ancestor
110131984|NCT01972113|Coagulants|coagulants|mesh-ancestor
110131985|NCT01972230|Remifentanil|remifentanil|mesh-list
110131986|NCT01972230|Sevoflurane|sevoflurane|mesh-list
110131987|NCT01972230|Propofol|propofol|mesh-list
110131988|NCT01972230|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110131989|NCT01972230|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110131990|NCT01972230|Anesthetics, General|anesthetics, general|mesh-ancestor
110131991|NCT01972230|Anesthetics|anesthetics|mesh-ancestor
110131992|NCT01972230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110131993|NCT01972230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110131994|NCT01972230|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110131995|NCT01972230|Narcotics|narcotics|mesh-ancestor
110131996|NCT01972230|Analgesics|analgesics|mesh-ancestor
110131997|NCT01972230|Sensory System Agents|sensory system agents|mesh-ancestor
110131998|NCT01972230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110131999|NCT01972230|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110132000|NCT01972230|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110132001|NCT01972269|Lidocaine|lidocaine|mesh-list
110132002|NCT01972269|Fentanyl|fentanyl|mesh-list
110132003|NCT01972269|Bupivacaine|bupivacaine|mesh-list
110132004|NCT01972269|Anesthetics, Local|anesthetics, local|mesh-ancestor
110132005|NCT01972269|Anesthetics|anesthetics|mesh-ancestor
110132006|NCT01972269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110132007|NCT01972269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110132008|NCT01972269|Sensory System Agents|sensory system agents|mesh-ancestor
110132009|NCT01972269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110132010|NCT01972269|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110132011|NCT01972269|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110132012|NCT01972269|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110132013|NCT01972269|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110132014|NCT01972269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110132015|NCT01972269|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110132016|NCT01972269|Narcotics|narcotics|mesh-ancestor
110132017|NCT01972269|Analgesics|analgesics|mesh-ancestor
110132018|NCT01972269|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110132019|NCT01972269|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110132020|NCT01972269|Anesthetics, General|anesthetics, general|mesh-ancestor
110132021|NCT01972373|Bevacizumab|bevacizumab|mesh-list
110132022|NCT01972373|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110132023|NCT01972373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110132024|NCT01972373|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110132025|NCT01972373|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110132026|NCT01972373|Growth Substances|growth substances|mesh-ancestor
110132027|NCT01972373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110132028|NCT01972373|Growth Inhibitors|growth inhibitors|mesh-ancestor
110132029|NCT01972490|Bevacizumab|bevacizumab|mesh-list
110132030|NCT01972490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110132031|NCT01972490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110132032|NCT01972490|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110132033|NCT01972490|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110132034|NCT01972490|Growth Substances|growth substances|mesh-ancestor
110132035|NCT01972490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110132036|NCT01972490|Growth Inhibitors|growth inhibitors|mesh-ancestor
110132037|NCT01972503|Oxaliplatin|oxaliplatin|mesh-list
110132038|NCT01972503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110132039|NCT01972620|Bupivacaine|bupivacaine|mesh-list
110132040|NCT01972620|Anesthetics, Local|anesthetics, local|mesh-ancestor
110132041|NCT01972620|Anesthetics|anesthetics|mesh-ancestor
110132042|NCT01972620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110132043|NCT01972620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110132044|NCT01972620|Sensory System Agents|sensory system agents|mesh-ancestor
110132045|NCT01972620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110132046|NCT01972711|Amisulpride|amisulpride|mesh-list
110132047|NCT01972711|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110132048|NCT01972711|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110132049|NCT01972711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110132050|NCT01972711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110132051|NCT01972711|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110132052|NCT01972711|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110132053|NCT01972711|Dopamine Agents|dopamine agents|mesh-ancestor
110132054|NCT01972711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110132055|NCT01972711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110132056|NCT01972711|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110132057|NCT01972711|Antidepressive Agents|antidepressive agents|mesh-ancestor
110132059|NCT01972763|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110132060|NCT01972763|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110132061|NCT01972763|Growth Substances|growth substances|mesh-ancestor
110132062|NCT01972763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110132063|NCT01972763|Growth Inhibitors|growth inhibitors|mesh-ancestor
110132064|NCT01972763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110132065|NCT01972828|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
110132066|NCT01972828|Plasma Substitutes|plasma substitutes|mesh-ancestor
110132068|NCT01972880|Ipragliflozin|ipragliflozin|mesh-list
110132069|NCT01972880|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110165300|NCT00023374|Pyrazinamide|pyrazinamide|mesh-list
110132070|NCT01972880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110132071|NCT01972880|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110132072|NCT01972880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110132073|NCT01972906|Ibuprofen|ibuprofen|mesh-list
110132074|NCT01972906|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110132075|NCT01972906|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110132076|NCT01972906|Analgesics|analgesics|mesh-ancestor
110132077|NCT01972906|Sensory System Agents|sensory system agents|mesh-ancestor
110132078|NCT01972906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110132079|NCT01972906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110132080|NCT01972906|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110132081|NCT01972906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110132082|NCT01972906|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110132083|NCT01972906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110132084|NCT01972906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110132085|NCT01972984|Anastrozole|anastrozole|mesh-list
110132086|NCT01972984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110132087|NCT01972984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110132088|NCT01972984|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110132089|NCT01972984|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110132090|NCT01972984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110132091|NCT01972984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110132092|NCT01972984|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110132093|NCT01972984|Hormone Antagonists|hormone antagonists|mesh-ancestor
110132094|NCT01972984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110132095|NCT01972984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110132096|NCT01973010|Ibuprofen|ibuprofen|mesh-list
110132097|NCT01973010|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110132098|NCT01973010|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110132099|NCT01973010|Analgesics|analgesics|mesh-ancestor
110132100|NCT01973010|Sensory System Agents|sensory system agents|mesh-ancestor
110132101|NCT01973010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110132102|NCT01973010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110132103|NCT01973010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110132104|NCT01973010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110132105|NCT01973010|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110132106|NCT01973010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110132107|NCT01973010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110132108|NCT01973101|Cisplatin|cisplatin|mesh-list
110132109|NCT01973101|Gemcitabine|gemcitabine|mesh-list
110132110|NCT01973101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110132111|NCT01973101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110132112|NCT01973101|Antimetabolites|antimetabolites|mesh-ancestor
110132113|NCT01973101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110132114|NCT01973114|Latanoprost|latanoprost|mesh-list
110132115|NCT01973114|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110132116|NCT01973114|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110132118|NCT01973140|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
110132119|NCT01973140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110132120|NCT01973140|Natriuretic Agents|natriuretic agents|mesh-ancestor
110132121|NCT01973140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110132123|NCT01973309|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110132124|NCT01973309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110132125|NCT01973309|Tubulin Modulators|tubulin modulators|mesh-ancestor
110132126|NCT01973309|Antimitotic Agents|antimitotic agents|mesh-ancestor
110132127|NCT01973309|Mitosis Modulators|mitosis modulators|mesh-ancestor
110132128|NCT01973309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110132129|NCT01973322|Vaccines|vaccines|mesh-list
110132130|NCT01973322|Complement Factor H|complement factor h|mesh-list
110132131|NCT01973322|Immunologic Factors|immunologic factors|mesh-ancestor
110132132|NCT01973322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110132133|NCT01973322|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
110132134|NCT01973322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110132135|NCT01973400|Tocotrienols|tocotrienols|mesh-list
110132136|NCT01973400|Vitamin E|vitamin e|mesh-list
110132137|NCT01973400|Tocopherols|tocopherols|mesh-list
110132139|NCT01973400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110132140|NCT01973400|Protective Agents|protective agents|mesh-ancestor
110132141|NCT01973400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110132142|NCT01973400|Vitamins|vitamins|mesh-ancestor
110132143|NCT01973400|Micronutrients|micronutrients|mesh-ancestor
110132144|NCT01973504|Chrysarobin|chrysarobin|mesh-list
110132145|NCT01973504|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110132146|NCT01973504|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110132147|NCT01973504|Analgesics|analgesics|mesh-ancestor
110132148|NCT01973504|Sensory System Agents|sensory system agents|mesh-ancestor
110132149|NCT01973504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110132150|NCT01973504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110132151|NCT01973504|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110132152|NCT01973504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110132153|NCT01973517|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
110132154|NCT01973517|Hematinics|hematinics|mesh-ancestor
110132155|NCT01973517|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
110132156|NCT01973517|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110132157|NCT01973660|Tamoxifen|tamoxifen|mesh-list
110132158|NCT01973660|Paclitaxel|paclitaxel|mesh-list
110132159|NCT01973660|Trastuzumab|trastuzumab|mesh-list
110132160|NCT01973660|Letrozole|letrozole|mesh-list
110132161|NCT01973660|Lapatinib|lapatinib|mesh-list
110132162|NCT01973660|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110132163|NCT01973660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110132164|NCT01973660|Tubulin Modulators|tubulin modulators|mesh-ancestor
110132165|NCT01973660|Antimitotic Agents|antimitotic agents|mesh-ancestor
110132166|NCT01973660|Mitosis Modulators|mitosis modulators|mesh-ancestor
110132167|NCT01973660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110132168|NCT01973660|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110132169|NCT01973660|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110132170|NCT01973660|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110132171|NCT01973660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110132172|NCT01973660|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110132173|NCT01973660|Hormone Antagonists|hormone antagonists|mesh-ancestor
110132174|NCT01973660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110132175|NCT01973660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110132176|NCT01973660|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110132177|NCT01973660|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110132178|NCT01973660|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110132179|NCT01973660|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110132182|NCT01973751|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110132183|NCT01973751|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110132184|NCT01973751|Autonomic Agents|autonomic agents|mesh-ancestor
110132185|NCT01973751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110132186|NCT01973751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110132187|NCT01973751|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110132188|NCT01973751|Respiratory System Agents|respiratory system agents|mesh-ancestor
110132189|NCT01973751|Glucocorticoids|glucocorticoids|mesh-ancestor
110132190|NCT01973751|Hormones|hormones|mesh-ancestor
110132191|NCT01973751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110132192|NCT01973790|Z 338|z 338|mesh-list
110132193|NCT01973790|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110132194|NCT01973790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110132195|NCT01973790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110132196|NCT01973790|Cholinergic Agents|cholinergic agents|mesh-ancestor
110132197|NCT01973790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110132198|NCT01973790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110132199|NCT01973790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110132200|NCT01973816|Cyproterone Acetate|cyproterone acetate|mesh-list
110132201|NCT01973816|Triptorelin Pamoate|triptorelin pamoate|mesh-list
110132202|NCT01973816|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110132203|NCT01973816|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110132204|NCT01973816|Estradiol|estradiol|mesh-list
110132205|NCT01973816|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110132206|NCT01973816|Cyproterone|cyproterone|mesh-list
110132207|NCT01973816|Estrogens|estrogens|mesh-ancestor
110132208|NCT01973816|Hormones|hormones|mesh-ancestor
110132209|NCT01973816|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110132210|NCT01973816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110132211|NCT01973816|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110132212|NCT01973816|Contraceptive Agents|contraceptive agents|mesh-ancestor
110132213|NCT01973816|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110132214|NCT01973816|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110132215|NCT01973816|Androgen Antagonists|androgen antagonists|mesh-ancestor
110132216|NCT01973816|Hormone Antagonists|hormone antagonists|mesh-ancestor
110132217|NCT01973816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110132218|NCT01973816|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110132219|NCT01973816|Luteolytic Agents|luteolytic agents|mesh-ancestor
110132220|NCT01973816|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110132221|NCT01973842|Triptorelin Pamoate|triptorelin pamoate|mesh-list
110132222|NCT01973842|Luteolytic Agents|luteolytic agents|mesh-ancestor
110132223|NCT01973842|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110132224|NCT01973842|Contraceptive Agents|contraceptive agents|mesh-ancestor
110132225|NCT01973842|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110132226|NCT01973842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110132227|NCT01973842|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110132228|NCT01973842|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110132229|NCT01973842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110132230|NCT01973855|Ribavirin|ribavirin|mesh-list
110132231|NCT01973855|Antimetabolites|antimetabolites|mesh-ancestor
110132232|NCT01973855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110132233|NCT01973855|Antiviral Agents|antiviral agents|mesh-ancestor
110132234|NCT01973855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110132235|NCT01973868|Cetuximab|cetuximab|mesh-list
110132236|NCT01973868|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110132237|NCT01973868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110132238|NCT01973920|Insulin|insulin|mesh-list
110132239|NCT01973920|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110132240|NCT01973920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110132241|NCT01973933|Metformin|metformin|mesh-list
110132242|NCT01973933|Pyrimethamine|pyrimethamine|mesh-list
110132243|NCT01973933|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110132244|NCT01973933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110132245|NCT01973933|Antimalarials|antimalarials|mesh-ancestor
110132246|NCT01973933|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110132247|NCT01973933|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110132248|NCT01973933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110132249|NCT01973933|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110132250|NCT01973933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110132251|NCT01973933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110132252|NCT01974024|Methylprednisolone|methylprednisolone|mesh-list
110132253|NCT01974024|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110132254|NCT01974024|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110132255|NCT01974024|Prednisolone|prednisolone|mesh-list
110132256|NCT01974024|Prednisolone acetate|prednisolone acetate|mesh-list
110132257|NCT01974024|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110132258|NCT01974024|Prednisolone phosphate|prednisolone phosphate|mesh-list
110132259|NCT01974024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110132260|NCT01974024|Antiemetics|antiemetics|mesh-ancestor
110132261|NCT01974024|Autonomic Agents|autonomic agents|mesh-ancestor
110132262|NCT01974024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110132263|NCT01974024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110132264|NCT01974024|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110132265|NCT01974024|Glucocorticoids|glucocorticoids|mesh-ancestor
110132266|NCT01974024|Hormones|hormones|mesh-ancestor
110132267|NCT01974024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110132268|NCT01974024|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110132269|NCT01974024|Protective Agents|protective agents|mesh-ancestor
110132270|NCT01974024|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110132271|NCT01974024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110132272|NCT01974037|Capsaicin|capsaicin|mesh-list
110132273|NCT01974037|Antipruritics|antipruritics|mesh-ancestor
110132274|NCT01974037|Dermatologic Agents|dermatologic agents|mesh-ancestor
110132275|NCT01974037|Sensory System Agents|sensory system agents|mesh-ancestor
110132276|NCT01974037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110132277|NCT01974037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110132279|NCT01974167|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
110132280|NCT01974167|Eldecalcitol|eldecalcitol|mesh-list
110132281|NCT01974167|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110132282|NCT01974167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110132283|NCT01974167|Vitamins|vitamins|mesh-ancestor
110132284|NCT01974167|Micronutrients|micronutrients|mesh-ancestor
110132285|NCT01974258|Vemurafenib|vemurafenib|mesh-list
110132286|NCT01974258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110132287|NCT01974258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110132288|NCT01974258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110132289|NCT01974258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110132290|NCT01974297|Atorvastatin|atorvastatin|mesh-list
110132291|NCT01974297|Fenofibric acid|fenofibric acid|mesh-list
110132292|NCT01974297|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110132293|NCT01974297|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110132294|NCT01974297|Antimetabolites|antimetabolites|mesh-ancestor
110132295|NCT01974297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110132296|NCT01974297|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110132297|NCT01974297|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110132298|NCT01974297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110132299|NCT01974336|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
110132300|NCT01974336|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
110132301|NCT01974336|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110132302|NCT01974375|Fluconazole|fluconazole|mesh-list
110132303|NCT01974375|Micafungin|micafungin|mesh-list
110132304|NCT01974375|Antifungal Agents|antifungal agents|mesh-ancestor
110132305|NCT01974375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110132306|NCT01974375|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110344418|NCT05834569|Antipyretics|antipyretics|mesh-ancestor
110132307|NCT01974375|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110132308|NCT01974375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110132309|NCT01974375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110132310|NCT01974375|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110132311|NCT01974375|Hormone Antagonists|hormone antagonists|mesh-ancestor
110132312|NCT01974375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110132313|NCT01974375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110132314|NCT01974375|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110132315|NCT01974375|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110132316|NCT01974401|Chlorhexidine|chlorhexidine|mesh-list
110132317|NCT01974401|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110132318|NCT01974401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110132319|NCT01974401|Disinfectants|disinfectants|mesh-ancestor
110132320|NCT01974518|Cyclophosphamide|cyclophosphamide|mesh-list
110132322|NCT01974518|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110132323|NCT01974518|Immunologic Factors|immunologic factors|mesh-ancestor
110132324|NCT01974518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110132325|NCT01974518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110132326|NCT01974518|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110132327|NCT01974518|Alkylating Agents|alkylating agents|mesh-ancestor
110368564|NCT04618107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110132328|NCT01974518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110132329|NCT01974518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110132330|NCT01974518|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110132331|NCT01974518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110132332|NCT01974622|Verteporfin|verteporfin|mesh-list
110132333|NCT01974622|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110132334|NCT01974622|Dermatologic Agents|dermatologic agents|mesh-ancestor
110132335|NCT01974648|Remifentanil|remifentanil|mesh-list
110132337|NCT01974648|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110132338|NCT01974648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110132339|NCT01974648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110132340|NCT01974648|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110132341|NCT01974648|Anesthetics, General|anesthetics, general|mesh-ancestor
110132342|NCT01974648|Anesthetics|anesthetics|mesh-ancestor
110132343|NCT01974648|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110132344|NCT01974648|Narcotics|narcotics|mesh-ancestor
110132345|NCT01974648|Analgesics|analgesics|mesh-ancestor
110132346|NCT01974648|Sensory System Agents|sensory system agents|mesh-ancestor
110132347|NCT01974648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110132348|NCT01974843|Bupivacaine|bupivacaine|mesh-list
110132349|NCT01974843|Levobupivacaine|levobupivacaine|mesh-list
110132350|NCT01974843|Anesthetics, Local|anesthetics, local|mesh-ancestor
110132351|NCT01974843|Anesthetics|anesthetics|mesh-ancestor
110132352|NCT01974843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110132353|NCT01974843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110132354|NCT01974843|Sensory System Agents|sensory system agents|mesh-ancestor
110132355|NCT01974843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110132356|NCT01974934|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
110132357|NCT01974934|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110132358|NCT01974934|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110132359|NCT01974934|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110132360|NCT01974934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110132361|NCT01974934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110132362|NCT01974934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110132363|NCT01974934|Antidepressive Agents|antidepressive agents|mesh-ancestor
110132364|NCT01974934|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110132365|NCT01975012|Rilpivirine|rilpivirine|mesh-list
110132366|NCT01975012|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110132367|NCT01975012|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110132368|NCT01975012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110132369|NCT01975012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110132370|NCT01975012|Antiviral Agents|antiviral agents|mesh-ancestor
110132371|NCT01975012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110132372|NCT01975012|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110132373|NCT01975012|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110132374|NCT01975051|Miltefosine|miltefosine|mesh-list
110132375|NCT01975051|Antifungal Agents|antifungal agents|mesh-ancestor
110132376|NCT01975051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110132377|NCT01975051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110132378|NCT01975051|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110132379|NCT01975051|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110132380|NCT01975129|Oxytocin|oxytocin|mesh-list
110132381|NCT01975129|Oxytocics|oxytocics|mesh-ancestor
110132382|NCT01975129|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110132383|NCT01975129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110132384|NCT01975142|Trastuzumab|trastuzumab|mesh-list
110132385|NCT01975142|Maytansine|maytansine|mesh-list
110132386|NCT01975142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110132387|NCT01975142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110132388|NCT01975142|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110132389|NCT01975142|Tubulin Modulators|tubulin modulators|mesh-ancestor
110132390|NCT01975142|Antimitotic Agents|antimitotic agents|mesh-ancestor
110132391|NCT01975142|Mitosis Modulators|mitosis modulators|mesh-ancestor
110132392|NCT01975142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110132393|NCT01975194|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110132394|NCT01975194|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110132395|NCT01975194|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110132396|NCT01975194|Antimetabolites|antimetabolites|mesh-ancestor
110132397|NCT01975194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110132398|NCT01975194|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110132399|NCT01975194|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110132400|NCT01975194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110132401|NCT01975259|Glucagon|glucagon|mesh-list
110132402|NCT01975259|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
110132403|NCT01975259|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
110132404|NCT01975259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110132405|NCT01975259|Hormones|hormones|mesh-ancestor
110132406|NCT01975259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110132407|NCT01975259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110132408|NCT01975259|Incretins|incretins|mesh-ancestor
110132409|NCT01975324|4-Aminopyridine|4-aminopyridine|mesh-list
110132410|NCT01975324|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
110132411|NCT01975324|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110132412|NCT01975324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110132413|NCT01975363|Curcumin|curcumin|mesh-list
110132414|NCT01975363|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110132415|NCT01975363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110132416|NCT01975363|Analgesics|analgesics|mesh-ancestor
110132417|NCT01975363|Sensory System Agents|sensory system agents|mesh-ancestor
110132418|NCT01975363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110132419|NCT01975363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110132420|NCT01975363|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110132421|NCT01975363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110132422|NCT01975363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110132423|NCT01975363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110132424|NCT01975363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110132425|NCT01975441|Ivermectin|ivermectin|mesh-list
110132426|NCT01975441|Albendazole|albendazole|mesh-list
110132427|NCT01975441|Diethylcarbamazine|diethylcarbamazine|mesh-list
110132428|NCT01975441|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110132429|NCT01975441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110132430|NCT01975441|Anthelmintics|anthelmintics|mesh-ancestor
110132431|NCT01975441|Anticestodal Agents|anticestodal agents|mesh-ancestor
110132432|NCT01975441|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110132433|NCT01975441|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110132434|NCT01975441|Tubulin Modulators|tubulin modulators|mesh-ancestor
110132435|NCT01975441|Antimitotic Agents|antimitotic agents|mesh-ancestor
110132436|NCT01975441|Mitosis Modulators|mitosis modulators|mesh-ancestor
110132437|NCT01975441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110132438|NCT01975441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110132439|NCT01975441|Filaricides|filaricides|mesh-ancestor
110132440|NCT01975441|Antinematodal Agents|antinematodal agents|mesh-ancestor
110132441|NCT01975441|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
110132442|NCT01975441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110132443|NCT01975454|Capecitabine|capecitabine|mesh-list
110132444|NCT01975454|Oxaliplatin|oxaliplatin|mesh-list
110132445|NCT01975454|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110132446|NCT01975454|Antimetabolites|antimetabolites|mesh-ancestor
110132447|NCT01975454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110132448|NCT01975454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110132449|NCT01975480|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
110132450|NCT01975480|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110132451|NCT01975480|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110132452|NCT01975480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110132453|NCT01975480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110132454|NCT01975480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110132455|NCT01975480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110132456|NCT01975480|Antidepressive Agents|antidepressive agents|mesh-ancestor
110132457|NCT01975480|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110132458|NCT01975662|Vancomycin|vancomycin|mesh-list
110132459|NCT01975662|Daptomycin|daptomycin|mesh-list
110132460|NCT01975662|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110132461|NCT01975662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110132462|NCT01975688|Nabiximols|nabiximols|mesh-list
110132463|NCT01975688|Analgesics|analgesics|mesh-ancestor
110132464|NCT01975688|Sensory System Agents|sensory system agents|mesh-ancestor
110132465|NCT01975688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110132466|NCT01975688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110132467|NCT01975714|Bimatoprost|bimatoprost|mesh-list
110132468|NCT01975714|Latanoprost|latanoprost|mesh-list
110132469|NCT01975714|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110132470|NCT01975714|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110132471|NCT01975714|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110132472|NCT01975727|Dexamethasone|dexamethasone|mesh-list
110132473|NCT01975727|Dexamethasone acetate|dexamethasone acetate|mesh-list
110132474|NCT01975727|BB 1101|bb 1101|mesh-list
110132475|NCT01975727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110132476|NCT01975727|Antiemetics|antiemetics|mesh-ancestor
110132477|NCT01975727|Autonomic Agents|autonomic agents|mesh-ancestor
110132478|NCT01975727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110132479|NCT01975727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110132480|NCT01975727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110132481|NCT01975727|Glucocorticoids|glucocorticoids|mesh-ancestor
110132482|NCT01975727|Hormones|hormones|mesh-ancestor
110132483|NCT01975727|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110132484|NCT01975727|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110132485|NCT01975727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110132486|NCT01975727|Protease Inhibitors|protease inhibitors|mesh-ancestor
110132487|NCT01975727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110132488|NCT01975727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110132489|NCT01975753|Fentanyl|fentanyl|mesh-list
110132490|NCT01975753|Morphine|morphine|mesh-list
110132491|NCT01975753|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110344450|NCT05819710|Zopiclone|zopiclone|mesh-list
110132492|NCT01975753|Narcotics|narcotics|mesh-ancestor
110132493|NCT01975753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110132494|NCT01975753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110132495|NCT01975753|Analgesics|analgesics|mesh-ancestor
110132496|NCT01975753|Sensory System Agents|sensory system agents|mesh-ancestor
110132497|NCT01975753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110132498|NCT01975753|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110132499|NCT01975753|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110132500|NCT01975753|Anesthetics, General|anesthetics, general|mesh-ancestor
110132501|NCT01975753|Anesthetics|anesthetics|mesh-ancestor
110132502|NCT01975779|(2-(6-fluoro-1H-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|(2-(6-fluoro-1h-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|mesh-list
110132503|NCT01975779|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110132504|NCT01975779|Serotonin Agents|serotonin agents|mesh-ancestor
110132505|NCT01975779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110132506|NCT01975779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110132507|NCT01975779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110132508|NCT01975805|Chlorhexidine|chlorhexidine|mesh-list
110132509|NCT01975805|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110132510|NCT01975805|Povidone-Iodine|povidone-iodine|mesh-list
110132511|NCT01975805|Povidone|povidone|mesh-list
110132512|NCT01975805|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110132513|NCT01975805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110132514|NCT01975805|Disinfectants|disinfectants|mesh-ancestor
110132515|NCT01975805|Dermatologic Agents|dermatologic agents|mesh-ancestor
110132516|NCT01975805|Plasma Substitutes|plasma substitutes|mesh-ancestor
110132517|NCT01975805|Blood Substitutes|blood substitutes|mesh-ancestor
110132518|NCT01975961|Telmisartan|telmisartan|mesh-list
110132519|NCT01975961|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110132520|NCT01975961|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110132521|NCT01975961|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110132522|NCT01975961|Antimetabolites|antimetabolites|mesh-ancestor
110132523|NCT01975961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110132524|NCT01975961|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110132525|NCT01975961|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110132526|NCT01975961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110132527|NCT01975961|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110132528|NCT01975961|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110132529|NCT01975961|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110132530|NCT01976078|Midazolam|midazolam|mesh-list
110132531|NCT01976078|Esomeprazole|esomeprazole|mesh-list
110132532|NCT01976078|Ranitidine|ranitidine|mesh-list
110132533|NCT01976078|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
110132534|NCT01976078|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110132535|NCT01976078|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110132536|NCT01976078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110132537|NCT01976078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110132538|NCT01976078|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110132539|NCT01976078|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110132540|NCT01976078|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110132541|NCT01976078|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110132542|NCT01976078|Anesthetics, General|anesthetics, general|mesh-ancestor
110132543|NCT01976078|Anesthetics|anesthetics|mesh-ancestor
110132544|NCT01976078|GABA Modulators|gaba modulators|mesh-ancestor
110132545|NCT01976078|GABA Agents|gaba agents|mesh-ancestor
110132546|NCT01976078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110132547|NCT01976078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110132548|NCT01976078|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110132549|NCT01976078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110132550|NCT01976078|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110132551|NCT01976078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110132552|NCT01976078|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110344463|NCT05811403|Eusol|eusol|mesh-list
110132553|NCT01976078|Histamine Antagonists|histamine antagonists|mesh-ancestor
110132554|NCT01976078|Histamine Agents|histamine agents|mesh-ancestor
110132555|NCT01976143|Etirinotecan pegol|etirinotecan pegol|mesh-list
110132556|NCT01976143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110132557|NCT01976143|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110132558|NCT01976143|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110132559|NCT01976143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110132560|NCT01976143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110132561|NCT01976195|Thalidomide|thalidomide|mesh-list
110132562|NCT01976195|Dexamethasone|dexamethasone|mesh-list
110132563|NCT01976195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110132564|NCT01976195|Antiemetics|antiemetics|mesh-ancestor
110132565|NCT01976195|Autonomic Agents|autonomic agents|mesh-ancestor
110132566|NCT01976195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110132567|NCT01976195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110132568|NCT01976195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110132569|NCT01976195|Glucocorticoids|glucocorticoids|mesh-ancestor
110132570|NCT01976195|Hormones|hormones|mesh-ancestor
110132571|NCT01976195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110132572|NCT01976195|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110132573|NCT01976195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110132574|NCT01976195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110132576|NCT01976195|Leprostatic Agents|leprostatic agents|mesh-ancestor
110132577|NCT01976195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110132578|NCT01976195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110132579|NCT01976195|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110132580|NCT01976195|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110132581|NCT01976195|Growth Substances|growth substances|mesh-ancestor
110132582|NCT01976195|Growth Inhibitors|growth inhibitors|mesh-ancestor
110132583|NCT01976208|Omalizumab|omalizumab|mesh-list
110132584|NCT01976208|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110132585|NCT01976208|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110132586|NCT01976208|Respiratory System Agents|respiratory system agents|mesh-ancestor
110132587|NCT01976520|Vaccines|vaccines|mesh-list
110132588|NCT01976520|Immunologic Factors|immunologic factors|mesh-ancestor
110132589|NCT01976520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110132590|NCT01976611|Botulinum Toxins|botulinum toxins|mesh-list
110132591|NCT01976611|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110132592|NCT01976611|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110132593|NCT01976611|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110132594|NCT01976611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110132595|NCT01976611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110132596|NCT01976611|Cholinergic Agents|cholinergic agents|mesh-ancestor
110132597|NCT01976611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110132598|NCT01976611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110132599|NCT01976611|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110132600|NCT01976611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110132601|NCT01976676|Folic Acid|folic acid|mesh-list
110132602|NCT01976676|Hematinics|hematinics|mesh-ancestor
110132603|NCT01976676|Vitamin B Complex|vitamin b complex|mesh-ancestor
110132604|NCT01976676|Vitamins|vitamins|mesh-ancestor
110132605|NCT01976676|Micronutrients|micronutrients|mesh-ancestor
110132606|NCT01976676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110132607|NCT01976780|Artesunate|artesunate|mesh-list
110132608|NCT01976780|Lumefantrine|lumefantrine|mesh-list
110132609|NCT01976780|Artemether|artemether|mesh-list
110132610|NCT01976780|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
110132611|NCT01976780|Mefloquine|mefloquine|mesh-list
110132612|NCT01976780|Antimalarials|antimalarials|mesh-ancestor
110132613|NCT01976780|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110132614|NCT01976780|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110132615|NCT01976780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110132616|NCT01976780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110132617|NCT01976780|Antiviral Agents|antiviral agents|mesh-ancestor
110132618|NCT01976780|Schistosomicides|schistosomicides|mesh-ancestor
110132619|NCT01976780|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110132620|NCT01976780|Anthelmintics|anthelmintics|mesh-ancestor
110132621|NCT01976923|Bevacizumab|bevacizumab|mesh-list
110132622|NCT01976923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110344475|NCT05807139|Spironolactone|spironolactone|mesh-list
110132623|NCT01976923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110132624|NCT01976923|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110132625|NCT01976923|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110132626|NCT01976923|Growth Substances|growth substances|mesh-ancestor
110132627|NCT01976923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110132628|NCT01976923|Growth Inhibitors|growth inhibitors|mesh-ancestor
110132630|NCT01976936|L 647318|l 647318|mesh-list
110132632|NCT01976936|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110132633|NCT01976936|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110132634|NCT01976936|Antimetabolites|antimetabolites|mesh-ancestor
110132635|NCT01976936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110132636|NCT01976936|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110132637|NCT01976936|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110132639|NCT01977118|Streptokinase|streptokinase|mesh-list
110132640|NCT01977118|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110132641|NCT01977118|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110132642|NCT01977118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110132643|NCT01977209|Gossypol|gossypol|mesh-list
110132644|NCT01977209|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110132645|NCT01977209|Contraceptive Agents|contraceptive agents|mesh-ancestor
110132646|NCT01977209|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110132647|NCT01977209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110132648|NCT01977300|Valproic Acid|valproic acid|mesh-list
110132649|NCT01977300|Olanzapine|olanzapine|mesh-list
110132650|NCT01977300|Risperidone|risperidone|mesh-list
110132651|NCT01977300|Lithium Carbonate|lithium carbonate|mesh-list
110132652|NCT01977300|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110132653|NCT01977300|Serotonin Agents|serotonin agents|mesh-ancestor
110132654|NCT01977300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110132655|NCT01977300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110132656|NCT01977300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110132657|NCT01977300|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110132658|NCT01977300|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110132659|NCT01977300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110132660|NCT01977300|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110132661|NCT01977300|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110132662|NCT01977300|Dopamine Agents|dopamine agents|mesh-ancestor
110132663|NCT01977300|Antiemetics|antiemetics|mesh-ancestor
110132664|NCT01977300|Autonomic Agents|autonomic agents|mesh-ancestor
110132665|NCT01977300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110132666|NCT01977300|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110132667|NCT01977300|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110132668|NCT01977300|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110132669|NCT01977300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110132670|NCT01977300|Antidepressive Agents|antidepressive agents|mesh-ancestor
110132671|NCT01977300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110132673|NCT01977300|Anticonvulsants|anticonvulsants|mesh-ancestor
110132674|NCT01977300|GABA Agents|gaba agents|mesh-ancestor
110132675|NCT01977339|Bupivacaine|bupivacaine|mesh-list
110132676|NCT01977339|Anesthetics, Local|anesthetics, local|mesh-ancestor
110132677|NCT01977339|Anesthetics|anesthetics|mesh-ancestor
110132678|NCT01977339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110132679|NCT01977339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110132680|NCT01977339|Sensory System Agents|sensory system agents|mesh-ancestor
110132681|NCT01977339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110132682|NCT01977378|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
110132683|NCT01977378|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
110132684|NCT01977378|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110132685|NCT01977378|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110132686|NCT01977378|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110344479|NCT05807139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110132687|NCT01977378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110132688|NCT01977378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110132689|NCT01977378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110132690|NCT01977378|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110132691|NCT01977378|Antidepressive Agents|antidepressive agents|mesh-ancestor
110132692|NCT01977378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110132693|NCT01977430|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110132694|NCT01977430|Furosemide|furosemide|mesh-list
110132695|NCT01977430|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110132696|NCT01977430|Diuretics|diuretics|mesh-ancestor
110132697|NCT01977430|Natriuretic Agents|natriuretic agents|mesh-ancestor
110132698|NCT01977430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110132699|NCT01977430|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110132700|NCT01977430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110132701|NCT01977430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110132702|NCT01977430|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110132703|NCT01977235|Irinotecan|irinotecan|mesh-list
110132704|NCT01977235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110132705|NCT01977235|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110132706|NCT01977235|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110132707|NCT01977235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110132708|NCT01977235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110132709|NCT01977443|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110132710|NCT01977443|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110132712|NCT01977859|Natriuretic Agents|natriuretic agents|mesh-ancestor
110132713|NCT01977859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110132714|NCT01977989|Vancomycin|vancomycin|mesh-list
110132715|NCT01977989|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110132716|NCT01977989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110132717|NCT01978015|Timolol|timolol|mesh-list
110132718|NCT01978015|Bimatoprost|bimatoprost|mesh-list
110132719|NCT01978015|Travoprost|travoprost|mesh-list
110132720|NCT01978015|Dextrans|dextrans|mesh-list
110132721|NCT01978015|Latanoprost|latanoprost|mesh-list
110132722|NCT01978015|Maleic acid|maleic acid|mesh-list
110132723|NCT01978015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110132724|NCT01978015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110132725|NCT01978015|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110132726|NCT01978015|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110132727|NCT01978015|Adrenergic Agents|adrenergic agents|mesh-ancestor
110132728|NCT01978015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110132729|NCT01978015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110132730|NCT01978015|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110132731|NCT01978015|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110132732|NCT01978015|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110132733|NCT01978015|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110132734|NCT01978015|Anticoagulants|anticoagulants|mesh-ancestor
110132735|NCT01978015|Plasma Substitutes|plasma substitutes|mesh-ancestor
110132736|NCT01978015|Blood Substitutes|blood substitutes|mesh-ancestor
110132737|NCT01978041|Fluorides|fluorides|mesh-list
110132738|NCT01978041|Cariostatic Agents|cariostatic agents|mesh-ancestor
110132739|NCT01978041|Protective Agents|protective agents|mesh-ancestor
110132740|NCT01978041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110132741|NCT01978301|Triamcinolone|triamcinolone|mesh-list
110132742|NCT01978301|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110132743|NCT01978301|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110132744|NCT01978301|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110132745|NCT01978301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110132746|NCT01978301|Glucocorticoids|glucocorticoids|mesh-ancestor
110132747|NCT01978301|Hormones|hormones|mesh-ancestor
110132748|NCT01978301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110132749|NCT01978301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110132750|NCT01978301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110132751|NCT01978301|Immunologic Factors|immunologic factors|mesh-ancestor
110132752|NCT01978301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110132753|NCT01978301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110132754|NCT01978405|Thioctic Acid|thioctic acid|mesh-list
110132755|NCT01978405|Antioxidants|antioxidants|mesh-ancestor
110132756|NCT01978405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110132757|NCT01978405|Protective Agents|protective agents|mesh-ancestor
110132758|NCT01978405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110132759|NCT01978405|Vitamin B Complex|vitamin b complex|mesh-ancestor
110132760|NCT01978405|Vitamins|vitamins|mesh-ancestor
110132761|NCT01978405|Micronutrients|micronutrients|mesh-ancestor
110132762|NCT01978418|Albuterol|albuterol|mesh-list
110132763|NCT01978418|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110132764|NCT01978418|Autonomic Agents|autonomic agents|mesh-ancestor
110132765|NCT01978418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110132766|NCT01978418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110132767|NCT01978418|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110132768|NCT01978418|Respiratory System Agents|respiratory system agents|mesh-ancestor
110132769|NCT01978418|Tocolytic Agents|tocolytic agents|mesh-ancestor
110132770|NCT01978418|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110132771|NCT01978418|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110132772|NCT01978418|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110132773|NCT01978418|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110132774|NCT01978418|Adrenergic Agents|adrenergic agents|mesh-ancestor
110132775|NCT01978418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110132776|NCT01978418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110132777|NCT01978457|Propranolol|propranolol|mesh-list
110132778|NCT01978457|Cocaine|cocaine|mesh-list
110132779|NCT01978457|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110132780|NCT01978457|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110132781|NCT01978457|Adrenergic Agents|adrenergic agents|mesh-ancestor
110132782|NCT01978457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110132783|NCT01978457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110132784|NCT01978457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110132785|NCT01978457|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110132786|NCT01978457|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110132788|NCT01978457|Anesthetics, Local|anesthetics, local|mesh-ancestor
110132790|NCT01978457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110132791|NCT01978457|Sensory System Agents|sensory system agents|mesh-ancestor
110132792|NCT01978457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110132793|NCT01978457|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110132794|NCT01978457|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110132795|NCT01978457|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110132796|NCT01978457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110132797|NCT01978457|Dopamine Agents|dopamine agents|mesh-ancestor
110132798|NCT01978483|Denosumab|denosumab|mesh-list
110132799|NCT01978483|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110132800|NCT01978483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110132801|NCT01978496|Eletriptan|eletriptan|mesh-list
110132802|NCT01978496|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110132803|NCT01978496|Serotonin Agents|serotonin agents|mesh-ancestor
110132804|NCT01978496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110132805|NCT01978496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110132806|NCT01978496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110132807|NCT01978665|Prednisone|prednisone|mesh-list
110132808|NCT01978665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110132809|NCT01978665|Glucocorticoids|glucocorticoids|mesh-ancestor
110132810|NCT01978665|Hormones|hormones|mesh-ancestor
110132811|NCT01978665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110344505|NCT05781035|Dexmedetomidine|dexmedetomidine|mesh-list
110132812|NCT01978665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110132813|NCT01978665|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110132814|NCT01978665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110132815|NCT01978678|Budesonide|budesonide|mesh-list
110132816|NCT01978678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110132817|NCT01978678|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110132818|NCT01978678|Autonomic Agents|autonomic agents|mesh-ancestor
110132819|NCT01978678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110132820|NCT01978678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110132821|NCT01978678|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110132822|NCT01978678|Respiratory System Agents|respiratory system agents|mesh-ancestor
110132823|NCT01978678|Glucocorticoids|glucocorticoids|mesh-ancestor
110132825|NCT01978678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110132826|NCT01978704|Insulin|insulin|mesh-list
110132827|NCT01978704|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110132828|NCT01978704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110132829|NCT01978704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110132830|NCT01978717|Anesthetics|anesthetics|mesh-list
110132831|NCT01978717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110132832|NCT01978717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110132833|NCT01978782|Raltegravir Potassium|raltegravir potassium|mesh-list
110132834|NCT01978782|Citalopram|citalopram|mesh-list
110132835|NCT01978782|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110132836|NCT01978782|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110132837|NCT01978782|Antiviral Agents|antiviral agents|mesh-ancestor
110132838|NCT01978782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110132839|NCT01978782|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110132840|NCT01978782|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110132841|NCT01978782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110132842|NCT01978782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110132843|NCT01978782|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110132844|NCT01978782|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110132845|NCT01978782|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110132846|NCT01978782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110132847|NCT01978782|Serotonin Agents|serotonin agents|mesh-ancestor
110132848|NCT01978782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110132849|NCT01978782|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110132850|NCT01978782|Antidepressive Agents|antidepressive agents|mesh-ancestor
110132851|NCT01978782|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110132852|NCT01978873|Ascorbic Acid|ascorbic acid|mesh-list
110132853|NCT01978873|Methyltestosterone|methyltestosterone|mesh-list
110132854|NCT01978873|Androgens|androgens|mesh-list
110132855|NCT01978873|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
110132856|NCT01978873|Hormones|hormones|mesh-ancestor
110132857|NCT01978873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110132858|NCT01978873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110132859|NCT01978873|Antioxidants|antioxidants|mesh-ancestor
110132860|NCT01978873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110132861|NCT01978873|Protective Agents|protective agents|mesh-ancestor
110132862|NCT01978873|Vitamins|vitamins|mesh-ancestor
110132863|NCT01978873|Micronutrients|micronutrients|mesh-ancestor
110132864|NCT01978873|Estrogens|estrogens|mesh-ancestor
110132865|NCT01978873|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110132866|NCT01978873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110132867|NCT01978873|Anabolic Agents|anabolic agents|mesh-ancestor
110132868|NCT01979341|Triptorelin Pamoate|triptorelin pamoate|mesh-list
110132869|NCT01979341|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
110132870|NCT01979341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110132871|NCT01979341|Luteolytic Agents|luteolytic agents|mesh-ancestor
110132872|NCT01979341|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110132873|NCT01979341|Contraceptive Agents|contraceptive agents|mesh-ancestor
110132874|NCT01979341|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110132875|NCT01979341|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110344519|NCT05780801|Glycerol|glycerol|mesh-list
110132876|NCT01979341|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110132877|NCT01979341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110132878|NCT01979354|Morphine|morphine|mesh-list
110132879|NCT01979354|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110132880|NCT01979354|Narcotics|narcotics|mesh-ancestor
110132881|NCT01979354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110132882|NCT01979354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110132883|NCT01979354|Analgesics|analgesics|mesh-ancestor
110132884|NCT01979354|Sensory System Agents|sensory system agents|mesh-ancestor
110132885|NCT01979354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110132886|NCT01979406|Vaccines|vaccines|mesh-list
110132887|NCT01979406|Immunologic Factors|immunologic factors|mesh-ancestor
110132888|NCT01979406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110132889|NCT01979510|Acetaminophen|acetaminophen|mesh-list
110132890|NCT01979510|Etoricoxib|etoricoxib|mesh-list
110132891|NCT01979510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110132892|NCT01979510|Analgesics|analgesics|mesh-ancestor
110132893|NCT01979510|Sensory System Agents|sensory system agents|mesh-ancestor
110132894|NCT01979510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110132895|NCT01979510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110132896|NCT01979510|Antipyretics|antipyretics|mesh-ancestor
110132897|NCT01979510|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110132898|NCT01979510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110132899|NCT01979510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110132900|NCT01979510|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110132901|NCT01979510|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110132902|NCT01979510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110132903|NCT01979510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110132904|NCT01979653|Midazolam|midazolam|mesh-list
110132905|NCT01979653|Dexmedetomidine|dexmedetomidine|mesh-list
110132906|NCT01979653|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110132907|NCT01979653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110132908|NCT01979653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110132909|NCT01979653|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110132910|NCT01979653|Analgesics|analgesics|mesh-ancestor
110132911|NCT01979653|Sensory System Agents|sensory system agents|mesh-ancestor
110132912|NCT01979653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110132913|NCT01979653|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110132914|NCT01979653|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110132915|NCT01979653|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110132916|NCT01979653|Adrenergic Agents|adrenergic agents|mesh-ancestor
110132917|NCT01979653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110132918|NCT01979653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110132919|NCT01979653|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110132920|NCT01979653|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110132921|NCT01979653|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110132922|NCT01979653|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110132923|NCT01979653|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110132924|NCT01979653|Anesthetics, General|anesthetics, general|mesh-ancestor
110132925|NCT01979653|Anesthetics|anesthetics|mesh-ancestor
110132926|NCT01979653|GABA Modulators|gaba modulators|mesh-ancestor
110132927|NCT01979653|GABA Agents|gaba agents|mesh-ancestor
110132928|NCT01979679|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
110132929|NCT01979679|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110132930|NCT01979679|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110132931|NCT01979679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110132932|NCT01979679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110132933|NCT01979679|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110132934|NCT01979679|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
110132935|NCT01979679|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110132937|NCT01979679|Adrenergic Agents|adrenergic agents|mesh-ancestor
110132938|NCT01979679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110344528|NCT05775289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110132939|NCT01979679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110132940|NCT01979679|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110132941|NCT01979679|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110132942|NCT01979679|Serotonin Agents|serotonin agents|mesh-ancestor
110132943|NCT01979679|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110132944|NCT01979679|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110132945|NCT01979679|Dopamine Agents|dopamine agents|mesh-ancestor
110132946|NCT01979965|Ranolazine|ranolazine|mesh-list
110132947|NCT01979965|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110132948|NCT01979965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110132949|NCT01979965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110132950|NCT01980004|Potassium Citrate|potassium citrate|mesh-list
110132951|NCT01980004|Diuretics|diuretics|mesh-ancestor
110132952|NCT01980004|Natriuretic Agents|natriuretic agents|mesh-ancestor
110132953|NCT01980004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110132954|NCT01980004|Expectorants|expectorants|mesh-ancestor
110132955|NCT01980004|Respiratory System Agents|respiratory system agents|mesh-ancestor
110132956|NCT01980069|Neostigmine|neostigmine|mesh-list
110165464|NCT00023920|Antimetabolites|antimetabolites|mesh-ancestor
110132957|NCT01980069|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110132959|NCT01980069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110132960|NCT01980069|Cholinergic Agents|cholinergic agents|mesh-ancestor
110132961|NCT01980069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110132962|NCT01980069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110132963|NCT01980069|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110132964|NCT01980069|Autonomic Agents|autonomic agents|mesh-ancestor
110132965|NCT01980069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110132967|NCT01980082|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110132968|NCT01980082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110132969|NCT01980277|Paclitaxel|paclitaxel|mesh-list
110132970|NCT01980277|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110132971|NCT01980277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110132972|NCT01980277|Tubulin Modulators|tubulin modulators|mesh-ancestor
110132973|NCT01980277|Antimitotic Agents|antimitotic agents|mesh-ancestor
110132974|NCT01980277|Mitosis Modulators|mitosis modulators|mesh-ancestor
110132975|NCT01980277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110132976|NCT01980303|Esketamine|esketamine|mesh-list
110132977|NCT01980303|Antidepressive Agents|antidepressive agents|mesh-ancestor
110132978|NCT01980303|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110132979|NCT01980316|Heparin|heparin|mesh-list
110132980|NCT01980316|Calcium heparin|calcium heparin|mesh-list
110132981|NCT01980316|Argatroban|argatroban|mesh-list
110132982|NCT01980316|Anticoagulants|anticoagulants|mesh-ancestor
110132983|NCT01980316|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110132984|NCT01980316|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110132985|NCT01980316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110132986|NCT01980316|Antithrombins|antithrombins|mesh-ancestor
110132987|NCT01980316|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110132988|NCT01980316|Protease Inhibitors|protease inhibitors|mesh-ancestor
110132989|NCT01980316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110132990|NCT01980316|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110132991|NCT01980329|Maraviroc|maraviroc|mesh-list
110132992|NCT01980329|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110132993|NCT01980329|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110132994|NCT01980329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110132995|NCT01980329|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110132996|NCT01980329|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110132997|NCT01980329|Antiviral Agents|antiviral agents|mesh-ancestor
110132998|NCT01980329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110132999|NCT01980329|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
110133000|NCT01980407|Leucovorin|leucovorin|mesh-list
110133001|NCT01980407|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
110133002|NCT01980407|Oxaliplatin|oxaliplatin|mesh-list
110133003|NCT01980407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110133004|NCT01980407|Antidotes|antidotes|mesh-ancestor
110133005|NCT01980407|Protective Agents|protective agents|mesh-ancestor
110133006|NCT01980407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110133008|NCT01980407|Vitamins|vitamins|mesh-ancestor
110133009|NCT01980407|Micronutrients|micronutrients|mesh-ancestor
110133010|NCT01980472|Paclitaxel|paclitaxel|mesh-list
110133011|NCT01980472|Bevacizumab|bevacizumab|mesh-list
110133012|NCT01980472|Carboplatin|carboplatin|mesh-list
110133013|NCT01980472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110133014|NCT01980472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110133015|NCT01980472|Tubulin Modulators|tubulin modulators|mesh-ancestor
110133016|NCT01980472|Antimitotic Agents|antimitotic agents|mesh-ancestor
110133017|NCT01980472|Mitosis Modulators|mitosis modulators|mesh-ancestor
110133018|NCT01980472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110133019|NCT01980472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110133020|NCT01980472|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110133021|NCT01980472|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110133022|NCT01980472|Growth Substances|growth substances|mesh-ancestor
110133023|NCT01980472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110133024|NCT01980472|Growth Inhibitors|growth inhibitors|mesh-ancestor
110133025|NCT01980498|Fentanyl|fentanyl|mesh-list
110133026|NCT01980498|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110133027|NCT01980498|Narcotics|narcotics|mesh-ancestor
110133028|NCT01980498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110133029|NCT01980498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110133030|NCT01980498|Analgesics|analgesics|mesh-ancestor
110133031|NCT01980498|Sensory System Agents|sensory system agents|mesh-ancestor
110133032|NCT01980498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110133033|NCT01980498|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110133034|NCT01980498|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110133035|NCT01980498|Anesthetics, General|anesthetics, general|mesh-ancestor
110133036|NCT01980498|Anesthetics|anesthetics|mesh-ancestor
110133037|NCT01980550|Nicotine|nicotine|mesh-list
110133038|NCT01980550|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110133039|NCT01980550|Autonomic Agents|autonomic agents|mesh-ancestor
110133040|NCT01980550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110133041|NCT01980550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110133042|NCT01980550|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110133043|NCT01980550|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110133044|NCT01980550|Cholinergic Agents|cholinergic agents|mesh-ancestor
110133045|NCT01980550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110133046|NCT01980550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110133047|NCT01980615|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
110133048|NCT01980615|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110133049|NCT01980615|Respiratory System Agents|respiratory system agents|mesh-ancestor
110133050|NCT01980667|Cisplatin|cisplatin|mesh-list
110133051|NCT01980667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110133052|NCT01980680|Estradiol|estradiol|mesh-list
110133053|NCT01980680|Progesterone|progesterone|mesh-list
110133054|NCT01980680|Estrogens|estrogens|mesh-ancestor
110133055|NCT01980680|Hormones|hormones|mesh-ancestor
110133056|NCT01980680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110133057|NCT01980680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110133058|NCT01980680|Progestins|progestins|mesh-ancestor
110133059|NCT01980745|Chloroquine|chloroquine|mesh-list
110133060|NCT01980745|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
110133061|NCT01980745|Amebicides|amebicides|mesh-ancestor
110133062|NCT01980745|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110133063|NCT01980745|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110133064|NCT01980745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110133065|NCT01980745|Antimalarials|antimalarials|mesh-ancestor
110133066|NCT01980745|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110133067|NCT01980745|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110133068|NCT01980745|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110133069|NCT01980745|Analgesics|analgesics|mesh-ancestor
110133070|NCT01980745|Sensory System Agents|sensory system agents|mesh-ancestor
110133071|NCT01980745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110133072|NCT01980745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110133073|NCT01980745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110133075|NCT01980745|Antinematodal Agents|antinematodal agents|mesh-ancestor
110133076|NCT01980745|Anthelmintics|anthelmintics|mesh-ancestor
110133077|NCT01980810|Paclitaxel|paclitaxel|mesh-list
110133078|NCT01980810|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110133079|NCT01980810|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110133080|NCT01980810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110133081|NCT01980810|Tubulin Modulators|tubulin modulators|mesh-ancestor
110133082|NCT01980810|Antimitotic Agents|antimitotic agents|mesh-ancestor
110133083|NCT01980810|Mitosis Modulators|mitosis modulators|mesh-ancestor
110133084|NCT01980810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110133086|NCT01980849|Anticoagulants|anticoagulants|mesh-ancestor
110133087|NCT01980849|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110133088|NCT01980849|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110133089|NCT01980849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110133090|NCT01980966|Oseltamivir|oseltamivir|mesh-list
110133091|NCT01980966|Antiviral Agents|antiviral agents|mesh-ancestor
110133092|NCT01980966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110133093|NCT01980966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110133094|NCT01980966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110133095|NCT01980979|Treprostinil|treprostinil|mesh-list
110133096|NCT01980979|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110133097|NCT01981031|Insulin Lispro|insulin lispro|mesh-list
110133098|NCT01981031|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110133099|NCT01981031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110133100|NCT01981278|Tapentadol|tapentadol|mesh-list
110133101|NCT01981278|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110133102|NCT01981278|Narcotics|narcotics|mesh-ancestor
110133103|NCT01981278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110133104|NCT01981278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110133105|NCT01981278|Analgesics|analgesics|mesh-ancestor
110133106|NCT01981278|Sensory System Agents|sensory system agents|mesh-ancestor
110133107|NCT01981278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110133108|NCT01981278|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110133109|NCT01981278|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110133110|NCT01981278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110133111|NCT01981278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110133112|NCT01981278|Adrenergic Agents|adrenergic agents|mesh-ancestor
110133113|NCT01981278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110133114|NCT01981291|Anesthetics|anesthetics|mesh-list
110133115|NCT01981291|Mepivacaine|mepivacaine|mesh-list
110133116|NCT01981291|Anesthetics, Local|anesthetics, local|mesh-list
110133117|NCT01981291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110133118|NCT01981291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110133119|NCT01981291|Sensory System Agents|sensory system agents|mesh-ancestor
110133120|NCT01981291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110133121|NCT01981330|Hyaluronic Acid|hyaluronic acid|mesh-list
110133122|NCT01981330|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110133123|NCT01981330|Immunologic Factors|immunologic factors|mesh-ancestor
110133124|NCT01981330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110133125|NCT01981330|Viscosupplements|viscosupplements|mesh-ancestor
110133126|NCT01981330|Protective Agents|protective agents|mesh-ancestor
110133127|NCT01981369|Dexmedetomidine|dexmedetomidine|mesh-list
110133128|NCT01981369|Propofol|propofol|mesh-list
110133129|NCT01981369|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110133130|NCT01981369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110133131|NCT01981369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110133132|NCT01981369|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110133133|NCT01981369|Analgesics|analgesics|mesh-ancestor
110133134|NCT01981369|Sensory System Agents|sensory system agents|mesh-ancestor
110133135|NCT01981369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110133136|NCT01981369|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110133137|NCT01981369|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110133138|NCT01981369|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110133139|NCT01981369|Adrenergic Agents|adrenergic agents|mesh-ancestor
110133140|NCT01981369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110133141|NCT01981369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110133142|NCT01981369|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110133143|NCT01981369|Anesthetics, General|anesthetics, general|mesh-ancestor
110133144|NCT01981369|Anesthetics|anesthetics|mesh-ancestor
110133145|NCT01981447|Lacosamide|lacosamide|mesh-list
110133146|NCT01981447|Anticonvulsants|anticonvulsants|mesh-ancestor
110133147|NCT01981447|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110133148|NCT01981447|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110133149|NCT01981447|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110133150|NCT01981447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110133151|NCT01981460|Methylene Blue|methylene blue|mesh-list
110344618|NCT05737628|Rituximab|rituximab|mesh-list
110133152|NCT01981460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110133153|NCT01981460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110133154|NCT01981499|Cetirizine|cetirizine|mesh-list
110133155|NCT01981499|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110133156|NCT01981499|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110133157|NCT01981499|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110133158|NCT01981499|Histamine Antagonists|histamine antagonists|mesh-ancestor
110133160|NCT01981499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110133161|NCT01981499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110133162|NCT01981499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110133163|NCT01981525|Metformin|metformin|mesh-list
110133164|NCT01981525|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110133165|NCT01981525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110133167|NCT01981707|Lipotropic Agents|lipotropic agents|mesh-ancestor
110133168|NCT01981707|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110133169|NCT01981707|Antimetabolites|antimetabolites|mesh-ancestor
110133170|NCT01981707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110133171|NCT01981707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110133172|NCT01981707|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110133173|NCT01981707|Nootropic Agents|nootropic agents|mesh-ancestor
110133174|NCT01981746|Ropivacaine|ropivacaine|mesh-list
110133175|NCT01981746|Anesthetics, Local|anesthetics, local|mesh-ancestor
110133176|NCT01981746|Anesthetics|anesthetics|mesh-ancestor
110133177|NCT01981746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110133178|NCT01981746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110133179|NCT01981746|Sensory System Agents|sensory system agents|mesh-ancestor
110133180|NCT01981746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110133181|NCT01981811|Aripiprazole|aripiprazole|mesh-list
110133182|NCT01981811|Antidepressive Agents|antidepressive agents|mesh-ancestor
110133183|NCT01981811|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110133184|NCT01981811|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110133185|NCT01981811|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110133186|NCT01981811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110133187|NCT01981811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110133188|NCT01981811|Dopamine Agonists|dopamine agonists|mesh-ancestor
110133189|NCT01981811|Dopamine Agents|dopamine agents|mesh-ancestor
110133190|NCT01981811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110133191|NCT01981811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110133192|NCT01981811|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110133193|NCT01981811|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110133194|NCT01981811|Serotonin Agents|serotonin agents|mesh-ancestor
110133195|NCT01981811|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110133196|NCT01981811|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110133197|NCT01981811|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110133198|NCT01981811|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110133200|NCT01981889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110133201|NCT01981889|Glucocorticoids|glucocorticoids|mesh-ancestor
110133202|NCT01981889|Hormones|hormones|mesh-ancestor
110344633|NCT05730036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110344634|NCT05730036|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110344635|NCT05730036|Glucocorticoids|glucocorticoids|mesh-ancestor
110344636|NCT05730036|Hormones|hormones|mesh-ancestor
110344637|NCT05730036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110344638|NCT05730036|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110344639|NCT05730036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110344640|NCT05730036|Immunologic Factors|immunologic factors|mesh-ancestor
110344641|NCT05730036|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110344642|NCT05730036|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110133203|NCT01981889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110133204|NCT01981889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110133205|NCT01981889|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110133206|NCT01981889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110133208|NCT01981941|Analgesics|analgesics|mesh-ancestor
110133209|NCT01981941|Sensory System Agents|sensory system agents|mesh-ancestor
110133210|NCT01981941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110133211|NCT01981941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110133212|NCT01981941|Anticonvulsants|anticonvulsants|mesh-ancestor
110133213|NCT01981941|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110133214|NCT01981941|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110133215|NCT01981941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110133216|NCT01981941|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110133217|NCT01981941|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110133218|NCT01981941|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110133219|NCT01981941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110133220|NCT01981941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110133221|NCT01981941|Antimanic Agents|antimanic agents|mesh-ancestor
110133222|NCT01982019|Hormones|hormones|mesh-list
110133223|NCT01982019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110133224|NCT01982019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110133225|NCT01982071|Micafungin|micafungin|mesh-list
110133226|NCT01982071|Antifungal Agents|antifungal agents|mesh-ancestor
110133227|NCT01982071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110133228|NCT01982097|Sorafenib|sorafenib|mesh-list
110133229|NCT01982097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110133230|NCT01982097|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110133231|NCT01982097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110165491|NCT00023959|Antisickling Agents|antisickling agents|mesh-ancestor
110133232|NCT01982097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110133234|NCT01982201|Gout Suppressants|gout suppressants|mesh-ancestor
110133235|NCT01982201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110133236|NCT01982201|Uricosuric Agents|uricosuric agents|mesh-ancestor
110133238|NCT01982396|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110133239|NCT01982396|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110133240|NCT01982396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110133241|NCT01982396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110133242|NCT01982396|Antiviral Agents|antiviral agents|mesh-ancestor
110133243|NCT01982396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110133244|NCT01982396|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110133245|NCT01982396|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110133246|NCT01982461|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110133247|NCT01982461|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110133248|NCT01982461|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110133249|NCT01982461|Antimetabolites|antimetabolites|mesh-ancestor
110133250|NCT01982461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110133251|NCT01982461|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110133252|NCT01982461|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110133253|NCT01982461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110133255|NCT01982578|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110133256|NCT01982578|Protective Agents|protective agents|mesh-ancestor
110133257|NCT01982578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110133258|NCT01982578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110133259|NCT01982578|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110133260|NCT01982578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110133261|NCT01982578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110133263|NCT01982578|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
110133264|NCT01982578|Estrogens|estrogens|mesh-ancestor
110133265|NCT01982578|Hormones|hormones|mesh-ancestor
110133266|NCT01982578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110133267|NCT01982734|Curcumin|curcumin|mesh-list
110133268|NCT01982734|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110133269|NCT01982734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110133270|NCT01982734|Analgesics|analgesics|mesh-ancestor
110133271|NCT01982734|Sensory System Agents|sensory system agents|mesh-ancestor
110133272|NCT01982734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110133273|NCT01982734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110133274|NCT01982734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110133275|NCT01982734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110133276|NCT01982734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110133277|NCT01982734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110133278|NCT01982734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110133279|NCT01982760|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
110133280|NCT01982760|Hemostatics|hemostatics|mesh-ancestor
110133281|NCT01982760|Coagulants|coagulants|mesh-ancestor
110133282|NCT01982760|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
110133283|NCT01982760|Natriuretic Agents|natriuretic agents|mesh-ancestor
110133284|NCT01982760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110133285|NCT01982799|Acetaminophen|acetaminophen|mesh-list
110133286|NCT01982799|Ibuprofen|ibuprofen|mesh-list
110133287|NCT01982799|Naproxen|naproxen|mesh-list
110133288|NCT01982799|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
110133289|NCT01982799|Hydrocodone|hydrocodone|mesh-list
110133290|NCT01982799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110133291|NCT01982799|Analgesics|analgesics|mesh-ancestor
110133292|NCT01982799|Sensory System Agents|sensory system agents|mesh-ancestor
110133293|NCT01982799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110133294|NCT01982799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110133295|NCT01982799|Antipyretics|antipyretics|mesh-ancestor
110133296|NCT01982799|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110133297|NCT01982799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110133298|NCT01982799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110133299|NCT01982799|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110133300|NCT01982799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110133301|NCT01982799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110133302|NCT01982799|Gout Suppressants|gout suppressants|mesh-ancestor
110133303|NCT01982799|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110133305|NCT01982799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110133307|NCT01982799|Respiratory System Agents|respiratory system agents|mesh-ancestor
110133308|NCT01982864|Gentamicins|gentamicins|mesh-list
110133309|NCT01982864|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110133310|NCT01982864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110133311|NCT01982864|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110133312|NCT01982864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110133313|NCT01982864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110133314|NCT01982929|Epinephrine|epinephrine|mesh-list
110133315|NCT01982929|Bupivacaine|bupivacaine|mesh-list
110133316|NCT01982929|Anesthetics, Local|anesthetics, local|mesh-ancestor
110133317|NCT01982929|Anesthetics|anesthetics|mesh-ancestor
110133318|NCT01982929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110133319|NCT01982929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110133320|NCT01982929|Sensory System Agents|sensory system agents|mesh-ancestor
110133321|NCT01982929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110133322|NCT01982929|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110133323|NCT01982929|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110133324|NCT01982929|Adrenergic Agents|adrenergic agents|mesh-ancestor
110133325|NCT01982929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110133326|NCT01982929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110133327|NCT01982929|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110133328|NCT01982929|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110133329|NCT01982929|Autonomic Agents|autonomic agents|mesh-ancestor
110133330|NCT01982929|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110133331|NCT01982929|Respiratory System Agents|respiratory system agents|mesh-ancestor
110133332|NCT01982929|Mydriatics|mydriatics|mesh-ancestor
110133333|NCT01982929|Sympathomimetics|sympathomimetics|mesh-ancestor
110133334|NCT01982929|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110133335|NCT01983124|Vemurafenib|vemurafenib|mesh-list
110133336|NCT01983124|Fotemustine|fotemustine|mesh-list
110133337|NCT01983124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110133338|NCT01983124|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110133339|NCT01983124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110133340|NCT01983124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110133341|NCT01983137|Oxycodone|oxycodone|mesh-list
110133342|NCT01983137|Naloxone|naloxone|mesh-list
110133343|NCT01983137|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110133344|NCT01983137|Narcotics|narcotics|mesh-ancestor
110133345|NCT01983137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110133346|NCT01983137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110133347|NCT01983137|Analgesics|analgesics|mesh-ancestor
110133348|NCT01983137|Sensory System Agents|sensory system agents|mesh-ancestor
110133349|NCT01983137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110133350|NCT01983137|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110133351|NCT01983371|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
110133352|NCT01983371|Hematinics|hematinics|mesh-ancestor
110133353|NCT01983371|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
110133354|NCT01983371|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110133355|NCT01983384|Anesthetics|anesthetics|mesh-list
110133356|NCT01983384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110133357|NCT01983384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110133358|NCT01983449|Dexamethasone|dexamethasone|mesh-list
110133359|NCT01983449|Dexamethasone acetate|dexamethasone acetate|mesh-list
110133360|NCT01983449|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
110133361|NCT01983449|BB 1101|bb 1101|mesh-list
110133362|NCT01983449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110133363|NCT01983449|Antiemetics|antiemetics|mesh-ancestor
110133364|NCT01983449|Autonomic Agents|autonomic agents|mesh-ancestor
110133365|NCT01983449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110133366|NCT01983449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110133367|NCT01983449|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110133368|NCT01983449|Glucocorticoids|glucocorticoids|mesh-ancestor
110133370|NCT01983449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110133371|NCT01983449|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110133372|NCT01983449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110133373|NCT01983449|Protease Inhibitors|protease inhibitors|mesh-ancestor
110133374|NCT01983449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110133375|NCT01983449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110133376|NCT01983475|Denosumab|denosumab|mesh-list
110133377|NCT01983475|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110133378|NCT01983475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110133380|NCT01983501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110133381|NCT01983501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110133382|NCT01983501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110133383|NCT01983501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110133384|NCT01983514|Oxytocin|oxytocin|mesh-list
110133385|NCT01983514|Oxytocics|oxytocics|mesh-ancestor
110133386|NCT01983514|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110133387|NCT01983514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110133389|NCT01983527|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110133390|NCT01983527|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110133391|NCT01983527|Prednisolone|prednisolone|mesh-list
110133392|NCT01983527|Prednisolone acetate|prednisolone acetate|mesh-list
110133393|NCT01983527|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110133394|NCT01983527|Prednisolone phosphate|prednisolone phosphate|mesh-list
110133395|NCT01983527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110133396|NCT01983527|Antiemetics|antiemetics|mesh-ancestor
110133397|NCT01983527|Autonomic Agents|autonomic agents|mesh-ancestor
110133398|NCT01983527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110133399|NCT01983527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110133400|NCT01983527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110133401|NCT01983527|Glucocorticoids|glucocorticoids|mesh-ancestor
110133402|NCT01983527|Hormones|hormones|mesh-ancestor
110133403|NCT01983527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110133404|NCT01983527|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110133405|NCT01983527|Protective Agents|protective agents|mesh-ancestor
110133406|NCT01983527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110133407|NCT01983527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110133408|NCT01983540|Vaccines|vaccines|mesh-list
110133409|NCT01983540|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110133410|NCT01983540|Immunologic Factors|immunologic factors|mesh-ancestor
110133411|NCT01983540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110133412|NCT01983657|Molgramostim|molgramostim|mesh-list
110133413|NCT01983657|Sargramostim|sargramostim|mesh-list
110133414|NCT01983657|Immunologic Factors|immunologic factors|mesh-ancestor
110133415|NCT01983657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110133416|NCT01983657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110133417|NCT01983722|Stiripentol|stiripentol|mesh-list
110133418|NCT01983722|Anticonvulsants|anticonvulsants|mesh-ancestor
110133419|NCT01983735|Niacin|niacin|mesh-list
110133420|NCT01983735|Amlodipine|amlodipine|mesh-list
110133421|NCT01983735|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110133422|NCT01983735|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110133423|NCT01983735|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110133424|NCT01983735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110133425|NCT01983735|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110133426|NCT01983735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110133427|NCT01983735|Vasodilator Agents|vasodilator agents|mesh-ancestor
110133428|NCT01983735|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110133429|NCT01983735|Antimetabolites|antimetabolites|mesh-ancestor
110133430|NCT01983735|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110133431|NCT01983735|Vitamin B Complex|vitamin b complex|mesh-ancestor
110133432|NCT01983735|Vitamins|vitamins|mesh-ancestor
110133433|NCT01983735|Micronutrients|micronutrients|mesh-ancestor
110133435|NCT01983761|Mycophenolic Acid|mycophenolic acid|mesh-list
110133436|NCT01983761|Fludarabine|fludarabine|mesh-list
110133437|NCT01983761|Fludarabine phosphate|fludarabine phosphate|mesh-list
110133439|NCT01983761|Busulfan|busulfan|mesh-list
110133440|NCT01983761|Clofarabine|clofarabine|mesh-list
110133441|NCT01983761|Tacrolimus|tacrolimus|mesh-list
110133442|NCT01983761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110133443|NCT01983761|Immunologic Factors|immunologic factors|mesh-ancestor
110133444|NCT01983761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110133445|NCT01983761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110133446|NCT01983761|Antimetabolites|antimetabolites|mesh-ancestor
110133447|NCT01983761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110133448|NCT01983761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110133449|NCT01983761|Antiviral Agents|antiviral agents|mesh-ancestor
110133450|NCT01983761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110133451|NCT01983761|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110133452|NCT01983761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110133453|NCT01983761|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110133454|NCT01983761|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110133455|NCT01983761|Antitubercular Agents|antitubercular agents|mesh-ancestor
110133456|NCT01983761|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110133457|NCT01983761|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110133458|NCT01983761|Alkylating Agents|alkylating agents|mesh-ancestor
110133459|NCT01983761|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110133460|NCT01983800|Midazolam|midazolam|mesh-list
110133461|NCT01983800|Propofol|propofol|mesh-list
110133462|NCT01983800|Isoflurane|isoflurane|mesh-list
110133463|NCT01983800|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110344732|NCT05660681|Glycerol|glycerol|mesh-list
110133464|NCT01983800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110133465|NCT01983800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110133466|NCT01983800|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110133467|NCT01983800|Anesthetics, General|anesthetics, general|mesh-ancestor
110133468|NCT01983800|Anesthetics|anesthetics|mesh-ancestor
110133469|NCT01983800|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110133470|NCT01983800|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110133471|NCT01983800|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110133472|NCT01983800|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110133473|NCT01983800|GABA Modulators|gaba modulators|mesh-ancestor
110133474|NCT01983800|GABA Agents|gaba agents|mesh-ancestor
110133475|NCT01983800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110133476|NCT01983800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110133477|NCT01983800|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110133478|NCT01983943|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
110133479|NCT01983943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110133480|NCT01983943|Antioxidants|antioxidants|mesh-ancestor
110133481|NCT01983943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110133482|NCT01983943|Protective Agents|protective agents|mesh-ancestor
110133483|NCT01983943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110133484|NCT01983943|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110133485|NCT01984008|Picosulfate sodium|picosulfate sodium|mesh-list
110133486|NCT01984008|Magnesium Oxide|magnesium oxide|mesh-list
110133487|NCT01984008|Citric Acid|citric acid|mesh-list
110133488|NCT01984008|Sodium Citrate|sodium citrate|mesh-list
110133489|NCT01984008|Anticoagulants|anticoagulants|mesh-ancestor
110344782|NCT05629702|Hormones|hormones|mesh-ancestor
110133490|NCT01984008|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110133491|NCT01984008|Chelating Agents|chelating agents|mesh-ancestor
110133492|NCT01984008|Sequestering Agents|sequestering agents|mesh-ancestor
110133493|NCT01984008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110133494|NCT01984008|Cathartics|cathartics|mesh-ancestor
110133495|NCT01984008|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110133496|NCT01984008|Antacids|antacids|mesh-ancestor
110133497|NCT01984073|Niacin|niacin|mesh-list
110133498|NCT01984073|Niacinamide|niacinamide|mesh-list
110133499|NCT01984073|Nicotinic Acids|nicotinic acids|mesh-list
110133500|NCT01984073|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110133501|NCT01984073|Antimetabolites|antimetabolites|mesh-ancestor
110133502|NCT01984073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110133503|NCT01984073|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110133505|NCT01984073|Vitamin B Complex|vitamin b complex|mesh-ancestor
110133506|NCT01984073|Vitamins|vitamins|mesh-ancestor
110133507|NCT01984073|Micronutrients|micronutrients|mesh-ancestor
110133508|NCT01984073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110133509|NCT01984086|Albuterol|albuterol|mesh-list
110133510|NCT01984086|Charcoal|charcoal|mesh-list
110133511|NCT01984086|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110133512|NCT01984086|Autonomic Agents|autonomic agents|mesh-ancestor
110133513|NCT01984086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110133514|NCT01984086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110133515|NCT01984086|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110133516|NCT01984086|Respiratory System Agents|respiratory system agents|mesh-ancestor
110133517|NCT01984086|Tocolytic Agents|tocolytic agents|mesh-ancestor
110133518|NCT01984086|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110133519|NCT01984086|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110133520|NCT01984086|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110133521|NCT01984086|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110133522|NCT01984086|Adrenergic Agents|adrenergic agents|mesh-ancestor
110133523|NCT01984086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110133524|NCT01984086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110133525|NCT01984086|Antidotes|antidotes|mesh-ancestor
110133526|NCT01984086|Protective Agents|protective agents|mesh-ancestor
110133527|NCT01984099|Folic Acid|folic acid|mesh-list
110133528|NCT01984099|Vitamin B Complex|vitamin b complex|mesh-list
110133529|NCT01984099|Methotrexate|methotrexate|mesh-list
110133530|NCT01984099|Vitamins|vitamins|mesh-ancestor
110133531|NCT01984099|Micronutrients|micronutrients|mesh-ancestor
110133532|NCT01984099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110133533|NCT01984099|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110133534|NCT01984099|Abortifacient Agents|abortifacient agents|mesh-ancestor
110133535|NCT01984099|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110133536|NCT01984099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110133538|NCT01984099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110133539|NCT01984099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110133540|NCT01984099|Dermatologic Agents|dermatologic agents|mesh-ancestor
110133541|NCT01984099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110133542|NCT01984099|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110133543|NCT01984099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110133544|NCT01984099|Immunologic Factors|immunologic factors|mesh-ancestor
110133545|NCT01984099|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110133546|NCT01984099|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110133547|NCT01984099|Hematinics|hematinics|mesh-ancestor
110133548|NCT01984177|Hormones|hormones|mesh-list
110133549|NCT01984177|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
110133550|NCT01984177|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
110133551|NCT01984177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110133552|NCT01984177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110133553|NCT01984255|Ipilimumab|ipilimumab|mesh-list
110133554|NCT01984255|Bavituximab|bavituximab|mesh-list
110133555|NCT01984255|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110133556|NCT01984255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110133557|NCT01984255|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110133558|NCT01984255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110133559|NCT01984372|Insulin|insulin|mesh-list
110133560|NCT01984372|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110133561|NCT01984372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110133562|NCT01984463|Fentanyl|fentanyl|mesh-list
110133563|NCT01984463|Morphine|morphine|mesh-list
110133564|NCT01984463|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110133565|NCT01984463|Narcotics|narcotics|mesh-ancestor
110133566|NCT01984463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110133567|NCT01984463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110133568|NCT01984463|Analgesics|analgesics|mesh-ancestor
110133569|NCT01984463|Sensory System Agents|sensory system agents|mesh-ancestor
110133570|NCT01984463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110133571|NCT01984463|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110345016|NCT05411718|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110345017|NCT05411718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110345018|NCT05411718|Antipyretics|antipyretics|mesh-ancestor
110345019|NCT05411718|Gout Suppressants|gout suppressants|mesh-ancestor
110345039|NCT05406713|Pembrolizumab|pembrolizumab|mesh-list
110345040|NCT05406713|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110345041|NCT05406713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110345042|NCT05406713|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110345043|NCT05406713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110345044|NCT05401565|Balovaptan|balovaptan|mesh-list
110133572|NCT01984463|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110133573|NCT01984463|Anesthetics, General|anesthetics, general|mesh-ancestor
110133574|NCT01984463|Anesthetics|anesthetics|mesh-ancestor
110133576|NCT01984567|Thioctic Acid|thioctic acid|mesh-list
110133577|NCT01984567|Vitamins|vitamins|mesh-ancestor
110133578|NCT01984567|Micronutrients|micronutrients|mesh-ancestor
110133579|NCT01984567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110133580|NCT01984567|Antioxidants|antioxidants|mesh-ancestor
110133581|NCT01984567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110133582|NCT01984567|Protective Agents|protective agents|mesh-ancestor
110133583|NCT01984567|Vitamin B Complex|vitamin b complex|mesh-ancestor
110133584|NCT01984606|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110133585|NCT01984606|Empagliflozin|empagliflozin|mesh-list
110133586|NCT01984606|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110133587|NCT01984606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110133588|NCT01984606|Incretins|incretins|mesh-ancestor
110133589|NCT01984606|Hormones|hormones|mesh-ancestor
110345080|NCT05374603|Durvalumab|durvalumab|mesh-list
110345083|NCT05374512|Paclitaxel|paclitaxel|mesh-list
110133590|NCT01984606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110133591|NCT01984606|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110133592|NCT01984606|Protease Inhibitors|protease inhibitors|mesh-ancestor
110133593|NCT01984606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110133594|NCT01984606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110133595|NCT01984606|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110133596|NCT01984749|Febuxostat|febuxostat|mesh-list
110133597|NCT01984749|Gout Suppressants|gout suppressants|mesh-ancestor
110133598|NCT01984749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110133599|NCT01984827|Moxifloxacin|moxifloxacin|mesh-list
110133600|NCT01984827|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110133601|NCT01984827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110133602|NCT01984827|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110133603|NCT01984827|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110133604|NCT01984827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110345139|NCT05320731|Anesthetics|anesthetics|mesh-ancestor
110133605|NCT01984827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110133606|NCT01984827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110133607|NCT01984931|Medazepam|medazepam|mesh-list
110133608|NCT01984931|Metoclopramide|metoclopramide|mesh-list
110133609|NCT01984931|Bromazepam|bromazepam|mesh-list
110133611|NCT01984931|Trimebutine|trimebutine|mesh-list
110133612|NCT01984931|Mosapride|mosapride|mesh-list
110133613|NCT01984931|Maleic acid|maleic acid|mesh-list
110133614|NCT01984931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110133615|NCT01984931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110133616|NCT01984931|Antiemetics|antiemetics|mesh-ancestor
110133617|NCT01984931|Autonomic Agents|autonomic agents|mesh-ancestor
110133618|NCT01984931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110133619|NCT01984931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110133620|NCT01984931|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110133621|NCT01984931|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110133622|NCT01984931|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110133623|NCT01984931|Dopamine Agents|dopamine agents|mesh-ancestor
110133624|NCT01984931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110133625|NCT01984931|Parasympatholytics|parasympatholytics|mesh-ancestor
110345269|NCT05230368|Romidepsin|romidepsin|mesh-list
110133626|NCT01984931|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110133627|NCT01984931|Serotonin Agents|serotonin agents|mesh-ancestor
110133628|NCT01984931|Antifoaming Agents|antifoaming agents|mesh-ancestor
110133629|NCT01984931|Emollients|emollients|mesh-ancestor
110133630|NCT01984931|Dermatologic Agents|dermatologic agents|mesh-ancestor
110133631|NCT01984931|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110133632|NCT01984931|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110133633|NCT01984931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110133634|NCT01984931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110133635|NCT01984931|GABA Modulators|gaba modulators|mesh-ancestor
110133636|NCT01984931|GABA Agents|gaba agents|mesh-ancestor
110133637|NCT01984931|Anticonvulsants|anticonvulsants|mesh-ancestor
110133638|NCT01984931|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110133639|NCT01984931|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110133640|NCT01984931|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110133641|NCT01985061|Busulfan|busulfan|mesh-list
110133642|NCT01985061|Alkylating Agents|alkylating agents|mesh-ancestor
110133643|NCT01985061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110133644|NCT01985061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110133645|NCT01985061|Immunologic Factors|immunologic factors|mesh-ancestor
110133646|NCT01985061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110133647|NCT01985061|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110133648|NCT01985061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110133649|NCT01985061|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110133651|NCT01985087|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110133652|NCT01985087|Alkylating Agents|alkylating agents|mesh-ancestor
110133653|NCT01985087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110133654|NCT01985087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110133655|NCT01985152|Choline|choline|mesh-list
110133656|NCT01985152|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
110133657|NCT01985152|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110133658|NCT01985152|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110133659|NCT01985152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110133660|NCT01985152|Lipotropic Agents|lipotropic agents|mesh-ancestor
110133661|NCT01985152|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110133662|NCT01985152|Antimetabolites|antimetabolites|mesh-ancestor
110133663|NCT01985152|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110133664|NCT01985152|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110133665|NCT01985152|Nootropic Agents|nootropic agents|mesh-ancestor
110133666|NCT01985256|Flucytosine|flucytosine|mesh-list
110133667|NCT01985256|Antifungal Agents|antifungal agents|mesh-ancestor
110133668|NCT01985256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110133669|NCT01985256|Antimetabolites|antimetabolites|mesh-ancestor
110133670|NCT01985256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110133671|NCT01985373|Immunoglobulins|immunoglobulins|mesh-list
110133672|NCT01985373|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110133673|NCT01985373|Antibodies|antibodies|mesh-list
110133674|NCT01985373|gamma-Globulins|gamma-globulins|mesh-list
110133675|NCT01985373|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110133676|NCT01985373|Immunologic Factors|immunologic factors|mesh-ancestor
110133677|NCT01985373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110133678|NCT01985451|Temozolomide|temozolomide|mesh-list
110133679|NCT01985451|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110133680|NCT01985451|Alkylating Agents|alkylating agents|mesh-ancestor
110133681|NCT01985451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110133682|NCT01985451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110133683|NCT01985477|Dexamethasone|dexamethasone|mesh-list
110133684|NCT01985477|Lenalidomide|lenalidomide|mesh-list
110133685|NCT01985477|Tretinoin|tretinoin|mesh-list
110345535|NCT05066308|Cannabidiol|cannabidiol|mesh-list
110133687|NCT01985477|Antiemetics|antiemetics|mesh-ancestor
110133688|NCT01985477|Autonomic Agents|autonomic agents|mesh-ancestor
110133689|NCT01985477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110133690|NCT01985477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110133691|NCT01985477|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110133692|NCT01985477|Glucocorticoids|glucocorticoids|mesh-ancestor
110133694|NCT01985477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110133695|NCT01985477|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110133696|NCT01985477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110133697|NCT01985477|Immunologic Factors|immunologic factors|mesh-ancestor
110133698|NCT01985477|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110133699|NCT01985477|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110133700|NCT01985477|Growth Substances|growth substances|mesh-ancestor
110133701|NCT01985477|Growth Inhibitors|growth inhibitors|mesh-ancestor
110133702|NCT01985477|Keratolytic Agents|keratolytic agents|mesh-ancestor
110133703|NCT01985477|Dermatologic Agents|dermatologic agents|mesh-ancestor
110133704|NCT01985594|Nifedipine|nifedipine|mesh-list
110133705|NCT01985594|Progesterone|progesterone|mesh-list
110345655|NCT05017012|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110133707|NCT01985594|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110133708|NCT01985594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110133709|NCT01985594|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110133710|NCT01985594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110133711|NCT01985594|Vasodilator Agents|vasodilator agents|mesh-ancestor
110133712|NCT01985594|Tocolytic Agents|tocolytic agents|mesh-ancestor
110133713|NCT01985594|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110133714|NCT01985594|Progestins|progestins|mesh-ancestor
110133715|NCT01985594|Hormones|hormones|mesh-ancestor
110133716|NCT01985594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110345726|NCT04992312|Glucagon|glucagon|mesh-list
110133717|NCT01985724|Cyclophosphamide|cyclophosphamide|mesh-list
110133718|NCT01985724|Docetaxel|docetaxel|mesh-list
110133719|NCT01985724|Epirubicin|epirubicin|mesh-list
110133720|NCT01985724|Fluorouracil|fluorouracil|mesh-list
110133721|NCT01985724|Lenograstim|lenograstim|mesh-list
110133722|NCT01985724|Mitogens|mitogens|mesh-list
110133723|NCT01985724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110133724|NCT01985724|Immunologic Factors|immunologic factors|mesh-ancestor
110133725|NCT01985724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110133726|NCT01985724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110133727|NCT01985724|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110133728|NCT01985724|Alkylating Agents|alkylating agents|mesh-ancestor
110133729|NCT01985724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110345790|NCT04950660|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110345791|NCT04950660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110345792|NCT04950660|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110345793|NCT04950660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110345794|NCT04950660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110345795|NCT04950660|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110345796|NCT04950660|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110345797|NCT04950660|Purinergic Agents|purinergic agents|mesh-ancestor
110345806|NCT04941898|Factor VIII|factor viii|mesh-list
110133730|NCT01985724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110133731|NCT01985724|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110133732|NCT01985724|Tubulin Modulators|tubulin modulators|mesh-ancestor
110133733|NCT01985724|Antimitotic Agents|antimitotic agents|mesh-ancestor
110133734|NCT01985724|Mitosis Modulators|mitosis modulators|mesh-ancestor
110133735|NCT01985724|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110133736|NCT01985724|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110133737|NCT01985724|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110133738|NCT01985724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110133739|NCT01985724|Antimetabolites|antimetabolites|mesh-ancestor
110133740|NCT01985724|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110133741|NCT01985724|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110133742|NCT01985750|Cycloserine|cycloserine|mesh-list
110133743|NCT01985750|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110133744|NCT01985750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110133745|NCT01985750|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110133746|NCT01985750|Antitubercular Agents|antitubercular agents|mesh-ancestor
110133747|NCT01985750|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110133748|NCT01985750|Antimetabolites|antimetabolites|mesh-ancestor
110133749|NCT01985750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110133750|NCT01985789|Diphenhydramine|diphenhydramine|mesh-list
110133751|NCT01985789|Promethazine|promethazine|mesh-list
110133752|NCT01985789|Cetirizine|cetirizine|mesh-list
110133753|NCT01985789|Desloratadine|desloratadine|mesh-list
110133754|NCT01985789|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110133755|NCT01985789|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110133756|NCT01985789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110133757|NCT01985789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110133758|NCT01985789|Anesthetics, Local|anesthetics, local|mesh-ancestor
110133759|NCT01985789|Anesthetics|anesthetics|mesh-ancestor
110133760|NCT01985789|Sensory System Agents|sensory system agents|mesh-ancestor
110133761|NCT01985789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110133762|NCT01985789|Antiemetics|antiemetics|mesh-ancestor
110133763|NCT01985789|Autonomic Agents|autonomic agents|mesh-ancestor
110133764|NCT01985789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110133765|NCT01985789|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110133766|NCT01985789|Histamine Antagonists|histamine antagonists|mesh-ancestor
110133767|NCT01985789|Histamine Agents|histamine agents|mesh-ancestor
110133768|NCT01985789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110133769|NCT01985789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110133770|NCT01985789|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110133771|NCT01985789|Antipruritics|antipruritics|mesh-ancestor
110133772|NCT01985789|Dermatologic Agents|dermatologic agents|mesh-ancestor
110133773|NCT01985789|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110133774|NCT01985789|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110133775|NCT01985789|Cholinergic Agents|cholinergic agents|mesh-ancestor
110133776|NCT01985828|Androgens|androgens|mesh-list
110133777|NCT01985828|Hormones|hormones|mesh-ancestor
110133778|NCT01985828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110133779|NCT01985828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110133780|NCT01985841|Cyclophosphamide|cyclophosphamide|mesh-list
110133781|NCT01985841|Docetaxel|docetaxel|mesh-list
110133782|NCT01985841|Fluorouracil|fluorouracil|mesh-list
110133783|NCT01985841|Epirubicin|epirubicin|mesh-list
110133784|NCT01985841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110133785|NCT01985841|Immunologic Factors|immunologic factors|mesh-ancestor
110133786|NCT01985841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110133787|NCT01985841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110133788|NCT01985841|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110133789|NCT01985841|Alkylating Agents|alkylating agents|mesh-ancestor
110133790|NCT01985841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110133791|NCT01985841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110133792|NCT01985841|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110133793|NCT01985841|Tubulin Modulators|tubulin modulators|mesh-ancestor
110133794|NCT01985841|Antimitotic Agents|antimitotic agents|mesh-ancestor
110133795|NCT01985841|Mitosis Modulators|mitosis modulators|mesh-ancestor
110133796|NCT01985841|Antimetabolites|antimetabolites|mesh-ancestor
110133797|NCT01985841|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110133798|NCT01985841|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110133799|NCT01985841|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110133800|NCT01985841|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110133801|NCT01985841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110133802|NCT01985854|Propofol|propofol|mesh-list
110133803|NCT01985854|Desflurane|desflurane|mesh-list
110133804|NCT01985854|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110133805|NCT01985854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110133806|NCT01985854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110133807|NCT01985854|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110133808|NCT01985854|Anesthetics, General|anesthetics, general|mesh-ancestor
110133809|NCT01985854|Anesthetics|anesthetics|mesh-ancestor
110133810|NCT01985854|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110133811|NCT01985893|Trastuzumab|trastuzumab|mesh-list
110133812|NCT01985893|Lapatinib|lapatinib|mesh-list
110133813|NCT01985893|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110133814|NCT01985893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110133815|NCT01985893|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110133816|NCT01985893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110133817|NCT01985893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110133818|NCT01986036|Calcium|calcium|mesh-list
110165590|NCT00024271|Doxorubicin|doxorubicin|mesh-list
110133819|NCT01986036|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110133820|NCT01986036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110133821|NCT01986049|Bupivacaine|bupivacaine|mesh-list
110133822|NCT01986049|Anesthetics, Local|anesthetics, local|mesh-ancestor
110133823|NCT01986049|Anesthetics|anesthetics|mesh-ancestor
110133824|NCT01986049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110133825|NCT01986049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110133826|NCT01986049|Sensory System Agents|sensory system agents|mesh-ancestor
110133827|NCT01986049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110133828|NCT01986088|Sumatriptan|sumatriptan|mesh-list
110133829|NCT01986088|Eletriptan|eletriptan|mesh-list
110133830|NCT01986088|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110133831|NCT01986088|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110133832|NCT01986088|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110133833|NCT01986088|Serotonin Agents|serotonin agents|mesh-ancestor
110133834|NCT01986088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110133835|NCT01986088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110133836|NCT01986088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110133837|NCT01986127|Adalimumab|adalimumab|mesh-list
110133838|NCT01986127|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110133839|NCT01986127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110133840|NCT01986127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110133841|NCT01986192|Warfarin|warfarin|mesh-list
110133842|NCT01986192|Rivaroxaban|rivaroxaban|mesh-list
110133843|NCT01986192|Anticoagulants|anticoagulants|mesh-ancestor
110133844|NCT01986192|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110133845|NCT01986192|Antithrombins|antithrombins|mesh-ancestor
110133846|NCT01986192|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110133847|NCT01986192|Protease Inhibitors|protease inhibitors|mesh-ancestor
110346450|NCT04538742|Paclitaxel|paclitaxel|mesh-list
110133848|NCT01986192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110133849|NCT01986192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110133851|NCT01986218|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
110133852|NCT01986218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110133853|NCT01986218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110133854|NCT01986270|Sumatriptan|sumatriptan|mesh-list
110133855|NCT01986270|Eletriptan|eletriptan|mesh-list
110133856|NCT01986270|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110133857|NCT01986270|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110133858|NCT01986270|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110133859|NCT01986270|Serotonin Agents|serotonin agents|mesh-ancestor
110133860|NCT01986270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110133861|NCT01986270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110133862|NCT01986270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110133863|NCT01986283|Oxycodone|oxycodone|mesh-list
110346506|NCT04526288|Cytarabine|cytarabine|mesh-list
110133864|NCT01986283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110133865|NCT01986283|Narcotics|narcotics|mesh-ancestor
110133866|NCT01986283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110133867|NCT01986283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110133868|NCT01986283|Analgesics|analgesics|mesh-ancestor
110133869|NCT01986283|Sensory System Agents|sensory system agents|mesh-ancestor
110133870|NCT01986283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110133871|NCT01986309|Lidocaine|lidocaine|mesh-list
110133872|NCT01986309|Anesthetics, Local|anesthetics, local|mesh-ancestor
110133873|NCT01986309|Anesthetics|anesthetics|mesh-ancestor
110133874|NCT01986309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110133875|NCT01986309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110133876|NCT01986309|Sensory System Agents|sensory system agents|mesh-ancestor
110133877|NCT01986309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110133878|NCT01986309|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110133879|NCT01986309|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110133880|NCT01986309|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110133881|NCT01986309|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110165602|NCT00024271|Antiviral Agents|antiviral agents|mesh-ancestor
110346563|NCT04495608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110133882|NCT01986309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110133884|NCT01986322|Immunologic Factors|immunologic factors|mesh-ancestor
110133885|NCT01986322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110133886|NCT01986426|Pembrolizumab|pembrolizumab|mesh-list
110133887|NCT01986426|Ipilimumab|ipilimumab|mesh-list
110133888|NCT01986426|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110133889|NCT01986426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110133890|NCT01986426|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110133891|NCT01986426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110133892|NCT01986465|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110133893|NCT01986465|Methylprednisolone|methylprednisolone|mesh-list
110133894|NCT01986465|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110133895|NCT01986465|Prednisolone|prednisolone|mesh-list
110133896|NCT01986465|Prednisolone acetate|prednisolone acetate|mesh-list
110133897|NCT01986465|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110133898|NCT01986465|Prednisolone phosphate|prednisolone phosphate|mesh-list
110133899|NCT01986465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110133900|NCT01986465|Antiemetics|antiemetics|mesh-ancestor
110133901|NCT01986465|Autonomic Agents|autonomic agents|mesh-ancestor
110133902|NCT01986465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110133903|NCT01986465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110133904|NCT01986465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110133905|NCT01986465|Glucocorticoids|glucocorticoids|mesh-ancestor
110133906|NCT01986465|Hormones|hormones|mesh-ancestor
110133907|NCT01986465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110133908|NCT01986465|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110133909|NCT01986465|Protective Agents|protective agents|mesh-ancestor
110133910|NCT01986465|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110133911|NCT01986465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110133912|NCT01986556|Lesinurad|lesinurad|mesh-list
110133913|NCT01986556|Gout Suppressants|gout suppressants|mesh-ancestor
110133914|NCT01986556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110133915|NCT01986556|Uricosuric Agents|uricosuric agents|mesh-ancestor
110133916|NCT01986582|Phenylephrine|phenylephrine|mesh-list
110133917|NCT01986582|Oxymetazoline|oxymetazoline|mesh-list
110133918|NCT01986582|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110133919|NCT01986582|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110133920|NCT01986582|Adrenergic Agents|adrenergic agents|mesh-ancestor
110133921|NCT01986582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110133922|NCT01986582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110133923|NCT01986582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110133925|NCT01986582|Autonomic Agents|autonomic agents|mesh-ancestor
110133926|NCT01986582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110133927|NCT01986582|Nasal Decongestants|nasal decongestants|mesh-ancestor
110133928|NCT01986582|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110133929|NCT01986582|Respiratory System Agents|respiratory system agents|mesh-ancestor
110133931|NCT01986582|Mydriatics|mydriatics|mesh-ancestor
110133932|NCT01986582|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110133934|NCT01986608|Lacosamide|lacosamide|mesh-list
110133935|NCT01986608|Anticonvulsants|anticonvulsants|mesh-ancestor
110133936|NCT01986608|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110133937|NCT01986608|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110133938|NCT01986608|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110133939|NCT01986608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110133941|NCT01986660|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110133942|NCT01986660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110133943|NCT01986660|Analgesics|analgesics|mesh-ancestor
110133944|NCT01986660|Sensory System Agents|sensory system agents|mesh-ancestor
110133945|NCT01986660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110133946|NCT01986660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110133947|NCT01986660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110133948|NCT01986660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110133949|NCT01986660|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110133950|NCT01986660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110133951|NCT01986660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110133952|NCT01986673|Sildenafil Citrate|sildenafil citrate|mesh-list
110133953|NCT01986673|Vasodilator Agents|vasodilator agents|mesh-ancestor
110133954|NCT01986673|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110133955|NCT01986673|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110133956|NCT01986673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110346778|NCT04310007|Ramucirumab|ramucirumab|mesh-list
110133957|NCT01986673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110133959|NCT01986764|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
110133960|NCT01986764|Estradiol|estradiol|mesh-list
110133961|NCT01986764|Estrogens|estrogens|mesh-list
110133962|NCT01986764|Hormones|hormones|mesh-ancestor
110133963|NCT01986764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110133964|NCT01986764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110133965|NCT01986764|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110133966|NCT01986764|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110133967|NCT01986764|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110133968|NCT01986764|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110133969|NCT01986764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110133970|NCT01986764|Dopamine Agents|dopamine agents|mesh-ancestor
110133971|NCT01986764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110133972|NCT01986777|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
110133973|NCT01986777|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110346843|NCT04305041|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110133974|NCT01986777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110133975|NCT01986777|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110133976|NCT01986777|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110133977|NCT01986777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110133978|NCT01986777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110133979|NCT01986777|Dopamine Agents|dopamine agents|mesh-ancestor
110133980|NCT01986777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110133981|NCT01986894|Moxifloxacin|moxifloxacin|mesh-list
110133982|NCT01986894|Thalidomide|thalidomide|mesh-list
110133983|NCT01986894|Pomalidomide|pomalidomide|mesh-list
110133984|NCT01986894|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110133985|NCT01986894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110133986|NCT01986894|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110133987|NCT01986894|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110133988|NCT01986894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110133989|NCT01986894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110133990|NCT01986894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110133991|NCT01986894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110133992|NCT01986894|Immunologic Factors|immunologic factors|mesh-ancestor
110133993|NCT01986894|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110133994|NCT01986894|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110133995|NCT01986894|Growth Substances|growth substances|mesh-ancestor
110133996|NCT01986894|Growth Inhibitors|growth inhibitors|mesh-ancestor
110133997|NCT01986894|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110133998|NCT01986894|Leprostatic Agents|leprostatic agents|mesh-ancestor
110133999|NCT01986998|Methylprednisolone|methylprednisolone|mesh-list
110134000|NCT01986998|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110134001|NCT01986998|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110346963|NCT04247074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110346964|NCT04247074|Cholinergic Agents|cholinergic agents|mesh-ancestor
110346965|NCT04247074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110346966|NCT04231448|Prednisone|prednisone|mesh-list
110134002|NCT01986998|Prednisolone|prednisolone|mesh-list
110134003|NCT01986998|Prednisolone acetate|prednisolone acetate|mesh-list
110134004|NCT01986998|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110134005|NCT01986998|Prednisolone phosphate|prednisolone phosphate|mesh-list
110134006|NCT01986998|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110134007|NCT01986998|Antiemetics|antiemetics|mesh-ancestor
110134008|NCT01986998|Autonomic Agents|autonomic agents|mesh-ancestor
110134009|NCT01986998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110134010|NCT01986998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110134011|NCT01986998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110134012|NCT01986998|Glucocorticoids|glucocorticoids|mesh-ancestor
110134013|NCT01986998|Hormones|hormones|mesh-ancestor
110347021|NCT04210115|Calcium, Dietary|calcium, dietary|mesh-list
110347022|NCT04210115|Leucovorin|leucovorin|mesh-list
110347023|NCT04210115|Pembrolizumab|pembrolizumab|mesh-list
110134014|NCT01986998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110134015|NCT01986998|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110134016|NCT01986998|Protective Agents|protective agents|mesh-ancestor
110134017|NCT01986998|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110134018|NCT01986998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110134019|NCT01987076|Prednisone|prednisone|mesh-list
110134020|NCT01987076|Clobetasol|clobetasol|mesh-list
110134021|NCT01987076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110134022|NCT01987076|Glucocorticoids|glucocorticoids|mesh-ancestor
110134023|NCT01987076|Hormones|hormones|mesh-ancestor
110134024|NCT01987076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110134025|NCT01987076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110134026|NCT01987076|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110134027|NCT01987076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110134028|NCT01987128|Ropivacaine|ropivacaine|mesh-list
110134029|NCT01987128|Anesthetics, Local|anesthetics, local|mesh-ancestor
110134030|NCT01987128|Anesthetics|anesthetics|mesh-ancestor
110134031|NCT01987128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110134032|NCT01987128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110134033|NCT01987128|Sensory System Agents|sensory system agents|mesh-ancestor
110134034|NCT01987128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110134035|NCT01987154|Caseins|caseins|mesh-list
110134036|NCT01987154|Chelating Agents|chelating agents|mesh-ancestor
110134037|NCT01987154|Sequestering Agents|sequestering agents|mesh-ancestor
110134038|NCT01987154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110134039|NCT01987167|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
110134040|NCT01987167|Hormones|hormones|mesh-ancestor
110134041|NCT01987167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110134042|NCT01987167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110134043|NCT01987297|Cytarabine|cytarabine|mesh-list
110134044|NCT01987297|Daunorubicin|daunorubicin|mesh-list
110134045|NCT01987297|Idarubicin|idarubicin|mesh-list
110134046|NCT01987297|Tretinoin|tretinoin|mesh-list
110134047|NCT01987297|Arsenic Trioxide|arsenic trioxide|mesh-list
110134048|NCT01987297|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110134049|NCT01987297|Antimetabolites|antimetabolites|mesh-ancestor
110134050|NCT01987297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110134051|NCT01987297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110134052|NCT01987297|Antiviral Agents|antiviral agents|mesh-ancestor
110134053|NCT01987297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110134054|NCT01987297|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110134055|NCT01987297|Immunologic Factors|immunologic factors|mesh-ancestor
110134056|NCT01987297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110134057|NCT01987297|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110134058|NCT01987297|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110134059|NCT01987297|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110134060|NCT01987297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110134061|NCT01987297|Keratolytic Agents|keratolytic agents|mesh-ancestor
110134062|NCT01987297|Dermatologic Agents|dermatologic agents|mesh-ancestor
110134063|NCT01987310|Atorvastatin|atorvastatin|mesh-list
110134064|NCT01987310|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110134065|NCT01987310|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110134066|NCT01987310|Antimetabolites|antimetabolites|mesh-ancestor
110134067|NCT01987310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110134068|NCT01987310|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110134069|NCT01987310|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110134070|NCT01987310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110134071|NCT01987323|Latanoprost|latanoprost|mesh-list
110134072|NCT01987323|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110134073|NCT01987323|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110134075|NCT01987375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110134076|NCT01987375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110134078|NCT01987570|Antimetabolites|antimetabolites|mesh-ancestor
110134079|NCT01987570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110134080|NCT01987570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110134081|NCT01987570|Gout Suppressants|gout suppressants|mesh-ancestor
110134082|NCT01987570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110134083|NCT01987570|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110134084|NCT01987570|Antioxidants|antioxidants|mesh-ancestor
110134085|NCT01987570|Protective Agents|protective agents|mesh-ancestor
110134086|NCT01987570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110134087|NCT01987739|Zolpidem|zolpidem|mesh-list
110134088|NCT01987739|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110134089|NCT01987739|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110347324|NCT04022967|Atazanavir Sulfate|atazanavir sulfate|mesh-list
110134090|NCT01987739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110134091|NCT01987739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110134092|NCT01987739|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
110134094|NCT01987739|GABA Agents|gaba agents|mesh-ancestor
110134095|NCT01987739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110134096|NCT01987739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110134097|NCT01987804|Oxytocin|oxytocin|mesh-list
110134098|NCT01987804|Oxytocics|oxytocics|mesh-ancestor
110134099|NCT01987804|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110134100|NCT01987804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110134101|NCT01988077|Ipilimumab|ipilimumab|mesh-list
110134102|NCT01988077|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110134103|NCT01988077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110134104|NCT01988077|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110134105|NCT01988077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110134106|NCT01988116|Calcitriol|calcitriol|mesh-list
110134107|NCT01988116|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110134108|NCT01988116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110134109|NCT01988116|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
110134110|NCT01988116|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110134111|NCT01988116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110134112|NCT01988116|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110134113|NCT01988116|Vitamins|vitamins|mesh-ancestor
110134114|NCT01988116|Micronutrients|micronutrients|mesh-ancestor
110134115|NCT01988116|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110134116|NCT01988298|Acetaminophen|acetaminophen|mesh-list
110134117|NCT01988298|Ibuprofen|ibuprofen|mesh-list
110134118|NCT01988298|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110134119|NCT01988298|Analgesics|analgesics|mesh-ancestor
110134120|NCT01988298|Sensory System Agents|sensory system agents|mesh-ancestor
110134121|NCT01988298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110134122|NCT01988298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110134123|NCT01988298|Antipyretics|antipyretics|mesh-ancestor
110134124|NCT01988298|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110134125|NCT01988298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110134126|NCT01988298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110134127|NCT01988298|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110134128|NCT01988298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110134129|NCT01988298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110134130|NCT01988311|Psilocybin|psilocybin|mesh-list
110134131|NCT01988311|Hallucinogens|hallucinogens|mesh-ancestor
110134132|NCT01988311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110347432|NCT03909334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110347445|NCT03895099|Progestins|progestins|mesh-ancestor
110134133|NCT01988311|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110134134|NCT01988428|Ceftriaxone|ceftriaxone|mesh-list
110134135|NCT01988428|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110134136|NCT01988428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110134137|NCT01988506|Interleukin-2|interleukin-2|mesh-list
110134138|NCT01988506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110134139|NCT01988506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110134140|NCT01988506|Analgesics|analgesics|mesh-ancestor
110134141|NCT01988506|Sensory System Agents|sensory system agents|mesh-ancestor
110134142|NCT01988506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110134143|NCT01988506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110134144|NCT01988545|Exenatide|exenatide|mesh-list
110134145|NCT01988545|Glucagon|glucagon|mesh-list
110134146|NCT01988545|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
110134147|NCT01988545|Incretins|incretins|mesh-ancestor
110134148|NCT01988545|Hormones|hormones|mesh-ancestor
110134149|NCT01988545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110134150|NCT01988545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110134151|NCT01988545|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110134152|NCT01988545|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110134153|NCT01988545|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110134154|NCT01988610|Mifepristone|mifepristone|mesh-list
110134155|NCT01988610|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
110134156|NCT01988610|Abortifacient Agents|abortifacient agents|mesh-ancestor
110134157|NCT01988610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110134158|NCT01988610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110134159|NCT01988610|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110134160|NCT01988610|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110134161|NCT01988610|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110134162|NCT01988610|Contraceptive Agents|contraceptive agents|mesh-ancestor
110134163|NCT01988610|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
110134164|NCT01988610|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
110134165|NCT01988610|Hormone Antagonists|hormone antagonists|mesh-ancestor
110134166|NCT01988610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110134167|NCT01988610|Luteolytic Agents|luteolytic agents|mesh-ancestor
110134168|NCT01988610|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110134169|NCT01988610|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
110134170|NCT01988649|Oxytocin|oxytocin|mesh-list
110134171|NCT01988649|Oxytocics|oxytocics|mesh-ancestor
110134172|NCT01988649|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110134173|NCT01988649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110134174|NCT01988831|Propranolol|propranolol|mesh-list
110347629|NCT03725007|Upadacitinib|upadacitinib|mesh-list
110347630|NCT03725007|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
110347631|NCT03725007|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110347632|NCT03725007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110347633|NCT03725007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110347634|NCT03725007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110134175|NCT01988831|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110134176|NCT01988831|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110134177|NCT01988831|Adrenergic Agents|adrenergic agents|mesh-ancestor
110134178|NCT01988831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110134179|NCT01988831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110134180|NCT01988831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110134181|NCT01988831|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110165682|NCT00024544|Antibodies|antibodies|mesh-list
110134182|NCT01988831|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110134183|NCT01988831|Vasodilator Agents|vasodilator agents|mesh-ancestor
110134184|NCT01988896|Atezolizumab|atezolizumab|mesh-list
110134185|NCT01988896|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110134186|NCT01988896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110347686|NCT03638141|Immunologic Factors|immunologic factors|mesh-ancestor
110347687|NCT03638141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110347688|NCT03638141|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110134187|NCT01988896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110134188|NCT01988896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110134190|NCT01988961|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110134191|NCT01988961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110134192|NCT01988961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110134193|NCT01988961|Immunologic Factors|immunologic factors|mesh-ancestor
110134194|NCT01988961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110134195|NCT01989000|Gemcitabine|gemcitabine|mesh-list
110134196|NCT01989000|Imidazole|imidazole|mesh-list
110134197|NCT01989000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110134198|NCT01989000|Antimetabolites|antimetabolites|mesh-ancestor
110134199|NCT01989000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110134200|NCT01989000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110134201|NCT01989000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110347749|NCT03586999|Prednisolone|prednisolone|mesh-list
110134202|NCT01989052|Lomustine|lomustine|mesh-list
110134203|NCT01989052|Carboxyamido-triazole|carboxyamido-triazole|mesh-list
110134204|NCT01989052|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110134205|NCT01989052|Alkylating Agents|alkylating agents|mesh-ancestor
110134206|NCT01989052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110134207|NCT01989052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110134208|NCT01989052|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110134209|NCT01989052|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110134210|NCT01989052|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110134211|NCT01989052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110134212|NCT01989078|Losartan|losartan|mesh-list
110134213|NCT01989078|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110134214|NCT01989078|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110134215|NCT01989078|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110134216|NCT01989078|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110134217|NCT01989078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110134219|NCT01989091|Anticoagulants|anticoagulants|mesh-ancestor
110134220|NCT01989091|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110134221|NCT01989091|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110134222|NCT01989091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110134223|NCT01989312|Lidocaine|lidocaine|mesh-list
110134224|NCT01989312|Epinephrine|epinephrine|mesh-list
110134225|NCT01989312|Midazolam|midazolam|mesh-list
110134226|NCT01989312|Levobupivacaine|levobupivacaine|mesh-list
110134227|NCT01989312|Anesthetics, Local|anesthetics, local|mesh-ancestor
110134228|NCT01989312|Anesthetics|anesthetics|mesh-ancestor
110134229|NCT01989312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110134230|NCT01989312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110134231|NCT01989312|Sensory System Agents|sensory system agents|mesh-ancestor
110134232|NCT01989312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110134233|NCT01989312|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110134234|NCT01989312|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110134235|NCT01989312|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110134236|NCT01989312|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110134237|NCT01989312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110134238|NCT01989312|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110134239|NCT01989312|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110134240|NCT01989312|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110134241|NCT01989312|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110134242|NCT01989312|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110347859|NCT03508570|Nivolumab|nivolumab|mesh-list
110134243|NCT01989312|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110134244|NCT01989312|Anesthetics, General|anesthetics, general|mesh-ancestor
110134245|NCT01989312|GABA Modulators|gaba modulators|mesh-ancestor
110134246|NCT01989312|GABA Agents|gaba agents|mesh-ancestor
110134247|NCT01989312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110134248|NCT01989312|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110134249|NCT01989312|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110134250|NCT01989312|Adrenergic Agents|adrenergic agents|mesh-ancestor
110134251|NCT01989312|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110134252|NCT01989312|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110134253|NCT01989312|Autonomic Agents|autonomic agents|mesh-ancestor
110134254|NCT01989312|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110134255|NCT01989312|Respiratory System Agents|respiratory system agents|mesh-ancestor
110134256|NCT01989312|Mydriatics|mydriatics|mesh-ancestor
110134257|NCT01989312|Sympathomimetics|sympathomimetics|mesh-ancestor
110134258|NCT01989312|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110134259|NCT01989416|Chlorhexidine|chlorhexidine|mesh-list
110134260|NCT01989416|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110134261|NCT01989416|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110134262|NCT01989416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110134264|NCT01989416|Dermatologic Agents|dermatologic agents|mesh-ancestor
110134265|NCT01989507|Nicotine|nicotine|mesh-list
110134266|NCT01989507|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110134267|NCT01989507|Autonomic Agents|autonomic agents|mesh-ancestor
110134268|NCT01989507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110134269|NCT01989507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110134270|NCT01989507|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110134271|NCT01989507|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110165714|NCT00025090|Fluorouracil|fluorouracil|mesh-list
110134272|NCT01989507|Cholinergic Agents|cholinergic agents|mesh-ancestor
110134273|NCT01989507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110134274|NCT01989507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110134275|NCT01989559|Vaccines|vaccines|mesh-list
110134276|NCT01989559|Immunologic Factors|immunologic factors|mesh-ancestor
110134277|NCT01989559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110134278|NCT01989611|Tenofovir|tenofovir|mesh-list
110134279|NCT01989611|Emtricitabine|emtricitabine|mesh-list
110134280|NCT01989611|Antiviral Agents|antiviral agents|mesh-ancestor
110134281|NCT01989611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110134282|NCT01989611|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110134283|NCT01989611|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110134284|NCT01989611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110134285|NCT01989611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110134286|NCT01989611|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110134287|NCT01989611|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110134288|NCT01989663|Tenofovir|tenofovir|mesh-list
110134289|NCT01989663|Antiviral Agents|antiviral agents|mesh-ancestor
110134291|NCT01989663|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110134292|NCT01989663|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110134293|NCT01989663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110134294|NCT01989663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110134295|NCT01989663|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110134296|NCT01989663|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110134298|NCT01989676|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110134299|NCT01989676|Trastuzumab|trastuzumab|mesh-list
110134300|NCT01989676|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110134301|NCT01989676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110134302|NCT01989676|Tubulin Modulators|tubulin modulators|mesh-ancestor
110134303|NCT01989676|Antimitotic Agents|antimitotic agents|mesh-ancestor
110134304|NCT01989676|Mitosis Modulators|mitosis modulators|mesh-ancestor
110134305|NCT01989676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110134306|NCT01989676|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110134308|NCT01989845|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110134309|NCT01989845|Antithrombins|antithrombins|mesh-ancestor
110134310|NCT01989845|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110134311|NCT01989845|Protease Inhibitors|protease inhibitors|mesh-ancestor
110134312|NCT01989845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110134313|NCT01989845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110134314|NCT01989845|Anticoagulants|anticoagulants|mesh-ancestor
110134316|NCT01989884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110134317|NCT01989897|Phenol|phenol|mesh-list
110348118|NCT03267680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110134318|NCT01989897|Histamine|histamine|mesh-list
110134319|NCT01989897|Histamine Agonists|histamine agonists|mesh-ancestor
110134320|NCT01989897|Histamine Agents|histamine agents|mesh-ancestor
110134321|NCT01989897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110134322|NCT01989897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110134323|NCT01989897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110134324|NCT01989897|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110134325|NCT01989897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110134326|NCT01989897|Disinfectants|disinfectants|mesh-ancestor
110134327|NCT01989897|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
110134328|NCT01989897|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110134329|NCT01989923|Nicotine|nicotine|mesh-list
110134330|NCT01989923|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110134331|NCT01989923|Autonomic Agents|autonomic agents|mesh-ancestor
110134332|NCT01989923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110134333|NCT01989923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110134334|NCT01989923|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110134335|NCT01989923|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110134336|NCT01989923|Cholinergic Agents|cholinergic agents|mesh-ancestor
110134337|NCT01989923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110134338|NCT01989923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110134339|NCT01989936|Eletriptan|eletriptan|mesh-list
110134340|NCT01989936|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110134341|NCT01989936|Serotonin Agents|serotonin agents|mesh-ancestor
110134342|NCT01989936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110134343|NCT01989936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110134344|NCT01989936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110134345|NCT01990079|Bupropion|bupropion|mesh-list
110134346|NCT01990079|Nicotine|nicotine|mesh-list
110134347|NCT01990079|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110134348|NCT01990079|Autonomic Agents|autonomic agents|mesh-ancestor
110134349|NCT01990079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110134350|NCT01990079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110134351|NCT01990079|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110134352|NCT01990079|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110134353|NCT01990079|Cholinergic Agents|cholinergic agents|mesh-ancestor
110134354|NCT01990079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110134355|NCT01990079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110134356|NCT01990079|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110134357|NCT01990079|Antidepressive Agents|antidepressive agents|mesh-ancestor
110134358|NCT01990079|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110134359|NCT01990079|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110134360|NCT01990079|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110134361|NCT01990079|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110134362|NCT01990079|Dopamine Agents|dopamine agents|mesh-ancestor
110134363|NCT01990079|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110134364|NCT01990079|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110134366|NCT01990118|Cyclosporine|cyclosporine|mesh-list
110134367|NCT01990118|Cyclosporins|cyclosporins|mesh-list
110134368|NCT01990118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110134369|NCT01990118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110134370|NCT01990118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110134371|NCT01990118|Immunologic Factors|immunologic factors|mesh-ancestor
110134372|NCT01990118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110134374|NCT01990118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110134375|NCT01990118|Dermatologic Agents|dermatologic agents|mesh-ancestor
110134376|NCT01990118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110134377|NCT01990118|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110134379|NCT01990144|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110134380|NCT01990144|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110134381|NCT01990144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110134382|NCT01990144|Immunologic Factors|immunologic factors|mesh-ancestor
110134383|NCT01990144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110134384|NCT01990144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110134385|NCT01990144|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110134386|NCT01990144|Alkylating Agents|alkylating agents|mesh-ancestor
110134387|NCT01990144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110134388|NCT01990378|Rabeprazole|rabeprazole|mesh-list
110134389|NCT01990378|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110134390|NCT01990378|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110134391|NCT01990378|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110134393|NCT01990378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110134394|NCT01990404|Nitrous Oxide|nitrous oxide|mesh-list
110134395|NCT01990404|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110134396|NCT01990404|Anesthetics, General|anesthetics, general|mesh-ancestor
110134397|NCT01990404|Anesthetics|anesthetics|mesh-ancestor
110134398|NCT01990404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110134399|NCT01990404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110134400|NCT01990404|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110134401|NCT01990404|Analgesics|analgesics|mesh-ancestor
110134402|NCT01990404|Sensory System Agents|sensory system agents|mesh-ancestor
110134403|NCT01990404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110134404|NCT01990443|Reslizumab|reslizumab|mesh-list
110134405|NCT01990443|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110134406|NCT01990443|Respiratory System Agents|respiratory system agents|mesh-ancestor
110134407|NCT01990586|Rabeprazole|rabeprazole|mesh-list
110134408|NCT01990586|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110134409|NCT01990586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110134410|NCT01990586|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110134411|NCT01990586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110134412|NCT01990586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110134413|NCT01990690|Antioxidants|antioxidants|mesh-list
110134414|NCT01990690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110134415|NCT01990690|Protective Agents|protective agents|mesh-ancestor
110134416|NCT01990690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110134417|NCT01990755|Chlordesmethyldiazepam|chlordesmethyldiazepam|mesh-list
110134418|NCT01990755|Olanzapine|olanzapine|mesh-list
110134419|NCT01990755|Antiemetics|antiemetics|mesh-ancestor
110134420|NCT01990755|Autonomic Agents|autonomic agents|mesh-ancestor
110348556|NCT02585388|Letrozole|letrozole|mesh-list
110134421|NCT01990755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110134422|NCT01990755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110134423|NCT01990755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110134424|NCT01990755|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110134425|NCT01990755|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110134426|NCT01990755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110134427|NCT01990755|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110165800|NCT00025363|Irinotecan|irinotecan|mesh-list
110134428|NCT01990755|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110134429|NCT01990755|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110134430|NCT01990755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110134431|NCT01990755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110134432|NCT01990755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110134434|NCT01990755|Anticonvulsants|anticonvulsants|mesh-ancestor
110134435|NCT01990781|Dexamethasone|dexamethasone|mesh-list
110134436|NCT01990781|Dexamethasone acetate|dexamethasone acetate|mesh-list
110134437|NCT01990781|Lidocaine|lidocaine|mesh-list
110134438|NCT01990781|BB 1101|bb 1101|mesh-list
110134440|NCT01990781|Antiemetics|antiemetics|mesh-ancestor
110134441|NCT01990781|Autonomic Agents|autonomic agents|mesh-ancestor
110134443|NCT01990781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110134444|NCT01990781|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110134445|NCT01990781|Glucocorticoids|glucocorticoids|mesh-ancestor
110134447|NCT01990781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110134448|NCT01990781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110134449|NCT01990781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110134450|NCT01990781|Protease Inhibitors|protease inhibitors|mesh-ancestor
110348670|NCT02386735|Prednisone|prednisone|mesh-list
110134451|NCT01990781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110134452|NCT01990781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110134453|NCT01990781|Anesthetics, Local|anesthetics, local|mesh-ancestor
110134454|NCT01990781|Anesthetics|anesthetics|mesh-ancestor
110134455|NCT01990781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110134456|NCT01990781|Sensory System Agents|sensory system agents|mesh-ancestor
110134457|NCT01990781|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110134458|NCT01990781|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110134459|NCT01990781|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110134460|NCT01990781|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110134461|NCT01990807|Idarubicin|idarubicin|mesh-list
110134462|NCT01990807|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110134463|NCT01990807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110134464|NCT01990807|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110134465|NCT01990807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110134466|NCT01990807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110134467|NCT01990807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110134469|NCT01990872|Cholecalciferol|cholecalciferol|mesh-list
110134470|NCT01990872|Vitamins|vitamins|mesh-ancestor
110134471|NCT01990872|Micronutrients|micronutrients|mesh-ancestor
110134472|NCT01990872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110134473|NCT01990872|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110134474|NCT01990872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110134475|NCT01990937|Midazolam|midazolam|mesh-list
110134476|NCT01990937|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110348812|NCT02101853|Antibodies|antibodies|mesh-list
110134477|NCT01990937|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110134478|NCT01990937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110134479|NCT01990937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110134480|NCT01990937|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110134481|NCT01990937|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110134482|NCT01990937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110134483|NCT01990937|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110134484|NCT01990937|Anesthetics, General|anesthetics, general|mesh-ancestor
110134485|NCT01990937|Anesthetics|anesthetics|mesh-ancestor
110134486|NCT01990937|GABA Modulators|gaba modulators|mesh-ancestor
110348872|NCT02048813|Cyclophosphamide|cyclophosphamide|mesh-list
110134487|NCT01990937|GABA Agents|gaba agents|mesh-ancestor
110134488|NCT01990937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110134489|NCT01990937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110134490|NCT01991028|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110134491|NCT01991054|Vitamin D|vitamin d|mesh-list
110134492|NCT01991054|Cholecalciferol|cholecalciferol|mesh-list
110134493|NCT01991054|Vitamins|vitamins|mesh-ancestor
110134494|NCT01991054|Micronutrients|micronutrients|mesh-ancestor
110134495|NCT01991054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110134496|NCT01991054|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110134497|NCT01991054|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110134498|NCT01991119|Dronedarone|dronedarone|mesh-list
110134499|NCT01991119|Propafenone|propafenone|mesh-list
110134500|NCT01991119|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110134501|NCT01991119|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110134502|NCT01991119|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110348938|NCT01799538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110134503|NCT01991119|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110134504|NCT01991119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110134505|NCT01991145|Epoetin Alfa|epoetin alfa|mesh-list
110134506|NCT01991145|Hematinics|hematinics|mesh-ancestor
110134507|NCT01991158|Dexamethasone|dexamethasone|mesh-list
110134508|NCT01991158|Gemcitabine|gemcitabine|mesh-list
110134509|NCT01991158|Methotrexate|methotrexate|mesh-list
110134510|NCT01991158|Pegaspargase|pegaspargase|mesh-list
110134511|NCT01991158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110134512|NCT01991158|Antiemetics|antiemetics|mesh-ancestor
110134513|NCT01991158|Autonomic Agents|autonomic agents|mesh-ancestor
110134514|NCT01991158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110134515|NCT01991158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110134518|NCT01991158|Hormones|hormones|mesh-ancestor
110134519|NCT01991158|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110134520|NCT01991158|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110134521|NCT01991158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110134522|NCT01991158|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110134523|NCT01991158|Antimetabolites|antimetabolites|mesh-ancestor
110134524|NCT01991158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110134525|NCT01991158|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110134526|NCT01991158|Abortifacient Agents|abortifacient agents|mesh-ancestor
110134527|NCT01991158|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110134528|NCT01991158|Dermatologic Agents|dermatologic agents|mesh-ancestor
110134529|NCT01991158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110134530|NCT01991158|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110134531|NCT01991158|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110134532|NCT01991158|Immunologic Factors|immunologic factors|mesh-ancestor
110134533|NCT01991158|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110134534|NCT01991158|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110134535|NCT01991275|Morphine|morphine|mesh-list
110134536|NCT01991275|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110134537|NCT01991275|Narcotics|narcotics|mesh-ancestor
110134538|NCT01991275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110134539|NCT01991275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110134540|NCT01991275|Analgesics|analgesics|mesh-ancestor
110134541|NCT01991275|Sensory System Agents|sensory system agents|mesh-ancestor
110134542|NCT01991275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110134543|NCT01991288|Epinephrine|epinephrine|mesh-list
110134544|NCT01991288|Racepinephrine|racepinephrine|mesh-list
110134545|NCT01991288|Bupivacaine|bupivacaine|mesh-list
110134546|NCT01991288|Levobupivacaine|levobupivacaine|mesh-list
110134547|NCT01991288|Epinephryl borate|epinephryl borate|mesh-list
110134548|NCT01991288|Anesthetics, Local|anesthetics, local|mesh-ancestor
110134549|NCT01991288|Anesthetics|anesthetics|mesh-ancestor
110134550|NCT01991288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110134551|NCT01991288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110134552|NCT01991288|Sensory System Agents|sensory system agents|mesh-ancestor
110134553|NCT01991288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110134554|NCT01991288|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110134555|NCT01991288|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110134556|NCT01991288|Adrenergic Agents|adrenergic agents|mesh-ancestor
110134557|NCT01991288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110134558|NCT01991288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110134559|NCT01991288|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110134560|NCT01991288|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110134561|NCT01991288|Autonomic Agents|autonomic agents|mesh-ancestor
110134562|NCT01991288|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110134563|NCT01991288|Respiratory System Agents|respiratory system agents|mesh-ancestor
110134565|NCT01991288|Sympathomimetics|sympathomimetics|mesh-ancestor
110134566|NCT01991288|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110134567|NCT01991327|Enclomiphene|enclomiphene|mesh-list
110134568|NCT01991327|Clomiphene|clomiphene|mesh-list
110134569|NCT01991327|Zuclomiphene|zuclomiphene|mesh-list
110134570|NCT01991327|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110134571|NCT01991327|Hormone Antagonists|hormone antagonists|mesh-ancestor
110134572|NCT01991327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110134573|NCT01991327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110134574|NCT01991327|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110134575|NCT01991327|Fertility Agents|fertility agents|mesh-ancestor
110134576|NCT01991327|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110134577|NCT01991327|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110134578|NCT01991327|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110134579|NCT01991561|Aluminum Hydroxide|aluminum hydroxide|mesh-list
110134580|NCT01991561|Vaccines|vaccines|mesh-list
110134581|NCT01991561|Immunologic Factors|immunologic factors|mesh-ancestor
110134582|NCT01991561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110134583|NCT01991561|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110134584|NCT01991561|Antacids|antacids|mesh-ancestor
110134585|NCT01991561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110134586|NCT01991561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110134587|NCT01991574|Calcium|calcium|mesh-list
110134588|NCT01991574|Calcium acetate|calcium acetate|mesh-list
110134589|NCT01991574|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110134590|NCT01991574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110134591|NCT01991574|Chelating Agents|chelating agents|mesh-ancestor
110134592|NCT01991574|Sequestering Agents|sequestering agents|mesh-ancestor
110134593|NCT01991574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110134594|NCT01991587|Vaccines|vaccines|mesh-list
110134595|NCT01991587|Immunologic Factors|immunologic factors|mesh-ancestor
110134596|NCT01991587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110134598|NCT01991626|Trace Elements|trace elements|mesh-list
110134599|NCT01991626|Micronutrients|micronutrients|mesh-list
110134600|NCT01991626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110134601|NCT01991678|Etirinotecan pegol|etirinotecan pegol|mesh-list
110134602|NCT01991678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110134603|NCT01991678|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110134604|NCT01991678|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110134605|NCT01991678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110134606|NCT01991678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110134608|NCT01991834|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110134609|NCT01991834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110134610|NCT01991951|Warfarin|warfarin|mesh-list
110134611|NCT01991951|Anticoagulants|anticoagulants|mesh-ancestor
110134612|NCT01992133|Vitamin D|vitamin d|mesh-list
110134613|NCT01992133|Cholecalciferol|cholecalciferol|mesh-list
110134614|NCT01992133|Vitamins|vitamins|mesh-ancestor
110134615|NCT01992133|Micronutrients|micronutrients|mesh-ancestor
110134616|NCT01992133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110349282|NCT01044745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110349283|NCT01044745|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110349284|NCT01044745|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110349285|NCT01044745|Antitubercular Agents|antitubercular agents|mesh-ancestor
110349286|NCT01044745|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110349287|NCT01044745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110349288|NCT00990275|Ethanol|ethanol|mesh-list
110349289|NCT00990275|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110349290|NCT00990275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110134617|NCT01992133|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110134618|NCT01992133|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110134619|NCT01992146|Naloxone|naloxone|mesh-list
110134620|NCT01992146|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110134621|NCT01992146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110134622|NCT01992146|Sensory System Agents|sensory system agents|mesh-ancestor
110134623|NCT01992146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110134624|NCT01992198|Chlorhexidine|chlorhexidine|mesh-list
110134625|NCT01992198|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110134626|NCT01992198|Metronidazole|metronidazole|mesh-list
110134627|NCT01992198|Meropenem|meropenem|mesh-list
110134628|NCT01992198|Cefoperazone|cefoperazone|mesh-list
110134629|NCT01992198|Sulperazone|sulperazone|mesh-list
110134630|NCT01992198|Somatostatin|somatostatin|mesh-list
110134631|NCT01992198|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110134632|NCT01992198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110134633|NCT01992198|Disinfectants|disinfectants|mesh-ancestor
110134634|NCT01992198|Dermatologic Agents|dermatologic agents|mesh-ancestor
110134635|NCT01992198|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110134636|NCT01992198|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110134637|NCT01992198|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110134639|NCT01992198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110134640|NCT01992198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110134641|NCT01992198|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110134642|NCT01992211|Metformin|metformin|mesh-list
110134643|NCT01992211|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110134644|NCT01992211|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110134645|NCT01992211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110134646|NCT01992211|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110134647|NCT01992211|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110134648|NCT01992211|Antimetabolites|antimetabolites|mesh-ancestor
110134649|NCT01992211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110134650|NCT01992211|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110134651|NCT01992211|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110134652|NCT01992211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110134653|NCT01992263|Vitamin D|vitamin d|mesh-list
110134654|NCT01992263|Ergocalciferols|ergocalciferols|mesh-list
110134655|NCT01992263|Cholecalciferol|cholecalciferol|mesh-list
110134656|NCT01992263|Vitamins|vitamins|mesh-list
110134657|NCT01992263|Micronutrients|micronutrients|mesh-ancestor
110134658|NCT01992263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110134659|NCT01992263|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110349407|NCT00557193|Etoposide|etoposide|mesh-list
110134660|NCT01992263|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110134661|NCT01992328|Immunoglobulins|immunoglobulins|mesh-list
110165884|NCT00000395|Methotrexate|methotrexate|mesh-list
110134662|NCT01992328|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110134663|NCT01992328|Antibodies|antibodies|mesh-list
110134664|NCT01992328|Immunoglobulin G|immunoglobulin g|mesh-list
110134665|NCT01992328|gamma-Globulins|gamma-globulins|mesh-list
110134666|NCT01992328|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110134667|NCT01992328|Immunologic Factors|immunologic factors|mesh-ancestor
110134668|NCT01992328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110134669|NCT01992341|Paclitaxel|paclitaxel|mesh-list
110134670|NCT01992341|Trebananib|trebananib|mesh-list
110349461|NCT00557193|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110134671|NCT01992341|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110134672|NCT01992341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110134673|NCT01992341|Tubulin Modulators|tubulin modulators|mesh-ancestor
110134674|NCT01992341|Antimitotic Agents|antimitotic agents|mesh-ancestor
110134675|NCT01992341|Mitosis Modulators|mitosis modulators|mesh-ancestor
110134676|NCT01992341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110134677|NCT01992341|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110134678|NCT01992341|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110134679|NCT01992341|Growth Substances|growth substances|mesh-ancestor
110134680|NCT01992341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110134681|NCT01992341|Growth Inhibitors|growth inhibitors|mesh-ancestor
110134683|NCT01992562|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110134684|NCT01992562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110134685|NCT01992562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110134686|NCT01992562|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110134687|NCT01992562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110134688|NCT01992562|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110134689|NCT01992562|Protective Agents|protective agents|mesh-ancestor
110134690|NCT01992562|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110134691|NCT01992562|Analgesics|analgesics|mesh-ancestor
110134692|NCT01992562|Sensory System Agents|sensory system agents|mesh-ancestor
110134693|NCT01992562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110134694|NCT01992588|Insulin|insulin|mesh-list
110134695|NCT01992588|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110134696|NCT01992588|Insulin Aspart|insulin aspart|mesh-list
110134697|NCT01992588|Insulin, Long-Acting|insulin, long-acting|mesh-list
110134698|NCT01992588|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
110134699|NCT01992588|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110134700|NCT01992588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110134701|NCT01992601|Telmisartan|telmisartan|mesh-list
110134702|NCT01992601|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110134703|NCT01992601|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110134704|NCT01992601|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110134705|NCT01992601|Antimetabolites|antimetabolites|mesh-ancestor
110134706|NCT01992601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110134707|NCT01992601|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110134708|NCT01992601|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110134709|NCT01992601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110134710|NCT01992601|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110134711|NCT01992601|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110134712|NCT01992601|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110134713|NCT01992705|Fluorouracil|fluorouracil|mesh-list
110134714|NCT01992705|Oxaliplatin|oxaliplatin|mesh-list
110134715|NCT01992705|Irinotecan|irinotecan|mesh-list
110134716|NCT01992705|Folfirinox|folfirinox|mesh-list
110134717|NCT01992705|Antimetabolites|antimetabolites|mesh-ancestor
110134718|NCT01992705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110134719|NCT01992705|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110134720|NCT01992705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110134721|NCT01992705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110134722|NCT01992705|Immunologic Factors|immunologic factors|mesh-ancestor
110134723|NCT01992705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110134724|NCT01992705|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110134725|NCT01992705|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110134726|NCT01992705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110134727|NCT01992796|Telmisartan|telmisartan|mesh-list
110134728|NCT01992796|Candesartan|candesartan|mesh-list
110134729|NCT01992796|Olmesartan|olmesartan|mesh-list
110134730|NCT01992796|Irbesartan|irbesartan|mesh-list
110134731|NCT01992796|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110134732|NCT01992796|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110134733|NCT01992796|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110134734|NCT01992796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110134735|NCT01992900|Piperaquine|piperaquine|mesh-list
110134736|NCT01992900|Artenimol|artenimol|mesh-list
110134737|NCT01992900|Artemisinins|artemisinins|mesh-list
110134738|NCT01992900|Antimalarials|antimalarials|mesh-ancestor
110134739|NCT01992900|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110134740|NCT01992900|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110134741|NCT01992900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110134742|NCT01993134|Cefazolin|cefazolin|mesh-list
110134743|NCT01993134|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110134744|NCT01993134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110134745|NCT01993173|Vaccines|vaccines|mesh-list
110134746|NCT01993173|Immunologic Factors|immunologic factors|mesh-ancestor
110134747|NCT01993173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110134748|NCT01993212|Enclomiphene|enclomiphene|mesh-list
110134749|NCT01993212|Testosterone|testosterone|mesh-list
110134750|NCT01993212|Androgens|androgens|mesh-ancestor
110134751|NCT01993212|Hormones|hormones|mesh-ancestor
110134752|NCT01993212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110134753|NCT01993212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110134754|NCT01993212|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110134755|NCT01993212|Hormone Antagonists|hormone antagonists|mesh-ancestor
110134756|NCT01993212|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110134757|NCT01993212|Fertility Agents|fertility agents|mesh-ancestor
110134758|NCT01993212|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110134759|NCT01993212|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110134760|NCT01993212|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110134761|NCT01993225|Enclomiphene|enclomiphene|mesh-list
110134762|NCT01993225|Testosterone|testosterone|mesh-list
110134763|NCT01993225|Androgens|androgens|mesh-ancestor
110134764|NCT01993225|Hormones|hormones|mesh-ancestor
110134765|NCT01993225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110134766|NCT01993225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110134767|NCT01993225|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110134768|NCT01993225|Hormone Antagonists|hormone antagonists|mesh-ancestor
110134769|NCT01993225|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110134770|NCT01993225|Fertility Agents|fertility agents|mesh-ancestor
110134771|NCT01993225|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110165921|NCT00025519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110349671|NCT02914626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110134772|NCT01993225|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110134773|NCT01993225|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110134774|NCT01993251|Melatonin|melatonin|mesh-list
110134775|NCT01993251|Antioxidants|antioxidants|mesh-ancestor
110134776|NCT01993251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110134777|NCT01993251|Protective Agents|protective agents|mesh-ancestor
110134778|NCT01993251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110134779|NCT01993251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110134780|NCT01993290|Ropivacaine|ropivacaine|mesh-list
110134781|NCT01993290|Anesthetics, Local|anesthetics, local|mesh-ancestor
110134782|NCT01993290|Anesthetics|anesthetics|mesh-ancestor
110134783|NCT01993290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110134784|NCT01993290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110134785|NCT01993290|Sensory System Agents|sensory system agents|mesh-ancestor
110134786|NCT01993290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110134787|NCT01993459|Midazolam|midazolam|mesh-list
110134788|NCT01993459|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110134789|NCT01993459|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110134790|NCT01993459|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110134791|NCT01993459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110134792|NCT01993459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110134793|NCT01993459|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110134794|NCT01993459|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110134795|NCT01993459|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110134796|NCT01993459|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110134797|NCT01993459|Anesthetics, General|anesthetics, general|mesh-ancestor
110134798|NCT01993459|Anesthetics|anesthetics|mesh-ancestor
110134799|NCT01993459|GABA Modulators|gaba modulators|mesh-ancestor
110134800|NCT01993459|GABA Agents|gaba agents|mesh-ancestor
110134801|NCT01993459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110134802|NCT01993459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110134803|NCT01993472|Andrographolide|andrographolide|mesh-list
110134804|NCT01993472|Capecitabine|capecitabine|mesh-list
110134805|NCT01993472|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110134806|NCT01993472|Antimetabolites|antimetabolites|mesh-ancestor
110134807|NCT01993472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110134808|NCT01993472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110134809|NCT01993472|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110134810|NCT01993472|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110134811|NCT01993472|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110134813|NCT01993472|Sensory System Agents|sensory system agents|mesh-ancestor
110134814|NCT01993472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110134815|NCT01993472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110134816|NCT01993472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110134817|NCT01993472|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110134818|NCT01993472|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110165940|NCT00025558|Carboplatin|carboplatin|mesh-list
110134820|NCT01993472|Antiviral Agents|antiviral agents|mesh-ancestor
110134821|NCT01993472|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110134822|NCT01993537|Vitamin D|vitamin d|mesh-list
110134823|NCT01993537|Vitamins|vitamins|mesh-ancestor
110134824|NCT01993537|Micronutrients|micronutrients|mesh-ancestor
110134825|NCT01993537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110134826|NCT01993537|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110134827|NCT01993589|Acetaminophen|acetaminophen|mesh-list
110134828|NCT01993589|Analgesics|analgesics|mesh-list
110134829|NCT01993589|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110134830|NCT01993589|Sensory System Agents|sensory system agents|mesh-ancestor
110134831|NCT01993589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110134832|NCT01993589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110134833|NCT01993589|Antipyretics|antipyretics|mesh-ancestor
110134834|NCT01993680|Fludrocortisone|fludrocortisone|mesh-list
110134835|NCT01993680|Bromides|bromides|mesh-list
110134836|NCT01993680|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
110134837|NCT01993680|Anticonvulsants|anticonvulsants|mesh-ancestor
110134838|NCT01993680|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110134839|NCT01993680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110134840|NCT01993680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110134841|NCT01993680|Cholinergic Agents|cholinergic agents|mesh-ancestor
110134842|NCT01993680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110134843|NCT01993680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110134844|NCT01993680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110134845|NCT01993771|Anesthetics|anesthetics|mesh-list
110134846|NCT01993771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110134847|NCT01993771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110134849|NCT01993784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110134850|NCT01993784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110134851|NCT01993979|Cisplatin|cisplatin|mesh-list
110134852|NCT01993979|Carboplatin|carboplatin|mesh-list
110134853|NCT01993979|Gemcitabine|gemcitabine|mesh-list
110134854|NCT01993979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110134855|NCT01993979|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110134856|NCT01993979|Antimetabolites|antimetabolites|mesh-ancestor
110134857|NCT01993979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110134858|NCT01994031|Paclitaxel|paclitaxel|mesh-list
110134859|NCT01994031|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110134860|NCT01994031|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110134861|NCT01994031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110134862|NCT01994031|Tubulin Modulators|tubulin modulators|mesh-ancestor
110134863|NCT01994031|Antimitotic Agents|antimitotic agents|mesh-ancestor
110134864|NCT01994031|Mitosis Modulators|mitosis modulators|mesh-ancestor
110134865|NCT01994031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110134866|NCT01994070|Procainamide|procainamide|mesh-list
110134867|NCT01994070|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110134868|NCT01994070|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110134869|NCT01994070|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110134870|NCT01994070|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110134871|NCT01994070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110134872|NCT01994096|Caspofungin|caspofungin|mesh-list
110134873|NCT01994096|Antifungal Agents|antifungal agents|mesh-ancestor
110134874|NCT01994096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110134875|NCT01994096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110134876|NCT01994096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110134878|NCT01994265|Dabigatran|dabigatran|mesh-list
110134879|NCT01994265|Anticoagulants|anticoagulants|mesh-ancestor
110134880|NCT01994265|Antithrombins|antithrombins|mesh-ancestor
110134881|NCT01994265|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110134882|NCT01994265|Protease Inhibitors|protease inhibitors|mesh-ancestor
110134883|NCT01994265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110134884|NCT01994265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110134885|NCT01994330|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
110134886|NCT01994330|Hemostatics|hemostatics|mesh-ancestor
110134887|NCT01994330|Coagulants|coagulants|mesh-ancestor
110134888|NCT01994330|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
110134889|NCT01994330|Natriuretic Agents|natriuretic agents|mesh-ancestor
110134890|NCT01994330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110134891|NCT01994356|Contraceptive Agents|contraceptive agents|mesh-list
110134892|NCT01994356|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110134893|NCT01994356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110134894|NCT01994460|Linezolid|linezolid|mesh-list
110134895|NCT01994460|Ethambutol|ethambutol|mesh-list
110134896|NCT01994460|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110134897|NCT01994460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110134898|NCT01994460|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110134899|NCT01994460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110134900|NCT01994460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110134901|NCT01994460|Antitubercular Agents|antitubercular agents|mesh-ancestor
110134903|NCT01994642|Dexamethasone|dexamethasone|mesh-list
110134904|NCT01994642|Dexamethasone acetate|dexamethasone acetate|mesh-list
110134905|NCT01994642|BB 1101|bb 1101|mesh-list
110134906|NCT01994642|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110134907|NCT01994642|Antiemetics|antiemetics|mesh-ancestor
110134908|NCT01994642|Autonomic Agents|autonomic agents|mesh-ancestor
110134909|NCT01994642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110349855|NCT04324294|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110134910|NCT01994642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110134911|NCT01994642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110134913|NCT01994642|Hormones|hormones|mesh-ancestor
110134914|NCT01994642|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110134915|NCT01994642|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110134916|NCT01994642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110134917|NCT01994642|Protease Inhibitors|protease inhibitors|mesh-ancestor
110134918|NCT01994642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110134919|NCT01994642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110134920|NCT01994642|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110134921|NCT01994642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110134922|NCT01994642|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110134923|NCT01994642|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110134924|NCT01994642|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110134925|NCT01994642|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110134926|NCT01994668|Lorazepam|lorazepam|mesh-list
110134927|NCT01994668|Anticonvulsants|anticonvulsants|mesh-ancestor
110134928|NCT01994668|Antiemetics|antiemetics|mesh-ancestor
110134929|NCT01994668|Autonomic Agents|autonomic agents|mesh-ancestor
110134930|NCT01994668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110134931|NCT01994668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110134932|NCT01994668|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110134933|NCT01994668|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110134934|NCT01994668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110134935|NCT01994668|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110134936|NCT01994668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110134938|NCT01994668|GABA Modulators|gaba modulators|mesh-ancestor
110134939|NCT01994668|GABA Agents|gaba agents|mesh-ancestor
110134940|NCT01994668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110134941|NCT01994668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110134942|NCT01994733|Calcium, Dietary|calcium, dietary|mesh-list
110134943|NCT01994733|Calcium Carbonate|calcium carbonate|mesh-list
110134944|NCT01994733|Calcium|calcium|mesh-list
110134945|NCT01994733|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110134946|NCT01994733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110134947|NCT01994733|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110134948|NCT01994733|Antacids|antacids|mesh-ancestor
110134949|NCT01994733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110134950|NCT01994733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110134952|NCT01994759|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110134953|NCT01994759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110134954|NCT01994759|Antiemetics|antiemetics|mesh-ancestor
110134955|NCT01994759|Autonomic Agents|autonomic agents|mesh-ancestor
110134956|NCT01994759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110134957|NCT01994759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110134958|NCT01994759|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110134959|NCT01994759|Glucocorticoids|glucocorticoids|mesh-ancestor
110134960|NCT01994759|Hormones|hormones|mesh-ancestor
110134961|NCT01994759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110134962|NCT01994759|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110134963|NCT01994759|Protective Agents|protective agents|mesh-ancestor
110134964|NCT01994824|Thymoglobulin|thymoglobulin|mesh-list
110134965|NCT01994824|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110134966|NCT01994824|Immunologic Factors|immunologic factors|mesh-ancestor
110134967|NCT01994824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110134968|NCT01994824|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110134969|NCT01994941|Clopidogrel|clopidogrel|mesh-list
110134970|NCT01994941|Ticagrelor|ticagrelor|mesh-list
110134971|NCT01994941|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110134972|NCT01994941|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110134973|NCT01994941|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110134974|NCT01994941|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110134975|NCT01994941|Purinergic Agents|purinergic agents|mesh-ancestor
110134976|NCT01994941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110134977|NCT01994941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110134978|NCT01994941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110134980|NCT01994967|Levobupivacaine|levobupivacaine|mesh-list
110134981|NCT01994967|Anesthetics, Local|anesthetics, local|mesh-ancestor
110134982|NCT01994967|Anesthetics|anesthetics|mesh-ancestor
110134983|NCT01994967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110134984|NCT01994967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110134985|NCT01994967|Sensory System Agents|sensory system agents|mesh-ancestor
110134986|NCT01994967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110134987|NCT01995006|Dipyrone|dipyrone|mesh-list
110134988|NCT01995006|Naproxen|naproxen|mesh-list
110134989|NCT01995006|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110134990|NCT01995006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110134991|NCT01995006|Analgesics|analgesics|mesh-ancestor
110134992|NCT01995006|Sensory System Agents|sensory system agents|mesh-ancestor
110134993|NCT01995006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110134994|NCT01995006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110134995|NCT01995006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110134996|NCT01995006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110134997|NCT01995006|Gout Suppressants|gout suppressants|mesh-ancestor
110134998|NCT01995006|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110134999|NCT01995006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110135000|NCT01995006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110135001|NCT01995006|Antipyretics|antipyretics|mesh-ancestor
110135002|NCT01995019|Methylprednisolone|methylprednisolone|mesh-list
110135003|NCT01995019|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110135004|NCT01995019|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110135005|NCT01995019|Prednisolone|prednisolone|mesh-list
110135006|NCT01995019|Prednisolone acetate|prednisolone acetate|mesh-list
110135007|NCT01995019|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110135008|NCT01995019|Prednisolone phosphate|prednisolone phosphate|mesh-list
110135009|NCT01995019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110135010|NCT01995019|Antiemetics|antiemetics|mesh-ancestor
110135011|NCT01995019|Autonomic Agents|autonomic agents|mesh-ancestor
110135012|NCT01995019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110135013|NCT01995019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110135015|NCT01995019|Glucocorticoids|glucocorticoids|mesh-ancestor
110135017|NCT01995019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110135018|NCT01995019|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110135019|NCT01995019|Protective Agents|protective agents|mesh-ancestor
110135020|NCT01995019|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110135021|NCT01995019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110135022|NCT01995032|Metformin|metformin|mesh-list
110135023|NCT01995032|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110135024|NCT01995032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110135025|NCT01995058|Prednisone|prednisone|mesh-list
110135026|NCT01995058|Abiraterone Acetate|abiraterone acetate|mesh-list
110135027|NCT01995058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110135028|NCT01995058|Glucocorticoids|glucocorticoids|mesh-ancestor
110135029|NCT01995058|Hormones|hormones|mesh-ancestor
110135030|NCT01995058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110135031|NCT01995058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110135032|NCT01995058|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110135033|NCT01995058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110135034|NCT01995058|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110135035|NCT01995058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110135036|NCT01995058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110135037|NCT01995058|Hormone Antagonists|hormone antagonists|mesh-ancestor
110135038|NCT01995058|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110135039|NCT01995084|Imidazole|imidazole|mesh-list
110135040|NCT01995084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110135041|NCT01995084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110135043|NCT01995188|Carboplatin|carboplatin|mesh-list
110135044|NCT01995188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110135045|NCT01995188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110135046|NCT01995188|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110135048|NCT01995188|Growth Substances|growth substances|mesh-ancestor
110135049|NCT01995188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110135050|NCT01995188|Growth Inhibitors|growth inhibitors|mesh-ancestor
110135052|NCT01995214|Sevoflurane|sevoflurane|mesh-list
110135053|NCT01995214|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110135054|NCT01995214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110135055|NCT01995214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110135056|NCT01995214|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110135057|NCT01995214|Anesthetics, General|anesthetics, general|mesh-ancestor
110135058|NCT01995214|Anesthetics|anesthetics|mesh-ancestor
110135059|NCT01995214|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110135060|NCT01995214|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110135061|NCT01995292|Anesthetics|anesthetics|mesh-list
110135062|NCT01995292|Anesthetics, Local|anesthetics, local|mesh-list
110135063|NCT01995292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110135064|NCT01995292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110135065|NCT01995292|Sensory System Agents|sensory system agents|mesh-ancestor
110135066|NCT01995292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110135067|NCT01995331|Cyclosporine|cyclosporine|mesh-list
110135068|NCT01995331|Cyclophosphamide|cyclophosphamide|mesh-list
110135069|NCT01995331|Cyclosporins|cyclosporins|mesh-list
110135070|NCT01995331|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110135071|NCT01995331|Immunologic Factors|immunologic factors|mesh-ancestor
110135072|NCT01995331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110135073|NCT01995331|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110135074|NCT01995331|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110135075|NCT01995331|Alkylating Agents|alkylating agents|mesh-ancestor
110135076|NCT01995331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110135077|NCT01995331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110135078|NCT01995331|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110135079|NCT01995331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110135080|NCT01995331|Antifungal Agents|antifungal agents|mesh-ancestor
110135081|NCT01995331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110135082|NCT01995331|Dermatologic Agents|dermatologic agents|mesh-ancestor
110135083|NCT01995331|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110135084|NCT01995370|Aspirin|aspirin|mesh-list
110135085|NCT01995370|Cilostazol|cilostazol|mesh-list
110135086|NCT01995370|Clopidogrel|clopidogrel|mesh-list
110135087|NCT01995370|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110135088|NCT01995370|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110135089|NCT01995370|Analgesics|analgesics|mesh-ancestor
110135090|NCT01995370|Sensory System Agents|sensory system agents|mesh-ancestor
110135091|NCT01995370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110135092|NCT01995370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110135093|NCT01995370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110135094|NCT01995370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110135095|NCT01995370|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110135096|NCT01995370|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110135097|NCT01995370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110135098|NCT01995370|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110135099|NCT01995370|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110135101|NCT01995370|Antipyretics|antipyretics|mesh-ancestor
110135102|NCT01995370|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110135103|NCT01995370|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110135104|NCT01995370|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110135105|NCT01995370|Purinergic Agents|purinergic agents|mesh-ancestor
110135106|NCT01995370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110135107|NCT01995370|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110135108|NCT01995370|Autonomic Agents|autonomic agents|mesh-ancestor
110135109|NCT01995370|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110135110|NCT01995370|Respiratory System Agents|respiratory system agents|mesh-ancestor
110135111|NCT01995370|Vasodilator Agents|vasodilator agents|mesh-ancestor
110135112|NCT01995370|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110135113|NCT01995370|Protective Agents|protective agents|mesh-ancestor
110135114|NCT01995370|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110350110|NCT02913690|Antioxidants|antioxidants|mesh-ancestor
110135115|NCT01995370|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110135116|NCT01995656|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110135117|NCT01995695|Vaccines|vaccines|mesh-list
110135118|NCT01995695|Immunologic Factors|immunologic factors|mesh-ancestor
110135119|NCT01995695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110135120|NCT01995734|Pasireotide|pasireotide|mesh-list
110135121|NCT01995734|Hormones|hormones|mesh-ancestor
110135122|NCT01995734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110135124|NCT01995799|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
110135125|NCT01995799|Hematinics|hematinics|mesh-ancestor
110135126|NCT01995799|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
110135127|NCT01995799|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110135128|NCT01995890|Nepafenac|nepafenac|mesh-list
110135129|NCT01995890|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110135130|NCT01995890|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110135131|NCT01995890|Analgesics|analgesics|mesh-ancestor
110135132|NCT01995890|Sensory System Agents|sensory system agents|mesh-ancestor
110135133|NCT01995890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110166017|NCT00025675|Gefitinib|gefitinib|mesh-list
110135134|NCT01995890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110135135|NCT01995890|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110135136|NCT01995890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110135137|NCT01996085|Amlodipine|amlodipine|mesh-list
110135138|NCT01996085|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110135139|NCT01996085|Telmisartan|telmisartan|mesh-list
110135140|NCT01996085|Lisinopril|lisinopril|mesh-list
110135141|NCT01996085|Nebivolol|nebivolol|mesh-list
110135142|NCT01996085|Indapamide|indapamide|mesh-list
110135143|NCT01996085|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110135144|NCT01996085|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110135145|NCT01996085|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110135146|NCT01996085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110135147|NCT01996085|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110135148|NCT01996085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110135149|NCT01996085|Vasodilator Agents|vasodilator agents|mesh-ancestor
110135150|NCT01996085|Diuretics|diuretics|mesh-ancestor
110135151|NCT01996085|Natriuretic Agents|natriuretic agents|mesh-ancestor
110135152|NCT01996085|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110135153|NCT01996085|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110135154|NCT01996085|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110135155|NCT01996085|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110135156|NCT01996085|Protease Inhibitors|protease inhibitors|mesh-ancestor
110135157|NCT01996085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110135158|NCT01996085|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110135159|NCT01996085|Protective Agents|protective agents|mesh-ancestor
110135160|NCT01996085|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
110135161|NCT01996085|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110135162|NCT01996085|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110135163|NCT01996085|Adrenergic Agents|adrenergic agents|mesh-ancestor
110135164|NCT01996085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110135165|NCT01996150|Sodium Hypochlorite|sodium hypochlorite|mesh-list
110135167|NCT01996150|Disinfectants|disinfectants|mesh-ancestor
110135168|NCT01996150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110135170|NCT01996189|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110135171|NCT01996189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110135172|NCT01996306|Leucovorin|leucovorin|mesh-list
110135173|NCT01996306|Bevacizumab|bevacizumab|mesh-list
110135174|NCT01996306|Fluorouracil|fluorouracil|mesh-list
110135175|NCT01996306|Capecitabine|capecitabine|mesh-list
110135176|NCT01996306|Irinotecan|irinotecan|mesh-list
110135177|NCT01996306|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110135178|NCT01996306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110135179|NCT01996306|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110135180|NCT01996306|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110135181|NCT01996306|Growth Substances|growth substances|mesh-ancestor
110135182|NCT01996306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110135183|NCT01996306|Growth Inhibitors|growth inhibitors|mesh-ancestor
110135184|NCT01996306|Antimetabolites|antimetabolites|mesh-ancestor
110135185|NCT01996306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110135186|NCT01996306|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110135188|NCT01996306|Immunologic Factors|immunologic factors|mesh-ancestor
110135189|NCT01996306|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110135190|NCT01996306|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110135191|NCT01996306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110135193|NCT01996306|Protective Agents|protective agents|mesh-ancestor
110135194|NCT01996306|Vitamin B Complex|vitamin b complex|mesh-ancestor
110135195|NCT01996306|Vitamins|vitamins|mesh-ancestor
110135196|NCT01996306|Micronutrients|micronutrients|mesh-ancestor
110135198|NCT01996358|Succinylcholine|succinylcholine|mesh-list
110135199|NCT01996358|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110135200|NCT01996358|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110135201|NCT01996358|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110135202|NCT01996358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110135203|NCT01996358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110135204|NCT01996358|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
110135205|NCT01996384|Lidocaine|lidocaine|mesh-list
110135206|NCT01996384|Anesthetics, Local|anesthetics, local|mesh-ancestor
110135207|NCT01996384|Anesthetics|anesthetics|mesh-ancestor
110135208|NCT01996384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110135209|NCT01996384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110135210|NCT01996384|Sensory System Agents|sensory system agents|mesh-ancestor
110135211|NCT01996384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110135212|NCT01996384|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110135213|NCT01996384|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110135214|NCT01996384|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110135215|NCT01996384|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110135216|NCT01996384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110135217|NCT01996423|Vitamin D|vitamin d|mesh-list
110135218|NCT01996423|Cholecalciferol|cholecalciferol|mesh-list
110135219|NCT01996423|Vitamins|vitamins|mesh-ancestor
110135220|NCT01996423|Micronutrients|micronutrients|mesh-ancestor
110135221|NCT01996423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110135222|NCT01996423|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110135223|NCT01996423|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110135224|NCT01996462|Dexetimide|dexetimide|mesh-list
110135225|NCT01996462|Citalopram|citalopram|mesh-list
110135226|NCT01996462|Escitalopram|escitalopram|mesh-list
110350235|NCT02935959|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110135227|NCT01996462|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110135228|NCT01996462|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110135229|NCT01996462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110135230|NCT01996462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110135232|NCT01996462|Serotonin Agents|serotonin agents|mesh-ancestor
110135233|NCT01996462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110135234|NCT01996462|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110135235|NCT01996462|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110135236|NCT01996462|Parasympatholytics|parasympatholytics|mesh-ancestor
110135237|NCT01996462|Autonomic Agents|autonomic agents|mesh-ancestor
110135238|NCT01996462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110135239|NCT01996462|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110135240|NCT01996462|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110135241|NCT01996462|Cholinergic Agents|cholinergic agents|mesh-ancestor
110135242|NCT01996462|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110135243|NCT01996462|Antidepressive Agents|antidepressive agents|mesh-ancestor
110135244|NCT01996462|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110135245|NCT01996475|Dexetimide|dexetimide|mesh-list
110135246|NCT01996475|Citalopram|citalopram|mesh-list
110135247|NCT01996475|Escitalopram|escitalopram|mesh-list
110135248|NCT01996475|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110135249|NCT01996475|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110135250|NCT01996475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110135251|NCT01996475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110135253|NCT01996475|Serotonin Agents|serotonin agents|mesh-ancestor
110135254|NCT01996475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110135255|NCT01996475|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110135256|NCT01996475|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110135257|NCT01996475|Parasympatholytics|parasympatholytics|mesh-ancestor
110135258|NCT01996475|Autonomic Agents|autonomic agents|mesh-ancestor
110135259|NCT01996475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110135260|NCT01996475|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110135261|NCT01996475|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110135262|NCT01996475|Cholinergic Agents|cholinergic agents|mesh-ancestor
110135263|NCT01996475|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110135264|NCT01996475|Antidepressive Agents|antidepressive agents|mesh-ancestor
110135265|NCT01996475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110135266|NCT01996488|Olanzapine|olanzapine|mesh-list
110135267|NCT01996488|Antiemetics|antiemetics|mesh-ancestor
110135268|NCT01996488|Autonomic Agents|autonomic agents|mesh-ancestor
110135269|NCT01996488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110135270|NCT01996488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110135271|NCT01996488|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110135272|NCT01996488|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110135273|NCT01996488|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110135274|NCT01996488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110135275|NCT01996488|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110135276|NCT01996488|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110135277|NCT01996488|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110135278|NCT01996488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110135279|NCT01996488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110135280|NCT01996488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110135281|NCT01996488|Serotonin Agents|serotonin agents|mesh-ancestor
110135283|NCT01996501|Antiemetics|antiemetics|mesh-ancestor
110135284|NCT01996501|Autonomic Agents|autonomic agents|mesh-ancestor
110135285|NCT01996501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110135286|NCT01996501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110135287|NCT01996501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110135288|NCT01996501|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110135289|NCT01996501|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110135290|NCT01996501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110135291|NCT01996501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110135292|NCT01996501|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110135293|NCT01996501|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110135294|NCT01996501|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110166073|NCT00026182|Rituximab|rituximab|mesh-list
110135295|NCT01996501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110135296|NCT01996501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110135297|NCT01996501|Serotonin Agents|serotonin agents|mesh-ancestor
110135298|NCT01996579|Lactoferrin|lactoferrin|mesh-list
110135299|NCT01996579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110135301|NCT01996618|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110135302|NCT01996618|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110135303|NCT01996618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110135304|NCT01996683|Deferiprone|deferiprone|mesh-list
110135305|NCT01996683|Deferoxamine|deferoxamine|mesh-list
110135306|NCT01996683|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110135307|NCT01996683|Chelating Agents|chelating agents|mesh-ancestor
110135308|NCT01996683|Sequestering Agents|sequestering agents|mesh-ancestor
110350380|NCT02935101|Antiemetics|antiemetics|mesh-ancestor
110135309|NCT01996683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110135311|NCT01996696|Metformin|metformin|mesh-list
110135312|NCT01996696|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110135313|NCT01996696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110135314|NCT01996735|Ticagrelor|ticagrelor|mesh-list
110135315|NCT01996735|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110135316|NCT01996735|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110135317|NCT01996735|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110135318|NCT01996735|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110135319|NCT01996735|Purinergic Agents|purinergic agents|mesh-ancestor
110135320|NCT01996735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110135321|NCT01996735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110135322|NCT01996735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110135323|NCT01996761|Cerebrolysin|cerebrolysin|mesh-list
110135324|NCT01996761|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110135325|NCT01996761|Protective Agents|protective agents|mesh-ancestor
110135326|NCT01996761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110135327|NCT01996761|Nootropic Agents|nootropic agents|mesh-ancestor
110135328|NCT01996891|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
110135329|NCT01996930|Silver Nitrate|silver nitrate|mesh-list
110135330|NCT01996930|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110135331|NCT01996930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110135333|NCT01997099|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110135334|NCT01997099|Anticonvulsants|anticonvulsants|mesh-ancestor
110135335|NCT01997099|Antiemetics|antiemetics|mesh-ancestor
110135336|NCT01997099|Autonomic Agents|autonomic agents|mesh-ancestor
110135337|NCT01997099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110135338|NCT01997099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110135339|NCT01997099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110135340|NCT01997099|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110135341|NCT01997099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110135342|NCT01997099|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110135343|NCT01997099|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110135344|NCT01997099|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110135345|NCT01997099|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110135346|NCT01997099|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110135348|NCT01997099|Anesthetics, General|anesthetics, general|mesh-ancestor
110135349|NCT01997099|Anesthetics|anesthetics|mesh-ancestor
110135350|NCT01997099|GABA Modulators|gaba modulators|mesh-ancestor
110135351|NCT01997099|GABA Agents|gaba agents|mesh-ancestor
110350420|NCT02933333|Molgramostim|molgramostim|mesh-list
110135352|NCT01997099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110135353|NCT01997099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110135355|NCT01997112|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110135356|NCT01997112|Analgesics|analgesics|mesh-ancestor
110135357|NCT01997112|Sensory System Agents|sensory system agents|mesh-ancestor
110135358|NCT01997112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110135359|NCT01997112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110135360|NCT01997112|Antipyretics|antipyretics|mesh-ancestor
110135361|NCT01997138|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
110135362|NCT01997138|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110135363|NCT01997164|Aflibercept|aflibercept|mesh-list
110135364|NCT01997164|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110135365|NCT01997164|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110135366|NCT01997164|Growth Substances|growth substances|mesh-ancestor
110135367|NCT01997164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110135368|NCT01997164|Growth Inhibitors|growth inhibitors|mesh-ancestor
110135369|NCT01997164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110135370|NCT01997203|Vitamin D|vitamin d|mesh-list
110135371|NCT01997203|Interferons|interferons|mesh-list
110135372|NCT01997203|Ribavirin|ribavirin|mesh-list
110135373|NCT01997203|Vitamins|vitamins|mesh-ancestor
110135374|NCT01997203|Micronutrients|micronutrients|mesh-ancestor
110135375|NCT01997203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110166140|NCT00026416|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110135376|NCT01997203|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110135377|NCT01997203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110135378|NCT01997203|Antiviral Agents|antiviral agents|mesh-ancestor
110135379|NCT01997203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110135380|NCT01997203|Antimetabolites|antimetabolites|mesh-ancestor
110135381|NCT01997203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110135382|NCT01997255|Everolimus|everolimus|mesh-list
110135383|NCT01997255|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110135384|NCT01997255|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110135385|NCT01997255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110135386|NCT01997255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110135387|NCT01997255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110135388|NCT01997255|Immunologic Factors|immunologic factors|mesh-ancestor
110135389|NCT01997255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110350456|NCT02933099|Hormones|hormones|mesh-ancestor
110135390|NCT01997255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110135391|NCT01997294|Atorvastatin|atorvastatin|mesh-list
110135392|NCT01997294|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110135393|NCT01997294|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110135394|NCT01997294|Antimetabolites|antimetabolites|mesh-ancestor
110135395|NCT01997294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110135396|NCT01997294|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110135397|NCT01997294|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110135398|NCT01997294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110135399|NCT01997580|Escitalopram|escitalopram|mesh-list
110135400|NCT01997580|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110135401|NCT01997580|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110135402|NCT01997580|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110135403|NCT01997580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110135404|NCT01997580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110135405|NCT01997580|Serotonin Agents|serotonin agents|mesh-ancestor
110135406|NCT01997580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110135407|NCT01997593|Ropivacaine|ropivacaine|mesh-list
110135408|NCT01997593|Anesthetics, Local|anesthetics, local|mesh-ancestor
110135409|NCT01997593|Anesthetics|anesthetics|mesh-ancestor
110135410|NCT01997593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110135411|NCT01997593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110135412|NCT01997593|Sensory System Agents|sensory system agents|mesh-ancestor
110135413|NCT01997593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110135414|NCT01997632|Vaccines|vaccines|mesh-list
110135415|NCT01997632|Immunologic Factors|immunologic factors|mesh-ancestor
110135416|NCT01997632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110135417|NCT01997658|Methylprednisolone|methylprednisolone|mesh-list
110135418|NCT01997658|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110135419|NCT01997658|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110135420|NCT01997658|Prednisolone|prednisolone|mesh-list
110135421|NCT01997658|Prednisolone acetate|prednisolone acetate|mesh-list
110135422|NCT01997658|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110135423|NCT01997658|Prednisolone phosphate|prednisolone phosphate|mesh-list
110135424|NCT01997658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110135426|NCT01997658|Autonomic Agents|autonomic agents|mesh-ancestor
110135427|NCT01997658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110166175|NCT00027079|Naltrexone|naltrexone|mesh-list
110135428|NCT01997658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110135429|NCT01997658|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110135430|NCT01997658|Glucocorticoids|glucocorticoids|mesh-ancestor
110135431|NCT01997658|Hormones|hormones|mesh-ancestor
110135432|NCT01997658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110135433|NCT01997658|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110135434|NCT01997658|Protective Agents|protective agents|mesh-ancestor
110135435|NCT01997658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110135436|NCT01997658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110135437|NCT01997762|Resveratrol|resveratrol|mesh-list
110135438|NCT01997762|Antioxidants|antioxidants|mesh-ancestor
110350492|NCT02911272|Oxytocin|oxytocin|mesh-list
110135439|NCT01997762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110135440|NCT01997762|Protective Agents|protective agents|mesh-ancestor
110135441|NCT01997762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110135442|NCT01997762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110135443|NCT01997762|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110135444|NCT01997775|Metformin|metformin|mesh-list
110135445|NCT01997775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110135446|NCT01997775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110135447|NCT01997788|Morphine|morphine|mesh-list
110135448|NCT01997788|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110135449|NCT01997788|Narcotics|narcotics|mesh-ancestor
110135450|NCT01997788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110135451|NCT01997788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110135452|NCT01997788|Analgesics|analgesics|mesh-ancestor
110135453|NCT01997788|Sensory System Agents|sensory system agents|mesh-ancestor
110135454|NCT01997788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110135455|NCT01997801|Ketamine|ketamine|mesh-list
110135456|NCT01997801|Analgesics|analgesics|mesh-ancestor
110135457|NCT01997801|Sensory System Agents|sensory system agents|mesh-ancestor
110135458|NCT01997801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110135459|NCT01997801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110135460|NCT01997801|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110135461|NCT01997801|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110135462|NCT01997801|Anesthetics, General|anesthetics, general|mesh-ancestor
110135463|NCT01997801|Anesthetics|anesthetics|mesh-ancestor
110135464|NCT01997801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110135465|NCT01997801|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110135466|NCT01997801|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110135467|NCT01997801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110135468|NCT01997801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110135469|NCT01997814|Immunologic Factors|immunologic factors|mesh-list
110135470|NCT01997814|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
110135471|NCT01997814|Immunomodulating Agents|immunomodulating agents|mesh-list
110135472|NCT01997814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110135473|NCT01997944|Interferons|interferons|mesh-list
110135474|NCT01997944|Interferon-alpha|interferon-alpha|mesh-list
110135475|NCT01997944|Interferon alpha-2|interferon alpha-2|mesh-list
110135476|NCT01997944|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110135477|NCT01997944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110135478|NCT01997944|Antiviral Agents|antiviral agents|mesh-ancestor
110135479|NCT01997944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110135480|NCT01997944|Immunologic Factors|immunologic factors|mesh-ancestor
110135481|NCT01997944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110135482|NCT01997983|Botulinum Toxins|botulinum toxins|mesh-list
110135483|NCT01997983|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110135484|NCT01997983|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110135485|NCT01997983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110135486|NCT01997983|Cholinergic Agents|cholinergic agents|mesh-ancestor
110135487|NCT01997983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110135488|NCT01997983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110135489|NCT01998061|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
110135490|NCT01998061|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110135491|NCT01998061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110135492|NCT01998061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110135493|NCT01998113|Insulin|insulin|mesh-list
110135494|NCT01998113|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110135495|NCT01998113|Metformin|metformin|mesh-list
110135496|NCT01998113|Glyburide|glyburide|mesh-list
110135497|NCT01998113|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110135498|NCT01998113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110135500|NCT01998126|Ipilimumab|ipilimumab|mesh-list
110135501|NCT01998126|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110135502|NCT01998126|Crizotinib|crizotinib|mesh-list
110135503|NCT01998126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110135504|NCT01998126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110135505|NCT01998126|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110135506|NCT01998126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110135507|NCT01998126|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110135508|NCT01998126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110135509|NCT01998165|Remifentanil|remifentanil|mesh-list
110135510|NCT01998165|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110135511|NCT01998165|Narcotics|narcotics|mesh-ancestor
110135512|NCT01998165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110135513|NCT01998165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110135514|NCT01998165|Analgesics|analgesics|mesh-ancestor
110135515|NCT01998165|Sensory System Agents|sensory system agents|mesh-ancestor
110135516|NCT01998165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110135517|NCT01998217|Flurbiprofen|flurbiprofen|mesh-list
110135518|NCT01998217|Remifentanil|remifentanil|mesh-list
110135519|NCT01998217|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110135520|NCT01998217|Narcotics|narcotics|mesh-ancestor
110135521|NCT01998217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110135522|NCT01998217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110135523|NCT01998217|Analgesics|analgesics|mesh-ancestor
110135524|NCT01998217|Sensory System Agents|sensory system agents|mesh-ancestor
110135525|NCT01998217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110135526|NCT01998217|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110135527|NCT01998217|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110135528|NCT01998217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110135529|NCT01998217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110135530|NCT01998217|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110135531|NCT01998217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110135532|NCT01998217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110135533|NCT01998295|Lumefantrine|lumefantrine|mesh-list
110135534|NCT01998295|Artemether|artemether|mesh-list
110135535|NCT01998295|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
110135536|NCT01998295|Antimalarials|antimalarials|mesh-ancestor
110135537|NCT01998295|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110135538|NCT01998295|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110135539|NCT01998295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110135540|NCT01998308|Hyaluronic Acid|hyaluronic acid|mesh-list
110135541|NCT01998308|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110135542|NCT01998308|Immunologic Factors|immunologic factors|mesh-ancestor
110135543|NCT01998308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110135544|NCT01998308|Viscosupplements|viscosupplements|mesh-ancestor
110135545|NCT01998308|Protective Agents|protective agents|mesh-ancestor
110135546|NCT01998347|Paclitaxel|paclitaxel|mesh-list
110135547|NCT01998347|Fluorouracil|fluorouracil|mesh-list
110135548|NCT01998347|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110135549|NCT01998347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110135550|NCT01998347|Tubulin Modulators|tubulin modulators|mesh-ancestor
110135551|NCT01998347|Antimitotic Agents|antimitotic agents|mesh-ancestor
110135552|NCT01998347|Mitosis Modulators|mitosis modulators|mesh-ancestor
110135553|NCT01998347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110350537|NCT02924909|Paclitaxel|paclitaxel|mesh-list
110135554|NCT01998347|Antimetabolites|antimetabolites|mesh-ancestor
110135555|NCT01998347|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110135556|NCT01998347|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110135557|NCT01998347|Immunologic Factors|immunologic factors|mesh-ancestor
110135558|NCT01998347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110135559|NCT01998386|Hydrogen Peroxide|hydrogen peroxide|mesh-list
110135560|NCT01998386|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110135561|NCT01998386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110135562|NCT01998451|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
110135563|NCT01998451|Antiviral Agents|antiviral agents|mesh-ancestor
110135564|NCT01998451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110135565|NCT01998451|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
110135566|NCT01998451|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110135567|NCT01998503|Dexamethasone|dexamethasone|mesh-list
110135569|NCT01998503|Melphalan|melphalan|mesh-list
110135570|NCT01998503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110135571|NCT01998503|Antiemetics|antiemetics|mesh-ancestor
110135573|NCT01998503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110135574|NCT01998503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110135575|NCT01998503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110135576|NCT01998503|Glucocorticoids|glucocorticoids|mesh-ancestor
110135577|NCT01998503|Hormones|hormones|mesh-ancestor
110135578|NCT01998503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110135579|NCT01998503|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110135580|NCT01998503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110135581|NCT01998503|Immunologic Factors|immunologic factors|mesh-ancestor
110135582|NCT01998503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110135583|NCT01998503|Alkylating Agents|alkylating agents|mesh-ancestor
110135584|NCT01998503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110135585|NCT01998503|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110135586|NCT01998503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110135587|NCT01998685|Fentanyl|fentanyl|mesh-list
110135588|NCT01998685|Midazolam|midazolam|mesh-list
110135589|NCT01998685|Remifentanil|remifentanil|mesh-list
110135590|NCT01998685|Propofol|propofol|mesh-list
110135591|NCT01998685|Sevoflurane|sevoflurane|mesh-list
110135592|NCT01998685|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110135593|NCT01998685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110135594|NCT01998685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110135595|NCT01998685|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110135596|NCT01998685|Anesthetics, General|anesthetics, general|mesh-ancestor
110135597|NCT01998685|Anesthetics|anesthetics|mesh-ancestor
110135598|NCT01998685|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110135599|NCT01998685|Narcotics|narcotics|mesh-ancestor
110135600|NCT01998685|Analgesics|analgesics|mesh-ancestor
110135601|NCT01998685|Sensory System Agents|sensory system agents|mesh-ancestor
110135602|NCT01998685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110135603|NCT01998685|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110135604|NCT01998685|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110135605|NCT01998685|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110135606|NCT01998685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110135607|NCT01998685|GABA Modulators|gaba modulators|mesh-ancestor
110135608|NCT01998685|GABA Agents|gaba agents|mesh-ancestor
110350552|NCT02924753|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110135609|NCT01998685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110135610|NCT01998685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110135611|NCT01998685|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110135612|NCT01998685|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110135614|NCT01998698|Dipivefrin|dipivefrin|mesh-list
110135615|NCT01998698|Hyaluronic Acid|hyaluronic acid|mesh-list
110135616|NCT01998698|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110135617|NCT01998698|Adrenergic Agents|adrenergic agents|mesh-ancestor
110135618|NCT01998698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110135619|NCT01998698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110135620|NCT01998698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110135621|NCT01998698|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110135622|NCT01998698|Immunologic Factors|immunologic factors|mesh-ancestor
110135623|NCT01998698|Viscosupplements|viscosupplements|mesh-ancestor
110166219|NCT00027391|Albuterol|albuterol|mesh-list
110135624|NCT01998698|Protective Agents|protective agents|mesh-ancestor
110135625|NCT01998698|Anesthetics, Local|anesthetics, local|mesh-ancestor
110135626|NCT01998698|Anesthetics|anesthetics|mesh-ancestor
110135627|NCT01998698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110135628|NCT01998698|Sensory System Agents|sensory system agents|mesh-ancestor
110135629|NCT01998698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110135630|NCT01998698|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110135631|NCT01998698|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110135632|NCT01998698|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110135633|NCT01998698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110135634|NCT01998763|Vitamin D|vitamin d|mesh-list
110135635|NCT01998763|Cholecalciferol|cholecalciferol|mesh-list
110135636|NCT01998763|Vitamins|vitamins|mesh-ancestor
110135637|NCT01998763|Micronutrients|micronutrients|mesh-ancestor
110135638|NCT01998763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110135639|NCT01998763|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110135640|NCT01998763|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110135641|NCT01998776|Misoprostol|misoprostol|mesh-list
110135642|NCT01998776|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110135643|NCT01998776|Abortifacient Agents|abortifacient agents|mesh-ancestor
110135644|NCT01998776|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110135645|NCT01998776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110135646|NCT01998776|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110135647|NCT01998776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110135649|NCT01998789|Everolimus|everolimus|mesh-list
110135650|NCT01998789|Tacrolimus|tacrolimus|mesh-list
110135651|NCT01998789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110135652|NCT01998789|Immunologic Factors|immunologic factors|mesh-ancestor
110135653|NCT01998789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110135654|NCT01998789|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110135655|NCT01998789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110135656|NCT01998789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110135657|NCT01998789|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110135658|NCT01998789|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110135659|NCT01998789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110135660|NCT01999153|Ropivacaine|ropivacaine|mesh-list
110135661|NCT01999153|Anesthetics, Local|anesthetics, local|mesh-ancestor
110135662|NCT01999153|Anesthetics|anesthetics|mesh-ancestor
110135663|NCT01999153|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110135664|NCT01999153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110135665|NCT01999153|Sensory System Agents|sensory system agents|mesh-ancestor
110135666|NCT01999153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110135667|NCT01999270|Bevacizumab|bevacizumab|mesh-list
110135668|NCT01999270|Irinotecan|irinotecan|mesh-list
110135669|NCT01999270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110135670|NCT01999270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110135671|NCT01999270|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110135672|NCT01999270|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110135674|NCT01999270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110135675|NCT01999270|Growth Inhibitors|growth inhibitors|mesh-ancestor
110135676|NCT01999270|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110135677|NCT01999270|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110135678|NCT01999270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110135679|NCT01999270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110135680|NCT01999309|Simvastatin|simvastatin|mesh-list
110135681|NCT01999309|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110135682|NCT01999309|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110135683|NCT01999309|Antimetabolites|antimetabolites|mesh-ancestor
110135684|NCT01999309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110135685|NCT01999309|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110135686|NCT01999309|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110135687|NCT01999309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110135688|NCT01999413|Cytarabine|cytarabine|mesh-list
110135689|NCT01999413|Daunorubicin|daunorubicin|mesh-list
110135690|NCT01999413|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110135691|NCT01999413|Antimetabolites|antimetabolites|mesh-ancestor
110135692|NCT01999413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110135693|NCT01999413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110135694|NCT01999413|Antiviral Agents|antiviral agents|mesh-ancestor
110135695|NCT01999413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110135696|NCT01999413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110135697|NCT01999413|Immunologic Factors|immunologic factors|mesh-ancestor
110135698|NCT01999413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110135699|NCT01999413|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110135700|NCT01999413|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110135701|NCT01999413|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110135702|NCT01999413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110135703|NCT01999647|Ropivacaine|ropivacaine|mesh-list
110135704|NCT01999647|Anesthetics, Local|anesthetics, local|mesh-list
110135705|NCT01999647|Anesthetics|anesthetics|mesh-list
110135706|NCT01999647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110135707|NCT01999647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110135708|NCT01999647|Sensory System Agents|sensory system agents|mesh-ancestor
110135709|NCT01999647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110135710|NCT01999673|Docetaxel|docetaxel|mesh-list
110135711|NCT01999673|Bavituximab|bavituximab|mesh-list
110135712|NCT01999673|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110135713|NCT01999673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110135714|NCT01999673|Tubulin Modulators|tubulin modulators|mesh-ancestor
110135716|NCT01999673|Mitosis Modulators|mitosis modulators|mesh-ancestor
110135717|NCT01999673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110135718|NCT01999673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110135719|NCT01999673|Immunologic Factors|immunologic factors|mesh-ancestor
110135720|NCT01999673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110135721|NCT01999686|Metformin|metformin|mesh-list
110135722|NCT01999686|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110135723|NCT01999686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110135724|NCT01999738|Folic Acid|folic acid|mesh-list
110135725|NCT01999738|Hematinics|hematinics|mesh-ancestor
110135726|NCT01999738|Vitamin B Complex|vitamin b complex|mesh-ancestor
110135727|NCT01999738|Vitamins|vitamins|mesh-ancestor
110135728|NCT01999738|Micronutrients|micronutrients|mesh-ancestor
110135729|NCT01999738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110135730|NCT01999829|Caffeine|caffeine|mesh-list
110135731|NCT01999829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110135732|NCT01999829|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110135733|NCT01999829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110135734|NCT01999829|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110135735|NCT01999829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110135736|NCT01999829|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110135737|NCT01999829|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110135738|NCT01999829|Purinergic Agents|purinergic agents|mesh-ancestor
110135739|NCT01999829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110135740|NCT01999842|Vaccines|vaccines|mesh-list
110135741|NCT01999842|Immunologic Factors|immunologic factors|mesh-ancestor
110135742|NCT01999842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110135743|NCT01999907|Vitamin D|vitamin d|mesh-list
110135744|NCT01999907|Ergocalciferols|ergocalciferols|mesh-list
110135745|NCT01999907|Cholecalciferol|cholecalciferol|mesh-list
110135746|NCT01999907|Vitamins|vitamins|mesh-list
110135747|NCT01999907|Micronutrients|micronutrients|mesh-ancestor
110135748|NCT01999907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110135749|NCT01999907|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110135750|NCT01999907|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110135751|NCT01999933|Cisplatin|cisplatin|mesh-list
110135752|NCT01999933|Docetaxel|docetaxel|mesh-list
110135753|NCT01999933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110135754|NCT01999933|Tubulin Modulators|tubulin modulators|mesh-ancestor
110135755|NCT01999933|Antimitotic Agents|antimitotic agents|mesh-ancestor
110135756|NCT01999933|Mitosis Modulators|mitosis modulators|mesh-ancestor
110135757|NCT01999933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110135758|NCT02000102|Aflibercept|aflibercept|mesh-list
110135759|NCT02000102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110135760|NCT02000102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110135761|NCT02000102|Growth Substances|growth substances|mesh-ancestor
110135762|NCT02000102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110135763|NCT02000102|Growth Inhibitors|growth inhibitors|mesh-ancestor
110135764|NCT02000102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110135766|NCT02000193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110135767|NCT02000193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110135768|NCT02000193|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110135769|NCT02000193|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110135770|NCT02000193|Hormone Antagonists|hormone antagonists|mesh-ancestor
110135771|NCT02000193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110135772|NCT02000193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110135775|NCT02000206|Propofol|propofol|mesh-list
110135776|NCT02000206|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110135777|NCT02000206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110135778|NCT02000206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110135779|NCT02000206|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110135780|NCT02000206|Anesthetics, General|anesthetics, general|mesh-ancestor
110135781|NCT02000206|Anesthetics|anesthetics|mesh-ancestor
110135782|NCT02000206|Analgesics|analgesics|mesh-ancestor
110135783|NCT02000206|Sensory System Agents|sensory system agents|mesh-ancestor
110135784|NCT02000206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110135785|NCT02000206|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110135786|NCT02000206|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110135787|NCT02000206|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110135788|NCT02000206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110135789|NCT02000206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110135790|NCT02000206|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110135791|NCT02000206|Narcotics|narcotics|mesh-ancestor
110135792|NCT02000336|Prednisolone|prednisolone|mesh-list
110135793|NCT02000336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110135794|NCT02000336|Glucocorticoids|glucocorticoids|mesh-ancestor
110135795|NCT02000336|Hormones|hormones|mesh-ancestor
110135796|NCT02000336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110135797|NCT02000336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110135798|NCT02000336|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110135800|NCT02000375|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
110135801|NCT02000375|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110135802|NCT02000375|Immunologic Factors|immunologic factors|mesh-ancestor
110135803|NCT02000375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110135804|NCT02000388|Ketorolac|ketorolac|mesh-list
110135805|NCT02000388|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
110135806|NCT02000388|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110135807|NCT02000388|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110135808|NCT02000388|Analgesics|analgesics|mesh-ancestor
110135809|NCT02000388|Sensory System Agents|sensory system agents|mesh-ancestor
110135810|NCT02000388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110135811|NCT02000388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110135812|NCT02000388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110135813|NCT02000388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110135814|NCT02000388|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110135815|NCT02000388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110135816|NCT02000388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110135817|NCT02000401|Ketorolac|ketorolac|mesh-list
110135818|NCT02000401|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
110135819|NCT02000401|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110135820|NCT02000401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110135821|NCT02000401|Analgesics|analgesics|mesh-ancestor
110135822|NCT02000401|Sensory System Agents|sensory system agents|mesh-ancestor
110350642|NCT04137770|Analgesics|analgesics|mesh-ancestor
110135823|NCT02000401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110135824|NCT02000401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110135825|NCT02000401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110135826|NCT02000401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110135827|NCT02000401|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110135828|NCT02000401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110135829|NCT02000401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110135830|NCT02000414|Daptomycin|daptomycin|mesh-list
110135831|NCT02000414|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110135832|NCT02000414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110135833|NCT02000674|Rocuronium|rocuronium|mesh-list
110135834|NCT02000674|Succinylcholine|succinylcholine|mesh-list
110135835|NCT02000674|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110135836|NCT02000674|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110135837|NCT02000674|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110135838|NCT02000674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110135839|NCT02000674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110135840|NCT02000674|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
110135841|NCT02000700|Canagliflozin|canagliflozin|mesh-list
110135842|NCT02000700|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110135843|NCT02000700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110135844|NCT02000700|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110135845|NCT02000700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110135846|NCT02000726|Antidepressive Agents|antidepressive agents|mesh-list
110135847|NCT02000726|Citalopram|citalopram|mesh-list
110135848|NCT02000726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110135849|NCT02000726|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110135850|NCT02000726|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110135851|NCT02000726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110135852|NCT02000726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110135853|NCT02000726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110135854|NCT02000726|Serotonin Agents|serotonin agents|mesh-ancestor
110135855|NCT02000726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110135856|NCT02000726|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110135858|NCT02000765|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110135859|NCT02000765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110135860|NCT02000765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110135861|NCT02000765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110135862|NCT02000804|Darapladib|darapladib|mesh-list
110135863|NCT02000804|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
110135864|NCT02000804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110135865|NCT02000804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110135866|NCT02000830|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
110135867|NCT02000830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110135868|NCT02000830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110135869|NCT02000947|Durvalumab|durvalumab|mesh-list
110135870|NCT02000947|Tremelimumab|tremelimumab|mesh-list
110135871|NCT02000947|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110135872|NCT02000947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110135873|NCT02000947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110135874|NCT02000947|Immunologic Factors|immunologic factors|mesh-ancestor
110135875|NCT02000947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110135876|NCT02001012|Chloroquine|chloroquine|mesh-list
110135877|NCT02001012|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
110135878|NCT02001012|Lumefantrine|lumefantrine|mesh-list
110135879|NCT02001012|Artemether|artemether|mesh-list
110135880|NCT02001012|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
110135881|NCT02001012|Amebicides|amebicides|mesh-ancestor
110135882|NCT02001012|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110135883|NCT02001012|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110135884|NCT02001012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110135885|NCT02001012|Antimalarials|antimalarials|mesh-ancestor
110135886|NCT02001012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110135887|NCT02001012|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110135888|NCT02001012|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110135889|NCT02001012|Analgesics|analgesics|mesh-ancestor
110135890|NCT02001012|Sensory System Agents|sensory system agents|mesh-ancestor
110135891|NCT02001012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110135892|NCT02001012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110135893|NCT02001012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110135894|NCT02001012|Filaricides|filaricides|mesh-ancestor
110135895|NCT02001012|Antinematodal Agents|antinematodal agents|mesh-ancestor
110135896|NCT02001012|Anthelmintics|anthelmintics|mesh-ancestor
110135897|NCT02001103|Memantine|memantine|mesh-list
110135898|NCT02001103|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110135899|NCT02001103|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110135900|NCT02001103|Dopamine Agents|dopamine agents|mesh-ancestor
110135901|NCT02001103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110135902|NCT02001103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110135903|NCT02001103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110135904|NCT02001103|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110135905|NCT02001103|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110135906|NCT02001168|Docetaxel|docetaxel|mesh-list
110135907|NCT02001168|Pemetrexed|pemetrexed|mesh-list
110135908|NCT02001168|Cisplatin|cisplatin|mesh-list
110135909|NCT02001168|Endostatins|endostatins|mesh-list
110135910|NCT02001168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110135911|NCT02001168|Tubulin Modulators|tubulin modulators|mesh-ancestor
110135912|NCT02001168|Antimitotic Agents|antimitotic agents|mesh-ancestor
110135913|NCT02001168|Mitosis Modulators|mitosis modulators|mesh-ancestor
110135914|NCT02001168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110135915|NCT02001168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110135916|NCT02001168|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110135917|NCT02001168|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110135918|NCT02001168|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110135919|NCT02001168|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110135920|NCT02001168|Growth Substances|growth substances|mesh-ancestor
110135921|NCT02001168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110135922|NCT02001168|Growth Inhibitors|growth inhibitors|mesh-ancestor
110135923|NCT02001207|Hydrocortisone|hydrocortisone|mesh-list
110135924|NCT02001207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110135926|NCT02001259|Anesthetics, Local|anesthetics, local|mesh-ancestor
110135927|NCT02001259|Anesthetics|anesthetics|mesh-ancestor
110135928|NCT02001259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110135929|NCT02001259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110135930|NCT02001259|Sensory System Agents|sensory system agents|mesh-ancestor
110135931|NCT02001259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110135932|NCT02001259|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110135933|NCT02001259|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110135934|NCT02001259|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110135935|NCT02001259|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110135936|NCT02001259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110135937|NCT02001272|Paclitaxel|paclitaxel|mesh-list
110135938|NCT02001272|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110135939|NCT02001272|Carboplatin|carboplatin|mesh-list
110135940|NCT02001272|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110135941|NCT02001272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110135942|NCT02001272|Tubulin Modulators|tubulin modulators|mesh-ancestor
110135943|NCT02001272|Antimitotic Agents|antimitotic agents|mesh-ancestor
110135944|NCT02001272|Mitosis Modulators|mitosis modulators|mesh-ancestor
110135945|NCT02001272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110135947|NCT02001285|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110135949|NCT02001285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110135950|NCT02001285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110135951|NCT02001285|Analgesics|analgesics|mesh-ancestor
110135952|NCT02001285|Sensory System Agents|sensory system agents|mesh-ancestor
110135953|NCT02001285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110135954|NCT02001298|Nitroprusside|nitroprusside|mesh-list
110135955|NCT02001298|Remifentanil|remifentanil|mesh-list
110135956|NCT02001298|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110135957|NCT02001298|Narcotics|narcotics|mesh-ancestor
110135958|NCT02001298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110135959|NCT02001298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110135960|NCT02001298|Analgesics|analgesics|mesh-ancestor
110135961|NCT02001298|Sensory System Agents|sensory system agents|mesh-ancestor
110135962|NCT02001298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110135963|NCT02001298|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110135964|NCT02001298|Vasodilator Agents|vasodilator agents|mesh-ancestor
110135965|NCT02001298|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
110135966|NCT02001298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110135967|NCT02001311|Chlorhexidine|chlorhexidine|mesh-list
110135968|NCT02001311|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110135969|NCT02001311|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110135970|NCT02001311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110135971|NCT02001311|Disinfectants|disinfectants|mesh-ancestor
110135972|NCT02001311|Dermatologic Agents|dermatologic agents|mesh-ancestor
110135973|NCT02001363|Liraglutide|liraglutide|mesh-list
110135974|NCT02001363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110135975|NCT02001363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110135976|NCT02001363|Incretins|incretins|mesh-ancestor
110135978|NCT02001363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110135979|NCT02001428|Piperaquine|piperaquine|mesh-list
110135980|NCT02001428|Artenimol|artenimol|mesh-list
110135981|NCT02001428|Antimalarials|antimalarials|mesh-ancestor
110135982|NCT02001428|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110135983|NCT02001428|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110135984|NCT02001428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110135985|NCT02001506|Docetaxel|docetaxel|mesh-list
110135986|NCT02001506|Epirubicin|epirubicin|mesh-list
110135987|NCT02001506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110135988|NCT02001506|Tubulin Modulators|tubulin modulators|mesh-ancestor
110135989|NCT02001506|Antimitotic Agents|antimitotic agents|mesh-ancestor
110135990|NCT02001506|Mitosis Modulators|mitosis modulators|mesh-ancestor
110135991|NCT02001506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110135992|NCT02001506|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110135993|NCT02001506|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110135994|NCT02001506|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110135995|NCT02001506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110135996|NCT02001571|Abiraterone Acetate|abiraterone acetate|mesh-list
110135997|NCT02001571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110135998|NCT02001571|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110135999|NCT02001571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110136000|NCT02001571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110136001|NCT02001571|Hormone Antagonists|hormone antagonists|mesh-ancestor
110136002|NCT02001571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110136003|NCT02001571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110136004|NCT02001571|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110136005|NCT02001584|Memantine|memantine|mesh-list
110136006|NCT02001584|Baclofen|baclofen|mesh-list
110136007|NCT02001584|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110136008|NCT02001584|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110136009|NCT02001584|Dopamine Agents|dopamine agents|mesh-ancestor
110136010|NCT02001584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110136011|NCT02001584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110136012|NCT02001584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110136013|NCT02001584|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110136014|NCT02001584|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110136015|NCT02001584|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110136016|NCT02001584|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110136017|NCT02001584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110136018|NCT02001584|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
110136019|NCT02001584|GABA Agonists|gaba agonists|mesh-ancestor
110136021|NCT02001740|Lidocaine|lidocaine|mesh-list
110136022|NCT02001740|Anesthetics, Local|anesthetics, local|mesh-ancestor
110136023|NCT02001740|Anesthetics|anesthetics|mesh-ancestor
110136024|NCT02001740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110136025|NCT02001740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110136026|NCT02001740|Sensory System Agents|sensory system agents|mesh-ancestor
110136027|NCT02001740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110136028|NCT02001740|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110136029|NCT02001740|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110136030|NCT02001740|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110136031|NCT02001740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110136032|NCT02001740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110136033|NCT02001857|Hemostatics|hemostatics|mesh-list
110136034|NCT02001857|Coagulants|coagulants|mesh-ancestor
110136035|NCT02001883|Policosanol|policosanol|mesh-list
110136036|NCT02001883|Atorvastatin|atorvastatin|mesh-list
110136037|NCT02001883|Simvastatin|simvastatin|mesh-list
110136038|NCT02001883|Red yeast rice|red yeast rice|mesh-list
110136039|NCT02001883|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110136040|NCT02001883|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110136041|NCT02001883|Antimetabolites|antimetabolites|mesh-ancestor
110136042|NCT02001883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110136043|NCT02001883|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110136044|NCT02001883|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110136045|NCT02001883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110136046|NCT02001883|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110136047|NCT02001896|Carboplatin|carboplatin|mesh-list
110136048|NCT02001896|Gemcitabine|gemcitabine|mesh-list
110350761|NCT02933853|Insulin|insulin|mesh-list
110136049|NCT02001896|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110136050|NCT02001896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110136051|NCT02001896|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110136052|NCT02001896|Antimetabolites|antimetabolites|mesh-ancestor
110136053|NCT02001896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110136054|NCT02001896|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110136055|NCT02001896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110136057|NCT02001909|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110136058|NCT02001909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110136059|NCT02001909|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110136060|NCT02001909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110136061|NCT02001909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110136062|NCT02001935|Theophylline|theophylline|mesh-list
110136063|NCT02001935|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110136064|NCT02001935|Autonomic Agents|autonomic agents|mesh-ancestor
110136065|NCT02001935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110136066|NCT02001935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110136067|NCT02001935|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110136068|NCT02001935|Respiratory System Agents|respiratory system agents|mesh-ancestor
110136069|NCT02001935|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110136070|NCT02001935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110136071|NCT02001935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110136072|NCT02001935|Vasodilator Agents|vasodilator agents|mesh-ancestor
110136073|NCT02001935|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110136074|NCT02001935|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110136076|NCT02001935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110136077|NCT02001948|Morphine|morphine|mesh-list
110136078|NCT02001948|Bupivacaine|bupivacaine|mesh-list
110136079|NCT02001948|Anesthetics, Local|anesthetics, local|mesh-ancestor
110136080|NCT02001948|Anesthetics|anesthetics|mesh-ancestor
110136081|NCT02001948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110136082|NCT02001948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110136083|NCT02001948|Sensory System Agents|sensory system agents|mesh-ancestor
110136084|NCT02001948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110136085|NCT02001948|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110136086|NCT02001948|Narcotics|narcotics|mesh-ancestor
110136087|NCT02001948|Analgesics|analgesics|mesh-ancestor
110136088|NCT02001974|Paclitaxel|paclitaxel|mesh-list
110136089|NCT02001974|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110136090|NCT02001974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110136091|NCT02001974|Tubulin Modulators|tubulin modulators|mesh-ancestor
110136092|NCT02001974|Antimitotic Agents|antimitotic agents|mesh-ancestor
110136093|NCT02001974|Mitosis Modulators|mitosis modulators|mesh-ancestor
110136094|NCT02001974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110136095|NCT02002000|Vitamin D|vitamin d|mesh-list
110136096|NCT02002000|Cholecalciferol|cholecalciferol|mesh-list
110136098|NCT02002000|Micronutrients|micronutrients|mesh-ancestor
110136099|NCT02002000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110136100|NCT02002000|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110136101|NCT02002000|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110136103|NCT02002039|Hematinics|hematinics|mesh-ancestor
110136104|NCT02002065|Vaccines|vaccines|mesh-list
110136105|NCT02002065|Immunologic Factors|immunologic factors|mesh-ancestor
110136106|NCT02002065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110136107|NCT02002078|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110136108|NCT02002078|Methylprednisolone|methylprednisolone|mesh-list
110136109|NCT02002078|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110136110|NCT02002078|Prednisolone|prednisolone|mesh-list
110136111|NCT02002078|Prednisolone acetate|prednisolone acetate|mesh-list
110136112|NCT02002078|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110136113|NCT02002078|Prednisolone phosphate|prednisolone phosphate|mesh-list
110136114|NCT02002078|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110136115|NCT02002078|Antiemetics|antiemetics|mesh-ancestor
110136116|NCT02002078|Autonomic Agents|autonomic agents|mesh-ancestor
110136117|NCT02002078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110136118|NCT02002078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110136119|NCT02002078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110136120|NCT02002078|Glucocorticoids|glucocorticoids|mesh-ancestor
110136121|NCT02002078|Hormones|hormones|mesh-ancestor
110136122|NCT02002078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110136123|NCT02002078|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110136124|NCT02002078|Protective Agents|protective agents|mesh-ancestor
110136125|NCT02002078|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110136126|NCT02002078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110136127|NCT02002156|Vaccines|vaccines|mesh-list
110136128|NCT02002156|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110136129|NCT02002156|BCG Vaccine|bcg vaccine|mesh-list
110136130|NCT02002156|Immunologic Factors|immunologic factors|mesh-ancestor
110136131|NCT02002156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110136132|NCT02002156|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110136133|NCT02002195|Leucovorin|leucovorin|mesh-list
110136134|NCT02002195|Fluorouracil|fluorouracil|mesh-list
110136136|NCT02002195|Oxaliplatin|oxaliplatin|mesh-list
110136137|NCT02002195|Antimetabolites|antimetabolites|mesh-ancestor
110136138|NCT02002195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110136139|NCT02002195|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110136140|NCT02002195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110136141|NCT02002195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110136143|NCT02002195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110136144|NCT02002195|Antidotes|antidotes|mesh-ancestor
110136145|NCT02002195|Protective Agents|protective agents|mesh-ancestor
110136146|NCT02002195|Vitamin B Complex|vitamin b complex|mesh-ancestor
110136147|NCT02002195|Vitamins|vitamins|mesh-ancestor
110136148|NCT02002195|Micronutrients|micronutrients|mesh-ancestor
110136149|NCT02002247|Selenium|selenium|mesh-list
110136150|NCT02002247|Selenious Acid|selenious acid|mesh-list
110136151|NCT02002247|Sodium Selenite|sodium selenite|mesh-list
110136152|NCT02002247|Antioxidants|antioxidants|mesh-ancestor
110136153|NCT02002247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110136154|NCT02002247|Protective Agents|protective agents|mesh-ancestor
110136155|NCT02002247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110136156|NCT02002247|Trace Elements|trace elements|mesh-ancestor
110136157|NCT02002247|Micronutrients|micronutrients|mesh-ancestor
110136158|NCT02002260|Levonorgestrel|levonorgestrel|mesh-list
110136159|NCT02002260|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110136160|NCT02002260|Contraceptive Agents|contraceptive agents|mesh-list
110136161|NCT02002260|Contraceptives, Oral|contraceptives, oral|mesh-list
110136162|NCT02002260|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
110136163|NCT02002260|Estradiol|estradiol|mesh-list
110136164|NCT02002260|Estrogens|estrogens|mesh-ancestor
110136165|NCT02002260|Hormones|hormones|mesh-ancestor
110136166|NCT02002260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110136167|NCT02002260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110136168|NCT02002260|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110136169|NCT02002260|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110136170|NCT02002260|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110136171|NCT02002260|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110136172|NCT02002260|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110136173|NCT02002286|Triptolide|triptolide|mesh-list
110136174|NCT02002286|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
110136175|NCT02002286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110136176|NCT02002286|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110136177|NCT02002286|Contraceptive Agents|contraceptive agents|mesh-ancestor
110136178|NCT02002286|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110136179|NCT02002286|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110136180|NCT02002286|Immunologic Factors|immunologic factors|mesh-ancestor
110136181|NCT02002286|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110136182|NCT02002286|Alkylating Agents|alkylating agents|mesh-ancestor
110136183|NCT02002286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110136184|NCT02002286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110136185|NCT02002312|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
110136186|NCT02002312|Chelating Agents|chelating agents|mesh-ancestor
110136187|NCT02002312|Sequestering Agents|sequestering agents|mesh-ancestor
110136188|NCT02002312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110136189|NCT02002325|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
110136190|NCT02002325|Plasminogen|plasminogen|mesh-list
110136191|NCT02002325|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110136192|NCT02002325|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110136193|NCT02002325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110136194|NCT02002377|Aflibercept|aflibercept|mesh-list
110136196|NCT02002377|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110136197|NCT02002377|Growth Substances|growth substances|mesh-ancestor
110136198|NCT02002377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110136199|NCT02002377|Growth Inhibitors|growth inhibitors|mesh-ancestor
110136200|NCT02002377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110136201|NCT02002390|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
110136202|NCT02002390|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
110136203|NCT02002390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110136204|NCT02002390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110136205|NCT02002390|Immunologic Factors|immunologic factors|mesh-ancestor
110136206|NCT02002390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110136208|NCT02002403|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110136209|NCT02002403|Hormone Antagonists|hormone antagonists|mesh-ancestor
110136210|NCT02002403|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110136211|NCT02002403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110136212|NCT02002442|Chlorhexidine|chlorhexidine|mesh-list
110136213|NCT02002442|Cetylpyridinium|cetylpyridinium|mesh-list
110136214|NCT02002442|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110136215|NCT02002442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110136216|NCT02002442|Disinfectants|disinfectants|mesh-ancestor
110136217|NCT02002598|Dexamethasone|dexamethasone|mesh-list
110136218|NCT02002598|Dexamethasone acetate|dexamethasone acetate|mesh-list
110136219|NCT02002598|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110136220|NCT02002598|BB 1101|bb 1101|mesh-list
110136221|NCT02002598|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110136222|NCT02002598|Antiemetics|antiemetics|mesh-ancestor
110136223|NCT02002598|Autonomic Agents|autonomic agents|mesh-ancestor
110136224|NCT02002598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110136225|NCT02002598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110136226|NCT02002598|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110136227|NCT02002598|Glucocorticoids|glucocorticoids|mesh-ancestor
110136228|NCT02002598|Hormones|hormones|mesh-ancestor
110136229|NCT02002598|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110136230|NCT02002598|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110136231|NCT02002598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110136232|NCT02002598|Protease Inhibitors|protease inhibitors|mesh-ancestor
110136233|NCT02002598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110136234|NCT02002598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110136235|NCT02002598|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110136236|NCT02002598|Alkylating Agents|alkylating agents|mesh-ancestor
110136237|NCT02002611|Warfarin|warfarin|mesh-list
110136238|NCT02002611|Anticoagulants|anticoagulants|mesh-ancestor
110136239|NCT02002663|Methylprednisolone|methylprednisolone|mesh-list
110136240|NCT02002663|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110136241|NCT02002663|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110136242|NCT02002663|Prednisolone|prednisolone|mesh-list
110136243|NCT02002663|Prednisolone acetate|prednisolone acetate|mesh-list
110136244|NCT02002663|Morphine|morphine|mesh-list
110136245|NCT02002663|Ropivacaine|ropivacaine|mesh-list
110136246|NCT02002663|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110136247|NCT02002663|Prednisolone phosphate|prednisolone phosphate|mesh-list
110136248|NCT02002663|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110136249|NCT02002663|Narcotics|narcotics|mesh-ancestor
110136250|NCT02002663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110136251|NCT02002663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110136252|NCT02002663|Analgesics|analgesics|mesh-ancestor
110136253|NCT02002663|Sensory System Agents|sensory system agents|mesh-ancestor
110136254|NCT02002663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110136255|NCT02002663|Anesthetics, Local|anesthetics, local|mesh-ancestor
110136256|NCT02002663|Anesthetics|anesthetics|mesh-ancestor
110136257|NCT02002663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110136258|NCT02002663|Antiemetics|antiemetics|mesh-ancestor
110136259|NCT02002663|Autonomic Agents|autonomic agents|mesh-ancestor
110136260|NCT02002663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110136261|NCT02002663|Glucocorticoids|glucocorticoids|mesh-ancestor
110136262|NCT02002663|Hormones|hormones|mesh-ancestor
110343817|NCT06022588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110136263|NCT02002663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110136264|NCT02002663|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110136265|NCT02002663|Protective Agents|protective agents|mesh-ancestor
110136266|NCT02002663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110136267|NCT02002663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110136269|NCT02002715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110136270|NCT02002715|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110136271|NCT02002715|Autonomic Agents|autonomic agents|mesh-ancestor
110136272|NCT02002715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110136273|NCT02002715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110136274|NCT02002715|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110136275|NCT02002715|Respiratory System Agents|respiratory system agents|mesh-ancestor
110136276|NCT02002715|Glucocorticoids|glucocorticoids|mesh-ancestor
110136278|NCT02002715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110136279|NCT02002741|Acetaminophen|acetaminophen|mesh-list
110136280|NCT02002741|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110136281|NCT02002741|Analgesics|analgesics|mesh-ancestor
110136282|NCT02002741|Sensory System Agents|sensory system agents|mesh-ancestor
110136283|NCT02002741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110136284|NCT02002741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110136285|NCT02002741|Antipyretics|antipyretics|mesh-ancestor
110136286|NCT02002754|Bambuterol|bambuterol|mesh-list
110136287|NCT02002754|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110136288|NCT02002754|Autonomic Agents|autonomic agents|mesh-ancestor
110136289|NCT02002754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110136290|NCT02002754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110136291|NCT02002754|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110136292|NCT02002754|Respiratory System Agents|respiratory system agents|mesh-ancestor
110136293|NCT02002806|Ethanol|ethanol|mesh-list
110136294|NCT02002806|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110136295|NCT02002806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110136296|NCT02002806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110136297|NCT02002806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110136298|NCT02002858|Nicotine|nicotine|mesh-list
110136299|NCT02002858|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110136300|NCT02002858|Autonomic Agents|autonomic agents|mesh-ancestor
110136301|NCT02002858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110166594|NCT00395434|Tubulin Modulators|tubulin modulators|mesh-ancestor
110136302|NCT02002858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110136303|NCT02002858|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110136304|NCT02002858|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110136305|NCT02002858|Cholinergic Agents|cholinergic agents|mesh-ancestor
110136306|NCT02002858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110351206|NCT01280266|Amlodipine|amlodipine|mesh-list
110136307|NCT02002858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110136309|NCT02002923|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110136310|NCT02002923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110136311|NCT02002923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110136312|NCT02002923|Cholinergic Agents|cholinergic agents|mesh-ancestor
110136313|NCT02002923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110136314|NCT02002923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110136315|NCT02002962|Botulinum Toxins|botulinum toxins|mesh-list
110136316|NCT02002962|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110136317|NCT02002962|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110136318|NCT02002962|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110136319|NCT02002962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110136320|NCT02002962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110136321|NCT02002962|Cholinergic Agents|cholinergic agents|mesh-ancestor
110136322|NCT02002962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110136323|NCT02002962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110136324|NCT02002962|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110136325|NCT02002962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110136326|NCT02003001|Botulinum Toxins|botulinum toxins|mesh-list
110136327|NCT02003001|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110136328|NCT02003001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110136329|NCT02003001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110136330|NCT02003001|Cholinergic Agents|cholinergic agents|mesh-ancestor
110136331|NCT02003001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110136332|NCT02003001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110136333|NCT02001818|Interferons|interferons|mesh-list
110136334|NCT02001818|Interferon-alpha|interferon-alpha|mesh-list
110136335|NCT02001818|Interferon alpha-2|interferon alpha-2|mesh-list
110136336|NCT02001818|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110136337|NCT02001818|Imatinib Mesylate|imatinib mesylate|mesh-list
110136338|NCT02001818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110136339|NCT02001818|Antiviral Agents|antiviral agents|mesh-ancestor
110136340|NCT02001818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110136341|NCT02001818|Immunologic Factors|immunologic factors|mesh-ancestor
110136342|NCT02001818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110136343|NCT02001818|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110136344|NCT02001818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110136345|NCT02001818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110136346|NCT02003313|Vaccines|vaccines|mesh-list
110136347|NCT02003313|Immunologic Factors|immunologic factors|mesh-ancestor
110136348|NCT02003313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110136349|NCT02003456|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110136350|NCT02003456|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110136351|NCT02003456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110136352|NCT02003495|Vaccines|vaccines|mesh-list
110136353|NCT02003495|Immunologic Factors|immunologic factors|mesh-ancestor
110136354|NCT02003495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110136355|NCT02003664|Baclofen|baclofen|mesh-list
110136356|NCT02003664|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110136357|NCT02003664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110136358|NCT02003664|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110136359|NCT02003664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110136360|NCT02003664|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
110136361|NCT02003664|GABA Agonists|gaba agonists|mesh-ancestor
110136362|NCT02003664|GABA Agents|gaba agents|mesh-ancestor
110136363|NCT02003664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110351238|NCT02932254|Tocolytic Agents|tocolytic agents|mesh-ancestor
110166612|NCT00012168|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
110136364|NCT02003664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110136366|NCT02003677|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110136367|NCT02003677|Insulin Aspart|insulin aspart|mesh-list
110136368|NCT02003677|Insulin, Long-Acting|insulin, long-acting|mesh-list
110136369|NCT02003677|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
110136370|NCT02003677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110136371|NCT02003677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110136372|NCT02003768|Propofol|propofol|mesh-list
110136373|NCT02003768|Desflurane|desflurane|mesh-list
110136374|NCT02003768|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110136375|NCT02003768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110136376|NCT02003768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110136377|NCT02003768|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110136378|NCT02003768|Anesthetics, General|anesthetics, general|mesh-ancestor
110136379|NCT02003768|Anesthetics|anesthetics|mesh-ancestor
110136380|NCT02003768|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110136381|NCT02003885|Desflurane|desflurane|mesh-list
110136382|NCT02003885|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110136383|NCT02003885|Anesthetics, General|anesthetics, general|mesh-ancestor
110136384|NCT02003885|Anesthetics|anesthetics|mesh-ancestor
110136385|NCT02003885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110136386|NCT02003885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110136387|NCT02004067|Cyclosporine|cyclosporine|mesh-list
110136388|NCT02004067|Castor Oil|castor oil|mesh-list
110136389|NCT02004067|Cyclosporins|cyclosporins|mesh-list
110136390|NCT02004067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110136391|NCT02004067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110136392|NCT02004067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110136393|NCT02004067|Immunologic Factors|immunologic factors|mesh-ancestor
110136394|NCT02004067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110136395|NCT02004067|Antifungal Agents|antifungal agents|mesh-ancestor
110136396|NCT02004067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110136397|NCT02004067|Dermatologic Agents|dermatologic agents|mesh-ancestor
110136399|NCT02004067|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110136400|NCT02004067|Cathartics|cathartics|mesh-ancestor
110136401|NCT02004067|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110136403|NCT02004171|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110136404|NCT02004171|Autonomic Agents|autonomic agents|mesh-ancestor
110136405|NCT02004171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110136406|NCT02004171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110136407|NCT02004171|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110136408|NCT02004171|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110136409|NCT02004171|Cholinergic Agents|cholinergic agents|mesh-ancestor
110136410|NCT02004171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110136411|NCT02004171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110136412|NCT02004184|Pemetrexed|pemetrexed|mesh-list
110136413|NCT02004184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110136414|NCT02004184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110136415|NCT02004184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110136416|NCT02004184|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110136417|NCT02004184|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110136418|NCT02004197|Amoxicillin|amoxicillin|mesh-list
110136419|NCT02004197|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
110136420|NCT02004197|Bismuth|bismuth|mesh-list
110136421|NCT02004197|Ranitidine|ranitidine|mesh-list
110136422|NCT02004197|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
110136423|NCT02004197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110136424|NCT02004197|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110136425|NCT02004197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110136426|NCT02004197|Antacids|antacids|mesh-ancestor
110136428|NCT02004197|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110136429|NCT02004197|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110136430|NCT02004197|Histamine Antagonists|histamine antagonists|mesh-ancestor
110136431|NCT02004197|Histamine Agents|histamine agents|mesh-ancestor
110136432|NCT02004197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110136433|NCT02004197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110136434|NCT02004301|Diclofenac|diclofenac|mesh-list
110136435|NCT02004301|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110136436|NCT02004301|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110136437|NCT02004301|Analgesics|analgesics|mesh-ancestor
110136438|NCT02004301|Sensory System Agents|sensory system agents|mesh-ancestor
110136439|NCT02004301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110136440|NCT02004301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110136441|NCT02004301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110136442|NCT02004301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110136443|NCT02004301|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110136444|NCT02004301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110136445|NCT02004301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110136446|NCT02004314|Chloroquine|chloroquine|mesh-list
110136447|NCT02004314|Amebicides|amebicides|mesh-ancestor
110136448|NCT02004314|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110136449|NCT02004314|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110136450|NCT02004314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110136451|NCT02004314|Antimalarials|antimalarials|mesh-ancestor
110136452|NCT02004314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110136453|NCT02004418|Choline|choline|mesh-list
110136454|NCT02004418|Lipotropic Agents|lipotropic agents|mesh-ancestor
110136455|NCT02004418|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110136456|NCT02004418|Antimetabolites|antimetabolites|mesh-ancestor
110136457|NCT02004418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110136458|NCT02004418|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110136459|NCT02004418|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110136460|NCT02004418|Nootropic Agents|nootropic agents|mesh-ancestor
110136461|NCT02004509|Anticoagulants|anticoagulants|mesh-list
110136462|NCT02004574|Betamethasone|betamethasone|mesh-list
110136463|NCT02004574|Betamethasone Valerate|betamethasone valerate|mesh-list
110136464|NCT02004574|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
110136465|NCT02004574|Betamethasone benzoate|betamethasone benzoate|mesh-list
110136466|NCT02004574|Calcipotriene|calcipotriene|mesh-list
110136467|NCT02004574|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
110136468|NCT02004574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110136469|NCT02004574|Glucocorticoids|glucocorticoids|mesh-ancestor
110136471|NCT02004574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110136472|NCT02004574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110136473|NCT02004574|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110136474|NCT02004574|Respiratory System Agents|respiratory system agents|mesh-ancestor
110136475|NCT02004574|Dermatologic Agents|dermatologic agents|mesh-ancestor
110136476|NCT02004652|Prucalopride|prucalopride|mesh-list
110136477|NCT02004652|Laxatives|laxatives|mesh-ancestor
110136478|NCT02004652|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110136479|NCT02004652|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
110136480|NCT02004652|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110136481|NCT02004652|Serotonin Agents|serotonin agents|mesh-ancestor
110136482|NCT02004652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110136483|NCT02004652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110136484|NCT02004652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110136485|NCT02004769|Docetaxel|docetaxel|mesh-list
110136486|NCT02004769|Capecitabine|capecitabine|mesh-list
110136487|NCT02004769|Trastuzumab|trastuzumab|mesh-list
110136488|NCT02004769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110136489|NCT02004769|Tubulin Modulators|tubulin modulators|mesh-ancestor
110136490|NCT02004769|Antimitotic Agents|antimitotic agents|mesh-ancestor
110136491|NCT02004769|Mitosis Modulators|mitosis modulators|mesh-ancestor
110351265|NCT02931786|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110136492|NCT02004769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110136493|NCT02004769|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110136494|NCT02004769|Antimetabolites|antimetabolites|mesh-ancestor
110136495|NCT02004769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110136496|NCT02004860|Ciclopirox|ciclopirox|mesh-list
110136497|NCT02004860|Tacrolimus|tacrolimus|mesh-list
110136498|NCT02004860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110136499|NCT02004860|Immunologic Factors|immunologic factors|mesh-ancestor
110166639|NCT00028327|Antiviral Agents|antiviral agents|mesh-ancestor
110136500|NCT02004860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110136501|NCT02004860|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110136502|NCT02004860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110136503|NCT02004860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110136504|NCT02004860|Antifungal Agents|antifungal agents|mesh-ancestor
110136505|NCT02004860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110136506|NCT02004899|Fentanyl|fentanyl|mesh-list
110136507|NCT02004899|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110136508|NCT02004899|Narcotics|narcotics|mesh-ancestor
110136509|NCT02004899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110136510|NCT02004899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110136511|NCT02004899|Analgesics|analgesics|mesh-ancestor
110136512|NCT02004899|Sensory System Agents|sensory system agents|mesh-ancestor
110136513|NCT02004899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110136514|NCT02004899|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110136515|NCT02004899|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110136516|NCT02004899|Anesthetics, General|anesthetics, general|mesh-ancestor
110136517|NCT02004899|Anesthetics|anesthetics|mesh-ancestor
110136518|NCT02005068|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
110136519|NCT02005068|Cephalosporins|cephalosporins|mesh-list
110136520|NCT02005068|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110136521|NCT02005068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110136522|NCT02005107|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
110136523|NCT02005107|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110136524|NCT02005107|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110136525|NCT02005107|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110136526|NCT02005107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110136527|NCT02005107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110136528|NCT02005107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110136529|NCT02005107|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110136530|NCT02005107|Antidepressive Agents|antidepressive agents|mesh-ancestor
110136531|NCT02005107|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110136532|NCT02005120|Bevacizumab|bevacizumab|mesh-list
110136533|NCT02005120|Endostatins|endostatins|mesh-list
110136534|NCT02005120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110136535|NCT02005120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110136536|NCT02005120|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110136537|NCT02005120|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110136538|NCT02005120|Growth Substances|growth substances|mesh-ancestor
110136539|NCT02005120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110136540|NCT02005120|Growth Inhibitors|growth inhibitors|mesh-ancestor
110136542|NCT02005302|Ergocalciferols|ergocalciferols|mesh-list
110136543|NCT02005302|Cholecalciferol|cholecalciferol|mesh-list
110136544|NCT02005302|Vitamins|vitamins|mesh-list
110136545|NCT02005302|Micronutrients|micronutrients|mesh-ancestor
110136546|NCT02005302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110136547|NCT02005302|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110136548|NCT02005302|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110136550|NCT02005315|Gemcitabine|gemcitabine|mesh-list
110136551|NCT02005315|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110136552|NCT02005315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110136553|NCT02005315|Tubulin Modulators|tubulin modulators|mesh-ancestor
110136554|NCT02005315|Antimitotic Agents|antimitotic agents|mesh-ancestor
110351282|NCT05465733|Pemetrexed|pemetrexed|mesh-list
110136555|NCT02005315|Mitosis Modulators|mitosis modulators|mesh-ancestor
110136556|NCT02005315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110166641|NCT00028327|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110136557|NCT02005315|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110136558|NCT02005315|Antimetabolites|antimetabolites|mesh-ancestor
110136559|NCT02005419|Metformin|metformin|mesh-list
110136560|NCT02005419|Gemcitabine|gemcitabine|mesh-list
110136561|NCT02005419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110136562|NCT02005419|Antimetabolites|antimetabolites|mesh-ancestor
110136563|NCT02005419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110136564|NCT02005419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110136565|NCT02005419|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110136566|NCT02005419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110136567|NCT02005523|RNS60|rns60|mesh-list
110136568|NCT02005523|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110136569|NCT02005523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110136570|NCT02005523|Analgesics|analgesics|mesh-ancestor
110136571|NCT02005523|Sensory System Agents|sensory system agents|mesh-ancestor
110136572|NCT02005523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110136573|NCT02005523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110136574|NCT02005523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110136575|NCT02005523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110136576|NCT02005523|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110136577|NCT02005575|Dexamethasone|dexamethasone|mesh-list
110136578|NCT02005575|Bupivacaine|bupivacaine|mesh-list
110136579|NCT02005575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110136580|NCT02005575|Antiemetics|antiemetics|mesh-ancestor
110136581|NCT02005575|Autonomic Agents|autonomic agents|mesh-ancestor
110136582|NCT02005575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110136583|NCT02005575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110136584|NCT02005575|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110136585|NCT02005575|Glucocorticoids|glucocorticoids|mesh-ancestor
110136586|NCT02005575|Hormones|hormones|mesh-ancestor
110136587|NCT02005575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110136588|NCT02005575|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110136589|NCT02005575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110136590|NCT02005575|Anesthetics, Local|anesthetics, local|mesh-ancestor
110136591|NCT02005575|Anesthetics|anesthetics|mesh-ancestor
110136592|NCT02005575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110136593|NCT02005575|Sensory System Agents|sensory system agents|mesh-ancestor
110136594|NCT02005588|Iron|iron|mesh-list
110136595|NCT02005588|Ferrous fumarate|ferrous fumarate|mesh-list
110136596|NCT02005588|Iron Chelating Agents|iron chelating agents|mesh-list
110136597|NCT02005588|Trace Elements|trace elements|mesh-ancestor
110136598|NCT02005588|Micronutrients|micronutrients|mesh-ancestor
110136599|NCT02005588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110136600|NCT02005588|Chelating Agents|chelating agents|mesh-ancestor
110136601|NCT02005588|Sequestering Agents|sequestering agents|mesh-ancestor
110136602|NCT02005588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110136603|NCT02005653|Doxycycline|doxycycline|mesh-list
110136604|NCT02005653|Albendazole|albendazole|mesh-list
110136605|NCT02005653|Diethylcarbamazine|diethylcarbamazine|mesh-list
110136606|NCT02005653|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110136607|NCT02005653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110136608|NCT02005653|Antimalarials|antimalarials|mesh-ancestor
110136609|NCT02005653|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110136610|NCT02005653|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110136611|NCT02005653|Anthelmintics|anthelmintics|mesh-ancestor
110136612|NCT02005653|Anticestodal Agents|anticestodal agents|mesh-ancestor
110136613|NCT02005653|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110136614|NCT02005653|Tubulin Modulators|tubulin modulators|mesh-ancestor
110136615|NCT02005653|Antimitotic Agents|antimitotic agents|mesh-ancestor
110136616|NCT02005653|Mitosis Modulators|mitosis modulators|mesh-ancestor
110351386|NCT02918825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110136617|NCT02005653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110136619|NCT02005653|Filaricides|filaricides|mesh-ancestor
110136620|NCT02005653|Antinematodal Agents|antinematodal agents|mesh-ancestor
110136621|NCT02005653|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
110136622|NCT02005653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110136623|NCT02005718|Cholecalciferol|cholecalciferol|mesh-list
110136624|NCT02005718|Vitamin D|vitamin d|mesh-list
110136625|NCT02005718|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110136626|NCT02005718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110136627|NCT02005718|Vitamins|vitamins|mesh-ancestor
110136629|NCT02005718|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110136630|NCT02005757|Mizoribine|mizoribine|mesh-list
110136631|NCT02005757|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110136632|NCT02005757|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110136634|NCT02005757|Sensory System Agents|sensory system agents|mesh-ancestor
110136635|NCT02005757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110136636|NCT02005757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110136637|NCT02005757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110136638|NCT02005757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110136639|NCT02005757|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110136640|NCT02005757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110136641|NCT02005757|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110136642|NCT02005757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110136643|NCT02005757|Antimalarials|antimalarials|mesh-ancestor
110136644|NCT02005757|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110136645|NCT02005757|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110136646|NCT02005757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110136647|NCT02005757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110136648|NCT02005757|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110136649|NCT02005757|Immunologic Factors|immunologic factors|mesh-ancestor
110136650|NCT02005770|Propofol|propofol|mesh-list
110136651|NCT02005770|Sevoflurane|sevoflurane|mesh-list
110136652|NCT02005770|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110136653|NCT02005770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110136654|NCT02005770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110136655|NCT02005770|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110136656|NCT02005770|Anesthetics, General|anesthetics, general|mesh-ancestor
110136657|NCT02005770|Anesthetics|anesthetics|mesh-ancestor
110136658|NCT02005770|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110136659|NCT02005770|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110136660|NCT02005783|Cyclophosphamide|cyclophosphamide|mesh-list
110136661|NCT02005783|Docetaxel|docetaxel|mesh-list
110136662|NCT02005783|Epirubicin|epirubicin|mesh-list
110136664|NCT02005783|Immunologic Factors|immunologic factors|mesh-ancestor
110136665|NCT02005783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110136666|NCT02005783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110136667|NCT02005783|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110136668|NCT02005783|Alkylating Agents|alkylating agents|mesh-ancestor
110136669|NCT02005783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110136670|NCT02005783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110136671|NCT02005783|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110351631|NCT04686825|DA-8010|da-8010|mesh-list
110136672|NCT02005783|Tubulin Modulators|tubulin modulators|mesh-ancestor
110136673|NCT02005783|Antimitotic Agents|antimitotic agents|mesh-ancestor
110136674|NCT02005783|Mitosis Modulators|mitosis modulators|mesh-ancestor
110136675|NCT02005783|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110136676|NCT02005783|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110136677|NCT02005783|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110136678|NCT02005783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110136679|NCT02005822|Valganciclovir|valganciclovir|mesh-list
110136680|NCT02005822|Antiviral Agents|antiviral agents|mesh-ancestor
110136681|NCT02005822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110136682|NCT02005848|Protease Inhibitors|protease inhibitors|mesh-list
110136683|NCT02005848|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
110136684|NCT02005848|Protein C Inhibitor|protein c inhibitor|mesh-list
110136685|NCT02005848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110136686|NCT02005848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110136687|NCT02005848|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
110136688|NCT02005848|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110136689|NCT02006043|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110136690|NCT02006043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110136691|NCT02006043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110136692|NCT02006043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110136693|NCT02006043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110136695|NCT02006173|Anesthetics, Local|anesthetics, local|mesh-ancestor
110136696|NCT02006173|Anesthetics|anesthetics|mesh-ancestor
110136697|NCT02006173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110136698|NCT02006173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110136699|NCT02006173|Sensory System Agents|sensory system agents|mesh-ancestor
110136700|NCT02006173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110136701|NCT02006173|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110136702|NCT02006173|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110136703|NCT02006173|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110136704|NCT02006173|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110136705|NCT02006173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110136707|NCT02006225|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110136708|NCT02006225|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110136709|NCT02006225|Antiviral Agents|antiviral agents|mesh-ancestor
110136710|NCT02006225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110136711|NCT02006277|Crizotinib|crizotinib|mesh-list
110136712|NCT02006277|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110136713|NCT02006277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110136714|NCT02006277|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110351811|NCT00534378|Midazolam|midazolam|mesh-list
110136715|NCT02006277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110136716|NCT02006277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110136718|NCT02006355|Anesthetics, Local|anesthetics, local|mesh-ancestor
110136719|NCT02006355|Anesthetics|anesthetics|mesh-ancestor
110136720|NCT02006355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110136721|NCT02006355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110136722|NCT02006355|Sensory System Agents|sensory system agents|mesh-ancestor
110136723|NCT02006355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110136724|NCT02006485|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110136725|NCT02006485|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110136726|NCT02006485|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110136727|NCT02006485|Alkylating Agents|alkylating agents|mesh-ancestor
110136728|NCT02006485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110136729|NCT02006485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110136730|NCT02006485|Immunologic Factors|immunologic factors|mesh-ancestor
110136731|NCT02006485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110136732|NCT05970900|Imatinib Mesylate|imatinib mesylate|mesh-list
110136733|NCT05970900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110136734|NCT05970900|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110136735|NCT05970900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110136736|NCT05970900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110136737|NCT05970887|Vaccines|vaccines|mesh-list
110136738|NCT05970887|Immunologic Factors|immunologic factors|mesh-ancestor
110136739|NCT05970887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110136740|NCT05970822|Azacitidine|azacitidine|mesh-list
110136741|NCT05970822|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110136742|NCT05970822|Antimetabolites|antimetabolites|mesh-ancestor
110136743|NCT05970822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110136744|NCT05970822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110136745|NCT05970822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110136746|NCT05970705|Trifluridine|trifluridine|mesh-list
110136747|NCT05970705|Antimetabolites|antimetabolites|mesh-ancestor
110136748|NCT05970705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110136749|NCT05970705|Antiviral Agents|antiviral agents|mesh-ancestor
110136750|NCT05970705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110136751|NCT05970679|Atorvastatin|atorvastatin|mesh-list
110136752|NCT05970679|Ezetimibe|ezetimibe|mesh-list
110136753|NCT05970679|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110136754|NCT05970679|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110136755|NCT05970679|Antimetabolites|antimetabolites|mesh-ancestor
110351992|NCT02071862|Everolimus|everolimus|mesh-list
110352015|NCT02021474|Phenol|phenol|mesh-list
110136756|NCT05970679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110136757|NCT05970679|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110136758|NCT05970679|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110136760|NCT05970666|Bevacizumab|bevacizumab|mesh-list
110136761|NCT05970666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110352062|NCT00535808|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
110136762|NCT05970666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110136763|NCT05970666|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110136764|NCT05970666|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110136765|NCT05970666|Growth Substances|growth substances|mesh-ancestor
110136766|NCT05970666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110136767|NCT05970666|Growth Inhibitors|growth inhibitors|mesh-ancestor
110136768|NCT05970627|Oxaliplatin|oxaliplatin|mesh-list
110136769|NCT05970627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110136770|NCT05970536|Acetic Acid|acetic acid|mesh-list
110136771|NCT05970536|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110136772|NCT05970536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110136773|NCT05970302|Bevacizumab|bevacizumab|mesh-list
110136774|NCT05970302|Tislelizumab|tislelizumab|mesh-list
110136775|NCT05970302|Capecitabine|capecitabine|mesh-list
110136776|NCT05970302|Oxaliplatin|oxaliplatin|mesh-list
110136777|NCT05970302|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110136778|NCT05970302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110136779|NCT05970302|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110136780|NCT05970302|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110136781|NCT05970302|Growth Substances|growth substances|mesh-ancestor
110136782|NCT05970302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110136783|NCT05970302|Growth Inhibitors|growth inhibitors|mesh-ancestor
110136784|NCT05970302|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110136786|NCT05970302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110136787|NCT05970263|Budesonide|budesonide|mesh-list
110136788|NCT05970263|Glycopyrrolate|glycopyrrolate|mesh-list
110136789|NCT05970263|Formoterol Fumarate|formoterol fumarate|mesh-list
110136790|NCT05970263|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110136791|NCT05970263|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110136792|NCT05970263|Autonomic Agents|autonomic agents|mesh-ancestor
110136793|NCT05970263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110136794|NCT05970263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110136795|NCT05970263|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110136796|NCT05970263|Respiratory System Agents|respiratory system agents|mesh-ancestor
110136797|NCT05970263|Glucocorticoids|glucocorticoids|mesh-ancestor
110136798|NCT05970263|Hormones|hormones|mesh-ancestor
110136799|NCT05970263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110136800|NCT05970263|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110136801|NCT05970263|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110136802|NCT05970263|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110136803|NCT05970263|Adrenergic Agents|adrenergic agents|mesh-ancestor
110136804|NCT05970263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110136805|NCT05970263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110136806|NCT05970263|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110136807|NCT05970263|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110136808|NCT05970263|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110136810|NCT05970250|Vitamin D|vitamin d|mesh-list
110136811|NCT05970250|Calcium|calcium|mesh-list
110136812|NCT05970250|Vitamins|vitamins|mesh-ancestor
110136813|NCT05970250|Micronutrients|micronutrients|mesh-ancestor
110136814|NCT05970250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110136815|NCT05970250|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110136816|NCT05970250|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110136817|NCT05969990|Tryptophan|tryptophan|mesh-list
110136818|NCT05969990|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110136819|NCT05969990|Antidepressive Agents|antidepressive agents|mesh-ancestor
110136820|NCT05969990|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110136822|NCT05969899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110136823|NCT05969899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110136824|NCT05969899|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110166689|NCT00012207|Hormones|hormones|mesh-ancestor
110136825|NCT05969899|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110136826|NCT05969899|Growth Substances|growth substances|mesh-ancestor
110136827|NCT05969899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110136828|NCT05969899|Growth Inhibitors|growth inhibitors|mesh-ancestor
110136830|NCT05969847|Oxaliplatin|oxaliplatin|mesh-list
110136831|NCT05969847|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110136832|NCT05969847|Antimetabolites|antimetabolites|mesh-ancestor
110136833|NCT05969847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110136834|NCT05969847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110136835|NCT05969834|Triptorelin Pamoate|triptorelin pamoate|mesh-list
110136836|NCT05969834|Luteolytic Agents|luteolytic agents|mesh-ancestor
110136837|NCT05969834|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110136838|NCT05969834|Contraceptive Agents|contraceptive agents|mesh-ancestor
110352444|NCT04326868|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110136839|NCT05969834|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110136840|NCT05969834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110136841|NCT05969834|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110136842|NCT05969834|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110136843|NCT05969834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110136844|NCT05969795|Progesterone|progesterone|mesh-list
110136845|NCT05969795|Progestins|progestins|mesh-ancestor
110136846|NCT05969795|Hormones|hormones|mesh-ancestor
110136847|NCT05969795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110136848|NCT05969795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110136850|NCT05969743|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110136851|NCT05969743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110136852|NCT05969743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110136853|NCT05969743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110136854|NCT05969743|Antiviral Agents|antiviral agents|mesh-ancestor
110136855|NCT05969743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110136856|NCT05969561|Analgesics|analgesics|mesh-list
110136857|NCT05969561|Sensory System Agents|sensory system agents|mesh-ancestor
110136858|NCT05969561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110136859|NCT05969561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110136860|NCT05969522|Cyclophosphamide|cyclophosphamide|mesh-list
110352582|NCT05312866|Hormones|hormones|mesh-ancestor
110136861|NCT05969522|Glucocorticoids|glucocorticoids|mesh-list
110136862|NCT05969522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110136863|NCT05969522|Immunologic Factors|immunologic factors|mesh-ancestor
110136864|NCT05969522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110136865|NCT05969522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110136866|NCT05969522|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110136867|NCT05969522|Alkylating Agents|alkylating agents|mesh-ancestor
110136868|NCT05969522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110136869|NCT05969522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110136870|NCT05969522|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110136871|NCT05969522|Hormones|hormones|mesh-ancestor
110352635|NCT00597181|Mitomycins|mitomycins|mesh-list
110136872|NCT05969522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110136881|NCT05969457|Ropivacaine|ropivacaine|mesh-list
110136882|NCT05969457|Anesthetics, Local|anesthetics, local|mesh-ancestor
110136883|NCT05969457|Anesthetics|anesthetics|mesh-ancestor
110136884|NCT05969457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110136885|NCT05969457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110136886|NCT05969457|Sensory System Agents|sensory system agents|mesh-ancestor
110136887|NCT05969457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110136888|NCT05969392|Ethanol|ethanol|mesh-list
110136889|NCT05969392|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110136890|NCT05969392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110136891|NCT05969392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110136892|NCT05969392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110136893|NCT05969236|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110136894|NCT05969236|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110136895|NCT05969184|Trastuzumab|trastuzumab|mesh-list
110136896|NCT05969184|Pertuzumab|pertuzumab|mesh-list
110136897|NCT05969184|Letrozole|letrozole|mesh-list
110136898|NCT05969184|Exemestane|exemestane|mesh-list
110352715|NCT00598195|Ketamine|ketamine|mesh-list
110136899|NCT05969184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110136900|NCT05969184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110136901|NCT05969184|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110136902|NCT05969184|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110136903|NCT05969184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110136904|NCT05969184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110136905|NCT05969184|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110136906|NCT05969184|Hormone Antagonists|hormone antagonists|mesh-ancestor
110136907|NCT05969184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110136908|NCT05969184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110136910|NCT05969171|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110136911|NCT05969171|Paclitaxel|paclitaxel|mesh-list
110136912|NCT05969171|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110136913|NCT05969171|Antimetabolites|antimetabolites|mesh-ancestor
110136914|NCT05969171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110136915|NCT05969171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110136916|NCT05969171|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110136917|NCT05969171|Tubulin Modulators|tubulin modulators|mesh-ancestor
110136918|NCT05969171|Antimitotic Agents|antimitotic agents|mesh-ancestor
110136919|NCT05969171|Mitosis Modulators|mitosis modulators|mesh-ancestor
110136920|NCT05969119|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
110136921|NCT05969119|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110136922|NCT05969119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110136923|NCT05969119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110136924|NCT05969119|Cholinergic Agents|cholinergic agents|mesh-ancestor
110136925|NCT05969119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110136926|NCT05969119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110136928|NCT05968937|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110136929|NCT05968937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110136930|NCT05968937|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110136931|NCT05968937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110136932|NCT05968937|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
110136933|NCT05968937|GABA Agonists|gaba agonists|mesh-ancestor
110136934|NCT05968937|GABA Agents|gaba agents|mesh-ancestor
110136935|NCT05968937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110136936|NCT05968937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110136937|NCT05968885|Solifenacin Succinate|solifenacin succinate|mesh-list
110136938|NCT05968885|Mirabegron|mirabegron|mesh-list
110136939|NCT05968885|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110136940|NCT05968885|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110136941|NCT05968885|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110136942|NCT05968885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110136943|NCT05968885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110136944|NCT05968885|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110136945|NCT05968885|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110352870|NCT05312346|Vitamin B Complex|vitamin b complex|mesh-ancestor
110136946|NCT05968885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110136947|NCT05968885|Cholinergic Agents|cholinergic agents|mesh-ancestor
110136948|NCT05968885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110136949|NCT05968885|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110136950|NCT05968885|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110136951|NCT05968885|Urological Agents|urological agents|mesh-ancestor
110136952|NCT05968885|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
110136953|NCT05968885|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110136954|NCT05968885|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110136955|NCT05968885|Adrenergic Agents|adrenergic agents|mesh-ancestor
110136956|NCT05968846|Iodine|iodine|mesh-list
110136957|NCT05968846|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110136958|NCT05968846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110136959|NCT05968846|Trace Elements|trace elements|mesh-ancestor
110136960|NCT05968846|Micronutrients|micronutrients|mesh-ancestor
110136961|NCT05968846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110136962|NCT05968651|Oxytocin|oxytocin|mesh-list
110136963|NCT05968651|Oxytocics|oxytocics|mesh-ancestor
110136964|NCT05968651|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110136965|NCT05968651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110136966|NCT05968612|Ivacaftor|ivacaftor|mesh-list
110136967|NCT05968612|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
110136968|NCT05968612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110136969|NCT05968612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110136970|NCT05968482|Diclofenac|diclofenac|mesh-list
110136971|NCT05968482|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110136972|NCT05968482|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110136973|NCT05968482|Analgesics|analgesics|mesh-ancestor
110136974|NCT05968482|Sensory System Agents|sensory system agents|mesh-ancestor
110136975|NCT05968482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110136976|NCT05968482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110136977|NCT05968482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110136978|NCT05968482|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110136979|NCT05968482|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110353070|NCT00551564|Rosiglitazone|rosiglitazone|mesh-list
110136980|NCT05968482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110136981|NCT05968482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110136982|NCT05968001|Obinutuzumab|obinutuzumab|mesh-list
110136983|NCT05968001|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110136984|NCT05968001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110136985|NCT05967936|Bupivacaine|bupivacaine|mesh-list
110136986|NCT05967936|Anesthetics, Local|anesthetics, local|mesh-ancestor
110136987|NCT05967936|Anesthetics|anesthetics|mesh-ancestor
110136988|NCT05967936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110136989|NCT05967936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110353127|NCT00552266|Methylphenidate|methylphenidate|mesh-list
110136990|NCT05967936|Sensory System Agents|sensory system agents|mesh-ancestor
110136991|NCT05967936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110136993|NCT05967884|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110136994|NCT05967884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110136995|NCT05967650|Vaccines|vaccines|mesh-list
110136996|NCT05967650|Immunologic Factors|immunologic factors|mesh-ancestor
110136997|NCT05967650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110136999|NCT05967442|Metoclopramide|metoclopramide|mesh-list
110137000|NCT05967442|Prochlorperazine|prochlorperazine|mesh-list
110137001|NCT05967442|Analgesics|analgesics|mesh-ancestor
110137002|NCT05967442|Sensory System Agents|sensory system agents|mesh-ancestor
110137003|NCT05967442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110137004|NCT05967442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110137005|NCT05967442|Anesthetics|anesthetics|mesh-ancestor
110137006|NCT05967442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110137007|NCT05967442|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110137008|NCT05967442|Anticonvulsants|anticonvulsants|mesh-ancestor
110137009|NCT05967442|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110137010|NCT05967442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110137011|NCT05967442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110137012|NCT05967442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110137013|NCT05967442|Tocolytic Agents|tocolytic agents|mesh-ancestor
110137014|NCT05967442|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110137016|NCT05967442|Autonomic Agents|autonomic agents|mesh-ancestor
110137017|NCT05967442|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110137018|NCT05967442|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110137019|NCT05967442|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110137020|NCT05967442|Dopamine Agents|dopamine agents|mesh-ancestor
110137021|NCT05967442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110137022|NCT05967442|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110137023|NCT05967442|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110137024|NCT05967442|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110137026|NCT05967403|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110137027|NCT05967403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110137028|NCT05967403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110137029|NCT05967403|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110137030|NCT05967403|Anesthetics, General|anesthetics, general|mesh-ancestor
110137031|NCT05967403|Anesthetics|anesthetics|mesh-ancestor
110137032|NCT05967377|Leucovorin|leucovorin|mesh-list
110137033|NCT05967377|Sorafenib|sorafenib|mesh-list
110137034|NCT05967377|Fluorouracil|fluorouracil|mesh-list
110137035|NCT05967377|Methotrexate|methotrexate|mesh-list
110137036|NCT05967377|Carboplatin|carboplatin|mesh-list
110137037|NCT05967377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110353395|NCT04003805|Nicotine|nicotine|mesh-list
110137038|NCT05967377|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110137039|NCT05967377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110137040|NCT05967377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110137041|NCT05967377|Antidotes|antidotes|mesh-ancestor
110137042|NCT05967377|Protective Agents|protective agents|mesh-ancestor
110137043|NCT05967377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110137045|NCT05967377|Vitamins|vitamins|mesh-ancestor
110137046|NCT05967377|Micronutrients|micronutrients|mesh-ancestor
110137047|NCT05967377|Antimetabolites|antimetabolites|mesh-ancestor
110137048|NCT05967377|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110137049|NCT05967377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110137050|NCT05967377|Immunologic Factors|immunologic factors|mesh-ancestor
110353447|NCT05414058|Methylphenidate|methylphenidate|mesh-list
110137051|NCT05967377|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110137053|NCT05967377|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110137054|NCT05967377|Dermatologic Agents|dermatologic agents|mesh-ancestor
110137055|NCT05967377|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110137056|NCT05967377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110137057|NCT05967377|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110137058|NCT05967182|Gemcitabine|gemcitabine|mesh-list
110137059|NCT05967182|Pembrolizumab|pembrolizumab|mesh-list
110137060|NCT05967182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110137061|NCT05967182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110137062|NCT05967182|Antimetabolites|antimetabolites|mesh-ancestor
110137063|NCT05967182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110137064|NCT05967182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110137065|NCT05967182|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110137066|NCT05967156|Empagliflozin|empagliflozin|mesh-list
110137067|NCT05967156|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110137068|NCT05967156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110137069|NCT05967156|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110137070|NCT05967156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110137071|NCT05966818|Dapagliflozin|dapagliflozin|mesh-list
110137072|NCT05966818|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
110137073|NCT05966818|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110137074|NCT05966818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110137075|NCT05966818|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110137076|NCT05966818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110137077|NCT05966818|Protease Inhibitors|protease inhibitors|mesh-ancestor
110137078|NCT05966818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110137079|NCT05966792|Metformin|metformin|mesh-list
110137080|NCT05966792|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
110137081|NCT05966792|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110137082|NCT05966792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110137083|NCT05966792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110137084|NCT05966727|Cholestyramine Resin|cholestyramine resin|mesh-list
110137085|NCT05966727|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110137086|NCT05966727|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110137087|NCT05966727|Antimetabolites|antimetabolites|mesh-ancestor
110137088|NCT05966727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110137089|NCT05966727|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110137090|NCT05965908|Metformin|metformin|mesh-list
110137091|NCT05965908|Liraglutide|liraglutide|mesh-list
110137092|NCT05965908|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110137093|NCT05965908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110137094|NCT05965908|Incretins|incretins|mesh-ancestor
110137095|NCT05965908|Hormones|hormones|mesh-ancestor
110137096|NCT05965908|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110137097|NCT05965895|Dexmedetomidine|dexmedetomidine|mesh-list
110137098|NCT05965895|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110137099|NCT05965895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110137100|NCT05965895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110137101|NCT05965895|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110137102|NCT05965895|Analgesics|analgesics|mesh-ancestor
110137103|NCT05965895|Sensory System Agents|sensory system agents|mesh-ancestor
110137104|NCT05965895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110137105|NCT05965895|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110137106|NCT05965895|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110137107|NCT05965895|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110137108|NCT05965895|Adrenergic Agents|adrenergic agents|mesh-ancestor
110137109|NCT05965895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110137110|NCT05965895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110137111|NCT05959252|Heparin|heparin|mesh-list
110137112|NCT05959252|Calcium heparin|calcium heparin|mesh-list
110137113|NCT05959252|Bivalirudin|bivalirudin|mesh-list
110137114|NCT05959252|Anticoagulants|anticoagulants|mesh-ancestor
110137115|NCT05959252|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110137116|NCT05959252|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110137117|NCT05959252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110137118|NCT05959252|Antithrombins|antithrombins|mesh-ancestor
110137119|NCT05959252|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110137120|NCT05959252|Protease Inhibitors|protease inhibitors|mesh-ancestor
110137121|NCT05959252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110137122|NCT05951387|Dexmedetomidine|dexmedetomidine|mesh-list
110137123|NCT05951387|Ketamine|ketamine|mesh-list
110137124|NCT05951387|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110137125|NCT05951387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110137126|NCT05951387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110137127|NCT05951387|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110137128|NCT05951387|Analgesics|analgesics|mesh-ancestor
110137129|NCT05951387|Sensory System Agents|sensory system agents|mesh-ancestor
110137130|NCT05951387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110137131|NCT05951387|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110137132|NCT05951387|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110137133|NCT05951387|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110137134|NCT05951387|Adrenergic Agents|adrenergic agents|mesh-ancestor
110137135|NCT05951387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110137136|NCT05951387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110137137|NCT05951387|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110137138|NCT05951387|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110137139|NCT05951387|Anesthetics, General|anesthetics, general|mesh-ancestor
110137140|NCT05951387|Anesthetics|anesthetics|mesh-ancestor
110137141|NCT05951387|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110137142|NCT05951387|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110137143|NCT05944926|Fluoxetine|fluoxetine|mesh-list
110137144|NCT05944926|Antidepressive Agents|antidepressive agents|mesh-list
110137145|NCT05944926|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110137146|NCT05944926|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110137147|NCT05944926|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110137148|NCT05944926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110137149|NCT05944926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110137151|NCT05944926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110137152|NCT05944926|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110137153|NCT05944926|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110137154|NCT05944926|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110137155|NCT05944926|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110137156|NCT05944926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110137157|NCT05940220|Acetazolamide|acetazolamide|mesh-list
110137158|NCT05940220|Anticonvulsants|anticonvulsants|mesh-ancestor
110137159|NCT05940220|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110137160|NCT05940220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110137161|NCT05940220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110137162|NCT05940220|Diuretics|diuretics|mesh-ancestor
110137163|NCT05940220|Natriuretic Agents|natriuretic agents|mesh-ancestor
110137164|NCT05940220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110137165|NCT05935631|Folic Acid|folic acid|mesh-list
110137166|NCT05935631|Hematinics|hematinics|mesh-ancestor
110137167|NCT05935631|Vitamin B Complex|vitamin b complex|mesh-ancestor
110137168|NCT05935631|Vitamins|vitamins|mesh-ancestor
110137169|NCT05935631|Micronutrients|micronutrients|mesh-ancestor
110137170|NCT05935631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110137171|NCT05934214|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
110137172|NCT05934214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110137173|NCT05934214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110137174|NCT05934214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110137175|NCT05928858|Calcium|calcium|mesh-list
110137176|NCT05928858|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110137177|NCT05928858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110137178|NCT05923476|Lithium Carbonate|lithium carbonate|mesh-list
110137179|NCT05923476|Antidepressive Agents|antidepressive agents|mesh-ancestor
110137180|NCT05923476|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110137181|NCT05923476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110137182|NCT05923476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110137183|NCT05923476|Antimanic Agents|antimanic agents|mesh-ancestor
110137184|NCT05923476|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110137185|NCT05923476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110137186|NCT05923476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110137187|NCT05917340|Aspirin|aspirin|mesh-list
110137188|NCT05917340|Moxifloxacin|moxifloxacin|mesh-list
110137189|NCT05917340|Rifampin|rifampin|mesh-list
110137190|NCT05917340|Isoniazid|isoniazid|mesh-list
110137191|NCT05917340|Pyrazinamide|pyrazinamide|mesh-list
110137192|NCT05917340|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110137193|NCT05917340|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110137194|NCT05917340|Analgesics|analgesics|mesh-ancestor
110137195|NCT05917340|Sensory System Agents|sensory system agents|mesh-ancestor
110137196|NCT05917340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110137197|NCT05917340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110137198|NCT05917340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110137199|NCT05917340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110137200|NCT05917340|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110137201|NCT05917340|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110137202|NCT05917340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110137203|NCT05917340|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110137204|NCT05917340|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110137205|NCT05917340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110137206|NCT05917340|Antipyretics|antipyretics|mesh-ancestor
110137207|NCT05917340|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110137208|NCT05917340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110137209|NCT05917340|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110137210|NCT05917340|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110137211|NCT05917340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110137212|NCT05917340|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110137213|NCT05917340|Antitubercular Agents|antitubercular agents|mesh-ancestor
110137214|NCT05917340|Leprostatic Agents|leprostatic agents|mesh-ancestor
110137215|NCT05917340|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110137216|NCT05917340|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110137217|NCT05917340|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110137218|NCT05917340|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110137219|NCT05917340|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110137220|NCT05917340|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110137221|NCT05917340|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110137222|NCT05917340|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
110137223|NCT05917340|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110137225|NCT05917340|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110137226|NCT05911061|Vaccines|vaccines|mesh-list
110137227|NCT05911061|Immunologic Factors|immunologic factors|mesh-ancestor
110137228|NCT05911061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110137229|NCT05911048|Vaccines|vaccines|mesh-list
110137230|NCT05911048|Immunologic Factors|immunologic factors|mesh-ancestor
110137231|NCT05911048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110137232|NCT05878639|Lactulose|lactulose|mesh-list
110137233|NCT05878639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110137234|NCT05876858|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110137235|NCT05876858|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110137236|NCT05876858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110137237|NCT05871684|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
110137238|NCT05871684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110137239|NCT05871684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110137240|NCT05871684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110137241|NCT05862545|Budesonide|budesonide|mesh-list
110137242|NCT05862545|Glycopyrrolate|glycopyrrolate|mesh-list
110137243|NCT05862545|Formoterol Fumarate|formoterol fumarate|mesh-list
110137244|NCT05862545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110137245|NCT05862545|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110137246|NCT05862545|Autonomic Agents|autonomic agents|mesh-ancestor
110137247|NCT05862545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110137248|NCT05862545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110137249|NCT05862545|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110137250|NCT05862545|Respiratory System Agents|respiratory system agents|mesh-ancestor
110137251|NCT05862545|Glucocorticoids|glucocorticoids|mesh-ancestor
110137253|NCT05862545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110137254|NCT05862545|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110137255|NCT05862545|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110137256|NCT05862545|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110137257|NCT05862545|Adrenergic Agents|adrenergic agents|mesh-ancestor
110137258|NCT05862545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110137259|NCT05862545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110137260|NCT05862545|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110137261|NCT05862545|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110137262|NCT05862545|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110137263|NCT05862545|Cholinergic Agents|cholinergic agents|mesh-ancestor
110137264|NCT05845645|Esomeprazole|esomeprazole|mesh-list
110137265|NCT05845645|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110137266|NCT05845645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110137267|NCT05845645|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110137268|NCT05845645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110137269|NCT05845645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110137270|NCT05845359|Methadone|methadone|mesh-list
110137271|NCT05845359|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110137272|NCT05845359|Narcotics|narcotics|mesh-ancestor
110137273|NCT05845359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110137274|NCT05845359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110137275|NCT05845359|Analgesics|analgesics|mesh-ancestor
110137276|NCT05845359|Sensory System Agents|sensory system agents|mesh-ancestor
110137277|NCT05845359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110137278|NCT05845359|Antitussive Agents|antitussive agents|mesh-ancestor
110137279|NCT05845359|Respiratory System Agents|respiratory system agents|mesh-ancestor
110137280|NCT05845138|Capecitabine|capecitabine|mesh-list
110137281|NCT05845138|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110137282|NCT05845138|Antimetabolites|antimetabolites|mesh-ancestor
110137283|NCT05845138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110137284|NCT05845138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110137285|NCT05835258|Melatonin|melatonin|mesh-list
110137286|NCT05835258|Capsaicin|capsaicin|mesh-list
110137287|NCT05835258|Antioxidants|antioxidants|mesh-ancestor
110137288|NCT05835258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110137289|NCT05835258|Protective Agents|protective agents|mesh-ancestor
110137290|NCT05835258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110137291|NCT05835258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110137292|NCT05835258|Antipruritics|antipruritics|mesh-ancestor
110137293|NCT05835258|Dermatologic Agents|dermatologic agents|mesh-ancestor
110137294|NCT05835258|Sensory System Agents|sensory system agents|mesh-ancestor
110137295|NCT05835258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110137297|NCT05834777|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110137298|NCT05834777|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110137299|NCT05834777|Analgesics|analgesics|mesh-ancestor
110137300|NCT05834777|Sensory System Agents|sensory system agents|mesh-ancestor
110137301|NCT05834777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110137302|NCT05834777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110137303|NCT05834777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110137304|NCT05834777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110137305|NCT05834777|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
110137306|NCT05834777|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
110137307|NCT05834777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110137308|NCT05834777|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
110137309|NCT05834777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110137310|NCT05834777|Immunologic Factors|immunologic factors|mesh-ancestor
110137311|NCT05803421|Insulin Glargine|insulin glargine|mesh-list
110137312|NCT05803421|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110137313|NCT05803421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110137314|NCT05798793|Cisplatin|cisplatin|mesh-list
110137315|NCT05798793|Docetaxel|docetaxel|mesh-list
110137316|NCT05798793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110137317|NCT05798793|Tubulin Modulators|tubulin modulators|mesh-ancestor
110137318|NCT05798793|Antimitotic Agents|antimitotic agents|mesh-ancestor
110137319|NCT05798793|Mitosis Modulators|mitosis modulators|mesh-ancestor
110137320|NCT05798793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110137321|NCT05783544|Interferons|interferons|mesh-list
110137322|NCT05783544|Interferon-gamma|interferon-gamma|mesh-list
110137323|NCT05783544|Interleukin-4|interleukin-4|mesh-list
110137324|NCT05783544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110137325|NCT05783544|Antiviral Agents|antiviral agents|mesh-ancestor
110137326|NCT05783544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110137327|NCT05783544|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110137328|NCT05783544|Immunologic Factors|immunologic factors|mesh-ancestor
110137329|NCT05783544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110137330|NCT05783544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110137331|NCT05769881|Anesthetics|anesthetics|mesh-list
110137332|NCT05769881|Anesthetics, Local|anesthetics, local|mesh-list
110166781|NCT00028717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110137333|NCT05769881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110137334|NCT05769881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110137335|NCT05769881|Sensory System Agents|sensory system agents|mesh-ancestor
110137336|NCT05769881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110137337|NCT05760677|Metformin|metformin|mesh-list
110137338|NCT05760677|Pioglitazone|pioglitazone|mesh-list
110137339|NCT05760677|Orlistat|orlistat|mesh-list
110137340|NCT05760677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110137341|NCT05760677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110137342|NCT05760677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110137343|NCT05760677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110137344|NCT05760677|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110137345|NCT05760677|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110137347|NCT05741502|Risperidone|risperidone|mesh-list
110137348|NCT05741502|Aripiprazole|aripiprazole|mesh-list
110137349|NCT05741502|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110137350|NCT05741502|Paliperidone Palmitate|paliperidone palmitate|mesh-list
110137351|NCT05741502|Ziprasidone|ziprasidone|mesh-list
110137352|NCT05741502|Antipsychotic Agents|antipsychotic agents|mesh-list
110137353|NCT05741502|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
110137354|NCT05741502|Clozapine|clozapine|mesh-list
110137355|NCT05741502|Cariprazine|cariprazine|mesh-list
110137356|NCT05741502|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110137357|NCT05741502|Serotonin Agents|serotonin agents|mesh-ancestor
110137358|NCT05741502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110137359|NCT05741502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110137360|NCT05741502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110137361|NCT05741502|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110137362|NCT05741502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110137363|NCT05741502|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110137364|NCT05741502|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110137365|NCT05741502|Dopamine Agents|dopamine agents|mesh-ancestor
110137366|NCT05741502|Antiemetics|antiemetics|mesh-ancestor
110137367|NCT05741502|Autonomic Agents|autonomic agents|mesh-ancestor
110137368|NCT05741502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110137369|NCT05741502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110137370|NCT05741502|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110137371|NCT05741502|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110137372|NCT05741502|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110137373|NCT05741502|Antidepressive Agents|antidepressive agents|mesh-ancestor
110137374|NCT05741502|Dopamine Agonists|dopamine agonists|mesh-ancestor
110137375|NCT05741502|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110137376|NCT05741502|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110137377|NCT05741502|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110137378|NCT05741502|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110137379|NCT05741502|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
110137380|NCT05741502|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110137381|NCT05741502|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110137382|NCT05741502|Adrenergic Agents|adrenergic agents|mesh-ancestor
110137383|NCT05741502|GABA Antagonists|gaba antagonists|mesh-ancestor
110137384|NCT05741502|GABA Agents|gaba agents|mesh-ancestor
110137385|NCT05725031|Ephedrine|ephedrine|mesh-list
110137386|NCT05725031|Rocuronium|rocuronium|mesh-list
110137387|NCT05725031|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110137388|NCT05725031|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110137389|NCT05725031|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110137390|NCT05725031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110137391|NCT05725031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110137392|NCT05725031|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110137393|NCT05725031|Sympathomimetics|sympathomimetics|mesh-ancestor
110137394|NCT05725031|Autonomic Agents|autonomic agents|mesh-ancestor
110137395|NCT05725031|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110137396|NCT05725031|Adrenergic Agents|adrenergic agents|mesh-ancestor
110137397|NCT05725031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110137398|NCT05725031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110368565|NCT04618107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110368566|NCT05423015|Levan|levan|mesh-list
110368567|NCT05423015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110368568|NCT04618146|Morphine|morphine|mesh-list
110368569|NCT04618146|Bupivacaine|bupivacaine|mesh-list
110368570|NCT04618146|Anesthetics, Local|anesthetics, local|mesh-ancestor
110368571|NCT04618146|Anesthetics|anesthetics|mesh-ancestor
110368572|NCT04618146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110368573|NCT04618146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110368574|NCT04618146|Sensory System Agents|sensory system agents|mesh-ancestor
110368575|NCT04618146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110368576|NCT04618146|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110368577|NCT04618146|Narcotics|narcotics|mesh-ancestor
110368579|NCT04651842|Insulin|insulin|mesh-list
110368580|NCT04651842|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110368581|NCT04651842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110368582|NCT05421962|Fentanyl|fentanyl|mesh-list
110368583|NCT05421962|Ketamine|ketamine|mesh-list
110368584|NCT05421962|Analgesics|analgesics|mesh-ancestor
110368585|NCT05421962|Sensory System Agents|sensory system agents|mesh-ancestor
110368586|NCT05421962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110368587|NCT05421962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110368588|NCT05421962|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110368589|NCT05421962|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110368590|NCT05421962|Anesthetics, General|anesthetics, general|mesh-ancestor
110368591|NCT05421962|Anesthetics|anesthetics|mesh-ancestor
110368592|NCT05421962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110368593|NCT05421962|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110368594|NCT05421962|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110368595|NCT05421962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110368596|NCT05421962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110368597|NCT05421962|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110368598|NCT05421962|Narcotics|narcotics|mesh-ancestor
110368599|NCT05421962|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110368600|NCT00557817|Darbepoetin alfa|darbepoetin alfa|mesh-list
110368601|NCT00557817|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
110368602|NCT00557817|Hematinics|hematinics|mesh-ancestor
110368603|NCT05419583|Aspirin|aspirin|mesh-list
110368604|NCT05419583|Warfarin|warfarin|mesh-list
110368605|NCT05419583|Apixaban|apixaban|mesh-list
110368606|NCT05419583|Anticoagulants|anticoagulants|mesh-list
110368607|NCT05419583|Edoxaban|edoxaban|mesh-list
110368608|NCT05419583|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
110368609|NCT05419583|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
110368610|NCT05419583|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110368611|NCT05419583|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110368612|NCT05419583|Analgesics|analgesics|mesh-ancestor
110368613|NCT05419583|Sensory System Agents|sensory system agents|mesh-ancestor
110368614|NCT05419583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110368615|NCT05419583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110368616|NCT05419583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110368617|NCT05419583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110137399|NCT05707754|Bupivacaine|bupivacaine|mesh-list
110137400|NCT05707754|Anesthetics, Local|anesthetics, local|mesh-ancestor
110137401|NCT05707754|Anesthetics|anesthetics|mesh-ancestor
110137402|NCT05707754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110137403|NCT05707754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110137404|NCT05707754|Sensory System Agents|sensory system agents|mesh-ancestor
110137405|NCT05707754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110137406|NCT05699824|Carvedilol|carvedilol|mesh-list
110137407|NCT05699824|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110137408|NCT05699824|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110137409|NCT05699824|Adrenergic Agents|adrenergic agents|mesh-ancestor
110137410|NCT05699824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110137411|NCT05699824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110137412|NCT05699824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110137413|NCT05699824|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110137414|NCT05699824|Antioxidants|antioxidants|mesh-ancestor
110137415|NCT05699824|Protective Agents|protective agents|mesh-ancestor
110137416|NCT05699824|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110137417|NCT05699824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110137418|NCT05699824|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110137419|NCT05699824|Vasodilator Agents|vasodilator agents|mesh-ancestor
110137420|NCT05699824|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110137421|NCT05699824|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110137422|NCT05698095|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
110137423|NCT05698095|Hallucinogens|hallucinogens|mesh-ancestor
110137424|NCT05698095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110137425|NCT05698095|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110137426|NCT05698095|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110137427|NCT05698095|Serotonin Agents|serotonin agents|mesh-ancestor
110137428|NCT05698095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110137429|NCT05698095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110137430|NCT05698095|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110137431|NCT05696626|Fulvestrant|fulvestrant|mesh-list
110137432|NCT05696626|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110137433|NCT05696626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110137434|NCT05696626|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110137435|NCT05696626|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110137436|NCT05696626|Hormone Antagonists|hormone antagonists|mesh-ancestor
110137437|NCT05696626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110137438|NCT05696626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110137439|NCT05694637|Varenicline|varenicline|mesh-list
110137440|NCT05694637|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110137441|NCT05694637|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110137442|NCT05694637|Cholinergic Agents|cholinergic agents|mesh-ancestor
110137443|NCT05694637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110137444|NCT05694637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110137445|NCT05694637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110137447|NCT05687253|Rocuronium|rocuronium|mesh-list
110137448|NCT05687253|Anticonvulsants|anticonvulsants|mesh-ancestor
110353638|NCT04356430|Prednisone|prednisone|mesh-list
110137449|NCT05687253|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110137450|NCT05687253|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110137451|NCT05687253|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110137452|NCT05687253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110137453|NCT05687253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110137455|NCT05686408|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110137456|NCT05686408|Antidepressive Agents|antidepressive agents|mesh-ancestor
110137457|NCT05686408|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110137458|NCT05683977|Durvalumab|durvalumab|mesh-list
110137459|NCT05683977|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110137460|NCT05683977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110137461|NCT05683821|Nicotine|nicotine|mesh-list
110137462|NCT05683821|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110137463|NCT05683821|Autonomic Agents|autonomic agents|mesh-ancestor
110137464|NCT05683821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110137465|NCT05683821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110137466|NCT05683821|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110137467|NCT05683821|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110137468|NCT05683821|Cholinergic Agents|cholinergic agents|mesh-ancestor
110137469|NCT05683821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110137470|NCT05683821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110137472|NCT05680805|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110137473|NCT05680805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110137474|NCT05651594|Leucovorin|leucovorin|mesh-list
110137475|NCT05651594|Pembrolizumab|pembrolizumab|mesh-list
110137476|NCT05651594|Fluorouracil|fluorouracil|mesh-list
110137477|NCT05651594|Oxaliplatin|oxaliplatin|mesh-list
110137478|NCT05651594|Propranolol|propranolol|mesh-list
110137479|NCT05651594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110137480|NCT05651594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110137481|NCT05651594|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110137482|NCT05651594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110137483|NCT05651594|Antimetabolites|antimetabolites|mesh-ancestor
110137484|NCT05651594|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110137485|NCT05651594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110137486|NCT05651594|Immunologic Factors|immunologic factors|mesh-ancestor
110137487|NCT05651594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110137488|NCT05651594|Antidotes|antidotes|mesh-ancestor
110137489|NCT05651594|Protective Agents|protective agents|mesh-ancestor
110137498|NCT05651594|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110137499|NCT05651594|Vasodilator Agents|vasodilator agents|mesh-ancestor
110137508|NCT05637970|Hemostatics|hemostatics|mesh-list
110137509|NCT05637970|Coagulants|coagulants|mesh-ancestor
110137510|NCT05626803|Vaccines|vaccines|mesh-list
110137511|NCT05626803|Immunologic Factors|immunologic factors|mesh-ancestor
110137512|NCT05626803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110137513|NCT05587894|Ritonavir|ritonavir|mesh-list
110137514|NCT05587894|Remdesivir|remdesivir|mesh-list
110137515|NCT05587894|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
110137516|NCT05587894|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110137517|NCT05587894|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110137518|NCT05587894|Protease Inhibitors|protease inhibitors|mesh-ancestor
110137519|NCT05587894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110137520|NCT05587894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110137521|NCT05587894|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110137522|NCT05587894|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110137523|NCT05587894|Antiviral Agents|antiviral agents|mesh-ancestor
110137524|NCT05587894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110353653|NCT03974139|Metformin|metformin|mesh-list
110137525|NCT05587894|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110137526|NCT05587894|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110137527|NCT05587894|Antimetabolites|antimetabolites|mesh-ancestor
110137528|NCT05584657|Amoxicillin|amoxicillin|mesh-list
110137529|NCT05584657|Clavulanic Acid|clavulanic acid|mesh-list
110137530|NCT05584657|Clavulanic Acids|clavulanic acids|mesh-list
110137531|NCT05584657|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
110137532|NCT05584657|Lactams|lactams|mesh-list
110137533|NCT05584657|Probenecid|probenecid|mesh-list
110137534|NCT05584657|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110137535|NCT05584657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110137536|NCT05584657|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110137537|NCT05584657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110137538|NCT05584657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110137539|NCT05584657|Uricosuric Agents|uricosuric agents|mesh-ancestor
110137540|NCT05584657|Gout Suppressants|gout suppressants|mesh-ancestor
110137541|NCT05584657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110137542|NCT05561543|Peppermint oil|peppermint oil|mesh-list
110137543|NCT05561543|Antiemetics|antiemetics|mesh-ancestor
110137544|NCT05561543|Autonomic Agents|autonomic agents|mesh-ancestor
110137545|NCT05561543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110137546|NCT05561543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110137547|NCT05561543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110137548|NCT05561543|Parasympatholytics|parasympatholytics|mesh-ancestor
110137549|NCT05558124|Cytarabine|cytarabine|mesh-list
110137550|NCT05558124|Daunorubicin|daunorubicin|mesh-list
110137551|NCT05558124|Gemtuzumab|gemtuzumab|mesh-list
110137552|NCT05558124|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110137553|NCT05558124|Antimetabolites|antimetabolites|mesh-ancestor
110137554|NCT05558124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110137555|NCT05558124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110137556|NCT05558124|Antiviral Agents|antiviral agents|mesh-ancestor
110137557|NCT05558124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110137558|NCT05558124|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110137559|NCT05558124|Immunologic Factors|immunologic factors|mesh-ancestor
110137560|NCT05558124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110137561|NCT05558124|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110137562|NCT05558124|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110137563|NCT05558124|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110137564|NCT05558124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110137565|NCT05558124|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110137566|NCT05558124|Immunotoxins|immunotoxins|mesh-ancestor
110137567|NCT05558124|Immunoconjugates|immunoconjugates|mesh-ancestor
110137568|NCT05555823|Repaglinide|repaglinide|mesh-list
110137569|NCT05555823|Celecoxib|celecoxib|mesh-list
110137570|NCT05555823|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110137571|NCT05555823|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110137572|NCT05555823|Analgesics|analgesics|mesh-ancestor
110137573|NCT05555823|Sensory System Agents|sensory system agents|mesh-ancestor
110137574|NCT05555823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110137575|NCT05555823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110137576|NCT05555823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110137577|NCT05555823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110137578|NCT05555823|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110137579|NCT05555823|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110137580|NCT05555823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110137581|NCT05555823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110137582|NCT05555823|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110137583|NCT05539729|Vancomycin|vancomycin|mesh-list
110137584|NCT05539729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110137585|NCT05539729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110137608|NCT05501886|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110137609|NCT05501886|Hormone Antagonists|hormone antagonists|mesh-ancestor
110137610|NCT05501886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110353678|NCT00532116|Selegiline|selegiline|mesh-list
110137611|NCT05501886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110137612|NCT05501886|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110137613|NCT05501886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110137614|NCT05501886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110137615|NCT05493371|Empagliflozin|empagliflozin|mesh-list
110137616|NCT05493371|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110137617|NCT05493371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110137619|NCT05493371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110137620|NCT05490680|Sildenafil Citrate|sildenafil citrate|mesh-list
110137621|NCT05490680|Vasodilator Agents|vasodilator agents|mesh-ancestor
110137622|NCT05490680|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110137623|NCT05490680|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110137624|NCT05490680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110137625|NCT05490680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110137626|NCT05490680|Urological Agents|urological agents|mesh-ancestor
110137627|NCT05488366|Pembrolizumab|pembrolizumab|mesh-list
110137628|NCT05488366|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110137629|NCT05488366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110137630|NCT05488366|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110137631|NCT05488366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110137632|NCT05474560|Allopurinol|allopurinol|mesh-list
110137634|NCT05474560|Antimetabolites|antimetabolites|mesh-ancestor
110137635|NCT05474560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110137636|NCT05474560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110137637|NCT05474560|Gout Suppressants|gout suppressants|mesh-ancestor
110137638|NCT05474560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110137639|NCT05474560|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110137640|NCT05474560|Antioxidants|antioxidants|mesh-ancestor
110137641|NCT05474560|Protective Agents|protective agents|mesh-ancestor
110137642|NCT05474560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110137643|NCT05469893|Dexamethasone|dexamethasone|mesh-list
110137644|NCT05469893|Lenalidomide|lenalidomide|mesh-list
110137645|NCT05469893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110137646|NCT05469893|Antiemetics|antiemetics|mesh-ancestor
110137647|NCT05469893|Autonomic Agents|autonomic agents|mesh-ancestor
110137648|NCT05469893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110137649|NCT05469893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110137650|NCT05469893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110137652|NCT05469893|Hormones|hormones|mesh-ancestor
110137653|NCT05469893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110137654|NCT05469893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110137655|NCT05469893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110137656|NCT05469893|Immunologic Factors|immunologic factors|mesh-ancestor
110137657|NCT05469893|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110137658|NCT05469893|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110137659|NCT05469893|Growth Substances|growth substances|mesh-ancestor
110137660|NCT05469893|Growth Inhibitors|growth inhibitors|mesh-ancestor
110137661|NCT05468957|Hemostatics|hemostatics|mesh-list
110137662|NCT05468957|Coagulants|coagulants|mesh-ancestor
110137663|NCT05444751|Anesthetics|anesthetics|mesh-list
110137664|NCT05444751|Anesthetics, General|anesthetics, general|mesh-list
110137665|NCT05444751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110137666|NCT05444751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110137667|NCT05422534|Ubiquinone|ubiquinone|mesh-list
110137668|NCT05422534|Micronutrients|micronutrients|mesh-ancestor
110137669|NCT05422534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110137670|NCT05422066|Prednisone|prednisone|mesh-list
110137671|NCT05422066|Cyclophosphamide|cyclophosphamide|mesh-list
110137672|NCT05422066|Rituximab|rituximab|mesh-list
110137673|NCT05422066|Doxorubicin|doxorubicin|mesh-list
110137674|NCT05422066|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110137675|NCT05422066|Vincristine|vincristine|mesh-list
110137676|NCT05422066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110137677|NCT05422066|Immunologic Factors|immunologic factors|mesh-ancestor
110137678|NCT05422066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110137679|NCT05422066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110137680|NCT05422066|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110137681|NCT05422066|Alkylating Agents|alkylating agents|mesh-ancestor
110137682|NCT05422066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110137683|NCT05422066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110137684|NCT05422066|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110137685|NCT05422066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110137686|NCT05422066|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110137687|NCT05422066|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110137688|NCT05422066|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110137689|NCT05422066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110137690|NCT05422066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110137691|NCT05422066|Glucocorticoids|glucocorticoids|mesh-ancestor
110137693|NCT05422066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110137694|NCT05422066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110137695|NCT05422066|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110137696|NCT05422066|Tubulin Modulators|tubulin modulators|mesh-ancestor
110137697|NCT05422066|Antimitotic Agents|antimitotic agents|mesh-ancestor
110137698|NCT05422066|Mitosis Modulators|mitosis modulators|mesh-ancestor
110137699|NCT05419505|Antifibrinolytic Agents|antifibrinolytic agents|mesh-list
110137700|NCT05419505|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110137701|NCT05419505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110137702|NCT05419505|Hemostatics|hemostatics|mesh-ancestor
110137703|NCT05419505|Coagulants|coagulants|mesh-ancestor
110137704|NCT05413343|Ceftazidime|ceftazidime|mesh-list
110137706|NCT05413343|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
110137707|NCT05413343|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110137708|NCT05413343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110137709|NCT05413343|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110137710|NCT05413343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110137711|NCT05413343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110137712|NCT05375929|Abrocitinib|abrocitinib|mesh-list
110137713|NCT05375929|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110137714|NCT05375929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110137715|NCT05375929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110137716|NCT05319899|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
110137717|NCT05319899|Choline|choline|mesh-list
110137718|NCT05319899|Omeprazole|omeprazole|mesh-list
110137719|NCT05319899|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110137720|NCT05319899|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110137721|NCT05319899|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110137722|NCT05319899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110137723|NCT05319899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110137724|NCT05319899|Lipotropic Agents|lipotropic agents|mesh-ancestor
110137725|NCT05319899|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110137726|NCT05319899|Antimetabolites|antimetabolites|mesh-ancestor
110137727|NCT05319899|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110137728|NCT05319899|Nootropic Agents|nootropic agents|mesh-ancestor
110137729|NCT05319899|Chelating Agents|chelating agents|mesh-ancestor
110137730|NCT05319899|Sequestering Agents|sequestering agents|mesh-ancestor
110137731|NCT05319899|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110137732|NCT05319899|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110137733|NCT05319899|Growth Substances|growth substances|mesh-ancestor
110137734|NCT05319899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110137735|NCT05319899|Growth Inhibitors|growth inhibitors|mesh-ancestor
110166828|NCT00012324|Antimetabolites|antimetabolites|mesh-ancestor
110137736|NCT05319899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110137737|NCT05304767|Xanomeline|xanomeline|mesh-list
110137738|NCT05304767|Trospium chloride|trospium chloride|mesh-list
110137739|NCT05304767|Parasympatholytics|parasympatholytics|mesh-ancestor
110137740|NCT05304767|Autonomic Agents|autonomic agents|mesh-ancestor
110137741|NCT05304767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110137742|NCT05304767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110137743|NCT05304767|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110137744|NCT05304767|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110137745|NCT05304767|Cholinergic Agents|cholinergic agents|mesh-ancestor
110137746|NCT05304767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110137747|NCT05304767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110137748|NCT05304767|Urological Agents|urological agents|mesh-ancestor
110137749|NCT05304767|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110137750|NCT05304767|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110137751|NCT05304767|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
110137752|NCT05304767|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110137754|NCT05302271|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110137755|NCT05302271|Glucocorticoids|glucocorticoids|mesh-ancestor
110137756|NCT05302271|Hormones|hormones|mesh-ancestor
110137757|NCT05302271|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110137758|NCT05302271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110137759|NCT05302271|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110137760|NCT05302271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110137761|NCT05291364|Ethanol|ethanol|mesh-list
110137762|NCT05291364|Dexmedetomidine|dexmedetomidine|mesh-list
110137763|NCT05291364|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110137764|NCT05291364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110137765|NCT05291364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110137766|NCT05291364|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110137767|NCT05291364|Analgesics|analgesics|mesh-ancestor
110137768|NCT05291364|Sensory System Agents|sensory system agents|mesh-ancestor
110137769|NCT05291364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110137770|NCT05291364|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110137771|NCT05291364|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110137772|NCT05291364|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110137773|NCT05291364|Adrenergic Agents|adrenergic agents|mesh-ancestor
110137774|NCT05291364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110137775|NCT05291364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110137776|NCT05291364|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110137777|NCT05291364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110137778|NCT05291221|Lidocaine|lidocaine|mesh-list
110137779|NCT05291221|Dexmedetomidine|dexmedetomidine|mesh-list
110137780|NCT05291221|Anesthetics, Local|anesthetics, local|mesh-ancestor
110137781|NCT05291221|Anesthetics|anesthetics|mesh-ancestor
110137782|NCT05291221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110137783|NCT05291221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110137784|NCT05291221|Sensory System Agents|sensory system agents|mesh-ancestor
110137785|NCT05291221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110137786|NCT05291221|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110137787|NCT05291221|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110137788|NCT05291221|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110137789|NCT05291221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110137790|NCT05291221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110137791|NCT05291221|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110137792|NCT05291221|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110137793|NCT05291221|Analgesics|analgesics|mesh-ancestor
110137794|NCT05291221|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110137795|NCT05291221|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110353772|NCT04320277|Ritonavir|ritonavir|mesh-list
110137796|NCT05291221|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110137797|NCT05291221|Adrenergic Agents|adrenergic agents|mesh-ancestor
110137798|NCT05291221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110137799|NCT05280132|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110137800|NCT05280132|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
110137801|NCT05280132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110137802|NCT05280132|Antitubercular Agents|antitubercular agents|mesh-ancestor
110137803|NCT05274269|Ivacaftor|ivacaftor|mesh-list
110137804|NCT05274269|Elexacaftor|elexacaftor|mesh-list
110137805|NCT05274269|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
110137806|NCT05274269|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110137807|NCT05274269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110137809|NCT05268614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110137810|NCT05266924|Hormones|hormones|mesh-list
110137811|NCT05266924|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
110137812|NCT05266924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110137813|NCT05266924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110137814|NCT05266196|Cyclophosphamide|cyclophosphamide|mesh-list
110137815|NCT05266196|Topotecan|topotecan|mesh-list
110137816|NCT05266196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110137817|NCT05266196|Immunologic Factors|immunologic factors|mesh-ancestor
110137818|NCT05266196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110137819|NCT05266196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110137820|NCT05266196|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110137821|NCT05266196|Alkylating Agents|alkylating agents|mesh-ancestor
110137822|NCT05266196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110137823|NCT05266196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110137824|NCT05266196|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110137825|NCT05266196|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110137826|NCT05266196|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110137827|NCT05266196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110137828|NCT05194592|Dapagliflozin|dapagliflozin|mesh-list
110353797|NCT04157153|Sirolimus|sirolimus|mesh-list
110137829|NCT05194592|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110137830|NCT05194592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110137832|NCT05194592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110137833|NCT05190562|Zinc Sulfate|zinc sulfate|mesh-list
110137834|NCT05190562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110137835|NCT05190562|Astringents|astringents|mesh-ancestor
110137836|NCT05190562|Dermatologic Agents|dermatologic agents|mesh-ancestor
110137837|NCT05184101|Heparin|heparin|mesh-list
110137838|NCT05184101|Calcium heparin|calcium heparin|mesh-list
110137839|NCT05184101|Anticoagulants|anticoagulants|mesh-ancestor
110137840|NCT05184101|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110137841|NCT05184101|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110137842|NCT05184101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110137843|NCT05152472|Atezolizumab|atezolizumab|mesh-list
110137844|NCT05152472|Imatinib Mesylate|imatinib mesylate|mesh-list
110137845|NCT05152472|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110137846|NCT05152472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110137847|NCT05152472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110137848|NCT05152472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110137849|NCT05152472|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110137850|NCT05152472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110137851|NCT05147272|Gemcitabine|gemcitabine|mesh-list
110137852|NCT05147272|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110137853|NCT05147272|Antimetabolites|antimetabolites|mesh-ancestor
110137854|NCT05147272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110137855|NCT05147272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110137856|NCT05145413|Xanomeline|xanomeline|mesh-list
110137857|NCT05145413|Trospium chloride|trospium chloride|mesh-list
110137858|NCT05145413|Parasympatholytics|parasympatholytics|mesh-ancestor
110137859|NCT05145413|Autonomic Agents|autonomic agents|mesh-ancestor
110137860|NCT05145413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110137861|NCT05145413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110137862|NCT05145413|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110137863|NCT05145413|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110137864|NCT05145413|Cholinergic Agents|cholinergic agents|mesh-ancestor
110137865|NCT05145413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110137866|NCT05145413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110137867|NCT05145413|Urological Agents|urological agents|mesh-ancestor
110137868|NCT05145413|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110137869|NCT05145413|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110137870|NCT05145413|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
110137871|NCT05145413|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110137925|NCT05022147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110137927|NCT05022147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110137928|NCT05022147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110137929|NCT05022147|Protective Agents|protective agents|mesh-ancestor
110137930|NCT05020860|Paclitaxel|paclitaxel|mesh-list
110137931|NCT05020860|Cyclophosphamide|cyclophosphamide|mesh-list
110137932|NCT05020860|Carboplatin|carboplatin|mesh-list
110137933|NCT05020860|Doxorubicin|doxorubicin|mesh-list
110137934|NCT05020860|Pembrolizumab|pembrolizumab|mesh-list
110137935|NCT05020860|Trastuzumab|trastuzumab|mesh-list
110137936|NCT05020860|Pertuzumab|pertuzumab|mesh-list
110137937|NCT05020860|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110137938|NCT05020860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110137939|NCT05020860|Tubulin Modulators|tubulin modulators|mesh-ancestor
110137940|NCT05020860|Antimitotic Agents|antimitotic agents|mesh-ancestor
110137941|NCT05020860|Mitosis Modulators|mitosis modulators|mesh-ancestor
110137942|NCT05020860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110137943|NCT05020860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110137944|NCT05020860|Immunologic Factors|immunologic factors|mesh-ancestor
110137945|NCT05020860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110137946|NCT05020860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110137947|NCT05020860|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110137948|NCT05020860|Alkylating Agents|alkylating agents|mesh-ancestor
110137949|NCT05020860|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110137950|NCT05020860|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110137951|NCT05020860|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110137952|NCT05020860|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110137953|NCT05020860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110137954|NCT05020860|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110137955|NCT05020860|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110137956|NCT05010538|Sarecycline|sarecycline|mesh-list
110137957|NCT05010538|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110137958|NCT05010538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110137959|NCT05010538|Dermatologic Agents|dermatologic agents|mesh-ancestor
110137960|NCT05005299|Cyclophosphamide|cyclophosphamide|mesh-list
110137961|NCT05005299|Fludarabine|fludarabine|mesh-list
110137962|NCT05005299|Venetoclax|venetoclax|mesh-list
110137963|NCT05005299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110137964|NCT05005299|Immunologic Factors|immunologic factors|mesh-ancestor
110137965|NCT05005299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110137966|NCT05005299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110137967|NCT05005299|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110137968|NCT05005299|Alkylating Agents|alkylating agents|mesh-ancestor
110137969|NCT05005299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110137970|NCT05005299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110137971|NCT05005299|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110137972|NCT04999449|Scopolamine|scopolamine|mesh-list
110137973|NCT04999449|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
110137974|NCT04999449|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110137975|NCT04999449|Antiemetics|antiemetics|mesh-ancestor
110137976|NCT04999449|Autonomic Agents|autonomic agents|mesh-ancestor
110137977|NCT04999449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110137978|NCT04999449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110137979|NCT04999449|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110137980|NCT04999449|Mydriatics|mydriatics|mesh-ancestor
110137981|NCT04999449|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110137982|NCT04999449|Cholinergic Agents|cholinergic agents|mesh-ancestor
110137983|NCT04999449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110137984|NCT04999449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110137985|NCT04999449|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110137986|NCT04999449|Parasympatholytics|parasympatholytics|mesh-ancestor
110137987|NCT04985929|Sildenafil Citrate|sildenafil citrate|mesh-list
110137989|NCT04985929|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110137990|NCT04985929|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110137991|NCT04985929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110137992|NCT04985929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110137993|NCT04985929|Urological Agents|urological agents|mesh-ancestor
110137994|NCT04971187|Cisplatin|cisplatin|mesh-list
110137995|NCT04971187|Carboplatin|carboplatin|mesh-list
110137996|NCT04971187|Pemetrexed|pemetrexed|mesh-list
110137997|NCT04971187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110137998|NCT04971187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110137999|NCT04971187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110138000|NCT04971187|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110138001|NCT04971187|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110138002|NCT04929379|Fenofibrate|fenofibrate|mesh-list
110138003|NCT04929379|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110138004|NCT04929379|Antimetabolites|antimetabolites|mesh-ancestor
110138005|NCT04929379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110138006|NCT04929379|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110138007|NCT04929080|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110138008|NCT04929080|Antibodies|antibodies|mesh-list
110138009|NCT04929080|Immunoglobulins|immunoglobulins|mesh-list
110138010|NCT04929080|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110138011|NCT04929080|Immunoglobulin G|immunoglobulin g|mesh-list
110138012|NCT04929080|Immunologic Factors|immunologic factors|mesh-ancestor
110138013|NCT04929080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110138014|NCT04929080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110138015|NCT04914676|Cytarabine|cytarabine|mesh-list
110138016|NCT04914676|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110138017|NCT04914676|Antimetabolites|antimetabolites|mesh-ancestor
110138018|NCT04914676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110138019|NCT04914676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110138020|NCT04914676|Antiviral Agents|antiviral agents|mesh-ancestor
110138021|NCT04914676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110138022|NCT04914676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110138023|NCT04914676|Immunologic Factors|immunologic factors|mesh-ancestor
110138024|NCT04914676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110138026|NCT04914195|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110138027|NCT04914195|Fertility Agents|fertility agents|mesh-ancestor
110138028|NCT04914195|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110138029|NCT04914195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110138030|NCT04914195|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110138031|NCT04914195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110138032|NCT04904588|Mycophenolic Acid|mycophenolic acid|mesh-list
110138033|NCT04904588|Cyclophosphamide|cyclophosphamide|mesh-list
110138034|NCT04904588|Melphalan|melphalan|mesh-list
110138035|NCT04904588|Busulfan|busulfan|mesh-list
110138036|NCT04904588|Fludarabine|fludarabine|mesh-list
110138037|NCT04904588|Tacrolimus|tacrolimus|mesh-list
110138038|NCT04904588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110138039|NCT04904588|Immunologic Factors|immunologic factors|mesh-ancestor
110138040|NCT04904588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110138041|NCT04904588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110138042|NCT04904588|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110138043|NCT04904588|Alkylating Agents|alkylating agents|mesh-ancestor
110138044|NCT04904588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110138045|NCT04904588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110138046|NCT04904588|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110138047|NCT04904588|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110138048|NCT04904588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110138049|NCT04904588|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110138050|NCT04904588|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110138051|NCT04904588|Antitubercular Agents|antitubercular agents|mesh-ancestor
110138052|NCT04904588|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110138053|NCT04904588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110138054|NCT04901299|Fulvestrant|fulvestrant|mesh-list
110138055|NCT04901299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110138056|NCT04901299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110138057|NCT04901299|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110138058|NCT04901299|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110138059|NCT04901299|Hormone Antagonists|hormone antagonists|mesh-ancestor
110138060|NCT04901299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110138061|NCT04901299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110138063|NCT04898075|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110138064|NCT04898075|Autonomic Agents|autonomic agents|mesh-ancestor
110138065|NCT04898075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110138066|NCT04898075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110138067|NCT04898075|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110138068|NCT04898075|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110138069|NCT04898075|Cholinergic Agents|cholinergic agents|mesh-ancestor
110138070|NCT04898075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110138071|NCT04898075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110138072|NCT04893655|Dobutamine|dobutamine|mesh-list
110138073|NCT04893655|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110138074|NCT04893655|Sympathomimetics|sympathomimetics|mesh-ancestor
110138075|NCT04893655|Autonomic Agents|autonomic agents|mesh-ancestor
110353918|NCT00545142|Dopamine Agonists|dopamine agonists|mesh-ancestor
110138076|NCT04893655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110138077|NCT04893655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110138078|NCT04893655|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
110138079|NCT04893655|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110138080|NCT04893655|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110138081|NCT04893655|Adrenergic Agents|adrenergic agents|mesh-ancestor
110138082|NCT04893655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110138083|NCT04893655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110138084|NCT04893655|Protective Agents|protective agents|mesh-ancestor
110138086|NCT04886986|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110138087|NCT04886986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110138088|NCT04882072|Ustekinumab|ustekinumab|mesh-list
110138089|NCT04882072|Dermatologic Agents|dermatologic agents|mesh-ancestor
110138090|NCT04870034|Palbociclib|palbociclib|mesh-list
110138094|NCT04870034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110138095|NCT04841343|Triamcinolone|triamcinolone|mesh-list
110138096|NCT04841343|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110138097|NCT04841343|Glucocorticoids|glucocorticoids|mesh-ancestor
110138098|NCT04841343|Hormones|hormones|mesh-ancestor
110138099|NCT04841343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110138100|NCT04841343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110138101|NCT04840342|Amlodipine|amlodipine|mesh-list
110138102|NCT04840342|Eplerenone|eplerenone|mesh-list
110138103|NCT04840342|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110138104|NCT04840342|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110138105|NCT04840342|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110138106|NCT04840342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110138107|NCT04840342|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110138108|NCT04840342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110138109|NCT04840342|Vasodilator Agents|vasodilator agents|mesh-ancestor
110138110|NCT04840342|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110138111|NCT04840342|Hormone Antagonists|hormone antagonists|mesh-ancestor
110138112|NCT04840342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110138113|NCT04840342|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110138114|NCT04840342|Diuretics|diuretics|mesh-ancestor
110138115|NCT04840342|Natriuretic Agents|natriuretic agents|mesh-ancestor
110138116|NCT04839627|Progesterone|progesterone|mesh-list
110138117|NCT04839627|Progestins|progestins|mesh-ancestor
110138118|NCT04839627|Hormones|hormones|mesh-ancestor
110138119|NCT04839627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110138120|NCT04839627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110138121|NCT04818866|Fibrin fragment D|fibrin fragment d|mesh-list
110138122|NCT04818866|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110138123|NCT04818866|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110138124|NCT04818866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110138125|NCT04818866|Hemostatics|hemostatics|mesh-ancestor
110138126|NCT04818866|Coagulants|coagulants|mesh-ancestor
110138127|NCT04816162|Dexmedetomidine|dexmedetomidine|mesh-list
110138128|NCT04816162|Ketamine|ketamine|mesh-list
110138129|NCT04816162|Propofol|propofol|mesh-list
110138130|NCT04816162|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110138131|NCT04816162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110138132|NCT04816162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110138133|NCT04816162|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110138134|NCT04816162|Analgesics|analgesics|mesh-ancestor
110138135|NCT04816162|Sensory System Agents|sensory system agents|mesh-ancestor
110138136|NCT04816162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110138137|NCT04816162|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110138138|NCT04816162|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110138139|NCT04816162|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110138140|NCT04816162|Adrenergic Agents|adrenergic agents|mesh-ancestor
110138141|NCT04816162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110138142|NCT04816162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110138143|NCT04816162|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110138144|NCT04816162|Anesthetics, General|anesthetics, general|mesh-ancestor
110138145|NCT04816162|Anesthetics|anesthetics|mesh-ancestor
110138146|NCT04816162|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110138147|NCT04816162|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110138148|NCT04816162|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110138152|NCT04811027|Pembrolizumab|pembrolizumab|mesh-list
110138153|NCT04811027|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110138154|NCT04811027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110138155|NCT04811027|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110138156|NCT04811027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110138157|NCT04808778|Hydroxyurea|hydroxyurea|mesh-list
110138158|NCT04808778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110138159|NCT04808778|Antisickling Agents|antisickling agents|mesh-ancestor
110138160|NCT04808778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110138161|NCT04808778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110138162|NCT04808778|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110138163|NCT04792580|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110138164|NCT04792580|Lifitegrast|lifitegrast|mesh-list
110138165|NCT04792580|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110138166|NCT04743804|Ravulizumab|ravulizumab|mesh-list
110138167|NCT04743804|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
110138168|NCT04743804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110138169|NCT04743804|Immunologic Factors|immunologic factors|mesh-ancestor
110138170|NCT04743804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110138171|NCT04742491|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110138172|NCT04742491|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
110138173|NCT04742491|Emtricitabine|emtricitabine|mesh-list
110138174|NCT04742491|Tenofovir|tenofovir|mesh-list
110138175|NCT04742491|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110138176|NCT04742491|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110138177|NCT04742491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110138178|NCT04742491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110138179|NCT04742491|Antiviral Agents|antiviral agents|mesh-ancestor
110138180|NCT04742491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110138181|NCT04742491|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110138182|NCT04742491|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110138183|NCT04741945|Metformin|metformin|mesh-list
110138184|NCT04741945|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110138185|NCT04741945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110138186|NCT04736433|Valsartan|valsartan|mesh-list
110138187|NCT04736433|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
110138188|NCT04736433|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
110138189|NCT04736433|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110138190|NCT04736433|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110138191|NCT04736433|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110138192|NCT04736433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110138193|NCT04736433|Protease Inhibitors|protease inhibitors|mesh-ancestor
110138194|NCT04736433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110138195|NCT04735523|Warfarin|warfarin|mesh-list
110138196|NCT04735523|Dabigatran|dabigatran|mesh-list
110138197|NCT04735523|Anticoagulants|anticoagulants|mesh-ancestor
110138198|NCT04735523|Antithrombins|antithrombins|mesh-ancestor
110138199|NCT04735523|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110138200|NCT04735523|Protease Inhibitors|protease inhibitors|mesh-ancestor
110138201|NCT04735523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110138202|NCT04735523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110138203|NCT04734730|Prednisone|prednisone|mesh-list
110138204|NCT04734730|Cortisone|cortisone|mesh-list
110138205|NCT04734730|Leuprolide|leuprolide|mesh-list
110138206|NCT04734730|Goserelin|goserelin|mesh-list
110138207|NCT04734730|Abiraterone Acetate|abiraterone acetate|mesh-list
110138208|NCT04734730|Bicalutamide|bicalutamide|mesh-list
110138209|NCT04734730|Talazoparib|talazoparib|mesh-list
110138210|NCT04734730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110138211|NCT04734730|Glucocorticoids|glucocorticoids|mesh-ancestor
110138212|NCT04734730|Hormones|hormones|mesh-ancestor
110138213|NCT04734730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110138214|NCT04734730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110138215|NCT04734730|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110138216|NCT04734730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110138217|NCT04734730|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110138218|NCT04734730|Fertility Agents|fertility agents|mesh-ancestor
110138219|NCT04734730|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110138220|NCT04734730|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110138221|NCT04734730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110354007|NCT00537966|Ritonavir|ritonavir|mesh-list
110368618|NCT05419583|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110138226|NCT04734730|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110138227|NCT04734080|Dronabinol|dronabinol|mesh-list
110138228|NCT04734080|Hallucinogens|hallucinogens|mesh-ancestor
110138229|NCT04734080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110138230|NCT04734080|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110138231|NCT04734080|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110138232|NCT04734080|Analgesics|analgesics|mesh-ancestor
110138233|NCT04734080|Sensory System Agents|sensory system agents|mesh-ancestor
110138234|NCT04734080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110138235|NCT04734080|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
110138236|NCT04734080|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110138237|NCT04734080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110138238|NCT04734080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110138239|NCT04734080|Hormones|hormones|mesh-ancestor
110138240|NCT04734080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110138241|NCT04702893|Nintedanib|nintedanib|mesh-list
110138242|NCT04702893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110138243|NCT04702893|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110138244|NCT04702893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110138245|NCT04702893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110138246|NCT04681820|Flumatinib|flumatinib|mesh-list
110138247|NCT04681820|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110138248|NCT04681820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110138249|NCT04681820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110138250|NCT04677504|Bevacizumab|bevacizumab|mesh-list
110138251|NCT04677504|Atezolizumab|atezolizumab|mesh-list
110138252|NCT04677504|Gemcitabine|gemcitabine|mesh-list
110138253|NCT04677504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110138254|NCT04677504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110138255|NCT04677504|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110138256|NCT04677504|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110138257|NCT04677504|Growth Substances|growth substances|mesh-ancestor
110138258|NCT04677504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110138259|NCT04677504|Growth Inhibitors|growth inhibitors|mesh-ancestor
110138260|NCT04677504|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110138261|NCT04677504|Antimetabolites|antimetabolites|mesh-ancestor
110138262|NCT04677504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110138263|NCT04677504|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110138264|NCT04675788|Ibutilide|ibutilide|mesh-list
110138265|NCT04675788|Testosterone|testosterone|mesh-list
110138266|NCT04675788|Progesterone|progesterone|mesh-list
110138267|NCT04675788|Androgens|androgens|mesh-ancestor
110138268|NCT04675788|Hormones|hormones|mesh-ancestor
110138269|NCT04675788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110138270|NCT04675788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110138271|NCT04675788|Progestins|progestins|mesh-ancestor
110138272|NCT04675788|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110138273|NCT04667572|Riboflavin|riboflavin|mesh-list
110138274|NCT04667572|Vitamin B Complex|vitamin b complex|mesh-ancestor
110138275|NCT04667572|Vitamins|vitamins|mesh-ancestor
110138276|NCT04667572|Micronutrients|micronutrients|mesh-ancestor
110138277|NCT04667572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110138278|NCT04667572|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110138279|NCT04667572|Dermatologic Agents|dermatologic agents|mesh-ancestor
110138280|NCT04651166|Tranexamic Acid|tranexamic acid|mesh-list
110138281|NCT04651166|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110138282|NCT04651166|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110138283|NCT04651166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110138284|NCT04651166|Hemostatics|hemostatics|mesh-ancestor
110138285|NCT04651166|Coagulants|coagulants|mesh-ancestor
110138286|NCT04642547|Lenvatinib|lenvatinib|mesh-list
110138287|NCT04642547|Gefitinib|gefitinib|mesh-list
110138288|NCT04642547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110138289|NCT04642547|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110138290|NCT04642547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110138291|NCT04642547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110138306|NCT04574960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110138308|NCT04539314|Bupivacaine|bupivacaine|mesh-list
110138309|NCT04539314|Anesthetics, Local|anesthetics, local|mesh-ancestor
110138310|NCT04539314|Anesthetics|anesthetics|mesh-ancestor
110138311|NCT04539314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110138312|NCT04539314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110138313|NCT04539314|Sensory System Agents|sensory system agents|mesh-ancestor
110138314|NCT04539314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110138315|NCT04539314|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110138316|NCT04539314|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110138317|NCT04539314|Analgesics|analgesics|mesh-ancestor
110138318|NCT04539314|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110138319|NCT04539314|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110138320|NCT04539314|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110138321|NCT04539314|Adrenergic Agents|adrenergic agents|mesh-ancestor
110138322|NCT04539314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110138323|NCT04539314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110138325|NCT04520711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110138326|NCT04520711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110138327|NCT04520711|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110138328|NCT04520711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110138329|NCT04508894|Dexmedetomidine|dexmedetomidine|mesh-list
110138330|NCT04508894|Ketamine|ketamine|mesh-list
110138331|NCT04508894|Bupivacaine|bupivacaine|mesh-list
110138332|NCT04508894|Anesthetics, Local|anesthetics, local|mesh-ancestor
110138333|NCT04508894|Anesthetics|anesthetics|mesh-ancestor
110138334|NCT04508894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110138335|NCT04508894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110138336|NCT04508894|Sensory System Agents|sensory system agents|mesh-ancestor
110138337|NCT04508894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110138338|NCT04508894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110138339|NCT04508894|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110138340|NCT04508894|Analgesics|analgesics|mesh-ancestor
110138341|NCT04508894|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110138342|NCT04508894|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110138343|NCT04508894|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110138344|NCT04508894|Adrenergic Agents|adrenergic agents|mesh-ancestor
110138345|NCT04508894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110138346|NCT04508894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110138347|NCT04508894|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110138348|NCT04508894|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110138349|NCT04508894|Anesthetics, General|anesthetics, general|mesh-ancestor
110138350|NCT04508894|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110138351|NCT04508894|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110138352|NCT04506125|Chrysarobin|chrysarobin|mesh-list
110138353|NCT04506125|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110138354|NCT04506125|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110138355|NCT04506125|Analgesics|analgesics|mesh-ancestor
110138356|NCT04506125|Sensory System Agents|sensory system agents|mesh-ancestor
110138357|NCT04506125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110138358|NCT04506125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110138359|NCT04506125|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110138360|NCT04506125|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110138361|NCT04487236|Capecitabine|capecitabine|mesh-list
110138362|NCT04487236|Trastuzumab|trastuzumab|mesh-list
110138363|NCT04487236|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110138364|NCT04487236|Antimetabolites|antimetabolites|mesh-ancestor
110138365|NCT04487236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110138366|NCT04487236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110138367|NCT04487236|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110138368|NCT04477772|Antibodies|antibodies|mesh-list
110138369|NCT04477772|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110138370|NCT04477772|Immunologic Factors|immunologic factors|mesh-ancestor
110138371|NCT04477772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110138372|NCT04429022|Acetaminophen|acetaminophen|mesh-list
110138374|NCT04429022|Ketorolac|ketorolac|mesh-list
110138375|NCT04429022|Oxycodone|oxycodone|mesh-list
110138376|NCT04429022|Gabapentin|gabapentin|mesh-list
110138378|NCT04429022|Ropivacaine|ropivacaine|mesh-list
110138379|NCT04429022|Anesthetics, Local|anesthetics, local|mesh-list
110138380|NCT04429022|Anesthetics|anesthetics|mesh-list
110138381|NCT04429022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110138382|NCT04429022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110138383|NCT04429022|Sensory System Agents|sensory system agents|mesh-ancestor
110138384|NCT04429022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110138385|NCT04429022|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110138387|NCT04429022|Antipyretics|antipyretics|mesh-ancestor
110138388|NCT04429022|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110138389|NCT04429022|Narcotics|narcotics|mesh-ancestor
110138390|NCT04429022|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110138391|NCT04429022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110138392|NCT04429022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110138393|NCT04429022|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110138394|NCT04429022|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110138395|NCT04429022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110138396|NCT04429022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110138397|NCT04429022|Anticonvulsants|anticonvulsants|mesh-ancestor
110138398|NCT04429022|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110138399|NCT04429022|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110138400|NCT04429022|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110138401|NCT04429022|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110138402|NCT04429022|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110138403|NCT04429022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110138404|NCT04429022|Antimanic Agents|antimanic agents|mesh-ancestor
110138405|NCT04400838|Vaccines|vaccines|mesh-list
110138406|NCT04400838|Immunologic Factors|immunologic factors|mesh-ancestor
110138407|NCT04400838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110138408|NCT04396990|Prednisolone|prednisolone|mesh-list
110138409|NCT04396990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110138410|NCT04396990|Glucocorticoids|glucocorticoids|mesh-ancestor
110138411|NCT04396990|Hormones|hormones|mesh-ancestor
110138412|NCT04396990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110138413|NCT04396990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110138414|NCT04396990|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110138415|NCT04396990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110138416|NCT04394624|Pembrolizumab|pembrolizumab|mesh-list
110138417|NCT04394624|Ramucirumab|ramucirumab|mesh-list
110138418|NCT04394624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110138419|NCT04394624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110138420|NCT04394624|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110138421|NCT04394624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110138422|NCT04364555|Clobetasol|clobetasol|mesh-list
110138423|NCT04364555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110138424|NCT04364555|Glucocorticoids|glucocorticoids|mesh-ancestor
110138425|NCT04364555|Hormones|hormones|mesh-ancestor
110138426|NCT04364555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110138427|NCT04364555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110138428|NCT04341350|Analgesics|analgesics|mesh-list
110138429|NCT04341350|Propofol|propofol|mesh-list
110138430|NCT04341350|Isoflurane|isoflurane|mesh-list
110138431|NCT04341350|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110138432|NCT04341350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110138433|NCT04341350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110138434|NCT04341350|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110138435|NCT04341350|Anesthetics, General|anesthetics, general|mesh-ancestor
110138436|NCT04341350|Anesthetics|anesthetics|mesh-ancestor
110138437|NCT04341350|Sensory System Agents|sensory system agents|mesh-ancestor
110138438|NCT04341350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110138439|NCT04341350|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110138440|NCT04324606|Acetaminophen|acetaminophen|mesh-list
110138441|NCT04324606|Vaccines|vaccines|mesh-list
110138442|NCT04324606|Immunologic Factors|immunologic factors|mesh-ancestor
110138443|NCT04324606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110138444|NCT04324606|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110138445|NCT04324606|Analgesics|analgesics|mesh-ancestor
110138446|NCT04324606|Sensory System Agents|sensory system agents|mesh-ancestor
110138447|NCT04324606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110138449|NCT04321408|Ziconotide|ziconotide|mesh-list
110138450|NCT04321408|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110138451|NCT04321408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110138452|NCT04321408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110138453|NCT04321408|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110138454|NCT04321408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110138455|NCT04321408|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110138457|NCT04321408|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110138458|NCT04321408|Analgesics|analgesics|mesh-ancestor
110138459|NCT04321408|Sensory System Agents|sensory system agents|mesh-ancestor
110138460|NCT04321408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110138461|NCT04300309|Lumefantrine|lumefantrine|mesh-list
110138462|NCT04300309|Artemether|artemether|mesh-list
110138463|NCT04300309|Antimalarials|antimalarials|mesh-ancestor
110138464|NCT04300309|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110138465|NCT04300309|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110138466|NCT04300309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110138467|NCT04298606|Vaccines|vaccines|mesh-list
110138469|NCT04298606|Mitogens|mitogens|mesh-list
110138470|NCT04298606|Immunologic Factors|immunologic factors|mesh-ancestor
110138471|NCT04298606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110138472|NCT04298606|Mitosis Modulators|mitosis modulators|mesh-ancestor
110138473|NCT04298606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110138474|NCT04298606|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110138475|NCT04288089|Palbociclib|palbociclib|mesh-list
110138476|NCT04288089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110138477|NCT04288089|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110138478|NCT04288089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110354134|NCT01266148|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110138479|NCT04288089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110138480|NCT04266938|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
110138481|NCT04266938|Antiviral Agents|antiviral agents|mesh-ancestor
110138482|NCT04266938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110138483|NCT04254081|Lidocaine|lidocaine|mesh-list
110138484|NCT04254081|Buprenorphine|buprenorphine|mesh-list
110138485|NCT04254081|Anesthetics, Local|anesthetics, local|mesh-ancestor
110138486|NCT04254081|Anesthetics|anesthetics|mesh-ancestor
110138487|NCT04254081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110138488|NCT04254081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110138489|NCT04254081|Sensory System Agents|sensory system agents|mesh-ancestor
110138490|NCT04254081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110138491|NCT04254081|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110138492|NCT04254081|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110138493|NCT04254081|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110138494|NCT04254081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110138495|NCT04254081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110138496|NCT04254081|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110138497|NCT04254081|Narcotics|narcotics|mesh-ancestor
110138498|NCT04254081|Analgesics|analgesics|mesh-ancestor
110138499|NCT04254081|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110138500|NCT04250948|Capecitabine|capecitabine|mesh-list
110138501|NCT04250948|Oxaliplatin|oxaliplatin|mesh-list
110138502|NCT04250948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110138503|NCT04250948|Antimetabolites|antimetabolites|mesh-ancestor
110138504|NCT04250948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110138505|NCT04250948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110138506|NCT04243122|Aspirin|aspirin|mesh-list
110138507|NCT04243122|Apixaban|apixaban|mesh-list
110138508|NCT04243122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110138509|NCT04243122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110138510|NCT04243122|Analgesics|analgesics|mesh-ancestor
110138511|NCT04243122|Sensory System Agents|sensory system agents|mesh-ancestor
110138512|NCT04243122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110138513|NCT04243122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110138514|NCT04243122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110138515|NCT04243122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110138516|NCT04243122|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110138517|NCT04243122|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110138518|NCT04243122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110138519|NCT04243122|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110138520|NCT04243122|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110138521|NCT04243122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110138522|NCT04243122|Antipyretics|antipyretics|mesh-ancestor
110138523|NCT04243122|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110138524|NCT04243122|Antithrombins|antithrombins|mesh-ancestor
110138525|NCT04243122|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110138526|NCT04243122|Protease Inhibitors|protease inhibitors|mesh-ancestor
110138527|NCT04243122|Anticoagulants|anticoagulants|mesh-ancestor
110138528|NCT04231760|Nitric Oxide|nitric oxide|mesh-list
110138529|NCT04231760|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110138530|NCT04231760|Autonomic Agents|autonomic agents|mesh-ancestor
110138531|NCT04231760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110138532|NCT04231760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110138533|NCT04231760|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110138534|NCT04231760|Respiratory System Agents|respiratory system agents|mesh-ancestor
110138535|NCT04231760|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110138537|NCT04231760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110138538|NCT04231760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110138539|NCT04231760|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
110138540|NCT04231760|Vasodilator Agents|vasodilator agents|mesh-ancestor
110138541|NCT04231760|Gasotransmitters|gasotransmitters|mesh-ancestor
110138542|NCT04231760|Protective Agents|protective agents|mesh-ancestor
110138543|NCT04230109|Pembrolizumab|pembrolizumab|mesh-list
110138544|NCT04230109|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
110138545|NCT04230109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110138546|NCT04230109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110138547|NCT04230109|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110138548|NCT04230109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110138549|NCT04230109|Immunoconjugates|immunoconjugates|mesh-ancestor
110138550|NCT04230109|Immunologic Factors|immunologic factors|mesh-ancestor
110138551|NCT04230109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110138552|NCT04221191|Dimethyl Fumarate|dimethyl fumarate|mesh-list
110138553|NCT04221191|Dermatologic Agents|dermatologic agents|mesh-ancestor
110138554|NCT04221191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110138555|NCT04221191|Immunologic Factors|immunologic factors|mesh-ancestor
110138556|NCT04221191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110138557|NCT04209296|Ketamine|ketamine|mesh-list
110138558|NCT04209296|Analgesics|analgesics|mesh-ancestor
110138559|NCT04209296|Sensory System Agents|sensory system agents|mesh-ancestor
110138560|NCT04209296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110138561|NCT04209296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110138562|NCT04209296|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110354189|NCT01265563|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110138563|NCT04209296|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110138564|NCT04209296|Anesthetics, General|anesthetics, general|mesh-ancestor
110138565|NCT04209296|Anesthetics|anesthetics|mesh-ancestor
110138566|NCT04209296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110138567|NCT04209296|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110138568|NCT04209296|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110138569|NCT04209296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110138570|NCT04209296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110138571|NCT04181359|Nitric Oxide|nitric oxide|mesh-list
110138572|NCT04181359|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110138573|NCT04181359|Autonomic Agents|autonomic agents|mesh-ancestor
110138574|NCT04181359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110138575|NCT04181359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110138576|NCT04181359|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110138577|NCT04181359|Respiratory System Agents|respiratory system agents|mesh-ancestor
110138578|NCT04181359|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110138579|NCT04181359|Antioxidants|antioxidants|mesh-ancestor
110138580|NCT04181359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110138581|NCT04181359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110138582|NCT04181359|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
110138583|NCT04181359|Vasodilator Agents|vasodilator agents|mesh-ancestor
110138584|NCT04181359|Gasotransmitters|gasotransmitters|mesh-ancestor
110138585|NCT04181359|Protective Agents|protective agents|mesh-ancestor
110343818|NCT06022588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110138609|NCT04122196|Pregabalin|pregabalin|mesh-list
110138610|NCT04122196|Analgesics|analgesics|mesh-ancestor
110138611|NCT04122196|Sensory System Agents|sensory system agents|mesh-ancestor
110138612|NCT04122196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110138613|NCT04122196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110138614|NCT04122196|Anticonvulsants|anticonvulsants|mesh-ancestor
110138615|NCT04122196|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110138616|NCT04122196|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110138617|NCT04122196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110138618|NCT04122196|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110138619|NCT04122196|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110138620|NCT04122196|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110138621|NCT04122196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110138622|NCT04122196|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110138623|NCT04106115|Durvalumab|durvalumab|mesh-list
110138624|NCT04106115|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
110138625|NCT04106115|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110138626|NCT04106115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110138627|NCT04106115|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110138628|NCT04106115|Immunologic Factors|immunologic factors|mesh-ancestor
110138629|NCT04106115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110138630|NCT04105231|Cannabidiol|cannabidiol|mesh-list
110138631|NCT04105231|Risperidone|risperidone|mesh-list
110354242|NCT01264939|Anesthetics|anesthetics|mesh-ancestor
110138632|NCT04105231|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110138633|NCT04105231|Serotonin Agents|serotonin agents|mesh-ancestor
110138634|NCT04105231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110138635|NCT04105231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110138636|NCT04105231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110138637|NCT04105231|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110138638|NCT04105231|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110138639|NCT04105231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110138640|NCT04105231|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110138641|NCT04105231|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110138642|NCT04105231|Dopamine Agents|dopamine agents|mesh-ancestor
110138643|NCT04105231|Anticonvulsants|anticonvulsants|mesh-ancestor
110138644|NCT04073615|Trifluridine|trifluridine|mesh-list
110138645|NCT04073615|Apatinib|apatinib|mesh-list
110138646|NCT04073615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110138647|NCT04073615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110138648|NCT04073615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110138649|NCT04073615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110138650|NCT04073615|Antimetabolites|antimetabolites|mesh-ancestor
110138651|NCT04073615|Antiviral Agents|antiviral agents|mesh-ancestor
110138652|NCT04073615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110138653|NCT04065399|Cobicistat|cobicistat|mesh-list
110138654|NCT04065399|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110138655|NCT04065399|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110138656|NCT04065399|Antiviral Agents|antiviral agents|mesh-ancestor
110138657|NCT04065399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110138658|NCT04065399|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110138659|NCT04065399|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110138660|NCT04065399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110138661|NCT04065399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110138662|NCT04058717|Nicotine|nicotine|mesh-list
110138663|NCT04058717|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110138664|NCT04058717|Autonomic Agents|autonomic agents|mesh-ancestor
110138665|NCT04058717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110138666|NCT04058717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110138667|NCT04058717|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110138668|NCT04058717|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110138669|NCT04058717|Cholinergic Agents|cholinergic agents|mesh-ancestor
110138670|NCT04058717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110138671|NCT04058717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110138672|NCT04050085|Nivolumab|nivolumab|mesh-list
110138673|NCT04050085|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110138674|NCT04050085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110138675|NCT04050085|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110138676|NCT04050085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110138677|NCT04042558|Bevacizumab|bevacizumab|mesh-list
110138678|NCT04042558|Atezolizumab|atezolizumab|mesh-list
110138679|NCT04042558|Carboplatin|carboplatin|mesh-list
110138680|NCT04042558|Pemetrexed|pemetrexed|mesh-list
110138681|NCT04042558|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110138682|NCT04042558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110138683|NCT04042558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110138684|NCT04042558|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110138685|NCT04042558|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110138686|NCT04042558|Growth Substances|growth substances|mesh-ancestor
110138687|NCT04042558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110138688|NCT04042558|Growth Inhibitors|growth inhibitors|mesh-ancestor
110138689|NCT04042558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110138690|NCT04042558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110138691|NCT04042558|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110138692|NCT04042558|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110138693|NCT04042558|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110138694|NCT04042558|Immunologic Factors|immunologic factors|mesh-ancestor
110138695|NCT04040946|Choline|choline|mesh-list
110138696|NCT04040946|Lipotropic Agents|lipotropic agents|mesh-ancestor
110138697|NCT04040946|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110138698|NCT04040946|Antimetabolites|antimetabolites|mesh-ancestor
110138699|NCT04040946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110138700|NCT04040946|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110138701|NCT04040946|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110138702|NCT04040946|Nootropic Agents|nootropic agents|mesh-ancestor
110138703|NCT04038099|Lidocaine|lidocaine|mesh-list
110138704|NCT04038099|Anesthetics, Local|anesthetics, local|mesh-ancestor
110138705|NCT04038099|Anesthetics|anesthetics|mesh-ancestor
110354343|NCT02236013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110138706|NCT04038099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110138707|NCT04038099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110138708|NCT04038099|Sensory System Agents|sensory system agents|mesh-ancestor
110138709|NCT04038099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110138710|NCT04038099|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110138711|NCT04038099|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110138712|NCT04038099|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110138713|NCT04038099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110138714|NCT04038099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110138716|NCT04034238|LMB-100|lmb-100|mesh-list
110138717|NCT04034238|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
110138718|NCT04034238|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110138719|NCT04034238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110354407|NCT01310192|Lipotropic Agents|lipotropic agents|mesh-ancestor
110138720|NCT04034238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110138721|NCT04034238|Immunoconjugates|immunoconjugates|mesh-ancestor
110138722|NCT04034238|Immunologic Factors|immunologic factors|mesh-ancestor
110138723|NCT04034238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110138724|NCT03994172|Calcium, Dietary|calcium, dietary|mesh-list
110138726|NCT03994172|Cholecalciferol|cholecalciferol|mesh-list
110138727|NCT03994172|Teriparatide|teriparatide|mesh-list
110138728|NCT03994172|Citric Acid|citric acid|mesh-list
110138729|NCT03994172|Sodium Citrate|sodium citrate|mesh-list
110138730|NCT03994172|Calcium|calcium|mesh-list
110138731|NCT03994172|Parathyroid Hormone|parathyroid hormone|mesh-list
110138732|NCT03994172|Cinacalcet|cinacalcet|mesh-list
110138733|NCT03994172|Hormones|hormones|mesh-list
110138734|NCT03994172|Vitamins|vitamins|mesh-ancestor
110354465|NCT00659711|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110138735|NCT03994172|Micronutrients|micronutrients|mesh-ancestor
110138736|NCT03994172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110138737|NCT03994172|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110138738|NCT03994172|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110138739|NCT03994172|Anticoagulants|anticoagulants|mesh-ancestor
110138740|NCT03994172|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110138741|NCT03994172|Chelating Agents|chelating agents|mesh-ancestor
110138742|NCT03994172|Sequestering Agents|sequestering agents|mesh-ancestor
110138743|NCT03994172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110343819|NCT06022003|Azacitidine|azacitidine|mesh-list
110138744|NCT03994172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110138745|NCT03994172|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
110138746|NCT03994172|Hormone Antagonists|hormone antagonists|mesh-ancestor
110138753|NCT03978442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110138754|NCT03978442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110138756|NCT03978442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110138757|NCT03978442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110354526|NCT02231723|Tubulin Modulators|tubulin modulators|mesh-ancestor
110138758|NCT03978442|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110138759|NCT03978442|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110138760|NCT03978442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110138762|NCT03975829|Dabrafenib|dabrafenib|mesh-list
110138763|NCT03975829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110138764|NCT03975829|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110138765|NCT03975829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110138766|NCT03975829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110138767|NCT03956966|Dexamethasone|dexamethasone|mesh-list
110138768|NCT03956966|Bupivacaine|bupivacaine|mesh-list
110138769|NCT03956966|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110138770|NCT03956966|Antiemetics|antiemetics|mesh-ancestor
110138771|NCT03956966|Autonomic Agents|autonomic agents|mesh-ancestor
110138772|NCT03956966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110138773|NCT03956966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110138774|NCT03956966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110138775|NCT03956966|Glucocorticoids|glucocorticoids|mesh-ancestor
110138776|NCT03956966|Hormones|hormones|mesh-ancestor
110138777|NCT03956966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110138778|NCT03956966|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110138779|NCT03956966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110138780|NCT03956966|Anesthetics, Local|anesthetics, local|mesh-ancestor
110138781|NCT03956966|Anesthetics|anesthetics|mesh-ancestor
110138782|NCT03956966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110138783|NCT03956966|Sensory System Agents|sensory system agents|mesh-ancestor
110138784|NCT03956056|Poly I-C|poly i-c|mesh-list
110138785|NCT03956056|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
110138786|NCT03956056|Poly ICLC|poly iclc|mesh-list
110138787|NCT03956056|Interferon Inducers|interferon inducers|mesh-ancestor
110138788|NCT03956056|Immunologic Factors|immunologic factors|mesh-ancestor
110138789|NCT03956056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110138790|NCT03956056|Laxatives|laxatives|mesh-ancestor
110138791|NCT03956056|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110138792|NCT03956056|Antiviral Agents|antiviral agents|mesh-ancestor
110138793|NCT03956056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110138794|NCT03954041|Glyburide|glyburide|mesh-list
110138795|NCT03954041|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110138796|NCT03954041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110138797|NCT03950154|Bevacizumab|bevacizumab|mesh-list
110138798|NCT03950154|Capecitabine|capecitabine|mesh-list
110138799|NCT03950154|Oxaliplatin|oxaliplatin|mesh-list
110138800|NCT03950154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110138801|NCT03950154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110138802|NCT03950154|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110138803|NCT03950154|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110138804|NCT03950154|Growth Substances|growth substances|mesh-ancestor
110138805|NCT03950154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110138806|NCT03950154|Growth Inhibitors|growth inhibitors|mesh-ancestor
110138807|NCT03950154|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110138808|NCT03950154|Antimetabolites|antimetabolites|mesh-ancestor
110138809|NCT03950154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110138811|NCT03948867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110138812|NCT03948867|Antisickling Agents|antisickling agents|mesh-ancestor
110138813|NCT03948867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110138814|NCT03948867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110138839|NCT03936829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110138840|NCT03936829|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110138842|NCT03936023|Incretins|incretins|mesh-ancestor
110138843|NCT03936023|Hormones|hormones|mesh-ancestor
110138844|NCT03936023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110138845|NCT03936023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110138846|NCT03936023|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110138847|NCT03936023|Protease Inhibitors|protease inhibitors|mesh-ancestor
110138848|NCT03936023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110138849|NCT03936023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110138850|NCT03936023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110138851|NCT03896659|Hydrocortisone|hydrocortisone|mesh-list
110138852|NCT03896659|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110138853|NCT03878199|Cytarabine|cytarabine|mesh-list
110138854|NCT03878199|Daunorubicin|daunorubicin|mesh-list
110138855|NCT03878199|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
110138856|NCT03878199|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110138857|NCT03878199|Antimetabolites|antimetabolites|mesh-ancestor
110138858|NCT03878199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110138859|NCT03878199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110138860|NCT03878199|Antiviral Agents|antiviral agents|mesh-ancestor
110138861|NCT03878199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110138862|NCT03878199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110138863|NCT03878199|Immunologic Factors|immunologic factors|mesh-ancestor
110138864|NCT03878199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110138865|NCT03878199|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110138866|NCT03878199|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110138867|NCT03878199|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110138868|NCT03878199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110138869|NCT03878199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110138870|NCT03859024|Acetaminophen|acetaminophen|mesh-list
110138871|NCT03859024|Dexamethasone|dexamethasone|mesh-list
110138872|NCT03859024|Ibuprofen|ibuprofen|mesh-list
110138873|NCT03859024|Celecoxib|celecoxib|mesh-list
110138874|NCT03859024|Oxycodone|oxycodone|mesh-list
110138875|NCT03859024|Gabapentin|gabapentin|mesh-list
110138876|NCT03859024|Bupivacaine|bupivacaine|mesh-list
110138877|NCT03859024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110138878|NCT03859024|Antiemetics|antiemetics|mesh-ancestor
110138879|NCT03859024|Autonomic Agents|autonomic agents|mesh-ancestor
110138880|NCT03859024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110138881|NCT03859024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110138882|NCT03859024|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110138883|NCT03859024|Glucocorticoids|glucocorticoids|mesh-ancestor
110138884|NCT03859024|Hormones|hormones|mesh-ancestor
110354782|NCT00548067|Diuretics|diuretics|mesh-ancestor
110138885|NCT03859024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110138886|NCT03859024|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110138887|NCT03859024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110138888|NCT03859024|Anesthetics, Local|anesthetics, local|mesh-ancestor
110138889|NCT03859024|Anesthetics|anesthetics|mesh-ancestor
110138896|NCT03859024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110138897|NCT03859024|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110138898|NCT03859024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110138903|NCT03859024|Anticonvulsants|anticonvulsants|mesh-ancestor
110138904|NCT03859024|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110138905|NCT03859024|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110138906|NCT03859024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110138907|NCT03859024|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110138908|NCT03859024|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110138909|NCT03859024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110138910|NCT03859024|Antimanic Agents|antimanic agents|mesh-ancestor
110138911|NCT03830866|Carboplatin|carboplatin|mesh-list
110138912|NCT03830866|Durvalumab|durvalumab|mesh-list
110138913|NCT03830866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110138914|NCT03830866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110138915|NCT03794388|Pregabalin|pregabalin|mesh-list
110138916|NCT03794388|Capsaicin|capsaicin|mesh-list
110138917|NCT03794388|Analgesics|analgesics|mesh-ancestor
110138918|NCT03794388|Sensory System Agents|sensory system agents|mesh-ancestor
110354841|NCT03781362|Capecitabine|capecitabine|mesh-list
110138919|NCT03794388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110138920|NCT03794388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110138921|NCT03794388|Anticonvulsants|anticonvulsants|mesh-ancestor
110138922|NCT03794388|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110138923|NCT03794388|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110138924|NCT03794388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110138925|NCT03794388|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110138926|NCT03794388|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110138927|NCT03794388|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110138928|NCT03794388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110138929|NCT03794388|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110138930|NCT03794388|Antipruritics|antipruritics|mesh-ancestor
110138931|NCT03794388|Dermatologic Agents|dermatologic agents|mesh-ancestor
110138939|NCT03725761|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
110138940|NCT03725761|Immunoconjugates|immunoconjugates|mesh-ancestor
110138941|NCT03725761|Immunologic Factors|immunologic factors|mesh-ancestor
110138942|NCT03725761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110138944|NCT03707951|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110138945|NCT03707951|Antiviral Agents|antiviral agents|mesh-ancestor
110138946|NCT03707951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110138947|NCT03707951|Expectorants|expectorants|mesh-ancestor
110138948|NCT03707951|Respiratory System Agents|respiratory system agents|mesh-ancestor
110138949|NCT03707951|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110138950|NCT03707951|Antioxidants|antioxidants|mesh-ancestor
110138951|NCT03707951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110138952|NCT03707951|Protective Agents|protective agents|mesh-ancestor
110138953|NCT03707951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110138954|NCT03707951|Antidotes|antidotes|mesh-ancestor
110138959|NCT03679949|Oxycodone|oxycodone|mesh-list
110166946|NCT00029458|Clozapine|clozapine|mesh-list
110138960|NCT03679949|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110138961|NCT03679949|Narcotics|narcotics|mesh-ancestor
110138962|NCT03679949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110138963|NCT03679949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110138964|NCT03679949|Analgesics|analgesics|mesh-ancestor
110138965|NCT03679949|Sensory System Agents|sensory system agents|mesh-ancestor
110138966|NCT03679949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110138967|NCT03679312|Nitric Oxide|nitric oxide|mesh-list
110138968|NCT03679312|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110138969|NCT03679312|Autonomic Agents|autonomic agents|mesh-ancestor
110138970|NCT03679312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110138971|NCT03679312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110138972|NCT03679312|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110138973|NCT03679312|Respiratory System Agents|respiratory system agents|mesh-ancestor
110138974|NCT03679312|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110138975|NCT03679312|Antioxidants|antioxidants|mesh-ancestor
110138976|NCT03679312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110138977|NCT03679312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110138978|NCT03679312|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
110138979|NCT03679312|Vasodilator Agents|vasodilator agents|mesh-ancestor
110138980|NCT03679312|Gasotransmitters|gasotransmitters|mesh-ancestor
110138981|NCT03679312|Protective Agents|protective agents|mesh-ancestor
110138982|NCT03637400|Doxycycline|doxycycline|mesh-list
110138983|NCT03637400|Trimethoprim|trimethoprim|mesh-list
110138984|NCT03637400|Sulfamethoxazole|sulfamethoxazole|mesh-list
110138985|NCT03637400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110138986|NCT03637400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110138987|NCT03637400|Antimalarials|antimalarials|mesh-ancestor
110138988|NCT03637400|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110138989|NCT03637400|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110138990|NCT03637400|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110138991|NCT03637400|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110138992|NCT03637400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110138993|NCT03637400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110138994|NCT03637400|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110138995|NCT03637400|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
110138996|NCT03637400|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110138997|NCT03631199|Paclitaxel|paclitaxel|mesh-list
110138998|NCT03631199|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110138999|NCT03631199|Carboplatin|carboplatin|mesh-list
110139000|NCT03631199|Pembrolizumab|pembrolizumab|mesh-list
110139001|NCT03631199|Pemetrexed|pemetrexed|mesh-list
110139002|NCT03631199|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110139003|NCT03631199|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110139004|NCT03631199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110139005|NCT03631199|Tubulin Modulators|tubulin modulators|mesh-ancestor
110139006|NCT03631199|Antimitotic Agents|antimitotic agents|mesh-ancestor
110139007|NCT03631199|Mitosis Modulators|mitosis modulators|mesh-ancestor
110139008|NCT03631199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110139009|NCT03631199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110139010|NCT03631199|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110139011|NCT03631199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110139012|NCT03631199|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110139013|NCT03631199|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110139014|NCT03631199|Immunologic Factors|immunologic factors|mesh-ancestor
110139015|NCT03631199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110139016|NCT03630666|Hormones|hormones|mesh-list
110139017|NCT03630666|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
110139018|NCT03630666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110139019|NCT03630666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110139020|NCT03607175|Triamcinolone|triamcinolone|mesh-list
110139021|NCT03607175|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110139022|NCT03607175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110139023|NCT03607175|Glucocorticoids|glucocorticoids|mesh-ancestor
110139024|NCT03607175|Hormones|hormones|mesh-ancestor
110139025|NCT03607175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110139026|NCT03607175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110139027|NCT03607175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110139028|NCT03607175|Immunologic Factors|immunologic factors|mesh-ancestor
110139029|NCT03573024|Azacitidine|azacitidine|mesh-list
110139030|NCT03573024|Venetoclax|venetoclax|mesh-list
110139031|NCT03573024|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110139032|NCT03573024|Antimetabolites|antimetabolites|mesh-ancestor
110139033|NCT03573024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110139034|NCT03573024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110139035|NCT03573024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110139036|NCT03560960|Pramlintide|pramlintide|mesh-list
110139037|NCT03560960|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110139038|NCT03560960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110139040|NCT03534323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110139041|NCT03520842|Methotrexate|methotrexate|mesh-list
110139042|NCT03520842|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110139043|NCT03520842|Abortifacient Agents|abortifacient agents|mesh-ancestor
110139044|NCT03520842|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110139045|NCT03520842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110139046|NCT03520842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110139047|NCT03520842|Antimetabolites|antimetabolites|mesh-ancestor
110139048|NCT03520842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110139049|NCT03520842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110139050|NCT03520842|Dermatologic Agents|dermatologic agents|mesh-ancestor
110139051|NCT03520842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110139052|NCT03520842|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110139053|NCT03520842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110139054|NCT03520842|Immunologic Factors|immunologic factors|mesh-ancestor
110139055|NCT03520842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110139056|NCT03520842|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110139057|NCT03479554|Antihypertensive Agents|antihypertensive agents|mesh-list
110139058|NCT03454529|Simvastatin|simvastatin|mesh-list
110139059|NCT03454529|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110139060|NCT03454529|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110139061|NCT03454529|Antimetabolites|antimetabolites|mesh-ancestor
110139062|NCT03454529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110139063|NCT03454529|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110139064|NCT03454529|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110139065|NCT03454529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110139066|NCT03414658|Trastuzumab|trastuzumab|mesh-list
110139068|NCT03414658|Vinorelbine|vinorelbine|mesh-list
110139069|NCT03414658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110139070|NCT03414658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110139071|NCT03414658|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110139072|NCT03414658|Tubulin Modulators|tubulin modulators|mesh-ancestor
110139073|NCT03414658|Antimitotic Agents|antimitotic agents|mesh-ancestor
110139074|NCT03414658|Mitosis Modulators|mitosis modulators|mesh-ancestor
110139075|NCT03414658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110139076|NCT03398148|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110139077|NCT03398148|Immunologic Factors|immunologic factors|mesh-ancestor
110139078|NCT03398148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110139079|NCT03377023|Nivolumab|nivolumab|mesh-list
110139080|NCT03377023|Ipilimumab|ipilimumab|mesh-list
110139081|NCT03377023|Nintedanib|nintedanib|mesh-list
110139082|NCT03377023|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110139083|NCT03377023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110139084|NCT03377023|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110139085|NCT03377023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110139086|NCT03377023|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110139088|NCT03358875|Docetaxel|docetaxel|mesh-list
110139089|NCT03358875|Tislelizumab|tislelizumab|mesh-list
110139090|NCT03358875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110139091|NCT03358875|Tubulin Modulators|tubulin modulators|mesh-ancestor
110139092|NCT03358875|Antimitotic Agents|antimitotic agents|mesh-ancestor
110139093|NCT03358875|Mitosis Modulators|mitosis modulators|mesh-ancestor
110139094|NCT03358875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110139095|NCT03358875|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110139097|NCT03301857|Immunoglobulins|immunoglobulins|mesh-list
110139098|NCT03301857|Immunoglobulin G|immunoglobulin g|mesh-list
110139099|NCT03301857|Immunologic Factors|immunologic factors|mesh-ancestor
110139100|NCT03301857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110139101|NCT03301857|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110139102|NCT03284502|Cetuximab|cetuximab|mesh-list
110139103|NCT03284502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110139104|NCT03284502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110355419|NCT00551850|MP 412|mp 412|mesh-list
110139105|NCT03277482|Durvalumab|durvalumab|mesh-list
110139106|NCT03277482|Tremelimumab|tremelimumab|mesh-list
110139107|NCT03277482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110139108|NCT03277482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110139109|NCT03249142|Durvalumab|durvalumab|mesh-list
110139110|NCT03249142|Tremelimumab|tremelimumab|mesh-list
110139111|NCT03249142|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110139112|NCT03249142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110139113|NCT03249142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110139114|NCT03249142|Immunologic Factors|immunologic factors|mesh-ancestor
110139115|NCT03249142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110139116|NCT03236428|Daratumumab|daratumumab|mesh-list
110139117|NCT03236428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110139118|NCT03149770|Naloxone|naloxone|mesh-list
110139119|NCT03149770|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110139120|NCT03149770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110139121|NCT03149770|Sensory System Agents|sensory system agents|mesh-ancestor
110139122|NCT03149770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110139123|NCT03095235|Riboflavin|riboflavin|mesh-list
110139124|NCT03095235|Vitamins|vitamins|mesh-ancestor
110139125|NCT03095235|Micronutrients|micronutrients|mesh-ancestor
110139126|NCT03095235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110139127|NCT03095235|Vitamin B Complex|vitamin b complex|mesh-ancestor
110139128|NCT03095235|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110139129|NCT03095235|Dermatologic Agents|dermatologic agents|mesh-ancestor
110139130|NCT03092674|Cytarabine|cytarabine|mesh-list
110139131|NCT03092674|Nivolumab|nivolumab|mesh-list
110139132|NCT03092674|Azacitidine|azacitidine|mesh-list
110139133|NCT03092674|Decitabine|decitabine|mesh-list
110139134|NCT03092674|Midostaurin|midostaurin|mesh-list
110139135|NCT03092674|Staurosporine|staurosporine|mesh-list
110139136|NCT03092674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110139137|NCT03092674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110139138|NCT03092674|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110139139|NCT03092674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110139140|NCT03092674|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110139141|NCT03092674|Antimetabolites|antimetabolites|mesh-ancestor
110139142|NCT03092674|Antiviral Agents|antiviral agents|mesh-ancestor
110139143|NCT03092674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110139144|NCT03092674|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110139145|NCT03092674|Immunologic Factors|immunologic factors|mesh-ancestor
110139146|NCT03092674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110139147|NCT03092674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110139148|NCT03092674|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110139149|NCT03055377|Acetylcysteine|acetylcysteine|mesh-list
110139150|NCT03055377|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110139151|NCT03055377|Antiviral Agents|antiviral agents|mesh-ancestor
110139152|NCT03055377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110139153|NCT03055377|Expectorants|expectorants|mesh-ancestor
110139154|NCT03055377|Respiratory System Agents|respiratory system agents|mesh-ancestor
110139155|NCT03055377|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110139156|NCT03055377|Antioxidants|antioxidants|mesh-ancestor
110355574|NCT00550992|Prednisone|prednisone|mesh-list
110139157|NCT03055377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110139158|NCT03055377|Protective Agents|protective agents|mesh-ancestor
110139159|NCT03055377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110139160|NCT03055377|Antidotes|antidotes|mesh-ancestor
110139161|NCT03016819|Dacarbazine|dacarbazine|mesh-list
110139162|NCT03016819|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110139163|NCT03016819|Alkylating Agents|alkylating agents|mesh-ancestor
110139164|NCT03016819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110139165|NCT03016819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110139166|NCT03012971|Dexmedetomidine|dexmedetomidine|mesh-list
110139167|NCT03012971|Morphine|morphine|mesh-list
110139168|NCT03012971|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110139169|NCT03012971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110139170|NCT03012971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110139171|NCT03012971|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110139172|NCT03012971|Analgesics|analgesics|mesh-ancestor
110139173|NCT03012971|Sensory System Agents|sensory system agents|mesh-ancestor
110139174|NCT03012971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110139175|NCT03012971|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110139176|NCT03012971|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110139177|NCT03012971|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110139178|NCT03012971|Adrenergic Agents|adrenergic agents|mesh-ancestor
110139179|NCT03012971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110139180|NCT03012971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110139181|NCT03012971|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110139182|NCT03012971|Narcotics|narcotics|mesh-ancestor
110139183|NCT02965963|Dopamine|dopamine|mesh-list
110139184|NCT02965963|Metoclopramide|metoclopramide|mesh-list
110139185|NCT02965963|Antiemetics|antiemetics|mesh-ancestor
110139186|NCT02965963|Autonomic Agents|autonomic agents|mesh-ancestor
110139187|NCT02965963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110139188|NCT02965963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110139189|NCT02965963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110139190|NCT02965963|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110139191|NCT02965963|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110139192|NCT02965963|Dopamine Agents|dopamine agents|mesh-ancestor
110139193|NCT02965963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110139194|NCT02965963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110139195|NCT02965963|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110139196|NCT02965963|Sympathomimetics|sympathomimetics|mesh-ancestor
110139200|NCT02960659|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110139201|NCT02960659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110139202|NCT02960659|Incretins|incretins|mesh-ancestor
110139203|NCT02960659|Hormones|hormones|mesh-ancestor
110139204|NCT02960659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110139205|NCT02953509|Rituximab|rituximab|mesh-list
110139206|NCT02953509|Magrolimab|magrolimab|mesh-list
110139207|NCT02953509|Gemcitabine|gemcitabine|mesh-list
110139208|NCT02953509|Oxaliplatin|oxaliplatin|mesh-list
110139209|NCT02953509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110139210|NCT02953509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110139211|NCT02953509|Immunologic Factors|immunologic factors|mesh-ancestor
110139212|NCT02953509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110139213|NCT02953509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110139214|NCT02953509|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110139215|NCT02953509|Antimetabolites|antimetabolites|mesh-ancestor
110139216|NCT02953509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110139217|NCT02936622|Paclitaxel|paclitaxel|mesh-list
110139218|NCT02936622|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110139219|NCT02936622|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110139220|NCT02936622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110139221|NCT02936622|Tubulin Modulators|tubulin modulators|mesh-ancestor
110139222|NCT02936622|Antimitotic Agents|antimitotic agents|mesh-ancestor
110139223|NCT02936622|Mitosis Modulators|mitosis modulators|mesh-ancestor
110139224|NCT02936622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110139225|NCT02916771|Dexamethasone|dexamethasone|mesh-list
110139226|NCT02916771|Lenalidomide|lenalidomide|mesh-list
110139228|NCT02916771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110139229|NCT02916771|Antiemetics|antiemetics|mesh-ancestor
110139230|NCT02916771|Autonomic Agents|autonomic agents|mesh-ancestor
110139231|NCT02916771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110139232|NCT02916771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110139233|NCT02916771|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110139234|NCT02916771|Glucocorticoids|glucocorticoids|mesh-ancestor
110139235|NCT02916771|Hormones|hormones|mesh-ancestor
110139236|NCT02916771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110139237|NCT02916771|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110139238|NCT02916771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110139239|NCT02916771|Immunologic Factors|immunologic factors|mesh-ancestor
110139240|NCT02916771|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110139241|NCT02916771|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110139242|NCT02916771|Growth Substances|growth substances|mesh-ancestor
110139243|NCT02916771|Growth Inhibitors|growth inhibitors|mesh-ancestor
110139244|NCT02916771|Protease Inhibitors|protease inhibitors|mesh-ancestor
110139245|NCT02916771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110139246|NCT02916771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110139249|NCT02913196|Abiraterone Acetate|abiraterone acetate|mesh-list
110139250|NCT02913196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110139251|NCT02913196|Tubulin Modulators|tubulin modulators|mesh-ancestor
110139252|NCT02913196|Antimitotic Agents|antimitotic agents|mesh-ancestor
110139253|NCT02913196|Mitosis Modulators|mitosis modulators|mesh-ancestor
110139254|NCT02913196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110139255|NCT02913196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110139256|NCT02913196|Glucocorticoids|glucocorticoids|mesh-ancestor
110139257|NCT02913196|Hormones|hormones|mesh-ancestor
110139258|NCT02913196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110355883|NCT04401176|Anticoagulants|anticoagulants|mesh-ancestor
110139259|NCT02913196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110139260|NCT02913196|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110139261|NCT02913196|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110139262|NCT02913196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110139263|NCT02913196|Hormone Antagonists|hormone antagonists|mesh-ancestor
110139264|NCT02913196|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110139265|NCT02890082|Tamoxifen|tamoxifen|mesh-list
110139266|NCT02890082|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110139267|NCT02890082|Hormone Antagonists|hormone antagonists|mesh-ancestor
110139268|NCT02890082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110139269|NCT02890082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110139270|NCT02890082|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110139271|NCT02890082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110139272|NCT02890082|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110139273|NCT02890082|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110139274|NCT02890082|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110139275|NCT02844933|Cannabidiol|cannabidiol|mesh-list
110139276|NCT02844933|Anticonvulsants|anticonvulsants|mesh-ancestor
110139277|NCT02844816|Atezolizumab|atezolizumab|mesh-list
110139278|NCT02844816|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110355930|NCT04090775|Cyclophosphamide|cyclophosphamide|mesh-list
110139279|NCT02844816|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110139280|NCT02844816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110139281|NCT02844816|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110139283|NCT02844816|Immunologic Factors|immunologic factors|mesh-ancestor
110139284|NCT02844816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110139285|NCT02842749|Everolimus|everolimus|mesh-list
110139286|NCT02842749|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110139287|NCT02842749|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110139288|NCT02842749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110139289|NCT02842749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110139290|NCT02842749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110139291|NCT02842749|Immunologic Factors|immunologic factors|mesh-ancestor
110139292|NCT02842749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110139293|NCT02842749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110139294|NCT02831764|Tenofovir|tenofovir|mesh-list
110139295|NCT02831764|Lamivudine|lamivudine|mesh-list
110139296|NCT02831764|Emtricitabine|emtricitabine|mesh-list
110139297|NCT02831764|Dolutegravir|dolutegravir|mesh-list
110139298|NCT02831764|Antiviral Agents|antiviral agents|mesh-ancestor
110139299|NCT02831764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110139300|NCT02831764|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110139301|NCT02831764|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110167059|NCT00012558|Vitamins|vitamins|mesh-ancestor
110139302|NCT02831764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110139303|NCT02831764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110139304|NCT02831764|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110139305|NCT02831764|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110139306|NCT02831764|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110139307|NCT02831764|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110139308|NCT02797470|Cytarabine|cytarabine|mesh-list
110139309|NCT02797470|Etoposide|etoposide|mesh-list
110139310|NCT02797470|Podophyllotoxin|podophyllotoxin|mesh-list
110139311|NCT02797470|Etoposide phosphate|etoposide phosphate|mesh-list
110139312|NCT02797470|Melphalan|melphalan|mesh-list
110139313|NCT02797470|Mechlorethamine|mechlorethamine|mesh-list
110139314|NCT02797470|Carmustine|carmustine|mesh-list
110139315|NCT02797470|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
110139316|NCT02797470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110356022|NCT03850535|Antimetabolites|antimetabolites|mesh-ancestor
110139317|NCT02797470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110139318|NCT02797470|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110139319|NCT02797470|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110139321|NCT02797470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110139322|NCT02797470|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110139324|NCT02797470|Antiviral Agents|antiviral agents|mesh-ancestor
110139325|NCT02797470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110139326|NCT02797470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110139327|NCT02797470|Immunologic Factors|immunologic factors|mesh-ancestor
110139328|NCT02797470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110139329|NCT02797470|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110139330|NCT02797470|Alkylating Agents|alkylating agents|mesh-ancestor
110139331|NCT02797470|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110139332|NCT02797470|Keratolytic Agents|keratolytic agents|mesh-ancestor
110139333|NCT02797470|Dermatologic Agents|dermatologic agents|mesh-ancestor
110139334|NCT02797470|Tubulin Modulators|tubulin modulators|mesh-ancestor
110139335|NCT02797470|Antimitotic Agents|antimitotic agents|mesh-ancestor
110139336|NCT02797470|Mitosis Modulators|mitosis modulators|mesh-ancestor
110139337|NCT02744690|Mitomycins|mitomycins|mesh-list
110139338|NCT02744690|Mitomycin|mitomycin|mesh-list
110139339|NCT02744690|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110139340|NCT02744690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110139341|NCT02744690|Alkylating Agents|alkylating agents|mesh-ancestor
110139342|NCT02744690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110139343|NCT02744690|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110139344|NCT02744690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110139345|NCT02721459|Vemurafenib|vemurafenib|mesh-list
110356146|NCT05098470|Metformin|metformin|mesh-list
110139346|NCT02721459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110139347|NCT02721459|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110139349|NCT02721459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110139350|NCT02705820|Pembrolizumab|pembrolizumab|mesh-list
110139351|NCT02705820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110139352|NCT02705820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110139353|NCT02705820|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110356206|NCT02469155|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110368619|NCT05419583|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110139354|NCT02705820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110139355|NCT02642042|Docetaxel|docetaxel|mesh-list
110139356|NCT02642042|Trametinib|trametinib|mesh-list
110139357|NCT02642042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110139358|NCT02642042|Tubulin Modulators|tubulin modulators|mesh-ancestor
110139359|NCT02642042|Antimitotic Agents|antimitotic agents|mesh-ancestor
110139360|NCT02642042|Mitosis Modulators|mitosis modulators|mesh-ancestor
110139361|NCT02642042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110139362|NCT02642042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110139363|NCT02642042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110139364|NCT02582775|Mycophenolic Acid|mycophenolic acid|mesh-list
110139365|NCT02582775|Cyclophosphamide|cyclophosphamide|mesh-list
110139366|NCT02582775|Busulfan|busulfan|mesh-list
110139367|NCT02582775|Fludarabine|fludarabine|mesh-list
110139368|NCT02582775|Fludarabine phosphate|fludarabine phosphate|mesh-list
110139369|NCT02582775|Tacrolimus|tacrolimus|mesh-list
110139370|NCT02582775|Thymoglobulin|thymoglobulin|mesh-list
110167070|NCT00000500|Aspirin|aspirin|mesh-list
110139371|NCT02582775|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110139372|NCT02582775|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110139373|NCT02582775|Immunologic Factors|immunologic factors|mesh-ancestor
110139374|NCT02582775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110139375|NCT02582775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110139376|NCT02582775|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110139377|NCT02582775|Alkylating Agents|alkylating agents|mesh-ancestor
110139378|NCT02582775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110139379|NCT02582775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110139380|NCT02582775|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110139381|NCT02582775|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110139383|NCT02582775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110139384|NCT02582775|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110139385|NCT02582775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110139386|NCT02582775|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110139387|NCT02582775|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110139388|NCT02582775|Antitubercular Agents|antitubercular agents|mesh-ancestor
110356350|NCT04684017|Etoposide|etoposide|mesh-list
110139389|NCT02582775|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110139390|NCT02506517|Afatinib|afatinib|mesh-list
110139391|NCT02506517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110139392|NCT02506517|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110139393|NCT02506517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110139394|NCT02506517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110139395|NCT02499835|Pembrolizumab|pembrolizumab|mesh-list
110139396|NCT02499835|Immunoglobulins|immunoglobulins|mesh-list
110139397|NCT02499835|Immunoglobulin G|immunoglobulin g|mesh-list
110139398|NCT02499835|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110139399|NCT02499835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110139400|NCT02499835|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110139401|NCT02499835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110139402|NCT02499835|Immunologic Factors|immunologic factors|mesh-ancestor
110139403|NCT02499835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110139405|NCT02460497|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110139406|NCT02460497|Vasodilator Agents|vasodilator agents|mesh-ancestor
110139407|NCT02460289|Minoxidil|minoxidil|mesh-list
110139408|NCT02460289|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110139409|NCT02460289|Vasodilator Agents|vasodilator agents|mesh-ancestor
110139410|NCT02311933|Tamoxifen|tamoxifen|mesh-list
110139411|NCT02311933|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110139412|NCT02311933|Hormone Antagonists|hormone antagonists|mesh-ancestor
110139413|NCT02311933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110139414|NCT02311933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110139415|NCT02311933|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110139416|NCT02311933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110139417|NCT02311933|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110139418|NCT02311933|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110139419|NCT02311933|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110139420|NCT02286154|Hydroxyurea|hydroxyurea|mesh-list
110139421|NCT02286154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110139422|NCT02286154|Antisickling Agents|antisickling agents|mesh-ancestor
110139423|NCT02286154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110139424|NCT02286154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110139425|NCT02286154|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110139426|NCT02274779|Leuprolide|leuprolide|mesh-list
110139427|NCT02274779|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110139428|NCT02274779|Fertility Agents|fertility agents|mesh-ancestor
110167078|NCT00000500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110139429|NCT02274779|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110139430|NCT02274779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110139431|NCT02274779|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110139432|NCT02274779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110139433|NCT02261883|Treprostinil|treprostinil|mesh-list
110139434|NCT02261883|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110139435|NCT02253316|Dexamethasone|dexamethasone|mesh-list
110139436|NCT02253316|Dexamethasone acetate|dexamethasone acetate|mesh-list
110139437|NCT02253316|Lenalidomide|lenalidomide|mesh-list
110139439|NCT02253316|BB 1101|bb 1101|mesh-list
110139440|NCT02253316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110139441|NCT02253316|Antiemetics|antiemetics|mesh-ancestor
110139442|NCT02253316|Autonomic Agents|autonomic agents|mesh-ancestor
110139443|NCT02253316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110139444|NCT02253316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110139445|NCT02253316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110139446|NCT02253316|Glucocorticoids|glucocorticoids|mesh-ancestor
110139447|NCT02253316|Hormones|hormones|mesh-ancestor
110139448|NCT02253316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110139449|NCT02253316|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110139450|NCT02253316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110139451|NCT02253316|Protease Inhibitors|protease inhibitors|mesh-ancestor
110139452|NCT02253316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110139453|NCT02253316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110139454|NCT02253316|Immunologic Factors|immunologic factors|mesh-ancestor
110139455|NCT02253316|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110139456|NCT02253316|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110139457|NCT02253316|Growth Substances|growth substances|mesh-ancestor
110139458|NCT02253316|Growth Inhibitors|growth inhibitors|mesh-ancestor
110139459|NCT02169089|Spironolactone|spironolactone|mesh-list
110139460|NCT02169089|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110139461|NCT02169089|Hormone Antagonists|hormone antagonists|mesh-ancestor
110139462|NCT02169089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110139463|NCT02169089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110139464|NCT02169089|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110139465|NCT02169089|Diuretics|diuretics|mesh-ancestor
110139466|NCT02169089|Natriuretic Agents|natriuretic agents|mesh-ancestor
110139467|NCT02130453|Regadenoson|regadenoson|mesh-list
110139468|NCT02130453|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
110139469|NCT02130453|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
110139470|NCT02130453|Purinergic Agonists|purinergic agonists|mesh-ancestor
110139471|NCT02130453|Purinergic Agents|purinergic agents|mesh-ancestor
110139472|NCT02130453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110139473|NCT02130453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110139474|NCT02130453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110139475|NCT02074839|Ivosidenib|ivosidenib|mesh-list
110139476|NCT02074839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110139477|NCT02074839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110139478|NCT02074839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110139479|NCT02059265|Dasatinib|dasatinib|mesh-list
110139480|NCT02059265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110139481|NCT02059265|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110139482|NCT02059265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110139483|NCT02059265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110139484|NCT01990352|Doxorubicin|doxorubicin|mesh-list
110139485|NCT01990352|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110139486|NCT01990352|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110139487|NCT01990352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110139488|NCT01990352|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110139489|NCT01990352|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110139490|NCT01990352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110139491|NCT01990352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110139493|NCT01886872|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110139494|NCT01886872|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110139496|NCT01886872|Immunoglobulins|immunoglobulins|mesh-list
110139497|NCT01886872|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110139498|NCT01886872|Immunologic Factors|immunologic factors|mesh-ancestor
110139499|NCT01886872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110139500|NCT01886872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110139501|NCT01886872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110139502|NCT01886872|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110139503|NCT01886872|Alkylating Agents|alkylating agents|mesh-ancestor
110139504|NCT01886872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110139505|NCT01856192|Prednisone|prednisone|mesh-list
110139506|NCT01856192|Cortisone|cortisone|mesh-list
110139507|NCT01856192|Cyclophosphamide|cyclophosphamide|mesh-list
110139508|NCT01856192|Rituximab|rituximab|mesh-list
110139509|NCT01856192|Doxorubicin|doxorubicin|mesh-list
110139510|NCT01856192|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110139511|NCT01856192|Vincristine|vincristine|mesh-list
110139512|NCT01856192|Lenalidomide|lenalidomide|mesh-list
110139513|NCT01856192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110139514|NCT01856192|Antibodies|antibodies|mesh-list
110139515|NCT01856192|Immunoglobulins|immunoglobulins|mesh-list
110139516|NCT01856192|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110139517|NCT01856192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110139518|NCT01856192|Immunologic Factors|immunologic factors|mesh-ancestor
110167108|NCT00000503|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110356577|NCT01231321|Adalimumab|adalimumab|mesh-list
110139519|NCT01856192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110139521|NCT01856192|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110139522|NCT01856192|Alkylating Agents|alkylating agents|mesh-ancestor
110139523|NCT01856192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110139524|NCT01856192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110139525|NCT01856192|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110139526|NCT01856192|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110139527|NCT01856192|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110139528|NCT01856192|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110139529|NCT01856192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110139530|NCT01856192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110139531|NCT01856192|Glucocorticoids|glucocorticoids|mesh-ancestor
110139532|NCT01856192|Hormones|hormones|mesh-ancestor
110139533|NCT01856192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110356651|NCT01230892|Atenolol|atenolol|mesh-list
110139535|NCT01856192|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110139536|NCT01856192|Tubulin Modulators|tubulin modulators|mesh-ancestor
110139537|NCT01856192|Antimitotic Agents|antimitotic agents|mesh-ancestor
110139538|NCT01856192|Mitosis Modulators|mitosis modulators|mesh-ancestor
110139539|NCT01856192|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110139540|NCT01856192|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110139541|NCT01856192|Growth Substances|growth substances|mesh-ancestor
110139542|NCT01856192|Growth Inhibitors|growth inhibitors|mesh-ancestor
110139543|NCT01757418|Immunoglobulins|immunoglobulins|mesh-list
110139544|NCT01757418|Antibodies|antibodies|mesh-list
110139545|NCT01757418|gamma-Globulins|gamma-globulins|mesh-list
110139546|NCT01757418|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110139547|NCT01757418|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110139548|NCT01757418|Immunologic Factors|immunologic factors|mesh-ancestor
110139549|NCT01757418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110139550|NCT01708954|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110139551|NCT01708954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110139552|NCT01708954|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110139553|NCT01708954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110139554|NCT01708954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110139555|NCT01708941|Interferons|interferons|mesh-list
110139556|NCT01708941|Interferon-alpha|interferon-alpha|mesh-list
110139557|NCT01708941|Interferon alpha-2|interferon alpha-2|mesh-list
110139558|NCT01708941|Ipilimumab|ipilimumab|mesh-list
110139559|NCT01708941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110139560|NCT01708941|Antiviral Agents|antiviral agents|mesh-ancestor
110139561|NCT01708941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110139562|NCT01708941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110139563|NCT01708941|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110139564|NCT01708941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110139565|NCT01708941|Immunologic Factors|immunologic factors|mesh-ancestor
110139566|NCT01708941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110139567|NCT01661647|Anesthetics|anesthetics|mesh-list
110139568|NCT01661647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110139569|NCT01661647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110139570|NCT01142388|Paclitaxel|paclitaxel|mesh-list
110139571|NCT01142388|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110139572|NCT01142388|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110139573|NCT01142388|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110139574|NCT01142388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110139575|NCT01142388|Tubulin Modulators|tubulin modulators|mesh-ancestor
110139576|NCT01142388|Antimitotic Agents|antimitotic agents|mesh-ancestor
110139577|NCT01142388|Mitosis Modulators|mitosis modulators|mesh-ancestor
110356799|NCT04665986|Antimitotic Agents|antimitotic agents|mesh-ancestor
110139578|NCT01142388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110139579|NCT01142388|Immunologic Factors|immunologic factors|mesh-ancestor
110139580|NCT01142388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110139582|NCT01134614|Sargramostim|sargramostim|mesh-list
110139583|NCT01134614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110139584|NCT01134614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110139585|NCT01134614|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110139586|NCT01134614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110139587|NCT01134614|Immunologic Factors|immunologic factors|mesh-ancestor
110139588|NCT01134614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110139589|NCT01130519|Bevacizumab|bevacizumab|mesh-list
110139590|NCT01130519|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110139591|NCT01130519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110139592|NCT01130519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110139593|NCT01130519|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110356881|NCT00557102|Vitamins|vitamins|mesh-ancestor
110139594|NCT01130519|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110139595|NCT01130519|Growth Substances|growth substances|mesh-ancestor
110139596|NCT01130519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110139597|NCT01130519|Growth Inhibitors|growth inhibitors|mesh-ancestor
110139598|NCT01130519|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110139599|NCT01130519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110139600|NCT01130519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110139601|NCT00655967|Acamprosate|acamprosate|mesh-list
110139602|NCT00655967|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110139603|NCT00601198|Leucovorin|leucovorin|mesh-list
110139604|NCT00601198|Oxaliplatin|oxaliplatin|mesh-list
110139605|NCT00601198|Levoleucovorin|levoleucovorin|mesh-list
110139606|NCT00601198|Amifostine|amifostine|mesh-list
110139607|NCT00601198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110356935|NCT04347915|Clevudine|clevudine|mesh-list
110139608|NCT00601198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110139609|NCT00601198|Antidotes|antidotes|mesh-ancestor
110139610|NCT00601198|Protective Agents|protective agents|mesh-ancestor
110139611|NCT00601198|Vitamin B Complex|vitamin b complex|mesh-ancestor
110139612|NCT00601198|Vitamins|vitamins|mesh-ancestor
110139613|NCT00601198|Micronutrients|micronutrients|mesh-ancestor
110139614|NCT00601198|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110139615|NCT00433511|Paclitaxel|paclitaxel|mesh-list
110139616|NCT00433511|Cyclophosphamide|cyclophosphamide|mesh-list
110139617|NCT00433511|Bevacizumab|bevacizumab|mesh-list
110139618|NCT00433511|Doxorubicin|doxorubicin|mesh-list
110139619|NCT00433511|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110139620|NCT00433511|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110139621|NCT00433511|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110139622|NCT00433511|Antibodies|antibodies|mesh-list
110139623|NCT00433511|Immunoglobulins|immunoglobulins|mesh-list
110139624|NCT00433511|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110139625|NCT00433511|Immunoglobulin G|immunoglobulin g|mesh-list
110139626|NCT00433511|Endothelial Growth Factors|endothelial growth factors|mesh-list
110139627|NCT00433511|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110139628|NCT00433511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110139629|NCT00433511|Tubulin Modulators|tubulin modulators|mesh-ancestor
110139630|NCT00433511|Antimitotic Agents|antimitotic agents|mesh-ancestor
110139631|NCT00433511|Mitosis Modulators|mitosis modulators|mesh-ancestor
110139632|NCT00433511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110139633|NCT00433511|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110139634|NCT00433511|Immunologic Factors|immunologic factors|mesh-ancestor
110139635|NCT00433511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110139636|NCT00433511|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110139637|NCT00433511|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110139639|NCT00433511|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110139640|NCT00433511|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110139641|NCT00433511|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110139642|NCT00433511|Growth Substances|growth substances|mesh-ancestor
110139643|NCT00433511|Growth Inhibitors|growth inhibitors|mesh-ancestor
110139644|NCT00433511|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110139645|NCT00433511|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110139646|NCT00433511|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110139647|NCT00433511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110139648|NCT00098475|Thalidomide|thalidomide|mesh-list
110139649|NCT00098475|Dexamethasone|dexamethasone|mesh-list
110139650|NCT00098475|Dexamethasone acetate|dexamethasone acetate|mesh-list
110139651|NCT00098475|Lenalidomide|lenalidomide|mesh-list
110139652|NCT00098475|Ichthammol|ichthammol|mesh-list
110139653|NCT00098475|BB 1101|bb 1101|mesh-list
110139654|NCT00098475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110139655|NCT00098475|Antiemetics|antiemetics|mesh-ancestor
110139656|NCT00098475|Autonomic Agents|autonomic agents|mesh-ancestor
110139657|NCT00098475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110139658|NCT00098475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110139659|NCT00098475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110139660|NCT00098475|Glucocorticoids|glucocorticoids|mesh-ancestor
110139661|NCT00098475|Hormones|hormones|mesh-ancestor
110139662|NCT00098475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110139663|NCT00098475|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110139664|NCT00098475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110139665|NCT00098475|Protease Inhibitors|protease inhibitors|mesh-ancestor
110139666|NCT00098475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110139667|NCT00098475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110139668|NCT00098475|Immunologic Factors|immunologic factors|mesh-ancestor
110139669|NCT00098475|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110139670|NCT00098475|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110139671|NCT00098475|Growth Substances|growth substances|mesh-ancestor
110139672|NCT00098475|Growth Inhibitors|growth inhibitors|mesh-ancestor
110139673|NCT00098475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110139674|NCT00098475|Leprostatic Agents|leprostatic agents|mesh-ancestor
110139675|NCT00098475|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110139676|NCT00098475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110357163|NCT01207414|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110139677|NCT00098475|Dermatologic Agents|dermatologic agents|mesh-ancestor
110139679|NCT02006498|Antioxidants|antioxidants|mesh-ancestor
110139680|NCT02006498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110139681|NCT02006498|Protective Agents|protective agents|mesh-ancestor
110139682|NCT02006498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110139683|NCT02006589|Candesartan|candesartan|mesh-list
110139684|NCT02006589|Candesartan cilexetil|candesartan cilexetil|mesh-list
110139685|NCT02006589|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110139686|NCT02006589|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110139687|NCT02006589|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110139688|NCT02006589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110139689|NCT02006602|Candesartan|candesartan|mesh-list
110139690|NCT02006602|Candesartan cilexetil|candesartan cilexetil|mesh-list
110139691|NCT02006602|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110139692|NCT02006602|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110139693|NCT02006602|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110139694|NCT02006602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110139695|NCT02006745|Ribavirin|ribavirin|mesh-list
110357226|NCT00557453|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110139696|NCT02006745|Antimetabolites|antimetabolites|mesh-ancestor
110139697|NCT02006745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110139698|NCT02006745|Antiviral Agents|antiviral agents|mesh-ancestor
110139699|NCT02006745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110139700|NCT02006849|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
110139702|NCT02006849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110139703|NCT02006849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110139704|NCT02006914|Chromium|chromium|mesh-list
110139705|NCT02006914|Picolinic acid|picolinic acid|mesh-list
110139706|NCT02006914|Trace Elements|trace elements|mesh-ancestor
110139707|NCT02006914|Micronutrients|micronutrients|mesh-ancestor
110139708|NCT02006914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110139709|NCT02006914|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110139710|NCT02006914|Chelating Agents|chelating agents|mesh-ancestor
110139712|NCT02006914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110139713|NCT02006966|Lidocaine|lidocaine|mesh-list
110139714|NCT02006966|Anesthetics, Local|anesthetics, local|mesh-ancestor
110139715|NCT02006966|Anesthetics|anesthetics|mesh-ancestor
110139716|NCT02006966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110139717|NCT02006966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110139718|NCT02006966|Sensory System Agents|sensory system agents|mesh-ancestor
110139719|NCT02006966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110139720|NCT02006966|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110139721|NCT02006966|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110139722|NCT02006966|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110139723|NCT02006966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110139724|NCT02006966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110139725|NCT02007005|Viscum album peptide|viscum album peptide|mesh-list
110139726|NCT02007005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110139727|NCT02007005|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110139728|NCT02007005|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110139729|NCT02007005|Antiviral Agents|antiviral agents|mesh-ancestor
110139730|NCT02007005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110139731|NCT02007148|Docetaxel|docetaxel|mesh-list
110139732|NCT02007148|Capecitabine|capecitabine|mesh-list
110139733|NCT02007148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110139734|NCT02007148|Tubulin Modulators|tubulin modulators|mesh-ancestor
110139735|NCT02007148|Antimitotic Agents|antimitotic agents|mesh-ancestor
110139736|NCT02007148|Mitosis Modulators|mitosis modulators|mesh-ancestor
110139737|NCT02007148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110139738|NCT02007148|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110139739|NCT02007148|Antimetabolites|antimetabolites|mesh-ancestor
110139740|NCT02007161|Diclofenac|diclofenac|mesh-list
110139741|NCT02007161|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110139742|NCT02007161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110139743|NCT02007161|Analgesics|analgesics|mesh-ancestor
110139744|NCT02007161|Sensory System Agents|sensory system agents|mesh-ancestor
110139745|NCT02007161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110139746|NCT02007161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110139747|NCT02007161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110139748|NCT02007161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110139749|NCT02007161|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110139750|NCT02007161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110139751|NCT02007161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110139752|NCT02007174|Bevacizumab|bevacizumab|mesh-list
110139753|NCT02007174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110139754|NCT02007174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110139755|NCT02007174|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110139757|NCT02007174|Growth Substances|growth substances|mesh-ancestor
110139758|NCT02007174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110139759|NCT02007174|Growth Inhibitors|growth inhibitors|mesh-ancestor
110139760|NCT02007330|Lidocaine|lidocaine|mesh-list
110139761|NCT02007330|Anesthetics, Local|anesthetics, local|mesh-ancestor
110139762|NCT02007330|Anesthetics|anesthetics|mesh-ancestor
110139763|NCT02007330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110139764|NCT02007330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110139765|NCT02007330|Sensory System Agents|sensory system agents|mesh-ancestor
110139766|NCT02007330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110139767|NCT02007330|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110357445|NCT04656665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110139768|NCT02007330|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110139769|NCT02007330|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110139770|NCT02007330|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110139771|NCT02007330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110139773|NCT02007408|Anesthetics, Local|anesthetics, local|mesh-ancestor
110139774|NCT02007408|Anesthetics|anesthetics|mesh-ancestor
110139775|NCT02007408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110139776|NCT02007408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110139777|NCT02007408|Sensory System Agents|sensory system agents|mesh-ancestor
110139778|NCT02007408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110357508|NCT00541710|Protective Agents|protective agents|mesh-ancestor
110139779|NCT02007408|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110139780|NCT02007408|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110139781|NCT02007408|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110167173|NCT00030355|Homoharringtonine|homoharringtonine|mesh-list
110139783|NCT02007408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110139784|NCT02007447|Oxytocin|oxytocin|mesh-list
110139785|NCT02007447|Oxytocics|oxytocics|mesh-ancestor
110139786|NCT02007447|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110139787|NCT02007447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110139788|NCT02007603|Amoxicillin|amoxicillin|mesh-list
110139789|NCT02007603|Ampicillin|ampicillin|mesh-list
110139790|NCT02007603|Clavulanic Acids|clavulanic acids|mesh-list
110139791|NCT02007603|Clavulanic Acid|clavulanic acid|mesh-list
110139792|NCT02007603|Sulbactam|sulbactam|mesh-list
110139793|NCT02007603|Sultamicillin|sultamicillin|mesh-list
110139794|NCT02007603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110139795|NCT02007603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110139796|NCT02007603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110139797|NCT02007603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110139798|NCT02007603|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110139799|NCT02007629|Riociguat|riociguat|mesh-list
110139800|NCT02007629|Enzyme Activators|enzyme activators|mesh-ancestor
110139801|NCT02007629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110139802|NCT02007746|Liver Extracts|liver extracts|mesh-list
110139803|NCT02007746|Hematinics|hematinics|mesh-ancestor
110139804|NCT02007798|Dexmedetomidine|dexmedetomidine|mesh-list
110139805|NCT02007798|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110139806|NCT02007798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110139807|NCT02007798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110139808|NCT02007798|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110139809|NCT02007798|Analgesics|analgesics|mesh-ancestor
110139810|NCT02007798|Sensory System Agents|sensory system agents|mesh-ancestor
110139811|NCT02007798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110139812|NCT02007798|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110139813|NCT02007798|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110139814|NCT02007798|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110139815|NCT02007798|Adrenergic Agents|adrenergic agents|mesh-ancestor
110139816|NCT02007798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110139817|NCT02007798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110139818|NCT02007837|Aspirin|aspirin|mesh-list
110357698|NCT00543075|Oblimersen|oblimersen|mesh-list
110139819|NCT02007837|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110139820|NCT02007837|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110139821|NCT02007837|Analgesics|analgesics|mesh-ancestor
110139822|NCT02007837|Sensory System Agents|sensory system agents|mesh-ancestor
110139823|NCT02007837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110139824|NCT02007837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110139825|NCT02007837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110139826|NCT02007837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110139827|NCT02007837|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110139828|NCT02007837|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110139829|NCT02007837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110139830|NCT02007837|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110139831|NCT02007837|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110139832|NCT02007837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110139833|NCT02007837|Antipyretics|antipyretics|mesh-ancestor
110139834|NCT02007850|Ropivacaine|ropivacaine|mesh-list
110139835|NCT02007850|Anesthetics, Local|anesthetics, local|mesh-ancestor
110139836|NCT02007850|Anesthetics|anesthetics|mesh-ancestor
110139837|NCT02007850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110139838|NCT02007850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110139839|NCT02007850|Sensory System Agents|sensory system agents|mesh-ancestor
110139840|NCT02007850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110139841|NCT02007915|Pamidronate|pamidronate|mesh-list
110139842|NCT02007915|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110139843|NCT02007915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110139845|NCT02007928|Risperidone|risperidone|mesh-list
110139846|NCT02007928|Aripiprazole|aripiprazole|mesh-list
110139847|NCT02007928|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110139848|NCT02007928|Serotonin Agents|serotonin agents|mesh-ancestor
110357816|NCT00557921|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110139849|NCT02007928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110139850|NCT02007928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110139851|NCT02007928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110139852|NCT02007928|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110139853|NCT02007928|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110139854|NCT02007928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110139855|NCT02007928|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110139856|NCT02007928|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110139857|NCT02007928|Dopamine Agents|dopamine agents|mesh-ancestor
110139858|NCT02007928|Antiemetics|antiemetics|mesh-ancestor
110139859|NCT02007928|Autonomic Agents|autonomic agents|mesh-ancestor
110139860|NCT02007928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110139861|NCT02007928|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110139862|NCT02007928|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110139863|NCT02007928|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110139864|NCT02007928|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110139865|NCT02007928|Antidepressive Agents|antidepressive agents|mesh-ancestor
110139866|NCT02007928|Dopamine Agonists|dopamine agonists|mesh-ancestor
110139867|NCT02007928|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110139868|NCT02007928|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110139869|NCT02007928|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110139870|NCT02007928|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110139872|NCT02008006|Etoposide|etoposide|mesh-list
110139873|NCT02008006|Melphalan|melphalan|mesh-list
110139874|NCT02008006|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110139875|NCT02008006|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110139876|NCT02008006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110139877|NCT02008006|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110139878|NCT02008006|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110139879|NCT02008006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110139880|NCT02008006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110139881|NCT02008006|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110139883|NCT02008006|Antiviral Agents|antiviral agents|mesh-ancestor
110139884|NCT02008006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110139885|NCT02008006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110139886|NCT02008006|Immunologic Factors|immunologic factors|mesh-ancestor
110139887|NCT02008006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110139888|NCT02008006|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110139889|NCT02008006|Alkylating Agents|alkylating agents|mesh-ancestor
110139890|NCT02008006|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110139891|NCT02008019|Everolimus|everolimus|mesh-list
110139892|NCT02008019|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110139893|NCT02008019|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110139894|NCT02008019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110139895|NCT02008019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110139896|NCT02008019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110139897|NCT02008019|Immunologic Factors|immunologic factors|mesh-ancestor
110358066|NCT03456531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110358068|NCT02909049|Midazolam|midazolam|mesh-list
110139898|NCT02008019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110139899|NCT02008019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110139900|NCT02008123|Primidone|primidone|mesh-list
110139901|NCT02008123|Anticonvulsants|anticonvulsants|mesh-ancestor
110139902|NCT02008123|GABA Modulators|gaba modulators|mesh-ancestor
110139903|NCT02008123|GABA Agents|gaba agents|mesh-ancestor
110139904|NCT02008123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110139905|NCT02008123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110139906|NCT02008123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110139907|NCT02008136|Botulinum Toxins|botulinum toxins|mesh-list
110139908|NCT02008136|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110358126|NCT06022276|Nimotuzumab|nimotuzumab|mesh-list
110139909|NCT02008136|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110139910|NCT02008136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110139911|NCT02008136|Cholinergic Agents|cholinergic agents|mesh-ancestor
110139912|NCT02008136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110139913|NCT02008136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110139915|NCT02008162|Albuterol|albuterol|mesh-list
110139916|NCT02008162|Tiotropium Bromide|tiotropium bromide|mesh-list
110139917|NCT02008162|Bronchodilator Agents|bronchodilator agents|mesh-list
110139919|NCT02008162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110167193|NCT00030433|Antimetabolites|antimetabolites|mesh-ancestor
110139920|NCT02008162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110139921|NCT02008162|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110139922|NCT02008162|Respiratory System Agents|respiratory system agents|mesh-ancestor
110139923|NCT02008162|Parasympatholytics|parasympatholytics|mesh-ancestor
110139924|NCT02008162|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110139925|NCT02008162|Cholinergic Agents|cholinergic agents|mesh-ancestor
110139926|NCT02008162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110139927|NCT02008162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110139928|NCT02008162|Anticonvulsants|anticonvulsants|mesh-ancestor
110139929|NCT02008162|Tocolytic Agents|tocolytic agents|mesh-ancestor
110139930|NCT02008162|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110139931|NCT02008162|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110139932|NCT02008162|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110139933|NCT02008162|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110139934|NCT02008162|Adrenergic Agents|adrenergic agents|mesh-ancestor
110139935|NCT02008201|Vitamin D|vitamin d|mesh-list
110139936|NCT02008201|Vitamins|vitamins|mesh-ancestor
110139937|NCT02008201|Micronutrients|micronutrients|mesh-ancestor
110139938|NCT02008201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110139939|NCT02008201|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110139940|NCT02008214|Pentoxifylline|pentoxifylline|mesh-list
110139941|NCT02008214|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110139942|NCT02008214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110139943|NCT02008214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110139944|NCT02008214|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110139945|NCT02008214|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110139946|NCT02008214|Protective Agents|protective agents|mesh-ancestor
110139947|NCT02008214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110139948|NCT02008214|Vasodilator Agents|vasodilator agents|mesh-ancestor
110139949|NCT02008214|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110139950|NCT02008214|Antioxidants|antioxidants|mesh-ancestor
110139951|NCT02008383|Panitumumab|panitumumab|mesh-list
110139952|NCT02008383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110139953|NCT02008383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110139956|NCT02008422|Endostar protein|endostar protein|mesh-list
110139957|NCT02008422|Endostatins|endostatins|mesh-list
110139958|NCT02008422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110139959|NCT02008422|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110139960|NCT02008422|Antimetabolites|antimetabolites|mesh-ancestor
110139961|NCT02008422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110139962|NCT02008422|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110139963|NCT02008422|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110139964|NCT02008422|Growth Substances|growth substances|mesh-ancestor
110139965|NCT02008422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110139966|NCT02008422|Growth Inhibitors|growth inhibitors|mesh-ancestor
110139967|NCT02008461|Botulinum Toxins|botulinum toxins|mesh-list
110139968|NCT02008461|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110139969|NCT02008461|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110139970|NCT02008461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110139972|NCT02008461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110139973|NCT02008461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110139974|NCT02008578|Immunoglobulins|immunoglobulins|mesh-list
110139975|NCT02008578|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110139976|NCT02008578|Antibodies|antibodies|mesh-list
110139977|NCT02008578|Immunologic Factors|immunologic factors|mesh-ancestor
110139978|NCT02008578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110139979|NCT02008721|Neuroprotective Agents|neuroprotective agents|mesh-list
110139980|NCT02008721|Protective Agents|protective agents|mesh-ancestor
110139981|NCT02008721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110139982|NCT02008734|Palbociclib|palbociclib|mesh-list
110139983|NCT02008734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110358298|NCT06020781|Analgesics|analgesics|mesh-ancestor
110139984|NCT02008734|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110139985|NCT02008734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110139986|NCT02008734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110139987|NCT02008747|Magnesium Sulfate|magnesium sulfate|mesh-list
110139988|NCT02008747|Analgesics|analgesics|mesh-ancestor
110139989|NCT02008747|Sensory System Agents|sensory system agents|mesh-ancestor
110139990|NCT02008747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110139991|NCT02008747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110139993|NCT02008747|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110139994|NCT02008747|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110139995|NCT02008747|Anticonvulsants|anticonvulsants|mesh-ancestor
110139996|NCT02008747|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110139997|NCT02008747|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110139998|NCT02008747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110139999|NCT02008747|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110140000|NCT02008747|Tocolytic Agents|tocolytic agents|mesh-ancestor
110140001|NCT02008747|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110140002|NCT02008786|Ramipril|ramipril|mesh-list
110140003|NCT02008786|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110140004|NCT02008786|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110140005|NCT02008786|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110140006|NCT02008786|Antimetabolites|antimetabolites|mesh-ancestor
110140007|NCT02008786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110140008|NCT02008786|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110140009|NCT02008786|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110140010|NCT02008786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110140011|NCT02008786|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110140012|NCT02008786|Protease Inhibitors|protease inhibitors|mesh-ancestor
110140013|NCT02008786|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110140014|NCT02008968|Allopurinol|allopurinol|mesh-list
110140015|NCT02008968|Antimetabolites|antimetabolites|mesh-ancestor
110140016|NCT02008968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110140017|NCT02008968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110140018|NCT02008968|Gout Suppressants|gout suppressants|mesh-ancestor
110140019|NCT02008968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110140020|NCT02008968|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110140021|NCT02008968|Antioxidants|antioxidants|mesh-ancestor
110140022|NCT02008968|Protective Agents|protective agents|mesh-ancestor
110140023|NCT02008968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110140024|NCT02008981|Aspirin|aspirin|mesh-list
110140025|NCT02008981|Turmeric extract|turmeric extract|mesh-list
110140026|NCT02008981|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110140027|NCT02008981|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110140028|NCT02008981|Analgesics|analgesics|mesh-ancestor
110140029|NCT02008981|Sensory System Agents|sensory system agents|mesh-ancestor
110140030|NCT02008981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110140031|NCT02008981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110140032|NCT02008981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110140033|NCT02008981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110140034|NCT02008981|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110140035|NCT02008981|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110140036|NCT02008981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110140037|NCT02008981|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110140038|NCT02008981|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110140039|NCT02008981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110140041|NCT02008981|Antioxidants|antioxidants|mesh-ancestor
110167207|NCT00000527|Aspirin|aspirin|mesh-list
110140042|NCT02008981|Protective Agents|protective agents|mesh-ancestor
110140043|NCT02009007|Phenylephrine|phenylephrine|mesh-list
110140044|NCT02009007|Dopamine|dopamine|mesh-list
110140045|NCT02009007|Oxymetazoline|oxymetazoline|mesh-list
110140046|NCT02009007|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110140047|NCT02009007|Mydriatics|mydriatics|mesh-ancestor
110140048|NCT02009007|Autonomic Agents|autonomic agents|mesh-ancestor
110140049|NCT02009007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110140050|NCT02009007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110140051|NCT02009007|Sympathomimetics|sympathomimetics|mesh-ancestor
110358534|NCT05708989|Dexmedetomidine|dexmedetomidine|mesh-list
110140052|NCT02009007|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110140053|NCT02009007|Nasal Decongestants|nasal decongestants|mesh-ancestor
110140054|NCT02009007|Respiratory System Agents|respiratory system agents|mesh-ancestor
110140055|NCT02009007|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110140056|NCT02009007|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110140057|NCT02009007|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110140058|NCT02009007|Adrenergic Agents|adrenergic agents|mesh-ancestor
110140059|NCT02009007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110140060|NCT02009007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110140061|NCT02009007|Protective Agents|protective agents|mesh-ancestor
110140062|NCT02009007|Dopamine Agents|dopamine agents|mesh-ancestor
110140063|NCT02009098|Cefuroxime|cefuroxime|mesh-list
110140064|NCT02009098|Cefuroxime axetil|cefuroxime axetil|mesh-list
110140065|NCT02009098|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110140066|NCT02009098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110140067|NCT02009189|Taurolidine|taurolidine|mesh-list
110140068|NCT02009189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110140069|NCT02009189|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110140070|NCT02009189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110140071|NCT02009202|Picosulfate sodium|picosulfate sodium|mesh-list
110140072|NCT02009202|Cathartics|cathartics|mesh-ancestor
110140073|NCT02009202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110140074|NCT02009215|Piperaquine|piperaquine|mesh-list
110140075|NCT02009215|Artenimol|artenimol|mesh-list
110140076|NCT02009215|Antimalarials|antimalarials|mesh-ancestor
110140077|NCT02009215|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110140078|NCT02009215|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110140079|NCT02009215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110140080|NCT05778825|Minoxidil|minoxidil|mesh-list
110140081|NCT05778825|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110140082|NCT05778825|Vasodilator Agents|vasodilator agents|mesh-ancestor
110140083|NCT05778461|N-Methylaspartate|n-methylaspartate|mesh-list
110140084|NCT05778461|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
110140085|NCT05778461|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110140086|NCT05778461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110140087|NCT05778461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110140088|NCT05778461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110140089|NCT05778305|Dexmedetomidine|dexmedetomidine|mesh-list
110140090|NCT05778305|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110358661|NCT05591144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110358662|NCT05591144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110358663|NCT05591144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110358664|NCT05591144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110358665|NCT05585229|Psilocybin|psilocybin|mesh-list
110358666|NCT05585229|Hallucinogens|hallucinogens|mesh-ancestor
110358667|NCT05585229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110140091|NCT05778305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110140092|NCT05778305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110140093|NCT05778305|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110140094|NCT05778305|Analgesics|analgesics|mesh-ancestor
110140095|NCT05778305|Sensory System Agents|sensory system agents|mesh-ancestor
110140096|NCT05778305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110140097|NCT05778305|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110140098|NCT05778305|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110140099|NCT05778305|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110140100|NCT05778305|Adrenergic Agents|adrenergic agents|mesh-ancestor
110140101|NCT05778305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110140102|NCT05778305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110140103|NCT05778227|Etidronic Acid|etidronic acid|mesh-list
110167234|NCT00030550|Thalidomide|thalidomide|mesh-list
110358712|NCT05542667|Fluorides|fluorides|mesh-list
110140104|NCT05778227|Sodium Hypochlorite|sodium hypochlorite|mesh-list
110140106|NCT05778227|Acetic Acid|acetic acid|mesh-list
110140107|NCT05778227|Retinol acetate|retinol acetate|mesh-list
110140108|NCT05778227|Ethylene|ethylene|mesh-list
110140109|NCT05778227|Maleic acid|maleic acid|mesh-list
110140110|NCT05778227|Disinfectants|disinfectants|mesh-ancestor
110140111|NCT05778227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110140112|NCT05778227|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110140113|NCT05778227|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110140114|NCT05778227|Immunologic Factors|immunologic factors|mesh-ancestor
110140115|NCT05778227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110140116|NCT05778227|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110140117|NCT05778227|Protective Agents|protective agents|mesh-ancestor
110140118|NCT05778227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110140119|NCT05778227|Plant Growth Regulators|plant growth regulators|mesh-ancestor
110140120|NCT05778227|Growth Substances|growth substances|mesh-ancestor
110140121|NCT05778227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110358765|NCT05403450|Antimetabolites|antimetabolites|mesh-ancestor
110140122|NCT05778227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110140123|NCT05778227|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110140124|NCT05778097|Androgens|androgens|mesh-list
110140125|NCT05778097|Hormones|hormones|mesh-ancestor
110140126|NCT05778097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110140127|NCT05778097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110140128|NCT05778084|Empagliflozin|empagliflozin|mesh-list
110140129|NCT05778084|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110140130|NCT05778084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110140131|NCT05778084|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110140132|NCT05778084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110140133|NCT05777902|Ozanimod|ozanimod|mesh-list
110140134|NCT05777902|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
110140135|NCT05777902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110358828|NCT05320380|Glucocorticoids|glucocorticoids|mesh-ancestor
110140136|NCT05777902|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110140137|NCT05777902|Immunologic Factors|immunologic factors|mesh-ancestor
110140138|NCT05777902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110140139|NCT05777824|Antibodies|antibodies|mesh-list
110140140|NCT05777824|Immunologic Factors|immunologic factors|mesh-ancestor
110140141|NCT05777824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110140142|NCT05777707|Paclitaxel|paclitaxel|mesh-list
110140143|NCT05777707|Carboplatin|carboplatin|mesh-list
110140144|NCT05777707|Nedaplatin|nedaplatin|mesh-list
110140145|NCT05777707|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110140146|NCT05777707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110140147|NCT05777707|Tubulin Modulators|tubulin modulators|mesh-ancestor
110140148|NCT05777707|Antimitotic Agents|antimitotic agents|mesh-ancestor
110140149|NCT05777707|Mitosis Modulators|mitosis modulators|mesh-ancestor
110140150|NCT05777707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110140151|NCT05777694|Anesthetics|anesthetics|mesh-list
110140152|NCT05777694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110140153|NCT05777694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110140154|NCT05777369|Prednisone|prednisone|mesh-list
110140155|NCT05777369|Cyclophosphamide|cyclophosphamide|mesh-list
110140156|NCT05777369|Rituximab|rituximab|mesh-list
110140157|NCT05777369|Vincristine|vincristine|mesh-list
110140158|NCT05777369|Mitoxantrone|mitoxantrone|mesh-list
110140159|NCT05777369|Vindesine|vindesine|mesh-list
110140160|NCT05777369|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110140161|NCT05777369|Immunologic Factors|immunologic factors|mesh-ancestor
110140162|NCT05777369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110140163|NCT05777369|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110140164|NCT05777369|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110140165|NCT05777369|Alkylating Agents|alkylating agents|mesh-ancestor
110140166|NCT05777369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110140167|NCT05777369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110140168|NCT05777369|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110140169|NCT05777369|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110140170|NCT05777369|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110140171|NCT05777369|Glucocorticoids|glucocorticoids|mesh-ancestor
110140173|NCT05777369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110140174|NCT05777369|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110140175|NCT05777369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110359044|NCT04724837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110140176|NCT05777369|Tubulin Modulators|tubulin modulators|mesh-ancestor
110140177|NCT05777369|Antimitotic Agents|antimitotic agents|mesh-ancestor
110140178|NCT05777369|Mitosis Modulators|mitosis modulators|mesh-ancestor
110140179|NCT05777369|Analgesics|analgesics|mesh-ancestor
110140180|NCT05777369|Sensory System Agents|sensory system agents|mesh-ancestor
110140181|NCT05777369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110140182|NCT05777369|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110140183|NCT05777369|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110140184|NCT05777369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110140185|NCT05777278|Docetaxel|docetaxel|mesh-list
110140186|NCT05777278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110140187|NCT05777278|Tubulin Modulators|tubulin modulators|mesh-ancestor
110140188|NCT05777278|Antimitotic Agents|antimitotic agents|mesh-ancestor
110140189|NCT05777278|Mitosis Modulators|mitosis modulators|mesh-ancestor
110140190|NCT05777278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110140191|NCT05777122|Lidocaine|lidocaine|mesh-list
110140192|NCT05777122|Anesthetics, Local|anesthetics, local|mesh-ancestor
110140193|NCT05777122|Anesthetics|anesthetics|mesh-ancestor
110140194|NCT05777122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110359104|NCT04532346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110140195|NCT05777122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110140196|NCT05777122|Sensory System Agents|sensory system agents|mesh-ancestor
110140197|NCT05777122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110140198|NCT05777122|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110140199|NCT05777122|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110140200|NCT05777122|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110140201|NCT05777122|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110140202|NCT05777122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110140203|NCT05616390|Bevacizumab|bevacizumab|mesh-list
110140204|NCT05616390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110140205|NCT05616390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110140206|NCT05616390|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110140207|NCT05616390|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110140208|NCT05616390|Growth Substances|growth substances|mesh-ancestor
110140209|NCT05616390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110140210|NCT05616390|Growth Inhibitors|growth inhibitors|mesh-ancestor
110140211|NCT05597150|Magnesium citrate|magnesium citrate|mesh-list
110140212|NCT05597150|Cathartics|cathartics|mesh-ancestor
110140213|NCT05597150|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110140214|NCT05548270|Scopolamine|scopolamine|mesh-list
110140215|NCT05548270|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110140216|NCT05548270|Antiemetics|antiemetics|mesh-ancestor
110140217|NCT05548270|Autonomic Agents|autonomic agents|mesh-ancestor
110140218|NCT05548270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110140219|NCT05548270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110140220|NCT05548270|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110140221|NCT05548270|Mydriatics|mydriatics|mesh-ancestor
110140222|NCT05548270|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110140223|NCT05548270|Cholinergic Agents|cholinergic agents|mesh-ancestor
110140224|NCT05548270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110140225|NCT05548270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110140226|NCT05548270|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110140228|NCT05534620|Treosulfan|treosulfan|mesh-list
110140229|NCT05534620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110140230|NCT05534620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110140231|NCT05534620|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110140232|NCT05534620|Alkylating Agents|alkylating agents|mesh-ancestor
110140237|NCT05493735|Lidocaine|lidocaine|mesh-list
110140238|NCT05493735|Anesthetics, Local|anesthetics, local|mesh-ancestor
110140239|NCT05493735|Anesthetics|anesthetics|mesh-ancestor
110359297|NCT04042935|Micronutrients|micronutrients|mesh-ancestor
110140240|NCT05493735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110140241|NCT05493735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110140242|NCT05493735|Sensory System Agents|sensory system agents|mesh-ancestor
110140243|NCT05493735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110140244|NCT05493735|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110140245|NCT05493735|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110140246|NCT05493735|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110140247|NCT05493735|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110359362|NCT03777462|Gemcitabine|gemcitabine|mesh-list
110359363|NCT03777462|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110359364|NCT03777462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110359365|NCT03777462|Tubulin Modulators|tubulin modulators|mesh-ancestor
110359366|NCT03777462|Antimitotic Agents|antimitotic agents|mesh-ancestor
110359367|NCT03777462|Mitosis Modulators|mitosis modulators|mesh-ancestor
110359368|NCT03777462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110359369|NCT03777462|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110359370|NCT03777462|Antimetabolites|antimetabolites|mesh-ancestor
110359371|NCT03745326|Aldesleukin|aldesleukin|mesh-list
110140248|NCT05493735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110140250|NCT05410158|Analgesics|analgesics|mesh-ancestor
110140251|NCT05410158|Sensory System Agents|sensory system agents|mesh-ancestor
110140252|NCT05410158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110140253|NCT05410158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110140254|NCT05410158|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110140255|NCT05410158|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110140256|NCT05410158|Anesthetics, General|anesthetics, general|mesh-ancestor
110140257|NCT05410158|Anesthetics|anesthetics|mesh-ancestor
110140258|NCT05410158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110140259|NCT05410158|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110140260|NCT05410158|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110140261|NCT05410158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110140262|NCT05410158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110140263|NCT05291403|Erythromycin|erythromycin|mesh-list
110140264|NCT05291403|Erythromycin Estolate|erythromycin estolate|mesh-list
110140265|NCT05291403|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
110140266|NCT05291403|Erythromycin stearate|erythromycin stearate|mesh-list
110140267|NCT05291403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110140268|NCT05291403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110140269|NCT05291403|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110140270|NCT05291403|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110140271|NCT05291403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110140272|NCT05291403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110140273|NCT05279690|Colchicine|colchicine|mesh-list
110140274|NCT05279690|Gout Suppressants|gout suppressants|mesh-ancestor
110140275|NCT05279690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110359484|NCT03530683|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110359485|NCT03530683|Antiemetics|antiemetics|mesh-ancestor
110359486|NCT03530683|Autonomic Agents|autonomic agents|mesh-ancestor
110359487|NCT03530683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110359499|NCT03505320|Leucovorin|leucovorin|mesh-list
110140277|NCT05279690|Antimitotic Agents|antimitotic agents|mesh-ancestor
110140278|NCT05279690|Mitosis Modulators|mitosis modulators|mesh-ancestor
110140279|NCT05279690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110140280|NCT05279690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110140290|NCT05138068|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
110140291|NCT05138068|Hallucinogens|hallucinogens|mesh-ancestor
110140292|NCT05138068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110140293|NCT05138068|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110140294|NCT05138068|Serotonin Agents|serotonin agents|mesh-ancestor
110140295|NCT05138068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110140296|NCT05138068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110140297|NCT05138068|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110140298|NCT05138068|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110140299|NCT05138068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110140300|NCT05138068|Adrenergic Agents|adrenergic agents|mesh-ancestor
110140302|NCT05121168|Anesthetics, Local|anesthetics, local|mesh-ancestor
110140303|NCT05121168|Anesthetics|anesthetics|mesh-ancestor
110140304|NCT05121168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110140305|NCT05121168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110140306|NCT05121168|Sensory System Agents|sensory system agents|mesh-ancestor
110140307|NCT05121168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110140308|NCT05091905|Ropivacaine|ropivacaine|mesh-list
110140309|NCT05091905|Anesthetics, Local|anesthetics, local|mesh-list
110140310|NCT05091905|Anesthetics|anesthetics|mesh-list
110359609|NCT03190941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110359610|NCT03190941|Immunologic Factors|immunologic factors|mesh-ancestor
110359611|NCT03190941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110359612|NCT03190941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110359613|NCT03190941|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110359614|NCT03190941|Alkylating Agents|alkylating agents|mesh-ancestor
110359615|NCT03190941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110359616|NCT03190941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110140311|NCT05091905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110140312|NCT05091905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110140313|NCT05091905|Sensory System Agents|sensory system agents|mesh-ancestor
110140314|NCT05091905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110140316|NCT05085873|Sodium Oxybate|sodium oxybate|mesh-list
110140317|NCT05085873|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110140318|NCT05085873|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110140319|NCT05085873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110140320|NCT05085873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110140321|NCT05085873|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110140322|NCT05085873|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110359679|NCT02542657|Hormones|hormones|mesh-ancestor
110140323|NCT05085873|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110140324|NCT05085873|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110140325|NCT05085873|Anesthetics, General|anesthetics, general|mesh-ancestor
110140326|NCT05085873|Anesthetics|anesthetics|mesh-ancestor
110140327|NCT05085873|GABA Modulators|gaba modulators|mesh-ancestor
110140328|NCT05085873|GABA Agents|gaba agents|mesh-ancestor
110140329|NCT05085873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110140330|NCT05085873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110140331|NCT04983589|Pilocarpine|pilocarpine|mesh-list
110140332|NCT04983589|Miotics|miotics|mesh-ancestor
110140333|NCT04983589|Autonomic Agents|autonomic agents|mesh-ancestor
110140334|NCT04983589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110140335|NCT04983589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110140336|NCT04983589|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
110140337|NCT04983589|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110140338|NCT04983589|Cholinergic Agents|cholinergic agents|mesh-ancestor
110140339|NCT04983589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110140340|NCT04983589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110140341|NCT04961580|Ceftazidime|ceftazidime|mesh-list
110140342|NCT04961580|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110359801|NCT01772563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110140344|NCT04886154|Vaccines|vaccines|mesh-list
110140345|NCT04886154|Immunologic Factors|immunologic factors|mesh-ancestor
110140346|NCT04886154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110140347|NCT04861922|Heparin|heparin|mesh-list
110140348|NCT04861922|Calcium heparin|calcium heparin|mesh-list
110140349|NCT04861922|Anticoagulants|anticoagulants|mesh-ancestor
110140350|NCT04861922|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110140351|NCT04861922|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110140352|NCT04861922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110140353|NCT04840472|Panitumumab|panitumumab|mesh-list
110140354|NCT04840472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110140355|NCT04840472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110140356|NCT04794517|Dapagliflozin|dapagliflozin|mesh-list
110140357|NCT04794517|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110140358|NCT04794517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110140359|NCT04794517|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110140360|NCT04794517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110167281|NCT00030862|Irinotecan|irinotecan|mesh-list
110140363|NCT04782830|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110140364|NCT04782830|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110140365|NCT04782830|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110140366|NCT04782830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110140367|NCT04782830|Adrenergic Agents|adrenergic agents|mesh-ancestor
110140368|NCT04782830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110140369|NCT04782830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110140370|NCT04782830|Sympathomimetics|sympathomimetics|mesh-ancestor
110140372|NCT04782830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110140373|NCT04782830|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110140374|NCT04782830|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110140375|NCT04782830|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110140376|NCT04782830|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110140377|NCT04771000|Ambrisentan|ambrisentan|mesh-list
110140378|NCT04771000|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110140379|NCT04620382|Midodrine|midodrine|mesh-list
110140380|NCT04620382|Sympathomimetics|sympathomimetics|mesh-ancestor
110140381|NCT04620382|Autonomic Agents|autonomic agents|mesh-ancestor
110140382|NCT04620382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110140383|NCT04620382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110140384|NCT04620382|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110140385|NCT04620382|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110140386|NCT04620382|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110140387|NCT04620382|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110140388|NCT04620382|Adrenergic Agents|adrenergic agents|mesh-ancestor
110140389|NCT04620382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110140390|NCT04620382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110140391|NCT04567420|Fulvestrant|fulvestrant|mesh-list
110140392|NCT04567420|Palbociclib|palbociclib|mesh-list
110140393|NCT04567420|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110140394|NCT04567420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110140395|NCT04567420|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110140396|NCT04567420|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110140397|NCT04567420|Hormone Antagonists|hormone antagonists|mesh-ancestor
110140398|NCT04567420|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110140399|NCT04567420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110140400|NCT04567420|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110140406|NCT04495855|Dienogest|dienogest|mesh-list
110140407|NCT04495855|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110140408|NCT04495855|Contraceptive Agents|contraceptive agents|mesh-ancestor
110140409|NCT04495855|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110140410|NCT04495855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110140411|NCT04495855|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110140412|NCT04495855|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110140413|NCT04495855|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110140414|NCT04495855|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110140415|NCT04495855|Hormone Antagonists|hormone antagonists|mesh-ancestor
110140416|NCT04495855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110140417|NCT04495855|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110140418|NCT04495855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110140419|NCT04461587|Pirfenidone|pirfenidone|mesh-list
110140420|NCT04461587|Analgesics|analgesics|mesh-ancestor
110359975|NCT00544596|Protective Agents|protective agents|mesh-ancestor
110140421|NCT04461587|Sensory System Agents|sensory system agents|mesh-ancestor
110140422|NCT04461587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110140423|NCT04461587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110140424|NCT04461587|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110140425|NCT04461587|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110140426|NCT04461587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110140427|NCT04461587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110140428|NCT04461587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110140429|NCT04371107|Azithromycin|azithromycin|mesh-list
110140430|NCT04371107|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110140431|NCT04371107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110140432|NCT04364984|Enzyme Inhibitors|enzyme inhibitors|mesh-list
110140433|NCT04364984|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
110140434|NCT04364984|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
110140435|NCT04364984|Renin Inhibitors|renin inhibitors|mesh-list
110140436|NCT04364984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110140437|NCT04364984|Protease Inhibitors|protease inhibitors|mesh-ancestor
110140438|NCT04278833|Dexamethasone|dexamethasone|mesh-list
110140439|NCT04278833|Triamcinolone|triamcinolone|mesh-list
110140440|NCT04278833|Betamethasone|betamethasone|mesh-list
110140441|NCT04278833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110140442|NCT04278833|Antiemetics|antiemetics|mesh-ancestor
110140443|NCT04278833|Autonomic Agents|autonomic agents|mesh-ancestor
110140444|NCT04278833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110140445|NCT04278833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110140446|NCT04278833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110140447|NCT04278833|Glucocorticoids|glucocorticoids|mesh-ancestor
110140448|NCT04278833|Hormones|hormones|mesh-ancestor
110140449|NCT04278833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110140450|NCT04278833|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110140451|NCT04278833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110140452|NCT04278833|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110140453|NCT04278833|Respiratory System Agents|respiratory system agents|mesh-ancestor
110140454|NCT04225065|Chlorhexidine|chlorhexidine|mesh-list
110140455|NCT04225065|Povidone-Iodine|povidone-iodine|mesh-list
110140456|NCT04225065|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110140457|NCT04225065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110140458|NCT04225065|Disinfectants|disinfectants|mesh-ancestor
110140459|NCT04221087|Dexamethasone|dexamethasone|mesh-list
110140460|NCT04221087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110140461|NCT04221087|Antiemetics|antiemetics|mesh-ancestor
110140462|NCT04221087|Autonomic Agents|autonomic agents|mesh-ancestor
110140463|NCT04221087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110140464|NCT04221087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110140465|NCT04221087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110140466|NCT04221087|Glucocorticoids|glucocorticoids|mesh-ancestor
110140467|NCT04221087|Hormones|hormones|mesh-ancestor
110140468|NCT04221087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110140469|NCT04221087|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110140470|NCT04221087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110140472|NCT04200911|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110140473|NCT04200911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110140474|NCT04200911|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110140475|NCT04200911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110140476|NCT04200911|Antifungal Agents|antifungal agents|mesh-ancestor
110140477|NCT04200911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110140478|NCT04200911|Immunologic Factors|immunologic factors|mesh-ancestor
110140479|NCT04200911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110140480|NCT04112641|Niacinamide|niacinamide|mesh-list
110140482|NCT04112641|Nicotinic Acids|nicotinic acids|mesh-list
110140483|NCT04112641|Vitamin B Complex|vitamin b complex|mesh-ancestor
110140484|NCT04112641|Vitamins|vitamins|mesh-ancestor
110140485|NCT04112641|Micronutrients|micronutrients|mesh-ancestor
110140486|NCT04112641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110140487|NCT04112641|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110140488|NCT04112641|Antimetabolites|antimetabolites|mesh-ancestor
110140489|NCT04112641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110140491|NCT04112641|Vasodilator Agents|vasodilator agents|mesh-ancestor
110140492|NCT04062591|Piroxicam|piroxicam|mesh-list
110140493|NCT04062591|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110140494|NCT04062591|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110140495|NCT04062591|Analgesics|analgesics|mesh-ancestor
110140496|NCT04062591|Sensory System Agents|sensory system agents|mesh-ancestor
110140497|NCT04062591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110140498|NCT04062591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110140499|NCT04062591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110140500|NCT04062591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110140501|NCT04062591|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110140502|NCT04062591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110140503|NCT04062591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110140504|NCT04059770|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
110140505|NCT04059770|Amphotericin B|amphotericin b|mesh-list
110140506|NCT04059770|Antifungal Agents|antifungal agents|mesh-ancestor
110140507|NCT04059770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110140508|NCT04059770|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110140509|NCT04059770|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110140510|NCT04059770|Amebicides|amebicides|mesh-ancestor
110140511|NCT04059770|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110140512|NCT04050280|Cytarabine|cytarabine|mesh-list
110140513|NCT04050280|Cladribine|cladribine|mesh-list
110140514|NCT04050280|Gemtuzumab|gemtuzumab|mesh-list
110140515|NCT04050280|Lenograstim|lenograstim|mesh-list
110140516|NCT04050280|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110140517|NCT04050280|Antimetabolites|antimetabolites|mesh-ancestor
110140518|NCT04050280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110140519|NCT04050280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110140520|NCT04050280|Antiviral Agents|antiviral agents|mesh-ancestor
110140521|NCT04050280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110140522|NCT04050280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110140523|NCT04050280|Immunologic Factors|immunologic factors|mesh-ancestor
110140524|NCT04050280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110140525|NCT04050280|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110140526|NCT04050280|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110140527|NCT04050280|Immunotoxins|immunotoxins|mesh-ancestor
110140528|NCT04050280|Immunoconjugates|immunoconjugates|mesh-ancestor
110360378|NCT00559169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110360383|NCT04642664|Apatinib|apatinib|mesh-list
110140529|NCT04018755|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
110140530|NCT04018755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110140531|NCT03994731|Acetaminophen|acetaminophen|mesh-list
110140532|NCT03994731|Folic Acid|folic acid|mesh-list
110140533|NCT03994731|Fexofenadine|fexofenadine|mesh-list
110140534|NCT03994731|Methylprednisolone|methylprednisolone|mesh-list
110140535|NCT03994731|Methotrexate|methotrexate|mesh-list
110140536|NCT03994731|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110140537|NCT03994731|Abortifacient Agents|abortifacient agents|mesh-ancestor
110140538|NCT03994731|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110140539|NCT03994731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110140540|NCT03994731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110140541|NCT03994731|Antimetabolites|antimetabolites|mesh-ancestor
110140542|NCT03994731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110140543|NCT03994731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110140544|NCT03994731|Dermatologic Agents|dermatologic agents|mesh-ancestor
110140545|NCT03994731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110140546|NCT03994731|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110140547|NCT03994731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110140548|NCT03994731|Immunologic Factors|immunologic factors|mesh-ancestor
110140549|NCT03994731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110140550|NCT03994731|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110140551|NCT03994731|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110140552|NCT03994731|Analgesics|analgesics|mesh-ancestor
110140553|NCT03994731|Sensory System Agents|sensory system agents|mesh-ancestor
110140554|NCT03994731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110140555|NCT03994731|Antipyretics|antipyretics|mesh-ancestor
110140556|NCT03994731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110140557|NCT03994731|Antiemetics|antiemetics|mesh-ancestor
110140558|NCT03994731|Autonomic Agents|autonomic agents|mesh-ancestor
110140559|NCT03994731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110140560|NCT03994731|Glucocorticoids|glucocorticoids|mesh-ancestor
110140561|NCT03994731|Hormones|hormones|mesh-ancestor
110140562|NCT03994731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110140563|NCT03994731|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110140564|NCT03994731|Protective Agents|protective agents|mesh-ancestor
110140565|NCT03994731|Hematinics|hematinics|mesh-ancestor
110140566|NCT03994731|Vitamin B Complex|vitamin b complex|mesh-ancestor
110140567|NCT03994731|Vitamins|vitamins|mesh-ancestor
110140568|NCT03994731|Micronutrients|micronutrients|mesh-ancestor
110140569|NCT03994731|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110140570|NCT03994731|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110140571|NCT03994731|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110140572|NCT03994731|Histamine Antagonists|histamine antagonists|mesh-ancestor
110140573|NCT03994731|Histamine Agents|histamine agents|mesh-ancestor
110140574|NCT03994731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110140575|NCT03984357|Gemcitabine|gemcitabine|mesh-list
110140577|NCT03984357|Antibodies, Blocking|antibodies, blocking|mesh-list
110140578|NCT03984357|Immunologic Factors|immunologic factors|mesh-ancestor
110140579|NCT03984357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110140580|NCT03984357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110140581|NCT03984357|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110140582|NCT03984357|Antimetabolites|antimetabolites|mesh-ancestor
110140583|NCT03984357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110140584|NCT03824522|BAX 855|bax 855|mesh-list
110140585|NCT03824522|Coagulants|coagulants|mesh-ancestor
110140586|NCT03812991|Calcitonin|calcitonin|mesh-list
110140587|NCT03812991|Salmon calcitonin|salmon calcitonin|mesh-list
110140588|NCT03812991|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
110140589|NCT03812991|Katacalcin|katacalcin|mesh-list
110140590|NCT03812991|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110140591|NCT03812991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110140592|NCT03812991|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110140593|NCT03812991|Vasodilator Agents|vasodilator agents|mesh-ancestor
110140595|NCT03737968|Tremelimumab|tremelimumab|mesh-list
110140596|NCT03737968|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110140597|NCT03737968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110140598|NCT03737968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110140599|NCT03737968|Immunologic Factors|immunologic factors|mesh-ancestor
110140600|NCT03737968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110140602|NCT03652753|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110140603|NCT03652753|Antiviral Agents|antiviral agents|mesh-ancestor
110140604|NCT03652753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110140605|NCT03652753|Expectorants|expectorants|mesh-ancestor
110140606|NCT03652753|Respiratory System Agents|respiratory system agents|mesh-ancestor
110140607|NCT03652753|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110140608|NCT03652753|Antioxidants|antioxidants|mesh-ancestor
110140609|NCT03652753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110140610|NCT03652753|Protective Agents|protective agents|mesh-ancestor
110140611|NCT03652753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110140612|NCT03652753|Antidotes|antidotes|mesh-ancestor
110140613|NCT03581877|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
110140614|NCT03581877|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110140615|NCT03581877|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110140616|NCT03581877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110140617|NCT03556202|Mirikizumab|mirikizumab|mesh-list
110167326|NCT00031057|Riboflavin|riboflavin|mesh-list
110140618|NCT03556202|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110140619|NCT03556202|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110140620|NCT03556202|Analgesics|analgesics|mesh-ancestor
110140621|NCT03556202|Sensory System Agents|sensory system agents|mesh-ancestor
110140622|NCT03556202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110140623|NCT03556202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110140624|NCT03556202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110360813|NCT02895672|Exenatide|exenatide|mesh-list
110140626|NCT03556202|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110140627|NCT03556202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110140628|NCT03480438|Blinatumomab|blinatumomab|mesh-list
110140629|NCT03480438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110140630|NCT03463876|Apatinib|apatinib|mesh-list
110140631|NCT03463876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110140632|NCT03463876|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110140633|NCT03463876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110140634|NCT03463876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110140635|NCT03461120|Anesthetics|anesthetics|mesh-list
110140636|NCT03461120|Anesthetics, Local|anesthetics, local|mesh-list
110360859|NCT04317703|Metformin|metformin|mesh-list
110140637|NCT03461120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110140638|NCT03461120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110140639|NCT03461120|Sensory System Agents|sensory system agents|mesh-ancestor
110140640|NCT03461120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110140641|NCT03396588|Clonidine|clonidine|mesh-list
110140642|NCT03396588|Morphine|morphine|mesh-list
110360923|NCT02894892|Antacids|antacids|mesh-ancestor
110140643|NCT03396588|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110140644|NCT03396588|Narcotics|narcotics|mesh-ancestor
110140645|NCT03396588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110140646|NCT03396588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110140647|NCT03396588|Analgesics|analgesics|mesh-ancestor
110140648|NCT03396588|Sensory System Agents|sensory system agents|mesh-ancestor
110140649|NCT03396588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110140650|NCT03396588|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110361032|NCT05655130|Hormones|hormones|mesh-ancestor
110140651|NCT03396588|Sympatholytics|sympatholytics|mesh-ancestor
110140652|NCT03396588|Autonomic Agents|autonomic agents|mesh-ancestor
110140653|NCT03396588|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110140654|NCT03396588|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110140655|NCT03396588|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110140656|NCT03396588|Adrenergic Agents|adrenergic agents|mesh-ancestor
110140657|NCT03396588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110140658|NCT03396588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110140659|NCT03361852|Rituximab|rituximab|mesh-list
110140660|NCT03361852|Pembrolizumab|pembrolizumab|mesh-list
110140661|NCT03361852|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110140662|NCT03361852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110140663|NCT03361852|Immunologic Factors|immunologic factors|mesh-ancestor
110361065|NCT05427942|Adalimumab|adalimumab|mesh-list
110140664|NCT03361852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110140665|NCT03361852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110140666|NCT03361852|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110140667|NCT03361852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110140668|NCT03350516|Calcium, Dietary|calcium, dietary|mesh-list
110140669|NCT03350516|Calcium Carbonate|calcium carbonate|mesh-list
110140670|NCT03350516|Calcium|calcium|mesh-list
110140671|NCT03350516|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110140672|NCT03350516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110140673|NCT03350516|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110140674|NCT03350516|Antacids|antacids|mesh-ancestor
110140675|NCT03350516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110140676|NCT03350516|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110140677|NCT03350451|Lumasiran|lumasiran|mesh-list
110140678|NCT03350451|Renal Agents|renal agents|mesh-ancestor
110140679|NCT03329508|Pramipexole|pramipexole|mesh-list
110140680|NCT03329508|Rasagiline|rasagiline|mesh-list
110140681|NCT03329508|Antioxidants|antioxidants|mesh-ancestor
110140682|NCT03329508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110140683|NCT03329508|Protective Agents|protective agents|mesh-ancestor
110140684|NCT03329508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110140685|NCT03329508|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110140686|NCT03329508|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110140687|NCT03329508|Dopamine Agonists|dopamine agonists|mesh-ancestor
110140689|NCT03329508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110140690|NCT03329508|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
110140691|NCT03329508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110140692|NCT03329508|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110140693|NCT03289039|Fulvestrant|fulvestrant|mesh-list
110140694|NCT03289039|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110140695|NCT03289039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110140696|NCT03289039|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110140697|NCT03289039|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110140698|NCT03289039|Hormone Antagonists|hormone antagonists|mesh-ancestor
110140699|NCT03289039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110140700|NCT03289039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110140701|NCT03281304|Tofacitinib|tofacitinib|mesh-list
110140702|NCT03281304|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
110140703|NCT03281304|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110140704|NCT03281304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110140705|NCT03281304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110140706|NCT03153319|Adalimumab|adalimumab|mesh-list
110140707|NCT03153319|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110140708|NCT03153319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110140709|NCT03153319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110140710|NCT03145272|Oxycodone|oxycodone|mesh-list
110140711|NCT03145272|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110140712|NCT03145272|Narcotics|narcotics|mesh-ancestor
110140713|NCT03145272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110140714|NCT03145272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110140715|NCT03145272|Analgesics|analgesics|mesh-ancestor
110140716|NCT03145272|Sensory System Agents|sensory system agents|mesh-ancestor
110140717|NCT03145272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110140718|NCT03127007|Atezolizumab|atezolizumab|mesh-list
110140719|NCT03127007|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110140720|NCT03127007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110140721|NCT03127007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110140722|NCT03127007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110140723|NCT03109093|Blinatumomab|blinatumomab|mesh-list
110140724|NCT03109093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110140725|NCT02726711|Trimethaphan|trimethaphan|mesh-list
110140726|NCT02726711|Trimethaphan camsylate|trimethaphan camsylate|mesh-list
110140727|NCT02726711|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110361231|NCT00446420|Analgesics|analgesics|mesh-ancestor
110140729|NCT02726711|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
110140730|NCT02726711|Autonomic Agents|autonomic agents|mesh-ancestor
110140731|NCT02726711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110140732|NCT02726711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110140733|NCT02726711|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
110140734|NCT02726711|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110140735|NCT02726711|Cholinergic Agents|cholinergic agents|mesh-ancestor
110140736|NCT02726711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110140737|NCT02726711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110140738|NCT02726711|Vasodilator Agents|vasodilator agents|mesh-ancestor
110140739|NCT02691065|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-list
110140740|NCT02691065|Integrase Inhibitors|integrase inhibitors|mesh-list
110140741|NCT02691065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110140742|NCT02691065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110140743|NCT02691065|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110140744|NCT02691065|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110140745|NCT02691065|Antiviral Agents|antiviral agents|mesh-ancestor
110140746|NCT02691065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110140747|NCT02649998|Furosemide|furosemide|mesh-list
110140748|NCT02649998|Isosorbide|isosorbide|mesh-list
110140749|NCT02649998|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
110140750|NCT02649998|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
110140752|NCT02649998|Natriuretic Agents|natriuretic agents|mesh-ancestor
110140753|NCT02649998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110140754|NCT02649998|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110140755|NCT02649998|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110140756|NCT02649998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110140758|NCT02649998|Vasodilator Agents|vasodilator agents|mesh-ancestor
110140759|NCT02649998|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
110140760|NCT02503358|Paclitaxel|paclitaxel|mesh-list
110140761|NCT02503358|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110140762|NCT02503358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110140763|NCT02503358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110140764|NCT02503358|Tubulin Modulators|tubulin modulators|mesh-ancestor
110140765|NCT02503358|Antimitotic Agents|antimitotic agents|mesh-ancestor
110140766|NCT02503358|Mitosis Modulators|mitosis modulators|mesh-ancestor
110140767|NCT02503358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110140768|NCT02432963|Pembrolizumab|pembrolizumab|mesh-list
110140769|NCT02432963|Vaccines|vaccines|mesh-list
110140770|NCT02432963|Immunologic Factors|immunologic factors|mesh-ancestor
110140771|NCT02432963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110140772|NCT02432963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110140773|NCT02432963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110140774|NCT02432963|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110140775|NCT02432963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110140776|NCT02358538|Ganaxolone|ganaxolone|mesh-list
110140777|NCT02358538|Neurosteroids|neurosteroids|mesh-ancestor
110140778|NCT02358538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110140779|NCT02358538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110140780|NCT02358538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110140782|NCT02358538|GABA Agents|gaba agents|mesh-ancestor
110140783|NCT02349906|Treosulfan|treosulfan|mesh-list
110140784|NCT02349906|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110140785|NCT02349906|Alkylating Agents|alkylating agents|mesh-ancestor
110140786|NCT02349906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110140787|NCT02349906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110140788|NCT02336087|Metformin|metformin|mesh-list
110140789|NCT02336087|Paclitaxel|paclitaxel|mesh-list
110140790|NCT02336087|Gemcitabine|gemcitabine|mesh-list
110140791|NCT02336087|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110140792|NCT02336087|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110140793|NCT02336087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110140794|NCT02336087|Tubulin Modulators|tubulin modulators|mesh-ancestor
110140795|NCT02336087|Antimitotic Agents|antimitotic agents|mesh-ancestor
110140796|NCT02336087|Mitosis Modulators|mitosis modulators|mesh-ancestor
110140797|NCT02336087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110140798|NCT02336087|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110140799|NCT02336087|Antimetabolites|antimetabolites|mesh-ancestor
110140800|NCT02336087|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110140801|NCT02336087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110140802|NCT02332980|Pembrolizumab|pembrolizumab|mesh-list
110140803|NCT02332980|Idelalisib|idelalisib|mesh-list
110140804|NCT02332980|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110140805|NCT02332980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110140806|NCT02332980|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110140807|NCT02332980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110140808|NCT02332980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110140809|NCT02087826|Metformin|metformin|mesh-list
110140810|NCT02087826|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110140811|NCT02087826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110140812|NCT02048150|Antibodies|antibodies|mesh-list
110140813|NCT02048150|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110140814|NCT02048150|Immunologic Factors|immunologic factors|mesh-ancestor
110140815|NCT02048150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110140816|NCT02038452|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110140817|NCT02038452|Methylprednisolone|methylprednisolone|mesh-list
110140818|NCT02038452|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110140819|NCT02038452|Prednisolone|prednisolone|mesh-list
110140820|NCT02038452|Prednisolone acetate|prednisolone acetate|mesh-list
110140821|NCT02038452|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110140822|NCT02038452|Prednisolone phosphate|prednisolone phosphate|mesh-list
110140823|NCT02038452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110140825|NCT02038452|Autonomic Agents|autonomic agents|mesh-ancestor
110140826|NCT02038452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110140827|NCT02038452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110140828|NCT02038452|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110140829|NCT02038452|Glucocorticoids|glucocorticoids|mesh-ancestor
110140830|NCT02038452|Hormones|hormones|mesh-ancestor
110140831|NCT02038452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110140832|NCT02038452|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110140833|NCT02038452|Protective Agents|protective agents|mesh-ancestor
110140834|NCT02038452|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110140835|NCT02038452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110140836|NCT01748448|Vitamin D|vitamin d|mesh-list
110140837|NCT01748448|Cholecalciferol|cholecalciferol|mesh-list
110140838|NCT01748448|Vitamins|vitamins|mesh-ancestor
110140839|NCT01748448|Micronutrients|micronutrients|mesh-ancestor
110140840|NCT01748448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110140841|NCT01748448|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110140842|NCT01748448|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110140843|NCT01476839|Cytarabine|cytarabine|mesh-list
110140844|NCT01476839|Etoposide|etoposide|mesh-list
110140845|NCT01476839|Etoposide phosphate|etoposide phosphate|mesh-list
110140846|NCT01476839|Melphalan|melphalan|mesh-list
110140847|NCT01476839|Carmustine|carmustine|mesh-list
110140848|NCT01476839|Basiliximab|basiliximab|mesh-list
110140849|NCT01476839|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110140850|NCT01476839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110140851|NCT01476839|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110140852|NCT01476839|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110361491|NCT00447863|Estradiol|estradiol|mesh-list
110140853|NCT01476839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110140854|NCT01476839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110140855|NCT01476839|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110140856|NCT01476839|Antimetabolites|antimetabolites|mesh-ancestor
110140857|NCT01476839|Antiviral Agents|antiviral agents|mesh-ancestor
110140858|NCT01476839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110140859|NCT01476839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110140860|NCT01476839|Immunologic Factors|immunologic factors|mesh-ancestor
110140861|NCT01476839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110140862|NCT01476839|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110140863|NCT01476839|Alkylating Agents|alkylating agents|mesh-ancestor
110140864|NCT01476839|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110140865|NCT01332097|Prednisone|prednisone|mesh-list
110140866|NCT01332097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110140867|NCT01332097|Glucocorticoids|glucocorticoids|mesh-ancestor
110140868|NCT01332097|Hormones|hormones|mesh-ancestor
110140869|NCT01332097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110140870|NCT01332097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110140871|NCT01332097|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110140872|NCT01332097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110140873|NCT01163357|Sirolimus|sirolimus|mesh-list
110140874|NCT01163357|Fludarabine|fludarabine|mesh-list
110140875|NCT01163357|Fludarabine phosphate|fludarabine phosphate|mesh-list
110140876|NCT01163357|Bortezomib|bortezomib|mesh-list
110140877|NCT01163357|Melphalan|melphalan|mesh-list
110140878|NCT01163357|Tacrolimus|tacrolimus|mesh-list
110140879|NCT01163357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110140880|NCT01163357|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110140881|NCT01163357|Antimetabolites|antimetabolites|mesh-ancestor
110140882|NCT01163357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110140883|NCT01163357|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110140884|NCT01163357|Immunologic Factors|immunologic factors|mesh-ancestor
110140885|NCT01163357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110140886|NCT01163357|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110140887|NCT01163357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110140888|NCT01163357|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110140889|NCT01163357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110140890|NCT01163357|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110140891|NCT01163357|Antifungal Agents|antifungal agents|mesh-ancestor
110140892|NCT01163357|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110140893|NCT01163357|Alkylating Agents|alkylating agents|mesh-ancestor
110140894|NCT01163357|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110140896|NCT00967005|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110140897|NCT00967005|Antiviral Agents|antiviral agents|mesh-ancestor
110140898|NCT00967005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110140899|NCT00967005|Expectorants|expectorants|mesh-ancestor
110140900|NCT00967005|Respiratory System Agents|respiratory system agents|mesh-ancestor
110140901|NCT00967005|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110140902|NCT00967005|Antioxidants|antioxidants|mesh-ancestor
110361605|NCT02901288|Levofloxacin|levofloxacin|mesh-list
110140903|NCT00967005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110140904|NCT00967005|Protective Agents|protective agents|mesh-ancestor
110140905|NCT00967005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110140906|NCT00967005|Antidotes|antidotes|mesh-ancestor
110140907|NCT00863369|Rituximab|rituximab|mesh-list
110140908|NCT00863369|Gemcitabine|gemcitabine|mesh-list
110140909|NCT00863369|Bortezomib|bortezomib|mesh-list
110140910|NCT00863369|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110140911|NCT00863369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110140912|NCT00863369|Immunologic Factors|immunologic factors|mesh-ancestor
110140913|NCT00863369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110140914|NCT00863369|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110140915|NCT00863369|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110140916|NCT00863369|Antimetabolites|antimetabolites|mesh-ancestor
110140917|NCT00863369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110140918|NCT00538031|Celecoxib|celecoxib|mesh-list
110140919|NCT00538031|Cyclophosphamide|cyclophosphamide|mesh-list
110140920|NCT00538031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110140921|NCT00538031|Immunologic Factors|immunologic factors|mesh-ancestor
110140922|NCT00538031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110140923|NCT00538031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110140924|NCT00538031|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110140925|NCT00538031|Alkylating Agents|alkylating agents|mesh-ancestor
110140926|NCT00538031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110140927|NCT00538031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110140928|NCT00538031|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110140929|NCT00538031|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110140930|NCT00538031|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110140931|NCT00538031|Analgesics|analgesics|mesh-ancestor
110140932|NCT00538031|Sensory System Agents|sensory system agents|mesh-ancestor
110140933|NCT00538031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110140934|NCT00538031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110140935|NCT00538031|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110140936|NCT00538031|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110140937|NCT00538031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110140938|NCT00203996|Pioglitazone|pioglitazone|mesh-list
110140939|NCT00203996|Leuprolide|leuprolide|mesh-list
110140940|NCT00203996|Estrogens|estrogens|mesh-list
110140941|NCT00203996|Progestins|progestins|mesh-list
110140942|NCT00203996|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110140943|NCT00203996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110140944|NCT00203996|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110140945|NCT00203996|Fertility Agents|fertility agents|mesh-ancestor
110140946|NCT00203996|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110140947|NCT00203996|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110140948|NCT00203996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110140949|NCT00203996|Hormones|hormones|mesh-ancestor
110140950|NCT00203996|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110140951|NCT02009280|Anesthetics|anesthetics|mesh-list
110140952|NCT02009280|Propofol|propofol|mesh-list
110140953|NCT02009280|Sevoflurane|sevoflurane|mesh-list
110140954|NCT02009280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110140956|NCT02009280|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110140957|NCT02009280|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110140958|NCT02009280|Anesthetics, General|anesthetics, general|mesh-ancestor
110140959|NCT02009280|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110140960|NCT02009280|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110140961|NCT02009306|Fentanyl|fentanyl|mesh-list
110140962|NCT02009306|Midazolam|midazolam|mesh-list
110140963|NCT02009306|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110140964|NCT02009306|Narcotics|narcotics|mesh-ancestor
110140965|NCT02009306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110140966|NCT02009306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110140967|NCT02009306|Analgesics|analgesics|mesh-ancestor
110140968|NCT02009306|Sensory System Agents|sensory system agents|mesh-ancestor
110140969|NCT02009306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110140970|NCT02009306|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110140971|NCT02009306|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110140972|NCT02009306|Anesthetics, General|anesthetics, general|mesh-ancestor
110140973|NCT02009306|Anesthetics|anesthetics|mesh-ancestor
110140974|NCT02009306|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110140975|NCT02009306|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110140976|NCT02009306|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110140977|NCT02009306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110140978|NCT02009306|GABA Modulators|gaba modulators|mesh-ancestor
110140979|NCT02009306|GABA Agents|gaba agents|mesh-ancestor
110140980|NCT02009306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110140981|NCT02009306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110140982|NCT02009410|Pancrelipase|pancrelipase|mesh-list
110140983|NCT02009410|Pancreatin|pancreatin|mesh-list
110140984|NCT02009410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110140985|NCT02009436|Azacitidine|azacitidine|mesh-list
110140986|NCT02009436|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110140987|NCT02009436|Antimetabolites|antimetabolites|mesh-ancestor
110140988|NCT02009436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110140989|NCT02009436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110140990|NCT02009436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110140991|NCT02009462|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
110140992|NCT02009462|Vasodilator Agents|vasodilator agents|mesh-ancestor
110140993|NCT02009462|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
110140994|NCT02009462|Protective Agents|protective agents|mesh-ancestor
110140995|NCT02009462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110140996|NCT02009488|Canagliflozin|canagliflozin|mesh-list
110140997|NCT02009488|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110140998|NCT02009488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110140999|NCT02009488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110141000|NCT02009488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110141001|NCT02009514|Dialysis Solutions|dialysis solutions|mesh-list
110141002|NCT02009514|Hemodialysis Solutions|hemodialysis solutions|mesh-list
110141003|NCT02009514|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110141004|NCT02009540|Botulinum Toxins|botulinum toxins|mesh-list
110141005|NCT02009540|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110141006|NCT02009540|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110141007|NCT02009540|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110141008|NCT02009540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110141009|NCT02009540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110361781|NCT00449618|Aspirin|aspirin|mesh-list
110141010|NCT02009540|Cholinergic Agents|cholinergic agents|mesh-ancestor
110141011|NCT02009540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110141012|NCT02009540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110141013|NCT02009540|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110141014|NCT02009540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110141015|NCT02009592|Rifaximin|rifaximin|mesh-list
110141016|NCT02009592|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110141017|NCT02009592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110141018|NCT02009592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110141019|NCT02009618|Rifaximin|rifaximin|mesh-list
110141020|NCT02009618|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110141021|NCT02009618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110141022|NCT02009618|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110141023|NCT02009631|Veliparib|veliparib|mesh-list
110141024|NCT02009631|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110141025|NCT02009631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110141026|NCT02009631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110141027|NCT02009631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110141028|NCT02009709|Riboflavin|riboflavin|mesh-list
110141029|NCT02009709|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110141030|NCT02009709|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110141031|NCT02009709|Vitamin B Complex|vitamin b complex|mesh-ancestor
110141032|NCT02009709|Vitamins|vitamins|mesh-ancestor
110141033|NCT02009709|Micronutrients|micronutrients|mesh-ancestor
110141034|NCT02009709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110141035|NCT02009709|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110361850|NCT02900742|Docetaxel|docetaxel|mesh-list
110141036|NCT02009709|Dermatologic Agents|dermatologic agents|mesh-ancestor
110141037|NCT02009748|Vitamin D|vitamin d|mesh-list
110141038|NCT02009748|Vitamins|vitamins|mesh-ancestor
110141039|NCT02009748|Micronutrients|micronutrients|mesh-ancestor
110141040|NCT02009748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110141041|NCT02009748|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110141042|NCT02009787|Vitamin D|vitamin d|mesh-list
110141043|NCT02009787|Cholecalciferol|cholecalciferol|mesh-list
110141044|NCT02009787|Vitamins|vitamins|mesh-ancestor
110141045|NCT02009787|Micronutrients|micronutrients|mesh-ancestor
110141046|NCT02009787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110141047|NCT02009787|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110141048|NCT02009787|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110141049|NCT02009943|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
110141050|NCT02009943|Hematinics|hematinics|mesh-ancestor
110141051|NCT02010164|Coenzyme Q10|coenzyme q10|mesh-list
110141052|NCT02010164|Ubiquinone|ubiquinone|mesh-list
110141053|NCT02010164|Vitamins|vitamins|mesh-ancestor
110141054|NCT02010164|Micronutrients|micronutrients|mesh-ancestor
110141055|NCT02010164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110141056|NCT02010411|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
110141057|NCT02010411|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
110141058|NCT02010411|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110141059|NCT02010411|Protease Inhibitors|protease inhibitors|mesh-ancestor
110141060|NCT02010411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110141061|NCT02010411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110141062|NCT02010437|Sodium Tetradecyl Sulfate|sodium tetradecyl sulfate|mesh-list
110141063|NCT02010437|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
110141064|NCT02010437|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110141065|NCT02010723|Polidocanol|polidocanol|mesh-list
110141066|NCT02010723|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
110141067|NCT02010723|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110141068|NCT02010762|Vitamin D|vitamin d|mesh-list
110141069|NCT02010762|Vitamins|vitamins|mesh-ancestor
110141070|NCT02010762|Micronutrients|micronutrients|mesh-ancestor
110141071|NCT02010762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110141072|NCT02010762|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110141073|NCT02010788|Botulinum Toxins|botulinum toxins|mesh-list
110141074|NCT02010788|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110141075|NCT02010788|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110141076|NCT02010788|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110141077|NCT02010788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110141078|NCT02010788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110141079|NCT02010788|Cholinergic Agents|cholinergic agents|mesh-ancestor
110141080|NCT02010788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110141081|NCT02010788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110141082|NCT02010788|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110141083|NCT02010788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110141084|NCT02010827|Glucagon|glucagon|mesh-list
110141085|NCT02010827|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110141087|NCT02010827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110141088|NCT02010827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110141089|NCT02010905|Losartan|losartan|mesh-list
110141090|NCT02010905|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110141091|NCT02010905|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110141092|NCT02010905|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110141093|NCT02010905|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110141094|NCT02010905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110141095|NCT02010944|Solifenacin Succinate|solifenacin succinate|mesh-list
110141096|NCT02010944|Mirabegron|mirabegron|mesh-list
110141097|NCT02010944|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110141098|NCT02010944|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110141099|NCT02010944|Cholinergic Agents|cholinergic agents|mesh-ancestor
110141100|NCT02010944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110141101|NCT02010944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110141102|NCT02010944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110141103|NCT02010944|Urological Agents|urological agents|mesh-ancestor
110141104|NCT02010944|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
110141105|NCT02010944|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110141106|NCT02010944|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110141107|NCT02010944|Adrenergic Agents|adrenergic agents|mesh-ancestor
110141109|NCT02010957|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110141110|NCT02010957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110141111|NCT02010957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110141112|NCT02010957|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110141113|NCT02010957|Anesthetics, General|anesthetics, general|mesh-ancestor
110141114|NCT02010957|Anesthetics|anesthetics|mesh-ancestor
110141115|NCT02010970|Itraconazole|itraconazole|mesh-list
110141116|NCT02010970|Diltiazem|diltiazem|mesh-list
110141117|NCT02010970|Calcium Channel Blockers|calcium channel blockers|mesh-list
110141118|NCT02010970|Midazolam|midazolam|mesh-list
110141119|NCT02010970|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110141120|NCT02010970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110141121|NCT02010970|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110141122|NCT02010970|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110141123|NCT02010970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110141124|NCT02010970|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110141125|NCT02010970|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110141126|NCT02010970|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110141127|NCT02010970|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110141128|NCT02010970|Anesthetics, General|anesthetics, general|mesh-ancestor
110141130|NCT02010970|GABA Modulators|gaba modulators|mesh-ancestor
110141131|NCT02010970|GABA Agents|gaba agents|mesh-ancestor
110141132|NCT02010970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110141133|NCT02010970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110141134|NCT02010970|Antifungal Agents|antifungal agents|mesh-ancestor
110141135|NCT02010970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110141136|NCT02010970|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110141137|NCT02010970|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110141138|NCT02010970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110141139|NCT02010970|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110141140|NCT02010970|Hormone Antagonists|hormone antagonists|mesh-ancestor
110362032|NCT00450827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110141141|NCT02010970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110141142|NCT02010970|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110141143|NCT02010970|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110141144|NCT02010970|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110141147|NCT02011126|Motesanib diphosphate|motesanib diphosphate|mesh-list
110141148|NCT02011126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110141149|NCT02011126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110141150|NCT02011126|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110141152|NCT02011191|Vitamin B Complex|vitamin b complex|mesh-ancestor
110141153|NCT02011191|Vitamins|vitamins|mesh-ancestor
110141154|NCT02011191|Micronutrients|micronutrients|mesh-ancestor
110141155|NCT02011191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110141156|NCT02011347|Ketamine|ketamine|mesh-list
110141157|NCT02011347|Analgesics|analgesics|mesh-ancestor
110141158|NCT02011347|Sensory System Agents|sensory system agents|mesh-ancestor
110141159|NCT02011347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110141160|NCT02011347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110141161|NCT02011347|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110141162|NCT02011347|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110141163|NCT02011347|Anesthetics, General|anesthetics, general|mesh-ancestor
110141164|NCT02011347|Anesthetics|anesthetics|mesh-ancestor
110141165|NCT02011347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110141166|NCT02011347|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110362215|NCT00624325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110141167|NCT02011347|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110141168|NCT02011347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110141169|NCT02011347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110141170|NCT02011594|Nimotuzumab|nimotuzumab|mesh-list
110141171|NCT02011594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110141172|NCT02011594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110141174|NCT02011620|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
110141175|NCT02011620|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
110141176|NCT02011620|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110141177|NCT02011620|Diuretics|diuretics|mesh-ancestor
110141178|NCT02011620|Natriuretic Agents|natriuretic agents|mesh-ancestor
110141179|NCT02011620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110141180|NCT02011620|Vasodilator Agents|vasodilator agents|mesh-ancestor
110141181|NCT02011620|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
110141182|NCT02011620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110141183|NCT02011633|Metformin|metformin|mesh-list
110141184|NCT02011633|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110141185|NCT02011633|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110141186|NCT02011633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110141187|NCT02011633|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110141188|NCT02011633|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110141189|NCT02011633|Antimetabolites|antimetabolites|mesh-ancestor
110141190|NCT02011633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110141191|NCT02011633|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110141192|NCT02011633|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110141193|NCT02011633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110141194|NCT02011659|Ramosetron|ramosetron|mesh-list
110141195|NCT02011659|Antiemetics|antiemetics|mesh-ancestor
110141196|NCT02011659|Autonomic Agents|autonomic agents|mesh-ancestor
110141197|NCT02011659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110141198|NCT02011659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110141199|NCT02011659|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110141200|NCT02011659|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110141201|NCT02011659|Serotonin Agents|serotonin agents|mesh-ancestor
110141202|NCT02011659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110141203|NCT02011659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110141204|NCT02011737|Naftopidil|naftopidil|mesh-list
110141205|NCT02011737|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110141206|NCT02011737|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110141207|NCT02011737|Adrenergic Agents|adrenergic agents|mesh-ancestor
110141208|NCT02011737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110141209|NCT02011737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110141210|NCT02011737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110141211|NCT02011737|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110141212|NCT02011737|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110141213|NCT02011737|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110141214|NCT02011737|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110141215|NCT02011737|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110141216|NCT02011750|Valproic Acid|valproic acid|mesh-list
110141217|NCT02011750|Anticonvulsants|anticonvulsants|mesh-ancestor
110141218|NCT02011750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110141219|NCT02011750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110141220|NCT02011750|GABA Agents|gaba agents|mesh-ancestor
110141221|NCT02011750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110141222|NCT02011750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110141223|NCT02011750|Antimanic Agents|antimanic agents|mesh-ancestor
110141224|NCT02011750|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110141225|NCT02011750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110141226|NCT02011750|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110141227|NCT02011828|Ergocalciferols|ergocalciferols|mesh-list
110141229|NCT02011828|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110141230|NCT02011828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110141231|NCT02011828|Vitamins|vitamins|mesh-ancestor
110141232|NCT02011828|Micronutrients|micronutrients|mesh-ancestor
110141233|NCT02011828|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110141234|NCT02011841|Ciprofloxacin|ciprofloxacin|mesh-list
110141235|NCT02011841|Rifaximin|rifaximin|mesh-list
110167470|NCT00031798|Methylphenidate|methylphenidate|mesh-list
110141236|NCT02011841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110141237|NCT02011841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110141238|NCT02011841|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110141239|NCT02011841|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110141240|NCT02011841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110141241|NCT02011841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110141242|NCT02011841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110141243|NCT02011841|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110141244|NCT02011841|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110141245|NCT02011841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110141246|NCT02011906|Vitamins|vitamins|mesh-list
110141247|NCT02011906|Vitamin E|vitamin e|mesh-list
110141248|NCT02011906|Tocopherols|tocopherols|mesh-list
110141249|NCT02011906|Tocotrienols|tocotrienols|mesh-list
110141250|NCT02011906|alpha-Tocopherol|alpha-tocopherol|mesh-list
110141251|NCT02011906|Micronutrients|micronutrients|mesh-ancestor
110141252|NCT02011906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110141253|NCT02011906|Antioxidants|antioxidants|mesh-ancestor
110141254|NCT02011906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110141255|NCT02011906|Protective Agents|protective agents|mesh-ancestor
110141256|NCT02011958|Amphotericin B|amphotericin b|mesh-list
110362526|NCT02153502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110141257|NCT02011958|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
110141258|NCT02011958|Miltefosine|miltefosine|mesh-list
110141259|NCT02011958|Amebicides|amebicides|mesh-ancestor
110141260|NCT02011958|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110141261|NCT02011958|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110141262|NCT02011958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110141263|NCT02011958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110141264|NCT02011958|Antifungal Agents|antifungal agents|mesh-ancestor
110141265|NCT02011958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110141266|NCT02012036|Aminolevulinic Acid|aminolevulinic acid|mesh-list
110141268|NCT02012036|Dermatologic Agents|dermatologic agents|mesh-ancestor
110141269|NCT02012049|Risperidone|risperidone|mesh-list
110141270|NCT02012049|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110141271|NCT02012049|Serotonin Agents|serotonin agents|mesh-ancestor
110141272|NCT02012049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110141273|NCT02012049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110141274|NCT02012049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110141275|NCT02012049|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110141276|NCT02012049|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110362634|NCT02916602|Vasodilator Agents|vasodilator agents|mesh-ancestor
110141277|NCT02012049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110141278|NCT02012049|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110141279|NCT02012049|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110141280|NCT02012049|Dopamine Agents|dopamine agents|mesh-ancestor
110141281|NCT02012062|Nimotuzumab|nimotuzumab|mesh-list
110141282|NCT02012062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110141283|NCT02012062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110141284|NCT02012075|Metoprolol|metoprolol|mesh-list
110141285|NCT02012075|Carvedilol|carvedilol|mesh-list
110141286|NCT02012075|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110141287|NCT02012075|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110141288|NCT02012075|Sympatholytics|sympatholytics|mesh-ancestor
110141289|NCT02012075|Autonomic Agents|autonomic agents|mesh-ancestor
110141290|NCT02012075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110141291|NCT02012075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110141292|NCT02012075|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110141293|NCT02012075|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110141294|NCT02012075|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110141295|NCT02012075|Adrenergic Agents|adrenergic agents|mesh-ancestor
110141296|NCT02012075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110141297|NCT02012075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110141298|NCT02012075|Antioxidants|antioxidants|mesh-ancestor
110141299|NCT02012075|Protective Agents|protective agents|mesh-ancestor
110141300|NCT02012075|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110141301|NCT02012075|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110141302|NCT02012075|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110141303|NCT02012075|Vasodilator Agents|vasodilator agents|mesh-ancestor
110141304|NCT02012075|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110141305|NCT02012075|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110141306|NCT02012088|Prednisone|prednisone|mesh-list
110141307|NCT02012088|Cyclophosphamide|cyclophosphamide|mesh-list
110141308|NCT02012088|Rituximab|rituximab|mesh-list
110141309|NCT02012088|Doxorubicin|doxorubicin|mesh-list
110141310|NCT02012088|Vincristine|vincristine|mesh-list
110141311|NCT02012088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110141312|NCT02012088|Immunologic Factors|immunologic factors|mesh-ancestor
110141313|NCT02012088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110141314|NCT02012088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110141315|NCT02012088|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110141317|NCT02012088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110141318|NCT02012088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110141319|NCT02012088|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110141320|NCT02012088|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110141321|NCT02012088|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110141322|NCT02012088|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110141323|NCT02012088|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110141324|NCT02012088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110141325|NCT02012088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110141326|NCT02012088|Glucocorticoids|glucocorticoids|mesh-ancestor
110141327|NCT02012088|Hormones|hormones|mesh-ancestor
110141328|NCT02012088|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110141329|NCT02012088|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110141330|NCT02012088|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110141331|NCT02012088|Tubulin Modulators|tubulin modulators|mesh-ancestor
110141332|NCT02012088|Antimitotic Agents|antimitotic agents|mesh-ancestor
110141333|NCT02012088|Mitosis Modulators|mitosis modulators|mesh-ancestor
110141334|NCT02012140|Ticagrelor|ticagrelor|mesh-list
110141335|NCT02012140|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110141336|NCT02012140|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110141337|NCT02012140|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110141338|NCT02012140|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110141339|NCT02012140|Purinergic Agents|purinergic agents|mesh-ancestor
110141340|NCT02012140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110141341|NCT02012140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110141342|NCT02012140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110141343|NCT02012166|Insulin|insulin|mesh-list
110141344|NCT02012166|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110141346|NCT02012166|Glucagon|glucagon|mesh-list
110141347|NCT02012166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110141348|NCT02012166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110141349|NCT02012166|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110141350|NCT02012166|Hormones|hormones|mesh-ancestor
110141351|NCT02012166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110141352|NCT02012166|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110141353|NCT02012166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110141355|NCT02012244|Anesthetics|anesthetics|mesh-list
110141356|NCT02012244|Anesthetics, Local|anesthetics, local|mesh-list
110141357|NCT02012244|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110141358|NCT02012244|Narcotics|narcotics|mesh-ancestor
110141359|NCT02012244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110141360|NCT02012244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110141361|NCT02012244|Analgesics|analgesics|mesh-ancestor
110141362|NCT02012244|Sensory System Agents|sensory system agents|mesh-ancestor
110141363|NCT02012244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110141364|NCT02012244|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110141365|NCT02012244|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110141366|NCT02012244|Anesthetics, General|anesthetics, general|mesh-ancestor
110141367|NCT02012309|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110141368|NCT02012309|Immunologic Factors|immunologic factors|mesh-ancestor
110141369|NCT02012309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110141371|NCT02012322|Coenzyme Q10|coenzyme q10|mesh-list
110141372|NCT02012322|Micronutrients|micronutrients|mesh-ancestor
110141373|NCT02012322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110141374|NCT02012322|Vitamins|vitamins|mesh-ancestor
110141375|NCT02012335|Ketamine|ketamine|mesh-list
110141376|NCT02012335|Analgesics|analgesics|mesh-ancestor
110141377|NCT02012335|Sensory System Agents|sensory system agents|mesh-ancestor
110141378|NCT02012335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110363054|NCT02912702|Autonomic Agents|autonomic agents|mesh-ancestor
110141379|NCT02012335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110141380|NCT02012335|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110141381|NCT02012335|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110141382|NCT02012335|Anesthetics, General|anesthetics, general|mesh-ancestor
110141383|NCT02012335|Anesthetics|anesthetics|mesh-ancestor
110141384|NCT02012335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110141385|NCT02012335|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110141386|NCT02012335|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110141387|NCT02012335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110141388|NCT02012335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110141390|NCT02012387|Vaccines|vaccines|mesh-list
110141391|NCT02012387|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110141392|NCT02012387|Immunologic Factors|immunologic factors|mesh-ancestor
110141393|NCT02012387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110141394|NCT02012387|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110141395|NCT02012387|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110141396|NCT02012387|Respiratory System Agents|respiratory system agents|mesh-ancestor
110141397|NCT02012465|Insulin|insulin|mesh-list
110141398|NCT02012465|Insulin Glargine|insulin glargine|mesh-list
110141399|NCT02012465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110363116|NCT02912234|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110141400|NCT02012465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110141401|NCT02012517|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110141402|NCT02012517|Cefazolin|cefazolin|mesh-list
110141403|NCT02012517|Cephalexin|cephalexin|mesh-list
110141404|NCT02012517|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
110141405|NCT02012517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110141406|NCT02012517|Antitubercular Agents|antitubercular agents|mesh-ancestor
110141407|NCT02012556|Tesamorelin|tesamorelin|mesh-list
110141408|NCT02012556|Growth Substances|growth substances|mesh-ancestor
110141409|NCT02012556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110141410|NCT02012569|Hemostatics|hemostatics|mesh-list
110141411|NCT02012569|Coagulants|coagulants|mesh-ancestor
110141412|NCT02012595|Donepezil|donepezil|mesh-list
110141413|NCT02012595|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110141414|NCT02012595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110141415|NCT02012595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110141416|NCT02012595|Cholinergic Agents|cholinergic agents|mesh-ancestor
110141417|NCT02012595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110141418|NCT02012595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110141419|NCT02012595|Nootropic Agents|nootropic agents|mesh-ancestor
110141420|NCT02012738|8-chloro-cyclic adenosine monophosphate|8-chloro-cyclic adenosine monophosphate|mesh-list
110141421|NCT02012738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110141422|NCT02012738|Immunologic Factors|immunologic factors|mesh-ancestor
110141423|NCT02012738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110141424|NCT02012777|Propranolol|propranolol|mesh-list
110141425|NCT02012777|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110141426|NCT02012777|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110141427|NCT02012777|Adrenergic Agents|adrenergic agents|mesh-ancestor
110141428|NCT02012777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110141429|NCT02012777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110141430|NCT02012777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110141431|NCT02012777|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110141432|NCT02012777|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110141433|NCT02012777|Vasodilator Agents|vasodilator agents|mesh-ancestor
110141434|NCT02012920|Seviteronel|seviteronel|mesh-list
110141435|NCT02012920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110141436|NCT02012920|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110141437|NCT02012920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110141438|NCT02012920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110141439|NCT02012933|Amifampridine|amifampridine|mesh-list
110141440|NCT02012933|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110141441|NCT02012933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110141442|NCT02012933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110141443|NCT02012933|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
110141444|NCT02012933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110141445|NCT02012933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110141446|NCT02012946|Simendan|simendan|mesh-list
110141447|NCT02012946|Dobutamine|dobutamine|mesh-list
110141448|NCT02012946|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110141449|NCT02012946|Vasodilator Agents|vasodilator agents|mesh-ancestor
110141450|NCT02012946|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110141451|NCT02012946|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110141453|NCT02012946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110141454|NCT02012946|Protective Agents|protective agents|mesh-ancestor
110141455|NCT02012946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110141456|NCT02012946|Sympathomimetics|sympathomimetics|mesh-ancestor
110141457|NCT02012946|Autonomic Agents|autonomic agents|mesh-ancestor
110141458|NCT02012946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110141459|NCT02012946|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
110363357|NCT02909972|Cytarabine|cytarabine|mesh-list
110141460|NCT02012946|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110141461|NCT02012946|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110141462|NCT02012946|Adrenergic Agents|adrenergic agents|mesh-ancestor
110141463|NCT02012946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110141464|NCT02012998|Vaccines|vaccines|mesh-list
110141465|NCT02012998|Immunologic Factors|immunologic factors|mesh-ancestor
110141466|NCT02012998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110141467|NCT02013102|Decitabine|decitabine|mesh-list
110141468|NCT02013102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110141469|NCT02013102|Antimetabolites|antimetabolites|mesh-ancestor
110141470|NCT02013102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110141471|NCT02013102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110141472|NCT02013102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110141473|NCT02013115|Budesonide|budesonide|mesh-list
110141474|NCT02013115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110141475|NCT02013115|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110141476|NCT02013115|Autonomic Agents|autonomic agents|mesh-ancestor
110141477|NCT02013115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110141478|NCT02013115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110141479|NCT02013115|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110141480|NCT02013115|Respiratory System Agents|respiratory system agents|mesh-ancestor
110141481|NCT02013115|Glucocorticoids|glucocorticoids|mesh-ancestor
110141482|NCT02013115|Hormones|hormones|mesh-ancestor
110141483|NCT02013115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110141484|NCT02013154|Paclitaxel|paclitaxel|mesh-list
110141485|NCT02013154|Pembrolizumab|pembrolizumab|mesh-list
110141486|NCT02013154|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110141487|NCT02013154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110141488|NCT02013154|Tubulin Modulators|tubulin modulators|mesh-ancestor
110141489|NCT02013154|Antimitotic Agents|antimitotic agents|mesh-ancestor
110141490|NCT02013154|Mitosis Modulators|mitosis modulators|mesh-ancestor
110141491|NCT02013154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110141492|NCT02013154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110141493|NCT02013154|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110141494|NCT02013219|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110141495|NCT02013219|Atezolizumab|atezolizumab|mesh-list
110141496|NCT02013219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110141497|NCT02013219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110141498|NCT02013219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110141499|NCT02013219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110141500|NCT02013219|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110141501|NCT02013219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110141502|NCT02013232|Aripiprazole|aripiprazole|mesh-list
110141503|NCT02013232|Antidepressive Agents|antidepressive agents|mesh-ancestor
110141504|NCT02013232|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110141505|NCT02013232|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110141506|NCT02013232|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110141507|NCT02013232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110141508|NCT02013232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110141509|NCT02013232|Dopamine Agonists|dopamine agonists|mesh-ancestor
110141511|NCT02013232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110141512|NCT02013232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110141513|NCT02013232|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110141514|NCT02013232|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110141515|NCT02013232|Serotonin Agents|serotonin agents|mesh-ancestor
110141516|NCT02013232|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110141517|NCT02013232|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110141518|NCT02013232|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110141519|NCT02013232|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110141520|NCT02013258|Oxytocin|oxytocin|mesh-list
110141521|NCT02013258|Oxytocics|oxytocics|mesh-ancestor
110141522|NCT02013258|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110141523|NCT02013258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110141524|NCT02013271|Paclitaxel|paclitaxel|mesh-list
110141525|NCT02013271|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110141526|NCT02013271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110141527|NCT02013271|Tubulin Modulators|tubulin modulators|mesh-ancestor
110141528|NCT02013271|Antimitotic Agents|antimitotic agents|mesh-ancestor
110141529|NCT02013271|Mitosis Modulators|mitosis modulators|mesh-ancestor
110141530|NCT02013271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110141531|NCT02013362|Folic Acid|folic acid|mesh-list
110141532|NCT02013362|Vitamin B 12|vitamin b 12|mesh-list
110141533|NCT02013362|Hydroxocobalamin|hydroxocobalamin|mesh-list
110141534|NCT02013362|Vitamins|vitamins|mesh-ancestor
110141535|NCT02013362|Micronutrients|micronutrients|mesh-ancestor
110141536|NCT02013362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110141537|NCT02013362|Hematinics|hematinics|mesh-ancestor
110141538|NCT02013362|Vitamin B Complex|vitamin b complex|mesh-ancestor
110141539|NCT02013453|Paclitaxel|paclitaxel|mesh-list
110141540|NCT02013453|Carboplatin|carboplatin|mesh-list
110141541|NCT02013453|Fluorouracil|fluorouracil|mesh-list
110141542|NCT02013453|Pemetrexed|pemetrexed|mesh-list
110141543|NCT02013453|Omeprazole|omeprazole|mesh-list
110141544|NCT02013453|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110141545|NCT02013453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110141546|NCT02013453|Tubulin Modulators|tubulin modulators|mesh-ancestor
110141547|NCT02013453|Antimitotic Agents|antimitotic agents|mesh-ancestor
110141548|NCT02013453|Mitosis Modulators|mitosis modulators|mesh-ancestor
110141549|NCT02013453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110363718|NCT04790045|Venetoclax|venetoclax|mesh-list
110141550|NCT02013453|Antimetabolites|antimetabolites|mesh-ancestor
110141551|NCT02013453|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110141552|NCT02013453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110141553|NCT02013453|Immunologic Factors|immunologic factors|mesh-ancestor
110141554|NCT02013453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110141555|NCT02013453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110141556|NCT02013453|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110141557|NCT02013453|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110363786|NCT01782729|Tacrolimus|tacrolimus|mesh-list
110141558|NCT02013453|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110141559|NCT02013453|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110141560|NCT02013453|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110141561|NCT02013570|Dexmedetomidine|dexmedetomidine|mesh-list
110141562|NCT02013570|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110141563|NCT02013570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110141564|NCT02013570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110141565|NCT02013570|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110141566|NCT02013570|Analgesics|analgesics|mesh-ancestor
110141567|NCT02013570|Sensory System Agents|sensory system agents|mesh-ancestor
110141568|NCT02013570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110167506|NCT00031954|Carboplatin|carboplatin|mesh-list
110141569|NCT02013570|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110141570|NCT02013570|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110141572|NCT02013570|Adrenergic Agents|adrenergic agents|mesh-ancestor
110141573|NCT02013570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110141574|NCT02013570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110141575|NCT02013856|Proanthocyanidin|proanthocyanidin|mesh-list
110141576|NCT02013856|Procyanidin|procyanidin|mesh-list
110141577|NCT02013856|Antioxidants|antioxidants|mesh-ancestor
110141578|NCT02013856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110141579|NCT02013856|Protective Agents|protective agents|mesh-ancestor
110141580|NCT02013856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110141581|NCT02013856|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110141582|NCT02013856|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110141583|NCT02013856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110141584|NCT02013895|Technetium Tc 99m DTPA-galactosyl-human serum albumin|technetium tc 99m dtpa-galactosyl-human serum albumin|mesh-list
110141585|NCT02013895|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110141586|NCT02013895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110141587|NCT02013960|Misoprostol|misoprostol|mesh-list
110141588|NCT02013960|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110141589|NCT02013960|Abortifacient Agents|abortifacient agents|mesh-ancestor
110141590|NCT02013960|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110141591|NCT02013960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110141592|NCT02013960|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110141594|NCT02013960|Oxytocics|oxytocics|mesh-ancestor
110141595|NCT02013986|Midazolam|midazolam|mesh-list
110141596|NCT02013986|Propofol|propofol|mesh-list
110141597|NCT02013986|Etomidate|etomidate|mesh-list
110141598|NCT02013986|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110141599|NCT02013986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110141600|NCT02013986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110141601|NCT02013986|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110141602|NCT02013986|Anesthetics, General|anesthetics, general|mesh-ancestor
110141603|NCT02013986|Anesthetics|anesthetics|mesh-ancestor
110141604|NCT02013986|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110141605|NCT02013986|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110141606|NCT02013986|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110141607|NCT02013986|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110141608|NCT02013986|GABA Modulators|gaba modulators|mesh-ancestor
110141609|NCT02013986|GABA Agents|gaba agents|mesh-ancestor
110141610|NCT02013986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110141611|NCT02013986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110141612|NCT02014064|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
110141613|NCT02014064|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110141614|NCT02014064|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110141615|NCT02014064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110141616|NCT02014064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110141617|NCT02014064|Adrenergic Agents|adrenergic agents|mesh-ancestor
110141618|NCT02014064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110141619|NCT02014064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110141621|NCT02013089|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110141622|NCT02013089|Sorafenib|sorafenib|mesh-list
110141623|NCT02013089|Sunitinib|sunitinib|mesh-list
110141624|NCT02013089|Imatinib Mesylate|imatinib mesylate|mesh-list
110141625|NCT02013089|Gefitinib|gefitinib|mesh-list
110141626|NCT02013089|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110141627|NCT02013089|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110141628|NCT02013089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110141629|NCT02013089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110141630|NCT02013089|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110141631|NCT02013089|Immunologic Factors|immunologic factors|mesh-ancestor
110141632|NCT02013089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110141633|NCT02013089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110141634|NCT02013089|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110141635|NCT02013089|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110141636|NCT02013089|Growth Substances|growth substances|mesh-ancestor
110141637|NCT02013089|Growth Inhibitors|growth inhibitors|mesh-ancestor
110141639|NCT02014103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110141640|NCT02014103|Immunologic Factors|immunologic factors|mesh-ancestor
110141641|NCT02014103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110141642|NCT02014103|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110141643|NCT02014103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110141644|NCT02014103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110141645|NCT02014337|Mifepristone|mifepristone|mesh-list
110141646|NCT02014337|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
110141647|NCT02014337|Abortifacient Agents|abortifacient agents|mesh-ancestor
110141648|NCT02014337|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110141649|NCT02014337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110141650|NCT02014337|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110141651|NCT02014337|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110141652|NCT02014337|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110141653|NCT02014337|Contraceptive Agents|contraceptive agents|mesh-ancestor
110141654|NCT02014337|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
110141655|NCT02014337|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
110141656|NCT02014337|Hormone Antagonists|hormone antagonists|mesh-ancestor
110364445|NCT03527576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110141657|NCT02014337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110141658|NCT02014337|Luteolytic Agents|luteolytic agents|mesh-ancestor
110141659|NCT02014337|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110141660|NCT02014337|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
110141662|NCT02014428|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110141663|NCT02014428|Immunologic Factors|immunologic factors|mesh-ancestor
110141664|NCT02014428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110141665|NCT02014428|Viscosupplements|viscosupplements|mesh-ancestor
110141666|NCT02014428|Protective Agents|protective agents|mesh-ancestor
110141667|NCT02014454|Propranolol|propranolol|mesh-list
110141668|NCT02014454|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110141669|NCT02014454|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110141670|NCT02014454|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110141671|NCT02014454|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110141672|NCT02014454|Adrenergic Agents|adrenergic agents|mesh-ancestor
110141673|NCT02014454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110141674|NCT02014454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110141675|NCT02014454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110141676|NCT02014454|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110141677|NCT02014454|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110141678|NCT02014454|Vasodilator Agents|vasodilator agents|mesh-ancestor
110141679|NCT02014506|Cyclophosphamide|cyclophosphamide|mesh-list
110141680|NCT02014506|Fludarabine|fludarabine|mesh-list
110141681|NCT02014506|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110141682|NCT02014506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110141683|NCT02014506|Immunologic Factors|immunologic factors|mesh-ancestor
110141684|NCT02014506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110141685|NCT02014506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110141686|NCT02014506|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110141687|NCT02014506|Alkylating Agents|alkylating agents|mesh-ancestor
110364636|NCT04678830|Antiviral Agents|antiviral agents|mesh-ancestor
110141688|NCT02014506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110141689|NCT02014506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110141690|NCT02014506|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110141691|NCT02014532|Montelukast|montelukast|mesh-list
110141692|NCT02014532|Leukotriene Antagonists|leukotriene antagonists|mesh-list
110141693|NCT02014532|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110141694|NCT02014532|Respiratory System Agents|respiratory system agents|mesh-ancestor
110141695|NCT02014532|Hormone Antagonists|hormone antagonists|mesh-ancestor
110141696|NCT02014532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110141697|NCT02014532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110141698|NCT02014532|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110141699|NCT02014532|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110167530|NCT00000575|Glucocorticoids|glucocorticoids|mesh-ancestor
110141700|NCT02014532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110141701|NCT02014545|Lucanthone|lucanthone|mesh-list
110141702|NCT02014545|Schistosomicides|schistosomicides|mesh-ancestor
110141703|NCT02014545|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110141704|NCT02014545|Anthelmintics|anthelmintics|mesh-ancestor
110141705|NCT02014545|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110141706|NCT02014545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110141709|NCT02014558|Midazolam|midazolam|mesh-list
110141710|NCT02014558|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110141711|NCT02014558|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110141712|NCT02014558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110141713|NCT02014558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110141714|NCT02014558|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110141715|NCT02014558|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110141717|NCT02014558|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110141718|NCT02014558|Anesthetics, General|anesthetics, general|mesh-ancestor
110141719|NCT02014558|Anesthetics|anesthetics|mesh-ancestor
110141720|NCT02014558|GABA Modulators|gaba modulators|mesh-ancestor
110141721|NCT02014558|GABA Agents|gaba agents|mesh-ancestor
110141722|NCT02014558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110141723|NCT02014558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110141724|NCT02014558|Antifungal Agents|antifungal agents|mesh-ancestor
110141725|NCT02014558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110141726|NCT02014558|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110141727|NCT02014558|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110141728|NCT02014558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110141729|NCT02014558|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110141730|NCT02014558|Hormone Antagonists|hormone antagonists|mesh-ancestor
110141731|NCT02014558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110141732|NCT02014558|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110365040|NCT02382510|Cholinergic Agents|cholinergic agents|mesh-ancestor
110141734|NCT02014623|Immunomodulating Agents|immunomodulating agents|mesh-list
110141735|NCT02014623|Histamine Antagonists|histamine antagonists|mesh-list
110141736|NCT02014623|Immunologic Factors|immunologic factors|mesh-ancestor
110141737|NCT02014623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110141738|NCT02014623|Histamine Agents|histamine agents|mesh-ancestor
110141739|NCT02014623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110141740|NCT02014623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110141741|NCT02014636|Pembrolizumab|pembrolizumab|mesh-list
110141742|NCT02014636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110141743|NCT02014636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110141744|NCT02014636|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110141745|NCT02014636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110141746|NCT02014714|Fentanyl|fentanyl|mesh-list
110141747|NCT02014714|Morphine|morphine|mesh-list
110141748|NCT02014714|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110141749|NCT02014714|Narcotics|narcotics|mesh-ancestor
110141750|NCT02014714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110141751|NCT02014714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110141752|NCT02014714|Analgesics|analgesics|mesh-ancestor
110141753|NCT02014714|Sensory System Agents|sensory system agents|mesh-ancestor
110141754|NCT02014714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110141755|NCT02014714|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110141756|NCT02014714|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110141757|NCT02014714|Anesthetics, General|anesthetics, general|mesh-ancestor
110141758|NCT02014714|Anesthetics|anesthetics|mesh-ancestor
110141759|NCT02014727|Aluminum Hydroxide|aluminum hydroxide|mesh-list
110141760|NCT02014727|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110141761|NCT02014727|Immunologic Factors|immunologic factors|mesh-ancestor
110141762|NCT02014727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110141763|NCT02014727|Antacids|antacids|mesh-ancestor
110141764|NCT02014727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110141765|NCT02014727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110141766|NCT02014753|Cobalt|cobalt|mesh-list
110141767|NCT02014753|Chromium|chromium|mesh-list
110141768|NCT02014753|Everolimus|everolimus|mesh-list
110141769|NCT02014753|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110141770|NCT02014753|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110141771|NCT02014753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110141772|NCT02014753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110141773|NCT02014753|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110141774|NCT02014753|Immunologic Factors|immunologic factors|mesh-ancestor
110365111|NCT00540137|Ritonavir|ritonavir|mesh-list
110141776|NCT02014753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110141777|NCT02014753|Trace Elements|trace elements|mesh-ancestor
110141778|NCT02014753|Micronutrients|micronutrients|mesh-ancestor
110141779|NCT02014831|Cetuximab|cetuximab|mesh-list
110141780|NCT02014831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110141781|NCT02014831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110141782|NCT02014922|Vitamin E|vitamin e|mesh-list
110141783|NCT02014922|alpha-Tocopherol|alpha-tocopherol|mesh-list
110141784|NCT02014922|Tocopherols|tocopherols|mesh-list
110141785|NCT02014922|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
110141786|NCT02014922|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110141787|NCT02014922|Lubricant Eye Drops|lubricant eye drops|mesh-list
110141788|NCT02014922|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110141789|NCT02014922|Laxatives|laxatives|mesh-ancestor
110141790|NCT02014922|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110141791|NCT02014922|Antioxidants|antioxidants|mesh-ancestor
110141792|NCT02014922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110141793|NCT02014922|Protective Agents|protective agents|mesh-ancestor
110141794|NCT02014922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110141795|NCT02014922|Vitamins|vitamins|mesh-ancestor
110141796|NCT02014922|Micronutrients|micronutrients|mesh-ancestor
110141797|NCT02015156|Trastuzumab|trastuzumab|mesh-list
110141798|NCT02015156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110141799|NCT02015156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110141800|NCT02015169|Lapatinib|lapatinib|mesh-list
110141801|NCT02015169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110141802|NCT02015169|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110141803|NCT02015169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110141804|NCT02015169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110141805|NCT02015182|Bupivacaine|bupivacaine|mesh-list
110141807|NCT02015182|Anesthetics|anesthetics|mesh-ancestor
110141808|NCT02015182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110141809|NCT02015182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110141810|NCT02015182|Sensory System Agents|sensory system agents|mesh-ancestor
110365492|NCT04648137|Hallucinogens|hallucinogens|mesh-ancestor
110141811|NCT02015182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110141812|NCT02015260|Citric Acid|citric acid|mesh-list
110141813|NCT02015260|Anticoagulants|anticoagulants|mesh-ancestor
110141814|NCT02015260|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110141815|NCT02015260|Chelating Agents|chelating agents|mesh-ancestor
110141816|NCT02015260|Sequestering Agents|sequestering agents|mesh-ancestor
110141817|NCT02015260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110141818|NCT02015299|Linagliptin|linagliptin|mesh-list
110141819|NCT02015299|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
110141820|NCT02015299|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110141821|NCT02015299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110141822|NCT02015299|Incretins|incretins|mesh-ancestor
110141823|NCT02015299|Hormones|hormones|mesh-ancestor
110365645|NCT00544232|Paclitaxel|paclitaxel|mesh-list
110141824|NCT02015299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110141825|NCT02015299|Protease Inhibitors|protease inhibitors|mesh-ancestor
110141826|NCT02015299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110141827|NCT02015299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110141828|NCT02015312|Silicon|silicon|mesh-list
110141829|NCT02015312|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
110141830|NCT02015312|Mannitol|mannitol|mesh-list
110365700|NCT00544349|Antidotes|antidotes|mesh-ancestor
110141831|NCT02015312|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110141832|NCT02015312|Diuretics|diuretics|mesh-ancestor
110141833|NCT02015312|Natriuretic Agents|natriuretic agents|mesh-ancestor
110141834|NCT02015312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110141835|NCT02015312|Trace Elements|trace elements|mesh-ancestor
110141836|NCT02015312|Micronutrients|micronutrients|mesh-ancestor
110141837|NCT02015312|Antioxidants|antioxidants|mesh-ancestor
110141838|NCT02015312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110141840|NCT02015312|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
110141841|NCT02015312|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110365768|NCT05824312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110141842|NCT02015312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110141843|NCT02015312|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110141844|NCT02015403|Acetylcysteine|acetylcysteine|mesh-list
110141845|NCT02015403|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110141846|NCT02015403|Antiviral Agents|antiviral agents|mesh-ancestor
110141847|NCT02015403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110141848|NCT02015403|Expectorants|expectorants|mesh-ancestor
110141849|NCT02015403|Respiratory System Agents|respiratory system agents|mesh-ancestor
110141850|NCT02015403|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110141851|NCT02015403|Antioxidants|antioxidants|mesh-ancestor
110141852|NCT02015403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110141853|NCT02015403|Protective Agents|protective agents|mesh-ancestor
110141854|NCT02015403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110141855|NCT02015403|Antidotes|antidotes|mesh-ancestor
110141856|NCT02015494|Hemagglutinins|hemagglutinins|mesh-list
110141857|NCT02015494|Immunologic Factors|immunologic factors|mesh-ancestor
110141858|NCT02015494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110141859|NCT02015494|Agglutinins|agglutinins|mesh-ancestor
110141860|NCT02015494|Coagulants|coagulants|mesh-ancestor
110141861|NCT02015507|Ciprofloxacin|ciprofloxacin|mesh-list
110141863|NCT02015507|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110141864|NCT02015507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110141865|NCT02015507|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110141866|NCT02015507|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110141867|NCT02015507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110141868|NCT02015507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110141869|NCT02015507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110141870|NCT02015507|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110141871|NCT02015507|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110141872|NCT02015507|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
110141873|NCT02015507|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110141874|NCT02015559|Protective Agents|protective agents|mesh-list
110141875|NCT02015559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110141876|NCT02015598|Carbocysteine|carbocysteine|mesh-list
110141877|NCT02015598|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110141878|NCT02015598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110141879|NCT02015598|Expectorants|expectorants|mesh-ancestor
110141880|NCT02015598|Respiratory System Agents|respiratory system agents|mesh-ancestor
110141881|NCT02015650|Fluorouracil|fluorouracil|mesh-list
110141883|NCT02015650|Mitomycins|mitomycins|mesh-list
110141884|NCT02015650|Mitomycin|mitomycin|mesh-list
110141885|NCT02015650|Antimetabolites|antimetabolites|mesh-ancestor
110141886|NCT02015650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110366174|NCT04666948|Vancomycin|vancomycin|mesh-list
110141887|NCT02015650|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110141888|NCT02015650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110141889|NCT02015650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110141890|NCT02015650|Immunologic Factors|immunologic factors|mesh-ancestor
110141891|NCT02015650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110141892|NCT02015650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110141893|NCT02015650|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110141894|NCT02015650|Alkylating Agents|alkylating agents|mesh-ancestor
110141895|NCT02015650|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110141896|NCT02015650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110141897|NCT02015728|Etoposide|etoposide|mesh-list
110141898|NCT02015728|Everolimus|everolimus|mesh-list
110141899|NCT02015728|Temozolomide|temozolomide|mesh-list
110141900|NCT02015728|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110141901|NCT02015728|Sorafenib|sorafenib|mesh-list
110141902|NCT02015728|Dasatinib|dasatinib|mesh-list
110141903|NCT02015728|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110366305|NCT03994393|Durvalumab|durvalumab|mesh-list
110141904|NCT02015728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110141905|NCT02015728|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110141906|NCT02015728|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110141907|NCT02015728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110141908|NCT02015728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110141909|NCT02015728|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110141910|NCT02015728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110141911|NCT02015728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110141912|NCT02015728|Immunologic Factors|immunologic factors|mesh-ancestor
110141913|NCT02015728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110141914|NCT02015728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110141915|NCT02015728|Alkylating Agents|alkylating agents|mesh-ancestor
110141916|NCT02015780|Hypoglycemic Agents|hypoglycemic agents|mesh-list
110141917|NCT02015780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110141918|NCT02015923|Panitumumab|panitumumab|mesh-list
110141919|NCT02015923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110141920|NCT02015923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110141921|NCT02015949|Methylphenidate|methylphenidate|mesh-list
110141922|NCT02015949|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110141923|NCT02015949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110141924|NCT02015949|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110141925|NCT02015949|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110141926|NCT02015949|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110141927|NCT02015949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110141929|NCT02015949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110141930|NCT02015988|Simvastatin|simvastatin|mesh-list
110141931|NCT02015988|Fenofibrate|fenofibrate|mesh-list
110141932|NCT02015988|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110141933|NCT02015988|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110141934|NCT02015988|Antimetabolites|antimetabolites|mesh-ancestor
110141935|NCT02015988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110141936|NCT02015988|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110141937|NCT02015988|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110141938|NCT02015988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110141939|NCT02016001|Fluorides|fluorides|mesh-list
110141940|NCT02016001|Cariostatic Agents|cariostatic agents|mesh-ancestor
110141941|NCT02016001|Protective Agents|protective agents|mesh-ancestor
110141942|NCT02016001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110141943|NCT02016157|Moxifloxacin|moxifloxacin|mesh-list
110141944|NCT02016157|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110141945|NCT02016157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110141946|NCT02016157|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110141947|NCT02016157|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110141948|NCT02016157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110141949|NCT02016157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110141950|NCT02016157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110141952|NCT02016196|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110141953|NCT02016196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110141954|NCT02016196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110141955|NCT02016209|Paclitaxel|paclitaxel|mesh-list
110141956|NCT02016209|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110141957|NCT02016209|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110141958|NCT02016209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110141959|NCT02016209|Tubulin Modulators|tubulin modulators|mesh-ancestor
110141960|NCT02016209|Antimitotic Agents|antimitotic agents|mesh-ancestor
110141961|NCT02016209|Mitosis Modulators|mitosis modulators|mesh-ancestor
110141962|NCT02016209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110141963|NCT02016261|Fluvoxamine|fluvoxamine|mesh-list
110141964|NCT02016261|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110141965|NCT02016261|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110141966|NCT02016261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110141967|NCT02016261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110141968|NCT02016261|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110141969|NCT02016261|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110141970|NCT02016261|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110141971|NCT02016261|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110141972|NCT02016261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110141973|NCT02016261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110141974|NCT02016261|Serotonin Agents|serotonin agents|mesh-ancestor
110141975|NCT02016261|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110141976|NCT02016261|Antidepressive Agents|antidepressive agents|mesh-ancestor
110141977|NCT02016261|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110141978|NCT02016261|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110141980|NCT02016261|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110141981|NCT02016274|Paclitaxel|paclitaxel|mesh-list
110141982|NCT02016274|Cisplatin|cisplatin|mesh-list
110141983|NCT02016274|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110141984|NCT02016274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110141985|NCT02016274|Tubulin Modulators|tubulin modulators|mesh-ancestor
110141986|NCT02016274|Antimitotic Agents|antimitotic agents|mesh-ancestor
110141987|NCT02016274|Mitosis Modulators|mitosis modulators|mesh-ancestor
110141988|NCT02016274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110141989|NCT02016287|Paclitaxel|paclitaxel|mesh-list
110141990|NCT02016287|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110141991|NCT02016287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110141992|NCT02016287|Tubulin Modulators|tubulin modulators|mesh-ancestor
110141993|NCT02016287|Antimitotic Agents|antimitotic agents|mesh-ancestor
110141994|NCT02016287|Mitosis Modulators|mitosis modulators|mesh-ancestor
110141995|NCT02016287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110141996|NCT02016365|Doxycycline|doxycycline|mesh-list
110141997|NCT02016365|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
110141998|NCT02016365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110141999|NCT02016365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110142000|NCT02016365|Antimalarials|antimalarials|mesh-ancestor
110142001|NCT02016365|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110142002|NCT02016365|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110142003|NCT02016365|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
110142004|NCT02016365|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110142005|NCT02016391|Dexmedetomidine|dexmedetomidine|mesh-list
110142006|NCT02016391|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110366695|NCT04645914|Nicotine|nicotine|mesh-list
110142007|NCT02016391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110142008|NCT02016391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110142009|NCT02016391|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110142010|NCT02016391|Analgesics|analgesics|mesh-ancestor
110142011|NCT02016391|Sensory System Agents|sensory system agents|mesh-ancestor
110142012|NCT02016391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110142013|NCT02016391|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110142014|NCT02016391|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110142015|NCT02016391|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110142017|NCT02016391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110142018|NCT02016391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110142019|NCT02016417|Cisplatin|cisplatin|mesh-list
110142020|NCT02016417|Gemcitabine|gemcitabine|mesh-list
110142021|NCT02016417|Docetaxel|docetaxel|mesh-list
110142022|NCT02016417|Fluorouracil|fluorouracil|mesh-list
110142023|NCT02016417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110142024|NCT02016417|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110142025|NCT02016417|Antimetabolites|antimetabolites|mesh-ancestor
110142026|NCT02016417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110142027|NCT02016417|Tubulin Modulators|tubulin modulators|mesh-ancestor
110142028|NCT02016417|Antimitotic Agents|antimitotic agents|mesh-ancestor
110142029|NCT02016417|Mitosis Modulators|mitosis modulators|mesh-ancestor
110142030|NCT02016417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110142031|NCT02016417|Immunologic Factors|immunologic factors|mesh-ancestor
110366783|NCT00546923|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110142032|NCT02016417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110142033|NCT02016443|Tizanidine|tizanidine|mesh-list
110142034|NCT02016443|Analgesics|analgesics|mesh-ancestor
110142035|NCT02016443|Sensory System Agents|sensory system agents|mesh-ancestor
110142036|NCT02016443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110142037|NCT02016443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110142038|NCT02016443|Anticonvulsants|anticonvulsants|mesh-ancestor
110142039|NCT02016443|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110142040|NCT02016443|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110142041|NCT02016443|Parasympatholytics|parasympatholytics|mesh-ancestor
110142042|NCT02016443|Autonomic Agents|autonomic agents|mesh-ancestor
110142043|NCT02016443|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110142044|NCT02016443|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110142045|NCT02016443|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110142046|NCT02016443|Adrenergic Agents|adrenergic agents|mesh-ancestor
110366862|NCT04644354|Nifedipine|nifedipine|mesh-list
110142047|NCT02016443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110142048|NCT02016443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110142049|NCT02016495|Thioctic Acid|thioctic acid|mesh-list
110142050|NCT02016495|Antioxidants|antioxidants|mesh-ancestor
110142051|NCT02016495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110142052|NCT02016495|Protective Agents|protective agents|mesh-ancestor
110142053|NCT02016495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110167553|NCT00032149|Mitoxantrone|mitoxantrone|mesh-list
110142054|NCT02016495|Vitamin B Complex|vitamin b complex|mesh-ancestor
110142055|NCT02016495|Vitamins|vitamins|mesh-ancestor
110142056|NCT02016495|Micronutrients|micronutrients|mesh-ancestor
110142057|NCT02016547|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
110142058|NCT02016547|Abciximab|abciximab|mesh-list
110142059|NCT02016547|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110142060|NCT02016547|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110142061|NCT02016547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110142062|NCT02016547|Anticoagulants|anticoagulants|mesh-ancestor
110142063|NCT02016547|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110142065|NCT02016664|Analgesics|analgesics|mesh-ancestor
110142067|NCT02016664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110142068|NCT02016664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110142069|NCT02016664|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110142070|NCT02016664|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110142071|NCT02016664|Anesthetics, General|anesthetics, general|mesh-ancestor
110142072|NCT02016664|Anesthetics|anesthetics|mesh-ancestor
110142073|NCT02016664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110142074|NCT02016664|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110142075|NCT02016664|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110142076|NCT02016664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110366955|NCT00560586|Hormones|hormones|mesh-ancestor
110142077|NCT02016664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110142078|NCT02016703|Erythritol|erythritol|mesh-list
110142079|NCT02016703|Vasodilator Agents|vasodilator agents|mesh-ancestor
110142080|NCT02016729|Trametinib|trametinib|mesh-list
110142081|NCT02016729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110142082|NCT02016729|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110142083|NCT02016729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110142084|NCT02016729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110142085|NCT02016807|Sucralfate|sucralfate|mesh-list
110142086|NCT02016807|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110142087|NCT02016807|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110142088|NCT02016820|Omeprazole|omeprazole|mesh-list
110142090|NCT02016820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110142091|NCT02016820|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110142093|NCT02016820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110142094|NCT02016846|Liraglutide|liraglutide|mesh-list
110142095|NCT02016846|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110142096|NCT02016846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110142097|NCT02016846|Incretins|incretins|mesh-ancestor
110142098|NCT02016846|Hormones|hormones|mesh-ancestor
110142099|NCT02016846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110142100|NCT02016976|Midazolam|midazolam|mesh-list
110142101|NCT02016976|Meperidine|meperidine|mesh-list
110142102|NCT02016976|Analgesics|analgesics|mesh-list
110142103|NCT02016976|Sensory System Agents|sensory system agents|mesh-ancestor
110142104|NCT02016976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110142105|NCT02016976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110142106|NCT02016976|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110142107|NCT02016976|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110142108|NCT02016976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110142109|NCT02016976|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110142110|NCT02016976|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110142111|NCT02016976|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110142112|NCT02016976|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110142113|NCT02016976|Anesthetics, General|anesthetics, general|mesh-ancestor
110142114|NCT02016976|Anesthetics|anesthetics|mesh-ancestor
110142115|NCT02016976|GABA Modulators|gaba modulators|mesh-ancestor
110142116|NCT02016976|GABA Agents|gaba agents|mesh-ancestor
110142117|NCT02016976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110142118|NCT02016976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110142119|NCT02016976|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110142120|NCT02016976|Narcotics|narcotics|mesh-ancestor
110142121|NCT02017119|Lactulose|lactulose|mesh-list
110142122|NCT02017119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110142123|NCT02017197|Warfarin|warfarin|mesh-list
110142124|NCT02017197|Anticoagulants|anticoagulants|mesh-ancestor
110142125|NCT02017314|Morphine|morphine|mesh-list
110142126|NCT02017314|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110142127|NCT02017314|Narcotics|narcotics|mesh-ancestor
110142128|NCT02017314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110142129|NCT02017314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110142130|NCT02017314|Analgesics|analgesics|mesh-ancestor
110142131|NCT02017314|Sensory System Agents|sensory system agents|mesh-ancestor
110142132|NCT02017314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110142133|NCT02017340|Nilvadipine|nilvadipine|mesh-list
110142134|NCT02017340|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110142135|NCT02017340|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110142136|NCT02017340|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110142137|NCT02017340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110142138|NCT02017340|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110142139|NCT02017340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110142140|NCT02017392|Lidocaine|lidocaine|mesh-list
110142141|NCT02017392|Anesthetics, Local|anesthetics, local|mesh-ancestor
110142142|NCT02017392|Anesthetics|anesthetics|mesh-ancestor
110142143|NCT02017392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110142144|NCT02017392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110142145|NCT02017392|Sensory System Agents|sensory system agents|mesh-ancestor
110142146|NCT02017392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110142147|NCT02017392|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110142148|NCT02017392|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110142149|NCT02017392|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110142150|NCT02017392|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110142151|NCT02017392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110142152|NCT02017405|Immunoglobulins|immunoglobulins|mesh-list
110142153|NCT02017405|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110142154|NCT02017405|Antibodies|antibodies|mesh-list
110142155|NCT02017405|Immunologic Factors|immunologic factors|mesh-ancestor
110142156|NCT02017405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110142158|NCT02017457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110142159|NCT02017457|Antimetabolites|antimetabolites|mesh-ancestor
110142160|NCT02017457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110142161|NCT02017457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110142162|NCT02017457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110142163|NCT02017561|Metformin|metformin|mesh-list
110142165|NCT02017561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110142166|NCT02017600|Fluorouracil|fluorouracil|mesh-list
110142167|NCT02017600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110142168|NCT02017600|Antimetabolites|antimetabolites|mesh-ancestor
110142169|NCT02017600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110142170|NCT02017600|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110142171|NCT02017600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110142172|NCT02017600|Immunologic Factors|immunologic factors|mesh-ancestor
110142173|NCT02017600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110142174|NCT02017613|Tenalisib|tenalisib|mesh-list
110142175|NCT02017613|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
110142176|NCT02017613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110142177|NCT02017613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110142179|NCT02017639|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110142180|NCT02017639|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110142181|NCT02017639|Antimetabolites|antimetabolites|mesh-ancestor
110142182|NCT02017639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110142183|NCT02017639|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110142184|NCT02017639|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110142185|NCT02017639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110142186|NCT02017873|Carbamide Peroxide|carbamide peroxide|mesh-list
110142187|NCT02017873|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110142188|NCT02017873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110142189|NCT02018055|Aspirin|aspirin|mesh-list
110142190|NCT02018055|Clopidogrel|clopidogrel|mesh-list
110142191|NCT02018055|Ticagrelor|ticagrelor|mesh-list
110142192|NCT02018055|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110142193|NCT02018055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110142194|NCT02018055|Analgesics|analgesics|mesh-ancestor
110142195|NCT02018055|Sensory System Agents|sensory system agents|mesh-ancestor
110142196|NCT02018055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110142197|NCT02018055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110142198|NCT02018055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110142199|NCT02018055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110142200|NCT02018055|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110142201|NCT02018055|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110142202|NCT02018055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110142203|NCT02018055|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110142204|NCT02018055|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110142205|NCT02018055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110142207|NCT02018055|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110142208|NCT02018055|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110142209|NCT02018055|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110142210|NCT02018055|Purinergic Agents|purinergic agents|mesh-ancestor
110142211|NCT02018055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110142213|NCT02018081|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110142214|NCT02018081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110142215|NCT02018081|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110142216|NCT02018081|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110142217|NCT02018081|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110142218|NCT02018081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110142219|NCT02018081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110142220|NCT02018081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110142221|NCT02018081|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110142222|NCT02018081|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110142224|NCT02018094|Chlorhexidine|chlorhexidine|mesh-list
110142225|NCT02018094|Povidone-Iodine|povidone-iodine|mesh-list
110142226|NCT02018094|Metronidazole|metronidazole|mesh-list
110142227|NCT02018094|Clindamycin|clindamycin|mesh-list
110142228|NCT02018094|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
110142229|NCT02018094|Teicoplanin|teicoplanin|mesh-list
110142230|NCT02018094|Povidone|povidone|mesh-list
110142231|NCT02018094|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110142232|NCT02018094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110142233|NCT02018094|Disinfectants|disinfectants|mesh-ancestor
110142234|NCT02018094|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110142235|NCT02018094|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110142236|NCT02018094|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110142237|NCT02018094|Trace Elements|trace elements|mesh-ancestor
110142238|NCT02018094|Micronutrients|micronutrients|mesh-ancestor
110142239|NCT02018094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110142240|NCT02018094|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110142241|NCT02018094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110142242|NCT02018094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110142243|NCT02018094|Plasma Substitutes|plasma substitutes|mesh-ancestor
110142244|NCT02018094|Blood Substitutes|blood substitutes|mesh-ancestor
110367627|NCT04537598|Narcotics|narcotics|mesh-ancestor
110142245|NCT02018094|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110142247|NCT02018133|Ergocalciferols|ergocalciferols|mesh-list
110142248|NCT02018133|Vitamins|vitamins|mesh-ancestor
110142249|NCT02018133|Micronutrients|micronutrients|mesh-ancestor
110142250|NCT02018133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110142251|NCT02018133|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110142252|NCT02018133|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110142253|NCT02018159|Menotropins|menotropins|mesh-list
110142254|NCT02018159|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110142255|NCT02018159|Fertility Agents|fertility agents|mesh-ancestor
110142256|NCT02018159|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110142257|NCT02018159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110142258|NCT02018250|Benzyl Alcohol|benzyl alcohol|mesh-list
110142259|NCT02018250|Anesthetics, Local|anesthetics, local|mesh-ancestor
110142260|NCT02018250|Anesthetics|anesthetics|mesh-ancestor
110142261|NCT02018250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110142262|NCT02018250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110142263|NCT02018250|Sensory System Agents|sensory system agents|mesh-ancestor
110142264|NCT02018250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110142265|NCT02018276|Lidocaine|lidocaine|mesh-list
110142266|NCT02018276|Anesthetics, Local|anesthetics, local|mesh-ancestor
110142267|NCT02018276|Anesthetics|anesthetics|mesh-ancestor
110142268|NCT02018276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110142270|NCT02018276|Sensory System Agents|sensory system agents|mesh-ancestor
110142271|NCT02018276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110142272|NCT02018276|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110142273|NCT02018276|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110142274|NCT02018276|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110142275|NCT02018276|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110142276|NCT02018276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110142277|NCT02018289|Triclosan|triclosan|mesh-list
110142278|NCT02018289|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110142279|NCT02018289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110142280|NCT02018289|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
110142281|NCT02018289|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110142282|NCT02018289|Antimetabolites|antimetabolites|mesh-ancestor
110142283|NCT02018289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110142284|NCT02018289|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110142285|NCT02018328|Curcumin|curcumin|mesh-list
110142286|NCT02018328|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110142287|NCT02018328|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110142289|NCT02018328|Sensory System Agents|sensory system agents|mesh-ancestor
110142290|NCT02018328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110142291|NCT02018328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110142292|NCT02018328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110142293|NCT02018328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110142294|NCT02018328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110142295|NCT02018328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110142296|NCT02018328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110142298|NCT02018367|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110142299|NCT02018367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110142300|NCT02018419|Vaccines|vaccines|mesh-list
110142301|NCT02018419|Immunologic Factors|immunologic factors|mesh-ancestor
110142302|NCT02018419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110142303|NCT02018523|Lenalidomide|lenalidomide|mesh-list
110142304|NCT02018523|Immunologic Factors|immunologic factors|mesh-ancestor
110142305|NCT02018523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110142306|NCT02018523|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110142307|NCT02018523|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110142308|NCT02018523|Growth Substances|growth substances|mesh-ancestor
110142309|NCT02018523|Growth Inhibitors|growth inhibitors|mesh-ancestor
110142310|NCT02018523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110142311|NCT02018536|Simeprevir|simeprevir|mesh-list
110142312|NCT02018536|Antiviral Agents|antiviral agents|mesh-ancestor
110142313|NCT02018536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110142314|NCT02018536|Protease Inhibitors|protease inhibitors|mesh-ancestor
110142315|NCT02018536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110142316|NCT02018536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110142317|NCT02018588|Tryptophan|tryptophan|mesh-list
110142318|NCT02018588|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110142319|NCT02018588|Antidepressive Agents|antidepressive agents|mesh-ancestor
110142320|NCT02018588|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110142321|NCT02018601|Acetaminophen|acetaminophen|mesh-list
110142322|NCT02018601|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
110142323|NCT02018601|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110142324|NCT02018601|Analgesics|analgesics|mesh-ancestor
110142325|NCT02018601|Sensory System Agents|sensory system agents|mesh-ancestor
110142326|NCT02018601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110142327|NCT02018601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110142328|NCT02018601|Antipyretics|antipyretics|mesh-ancestor
110142329|NCT02018601|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110142330|NCT02018601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110142331|NCT02018601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110142332|NCT02018731|Metformin|metformin|mesh-list
110142333|NCT02018731|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110142334|NCT02018731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110142335|NCT02018757|Chlorotrianisene|chlorotrianisene|mesh-list
110142336|NCT02018757|Arsenic Trioxide|arsenic trioxide|mesh-list
110142337|NCT02018757|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
110142338|NCT02018757|Estrogens|estrogens|mesh-ancestor
110142339|NCT02018757|Hormones|hormones|mesh-ancestor
110142340|NCT02018757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110142341|NCT02018757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110142342|NCT02018757|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110142343|NCT02018757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110142344|NCT02018783|Listerine|listerine|mesh-list
110142345|NCT02018783|Sodium Fluoride|sodium fluoride|mesh-list
110142346|NCT02018783|Cariostatic Agents|cariostatic agents|mesh-ancestor
110142347|NCT02018783|Protective Agents|protective agents|mesh-ancestor
110142348|NCT02018783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110142349|NCT02018783|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110142350|NCT02018783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110142351|NCT02018874|Gemcitabine|gemcitabine|mesh-list
110142352|NCT02018874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110142353|NCT02018874|Antimetabolites|antimetabolites|mesh-ancestor
110142354|NCT02018874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110142355|NCT02018874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110142356|NCT02018965|Vitamins|vitamins|mesh-list
110142357|NCT02018965|Niacin|niacin|mesh-list
110142358|NCT02018965|Niacinamide|niacinamide|mesh-list
110142359|NCT02018965|Nicotinic Acids|nicotinic acids|mesh-list
110142360|NCT02018965|Vitamin B Complex|vitamin b complex|mesh-list
110142361|NCT02018965|Micronutrients|micronutrients|mesh-ancestor
110142362|NCT02018965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110142363|NCT02018965|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110142364|NCT02018965|Antimetabolites|antimetabolites|mesh-ancestor
110142365|NCT02018965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110142366|NCT02018965|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110142367|NCT02018965|Vasodilator Agents|vasodilator agents|mesh-ancestor
110142368|NCT02018991|Everolimus|everolimus|mesh-list
110142369|NCT02018991|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110142370|NCT02018991|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110142371|NCT02018991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110142372|NCT02018991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110142373|NCT02018991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110142374|NCT02018991|Immunologic Factors|immunologic factors|mesh-ancestor
110142375|NCT02018991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110142376|NCT02018991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110142377|NCT02019017|Botulinum Toxins|botulinum toxins|mesh-list
110142378|NCT02019017|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110142379|NCT02019017|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110142380|NCT02019017|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110142381|NCT02019017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110142382|NCT02019017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110142383|NCT02019017|Cholinergic Agents|cholinergic agents|mesh-ancestor
110142384|NCT02019017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110142385|NCT02019017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110142386|NCT02019017|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110142387|NCT02019017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110142388|NCT02019056|Pyridoxine|pyridoxine|mesh-list
110142389|NCT02019056|Metadoxine|metadoxine|mesh-list
110142390|NCT02019056|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110142391|NCT02019056|Vitamin B Complex|vitamin b complex|mesh-ancestor
110142392|NCT02019056|Vitamins|vitamins|mesh-ancestor
110142393|NCT02019056|Micronutrients|micronutrients|mesh-ancestor
110142394|NCT02019056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110142395|NCT02019095|Dimercaprol|dimercaprol|mesh-list
110142396|NCT02019095|Chelating Agents|chelating agents|mesh-ancestor
110142397|NCT02019095|Sequestering Agents|sequestering agents|mesh-ancestor
110142398|NCT02019095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110142399|NCT02019160|Silver Nitrate|silver nitrate|mesh-list
110142402|NCT02019160|Sodium Fluoride|sodium fluoride|mesh-list
110142403|NCT02019160|Cariostatic Agents|cariostatic agents|mesh-ancestor
110142404|NCT02019160|Protective Agents|protective agents|mesh-ancestor
110142405|NCT02019160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110142406|NCT02019160|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110142407|NCT02019160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110142408|NCT02019186|Vitamins|vitamins|mesh-list
110142409|NCT02019186|Vitamin E|vitamin e|mesh-list
110142410|NCT02019186|Micronutrients|micronutrients|mesh-ancestor
110142411|NCT02019186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110142412|NCT02019186|Antioxidants|antioxidants|mesh-ancestor
110142413|NCT02019186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110142414|NCT02019186|Protective Agents|protective agents|mesh-ancestor
110142415|NCT02019290|Midazolam|midazolam|mesh-list
110142416|NCT02019290|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110142417|NCT02019290|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110142418|NCT02019290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110142419|NCT02019290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110142420|NCT02019290|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110142421|NCT02019290|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110142422|NCT02019290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110142423|NCT02019290|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110367985|NCT04623840|Tadalafil|tadalafil|mesh-list
110142424|NCT02019290|Anesthetics, General|anesthetics, general|mesh-ancestor
110142426|NCT02019290|GABA Modulators|gaba modulators|mesh-ancestor
110142427|NCT02019290|GABA Agents|gaba agents|mesh-ancestor
110142428|NCT02019290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110142429|NCT02019290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110142430|NCT02019329|Risperidone|risperidone|mesh-list
110142431|NCT02019329|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110142432|NCT02019329|Serotonin Agents|serotonin agents|mesh-ancestor
110142433|NCT02019329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110142434|NCT02019329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110142435|NCT02019329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110142436|NCT02019329|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110142437|NCT02019329|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110142438|NCT02019329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110142439|NCT02019329|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110142440|NCT02019329|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110142441|NCT02019329|Dopamine Agents|dopamine agents|mesh-ancestor
110142443|NCT02019355|Calcipotriene|calcipotriene|mesh-list
110142444|NCT02019355|Petrolatum|petrolatum|mesh-list
110142445|NCT02019355|Antimetabolites|antimetabolites|mesh-ancestor
110142446|NCT02019355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110142447|NCT02019355|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110142448|NCT02019355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110142449|NCT02019355|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110142450|NCT02019355|Immunologic Factors|immunologic factors|mesh-ancestor
110142451|NCT02019355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110142452|NCT02019355|Dermatologic Agents|dermatologic agents|mesh-ancestor
110142453|NCT02019355|Emollients|emollients|mesh-ancestor
110142454|NCT02019381|Vitamin D|vitamin d|mesh-list
110142455|NCT02019381|Ergocalciferols|ergocalciferols|mesh-list
110142456|NCT02019381|Cholecalciferol|cholecalciferol|mesh-list
110142457|NCT02019381|Vitamins|vitamins|mesh-list
110142458|NCT02019381|Micronutrients|micronutrients|mesh-ancestor
110142459|NCT02019381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110142460|NCT02019381|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110142461|NCT02019381|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110142462|NCT02019394|(2-(6-fluoro-1H-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|(2-(6-fluoro-1h-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|mesh-list
110142463|NCT02019394|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110142464|NCT02019394|Serotonin Agents|serotonin agents|mesh-ancestor
110142465|NCT02019394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110142466|NCT02019394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110142467|NCT02019394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110142468|NCT02019446|Terbinafine|terbinafine|mesh-list
110142469|NCT02019446|Antifungal Agents|antifungal agents|mesh-ancestor
110142470|NCT02019446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110142471|NCT02019446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110167598|NCT00000596|Dapsone|dapsone|mesh-list
110142472|NCT02019446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110142474|NCT02019459|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110142475|NCT02019459|Autonomic Agents|autonomic agents|mesh-ancestor
110142476|NCT02019459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110142477|NCT02019459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110142478|NCT02019459|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110142479|NCT02019459|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110142480|NCT02019459|Cholinergic Agents|cholinergic agents|mesh-ancestor
110142481|NCT02019459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110142482|NCT02019459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110142483|NCT02019485|Tapentadol|tapentadol|mesh-list
110368078|NCT02901977|Ramipril|ramipril|mesh-list
110142484|NCT02019485|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110142485|NCT02019485|Narcotics|narcotics|mesh-ancestor
110142486|NCT02019485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110142487|NCT02019485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110142488|NCT02019485|Analgesics|analgesics|mesh-ancestor
110142489|NCT02019485|Sensory System Agents|sensory system agents|mesh-ancestor
110142490|NCT02019485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110142491|NCT02019485|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110142492|NCT02019485|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110142493|NCT02019485|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110142494|NCT02019485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110142495|NCT02019485|Adrenergic Agents|adrenergic agents|mesh-ancestor
110142496|NCT02019485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110142497|NCT02019524|Folic Acid|folic acid|mesh-list
110142498|NCT02019524|Vitamin B Complex|vitamin b complex|mesh-list
110142499|NCT02019524|Molgramostim|molgramostim|mesh-list
110142500|NCT02019524|Vaccines|vaccines|mesh-list
110142502|NCT02019524|Immunologic Factors|immunologic factors|mesh-ancestor
110142503|NCT02019524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110142504|NCT02019524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110142505|NCT02019524|Hematinics|hematinics|mesh-ancestor
110142506|NCT02019524|Vitamins|vitamins|mesh-ancestor
110142507|NCT02019524|Micronutrients|micronutrients|mesh-ancestor
110142508|NCT02019784|Rifaximin|rifaximin|mesh-list
110142509|NCT02019784|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110142510|NCT02019784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110142512|NCT02019797|Desflurane|desflurane|mesh-list
110142513|NCT02019797|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110142514|NCT02019797|Anesthetics, General|anesthetics, general|mesh-ancestor
110142515|NCT02019797|Anesthetics|anesthetics|mesh-ancestor
110142516|NCT02019797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110142517|NCT02019797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110142518|NCT02019810|Dobutamine|dobutamine|mesh-list
110142519|NCT02019810|Norepinephrine|norepinephrine|mesh-list
110142520|NCT02019810|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110142521|NCT02019810|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110142522|NCT02019810|Adrenergic Agents|adrenergic agents|mesh-ancestor
110142523|NCT02019810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110142524|NCT02019810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110368249|NCT04621227|Anesthetics|anesthetics|mesh-ancestor
110142525|NCT02019810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110142527|NCT02019810|Autonomic Agents|autonomic agents|mesh-ancestor
110142528|NCT02019810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110142529|NCT02019810|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110142530|NCT02019810|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110142531|NCT02019810|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
110142532|NCT02019810|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110142533|NCT02019810|Protective Agents|protective agents|mesh-ancestor
110142534|NCT02019836|Vitamin D|vitamin d|mesh-list
110142535|NCT02019836|Vitamins|vitamins|mesh-ancestor
110142536|NCT02019836|Micronutrients|micronutrients|mesh-ancestor
110142537|NCT02019836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110142538|NCT02019836|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110142539|NCT02020005|Nicotine|nicotine|mesh-list
110142540|NCT02020005|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110142541|NCT02020005|Autonomic Agents|autonomic agents|mesh-ancestor
110142542|NCT02020005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110142543|NCT02020005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110142544|NCT02020005|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110142545|NCT02020005|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110142546|NCT02020005|Cholinergic Agents|cholinergic agents|mesh-ancestor
110142547|NCT02020005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110142548|NCT02020005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110142550|NCT02020122|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110142551|NCT02020122|Analgesics|analgesics|mesh-ancestor
110142552|NCT02020122|Sensory System Agents|sensory system agents|mesh-ancestor
110142553|NCT02020122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110142554|NCT02020122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110142555|NCT02020122|Anticonvulsants|anticonvulsants|mesh-ancestor
110142556|NCT02020122|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110142557|NCT02020122|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110142558|NCT02020122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110142559|NCT02020122|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110142560|NCT02020122|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110142561|NCT02020122|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110142562|NCT02020122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110142563|NCT02020122|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110142564|NCT02020122|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110142565|NCT02020122|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110142566|NCT02020122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110142567|NCT02020122|Antidepressive Agents|antidepressive agents|mesh-ancestor
110142568|NCT02020122|Dopamine Agents|dopamine agents|mesh-ancestor
110142569|NCT02020161|Methotrexate|methotrexate|mesh-list
110142570|NCT02020161|Idarubicin|idarubicin|mesh-list
110142571|NCT02020161|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110142572|NCT02020161|Abortifacient Agents|abortifacient agents|mesh-ancestor
110142573|NCT02020161|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110142574|NCT02020161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110142575|NCT02020161|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110142576|NCT02020161|Antimetabolites|antimetabolites|mesh-ancestor
110142577|NCT02020161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110142578|NCT02020161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110142579|NCT02020161|Dermatologic Agents|dermatologic agents|mesh-ancestor
110142580|NCT02020161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110142581|NCT02020161|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110142582|NCT02020161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110142583|NCT02020161|Immunologic Factors|immunologic factors|mesh-ancestor
110142584|NCT02020161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110142585|NCT02020161|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110142586|NCT02020161|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110142587|NCT02020161|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110142588|NCT02020161|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110142589|NCT02020200|Methylphenidate|methylphenidate|mesh-list
110142590|NCT02020200|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110142591|NCT02020200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110142592|NCT02020200|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110142593|NCT02020200|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110142594|NCT02020200|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110142595|NCT02020200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110142596|NCT02020200|Dopamine Agents|dopamine agents|mesh-ancestor
110142597|NCT02020200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110142598|NCT02020213|Posaconazole|posaconazole|mesh-list
110142599|NCT02020213|Antifungal Agents|antifungal agents|mesh-ancestor
110142600|NCT02020213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110142601|NCT02020213|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
110142602|NCT02020213|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110142603|NCT02020213|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110142604|NCT02020213|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110142605|NCT02020213|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110368354|NCT04619862|Gabapentin|gabapentin|mesh-list
110142606|NCT02020213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110142607|NCT02020213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110142608|NCT02020213|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110142609|NCT02020213|Hormone Antagonists|hormone antagonists|mesh-ancestor
110142610|NCT02020213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110142611|NCT02020213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110142613|NCT02020330|Artemether|artemether|mesh-list
110142614|NCT02020330|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
110142615|NCT02020330|Antimalarials|antimalarials|mesh-ancestor
110142616|NCT02020330|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110142617|NCT02020330|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110142618|NCT02020330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110142620|NCT02020499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110142621|NCT02020551|Lidocaine|lidocaine|mesh-list
110142622|NCT02020551|Anesthetics, Local|anesthetics, local|mesh-ancestor
110142623|NCT02020551|Anesthetics|anesthetics|mesh-ancestor
110368375|NCT00562770|Valacyclovir|valacyclovir|mesh-list
110142624|NCT02020551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110142625|NCT02020551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110142626|NCT02020551|Sensory System Agents|sensory system agents|mesh-ancestor
110142627|NCT02020551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110142628|NCT02020551|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110142629|NCT02020551|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110142630|NCT02020551|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110142631|NCT02020551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110142632|NCT02020551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110142633|NCT02020603|Epinephrine|epinephrine|mesh-list
110142634|NCT02020603|Racepinephrine|racepinephrine|mesh-list
110142635|NCT02020603|Hemostatics|hemostatics|mesh-list
110142636|NCT02020603|Epinephryl borate|epinephryl borate|mesh-list
110142637|NCT02020603|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110142638|NCT02020603|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110142639|NCT02020603|Adrenergic Agents|adrenergic agents|mesh-ancestor
110142640|NCT02020603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110142641|NCT02020603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110142642|NCT02020603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110142643|NCT02020603|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110142644|NCT02020603|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110142645|NCT02020603|Autonomic Agents|autonomic agents|mesh-ancestor
110142646|NCT02020603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110142647|NCT02020603|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110142648|NCT02020603|Respiratory System Agents|respiratory system agents|mesh-ancestor
110142649|NCT02020603|Mydriatics|mydriatics|mesh-ancestor
110142650|NCT02020603|Sympathomimetics|sympathomimetics|mesh-ancestor
110142651|NCT02020603|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110142652|NCT02020603|Coagulants|coagulants|mesh-ancestor
110142653|NCT02020629|Lixisenatide|lixisenatide|mesh-list
110142654|NCT02020629|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110142655|NCT02020629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110142657|NCT02020681|Cariostatic Agents|cariostatic agents|mesh-ancestor
110142658|NCT02020681|Protective Agents|protective agents|mesh-ancestor
110142659|NCT02020681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110142660|NCT02018796|Misoprostol|misoprostol|mesh-list
110142661|NCT02018796|Mifepristone|mifepristone|mesh-list
110142662|NCT02018796|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110142663|NCT02018796|Abortifacient Agents|abortifacient agents|mesh-ancestor
110142664|NCT02018796|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110142665|NCT02018796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110142666|NCT02018796|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110142667|NCT02018796|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110142668|NCT02018796|Oxytocics|oxytocics|mesh-ancestor
110142669|NCT02018796|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
110142670|NCT02018796|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110142671|NCT02018796|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110142672|NCT02018796|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110142673|NCT02018796|Contraceptive Agents|contraceptive agents|mesh-ancestor
110142674|NCT02018796|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
110142675|NCT02018796|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
110142676|NCT02018796|Hormone Antagonists|hormone antagonists|mesh-ancestor
110142677|NCT02018796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110142678|NCT02018796|Luteolytic Agents|luteolytic agents|mesh-ancestor
110142679|NCT02018796|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110142680|NCT02018796|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
110142681|NCT02021097|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110142682|NCT02021097|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110142684|NCT02021097|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110142685|NCT02021097|Estradiol|estradiol|mesh-list
110142686|NCT02021097|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110142687|NCT02021097|Estrogens|estrogens|mesh-ancestor
110142688|NCT02021097|Hormones|hormones|mesh-ancestor
110142689|NCT02021097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110142690|NCT02021097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110142691|NCT02021097|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110142692|NCT02021097|Contraceptive Agents|contraceptive agents|mesh-ancestor
110142693|NCT02021097|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110142695|NCT02021097|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110142696|NCT02021097|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110142697|NCT02021097|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110142698|NCT02021110|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
110142699|NCT02021110|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
110142700|NCT02021110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110142701|NCT02021123|Anidulafungin|anidulafungin|mesh-list
110142702|NCT02021123|Antifungal Agents|antifungal agents|mesh-ancestor
110142703|NCT02021123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110142704|NCT02021201|Risperidone|risperidone|mesh-list
110142705|NCT02021201|Sertindole|sertindole|mesh-list
110142706|NCT02021201|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110142707|NCT02021201|Serotonin Agents|serotonin agents|mesh-ancestor
110142708|NCT02021201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110142709|NCT02021201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110142710|NCT02021201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110142711|NCT02021201|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110142712|NCT02021201|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110142713|NCT02021201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110142714|NCT02021201|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110142715|NCT02021201|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110142716|NCT02021201|Dopamine Agents|dopamine agents|mesh-ancestor
110142717|NCT02021214|Methylphenidate|methylphenidate|mesh-list
110142718|NCT02021214|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110142719|NCT02021214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110142720|NCT02021214|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110142721|NCT02021214|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110142722|NCT02021214|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110142723|NCT02021214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110142724|NCT02021214|Dopamine Agents|dopamine agents|mesh-ancestor
110142725|NCT02021214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110142726|NCT02021240|Dexamethasone|dexamethasone|mesh-list
110142727|NCT02021240|Ketamine|ketamine|mesh-list
110142728|NCT02021240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110142729|NCT02021240|Antiemetics|antiemetics|mesh-ancestor
110142730|NCT02021240|Autonomic Agents|autonomic agents|mesh-ancestor
110142731|NCT02021240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110142732|NCT02021240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110142733|NCT02021240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110142734|NCT02021240|Glucocorticoids|glucocorticoids|mesh-ancestor
110142735|NCT02021240|Hormones|hormones|mesh-ancestor
110142736|NCT02021240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110142737|NCT02021240|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110142738|NCT02021240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110142739|NCT02021240|Analgesics|analgesics|mesh-ancestor
110142740|NCT02021240|Sensory System Agents|sensory system agents|mesh-ancestor
110142741|NCT02021240|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110142742|NCT02021240|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110142743|NCT02021240|Anesthetics, General|anesthetics, general|mesh-ancestor
110142745|NCT02021240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110142746|NCT02021240|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110142747|NCT02021240|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110142748|NCT02021240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110142749|NCT02021240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110142750|NCT02021409|Darbepoetin alfa|darbepoetin alfa|mesh-list
110142751|NCT02021409|Hematinics|hematinics|mesh-ancestor
110142752|NCT02020980|Botulinum Toxins|botulinum toxins|mesh-list
110142753|NCT02020980|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110142754|NCT02020980|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110142755|NCT02020980|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110142756|NCT02020980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110142757|NCT02020980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110142758|NCT02020980|Cholinergic Agents|cholinergic agents|mesh-ancestor
110142759|NCT02020980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110142760|NCT02020980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110142761|NCT02020980|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110142762|NCT02020980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110142763|NCT02021422|Fluorouracil|fluorouracil|mesh-list
110142764|NCT02021422|Oxaliplatin|oxaliplatin|mesh-list
110142765|NCT02021422|Irinotecan|irinotecan|mesh-list
110142766|NCT02021422|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
110142768|NCT02021422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110142769|NCT02021422|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110142770|NCT02021422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110142771|NCT02021422|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110142772|NCT02021422|Immunologic Factors|immunologic factors|mesh-ancestor
110142773|NCT02021422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110142775|NCT02021422|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110142776|NCT02021422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110142777|NCT02021422|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110142778|NCT02021500|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110142779|NCT02021500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110142781|NCT02021539|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110142782|NCT02021539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110142783|NCT02021825|Mitoxantrone|mitoxantrone|mesh-list
110142784|NCT02021825|Analgesics|analgesics|mesh-ancestor
110142785|NCT02021825|Sensory System Agents|sensory system agents|mesh-ancestor
110142786|NCT02021825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110142787|NCT02021825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110142788|NCT02021825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110142789|NCT02021825|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110142790|NCT02021825|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110142791|NCT02021825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110064083|NCT01526083|Lacosamide|lacosamide|mesh-list
110142792|NCT02021825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110142794|NCT02021851|Dexamethasone acetate|dexamethasone acetate|mesh-list
110142795|NCT02021851|Ondansetron|ondansetron|mesh-list
110142796|NCT02021851|Aprepitant|aprepitant|mesh-list
110142797|NCT02021851|BB 1101|bb 1101|mesh-list
110142798|NCT02021851|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110142799|NCT02021851|Antiemetics|antiemetics|mesh-ancestor
110142800|NCT02021851|Autonomic Agents|autonomic agents|mesh-ancestor
110142801|NCT02021851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110142802|NCT02021851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110142803|NCT02021851|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110142804|NCT02021851|Glucocorticoids|glucocorticoids|mesh-ancestor
110142805|NCT02021851|Hormones|hormones|mesh-ancestor
110142806|NCT02021851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110142807|NCT02021851|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110142808|NCT02021851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110142809|NCT02021851|Protease Inhibitors|protease inhibitors|mesh-ancestor
110142810|NCT02021851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110142811|NCT02021851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110142812|NCT02021851|Antipruritics|antipruritics|mesh-ancestor
110142813|NCT02021851|Dermatologic Agents|dermatologic agents|mesh-ancestor
110064141|NCT01526174|Immunologic Factors|immunologic factors|mesh-ancestor
110142814|NCT02021851|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110142815|NCT02021851|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110142816|NCT02021851|Serotonin Agents|serotonin agents|mesh-ancestor
110142817|NCT02021851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110142818|NCT02021851|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110142819|NCT02021864|Vitamin D|vitamin d|mesh-list
110142820|NCT02021864|Cholecalciferol|cholecalciferol|mesh-list
110142821|NCT02021864|Vitamins|vitamins|mesh-ancestor
110142822|NCT02021864|Micronutrients|micronutrients|mesh-ancestor
110142823|NCT02021864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110142824|NCT02021864|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110142825|NCT02021864|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110142826|NCT02022163|Aluminum Hydroxide|aluminum hydroxide|mesh-list
110142827|NCT02022163|Vaccines|vaccines|mesh-list
110142828|NCT02022163|Immunologic Factors|immunologic factors|mesh-ancestor
110142829|NCT02022163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110142830|NCT02022163|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110142831|NCT02022163|Antacids|antacids|mesh-ancestor
110142832|NCT02022163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110142833|NCT02022163|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110142834|NCT02022215|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110142835|NCT02022228|Triptorelin Pamoate|triptorelin pamoate|mesh-list
110142836|NCT02022228|Luteolytic Agents|luteolytic agents|mesh-ancestor
110142837|NCT02022228|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110142838|NCT02022228|Contraceptive Agents|contraceptive agents|mesh-ancestor
110142839|NCT02022228|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110142840|NCT02022228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110142841|NCT02022228|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110142842|NCT02022228|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110142843|NCT02022228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110142845|NCT02022241|Luteolytic Agents|luteolytic agents|mesh-ancestor
110142846|NCT02022241|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110142847|NCT02022241|Contraceptive Agents|contraceptive agents|mesh-ancestor
110142848|NCT02022241|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110142849|NCT02022241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110142850|NCT02022241|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110142851|NCT02022241|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110142852|NCT02022241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110142853|NCT02022254|Metformin|metformin|mesh-list
110142855|NCT02022254|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110142856|NCT02022254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110142857|NCT02022254|Anticoagulants|anticoagulants|mesh-ancestor
110142858|NCT02022293|Atorvastatin|atorvastatin|mesh-list
110142859|NCT02022293|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110142860|NCT02022293|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110142861|NCT02022293|Antimetabolites|antimetabolites|mesh-ancestor
110142862|NCT02022293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110142863|NCT02022293|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110142864|NCT02022293|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110142865|NCT02022293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110142866|NCT02022358|Leucovorin|leucovorin|mesh-list
110142867|NCT02022358|Folic Acid|folic acid|mesh-list
110142868|NCT02022358|Methotrexate|methotrexate|mesh-list
110142869|NCT02022358|Levoleucovorin|levoleucovorin|mesh-list
110142870|NCT02022358|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110142871|NCT02022358|Abortifacient Agents|abortifacient agents|mesh-ancestor
110142872|NCT02022358|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110064307|NCT01526941|Insulin|insulin|mesh-list
110142873|NCT02022358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110142874|NCT02022358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110142875|NCT02022358|Antimetabolites|antimetabolites|mesh-ancestor
110142876|NCT02022358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110142877|NCT02022358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110142878|NCT02022358|Dermatologic Agents|dermatologic agents|mesh-ancestor
110142879|NCT02022358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110142880|NCT02022358|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110142881|NCT02022358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110142882|NCT02022358|Immunologic Factors|immunologic factors|mesh-ancestor
110142883|NCT02022358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110142884|NCT02022358|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110142885|NCT02022358|Antidotes|antidotes|mesh-ancestor
110142886|NCT02022358|Protective Agents|protective agents|mesh-ancestor
110142887|NCT02022358|Vitamin B Complex|vitamin b complex|mesh-ancestor
110142888|NCT02022358|Vitamins|vitamins|mesh-ancestor
110142889|NCT02022358|Micronutrients|micronutrients|mesh-ancestor
110142890|NCT02022358|Hematinics|hematinics|mesh-ancestor
110142891|NCT02022475|Vitamin D|vitamin d|mesh-list
110142892|NCT02022475|Cholecalciferol|cholecalciferol|mesh-list
110142893|NCT02022475|Vitamins|vitamins|mesh-ancestor
110142894|NCT02022475|Micronutrients|micronutrients|mesh-ancestor
110142895|NCT02022475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110142896|NCT02022475|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110142897|NCT02022475|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110142898|NCT02022488|Midazolam|midazolam|mesh-list
110142899|NCT02022488|Ketamine|ketamine|mesh-list
110142900|NCT02022488|Alfentanil|alfentanil|mesh-list
110142901|NCT02022488|Analgesics|analgesics|mesh-ancestor
110142902|NCT02022488|Sensory System Agents|sensory system agents|mesh-ancestor
110142903|NCT02022488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110142904|NCT02022488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110142905|NCT02022488|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110142906|NCT02022488|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110142907|NCT02022488|Anesthetics, General|anesthetics, general|mesh-ancestor
110142908|NCT02022488|Anesthetics|anesthetics|mesh-ancestor
110142909|NCT02022488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110142910|NCT02022488|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110142911|NCT02022488|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110142912|NCT02022488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110142913|NCT02022488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110142914|NCT02022488|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110142915|NCT02022488|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110142916|NCT02022488|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110142917|NCT02022488|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110142918|NCT02022488|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110142919|NCT02022488|GABA Modulators|gaba modulators|mesh-ancestor
110142920|NCT02022488|GABA Agents|gaba agents|mesh-ancestor
110142921|NCT02022488|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110142922|NCT02022488|Narcotics|narcotics|mesh-ancestor
110142923|NCT02022527|Aspirin|aspirin|mesh-list
110142924|NCT02022527|Salicylic Acid|salicylic acid|mesh-list
110142925|NCT02022527|Salicylates|salicylates|mesh-list
110142926|NCT02022527|Warfarin|warfarin|mesh-list
110142927|NCT02022527|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110142928|NCT02022527|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110142929|NCT02022527|Analgesics|analgesics|mesh-ancestor
110142930|NCT02022527|Sensory System Agents|sensory system agents|mesh-ancestor
110142931|NCT02022527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110142932|NCT02022527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110142933|NCT02022527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110142934|NCT02022527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110142935|NCT02022527|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110142936|NCT02022527|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110142937|NCT02022527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110142938|NCT02022527|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110142939|NCT02022527|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110142940|NCT02022527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110142941|NCT02022527|Antipyretics|antipyretics|mesh-ancestor
110142942|NCT02022527|Anticoagulants|anticoagulants|mesh-ancestor
110142943|NCT02022527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110142944|NCT02022527|Antifungal Agents|antifungal agents|mesh-ancestor
110142945|NCT02022527|Keratolytic Agents|keratolytic agents|mesh-ancestor
110142946|NCT02022527|Dermatologic Agents|dermatologic agents|mesh-ancestor
110142947|NCT02022540|Ranibizumab|ranibizumab|mesh-list
110142948|NCT02022540|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110142949|NCT02022540|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110142950|NCT02022540|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110142951|NCT02022540|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110142952|NCT02022540|Growth Substances|growth substances|mesh-ancestor
110142953|NCT02022540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110142954|NCT02022540|Growth Inhibitors|growth inhibitors|mesh-ancestor
110167707|NCT00033046|Modafinil|modafinil|mesh-list
110142955|NCT02022540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110142957|NCT02022722|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110142958|NCT02022722|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110142959|NCT02022722|Bupivacaine|bupivacaine|mesh-list
110142960|NCT02022722|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110142961|NCT02022722|Anesthetics, Local|anesthetics, local|mesh-ancestor
110142963|NCT02022722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110142964|NCT02022722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110142965|NCT02022722|Sensory System Agents|sensory system agents|mesh-ancestor
110142966|NCT02022722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110142967|NCT02022722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110142968|NCT02022722|Glucocorticoids|glucocorticoids|mesh-ancestor
110142969|NCT02022722|Hormones|hormones|mesh-ancestor
110142970|NCT02022722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110142971|NCT02022722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110142972|NCT02022722|Immunologic Factors|immunologic factors|mesh-ancestor
110142973|NCT02022722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110142974|NCT02022722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110142975|NCT02022761|Laninamivir|laninamivir|mesh-list
110142976|NCT02022761|Antiviral Agents|antiviral agents|mesh-ancestor
110142977|NCT02022761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110142978|NCT02022852|Capecitabine|capecitabine|mesh-list
110064573|NCT01528163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110142979|NCT02022852|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110142981|NCT02022852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110142982|NCT02022852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110142983|NCT02022917|Bevacizumab|bevacizumab|mesh-list
110142984|NCT02022917|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110142985|NCT02022917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110142986|NCT02022917|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110142987|NCT02022917|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110142988|NCT02022917|Growth Substances|growth substances|mesh-ancestor
110142989|NCT02022917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110142990|NCT02022917|Growth Inhibitors|growth inhibitors|mesh-ancestor
110142991|NCT02022930|Triamcinolone|triamcinolone|mesh-list
110142992|NCT02022930|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110142993|NCT02022930|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110142994|NCT02022930|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110142995|NCT02022930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110064637|NCT01528644|Calcium|calcium|mesh-list
110142996|NCT02022930|Glucocorticoids|glucocorticoids|mesh-ancestor
110142997|NCT02022930|Hormones|hormones|mesh-ancestor
110142998|NCT02022930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110142999|NCT02022930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110143000|NCT02022930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110143001|NCT02022930|Immunologic Factors|immunologic factors|mesh-ancestor
110143002|NCT02022930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110143003|NCT02022930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110143004|NCT02023021|Paclitaxel|paclitaxel|mesh-list
110143005|NCT02023021|Gemcitabine|gemcitabine|mesh-list
110143006|NCT02023021|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110064690|NCT01529073|Nitazoxanide|nitazoxanide|mesh-list
110143007|NCT02023021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110143008|NCT02023021|Tubulin Modulators|tubulin modulators|mesh-ancestor
110143009|NCT02023021|Antimitotic Agents|antimitotic agents|mesh-ancestor
110143010|NCT02023021|Mitosis Modulators|mitosis modulators|mesh-ancestor
110143011|NCT02023021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110143012|NCT02023021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110143013|NCT02023021|Antimetabolites|antimetabolites|mesh-ancestor
110143014|NCT02023047|Nifedipine|nifedipine|mesh-list
110143015|NCT02023047|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110143016|NCT02023047|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110143017|NCT02023047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110143018|NCT02023047|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110143019|NCT02023047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110143020|NCT02023047|Vasodilator Agents|vasodilator agents|mesh-ancestor
110143021|NCT02023047|Tocolytic Agents|tocolytic agents|mesh-ancestor
110143022|NCT02023047|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110143023|NCT02023086|Tropicamide|tropicamide|mesh-list
110143024|NCT02023086|Mydriatics|mydriatics|mesh-list
110143025|NCT02023086|Autonomic Agents|autonomic agents|mesh-ancestor
110143026|NCT02023086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110143027|NCT02023086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110143028|NCT02023086|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110143029|NCT02023086|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110143030|NCT02023086|Cholinergic Agents|cholinergic agents|mesh-ancestor
110143031|NCT02023086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110143032|NCT02023086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110143033|NCT02023164|Diphenhydramine|diphenhydramine|mesh-list
110143034|NCT02023164|Promethazine|promethazine|mesh-list
110143035|NCT02023164|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110143036|NCT02023164|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110143037|NCT02023164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110143038|NCT02023164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110143039|NCT02023164|Anesthetics, Local|anesthetics, local|mesh-ancestor
110143040|NCT02023164|Anesthetics|anesthetics|mesh-ancestor
110143041|NCT02023164|Sensory System Agents|sensory system agents|mesh-ancestor
110064804|NCT01529242|Glucocorticoids|glucocorticoids|mesh-ancestor
110143042|NCT02023164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110143043|NCT02023164|Antiemetics|antiemetics|mesh-ancestor
110143044|NCT02023164|Autonomic Agents|autonomic agents|mesh-ancestor
110143045|NCT02023164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110143046|NCT02023164|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110143047|NCT02023164|Histamine Antagonists|histamine antagonists|mesh-ancestor
110143048|NCT02023164|Histamine Agents|histamine agents|mesh-ancestor
110143049|NCT02023164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110143050|NCT02023164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110143051|NCT02023164|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110143052|NCT02023164|Antipruritics|antipruritics|mesh-ancestor
110143053|NCT02023164|Dermatologic Agents|dermatologic agents|mesh-ancestor
110143054|NCT02023359|Everolimus|everolimus|mesh-list
110143055|NCT02023359|Exemestane|exemestane|mesh-list
110143056|NCT02023359|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110143057|NCT02023359|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110064868|NCT01529528|Anagliptin|anagliptin|mesh-list
110143058|NCT02023359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110143059|NCT02023359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110143060|NCT02023359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110143061|NCT02023359|Immunologic Factors|immunologic factors|mesh-ancestor
110143062|NCT02023359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110143063|NCT02023359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110143064|NCT02023359|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110143065|NCT02023359|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110143066|NCT02023359|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110143067|NCT02023359|Hormone Antagonists|hormone antagonists|mesh-ancestor
110143068|NCT02023359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110143069|NCT02023424|Glatiramer Acetate|glatiramer acetate|mesh-list
110143070|NCT02023424|(T,G)-A-L|(t,g)-a-l|mesh-list
110143071|NCT02023424|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110143072|NCT02023424|Immunologic Factors|immunologic factors|mesh-ancestor
110143073|NCT02023424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110143074|NCT02023424|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110143075|NCT02023424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110143076|NCT02023450|Ritonavir|ritonavir|mesh-list
110143077|NCT02023450|Saquinavir|saquinavir|mesh-list
110143078|NCT02023450|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110143079|NCT02023450|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110143080|NCT02023450|Protease Inhibitors|protease inhibitors|mesh-ancestor
110143081|NCT02023450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110143082|NCT02023450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110143083|NCT02023450|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110143084|NCT02023450|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110143085|NCT02023450|Antiviral Agents|antiviral agents|mesh-ancestor
110143086|NCT02023450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110143087|NCT02023450|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110143088|NCT02023450|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110143089|NCT02023554|Azithromycin|azithromycin|mesh-list
110143090|NCT02023554|Theophylline|theophylline|mesh-list
110143091|NCT02023554|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110064986|NCT01530230|Oxytocin|oxytocin|mesh-list
110143094|NCT02023554|Autonomic Agents|autonomic agents|mesh-ancestor
110143095|NCT02023554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110143096|NCT02023554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110143097|NCT02023554|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110143098|NCT02023554|Respiratory System Agents|respiratory system agents|mesh-ancestor
110143099|NCT02023554|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110143100|NCT02023554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110143101|NCT02023554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110143102|NCT02023554|Vasodilator Agents|vasodilator agents|mesh-ancestor
110143103|NCT02023554|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110143104|NCT02023554|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110143105|NCT02023554|Purinergic Agents|purinergic agents|mesh-ancestor
110143106|NCT02023554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110143107|NCT02023567|Serotonin|serotonin|mesh-list
110143108|NCT02023567|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
110143109|NCT02023567|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110143110|NCT02023567|Serotonin Agents|serotonin agents|mesh-ancestor
110143111|NCT02023567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110143112|NCT02023567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110143113|NCT02023567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110143114|NCT02023567|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110143115|NCT02023567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110143116|NCT02023684|Lidocaine|lidocaine|mesh-list
110143117|NCT02023684|Ropivacaine|ropivacaine|mesh-list
110143118|NCT02023684|Anesthetics, Local|anesthetics, local|mesh-ancestor
110143119|NCT02023684|Anesthetics|anesthetics|mesh-ancestor
110143120|NCT02023684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110143121|NCT02023684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110143122|NCT02023684|Sensory System Agents|sensory system agents|mesh-ancestor
110143123|NCT02023684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110143124|NCT02023684|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110143125|NCT02023684|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110065036|NCT01530490|Dopamine Agents|dopamine agents|mesh-ancestor
110143126|NCT02023684|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110143127|NCT02023684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110143128|NCT02023684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110143130|NCT02023710|Bevacizumab|bevacizumab|mesh-list
110143131|NCT02023710|Carboplatin|carboplatin|mesh-list
110143132|NCT02023710|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110143133|NCT02023710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110143134|NCT02023710|Tubulin Modulators|tubulin modulators|mesh-ancestor
110143135|NCT02023710|Antimitotic Agents|antimitotic agents|mesh-ancestor
110143136|NCT02023710|Mitosis Modulators|mitosis modulators|mesh-ancestor
110143137|NCT02023710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110143138|NCT02023710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110143139|NCT02023710|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110143140|NCT02023710|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110143141|NCT02023710|Growth Substances|growth substances|mesh-ancestor
110143142|NCT02023710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110143143|NCT02023710|Growth Inhibitors|growth inhibitors|mesh-ancestor
110143144|NCT02023840|Metronidazole|metronidazole|mesh-list
110143145|NCT02023840|Erythritol|erythritol|mesh-list
110143146|NCT02023840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110143147|NCT02023840|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110143148|NCT02023840|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110143149|NCT02023840|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110143150|NCT02023840|Vasodilator Agents|vasodilator agents|mesh-ancestor
110143151|NCT02023853|Metronidazole|metronidazole|mesh-list
110143152|NCT02023853|Erythritol|erythritol|mesh-list
110143153|NCT02023853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110065075|NCT01530607|Goserelin|goserelin|mesh-list
110143154|NCT02023853|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110143155|NCT02023853|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110143156|NCT02023853|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110143157|NCT02023853|Vasodilator Agents|vasodilator agents|mesh-ancestor
110143158|NCT02023892|Atorvastatin|atorvastatin|mesh-list
110143159|NCT02023892|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110143160|NCT02023892|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110143161|NCT02023892|Antimetabolites|antimetabolites|mesh-ancestor
110143162|NCT02023892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110143163|NCT02023892|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110143164|NCT02023892|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110143165|NCT02023892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110143166|NCT02023931|Sulforaphane|sulforaphane|mesh-list
110143167|NCT02023931|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110143168|NCT02023931|Protective Agents|protective agents|mesh-ancestor
110143169|NCT02023931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110143170|NCT02023931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110143172|NCT02024009|Paclitaxel|paclitaxel|mesh-list
110143173|NCT02024009|Gemcitabine|gemcitabine|mesh-list
110143174|NCT02024009|Capecitabine|capecitabine|mesh-list
110143175|NCT02024009|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110143176|NCT02024009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110143177|NCT02024009|Tubulin Modulators|tubulin modulators|mesh-ancestor
110143178|NCT02024009|Antimitotic Agents|antimitotic agents|mesh-ancestor
110143179|NCT02024009|Mitosis Modulators|mitosis modulators|mesh-ancestor
110143180|NCT02024009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110143181|NCT02024009|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110143182|NCT02024009|Antimetabolites|antimetabolites|mesh-ancestor
110143183|NCT02024009|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110143184|NCT02024009|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110143185|NCT02024009|Protease Inhibitors|protease inhibitors|mesh-ancestor
110143186|NCT02024009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110143187|NCT02024009|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110143188|NCT02024009|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110143189|NCT02024009|Antiviral Agents|antiviral agents|mesh-ancestor
110143190|NCT02024009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110143191|NCT02024022|Magnesium citrate|magnesium citrate|mesh-list
110143192|NCT02024022|Picosulfate sodium|picosulfate sodium|mesh-list
110143193|NCT02024022|Cathartics|cathartics|mesh-ancestor
110143194|NCT02024022|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110143195|NCT02024152|Cetirizine|cetirizine|mesh-list
110143196|NCT02024152|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110143197|NCT02024152|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110143198|NCT02024152|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110143199|NCT02024152|Histamine Antagonists|histamine antagonists|mesh-ancestor
110143200|NCT02024152|Histamine Agents|histamine agents|mesh-ancestor
110143201|NCT02024152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110143202|NCT02024152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110143203|NCT02024152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110143204|NCT02024217|Oxaliplatin|oxaliplatin|mesh-list
110143205|NCT02024217|Tegafur|tegafur|mesh-list
110143206|NCT02024217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110143207|NCT02024217|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110143208|NCT02024217|Antimetabolites|antimetabolites|mesh-ancestor
110143209|NCT02024217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110143210|NCT02024256|Magnesium Sulfate|magnesium sulfate|mesh-list
110143211|NCT02024256|Analgesics|analgesics|mesh-ancestor
110143212|NCT02024256|Sensory System Agents|sensory system agents|mesh-ancestor
110143213|NCT02024256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110143214|NCT02024256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110143216|NCT02024256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110143217|NCT02024256|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110143218|NCT02024256|Anticonvulsants|anticonvulsants|mesh-ancestor
110143219|NCT02024256|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110143220|NCT02024256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110143221|NCT02024256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110143222|NCT02024256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110143223|NCT02024256|Tocolytic Agents|tocolytic agents|mesh-ancestor
110143224|NCT02024256|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110143225|NCT02024295|Choline|choline|mesh-list
110143226|NCT02024295|Polyene phosphatidylcholine|polyene phosphatidylcholine|mesh-list
110143227|NCT02024295|Lipotropic Agents|lipotropic agents|mesh-ancestor
110143228|NCT02024295|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110143229|NCT02024295|Antimetabolites|antimetabolites|mesh-ancestor
110143230|NCT02024295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110143231|NCT02024295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110167736|NCT00033163|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110143232|NCT02024295|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110143233|NCT02024295|Nootropic Agents|nootropic agents|mesh-ancestor
110143235|NCT02024308|Fludarabine|fludarabine|mesh-list
110143236|NCT02024308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110143237|NCT02024308|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110143238|NCT02024308|Antimetabolites|antimetabolites|mesh-ancestor
110143239|NCT02024308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110143240|NCT02024308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110143241|NCT02024308|Immunologic Factors|immunologic factors|mesh-ancestor
110143242|NCT02024308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110143243|NCT02024308|Antiviral Agents|antiviral agents|mesh-ancestor
110143244|NCT02024308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110143245|NCT02024334|Leflunomide|leflunomide|mesh-list
110143246|NCT02024334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110143247|NCT02024334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110143248|NCT02024334|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110143249|NCT02024334|Immunologic Factors|immunologic factors|mesh-ancestor
110143250|NCT02024334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110143251|NCT02024373|Atorvastatin|atorvastatin|mesh-list
110143252|NCT02024373|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110143253|NCT02024373|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110143254|NCT02024373|Antimetabolites|antimetabolites|mesh-ancestor
110143255|NCT02024373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110143256|NCT02024373|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110143257|NCT02024373|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110143258|NCT02024373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110143259|NCT02024425|Antioxidants|antioxidants|mesh-list
110143260|NCT02024425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110143261|NCT02024425|Protective Agents|protective agents|mesh-ancestor
110143262|NCT02024425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110143263|NCT02024555|Azithromycin|azithromycin|mesh-list
110143264|NCT02024555|Levofloxacin|levofloxacin|mesh-list
110143265|NCT02024555|Rifampin|rifampin|mesh-list
110143266|NCT02024555|Ethambutol|ethambutol|mesh-list
110143267|NCT02024555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110143268|NCT02024555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110143269|NCT02024555|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110143270|NCT02024555|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110143271|NCT02024555|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110143272|NCT02024555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110143273|NCT02024555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110143274|NCT02024555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110143275|NCT02024555|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110143276|NCT02024555|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110143277|NCT02024555|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110143278|NCT02024555|Antitubercular Agents|antitubercular agents|mesh-ancestor
110143279|NCT02024555|Leprostatic Agents|leprostatic agents|mesh-ancestor
110143280|NCT02024555|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110143281|NCT02024555|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110143282|NCT02024555|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110143283|NCT02024555|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110143284|NCT02024555|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110143285|NCT02024555|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110143286|NCT02024555|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110143287|NCT02024568|Pregabalin|pregabalin|mesh-list
110143288|NCT02024568|Analgesics|analgesics|mesh-ancestor
110143289|NCT02024568|Sensory System Agents|sensory system agents|mesh-ancestor
110143290|NCT02024568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110143291|NCT02024568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110143293|NCT02024568|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110143294|NCT02024568|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110143295|NCT02024568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110143296|NCT02024568|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110143297|NCT02024568|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110143298|NCT02024568|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110143299|NCT02024568|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110143300|NCT02024568|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110143301|NCT02024594|Nitrous Oxide|nitrous oxide|mesh-list
110143302|NCT02024594|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110143303|NCT02024594|Anesthetics, General|anesthetics, general|mesh-ancestor
110143304|NCT02024594|Anesthetics|anesthetics|mesh-ancestor
110143305|NCT02024594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110143306|NCT02024594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110143307|NCT02024594|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110143308|NCT02024594|Analgesics|analgesics|mesh-ancestor
110143309|NCT02024594|Sensory System Agents|sensory system agents|mesh-ancestor
110143310|NCT02024594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110143311|NCT02024633|Gemcitabine|gemcitabine|mesh-list
110143312|NCT02024633|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110143313|NCT02024633|Antimetabolites|antimetabolites|mesh-ancestor
110143314|NCT02024633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110143315|NCT02024633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110143316|NCT02024659|Budesonide|budesonide|mesh-list
110143317|NCT02024659|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110143318|NCT02024659|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110143319|NCT02024659|Autonomic Agents|autonomic agents|mesh-ancestor
110143320|NCT02024659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110143321|NCT02024659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110143322|NCT02024659|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110143323|NCT02024659|Respiratory System Agents|respiratory system agents|mesh-ancestor
110143324|NCT02024659|Glucocorticoids|glucocorticoids|mesh-ancestor
110143325|NCT02024659|Hormones|hormones|mesh-ancestor
110143326|NCT02024659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110143327|NCT02024841|Docetaxel|docetaxel|mesh-list
110143328|NCT02024841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110143329|NCT02024841|Tubulin Modulators|tubulin modulators|mesh-ancestor
110143330|NCT02024841|Antimitotic Agents|antimitotic agents|mesh-ancestor
110143331|NCT02024841|Mitosis Modulators|mitosis modulators|mesh-ancestor
110143332|NCT02024841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110143333|NCT02024906|Caseins|caseins|mesh-list
110143334|NCT02024906|Chelating Agents|chelating agents|mesh-ancestor
110143335|NCT02024906|Sequestering Agents|sequestering agents|mesh-ancestor
110143336|NCT02024906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110143337|NCT02024919|Diltiazem|diltiazem|mesh-list
110143338|NCT02024919|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110143339|NCT02024919|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110143340|NCT02024919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110143341|NCT02024919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110143342|NCT02024919|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110143343|NCT02024919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110143344|NCT02024919|Vasodilator Agents|vasodilator agents|mesh-ancestor
110143345|NCT02024945|Propiverine|propiverine|mesh-list
110143346|NCT02024945|Parasympatholytics|parasympatholytics|mesh-ancestor
110143348|NCT02024945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110143349|NCT02024945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110143350|NCT02024945|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110143351|NCT02024945|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110143352|NCT02024945|Cholinergic Agents|cholinergic agents|mesh-ancestor
110143353|NCT02024945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110143354|NCT02024945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110143355|NCT02024945|Urological Agents|urological agents|mesh-ancestor
110143356|NCT02024984|Clomiphene|clomiphene|mesh-list
110143357|NCT02024984|Enclomiphene|enclomiphene|mesh-list
110143358|NCT02024984|Zuclomiphene|zuclomiphene|mesh-list
110143359|NCT02024984|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110143360|NCT02024984|Hormone Antagonists|hormone antagonists|mesh-ancestor
110143361|NCT02024984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110143362|NCT02024984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110143364|NCT02024984|Fertility Agents|fertility agents|mesh-ancestor
110143365|NCT02024984|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110143366|NCT02024984|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110143367|NCT02024984|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110143369|NCT02025023|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110143370|NCT02025023|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110143371|NCT02025023|Fluorouracil|fluorouracil|mesh-list
110143372|NCT02025023|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110143373|NCT02025023|Antimetabolites|antimetabolites|mesh-ancestor
110143374|NCT02025023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110143375|NCT02025023|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110143376|NCT02025023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110143377|NCT02025023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110143378|NCT02025023|Immunologic Factors|immunologic factors|mesh-ancestor
110143379|NCT02025023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110143380|NCT02025023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110143381|NCT02025023|Glucocorticoids|glucocorticoids|mesh-ancestor
110143382|NCT02025023|Hormones|hormones|mesh-ancestor
110143383|NCT02025023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110065746|NCT01534702|Antiviral Agents|antiviral agents|mesh-ancestor
110143384|NCT02025023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110143385|NCT02025140|Anesthetics|anesthetics|mesh-list
110143386|NCT02025140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110143387|NCT02025140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110143388|NCT02025166|Acetaminophen|acetaminophen|mesh-list
110143389|NCT02025166|Lornoxicam|lornoxicam|mesh-list
110143390|NCT02025166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110143391|NCT02025166|Analgesics|analgesics|mesh-ancestor
110143392|NCT02025166|Sensory System Agents|sensory system agents|mesh-ancestor
110065807|NCT01535027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110143393|NCT02025166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110143394|NCT02025166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110143395|NCT02025166|Antipyretics|antipyretics|mesh-ancestor
110143396|NCT02025166|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110143397|NCT02025166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110143398|NCT02025166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110143399|NCT02025192|Capecitabine|capecitabine|mesh-list
110143400|NCT02025192|Trastuzumab|trastuzumab|mesh-list
110143401|NCT02025192|Tucatinib|tucatinib|mesh-list
110143402|NCT02025192|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110143403|NCT02025192|Antimetabolites|antimetabolites|mesh-ancestor
110143404|NCT02025192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110143405|NCT02025192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110143406|NCT02025192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110143407|NCT02025192|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110143408|NCT02025192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110143409|NCT02025218|Gefitinib|gefitinib|mesh-list
110143410|NCT02025218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110143411|NCT02025218|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110143412|NCT02025218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110143413|NCT02025218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110143414|NCT02025348|Metoprolol|metoprolol|mesh-list
110143415|NCT02025348|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110143416|NCT02025348|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110143417|NCT02025348|Sympatholytics|sympatholytics|mesh-ancestor
110143418|NCT02025348|Autonomic Agents|autonomic agents|mesh-ancestor
110143419|NCT02025348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110143420|NCT02025348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110065937|NCT01535859|Cabergoline|cabergoline|mesh-list
110143421|NCT02025348|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110143422|NCT02025348|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110143423|NCT02025348|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110143424|NCT02025348|Adrenergic Agents|adrenergic agents|mesh-ancestor
110143425|NCT02025348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110143426|NCT02025348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110143427|NCT02025361|Lidocaine|lidocaine|mesh-list
110143428|NCT02025361|Anesthetics, Local|anesthetics, local|mesh-ancestor
110143429|NCT02025361|Anesthetics|anesthetics|mesh-ancestor
110143430|NCT02025361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110143431|NCT02025361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110143432|NCT02025361|Sensory System Agents|sensory system agents|mesh-ancestor
110143433|NCT02025361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110143434|NCT02025361|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110143435|NCT02025361|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110143436|NCT02025361|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110143437|NCT02025361|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110143438|NCT02025361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110143439|NCT02025374|Bupivacaine|bupivacaine|mesh-list
110143440|NCT02025374|Levobupivacaine|levobupivacaine|mesh-list
110143441|NCT02025374|Anesthetics, Local|anesthetics, local|mesh-ancestor
110143442|NCT02025374|Anesthetics|anesthetics|mesh-ancestor
110143443|NCT02025374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110143444|NCT02025374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110143445|NCT02025374|Sensory System Agents|sensory system agents|mesh-ancestor
110143446|NCT02025374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110143447|NCT02025465|Metoprolol|metoprolol|mesh-list
110143448|NCT02025465|Diltiazem|diltiazem|mesh-list
110143449|NCT02025465|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110143450|NCT02025465|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110143451|NCT02025465|Sympatholytics|sympatholytics|mesh-ancestor
110143452|NCT02025465|Autonomic Agents|autonomic agents|mesh-ancestor
110143453|NCT02025465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110143454|NCT02025465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110143455|NCT02025465|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110143456|NCT02025465|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110143457|NCT02025465|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110143458|NCT02025465|Adrenergic Agents|adrenergic agents|mesh-ancestor
110143459|NCT02025465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110143460|NCT02025465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110143461|NCT02025465|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110143462|NCT02025465|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110143463|NCT02025465|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110143464|NCT02025465|Vasodilator Agents|vasodilator agents|mesh-ancestor
110143465|NCT02025491|Amphotericin B|amphotericin b|mesh-list
110143466|NCT02025491|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
110143467|NCT02025491|Amebicides|amebicides|mesh-ancestor
110143468|NCT02025491|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110143469|NCT02025491|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110143470|NCT02025491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110143471|NCT02025491|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110143472|NCT02025491|Antifungal Agents|antifungal agents|mesh-ancestor
110143473|NCT02025608|Pramipexole|pramipexole|mesh-list
110143474|NCT02025608|Antioxidants|antioxidants|mesh-ancestor
110143475|NCT02025608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110143476|NCT02025608|Protective Agents|protective agents|mesh-ancestor
110143477|NCT02025608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110143478|NCT02025608|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110143479|NCT02025608|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110143480|NCT02025608|Dopamine Agonists|dopamine agonists|mesh-ancestor
110143481|NCT02025608|Dopamine Agents|dopamine agents|mesh-ancestor
110143482|NCT02025608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110143483|NCT02025712|Everolimus|everolimus|mesh-list
110143484|NCT02025712|Exemestane|exemestane|mesh-list
110143485|NCT02025712|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110143486|NCT02025712|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110143487|NCT02025712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110143488|NCT02025712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110143489|NCT02025712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110143490|NCT02025712|Immunologic Factors|immunologic factors|mesh-ancestor
110143491|NCT02025712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110143492|NCT02025712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110143493|NCT02025712|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110143494|NCT02025712|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110143495|NCT02025712|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110143496|NCT02025712|Hormone Antagonists|hormone antagonists|mesh-ancestor
110143497|NCT02025712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110143498|NCT02025803|Capecitabine|capecitabine|mesh-list
110143499|NCT02025803|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110143500|NCT02025803|Antimetabolites|antimetabolites|mesh-ancestor
110143501|NCT02025803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110143502|NCT02025803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110143503|NCT02025855|Methadone|methadone|mesh-list
110143504|NCT02025855|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110143505|NCT02025855|Narcotics|narcotics|mesh-ancestor
110143506|NCT02025855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110143507|NCT02025855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110143508|NCT02025855|Analgesics|analgesics|mesh-ancestor
110143509|NCT02025855|Sensory System Agents|sensory system agents|mesh-ancestor
110143510|NCT02025855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110143512|NCT02025855|Respiratory System Agents|respiratory system agents|mesh-ancestor
110143513|NCT02025868|Raltegravir Potassium|raltegravir potassium|mesh-list
110143514|NCT02025868|Darunavir|darunavir|mesh-list
110143515|NCT02025868|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
110143516|NCT02025868|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110143517|NCT02025868|Antiviral Agents|antiviral agents|mesh-ancestor
110143518|NCT02025868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110143519|NCT02025868|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110143520|NCT02025868|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110143521|NCT02025868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110143522|NCT02025868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110143523|NCT02025868|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110143524|NCT02025868|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110143525|NCT02025868|Protease Inhibitors|protease inhibitors|mesh-ancestor
110143526|NCT02025881|Cyclophosphamide|cyclophosphamide|mesh-list
110143527|NCT02025881|Thiotepa|thiotepa|mesh-list
110143528|NCT02025881|Carboplatin|carboplatin|mesh-list
110143529|NCT02025881|Etoposide|etoposide|mesh-list
110143530|NCT02025881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110143531|NCT02025881|Immunologic Factors|immunologic factors|mesh-ancestor
110143532|NCT02025881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110143533|NCT02025881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110143534|NCT02025881|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110143535|NCT02025881|Alkylating Agents|alkylating agents|mesh-ancestor
110143536|NCT02025881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110143537|NCT02025881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110143538|NCT02025881|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110143539|NCT02025881|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110143540|NCT02025881|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110143541|NCT02025881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110143542|NCT02025881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110143543|NCT02025998|Ibudilast|ibudilast|mesh-list
110143544|NCT02025998|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110143545|NCT02025998|Autonomic Agents|autonomic agents|mesh-ancestor
110066280|NCT01537861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110143546|NCT02025998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110143547|NCT02025998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110143548|NCT02025998|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110143549|NCT02025998|Respiratory System Agents|respiratory system agents|mesh-ancestor
110143550|NCT02025998|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110143551|NCT02025998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110143552|NCT02025998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110143553|NCT02025998|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110143554|NCT02025998|Vasodilator Agents|vasodilator agents|mesh-ancestor
110143556|NCT02026050|Dexamethasone acetate|dexamethasone acetate|mesh-list
110143557|NCT02026050|BB 1101|bb 1101|mesh-list
110143558|NCT02026050|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110143559|NCT02026050|Antiemetics|antiemetics|mesh-ancestor
110143560|NCT02026050|Autonomic Agents|autonomic agents|mesh-ancestor
110143561|NCT02026050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110143562|NCT02026050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110143563|NCT02026050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110143564|NCT02026050|Glucocorticoids|glucocorticoids|mesh-ancestor
110143565|NCT02026050|Hormones|hormones|mesh-ancestor
110143566|NCT02026050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110143567|NCT02026050|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110143568|NCT02026050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110143569|NCT02026050|Protease Inhibitors|protease inhibitors|mesh-ancestor
110143570|NCT02026050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110143571|NCT02026050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110143572|NCT02026219|Clopidogrel|clopidogrel|mesh-list
110143573|NCT02026219|Ticagrelor|ticagrelor|mesh-list
110143574|NCT02026219|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110143575|NCT02026219|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110143576|NCT02026219|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110143577|NCT02026219|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110143578|NCT02026219|Purinergic Agents|purinergic agents|mesh-ancestor
110143579|NCT02026219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110066376|NCT01538459|Dexamethasone|dexamethasone|mesh-list
110143580|NCT02026219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110143581|NCT02026219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110143582|NCT02026310|Metformin|metformin|mesh-list
110143583|NCT02026310|Glimepiride|glimepiride|mesh-list
110143584|NCT02026310|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110143585|NCT02026310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110143586|NCT02026310|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110143587|NCT02026310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110143588|NCT02026310|Immunologic Factors|immunologic factors|mesh-ancestor
110143589|NCT02026479|Dexamethasone|dexamethasone|mesh-list
110143590|NCT02026479|Dexamethasone acetate|dexamethasone acetate|mesh-list
110143591|NCT02026479|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
110143592|NCT02026479|BB 1101|bb 1101|mesh-list
110143593|NCT02026479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110143594|NCT02026479|Antiemetics|antiemetics|mesh-ancestor
110143595|NCT02026479|Autonomic Agents|autonomic agents|mesh-ancestor
110143596|NCT02026479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110143597|NCT02026479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110143598|NCT02026479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110143599|NCT02026479|Glucocorticoids|glucocorticoids|mesh-ancestor
110143600|NCT02026479|Hormones|hormones|mesh-ancestor
110143601|NCT02026479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110143602|NCT02026479|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110143603|NCT02026479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110143604|NCT02026479|Protease Inhibitors|protease inhibitors|mesh-ancestor
110143605|NCT02026479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110143606|NCT02026479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110143607|NCT02026492|Methacholine Chloride|methacholine chloride|mesh-list
110143608|NCT02026492|Miotics|miotics|mesh-ancestor
110143609|NCT02026492|Autonomic Agents|autonomic agents|mesh-ancestor
110143610|NCT02026492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110143611|NCT02026492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110143612|NCT02026492|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110143613|NCT02026492|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
110143614|NCT02026492|Respiratory System Agents|respiratory system agents|mesh-ancestor
110143615|NCT02026492|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
110143616|NCT02026492|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110143617|NCT02026492|Cholinergic Agents|cholinergic agents|mesh-ancestor
110143618|NCT02026492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110143619|NCT02026492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110143620|NCT02026505|Bortezomib|bortezomib|mesh-list
110143621|NCT02026505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110143622|NCT02026518|Vitamin D|vitamin d|mesh-list
110143623|NCT02026518|Cholecalciferol|cholecalciferol|mesh-list
110143624|NCT02026518|Vitamins|vitamins|mesh-ancestor
110143625|NCT02026518|Micronutrients|micronutrients|mesh-ancestor
110143626|NCT02026518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110143627|NCT02026518|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110143628|NCT02026518|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110143629|NCT02026583|Simvastatin|simvastatin|mesh-list
110143630|NCT02026583|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110143631|NCT02026583|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110143632|NCT02026583|Antimetabolites|antimetabolites|mesh-ancestor
110066491|NCT01538849|Esomeprazole|esomeprazole|mesh-list
110143633|NCT02026583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110143634|NCT02026583|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110143635|NCT02026583|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110143636|NCT02026583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110143637|NCT02026765|Heparin|heparin|mesh-list
110143638|NCT02026765|Anticoagulants|anticoagulants|mesh-ancestor
110143639|NCT02026765|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110143640|NCT02026765|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110143641|NCT02026765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110143642|NCT02026778|Betahistine|betahistine|mesh-list
110143643|NCT02026778|Ondansetron|ondansetron|mesh-list
110143644|NCT02026778|Antiemetics|antiemetics|mesh-ancestor
110143645|NCT02026778|Autonomic Agents|autonomic agents|mesh-ancestor
110066535|NCT01539018|Antimetabolites|antimetabolites|mesh-ancestor
110143646|NCT02026778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110143647|NCT02026778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110143648|NCT02026778|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110143649|NCT02026778|Antipruritics|antipruritics|mesh-ancestor
110143650|NCT02026778|Dermatologic Agents|dermatologic agents|mesh-ancestor
110143651|NCT02026778|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110143652|NCT02026778|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110143653|NCT02026778|Serotonin Agents|serotonin agents|mesh-ancestor
110143654|NCT02026778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110143655|NCT02026778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110143656|NCT02026778|Vasodilator Agents|vasodilator agents|mesh-ancestor
110143657|NCT02026778|Histamine Agonists|histamine agonists|mesh-ancestor
110143658|NCT02026778|Histamine Agents|histamine agents|mesh-ancestor
110143660|NCT02026817|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110143661|NCT02026817|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110143662|NCT02026817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110143663|NCT02026817|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110143664|NCT02026817|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110143665|NCT02026817|Antimetabolites|antimetabolites|mesh-ancestor
110143666|NCT02026817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110143667|NCT02026817|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110143668|NCT02026817|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110143669|NCT02026817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110143670|NCT02026856|Selenious Acid|selenious acid|mesh-list
110143671|NCT02026856|Sodium Selenite|sodium selenite|mesh-list
110143672|NCT02026856|Trace Elements|trace elements|mesh-ancestor
110143673|NCT02026856|Micronutrients|micronutrients|mesh-ancestor
110143674|NCT02026856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110143675|NCT02026869|Metformin|metformin|mesh-list
110143676|NCT02026869|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110143677|NCT02026869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110143678|NCT02026921|Carboplatin|carboplatin|mesh-list
110143679|NCT02026921|Docetaxel|docetaxel|mesh-list
110143680|NCT02026921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110143681|NCT02026921|Tubulin Modulators|tubulin modulators|mesh-ancestor
110143682|NCT02026921|Antimitotic Agents|antimitotic agents|mesh-ancestor
110143683|NCT02026921|Mitosis Modulators|mitosis modulators|mesh-ancestor
110143684|NCT02026921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110143685|NCT02026947|Sodium Benzoate|sodium benzoate|mesh-list
110143686|NCT02026947|Antifungal Agents|antifungal agents|mesh-ancestor
110143687|NCT02026947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110143688|NCT02026973|Fulvestrant|fulvestrant|mesh-list
110143689|NCT02026973|Anastrozole|anastrozole|mesh-list
110143690|NCT02026973|Somatostatin|somatostatin|mesh-list
110143691|NCT02026973|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110143692|NCT02026973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110143693|NCT02026973|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110143694|NCT02026973|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110143695|NCT02026973|Hormone Antagonists|hormone antagonists|mesh-ancestor
110143696|NCT02026973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110143697|NCT02026973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110143698|NCT02026973|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110143699|NCT02026973|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110143700|NCT02026973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110143701|NCT02026973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110143702|NCT02026973|Hormones|hormones|mesh-ancestor
110143703|NCT02027064|Interferons|interferons|mesh-list
110143704|NCT02027064|Interferon-alpha|interferon-alpha|mesh-list
110143705|NCT02027064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110143706|NCT02027064|Antiviral Agents|antiviral agents|mesh-ancestor
110143707|NCT02027064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110143708|NCT02027064|Immunologic Factors|immunologic factors|mesh-ancestor
110143709|NCT02027064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110143710|NCT02027103|Metformin|metformin|mesh-list
110143711|NCT02027103|Pioglitazone|pioglitazone|mesh-list
110143712|NCT02027103|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110143713|NCT02027103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110143715|NCT02027220|Cyclophosphamide|cyclophosphamide|mesh-list
110143717|NCT02027220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110143718|NCT02027220|Immunologic Factors|immunologic factors|mesh-ancestor
110143719|NCT02027220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110143720|NCT02027220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110143721|NCT02027220|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110143722|NCT02027220|Alkylating Agents|alkylating agents|mesh-ancestor
110143723|NCT02027220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110143724|NCT02027220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110143725|NCT02027220|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110143726|NCT02027220|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110143728|NCT02027220|Autonomic Agents|autonomic agents|mesh-ancestor
110143729|NCT02027220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110143730|NCT02027220|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110143731|NCT02027220|Glucocorticoids|glucocorticoids|mesh-ancestor
110143733|NCT02027220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110143734|NCT02027220|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110143735|NCT02027298|Abatacept|abatacept|mesh-list
110143736|NCT02027298|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110143737|NCT02027298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110143738|NCT02027298|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110143739|NCT02027298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110143740|NCT02027298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110143741|NCT02027298|Immunologic Factors|immunologic factors|mesh-ancestor
110143742|NCT02027298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110143743|NCT02027298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110143745|NCT02027324|Povidone-Iodine|povidone-iodine|mesh-list
110143746|NCT02027324|Povidone|povidone|mesh-list
110143747|NCT02027324|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110143748|NCT02027324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110143749|NCT02027324|Disinfectants|disinfectants|mesh-ancestor
110143750|NCT02027324|Plasma Substitutes|plasma substitutes|mesh-ancestor
110143751|NCT02027324|Blood Substitutes|blood substitutes|mesh-ancestor
110143752|NCT02027337|Cyproterone Acetate|cyproterone acetate|mesh-list
110143753|NCT02027337|Drospirenone|drospirenone|mesh-list
110143754|NCT02027337|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110143755|NCT02027337|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
110143756|NCT02027337|Cyproterone|cyproterone|mesh-list
110143757|NCT02027337|Cyproterone acetate, ethinyl estradiol drug combination|cyproterone acetate, ethinyl estradiol drug combination|mesh-list
110143758|NCT02027337|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110143759|NCT02027337|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110143760|NCT02027337|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110143761|NCT02027337|Contraceptive Agents|contraceptive agents|mesh-ancestor
110143762|NCT02027337|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110143763|NCT02027337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110143764|NCT02027337|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110143765|NCT02027337|Estrogens|estrogens|mesh-ancestor
110143766|NCT02027337|Hormones|hormones|mesh-ancestor
110143767|NCT02027337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110143768|NCT02027337|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110143769|NCT02027337|Hormone Antagonists|hormone antagonists|mesh-ancestor
110143770|NCT02027337|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110143771|NCT02027337|Diuretics|diuretics|mesh-ancestor
110143772|NCT02027337|Natriuretic Agents|natriuretic agents|mesh-ancestor
110143773|NCT02027337|Androgen Antagonists|androgen antagonists|mesh-ancestor
110143774|NCT02027337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110143775|NCT02027337|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110143776|NCT02027363|Capecitabine|capecitabine|mesh-list
110143777|NCT02027363|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110143778|NCT02027363|Antimetabolites|antimetabolites|mesh-ancestor
110143779|NCT02027363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110143780|NCT02027363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110143782|NCT02027454|Cabotegravir|cabotegravir|mesh-list
110143783|NCT02027454|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110143784|NCT02027454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110143786|NCT02027454|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110143787|NCT02027454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110143788|NCT02027454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110143789|NCT02027454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110143790|NCT02027454|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110143791|NCT02027454|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110143792|NCT02027454|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110143793|NCT02027454|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110143794|NCT02027454|Antiviral Agents|antiviral agents|mesh-ancestor
110143795|NCT02027493|Interferons|interferons|mesh-list
110143796|NCT02027493|Ribavirin|ribavirin|mesh-list
110143797|NCT02027493|Interferon-alpha|interferon-alpha|mesh-list
110066992|NCT01541436|Capsaicin|capsaicin|mesh-list
110143799|NCT02027493|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110143800|NCT02027493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110143801|NCT02027493|Antiviral Agents|antiviral agents|mesh-ancestor
110143802|NCT02027493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110143803|NCT02027493|Antimetabolites|antimetabolites|mesh-ancestor
110143804|NCT02027493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110143805|NCT02027493|Immunologic Factors|immunologic factors|mesh-ancestor
110143806|NCT02027493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110143807|NCT02027532|Vancomycin|vancomycin|mesh-list
110143808|NCT02027532|Cefazolin|cefazolin|mesh-list
110143809|NCT02027532|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110143810|NCT02027532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110143811|NCT02027675|Micronutrients|micronutrients|mesh-list
110143812|NCT02027675|Trace Elements|trace elements|mesh-list
110143813|NCT02027675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110143814|NCT02027753|Metformin|metformin|mesh-list
110143815|NCT02027753|Insulin Glargine|insulin glargine|mesh-list
110143816|NCT02027753|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
110143817|NCT02027753|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110143818|NCT02027753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110143819|NCT02027753|Protease Inhibitors|protease inhibitors|mesh-ancestor
110143820|NCT02027753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110143821|NCT02027753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110143823|NCT02027792|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110143824|NCT02027792|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110143825|NCT02027792|Analgesics|analgesics|mesh-ancestor
110143826|NCT02027792|Sensory System Agents|sensory system agents|mesh-ancestor
110143827|NCT02027792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110067113|NCT01542138|Desonide|desonide|mesh-list
110143828|NCT02027792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110143829|NCT02027792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110143831|NCT02027792|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110143832|NCT02027792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110143833|NCT02027792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110143834|NCT02027870|Sirolimus|sirolimus|mesh-list
110143835|NCT02027870|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110143836|NCT02027870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110143837|NCT02027870|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110143838|NCT02027870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110143839|NCT02027870|Antifungal Agents|antifungal agents|mesh-ancestor
110143840|NCT02027870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110143841|NCT02027870|Immunologic Factors|immunologic factors|mesh-ancestor
110143842|NCT02027870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110143843|NCT02027922|Sodium fluoride topical preparation|sodium fluoride topical preparation|mesh-list
110143844|NCT02027922|Cariostatic Agents|cariostatic agents|mesh-ancestor
110143845|NCT02027922|Protective Agents|protective agents|mesh-ancestor
110143846|NCT02027922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110143847|NCT02027961|Durvalumab|durvalumab|mesh-list
110143848|NCT02027961|Trametinib|trametinib|mesh-list
110143849|NCT02027961|Dabrafenib|dabrafenib|mesh-list
110143850|NCT02027961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110143851|NCT02027961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110143852|NCT02027961|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110143853|NCT02027961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110143854|NCT02027961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110143855|NCT02027987|Valproic Acid|valproic acid|mesh-list
110143856|NCT02027987|Anticonvulsants|anticonvulsants|mesh-ancestor
110143857|NCT02027987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110067231|NCT01542801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110143858|NCT02027987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110143859|NCT02027987|GABA Agents|gaba agents|mesh-ancestor
110143860|NCT02027987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110143861|NCT02027987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110143862|NCT02027987|Antimanic Agents|antimanic agents|mesh-ancestor
110143863|NCT02027987|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110143864|NCT02027987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110143865|NCT02027987|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110143867|NCT02028026|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
110143868|NCT02028026|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110143869|NCT02028026|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110143870|NCT02028026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110143871|NCT02028026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110143872|NCT02028026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110143873|NCT02028026|Serotonin Agents|serotonin agents|mesh-ancestor
110143874|NCT02028026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110143875|NCT02028026|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110143876|NCT02028026|Antidepressive Agents|antidepressive agents|mesh-ancestor
110143877|NCT02028026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110143878|NCT02028026|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110143879|NCT02028026|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110143881|NCT02028078|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110143882|NCT02028078|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110143883|NCT02028078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110143885|NCT02028234|Pantoprazole|pantoprazole|mesh-list
110143886|NCT02028234|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110143887|NCT02028234|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110143888|NCT02028234|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110143889|NCT02028234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110143890|NCT02028234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110067290|NCT01543321|Adrenergic Agents|adrenergic agents|mesh-ancestor
110143892|NCT02028260|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110143893|NCT02028260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110143894|NCT02028260|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
110143895|NCT02028260|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110143896|NCT02028260|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110143897|NCT02028260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110067358|NCT01543932|Clopidogrel|clopidogrel|mesh-list
110143898|NCT02028299|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110143899|NCT02028312|Loteprednol Etabonate|loteprednol etabonate|mesh-list
110143900|NCT02028312|Lubricant Eye Drops|lubricant eye drops|mesh-list
110143901|NCT02028312|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110143902|NCT02028312|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110143903|NCT02028312|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110143905|NCT02028403|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110143906|NCT02028403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110143907|NCT02028403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110143908|NCT02028403|Immunologic Factors|immunologic factors|mesh-ancestor
110143909|NCT02028403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110143910|NCT02028416|Thymoglobulin|thymoglobulin|mesh-list
110143911|NCT02028416|Immunologic Factors|immunologic factors|mesh-ancestor
110143912|NCT02028416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110143913|NCT02028416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110143914|NCT02028429|Sildenafil Citrate|sildenafil citrate|mesh-list
110143915|NCT02028429|Vasodilator Agents|vasodilator agents|mesh-ancestor
110143916|NCT02028429|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110143917|NCT02028429|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110143918|NCT02028429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110143919|NCT02028429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110143920|NCT02028429|Urological Agents|urological agents|mesh-ancestor
110143922|NCT02028494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110143923|NCT02028494|Antimetabolites|antimetabolites|mesh-ancestor
110143924|NCT02028494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110143925|NCT02028494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110143926|NCT02028507|Capecitabine|capecitabine|mesh-list
110143927|NCT02028507|Fulvestrant|fulvestrant|mesh-list
110143928|NCT02028507|Palbociclib|palbociclib|mesh-list
110143929|NCT02028507|Exemestane|exemestane|mesh-list
110143930|NCT02028507|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110143931|NCT02028507|Antimetabolites|antimetabolites|mesh-ancestor
110260167|NCT00168870|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110143932|NCT02028507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110143933|NCT02028507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110143934|NCT02028507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110143935|NCT02028507|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110143937|NCT02028507|Hormone Antagonists|hormone antagonists|mesh-ancestor
110143938|NCT02028507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110143939|NCT02028507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110143940|NCT02028507|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110143941|NCT02028507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110143942|NCT02028507|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110143943|NCT02028507|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110143944|NCT02028533|Oxytocin|oxytocin|mesh-list
110143945|NCT02028533|Oxytocics|oxytocics|mesh-ancestor
110143946|NCT02028533|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110143947|NCT02028533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110143948|NCT02028598|Sildenafil Citrate|sildenafil citrate|mesh-list
110143949|NCT02028598|Clomipramine|clomipramine|mesh-list
110143950|NCT02028598|Citric Acid|citric acid|mesh-list
110143951|NCT02028598|Sodium Citrate|sodium citrate|mesh-list
110143952|NCT02028598|Anticoagulants|anticoagulants|mesh-ancestor
110143953|NCT02028598|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110143954|NCT02028598|Chelating Agents|chelating agents|mesh-ancestor
110143955|NCT02028598|Sequestering Agents|sequestering agents|mesh-ancestor
110143956|NCT02028598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110067580|NCT01544907|Mitosis Modulators|mitosis modulators|mesh-ancestor
110143957|NCT02028598|Vasodilator Agents|vasodilator agents|mesh-ancestor
110143958|NCT02028598|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110143959|NCT02028598|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110143960|NCT02028598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110143961|NCT02028598|Urological Agents|urological agents|mesh-ancestor
110143962|NCT02028598|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110143963|NCT02028598|Antidepressive Agents|antidepressive agents|mesh-ancestor
110143964|NCT02028598|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110143965|NCT02028598|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110143966|NCT02028598|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110143967|NCT02028598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110143968|NCT02028598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110143970|NCT02028598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110143971|NCT02028663|Esomeprazole|esomeprazole|mesh-list
110143972|NCT02028663|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110143973|NCT02028663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110143974|NCT02028663|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110143975|NCT02028663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110143976|NCT02028663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110143977|NCT02028689|Metformin|metformin|mesh-list
110143978|NCT02028689|Lesinurad|lesinurad|mesh-list
110143979|NCT02028689|Furosemide|furosemide|mesh-list
110143980|NCT02028689|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110143981|NCT02028689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110143982|NCT02028689|Diuretics|diuretics|mesh-ancestor
110143983|NCT02028689|Natriuretic Agents|natriuretic agents|mesh-ancestor
110143984|NCT02028689|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110143985|NCT02028689|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110143986|NCT02028689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110143987|NCT02028689|Gout Suppressants|gout suppressants|mesh-ancestor
110143988|NCT02028689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110143989|NCT02028689|Uricosuric Agents|uricosuric agents|mesh-ancestor
110143990|NCT02028819|Dolutegravir|dolutegravir|mesh-list
110143991|NCT02028819|Ibalizumab|ibalizumab|mesh-list
110143992|NCT02028819|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110143993|NCT02028819|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110143994|NCT02028819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110143995|NCT02028819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110143996|NCT02028819|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110143997|NCT02028819|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110143998|NCT02028819|Antiviral Agents|antiviral agents|mesh-ancestor
110143999|NCT02028819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110144000|NCT02028910|Ondansetron|ondansetron|mesh-list
110144001|NCT02028910|Antiemetics|antiemetics|mesh-ancestor
110144003|NCT02028910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110144004|NCT02028910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110144005|NCT02028910|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110144006|NCT02028910|Antipruritics|antipruritics|mesh-ancestor
110144007|NCT02028910|Dermatologic Agents|dermatologic agents|mesh-ancestor
110144008|NCT02028910|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110144009|NCT02028910|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110144010|NCT02028910|Serotonin Agents|serotonin agents|mesh-ancestor
110144011|NCT02028910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110144012|NCT02028910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110144013|NCT02028923|Morphine|morphine|mesh-list
110144014|NCT02028923|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110144015|NCT02028923|Narcotics|narcotics|mesh-ancestor
110144016|NCT02028923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110144018|NCT02028923|Analgesics|analgesics|mesh-ancestor
110144019|NCT02028923|Sensory System Agents|sensory system agents|mesh-ancestor
110144020|NCT02028923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110144021|NCT02028949|Idarubicin|idarubicin|mesh-list
110144022|NCT02028949|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110144023|NCT02028949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110144024|NCT02028949|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110144025|NCT02028949|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110144026|NCT02028949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110144027|NCT02028949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110144028|NCT02029105|Hyaluronic Acid|hyaluronic acid|mesh-list
110144029|NCT02029105|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110144030|NCT02029105|Immunologic Factors|immunologic factors|mesh-ancestor
110144031|NCT02029105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110144032|NCT02029105|Viscosupplements|viscosupplements|mesh-ancestor
110144033|NCT02029105|Protective Agents|protective agents|mesh-ancestor
110144034|NCT02029118|Aspirin|aspirin|mesh-list
110144035|NCT02029118|Metoprolol|metoprolol|mesh-list
110144036|NCT02029118|Ramipril|ramipril|mesh-list
110144037|NCT02029118|Atorvastatin|atorvastatin|mesh-list
110144038|NCT02029118|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110144039|NCT02029118|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110144040|NCT02029118|Analgesics|analgesics|mesh-ancestor
110144041|NCT02029118|Sensory System Agents|sensory system agents|mesh-ancestor
110144042|NCT02029118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110144043|NCT02029118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110144044|NCT02029118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110144045|NCT02029118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110144046|NCT02029118|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110144047|NCT02029118|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110144048|NCT02029118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110144049|NCT02029118|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110144050|NCT02029118|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110144051|NCT02029118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110144052|NCT02029118|Antipyretics|antipyretics|mesh-ancestor
110144053|NCT02029118|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110144054|NCT02029118|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110144055|NCT02029118|Antimetabolites|antimetabolites|mesh-ancestor
110144056|NCT02029118|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110144057|NCT02029118|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110144058|NCT02029118|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110144059|NCT02029118|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110144060|NCT02029118|Sympatholytics|sympatholytics|mesh-ancestor
110144061|NCT02029118|Autonomic Agents|autonomic agents|mesh-ancestor
110144062|NCT02029118|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110144064|NCT02029118|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110144065|NCT02029118|Adrenergic Agents|adrenergic agents|mesh-ancestor
110144066|NCT02029118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110144067|NCT02029118|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110144068|NCT02029118|Protease Inhibitors|protease inhibitors|mesh-ancestor
110144069|NCT02029313|Montelukast|montelukast|mesh-list
110144070|NCT02029313|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110144071|NCT02029313|Respiratory System Agents|respiratory system agents|mesh-ancestor
110144072|NCT02029313|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110144073|NCT02029313|Hormone Antagonists|hormone antagonists|mesh-ancestor
110068138|NCT01548859|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110144074|NCT02029313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110144075|NCT02029313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110144076|NCT02029313|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110144077|NCT02029313|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110144078|NCT02029313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110068199|NCT01549236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110144080|NCT02029378|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
110144081|NCT02029378|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110144082|NCT02029378|Immunologic Factors|immunologic factors|mesh-ancestor
110144083|NCT02029378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110144084|NCT02029456|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
110144085|NCT02029456|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110144086|NCT02029456|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110144087|NCT02029456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110144088|NCT02029482|Ponesimod|ponesimod|mesh-list
110144089|NCT02029482|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
110144090|NCT02029482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110144091|NCT02029482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110144092|NCT02029482|Immunologic Factors|immunologic factors|mesh-ancestor
110144093|NCT02029482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110144094|NCT02029534|Atorvastatin|atorvastatin|mesh-list
110144095|NCT02029534|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110144096|NCT02029534|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110144097|NCT02029534|Antimetabolites|antimetabolites|mesh-ancestor
110144098|NCT02029534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110144099|NCT02029534|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110144100|NCT02029534|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110144101|NCT02029534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110144102|NCT02029573|Temozolomide|temozolomide|mesh-list
110144103|NCT02029573|Atorvastatin|atorvastatin|mesh-list
110144104|NCT02029573|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110144105|NCT02029573|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110144106|NCT02029573|Antimetabolites|antimetabolites|mesh-ancestor
110144107|NCT02029573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110144108|NCT02029573|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110144109|NCT02029573|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110144110|NCT02029573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110144111|NCT02029573|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110144112|NCT02029573|Alkylating Agents|alkylating agents|mesh-ancestor
110144113|NCT02029573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110144114|NCT02029586|Beta-lapachone|beta-lapachone|mesh-list
110068326|NCT01550055|Irinotecan|irinotecan|mesh-list
110144115|NCT02029586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110144116|NCT02029586|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110144117|NCT02029586|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110144118|NCT02029586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110144119|NCT02029586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110144120|NCT02029586|Antiviral Agents|antiviral agents|mesh-ancestor
110144121|NCT02029599|Acetaminophen|acetaminophen|mesh-list
110144122|NCT02029599|Methotrexate|methotrexate|mesh-list
110144123|NCT02029599|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110144124|NCT02029599|Abortifacient Agents|abortifacient agents|mesh-ancestor
110144125|NCT02029599|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110144126|NCT02029599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110144127|NCT02029599|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110144128|NCT02029599|Antimetabolites|antimetabolites|mesh-ancestor
110144129|NCT02029599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110144130|NCT02029599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110144131|NCT02029599|Dermatologic Agents|dermatologic agents|mesh-ancestor
110144132|NCT02029599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110144133|NCT02029599|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110144134|NCT02029599|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110144135|NCT02029599|Immunologic Factors|immunologic factors|mesh-ancestor
110144136|NCT02029599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110144137|NCT02029599|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110144138|NCT02029599|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110144139|NCT02029599|Analgesics|analgesics|mesh-ancestor
110068456|NCT01551147|Montelukast|montelukast|mesh-list
110144140|NCT02029599|Sensory System Agents|sensory system agents|mesh-ancestor
110144141|NCT02029599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110144142|NCT02029599|Antipyretics|antipyretics|mesh-ancestor
110144143|NCT02029612|Nicotine|nicotine|mesh-list
110144144|NCT02029612|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110144145|NCT02029612|Autonomic Agents|autonomic agents|mesh-ancestor
110144146|NCT02029612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110144147|NCT02029612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110144148|NCT02029612|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110144149|NCT02029612|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110144150|NCT02029612|Cholinergic Agents|cholinergic agents|mesh-ancestor
110144151|NCT02029612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110144152|NCT02029612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110144153|NCT02029625|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110144154|NCT02029625|Ezetimibe|ezetimibe|mesh-list
110144155|NCT02029625|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110144156|NCT02029625|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110144157|NCT02029625|Antimetabolites|antimetabolites|mesh-ancestor
110144158|NCT02029625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110144159|NCT02029625|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110068506|NCT01551394|Cefoxitin|cefoxitin|mesh-list
110144160|NCT02029625|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110144161|NCT02029625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110144162|NCT02029794|Acetic Acid|acetic acid|mesh-list
110144163|NCT02029794|Retinol acetate|retinol acetate|mesh-list
110144164|NCT02029794|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110144165|NCT02029794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110144166|NCT02029794|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110144167|NCT02029794|Immunologic Factors|immunologic factors|mesh-ancestor
110144168|NCT02029794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110144169|NCT02029794|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110144170|NCT02029794|Protective Agents|protective agents|mesh-ancestor
110144171|NCT02029794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110144172|NCT02029898|Remifentanil|remifentanil|mesh-list
110144173|NCT02029898|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110144174|NCT02029898|Narcotics|narcotics|mesh-ancestor
110144175|NCT02029898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110144176|NCT02029898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110144177|NCT02029898|Analgesics|analgesics|mesh-ancestor
110144178|NCT02029898|Sensory System Agents|sensory system agents|mesh-ancestor
110144179|NCT02029898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110144180|NCT02029924|Insulin Lispro|insulin lispro|mesh-list
110144181|NCT02029924|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110144182|NCT02029924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110144183|NCT02029937|Proflavine|proflavine|mesh-list
110144184|NCT02029937|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110144185|NCT02029937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110144186|NCT02029950|Cytarabine|cytarabine|mesh-list
110144187|NCT02029950|Etoposide|etoposide|mesh-list
110144189|NCT02029950|Daunorubicin|daunorubicin|mesh-list
110144190|NCT02029950|Idarubicin|idarubicin|mesh-list
110144191|NCT02029950|Etoposide phosphate|etoposide phosphate|mesh-list
110144192|NCT02029950|Pomalidomide|pomalidomide|mesh-list
110068620|NCT01552005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110144193|NCT02029950|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110144194|NCT02029950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110144195|NCT02029950|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110144196|NCT02029950|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110144198|NCT02029950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110144199|NCT02029950|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110144200|NCT02029950|Antimetabolites|antimetabolites|mesh-ancestor
110144201|NCT02029950|Antiviral Agents|antiviral agents|mesh-ancestor
110144202|NCT02029950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110144203|NCT02029950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110144204|NCT02029950|Immunologic Factors|immunologic factors|mesh-ancestor
110144205|NCT02029950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110068682|NCT01552629|Cyclosporine|cyclosporine|mesh-list
110144206|NCT02029950|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110144207|NCT02029950|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110144208|NCT02029950|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110144210|NCT02029950|Growth Inhibitors|growth inhibitors|mesh-ancestor
110144211|NCT02029950|Keratolytic Agents|keratolytic agents|mesh-ancestor
110144212|NCT02029950|Dermatologic Agents|dermatologic agents|mesh-ancestor
110144213|NCT02029950|Tubulin Modulators|tubulin modulators|mesh-ancestor
110144214|NCT02029950|Antimitotic Agents|antimitotic agents|mesh-ancestor
110144215|NCT02029950|Mitosis Modulators|mitosis modulators|mesh-ancestor
110144216|NCT02030561|Trastuzumab|trastuzumab|mesh-list
110068744|NCT01552993|Acetaminophen|acetaminophen|mesh-list
110144217|NCT02030561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110144218|NCT02030561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110144219|NCT02031367|Triamcinolone|triamcinolone|mesh-list
110144220|NCT02031367|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110144221|NCT02031367|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110144222|NCT02031367|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110144223|NCT02031367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110144224|NCT02031367|Glucocorticoids|glucocorticoids|mesh-ancestor
110144225|NCT02031367|Hormones|hormones|mesh-ancestor
110144226|NCT02031367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110144227|NCT02031367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110144228|NCT02031367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110144229|NCT02031367|Immunologic Factors|immunologic factors|mesh-ancestor
110144230|NCT02031367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110260168|NCT00168870|Alkylating Agents|alkylating agents|mesh-ancestor
110144231|NCT02031367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110144232|NCT02031692|Cholecalciferol|cholecalciferol|mesh-list
110144233|NCT02031692|Vitamin D|vitamin d|mesh-list
110144234|NCT02031692|Calcium Carbonate|calcium carbonate|mesh-list
110144235|NCT02031692|Calcium|calcium|mesh-list
110068808|NCT01553786|Lenalidomide|lenalidomide|mesh-list
110144236|NCT02031692|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110144237|NCT02031692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110144238|NCT02031692|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110144239|NCT02031692|Vitamins|vitamins|mesh-ancestor
110144240|NCT02031692|Micronutrients|micronutrients|mesh-ancestor
110144241|NCT02031692|Antacids|antacids|mesh-ancestor
110144242|NCT02031692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110144243|NCT02031692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110144244|NCT02031991|Bevacizumab|bevacizumab|mesh-list
110144245|NCT02031991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110144246|NCT02031991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110144247|NCT02031991|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110144248|NCT02031991|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110144249|NCT02031991|Growth Substances|growth substances|mesh-ancestor
110144250|NCT02031991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110144251|NCT02031991|Growth Inhibitors|growth inhibitors|mesh-ancestor
110144252|NCT02032043|Ivermectin|ivermectin|mesh-list
110144253|NCT02032043|Albendazole|albendazole|mesh-list
110144254|NCT02032043|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110144255|NCT02032043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110144256|NCT02032043|Anthelmintics|anthelmintics|mesh-ancestor
110144257|NCT02032043|Anticestodal Agents|anticestodal agents|mesh-ancestor
110144258|NCT02032043|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110144259|NCT02032043|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110144260|NCT02032043|Tubulin Modulators|tubulin modulators|mesh-ancestor
110144261|NCT02032043|Antimitotic Agents|antimitotic agents|mesh-ancestor
110144262|NCT02032043|Mitosis Modulators|mitosis modulators|mesh-ancestor
110144263|NCT02032043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110144264|NCT02032043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110144265|NCT02032134|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
110144266|NCT02032134|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
110144267|NCT02032134|Protective Agents|protective agents|mesh-ancestor
110144268|NCT02032134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110144269|NCT02032134|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110144270|NCT02032134|Antioxidants|antioxidants|mesh-ancestor
110144271|NCT02032134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110144272|NCT02032186|Magnesium citrate|magnesium citrate|mesh-list
110144273|NCT02032186|Cathartics|cathartics|mesh-ancestor
110144274|NCT02032186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110144276|NCT02033356|Anesthetics, Local|anesthetics, local|mesh-ancestor
110144277|NCT02033356|Anesthetics|anesthetics|mesh-ancestor
110144278|NCT02033356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110144279|NCT02033356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110144280|NCT02033356|Sensory System Agents|sensory system agents|mesh-ancestor
110144281|NCT02033356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110144282|NCT02033356|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110144283|NCT02033356|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110144284|NCT02033356|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110144285|NCT02033356|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110144286|NCT02033356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110144288|NCT02033733|Atracurium|atracurium|mesh-list
110144289|NCT02033733|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
110144290|NCT02033733|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110144291|NCT02033733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110144292|NCT02033733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110144293|NCT02033733|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110144294|NCT02033733|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
110144295|NCT02033733|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110144296|NCT02033733|Cholinergic Agents|cholinergic agents|mesh-ancestor
110144297|NCT02033733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110068974|NCT01555060|Ferrous gluconate|ferrous gluconate|mesh-list
110144298|NCT02033733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110144299|NCT02034253|Risperidone|risperidone|mesh-list
110144300|NCT02034253|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110144301|NCT02034253|Serotonin Agents|serotonin agents|mesh-ancestor
110144302|NCT02034253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110144303|NCT02034253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110144304|NCT02034253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110144305|NCT02034253|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110144306|NCT02034253|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110144307|NCT02034253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110144308|NCT02034253|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110144309|NCT02034253|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110144310|NCT02034253|Dopamine Agents|dopamine agents|mesh-ancestor
110144311|NCT02035020|Interferons|interferons|mesh-list
110144313|NCT02035020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110144314|NCT02035020|Antiviral Agents|antiviral agents|mesh-ancestor
110144315|NCT02035020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110144316|NCT02035709|Hydromorphone|hydromorphone|mesh-list
110144317|NCT02035709|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110144318|NCT02035709|Narcotics|narcotics|mesh-ancestor
110144319|NCT02035709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110144320|NCT02035709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110144321|NCT02035709|Analgesics|analgesics|mesh-ancestor
110144322|NCT02035709|Sensory System Agents|sensory system agents|mesh-ancestor
110144324|NCT02035891|Colchicine|colchicine|mesh-list
110144325|NCT02035891|Gout Suppressants|gout suppressants|mesh-ancestor
110144326|NCT02035891|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110144327|NCT02035891|Tubulin Modulators|tubulin modulators|mesh-ancestor
110144328|NCT02035891|Antimitotic Agents|antimitotic agents|mesh-ancestor
110144329|NCT02035891|Mitosis Modulators|mitosis modulators|mesh-ancestor
110144330|NCT02035891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110144331|NCT02035891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110144332|NCT02035956|Vaccines|vaccines|mesh-list
110069090|NCT01555970|Acetylcysteine|acetylcysteine|mesh-list
110144333|NCT02035956|Immunologic Factors|immunologic factors|mesh-ancestor
110144334|NCT02035956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110144335|NCT02036151|Fluorides|fluorides|mesh-list
110144336|NCT02036151|Fluorides, Topical|fluorides, topical|mesh-list
110144337|NCT02036151|Cariostatic Agents|cariostatic agents|mesh-ancestor
110144338|NCT02036151|Protective Agents|protective agents|mesh-ancestor
110144339|NCT02036151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110144341|NCT02036255|Heparin|heparin|mesh-list
110144342|NCT02036255|Anticoagulants|anticoagulants|mesh-ancestor
110144343|NCT02036255|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110144344|NCT02036255|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110144345|NCT02036255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110144346|NCT02036255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110144347|NCT02036255|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110144348|NCT02036255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110144349|NCT02038062|Sevoflurane|sevoflurane|mesh-list
110144350|NCT02038062|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110144351|NCT02038062|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110144352|NCT02038062|Anesthetics, General|anesthetics, general|mesh-ancestor
110144353|NCT02038062|Anesthetics|anesthetics|mesh-ancestor
110144354|NCT02038062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110144355|NCT02038062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110144356|NCT02039453|Fentanyl|fentanyl|mesh-list
110144357|NCT02039453|Meperidine|meperidine|mesh-list
110144358|NCT02039453|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110144359|NCT02039453|Narcotics|narcotics|mesh-ancestor
110144360|NCT02039453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110144361|NCT02039453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110144362|NCT02039453|Analgesics|analgesics|mesh-ancestor
110144363|NCT02039453|Sensory System Agents|sensory system agents|mesh-ancestor
110144364|NCT02039453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110144365|NCT02039453|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110144366|NCT02039453|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110144367|NCT02039453|Anesthetics, General|anesthetics, general|mesh-ancestor
110144368|NCT02039453|Anesthetics|anesthetics|mesh-ancestor
110144369|NCT02039492|Spironolactone|spironolactone|mesh-list
110144370|NCT02039492|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110144371|NCT02039492|Hormone Antagonists|hormone antagonists|mesh-ancestor
110144372|NCT02039492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110144373|NCT02039492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110144374|NCT02039492|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110144375|NCT02039492|Diuretics|diuretics|mesh-ancestor
110144376|NCT02039492|Natriuretic Agents|natriuretic agents|mesh-ancestor
110144377|NCT02039869|Omeprazole|omeprazole|mesh-list
110144378|NCT02039869|Sucralfate|sucralfate|mesh-list
110144379|NCT02039869|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
110144380|NCT02039869|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110144381|NCT02039869|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110144382|NCT02039869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110144383|NCT02039869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110144384|NCT02040064|Gefitinib|gefitinib|mesh-list
110144385|NCT02040064|Tremelimumab|tremelimumab|mesh-list
110144386|NCT02040064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110144387|NCT02040064|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110144388|NCT02040064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110144389|NCT02040064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110144390|NCT02040142|Mitomycins|mitomycins|mesh-list
110144391|NCT02040142|Mitomycin|mitomycin|mesh-list
110144392|NCT02040142|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110144393|NCT02040142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110144394|NCT02040142|Alkylating Agents|alkylating agents|mesh-ancestor
110069224|NCT05847088|Hormones|hormones|mesh-ancestor
110144395|NCT02040142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110144396|NCT02040142|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110144398|NCT02040220|Aflibercept|aflibercept|mesh-list
110144399|NCT02040220|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110144400|NCT02040220|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110144401|NCT02040220|Growth Substances|growth substances|mesh-ancestor
110144402|NCT02040220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110144403|NCT02040220|Growth Inhibitors|growth inhibitors|mesh-ancestor
110144404|NCT02040220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110144405|NCT02040246|Metformin|metformin|mesh-list
110144406|NCT02040246|Repaglinide|repaglinide|mesh-list
110144407|NCT02040246|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110144408|NCT02040246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110144410|NCT02040285|Bisacodyl|bisacodyl|mesh-list
110144411|NCT02040285|Antiemetics|antiemetics|mesh-ancestor
110144412|NCT02040285|Autonomic Agents|autonomic agents|mesh-ancestor
110144413|NCT02040285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110144414|NCT02040285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110144415|NCT02040285|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110144416|NCT02040285|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110144417|NCT02040285|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110144418|NCT02040285|Dopamine Agents|dopamine agents|mesh-ancestor
110144419|NCT02040285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110144420|NCT02040285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110144421|NCT02040285|Cathartics|cathartics|mesh-ancestor
110144422|NCT02040285|Laxatives|laxatives|mesh-ancestor
110144423|NCT02040311|Topiramate|topiramate|mesh-list
110144424|NCT02040311|Anticonvulsants|anticonvulsants|mesh-ancestor
110069298|NCT05840536|Chlorothiazide|chlorothiazide|mesh-list
110144425|NCT02040311|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110144426|NCT02040311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110144427|NCT02040350|Pralidoxime|pralidoxime|mesh-list
110144428|NCT02040350|Antidotes|antidotes|mesh-ancestor
110144429|NCT02040350|Protective Agents|protective agents|mesh-ancestor
110144430|NCT02040350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110144431|NCT02040350|Cholinesterase Reactivators|cholinesterase reactivators|mesh-ancestor
110144432|NCT02040350|Enzyme Reactivators|enzyme reactivators|mesh-ancestor
110144433|NCT02040350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110144434|NCT02040350|Cholinergic Agents|cholinergic agents|mesh-ancestor
110144435|NCT02040350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110144436|NCT02040402|Vaccines|vaccines|mesh-list
110144437|NCT02040402|Immunologic Factors|immunologic factors|mesh-ancestor
110144438|NCT02040402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110144439|NCT02040415|Eperisone|eperisone|mesh-list
110144440|NCT02040415|Anticonvulsants|anticonvulsants|mesh-ancestor
110144441|NCT02040415|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110144442|NCT02040415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110144443|NCT02040415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110144444|NCT02040415|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110144445|NCT02040415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110069413|NCT05839548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110144446|NCT02040415|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110144447|NCT02040415|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110144448|NCT02040415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110144449|NCT02040415|Parasympatholytics|parasympatholytics|mesh-ancestor
110144450|NCT02040415|Autonomic Agents|autonomic agents|mesh-ancestor
110144451|NCT02040415|Vasodilator Agents|vasodilator agents|mesh-ancestor
110144452|NCT02040441|Spironolactone|spironolactone|mesh-list
110144453|NCT02040441|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110144454|NCT02040441|Hormone Antagonists|hormone antagonists|mesh-ancestor
110144455|NCT02040441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110144456|NCT02040441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110144457|NCT02040441|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110144459|NCT02040441|Natriuretic Agents|natriuretic agents|mesh-ancestor
110260169|NCT02944201|Carvedilol|carvedilol|mesh-list
110144461|NCT02040454|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110144462|NCT02040454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110144463|NCT02040454|Tubulin Modulators|tubulin modulators|mesh-ancestor
110144464|NCT02040454|Antimitotic Agents|antimitotic agents|mesh-ancestor
110144465|NCT02040454|Mitosis Modulators|mitosis modulators|mesh-ancestor
110144466|NCT02040454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110144467|NCT02040571|Insulin|insulin|mesh-list
110144468|NCT02040571|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110069483|NCT05838846|Milrinone|milrinone|mesh-list
110144469|NCT02040571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110144470|NCT02040597|Beclomethasone|beclomethasone|mesh-list
110144471|NCT02040597|Glycopyrrolate|glycopyrrolate|mesh-list
110144472|NCT02040597|Formoterol Fumarate|formoterol fumarate|mesh-list
110144473|NCT02040597|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110144474|NCT02040597|Autonomic Agents|autonomic agents|mesh-ancestor
110144475|NCT02040597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110144476|NCT02040597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110144477|NCT02040597|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110144478|NCT02040597|Respiratory System Agents|respiratory system agents|mesh-ancestor
110144479|NCT02040597|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110144480|NCT02040597|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110144481|NCT02040597|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110144482|NCT02040597|Adrenergic Agents|adrenergic agents|mesh-ancestor
110144483|NCT02040597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110144484|NCT02040597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110144485|NCT02040597|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110144486|NCT02040597|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110144487|NCT02040597|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110144488|NCT02040597|Cholinergic Agents|cholinergic agents|mesh-ancestor
110144489|NCT02040597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110144490|NCT02040597|Glucocorticoids|glucocorticoids|mesh-ancestor
110144492|NCT02040597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110144493|NCT02040636|Vaccines|vaccines|mesh-list
110144494|NCT02040636|Immunologic Factors|immunologic factors|mesh-ancestor
110144495|NCT02040636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110144496|NCT02040649|Midazolam|midazolam|mesh-list
110144497|NCT02040649|Propofol|propofol|mesh-list
110144498|NCT02040649|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110144499|NCT02040649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110144500|NCT02040649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110144501|NCT02040649|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110144502|NCT02040649|Anesthetics, General|anesthetics, general|mesh-ancestor
110144503|NCT02040649|Anesthetics|anesthetics|mesh-ancestor
110144504|NCT02040649|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110144505|NCT02040649|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110144506|NCT02040649|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110144507|NCT02040649|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110144508|NCT02040649|GABA Modulators|gaba modulators|mesh-ancestor
110144509|NCT02040649|GABA Agents|gaba agents|mesh-ancestor
110144510|NCT02040649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110144511|NCT02040649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110144513|NCT02040662|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110144514|NCT02040662|Narcotics|narcotics|mesh-ancestor
110144515|NCT02040662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110144516|NCT02040662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110144517|NCT02040662|Analgesics|analgesics|mesh-ancestor
110144518|NCT02040662|Sensory System Agents|sensory system agents|mesh-ancestor
110144519|NCT02040662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110144520|NCT02040818|Acetylcysteine|acetylcysteine|mesh-list
110144521|NCT02040818|Tigecycline|tigecycline|mesh-list
110144522|NCT02040818|Heparin|heparin|mesh-list
110144523|NCT02040818|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110144524|NCT02040818|Anticoagulants|anticoagulants|mesh-ancestor
110144525|NCT02040818|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110144526|NCT02040818|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110144527|NCT02040818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110167881|NCT00033436|Vitamins|vitamins|mesh-ancestor
110144528|NCT02040818|Antiviral Agents|antiviral agents|mesh-ancestor
110144529|NCT02040818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110144530|NCT02040818|Expectorants|expectorants|mesh-ancestor
110144531|NCT02040818|Respiratory System Agents|respiratory system agents|mesh-ancestor
110144532|NCT02040818|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110144533|NCT02040818|Antioxidants|antioxidants|mesh-ancestor
110144534|NCT02040818|Protective Agents|protective agents|mesh-ancestor
110144535|NCT02040818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110144536|NCT02040818|Antidotes|antidotes|mesh-ancestor
110144537|NCT02040818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110144538|NCT02040818|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110144539|NCT02040818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110144540|NCT02040831|Vaccines|vaccines|mesh-list
110144541|NCT02040831|Immunologic Factors|immunologic factors|mesh-ancestor
110144542|NCT02040831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110144543|NCT02040883|Olanzapine|olanzapine|mesh-list
110144544|NCT02040883|Risperidone|risperidone|mesh-list
110144545|NCT02040883|Aripiprazole|aripiprazole|mesh-list
110144546|NCT02040883|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110144547|NCT02040883|Ziprasidone|ziprasidone|mesh-list
110144548|NCT02040883|Tandospirone|tandospirone|mesh-list
110144549|NCT02040883|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110144550|NCT02040883|Serotonin Agents|serotonin agents|mesh-ancestor
110144551|NCT02040883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110144552|NCT02040883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110144553|NCT02040883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110069735|NCT05049278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110144554|NCT02040883|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110144555|NCT02040883|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110144556|NCT02040883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110144557|NCT02040883|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110144558|NCT02040883|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110144559|NCT02040883|Dopamine Agents|dopamine agents|mesh-ancestor
110144560|NCT02040883|Antiemetics|antiemetics|mesh-ancestor
110144561|NCT02040883|Autonomic Agents|autonomic agents|mesh-ancestor
110144562|NCT02040883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110144563|NCT02040883|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110144564|NCT02040883|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110144565|NCT02040883|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110144566|NCT02040883|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110144567|NCT02040883|Antidepressive Agents|antidepressive agents|mesh-ancestor
110144569|NCT02040883|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110144570|NCT02040883|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110144571|NCT02040883|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110144572|NCT02040883|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110144573|NCT02040883|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110144574|NCT02040909|Propofol|propofol|mesh-list
110144575|NCT02040909|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110144576|NCT02040909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110144577|NCT02040909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110144578|NCT02040909|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110144579|NCT02040909|Anesthetics, General|anesthetics, general|mesh-ancestor
110144580|NCT02040909|Anesthetics|anesthetics|mesh-ancestor
110144581|NCT02040935|Trastuzumab|trastuzumab|mesh-list
110144582|NCT02040935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110144583|NCT02040935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110144584|NCT02040987|Moxifloxacin|moxifloxacin|mesh-list
110144585|NCT02040987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110144586|NCT02040987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110144587|NCT02040987|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110144588|NCT02040987|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110144589|NCT02040987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110167885|NCT00033436|Antimetabolites|antimetabolites|mesh-ancestor
110144590|NCT02040987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110144591|NCT02040987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110144592|NCT02041117|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110144593|NCT02041117|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110144594|NCT02041117|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110144595|NCT02041117|Antimetabolites|antimetabolites|mesh-ancestor
110144596|NCT02041117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110144597|NCT02041117|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110144598|NCT02041117|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110144599|NCT02041117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110144601|NCT02041143|Chelating Agents|chelating agents|mesh-ancestor
110144602|NCT02041143|Sequestering Agents|sequestering agents|mesh-ancestor
110144603|NCT02041143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110144604|NCT02041273|Palbociclib|palbociclib|mesh-list
110144605|NCT02041273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110144606|NCT02041273|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110144607|NCT02041273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110144608|NCT02041273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110144609|NCT02041338|Paclitaxel|paclitaxel|mesh-list
110144610|NCT02041338|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110144611|NCT02041338|Carboplatin|carboplatin|mesh-list
110144612|NCT02041338|Epirubicin|epirubicin|mesh-list
110144613|NCT02041338|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110144614|NCT02041338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110144615|NCT02041338|Tubulin Modulators|tubulin modulators|mesh-ancestor
110144616|NCT02041338|Antimitotic Agents|antimitotic agents|mesh-ancestor
110144617|NCT02041338|Mitosis Modulators|mitosis modulators|mesh-ancestor
110144618|NCT02041338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110144619|NCT02041338|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110144620|NCT02041338|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110144621|NCT02041338|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110144622|NCT02041338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110144623|NCT02041351|Docetaxel|docetaxel|mesh-list
110144624|NCT02041351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110144625|NCT02041351|Tubulin Modulators|tubulin modulators|mesh-ancestor
110144626|NCT02041351|Antimitotic Agents|antimitotic agents|mesh-ancestor
110069839|NCT04835129|Hormones|hormones|mesh-ancestor
110144627|NCT02041351|Mitosis Modulators|mitosis modulators|mesh-ancestor
110144628|NCT02041351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110144629|NCT02041455|Amitriptyline|amitriptyline|mesh-list
110144630|NCT02041455|Melatonin|melatonin|mesh-list
110144631|NCT02041455|Antioxidants|antioxidants|mesh-ancestor
110144632|NCT02041455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110144633|NCT02041455|Protective Agents|protective agents|mesh-ancestor
110144634|NCT02041455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110144635|NCT02041455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110144636|NCT02041455|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110144637|NCT02041455|Antidepressive Agents|antidepressive agents|mesh-ancestor
110144638|NCT02041455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110144639|NCT02041455|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110144640|NCT02041455|Analgesics|analgesics|mesh-ancestor
110144641|NCT02041455|Sensory System Agents|sensory system agents|mesh-ancestor
110144642|NCT02041455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110144643|NCT02041455|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110144644|NCT02041455|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110144645|NCT02041455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110144646|NCT02041455|Adrenergic Agents|adrenergic agents|mesh-ancestor
110144647|NCT02041455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110144648|NCT02041481|Leucovorin|leucovorin|mesh-list
110144649|NCT02041481|Fluorouracil|fluorouracil|mesh-list
110144650|NCT02041481|Oxaliplatin|oxaliplatin|mesh-list
110144651|NCT02041481|Calcium|calcium|mesh-list
110144652|NCT02041481|Levoleucovorin|levoleucovorin|mesh-list
110144653|NCT02041481|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110144654|NCT02041481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110144655|NCT02041481|Antimetabolites|antimetabolites|mesh-ancestor
110144656|NCT02041481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110144657|NCT02041481|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110144658|NCT02041481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110144659|NCT02041481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110167901|NCT00033553|Gemcitabine|gemcitabine|mesh-list
110144660|NCT02041481|Immunologic Factors|immunologic factors|mesh-ancestor
110144661|NCT02041481|Antidotes|antidotes|mesh-ancestor
110144662|NCT02041481|Protective Agents|protective agents|mesh-ancestor
110144663|NCT02041481|Vitamin B Complex|vitamin b complex|mesh-ancestor
110144664|NCT02041481|Vitamins|vitamins|mesh-ancestor
110144665|NCT02041481|Micronutrients|micronutrients|mesh-ancestor
110144666|NCT02041546|Pulmonary Surfactants|pulmonary surfactants|mesh-list
110144667|NCT02041546|Poractant alfa|poractant alfa|mesh-list
110069923|NCT04591431|Antimitotic Agents|antimitotic agents|mesh-ancestor
110144668|NCT02041546|Respiratory System Agents|respiratory system agents|mesh-ancestor
110144670|NCT02041650|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110144671|NCT02041650|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110144672|NCT02041650|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110144673|NCT02041650|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110144674|NCT02041650|Purinergic Agents|purinergic agents|mesh-ancestor
110144675|NCT02041650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110144676|NCT02041650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110144678|NCT02041767|Ertapenem|ertapenem|mesh-list
110144679|NCT02041767|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110144680|NCT02041767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110144681|NCT02041819|Nimotuzumab|nimotuzumab|mesh-list
110144682|NCT02041819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110144683|NCT02041819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110144684|NCT02042027|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110144685|NCT02042027|Immunologic Factors|immunologic factors|mesh-ancestor
110144686|NCT02042027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110144687|NCT02042170|Hormones|hormones|mesh-list
110144688|NCT02042170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110144689|NCT02042170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110144690|NCT02042196|Cetrorelix|cetrorelix|mesh-list
110144691|NCT02042196|Estradiol|estradiol|mesh-list
110144692|NCT02042196|Estrogens|estrogens|mesh-ancestor
110144693|NCT02042196|Hormones|hormones|mesh-ancestor
110144694|NCT02042196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110144695|NCT02042196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110144696|NCT02042196|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110144697|NCT02042196|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110144698|NCT02042196|Fertility Agents|fertility agents|mesh-ancestor
110144699|NCT02042196|Hormone Antagonists|hormone antagonists|mesh-ancestor
110144700|NCT02042222|Hydroxyurea|hydroxyurea|mesh-list
110144701|NCT02042222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110144702|NCT02042222|Antisickling Agents|antisickling agents|mesh-ancestor
110144703|NCT02042222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110144704|NCT02042222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110144705|NCT02042222|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110144706|NCT02042482|Ubiquinone|ubiquinone|mesh-list
110144707|NCT02042482|Coenzyme Q10|coenzyme q10|mesh-list
110144708|NCT02042482|Micronutrients|micronutrients|mesh-ancestor
110144709|NCT02042482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110144710|NCT02042482|Vitamins|vitamins|mesh-ancestor
110144711|NCT02042495|Metformin|metformin|mesh-list
110144712|NCT02042495|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110144713|NCT02042495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110144714|NCT02042573|Sertraline|sertraline|mesh-list
110144715|NCT02042573|Antidepressive Agents|antidepressive agents|mesh-ancestor
110144716|NCT02042573|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110144717|NCT02042573|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110144718|NCT02042573|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110144719|NCT02042573|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110144720|NCT02042573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110144721|NCT02042573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110144722|NCT02042573|Serotonin Agents|serotonin agents|mesh-ancestor
110144723|NCT02042573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110144724|NCT02042599|Sevoflurane|sevoflurane|mesh-list
110144725|NCT02042599|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110144726|NCT02042599|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110144727|NCT02042599|Anesthetics, General|anesthetics, general|mesh-ancestor
110144728|NCT02042599|Anesthetics|anesthetics|mesh-ancestor
110144729|NCT02042599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110144730|NCT02042599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110144731|NCT02042612|Sevoflurane|sevoflurane|mesh-list
110144732|NCT02042612|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110144733|NCT02042612|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110144734|NCT02042612|Anesthetics, General|anesthetics, general|mesh-ancestor
110144735|NCT02042612|Anesthetics|anesthetics|mesh-ancestor
110144736|NCT02042612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110144737|NCT02042612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110144738|NCT02042638|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
110070085|NCT04204252|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
110144739|NCT02042638|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110144740|NCT02042638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110144742|NCT02042664|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110144743|NCT02042664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110144744|NCT02042690|Dexamethasone|dexamethasone|mesh-list
110144745|NCT02042690|Cyclophosphamide|cyclophosphamide|mesh-list
110144746|NCT02042690|Methotrexate|methotrexate|mesh-list
110144747|NCT02042690|Epirubicin|epirubicin|mesh-list
110144748|NCT02042690|Mercaptopurine|mercaptopurine|mesh-list
110144749|NCT02042690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110144750|NCT02042690|Immunologic Factors|immunologic factors|mesh-ancestor
110144751|NCT02042690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110144752|NCT02042690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110144753|NCT02042690|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110144754|NCT02042690|Alkylating Agents|alkylating agents|mesh-ancestor
110144755|NCT02042690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110144756|NCT02042690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110144757|NCT02042690|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110144758|NCT02042690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110144759|NCT02042690|Antiemetics|antiemetics|mesh-ancestor
110144760|NCT02042690|Autonomic Agents|autonomic agents|mesh-ancestor
110144761|NCT02042690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110144762|NCT02042690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110144763|NCT02042690|Glucocorticoids|glucocorticoids|mesh-ancestor
110144765|NCT02042690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110144766|NCT02042690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110144767|NCT02042690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110144768|NCT02042690|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110144769|NCT02042690|Abortifacient Agents|abortifacient agents|mesh-ancestor
110144770|NCT02042690|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110144771|NCT02042690|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110144772|NCT02042690|Antimetabolites|antimetabolites|mesh-ancestor
110144773|NCT02042690|Dermatologic Agents|dermatologic agents|mesh-ancestor
110144774|NCT02042690|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110144775|NCT02042690|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110144776|NCT02042690|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110070178|NCT04014075|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
110070179|NCT04014075|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110070180|NCT04014075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110070181|NCT04014075|Immunoconjugates|immunoconjugates|mesh-ancestor
110070182|NCT04014075|Immunologic Factors|immunologic factors|mesh-ancestor
110070183|NCT04014075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110070184|NCT04009109|Dexamethasone|dexamethasone|mesh-list
110070185|NCT04009109|Lenalidomide|lenalidomide|mesh-list
110070186|NCT04009109|Daratumumab|daratumumab|mesh-list
110070187|NCT04009109|Ixazomib|ixazomib|mesh-list
110070188|NCT04009109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110070189|NCT04009109|Antiemetics|antiemetics|mesh-ancestor
110070190|NCT04009109|Autonomic Agents|autonomic agents|mesh-ancestor
110070191|NCT04009109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110070192|NCT04009109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110070193|NCT04009109|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110070194|NCT04009109|Glucocorticoids|glucocorticoids|mesh-ancestor
110070195|NCT04009109|Hormones|hormones|mesh-ancestor
110070196|NCT04009109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110070197|NCT04009109|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110070198|NCT04009109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110070199|NCT04009109|Immunologic Factors|immunologic factors|mesh-ancestor
110070200|NCT04009109|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110070201|NCT04009109|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110144777|NCT02042690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110144778|NCT02042690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110144779|NCT02042742|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
110144781|NCT02042742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110144782|NCT02042742|Antioxidants|antioxidants|mesh-ancestor
110144783|NCT02042742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110144784|NCT02042742|Protective Agents|protective agents|mesh-ancestor
110144785|NCT02042742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110144786|NCT02042742|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110144787|NCT02042742|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110144788|NCT02042742|Disinfectants|disinfectants|mesh-ancestor
110144789|NCT02043002|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110070245|NCT03909152|Anastrozole|anastrozole|mesh-list
110070246|NCT03909152|Onapristone|onapristone|mesh-list
110070247|NCT03909152|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110070248|NCT03909152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110070249|NCT03909152|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110070251|NCT03909152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110144790|NCT02043002|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110144791|NCT02043002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110144792|NCT02043054|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110144793|NCT02043054|Liraglutide|liraglutide|mesh-list
110144794|NCT02043054|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110144795|NCT02043054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110144796|NCT02043054|Incretins|incretins|mesh-ancestor
110144797|NCT02043054|Hormones|hormones|mesh-ancestor
110144798|NCT02043054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110144799|NCT02043054|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110144800|NCT02043054|Protease Inhibitors|protease inhibitors|mesh-ancestor
110144801|NCT02043054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110343820|NCT06022003|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110144802|NCT02043054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110144804|NCT02043171|Ergocalciferols|ergocalciferols|mesh-list
110144805|NCT02043171|Cholecalciferol|cholecalciferol|mesh-list
110144806|NCT02043171|Vitamins|vitamins|mesh-list
110144807|NCT02043171|Micronutrients|micronutrients|mesh-ancestor
110144808|NCT02043171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110144809|NCT02043171|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110144810|NCT02043171|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110144811|NCT02043223|Vitamins|vitamins|mesh-list
110144812|NCT02043223|Vitamin A|vitamin a|mesh-list
110144813|NCT02043223|Retinol palmitate|retinol palmitate|mesh-list
110144814|NCT02043223|Micronutrients|micronutrients|mesh-ancestor
110144815|NCT02043223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110144816|NCT02043223|Antioxidants|antioxidants|mesh-ancestor
110144817|NCT02043223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110144818|NCT02043223|Protective Agents|protective agents|mesh-ancestor
110144819|NCT02043223|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110144820|NCT02043223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110144821|NCT02043288|Gemcitabine|gemcitabine|mesh-list
110144822|NCT02043288|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110144823|NCT02043288|Antimetabolites|antimetabolites|mesh-ancestor
110070360|NCT03634852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110144824|NCT02043288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110144825|NCT02043288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110144827|NCT02043314|Antitubercular Agents|antitubercular agents|mesh-ancestor
110144828|NCT02043314|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110144829|NCT02043314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110144830|NCT02043314|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
110144831|NCT02043314|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110144832|NCT02043314|Antimetabolites|antimetabolites|mesh-ancestor
110144833|NCT02043314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110144834|NCT02043314|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110144835|NCT02043340|Photosensitizing Agents|photosensitizing agents|mesh-list
110144836|NCT02043340|Dermatologic Agents|dermatologic agents|mesh-ancestor
110144837|NCT02043717|Vitamin D|vitamin d|mesh-list
110144838|NCT02043717|Vitamins|vitamins|mesh-ancestor
110144839|NCT02043717|Micronutrients|micronutrients|mesh-ancestor
110144840|NCT02043717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110144841|NCT02043717|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110144842|NCT02043730|Paclitaxel|paclitaxel|mesh-list
110144843|NCT02043730|Gemcitabine|gemcitabine|mesh-list
110144844|NCT02043730|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110070558|NCT03321526|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110144845|NCT02043730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110144846|NCT02043730|Tubulin Modulators|tubulin modulators|mesh-ancestor
110144847|NCT02043730|Antimitotic Agents|antimitotic agents|mesh-ancestor
110144848|NCT02043730|Mitosis Modulators|mitosis modulators|mesh-ancestor
110144849|NCT02043730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110144850|NCT02043730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110144851|NCT02043730|Antimetabolites|antimetabolites|mesh-ancestor
110144852|NCT02043756|Mitoxantrone|mitoxantrone|mesh-list
110144853|NCT02043756|Analgesics|analgesics|mesh-ancestor
110144854|NCT02043756|Sensory System Agents|sensory system agents|mesh-ancestor
110144855|NCT02043756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110144856|NCT02043756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110144857|NCT02043756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110144858|NCT02043756|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110144859|NCT02043756|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110144860|NCT02043756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110144861|NCT02043756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110144862|NCT02043821|Capecitabine|capecitabine|mesh-list
110144863|NCT02043821|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110144864|NCT02043821|Antimetabolites|antimetabolites|mesh-ancestor
110144865|NCT02043821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110144866|NCT02043821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110144868|NCT02043886|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
110144869|NCT02043886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110144870|NCT02043886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110144871|NCT02043886|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110144872|NCT02043886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110144874|NCT02043912|Haloperidol decanoate|haloperidol decanoate|mesh-list
110144875|NCT02043912|Antiemetics|antiemetics|mesh-ancestor
110144876|NCT02043912|Autonomic Agents|autonomic agents|mesh-ancestor
110144877|NCT02043912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110144878|NCT02043912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110144879|NCT02043912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110144880|NCT02043912|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110144881|NCT02043912|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110144882|NCT02043912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110144883|NCT02043912|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110144884|NCT02043912|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110144885|NCT02043912|Dopamine Agents|dopamine agents|mesh-ancestor
110144886|NCT02043912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110144887|NCT02043912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110144888|NCT02043912|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110144889|NCT02043977|Propofol|propofol|mesh-list
110144890|NCT02043977|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110144891|NCT02043977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110144892|NCT02043977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110144893|NCT02043977|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110144894|NCT02043977|Anesthetics, General|anesthetics, general|mesh-ancestor
110144895|NCT02043977|Anesthetics|anesthetics|mesh-ancestor
110144896|NCT02044120|Irinotecan|irinotecan|mesh-list
110144897|NCT02044120|Temozolomide|temozolomide|mesh-list
110144898|NCT02044120|Niraparib|niraparib|mesh-list
110144899|NCT02044120|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110144900|NCT02044120|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110144901|NCT02044120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110144902|NCT02044120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110144903|NCT02044120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110144904|NCT02044120|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110144905|NCT02044120|Alkylating Agents|alkylating agents|mesh-ancestor
110144906|NCT02044120|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110144907|NCT02044133|Vitamin D|vitamin d|mesh-list
110144908|NCT02044133|Vitamins|vitamins|mesh-ancestor
110144909|NCT02044133|Micronutrients|micronutrients|mesh-ancestor
110144910|NCT02044133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110144911|NCT02044133|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110144912|NCT02044146|Clopidogrel|clopidogrel|mesh-list
110144913|NCT02044146|Ticagrelor|ticagrelor|mesh-list
110144914|NCT02044146|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
110144915|NCT02044146|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110144916|NCT02044146|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110144918|NCT02044146|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110144919|NCT02044146|Purinergic Agents|purinergic agents|mesh-ancestor
110144920|NCT02044146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110144921|NCT02044146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110144922|NCT02044146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110144924|NCT02044224|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110144925|NCT02044224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110144926|NCT02044224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110144927|NCT02044224|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110144928|NCT02044224|Analgesics|analgesics|mesh-ancestor
110144929|NCT02044224|Sensory System Agents|sensory system agents|mesh-ancestor
110144930|NCT02044224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110144931|NCT02044224|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110144932|NCT02044224|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110144933|NCT02044224|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110144934|NCT02044224|Adrenergic Agents|adrenergic agents|mesh-ancestor
110144935|NCT02044224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110144936|NCT02044224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110144937|NCT02044250|Aspirin|aspirin|mesh-list
110144938|NCT02044250|Clopidogrel|clopidogrel|mesh-list
110144939|NCT02044250|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110144940|NCT02044250|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110144941|NCT02044250|Analgesics|analgesics|mesh-ancestor
110144942|NCT02044250|Sensory System Agents|sensory system agents|mesh-ancestor
110144943|NCT02044250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110144944|NCT02044250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110144945|NCT02044250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110144946|NCT02044250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110144947|NCT02044250|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110144948|NCT02044250|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110144949|NCT02044250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110144950|NCT02044250|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110144951|NCT02044250|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110144953|NCT02044250|Antipyretics|antipyretics|mesh-ancestor
110144954|NCT02044250|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110144955|NCT02044250|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110144956|NCT02044250|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110144957|NCT02044250|Purinergic Agents|purinergic agents|mesh-ancestor
110144958|NCT02044250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110144960|NCT02044354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110144961|NCT02044354|Tubulin Modulators|tubulin modulators|mesh-ancestor
110144962|NCT02044354|Antimitotic Agents|antimitotic agents|mesh-ancestor
110144963|NCT02044354|Mitosis Modulators|mitosis modulators|mesh-ancestor
110144964|NCT02044354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110144965|NCT02044549|Oxytocin|oxytocin|mesh-list
110144966|NCT02044549|Carbetocin|carbetocin|mesh-list
110144967|NCT02044549|Methylergonovine|methylergonovine|mesh-list
110144968|NCT02044549|Syntometrine|syntometrine|mesh-list
110144969|NCT02044549|Oxytocics|oxytocics|mesh-ancestor
110144970|NCT02044549|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110144971|NCT02044549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110144972|NCT02044601|Paclitaxel|paclitaxel|mesh-list
110144973|NCT02044601|Carboplatin|carboplatin|mesh-list
110144974|NCT02044601|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110144975|NCT02044601|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110144976|NCT02044601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110144977|NCT02044601|Tubulin Modulators|tubulin modulators|mesh-ancestor
110144978|NCT02044601|Antimitotic Agents|antimitotic agents|mesh-ancestor
110144979|NCT02044601|Mitosis Modulators|mitosis modulators|mesh-ancestor
110144980|NCT02044601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110144981|NCT02044601|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110144982|NCT02044601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110144983|NCT02044627|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
110144984|NCT02044627|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110144985|NCT02044627|Antimetabolites|antimetabolites|mesh-ancestor
110144986|NCT02044627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110144987|NCT02044627|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110144988|NCT02044627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110144989|NCT02044627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110144990|NCT02044627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110144991|NCT02044653|Darbepoetin alfa|darbepoetin alfa|mesh-list
110144992|NCT02044653|Hematinics|hematinics|mesh-ancestor
110144993|NCT02044809|Cannabidiol|cannabidiol|mesh-list
110144994|NCT02044809|Anticonvulsants|anticonvulsants|mesh-ancestor
110144995|NCT02044952|Mesalamine|mesalamine|mesh-list
110144996|NCT02044952|Triptolide|triptolide|mesh-list
110343821|NCT06022003|Antimetabolites|antimetabolites|mesh-ancestor
110144997|NCT02044952|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110145000|NCT02044952|Sensory System Agents|sensory system agents|mesh-ancestor
110145001|NCT02044952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110145002|NCT02044952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110145003|NCT02044952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110145004|NCT02044952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110145005|NCT02044952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110145006|NCT02044952|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
110145007|NCT02044952|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110145008|NCT02044952|Contraceptive Agents|contraceptive agents|mesh-ancestor
110145009|NCT02044952|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110145010|NCT02044952|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110145011|NCT02044952|Immunologic Factors|immunologic factors|mesh-ancestor
110145012|NCT02044952|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110145013|NCT02044952|Alkylating Agents|alkylating agents|mesh-ancestor
110145014|NCT02044952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110145015|NCT02044965|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110145016|NCT02044965|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
110145017|NCT02044965|Trimethoprim|trimethoprim|mesh-list
110145018|NCT02044965|Sulfamethoxazole|sulfamethoxazole|mesh-list
110145019|NCT02044965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110145020|NCT02044965|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110145021|NCT02044965|Antimalarials|antimalarials|mesh-ancestor
110145022|NCT02044965|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110145023|NCT02044965|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110145024|NCT02044965|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110145025|NCT02044965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110145026|NCT02044965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110145027|NCT02044965|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110145028|NCT02044965|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
110145029|NCT02044965|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110145030|NCT02044978|Zoledronic Acid|zoledronic acid|mesh-list
110145031|NCT02044978|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110145032|NCT02044978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110145033|NCT02045017|Dexamethasone|dexamethasone|mesh-list
110145034|NCT02045017|Pomalidomide|pomalidomide|mesh-list
110145035|NCT02045017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110145036|NCT02045017|Antiemetics|antiemetics|mesh-ancestor
110145037|NCT02045017|Autonomic Agents|autonomic agents|mesh-ancestor
110145038|NCT02045017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110145039|NCT02045017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110145040|NCT02045017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110145041|NCT02045017|Glucocorticoids|glucocorticoids|mesh-ancestor
110145043|NCT02045017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110145044|NCT02045017|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110145045|NCT02045017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110145046|NCT02045017|Immunologic Factors|immunologic factors|mesh-ancestor
110145047|NCT02045017|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110145048|NCT02045017|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110145049|NCT02045017|Growth Substances|growth substances|mesh-ancestor
110145050|NCT02045017|Growth Inhibitors|growth inhibitors|mesh-ancestor
110145051|NCT02045030|Aflibercept|aflibercept|mesh-list
110145052|NCT02045030|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110145053|NCT02045030|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110145054|NCT02045030|Growth Substances|growth substances|mesh-ancestor
110145055|NCT02045030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110145056|NCT02045030|Growth Inhibitors|growth inhibitors|mesh-ancestor
110145057|NCT02045030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110145059|NCT02045056|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110145060|NCT02045056|Antimetabolites|antimetabolites|mesh-ancestor
110145061|NCT02045056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110145062|NCT02045056|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110145063|NCT02045056|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
110145064|NCT02045056|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110145065|NCT02045056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110145066|NCT02045069|Ivermectin|ivermectin|mesh-list
110145067|NCT02045069|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110145068|NCT02045069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110145069|NCT02045290|Metformin|metformin|mesh-list
110145070|NCT02045290|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110145071|NCT02045290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110145072|NCT02045368|Methotrexate|methotrexate|mesh-list
110145073|NCT02045368|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110145074|NCT02045368|Abortifacient Agents|abortifacient agents|mesh-ancestor
110145075|NCT02045368|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110145076|NCT02045368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110145077|NCT02045368|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110145078|NCT02045368|Antimetabolites|antimetabolites|mesh-ancestor
110145079|NCT02045368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110145080|NCT02045368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110145081|NCT02045368|Dermatologic Agents|dermatologic agents|mesh-ancestor
110145082|NCT02045368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110145083|NCT02045368|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110145084|NCT02045368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110145085|NCT02045368|Immunologic Factors|immunologic factors|mesh-ancestor
110145086|NCT02045368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110145087|NCT02045368|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110145088|NCT02045589|Gemcitabine|gemcitabine|mesh-list
110145089|NCT02045589|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110145090|NCT02045589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110145091|NCT02045589|Antimetabolites|antimetabolites|mesh-ancestor
110145092|NCT02045589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110145093|NCT02045589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110145094|NCT02045602|Gemcitabine|gemcitabine|mesh-list
110145095|NCT02045602|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110145096|NCT02045602|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110145097|NCT02045602|Antimetabolites|antimetabolites|mesh-ancestor
110145098|NCT02045602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110145099|NCT02045602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110145101|NCT02045667|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110145102|NCT02045667|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110145103|NCT02045667|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110145104|NCT02045667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110145105|NCT02045667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110145106|NCT02045693|Buprenorphine|buprenorphine|mesh-list
110145107|NCT02045693|Methadone|methadone|mesh-list
110145108|NCT02045693|Naloxone|naloxone|mesh-list
110145109|NCT02045693|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110071015|NCT01556737|Daidzein|daidzein|mesh-list
110145110|NCT02045693|Narcotics|narcotics|mesh-ancestor
110145111|NCT02045693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110145112|NCT02045693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110145113|NCT02045693|Analgesics|analgesics|mesh-ancestor
110145114|NCT02045693|Sensory System Agents|sensory system agents|mesh-ancestor
110145115|NCT02045693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110145116|NCT02045693|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110145117|NCT02045693|Antitussive Agents|antitussive agents|mesh-ancestor
110145118|NCT02045693|Respiratory System Agents|respiratory system agents|mesh-ancestor
110145119|NCT02045797|Gepotidacin|gepotidacin|mesh-list
110145120|NCT02045797|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110145121|NCT02045797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110145122|NCT02045797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110145123|NCT02045797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110145124|NCT02045810|Levobupivacaine|levobupivacaine|mesh-list
110145125|NCT02045810|Anesthetics, Local|anesthetics, local|mesh-ancestor
110145127|NCT02045810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110145128|NCT02045810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110145129|NCT02045810|Sensory System Agents|sensory system agents|mesh-ancestor
110145130|NCT02045810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110145131|NCT02045849|Itraconazole|itraconazole|mesh-list
110145132|NCT02045849|Gepotidacin|gepotidacin|mesh-list
110145133|NCT02045849|Antifungal Agents|antifungal agents|mesh-ancestor
110145134|NCT02045849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110145135|NCT02045849|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110145136|NCT02045849|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110145137|NCT02045849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110145138|NCT02045849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110145139|NCT02045849|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110145140|NCT02045849|Hormone Antagonists|hormone antagonists|mesh-ancestor
110145141|NCT02045849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110145142|NCT02045849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110145143|NCT02045849|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110145144|NCT02045849|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110145145|NCT02045849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110145148|NCT02045914|Ionomycin|ionomycin|mesh-list
110145149|NCT02045914|Calcium Ionophores|calcium ionophores|mesh-list
110145150|NCT02045914|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110145151|NCT02045914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110145152|NCT02045914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110145153|NCT02045914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110145154|NCT02045940|GSK2881078|gsk2881078|mesh-list
110145155|NCT02045940|Anabolic Agents|anabolic agents|mesh-ancestor
110145156|NCT02045940|Hormones|hormones|mesh-ancestor
110145157|NCT02045940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110145158|NCT02045940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110145159|NCT02045953|Albuterol|albuterol|mesh-list
110145160|NCT02045953|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110145161|NCT02045953|Autonomic Agents|autonomic agents|mesh-ancestor
110145162|NCT02045953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110145163|NCT02045953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110145165|NCT02045953|Respiratory System Agents|respiratory system agents|mesh-ancestor
110145166|NCT02045953|Tocolytic Agents|tocolytic agents|mesh-ancestor
110145167|NCT02045953|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110145168|NCT02045953|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110145169|NCT02045953|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110145170|NCT02045953|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110145171|NCT02045953|Adrenergic Agents|adrenergic agents|mesh-ancestor
110145172|NCT02045953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110145173|NCT02045953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110145174|NCT02045992|Caffeine|caffeine|mesh-list
110145175|NCT02045992|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110145176|NCT02045992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110145177|NCT02045992|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110145178|NCT02045992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110145179|NCT02045992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110145180|NCT02045992|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110145181|NCT02045992|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110145182|NCT02045992|Purinergic Agents|purinergic agents|mesh-ancestor
110145183|NCT02045992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110145184|NCT02046044|Digoxin|digoxin|mesh-list
110145185|NCT02046044|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110145186|NCT02046044|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110145187|NCT02046044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110145188|NCT02046044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110145189|NCT02046044|Protective Agents|protective agents|mesh-ancestor
110145190|NCT02046044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110145191|NCT02046109|Chlorhexidine|chlorhexidine|mesh-list
110167967|NCT00000641|Rifampin|rifampin|mesh-list
110145192|NCT02046109|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110145193|NCT02046109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110145194|NCT02046109|Disinfectants|disinfectants|mesh-ancestor
110145195|NCT02046187|Temozolomide|temozolomide|mesh-list
110145196|NCT02046187|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110145197|NCT02046187|Alkylating Agents|alkylating agents|mesh-ancestor
110145198|NCT02046187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110145199|NCT02046187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110145200|NCT02046304|Gemcitabine|gemcitabine|mesh-list
110145201|NCT02046304|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110145202|NCT02046304|Antimetabolites|antimetabolites|mesh-ancestor
110145203|NCT02046304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110145204|NCT02046304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110145205|NCT02046421|Carboplatin|carboplatin|mesh-list
110145206|NCT02046421|Gemcitabine|gemcitabine|mesh-list
110145207|NCT02046421|Mifepristone|mifepristone|mesh-list
110145208|NCT02046421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110145209|NCT02046421|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110145210|NCT02046421|Antimetabolites|antimetabolites|mesh-ancestor
110145211|NCT02046421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110145212|NCT02046421|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
110145213|NCT02046421|Abortifacient Agents|abortifacient agents|mesh-ancestor
110145214|NCT02046421|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110145215|NCT02046421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110145216|NCT02046421|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110145217|NCT02046421|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110145218|NCT02046421|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110145219|NCT02046421|Contraceptive Agents|contraceptive agents|mesh-ancestor
110145220|NCT02046421|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
110145221|NCT02046421|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
110145222|NCT02046421|Hormone Antagonists|hormone antagonists|mesh-ancestor
110145223|NCT02046421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110145224|NCT02046421|Luteolytic Agents|luteolytic agents|mesh-ancestor
110145225|NCT02046421|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110145226|NCT02046421|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
110145227|NCT02046447|Trihexyphenidyl|trihexyphenidyl|mesh-list
110145228|NCT02046447|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110145229|NCT02046447|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110145230|NCT02046447|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110145231|NCT02046447|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110145232|NCT02046447|Cholinergic Agents|cholinergic agents|mesh-ancestor
110145233|NCT02046447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110145234|NCT02046447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110145235|NCT02046447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110145237|NCT02046486|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110145238|NCT02046486|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110145239|NCT02046486|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110145240|NCT02046486|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110145241|NCT02046486|Purinergic Agents|purinergic agents|mesh-ancestor
110145242|NCT02046486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110145243|NCT02046486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110145244|NCT02046486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110145245|NCT02046499|Oxytocin|oxytocin|mesh-list
110145246|NCT02046499|Ergonovine|ergonovine|mesh-list
110145247|NCT02046499|Syntometrine|syntometrine|mesh-list
110145248|NCT02046499|Oxytocics|oxytocics|mesh-ancestor
110145249|NCT02046499|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110145250|NCT02046499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110145251|NCT02046538|Leucovorin|leucovorin|mesh-list
110145252|NCT02046538|Fluorouracil|fluorouracil|mesh-list
110145253|NCT02046538|Oxaliplatin|oxaliplatin|mesh-list
110145254|NCT02046538|Irinotecan|irinotecan|mesh-list
110145255|NCT02046538|Antimetabolites|antimetabolites|mesh-ancestor
110145256|NCT02046538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110145257|NCT02046538|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110145258|NCT02046538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110145259|NCT02046538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110145260|NCT02046538|Immunologic Factors|immunologic factors|mesh-ancestor
110145261|NCT02046538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110145262|NCT02046538|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110145263|NCT02046538|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110145264|NCT02046538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110145265|NCT02046538|Antidotes|antidotes|mesh-ancestor
110145266|NCT02046538|Protective Agents|protective agents|mesh-ancestor
110145267|NCT02046538|Vitamin B Complex|vitamin b complex|mesh-ancestor
110145268|NCT02046538|Vitamins|vitamins|mesh-ancestor
110145269|NCT02046538|Micronutrients|micronutrients|mesh-ancestor
110145270|NCT02046551|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
110145271|NCT02046551|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110145272|NCT02046551|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110145273|NCT02046551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110145274|NCT02046551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110145275|NCT02046551|Adrenergic Agents|adrenergic agents|mesh-ancestor
110145276|NCT02046551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110145277|NCT02046551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110145278|NCT02046577|Vitamin D|vitamin d|mesh-list
110145279|NCT02046577|Cholecalciferol|cholecalciferol|mesh-list
110145280|NCT02046577|Vitamins|vitamins|mesh-ancestor
110145281|NCT02046577|Micronutrients|micronutrients|mesh-ancestor
110071333|NCT01558869|Capecitabine|capecitabine|mesh-list
110145282|NCT02046577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110145283|NCT02046577|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110145284|NCT02046577|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110145285|NCT02046629|Teriflunomide|teriflunomide|mesh-list
110145286|NCT02046629|Cholestyramine Resin|cholestyramine resin|mesh-list
110145287|NCT02046629|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110145288|NCT02046629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110145289|NCT02046629|Analgesics|analgesics|mesh-ancestor
110145290|NCT02046629|Sensory System Agents|sensory system agents|mesh-ancestor
110145291|NCT02046629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110145292|NCT02046629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110145293|NCT02046629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110145294|NCT02046629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110145295|NCT02046629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110145296|NCT02046629|Immunologic Factors|immunologic factors|mesh-ancestor
110145297|NCT02046629|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110145298|NCT02046629|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110145299|NCT02046629|Antimetabolites|antimetabolites|mesh-ancestor
110145300|NCT02046629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110145301|NCT02046629|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110145302|NCT02046668|Spironolactone|spironolactone|mesh-list
110145303|NCT02046668|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110145304|NCT02046668|Hormone Antagonists|hormone antagonists|mesh-ancestor
110145305|NCT02046668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110145306|NCT02046668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110145307|NCT02046668|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110145308|NCT02046668|Diuretics|diuretics|mesh-ancestor
110145309|NCT02046668|Natriuretic Agents|natriuretic agents|mesh-ancestor
110145310|NCT02046720|Propofol|propofol|mesh-list
110145311|NCT02046720|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110145312|NCT02046720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110145313|NCT02046720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110145314|NCT02046720|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110145315|NCT02046720|Anesthetics, General|anesthetics, general|mesh-ancestor
110145316|NCT02046720|Anesthetics|anesthetics|mesh-ancestor
110145317|NCT02046733|Nivolumab|nivolumab|mesh-list
110145318|NCT02046733|Ipilimumab|ipilimumab|mesh-list
110145319|NCT02046733|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110145321|NCT02046733|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110145322|NCT02046733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110145323|NCT02046785|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110145324|NCT02046850|Rifampin|rifampin|mesh-list
110145325|NCT02046850|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110145326|NCT02046850|Antitubercular Agents|antitubercular agents|mesh-ancestor
110145327|NCT02046850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110145328|NCT02046850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110145329|NCT02046850|Leprostatic Agents|leprostatic agents|mesh-ancestor
110145330|NCT02046850|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110145331|NCT02046850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110145332|NCT02046850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110145333|NCT02046850|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110145334|NCT02046850|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110145335|NCT02046850|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110145336|NCT02046850|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110145337|NCT02046850|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110145338|NCT02046850|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110145339|NCT02046915|Dexamethasone|dexamethasone|mesh-list
110145340|NCT02046915|Cyclophosphamide|cyclophosphamide|mesh-list
110145341|NCT02046915|Pomalidomide|pomalidomide|mesh-list
110145342|NCT02046915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110145343|NCT02046915|Immunologic Factors|immunologic factors|mesh-ancestor
110145344|NCT02046915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110145345|NCT02046915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110145346|NCT02046915|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110145347|NCT02046915|Alkylating Agents|alkylating agents|mesh-ancestor
110145348|NCT02046915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110145349|NCT02046915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110145350|NCT02046915|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110145351|NCT02046915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110145352|NCT02046915|Antiemetics|antiemetics|mesh-ancestor
110145353|NCT02046915|Autonomic Agents|autonomic agents|mesh-ancestor
110071501|NCT01560117|Rituximab|rituximab|mesh-list
110145354|NCT02046915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110145355|NCT02046915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110145356|NCT02046915|Glucocorticoids|glucocorticoids|mesh-ancestor
110145357|NCT02046915|Hormones|hormones|mesh-ancestor
110145358|NCT02046915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110145359|NCT02046915|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110145360|NCT02046915|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110145361|NCT02046915|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110145362|NCT02046915|Growth Substances|growth substances|mesh-ancestor
110145363|NCT02046915|Growth Inhibitors|growth inhibitors|mesh-ancestor
110145365|NCT02047006|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110145366|NCT02047006|Antithrombins|antithrombins|mesh-ancestor
110145367|NCT02047006|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110145368|NCT02047006|Protease Inhibitors|protease inhibitors|mesh-ancestor
110145369|NCT02047006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110145370|NCT02047006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110145371|NCT02047006|Anticoagulants|anticoagulants|mesh-ancestor
110145372|NCT02047019|Candesartan|candesartan|mesh-list
110145373|NCT02047019|Candesartan cilexetil|candesartan cilexetil|mesh-list
110145374|NCT02047019|Nifedipine|nifedipine|mesh-list
110145375|NCT02047019|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110145376|NCT02047019|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110145377|NCT02047019|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110145378|NCT02047019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110145379|NCT02047019|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110145380|NCT02047019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110145381|NCT02047019|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110145382|NCT02047019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110145384|NCT02047019|Tocolytic Agents|tocolytic agents|mesh-ancestor
110145385|NCT02047019|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110145386|NCT02047136|Histamine|histamine|mesh-list
110145387|NCT02047136|Histamine Agonists|histamine agonists|mesh-ancestor
110145388|NCT02047136|Histamine Agents|histamine agents|mesh-ancestor
110145389|NCT02047136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110145390|NCT02047136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110145391|NCT02047136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110145392|NCT02047149|Zileuton|zileuton|mesh-list
110145393|NCT02047149|Dasatinib|dasatinib|mesh-list
110145394|NCT02047149|Hydroxyurea|hydroxyurea|mesh-list
110145395|NCT02047149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110145396|NCT02047149|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110145397|NCT02047149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110145398|NCT02047149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110145399|NCT02047149|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110145400|NCT02047149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110145401|NCT02047149|Analgesics|analgesics|mesh-ancestor
110145402|NCT02047149|Sensory System Agents|sensory system agents|mesh-ancestor
110145403|NCT02047149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110145404|NCT02047149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110145406|NCT02047149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110145407|NCT02047149|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
110145408|NCT02047149|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110145409|NCT02047149|Hormone Antagonists|hormone antagonists|mesh-ancestor
110145410|NCT02047149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110145411|NCT02047149|Antisickling Agents|antisickling agents|mesh-ancestor
110145412|NCT02047149|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110145414|NCT02047162|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
110145415|NCT02047162|Antacids|antacids|mesh-ancestor
110145416|NCT02047162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110145417|NCT02047162|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110145418|NCT02047162|Antidiarrheals|antidiarrheals|mesh-ancestor
110145420|NCT02047175|Amlodipine|amlodipine|mesh-list
110145421|NCT02047175|Telmisartan|telmisartan|mesh-list
110145422|NCT02047175|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110145423|NCT02047175|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110145424|NCT02047175|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110145425|NCT02047175|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110145426|NCT02047175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110145427|NCT02047175|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110145428|NCT02047175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110145429|NCT02047175|Vasodilator Agents|vasodilator agents|mesh-ancestor
110145430|NCT02047175|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110145431|NCT02047175|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110145432|NCT02047175|Antimetabolites|antimetabolites|mesh-ancestor
110145433|NCT02047175|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110145434|NCT02047175|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110145435|NCT02047175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110145436|NCT02047175|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110145437|NCT02047175|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110145438|NCT02047175|Vitamin B Complex|vitamin b complex|mesh-ancestor
110145439|NCT02047175|Vitamins|vitamins|mesh-ancestor
110145440|NCT02047175|Micronutrients|micronutrients|mesh-ancestor
110145441|NCT02047201|Docetaxel|docetaxel|mesh-list
110145442|NCT02047201|Fluorouracil|fluorouracil|mesh-list
110145443|NCT02047201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110145444|NCT02047201|Tubulin Modulators|tubulin modulators|mesh-ancestor
110145445|NCT02047201|Antimitotic Agents|antimitotic agents|mesh-ancestor
110145446|NCT02047201|Mitosis Modulators|mitosis modulators|mesh-ancestor
110145447|NCT02047201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110145448|NCT02047201|Antimetabolites|antimetabolites|mesh-ancestor
110145449|NCT02047201|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110145450|NCT02047201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110145451|NCT02047201|Immunologic Factors|immunologic factors|mesh-ancestor
110145452|NCT02047201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110145453|NCT02047292|Tacrine|tacrine|mesh-list
110145454|NCT02047292|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110145455|NCT02047292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110145456|NCT02047292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110145458|NCT02047292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110145459|NCT02047292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110145460|NCT02047292|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110145461|NCT02047292|Autonomic Agents|autonomic agents|mesh-ancestor
110145462|NCT02047292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110145463|NCT02047292|Nootropic Agents|nootropic agents|mesh-ancestor
110145464|NCT00005823|Cytarabine|cytarabine|mesh-list
110145465|NCT00005823|Etoposide|etoposide|mesh-list
110145467|NCT00005823|Mitoxantrone|mitoxantrone|mesh-list
110145468|NCT00005823|Idarubicin|idarubicin|mesh-list
110145469|NCT00005823|Hydroxyurea|hydroxyurea|mesh-list
110145470|NCT00005823|Tretinoin|tretinoin|mesh-list
110145471|NCT00005823|Thioguanine|thioguanine|mesh-list
110145472|NCT00005823|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110145473|NCT00005823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110145474|NCT00005823|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110145475|NCT00005823|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110145476|NCT00005823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110145477|NCT00005823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110145478|NCT00005823|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110145479|NCT00005823|Antimetabolites|antimetabolites|mesh-ancestor
110145480|NCT00005823|Antiviral Agents|antiviral agents|mesh-ancestor
110145481|NCT00005823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110145482|NCT00005823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110145483|NCT00005823|Immunologic Factors|immunologic factors|mesh-ancestor
110145484|NCT00005823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110145485|NCT00005823|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110145486|NCT00005823|Analgesics|analgesics|mesh-ancestor
110145487|NCT00005823|Sensory System Agents|sensory system agents|mesh-ancestor
110145488|NCT00005823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110145489|NCT00005823|Antisickling Agents|antisickling agents|mesh-ancestor
110145490|NCT00005823|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110145491|NCT00005823|Keratolytic Agents|keratolytic agents|mesh-ancestor
110145492|NCT00005823|Dermatologic Agents|dermatologic agents|mesh-ancestor
110145493|NCT00005826|Rubitecan|rubitecan|mesh-list
110145494|NCT00005826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110145495|NCT00005826|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110145496|NCT00005826|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110145497|NCT00005826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110145498|NCT00005826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110145499|NCT00005829|Gemcitabine|gemcitabine|mesh-list
110145500|NCT00005829|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110145501|NCT00005829|Antimetabolites|antimetabolites|mesh-ancestor
110145502|NCT00005829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110145503|NCT00005829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110145504|NCT00005832|Tipifarnib|tipifarnib|mesh-list
110145505|NCT00005832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110145506|NCT00005838|Paclitaxel|paclitaxel|mesh-list
110145507|NCT00005838|Vinorelbine|vinorelbine|mesh-list
110145508|NCT00005838|Carboplatin|carboplatin|mesh-list
110145509|NCT00005838|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110145510|NCT00005838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110145511|NCT00005838|Tubulin Modulators|tubulin modulators|mesh-ancestor
110145512|NCT00005838|Antimitotic Agents|antimitotic agents|mesh-ancestor
110145513|NCT00005838|Mitosis Modulators|mitosis modulators|mesh-ancestor
110071773|NCT04227483|Prednisolone|prednisolone|mesh-list
110145514|NCT00005838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110145516|NCT00005841|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110145517|NCT00005841|Immunologic Factors|immunologic factors|mesh-ancestor
110145518|NCT00005841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110145519|NCT00005844|Oxaliplatin|oxaliplatin|mesh-list
110145520|NCT00005844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110145521|NCT00005850|Gemcitabine|gemcitabine|mesh-list
110145522|NCT00005850|Fluoxetine|fluoxetine|mesh-list
110145523|NCT00005850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110145524|NCT00005850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110145525|NCT00005850|Antimetabolites|antimetabolites|mesh-ancestor
110145526|NCT00005850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110145527|NCT00005850|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110145528|NCT00005850|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110145529|NCT00005850|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110145530|NCT00005850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110145531|NCT00005850|Serotonin Agents|serotonin agents|mesh-ancestor
110145533|NCT00005850|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110145534|NCT00005850|Antidepressive Agents|antidepressive agents|mesh-ancestor
110145535|NCT00005850|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110145536|NCT00005850|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110145537|NCT00005850|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110145538|NCT00005850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110145540|NCT00005853|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110145541|NCT00005853|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110145542|NCT00005853|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110145543|NCT00005853|Analgesics|analgesics|mesh-ancestor
110145544|NCT00005853|Sensory System Agents|sensory system agents|mesh-ancestor
110145545|NCT00005853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110145546|NCT00005853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110145547|NCT00005853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110145548|NCT00005853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110145550|NCT00005853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110145551|NCT00005853|Immunologic Factors|immunologic factors|mesh-ancestor
110145552|NCT00005856|Oxaliplatin|oxaliplatin|mesh-list
110145553|NCT00005856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110145555|NCT00005859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110145556|NCT00005862|Semaxinib|semaxinib|mesh-list
110145557|NCT00005862|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110145558|NCT00005862|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110145559|NCT00005862|Growth Substances|growth substances|mesh-ancestor
110145560|NCT00005862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110145561|NCT00005862|Growth Inhibitors|growth inhibitors|mesh-ancestor
110145562|NCT00005862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110145563|NCT00005862|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110145564|NCT00005862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110145565|NCT00005862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110145566|NCT00005865|Vinorelbine|vinorelbine|mesh-list
110145567|NCT00005865|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110145568|NCT00005865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110145569|NCT00005865|Tubulin Modulators|tubulin modulators|mesh-ancestor
110145570|NCT00005865|Antimitotic Agents|antimitotic agents|mesh-ancestor
110145572|NCT00005865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110145573|NCT00005868|Docetaxel|docetaxel|mesh-list
110145574|NCT00005868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110145575|NCT00005868|Tubulin Modulators|tubulin modulators|mesh-ancestor
110145576|NCT00005868|Antimitotic Agents|antimitotic agents|mesh-ancestor
110145577|NCT00005868|Mitosis Modulators|mitosis modulators|mesh-ancestor
110145578|NCT00005868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110145579|NCT00005871|Fluorouracil|fluorouracil|mesh-list
110145580|NCT00005871|Rubitecan|rubitecan|mesh-list
110145581|NCT00005871|Antimetabolites|antimetabolites|mesh-ancestor
110145582|NCT00005871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110145583|NCT00005871|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110145584|NCT00005871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110071925|NCT02909686|Curcumin|curcumin|mesh-list
110145585|NCT00005871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110145586|NCT00005871|Immunologic Factors|immunologic factors|mesh-ancestor
110145587|NCT00005871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110145588|NCT00005871|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110145589|NCT00005871|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110145590|NCT00005871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110145591|NCT00005874|Rubitecan|rubitecan|mesh-list
110145592|NCT00005874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110145593|NCT00005874|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110145594|NCT00005874|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110145595|NCT00005874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110145596|NCT00005874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110145597|NCT00005877|Rubitecan|rubitecan|mesh-list
110145598|NCT00005877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110145599|NCT00005877|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110145600|NCT00005877|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110145601|NCT00005877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110145602|NCT00005877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110145603|NCT00005880|Budesonide|budesonide|mesh-list
110145604|NCT00005880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110145605|NCT00005880|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110145606|NCT00005880|Autonomic Agents|autonomic agents|mesh-ancestor
110145608|NCT00005880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110145609|NCT00005880|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110145610|NCT00005880|Respiratory System Agents|respiratory system agents|mesh-ancestor
110145611|NCT00005880|Glucocorticoids|glucocorticoids|mesh-ancestor
110145612|NCT00005880|Hormones|hormones|mesh-ancestor
110145613|NCT00005880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110145614|NCT00005883|Phenethyl isothiocyanate|phenethyl isothiocyanate|mesh-list
110145616|NCT00005883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110145617|NCT00005883|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110145618|NCT00005883|Protective Agents|protective agents|mesh-ancestor
110145619|NCT00005883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110145620|NCT00005883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110145621|NCT00005886|Tamoxifen|tamoxifen|mesh-list
110145622|NCT00005886|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110145623|NCT00005886|Hormone Antagonists|hormone antagonists|mesh-ancestor
110145624|NCT00005886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110145625|NCT00005886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110145626|NCT00005886|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110145627|NCT00005886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110145628|NCT00005886|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110145629|NCT00005886|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110145630|NCT00005886|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110145631|NCT00005889|Glucagon|glucagon|mesh-list
110145632|NCT00005889|Glycerol|glycerol|mesh-list
110145633|NCT00005889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110145634|NCT00005889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110145635|NCT00005889|Hormones|hormones|mesh-ancestor
110145636|NCT00005889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110145637|NCT00005889|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
110145638|NCT00005889|Protective Agents|protective agents|mesh-ancestor
110145639|NCT00005892|Cyclophosphamide|cyclophosphamide|mesh-list
110145640|NCT00005892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110145641|NCT00005892|Immunologic Factors|immunologic factors|mesh-ancestor
110145642|NCT00005892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110145643|NCT00005892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110145644|NCT00005892|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110145645|NCT00005892|Alkylating Agents|alkylating agents|mesh-ancestor
110145646|NCT00005892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110145647|NCT00005892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110145648|NCT00005892|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110145649|NCT00005898|Cyclosporine|cyclosporine|mesh-list
110145650|NCT00005898|Methylprednisolone|methylprednisolone|mesh-list
110145651|NCT00005898|Cyclophosphamide|cyclophosphamide|mesh-list
110145652|NCT00005898|Fludarabine|fludarabine|mesh-list
110145653|NCT00005898|Cyclosporins|cyclosporins|mesh-list
110145654|NCT00005898|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110145655|NCT00005898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110145656|NCT00005898|Immunologic Factors|immunologic factors|mesh-ancestor
110145657|NCT00005898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110145658|NCT00005898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110145659|NCT00005898|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110145660|NCT00005898|Alkylating Agents|alkylating agents|mesh-ancestor
110145661|NCT00005898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110145662|NCT00005898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110145663|NCT00005898|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110145664|NCT00005898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110145665|NCT00005898|Antifungal Agents|antifungal agents|mesh-ancestor
110145666|NCT00005898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110145667|NCT00005898|Dermatologic Agents|dermatologic agents|mesh-ancestor
110145668|NCT00005898|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110145669|NCT00005898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110145670|NCT00005898|Antiemetics|antiemetics|mesh-ancestor
110145671|NCT00005898|Autonomic Agents|autonomic agents|mesh-ancestor
110145672|NCT00005898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110145674|NCT00005898|Glucocorticoids|glucocorticoids|mesh-ancestor
110145676|NCT00005898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110145677|NCT00005898|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110145678|NCT00005898|Protective Agents|protective agents|mesh-ancestor
110145679|NCT00386412|Valganciclovir|valganciclovir|mesh-list
110145681|NCT00386412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110145682|NCT00386529|Aspirin|aspirin|mesh-list
110145683|NCT00386529|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110145684|NCT00386529|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110145685|NCT00386529|Analgesics|analgesics|mesh-ancestor
110145686|NCT00386529|Sensory System Agents|sensory system agents|mesh-ancestor
110145687|NCT00386529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110145688|NCT00386529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110145689|NCT00386529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110145690|NCT00386529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110145691|NCT00386529|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110145692|NCT00386529|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110145693|NCT00386529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110145694|NCT00386529|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110145695|NCT00386529|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110145696|NCT00386529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110145697|NCT00386529|Antipyretics|antipyretics|mesh-ancestor
110145698|NCT00005922|Triamcinolone|triamcinolone|mesh-list
110145699|NCT00005922|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110145700|NCT00005922|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110145701|NCT00005922|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110072200|NCT01569685|Serotonin Agents|serotonin agents|mesh-ancestor
110145702|NCT00005922|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110145703|NCT00005922|Glucocorticoids|glucocorticoids|mesh-ancestor
110145704|NCT00005922|Hormones|hormones|mesh-ancestor
110145705|NCT00005922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110145706|NCT00005922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110145707|NCT00005922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110145708|NCT00005922|Immunologic Factors|immunologic factors|mesh-ancestor
110145709|NCT00005922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110145710|NCT00005922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110145711|NCT00005925|Muscimol|muscimol|mesh-list
110145712|NCT00005925|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
110145713|NCT00005925|GABA Agonists|gaba agonists|mesh-ancestor
110145714|NCT00005925|GABA Agents|gaba agents|mesh-ancestor
110145715|NCT00005925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110145716|NCT00005925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110145717|NCT00005925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110145718|NCT00005928|Ramipril|ramipril|mesh-list
110145719|NCT00005928|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110145720|NCT00005928|Protease Inhibitors|protease inhibitors|mesh-ancestor
110145721|NCT00005928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110145722|NCT00005928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110145723|NCT00005928|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110145725|NCT00005931|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110145726|NCT00005931|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110145727|NCT00005931|Growth Substances|growth substances|mesh-ancestor
110145728|NCT00005931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110145729|NCT00005931|Growth Inhibitors|growth inhibitors|mesh-ancestor
110145730|NCT00005931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110145731|NCT00005931|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110145732|NCT00005931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110145733|NCT00005931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110145734|NCT00005934|Azacitidine|azacitidine|mesh-list
110145735|NCT00005934|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110145736|NCT00005934|Antimetabolites|antimetabolites|mesh-ancestor
110145737|NCT00005934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110145738|NCT00005934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110145739|NCT00005934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110145740|NCT00005940|Iodine|iodine|mesh-list
110145741|NCT00005940|Cyclosporine|cyclosporine|mesh-list
110145742|NCT00005940|Cyclophosphamide|cyclophosphamide|mesh-list
110145743|NCT00005940|Busulfan|busulfan|mesh-list
110145744|NCT00005940|Methotrexate|methotrexate|mesh-list
110145745|NCT00005940|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110145746|NCT00005940|Cyclosporins|cyclosporins|mesh-list
110145747|NCT00005940|Antibodies|antibodies|mesh-list
110145748|NCT00005940|Immunoglobulins|immunoglobulins|mesh-list
110145749|NCT00005940|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110145750|NCT00005940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110145751|NCT00005940|Immunologic Factors|immunologic factors|mesh-ancestor
110145752|NCT00005940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110145753|NCT00005940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110145754|NCT00005940|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110145756|NCT00005940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110145757|NCT00005940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110145758|NCT00005940|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110145759|NCT00005940|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110145760|NCT00005940|Abortifacient Agents|abortifacient agents|mesh-ancestor
110145761|NCT00005940|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110145762|NCT00005940|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110145763|NCT00005940|Antimetabolites|antimetabolites|mesh-ancestor
110145764|NCT00005940|Dermatologic Agents|dermatologic agents|mesh-ancestor
110145765|NCT00005940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110145766|NCT00005940|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110145767|NCT00005940|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110145768|NCT00005940|Antifungal Agents|antifungal agents|mesh-ancestor
110145769|NCT00005940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110145770|NCT00005940|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110145771|NCT00005940|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110145772|NCT00005940|Trace Elements|trace elements|mesh-ancestor
110145773|NCT00005940|Micronutrients|micronutrients|mesh-ancestor
110145774|NCT00005943|Aldesleukin|aldesleukin|mesh-list
110145775|NCT00005943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110145776|NCT00005943|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110145777|NCT00005943|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110145778|NCT00005943|Antiviral Agents|antiviral agents|mesh-ancestor
110145779|NCT00005943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110145780|NCT00005946|Cyclophosphamide|cyclophosphamide|mesh-list
110145781|NCT00005946|Etoposide|etoposide|mesh-list
110145782|NCT00005946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110145783|NCT00005946|Immunologic Factors|immunologic factors|mesh-ancestor
110145784|NCT00005946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110145785|NCT00005946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110145786|NCT00005946|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110145787|NCT00005946|Alkylating Agents|alkylating agents|mesh-ancestor
110072546|NCT01572116|Epinephryl borate|epinephryl borate|mesh-list
110145788|NCT00005946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110145790|NCT00005946|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110145791|NCT00005946|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110145792|NCT00005946|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110145793|NCT00005946|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110145794|NCT00005946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110145795|NCT00005949|Aldesleukin|aldesleukin|mesh-list
110145796|NCT00005949|Interleukin-2|interleukin-2|mesh-list
110145797|NCT00005949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110145798|NCT00005949|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110145799|NCT00005949|Analgesics|analgesics|mesh-ancestor
110145800|NCT00005949|Sensory System Agents|sensory system agents|mesh-ancestor
110145801|NCT00005949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110145802|NCT00005949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110145804|NCT00005949|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110145805|NCT00005949|Antiviral Agents|antiviral agents|mesh-ancestor
110145806|NCT00005949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110145807|NCT00005952|Temozolomide|temozolomide|mesh-list
110145808|NCT00005952|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110145809|NCT00005952|Alkylating Agents|alkylating agents|mesh-ancestor
110145810|NCT00005952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110145811|NCT00005952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110145812|NCT00005955|Temozolomide|temozolomide|mesh-list
110145813|NCT00005955|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110145814|NCT00005955|Alkylating Agents|alkylating agents|mesh-ancestor
110145815|NCT00005955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110145816|NCT00005955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110145817|NCT00005958|Gemcitabine|gemcitabine|mesh-list
110145819|NCT00005958|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110145820|NCT00005958|Antimetabolites|antimetabolites|mesh-ancestor
110145821|NCT00005958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110145822|NCT00005958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110072730|NCT01572649|Lixisenatide|lixisenatide|mesh-list
110145823|NCT00005958|Tubulin Modulators|tubulin modulators|mesh-ancestor
110145824|NCT00005958|Antimitotic Agents|antimitotic agents|mesh-ancestor
110168014|NCT00389090|Temozolomide|temozolomide|mesh-list
110145825|NCT00005958|Mitosis Modulators|mitosis modulators|mesh-ancestor
110145826|NCT00005961|Carmustine|carmustine|mesh-list
110145827|NCT00005961|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
110145828|NCT00005961|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110145829|NCT00005961|Alkylating Agents|alkylating agents|mesh-ancestor
110145830|NCT00005961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110145831|NCT00005961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110145832|NCT00005961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110145833|NCT00005964|Prednisone|prednisone|mesh-list
110145834|NCT00005964|Cyclophosphamide|cyclophosphamide|mesh-list
110145835|NCT00005964|Doxorubicin|doxorubicin|mesh-list
110145836|NCT00005964|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110145837|NCT00005964|Etoposide|etoposide|mesh-list
110145838|NCT00005964|Vincristine|vincristine|mesh-list
110145839|NCT00005964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110145840|NCT00005964|Immunologic Factors|immunologic factors|mesh-ancestor
110145841|NCT00005964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110145842|NCT00005964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110145843|NCT00005964|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110145844|NCT00005964|Alkylating Agents|alkylating agents|mesh-ancestor
110145845|NCT00005964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110145846|NCT00005964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110145847|NCT00005964|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110145848|NCT00005964|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110145849|NCT00005964|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110145850|NCT00005964|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110145851|NCT00005964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110145852|NCT00005964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110145853|NCT00005964|Glucocorticoids|glucocorticoids|mesh-ancestor
110145854|NCT00005964|Hormones|hormones|mesh-ancestor
110145855|NCT00005964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110145856|NCT00005964|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110145857|NCT00005964|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110145859|NCT00005964|Antimitotic Agents|antimitotic agents|mesh-ancestor
110145860|NCT00005964|Mitosis Modulators|mitosis modulators|mesh-ancestor
110145861|NCT00005967|Tipifarnib|tipifarnib|mesh-list
110145862|NCT00005967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110145863|NCT00005970|Tamoxifen|tamoxifen|mesh-list
110145864|NCT00005970|Paclitaxel|paclitaxel|mesh-list
110145865|NCT00005970|Cyclophosphamide|cyclophosphamide|mesh-list
110145866|NCT00005970|Doxorubicin|doxorubicin|mesh-list
110072914|NCT01574261|Inositol|inositol|mesh-list
110145867|NCT00005970|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110145868|NCT00005970|Trastuzumab|trastuzumab|mesh-list
110145869|NCT00005970|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110145870|NCT00005970|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
110145871|NCT00005970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110145872|NCT00005970|Antibodies|antibodies|mesh-list
110145873|NCT00005970|Immunoglobulins|immunoglobulins|mesh-list
110145874|NCT00005970|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110145875|NCT00005970|Aromatase Inhibitors|aromatase inhibitors|mesh-list
110145876|NCT00005970|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110145877|NCT00005970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110145878|NCT00005970|Tubulin Modulators|tubulin modulators|mesh-ancestor
110145879|NCT00005970|Antimitotic Agents|antimitotic agents|mesh-ancestor
110145880|NCT00005970|Mitosis Modulators|mitosis modulators|mesh-ancestor
110145881|NCT00005970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110145882|NCT00005970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110145883|NCT00005970|Immunologic Factors|immunologic factors|mesh-ancestor
110145884|NCT00005970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110145885|NCT00005970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110145886|NCT00005970|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110145887|NCT00005970|Alkylating Agents|alkylating agents|mesh-ancestor
110145888|NCT00005970|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110145889|NCT00005970|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110145890|NCT00005970|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110145891|NCT00005970|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110145892|NCT00005970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110145893|NCT00005970|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110145894|NCT00005970|Hormone Antagonists|hormone antagonists|mesh-ancestor
110168017|NCT00389090|Alkylating Agents|alkylating agents|mesh-ancestor
110145895|NCT00005970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110145896|NCT00005970|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110145897|NCT00005970|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110145898|NCT00005970|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110145899|NCT00005970|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110073018|NCT01575613|Lumefantrine|lumefantrine|mesh-list
110145901|NCT00005976|Carboplatin|carboplatin|mesh-list
110145902|NCT00005976|NSC 366140|nsc 366140|mesh-list
110145903|NCT00005976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110145904|NCT00005979|Leucovorin|leucovorin|mesh-list
110145905|NCT00005979|Fluorouracil|fluorouracil|mesh-list
110145906|NCT00005979|Irinotecan|irinotecan|mesh-list
110145907|NCT00005979|Calcium|calcium|mesh-list
110145908|NCT00005979|Levoleucovorin|levoleucovorin|mesh-list
110145909|NCT00005979|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110145910|NCT00005979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110145911|NCT00005979|Antimetabolites|antimetabolites|mesh-ancestor
110145912|NCT00005979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110145913|NCT00005979|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110073130|NCT01576627|Zinc|zinc|mesh-list
110145914|NCT00005979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110145915|NCT00005979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110145916|NCT00005979|Immunologic Factors|immunologic factors|mesh-ancestor
110145917|NCT00005979|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110145918|NCT00005979|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110145919|NCT00005979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110145920|NCT00005979|Antidotes|antidotes|mesh-ancestor
110145921|NCT00005979|Protective Agents|protective agents|mesh-ancestor
110145922|NCT00005979|Vitamin B Complex|vitamin b complex|mesh-ancestor
110145923|NCT00005979|Vitamins|vitamins|mesh-ancestor
110145924|NCT00005979|Micronutrients|micronutrients|mesh-ancestor
110145925|NCT00005985|Cytarabine|cytarabine|mesh-list
110145926|NCT00005985|Dexamethasone|dexamethasone|mesh-list
110145927|NCT00005985|Cyclophosphamide|cyclophosphamide|mesh-list
110145928|NCT00005985|Carmustine|carmustine|mesh-list
110145930|NCT00005985|Mitoxantrone|mitoxantrone|mesh-list
110145931|NCT00005985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110145932|NCT00005985|Immunologic Factors|immunologic factors|mesh-ancestor
110145933|NCT00005985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110145934|NCT00005985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110145935|NCT00005985|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110145936|NCT00005985|Alkylating Agents|alkylating agents|mesh-ancestor
110145937|NCT00005985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110073205|NCT01577017|Letrozole|letrozole|mesh-list
110145938|NCT00005985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110145939|NCT00005985|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110145940|NCT00005985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110145941|NCT00005985|Antiemetics|antiemetics|mesh-ancestor
110145942|NCT00005985|Autonomic Agents|autonomic agents|mesh-ancestor
110145943|NCT00005985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110145944|NCT00005985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110145945|NCT00005985|Glucocorticoids|glucocorticoids|mesh-ancestor
110145946|NCT00005985|Hormones|hormones|mesh-ancestor
110145947|NCT00005985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110145948|NCT00005985|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110145949|NCT00005985|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110145950|NCT00005985|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110145951|NCT00005985|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110145952|NCT00005985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110145953|NCT00005985|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110145954|NCT00005985|Antimetabolites|antimetabolites|mesh-ancestor
110145955|NCT00005985|Antiviral Agents|antiviral agents|mesh-ancestor
110145956|NCT00005985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110145957|NCT00005985|Analgesics|analgesics|mesh-ancestor
110145958|NCT00005985|Sensory System Agents|sensory system agents|mesh-ancestor
110145959|NCT00005988|Leucovorin|leucovorin|mesh-list
110145960|NCT00005988|Cyclosporine|cyclosporine|mesh-list
110145961|NCT00005988|Methylprednisolone|methylprednisolone|mesh-list
110145962|NCT00005988|Cyclophosphamide|cyclophosphamide|mesh-list
110145963|NCT00005988|Methotrexate|methotrexate|mesh-list
110145964|NCT00005988|Cyclosporins|cyclosporins|mesh-list
110145965|NCT00005988|Levoleucovorin|levoleucovorin|mesh-list
110145966|NCT00005988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110145967|NCT00005988|Immunologic Factors|immunologic factors|mesh-ancestor
110145968|NCT00005988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110145969|NCT00005988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110145970|NCT00005988|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110145971|NCT00005988|Alkylating Agents|alkylating agents|mesh-ancestor
110145972|NCT00005988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110145973|NCT00005988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110145974|NCT00005988|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110145975|NCT00005988|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110145976|NCT00005988|Abortifacient Agents|abortifacient agents|mesh-ancestor
110145977|NCT00005988|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110145978|NCT00005988|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110145979|NCT00005988|Antimetabolites|antimetabolites|mesh-ancestor
110145980|NCT00005988|Dermatologic Agents|dermatologic agents|mesh-ancestor
110145981|NCT00005988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110145982|NCT00005988|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110145983|NCT00005988|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110145984|NCT00005988|Antidotes|antidotes|mesh-ancestor
110145985|NCT00005988|Protective Agents|protective agents|mesh-ancestor
110145986|NCT00005988|Vitamin B Complex|vitamin b complex|mesh-ancestor
110145987|NCT00005988|Vitamins|vitamins|mesh-ancestor
110145988|NCT00005988|Micronutrients|micronutrients|mesh-ancestor
110145989|NCT00005988|Antifungal Agents|antifungal agents|mesh-ancestor
110145990|NCT00005988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110145991|NCT00005988|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110145992|NCT00005988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110145993|NCT00005988|Antiemetics|antiemetics|mesh-ancestor
110145994|NCT00005988|Autonomic Agents|autonomic agents|mesh-ancestor
110145995|NCT00005988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110145996|NCT00005988|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110145997|NCT00005988|Glucocorticoids|glucocorticoids|mesh-ancestor
110145998|NCT00005988|Hormones|hormones|mesh-ancestor
110145999|NCT00005988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110146000|NCT00005988|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110146001|NCT00005991|Gemcitabine|gemcitabine|mesh-list
110146002|NCT00005991|Doxorubicin|doxorubicin|mesh-list
110146003|NCT00005991|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110146004|NCT00005991|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110146005|NCT00005991|Antimetabolites|antimetabolites|mesh-ancestor
110146006|NCT00005991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110146007|NCT00005991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110146008|NCT00005991|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110146009|NCT00005991|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110146010|NCT00005991|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110146011|NCT00005991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110146012|NCT00005994|Ondansetron|ondansetron|mesh-list
110146013|NCT00005994|Antiemetics|antiemetics|mesh-ancestor
110146014|NCT00005994|Autonomic Agents|autonomic agents|mesh-ancestor
110146015|NCT00005994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110146016|NCT00005994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110146017|NCT00005994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110146019|NCT00005994|Dermatologic Agents|dermatologic agents|mesh-ancestor
110146020|NCT00005994|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110146021|NCT00005994|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110146022|NCT00005994|Serotonin Agents|serotonin agents|mesh-ancestor
110146023|NCT00005994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110146024|NCT00005994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110146025|NCT00006000|Irinotecan|irinotecan|mesh-list
110146026|NCT00006000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110146027|NCT00006000|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110146028|NCT00006000|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110146029|NCT00006000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110146030|NCT00006000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110146031|NCT00006003|Semaxinib|semaxinib|mesh-list
110146032|NCT00006003|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110146033|NCT00006003|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110146034|NCT00006003|Growth Substances|growth substances|mesh-ancestor
110146035|NCT00006003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110146036|NCT00006003|Growth Inhibitors|growth inhibitors|mesh-ancestor
110146037|NCT00006003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110146038|NCT00006003|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110146039|NCT00006003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110073479|NCT01578434|Calcium|calcium|mesh-list
110146040|NCT00006003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110146042|NCT00006006|Interferon-alpha|interferon-alpha|mesh-list
110146043|NCT00006006|Thalidomide|thalidomide|mesh-list
110146044|NCT00006006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110146045|NCT00006006|Antiviral Agents|antiviral agents|mesh-ancestor
110146046|NCT00006006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110146047|NCT00006006|Immunologic Factors|immunologic factors|mesh-ancestor
110146048|NCT00006006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110146049|NCT00006006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110146050|NCT00006006|Leprostatic Agents|leprostatic agents|mesh-ancestor
110146051|NCT00006006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110146052|NCT00006006|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110146053|NCT00006006|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110146054|NCT00006006|Growth Substances|growth substances|mesh-ancestor
110146055|NCT00006006|Growth Inhibitors|growth inhibitors|mesh-ancestor
110146056|NCT00006009|Visilizumab|visilizumab|mesh-list
110146057|NCT00006009|Immunologic Factors|immunologic factors|mesh-ancestor
110146059|NCT00006012|Paclitaxel|paclitaxel|mesh-list
110146060|NCT00006012|Etoposide|etoposide|mesh-list
110146061|NCT00006012|Topotecan|topotecan|mesh-list
110146062|NCT00006012|Amifostine|amifostine|mesh-list
110146063|NCT00006012|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110146064|NCT00006012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110146065|NCT00006012|Tubulin Modulators|tubulin modulators|mesh-ancestor
110146066|NCT00006012|Antimitotic Agents|antimitotic agents|mesh-ancestor
110146067|NCT00006012|Mitosis Modulators|mitosis modulators|mesh-ancestor
110146068|NCT00006012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110146069|NCT00006012|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110146070|NCT00006012|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110146071|NCT00006012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110146072|NCT00006012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110146073|NCT00006012|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110168035|NCT00034060|Etanercept|etanercept|mesh-list
110146074|NCT00006012|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110146075|NCT00006012|Protective Agents|protective agents|mesh-ancestor
110146076|NCT00006015|Leucovorin|leucovorin|mesh-list
110146077|NCT00006015|Fluorouracil|fluorouracil|mesh-list
110146078|NCT00006015|Oxaliplatin|oxaliplatin|mesh-list
110146079|NCT00006015|Trastuzumab|trastuzumab|mesh-list
110146080|NCT00006015|Calcium|calcium|mesh-list
110146081|NCT00006015|Levoleucovorin|levoleucovorin|mesh-list
110146082|NCT00006015|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110146083|NCT00006015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110146084|NCT00006015|Antimetabolites|antimetabolites|mesh-ancestor
110146085|NCT00006015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110146086|NCT00006015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110146087|NCT00006015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110146088|NCT00006015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110146089|NCT00006015|Immunologic Factors|immunologic factors|mesh-ancestor
110146090|NCT00006015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110146091|NCT00006015|Antidotes|antidotes|mesh-ancestor
110146092|NCT00006015|Protective Agents|protective agents|mesh-ancestor
110146093|NCT00006015|Vitamin B Complex|vitamin b complex|mesh-ancestor
110146094|NCT00006015|Vitamins|vitamins|mesh-ancestor
110146095|NCT00006015|Micronutrients|micronutrients|mesh-ancestor
110146096|NCT00006018|Paclitaxel|paclitaxel|mesh-list
110146097|NCT00006018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110146098|NCT00006018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110146099|NCT00006018|Tubulin Modulators|tubulin modulators|mesh-ancestor
110146100|NCT00006018|Antimitotic Agents|antimitotic agents|mesh-ancestor
110146101|NCT00006018|Mitosis Modulators|mitosis modulators|mesh-ancestor
110146102|NCT00006018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110146103|NCT00006021|Ascorbic Acid|ascorbic acid|mesh-list
110146104|NCT00006021|Arsenic Trioxide|arsenic trioxide|mesh-list
110146106|NCT00006021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110146107|NCT00006021|Protective Agents|protective agents|mesh-ancestor
110146108|NCT00006021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110146109|NCT00006021|Vitamins|vitamins|mesh-ancestor
110146110|NCT00006021|Micronutrients|micronutrients|mesh-ancestor
110146111|NCT00006021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110146112|NCT00006024|Temozolomide|temozolomide|mesh-list
110146113|NCT00006024|Lomustine|lomustine|mesh-list
110146114|NCT00006024|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110146115|NCT00006024|Alkylating Agents|alkylating agents|mesh-ancestor
110146116|NCT00006024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110146117|NCT00006024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110146119|NCT00006027|Cisplatin|cisplatin|mesh-list
110146120|NCT00006027|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110146121|NCT00006027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110146122|NCT00006027|Tubulin Modulators|tubulin modulators|mesh-ancestor
110146123|NCT00006027|Antimitotic Agents|antimitotic agents|mesh-ancestor
110146124|NCT00006027|Mitosis Modulators|mitosis modulators|mesh-ancestor
110146125|NCT00006027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110146126|NCT00386646|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
110146127|NCT00386646|Laxatives|laxatives|mesh-ancestor
110146128|NCT00386646|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110146129|NCT00386685|Trastuzumab|trastuzumab|mesh-list
110146130|NCT00386685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110146131|NCT00386685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110146132|NCT00006030|Tamoxifen|tamoxifen|mesh-list
110146133|NCT00006030|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110146134|NCT00006030|Hormone Antagonists|hormone antagonists|mesh-ancestor
110146135|NCT00006030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110146137|NCT00006030|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110146138|NCT00006030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110146139|NCT00006030|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110146140|NCT00006030|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110146141|NCT00006030|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110146143|NCT00006033|Interleukin-2|interleukin-2|mesh-list
110146144|NCT00006033|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110146145|NCT00006033|Abortifacient Agents|abortifacient agents|mesh-ancestor
110146146|NCT00006033|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110146147|NCT00006033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110146148|NCT00006033|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110146150|NCT00006033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110146151|NCT00006033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110146152|NCT00006033|Dermatologic Agents|dermatologic agents|mesh-ancestor
110146153|NCT00006033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110146154|NCT00006033|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110146155|NCT00006033|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110146156|NCT00006033|Immunologic Factors|immunologic factors|mesh-ancestor
110146157|NCT00006033|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110146158|NCT00006033|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110146159|NCT00006033|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110146160|NCT00006033|Analgesics|analgesics|mesh-ancestor
110146161|NCT00006033|Sensory System Agents|sensory system agents|mesh-ancestor
110146162|NCT00006033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110146163|NCT00006036|Lurtotecan|lurtotecan|mesh-list
110146164|NCT00006036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110146165|NCT00006039|Interferons|interferons|mesh-list
110146166|NCT00006039|Interferon-alpha|interferon-alpha|mesh-list
110146167|NCT00006039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110146168|NCT00006039|Antiviral Agents|antiviral agents|mesh-ancestor
110146169|NCT00006039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110146170|NCT00006039|Immunologic Factors|immunologic factors|mesh-ancestor
110146171|NCT00006039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110146173|NCT00006042|Cyclophosphamide|cyclophosphamide|mesh-list
110146174|NCT00006042|Fludarabine|fludarabine|mesh-list
110146175|NCT00006042|Fludarabine phosphate|fludarabine phosphate|mesh-list
110146176|NCT00006042|Tacrolimus|tacrolimus|mesh-list
110146177|NCT00006042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110146178|NCT00006042|Immunologic Factors|immunologic factors|mesh-ancestor
110146179|NCT00006042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110146180|NCT00006042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110146181|NCT00006042|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110146182|NCT00006042|Alkylating Agents|alkylating agents|mesh-ancestor
110146183|NCT00006042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110146184|NCT00006042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110146185|NCT00006042|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110146186|NCT00006042|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110146187|NCT00006042|Antimetabolites|antimetabolites|mesh-ancestor
110146188|NCT00006042|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110146189|NCT00006042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110146190|NCT00006042|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110146191|NCT00006042|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110146192|NCT00006042|Antitubercular Agents|antitubercular agents|mesh-ancestor
110146193|NCT00006042|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110146194|NCT00006042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110146195|NCT05680974|Antibodies|antibodies|mesh-list
110146196|NCT05680974|Immunologic Factors|immunologic factors|mesh-ancestor
110146197|NCT05680974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110146198|NCT00386763|Lumefantrine|lumefantrine|mesh-list
110146199|NCT00386763|Artemether|artemether|mesh-list
110146200|NCT00386763|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
110146202|NCT00386763|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110146203|NCT00386763|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110146204|NCT00386763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110146205|NCT05680662|Metformin|metformin|mesh-list
110146206|NCT05680662|Quercetin|quercetin|mesh-list
110146207|NCT05680662|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110146208|NCT05680662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110146209|NCT05680662|Antioxidants|antioxidants|mesh-ancestor
110146210|NCT05680662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110146211|NCT05680662|Protective Agents|protective agents|mesh-ancestor
110146212|NCT05680545|Sevoflurane|sevoflurane|mesh-list
110146213|NCT05680545|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110146214|NCT05680545|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110146215|NCT05680545|Anesthetics, General|anesthetics, general|mesh-ancestor
110146216|NCT05680545|Anesthetics|anesthetics|mesh-ancestor
110146217|NCT05680545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110146220|NCT05680389|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110146221|NCT05680389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110146222|NCT05680194|Diphosphonates|diphosphonates|mesh-list
110146223|NCT05680194|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110146224|NCT05680194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110146225|NCT00386802|Antifungal Agents|antifungal agents|mesh-list
110146226|NCT00386802|Clotrimazole|clotrimazole|mesh-list
110146227|NCT00386802|Miconazole|miconazole|mesh-list
110146228|NCT00386802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110146229|NCT00386802|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110146230|NCT00386802|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110146231|NCT00386802|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110146232|NCT00386802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110146233|NCT00386802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110146234|NCT00386802|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110146235|NCT00386802|Hormone Antagonists|hormone antagonists|mesh-ancestor
110146236|NCT00386802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110074249|NCT01591850|Antifungal Agents|antifungal agents|mesh-ancestor
110074263|NCT01591902|Tesamorelin|tesamorelin|mesh-list
110146237|NCT00386802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110146238|NCT00386802|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110146239|NCT00386802|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110146240|NCT00386841|Escitalopram|escitalopram|mesh-list
110146241|NCT00386841|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110146242|NCT00386841|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110146243|NCT00386841|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110146244|NCT00386841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110146245|NCT00386841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110146246|NCT00386841|Serotonin Agents|serotonin agents|mesh-ancestor
110146247|NCT00386841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110146248|NCT05679453|Etodolac|etodolac|mesh-list
110146249|NCT05679453|Lornoxicam|lornoxicam|mesh-list
110146250|NCT05679453|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110146252|NCT05679453|Analgesics|analgesics|mesh-ancestor
110146253|NCT05679453|Sensory System Agents|sensory system agents|mesh-ancestor
110146254|NCT05679453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110146255|NCT05679453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110146256|NCT05679453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110146257|NCT05679453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110146258|NCT05679453|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110146259|NCT05679453|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110146260|NCT05679453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110146261|NCT05679453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110146262|NCT05679375|Ketamine|ketamine|mesh-list
110146263|NCT05679375|Analgesics|analgesics|mesh-ancestor
110146264|NCT05679375|Sensory System Agents|sensory system agents|mesh-ancestor
110146265|NCT05679375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110146266|NCT05679375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110146267|NCT05679375|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110146268|NCT05679375|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110168098|NCT00014001|Fluphenazine|fluphenazine|mesh-list
110146269|NCT05679375|Anesthetics, General|anesthetics, general|mesh-ancestor
110146271|NCT05679375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110146272|NCT05679375|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110146273|NCT05679375|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110146274|NCT05679375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110146275|NCT05679375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110146276|NCT05679336|Cyclophosphamide|cyclophosphamide|mesh-list
110146278|NCT05679336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110146279|NCT05679336|Immunologic Factors|immunologic factors|mesh-ancestor
110146280|NCT05679336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110146281|NCT05679336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110146282|NCT05679336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110146284|NCT05679336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110146285|NCT05679336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110146286|NCT05679336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110146287|NCT05679336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110146288|NCT05677152|Zoledronic Acid|zoledronic acid|mesh-list
110146289|NCT05677152|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110146290|NCT05677152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110146291|NCT05626725|Insulin|insulin|mesh-list
110146292|NCT05626725|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110146293|NCT05626725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110146294|NCT05597163|Atropine|atropine|mesh-list
110146295|NCT05597163|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110146296|NCT05597163|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110146297|NCT05597163|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110146298|NCT05597163|Autonomic Agents|autonomic agents|mesh-ancestor
110146299|NCT05597163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110146300|NCT05597163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110146301|NCT05597163|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110146302|NCT05597163|Respiratory System Agents|respiratory system agents|mesh-ancestor
110146303|NCT05597163|Mydriatics|mydriatics|mesh-ancestor
110146304|NCT05597163|Parasympatholytics|parasympatholytics|mesh-ancestor
110146305|NCT05597163|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110146306|NCT05597163|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110146307|NCT05597163|Cholinergic Agents|cholinergic agents|mesh-ancestor
110146308|NCT05597163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110146309|NCT05597163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110146310|NCT05550129|Metformin|metformin|mesh-list
110146311|NCT05550129|Sotorasib|sotorasib|mesh-list
110146312|NCT05550129|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110146313|NCT05550129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110146314|NCT05550129|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110146315|NCT05550129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110146316|NCT05550129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110146317|NCT05550129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110146318|NCT00386958|Povidone-Iodine|povidone-iodine|mesh-list
110146319|NCT00386958|Povidone|povidone|mesh-list
110146320|NCT00386958|Plasma Substitutes|plasma substitutes|mesh-ancestor
110146321|NCT00386958|Blood Substitutes|blood substitutes|mesh-ancestor
110146322|NCT00386958|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110146323|NCT00386958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110146324|NCT00386997|Amphotericin B|amphotericin b|mesh-list
110146325|NCT00386997|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
110146326|NCT00386997|Amebicides|amebicides|mesh-ancestor
110146327|NCT00386997|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110146328|NCT00386997|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110146329|NCT00386997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110146330|NCT00386997|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110146331|NCT00386997|Antifungal Agents|antifungal agents|mesh-ancestor
110146332|NCT03940131|Panitumumab|panitumumab|mesh-list
110146333|NCT03940131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110146334|NCT03940131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110146335|NCT05160597|Edetic Acid|edetic acid|mesh-list
110146336|NCT05160597|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
110146337|NCT05160597|Chelating Agents|chelating agents|mesh-ancestor
110146338|NCT05160597|Sequestering Agents|sequestering agents|mesh-ancestor
110146339|NCT05160597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110146340|NCT05160597|Anticoagulants|anticoagulants|mesh-ancestor
110146341|NCT05160597|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110146342|NCT05160597|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110146343|NCT00387309|Methylnaltrexone|methylnaltrexone|mesh-list
110146344|NCT00387309|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110146345|NCT00387309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110146346|NCT00387309|Sensory System Agents|sensory system agents|mesh-ancestor
110146347|NCT00387309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110146348|NCT04921722|Sirolimus|sirolimus|mesh-list
110146349|NCT04921722|Temsirolimus|temsirolimus|mesh-list
110146350|NCT04921722|MTOR Inhibitors|mtor inhibitors|mesh-list
110146351|NCT04921722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110146352|NCT04921722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110146353|NCT04921722|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110146354|NCT04921722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110146355|NCT04921722|Antifungal Agents|antifungal agents|mesh-ancestor
110146356|NCT04921722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110146357|NCT04921722|Immunologic Factors|immunologic factors|mesh-ancestor
110146358|NCT04921722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110146359|NCT04921722|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110146360|NCT04921722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110146361|NCT04921722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110146362|NCT04833387|Antibodies|antibodies|mesh-list
110146363|NCT04833387|Immunologic Factors|immunologic factors|mesh-ancestor
110146364|NCT04833387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110146365|NCT04803084|TEMPO|tempo|mesh-list
110146366|NCT04803084|Antioxidants|antioxidants|mesh-ancestor
110146367|NCT04803084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110146368|NCT04803084|Protective Agents|protective agents|mesh-ancestor
110146369|NCT04803084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110146370|NCT04793685|Prazosin|prazosin|mesh-list
110146371|NCT04793685|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110146372|NCT04793685|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110146373|NCT04793685|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110146374|NCT04793685|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110146375|NCT04793685|Adrenergic Agents|adrenergic agents|mesh-ancestor
110146376|NCT04793685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110146377|NCT04793685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110146378|NCT04793685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110146379|NCT04552080|Amoxicillin|amoxicillin|mesh-list
110146380|NCT04552080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110146381|NCT04552080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110146382|NCT03834909|Tenofovir|tenofovir|mesh-list
110146383|NCT03834909|Emtricitabine|emtricitabine|mesh-list
110146384|NCT03834909|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110146385|NCT03834909|Antiviral Agents|antiviral agents|mesh-ancestor
110146386|NCT03834909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110146387|NCT03834909|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110146388|NCT03834909|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110146389|NCT03834909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110146390|NCT03834909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110146391|NCT03834909|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110146392|NCT03834909|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110146393|NCT04360473|Magnesium Sulfate|magnesium sulfate|mesh-list
110146395|NCT04360473|Anesthetics|anesthetics|mesh-list
110146396|NCT04360473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110146397|NCT04360473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110146398|NCT04360473|Analgesics|analgesics|mesh-ancestor
110146399|NCT04360473|Sensory System Agents|sensory system agents|mesh-ancestor
110146400|NCT04360473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110146401|NCT04360473|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110146402|NCT04360473|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110146403|NCT04360473|Anesthetics, General|anesthetics, general|mesh-ancestor
110146404|NCT04360473|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110146405|NCT04360473|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110146406|NCT04360473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110146407|NCT04360473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110146408|NCT04360473|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110146409|NCT04360473|Anticonvulsants|anticonvulsants|mesh-ancestor
110146410|NCT04360473|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110146411|NCT04360473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110074767|NCT01594489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110183170|NCT03959969|Ibuprofen|ibuprofen|mesh-list
110146412|NCT04360473|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110146413|NCT04360473|Tocolytic Agents|tocolytic agents|mesh-ancestor
110146414|NCT04360473|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110146415|NCT04305795|Pembrolizumab|pembrolizumab|mesh-list
110146416|NCT04305795|Cemiplimab|cemiplimab|mesh-list
110146417|NCT04305795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110146418|NCT04305795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110146419|NCT04305795|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110146420|NCT04305795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110146421|NCT00423384|Ibandronic Acid|ibandronic acid|mesh-list
110146422|NCT00423384|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110146423|NCT00423384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110146424|NCT03913221|Caffeine|caffeine|mesh-list
110146425|NCT03913221|Caffeine citrate|caffeine citrate|mesh-list
110146426|NCT03913221|Citric Acid|citric acid|mesh-list
110146427|NCT03913221|Sodium Citrate|sodium citrate|mesh-list
110146428|NCT03913221|Anticoagulants|anticoagulants|mesh-ancestor
110146429|NCT03913221|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110146430|NCT03913221|Chelating Agents|chelating agents|mesh-ancestor
110146431|NCT03913221|Sequestering Agents|sequestering agents|mesh-ancestor
110146432|NCT03913221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110146433|NCT03913221|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110146434|NCT03913221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110146435|NCT03913221|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110146436|NCT03913221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110146437|NCT03913221|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110146438|NCT03913221|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110146439|NCT03913221|Purinergic Agents|purinergic agents|mesh-ancestor
110146440|NCT03913221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110146442|NCT03869736|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110146443|NCT03869736|Anesthetics, General|anesthetics, general|mesh-ancestor
110146444|NCT03869736|Anesthetics|anesthetics|mesh-ancestor
110146445|NCT03869736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110146446|NCT03869736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110146447|NCT03869736|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110146448|NCT03869736|Analgesics|analgesics|mesh-ancestor
110146449|NCT03869736|Sensory System Agents|sensory system agents|mesh-ancestor
110146450|NCT03869736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110146451|NCT03786081|Bevacizumab|bevacizumab|mesh-list
110146452|NCT03786081|Pembrolizumab|pembrolizumab|mesh-list
110146453|NCT03786081|Tisotumab vedotin|tisotumab vedotin|mesh-list
110146454|NCT03786081|Carboplatin|carboplatin|mesh-list
110146455|NCT03786081|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110146456|NCT03786081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110146457|NCT03786081|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110146458|NCT03786081|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110146459|NCT03786081|Growth Substances|growth substances|mesh-ancestor
110146460|NCT03786081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110146461|NCT03786081|Growth Inhibitors|growth inhibitors|mesh-ancestor
110146462|NCT03786081|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110146463|NCT03786081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110146464|NCT03782259|Dapagliflozin|dapagliflozin|mesh-list
110146465|NCT03782259|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110146466|NCT03782259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110146467|NCT03782259|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110146468|NCT03782259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110146469|NCT03741933|Apremilast|apremilast|mesh-list
110146470|NCT03741933|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110146471|NCT03741933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110146472|NCT03741933|Analgesics|analgesics|mesh-ancestor
110146473|NCT03741933|Sensory System Agents|sensory system agents|mesh-ancestor
110146474|NCT03741933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110146475|NCT03741933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110146476|NCT03741933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110146477|NCT03741933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110146478|NCT03741933|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
110146479|NCT03741933|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110146480|NCT03741933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110146481|NCT03741933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110146482|NCT03002259|Dexamethasone|dexamethasone|mesh-list
110146483|NCT03002259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110146484|NCT03002259|Antiemetics|antiemetics|mesh-ancestor
110146485|NCT03002259|Autonomic Agents|autonomic agents|mesh-ancestor
110146486|NCT03002259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110146487|NCT03002259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110146488|NCT03002259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110146489|NCT03002259|Glucocorticoids|glucocorticoids|mesh-ancestor
110146490|NCT03002259|Hormones|hormones|mesh-ancestor
110146491|NCT03002259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110146492|NCT03002259|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110146493|NCT03002259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110146494|NCT00387504|Fenretinide|fenretinide|mesh-list
110146495|NCT00387504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110146496|NCT00387504|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110146497|NCT00387504|Protective Agents|protective agents|mesh-ancestor
110146498|NCT00387504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110146499|NCT02936505|Cyclosporine|cyclosporine|mesh-list
110146500|NCT02936505|Mycophenolic Acid|mycophenolic acid|mesh-list
110146501|NCT02936505|Tacrolimus|tacrolimus|mesh-list
110146503|NCT02936505|Thymoglobulin|thymoglobulin|mesh-list
110146504|NCT02936505|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110146505|NCT02936505|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110146506|NCT02936505|Immunologic Factors|immunologic factors|mesh-ancestor
110146507|NCT02936505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110146508|NCT02936505|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110146509|NCT02936505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110146510|NCT02936505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110146511|NCT02936505|Antifungal Agents|antifungal agents|mesh-ancestor
110146512|NCT02936505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110146513|NCT02936505|Dermatologic Agents|dermatologic agents|mesh-ancestor
110146514|NCT02936505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110146515|NCT02936505|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110146516|NCT02936505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110146517|NCT02936505|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110146518|NCT02936505|Antitubercular Agents|antitubercular agents|mesh-ancestor
110146519|NCT02936505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110146520|NCT02931903|Lithium Carbonate|lithium carbonate|mesh-list
110146521|NCT02931903|Antidepressive Agents|antidepressive agents|mesh-ancestor
110146522|NCT02931903|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110146523|NCT02931903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110146524|NCT02931903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110146525|NCT02931903|Antimanic Agents|antimanic agents|mesh-ancestor
110146526|NCT02931903|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110146527|NCT02931903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110146528|NCT02931903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110146529|NCT02648997|Nivolumab|nivolumab|mesh-list
110146530|NCT02648997|Ipilimumab|ipilimumab|mesh-list
110146531|NCT02648997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110146532|NCT02648997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110146533|NCT02648997|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110146534|NCT02648997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110146535|NCT02593110|Telmisartan|telmisartan|mesh-list
110146536|NCT02593110|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110146537|NCT02593110|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110146538|NCT02593110|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110146539|NCT02593110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110146541|NCT02373813|Etanercept|etanercept|mesh-list
110146542|NCT02373813|Methotrexate|methotrexate|mesh-list
110146543|NCT02373813|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110146544|NCT02373813|Abortifacient Agents|abortifacient agents|mesh-ancestor
110146545|NCT02373813|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110146546|NCT02373813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110146547|NCT02373813|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110146548|NCT02373813|Antimetabolites|antimetabolites|mesh-ancestor
110146549|NCT02373813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110146550|NCT02373813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110146551|NCT02373813|Dermatologic Agents|dermatologic agents|mesh-ancestor
110146552|NCT02373813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110146553|NCT02373813|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110146554|NCT02373813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110146555|NCT02373813|Immunologic Factors|immunologic factors|mesh-ancestor
110146556|NCT02373813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110146557|NCT02373813|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110146558|NCT02373813|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110146559|NCT02373813|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110146560|NCT02373813|Analgesics|analgesics|mesh-ancestor
110146561|NCT02373813|Sensory System Agents|sensory system agents|mesh-ancestor
110146562|NCT02373813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110146563|NCT02373813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110146564|NCT02373813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110146565|NCT02373813|Hematinics|hematinics|mesh-ancestor
110146566|NCT02373813|Vitamin B Complex|vitamin b complex|mesh-ancestor
110146567|NCT02373813|Vitamins|vitamins|mesh-ancestor
110146568|NCT02373813|Micronutrients|micronutrients|mesh-ancestor
110146569|NCT01959204|Oxycodone|oxycodone|mesh-list
110146570|NCT01959204|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110146571|NCT01959204|Narcotics|narcotics|mesh-ancestor
110146572|NCT01959204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110146573|NCT01959204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110146574|NCT01959204|Analgesics|analgesics|mesh-ancestor
110146575|NCT01959204|Sensory System Agents|sensory system agents|mesh-ancestor
110146576|NCT01959204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110146577|NCT01853748|Paclitaxel|paclitaxel|mesh-list
110146578|NCT01853748|Maytansine|maytansine|mesh-list
110146579|NCT01853748|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
110146580|NCT01853748|Trastuzumab|trastuzumab|mesh-list
110146581|NCT01853748|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110146582|NCT01853748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110146583|NCT01853748|Tubulin Modulators|tubulin modulators|mesh-ancestor
110146584|NCT01853748|Antimitotic Agents|antimitotic agents|mesh-ancestor
110146585|NCT01853748|Mitosis Modulators|mitosis modulators|mesh-ancestor
110146586|NCT01853748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110146587|NCT01853748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110146588|NCT01853748|Immunotoxins|immunotoxins|mesh-ancestor
110146589|NCT01853748|Immunoconjugates|immunoconjugates|mesh-ancestor
110146590|NCT01853748|Immunologic Factors|immunologic factors|mesh-ancestor
110146591|NCT01853748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110146593|NCT00006045|Etoposide|etoposide|mesh-list
110146594|NCT00006045|Mitoxantrone|mitoxantrone|mesh-list
110146595|NCT00006045|Lintuzumab|lintuzumab|mesh-list
110146596|NCT00006045|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110074953|NCT01595737|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110146597|NCT00006045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110146598|NCT00006045|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110146599|NCT00006045|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110146600|NCT00006045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110146601|NCT00006045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110146602|NCT00006045|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110146603|NCT00006045|Antimetabolites|antimetabolites|mesh-ancestor
110146604|NCT00006045|Antiviral Agents|antiviral agents|mesh-ancestor
110146605|NCT00006045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110146606|NCT00006045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110146607|NCT00006045|Immunologic Factors|immunologic factors|mesh-ancestor
110146608|NCT00006045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110146609|NCT00006045|Analgesics|analgesics|mesh-ancestor
110146610|NCT00006045|Sensory System Agents|sensory system agents|mesh-ancestor
110146611|NCT00006045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110146612|NCT00006045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110146613|NCT00006048|Gemcitabine|gemcitabine|mesh-list
110146614|NCT00006048|Gefitinib|gefitinib|mesh-list
110146615|NCT00006048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110146616|NCT00006048|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110146617|NCT00006048|Antimetabolites|antimetabolites|mesh-ancestor
110146618|NCT00006048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110146619|NCT00006048|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110146620|NCT00006048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110146621|NCT00006051|Fluorouracil|fluorouracil|mesh-list
110146622|NCT00006051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110146623|NCT00006051|Antimetabolites|antimetabolites|mesh-ancestor
110146624|NCT00006051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110146625|NCT00006051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110146626|NCT00006051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110146627|NCT00006051|Immunologic Factors|immunologic factors|mesh-ancestor
110146628|NCT00006051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110146630|NCT00006054|Prednisone|prednisone|mesh-list
110146631|NCT00006054|Methylprednisolone|methylprednisolone|mesh-list
110146632|NCT00006054|Cyclophosphamide|cyclophosphamide|mesh-list
110146633|NCT00006054|Busulfan|busulfan|mesh-list
110146634|NCT00006054|Methotrexate|methotrexate|mesh-list
110146635|NCT00006054|Etoposide|etoposide|mesh-list
110146636|NCT00006054|Cyclosporins|cyclosporins|mesh-list
110146637|NCT00006054|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110146638|NCT00006054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110146639|NCT00006054|Immunologic Factors|immunologic factors|mesh-ancestor
110146640|NCT00006054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110146641|NCT00006054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110146642|NCT00006054|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110146643|NCT00006054|Alkylating Agents|alkylating agents|mesh-ancestor
110146644|NCT00006054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110146645|NCT00006054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110146646|NCT00006054|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110146647|NCT00006054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110146648|NCT00006054|Glucocorticoids|glucocorticoids|mesh-ancestor
110146649|NCT00006054|Hormones|hormones|mesh-ancestor
110146650|NCT00006054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110146651|NCT00006054|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110075044|NCT01596010|Estradiol|estradiol|mesh-list
110146652|NCT00006054|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110146653|NCT00006054|Abortifacient Agents|abortifacient agents|mesh-ancestor
110146654|NCT00006054|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110146655|NCT00006054|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110146657|NCT00006054|Dermatologic Agents|dermatologic agents|mesh-ancestor
110146658|NCT00006054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110146659|NCT00006054|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110146660|NCT00006054|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110146661|NCT00006054|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110146662|NCT00006054|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110146663|NCT00006054|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110146664|NCT00006054|Antifungal Agents|antifungal agents|mesh-ancestor
110146665|NCT00006054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110146666|NCT00006054|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110146667|NCT00006054|Antiemetics|antiemetics|mesh-ancestor
110146668|NCT00006054|Autonomic Agents|autonomic agents|mesh-ancestor
110146669|NCT00006054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110146670|NCT00006054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110146671|NCT00006054|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110146672|NCT00006054|Protective Agents|protective agents|mesh-ancestor
110146673|NCT00006063|Pancrelipase|pancrelipase|mesh-list
110146674|NCT00006063|Pancreatin|pancreatin|mesh-list
110146675|NCT00006063|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110146676|NCT00006066|Aldesleukin|aldesleukin|mesh-list
110146677|NCT00006066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110146678|NCT00006066|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110146679|NCT00006066|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110146680|NCT00006066|Antiviral Agents|antiviral agents|mesh-ancestor
110146681|NCT00006066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110146682|NCT00006072|Rituximab|rituximab|mesh-list
110146683|NCT00006072|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110146684|NCT00006072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110146685|NCT00006072|Immunologic Factors|immunologic factors|mesh-ancestor
110146686|NCT00006072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110146687|NCT00006072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110146688|NCT00006075|Chlorhexidine|chlorhexidine|mesh-list
110146689|NCT00006075|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110146690|NCT00006075|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110146691|NCT00006075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110146692|NCT00006075|Disinfectants|disinfectants|mesh-ancestor
110146693|NCT00006075|Dermatologic Agents|dermatologic agents|mesh-ancestor
110146694|NCT00006078|Lycopene|lycopene|mesh-list
110146695|NCT00006078|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110146696|NCT00006078|Antioxidants|antioxidants|mesh-ancestor
110075082|NCT01596166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110146697|NCT00006078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110146698|NCT00006078|Protective Agents|protective agents|mesh-ancestor
110146699|NCT00006078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110146700|NCT00006078|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110146701|NCT00006078|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110146702|NCT00006078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110146704|NCT00006081|Bryostatin 1|bryostatin 1|mesh-list
110146705|NCT00006081|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110146706|NCT00006081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110146707|NCT00006081|Tubulin Modulators|tubulin modulators|mesh-ancestor
110146708|NCT00006081|Antimitotic Agents|antimitotic agents|mesh-ancestor
110146709|NCT00006081|Mitosis Modulators|mitosis modulators|mesh-ancestor
110146710|NCT00006081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110168173|NCT00000674|Leucovorin|leucovorin|mesh-list
110146711|NCT00006081|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110146712|NCT00006081|Immunologic Factors|immunologic factors|mesh-ancestor
110146713|NCT00006081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110146714|NCT00006084|Lintuzumab|lintuzumab|mesh-list
110146715|NCT00006084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110146716|NCT00006084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110146717|NCT00006090|Arsenic Trioxide|arsenic trioxide|mesh-list
110146718|NCT00006090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110146719|NCT00006096|Cisplatin|cisplatin|mesh-list
110146720|NCT00006096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110146721|NCT00006105|Gemcitabine|gemcitabine|mesh-list
110146722|NCT00006105|Amifostine|amifostine|mesh-list
110146723|NCT00006105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110146724|NCT00006105|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110146725|NCT00006105|Antimetabolites|antimetabolites|mesh-ancestor
110146726|NCT00006105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110146727|NCT00006105|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110146728|NCT00006105|Protective Agents|protective agents|mesh-ancestor
110146729|NCT00006105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110146730|NCT00006108|Paclitaxel|paclitaxel|mesh-list
110146731|NCT00006108|Capecitabine|capecitabine|mesh-list
110146732|NCT00006108|Trastuzumab|trastuzumab|mesh-list
110146733|NCT00006108|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110146734|NCT00006108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110146735|NCT00006108|Tubulin Modulators|tubulin modulators|mesh-ancestor
110146736|NCT00006108|Antimitotic Agents|antimitotic agents|mesh-ancestor
110146737|NCT00006108|Mitosis Modulators|mitosis modulators|mesh-ancestor
110146738|NCT00006108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110146739|NCT00006108|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110146740|NCT00006108|Antimetabolites|antimetabolites|mesh-ancestor
110146741|NCT00006108|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110146742|NCT00006111|Fluorouracil|fluorouracil|mesh-list
110146743|NCT00006111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110146744|NCT00006111|Antimetabolites|antimetabolites|mesh-ancestor
110146745|NCT00006111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110146746|NCT00006111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110146747|NCT00006111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110146748|NCT00006111|Immunologic Factors|immunologic factors|mesh-ancestor
110146749|NCT00006111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110146750|NCT00006114|Vinorelbine|vinorelbine|mesh-list
110146751|NCT00006114|Mitoxantrone|mitoxantrone|mesh-list
110146752|NCT00006114|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110146753|NCT00006114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110146755|NCT00006114|Antimitotic Agents|antimitotic agents|mesh-ancestor
110146756|NCT00006114|Mitosis Modulators|mitosis modulators|mesh-ancestor
110146757|NCT00006114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110146758|NCT00006114|Analgesics|analgesics|mesh-ancestor
110146759|NCT00006114|Sensory System Agents|sensory system agents|mesh-ancestor
110146760|NCT00006114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110146761|NCT00006114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110146763|NCT00006114|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110146764|NCT00006114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110146765|NCT00006117|Gemcitabine|gemcitabine|mesh-list
110146766|NCT00006117|Oxaliplatin|oxaliplatin|mesh-list
110146767|NCT00006117|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110146768|NCT00006117|Antimetabolites|antimetabolites|mesh-ancestor
110146769|NCT00006117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110146770|NCT00006117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110146771|NCT00006120|Paclitaxel|paclitaxel|mesh-list
110146772|NCT00006120|Docetaxel|docetaxel|mesh-list
110146773|NCT00006120|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110146774|NCT00006120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110146775|NCT00006120|Tubulin Modulators|tubulin modulators|mesh-ancestor
110146776|NCT00006120|Antimitotic Agents|antimitotic agents|mesh-ancestor
110146777|NCT00006120|Mitosis Modulators|mitosis modulators|mesh-ancestor
110075204|NCT01596647|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110146778|NCT00006120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110146779|NCT00006123|Cyclophosphamide|cyclophosphamide|mesh-list
110146780|NCT00006123|Thiotepa|thiotepa|mesh-list
110146781|NCT00006123|Carmustine|carmustine|mesh-list
110146782|NCT00006123|Carboplatin|carboplatin|mesh-list
110146783|NCT00006123|Trastuzumab|trastuzumab|mesh-list
110146784|NCT00006123|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110146785|NCT00006123|Immunologic Factors|immunologic factors|mesh-ancestor
110146786|NCT00006123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110146787|NCT00006123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110146788|NCT00006123|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110146789|NCT00006123|Alkylating Agents|alkylating agents|mesh-ancestor
110146790|NCT00006123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110146791|NCT00006123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110146792|NCT00006123|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110146793|NCT00006123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110146794|NCT00006126|Cyclophosphamide|cyclophosphamide|mesh-list
110146796|NCT00006126|Fludarabine|fludarabine|mesh-list
110146797|NCT00006126|Fludarabine phosphate|fludarabine phosphate|mesh-list
110146798|NCT00006126|Etoposide|etoposide|mesh-list
110146799|NCT00006126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110146800|NCT00006126|Immunologic Factors|immunologic factors|mesh-ancestor
110146801|NCT00006126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110146802|NCT00006126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110146803|NCT00006126|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110146804|NCT00006126|Alkylating Agents|alkylating agents|mesh-ancestor
110146805|NCT00006126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110146806|NCT00006126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110146807|NCT00006126|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110146808|NCT00006126|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110146809|NCT00006126|Antimetabolites|antimetabolites|mesh-ancestor
110146810|NCT00006126|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110146811|NCT00006126|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110146812|NCT00006126|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110146813|NCT00006126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110146815|NCT00006129|Androgens|androgens|mesh-ancestor
110146816|NCT00006129|Hormones|hormones|mesh-ancestor
110146817|NCT00006129|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110146818|NCT00006129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110146819|NCT00006132|Acyclovir|acyclovir|mesh-list
110146820|NCT00006132|Antiviral Agents|antiviral agents|mesh-ancestor
110146821|NCT00006132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110146822|NCT00006135|Acyclovir|acyclovir|mesh-list
110146823|NCT00006135|Antiviral Agents|antiviral agents|mesh-ancestor
110146824|NCT00006135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110146825|NCT00006144|Ritonavir|ritonavir|mesh-list
110146826|NCT00006144|Lopinavir|lopinavir|mesh-list
110146827|NCT00006144|Emtricitabine|emtricitabine|mesh-list
110146828|NCT00006144|Stavudine|stavudine|mesh-list
110146829|NCT00006144|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110146830|NCT00006144|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110146831|NCT00006144|Protease Inhibitors|protease inhibitors|mesh-ancestor
110146832|NCT00006144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110146834|NCT00006144|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110146835|NCT00006144|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110146836|NCT00006144|Antiviral Agents|antiviral agents|mesh-ancestor
110146837|NCT00006144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110146838|NCT00006144|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110146839|NCT00006144|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110146840|NCT00006144|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110146841|NCT00006144|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110146842|NCT00006144|Antimetabolites|antimetabolites|mesh-ancestor
110146843|NCT00006168|Methotrexate|methotrexate|mesh-list
110146844|NCT00006168|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110146845|NCT00006168|Abortifacient Agents|abortifacient agents|mesh-ancestor
110146846|NCT00006168|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110146847|NCT00006168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110146848|NCT00006168|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110146849|NCT00006168|Antimetabolites|antimetabolites|mesh-ancestor
110146850|NCT00006168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110146851|NCT00006168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110146852|NCT00006168|Dermatologic Agents|dermatologic agents|mesh-ancestor
110146853|NCT00006168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110146854|NCT00006168|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110146855|NCT00006168|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110146856|NCT00006168|Immunologic Factors|immunologic factors|mesh-ancestor
110146857|NCT00006168|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110146858|NCT00006168|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110146860|NCT00006174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110146861|NCT00006174|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110146862|NCT00006174|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110146863|NCT00006174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110146864|NCT00006174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110146865|NCT00006174|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110146866|NCT00006174|Hormone Antagonists|hormone antagonists|mesh-ancestor
110146867|NCT00006174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110146868|NCT00006174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110146869|NCT00006180|Alendronate|alendronate|mesh-list
110146870|NCT00006180|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110146871|NCT00006180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110146873|NCT00006195|Risperidone|risperidone|mesh-list
110146874|NCT00006195|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110146875|NCT00006195|Serotonin Agents|serotonin agents|mesh-ancestor
110146876|NCT00006195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110146877|NCT00006195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110146878|NCT00006195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110146879|NCT00006195|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110146880|NCT00006195|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110146881|NCT00006195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110146882|NCT00006195|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110146884|NCT00006195|Dopamine Agents|dopamine agents|mesh-ancestor
110146885|NCT00006195|Antiemetics|antiemetics|mesh-ancestor
110146886|NCT00006195|Autonomic Agents|autonomic agents|mesh-ancestor
110146887|NCT00006195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110146888|NCT00006195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110146889|NCT00006195|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110146890|NCT00006195|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110146891|NCT00006195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110146892|NCT00006198|Thalidomide|thalidomide|mesh-list
110146893|NCT00006198|Doxorubicin|doxorubicin|mesh-list
110146894|NCT00006198|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110146895|NCT00006198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110146896|NCT00006198|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110146897|NCT00006198|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110146898|NCT00006198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110146899|NCT00006198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110146900|NCT00006198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110146901|NCT00006198|Immunologic Factors|immunologic factors|mesh-ancestor
110075534|NCT01597986|Estradiol|estradiol|mesh-list
110146903|NCT00006198|Leprostatic Agents|leprostatic agents|mesh-ancestor
110146904|NCT00006198|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110146905|NCT00006198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110146906|NCT00006198|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110146907|NCT00006198|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110146908|NCT00006198|Growth Substances|growth substances|mesh-ancestor
110146909|NCT00006198|Growth Inhibitors|growth inhibitors|mesh-ancestor
110146910|NCT00006204|Naltrexone|naltrexone|mesh-list
110146911|NCT00006204|Fluoxetine|fluoxetine|mesh-list
110146912|NCT00006204|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110146913|NCT00006204|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110146914|NCT00006204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110146915|NCT00006204|Sensory System Agents|sensory system agents|mesh-ancestor
110146916|NCT00006204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110146917|NCT00006204|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110146918|NCT00006204|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110146919|NCT00006204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110146920|NCT00006204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110146921|NCT00006204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110146922|NCT00006204|Serotonin Agents|serotonin agents|mesh-ancestor
110146923|NCT00006204|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110146924|NCT00006204|Antidepressive Agents|antidepressive agents|mesh-ancestor
110146926|NCT00006204|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110146927|NCT00006204|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110146928|NCT00006204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110146929|NCT00006216|Ganciclovir|ganciclovir|mesh-list
110146930|NCT00006216|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
110146931|NCT00006216|Antiviral Agents|antiviral agents|mesh-ancestor
110146932|NCT00006216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110146933|NCT00006216|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110146934|NCT00006216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110146935|NCT00006216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110146936|NCT00006219|Clarithromycin|clarithromycin|mesh-list
110146937|NCT00006219|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
110146938|NCT00006219|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110146939|NCT00006219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110146940|NCT00006219|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110146941|NCT00006219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110146942|NCT00006219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110146943|NCT00006219|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110146944|NCT00006219|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110146945|NCT00006219|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110146946|NCT00006219|Immunologic Factors|immunologic factors|mesh-ancestor
110146947|NCT00006219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110146948|NCT00387582|Ranibizumab|ranibizumab|mesh-list
110146949|NCT00387582|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110146950|NCT00387582|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110146951|NCT00387582|Growth Substances|growth substances|mesh-ancestor
110146952|NCT00387582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110146953|NCT00387582|Growth Inhibitors|growth inhibitors|mesh-ancestor
110146954|NCT00387582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110146955|NCT00006228|Aldesleukin|aldesleukin|mesh-list
110146956|NCT00006228|Trastuzumab|trastuzumab|mesh-list
110146957|NCT00006228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110146958|NCT00006228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110146959|NCT00006228|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110146960|NCT00006228|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110146961|NCT00006228|Antiviral Agents|antiviral agents|mesh-ancestor
110146962|NCT00006228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110146963|NCT03751800|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
110146965|NCT03751800|Levonorgestrel|levonorgestrel|mesh-list
110146966|NCT03751800|Medroxyprogesterone|medroxyprogesterone|mesh-list
110146967|NCT03751800|Estradiol|estradiol|mesh-list
110146968|NCT03751800|Estrogens|estrogens|mesh-ancestor
110146969|NCT03751800|Hormones|hormones|mesh-ancestor
110146970|NCT03751800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110146971|NCT03751800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110146972|NCT03751800|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110146973|NCT03751800|Contraceptive Agents|contraceptive agents|mesh-ancestor
110146974|NCT03751800|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110146975|NCT03751800|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110146976|NCT03751800|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110146977|NCT03751800|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110146978|NCT03751800|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110146979|NCT03751800|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110146980|NCT03751800|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110146981|NCT03751800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110146982|NCT03751800|Hormone Antagonists|hormone antagonists|mesh-ancestor
110146983|NCT00006240|Dexamethasone|dexamethasone|mesh-list
110146984|NCT00006240|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
110146985|NCT00006240|Sargramostim|sargramostim|mesh-list
110146986|NCT00006240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110146987|NCT00006240|Antiemetics|antiemetics|mesh-ancestor
110146988|NCT00006240|Autonomic Agents|autonomic agents|mesh-ancestor
110146989|NCT00006240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110146990|NCT00006240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110146991|NCT00006240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110146992|NCT00006240|Glucocorticoids|glucocorticoids|mesh-ancestor
110146994|NCT00006240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110146995|NCT00006240|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110146996|NCT00006240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110146997|NCT00006240|Immunologic Factors|immunologic factors|mesh-ancestor
110146998|NCT02972463|Immunoglobulins|immunoglobulins|mesh-list
110146999|NCT02972463|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110147000|NCT02972463|Antibodies|antibodies|mesh-list
110147001|NCT02972463|Immunologic Factors|immunologic factors|mesh-ancestor
110168335|NCT00000689|Autonomic Agents|autonomic agents|mesh-ancestor
110147002|NCT02972463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110147003|NCT00006243|Sargramostim|sargramostim|mesh-list
110147004|NCT00006243|Freund's Adjuvant|freund's adjuvant|mesh-list
110147005|NCT00006243|Immunologic Factors|immunologic factors|mesh-ancestor
110147006|NCT00006243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110147007|NCT00006243|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110147008|NCT00006246|Busulfan|busulfan|mesh-list
110147009|NCT00006246|Alkylating Agents|alkylating agents|mesh-ancestor
110147010|NCT00006246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110147011|NCT00006246|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110147012|NCT00006246|Immunologic Factors|immunologic factors|mesh-ancestor
110147013|NCT00006246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110147014|NCT00006246|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110147015|NCT00006246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110147016|NCT00006246|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110147017|NCT00006249|Interferons|interferons|mesh-list
110147018|NCT00006249|Interferon-alpha|interferon-alpha|mesh-list
110147019|NCT00006249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110147021|NCT00006249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110147022|NCT00006249|Immunologic Factors|immunologic factors|mesh-ancestor
110147023|NCT00006249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110147024|NCT00006252|Cyclophosphamide|cyclophosphamide|mesh-list
110147026|NCT00006252|Fludarabine phosphate|fludarabine phosphate|mesh-list
110147027|NCT00006252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110147028|NCT00006252|Immunologic Factors|immunologic factors|mesh-ancestor
110147029|NCT00006252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110147030|NCT00006252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110147031|NCT00006252|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110147032|NCT00006252|Alkylating Agents|alkylating agents|mesh-ancestor
110147033|NCT00006252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110075848|NCT05689671|Paclitaxel|paclitaxel|mesh-list
110147034|NCT00006252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110147035|NCT00006252|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110147036|NCT00006252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110147037|NCT00006252|Antimetabolites|antimetabolites|mesh-ancestor
110147038|NCT00006258|Cyclophosphamide|cyclophosphamide|mesh-list
110147039|NCT00006258|Methotrexate|methotrexate|mesh-list
110147040|NCT00006258|Etoposide|etoposide|mesh-list
110147041|NCT00006258|Vincristine|vincristine|mesh-list
110147042|NCT00006258|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110147043|NCT00006258|Immunologic Factors|immunologic factors|mesh-ancestor
110147044|NCT00006258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110147045|NCT00006258|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110147046|NCT00006258|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110147047|NCT00006258|Alkylating Agents|alkylating agents|mesh-ancestor
110147048|NCT00006258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110147049|NCT00006258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110147050|NCT00006258|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110147051|NCT00006258|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110147052|NCT00006258|Abortifacient Agents|abortifacient agents|mesh-ancestor
110147053|NCT00006258|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110147054|NCT00006258|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110147055|NCT00006258|Antimetabolites|antimetabolites|mesh-ancestor
110147056|NCT00006258|Dermatologic Agents|dermatologic agents|mesh-ancestor
110147057|NCT00006258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110147058|NCT00006258|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110147059|NCT00006258|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110147060|NCT00006258|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110075901|NCT05688046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110147061|NCT00006258|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110147062|NCT00006258|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110147063|NCT00006258|Tubulin Modulators|tubulin modulators|mesh-ancestor
110075906|NCT05618132|Acetylcholine|acetylcholine|mesh-list
110147065|NCT00006258|Mitosis Modulators|mitosis modulators|mesh-ancestor
110147066|NCT00006261|Cyclophosphamide|cyclophosphamide|mesh-list
110147067|NCT00006261|Docetaxel|docetaxel|mesh-list
110147068|NCT00006261|Doxorubicin|doxorubicin|mesh-list
110147069|NCT00006261|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110147070|NCT00006261|Fludarabine|fludarabine|mesh-list
110147071|NCT00006261|Fludarabine phosphate|fludarabine phosphate|mesh-list
110147072|NCT00006261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110147073|NCT00006261|Immunologic Factors|immunologic factors|mesh-ancestor
110147074|NCT00006261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110147075|NCT00006261|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110147076|NCT00006261|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110147077|NCT00006261|Alkylating Agents|alkylating agents|mesh-ancestor
110147078|NCT00006261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110147079|NCT00006261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110147080|NCT00006261|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110147081|NCT00006261|Tubulin Modulators|tubulin modulators|mesh-ancestor
110147082|NCT00006261|Antimitotic Agents|antimitotic agents|mesh-ancestor
110147083|NCT00006261|Mitosis Modulators|mitosis modulators|mesh-ancestor
110147084|NCT00006261|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110075927|NCT05540184|Antioxidants|antioxidants|mesh-ancestor
110147085|NCT00006261|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110147086|NCT00006261|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110147087|NCT00006261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110147088|NCT00006261|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110147089|NCT00006261|Antimetabolites|antimetabolites|mesh-ancestor
110147090|NCT00006264|Zidovudine|zidovudine|mesh-list
110147091|NCT00006264|Aldesleukin|aldesleukin|mesh-list
110147092|NCT00006264|Ganciclovir|ganciclovir|mesh-list
110147093|NCT00006264|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
110147094|NCT00006264|Antimetabolites|antimetabolites|mesh-ancestor
110147095|NCT00006264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110147096|NCT00006264|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110147097|NCT00006264|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110147098|NCT00006264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110147099|NCT00006264|Antiviral Agents|antiviral agents|mesh-ancestor
110147100|NCT00006264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110147101|NCT00006264|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110147102|NCT00006264|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110147103|NCT00006264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110147105|NCT00006267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110147106|NCT00006267|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110147107|NCT00006267|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110147108|NCT00006267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110147109|NCT00006267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110147111|NCT00006270|Metyrapone|metyrapone|mesh-list
110147112|NCT00006270|Hormones|hormones|mesh-ancestor
110147113|NCT00006270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110147114|NCT00006270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110147115|NCT00006270|Antimetabolites|antimetabolites|mesh-ancestor
110147116|NCT00006270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110147117|NCT00006270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110147118|NCT00006276|Paclitaxel|paclitaxel|mesh-list
110147119|NCT00006276|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110147120|NCT00006276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110147121|NCT00006276|Tubulin Modulators|tubulin modulators|mesh-ancestor
110147122|NCT00006276|Antimitotic Agents|antimitotic agents|mesh-ancestor
110147123|NCT00006276|Mitosis Modulators|mitosis modulators|mesh-ancestor
110147124|NCT00006276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110147125|NCT00006279|Nevirapine|nevirapine|mesh-list
110147126|NCT00006279|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110147127|NCT00006279|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110147128|NCT00006279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110147129|NCT00006279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110147130|NCT00006279|Antiviral Agents|antiviral agents|mesh-ancestor
110147131|NCT00006279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110147132|NCT00006279|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110147133|NCT00006279|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110147134|NCT00006279|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110147135|NCT00006279|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110147136|NCT00006291|Aldesleukin|aldesleukin|mesh-list
110147137|NCT00006291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110147138|NCT00006291|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110147139|NCT00006291|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110147140|NCT00006291|Antiviral Agents|antiviral agents|mesh-ancestor
110168370|NCT00000707|Pentamidine|pentamidine|mesh-list
110147141|NCT00006291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110076116|NCT04563494|Autonomic Agents|autonomic agents|mesh-ancestor
110147142|NCT00006294|Amlodipine|amlodipine|mesh-list
110147143|NCT00006294|Lisinopril|lisinopril|mesh-list
110147144|NCT00006294|Chlorthalidone|chlorthalidone|mesh-list
110147145|NCT00006294|Doxazosin|doxazosin|mesh-list
110147146|NCT00006294|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110147147|NCT00006294|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110147148|NCT00006294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110147149|NCT00006294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110147150|NCT00006294|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110147151|NCT00006294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110147152|NCT00006294|Vasodilator Agents|vasodilator agents|mesh-ancestor
110147153|NCT00006294|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110147154|NCT00006294|Protease Inhibitors|protease inhibitors|mesh-ancestor
110147155|NCT00006294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110147156|NCT00006294|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110147157|NCT00006294|Protective Agents|protective agents|mesh-ancestor
110147158|NCT00006294|Diuretics|diuretics|mesh-ancestor
110076171|NCT04403321|Tacrolimus|tacrolimus|mesh-list
110147159|NCT00006294|Natriuretic Agents|natriuretic agents|mesh-ancestor
110147160|NCT00006294|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110147161|NCT00006294|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110147162|NCT00006294|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110147163|NCT00006294|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110147164|NCT00006294|Adrenergic Agents|adrenergic agents|mesh-ancestor
110147165|NCT00006294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110147166|NCT00005818|Irinotecan|irinotecan|mesh-list
110147167|NCT00005818|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110147168|NCT00005818|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110147169|NCT00005818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110147170|NCT00005818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110147172|NCT00006324|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
110147173|NCT00006324|Levonorgestrel|levonorgestrel|mesh-list
110147174|NCT00006324|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110147175|NCT00006324|Medroxyprogesterone|medroxyprogesterone|mesh-list
110147176|NCT00006324|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
110147177|NCT00006324|Estradiol|estradiol|mesh-list
110147178|NCT00006324|Estrogens|estrogens|mesh-ancestor
110147179|NCT00006324|Hormones|hormones|mesh-ancestor
110076225|NCT03871153|Paclitaxel|paclitaxel|mesh-list
110147180|NCT00006324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110147181|NCT00006324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110147182|NCT00006324|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110147183|NCT00006324|Contraceptive Agents|contraceptive agents|mesh-ancestor
110147184|NCT00006324|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110147185|NCT00006324|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110147186|NCT00006324|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110147187|NCT00006324|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110147188|NCT00006324|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110147189|NCT00006324|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110147190|NCT00006324|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110147191|NCT00006324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110147192|NCT00006324|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110147193|NCT00005824|Cyclophosphamide|cyclophosphamide|mesh-list
110147195|NCT00005824|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110147196|NCT00005824|Immunologic Factors|immunologic factors|mesh-ancestor
110168371|NCT00000707|Antifungal Agents|antifungal agents|mesh-ancestor
110147197|NCT00005824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110147198|NCT00005824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110147199|NCT00005824|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110147200|NCT00005824|Alkylating Agents|alkylating agents|mesh-ancestor
110147201|NCT00005824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110147202|NCT00005824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110147203|NCT00005824|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110147204|NCT00005827|Genistein|genistein|mesh-list
110147205|NCT00005827|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110147206|NCT00005827|Protective Agents|protective agents|mesh-ancestor
110147207|NCT00005827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110147208|NCT00005827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110147209|NCT00005827|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110147210|NCT00005827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110147211|NCT00005827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110147212|NCT00005827|Phytoestrogens|phytoestrogens|mesh-ancestor
110147213|NCT00005827|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
110147214|NCT00005827|Estrogens|estrogens|mesh-ancestor
110147215|NCT00005827|Hormones|hormones|mesh-ancestor
110147216|NCT00005827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110147217|NCT00005830|Doxorubicin|doxorubicin|mesh-list
110147218|NCT00005830|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110147219|NCT00005830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110147220|NCT00005830|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110147221|NCT00005830|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110147222|NCT00005830|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110147223|NCT00005830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110147224|NCT00005830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110147226|NCT00005833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110147227|NCT00005836|Oxaliplatin|oxaliplatin|mesh-list
110147228|NCT00005836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110147229|NCT00006330|Digoxin|digoxin|mesh-list
110147230|NCT00006330|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110147231|NCT00006330|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110147232|NCT00006330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110147233|NCT00006330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110147234|NCT00006330|Protective Agents|protective agents|mesh-ancestor
110147235|NCT00006330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110147236|NCT00005839|Capecitabine|capecitabine|mesh-list
110147237|NCT00005839|Oxaliplatin|oxaliplatin|mesh-list
110147238|NCT00005839|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110147239|NCT00005839|Antimetabolites|antimetabolites|mesh-ancestor
110147240|NCT00005839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110147241|NCT00005839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110147242|NCT00005842|Trastuzumab|trastuzumab|mesh-list
110147243|NCT00005842|Tipifarnib|tipifarnib|mesh-list
110147244|NCT00005842|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110147245|NCT00005842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110147246|NCT00005845|Tipifarnib|tipifarnib|mesh-list
110147247|NCT00005845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110147248|NCT00005848|Tipifarnib|tipifarnib|mesh-list
110147249|NCT00005848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110147250|NCT00005851|Cyclosporine|cyclosporine|mesh-list
110147251|NCT00005851|Mycophenolic Acid|mycophenolic acid|mesh-list
110147252|NCT00005851|Fludarabine|fludarabine|mesh-list
110147253|NCT00005851|Fludarabine phosphate|fludarabine phosphate|mesh-list
110147254|NCT00005851|Cyclosporins|cyclosporins|mesh-list
110147255|NCT00005851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110147256|NCT00005851|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110147257|NCT00005851|Antimetabolites|antimetabolites|mesh-ancestor
110147258|NCT00005851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110147260|NCT00005851|Immunologic Factors|immunologic factors|mesh-ancestor
110147261|NCT00005851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110147262|NCT00005851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110147263|NCT00005851|Antifungal Agents|antifungal agents|mesh-ancestor
110147264|NCT00005851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110147265|NCT00005851|Dermatologic Agents|dermatologic agents|mesh-ancestor
110147266|NCT00005851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110147267|NCT00005851|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110147268|NCT00005851|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110147269|NCT00005851|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110147270|NCT00005851|Antitubercular Agents|antitubercular agents|mesh-ancestor
110147271|NCT00005851|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110147272|NCT00005854|Cyclosporine|cyclosporine|mesh-list
110147273|NCT00005854|Cyclophosphamide|cyclophosphamide|mesh-list
110147274|NCT00005854|Methotrexate|methotrexate|mesh-list
110147275|NCT00005854|Cyclosporins|cyclosporins|mesh-list
110168442|NCT00035035|Pemetrexed|pemetrexed|mesh-list
110147276|NCT00005854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110147277|NCT00005854|Immunologic Factors|immunologic factors|mesh-ancestor
110147278|NCT00005854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110147279|NCT00005854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110147280|NCT00005854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110147281|NCT00005854|Alkylating Agents|alkylating agents|mesh-ancestor
110147282|NCT00005854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110147283|NCT00005854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110147284|NCT00005854|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110147285|NCT00005854|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110147286|NCT00005854|Abortifacient Agents|abortifacient agents|mesh-ancestor
110147287|NCT00005854|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110147288|NCT00005854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110147290|NCT00005854|Dermatologic Agents|dermatologic agents|mesh-ancestor
110147291|NCT00005854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110147292|NCT00005854|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110147293|NCT00005854|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110147294|NCT00005854|Antifungal Agents|antifungal agents|mesh-ancestor
110147295|NCT00005854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110147296|NCT00005854|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110147297|NCT00005857|Docetaxel|docetaxel|mesh-list
110147298|NCT00005857|Trastuzumab|trastuzumab|mesh-list
110147299|NCT00005857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110147300|NCT00005857|Tubulin Modulators|tubulin modulators|mesh-ancestor
110147301|NCT00005857|Antimitotic Agents|antimitotic agents|mesh-ancestor
110147302|NCT00005857|Mitosis Modulators|mitosis modulators|mesh-ancestor
110147303|NCT00005857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110147304|NCT00005857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110147305|NCT00005860|Leucovorin|leucovorin|mesh-list
110147306|NCT00005860|Oxaliplatin|oxaliplatin|mesh-list
110147307|NCT00005860|Floxuridine|floxuridine|mesh-list
110147308|NCT00005860|Calcium|calcium|mesh-list
110147309|NCT00005860|Levoleucovorin|levoleucovorin|mesh-list
110147310|NCT00005860|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110147311|NCT00005860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110147312|NCT00005860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110147313|NCT00005860|Antidotes|antidotes|mesh-ancestor
110147314|NCT00005860|Protective Agents|protective agents|mesh-ancestor
110147315|NCT00005860|Vitamin B Complex|vitamin b complex|mesh-ancestor
110147316|NCT00005860|Vitamins|vitamins|mesh-ancestor
110147317|NCT00005860|Micronutrients|micronutrients|mesh-ancestor
110147318|NCT00005860|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110147319|NCT00005860|Antimetabolites|antimetabolites|mesh-ancestor
110147320|NCT00005860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110147321|NCT00005863|Cytarabine|cytarabine|mesh-list
110147322|NCT00005863|Fludarabine|fludarabine|mesh-list
110147323|NCT00005863|Fludarabine phosphate|fludarabine phosphate|mesh-list
110147324|NCT00005863|Etoposide|etoposide|mesh-list
110076470|NCT05458232|Tadalafil|tadalafil|mesh-list
110147326|NCT00005863|Tretinoin|tretinoin|mesh-list
110147327|NCT00005863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110147328|NCT00005863|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110147329|NCT00005863|Antimetabolites|antimetabolites|mesh-ancestor
110147330|NCT00005863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110147331|NCT00005863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110147332|NCT00005863|Immunologic Factors|immunologic factors|mesh-ancestor
110147333|NCT00005863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110147334|NCT00005863|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110147335|NCT00005863|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110147336|NCT00005863|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110147337|NCT00005863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110147338|NCT00005863|Antiviral Agents|antiviral agents|mesh-ancestor
110147339|NCT00005863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110147340|NCT00005863|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110147341|NCT00005863|Keratolytic Agents|keratolytic agents|mesh-ancestor
110147342|NCT00005863|Dermatologic Agents|dermatologic agents|mesh-ancestor
110147343|NCT00005866|Cyclosporine|cyclosporine|mesh-list
110147344|NCT00005866|Cyclophosphamide|cyclophosphamide|mesh-list
110147345|NCT00005866|Busulfan|busulfan|mesh-list
110147346|NCT00005866|Methotrexate|methotrexate|mesh-list
110147347|NCT00005866|Cyclosporins|cyclosporins|mesh-list
110147348|NCT00005866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110147349|NCT00005866|Immunologic Factors|immunologic factors|mesh-ancestor
110147350|NCT00005866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110147351|NCT00005866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110147352|NCT00005866|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110147353|NCT00005866|Alkylating Agents|alkylating agents|mesh-ancestor
110147354|NCT00005866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110147355|NCT00005866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110147356|NCT00005866|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110147357|NCT00005866|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110147358|NCT00005866|Abortifacient Agents|abortifacient agents|mesh-ancestor
110147359|NCT00005866|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110147360|NCT00005866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110147361|NCT00005866|Antimetabolites|antimetabolites|mesh-ancestor
110147362|NCT00005866|Dermatologic Agents|dermatologic agents|mesh-ancestor
110147363|NCT00005866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110147364|NCT00005866|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110147365|NCT00005866|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110147366|NCT00005866|Antifungal Agents|antifungal agents|mesh-ancestor
110147367|NCT00005866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110147368|NCT00005866|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110147369|NCT00005869|Gemcitabine|gemcitabine|mesh-list
110147370|NCT00005869|Rubitecan|rubitecan|mesh-list
110147371|NCT00005869|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110147372|NCT00005869|Antimetabolites|antimetabolites|mesh-ancestor
110168474|NCT00035074|Antimetabolites|antimetabolites|mesh-ancestor
110147373|NCT00005869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110147375|NCT00005869|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110147376|NCT00005869|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110147377|NCT00005869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110147378|NCT00005872|Rubitecan|rubitecan|mesh-list
110147379|NCT00005872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110147380|NCT00005872|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110147381|NCT00005872|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110147382|NCT00005872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110076642|NCT03736863|Apatinib|apatinib|mesh-list
110076654|NCT03703492|Estradiol|estradiol|mesh-list
110147383|NCT00005872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110147384|NCT00005875|Rubitecan|rubitecan|mesh-list
110147385|NCT00005875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110147386|NCT00005875|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110147387|NCT00005875|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110147388|NCT00005875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110147389|NCT00005875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110147390|NCT00005878|Celecoxib|celecoxib|mesh-list
110147391|NCT00005878|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110147392|NCT00005878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110147393|NCT00005878|Analgesics|analgesics|mesh-ancestor
110147394|NCT00005878|Sensory System Agents|sensory system agents|mesh-ancestor
110147395|NCT00005878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110147396|NCT00005878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110147397|NCT00005878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110147398|NCT00005878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110147399|NCT00005878|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110147400|NCT00005878|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110147401|NCT00005878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110147402|NCT00005878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110147403|NCT00005884|Eflornithine|eflornithine|mesh-list
110147404|NCT00005884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110147405|NCT00005884|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
110147406|NCT00005884|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110147407|NCT00005884|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110076691|NCT03476642|Anesthetics|anesthetics|mesh-ancestor
110147408|NCT00005884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110147409|NCT00005884|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
110147410|NCT00005884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110147411|NCT00005884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110147412|NCT00005887|Efaproxiral|efaproxiral|mesh-list
110147413|NCT00005887|Antisickling Agents|antisickling agents|mesh-ancestor
110147414|NCT00006339|Ritonavir|ritonavir|mesh-list
110147415|NCT00006339|Indinavir|indinavir|mesh-list
110147416|NCT00006339|Stavudine|stavudine|mesh-list
110147417|NCT00006339|Didanosine|didanosine|mesh-list
110147418|NCT00006339|Hydroxyurea|hydroxyurea|mesh-list
110147419|NCT00006339|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110147420|NCT00006339|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110147421|NCT00006339|Protease Inhibitors|protease inhibitors|mesh-ancestor
110147422|NCT00006339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110147423|NCT00006339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110076743|NCT03106454|Trace Elements|trace elements|mesh-ancestor
110147424|NCT00006339|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110147425|NCT00006339|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110147426|NCT00006339|Antiviral Agents|antiviral agents|mesh-ancestor
110147427|NCT00006339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110147428|NCT00006339|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110147429|NCT00006339|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110147430|NCT00006339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110147431|NCT00006339|Antisickling Agents|antisickling agents|mesh-ancestor
110147432|NCT00006339|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110147433|NCT00006339|Antimetabolites|antimetabolites|mesh-ancestor
110147434|NCT00006339|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110147435|NCT00005890|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
110147436|NCT00005890|Hormones|hormones|mesh-ancestor
110147437|NCT00005890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110147438|NCT00005890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110147439|NCT00005893|Cyclophosphamide|cyclophosphamide|mesh-list
110147440|NCT00005893|Busulfan|busulfan|mesh-list
110147441|NCT00005893|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110147442|NCT00005893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110147443|NCT00005893|Immunologic Factors|immunologic factors|mesh-ancestor
110147444|NCT00005893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110147445|NCT00005893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110147446|NCT00005893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110147447|NCT00005893|Alkylating Agents|alkylating agents|mesh-ancestor
110147448|NCT00005893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110147449|NCT00005893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110147450|NCT00005893|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110147451|NCT00005896|Lenograstim|lenograstim|mesh-list
110147452|NCT00005896|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110147453|NCT00005896|Immunologic Factors|immunologic factors|mesh-ancestor
110147454|NCT00005896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110147455|NCT00386503|Artesunate|artesunate|mesh-list
110147456|NCT00386503|Amodiaquine|amodiaquine|mesh-list
110147457|NCT00386503|Antimalarials|antimalarials|mesh-ancestor
110147458|NCT00386503|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110147459|NCT00386503|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110147460|NCT00386503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110147462|NCT00386503|Antiviral Agents|antiviral agents|mesh-ancestor
110147463|NCT00386503|Schistosomicides|schistosomicides|mesh-ancestor
110147464|NCT00386503|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110147465|NCT00386503|Anthelmintics|anthelmintics|mesh-ancestor
110147466|NCT00386581|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
110147467|NCT00386581|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110147468|NCT00386581|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110147469|NCT00386581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110147470|NCT00386581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110147471|NCT00386581|Adrenergic Agents|adrenergic agents|mesh-ancestor
110147472|NCT00386581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110147475|NCT00006345|Denileukin diftitox|denileukin diftitox|mesh-list
110147476|NCT00006345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110147477|NCT00006345|Antiemetics|antiemetics|mesh-ancestor
110147478|NCT00006345|Autonomic Agents|autonomic agents|mesh-ancestor
110168579|NCT00014430|Tubulin Modulators|tubulin modulators|mesh-ancestor
110147479|NCT00006345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110147480|NCT00006345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110076880|NCT01746173|Prednisone|prednisone|mesh-list
110147481|NCT00006345|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110147482|NCT00006345|Glucocorticoids|glucocorticoids|mesh-ancestor
110147483|NCT00006345|Hormones|hormones|mesh-ancestor
110147484|NCT00006345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110147485|NCT00006345|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110147486|NCT00006345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110147487|NCT00005920|Caspofungin|caspofungin|mesh-list
110147488|NCT00005920|Antifungal Agents|antifungal agents|mesh-ancestor
110147489|NCT00005920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110147490|NCT00005920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110147491|NCT00005920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110147492|NCT00005926|Gemcitabine|gemcitabine|mesh-list
110147493|NCT00005926|Trastuzumab|trastuzumab|mesh-list
110147494|NCT00005926|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110147495|NCT00005926|Antimetabolites|antimetabolites|mesh-ancestor
110147496|NCT00005926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110147497|NCT00005926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110147498|NCT00005926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110147499|NCT00005935|Cyclosporine|cyclosporine|mesh-list
110147500|NCT00005935|Mycophenolic Acid|mycophenolic acid|mesh-list
110147501|NCT00005935|Cyclosporins|cyclosporins|mesh-list
110147502|NCT00005935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110147503|NCT00005935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110147504|NCT00005935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110147505|NCT00005935|Immunologic Factors|immunologic factors|mesh-ancestor
110147506|NCT00005935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110147507|NCT00005935|Antifungal Agents|antifungal agents|mesh-ancestor
110147508|NCT00005935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110147509|NCT00005935|Dermatologic Agents|dermatologic agents|mesh-ancestor
110147510|NCT00005935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110147511|NCT00005935|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110147512|NCT00005935|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110147513|NCT00005935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110147514|NCT00005935|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110147515|NCT00005935|Antitubercular Agents|antitubercular agents|mesh-ancestor
110147516|NCT00005935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110147517|NCT00006348|Ondansetron|ondansetron|mesh-list
110147518|NCT00006348|Antiemetics|antiemetics|mesh-ancestor
110147519|NCT00006348|Autonomic Agents|autonomic agents|mesh-ancestor
110147520|NCT00006348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110147521|NCT00006348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110147522|NCT00006348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110147523|NCT00006348|Antipruritics|antipruritics|mesh-ancestor
110147524|NCT00006348|Dermatologic Agents|dermatologic agents|mesh-ancestor
110147525|NCT00006348|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110147526|NCT00006348|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110147527|NCT00006348|Serotonin Agents|serotonin agents|mesh-ancestor
110147528|NCT00006348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110147529|NCT00006348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110147530|NCT00005938|Exatecan|exatecan|mesh-list
110147531|NCT00005938|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110147532|NCT00005938|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110147533|NCT00005938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110147534|NCT00005938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110147535|NCT00005938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110147536|NCT00005941|Cyclosporine|cyclosporine|mesh-list
110147537|NCT00005941|Mycophenolic Acid|mycophenolic acid|mesh-list
110147538|NCT00005941|Fludarabine|fludarabine|mesh-list
110147539|NCT00005941|Fludarabine phosphate|fludarabine phosphate|mesh-list
110147540|NCT00005941|Cyclosporins|cyclosporins|mesh-list
110147541|NCT00005941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110147542|NCT00005941|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110147543|NCT00005941|Antimetabolites|antimetabolites|mesh-ancestor
110147544|NCT00005941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110147545|NCT00005941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110147546|NCT00005941|Immunologic Factors|immunologic factors|mesh-ancestor
110147547|NCT00005941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110147548|NCT00005941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110147549|NCT00005941|Antifungal Agents|antifungal agents|mesh-ancestor
110147550|NCT00005941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110147551|NCT00005941|Dermatologic Agents|dermatologic agents|mesh-ancestor
110147552|NCT00005941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110147553|NCT00005941|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110147554|NCT00005941|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110147555|NCT00005941|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110147556|NCT00005941|Antitubercular Agents|antitubercular agents|mesh-ancestor
110147557|NCT00005941|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110147558|NCT00005944|Leucovorin|leucovorin|mesh-list
110147559|NCT00005944|Fluorouracil|fluorouracil|mesh-list
110147560|NCT00005944|Mitomycins|mitomycins|mesh-list
110147561|NCT00005944|Mitomycin|mitomycin|mesh-list
110147562|NCT00005944|Calcium|calcium|mesh-list
110147563|NCT00005944|Levoleucovorin|levoleucovorin|mesh-list
110147564|NCT00005944|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110147565|NCT00005944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110147566|NCT00005944|Antimetabolites|antimetabolites|mesh-ancestor
110147567|NCT00005944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110147568|NCT00005944|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110147569|NCT00005944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110147570|NCT00005944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110147571|NCT00005944|Immunologic Factors|immunologic factors|mesh-ancestor
110147572|NCT00005944|Antidotes|antidotes|mesh-ancestor
110147573|NCT00005944|Protective Agents|protective agents|mesh-ancestor
110147574|NCT00005944|Vitamin B Complex|vitamin b complex|mesh-ancestor
110147575|NCT00005944|Vitamins|vitamins|mesh-ancestor
110147576|NCT00005944|Micronutrients|micronutrients|mesh-ancestor
110147577|NCT00005944|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110147578|NCT00005944|Alkylating Agents|alkylating agents|mesh-ancestor
110147579|NCT00005944|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110147580|NCT00005944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110147581|NCT00387699|Bevacizumab|bevacizumab|mesh-list
110147582|NCT00387699|Etoposide|etoposide|mesh-list
110147583|NCT00387699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110147584|NCT00387699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110147585|NCT00387699|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110076984|NCT03134196|Valacyclovir|valacyclovir|mesh-list
110147586|NCT00387699|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110147587|NCT00387699|Growth Substances|growth substances|mesh-ancestor
110147588|NCT00387699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110147589|NCT00387699|Growth Inhibitors|growth inhibitors|mesh-ancestor
110147590|NCT00387699|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110147591|NCT00387699|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110147592|NCT00387699|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110147593|NCT00387699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110147594|NCT00387699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110147595|NCT00005959|Prednisone|prednisone|mesh-list
110147596|NCT00005959|Cyclophosphamide|cyclophosphamide|mesh-list
110147597|NCT00005959|Rituximab|rituximab|mesh-list
110147598|NCT00005959|Doxorubicin|doxorubicin|mesh-list
110147599|NCT00005959|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110147600|NCT00005959|Vincristine|vincristine|mesh-list
110147601|NCT00005959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110147602|NCT00005959|Immunologic Factors|immunologic factors|mesh-ancestor
110147603|NCT00005959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110147604|NCT00005959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110077026|NCT02829931|Nivolumab|nivolumab|mesh-list
110147605|NCT00005959|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110147606|NCT00005959|Alkylating Agents|alkylating agents|mesh-ancestor
110147607|NCT00005959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110147608|NCT00005959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110147609|NCT00005959|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110147610|NCT00005959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110147611|NCT00005959|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110147612|NCT00005959|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110147613|NCT00005959|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110147615|NCT00005959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110147616|NCT00005959|Glucocorticoids|glucocorticoids|mesh-ancestor
110147617|NCT00005959|Hormones|hormones|mesh-ancestor
110147618|NCT00005959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110147619|NCT00005959|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110147620|NCT00005959|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110147621|NCT00005959|Tubulin Modulators|tubulin modulators|mesh-ancestor
110147622|NCT00005959|Antimitotic Agents|antimitotic agents|mesh-ancestor
110147623|NCT00005959|Mitosis Modulators|mitosis modulators|mesh-ancestor
110147624|NCT00387738|Histamine|histamine|mesh-list
110147625|NCT00387738|Histamine Agonists|histamine agonists|mesh-ancestor
110147626|NCT00387738|Histamine Agents|histamine agents|mesh-ancestor
110147627|NCT00387738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110147628|NCT00387738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110147629|NCT00387738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110147630|NCT00005965|Bryostatin 1|bryostatin 1|mesh-list
110147631|NCT00005965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110147632|NCT00005965|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110147633|NCT00005965|Immunologic Factors|immunologic factors|mesh-ancestor
110147634|NCT00005965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110147636|NCT00005968|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110147637|NCT00005968|Alkylating Agents|alkylating agents|mesh-ancestor
110147638|NCT00005968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110147639|NCT00005968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110147640|NCT00387777|Buprenorphine|buprenorphine|mesh-list
110147641|NCT00387777|Analgesics|analgesics|mesh-list
110147642|NCT00387777|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110147643|NCT00387777|Narcotics|narcotics|mesh-ancestor
110147644|NCT00387777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110147645|NCT00387777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110147646|NCT00387777|Sensory System Agents|sensory system agents|mesh-ancestor
110147647|NCT00387777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110147648|NCT00387777|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110147649|NCT00005971|Alvocidib|alvocidib|mesh-list
110147650|NCT00005971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110147651|NCT00005971|Growth Inhibitors|growth inhibitors|mesh-ancestor
110147652|NCT00005971|Growth Substances|growth substances|mesh-ancestor
110147653|NCT00005971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110147654|NCT00005971|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110147655|NCT00005971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110147656|NCT00005971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110147658|NCT00005974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110147659|NCT00005974|Growth Inhibitors|growth inhibitors|mesh-ancestor
110147660|NCT00005974|Growth Substances|growth substances|mesh-ancestor
110147661|NCT00005974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110147662|NCT00005974|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110147663|NCT00005974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110147664|NCT00005974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110147665|NCT00005977|Leucovorin|leucovorin|mesh-list
110147666|NCT00005977|Cytarabine|cytarabine|mesh-list
110147667|NCT00005977|Dexamethasone|dexamethasone|mesh-list
110147668|NCT00005977|Cyclophosphamide|cyclophosphamide|mesh-list
110147669|NCT00005977|Ifosfamide|ifosfamide|mesh-list
110147670|NCT00005977|Doxorubicin|doxorubicin|mesh-list
110147671|NCT00005977|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110147672|NCT00005977|Methotrexate|methotrexate|mesh-list
110147673|NCT00005977|Etoposide|etoposide|mesh-list
110147674|NCT00005977|Vincristine|vincristine|mesh-list
110147675|NCT00005977|Lenograstim|lenograstim|mesh-list
110147676|NCT00005977|Levoleucovorin|levoleucovorin|mesh-list
110147677|NCT00005977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110147678|NCT00005977|Immunologic Factors|immunologic factors|mesh-ancestor
110147679|NCT00005977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110147680|NCT00005977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110147681|NCT00005977|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110168735|NCT00000779|Antacids|antacids|mesh-ancestor
110147682|NCT00005977|Alkylating Agents|alkylating agents|mesh-ancestor
110147683|NCT00005977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110147684|NCT00005977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110147685|NCT00005977|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110147686|NCT00005977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110147687|NCT00005977|Antiemetics|antiemetics|mesh-ancestor
110147688|NCT00005977|Autonomic Agents|autonomic agents|mesh-ancestor
110147689|NCT00005977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110147690|NCT00005977|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110147691|NCT00005977|Glucocorticoids|glucocorticoids|mesh-ancestor
110147692|NCT00005977|Hormones|hormones|mesh-ancestor
110442351|NCT00634348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110147693|NCT00005977|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110147694|NCT00005977|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110147695|NCT00005977|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110147696|NCT00005977|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110147697|NCT00005977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110147698|NCT00005977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110147699|NCT00005977|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110147700|NCT00005977|Abortifacient Agents|abortifacient agents|mesh-ancestor
110147701|NCT00005977|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110147702|NCT00005977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110147704|NCT00005977|Dermatologic Agents|dermatologic agents|mesh-ancestor
110147705|NCT00005977|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110147706|NCT00005977|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110147707|NCT00005977|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110147708|NCT00005977|Antiviral Agents|antiviral agents|mesh-ancestor
110147709|NCT00005977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110147710|NCT00005977|Antidotes|antidotes|mesh-ancestor
110147711|NCT00005977|Protective Agents|protective agents|mesh-ancestor
110147712|NCT00005977|Vitamin B Complex|vitamin b complex|mesh-ancestor
110147713|NCT00005977|Vitamins|vitamins|mesh-ancestor
110147714|NCT00005977|Micronutrients|micronutrients|mesh-ancestor
110147715|NCT00005977|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110147716|NCT00005977|Tubulin Modulators|tubulin modulators|mesh-ancestor
110147717|NCT00005977|Antimitotic Agents|antimitotic agents|mesh-ancestor
110147718|NCT00005977|Mitosis Modulators|mitosis modulators|mesh-ancestor
110147719|NCT00005980|Doxorubicin|doxorubicin|mesh-list
110147720|NCT00005980|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110147721|NCT00005980|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110147722|NCT00005980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110147723|NCT00005980|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110147724|NCT00005980|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110147725|NCT00005980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110147726|NCT00005980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110147727|NCT00005986|Interferons|interferons|mesh-list
110147728|NCT00005986|Interferon-alpha|interferon-alpha|mesh-list
110147729|NCT00005986|Cyclophosphamide|cyclophosphamide|mesh-list
110147730|NCT00005986|Busulfan|busulfan|mesh-list
110147731|NCT00005986|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110147732|NCT00005986|Immunologic Factors|immunologic factors|mesh-ancestor
110077278|NCT01601028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110147733|NCT00005986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110147734|NCT00005986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110147735|NCT00005986|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110147736|NCT00005986|Alkylating Agents|alkylating agents|mesh-ancestor
110147737|NCT00005986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110147738|NCT00005986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110147739|NCT00005986|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110147740|NCT00005986|Antiviral Agents|antiviral agents|mesh-ancestor
110147741|NCT00005986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110147742|NCT00005989|Tipifarnib|tipifarnib|mesh-list
110147743|NCT00005989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110147745|NCT00005998|Dexamethasone|dexamethasone|mesh-list
110147746|NCT00005998|Cyclophosphamide|cyclophosphamide|mesh-list
110147747|NCT00005998|Carmustine|carmustine|mesh-list
110147748|NCT00005998|Etoposide|etoposide|mesh-list
110147749|NCT00005998|Mitoxantrone|mitoxantrone|mesh-list
110147750|NCT00005998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110147751|NCT00005998|Immunologic Factors|immunologic factors|mesh-ancestor
110147752|NCT00005998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110147753|NCT00005998|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110147754|NCT00005998|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110147755|NCT00005998|Alkylating Agents|alkylating agents|mesh-ancestor
110147756|NCT00005998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110147757|NCT00005998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110147758|NCT00005998|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110147759|NCT00005998|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110147760|NCT00005998|Antiemetics|antiemetics|mesh-ancestor
110147761|NCT00005998|Autonomic Agents|autonomic agents|mesh-ancestor
110147762|NCT00005998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110147763|NCT00005998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110147764|NCT00005998|Glucocorticoids|glucocorticoids|mesh-ancestor
110147766|NCT00005998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110147767|NCT00005998|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110147768|NCT00005998|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110147769|NCT00005998|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110147770|NCT00005998|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110147771|NCT00005998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110147772|NCT00005998|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110147773|NCT00005998|Antimetabolites|antimetabolites|mesh-ancestor
110147774|NCT00005998|Antiviral Agents|antiviral agents|mesh-ancestor
110147775|NCT00005998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110147776|NCT00005998|Analgesics|analgesics|mesh-ancestor
110147777|NCT00005998|Sensory System Agents|sensory system agents|mesh-ancestor
110147778|NCT00006351|Gemcitabine|gemcitabine|mesh-list
110147779|NCT00006351|Lonafarnib|lonafarnib|mesh-list
110147780|NCT00006351|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110147781|NCT00006351|Antimetabolites|antimetabolites|mesh-ancestor
110147782|NCT00006351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110147783|NCT00006351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110147784|NCT00006351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110147785|NCT00006001|Semaxinib|semaxinib|mesh-list
110147786|NCT00006001|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110147787|NCT00006001|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110147788|NCT00006001|Growth Substances|growth substances|mesh-ancestor
110147789|NCT00006001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110147790|NCT00006001|Growth Inhibitors|growth inhibitors|mesh-ancestor
110147791|NCT00006001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110147792|NCT00006001|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110147793|NCT00006001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110147794|NCT00006001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110147796|NCT00006007|Pemetrexed|pemetrexed|mesh-list
110147797|NCT00006007|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110147798|NCT00006007|Antimetabolites|antimetabolites|mesh-ancestor
110147799|NCT00006007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110147800|NCT00006007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110147801|NCT00006007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110147802|NCT00006007|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110147803|NCT00006007|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110147804|NCT00006010|Gemcitabine|gemcitabine|mesh-list
110147805|NCT00006010|Docetaxel|docetaxel|mesh-list
110147806|NCT00006010|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110147807|NCT00006010|Antimetabolites|antimetabolites|mesh-ancestor
110147808|NCT00006010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110147809|NCT00006010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110168759|NCT02971345|Iodine|iodine|mesh-list
110147810|NCT00006010|Tubulin Modulators|tubulin modulators|mesh-ancestor
110147811|NCT00006010|Antimitotic Agents|antimitotic agents|mesh-ancestor
110147812|NCT00006010|Mitosis Modulators|mitosis modulators|mesh-ancestor
110147814|NCT00006013|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110147815|NCT00006013|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110147816|NCT00006013|Growth Substances|growth substances|mesh-ancestor
110077452|NCT01610141|Warfarin|warfarin|mesh-list
110147817|NCT00006013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110147818|NCT00006013|Growth Inhibitors|growth inhibitors|mesh-ancestor
110147819|NCT00006013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110147820|NCT00006013|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110147821|NCT00006013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110147822|NCT00006013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110147823|NCT00006357|Imatinib Mesylate|imatinib mesylate|mesh-list
110147824|NCT00006357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110147825|NCT00006357|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110147826|NCT00006357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110147827|NCT00006357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110147828|NCT00006016|Thalidomide|thalidomide|mesh-list
110147829|NCT00006016|Doxorubicin|doxorubicin|mesh-list
110147830|NCT00006016|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110147831|NCT00006016|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110147832|NCT00006016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110147833|NCT00006016|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110147834|NCT00006016|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110147835|NCT00006016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110147836|NCT00006016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110147837|NCT00006016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110147838|NCT00006016|Immunologic Factors|immunologic factors|mesh-ancestor
110147839|NCT00006016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110147840|NCT00006016|Leprostatic Agents|leprostatic agents|mesh-ancestor
110147841|NCT00006016|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110147842|NCT00006016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110147843|NCT00006016|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110147844|NCT00006016|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110147845|NCT00006016|Growth Substances|growth substances|mesh-ancestor
110147846|NCT00006016|Growth Inhibitors|growth inhibitors|mesh-ancestor
110147847|NCT00006019|Azacitidine|azacitidine|mesh-list
110147848|NCT00006019|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
110147849|NCT00006019|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110147850|NCT00006019|Antimetabolites|antimetabolites|mesh-ancestor
110147851|NCT00006019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110147852|NCT00006019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110147853|NCT00006019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110147854|NCT00006022|Aldesleukin|aldesleukin|mesh-list
110147855|NCT00006022|Bryostatin 1|bryostatin 1|mesh-list
110147856|NCT00006022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110147857|NCT00006022|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110147858|NCT00006022|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110147859|NCT00006022|Antiviral Agents|antiviral agents|mesh-ancestor
110147860|NCT00006022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110147861|NCT00006022|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110147863|NCT00006022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110147864|NCT00006025|Irinotecan|irinotecan|mesh-list
110147865|NCT00006025|Temozolomide|temozolomide|mesh-list
110147866|NCT00006025|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110147867|NCT00006025|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110147868|NCT00006025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110147869|NCT00006025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110147870|NCT00006025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110147871|NCT00006025|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110147872|NCT00006025|Alkylating Agents|alkylating agents|mesh-ancestor
110147873|NCT00386659|Ritonavir|ritonavir|mesh-list
110147874|NCT00386659|Lopinavir|lopinavir|mesh-list
110147875|NCT00386659|Tenofovir|tenofovir|mesh-list
110147876|NCT00386659|Abacavir|abacavir|mesh-list
110147877|NCT00386659|Efavirenz|efavirenz|mesh-list
110147878|NCT00386659|Dideoxynucleosides|dideoxynucleosides|mesh-list
110147879|NCT00386659|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110147880|NCT00386659|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110147881|NCT00386659|Protease Inhibitors|protease inhibitors|mesh-ancestor
110147882|NCT00386659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110168760|NCT02971345|Cadexomer iodine|cadexomer iodine|mesh-list
110147883|NCT00386659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110147884|NCT00386659|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110147885|NCT00386659|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110147886|NCT00386659|Antiviral Agents|antiviral agents|mesh-ancestor
110147887|NCT00386659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110147888|NCT00386659|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110147889|NCT00386659|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110147890|NCT00386659|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110147891|NCT00386659|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110147892|NCT00386659|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110147893|NCT00386659|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110147894|NCT00386659|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110147895|NCT00386659|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110147896|NCT00386659|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110147897|NCT00386659|Antimetabolites|antimetabolites|mesh-ancestor
110147898|NCT00006028|Gemcitabine|gemcitabine|mesh-list
110147899|NCT00006028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110147900|NCT00006028|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110147901|NCT00006028|Antimetabolites|antimetabolites|mesh-ancestor
110147902|NCT00006028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110147903|NCT00387933|Imatinib Mesylate|imatinib mesylate|mesh-list
110147904|NCT00387933|Hydroxyurea|hydroxyurea|mesh-list
110147905|NCT00387933|Vatalanib|vatalanib|mesh-list
110147906|NCT00387933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110147907|NCT00387933|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110147908|NCT00387933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110147909|NCT00387933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110147910|NCT00387933|Antisickling Agents|antisickling agents|mesh-ancestor
110147911|NCT00387933|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110147912|NCT00006034|Doxorubicin|doxorubicin|mesh-list
110147913|NCT00006034|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110147914|NCT00006034|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
110147915|NCT00006034|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110147916|NCT00006034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110147917|NCT00006034|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110147918|NCT00006034|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110147919|NCT00006034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110147920|NCT00006034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110147921|NCT00006034|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110147922|NCT00006034|Immunologic Factors|immunologic factors|mesh-ancestor
110147923|NCT00006034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110147924|NCT00006037|Fluorouracil|fluorouracil|mesh-list
110147926|NCT00006037|Antimetabolites|antimetabolites|mesh-ancestor
110147927|NCT00006037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110147928|NCT00006037|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110147929|NCT00006037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110147930|NCT00006037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110147931|NCT00006037|Immunologic Factors|immunologic factors|mesh-ancestor
110147932|NCT00006037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110147933|NCT00006037|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110147934|NCT00006037|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110147935|NCT00006037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110147937|NCT00006040|Antibodies|antibodies|mesh-list
110147938|NCT00006040|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110147939|NCT00006040|Immunologic Factors|immunologic factors|mesh-ancestor
110147940|NCT00006040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110077635|NCT01611909|Terpin|terpin|mesh-list
110147941|NCT00006040|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110147943|NCT00006040|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110147944|NCT00006040|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110147945|NCT00006040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110147946|NCT00006040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110147947|NCT00006363|Cytarabine|cytarabine|mesh-list
110147948|NCT00006363|Aldesleukin|aldesleukin|mesh-list
110147949|NCT00006363|Etoposide|etoposide|mesh-list
110147950|NCT00006363|Daunorubicin|daunorubicin|mesh-list
110147951|NCT00006363|Etoposide phosphate|etoposide phosphate|mesh-list
110147952|NCT00006363|Busulfan|busulfan|mesh-list
110147953|NCT00006363|Interleukin-2|interleukin-2|mesh-list
110147954|NCT00006363|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110147955|NCT00006363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110147956|NCT00006363|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110147957|NCT00006363|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110147958|NCT00006363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110147959|NCT00006363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110147960|NCT00006363|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110147961|NCT00006363|Antimetabolites|antimetabolites|mesh-ancestor
110147962|NCT00006363|Antiviral Agents|antiviral agents|mesh-ancestor
110077654|NCT01612078|Droxidopa|droxidopa|mesh-list
110147963|NCT00006363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110147964|NCT00006363|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110147965|NCT00006363|Immunologic Factors|immunologic factors|mesh-ancestor
110147966|NCT00006363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110147967|NCT00006363|Alkylating Agents|alkylating agents|mesh-ancestor
110147968|NCT00006363|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110147969|NCT00006363|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110147970|NCT00006363|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110147971|NCT00006363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110147972|NCT00006363|Analgesics|analgesics|mesh-ancestor
110147973|NCT00006363|Sensory System Agents|sensory system agents|mesh-ancestor
110147974|NCT00006363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110147975|NCT00006363|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110147976|NCT00006363|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110147977|NCT05680870|Omeprazole|omeprazole|mesh-list
110147978|NCT05680870|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110147979|NCT05680870|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110147980|NCT05680870|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110147981|NCT05680870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110147982|NCT05680870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110147983|NCT00006366|Fluorouracil|fluorouracil|mesh-list
110147984|NCT00006366|Irinotecan|irinotecan|mesh-list
110147985|NCT00006366|Antimetabolites|antimetabolites|mesh-ancestor
110147986|NCT00006366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110147987|NCT00006366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110147988|NCT00006366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110077713|NCT01612299|Everolimus|everolimus|mesh-list
110147989|NCT00006366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110147990|NCT00006366|Immunologic Factors|immunologic factors|mesh-ancestor
110147991|NCT00006366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110147992|NCT00006366|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110147993|NCT00006366|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110147994|NCT00006366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110147995|NCT00006372|Gemcitabine|gemcitabine|mesh-list
110147996|NCT00006372|Doxorubicin|doxorubicin|mesh-list
110147997|NCT00006372|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110147998|NCT00006372|Vinorelbine|vinorelbine|mesh-list
110147999|NCT00006372|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110148000|NCT00006372|Antimetabolites|antimetabolites|mesh-ancestor
110148001|NCT00006372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110148002|NCT00006372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110148003|NCT00006372|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110148004|NCT00006372|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110148005|NCT00006372|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110148007|NCT00006372|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110148008|NCT00006372|Tubulin Modulators|tubulin modulators|mesh-ancestor
110148009|NCT00006372|Antimitotic Agents|antimitotic agents|mesh-ancestor
110148010|NCT00006372|Mitosis Modulators|mitosis modulators|mesh-ancestor
110148011|NCT00006378|Paclitaxel|paclitaxel|mesh-list
110148012|NCT00006378|Carboplatin|carboplatin|mesh-list
110148013|NCT00006378|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110148014|NCT00006378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110148015|NCT00006378|Tubulin Modulators|tubulin modulators|mesh-ancestor
110148016|NCT00006378|Antimitotic Agents|antimitotic agents|mesh-ancestor
110148017|NCT00006378|Mitosis Modulators|mitosis modulators|mesh-ancestor
110148018|NCT00006378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110148019|NCT00006381|Celecoxib|celecoxib|mesh-list
110148020|NCT00006381|Trastuzumab|trastuzumab|mesh-list
110148021|NCT00006381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110148022|NCT00006381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110148023|NCT00006381|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110148024|NCT00006381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110148026|NCT00006381|Sensory System Agents|sensory system agents|mesh-ancestor
110148027|NCT00006381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110148028|NCT00006381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110148029|NCT00006381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110148031|NCT00006381|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110148032|NCT00006381|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110148033|NCT00006381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110148034|NCT00006381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110148035|NCT00006384|Interferons|interferons|mesh-list
110148036|NCT00006384|Interferon-alpha|interferon-alpha|mesh-list
110148037|NCT00006384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110148038|NCT00006384|Antiviral Agents|antiviral agents|mesh-ancestor
110148039|NCT00006384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110148040|NCT00006384|Immunologic Factors|immunologic factors|mesh-ancestor
110148041|NCT00006384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110148042|NCT00386815|Pemetrexed|pemetrexed|mesh-list
110148043|NCT00386815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110148044|NCT00386815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110148045|NCT00386815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110148046|NCT00386815|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110148047|NCT00386815|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110148048|NCT05679388|Ritonavir|ritonavir|mesh-list
110148049|NCT05679388|Itraconazole|itraconazole|mesh-list
110148050|NCT05679388|Relugolix|relugolix|mesh-list
110148051|NCT05679388|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110148052|NCT05679388|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110148053|NCT05679388|Protease Inhibitors|protease inhibitors|mesh-ancestor
110148054|NCT05679388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110148055|NCT05679388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110148056|NCT05679388|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110148057|NCT05679388|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110148058|NCT05679388|Antiviral Agents|antiviral agents|mesh-ancestor
110148059|NCT05679388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110148060|NCT05679388|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110148061|NCT05679388|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110148062|NCT05679388|Antifungal Agents|antifungal agents|mesh-ancestor
110148063|NCT05679388|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110148064|NCT05679388|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110148065|NCT05679388|Hormone Antagonists|hormone antagonists|mesh-ancestor
110148066|NCT05679388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110148067|NCT05679388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110148068|NCT05679388|Androgen Antagonists|androgen antagonists|mesh-ancestor
110148069|NCT05678296|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110148071|NCT05678296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110148072|NCT05678296|Sensory System Agents|sensory system agents|mesh-ancestor
110148073|NCT05678296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110148074|NCT05678296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110148075|NCT05675293|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110148076|NCT05675293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110148079|NCT00006396|Antimetabolites|antimetabolites|mesh-ancestor
110148080|NCT00006396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110148081|NCT00006396|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110148082|NCT00006396|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110148083|NCT00006396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110148084|NCT00006396|Antiviral Agents|antiviral agents|mesh-ancestor
110148085|NCT00006396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110148086|NCT00006396|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110148087|NCT00006396|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110148088|NCT00006396|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110148089|NCT00006396|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110148090|NCT03996148|Dexmedetomidine|dexmedetomidine|mesh-list
110148092|NCT03996148|Propofol|propofol|mesh-list
110148093|NCT03996148|Desflurane|desflurane|mesh-list
110148094|NCT03996148|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110148095|NCT03996148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110148096|NCT03996148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110148097|NCT03996148|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110148098|NCT03996148|Analgesics|analgesics|mesh-ancestor
110148099|NCT03996148|Sensory System Agents|sensory system agents|mesh-ancestor
110148100|NCT03996148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110148101|NCT03996148|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110148102|NCT03996148|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110148103|NCT03996148|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110148104|NCT03996148|Adrenergic Agents|adrenergic agents|mesh-ancestor
110148105|NCT03996148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110148106|NCT03996148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110148107|NCT03996148|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110148108|NCT03996148|Anesthetics, General|anesthetics, general|mesh-ancestor
110148109|NCT03996148|Anesthetics|anesthetics|mesh-ancestor
110148110|NCT03996148|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110148111|NCT03996148|Narcotics|narcotics|mesh-ancestor
110148112|NCT03996148|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110148113|NCT00006399|Donepezil|donepezil|mesh-list
110148114|NCT00006399|Progesterone|progesterone|mesh-list
110148115|NCT00006399|Estrogens|estrogens|mesh-list
110148116|NCT00006399|Progestins|progestins|mesh-ancestor
110148117|NCT00006399|Hormones|hormones|mesh-ancestor
110148118|NCT00006399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110148119|NCT00006399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110148120|NCT00006399|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110148121|NCT00006399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110148122|NCT00006399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110148123|NCT00006399|Cholinergic Agents|cholinergic agents|mesh-ancestor
110148124|NCT00006399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110148125|NCT00006399|Nootropic Agents|nootropic agents|mesh-ancestor
110148126|NCT05660200|Iron|iron|mesh-list
110148127|NCT05660200|Trace Elements|trace elements|mesh-ancestor
110148128|NCT05660200|Micronutrients|micronutrients|mesh-ancestor
110148129|NCT05660200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110148130|NCT05552404|Aminophylline|aminophylline|mesh-list
110148131|NCT05552404|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110148132|NCT05552404|Autonomic Agents|autonomic agents|mesh-ancestor
110148133|NCT05552404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110148134|NCT05552404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110148135|NCT05552404|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110148136|NCT05552404|Respiratory System Agents|respiratory system agents|mesh-ancestor
110148137|NCT05552404|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110148138|NCT05552404|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110148140|NCT05552404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110148141|NCT05552404|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110148142|NCT05552404|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110148143|NCT05552404|Purinergic Agents|purinergic agents|mesh-ancestor
110148144|NCT05552404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110148145|NCT05552404|Protective Agents|protective agents|mesh-ancestor
110148146|NCT05546320|Aspirin|aspirin|mesh-list
110148147|NCT05546320|Metoprolol|metoprolol|mesh-list
110148148|NCT05546320|Rivaroxaban|rivaroxaban|mesh-list
110148149|NCT05546320|Clopidogrel|clopidogrel|mesh-list
110148150|NCT05546320|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110148151|NCT05546320|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110148152|NCT05546320|Analgesics|analgesics|mesh-ancestor
110148153|NCT05546320|Sensory System Agents|sensory system agents|mesh-ancestor
110148154|NCT05546320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110148155|NCT05546320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110148156|NCT05546320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110078048|NCT01614223|Betamethasone|betamethasone|mesh-list
110148157|NCT05546320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110148158|NCT05546320|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110148159|NCT05546320|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110148160|NCT05546320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110148161|NCT05546320|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110148162|NCT05546320|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110148163|NCT05546320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110148164|NCT05546320|Antipyretics|antipyretics|mesh-ancestor
110148165|NCT05546320|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110148166|NCT05546320|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110148167|NCT05546320|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110078108|NCT01614405|Ritonavir|ritonavir|mesh-list
110148168|NCT05546320|Purinergic Agents|purinergic agents|mesh-ancestor
110148169|NCT05546320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110148170|NCT05546320|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110148171|NCT05546320|Antithrombins|antithrombins|mesh-ancestor
110148172|NCT05546320|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110148173|NCT05546320|Protease Inhibitors|protease inhibitors|mesh-ancestor
110148174|NCT05546320|Anticoagulants|anticoagulants|mesh-ancestor
110148175|NCT05546320|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110148176|NCT05546320|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110148177|NCT05546320|Sympatholytics|sympatholytics|mesh-ancestor
110148178|NCT05546320|Autonomic Agents|autonomic agents|mesh-ancestor
110148179|NCT05546320|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110148180|NCT05546320|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110148181|NCT05546320|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110148182|NCT05546320|Adrenergic Agents|adrenergic agents|mesh-ancestor
110148183|NCT05535595|Perindopril|perindopril|mesh-list
110148184|NCT05535595|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110148185|NCT05535595|Protease Inhibitors|protease inhibitors|mesh-ancestor
110148186|NCT05535595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110148187|NCT05535595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110148188|NCT05535595|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110148189|NCT05470816|Tranexamic Acid|tranexamic acid|mesh-list
110148190|NCT05470816|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110148191|NCT05470816|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110148192|NCT05470816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110148193|NCT05470816|Hemostatics|hemostatics|mesh-ancestor
110148194|NCT05470816|Coagulants|coagulants|mesh-ancestor
110148195|NCT05431543|Brimonidine Tartrate|brimonidine tartrate|mesh-list
110148196|NCT05431543|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110148197|NCT05431543|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110148199|NCT05431543|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110148200|NCT05431543|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110148201|NCT05431543|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110148202|NCT05431543|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110148203|NCT05431543|Adrenergic Agents|adrenergic agents|mesh-ancestor
110148204|NCT05431543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110148205|NCT05431543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110148206|NCT05431543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110148207|NCT05431543|Miotics|miotics|mesh-ancestor
110148208|NCT05431543|Autonomic Agents|autonomic agents|mesh-ancestor
110078297|NCT01615757|Cytarabine|cytarabine|mesh-list
110148209|NCT05431543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110148210|NCT05431543|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110148211|NCT05401786|Ipilimumab|ipilimumab|mesh-list
110148212|NCT05401786|Cemiplimab|cemiplimab|mesh-list
110148213|NCT05401786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110148214|NCT05401786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110148215|NCT05401786|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110148216|NCT05401786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110148217|NCT05285683|Levodopa|levodopa|mesh-list
110148218|NCT05285683|Carbidopa|carbidopa|mesh-list
110078355|NCT01616069|Mydriatics|mydriatics|mesh-ancestor
110148219|NCT05285683|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
110148220|NCT05285683|Methylphenidate|methylphenidate|mesh-list
110148221|NCT05285683|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110148222|NCT05285683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110148223|NCT05285683|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110148224|NCT05285683|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110148225|NCT05285683|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110148226|NCT05285683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110148227|NCT05285683|Dopamine Agents|dopamine agents|mesh-ancestor
110148228|NCT05285683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110148229|NCT05285683|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110168789|NCT00036088|Serotonin Agents|serotonin agents|mesh-ancestor
110078408|NCT01616407|Dopamine Agents|dopamine agents|mesh-ancestor
110148230|NCT05285683|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110148231|NCT05285683|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
110148232|NCT05285683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110148233|NCT05285683|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110148234|NCT05285683|Immunologic Factors|immunologic factors|mesh-ancestor
110148235|NCT05285683|Dopamine Agonists|dopamine agonists|mesh-ancestor
110148238|NCT05247970|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110148239|NCT05247970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110148240|NCT05247970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110148241|NCT05247970|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110148242|NCT05247970|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110148243|NCT05247970|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110148244|NCT05247970|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110148245|NCT05247970|Anesthetics, General|anesthetics, general|mesh-ancestor
110148247|NCT05247970|GABA Modulators|gaba modulators|mesh-ancestor
110148248|NCT05247970|GABA Agents|gaba agents|mesh-ancestor
110148249|NCT05247970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110148250|NCT05247970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110148251|NCT00006441|Lamivudine|lamivudine|mesh-list
110148252|NCT00006441|Zidovudine|zidovudine|mesh-list
110148253|NCT00006441|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
110148254|NCT00006441|Aldesleukin|aldesleukin|mesh-list
110148255|NCT00006441|Nelfinavir|nelfinavir|mesh-list
110148256|NCT00006441|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110148257|NCT00006441|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110148258|NCT00006441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110148259|NCT00006441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110148260|NCT00006441|Antiviral Agents|antiviral agents|mesh-ancestor
110148261|NCT00006441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110148262|NCT00006441|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110148263|NCT00006441|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110148264|NCT00006441|Antimetabolites|antimetabolites|mesh-ancestor
110148265|NCT00006441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110148266|NCT00006441|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110148267|NCT00006441|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110148268|NCT00006441|Protease Inhibitors|protease inhibitors|mesh-ancestor
110148269|NCT05147233|Dexamethasone|dexamethasone|mesh-list
110148270|NCT05147233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110148271|NCT05147233|Antiemetics|antiemetics|mesh-ancestor
110148272|NCT05147233|Autonomic Agents|autonomic agents|mesh-ancestor
110148273|NCT05147233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110148274|NCT05147233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110148275|NCT05147233|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110148276|NCT05147233|Glucocorticoids|glucocorticoids|mesh-ancestor
110148277|NCT05147233|Hormones|hormones|mesh-ancestor
110148278|NCT05147233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110148279|NCT05147233|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110148280|NCT05147233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110148281|NCT03926845|Thiamidol|thiamidol|mesh-list
110148282|NCT03926845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110148283|NCT03926845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110148284|NCT00006450|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
110148285|NCT00006450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110148286|NCT00006453|Carboplatin|carboplatin|mesh-list
110148287|NCT00006453|Gemcitabine|gemcitabine|mesh-list
110148288|NCT00006453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110148289|NCT00006453|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110148290|NCT00006453|Antimetabolites|antimetabolites|mesh-ancestor
110148291|NCT00006453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110148292|NCT00387322|Pemetrexed|pemetrexed|mesh-list
110148293|NCT00387322|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110148294|NCT00387322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110148295|NCT00387322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110148296|NCT00387322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110148297|NCT00387322|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110148298|NCT00387322|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110148299|NCT00387322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110148300|NCT00006459|Paclitaxel|paclitaxel|mesh-list
110148301|NCT00006459|Gemcitabine|gemcitabine|mesh-list
110148302|NCT00006459|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110148303|NCT00006459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110148304|NCT00006459|Tubulin Modulators|tubulin modulators|mesh-ancestor
110148305|NCT00006459|Antimitotic Agents|antimitotic agents|mesh-ancestor
110148306|NCT00006459|Mitosis Modulators|mitosis modulators|mesh-ancestor
110148307|NCT00006459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110148308|NCT00006459|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110148311|NCT03876106|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110148312|NCT03876106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110368818|NCT00553943|Antiviral Agents|antiviral agents|mesh-ancestor
110369046|NCT00563589|Antimetabolites|antimetabolites|mesh-ancestor
110369419|NCT01165021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110369512|NCT01941836|Ezetimibe|ezetimibe|mesh-list
110369713|NCT04676789|Pegaspargase|pegaspargase|mesh-list
110370159|NCT00555386|Selenium|selenium|mesh-list
110370391|NCT01160614|Oxycodone|oxycodone|mesh-list
110370469|NCT04631627|Aspirin|aspirin|mesh-list
110370833|NCT01155583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110371360|NCT01151410|Protease Inhibitors|protease inhibitors|mesh-ancestor
110371803|NCT04617626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110372252|NCT04611776|Pemetrexed|pemetrexed|mesh-list
110372327|NCT01149460|Valacyclovir|valacyclovir|mesh-list
110372406|NCT04600037|Pregabalin|pregabalin|mesh-list
110148313|NCT03876106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110372919|NCT04592666|Carboplatin|carboplatin|mesh-list
110372995|NCT00580359|Capecitabine|capecitabine|mesh-list
110373593|NCT04575675|Antioxidants|antioxidants|mesh-ancestor
110148315|NCT00388011|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110374410|NCT00555854|Benzocaine|benzocaine|mesh-list
110374715|NCT00195351|Metronidazole|metronidazole|mesh-list
110375538|NCT00583427|Anticoagulants|anticoagulants|mesh-ancestor
110148316|NCT00388011|Narcotics|narcotics|mesh-ancestor
110375973|NCT01087905|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110376271|NCT00590447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110148317|NCT00388011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110376421|NCT01080222|Ribavirin|ribavirin|mesh-list
110376867|NCT00191984|Irinotecan|irinotecan|mesh-list
110377169|NCT04562103|Anesthetics|anesthetics|mesh-ancestor
110377243|NCT00477971|Autonomic Agents|autonomic agents|mesh-ancestor
110377393|NCT00470834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110377538|NCT02212821|Erythromycin|erythromycin|mesh-list
110377691|NCT02213718|Anesthetics|anesthetics|mesh-ancestor
110377988|NCT04571489|Tegafur|tegafur|mesh-list
110378893|NCT04538391|Bupivacaine|bupivacaine|mesh-list
110379192|NCT00577967|Gabapentin|gabapentin|mesh-list
110148318|NCT00388011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110379943|NCT01119898|Diclofenac|diclofenac|mesh-list
110380013|NCT05092984|Spironolactone|spironolactone|mesh-list
110381216|NCT02215148|Tolvaptan|tolvaptan|mesh-list
110381290|NCT01682499|Analgesics|analgesics|mesh-ancestor
110381814|NCT04527666|Anticoagulants|anticoagulants|mesh-list
110382109|NCT04529525|Ivermectin|ivermectin|mesh-list
110382264|NCT01196104|Insulin|insulin|mesh-list
110382372|NCT02219867|Ketamine|ketamine|mesh-list
110383605|NCT06043336|Antiemetics|antiemetics|mesh-ancestor
110148320|NCT00388011|Sensory System Agents|sensory system agents|mesh-ancestor
110385023|NCT05519085|Bortezomib|bortezomib|mesh-list
110385549|NCT05284643|Bevacizumab|bevacizumab|mesh-list
110148321|NCT00388011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110386078|NCT05032183|Lenograstim|lenograstim|mesh-list
110387064|NCT04410796|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110387291|NCT04242329|Immunomodulating Agents|immunomodulating agents|mesh-list
110387366|NCT04193293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110387818|NCT03712956|Doxorubicin|doxorubicin|mesh-list
110388044|NCT03519971|Carboplatin|carboplatin|mesh-list
110388350|NCT03215030|Hormones|hormones|mesh-ancestor
110389076|NCT02542293|Paclitaxel|paclitaxel|mesh-list
110389263|NCT02312258|Protease Inhibitors|protease inhibitors|mesh-ancestor
110389497|NCT01659658|Antiemetics|antiemetics|mesh-ancestor
110389651|NCT01190930|2-Aminopurine|2-aminopurine|mesh-list
110390179|NCT05989828|Interleukin-2|interleukin-2|mesh-list
110390478|NCT05615012|Antidotes|antidotes|mesh-ancestor
110390705|NCT05198050|Oxytocics|oxytocics|mesh-ancestor
110390931|NCT04691986|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110391476|NCT03776487|Fluorouracil|fluorouracil|mesh-list
110391609|NCT03334617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110391980|NCT04488237|Micronutrients|micronutrients|mesh-ancestor
110392129|NCT01645124|Hydroxyurea|hydroxyurea|mesh-list
110392430|NCT01647659|Trametinib|trametinib|mesh-list
110392581|NCT01608984|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110392583|NCT01608984|Anesthetics|anesthetics|mesh-ancestor
110392733|NCT02279615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110392970|NCT01604889|Ipilimumab|ipilimumab|mesh-list
110393102|NCT01686464|Prednisone|prednisone|mesh-list
110393324|NCT01689311|Vasodilator Agents|vasodilator agents|mesh-ancestor
110394224|NCT01600274|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110394376|NCT01601327|Testosterone|testosterone|mesh-list
110395137|NCT00595140|Hormones|hormones|mesh-ancestor
110395431|NCT04327245|Chelating Agents|chelating agents|mesh-ancestor
110395507|NCT00107900|Anticoagulants|anticoagulants|mesh-ancestor
110396168|NCT01115491|Alkylating Agents|alkylating agents|mesh-ancestor
110396390|NCT00592670|Serotonin Agents|serotonin agents|mesh-ancestor
110396768|NCT01323920|Bortezomib|bortezomib|mesh-list
110396836|NCT00600093|Analgesics|analgesics|mesh-ancestor
110396988|NCT01101841|Serotonin Agents|serotonin agents|mesh-ancestor
110397063|NCT01323621|Tocolytic Agents|tocolytic agents|mesh-ancestor
110397361|NCT01114672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110397442|NCT01078441|Antiemetics|antiemetics|mesh-ancestor
110397524|NCT01305200|Calcium|calcium|mesh-list
110397687|NCT01104376|Efavirenz|efavirenz|mesh-list
110398102|NCT04326959|Glucocorticoids|glucocorticoids|mesh-ancestor
110398177|NCT00597233|Insulin|insulin|mesh-list
110398405|NCT01303965|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110398555|NCT05643417|Bevacizumab|bevacizumab|mesh-list
110398783|NCT04309240|Rivaroxaban|rivaroxaban|mesh-list
110399317|NCT01023061|Prednisone|prednisone|mesh-list
110400133|NCT02871193|Anesthetics|anesthetics|mesh-ancestor
110400429|NCT04322175|Analgesics|analgesics|mesh-ancestor
110400731|NCT01300572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110401031|NCT04305964|Silicon|silicon|mesh-list
110401739|NCT06055465|Pembrolizumab|pembrolizumab|mesh-list
110401886|NCT06054529|Niacinamide|niacinamide|mesh-list
110402266|NCT05927714|Hemostatics|hemostatics|mesh-list
110403699|NCT04368429|Vaccines|vaccines|mesh-list
110403770|NCT04334759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110404013|NCT04084769|Vaccines|vaccines|mesh-list
110404379|NCT03661684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110404538|NCT03469271|Vitamins|vitamins|mesh-ancestor
110404685|NCT03228537|Cisplatin|cisplatin|mesh-list
110404916|NCT02941783|Factor VIII|factor viii|mesh-list
110405062|NCT02685826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110405151|NCT02498613|Olaparib|olaparib|mesh-list
110405368|NCT02003222|Antibodies, Bispecific|antibodies, bispecific|mesh-list
110405447|NCT01867333|Metronidazole|metronidazole|mesh-list
110405519|NCT01534494|Psilocybin|psilocybin|mesh-list
110078835|NCT01618877|Levetiracetam|levetiracetam|mesh-list
110148322|NCT04852978|Casirivimab and imdevimab drug combination|casirivimab and imdevimab drug combination|mesh-list
110148323|NCT04852978|Antiviral Agents|antiviral agents|mesh-ancestor
110148324|NCT04852978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110148325|NCT00388089|Bortezomib|bortezomib|mesh-list
110148326|NCT00388089|Topotecan|topotecan|mesh-list
110148327|NCT00388089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110148328|NCT00388089|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110148329|NCT00388089|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110148330|NCT00388089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110148331|NCT00388089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110148332|NCT04742023|Insulin|insulin|mesh-list
110148333|NCT04742023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110148334|NCT04742023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110148335|NCT00388128|Caffeine|caffeine|mesh-list
110148336|NCT00388128|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110307571|NCT00296205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110307572|NCT00296205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110307573|NCT00296205|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110307574|NCT00296205|Alkylating Agents|alkylating agents|mesh-ancestor
110307575|NCT00296205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110307576|NCT00296205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110307577|NCT00296205|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110307578|NCT00267683|Insulin Aspart|insulin aspart|mesh-list
110307580|NCT00267683|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110307581|NCT00267683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110307582|NCT00267722|Visilizumab|visilizumab|mesh-list
110307583|NCT00267722|Immunologic Factors|immunologic factors|mesh-ancestor
110307584|NCT00267722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110307585|NCT00301938|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
110307586|NCT00301938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110307587|NCT00301938|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110307588|NCT00301938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110307589|NCT00301938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110307590|NCT00267917|Fenoterol|fenoterol|mesh-list
110307591|NCT00267917|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
110307592|NCT00267917|Ipratropium|ipratropium|mesh-list
110078898|NCT01619163|Prednisolone|prednisolone|mesh-list
110307593|NCT00267917|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110307594|NCT00267917|Autonomic Agents|autonomic agents|mesh-ancestor
110307595|NCT00267917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110307596|NCT00267917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110307597|NCT00267917|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110307598|NCT00267917|Respiratory System Agents|respiratory system agents|mesh-ancestor
110307599|NCT00267917|Sympathomimetics|sympathomimetics|mesh-ancestor
110307600|NCT00267917|Tocolytic Agents|tocolytic agents|mesh-ancestor
110307601|NCT00267917|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110307602|NCT00267917|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110307603|NCT00267917|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110307604|NCT00267917|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110307605|NCT00267917|Adrenergic Agents|adrenergic agents|mesh-ancestor
110307606|NCT00267917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110307607|NCT00267917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110307608|NCT00267917|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110307609|NCT00267917|Cholinergic Agents|cholinergic agents|mesh-ancestor
110307611|NCT00296361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110307612|NCT00296361|Immunologic Factors|immunologic factors|mesh-ancestor
110307613|NCT00296361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110307614|NCT00296361|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110307615|NCT00296361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110307616|NCT00296361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110307617|NCT00415922|Levodopa|levodopa|mesh-list
110307618|NCT00415922|Carbidopa|carbidopa|mesh-list
110307619|NCT00415922|Entacapone|entacapone|mesh-list
110307620|NCT00415922|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
110307621|NCT00415922|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110307622|NCT00415922|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110307623|NCT00415922|Dopamine Agents|dopamine agents|mesh-ancestor
110307624|NCT00415922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110307625|NCT00415922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110307626|NCT00415922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110307627|NCT00415922|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
110307628|NCT00415922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110307629|NCT00415922|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
110307630|NCT00415922|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110307631|NCT00415922|Immunologic Factors|immunologic factors|mesh-ancestor
110307632|NCT00415922|Dopamine Agonists|dopamine agonists|mesh-ancestor
110307633|NCT00415961|Paclitaxel|paclitaxel|mesh-list
110078948|NCT01619566|Analgesics|analgesics|mesh-ancestor
110307634|NCT00415961|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110307635|NCT00415961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110307636|NCT00415961|Tubulin Modulators|tubulin modulators|mesh-ancestor
110307637|NCT00415961|Antimitotic Agents|antimitotic agents|mesh-ancestor
110307638|NCT00415961|Mitosis Modulators|mitosis modulators|mesh-ancestor
110307639|NCT00415961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110307640|NCT00416039|Midazolam|midazolam|mesh-list
110307641|NCT00416039|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110307642|NCT00416039|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110307643|NCT00416039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110307644|NCT00416039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110307645|NCT00416039|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110307646|NCT00416039|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110307647|NCT00416039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110307648|NCT00416039|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110307649|NCT00416039|Anesthetics, General|anesthetics, general|mesh-ancestor
110307650|NCT00416039|Anesthetics|anesthetics|mesh-ancestor
110307651|NCT00416039|GABA Modulators|gaba modulators|mesh-ancestor
110307652|NCT00416039|GABA Agents|gaba agents|mesh-ancestor
110307653|NCT00416039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110307654|NCT00416039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110307655|NCT00296478|Progesterone|progesterone|mesh-list
110307656|NCT00296478|Progestins|progestins|mesh-ancestor
110307657|NCT00296478|Hormones|hormones|mesh-ancestor
110307658|NCT00296478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110307659|NCT00296478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110307660|NCT00268151|Capecitabine|capecitabine|mesh-list
110307661|NCT00268151|Oxaliplatin|oxaliplatin|mesh-list
110307662|NCT00268151|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110307663|NCT00268151|Antimetabolites|antimetabolites|mesh-ancestor
110307664|NCT00268151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110307665|NCT00268151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110307666|NCT00418080|Bicalutamide|bicalutamide|mesh-list
110307667|NCT00418080|Androgen Antagonists|androgen antagonists|mesh-ancestor
110307668|NCT00418080|Hormone Antagonists|hormone antagonists|mesh-ancestor
110307669|NCT00418080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110307670|NCT00418080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110307671|NCT00418080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110307672|NCT00268229|Cytarabine|cytarabine|mesh-list
110307673|NCT00268229|Imatinib Mesylate|imatinib mesylate|mesh-list
110307674|NCT00268229|Daunorubicin|daunorubicin|mesh-list
110307675|NCT00268229|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110307676|NCT00268229|Antimetabolites|antimetabolites|mesh-ancestor
110079017|NCT01619891|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110307677|NCT00268229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110307678|NCT00268229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110307679|NCT00268229|Antiviral Agents|antiviral agents|mesh-ancestor
110307680|NCT00268229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110307681|NCT00268229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110307682|NCT00268229|Immunologic Factors|immunologic factors|mesh-ancestor
110307683|NCT00268229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110307684|NCT00268229|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110307685|NCT00268229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110307686|NCT00268229|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110307687|NCT00268229|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110307688|NCT00268229|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110307689|NCT00302289|Caffeine|caffeine|mesh-list
110307690|NCT00302289|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110307691|NCT00302289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110307692|NCT00302289|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110307693|NCT00302289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110307694|NCT00302289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110307695|NCT00302289|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110307696|NCT00302289|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110307697|NCT00302289|Purinergic Agents|purinergic agents|mesh-ancestor
110307698|NCT00302289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110307699|NCT00296634|Aluminum Hydroxide|aluminum hydroxide|mesh-list
110307700|NCT00296634|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110307701|NCT00296634|Immunologic Factors|immunologic factors|mesh-ancestor
110307702|NCT00296634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110307703|NCT00296634|Antacids|antacids|mesh-ancestor
110307704|NCT00296634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110307705|NCT00296634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110307706|NCT00268619|Ramipril|ramipril|mesh-list
110307707|NCT00268619|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110307708|NCT00268619|Protease Inhibitors|protease inhibitors|mesh-ancestor
110307709|NCT00268619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110079080|NCT01620333|Insulin Aspart|insulin aspart|mesh-list
110307710|NCT00268619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110307711|NCT00268619|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110307712|NCT00296712|Dexetimide|dexetimide|mesh-list
110307713|NCT00296712|Citalopram|citalopram|mesh-list
110307714|NCT00296712|Bupropion|bupropion|mesh-list
110307715|NCT00296712|Escitalopram|escitalopram|mesh-list
110307716|NCT00296712|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110307717|NCT00296712|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110307718|NCT00296712|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110307719|NCT00296712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110307720|NCT00296712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110307721|NCT00296712|Serotonin Agents|serotonin agents|mesh-ancestor
110307722|NCT00296712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110307723|NCT00296712|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110307724|NCT00296712|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110307725|NCT00296712|Parasympatholytics|parasympatholytics|mesh-ancestor
110307726|NCT00296712|Autonomic Agents|autonomic agents|mesh-ancestor
110307727|NCT00296712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110307728|NCT00296712|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110307729|NCT00296712|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110307730|NCT00296712|Cholinergic Agents|cholinergic agents|mesh-ancestor
110307731|NCT00296712|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110307732|NCT00296712|Antidepressive Agents|antidepressive agents|mesh-ancestor
110307733|NCT00296712|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110307734|NCT00296712|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110307735|NCT00296712|Dopamine Agents|dopamine agents|mesh-ancestor
110307736|NCT00296712|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110307737|NCT00296712|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110307738|NCT00296712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110307740|NCT00268697|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110307741|NCT00268697|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110307742|NCT00268697|Antimetabolites|antimetabolites|mesh-ancestor
110307743|NCT00268697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110307744|NCT00268697|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110307745|NCT00296751|Fentanyl|fentanyl|mesh-list
110307746|NCT00296751|Meperidine|meperidine|mesh-list
110307747|NCT00296751|Bupivacaine|bupivacaine|mesh-list
110307748|NCT00296751|Anesthetics, Local|anesthetics, local|mesh-ancestor
110307749|NCT00296751|Anesthetics|anesthetics|mesh-ancestor
110307750|NCT00296751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110307751|NCT00296751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110307752|NCT00296751|Sensory System Agents|sensory system agents|mesh-ancestor
110307753|NCT00296751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110307754|NCT00296751|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110307755|NCT00296751|Narcotics|narcotics|mesh-ancestor
110307756|NCT00296751|Analgesics|analgesics|mesh-ancestor
110307757|NCT00296751|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110307758|NCT00296751|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110307759|NCT00296751|Anesthetics, General|anesthetics, general|mesh-ancestor
110307760|NCT00302367|Methylphenidate|methylphenidate|mesh-list
110307761|NCT00302367|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110307762|NCT00302367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110307763|NCT00302367|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110307764|NCT00302367|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110307765|NCT00302367|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110307766|NCT00302367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110307767|NCT00302367|Dopamine Agents|dopamine agents|mesh-ancestor
110307768|NCT00302367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110307770|NCT00296790|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110307771|NCT00296790|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110307772|NCT00296790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110307773|NCT00296790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110079225|NCT01621256|Ancrod|ancrod|mesh-list
110307774|NCT00296790|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
110307775|NCT00296790|GABA Agonists|gaba agonists|mesh-ancestor
110307777|NCT00296790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110307778|NCT00296790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110307779|NCT00302406|Methylphenidate|methylphenidate|mesh-list
110307780|NCT00302406|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110307781|NCT00302406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110307782|NCT00302406|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110307783|NCT00302406|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110307784|NCT00302406|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110307785|NCT00302406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110307786|NCT00302406|Dopamine Agents|dopamine agents|mesh-ancestor
110307787|NCT00302406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110307788|NCT00268814|Methadone|methadone|mesh-list
110307789|NCT00268814|Heroin|heroin|mesh-list
110307790|NCT00268814|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110307791|NCT00268814|Narcotics|narcotics|mesh-ancestor
110307792|NCT00268814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110307793|NCT00268814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110307795|NCT00268814|Sensory System Agents|sensory system agents|mesh-ancestor
110307796|NCT00268814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110307797|NCT00268814|Antitussive Agents|antitussive agents|mesh-ancestor
110307798|NCT00268814|Respiratory System Agents|respiratory system agents|mesh-ancestor
110307799|NCT00302484|Zoledronic Acid|zoledronic acid|mesh-list
110307800|NCT00302484|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110307801|NCT00302484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110307802|NCT00296868|Ascorbic Acid|ascorbic acid|mesh-list
110307803|NCT00296868|Vitamins|vitamins|mesh-ancestor
110307804|NCT00296868|Micronutrients|micronutrients|mesh-ancestor
110307805|NCT00296868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110307806|NCT00296868|Antioxidants|antioxidants|mesh-ancestor
110307807|NCT00296868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110307808|NCT00296868|Protective Agents|protective agents|mesh-ancestor
110307809|NCT00268970|Paclitaxel|paclitaxel|mesh-list
110307810|NCT00268970|Satraplatin|satraplatin|mesh-list
110307811|NCT00268970|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110307812|NCT00268970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110307813|NCT00268970|Tubulin Modulators|tubulin modulators|mesh-ancestor
110307814|NCT00268970|Antimitotic Agents|antimitotic agents|mesh-ancestor
110307815|NCT00268970|Mitosis Modulators|mitosis modulators|mesh-ancestor
110307816|NCT00268970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110307817|NCT00296946|Bromides|bromides|mesh-list
110307818|NCT00296946|Ipratropium|ipratropium|mesh-list
110307819|NCT00296946|Anticonvulsants|anticonvulsants|mesh-ancestor
110307820|NCT00296946|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110307821|NCT00296946|Autonomic Agents|autonomic agents|mesh-ancestor
110307822|NCT00296946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110307823|NCT00296946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110307824|NCT00296946|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110307825|NCT00296946|Respiratory System Agents|respiratory system agents|mesh-ancestor
110307826|NCT00296946|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110307827|NCT00296946|Cholinergic Agents|cholinergic agents|mesh-ancestor
110307828|NCT00296946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110307829|NCT00296946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110307830|NCT00269048|Darapladib|darapladib|mesh-list
110307831|NCT00269048|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
110307832|NCT00269048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110307833|NCT00269048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110307834|NCT00302523|Tacrolimus|tacrolimus|mesh-list
110307835|NCT00302523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110307836|NCT00302523|Immunologic Factors|immunologic factors|mesh-ancestor
110307837|NCT00302523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110307838|NCT00302523|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110307839|NCT00302523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110307840|NCT00302523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110307841|NCT02960412|Furosemide|furosemide|mesh-list
110307842|NCT02960412|Diuretics|diuretics|mesh-ancestor
110307843|NCT02960412|Natriuretic Agents|natriuretic agents|mesh-ancestor
110307844|NCT02960412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110260170|NCT02944201|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110307845|NCT02960412|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110307846|NCT02960412|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110307847|NCT02960412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110307848|NCT00269126|Fluticasone|fluticasone|mesh-list
110307849|NCT00269126|Xhance|xhance|mesh-list
110307850|NCT00269126|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110307851|NCT00269126|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
110307852|NCT00269126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110307853|NCT00269126|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110307854|NCT00269126|Autonomic Agents|autonomic agents|mesh-ancestor
110307855|NCT00269126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110307856|NCT00269126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110307857|NCT00269126|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110307858|NCT00269126|Respiratory System Agents|respiratory system agents|mesh-ancestor
110307859|NCT00269126|Dermatologic Agents|dermatologic agents|mesh-ancestor
110307860|NCT00269126|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110307861|NCT00269126|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110307862|NCT00269126|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110307863|NCT00269126|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110307864|NCT00269126|Adrenergic Agents|adrenergic agents|mesh-ancestor
110307865|NCT00269126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110307866|NCT00269126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110307867|NCT00269126|Glucocorticoids|glucocorticoids|mesh-ancestor
110307869|NCT00269126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110307870|NCT00269126|Sympathomimetics|sympathomimetics|mesh-ancestor
110307871|NCT00269204|Niacin|niacin|mesh-list
110307872|NCT00269204|Niacinamide|niacinamide|mesh-list
110307873|NCT00269204|Nicotinic Acids|nicotinic acids|mesh-list
110307874|NCT00269204|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110307875|NCT00269204|Antimetabolites|antimetabolites|mesh-ancestor
110307876|NCT00269204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110307877|NCT00269204|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110307878|NCT00269204|Vasodilator Agents|vasodilator agents|mesh-ancestor
110307879|NCT00269204|Vitamin B Complex|vitamin b complex|mesh-ancestor
110307881|NCT00269204|Micronutrients|micronutrients|mesh-ancestor
110307882|NCT00269204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110307883|NCT00297141|Capecitabine|capecitabine|mesh-list
110307884|NCT00297141|Oxaliplatin|oxaliplatin|mesh-list
110307885|NCT00297141|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110307886|NCT00297141|Antimetabolites|antimetabolites|mesh-ancestor
110307887|NCT00297141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110307888|NCT00297141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110307889|NCT00269243|Quinapril|quinapril|mesh-list
110307890|NCT00269243|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110307891|NCT00269243|Protease Inhibitors|protease inhibitors|mesh-ancestor
110307892|NCT00269243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110307893|NCT00269243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110307894|NCT00269243|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110307895|NCT04718064|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
110307896|NCT04718064|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
110307897|NCT04718064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110307898|NCT04718064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110168836|NCT00000794|Pyrimethamine|pyrimethamine|mesh-list
110307899|NCT04718064|Immunologic Factors|immunologic factors|mesh-ancestor
110307900|NCT04718064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110307901|NCT00297219|Calcium, Dietary|calcium, dietary|mesh-list
110307902|NCT00297219|Dialysis Solutions|dialysis solutions|mesh-list
110307903|NCT00297219|Calcium|calcium|mesh-list
110307904|NCT00297219|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110307905|NCT00297219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110307906|NCT00297219|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110307907|NCT00297219|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110307908|NCT00302640|Nitazoxanide|nitazoxanide|mesh-list
110307909|NCT00302640|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110307910|NCT00302640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110307911|NCT00418353|Dexamethasone|dexamethasone|mesh-list
110307912|NCT00418353|Betamethasone|betamethasone|mesh-list
110307913|NCT00418353|Betamethasone Valerate|betamethasone valerate|mesh-list
110307914|NCT00418353|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
110307915|NCT00418353|Betamethasone benzoate|betamethasone benzoate|mesh-list
110307916|NCT00418353|Betamethasone acetate phosphate|betamethasone acetate phosphate|mesh-list
110307917|NCT00418353|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
110307918|NCT00418353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110307919|NCT00418353|Antiemetics|antiemetics|mesh-ancestor
110307920|NCT00418353|Autonomic Agents|autonomic agents|mesh-ancestor
110307921|NCT00418353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110307922|NCT00418353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110307923|NCT00418353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110307924|NCT00418353|Glucocorticoids|glucocorticoids|mesh-ancestor
110307925|NCT00418353|Hormones|hormones|mesh-ancestor
110307926|NCT00418353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110307927|NCT00418353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110307928|NCT00418353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110307929|NCT00418353|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110307930|NCT00418353|Respiratory System Agents|respiratory system agents|mesh-ancestor
110307931|NCT00418353|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110307932|NCT00418392|Minocycline|minocycline|mesh-list
110307933|NCT00418392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110307934|NCT00418392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110307935|NCT00269555|Genistein|genistein|mesh-list
110307936|NCT00269555|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110307937|NCT00269555|Protective Agents|protective agents|mesh-ancestor
110307938|NCT00269555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110307940|NCT00269555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110307941|NCT00269555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110358789|NCT05338619|Lazertinib|lazertinib|mesh-list
110060353|NCT01523041|Insulin Aspart|insulin aspart|mesh-list
110307942|NCT00269555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110307943|NCT00269555|Phytoestrogens|phytoestrogens|mesh-ancestor
110307944|NCT00269555|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
110307945|NCT00269555|Estrogens|estrogens|mesh-ancestor
110307946|NCT00269555|Hormones|hormones|mesh-ancestor
110307947|NCT00269555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110307948|NCT00418431|Bevacizumab|bevacizumab|mesh-list
110307949|NCT00418431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110307950|NCT00418431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110307951|NCT00418431|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110307952|NCT00418431|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110307953|NCT00418431|Growth Substances|growth substances|mesh-ancestor
110307954|NCT00418431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110307955|NCT00418431|Growth Inhibitors|growth inhibitors|mesh-ancestor
110307956|NCT00269594|Lamotrigine|lamotrigine|mesh-list
110307957|NCT00269594|Anticonvulsants|anticonvulsants|mesh-ancestor
110307958|NCT00269594|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110307959|NCT00269594|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110307960|NCT00269594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110307961|NCT00269594|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110307962|NCT00269594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110307963|NCT00269594|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110307964|NCT00269594|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110307965|NCT00269594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110307966|NCT00269594|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110307967|NCT00269594|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110307968|NCT00418470|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110307969|NCT00418470|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
110307970|NCT00418470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110307971|NCT00418470|Antitubercular Agents|antitubercular agents|mesh-ancestor
110307972|NCT00269672|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110307973|NCT00269672|Immunologic Factors|immunologic factors|mesh-ancestor
110307974|NCT00269672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110307976|NCT00302835|Sensory System Agents|sensory system agents|mesh-ancestor
110307977|NCT00302835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110307978|NCT00302835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110307979|NCT00269750|Oxybutynin|oxybutynin|mesh-list
110307980|NCT00269750|Parasympatholytics|parasympatholytics|mesh-ancestor
110307981|NCT00269750|Autonomic Agents|autonomic agents|mesh-ancestor
110307982|NCT00269750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110307983|NCT00269750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110307984|NCT00269750|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110307985|NCT00269750|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110307986|NCT00269750|Cholinergic Agents|cholinergic agents|mesh-ancestor
110307987|NCT00269750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110307988|NCT00269750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110307990|NCT00269789|Methylphenidate|methylphenidate|mesh-list
110307991|NCT00269789|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110307992|NCT00269789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110307993|NCT00269789|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110307994|NCT00269789|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110307995|NCT00269789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110307996|NCT00269789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110307997|NCT00269789|Dopamine Agents|dopamine agents|mesh-ancestor
110307998|NCT00269789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110307999|NCT00302913|Clopidogrel|clopidogrel|mesh-list
110308000|NCT00302913|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110308001|NCT00302913|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110308002|NCT00302913|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110308003|NCT00302913|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110308004|NCT00302913|Purinergic Agents|purinergic agents|mesh-ancestor
110308005|NCT00302913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110308006|NCT00302913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110308007|NCT00302913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110308009|NCT00269828|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110308010|NCT00269828|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
110308011|NCT00269828|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110308012|NCT00269828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110308013|NCT00269828|Tubulin Modulators|tubulin modulators|mesh-ancestor
110308014|NCT00269828|Antimitotic Agents|antimitotic agents|mesh-ancestor
110308015|NCT00269828|Mitosis Modulators|mitosis modulators|mesh-ancestor
110308016|NCT00269828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110308018|NCT00269867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110308019|NCT00269867|Antibodies|antibodies|mesh-list
110308020|NCT00269867|Immunoglobulins|immunoglobulins|mesh-list
110308021|NCT00269867|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110308022|NCT00269867|Immunologic Factors|immunologic factors|mesh-ancestor
110308023|NCT00269867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110308024|NCT00269867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110308025|NCT00269867|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110308026|NCT00269867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110308027|NCT00269867|Dermatologic Agents|dermatologic agents|mesh-ancestor
110308028|NCT00269867|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110308029|NCT00269867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110308030|NCT00269906|Abciximab|abciximab|mesh-list
110308031|NCT00269906|Anticoagulants|anticoagulants|mesh-ancestor
110308032|NCT00269906|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110308034|NCT00269945|Hematinics|hematinics|mesh-ancestor
110308035|NCT00269984|Epoetin Alfa|epoetin alfa|mesh-list
110308036|NCT00269984|Hematinics|hematinics|mesh-ancestor
110308037|NCT00297336|Topiramate|topiramate|mesh-list
110308038|NCT00297336|Anticonvulsants|anticonvulsants|mesh-ancestor
110308039|NCT00297336|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110308040|NCT00297336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110308041|NCT00270023|Epoetin Alfa|epoetin alfa|mesh-list
110308042|NCT00270023|Hematinics|hematinics|mesh-ancestor
110308043|NCT00297375|Acetaminophen|acetaminophen|mesh-list
110308044|NCT00297375|Tramadol|tramadol|mesh-list
110308045|NCT00297375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110308046|NCT00297375|Analgesics|analgesics|mesh-ancestor
110080128|NCT01627353|Anesthetics, Local|anesthetics, local|mesh-ancestor
110308047|NCT00297375|Sensory System Agents|sensory system agents|mesh-ancestor
110308048|NCT00297375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110308049|NCT00297375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110308051|NCT00297375|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110308052|NCT00297375|Narcotics|narcotics|mesh-ancestor
110308053|NCT00297375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110308054|NCT00270062|Epoetin Alfa|epoetin alfa|mesh-list
110308055|NCT00270062|Hematinics|hematinics|mesh-ancestor
110308056|NCT00270101|Epoetin Alfa|epoetin alfa|mesh-list
110308057|NCT00270101|Hematinics|hematinics|mesh-ancestor
110308058|NCT00270140|Epoetin Alfa|epoetin alfa|mesh-list
110308059|NCT00270140|Hematinics|hematinics|mesh-ancestor
110308060|NCT00270179|Epoetin Alfa|epoetin alfa|mesh-list
110308061|NCT00270179|Hematinics|hematinics|mesh-ancestor
110308062|NCT00297570|Interferons|interferons|mesh-list
110308063|NCT00297570|Imatinib Mesylate|imatinib mesylate|mesh-list
110308064|NCT00297570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110308065|NCT00297570|Antiviral Agents|antiviral agents|mesh-ancestor
110308066|NCT00297570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110308067|NCT00297570|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110308068|NCT00297570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110308069|NCT00297570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110308070|NCT00270335|Propofol|propofol|mesh-list
110308071|NCT00270335|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110308072|NCT00270335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110308073|NCT00270335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110308074|NCT00270335|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110308075|NCT00270335|Anesthetics, General|anesthetics, general|mesh-ancestor
110308076|NCT00270335|Anesthetics|anesthetics|mesh-ancestor
110308077|NCT00270374|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
110308078|NCT00270374|Natriuretic Agents|natriuretic agents|mesh-ancestor
110308079|NCT00270374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110308080|NCT00270491|Paclitaxel|paclitaxel|mesh-list
110308081|NCT00270491|Capecitabine|capecitabine|mesh-list
110308082|NCT00270491|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110308083|NCT00270491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110308084|NCT00270491|Tubulin Modulators|tubulin modulators|mesh-ancestor
110308085|NCT00270491|Antimitotic Agents|antimitotic agents|mesh-ancestor
110308086|NCT00270491|Mitosis Modulators|mitosis modulators|mesh-ancestor
110442352|NCT00634348|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110308087|NCT00270491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110308088|NCT00270491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110308090|NCT00270530|Pyrimethamine|pyrimethamine|mesh-list
110308091|NCT00270530|Sulfadoxine|sulfadoxine|mesh-list
110308092|NCT00270530|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
110308093|NCT00270530|Antimalarials|antimalarials|mesh-ancestor
110308094|NCT00270530|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110308095|NCT00270530|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110308096|NCT00270530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110308097|NCT00270530|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110308098|NCT00270530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110308099|NCT00270530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110308100|NCT00270530|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110308101|NCT00297765|Tacrolimus|tacrolimus|mesh-list
110308102|NCT00297765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110308103|NCT00297765|Immunologic Factors|immunologic factors|mesh-ancestor
110308104|NCT00297765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110308105|NCT00297765|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110308106|NCT00297765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110308107|NCT00297765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110308108|NCT00270569|Cisplatin|cisplatin|mesh-list
110308109|NCT00270569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110308110|NCT00297804|Paclitaxel|paclitaxel|mesh-list
110308111|NCT00297804|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110308112|NCT00297804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110308113|NCT00297804|Tubulin Modulators|tubulin modulators|mesh-ancestor
110308114|NCT00297804|Antimitotic Agents|antimitotic agents|mesh-ancestor
110308115|NCT00297804|Mitosis Modulators|mitosis modulators|mesh-ancestor
110308116|NCT00297804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110308117|NCT00270647|Vitamins|vitamins|mesh-list
110308118|NCT00270647|Vitamin E|vitamin e|mesh-list
110308119|NCT00270647|Beta Carotene|beta carotene|mesh-list
110308120|NCT00270647|Carotenoids|carotenoids|mesh-list
110308121|NCT00270647|Micronutrients|micronutrients|mesh-ancestor
110308122|NCT00270647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110308123|NCT00270647|Antioxidants|antioxidants|mesh-ancestor
110308124|NCT00270647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110308125|NCT00270647|Protective Agents|protective agents|mesh-ancestor
110308126|NCT00270647|Provitamins|provitamins|mesh-ancestor
110308127|NCT00297960|Olanzapine|olanzapine|mesh-list
110308128|NCT00297960|Ziprasidone|ziprasidone|mesh-list
110308129|NCT00297960|Antiemetics|antiemetics|mesh-ancestor
110308130|NCT00297960|Autonomic Agents|autonomic agents|mesh-ancestor
110308131|NCT00297960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110308132|NCT00297960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110308133|NCT00297960|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110308134|NCT00297960|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110308135|NCT00297960|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110308136|NCT00297960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110308137|NCT00297960|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110308138|NCT00297960|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110308139|NCT00297960|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110308140|NCT00297960|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110308141|NCT00297960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110308142|NCT00297960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110308143|NCT00297960|Serotonin Agents|serotonin agents|mesh-ancestor
110308144|NCT00297960|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110308145|NCT00297960|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110308146|NCT00297960|Dopamine Agents|dopamine agents|mesh-ancestor
110308147|NCT00270881|Cytarabine|cytarabine|mesh-list
110308148|NCT00270881|Cyclophosphamide|cyclophosphamide|mesh-list
110308149|NCT00270881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110308150|NCT00270881|Immunologic Factors|immunologic factors|mesh-ancestor
110308151|NCT00270881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110308152|NCT00270881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110308153|NCT00270881|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110308154|NCT00270881|Alkylating Agents|alkylating agents|mesh-ancestor
110308155|NCT00270881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110308156|NCT00270881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110308157|NCT00270881|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110308158|NCT00270881|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110308159|NCT00270881|Antimetabolites|antimetabolites|mesh-ancestor
110308160|NCT00270881|Antiviral Agents|antiviral agents|mesh-ancestor
110308161|NCT00270881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110308162|NCT00298194|Z 338|z 338|mesh-list
110308163|NCT00298194|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110308164|NCT00298194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110308165|NCT00298194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110308166|NCT00298194|Cholinergic Agents|cholinergic agents|mesh-ancestor
110308167|NCT00298194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110308168|NCT00298194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110308169|NCT00298194|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110308171|NCT00418548|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110308172|NCT00418548|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110308174|NCT00418548|Sensory System Agents|sensory system agents|mesh-ancestor
110308175|NCT00418548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110308176|NCT00418548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110308177|NCT00418548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110308178|NCT00418548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110308179|NCT00418548|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110308180|NCT00418548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110080665|NCT01631058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110308181|NCT00418548|Immunologic Factors|immunologic factors|mesh-ancestor
110308182|NCT00418587|Vitamin D|vitamin d|mesh-list
110308183|NCT00418587|Ergocalciferols|ergocalciferols|mesh-list
110308184|NCT00418587|Cholecalciferol|cholecalciferol|mesh-list
110308185|NCT00418587|Vitamins|vitamins|mesh-list
110308186|NCT00418587|Micronutrients|micronutrients|mesh-ancestor
110308187|NCT00418587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110308188|NCT00418587|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110308189|NCT00418587|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110308190|NCT00416273|Bortezomib|bortezomib|mesh-list
110308191|NCT00416273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110308192|NCT00306462|Magnesium Sulfate|magnesium sulfate|mesh-list
110308193|NCT00306462|Nifedipine|nifedipine|mesh-list
110308194|NCT00306462|Analgesics|analgesics|mesh-ancestor
110308195|NCT00306462|Sensory System Agents|sensory system agents|mesh-ancestor
110308196|NCT00306462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110308197|NCT00306462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110308198|NCT00306462|Anesthetics|anesthetics|mesh-ancestor
110308199|NCT00306462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110308200|NCT00306462|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110308201|NCT00306462|Anticonvulsants|anticonvulsants|mesh-ancestor
110308202|NCT00306462|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110308203|NCT00306462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110308204|NCT00306462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110308205|NCT00306462|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110308206|NCT00306462|Tocolytic Agents|tocolytic agents|mesh-ancestor
110308207|NCT00306462|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110308208|NCT00306462|Vasodilator Agents|vasodilator agents|mesh-ancestor
110308209|NCT00416390|Lycopene|lycopene|mesh-list
110308210|NCT00416390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110308211|NCT00416390|Antioxidants|antioxidants|mesh-ancestor
110308212|NCT00416390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110308213|NCT00416390|Protective Agents|protective agents|mesh-ancestor
110308214|NCT00416390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110308215|NCT00416390|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110308216|NCT00416390|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110308217|NCT00416390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110308218|NCT00416429|Interferons|interferons|mesh-list
110308219|NCT00416429|Interferon-alpha|interferon-alpha|mesh-list
110308220|NCT00416429|Interferon alpha-2|interferon alpha-2|mesh-list
110308221|NCT00416429|Aldesleukin|aldesleukin|mesh-list
110308222|NCT00416429|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
110308223|NCT00416429|Medroxyprogesterone|medroxyprogesterone|mesh-list
110308224|NCT00416429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110308225|NCT00416429|Antiviral Agents|antiviral agents|mesh-ancestor
110308226|NCT00416429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110308227|NCT00416429|Immunologic Factors|immunologic factors|mesh-ancestor
110308228|NCT00416429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110308229|NCT00416429|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110080848|NCT01631994|Autonomic Agents|autonomic agents|mesh-ancestor
110308230|NCT00416429|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110308231|NCT00416429|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110308232|NCT00416429|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110308233|NCT00416429|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110308234|NCT00416429|Contraceptive Agents|contraceptive agents|mesh-ancestor
110308235|NCT00416429|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110308236|NCT00416429|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110308237|NCT00416429|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110308238|NCT00416429|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110308239|NCT00416429|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110308240|NCT00306540|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110308241|NCT00306540|Antidepressive Agents|antidepressive agents|mesh-ancestor
110308242|NCT00306540|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110308243|NCT00306540|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110308244|NCT00306540|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110308245|NCT00306540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110308246|NCT00306540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110308247|NCT00271271|Gemcitabine|gemcitabine|mesh-list
110308248|NCT00271271|Vinorelbine|vinorelbine|mesh-list
110308249|NCT00271271|Oxaliplatin|oxaliplatin|mesh-list
110080906|NCT01632540|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110308250|NCT00271271|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110308251|NCT00271271|Antimetabolites|antimetabolites|mesh-ancestor
110308252|NCT00271271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110308253|NCT00271271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110308254|NCT00271271|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110308255|NCT00271271|Tubulin Modulators|tubulin modulators|mesh-ancestor
110308256|NCT00271271|Antimitotic Agents|antimitotic agents|mesh-ancestor
110308257|NCT00271271|Mitosis Modulators|mitosis modulators|mesh-ancestor
110308258|NCT00306618|2-Methoxyestradiol|2-methoxyestradiol|mesh-list
110308259|NCT00306618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110308260|NCT00306618|Tubulin Modulators|tubulin modulators|mesh-ancestor
110308261|NCT00306618|Antimitotic Agents|antimitotic agents|mesh-ancestor
110308262|NCT00306618|Mitosis Modulators|mitosis modulators|mesh-ancestor
110308263|NCT00306618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110308265|NCT00271349|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110308266|NCT00271349|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110308267|NCT00271349|Autonomic Agents|autonomic agents|mesh-ancestor
110308268|NCT00271349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110308269|NCT00271349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110308270|NCT00271349|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110308271|NCT00271349|Respiratory System Agents|respiratory system agents|mesh-ancestor
110308272|NCT00271349|Glucocorticoids|glucocorticoids|mesh-ancestor
110308274|NCT00271349|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110308275|NCT00306696|Rosiglitazone|rosiglitazone|mesh-list
110308276|NCT00306696|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110308277|NCT00306696|Spironolactone|spironolactone|mesh-list
110308278|NCT00306696|Furosemide|furosemide|mesh-list
110308279|NCT00306696|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110308280|NCT00306696|Diuretics|diuretics|mesh-ancestor
110308281|NCT00306696|Natriuretic Agents|natriuretic agents|mesh-ancestor
110308282|NCT00306696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110308283|NCT00306696|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110308284|NCT00306696|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110308285|NCT00306696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110308286|NCT00306696|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110308287|NCT00306696|Hormone Antagonists|hormone antagonists|mesh-ancestor
110308288|NCT00306696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110308289|NCT00306696|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110308290|NCT00306696|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110308291|NCT00306696|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110308292|NCT00271427|Selenium|selenium|mesh-list
110308293|NCT00271427|Antioxidants|antioxidants|mesh-ancestor
110308294|NCT00271427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110308295|NCT00271427|Protective Agents|protective agents|mesh-ancestor
110308296|NCT00271427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110308297|NCT00271427|Trace Elements|trace elements|mesh-ancestor
110308298|NCT00271427|Micronutrients|micronutrients|mesh-ancestor
110308299|NCT00271466|Fentanyl|fentanyl|mesh-list
110308300|NCT00271466|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110308301|NCT00271466|Narcotics|narcotics|mesh-ancestor
110308302|NCT00271466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110308303|NCT00271466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110308304|NCT00271466|Analgesics|analgesics|mesh-ancestor
110308305|NCT00271466|Sensory System Agents|sensory system agents|mesh-ancestor
110308306|NCT00271466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110308307|NCT00271466|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110308308|NCT00271466|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110308309|NCT00271466|Anesthetics, General|anesthetics, general|mesh-ancestor
110308311|NCT00306735|Palonosetron|palonosetron|mesh-list
110308312|NCT00306735|Antiemetics|antiemetics|mesh-ancestor
110308313|NCT00306735|Autonomic Agents|autonomic agents|mesh-ancestor
110308314|NCT00306735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110308315|NCT00306735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110308316|NCT00306735|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110308317|NCT00306735|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110308318|NCT00306735|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110308319|NCT00306735|Serotonin Agents|serotonin agents|mesh-ancestor
110308321|NCT00306735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110308322|NCT00271583|Levonorgestrel|levonorgestrel|mesh-list
110308323|NCT00271583|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110308324|NCT00271583|Contraceptive Agents|contraceptive agents|mesh-ancestor
110308325|NCT00271583|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110308326|NCT00271583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110081202|NCT01634698|Antioxidants|antioxidants|mesh-ancestor
110308327|NCT00271583|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110308328|NCT00271583|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110308329|NCT00271583|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110308330|NCT00306774|Vitamin D|vitamin d|mesh-list
110308331|NCT00306774|Cholecalciferol|cholecalciferol|mesh-list
110308332|NCT00306774|Vitamins|vitamins|mesh-ancestor
110308333|NCT00306774|Micronutrients|micronutrients|mesh-ancestor
110308334|NCT00306774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110308335|NCT00306774|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110308336|NCT00306774|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110308337|NCT00306813|Lenalidomide|lenalidomide|mesh-list
110308338|NCT00306813|Immunologic Factors|immunologic factors|mesh-ancestor
110308339|NCT00306813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110308340|NCT00306813|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110308341|NCT00306813|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110308342|NCT00306813|Growth Substances|growth substances|mesh-ancestor
110308343|NCT00306813|Growth Inhibitors|growth inhibitors|mesh-ancestor
110308344|NCT00306813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110308345|NCT00271973|Oxycodone|oxycodone|mesh-list
110308346|NCT00271973|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110308347|NCT00271973|Narcotics|narcotics|mesh-ancestor
110308348|NCT00271973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110308349|NCT00271973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110308350|NCT00271973|Analgesics|analgesics|mesh-ancestor
110308351|NCT00271973|Sensory System Agents|sensory system agents|mesh-ancestor
110308352|NCT00271973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110308353|NCT00306969|Bexarotene|bexarotene|mesh-list
110308354|NCT00306969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110308355|NCT00272012|Insulin glulisine|insulin glulisine|mesh-list
110308356|NCT00272012|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110308357|NCT00272012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110308358|NCT00307008|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110308359|NCT00307008|Immunologic Factors|immunologic factors|mesh-ancestor
110308360|NCT00307008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110308361|NCT00272051|Xaliproden|xaliproden|mesh-list
110308362|NCT00272051|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110308363|NCT00272051|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110308364|NCT00272051|Serotonin Agents|serotonin agents|mesh-ancestor
110308365|NCT00272051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110081265|NCT01635114|Resveratrol|resveratrol|mesh-list
110308366|NCT00272051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110308367|NCT00272051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110308368|NCT00307203|Bupropion|bupropion|mesh-list
110308369|NCT00307203|Nicotine|nicotine|mesh-list
110168911|NCT00036439|Infliximab|infliximab|mesh-list
110308370|NCT00307203|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110308371|NCT00307203|Autonomic Agents|autonomic agents|mesh-ancestor
110308372|NCT00307203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110308373|NCT00307203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110308374|NCT00307203|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110308375|NCT00307203|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110308376|NCT00307203|Cholinergic Agents|cholinergic agents|mesh-ancestor
110308377|NCT00307203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110308378|NCT00307203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110308379|NCT00307203|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110308380|NCT00307203|Antidepressive Agents|antidepressive agents|mesh-ancestor
110308381|NCT00307203|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110308382|NCT00307203|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110308383|NCT00307203|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110308384|NCT00307203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110308385|NCT00307203|Dopamine Agents|dopamine agents|mesh-ancestor
110308386|NCT00307203|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110308387|NCT00307203|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110308388|NCT00307203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110308389|NCT00272090|Insulin Glargine|insulin glargine|mesh-list
110308390|NCT00272090|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110308391|NCT00272090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110308393|NCT00272207|Antiemetics|antiemetics|mesh-ancestor
110308394|NCT00272207|Autonomic Agents|autonomic agents|mesh-ancestor
110308395|NCT00272207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110308396|NCT00272207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110308397|NCT00272207|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110308399|NCT00272207|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110308400|NCT00272207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110308401|NCT00272207|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110308402|NCT00307515|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
110308403|NCT00307515|Hemostatics|hemostatics|mesh-ancestor
110308404|NCT00307515|Coagulants|coagulants|mesh-ancestor
110308405|NCT00272285|Granisetron|granisetron|mesh-list
110308406|NCT00272285|Ramosetron|ramosetron|mesh-list
110308407|NCT00272285|Antiemetics|antiemetics|mesh-ancestor
110308408|NCT00272285|Autonomic Agents|autonomic agents|mesh-ancestor
110308409|NCT00272285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110308410|NCT00272285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110308411|NCT00272285|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110308412|NCT00272285|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110308413|NCT00272285|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110308414|NCT00272285|Serotonin Agents|serotonin agents|mesh-ancestor
110308415|NCT00272285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110308416|NCT00272285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110308418|NCT00272324|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110308419|NCT00272324|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110308420|NCT00272324|Analgesics|analgesics|mesh-ancestor
110308421|NCT00272324|Sensory System Agents|sensory system agents|mesh-ancestor
110308422|NCT00272324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110308423|NCT00272324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110308424|NCT00272324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110308425|NCT00272324|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110308426|NCT00272324|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110308427|NCT00272324|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110308428|NCT00272324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110308429|NCT00272324|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110308430|NCT00272324|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110308431|NCT00272324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110308432|NCT00272324|Antipyretics|antipyretics|mesh-ancestor
110308433|NCT00307593|Infliximab|infliximab|mesh-list
110308434|NCT00307593|Rituximab|rituximab|mesh-list
110308435|NCT00307593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110308436|NCT00307593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110308437|NCT00307593|Immunologic Factors|immunologic factors|mesh-ancestor
110308438|NCT00307593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110308439|NCT00307593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110308440|NCT00307593|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110308441|NCT00307593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110308442|NCT00307593|Dermatologic Agents|dermatologic agents|mesh-ancestor
110308443|NCT00307593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110308444|NCT00307632|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110308446|NCT00307632|Estrogens|estrogens|mesh-ancestor
110308447|NCT00307632|Hormones|hormones|mesh-ancestor
110308448|NCT00307632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110308449|NCT00307632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110308450|NCT00307632|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110308451|NCT00307632|Contraceptive Agents|contraceptive agents|mesh-ancestor
110308452|NCT00307632|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110308453|NCT00307632|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110308454|NCT00307632|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110308455|NCT00307632|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110308456|NCT00272480|Lamivudine|lamivudine|mesh-list
110308457|NCT00272480|Zidovudine|zidovudine|mesh-list
110308458|NCT00272480|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110308459|NCT00272480|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110308460|NCT00272480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110308461|NCT00272480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110308462|NCT00272480|Antiviral Agents|antiviral agents|mesh-ancestor
110308463|NCT00272480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110308464|NCT00272480|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110308465|NCT00272480|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110308466|NCT00272480|Antimetabolites|antimetabolites|mesh-ancestor
110308467|NCT00307671|Mycophenolic Acid|mycophenolic acid|mesh-list
110308469|NCT00307671|Methylprednisolone|methylprednisolone|mesh-list
110308470|NCT00307671|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110308471|NCT00307671|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110308472|NCT00307671|Prednisolone|prednisolone|mesh-list
110308473|NCT00307671|Prednisolone acetate|prednisolone acetate|mesh-list
110308474|NCT00307671|Cyclophosphamide|cyclophosphamide|mesh-list
110308475|NCT00307671|Methotrexate|methotrexate|mesh-list
110308476|NCT00307671|Azathioprine|azathioprine|mesh-list
110308477|NCT00307671|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110308478|NCT00307671|Prednisolone phosphate|prednisolone phosphate|mesh-list
110308479|NCT00307671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110308480|NCT00307671|Immunologic Factors|immunologic factors|mesh-ancestor
110308481|NCT00307671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110308482|NCT00307671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110308483|NCT00307671|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110308484|NCT00307671|Alkylating Agents|alkylating agents|mesh-ancestor
110308485|NCT00307671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110308487|NCT00307671|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110308488|NCT00307671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110308489|NCT00307671|Glucocorticoids|glucocorticoids|mesh-ancestor
110308490|NCT00307671|Hormones|hormones|mesh-ancestor
110308491|NCT00307671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110308492|NCT00307671|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110308493|NCT00307671|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110308494|NCT00307671|Abortifacient Agents|abortifacient agents|mesh-ancestor
110308495|NCT00307671|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110308496|NCT00307671|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110308497|NCT00307671|Antimetabolites|antimetabolites|mesh-ancestor
110308498|NCT00307671|Dermatologic Agents|dermatologic agents|mesh-ancestor
110308499|NCT00307671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110308500|NCT00307671|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110308501|NCT00307671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110308502|NCT00307671|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110308503|NCT00307671|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110308504|NCT00307671|Antitubercular Agents|antitubercular agents|mesh-ancestor
110308505|NCT00307671|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110308506|NCT00307671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110308507|NCT00307671|Antiemetics|antiemetics|mesh-ancestor
110308508|NCT00307671|Autonomic Agents|autonomic agents|mesh-ancestor
110308509|NCT00307671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110308510|NCT00307671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110308511|NCT00307671|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110168928|NCT00000827|Immune Sera|immune sera|mesh-list
110308512|NCT00307671|Protective Agents|protective agents|mesh-ancestor
110308513|NCT00272558|Carboplatin|carboplatin|mesh-list
110308514|NCT00272558|Vinorelbine|vinorelbine|mesh-list
110308515|NCT00272558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110308516|NCT00272558|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110308517|NCT00272558|Tubulin Modulators|tubulin modulators|mesh-ancestor
110308518|NCT00272558|Antimitotic Agents|antimitotic agents|mesh-ancestor
110308519|NCT00272558|Mitosis Modulators|mitosis modulators|mesh-ancestor
110308520|NCT00272558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110308521|NCT00272597|Risperidone|risperidone|mesh-list
110308522|NCT00272597|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110308523|NCT00272597|Serotonin Agents|serotonin agents|mesh-ancestor
110308524|NCT00272597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110308525|NCT00272597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110308526|NCT00272597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110308527|NCT00272597|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110308528|NCT00272597|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110308529|NCT00272597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110308530|NCT00272597|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110308531|NCT00272597|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110308532|NCT00272597|Dopamine Agents|dopamine agents|mesh-ancestor
110308533|NCT00272636|Amiodarone|amiodarone|mesh-list
110308534|NCT00272636|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110308535|NCT00272636|Vasodilator Agents|vasodilator agents|mesh-ancestor
110308536|NCT00272636|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
110308537|NCT00272636|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110081760|NCT01637454|Sympathomimetics|sympathomimetics|mesh-ancestor
110308538|NCT00272636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110308539|NCT00272636|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110308540|NCT00272636|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110308541|NCT00272636|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110308542|NCT00272636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110308543|NCT00272636|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110308544|NCT00272636|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110081814|NCT01637636|Ketoconazole|ketoconazole|mesh-list
110308545|NCT00272636|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110308546|NCT00281970|Docetaxel|docetaxel|mesh-list
110308547|NCT00281970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110308548|NCT00281970|Tubulin Modulators|tubulin modulators|mesh-ancestor
110308549|NCT00281970|Antimitotic Agents|antimitotic agents|mesh-ancestor
110308550|NCT00281970|Mitosis Modulators|mitosis modulators|mesh-ancestor
110308551|NCT00281970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110308552|NCT00272675|Chlorhexidine|chlorhexidine|mesh-list
110308553|NCT00272675|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110308554|NCT00272675|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110308555|NCT00272675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110308556|NCT00272675|Disinfectants|disinfectants|mesh-ancestor
110308557|NCT00272675|Dermatologic Agents|dermatologic agents|mesh-ancestor
110308558|NCT00307827|Visilizumab|visilizumab|mesh-list
110308559|NCT00307827|Immunologic Factors|immunologic factors|mesh-ancestor
110308560|NCT00307827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110308561|NCT00272753|Budesonide|budesonide|mesh-list
110308562|NCT00272753|Albuterol|albuterol|mesh-list
110308563|NCT00272753|Formoterol Fumarate|formoterol fumarate|mesh-list
110308564|NCT00272753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110308565|NCT00272753|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110308566|NCT00272753|Autonomic Agents|autonomic agents|mesh-ancestor
110308567|NCT00272753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110308568|NCT00272753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110308569|NCT00272753|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110308570|NCT00272753|Respiratory System Agents|respiratory system agents|mesh-ancestor
110308571|NCT00272753|Glucocorticoids|glucocorticoids|mesh-ancestor
110308572|NCT00272753|Hormones|hormones|mesh-ancestor
110308573|NCT00272753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110308574|NCT00272753|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110308575|NCT00272753|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110308576|NCT00272753|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110308577|NCT00272753|Adrenergic Agents|adrenergic agents|mesh-ancestor
110308578|NCT00272753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110168929|NCT00000827|Immunologic Factors|immunologic factors|mesh-ancestor
110308579|NCT00272753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110308580|NCT00272753|Tocolytic Agents|tocolytic agents|mesh-ancestor
110308581|NCT00272753|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110308583|NCT00272831|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110308584|NCT00272831|Autonomic Agents|autonomic agents|mesh-ancestor
110308585|NCT00272831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110308586|NCT00272831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110308587|NCT00272831|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110308588|NCT00272831|Respiratory System Agents|respiratory system agents|mesh-ancestor
110308589|NCT00272831|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110308590|NCT00272831|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110308591|NCT00272831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110308592|NCT00272831|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110308593|NCT00272831|Vasodilator Agents|vasodilator agents|mesh-ancestor
110308594|NCT00272831|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110308595|NCT00272831|Protective Agents|protective agents|mesh-ancestor
110308596|NCT00272831|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110308597|NCT00272831|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110308598|NCT00272831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110308599|NCT00416468|Valsartan|valsartan|mesh-list
110308600|NCT00416468|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110308601|NCT00416468|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110308602|NCT00416468|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110308603|NCT00416468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110308604|NCT00307944|Pantoprazole|pantoprazole|mesh-list
110308605|NCT00307944|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110308606|NCT00307944|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110308607|NCT00307944|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110308608|NCT00307944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110082005|NCT01638624|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110308609|NCT00307944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110308611|NCT00416507|Fluorouracil|fluorouracil|mesh-list
110308612|NCT00416507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110308613|NCT00416507|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110308614|NCT00416507|Antimetabolites|antimetabolites|mesh-ancestor
110308615|NCT00416507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110308616|NCT00416507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110308617|NCT00416507|Immunologic Factors|immunologic factors|mesh-ancestor
110308618|NCT00416507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110308620|NCT00282126|Diuretics|diuretics|mesh-ancestor
110308621|NCT00282126|Natriuretic Agents|natriuretic agents|mesh-ancestor
110308622|NCT00282126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110308623|NCT00282126|Expectorants|expectorants|mesh-ancestor
110308624|NCT00282126|Respiratory System Agents|respiratory system agents|mesh-ancestor
110308625|NCT00272870|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
110308626|NCT00272870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110308627|NCT00272870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110308628|NCT00272870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110308629|NCT00272909|Piclozotan|piclozotan|mesh-list
110308630|NCT00272909|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110308631|NCT00272909|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110308632|NCT00272909|Serotonin Agents|serotonin agents|mesh-ancestor
110308633|NCT00272909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110308634|NCT00272909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110308635|NCT00272909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110308636|NCT00282165|Naratriptan|naratriptan|mesh-list
110308637|NCT00282165|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110308638|NCT00282165|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110308639|NCT00282165|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110308640|NCT00282165|Serotonin Agents|serotonin agents|mesh-ancestor
110308641|NCT00282165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110308642|NCT00282165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110308643|NCT00282165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110308645|NCT00272948|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110308646|NCT00272948|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110442353|NCT00634348|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110308647|NCT00272948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110308648|NCT00272948|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110308649|NCT00308100|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
110308651|NCT00308100|Blood Substitutes|blood substitutes|mesh-ancestor
110308652|NCT00273026|Fluticasone|fluticasone|mesh-list
110308654|NCT00273026|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110308655|NCT00273026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110308656|NCT00273026|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110308657|NCT00273026|Autonomic Agents|autonomic agents|mesh-ancestor
110308658|NCT00273026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110308659|NCT00273026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110308660|NCT00273026|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110308661|NCT00273026|Respiratory System Agents|respiratory system agents|mesh-ancestor
110308662|NCT00273026|Dermatologic Agents|dermatologic agents|mesh-ancestor
110308663|NCT00273026|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110308664|NCT00273026|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110308665|NCT00273026|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110308666|NCT00273026|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110308667|NCT00273026|Adrenergic Agents|adrenergic agents|mesh-ancestor
110308668|NCT00273026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110308669|NCT00273026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110308670|NCT00308178|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110308671|NCT00308178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110308672|NCT00282360|Trimetazidine|trimetazidine|mesh-list
110308673|NCT00282360|Vasodilator Agents|vasodilator agents|mesh-ancestor
110308674|NCT00273065|Neosaxitoxin|neosaxitoxin|mesh-list
110082214|NCT01639547|Ribavirin|ribavirin|mesh-list
110308675|NCT00273065|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110308676|NCT00273065|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110308677|NCT00273065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110308678|NCT00273065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110308679|NCT00418704|Docetaxel|docetaxel|mesh-list
110308680|NCT00418704|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110308681|NCT00418704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110308682|NCT00418704|Tubulin Modulators|tubulin modulators|mesh-ancestor
110308683|NCT00418704|Antimitotic Agents|antimitotic agents|mesh-ancestor
110308684|NCT00418704|Mitosis Modulators|mitosis modulators|mesh-ancestor
110308685|NCT00418704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110308686|NCT00418704|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110308687|NCT00418704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110308688|NCT00313950|Vaccines|vaccines|mesh-list
110308689|NCT00313950|Immunologic Factors|immunologic factors|mesh-ancestor
110308690|NCT00313950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110308691|NCT00273299|Valsartan|valsartan|mesh-list
110308692|NCT00273299|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110308693|NCT00273299|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110308694|NCT00273299|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110308695|NCT00273299|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110308696|NCT00273299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110308697|NCT00273299|Diuretics|diuretics|mesh-ancestor
110308698|NCT00273299|Natriuretic Agents|natriuretic agents|mesh-ancestor
110308699|NCT00273299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110308700|NCT00273299|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110308701|NCT00273299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110308702|NCT00418782|Naproxen|naproxen|mesh-list
110308703|NCT00418782|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110308704|NCT00418782|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110308705|NCT00418782|Analgesics|analgesics|mesh-ancestor
110308706|NCT00418782|Sensory System Agents|sensory system agents|mesh-ancestor
110308707|NCT00418782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110308708|NCT00418782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110308709|NCT00418782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110308710|NCT00418782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110308711|NCT00418782|Gout Suppressants|gout suppressants|mesh-ancestor
110308712|NCT00418782|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110308713|NCT00418782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110308714|NCT00418782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110308716|NCT00273338|Docetaxel|docetaxel|mesh-list
110308717|NCT00273338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110308718|NCT00273338|Tubulin Modulators|tubulin modulators|mesh-ancestor
110308719|NCT00273338|Antimitotic Agents|antimitotic agents|mesh-ancestor
110308720|NCT00273338|Mitosis Modulators|mitosis modulators|mesh-ancestor
110308721|NCT00273338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110308722|NCT00273338|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110308723|NCT00273338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110308724|NCT00273338|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
110308725|NCT00273338|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110308726|NCT00273338|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110308728|NCT00273338|Micronutrients|micronutrients|mesh-ancestor
110308729|NCT00273338|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110308731|NCT00273377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110308732|NCT00273377|Antiemetics|antiemetics|mesh-ancestor
110308733|NCT00273377|Autonomic Agents|autonomic agents|mesh-ancestor
110308734|NCT00273377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110308735|NCT00273377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110308736|NCT00273377|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110308737|NCT00273377|Glucocorticoids|glucocorticoids|mesh-ancestor
110308738|NCT00273377|Hormones|hormones|mesh-ancestor
110308739|NCT00273377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110308740|NCT00273377|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110308741|NCT00273377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110308742|NCT00273416|Sildenafil Citrate|sildenafil citrate|mesh-list
110082386|NCT01645839|Antimetabolites|antimetabolites|mesh-ancestor
110308743|NCT00273416|Vasodilator Agents|vasodilator agents|mesh-ancestor
110308744|NCT00273416|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110308745|NCT00273416|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110308746|NCT00273416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110308747|NCT00273416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110308748|NCT00273416|Urological Agents|urological agents|mesh-ancestor
110308749|NCT00314184|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110308750|NCT00314184|Antidepressive Agents|antidepressive agents|mesh-ancestor
110308751|NCT00314184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110308752|NCT00314184|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110308753|NCT00314184|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110308754|NCT00314184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110308755|NCT00314184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110308756|NCT00273455|Timolol|timolol|mesh-list
110308757|NCT00273455|Bimatoprost|bimatoprost|mesh-list
110308758|NCT00273455|Dorzolamide|dorzolamide|mesh-list
110308759|NCT00273455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110308760|NCT00273455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110308761|NCT00273455|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110308762|NCT00273455|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110308763|NCT00273455|Adrenergic Agents|adrenergic agents|mesh-ancestor
110308764|NCT00273455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110308765|NCT00273455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110308766|NCT00273455|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110308767|NCT00273455|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110308768|NCT00273455|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110308770|NCT00273533|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110308771|NCT00273533|Protease Inhibitors|protease inhibitors|mesh-ancestor
110308772|NCT00273533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110308773|NCT00273533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110308774|NCT00273533|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110308775|NCT00273611|Vitamin D|vitamin d|mesh-list
110308776|NCT00273611|Vitamins|vitamins|mesh-ancestor
110308777|NCT00273611|Micronutrients|micronutrients|mesh-ancestor
110308778|NCT00273611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110168954|NCT00036751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110308779|NCT00273611|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110308780|NCT00273689|Albuterol|albuterol|mesh-list
110308781|NCT00273689|Montelukast|montelukast|mesh-list
110308782|NCT00273689|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110308783|NCT00273689|Respiratory System Agents|respiratory system agents|mesh-ancestor
110308784|NCT00273689|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110308785|NCT00273689|Hormone Antagonists|hormone antagonists|mesh-ancestor
110308786|NCT00273689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110308787|NCT00273689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110308788|NCT00273689|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110308789|NCT00273689|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110308790|NCT00273689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110308791|NCT00273689|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110308792|NCT00273689|Autonomic Agents|autonomic agents|mesh-ancestor
110308793|NCT00273689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110308794|NCT00273689|Tocolytic Agents|tocolytic agents|mesh-ancestor
110308795|NCT00273689|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110308796|NCT00273689|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110308797|NCT00273689|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110308798|NCT00273689|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110308799|NCT00273689|Adrenergic Agents|adrenergic agents|mesh-ancestor
110308800|NCT00273689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110308801|NCT00308334|Domperidone|domperidone|mesh-list
110308802|NCT00308334|Antiemetics|antiemetics|mesh-ancestor
110308803|NCT00308334|Autonomic Agents|autonomic agents|mesh-ancestor
110308804|NCT00308334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110308805|NCT00308334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110308806|NCT00308334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110308807|NCT00308334|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110308808|NCT00308334|Dopamine Agents|dopamine agents|mesh-ancestor
110308809|NCT00308334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110308810|NCT00308334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110308811|NCT00273767|Epoetin Alfa|epoetin alfa|mesh-list
110308812|NCT00273767|Hematinics|hematinics|mesh-ancestor
110308813|NCT00314379|Vitamin E|vitamin e|mesh-list
110308814|NCT00314379|Vitamins|vitamins|mesh-ancestor
110308815|NCT00314379|Micronutrients|micronutrients|mesh-ancestor
110308816|NCT00314379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110308817|NCT00314379|Antioxidants|antioxidants|mesh-ancestor
110308818|NCT00314379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110308819|NCT00314379|Protective Agents|protective agents|mesh-ancestor
110308820|NCT00273884|Cytarabine|cytarabine|mesh-list
110308821|NCT00273884|Amonafide|amonafide|mesh-list
110308822|NCT00273884|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110308823|NCT00273884|Antimetabolites|antimetabolites|mesh-ancestor
110308824|NCT00273884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110308825|NCT00273884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110308826|NCT00273884|Antiviral Agents|antiviral agents|mesh-ancestor
110308827|NCT00273884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110308828|NCT00273884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110308829|NCT00273884|Immunologic Factors|immunologic factors|mesh-ancestor
110308830|NCT00273884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110308831|NCT00273884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110308832|NCT00308373|Metformin|metformin|mesh-list
110308833|NCT00308373|Pioglitazone|pioglitazone|mesh-list
110308834|NCT00308373|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
110308835|NCT00308373|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110308836|NCT00308373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110308838|NCT00273962|Ipratropium|ipratropium|mesh-list
110308839|NCT00273962|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110308840|NCT00273962|Autonomic Agents|autonomic agents|mesh-ancestor
110308841|NCT00273962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110308842|NCT00273962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110308843|NCT00273962|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110082573|NCT01650506|Metformin|metformin|mesh-list
110308844|NCT00273962|Respiratory System Agents|respiratory system agents|mesh-ancestor
110308846|NCT00273962|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110308847|NCT00273962|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110308848|NCT00273962|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110308849|NCT00273962|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110308850|NCT00273962|Adrenergic Agents|adrenergic agents|mesh-ancestor
110308851|NCT00273962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110308852|NCT00273962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110308853|NCT00273962|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110308854|NCT00273962|Cholinergic Agents|cholinergic agents|mesh-ancestor
110308856|NCT00274001|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110308857|NCT00274001|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110308858|NCT00274001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110308859|NCT00274001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110308860|NCT00274001|Antiviral Agents|antiviral agents|mesh-ancestor
110308861|NCT00274001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110308862|NCT00274001|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110308863|NCT00274001|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110308864|NCT00274001|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110308865|NCT00274001|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110308866|NCT00274040|Tiotropium Bromide|tiotropium bromide|mesh-list
110308867|NCT00274040|Ipratropium|ipratropium|mesh-list
110308868|NCT00274040|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110308869|NCT00274040|Autonomic Agents|autonomic agents|mesh-ancestor
110308870|NCT00274040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110308871|NCT00274040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110308872|NCT00274040|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110308873|NCT00274040|Respiratory System Agents|respiratory system agents|mesh-ancestor
110308874|NCT00274040|Parasympatholytics|parasympatholytics|mesh-ancestor
110308875|NCT00274040|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110308876|NCT00274040|Cholinergic Agents|cholinergic agents|mesh-ancestor
110308877|NCT00274040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110308878|NCT00274040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110308879|NCT00314457|Bupivacaine|bupivacaine|mesh-list
110308880|NCT00314457|Anesthetics, Local|anesthetics, local|mesh-ancestor
110308881|NCT00314457|Anesthetics|anesthetics|mesh-ancestor
110308882|NCT00314457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110308883|NCT00314457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110308884|NCT00314457|Sensory System Agents|sensory system agents|mesh-ancestor
110308885|NCT00314457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110308886|NCT00308451|Chromium|chromium|mesh-list
110308888|NCT00308451|Picolinic acid|picolinic acid|mesh-list
110308889|NCT00308451|Trace Elements|trace elements|mesh-ancestor
110308890|NCT00308451|Micronutrients|micronutrients|mesh-ancestor
110308891|NCT00308451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110308892|NCT00308451|Vitamin B Complex|vitamin b complex|mesh-ancestor
110308893|NCT00308451|Vitamins|vitamins|mesh-ancestor
110308894|NCT00308451|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110308895|NCT00308451|Chelating Agents|chelating agents|mesh-ancestor
110308896|NCT00308451|Sequestering Agents|sequestering agents|mesh-ancestor
110308897|NCT00308451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110308898|NCT00274079|Tiotropium Bromide|tiotropium bromide|mesh-list
110308899|NCT00274079|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110308900|NCT00274079|Autonomic Agents|autonomic agents|mesh-ancestor
110308901|NCT00274079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110308902|NCT00274079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110308903|NCT00274079|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110308904|NCT00274079|Respiratory System Agents|respiratory system agents|mesh-ancestor
110308905|NCT00274079|Parasympatholytics|parasympatholytics|mesh-ancestor
110308906|NCT00274079|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110308907|NCT00274079|Cholinergic Agents|cholinergic agents|mesh-ancestor
110308908|NCT00274079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110308909|NCT00274079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110308910|NCT00274118|Telmisartan|telmisartan|mesh-list
110308911|NCT00274118|Enalapril|enalapril|mesh-list
110308912|NCT00274118|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110308913|NCT00274118|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110308914|NCT00274118|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110308915|NCT00274118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110308916|NCT00274118|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110308917|NCT00274118|Protease Inhibitors|protease inhibitors|mesh-ancestor
110308918|NCT00274118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110308919|NCT00308490|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
110308920|NCT00308490|Hematinics|hematinics|mesh-ancestor
110308921|NCT00416585|Isotretinoin|isotretinoin|mesh-list
110308922|NCT00416585|Dermatologic Agents|dermatologic agents|mesh-ancestor
110308923|NCT00308529|Bevacizumab|bevacizumab|mesh-list
110308924|NCT00308529|Carboplatin|carboplatin|mesh-list
110308925|NCT00308529|Irinotecan|irinotecan|mesh-list
110308926|NCT00308529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110308927|NCT00308529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110308928|NCT00308529|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110308929|NCT00308529|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110308930|NCT00308529|Growth Substances|growth substances|mesh-ancestor
110308931|NCT00308529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110308932|NCT00308529|Growth Inhibitors|growth inhibitors|mesh-ancestor
110308933|NCT00308529|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110308934|NCT00308529|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110308935|NCT00308529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110308936|NCT00308529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110308937|NCT00274235|Pyrimethamine|pyrimethamine|mesh-list
110308938|NCT00274235|Sulfadoxine|sulfadoxine|mesh-list
110308939|NCT00274235|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
110308940|NCT00274235|Mefloquine|mefloquine|mesh-list
110308941|NCT00274235|Antimalarials|antimalarials|mesh-ancestor
110308942|NCT00274235|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110308943|NCT00274235|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110308944|NCT00274235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110308945|NCT00274235|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110308946|NCT00274235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110308947|NCT00274235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110308948|NCT00274235|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110308949|NCT00274274|Insulin|insulin|mesh-list
110308950|NCT00274274|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110308951|NCT00274274|Insulin Aspart|insulin aspart|mesh-list
110308952|NCT00274274|Insulin Detemir|insulin detemir|mesh-list
110308953|NCT00274274|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110308954|NCT00274274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110308955|NCT00308607|Interferons|interferons|mesh-list
110308956|NCT00308607|Interferon-alpha|interferon-alpha|mesh-list
110308957|NCT00308607|Interferon alpha-2|interferon alpha-2|mesh-list
110308958|NCT00308607|Bevacizumab|bevacizumab|mesh-list
110308959|NCT00308607|Dacarbazine|dacarbazine|mesh-list
110308960|NCT00308607|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110308961|NCT00308607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110308962|NCT00308607|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110308963|NCT00308607|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110308964|NCT00308607|Growth Substances|growth substances|mesh-ancestor
110442354|NCT00634348|Serotonin Agents|serotonin agents|mesh-ancestor
110308965|NCT00308607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110308966|NCT00308607|Growth Inhibitors|growth inhibitors|mesh-ancestor
110308967|NCT00308607|Antiviral Agents|antiviral agents|mesh-ancestor
110308968|NCT00308607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110308969|NCT00308607|Immunologic Factors|immunologic factors|mesh-ancestor
110308970|NCT00308607|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110308971|NCT00308607|Alkylating Agents|alkylating agents|mesh-ancestor
110308972|NCT00308607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110308973|NCT00314613|Risperidone|risperidone|mesh-list
110308974|NCT00314613|Antipsychotic Agents|antipsychotic agents|mesh-list
110308975|NCT00314613|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110308976|NCT00314613|Serotonin Agents|serotonin agents|mesh-ancestor
110308977|NCT00314613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110308978|NCT00314613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110308979|NCT00314613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110308980|NCT00314613|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110308981|NCT00314613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110308982|NCT00314613|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110308983|NCT00314613|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110308984|NCT00314613|Dopamine Agents|dopamine agents|mesh-ancestor
110308985|NCT00274352|Adalimumab|adalimumab|mesh-list
110308986|NCT00274352|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110308987|NCT00274352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110308988|NCT00274352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110308989|NCT00314652|Buprenorphine|buprenorphine|mesh-list
110308990|NCT00314652|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110308991|NCT00314652|Narcotics|narcotics|mesh-ancestor
110308992|NCT00314652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110308993|NCT00314652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110308994|NCT00314652|Analgesics|analgesics|mesh-ancestor
110308995|NCT00314652|Sensory System Agents|sensory system agents|mesh-ancestor
110308996|NCT00314652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110308997|NCT00314652|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110308999|NCT00274391|Diuretics|diuretics|mesh-ancestor
110082801|NCT01651962|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110309000|NCT00274391|Natriuretic Agents|natriuretic agents|mesh-ancestor
110309001|NCT00274391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110309002|NCT00274391|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
110309003|NCT00274391|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110309004|NCT00274391|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110309005|NCT00274391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110309006|NCT00274391|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
110309007|NCT00274391|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110309008|NCT00274430|Dexamethasone|dexamethasone|mesh-list
110309009|NCT00274430|Tadalafil|tadalafil|mesh-list
110309010|NCT00274430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110309011|NCT00274430|Antiemetics|antiemetics|mesh-ancestor
110309012|NCT00274430|Autonomic Agents|autonomic agents|mesh-ancestor
110309013|NCT00274430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110309014|NCT00274430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110309015|NCT00274430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110309016|NCT00274430|Glucocorticoids|glucocorticoids|mesh-ancestor
110309017|NCT00274430|Hormones|hormones|mesh-ancestor
110309018|NCT00274430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110309019|NCT00274430|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110309020|NCT00274430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110309021|NCT00274430|Vasodilator Agents|vasodilator agents|mesh-ancestor
110309022|NCT00274430|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110082859|NCT01652118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110309023|NCT00274430|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110309024|NCT00274430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110309025|NCT00274430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110309026|NCT00274430|Urological Agents|urological agents|mesh-ancestor
110309027|NCT00274508|Bromides|bromides|mesh-list
110309028|NCT00274508|Tiotropium Bromide|tiotropium bromide|mesh-list
110309029|NCT00274508|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110309030|NCT00274508|Autonomic Agents|autonomic agents|mesh-ancestor
110309031|NCT00274508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110309032|NCT00274508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110309033|NCT00274508|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110309034|NCT00274508|Respiratory System Agents|respiratory system agents|mesh-ancestor
110309035|NCT00274508|Parasympatholytics|parasympatholytics|mesh-ancestor
110309036|NCT00274508|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110082921|NCT01652326|GABA Modulators|gaba modulators|mesh-ancestor
110309037|NCT00274508|Cholinergic Agents|cholinergic agents|mesh-ancestor
110309038|NCT00274508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110309039|NCT00274508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110309040|NCT00274508|Anticonvulsants|anticonvulsants|mesh-ancestor
110309041|NCT00274547|Tiotropium Bromide|tiotropium bromide|mesh-list
110309042|NCT00274547|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110309043|NCT00274547|Autonomic Agents|autonomic agents|mesh-ancestor
110309044|NCT00274547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110309045|NCT00274547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110309046|NCT00274547|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110309047|NCT00274547|Respiratory System Agents|respiratory system agents|mesh-ancestor
110309048|NCT00274547|Parasympatholytics|parasympatholytics|mesh-ancestor
110309049|NCT00274547|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110309050|NCT00274547|Cholinergic Agents|cholinergic agents|mesh-ancestor
110309051|NCT00274547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110309052|NCT00274547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110309053|NCT00308763|Bupropion|bupropion|mesh-list
110309054|NCT00308763|Nicotine|nicotine|mesh-list
110309055|NCT00308763|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110309056|NCT00308763|Autonomic Agents|autonomic agents|mesh-ancestor
110309057|NCT00308763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110309058|NCT00308763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110309060|NCT00308763|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110309061|NCT00308763|Cholinergic Agents|cholinergic agents|mesh-ancestor
110309062|NCT00308763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110309063|NCT00308763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110168967|NCT00000857|Interleukin-12|interleukin-12|mesh-list
110309064|NCT00308763|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110309065|NCT00308763|Antidepressive Agents|antidepressive agents|mesh-ancestor
110309066|NCT00308763|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110309067|NCT00308763|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110309068|NCT00308763|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110309069|NCT00308763|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110309071|NCT00308763|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110309072|NCT00308763|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110309073|NCT00308763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110309074|NCT00274586|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
110309075|NCT00274586|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110309077|NCT00274820|Thalidomide|thalidomide|mesh-list
110309078|NCT00274820|Dexamethasone|dexamethasone|mesh-list
110309079|NCT00274820|Arsenic Trioxide|arsenic trioxide|mesh-list
110309080|NCT00274820|Vitamins|vitamins|mesh-ancestor
110309081|NCT00274820|Micronutrients|micronutrients|mesh-ancestor
110309082|NCT00274820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110309083|NCT00274820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110309084|NCT00274820|Antiemetics|antiemetics|mesh-ancestor
110309085|NCT00274820|Autonomic Agents|autonomic agents|mesh-ancestor
110309086|NCT00274820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110309087|NCT00274820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110309088|NCT00274820|Glucocorticoids|glucocorticoids|mesh-ancestor
110309089|NCT00274820|Hormones|hormones|mesh-ancestor
110309090|NCT00274820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110309091|NCT00274820|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110309092|NCT00274820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110309094|NCT00274820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110309095|NCT00274820|Protective Agents|protective agents|mesh-ancestor
110309096|NCT00274820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110309097|NCT00274820|Immunologic Factors|immunologic factors|mesh-ancestor
110309098|NCT00274820|Leprostatic Agents|leprostatic agents|mesh-ancestor
110309099|NCT00274820|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110309100|NCT00274820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110309101|NCT00274820|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110309102|NCT00274820|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110309103|NCT00274820|Growth Substances|growth substances|mesh-ancestor
110309104|NCT00274820|Growth Inhibitors|growth inhibitors|mesh-ancestor
110309105|NCT00308841|Lidocaine|lidocaine|mesh-list
110309106|NCT00308841|Anesthetics, Local|anesthetics, local|mesh-ancestor
110309107|NCT00308841|Anesthetics|anesthetics|mesh-ancestor
110309108|NCT00308841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110309109|NCT00308841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110309110|NCT00308841|Sensory System Agents|sensory system agents|mesh-ancestor
110309111|NCT00308841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110309112|NCT00308841|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110309113|NCT00308841|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110309114|NCT00308841|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110309115|NCT00308841|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110309116|NCT00308841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110309117|NCT00274859|Gemcitabine|gemcitabine|mesh-list
110309118|NCT00274859|Oxaliplatin|oxaliplatin|mesh-list
110309119|NCT00274859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110309120|NCT00274859|Antimetabolites|antimetabolites|mesh-ancestor
110309121|NCT00274859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110309122|NCT00274859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110309123|NCT00274898|Celecoxib|celecoxib|mesh-list
110309124|NCT00274898|Docetaxel|docetaxel|mesh-list
110309125|NCT00274898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110309126|NCT00274898|Tubulin Modulators|tubulin modulators|mesh-ancestor
110309127|NCT00274898|Antimitotic Agents|antimitotic agents|mesh-ancestor
110309128|NCT00274898|Mitosis Modulators|mitosis modulators|mesh-ancestor
110309129|NCT00274898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110309130|NCT00274898|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110309131|NCT00274898|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110309132|NCT00274898|Analgesics|analgesics|mesh-ancestor
110309133|NCT00274898|Sensory System Agents|sensory system agents|mesh-ancestor
110309134|NCT00274898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110309135|NCT00274898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110309136|NCT00274898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110309137|NCT00274898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110309138|NCT00274898|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110309139|NCT00274898|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110309140|NCT00274898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110309141|NCT00308880|Tranexamic Acid|tranexamic acid|mesh-list
110309142|NCT00308880|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110309143|NCT00308880|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110309144|NCT00308880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110309146|NCT00308880|Coagulants|coagulants|mesh-ancestor
110309147|NCT00277199|Abatacept|abatacept|mesh-list
110309148|NCT00277199|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110309149|NCT00277199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110309150|NCT00277199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110309151|NCT00277199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110309152|NCT00277199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110309153|NCT00277199|Immunologic Factors|immunologic factors|mesh-ancestor
110309154|NCT00277199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110309155|NCT00277199|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110309156|NCT00277472|Valsartan|valsartan|mesh-list
110309157|NCT00277472|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110309158|NCT00277472|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110309159|NCT00277472|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110309160|NCT00277472|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110309161|NCT00277472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110309162|NCT00277472|Diuretics|diuretics|mesh-ancestor
110309163|NCT00277472|Natriuretic Agents|natriuretic agents|mesh-ancestor
110309164|NCT00277472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110309165|NCT00277472|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110083173|NCT01653457|Dopamine Agents|dopamine agents|mesh-ancestor
110309166|NCT00277472|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110309167|NCT00277511|Levofloxacin|levofloxacin|mesh-list
110309168|NCT00277511|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110309169|NCT00277511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110309170|NCT00277511|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110309171|NCT00277511|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110309172|NCT00277511|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110309173|NCT00277511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110309174|NCT00277511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110309175|NCT00277511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110309176|NCT00277511|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110309177|NCT00277511|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110309178|NCT00315003|Azithromycin|azithromycin|mesh-list
110309179|NCT00315003|Telithromycin|telithromycin|mesh-list
110309180|NCT00315003|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110309181|NCT00315003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110309182|NCT00277550|Tegaserod|tegaserod|mesh-list
110309183|NCT00277550|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110309184|NCT00277550|Serotonin Agents|serotonin agents|mesh-ancestor
110309185|NCT00277550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110309186|NCT00277550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110309187|NCT00277550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110309189|NCT00277589|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110309190|NCT00277589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110309192|NCT00277589|Micronutrients|micronutrients|mesh-ancestor
110309193|NCT00277589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110309194|NCT00315042|Penicillins|penicillins|mesh-list
110309195|NCT00315042|Telithromycin|telithromycin|mesh-list
110309196|NCT00315042|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110309197|NCT00315042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110309198|NCT00277667|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110309199|NCT00277667|Antidepressive Agents|antidepressive agents|mesh-ancestor
110309200|NCT00277667|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110309201|NCT00277667|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110309202|NCT00277667|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110309203|NCT00277667|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110309204|NCT00277667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110309205|NCT00315081|Bromocriptine|bromocriptine|mesh-list
110309207|NCT00315081|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110309208|NCT00315081|Hormone Antagonists|hormone antagonists|mesh-ancestor
110309209|NCT00315081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110309210|NCT00315081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110309211|NCT00315081|Dopamine Agonists|dopamine agonists|mesh-ancestor
110309212|NCT00315081|Dopamine Agents|dopamine agents|mesh-ancestor
110309213|NCT00315081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110309214|NCT00315081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110309215|NCT00277706|Vitamin D|vitamin d|mesh-list
110309217|NCT00277706|Vitamins|vitamins|mesh-ancestor
110309218|NCT00277706|Micronutrients|micronutrients|mesh-ancestor
110309219|NCT00277706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110309220|NCT00277706|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110309221|NCT00277706|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110309222|NCT00277862|Ribavirin|ribavirin|mesh-list
110309223|NCT00277862|Interferon-alpha|interferon-alpha|mesh-list
110309224|NCT00277862|Interferon alpha-2|interferon alpha-2|mesh-list
110309225|NCT00277862|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
110309226|NCT00277862|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110309227|NCT00277862|Antimetabolites|antimetabolites|mesh-ancestor
110309228|NCT00277862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110309229|NCT00277862|Antiviral Agents|antiviral agents|mesh-ancestor
110309230|NCT00277862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110309231|NCT00277862|Immunologic Factors|immunologic factors|mesh-ancestor
110309232|NCT00277862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110309233|NCT00277862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110309234|NCT00278018|Immunomodulating Agents|immunomodulating agents|mesh-list
110309235|NCT00278018|Immunologic Factors|immunologic factors|mesh-ancestor
110309236|NCT00278018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110309237|NCT00309270|Alemtuzumab|alemtuzumab|mesh-list
110309238|NCT00309270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110309239|NCT00309270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110309240|NCT00315276|Modafinil|modafinil|mesh-list
110083345|NCT01654640|Metformin|metformin|mesh-list
110309241|NCT00315276|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110309242|NCT00315276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110309243|NCT00315276|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
110309244|NCT00315276|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110309245|NCT00315276|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110309246|NCT00315276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110309247|NCT00309309|Rosiglitazone|rosiglitazone|mesh-list
110309248|NCT00309309|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110309249|NCT00309309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110309250|NCT00278174|Interferons|interferons|mesh-list
110309251|NCT00278174|Interferon-alpha|interferon-alpha|mesh-list
110309252|NCT00278174|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
110309253|NCT00278174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110309254|NCT00278174|Antiviral Agents|antiviral agents|mesh-ancestor
110309255|NCT00278174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110309256|NCT00278174|Immunologic Factors|immunologic factors|mesh-ancestor
110309257|NCT00278174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110309258|NCT00278213|Cyclophosphamide|cyclophosphamide|mesh-list
110309259|NCT00278213|Fludarabine|fludarabine|mesh-list
110309260|NCT00278213|Fludarabine phosphate|fludarabine phosphate|mesh-list
110309261|NCT00278213|Mitoxantrone|mitoxantrone|mesh-list
110309262|NCT00278213|Alemtuzumab|alemtuzumab|mesh-list
110309263|NCT00278213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110309264|NCT00278213|Immunologic Factors|immunologic factors|mesh-ancestor
110309265|NCT00278213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110309266|NCT00278213|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110309267|NCT00278213|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110309268|NCT00278213|Alkylating Agents|alkylating agents|mesh-ancestor
110309269|NCT00278213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110309270|NCT00278213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110309271|NCT00278213|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110309272|NCT00278213|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110309273|NCT00278213|Antimetabolites|antimetabolites|mesh-ancestor
110309274|NCT00278213|Analgesics|analgesics|mesh-ancestor
110309275|NCT00278213|Sensory System Agents|sensory system agents|mesh-ancestor
110309276|NCT00278213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110309277|NCT00278213|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110309278|NCT00278213|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110309279|NCT00278213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110309280|NCT00278213|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110309282|NCT00278252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110309283|NCT00278252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110309284|NCT00278252|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110309285|NCT00278252|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110309286|NCT00278252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110309287|NCT00278252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110309288|NCT00315432|Interferons|interferons|mesh-list
110309289|NCT00315432|Ribavirin|ribavirin|mesh-list
110309290|NCT00315432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110309291|NCT00315432|Antiviral Agents|antiviral agents|mesh-ancestor
110309292|NCT00315432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110309293|NCT00315432|Antimetabolites|antimetabolites|mesh-ancestor
110309294|NCT00315432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110309296|NCT00278330|Alvocidib|alvocidib|mesh-list
110309297|NCT00278330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110309298|NCT00278330|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110309299|NCT00278330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110309300|NCT00278330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110309301|NCT00278330|Growth Inhibitors|growth inhibitors|mesh-ancestor
110309302|NCT00278330|Growth Substances|growth substances|mesh-ancestor
110309303|NCT00278330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110309304|NCT00278330|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110309305|NCT00315510|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110309306|NCT00315510|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110309307|NCT00315510|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110309308|NCT00315510|Antimetabolites|antimetabolites|mesh-ancestor
110309309|NCT00315510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110309310|NCT00315510|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110309311|NCT00315510|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110309312|NCT00315510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110309313|NCT00278369|Aldesleukin|aldesleukin|mesh-list
110309314|NCT00278369|Interleukin-2|interleukin-2|mesh-list
110309315|NCT00278369|Denileukin diftitox|denileukin diftitox|mesh-list
110309316|NCT00278369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110309317|NCT00278369|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110309318|NCT00278369|Analgesics|analgesics|mesh-ancestor
110309319|NCT00278369|Sensory System Agents|sensory system agents|mesh-ancestor
110309320|NCT00278369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110309321|NCT00278369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110309322|NCT00278369|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110309323|NCT00278369|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110309324|NCT00278369|Antiviral Agents|antiviral agents|mesh-ancestor
110309325|NCT00278369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110309326|NCT00315549|Penicillins|penicillins|mesh-list
110309327|NCT00315549|Telithromycin|telithromycin|mesh-list
110309328|NCT00315549|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110309329|NCT00315549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110309330|NCT00278408|Prednisone|prednisone|mesh-list
110309331|NCT00278408|Cyclophosphamide|cyclophosphamide|mesh-list
110309332|NCT00278408|Rituximab|rituximab|mesh-list
110309333|NCT00278408|Doxorubicin|doxorubicin|mesh-list
110309334|NCT00278408|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110309335|NCT00278408|Vincristine|vincristine|mesh-list
110309336|NCT00278408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110309337|NCT00278408|Immunologic Factors|immunologic factors|mesh-ancestor
110309338|NCT00278408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110309339|NCT00278408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110309340|NCT00278408|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110309341|NCT00278408|Alkylating Agents|alkylating agents|mesh-ancestor
110309342|NCT00278408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110309343|NCT00278408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110309344|NCT00278408|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110309345|NCT00278408|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110168989|NCT00036868|Antimetabolites|antimetabolites|mesh-ancestor
110309346|NCT00278408|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110309347|NCT00278408|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110309348|NCT00278408|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110309349|NCT00278408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110309350|NCT00278408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110309351|NCT00278408|Glucocorticoids|glucocorticoids|mesh-ancestor
110309352|NCT00278408|Hormones|hormones|mesh-ancestor
110309353|NCT00278408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110083506|NCT01655524|Aminophylline|aminophylline|mesh-list
110309354|NCT00278408|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110309355|NCT00278408|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110309356|NCT00278408|Tubulin Modulators|tubulin modulators|mesh-ancestor
110309357|NCT00278408|Antimitotic Agents|antimitotic agents|mesh-ancestor
110309358|NCT00278408|Mitosis Modulators|mitosis modulators|mesh-ancestor
110309359|NCT00315666|Memantine|memantine|mesh-list
110309360|NCT00315666|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110309361|NCT00315666|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110309362|NCT00315666|Dopamine Agents|dopamine agents|mesh-ancestor
110309363|NCT00315666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110309364|NCT00315666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110309365|NCT00315666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110309366|NCT00315666|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110309367|NCT00315666|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110309368|NCT00315744|Fluticasone|fluticasone|mesh-list
110309369|NCT00315744|Xhance|xhance|mesh-list
110309370|NCT00315744|Albuterol|albuterol|mesh-list
110309371|NCT00315744|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110309372|NCT00315744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110309373|NCT00315744|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110309374|NCT00315744|Autonomic Agents|autonomic agents|mesh-ancestor
110309375|NCT00315744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110309376|NCT00315744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110309377|NCT00315744|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110309378|NCT00315744|Respiratory System Agents|respiratory system agents|mesh-ancestor
110309379|NCT00315744|Dermatologic Agents|dermatologic agents|mesh-ancestor
110309380|NCT00315744|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110309381|NCT00315744|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110309382|NCT00315744|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110309383|NCT00315744|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110309384|NCT00315744|Adrenergic Agents|adrenergic agents|mesh-ancestor
110309385|NCT00315744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110309386|NCT00315744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110309387|NCT00315744|Tocolytic Agents|tocolytic agents|mesh-ancestor
110309388|NCT00315744|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110309389|NCT00309543|Leucovorin|leucovorin|mesh-list
110309390|NCT00309543|Fluorouracil|fluorouracil|mesh-list
110309391|NCT00309543|Antimetabolites|antimetabolites|mesh-ancestor
110309392|NCT00309543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110309393|NCT00309543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110309394|NCT00309543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110309395|NCT00309543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110309396|NCT00309543|Immunologic Factors|immunologic factors|mesh-ancestor
110309397|NCT00309543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110309398|NCT00309543|Antidotes|antidotes|mesh-ancestor
110309399|NCT00309543|Protective Agents|protective agents|mesh-ancestor
110309400|NCT00309543|Vitamin B Complex|vitamin b complex|mesh-ancestor
110309401|NCT00309543|Vitamins|vitamins|mesh-ancestor
110309402|NCT00309543|Micronutrients|micronutrients|mesh-ancestor
110309403|NCT00315861|Pemetrexed|pemetrexed|mesh-list
110309404|NCT00315861|Topotecan|topotecan|mesh-list
110309405|NCT00315861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110309406|NCT00315861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110309407|NCT00315861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110309408|NCT00315861|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110309409|NCT00315861|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110309410|NCT00315861|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110309411|NCT00315861|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110309412|NCT00309660|Rosiglitazone|rosiglitazone|mesh-list
110309413|NCT00309660|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110309414|NCT00309660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110309415|NCT00315900|Valproic Acid|valproic acid|mesh-list
110309416|NCT00315900|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110309417|NCT00315900|Antidepressive Agents|antidepressive agents|mesh-ancestor
110309418|NCT00315900|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110309419|NCT00315900|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110309420|NCT00315900|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110309421|NCT00315900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110309422|NCT00315900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110309423|NCT00315900|Anticonvulsants|anticonvulsants|mesh-ancestor
110309424|NCT00315900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110309425|NCT00315900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110309426|NCT00315900|GABA Agents|gaba agents|mesh-ancestor
110083661|NCT01656005|Antioxidants|antioxidants|mesh-ancestor
110309427|NCT00315900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110309428|NCT00315900|Antimanic Agents|antimanic agents|mesh-ancestor
110309429|NCT00279110|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
110309430|NCT00279110|Antiviral Agents|antiviral agents|mesh-ancestor
110309431|NCT00279110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110309432|NCT00309699|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110309433|NCT00309699|Paliperidone Palmitate|paliperidone palmitate|mesh-list
110309434|NCT00309699|Antidepressive Agents|antidepressive agents|mesh-ancestor
110309435|NCT00309699|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110309436|NCT00309699|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110309437|NCT00309699|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110309438|NCT00309699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110309439|NCT00309699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110309440|NCT00309699|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110309441|NCT00309699|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110309442|NCT00309699|Serotonin Agents|serotonin agents|mesh-ancestor
110309443|NCT00309699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110309444|NCT00309699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110309445|NCT00309699|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110083719|NCT01656122|Abacavir|abacavir|mesh-list
110309447|NCT00309699|Dopamine Agents|dopamine agents|mesh-ancestor
110309448|NCT00309816|Sildenafil Citrate|sildenafil citrate|mesh-list
110309449|NCT00309816|Vasodilator Agents|vasodilator agents|mesh-ancestor
110309450|NCT00309816|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110309451|NCT00309816|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110309452|NCT00309816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110309453|NCT00309816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110309454|NCT00309816|Urological Agents|urological agents|mesh-ancestor
110309455|NCT00279266|Thiamine|thiamine|mesh-list
110309456|NCT00279266|Vitamin B Complex|vitamin b complex|mesh-ancestor
110309457|NCT00279266|Vitamins|vitamins|mesh-ancestor
110309458|NCT00279266|Micronutrients|micronutrients|mesh-ancestor
110309459|NCT00279266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110309460|NCT00316095|Telmisartan|telmisartan|mesh-list
110309461|NCT00316095|Simvastatin|simvastatin|mesh-list
110309462|NCT00316095|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110309463|NCT00316095|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110309464|NCT00316095|Antimetabolites|antimetabolites|mesh-ancestor
110442355|NCT00634348|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110309465|NCT00316095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110309466|NCT00316095|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110309467|NCT00316095|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110309468|NCT00316095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110309469|NCT00316095|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110309470|NCT00316095|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110309471|NCT00316095|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110309473|NCT00279344|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110309474|NCT00279344|Narcotics|narcotics|mesh-ancestor
110309475|NCT00279344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110309476|NCT00279344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110309477|NCT00279344|Analgesics|analgesics|mesh-ancestor
110309478|NCT00279344|Sensory System Agents|sensory system agents|mesh-ancestor
110309479|NCT00279344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110309480|NCT00279344|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110309481|NCT00279344|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110309482|NCT00279344|Anesthetics, General|anesthetics, general|mesh-ancestor
110309483|NCT00279344|Anesthetics|anesthetics|mesh-ancestor
110309484|NCT00418860|Aspirin|aspirin|mesh-list
110309485|NCT00418860|Clopidogrel|clopidogrel|mesh-list
110309486|NCT00418860|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110309487|NCT00418860|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110309488|NCT00418860|Analgesics|analgesics|mesh-ancestor
110309489|NCT00418860|Sensory System Agents|sensory system agents|mesh-ancestor
110309490|NCT00418860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110309491|NCT00418860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110309492|NCT00418860|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110309494|NCT00418860|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110309495|NCT00418860|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110309496|NCT00418860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110309497|NCT00418860|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110309498|NCT00418860|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110309499|NCT00418860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110309500|NCT00418860|Antipyretics|antipyretics|mesh-ancestor
110309501|NCT00418860|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110309502|NCT00418860|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110309503|NCT00418860|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110309504|NCT00418860|Purinergic Agents|purinergic agents|mesh-ancestor
110309505|NCT00418860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110309506|NCT00316212|INS 50589|ins 50589|mesh-list
110309507|NCT00316212|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110309508|NCT00316212|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110309509|NCT00316212|Purinergic Agents|purinergic agents|mesh-ancestor
110309510|NCT00316212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110309511|NCT00316212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110309512|NCT00316212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110083831|NCT01657071|Aspirin|aspirin|mesh-list
110309514|NCT00309855|Testosterone|testosterone|mesh-list
110309515|NCT00309855|Dutasteride|dutasteride|mesh-list
110309516|NCT00309855|Androgens|androgens|mesh-ancestor
110309517|NCT00309855|Hormones|hormones|mesh-ancestor
110309518|NCT00309855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110309519|NCT00309855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110309520|NCT00309855|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110309522|NCT00309855|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
110309523|NCT00309855|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110309524|NCT00309855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110309525|NCT00309855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110309526|NCT00309855|Hormone Antagonists|hormone antagonists|mesh-ancestor
110309527|NCT00309855|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110309528|NCT00309855|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110309530|NCT00279383|Hemostatics|hemostatics|mesh-ancestor
110309531|NCT00279383|Coagulants|coagulants|mesh-ancestor
110309532|NCT00279422|Visilizumab|visilizumab|mesh-list
110309533|NCT00279422|Immunologic Factors|immunologic factors|mesh-ancestor
110309534|NCT00279422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110309535|NCT00309894|Ketoconazole|ketoconazole|mesh-list
110309536|NCT00309894|Hydrocortisone|hydrocortisone|mesh-list
110309537|NCT00309894|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
110309538|NCT00309894|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
110309539|NCT00309894|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
110309540|NCT00309894|Sargramostim|sargramostim|mesh-list
110309541|NCT00309894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110309542|NCT00309894|Immunologic Factors|immunologic factors|mesh-ancestor
110309543|NCT00309894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110309544|NCT00309894|Antifungal Agents|antifungal agents|mesh-ancestor
110309545|NCT00309894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110309546|NCT00309894|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110309547|NCT00309894|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110309548|NCT00309894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110309549|NCT00309894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110309550|NCT00309894|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110309551|NCT00309894|Hormone Antagonists|hormone antagonists|mesh-ancestor
110309552|NCT00309894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110309553|NCT00309894|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110309554|NCT00279461|Vitamin D|vitamin d|mesh-list
110309555|NCT00279461|Ergocalciferols|ergocalciferols|mesh-list
110309556|NCT00279461|Cholecalciferol|cholecalciferol|mesh-list
110309557|NCT00279461|Vitamins|vitamins|mesh-list
110309558|NCT00279461|Micronutrients|micronutrients|mesh-ancestor
110083901|NCT01657331|Immunotoxins|immunotoxins|mesh-ancestor
110309559|NCT00279461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110309560|NCT00279461|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110309561|NCT00279461|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110309563|NCT00316329|Amodiaquine|amodiaquine|mesh-list
110309564|NCT00316329|Antimalarials|antimalarials|mesh-ancestor
110309565|NCT00316329|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110309566|NCT00316329|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110309567|NCT00316329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110309568|NCT00316329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110309569|NCT00316329|Antiviral Agents|antiviral agents|mesh-ancestor
110309570|NCT00316329|Schistosomicides|schistosomicides|mesh-ancestor
110309571|NCT00316329|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110309572|NCT00316329|Anthelmintics|anthelmintics|mesh-ancestor
110309573|NCT00279539|Mitogens|mitogens|mesh-list
110309574|NCT00279539|Endothelial Growth Factors|endothelial growth factors|mesh-list
110309575|NCT00279539|Mitosis Modulators|mitosis modulators|mesh-ancestor
110309576|NCT00279539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110309577|NCT00279539|Growth Substances|growth substances|mesh-ancestor
110309578|NCT00279539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110309580|NCT00279578|Factor VIII|factor viii|mesh-list
110309581|NCT00279578|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110309582|NCT00279578|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110309583|NCT00279578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110309584|NCT00279578|Hemostatics|hemostatics|mesh-ancestor
110309585|NCT00279578|Coagulants|coagulants|mesh-ancestor
110309586|NCT00279617|Levetiracetam|levetiracetam|mesh-list
110309587|NCT00279617|Anticonvulsants|anticonvulsants|mesh-ancestor
110309588|NCT00279617|Nootropic Agents|nootropic agents|mesh-ancestor
110309589|NCT00310011|Paclitaxel|paclitaxel|mesh-list
110309590|NCT00310011|Gemcitabine|gemcitabine|mesh-list
110309591|NCT00310011|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110309592|NCT00310011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110309593|NCT00310011|Tubulin Modulators|tubulin modulators|mesh-ancestor
110309594|NCT00310011|Antimitotic Agents|antimitotic agents|mesh-ancestor
110309595|NCT00310011|Mitosis Modulators|mitosis modulators|mesh-ancestor
110309596|NCT00310011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110309597|NCT00310011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110309598|NCT00310011|Antimetabolites|antimetabolites|mesh-ancestor
110309599|NCT00316407|Paclitaxel|paclitaxel|mesh-list
110309600|NCT00316407|Carboplatin|carboplatin|mesh-list
110309601|NCT00316407|Lapatinib|lapatinib|mesh-list
110309602|NCT00316407|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110309603|NCT00316407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110309604|NCT00316407|Tubulin Modulators|tubulin modulators|mesh-ancestor
110309605|NCT00316407|Antimitotic Agents|antimitotic agents|mesh-ancestor
110309606|NCT00316407|Mitosis Modulators|mitosis modulators|mesh-ancestor
110309607|NCT00316407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110309608|NCT00316407|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110309609|NCT00316407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110309610|NCT00310089|Cyclophosphamide|cyclophosphamide|mesh-list
110309611|NCT00310089|Docetaxel|docetaxel|mesh-list
110309612|NCT00310089|Doxorubicin|doxorubicin|mesh-list
110309613|NCT00310089|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110309614|NCT00310089|Cediranib|cediranib|mesh-list
110309615|NCT00310089|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110309616|NCT00310089|Immunologic Factors|immunologic factors|mesh-ancestor
110309617|NCT00310089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110309618|NCT00310089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110309619|NCT00310089|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110309620|NCT00310089|Alkylating Agents|alkylating agents|mesh-ancestor
110309621|NCT00310089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110309622|NCT00310089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110309623|NCT00310089|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110309624|NCT00310089|Tubulin Modulators|tubulin modulators|mesh-ancestor
110309625|NCT00310089|Antimitotic Agents|antimitotic agents|mesh-ancestor
110309626|NCT00310089|Mitosis Modulators|mitosis modulators|mesh-ancestor
110309627|NCT00310089|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110309628|NCT00310089|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110309629|NCT00310089|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110309631|NCT00310089|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110309632|NCT00279734|Abatacept|abatacept|mesh-list
110309633|NCT00279734|Vaccines|vaccines|mesh-list
110309634|NCT00279734|Immunologic Factors|immunologic factors|mesh-ancestor
110309635|NCT00279734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110309636|NCT00279734|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110309637|NCT00279734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110309638|NCT00279734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110309639|NCT00279734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110309640|NCT00279734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110309641|NCT00279734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110309642|NCT00310128|Cytarabine|cytarabine|mesh-list
110309643|NCT00310128|Methylprednisolone|methylprednisolone|mesh-list
110309644|NCT00310128|Rituximab|rituximab|mesh-list
110309645|NCT00310128|Etoposide|etoposide|mesh-list
110309646|NCT00310128|Antibodies|antibodies|mesh-list
110309647|NCT00310128|Immunoglobulins|immunoglobulins|mesh-list
110309648|NCT00310128|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110309649|NCT00310128|Immunologic Factors|immunologic factors|mesh-ancestor
110084041|NCT01657929|Aluminum Hydroxide|aluminum hydroxide|mesh-list
110084042|NCT01657929|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110309650|NCT00310128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110309651|NCT00310128|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110309652|NCT00310128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110309653|NCT00310128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110309654|NCT00310128|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110309655|NCT00310128|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110309656|NCT00310128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110309657|NCT00310128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110309658|NCT00310128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110309659|NCT00310128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110309660|NCT00310128|Antimetabolites|antimetabolites|mesh-ancestor
110309661|NCT00310128|Antiviral Agents|antiviral agents|mesh-ancestor
110309662|NCT00310128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110309663|NCT00310128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110309664|NCT00310128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110309665|NCT00310128|Antiemetics|antiemetics|mesh-ancestor
110309666|NCT00310128|Autonomic Agents|autonomic agents|mesh-ancestor
110309667|NCT00310128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110309668|NCT00310128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110309669|NCT00310128|Glucocorticoids|glucocorticoids|mesh-ancestor
110309670|NCT00310128|Hormones|hormones|mesh-ancestor
110309671|NCT00310128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110309672|NCT00310128|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110309673|NCT00310128|Protective Agents|protective agents|mesh-ancestor
110309675|NCT00316563|Hallucinogens|hallucinogens|mesh-ancestor
110309676|NCT00316563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110309677|NCT00316563|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110309678|NCT00316563|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110309679|NCT00316563|Analgesics|analgesics|mesh-ancestor
110309680|NCT00316563|Sensory System Agents|sensory system agents|mesh-ancestor
110309681|NCT00316563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110309682|NCT00316563|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
110309683|NCT00316563|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110309684|NCT00316563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110309685|NCT00316563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110309686|NCT00316563|Hormones|hormones|mesh-ancestor
110309687|NCT00316563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110309688|NCT00416819|Leucovorin|leucovorin|mesh-list
110309689|NCT00416819|Cytarabine|cytarabine|mesh-list
110309690|NCT00416819|Rituximab|rituximab|mesh-list
110309691|NCT00416819|Methotrexate|methotrexate|mesh-list
110309692|NCT00416819|Etoposide|etoposide|mesh-list
110309693|NCT00416819|Temozolomide|temozolomide|mesh-list
110309694|NCT00416819|Etoposide phosphate|etoposide phosphate|mesh-list
110309695|NCT00416819|Levoleucovorin|levoleucovorin|mesh-list
110309696|NCT00416819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110309697|NCT00416819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110309698|NCT00416819|Immunologic Factors|immunologic factors|mesh-ancestor
110309699|NCT00416819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110309700|NCT00416819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110309701|NCT00416819|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110309702|NCT00416819|Abortifacient Agents|abortifacient agents|mesh-ancestor
110309703|NCT00416819|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110309704|NCT00416819|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110309706|NCT00416819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110309707|NCT00416819|Dermatologic Agents|dermatologic agents|mesh-ancestor
110309708|NCT00416819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110309709|NCT00416819|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110309710|NCT00416819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110309711|NCT00416819|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110309712|NCT00416819|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110309713|NCT00416819|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110309714|NCT00416819|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110309715|NCT00416819|Antiviral Agents|antiviral agents|mesh-ancestor
110309716|NCT00416819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110309717|NCT00416819|Antidotes|antidotes|mesh-ancestor
110309718|NCT00416819|Protective Agents|protective agents|mesh-ancestor
110309719|NCT00416819|Vitamin B Complex|vitamin b complex|mesh-ancestor
110309720|NCT00416819|Vitamins|vitamins|mesh-ancestor
110309721|NCT00416819|Micronutrients|micronutrients|mesh-ancestor
110309722|NCT00416819|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110309723|NCT00416819|Alkylating Agents|alkylating agents|mesh-ancestor
110309724|NCT00310206|Vaccines|vaccines|mesh-list
110309725|NCT00310206|Immunologic Factors|immunologic factors|mesh-ancestor
110309726|NCT00310206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110309727|NCT00280007|Bevacizumab|bevacizumab|mesh-list
110309728|NCT00280007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110309729|NCT00280007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110309730|NCT00280007|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110084186|NCT01658553|Trametinib|trametinib|mesh-list
110309731|NCT00280007|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110309732|NCT00280007|Growth Substances|growth substances|mesh-ancestor
110309733|NCT00280007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110309734|NCT00280007|Growth Inhibitors|growth inhibitors|mesh-ancestor
110309735|NCT00316680|Vaccines|vaccines|mesh-list
110309736|NCT00316680|Immunologic Factors|immunologic factors|mesh-ancestor
110309737|NCT00316680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110309738|NCT00280046|Insulin Aspart|insulin aspart|mesh-list
110309739|NCT00280046|Biphasic Insulins|biphasic insulins|mesh-list
110309740|NCT00280046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110309741|NCT00280046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110309742|NCT00310323|Dextromethorphan|dextromethorphan|mesh-list
110309743|NCT00310323|Caffeine|caffeine|mesh-list
110309744|NCT00310323|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110309745|NCT00310323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110309746|NCT00310323|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110309747|NCT00310323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110309748|NCT00310323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110309749|NCT00310323|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110309750|NCT00310323|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110309751|NCT00310323|Purinergic Agents|purinergic agents|mesh-ancestor
110309752|NCT00310323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110309753|NCT00310323|Antitussive Agents|antitussive agents|mesh-ancestor
110309754|NCT00310323|Respiratory System Agents|respiratory system agents|mesh-ancestor
110309755|NCT00310323|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110309756|NCT00310323|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110309758|NCT00280280|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110309759|NCT00280280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110309760|NCT00280280|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110309761|NCT00280280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110309762|NCT00280280|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
110309763|NCT00280280|GABA Agonists|gaba agonists|mesh-ancestor
110309764|NCT00280280|GABA Agents|gaba agents|mesh-ancestor
110309765|NCT00280280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110309766|NCT00280280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110309767|NCT00316758|Metformin|metformin|mesh-list
110309768|NCT00316758|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110309769|NCT00316758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110309770|NCT00280358|Fluticasone|fluticasone|mesh-list
110309772|NCT00280358|Formoterol Fumarate|formoterol fumarate|mesh-list
110309773|NCT00280358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110309774|NCT00280358|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110309775|NCT00280358|Autonomic Agents|autonomic agents|mesh-ancestor
110309776|NCT00280358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110309777|NCT00280358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110309778|NCT00280358|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110309779|NCT00280358|Respiratory System Agents|respiratory system agents|mesh-ancestor
110309780|NCT00280358|Dermatologic Agents|dermatologic agents|mesh-ancestor
110309781|NCT00280358|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110309782|NCT00280358|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110309783|NCT00280358|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110309784|NCT00280358|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110309785|NCT00280358|Adrenergic Agents|adrenergic agents|mesh-ancestor
110309786|NCT00280358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110442356|NCT00634348|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110309787|NCT00280358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110309789|NCT00310518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110309790|NCT00310518|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110309791|NCT00310518|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110309792|NCT00310518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110309793|NCT00310518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110309794|NCT00310518|Antiviral Agents|antiviral agents|mesh-ancestor
110309795|NCT00280436|Casopitant|casopitant|mesh-list
110309796|NCT00280436|Antiemetics|antiemetics|mesh-ancestor
110309797|NCT00280436|Autonomic Agents|autonomic agents|mesh-ancestor
110309798|NCT00280436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110309799|NCT00280436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110309800|NCT00280436|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110309801|NCT00280436|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110309802|NCT00280436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110309803|NCT00280436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110309804|NCT00280514|Moxifloxacin|moxifloxacin|mesh-list
110309805|NCT00280514|Cefpirome|cefpirome|mesh-list
110309806|NCT00280514|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110309807|NCT00280514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110309808|NCT00280514|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110309809|NCT00280514|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110309810|NCT00280514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110309811|NCT00280514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110309812|NCT00280514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110309813|NCT00280553|Bupivacaine|bupivacaine|mesh-list
110309814|NCT00280553|Anesthetics, Local|anesthetics, local|mesh-ancestor
110309815|NCT00280553|Anesthetics|anesthetics|mesh-ancestor
110309816|NCT00280553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110309817|NCT00280553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110309818|NCT00280553|Sensory System Agents|sensory system agents|mesh-ancestor
110309819|NCT00280553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110309820|NCT00316875|Doxorubicin|doxorubicin|mesh-list
110309821|NCT00316875|Lapatinib|lapatinib|mesh-list
110309822|NCT00316875|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110309823|NCT00316875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110309824|NCT00316875|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110309825|NCT00316875|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110309826|NCT00316875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110309827|NCT00316875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110309828|NCT00316875|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110309830|NCT00316953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110309831|NCT00316953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110309832|NCT00316953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110309833|NCT00316953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110309834|NCT00419172|Rifampin|rifampin|mesh-list
110309835|NCT00419172|Deferasirox|deferasirox|mesh-list
110309836|NCT00419172|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110309837|NCT00419172|Antitubercular Agents|antitubercular agents|mesh-ancestor
110309838|NCT00419172|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110309839|NCT00419172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110309840|NCT00419172|Leprostatic Agents|leprostatic agents|mesh-ancestor
110309841|NCT00419172|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110309842|NCT00419172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110309843|NCT00419172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110309844|NCT00419172|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110309845|NCT00419172|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110309846|NCT00419172|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110309847|NCT00419172|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110309848|NCT00419172|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110309849|NCT00419172|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110309850|NCT00419172|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110309851|NCT00419172|Chelating Agents|chelating agents|mesh-ancestor
110309852|NCT00419172|Sequestering Agents|sequestering agents|mesh-ancestor
110309853|NCT00280787|Paclitaxel|paclitaxel|mesh-list
110309854|NCT00280787|Carboplatin|carboplatin|mesh-list
110309855|NCT00280787|Irinotecan|irinotecan|mesh-list
110309856|NCT00280787|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110309857|NCT00280787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110309858|NCT00280787|Tubulin Modulators|tubulin modulators|mesh-ancestor
110309859|NCT00280787|Antimitotic Agents|antimitotic agents|mesh-ancestor
110309860|NCT00280787|Mitosis Modulators|mitosis modulators|mesh-ancestor
110309861|NCT00280787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110309862|NCT00280787|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110309863|NCT00280787|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110309864|NCT00280787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110309865|NCT00310596|Moxifloxacin|moxifloxacin|mesh-list
110309866|NCT00310596|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
110309867|NCT00310596|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110309868|NCT00310596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110309869|NCT00310596|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110309870|NCT00310596|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110309871|NCT00310596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110309872|NCT00310596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110309873|NCT00310596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110309874|NCT00310596|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110309875|NCT00310596|Contraceptive Agents|contraceptive agents|mesh-ancestor
110309876|NCT00310596|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110309877|NCT00310596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110309878|NCT00310596|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110309879|NCT00310596|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110309880|NCT00310596|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110309881|NCT00280865|Pioglitazone|pioglitazone|mesh-list
110309882|NCT00280865|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110309883|NCT00280865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110309884|NCT00317031|Naltrexone|naltrexone|mesh-list
110309885|NCT00317031|Acamprosate|acamprosate|mesh-list
110309886|NCT00317031|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110309887|NCT00317031|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110309888|NCT00317031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110309889|NCT00317031|Sensory System Agents|sensory system agents|mesh-ancestor
110309890|NCT00317031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110309891|NCT00317070|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
110309892|NCT00317070|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
110309893|NCT00317070|Protective Agents|protective agents|mesh-ancestor
110309894|NCT00317070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110309896|NCT00317070|Antioxidants|antioxidants|mesh-ancestor
110309897|NCT00317070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110309898|NCT00281255|Allopurinol|allopurinol|mesh-list
110309900|NCT00281255|Antimetabolites|antimetabolites|mesh-ancestor
110309901|NCT00281255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110309902|NCT00281255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110309903|NCT00281255|Gout Suppressants|gout suppressants|mesh-ancestor
110309904|NCT00281255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110309905|NCT00281255|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110309906|NCT00281255|Antioxidants|antioxidants|mesh-ancestor
110309907|NCT00281255|Protective Agents|protective agents|mesh-ancestor
110309908|NCT00281255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110309909|NCT00281255|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110309910|NCT00281255|Sympathomimetics|sympathomimetics|mesh-ancestor
110309911|NCT00281255|Autonomic Agents|autonomic agents|mesh-ancestor
110309912|NCT00281255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110309913|NCT00281255|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
110309914|NCT00281255|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110309915|NCT00281255|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110309916|NCT00281255|Adrenergic Agents|adrenergic agents|mesh-ancestor
110309917|NCT00281255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110309919|NCT00317187|Immunologic Factors|immunologic factors|mesh-ancestor
110309920|NCT00317187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110309921|NCT00310908|Tramadol|tramadol|mesh-list
110309922|NCT00310908|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110309923|NCT00310908|Narcotics|narcotics|mesh-ancestor
110309924|NCT00310908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110309925|NCT00310908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110309926|NCT00310908|Analgesics|analgesics|mesh-ancestor
110309927|NCT00310908|Sensory System Agents|sensory system agents|mesh-ancestor
110309928|NCT00310908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110309929|NCT00281489|Anesthetics|anesthetics|mesh-list
110309930|NCT00281489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110309931|NCT00281489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110309932|NCT00317343|Anticoagulants|anticoagulants|mesh-list
110309933|NCT00317343|Bivalirudin|bivalirudin|mesh-list
110309934|NCT00317343|Thrombin|thrombin|mesh-list
110309935|NCT00317343|Hemostatics|hemostatics|mesh-ancestor
110309936|NCT00317343|Coagulants|coagulants|mesh-ancestor
110309937|NCT00317343|Antithrombins|antithrombins|mesh-ancestor
110309938|NCT00317343|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110309939|NCT00317343|Protease Inhibitors|protease inhibitors|mesh-ancestor
110309940|NCT00317343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110309941|NCT00317343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110309942|NCT00416858|Fluorouracil|fluorouracil|mesh-list
110309943|NCT00416858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110309944|NCT00416858|Antimetabolites|antimetabolites|mesh-ancestor
110309945|NCT00416858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110309946|NCT00416858|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110309947|NCT00416858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110309948|NCT00416858|Immunologic Factors|immunologic factors|mesh-ancestor
110309949|NCT00416858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110309950|NCT00416897|Dexamethasone|dexamethasone|mesh-list
110309951|NCT00416897|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110309952|NCT00416897|Antiemetics|antiemetics|mesh-ancestor
110309953|NCT00416897|Autonomic Agents|autonomic agents|mesh-ancestor
110309954|NCT00416897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110309955|NCT00416897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110309956|NCT00416897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110309957|NCT00416897|Glucocorticoids|glucocorticoids|mesh-ancestor
110309958|NCT00416897|Hormones|hormones|mesh-ancestor
110309959|NCT00416897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110309960|NCT00416897|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110309961|NCT00416897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110309962|NCT00417014|Prednisolone|prednisolone|mesh-list
110309963|NCT00417014|Vinblastine|vinblastine|mesh-list
110309964|NCT00417014|Procarbazine|procarbazine|mesh-list
110309965|NCT00417014|Chlorambucil|chlorambucil|mesh-list
110309966|NCT00417014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110309967|NCT00417014|Glucocorticoids|glucocorticoids|mesh-ancestor
110309968|NCT00417014|Hormones|hormones|mesh-ancestor
110309969|NCT00417014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110309970|NCT00417014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110309971|NCT00417014|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110309972|NCT00417014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110309973|NCT00417014|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110309974|NCT00417014|Tubulin Modulators|tubulin modulators|mesh-ancestor
110309975|NCT00417014|Antimitotic Agents|antimitotic agents|mesh-ancestor
110309976|NCT00417014|Mitosis Modulators|mitosis modulators|mesh-ancestor
110084524|NCT01660477|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110309977|NCT00417014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110309978|NCT00417014|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110309979|NCT00417014|Alkylating Agents|alkylating agents|mesh-ancestor
110309980|NCT00317421|Sildenafil Citrate|sildenafil citrate|mesh-list
110309981|NCT00317421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110309982|NCT00317421|Vasodilator Agents|vasodilator agents|mesh-ancestor
110309983|NCT00317421|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110309984|NCT00317421|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110309985|NCT00317421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110309986|NCT00317421|Urological Agents|urological agents|mesh-ancestor
110309987|NCT00417053|Cyclophosphamide|cyclophosphamide|mesh-list
110309989|NCT00417053|Busulfan|busulfan|mesh-list
110309990|NCT00417053|Carboplatin|carboplatin|mesh-list
110309991|NCT00417053|Doxorubicin|doxorubicin|mesh-list
110309992|NCT00417053|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110309994|NCT00417053|Vincristine|vincristine|mesh-list
110309995|NCT00417053|Etoposide phosphate|etoposide phosphate|mesh-list
110309996|NCT00417053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110309997|NCT00417053|Immunologic Factors|immunologic factors|mesh-ancestor
110309998|NCT00417053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110309999|NCT00417053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110310000|NCT00417053|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110310001|NCT00417053|Alkylating Agents|alkylating agents|mesh-ancestor
110310002|NCT00417053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110310003|NCT00417053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110310004|NCT00417053|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110310005|NCT00417053|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110310006|NCT00417053|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110310007|NCT00417053|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110310008|NCT00417053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110310009|NCT00417053|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110310010|NCT00417053|Tubulin Modulators|tubulin modulators|mesh-ancestor
110310011|NCT00417053|Antimitotic Agents|antimitotic agents|mesh-ancestor
110310012|NCT00417053|Mitosis Modulators|mitosis modulators|mesh-ancestor
110310013|NCT00281567|Tiotropium Bromide|tiotropium bromide|mesh-list
110310014|NCT00281567|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110310015|NCT00281567|Autonomic Agents|autonomic agents|mesh-ancestor
110310016|NCT00281567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110310017|NCT00281567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110310018|NCT00281567|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110310019|NCT00281567|Respiratory System Agents|respiratory system agents|mesh-ancestor
110310020|NCT00281567|Parasympatholytics|parasympatholytics|mesh-ancestor
110310021|NCT00281567|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110310022|NCT00281567|Cholinergic Agents|cholinergic agents|mesh-ancestor
110310023|NCT00281567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110310024|NCT00281567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110310025|NCT00317499|Etanercept|etanercept|mesh-list
110310026|NCT00317499|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110310027|NCT00317499|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110310028|NCT00317499|Analgesics|analgesics|mesh-ancestor
110310029|NCT00317499|Sensory System Agents|sensory system agents|mesh-ancestor
110310030|NCT00317499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110310031|NCT00317499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110310032|NCT00317499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110310033|NCT00317499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110310034|NCT00317499|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110310035|NCT00317499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110084683|NCT01661322|Purinergic Agents|purinergic agents|mesh-ancestor
110310036|NCT00317499|Immunologic Factors|immunologic factors|mesh-ancestor
110310037|NCT00281606|Ritonavir|ritonavir|mesh-list
110310038|NCT00281606|Lopinavir|lopinavir|mesh-list
110310039|NCT00281606|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110310040|NCT00281606|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110310041|NCT00281606|Protease Inhibitors|protease inhibitors|mesh-ancestor
110310042|NCT00281606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110310043|NCT00281606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110310044|NCT00281606|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110310045|NCT00281606|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110310046|NCT00281606|Antiviral Agents|antiviral agents|mesh-ancestor
110310047|NCT00281606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110084747|NCT01661777|Diuretics|diuretics|mesh-list
110310048|NCT00281606|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110310049|NCT00281606|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110310050|NCT00317538|Infliximab|infliximab|mesh-list
110310051|NCT00317538|Etanercept|etanercept|mesh-list
110310052|NCT00317538|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110310053|NCT00317538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110310054|NCT00317538|Dermatologic Agents|dermatologic agents|mesh-ancestor
110310055|NCT00317538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110310056|NCT00317538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110442357|NCT00634348|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110310057|NCT00317538|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110310058|NCT00317538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110310059|NCT00317538|Analgesics|analgesics|mesh-ancestor
110310060|NCT00317538|Sensory System Agents|sensory system agents|mesh-ancestor
110310061|NCT00317538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110310062|NCT00317538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110310063|NCT00317538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110310064|NCT00317538|Immunologic Factors|immunologic factors|mesh-ancestor
110310065|NCT00281645|Analgesics|analgesics|mesh-list
110310066|NCT00281645|Sensory System Agents|sensory system agents|mesh-ancestor
110310067|NCT00281645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110310068|NCT00281645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110310069|NCT00317577|Timolol|timolol|mesh-list
110310070|NCT00317577|Brimonidine Tartrate|brimonidine tartrate|mesh-list
110310071|NCT00317577|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110310072|NCT00317577|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110310073|NCT00317577|Adrenergic Agents|adrenergic agents|mesh-ancestor
110310074|NCT00317577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110310075|NCT00317577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110310076|NCT00317577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110310077|NCT00317577|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110310078|NCT00317577|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110310079|NCT00317577|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110310080|NCT00317577|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110310081|NCT00317577|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110310082|NCT00317655|Ibuprofen|ibuprofen|mesh-list
110310083|NCT00317655|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110310084|NCT00317655|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110310085|NCT00317655|Analgesics|analgesics|mesh-ancestor
110310086|NCT00317655|Sensory System Agents|sensory system agents|mesh-ancestor
110310087|NCT00317655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110310088|NCT00317655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110310089|NCT00317655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110310090|NCT00317655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110310091|NCT00317655|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110310092|NCT00317655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110310093|NCT00317655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110310094|NCT00281996|Gemcitabine|gemcitabine|mesh-list
110310095|NCT00281996|Imatinib Mesylate|imatinib mesylate|mesh-list
110310096|NCT00281996|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110310097|NCT00281996|Antimetabolites|antimetabolites|mesh-ancestor
110310098|NCT00281996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110310099|NCT00281996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110310100|NCT00281996|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110310101|NCT00281996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110310102|NCT00311259|Melatonin|melatonin|mesh-list
110310103|NCT00311259|Antioxidants|antioxidants|mesh-ancestor
110310104|NCT00311259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110310105|NCT00311259|Protective Agents|protective agents|mesh-ancestor
110310106|NCT00311259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110310107|NCT00311259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110310108|NCT00317733|Ketoprofen|ketoprofen|mesh-list
110084927|NCT01663077|Clozapine|clozapine|mesh-list
110310109|NCT00317733|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110310111|NCT00317733|Analgesics|analgesics|mesh-ancestor
110310112|NCT00317733|Sensory System Agents|sensory system agents|mesh-ancestor
110310113|NCT00317733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110310114|NCT00317733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110310115|NCT00317733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110310116|NCT00317733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110310117|NCT00317733|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110310118|NCT00317733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110310119|NCT00317733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110310120|NCT00311337|Bortezomib|bortezomib|mesh-list
110310121|NCT00311337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110310122|NCT00317811|Ascorbic Acid|ascorbic acid|mesh-list
110310123|NCT00317811|Bortezomib|bortezomib|mesh-list
110310124|NCT00317811|Melphalan|melphalan|mesh-list
110310125|NCT00317811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110310126|NCT00317811|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110310127|NCT00317811|Alkylating Agents|alkylating agents|mesh-ancestor
110310128|NCT00317811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110310129|NCT00317811|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110310130|NCT00317811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110310131|NCT00317811|Immunologic Factors|immunologic factors|mesh-ancestor
110310132|NCT00317811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110310133|NCT00317811|Antioxidants|antioxidants|mesh-ancestor
110310134|NCT00317811|Protective Agents|protective agents|mesh-ancestor
110310135|NCT00317811|Vitamins|vitamins|mesh-ancestor
110310136|NCT00317811|Micronutrients|micronutrients|mesh-ancestor
110310137|NCT00282386|Rofecoxib|rofecoxib|mesh-list
110310138|NCT00282386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110310139|NCT00282386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110084981|NCT01663961|Digoxin|digoxin|mesh-list
110310140|NCT00282386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110310141|NCT00282386|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110310142|NCT00282386|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110310143|NCT00282386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110310144|NCT00282386|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110310145|NCT00282386|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110310146|NCT00282386|Analgesics|analgesics|mesh-ancestor
110310147|NCT00282386|Sensory System Agents|sensory system agents|mesh-ancestor
110310148|NCT00282386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110310149|NCT00282386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110310150|NCT00317850|Gabapentin|gabapentin|mesh-list
110310151|NCT00317850|Analgesics|analgesics|mesh-ancestor
110310152|NCT00317850|Sensory System Agents|sensory system agents|mesh-ancestor
110310153|NCT00317850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110310154|NCT00317850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110310155|NCT00317850|Anticonvulsants|anticonvulsants|mesh-ancestor
110310156|NCT00317850|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110310157|NCT00317850|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110310158|NCT00317850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110310159|NCT00317850|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110310160|NCT00317850|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110310161|NCT00317850|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110310162|NCT00317850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110310163|NCT00317850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110310164|NCT00317850|Antimanic Agents|antimanic agents|mesh-ancestor
110310165|NCT00282503|Methylprednisolone|methylprednisolone|mesh-list
110310166|NCT00282503|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110310167|NCT00282503|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110310168|NCT00282503|Prednisolone|prednisolone|mesh-list
110310169|NCT00282503|Prednisolone acetate|prednisolone acetate|mesh-list
110310170|NCT00282503|Methoxsalen|methoxsalen|mesh-list
110310171|NCT00282503|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110310172|NCT00282503|Prednisolone phosphate|prednisolone phosphate|mesh-list
110310173|NCT00282503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110310174|NCT00282503|Antiemetics|antiemetics|mesh-ancestor
110310175|NCT00282503|Autonomic Agents|autonomic agents|mesh-ancestor
110310176|NCT00282503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110310177|NCT00282503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110310178|NCT00282503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110310179|NCT00282503|Glucocorticoids|glucocorticoids|mesh-ancestor
110310180|NCT00282503|Hormones|hormones|mesh-ancestor
110310181|NCT00282503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110310182|NCT00282503|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110310183|NCT00282503|Protective Agents|protective agents|mesh-ancestor
110310184|NCT00282503|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110310185|NCT00282503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110310186|NCT00282503|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110310188|NCT00317928|Metformin|metformin|mesh-list
110310189|NCT00317928|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110310190|NCT00317928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110310191|NCT00282698|Insulin|insulin|mesh-list
110310192|NCT00282698|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110310193|NCT00282698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110310194|NCT00317967|Atorvastatin|atorvastatin|mesh-list
110310195|NCT00317967|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110310196|NCT00317967|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110310197|NCT00317967|Antimetabolites|antimetabolites|mesh-ancestor
110310198|NCT00317967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110310199|NCT00317967|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110310200|NCT00317967|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110310201|NCT00317967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110310203|NCT00318084|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110310204|NCT00318084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110310205|NCT00318084|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110310206|NCT00318084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110310207|NCT00318084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110310208|NCT00282932|Tolterodine Tartrate|tolterodine tartrate|mesh-list
110310209|NCT00282932|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110310210|NCT00282932|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110310211|NCT00282932|Cholinergic Agents|cholinergic agents|mesh-ancestor
110310212|NCT00282932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110310213|NCT00282932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110310214|NCT00282932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110310215|NCT00282932|Urological Agents|urological agents|mesh-ancestor
110310216|NCT00318162|Naltrexone|naltrexone|mesh-list
110310217|NCT00318162|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110310218|NCT00318162|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110310219|NCT00318162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110310220|NCT00318162|Sensory System Agents|sensory system agents|mesh-ancestor
110310221|NCT00318162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110310222|NCT00283088|Plasminogen|plasminogen|mesh-list
110310223|NCT00283088|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
110310224|NCT00283088|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110310225|NCT00283088|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110310226|NCT00283088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110310227|NCT00318201|Erythromycin|erythromycin|mesh-list
110310228|NCT00318201|Erythromycin Estolate|erythromycin estolate|mesh-list
110310229|NCT00318201|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
110310230|NCT00318201|Erythromycin stearate|erythromycin stearate|mesh-list
110310231|NCT00318201|Diltiazem|diltiazem|mesh-list
110310232|NCT00318201|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110310233|NCT00318201|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110310234|NCT00318201|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110310235|NCT00318201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110310236|NCT00318201|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110169077|NCT00037180|Antimetabolites|antimetabolites|mesh-ancestor
110310237|NCT00318201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110310239|NCT00318201|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110310240|NCT00318201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110310241|NCT00318201|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110310242|NCT00318201|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110310243|NCT00318201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110310244|NCT00311688|Interleukin-2|interleukin-2|mesh-list
110310245|NCT00311688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110310246|NCT00311688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110310247|NCT00311688|Analgesics|analgesics|mesh-ancestor
110310248|NCT00311688|Sensory System Agents|sensory system agents|mesh-ancestor
110310249|NCT00311688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110310250|NCT00311688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110310251|NCT00283478|Gemcitabine|gemcitabine|mesh-list
110310252|NCT00283478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110310253|NCT00283478|Antimetabolites|antimetabolites|mesh-ancestor
110310254|NCT00283478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110310255|NCT00283478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110310256|NCT00318318|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
110310257|NCT00318318|Estrogens|estrogens|mesh-ancestor
110310258|NCT00318318|Hormones|hormones|mesh-ancestor
110310259|NCT00318318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110310260|NCT00318318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110310261|NCT00283517|Antipsychotic Agents|antipsychotic agents|mesh-list
110310262|NCT00283517|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110310263|NCT00283517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110310264|NCT00283517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110310265|NCT00283517|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110310266|NCT00311883|Hydroxychloroquine|hydroxychloroquine|mesh-list
110310268|NCT00311883|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110310269|NCT00311883|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110310270|NCT00311883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110310271|NCT00311883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110310272|NCT00311883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110310273|NCT00311883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110310274|NCT00283556|Irinotecan|irinotecan|mesh-list
110310275|NCT00283556|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110310276|NCT00283556|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110310277|NCT00283556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110310278|NCT00283556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110310279|NCT00283556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110310280|NCT00283634|Bortezomib|bortezomib|mesh-list
110310281|NCT00283634|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110310282|NCT00283634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110310283|NCT00283634|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110310284|NCT00283634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110310285|NCT00283634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110310286|NCT00318513|Bevacizumab|bevacizumab|mesh-list
110310287|NCT00318513|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110310288|NCT00318513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110310289|NCT00318513|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110310290|NCT00318513|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110310291|NCT00318513|Growth Substances|growth substances|mesh-ancestor
110310292|NCT00318513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110310293|NCT00318513|Growth Inhibitors|growth inhibitors|mesh-ancestor
110310294|NCT00318552|Meropenem|meropenem|mesh-list
110310295|NCT00318552|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110310296|NCT00318552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110310297|NCT00283751|Insulin|insulin|mesh-list
110310298|NCT00283751|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110310299|NCT00283751|Insulin Glargine|insulin glargine|mesh-list
110310300|NCT00283751|Insulin Detemir|insulin detemir|mesh-list
110085268|NCT01665742|Tocopherols|tocopherols|mesh-list
110310301|NCT00283751|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110310302|NCT00283751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110310304|NCT00318630|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110310305|NCT00318630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110310306|NCT00283790|Zolpidem|zolpidem|mesh-list
110310307|NCT00283790|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110310308|NCT00283790|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110310309|NCT00283790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110310310|NCT00283790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110310311|NCT00283790|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
110310312|NCT00283790|GABA Agonists|gaba agonists|mesh-ancestor
110310313|NCT00283790|GABA Agents|gaba agents|mesh-ancestor
110310314|NCT00283790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110310315|NCT00283790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110310316|NCT00318669|Paroxetine|paroxetine|mesh-list
110310317|NCT00318669|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110310318|NCT00318669|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110310319|NCT00318669|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110310320|NCT00318669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110310321|NCT00318669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110310322|NCT00318669|Serotonin Agents|serotonin agents|mesh-ancestor
110310323|NCT00318669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110310324|NCT00318669|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110310325|NCT00318669|Antidepressive Agents|antidepressive agents|mesh-ancestor
110310326|NCT00318669|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110310327|NCT00318669|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110310328|NCT00318669|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110310329|NCT00318669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110310330|NCT00283829|Docetaxel|docetaxel|mesh-list
110310331|NCT00283829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110310332|NCT00283829|Tubulin Modulators|tubulin modulators|mesh-ancestor
110310333|NCT00283829|Antimitotic Agents|antimitotic agents|mesh-ancestor
110310334|NCT00283829|Mitosis Modulators|mitosis modulators|mesh-ancestor
110310335|NCT00283829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110310336|NCT00311961|Prednisolone|prednisolone|mesh-list
110085312|NCT01666223|Cathartics|cathartics|mesh-ancestor
110310337|NCT00311961|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110310338|NCT00311961|Methylprednisolone|methylprednisolone|mesh-list
110310339|NCT00311961|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110310340|NCT00311961|Prednisolone acetate|prednisolone acetate|mesh-list
110310341|NCT00311961|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110310342|NCT00311961|Prednisolone phosphate|prednisolone phosphate|mesh-list
110310343|NCT00311961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110310344|NCT00311961|Glucocorticoids|glucocorticoids|mesh-ancestor
110310345|NCT00311961|Hormones|hormones|mesh-ancestor
110310346|NCT00311961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110310347|NCT00311961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110310348|NCT00311961|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110310349|NCT00311961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110310350|NCT00311961|Antiemetics|antiemetics|mesh-ancestor
110310351|NCT00311961|Autonomic Agents|autonomic agents|mesh-ancestor
110310352|NCT00311961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110310353|NCT00311961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110310354|NCT00311961|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110310355|NCT00311961|Protective Agents|protective agents|mesh-ancestor
110310357|NCT00283946|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110310358|NCT00283946|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110310359|NCT00283946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110310360|NCT00283946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110310361|NCT00283946|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
110310362|NCT00283946|GABA Agonists|gaba agonists|mesh-ancestor
110310363|NCT00283946|GABA Agents|gaba agents|mesh-ancestor
110310364|NCT00283946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110310365|NCT00283946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110310367|NCT00312000|Irinotecan|irinotecan|mesh-list
110310368|NCT00312000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110310369|NCT00312000|Antimetabolites|antimetabolites|mesh-ancestor
110310370|NCT00312000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110310371|NCT00312000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110310372|NCT00312000|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110310373|NCT00312000|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110310374|NCT00312000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110310375|NCT00283985|Dexamethasone|dexamethasone|mesh-list
110310376|NCT00283985|Methotrexate|methotrexate|mesh-list
110310377|NCT00283985|Asparaginase|asparaginase|mesh-list
110310378|NCT00283985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110310379|NCT00283985|Antiemetics|antiemetics|mesh-ancestor
110310380|NCT00283985|Autonomic Agents|autonomic agents|mesh-ancestor
110310381|NCT00283985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110310382|NCT00283985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110310383|NCT00283985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110310384|NCT00283985|Glucocorticoids|glucocorticoids|mesh-ancestor
110310385|NCT00283985|Hormones|hormones|mesh-ancestor
110310386|NCT00283985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110310387|NCT00283985|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110310388|NCT00283985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110310389|NCT00283985|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110310390|NCT00283985|Abortifacient Agents|abortifacient agents|mesh-ancestor
110310391|NCT00283985|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110310392|NCT00283985|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110310393|NCT00283985|Antimetabolites|antimetabolites|mesh-ancestor
110310394|NCT00283985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110310395|NCT00283985|Dermatologic Agents|dermatologic agents|mesh-ancestor
110310396|NCT00283985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110310397|NCT00283985|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110310398|NCT00283985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110310399|NCT00283985|Immunologic Factors|immunologic factors|mesh-ancestor
110310400|NCT00283985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110310401|NCT00283985|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110310403|NCT00419250|Immunologic Factors|immunologic factors|mesh-ancestor
110310404|NCT00419250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110310405|NCT00419250|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110310406|NCT00419250|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110310407|NCT00419250|Growth Substances|growth substances|mesh-ancestor
110310408|NCT00419250|Growth Inhibitors|growth inhibitors|mesh-ancestor
110310409|NCT00419250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110310410|NCT00284024|Domperidone|domperidone|mesh-list
110310411|NCT00284024|Antiemetics|antiemetics|mesh-ancestor
110310412|NCT00284024|Autonomic Agents|autonomic agents|mesh-ancestor
110310413|NCT00284024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110310414|NCT00284024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110310415|NCT00284024|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110310416|NCT00284024|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110310417|NCT00284024|Dopamine Agents|dopamine agents|mesh-ancestor
110310418|NCT00284024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110310419|NCT00284024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110310421|NCT00284258|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110310422|NCT00284258|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110310423|NCT00284258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110310424|NCT00284258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110310425|NCT00284258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110310426|NCT00318786|Insulin Aspart|insulin aspart|mesh-list
110310427|NCT00318786|Biphasic Insulins|biphasic insulins|mesh-list
110310428|NCT00318786|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110310429|NCT00318786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110310430|NCT00284336|Cyclophosphamide|cyclophosphamide|mesh-list
110310431|NCT00284336|Doxorubicin|doxorubicin|mesh-list
110310432|NCT00284336|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110310433|NCT00284336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110310434|NCT00284336|Immunologic Factors|immunologic factors|mesh-ancestor
110310435|NCT00284336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110310436|NCT00284336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110310437|NCT00284336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110310438|NCT00284336|Alkylating Agents|alkylating agents|mesh-ancestor
110310439|NCT00284336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110310440|NCT00284336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110310441|NCT00284336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110310442|NCT00284336|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110310443|NCT00284336|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110310444|NCT00284336|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110310445|NCT00284336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110310447|NCT00312156|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110310448|NCT00312156|Insulin Aspart|insulin aspart|mesh-list
110310449|NCT00312156|Insulin Detemir|insulin detemir|mesh-list
110310450|NCT00312156|Isophane Insulin, Human|isophane insulin, human|mesh-list
110310451|NCT00312156|Insulin, Isophane|insulin, isophane|mesh-list
110310452|NCT00312156|Isophane insulin, beef|isophane insulin, beef|mesh-list
110310453|NCT00312156|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110310454|NCT00312156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110310456|NCT00318825|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110310457|NCT00318825|Anesthetics, General|anesthetics, general|mesh-ancestor
110310458|NCT00318825|Anesthetics|anesthetics|mesh-ancestor
110310459|NCT00318825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110310460|NCT00318825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110310461|NCT00318825|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110310462|NCT00318825|Analgesics|analgesics|mesh-ancestor
110310463|NCT00318825|Sensory System Agents|sensory system agents|mesh-ancestor
110310464|NCT00318825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110310465|NCT00284531|Daclizumab|daclizumab|mesh-list
110310466|NCT00284531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110310467|NCT00284531|Immunologic Factors|immunologic factors|mesh-ancestor
110310468|NCT00284531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110310469|NCT00312273|Aminophylline|aminophylline|mesh-list
110310470|NCT00312273|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110310471|NCT00312273|Autonomic Agents|autonomic agents|mesh-ancestor
110310472|NCT00312273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110310473|NCT00312273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110310474|NCT00312273|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110310475|NCT00312273|Respiratory System Agents|respiratory system agents|mesh-ancestor
110310476|NCT00312273|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110310477|NCT00312273|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110310478|NCT00312273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110310479|NCT00312273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110310480|NCT00312273|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110310481|NCT00312273|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110310482|NCT00312273|Purinergic Agents|purinergic agents|mesh-ancestor
110310483|NCT00312273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110310484|NCT00312273|Protective Agents|protective agents|mesh-ancestor
110310485|NCT00312312|Immunomodulating Agents|immunomodulating agents|mesh-list
110310486|NCT00312312|Immunologic Factors|immunologic factors|mesh-ancestor
110310487|NCT00312312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110310489|NCT00284687|Antimalarials|antimalarials|mesh-ancestor
110310490|NCT00284687|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110310491|NCT00284687|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110310492|NCT00284687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110310493|NCT00284687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110310494|NCT00284687|Antiviral Agents|antiviral agents|mesh-ancestor
110310495|NCT00284687|Schistosomicides|schistosomicides|mesh-ancestor
110310496|NCT00284687|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110310497|NCT00284687|Anthelmintics|anthelmintics|mesh-ancestor
110310498|NCT00284765|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
110310499|NCT00284765|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110310500|NCT00284765|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110310502|NCT00284765|Sensory System Agents|sensory system agents|mesh-ancestor
110310503|NCT00284765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110310504|NCT00284765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110310505|NCT00284765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110310506|NCT00284765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110310508|NCT00318981|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110310509|NCT00318981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110310510|NCT00318981|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110310511|NCT00318981|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110310512|NCT00318981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110310513|NCT00318981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110310515|NCT00318981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110310516|NCT00284921|Mycophenolic Acid|mycophenolic acid|mesh-list
110310517|NCT00284921|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110310518|NCT00284921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110310519|NCT00284921|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110310520|NCT00284921|Antitubercular Agents|antitubercular agents|mesh-ancestor
110310521|NCT00284921|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110310522|NCT00284921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110310523|NCT00284921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110310524|NCT00284921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110310526|NCT00319059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110310527|NCT00319059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110310528|NCT00312507|Pulmonary Surfactants|pulmonary surfactants|mesh-list
110310529|NCT00312507|Respiratory System Agents|respiratory system agents|mesh-ancestor
110085770|NCT01669226|Taxane|taxane|mesh-list
110310531|NCT00312546|Valproic Acid|valproic acid|mesh-list
110310532|NCT00312546|Anticonvulsants|anticonvulsants|mesh-ancestor
110310533|NCT00312546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110310534|NCT00312546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110310535|NCT00312546|GABA Agents|gaba agents|mesh-ancestor
110310536|NCT00312546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110310537|NCT00312546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110310538|NCT00312546|Antimanic Agents|antimanic agents|mesh-ancestor
110310539|NCT00312546|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110310540|NCT00312546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110310541|NCT00312546|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110310542|NCT00312546|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110310543|NCT00312546|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110310544|NCT00312546|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110310545|NCT00312546|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110310546|NCT00312546|Antiviral Agents|antiviral agents|mesh-ancestor
110310547|NCT00312546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110310548|NCT00425009|Metformin|metformin|mesh-list
110310549|NCT00425009|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110310550|NCT00425009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110310551|NCT04718402|Mitoxantrone|mitoxantrone|mesh-list
110310552|NCT04718402|Analgesics|analgesics|mesh-ancestor
110310553|NCT04718402|Sensory System Agents|sensory system agents|mesh-ancestor
110310554|NCT04718402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110310555|NCT04718402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110310556|NCT04718402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110310557|NCT04718402|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110310558|NCT04718402|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110310559|NCT04718402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110310560|NCT04718402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110310561|NCT00319215|Zopiclone|zopiclone|mesh-list
110310562|NCT00319215|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110310563|NCT00319215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110310564|NCT00319215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110310565|NCT00285155|Bupropion|bupropion|mesh-list
110310566|NCT00285155|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110310567|NCT00285155|Antidepressive Agents|antidepressive agents|mesh-ancestor
110310568|NCT00285155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110310569|NCT00285155|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110310570|NCT00285155|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110310571|NCT00285155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110310572|NCT00285155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110310573|NCT00285155|Dopamine Agents|dopamine agents|mesh-ancestor
110310574|NCT00285155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110310575|NCT00285155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110310576|NCT00285155|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110310577|NCT00285155|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110310578|NCT00285155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110310579|NCT00319293|Metformin|metformin|mesh-list
110310580|NCT00319293|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110310581|NCT00319293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110310583|NCT00319332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110310584|NCT00285350|Mycophenolic Acid|mycophenolic acid|mesh-list
110310585|NCT00285350|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110310586|NCT00285350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110310587|NCT00285350|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110310588|NCT00285350|Antitubercular Agents|antitubercular agents|mesh-ancestor
110310589|NCT00285350|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110310590|NCT00285350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110310591|NCT00285350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110310592|NCT00285350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110310593|NCT00285389|Dexamethasone|dexamethasone|mesh-list
110310594|NCT00285389|Cyclophosphamide|cyclophosphamide|mesh-list
110310595|NCT00285389|Melphalan|melphalan|mesh-list
110310596|NCT00285389|Chlorambucil|chlorambucil|mesh-list
110310597|NCT00285389|Rituximab|rituximab|mesh-list
110310598|NCT00285389|Vincristine|vincristine|mesh-list
110310599|NCT00285389|Doxorubicin|doxorubicin|mesh-list
110310600|NCT00285389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110310601|NCT00285389|Immunologic Factors|immunologic factors|mesh-ancestor
110310602|NCT00285389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110310603|NCT00285389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110310604|NCT00285389|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110310605|NCT00285389|Alkylating Agents|alkylating agents|mesh-ancestor
110310606|NCT00285389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110310607|NCT00285389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110310608|NCT00285389|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110310609|NCT00285389|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110310610|NCT00285389|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110310611|NCT00285389|Antiemetics|antiemetics|mesh-ancestor
110310612|NCT00285389|Autonomic Agents|autonomic agents|mesh-ancestor
110310613|NCT00285389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110310614|NCT00285389|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110310615|NCT00285389|Glucocorticoids|glucocorticoids|mesh-ancestor
110310616|NCT00285389|Hormones|hormones|mesh-ancestor
110310617|NCT00285389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110310618|NCT00285389|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110310619|NCT00285389|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110310620|NCT00285389|Tubulin Modulators|tubulin modulators|mesh-ancestor
110310621|NCT00285389|Antimitotic Agents|antimitotic agents|mesh-ancestor
110310622|NCT00285389|Mitosis Modulators|mitosis modulators|mesh-ancestor
110310623|NCT00285389|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110442358|NCT00634348|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110310624|NCT00285389|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110310625|NCT00285389|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110310626|NCT00285389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110310628|NCT00285428|Antibodies|antibodies|mesh-list
110310629|NCT00285428|Immunologic Factors|immunologic factors|mesh-ancestor
110310630|NCT00285428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110310631|NCT00285428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110310632|NCT00312819|Disulfiram|disulfiram|mesh-list
110310633|NCT00312819|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110310634|NCT00312819|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
110310635|NCT00312819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110310636|NCT00312819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110310637|NCT00319488|Budesonide|budesonide|mesh-list
110310638|NCT00319488|Albuterol|albuterol|mesh-list
110310639|NCT00319488|Montelukast|montelukast|mesh-list
110310640|NCT00319488|Leukotriene Antagonists|leukotriene antagonists|mesh-list
110310641|NCT00319488|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110310642|NCT00319488|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110310643|NCT00319488|Autonomic Agents|autonomic agents|mesh-ancestor
110310644|NCT00319488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110310645|NCT00319488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110310646|NCT00319488|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110310647|NCT00319488|Respiratory System Agents|respiratory system agents|mesh-ancestor
110310649|NCT00319488|Hormones|hormones|mesh-ancestor
110310650|NCT00319488|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110310651|NCT00319488|Hormone Antagonists|hormone antagonists|mesh-ancestor
110310652|NCT00319488|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110310653|NCT00319488|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110310654|NCT00319488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110310655|NCT00319488|Tocolytic Agents|tocolytic agents|mesh-ancestor
110310656|NCT00319488|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110310657|NCT00319488|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110310658|NCT00319488|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110310659|NCT00319488|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110310660|NCT00319488|Adrenergic Agents|adrenergic agents|mesh-ancestor
110310661|NCT00319488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110310662|NCT00285623|Thrombin|thrombin|mesh-list
110310663|NCT00285623|Hemostatics|hemostatics|mesh-ancestor
110310664|NCT00285623|Coagulants|coagulants|mesh-ancestor
110310665|NCT00285662|Artesunate|artesunate|mesh-list
110310666|NCT00285662|Pyrimethamine|pyrimethamine|mesh-list
110310667|NCT00285662|Sulfadoxine|sulfadoxine|mesh-list
110310668|NCT00285662|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
110310669|NCT00285662|Amodiaquine|amodiaquine|mesh-list
110310670|NCT00285662|Antimalarials|antimalarials|mesh-ancestor
110310671|NCT00285662|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110310672|NCT00285662|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110310673|NCT00285662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110310674|NCT00285662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110310675|NCT00285662|Antiviral Agents|antiviral agents|mesh-ancestor
110310676|NCT00285662|Schistosomicides|schistosomicides|mesh-ancestor
110310677|NCT00285662|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110310678|NCT00285662|Anthelmintics|anthelmintics|mesh-ancestor
110310679|NCT00285662|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110310680|NCT00285662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110310681|NCT00285662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110310682|NCT00285662|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110310683|NCT00319566|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
110310684|NCT00319566|Medroxyprogesterone|medroxyprogesterone|mesh-list
110310685|NCT00319566|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
110310686|NCT00319566|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110310687|NCT00319566|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110310688|NCT00319566|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110310689|NCT00319566|Contraceptive Agents|contraceptive agents|mesh-ancestor
110310690|NCT00319566|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110310691|NCT00319566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110310692|NCT00319566|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110310693|NCT00319566|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110310694|NCT00319566|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110310695|NCT00319566|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110310696|NCT00319566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110310697|NCT00319566|Estrogens|estrogens|mesh-ancestor
110310698|NCT00319566|Hormones|hormones|mesh-ancestor
110310699|NCT00319566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110310700|NCT00319605|Levetiracetam|levetiracetam|mesh-list
110310701|NCT00319605|Anticonvulsants|anticonvulsants|mesh-ancestor
110310702|NCT00319605|Nootropic Agents|nootropic agents|mesh-ancestor
110310703|NCT00313053|Vincristine|vincristine|mesh-list
110310704|NCT00313053|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110310705|NCT00313053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110310706|NCT00313053|Tubulin Modulators|tubulin modulators|mesh-ancestor
110310707|NCT00313053|Antimitotic Agents|antimitotic agents|mesh-ancestor
110310708|NCT00313053|Mitosis Modulators|mitosis modulators|mesh-ancestor
110310709|NCT00313053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110310710|NCT00285896|Glucagon|glucagon|mesh-list
110310711|NCT00285896|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
110310712|NCT00285896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110310713|NCT00285896|Hormones|hormones|mesh-ancestor
110310714|NCT00285896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110310715|NCT00285896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110310716|NCT00285896|Incretins|incretins|mesh-ancestor
110310717|NCT00319683|Eniluracil|eniluracil|mesh-list
110310719|NCT00319683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110310720|NCT00286052|Naloxone|naloxone|mesh-list
110310721|NCT00286052|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110310722|NCT00286052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110310723|NCT00286052|Sensory System Agents|sensory system agents|mesh-ancestor
110310724|NCT00286052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110310725|NCT00319761|Calcitriol|calcitriol|mesh-list
110148337|NCT00388128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110310726|NCT00319761|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110310727|NCT00319761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110310728|NCT00319761|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
110310729|NCT00319761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110310730|NCT00319761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110310731|NCT00319761|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110310732|NCT00319761|Vitamins|vitamins|mesh-ancestor
110310733|NCT00319761|Micronutrients|micronutrients|mesh-ancestor
110310734|NCT00319761|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110310735|NCT00286130|Leucovorin|leucovorin|mesh-list
110310736|NCT00286130|Oxaliplatin|oxaliplatin|mesh-list
110310737|NCT00286130|Irinotecan|irinotecan|mesh-list
110310738|NCT00286130|Cetuximab|cetuximab|mesh-list
110310739|NCT00286130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110310740|NCT00286130|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110310741|NCT00286130|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110310742|NCT00286130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110369331|NCT01998035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110310743|NCT00286130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110310744|NCT00286130|Antidotes|antidotes|mesh-ancestor
110310745|NCT00286130|Protective Agents|protective agents|mesh-ancestor
110369393|NCT00561054|Cetuximab|cetuximab|mesh-list
110310746|NCT00286130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110310747|NCT00286130|Vitamin B Complex|vitamin b complex|mesh-ancestor
110310748|NCT00286130|Vitamins|vitamins|mesh-ancestor
110310749|NCT00286130|Micronutrients|micronutrients|mesh-ancestor
110310750|NCT00286130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110310751|NCT00286208|Misoprostol|misoprostol|mesh-list
110310752|NCT00286208|Mifepristone|mifepristone|mesh-list
110310753|NCT00286208|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110310754|NCT00286208|Abortifacient Agents|abortifacient agents|mesh-ancestor
110310755|NCT00286208|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110310756|NCT00286208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110310757|NCT00286208|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110310758|NCT00286208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110310759|NCT00286208|Oxytocics|oxytocics|mesh-ancestor
110310760|NCT00286208|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
110310761|NCT00286208|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110310762|NCT00286208|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110310763|NCT00286208|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110310764|NCT00286208|Contraceptive Agents|contraceptive agents|mesh-ancestor
110310765|NCT00286208|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
110310766|NCT00286208|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
110310767|NCT00286208|Hormone Antagonists|hormone antagonists|mesh-ancestor
110310768|NCT00286208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110369924|NCT00565461|Vaccines|vaccines|mesh-list
110310769|NCT00286208|Luteolytic Agents|luteolytic agents|mesh-ancestor
110310770|NCT00286208|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110310771|NCT00286208|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
110310772|NCT00319800|Irinotecan|irinotecan|mesh-list
110310773|NCT00319800|Gefitinib|gefitinib|mesh-list
110310774|NCT00319800|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110310775|NCT00319800|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110310776|NCT00319800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110260171|NCT02944201|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110310777|NCT00319800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110310778|NCT00319800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110310779|NCT00319800|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110310780|NCT00313131|Metronidazole|metronidazole|mesh-list
110310781|NCT00313131|Fluconazole|fluconazole|mesh-list
110310782|NCT00313131|Clotrimazole|clotrimazole|mesh-list
110310783|NCT00313131|Miconazole|miconazole|mesh-list
110310784|NCT00313131|Tinidazole|tinidazole|mesh-list
110310785|NCT00313131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110370213|NCT04187755|Ceftazidime|ceftazidime|mesh-list
110310786|NCT00313131|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110310787|NCT00313131|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110310788|NCT00313131|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110310789|NCT00313131|Antifungal Agents|antifungal agents|mesh-ancestor
110310790|NCT00313131|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110310791|NCT00313131|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110310792|NCT00313131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110310793|NCT00313131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110310794|NCT00313131|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110310795|NCT00313131|Hormone Antagonists|hormone antagonists|mesh-ancestor
110310796|NCT00313131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110370429|NCT04631822|Dexamethasone|dexamethasone|mesh-list
110310797|NCT00313131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110310798|NCT00313131|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110310799|NCT00313131|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110310800|NCT00313131|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110310801|NCT00313131|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110310802|NCT00313131|Alkylating Agents|alkylating agents|mesh-ancestor
110310803|NCT00313131|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
110310804|NCT00319878|Cyclosporine|cyclosporine|mesh-list
110310805|NCT00319878|Sirolimus|sirolimus|mesh-list
110310806|NCT00319878|Cyclosporins|cyclosporins|mesh-list
110310807|NCT00319878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110310808|NCT00319878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110310809|NCT00319878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110310810|NCT00319878|Immunologic Factors|immunologic factors|mesh-ancestor
110310811|NCT00319878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110310812|NCT00319878|Antifungal Agents|antifungal agents|mesh-ancestor
110310813|NCT00319878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110310814|NCT00319878|Dermatologic Agents|dermatologic agents|mesh-ancestor
110310815|NCT00319878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110310816|NCT00319878|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110310817|NCT00319878|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110310818|NCT00319878|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110310819|NCT00319878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110310820|NCT00286364|Androgens|androgens|mesh-list
110310821|NCT00286364|Aromatase Inhibitors|aromatase inhibitors|mesh-list
110310822|NCT00286364|Hormones|hormones|mesh-ancestor
110260172|NCT02944201|Adrenergic Agents|adrenergic agents|mesh-ancestor
110310823|NCT00286364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110310824|NCT00286364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110310825|NCT00286364|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110310826|NCT00286364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110371022|NCT00567099|Serotonin Agents|serotonin agents|mesh-ancestor
110310827|NCT00286364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110310828|NCT00286364|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110310830|NCT00319917|Tacrolimus|tacrolimus|mesh-list
110310831|NCT00319917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110310832|NCT00319917|Immunologic Factors|immunologic factors|mesh-ancestor
110310833|NCT00319917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110310834|NCT00319917|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110310835|NCT00319917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110310836|NCT00319917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110310838|NCT00286403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110310839|NCT00286403|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110310840|NCT00286403|Vasodilator Agents|vasodilator agents|mesh-ancestor
110310841|NCT00286403|Dopamine Agonists|dopamine agonists|mesh-ancestor
110310843|NCT00286403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110310844|NCT00286403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110310845|NCT00313287|Clevudine|clevudine|mesh-list
110310846|NCT00313287|Antiviral Agents|antiviral agents|mesh-ancestor
110310847|NCT00313287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110310848|NCT00286481|Simvastatin|simvastatin|mesh-list
110310849|NCT00286481|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110310850|NCT00286481|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110310851|NCT00286481|Antimetabolites|antimetabolites|mesh-ancestor
110310852|NCT00286481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110310853|NCT00286481|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110310854|NCT00286481|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110310855|NCT00286481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110310856|NCT00320034|Albuterol|albuterol|mesh-list
110310857|NCT00320034|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110310858|NCT00320034|Autonomic Agents|autonomic agents|mesh-ancestor
110310859|NCT00320034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110310860|NCT00320034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110310861|NCT00320034|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110310862|NCT00320034|Respiratory System Agents|respiratory system agents|mesh-ancestor
110310863|NCT00320034|Tocolytic Agents|tocolytic agents|mesh-ancestor
110310864|NCT00320034|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110310865|NCT00320034|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110310866|NCT00320034|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110310867|NCT00320034|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110310868|NCT00320034|Adrenergic Agents|adrenergic agents|mesh-ancestor
110371529|NCT04619303|Hormones|hormones|mesh-ancestor
110310869|NCT00320034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110310870|NCT00320034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110310871|NCT00320073|Pemetrexed|pemetrexed|mesh-list
110310872|NCT00320073|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110310873|NCT00320073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110310874|NCT00320073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110310875|NCT00320073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110310876|NCT00320073|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110310877|NCT00320073|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110310878|NCT00320073|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110310879|NCT00286871|Tacrolimus|tacrolimus|mesh-list
110310880|NCT00286871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110310881|NCT00286871|Immunologic Factors|immunologic factors|mesh-ancestor
110310882|NCT00286871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110310883|NCT00286871|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110310884|NCT00286871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110310885|NCT00286871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110310886|NCT00417326|Sivelestat|sivelestat|mesh-list
110310887|NCT00417326|Glycine|glycine|mesh-list
110310888|NCT00417326|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110310889|NCT00417326|Protease Inhibitors|protease inhibitors|mesh-ancestor
110310890|NCT00417326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110310891|NCT00417326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110310892|NCT00417326|Glycine Agents|glycine agents|mesh-ancestor
110310893|NCT00417326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110310894|NCT00417326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110310895|NCT00320229|Abciximab|abciximab|mesh-list
110310896|NCT00320229|Anticoagulants|anticoagulants|mesh-ancestor
110310897|NCT00320229|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110310898|NCT00320268|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110310899|NCT00320268|Antidepressive Agents|antidepressive agents|mesh-ancestor
110310900|NCT00320268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110310901|NCT00320268|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110310902|NCT00320268|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110310903|NCT00320268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110371958|NCT00570999|Mitosis Modulators|mitosis modulators|mesh-ancestor
110310904|NCT00320268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110310905|NCT00417404|Vitamins|vitamins|mesh-list
110310906|NCT00417404|Vitamin A|vitamin a|mesh-list
110310907|NCT00417404|Retinol palmitate|retinol palmitate|mesh-list
110310908|NCT00417404|Micronutrients|micronutrients|mesh-ancestor
110310909|NCT00417404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110310910|NCT00417404|Antioxidants|antioxidants|mesh-ancestor
110310911|NCT00417404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110310912|NCT00417404|Protective Agents|protective agents|mesh-ancestor
110310913|NCT00417404|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110310915|NCT00417443|Clonidine|clonidine|mesh-list
110310916|NCT00417443|Analgesics|analgesics|mesh-ancestor
110310917|NCT00417443|Sensory System Agents|sensory system agents|mesh-ancestor
110310918|NCT00417443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110310919|NCT00417443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110310920|NCT00417443|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110310921|NCT00417443|Sympatholytics|sympatholytics|mesh-ancestor
110310922|NCT00417443|Autonomic Agents|autonomic agents|mesh-ancestor
110310923|NCT00417443|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110310924|NCT00417443|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110310925|NCT00417443|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110310926|NCT00417443|Adrenergic Agents|adrenergic agents|mesh-ancestor
110310927|NCT00417443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110310928|NCT00417443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110310929|NCT00313482|Prednisone|prednisone|mesh-list
110310930|NCT00313482|Docetaxel|docetaxel|mesh-list
110310931|NCT00313482|Sargramostim|sargramostim|mesh-list
110310932|NCT00313482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110372253|NCT04611776|Atezolizumab|atezolizumab|mesh-list
110310933|NCT00313482|Tubulin Modulators|tubulin modulators|mesh-ancestor
110310934|NCT00313482|Antimitotic Agents|antimitotic agents|mesh-ancestor
110310935|NCT00313482|Mitosis Modulators|mitosis modulators|mesh-ancestor
110310936|NCT00313482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110310938|NCT00313482|Glucocorticoids|glucocorticoids|mesh-ancestor
110310939|NCT00313482|Hormones|hormones|mesh-ancestor
110310940|NCT00313482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110310941|NCT00313482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110310942|NCT00313482|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110310943|NCT00313482|Immunologic Factors|immunologic factors|mesh-ancestor
110310944|NCT00286988|Topiramate|topiramate|mesh-list
110310945|NCT00286988|Anticonvulsants|anticonvulsants|mesh-ancestor
110310946|NCT00286988|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110310947|NCT00286988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110310949|NCT00320307|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110372399|NCT04600115|Vasodilator Agents|vasodilator agents|mesh-ancestor
110310950|NCT00320307|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110310951|NCT00320307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110310952|NCT00320307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110310954|NCT00320307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110310955|NCT00320307|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110310956|NCT00320307|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110310957|NCT00287027|Antipsychotic Agents|antipsychotic agents|mesh-list
110310958|NCT00287027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110310959|NCT00287027|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110310960|NCT00287027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110310961|NCT00287027|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110310962|NCT02960906|Nivolumab|nivolumab|mesh-list
110310963|NCT02960906|Ipilimumab|ipilimumab|mesh-list
110310964|NCT02960906|Sunitinib|sunitinib|mesh-list
110310965|NCT02960906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110310966|NCT02960906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110310967|NCT02960906|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110310968|NCT02960906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110310969|NCT02960906|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110310970|NCT02960906|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110310971|NCT02960906|Growth Substances|growth substances|mesh-ancestor
110310972|NCT02960906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110310973|NCT02960906|Growth Inhibitors|growth inhibitors|mesh-ancestor
110310974|NCT02960906|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110310975|NCT02960906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110310977|NCT00287066|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110310978|NCT00287066|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110310979|NCT00287066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110310981|NCT00313521|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110310982|NCT00313521|Alkylating Agents|alkylating agents|mesh-ancestor
110442359|NCT00680329|Timolol|timolol|mesh-list
110372615|NCT00576615|Propofol|propofol|mesh-list
110310983|NCT00313521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110310984|NCT00313521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110310985|NCT00313521|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110310986|NCT00313521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110310987|NCT00313521|Immunologic Factors|immunologic factors|mesh-ancestor
110310988|NCT00313521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110310990|NCT00287261|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110310991|NCT00287261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110310992|NCT00313599|Paclitaxel|paclitaxel|mesh-list
110310993|NCT00313599|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110310994|NCT00313599|Lapatinib|lapatinib|mesh-list
110310995|NCT00313599|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110310996|NCT00313599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110310997|NCT00313599|Tubulin Modulators|tubulin modulators|mesh-ancestor
110310998|NCT00313599|Antimitotic Agents|antimitotic agents|mesh-ancestor
110310999|NCT00313599|Mitosis Modulators|mitosis modulators|mesh-ancestor
110311000|NCT00313599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110311001|NCT00313599|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110311002|NCT00313599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110311003|NCT00287300|Azithromycin|azithromycin|mesh-list
110311004|NCT00287300|Artesunate|artesunate|mesh-list
110311005|NCT00287300|Pyrimethamine|pyrimethamine|mesh-list
110311006|NCT00287300|Sulfadoxine|sulfadoxine|mesh-list
110311007|NCT00287300|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
110311008|NCT00287300|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110311009|NCT00287300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110311010|NCT00287300|Antimalarials|antimalarials|mesh-ancestor
110311011|NCT00287300|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110311012|NCT00287300|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110311013|NCT00287300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110311014|NCT00287300|Antiviral Agents|antiviral agents|mesh-ancestor
110311015|NCT00287300|Schistosomicides|schistosomicides|mesh-ancestor
110311016|NCT00287300|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110311017|NCT00287300|Anthelmintics|anthelmintics|mesh-ancestor
110311018|NCT00287300|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110311019|NCT00287300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110311020|NCT00287300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110311021|NCT00287300|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110311022|NCT00287378|Omalizumab|omalizumab|mesh-list
110311023|NCT00287378|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110086764|NCT03366974|Midazolam|midazolam|mesh-list
110311024|NCT00287378|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110311025|NCT00287378|Respiratory System Agents|respiratory system agents|mesh-ancestor
110311026|NCT00320580|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110311027|NCT00320580|Norelgestromin|norelgestromin|mesh-list
110311028|NCT00320580|Estradiol|estradiol|mesh-list
110311029|NCT00320580|Estrogens|estrogens|mesh-ancestor
110311030|NCT00320580|Hormones|hormones|mesh-ancestor
110311031|NCT00320580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110311032|NCT00320580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110311033|NCT00320580|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110311034|NCT00320580|Contraceptive Agents|contraceptive agents|mesh-ancestor
110311035|NCT00320580|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110311036|NCT00320580|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110311037|NCT00320580|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110311038|NCT00320580|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110311039|NCT00320619|Aminocaproic Acid|aminocaproic acid|mesh-list
110311040|NCT00320619|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110311041|NCT00320619|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110311042|NCT00320619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110311043|NCT00320619|Hemostatics|hemostatics|mesh-ancestor
110311044|NCT00320619|Coagulants|coagulants|mesh-ancestor
110311045|NCT00287456|Insulin|insulin|mesh-list
110311046|NCT00287456|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110311047|NCT00287456|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110311048|NCT00287456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110311049|NCT00313833|Buprenorphine|buprenorphine|mesh-list
110311050|NCT00313833|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110311051|NCT00313833|Narcotics|narcotics|mesh-ancestor
110311052|NCT00313833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110311053|NCT00313833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110311054|NCT00313833|Analgesics|analgesics|mesh-ancestor
110311055|NCT00313833|Sensory System Agents|sensory system agents|mesh-ancestor
110311056|NCT00313833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110311057|NCT00313833|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110311058|NCT00287495|Sorafenib|sorafenib|mesh-list
110311059|NCT00287495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110311060|NCT00287495|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110311061|NCT00287495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110311062|NCT00287495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110311063|NCT00320658|Aluminum Hydroxide|aluminum hydroxide|mesh-list
110311064|NCT00320658|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110311065|NCT00320658|Immunologic Factors|immunologic factors|mesh-ancestor
110311066|NCT00320658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110311067|NCT00320658|Antacids|antacids|mesh-ancestor
110311068|NCT00320658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110311069|NCT00320658|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110311070|NCT00287534|Tamoxifen|tamoxifen|mesh-list
110311071|NCT00287534|Anastrozole|anastrozole|mesh-list
110311072|NCT00287534|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110311073|NCT00287534|Hormone Antagonists|hormone antagonists|mesh-ancestor
110311074|NCT00287534|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110311075|NCT00287534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110311076|NCT00287534|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110311077|NCT00287534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110311078|NCT00287534|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110311079|NCT00287534|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110311080|NCT00287534|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110311081|NCT00287534|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110311082|NCT00287534|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110311083|NCT00287534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110311084|NCT00287534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110311086|NCT00320697|Nicotine|nicotine|mesh-list
110311087|NCT00320697|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110311088|NCT00320697|Autonomic Agents|autonomic agents|mesh-ancestor
110311089|NCT00320697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110311090|NCT00320697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110311091|NCT00320697|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110311092|NCT00320697|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110311093|NCT00320697|Cholinergic Agents|cholinergic agents|mesh-ancestor
110311094|NCT00320697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110311095|NCT00320697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110311096|NCT00320697|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110311097|NCT00320697|Antidepressive Agents|antidepressive agents|mesh-ancestor
110311098|NCT00320697|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110311099|NCT00320697|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110311100|NCT00320697|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110311101|NCT00320697|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110311102|NCT00320697|Dopamine Agents|dopamine agents|mesh-ancestor
110311103|NCT00320697|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110311104|NCT00320697|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110311105|NCT00320697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110311107|NCT00287651|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110311108|NCT00287651|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110373485|NCT00567060|Nootropic Agents|nootropic agents|mesh-ancestor
110311109|NCT00287651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110311111|NCT00322296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110311112|NCT00320736|Galantamine|galantamine|mesh-list
110442360|NCT00680329|Travoprost|travoprost|mesh-list
110311113|NCT00320736|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110311114|NCT00320736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110311115|NCT00320736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110311116|NCT00320736|Cholinergic Agents|cholinergic agents|mesh-ancestor
110311117|NCT00320736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110311118|NCT00320736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110311119|NCT00320736|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110311120|NCT00320736|Autonomic Agents|autonomic agents|mesh-ancestor
110311121|NCT00320736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110311122|NCT00320736|Nootropic Agents|nootropic agents|mesh-ancestor
110311123|NCT00287768|Docetaxel|docetaxel|mesh-list
110311124|NCT00287768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110311125|NCT00287768|Tubulin Modulators|tubulin modulators|mesh-ancestor
110311126|NCT00287768|Antimitotic Agents|antimitotic agents|mesh-ancestor
110311127|NCT00287768|Mitosis Modulators|mitosis modulators|mesh-ancestor
110311128|NCT00287768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110311129|NCT00320775|Aflibercept|aflibercept|mesh-list
110311131|NCT00320775|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110311132|NCT00320775|Growth Substances|growth substances|mesh-ancestor
110311133|NCT00320775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110311134|NCT00320775|Growth Inhibitors|growth inhibitors|mesh-ancestor
110311135|NCT00320775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110311136|NCT00320814|Aflibercept|aflibercept|mesh-list
110311137|NCT00320814|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110311138|NCT00320814|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110311139|NCT00320814|Growth Substances|growth substances|mesh-ancestor
110311140|NCT00320814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110311141|NCT00320814|Growth Inhibitors|growth inhibitors|mesh-ancestor
110311142|NCT00320814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110311143|NCT00287846|Imatinib Mesylate|imatinib mesylate|mesh-list
110311144|NCT00287846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110311145|NCT00287846|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110311146|NCT00287846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110311147|NCT00287846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110311148|NCT00322413|Epoetin Alfa|epoetin alfa|mesh-list
110311149|NCT00322413|Hematinics|hematinics|mesh-ancestor
110311150|NCT00320853|Vitamin D|vitamin d|mesh-list
110311151|NCT00320853|Vitamins|vitamins|mesh-ancestor
110311152|NCT00320853|Micronutrients|micronutrients|mesh-ancestor
110311153|NCT00320853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110311154|NCT00320853|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110311155|NCT00287885|Docetaxel|docetaxel|mesh-list
110311156|NCT00287885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110311157|NCT00287885|Tubulin Modulators|tubulin modulators|mesh-ancestor
110311159|NCT00287885|Mitosis Modulators|mitosis modulators|mesh-ancestor
110442361|NCT00680329|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110311160|NCT00287885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110311162|NCT00287924|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110311163|NCT00287924|Abortifacient Agents|abortifacient agents|mesh-ancestor
110373552|NCT04582136|Sirolimus|sirolimus|mesh-list
110311164|NCT00287924|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110311165|NCT00287924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110311166|NCT00287924|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110311167|NCT00287924|Antimetabolites|antimetabolites|mesh-ancestor
110311168|NCT00287924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110311169|NCT00287924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110311170|NCT00287924|Dermatologic Agents|dermatologic agents|mesh-ancestor
110311171|NCT00287924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110311172|NCT00287924|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110311173|NCT00287924|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110311174|NCT00287924|Immunologic Factors|immunologic factors|mesh-ancestor
110311175|NCT00287924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110311176|NCT00287924|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110311177|NCT00287963|Topotecan|topotecan|mesh-list
110311178|NCT00287963|Vinorelbine|vinorelbine|mesh-list
110311179|NCT00287963|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110311180|NCT00287963|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110311181|NCT00287963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110311182|NCT00287963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110311183|NCT00287963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110311184|NCT00287963|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110311185|NCT00287963|Tubulin Modulators|tubulin modulators|mesh-ancestor
110311186|NCT00287963|Antimitotic Agents|antimitotic agents|mesh-ancestor
110311187|NCT00287963|Mitosis Modulators|mitosis modulators|mesh-ancestor
110311188|NCT00320892|Atropine|atropine|mesh-list
110311189|NCT00320892|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110087196|NCT05324761|Pregabalin|pregabalin|mesh-list
110311190|NCT00320892|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110311191|NCT00320892|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110311192|NCT00320892|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110311193|NCT00320892|Autonomic Agents|autonomic agents|mesh-ancestor
110311194|NCT00320892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110311195|NCT00320892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110311196|NCT00320892|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110311197|NCT00320892|Respiratory System Agents|respiratory system agents|mesh-ancestor
110311199|NCT00320892|Parasympatholytics|parasympatholytics|mesh-ancestor
110087259|NCT05232344|Hormones|hormones|mesh-ancestor
110311200|NCT00320892|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110311201|NCT00320892|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110311202|NCT00320892|Cholinergic Agents|cholinergic agents|mesh-ancestor
110311203|NCT00320892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110311204|NCT00320892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110311205|NCT00320892|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110311206|NCT00288002|Cyclophosphamide|cyclophosphamide|mesh-list
110311207|NCT00288002|Docetaxel|docetaxel|mesh-list
110311208|NCT00288002|Capecitabine|capecitabine|mesh-list
110311209|NCT00288002|Trastuzumab|trastuzumab|mesh-list
110311210|NCT00288002|Epirubicin|epirubicin|mesh-list
110311211|NCT00288002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110311212|NCT00288002|Immunologic Factors|immunologic factors|mesh-ancestor
110311213|NCT00288002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110311214|NCT00288002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110311215|NCT00288002|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110311216|NCT00288002|Alkylating Agents|alkylating agents|mesh-ancestor
110311217|NCT00288002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110311218|NCT00288002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110311219|NCT00288002|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110311220|NCT00288002|Tubulin Modulators|tubulin modulators|mesh-ancestor
110311221|NCT00288002|Antimitotic Agents|antimitotic agents|mesh-ancestor
110311222|NCT00288002|Mitosis Modulators|mitosis modulators|mesh-ancestor
110087323|NCT04745234|Mogamulizumab|mogamulizumab|mesh-list
110311223|NCT00288002|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110311224|NCT00288002|Antimetabolites|antimetabolites|mesh-ancestor
110311225|NCT00288002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110311226|NCT00288002|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110311227|NCT00288002|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110311228|NCT00288002|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110311229|NCT00288002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110311232|NCT00322569|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110311233|NCT00322569|Tacrolimus|tacrolimus|mesh-list
110311234|NCT00322569|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110169271|NCT00000941|Ritonavir|ritonavir|mesh-list
110311235|NCT00322569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110311236|NCT00322569|Tubulin Modulators|tubulin modulators|mesh-ancestor
110311237|NCT00322569|Antimitotic Agents|antimitotic agents|mesh-ancestor
110311238|NCT00322569|Mitosis Modulators|mitosis modulators|mesh-ancestor
110311239|NCT00322569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110311240|NCT00322569|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110311241|NCT00322569|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110311243|NCT00322569|Sensory System Agents|sensory system agents|mesh-ancestor
110311244|NCT00322569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110311245|NCT00322569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110311246|NCT00322569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110311247|NCT00322569|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110311248|NCT00322569|Dermatologic Agents|dermatologic agents|mesh-ancestor
110311249|NCT00322569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110311250|NCT00322569|Immunologic Factors|immunologic factors|mesh-ancestor
110311251|NCT00322569|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110311252|NCT00322569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110311253|NCT00288041|Paclitaxel|paclitaxel|mesh-list
110311254|NCT00288041|Carboplatin|carboplatin|mesh-list
110311255|NCT00288041|Bortezomib|bortezomib|mesh-list
110311256|NCT00288041|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110311257|NCT00288041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110311258|NCT00288041|Tubulin Modulators|tubulin modulators|mesh-ancestor
110311259|NCT00288041|Antimitotic Agents|antimitotic agents|mesh-ancestor
110311260|NCT00288041|Mitosis Modulators|mitosis modulators|mesh-ancestor
110311261|NCT00288041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110311262|NCT00320970|Candesartan|candesartan|mesh-list
110311263|NCT00320970|Candesartan cilexetil|candesartan cilexetil|mesh-list
110311264|NCT00320970|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110311265|NCT00320970|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110311266|NCT00320970|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110311267|NCT00320970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110311268|NCT00288158|Allopurinol|allopurinol|mesh-list
110311269|NCT00288158|Probenecid|probenecid|mesh-list
110311270|NCT00288158|Antimetabolites|antimetabolites|mesh-ancestor
110311271|NCT00288158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110311272|NCT00288158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110311273|NCT00288158|Gout Suppressants|gout suppressants|mesh-ancestor
110311274|NCT00288158|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110311275|NCT00288158|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110311276|NCT00288158|Antioxidants|antioxidants|mesh-ancestor
110311277|NCT00288158|Protective Agents|protective agents|mesh-ancestor
110311278|NCT00288158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110311279|NCT00288158|Uricosuric Agents|uricosuric agents|mesh-ancestor
110311280|NCT04717752|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
110311281|NCT04717752|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110311282|NCT04717752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110311284|NCT00288197|Antifungal Agents|antifungal agents|mesh-ancestor
110311285|NCT00288197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110311286|NCT00288197|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110311287|NCT00288197|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110311288|NCT00288197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110311289|NCT00288197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110311290|NCT00288197|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110311291|NCT00288197|Hormone Antagonists|hormone antagonists|mesh-ancestor
110311292|NCT00288197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110311293|NCT00288197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110311294|NCT00288197|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110311295|NCT00288236|Rimonabant|rimonabant|mesh-list
110311296|NCT00288236|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110311297|NCT00288236|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
110311298|NCT00288236|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110311299|NCT00288236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110311300|NCT00288236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110311301|NCT00288236|Hormones|hormones|mesh-ancestor
110311302|NCT00288236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110311303|NCT00288236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110311304|NCT00321126|Zinc|zinc|mesh-list
110311305|NCT00321126|Trace Elements|trace elements|mesh-ancestor
110311306|NCT00321126|Micronutrients|micronutrients|mesh-ancestor
110311307|NCT00321126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110087611|NCT01681875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110311309|NCT00288353|Ziprasidone|ziprasidone|mesh-list
110311310|NCT00288353|Antidepressive Agents|antidepressive agents|mesh-ancestor
110311311|NCT00288353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110311312|NCT00288353|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110311313|NCT00288353|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110311314|NCT00288353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110311315|NCT00288353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110311316|NCT00288353|Dopamine Agonists|dopamine agonists|mesh-ancestor
110311317|NCT00288353|Dopamine Agents|dopamine agents|mesh-ancestor
110311318|NCT00288353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110311319|NCT00288353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110311320|NCT00288353|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110311321|NCT00288353|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110311322|NCT00288353|Serotonin Agents|serotonin agents|mesh-ancestor
110311323|NCT00288353|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110311324|NCT00288353|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110311325|NCT00288353|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110311326|NCT00288353|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110311327|NCT00288431|Sirolimus|sirolimus|mesh-list
110311328|NCT00288431|Doxorubicin|doxorubicin|mesh-list
110311329|NCT00288431|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110311330|NCT00288431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110311331|NCT00288431|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110311332|NCT00288431|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110311333|NCT00288431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110311334|NCT00288431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110311335|NCT00288431|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110311336|NCT00288431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110311337|NCT00288431|Antifungal Agents|antifungal agents|mesh-ancestor
110311338|NCT00288431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110311339|NCT00288431|Immunologic Factors|immunologic factors|mesh-ancestor
110311340|NCT00288431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110311341|NCT00321165|Taurolidine|taurolidine|mesh-list
110311342|NCT00321165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110311343|NCT00321165|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110311344|NCT00321165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110311345|NCT00322803|1-(4-chlorophenyl)-4-piperidin-1-yl-1,5-dihydroimidazol-2-one|1-(4-chlorophenyl)-4-piperidin-1-yl-1,5-dihydroimidazol-2-one|mesh-list
110311346|NCT00322803|Anticonvulsants|anticonvulsants|mesh-ancestor
110311347|NCT00322803|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110311348|NCT00322803|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110185393|NCT00846950|Histamine Agents|histamine agents|mesh-ancestor
110311349|NCT00322803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110311350|NCT00322803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110311351|NCT00322803|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110311352|NCT00322803|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
110311353|NCT00322803|GABA Agonists|gaba agonists|mesh-ancestor
110311354|NCT00322803|GABA Agents|gaba agents|mesh-ancestor
110311355|NCT00322803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110311356|NCT00322803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110311357|NCT00322920|Topotecan|topotecan|mesh-list
110311358|NCT00322920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110311359|NCT00322920|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110311360|NCT00322920|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110311361|NCT00322920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110311362|NCT00322920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110311363|NCT00321009|Enoxaparin|enoxaparin|mesh-list
110311364|NCT00321009|Anticoagulants|anticoagulants|mesh-ancestor
110311365|NCT00321009|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110311366|NCT00321009|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110311367|NCT00321009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110311368|NCT00417677|Sirolimus|sirolimus|mesh-list
110311369|NCT00417677|Sunitinib|sunitinib|mesh-list
110311370|NCT00417677|Temsirolimus|temsirolimus|mesh-list
110311371|NCT00417677|MTOR Inhibitors|mtor inhibitors|mesh-list
110311372|NCT00417677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110311373|NCT00417677|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110311374|NCT00417677|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110311375|NCT00417677|Growth Substances|growth substances|mesh-ancestor
110311376|NCT00417677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110311377|NCT00417677|Growth Inhibitors|growth inhibitors|mesh-ancestor
110311378|NCT00417677|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110311379|NCT00417677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110311380|NCT00417677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110311382|NCT00417677|Immunologic Factors|immunologic factors|mesh-ancestor
110311383|NCT00417677|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110311384|NCT00417677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110311385|NCT00417677|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110311386|NCT00417677|Antifungal Agents|antifungal agents|mesh-ancestor
110311388|NCT00417716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110311389|NCT00417716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110311390|NCT00417716|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110311391|NCT00417716|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110311392|NCT00417716|Growth Substances|growth substances|mesh-ancestor
110373628|NCT00568568|Hormones|hormones|mesh-list
110311393|NCT00417716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110311394|NCT00417716|Growth Inhibitors|growth inhibitors|mesh-ancestor
110311395|NCT00288470|Hylan|hylan|mesh-list
110311396|NCT00288470|Viscosupplements|viscosupplements|mesh-ancestor
110311397|NCT00288470|Protective Agents|protective agents|mesh-ancestor
110311398|NCT00288470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110311399|NCT00321360|Propofol|propofol|mesh-list
110311400|NCT00321360|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110311401|NCT00321360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110311402|NCT00321360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110311403|NCT00321360|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110311404|NCT00321360|Anesthetics, General|anesthetics, general|mesh-ancestor
110311406|NCT00288548|Metoprolol|metoprolol|mesh-list
110311407|NCT00288548|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110311408|NCT00288548|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110311409|NCT00288548|Sympatholytics|sympatholytics|mesh-ancestor
110311410|NCT00288548|Autonomic Agents|autonomic agents|mesh-ancestor
110311411|NCT00288548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110311412|NCT00288548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110311413|NCT00288548|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110311414|NCT00288548|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110311415|NCT00288548|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110311416|NCT00288548|Adrenergic Agents|adrenergic agents|mesh-ancestor
110311417|NCT00288548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110311418|NCT00288548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110311419|NCT00321477|Casopitant|casopitant|mesh-list
110311420|NCT00321477|Antiemetics|antiemetics|mesh-ancestor
110311421|NCT00321477|Autonomic Agents|autonomic agents|mesh-ancestor
110311422|NCT00321477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110311423|NCT00321477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110311424|NCT00321477|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110311425|NCT00321477|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110311426|NCT00321477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110311427|NCT00321477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110311428|NCT00321516|Aripiprazole|aripiprazole|mesh-list
110311429|NCT00321516|Antidepressive Agents|antidepressive agents|mesh-ancestor
110311430|NCT00321516|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110311431|NCT00321516|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110311432|NCT00321516|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110311433|NCT00321516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110311434|NCT00321516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110311435|NCT00321516|Dopamine Agonists|dopamine agonists|mesh-ancestor
110311437|NCT00321516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110311438|NCT00321516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110311439|NCT00321516|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110311440|NCT00321516|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110311441|NCT00321516|Serotonin Agents|serotonin agents|mesh-ancestor
110311442|NCT00321516|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110311443|NCT00321516|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110311444|NCT00321516|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110311445|NCT00321516|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110311446|NCT00288743|Insulin|insulin|mesh-list
110311447|NCT00288743|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110311448|NCT00288743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110311449|NCT00321633|Carboplatin|carboplatin|mesh-list
110311450|NCT00321633|Docetaxel|docetaxel|mesh-list
110311451|NCT00321633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110311452|NCT00321633|Tubulin Modulators|tubulin modulators|mesh-ancestor
110311453|NCT00321633|Antimitotic Agents|antimitotic agents|mesh-ancestor
110311454|NCT00321633|Mitosis Modulators|mitosis modulators|mesh-ancestor
110311455|NCT00321633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110311456|NCT00288782|Mirtazapine|mirtazapine|mesh-list
110311457|NCT00288782|Antidepressive Agents|antidepressive agents|mesh-ancestor
110311458|NCT00288782|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110311459|NCT00288782|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110311460|NCT00288782|Histamine Antagonists|histamine antagonists|mesh-ancestor
110311461|NCT00288782|Histamine Agents|histamine agents|mesh-ancestor
110311462|NCT00288782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110311463|NCT00288782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110311464|NCT00288782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110311465|NCT00288782|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110311466|NCT00288782|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110088272|NCT01693302|Insulin|insulin|mesh-list
110311467|NCT00288782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110311468|NCT00288782|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
110311469|NCT00288782|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110311470|NCT00288782|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110311471|NCT00288782|Adrenergic Agents|adrenergic agents|mesh-ancestor
110311472|NCT00288782|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110311473|NCT00288782|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110311474|NCT00288782|Serotonin Agents|serotonin agents|mesh-ancestor
110088335|NCT01693679|Lamivudine|lamivudine|mesh-list
110311475|NCT00288782|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110311476|NCT01059825|Metformin|metformin|mesh-list
110311477|NCT01059825|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110311478|NCT01059825|Ertugliflozin|ertugliflozin|mesh-list
110311479|NCT01059825|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110311480|NCT01059825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110311481|NCT01059825|Incretins|incretins|mesh-ancestor
110311482|NCT01059825|Hormones|hormones|mesh-ancestor
110311483|NCT01059825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110311484|NCT01059825|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110311485|NCT01059825|Protease Inhibitors|protease inhibitors|mesh-ancestor
110311486|NCT01059825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110311487|NCT01059825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110311488|NCT01059825|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110311489|NCT00321750|Pimecrolimus|pimecrolimus|mesh-list
110311490|NCT00321750|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110311491|NCT00321750|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110311492|NCT00321750|Analgesics|analgesics|mesh-ancestor
110311493|NCT00321750|Sensory System Agents|sensory system agents|mesh-ancestor
110088463|NCT05291195|Eusol|eusol|mesh-list
110311494|NCT00321750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110311495|NCT00321750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110311496|NCT00321750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110311497|NCT00321750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110311498|NCT00321750|Dermatologic Agents|dermatologic agents|mesh-ancestor
110311499|NCT00321750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110311500|NCT00321750|Immunologic Factors|immunologic factors|mesh-ancestor
110311501|NCT00321750|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110311502|NCT00321750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110311503|NCT00321750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110311504|NCT00321945|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
110311505|NCT00321945|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
110311506|NCT00321945|Protease Inhibitors|protease inhibitors|mesh-ancestor
110311507|NCT00321945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110311508|NCT00321945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110311509|NCT00323076|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
110311510|NCT00323076|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110311511|NCT00323076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110311512|NCT00323154|Nalbuphine|nalbuphine|mesh-list
110311513|NCT00323154|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110311514|NCT00323154|Narcotics|narcotics|mesh-ancestor
110311515|NCT00323154|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110169289|NCT00000941|Protease Inhibitors|protease inhibitors|mesh-ancestor
110311516|NCT00323154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110311518|NCT00323154|Sensory System Agents|sensory system agents|mesh-ancestor
110311519|NCT00323154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110311520|NCT00289250|Artesunate|artesunate|mesh-list
110311521|NCT00289250|Pyrimethamine|pyrimethamine|mesh-list
110311522|NCT00289250|Sulfadoxine|sulfadoxine|mesh-list
110311523|NCT00289250|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
110311524|NCT00289250|Antimalarials|antimalarials|mesh-ancestor
110311525|NCT00289250|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110311526|NCT00289250|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110311527|NCT00289250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110311528|NCT00289250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110311529|NCT00289250|Antiviral Agents|antiviral agents|mesh-ancestor
110311530|NCT00289250|Schistosomicides|schistosomicides|mesh-ancestor
110311531|NCT00289250|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110311532|NCT00289250|Anthelmintics|anthelmintics|mesh-ancestor
110311533|NCT00289250|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110311534|NCT00289250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110148338|NCT00388128|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110311535|NCT00289250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110311536|NCT00289250|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110311537|NCT00323505|Interferons|interferons|mesh-list
110311539|NCT00323505|Interferon alpha-2|interferon alpha-2|mesh-list
110311541|NCT00323505|Antiviral Agents|antiviral agents|mesh-ancestor
110311542|NCT00323505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110311543|NCT00323505|Immunologic Factors|immunologic factors|mesh-ancestor
110311544|NCT00323505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110311546|NCT00289406|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110311547|NCT00289406|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110311548|NCT00289406|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110311549|NCT00289406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110311550|NCT00289406|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110311551|NCT00289406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110311554|NCT00323544|Lamivudine|lamivudine|mesh-list
110311555|NCT00323544|Emtricitabine|emtricitabine|mesh-list
110311556|NCT00323544|Zidovudine|zidovudine|mesh-list
110311557|NCT00323544|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
110311558|NCT00323544|Antiviral Agents|antiviral agents|mesh-ancestor
110311559|NCT00323544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110148339|NCT00388128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110311560|NCT00323544|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110311561|NCT00323544|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110311562|NCT00323544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110311563|NCT00323544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110311564|NCT00323544|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110311565|NCT00323544|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110311566|NCT00323544|Antimetabolites|antimetabolites|mesh-ancestor
110311568|NCT00289445|Folic Acid|folic acid|mesh-list
110311569|NCT00289445|Mitomycins|mitomycins|mesh-list
110311570|NCT00289445|Mitomycin|mitomycin|mesh-list
110311571|NCT00289445|Levoleucovorin|levoleucovorin|mesh-list
110311572|NCT00289445|Antidotes|antidotes|mesh-ancestor
110311573|NCT00289445|Protective Agents|protective agents|mesh-ancestor
110311574|NCT00289445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110311575|NCT00289445|Vitamin B Complex|vitamin b complex|mesh-ancestor
110311576|NCT00289445|Vitamins|vitamins|mesh-ancestor
110311577|NCT00289445|Micronutrients|micronutrients|mesh-ancestor
110311578|NCT00289445|Hematinics|hematinics|mesh-ancestor
110311579|NCT00289445|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110311580|NCT00289445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110442362|NCT00680329|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110311582|NCT00289445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110311583|NCT00289445|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110311585|NCT00323583|Leucovorin|leucovorin|mesh-list
110311586|NCT00323583|Paclitaxel|paclitaxel|mesh-list
110311587|NCT00323583|Fluorouracil|fluorouracil|mesh-list
110311588|NCT00323583|Oxaliplatin|oxaliplatin|mesh-list
110311589|NCT00323583|Calcium|calcium|mesh-list
110311590|NCT00323583|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110311591|NCT00323583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110311592|NCT00323583|Tubulin Modulators|tubulin modulators|mesh-ancestor
110311593|NCT00323583|Antimitotic Agents|antimitotic agents|mesh-ancestor
110311594|NCT00323583|Mitosis Modulators|mitosis modulators|mesh-ancestor
110311595|NCT00323583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110311596|NCT00323583|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110311597|NCT00323583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110311598|NCT00323583|Antimetabolites|antimetabolites|mesh-ancestor
110311599|NCT00323583|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110311600|NCT00323583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110311601|NCT00323583|Immunologic Factors|immunologic factors|mesh-ancestor
110311602|NCT00323583|Antidotes|antidotes|mesh-ancestor
110311603|NCT00323583|Protective Agents|protective agents|mesh-ancestor
110311604|NCT00323583|Vitamin B Complex|vitamin b complex|mesh-ancestor
110311605|NCT00323583|Vitamins|vitamins|mesh-ancestor
110311606|NCT00323583|Micronutrients|micronutrients|mesh-ancestor
110311607|NCT00289601|Eptifibatide|eptifibatide|mesh-list
110311608|NCT00289601|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110311609|NCT00323778|Hyaluronic Acid|hyaluronic acid|mesh-list
110311610|NCT00323778|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110311611|NCT00323778|Immunologic Factors|immunologic factors|mesh-ancestor
110311612|NCT00323778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110311613|NCT00323778|Viscosupplements|viscosupplements|mesh-ancestor
110311614|NCT00323778|Protective Agents|protective agents|mesh-ancestor
110311615|NCT00323817|Z 338|z 338|mesh-list
110311616|NCT00323817|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110311617|NCT00323817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110311618|NCT00323817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110311619|NCT00323817|Cholinergic Agents|cholinergic agents|mesh-ancestor
110311620|NCT00323817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110311621|NCT00323817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110311622|NCT00323817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110311623|NCT00289835|Paclitaxel|paclitaxel|mesh-list
110311625|NCT00289835|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110311626|NCT00289835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110311627|NCT00289835|Tubulin Modulators|tubulin modulators|mesh-ancestor
110311628|NCT00289835|Antimitotic Agents|antimitotic agents|mesh-ancestor
110311629|NCT00289835|Mitosis Modulators|mitosis modulators|mesh-ancestor
110089022|NCT05192629|Anesthetics|anesthetics|mesh-ancestor
110311630|NCT00289835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110311631|NCT00303225|Tecovirimat|tecovirimat|mesh-list
110311632|NCT00303225|Antiviral Agents|antiviral agents|mesh-ancestor
110311633|NCT00303225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110311634|NCT00323934|Mocetinostat|mocetinostat|mesh-list
110311635|NCT00323934|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110311636|NCT00323934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110311637|NCT00323934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110311639|NCT00290030|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110311640|NCT00290030|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110311641|NCT00290030|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110311642|NCT00290030|Adrenergic Agents|adrenergic agents|mesh-ancestor
110169297|NCT00014937|Lopinavir|lopinavir|mesh-list
110311643|NCT00290030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110311644|NCT00290030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110311645|NCT00290030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110311646|NCT00290030|Urological Agents|urological agents|mesh-ancestor
110311647|NCT00303264|Esomeprazole|esomeprazole|mesh-list
110311648|NCT00303264|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110311649|NCT00303264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110311650|NCT00303264|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110311651|NCT00303264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110311652|NCT00303264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110311654|NCT00290069|Tacrolimus|tacrolimus|mesh-list
110311655|NCT00290069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110311656|NCT00290069|Immunologic Factors|immunologic factors|mesh-ancestor
110089131|NCT05008926|Naloxegol|naloxegol|mesh-list
110311657|NCT00290069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110311658|NCT00290069|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110311659|NCT00290069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110311660|NCT00290069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110311661|NCT00290069|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110311662|NCT00290069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110311664|NCT00290069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110311665|NCT00290069|Antifungal Agents|antifungal agents|mesh-ancestor
110311667|NCT04718259|Bupivacaine|bupivacaine|mesh-list
110311668|NCT04718259|Anesthetics, Local|anesthetics, local|mesh-ancestor
110311669|NCT04718259|Anesthetics|anesthetics|mesh-ancestor
110311670|NCT04718259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110311671|NCT04718259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110311673|NCT04718259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110311674|NCT04718259|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110311675|NCT04718259|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110311676|NCT04718259|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110311677|NCT04718259|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110311678|NCT04718259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110311679|NCT04718259|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110311680|NCT04718259|Anesthetics, General|anesthetics, general|mesh-ancestor
110311682|NCT04718259|GABA Agents|gaba agents|mesh-ancestor
110311683|NCT04718259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110311684|NCT04718259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110311685|NCT00290108|Propofol|propofol|mesh-list
110311686|NCT00290108|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110311687|NCT00290108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110311688|NCT00290108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110311689|NCT00290108|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110311690|NCT00290108|Anesthetics, General|anesthetics, general|mesh-ancestor
110311692|NCT00323973|Bisoprolol|bisoprolol|mesh-list
110311693|NCT00323973|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110311694|NCT00323973|Sympatholytics|sympatholytics|mesh-ancestor
110311695|NCT00323973|Autonomic Agents|autonomic agents|mesh-ancestor
110311696|NCT00323973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110311697|NCT00323973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110311698|NCT00323973|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110311699|NCT00323973|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110311700|NCT00323973|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110311701|NCT00323973|Adrenergic Agents|adrenergic agents|mesh-ancestor
110311702|NCT00323973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110311703|NCT00323973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110311704|NCT00324012|Docetaxel|docetaxel|mesh-list
110311705|NCT00324012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110311706|NCT00324012|Tubulin Modulators|tubulin modulators|mesh-ancestor
110311707|NCT00324012|Antimitotic Agents|antimitotic agents|mesh-ancestor
110311708|NCT00324012|Mitosis Modulators|mitosis modulators|mesh-ancestor
110311709|NCT00324012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110311711|NCT00290264|Formoterol Fumarate|formoterol fumarate|mesh-list
110311712|NCT00290264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110311713|NCT00290264|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110311714|NCT00290264|Autonomic Agents|autonomic agents|mesh-ancestor
110311715|NCT00290264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110311716|NCT00290264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110311718|NCT00290264|Respiratory System Agents|respiratory system agents|mesh-ancestor
110311719|NCT00290264|Glucocorticoids|glucocorticoids|mesh-ancestor
110311720|NCT00290264|Hormones|hormones|mesh-ancestor
110148340|NCT00388128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110311721|NCT00290264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110311722|NCT00290264|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110311723|NCT00290264|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110311724|NCT00290264|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110311726|NCT00290264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110311727|NCT00290264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110311728|NCT00324051|Olanzapine|olanzapine|mesh-list
110311730|NCT00324051|Autonomic Agents|autonomic agents|mesh-ancestor
110311731|NCT00324051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110311732|NCT00324051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110311733|NCT00324051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110311735|NCT00324051|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110311736|NCT00324051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110311737|NCT00324051|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110148341|NCT00388128|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110148342|NCT00388128|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110311738|NCT00324051|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110169317|NCT00014937|Antimetabolites|antimetabolites|mesh-ancestor
110311739|NCT00324051|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110148343|NCT00388128|Purinergic Agents|purinergic agents|mesh-ancestor
110311740|NCT00324051|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110148344|NCT00388128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110311741|NCT00324051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110311742|NCT00324051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110311744|NCT00303381|Interferons|interferons|mesh-list
110311745|NCT00303381|Interferon-beta|interferon-beta|mesh-list
110311746|NCT00303381|Interferon beta-1a|interferon beta-1a|mesh-list
110311747|NCT00303381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110311748|NCT00303381|Antiviral Agents|antiviral agents|mesh-ancestor
110311749|NCT00303381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110311750|NCT00303381|Immunologic Factors|immunologic factors|mesh-ancestor
110311751|NCT00303381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110311752|NCT00303381|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110311753|NCT00290420|Chloroquine|chloroquine|mesh-list
110311755|NCT00290420|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110311756|NCT00290420|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110311757|NCT00290420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110311759|NCT00290420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110148345|NCT00006462|Gemcitabine|gemcitabine|mesh-list
110311760|NCT00303420|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
110311761|NCT00303420|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110311762|NCT00303420|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110148346|NCT00006462|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110311763|NCT00303420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110311765|NCT00324129|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110311766|NCT00324129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110311767|NCT00324129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110311768|NCT00303537|Metformin|metformin|mesh-list
110311769|NCT00303537|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110148347|NCT00006462|Antimetabolites|antimetabolites|mesh-ancestor
110311770|NCT00303537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110311771|NCT00290849|Bivalirudin|bivalirudin|mesh-list
110311772|NCT00290849|Antithrombins|antithrombins|mesh-ancestor
110089581|NCT04012177|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110311773|NCT00290849|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110311774|NCT00290849|Protease Inhibitors|protease inhibitors|mesh-ancestor
110311775|NCT00290849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110311776|NCT00290849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110311777|NCT00290849|Anticoagulants|anticoagulants|mesh-ancestor
110311778|NCT00290927|Insulin glulisine|insulin glulisine|mesh-list
110311779|NCT00290927|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110311780|NCT00290927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110311782|NCT00303576|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110311785|NCT00303576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110311786|NCT00291005|Docetaxel|docetaxel|mesh-list
110311787|NCT00291005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110311788|NCT00291005|Tubulin Modulators|tubulin modulators|mesh-ancestor
110311789|NCT00291005|Antimitotic Agents|antimitotic agents|mesh-ancestor
110311790|NCT00291005|Mitosis Modulators|mitosis modulators|mesh-ancestor
110311791|NCT00291005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110311794|NCT00303615|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110311795|NCT00303615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110311796|NCT00303615|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110311797|NCT00303615|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110311798|NCT00303615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110311799|NCT00303615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110311800|NCT00303615|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110311801|NCT00303615|Hormone Antagonists|hormone antagonists|mesh-ancestor
110311802|NCT00303615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110311803|NCT00303615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110311804|NCT00303615|Anabolic Agents|anabolic agents|mesh-ancestor
110311805|NCT00303615|Hormones|hormones|mesh-ancestor
110311806|NCT00324324|Moxifloxacin|moxifloxacin|mesh-list
110311807|NCT00324324|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
110311808|NCT00324324|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110311809|NCT00324324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110311810|NCT00324324|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110311811|NCT00324324|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110311812|NCT00324324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110311813|NCT00324324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110311814|NCT00324324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110311815|NCT00324324|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110311816|NCT00324324|Contraceptive Agents|contraceptive agents|mesh-ancestor
110311817|NCT00324324|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110311818|NCT00324324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110311819|NCT00324324|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110311820|NCT00324324|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110311821|NCT00324324|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110311822|NCT00291122|Celecoxib|celecoxib|mesh-list
110311823|NCT00291122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110311824|NCT00291122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110311825|NCT00291122|Analgesics|analgesics|mesh-ancestor
110311826|NCT00291122|Sensory System Agents|sensory system agents|mesh-ancestor
110311827|NCT00291122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110311828|NCT00291122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110311829|NCT00291122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110311830|NCT00291122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110311831|NCT00291122|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110311832|NCT00291122|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110311833|NCT00291122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110311834|NCT00291122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110311836|NCT00324363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110311837|NCT00324363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110311838|NCT00324363|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110311839|NCT00324363|Incretins|incretins|mesh-ancestor
110311840|NCT00324363|Hormones|hormones|mesh-ancestor
110311841|NCT00324363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110311842|NCT00303732|Everolimus|everolimus|mesh-list
110311843|NCT00303732|Vatalanib|vatalanib|mesh-list
110311844|NCT00303732|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110311845|NCT00303732|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110311846|NCT00303732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110311847|NCT00303732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110311848|NCT00303732|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110311849|NCT00303732|Immunologic Factors|immunologic factors|mesh-ancestor
110311850|NCT00303732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110311851|NCT00303732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110311852|NCT00303771|Leucovorin|leucovorin|mesh-list
110311853|NCT00303771|Fluorouracil|fluorouracil|mesh-list
110311854|NCT00303771|Irinotecan|irinotecan|mesh-list
110311855|NCT00303771|Calcium|calcium|mesh-list
110311856|NCT00303771|Levoleucovorin|levoleucovorin|mesh-list
110311857|NCT00303771|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110311858|NCT00303771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110311859|NCT00303771|Antimetabolites|antimetabolites|mesh-ancestor
110311860|NCT00303771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110311861|NCT00303771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110311862|NCT00303771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110311863|NCT00303771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110311864|NCT00303771|Immunologic Factors|immunologic factors|mesh-ancestor
110311865|NCT00303771|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110311866|NCT00303771|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110311867|NCT00303771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110311869|NCT00303771|Protective Agents|protective agents|mesh-ancestor
110311870|NCT00303771|Vitamin B Complex|vitamin b complex|mesh-ancestor
110311871|NCT00303771|Vitamins|vitamins|mesh-ancestor
110311872|NCT00303771|Micronutrients|micronutrients|mesh-ancestor
110311873|NCT00303810|Cyclophosphamide|cyclophosphamide|mesh-list
110311874|NCT00303810|Thiotepa|thiotepa|mesh-list
110311875|NCT00303810|Lomustine|lomustine|mesh-list
110311876|NCT00303810|Carboplatin|carboplatin|mesh-list
110311877|NCT00303810|Methotrexate|methotrexate|mesh-list
110311878|NCT00303810|Etoposide|etoposide|mesh-list
110311879|NCT00303810|Vincristine|vincristine|mesh-list
110311880|NCT00303810|Etoposide phosphate|etoposide phosphate|mesh-list
110311881|NCT00303810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110311882|NCT00303810|Immunologic Factors|immunologic factors|mesh-ancestor
110311883|NCT00303810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110311885|NCT00303810|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110311887|NCT00303810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110311888|NCT00303810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110311889|NCT00303810|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110311890|NCT00303810|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110311891|NCT00303810|Abortifacient Agents|abortifacient agents|mesh-ancestor
110311892|NCT00303810|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110311895|NCT00303810|Dermatologic Agents|dermatologic agents|mesh-ancestor
110311896|NCT00303810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110311897|NCT00303810|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110311898|NCT00303810|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110311899|NCT00303810|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110311900|NCT00303810|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110311901|NCT00303810|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110311902|NCT00303810|Tubulin Modulators|tubulin modulators|mesh-ancestor
110311903|NCT00303810|Antimitotic Agents|antimitotic agents|mesh-ancestor
110311904|NCT00303810|Mitosis Modulators|mitosis modulators|mesh-ancestor
110311906|NCT00324480|Alvocidib|alvocidib|mesh-list
110311907|NCT00324480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110311908|NCT00324480|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110311909|NCT00324480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110311910|NCT00324480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110311911|NCT00324480|Growth Inhibitors|growth inhibitors|mesh-ancestor
110311912|NCT00324480|Growth Substances|growth substances|mesh-ancestor
110311913|NCT00324480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110311914|NCT00324480|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110311916|NCT00303888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110311917|NCT00303888|Tubulin Modulators|tubulin modulators|mesh-ancestor
110311918|NCT00303888|Antimitotic Agents|antimitotic agents|mesh-ancestor
110311919|NCT00303888|Mitosis Modulators|mitosis modulators|mesh-ancestor
110311920|NCT00303888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110311921|NCT00291707|Pemetrexed|pemetrexed|mesh-list
110311923|NCT00291707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110311924|NCT00291707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110311925|NCT00291707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110311926|NCT00291707|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110311927|NCT00291707|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110311930|NCT00324519|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110311931|NCT00324519|Abortifacient Agents|abortifacient agents|mesh-ancestor
110311932|NCT00324519|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110311933|NCT00324519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110311934|NCT00324519|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110311935|NCT00324519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110311937|NCT00291746|Esomeprazole|esomeprazole|mesh-list
110311938|NCT00291746|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110311939|NCT00291746|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110311940|NCT00291746|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110311941|NCT00291746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110311942|NCT00291746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110311944|NCT00303927|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110311945|NCT00303927|Antimetabolites|antimetabolites|mesh-ancestor
110311946|NCT00303927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110311947|NCT00303927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110311948|NCT00419484|Pioglitazone|pioglitazone|mesh-list
110311950|NCT00419484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110311952|NCT00291785|Folic Acid|folic acid|mesh-list
110311955|NCT00291785|Antimetabolites|antimetabolites|mesh-ancestor
110311956|NCT00291785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110311957|NCT00291785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110311958|NCT00291785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110311959|NCT00291785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110311961|NCT00291785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110311962|NCT00291785|Antidotes|antidotes|mesh-ancestor
110311963|NCT00291785|Protective Agents|protective agents|mesh-ancestor
110311964|NCT00291785|Vitamin B Complex|vitamin b complex|mesh-ancestor
110311965|NCT00291785|Vitamins|vitamins|mesh-ancestor
110311966|NCT00291785|Micronutrients|micronutrients|mesh-ancestor
110311967|NCT00291785|Hematinics|hematinics|mesh-ancestor
110311968|NCT00324558|Bemiparin|bemiparin|mesh-list
110311969|NCT00324558|Anticoagulants|anticoagulants|mesh-ancestor
110311970|NCT00291863|Simvastatin|simvastatin|mesh-list
110311971|NCT00291863|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110311972|NCT00291863|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110311973|NCT00291863|Antimetabolites|antimetabolites|mesh-ancestor
110311974|NCT00291863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110311975|NCT00291863|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110311976|NCT00291863|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110311977|NCT00291863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110311978|NCT00304200|Temozolomide|temozolomide|mesh-list
110311979|NCT00304200|Sunitinib|sunitinib|mesh-list
110311980|NCT00304200|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110169353|NCT00396682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110311982|NCT00304200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110311983|NCT00304200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110311984|NCT00304200|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110311985|NCT00304200|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110311987|NCT00304200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110311988|NCT00304200|Growth Inhibitors|growth inhibitors|mesh-ancestor
110311989|NCT00304200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110311990|NCT00304200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110311992|NCT00291980|Immunologic Factors|immunologic factors|mesh-ancestor
110311993|NCT00291980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110311994|NCT00324597|Gemcitabine|gemcitabine|mesh-list
110311995|NCT00324597|Motesanib diphosphate|motesanib diphosphate|mesh-list
110311996|NCT00324597|Imetelstat|imetelstat|mesh-list
110311997|NCT00324597|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110090001|NCT05559476|Vaccines|vaccines|mesh-list
110311998|NCT00324597|Antimetabolites|antimetabolites|mesh-ancestor
110311999|NCT00324597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110312001|NCT00324597|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110312002|NCT00324597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110312003|NCT00324714|Risedronic Acid|risedronic acid|mesh-list
110312004|NCT00324714|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110312005|NCT00324714|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110312006|NCT00324714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110312007|NCT00324714|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110312008|NCT00324714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110312009|NCT00324714|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110312011|NCT00304317|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110312014|NCT00304317|Sensory System Agents|sensory system agents|mesh-ancestor
110312015|NCT00304317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110312016|NCT00304317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110312017|NCT00304317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110312018|NCT00304317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110312019|NCT00304317|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110312020|NCT00304317|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110312021|NCT00304317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110312022|NCT00304317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110312024|NCT00324792|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110312025|NCT00324792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110312026|NCT00292214|Acetaminophen|acetaminophen|mesh-list
110312027|NCT00292214|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110312028|NCT00292214|Analgesics|analgesics|mesh-ancestor
110312029|NCT00292214|Sensory System Agents|sensory system agents|mesh-ancestor
110312030|NCT00292214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110312031|NCT00292214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110312032|NCT00292214|Antipyretics|antipyretics|mesh-ancestor
110312033|NCT00324831|Prednisone|prednisone|mesh-list
110312034|NCT00324831|Cyclophosphamide|cyclophosphamide|mesh-list
110312035|NCT00324831|Rituximab|rituximab|mesh-list
110312036|NCT00324831|Doxorubicin|doxorubicin|mesh-list
110312037|NCT00324831|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110312038|NCT00324831|Vincristine|vincristine|mesh-list
110312039|NCT00324831|Vaccines|vaccines|mesh-list
110312040|NCT00324831|Antibodies|antibodies|mesh-list
110312041|NCT00324831|Immunoglobulins|immunoglobulins|mesh-list
110312042|NCT00324831|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110312044|NCT00324831|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
110312045|NCT00324831|Immunomodulating Agents|immunomodulating agents|mesh-list
110312046|NCT00324831|Immunologic Factors|immunologic factors|mesh-ancestor
110312047|NCT00324831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110312048|NCT00324831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110312049|NCT00324831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110312050|NCT00324831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110312052|NCT00324831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110312053|NCT00324831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110312054|NCT00324831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110312055|NCT00324831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110312056|NCT00324831|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110312057|NCT00324831|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110312058|NCT00324831|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110312059|NCT00324831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110312060|NCT00324831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110312063|NCT00324831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110312064|NCT00324831|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110312065|NCT00324831|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110312066|NCT00324831|Tubulin Modulators|tubulin modulators|mesh-ancestor
110312067|NCT00324831|Antimitotic Agents|antimitotic agents|mesh-ancestor
110312068|NCT00324831|Mitosis Modulators|mitosis modulators|mesh-ancestor
110312069|NCT00292253|Interferon beta-1a|interferon beta-1a|mesh-list
110312070|NCT00292253|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110312071|NCT00292253|Immunologic Factors|immunologic factors|mesh-ancestor
110312072|NCT00292253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110312073|NCT00292253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110312077|NCT00304434|Probenecid|probenecid|mesh-list
110312078|NCT00304434|Antiviral Agents|antiviral agents|mesh-ancestor
110312079|NCT00304434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110312080|NCT00304434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110312081|NCT00304434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110312082|NCT00304434|Uricosuric Agents|uricosuric agents|mesh-ancestor
110312083|NCT00304434|Gout Suppressants|gout suppressants|mesh-ancestor
110312084|NCT00304434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110312085|NCT00292409|Aripiprazole|aripiprazole|mesh-list
110312086|NCT00292409|Antidepressive Agents|antidepressive agents|mesh-ancestor
110312087|NCT00292409|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110312088|NCT00292409|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110312089|NCT00292409|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110312090|NCT00292409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110312091|NCT00292409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110312092|NCT00292409|Dopamine Agonists|dopamine agonists|mesh-ancestor
110312093|NCT00292409|Dopamine Agents|dopamine agents|mesh-ancestor
110312094|NCT00292409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110312095|NCT00292409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110312096|NCT00292409|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110312097|NCT00292409|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110312098|NCT00292409|Serotonin Agents|serotonin agents|mesh-ancestor
110312099|NCT00292409|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110312100|NCT00292409|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110312101|NCT00292409|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110312102|NCT00292409|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110312103|NCT00304473|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110312104|NCT00304473|Antidepressive Agents|antidepressive agents|mesh-ancestor
110312105|NCT00304473|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110312106|NCT00304473|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110312108|NCT00304473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110312109|NCT00304473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110312110|NCT00292448|Tiotropium Bromide|tiotropium bromide|mesh-list
110312111|NCT00292448|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110312112|NCT00292448|Autonomic Agents|autonomic agents|mesh-ancestor
110312113|NCT00292448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110312114|NCT00292448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110312115|NCT00292448|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110312116|NCT00292448|Respiratory System Agents|respiratory system agents|mesh-ancestor
110312117|NCT00292448|Parasympatholytics|parasympatholytics|mesh-ancestor
110312118|NCT00292448|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110312119|NCT00292448|Cholinergic Agents|cholinergic agents|mesh-ancestor
110312120|NCT00292448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110312121|NCT00292448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110312122|NCT00324948|Alprostadil|alprostadil|mesh-list
110312123|NCT00324948|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110312124|NCT00324948|Vasodilator Agents|vasodilator agents|mesh-ancestor
110312125|NCT00324948|Urological Agents|urological agents|mesh-ancestor
110312126|NCT00304551|Ribavirin|ribavirin|mesh-list
110312127|NCT00304551|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110312128|NCT00304551|Interferon-alpha|interferon-alpha|mesh-list
110312130|NCT00304551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110312131|NCT00304551|Antiviral Agents|antiviral agents|mesh-ancestor
110312132|NCT00304551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110312133|NCT00304551|Immunologic Factors|immunologic factors|mesh-ancestor
110312134|NCT00304551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110312136|NCT00325026|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110312138|NCT00325026|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110312139|NCT00325026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110312140|NCT00325026|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110312141|NCT00325026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110312142|NCT00325026|Oxytocics|oxytocics|mesh-ancestor
110312144|NCT00325104|Parathyroid Hormone|parathyroid hormone|mesh-list
110312145|NCT00325104|Hormones|hormones|mesh-list
110169374|NCT00396721|Antimetabolites|antimetabolites|mesh-ancestor
110312146|NCT00325104|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110312147|NCT00325104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110312148|NCT00325104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110312149|NCT00292526|Enalapril|enalapril|mesh-list
110312150|NCT00292526|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110312151|NCT00292526|Protease Inhibitors|protease inhibitors|mesh-ancestor
110312153|NCT00292526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110312154|NCT00292526|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110312155|NCT00418509|Mometasone Furoate|mometasone furoate|mesh-list
110312156|NCT00418509|Formoterol Fumarate|formoterol fumarate|mesh-list
110312157|NCT00418509|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110312159|NCT00418509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110312160|NCT00418509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110312161|NCT00418509|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110312162|NCT00418509|Respiratory System Agents|respiratory system agents|mesh-ancestor
110312163|NCT00418509|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110312164|NCT00418509|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110312166|NCT00418509|Adrenergic Agents|adrenergic agents|mesh-ancestor
110312167|NCT00418509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110312168|NCT00418509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110312170|NCT00418509|Dermatologic Agents|dermatologic agents|mesh-ancestor
110312171|NCT00418509|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110312173|NCT00292721|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110312174|NCT00292721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110312175|NCT00292721|Analgesics|analgesics|mesh-ancestor
110312176|NCT00292721|Sensory System Agents|sensory system agents|mesh-ancestor
110312177|NCT00292721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110312178|NCT00292721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110312179|NCT00292721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110312180|NCT00292721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110312181|NCT00292721|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110312182|NCT00292721|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110312183|NCT00292721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110312184|NCT00292721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110312186|NCT00292760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110373695|NCT00583986|Autonomic Agents|autonomic agents|mesh-ancestor
110312187|NCT00292760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110312188|NCT00325182|Levetiracetam|levetiracetam|mesh-list
110312189|NCT00325182|Anticonvulsants|anticonvulsants|mesh-ancestor
110312190|NCT00325182|Nootropic Agents|nootropic agents|mesh-ancestor
110312191|NCT00292799|Metformin|metformin|mesh-list
110312192|NCT00292799|Orlistat|orlistat|mesh-list
110312193|NCT00292799|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110312194|NCT00292799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110312195|NCT00292799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110312196|NCT00292799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110312197|NCT00292799|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110312198|NCT00292799|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110312199|NCT00304629|Galantamine|galantamine|mesh-list
110312200|NCT00304629|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110312201|NCT00304629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110442363|NCT00680329|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110312202|NCT00304629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110312203|NCT00304629|Cholinergic Agents|cholinergic agents|mesh-ancestor
110312204|NCT00304629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110312205|NCT00304629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110312206|NCT00304629|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110312207|NCT00304629|Autonomic Agents|autonomic agents|mesh-ancestor
110312208|NCT00304629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110312209|NCT00304629|Nootropic Agents|nootropic agents|mesh-ancestor
110312210|NCT00292838|Fluticasone|fluticasone|mesh-list
110312211|NCT00292838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110312212|NCT00292838|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110312213|NCT00292838|Autonomic Agents|autonomic agents|mesh-ancestor
110312214|NCT00292838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110312215|NCT00292838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110312217|NCT00292838|Respiratory System Agents|respiratory system agents|mesh-ancestor
110312218|NCT00292838|Dermatologic Agents|dermatologic agents|mesh-ancestor
110312219|NCT00292838|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110312221|NCT00304668|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110312222|NCT00304668|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110312223|NCT00304668|Antiviral Agents|antiviral agents|mesh-ancestor
110312224|NCT00304668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110312225|NCT00292955|Cetuximab|cetuximab|mesh-list
110312226|NCT00292955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110312227|NCT00292955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110312230|NCT00293072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110312231|NCT00293072|Immunologic Factors|immunologic factors|mesh-ancestor
110312232|NCT00293072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110312233|NCT00293072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110312234|NCT00293111|Etodolac|etodolac|mesh-list
110312235|NCT00293111|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110312236|NCT00293111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110312237|NCT00293111|Analgesics|analgesics|mesh-ancestor
110312238|NCT00293111|Sensory System Agents|sensory system agents|mesh-ancestor
110312239|NCT00293111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110312240|NCT00293111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110312242|NCT00293111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110312243|NCT00293111|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110312244|NCT00293111|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110312245|NCT00293111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110312246|NCT00293111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110312247|NCT00304785|Latanoprost|latanoprost|mesh-list
110312248|NCT00304785|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110312249|NCT00304785|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110312251|NCT00293150|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110312252|NCT00293150|Hormone Antagonists|hormone antagonists|mesh-ancestor
110312253|NCT00293150|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110312255|NCT00293150|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110312256|NCT00293150|Diuretics|diuretics|mesh-ancestor
110312257|NCT00293150|Natriuretic Agents|natriuretic agents|mesh-ancestor
110312258|NCT00293150|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110312260|NCT00293228|Antitubercular Agents|antitubercular agents|mesh-ancestor
110312261|NCT00293228|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110312262|NCT00293228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110312263|NCT00293228|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
110312264|NCT00293228|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110312265|NCT00293228|Antimetabolites|antimetabolites|mesh-ancestor
110312266|NCT00293228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110312267|NCT00293228|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110312269|NCT00293345|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110312270|NCT00293345|Antimetabolites|antimetabolites|mesh-ancestor
110312271|NCT00293345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110312272|NCT00293345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110312273|NCT00293501|Tinzaparin|tinzaparin|mesh-list
110312274|NCT00293501|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
110312275|NCT00293501|Dalteparin|dalteparin|mesh-list
110312276|NCT00293501|Anticoagulants|anticoagulants|mesh-ancestor
110312277|NCT00293501|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110312278|NCT00293501|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110312279|NCT00293501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110312280|NCT00325455|Anacetrapib|anacetrapib|mesh-list
110312281|NCT00325455|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110312282|NCT00325455|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110312283|NCT00325455|Antimetabolites|antimetabolites|mesh-ancestor
110312284|NCT00325455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110312285|NCT00325455|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110312286|NCT00293657|Lornoxicam|lornoxicam|mesh-list
110312287|NCT00293657|Piroxicam|piroxicam|mesh-list
110312288|NCT00293657|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110312289|NCT00293657|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110312290|NCT00293657|Analgesics|analgesics|mesh-ancestor
110312291|NCT00293657|Sensory System Agents|sensory system agents|mesh-ancestor
110312292|NCT00293657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110312293|NCT00293657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110312294|NCT00293657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110312295|NCT00293657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110312296|NCT00293657|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110312297|NCT00293657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110312298|NCT00293657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110312299|NCT00293696|Goserelin|goserelin|mesh-list
110312300|NCT00293696|Bicalutamide|bicalutamide|mesh-list
110312301|NCT00293696|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110312302|NCT00293696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110312303|NCT00293696|Androgen Antagonists|androgen antagonists|mesh-ancestor
110148348|NCT00006462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110312305|NCT00293696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110312306|NCT00293696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110312308|NCT00293735|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110312309|NCT00293735|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110312310|NCT00293735|Adrenergic Agents|adrenergic agents|mesh-ancestor
110312312|NCT00293735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110312313|NCT00293735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110312314|NCT00293735|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110312315|NCT00293735|Sympathomimetics|sympathomimetics|mesh-ancestor
110312316|NCT00293735|Autonomic Agents|autonomic agents|mesh-ancestor
110312317|NCT00293735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110312318|NCT00293735|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110312319|NCT00293735|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110312320|NCT00304980|Lumefantrine|lumefantrine|mesh-list
110312322|NCT00304980|Pyrimethamine|pyrimethamine|mesh-list
110312323|NCT00304980|Sulfadoxine|sulfadoxine|mesh-list
110312324|NCT00304980|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
110312325|NCT00304980|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
110312326|NCT00304980|Antimalarials|antimalarials|mesh-ancestor
110312327|NCT00304980|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110312328|NCT00304980|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110312329|NCT00304980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110312330|NCT00304980|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110312331|NCT00304980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110312332|NCT00304980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110312333|NCT00304980|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110312334|NCT00293891|Tacrolimus|tacrolimus|mesh-list
110312335|NCT00293891|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110312336|NCT00293891|Immunologic Factors|immunologic factors|mesh-ancestor
110312337|NCT00293891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110312338|NCT00293891|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110312339|NCT00293891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110312340|NCT00293891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110312341|NCT00293930|Tacrolimus|tacrolimus|mesh-list
110312342|NCT00293930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110312343|NCT00293930|Immunologic Factors|immunologic factors|mesh-ancestor
110312344|NCT00293930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110312346|NCT00293930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110312347|NCT00293930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110312348|NCT00305019|Clevudine|clevudine|mesh-list
110312349|NCT00305019|Antiviral Agents|antiviral agents|mesh-ancestor
110312350|NCT00305019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110312351|NCT00293969|Morphine|morphine|mesh-list
110312352|NCT00293969|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110312354|NCT00293969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110312355|NCT00293969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110312356|NCT00293969|Analgesics|analgesics|mesh-ancestor
110312357|NCT00293969|Sensory System Agents|sensory system agents|mesh-ancestor
110312358|NCT00293969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110312359|NCT00294008|Risperidone|risperidone|mesh-list
110312360|NCT00294008|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110312361|NCT00294008|Serotonin Agents|serotonin agents|mesh-ancestor
110312362|NCT00294008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110312363|NCT00294008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110312364|NCT00294008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110312366|NCT00294008|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110312367|NCT00294008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110312368|NCT00294008|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110312369|NCT00294008|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110312370|NCT00294008|Dopamine Agents|dopamine agents|mesh-ancestor
110312371|NCT00294086|Valsartan|valsartan|mesh-list
110312372|NCT00294086|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110312373|NCT00294086|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110312374|NCT00294086|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110312375|NCT00294086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110312377|NCT00325689|Aripiprazole|aripiprazole|mesh-list
110312378|NCT00325689|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110312379|NCT00325689|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110312380|NCT00325689|Serotonin Agents|serotonin agents|mesh-ancestor
110312381|NCT00325689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110312382|NCT00325689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110312383|NCT00325689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110312384|NCT00325689|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110312385|NCT00325689|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110312386|NCT00325689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110312387|NCT00325689|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110312388|NCT00325689|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110312389|NCT00325689|Dopamine Agents|dopamine agents|mesh-ancestor
110312390|NCT00325689|Antidepressive Agents|antidepressive agents|mesh-ancestor
110312391|NCT00325689|Dopamine Agonists|dopamine agonists|mesh-ancestor
110312392|NCT00325689|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110312393|NCT00325689|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110312394|NCT00325689|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110312395|NCT00325689|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110312396|NCT00294164|Hormones|hormones|mesh-list
110148349|NCT00006462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110312397|NCT00294164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110312398|NCT00294164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110312399|NCT00417794|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
110312400|NCT00417794|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110148350|NCT00006465|Capecitabine|capecitabine|mesh-list
110312401|NCT00417794|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110312402|NCT00417794|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110148351|NCT00006465|Oxaliplatin|oxaliplatin|mesh-list
110312403|NCT00417794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110312404|NCT00417794|Adrenergic Agents|adrenergic agents|mesh-ancestor
110312405|NCT00417794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110312406|NCT00417794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110312407|NCT00417833|Bevacizumab|bevacizumab|mesh-list
110312408|NCT00417833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110312409|NCT00417833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110312410|NCT00417833|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110148352|NCT00006465|Irinotecan|irinotecan|mesh-list
110312411|NCT00417833|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110312412|NCT00417833|Growth Substances|growth substances|mesh-ancestor
110312413|NCT00417833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110312415|NCT00417872|Metronidazole|metronidazole|mesh-list
110312416|NCT00417872|Nitazoxanide|nitazoxanide|mesh-list
110312417|NCT00417872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110148353|NCT00006465|Camptothecin|camptothecin|mesh-list
110312418|NCT00417872|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110312419|NCT00417872|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110312420|NCT00417872|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110312421|NCT00294203|Epoetin Alfa|epoetin alfa|mesh-list
110312422|NCT00294203|Hematinics|hematinics|mesh-ancestor
110312424|NCT00305292|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110312425|NCT00305292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110312426|NCT00305292|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
110312427|NCT00305292|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110312428|NCT00305292|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110312429|NCT00305292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110312431|NCT00305331|Antiemetics|antiemetics|mesh-ancestor
110312432|NCT00305331|Autonomic Agents|autonomic agents|mesh-ancestor
110312433|NCT00305331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110312434|NCT00305331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110312435|NCT00305331|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110312436|NCT00305331|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110312437|NCT00305331|Dopamine Agents|dopamine agents|mesh-ancestor
110312438|NCT00305331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110169424|NCT00015171|Naloxone|naloxone|mesh-list
110312439|NCT00305331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110312441|NCT00325767|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110312442|NCT00325767|Autonomic Agents|autonomic agents|mesh-ancestor
110312443|NCT00325767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110312444|NCT00325767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110312445|NCT00325767|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110312446|NCT00325767|Respiratory System Agents|respiratory system agents|mesh-ancestor
110312448|NCT00325767|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110312449|NCT00325767|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110312450|NCT00325767|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110312451|NCT00325767|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110312452|NCT00325767|Adrenergic Agents|adrenergic agents|mesh-ancestor
110312453|NCT00325767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110312454|NCT00325767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110312455|NCT00294359|Bevacizumab|bevacizumab|mesh-list
110312456|NCT00294359|Capecitabine|capecitabine|mesh-list
110312457|NCT00294359|Mitomycins|mitomycins|mesh-list
110312458|NCT00294359|Mitomycin|mitomycin|mesh-list
110312459|NCT00294359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110312460|NCT00294359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110312461|NCT00294359|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110312462|NCT00294359|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110312463|NCT00294359|Growth Substances|growth substances|mesh-ancestor
110312464|NCT00294359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110312465|NCT00294359|Growth Inhibitors|growth inhibitors|mesh-ancestor
110312466|NCT00294359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110312467|NCT00294359|Antimetabolites|antimetabolites|mesh-ancestor
110312468|NCT00294359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110312469|NCT00294359|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110312470|NCT00294359|Alkylating Agents|alkylating agents|mesh-ancestor
110312471|NCT00294359|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110312472|NCT00294359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110312473|NCT00294437|Zoledronic Acid|zoledronic acid|mesh-list
110312474|NCT00294437|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110312475|NCT00294437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110312476|NCT00305370|Aripiprazole|aripiprazole|mesh-list
110312477|NCT00305370|Antidepressive Agents|antidepressive agents|mesh-ancestor
110312478|NCT00305370|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110312479|NCT00305370|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110312480|NCT00305370|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110312481|NCT00305370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110312482|NCT00305370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110312483|NCT00305370|Dopamine Agonists|dopamine agonists|mesh-ancestor
110312484|NCT00305370|Dopamine Agents|dopamine agents|mesh-ancestor
110312485|NCT00305370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110312486|NCT00305370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110312487|NCT00305370|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110312488|NCT00305370|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110312489|NCT00305370|Serotonin Agents|serotonin agents|mesh-ancestor
110312490|NCT00305370|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110312491|NCT00305370|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110312492|NCT00305370|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110312493|NCT00305370|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110312494|NCT00325806|Ramipril|ramipril|mesh-list
110312495|NCT00325806|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110312496|NCT00325806|Protease Inhibitors|protease inhibitors|mesh-ancestor
110312497|NCT00325806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110312498|NCT00325806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110312499|NCT00325806|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110312500|NCT00305409|Sulfalene|sulfalene|mesh-list
110312501|NCT00305409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110312502|NCT00305409|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110312503|NCT00305409|Antimalarials|antimalarials|mesh-ancestor
110312504|NCT00305409|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110312505|NCT00305409|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110312506|NCT00294593|Leucovorin|leucovorin|mesh-list
110312507|NCT00294593|Folic Acid|folic acid|mesh-list
110312508|NCT00294593|Levoleucovorin|levoleucovorin|mesh-list
110312509|NCT00294593|Antidotes|antidotes|mesh-ancestor
110312510|NCT00294593|Protective Agents|protective agents|mesh-ancestor
110312511|NCT00294593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110312512|NCT00294593|Vitamin B Complex|vitamin b complex|mesh-ancestor
110312513|NCT00294593|Vitamins|vitamins|mesh-ancestor
110312514|NCT00294593|Micronutrients|micronutrients|mesh-ancestor
110312515|NCT00294593|Hematinics|hematinics|mesh-ancestor
110312516|NCT00325845|Hylan|hylan|mesh-list
110312517|NCT00325845|Viscosupplements|viscosupplements|mesh-ancestor
110312518|NCT00325845|Protective Agents|protective agents|mesh-ancestor
110312519|NCT00325845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110312520|NCT00294749|Ciprofloxacin|ciprofloxacin|mesh-list
110312521|NCT00294749|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110312522|NCT00294749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110312523|NCT00294749|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110312524|NCT00294749|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110312525|NCT00294749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110312526|NCT00294749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110312527|NCT00294749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110312528|NCT00294749|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110312529|NCT00294749|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110312531|NCT00325962|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110312532|NCT00325962|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110312533|NCT00325962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110260173|NCT02944201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110312534|NCT00325962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110148354|NCT00006465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110312535|NCT00325962|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110312536|NCT00325962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110312537|NCT00325962|Vasodilator Agents|vasodilator agents|mesh-ancestor
110312538|NCT00305487|Ciclesonide|ciclesonide|mesh-list
110312539|NCT00305487|Glucocorticoids|glucocorticoids|mesh-ancestor
110148355|NCT00006465|Antimetabolites|antimetabolites|mesh-ancestor
110312541|NCT00305487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110312542|NCT00305487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110312543|NCT00305487|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110312544|NCT00294944|Idazoxan|idazoxan|mesh-list
110312545|NCT00294944|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
110312546|NCT00294944|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110312547|NCT00294944|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110312548|NCT00294944|Adrenergic Agents|adrenergic agents|mesh-ancestor
110312549|NCT00294944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110312550|NCT00294944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110312551|NCT00294944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110312552|NCT00326157|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
110312553|NCT00326157|Antifungal Agents|antifungal agents|mesh-ancestor
110312554|NCT00326157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110312555|NCT00326157|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110312556|NCT00326157|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110312558|NCT00295100|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110312559|NCT00295100|Hormone Antagonists|hormone antagonists|mesh-ancestor
110148356|NCT00006465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110148357|NCT00006465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110148358|NCT00006465|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110148359|NCT00006465|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110148360|NCT00006465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110148361|NCT00006465|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110148362|NCT04575181|Insulin|insulin|mesh-list
110148363|NCT04575181|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110148364|NCT04575181|Insulin Glargine|insulin glargine|mesh-list
110148365|NCT04575181|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110148366|NCT04575181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110312560|NCT00295100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110312561|NCT00295100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110312562|NCT00295100|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110148367|NCT00006468|Leucovorin|leucovorin|mesh-list
110148368|NCT00006468|Fluorouracil|fluorouracil|mesh-list
110312563|NCT00295100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110312564|NCT00295100|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110148369|NCT00006468|Oxaliplatin|oxaliplatin|mesh-list
110148370|NCT00006468|Calcium|calcium|mesh-list
110148371|NCT00006468|Levoleucovorin|levoleucovorin|mesh-list
110312565|NCT00295100|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110312566|NCT00295100|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110312567|NCT00326235|Buspirone|buspirone|mesh-list
110312568|NCT00326235|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110312569|NCT00326235|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110312570|NCT00326235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110312571|NCT00326235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110312572|NCT00326235|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110312573|NCT00326235|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110312574|NCT00326235|Serotonin Agents|serotonin agents|mesh-ancestor
110312575|NCT00326235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110312576|NCT00326235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110312577|NCT00295178|Vancomycin|vancomycin|mesh-list
110312578|NCT00295178|Daptomycin|daptomycin|mesh-list
110312579|NCT00295178|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110312580|NCT00295178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110312582|NCT00305838|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110312583|NCT00305838|Hormone Antagonists|hormone antagonists|mesh-ancestor
110148372|NCT00006468|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110090597|NCT02960230|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110090598|NCT02960230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110090599|NCT02960230|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110090600|NCT02960230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110312584|NCT00305838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110312586|NCT00305838|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110312587|NCT00305838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110312588|NCT00305838|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110312589|NCT00305838|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110312590|NCT00305838|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110312591|NCT00295373|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110312592|NCT00295373|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110312593|NCT00295373|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110312594|NCT00295373|Antimetabolites|antimetabolites|mesh-ancestor
110148373|NCT00006468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110148374|NCT00006468|Antimetabolites|antimetabolites|mesh-ancestor
110312595|NCT00295373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110312596|NCT00295373|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110312597|NCT00295373|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110312598|NCT00295373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110312599|NCT00295412|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110312600|NCT00295412|Antidepressive Agents|antidepressive agents|mesh-ancestor
110312601|NCT00295412|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110312602|NCT00295412|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110312603|NCT00295412|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110312604|NCT00295412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110312605|NCT00295412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110312606|NCT00326352|Remifentanil|remifentanil|mesh-list
110312608|NCT00326352|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110312609|NCT00326352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110312610|NCT00326352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110312611|NCT00326352|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110312612|NCT00326352|Anesthetics, General|anesthetics, general|mesh-ancestor
110312613|NCT00326352|Anesthetics|anesthetics|mesh-ancestor
110312614|NCT00326352|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110312616|NCT00326352|Analgesics|analgesics|mesh-ancestor
110312617|NCT00326352|Sensory System Agents|sensory system agents|mesh-ancestor
110312618|NCT00326352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110312620|NCT00419601|Remifentanil|remifentanil|mesh-list
110312621|NCT00419601|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110312622|NCT00419601|Narcotics|narcotics|mesh-ancestor
110312623|NCT00419601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110312624|NCT00419601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110312625|NCT00419601|Analgesics|analgesics|mesh-ancestor
110312626|NCT00419601|Sensory System Agents|sensory system agents|mesh-ancestor
110312627|NCT00419601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110312628|NCT00419601|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110312629|NCT00419601|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110312630|NCT00419601|Anesthetics, General|anesthetics, general|mesh-ancestor
110312631|NCT00419601|Anesthetics|anesthetics|mesh-ancestor
110312632|NCT00306033|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110312633|NCT00306033|gamma-Globulins|gamma-globulins|mesh-list
110312634|NCT00306033|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110312635|NCT00306033|Immunoglobulins|immunoglobulins|mesh-list
110312636|NCT00306033|Immunologic Factors|immunologic factors|mesh-ancestor
110312637|NCT00306033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110312638|NCT00295607|Antibodies|antibodies|mesh-list
110312639|NCT00295607|Tacrolimus|tacrolimus|mesh-list
110312640|NCT00295607|Immunologic Factors|immunologic factors|mesh-ancestor
110312641|NCT00295607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110312642|NCT00295607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110312643|NCT00295607|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110090610|NCT02701699|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
110090611|NCT02701699|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110312644|NCT00295607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110312645|NCT00295607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110312646|NCT00326391|Methylphenidate|methylphenidate|mesh-list
110312647|NCT00326391|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110312648|NCT00326391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110312649|NCT00326391|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110312650|NCT00326391|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110312651|NCT00326391|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110312652|NCT00326391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110312653|NCT00326391|Dopamine Agents|dopamine agents|mesh-ancestor
110312654|NCT00326391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110312656|NCT00295685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110312657|NCT00295685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110312658|NCT00306150|Aprotinin|aprotinin|mesh-list
110312659|NCT00306150|Hemostatics|hemostatics|mesh-ancestor
110312660|NCT00306150|Coagulants|coagulants|mesh-ancestor
110312661|NCT00306150|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
110312662|NCT00306150|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110312663|NCT00306150|Protease Inhibitors|protease inhibitors|mesh-ancestor
110312664|NCT00306150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110312665|NCT00306150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110312667|NCT00417911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110312668|NCT00326469|Lanreotide|lanreotide|mesh-list
110312669|NCT00326469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110312670|NCT00417950|Acarbose|acarbose|mesh-list
110312671|NCT00417950|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
110312672|NCT00417950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110312673|NCT00417950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110312674|NCT00417950|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110312675|NCT00417950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110312676|NCT00306267|Epoetin Alfa|epoetin alfa|mesh-list
110312677|NCT00306267|Hematinics|hematinics|mesh-ancestor
110312678|NCT00326508|Daclizumab|daclizumab|mesh-list
110312679|NCT00326508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110312680|NCT00326508|Immunologic Factors|immunologic factors|mesh-ancestor
110312681|NCT00326508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110312682|NCT00326586|Androgen Receptor Antagonists|androgen receptor antagonists|mesh-list
110312683|NCT00326586|Androgen Antagonists|androgen antagonists|mesh-ancestor
110312684|NCT00326586|Hormone Antagonists|hormone antagonists|mesh-ancestor
110148375|NCT00006468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110312685|NCT00326586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110312686|NCT00326586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110312687|NCT00295841|Cytarabine|cytarabine|mesh-list
110312688|NCT00295841|Clofarabine|clofarabine|mesh-list
110312689|NCT00295841|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110090616|NCT02351869|Nitrous Oxide|nitrous oxide|mesh-list
110312690|NCT00295841|Antimetabolites|antimetabolites|mesh-ancestor
110312691|NCT00295841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110312692|NCT00295841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110312693|NCT00295841|Antiviral Agents|antiviral agents|mesh-ancestor
110312694|NCT00295841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110312695|NCT00295841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110312696|NCT00295841|Immunologic Factors|immunologic factors|mesh-ancestor
110312697|NCT00295841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110312698|NCT00326664|Cediranib|cediranib|mesh-list
110312699|NCT00326664|Maleic acid|maleic acid|mesh-list
110312700|NCT00326664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110312701|NCT00326664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110312702|NCT00326664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110312703|NCT00326664|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110312704|NCT00295919|Ketoconazole|ketoconazole|mesh-list
110312705|NCT00295919|Fenretinide|fenretinide|mesh-list
110312706|NCT00295919|Antifungal Agents|antifungal agents|mesh-ancestor
110312707|NCT00295919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110312708|NCT00295919|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110312709|NCT00295919|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110312710|NCT00295919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110312711|NCT00295919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110312712|NCT00295919|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110312713|NCT00295919|Hormone Antagonists|hormone antagonists|mesh-ancestor
110148376|NCT00006468|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110148377|NCT00006468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110148378|NCT00006468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110312714|NCT00295919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110312715|NCT00295919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110312716|NCT00295919|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110312717|NCT00295919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110148379|NCT00006468|Immunologic Factors|immunologic factors|mesh-ancestor
110148380|NCT00006468|Antidotes|antidotes|mesh-ancestor
110312718|NCT00295919|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110312719|NCT00295919|Protective Agents|protective agents|mesh-ancestor
110312720|NCT00295958|Freund's Adjuvant|freund's adjuvant|mesh-list
110312721|NCT00295958|Immunotoxins|immunotoxins|mesh-list
110312722|NCT00295958|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110312723|NCT00295958|Immunologic Factors|immunologic factors|mesh-ancestor
110312724|NCT00295958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110312725|NCT00295958|Immunoconjugates|immunoconjugates|mesh-ancestor
110312726|NCT00295997|Mycophenolic Acid|mycophenolic acid|mesh-list
110312728|NCT00295997|Busulfan|busulfan|mesh-list
110312729|NCT00295997|Methotrexate|methotrexate|mesh-list
110312730|NCT00295997|Fludarabine|fludarabine|mesh-list
110312731|NCT00295997|Fludarabine phosphate|fludarabine phosphate|mesh-list
110312733|NCT00295997|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110312734|NCT00295997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110312735|NCT00295997|Immunologic Factors|immunologic factors|mesh-ancestor
110148381|NCT00006468|Protective Agents|protective agents|mesh-ancestor
110312736|NCT00295997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110312737|NCT00295997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110312738|NCT00295997|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110312739|NCT00295997|Alkylating Agents|alkylating agents|mesh-ancestor
110312740|NCT00295997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110312741|NCT00295997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110312742|NCT00295997|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110312743|NCT00295997|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110312744|NCT00295997|Abortifacient Agents|abortifacient agents|mesh-ancestor
110312745|NCT00295997|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110312746|NCT00295997|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110312747|NCT00295997|Antimetabolites|antimetabolites|mesh-ancestor
110312748|NCT00295997|Dermatologic Agents|dermatologic agents|mesh-ancestor
110312749|NCT00295997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110312750|NCT00295997|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110312751|NCT00295997|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110312752|NCT00295997|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110312753|NCT00295997|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110312754|NCT00295997|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110148382|NCT00006468|Vitamin B Complex|vitamin b complex|mesh-ancestor
110148383|NCT00006468|Vitamins|vitamins|mesh-ancestor
110312755|NCT00295997|Antitubercular Agents|antitubercular agents|mesh-ancestor
110312756|NCT00295997|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110312757|NCT00295997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110312759|NCT00418067|Paclitaxel|paclitaxel|mesh-list
110312760|NCT00418067|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110312761|NCT00418067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110312762|NCT00418067|Tubulin Modulators|tubulin modulators|mesh-ancestor
110312763|NCT00418067|Antimitotic Agents|antimitotic agents|mesh-ancestor
110312764|NCT00418067|Mitosis Modulators|mitosis modulators|mesh-ancestor
110312765|NCT00418067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110312766|NCT00418067|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110312767|NCT00418067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110312768|NCT00418067|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110312769|NCT00418067|Antifungal Agents|antifungal agents|mesh-ancestor
110312770|NCT00418067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110312771|NCT00418067|Immunologic Factors|immunologic factors|mesh-ancestor
110312772|NCT00418067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110312773|NCT00296309|Tacrolimus|tacrolimus|mesh-list
110312774|NCT00296309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110312775|NCT00296309|Immunologic Factors|immunologic factors|mesh-ancestor
110148384|NCT00006468|Micronutrients|micronutrients|mesh-ancestor
110312776|NCT00296309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110312777|NCT00296309|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110312778|NCT00296309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110312779|NCT00296309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110312780|NCT00296348|Mycophenolic Acid|mycophenolic acid|mesh-list
110312781|NCT00296348|Tacrolimus|tacrolimus|mesh-list
110312782|NCT00296348|Daclizumab|daclizumab|mesh-list
110312783|NCT00296348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110312784|NCT00296348|Immunologic Factors|immunologic factors|mesh-ancestor
110312785|NCT00296348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110312786|NCT00296348|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110312787|NCT00296348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110312788|NCT00296348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110312789|NCT00296348|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110312790|NCT00296348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110312791|NCT00296348|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110312792|NCT00296348|Antitubercular Agents|antitubercular agents|mesh-ancestor
110312793|NCT00296348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110312794|NCT00296348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110312795|NCT00296387|Atorvastatin|atorvastatin|mesh-list
110312796|NCT00296387|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110312797|NCT00296387|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110312798|NCT00296387|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110312799|NCT00296387|Antimetabolites|antimetabolites|mesh-ancestor
110312800|NCT00296387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110312801|NCT00296387|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110312802|NCT00296387|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110312803|NCT00296387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110312804|NCT00326820|Zoledronic Acid|zoledronic acid|mesh-list
110312805|NCT00326820|Ibandronic Acid|ibandronic acid|mesh-list
110312806|NCT00326820|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110312807|NCT00326820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110312808|NCT00296465|Citric Acid|citric acid|mesh-list
110312809|NCT00296465|Sodium Citrate|sodium citrate|mesh-list
110312810|NCT00296465|Clomiphene|clomiphene|mesh-list
110312811|NCT00296465|Enclomiphene|enclomiphene|mesh-list
110312812|NCT00296465|Zuclomiphene|zuclomiphene|mesh-list
110312813|NCT00296465|Hormones|hormones|mesh-list
110169550|NCT05076877|Antimetabolites|antimetabolites|mesh-ancestor
110312814|NCT00296465|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
110312815|NCT00296465|Anticoagulants|anticoagulants|mesh-ancestor
110312816|NCT00296465|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110312817|NCT00296465|Chelating Agents|chelating agents|mesh-ancestor
110312818|NCT00296465|Sequestering Agents|sequestering agents|mesh-ancestor
110312819|NCT00296465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110312820|NCT00296465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110312821|NCT00296465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110312822|NCT00296465|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110312823|NCT00296465|Hormone Antagonists|hormone antagonists|mesh-ancestor
110312824|NCT00296465|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110312825|NCT00296465|Fertility Agents|fertility agents|mesh-ancestor
110312826|NCT00296465|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110312827|NCT00296465|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110312828|NCT00296465|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110312829|NCT00326859|Remifentanil|remifentanil|mesh-list
110312830|NCT00326859|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110312831|NCT00326859|Narcotics|narcotics|mesh-ancestor
110312832|NCT00326859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110312833|NCT00326859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110312834|NCT00326859|Analgesics|analgesics|mesh-ancestor
110312835|NCT00326859|Sensory System Agents|sensory system agents|mesh-ancestor
110312836|NCT00326859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110312837|NCT00296699|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110312838|NCT00296699|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110312839|NCT00296699|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110312840|NCT00296699|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110312841|NCT00296699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110312842|NCT00296699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110312843|NCT00296699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110312844|NCT00296699|Analgesics|analgesics|mesh-ancestor
110312845|NCT00296699|Sensory System Agents|sensory system agents|mesh-ancestor
110312846|NCT00296699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110312847|NCT00296699|Antidepressive Agents|antidepressive agents|mesh-ancestor
110312848|NCT00296699|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110312849|NCT00296699|Dopamine Agents|dopamine agents|mesh-ancestor
110312850|NCT00296777|Bupropion|bupropion|mesh-list
110312851|NCT00296777|Imipramine|imipramine|mesh-list
110312852|NCT00296777|Escitalopram|escitalopram|mesh-list
110312853|NCT00296777|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110312854|NCT00296777|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110312855|NCT00296777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110312856|NCT00296777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110312857|NCT00296777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110312858|NCT00296777|Serotonin Agents|serotonin agents|mesh-ancestor
110312859|NCT00296777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110312860|NCT00296777|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110312861|NCT00296777|Antidepressive Agents|antidepressive agents|mesh-ancestor
110312862|NCT00296777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110312863|NCT00296777|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110312864|NCT00296777|Dopamine Agents|dopamine agents|mesh-ancestor
110312865|NCT00296777|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110312866|NCT00296777|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110312867|NCT00296777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110312868|NCT00296777|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110312869|NCT00296777|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110312870|NCT00296777|Adrenergic Agents|adrenergic agents|mesh-ancestor
110312871|NCT00296894|Adalimumab|adalimumab|mesh-list
110312872|NCT00296894|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110312873|NCT00296894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110312874|NCT00296894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110312875|NCT00296933|Bupropion|bupropion|mesh-list
110312876|NCT00296933|Escitalopram|escitalopram|mesh-list
110312877|NCT00296933|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110169560|NCT00396604|Maleic acid|maleic acid|mesh-list
110312878|NCT00296933|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110090915|NCT03673826|Hormones|hormones|mesh-ancestor
110312879|NCT00296933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110312880|NCT00296933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110312881|NCT00296933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110312882|NCT00296933|Serotonin Agents|serotonin agents|mesh-ancestor
110312883|NCT00296933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110312884|NCT00296933|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110312885|NCT00296933|Antidepressive Agents|antidepressive agents|mesh-ancestor
110312886|NCT00296933|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110312887|NCT00296933|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110312889|NCT00296933|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110312890|NCT00296933|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110312891|NCT00296933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110312892|NCT00296972|Interferons|interferons|mesh-list
110312894|NCT00296972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110312895|NCT00296972|Antiviral Agents|antiviral agents|mesh-ancestor
110312896|NCT00296972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110312897|NCT00296972|Antimetabolites|antimetabolites|mesh-ancestor
110312898|NCT00296972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110312899|NCT00297011|Valacyclovir|valacyclovir|mesh-list
110312900|NCT00297011|Clobetasol|clobetasol|mesh-list
110312901|NCT00297011|Antiviral Agents|antiviral agents|mesh-ancestor
110312902|NCT00297011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110312903|NCT00297011|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110312904|NCT00297011|Glucocorticoids|glucocorticoids|mesh-ancestor
110312905|NCT00297011|Hormones|hormones|mesh-ancestor
110312906|NCT00297011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110312907|NCT00297011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110312908|NCT00327093|Bevacizumab|bevacizumab|mesh-list
110312909|NCT00327093|Cetuximab|cetuximab|mesh-list
110312910|NCT00327093|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110312911|NCT00327093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110312912|NCT00327093|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110312913|NCT00327093|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110312914|NCT00327093|Growth Substances|growth substances|mesh-ancestor
110312915|NCT00327093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110312916|NCT00327093|Growth Inhibitors|growth inhibitors|mesh-ancestor
110312917|NCT00297050|Peramivir|peramivir|mesh-list
110312918|NCT00297050|Antiviral Agents|antiviral agents|mesh-ancestor
110091017|NCT03518242|Capecitabine|capecitabine|mesh-list
110312919|NCT00297050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110312920|NCT00297050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110312921|NCT00297050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110312922|NCT00297128|Capecitabine|capecitabine|mesh-list
110312923|NCT00297128|Cetuximab|cetuximab|mesh-list
110312924|NCT00297128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110312925|NCT00297128|Antimetabolites|antimetabolites|mesh-ancestor
110312926|NCT00297128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110312927|NCT00297128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110312928|NCT00297128|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110312929|NCT00327132|Amoxicillin|amoxicillin|mesh-list
110312930|NCT00327132|Clarithromycin|clarithromycin|mesh-list
110312931|NCT00327132|Omeprazole|omeprazole|mesh-list
110312932|NCT00327132|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110312933|NCT00327132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110312934|NCT00327132|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110312935|NCT00327132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110312936|NCT00327132|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110312937|NCT00327132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110312938|NCT00327132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110312939|NCT00327132|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110312940|NCT00327132|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110312941|NCT00327132|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110312942|NCT00297206|Valacyclovir|valacyclovir|mesh-list
110312943|NCT00297206|Antiviral Agents|antiviral agents|mesh-ancestor
110312944|NCT00297206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110312945|NCT04478019|Povidone-Iodine|povidone-iodine|mesh-list
110312946|NCT04478019|Povidone|povidone|mesh-list
110312947|NCT04478019|Plasma Substitutes|plasma substitutes|mesh-ancestor
110312948|NCT04478019|Blood Substitutes|blood substitutes|mesh-ancestor
110312949|NCT04478019|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110312950|NCT04478019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110312951|NCT00297284|Modafinil|modafinil|mesh-list
110312952|NCT00297284|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110312953|NCT00297284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110312954|NCT00297284|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
110312955|NCT00297284|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110312956|NCT00297284|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110312957|NCT00297284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110312958|NCT04392531|Cyclosporine|cyclosporine|mesh-list
110312959|NCT04392531|Cyclosporins|cyclosporins|mesh-list
110312960|NCT04392531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110312961|NCT04392531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110312962|NCT04392531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110373799|NCT04580342|Propranolol|propranolol|mesh-list
110312963|NCT04392531|Immunologic Factors|immunologic factors|mesh-ancestor
110312964|NCT04392531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110312965|NCT04392531|Antifungal Agents|antifungal agents|mesh-ancestor
110312966|NCT04392531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110312967|NCT04392531|Dermatologic Agents|dermatologic agents|mesh-ancestor
110312968|NCT04392531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110312969|NCT04392531|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110312970|NCT00297323|Topiramate|topiramate|mesh-list
110312971|NCT00297323|Anticonvulsants|anticonvulsants|mesh-ancestor
110312972|NCT00297323|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110312973|NCT00297323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110312975|NCT00327288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110312976|NCT00327288|Tubulin Modulators|tubulin modulators|mesh-ancestor
110312977|NCT00327288|Antimitotic Agents|antimitotic agents|mesh-ancestor
110312978|NCT00327288|Mitosis Modulators|mitosis modulators|mesh-ancestor
110312979|NCT00327288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110312980|NCT04333134|Fluzoparib|fluzoparib|mesh-list
110312981|NCT04333134|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110312982|NCT04333134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110312983|NCT04333134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110312984|NCT04333134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110312985|NCT00327327|Gemcitabine|gemcitabine|mesh-list
110312986|NCT00327327|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110312987|NCT00327327|Antimetabolites|antimetabolites|mesh-ancestor
110312988|NCT00327327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110312989|NCT00327327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110312990|NCT00297362|Galantamine|galantamine|mesh-list
110312991|NCT00297362|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110312992|NCT00297362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110312993|NCT00297362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110312994|NCT00297362|Cholinergic Agents|cholinergic agents|mesh-ancestor
110312995|NCT00297362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110312996|NCT00297362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110312997|NCT00297362|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110312998|NCT00297362|Autonomic Agents|autonomic agents|mesh-ancestor
110312999|NCT00297362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110313000|NCT00297362|Nootropic Agents|nootropic agents|mesh-ancestor
110313001|NCT04231773|Nitric Oxide|nitric oxide|mesh-list
110313002|NCT04231773|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110169652|NCT04680442|Trastuzumab|trastuzumab|mesh-list
110313004|NCT04231773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110313005|NCT04231773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110313006|NCT04231773|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110313007|NCT04231773|Respiratory System Agents|respiratory system agents|mesh-ancestor
110313008|NCT04231773|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110313009|NCT04231773|Antioxidants|antioxidants|mesh-ancestor
110313010|NCT04231773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110313012|NCT04231773|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
110313013|NCT04231773|Vasodilator Agents|vasodilator agents|mesh-ancestor
110313014|NCT04231773|Gasotransmitters|gasotransmitters|mesh-ancestor
110313015|NCT04231773|Protective Agents|protective agents|mesh-ancestor
110313017|NCT00297674|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110313018|NCT00297674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110313019|NCT00297674|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110313020|NCT00297674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110373813|NCT00571142|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110313021|NCT00297674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110313022|NCT00297674|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110313023|NCT00297674|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110313024|NCT00297752|Silver Sulfadiazine|silver sulfadiazine|mesh-list
110313025|NCT00297752|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110313026|NCT00297752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110313027|NCT00297947|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110313028|NCT00297947|Antidepressive Agents|antidepressive agents|mesh-ancestor
110313029|NCT00297947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110313030|NCT00297947|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110313031|NCT00297947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110313032|NCT00297947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110313033|NCT00297947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110313035|NCT04718714|Dexmedetomidine|dexmedetomidine|mesh-list
110313037|NCT04718714|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110313038|NCT04718714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110313039|NCT04718714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110313040|NCT04718714|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110313041|NCT04718714|Analgesics|analgesics|mesh-ancestor
110313042|NCT04718714|Sensory System Agents|sensory system agents|mesh-ancestor
110313043|NCT04718714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110313044|NCT04718714|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110313045|NCT04718714|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110313046|NCT04718714|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110313047|NCT04718714|Adrenergic Agents|adrenergic agents|mesh-ancestor
110313048|NCT04718714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110091403|NCT03133260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110313049|NCT04718714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110313050|NCT04718714|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110313051|NCT04718714|Anesthetics, General|anesthetics, general|mesh-ancestor
110313052|NCT04718714|Anesthetics|anesthetics|mesh-ancestor
110313053|NCT04718714|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110313054|NCT04718714|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110313055|NCT04718714|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110313056|NCT04718714|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110313057|NCT04718714|GABA Modulators|gaba modulators|mesh-ancestor
110313058|NCT04718714|GABA Agents|gaba agents|mesh-ancestor
110313059|NCT00298025|Cetrorelix|cetrorelix|mesh-list
110313060|NCT00298025|Menotropins|menotropins|mesh-list
110313061|NCT00298025|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
110313062|NCT00298025|Hormones|hormones|mesh-list
110313063|NCT00298025|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
110313064|NCT00298025|Ganirelix|ganirelix|mesh-list
110313065|NCT00298025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110313066|NCT00298025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110313067|NCT00298025|Hormone Antagonists|hormone antagonists|mesh-ancestor
110313068|NCT00298025|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110313069|NCT00298025|Fertility Agents|fertility agents|mesh-ancestor
110313070|NCT00298025|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110313071|NCT00298181|polysaccharide-K|polysaccharide-k|mesh-list
110313072|NCT00298181|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110313073|NCT00298181|Immunologic Factors|immunologic factors|mesh-ancestor
110313074|NCT00298181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110313075|NCT00298181|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110313076|NCT00298181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110313077|NCT00298181|Antiviral Agents|antiviral agents|mesh-ancestor
110313078|NCT00298181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110313079|NCT00298181|Interferon Inducers|interferon inducers|mesh-ancestor
110313080|NCT00298181|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110313081|NCT00298181|Protective Agents|protective agents|mesh-ancestor
110313082|NCT05458089|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110313083|NCT05458089|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110313084|NCT05458089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110313085|NCT03754140|Polidocanol|polidocanol|mesh-list
110313086|NCT03754140|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
110313087|NCT03754140|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110313088|NCT00298415|Paclitaxel|paclitaxel|mesh-list
110313089|NCT00298415|Vinorelbine|vinorelbine|mesh-list
110313090|NCT00298415|Carboplatin|carboplatin|mesh-list
110313091|NCT00298415|Gemcitabine|gemcitabine|mesh-list
110313092|NCT00298415|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110313093|NCT00298415|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110169679|NCT00015834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110313094|NCT00298415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110313095|NCT00298415|Tubulin Modulators|tubulin modulators|mesh-ancestor
110313096|NCT00298415|Antimitotic Agents|antimitotic agents|mesh-ancestor
110313097|NCT00298415|Mitosis Modulators|mitosis modulators|mesh-ancestor
110313098|NCT00298415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110313099|NCT00298415|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110313101|NCT00298415|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110313102|NCT00298415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110313104|NCT00298454|Diuretics|diuretics|mesh-ancestor
110313105|NCT00298454|Natriuretic Agents|natriuretic agents|mesh-ancestor
110313106|NCT00298454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110313107|NCT00298454|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110313108|NCT00298454|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110313109|NCT00298454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110313110|NCT00298571|Epinephrine|epinephrine|mesh-list
110313111|NCT00298571|Bupivacaine|bupivacaine|mesh-list
110313112|NCT00298571|Anesthetics, Local|anesthetics, local|mesh-ancestor
110313113|NCT00298571|Anesthetics|anesthetics|mesh-ancestor
110313114|NCT00298571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110313115|NCT00298571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110313116|NCT00298571|Sensory System Agents|sensory system agents|mesh-ancestor
110313117|NCT00298571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110313118|NCT00298571|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110313119|NCT00298571|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110313120|NCT00298571|Adrenergic Agents|adrenergic agents|mesh-ancestor
110313121|NCT00298571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110313122|NCT00298571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110313123|NCT00298571|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110313124|NCT00298571|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110313125|NCT00298571|Autonomic Agents|autonomic agents|mesh-ancestor
110313126|NCT00298571|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110313127|NCT00298571|Respiratory System Agents|respiratory system agents|mesh-ancestor
110313128|NCT00298571|Mydriatics|mydriatics|mesh-ancestor
110313129|NCT00298571|Sympathomimetics|sympathomimetics|mesh-ancestor
110313130|NCT00298571|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110313131|NCT00298688|Gefitinib|gefitinib|mesh-list
110313132|NCT00298688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110313133|NCT00298688|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110169729|NCT00015912|Interferons|interferons|mesh-list
110313134|NCT00298688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110313135|NCT00298688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110313137|NCT05457894|Immunologic Factors|immunologic factors|mesh-ancestor
110313138|NCT05457894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110313139|NCT00298883|Mycophenolic Acid|mycophenolic acid|mesh-list
110313140|NCT00298883|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110313141|NCT00298883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110313143|NCT00298883|Antitubercular Agents|antitubercular agents|mesh-ancestor
110313144|NCT00298883|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110313145|NCT00298883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110313146|NCT00298883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110313147|NCT00298883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110313148|NCT00298922|Azithromycin|azithromycin|mesh-list
110313149|NCT00298922|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110313150|NCT00298922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110313151|NCT00299039|Acetaminophen|acetaminophen|mesh-list
110313152|NCT00299039|Ibuprofen|ibuprofen|mesh-list
110313153|NCT00299039|Codeine|codeine|mesh-list
110313154|NCT00299039|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110313155|NCT00299039|Analgesics|analgesics|mesh-ancestor
110313156|NCT00299039|Sensory System Agents|sensory system agents|mesh-ancestor
110313157|NCT00299039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110313158|NCT00299039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110313159|NCT00299039|Antipyretics|antipyretics|mesh-ancestor
110313160|NCT00299039|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110313161|NCT00299039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110313162|NCT00299039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110313163|NCT00299039|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110313164|NCT00299039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110313165|NCT00299039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110313166|NCT00299039|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110313167|NCT00299039|Narcotics|narcotics|mesh-ancestor
110313168|NCT00299039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110313169|NCT00299039|Antitussive Agents|antitussive agents|mesh-ancestor
110313170|NCT00299039|Respiratory System Agents|respiratory system agents|mesh-ancestor
110313171|NCT00299234|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
110313172|NCT00299234|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110313173|NCT00299234|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110313174|NCT00299234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110313175|NCT00299234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110313176|NCT00299234|Adrenergic Agents|adrenergic agents|mesh-ancestor
110313177|NCT00299234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110313178|NCT00299234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110313180|NCT00299351|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110313181|NCT00299351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110313182|NCT00299351|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110313183|NCT00299351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110313184|NCT00299351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110313186|NCT00299390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110313187|NCT02808585|VIP-ELP fusion molecule PB1046|vip-elp fusion molecule pb1046|mesh-list
110313188|NCT02808585|Vasodilator Agents|vasodilator agents|mesh-ancestor
110313189|NCT00299819|Sifalimumab|sifalimumab|mesh-list
110313190|NCT00299819|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110313191|NCT00299819|Immunologic Factors|immunologic factors|mesh-ancestor
110313192|NCT00299819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110313193|NCT00299858|Theophylline|theophylline|mesh-list
110313194|NCT00299858|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110313195|NCT00299858|Autonomic Agents|autonomic agents|mesh-ancestor
110313196|NCT00299858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110313197|NCT00299858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110313198|NCT00299858|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110313199|NCT00299858|Respiratory System Agents|respiratory system agents|mesh-ancestor
110313200|NCT00299858|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110313201|NCT00299858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110313202|NCT00299858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110313203|NCT00299858|Vasodilator Agents|vasodilator agents|mesh-ancestor
110313204|NCT00299858|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110313205|NCT00299858|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110313206|NCT00299858|Purinergic Agents|purinergic agents|mesh-ancestor
110313207|NCT00299858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110313209|NCT05455944|Analgesics|analgesics|mesh-ancestor
110313210|NCT05455944|Sensory System Agents|sensory system agents|mesh-ancestor
110313211|NCT05455944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110313212|NCT05455944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110313213|NCT05455944|Anticonvulsants|anticonvulsants|mesh-ancestor
110313214|NCT05455944|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110313215|NCT05455944|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110313216|NCT05455944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110313217|NCT05455944|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110313218|NCT05455944|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110313219|NCT05455944|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110313220|NCT05455944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110313221|NCT05455944|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110313222|NCT00299936|Ribavirin|ribavirin|mesh-list
110313223|NCT00299936|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110313224|NCT00299936|Antimetabolites|antimetabolites|mesh-ancestor
110313225|NCT00299936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110313226|NCT00299936|Antiviral Agents|antiviral agents|mesh-ancestor
110313227|NCT00299936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110313228|NCT00300014|Triamcinolone|triamcinolone|mesh-list
110313229|NCT00300014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110313230|NCT00300014|Glucocorticoids|glucocorticoids|mesh-ancestor
110313231|NCT00300014|Hormones|hormones|mesh-ancestor
110313232|NCT00300014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110313233|NCT00300014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110313235|NCT00300131|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110313236|NCT00300131|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110313237|NCT00300131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110313238|NCT00300131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110313239|NCT00300131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110313240|NCT00300131|Immunologic Factors|immunologic factors|mesh-ancestor
110313241|NCT00300131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110313242|NCT00300131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110313243|NCT01785459|Prochlorperazine|prochlorperazine|mesh-list
110313244|NCT01785459|Bupivacaine|bupivacaine|mesh-list
110313245|NCT01785459|Anesthetics, Local|anesthetics, local|mesh-ancestor
110313246|NCT01785459|Anesthetics|anesthetics|mesh-ancestor
110313247|NCT01785459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110313248|NCT01785459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110313249|NCT01785459|Sensory System Agents|sensory system agents|mesh-ancestor
110313250|NCT01785459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110313251|NCT01785459|Antiemetics|antiemetics|mesh-ancestor
110313252|NCT01785459|Autonomic Agents|autonomic agents|mesh-ancestor
110169786|NCT00001076|polysaccharide-K|polysaccharide-k|mesh-list
110313253|NCT01785459|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110313254|NCT01785459|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110313255|NCT01785459|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110313256|NCT01785459|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110313257|NCT01785459|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110313258|NCT01785459|Dopamine Agents|dopamine agents|mesh-ancestor
110313259|NCT01785459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110313260|NCT01785459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110313261|NCT04716894|Itraconazole|itraconazole|mesh-list
110313262|NCT04716894|Antifungal Agents|antifungal agents|mesh-ancestor
110313263|NCT04716894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110313264|NCT04716894|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110313265|NCT04716894|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110313266|NCT04716894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110313267|NCT04716894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110092100|NCT00942877|Cediranib|cediranib|mesh-list
110313268|NCT04716894|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110313269|NCT04716894|Hormone Antagonists|hormone antagonists|mesh-ancestor
110313270|NCT04716894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110313271|NCT04716894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110313272|NCT04716894|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110313274|NCT00300287|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110313275|NCT00300287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110313276|NCT00300287|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110313277|NCT00300287|Protease Inhibitors|protease inhibitors|mesh-ancestor
110313278|NCT00300287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110313279|NCT00300287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110313280|NCT00300404|Leucovorin|leucovorin|mesh-list
110313281|NCT00300404|Folic Acid|folic acid|mesh-list
110313282|NCT00300404|Pyrimethamine|pyrimethamine|mesh-list
110313283|NCT00300404|Levoleucovorin|levoleucovorin|mesh-list
110313284|NCT00300404|Antidotes|antidotes|mesh-ancestor
110313285|NCT00300404|Protective Agents|protective agents|mesh-ancestor
110313286|NCT00300404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110313287|NCT00300404|Vitamin B Complex|vitamin b complex|mesh-ancestor
110313288|NCT00300404|Vitamins|vitamins|mesh-ancestor
110313289|NCT00300404|Micronutrients|micronutrients|mesh-ancestor
110313290|NCT00300404|Hematinics|hematinics|mesh-ancestor
110313291|NCT00300404|Antimalarials|antimalarials|mesh-ancestor
110313292|NCT00300404|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110313293|NCT00300404|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110313294|NCT00300404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110313295|NCT00300404|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110313296|NCT00300404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110313297|NCT00300404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110313298|NCT01539447|Naproxen|naproxen|mesh-list
110313299|NCT01539447|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110313300|NCT01539447|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110313301|NCT01539447|Analgesics|analgesics|mesh-ancestor
110313302|NCT01539447|Sensory System Agents|sensory system agents|mesh-ancestor
110313303|NCT01539447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110313304|NCT01539447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110313305|NCT01539447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110313306|NCT01539447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110313307|NCT01539447|Gout Suppressants|gout suppressants|mesh-ancestor
110313308|NCT01539447|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110313309|NCT01539447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110092274|NCT01694732|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110313310|NCT01539447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110313312|NCT00300443|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110313313|NCT00300560|Colistin|colistin|mesh-list
110313314|NCT00300560|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110313315|NCT00300560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110358790|NCT05338619|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110313316|NCT00327522|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110313317|NCT00327522|Immunologic Factors|immunologic factors|mesh-ancestor
110313318|NCT00327522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110313319|NCT00300716|Memantine|memantine|mesh-list
110313320|NCT00300716|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110313321|NCT00300716|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110313322|NCT00300716|Dopamine Agents|dopamine agents|mesh-ancestor
110313323|NCT00300716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110313324|NCT00300716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110313325|NCT00300716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110313326|NCT00300716|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110313327|NCT00300716|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110313328|NCT00300794|Ketamine|ketamine|mesh-list
110313329|NCT00300794|Analgesics|analgesics|mesh-ancestor
110313330|NCT00300794|Sensory System Agents|sensory system agents|mesh-ancestor
110313331|NCT00300794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110313332|NCT00300794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110313333|NCT00300794|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110313334|NCT00300794|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110313335|NCT00300794|Anesthetics, General|anesthetics, general|mesh-ancestor
110313336|NCT00300794|Anesthetics|anesthetics|mesh-ancestor
110313337|NCT00300794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110313338|NCT00300794|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110313339|NCT00300794|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110313340|NCT00300794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110313341|NCT00300794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110313343|NCT05373303|Hematinics|hematinics|mesh-ancestor
110313344|NCT00300833|Tirofiban|tirofiban|mesh-list
110313345|NCT00300833|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110092333|NCT01695174|Rifaximin|rifaximin|mesh-list
110313346|NCT00300833|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110313347|NCT00300833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110313348|NCT00300833|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110313349|NCT00300911|Rosiglitazone|rosiglitazone|mesh-list
110313350|NCT00300911|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110313351|NCT00300911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110313352|NCT00327678|Rituximab|rituximab|mesh-list
110313353|NCT00327678|Imatinib Mesylate|imatinib mesylate|mesh-list
110313354|NCT00327678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110313355|NCT00327678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110313356|NCT00327678|Immunologic Factors|immunologic factors|mesh-ancestor
110313357|NCT00327678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110313358|NCT00327678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110313359|NCT00327678|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110313360|NCT00327678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110313361|NCT00327678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110313362|NCT00300950|Gemcitabine|gemcitabine|mesh-list
110313363|NCT00300950|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110313364|NCT00300950|Antimetabolites|antimetabolites|mesh-ancestor
110313365|NCT00300950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110313366|NCT00300950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110313367|NCT00327756|Ubiquinone|ubiquinone|mesh-list
110313368|NCT00327756|Coenzyme Q10|coenzyme q10|mesh-list
110313369|NCT00327756|Micronutrients|micronutrients|mesh-ancestor
110313370|NCT00327756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110313371|NCT00327756|Vitamins|vitamins|mesh-ancestor
110313372|NCT00301106|Interleukin-12|interleukin-12|mesh-list
110313373|NCT00301106|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110313374|NCT00301106|Immunologic Factors|immunologic factors|mesh-ancestor
110313375|NCT00301106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110313376|NCT00301106|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110313377|NCT00301106|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110313378|NCT00301106|Growth Substances|growth substances|mesh-ancestor
110313379|NCT00301106|Growth Inhibitors|growth inhibitors|mesh-ancestor
110313380|NCT00301106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110313381|NCT00301145|Varenicline|varenicline|mesh-list
110313382|NCT00301145|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110313383|NCT00301145|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110313384|NCT00301145|Cholinergic Agents|cholinergic agents|mesh-ancestor
110313385|NCT00301145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110313386|NCT00301145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110313387|NCT00301145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110313388|NCT00301223|Pregabalin|pregabalin|mesh-list
110313390|NCT00301223|Sensory System Agents|sensory system agents|mesh-ancestor
110313391|NCT00301223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110313392|NCT00301223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110313393|NCT00301223|Anticonvulsants|anticonvulsants|mesh-ancestor
110313394|NCT00301223|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110313395|NCT00301223|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110313396|NCT00301223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110313397|NCT00301223|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110313398|NCT00301223|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110092488|NCT01696630|Desflurane|desflurane|mesh-list
110313399|NCT00301223|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110313400|NCT00301223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110313401|NCT00301223|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110313402|NCT00301301|Rituximab|rituximab|mesh-list
110313403|NCT00301301|Gemcitabine|gemcitabine|mesh-list
110313404|NCT00301301|Cisplatin|cisplatin|mesh-list
110313405|NCT00301301|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110313406|NCT00301301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110313407|NCT00301301|Immunologic Factors|immunologic factors|mesh-ancestor
110313408|NCT00301301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110313409|NCT00301301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110313410|NCT00301301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110313411|NCT00301301|Antimetabolites|antimetabolites|mesh-ancestor
110313412|NCT00301301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110313413|NCT00301535|Chrysarobin|chrysarobin|mesh-list
110313414|NCT00301535|HBOC 201|hboc 201|mesh-list
110313415|NCT00301535|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110313416|NCT00301535|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110313417|NCT00301535|Analgesics|analgesics|mesh-ancestor
110313418|NCT00301535|Sensory System Agents|sensory system agents|mesh-ancestor
110313419|NCT00301535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110313420|NCT00301535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110313421|NCT00301535|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110313422|NCT00301535|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110313423|NCT00301535|Blood Substitutes|blood substitutes|mesh-ancestor
110313424|NCT00301574|Galantamine|galantamine|mesh-list
110313425|NCT00301574|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110313426|NCT00301574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110313427|NCT00301574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110313428|NCT00301574|Cholinergic Agents|cholinergic agents|mesh-ancestor
110313429|NCT00301574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110092597|NCT01697293|Paclitaxel|paclitaxel|mesh-list
110313430|NCT00301574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110313431|NCT00301574|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110313432|NCT00301574|Autonomic Agents|autonomic agents|mesh-ancestor
110313433|NCT00301574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110313434|NCT00301574|Nootropic Agents|nootropic agents|mesh-ancestor
110313435|NCT00327834|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
110169807|NCT00015990|Growth Inhibitors|growth inhibitors|mesh-ancestor
110313436|NCT00327834|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110313437|NCT00327834|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110313438|NCT00327834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110313439|NCT00327834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110313440|NCT00327834|Adrenergic Agents|adrenergic agents|mesh-ancestor
110313441|NCT00327834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110313442|NCT00327834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110313443|NCT00301613|Mycophenolic Acid|mycophenolic acid|mesh-list
110313444|NCT00301613|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110313445|NCT00301613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110313446|NCT00301613|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110313447|NCT00301613|Antitubercular Agents|antitubercular agents|mesh-ancestor
110313448|NCT00301613|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110313449|NCT00301613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110313450|NCT00301613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110313451|NCT00301613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110313452|NCT00301652|Mycophenolic Acid|mycophenolic acid|mesh-list
110313453|NCT00301652|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110313454|NCT00301652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110313455|NCT00301652|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110313456|NCT00301652|Antitubercular Agents|antitubercular agents|mesh-ancestor
110313457|NCT00301652|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110313458|NCT00301652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110313459|NCT00301652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110313460|NCT00301652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110313462|NCT00301730|Paclitaxel|paclitaxel|mesh-list
110313463|NCT00301730|Trastuzumab|trastuzumab|mesh-list
110313464|NCT00301730|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110313465|NCT00301730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110313466|NCT00301730|Tubulin Modulators|tubulin modulators|mesh-ancestor
110313467|NCT00301730|Antimitotic Agents|antimitotic agents|mesh-ancestor
110313468|NCT00301730|Mitosis Modulators|mitosis modulators|mesh-ancestor
110313469|NCT00301730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110313470|NCT00301730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110313471|NCT00301730|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110313472|NCT00301730|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110313473|NCT00301730|Antiviral Agents|antiviral agents|mesh-ancestor
110313474|NCT00301730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110313475|NCT00301847|Sorafenib|sorafenib|mesh-list
110313476|NCT00301847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110313477|NCT00301847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110313478|NCT00301847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110313479|NCT00301847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110313480|NCT00327990|Alendronate|alendronate|mesh-list
110313481|NCT00327990|Ibandronic Acid|ibandronic acid|mesh-list
110313482|NCT00327990|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110313483|NCT00327990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110313484|NCT00301886|Zoledronic Acid|zoledronic acid|mesh-list
110313485|NCT00301886|Ibandronic Acid|ibandronic acid|mesh-list
110313486|NCT00301886|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110313487|NCT00301886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110313488|NCT00301925|Cyclophosphamide|cyclophosphamide|mesh-list
110313489|NCT00301925|Fluorouracil|fluorouracil|mesh-list
110313490|NCT00301925|Capecitabine|capecitabine|mesh-list
110313491|NCT00301925|Methotrexate|methotrexate|mesh-list
110313493|NCT00301925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110313494|NCT00301925|Immunologic Factors|immunologic factors|mesh-ancestor
110313495|NCT00301925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110313496|NCT00301925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110313497|NCT00301925|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110313498|NCT00301925|Alkylating Agents|alkylating agents|mesh-ancestor
110313499|NCT00301925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110313500|NCT00301925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110313501|NCT00301925|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110313502|NCT00301925|Antimetabolites|antimetabolites|mesh-ancestor
110313503|NCT00301925|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110313504|NCT00301925|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110313505|NCT00301925|Abortifacient Agents|abortifacient agents|mesh-ancestor
110313506|NCT00301925|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110313507|NCT00301925|Dermatologic Agents|dermatologic agents|mesh-ancestor
110313508|NCT00301925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110313509|NCT00301925|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110092835|NCT01698788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110313510|NCT00301925|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110313511|NCT00301925|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110313512|NCT00301925|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110313513|NCT00301925|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110313514|NCT00328029|Busulfan|busulfan|mesh-list
110313515|NCT00328029|Alkylating Agents|alkylating agents|mesh-ancestor
110313516|NCT00328029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110313517|NCT00328029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110313518|NCT00328029|Immunologic Factors|immunologic factors|mesh-ancestor
110313519|NCT00328029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110313520|NCT00328029|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110313521|NCT00328029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110313522|NCT00328029|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110313523|NCT00302354|Methylphenidate|methylphenidate|mesh-list
110313524|NCT00302354|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110313525|NCT00302354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110313526|NCT00302354|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110313527|NCT00302354|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110313528|NCT00302354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110313529|NCT00302354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110313530|NCT00302354|Dopamine Agents|dopamine agents|mesh-ancestor
110313531|NCT00302354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110313532|NCT00302393|Methylphenidate|methylphenidate|mesh-list
110092895|NCT01699412|Dexamethasone|dexamethasone|mesh-list
110313533|NCT00302393|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110313534|NCT00302393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110313535|NCT00302393|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110313536|NCT00302393|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110313537|NCT00302393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110313538|NCT00302393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110313540|NCT00302393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110313541|NCT00328107|Hemagglutinins|hemagglutinins|mesh-list
110313542|NCT00328107|Agglutinins|agglutinins|mesh-ancestor
110373903|NCT00571337|Infliximab|infliximab|mesh-list
110313543|NCT00328107|Immunologic Factors|immunologic factors|mesh-ancestor
110313544|NCT00328107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110313545|NCT00328107|Coagulants|coagulants|mesh-ancestor
110313546|NCT00302432|Menthol|menthol|mesh-list
110313547|NCT00302432|Antipruritics|antipruritics|mesh-ancestor
110313548|NCT00302432|Dermatologic Agents|dermatologic agents|mesh-ancestor
110313549|NCT00419913|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
110313550|NCT00419913|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110313551|NCT00419913|Immunologic Factors|immunologic factors|mesh-ancestor
110313552|NCT00419913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110313553|NCT00302549|Tacrolimus|tacrolimus|mesh-list
110313554|NCT00302549|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110313555|NCT00302549|Immunologic Factors|immunologic factors|mesh-ancestor
110313556|NCT00302549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110313557|NCT00302549|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110313558|NCT00302549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110313559|NCT00302549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110313560|NCT00419991|Tigecycline|tigecycline|mesh-list
110313561|NCT00419991|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110313562|NCT00419991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110313563|NCT00419991|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110313564|NCT00419991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110442364|NCT00680329|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110092991|NCT01699828|Serotonin Agents|serotonin agents|mesh-ancestor
110313565|NCT00419991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110313566|NCT00302627|Calcium, Dietary|calcium, dietary|mesh-list
110313567|NCT00302627|Vitamin D|vitamin d|mesh-list
110313568|NCT00302627|Ergocalciferols|ergocalciferols|mesh-list
110313569|NCT00302627|Cholecalciferol|cholecalciferol|mesh-list
110313570|NCT00302627|Pamidronate|pamidronate|mesh-list
110313571|NCT00302627|Vitamins|vitamins|mesh-list
110313572|NCT00302627|Calcium Carbonate|calcium carbonate|mesh-list
110313573|NCT00302627|Calcium|calcium|mesh-list
110313574|NCT00302627|Micronutrients|micronutrients|mesh-ancestor
110313575|NCT00302627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110313576|NCT00302627|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110313577|NCT00302627|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110313578|NCT00302627|Antacids|antacids|mesh-ancestor
110313579|NCT00302627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110313580|NCT00302627|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110313581|NCT00302666|Dienogest|dienogest|mesh-list
110313582|NCT00302666|Nandrolone|nandrolone|mesh-list
110442365|NCT00680329|Adrenergic Agents|adrenergic agents|mesh-ancestor
110313583|NCT00302666|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110313584|NCT00302666|Contraceptive Agents|contraceptive agents|mesh-ancestor
110313585|NCT00302666|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110313586|NCT00302666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110313587|NCT00302666|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110313588|NCT00302666|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110313589|NCT00302666|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110313590|NCT00302666|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110313591|NCT00302666|Hormone Antagonists|hormone antagonists|mesh-ancestor
110313592|NCT00302666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110313593|NCT00302666|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110313594|NCT00302666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110313595|NCT00302666|Androgens|androgens|mesh-ancestor
110313596|NCT00302666|Hormones|hormones|mesh-ancestor
110313597|NCT00302666|Anabolic Agents|anabolic agents|mesh-ancestor
110313598|NCT00328302|Candesartan|candesartan|mesh-list
110313599|NCT00328302|Candesartan cilexetil|candesartan cilexetil|mesh-list
110313600|NCT00328302|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110313601|NCT00328302|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110313602|NCT00328302|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110313603|NCT00328302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110313605|NCT00328380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110313606|NCT00328380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110313607|NCT00328380|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110313608|NCT00418496|Aldesleukin|aldesleukin|mesh-list
110313609|NCT00418496|Sorafenib|sorafenib|mesh-list
110313610|NCT00418496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110313611|NCT00418496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110313612|NCT00418496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110358791|NCT05338619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110313613|NCT00418496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110313614|NCT00418496|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110313615|NCT00418496|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110313616|NCT00418496|Antiviral Agents|antiviral agents|mesh-ancestor
110313617|NCT00418496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110313619|NCT00302705|Enalapril|enalapril|mesh-list
110313620|NCT00302705|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110313621|NCT00302705|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110313622|NCT00302705|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110313623|NCT00302705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110313624|NCT00302705|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110313625|NCT00302705|Protease Inhibitors|protease inhibitors|mesh-ancestor
110313626|NCT00302705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110313627|NCT00302822|Tenofovir|tenofovir|mesh-list
110313628|NCT00302822|Emtricitabine|emtricitabine|mesh-list
110313629|NCT00302822|Efavirenz|efavirenz|mesh-list
110313630|NCT00302822|Lopinavir|lopinavir|mesh-list
110313631|NCT00302822|Enfuvirtide|enfuvirtide|mesh-list
110313632|NCT00302822|Antiviral Agents|antiviral agents|mesh-ancestor
110313633|NCT00302822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110313634|NCT00302822|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110313635|NCT00302822|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110313636|NCT00302822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110313637|NCT00302822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110313638|NCT00302822|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110313639|NCT00302822|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110313640|NCT00302822|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110313641|NCT00302822|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110313642|NCT00302822|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110313643|NCT00302822|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110169844|NCT00016107|Docetaxel|docetaxel|mesh-list
110313644|NCT00302822|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110313645|NCT00302822|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110313646|NCT00302822|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110313647|NCT00302822|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110313648|NCT00302822|Protease Inhibitors|protease inhibitors|mesh-ancestor
110313649|NCT00302822|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110313650|NCT00302822|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110313651|NCT00302822|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110313652|NCT00328458|Epothilones|epothilones|mesh-list
110313653|NCT00328458|Epothilone B|epothilone b|mesh-list
110313654|NCT00328458|Tubulin Modulators|tubulin modulators|mesh-ancestor
110313656|NCT00328458|Mitosis Modulators|mitosis modulators|mesh-ancestor
110313657|NCT00328458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110313658|NCT00328458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110313659|NCT00303017|Naproxen|naproxen|mesh-list
110313660|NCT00303017|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110313661|NCT00303017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110313662|NCT00303017|Analgesics|analgesics|mesh-ancestor
110313663|NCT00303017|Sensory System Agents|sensory system agents|mesh-ancestor
110313664|NCT00303017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110313665|NCT00303017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110313666|NCT00303017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110313667|NCT00303017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110313668|NCT00303017|Gout Suppressants|gout suppressants|mesh-ancestor
110313669|NCT00303017|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110313670|NCT00303017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110373919|NCT04575519|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110313671|NCT00303017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110313672|NCT00303056|Icatibant|icatibant|mesh-list
110313673|NCT00303056|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110313674|NCT00303056|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110313675|NCT00303056|Analgesics|analgesics|mesh-ancestor
110313676|NCT00303056|Sensory System Agents|sensory system agents|mesh-ancestor
110313677|NCT00303056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110313678|NCT00303056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110093400|NCT01702181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110313679|NCT00303056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110313680|NCT00303056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110313681|NCT00303056|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
110313682|NCT00303056|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
110313683|NCT00303056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110313684|NCT00303056|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
110313685|NCT00303056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110313686|NCT00303056|Immunologic Factors|immunologic factors|mesh-ancestor
110313687|NCT00328497|Bevacizumab|bevacizumab|mesh-list
110313688|NCT00328497|2-Methoxyestradiol|2-methoxyestradiol|mesh-list
110313689|NCT00328497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110313690|NCT00328497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110313691|NCT00328497|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110313692|NCT00328497|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110313693|NCT00328497|Growth Substances|growth substances|mesh-ancestor
110313694|NCT00328497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110313695|NCT00328497|Growth Inhibitors|growth inhibitors|mesh-ancestor
110313696|NCT00328497|Tubulin Modulators|tubulin modulators|mesh-ancestor
110313697|NCT00328497|Antimitotic Agents|antimitotic agents|mesh-ancestor
110313698|NCT00328497|Mitosis Modulators|mitosis modulators|mesh-ancestor
110313699|NCT00328497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110313700|NCT00303290|Interferons|interferons|mesh-list
110313701|NCT00303290|Cytarabine|cytarabine|mesh-list
110313702|NCT00303290|Interferon-alpha|interferon-alpha|mesh-list
110313703|NCT00303290|Interferon alpha-2|interferon alpha-2|mesh-list
110093460|NCT01702701|Fluticasone|fluticasone|mesh-list
110313705|NCT00303290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110313706|NCT00303290|Antiviral Agents|antiviral agents|mesh-ancestor
110313707|NCT00303290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110169848|NCT00016107|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110313708|NCT00303290|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110313709|NCT00303290|Antimetabolites|antimetabolites|mesh-ancestor
110313710|NCT00303290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110313711|NCT00303290|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110313712|NCT00303290|Immunologic Factors|immunologic factors|mesh-ancestor
110313713|NCT00303290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110313714|NCT00328692|Rolofylline|rolofylline|mesh-list
110313715|NCT00328692|Diuretics|diuretics|mesh-ancestor
110313716|NCT00328692|Natriuretic Agents|natriuretic agents|mesh-ancestor
110313717|NCT00328692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110313719|NCT00419718|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110313720|NCT00419718|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110313721|NCT00419718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110313722|NCT00303407|Nadroparin|nadroparin|mesh-list
110313723|NCT00303407|Anticoagulants|anticoagulants|mesh-ancestor
110313724|NCT00303407|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110313725|NCT00303407|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110313726|NCT00303407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110313727|NCT00303524|Goserelin|goserelin|mesh-list
110313728|NCT00303524|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110313729|NCT00303524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110313730|NCT00419796|Lumiracoxib|lumiracoxib|mesh-list
110313731|NCT00419796|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110313732|NCT00419796|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110313733|NCT00419796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110313734|NCT00419796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110313735|NCT00419796|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110313736|NCT00419796|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110313737|NCT00419796|Analgesics|analgesics|mesh-ancestor
110313738|NCT00419796|Sensory System Agents|sensory system agents|mesh-ancestor
110313739|NCT00419796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110313740|NCT00419796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110148385|NCT00006471|Fenretinide|fenretinide|mesh-list
110313741|NCT00419796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110313742|NCT00419796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110313743|NCT00419835|Losartan|losartan|mesh-list
110313744|NCT00419835|Enalapril|enalapril|mesh-list
110313745|NCT00419835|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110313746|NCT00419835|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110313747|NCT00419835|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110313748|NCT00419835|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110313749|NCT00419835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110313750|NCT00419835|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110313751|NCT00419835|Protease Inhibitors|protease inhibitors|mesh-ancestor
110313752|NCT00419835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110313753|NCT00328809|Spironolactone|spironolactone|mesh-list
110093628|NCT01703910|Paclitaxel|paclitaxel|mesh-list
110313754|NCT00328809|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110313755|NCT00328809|Hormone Antagonists|hormone antagonists|mesh-ancestor
110313756|NCT00328809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110313757|NCT00328809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110313758|NCT00328809|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110313759|NCT00328809|Diuretics|diuretics|mesh-ancestor
110313760|NCT00328809|Natriuretic Agents|natriuretic agents|mesh-ancestor
110313761|NCT00420030|Abciximab|abciximab|mesh-list
110313762|NCT00420030|Anticoagulants|anticoagulants|mesh-ancestor
110313763|NCT00420030|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110313764|NCT00303758|Leucovorin|leucovorin|mesh-list
110313765|NCT00303758|Gemcitabine|gemcitabine|mesh-list
110313766|NCT00303758|Fluorouracil|fluorouracil|mesh-list
110313767|NCT00303758|Calcium|calcium|mesh-list
110313768|NCT00303758|Levoleucovorin|levoleucovorin|mesh-list
110313769|NCT00303758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110313770|NCT00303758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110313771|NCT00303758|Antimetabolites|antimetabolites|mesh-ancestor
110313772|NCT00303758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110313773|NCT00303758|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110169857|NCT00016107|Antimitotic Agents|antimitotic agents|mesh-ancestor
110093686|NCT01704092|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110313774|NCT00303758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110313775|NCT00303758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110313776|NCT00303758|Immunologic Factors|immunologic factors|mesh-ancestor
110313777|NCT00303758|Antidotes|antidotes|mesh-ancestor
110313778|NCT00303758|Protective Agents|protective agents|mesh-ancestor
110313779|NCT00303758|Vitamin B Complex|vitamin b complex|mesh-ancestor
110313781|NCT00303758|Micronutrients|micronutrients|mesh-ancestor
110313782|NCT00303797|Bortezomib|bortezomib|mesh-list
110313783|NCT00303797|Sorafenib|sorafenib|mesh-list
110313784|NCT00303797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110313785|NCT00303797|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110313786|NCT00303797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110313787|NCT00303797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110313788|NCT00303836|Aldesleukin|aldesleukin|mesh-list
110313789|NCT00303836|Cyclophosphamide|cyclophosphamide|mesh-list
110313790|NCT00303836|Fludarabine|fludarabine|mesh-list
110313791|NCT00303836|Fludarabine phosphate|fludarabine phosphate|mesh-list
110313792|NCT00303836|Interleukin-2|interleukin-2|mesh-list
110313793|NCT00303836|Freund's Adjuvant|freund's adjuvant|mesh-list
110313794|NCT00303836|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110313795|NCT00303836|Immunologic Factors|immunologic factors|mesh-ancestor
110313796|NCT00303836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110313797|NCT00303836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110313798|NCT00303836|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110313799|NCT00303836|Alkylating Agents|alkylating agents|mesh-ancestor
110313800|NCT00303836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110313801|NCT00303836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110313802|NCT00303836|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110313803|NCT00303836|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110313804|NCT00303836|Antimetabolites|antimetabolites|mesh-ancestor
110313805|NCT00303836|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110313806|NCT00303836|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110313807|NCT00303836|Analgesics|analgesics|mesh-ancestor
110313808|NCT00303836|Sensory System Agents|sensory system agents|mesh-ancestor
110313809|NCT00303836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110313810|NCT00303836|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110313811|NCT00303836|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110313812|NCT00303836|Antiviral Agents|antiviral agents|mesh-ancestor
110313813|NCT00303836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110313814|NCT00303992|Trastuzumab|trastuzumab|mesh-list
110313815|NCT00303992|Irinotecan|irinotecan|mesh-list
110313816|NCT00303992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110313817|NCT00303992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110313818|NCT00303992|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110313819|NCT00303992|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110313820|NCT00303992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110313821|NCT00303992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110313824|NCT00304226|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110313825|NCT00304226|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110313826|NCT00304226|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110313827|NCT00304226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110169864|NCT00001118|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110313828|NCT00304226|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110093852|NCT01705002|Growth Substances|growth substances|mesh-ancestor
110313829|NCT00304226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110313830|NCT00304226|Vasodilator Agents|vasodilator agents|mesh-ancestor
110313831|NCT00304226|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110313832|NCT00304226|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110313834|NCT00332319|Antiemetics|antiemetics|mesh-ancestor
110313835|NCT00332319|Autonomic Agents|autonomic agents|mesh-ancestor
110313836|NCT00332319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110313837|NCT00332319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110313838|NCT00332319|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110313839|NCT00332319|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110313840|NCT00332319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110313841|NCT00332319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110313843|NCT00304382|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110313844|NCT00304382|Immunologic Factors|immunologic factors|mesh-ancestor
110313845|NCT00304382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110313846|NCT00304421|Rabeprazole|rabeprazole|mesh-list
110313847|NCT00304421|Pantoprazole|pantoprazole|mesh-list
110313848|NCT00304421|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110313849|NCT00304421|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110313850|NCT00304421|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110313851|NCT00304421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110313852|NCT00304421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110313853|NCT00332397|Sirolimus|sirolimus|mesh-list
110313854|NCT00332397|Temsirolimus|temsirolimus|mesh-list
110313855|NCT00332397|MTOR Inhibitors|mtor inhibitors|mesh-list
110313856|NCT00332397|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110313857|NCT00332397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110313858|NCT00332397|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110313859|NCT00332397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110313860|NCT00332397|Antifungal Agents|antifungal agents|mesh-ancestor
110313861|NCT00332397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110313862|NCT00332397|Immunologic Factors|immunologic factors|mesh-ancestor
110313863|NCT00332397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110313864|NCT00332397|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110313865|NCT00332397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110313866|NCT00332397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110313867|NCT00304460|Aldesleukin|aldesleukin|mesh-list
110313868|NCT00304460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110313869|NCT00304460|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110313870|NCT00304460|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110313871|NCT00304460|Antiviral Agents|antiviral agents|mesh-ancestor
110313872|NCT00304460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110313873|NCT00304499|Oxybutynin|oxybutynin|mesh-list
110313874|NCT00304499|Parasympatholytics|parasympatholytics|mesh-ancestor
110313875|NCT00304499|Autonomic Agents|autonomic agents|mesh-ancestor
110313876|NCT00304499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110093968|NCT01705808|Anticoagulants|anticoagulants|mesh-ancestor
110313877|NCT00304499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110313878|NCT00304499|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110313879|NCT00304499|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110313880|NCT00304499|Cholinergic Agents|cholinergic agents|mesh-ancestor
110313881|NCT00304499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110313882|NCT00304499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110313884|NCT00304538|Glucagon|glucagon|mesh-list
110313885|NCT00304538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110313886|NCT00304538|Hormones|hormones|mesh-ancestor
110313887|NCT00304538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110313888|NCT00304538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110313889|NCT00420498|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
110313890|NCT00420498|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110313891|NCT00420498|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110313892|NCT00420498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110313893|NCT00420498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110313894|NCT00420498|Adrenergic Agents|adrenergic agents|mesh-ancestor
110313895|NCT00420498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110313896|NCT00420498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110313898|NCT00328965|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110313899|NCT00328965|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110313900|NCT00328965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110313901|NCT00328965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110313902|NCT00328965|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110313903|NCT00328965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110313904|NCT00304616|Olanzapine|olanzapine|mesh-list
110313905|NCT00304616|Risperidone|risperidone|mesh-list
110313906|NCT00304616|Aripiprazole|aripiprazole|mesh-list
110313907|NCT00304616|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110313908|NCT00304616|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110313909|NCT00304616|Serotonin Agents|serotonin agents|mesh-ancestor
110313910|NCT00304616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110313911|NCT00304616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110313912|NCT00304616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110313914|NCT00304616|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110313915|NCT00304616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110313916|NCT00304616|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110313917|NCT00304616|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110313918|NCT00304616|Dopamine Agents|dopamine agents|mesh-ancestor
110313919|NCT00304616|Antiemetics|antiemetics|mesh-ancestor
110313920|NCT00304616|Autonomic Agents|autonomic agents|mesh-ancestor
110313921|NCT00304616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110313922|NCT00304616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110313923|NCT00304616|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110313924|NCT00304616|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110313925|NCT00304616|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110313926|NCT00304616|Antidepressive Agents|antidepressive agents|mesh-ancestor
110313927|NCT00304616|Dopamine Agonists|dopamine agonists|mesh-ancestor
110313928|NCT00304616|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110313929|NCT00304616|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110313930|NCT00304616|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110313931|NCT00304616|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110313932|NCT00332436|Timolol|timolol|mesh-list
110313933|NCT00332436|Brimonidine Tartrate|brimonidine tartrate|mesh-list
110313934|NCT00332436|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110313935|NCT00332436|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110313936|NCT00332436|Adrenergic Agents|adrenergic agents|mesh-ancestor
110313937|NCT00332436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110313938|NCT00332436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110313939|NCT00332436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110313940|NCT00332436|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110313941|NCT00332436|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110313942|NCT00332436|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110313943|NCT00332436|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110094120|NCT01707199|Artesunate|artesunate|mesh-list
110313944|NCT00332436|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110313945|NCT00304655|Aripiprazole|aripiprazole|mesh-list
110313946|NCT00304655|Antidepressive Agents|antidepressive agents|mesh-ancestor
110313947|NCT00304655|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110313948|NCT00304655|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110313949|NCT00304655|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110313950|NCT00304655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110313951|NCT00304655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110313952|NCT00304655|Dopamine Agonists|dopamine agonists|mesh-ancestor
110313953|NCT00304655|Dopamine Agents|dopamine agents|mesh-ancestor
110313954|NCT00304655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110313955|NCT00304655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110313956|NCT00304655|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110313957|NCT00304655|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110313958|NCT00304655|Serotonin Agents|serotonin agents|mesh-ancestor
110313959|NCT00304655|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110313960|NCT00304655|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110313961|NCT00304655|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110313963|NCT00332553|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
110313964|NCT00332553|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
110313965|NCT00332553|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110313966|NCT00332553|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110313967|NCT00332553|Medroxyprogesterone|medroxyprogesterone|mesh-list
110313968|NCT00332553|Estradiol|estradiol|mesh-list
110313969|NCT00332553|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110313970|NCT00332553|Estrogens|estrogens|mesh-list
110313971|NCT00332553|Hormones|hormones|mesh-ancestor
110313972|NCT00332553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110313973|NCT00332553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110313974|NCT00332553|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110313975|NCT00332553|Contraceptive Agents|contraceptive agents|mesh-ancestor
110313976|NCT00332553|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110094230|NCT01707745|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110313977|NCT00332553|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110313978|NCT00332553|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110313979|NCT00332553|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110313980|NCT00332553|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110313981|NCT00332553|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110313982|NCT00332553|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110313983|NCT00332553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110313984|NCT00332553|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110313985|NCT00332553|Hormone Antagonists|hormone antagonists|mesh-ancestor
110313986|NCT00332553|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110313987|NCT00332553|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110313988|NCT00332553|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110313989|NCT00332631|Acetylcysteine|acetylcysteine|mesh-list
110313990|NCT00332631|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110313991|NCT00332631|Antiviral Agents|antiviral agents|mesh-ancestor
110313992|NCT00332631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110313993|NCT00332631|Expectorants|expectorants|mesh-ancestor
110313994|NCT00332631|Respiratory System Agents|respiratory system agents|mesh-ancestor
110313995|NCT00332631|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110313996|NCT00332631|Antioxidants|antioxidants|mesh-ancestor
110313997|NCT00332631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110313998|NCT00332631|Protective Agents|protective agents|mesh-ancestor
110313999|NCT00332631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110314000|NCT00332631|Antidotes|antidotes|mesh-ancestor
110314001|NCT00304772|Fluconazole|fluconazole|mesh-list
110314002|NCT00304772|Micafungin|micafungin|mesh-list
110314003|NCT00304772|Antifungal Agents|antifungal agents|mesh-ancestor
110314004|NCT00304772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110314005|NCT00304772|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110314006|NCT00304772|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110314007|NCT00304772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110314008|NCT00304772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110314009|NCT00304772|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110314010|NCT00304772|Hormone Antagonists|hormone antagonists|mesh-ancestor
110314011|NCT00304772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110314012|NCT00304772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110314013|NCT00304772|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110314014|NCT00304772|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110314016|NCT00304811|Rifampin|rifampin|mesh-list
110314017|NCT00304811|Gentamicins|gentamicins|mesh-list
110314018|NCT00304811|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110314019|NCT00304811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110314020|NCT00304811|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110314021|NCT00304811|Antitubercular Agents|antitubercular agents|mesh-ancestor
110314022|NCT00304811|Leprostatic Agents|leprostatic agents|mesh-ancestor
110314023|NCT00304811|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110314024|NCT00304811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110314025|NCT00304811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110314026|NCT00304811|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110314027|NCT00304811|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110314028|NCT00304811|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110169900|NCT00016224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110314030|NCT00304811|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110314031|NCT00304811|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110314033|NCT00332787|Fluoxetine|fluoxetine|mesh-list
110314034|NCT00332787|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110314035|NCT00332787|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110314036|NCT00332787|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110314037|NCT00332787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110314038|NCT00332787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110314040|NCT00332787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110314041|NCT00332787|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110314042|NCT00332787|Antidepressive Agents|antidepressive agents|mesh-ancestor
110314043|NCT00332787|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110314044|NCT00332787|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110314045|NCT00332787|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110314046|NCT00332787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110314047|NCT00304850|Ketamine|ketamine|mesh-list
110314048|NCT00304850|Analgesics|analgesics|mesh-ancestor
110314049|NCT00304850|Sensory System Agents|sensory system agents|mesh-ancestor
110314050|NCT00304850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110314051|NCT00304850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110314052|NCT00304850|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110094454|NCT01709370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110314053|NCT00304850|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110314054|NCT00304850|Anesthetics, General|anesthetics, general|mesh-ancestor
110373976|NCT02883556|Pembrolizumab|pembrolizumab|mesh-list
110314056|NCT00304850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110314057|NCT00304850|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110314058|NCT00304850|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110314059|NCT00304850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110314060|NCT00304850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110314061|NCT00329316|Progesterone|progesterone|mesh-list
110314062|NCT00329316|Progestins|progestins|mesh-ancestor
110314063|NCT00329316|Hormones|hormones|mesh-ancestor
110314064|NCT00329316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110314065|NCT00329316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110314066|NCT00332826|Insulin|insulin|mesh-list
110314067|NCT00332826|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110314068|NCT00332826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110314069|NCT00305201|Pravastatin|pravastatin|mesh-list
110314070|NCT00305201|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110314071|NCT00305201|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110314072|NCT00305201|Antimetabolites|antimetabolites|mesh-ancestor
110314073|NCT00305201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110314074|NCT00305201|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110314075|NCT00305201|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110314076|NCT00305201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110314077|NCT00329355|Naproxen|naproxen|mesh-list
110314078|NCT00329355|Sumatriptan|sumatriptan|mesh-list
110314079|NCT00329355|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110314080|NCT00329355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110314081|NCT00329355|Analgesics|analgesics|mesh-ancestor
110314082|NCT00329355|Sensory System Agents|sensory system agents|mesh-ancestor
110314083|NCT00329355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110314084|NCT00329355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110314085|NCT00329355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110314086|NCT00329355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110314087|NCT00329355|Gout Suppressants|gout suppressants|mesh-ancestor
110314088|NCT00329355|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110314089|NCT00329355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110314090|NCT00329355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110314091|NCT00329355|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110314092|NCT00329355|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110314093|NCT00329355|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110314094|NCT00329355|Serotonin Agents|serotonin agents|mesh-ancestor
110314095|NCT00329355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110314096|NCT00332904|Propranolol|propranolol|mesh-list
110314097|NCT00332904|Spironolactone|spironolactone|mesh-list
110314098|NCT00332904|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110314099|NCT00332904|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110314100|NCT00332904|Adrenergic Agents|adrenergic agents|mesh-ancestor
110314101|NCT00332904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110314102|NCT00332904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110314103|NCT00332904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110314104|NCT00332904|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110314105|NCT00332904|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110314106|NCT00332904|Vasodilator Agents|vasodilator agents|mesh-ancestor
110314107|NCT00332904|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110314108|NCT00332904|Hormone Antagonists|hormone antagonists|mesh-ancestor
110314109|NCT00332904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110314110|NCT00332904|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110314112|NCT00332904|Natriuretic Agents|natriuretic agents|mesh-ancestor
110314114|NCT00329394|Analgesics|analgesics|mesh-ancestor
110314115|NCT00329394|Sensory System Agents|sensory system agents|mesh-ancestor
110314116|NCT00329394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110314117|NCT00329394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110373989|NCT00572312|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110314118|NCT00329394|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110314119|NCT00329394|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110314120|NCT00329394|Anesthetics, General|anesthetics, general|mesh-ancestor
110314121|NCT00329394|Anesthetics|anesthetics|mesh-ancestor
110314122|NCT00329394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110314123|NCT00329394|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110314124|NCT00329394|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110314125|NCT00329394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110314126|NCT00329394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110314128|NCT00305396|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110314129|NCT00305396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110314130|NCT00305396|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110314131|NCT00305396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110314132|NCT00305396|Antifungal Agents|antifungal agents|mesh-ancestor
110314133|NCT00305396|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110314134|NCT00305396|Immunologic Factors|immunologic factors|mesh-ancestor
110314135|NCT00305396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110314136|NCT00329472|Gemcitabine|gemcitabine|mesh-list
110314137|NCT00329472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110314138|NCT00329472|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110314139|NCT00329472|Antimetabolites|antimetabolites|mesh-ancestor
110314140|NCT00329472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110314141|NCT00305474|Risperidone|risperidone|mesh-list
110314142|NCT00305474|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110314143|NCT00305474|Serotonin Agents|serotonin agents|mesh-ancestor
110314144|NCT00305474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110314145|NCT00305474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110314146|NCT00305474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110314147|NCT00305474|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110314148|NCT00305474|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110314149|NCT00305474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110314150|NCT00305474|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110314151|NCT00305474|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110314152|NCT00305474|Dopamine Agents|dopamine agents|mesh-ancestor
110314154|NCT00329511|Methyldopa|methyldopa|mesh-list
110314155|NCT00329511|Analgesics|analgesics|mesh-ancestor
110314156|NCT00329511|Sensory System Agents|sensory system agents|mesh-ancestor
110314157|NCT00329511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110314158|NCT00329511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110314159|NCT00329511|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110314161|NCT00329511|Autonomic Agents|autonomic agents|mesh-ancestor
110314162|NCT00329511|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110314163|NCT00329511|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110314164|NCT00329511|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110314165|NCT00329511|Adrenergic Agents|adrenergic agents|mesh-ancestor
110314166|NCT00329511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110314167|NCT00329511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110314168|NCT00305513|Caffeine|caffeine|mesh-list
110314169|NCT00305513|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110314170|NCT00305513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110314171|NCT00305513|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110314173|NCT00305513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110314174|NCT00305513|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110314175|NCT00305513|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110314176|NCT00305513|Purinergic Agents|purinergic agents|mesh-ancestor
110314177|NCT00305513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110314179|NCT00333021|Fondaparinux|fondaparinux|mesh-list
110314180|NCT00333021|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110314181|NCT00333021|Antithrombins|antithrombins|mesh-ancestor
110314182|NCT00333021|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110314183|NCT00333021|Protease Inhibitors|protease inhibitors|mesh-ancestor
110314184|NCT00333021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110314185|NCT00333021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110314186|NCT00333021|Anticoagulants|anticoagulants|mesh-ancestor
110314187|NCT00333021|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110314188|NCT00333021|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110314189|NCT00305552|Thalidomide|thalidomide|mesh-list
110314190|NCT00305552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110314191|NCT00305552|Immunologic Factors|immunologic factors|mesh-ancestor
110314192|NCT00305552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110314193|NCT00305552|Leprostatic Agents|leprostatic agents|mesh-ancestor
110314194|NCT00305552|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110314195|NCT00305552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110314196|NCT00305552|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110314197|NCT00305552|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110314198|NCT00305552|Growth Substances|growth substances|mesh-ancestor
110314199|NCT00305552|Growth Inhibitors|growth inhibitors|mesh-ancestor
110314200|NCT00305552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110314201|NCT00329589|Bortezomib|bortezomib|mesh-list
110314202|NCT00329589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110314203|NCT00305591|N-Methylaspartate|n-methylaspartate|mesh-list
110314204|NCT00305591|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
110314205|NCT00305591|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110314206|NCT00305591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110314207|NCT00305591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110314208|NCT00305591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110314209|NCT00333060|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110314210|NCT00333060|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110314211|NCT00305630|Triamcinolone|triamcinolone|mesh-list
110314212|NCT00305630|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110314213|NCT00305630|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110314214|NCT00305630|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110314215|NCT00305630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110314216|NCT00305630|Glucocorticoids|glucocorticoids|mesh-ancestor
110314218|NCT00305630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110314219|NCT00305630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110314220|NCT00305630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110314221|NCT00305630|Immunologic Factors|immunologic factors|mesh-ancestor
110314222|NCT00305630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110314223|NCT00305630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110314224|NCT00329628|Enoxaparin|enoxaparin|mesh-list
110314225|NCT00329628|Rivaroxaban|rivaroxaban|mesh-list
110314226|NCT00329628|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110314227|NCT00329628|Antithrombins|antithrombins|mesh-ancestor
110314228|NCT00329628|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110314229|NCT00329628|Protease Inhibitors|protease inhibitors|mesh-ancestor
110314230|NCT00329628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110314231|NCT00329628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110314233|NCT00329628|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110314234|NCT00329628|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110314235|NCT00305669|Sargramostim|sargramostim|mesh-list
110095031|NCT01712295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110314236|NCT00305669|Immunologic Factors|immunologic factors|mesh-ancestor
110314237|NCT00305669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110314238|NCT00305708|Fludarabine|fludarabine|mesh-list
110314239|NCT00305708|Fludarabine phosphate|fludarabine phosphate|mesh-list
110314240|NCT00305708|Busulfan|busulfan|mesh-list
110314241|NCT00305708|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110314242|NCT00305708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110314243|NCT00305708|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110314244|NCT00305708|Antimetabolites|antimetabolites|mesh-ancestor
110314245|NCT00305708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110314246|NCT00305708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110314247|NCT00305708|Immunologic Factors|immunologic factors|mesh-ancestor
110314248|NCT00305708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110314249|NCT00305708|Alkylating Agents|alkylating agents|mesh-ancestor
110314250|NCT00305708|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110314251|NCT00305708|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110314253|NCT00305747|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110314254|NCT00305747|Protective Agents|protective agents|mesh-ancestor
110314255|NCT00305747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110314256|NCT00305747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110314257|NCT00333255|Nepafenac|nepafenac|mesh-list
110095080|NCT01710761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110314258|NCT00333255|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110314259|NCT00333255|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110314260|NCT00333255|Analgesics|analgesics|mesh-ancestor
110314261|NCT00333255|Sensory System Agents|sensory system agents|mesh-ancestor
110314262|NCT00333255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110314263|NCT00333255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110314264|NCT00333255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110314265|NCT00333255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110314266|NCT00305786|Gemcitabine|gemcitabine|mesh-list
110314267|NCT00305786|Oxaliplatin|oxaliplatin|mesh-list
110314268|NCT00305786|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110314269|NCT00305786|Antimetabolites|antimetabolites|mesh-ancestor
110314270|NCT00305786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110314271|NCT00305786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110314272|NCT00305825|Bevacizumab|bevacizumab|mesh-list
110314273|NCT00305825|Letrozole|letrozole|mesh-list
110314274|NCT00305825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110314275|NCT00305825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110314276|NCT00305825|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110314277|NCT00305825|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110314278|NCT00305825|Growth Substances|growth substances|mesh-ancestor
110314279|NCT00305825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110314280|NCT00305825|Growth Inhibitors|growth inhibitors|mesh-ancestor
110314281|NCT00305825|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110314282|NCT00305825|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110314283|NCT00305825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110314284|NCT00305825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110314285|NCT00305825|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110314286|NCT00305825|Hormone Antagonists|hormone antagonists|mesh-ancestor
110314287|NCT00305825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110314288|NCT00333294|Vinorelbine|vinorelbine|mesh-list
110314290|NCT00333294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110314291|NCT00333294|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110314292|NCT00333294|Tubulin Modulators|tubulin modulators|mesh-ancestor
110314293|NCT00333294|Antimitotic Agents|antimitotic agents|mesh-ancestor
110314294|NCT00333294|Mitosis Modulators|mitosis modulators|mesh-ancestor
110314295|NCT00333294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110314296|NCT00333294|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110314297|NCT00333294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110314298|NCT00305903|Memantine|memantine|mesh-list
110314299|NCT00305903|Rivastigmine|rivastigmine|mesh-list
110314300|NCT00305903|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110314301|NCT00305903|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110314302|NCT00305903|Dopamine Agents|dopamine agents|mesh-ancestor
110314303|NCT00305903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110314304|NCT00305903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110314305|NCT00305903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110314306|NCT00305903|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110314307|NCT00305903|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110314308|NCT00305903|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110314309|NCT00305903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110314310|NCT00305903|Cholinergic Agents|cholinergic agents|mesh-ancestor
110314311|NCT00305903|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110314312|NCT00305903|Protective Agents|protective agents|mesh-ancestor
110314313|NCT00329823|Etanercept|etanercept|mesh-list
110314314|NCT00329823|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110314315|NCT00329823|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110314316|NCT00329823|Analgesics|analgesics|mesh-ancestor
110314317|NCT00329823|Sensory System Agents|sensory system agents|mesh-ancestor
110314318|NCT00329823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110314319|NCT00329823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110314320|NCT00329823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110314321|NCT00329823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110314322|NCT00329823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110314323|NCT00329823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110314324|NCT00329823|Immunologic Factors|immunologic factors|mesh-ancestor
110314325|NCT00306020|Morphine|morphine|mesh-list
110314326|NCT00306020|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110314327|NCT00306020|Narcotics|narcotics|mesh-ancestor
110314328|NCT00306020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110314329|NCT00306020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110314330|NCT00306020|Analgesics|analgesics|mesh-ancestor
110314331|NCT00306020|Sensory System Agents|sensory system agents|mesh-ancestor
110314332|NCT00306020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110314333|NCT00306137|Aprotinin|aprotinin|mesh-list
110314334|NCT00306137|Hemostatics|hemostatics|mesh-ancestor
110314335|NCT00306137|Coagulants|coagulants|mesh-ancestor
110095296|NCT01713803|Buprenorphine|buprenorphine|mesh-list
110314336|NCT00306137|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
110314337|NCT00306137|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110314338|NCT00306137|Protease Inhibitors|protease inhibitors|mesh-ancestor
110314339|NCT00306137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110314340|NCT00306137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110314341|NCT00329940|Letrozole|letrozole|mesh-list
110314342|NCT00329940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110314343|NCT00329940|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110314344|NCT00329940|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110314345|NCT00329940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110314346|NCT00329940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110314347|NCT00329940|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110314348|NCT00329940|Hormone Antagonists|hormone antagonists|mesh-ancestor
110314349|NCT00329940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110095358|NCT01714089|Immunologic Factors|immunologic factors|mesh-ancestor
110314350|NCT00329940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110314352|NCT00306176|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110314353|NCT00306176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110314354|NCT00333372|Z 338|z 338|mesh-list
110314355|NCT00333372|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110314356|NCT00333372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110314357|NCT00333372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110314358|NCT00333372|Cholinergic Agents|cholinergic agents|mesh-ancestor
110314359|NCT00333372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110314360|NCT00333372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110314361|NCT00333372|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110314362|NCT00330018|Valganciclovir|valganciclovir|mesh-list
110314363|NCT00330018|Acyclovir|acyclovir|mesh-list
110314364|NCT00330018|Antiviral Agents|antiviral agents|mesh-ancestor
110314365|NCT00330018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110314366|NCT00333450|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110314367|NCT00333450|Immunologic Factors|immunologic factors|mesh-ancestor
110095417|NCT01714206|Digoxin|digoxin|mesh-list
110314368|NCT00333450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110314369|NCT00306254|Enoxaparin|enoxaparin|mesh-list
110343822|NCT06022003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110314370|NCT00306254|N-(4-chlorophenyl)-N-(2-fluoro-4-(2-oxopyridin-1(2H)-yl)phenyl)-4-methoxypyrrolidiine-1,2-dicarboxamide|n-(4-chlorophenyl)-n-(2-fluoro-4-(2-oxopyridin-1(2h)-yl)phenyl)-4-methoxypyrrolidiine-1,2-dicarboxamide|mesh-list
110314371|NCT00306254|Anticoagulants|anticoagulants|mesh-ancestor
110314372|NCT00306254|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110314373|NCT00306254|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110314374|NCT00306254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110314375|NCT00306254|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110314376|NCT00306254|Antithrombins|antithrombins|mesh-ancestor
110314377|NCT00306254|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110314378|NCT00306254|Protease Inhibitors|protease inhibitors|mesh-ancestor
110314379|NCT00306254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110314380|NCT00333489|Valsartan|valsartan|mesh-list
110314381|NCT00333489|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110314382|NCT00333489|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110314383|NCT00333489|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110314384|NCT00333489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110314386|NCT00330135|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110314387|NCT00330135|Immunologic Factors|immunologic factors|mesh-ancestor
110314388|NCT00330135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110314389|NCT00330135|Viscosupplements|viscosupplements|mesh-ancestor
110314390|NCT00330135|Protective Agents|protective agents|mesh-ancestor
110314391|NCT03275558|Sunitinib|sunitinib|mesh-list
110314392|NCT03275558|Axitinib|axitinib|mesh-list
110314393|NCT03275558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110314394|NCT03275558|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110314395|NCT03275558|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110314396|NCT03275558|Growth Substances|growth substances|mesh-ancestor
110314397|NCT03275558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110314398|NCT03275558|Growth Inhibitors|growth inhibitors|mesh-ancestor
110314399|NCT03275558|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110314400|NCT03275558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110314401|NCT03275558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110314402|NCT03275519|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110314403|NCT03275519|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
110314404|NCT03275519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110314405|NCT03275519|Antitubercular Agents|antitubercular agents|mesh-ancestor
110314406|NCT00333567|Lumiracoxib|lumiracoxib|mesh-list
110314407|NCT00333567|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110314408|NCT00333567|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110314409|NCT00333567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110314410|NCT00333567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110314411|NCT00333567|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110314412|NCT00333567|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110314413|NCT00333567|Analgesics|analgesics|mesh-ancestor
110314414|NCT00333567|Sensory System Agents|sensory system agents|mesh-ancestor
110314415|NCT00333567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110314416|NCT00333567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110314417|NCT00333567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110314418|NCT00333567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110314419|NCT00330252|Rituximab|rituximab|mesh-list
110314420|NCT00330252|Alemtuzumab|alemtuzumab|mesh-list
110314421|NCT00330252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110314422|NCT00330252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110314423|NCT00330252|Immunologic Factors|immunologic factors|mesh-ancestor
110314424|NCT00330252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110314425|NCT00330252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110314426|NCT00333645|Caspofungin|caspofungin|mesh-list
110314427|NCT00333645|Antifungal Agents|antifungal agents|mesh-ancestor
110314428|NCT00333645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110314429|NCT00333645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110314430|NCT00333645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110314431|NCT00451100|Glycopyrrolate|glycopyrrolate|mesh-list
110314432|NCT00451100|Neostigmine|neostigmine|mesh-list
110314433|NCT00451100|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110314434|NCT00451100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110169940|NCT00016302|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110314435|NCT00451100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110314436|NCT00451100|Cholinergic Agents|cholinergic agents|mesh-ancestor
110314437|NCT00451100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110314438|NCT00451100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110314439|NCT00451100|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110314440|NCT00451100|Autonomic Agents|autonomic agents|mesh-ancestor
110314441|NCT00451100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110314442|NCT00451100|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110314443|NCT00451100|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110314444|NCT00451100|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110314445|NCT00420537|Cyclosporine|cyclosporine|mesh-list
110314446|NCT00420537|Mycophenolic Acid|mycophenolic acid|mesh-list
110314448|NCT00420537|Cyclosporins|cyclosporins|mesh-list
110314449|NCT00420537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110314450|NCT00420537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110314451|NCT00420537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110314452|NCT00420537|Immunologic Factors|immunologic factors|mesh-ancestor
110314453|NCT00420537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110314454|NCT00420537|Antifungal Agents|antifungal agents|mesh-ancestor
110314455|NCT00420537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110314456|NCT00420537|Dermatologic Agents|dermatologic agents|mesh-ancestor
110314457|NCT00420537|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110314458|NCT00420537|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110314459|NCT00420537|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110314460|NCT00420537|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110314461|NCT00420537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110314462|NCT00420537|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110314463|NCT00420537|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110314464|NCT00420537|Antitubercular Agents|antitubercular agents|mesh-ancestor
110314465|NCT00420537|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110314466|NCT00451139|Lumefantrine|lumefantrine|mesh-list
110314468|NCT00451139|Quinine|quinine|mesh-list
110314469|NCT00451139|Atovaquone|atovaquone|mesh-list
110314470|NCT00451139|Proguanil|proguanil|mesh-list
110314471|NCT00451139|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
110314472|NCT00451139|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
110314473|NCT00451139|Antimalarials|antimalarials|mesh-ancestor
110314474|NCT00451139|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110314475|NCT00451139|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110314476|NCT00451139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110314477|NCT00451139|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110314478|NCT00451139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110314479|NCT00451139|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110314480|NCT00451139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110314481|NCT00451139|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110314482|NCT00451139|Analgesics|analgesics|mesh-ancestor
110314483|NCT00451139|Sensory System Agents|sensory system agents|mesh-ancestor
110314484|NCT00451139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110314485|NCT00451139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110314486|NCT00451139|Antimetabolites|antimetabolites|mesh-ancestor
110314487|NCT00330486|Acamprosate|acamprosate|mesh-list
110314488|NCT00330486|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110314489|NCT00451373|Vancomycin|vancomycin|mesh-list
110314490|NCT00451373|Daptomycin|daptomycin|mesh-list
110314491|NCT00451373|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110314492|NCT00451373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110314493|NCT00333723|Rosiglitazone|rosiglitazone|mesh-list
110314494|NCT00333723|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110314495|NCT00333723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110314496|NCT00451412|Heparin|heparin|mesh-list
110314497|NCT00451412|Calcium heparin|calcium heparin|mesh-list
110314498|NCT00451412|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
110314499|NCT00451412|Tinzaparin|tinzaparin|mesh-list
110314500|NCT00451412|Dalteparin|dalteparin|mesh-list
110314501|NCT00451412|Certoparin|certoparin|mesh-list
110314503|NCT00451412|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110314504|NCT00451412|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110314505|NCT00451412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110314506|NCT00451490|Agomelatine|agomelatine|mesh-list
110314507|NCT00451490|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110374058|NCT00572741|Cod Liver Oil|cod liver oil|mesh-list
110314508|NCT00451490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110314509|NCT00451490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110314510|NCT00330525|Sibutramine|sibutramine|mesh-list
110314511|NCT00330525|Antidepressive Agents|antidepressive agents|mesh-ancestor
110314512|NCT00330525|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110314513|NCT00330525|Appetite Depressants|appetite depressants|mesh-ancestor
110314514|NCT00330525|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110314515|NCT00333918|Bromfenac|bromfenac|mesh-list
110314516|NCT00333918|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110314517|NCT00333918|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110095812|NCT01716637|Etanercept|etanercept|mesh-list
110314518|NCT00333918|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110314519|NCT00333918|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110314520|NCT00333918|Analgesics|analgesics|mesh-ancestor
110314521|NCT00333918|Sensory System Agents|sensory system agents|mesh-ancestor
110314522|NCT00333918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110314523|NCT00333918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110314524|NCT00333918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110314525|NCT00333918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110314526|NCT00451568|Metformin|metformin|mesh-list
110314527|NCT00451568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110314528|NCT00451568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110314529|NCT00451646|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
110314530|NCT00451646|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
110314531|NCT00451646|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
110314532|NCT00451646|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110314533|NCT00451724|Ketamine|ketamine|mesh-list
110314534|NCT00451724|Analgesics|analgesics|mesh-ancestor
110314535|NCT00451724|Sensory System Agents|sensory system agents|mesh-ancestor
110314536|NCT00451724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110314537|NCT00451724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110314538|NCT00451724|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110095844|NCT01716767|Menthol|menthol|mesh-list
110314539|NCT00451724|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110314540|NCT00451724|Anesthetics, General|anesthetics, general|mesh-ancestor
110314541|NCT00451724|Anesthetics|anesthetics|mesh-ancestor
110314542|NCT00451724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110314543|NCT00451724|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110314544|NCT00451724|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110314545|NCT00451724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110314546|NCT00451724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110314547|NCT00451763|Bevacizumab|bevacizumab|mesh-list
110314548|NCT00451763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110314549|NCT00451763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110314550|NCT00451763|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110314551|NCT00451763|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110314552|NCT00451763|Growth Substances|growth substances|mesh-ancestor
110314553|NCT00451763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110314554|NCT00451763|Growth Inhibitors|growth inhibitors|mesh-ancestor
110314555|NCT00330798|Ketorolac|ketorolac|mesh-list
110314556|NCT00330798|Nepafenac|nepafenac|mesh-list
110314557|NCT00330798|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110314558|NCT00330798|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110314559|NCT00330798|Analgesics|analgesics|mesh-ancestor
110314560|NCT00330798|Sensory System Agents|sensory system agents|mesh-ancestor
110314561|NCT00330798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110314562|NCT00330798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110314563|NCT00330798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110314564|NCT00330798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110374069|NCT00572819|Oxytocics|oxytocics|mesh-ancestor
110314565|NCT00330798|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110314566|NCT00330798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110314567|NCT00330798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110314568|NCT00451880|Famotidine|famotidine|mesh-list
110314569|NCT00451880|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110314570|NCT00451880|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110314571|NCT00451880|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110314572|NCT00451880|Histamine Antagonists|histamine antagonists|mesh-ancestor
110314573|NCT00451880|Histamine Agents|histamine agents|mesh-ancestor
110314574|NCT00451880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110314575|NCT00451880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110314576|NCT00451880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110314577|NCT00451997|Cytarabine|cytarabine|mesh-list
110314578|NCT00451997|Imatinib Mesylate|imatinib mesylate|mesh-list
110314579|NCT00451997|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110314580|NCT00451997|Antimetabolites|antimetabolites|mesh-ancestor
110314581|NCT00451997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110314582|NCT00451997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110314583|NCT00451997|Antiviral Agents|antiviral agents|mesh-ancestor
110314584|NCT00451997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110314585|NCT00451997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110314586|NCT00451997|Immunologic Factors|immunologic factors|mesh-ancestor
110314587|NCT00451997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110314588|NCT00451997|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110314589|NCT00451997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110314590|NCT00330993|Misoprostol|misoprostol|mesh-list
110314591|NCT00330993|Mifepristone|mifepristone|mesh-list
110314592|NCT00330993|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110314593|NCT00330993|Abortifacient Agents|abortifacient agents|mesh-ancestor
110314594|NCT00330993|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110314595|NCT00330993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110314596|NCT00330993|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110314597|NCT00330993|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110314598|NCT00330993|Oxytocics|oxytocics|mesh-ancestor
110314599|NCT00330993|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
110314600|NCT00330993|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110314601|NCT00330993|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110314602|NCT00330993|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110314603|NCT00330993|Contraceptive Agents|contraceptive agents|mesh-ancestor
110314604|NCT00330993|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
110314605|NCT00330993|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
110314606|NCT00330993|Hormone Antagonists|hormone antagonists|mesh-ancestor
110314607|NCT00330993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110314608|NCT00330993|Luteolytic Agents|luteolytic agents|mesh-ancestor
110314609|NCT00330993|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110314610|NCT00330993|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
110314611|NCT00452075|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110314612|NCT00452075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110314613|NCT00452075|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110314614|NCT00452075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110314615|NCT00452075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110095984|NCT01717846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110095986|NCT01717911|Metformin|metformin|mesh-list
110314616|NCT00331071|Contraceptive Agents|contraceptive agents|mesh-list
110314617|NCT00331071|Ortho Evra|ortho evra|mesh-list
110314618|NCT00331071|Contraceptives, Oral|contraceptives, oral|mesh-list
110314619|NCT00331071|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110314620|NCT00331071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110314621|NCT00331071|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110314622|NCT00331071|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110314623|NCT00333996|Dexamethasone|dexamethasone|mesh-list
110314624|NCT00333996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110314625|NCT00333996|Antiemetics|antiemetics|mesh-ancestor
110314626|NCT00333996|Autonomic Agents|autonomic agents|mesh-ancestor
110314627|NCT00333996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110314628|NCT00333996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110314629|NCT00333996|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110314630|NCT00333996|Glucocorticoids|glucocorticoids|mesh-ancestor
110314632|NCT00333996|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110314633|NCT00333996|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110314634|NCT00333996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110314635|NCT00452192|Telmisartan|telmisartan|mesh-list
110314636|NCT00452192|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110314637|NCT00452192|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110314638|NCT00452192|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110314639|NCT00452192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110314640|NCT00334035|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110314641|NCT00334035|Antidepressive Agents|antidepressive agents|mesh-ancestor
110314642|NCT00334035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110314643|NCT00334035|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110314644|NCT00334035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110314645|NCT00334035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110314646|NCT00334035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110314647|NCT00334152|Casopitant|casopitant|mesh-list
110314648|NCT00334152|Antiemetics|antiemetics|mesh-ancestor
110314649|NCT00334152|Autonomic Agents|autonomic agents|mesh-ancestor
110314650|NCT00334152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110314651|NCT00334152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110314652|NCT00334152|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110314653|NCT00334152|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110314654|NCT00334152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110314655|NCT00334152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110314656|NCT04698512|Sirolimus|sirolimus|mesh-list
110314657|NCT04698512|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110314658|NCT04698512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110314659|NCT04698512|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110314660|NCT04698512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110314661|NCT04698512|Antifungal Agents|antifungal agents|mesh-ancestor
110314662|NCT04698512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110314663|NCT04698512|Immunologic Factors|immunologic factors|mesh-ancestor
110314664|NCT04698512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110314666|NCT00334308|Chelating Agents|chelating agents|mesh-ancestor
110314667|NCT00334308|Sequestering Agents|sequestering agents|mesh-ancestor
110314668|NCT00334308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110314669|NCT00334347|Valproic Acid|valproic acid|mesh-list
110314670|NCT00334347|Anticonvulsants|anticonvulsants|mesh-ancestor
110314671|NCT00334347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110314672|NCT00334347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110314673|NCT00334347|GABA Agents|gaba agents|mesh-ancestor
110314674|NCT00334347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110314675|NCT00334347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110314676|NCT00334347|Antimanic Agents|antimanic agents|mesh-ancestor
110314677|NCT00334347|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110096170|NCT01718626|Docetaxel|docetaxel|mesh-list
110314678|NCT00334347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110314679|NCT00334347|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110314680|NCT00334386|Torsemide|torsemide|mesh-list
110314681|NCT00334386|Diuretics|diuretics|mesh-list
110314682|NCT00334386|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
110314683|NCT00334386|Natriuretic Agents|natriuretic agents|mesh-ancestor
110314684|NCT00334386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110314685|NCT00334386|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110314686|NCT00334386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110314687|NCT00334386|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110314688|NCT00452231|Cycloserine|cycloserine|mesh-list
110314689|NCT00452231|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110314690|NCT00452231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110314691|NCT00452231|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110314692|NCT00452231|Antitubercular Agents|antitubercular agents|mesh-ancestor
110314693|NCT00452231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110314694|NCT00452231|Antimetabolites|antimetabolites|mesh-ancestor
110314695|NCT00452231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110314696|NCT00334425|Menotropins|menotropins|mesh-list
110314697|NCT00334425|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110314698|NCT00334425|Fertility Agents|fertility agents|mesh-ancestor
110314699|NCT00334425|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110314700|NCT00334425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110314701|NCT03275207|Dexmedetomidine|dexmedetomidine|mesh-list
110314702|NCT03275207|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110314703|NCT03275207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110314704|NCT03275207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110314705|NCT03275207|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110314706|NCT03275207|Analgesics|analgesics|mesh-ancestor
110314707|NCT03275207|Sensory System Agents|sensory system agents|mesh-ancestor
110314708|NCT03275207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110314709|NCT03275207|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110314710|NCT03275207|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110314711|NCT03275207|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110314712|NCT03275207|Adrenergic Agents|adrenergic agents|mesh-ancestor
110314713|NCT03275207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110314714|NCT03275207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110314716|NCT00334464|Anticoagulants|anticoagulants|mesh-ancestor
110314717|NCT03275012|Morphine|morphine|mesh-list
110314718|NCT03275012|Gabapentin|gabapentin|mesh-list
110314719|NCT03275012|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110314720|NCT03275012|Narcotics|narcotics|mesh-ancestor
110314721|NCT03275012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110314722|NCT03275012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110314723|NCT03275012|Analgesics|analgesics|mesh-ancestor
110314724|NCT03275012|Sensory System Agents|sensory system agents|mesh-ancestor
110314725|NCT03275012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110314726|NCT03275012|Anticonvulsants|anticonvulsants|mesh-ancestor
110314727|NCT03275012|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110314728|NCT03275012|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110314729|NCT03275012|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110314730|NCT03275012|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110314731|NCT03275012|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110314732|NCT03275012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110314733|NCT03275012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110314734|NCT03275012|Antimanic Agents|antimanic agents|mesh-ancestor
110314735|NCT00334503|Miglitol|miglitol|mesh-list
110314736|NCT00334503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110314737|NCT00334503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110314738|NCT00334503|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110096331|NCT01719614|Metformin|metformin|mesh-list
110314739|NCT00334503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110314740|NCT00334503|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
110314741|NCT00334581|Irbesartan|irbesartan|mesh-list
110314742|NCT00334581|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110314743|NCT00334581|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110314744|NCT00334581|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110314745|NCT00334581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110314746|NCT00452270|Xylometazoline|xylometazoline|mesh-list
110314747|NCT00452270|Nasal Decongestants|nasal decongestants|mesh-ancestor
110314748|NCT00452270|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110314749|NCT00452270|Respiratory System Agents|respiratory system agents|mesh-ancestor
110314750|NCT00452582|Sildenafil Citrate|sildenafil citrate|mesh-list
110314751|NCT00452582|Vasodilator Agents|vasodilator agents|mesh-ancestor
110314752|NCT00452582|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110314753|NCT00452582|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110314754|NCT00452582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110314755|NCT00452582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110314756|NCT00452582|Urological Agents|urological agents|mesh-ancestor
110314757|NCT00334698|Cetirizine|cetirizine|mesh-list
110314758|NCT00334698|Pseudoephedrine|pseudoephedrine|mesh-list
110314759|NCT00334698|Ephedrine|ephedrine|mesh-list
110314760|NCT00334698|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110314761|NCT00334698|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110314762|NCT00334698|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110314763|NCT00334698|Histamine Antagonists|histamine antagonists|mesh-ancestor
110314764|NCT00334698|Histamine Agents|histamine agents|mesh-ancestor
110314765|NCT00334698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110314766|NCT00334698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110314767|NCT00334698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110314768|NCT00334698|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110314769|NCT00334698|Autonomic Agents|autonomic agents|mesh-ancestor
110314770|NCT00334698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110314771|NCT00334698|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110314772|NCT00334698|Respiratory System Agents|respiratory system agents|mesh-ancestor
110314773|NCT00334698|Nasal Decongestants|nasal decongestants|mesh-ancestor
110314774|NCT00334698|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110169974|NCT00016341|Paclitaxel|paclitaxel|mesh-list
110314775|NCT00334698|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110314777|NCT00334698|Adrenergic Agents|adrenergic agents|mesh-ancestor
110314778|NCT00452660|Deferasirox|deferasirox|mesh-list
110314779|NCT00452660|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110314780|NCT00452660|Chelating Agents|chelating agents|mesh-ancestor
110314781|NCT00452660|Sequestering Agents|sequestering agents|mesh-ancestor
110314782|NCT00452660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110314783|NCT00334854|Doxorubicin|doxorubicin|mesh-list
110314784|NCT00334854|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110314785|NCT00334854|Ifosfamide|ifosfamide|mesh-list
110314786|NCT00334854|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110096422|NCT01719926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110314787|NCT00334854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110314788|NCT00334854|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110314789|NCT00334854|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110314790|NCT00334854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110314791|NCT00334854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110314792|NCT00334854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110314793|NCT00334854|Alkylating Agents|alkylating agents|mesh-ancestor
110314794|NCT00334932|Doxorubicin|doxorubicin|mesh-list
110314795|NCT00334932|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110314796|NCT00334932|Bortezomib|bortezomib|mesh-list
110314797|NCT00334932|Melphalan|melphalan|mesh-list
110314798|NCT00334932|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110314799|NCT00334932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110314800|NCT00334932|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110314801|NCT00334932|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110314802|NCT00334932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110314803|NCT00334932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110314804|NCT00334932|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110314805|NCT00334932|Alkylating Agents|alkylating agents|mesh-ancestor
110314806|NCT00334932|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110314807|NCT00334932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110314808|NCT00334932|Immunologic Factors|immunologic factors|mesh-ancestor
110314809|NCT00334932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110314810|NCT00335010|Nitroglycerin|nitroglycerin|mesh-list
110314811|NCT00335010|Vasodilator Agents|vasodilator agents|mesh-ancestor
110314812|NCT00452855|Remifentanil|remifentanil|mesh-list
110314813|NCT00452855|Sevoflurane|sevoflurane|mesh-list
110314814|NCT00452855|Anesthetics|anesthetics|mesh-ancestor
110314815|NCT00452855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110314816|NCT00452855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110314817|NCT00452855|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110314818|NCT00452855|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110314819|NCT00452855|Anesthetics, General|anesthetics, general|mesh-ancestor
110314820|NCT00452855|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110314821|NCT00452855|Narcotics|narcotics|mesh-ancestor
110314822|NCT00452855|Analgesics|analgesics|mesh-ancestor
110314823|NCT00452855|Sensory System Agents|sensory system agents|mesh-ancestor
110314824|NCT00452855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110314826|NCT00335088|Moxifloxacin|moxifloxacin|mesh-list
110314827|NCT00335088|Povidone-Iodine|povidone-iodine|mesh-list
110314828|NCT00335088|Povidone|povidone|mesh-list
110314829|NCT00335088|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110314830|NCT00335088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110314831|NCT00335088|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110096528|NCT01724450|Antioxidants|antioxidants|mesh-ancestor
110314832|NCT00335088|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110314833|NCT00335088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110314834|NCT00335088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110314835|NCT00335088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110314836|NCT00335088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110314837|NCT00335088|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110314839|NCT00335088|Micronutrients|micronutrients|mesh-ancestor
110314840|NCT00335088|Plasma Substitutes|plasma substitutes|mesh-ancestor
110314841|NCT00335088|Blood Substitutes|blood substitutes|mesh-ancestor
110314842|NCT00452894|Varenicline|varenicline|mesh-list
110314843|NCT00452894|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110314844|NCT00452894|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110314845|NCT00452894|Cholinergic Agents|cholinergic agents|mesh-ancestor
110314846|NCT00452894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110314847|NCT00452894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110314848|NCT00452894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110314849|NCT00335166|Pramipexole|pramipexole|mesh-list
110314850|NCT00335166|Antioxidants|antioxidants|mesh-ancestor
110314851|NCT00335166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110314852|NCT00335166|Protective Agents|protective agents|mesh-ancestor
110314853|NCT00335166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110314854|NCT00335166|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110314855|NCT00335166|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110314856|NCT00335166|Dopamine Agonists|dopamine agonists|mesh-ancestor
110314857|NCT00335166|Dopamine Agents|dopamine agents|mesh-ancestor
110096586|NCT01727427|Antipyretics|antipyretics|mesh-ancestor
110314858|NCT00335166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110314859|NCT00452972|Anesthetics|anesthetics|mesh-list
110314860|NCT00452972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110314861|NCT00452972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110314863|NCT00335205|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110314864|NCT00335205|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110314865|NCT00335205|Dopamine Agonists|dopamine agonists|mesh-ancestor
110314866|NCT00335205|Dopamine Agents|dopamine agents|mesh-ancestor
110314867|NCT00335205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110314868|NCT00335205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110096635|NCT01730222|Paclitaxel|paclitaxel|mesh-list
110314869|NCT00335205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110314870|NCT00453050|Imiquimod|imiquimod|mesh-list
110314871|NCT00453050|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110314872|NCT00453050|Immunologic Factors|immunologic factors|mesh-ancestor
110314873|NCT00453050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110314874|NCT00453050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110314875|NCT00453050|Interferon Inducers|interferon inducers|mesh-ancestor
110314876|NCT00335400|Anesthetics|anesthetics|mesh-list
110314877|NCT00335400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110314878|NCT00335400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110314879|NCT00420615|Epothilone B|epothilone b|mesh-list
110314880|NCT00420615|Epothilones|epothilones|mesh-list
110314881|NCT00420615|Omeprazole|omeprazole|mesh-list
110314882|NCT00420615|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110314883|NCT00420615|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110314884|NCT00420615|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110314885|NCT00420615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110314886|NCT00420615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110314887|NCT00420615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110314888|NCT00420615|Tubulin Modulators|tubulin modulators|mesh-ancestor
110314889|NCT00420615|Antimitotic Agents|antimitotic agents|mesh-ancestor
110314890|NCT00420615|Mitosis Modulators|mitosis modulators|mesh-ancestor
110314891|NCT00453167|Paclitaxel|paclitaxel|mesh-list
110314892|NCT00453167|Gemcitabine|gemcitabine|mesh-list
110314893|NCT00453167|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110314894|NCT00453167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110314895|NCT00453167|Tubulin Modulators|tubulin modulators|mesh-ancestor
110314896|NCT00453167|Antimitotic Agents|antimitotic agents|mesh-ancestor
110314897|NCT00453167|Mitosis Modulators|mitosis modulators|mesh-ancestor
110314898|NCT00453167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110314899|NCT00453167|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110314901|NCT00420654|Hormones|hormones|mesh-list
110314902|NCT00420654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110314903|NCT00420654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110314904|NCT00420693|Sevoflurane|sevoflurane|mesh-list
110314905|NCT00420693|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110314906|NCT00420693|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110314907|NCT00420693|Anesthetics, General|anesthetics, general|mesh-ancestor
110314908|NCT00420693|Anesthetics|anesthetics|mesh-ancestor
110314909|NCT00420693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110314910|NCT00420693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110314911|NCT00453323|Paclitaxel|paclitaxel|mesh-list
110314912|NCT00453323|Capecitabine|capecitabine|mesh-list
110374105|NCT00585741|Alovudine|alovudine|mesh-list
110314913|NCT00453323|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110314914|NCT00453323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110314915|NCT00453323|Tubulin Modulators|tubulin modulators|mesh-ancestor
110314916|NCT00453323|Antimitotic Agents|antimitotic agents|mesh-ancestor
110314917|NCT00453323|Mitosis Modulators|mitosis modulators|mesh-ancestor
110314918|NCT00453323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110314919|NCT00453323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110314920|NCT00453323|Antimetabolites|antimetabolites|mesh-ancestor
110314921|NCT00335439|Ketorolac|ketorolac|mesh-list
110314922|NCT00335439|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
110314923|NCT00335439|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110314924|NCT00335439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110314925|NCT00335439|Analgesics|analgesics|mesh-ancestor
110314926|NCT00335439|Sensory System Agents|sensory system agents|mesh-ancestor
110314927|NCT00335439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110314928|NCT00335439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110314929|NCT00335439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110314930|NCT00335439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110314931|NCT00335439|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110314932|NCT00335439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110314933|NCT00335439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110314934|NCT00453401|5-((2-(6-Amino-9H-purin-9-yl) ethyl) amino)-1-pentanol|5-((2-(6-amino-9h-purin-9-yl) ethyl) amino)-1-pentanol|mesh-list
110314935|NCT00453401|Adenylyl Cyclase Inhibitors|adenylyl cyclase inhibitors|mesh-ancestor
110314936|NCT00453401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110314937|NCT00453401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110314938|NCT00335673|Irbesartan|irbesartan|mesh-list
110314939|NCT00335673|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110314940|NCT00335673|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110314941|NCT00335673|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110314942|NCT00335673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110314943|NCT00453635|Carboplatin|carboplatin|mesh-list
110314944|NCT00453635|Docetaxel|docetaxel|mesh-list
110314945|NCT00453635|Trastuzumab|trastuzumab|mesh-list
110314946|NCT00453635|Vinorelbine|vinorelbine|mesh-list
110314947|NCT00453635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110314948|NCT00453635|Tubulin Modulators|tubulin modulators|mesh-ancestor
110314949|NCT00453635|Antimitotic Agents|antimitotic agents|mesh-ancestor
110314950|NCT00453635|Mitosis Modulators|mitosis modulators|mesh-ancestor
110314951|NCT00453635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110314952|NCT00453635|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110314953|NCT00453635|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110314954|NCT00335907|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
110314955|NCT00335985|Immunoglobulins|immunoglobulins|mesh-list
110314956|NCT00335985|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110314957|NCT00335985|gamma-Globulins|gamma-globulins|mesh-list
110314958|NCT00335985|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110314959|NCT00335985|Immunologic Factors|immunologic factors|mesh-ancestor
110314960|NCT00335985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110314961|NCT00336141|Vorinostat|vorinostat|mesh-list
110314962|NCT00336141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110314963|NCT00336141|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110314964|NCT00336141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110314965|NCT00336141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110314966|NCT00336219|Pantoprazole|pantoprazole|mesh-list
110314967|NCT00336219|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110314968|NCT00336219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110314969|NCT00336219|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110314970|NCT00336219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110314971|NCT00336219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110314972|NCT00453908|Alfuzosin|alfuzosin|mesh-list
110314973|NCT00453908|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110314974|NCT00453908|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110314975|NCT00453908|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110314976|NCT00453908|Adrenergic Agents|adrenergic agents|mesh-ancestor
110314977|NCT00453908|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110314978|NCT00453908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110314979|NCT00453908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110314980|NCT00453908|Urological Agents|urological agents|mesh-ancestor
110314981|NCT00336336|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110314982|NCT00336336|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110314983|NCT00336336|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110314984|NCT00336336|Antimetabolites|antimetabolites|mesh-ancestor
110169991|NCT00016341|Hormone Antagonists|hormone antagonists|mesh-ancestor
110314985|NCT00336336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110314987|NCT00336336|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110314988|NCT00336336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110314990|NCT00336375|Artemether|artemether|mesh-list
110314991|NCT00336375|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
110314992|NCT00336375|Antimalarials|antimalarials|mesh-ancestor
110314993|NCT00336375|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110314994|NCT00336375|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110314995|NCT00336375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110314996|NCT00336414|Prednisone|prednisone|mesh-list
110314997|NCT00336414|Cyclophosphamide|cyclophosphamide|mesh-list
110314998|NCT00336414|Azathioprine|azathioprine|mesh-list
110314999|NCT00336414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110315000|NCT00336414|Immunologic Factors|immunologic factors|mesh-ancestor
110315001|NCT00336414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110315002|NCT00336414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110315003|NCT00336414|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110315004|NCT00336414|Alkylating Agents|alkylating agents|mesh-ancestor
110315005|NCT00336414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110315006|NCT00336414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110315007|NCT00336414|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110315008|NCT00336414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110315009|NCT00336414|Glucocorticoids|glucocorticoids|mesh-ancestor
110315010|NCT00336414|Hormones|hormones|mesh-ancestor
110315011|NCT00336414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110315012|NCT00336414|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110315013|NCT00336414|Antimetabolites|antimetabolites|mesh-ancestor
110315014|NCT00336414|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110315015|NCT00336453|Hemagglutinins|hemagglutinins|mesh-list
110315016|NCT00336453|Agglutinins|agglutinins|mesh-ancestor
110315017|NCT00336453|Immunologic Factors|immunologic factors|mesh-ancestor
110315018|NCT00336453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110315019|NCT00336453|Coagulants|coagulants|mesh-ancestor
110315020|NCT00336531|Itraconazole|itraconazole|mesh-list
110315021|NCT00336531|Antifungal Agents|antifungal agents|mesh-ancestor
110315022|NCT00336531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110315023|NCT00336531|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110315024|NCT00336531|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110315025|NCT00336531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110315026|NCT00336531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110315027|NCT00336531|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110315028|NCT00336531|Hormone Antagonists|hormone antagonists|mesh-ancestor
110315029|NCT00336531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110315030|NCT00336531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110315031|NCT00336531|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110315032|NCT00322062|Ascorbic Acid|ascorbic acid|mesh-list
110315033|NCT00322062|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
110315034|NCT00322062|Antioxidants|antioxidants|mesh-ancestor
110315035|NCT00322062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110315036|NCT00322062|Protective Agents|protective agents|mesh-ancestor
110315037|NCT00322062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110315039|NCT00322062|Micronutrients|micronutrients|mesh-ancestor
110315040|NCT00322062|Laxatives|laxatives|mesh-ancestor
110374121|NCT04312750|Lidocaine|lidocaine|mesh-list
110315041|NCT00322062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110315042|NCT00336648|Bevacizumab|bevacizumab|mesh-list
110315043|NCT00336648|Gemcitabine|gemcitabine|mesh-list
110315044|NCT00336648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110315045|NCT00336648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110315046|NCT00336648|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110315047|NCT00336648|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110315048|NCT00336648|Growth Substances|growth substances|mesh-ancestor
110315049|NCT00336648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110315051|NCT00336648|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110315052|NCT00336648|Antimetabolites|antimetabolites|mesh-ancestor
110315053|NCT00336648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110315054|NCT03274817|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
110315055|NCT03274817|Escitalopram|escitalopram|mesh-list
110315056|NCT03274817|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110315057|NCT03274817|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110315058|NCT03274817|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110315059|NCT03274817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110315060|NCT03274817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110315061|NCT03274817|Serotonin Agents|serotonin agents|mesh-ancestor
110315062|NCT03274817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110315063|NCT03274817|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110315064|NCT03274817|Antidepressive Agents|antidepressive agents|mesh-ancestor
110315065|NCT03274817|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110315066|NCT03274817|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110315067|NCT00230204|Antibodies|antibodies|mesh-list
110315068|NCT00230204|Immunologic Factors|immunologic factors|mesh-ancestor
110315069|NCT00230204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110315070|NCT00230321|Darbepoetin alfa|darbepoetin alfa|mesh-list
110315071|NCT00230321|Hematinics|hematinics|mesh-ancestor
110315072|NCT00230399|Celecoxib|celecoxib|mesh-list
110315073|NCT00230399|Capecitabine|capecitabine|mesh-list
110315074|NCT00230399|Irinotecan|irinotecan|mesh-list
110315075|NCT00230399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110315076|NCT00230399|Antimetabolites|antimetabolites|mesh-ancestor
110315077|NCT00230399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110315078|NCT00230399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110315079|NCT00230399|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110315080|NCT00230399|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110315081|NCT00230399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110315082|NCT00230399|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110315083|NCT00230399|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110315084|NCT00230399|Analgesics|analgesics|mesh-ancestor
110315085|NCT00230399|Sensory System Agents|sensory system agents|mesh-ancestor
110315086|NCT00230399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110315087|NCT00230399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110315088|NCT00230399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110096973|NCT01732224|Tenofovir|tenofovir|mesh-list
110315089|NCT00230399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110315090|NCT00230399|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110315091|NCT00230399|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110315093|NCT00336765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110315094|NCT00336765|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110315095|NCT00336765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110315096|NCT00336765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110315098|NCT00230477|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
110315099|NCT00230477|Adefovir|adefovir|mesh-list
110315100|NCT00230477|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110315101|NCT00230477|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110315102|NCT00230477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110315103|NCT00230477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110315104|NCT00230477|Antiviral Agents|antiviral agents|mesh-ancestor
110315105|NCT00230477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110315106|NCT00230477|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110315107|NCT00230477|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110315108|NCT00230516|Lansoprazole|lansoprazole|mesh-list
110315109|NCT00230516|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110315110|NCT00230516|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110170010|NCT00016380|Ondansetron|ondansetron|mesh-list
110315111|NCT00230516|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110315112|NCT00230516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110315113|NCT00230516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110315114|NCT00336882|Midazolam|midazolam|mesh-list
110315115|NCT00336882|Propofol|propofol|mesh-list
110315116|NCT00336882|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110315117|NCT00336882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110315118|NCT00336882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110315119|NCT00336882|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110315120|NCT00336882|Anesthetics, General|anesthetics, general|mesh-ancestor
110315121|NCT00336882|Anesthetics|anesthetics|mesh-ancestor
110315122|NCT00336882|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110315123|NCT00336882|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110315124|NCT00336882|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110315125|NCT00336882|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110315127|NCT00336882|GABA Agents|gaba agents|mesh-ancestor
110315128|NCT00336882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110315129|NCT00336882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110315130|NCT00336921|Alfuzosin|alfuzosin|mesh-list
110315131|NCT00336921|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110315132|NCT00336921|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110315133|NCT00336921|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110315134|NCT00336921|Adrenergic Agents|adrenergic agents|mesh-ancestor
110315135|NCT00336921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110315136|NCT00336921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110315137|NCT00336921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110315138|NCT00336921|Urological Agents|urological agents|mesh-ancestor
110315139|NCT00336960|Celecoxib|celecoxib|mesh-list
110315140|NCT00336960|Fluorouracil|fluorouracil|mesh-list
110315141|NCT00336960|Antimetabolites|antimetabolites|mesh-ancestor
110315142|NCT00336960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110315143|NCT00336960|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110315144|NCT00336960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110315145|NCT00336960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110315146|NCT00336960|Immunologic Factors|immunologic factors|mesh-ancestor
110315147|NCT00336960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110315148|NCT00336960|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110315149|NCT00336960|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110315150|NCT00336960|Analgesics|analgesics|mesh-ancestor
110315151|NCT00336960|Sensory System Agents|sensory system agents|mesh-ancestor
110315152|NCT00336960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110315153|NCT00336960|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110315154|NCT00336960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110315155|NCT00336960|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110315156|NCT00336960|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110315157|NCT00336960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110315158|NCT00306410|Cholecalciferol|cholecalciferol|mesh-list
110315159|NCT00306410|Vitamin D|vitamin d|mesh-list
110315160|NCT00306410|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110315161|NCT00306410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110315162|NCT00306410|Vitamins|vitamins|mesh-ancestor
110315163|NCT00306410|Micronutrients|micronutrients|mesh-ancestor
110315164|NCT00306410|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110315165|NCT00340080|Abacavir|abacavir|mesh-list
110315166|NCT00340080|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110315167|NCT00340080|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110315168|NCT00340080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110315169|NCT00340080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110315170|NCT00340080|Antiviral Agents|antiviral agents|mesh-ancestor
110315171|NCT00340080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110315172|NCT00340080|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110315173|NCT00340080|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110315174|NCT00418535|Cisplatin|cisplatin|mesh-list
110315175|NCT00418535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110315176|NCT02960711|Metformin|metformin|mesh-list
110315177|NCT02960711|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110315178|NCT02960711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110315179|NCT00337155|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
110170017|NCT00016380|Glucocorticoids|glucocorticoids|mesh-ancestor
110315180|NCT00337155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110315181|NCT00340314|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
110315182|NCT00306644|Rosiglitazone|rosiglitazone|mesh-list
110315183|NCT00306644|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110315184|NCT00306644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110315185|NCT00306683|Diazoxide|diazoxide|mesh-list
110315186|NCT00306683|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110315187|NCT00306683|Vasodilator Agents|vasodilator agents|mesh-ancestor
110315188|NCT00306722|Fospropofol|fospropofol|mesh-list
110315189|NCT00306722|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110315190|NCT00306722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110315191|NCT00306722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110315192|NCT00337389|Leucovorin|leucovorin|mesh-list
110315193|NCT00337389|Bevacizumab|bevacizumab|mesh-list
110315194|NCT00337389|Fluorouracil|fluorouracil|mesh-list
110315195|NCT00337389|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110315196|NCT00337389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110315197|NCT00337389|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110315198|NCT00337389|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110315199|NCT00337389|Growth Substances|growth substances|mesh-ancestor
110315200|NCT00337389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110315201|NCT00337389|Growth Inhibitors|growth inhibitors|mesh-ancestor
110315202|NCT00337389|Antimetabolites|antimetabolites|mesh-ancestor
110315203|NCT00337389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110315204|NCT00337389|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110315205|NCT00337389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110315206|NCT00337389|Immunologic Factors|immunologic factors|mesh-ancestor
110315207|NCT00337389|Antidotes|antidotes|mesh-ancestor
110315208|NCT00337389|Protective Agents|protective agents|mesh-ancestor
110315209|NCT00337389|Vitamin B Complex|vitamin b complex|mesh-ancestor
110315210|NCT00337389|Vitamins|vitamins|mesh-ancestor
110315211|NCT00337389|Micronutrients|micronutrients|mesh-ancestor
110315212|NCT00306800|Aminolevulinic Acid|aminolevulinic acid|mesh-list
110315213|NCT00306800|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
110315214|NCT00306800|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110315215|NCT00306800|Dermatologic Agents|dermatologic agents|mesh-ancestor
110315217|NCT00306878|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110315218|NCT00306878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110315219|NCT00306878|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110315220|NCT00306878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110315221|NCT00306878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110315222|NCT00306878|Immunologic Factors|immunologic factors|mesh-ancestor
110315223|NCT00306878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110315224|NCT00306878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110315225|NCT00337506|Dexamethasone|dexamethasone|mesh-list
110315227|NCT00337506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110315228|NCT00337506|Antiemetics|antiemetics|mesh-ancestor
110315229|NCT00337506|Autonomic Agents|autonomic agents|mesh-ancestor
110315230|NCT00337506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110315231|NCT00337506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110315232|NCT00337506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110315233|NCT00337506|Glucocorticoids|glucocorticoids|mesh-ancestor
110315234|NCT00337506|Hormones|hormones|mesh-ancestor
110315235|NCT00337506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110315236|NCT00337506|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110315237|NCT00337506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110315238|NCT00307307|Niacin|niacin|mesh-list
110315239|NCT00307307|Simvastatin|simvastatin|mesh-list
110315240|NCT00307307|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110315241|NCT00307307|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110315242|NCT00307307|Antimetabolites|antimetabolites|mesh-ancestor
110315243|NCT00307307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110315244|NCT00307307|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110315245|NCT00307307|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110315246|NCT00307307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110315247|NCT00307307|Vasodilator Agents|vasodilator agents|mesh-ancestor
110315248|NCT00307307|Vitamin B Complex|vitamin b complex|mesh-ancestor
110315249|NCT00307307|Vitamins|vitamins|mesh-ancestor
110315250|NCT00307307|Micronutrients|micronutrients|mesh-ancestor
110315251|NCT00307307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110315252|NCT00337623|Prednisolone|prednisolone|mesh-list
110315253|NCT00337623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110315254|NCT00337623|Glucocorticoids|glucocorticoids|mesh-ancestor
110315255|NCT00337623|Hormones|hormones|mesh-ancestor
110315256|NCT00337623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110315257|NCT00337623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110315258|NCT00337623|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110315259|NCT00337623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110315260|NCT00337701|Enfuvirtide|enfuvirtide|mesh-list
110315261|NCT00337701|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110315262|NCT00337701|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110315263|NCT00337701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110315264|NCT00337701|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110315265|NCT00337701|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110315266|NCT00337701|Antiviral Agents|antiviral agents|mesh-ancestor
110315267|NCT00337701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110315268|NCT00307463|Antihypertensive Agents|antihypertensive agents|mesh-list
110315269|NCT00337740|Propranolol|propranolol|mesh-list
110315270|NCT00337740|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110315271|NCT00337740|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110315272|NCT00337740|Adrenergic Agents|adrenergic agents|mesh-ancestor
110315273|NCT00337740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110315274|NCT00337740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110315275|NCT00337740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110315276|NCT00337740|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110315277|NCT00337740|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110315278|NCT00337740|Vasodilator Agents|vasodilator agents|mesh-ancestor
110315279|NCT00307502|Ritonavir|ritonavir|mesh-list
110315280|NCT00307502|Lopinavir|lopinavir|mesh-list
110315281|NCT00307502|Atazanavir Sulfate|atazanavir sulfate|mesh-list
110315282|NCT00307502|Darunavir|darunavir|mesh-list
110315283|NCT00307502|Nelfinavir|nelfinavir|mesh-list
110315284|NCT00307502|Indinavir|indinavir|mesh-list
110315285|NCT00307502|Saquinavir|saquinavir|mesh-list
110315286|NCT00307502|Amprenavir|amprenavir|mesh-list
110315287|NCT00307502|Fosamprenavir|fosamprenavir|mesh-list
110315288|NCT00307502|Nevirapine|nevirapine|mesh-list
110315289|NCT00307502|Tipranavir|tipranavir|mesh-list
110315290|NCT00307502|Efavirenz|efavirenz|mesh-list
110315291|NCT00307502|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110315292|NCT00307502|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110315293|NCT00307502|Protease Inhibitors|protease inhibitors|mesh-ancestor
110315294|NCT00307502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110315295|NCT00307502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110315296|NCT00307502|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110315297|NCT00307502|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110315298|NCT00307502|Antiviral Agents|antiviral agents|mesh-ancestor
110315299|NCT00307502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110315300|NCT00307502|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110315301|NCT00307502|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110315302|NCT00307502|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110315303|NCT00307502|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110315304|NCT00307502|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110315305|NCT00307502|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110315306|NCT00307502|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110315307|NCT00307502|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110315308|NCT00307502|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110315309|NCT00307502|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110315310|NCT00307502|Antitubercular Agents|antitubercular agents|mesh-ancestor
110315311|NCT00307502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110315312|NCT00307580|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
110315313|NCT00307580|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110315314|NCT00307580|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110315315|NCT00307580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110315316|NCT00307619|Topiramate|topiramate|mesh-list
110315317|NCT00307619|Anticonvulsants|anticonvulsants|mesh-ancestor
110315318|NCT00307619|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110170034|NCT00001202|Deslorelin|deslorelin|mesh-list
110315319|NCT00307619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110315321|NCT00307658|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110315322|NCT00307658|Antibodies|antibodies|mesh-list
110315323|NCT00307658|Immunoglobulin G|immunoglobulin g|mesh-list
110315324|NCT00307658|gamma-Globulins|gamma-globulins|mesh-list
110315325|NCT00307658|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110315326|NCT00307658|Immunologic Factors|immunologic factors|mesh-ancestor
110315327|NCT00307658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110315329|NCT00337545|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110315330|NCT00337545|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110315331|NCT00337545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110315332|NCT00337545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110315333|NCT00337545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110315334|NCT00337545|Immunologic Factors|immunologic factors|mesh-ancestor
110315335|NCT00337545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110315336|NCT00337545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110315337|NCT00307775|Estradiol|estradiol|mesh-list
110315338|NCT00307775|Estrogens|estrogens|mesh-ancestor
110315339|NCT00307775|Hormones|hormones|mesh-ancestor
110315340|NCT00307775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110315341|NCT00307775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110315342|NCT00307814|Epoetin Alfa|epoetin alfa|mesh-list
110315343|NCT00307814|Hematinics|hematinics|mesh-ancestor
110315344|NCT00341055|Epoetin Alfa|epoetin alfa|mesh-list
110315345|NCT00341055|Hematinics|hematinics|mesh-ancestor
110315346|NCT00338052|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110315347|NCT00338052|Norethindrone|norethindrone|mesh-list
110315348|NCT00338052|Norethindrone Acetate|norethindrone acetate|mesh-list
110315349|NCT00338052|Estradiol|estradiol|mesh-list
110315350|NCT00338052|Estrogens|estrogens|mesh-ancestor
110315351|NCT00338052|Hormones|hormones|mesh-ancestor
110315352|NCT00338052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110315353|NCT00338052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110315354|NCT00338052|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110315355|NCT00338052|Contraceptive Agents|contraceptive agents|mesh-ancestor
110315356|NCT00338052|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110315357|NCT00338052|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110315358|NCT00338052|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110315359|NCT00338052|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110315360|NCT00338052|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110315362|NCT00338091|Benazepril|benazepril|mesh-list
110315363|NCT00338091|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110315364|NCT00338091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110315365|NCT00338091|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110315366|NCT00338091|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110315367|NCT00338091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110315368|NCT00338091|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110315369|NCT00338091|Protease Inhibitors|protease inhibitors|mesh-ancestor
110315370|NCT00338091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110315371|NCT00308048|Interferons|interferons|mesh-list
110315372|NCT00308048|Ribavirin|ribavirin|mesh-list
110315373|NCT00308048|Interferon-alpha|interferon-alpha|mesh-list
110315374|NCT00308048|Interferon alpha-2|interferon alpha-2|mesh-list
110315375|NCT00308048|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110315376|NCT00308048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110315377|NCT00308048|Antiviral Agents|antiviral agents|mesh-ancestor
110315378|NCT00308048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110315379|NCT00308048|Antimetabolites|antimetabolites|mesh-ancestor
110315380|NCT00308048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110315381|NCT00308048|Immunologic Factors|immunologic factors|mesh-ancestor
110315382|NCT00308048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110315383|NCT00338130|Temozolomide|temozolomide|mesh-list
110315384|NCT00338130|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110315385|NCT00338130|Alkylating Agents|alkylating agents|mesh-ancestor
110315386|NCT00338130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110315387|NCT00338130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110315388|NCT00308126|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
110315389|NCT00308126|Plasma Substitutes|plasma substitutes|mesh-ancestor
110315390|NCT00308126|Blood Substitutes|blood substitutes|mesh-ancestor
110315392|NCT00308165|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110315393|NCT00308165|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110315394|NCT00308165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110315395|NCT00308165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110315396|NCT00308165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110315397|NCT00425334|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110315398|NCT00338247|Capecitabine|capecitabine|mesh-list
110315399|NCT00338247|Lapatinib|lapatinib|mesh-list
110315400|NCT00338247|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110315401|NCT00338247|Antimetabolites|antimetabolites|mesh-ancestor
110315402|NCT00338247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110315403|NCT00338247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110315404|NCT00338247|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110315405|NCT00338247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110315407|NCT00308321|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110315408|NCT00308321|Methylprednisolone|methylprednisolone|mesh-list
110315409|NCT00308321|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110315410|NCT00308321|Prednisolone acetate|prednisolone acetate|mesh-list
110315411|NCT00308321|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110315412|NCT00308321|Prednisolone phosphate|prednisolone phosphate|mesh-list
110315413|NCT00308321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110315414|NCT00308321|Glucocorticoids|glucocorticoids|mesh-ancestor
110315415|NCT00308321|Hormones|hormones|mesh-ancestor
110315416|NCT00308321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110315417|NCT00308321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110315418|NCT00308321|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110315419|NCT00308321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110315420|NCT00308321|Antiemetics|antiemetics|mesh-ancestor
110315421|NCT00308321|Autonomic Agents|autonomic agents|mesh-ancestor
110315422|NCT00308321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110315423|NCT00308321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110315424|NCT00308321|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110315425|NCT00308321|Protective Agents|protective agents|mesh-ancestor
110315427|NCT00308360|Risperidone|risperidone|mesh-list
110315428|NCT00308360|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110315429|NCT00308360|Serotonin Agents|serotonin agents|mesh-ancestor
110315430|NCT00308360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110315431|NCT00308360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110315432|NCT00308360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110315433|NCT00308360|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110315434|NCT00308360|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110315435|NCT00308360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110315436|NCT00308360|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110315437|NCT00308360|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110315438|NCT00308360|Dopamine Agents|dopamine agents|mesh-ancestor
110315439|NCT00308360|Anticonvulsants|anticonvulsants|mesh-ancestor
110315440|NCT00308360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110315441|NCT00308360|GABA Agents|gaba agents|mesh-ancestor
110315442|NCT00308360|Antimanic Agents|antimanic agents|mesh-ancestor
110315443|NCT00341250|Aluminum Hydroxide|aluminum hydroxide|mesh-list
110315444|NCT00341250|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110315445|NCT00341250|Immunologic Factors|immunologic factors|mesh-ancestor
110315446|NCT00341250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110315447|NCT00341250|Antacids|antacids|mesh-ancestor
110315448|NCT00341250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110315449|NCT00341250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110315450|NCT00308438|Teduglutide|teduglutide|mesh-list
110315451|NCT00308438|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110315452|NCT00308438|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110315453|NCT00308438|Protective Agents|protective agents|mesh-ancestor
110315454|NCT00308438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110315455|NCT00308477|Dexamethasone|dexamethasone|mesh-list
110315456|NCT00308477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110315457|NCT00308477|Antiemetics|antiemetics|mesh-ancestor
110315458|NCT00308477|Autonomic Agents|autonomic agents|mesh-ancestor
110315459|NCT00308477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110315460|NCT00308477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110315461|NCT00308477|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110315462|NCT00308477|Glucocorticoids|glucocorticoids|mesh-ancestor
110315463|NCT00308477|Hormones|hormones|mesh-ancestor
110315464|NCT00308477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110315465|NCT00308477|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110315466|NCT00308477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110315467|NCT00308594|Dexamethasone|dexamethasone|mesh-list
110315468|NCT00308594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110315469|NCT00308594|Antiemetics|antiemetics|mesh-ancestor
110315470|NCT00308594|Autonomic Agents|autonomic agents|mesh-ancestor
110315471|NCT00308594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110315472|NCT00308594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110315473|NCT00308594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110315474|NCT00308594|Glucocorticoids|glucocorticoids|mesh-ancestor
110315475|NCT00308594|Hormones|hormones|mesh-ancestor
110315476|NCT00308594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110315477|NCT00308594|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110315478|NCT00308594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110315479|NCT00308945|Travoprost|travoprost|mesh-list
110315480|NCT00308945|Latanoprost|latanoprost|mesh-list
110315481|NCT00308945|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110315482|NCT00308945|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110315483|NCT00308945|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110315484|NCT00338481|Morphine|morphine|mesh-list
110315485|NCT00338481|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110315486|NCT00338481|Narcotics|narcotics|mesh-ancestor
110315487|NCT00338481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110315488|NCT00338481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110315489|NCT00338481|Analgesics|analgesics|mesh-ancestor
110315490|NCT00338481|Sensory System Agents|sensory system agents|mesh-ancestor
110315491|NCT00338481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110315492|NCT00309101|Tacrolimus|tacrolimus|mesh-list
110315493|NCT00309101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110315494|NCT00309101|Immunologic Factors|immunologic factors|mesh-ancestor
110315495|NCT00309101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110315496|NCT00309101|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110315497|NCT00309101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110315498|NCT00309101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110315499|NCT00309218|Methylprednisolone|methylprednisolone|mesh-list
110315500|NCT00309218|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110315501|NCT00309218|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110315502|NCT00309218|Prednisolone|prednisolone|mesh-list
110315503|NCT00309218|Prednisolone acetate|prednisolone acetate|mesh-list
110315504|NCT00309218|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110315505|NCT00309218|Prednisolone phosphate|prednisolone phosphate|mesh-list
110315506|NCT00309218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110315507|NCT00309218|Antiemetics|antiemetics|mesh-ancestor
110315508|NCT00309218|Autonomic Agents|autonomic agents|mesh-ancestor
110315509|NCT00309218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110315510|NCT00309218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110315511|NCT00309218|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110315512|NCT00309218|Glucocorticoids|glucocorticoids|mesh-ancestor
110315514|NCT00309218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110315515|NCT00309218|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110315516|NCT00309218|Protective Agents|protective agents|mesh-ancestor
110315517|NCT00309218|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110315518|NCT00309218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110315519|NCT00309335|Phentolamine|phentolamine|mesh-list
110315520|NCT00309335|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110315521|NCT00309335|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110315522|NCT00309335|Adrenergic Agents|adrenergic agents|mesh-ancestor
110315523|NCT00309335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110315524|NCT00309335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110315525|NCT00309335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110315526|NCT00309335|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110315527|NCT00309374|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110315528|NCT00309374|Simvastatin|simvastatin|mesh-list
110315529|NCT00309374|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110315530|NCT00309374|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110315531|NCT00309374|Antimetabolites|antimetabolites|mesh-ancestor
110315532|NCT00309374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110315533|NCT00309374|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110315534|NCT00309374|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110315535|NCT00309374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110315536|NCT00309413|Cannabidiol|cannabidiol|mesh-list
110315537|NCT00309413|Anticonvulsants|anticonvulsants|mesh-ancestor
110315538|NCT00309491|Tamoxifen|tamoxifen|mesh-list
110315539|NCT00309491|Aminoglutethimide|aminoglutethimide|mesh-list
110315540|NCT00309491|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110315541|NCT00309491|Hormone Antagonists|hormone antagonists|mesh-ancestor
110315542|NCT00309491|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110315543|NCT00309491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110315544|NCT00309491|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110315546|NCT00309491|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110315547|NCT00309491|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110315548|NCT00309491|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110315549|NCT00309491|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110315550|NCT00309491|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110315551|NCT00309491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110315552|NCT00309491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110315553|NCT02960048|Salicylic Acid|salicylic acid|mesh-list
110315554|NCT02960048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110315555|NCT02960048|Antifungal Agents|antifungal agents|mesh-ancestor
110315556|NCT02960048|Keratolytic Agents|keratolytic agents|mesh-ancestor
110315557|NCT02960048|Dermatologic Agents|dermatologic agents|mesh-ancestor
110315558|NCT00309530|Interferons|interferons|mesh-list
110315559|NCT00309530|Fluorouracil|fluorouracil|mesh-list
110315560|NCT00309530|Antimetabolites|antimetabolites|mesh-ancestor
110315561|NCT00309530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110315562|NCT00309530|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110315563|NCT00309530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110315564|NCT00309530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110315565|NCT00309530|Immunologic Factors|immunologic factors|mesh-ancestor
110315566|NCT00309530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110315567|NCT00309530|Antiviral Agents|antiviral agents|mesh-ancestor
110315568|NCT00309530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110315569|NCT00309569|Cyclophosphamide|cyclophosphamide|mesh-list
110315570|NCT00309569|Fluorouracil|fluorouracil|mesh-list
110315571|NCT00309569|Methotrexate|methotrexate|mesh-list
110315572|NCT00309569|Epirubicin|epirubicin|mesh-list
110315573|NCT00309569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110315574|NCT00309569|Immunologic Factors|immunologic factors|mesh-ancestor
110315575|NCT00309569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110315576|NCT00309569|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110315577|NCT00309569|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110315578|NCT00309569|Alkylating Agents|alkylating agents|mesh-ancestor
110315579|NCT00309569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110315580|NCT00309569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110315581|NCT00309569|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110315582|NCT00309569|Antimetabolites|antimetabolites|mesh-ancestor
110315583|NCT00309569|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110315584|NCT00309569|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110315585|NCT00309569|Abortifacient Agents|abortifacient agents|mesh-ancestor
110315586|NCT00309569|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110315587|NCT00309569|Dermatologic Agents|dermatologic agents|mesh-ancestor
110315588|NCT00309569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110315589|NCT00309569|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110315590|NCT00309569|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110315591|NCT00309569|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110315592|NCT00309569|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110315593|NCT00309569|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110315596|NCT00309686|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110315597|NCT00309686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110315598|NCT00309686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110315599|NCT00309686|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110315600|NCT00309686|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110315601|NCT00309686|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110315602|NCT00309686|Serotonin Agents|serotonin agents|mesh-ancestor
110315603|NCT00309686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110315604|NCT00309686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110315605|NCT00309686|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110315606|NCT00309686|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110315607|NCT00309686|Dopamine Agents|dopamine agents|mesh-ancestor
110315608|NCT00309725|Galantamine|galantamine|mesh-list
110315609|NCT00309725|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110315610|NCT00309725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110315611|NCT00309725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110315613|NCT00309725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110315614|NCT00309725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110315615|NCT00309725|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110315616|NCT00309725|Autonomic Agents|autonomic agents|mesh-ancestor
110315617|NCT00309725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110315618|NCT00309725|Nootropic Agents|nootropic agents|mesh-ancestor
110315619|NCT00338754|Adalimumab|adalimumab|mesh-list
110315620|NCT00338754|Antibodies|antibodies|mesh-list
110315621|NCT00338754|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110315622|NCT00338754|Immunologic Factors|immunologic factors|mesh-ancestor
110315623|NCT00338754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110315624|NCT00338754|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110315625|NCT00338754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110315626|NCT00338754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110315627|NCT00338793|Prednisolone|prednisolone|mesh-list
110315628|NCT00338793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110315629|NCT00338793|Glucocorticoids|glucocorticoids|mesh-ancestor
110315630|NCT00338793|Hormones|hormones|mesh-ancestor
110315631|NCT00338793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110097616|NCT01736878|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110315632|NCT00338793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110315633|NCT00338793|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110315634|NCT00338793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110315635|NCT00418847|Miglustat|miglustat|mesh-list
110315636|NCT00418847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110315637|NCT00418847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110315638|NCT00418847|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110315639|NCT00418847|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110315640|NCT00418847|Antiviral Agents|antiviral agents|mesh-ancestor
110315641|NCT00418847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110315642|NCT00418847|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
110315643|NCT00418847|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110315644|NCT00418847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110315645|NCT00309881|Prednisone|prednisone|mesh-list
110315647|NCT00309881|Rituximab|rituximab|mesh-list
110315648|NCT00309881|Doxorubicin|doxorubicin|mesh-list
110315649|NCT00309881|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110315650|NCT00309881|Vincristine|vincristine|mesh-list
110315651|NCT00309881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110315652|NCT00309881|Immunologic Factors|immunologic factors|mesh-ancestor
110315653|NCT00309881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110315654|NCT00309881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110315655|NCT00309881|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110315656|NCT00309881|Alkylating Agents|alkylating agents|mesh-ancestor
110315657|NCT00309881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110315658|NCT00309881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110315659|NCT00309881|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110315660|NCT00309881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110315661|NCT00309881|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110315662|NCT00309881|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110315663|NCT00309881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110315664|NCT00309881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110315665|NCT00309881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110315667|NCT00309881|Hormones|hormones|mesh-ancestor
110315668|NCT00309881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110315669|NCT00309881|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110315670|NCT00309881|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110315671|NCT00309881|Tubulin Modulators|tubulin modulators|mesh-ancestor
110315672|NCT00309881|Antimitotic Agents|antimitotic agents|mesh-ancestor
110315673|NCT00309881|Mitosis Modulators|mitosis modulators|mesh-ancestor
110315674|NCT00309920|Cyclophosphamide|cyclophosphamide|mesh-list
110315675|NCT00309920|Docetaxel|docetaxel|mesh-list
110315676|NCT00309920|Doxorubicin|doxorubicin|mesh-list
110315677|NCT00309920|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110315678|NCT00309920|Fluorouracil|fluorouracil|mesh-list
110315679|NCT00309920|Epirubicin|epirubicin|mesh-list
110315680|NCT00309920|Darbepoetin alfa|darbepoetin alfa|mesh-list
110315681|NCT00309920|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110315682|NCT00309920|Immunologic Factors|immunologic factors|mesh-ancestor
110315683|NCT00309920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110315684|NCT00309920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110315685|NCT00309920|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110315686|NCT00309920|Alkylating Agents|alkylating agents|mesh-ancestor
110315687|NCT00309920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110315688|NCT00309920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110315689|NCT00309920|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110315690|NCT00309920|Tubulin Modulators|tubulin modulators|mesh-ancestor
110315691|NCT00309920|Antimitotic Agents|antimitotic agents|mesh-ancestor
110315692|NCT00309920|Mitosis Modulators|mitosis modulators|mesh-ancestor
110315693|NCT00309920|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110315694|NCT00309920|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110315695|NCT00309920|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110315696|NCT00309920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110315697|NCT00309920|Antimetabolites|antimetabolites|mesh-ancestor
110315698|NCT00309920|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110315699|NCT00309920|Hematinics|hematinics|mesh-ancestor
110315700|NCT00309998|Bevacizumab|bevacizumab|mesh-list
110315701|NCT00309998|Vinorelbine|vinorelbine|mesh-list
110315702|NCT00309998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110315703|NCT00309998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110315704|NCT00309998|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110315705|NCT00309998|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110315706|NCT00309998|Growth Substances|growth substances|mesh-ancestor
110315707|NCT00309998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110315708|NCT00309998|Growth Inhibitors|growth inhibitors|mesh-ancestor
110315709|NCT00309998|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110315711|NCT00309998|Antimitotic Agents|antimitotic agents|mesh-ancestor
110315712|NCT00309998|Mitosis Modulators|mitosis modulators|mesh-ancestor
110315713|NCT00309998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110315715|NCT04715217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110315716|NCT04715217|Immunologic Factors|immunologic factors|mesh-ancestor
110315717|NCT04715217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110315718|NCT04715217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110315719|NCT04715217|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110315720|NCT04715217|Alkylating Agents|alkylating agents|mesh-ancestor
110315721|NCT04715217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110315722|NCT04715217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110315723|NCT04715217|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110315724|NCT00310154|Docetaxel|docetaxel|mesh-list
110315725|NCT00310154|Gefitinib|gefitinib|mesh-list
110315726|NCT00310154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110315727|NCT00310154|Tubulin Modulators|tubulin modulators|mesh-ancestor
110315728|NCT00310154|Antimitotic Agents|antimitotic agents|mesh-ancestor
110315729|NCT00310154|Mitosis Modulators|mitosis modulators|mesh-ancestor
110315730|NCT00310154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110315731|NCT00310154|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110315732|NCT00310154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110315733|NCT00338910|Metronidazole|metronidazole|mesh-list
110315734|NCT00338910|Budesonide|budesonide|mesh-list
110315735|NCT00338910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110315736|NCT00338910|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110315737|NCT00338910|Autonomic Agents|autonomic agents|mesh-ancestor
110315738|NCT00338910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110315739|NCT00338910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110315740|NCT00338910|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110315741|NCT00338910|Respiratory System Agents|respiratory system agents|mesh-ancestor
110315742|NCT00338910|Glucocorticoids|glucocorticoids|mesh-ancestor
110315744|NCT00338910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110315745|NCT00338910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110315746|NCT00338910|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110315747|NCT00338910|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110315748|NCT00338910|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110315749|NCT00310232|Epoetin Alfa|epoetin alfa|mesh-list
110315750|NCT00310232|Hematinics|hematinics|mesh-ancestor
110315751|NCT00418730|Proteasome Inhibitors|proteasome inhibitors|mesh-list
110315752|NCT00418730|Protease Inhibitors|protease inhibitors|mesh-ancestor
110315753|NCT00418730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110097865|NCT01738724|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110315754|NCT00418730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110315755|NCT00310349|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110315756|NCT00310349|Immunologic Factors|immunologic factors|mesh-ancestor
110315757|NCT00310349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110315758|NCT00310505|Amphotericin B|amphotericin b|mesh-list
110315759|NCT00310505|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
110315760|NCT00310505|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
110315761|NCT00310505|Deoxycholic Acid|deoxycholic acid|mesh-list
110315762|NCT00310505|Amebicides|amebicides|mesh-ancestor
110315763|NCT00310505|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110315764|NCT00310505|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110315765|NCT00310505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110315766|NCT00310505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110315767|NCT00310505|Antifungal Agents|antifungal agents|mesh-ancestor
110315768|NCT00310505|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
110315769|NCT00310505|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110315771|NCT00339066|Antidepressive Agents|antidepressive agents|mesh-ancestor
110315772|NCT00339066|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110315773|NCT00339066|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110315774|NCT00339066|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110315775|NCT00339066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110315776|NCT00339066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110315777|NCT00339066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110315778|NCT00339066|Serotonin Agents|serotonin agents|mesh-ancestor
110315779|NCT00339066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110315781|NCT00310583|Analgesics|analgesics|mesh-ancestor
110097925|NCT01739127|Risperidone|risperidone|mesh-list
110315782|NCT00310583|Sensory System Agents|sensory system agents|mesh-ancestor
110315783|NCT00310583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110315784|NCT00310583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110315785|NCT00310583|Anticonvulsants|anticonvulsants|mesh-ancestor
110315786|NCT00310583|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110315787|NCT00310583|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110315788|NCT00310583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110315789|NCT00310583|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110315790|NCT00310583|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110315791|NCT00310583|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110315792|NCT00310583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110315793|NCT00310583|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110315794|NCT00421044|Epothilone B|epothilone b|mesh-list
110315795|NCT00421044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110315796|NCT00421044|Tubulin Modulators|tubulin modulators|mesh-ancestor
110315797|NCT00421044|Antimitotic Agents|antimitotic agents|mesh-ancestor
110315798|NCT00421044|Mitosis Modulators|mitosis modulators|mesh-ancestor
110315799|NCT00421044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110315800|NCT00425217|Rituximab|rituximab|mesh-list
110315801|NCT00425217|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110315802|NCT00425217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110315803|NCT00425217|Immunologic Factors|immunologic factors|mesh-ancestor
110315804|NCT00425217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110315805|NCT00425217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110315806|NCT00310778|Atenolol|atenolol|mesh-list
110315807|NCT00310778|Valsartan|valsartan|mesh-list
110315808|NCT00310778|Candesartan|candesartan|mesh-list
110315809|NCT00310778|Candesartan cilexetil|candesartan cilexetil|mesh-list
110315810|NCT00310778|Ramipril|ramipril|mesh-list
110315811|NCT00310778|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110097971|NCT01739218|Growth Substances|growth substances|mesh-ancestor
110315812|NCT00310778|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110315813|NCT00310778|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110315814|NCT00310778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110315815|NCT00310778|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110315816|NCT00310778|Protease Inhibitors|protease inhibitors|mesh-ancestor
110315817|NCT00310778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110315818|NCT00310778|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110315819|NCT00310778|Sympatholytics|sympatholytics|mesh-ancestor
110315820|NCT00310778|Autonomic Agents|autonomic agents|mesh-ancestor
110315821|NCT00310778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110315822|NCT00310778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110315823|NCT00310778|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110315824|NCT00310778|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110315825|NCT00310778|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110315826|NCT00310778|Adrenergic Agents|adrenergic agents|mesh-ancestor
110315827|NCT00310778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110315829|NCT00421083|Vasodilator Agents|vasodilator agents|mesh-ancestor
110315830|NCT00421083|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110315831|NCT00421083|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110315832|NCT00421083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110315833|NCT00421083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110315834|NCT00421083|Urological Agents|urological agents|mesh-ancestor
110315835|NCT00310895|Imetelstat|imetelstat|mesh-list
110315836|NCT00310895|Motesanib diphosphate|motesanib diphosphate|mesh-list
110315837|NCT00310895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110315838|NCT00310895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110315839|NCT00310895|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110315840|NCT00310934|Buprenorphine|buprenorphine|mesh-list
110315841|NCT00310934|Methadone|methadone|mesh-list
110315842|NCT00310934|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110315843|NCT00310934|Narcotics|narcotics|mesh-ancestor
110315844|NCT00310934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110315845|NCT00310934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110315846|NCT00310934|Analgesics|analgesics|mesh-ancestor
110315847|NCT00310934|Sensory System Agents|sensory system agents|mesh-ancestor
110315848|NCT00310934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110315849|NCT00310934|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110315850|NCT00310934|Antitussive Agents|antitussive agents|mesh-ancestor
110315851|NCT00310934|Respiratory System Agents|respiratory system agents|mesh-ancestor
110315852|NCT00421122|Budesonide|budesonide|mesh-list
110315853|NCT00421122|Terbutaline|terbutaline|mesh-list
110315854|NCT00421122|Formoterol Fumarate|formoterol fumarate|mesh-list
110315855|NCT00421122|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
110315856|NCT00421122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110315857|NCT00421122|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110315858|NCT00421122|Autonomic Agents|autonomic agents|mesh-ancestor
110315859|NCT00421122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110315860|NCT00421122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110315861|NCT00421122|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110315862|NCT00421122|Respiratory System Agents|respiratory system agents|mesh-ancestor
110315863|NCT00421122|Glucocorticoids|glucocorticoids|mesh-ancestor
110315865|NCT00421122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110315866|NCT00421122|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110315867|NCT00421122|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110315868|NCT00421122|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110315869|NCT00421122|Adrenergic Agents|adrenergic agents|mesh-ancestor
110315870|NCT00421122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110442366|NCT00680329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110315871|NCT00421122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110315872|NCT00421122|Sympathomimetics|sympathomimetics|mesh-ancestor
110315873|NCT00421122|Tocolytic Agents|tocolytic agents|mesh-ancestor
110315874|NCT00421122|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110315875|NCT00311051|Ramatroban|ramatroban|mesh-list
110315876|NCT00311051|Montelukast|montelukast|mesh-list
110315877|NCT00311051|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110315878|NCT00311051|Respiratory System Agents|respiratory system agents|mesh-ancestor
110315879|NCT00311051|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110315880|NCT00311051|Hormone Antagonists|hormone antagonists|mesh-ancestor
110315881|NCT00311051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110315882|NCT00311051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110315883|NCT00311051|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110315884|NCT00311051|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110315885|NCT00311051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110315886|NCT00311051|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110315887|NCT00311129|Rituximab|rituximab|mesh-list
110315888|NCT00311129|Fludarabine|fludarabine|mesh-list
110315889|NCT00311129|Fludarabine phosphate|fludarabine phosphate|mesh-list
110315890|NCT00311129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110315891|NCT00311129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110315892|NCT00311129|Immunologic Factors|immunologic factors|mesh-ancestor
110315893|NCT00311129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110315894|NCT00311129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110315895|NCT00311129|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110315896|NCT00311129|Antimetabolites|antimetabolites|mesh-ancestor
110315897|NCT00311129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110315898|NCT00311129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110315899|NCT00311285|Hydrocortisone|hydrocortisone|mesh-list
110315900|NCT00311285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110315901|NCT00342381|Amifampridine|amifampridine|mesh-list
110315902|NCT00342381|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110315903|NCT00342381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110315904|NCT00342381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110315905|NCT00342381|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
110315906|NCT00342381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110315907|NCT00342381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110315908|NCT00311558|Interferons|interferons|mesh-list
110315909|NCT00311558|Interferon-alpha|interferon-alpha|mesh-list
110315910|NCT00311558|Interferon alpha-2|interferon alpha-2|mesh-list
110315911|NCT00311558|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
110315912|NCT00311558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110315913|NCT00311558|Antiviral Agents|antiviral agents|mesh-ancestor
110315914|NCT00311558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110315915|NCT00311558|Immunologic Factors|immunologic factors|mesh-ancestor
110315916|NCT00311558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110315917|NCT00311558|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110315918|NCT00311558|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110315919|NCT00311558|Schistosomicides|schistosomicides|mesh-ancestor
110315920|NCT00311558|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110315921|NCT00311558|Anthelmintics|anthelmintics|mesh-ancestor
110315922|NCT00418925|Dronabinol|dronabinol|mesh-list
110315923|NCT00418925|Hallucinogens|hallucinogens|mesh-ancestor
110315924|NCT00418925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110315925|NCT00418925|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110315926|NCT00418925|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110315927|NCT00418925|Analgesics|analgesics|mesh-ancestor
110315928|NCT00418925|Sensory System Agents|sensory system agents|mesh-ancestor
110315929|NCT00418925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110315930|NCT00418925|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
110315931|NCT00418925|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110315932|NCT00418925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110315933|NCT00418925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110315934|NCT00418925|Hormones|hormones|mesh-ancestor
110315935|NCT00418925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110315936|NCT00339417|Ivermectin|ivermectin|mesh-list
110315937|NCT00339417|Albendazole|albendazole|mesh-list
110315938|NCT00339417|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110315940|NCT00339417|Anthelmintics|anthelmintics|mesh-ancestor
110315941|NCT00339417|Anticestodal Agents|anticestodal agents|mesh-ancestor
110315942|NCT00339417|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110315944|NCT00339417|Tubulin Modulators|tubulin modulators|mesh-ancestor
110315945|NCT00339417|Antimitotic Agents|antimitotic agents|mesh-ancestor
110315946|NCT00339417|Mitosis Modulators|mitosis modulators|mesh-ancestor
110315947|NCT00339417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110315948|NCT00339417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110315949|NCT00311636|Paclitaxel|paclitaxel|mesh-list
110315950|NCT00311636|Docetaxel|docetaxel|mesh-list
110315951|NCT00311636|Cyclophosphamide|cyclophosphamide|mesh-list
110315952|NCT00311636|Doxorubicin|doxorubicin|mesh-list
110315953|NCT00311636|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110315954|NCT00311636|Fluorouracil|fluorouracil|mesh-list
110315955|NCT00311636|Methotrexate|methotrexate|mesh-list
110315957|NCT00311636|Triptorelin Pamoate|triptorelin pamoate|mesh-list
110315958|NCT00311636|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110315960|NCT00311636|Tubulin Modulators|tubulin modulators|mesh-ancestor
110315961|NCT00311636|Antimitotic Agents|antimitotic agents|mesh-ancestor
110315962|NCT00311636|Mitosis Modulators|mitosis modulators|mesh-ancestor
110315963|NCT00311636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110315964|NCT00311636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110315965|NCT00311636|Immunologic Factors|immunologic factors|mesh-ancestor
110315966|NCT00311636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110315967|NCT00311636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110315968|NCT00311636|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110315969|NCT00311636|Alkylating Agents|alkylating agents|mesh-ancestor
110315970|NCT00311636|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110315971|NCT00311636|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110098175|NCT01741077|Folic Acid|folic acid|mesh-list
110315972|NCT00311636|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110315973|NCT00311636|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110315974|NCT00311636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110315975|NCT00311636|Antimetabolites|antimetabolites|mesh-ancestor
110315976|NCT00311636|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110315977|NCT00311636|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110315978|NCT00311636|Abortifacient Agents|abortifacient agents|mesh-ancestor
110315979|NCT00311636|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110315980|NCT00311636|Dermatologic Agents|dermatologic agents|mesh-ancestor
110315981|NCT00311636|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110315982|NCT00311636|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110315983|NCT00311636|Luteolytic Agents|luteolytic agents|mesh-ancestor
110315984|NCT00311636|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110315985|NCT00311636|Contraceptive Agents|contraceptive agents|mesh-ancestor
110315986|NCT00311636|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110315987|NCT00311636|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110315988|NCT00311753|Heparin|heparin|mesh-list
110315989|NCT00311753|Certoparin|certoparin|mesh-list
110374240|NCT01137955|Rifaximin|rifaximin|mesh-list
110315990|NCT00311753|Anticoagulants|anticoagulants|mesh-ancestor
110315991|NCT00311753|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110315992|NCT00311753|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110315993|NCT00311753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110315994|NCT00311870|Lisinopril|lisinopril|mesh-list
110315995|NCT00311870|Nisoldipine|nisoldipine|mesh-list
110315996|NCT00311870|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110315997|NCT00311870|Protease Inhibitors|protease inhibitors|mesh-ancestor
110315998|NCT00311870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110315999|NCT00311870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110316000|NCT00311870|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110316001|NCT00311870|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110316002|NCT00311870|Protective Agents|protective agents|mesh-ancestor
110316003|NCT00311870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110316004|NCT00311870|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110316005|NCT00311870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110316006|NCT00311870|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110316007|NCT00311870|Vasodilator Agents|vasodilator agents|mesh-ancestor
110316008|NCT00311987|3,5-diiodothyropropionic acid|3,5-diiodothyropropionic acid|mesh-list
110316009|NCT00311987|Hormones|hormones|mesh-ancestor
110316010|NCT00311987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110316011|NCT00311987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110316013|NCT00342849|Antidotes|antidotes|mesh-ancestor
110316014|NCT00342849|Protective Agents|protective agents|mesh-ancestor
110316015|NCT00342849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110316016|NCT00342849|Chelating Agents|chelating agents|mesh-ancestor
110316017|NCT00342849|Sequestering Agents|sequestering agents|mesh-ancestor
110316018|NCT00342849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110316020|NCT00312104|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110316021|NCT00312104|Insulin Glargine|insulin glargine|mesh-list
110316022|NCT00312104|Insulin Aspart|insulin aspart|mesh-list
110316023|NCT00312104|Insulin Detemir|insulin detemir|mesh-list
110316024|NCT00312104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110098275|NCT01741623|Bisoprolol|bisoprolol|mesh-list
110316025|NCT00312104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110316026|NCT00312143|Mycophenolic Acid|mycophenolic acid|mesh-list
110316027|NCT00312143|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110316028|NCT00312143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110316029|NCT00312143|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110316030|NCT00312143|Antitubercular Agents|antitubercular agents|mesh-ancestor
110316031|NCT00312143|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110316032|NCT00312143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110316033|NCT00312143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110316034|NCT00312143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110316035|NCT00343005|Aluminum Hydroxide|aluminum hydroxide|mesh-list
110316036|NCT00343005|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110316037|NCT00343005|Immunologic Factors|immunologic factors|mesh-ancestor
110316038|NCT00343005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110316039|NCT00343005|Antacids|antacids|mesh-ancestor
110316040|NCT00343005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110316041|NCT00343005|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110316042|NCT00312182|Nelfinavir|nelfinavir|mesh-list
110316044|NCT00312182|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110316045|NCT00312182|Protease Inhibitors|protease inhibitors|mesh-ancestor
110316046|NCT00312182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110316047|NCT00312182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110316048|NCT00312182|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110316049|NCT00312182|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110316050|NCT00312182|Antiviral Agents|antiviral agents|mesh-ancestor
110316051|NCT00312182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110316052|NCT00312260|Gabapentin|gabapentin|mesh-list
110316053|NCT00312260|Amitriptyline|amitriptyline|mesh-list
110316054|NCT00312260|Analgesics|analgesics|mesh-ancestor
110316055|NCT00312260|Sensory System Agents|sensory system agents|mesh-ancestor
110316056|NCT00312260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110316057|NCT00312260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110316058|NCT00312260|Anticonvulsants|anticonvulsants|mesh-ancestor
110316059|NCT00312260|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110316060|NCT00312260|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110316061|NCT00312260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110316062|NCT00312260|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110316063|NCT00312260|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110316064|NCT00312260|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110316065|NCT00312260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110316066|NCT00312260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110316067|NCT00312260|Antimanic Agents|antimanic agents|mesh-ancestor
110316068|NCT00312260|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110316069|NCT00312260|Antidepressive Agents|antidepressive agents|mesh-ancestor
110316070|NCT00312260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110316071|NCT00312260|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110316072|NCT00312260|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110316073|NCT00312260|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110316074|NCT00312260|Adrenergic Agents|adrenergic agents|mesh-ancestor
110316075|NCT00312299|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
110316076|NCT00312299|Vasodilator Agents|vasodilator agents|mesh-ancestor
110316077|NCT00312299|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
110316078|NCT00312299|Protective Agents|protective agents|mesh-ancestor
110316079|NCT00312299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110316081|NCT00312416|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110316082|NCT00312416|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110316083|NCT00312416|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110316084|NCT00312416|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110316085|NCT00312416|Adrenergic Agents|adrenergic agents|mesh-ancestor
110316086|NCT00312416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110098446|NCT01742676|Tacrolimus|tacrolimus|mesh-list
110316087|NCT00312416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110316088|NCT00312416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110316089|NCT00339768|Amoxicillin|amoxicillin|mesh-list
110316091|NCT00339768|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110316092|NCT00339768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110316093|NCT00339768|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110316094|NCT00339768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110316095|NCT00339768|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110316096|NCT00339768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110316097|NCT00339768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110316098|NCT00343161|Esomeprazole|esomeprazole|mesh-list
110316099|NCT00343161|Aluminum Hydroxide|aluminum hydroxide|mesh-list
110316100|NCT00343161|Magnesium trisilicate|magnesium trisilicate|mesh-list
110316101|NCT00343161|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110316102|NCT00343161|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110316103|NCT00343161|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110316104|NCT00343161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110316105|NCT00343161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110316106|NCT00343161|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110316107|NCT00343161|Immunologic Factors|immunologic factors|mesh-ancestor
110316108|NCT00343161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110316110|NCT00312533|Hylan|hylan|mesh-list
110316111|NCT00312533|Viscosupplements|viscosupplements|mesh-ancestor
110316112|NCT00312533|Protective Agents|protective agents|mesh-ancestor
110316113|NCT00312533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110316115|NCT00312650|Doxorubicin|doxorubicin|mesh-list
110316116|NCT00312650|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110316117|NCT00312650|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110316118|NCT00312650|Antimetabolites|antimetabolites|mesh-ancestor
110316119|NCT00312650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110316120|NCT00312650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110316121|NCT00312650|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110316122|NCT00312650|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110316123|NCT00312650|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110316124|NCT00312650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110316125|NCT00343200|Sildenafil Citrate|sildenafil citrate|mesh-list
110098541|NCT01743014|Purinergic Agents|purinergic agents|mesh-ancestor
110316126|NCT00343200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110316127|NCT00343200|Vasodilator Agents|vasodilator agents|mesh-ancestor
110316128|NCT00343200|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110316129|NCT00343200|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110316130|NCT00343200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110316131|NCT00343200|Urological Agents|urological agents|mesh-ancestor
110316132|NCT00312806|Pantoprazole|pantoprazole|mesh-list
110316133|NCT00312806|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110316134|NCT00312806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110316135|NCT00312806|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110316136|NCT00312806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110316137|NCT00312806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110316139|NCT00347685|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110316140|NCT00347685|Narcotics|narcotics|mesh-ancestor
110316141|NCT00347685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110316142|NCT00347685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110316143|NCT00347685|Analgesics|analgesics|mesh-ancestor
110316144|NCT00347685|Sensory System Agents|sensory system agents|mesh-ancestor
110316145|NCT00347685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110316146|NCT00343239|Docetaxel|docetaxel|mesh-list
110316147|NCT00343239|Fluorouracil|fluorouracil|mesh-list
110316148|NCT00343239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110316149|NCT00343239|Tubulin Modulators|tubulin modulators|mesh-ancestor
110316150|NCT00343239|Antimitotic Agents|antimitotic agents|mesh-ancestor
110098599|NCT01743235|Buspirone|buspirone|mesh-list
110316151|NCT00343239|Mitosis Modulators|mitosis modulators|mesh-ancestor
110316152|NCT00343239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110316154|NCT00343239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110316155|NCT00343239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110316156|NCT00343239|Immunologic Factors|immunologic factors|mesh-ancestor
110316157|NCT00343239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110316158|NCT00313001|Insulin Aspart|insulin aspart|mesh-list
110316159|NCT00313001|Exenatide|exenatide|mesh-list
110316160|NCT00313001|Biphasic Insulins|biphasic insulins|mesh-list
110316161|NCT00313001|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110316162|NCT00313001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110316163|NCT00313001|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110316164|NCT00313001|Incretins|incretins|mesh-ancestor
110316165|NCT00313001|Hormones|hormones|mesh-ancestor
110316166|NCT00313001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110316167|NCT00343278|Valacyclovir|valacyclovir|mesh-list
110316168|NCT00343278|Antiviral Agents|antiviral agents|mesh-ancestor
110316169|NCT00343278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110316170|NCT00343317|Cefoxitin|cefoxitin|mesh-list
110316171|NCT00343317|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110316172|NCT00343317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110316173|NCT00313079|Vincristine|vincristine|mesh-list
110316174|NCT00313079|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110316175|NCT00313079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110316176|NCT00313079|Tubulin Modulators|tubulin modulators|mesh-ancestor
110316177|NCT00313079|Antimitotic Agents|antimitotic agents|mesh-ancestor
110316178|NCT00313079|Mitosis Modulators|mitosis modulators|mesh-ancestor
110316179|NCT00313079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110316180|NCT00347724|Tramadol|tramadol|mesh-list
110316181|NCT00347724|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110316182|NCT00347724|Narcotics|narcotics|mesh-ancestor
110316183|NCT00347724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110316184|NCT00347724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110316185|NCT00347724|Analgesics|analgesics|mesh-ancestor
110316186|NCT00347724|Sensory System Agents|sensory system agents|mesh-ancestor
110316187|NCT00347724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110316188|NCT00313157|Metoprolol|metoprolol|mesh-list
110316189|NCT00313157|Verapamil|verapamil|mesh-list
110316190|NCT00313157|Carvedilol|carvedilol|mesh-list
110316191|NCT00313157|Diltiazem|diltiazem|mesh-list
110316192|NCT00313157|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110316193|NCT00313157|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110316194|NCT00313157|Sympatholytics|sympatholytics|mesh-ancestor
110316195|NCT00313157|Autonomic Agents|autonomic agents|mesh-ancestor
110316196|NCT00313157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110316197|NCT00313157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110316198|NCT00313157|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110316199|NCT00313157|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110316200|NCT00313157|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110316201|NCT00313157|Adrenergic Agents|adrenergic agents|mesh-ancestor
110316202|NCT00313157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110316203|NCT00313157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110316205|NCT00313157|Protective Agents|protective agents|mesh-ancestor
110316206|NCT00313157|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110316207|NCT00313157|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110316208|NCT00313157|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110316209|NCT00313157|Vasodilator Agents|vasodilator agents|mesh-ancestor
110316210|NCT00313157|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110316211|NCT00313157|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110316212|NCT00347763|Permethrin|permethrin|mesh-list
110316213|NCT00347763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110316214|NCT00347763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110316215|NCT00313235|Cyclophosphamide|cyclophosphamide|mesh-list
110316216|NCT00313235|Vaccines|vaccines|mesh-list
110316217|NCT00313235|Immunologic Factors|immunologic factors|mesh-ancestor
110316218|NCT00313235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110316219|NCT00313235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110316220|NCT00313235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110316221|NCT00313235|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110316222|NCT00313235|Alkylating Agents|alkylating agents|mesh-ancestor
110316223|NCT00313235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110316224|NCT00313235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110316225|NCT00313235|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110316226|NCT00347802|Bimatoprost|bimatoprost|mesh-list
110316228|NCT00347802|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110316230|NCT00313274|Antiviral Agents|antiviral agents|mesh-ancestor
110316231|NCT00313274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110316232|NCT00419042|Gemcitabine|gemcitabine|mesh-list
110316233|NCT00419042|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110316234|NCT00419042|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110316235|NCT00419042|Antimetabolites|antimetabolites|mesh-ancestor
110316236|NCT00419042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110316237|NCT00419042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110316238|NCT00419042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110316239|NCT00419042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110316240|NCT00347841|Bimatoprost|bimatoprost|mesh-list
110316241|NCT00347841|Latanoprost|latanoprost|mesh-list
110316242|NCT00347841|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110316243|NCT00347841|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110316244|NCT00347841|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110316245|NCT00425126|Epoetin Alfa|epoetin alfa|mesh-list
110316246|NCT00425126|Hematinics|hematinics|mesh-ancestor
110316247|NCT00343629|Sulindac|sulindac|mesh-list
110316248|NCT00343629|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110316249|NCT00343629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110316250|NCT00343629|Analgesics|analgesics|mesh-ancestor
110316251|NCT00343629|Sensory System Agents|sensory system agents|mesh-ancestor
110316252|NCT00343629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110316253|NCT00343629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110316254|NCT00343629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110316255|NCT00343629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110316256|NCT00343629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110316257|NCT00343629|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110316258|NCT00343629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110316259|NCT00343629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110316260|NCT00343668|Irinotecan|irinotecan|mesh-list
110316261|NCT00343668|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110316262|NCT00343668|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110316263|NCT00343668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110316264|NCT00343668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110316265|NCT00343668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110316266|NCT00343707|Paroxetine|paroxetine|mesh-list
110316267|NCT00343707|Vestipitant|vestipitant|mesh-list
110316268|NCT00343707|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110316269|NCT00343707|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110316270|NCT00343707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110316271|NCT00343707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110316272|NCT00343707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110316274|NCT00343707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110316275|NCT00343707|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110316276|NCT00343707|Antidepressive Agents|antidepressive agents|mesh-ancestor
110316277|NCT00343707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110316278|NCT00343707|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110316279|NCT00343707|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110316280|NCT00343707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110316281|NCT00343707|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110316283|NCT00313391|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110316284|NCT00313391|Serotonin Agents|serotonin agents|mesh-ancestor
110316285|NCT00313391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110316286|NCT00313391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110316287|NCT00313391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110316288|NCT00313391|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110316289|NCT00313391|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110316290|NCT00313391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110316291|NCT00313391|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110316292|NCT00313391|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110316293|NCT00313391|Dopamine Agents|dopamine agents|mesh-ancestor
110316294|NCT00348153|Adalimumab|adalimumab|mesh-list
110316295|NCT00348153|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110316296|NCT00348153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110316297|NCT00348153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110316298|NCT00313508|Vidarabine|vidarabine|mesh-list
110316299|NCT00313508|Fludarabine|fludarabine|mesh-list
110316300|NCT00313508|Fludarabine phosphate|fludarabine phosphate|mesh-list
110316301|NCT00313508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110316302|NCT00313508|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110316303|NCT00313508|Antimetabolites|antimetabolites|mesh-ancestor
110316304|NCT00313508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110316305|NCT00313508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110316306|NCT00313508|Immunologic Factors|immunologic factors|mesh-ancestor
110316307|NCT00313508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110316308|NCT00313508|Antiviral Agents|antiviral agents|mesh-ancestor
110316309|NCT00313508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110316310|NCT00313547|Amlodipine|amlodipine|mesh-list
110316311|NCT00313547|Quinapril|quinapril|mesh-list
110316312|NCT00313547|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110316313|NCT00313547|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110316314|NCT00313547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110316315|NCT00313547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110316316|NCT00313547|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110316317|NCT00313547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110316318|NCT00313547|Vasodilator Agents|vasodilator agents|mesh-ancestor
110316319|NCT00313547|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110316320|NCT00313547|Protease Inhibitors|protease inhibitors|mesh-ancestor
110316321|NCT00313547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110316322|NCT00348192|Donepezil|donepezil|mesh-list
110316323|NCT00348192|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110316324|NCT00348192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110316325|NCT00348192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110316326|NCT00348192|Cholinergic Agents|cholinergic agents|mesh-ancestor
110316327|NCT00348192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110316328|NCT00348192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110316330|NCT00313625|Methotrexate|methotrexate|mesh-list
110316331|NCT00313625|Melphalan|melphalan|mesh-list
110316332|NCT00313625|Busulfan|busulfan|mesh-list
110316333|NCT00313625|Tacrolimus|tacrolimus|mesh-list
110316334|NCT00313625|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110316335|NCT00313625|Abortifacient Agents|abortifacient agents|mesh-ancestor
110316336|NCT00313625|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110316337|NCT00313625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110316338|NCT00313625|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110316339|NCT00313625|Antimetabolites|antimetabolites|mesh-ancestor
110316340|NCT00313625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110316341|NCT00313625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110316342|NCT00313625|Dermatologic Agents|dermatologic agents|mesh-ancestor
110316343|NCT00313625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110316344|NCT00313625|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110316345|NCT00313625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110316346|NCT00313625|Immunologic Factors|immunologic factors|mesh-ancestor
110316347|NCT00313625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110316348|NCT00313625|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110316349|NCT00313625|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110316350|NCT00313625|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110316351|NCT00313625|Alkylating Agents|alkylating agents|mesh-ancestor
110316352|NCT00313625|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110316354|NCT00343980|Glimepiride|glimepiride|mesh-list
110316355|NCT00343980|Rosiglitazone|rosiglitazone|mesh-list
110316356|NCT00343980|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110316357|NCT00343980|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110316358|NCT00343980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110316359|NCT00343980|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110316360|NCT00343980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110316361|NCT00343980|Immunologic Factors|immunologic factors|mesh-ancestor
110316363|NCT00313742|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110316364|NCT00313742|Insulin Glargine|insulin glargine|mesh-list
110316365|NCT00313742|Insulin Detemir|insulin detemir|mesh-list
110316366|NCT00313742|Isophane Insulin, Human|isophane insulin, human|mesh-list
110316367|NCT00313742|Insulin, Isophane|insulin, isophane|mesh-list
110316368|NCT00313742|Isophane insulin, beef|isophane insulin, beef|mesh-list
110316369|NCT00313742|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110316370|NCT00313742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110316371|NCT00313859|Simvastatin|simvastatin|mesh-list
110316372|NCT00313859|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110316373|NCT00313859|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110316374|NCT00313859|Antimetabolites|antimetabolites|mesh-ancestor
110316375|NCT00313859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110316376|NCT00313859|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110316377|NCT00313859|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110316378|NCT00313859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110316380|NCT00348231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110316381|NCT00348231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110316382|NCT00313898|Sildenafil Citrate|sildenafil citrate|mesh-list
110316383|NCT00313898|Vasodilator Agents|vasodilator agents|mesh-ancestor
110316384|NCT00313898|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110316385|NCT00313898|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110316386|NCT00313898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110316387|NCT00313898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110316388|NCT00313898|Urological Agents|urological agents|mesh-ancestor
110316389|NCT00344058|Magnesium Sulfate|magnesium sulfate|mesh-list
110316390|NCT00344058|Analgesics|analgesics|mesh-ancestor
110316391|NCT00344058|Sensory System Agents|sensory system agents|mesh-ancestor
110148801|NCT00006088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110316392|NCT00344058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110316393|NCT00344058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110316394|NCT00344058|Anesthetics|anesthetics|mesh-ancestor
110316395|NCT00344058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110316396|NCT00344058|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110316397|NCT00344058|Anticonvulsants|anticonvulsants|mesh-ancestor
110316398|NCT00344058|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110316399|NCT00344058|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110316400|NCT00344058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110316401|NCT00344058|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110316402|NCT00344058|Tocolytic Agents|tocolytic agents|mesh-ancestor
110316403|NCT00344058|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110316404|NCT00313937|Insulin Glargine|insulin glargine|mesh-list
110316405|NCT00313937|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110316406|NCT00313937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110316407|NCT00313976|Interferons|interferons|mesh-list
110316408|NCT00313976|Interferon-beta|interferon-beta|mesh-list
110316409|NCT00313976|Interferon beta-1b|interferon beta-1b|mesh-list
110316410|NCT00313976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110316411|NCT00313976|Antiviral Agents|antiviral agents|mesh-ancestor
110316412|NCT00313976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110316413|NCT00313976|Immunologic Factors|immunologic factors|mesh-ancestor
110316414|NCT00313976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110316415|NCT00313976|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110316416|NCT00348387|Vaccines|vaccines|mesh-list
110316417|NCT00348387|Immunologic Factors|immunologic factors|mesh-ancestor
110316418|NCT00348387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110316420|NCT00314171|Dorzolamide|dorzolamide|mesh-list
110316421|NCT00314171|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110316422|NCT00314171|Brinzolamide|brinzolamide|mesh-list
110316423|NCT00314171|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110316424|NCT00314171|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110316425|NCT00314171|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110316426|NCT00314171|Adrenergic Agents|adrenergic agents|mesh-ancestor
110316427|NCT00314171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110316428|NCT00314171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110316429|NCT00314171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110316430|NCT00314171|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110316431|NCT00314171|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110316432|NCT00314171|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110316433|NCT00314171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110316434|NCT00348426|Antitoxins|antitoxins|mesh-list
110316435|NCT00348426|Botulinum Antitoxin|botulinum antitoxin|mesh-list
110316436|NCT00348426|Immunologic Factors|immunologic factors|mesh-ancestor
110316437|NCT00348426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110316438|NCT00314210|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110316439|NCT00314210|Antidepressive Agents|antidepressive agents|mesh-ancestor
110316440|NCT00314210|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110316441|NCT00314210|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110316442|NCT00314210|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110316443|NCT00314210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110316444|NCT00314210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110316446|NCT00344253|Interferon-beta|interferon-beta|mesh-list
110316447|NCT00344253|Methotrexate|methotrexate|mesh-list
110316448|NCT00344253|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110316449|NCT00344253|Abortifacient Agents|abortifacient agents|mesh-ancestor
110316450|NCT00344253|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110316451|NCT00344253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110316452|NCT00344253|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110316453|NCT00344253|Antimetabolites|antimetabolites|mesh-ancestor
110316454|NCT00344253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110316455|NCT00344253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110316456|NCT00344253|Dermatologic Agents|dermatologic agents|mesh-ancestor
110316457|NCT00344253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110148904|NCT00006115|Vitamins|vitamins|mesh-ancestor
110316458|NCT00344253|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110316459|NCT00344253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110316460|NCT00344253|Immunologic Factors|immunologic factors|mesh-ancestor
110316461|NCT00344253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110316462|NCT00344253|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110316464|NCT00344253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110316465|NCT00314405|Methylene Blue|methylene blue|mesh-list
110316466|NCT00314405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110316467|NCT00314405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110316468|NCT04715295|Azithromycin|azithromycin|mesh-list
110316469|NCT04715295|Doxycycline|doxycycline|mesh-list
110316470|NCT04715295|Hydroxychloroquine|hydroxychloroquine|mesh-list
110316471|NCT04715295|Rivaroxaban|rivaroxaban|mesh-list
110316472|NCT04715295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110316473|NCT04715295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110316474|NCT04715295|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110316475|NCT04715295|Antithrombins|antithrombins|mesh-ancestor
110316476|NCT04715295|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110316477|NCT04715295|Protease Inhibitors|protease inhibitors|mesh-ancestor
110316478|NCT04715295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110316479|NCT04715295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110316480|NCT04715295|Anticoagulants|anticoagulants|mesh-ancestor
110316481|NCT04715295|Antimalarials|antimalarials|mesh-ancestor
110316482|NCT04715295|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110316483|NCT04715295|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110316484|NCT04715295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110316485|NCT00348504|Simendan|simendan|mesh-list
110316486|NCT00348504|Dobutamine|dobutamine|mesh-list
110316487|NCT00348504|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110316488|NCT00348504|Vasodilator Agents|vasodilator agents|mesh-ancestor
110316489|NCT00348504|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110316490|NCT00348504|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110316491|NCT00348504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110316492|NCT00348504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110316493|NCT00348504|Protective Agents|protective agents|mesh-ancestor
110316494|NCT00348504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110316495|NCT00348504|Sympathomimetics|sympathomimetics|mesh-ancestor
110316496|NCT00348504|Autonomic Agents|autonomic agents|mesh-ancestor
110316497|NCT00348504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110316498|NCT00348504|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
110316499|NCT00348504|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110316500|NCT00348504|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110316501|NCT00348504|Adrenergic Agents|adrenergic agents|mesh-ancestor
110316502|NCT00348504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110316503|NCT00314561|Pioglitazone|pioglitazone|mesh-list
110316504|NCT00314561|Rosiglitazone|rosiglitazone|mesh-list
110316505|NCT00314561|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110316506|NCT00314561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110316507|NCT00344409|Darbepoetin alfa|darbepoetin alfa|mesh-list
110316509|NCT00348582|Ketorolac|ketorolac|mesh-list
110316510|NCT00348582|Nepafenac|nepafenac|mesh-list
110316511|NCT00348582|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110316512|NCT00348582|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110316513|NCT00348582|Analgesics|analgesics|mesh-ancestor
110316514|NCT00348582|Sensory System Agents|sensory system agents|mesh-ancestor
110316515|NCT00348582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110316516|NCT00348582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110316517|NCT00348582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110316518|NCT00348582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110316519|NCT00348582|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110316520|NCT00348582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110316521|NCT00348582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110316522|NCT00314639|Modafinil|modafinil|mesh-list
110316523|NCT00314639|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110316524|NCT00314639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110316525|NCT00314639|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
110316526|NCT00314639|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110316527|NCT00314639|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110316528|NCT00314639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110316529|NCT00314678|Paclitaxel|paclitaxel|mesh-list
110316530|NCT00314678|Topotecan|topotecan|mesh-list
110316531|NCT00314678|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110316532|NCT00314678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110316533|NCT00314678|Tubulin Modulators|tubulin modulators|mesh-ancestor
110316534|NCT00314678|Antimitotic Agents|antimitotic agents|mesh-ancestor
110316535|NCT00314678|Mitosis Modulators|mitosis modulators|mesh-ancestor
110316536|NCT00314678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110316537|NCT00314678|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110316538|NCT00314678|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110316539|NCT00314678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110316540|NCT00344526|Dexamethasone|dexamethasone|mesh-list
110316542|NCT00344526|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110316543|NCT00344526|Antiemetics|antiemetics|mesh-ancestor
110316544|NCT00344526|Autonomic Agents|autonomic agents|mesh-ancestor
110316545|NCT00344526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110316546|NCT00344526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110316547|NCT00344526|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110316548|NCT00344526|Glucocorticoids|glucocorticoids|mesh-ancestor
110316549|NCT00344526|Hormones|hormones|mesh-ancestor
110316550|NCT00344526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110316551|NCT00344526|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110316552|NCT00344526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110316553|NCT00344526|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110316554|NCT00344526|Alkylating Agents|alkylating agents|mesh-ancestor
110316555|NCT00344526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110316556|NCT00344526|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110316557|NCT00344526|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110316558|NCT00344526|Immunologic Factors|immunologic factors|mesh-ancestor
110316560|NCT00344565|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110316561|NCT00344565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110316562|NCT00344565|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
110316563|NCT00344565|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110316564|NCT00344565|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110316565|NCT00344565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110316566|NCT00314873|Imatinib Mesylate|imatinib mesylate|mesh-list
110316567|NCT00314873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110316568|NCT00314873|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110316569|NCT00314873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110316570|NCT00314873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110316571|NCT00348738|Epoetin Alfa|epoetin alfa|mesh-list
110316572|NCT00348738|Hematinics|hematinics|mesh-ancestor
110316573|NCT00314912|Tramiprosate|tramiprosate|mesh-list
110316574|NCT00314912|Anticonvulsants|anticonvulsants|mesh-ancestor
110316575|NCT00314912|GABA Agonists|gaba agonists|mesh-ancestor
110316576|NCT00314912|GABA Agents|gaba agents|mesh-ancestor
110316577|NCT00314912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110316578|NCT00314912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110316579|NCT00314912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110316581|NCT00314990|Pyridoxine|pyridoxine|mesh-list
110316582|NCT00314990|Vitamin B 12|vitamin b 12|mesh-list
110316583|NCT00314990|Hydroxocobalamin|hydroxocobalamin|mesh-list
110316584|NCT00314990|Hematinics|hematinics|mesh-ancestor
110316585|NCT00314990|Vitamin B Complex|vitamin b complex|mesh-ancestor
110316586|NCT00314990|Vitamins|vitamins|mesh-ancestor
110316587|NCT00314990|Micronutrients|micronutrients|mesh-ancestor
110316588|NCT00314990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110316589|NCT02960126|Aspirin|aspirin|mesh-list
110316590|NCT02960126|Clopidogrel|clopidogrel|mesh-list
110316591|NCT02960126|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110316592|NCT02960126|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110316593|NCT02960126|Analgesics|analgesics|mesh-ancestor
110316594|NCT02960126|Sensory System Agents|sensory system agents|mesh-ancestor
110316595|NCT02960126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110316596|NCT02960126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110316598|NCT02960126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110316599|NCT02960126|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110316600|NCT02960126|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110316601|NCT02960126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110316602|NCT02960126|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110316603|NCT02960126|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110316604|NCT02960126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110316605|NCT02960126|Antipyretics|antipyretics|mesh-ancestor
110316606|NCT02960126|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110316607|NCT02960126|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110316608|NCT02960126|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110316609|NCT02960126|Purinergic Agents|purinergic agents|mesh-ancestor
110316610|NCT02960126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110316611|NCT00315185|Cetuximab|cetuximab|mesh-list
110316612|NCT00315185|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110316613|NCT00315185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110316614|NCT00344760|Tenofovir|tenofovir|mesh-list
110316615|NCT00344760|Lamivudine|lamivudine|mesh-list
110316616|NCT00344760|Efavirenz|efavirenz|mesh-list
110316617|NCT00344760|Enfuvirtide|enfuvirtide|mesh-list
110316618|NCT00344760|Antiviral Agents|antiviral agents|mesh-ancestor
110316619|NCT00344760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110316620|NCT00344760|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110316621|NCT00344760|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110316622|NCT00344760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110149096|NCT00006220|Keratolytic Agents|keratolytic agents|mesh-ancestor
110316623|NCT00344760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110316624|NCT00344760|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110316625|NCT00344760|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110316626|NCT00344760|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110316627|NCT00344760|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110316628|NCT00344760|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110316629|NCT00344760|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110316630|NCT00344760|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110316631|NCT00344760|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110316632|NCT00344760|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110316633|NCT00344760|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110316634|NCT00348894|Reboxetine|reboxetine|mesh-list
110316635|NCT00348894|Antidepressive Agents|antidepressive agents|mesh-ancestor
110316636|NCT00348894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110316637|NCT00348894|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110316638|NCT00348894|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110316639|NCT00348894|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110316640|NCT00348894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110316641|NCT00348894|Adrenergic Agents|adrenergic agents|mesh-ancestor
110316642|NCT00348894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110316643|NCT00348894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110316644|NCT00315536|Glycopyrrolate|glycopyrrolate|mesh-list
110316645|NCT00315536|Remifentanil|remifentanil|mesh-list
110316646|NCT00315536|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110316648|NCT00315536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110316649|NCT00315536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110316650|NCT00315536|Analgesics|analgesics|mesh-ancestor
110316651|NCT00315536|Sensory System Agents|sensory system agents|mesh-ancestor
110316652|NCT00315536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110316653|NCT00315536|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110316654|NCT00315536|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110316655|NCT00315536|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110316656|NCT00315536|Cholinergic Agents|cholinergic agents|mesh-ancestor
110316657|NCT00315536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110149142|NCT00006232|Antimitotic Agents|antimitotic agents|mesh-ancestor
110316658|NCT00315536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110316659|NCT00348972|Insulin Glargine|insulin glargine|mesh-list
110316660|NCT00348972|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110316661|NCT00348972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110316662|NCT00349089|Pemetrexed|pemetrexed|mesh-list
110316663|NCT00349089|Vinorelbine|vinorelbine|mesh-list
110316664|NCT00349089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110316665|NCT00349089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110316666|NCT00349089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110316667|NCT00349089|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110316668|NCT00349089|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110316669|NCT00349089|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110316670|NCT00349089|Tubulin Modulators|tubulin modulators|mesh-ancestor
110316671|NCT00349089|Antimitotic Agents|antimitotic agents|mesh-ancestor
110316672|NCT00349089|Mitosis Modulators|mitosis modulators|mesh-ancestor
110316673|NCT00349128|Metformin|metformin|mesh-list
110316674|NCT00349128|Fenofibrate|fenofibrate|mesh-list
110316675|NCT00349128|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110316676|NCT00349128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110316677|NCT00349128|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110316678|NCT00349128|Antimetabolites|antimetabolites|mesh-ancestor
110316679|NCT00349128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110316680|NCT00349128|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110316682|NCT00315848|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110316683|NCT00315848|Narcotics|narcotics|mesh-ancestor
110316684|NCT00315848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110316685|NCT00315848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110316686|NCT00315848|Analgesics|analgesics|mesh-ancestor
110316687|NCT00315848|Sensory System Agents|sensory system agents|mesh-ancestor
110316688|NCT00315848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110316689|NCT00315848|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110316690|NCT00349206|Sirolimus|sirolimus|mesh-list
110316691|NCT00349206|Sorafenib|sorafenib|mesh-list
110316692|NCT00349206|Temsirolimus|temsirolimus|mesh-list
110316693|NCT00349206|MTOR Inhibitors|mtor inhibitors|mesh-list
110316694|NCT00349206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110316695|NCT00349206|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110316696|NCT00349206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110316697|NCT00349206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110316698|NCT00349206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110316699|NCT00349206|Immunologic Factors|immunologic factors|mesh-ancestor
110316700|NCT00349206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110316701|NCT00349206|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110316702|NCT00349206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110316703|NCT00349206|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110316704|NCT00349206|Antifungal Agents|antifungal agents|mesh-ancestor
110316705|NCT00315887|Buprenorphine|buprenorphine|mesh-list
110316706|NCT00315887|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110316707|NCT00315887|Narcotics|narcotics|mesh-ancestor
110316708|NCT00315887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110316709|NCT00315887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110316710|NCT00315887|Analgesics|analgesics|mesh-ancestor
110316711|NCT00315887|Sensory System Agents|sensory system agents|mesh-ancestor
110316712|NCT00315887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110316713|NCT00315887|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110316714|NCT00421395|Epratuzumab|epratuzumab|mesh-list
110316715|NCT00421395|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110316716|NCT00421395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110316717|NCT00315926|Melatonin|melatonin|mesh-list
110316718|NCT00315926|Antioxidants|antioxidants|mesh-ancestor
110316719|NCT00315926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110316720|NCT00315926|Protective Agents|protective agents|mesh-ancestor
110316721|NCT00315926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110316722|NCT00315926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110316723|NCT00421434|Ribavirin|ribavirin|mesh-list
110316724|NCT00421434|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110316725|NCT00421434|Interferon-alpha|interferon-alpha|mesh-list
110316726|NCT00421434|Nitazoxanide|nitazoxanide|mesh-list
110316727|NCT00421434|Antimetabolites|antimetabolites|mesh-ancestor
110316728|NCT00421434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110316729|NCT00421434|Antiviral Agents|antiviral agents|mesh-ancestor
110316730|NCT00421434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110316731|NCT00421434|Immunologic Factors|immunologic factors|mesh-ancestor
110316732|NCT00421434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110316733|NCT00421434|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110316734|NCT00315965|Nitric Oxide|nitric oxide|mesh-list
110316735|NCT00315965|Carbon Monoxide|carbon monoxide|mesh-list
110316736|NCT00315965|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110316737|NCT00315965|Autonomic Agents|autonomic agents|mesh-ancestor
110316738|NCT00315965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110316739|NCT00315965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110316740|NCT00315965|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110316741|NCT00315965|Respiratory System Agents|respiratory system agents|mesh-ancestor
110316742|NCT00315965|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110316744|NCT00315965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110316745|NCT00315965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110316746|NCT00315965|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
110316747|NCT00315965|Vasodilator Agents|vasodilator agents|mesh-ancestor
110316748|NCT00315965|Gasotransmitters|gasotransmitters|mesh-ancestor
110316749|NCT00315965|Protective Agents|protective agents|mesh-ancestor
110316750|NCT00315965|Antimetabolites|antimetabolites|mesh-ancestor
110316751|NCT00349245|Dexmedetomidine|dexmedetomidine|mesh-list
110316752|NCT00349245|Remifentanil|remifentanil|mesh-list
110316753|NCT00349245|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110316754|NCT00349245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110316755|NCT00349245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110316756|NCT00349245|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110316757|NCT00349245|Analgesics|analgesics|mesh-ancestor
110316758|NCT00349245|Sensory System Agents|sensory system agents|mesh-ancestor
110316759|NCT00349245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110316760|NCT00349245|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110316761|NCT00349245|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110316762|NCT00349245|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110316763|NCT00349245|Adrenergic Agents|adrenergic agents|mesh-ancestor
110316764|NCT00349245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110316765|NCT00349245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110316766|NCT00349245|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110316767|NCT00349245|Narcotics|narcotics|mesh-ancestor
110316768|NCT00349284|Ezetimibe|ezetimibe|mesh-list
110316769|NCT00349284|Fenofibrate|fenofibrate|mesh-list
110316770|NCT00349284|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110316771|NCT00349284|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110316772|NCT00349284|Antimetabolites|antimetabolites|mesh-ancestor
110316773|NCT00349284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110316774|NCT00349284|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110316775|NCT00316160|Bupropion|bupropion|mesh-list
110316776|NCT00316160|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
110316777|NCT00316160|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110316778|NCT00316160|Antidepressive Agents|antidepressive agents|mesh-ancestor
110316779|NCT00316160|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110316780|NCT00316160|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110316781|NCT00316160|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110316782|NCT00316160|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110316783|NCT00316160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110316785|NCT00316160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110316786|NCT00316160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110316787|NCT00316160|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110316788|NCT00316160|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110316789|NCT00316160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110316790|NCT00316160|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110316791|NCT00349362|Testosterone|testosterone|mesh-list
110316792|NCT00349362|Androgens|androgens|mesh-ancestor
110316793|NCT00349362|Hormones|hormones|mesh-ancestor
110316794|NCT00349362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110316795|NCT00349362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110316796|NCT00316238|Olanzapine|olanzapine|mesh-list
110316797|NCT00316238|Antiemetics|antiemetics|mesh-ancestor
110316798|NCT00316238|Autonomic Agents|autonomic agents|mesh-ancestor
110316799|NCT00316238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110316800|NCT00316238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110316801|NCT00316238|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110316802|NCT00316238|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110316803|NCT00316238|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110316804|NCT00316238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110316805|NCT00316238|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110316806|NCT00316238|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110316807|NCT00316238|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110316808|NCT00316238|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110316809|NCT00316238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110316810|NCT00316238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110316811|NCT00316238|Serotonin Agents|serotonin agents|mesh-ancestor
110316814|NCT00349401|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110316815|NCT00349401|Narcotics|narcotics|mesh-ancestor
110316816|NCT00349401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110316817|NCT00349401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110316818|NCT00349401|Analgesics|analgesics|mesh-ancestor
110316819|NCT00349401|Sensory System Agents|sensory system agents|mesh-ancestor
110316820|NCT00349401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110316821|NCT00349401|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110316822|NCT00349401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110316823|NCT00349401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110316824|NCT00349401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110316825|NCT00349401|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110316826|NCT00349401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110316827|NCT00349401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110316828|NCT00349440|Cyclosporine|cyclosporine|mesh-list
110316829|NCT00349440|Cyclosporins|cyclosporins|mesh-list
110316830|NCT00349440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110316831|NCT00349440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110316832|NCT00349440|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110316833|NCT00349440|Immunologic Factors|immunologic factors|mesh-ancestor
110316834|NCT00349440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110316835|NCT00349440|Antifungal Agents|antifungal agents|mesh-ancestor
110316836|NCT00349440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110316837|NCT00349440|Dermatologic Agents|dermatologic agents|mesh-ancestor
110316838|NCT00349440|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110316839|NCT00349440|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110316840|NCT00316433|Oxaliplatin|oxaliplatin|mesh-list
110316841|NCT00316433|Irinotecan|irinotecan|mesh-list
110316842|NCT00316433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110316843|NCT00316433|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110316845|NCT00316433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110316846|NCT00316433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110170158|NCT00038389|Rofecoxib|rofecoxib|mesh-list
110316848|NCT00349518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110316849|NCT00349518|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110316850|NCT00349518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110316851|NCT00349518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110316852|NCT00316472|Niacinamide|niacinamide|mesh-list
110316853|NCT00316472|Niacin|niacin|mesh-list
110316854|NCT00316472|Nicotinic Acids|nicotinic acids|mesh-list
110316855|NCT00316472|Vitamin B Complex|vitamin b complex|mesh-ancestor
110316856|NCT00316472|Vitamins|vitamins|mesh-ancestor
110316857|NCT00316472|Micronutrients|micronutrients|mesh-ancestor
110316858|NCT00316472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110316859|NCT00316472|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110316860|NCT00316472|Antimetabolites|antimetabolites|mesh-ancestor
110316861|NCT00316472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110316862|NCT00316472|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110316863|NCT00316472|Vasodilator Agents|vasodilator agents|mesh-ancestor
110316864|NCT00349557|Bevacizumab|bevacizumab|mesh-list
110316865|NCT00349557|Goserelin|goserelin|mesh-list
110316866|NCT00349557|Bicalutamide|bicalutamide|mesh-list
110316867|NCT00349557|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110316868|NCT00349557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110316869|NCT00349557|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110316870|NCT00349557|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110316871|NCT00349557|Growth Substances|growth substances|mesh-ancestor
110316872|NCT00349557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110316873|NCT00349557|Growth Inhibitors|growth inhibitors|mesh-ancestor
110316874|NCT00349557|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110316875|NCT00349557|Androgen Antagonists|androgen antagonists|mesh-ancestor
110316876|NCT00349557|Hormone Antagonists|hormone antagonists|mesh-ancestor
110316877|NCT00349557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110316878|NCT00349596|Decitabine|decitabine|mesh-list
110316879|NCT00349596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110316880|NCT00349596|Antimetabolites|antimetabolites|mesh-ancestor
110316881|NCT00349596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110316882|NCT00349596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110316883|NCT00349596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110316885|NCT00349635|Fenofibrate|fenofibrate|mesh-list
110316886|NCT00349635|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110316887|NCT00349635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110316888|NCT00349635|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110316889|NCT00349635|Antimetabolites|antimetabolites|mesh-ancestor
110316890|NCT00349635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110316891|NCT00349635|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110316892|NCT00316745|Leucovorin|leucovorin|mesh-list
110316893|NCT00316745|Fluorouracil|fluorouracil|mesh-list
110316894|NCT00316745|Oxaliplatin|oxaliplatin|mesh-list
110316895|NCT00316745|Irinotecan|irinotecan|mesh-list
110316896|NCT00316745|Antimetabolites|antimetabolites|mesh-ancestor
110316897|NCT00316745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110316898|NCT00316745|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110316899|NCT00316745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110316900|NCT00316745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110316901|NCT00316745|Immunologic Factors|immunologic factors|mesh-ancestor
110316902|NCT00316745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110316903|NCT00316745|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110316904|NCT00316745|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110316905|NCT00316745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110316907|NCT00316745|Protective Agents|protective agents|mesh-ancestor
110316908|NCT00316745|Vitamin B Complex|vitamin b complex|mesh-ancestor
110316909|NCT00316745|Vitamins|vitamins|mesh-ancestor
110316910|NCT00316745|Micronutrients|micronutrients|mesh-ancestor
110316911|NCT00349674|Methotrexate|methotrexate|mesh-list
110316912|NCT00349674|Azathioprine|azathioprine|mesh-list
110316913|NCT00349674|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110316914|NCT00349674|Abortifacient Agents|abortifacient agents|mesh-ancestor
110316915|NCT00349674|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110316916|NCT00349674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110316917|NCT00349674|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110316918|NCT00349674|Antimetabolites|antimetabolites|mesh-ancestor
110316919|NCT00349674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110316920|NCT00349674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110316921|NCT00349674|Dermatologic Agents|dermatologic agents|mesh-ancestor
110316922|NCT00349674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110316923|NCT00349674|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110316924|NCT00349674|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110316925|NCT00349674|Immunologic Factors|immunologic factors|mesh-ancestor
110316926|NCT00349674|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110316927|NCT00349674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110316928|NCT00344916|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
110316929|NCT00344916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110316930|NCT00344916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110316931|NCT00344955|Atorvastatin|atorvastatin|mesh-list
110316932|NCT00344955|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110316933|NCT00344955|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110316934|NCT00344955|Antimetabolites|antimetabolites|mesh-ancestor
110316935|NCT00344955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110316936|NCT00344955|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110316937|NCT00344955|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110316938|NCT00344955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110316939|NCT00316901|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110316940|NCT00316901|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110316941|NCT00316901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110316943|NCT00316940|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
110316944|NCT00316940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110316945|NCT00316940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110316946|NCT00316940|Analgesics|analgesics|mesh-ancestor
110316947|NCT00316940|Sensory System Agents|sensory system agents|mesh-ancestor
110316948|NCT00316940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110316949|NCT00316940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110316951|NCT00344994|Antioxidants|antioxidants|mesh-ancestor
110316952|NCT00344994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110316953|NCT00344994|Protective Agents|protective agents|mesh-ancestor
110316954|NCT00344994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110316955|NCT00344994|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110316956|NCT00344994|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110316957|NCT00344994|Dopamine Agonists|dopamine agonists|mesh-ancestor
110316958|NCT00344994|Dopamine Agents|dopamine agents|mesh-ancestor
110316959|NCT00344994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110316960|NCT00349791|Testosterone|testosterone|mesh-list
110316961|NCT00349791|Androgens|androgens|mesh-ancestor
110316962|NCT00349791|Hormones|hormones|mesh-ancestor
110316963|NCT00349791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110316964|NCT00349791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110316965|NCT00317096|Rituximab|rituximab|mesh-list
110316966|NCT00317096|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110316967|NCT00317096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110316968|NCT00317096|Immunologic Factors|immunologic factors|mesh-ancestor
110316969|NCT00317096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110316970|NCT00317096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110316971|NCT00317135|Vaccines|vaccines|mesh-list
110316972|NCT00317135|Immunologic Factors|immunologic factors|mesh-ancestor
110316973|NCT00317135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110316974|NCT00349986|Insulin Glargine|insulin glargine|mesh-list
110316975|NCT00349986|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110316976|NCT00349986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110316977|NCT00345150|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
110316978|NCT00345150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110316979|NCT00345150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110316980|NCT00317252|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
110316981|NCT00317252|Protease Inhibitors|protease inhibitors|mesh-ancestor
110316982|NCT00317252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110316983|NCT00317252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110316984|NCT00317330|Rifampin|rifampin|mesh-list
110316985|NCT00317330|Isoniazid|isoniazid|mesh-list
110316986|NCT00317330|Pyrazinamide|pyrazinamide|mesh-list
110316987|NCT00317330|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110316988|NCT00317330|Antitubercular Agents|antitubercular agents|mesh-ancestor
110316989|NCT00317330|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110316990|NCT00317330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110316991|NCT00317330|Leprostatic Agents|leprostatic agents|mesh-ancestor
110316992|NCT00317330|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110316993|NCT00317330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110316994|NCT00317330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110316995|NCT00317330|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110316996|NCT00317330|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110316997|NCT00317330|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110316998|NCT00317330|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110316999|NCT00317330|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110317000|NCT00317330|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110317001|NCT00317330|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
110317002|NCT00317330|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110317003|NCT00317330|Antimetabolites|antimetabolites|mesh-ancestor
110317004|NCT00317330|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110317006|NCT00317408|Cytarabine|cytarabine|mesh-list
110317007|NCT00317408|Cyclosporine|cyclosporine|mesh-list
110317008|NCT00317408|Dexamethasone|dexamethasone|mesh-list
110317009|NCT00317408|Prednisolone|prednisolone|mesh-list
110317010|NCT00317408|Carboplatin|carboplatin|mesh-list
110317011|NCT00317408|Methotrexate|methotrexate|mesh-list
110317012|NCT00317408|Etoposide|etoposide|mesh-list
110317013|NCT00317408|Melphalan|melphalan|mesh-list
110317014|NCT00317408|Busulfan|busulfan|mesh-list
110317015|NCT00317408|Ifosfamide|ifosfamide|mesh-list
110317016|NCT00317408|Mitoxantrone|mitoxantrone|mesh-list
110317017|NCT00317408|Idarubicin|idarubicin|mesh-list
110317018|NCT00317408|Thiotepa|thiotepa|mesh-list
110317019|NCT00317408|Carmustine|carmustine|mesh-list
110317020|NCT00317408|Vinblastine|vinblastine|mesh-list
110317021|NCT00317408|Lomustine|lomustine|mesh-list
110317022|NCT00317408|Etoposide phosphate|etoposide phosphate|mesh-list
110317023|NCT00317408|Vindesine|vindesine|mesh-list
110317024|NCT00317408|Cyclosporins|cyclosporins|mesh-list
110317025|NCT00317408|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110317026|NCT00317408|Levoleucovorin|levoleucovorin|mesh-list
110317027|NCT00317408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110317028|NCT00317408|Antiemetics|antiemetics|mesh-ancestor
110317029|NCT00317408|Autonomic Agents|autonomic agents|mesh-ancestor
110317030|NCT00317408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110317031|NCT00317408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110317033|NCT00317408|Glucocorticoids|glucocorticoids|mesh-ancestor
110317034|NCT00317408|Hormones|hormones|mesh-ancestor
110317035|NCT00317408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110317036|NCT00317408|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110317037|NCT00317408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110317038|NCT00317408|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110317039|NCT00317408|Abortifacient Agents|abortifacient agents|mesh-ancestor
110317040|NCT00317408|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110317041|NCT00317408|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110317042|NCT00317408|Antimetabolites|antimetabolites|mesh-ancestor
110317043|NCT00317408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110317044|NCT00317408|Dermatologic Agents|dermatologic agents|mesh-ancestor
110317045|NCT00317408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110317046|NCT00317408|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110317047|NCT00317408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110317048|NCT00317408|Immunologic Factors|immunologic factors|mesh-ancestor
110317049|NCT00317408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110317050|NCT00317408|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110317051|NCT00317408|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110317052|NCT00317408|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110317053|NCT00317408|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110317054|NCT00317408|Antiviral Agents|antiviral agents|mesh-ancestor
110317055|NCT00317408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110317056|NCT00317408|Antidotes|antidotes|mesh-ancestor
110317057|NCT00317408|Protective Agents|protective agents|mesh-ancestor
110317058|NCT00317408|Vitamin B Complex|vitamin b complex|mesh-ancestor
110317059|NCT00317408|Vitamins|vitamins|mesh-ancestor
110317060|NCT00317408|Micronutrients|micronutrients|mesh-ancestor
110317061|NCT00317408|Antifungal Agents|antifungal agents|mesh-ancestor
110317062|NCT00317408|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110317063|NCT00317408|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110317064|NCT00317408|Alkylating Agents|alkylating agents|mesh-ancestor
110317065|NCT00317408|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110317066|NCT00317408|Analgesics|analgesics|mesh-ancestor
110317067|NCT00317408|Sensory System Agents|sensory system agents|mesh-ancestor
110317068|NCT00317408|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110317069|NCT00317408|Tubulin Modulators|tubulin modulators|mesh-ancestor
110317070|NCT00317408|Antimitotic Agents|antimitotic agents|mesh-ancestor
110317071|NCT00317408|Mitosis Modulators|mitosis modulators|mesh-ancestor
110317072|NCT00317447|Prednisone|prednisone|mesh-list
110317073|NCT00317447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110317074|NCT00317447|Glucocorticoids|glucocorticoids|mesh-ancestor
110317075|NCT00317447|Hormones|hormones|mesh-ancestor
110317076|NCT00317447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110317077|NCT00317447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110317078|NCT00317447|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110317079|NCT00317447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110317080|NCT02959554|Nivolumab|nivolumab|mesh-list
110317081|NCT02959554|Sunitinib|sunitinib|mesh-list
110317082|NCT02959554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110317083|NCT02959554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110317084|NCT02959554|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110317085|NCT02959554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110317086|NCT02959554|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110317087|NCT02959554|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110317088|NCT02959554|Growth Substances|growth substances|mesh-ancestor
110317089|NCT02959554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110317090|NCT02959554|Growth Inhibitors|growth inhibitors|mesh-ancestor
110317091|NCT02959554|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110317092|NCT02959554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110317093|NCT00345306|Progesterone|progesterone|mesh-list
110317094|NCT00345306|Progestins|progestins|mesh-ancestor
110317095|NCT00345306|Hormones|hormones|mesh-ancestor
110317096|NCT00345306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110317097|NCT00345306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110317098|NCT00317681|Tacrolimus|tacrolimus|mesh-list
110317099|NCT00317681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110317100|NCT00317681|Immunologic Factors|immunologic factors|mesh-ancestor
110317101|NCT00317681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110317102|NCT00317681|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110317103|NCT00317681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110317104|NCT00317681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110317105|NCT00350181|Mycophenolic Acid|mycophenolic acid|mesh-list
110317107|NCT00350181|Cyclophosphamide|cyclophosphamide|mesh-list
110317108|NCT00350181|Busulfan|busulfan|mesh-list
110317109|NCT00350181|Carmustine|carmustine|mesh-list
110317110|NCT00350181|Etoposide|etoposide|mesh-list
110317111|NCT00350181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110317112|NCT00350181|Immunologic Factors|immunologic factors|mesh-ancestor
110317113|NCT00350181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110317114|NCT00350181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110317115|NCT00350181|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110317116|NCT00350181|Alkylating Agents|alkylating agents|mesh-ancestor
110317117|NCT00350181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110317118|NCT00350181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110317119|NCT00350181|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110317120|NCT00350181|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110317121|NCT00350181|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110317122|NCT00350181|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110317123|NCT00350181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110317124|NCT00350181|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110317125|NCT00350181|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110317126|NCT00350181|Antitubercular Agents|antitubercular agents|mesh-ancestor
110317127|NCT00350181|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110317128|NCT00350181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110317129|NCT00350181|Antifungal Agents|antifungal agents|mesh-ancestor
110317130|NCT00317759|Fludarabine|fludarabine|mesh-list
110317131|NCT00317759|Fludarabine phosphate|fludarabine phosphate|mesh-list
110317132|NCT00317759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110317133|NCT00317759|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110317134|NCT00317759|Antimetabolites|antimetabolites|mesh-ancestor
110317135|NCT00317759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110317136|NCT00317759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110317137|NCT00317759|Immunologic Factors|immunologic factors|mesh-ancestor
110317138|NCT00317759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110317139|NCT00317798|Sirolimus|sirolimus|mesh-list
110317140|NCT00317798|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110317141|NCT00317798|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110317142|NCT00317798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110317143|NCT00317798|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110317144|NCT00317798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110317145|NCT00317798|Antifungal Agents|antifungal agents|mesh-ancestor
110317146|NCT00317798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110317147|NCT00317798|Immunologic Factors|immunologic factors|mesh-ancestor
110317148|NCT00317798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110317149|NCT00345501|Iloprost|iloprost|mesh-list
110317150|NCT00345501|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110317152|NCT00345657|Niacin|niacin|mesh-list
110317153|NCT00345657|Lovastatin|lovastatin|mesh-list
110317154|NCT00345657|L 647318|l 647318|mesh-list
110317155|NCT00345657|Dihydromevinolin|dihydromevinolin|mesh-list
110317156|NCT00345657|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110317157|NCT00345657|Antimetabolites|antimetabolites|mesh-ancestor
110317158|NCT00345657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110317159|NCT00345657|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110317160|NCT00345657|Vasodilator Agents|vasodilator agents|mesh-ancestor
110317161|NCT00345657|Vitamin B Complex|vitamin b complex|mesh-ancestor
110317162|NCT00345657|Vitamins|vitamins|mesh-ancestor
110317163|NCT00345657|Micronutrients|micronutrients|mesh-ancestor
110317164|NCT00345657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110317165|NCT00345657|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110317166|NCT00345657|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110317167|NCT00345657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110317168|NCT00317876|Cyclosporine|cyclosporine|mesh-list
110317169|NCT00317876|Cyclophosphamide|cyclophosphamide|mesh-list
110317170|NCT00317876|Methotrexate|methotrexate|mesh-list
110317171|NCT00317876|Cyclosporins|cyclosporins|mesh-list
110317172|NCT00317876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110317173|NCT00317876|Immunologic Factors|immunologic factors|mesh-ancestor
110317174|NCT00317876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110317175|NCT00317876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110317176|NCT00317876|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110317177|NCT00317876|Alkylating Agents|alkylating agents|mesh-ancestor
110317178|NCT00317876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110317179|NCT00317876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110317180|NCT00317876|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110317181|NCT00317876|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110317182|NCT00317876|Abortifacient Agents|abortifacient agents|mesh-ancestor
110317183|NCT00317876|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110317184|NCT00317876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110317185|NCT00317876|Antimetabolites|antimetabolites|mesh-ancestor
110317186|NCT00317876|Dermatologic Agents|dermatologic agents|mesh-ancestor
110317187|NCT00317876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110317188|NCT00317876|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110317189|NCT00317876|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110317190|NCT00317876|Antifungal Agents|antifungal agents|mesh-ancestor
110317191|NCT00317876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110317192|NCT00317876|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110317193|NCT04714827|Cyclophosphamide|cyclophosphamide|mesh-list
110317194|NCT04714827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110317195|NCT04714827|Immunologic Factors|immunologic factors|mesh-ancestor
110317196|NCT04714827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110317197|NCT04714827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110317198|NCT04714827|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110317199|NCT04714827|Alkylating Agents|alkylating agents|mesh-ancestor
110317200|NCT04714827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110317201|NCT04714827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110317202|NCT04714827|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110317203|NCT00317915|Irbesartan|irbesartan|mesh-list
110317204|NCT00317915|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110317205|NCT00317915|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110317206|NCT00317915|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110317207|NCT00317915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110317208|NCT00317954|Spironolactone|spironolactone|mesh-list
110317209|NCT00317954|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110317210|NCT00317954|Hormone Antagonists|hormone antagonists|mesh-ancestor
110317211|NCT00317954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110317212|NCT00317954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110317213|NCT00317954|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110317214|NCT00317954|Diuretics|diuretics|mesh-ancestor
110317215|NCT00317954|Natriuretic Agents|natriuretic agents|mesh-ancestor
110317216|NCT00317993|Simvastatin|simvastatin|mesh-list
110317217|NCT00317993|Ezetimibe|ezetimibe|mesh-list
110317218|NCT00317993|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110317219|NCT00317993|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110317220|NCT00317993|Antimetabolites|antimetabolites|mesh-ancestor
110317221|NCT00317993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110317222|NCT00317993|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110317223|NCT00317993|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110317224|NCT00317993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110317226|NCT00350415|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110317227|NCT00350415|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110317228|NCT00350415|Analgesics|analgesics|mesh-ancestor
110317229|NCT00350415|Sensory System Agents|sensory system agents|mesh-ancestor
110317230|NCT00350415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110317231|NCT00350415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110317232|NCT00350415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110317233|NCT00350415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110317234|NCT00345696|Bevacizumab|bevacizumab|mesh-list
110317235|NCT00345696|Capecitabine|capecitabine|mesh-list
110317236|NCT00345696|Oxaliplatin|oxaliplatin|mesh-list
110317237|NCT00345696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110317238|NCT00345696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110317239|NCT00345696|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110317240|NCT00345696|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110317241|NCT00345696|Growth Substances|growth substances|mesh-ancestor
110317242|NCT00345696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110317243|NCT00345696|Growth Inhibitors|growth inhibitors|mesh-ancestor
110317244|NCT00345696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110317245|NCT00345696|Antimetabolites|antimetabolites|mesh-ancestor
110317246|NCT00345696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110317247|NCT00350454|Sirolimus|sirolimus|mesh-list
110317248|NCT00350454|Temsirolimus|temsirolimus|mesh-list
110317249|NCT00350454|MTOR Inhibitors|mtor inhibitors|mesh-list
110317250|NCT00350454|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110317251|NCT00350454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110317252|NCT00350454|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110317253|NCT00350454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110317254|NCT00350454|Antifungal Agents|antifungal agents|mesh-ancestor
110317255|NCT00350454|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110317256|NCT00350454|Immunologic Factors|immunologic factors|mesh-ancestor
110317257|NCT00350454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110317258|NCT00350454|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110317259|NCT00350454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110317260|NCT00350454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110317261|NCT00345735|Fentanyl|fentanyl|mesh-list
110317262|NCT00345735|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110317263|NCT00345735|Narcotics|narcotics|mesh-ancestor
110317264|NCT00345735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110317265|NCT00345735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110317266|NCT00345735|Analgesics|analgesics|mesh-ancestor
110317267|NCT00345735|Sensory System Agents|sensory system agents|mesh-ancestor
110170199|NCT00038545|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110317268|NCT00345735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110317269|NCT00345735|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110317270|NCT00345735|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110317272|NCT00345735|Anesthetics|anesthetics|mesh-ancestor
110317273|NCT02959749|Bevacizumab|bevacizumab|mesh-list
110317274|NCT02959749|Docetaxel|docetaxel|mesh-list
110317275|NCT02959749|Osimertinib|osimertinib|mesh-list
110317276|NCT02959749|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110317277|NCT02959749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110317278|NCT02959749|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110317279|NCT02959749|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110317280|NCT02959749|Growth Substances|growth substances|mesh-ancestor
110317281|NCT02959749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110317282|NCT02959749|Growth Inhibitors|growth inhibitors|mesh-ancestor
110317283|NCT02959749|Tubulin Modulators|tubulin modulators|mesh-ancestor
110317284|NCT02959749|Antimitotic Agents|antimitotic agents|mesh-ancestor
110317285|NCT02959749|Mitosis Modulators|mitosis modulators|mesh-ancestor
110317286|NCT02959749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110317287|NCT02959749|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110317288|NCT02959749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110317289|NCT00318383|Vaccines|vaccines|mesh-list
110317290|NCT00318383|Immunologic Factors|immunologic factors|mesh-ancestor
110317291|NCT00318383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110317292|NCT00318422|Liraglutide|liraglutide|mesh-list
110317293|NCT00318422|Glimepiride|glimepiride|mesh-list
110317294|NCT00318422|Rosiglitazone|rosiglitazone|mesh-list
110317295|NCT00318422|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110317296|NCT00318422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110317297|NCT00318422|Incretins|incretins|mesh-ancestor
110317298|NCT00318422|Hormones|hormones|mesh-ancestor
110317299|NCT00318422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110317300|NCT00318422|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110317301|NCT00318422|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110317302|NCT00318422|Immunologic Factors|immunologic factors|mesh-ancestor
110317303|NCT00318539|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110317304|NCT00318539|Antidepressive Agents|antidepressive agents|mesh-ancestor
110317305|NCT00318539|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110317306|NCT00318539|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110317307|NCT00318539|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110317308|NCT00318539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110317309|NCT00318539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110317310|NCT00346047|Buprenorphine|buprenorphine|mesh-list
110317311|NCT00346047|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110317312|NCT00346047|Narcotics|narcotics|mesh-ancestor
110317313|NCT00346047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110317314|NCT00346047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110317315|NCT00346047|Analgesics|analgesics|mesh-ancestor
110317316|NCT00346047|Sensory System Agents|sensory system agents|mesh-ancestor
110317317|NCT00346047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110317318|NCT00346047|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110317319|NCT00421200|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
110317320|NCT00421200|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110317321|NCT00421200|Plasma Substitutes|plasma substitutes|mesh-ancestor
110317322|NCT00421200|Blood Substitutes|blood substitutes|mesh-ancestor
110317323|NCT00318773|Sertraline|sertraline|mesh-list
110317324|NCT00318773|Antidepressive Agents|antidepressive agents|mesh-ancestor
110317325|NCT00318773|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110317326|NCT00318773|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110317327|NCT00318773|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110317328|NCT00318773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110317329|NCT00318773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110317330|NCT00318773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110317332|NCT00318773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110317334|NCT00318890|Amifostine|amifostine|mesh-list
110317335|NCT00318890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110317336|NCT00318890|Tubulin Modulators|tubulin modulators|mesh-ancestor
110317337|NCT00318890|Antimitotic Agents|antimitotic agents|mesh-ancestor
110317338|NCT00318890|Mitosis Modulators|mitosis modulators|mesh-ancestor
110317339|NCT00318890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110170201|NCT00038584|Lonafarnib|lonafarnib|mesh-list
110317340|NCT00318890|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110317341|NCT00318890|Protective Agents|protective agents|mesh-ancestor
110317342|NCT00318890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110317343|NCT00318968|Esomeprazole|esomeprazole|mesh-list
110317344|NCT00318968|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110317345|NCT00318968|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110317346|NCT00318968|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110317347|NCT00318968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110317348|NCT00318968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110317349|NCT00319007|Sulindac|sulindac|mesh-list
110317350|NCT00319007|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110317351|NCT00319007|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110317352|NCT00319007|Analgesics|analgesics|mesh-ancestor
110317353|NCT00319007|Sensory System Agents|sensory system agents|mesh-ancestor
110317354|NCT00319007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110317355|NCT00319007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110317356|NCT00319007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110317357|NCT00319007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110317358|NCT00319007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110317359|NCT00319007|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110317360|NCT00319007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110317361|NCT00319007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110317362|NCT00350961|Gemcitabine|gemcitabine|mesh-list
110317363|NCT00350961|Capecitabine|capecitabine|mesh-list
110317364|NCT00350961|Oxaliplatin|oxaliplatin|mesh-list
110317365|NCT00350961|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110317366|NCT00350961|Antimetabolites|antimetabolites|mesh-ancestor
110317367|NCT00350961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110317368|NCT00350961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110317369|NCT00346242|Zoledronic Acid|zoledronic acid|mesh-list
110317370|NCT00346242|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110317371|NCT00346242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110317372|NCT00421473|Atovaquone|atovaquone|mesh-list
110317373|NCT00421473|Proguanil|proguanil|mesh-list
110317374|NCT00421473|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
110317375|NCT00421473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110317376|NCT00421473|Antimalarials|antimalarials|mesh-ancestor
110317377|NCT00421473|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110317378|NCT00421473|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110317379|NCT00421473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110317380|NCT00421473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110317381|NCT00421473|Antimetabolites|antimetabolites|mesh-ancestor
110317382|NCT00319163|Levonorgestrel|levonorgestrel|mesh-list
110317383|NCT00319163|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110317384|NCT00319163|Estradiol|estradiol|mesh-list
110317385|NCT00319163|Estrogens|estrogens|mesh-ancestor
110317386|NCT00319163|Hormones|hormones|mesh-ancestor
110317387|NCT00319163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110317388|NCT00319163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110317389|NCT00319163|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110317390|NCT00319163|Contraceptive Agents|contraceptive agents|mesh-ancestor
110317391|NCT00319163|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110317392|NCT00319163|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110317393|NCT00319163|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110317394|NCT00319163|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110317395|NCT00319163|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110317396|NCT00319202|Candesartan|candesartan|mesh-list
110317397|NCT00319202|Candesartan cilexetil|candesartan cilexetil|mesh-list
110317398|NCT00319202|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110317399|NCT00319202|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110317400|NCT00319202|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110317401|NCT00319202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110317403|NCT00421512|Sunitinib|sunitinib|mesh-list
110317404|NCT00421512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110317405|NCT00421512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110317406|NCT00421512|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110317407|NCT00421512|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110317408|NCT00421512|Growth Substances|growth substances|mesh-ancestor
110317409|NCT00421512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110317410|NCT00421512|Growth Inhibitors|growth inhibitors|mesh-ancestor
110317411|NCT00421512|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110317412|NCT00421512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110317413|NCT00421512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110317414|NCT00319319|Mecamylamine|mecamylamine|mesh-list
110317415|NCT00319319|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110317416|NCT00319319|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
110317417|NCT00319319|Autonomic Agents|autonomic agents|mesh-ancestor
110317418|NCT00319319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110317419|NCT00319319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110317420|NCT00319319|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
110317421|NCT00319319|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110317422|NCT00319319|Cholinergic Agents|cholinergic agents|mesh-ancestor
110317423|NCT00319319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110317424|NCT00319319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110317425|NCT00346359|Methotrexate|methotrexate|mesh-list
110317426|NCT00346359|Fludarabine phosphate|fludarabine phosphate|mesh-list
110317427|NCT00346359|Fludarabine|fludarabine|mesh-list
110317428|NCT00346359|Busulfan|busulfan|mesh-list
110317429|NCT00346359|Tacrolimus|tacrolimus|mesh-list
110317430|NCT00346359|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110317431|NCT00346359|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110317432|NCT00346359|Abortifacient Agents|abortifacient agents|mesh-ancestor
110317433|NCT00346359|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110317434|NCT00346359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110317435|NCT00346359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110317437|NCT00346359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110317438|NCT00346359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110317439|NCT00346359|Dermatologic Agents|dermatologic agents|mesh-ancestor
110317440|NCT00346359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110317441|NCT00346359|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110317442|NCT00346359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110317443|NCT00346359|Immunologic Factors|immunologic factors|mesh-ancestor
110317444|NCT00346359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110317445|NCT00346359|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110317446|NCT00346359|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110317447|NCT00346359|Alkylating Agents|alkylating agents|mesh-ancestor
110317448|NCT00346359|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110317449|NCT00346359|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110317450|NCT00319358|Antioxidants|antioxidants|mesh-list
110317451|NCT00319358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110317452|NCT00319358|Protective Agents|protective agents|mesh-ancestor
110317453|NCT00319358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110317454|NCT00319514|Docetaxel|docetaxel|mesh-list
110317455|NCT00319514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110317456|NCT00319514|Tubulin Modulators|tubulin modulators|mesh-ancestor
110317457|NCT00319514|Antimitotic Agents|antimitotic agents|mesh-ancestor
110317458|NCT00319514|Mitosis Modulators|mitosis modulators|mesh-ancestor
110317459|NCT00319514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110317460|NCT00319670|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
110317461|NCT00319670|Laxatives|laxatives|mesh-ancestor
110317462|NCT00319670|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110317463|NCT00351195|Capecitabine|capecitabine|mesh-list
110317464|NCT00351195|Oxaliplatin|oxaliplatin|mesh-list
110317465|NCT00351195|Etoposide|etoposide|mesh-list
110317466|NCT00351195|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110317467|NCT00351195|Antimetabolites|antimetabolites|mesh-ancestor
110317468|NCT00351195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110317469|NCT00351195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110317470|NCT00351195|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110317471|NCT00351195|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110317472|NCT00351195|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110317473|NCT00351195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110317474|NCT00319709|Amibegron|amibegron|mesh-list
110170210|NCT00038662|Atrasentan|atrasentan|mesh-list
110317475|NCT00319709|Amibegron hydrochloride|amibegron hydrochloride|mesh-list
110317476|NCT00319709|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110317477|NCT00319709|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110317478|NCT00319709|Adrenergic Agents|adrenergic agents|mesh-ancestor
110317479|NCT00319709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110317480|NCT00319709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110317481|NCT00319709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110317482|NCT00319709|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
110317484|NCT00319787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110317485|NCT00319787|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110317486|NCT00319787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110317487|NCT00319787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110317488|NCT00319865|Thalidomide|thalidomide|mesh-list
110317489|NCT00319865|Dexamethasone|dexamethasone|mesh-list
110317490|NCT00319865|Doxorubicin|doxorubicin|mesh-list
110317491|NCT00319865|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110317492|NCT00319865|Bortezomib|bortezomib|mesh-list
110317493|NCT00319865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110317494|NCT00319865|Antiemetics|antiemetics|mesh-ancestor
110317495|NCT00319865|Autonomic Agents|autonomic agents|mesh-ancestor
110317496|NCT00319865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110317497|NCT00319865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110317498|NCT00319865|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110317499|NCT00319865|Glucocorticoids|glucocorticoids|mesh-ancestor
110317500|NCT00319865|Hormones|hormones|mesh-ancestor
110317501|NCT00319865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110317502|NCT00319865|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110317503|NCT00319865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110317504|NCT00319865|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110317505|NCT00319865|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110317506|NCT00319865|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110317507|NCT00319865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110317508|NCT00319865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110317509|NCT00319865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110317510|NCT00319865|Immunologic Factors|immunologic factors|mesh-ancestor
110317511|NCT00319865|Leprostatic Agents|leprostatic agents|mesh-ancestor
110317512|NCT00319865|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110317513|NCT00319865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110317514|NCT00319865|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110317515|NCT00319865|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110317516|NCT00319865|Growth Substances|growth substances|mesh-ancestor
110317517|NCT00319865|Growth Inhibitors|growth inhibitors|mesh-ancestor
110317518|NCT00320021|Pyridoxamine|pyridoxamine|mesh-list
110317519|NCT00320021|Vitamin B Complex|vitamin b complex|mesh-ancestor
110317520|NCT00320021|Vitamins|vitamins|mesh-ancestor
110317521|NCT00320021|Micronutrients|micronutrients|mesh-ancestor
110317522|NCT00320021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110317523|NCT00320060|Pyridoxamine|pyridoxamine|mesh-list
110317524|NCT00320060|Vitamin B Complex|vitamin b complex|mesh-ancestor
110317525|NCT00320060|Vitamins|vitamins|mesh-ancestor
110317526|NCT00320060|Micronutrients|micronutrients|mesh-ancestor
110317527|NCT00320060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110317529|NCT00320099|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110317530|NCT00320099|Hydrocortisone|hydrocortisone|mesh-list
110317531|NCT00320099|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
110317532|NCT00320099|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
110317533|NCT00320099|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
110317534|NCT00320099|Fludrocortisone|fludrocortisone|mesh-list
110317535|NCT00320099|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110317536|NCT00320099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110317537|NCT00320099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110317538|NCT00320294|Irinotecan|irinotecan|mesh-list
110317539|NCT00320294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110317540|NCT00320294|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110317541|NCT00320294|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110317542|NCT00320294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110317543|NCT00320294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110317544|NCT00346749|Fluticasone|fluticasone|mesh-list
110317545|NCT00346749|Xhance|xhance|mesh-list
110317546|NCT00346749|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110317547|NCT00346749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110317548|NCT00346749|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110317549|NCT00346749|Autonomic Agents|autonomic agents|mesh-ancestor
110317550|NCT00346749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110317551|NCT00346749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110317552|NCT00346749|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110317553|NCT00346749|Respiratory System Agents|respiratory system agents|mesh-ancestor
110317554|NCT00346749|Dermatologic Agents|dermatologic agents|mesh-ancestor
110317555|NCT00346749|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110317556|NCT00346749|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110317557|NCT00346749|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110317558|NCT00346749|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110317559|NCT00346749|Adrenergic Agents|adrenergic agents|mesh-ancestor
110317560|NCT00346749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110317561|NCT00346749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110317562|NCT00351507|Vildagliptin|vildagliptin|mesh-list
110317563|NCT00351507|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110317564|NCT00351507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110317565|NCT00351507|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110317566|NCT00351507|Protease Inhibitors|protease inhibitors|mesh-ancestor
110317567|NCT00351507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110317568|NCT00351507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110317569|NCT00320567|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110317570|NCT00320567|Norgestimate|norgestimate|mesh-list
110317571|NCT00320567|Estradiol|estradiol|mesh-list
110317572|NCT00320567|Estrogens|estrogens|mesh-ancestor
110317573|NCT00320567|Hormones|hormones|mesh-ancestor
110317574|NCT00320567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110317575|NCT00320567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110317576|NCT00320567|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110317577|NCT00320567|Contraceptive Agents|contraceptive agents|mesh-ancestor
110317578|NCT00320567|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110317579|NCT00320567|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110317580|NCT00320567|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110317581|NCT00320567|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110317582|NCT00320567|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110317583|NCT00346827|Apomorphine|apomorphine|mesh-list
110317584|NCT00346827|Emetics|emetics|mesh-ancestor
110317585|NCT00346827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110317586|NCT00346827|Autonomic Agents|autonomic agents|mesh-ancestor
110317587|NCT00346827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110317588|NCT00346827|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110317589|NCT00346827|Dopamine Agonists|dopamine agonists|mesh-ancestor
110317590|NCT00346827|Dopamine Agents|dopamine agents|mesh-ancestor
110317591|NCT00346827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110317592|NCT00346827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110317593|NCT00346866|Anecortave|anecortave|mesh-list
110317594|NCT00346866|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110317595|NCT00346866|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110317596|NCT00346866|Growth Substances|growth substances|mesh-ancestor
110317597|NCT00346866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110317598|NCT00346866|Growth Inhibitors|growth inhibitors|mesh-ancestor
110317599|NCT00346866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110317600|NCT00320723|Bupropion|bupropion|mesh-list
110317601|NCT00320723|Nicotine|nicotine|mesh-list
110317602|NCT00320723|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110317603|NCT00320723|Autonomic Agents|autonomic agents|mesh-ancestor
110317604|NCT00320723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110317605|NCT00320723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110317606|NCT00320723|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110317607|NCT00320723|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110317608|NCT00320723|Cholinergic Agents|cholinergic agents|mesh-ancestor
110317609|NCT00320723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110317610|NCT00320723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110317611|NCT00320723|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110317612|NCT00320723|Antidepressive Agents|antidepressive agents|mesh-ancestor
110317613|NCT00320723|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110317614|NCT00320723|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110317615|NCT00320723|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110317616|NCT00320723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110317617|NCT00320723|Dopamine Agents|dopamine agents|mesh-ancestor
110317618|NCT00320723|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110317619|NCT00320723|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110317620|NCT00320723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110317621|NCT00351546|Vildagliptin|vildagliptin|mesh-list
110317622|NCT00351546|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110317623|NCT00351546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110317624|NCT00351546|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110317625|NCT00351546|Protease Inhibitors|protease inhibitors|mesh-ancestor
110317626|NCT00351546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110317627|NCT00351546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110317628|NCT00351585|Vildagliptin|vildagliptin|mesh-list
110317629|NCT00351585|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110317630|NCT00351585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110317631|NCT00351585|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110317632|NCT00351585|Protease Inhibitors|protease inhibitors|mesh-ancestor
110317633|NCT00351585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110317634|NCT00351585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110317635|NCT00320879|Irbesartan|irbesartan|mesh-list
110317636|NCT00320879|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110317637|NCT00320879|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110317638|NCT00320879|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110317639|NCT00320879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110317640|NCT00347100|Metformin|metformin|mesh-list
110317641|NCT00347100|Insulin Glargine|insulin glargine|mesh-list
110317642|NCT00347100|Glyburide|glyburide|mesh-list
110317643|NCT00347100|Glipizide|glipizide|mesh-list
110317644|NCT00347100|Gliclazide|gliclazide|mesh-list
110317645|NCT00347100|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110317646|NCT00347100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110317647|NCT00347139|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110317648|NCT00347139|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110317649|NCT00347139|Autonomic Agents|autonomic agents|mesh-ancestor
110317650|NCT00347139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110317651|NCT00347139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110317652|NCT00347139|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110317653|NCT00347139|Respiratory System Agents|respiratory system agents|mesh-ancestor
110317654|NCT00347139|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110317655|NCT00347139|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110317656|NCT00347139|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110317657|NCT00347139|Adrenergic Agents|adrenergic agents|mesh-ancestor
110317658|NCT00347139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110317659|NCT00347139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110317661|NCT00321074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110317662|NCT00321074|Immunologic Factors|immunologic factors|mesh-ancestor
110317663|NCT00321074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110317664|NCT00321074|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110317665|NCT00321074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110317666|NCT00321074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110317667|NCT00321113|Mycophenolic Acid|mycophenolic acid|mesh-list
110317668|NCT00321113|Tacrolimus|tacrolimus|mesh-list
110317669|NCT00321113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110317670|NCT00321113|Immunologic Factors|immunologic factors|mesh-ancestor
110317671|NCT00321113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110317672|NCT00321113|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110317673|NCT00321113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110170236|NCT00017004|Hematinics|hematinics|mesh-ancestor
110317674|NCT00321113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110317675|NCT00321113|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110317676|NCT00321113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110317677|NCT00321113|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110317678|NCT00321113|Antitubercular Agents|antitubercular agents|mesh-ancestor
110317679|NCT00321113|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110317680|NCT00321113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110317681|NCT00347256|Cisplatin|cisplatin|mesh-list
110317682|NCT00347256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110317683|NCT00347295|Estazolam|estazolam|mesh-list
110317684|NCT00347295|Brotizolam|brotizolam|mesh-list
110317685|NCT00347295|Anticonvulsants|anticonvulsants|mesh-ancestor
110317686|NCT00347295|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110317687|NCT00347295|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110317688|NCT00347295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110317689|NCT00347295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110317690|NCT00347295|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110317691|NCT00347295|GABA Modulators|gaba modulators|mesh-ancestor
110317692|NCT00347295|GABA Agents|gaba agents|mesh-ancestor
110317693|NCT00347295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110317694|NCT00347295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110317695|NCT00347295|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110317696|NCT00321191|Nitrous Oxide|nitrous oxide|mesh-list
110317697|NCT00321191|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110317698|NCT00321191|Anesthetics, General|anesthetics, general|mesh-ancestor
110317699|NCT00321191|Anesthetics|anesthetics|mesh-ancestor
110317700|NCT00321191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110317701|NCT00321191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110317702|NCT00321191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110317703|NCT00321191|Analgesics|analgesics|mesh-ancestor
110317704|NCT00321191|Sensory System Agents|sensory system agents|mesh-ancestor
110317705|NCT00321191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110317706|NCT00321230|Ascorbic Acid|ascorbic acid|mesh-list
110317707|NCT00321230|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
110317708|NCT00321230|Antioxidants|antioxidants|mesh-ancestor
110317709|NCT00321230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110317710|NCT00321230|Protective Agents|protective agents|mesh-ancestor
110317711|NCT00321230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110317712|NCT00321230|Vitamins|vitamins|mesh-ancestor
110317713|NCT00321230|Micronutrients|micronutrients|mesh-ancestor
110317714|NCT00321230|Laxatives|laxatives|mesh-ancestor
110317715|NCT00321230|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110317716|NCT00351663|Enoxaparin|enoxaparin|mesh-list
110317717|NCT00351663|Anticoagulants|anticoagulants|mesh-ancestor
110317718|NCT00351663|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110317719|NCT00351663|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110317720|NCT00351663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110317721|NCT00321347|Lidocaine|lidocaine|mesh-list
110317722|NCT00321347|Anesthetics, Local|anesthetics, local|mesh-ancestor
110317723|NCT00321347|Anesthetics|anesthetics|mesh-ancestor
110317724|NCT00321347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110317725|NCT00321347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110317726|NCT00321347|Sensory System Agents|sensory system agents|mesh-ancestor
110317727|NCT00321347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110317728|NCT00321347|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110317729|NCT00321347|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110317730|NCT00321347|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110317731|NCT00321347|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110317732|NCT00321347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110317733|NCT00351702|Isoniazid|isoniazid|mesh-list
110317734|NCT00351702|Ethambutol|ethambutol|mesh-list
110317735|NCT00351702|Antitubercular Agents|antitubercular agents|mesh-ancestor
110317736|NCT00351702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110317737|NCT00351702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110317738|NCT00351702|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
110317739|NCT00351702|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110317740|NCT00351702|Antimetabolites|antimetabolites|mesh-ancestor
110317741|NCT00351702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110317742|NCT00351702|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110317743|NCT00351975|Azacitidine|azacitidine|mesh-list
110317745|NCT00351975|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110317746|NCT00351975|Antimetabolites|antimetabolites|mesh-ancestor
110317747|NCT00351975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110317748|NCT00351975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110317749|NCT00351975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110317750|NCT00351975|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110317752|NCT00321581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110317753|NCT00321581|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110317754|NCT00321581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110148386|NCT00006471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110317755|NCT00321581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110317757|NCT00352092|Sirolimus|sirolimus|mesh-list
110317758|NCT00352092|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
110317759|NCT00352092|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110317760|NCT00352092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110317761|NCT00352092|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110317762|NCT00352092|Antitubercular Agents|antitubercular agents|mesh-ancestor
110317763|NCT00352092|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110317764|NCT00352092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110317765|NCT00352092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110317766|NCT00352092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110317767|NCT00352092|Antifungal Agents|antifungal agents|mesh-ancestor
110317768|NCT00352092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110317769|NCT00352092|Immunologic Factors|immunologic factors|mesh-ancestor
110317770|NCT00352092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110317771|NCT00322127|Plerixafor|plerixafor|mesh-list
110317772|NCT00322127|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110317773|NCT00322127|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110317774|NCT00322127|Antiviral Agents|antiviral agents|mesh-ancestor
110317775|NCT00322127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110317776|NCT00352170|Calcium, Dietary|calcium, dietary|mesh-list
110317777|NCT00352170|Vitamin D|vitamin d|mesh-list
110317778|NCT00352170|Cholecalciferol|cholecalciferol|mesh-list
110317779|NCT00352170|Calcium|calcium|mesh-list
110317780|NCT00352170|Vitamins|vitamins|mesh-ancestor
110317781|NCT00352170|Micronutrients|micronutrients|mesh-ancestor
110317782|NCT00352170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110317783|NCT00352170|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110317784|NCT00352170|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110317785|NCT00322166|Calcium|calcium|mesh-list
110317786|NCT00322166|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110374355|NCT00586794|Sildenafil Citrate|sildenafil citrate|mesh-list
110317787|NCT00322166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110317788|NCT02959580|Hydrocortisone|hydrocortisone|mesh-list
110317789|NCT02959580|Hydrocortisone-17-butyrate|hydrocortisone-17-butyrate|mesh-list
110317790|NCT02959580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110317791|NCT02959580|Dermatologic Agents|dermatologic agents|mesh-ancestor
110317792|NCT00352287|Pioglitazone|pioglitazone|mesh-list
110317793|NCT00352287|Hormones|hormones|mesh-list
110317794|NCT00352287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110317795|NCT00352287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110317796|NCT00352287|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110317797|NCT00352443|Everolimus|everolimus|mesh-list
110317798|NCT00352443|Lapatinib|lapatinib|mesh-list
110317799|NCT00352443|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110317800|NCT00352443|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110317801|NCT00352443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110317802|NCT00352443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110317803|NCT00352443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110317804|NCT00352443|Immunologic Factors|immunologic factors|mesh-ancestor
110317805|NCT00352443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110317806|NCT00352443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110317807|NCT00352482|Sildenafil Citrate|sildenafil citrate|mesh-list
110317808|NCT00352482|Vasodilator Agents|vasodilator agents|mesh-ancestor
110317809|NCT00352482|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110317810|NCT00352482|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110317811|NCT00352482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110170251|NCT00039052|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110317812|NCT00352482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110317813|NCT00352482|Urological Agents|urological agents|mesh-ancestor
110317815|NCT00322400|Docetaxel|docetaxel|mesh-list
110317816|NCT00322400|Motesanib diphosphate|motesanib diphosphate|mesh-list
110317817|NCT00322400|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110317818|NCT00322400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110317819|NCT00322400|Tubulin Modulators|tubulin modulators|mesh-ancestor
110317821|NCT00322400|Mitosis Modulators|mitosis modulators|mesh-ancestor
110317822|NCT00322400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110317823|NCT00322400|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110317824|NCT00322400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110317825|NCT00352521|Bevacizumab|bevacizumab|mesh-list
110317826|NCT00352521|Irinotecan|irinotecan|mesh-list
110317827|NCT00352521|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110317828|NCT00352521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110317829|NCT00352521|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110317830|NCT00352521|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110317831|NCT00352521|Growth Substances|growth substances|mesh-ancestor
110317832|NCT00352521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110317833|NCT00352521|Growth Inhibitors|growth inhibitors|mesh-ancestor
110317834|NCT00352521|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110317835|NCT00352521|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110317836|NCT00352521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110317837|NCT00352521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110317838|NCT00352599|Lovastatin|lovastatin|mesh-list
110317839|NCT00352599|L 647318|l 647318|mesh-list
110317840|NCT00352599|Dihydromevinolin|dihydromevinolin|mesh-list
110317841|NCT00352599|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110317842|NCT00352599|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110317843|NCT00352599|Antimetabolites|antimetabolites|mesh-ancestor
110317844|NCT00352599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110317845|NCT00352599|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110317846|NCT00352599|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110317847|NCT00352599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110317848|NCT00322595|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110317849|NCT00322595|Paroxetine|paroxetine|mesh-list
110317850|NCT00322595|Antidepressive Agents|antidepressive agents|mesh-ancestor
110374377|NCT00586911|Antimetabolites|antimetabolites|mesh-ancestor
110317851|NCT00322595|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110317852|NCT00322595|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110317853|NCT00322595|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110317854|NCT00322595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110317855|NCT00322595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110317856|NCT00322595|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110317857|NCT00322595|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110317858|NCT00322595|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110317859|NCT00322595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110317860|NCT00322595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110317861|NCT00322595|Serotonin Agents|serotonin agents|mesh-ancestor
110317862|NCT00322595|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110317863|NCT00322595|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110317864|NCT00322595|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110317865|NCT00322595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110317866|NCT00352677|Bafetinib|bafetinib|mesh-list
110317867|NCT00352677|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110317868|NCT00352677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110317869|NCT00352677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110317870|NCT00331149|Ropinirole|ropinirole|mesh-list
110317871|NCT00331149|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110317872|NCT00331149|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110317873|NCT00331149|Dopamine Agonists|dopamine agonists|mesh-ancestor
110317874|NCT00331149|Dopamine Agents|dopamine agents|mesh-ancestor
110317875|NCT00331149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110317876|NCT00331149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110317877|NCT00331149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110317878|NCT00331188|Vapreotide|vapreotide|mesh-list
110317879|NCT00331188|Analgesics|analgesics|mesh-ancestor
110317880|NCT00331188|Sensory System Agents|sensory system agents|mesh-ancestor
110170259|NCT00039091|Ipilimumab|ipilimumab|mesh-list
110317882|NCT00331188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110317883|NCT00331188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110317884|NCT00352833|Catumaxomab|catumaxomab|mesh-list
110317885|NCT00352833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110317886|NCT00331305|Sertraline|sertraline|mesh-list
110317887|NCT00331305|Antidepressive Agents|antidepressive agents|mesh-ancestor
110317888|NCT00331305|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110317889|NCT00331305|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110317890|NCT00331305|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110317891|NCT00331305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110317892|NCT00331305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110317893|NCT00331305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110317894|NCT00331305|Serotonin Agents|serotonin agents|mesh-ancestor
110317895|NCT00331305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110317896|NCT00322751|Topotecan|topotecan|mesh-list
110317897|NCT00322751|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110317898|NCT00322751|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110317899|NCT00322751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110317900|NCT00322751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110317901|NCT00322751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110317902|NCT00352950|Panitumumab|panitumumab|mesh-list
110317903|NCT00352950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110317904|NCT00352950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110317905|NCT00322907|Mefloquine|mefloquine|mesh-list
110317906|NCT00322907|Quinine|quinine|mesh-list
110317907|NCT00322907|Antimalarials|antimalarials|mesh-ancestor
110317908|NCT00322907|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110317909|NCT00322907|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110317910|NCT00322907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110317911|NCT00322907|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110317912|NCT00322907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110317914|NCT00322907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110317915|NCT00322907|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110317916|NCT00322907|Analgesics|analgesics|mesh-ancestor
110317917|NCT00322907|Sensory System Agents|sensory system agents|mesh-ancestor
110317918|NCT00331500|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
110317919|NCT00331500|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110317920|NCT00331500|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110317921|NCT00331500|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110317922|NCT00331500|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110317923|NCT00331500|Analgesics|analgesics|mesh-ancestor
110317924|NCT00331500|Sensory System Agents|sensory system agents|mesh-ancestor
110317925|NCT00331500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110317926|NCT00331500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110317927|NCT00331500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110317928|NCT00331500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110317929|NCT00331500|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110317930|NCT00331500|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110317931|NCT00331500|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110317932|NCT00331500|Histamine Antagonists|histamine antagonists|mesh-ancestor
110317933|NCT00331500|Histamine Agents|histamine agents|mesh-ancestor
110317934|NCT00331500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110317935|NCT00331500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110317936|NCT00322985|Lenalidomide|lenalidomide|mesh-list
110317937|NCT00322985|Immunologic Factors|immunologic factors|mesh-ancestor
110317938|NCT00322985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110317939|NCT00322985|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110317940|NCT00322985|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110317941|NCT00322985|Growth Substances|growth substances|mesh-ancestor
110317942|NCT00322985|Growth Inhibitors|growth inhibitors|mesh-ancestor
110317943|NCT00322985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110317944|NCT00353028|Fluvoxamine|fluvoxamine|mesh-list
110317945|NCT00353028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110317946|NCT00353028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110317947|NCT00353028|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110317948|NCT00353028|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110317949|NCT00353028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110317950|NCT00353028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110317951|NCT00353028|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110317952|NCT00353028|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110317953|NCT00353028|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110317954|NCT00353028|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110317955|NCT00353028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110317956|NCT00353028|Serotonin Agents|serotonin agents|mesh-ancestor
110317957|NCT00353028|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110317958|NCT00353028|Antidepressive Agents|antidepressive agents|mesh-ancestor
110317959|NCT00353028|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110317960|NCT00353028|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110317961|NCT00353028|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110317962|NCT00353067|2-(4-(quinolin-2-yl-methoxy)phenyl)-2-cyclopentylacetic acid|2-(4-(quinolin-2-yl-methoxy)phenyl)-2-cyclopentylacetic acid|mesh-list
110317963|NCT00353067|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110317964|NCT00353067|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110317965|NCT00353067|Analgesics|analgesics|mesh-ancestor
110317966|NCT00353067|Sensory System Agents|sensory system agents|mesh-ancestor
110317967|NCT00353067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110317968|NCT00353067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110317969|NCT00353067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110317970|NCT00353067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110317971|NCT00353067|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
110317972|NCT00353067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110317973|NCT00353067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110317974|NCT00323219|Moxifloxacin|moxifloxacin|mesh-list
110317975|NCT00323219|Cefazolin|cefazolin|mesh-list
110317976|NCT00323219|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110317977|NCT00323219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110317978|NCT00323219|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110317979|NCT00323219|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110317980|NCT00323219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110317981|NCT00323219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110317982|NCT00323219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110317983|NCT00323375|Chloroquine|chloroquine|mesh-list
110317984|NCT00323375|Amebicides|amebicides|mesh-ancestor
110317985|NCT00323375|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110317986|NCT00323375|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110317987|NCT00323375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110317988|NCT00323375|Antimalarials|antimalarials|mesh-ancestor
110317989|NCT00323375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110317990|NCT00331695|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
110317991|NCT00331695|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
110317992|NCT00331695|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110317993|NCT00331695|Hormone Antagonists|hormone antagonists|mesh-ancestor
110317994|NCT00331695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110317995|NCT00331695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110317996|NCT00331695|Progestins|progestins|mesh-ancestor
110317997|NCT00331695|Hormones|hormones|mesh-ancestor
110317998|NCT00353145|Gemcitabine|gemcitabine|mesh-list
110317999|NCT00353145|Oxaliplatin|oxaliplatin|mesh-list
110318000|NCT00353145|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110318001|NCT00353145|Antimetabolites|antimetabolites|mesh-ancestor
110318002|NCT00353145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110318003|NCT00353145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110318004|NCT00323648|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110318005|NCT00323648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110318006|NCT00353184|Montelukast|montelukast|mesh-list
110318007|NCT00353184|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110318009|NCT00353184|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110318010|NCT00353184|Hormone Antagonists|hormone antagonists|mesh-ancestor
110318011|NCT00353184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110170268|NCT00039169|IDN 5109|idn 5109|mesh-list
110318012|NCT00353184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110318013|NCT00353184|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110318014|NCT00353184|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110318015|NCT00353184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110318016|NCT00323687|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110318017|NCT00323687|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110318018|NCT00323687|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110318019|NCT00323687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110318020|NCT00323687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110318021|NCT00323687|Antiviral Agents|antiviral agents|mesh-ancestor
110318022|NCT00323687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110318023|NCT00323687|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110318024|NCT00323687|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110318025|NCT00323804|Ribavirin|ribavirin|mesh-list
110318026|NCT00323804|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110318027|NCT00323804|Antimetabolites|antimetabolites|mesh-ancestor
110318028|NCT00323804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110318029|NCT00323804|Antiviral Agents|antiviral agents|mesh-ancestor
110318030|NCT00323804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110318031|NCT00353340|Acetylcysteine|acetylcysteine|mesh-list
110318032|NCT00353340|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110318033|NCT00353340|Antiviral Agents|antiviral agents|mesh-ancestor
110318034|NCT00353340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110318035|NCT00353340|Expectorants|expectorants|mesh-ancestor
110318036|NCT00353340|Respiratory System Agents|respiratory system agents|mesh-ancestor
110318037|NCT00353340|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110318039|NCT00353340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110318040|NCT00353340|Protective Agents|protective agents|mesh-ancestor
110318041|NCT00353340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110318042|NCT00353340|Antidotes|antidotes|mesh-ancestor
110318043|NCT00323843|Isoproterenol|isoproterenol|mesh-list
110318044|NCT00323843|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110318045|NCT00323843|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110318046|NCT00323843|Adrenergic Agents|adrenergic agents|mesh-ancestor
110318047|NCT00323843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110318048|NCT00323843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110318049|NCT00323843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110318050|NCT00323843|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110318051|NCT00323843|Autonomic Agents|autonomic agents|mesh-ancestor
110318052|NCT00323843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110318053|NCT00323843|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110318054|NCT00323843|Respiratory System Agents|respiratory system agents|mesh-ancestor
110318055|NCT00323843|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110318056|NCT00323843|Sympathomimetics|sympathomimetics|mesh-ancestor
110318057|NCT00323843|Protective Agents|protective agents|mesh-ancestor
110318058|NCT00323921|Dermatologic Agents|dermatologic agents|mesh-list
110318060|NCT00331851|Insulin Glargine|insulin glargine|mesh-list
110318061|NCT00331851|Liraglutide|liraglutide|mesh-list
110318062|NCT00331851|Glimepiride|glimepiride|mesh-list
110318063|NCT00331851|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110318064|NCT00331851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110318065|NCT00331851|Incretins|incretins|mesh-ancestor
110318066|NCT00331851|Hormones|hormones|mesh-ancestor
110318067|NCT00331851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110318068|NCT00331851|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110318069|NCT00331851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110318070|NCT00331851|Immunologic Factors|immunologic factors|mesh-ancestor
110318071|NCT00331890|Choline|choline|mesh-list
110318072|NCT00331890|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
110318073|NCT00331890|Lipotropic Agents|lipotropic agents|mesh-ancestor
110170285|NCT00039208|Leucovorin|leucovorin|mesh-list
110318074|NCT00331890|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110318075|NCT00331890|Antimetabolites|antimetabolites|mesh-ancestor
110318076|NCT00331890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110318077|NCT00331890|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110318078|NCT00331890|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110318079|NCT00331890|Nootropic Agents|nootropic agents|mesh-ancestor
110318080|NCT01059773|Methotrexate|methotrexate|mesh-list
110318081|NCT01059773|Ustekinumab|ustekinumab|mesh-list
110318082|NCT01059773|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110318083|NCT01059773|Abortifacient Agents|abortifacient agents|mesh-ancestor
110318084|NCT01059773|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110318085|NCT01059773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110318086|NCT01059773|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110318088|NCT01059773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110318089|NCT01059773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110318090|NCT01059773|Dermatologic Agents|dermatologic agents|mesh-ancestor
110318091|NCT01059773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110318092|NCT01059773|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110318093|NCT01059773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110318094|NCT01059773|Immunologic Factors|immunologic factors|mesh-ancestor
110318095|NCT01059773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110318096|NCT01059773|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110318097|NCT00353379|Guanfacine|guanfacine|mesh-list
110318098|NCT00353379|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110318099|NCT00353379|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110318100|NCT00353379|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110318101|NCT00353379|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110318102|NCT00353379|Adrenergic Agents|adrenergic agents|mesh-ancestor
110318103|NCT00353379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110318104|NCT00353379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110318105|NCT00353379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110318106|NCT00324077|Imatinib Mesylate|imatinib mesylate|mesh-list
110318108|NCT00324077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110318109|NCT00324077|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110318110|NCT00324077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110318111|NCT00324077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110318112|NCT00324194|Mocetinostat|mocetinostat|mesh-list
110318113|NCT00324194|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110318114|NCT00324194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110318115|NCT00324194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110318116|NCT00324389|Interferons|interferons|mesh-list
110318117|NCT00324389|Interferon-alpha|interferon-alpha|mesh-list
110318118|NCT00324389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110318119|NCT00324389|Antiviral Agents|antiviral agents|mesh-ancestor
110318121|NCT00324389|Immunologic Factors|immunologic factors|mesh-ancestor
110318122|NCT00324389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110318123|NCT00353691|Metformin|metformin|mesh-list
110318124|NCT00353691|Glimepiride|glimepiride|mesh-list
110318125|NCT00353691|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110318126|NCT00353691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110318127|NCT00353691|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110318128|NCT00353691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110318129|NCT00353691|Immunologic Factors|immunologic factors|mesh-ancestor
110318130|NCT00332046|Casopitant|casopitant|mesh-list
110318131|NCT00332046|Antiemetics|antiemetics|mesh-ancestor
110318132|NCT00332046|Autonomic Agents|autonomic agents|mesh-ancestor
110318133|NCT00332046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110318134|NCT00332046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110318135|NCT00332046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110318136|NCT00332046|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110318137|NCT00332046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110318138|NCT00332046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110318139|NCT00324467|Acetaminophen|acetaminophen|mesh-list
110318140|NCT00324467|Diphenhydramine|diphenhydramine|mesh-list
110318141|NCT00324467|Promethazine|promethazine|mesh-list
110318142|NCT00324467|Dexamethasone|dexamethasone|mesh-list
110318143|NCT00324467|Dexamethasone acetate|dexamethasone acetate|mesh-list
110318145|NCT00324467|Cyclophosphamide|cyclophosphamide|mesh-list
110318146|NCT00324467|Ifosfamide|ifosfamide|mesh-list
110318147|NCT00324467|Rituximab|rituximab|mesh-list
110318148|NCT00324467|Carboplatin|carboplatin|mesh-list
110318149|NCT00324467|Doxorubicin|doxorubicin|mesh-list
110318150|NCT00324467|Etoposide|etoposide|mesh-list
110318151|NCT00324467|Vincristine|vincristine|mesh-list
110318152|NCT00324467|Ondansetron|ondansetron|mesh-list
110318153|NCT00324467|BB 1101|bb 1101|mesh-list
110318154|NCT00324467|Mesna|mesna|mesh-list
110318155|NCT00324467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110318156|NCT00324467|Immunologic Factors|immunologic factors|mesh-ancestor
110318157|NCT00324467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110318158|NCT00324467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110318159|NCT00324467|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110318160|NCT00324467|Alkylating Agents|alkylating agents|mesh-ancestor
110318161|NCT00324467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110318162|NCT00324467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110318163|NCT00324467|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110318164|NCT00324467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110318165|NCT00324467|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110318166|NCT00324467|Antiemetics|antiemetics|mesh-ancestor
110318167|NCT00324467|Autonomic Agents|autonomic agents|mesh-ancestor
110318168|NCT00324467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110318169|NCT00324467|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110318170|NCT00324467|Glucocorticoids|glucocorticoids|mesh-ancestor
110318171|NCT00324467|Hormones|hormones|mesh-ancestor
110318172|NCT00324467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110318173|NCT00324467|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110318174|NCT00324467|Protease Inhibitors|protease inhibitors|mesh-ancestor
110318175|NCT00324467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110318176|NCT00324467|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110318177|NCT00324467|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110318178|NCT00324467|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110318179|NCT00324467|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110318180|NCT00324467|Tubulin Modulators|tubulin modulators|mesh-ancestor
110318181|NCT00324467|Antimitotic Agents|antimitotic agents|mesh-ancestor
110318182|NCT00324467|Mitosis Modulators|mitosis modulators|mesh-ancestor
110318183|NCT00324467|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110318185|NCT00324467|Sensory System Agents|sensory system agents|mesh-ancestor
110318186|NCT00324467|Antipyretics|antipyretics|mesh-ancestor
110318187|NCT00324467|Antipruritics|antipruritics|mesh-ancestor
110318188|NCT00324467|Dermatologic Agents|dermatologic agents|mesh-ancestor
110318189|NCT00324467|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110318190|NCT00324467|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110318191|NCT00324467|Serotonin Agents|serotonin agents|mesh-ancestor
110318192|NCT00324467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110318193|NCT00324467|Protective Agents|protective agents|mesh-ancestor
110318194|NCT00324467|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110318195|NCT00324467|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110318196|NCT00324467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110318197|NCT00324467|Anesthetics, Local|anesthetics, local|mesh-ancestor
110318198|NCT00324467|Anesthetics|anesthetics|mesh-ancestor
110318199|NCT00324467|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110318200|NCT00324467|Histamine Antagonists|histamine antagonists|mesh-ancestor
110318201|NCT00324467|Histamine Agents|histamine agents|mesh-ancestor
110318202|NCT00324467|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110318203|NCT00332085|Chromium|chromium|mesh-list
110318204|NCT00332085|Picolinic acid|picolinic acid|mesh-list
110318205|NCT00332085|Trace Elements|trace elements|mesh-ancestor
110318206|NCT00332085|Micronutrients|micronutrients|mesh-ancestor
110318207|NCT00332085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110318208|NCT00332085|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110318209|NCT00332085|Chelating Agents|chelating agents|mesh-ancestor
110318210|NCT00332085|Sequestering Agents|sequestering agents|mesh-ancestor
110318211|NCT00332085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110318212|NCT00324506|Mycophenolic Acid|mycophenolic acid|mesh-list
110318213|NCT00324506|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110318214|NCT00324506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110318215|NCT00324506|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110318216|NCT00324506|Antitubercular Agents|antitubercular agents|mesh-ancestor
110318217|NCT00324506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110318218|NCT00324506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110318219|NCT00324506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110318220|NCT00324506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110318221|NCT00332124|Choline|choline|mesh-list
110318222|NCT00332124|Lipotropic Agents|lipotropic agents|mesh-ancestor
110318223|NCT00332124|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110318224|NCT00332124|Antimetabolites|antimetabolites|mesh-ancestor
110318225|NCT00332124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110318226|NCT00332124|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110318227|NCT00332124|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110318228|NCT00332124|Nootropic Agents|nootropic agents|mesh-ancestor
110318229|NCT04714554|Erythromycin|erythromycin|mesh-list
110318230|NCT04714554|Erythromycin Estolate|erythromycin estolate|mesh-list
110318231|NCT04714554|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
110318232|NCT04714554|Erythromycin stearate|erythromycin stearate|mesh-list
110318233|NCT04714554|Relugolix|relugolix|mesh-list
110318234|NCT04714554|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110318235|NCT04714554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110318236|NCT04714554|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110318237|NCT04714554|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110318238|NCT04714554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110318239|NCT04714554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110318240|NCT04714554|Androgen Antagonists|androgen antagonists|mesh-ancestor
110318241|NCT04714554|Hormone Antagonists|hormone antagonists|mesh-ancestor
110318242|NCT04714554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110318243|NCT04714554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110318244|NCT00419471|Escitalopram|escitalopram|mesh-list
110318245|NCT00419471|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110318246|NCT00419471|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110318247|NCT00419471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110318248|NCT00419471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110318249|NCT00419471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110318250|NCT00419471|Serotonin Agents|serotonin agents|mesh-ancestor
110318251|NCT00419471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110318252|NCT00426348|Valsartan|valsartan|mesh-list
110318253|NCT00426348|Probucol|probucol|mesh-list
110318254|NCT00426348|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110318255|NCT00426348|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110318256|NCT00426348|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110318257|NCT00426348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110318258|NCT00426348|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110318259|NCT00426348|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110318260|NCT00426348|Antimetabolites|antimetabolites|mesh-ancestor
110318261|NCT00426348|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110318262|NCT00426348|Antioxidants|antioxidants|mesh-ancestor
110318263|NCT00426348|Protective Agents|protective agents|mesh-ancestor
110318264|NCT00426348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110318265|NCT00353808|Reboxetine|reboxetine|mesh-list
110318266|NCT00353808|Antidepressive Agents|antidepressive agents|mesh-ancestor
110318267|NCT00353808|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110318268|NCT00353808|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110318269|NCT00353808|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110318270|NCT00353808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110318271|NCT00353808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110318272|NCT00353808|Adrenergic Agents|adrenergic agents|mesh-ancestor
110318273|NCT00353808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110318274|NCT00353808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110318275|NCT00324623|Cyclophosphamide|cyclophosphamide|mesh-list
110318276|NCT00324623|Fludarabine|fludarabine|mesh-list
110318277|NCT00324623|Fludarabine phosphate|fludarabine phosphate|mesh-list
110318278|NCT00324623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110318279|NCT00324623|Immunologic Factors|immunologic factors|mesh-ancestor
110170307|NCT00017121|Sargramostim|sargramostim|mesh-list
110318280|NCT00324623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110318281|NCT00324623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110318282|NCT00324623|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110318283|NCT00324623|Alkylating Agents|alkylating agents|mesh-ancestor
110318284|NCT00324623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110318285|NCT00324623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110318286|NCT00324623|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110318287|NCT00324623|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110318288|NCT00324623|Antimetabolites|antimetabolites|mesh-ancestor
110318289|NCT00324779|Rituximab|rituximab|mesh-list
110318290|NCT00324779|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110318291|NCT00324779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110318292|NCT00324779|Immunologic Factors|immunologic factors|mesh-ancestor
110318293|NCT00324779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110318294|NCT00324779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110318295|NCT00324818|Azithromycin|azithromycin|mesh-list
110318296|NCT00324818|Metronidazole|metronidazole|mesh-list
110318297|NCT00324818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110318298|NCT00324818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110318299|NCT00324818|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110318300|NCT00324818|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110318301|NCT00324974|Lansoprazole|lansoprazole|mesh-list
110318302|NCT00324974|Dexlansoprazole|dexlansoprazole|mesh-list
110318303|NCT00324974|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110318304|NCT00324974|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110318305|NCT00324974|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110318306|NCT00324974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110318307|NCT00324974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110318308|NCT00325169|Tiotropium Bromide|tiotropium bromide|mesh-list
110318309|NCT00325169|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
110318310|NCT00325169|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110318311|NCT00325169|Autonomic Agents|autonomic agents|mesh-ancestor
110318312|NCT00325169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110318313|NCT00325169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110318314|NCT00325169|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110318315|NCT00325169|Respiratory System Agents|respiratory system agents|mesh-ancestor
110318316|NCT00325169|Parasympatholytics|parasympatholytics|mesh-ancestor
110318317|NCT00325169|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110318318|NCT00325169|Cholinergic Agents|cholinergic agents|mesh-ancestor
110318319|NCT00325169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110318320|NCT00325169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110318321|NCT00325169|Glucocorticoids|glucocorticoids|mesh-ancestor
110318322|NCT00325169|Hormones|hormones|mesh-ancestor
110318323|NCT00325169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110318324|NCT00325169|Sympathomimetics|sympathomimetics|mesh-ancestor
110318325|NCT00426543|Rituximab|rituximab|mesh-list
110318326|NCT00426543|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110318327|NCT00426543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110318328|NCT00426543|Immunologic Factors|immunologic factors|mesh-ancestor
110318329|NCT00426543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110318330|NCT00426543|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110318331|NCT00325286|Carbamazepine|carbamazepine|mesh-list
110318332|NCT00325286|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110318333|NCT00325286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110318334|NCT00325286|Antimanic Agents|antimanic agents|mesh-ancestor
110318335|NCT00325286|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110318336|NCT00325286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110318337|NCT00325286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110318338|NCT00325286|Anticonvulsants|anticonvulsants|mesh-ancestor
110318339|NCT00325286|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110318340|NCT00325286|Analgesics|analgesics|mesh-ancestor
110318341|NCT00325286|Sensory System Agents|sensory system agents|mesh-ancestor
110318342|NCT00325286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110318343|NCT00325286|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110318344|NCT00325286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110318345|NCT00325286|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110318346|NCT00325286|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110318347|NCT00325325|Everolimus|everolimus|mesh-list
110318348|NCT00325325|Tacrolimus|tacrolimus|mesh-list
110318350|NCT00325325|Immunologic Factors|immunologic factors|mesh-ancestor
110318351|NCT00325325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110318352|NCT00325325|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110318353|NCT00325325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110318354|NCT00325325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110318355|NCT00325325|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110318356|NCT00325325|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110318357|NCT00325325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110318358|NCT00354081|Vitamins|vitamins|mesh-list
110318359|NCT00354081|Folic Acid|folic acid|mesh-list
110318360|NCT00354081|Hydroxocobalamin|hydroxocobalamin|mesh-list
110318361|NCT00354081|Vitamin B 12|vitamin b 12|mesh-list
110318362|NCT00354081|Pyridoxine|pyridoxine|mesh-list
110318363|NCT00354081|Pyridoxal|pyridoxal|mesh-list
110318364|NCT00354081|Vitamin B 6|vitamin b 6|mesh-list
110318365|NCT00354081|Vitamin B Complex|vitamin b complex|mesh-list
110318366|NCT00354081|Micronutrients|micronutrients|mesh-ancestor
110318367|NCT00354081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110318368|NCT00354081|Hematinics|hematinics|mesh-ancestor
110318369|NCT00325637|Losartan|losartan|mesh-list
110318370|NCT00325637|Cilnidipine|cilnidipine|mesh-list
110318371|NCT00325637|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110318372|NCT00325637|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110318373|NCT00325637|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110318374|NCT00325637|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110318375|NCT00325637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110318376|NCT00325637|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110318377|NCT00325637|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110318378|NCT00325637|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110318379|NCT00325637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110318380|NCT04714593|Cyclophosphamide|cyclophosphamide|mesh-list
110318381|NCT04714593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110318382|NCT04714593|Immunologic Factors|immunologic factors|mesh-ancestor
110318383|NCT04714593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110318384|NCT04714593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110318385|NCT04714593|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110318386|NCT04714593|Alkylating Agents|alkylating agents|mesh-ancestor
110318387|NCT04714593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110318388|NCT04714593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110318389|NCT04714593|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110318390|NCT00426582|Epothilone B|epothilone b|mesh-list
110318391|NCT00426582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110318392|NCT00426582|Tubulin Modulators|tubulin modulators|mesh-ancestor
110318393|NCT00426582|Antimitotic Agents|antimitotic agents|mesh-ancestor
110318394|NCT00426582|Mitosis Modulators|mitosis modulators|mesh-ancestor
110318395|NCT00426582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110318396|NCT00354198|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110318398|NCT00354198|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110318399|NCT00354198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110318400|NCT00354198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110318401|NCT00354198|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110318402|NCT00354198|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110318403|NCT00354198|Protective Agents|protective agents|mesh-ancestor
110318404|NCT00354198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110318405|NCT00354198|Vasodilator Agents|vasodilator agents|mesh-ancestor
110318406|NCT00354198|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110318407|NCT00354198|Antioxidants|antioxidants|mesh-ancestor
110318408|NCT00354198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110318409|NCT00354198|Glucocorticoids|glucocorticoids|mesh-ancestor
110318410|NCT00354198|Hormones|hormones|mesh-ancestor
110318411|NCT00354198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110318412|NCT00354198|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110318413|NCT00354198|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110374426|NCT04674176|Rifaximin|rifaximin|mesh-list
110318414|NCT00354198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110318415|NCT00325676|Pantoprazole|pantoprazole|mesh-list
110318416|NCT00325676|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110318417|NCT00325676|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110318418|NCT00325676|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110318419|NCT00325676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110318420|NCT00325676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110318421|NCT00325715|Esomeprazole|esomeprazole|mesh-list
110318422|NCT00325715|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110318423|NCT00325715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110318424|NCT00325715|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110318425|NCT00325715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110318426|NCT00325715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110318427|NCT00354237|Hypoglycemic Agents|hypoglycemic agents|mesh-list
110318428|NCT00354237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110318429|NCT00325793|Nicardipine|nicardipine|mesh-list
110318430|NCT00325793|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110318431|NCT00325793|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110318432|NCT00325793|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110318433|NCT00325793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110318434|NCT00325793|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110318435|NCT00325793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110318436|NCT00325793|Vasodilator Agents|vasodilator agents|mesh-ancestor
110318437|NCT00426621|Diclofenac|diclofenac|mesh-list
110318438|NCT00426621|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110318440|NCT00426621|Analgesics|analgesics|mesh-ancestor
110318441|NCT00426621|Sensory System Agents|sensory system agents|mesh-ancestor
110318442|NCT00426621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110318443|NCT00426621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110318444|NCT00426621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110318445|NCT00426621|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110318446|NCT00426621|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110318447|NCT00426621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110318448|NCT00426621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110318449|NCT04714242|Ranibizumab|ranibizumab|mesh-list
110318450|NCT04714242|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110318451|NCT04714242|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110318452|NCT04714242|Growth Substances|growth substances|mesh-ancestor
110318453|NCT04714242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110318454|NCT04714242|Growth Inhibitors|growth inhibitors|mesh-ancestor
110318455|NCT04714242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110318456|NCT00354276|Cytarabine|cytarabine|mesh-list
110318457|NCT00354276|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110318458|NCT00354276|Antimetabolites|antimetabolites|mesh-ancestor
110318459|NCT00354276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110318460|NCT00354276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110318461|NCT00354276|Antiviral Agents|antiviral agents|mesh-ancestor
110318462|NCT00354276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110318463|NCT00354276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110318464|NCT00354276|Immunologic Factors|immunologic factors|mesh-ancestor
110318465|NCT00354276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110318466|NCT00325910|Metformin|metformin|mesh-list
110318467|NCT00325910|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110318468|NCT00325910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110318469|NCT00325949|Acetaminophen|acetaminophen|mesh-list
110318470|NCT00325949|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
110318471|NCT00325949|Hydrocodone|hydrocodone|mesh-list
110318472|NCT00325949|Oxycodone|oxycodone|mesh-list
110318473|NCT00325949|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110318474|NCT00325949|Analgesics|analgesics|mesh-ancestor
110318475|NCT00325949|Sensory System Agents|sensory system agents|mesh-ancestor
110318476|NCT00325949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110318477|NCT00325949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110318478|NCT00325949|Antipyretics|antipyretics|mesh-ancestor
110318479|NCT00325949|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110318480|NCT00325949|Narcotics|narcotics|mesh-ancestor
110318481|NCT00325949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110318482|NCT00325949|Antitussive Agents|antitussive agents|mesh-ancestor
110318483|NCT00325949|Respiratory System Agents|respiratory system agents|mesh-ancestor
110318484|NCT00325949|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110318485|NCT00325949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110318486|NCT00325949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110318487|NCT00326027|Pantoprazole|pantoprazole|mesh-list
110318488|NCT00326027|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110318489|NCT00326027|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110318490|NCT00326027|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110318491|NCT00326027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110318492|NCT00326027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110318493|NCT01059318|Everolimus|everolimus|mesh-list
110318494|NCT01059318|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110318495|NCT01059318|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110318496|NCT01059318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110318497|NCT01059318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110318498|NCT01059318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110318499|NCT01059318|Immunologic Factors|immunologic factors|mesh-ancestor
110318500|NCT01059318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110318501|NCT01059318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110318502|NCT04714515|Hydroxychloroquine|hydroxychloroquine|mesh-list
110318503|NCT04714515|Ivermectin|ivermectin|mesh-list
110318504|NCT04714515|Montelukast|montelukast|mesh-list
110318505|NCT04714515|Antimalarials|antimalarials|mesh-ancestor
110318506|NCT04714515|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110318507|NCT04714515|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110318508|NCT04714515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110318509|NCT04714515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110318510|NCT04714515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110318511|NCT04714515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110318512|NCT04714515|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110318513|NCT04714515|Respiratory System Agents|respiratory system agents|mesh-ancestor
110318514|NCT04714515|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110318515|NCT04714515|Hormone Antagonists|hormone antagonists|mesh-ancestor
110318516|NCT04714515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110318517|NCT04714515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110318518|NCT04714515|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110318519|NCT04714515|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110318520|NCT00326105|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110318521|NCT00326105|Antidepressive Agents|antidepressive agents|mesh-ancestor
110318522|NCT00326105|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110318523|NCT00326105|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110318524|NCT00326105|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110318525|NCT00326105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110318526|NCT00326105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110318527|NCT00354354|Ipratropium|ipratropium|mesh-list
110318528|NCT00354354|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110318529|NCT00354354|Autonomic Agents|autonomic agents|mesh-ancestor
110318530|NCT00354354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110318531|NCT00354354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110318532|NCT00354354|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110318533|NCT00354354|Respiratory System Agents|respiratory system agents|mesh-ancestor
110318534|NCT00354354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110318535|NCT00354354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110318536|NCT00354354|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110318537|NCT00354354|Cholinergic Agents|cholinergic agents|mesh-ancestor
110318538|NCT00326144|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110318539|NCT00326144|Antidepressive Agents|antidepressive agents|mesh-ancestor
110318540|NCT00326144|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110318541|NCT00326144|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110318542|NCT00326144|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110318543|NCT00326144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110318544|NCT00326144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110318545|NCT01058655|Everolimus|everolimus|mesh-list
110318546|NCT01058655|Tivozanib|tivozanib|mesh-list
110318547|NCT01058655|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110318548|NCT01058655|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110318549|NCT01058655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110318550|NCT01058655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110318551|NCT01058655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110318552|NCT01058655|Immunologic Factors|immunologic factors|mesh-ancestor
110318553|NCT01058655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110318554|NCT01058655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110318555|NCT00326300|Methylphenidate|methylphenidate|mesh-list
110318556|NCT00326300|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110318557|NCT00326300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110318558|NCT00326300|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110318559|NCT00326300|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110318560|NCT00326300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110318561|NCT00326300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110318562|NCT00326300|Dopamine Agents|dopamine agents|mesh-ancestor
110318563|NCT00326300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110318564|NCT00426777|Risedronic Acid|risedronic acid|mesh-list
110318566|NCT00426777|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110318567|NCT00426777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110318568|NCT00426777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110318569|NCT00426777|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110318570|NCT00426777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110318571|NCT00426777|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110318572|NCT00419549|Valdecoxib|valdecoxib|mesh-list
110318573|NCT00419549|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110318574|NCT00419549|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110318575|NCT00419549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110318576|NCT00419549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110318577|NCT00419549|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110318578|NCT00419549|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110318580|NCT00419549|Sensory System Agents|sensory system agents|mesh-ancestor
110318581|NCT00419549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110318582|NCT00419549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110318583|NCT00419549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110318584|NCT00419549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110318585|NCT00326378|Docetaxel|docetaxel|mesh-list
110318586|NCT00326378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110318587|NCT00326378|Tubulin Modulators|tubulin modulators|mesh-ancestor
110318588|NCT00326378|Antimitotic Agents|antimitotic agents|mesh-ancestor
110318589|NCT00326378|Mitosis Modulators|mitosis modulators|mesh-ancestor
110318590|NCT00326378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110318591|NCT00326768|Telmisartan|telmisartan|mesh-list
110318592|NCT00326768|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110318593|NCT00326768|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110318594|NCT00326768|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110318595|NCT00326768|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110318596|NCT00326768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110318597|NCT00326768|Diuretics|diuretics|mesh-ancestor
110318598|NCT00326768|Natriuretic Agents|natriuretic agents|mesh-ancestor
110318599|NCT00326768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110318600|NCT00326768|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110318601|NCT00326768|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110318602|NCT00326807|Naltrexone|naltrexone|mesh-list
110318603|NCT00326807|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110318604|NCT00326807|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110318605|NCT00326807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110318606|NCT00326807|Sensory System Agents|sensory system agents|mesh-ancestor
110318607|NCT00326807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110318608|NCT00354549|Bevacizumab|bevacizumab|mesh-list
110318609|NCT00354549|Carboplatin|carboplatin|mesh-list
110318610|NCT00354549|Gemcitabine|gemcitabine|mesh-list
110318611|NCT00354549|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110318612|NCT00354549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110318613|NCT00354549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110318614|NCT00354549|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110318615|NCT00354549|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110318616|NCT00354549|Growth Substances|growth substances|mesh-ancestor
110318617|NCT00354549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110318618|NCT00354549|Growth Inhibitors|growth inhibitors|mesh-ancestor
110318619|NCT00354549|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110318621|NCT00354549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110318622|NCT00354549|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110318623|NCT00354549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110318624|NCT01057251|Nebivolol|nebivolol|mesh-list
110318625|NCT01057251|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110318626|NCT01057251|Vasodilator Agents|vasodilator agents|mesh-ancestor
110318627|NCT01057251|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
110318628|NCT01057251|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110318629|NCT01057251|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110318630|NCT01057251|Adrenergic Agents|adrenergic agents|mesh-ancestor
110318631|NCT01057251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110318632|NCT01057251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110318633|NCT01057251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110318635|NCT04708353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110318637|NCT04708353|Sensory System Agents|sensory system agents|mesh-ancestor
110318638|NCT04708353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110318639|NCT04708353|Anticonvulsants|anticonvulsants|mesh-ancestor
110318640|NCT04708353|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110318641|NCT04708353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110318642|NCT04708353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110318643|NCT04708353|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110318644|NCT04708353|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110318645|NCT04708353|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110170389|NCT00001328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110318646|NCT04708353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110318648|NCT00425646|Bevacizumab|bevacizumab|mesh-list
110318649|NCT00425646|Imatinib Mesylate|imatinib mesylate|mesh-list
110318650|NCT00425646|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110318651|NCT00425646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110318652|NCT00425646|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110318653|NCT00425646|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110318654|NCT00425646|Growth Substances|growth substances|mesh-ancestor
110318655|NCT00425646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110318656|NCT00425646|Growth Inhibitors|growth inhibitors|mesh-ancestor
110149493|NCT00006379|Fludarabine|fludarabine|mesh-list
110318657|NCT00425646|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110318658|NCT00425646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110318659|NCT00425646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110318660|NCT00327080|Acetylcholine|acetylcholine|mesh-list
110318661|NCT00327080|Vasodilator Agents|vasodilator agents|mesh-ancestor
110318662|NCT00327080|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110318663|NCT00327080|Cholinergic Agents|cholinergic agents|mesh-ancestor
110318664|NCT00327080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110318665|NCT00327080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110318666|NCT00327080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110318667|NCT00327119|Panitumumab|panitumumab|mesh-list
110318668|NCT00327119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110318669|NCT00327119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110318670|NCT00426933|Vancomycin|vancomycin|mesh-list
110318671|NCT00426933|Daptomycin|daptomycin|mesh-list
110318672|NCT00426933|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110318673|NCT00426933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110318674|NCT00327197|Prednisolone|prednisolone|mesh-list
110318675|NCT00327197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110318676|NCT00327197|Glucocorticoids|glucocorticoids|mesh-ancestor
110318677|NCT00327197|Hormones|hormones|mesh-ancestor
110374458|NCT01137604|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110318678|NCT00327197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110318679|NCT00327197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110318680|NCT00327197|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110318681|NCT00327197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110318682|NCT00425724|Cyclosporine|cyclosporine|mesh-list
110318683|NCT00425724|Prednisone|prednisone|mesh-list
110318684|NCT00425724|Methylprednisolone|methylprednisolone|mesh-list
110318685|NCT00425724|Cyclosporins|cyclosporins|mesh-list
110318686|NCT00425724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110318687|NCT00425724|Glucocorticoids|glucocorticoids|mesh-ancestor
110318688|NCT00425724|Hormones|hormones|mesh-ancestor
110318689|NCT00425724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110318690|NCT00425724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110318691|NCT00425724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110318692|NCT00425724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110318693|NCT00425724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110318694|NCT00425724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110318695|NCT00425724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110318696|NCT00425724|Immunologic Factors|immunologic factors|mesh-ancestor
110318697|NCT00425724|Antifungal Agents|antifungal agents|mesh-ancestor
110318698|NCT00425724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110318699|NCT00425724|Dermatologic Agents|dermatologic agents|mesh-ancestor
110318700|NCT00425724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110318701|NCT00425724|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110318702|NCT00425724|Antiemetics|antiemetics|mesh-ancestor
110318703|NCT00425724|Autonomic Agents|autonomic agents|mesh-ancestor
110318704|NCT00425724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110318705|NCT00425724|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110318706|NCT00425724|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110318707|NCT00425724|Protective Agents|protective agents|mesh-ancestor
110318708|NCT00426972|Estradiol|estradiol|mesh-list
110318709|NCT00426972|Estrogens|estrogens|mesh-ancestor
110318711|NCT00426972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110318712|NCT00426972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110318713|NCT00327353|Formoterol Fumarate|formoterol fumarate|mesh-list
110318714|NCT00327353|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110318715|NCT00327353|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110318716|NCT00327353|Autonomic Agents|autonomic agents|mesh-ancestor
110318717|NCT00327353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110318718|NCT00327353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110318719|NCT00327353|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110318720|NCT00327353|Respiratory System Agents|respiratory system agents|mesh-ancestor
110318721|NCT00327353|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110318722|NCT00327353|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110318723|NCT00327353|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110318724|NCT00327353|Adrenergic Agents|adrenergic agents|mesh-ancestor
110318725|NCT00327353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110374471|NCT00198822|Vitamin A|vitamin a|mesh-list
110318726|NCT00327353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110318727|NCT00425841|Gemcitabine|gemcitabine|mesh-list
110318728|NCT00425841|Oxaliplatin|oxaliplatin|mesh-list
110318729|NCT00425841|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110318730|NCT00425841|Antimetabolites|antimetabolites|mesh-ancestor
110318731|NCT00425841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110318732|NCT00425841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110318733|NCT00427089|Ascorbic Acid|ascorbic acid|mesh-list
110318734|NCT00427089|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
110318735|NCT00427089|Antioxidants|antioxidants|mesh-ancestor
110318736|NCT00427089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110318737|NCT00427089|Protective Agents|protective agents|mesh-ancestor
110318738|NCT00427089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110318740|NCT00427089|Micronutrients|micronutrients|mesh-ancestor
110318741|NCT00427089|Laxatives|laxatives|mesh-ancestor
110318742|NCT00427089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110318743|NCT00427128|Fluoxetine|fluoxetine|mesh-list
110318744|NCT00427128|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110318745|NCT00427128|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110318746|NCT00427128|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110318747|NCT00427128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110318748|NCT00427128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110318749|NCT00427128|Serotonin Agents|serotonin agents|mesh-ancestor
110318750|NCT00427128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110318751|NCT00427128|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110318752|NCT00427128|Antidepressive Agents|antidepressive agents|mesh-ancestor
110318753|NCT00427128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110318754|NCT00427128|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110318755|NCT00427128|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110318756|NCT00427128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110318757|NCT00427167|Aluminum Hydroxide|aluminum hydroxide|mesh-list
110318758|NCT00427167|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110318759|NCT00427167|Immunologic Factors|immunologic factors|mesh-ancestor
110318760|NCT00427167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110318761|NCT00427167|Antacids|antacids|mesh-ancestor
110318762|NCT00427167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110318763|NCT00427167|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110318764|NCT00427206|Acetaminophen|acetaminophen|mesh-list
110318765|NCT00427206|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110318766|NCT00427206|Analgesics|analgesics|mesh-ancestor
110318767|NCT00427206|Sensory System Agents|sensory system agents|mesh-ancestor
110318768|NCT00427206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110318769|NCT00427206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110318770|NCT00427206|Antipyretics|antipyretics|mesh-ancestor
110318771|NCT00425997|Amlodipine|amlodipine|mesh-list
110318773|NCT00425997|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110318774|NCT00425997|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110318775|NCT00425997|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110318776|NCT00425997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110318777|NCT00425997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110318778|NCT00425997|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110318780|NCT00425997|Vasodilator Agents|vasodilator agents|mesh-ancestor
110318781|NCT00425997|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110170403|NCT00017160|Alkylating Agents|alkylating agents|mesh-ancestor
110318782|NCT00425997|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110318784|NCT00425997|Natriuretic Agents|natriuretic agents|mesh-ancestor
110318785|NCT00425997|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110318786|NCT00427245|Cyclophosphamide|cyclophosphamide|mesh-list
110318787|NCT00427245|Goserelin|goserelin|mesh-list
110318788|NCT00427245|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110318789|NCT00427245|Immunologic Factors|immunologic factors|mesh-ancestor
110318790|NCT00427245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110318791|NCT00427245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110318792|NCT00427245|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110318793|NCT00427245|Alkylating Agents|alkylating agents|mesh-ancestor
110318794|NCT00427245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110318795|NCT00427245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110318796|NCT00427245|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110318797|NCT00427245|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110318798|NCT05458076|Ritonavir|ritonavir|mesh-list
110318799|NCT05458076|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110318800|NCT05458076|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110318801|NCT05458076|Protease Inhibitors|protease inhibitors|mesh-ancestor
110318802|NCT05458076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110318803|NCT05458076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110318804|NCT05458076|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110318805|NCT05458076|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110318806|NCT05458076|Antiviral Agents|antiviral agents|mesh-ancestor
110318807|NCT05458076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110318808|NCT05458076|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110318809|NCT05458076|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110318810|NCT00427362|Adalimumab|adalimumab|mesh-list
110318811|NCT00427362|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110318812|NCT00427362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110318813|NCT00427362|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110318814|NCT00426192|Mannitol|mannitol|mesh-list
110318815|NCT00426192|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110318816|NCT00426192|Diuretics|diuretics|mesh-ancestor
110318817|NCT00426192|Natriuretic Agents|natriuretic agents|mesh-ancestor
110318818|NCT00426192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110318819|NCT05457530|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
110318820|NCT05457530|Antiviral Agents|antiviral agents|mesh-ancestor
110318821|NCT05457530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110318822|NCT05457530|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110318823|NCT05457530|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110318824|NCT05457530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110318825|NCT05457530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110318826|NCT05457530|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110318827|NCT05457530|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110318828|NCT00432393|Levodopa|levodopa|mesh-list
110318829|NCT00432393|Carbidopa|carbidopa|mesh-list
110318830|NCT00432393|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
110318831|NCT00432393|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110318832|NCT00432393|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110318833|NCT00432393|Dopamine Agents|dopamine agents|mesh-ancestor
110318834|NCT00432393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110318835|NCT00432393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110318836|NCT00432393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110318837|NCT00432393|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
110318838|NCT00432393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110318839|NCT00432393|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110318840|NCT00432393|Immunologic Factors|immunologic factors|mesh-ancestor
110318841|NCT00432393|Dopamine Agonists|dopamine agonists|mesh-ancestor
110318842|NCT05453045|Albendazole|albendazole|mesh-list
110318843|NCT05453045|Anthelmintics|anthelmintics|mesh-ancestor
110318844|NCT05453045|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110318845|NCT05453045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110318846|NCT05453045|Anticestodal Agents|anticestodal agents|mesh-ancestor
110318847|NCT05453045|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110318848|NCT05453045|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110318849|NCT05453045|Tubulin Modulators|tubulin modulators|mesh-ancestor
110318850|NCT05453045|Antimitotic Agents|antimitotic agents|mesh-ancestor
110318851|NCT05453045|Mitosis Modulators|mitosis modulators|mesh-ancestor
110318852|NCT05453045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110318853|NCT05453045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110318855|NCT00432432|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110318856|NCT00432432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110318857|NCT00432432|Dermatologic Agents|dermatologic agents|mesh-ancestor
110318858|NCT00432432|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110318859|NCT00432432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110318861|NCT02957448|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110318862|NCT02957448|Antitubercular Agents|antitubercular agents|mesh-ancestor
110318863|NCT02957448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110318864|NCT02957448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110318865|NCT02957448|Leprostatic Agents|leprostatic agents|mesh-ancestor
110318866|NCT02957448|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110318867|NCT02957448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110318868|NCT02957448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110318869|NCT02957448|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110318870|NCT02957448|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110318871|NCT02957448|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110318872|NCT02957448|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110318873|NCT02957448|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110318874|NCT02957448|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110318875|NCT00427596|Solabegron|solabegron|mesh-list
110318876|NCT00427596|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
110318877|NCT00427596|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110318878|NCT00427596|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110318879|NCT00427596|Adrenergic Agents|adrenergic agents|mesh-ancestor
110318880|NCT00427596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110318881|NCT00427596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110318882|NCT00427596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110318883|NCT00432510|Complement C1s|complement c1s|mesh-list
110318884|NCT00432510|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
110318885|NCT00432510|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
110318886|NCT00432510|Immunologic Factors|immunologic factors|mesh-ancestor
110318887|NCT00432510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110318888|NCT00432510|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
110318889|NCT00432510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110318890|NCT05354258|Pyrimethamine|pyrimethamine|mesh-list
110318891|NCT05354258|Sulfadoxine|sulfadoxine|mesh-list
110318892|NCT05354258|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
110318893|NCT05354258|Amodiaquine|amodiaquine|mesh-list
110318894|NCT05354258|Albendazole|albendazole|mesh-list
110318895|NCT05354258|Praziquantel|praziquantel|mesh-list
110318896|NCT05354258|Antimalarials|antimalarials|mesh-ancestor
110318897|NCT05354258|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110318898|NCT05354258|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110318899|NCT05354258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110318900|NCT05354258|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110318901|NCT05354258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110318902|NCT05354258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110318903|NCT05354258|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110318904|NCT05354258|Anthelmintics|anthelmintics|mesh-ancestor
110318905|NCT05354258|Anticestodal Agents|anticestodal agents|mesh-ancestor
110318906|NCT05354258|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110318907|NCT05354258|Tubulin Modulators|tubulin modulators|mesh-ancestor
110318908|NCT05354258|Antimitotic Agents|antimitotic agents|mesh-ancestor
110318909|NCT05354258|Mitosis Modulators|mitosis modulators|mesh-ancestor
110318910|NCT05354258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110318911|NCT05338580|Pembrolizumab|pembrolizumab|mesh-list
110318912|NCT05338580|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110318913|NCT05338580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110318914|NCT05338580|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110318915|NCT05338580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110318916|NCT02273466|Desipramine|desipramine|mesh-list
110318917|NCT02273466|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110318918|NCT02273466|Antidepressive Agents|antidepressive agents|mesh-ancestor
110318919|NCT02273466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110318920|NCT02273466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110318921|NCT02273466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110318922|NCT02273466|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110318923|NCT02273466|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110318924|NCT02273466|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110318925|NCT02273466|Adrenergic Agents|adrenergic agents|mesh-ancestor
110318926|NCT02273466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110318927|NCT02273466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110318928|NCT00427713|Capecitabine|capecitabine|mesh-list
110318929|NCT00427713|Oxaliplatin|oxaliplatin|mesh-list
110318930|NCT00427713|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110318931|NCT00427713|Antimetabolites|antimetabolites|mesh-ancestor
110318932|NCT00427713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110318933|NCT00427713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110318935|NCT02273505|Salicylic Acid|salicylic acid|mesh-list
110318936|NCT02273505|Salicylates|salicylates|mesh-list
110318937|NCT02273505|Dipyridamole|dipyridamole|mesh-list
110318938|NCT02273505|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
110318939|NCT02273505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110318940|NCT02273505|Antifungal Agents|antifungal agents|mesh-ancestor
110318941|NCT02273505|Keratolytic Agents|keratolytic agents|mesh-ancestor
110318942|NCT02273505|Dermatologic Agents|dermatologic agents|mesh-ancestor
110318943|NCT02273505|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110318944|NCT02273505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110318945|NCT02273505|Analgesics|analgesics|mesh-ancestor
110318946|NCT02273505|Sensory System Agents|sensory system agents|mesh-ancestor
110318947|NCT02273505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110318948|NCT02273505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110318949|NCT02273505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110318950|NCT02273505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110318951|NCT02273505|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110318952|NCT02273505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110318953|NCT02273505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110318954|NCT02273505|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110318955|NCT02273505|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110318956|NCT02273505|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110318957|NCT02273505|Antipyretics|antipyretics|mesh-ancestor
110318958|NCT02273505|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110318959|NCT02273505|Vasodilator Agents|vasodilator agents|mesh-ancestor
110318960|NCT05210621|Ocrelizumab|ocrelizumab|mesh-list
110318961|NCT05210621|Immunologic Factors|immunologic factors|mesh-ancestor
110318962|NCT05210621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110318963|NCT05198960|Aspirin|aspirin|mesh-list
110318964|NCT05198960|Anticoagulants|anticoagulants|mesh-list
110318965|NCT05198960|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110318966|NCT05198960|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110318967|NCT05198960|Analgesics|analgesics|mesh-ancestor
110318968|NCT05198960|Sensory System Agents|sensory system agents|mesh-ancestor
110318969|NCT05198960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110318970|NCT05198960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110318971|NCT05198960|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110318972|NCT05198960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110318973|NCT05198960|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110318974|NCT05198960|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110318975|NCT05198960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110318976|NCT05198960|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110318977|NCT05198960|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110318978|NCT05198960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110318979|NCT05198960|Antipyretics|antipyretics|mesh-ancestor
110318980|NCT00432549|Topiramate|topiramate|mesh-list
110318981|NCT00432549|Almotriptan|almotriptan|mesh-list
110318982|NCT00432549|Anticonvulsants|anticonvulsants|mesh-ancestor
110318983|NCT00432549|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110318984|NCT00432549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110318985|NCT00432549|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110318986|NCT00432549|Serotonin Agents|serotonin agents|mesh-ancestor
110318987|NCT00432549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110318988|NCT00432549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110318989|NCT00427947|Ropivacaine|ropivacaine|mesh-list
110318990|NCT00427947|Anesthetics, Local|anesthetics, local|mesh-ancestor
110318991|NCT00427947|Anesthetics|anesthetics|mesh-ancestor
110318992|NCT00427947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110318993|NCT00427947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110318994|NCT00427947|Sensory System Agents|sensory system agents|mesh-ancestor
110318995|NCT00427947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110318996|NCT00432588|Misoprostol|misoprostol|mesh-list
110318997|NCT00432588|Dinoprostone|dinoprostone|mesh-list
110318998|NCT00432588|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110318999|NCT00432588|Abortifacient Agents|abortifacient agents|mesh-ancestor
110319000|NCT00432588|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110319001|NCT00432588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110319002|NCT00432588|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110319003|NCT00432588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110319004|NCT00432588|Oxytocics|oxytocics|mesh-ancestor
110319005|NCT00428025|Diclofenac|diclofenac|mesh-list
110319006|NCT00428025|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110319007|NCT00428025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110319008|NCT00428025|Analgesics|analgesics|mesh-ancestor
110319009|NCT00428025|Sensory System Agents|sensory system agents|mesh-ancestor
110319010|NCT00428025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110319011|NCT00428025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110319012|NCT00428025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110319013|NCT00428025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110319014|NCT00428025|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110319015|NCT00428025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110319016|NCT00428025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110319017|NCT00428064|Cyclosporine|cyclosporine|mesh-list
110319018|NCT00428064|Sirolimus|sirolimus|mesh-list
110319019|NCT00428064|Cyclosporins|cyclosporins|mesh-list
110319020|NCT00428064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110319021|NCT00428064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110319022|NCT00428064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110319023|NCT00428064|Immunologic Factors|immunologic factors|mesh-ancestor
110319024|NCT00428064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110319025|NCT00428064|Antifungal Agents|antifungal agents|mesh-ancestor
110319026|NCT00428064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110319027|NCT00428064|Dermatologic Agents|dermatologic agents|mesh-ancestor
110319028|NCT00428064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110319029|NCT00428064|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110319030|NCT00428064|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110319031|NCT00428064|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110319032|NCT00428064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110319033|NCT00432627|Deferasirox|deferasirox|mesh-list
110319034|NCT00432627|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110319035|NCT00432627|Chelating Agents|chelating agents|mesh-ancestor
110319036|NCT00432627|Sequestering Agents|sequestering agents|mesh-ancestor
110319037|NCT00432627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110319038|NCT00419783|Moxifloxacin|moxifloxacin|mesh-list
110319039|NCT00419783|Ketoconazole|ketoconazole|mesh-list
110319040|NCT00419783|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110319041|NCT00419783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110319042|NCT00419783|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110319043|NCT00419783|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110319044|NCT00419783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110170434|NCT00040027|Thymalfasin|thymalfasin|mesh-list
110319045|NCT00419783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110319046|NCT00419783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110319047|NCT00419783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110319048|NCT00419783|Antifungal Agents|antifungal agents|mesh-ancestor
110319049|NCT00419783|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110319050|NCT00419783|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110319051|NCT00419783|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110319052|NCT00419783|Hormone Antagonists|hormone antagonists|mesh-ancestor
110319053|NCT00419783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110319054|NCT00419783|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110319055|NCT00428181|Ethanol|ethanol|mesh-list
110319056|NCT00428181|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110319057|NCT00428181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110319058|NCT00428181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110319059|NCT00428181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110319060|NCT00432861|Pancrelipase|pancrelipase|mesh-list
110319061|NCT00432861|Pancreatin|pancreatin|mesh-list
110319062|NCT00432861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110319063|NCT04575233|Ropivacaine|ropivacaine|mesh-list
110319064|NCT04575233|Anesthetics, Local|anesthetics, local|mesh-ancestor
110319065|NCT04575233|Anesthetics|anesthetics|mesh-ancestor
110319066|NCT04575233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110319067|NCT04575233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110319068|NCT04575233|Sensory System Agents|sensory system agents|mesh-ancestor
110319069|NCT04575233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110319070|NCT00428454|Sirolimus|sirolimus|mesh-list
110319071|NCT00428454|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110319072|NCT00428454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110319073|NCT00428454|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110319074|NCT00428454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110319075|NCT00428454|Antifungal Agents|antifungal agents|mesh-ancestor
110319076|NCT00428454|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110319077|NCT00428454|Immunologic Factors|immunologic factors|mesh-ancestor
110319078|NCT00428454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110319079|NCT00432978|Bosentan|bosentan|mesh-list
110319080|NCT00432978|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110319081|NCT00432978|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
110319082|NCT00432978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110319083|NCT01051791|Everolimus|everolimus|mesh-list
110319084|NCT01051791|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110319085|NCT01051791|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110319086|NCT01051791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110319087|NCT01051791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110319088|NCT01051791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110319089|NCT01051791|Immunologic Factors|immunologic factors|mesh-ancestor
110319090|NCT01051791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110319091|NCT01051791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110319092|NCT01056510|Rituximab|rituximab|mesh-list
110319093|NCT01056510|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110319094|NCT01056510|Chlorambucil|chlorambucil|mesh-list
110319095|NCT01056510|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110319096|NCT01056510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110319097|NCT01056510|Immunologic Factors|immunologic factors|mesh-ancestor
110319098|NCT01056510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110319099|NCT01056510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110319100|NCT01056510|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110319101|NCT01056510|Alkylating Agents|alkylating agents|mesh-ancestor
110319102|NCT01056510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110319103|NCT01056276|Dexamethasone|dexamethasone|mesh-list
110319104|NCT01056276|Bortezomib|bortezomib|mesh-list
110319105|NCT01056276|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110319106|NCT01056276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110319107|NCT01056276|Antiemetics|antiemetics|mesh-ancestor
110319108|NCT01056276|Autonomic Agents|autonomic agents|mesh-ancestor
110319109|NCT01056276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110319110|NCT01056276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110319111|NCT01056276|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110319112|NCT01056276|Glucocorticoids|glucocorticoids|mesh-ancestor
110319113|NCT01056276|Hormones|hormones|mesh-ancestor
110319114|NCT01056276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110319115|NCT01056276|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110319116|NCT01056276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110319117|NCT01056276|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110319118|NCT01056276|Alkylating Agents|alkylating agents|mesh-ancestor
110319119|NCT01056276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110319120|NCT01055886|Nicotine|nicotine|mesh-list
110319121|NCT01055886|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110319122|NCT01055886|Autonomic Agents|autonomic agents|mesh-ancestor
110319123|NCT01055886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110319124|NCT01055886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110319125|NCT01055886|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110319126|NCT01055886|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110319127|NCT01055886|Cholinergic Agents|cholinergic agents|mesh-ancestor
110319128|NCT01055886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110319129|NCT01055886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110319130|NCT00433095|Trastuzumab|trastuzumab|mesh-list
110319131|NCT00433095|Vinorelbine|vinorelbine|mesh-list
110319132|NCT00433095|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110319133|NCT00433095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110319134|NCT00433095|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110319136|NCT00433095|Antimitotic Agents|antimitotic agents|mesh-ancestor
110319137|NCT00433095|Mitosis Modulators|mitosis modulators|mesh-ancestor
110319138|NCT00433095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110319139|NCT01055613|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110319140|NCT01055457|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110319141|NCT00428649|Selenium|selenium|mesh-list
110319142|NCT00428649|Antioxidants|antioxidants|mesh-ancestor
110319143|NCT00428649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110319144|NCT00428649|Protective Agents|protective agents|mesh-ancestor
110319145|NCT00428649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110319146|NCT00428649|Trace Elements|trace elements|mesh-ancestor
110319147|NCT00428649|Micronutrients|micronutrients|mesh-ancestor
110319148|NCT00433173|Anastrozole|anastrozole|mesh-list
110319149|NCT00433173|Goserelin|goserelin|mesh-list
110319150|NCT00433173|Testosterone|testosterone|mesh-list
110319151|NCT00433173|Androgens|androgens|mesh-ancestor
110319152|NCT00433173|Hormones|hormones|mesh-ancestor
110319153|NCT00433173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110319154|NCT00433173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110319155|NCT00433173|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110319156|NCT00433173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110319157|NCT00433173|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110319158|NCT00433173|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110319159|NCT00433173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110319160|NCT00433173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110319161|NCT00433173|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110319162|NCT00433173|Hormone Antagonists|hormone antagonists|mesh-ancestor
110319163|NCT01055028|Paclitaxel|paclitaxel|mesh-list
110319164|NCT01055028|Bevacizumab|bevacizumab|mesh-list
110319165|NCT01055028|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110319166|NCT01055028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110319167|NCT01055028|Tubulin Modulators|tubulin modulators|mesh-ancestor
110319168|NCT01055028|Antimitotic Agents|antimitotic agents|mesh-ancestor
110319169|NCT01055028|Mitosis Modulators|mitosis modulators|mesh-ancestor
110319170|NCT01055028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110319171|NCT01055028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110319172|NCT01055028|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110319173|NCT01055028|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110319174|NCT01055028|Growth Substances|growth substances|mesh-ancestor
110319175|NCT01055028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110319176|NCT01055028|Growth Inhibitors|growth inhibitors|mesh-ancestor
110319177|NCT00428727|Nitric Oxide|nitric oxide|mesh-list
110319178|NCT00428727|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110319179|NCT00428727|Autonomic Agents|autonomic agents|mesh-ancestor
110319180|NCT00428727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110319181|NCT00428727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110319182|NCT00428727|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110319183|NCT00428727|Respiratory System Agents|respiratory system agents|mesh-ancestor
110319184|NCT00428727|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110319185|NCT00428727|Antioxidants|antioxidants|mesh-ancestor
110319186|NCT00428727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110319187|NCT00428727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110319188|NCT00428727|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
110319189|NCT00428727|Vasodilator Agents|vasodilator agents|mesh-ancestor
110319190|NCT00428727|Gasotransmitters|gasotransmitters|mesh-ancestor
110319191|NCT00428727|Protective Agents|protective agents|mesh-ancestor
110319192|NCT00433368|N-Methylaspartate|n-methylaspartate|mesh-list
110319193|NCT00433368|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
110319194|NCT00433368|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110319195|NCT00433368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110343823|NCT06022003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110319196|NCT00433368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110319197|NCT00433368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110319199|NCT00428766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110319201|NCT04716569|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110319202|NCT04716569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110319203|NCT04703127|Lidocaine|lidocaine|mesh-list
110319204|NCT04703127|Tadalafil|tadalafil|mesh-list
110319205|NCT04703127|Anesthetics, Local|anesthetics, local|mesh-ancestor
110319206|NCT04703127|Anesthetics|anesthetics|mesh-ancestor
110319207|NCT04703127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110319208|NCT04703127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110319209|NCT04703127|Sensory System Agents|sensory system agents|mesh-ancestor
110319210|NCT04703127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110319211|NCT04703127|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110319212|NCT04703127|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110319213|NCT04703127|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110319214|NCT04703127|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110319215|NCT04703127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110319216|NCT04703127|Vasodilator Agents|vasodilator agents|mesh-ancestor
110319217|NCT04703127|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110319218|NCT04703127|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110319219|NCT04703127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110319220|NCT04703127|Urological Agents|urological agents|mesh-ancestor
110319222|NCT00428883|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110319223|NCT00428883|Antiviral Agents|antiviral agents|mesh-ancestor
110319224|NCT00428883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110319225|NCT00428883|Expectorants|expectorants|mesh-ancestor
110319226|NCT00428883|Respiratory System Agents|respiratory system agents|mesh-ancestor
110319227|NCT00428883|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110319229|NCT00428883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110319230|NCT00428883|Protective Agents|protective agents|mesh-ancestor
110319231|NCT00428883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110319232|NCT00428883|Antidotes|antidotes|mesh-ancestor
110319233|NCT04702971|Flunarizine|flunarizine|mesh-list
110319234|NCT04702971|Anticonvulsants|anticonvulsants|mesh-ancestor
110319235|NCT04702971|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110319236|NCT04702971|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110319237|NCT04702971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110319238|NCT04702971|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110319239|NCT04702971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110319240|NCT04702971|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110319241|NCT04702971|Histamine Antagonists|histamine antagonists|mesh-ancestor
110319242|NCT04702971|Histamine Agents|histamine agents|mesh-ancestor
110319243|NCT04702971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110319244|NCT04702971|Vasodilator Agents|vasodilator agents|mesh-ancestor
110319245|NCT00433407|Trastuzumab|trastuzumab|mesh-list
110319246|NCT00433407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110319247|NCT00433407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110319248|NCT00433485|Sirolimus|sirolimus|mesh-list
110319249|NCT00433485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110319250|NCT00433485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110319251|NCT00433485|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110319252|NCT00433485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110319253|NCT00433485|Antifungal Agents|antifungal agents|mesh-ancestor
110319254|NCT00433485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110319255|NCT00433485|Immunologic Factors|immunologic factors|mesh-ancestor
110319256|NCT00433485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110319257|NCT02676791|Povidone-Iodine|povidone-iodine|mesh-list
110319258|NCT02676791|Povidone|povidone|mesh-list
110319259|NCT02676791|Plasma Substitutes|plasma substitutes|mesh-ancestor
110319260|NCT02676791|Blood Substitutes|blood substitutes|mesh-ancestor
110319261|NCT02676791|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110319262|NCT02676791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110319263|NCT01600079|Vaccines|vaccines|mesh-list
110319264|NCT01600079|Immunologic Factors|immunologic factors|mesh-ancestor
110319265|NCT01600079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110319266|NCT01370486|Melatonin|melatonin|mesh-list
110319267|NCT01370486|Antioxidants|antioxidants|mesh-ancestor
110319268|NCT01370486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110319269|NCT01370486|Protective Agents|protective agents|mesh-ancestor
110319270|NCT01370486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110319271|NCT01370486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110319272|NCT00327587|Amlodipine|amlodipine|mesh-list
110319273|NCT00327587|Valsartan|valsartan|mesh-list
110319275|NCT00327587|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110319276|NCT00327587|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110319277|NCT00327587|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110319278|NCT00327587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110319279|NCT00327587|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110319280|NCT00327587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110319281|NCT00327587|Vasodilator Agents|vasodilator agents|mesh-ancestor
110319282|NCT00327587|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110319283|NCT00327587|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110319284|NCT00327587|Diuretics|diuretics|mesh-ancestor
110319285|NCT00327587|Natriuretic Agents|natriuretic agents|mesh-ancestor
110319286|NCT00327587|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110319287|NCT00327665|Vaccines|vaccines|mesh-list
110319288|NCT00327665|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110319289|NCT00327665|Immunologic Factors|immunologic factors|mesh-ancestor
110319290|NCT00327665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110319291|NCT00433641|Sibutramine|sibutramine|mesh-list
110319292|NCT00433641|Antidepressive Agents|antidepressive agents|mesh-ancestor
110319293|NCT00433641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110319294|NCT00433641|Appetite Depressants|appetite depressants|mesh-ancestor
110319295|NCT00433641|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110319296|NCT00429234|Gemcitabine|gemcitabine|mesh-list
110319297|NCT00429234|Dasatinib|dasatinib|mesh-list
110319298|NCT00429234|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110319299|NCT00429234|Antimetabolites|antimetabolites|mesh-ancestor
110319300|NCT00429234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110319301|NCT00429234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110319302|NCT00429234|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110319303|NCT00429234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110319304|NCT00433719|Efavirenz|efavirenz|mesh-list
110319305|NCT00433719|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
110319306|NCT00433719|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110319307|NCT00433719|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110319308|NCT00433719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110319309|NCT00433719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110319310|NCT00433719|Antiviral Agents|antiviral agents|mesh-ancestor
110319311|NCT00433719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110319312|NCT00433719|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110319313|NCT00433719|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110319314|NCT00433719|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110319315|NCT00433719|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110319316|NCT00433719|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110319317|NCT00433719|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110319318|NCT00433719|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110319319|NCT00433719|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110319321|NCT04704297|Ibuprofen|ibuprofen|mesh-list
110319322|NCT04704297|Ketorolac|ketorolac|mesh-list
110319323|NCT04704297|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
110319324|NCT04704297|Amitriptyline|amitriptyline|mesh-list
110319325|NCT04704297|Bupivacaine|bupivacaine|mesh-list
110319326|NCT04704297|Cyclobenzaprine|cyclobenzaprine|mesh-list
110319327|NCT04704297|Anesthetics, Local|anesthetics, local|mesh-ancestor
110319328|NCT04704297|Anesthetics|anesthetics|mesh-ancestor
110319329|NCT04704297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110319330|NCT04704297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110319331|NCT04704297|Sensory System Agents|sensory system agents|mesh-ancestor
110319332|NCT04704297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110319333|NCT04704297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110319335|NCT04704297|Antipyretics|antipyretics|mesh-ancestor
110319336|NCT04704297|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110319337|NCT04704297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110319338|NCT04704297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110319339|NCT04704297|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110319340|NCT04704297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110319341|NCT04704297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110319342|NCT04704297|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110319343|NCT04704297|Antidepressive Agents|antidepressive agents|mesh-ancestor
110319344|NCT04704297|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110319345|NCT04704297|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110319346|NCT04704297|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110319347|NCT04704297|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110319348|NCT04704297|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110319349|NCT04704297|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110319350|NCT04704297|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110319351|NCT04704297|Adrenergic Agents|adrenergic agents|mesh-ancestor
110319352|NCT04704297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110319353|NCT00328211|Bile Acids and Salts|bile acids and salts|mesh-list
110319354|NCT00328211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110319355|NCT00328367|Aripiprazole|aripiprazole|mesh-list
110319356|NCT00328367|Antidepressive Agents|antidepressive agents|mesh-ancestor
110319357|NCT00328367|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110319358|NCT00328367|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110319359|NCT00328367|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110319360|NCT00328367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110319361|NCT00328367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110319363|NCT00328367|Dopamine Agents|dopamine agents|mesh-ancestor
110319364|NCT00328367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110319365|NCT00328367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110319366|NCT00328367|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110319367|NCT00328367|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110319368|NCT00328367|Serotonin Agents|serotonin agents|mesh-ancestor
110319369|NCT00328367|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110319370|NCT00328367|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110319371|NCT00328367|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110319372|NCT00328367|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110319373|NCT04703088|Ondansetron|ondansetron|mesh-list
110319375|NCT04703088|Autonomic Agents|autonomic agents|mesh-ancestor
110319376|NCT04703088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110319377|NCT04703088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110319378|NCT04703088|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110319379|NCT04703088|Antipruritics|antipruritics|mesh-ancestor
110319380|NCT04703088|Dermatologic Agents|dermatologic agents|mesh-ancestor
110319381|NCT04703088|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110319382|NCT04703088|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110319383|NCT04703088|Serotonin Agents|serotonin agents|mesh-ancestor
110319384|NCT04703088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110319385|NCT04703088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110319388|NCT00328718|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110319389|NCT00328718|Montelukast|montelukast|mesh-list
110319390|NCT00328718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110319391|NCT00328718|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110319392|NCT00328718|Autonomic Agents|autonomic agents|mesh-ancestor
110319393|NCT00328718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110319394|NCT00328718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110319395|NCT00328718|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110319396|NCT00328718|Respiratory System Agents|respiratory system agents|mesh-ancestor
110319397|NCT00328718|Dermatologic Agents|dermatologic agents|mesh-ancestor
110319398|NCT00328718|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110319399|NCT00328718|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110319400|NCT00328718|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110319401|NCT00328718|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110319402|NCT00328718|Adrenergic Agents|adrenergic agents|mesh-ancestor
110319403|NCT00328718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110319404|NCT00328718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110319405|NCT00328718|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110319406|NCT00328718|Hormone Antagonists|hormone antagonists|mesh-ancestor
110319407|NCT00328718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110319408|NCT00328718|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110319409|NCT00328718|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110319410|NCT00328796|Lidocaine|lidocaine|mesh-list
110319411|NCT00328796|Anesthetics, Local|anesthetics, local|mesh-ancestor
110319412|NCT00328796|Anesthetics|anesthetics|mesh-ancestor
110319413|NCT00328796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110319414|NCT00328796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110319415|NCT00328796|Sensory System Agents|sensory system agents|mesh-ancestor
110319416|NCT00328796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110319417|NCT00328796|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110319418|NCT00328796|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110319419|NCT00328796|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110319420|NCT00328796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110319421|NCT00328796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110319422|NCT00429468|Acetaminophen|acetaminophen|mesh-list
110319423|NCT00429468|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
110319424|NCT00429468|Hydrocodone|hydrocodone|mesh-list
110319425|NCT00429468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110319426|NCT00429468|Analgesics|analgesics|mesh-ancestor
110319427|NCT00429468|Sensory System Agents|sensory system agents|mesh-ancestor
110319428|NCT00429468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110319429|NCT00429468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110319430|NCT00429468|Antipyretics|antipyretics|mesh-ancestor
110319431|NCT00429468|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110319432|NCT00429468|Narcotics|narcotics|mesh-ancestor
110319433|NCT00429468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110319434|NCT00429468|Antitussive Agents|antitussive agents|mesh-ancestor
110319435|NCT00429468|Respiratory System Agents|respiratory system agents|mesh-ancestor
110319436|NCT00429468|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110319437|NCT00429468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110319438|NCT00429468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110319439|NCT04702698|Peposertib|peposertib|mesh-list
110319440|NCT04702698|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110319441|NCT04702698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110319442|NCT04702698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110319443|NCT00328874|Ubiquinone|ubiquinone|mesh-list
110319444|NCT00328874|Coenzyme Q10|coenzyme q10|mesh-list
110319445|NCT00328874|Micronutrients|micronutrients|mesh-ancestor
110319446|NCT00328874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110319448|NCT00328913|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
110319449|NCT00328913|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110319450|NCT00328913|Antidepressive Agents|antidepressive agents|mesh-ancestor
110319451|NCT00328913|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110319452|NCT00433953|Mycophenolic Acid|mycophenolic acid|mesh-list
110319453|NCT00433953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110319454|NCT00433953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110319455|NCT00433953|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110319456|NCT00433953|Antitubercular Agents|antitubercular agents|mesh-ancestor
110319457|NCT00433953|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110319458|NCT00433953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110319459|NCT00433953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110319460|NCT00433953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110319461|NCT02957643|Iron|iron|mesh-list
110319462|NCT02957643|Trace Elements|trace elements|mesh-ancestor
110319463|NCT02957643|Micronutrients|micronutrients|mesh-ancestor
110319464|NCT02957643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110319465|NCT02957604|Evolocumab|evolocumab|mesh-list
110319466|NCT02957604|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
110319467|NCT02957604|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110319468|NCT02957604|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110319469|NCT02957604|Antimetabolites|antimetabolites|mesh-ancestor
110319470|NCT02957604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110319471|NCT02957604|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110319472|NCT02957604|Protease Inhibitors|protease inhibitors|mesh-ancestor
110319473|NCT02957604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110319474|NCT02957604|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110319475|NCT00329069|Atorvastatin|atorvastatin|mesh-list
110319476|NCT00329069|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110319477|NCT00329069|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110319478|NCT00329069|Antimetabolites|antimetabolites|mesh-ancestor
110319479|NCT00329069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110319480|NCT00329069|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110319481|NCT00329069|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110319482|NCT00329069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110319483|NCT00429624|Acetaminophen|acetaminophen|mesh-list
110319484|NCT00429624|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110319485|NCT00429624|Analgesics|analgesics|mesh-ancestor
110319486|NCT00429624|Sensory System Agents|sensory system agents|mesh-ancestor
110319487|NCT00429624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110319488|NCT00429624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110319489|NCT00429624|Antipyretics|antipyretics|mesh-ancestor
110319490|NCT00329147|Paroxetine|paroxetine|mesh-list
110319491|NCT00329147|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
110319492|NCT00329147|Desipramine|desipramine|mesh-list
110319493|NCT00329147|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110319494|NCT00329147|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110319495|NCT00329147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110319496|NCT00329147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110319497|NCT00329147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110319498|NCT00329147|Serotonin Agents|serotonin agents|mesh-ancestor
110319499|NCT00329147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110319500|NCT00329147|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110319501|NCT00329147|Antidepressive Agents|antidepressive agents|mesh-ancestor
110319502|NCT00329147|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110319503|NCT00329147|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110319504|NCT00329147|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110319505|NCT00329147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110319506|NCT00329147|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110319507|NCT00329147|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110319508|NCT00329147|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110319509|NCT00329147|Adrenergic Agents|adrenergic agents|mesh-ancestor
110319510|NCT00329186|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
110319511|NCT00329186|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
110319512|NCT00329186|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110319513|NCT00329186|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110319514|NCT00329186|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110319515|NCT00329186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110319516|NCT00329186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110319517|NCT00329186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110319518|NCT00329186|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110319519|NCT00329186|Antidepressive Agents|antidepressive agents|mesh-ancestor
110319520|NCT00329186|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110319521|NCT00434031|Cyclophosphamide|cyclophosphamide|mesh-list
110319522|NCT00434031|Docetaxel|docetaxel|mesh-list
110319523|NCT00434031|Doxorubicin|doxorubicin|mesh-list
110319524|NCT00434031|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110319525|NCT00434031|Trastuzumab|trastuzumab|mesh-list
110319526|NCT00434031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110319527|NCT00434031|Immunologic Factors|immunologic factors|mesh-ancestor
110319528|NCT00434031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110319529|NCT00434031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110319530|NCT00434031|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110319531|NCT00434031|Alkylating Agents|alkylating agents|mesh-ancestor
110319532|NCT00434031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110319533|NCT00434031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110319534|NCT00434031|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110319535|NCT00434031|Tubulin Modulators|tubulin modulators|mesh-ancestor
110319536|NCT00434031|Antimitotic Agents|antimitotic agents|mesh-ancestor
110319537|NCT00434031|Mitosis Modulators|mitosis modulators|mesh-ancestor
110319538|NCT00434031|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110319539|NCT00434031|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110319540|NCT00434031|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110319541|NCT00434031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110319542|NCT00434031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110319543|NCT00329225|Rosiglitazone|rosiglitazone|mesh-list
110319544|NCT00329225|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110319545|NCT00329225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110319546|NCT01050543|Neostigmine|neostigmine|mesh-list
110319547|NCT01050543|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110319548|NCT01050543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110319549|NCT01050543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110319550|NCT01050543|Cholinergic Agents|cholinergic agents|mesh-ancestor
110319551|NCT01050543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110319552|NCT01050543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110319553|NCT01050543|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110319554|NCT01050543|Autonomic Agents|autonomic agents|mesh-ancestor
110319555|NCT01050543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110319556|NCT00329264|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110319557|NCT00329264|Antidepressive Agents|antidepressive agents|mesh-ancestor
110319559|NCT00329264|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110319560|NCT00329264|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110319561|NCT00329264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110319562|NCT00329264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110319563|NCT00329381|Omalizumab|omalizumab|mesh-list
110319564|NCT00329381|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110319565|NCT00329381|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110319566|NCT00329381|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110319567|NCT00329381|Respiratory System Agents|respiratory system agents|mesh-ancestor
110319568|NCT00329381|Immunologic Factors|immunologic factors|mesh-ancestor
110319569|NCT00329381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110319570|NCT00429780|Aluminum sulfate|aluminum sulfate|mesh-list
110319571|NCT00429780|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110319572|NCT00429780|Immunologic Factors|immunologic factors|mesh-ancestor
110319573|NCT00429780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110319574|NCT00329459|Naproxen|naproxen|mesh-list
110319575|NCT00329459|Sumatriptan|sumatriptan|mesh-list
110319576|NCT00329459|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110319577|NCT00329459|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110319578|NCT00329459|Analgesics|analgesics|mesh-ancestor
110319579|NCT00329459|Sensory System Agents|sensory system agents|mesh-ancestor
110319580|NCT00329459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110319581|NCT00329459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110319582|NCT00329459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110319583|NCT00329459|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110319584|NCT00329459|Gout Suppressants|gout suppressants|mesh-ancestor
110319585|NCT00329459|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110319586|NCT00329459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110319587|NCT00329459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110319588|NCT00329459|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110319589|NCT00329459|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110319590|NCT00329459|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110319591|NCT00329459|Serotonin Agents|serotonin agents|mesh-ancestor
110319592|NCT00329459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110319593|NCT00329498|Ascorbic Acid|ascorbic acid|mesh-list
110319594|NCT00329498|Antioxidants|antioxidants|mesh-ancestor
110319595|NCT00329498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110319596|NCT00329498|Protective Agents|protective agents|mesh-ancestor
110319597|NCT00329498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110319598|NCT00329498|Vitamins|vitamins|mesh-ancestor
110319599|NCT00329498|Micronutrients|micronutrients|mesh-ancestor
110319600|NCT00329537|Sargramostim|sargramostim|mesh-list
110319601|NCT00329537|Immunologic Factors|immunologic factors|mesh-ancestor
110319602|NCT00329537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110319603|NCT00429897|Bendroflumethiazide|bendroflumethiazide|mesh-list
110319604|NCT00429897|Amiloride|amiloride|mesh-list
110319605|NCT00429897|Spironolactone|spironolactone|mesh-list
110319606|NCT00429897|Furosemide|furosemide|mesh-list
110319607|NCT00429897|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110319608|NCT00429897|Hormone Antagonists|hormone antagonists|mesh-ancestor
110319609|NCT00429897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110319610|NCT00429897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110319611|NCT00429897|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110319612|NCT00429897|Diuretics|diuretics|mesh-ancestor
110319613|NCT00429897|Natriuretic Agents|natriuretic agents|mesh-ancestor
110319614|NCT00429897|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
110319615|NCT00429897|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110319616|NCT00429897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110319617|NCT00429897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110319618|NCT00429897|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
110319619|NCT00429897|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110319620|NCT00429897|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110319621|NCT00429897|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110319622|NCT00429936|Fenretinide|fenretinide|mesh-list
110319623|NCT00429936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110319624|NCT00429936|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110319625|NCT00429936|Protective Agents|protective agents|mesh-ancestor
110319626|NCT00429936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110319627|NCT00429975|Levofloxacin|levofloxacin|mesh-list
110319628|NCT00429975|Ceftriaxone|ceftriaxone|mesh-list
110149561|NCT00008034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110319629|NCT00429975|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110319630|NCT00429975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110319631|NCT00429975|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110319632|NCT00429975|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110319633|NCT00429975|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110319634|NCT00429975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110319635|NCT00429975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110319636|NCT00429975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110319637|NCT00429975|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110319638|NCT00429975|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110319639|NCT00329615|Isophane Insulin, Human|isophane insulin, human|mesh-list
110319640|NCT00329615|Insulin, Isophane|insulin, isophane|mesh-list
110319641|NCT00329615|Isophane insulin, beef|isophane insulin, beef|mesh-list
110319642|NCT00329615|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110319643|NCT00329615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110319644|NCT04716686|Niraparib|niraparib|mesh-list
110319645|NCT04716686|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110319646|NCT04716686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110319647|NCT04716686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110319648|NCT04716686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110319649|NCT01056393|Ibalizumab|ibalizumab|mesh-list
110319650|NCT01056393|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110319651|NCT01056393|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110319652|NCT01056393|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110319653|NCT01056393|Antiviral Agents|antiviral agents|mesh-ancestor
110319654|NCT01056393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110319655|NCT01056393|Immunologic Factors|immunologic factors|mesh-ancestor
110319656|NCT01056393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110319657|NCT01055106|Metronidazole|metronidazole|mesh-list
110319658|NCT01055106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110319659|NCT01055106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110319660|NCT01055106|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110319661|NCT01055106|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110319662|NCT00329693|Quinagolide|quinagolide|mesh-list
110319663|NCT00329693|Dopamine Agonists|dopamine agonists|mesh-ancestor
110319664|NCT00329693|Dopamine Agents|dopamine agents|mesh-ancestor
110319665|NCT00329693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110319666|NCT00329693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110319667|NCT00329693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110319668|NCT00329810|Aripiprazole|aripiprazole|mesh-list
110319669|NCT00329810|Antidepressive Agents|antidepressive agents|mesh-ancestor
110319670|NCT00329810|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110319671|NCT00329810|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110319672|NCT00329810|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110319673|NCT00329810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110319674|NCT00329810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110319675|NCT00329810|Dopamine Agonists|dopamine agonists|mesh-ancestor
110319676|NCT00329810|Dopamine Agents|dopamine agents|mesh-ancestor
110319677|NCT00329810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110319678|NCT00329810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110319679|NCT00329810|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110319680|NCT00329810|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110319681|NCT00329810|Serotonin Agents|serotonin agents|mesh-ancestor
110319682|NCT00329810|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110319683|NCT00329810|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110319684|NCT00329810|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110319685|NCT00329810|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110319686|NCT00430170|Dipyridamole|dipyridamole|mesh-list
110319687|NCT00430170|Caffeine|caffeine|mesh-list
110319688|NCT00430170|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110319689|NCT00430170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110319690|NCT00430170|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110319691|NCT00430170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110319692|NCT00430170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110319693|NCT00430170|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110319694|NCT00430170|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110319695|NCT00430170|Purinergic Agents|purinergic agents|mesh-ancestor
110319696|NCT00430170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110319697|NCT00430170|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110319698|NCT00430170|Vasodilator Agents|vasodilator agents|mesh-ancestor
110319699|NCT00330044|Carboplatin|carboplatin|mesh-list
110319700|NCT00330044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110319701|NCT00430365|Lenalidomide|lenalidomide|mesh-list
110319702|NCT00430365|Immunologic Factors|immunologic factors|mesh-ancestor
110319703|NCT00430365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110319704|NCT00430365|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110319705|NCT00430365|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110319706|NCT00430365|Growth Substances|growth substances|mesh-ancestor
110319707|NCT00430365|Growth Inhibitors|growth inhibitors|mesh-ancestor
110319708|NCT00430365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110319709|NCT00330239|Paroxetine|paroxetine|mesh-list
110319710|NCT00330239|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110319711|NCT00330239|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110319712|NCT00330239|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110319713|NCT00330239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110319714|NCT00330239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110319715|NCT00330239|Serotonin Agents|serotonin agents|mesh-ancestor
110319716|NCT00330239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110319717|NCT00330239|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110319718|NCT00330239|Antidepressive Agents|antidepressive agents|mesh-ancestor
110319719|NCT00330239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110319720|NCT00330239|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110319721|NCT00330239|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110319722|NCT00330239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110319723|NCT01051557|Sirolimus|sirolimus|mesh-list
110319724|NCT01051557|Temsirolimus|temsirolimus|mesh-list
110319725|NCT01051557|MTOR Inhibitors|mtor inhibitors|mesh-list
110319726|NCT01051557|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110319727|NCT01051557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110319728|NCT01051557|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110319729|NCT01051557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110319730|NCT01051557|Antifungal Agents|antifungal agents|mesh-ancestor
110319731|NCT01051557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110319732|NCT01051557|Immunologic Factors|immunologic factors|mesh-ancestor
110319733|NCT01051557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110319734|NCT01051557|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110319735|NCT01051557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110319736|NCT01051557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110319738|NCT00330278|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110319739|NCT00330278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110319740|NCT00330317|Letrozole|letrozole|mesh-list
110319741|NCT00330317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110319742|NCT00330317|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110319743|NCT00330317|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110319744|NCT00330317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110319745|NCT00330317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110319746|NCT00330317|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110319747|NCT00330317|Hormone Antagonists|hormone antagonists|mesh-ancestor
110319748|NCT00330317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110319749|NCT00330317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110319751|NCT00430443|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110319752|NCT00430443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110319753|NCT00330395|Caspofungin|caspofungin|mesh-list
110319754|NCT00330395|Antifungal Agents|antifungal agents|mesh-ancestor
110319755|NCT00330395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110319756|NCT00330395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110319757|NCT00330395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110319758|NCT00434382|Fentanyl|fentanyl|mesh-list
110319759|NCT00434382|Sufentanil|sufentanil|mesh-list
110319760|NCT00434382|Remifentanil|remifentanil|mesh-list
110319761|NCT00434382|Alfentanil|alfentanil|mesh-list
110319762|NCT00434382|Propofol|propofol|mesh-list
110319763|NCT00434382|Sevoflurane|sevoflurane|mesh-list
110319764|NCT00434382|Desflurane|desflurane|mesh-list
110319765|NCT00434382|Isoflurane|isoflurane|mesh-list
110319766|NCT00434382|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110319767|NCT00434382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110319768|NCT00434382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110319769|NCT00434382|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110319770|NCT00434382|Anesthetics, General|anesthetics, general|mesh-ancestor
110319771|NCT00434382|Anesthetics|anesthetics|mesh-ancestor
110319772|NCT00434382|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110319773|NCT00434382|Narcotics|narcotics|mesh-ancestor
110319774|NCT00434382|Analgesics|analgesics|mesh-ancestor
110319775|NCT00434382|Sensory System Agents|sensory system agents|mesh-ancestor
110319776|NCT00434382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110319777|NCT00434382|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110319778|NCT00434382|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110319779|NCT00434382|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110319780|NCT00330707|Interferons|interferons|mesh-list
110319781|NCT00330707|Interferon-alpha|interferon-alpha|mesh-list
110319782|NCT00330707|BCG Vaccine|bcg vaccine|mesh-list
110319783|NCT00330707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110319784|NCT00330707|Antiviral Agents|antiviral agents|mesh-ancestor
110319785|NCT00330707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110319786|NCT00330707|Immunologic Factors|immunologic factors|mesh-ancestor
110319787|NCT00330707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110319788|NCT00330707|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110319789|NCT00330746|Gemcitabine|gemcitabine|mesh-list
110319790|NCT00330746|Cetuximab|cetuximab|mesh-list
110319791|NCT00330746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110319792|NCT00330746|Antimetabolites|antimetabolites|mesh-ancestor
110319793|NCT00330746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110319794|NCT00330746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110319795|NCT00330746|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110319796|NCT01053741|Plasma-lyte 148|plasma-lyte 148|mesh-list
110319797|NCT01053741|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110319798|NCT01053741|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110319799|NCT00330785|Amlodipine|amlodipine|mesh-list
110319800|NCT00330785|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
110319801|NCT00330785|Atorvastatin|atorvastatin|mesh-list
110319802|NCT00330785|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110319803|NCT00330785|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110319804|NCT00330785|Antimetabolites|antimetabolites|mesh-ancestor
110319805|NCT00330785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110319806|NCT00330785|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110319807|NCT00330785|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110319808|NCT00330785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110319809|NCT00330785|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110319810|NCT00330785|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110319811|NCT00330785|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110319812|NCT00330785|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110319813|NCT00330785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110319814|NCT00330785|Vasodilator Agents|vasodilator agents|mesh-ancestor
110319815|NCT00330824|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110319816|NCT00330824|Moxifloxacin|moxifloxacin|mesh-list
110319817|NCT00330824|Dexamethasone|dexamethasone|mesh-list
110319818|NCT00330824|Dexamethasone acetate|dexamethasone acetate|mesh-list
110319819|NCT00330824|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
110319820|NCT00330824|BB 1101|bb 1101|mesh-list
110319821|NCT00330824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110319822|NCT00330824|Antiemetics|antiemetics|mesh-ancestor
110319823|NCT00330824|Autonomic Agents|autonomic agents|mesh-ancestor
110319824|NCT00330824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110319825|NCT00330824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110319826|NCT00330824|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110319827|NCT00330824|Glucocorticoids|glucocorticoids|mesh-ancestor
110319828|NCT00330824|Hormones|hormones|mesh-ancestor
110319829|NCT00330824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110319830|NCT00330824|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110319831|NCT00330824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110319832|NCT00330824|Protease Inhibitors|protease inhibitors|mesh-ancestor
110319833|NCT00330824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110319834|NCT00330824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110319835|NCT00330824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110319836|NCT00330824|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110319837|NCT00330824|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110319838|NCT00330824|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110319839|NCT00330824|Contraceptive Agents|contraceptive agents|mesh-ancestor
110319840|NCT00330824|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110170532|NCT00040690|Leucovorin|leucovorin|mesh-list
110319841|NCT00330824|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110319842|NCT00330824|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110319843|NCT00330824|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110319844|NCT00330902|Artesunate|artesunate|mesh-list
110319846|NCT00330902|Primaquine|primaquine|mesh-list
110319847|NCT00330902|Sulfadoxine|sulfadoxine|mesh-list
110319848|NCT00330902|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
110319849|NCT00330902|Antimalarials|antimalarials|mesh-ancestor
110319850|NCT00330902|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110319851|NCT00330902|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110319852|NCT00330902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110319853|NCT00330902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110319854|NCT00330902|Antiviral Agents|antiviral agents|mesh-ancestor
110319855|NCT00330902|Schistosomicides|schistosomicides|mesh-ancestor
110319856|NCT00330902|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110319857|NCT00330902|Anthelmintics|anthelmintics|mesh-ancestor
110319858|NCT00330902|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110319859|NCT00330902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110319860|NCT00330902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110319861|NCT00330902|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110319862|NCT04703868|Rabeprazole|rabeprazole|mesh-list
110319863|NCT04703868|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110319864|NCT04703868|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110319865|NCT04703868|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110319866|NCT04703868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110319867|NCT04703868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110319868|NCT00430794|Spironolactone|spironolactone|mesh-list
110319869|NCT00430794|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110319870|NCT00430794|Hormone Antagonists|hormone antagonists|mesh-ancestor
110319871|NCT00430794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110319872|NCT00430794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110319873|NCT00430794|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110319874|NCT00430794|Diuretics|diuretics|mesh-ancestor
110319875|NCT00430794|Natriuretic Agents|natriuretic agents|mesh-ancestor
110319876|NCT00330980|Simvastatin|simvastatin|mesh-list
110319877|NCT00330980|Pravastatin|pravastatin|mesh-list
110319878|NCT00330980|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110319879|NCT00330980|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110319880|NCT00330980|Antimetabolites|antimetabolites|mesh-ancestor
110319881|NCT00330980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110319882|NCT00330980|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110319883|NCT00330980|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110319884|NCT00330980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110319885|NCT00430833|Candesartan|candesartan|mesh-list
110319886|NCT00430833|Candesartan cilexetil|candesartan cilexetil|mesh-list
110319887|NCT00430833|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110319888|NCT00430833|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110319889|NCT00430833|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110319890|NCT00430833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110319891|NCT00331058|Prednisolone|prednisolone|mesh-list
110319892|NCT00331058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110319893|NCT00331058|Glucocorticoids|glucocorticoids|mesh-ancestor
110319895|NCT00331058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110319896|NCT00331058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110319897|NCT00331058|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110319898|NCT00331058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110319899|NCT00331097|Cyclophosphamide|cyclophosphamide|mesh-list
110319900|NCT00331097|Docetaxel|docetaxel|mesh-list
110319901|NCT00331097|Fluorouracil|fluorouracil|mesh-list
110319902|NCT00331097|Methotrexate|methotrexate|mesh-list
110319903|NCT00331097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110319904|NCT00331097|Immunologic Factors|immunologic factors|mesh-ancestor
110319905|NCT00331097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110319906|NCT00331097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110319907|NCT00331097|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110319908|NCT00331097|Alkylating Agents|alkylating agents|mesh-ancestor
110319909|NCT00331097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110319910|NCT00331097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110319911|NCT00331097|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110319912|NCT00331097|Tubulin Modulators|tubulin modulators|mesh-ancestor
110319913|NCT00331097|Antimitotic Agents|antimitotic agents|mesh-ancestor
110319914|NCT00331097|Mitosis Modulators|mitosis modulators|mesh-ancestor
110319915|NCT00331097|Antimetabolites|antimetabolites|mesh-ancestor
110319916|NCT00331097|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110319917|NCT00331097|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110319919|NCT00331097|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110319920|NCT00331097|Dermatologic Agents|dermatologic agents|mesh-ancestor
110319921|NCT00331097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110319922|NCT00331097|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110319923|NCT00331097|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110319924|NCT00331214|Testosterone|testosterone|mesh-list
110319925|NCT00331214|Androgens|androgens|mesh-ancestor
110319926|NCT00331214|Hormones|hormones|mesh-ancestor
110319927|NCT00331214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110319928|NCT00331214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110319929|NCT00434772|Glucagon|glucagon|mesh-list
110319930|NCT00434772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110319931|NCT00434772|Hormones|hormones|mesh-ancestor
110319932|NCT00434772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110319933|NCT00434772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110319934|NCT00431028|Ciprofloxacin|ciprofloxacin|mesh-list
110319935|NCT00431028|Triamcinolone|triamcinolone|mesh-list
110319936|NCT00431028|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110319937|NCT00431028|Glucocorticoids|glucocorticoids|mesh-ancestor
110319938|NCT00431028|Hormones|hormones|mesh-ancestor
110319939|NCT00431028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110319940|NCT00431028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110319941|NCT00431028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110319942|NCT00431028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110319943|NCT00431028|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110319944|NCT00431028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110319945|NCT00431028|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110319946|NCT00431028|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110319947|NCT00431028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110319948|NCT00431028|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110319949|NCT00431028|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110319950|NCT00431106|Gemcitabine|gemcitabine|mesh-list
110319951|NCT00431106|Capecitabine|capecitabine|mesh-list
110319952|NCT00431106|Vinorelbine|vinorelbine|mesh-list
110319953|NCT00431106|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110319954|NCT00431106|Antimetabolites|antimetabolites|mesh-ancestor
110319955|NCT00431106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110319956|NCT00431106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110319957|NCT00431106|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110319958|NCT00431106|Tubulin Modulators|tubulin modulators|mesh-ancestor
110319959|NCT00431106|Antimitotic Agents|antimitotic agents|mesh-ancestor
110319960|NCT00431106|Mitosis Modulators|mitosis modulators|mesh-ancestor
110319961|NCT00431145|Niacin|niacin|mesh-list
110319962|NCT00431145|Niacinamide|niacinamide|mesh-list
110319963|NCT00431145|Nicotinic Acids|nicotinic acids|mesh-list
110319964|NCT00431145|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110319965|NCT00431145|Antimetabolites|antimetabolites|mesh-ancestor
110319966|NCT00431145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110319967|NCT00431145|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110319968|NCT00431145|Vasodilator Agents|vasodilator agents|mesh-ancestor
110319969|NCT00431145|Vitamin B Complex|vitamin b complex|mesh-ancestor
110319971|NCT00431145|Micronutrients|micronutrients|mesh-ancestor
110319972|NCT00431145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110319973|NCT00331487|Pioglitazone|pioglitazone|mesh-list
110319974|NCT00331487|Rosiglitazone|rosiglitazone|mesh-list
110319975|NCT00331487|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110319976|NCT00331487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110319977|NCT00331526|Aldesleukin|aldesleukin|mesh-list
110319978|NCT00331526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110319979|NCT00331526|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110319980|NCT00331526|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110319981|NCT00331526|Antiviral Agents|antiviral agents|mesh-ancestor
110319982|NCT00331526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110319983|NCT00431262|Disulfiram|disulfiram|mesh-list
110319984|NCT00431262|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110319985|NCT00431262|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
110319986|NCT00431262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110319987|NCT00431262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110319988|NCT00331604|Insulin|insulin|mesh-list
110319989|NCT00331604|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110319990|NCT00331604|Insulin Aspart|insulin aspart|mesh-list
110319991|NCT00331604|Insulin, Long-Acting|insulin, long-acting|mesh-list
110319992|NCT00331604|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
110319993|NCT00331604|Insulin Detemir|insulin detemir|mesh-list
110319994|NCT00331604|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110319995|NCT00331604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110319996|NCT00331643|Epothilones|epothilones|mesh-list
110319997|NCT00331643|Epothilone B|epothilone b|mesh-list
110319998|NCT00331643|Tubulin Modulators|tubulin modulators|mesh-ancestor
110319999|NCT00331643|Antimitotic Agents|antimitotic agents|mesh-ancestor
110320000|NCT00331643|Mitosis Modulators|mitosis modulators|mesh-ancestor
110320001|NCT00331643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110320002|NCT00331643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110320003|NCT00431340|Belinostat|belinostat|mesh-list
110320004|NCT00431340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110320005|NCT00431340|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110320006|NCT00431340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110320007|NCT00431340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110320008|NCT00431379|Tenecteplase|tenecteplase|mesh-list
110320009|NCT00431379|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110320010|NCT00431379|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110320011|NCT00431379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110320012|NCT00331838|Enoxaparin|enoxaparin|mesh-list
110320013|NCT00331838|Semuloparin|semuloparin|mesh-list
110320014|NCT00331838|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
110320015|NCT00331838|Enoxaparin sodium|enoxaparin sodium|mesh-list
110320016|NCT00331838|Anticoagulants|anticoagulants|mesh-ancestor
110320017|NCT00331838|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110320018|NCT00331838|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110320019|NCT00331838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110320020|NCT00431418|Sildenafil Citrate|sildenafil citrate|mesh-list
110320021|NCT00431418|Vasodilator Agents|vasodilator agents|mesh-ancestor
110320022|NCT00431418|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110320023|NCT00431418|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110320024|NCT00431418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110320025|NCT00431418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110320026|NCT00431418|Urological Agents|urological agents|mesh-ancestor
110320028|NCT00331955|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110320029|NCT00331955|Vorinostat|vorinostat|mesh-list
110320030|NCT00331955|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110320031|NCT00331955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110320032|NCT00331955|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110320033|NCT00331955|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110320034|NCT00331955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110320035|NCT00331955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110320036|NCT00331955|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110320037|NCT00331994|Metronidazole|metronidazole|mesh-list
110320038|NCT00331994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110320039|NCT00331994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110320040|NCT00331994|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110320041|NCT00331994|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110320042|NCT00332033|Pirfenidone|pirfenidone|mesh-list
110320043|NCT00332033|Analgesics|analgesics|mesh-ancestor
110320044|NCT00332033|Sensory System Agents|sensory system agents|mesh-ancestor
110320045|NCT00332033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110320046|NCT00332033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110320047|NCT00332033|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110320048|NCT00332033|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110320049|NCT00332033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110320050|NCT00332033|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110320051|NCT00332033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110320052|NCT00435279|Eszopiclone|eszopiclone|mesh-list
110320053|NCT00435279|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
110320054|NCT00435279|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110320055|NCT00435279|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110320056|NCT00435279|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110320057|NCT00435279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110320058|NCT00435279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110320059|NCT00435279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110320060|NCT00435279|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110320061|NCT00435279|Antidepressive Agents|antidepressive agents|mesh-ancestor
110320062|NCT00435279|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110320063|NCT00435279|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110320064|NCT00435279|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110320066|NCT00332072|Bimatoprost|bimatoprost|mesh-list
110320067|NCT00332072|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110320068|NCT00332072|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110320069|NCT00332072|Adrenergic Agents|adrenergic agents|mesh-ancestor
110320070|NCT00332072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110320071|NCT00332072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110320072|NCT00332072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110320074|NCT00332072|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110320075|NCT00431613|Carboplatin|carboplatin|mesh-list
110320076|NCT00431613|Gemcitabine|gemcitabine|mesh-list
110320078|NCT00431613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110320079|NCT00431613|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110320080|NCT00431613|Antimetabolites|antimetabolites|mesh-ancestor
110320081|NCT00431613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110320082|NCT00431613|Tubulin Modulators|tubulin modulators|mesh-ancestor
110320083|NCT00431613|Antimitotic Agents|antimitotic agents|mesh-ancestor
110320084|NCT00431613|Mitosis Modulators|mitosis modulators|mesh-ancestor
110320085|NCT00332228|Naltrexone|naltrexone|mesh-list
110320086|NCT00332228|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110320087|NCT00332228|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110320088|NCT00332228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110320089|NCT00332228|Sensory System Agents|sensory system agents|mesh-ancestor
110320090|NCT00332228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110320091|NCT00431691|Nitroglycerin|nitroglycerin|mesh-list
110320092|NCT00431691|Vasodilator Agents|vasodilator agents|mesh-ancestor
110320093|NCT00332306|Lamivudine|lamivudine|mesh-list
110320094|NCT00332306|Efavirenz|efavirenz|mesh-list
110320095|NCT00332306|Nevirapine|nevirapine|mesh-list
110320096|NCT00332306|Didanosine|didanosine|mesh-list
110320097|NCT00332306|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110320098|NCT00332306|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110320099|NCT00332306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110320100|NCT00332306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110320101|NCT00332306|Antiviral Agents|antiviral agents|mesh-ancestor
110320102|NCT00332306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110320103|NCT00332306|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110320104|NCT00332306|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110320105|NCT00332306|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110320106|NCT00332306|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110320107|NCT00332306|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110320108|NCT00332306|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110320109|NCT00332306|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110320110|NCT00332306|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110320111|NCT00332306|Antimetabolites|antimetabolites|mesh-ancestor
110320112|NCT00332345|Timolol|timolol|mesh-list
110320113|NCT00332345|Brimonidine Tartrate|brimonidine tartrate|mesh-list
110320114|NCT00332345|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110320115|NCT00332345|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110320116|NCT00332345|Adrenergic Agents|adrenergic agents|mesh-ancestor
110320117|NCT00332345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110320118|NCT00332345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110320119|NCT00332345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110320120|NCT00332345|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110320121|NCT00332345|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110320122|NCT00332345|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110320123|NCT00332345|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110320125|NCT00332384|Timolol|timolol|mesh-list
110320126|NCT00332384|Brimonidine Tartrate|brimonidine tartrate|mesh-list
110320127|NCT00332384|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110320128|NCT00332384|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110320129|NCT00332384|Adrenergic Agents|adrenergic agents|mesh-ancestor
110320130|NCT00332384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110320131|NCT00332384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110320132|NCT00332384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110320133|NCT00332384|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110320134|NCT00332384|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110149576|NCT00008073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110320135|NCT00332384|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110320136|NCT00332384|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110320137|NCT00332384|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110320139|NCT00435435|Acamprosate|acamprosate|mesh-list
110320140|NCT00435435|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110320141|NCT00435435|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
110320142|NCT00435435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110320143|NCT00435435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110320144|NCT00332540|Timolol|timolol|mesh-list
110320145|NCT00332540|Bimatoprost|bimatoprost|mesh-list
110320146|NCT00332540|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110320147|NCT00332540|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110320148|NCT00332540|Adrenergic Agents|adrenergic agents|mesh-ancestor
110320149|NCT00332540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110320150|NCT00332540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110320151|NCT00332540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110320152|NCT00332540|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110320153|NCT00332540|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110320154|NCT00332618|Glycerol|glycerol|mesh-list
110320155|NCT00332618|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
110320156|NCT00332618|Protective Agents|protective agents|mesh-ancestor
110320157|NCT00332618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110320158|NCT00332735|Bupivacaine|bupivacaine|mesh-list
110320159|NCT00332735|Carticaine|carticaine|mesh-list
110320160|NCT00332735|Anesthetics, Local|anesthetics, local|mesh-ancestor
110320161|NCT00332735|Anesthetics|anesthetics|mesh-ancestor
110320162|NCT00332735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110320163|NCT00332735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110320164|NCT00332735|Sensory System Agents|sensory system agents|mesh-ancestor
110320165|NCT00332735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110320166|NCT00332774|Ketorolac|ketorolac|mesh-list
110320167|NCT00332774|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
110320168|NCT00332774|Nepafenac|nepafenac|mesh-list
110320169|NCT00332774|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110320170|NCT00332774|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110320171|NCT00332774|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110320172|NCT00332774|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110320173|NCT00332774|Analgesics|analgesics|mesh-ancestor
110320174|NCT00332774|Sensory System Agents|sensory system agents|mesh-ancestor
110320175|NCT00332774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110320176|NCT00332774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110320177|NCT00332774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110320178|NCT00332774|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110320179|NCT00332774|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110320180|NCT00332774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110320181|NCT00332774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110320182|NCT00431769|Bortezomib|bortezomib|mesh-list
110320183|NCT00431769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110320184|NCT00332852|Letrozole|letrozole|mesh-list
110320185|NCT00332852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110320186|NCT00332852|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110320187|NCT00332852|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110320188|NCT00332852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110320189|NCT00332852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110320190|NCT00332852|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110320191|NCT00332852|Hormone Antagonists|hormone antagonists|mesh-ancestor
110320192|NCT00332852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110320193|NCT00332852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110320194|NCT00332891|Amibegron|amibegron|mesh-list
110320195|NCT00332891|Amibegron hydrochloride|amibegron hydrochloride|mesh-list
110320196|NCT00332891|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110320197|NCT00332891|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110320198|NCT00332891|Adrenergic Agents|adrenergic agents|mesh-ancestor
110320199|NCT00332891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110320200|NCT00332891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110320201|NCT00332891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110320202|NCT00332891|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
110320203|NCT00332930|Interferons|interferons|mesh-list
110320204|NCT00332930|Interferon-gamma|interferon-gamma|mesh-list
110320205|NCT00332930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110320206|NCT00332930|Antiviral Agents|antiviral agents|mesh-ancestor
110320207|NCT00332930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110320208|NCT00332969|Octreotide|octreotide|mesh-list
110320209|NCT00332969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110320210|NCT00332969|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110320211|NCT00332969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110320212|NCT00333008|Prednisone|prednisone|mesh-list
110320213|NCT00333008|Cyclophosphamide|cyclophosphamide|mesh-list
110320214|NCT00333008|Rituximab|rituximab|mesh-list
110320215|NCT00333008|Vincristine|vincristine|mesh-list
110320216|NCT00333008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110320217|NCT00333008|Immunologic Factors|immunologic factors|mesh-ancestor
110320218|NCT00333008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110320219|NCT00333008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110320220|NCT00333008|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110320221|NCT00333008|Alkylating Agents|alkylating agents|mesh-ancestor
110320222|NCT00333008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110320223|NCT00333008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110320224|NCT00333008|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110320225|NCT00333008|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110320226|NCT00333008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110320227|NCT00333008|Glucocorticoids|glucocorticoids|mesh-ancestor
110320228|NCT00333008|Hormones|hormones|mesh-ancestor
110320229|NCT00333008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110320230|NCT00333008|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110320231|NCT00333008|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110320232|NCT00333008|Tubulin Modulators|tubulin modulators|mesh-ancestor
110320233|NCT00333008|Antimitotic Agents|antimitotic agents|mesh-ancestor
110320234|NCT00333008|Mitosis Modulators|mitosis modulators|mesh-ancestor
110320235|NCT00435747|Parecoxib|parecoxib|mesh-list
110320236|NCT00435747|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110320237|NCT00435747|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110320238|NCT00435747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110320239|NCT00435747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110320240|NCT00435747|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110320241|NCT00435747|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110320242|NCT00435747|Analgesics|analgesics|mesh-ancestor
110320243|NCT00435747|Sensory System Agents|sensory system agents|mesh-ancestor
110320244|NCT00435747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110320245|NCT00435747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110320246|NCT00435747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110320247|NCT00435747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110320248|NCT00333047|Letrozole|letrozole|mesh-list
110320249|NCT00333047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110320250|NCT00333047|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110320251|NCT00333047|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110320252|NCT00333047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110320253|NCT00333047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110320254|NCT00333047|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110320255|NCT00333047|Hormone Antagonists|hormone antagonists|mesh-ancestor
110320256|NCT00333047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110320257|NCT00333047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110320258|NCT00333086|Letrozole|letrozole|mesh-list
110320259|NCT00333086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110320260|NCT00333086|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110320261|NCT00333086|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110320262|NCT00333086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110320263|NCT00333086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110320264|NCT00333086|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110320265|NCT00333086|Hormone Antagonists|hormone antagonists|mesh-ancestor
110320266|NCT00333086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110320267|NCT00333086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110320268|NCT00333125|Timolol|timolol|mesh-list
110320269|NCT00333125|Travoprost|travoprost|mesh-list
110320270|NCT00333125|Dorzolamide|dorzolamide|mesh-list
110320271|NCT00333125|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110320272|NCT00333125|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110320273|NCT00333125|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110320274|NCT00333125|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110320275|NCT00333125|Adrenergic Agents|adrenergic agents|mesh-ancestor
110320276|NCT00333125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110320277|NCT00333125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110320278|NCT00333125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110320279|NCT00333125|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110320280|NCT00333125|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110320281|NCT00333125|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110320282|NCT00333125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110320283|NCT00333164|Cilostazol|cilostazol|mesh-list
110320284|NCT00333164|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110320285|NCT00333164|Autonomic Agents|autonomic agents|mesh-ancestor
110320286|NCT00333164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110320287|NCT00333164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110320288|NCT00333164|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110320289|NCT00333164|Respiratory System Agents|respiratory system agents|mesh-ancestor
110320290|NCT00333164|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110320291|NCT00333164|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110320292|NCT00333164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110320293|NCT00333164|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110320294|NCT00333164|Vasodilator Agents|vasodilator agents|mesh-ancestor
110320295|NCT00333164|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110320296|NCT00333164|Protective Agents|protective agents|mesh-ancestor
110320297|NCT00333164|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110320298|NCT00333164|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110320299|NCT00333164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110320300|NCT01052493|Pancreatic Polypeptide|pancreatic polypeptide|mesh-list
110170593|NCT00001421|Methimazole|methimazole|mesh-list
110320301|NCT01052493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110320302|NCT01052493|Hormones|hormones|mesh-ancestor
110320303|NCT01052493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110320304|NCT01052493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110320305|NCT00333242|Dextromethorphan|dextromethorphan|mesh-list
110320306|NCT00333242|Antitussive Agents|antitussive agents|mesh-ancestor
110320307|NCT00333242|Respiratory System Agents|respiratory system agents|mesh-ancestor
110320308|NCT00333242|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110320309|NCT00333242|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110320310|NCT00333242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110320311|NCT00333242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110320312|NCT00333242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110320313|NCT00333281|Tadalafil|tadalafil|mesh-list
110320314|NCT00333281|Vasodilator Agents|vasodilator agents|mesh-ancestor
110320315|NCT00333281|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110320316|NCT00333281|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110320317|NCT00333281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110320318|NCT00333281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110320319|NCT00333281|Urological Agents|urological agents|mesh-ancestor
110320320|NCT00333398|Vaccines|vaccines|mesh-list
110320321|NCT00333398|Immunologic Factors|immunologic factors|mesh-ancestor
110320322|NCT00333398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110320323|NCT00333476|Squalamine|squalamine|mesh-list
110320324|NCT00333476|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110320325|NCT00333476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110320326|NCT00333476|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110320327|NCT00333476|Protective Agents|protective agents|mesh-ancestor
110320328|NCT00333476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110320329|NCT00333476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110320330|NCT00333476|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110320331|NCT00333476|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110320332|NCT00333476|Growth Substances|growth substances|mesh-ancestor
110320333|NCT00333476|Growth Inhibitors|growth inhibitors|mesh-ancestor
110320334|NCT00435981|Aluminum Hydroxide|aluminum hydroxide|mesh-list
110320335|NCT00435981|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110320336|NCT00435981|Immunologic Factors|immunologic factors|mesh-ancestor
110320337|NCT00435981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110320338|NCT00435981|Antacids|antacids|mesh-ancestor
110320339|NCT00435981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110320340|NCT00435981|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110320341|NCT00432081|Indomethacin|indomethacin|mesh-list
110320342|NCT00432081|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110320343|NCT00432081|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110320344|NCT00432081|Analgesics|analgesics|mesh-ancestor
110320345|NCT00432081|Sensory System Agents|sensory system agents|mesh-ancestor
110320346|NCT00432081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110320347|NCT00432081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110320348|NCT00432081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110320349|NCT00432081|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110320350|NCT00432081|Gout Suppressants|gout suppressants|mesh-ancestor
110320351|NCT00432081|Tocolytic Agents|tocolytic agents|mesh-ancestor
110320352|NCT00432081|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110320353|NCT00432081|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110320354|NCT00432081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110320355|NCT00432081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110320356|NCT00333632|Fentanyl|fentanyl|mesh-list
110320357|NCT00333632|Midazolam|midazolam|mesh-list
110320358|NCT00333632|Dexmedetomidine|dexmedetomidine|mesh-list
110320359|NCT00333632|Propofol|propofol|mesh-list
110320360|NCT00333632|Isoflurane|isoflurane|mesh-list
110320361|NCT00333632|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110320362|NCT00333632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110320363|NCT00333632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110320364|NCT00333632|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110320365|NCT00333632|Analgesics|analgesics|mesh-ancestor
110320366|NCT00333632|Sensory System Agents|sensory system agents|mesh-ancestor
110320367|NCT00333632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110320368|NCT00333632|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110343824|NCT06022003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110320369|NCT00333632|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110320370|NCT00333632|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110320371|NCT00333632|Adrenergic Agents|adrenergic agents|mesh-ancestor
110320372|NCT00333632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110320373|NCT00333632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110320374|NCT00333632|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110320375|NCT00333632|Anesthetics, General|anesthetics, general|mesh-ancestor
110320376|NCT00333632|Anesthetics|anesthetics|mesh-ancestor
110320377|NCT00333632|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110320378|NCT00333632|Narcotics|narcotics|mesh-ancestor
110320379|NCT00333632|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110320380|NCT00333632|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110320381|NCT00333632|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110320382|NCT00333632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110320383|NCT00333632|GABA Modulators|gaba modulators|mesh-ancestor
110320384|NCT00333632|GABA Agents|gaba agents|mesh-ancestor
110320385|NCT00333632|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110320386|NCT00436059|Bortezomib|bortezomib|mesh-list
110320387|NCT00436059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110320388|NCT00420524|Epothilone B|epothilone b|mesh-list
110320389|NCT00420524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110320390|NCT00420524|Tubulin Modulators|tubulin modulators|mesh-ancestor
110320391|NCT00420524|Antimitotic Agents|antimitotic agents|mesh-ancestor
110320392|NCT00420524|Mitosis Modulators|mitosis modulators|mesh-ancestor
110320393|NCT00420524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110320394|NCT00432120|Clopidogrel|clopidogrel|mesh-list
110320395|NCT00432120|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110320396|NCT00432120|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110320397|NCT00432120|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110320398|NCT00432120|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110320399|NCT00432120|Purinergic Agents|purinergic agents|mesh-ancestor
110320400|NCT00432120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110320401|NCT00432120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110320402|NCT00432120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110320403|NCT00432198|Zolpidem|zolpidem|mesh-list
110320404|NCT00432198|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110320405|NCT00432198|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110320406|NCT00432198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110320407|NCT00432198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110320408|NCT00432198|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
110320409|NCT00432198|GABA Agonists|gaba agonists|mesh-ancestor
110320410|NCT00432198|GABA Agents|gaba agents|mesh-ancestor
110320411|NCT00432198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110320412|NCT00432198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110320413|NCT00420563|Cyclophosphamide|cyclophosphamide|mesh-list
110320414|NCT00420563|Megestrol|megestrol|mesh-list
110320415|NCT00420563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110320416|NCT00420563|Immunologic Factors|immunologic factors|mesh-ancestor
110320417|NCT00420563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110320418|NCT00420563|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110320419|NCT00420563|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110320420|NCT00420563|Alkylating Agents|alkylating agents|mesh-ancestor
110320421|NCT00420563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110320422|NCT00420563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110320423|NCT00420563|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110320424|NCT00420563|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110320425|NCT00420563|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110320426|NCT00420563|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110320427|NCT00420563|Contraceptive Agents|contraceptive agents|mesh-ancestor
110320428|NCT00420563|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110320429|NCT00420563|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110320430|NCT00420563|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110320431|NCT00420563|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110320433|NCT00432315|Cisplatin|cisplatin|mesh-list
110320434|NCT00432315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110320435|NCT00432315|Tubulin Modulators|tubulin modulators|mesh-ancestor
110320436|NCT00432315|Antimitotic Agents|antimitotic agents|mesh-ancestor
110320437|NCT00432315|Mitosis Modulators|mitosis modulators|mesh-ancestor
110320438|NCT00432315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110320439|NCT00333671|Glycerol|glycerol|mesh-list
110320440|NCT00333671|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
110320441|NCT00333671|Protective Agents|protective agents|mesh-ancestor
110320442|NCT00333671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110320443|NCT00432354|Atorvastatin|atorvastatin|mesh-list
110320444|NCT00432354|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110320445|NCT00432354|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110320447|NCT00432354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110320448|NCT00432354|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110320449|NCT00432354|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110320450|NCT00432354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110320451|NCT00333944|Pralidoxime|pralidoxime|mesh-list
110320452|NCT00333944|Antidotes|antidotes|mesh-ancestor
110320453|NCT00333944|Protective Agents|protective agents|mesh-ancestor
110320454|NCT00333944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110320455|NCT00333944|Cholinesterase Reactivators|cholinesterase reactivators|mesh-ancestor
110320456|NCT00333944|Enzyme Reactivators|enzyme reactivators|mesh-ancestor
110320457|NCT00333944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110320458|NCT00333944|Cholinergic Agents|cholinergic agents|mesh-ancestor
110320459|NCT00333944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110320460|NCT00334022|Enfuvirtide|enfuvirtide|mesh-list
110320461|NCT00334022|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110320462|NCT00334022|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110320463|NCT00334022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110320464|NCT00334022|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110320465|NCT00334022|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110320466|NCT00334022|Antiviral Agents|antiviral agents|mesh-ancestor
110320467|NCT00334022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110320468|NCT04701528|Tacrolimus|tacrolimus|mesh-list
110320469|NCT04701528|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110320470|NCT04701528|Immunologic Factors|immunologic factors|mesh-ancestor
110320471|NCT04701528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110320472|NCT04701528|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110320473|NCT04701528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110320474|NCT04701528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110320475|NCT00334139|Zoledronic Acid|zoledronic acid|mesh-list
110320476|NCT00334139|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110320477|NCT00334139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110320478|NCT03279978|Midazolam|midazolam|mesh-list
110320479|NCT03279978|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110320480|NCT03279978|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110320481|NCT03279978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110320482|NCT03279978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110320483|NCT03279978|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110320484|NCT03279978|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110320485|NCT03279978|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110320486|NCT03279978|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110320487|NCT03279978|Anesthetics, General|anesthetics, general|mesh-ancestor
110320489|NCT03279978|GABA Modulators|gaba modulators|mesh-ancestor
110320490|NCT03279978|GABA Agents|gaba agents|mesh-ancestor
110320491|NCT03279978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110320492|NCT03279978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110320493|NCT00438048|Pilocarpine|pilocarpine|mesh-list
110320494|NCT00438048|Miotics|miotics|mesh-ancestor
110320495|NCT00438048|Autonomic Agents|autonomic agents|mesh-ancestor
110149583|NCT00006397|Ritonavir|ritonavir|mesh-list
110320496|NCT00438048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110320497|NCT00438048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110320499|NCT00438048|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110320500|NCT00438048|Cholinergic Agents|cholinergic agents|mesh-ancestor
110320501|NCT00438048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110320502|NCT00438048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110320503|NCT00334256|Tenofovir|tenofovir|mesh-list
110320504|NCT00334256|Emtricitabine|emtricitabine|mesh-list
110320505|NCT00334256|Antiviral Agents|antiviral agents|mesh-ancestor
110320506|NCT00334256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110320507|NCT00334256|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110320508|NCT00334256|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110320509|NCT00334256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110320510|NCT00334256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110320511|NCT00334256|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110320512|NCT00334256|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110320513|NCT00438087|Methylprednisolone|methylprednisolone|mesh-list
110320514|NCT00438087|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110320515|NCT00438087|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110320516|NCT00438087|Prednisolone|prednisolone|mesh-list
110320518|NCT00438087|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110320519|NCT00438087|Prednisolone phosphate|prednisolone phosphate|mesh-list
110320520|NCT00438087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110320521|NCT00438087|Antiemetics|antiemetics|mesh-ancestor
110320522|NCT00438087|Autonomic Agents|autonomic agents|mesh-ancestor
110320523|NCT00438087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110320524|NCT00438087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110320525|NCT00438087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110320526|NCT00438087|Glucocorticoids|glucocorticoids|mesh-ancestor
110320527|NCT00438087|Hormones|hormones|mesh-ancestor
110320528|NCT00438087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110320529|NCT00438087|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110320530|NCT00438087|Protective Agents|protective agents|mesh-ancestor
110320531|NCT00438087|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110320532|NCT00438087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110320533|NCT00334412|Caspofungin|caspofungin|mesh-list
110320534|NCT00334412|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
110320535|NCT00334412|Antifungal Agents|antifungal agents|mesh-ancestor
110320536|NCT00334412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110320537|NCT00334412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110320538|NCT00334412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110320539|NCT00334412|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110320540|NCT00334412|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110320541|NCT00334490|Sildenafil Citrate|sildenafil citrate|mesh-list
110320542|NCT00334490|Vasodilator Agents|vasodilator agents|mesh-ancestor
110320543|NCT00334490|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110320544|NCT00334490|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110320545|NCT00334490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110320546|NCT00334490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110320547|NCT00334490|Urological Agents|urological agents|mesh-ancestor
110320548|NCT00334529|Oseltamivir|oseltamivir|mesh-list
110320549|NCT00334529|Antiviral Agents|antiviral agents|mesh-ancestor
110320550|NCT00334529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110320551|NCT00334529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110320552|NCT00334529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110320553|NCT00334568|Rosiglitazone|rosiglitazone|mesh-list
110320554|NCT00334568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110320555|NCT00334568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110320556|NCT02273544|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
110320557|NCT02273544|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110320558|NCT00436293|Docetaxel|docetaxel|mesh-list
110320559|NCT00436293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110320560|NCT00436293|Tubulin Modulators|tubulin modulators|mesh-ancestor
110320561|NCT00436293|Antimitotic Agents|antimitotic agents|mesh-ancestor
110320562|NCT00436293|Mitosis Modulators|mitosis modulators|mesh-ancestor
110343825|NCT06021808|Anticoagulants|anticoagulants|mesh-list
110320563|NCT00436293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110320564|NCT00334646|Cyclophosphamide|cyclophosphamide|mesh-list
110320565|NCT00334646|Casopitant|casopitant|mesh-list
110320566|NCT00334646|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110320567|NCT00334646|Immunologic Factors|immunologic factors|mesh-ancestor
110149586|NCT00006397|Didanosine|didanosine|mesh-list
110320568|NCT00334646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110320569|NCT00334646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110320570|NCT00334646|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110320571|NCT00334646|Alkylating Agents|alkylating agents|mesh-ancestor
110320572|NCT00334646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110320573|NCT00334646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110320574|NCT00334646|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110320575|NCT00334646|Antiemetics|antiemetics|mesh-ancestor
110320576|NCT00334646|Autonomic Agents|autonomic agents|mesh-ancestor
110320577|NCT00334646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110320578|NCT00334646|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110320579|NCT00334646|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110320580|NCT00334646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110320581|NCT04701606|Artesunate|artesunate|mesh-list
110320582|NCT04701606|Pyronaridine|pyronaridine|mesh-list
110320583|NCT04701606|Pyronaridine tetraphosphate, artesunate drug combination|pyronaridine tetraphosphate, artesunate drug combination|mesh-list
110320584|NCT04701606|Antimalarials|antimalarials|mesh-ancestor
110320585|NCT04701606|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110320586|NCT04701606|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110170612|NCT00041236|Exatecan|exatecan|mesh-list
110320588|NCT04701606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110320589|NCT04701606|Antiviral Agents|antiviral agents|mesh-ancestor
110320590|NCT04701606|Schistosomicides|schistosomicides|mesh-ancestor
110320591|NCT04701606|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110320592|NCT04701606|Anthelmintics|anthelmintics|mesh-ancestor
110320594|NCT00334685|Reboxetine|reboxetine|mesh-list
110320595|NCT00334685|Analgesics|analgesics|mesh-ancestor
110320596|NCT00334685|Sensory System Agents|sensory system agents|mesh-ancestor
110320597|NCT00334685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110320598|NCT00334685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110320599|NCT00334685|Anticonvulsants|anticonvulsants|mesh-ancestor
110320600|NCT00334685|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110320601|NCT00334685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110320602|NCT00334685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110320603|NCT00334685|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110320604|NCT00334685|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110320605|NCT00334685|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110320606|NCT00334685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110320607|NCT00334685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110320608|NCT00334685|Antidepressive Agents|antidepressive agents|mesh-ancestor
110320609|NCT00334685|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110320610|NCT00334685|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110320611|NCT00334685|Adrenergic Agents|adrenergic agents|mesh-ancestor
110320612|NCT00334685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110320613|NCT00436371|Amisulpride|amisulpride|mesh-list
110320614|NCT00436371|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110320615|NCT00436371|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110320616|NCT00436371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110320617|NCT00436371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110320618|NCT00436371|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110320619|NCT00436371|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110320620|NCT00436371|Dopamine Agents|dopamine agents|mesh-ancestor
110320621|NCT00436371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110320622|NCT00436371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110320623|NCT00436371|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110320624|NCT00436371|Antidepressive Agents|antidepressive agents|mesh-ancestor
110320625|NCT00334763|Paclitaxel|paclitaxel|mesh-list
110320626|NCT00334763|Bevacizumab|bevacizumab|mesh-list
110320627|NCT00334763|Carboplatin|carboplatin|mesh-list
110320628|NCT00334763|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110320629|NCT00334763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110320630|NCT00334763|Tubulin Modulators|tubulin modulators|mesh-ancestor
110320631|NCT00334763|Antimitotic Agents|antimitotic agents|mesh-ancestor
110320632|NCT00334763|Mitosis Modulators|mitosis modulators|mesh-ancestor
110320633|NCT00334763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110320634|NCT00334763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110320635|NCT00334763|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110320636|NCT00334763|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110320637|NCT00334763|Growth Substances|growth substances|mesh-ancestor
110320638|NCT00334763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110320639|NCT00334763|Growth Inhibitors|growth inhibitors|mesh-ancestor
110320640|NCT00436722|Immunoglobulins|immunoglobulins|mesh-list
110320641|NCT00436722|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110320642|NCT00436722|Immunologic Factors|immunologic factors|mesh-ancestor
110320643|NCT00436722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110320644|NCT00436722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110320645|NCT00334880|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
110320646|NCT00334880|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110320647|NCT00334880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110320648|NCT00334880|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110320649|NCT00334880|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110320650|NCT00334880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110320651|NCT00334880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110320652|NCT00334880|Dopamine Agents|dopamine agents|mesh-ancestor
110320653|NCT00334880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110320654|NCT00436761|Cyclosporine|cyclosporine|mesh-list
110170618|NCT00017316|Thalidomide|thalidomide|mesh-list
110320655|NCT00436761|Methylprednisolone|methylprednisolone|mesh-list
110320656|NCT00436761|Melphalan|melphalan|mesh-list
110320657|NCT00436761|Busulfan|busulfan|mesh-list
110320658|NCT00436761|Cyclosporins|cyclosporins|mesh-list
110320659|NCT00436761|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110320660|NCT00436761|Sargramostim|sargramostim|mesh-list
110320661|NCT00436761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110320662|NCT00436761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110320663|NCT00436761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110320664|NCT00436761|Immunologic Factors|immunologic factors|mesh-ancestor
110320665|NCT00436761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110320666|NCT00436761|Antifungal Agents|antifungal agents|mesh-ancestor
110320667|NCT00436761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110320668|NCT00436761|Dermatologic Agents|dermatologic agents|mesh-ancestor
110320669|NCT00436761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110320670|NCT00436761|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110320671|NCT00436761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110320672|NCT00436761|Antiemetics|antiemetics|mesh-ancestor
110320673|NCT00436761|Autonomic Agents|autonomic agents|mesh-ancestor
110320674|NCT00436761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110320675|NCT00436761|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110320676|NCT00436761|Glucocorticoids|glucocorticoids|mesh-ancestor
110320677|NCT00436761|Hormones|hormones|mesh-ancestor
110320678|NCT00436761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110320679|NCT00436761|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110320680|NCT00436761|Protective Agents|protective agents|mesh-ancestor
110320681|NCT00436761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110320682|NCT00436761|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110320683|NCT00436761|Alkylating Agents|alkylating agents|mesh-ancestor
110320684|NCT00436761|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110320685|NCT00436800|Gemcitabine|gemcitabine|mesh-list
110320686|NCT00436800|Oxaliplatin|oxaliplatin|mesh-list
110320687|NCT00436800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110320688|NCT00436800|Antimetabolites|antimetabolites|mesh-ancestor
110343826|NCT06020755|Dactinomycin|dactinomycin|mesh-list
110320689|NCT00436800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110320690|NCT00436800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110320691|NCT00436839|Prednisone|prednisone|mesh-list
110320692|NCT00436839|Docetaxel|docetaxel|mesh-list
110320693|NCT00436839|Mitoxantrone|mitoxantrone|mesh-list
110320694|NCT00436839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110320695|NCT00436839|Tubulin Modulators|tubulin modulators|mesh-ancestor
110320696|NCT00436839|Antimitotic Agents|antimitotic agents|mesh-ancestor
110320697|NCT00436839|Mitosis Modulators|mitosis modulators|mesh-ancestor
110320698|NCT00436839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110320699|NCT00436839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110320700|NCT00436839|Glucocorticoids|glucocorticoids|mesh-ancestor
110320701|NCT00436839|Hormones|hormones|mesh-ancestor
110320702|NCT00436839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110320703|NCT00436839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110320704|NCT00436839|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110320705|NCT00436839|Analgesics|analgesics|mesh-ancestor
110320706|NCT00436839|Sensory System Agents|sensory system agents|mesh-ancestor
110320707|NCT00436839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110149592|NCT00006397|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110320708|NCT00436839|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110320709|NCT00436839|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110320710|NCT00436839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110320711|NCT00335075|Temozolomide|temozolomide|mesh-list
110320712|NCT00335075|Semustine|semustine|mesh-list
110320713|NCT00335075|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110320714|NCT00335075|Alkylating Agents|alkylating agents|mesh-ancestor
110320715|NCT00335075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110320716|NCT00335075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110320717|NCT00436995|Darbepoetin alfa|darbepoetin alfa|mesh-list
110320718|NCT00436995|Hematinics|hematinics|mesh-ancestor
110320719|NCT04716179|Hormones|hormones|mesh-list
110320720|NCT04716179|Testosterone|testosterone|mesh-list
110320721|NCT04716179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110320722|NCT04716179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110320723|NCT04716179|Androgens|androgens|mesh-ancestor
110320725|NCT00437229|Dexamethasone acetate|dexamethasone acetate|mesh-list
110320726|NCT00437229|Ondansetron|ondansetron|mesh-list
110320727|NCT00437229|Casopitant|casopitant|mesh-list
110320728|NCT00437229|BB 1101|bb 1101|mesh-list
110320729|NCT00437229|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110320730|NCT00437229|Antiemetics|antiemetics|mesh-ancestor
110320731|NCT00437229|Autonomic Agents|autonomic agents|mesh-ancestor
110320732|NCT00437229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110320733|NCT00437229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110320734|NCT00437229|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110320735|NCT00437229|Glucocorticoids|glucocorticoids|mesh-ancestor
110320736|NCT00437229|Hormones|hormones|mesh-ancestor
110320737|NCT00437229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110320738|NCT00437229|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110320739|NCT00437229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110320740|NCT00437229|Protease Inhibitors|protease inhibitors|mesh-ancestor
110320741|NCT00437229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110320742|NCT00437229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110320743|NCT00437229|Antipruritics|antipruritics|mesh-ancestor
110320744|NCT00437229|Dermatologic Agents|dermatologic agents|mesh-ancestor
110320745|NCT00437229|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110320746|NCT00437229|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110320747|NCT00437229|Serotonin Agents|serotonin agents|mesh-ancestor
110320748|NCT00437229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110320749|NCT00437229|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110320750|NCT00335192|Tenofovir|tenofovir|mesh-list
110320751|NCT00335192|Lamivudine|lamivudine|mesh-list
110320752|NCT00335192|Abacavir|abacavir|mesh-list
110320753|NCT00335192|Antiviral Agents|antiviral agents|mesh-ancestor
110320754|NCT00335192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110320755|NCT00335192|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110320756|NCT00335192|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110320757|NCT00335192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110320758|NCT00335192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110320759|NCT00335192|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110320760|NCT00335192|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110320761|NCT00437307|Topotecan|topotecan|mesh-list
110320762|NCT00437307|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110320763|NCT00437307|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110320764|NCT00437307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110320765|NCT00437307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110320766|NCT00437307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110320767|NCT00335231|Gatifloxacin|gatifloxacin|mesh-list
110320768|NCT00335231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110320769|NCT00335231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110320770|NCT00335231|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110320771|NCT00335231|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110320772|NCT00335231|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110320773|NCT00335231|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110320774|NCT00335231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110320775|NCT00335231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110320776|NCT00335231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110320777|NCT00335270|Ritonavir|ritonavir|mesh-list
110320778|NCT00335270|Amprenavir|amprenavir|mesh-list
110320779|NCT00335270|Fosamprenavir|fosamprenavir|mesh-list
110320780|NCT00335270|Lamivudine|lamivudine|mesh-list
110320781|NCT00335270|Abacavir|abacavir|mesh-list
110320782|NCT00335270|Calcium|calcium|mesh-list
110320783|NCT00335270|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110320784|NCT00335270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110320785|NCT00335270|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110320786|NCT00335270|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110320787|NCT00335270|Protease Inhibitors|protease inhibitors|mesh-ancestor
110320788|NCT00335270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110320789|NCT00335270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110320790|NCT00335270|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110320791|NCT00335270|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110320792|NCT00335270|Antiviral Agents|antiviral agents|mesh-ancestor
110320793|NCT00335270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110320794|NCT00335270|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110320795|NCT00335270|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110320796|NCT00335270|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110320797|NCT00335270|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110320798|NCT00335270|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110320799|NCT00335270|Antitubercular Agents|antitubercular agents|mesh-ancestor
110320800|NCT00335270|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110320801|NCT00437385|Lithium Carbonate|lithium carbonate|mesh-list
110320802|NCT00437385|Antidepressive Agents|antidepressive agents|mesh-ancestor
110320803|NCT00437385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110320804|NCT00437385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110320805|NCT00437385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110320806|NCT00437385|Antimanic Agents|antimanic agents|mesh-ancestor
110320807|NCT00437385|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110320808|NCT00437385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110320809|NCT00437385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110320810|NCT00335309|Amoxicillin|amoxicillin|mesh-list
110320811|NCT00335309|Clavulanic Acid|clavulanic acid|mesh-list
110320812|NCT00335309|Clavulanic Acids|clavulanic acids|mesh-list
110320813|NCT00335309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110320814|NCT00335309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110320815|NCT00335309|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110320816|NCT00335309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110320817|NCT00335309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110320818|NCT00335348|Dexamethasone|dexamethasone|mesh-list
110320819|NCT00335348|Bortezomib|bortezomib|mesh-list
110320820|NCT00335348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110320821|NCT00335348|Antiemetics|antiemetics|mesh-ancestor
110320822|NCT00335348|Autonomic Agents|autonomic agents|mesh-ancestor
110320823|NCT00335348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110320824|NCT00335348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110320825|NCT00335348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110320826|NCT00335348|Glucocorticoids|glucocorticoids|mesh-ancestor
110320828|NCT00335348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110320829|NCT00335348|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110320830|NCT00335348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110320831|NCT00334919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
110320832|NCT00437463|Ramipril|ramipril|mesh-list
110320833|NCT00437463|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110320834|NCT00437463|Protease Inhibitors|protease inhibitors|mesh-ancestor
110320835|NCT00437463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110320836|NCT00437463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110320837|NCT00437463|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110320838|NCT00437502|Vaccines|vaccines|mesh-list
110320839|NCT00437502|Immunologic Factors|immunologic factors|mesh-ancestor
110320840|NCT00437502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110320841|NCT00420797|Phenylephrine|phenylephrine|mesh-list
110320842|NCT00420797|Oxymetazoline|oxymetazoline|mesh-list
110320843|NCT00420797|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110320844|NCT00420797|Mydriatics|mydriatics|mesh-ancestor
110320845|NCT00420797|Autonomic Agents|autonomic agents|mesh-ancestor
110320846|NCT00420797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110320847|NCT00420797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110320848|NCT00420797|Sympathomimetics|sympathomimetics|mesh-ancestor
110320849|NCT00420797|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110320850|NCT00420797|Nasal Decongestants|nasal decongestants|mesh-ancestor
110320851|NCT00420797|Respiratory System Agents|respiratory system agents|mesh-ancestor
110320852|NCT00420797|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110320853|NCT00420797|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110320854|NCT00420797|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110320855|NCT00420797|Adrenergic Agents|adrenergic agents|mesh-ancestor
110320856|NCT00420797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110320857|NCT00420797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110320858|NCT00420797|Protective Agents|protective agents|mesh-ancestor
110320859|NCT00437619|Calcipotriene|calcipotriene|mesh-list
110320860|NCT00437619|Dermatologic Agents|dermatologic agents|mesh-ancestor
110320861|NCT00420836|Tobramycin|tobramycin|mesh-list
110320862|NCT00420836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110320863|NCT00420836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110320864|NCT00437697|Dalteparin|dalteparin|mesh-list
110320865|NCT00437697|Tinzaparin|tinzaparin|mesh-list
110320866|NCT00437697|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
110320868|NCT00437697|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110320869|NCT00437697|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110320870|NCT00437697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110320871|NCT00335465|Insulin Glargine|insulin glargine|mesh-list
110320872|NCT00335465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110320873|NCT00335465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110320874|NCT00335543|Gemcitabine|gemcitabine|mesh-list
110320875|NCT00335543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110320876|NCT00335543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110320877|NCT00335543|Antimetabolites|antimetabolites|mesh-ancestor
110320878|NCT00335543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110320879|NCT00437814|Ketamine|ketamine|mesh-list
110320880|NCT00437814|Analgesics|analgesics|mesh-ancestor
110320881|NCT00437814|Sensory System Agents|sensory system agents|mesh-ancestor
110320882|NCT00437814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110320883|NCT00437814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110320884|NCT00437814|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110320885|NCT00437814|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110320886|NCT00437814|Anesthetics, General|anesthetics, general|mesh-ancestor
110320887|NCT00437814|Anesthetics|anesthetics|mesh-ancestor
110320888|NCT00437814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110320889|NCT00437814|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110320890|NCT00437814|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110320891|NCT00437814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110320892|NCT00437814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110320893|NCT00335582|Clonidine|clonidine|mesh-list
110320894|NCT00335582|Analgesics|analgesics|mesh-ancestor
110320895|NCT00335582|Sensory System Agents|sensory system agents|mesh-ancestor
110320896|NCT00335582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110320897|NCT00335582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110320898|NCT00335582|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110320899|NCT00335582|Sympatholytics|sympatholytics|mesh-ancestor
110320900|NCT00335582|Autonomic Agents|autonomic agents|mesh-ancestor
110320901|NCT00335582|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110320902|NCT00335582|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110320903|NCT00335582|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110320904|NCT00335582|Adrenergic Agents|adrenergic agents|mesh-ancestor
110320905|NCT00335582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110320906|NCT00335582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110320907|NCT00437853|Anastrozole|anastrozole|mesh-list
110320908|NCT00437853|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110320909|NCT00437853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110320910|NCT00437853|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110320911|NCT00437853|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110320912|NCT00437853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110320913|NCT00437853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110320914|NCT00437853|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110320915|NCT00437853|Hormone Antagonists|hormone antagonists|mesh-ancestor
110320916|NCT00437853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110320917|NCT00437853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110320918|NCT00335621|Tiotropium Bromide|tiotropium bromide|mesh-list
110320919|NCT00335621|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110320920|NCT00335621|Autonomic Agents|autonomic agents|mesh-ancestor
110320921|NCT00335621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110320922|NCT00335621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110320923|NCT00335621|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110320924|NCT00335621|Respiratory System Agents|respiratory system agents|mesh-ancestor
110320925|NCT00335621|Parasympatholytics|parasympatholytics|mesh-ancestor
110320927|NCT00335621|Cholinergic Agents|cholinergic agents|mesh-ancestor
110320928|NCT00335621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110320929|NCT00335621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110320930|NCT00437892|Atorvastatin|atorvastatin|mesh-list
110320931|NCT00437892|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110320932|NCT00437892|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110320933|NCT00437892|Antimetabolites|antimetabolites|mesh-ancestor
110320934|NCT00437892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110320935|NCT00437892|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110320936|NCT00437892|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110320937|NCT00437892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110320938|NCT00437970|Metformin|metformin|mesh-list
110320939|NCT00437970|Pioglitazone|pioglitazone|mesh-list
110320940|NCT00437970|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110320941|NCT00437970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110320942|NCT00335699|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110320943|NCT00335699|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110320944|NCT00335699|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110320945|NCT00335699|Antimetabolites|antimetabolites|mesh-ancestor
110320946|NCT00335699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110320947|NCT00335699|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110320948|NCT00335699|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110320949|NCT00335699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110320950|NCT03277170|Montelukast|montelukast|mesh-list
110320951|NCT03277170|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110320952|NCT03277170|Respiratory System Agents|respiratory system agents|mesh-ancestor
110320953|NCT03277170|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110320954|NCT03277170|Hormone Antagonists|hormone antagonists|mesh-ancestor
110320955|NCT03277170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110320956|NCT03277170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110320957|NCT03277170|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110320958|NCT03277170|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110148387|NCT00006471|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110320959|NCT03277170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110320960|NCT00335933|Gabapentin|gabapentin|mesh-list
110320961|NCT00335933|Analgesics|analgesics|mesh-ancestor
110320962|NCT00335933|Sensory System Agents|sensory system agents|mesh-ancestor
110320963|NCT00335933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110320964|NCT00335933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110320965|NCT00335933|Anticonvulsants|anticonvulsants|mesh-ancestor
110320966|NCT00335933|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110320967|NCT00335933|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110320968|NCT00335933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110320969|NCT00335933|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110320970|NCT00335933|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110320971|NCT00335933|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110320972|NCT00335933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110320973|NCT00335933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110320974|NCT00335933|Antimanic Agents|antimanic agents|mesh-ancestor
110320975|NCT00336167|Bezafibrate|bezafibrate|mesh-list
110320976|NCT00336167|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110320977|NCT00336167|Antimetabolites|antimetabolites|mesh-ancestor
110320978|NCT00336167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110320979|NCT00336167|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110320980|NCT00336206|Alemtuzumab|alemtuzumab|mesh-list
110320981|NCT00336206|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110320982|NCT00336206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110320983|NCT00336245|Copper|copper|mesh-list
110320984|NCT00336245|Contraceptive Agents|contraceptive agents|mesh-list
110320985|NCT00336245|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110320986|NCT00336245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110320987|NCT00336245|Trace Elements|trace elements|mesh-ancestor
110320988|NCT00336245|Micronutrients|micronutrients|mesh-ancestor
110320989|NCT00336362|Hydroxyurea|hydroxyurea|mesh-list
110320990|NCT00336362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110320991|NCT00336362|Antisickling Agents|antisickling agents|mesh-ancestor
110320992|NCT00336362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110320993|NCT00336362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110320994|NCT00336362|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110320995|NCT00336401|Propofol|propofol|mesh-list
110320996|NCT00336401|Sevoflurane|sevoflurane|mesh-list
110320997|NCT00336401|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110320998|NCT00336401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110320999|NCT00336401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110321000|NCT00336401|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110321001|NCT00336401|Anesthetics, General|anesthetics, general|mesh-ancestor
110321002|NCT00336401|Anesthetics|anesthetics|mesh-ancestor
110321003|NCT00336401|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110321004|NCT00336401|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110321006|NCT00336518|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110321007|NCT00336518|Antimetabolites|antimetabolites|mesh-ancestor
110321008|NCT00336518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110321009|NCT00336518|Antiviral Agents|antiviral agents|mesh-ancestor
110321010|NCT00336518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110321011|NCT03277872|Pyrithione zinc|pyrithione zinc|mesh-list
110321012|NCT03277872|Keratolytic Agents|keratolytic agents|mesh-ancestor
110321013|NCT03277872|Dermatologic Agents|dermatologic agents|mesh-ancestor
110321014|NCT00347490|Enoxaparin|enoxaparin|mesh-list
110321015|NCT00347490|Anticoagulants|anticoagulants|mesh-ancestor
110321016|NCT00347490|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110321017|NCT00347490|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110321018|NCT00347490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110321019|NCT00336674|Insulin|insulin|mesh-list
110321020|NCT00336674|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110321021|NCT00336674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110321022|NCT00444522|Alprazolam|alprazolam|mesh-list
110321023|NCT00444522|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110321024|NCT00444522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110321025|NCT00444522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110321026|NCT00444522|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110321027|NCT00444522|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110321028|NCT00444522|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110321029|NCT00444522|GABA Modulators|gaba modulators|mesh-ancestor
110321030|NCT00444522|GABA Agents|gaba agents|mesh-ancestor
110321031|NCT00444522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110321032|NCT00444522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110321033|NCT00336791|Paclitaxel|paclitaxel|mesh-list
110321034|NCT00336791|Cyclophosphamide|cyclophosphamide|mesh-list
110321035|NCT00336791|Doxorubicin|doxorubicin|mesh-list
110321036|NCT00336791|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110321037|NCT00336791|Fluorouracil|fluorouracil|mesh-list
110321038|NCT00336791|Epirubicin|epirubicin|mesh-list
110321039|NCT00336791|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110321040|NCT00336791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110321041|NCT00336791|Tubulin Modulators|tubulin modulators|mesh-ancestor
110321042|NCT00336791|Antimitotic Agents|antimitotic agents|mesh-ancestor
110321043|NCT00336791|Mitosis Modulators|mitosis modulators|mesh-ancestor
110321044|NCT00336791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110321045|NCT00336791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110321046|NCT00336791|Immunologic Factors|immunologic factors|mesh-ancestor
110321047|NCT00336791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110321048|NCT00336791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110321049|NCT00336791|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110321050|NCT00336791|Alkylating Agents|alkylating agents|mesh-ancestor
110321051|NCT00336791|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110321052|NCT00336791|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110321053|NCT00336791|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110321054|NCT00336791|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110321055|NCT00336791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110321056|NCT00336791|Antimetabolites|antimetabolites|mesh-ancestor
110321057|NCT00336791|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110321058|NCT00444561|Pramlintide|pramlintide|mesh-list
110321059|NCT00444561|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110321060|NCT00444561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110321061|NCT00444639|Triptorelin Pamoate|triptorelin pamoate|mesh-list
110321062|NCT00444639|Luteolytic Agents|luteolytic agents|mesh-ancestor
110321063|NCT00444639|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110321064|NCT00444639|Contraceptive Agents|contraceptive agents|mesh-ancestor
110321065|NCT00444639|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110321066|NCT00444639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110321067|NCT00444639|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110321068|NCT00444639|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110321069|NCT00444639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110321070|NCT00336947|Tegafur|tegafur|mesh-list
110321071|NCT00336947|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110321072|NCT00336947|Antimetabolites|antimetabolites|mesh-ancestor
110321073|NCT00336947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110321074|NCT00336947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110321075|NCT00444717|Pitavastatin|pitavastatin|mesh-list
110321076|NCT00444717|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110321077|NCT00444717|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110321078|NCT00444717|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110321079|NCT00444717|Antimetabolites|antimetabolites|mesh-ancestor
110321080|NCT00444717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110321081|NCT00444717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110321082|NCT00444717|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110321083|NCT00347646|Fibrinolysin|fibrinolysin|mesh-list
110321084|NCT00347646|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110321085|NCT00347646|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110321086|NCT00347646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110321087|NCT00421317|Imatinib Mesylate|imatinib mesylate|mesh-list
110321088|NCT00421317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110321089|NCT00421317|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110321090|NCT00421317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110321091|NCT00421317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110321092|NCT00337259|Gemcitabine|gemcitabine|mesh-list
110321093|NCT00337259|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110321094|NCT00337259|Antimetabolites|antimetabolites|mesh-ancestor
110321095|NCT00337259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110321096|NCT00337259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110321098|NCT04699734|Anesthetics, Local|anesthetics, local|mesh-ancestor
110321099|NCT04699734|Anesthetics|anesthetics|mesh-ancestor
110321100|NCT04699734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110321101|NCT04699734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110321102|NCT04699734|Sensory System Agents|sensory system agents|mesh-ancestor
110321103|NCT04699734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110321104|NCT04699734|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110321105|NCT04699734|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110321106|NCT04699734|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110321107|NCT04699734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110321108|NCT04699734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110321109|NCT00337298|Amlodipine|amlodipine|mesh-list
110321110|NCT00337298|Lisinopril|lisinopril|mesh-list
110321111|NCT00337298|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110321112|NCT00337298|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110321113|NCT00337298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110321114|NCT00337298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110321115|NCT00337298|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110321116|NCT00337298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110321117|NCT00337298|Vasodilator Agents|vasodilator agents|mesh-ancestor
110321118|NCT00337298|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110321119|NCT00337298|Protease Inhibitors|protease inhibitors|mesh-ancestor
110321120|NCT00337298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110321121|NCT00337298|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110170652|NCT00017394|Vinorelbine|vinorelbine|mesh-list
110321122|NCT00337298|Protective Agents|protective agents|mesh-ancestor
110321123|NCT00337376|Sirolimus|sirolimus|mesh-list
110321124|NCT00337376|Paclitaxel|paclitaxel|mesh-list
110321125|NCT00337376|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110321126|NCT00337376|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110321127|NCT00337376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110321128|NCT00337376|Tubulin Modulators|tubulin modulators|mesh-ancestor
110321129|NCT00337376|Antimitotic Agents|antimitotic agents|mesh-ancestor
110321130|NCT00337376|Mitosis Modulators|mitosis modulators|mesh-ancestor
110321131|NCT00337376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110321132|NCT00337376|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110321133|NCT00337376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110321134|NCT00337376|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110321135|NCT00337376|Antifungal Agents|antifungal agents|mesh-ancestor
110321136|NCT00337376|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110321137|NCT00337376|Immunologic Factors|immunologic factors|mesh-ancestor
110321138|NCT00337376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110321139|NCT00337493|Cyclosporine|cyclosporine|mesh-list
110321140|NCT00337493|Mycophenolic Acid|mycophenolic acid|mesh-list
110321141|NCT00337493|Tacrolimus|tacrolimus|mesh-list
110321142|NCT00337493|Cyclosporins|cyclosporins|mesh-list
110321143|NCT00337493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110321144|NCT00337493|Immunologic Factors|immunologic factors|mesh-ancestor
110321145|NCT00337493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110321146|NCT00337493|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110321147|NCT00337493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110321148|NCT00337493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110321149|NCT00337493|Antifungal Agents|antifungal agents|mesh-ancestor
110321150|NCT00337493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110321151|NCT00337493|Dermatologic Agents|dermatologic agents|mesh-ancestor
110321152|NCT00337493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110321153|NCT00337493|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110321154|NCT00337493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110321155|NCT00337493|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110321156|NCT00337493|Antitubercular Agents|antitubercular agents|mesh-ancestor
110321157|NCT00337493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110321158|NCT00444756|Lidocaine|lidocaine|mesh-list
110321159|NCT00444756|Anesthetics, Local|anesthetics, local|mesh-ancestor
110321160|NCT00444756|Anesthetics|anesthetics|mesh-ancestor
110321161|NCT00444756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110321162|NCT00444756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110321163|NCT00444756|Sensory System Agents|sensory system agents|mesh-ancestor
110321164|NCT00444756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110321165|NCT00444756|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110321166|NCT00444756|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110321167|NCT00444756|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110321168|NCT00444756|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110321169|NCT00444756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110321170|NCT00444834|Carvedilol|carvedilol|mesh-list
110321171|NCT00444834|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110321172|NCT00444834|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110321173|NCT00444834|Adrenergic Agents|adrenergic agents|mesh-ancestor
110321174|NCT00444834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110321175|NCT00444834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110321176|NCT00444834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110321177|NCT00444834|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110321178|NCT00444834|Antioxidants|antioxidants|mesh-ancestor
110321179|NCT00444834|Protective Agents|protective agents|mesh-ancestor
110321180|NCT00444834|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110321181|NCT00444834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110321182|NCT00444834|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110321183|NCT00444834|Vasodilator Agents|vasodilator agents|mesh-ancestor
110321184|NCT00444834|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110321185|NCT00444834|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110170681|NCT00041548|Nitric Oxide|nitric oxide|mesh-list
110321186|NCT00337766|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
110321187|NCT00337766|Hemostatics|hemostatics|mesh-ancestor
110321188|NCT00337766|Coagulants|coagulants|mesh-ancestor
110321189|NCT00337766|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
110321190|NCT00337766|Natriuretic Agents|natriuretic agents|mesh-ancestor
110321191|NCT00337766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110321192|NCT00444873|Lanreotide|lanreotide|mesh-list
110321193|NCT00444873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110321194|NCT00337805|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
110321195|NCT00337805|Plasma Substitutes|plasma substitutes|mesh-ancestor
110321196|NCT00337805|Blood Substitutes|blood substitutes|mesh-ancestor
110321197|NCT00337883|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110321198|NCT00337883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110321199|NCT00337883|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110321200|NCT00337883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110321201|NCT00337883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110321202|NCT00451113|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110321203|NCT00451113|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
110321204|NCT00451113|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110321205|NCT00451113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110321207|NCT00451113|Hormones|hormones|mesh-ancestor
110321208|NCT00451113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110321209|NCT00451113|Protease Inhibitors|protease inhibitors|mesh-ancestor
110321210|NCT00451113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110321211|NCT00451113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110321212|NCT00337922|Lamivudine|lamivudine|mesh-list
110321213|NCT00337922|Abacavir|abacavir|mesh-list
110321214|NCT00337922|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110321215|NCT00337922|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110321216|NCT00337922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110321217|NCT00337922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110321218|NCT00337922|Antiviral Agents|antiviral agents|mesh-ancestor
110321219|NCT00337922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110321220|NCT00337922|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110321221|NCT00337922|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110321222|NCT00451230|Hydrocortisone|hydrocortisone|mesh-list
110321223|NCT00451230|Cocaine|cocaine|mesh-list
110321224|NCT00451230|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110321225|NCT00451230|Anesthetics, Local|anesthetics, local|mesh-ancestor
110321226|NCT00451230|Anesthetics|anesthetics|mesh-ancestor
110321227|NCT00451230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110321228|NCT00451230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110321229|NCT00451230|Sensory System Agents|sensory system agents|mesh-ancestor
110321230|NCT00451230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110321231|NCT00451230|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110321232|NCT00451230|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110321233|NCT00451230|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110321234|NCT00451230|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110321235|NCT00451230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110321236|NCT00451230|Dopamine Agents|dopamine agents|mesh-ancestor
110321237|NCT00451230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110321238|NCT00338000|Epoetin Alfa|epoetin alfa|mesh-list
110321239|NCT00338000|Hematinics|hematinics|mesh-ancestor
110321240|NCT00338117|Galantamine|galantamine|mesh-list
110321241|NCT00338117|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110321242|NCT00338117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110321243|NCT00338117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110321244|NCT00338117|Cholinergic Agents|cholinergic agents|mesh-ancestor
110321245|NCT00338117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110321246|NCT00338117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110321247|NCT00338117|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110321248|NCT00338117|Autonomic Agents|autonomic agents|mesh-ancestor
110321249|NCT00338117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110321250|NCT00338117|Nootropic Agents|nootropic agents|mesh-ancestor
110321251|NCT00338195|Caffeine|caffeine|mesh-list
110321252|NCT00338195|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110170689|NCT00041548|Antioxidants|antioxidants|mesh-ancestor
110321253|NCT00338195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110321254|NCT00338195|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110321255|NCT00338195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110321256|NCT00338195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110321257|NCT00338195|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110321258|NCT00338195|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110321259|NCT00338195|Purinergic Agents|purinergic agents|mesh-ancestor
110321260|NCT00338195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110321261|NCT00338273|Aripiprazole|aripiprazole|mesh-list
110321262|NCT00338273|Antidepressive Agents|antidepressive agents|mesh-ancestor
110321263|NCT00338273|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110321264|NCT00338273|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110321265|NCT00338273|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110321266|NCT00338273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110321267|NCT00338273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110321268|NCT00338273|Dopamine Agonists|dopamine agonists|mesh-ancestor
110321269|NCT00338273|Dopamine Agents|dopamine agents|mesh-ancestor
110321270|NCT00338273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110321271|NCT00338273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110321272|NCT00338273|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110321273|NCT00338273|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110321274|NCT00338273|Serotonin Agents|serotonin agents|mesh-ancestor
110321275|NCT00338273|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110321276|NCT00338273|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110321277|NCT00338273|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110321278|NCT00338273|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110321279|NCT00338312|Testosterone|testosterone|mesh-list
110321280|NCT00338312|Androgens|androgens|mesh-ancestor
110321282|NCT00338312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110321283|NCT00338312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110321284|NCT00451386|Ceftriaxone|ceftriaxone|mesh-list
110321285|NCT00451386|Ertapenem|ertapenem|mesh-list
110321286|NCT00451386|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110321287|NCT00451386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110321288|NCT00338390|Lamivudine|lamivudine|mesh-list
110321289|NCT00338390|Abacavir|abacavir|mesh-list
110321290|NCT00338390|Dideoxynucleosides|dideoxynucleosides|mesh-list
110321291|NCT00338390|Didanosine|didanosine|mesh-list
110321292|NCT00338390|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110321293|NCT00338390|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110321294|NCT00338390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110321295|NCT00338390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110321296|NCT00338390|Antiviral Agents|antiviral agents|mesh-ancestor
110321297|NCT00338390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110321298|NCT00338390|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110321299|NCT00338390|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110321300|NCT00338390|Antimetabolites|antimetabolites|mesh-ancestor
110321301|NCT00338468|Epoetin Alfa|epoetin alfa|mesh-list
110321302|NCT00338468|Hematinics|hematinics|mesh-ancestor
110321303|NCT00338507|Erdosteine|erdosteine|mesh-list
110321304|NCT00338507|Expectorants|expectorants|mesh-ancestor
110321305|NCT00338507|Respiratory System Agents|respiratory system agents|mesh-ancestor
110321306|NCT00445185|Vaccines|vaccines|mesh-list
110321307|NCT00445185|Immunologic Factors|immunologic factors|mesh-ancestor
110321308|NCT00445185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110321309|NCT00338546|Cocaine|cocaine|mesh-list
110321310|NCT00338546|Dexmedetomidine|dexmedetomidine|mesh-list
110321311|NCT00338546|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110321312|NCT00338546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110321313|NCT00338546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110321314|NCT00338546|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110321315|NCT00338546|Analgesics|analgesics|mesh-ancestor
110321316|NCT00338546|Sensory System Agents|sensory system agents|mesh-ancestor
110321317|NCT00338546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110321318|NCT00338546|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110321319|NCT00338546|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110321320|NCT00338546|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110321321|NCT00338546|Adrenergic Agents|adrenergic agents|mesh-ancestor
110321322|NCT00338546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110321323|NCT00338546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110321324|NCT00338546|Anesthetics, Local|anesthetics, local|mesh-ancestor
110321325|NCT00338546|Anesthetics|anesthetics|mesh-ancestor
110321326|NCT00338546|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110321327|NCT00338546|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110321328|NCT00338546|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110321329|NCT00338546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110321330|NCT00338546|Dopamine Agents|dopamine agents|mesh-ancestor
110321331|NCT00338624|Oxybutynin|oxybutynin|mesh-list
110321332|NCT00338624|Parasympatholytics|parasympatholytics|mesh-ancestor
110321333|NCT00338624|Autonomic Agents|autonomic agents|mesh-ancestor
110321334|NCT00338624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110321335|NCT00338624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110321336|NCT00338624|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110321337|NCT00338624|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110321338|NCT00338624|Cholinergic Agents|cholinergic agents|mesh-ancestor
110321339|NCT00338624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110321340|NCT00338624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110321341|NCT00338624|Urological Agents|urological agents|mesh-ancestor
110321342|NCT00338780|Lamivudine|lamivudine|mesh-list
110321343|NCT00338780|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110321344|NCT00338780|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110321345|NCT00338780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110321346|NCT00338780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110321347|NCT00338780|Antiviral Agents|antiviral agents|mesh-ancestor
110321348|NCT00338780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110321349|NCT00338780|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110321350|NCT00338780|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110321351|NCT00451620|Glyburide|glyburide|mesh-list
110321352|NCT00451620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110321353|NCT00451620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110321354|NCT00445497|Amoxicillin|amoxicillin|mesh-list
110321355|NCT00445497|Ciprofloxacin|ciprofloxacin|mesh-list
110321356|NCT00445497|Clavulanic Acid|clavulanic acid|mesh-list
110321357|NCT00445497|Clavulanic Acids|clavulanic acids|mesh-list
110321358|NCT00445497|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
110321359|NCT00445497|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110321360|NCT00445497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110321361|NCT00445497|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110321362|NCT00445497|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110321363|NCT00445497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110321364|NCT00445497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110321365|NCT00445497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110321366|NCT00445497|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110321367|NCT00445497|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110321368|NCT00445497|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110321369|NCT00451776|Propofol|propofol|mesh-list
110321370|NCT00451776|Etomidate|etomidate|mesh-list
110321371|NCT00451776|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110321372|NCT00451776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110321373|NCT00451776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110321374|NCT00451776|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110321375|NCT00451776|Anesthetics, General|anesthetics, general|mesh-ancestor
110321376|NCT00451776|Anesthetics|anesthetics|mesh-ancestor
110321377|NCT00338936|Valsartan|valsartan|mesh-list
110321378|NCT00338936|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110321379|NCT00338936|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110321380|NCT00338936|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110321381|NCT00338936|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110321382|NCT00338936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110321383|NCT00338936|Diuretics|diuretics|mesh-ancestor
110321384|NCT00338936|Natriuretic Agents|natriuretic agents|mesh-ancestor
110321385|NCT00338936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110321386|NCT00338936|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110321387|NCT00338936|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110321388|NCT00445575|Risedronic Acid|risedronic acid|mesh-list
110321389|NCT00445575|Etidronic Acid|etidronic acid|mesh-list
110321390|NCT00445575|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110321391|NCT00445575|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110321392|NCT00445575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110321394|NCT00445575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110321395|NCT00445575|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110321396|NCT00339014|Zonisamide|zonisamide|mesh-list
110321397|NCT00339014|Bupropion|bupropion|mesh-list
110321398|NCT00339014|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110321399|NCT00339014|Antidepressive Agents|antidepressive agents|mesh-ancestor
110321400|NCT00339014|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110321401|NCT00339014|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110321402|NCT00339014|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110321403|NCT00339014|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110321404|NCT00339014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110321405|NCT00339014|Dopamine Agents|dopamine agents|mesh-ancestor
110321406|NCT00339014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110321407|NCT00339014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110321408|NCT00339014|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110321409|NCT00339014|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110321410|NCT00339014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110321411|NCT00339014|Anticonvulsants|anticonvulsants|mesh-ancestor
110321412|NCT00339014|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110321413|NCT00339014|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110321414|NCT00420953|Amiodarone|amiodarone|mesh-list
110321415|NCT00420953|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110321416|NCT00420953|Vasodilator Agents|vasodilator agents|mesh-ancestor
110321417|NCT00420953|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
110321418|NCT00420953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110149620|NCT00006427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110321419|NCT00420953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110321420|NCT00420953|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110321421|NCT00420953|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110321422|NCT00420953|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110321423|NCT00420953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110321424|NCT00420953|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110321425|NCT00420953|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110321426|NCT00420953|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110321427|NCT00425204|Panitumumab|panitumumab|mesh-list
110321428|NCT00425204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110321429|NCT00425204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110321430|NCT00425243|Zolpidem|zolpidem|mesh-list
110321431|NCT00425243|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110321432|NCT00425243|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110321433|NCT00425243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110321434|NCT00425243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110321435|NCT00425243|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
110321436|NCT00425243|GABA Agonists|gaba agonists|mesh-ancestor
110321437|NCT00425243|GABA Agents|gaba agents|mesh-ancestor
110321438|NCT00425243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110321439|NCT00425243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110321440|NCT00339131|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
110321441|NCT00339131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110321442|NCT00339131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110321443|NCT00339131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110321444|NCT00339131|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110321445|NCT00451971|Leflunomide|leflunomide|mesh-list
110321446|NCT00451971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110321447|NCT00451971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110321448|NCT00451971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110321449|NCT00451971|Immunologic Factors|immunologic factors|mesh-ancestor
110321450|NCT00451971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110321451|NCT00452166|Rosiglitazone|rosiglitazone|mesh-list
110321452|NCT00452166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110321453|NCT00452166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110321454|NCT00446004|Imatinib Mesylate|imatinib mesylate|mesh-list
110321456|NCT00446004|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
110321457|NCT00446004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110321458|NCT00446004|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110321460|NCT00446004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110321461|NCT00446004|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110321462|NCT00446004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110321463|NCT00446082|Pasireotide|pasireotide|mesh-list
110321464|NCT00446082|Hormones|hormones|mesh-ancestor
110321465|NCT00446082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110321466|NCT00446082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110321467|NCT03275376|Atorvastatin|atorvastatin|mesh-list
110321468|NCT03275376|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110321469|NCT03275376|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110321470|NCT03275376|Antimetabolites|antimetabolites|mesh-ancestor
110374540|NCT00197106|Fluticasone|fluticasone|mesh-list
110321471|NCT03275376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110321472|NCT03275376|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110321473|NCT03275376|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110321474|NCT03275376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110321476|NCT00340184|Carboplatin|carboplatin|mesh-list
110321477|NCT00340184|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110321478|NCT00340184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110321479|NCT00340184|Tubulin Modulators|tubulin modulators|mesh-ancestor
110321480|NCT00340184|Antimitotic Agents|antimitotic agents|mesh-ancestor
110321481|NCT00340184|Mitosis Modulators|mitosis modulators|mesh-ancestor
110321482|NCT00340184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110321483|NCT00446316|Imatinib Mesylate|imatinib mesylate|mesh-list
110321484|NCT00446316|Antacids|antacids|mesh-list
110321485|NCT00446316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110321486|NCT00446316|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110321487|NCT00446316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110321488|NCT00446316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110321489|NCT00446316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110321490|NCT00446433|Lenalidomide|lenalidomide|mesh-list
110321491|NCT00446433|Immunologic Factors|immunologic factors|mesh-ancestor
110321492|NCT00446433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110321493|NCT00446433|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110321494|NCT00446433|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110321495|NCT00446433|Growth Substances|growth substances|mesh-ancestor
110321496|NCT00446433|Growth Inhibitors|growth inhibitors|mesh-ancestor
110321497|NCT00446433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110321498|NCT00340574|Aluminum Hydroxide|aluminum hydroxide|mesh-list
110321499|NCT00340574|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110321500|NCT00340574|Immunologic Factors|immunologic factors|mesh-ancestor
110321501|NCT00340574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110321502|NCT00340574|Antacids|antacids|mesh-ancestor
110321503|NCT00340574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110321504|NCT00340574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110321505|NCT00340613|Insulin Glargine|insulin glargine|mesh-list
110321506|NCT00340613|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110321507|NCT00340613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110321508|NCT00340691|Doxycycline|doxycycline|mesh-list
110321509|NCT00340691|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110321510|NCT00340691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110321511|NCT00340691|Antimalarials|antimalarials|mesh-ancestor
110321512|NCT00340691|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110321513|NCT00340691|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110321514|NCT00452244|Gefitinib|gefitinib|mesh-list
110321515|NCT00452244|Simvastatin|simvastatin|mesh-list
110321516|NCT00452244|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110321517|NCT00452244|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110321518|NCT00452244|Antimetabolites|antimetabolites|mesh-ancestor
110321519|NCT00452244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110321520|NCT00452244|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110321521|NCT00452244|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110321522|NCT00452244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110321523|NCT00452244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110321524|NCT00452244|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110321525|NCT00446472|Becaplermin|becaplermin|mesh-list
110321526|NCT00446472|Anticoagulants|anticoagulants|mesh-ancestor
110321527|NCT00446472|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
110321528|NCT00446472|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110170713|NCT00041782|Dalteparin|dalteparin|mesh-list
110321529|NCT00446472|Growth Substances|growth substances|mesh-ancestor
110321530|NCT00446472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110321531|NCT00446589|Teriparatide|teriparatide|mesh-list
110321532|NCT00446589|Ibandronic Acid|ibandronic acid|mesh-list
110321533|NCT00446589|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110321534|NCT00446589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110321535|NCT00446589|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110321536|NCT00452322|Methyltestosterone|methyltestosterone|mesh-list
110321537|NCT00452322|Testosterone|testosterone|mesh-list
110321538|NCT00452322|Testosterone undecanoate|testosterone undecanoate|mesh-list
110321539|NCT00452322|Testosterone enanthate|testosterone enanthate|mesh-list
110321540|NCT00452322|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
110321541|NCT00452322|Androgens|androgens|mesh-ancestor
110321542|NCT00452322|Hormones|hormones|mesh-ancestor
110321543|NCT00452322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110321544|NCT00452322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110321545|NCT00452322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110321546|NCT00452322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110321548|NCT00452556|Docetaxel|docetaxel|mesh-list
110321549|NCT00452556|Leuprolide|leuprolide|mesh-list
110321550|NCT00452556|Androgens|androgens|mesh-list
110321551|NCT00452556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110321552|NCT00452556|Tubulin Modulators|tubulin modulators|mesh-ancestor
110321553|NCT00452556|Antimitotic Agents|antimitotic agents|mesh-ancestor
110321554|NCT00452556|Mitosis Modulators|mitosis modulators|mesh-ancestor
110321555|NCT00452556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110321556|NCT00452556|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110321557|NCT00452556|Fertility Agents|fertility agents|mesh-ancestor
110321558|NCT00452556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110321559|NCT00452556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110321560|NCT00452556|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110321561|NCT00452556|Hormones|hormones|mesh-ancestor
110321562|NCT00452556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110321564|NCT00446667|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110321565|NCT00446667|Diuretics|diuretics|mesh-ancestor
110321566|NCT00446667|Natriuretic Agents|natriuretic agents|mesh-ancestor
110321567|NCT00446667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110321568|NCT03277755|Adafosbuvir|adafosbuvir|mesh-list
110321569|NCT03277755|Antiviral Agents|antiviral agents|mesh-ancestor
110321570|NCT03277755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110321571|NCT00452595|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
110321572|NCT00452595|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110321573|NCT00452595|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110321574|NCT00452595|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110321575|NCT00452595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110321576|NCT00452595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110321577|NCT00452595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110321578|NCT00452595|Antidepressive Agents|antidepressive agents|mesh-ancestor
110321579|NCT00452595|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110321580|NCT00341432|Nicotine|nicotine|mesh-list
110321581|NCT00341432|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110321582|NCT00341432|Autonomic Agents|autonomic agents|mesh-ancestor
110321583|NCT00341432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110321584|NCT00341432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110321585|NCT00341432|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110321586|NCT00341432|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110321587|NCT00341432|Cholinergic Agents|cholinergic agents|mesh-ancestor
110321588|NCT00341432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110321589|NCT00341432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110321590|NCT00452634|Irinotecan|irinotecan|mesh-list
110321591|NCT00452634|Simvastatin|simvastatin|mesh-list
110321592|NCT00452634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110321593|NCT00452634|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110321594|NCT00452634|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110321595|NCT00452634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110321596|NCT00452634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110321597|NCT00452634|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110321598|NCT00452634|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110321599|NCT00452634|Antimetabolites|antimetabolites|mesh-ancestor
110321600|NCT00452634|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110321601|NCT00452634|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110321602|NCT03277599|Tramadol|tramadol|mesh-list
110321603|NCT03277599|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110321604|NCT03277599|Narcotics|narcotics|mesh-ancestor
110321605|NCT03277599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110321606|NCT03277599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110321607|NCT03277599|Analgesics|analgesics|mesh-ancestor
110321608|NCT03277599|Sensory System Agents|sensory system agents|mesh-ancestor
110321609|NCT03277599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110321610|NCT00452829|Folic Acid|folic acid|mesh-list
110321611|NCT00452829|Vitamin B Complex|vitamin b complex|mesh-list
110321612|NCT00452829|Inositol|inositol|mesh-list
110321613|NCT00452829|Hematinics|hematinics|mesh-ancestor
110321614|NCT00452829|Vitamins|vitamins|mesh-ancestor
110321615|NCT00452829|Micronutrients|micronutrients|mesh-ancestor
110321616|NCT00452829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110321617|NCT00452907|Artesunate|artesunate|mesh-list
110321618|NCT00452907|Lumefantrine|lumefantrine|mesh-list
110321619|NCT00452907|Pyrimethamine|pyrimethamine|mesh-list
110321620|NCT00452907|Sulfadoxine|sulfadoxine|mesh-list
110321621|NCT00452907|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
110321622|NCT00452907|Antimalarials|antimalarials|mesh-ancestor
110321623|NCT00452907|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110321624|NCT00452907|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110321625|NCT00452907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110321626|NCT00452907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110321627|NCT00452907|Antiviral Agents|antiviral agents|mesh-ancestor
110321628|NCT00452907|Schistosomicides|schistosomicides|mesh-ancestor
110321629|NCT00452907|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110321630|NCT00452907|Anthelmintics|anthelmintics|mesh-ancestor
110321631|NCT00452907|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110321632|NCT00452907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110321633|NCT00452907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110321634|NCT00452907|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110321635|NCT00446784|Methotrexate|methotrexate|mesh-list
110321636|NCT00446784|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110321637|NCT00446784|Abortifacient Agents|abortifacient agents|mesh-ancestor
110321638|NCT00446784|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110321639|NCT00446784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110321640|NCT00446784|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110321641|NCT00446784|Antimetabolites|antimetabolites|mesh-ancestor
110321642|NCT00446784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110321643|NCT00446784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110321644|NCT00446784|Dermatologic Agents|dermatologic agents|mesh-ancestor
110321645|NCT00446784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110321646|NCT00446784|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110321647|NCT00446784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110321648|NCT00446784|Immunologic Factors|immunologic factors|mesh-ancestor
110321649|NCT00446784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110321650|NCT00446784|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110321651|NCT00452985|Carboplatin|carboplatin|mesh-list
110321652|NCT00452985|Docetaxel|docetaxel|mesh-list
110321653|NCT00452985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110321654|NCT00452985|Tubulin Modulators|tubulin modulators|mesh-ancestor
110321655|NCT00452985|Antimitotic Agents|antimitotic agents|mesh-ancestor
110321656|NCT00452985|Mitosis Modulators|mitosis modulators|mesh-ancestor
110321657|NCT00452985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110321658|NCT03277209|Plerixafor|plerixafor|mesh-list
110321659|NCT03277209|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110321660|NCT03277209|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110321661|NCT03277209|Antiviral Agents|antiviral agents|mesh-ancestor
110321662|NCT03277209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110321663|NCT00453141|Betamethasone|betamethasone|mesh-list
110321664|NCT00453141|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110321665|NCT00453141|Glucocorticoids|glucocorticoids|mesh-ancestor
110321666|NCT00453141|Hormones|hormones|mesh-ancestor
110321667|NCT00453141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110321668|NCT00453141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110321669|NCT00453141|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110321670|NCT00453141|Respiratory System Agents|respiratory system agents|mesh-ancestor
110321671|NCT00421109|Levocetirizine|levocetirizine|mesh-list
110321672|NCT00421109|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110321673|NCT00421109|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110321674|NCT00421109|Histamine Antagonists|histamine antagonists|mesh-ancestor
110321675|NCT00421109|Histamine Agents|histamine agents|mesh-ancestor
110321676|NCT00421109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110321677|NCT00421109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110321678|NCT00421109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110321679|NCT02273583|Cyclophosphamide|cyclophosphamide|mesh-list
110321680|NCT02273583|Methotrexate|methotrexate|mesh-list
110321681|NCT02273583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110321682|NCT02273583|Immunologic Factors|immunologic factors|mesh-ancestor
110321683|NCT02273583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110321684|NCT02273583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110321685|NCT02273583|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110321686|NCT02273583|Alkylating Agents|alkylating agents|mesh-ancestor
110321687|NCT02273583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110321688|NCT02273583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110321689|NCT02273583|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110321690|NCT02273583|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110321691|NCT02273583|Abortifacient Agents|abortifacient agents|mesh-ancestor
110321692|NCT02273583|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110321693|NCT02273583|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110321694|NCT02273583|Antimetabolites|antimetabolites|mesh-ancestor
110321695|NCT02273583|Dermatologic Agents|dermatologic agents|mesh-ancestor
110321696|NCT02273583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110321697|NCT02273583|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110321698|NCT02273583|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110321700|NCT00446862|Enalapril|enalapril|mesh-list
110321701|NCT00446862|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
110321702|NCT00446862|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
110321703|NCT00446862|Enzyme Inhibitors|enzyme inhibitors|mesh-list
110321704|NCT00446862|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110321705|NCT00446862|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110321706|NCT00446862|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110321707|NCT00446862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110321708|NCT00446862|Protease Inhibitors|protease inhibitors|mesh-ancestor
110321709|NCT00446901|Selenium|selenium|mesh-list
110321710|NCT00446901|Antioxidants|antioxidants|mesh-ancestor
110321711|NCT00446901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110321712|NCT00446901|Protective Agents|protective agents|mesh-ancestor
110321713|NCT00446901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110321714|NCT00446901|Trace Elements|trace elements|mesh-ancestor
110321715|NCT00446901|Micronutrients|micronutrients|mesh-ancestor
110321716|NCT00453375|Butylated Hydroxytoluene|butylated hydroxytoluene|mesh-list
110321717|NCT00453375|Antioxidants|antioxidants|mesh-ancestor
110321718|NCT00453375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110321719|NCT00453375|Protective Agents|protective agents|mesh-ancestor
110321720|NCT00453375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110321721|NCT00446940|Atorvastatin|atorvastatin|mesh-list
110321722|NCT00446940|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110321723|NCT00446940|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110321724|NCT00446940|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110321725|NCT00446940|Antimetabolites|antimetabolites|mesh-ancestor
110321726|NCT00446940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110321727|NCT00446940|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110321728|NCT00446940|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110321729|NCT00446940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110321730|NCT00453414|Iloprost|iloprost|mesh-list
110321731|NCT00453414|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110321732|NCT00453414|Vasodilator Agents|vasodilator agents|mesh-ancestor
110321733|NCT00446979|UC-781|uc-781|mesh-list
110321734|NCT00446979|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110321735|NCT00446979|Antiviral Agents|antiviral agents|mesh-ancestor
110321736|NCT00446979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110321737|NCT00453453|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
110321738|NCT00453453|Natriuretic Agents|natriuretic agents|mesh-ancestor
110321739|NCT00453453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110321740|NCT00447018|Mannitol|mannitol|mesh-list
110321741|NCT00447018|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110321742|NCT00447018|Diuretics|diuretics|mesh-ancestor
110321743|NCT00447018|Natriuretic Agents|natriuretic agents|mesh-ancestor
110321744|NCT00447018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110321745|NCT00343070|Escitalopram|escitalopram|mesh-list
110321746|NCT00343070|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110321747|NCT00343070|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110321748|NCT00343070|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110321749|NCT00343070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110321750|NCT00343070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110321751|NCT00343070|Serotonin Agents|serotonin agents|mesh-ancestor
110321752|NCT00343070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110321753|NCT00453492|Risedronic Acid|risedronic acid|mesh-list
110321754|NCT00453492|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110321755|NCT00453492|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110321756|NCT00453492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110321757|NCT00453492|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110321758|NCT00453492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110321759|NCT00453492|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110321760|NCT00343187|Dapsone|dapsone|mesh-list
110321761|NCT00343187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110321762|NCT00343187|Antimalarials|antimalarials|mesh-ancestor
110321763|NCT00343187|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110321765|NCT00343187|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110321767|NCT00343187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110321768|NCT00343187|Leprostatic Agents|leprostatic agents|mesh-ancestor
110321769|NCT00343187|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110321770|NCT00343226|Basiliximab|basiliximab|mesh-list
110321771|NCT00343226|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110321772|NCT00343226|Immunologic Factors|immunologic factors|mesh-ancestor
110321773|NCT00343226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110321774|NCT00343265|Progesterone|progesterone|mesh-list
110321775|NCT00343265|Progestins|progestins|mesh-ancestor
110321776|NCT00343265|Hormones|hormones|mesh-ancestor
110321777|NCT00343265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110321778|NCT00343265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110321779|NCT00453609|Naltrexone|naltrexone|mesh-list
110321780|NCT00453609|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110321781|NCT00453609|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110321782|NCT00453609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110321783|NCT00453609|Sensory System Agents|sensory system agents|mesh-ancestor
110321784|NCT00453609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110321785|NCT00447213|Insulin|insulin|mesh-list
110321786|NCT00447213|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110321787|NCT00447213|Insulin Glargine|insulin glargine|mesh-list
110321788|NCT00447213|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110321789|NCT00447213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110321790|NCT00453648|Vitamin A|vitamin a|mesh-list
110321791|NCT00453648|Retinol palmitate|retinol palmitate|mesh-list
110321792|NCT00453648|Antioxidants|antioxidants|mesh-ancestor
110321793|NCT00453648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110321794|NCT00453648|Protective Agents|protective agents|mesh-ancestor
110321795|NCT00453648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110321796|NCT00453648|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110321797|NCT00453648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110321798|NCT00453648|Vitamins|vitamins|mesh-ancestor
110321799|NCT00453648|Micronutrients|micronutrients|mesh-ancestor
110321800|NCT00343421|Vaccines|vaccines|mesh-list
110321801|NCT00343421|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110321802|NCT00343421|Immunologic Factors|immunologic factors|mesh-ancestor
110321803|NCT00343421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110321804|NCT00343499|Valsartan|valsartan|mesh-list
110321805|NCT00343499|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110321806|NCT00343499|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110321807|NCT00343499|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110321808|NCT00343499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110321809|NCT04715360|Favipiravir|favipiravir|mesh-list
110321810|NCT04715360|Antiviral Agents|antiviral agents|mesh-ancestor
110321811|NCT04715360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110321812|NCT00447369|Pregabalin|pregabalin|mesh-list
110321813|NCT00447369|Valproic Acid|valproic acid|mesh-list
110321814|NCT00447369|Analgesics|analgesics|mesh-ancestor
110321815|NCT00447369|Sensory System Agents|sensory system agents|mesh-ancestor
110321816|NCT00447369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110321817|NCT00447369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110321818|NCT00447369|Anticonvulsants|anticonvulsants|mesh-ancestor
110321819|NCT00447369|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110321820|NCT00447369|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110321821|NCT00447369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110321822|NCT00447369|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110321823|NCT00447369|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110321824|NCT00447369|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110321825|NCT00447369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110321826|NCT00447369|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110321827|NCT00447369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110321828|NCT00447369|GABA Agents|gaba agents|mesh-ancestor
110321829|NCT00447369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110321830|NCT00447369|Antimanic Agents|antimanic agents|mesh-ancestor
110321831|NCT00343655|Atorvastatin|atorvastatin|mesh-list
110321832|NCT00343655|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110321833|NCT00343655|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110321835|NCT00343655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110321836|NCT00343655|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110321837|NCT00343655|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110321838|NCT00343655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110321839|NCT00453765|Montelukast|montelukast|mesh-list
110321840|NCT00453765|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110321841|NCT00453765|Respiratory System Agents|respiratory system agents|mesh-ancestor
110321842|NCT00453765|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110321843|NCT00453765|Hormone Antagonists|hormone antagonists|mesh-ancestor
110321844|NCT00453765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110321845|NCT00453765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110321846|NCT00453765|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110321847|NCT00453765|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110321848|NCT00453765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110321850|NCT00343733|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110321851|NCT00343733|Narcotics|narcotics|mesh-ancestor
110321852|NCT00343733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110321853|NCT00343733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110321854|NCT00343733|Analgesics|analgesics|mesh-ancestor
110321855|NCT00343733|Sensory System Agents|sensory system agents|mesh-ancestor
110321856|NCT00343733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110321857|NCT00343733|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110321858|NCT00343733|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110321859|NCT00343733|Anesthetics, General|anesthetics, general|mesh-ancestor
110321860|NCT00343733|Anesthetics|anesthetics|mesh-ancestor
110321861|NCT00343811|Modafinil|modafinil|mesh-list
110321862|NCT00343811|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110321863|NCT00343811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110321864|NCT00343811|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
110321865|NCT00343811|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110321866|NCT00343811|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110321867|NCT00343811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110321868|NCT00453804|Naltrexone|naltrexone|mesh-list
110321869|NCT00453804|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110321870|NCT00453804|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110321871|NCT00453804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110321872|NCT00453804|Sensory System Agents|sensory system agents|mesh-ancestor
110321873|NCT00453804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110321875|NCT00343850|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110321876|NCT00343850|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110321877|NCT00343850|Analgesics|analgesics|mesh-ancestor
110321878|NCT00343850|Sensory System Agents|sensory system agents|mesh-ancestor
110321879|NCT00343850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110321880|NCT00343850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110321881|NCT00343850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110321882|NCT00343850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110321883|NCT00344006|Artesunate|artesunate|mesh-list
110321884|NCT00344006|Lumefantrine|lumefantrine|mesh-list
110321885|NCT00344006|Artemether|artemether|mesh-list
110321886|NCT00344006|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
110321887|NCT00344006|Dapsone|dapsone|mesh-list
110321888|NCT00344006|Chlorproguanil|chlorproguanil|mesh-list
110321889|NCT00344006|Proguanil|proguanil|mesh-list
110321890|NCT00344006|Antimalarials|antimalarials|mesh-ancestor
110321891|NCT00344006|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110321892|NCT00344006|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110321893|NCT00344006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110321894|NCT00344006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110321895|NCT00344006|Antiviral Agents|antiviral agents|mesh-ancestor
110321896|NCT00344006|Schistosomicides|schistosomicides|mesh-ancestor
110321897|NCT00344006|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110321898|NCT00344006|Anthelmintics|anthelmintics|mesh-ancestor
110321899|NCT00344006|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110321900|NCT00344006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110321901|NCT00344006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110321902|NCT00344006|Leprostatic Agents|leprostatic agents|mesh-ancestor
110321903|NCT00344006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110321904|NCT00344006|Antimetabolites|antimetabolites|mesh-ancestor
110321905|NCT02273661|Amphotericin B|amphotericin b|mesh-list
110321906|NCT02273661|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
110321907|NCT02273661|Amebicides|amebicides|mesh-ancestor
110321908|NCT02273661|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110321909|NCT02273661|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110321910|NCT02273661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110321911|NCT02273661|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110321912|NCT02273661|Antifungal Agents|antifungal agents|mesh-ancestor
110321913|NCT00344123|Ritonavir|ritonavir|mesh-list
110321915|NCT00344123|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110321916|NCT00344123|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110321917|NCT00344123|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110321918|NCT00344123|Protease Inhibitors|protease inhibitors|mesh-ancestor
110321919|NCT00344123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110321920|NCT00344123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110321921|NCT00344123|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110321922|NCT00344123|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110321924|NCT00344123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110321925|NCT00344123|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110321926|NCT00344123|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110321927|NCT00344123|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110321928|NCT00344123|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110321929|NCT00344123|Antimetabolites|antimetabolites|mesh-ancestor
110321930|NCT00344123|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110321931|NCT00344123|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110321932|NCT00344201|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
110321933|NCT00344201|Hemostatics|hemostatics|mesh-ancestor
110321934|NCT00344201|Coagulants|coagulants|mesh-ancestor
110321935|NCT00453960|Norethindrone|norethindrone|mesh-list
110321936|NCT00453960|Norethindrone Acetate|norethindrone acetate|mesh-list
110321937|NCT00453960|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110321938|NCT00453960|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110321939|NCT00453960|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110321940|NCT00453960|Contraceptive Agents|contraceptive agents|mesh-ancestor
110321941|NCT00453960|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110321942|NCT00453960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110321943|NCT00453960|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110321944|NCT00453960|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110321945|NCT00447681|Fezakinumab|fezakinumab|mesh-list
110321946|NCT00447681|Dermatologic Agents|dermatologic agents|mesh-ancestor
110321947|NCT00447759|Ibuprofen|ibuprofen|mesh-list
110321948|NCT00447759|Celecoxib|celecoxib|mesh-list
110321949|NCT00447759|Diclofenac|diclofenac|mesh-list
110321950|NCT00447759|Naproxen|naproxen|mesh-list
110321951|NCT00447759|Meloxicam|meloxicam|mesh-list
110321952|NCT00447759|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110321953|NCT00447759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110321954|NCT00447759|Analgesics|analgesics|mesh-ancestor
110321955|NCT00447759|Sensory System Agents|sensory system agents|mesh-ancestor
110321956|NCT00447759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110321957|NCT00447759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110321958|NCT00447759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110321959|NCT00447759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110321960|NCT00447759|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110321961|NCT00447759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110321962|NCT00447759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110321963|NCT00447759|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110321964|NCT00447759|Gout Suppressants|gout suppressants|mesh-ancestor
110321965|NCT00344513|Carvedilol|carvedilol|mesh-list
110321966|NCT00344513|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
110321967|NCT00344513|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
110321968|NCT00344513|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110321969|NCT00344513|Adrenergic Agents|adrenergic agents|mesh-ancestor
110321970|NCT00344513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110321971|NCT00344513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110321972|NCT00344513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110321973|NCT00344513|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110321974|NCT00344513|Antioxidants|antioxidants|mesh-ancestor
110321975|NCT00344513|Protective Agents|protective agents|mesh-ancestor
110321976|NCT00344513|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110321977|NCT00344513|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110321978|NCT00344513|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110321979|NCT00344513|Vasodilator Agents|vasodilator agents|mesh-ancestor
110321980|NCT00344513|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110321981|NCT00344513|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110321982|NCT00344513|Protease Inhibitors|protease inhibitors|mesh-ancestor
110321983|NCT00344513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110321984|NCT00344552|Paclitaxel|paclitaxel|mesh-list
110321985|NCT00344552|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110321986|NCT00344552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110321987|NCT00344552|Tubulin Modulators|tubulin modulators|mesh-ancestor
110321988|NCT00344552|Antimitotic Agents|antimitotic agents|mesh-ancestor
110321989|NCT00344552|Mitosis Modulators|mitosis modulators|mesh-ancestor
110321990|NCT00344552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110321991|NCT00447915|Vitamin D|vitamin d|mesh-list
110321992|NCT00447915|Cholecalciferol|cholecalciferol|mesh-list
110321993|NCT00447915|Ibandronic Acid|ibandronic acid|mesh-list
110321995|NCT00447915|Vitamins|vitamins|mesh-ancestor
110321996|NCT00447915|Micronutrients|micronutrients|mesh-ancestor
110321997|NCT00447915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110321998|NCT00447915|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110321999|NCT00447915|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110322000|NCT00344669|Albendazole|albendazole|mesh-list
110322001|NCT00344669|Anthelmintics|anthelmintics|mesh-ancestor
110322002|NCT00344669|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110322003|NCT00344669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110322004|NCT00344669|Anticestodal Agents|anticestodal agents|mesh-ancestor
110322005|NCT00344669|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110322006|NCT00344669|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110322007|NCT00344669|Tubulin Modulators|tubulin modulators|mesh-ancestor
110322008|NCT00344669|Antimitotic Agents|antimitotic agents|mesh-ancestor
110322009|NCT00344669|Mitosis Modulators|mitosis modulators|mesh-ancestor
110322010|NCT00344669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110322011|NCT00344669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110322012|NCT04715165|Dexmedetomidine|dexmedetomidine|mesh-list
110322013|NCT04715165|Bupivacaine|bupivacaine|mesh-list
110322014|NCT04715165|Anesthetics, Local|anesthetics, local|mesh-ancestor
110322015|NCT04715165|Anesthetics|anesthetics|mesh-ancestor
110322016|NCT04715165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110322017|NCT04715165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110322018|NCT04715165|Sensory System Agents|sensory system agents|mesh-ancestor
110322019|NCT04715165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110322020|NCT04715165|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110322021|NCT04715165|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110322022|NCT04715165|Analgesics|analgesics|mesh-ancestor
110322023|NCT04715165|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110322024|NCT04715165|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110322025|NCT04715165|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110322026|NCT04715165|Adrenergic Agents|adrenergic agents|mesh-ancestor
110322027|NCT04715165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110322028|NCT04715165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110322029|NCT00454233|Metformin|metformin|mesh-list
110322030|NCT00454233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110322031|NCT00454233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110322032|NCT00454272|Vancomycin|vancomycin|mesh-list
110322033|NCT00454272|Teicoplanin|teicoplanin|mesh-list
110322034|NCT00454272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110322035|NCT00454272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110322036|NCT00344825|Fludarabine|fludarabine|mesh-list
110322037|NCT00344825|Fludarabine phosphate|fludarabine phosphate|mesh-list
110322038|NCT00344825|Alemtuzumab|alemtuzumab|mesh-list
110322039|NCT00344825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110322040|NCT00344825|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110322041|NCT00344825|Antimetabolites|antimetabolites|mesh-ancestor
110322042|NCT00344825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110322043|NCT00344825|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110322044|NCT00344825|Immunologic Factors|immunologic factors|mesh-ancestor
110322045|NCT00344825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110322046|NCT00344825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110322047|NCT00448110|Diclofenac|diclofenac|mesh-list
110322048|NCT00448110|Ketorolac|ketorolac|mesh-list
110322049|NCT00448110|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110322050|NCT00448110|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110322051|NCT00448110|Analgesics|analgesics|mesh-ancestor
110322052|NCT00448110|Sensory System Agents|sensory system agents|mesh-ancestor
110322053|NCT00448110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110374641|NCT01135498|Bevacizumab|bevacizumab|mesh-list
110322054|NCT00448110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110322055|NCT00448110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110322056|NCT00448110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110322057|NCT00448110|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110322058|NCT00448110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110322059|NCT00448110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110322060|NCT00448149|Everolimus|everolimus|mesh-list
110322061|NCT00448149|Sorafenib|sorafenib|mesh-list
110322062|NCT00448149|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110322063|NCT00448149|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110322064|NCT00448149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110149654|NCT00008151|Antitubercular Agents|antitubercular agents|mesh-ancestor
110322065|NCT00448149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110322066|NCT00448149|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110322067|NCT00448149|Immunologic Factors|immunologic factors|mesh-ancestor
110322068|NCT00448149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110322069|NCT00448149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110322071|NCT00344942|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110322072|NCT00344942|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110322073|NCT00344942|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110322074|NCT00344942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110322075|NCT00344942|Glucocorticoids|glucocorticoids|mesh-ancestor
110322076|NCT00344942|Hormones|hormones|mesh-ancestor
110170769|NCT00017589|Gemtuzumab|gemtuzumab|mesh-list
110322077|NCT00344942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110322078|NCT00344942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110322079|NCT00344942|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110322081|NCT00344942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110322082|NCT00344942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110322083|NCT00454350|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
110322084|NCT00454350|Vitamins|vitamins|mesh-ancestor
110322085|NCT00454350|Micronutrients|micronutrients|mesh-ancestor
110322086|NCT00454350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110322087|NCT00454350|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110322088|NCT00454389|Ranibizumab|ranibizumab|mesh-list
110322089|NCT00454389|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110322090|NCT00454389|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110322091|NCT00454389|Growth Substances|growth substances|mesh-ancestor
110322092|NCT00454389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110322093|NCT00454389|Growth Inhibitors|growth inhibitors|mesh-ancestor
110322094|NCT00454389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110322095|NCT00344981|Tenofovir|tenofovir|mesh-list
110322096|NCT00344981|Hydroxyurea|hydroxyurea|mesh-list
110322097|NCT00344981|Antiviral Agents|antiviral agents|mesh-ancestor
110322098|NCT00344981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110322099|NCT00344981|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110322100|NCT00344981|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110322101|NCT00344981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110322102|NCT00344981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110322103|NCT00344981|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110322104|NCT00344981|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110322105|NCT00344981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110322106|NCT00344981|Antisickling Agents|antisickling agents|mesh-ancestor
110322107|NCT00448266|Cyclophosphamide|cyclophosphamide|mesh-list
110322108|NCT00448266|Thiotepa|thiotepa|mesh-list
110322109|NCT00448266|Carboplatin|carboplatin|mesh-list
110322110|NCT00448266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110322111|NCT00448266|Immunologic Factors|immunologic factors|mesh-ancestor
110322112|NCT00448266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110322113|NCT00448266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110322114|NCT00448266|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110322115|NCT00448266|Alkylating Agents|alkylating agents|mesh-ancestor
110322116|NCT00448266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110322117|NCT00448266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110322118|NCT00448266|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110322119|NCT00454545|Atorvastatin|atorvastatin|mesh-list
110322120|NCT00454545|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110322121|NCT00454545|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110322122|NCT00454545|Antimetabolites|antimetabolites|mesh-ancestor
110322123|NCT00454545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110322124|NCT00454545|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110322125|NCT00454545|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110322126|NCT00454545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110322127|NCT00345059|Gemcitabine|gemcitabine|mesh-list
110322128|NCT00345059|Capecitabine|capecitabine|mesh-list
110322129|NCT00345059|Docetaxel|docetaxel|mesh-list
110322130|NCT00345059|Vinorelbine|vinorelbine|mesh-list
110322131|NCT00345059|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110322132|NCT00345059|Antimetabolites|antimetabolites|mesh-ancestor
110322133|NCT00345059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110322134|NCT00345059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110322135|NCT00345059|Tubulin Modulators|tubulin modulators|mesh-ancestor
110322136|NCT00345059|Antimitotic Agents|antimitotic agents|mesh-ancestor
110322137|NCT00345059|Mitosis Modulators|mitosis modulators|mesh-ancestor
110322138|NCT00345059|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110322139|NCT00345098|Amibegron|amibegron|mesh-list
110322140|NCT00345098|Amibegron hydrochloride|amibegron hydrochloride|mesh-list
110322141|NCT00345098|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110322142|NCT00345098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110322143|NCT00345098|Adrenergic Agents|adrenergic agents|mesh-ancestor
110322144|NCT00345098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110322145|NCT00345098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110322146|NCT00345098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110322147|NCT00345098|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
110322148|NCT00448305|Paclitaxel|paclitaxel|mesh-list
110322149|NCT00448305|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110322150|NCT00448305|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110322151|NCT00448305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110322152|NCT00448305|Tubulin Modulators|tubulin modulators|mesh-ancestor
110322153|NCT00448305|Antimitotic Agents|antimitotic agents|mesh-ancestor
110322154|NCT00448305|Mitosis Modulators|mitosis modulators|mesh-ancestor
110322155|NCT00448305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110322156|NCT00345137|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
110322157|NCT00345137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110322158|NCT00345137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110322159|NCT00448383|Adalimumab|adalimumab|mesh-list
110322160|NCT00448383|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110322161|NCT00448383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110322162|NCT00448383|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110322163|NCT00448461|Heparin|heparin|mesh-list
110322164|NCT00448461|Bivalirudin|bivalirudin|mesh-list
110322165|NCT00448461|Anticoagulants|anticoagulants|mesh-ancestor
110322166|NCT00448461|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110322167|NCT00448461|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110322168|NCT00448461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110322169|NCT00448461|Antithrombins|antithrombins|mesh-ancestor
110322170|NCT00448461|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110322171|NCT00448461|Protease Inhibitors|protease inhibitors|mesh-ancestor
110322172|NCT00448461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110322173|NCT00454662|Amlodipine|amlodipine|mesh-list
110322174|NCT00454662|Olmesartan|olmesartan|mesh-list
110322175|NCT00454662|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
110322176|NCT00454662|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110322177|NCT00454662|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110322178|NCT00454662|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110322179|NCT00454662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110322180|NCT00454662|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110322181|NCT00454662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110322182|NCT00454662|Vasodilator Agents|vasodilator agents|mesh-ancestor
110322183|NCT00454662|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110322184|NCT00454662|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110322185|NCT00345644|Risedronic Acid|risedronic acid|mesh-list
110322186|NCT00345644|Etidronic Acid|etidronic acid|mesh-list
110322187|NCT00345644|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110322188|NCT00345644|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110322189|NCT00345644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110322190|NCT00345644|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110322191|NCT00345644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110322192|NCT00345644|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110322194|NCT00454701|Dermatologic Agents|dermatologic agents|mesh-ancestor
110322195|NCT00454701|Immunologic Factors|immunologic factors|mesh-ancestor
110322196|NCT00454701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110322197|NCT00345761|Bevacizumab|bevacizumab|mesh-list
110322198|NCT00345761|Capecitabine|capecitabine|mesh-list
110322199|NCT00345761|Oxaliplatin|oxaliplatin|mesh-list
110322200|NCT00345761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110322201|NCT00345761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110322202|NCT00345761|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110322203|NCT00345761|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110322204|NCT00345761|Growth Substances|growth substances|mesh-ancestor
110322205|NCT00345761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110322206|NCT00345761|Growth Inhibitors|growth inhibitors|mesh-ancestor
110149659|NCT00006448|Methadone|methadone|mesh-list
110322207|NCT00345761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110322208|NCT00345761|Antimetabolites|antimetabolites|mesh-ancestor
110322209|NCT00345761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110322210|NCT00345800|Sodium Oxybate|sodium oxybate|mesh-list
110322211|NCT00345800|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110322212|NCT00345800|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110322213|NCT00345800|Anesthetics, General|anesthetics, general|mesh-ancestor
110322214|NCT00345800|Anesthetics|anesthetics|mesh-ancestor
110322215|NCT00345800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110322216|NCT00345800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110322217|NCT00454740|Solifenacin Succinate|solifenacin succinate|mesh-list
110322218|NCT00454740|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110322219|NCT00454740|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110322220|NCT00454740|Cholinergic Agents|cholinergic agents|mesh-ancestor
110322221|NCT00454740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110322222|NCT00454740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110322223|NCT00454740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110322224|NCT00454740|Urological Agents|urological agents|mesh-ancestor
110322225|NCT03276858|Midazolam|midazolam|mesh-list
110322226|NCT03276858|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110322227|NCT03276858|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110322228|NCT03276858|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110322229|NCT03276858|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110322230|NCT03276858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110322231|NCT03276858|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110322232|NCT03276858|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110322233|NCT03276858|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110322234|NCT03276858|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110322235|NCT03276858|Anesthetics, General|anesthetics, general|mesh-ancestor
110322236|NCT03276858|Anesthetics|anesthetics|mesh-ancestor
110322237|NCT03276858|GABA Modulators|gaba modulators|mesh-ancestor
110322238|NCT03276858|GABA Agents|gaba agents|mesh-ancestor
110322239|NCT03276858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110322240|NCT03276858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110322241|NCT00421187|Amphotericin B|amphotericin b|mesh-list
110322242|NCT00421187|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
110322243|NCT00421187|Amebicides|amebicides|mesh-ancestor
110322244|NCT00421187|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110322245|NCT00421187|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110322246|NCT00421187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110322247|NCT00421187|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110322248|NCT00421187|Antifungal Agents|antifungal agents|mesh-ancestor
110322249|NCT00454896|Solifenacin Succinate|solifenacin succinate|mesh-list
110322250|NCT00454896|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110322251|NCT00454896|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110322252|NCT00454896|Cholinergic Agents|cholinergic agents|mesh-ancestor
110322253|NCT00454896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110322254|NCT00454896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110322255|NCT00454896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110322256|NCT00454896|Urological Agents|urological agents|mesh-ancestor
110322257|NCT00346190|Alendronate|alendronate|mesh-list
110322258|NCT00346190|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110322259|NCT00346190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110322260|NCT00346229|Doxorubicin|doxorubicin|mesh-list
110322261|NCT00346229|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110322262|NCT00346229|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110322263|NCT00346229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110322264|NCT00346229|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110322265|NCT00346229|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110322266|NCT00346229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110322267|NCT00346229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110322268|NCT00346385|Lorvotuzumab mertansine|lorvotuzumab mertansine|mesh-list
110322269|NCT00346385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110322270|NCT00346385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110322271|NCT00346385|Immunotoxins|immunotoxins|mesh-ancestor
110322272|NCT00346385|Immunoconjugates|immunoconjugates|mesh-ancestor
110322273|NCT00346385|Immunologic Factors|immunologic factors|mesh-ancestor
110322274|NCT00346385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110322275|NCT00346385|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110322276|NCT00448578|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110322277|NCT00448578|Antidepressive Agents|antidepressive agents|mesh-ancestor
110322278|NCT00448578|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110322280|NCT00448578|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110322281|NCT00448578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110322282|NCT00448578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110322283|NCT00346463|Allopurinol|allopurinol|mesh-list
110322284|NCT00346463|Antimetabolites|antimetabolites|mesh-ancestor
110322285|NCT00346463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110322286|NCT00346463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110322287|NCT00346463|Gout Suppressants|gout suppressants|mesh-ancestor
110322288|NCT00346463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110322289|NCT00346463|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110322290|NCT00346463|Antioxidants|antioxidants|mesh-ancestor
110322291|NCT00346463|Protective Agents|protective agents|mesh-ancestor
110322292|NCT00346463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110322293|NCT00455091|Lamivudine|lamivudine|mesh-list
110322294|NCT00455091|Adefovir|adefovir|mesh-list
110322295|NCT00455091|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
110322296|NCT00455091|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110322297|NCT00455091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110322298|NCT00455091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110322299|NCT00455091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110322300|NCT00455091|Antiviral Agents|antiviral agents|mesh-ancestor
110322301|NCT00455091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110322302|NCT00455091|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110322303|NCT00455091|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110322304|NCT00346580|Nelfinavir|nelfinavir|mesh-list
110322305|NCT00346580|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110322306|NCT00346580|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110322307|NCT00346580|Protease Inhibitors|protease inhibitors|mesh-ancestor
110322308|NCT00346580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110322309|NCT00346580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110322310|NCT00346580|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110322311|NCT00346580|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110322312|NCT00346580|Antiviral Agents|antiviral agents|mesh-ancestor
110322313|NCT00346580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110322314|NCT00346619|Nelfinavir|nelfinavir|mesh-list
110322315|NCT00346619|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110322316|NCT00346619|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110322317|NCT00346619|Protease Inhibitors|protease inhibitors|mesh-ancestor
110322318|NCT00346619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110322319|NCT00346619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110322320|NCT00346619|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110322321|NCT00346619|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110322322|NCT00346619|Antiviral Agents|antiviral agents|mesh-ancestor
110322323|NCT00346619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110322324|NCT02273700|Rivaroxaban|rivaroxaban|mesh-list
110322325|NCT02273700|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110322326|NCT02273700|Antithrombins|antithrombins|mesh-ancestor
110322327|NCT02273700|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110322328|NCT02273700|Protease Inhibitors|protease inhibitors|mesh-ancestor
110322329|NCT02273700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110322330|NCT02273700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110322331|NCT02273700|Anticoagulants|anticoagulants|mesh-ancestor
110322332|NCT02959658|Dimethyl Fumarate|dimethyl fumarate|mesh-list
110322333|NCT02959658|Dermatologic Agents|dermatologic agents|mesh-ancestor
110322334|NCT02959658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110322335|NCT02959658|Immunologic Factors|immunologic factors|mesh-ancestor
110322336|NCT02959658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110322337|NCT04698213|Avelumab|avelumab|mesh-list
110322338|NCT04698213|Axitinib|axitinib|mesh-list
110322339|NCT04698213|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110322340|NCT04698213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110322341|NCT04698213|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110322342|NCT04698213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110322343|NCT04698213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110322344|NCT02273817|Ciclesonide|ciclesonide|mesh-list
110322345|NCT02273817|Glucocorticoids|glucocorticoids|mesh-ancestor
110322346|NCT02273817|Hormones|hormones|mesh-ancestor
110322347|NCT02273817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110322348|NCT02273817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110322349|NCT02273817|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110322350|NCT00346853|Fomepizole|fomepizole|mesh-list
110322351|NCT00346853|Antidotes|antidotes|mesh-ancestor
110322352|NCT00346853|Protective Agents|protective agents|mesh-ancestor
110322353|NCT00346853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110322354|NCT00346853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110322355|NCT00346853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110322356|NCT00346970|Niacin|niacin|mesh-list
110322357|NCT00346970|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110322358|NCT00346970|Antimetabolites|antimetabolites|mesh-ancestor
110322359|NCT00346970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110322360|NCT00346970|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110322361|NCT00346970|Vasodilator Agents|vasodilator agents|mesh-ancestor
110322362|NCT00346970|Vitamin B Complex|vitamin b complex|mesh-ancestor
110322363|NCT00346970|Vitamins|vitamins|mesh-ancestor
110322364|NCT00346970|Micronutrients|micronutrients|mesh-ancestor
110322365|NCT00346970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110322366|NCT00455130|Mannitol|mannitol|mesh-list
110322367|NCT00455130|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110322368|NCT00455130|Diuretics|diuretics|mesh-ancestor
110322369|NCT00455130|Natriuretic Agents|natriuretic agents|mesh-ancestor
110322370|NCT00455130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110322371|NCT00347048|Tacrolimus|tacrolimus|mesh-list
110322372|NCT00347048|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110322373|NCT00347048|Immunologic Factors|immunologic factors|mesh-ancestor
110322374|NCT00347048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110322375|NCT00347048|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110322376|NCT00347048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110322377|NCT00347048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110322378|NCT00347087|Irbesartan|irbesartan|mesh-list
110322379|NCT00347087|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110322380|NCT00347087|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110322381|NCT00347087|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110322382|NCT00347087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110322383|NCT00347165|Bevacizumab|bevacizumab|mesh-list
110322384|NCT00347165|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110322385|NCT00347165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110322386|NCT00347165|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110322387|NCT00347165|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110322388|NCT00347165|Growth Substances|growth substances|mesh-ancestor
110322389|NCT00347165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110322390|NCT00347165|Growth Inhibitors|growth inhibitors|mesh-ancestor
110322391|NCT00347204|Ketorolac|ketorolac|mesh-list
110322392|NCT00347204|Nepafenac|nepafenac|mesh-list
110322393|NCT00347204|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110322394|NCT00347204|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110322395|NCT00347204|Analgesics|analgesics|mesh-ancestor
110322396|NCT00347204|Sensory System Agents|sensory system agents|mesh-ancestor
110322397|NCT00347204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110322398|NCT00347204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110322399|NCT00347204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110322400|NCT00347204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110322401|NCT00347204|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110322402|NCT00347204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110322403|NCT00347204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110322404|NCT00455286|Methylprednisolone|methylprednisolone|mesh-list
110322405|NCT00455286|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110322406|NCT00455286|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110322407|NCT00455286|Prednisolone|prednisolone|mesh-list
110322408|NCT00455286|Prednisolone acetate|prednisolone acetate|mesh-list
110322409|NCT00455286|Methotrexate|methotrexate|mesh-list
110322410|NCT00455286|Temozolomide|temozolomide|mesh-list
110322411|NCT00455286|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110322412|NCT00455286|Prednisolone phosphate|prednisolone phosphate|mesh-list
110322413|NCT00455286|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110322414|NCT00455286|Abortifacient Agents|abortifacient agents|mesh-ancestor
110322415|NCT00455286|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110322416|NCT00455286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110322417|NCT00455286|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110322418|NCT00455286|Antimetabolites|antimetabolites|mesh-ancestor
110322419|NCT00455286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110322420|NCT00455286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110322421|NCT00455286|Dermatologic Agents|dermatologic agents|mesh-ancestor
110322422|NCT00455286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110322423|NCT00455286|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110149669|NCT00008190|Aldesleukin|aldesleukin|mesh-list
110322424|NCT00455286|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110322426|NCT00455286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110322427|NCT00455286|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110322428|NCT00455286|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110322429|NCT00455286|Alkylating Agents|alkylating agents|mesh-ancestor
110322430|NCT00455286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110322431|NCT00455286|Antiemetics|antiemetics|mesh-ancestor
110322432|NCT00455286|Autonomic Agents|autonomic agents|mesh-ancestor
110322433|NCT00455286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110322434|NCT00455286|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110322435|NCT00455286|Glucocorticoids|glucocorticoids|mesh-ancestor
110322436|NCT00455286|Hormones|hormones|mesh-ancestor
110322437|NCT00455286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110322438|NCT00455286|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110322439|NCT00455286|Protective Agents|protective agents|mesh-ancestor
110322440|NCT00455286|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110322441|NCT00455364|Voriconazole|voriconazole|mesh-list
110322442|NCT00455364|Antifungal Agents|antifungal agents|mesh-ancestor
110322443|NCT00455364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110322444|NCT00455364|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110322445|NCT00455364|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110322446|NCT00455364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110322447|NCT00455364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110322448|NCT00455364|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110322449|NCT00455364|Hormone Antagonists|hormone antagonists|mesh-ancestor
110322450|NCT00455364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110322451|NCT00455364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110322452|NCT00455364|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110322453|NCT00347399|Bevacizumab|bevacizumab|mesh-list
110322454|NCT00347399|Verteporfin|verteporfin|mesh-list
110322455|NCT00347399|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110322456|NCT00347399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110322457|NCT00347399|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110322458|NCT00347399|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110322459|NCT00347399|Growth Substances|growth substances|mesh-ancestor
110322460|NCT00347399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110322461|NCT00347399|Growth Inhibitors|growth inhibitors|mesh-ancestor
110322462|NCT00347399|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110322463|NCT00347399|Dermatologic Agents|dermatologic agents|mesh-ancestor
110322464|NCT00455442|Mifepristone|mifepristone|mesh-list
110322465|NCT00455442|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
110322466|NCT00455442|Abortifacient Agents|abortifacient agents|mesh-ancestor
110322467|NCT00455442|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110322468|NCT00455442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110322469|NCT00455442|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110322470|NCT00455442|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110322471|NCT00455442|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110322472|NCT00455442|Contraceptive Agents|contraceptive agents|mesh-ancestor
110322473|NCT00455442|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
110322474|NCT00455442|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
110322475|NCT00455442|Hormone Antagonists|hormone antagonists|mesh-ancestor
110322476|NCT00455442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110322477|NCT00455442|Luteolytic Agents|luteolytic agents|mesh-ancestor
110322478|NCT00455442|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110322479|NCT00455442|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
110322480|NCT00347555|Aluminum phosphate|aluminum phosphate|mesh-list
110322481|NCT00347555|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110322482|NCT00347555|Immunologic Factors|immunologic factors|mesh-ancestor
110322483|NCT00347555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110322484|NCT00347555|Antacids|antacids|mesh-ancestor
110322485|NCT00347555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110322486|NCT00347555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110322487|NCT00455637|Botulinum Toxins|botulinum toxins|mesh-list
110322488|NCT00455637|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110322489|NCT00455637|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110322490|NCT00455637|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110322491|NCT00455637|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110322492|NCT00455637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110322493|NCT00455637|Cholinergic Agents|cholinergic agents|mesh-ancestor
110322494|NCT00455637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110322495|NCT00455637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110322496|NCT00455637|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110322497|NCT00455637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110322498|NCT00347750|Lopinavir|lopinavir|mesh-list
110322499|NCT00347750|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110322500|NCT00347750|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110170789|NCT00042328|Valacyclovir|valacyclovir|mesh-list
110322501|NCT00347750|Protease Inhibitors|protease inhibitors|mesh-ancestor
110322502|NCT00347750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110322503|NCT00347750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110322504|NCT00347750|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110322505|NCT00347750|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110322506|NCT00347750|Antiviral Agents|antiviral agents|mesh-ancestor
110322507|NCT00347750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110322508|NCT00347750|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110322509|NCT00347750|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110322511|NCT00347828|Gatifloxacin|gatifloxacin|mesh-list
110322512|NCT00347828|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110322513|NCT00347828|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110322514|NCT00347828|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110322515|NCT00347828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110322516|NCT00347828|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110322517|NCT00347828|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110322518|NCT00347828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110322519|NCT00347828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110322520|NCT00347828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110322521|NCT00347867|Sildenafil Citrate|sildenafil citrate|mesh-list
110322522|NCT00347867|Vasodilator Agents|vasodilator agents|mesh-ancestor
110322523|NCT00347867|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110322524|NCT00347867|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110322525|NCT00347867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110322526|NCT00347867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110322527|NCT00347867|Urological Agents|urological agents|mesh-ancestor
110322528|NCT00449202|Oleoyl-estrone|oleoyl-estrone|mesh-list
110322529|NCT00449202|Estrone|estrone|mesh-list
110322530|NCT00449202|Estrogens|estrogens|mesh-ancestor
110322531|NCT00449202|Hormones|hormones|mesh-ancestor
110322532|NCT00449202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110322533|NCT00449202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110322534|NCT00449202|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110322535|NCT00455715|Sildenafil Citrate|sildenafil citrate|mesh-list
110322536|NCT00455715|Vasodilator Agents|vasodilator agents|mesh-ancestor
110322537|NCT00455715|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110322538|NCT00455715|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110322539|NCT00455715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110322540|NCT00455715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110322541|NCT00455715|Urological Agents|urological agents|mesh-ancestor
110322542|NCT00455754|Esomeprazole|esomeprazole|mesh-list
110322543|NCT00455754|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110322544|NCT00455754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110322545|NCT00455754|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110322546|NCT00455754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110322547|NCT00455754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110322548|NCT00347984|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110322549|NCT00347984|Lubricant Eye Drops|lubricant eye drops|mesh-list
110322550|NCT00347984|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110322551|NCT00348023|Timolol|timolol|mesh-list
110322552|NCT00348023|Bimatoprost|bimatoprost|mesh-list
110322553|NCT00348023|Travoprost|travoprost|mesh-list
110322554|NCT00348023|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110322555|NCT00348023|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110322556|NCT00348023|Adrenergic Agents|adrenergic agents|mesh-ancestor
110322557|NCT00348023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110322558|NCT00348023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110322559|NCT00348023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110322560|NCT00348023|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110322561|NCT00348023|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110322563|NCT00348062|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110322564|NCT00348101|Enoximone|enoximone|mesh-list
110322565|NCT00348101|Esmolol|esmolol|mesh-list
110322566|NCT00348101|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110322567|NCT00348101|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110322568|NCT00348101|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110322569|NCT00348101|Adrenergic Agents|adrenergic agents|mesh-ancestor
110322570|NCT00348101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110322571|NCT00348101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110322572|NCT00348101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110322573|NCT00348101|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110322574|NCT00348101|Vasodilator Agents|vasodilator agents|mesh-ancestor
110322575|NCT00348101|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110322576|NCT00348101|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110322577|NCT00348101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110322578|NCT00348101|Protective Agents|protective agents|mesh-ancestor
110322580|NCT00455832|Antimetabolites|antimetabolites|mesh-ancestor
110322581|NCT00455832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110322582|NCT00455832|Antiviral Agents|antiviral agents|mesh-ancestor
110322583|NCT00455832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110322584|NCT00455871|Ranibizumab|ranibizumab|mesh-list
110322585|NCT00455871|Verteporfin|verteporfin|mesh-list
110322586|NCT00455871|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110322587|NCT00455871|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110322588|NCT00455871|Growth Substances|growth substances|mesh-ancestor
110322589|NCT00455871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110322590|NCT00455871|Growth Inhibitors|growth inhibitors|mesh-ancestor
110322591|NCT00455871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110322592|NCT00455871|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110322593|NCT00455871|Dermatologic Agents|dermatologic agents|mesh-ancestor
110322594|NCT00449280|Sirolimus|sirolimus|mesh-list
110322595|NCT00449280|Sorafenib|sorafenib|mesh-list
110322596|NCT00449280|Temsirolimus|temsirolimus|mesh-list
110322597|NCT00449280|MTOR Inhibitors|mtor inhibitors|mesh-list
110322598|NCT00449280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110322599|NCT00449280|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110322600|NCT00449280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110322601|NCT00449280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110322602|NCT00449280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110322603|NCT00449280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110322604|NCT00449280|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110322605|NCT00449280|Antifungal Agents|antifungal agents|mesh-ancestor
110322606|NCT00449280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110322607|NCT00449280|Immunologic Factors|immunologic factors|mesh-ancestor
110322608|NCT00449280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110322609|NCT00455910|Thalidomide|thalidomide|mesh-list
110322610|NCT00455910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110322611|NCT00455910|Immunologic Factors|immunologic factors|mesh-ancestor
110322612|NCT00455910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110322613|NCT00455910|Leprostatic Agents|leprostatic agents|mesh-ancestor
110322614|NCT00455910|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110322615|NCT00455910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110322616|NCT00455910|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110322617|NCT00455910|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110322618|NCT00455910|Growth Substances|growth substances|mesh-ancestor
110322619|NCT00455910|Growth Inhibitors|growth inhibitors|mesh-ancestor
110322620|NCT00455910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110322621|NCT00348296|Immunoglobulins|immunoglobulins|mesh-list
110322622|NCT00348296|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110322624|NCT00348296|gamma-Globulins|gamma-globulins|mesh-list
110322625|NCT00348296|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110322626|NCT00348296|Immunologic Factors|immunologic factors|mesh-ancestor
110322627|NCT00348296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110322628|NCT00449319|Daunorubicin|daunorubicin|mesh-list
110322629|NCT00449319|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110322630|NCT00449319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110322631|NCT00449319|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110322632|NCT00449319|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110322633|NCT00449319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110322634|NCT00449319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110322635|NCT00348335|Cyclosporine|cyclosporine|mesh-list
110322636|NCT00348335|Cyclosporins|cyclosporins|mesh-list
110322637|NCT00348335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110322638|NCT00348335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110322639|NCT00348335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110322640|NCT00348335|Immunologic Factors|immunologic factors|mesh-ancestor
110322642|NCT00348335|Antifungal Agents|antifungal agents|mesh-ancestor
110322643|NCT00348335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110322644|NCT00348335|Dermatologic Agents|dermatologic agents|mesh-ancestor
110322645|NCT00348335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110322646|NCT00348335|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110322647|NCT00348413|Methylprednisolone|methylprednisolone|mesh-list
110322648|NCT00348413|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110374656|NCT01135498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110322649|NCT00348413|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110322650|NCT00348413|Prednisolone|prednisolone|mesh-list
110322651|NCT00348413|Prednisolone acetate|prednisolone acetate|mesh-list
110322652|NCT00348413|Methotrexate|methotrexate|mesh-list
110322653|NCT00348413|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110322654|NCT00348413|Prednisolone phosphate|prednisolone phosphate|mesh-list
110322655|NCT00348413|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110322656|NCT00348413|Abortifacient Agents|abortifacient agents|mesh-ancestor
110322657|NCT00348413|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110322658|NCT00348413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110322659|NCT00348413|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110322660|NCT00348413|Antimetabolites|antimetabolites|mesh-ancestor
110322661|NCT00348413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110322662|NCT00348413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110322663|NCT00348413|Dermatologic Agents|dermatologic agents|mesh-ancestor
110322664|NCT00348413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110322665|NCT00348413|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110322666|NCT00348413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110322667|NCT00348413|Immunologic Factors|immunologic factors|mesh-ancestor
110322668|NCT00348413|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110322669|NCT00348413|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110322670|NCT00348413|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110322671|NCT00348413|Antiemetics|antiemetics|mesh-ancestor
110322672|NCT00348413|Autonomic Agents|autonomic agents|mesh-ancestor
110322673|NCT00348413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110322674|NCT00348413|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110322675|NCT00348413|Glucocorticoids|glucocorticoids|mesh-ancestor
110322676|NCT00348413|Hormones|hormones|mesh-ancestor
110322677|NCT00348413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110322678|NCT00348413|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110322679|NCT00348413|Protective Agents|protective agents|mesh-ancestor
110322680|NCT00348413|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110322681|NCT00348452|Celecoxib|celecoxib|mesh-list
110322682|NCT00348452|Tramadol|tramadol|mesh-list
110322683|NCT00348452|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110322684|NCT00348452|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110322685|NCT00348452|Analgesics|analgesics|mesh-ancestor
110322686|NCT00348452|Sensory System Agents|sensory system agents|mesh-ancestor
110322687|NCT00348452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110322688|NCT00348452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110322689|NCT00348452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110322690|NCT00348452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110322691|NCT00348452|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110322692|NCT00348452|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110322693|NCT00348452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110322694|NCT00348452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110322695|NCT00348452|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110322697|NCT00348452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110322698|NCT00449397|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110322699|NCT00449397|Antidepressive Agents|antidepressive agents|mesh-ancestor
110322700|NCT00449397|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110322701|NCT00449397|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110322702|NCT00449397|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110322703|NCT00449397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110322704|NCT00449397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110322705|NCT00348491|Lumiracoxib|lumiracoxib|mesh-list
110322706|NCT00348491|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110322707|NCT00348491|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110322708|NCT00348491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110322709|NCT00348491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110322710|NCT00348491|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110322711|NCT00348491|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110322712|NCT00348491|Analgesics|analgesics|mesh-ancestor
110322713|NCT00348491|Sensory System Agents|sensory system agents|mesh-ancestor
110322714|NCT00348491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110322715|NCT00348491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110322716|NCT00348491|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110322717|NCT00348491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110322719|NCT03274323|Latanoprost|latanoprost|mesh-list
110322720|NCT03274323|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110322721|NCT03274323|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110322722|NCT03274323|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110322723|NCT00348530|Verapamil|verapamil|mesh-list
110322724|NCT00348530|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110322725|NCT00348530|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110322726|NCT00348530|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110322727|NCT00348530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110322728|NCT00348530|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110322729|NCT00348530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110322730|NCT00348530|Vasodilator Agents|vasodilator agents|mesh-ancestor
110322731|NCT00449436|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
110322732|NCT00449436|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
110322733|NCT00449436|Protease Inhibitors|protease inhibitors|mesh-list
110322734|NCT00449436|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110322735|NCT00449436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110322736|NCT00449436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110322737|NCT00449436|Antiviral Agents|antiviral agents|mesh-ancestor
110322738|NCT00449436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110322739|NCT00449436|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110322740|NCT00449436|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110322741|NCT00449436|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110322742|NCT00456027|Aluminum Hydroxide|aluminum hydroxide|mesh-list
110322743|NCT00456027|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110322744|NCT00456027|Immunologic Factors|immunologic factors|mesh-ancestor
110322745|NCT00456027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110322746|NCT00456027|Antacids|antacids|mesh-ancestor
110322747|NCT00456027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110322748|NCT00456027|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110322749|NCT00448734|Docetaxel|docetaxel|mesh-list
110322750|NCT00448734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110322751|NCT00448734|Tubulin Modulators|tubulin modulators|mesh-ancestor
110322752|NCT00448734|Antimitotic Agents|antimitotic agents|mesh-ancestor
110322753|NCT00448734|Mitosis Modulators|mitosis modulators|mesh-ancestor
110322754|NCT00448734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110322755|NCT00348725|Metformin|metformin|mesh-list
110322756|NCT00348725|Fenofibrate|fenofibrate|mesh-list
110322757|NCT00348725|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110322758|NCT00348725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110322759|NCT00348725|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110322760|NCT00348725|Antimetabolites|antimetabolites|mesh-ancestor
110322761|NCT00348725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110322762|NCT00348725|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110322763|NCT00348764|Polidocanol|polidocanol|mesh-list
110322764|NCT00348764|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
110322765|NCT00348764|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110322766|NCT03276156|Apatinib|apatinib|mesh-list
110322767|NCT03276156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110322768|NCT03276156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110322769|NCT03276156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110322770|NCT03276156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110322771|NCT00456144|Hormones|hormones|mesh-list
110322772|NCT00456144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110322773|NCT00456144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110322774|NCT00348920|Bupivacaine|bupivacaine|mesh-list
110322775|NCT00348920|Anesthetics, Local|anesthetics, local|mesh-ancestor
110322776|NCT00348920|Anesthetics|anesthetics|mesh-ancestor
110149687|NCT00008190|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110322777|NCT00348920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110322778|NCT00348920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110322779|NCT00348920|Sensory System Agents|sensory system agents|mesh-ancestor
110322780|NCT00348920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110322782|NCT00449514|Clomiphene|clomiphene|mesh-list
110322783|NCT00449514|Enclomiphene|enclomiphene|mesh-list
110322784|NCT00449514|Zuclomiphene|zuclomiphene|mesh-list
110322785|NCT00449514|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110322786|NCT00449514|Hormone Antagonists|hormone antagonists|mesh-ancestor
110322787|NCT00449514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110322788|NCT00449514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110322790|NCT00449514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110322791|NCT00449514|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110322792|NCT00449514|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110322793|NCT00449514|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110322794|NCT00449514|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110322795|NCT00449514|Fertility Agents|fertility agents|mesh-ancestor
110322796|NCT00449514|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110322797|NCT00348998|Bevacizumab|bevacizumab|mesh-list
110322798|NCT00348998|Goserelin|goserelin|mesh-list
110322799|NCT00348998|Bicalutamide|bicalutamide|mesh-list
110322800|NCT00348998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110322801|NCT00348998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110322802|NCT00348998|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110322803|NCT00348998|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110322804|NCT00348998|Growth Substances|growth substances|mesh-ancestor
110322805|NCT00348998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110322806|NCT00348998|Growth Inhibitors|growth inhibitors|mesh-ancestor
110322807|NCT00348998|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110322808|NCT00348998|Androgen Antagonists|androgen antagonists|mesh-ancestor
110322809|NCT00348998|Hormone Antagonists|hormone antagonists|mesh-ancestor
110322810|NCT00348998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110322811|NCT00449553|Metformin|metformin|mesh-list
110322812|NCT00449553|Pioglitazone|pioglitazone|mesh-list
110322813|NCT00449553|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110322814|NCT00449553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110322815|NCT00349076|Oxaliplatin|oxaliplatin|mesh-list
110322816|NCT00349076|Fluorouracil|fluorouracil|mesh-list
110322817|NCT00349076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110322818|NCT00349076|Antimetabolites|antimetabolites|mesh-ancestor
110322819|NCT00349076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110322820|NCT00349076|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110322821|NCT00349076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110322822|NCT00349076|Immunologic Factors|immunologic factors|mesh-ancestor
110322823|NCT00349076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110322824|NCT00349115|Thalidomide|thalidomide|mesh-list
110322825|NCT00349115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110322826|NCT00349115|Immunologic Factors|immunologic factors|mesh-ancestor
110322827|NCT00349115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110322828|NCT00349115|Leprostatic Agents|leprostatic agents|mesh-ancestor
110322829|NCT00349115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110322830|NCT00349115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110322831|NCT00349115|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110322832|NCT00349115|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110322833|NCT00349115|Growth Substances|growth substances|mesh-ancestor
110322834|NCT00349115|Growth Inhibitors|growth inhibitors|mesh-ancestor
110322835|NCT00349115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110322836|NCT00456339|Amoxicillin|amoxicillin|mesh-list
110322837|NCT00456339|Clavulanic Acid|clavulanic acid|mesh-list
110322838|NCT00456339|Clavulanic Acids|clavulanic acids|mesh-list
110322839|NCT00456339|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
110322840|NCT00456339|Prednisolone|prednisolone|mesh-list
110322841|NCT00456339|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110322842|NCT00456339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110322843|NCT00456339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110322846|NCT00456339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110322847|NCT00456339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110149691|NCT00006451|Cyclosporine|cyclosporine|mesh-list
110322848|NCT00456339|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110322849|NCT00456339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110322850|NCT00456339|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110322851|NCT00456339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110322852|NCT00456339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110322853|NCT00421421|Dutasteride|dutasteride|mesh-list
110322854|NCT00421421|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
110322855|NCT00421421|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110322856|NCT00421421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110322857|NCT00421421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110322858|NCT00421421|Hormone Antagonists|hormone antagonists|mesh-ancestor
110322859|NCT00421421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110322860|NCT00421421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110322861|NCT00421460|Methyltestosterone|methyltestosterone|mesh-list
110322862|NCT00421460|Testosterone|testosterone|mesh-list
110322863|NCT00421460|Testosterone undecanoate|testosterone undecanoate|mesh-list
110322864|NCT00421460|Testosterone enanthate|testosterone enanthate|mesh-list
110322865|NCT00421460|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
110322866|NCT00421460|Androgens|androgens|mesh-ancestor
110322867|NCT00421460|Hormones|hormones|mesh-ancestor
110322868|NCT00421460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110322869|NCT00421460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110322870|NCT00421460|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110322871|NCT00421460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110322872|NCT00421460|Anabolic Agents|anabolic agents|mesh-ancestor
110322873|NCT00349310|Pramipexole|pramipexole|mesh-list
110322874|NCT00349310|Antioxidants|antioxidants|mesh-ancestor
110322875|NCT00349310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110322876|NCT00349310|Protective Agents|protective agents|mesh-ancestor
110322877|NCT00349310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110322878|NCT00349310|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110322879|NCT00349310|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110322880|NCT00349310|Dopamine Agonists|dopamine agonists|mesh-ancestor
110322881|NCT00349310|Dopamine Agents|dopamine agents|mesh-ancestor
110322882|NCT00349310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110322884|NCT03274167|Analgesics|analgesics|mesh-ancestor
110322885|NCT03274167|Sensory System Agents|sensory system agents|mesh-ancestor
110322886|NCT03274167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110322887|NCT03274167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110322888|NCT03274167|Anticonvulsants|anticonvulsants|mesh-ancestor
110322889|NCT03274167|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110322890|NCT03274167|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110322891|NCT03274167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110322892|NCT03274167|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110322893|NCT03274167|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110322894|NCT03274167|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110322895|NCT03274167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110322896|NCT03274167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110322897|NCT03274167|Antimanic Agents|antimanic agents|mesh-ancestor
110322898|NCT00349427|Rosiglitazone|rosiglitazone|mesh-list
110322899|NCT00349427|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110322900|NCT00349427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110322901|NCT00349583|Cyclosporine|cyclosporine|mesh-list
110322902|NCT00349583|Cyclosporins|cyclosporins|mesh-list
110322903|NCT00349583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110322904|NCT00349583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110322905|NCT00349583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110322906|NCT00349583|Immunologic Factors|immunologic factors|mesh-ancestor
110322907|NCT00349583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110322908|NCT00349583|Antifungal Agents|antifungal agents|mesh-ancestor
110322909|NCT00349583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110322910|NCT00349583|Dermatologic Agents|dermatologic agents|mesh-ancestor
110322911|NCT00349583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110322912|NCT00349583|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110322913|NCT00349739|Anecortave|anecortave|mesh-list
110322914|NCT00349739|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110322915|NCT00349739|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110322916|NCT00349739|Growth Substances|growth substances|mesh-ancestor
110322917|NCT00349739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110322918|NCT00349739|Growth Inhibitors|growth inhibitors|mesh-ancestor
110322919|NCT00349739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110322920|NCT00456729|Metronidazole|metronidazole|mesh-list
110322921|NCT00456729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110322922|NCT00456729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110322923|NCT00456729|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110322924|NCT00456729|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110322925|NCT00450099|Bupivacaine|bupivacaine|mesh-list
110322926|NCT00450099|Anesthetics, Local|anesthetics, local|mesh-ancestor
110322927|NCT00450099|Anesthetics|anesthetics|mesh-ancestor
110322928|NCT00450099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110322929|NCT00450099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110322930|NCT00450099|Sensory System Agents|sensory system agents|mesh-ancestor
110322931|NCT00450099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110322932|NCT00450138|Cisplatin|cisplatin|mesh-list
110322933|NCT00450138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110322934|NCT00350051|Prednisone|prednisone|mesh-list
110322935|NCT00350051|Sagopilone|sagopilone|mesh-list
110322936|NCT00350051|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110322937|NCT00350051|Glucocorticoids|glucocorticoids|mesh-ancestor
110322938|NCT00350051|Hormones|hormones|mesh-ancestor
110322939|NCT00350051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110322940|NCT00350051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110322941|NCT00350051|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110322942|NCT00350051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110322943|NCT00350090|Epoetin Alfa|epoetin alfa|mesh-list
110322944|NCT00350090|Hematinics|hematinics|mesh-ancestor
110322945|NCT04699110|Adenosine|adenosine|mesh-list
110322946|NCT04699110|Epinephrine|epinephrine|mesh-list
110322947|NCT04699110|Racepinephrine|racepinephrine|mesh-list
110322948|NCT04699110|Epinephryl borate|epinephryl borate|mesh-list
110322949|NCT04699110|Analgesics|analgesics|mesh-ancestor
110322950|NCT04699110|Sensory System Agents|sensory system agents|mesh-ancestor
110322951|NCT04699110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110322952|NCT04699110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110322953|NCT04699110|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110322954|NCT04699110|Vasodilator Agents|vasodilator agents|mesh-ancestor
110322955|NCT04699110|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
110322957|NCT04699110|Purinergic Agents|purinergic agents|mesh-ancestor
110322958|NCT04699110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110322959|NCT04699110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110322960|NCT04699110|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110322961|NCT04699110|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110322962|NCT04699110|Adrenergic Agents|adrenergic agents|mesh-ancestor
110322963|NCT04699110|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110322964|NCT04699110|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110322965|NCT04699110|Autonomic Agents|autonomic agents|mesh-ancestor
110322966|NCT04699110|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110322967|NCT04699110|Respiratory System Agents|respiratory system agents|mesh-ancestor
110322968|NCT04699110|Mydriatics|mydriatics|mesh-ancestor
110322969|NCT04699110|Sympathomimetics|sympathomimetics|mesh-ancestor
110322970|NCT04699110|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110322971|NCT00350168|Amlodipine|amlodipine|mesh-list
110322972|NCT00350168|Valsartan|valsartan|mesh-list
110322973|NCT00350168|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110322974|NCT00350168|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110322975|NCT00350168|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110322976|NCT00350168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110322977|NCT00350168|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110322978|NCT00350168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110322979|NCT00350168|Vasodilator Agents|vasodilator agents|mesh-ancestor
110322980|NCT00350168|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110322981|NCT00350168|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110322982|NCT00105534|Azithromycin|azithromycin|mesh-list
110322983|NCT00105534|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110322984|NCT00105534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110170826|NCT00017628|Prednisolone|prednisolone|mesh-list
110322985|NCT00350441|Sildenafil Citrate|sildenafil citrate|mesh-list
110322986|NCT00350441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110322987|NCT00350441|Vasodilator Agents|vasodilator agents|mesh-ancestor
110322988|NCT00350441|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110322989|NCT00350441|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110322990|NCT00350441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110322991|NCT00350441|Urological Agents|urological agents|mesh-ancestor
110322992|NCT00350480|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
110322993|NCT00350480|Contraceptives, Oral|contraceptives, oral|mesh-list
110322994|NCT00350480|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
110322995|NCT00350480|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110322996|NCT00350480|Contraceptive Agents|contraceptive agents|mesh-ancestor
110322997|NCT00350480|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110322998|NCT00350480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110322999|NCT00350480|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110323000|NCT00350480|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110323001|NCT00350480|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110323002|NCT00350480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110323003|NCT00456963|Losartan|losartan|mesh-list
110323004|NCT00456963|Enalapril|enalapril|mesh-list
110323005|NCT00456963|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110323006|NCT00456963|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110323007|NCT00456963|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110323008|NCT00456963|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110323009|NCT00456963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110323010|NCT00456963|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110323011|NCT00456963|Protease Inhibitors|protease inhibitors|mesh-ancestor
110323012|NCT00456963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110323013|NCT00350597|Molgramostim|molgramostim|mesh-list
110323014|NCT00350597|Sargramostim|sargramostim|mesh-list
110323015|NCT00350597|Immunologic Factors|immunologic factors|mesh-ancestor
110323016|NCT00350597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110323017|NCT00350597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110323018|NCT00350753|Bevacizumab|bevacizumab|mesh-list
110323019|NCT00350753|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110323020|NCT00350753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110323021|NCT00350753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110323022|NCT00350753|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110323023|NCT00350753|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110323024|NCT00350753|Growth Substances|growth substances|mesh-ancestor
110021847|NCT00002748|Vaccines|vaccines|mesh-list
110323025|NCT00350753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110323026|NCT00350753|Growth Inhibitors|growth inhibitors|mesh-ancestor
110323027|NCT00350753|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110323028|NCT00350753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110323029|NCT00350753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110323030|NCT00457119|Everolimus|everolimus|mesh-list
110323031|NCT00457119|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110323032|NCT00457119|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110323033|NCT00457119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110323034|NCT00457119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110323035|NCT00457119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110323036|NCT00457119|Immunologic Factors|immunologic factors|mesh-ancestor
110323037|NCT00457119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110323038|NCT00457119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110323039|NCT00350948|Doxorubicin|doxorubicin|mesh-list
110323040|NCT00350948|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110323041|NCT00350948|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110323042|NCT00350948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110323043|NCT00350948|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110323044|NCT00350948|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110323045|NCT00350948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110323046|NCT00350948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110323047|NCT00450567|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110323048|NCT00450567|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110323049|NCT00450567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110323050|NCT00421538|Nadroparin|nadroparin|mesh-list
110323051|NCT00421538|Calcium|calcium|mesh-list
110323052|NCT00421538|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110323053|NCT00421538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110323054|NCT00421538|Anticoagulants|anticoagulants|mesh-ancestor
110323055|NCT00421538|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110323056|NCT00421538|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110323057|NCT00421538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110323059|NCT00351026|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110323060|NCT00351026|Narcotics|narcotics|mesh-ancestor
110323061|NCT00351026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110323062|NCT00351026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110323063|NCT00351026|Analgesics|analgesics|mesh-ancestor
110323064|NCT00351026|Sensory System Agents|sensory system agents|mesh-ancestor
110323065|NCT00351026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110323066|NCT00351026|Antitussive Agents|antitussive agents|mesh-ancestor
110323067|NCT00351026|Respiratory System Agents|respiratory system agents|mesh-ancestor
110323068|NCT00351104|Ketoprofen|ketoprofen|mesh-list
110323069|NCT00351104|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110323070|NCT00351104|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110323071|NCT00351104|Analgesics|analgesics|mesh-ancestor
110323072|NCT00351104|Sensory System Agents|sensory system agents|mesh-ancestor
110323073|NCT00351104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110323074|NCT00351104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110323075|NCT00351104|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110323076|NCT00351104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110323077|NCT00351104|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110323078|NCT00351104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110323079|NCT00351104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110323080|NCT00351143|Fluticasone|fluticasone|mesh-list
110323082|NCT00351143|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110323083|NCT00351143|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110323084|NCT00351143|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110323085|NCT00351143|Autonomic Agents|autonomic agents|mesh-ancestor
110323086|NCT00351143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110323087|NCT00351143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110323088|NCT00351143|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110323089|NCT00351143|Respiratory System Agents|respiratory system agents|mesh-ancestor
110323090|NCT00351143|Dermatologic Agents|dermatologic agents|mesh-ancestor
110323091|NCT00351143|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110323092|NCT00351143|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110323093|NCT00351143|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110323094|NCT00351143|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110323095|NCT00351143|Adrenergic Agents|adrenergic agents|mesh-ancestor
110323096|NCT00351143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110323097|NCT00351143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110323098|NCT00457470|Rucaparib|rucaparib|mesh-list
110323099|NCT00457470|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110323100|NCT00457470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110323101|NCT00457470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110323102|NCT00457470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110323103|NCT00457509|Vaccines|vaccines|mesh-list
110323104|NCT00457509|Immunologic Factors|immunologic factors|mesh-ancestor
110323105|NCT00457509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110323106|NCT00450645|Heparin|heparin|mesh-list
110323107|NCT00450645|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
110323108|NCT00450645|Tinzaparin|tinzaparin|mesh-list
110323109|NCT00450645|Dalteparin|dalteparin|mesh-list
110323110|NCT00450645|Anticoagulants|anticoagulants|mesh-ancestor
110323111|NCT00450645|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110323112|NCT00450645|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110323113|NCT00450645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110323114|NCT00351182|Doxycycline|doxycycline|mesh-list
110323115|NCT00351182|Telithromycin|telithromycin|mesh-list
110323116|NCT00351182|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110323117|NCT00351182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110323118|NCT00351182|Antimalarials|antimalarials|mesh-ancestor
110323119|NCT00351182|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110323120|NCT00351182|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110323121|NCT00457860|Immunotoxin HA22|immunotoxin ha22|mesh-list
110323122|NCT00457860|Immunotoxins|immunotoxins|mesh-list
110323123|NCT00457860|Immunoconjugates|immunoconjugates|mesh-ancestor
110323124|NCT00457860|Immunologic Factors|immunologic factors|mesh-ancestor
110323125|NCT00457860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110323126|NCT00457860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110323127|NCT00457899|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110323128|NCT00457899|Antidepressive Agents|antidepressive agents|mesh-ancestor
110323129|NCT00457899|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110323130|NCT00457899|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110323131|NCT00457899|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110323132|NCT00457899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110323133|NCT00457899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110323134|NCT00351884|Vildagliptin|vildagliptin|mesh-list
110323135|NCT00351884|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110323136|NCT00351884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110323137|NCT00351884|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110323138|NCT00351884|Protease Inhibitors|protease inhibitors|mesh-ancestor
110323139|NCT00351884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110323140|NCT00351884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110323141|NCT00458055|Niacin|niacin|mesh-list
110323142|NCT00458055|Atorvastatin|atorvastatin|mesh-list
110323143|NCT00458055|Fenofibrate|fenofibrate|mesh-list
110323144|NCT00458055|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110323145|NCT00458055|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110323146|NCT00458055|Antimetabolites|antimetabolites|mesh-ancestor
110323147|NCT00458055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110323148|NCT00458055|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110323149|NCT00458055|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110323150|NCT00458055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110323151|NCT00458055|Vasodilator Agents|vasodilator agents|mesh-ancestor
110323152|NCT00458055|Vitamin B Complex|vitamin b complex|mesh-ancestor
110323153|NCT00458055|Vitamins|vitamins|mesh-ancestor
110323154|NCT00458055|Micronutrients|micronutrients|mesh-ancestor
110323155|NCT00458055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110323156|NCT00450762|Carboplatin|carboplatin|mesh-list
110323157|NCT00450762|Gemcitabine|gemcitabine|mesh-list
110323159|NCT00450762|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110323160|NCT00450762|Antimetabolites|antimetabolites|mesh-ancestor
110323161|NCT00450762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110323162|NCT00450840|Simvastatin|simvastatin|mesh-list
110323163|NCT00450840|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110323164|NCT00450840|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110323165|NCT00450840|Antimetabolites|antimetabolites|mesh-ancestor
110323166|NCT00450840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110323167|NCT00450840|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110323168|NCT00450840|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110323169|NCT00450840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110323170|NCT00352196|Risperidone|risperidone|mesh-list
110323171|NCT00352196|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110323172|NCT00352196|Serotonin Agents|serotonin agents|mesh-ancestor
110323173|NCT00352196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110323174|NCT00352196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110323175|NCT00352196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110323176|NCT00352196|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110323177|NCT00352196|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110323178|NCT00352196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110323179|NCT00352196|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110323180|NCT00352196|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110323181|NCT00352196|Dopamine Agents|dopamine agents|mesh-ancestor
110323182|NCT00352235|KRN 7000|krn 7000|mesh-list
110323183|NCT00352235|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110323184|NCT00352235|Immunologic Factors|immunologic factors|mesh-ancestor
110323185|NCT00352235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110323186|NCT00352235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110323187|NCT00352313|Carboplatin|carboplatin|mesh-list
110323188|NCT00352313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110323189|NCT00450957|Lycopene|lycopene|mesh-list
110323190|NCT00450957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110323191|NCT00450957|Antioxidants|antioxidants|mesh-ancestor
110323192|NCT00450957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110323193|NCT00450957|Protective Agents|protective agents|mesh-ancestor
110323194|NCT00450957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110323195|NCT00450957|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110323196|NCT00450957|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110323197|NCT00450957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110323199|NCT00352430|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110323201|NCT00352430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110323202|NCT00352430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110323203|NCT00352430|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110323204|NCT00352430|Respiratory System Agents|respiratory system agents|mesh-ancestor
110323205|NCT00352430|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110323206|NCT00352430|Antioxidants|antioxidants|mesh-ancestor
110323207|NCT00352430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110323208|NCT00352430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110323209|NCT00352430|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
110323210|NCT00352430|Vasodilator Agents|vasodilator agents|mesh-ancestor
110323211|NCT00352430|Gasotransmitters|gasotransmitters|mesh-ancestor
110323212|NCT00352430|Protective Agents|protective agents|mesh-ancestor
110323213|NCT00352469|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110323214|NCT00352469|Antidepressive Agents|antidepressive agents|mesh-ancestor
110323215|NCT00352469|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110323216|NCT00352469|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110323217|NCT00352469|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110323218|NCT00352469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110323219|NCT00352469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110323220|NCT00451074|Gentamicins|gentamicins|mesh-list
110323221|NCT00451074|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110323222|NCT00451074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110323223|NCT00451074|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110323224|NCT00451074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110323225|NCT00451074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110323226|NCT00465621|Latanoprost|latanoprost|mesh-list
110323227|NCT00465621|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110323228|NCT00465621|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110323229|NCT00352625|Ketoprofen|ketoprofen|mesh-list
110323230|NCT00352625|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110323231|NCT00352625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110323232|NCT00352625|Analgesics|analgesics|mesh-ancestor
110323233|NCT00352625|Sensory System Agents|sensory system agents|mesh-ancestor
110323234|NCT00352625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110323235|NCT00352625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110323237|NCT00352625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110323238|NCT00352625|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110323239|NCT00352625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110323240|NCT00352625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110323241|NCT00352742|Bortezomib|bortezomib|mesh-list
110323242|NCT00352742|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
110323243|NCT00352742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110323244|NCT00352742|Chelating Agents|chelating agents|mesh-ancestor
110323245|NCT00352742|Sequestering Agents|sequestering agents|mesh-ancestor
110323246|NCT00352742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110323247|NCT00352742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110323248|NCT00352742|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110323249|NCT00352742|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110149724|NCT00006451|Hormones|hormones|mesh-ancestor
110323250|NCT00352742|Growth Substances|growth substances|mesh-ancestor
110323251|NCT00352742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110323252|NCT00352742|Growth Inhibitors|growth inhibitors|mesh-ancestor
110323254|NCT00352859|Gemcitabine|gemcitabine|mesh-list
110323255|NCT00352859|Sorafenib|sorafenib|mesh-list
110323256|NCT00352859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110323257|NCT00352859|Antimetabolites|antimetabolites|mesh-ancestor
110323258|NCT00352859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110323259|NCT00352859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110323260|NCT00352859|Antiviral Agents|antiviral agents|mesh-ancestor
110323261|NCT00352859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110323262|NCT00352859|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110323263|NCT00352859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110323264|NCT00105183|Immunoglobulins|immunoglobulins|mesh-list
110323265|NCT00105183|Antibodies|antibodies|mesh-list
110323266|NCT00105183|gamma-Globulins|gamma-globulins|mesh-list
110323267|NCT00105183|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110323268|NCT00105183|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110323269|NCT00105183|Immunoglobulin G|immunoglobulin g|mesh-list
110323270|NCT00105183|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110323271|NCT00105183|Immunologic Factors|immunologic factors|mesh-ancestor
110323272|NCT00105183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110323273|NCT00105183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110323274|NCT00466089|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110323275|NCT00466089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110323276|NCT00466089|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110323277|NCT00466089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110323278|NCT00466089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110323279|NCT00466128|Indomethacin|indomethacin|mesh-list
110323280|NCT00466128|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110323281|NCT00466128|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110323282|NCT00466128|Analgesics|analgesics|mesh-ancestor
110323283|NCT00466128|Sensory System Agents|sensory system agents|mesh-ancestor
110323284|NCT00466128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110323285|NCT00466128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110323286|NCT00466128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110323287|NCT00466128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110323288|NCT00466128|Gout Suppressants|gout suppressants|mesh-ancestor
110323289|NCT00466128|Tocolytic Agents|tocolytic agents|mesh-ancestor
110323290|NCT00466128|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110323291|NCT00466128|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110323292|NCT00466128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110323293|NCT00466128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110323294|NCT00353015|Cisplatin|cisplatin|mesh-list
110323295|NCT00353015|Irinotecan|irinotecan|mesh-list
110323296|NCT00353015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110323297|NCT00353015|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110323298|NCT00353015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110323299|NCT00353015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110323300|NCT00353015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110323301|NCT00466284|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110323302|NCT00466284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110323303|NCT00466284|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110323304|NCT00466284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110323305|NCT00466284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110323306|NCT00353054|Calcium Carbonate|calcium carbonate|mesh-list
110323307|NCT00353054|Antacids|antacids|mesh-ancestor
110323308|NCT00353054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110323309|NCT00353054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110323310|NCT00466401|Simvastatin|simvastatin|mesh-list
110323311|NCT00466401|Ezetimibe|ezetimibe|mesh-list
110323312|NCT00466401|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110323313|NCT00466401|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110323314|NCT00466401|Antimetabolites|antimetabolites|mesh-ancestor
110323315|NCT00466401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110323316|NCT00466401|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110323317|NCT00466401|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110323318|NCT00466401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110323319|NCT00466479|Brimonidine Tartrate|brimonidine tartrate|mesh-list
110323320|NCT00466479|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110374739|NCT00195273|Cyclosporine|cyclosporine|mesh-list
110323321|NCT00466479|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110323322|NCT00466479|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110323323|NCT00466479|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110323324|NCT00466479|Adrenergic Agents|adrenergic agents|mesh-ancestor
110323325|NCT00466479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110170851|NCT00042562|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110323326|NCT00466479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110323327|NCT00466479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110323328|NCT00466518|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110323329|NCT00466518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110323330|NCT00466518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110323331|NCT00466518|Incretins|incretins|mesh-ancestor
110323332|NCT00466518|Hormones|hormones|mesh-ancestor
110323333|NCT00466518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110323334|NCT00466518|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110323335|NCT00466518|Protease Inhibitors|protease inhibitors|mesh-ancestor
110323336|NCT00466518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110323337|NCT00466518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110323338|NCT00353561|Fluconazole|fluconazole|mesh-list
110323339|NCT00353561|Antifungal Agents|antifungal agents|mesh-ancestor
110323340|NCT00353561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110323341|NCT00353561|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110323342|NCT00353561|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110323343|NCT00353561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110323344|NCT00353561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110323345|NCT00353561|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110323346|NCT00353561|Hormone Antagonists|hormone antagonists|mesh-ancestor
110323347|NCT00353561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110323348|NCT00353561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110323349|NCT00353561|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110323350|NCT00353561|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110323351|NCT00466596|Vitamins|vitamins|mesh-list
110323352|NCT00466596|Vitamin E|vitamin e|mesh-list
110323353|NCT00466596|Tocopherols|tocopherols|mesh-list
110323354|NCT00466596|Tocotrienols|tocotrienols|mesh-list
110323355|NCT00466596|alpha-Tocopherol|alpha-tocopherol|mesh-list
110323356|NCT00466596|gamma-Tocopherol|gamma-tocopherol|mesh-list
110323357|NCT00466596|Micronutrients|micronutrients|mesh-ancestor
110323358|NCT00466596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110323359|NCT00466596|Antioxidants|antioxidants|mesh-ancestor
110323360|NCT00466596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110323361|NCT00466596|Protective Agents|protective agents|mesh-ancestor
110323363|NCT00353678|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110323364|NCT00353678|Antithrombins|antithrombins|mesh-ancestor
110323365|NCT00353678|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110323366|NCT00353678|Protease Inhibitors|protease inhibitors|mesh-ancestor
110323367|NCT00353678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110323368|NCT00353678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110323369|NCT00353678|Anticoagulants|anticoagulants|mesh-ancestor
110323370|NCT00458250|Cyclosporine|cyclosporine|mesh-list
110323371|NCT00458250|Cyclophosphamide|cyclophosphamide|mesh-list
110323372|NCT00458250|Busulfan|busulfan|mesh-list
110323373|NCT00458250|Methotrexate|methotrexate|mesh-list
110323374|NCT00458250|Alemtuzumab|alemtuzumab|mesh-list
110323375|NCT00458250|Cyclosporins|cyclosporins|mesh-list
110323376|NCT00458250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110323377|NCT00458250|Immunologic Factors|immunologic factors|mesh-ancestor
110323378|NCT00458250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110323379|NCT00458250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110323380|NCT00458250|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110323381|NCT00458250|Alkylating Agents|alkylating agents|mesh-ancestor
110323382|NCT00458250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110323383|NCT00458250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110323384|NCT00458250|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110323385|NCT00458250|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110323386|NCT00458250|Abortifacient Agents|abortifacient agents|mesh-ancestor
110323387|NCT00458250|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110323388|NCT00458250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110323389|NCT00458250|Antimetabolites|antimetabolites|mesh-ancestor
110323390|NCT00458250|Dermatologic Agents|dermatologic agents|mesh-ancestor
110323391|NCT00458250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110323392|NCT00458250|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110323393|NCT00458250|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110323394|NCT00458250|Antifungal Agents|antifungal agents|mesh-ancestor
110323395|NCT00458250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110323396|NCT00458250|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110323397|NCT00458250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110323399|NCT00353717|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110323400|NCT00353717|Cetuximab|cetuximab|mesh-list
110323401|NCT00353717|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110323402|NCT00353717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110323403|NCT00353717|Tubulin Modulators|tubulin modulators|mesh-ancestor
110323404|NCT00353717|Antimitotic Agents|antimitotic agents|mesh-ancestor
110323405|NCT00353717|Mitosis Modulators|mitosis modulators|mesh-ancestor
110323406|NCT00353717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110323407|NCT00353717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110323408|NCT00466713|Rosiglitazone|rosiglitazone|mesh-list
110323409|NCT00466713|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110323410|NCT00466713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110323411|NCT00466791|Methylphenidate|methylphenidate|mesh-list
110323412|NCT00466791|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110323413|NCT00466791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110323414|NCT00466791|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110323415|NCT00466791|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110323416|NCT00466791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110323417|NCT00466791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110323418|NCT00466791|Dopamine Agents|dopamine agents|mesh-ancestor
110323419|NCT00466791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110323420|NCT00353912|Amlodipine|amlodipine|mesh-list
110323421|NCT00353912|Valsartan|valsartan|mesh-list
110323422|NCT00353912|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110323423|NCT00353912|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110323424|NCT00353912|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110323425|NCT00353912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110323426|NCT00353912|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110323427|NCT00353912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110323428|NCT00353912|Vasodilator Agents|vasodilator agents|mesh-ancestor
110323429|NCT00353912|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110323430|NCT00353912|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110323432|NCT00353990|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110323433|NCT00353990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110323434|NCT00458328|Z 338|z 338|mesh-list
110323435|NCT00458328|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110323436|NCT00458328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110323437|NCT00458328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110323438|NCT00458328|Cholinergic Agents|cholinergic agents|mesh-ancestor
110323439|NCT00458328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110323440|NCT00458328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110323441|NCT00458328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110323442|NCT00354068|Temozolomide|temozolomide|mesh-list
110323443|NCT00354068|Imatinib Mesylate|imatinib mesylate|mesh-list
110323444|NCT00354068|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110323445|NCT00354068|Alkylating Agents|alkylating agents|mesh-ancestor
110323446|NCT00354068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110323447|NCT00354068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110323449|NCT00354068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110323450|NCT00466869|Betahistine|betahistine|mesh-list
110323451|NCT00466869|Vasodilator Agents|vasodilator agents|mesh-ancestor
110323452|NCT00466869|Histamine Agonists|histamine agonists|mesh-ancestor
110323453|NCT00466869|Histamine Agents|histamine agents|mesh-ancestor
110323454|NCT00466869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110323455|NCT00466869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110323456|NCT00466869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110323457|NCT00354146|Tipifarnib|tipifarnib|mesh-list
110323458|NCT00354146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110323459|NCT00458367|Risperidone|risperidone|mesh-list
110323460|NCT00458367|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110323461|NCT00458367|Serotonin Agents|serotonin agents|mesh-ancestor
110323462|NCT00458367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110323463|NCT00458367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110323464|NCT00458367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110323465|NCT00458367|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110323466|NCT00458367|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110170865|NCT00001487|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110323467|NCT00458367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110323468|NCT00458367|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110323469|NCT00458367|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110323472|NCT00354185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110323473|NCT00354185|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110323474|NCT00354185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110323475|NCT00354185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110323476|NCT00466986|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110323477|NCT00466986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110323478|NCT00354302|Calcium, Dietary|calcium, dietary|mesh-list
110323479|NCT00354302|Cholecalciferol|cholecalciferol|mesh-list
110323480|NCT00354302|Alendronate|alendronate|mesh-list
110323481|NCT00354302|Risedronic Acid|risedronic acid|mesh-list
110323482|NCT00354302|Calcium Carbonate|calcium carbonate|mesh-list
110323483|NCT00354302|Calcium|calcium|mesh-list
110323484|NCT00354302|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110323485|NCT00354302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110323486|NCT00354302|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110323487|NCT00354302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110323488|NCT00354302|Vitamins|vitamins|mesh-ancestor
110323489|NCT00354302|Micronutrients|micronutrients|mesh-ancestor
110323490|NCT00354302|Antacids|antacids|mesh-ancestor
110323491|NCT00354302|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110323492|NCT00354302|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110323493|NCT00354302|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110323494|NCT04714229|Vaccines|vaccines|mesh-list
110323495|NCT04714229|Immunologic Factors|immunologic factors|mesh-ancestor
110323496|NCT04714229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110323497|NCT00458523|Alemtuzumab|alemtuzumab|mesh-list
110323498|NCT00458523|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110323499|NCT00458523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110323500|NCT00354380|Artesunate|artesunate|mesh-list
110323501|NCT00354380|Amodiaquine|amodiaquine|mesh-list
110323502|NCT00354380|Methylene Blue|methylene blue|mesh-list
110323503|NCT00354380|Antimalarials|antimalarials|mesh-ancestor
110323504|NCT00354380|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110323505|NCT00354380|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110323506|NCT00354380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110323507|NCT00354380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110323508|NCT00354380|Antiviral Agents|antiviral agents|mesh-ancestor
110323509|NCT00354380|Schistosomicides|schistosomicides|mesh-ancestor
110323510|NCT00354380|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110323511|NCT00354380|Anthelmintics|anthelmintics|mesh-ancestor
110323512|NCT00354380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110323513|NCT00354380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110323515|NCT00354419|Mycophenolic Acid|mycophenolic acid|mesh-list
110323516|NCT00354419|Cyclophosphamide|cyclophosphamide|mesh-list
110323518|NCT00354419|Thymoglobulin|thymoglobulin|mesh-list
110323519|NCT00354419|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110323520|NCT00354419|Lenograstim|lenograstim|mesh-list
110323521|NCT00354419|Immunoglobulins|immunoglobulins|mesh-list
110323522|NCT00354419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110323523|NCT00354419|Immunologic Factors|immunologic factors|mesh-ancestor
110323524|NCT00354419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110323525|NCT00354419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110323526|NCT00354419|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110323527|NCT00354419|Alkylating Agents|alkylating agents|mesh-ancestor
110323528|NCT00354419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110323529|NCT00354419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110323530|NCT00354419|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110323531|NCT00354419|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110323532|NCT00354419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110323533|NCT00354419|Antifungal Agents|antifungal agents|mesh-ancestor
110323534|NCT00354419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110323535|NCT00354419|Dermatologic Agents|dermatologic agents|mesh-ancestor
110323536|NCT00354419|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110323537|NCT00354419|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110170868|NCT00042601|Pramlintide|pramlintide|mesh-list
110323538|NCT00354419|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110323539|NCT00354419|Antitubercular Agents|antitubercular agents|mesh-ancestor
110323540|NCT00354419|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110323541|NCT00354458|Rolofylline|rolofylline|mesh-list
110323542|NCT00354458|Diuretics|diuretics|mesh-ancestor
110323543|NCT00354458|Natriuretic Agents|natriuretic agents|mesh-ancestor
110323544|NCT00354458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110323545|NCT00458718|Rimonabant|rimonabant|mesh-list
110323546|NCT00458718|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110323547|NCT00458718|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
110323548|NCT00458718|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110323549|NCT00458718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110323550|NCT00458718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110323551|NCT00458718|Hormones|hormones|mesh-ancestor
110323552|NCT00458718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110323553|NCT00458718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110323555|NCT00467181|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110323556|NCT00467181|Vasodilator Agents|vasodilator agents|mesh-ancestor
110323557|NCT00467181|Dopamine Agonists|dopamine agonists|mesh-ancestor
110323558|NCT00467181|Dopamine Agents|dopamine agents|mesh-ancestor
110323559|NCT00467181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110323560|NCT00467181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110323561|NCT00467181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110323562|NCT00425711|Acamprosate|acamprosate|mesh-list
110323563|NCT00425711|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110323564|NCT03274011|Apatinib|apatinib|mesh-list
110323565|NCT03274011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110323566|NCT03274011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110323567|NCT03274011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110323568|NCT03274011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110323569|NCT00425906|Nicotine|nicotine|mesh-list
110323570|NCT00425906|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110323571|NCT00425906|Autonomic Agents|autonomic agents|mesh-ancestor
110323572|NCT00425906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110323573|NCT00425906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110323574|NCT00425906|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110323575|NCT00425906|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110323576|NCT00425906|Cholinergic Agents|cholinergic agents|mesh-ancestor
110323577|NCT00425906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110323578|NCT00425906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110323579|NCT00467376|Insulin|insulin|mesh-list
110149764|NCT00008268|Melphalan|melphalan|mesh-list
110323580|NCT00467376|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110323581|NCT00467376|Insulin Glargine|insulin glargine|mesh-list
110323582|NCT00467376|Insulin glulisine|insulin glulisine|mesh-list
110323583|NCT00467376|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110323584|NCT00467376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110323585|NCT00426023|Ketotifen|ketotifen|mesh-list
110323586|NCT00426023|Cyclosporine|cyclosporine|mesh-list
110323587|NCT00426023|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110323588|NCT00426023|Cyclosporins|cyclosporins|mesh-list
110323589|NCT00426023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110323590|NCT00426023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110323591|NCT00426023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110323592|NCT00426023|Immunologic Factors|immunologic factors|mesh-ancestor
110323593|NCT00426023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110323594|NCT00426023|Antifungal Agents|antifungal agents|mesh-ancestor
110323595|NCT00426023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110323596|NCT00426023|Dermatologic Agents|dermatologic agents|mesh-ancestor
110323597|NCT00426023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110323598|NCT00426023|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110323599|NCT00426023|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110323600|NCT00426023|Antipruritics|antipruritics|mesh-ancestor
110323601|NCT00426023|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110323602|NCT00426023|Histamine Antagonists|histamine antagonists|mesh-ancestor
110323603|NCT00426023|Histamine Agents|histamine agents|mesh-ancestor
110323604|NCT00426023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110323605|NCT00426023|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110323606|NCT00467454|Naltrexone|naltrexone|mesh-list
110323607|NCT00467454|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110323608|NCT00467454|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110323609|NCT00467454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110323610|NCT00467454|Sensory System Agents|sensory system agents|mesh-ancestor
110323611|NCT00467454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110323613|NCT00426101|Dexamethasone|dexamethasone|mesh-list
110323614|NCT00426101|Etoposide|etoposide|mesh-list
110323615|NCT00426101|Cyclosporins|cyclosporins|mesh-list
110323616|NCT00426101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110323617|NCT00426101|Antiemetics|antiemetics|mesh-ancestor
110323618|NCT00426101|Autonomic Agents|autonomic agents|mesh-ancestor
110323619|NCT00426101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110323620|NCT00426101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110323621|NCT00426101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110323622|NCT00426101|Glucocorticoids|glucocorticoids|mesh-ancestor
110323623|NCT00426101|Hormones|hormones|mesh-ancestor
110323624|NCT00426101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110323625|NCT00426101|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110323626|NCT00426101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110323627|NCT00426101|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110323628|NCT00426101|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110323629|NCT00426101|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110323630|NCT00426101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110323631|NCT00426101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110323632|NCT00426101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110323633|NCT00426101|Immunologic Factors|immunologic factors|mesh-ancestor
110323634|NCT00426101|Antifungal Agents|antifungal agents|mesh-ancestor
110323635|NCT00426101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110323636|NCT00426101|Dermatologic Agents|dermatologic agents|mesh-ancestor
110323637|NCT00426101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110323638|NCT00426101|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110323639|NCT00426140|Epothilone B|epothilone b|mesh-list
110323640|NCT00426140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110323641|NCT00426140|Tubulin Modulators|tubulin modulators|mesh-ancestor
110323642|NCT00426140|Antimitotic Agents|antimitotic agents|mesh-ancestor
110323643|NCT00426140|Mitosis Modulators|mitosis modulators|mesh-ancestor
110323644|NCT00426140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110323645|NCT00467493|Anastrozole|anastrozole|mesh-list
110323646|NCT00467493|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110323647|NCT00467493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110323648|NCT00467493|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110323649|NCT00467493|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110323650|NCT00467493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110323651|NCT00467493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110323652|NCT00467493|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110323653|NCT00467493|Hormone Antagonists|hormone antagonists|mesh-ancestor
110323654|NCT00467493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110323655|NCT00467493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110323656|NCT00426179|Imatinib Mesylate|imatinib mesylate|mesh-list
110323657|NCT00426179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110323658|NCT00426179|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110323659|NCT00426179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110323660|NCT00426179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110323661|NCT00458913|Bortezomib|bortezomib|mesh-list
110323662|NCT00458913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110323663|NCT00458991|Dextromethorphan|dextromethorphan|mesh-list
110323664|NCT00458991|Caffeine|caffeine|mesh-list
110323665|NCT00458991|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110323666|NCT00458991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110323667|NCT00458991|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110323669|NCT00458991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110323670|NCT00458991|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110323671|NCT00458991|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110323672|NCT00458991|Purinergic Agents|purinergic agents|mesh-ancestor
110323673|NCT00458991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110323674|NCT00458991|Antitussive Agents|antitussive agents|mesh-ancestor
110323675|NCT00458991|Respiratory System Agents|respiratory system agents|mesh-ancestor
110323676|NCT00458991|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110323677|NCT00458991|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110323678|NCT01059617|Vaccines|vaccines|mesh-list
110323679|NCT01059617|Immunologic Factors|immunologic factors|mesh-ancestor
110323680|NCT01059617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110323681|NCT04705337|Simendan|simendan|mesh-list
110323682|NCT04705337|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110323683|NCT04705337|Vasodilator Agents|vasodilator agents|mesh-ancestor
110323684|NCT04705337|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110323685|NCT04705337|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110323686|NCT04705337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110323687|NCT04705337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110323688|NCT04705337|Protective Agents|protective agents|mesh-ancestor
110323689|NCT04705337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110323690|NCT00467571|Amoxicillin|amoxicillin|mesh-list
110323691|NCT00467571|Clarithromycin|clarithromycin|mesh-list
110323692|NCT00467571|Lansoprazole|lansoprazole|mesh-list
110323693|NCT00467571|Dexlansoprazole|dexlansoprazole|mesh-list
110323694|NCT00467571|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110323695|NCT00467571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110323696|NCT00467571|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110323697|NCT00467571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110323698|NCT00467571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110323699|NCT00467571|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110323700|NCT00467571|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110323701|NCT00467571|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110323702|NCT00467571|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110323703|NCT00467571|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110323704|NCT00426296|Ritonavir|ritonavir|mesh-list
110323706|NCT00426296|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110323707|NCT00426296|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110323708|NCT00426296|Protease Inhibitors|protease inhibitors|mesh-ancestor
110323709|NCT00426296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110323710|NCT00426296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110323711|NCT00426296|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110323712|NCT00426296|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110323713|NCT00426296|Antiviral Agents|antiviral agents|mesh-ancestor
110323714|NCT00426296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110323715|NCT00426296|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110323716|NCT00426296|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110323717|NCT03271905|Bromides|bromides|mesh-list
110323718|NCT03271905|Albuterol|albuterol|mesh-list
110323719|NCT03271905|Ipratropium|ipratropium|mesh-list
110323720|NCT03271905|Anticonvulsants|anticonvulsants|mesh-ancestor
110323721|NCT03271905|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110323722|NCT03271905|Autonomic Agents|autonomic agents|mesh-ancestor
110323723|NCT03271905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110323724|NCT03271905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110323725|NCT03271905|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110323726|NCT03271905|Respiratory System Agents|respiratory system agents|mesh-ancestor
110323728|NCT03271905|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110323729|NCT03271905|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110323730|NCT03271905|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110323731|NCT03271905|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110323732|NCT03271905|Adrenergic Agents|adrenergic agents|mesh-ancestor
110323733|NCT03271905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110323734|NCT03271905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110323735|NCT03271905|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110323736|NCT03271905|Cholinergic Agents|cholinergic agents|mesh-ancestor
110323737|NCT00426413|Pioglitazone|pioglitazone|mesh-list
110323738|NCT00426413|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110323739|NCT00426413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110323740|NCT00459264|Folic Acid|folic acid|mesh-list
110323741|NCT00459264|Hematinics|hematinics|mesh-ancestor
110323742|NCT00459264|Vitamin B Complex|vitamin b complex|mesh-ancestor
110323743|NCT00459264|Vitamins|vitamins|mesh-ancestor
110323744|NCT00459264|Micronutrients|micronutrients|mesh-ancestor
110323745|NCT00459264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110323746|NCT00426452|Vatalanib|vatalanib|mesh-list
110323747|NCT00426452|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110323748|NCT00426452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110323749|NCT00426452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110323750|NCT00426491|Misoprostol|misoprostol|mesh-list
110323751|NCT00426491|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110323752|NCT00426491|Abortifacient Agents|abortifacient agents|mesh-ancestor
110323753|NCT00426491|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110323754|NCT00426491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110323755|NCT00426491|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110323756|NCT00426491|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110323757|NCT00426491|Oxytocics|oxytocics|mesh-ancestor
110323758|NCT00426530|Everolimus|everolimus|mesh-list
110323759|NCT00426530|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110323760|NCT00426530|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110323761|NCT00426530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110323762|NCT00426530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110323763|NCT00426530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110323764|NCT00426530|Immunologic Factors|immunologic factors|mesh-ancestor
110323765|NCT00426530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110323766|NCT00426530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110323767|NCT00459420|Caffeine|caffeine|mesh-list
110323768|NCT00459420|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110323769|NCT00459420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110323770|NCT00459420|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110323771|NCT00459420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110323772|NCT00459420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110323773|NCT00459420|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110323774|NCT00459420|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110323775|NCT00459420|Purinergic Agents|purinergic agents|mesh-ancestor
110323776|NCT00459420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110323777|NCT00467766|Donepezil|donepezil|mesh-list
110323778|NCT00467766|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110323779|NCT00467766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110323780|NCT00467766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110323781|NCT00467766|Cholinergic Agents|cholinergic agents|mesh-ancestor
110323782|NCT00467766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110323783|NCT00467766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110323784|NCT00467766|Nootropic Agents|nootropic agents|mesh-ancestor
110323785|NCT04705415|Niclosamide|niclosamide|mesh-list
110323786|NCT04705415|Anticestodal Agents|anticestodal agents|mesh-ancestor
110323787|NCT04705415|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110323788|NCT04705415|Anthelmintics|anthelmintics|mesh-ancestor
110323789|NCT04705415|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110323790|NCT04705415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110323791|NCT04705415|Antinematodal Agents|antinematodal agents|mesh-ancestor
110323792|NCT00467883|Amphotericin B|amphotericin b|mesh-list
110323793|NCT00467883|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
110323794|NCT00467883|Amebicides|amebicides|mesh-ancestor
110323795|NCT00467883|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110323796|NCT00467883|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110323797|NCT00467883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110323798|NCT00467883|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110323799|NCT00467883|Antifungal Agents|antifungal agents|mesh-ancestor
110323800|NCT00426608|Alprazolam|alprazolam|mesh-list
110323801|NCT00426608|Metyrapone|metyrapone|mesh-list
110323802|NCT00426608|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110323803|NCT00426608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110323804|NCT00426608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110323805|NCT00426608|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110323806|NCT00426608|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110323807|NCT00426608|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110323808|NCT00426608|GABA Modulators|gaba modulators|mesh-ancestor
110323809|NCT00426608|GABA Agents|gaba agents|mesh-ancestor
110323810|NCT00426608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110323811|NCT00426608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110323812|NCT00426608|Antimetabolites|antimetabolites|mesh-ancestor
110323813|NCT00426608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110323814|NCT00426647|Buprenorphine|buprenorphine|mesh-list
110323815|NCT00426647|Tramadol|tramadol|mesh-list
110323816|NCT00426647|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110323817|NCT00426647|Narcotics|narcotics|mesh-ancestor
110323818|NCT00426647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110323819|NCT00426647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110323820|NCT00426647|Analgesics|analgesics|mesh-ancestor
110323821|NCT00426647|Sensory System Agents|sensory system agents|mesh-ancestor
110323822|NCT00426647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110323823|NCT00426647|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110323837|NCT00459615|Artesunate|artesunate|mesh-list
110323838|NCT00459615|Antimalarials|antimalarials|mesh-ancestor
110323839|NCT00459615|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110323840|NCT00459615|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110323841|NCT00459615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110323842|NCT00459615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110323843|NCT00459615|Antiviral Agents|antiviral agents|mesh-ancestor
110323844|NCT00459615|Schistosomicides|schistosomicides|mesh-ancestor
110323845|NCT00459615|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110323846|NCT00459615|Anthelmintics|anthelmintics|mesh-ancestor
110323847|NCT00468351|Triamcinolone|triamcinolone|mesh-list
110323848|NCT00468351|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110323849|NCT00468351|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110323850|NCT00468351|Bevacizumab|bevacizumab|mesh-list
110323851|NCT00468351|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110323852|NCT00468351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110323853|NCT00468351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110323854|NCT00468351|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110323855|NCT00468351|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110323856|NCT00468351|Growth Substances|growth substances|mesh-ancestor
110323857|NCT00468351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110323858|NCT00468351|Growth Inhibitors|growth inhibitors|mesh-ancestor
110323859|NCT00468351|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110323860|NCT00468351|Glucocorticoids|glucocorticoids|mesh-ancestor
110323861|NCT00468351|Hormones|hormones|mesh-ancestor
110323862|NCT00468351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110323863|NCT00468351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110323864|NCT00468351|Immunologic Factors|immunologic factors|mesh-ancestor
110323865|NCT00468351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110323866|NCT00468351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110323867|NCT00459654|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
110323868|NCT00459654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110323869|NCT00468429|Bevacizumab|bevacizumab|mesh-list
110323870|NCT00468429|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110323871|NCT00468429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110323872|NCT00468429|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110323873|NCT00468429|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110323874|NCT00468429|Growth Substances|growth substances|mesh-ancestor
110323875|NCT00468429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110323876|NCT00468429|Growth Inhibitors|growth inhibitors|mesh-ancestor
110323878|NCT00459771|Candesartan cilexetil|candesartan cilexetil|mesh-list
110323879|NCT00459771|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110323880|NCT00459771|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110323881|NCT00459771|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110323882|NCT00459771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110323883|NCT01058369|Deferasirox|deferasirox|mesh-list
110323884|NCT01058369|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110323885|NCT01058369|Chelating Agents|chelating agents|mesh-ancestor
110323886|NCT01058369|Sequestering Agents|sequestering agents|mesh-ancestor
110323887|NCT01058369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110323888|NCT01057433|Ritonavir|ritonavir|mesh-list
110323889|NCT01057433|Lopinavir|lopinavir|mesh-list
110323891|NCT01057433|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110323892|NCT01057433|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110323893|NCT01057433|Protease Inhibitors|protease inhibitors|mesh-ancestor
110323894|NCT01057433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110323895|NCT01057433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110323896|NCT01057433|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110323897|NCT01057433|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110323898|NCT01057433|Antiviral Agents|antiviral agents|mesh-ancestor
110323899|NCT01057433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110323900|NCT01057433|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110323901|NCT01057433|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110323902|NCT01057433|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110323903|NCT01057433|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110323904|NCT01057433|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110323905|NCT01057433|Antimetabolites|antimetabolites|mesh-ancestor
110323906|NCT01057433|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110323907|NCT01058642|Pregabalin|pregabalin|mesh-list
110323908|NCT01058642|Analgesics|analgesics|mesh-ancestor
110323909|NCT01058642|Sensory System Agents|sensory system agents|mesh-ancestor
110323910|NCT01058642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110323911|NCT01058642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110323912|NCT01058642|Anticonvulsants|anticonvulsants|mesh-ancestor
110323913|NCT01058642|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110323914|NCT01058642|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110323915|NCT01058642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110323916|NCT01058642|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110323917|NCT01058642|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110323918|NCT01058642|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110323919|NCT01058642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110323920|NCT01058642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110323921|NCT00426920|Insulin|insulin|mesh-list
110323922|NCT00426920|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110323923|NCT00426920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110323924|NCT00426998|Bevacizumab|bevacizumab|mesh-list
110323925|NCT00426998|Verteporfin|verteporfin|mesh-list
110323926|NCT00426998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110323927|NCT00426998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110323928|NCT00426998|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110323929|NCT00426998|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110323930|NCT00426998|Growth Substances|growth substances|mesh-ancestor
110323931|NCT00426998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110323933|NCT00426998|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110323934|NCT00426998|Dermatologic Agents|dermatologic agents|mesh-ancestor
110323935|NCT00427076|Vancomycin|vancomycin|mesh-list
110323936|NCT00427076|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
110323937|NCT00427076|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110323938|NCT00427076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110323939|NCT00427076|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110323940|NCT00427076|Antimalarials|antimalarials|mesh-ancestor
110323941|NCT00427076|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110323942|NCT00427076|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110323943|NCT00427232|BQ 788|bq 788|mesh-list
110323944|NCT00427232|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110323945|NCT00427232|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
110323946|NCT00427232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110323947|NCT00427232|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
110323948|NCT00427271|Aspirin|aspirin|mesh-list
110323949|NCT00427271|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110323950|NCT00427271|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110323951|NCT00427271|Analgesics|analgesics|mesh-ancestor
110323952|NCT00427271|Sensory System Agents|sensory system agents|mesh-ancestor
110323953|NCT00427271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110323954|NCT00427271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110323955|NCT00427271|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110323956|NCT00427271|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110323957|NCT00427271|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110323958|NCT00427271|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110323959|NCT00427271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110323960|NCT00427271|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110323961|NCT00427271|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110323962|NCT00427271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110323964|NCT00460083|Pimecrolimus|pimecrolimus|mesh-list
110323965|NCT00460083|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110323966|NCT00460083|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110323967|NCT00460083|Analgesics|analgesics|mesh-ancestor
110323968|NCT00460083|Sensory System Agents|sensory system agents|mesh-ancestor
110323969|NCT00460083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110323970|NCT00460083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110323971|NCT00460083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110323972|NCT00460083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110323973|NCT00460083|Dermatologic Agents|dermatologic agents|mesh-ancestor
110323974|NCT00460083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110323975|NCT00460083|Immunologic Factors|immunologic factors|mesh-ancestor
110323976|NCT00460083|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110323977|NCT00460083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110323978|NCT00460083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110323979|NCT00427310|Fluorouracil|fluorouracil|mesh-list
110323980|NCT00427310|Heparin|heparin|mesh-list
110323981|NCT00427310|Calcium heparin|calcium heparin|mesh-list
110323982|NCT00427310|Antimetabolites|antimetabolites|mesh-ancestor
110323983|NCT00427310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110323984|NCT00427310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110323985|NCT00427310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110323986|NCT00427310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110323987|NCT00427310|Immunologic Factors|immunologic factors|mesh-ancestor
110323988|NCT00427310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110323989|NCT00427310|Anticoagulants|anticoagulants|mesh-ancestor
110323990|NCT00427310|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110323991|NCT00427310|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110323992|NCT00427388|Methylprednisolone|methylprednisolone|mesh-list
110323993|NCT00427388|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110323994|NCT00427388|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110323995|NCT00427388|Prednisolone|prednisolone|mesh-list
110323996|NCT00427388|Prednisolone acetate|prednisolone acetate|mesh-list
110323997|NCT00427388|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110323998|NCT00427388|Prednisolone phosphate|prednisolone phosphate|mesh-list
110323999|NCT00427388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110324000|NCT00427388|Antiemetics|antiemetics|mesh-ancestor
110324001|NCT00427388|Autonomic Agents|autonomic agents|mesh-ancestor
110324002|NCT00427388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110324003|NCT00427388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110324004|NCT00427388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110324005|NCT00427388|Glucocorticoids|glucocorticoids|mesh-ancestor
110324006|NCT00427388|Hormones|hormones|mesh-ancestor
110324007|NCT00427388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110324008|NCT00427388|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110324009|NCT00427388|Protective Agents|protective agents|mesh-ancestor
110324010|NCT00427388|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110324011|NCT00427388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110324012|NCT00427427|Trastuzumab|trastuzumab|mesh-list
110324013|NCT00427427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110324014|NCT00427427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110324015|NCT04704947|Alendronate|alendronate|mesh-list
110324016|NCT04704947|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
110324017|NCT04704947|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-list
110324018|NCT04704947|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110324019|NCT04704947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110324020|NCT04704947|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110324021|NCT04704947|Adrenergic Agents|adrenergic agents|mesh-ancestor
110324022|NCT04704947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110324023|NCT04704947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110324024|NCT00427466|Pemetrexed|pemetrexed|mesh-list
110324025|NCT00427466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110324026|NCT00427466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110324027|NCT00427466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110324028|NCT00427466|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110324029|NCT00427466|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110324030|NCT00427505|Deferasirox|deferasirox|mesh-list
110324031|NCT00427505|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110324032|NCT00427505|Chelating Agents|chelating agents|mesh-ancestor
110324033|NCT00427505|Sequestering Agents|sequestering agents|mesh-ancestor
110324034|NCT00427505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110324036|NCT00427583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110324037|NCT00427583|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110324038|NCT00427583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110324039|NCT00427583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110324040|NCT00468936|Mycophenolic Acid|mycophenolic acid|mesh-list
110324041|NCT00468936|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110324042|NCT00468936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110324043|NCT00468936|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110324044|NCT00468936|Antitubercular Agents|antitubercular agents|mesh-ancestor
110324045|NCT00468936|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110324046|NCT00468936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110324047|NCT00468936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110324048|NCT00468936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110324049|NCT00469053|Buprenorphine|buprenorphine|mesh-list
110324050|NCT00469053|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110324051|NCT00469053|Narcotics|narcotics|mesh-ancestor
110324052|NCT00469053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110324053|NCT00469053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110324054|NCT00469053|Analgesics|analgesics|mesh-ancestor
110324055|NCT00469053|Sensory System Agents|sensory system agents|mesh-ancestor
110324056|NCT00469053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110324057|NCT00469053|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110324058|NCT00469131|Mycophenolic Acid|mycophenolic acid|mesh-list
110324059|NCT00469131|Tacrolimus|tacrolimus|mesh-list
110324060|NCT00469131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110324061|NCT00469131|Immunologic Factors|immunologic factors|mesh-ancestor
110324062|NCT00469131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110324063|NCT00469131|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110324064|NCT00469131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110324065|NCT00469131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110324066|NCT00469131|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110324067|NCT00469131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110324068|NCT00469131|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110324069|NCT00469131|Antitubercular Agents|antitubercular agents|mesh-ancestor
110324070|NCT00469131|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110324071|NCT00469131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110324073|NCT00428129|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110324074|NCT00428129|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110324075|NCT00428129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110324076|NCT00428168|Betahistine|betahistine|mesh-list
110324077|NCT00428168|Vasodilator Agents|vasodilator agents|mesh-ancestor
110324078|NCT00428168|Histamine Agonists|histamine agonists|mesh-ancestor
110324079|NCT00428168|Histamine Agents|histamine agents|mesh-ancestor
110324080|NCT00428168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110324081|NCT00428168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110149808|NCT00008307|Glucocorticoids|glucocorticoids|mesh-ancestor
110324082|NCT00428168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110324083|NCT00428480|Methamphetamine|methamphetamine|mesh-list
110324084|NCT00428480|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110324085|NCT00428480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110324086|NCT00428480|Sympathomimetics|sympathomimetics|mesh-ancestor
110324087|NCT00428480|Autonomic Agents|autonomic agents|mesh-ancestor
110324088|NCT00428480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110324089|NCT00428480|Dopamine Agents|dopamine agents|mesh-ancestor
110324090|NCT00428480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110324091|NCT00428480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110324092|NCT00428480|Adrenergic Agents|adrenergic agents|mesh-ancestor
110324093|NCT00428480|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110324094|NCT00428480|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110324095|NCT00428480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110324096|NCT00428480|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110324097|NCT00460473|Dexmedetomidine|dexmedetomidine|mesh-list
110324098|NCT00460473|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110324099|NCT00460473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110324100|NCT00460473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110324101|NCT00460473|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110324103|NCT00460473|Sensory System Agents|sensory system agents|mesh-ancestor
110324104|NCT00460473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110324105|NCT00460473|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110324106|NCT00460473|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110324107|NCT00460473|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110324108|NCT00460473|Adrenergic Agents|adrenergic agents|mesh-ancestor
110324109|NCT00460473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110324110|NCT00460473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110324111|NCT00428519|Aprepitant|aprepitant|mesh-list
110324112|NCT00428519|Fosaprepitant|fosaprepitant|mesh-list
110324113|NCT00428519|Antiemetics|antiemetics|mesh-ancestor
110324114|NCT00428519|Autonomic Agents|autonomic agents|mesh-ancestor
110324115|NCT00428519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110324116|NCT00428519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110324117|NCT00428519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110324118|NCT00428519|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110324119|NCT00428519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110324120|NCT00428519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110324121|NCT00428558|Cytarabine|cytarabine|mesh-list
110324122|NCT00428558|Daunorubicin|daunorubicin|mesh-list
110324123|NCT00428558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110324124|NCT00428558|Antimetabolites|antimetabolites|mesh-ancestor
110324125|NCT00428558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110324126|NCT00428558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110324127|NCT00428558|Antiviral Agents|antiviral agents|mesh-ancestor
110324128|NCT00428558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110324129|NCT00428558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110324130|NCT00428558|Immunologic Factors|immunologic factors|mesh-ancestor
110324131|NCT00428558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110324132|NCT00428558|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110324133|NCT00428558|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110324134|NCT00428558|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110324135|NCT00428558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110324136|NCT00460512|Paliperidone Palmitate|paliperidone palmitate|mesh-list
110324137|NCT00460512|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110324138|NCT00460512|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110324139|NCT00460512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110324140|NCT00460512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110324141|NCT00460512|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110324142|NCT00460512|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110324143|NCT00460512|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110324144|NCT00460512|Serotonin Agents|serotonin agents|mesh-ancestor
110324145|NCT00460512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110324146|NCT00460512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110324147|NCT00460512|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110324148|NCT00460512|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110324149|NCT00460512|Dopamine Agents|dopamine agents|mesh-ancestor
110324150|NCT01056380|Nitazoxanide|nitazoxanide|mesh-list
110324151|NCT01056380|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110324152|NCT01056380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110324154|NCT01055834|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110324155|NCT01055834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110324156|NCT01055834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110324157|NCT00469326|Atorvastatin|atorvastatin|mesh-list
110324158|NCT00469326|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110324159|NCT00469326|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110324160|NCT00469326|Antimetabolites|antimetabolites|mesh-ancestor
110324161|NCT00469326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110324162|NCT00469326|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110324163|NCT00469326|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110324164|NCT00469326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110324165|NCT04704713|Afamelanotide|afamelanotide|mesh-list
110324166|NCT04704713|Dermatologic Agents|dermatologic agents|mesh-ancestor
110324167|NCT00460707|Ketoconazole|ketoconazole|mesh-list
110324168|NCT00460707|Casopitant|casopitant|mesh-list
110324169|NCT00460707|Antifungal Agents|antifungal agents|mesh-ancestor
110324170|NCT00460707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110324171|NCT00460707|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110324172|NCT00460707|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110324173|NCT00460707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110324174|NCT00460707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110324175|NCT00460707|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110324176|NCT00460707|Hormone Antagonists|hormone antagonists|mesh-ancestor
110324177|NCT00460707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110324178|NCT00460707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110324179|NCT00460707|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110324181|NCT00460707|Autonomic Agents|autonomic agents|mesh-ancestor
110324182|NCT00460707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110324183|NCT00460707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110324184|NCT00460707|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110324185|NCT00460707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110324186|NCT00469404|Buprenorphine|buprenorphine|mesh-list
110170966|NCT00043069|Antacids|antacids|mesh-ancestor
110324187|NCT00469404|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110324189|NCT00469404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110324190|NCT00469404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110324191|NCT00469404|Analgesics|analgesics|mesh-ancestor
110324192|NCT00469404|Sensory System Agents|sensory system agents|mesh-ancestor
110324193|NCT00469404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110324194|NCT00469404|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110324195|NCT00460785|Analgesics, Opioid|analgesics, opioid|mesh-list
110324196|NCT00460785|Narcotics|narcotics|mesh-ancestor
110324197|NCT00460785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110324198|NCT00460785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110324199|NCT00460785|Analgesics|analgesics|mesh-ancestor
110324200|NCT00460785|Sensory System Agents|sensory system agents|mesh-ancestor
110324201|NCT00460785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110324202|NCT01054976|Galantamine|galantamine|mesh-list
110324203|NCT01054976|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110324204|NCT01054976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110324205|NCT01054976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110324206|NCT01054976|Cholinergic Agents|cholinergic agents|mesh-ancestor
110324207|NCT01054976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110324208|NCT01054976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110324209|NCT01054976|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110324210|NCT01054976|Autonomic Agents|autonomic agents|mesh-ancestor
110324211|NCT01054976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110324212|NCT01054976|Nootropic Agents|nootropic agents|mesh-ancestor
110324213|NCT00469443|Leucovorin|leucovorin|mesh-list
110324214|NCT00469443|Bevacizumab|bevacizumab|mesh-list
110324215|NCT00469443|Fluorouracil|fluorouracil|mesh-list
110324216|NCT00469443|Capecitabine|capecitabine|mesh-list
110324217|NCT00469443|Irinotecan|irinotecan|mesh-list
110324218|NCT00469443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110324219|NCT00469443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110324220|NCT00469443|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110324221|NCT00469443|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110324222|NCT00469443|Growth Substances|growth substances|mesh-ancestor
110324223|NCT00469443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110324224|NCT00469443|Growth Inhibitors|growth inhibitors|mesh-ancestor
110324225|NCT00469443|Antimetabolites|antimetabolites|mesh-ancestor
110324226|NCT00469443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110324227|NCT00469443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110324228|NCT00469443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110324229|NCT00469443|Immunologic Factors|immunologic factors|mesh-ancestor
110324230|NCT00469443|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110324231|NCT00469443|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110324232|NCT00469443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110324233|NCT00469443|Antidotes|antidotes|mesh-ancestor
110324234|NCT00469443|Protective Agents|protective agents|mesh-ancestor
110324235|NCT00469443|Vitamin B Complex|vitamin b complex|mesh-ancestor
110324236|NCT00469443|Vitamins|vitamins|mesh-ancestor
110324237|NCT00469443|Micronutrients|micronutrients|mesh-ancestor
110324238|NCT00460863|Dialysis Solutions|dialysis solutions|mesh-list
110324239|NCT00460863|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110324240|NCT00428909|Acetaminophen|acetaminophen|mesh-list
110324241|NCT00428909|Imatinib Mesylate|imatinib mesylate|mesh-list
110324242|NCT00428909|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110324243|NCT00428909|Analgesics|analgesics|mesh-ancestor
110324244|NCT00428909|Sensory System Agents|sensory system agents|mesh-ancestor
110324245|NCT00428909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110324246|NCT00428909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110324247|NCT00428909|Antipyretics|antipyretics|mesh-ancestor
110324248|NCT00428909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110324249|NCT00428909|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110324250|NCT00428909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110324251|NCT00428909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110324252|NCT00429065|Rituximab|rituximab|mesh-list
110324253|NCT00429065|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110324254|NCT00429065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110324255|NCT00429065|Immunologic Factors|immunologic factors|mesh-ancestor
110324256|NCT00429065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110324257|NCT00429065|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110324258|NCT00469560|Deferasirox|deferasirox|mesh-list
110324259|NCT00469560|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110324260|NCT00469560|Chelating Agents|chelating agents|mesh-ancestor
110324261|NCT00469560|Sequestering Agents|sequestering agents|mesh-ancestor
110324262|NCT00469560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110324263|NCT00469599|Alfacalcidol|alfacalcidol|mesh-list
110324264|NCT00469599|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
110324265|NCT00469599|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110324266|NCT00469599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110324267|NCT00469599|Vitamins|vitamins|mesh-ancestor
110324268|NCT00469599|Micronutrients|micronutrients|mesh-ancestor
110324269|NCT00429377|Tacrolimus|tacrolimus|mesh-list
110324270|NCT00429377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110324271|NCT00429377|Immunologic Factors|immunologic factors|mesh-ancestor
110324272|NCT00429377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110324273|NCT00429377|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110324274|NCT00429377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110324275|NCT00429377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110324276|NCT00469716|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
110324277|NCT00469716|Plasma Substitutes|plasma substitutes|mesh-ancestor
110324278|NCT00469716|Blood Substitutes|blood substitutes|mesh-ancestor
110324279|NCT00429533|Dapsone|dapsone|mesh-list
110324280|NCT00429533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110324281|NCT00429533|Antimalarials|antimalarials|mesh-ancestor
110324282|NCT00429533|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110324283|NCT00429533|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110324284|NCT00429533|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110324285|NCT00429533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110324286|NCT00429533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110324287|NCT00429533|Leprostatic Agents|leprostatic agents|mesh-ancestor
110324288|NCT00429533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110324289|NCT04704245|Petrolatum|petrolatum|mesh-list
110324290|NCT04704245|Mitogens|mitogens|mesh-list
110324291|NCT04704245|Mitosis Modulators|mitosis modulators|mesh-ancestor
110324292|NCT04704245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110324293|NCT04704245|Emollients|emollients|mesh-ancestor
110324294|NCT04704245|Dermatologic Agents|dermatologic agents|mesh-ancestor
110324295|NCT00429806|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
110324296|NCT00429806|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110324297|NCT00429806|Immunologic Factors|immunologic factors|mesh-ancestor
110324298|NCT00429806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110324299|NCT00429962|Ranibizumab|ranibizumab|mesh-list
110324300|NCT00429962|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110324301|NCT00429962|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110324302|NCT00429962|Growth Substances|growth substances|mesh-ancestor
110324303|NCT00429962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110324304|NCT00429962|Growth Inhibitors|growth inhibitors|mesh-ancestor
110324305|NCT00429962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110324306|NCT00430001|Docetaxel|docetaxel|mesh-list
110324307|NCT00430001|Trastuzumab|trastuzumab|mesh-list
110324308|NCT00430001|Vinorelbine|vinorelbine|mesh-list
110324309|NCT00430001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110324310|NCT00430001|Tubulin Modulators|tubulin modulators|mesh-ancestor
110324311|NCT00430001|Antimitotic Agents|antimitotic agents|mesh-ancestor
110324312|NCT00430001|Mitosis Modulators|mitosis modulators|mesh-ancestor
110324313|NCT00430001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110324314|NCT00430001|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110324315|NCT00430001|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110324316|NCT00430079|Etanidazole|etanidazole|mesh-list
110324317|NCT00430079|Imidazole|imidazole|mesh-list
110324318|NCT00430079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110324319|NCT00430079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110324320|NCT00430079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110324321|NCT00430118|Cytarabine|cytarabine|mesh-list
110324322|NCT00430118|Dexamethasone|dexamethasone|mesh-list
110324323|NCT00430118|Prednisone|prednisone|mesh-list
110324324|NCT00430118|Cyclophosphamide|cyclophosphamide|mesh-list
110324325|NCT00430118|Ifosfamide|ifosfamide|mesh-list
110324326|NCT00430118|Doxorubicin|doxorubicin|mesh-list
110324327|NCT00430118|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110324328|NCT00430118|Methotrexate|methotrexate|mesh-list
110324329|NCT00430118|Etoposide|etoposide|mesh-list
110324330|NCT00430118|Vincristine|vincristine|mesh-list
110324331|NCT00430118|Daunorubicin|daunorubicin|mesh-list
110324332|NCT00430118|Asparaginase|asparaginase|mesh-list
110324333|NCT00430118|Mercaptopurine|mercaptopurine|mesh-list
110324334|NCT00430118|Thioguanine|thioguanine|mesh-list
110324335|NCT00430118|Vindesine|vindesine|mesh-list
110324336|NCT00430118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110324337|NCT00430118|Immunologic Factors|immunologic factors|mesh-ancestor
110324338|NCT00430118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110324339|NCT00430118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110324340|NCT00430118|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110324341|NCT00430118|Alkylating Agents|alkylating agents|mesh-ancestor
110324342|NCT00430118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110324343|NCT00430118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110324344|NCT00430118|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110324345|NCT00430118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110324346|NCT00430118|Antiemetics|antiemetics|mesh-ancestor
110324347|NCT00430118|Autonomic Agents|autonomic agents|mesh-ancestor
110324348|NCT00430118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110324349|NCT00430118|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110324350|NCT00430118|Glucocorticoids|glucocorticoids|mesh-ancestor
110324351|NCT00430118|Hormones|hormones|mesh-ancestor
110324352|NCT00430118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110324353|NCT00430118|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110324354|NCT00430118|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110324355|NCT00430118|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110324356|NCT00430118|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110324357|NCT00430118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110324358|NCT00430118|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110324359|NCT00430118|Abortifacient Agents|abortifacient agents|mesh-ancestor
110324360|NCT00430118|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110324361|NCT00430118|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110324362|NCT00430118|Antimetabolites|antimetabolites|mesh-ancestor
110324363|NCT00430118|Dermatologic Agents|dermatologic agents|mesh-ancestor
110324364|NCT00430118|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110324365|NCT00430118|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110324366|NCT00430118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110324367|NCT00430118|Antiviral Agents|antiviral agents|mesh-ancestor
110324368|NCT00430118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110324369|NCT00430118|Tubulin Modulators|tubulin modulators|mesh-ancestor
110324370|NCT00430118|Antimitotic Agents|antimitotic agents|mesh-ancestor
110324371|NCT00430118|Mitosis Modulators|mitosis modulators|mesh-ancestor
110324372|NCT00430157|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|mesh-list
110324373|NCT00430157|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
110324374|NCT00430157|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110324375|NCT00430157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110324376|NCT00430157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110324377|NCT00461565|Sildenafil Citrate|sildenafil citrate|mesh-list
110324378|NCT00461565|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
110324379|NCT00461565|Vasodilator Agents|vasodilator agents|mesh-ancestor
110324380|NCT00461565|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110324381|NCT00461565|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110324382|NCT00461565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110324383|NCT00461565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110324384|NCT00461565|Urological Agents|urological agents|mesh-ancestor
110324386|NCT00430196|Analgesics|analgesics|mesh-ancestor
110324387|NCT00430196|Sensory System Agents|sensory system agents|mesh-ancestor
110324388|NCT00430196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110148388|NCT00006471|Protective Agents|protective agents|mesh-ancestor
110324389|NCT00430196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110324390|NCT00430196|Anticonvulsants|anticonvulsants|mesh-ancestor
110324391|NCT00430196|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110324392|NCT00430196|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110324393|NCT00430196|Parasympatholytics|parasympatholytics|mesh-ancestor
110324394|NCT00430196|Autonomic Agents|autonomic agents|mesh-ancestor
110324395|NCT00430196|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110324396|NCT00430196|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110324397|NCT00430196|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110324398|NCT00430196|Adrenergic Agents|adrenergic agents|mesh-ancestor
110324399|NCT00430196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110324400|NCT00430196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110324402|NCT00430235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110324403|NCT00430235|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110324404|NCT00430235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110324405|NCT00430235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110324406|NCT00470340|Gemcitabine|gemcitabine|mesh-list
110324407|NCT00470340|Oxaliplatin|oxaliplatin|mesh-list
110324408|NCT00470340|Ethiodized Oil|ethiodized oil|mesh-list
110324409|NCT00470340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110324410|NCT00470340|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110324411|NCT00470340|Antimetabolites|antimetabolites|mesh-ancestor
110324412|NCT00470340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110324413|NCT00430469|Lactoferrin|lactoferrin|mesh-list
110324414|NCT00430469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110324415|NCT00461643|Metformin|metformin|mesh-list
110324416|NCT00461643|Citric Acid|citric acid|mesh-list
110324417|NCT00461643|Sodium Citrate|sodium citrate|mesh-list
110324418|NCT00461643|Clomiphene|clomiphene|mesh-list
110324419|NCT00461643|Enclomiphene|enclomiphene|mesh-list
110324420|NCT00461643|Zuclomiphene|zuclomiphene|mesh-list
110324421|NCT00461643|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110324422|NCT00461643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110324423|NCT00461643|Anticoagulants|anticoagulants|mesh-ancestor
110324424|NCT00461643|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110324425|NCT00461643|Chelating Agents|chelating agents|mesh-ancestor
110324426|NCT00461643|Sequestering Agents|sequestering agents|mesh-ancestor
110324427|NCT00461643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110324428|NCT00461643|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110324429|NCT00461643|Hormone Antagonists|hormone antagonists|mesh-ancestor
110324430|NCT00461643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110324431|NCT00461643|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110324432|NCT00461643|Fertility Agents|fertility agents|mesh-ancestor
110324433|NCT00461643|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110324434|NCT00461643|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110324435|NCT00461643|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110324436|NCT00430547|Carbimazole|carbimazole|mesh-list
110324437|NCT00430547|Antithyroid Agents|antithyroid agents|mesh-ancestor
110324438|NCT00430547|Hormone Antagonists|hormone antagonists|mesh-ancestor
110324439|NCT00430547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110324440|NCT00430547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110324442|NCT00430586|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110324443|NCT00430586|Botulinum Toxins|botulinum toxins|mesh-list
110324444|NCT00430586|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110324445|NCT00430586|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110324446|NCT00430586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110324447|NCT00430586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110324448|NCT00430586|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110324449|NCT00430586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110324450|NCT00430586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110324451|NCT00430586|Cholinergic Agents|cholinergic agents|mesh-ancestor
110324452|NCT00430586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110324454|NCT01053962|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
110324455|NCT01053962|Enzyme Activators|enzyme activators|mesh-ancestor
110324456|NCT01053962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110324457|NCT01053962|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110324458|NCT00461799|Orlistat|orlistat|mesh-list
110324459|NCT00461799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110324460|NCT00461799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110324461|NCT00461799|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110324462|NCT00461799|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110324463|NCT00430664|Povidone-Iodine|povidone-iodine|mesh-list
110324464|NCT00430664|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110324465|NCT00430664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110324466|NCT00430742|N-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|n-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|mesh-list
110324467|NCT00430742|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
110324468|NCT00430742|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110324469|NCT00430742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110324470|NCT00430742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110324471|NCT00430742|Hormones|hormones|mesh-ancestor
110324472|NCT00430742|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110324473|NCT00430742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110324474|NCT00470457|Immunomodulating Agents|immunomodulating agents|mesh-list
110324475|NCT00470457|Immunologic Factors|immunologic factors|mesh-ancestor
110324476|NCT00470457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110324477|NCT03271164|Vitamin E|vitamin e|mesh-list
110324478|NCT03271164|Vitamins|vitamins|mesh-ancestor
110324479|NCT03271164|Micronutrients|micronutrients|mesh-ancestor
110324480|NCT03271164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110324481|NCT03271164|Antioxidants|antioxidants|mesh-ancestor
110324482|NCT03271164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110324483|NCT03271164|Protective Agents|protective agents|mesh-ancestor
110324484|NCT00430898|Basiliximab|basiliximab|mesh-list
110324485|NCT00430898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110324486|NCT00430898|Immunologic Factors|immunologic factors|mesh-ancestor
110324487|NCT00430898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110324488|NCT00461916|Triptorelin Pamoate|triptorelin pamoate|mesh-list
110324489|NCT00461916|Buserelin|buserelin|mesh-list
110324490|NCT00461916|Luteolytic Agents|luteolytic agents|mesh-ancestor
110324491|NCT00461916|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110324492|NCT00461916|Contraceptive Agents|contraceptive agents|mesh-ancestor
110324493|NCT00461916|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110324494|NCT00461916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110324495|NCT00461916|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110324496|NCT00461916|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110324497|NCT00461916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110324498|NCT00461916|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110324499|NCT00461916|Fertility Agents|fertility agents|mesh-ancestor
110324500|NCT02957409|Valsartan|valsartan|mesh-list
110324501|NCT02957409|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
110324502|NCT02957409|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110324503|NCT02957409|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110324504|NCT02957409|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110324505|NCT02957409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110324506|NCT01053221|Mycophenolic Acid|mycophenolic acid|mesh-list
110324507|NCT01053221|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110324508|NCT01053221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110324509|NCT01053221|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110171026|NCT02970604|Analgesics|analgesics|mesh-ancestor
110324510|NCT01053221|Antitubercular Agents|antitubercular agents|mesh-ancestor
110324511|NCT01053221|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110324512|NCT01053221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110324513|NCT01053221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110324514|NCT01053221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110324516|NCT00431054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110324517|NCT00431054|Tubulin Modulators|tubulin modulators|mesh-ancestor
110324518|NCT00431054|Antimitotic Agents|antimitotic agents|mesh-ancestor
110324519|NCT00431054|Mitosis Modulators|mitosis modulators|mesh-ancestor
110324520|NCT00431054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110324521|NCT00431171|Lithium Carbonate|lithium carbonate|mesh-list
110324522|NCT00431171|Antidepressive Agents|antidepressive agents|mesh-ancestor
110324524|NCT00431171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110324525|NCT00431171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110324526|NCT00431171|Antimanic Agents|antimanic agents|mesh-ancestor
110324527|NCT00431171|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110324528|NCT00431171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110324529|NCT00431171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110324530|NCT00431210|Immunomodulating Agents|immunomodulating agents|mesh-list
110324531|NCT00431210|Immunologic Factors|immunologic factors|mesh-ancestor
110324532|NCT00431210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110324533|NCT00431249|Cilostazol|cilostazol|mesh-list
110324534|NCT00431249|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110324535|NCT00431249|Autonomic Agents|autonomic agents|mesh-ancestor
110324536|NCT00431249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110324537|NCT00431249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110324538|NCT00431249|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110324539|NCT00431249|Respiratory System Agents|respiratory system agents|mesh-ancestor
110324540|NCT00431249|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110324541|NCT00431249|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110324542|NCT00431249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110324543|NCT00431249|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110324544|NCT00431249|Vasodilator Agents|vasodilator agents|mesh-ancestor
110324545|NCT00431249|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110324546|NCT00431249|Protective Agents|protective agents|mesh-ancestor
110324547|NCT00431249|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110324548|NCT00431249|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110324549|NCT00431249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110324550|NCT00470886|Telmisartan|telmisartan|mesh-list
110324551|NCT00470886|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110324552|NCT00470886|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110324553|NCT00470886|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110324554|NCT00470886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110324555|NCT00431522|Valproic Acid|valproic acid|mesh-list
110324556|NCT00431522|Anticonvulsants|anticonvulsants|mesh-ancestor
110324557|NCT00431522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110324558|NCT00431522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110324559|NCT00431522|GABA Agents|gaba agents|mesh-ancestor
110324560|NCT00431522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110324561|NCT00431522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110324562|NCT00431522|Antimanic Agents|antimanic agents|mesh-ancestor
110324563|NCT00431522|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110324564|NCT00431522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110324565|NCT00431522|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110324566|NCT00462111|Indomethacin|indomethacin|mesh-list
110324567|NCT00462111|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110324568|NCT00462111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110324569|NCT00462111|Analgesics|analgesics|mesh-ancestor
110324570|NCT00462111|Sensory System Agents|sensory system agents|mesh-ancestor
110324571|NCT00462111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110324572|NCT00462111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110324573|NCT00462111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110324574|NCT00462111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110324575|NCT00462111|Gout Suppressants|gout suppressants|mesh-ancestor
110324576|NCT00462111|Tocolytic Agents|tocolytic agents|mesh-ancestor
110324577|NCT00462111|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110324578|NCT00462111|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110324579|NCT00462111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110324580|NCT00462111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110324581|NCT00431561|Temozolomide|temozolomide|mesh-list
110324582|NCT00431561|Lomustine|lomustine|mesh-list
110324583|NCT00431561|Trabedersen|trabedersen|mesh-list
110324584|NCT00431561|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110324585|NCT00431561|Alkylating Agents|alkylating agents|mesh-ancestor
110324586|NCT00431561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110324587|NCT00431561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110324588|NCT00462189|Immunotoxin HA22|immunotoxin ha22|mesh-list
110324589|NCT00462189|Immunotoxins|immunotoxins|mesh-list
110324590|NCT00462189|Immunoconjugates|immunoconjugates|mesh-ancestor
110324591|NCT00462189|Immunologic Factors|immunologic factors|mesh-ancestor
110324592|NCT00462189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110324593|NCT00462189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110324594|NCT00431678|Moxifloxacin|moxifloxacin|mesh-list
110324595|NCT00431678|Levofloxacin|levofloxacin|mesh-list
110324596|NCT00431678|Ceftriaxone|ceftriaxone|mesh-list
110324597|NCT00431678|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
110324599|NCT00431678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110324600|NCT00431678|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110324601|NCT00431678|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110324602|NCT00431678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110324603|NCT00431678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110324604|NCT00431678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110324605|NCT00431678|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110324606|NCT00431678|Contraceptive Agents|contraceptive agents|mesh-ancestor
110324607|NCT00431678|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110324608|NCT00431678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110324609|NCT00431678|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110324610|NCT00431678|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110324611|NCT00431678|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110324612|NCT00431678|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110324613|NCT00431678|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110324614|NCT00431678|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110324615|NCT00471003|Telmisartan|telmisartan|mesh-list
110324616|NCT00471003|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110324617|NCT00471003|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110324618|NCT00471003|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110324619|NCT00471003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110324620|NCT00471042|Buprenorphine|buprenorphine|mesh-list
110324621|NCT00471042|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110324622|NCT00471042|Narcotics|narcotics|mesh-ancestor
110324623|NCT00471042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110324624|NCT00471042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110324625|NCT00471042|Analgesics|analgesics|mesh-ancestor
110324626|NCT00471042|Sensory System Agents|sensory system agents|mesh-ancestor
110324627|NCT00471042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110324628|NCT00471042|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110324629|NCT00462540|Bromides|bromides|mesh-list
110324630|NCT00462540|Albuterol|albuterol|mesh-list
110324631|NCT00462540|Formoterol Fumarate|formoterol fumarate|mesh-list
110324632|NCT00462540|Ipratropium|ipratropium|mesh-list
110324633|NCT00462540|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110324634|NCT00462540|Autonomic Agents|autonomic agents|mesh-ancestor
110324635|NCT00462540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110324636|NCT00462540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110324637|NCT00462540|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110324638|NCT00462540|Respiratory System Agents|respiratory system agents|mesh-ancestor
110324639|NCT00462540|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110324640|NCT00462540|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110324641|NCT00462540|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110324642|NCT00462540|Adrenergic Agents|adrenergic agents|mesh-ancestor
110149841|NCT00006475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110324643|NCT00462540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110324644|NCT00462540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110324646|NCT00462540|Tocolytic Agents|tocolytic agents|mesh-ancestor
110324647|NCT00462540|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110324648|NCT00462540|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110324649|NCT00462540|Cholinergic Agents|cholinergic agents|mesh-ancestor
110324651|NCT04703465|Antiviral Agents|antiviral agents|mesh-ancestor
110324652|NCT04703465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110324653|NCT04703465|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110324654|NCT04703465|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110324655|NCT04703465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110324656|NCT04703465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110324657|NCT04703465|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110324658|NCT04703465|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110324659|NCT00471159|Docetaxel|docetaxel|mesh-list
110324660|NCT00471159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110324661|NCT00471159|Tubulin Modulators|tubulin modulators|mesh-ancestor
110324662|NCT00471159|Antimitotic Agents|antimitotic agents|mesh-ancestor
110324663|NCT00471159|Mitosis Modulators|mitosis modulators|mesh-ancestor
110324664|NCT00471159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110324665|NCT00462618|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110324666|NCT00462618|Antidepressive Agents|antidepressive agents|mesh-ancestor
110324667|NCT00462618|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110324668|NCT00462618|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110324669|NCT00462618|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110324670|NCT00462618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110324671|NCT00462618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110324672|NCT00431795|Doxorubicin|doxorubicin|mesh-list
110324673|NCT00431795|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110324674|NCT00431795|Epirubicin|epirubicin|mesh-list
110324675|NCT00431795|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110324676|NCT00431795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110324677|NCT00431795|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110324678|NCT00431795|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110324679|NCT00431795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110148389|NCT00006471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110324680|NCT00431795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110324681|NCT00462657|Dimercaprol|dimercaprol|mesh-list
110324682|NCT00462657|Chelating Agents|chelating agents|mesh-ancestor
110324683|NCT00462657|Sequestering Agents|sequestering agents|mesh-ancestor
110324684|NCT00462657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110324685|NCT00431990|Dexamethasone|dexamethasone|mesh-list
110324686|NCT00431990|Bortezomib|bortezomib|mesh-list
110324687|NCT00431990|Romidepsin|romidepsin|mesh-list
110324688|NCT00431990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110324689|NCT00431990|Antiemetics|antiemetics|mesh-ancestor
110324690|NCT00431990|Autonomic Agents|autonomic agents|mesh-ancestor
110324691|NCT00431990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110324692|NCT00431990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110324693|NCT00431990|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110324694|NCT00431990|Glucocorticoids|glucocorticoids|mesh-ancestor
110324695|NCT00431990|Hormones|hormones|mesh-ancestor
110324696|NCT00431990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110324697|NCT00431990|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110324698|NCT00431990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110324699|NCT00431990|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110324700|NCT00431990|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110324701|NCT00431990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110324702|NCT00431990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110324703|NCT00462696|Docetaxel|docetaxel|mesh-list
110324704|NCT00462696|Epirubicin|epirubicin|mesh-list
110324705|NCT00462696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110324706|NCT00462696|Tubulin Modulators|tubulin modulators|mesh-ancestor
110324707|NCT00462696|Antimitotic Agents|antimitotic agents|mesh-ancestor
110324708|NCT00462696|Mitosis Modulators|mitosis modulators|mesh-ancestor
110324709|NCT00462696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110324710|NCT00462696|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110324711|NCT00462696|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110324712|NCT00462696|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110324713|NCT00462696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110324714|NCT00462813|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
110324715|NCT00462813|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110324716|NCT00462813|Protective Agents|protective agents|mesh-ancestor
110324717|NCT00462813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110324718|NCT00462813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110324719|NCT01052012|Bupivacaine|bupivacaine|mesh-list
110324720|NCT01052012|Anesthetics, Local|anesthetics, local|mesh-ancestor
110324721|NCT01052012|Anesthetics|anesthetics|mesh-ancestor
110324722|NCT01052012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110324723|NCT01052012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110324724|NCT01052012|Sensory System Agents|sensory system agents|mesh-ancestor
110324725|NCT01052012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110324726|NCT00462852|Gemcitabine|gemcitabine|mesh-list
110324727|NCT00462852|Dalteparin|dalteparin|mesh-list
110324728|NCT00462852|Tinzaparin|tinzaparin|mesh-list
110324729|NCT00462852|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
110324730|NCT00462852|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110324731|NCT00462852|Antimetabolites|antimetabolites|mesh-ancestor
110324732|NCT00462852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110324733|NCT00462852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110324734|NCT00462852|Anticoagulants|anticoagulants|mesh-ancestor
110324735|NCT00462852|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110324736|NCT00462852|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110324737|NCT00471393|Diclofenac|diclofenac|mesh-list
110324738|NCT00471393|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
110324739|NCT00471393|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110324740|NCT00471393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110324741|NCT00471393|Analgesics|analgesics|mesh-ancestor
110324742|NCT00471393|Sensory System Agents|sensory system agents|mesh-ancestor
110324743|NCT00471393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110324744|NCT00471393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110324745|NCT00471393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110324746|NCT00471393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110324747|NCT00471393|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110324748|NCT00471393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110324749|NCT00471393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110324750|NCT00471393|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
110324751|NCT00471393|Protective Agents|protective agents|mesh-ancestor
110324752|NCT00471393|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110324754|NCT00432068|Octreotide|octreotide|mesh-list
110324755|NCT00432068|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110324756|NCT00432068|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110324757|NCT00432068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110324758|NCT03273231|Ketamine|ketamine|mesh-list
110324759|NCT03273231|Analgesics|analgesics|mesh-ancestor
110324760|NCT03273231|Sensory System Agents|sensory system agents|mesh-ancestor
110324761|NCT03273231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110324762|NCT03273231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110324763|NCT03273231|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110324764|NCT03273231|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110324765|NCT03273231|Anesthetics, General|anesthetics, general|mesh-ancestor
110324766|NCT03273231|Anesthetics|anesthetics|mesh-ancestor
110324767|NCT03273231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110324768|NCT03273231|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110324769|NCT03273231|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110324770|NCT03273231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110324771|NCT03273231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110324772|NCT00432146|Lugol's solution|lugol's solution|mesh-list
110324773|NCT00432146|Hemostatics|hemostatics|mesh-ancestor
110324774|NCT00432146|Coagulants|coagulants|mesh-ancestor
110324775|NCT00432302|Sagopilone|sagopilone|mesh-list
110324776|NCT00432302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110324777|NCT00463008|Methotrexate|methotrexate|mesh-list
110324778|NCT00463008|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110324779|NCT00463008|Abortifacient Agents|abortifacient agents|mesh-ancestor
110324780|NCT00463008|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110324781|NCT00463008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110324782|NCT00463008|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110324783|NCT00463008|Antimetabolites|antimetabolites|mesh-ancestor
110324784|NCT00463008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110324785|NCT00463008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110324786|NCT00463008|Dermatologic Agents|dermatologic agents|mesh-ancestor
110324787|NCT00463008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110324788|NCT00463008|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110324789|NCT00463008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110324790|NCT00463008|Immunologic Factors|immunologic factors|mesh-ancestor
110324791|NCT00463008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110324792|NCT00463008|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110324793|NCT00463086|Isoniazid|isoniazid|mesh-list
110324794|NCT00463086|Antitubercular Agents|antitubercular agents|mesh-ancestor
110324795|NCT00463086|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110324796|NCT00463086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110324797|NCT00463086|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
110324798|NCT00463086|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110324799|NCT00463086|Antimetabolites|antimetabolites|mesh-ancestor
110324800|NCT00463086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110324801|NCT00463086|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110324802|NCT02957435|Eplerenone|eplerenone|mesh-list
110324803|NCT02957435|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110324804|NCT02957435|Hormone Antagonists|hormone antagonists|mesh-ancestor
110324805|NCT02957435|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110324806|NCT02957435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110324807|NCT02957435|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110324808|NCT02957435|Diuretics|diuretics|mesh-ancestor
110324809|NCT02957435|Natriuretic Agents|natriuretic agents|mesh-ancestor
110324810|NCT02957435|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110324811|NCT00471471|Sargramostim|sargramostim|mesh-list
110324812|NCT00471471|Immunologic Factors|immunologic factors|mesh-ancestor
110324813|NCT00471471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110324814|NCT02273492|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
110324815|NCT02273492|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110324816|NCT00471510|Proteasome Inhibitors|proteasome inhibitors|mesh-list
110324817|NCT00471510|Protease Inhibitors|protease inhibitors|mesh-ancestor
110324818|NCT00471510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110324819|NCT00471510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110324820|NCT02273531|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
110324821|NCT02273531|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110324822|NCT00463203|Bevacizumab|bevacizumab|mesh-list
110324824|NCT00463203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110324825|NCT00463203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110171057|NCT00043537|Fluoxetine|fluoxetine|mesh-list
110324826|NCT00463203|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110324827|NCT00463203|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110324828|NCT00463203|Growth Substances|growth substances|mesh-ancestor
110324829|NCT00463203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110324830|NCT00463203|Growth Inhibitors|growth inhibitors|mesh-ancestor
110324831|NCT00463203|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110324832|NCT00463203|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110324833|NCT00463203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110324834|NCT00463203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110324835|NCT00471549|Simvastatin|simvastatin|mesh-list
110324836|NCT00471549|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110324837|NCT00471549|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110324838|NCT00471549|Antimetabolites|antimetabolites|mesh-ancestor
110324839|NCT00471549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110324840|NCT00471549|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110324841|NCT00471549|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110324842|NCT00471549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110324844|NCT00432575|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
110324845|NCT00432575|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110324846|NCT00432575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110324847|NCT00432575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110324848|NCT00432575|Hormones|hormones|mesh-ancestor
110324849|NCT00432575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110324850|NCT00432575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110324851|NCT00432614|Escitalopram|escitalopram|mesh-list
110324852|NCT00432614|Amibegron|amibegron|mesh-list
110324853|NCT00432614|Amibegron hydrochloride|amibegron hydrochloride|mesh-list
110324854|NCT00432614|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110324855|NCT00432614|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110324856|NCT00432614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110324857|NCT00432614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110324858|NCT00432614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110324859|NCT00432614|Serotonin Agents|serotonin agents|mesh-ancestor
110324860|NCT00432614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110324861|NCT00432614|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110324862|NCT00432614|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110324863|NCT00432614|Adrenergic Agents|adrenergic agents|mesh-ancestor
110324864|NCT00432614|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
110324865|NCT00463320|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110324866|NCT00463320|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110324868|NCT00432653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110324869|NCT00432653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110324870|NCT00432653|Immunologic Factors|immunologic factors|mesh-ancestor
110324871|NCT00432653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110324872|NCT00432653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110324873|NCT00471588|Pramipexole|pramipexole|mesh-list
110324874|NCT00471588|Amisulpride|amisulpride|mesh-list
110324875|NCT00471588|Antioxidants|antioxidants|mesh-ancestor
110324876|NCT00471588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110324877|NCT00471588|Protective Agents|protective agents|mesh-ancestor
110324878|NCT00471588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110324879|NCT00471588|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110324880|NCT00471588|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110324881|NCT00471588|Dopamine Agonists|dopamine agonists|mesh-ancestor
110324882|NCT00471588|Dopamine Agents|dopamine agents|mesh-ancestor
110324883|NCT00471588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110324884|NCT00471588|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110324885|NCT00471588|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110324886|NCT00471588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110324887|NCT00471588|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110324888|NCT00471588|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110324889|NCT00471588|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110324890|NCT00471588|Antidepressive Agents|antidepressive agents|mesh-ancestor
110324891|NCT00463359|Imiquimod|imiquimod|mesh-list
110374762|NCT00564200|Melphalan|melphalan|mesh-list
110324892|NCT00463359|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110324893|NCT00463359|Immunologic Factors|immunologic factors|mesh-ancestor
110324894|NCT00463359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110324895|NCT00463359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110324897|NCT00471627|Pancrelipase|pancrelipase|mesh-list
110324898|NCT00471627|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110324899|NCT00432887|Caffeine|caffeine|mesh-list
110324900|NCT00432887|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110324901|NCT00432887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110324902|NCT00432887|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110324903|NCT00432887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110324904|NCT00432887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110324905|NCT00432887|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110324906|NCT00432887|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110324907|NCT00432887|Purinergic Agents|purinergic agents|mesh-ancestor
110324908|NCT00432887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110324909|NCT00471744|Levetiracetam|levetiracetam|mesh-list
110324910|NCT00471744|Sulthiame|sulthiame|mesh-list
110324911|NCT00471744|Anticonvulsants|anticonvulsants|mesh-ancestor
110324912|NCT00471744|Nootropic Agents|nootropic agents|mesh-ancestor
110324913|NCT00471783|Chlorhexidine|chlorhexidine|mesh-list
110324914|NCT00471783|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110324915|NCT00471783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110324916|NCT00471783|Disinfectants|disinfectants|mesh-ancestor
110324917|NCT00463515|Carboplatin|carboplatin|mesh-list
110324918|NCT00463515|Gemcitabine|gemcitabine|mesh-list
110324919|NCT00463515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110324920|NCT00463515|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110324921|NCT00463515|Antimetabolites|antimetabolites|mesh-ancestor
110324922|NCT00463515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110324923|NCT00433043|Metoprolol|metoprolol|mesh-list
110324924|NCT00433043|Carvedilol|carvedilol|mesh-list
110324925|NCT00433043|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
110324926|NCT00433043|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110324927|NCT00433043|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110324928|NCT00433043|Sympatholytics|sympatholytics|mesh-ancestor
110324929|NCT00433043|Autonomic Agents|autonomic agents|mesh-ancestor
110324930|NCT00433043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110324931|NCT00433043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110324932|NCT00433043|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110324933|NCT00433043|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110324934|NCT00433043|Adrenergic Agents|adrenergic agents|mesh-ancestor
110324935|NCT00433043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110324936|NCT00433043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110324937|NCT00433043|Antioxidants|antioxidants|mesh-ancestor
110324938|NCT00433043|Protective Agents|protective agents|mesh-ancestor
110324939|NCT00433043|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110324940|NCT00433043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110324941|NCT00433043|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110324942|NCT00433043|Vasodilator Agents|vasodilator agents|mesh-ancestor
110324943|NCT00433043|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110324944|NCT00433043|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110324946|NCT03273075|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
110324948|NCT03273075|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110324949|NCT03273075|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110324950|NCT03273075|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110324951|NCT03273075|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110324952|NCT03273075|Purinergic Agents|purinergic agents|mesh-ancestor
110324953|NCT03273075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110324954|NCT03273075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110324955|NCT03273075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110324956|NCT00471900|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
110324957|NCT00471900|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110324958|NCT00471900|Immunologic Factors|immunologic factors|mesh-ancestor
110324959|NCT00471900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110324960|NCT01051661|Vaccines|vaccines|mesh-list
110324961|NCT01051661|Immunologic Factors|immunologic factors|mesh-ancestor
110324962|NCT01051661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110324963|NCT01051466|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110324964|NCT01051466|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110324965|NCT01051466|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110324966|NCT01051466|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110324967|NCT01051466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110324968|NCT01051466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110324969|NCT01051466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110324971|NCT01051466|Sensory System Agents|sensory system agents|mesh-ancestor
110324972|NCT01051466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110324973|NCT01051466|Antidepressive Agents|antidepressive agents|mesh-ancestor
110324974|NCT01051466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110324975|NCT01051466|Dopamine Agents|dopamine agents|mesh-ancestor
110324977|NCT04446793|Onvansertib|onvansertib|mesh-list
110324978|NCT04446793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110324979|NCT04446793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110324980|NCT04446793|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110324981|NCT04446793|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110324982|NCT04446793|Growth Substances|growth substances|mesh-ancestor
110324983|NCT04446793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110324984|NCT04446793|Growth Inhibitors|growth inhibitors|mesh-ancestor
110324985|NCT04446793|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110324986|NCT04446793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110324987|NCT04446793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110324988|NCT01051349|Daclizumab|daclizumab|mesh-list
110324989|NCT01051349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110324990|NCT01051349|Immunologic Factors|immunologic factors|mesh-ancestor
110324991|NCT01051349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110324992|NCT00433121|Olanzapine|olanzapine|mesh-list
110324993|NCT00433121|Risperidone|risperidone|mesh-list
110324994|NCT00433121|Citalopram|citalopram|mesh-list
110324995|NCT00433121|Escitalopram|escitalopram|mesh-list
110324996|NCT00433121|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110324997|NCT00433121|Serotonin Agents|serotonin agents|mesh-ancestor
110324998|NCT00433121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110324999|NCT00433121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110325000|NCT00433121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110325001|NCT00433121|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110325002|NCT00433121|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110325003|NCT00433121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110325004|NCT00433121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110325005|NCT00433121|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110325006|NCT00433121|Dopamine Agents|dopamine agents|mesh-ancestor
110325007|NCT00433121|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110325008|NCT00433121|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110325009|NCT00433121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110325010|NCT00433121|Autonomic Agents|autonomic agents|mesh-ancestor
110325011|NCT00433121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110325012|NCT00433121|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110325013|NCT00433121|Antidepressive Agents|antidepressive agents|mesh-ancestor
110325015|NCT00433121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110325016|NCT00463671|Acetylcysteine|acetylcysteine|mesh-list
110325017|NCT00463671|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110325018|NCT00463671|Antiviral Agents|antiviral agents|mesh-ancestor
110325019|NCT00463671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110325020|NCT00463671|Expectorants|expectorants|mesh-ancestor
110325021|NCT00463671|Respiratory System Agents|respiratory system agents|mesh-ancestor
110325022|NCT00463671|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110325023|NCT00463671|Antioxidants|antioxidants|mesh-ancestor
110325024|NCT00463671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110325025|NCT00463671|Protective Agents|protective agents|mesh-ancestor
110325026|NCT00463671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110325027|NCT00463671|Antidotes|antidotes|mesh-ancestor
110325028|NCT00591526|Cytarabine|cytarabine|mesh-list
110325029|NCT00591526|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110325030|NCT00591526|Antimetabolites|antimetabolites|mesh-ancestor
110325031|NCT00591526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110325032|NCT00591526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110325033|NCT00591526|Antiviral Agents|antiviral agents|mesh-ancestor
110325034|NCT00591526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110325035|NCT00591526|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110325036|NCT00591526|Immunologic Factors|immunologic factors|mesh-ancestor
110325037|NCT00591526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110325038|NCT00463710|Interferon beta-1a|interferon beta-1a|mesh-list
110325039|NCT00463710|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110325040|NCT00463710|Immunologic Factors|immunologic factors|mesh-ancestor
110325041|NCT00463710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110325042|NCT00463710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110325043|NCT00463710|Antiviral Agents|antiviral agents|mesh-ancestor
110325044|NCT00463710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110325045|NCT00433277|Cyclosporine|cyclosporine|mesh-list
110325046|NCT00433277|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110325047|NCT00433277|Cyclosporins|cyclosporins|mesh-list
110325048|NCT00433277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110325049|NCT00433277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110325050|NCT00433277|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110325051|NCT00433277|Immunologic Factors|immunologic factors|mesh-ancestor
110325052|NCT00433277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110325053|NCT00433277|Antifungal Agents|antifungal agents|mesh-ancestor
110325054|NCT00433277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110325055|NCT00433277|Dermatologic Agents|dermatologic agents|mesh-ancestor
110325056|NCT00433277|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110325057|NCT00433277|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110325058|NCT00433277|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110325059|NCT00463827|Atorvastatin|atorvastatin|mesh-list
110325060|NCT00463827|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110325061|NCT00463827|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110325062|NCT00463827|Antimetabolites|antimetabolites|mesh-ancestor
110325063|NCT00463827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110325064|NCT00463827|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110325065|NCT00463827|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110325066|NCT00463827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110325067|NCT00433316|Ropivacaine|ropivacaine|mesh-list
110325068|NCT00433316|Anesthetics, Local|anesthetics, local|mesh-ancestor
110325069|NCT00433316|Anesthetics|anesthetics|mesh-ancestor
110325070|NCT00433316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110325071|NCT00433316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110325072|NCT00433316|Sensory System Agents|sensory system agents|mesh-ancestor
110325073|NCT00433316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110325074|NCT00472134|Bupivacaine|bupivacaine|mesh-list
110325075|NCT00472134|Anesthetics, Local|anesthetics, local|mesh-ancestor
110325076|NCT00472134|Anesthetics|anesthetics|mesh-ancestor
110325077|NCT00472134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110325078|NCT00472134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110325079|NCT00472134|Sensory System Agents|sensory system agents|mesh-ancestor
110325080|NCT00472134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110325081|NCT00433433|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110325082|NCT00433433|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110325083|NCT00433433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110325085|NCT00463983|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110325086|NCT00463983|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110325087|NCT00463983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110325088|NCT01050998|Mavrilimumab|mavrilimumab|mesh-list
110325089|NCT01050998|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110325090|NCT01050998|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110325091|NCT01050998|Immunologic Factors|immunologic factors|mesh-ancestor
110325092|NCT01050998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110325093|NCT00472173|Calcium|calcium|mesh-list
110325094|NCT00472173|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110325095|NCT00472173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110325096|NCT00472329|Fludarabine|fludarabine|mesh-list
110325097|NCT00472329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110325098|NCT00464217|Idarubicin|idarubicin|mesh-list
110325099|NCT00464217|Molgramostim|molgramostim|mesh-list
110325100|NCT00464217|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110325101|NCT00464217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110325102|NCT00464217|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110325103|NCT00464217|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110325104|NCT00464217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110325105|NCT00464217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110325106|NCT00433784|Clopidogrel|clopidogrel|mesh-list
110325107|NCT00433784|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110325108|NCT00433784|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110325109|NCT00433784|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110325110|NCT00433784|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110325111|NCT00433784|Purinergic Agents|purinergic agents|mesh-ancestor
110325112|NCT00433784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110325113|NCT00433784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110325114|NCT00433784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110325116|NCT00464256|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110325117|NCT00464256|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
110325118|NCT00464256|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110325119|NCT00464256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110325120|NCT00464256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110325121|NCT00464256|Hormones|hormones|mesh-ancestor
110325122|NCT00464256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110325123|NCT00464256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110325124|NCT00433823|Atorvastatin|atorvastatin|mesh-list
110325125|NCT00433823|Ezetimibe|ezetimibe|mesh-list
110325126|NCT00433823|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110325127|NCT00433823|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110325128|NCT00433823|Antimetabolites|antimetabolites|mesh-ancestor
110325129|NCT00433823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110325130|NCT00433823|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110325131|NCT00433823|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110325132|NCT00433823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110325133|NCT00464295|Capecitabine|capecitabine|mesh-list
110325134|NCT00464295|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110325135|NCT00464295|Antimetabolites|antimetabolites|mesh-ancestor
110325136|NCT00464295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110325137|NCT00464295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110325138|NCT03273036|Triamcinolone|triamcinolone|mesh-list
110325139|NCT03273036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110325140|NCT03273036|Glucocorticoids|glucocorticoids|mesh-ancestor
110325141|NCT03273036|Hormones|hormones|mesh-ancestor
110325142|NCT03273036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110325143|NCT03273036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110325144|NCT03270735|Thrombin|thrombin|mesh-list
110325145|NCT03270735|Hemostatics|hemostatics|mesh-ancestor
110325146|NCT03270735|Coagulants|coagulants|mesh-ancestor
110325147|NCT04702685|Ropivacaine|ropivacaine|mesh-list
110325148|NCT04702685|Anesthetics, Local|anesthetics, local|mesh-ancestor
110325149|NCT04702685|Anesthetics|anesthetics|mesh-ancestor
110325150|NCT04702685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110325151|NCT04702685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110325152|NCT04702685|Sensory System Agents|sensory system agents|mesh-ancestor
110325153|NCT04702685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110325154|NCT00464373|Botulinum Toxins|botulinum toxins|mesh-list
110325155|NCT00464373|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110325156|NCT00464373|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110325157|NCT00464373|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110325158|NCT00464373|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110325159|NCT00464373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110325160|NCT00464373|Cholinergic Agents|cholinergic agents|mesh-ancestor
110325161|NCT00464373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110325162|NCT00464373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110325163|NCT00464373|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110325164|NCT00464373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110325166|NCT00472368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110325167|NCT00472368|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110325168|NCT00472368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110325169|NCT00472368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110325170|NCT00106028|Risedronic Acid|risedronic acid|mesh-list
110325171|NCT00106028|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110325172|NCT00106028|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110325173|NCT00106028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110325174|NCT00106028|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110325175|NCT00106028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110325176|NCT00106028|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110325178|NCT00464451|Chloral Hydrate|chloral hydrate|mesh-list
110325179|NCT00464451|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110325180|NCT00464451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110325181|NCT00464451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110325182|NCT00464451|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110325183|NCT00464451|Analgesics|analgesics|mesh-ancestor
110325184|NCT00464451|Sensory System Agents|sensory system agents|mesh-ancestor
110325185|NCT00464451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110325186|NCT00464451|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110325187|NCT00464451|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110325188|NCT00464451|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110325189|NCT00464451|Adrenergic Agents|adrenergic agents|mesh-ancestor
110325190|NCT00464451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110325191|NCT00464451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110325192|NCT00433940|Prednisolone|prednisolone|mesh-list
110325193|NCT00433940|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110325194|NCT00433940|Glucocorticoids|glucocorticoids|mesh-ancestor
110325195|NCT00433940|Hormones|hormones|mesh-ancestor
110325196|NCT00433940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110325197|NCT00433940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110325198|NCT00433940|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110325199|NCT00433940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110325200|NCT00433979|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
110325201|NCT00433979|Antiviral Agents|antiviral agents|mesh-ancestor
110325202|NCT00433979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110325203|NCT01050764|Vidarabine|vidarabine|mesh-list
110325204|NCT01050764|Fludarabine|fludarabine|mesh-list
110325205|NCT01050764|Fludarabine phosphate|fludarabine phosphate|mesh-list
110325206|NCT01050764|Melphalan|melphalan|mesh-list
110325207|NCT01050764|Thiotepa|thiotepa|mesh-list
110325208|NCT01050764|Thymoglobulin|thymoglobulin|mesh-list
110325209|NCT01050764|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110325210|NCT01050764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110325211|NCT01050764|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110325212|NCT01050764|Antimetabolites|antimetabolites|mesh-ancestor
110325213|NCT01050764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110325214|NCT01050764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110325215|NCT01050764|Immunologic Factors|immunologic factors|mesh-ancestor
110325216|NCT01050764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110325218|NCT01050764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110325219|NCT01050764|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110325220|NCT01050764|Alkylating Agents|alkylating agents|mesh-ancestor
110325221|NCT01050764|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110325222|NCT00434096|Rimonabant|rimonabant|mesh-list
110325223|NCT00434096|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110325224|NCT00434096|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
110325225|NCT00434096|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110325226|NCT00434096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110325227|NCT00434096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110325228|NCT00434096|Hormones|hormones|mesh-ancestor
110325229|NCT00434096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110325230|NCT00434096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110325231|NCT01050569|Nicotine|nicotine|mesh-list
110325232|NCT01050569|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110325233|NCT01050569|Autonomic Agents|autonomic agents|mesh-ancestor
110325234|NCT01050569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110325235|NCT01050569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110325236|NCT01050569|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110325237|NCT01050569|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110325238|NCT01050569|Cholinergic Agents|cholinergic agents|mesh-ancestor
110325239|NCT01050569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110325240|NCT01050569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110325242|NCT04702490|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110325243|NCT04702490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110325244|NCT04702490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110325245|NCT04702490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110325246|NCT00464763|Dexmedetomidine|dexmedetomidine|mesh-list
110325247|NCT00464763|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110325248|NCT00464763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110325249|NCT00464763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110325250|NCT00464763|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110325251|NCT00464763|Analgesics|analgesics|mesh-ancestor
110325252|NCT00464763|Sensory System Agents|sensory system agents|mesh-ancestor
110325253|NCT00464763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110325254|NCT00464763|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110325255|NCT00464763|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110325256|NCT00464763|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110325257|NCT00464763|Adrenergic Agents|adrenergic agents|mesh-ancestor
110325258|NCT00464763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110325259|NCT00464763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110325260|NCT00434135|Paclitaxel|paclitaxel|mesh-list
110325261|NCT00434135|Gemcitabine|gemcitabine|mesh-list
110325262|NCT00434135|Pemetrexed|pemetrexed|mesh-list
110325263|NCT00434135|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110325264|NCT00434135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110325265|NCT00434135|Tubulin Modulators|tubulin modulators|mesh-ancestor
110325266|NCT00434135|Antimitotic Agents|antimitotic agents|mesh-ancestor
110325267|NCT00434135|Mitosis Modulators|mitosis modulators|mesh-ancestor
110325268|NCT00434135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110325269|NCT00434135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110325270|NCT00434135|Antimetabolites|antimetabolites|mesh-ancestor
110325271|NCT00434135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110325272|NCT00434135|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110325273|NCT00434135|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110325274|NCT01050530|Tolvaptan|tolvaptan|mesh-list
110325275|NCT01050530|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
110325276|NCT01050530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110325277|NCT01050530|Natriuretic Agents|natriuretic agents|mesh-ancestor
110325278|NCT01050530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110325279|NCT01050257|Oseltamivir|oseltamivir|mesh-list
110325280|NCT01050257|Antiviral Agents|antiviral agents|mesh-ancestor
110325281|NCT01050257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110325282|NCT01050257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110325283|NCT01050257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110325284|NCT03272802|Riluzole|riluzole|mesh-list
110325285|NCT03272802|Edaravone|edaravone|mesh-list
110325286|NCT03272802|Anticonvulsants|anticonvulsants|mesh-ancestor
110325287|NCT03272802|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110325288|NCT03272802|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110325290|NCT03272802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110325291|NCT03272802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110325292|NCT03272802|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110325293|NCT03272802|Protective Agents|protective agents|mesh-ancestor
110325294|NCT03272802|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110325295|NCT03272802|Antioxidants|antioxidants|mesh-ancestor
110325296|NCT01050218|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
110325297|NCT01050218|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110325298|NCT01050218|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110325299|NCT01050218|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110325300|NCT01050218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110325301|NCT01050218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110325302|NCT01050218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110325303|NCT01050218|Antidepressive Agents|antidepressive agents|mesh-ancestor
110325304|NCT01050218|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110325305|NCT01050062|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110325308|NCT01050062|Diuretics|diuretics|mesh-ancestor
110325309|NCT01050062|Natriuretic Agents|natriuretic agents|mesh-ancestor
110325310|NCT01050062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110325311|NCT01050062|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110325312|NCT01050062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110325313|NCT01050062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110325314|NCT01050062|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110325315|NCT01050062|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110325316|NCT00464919|Sorafenib|sorafenib|mesh-list
110325317|NCT00464919|Tegafur|tegafur|mesh-list
110325318|NCT00464919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110325319|NCT00464919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110325320|NCT00464919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110325321|NCT00464919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110325322|NCT00464919|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110325323|NCT00464919|Antimetabolites|antimetabolites|mesh-ancestor
110325324|NCT00434174|Pemetrexed|pemetrexed|mesh-list
110325325|NCT00434174|Everolimus|everolimus|mesh-list
110325326|NCT00434174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110325327|NCT00434174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110325328|NCT00434174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110325329|NCT00434174|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110325330|NCT00434174|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110325331|NCT00434174|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110325332|NCT00434174|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110325333|NCT00434174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110325334|NCT00434174|Immunologic Factors|immunologic factors|mesh-ancestor
110325335|NCT00434174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110325337|NCT00464958|Analgesics|analgesics|mesh-ancestor
110325338|NCT00464958|Sensory System Agents|sensory system agents|mesh-ancestor
110325339|NCT00464958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110325340|NCT00464958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110325341|NCT00464958|Anticonvulsants|anticonvulsants|mesh-ancestor
110325342|NCT00464958|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110325343|NCT00464958|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110325344|NCT00464958|Parasympatholytics|parasympatholytics|mesh-ancestor
110325345|NCT00464958|Autonomic Agents|autonomic agents|mesh-ancestor
110325346|NCT00464958|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110325347|NCT00464958|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110325348|NCT00464958|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110325349|NCT00464958|Adrenergic Agents|adrenergic agents|mesh-ancestor
110325350|NCT00464958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110325351|NCT00464958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110325352|NCT00472758|Sifalimumab|sifalimumab|mesh-list
110325353|NCT00472758|Immunologic Factors|immunologic factors|mesh-ancestor
110325354|NCT00472758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110325355|NCT01055444|Lidocaine|lidocaine|mesh-list
110325356|NCT01055444|Tetracaine|tetracaine|mesh-list
110325357|NCT01055444|Anesthetics, Local|anesthetics, local|mesh-ancestor
110325358|NCT01055444|Anesthetics|anesthetics|mesh-ancestor
110325359|NCT01055444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110325360|NCT01055444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110325361|NCT01055444|Sensory System Agents|sensory system agents|mesh-ancestor
110325362|NCT01055444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110325363|NCT01055444|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110325364|NCT01055444|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110325365|NCT01055444|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110325366|NCT01055444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110325367|NCT01055444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110325369|NCT01055015|Oxycodone|oxycodone|mesh-list
110325370|NCT01055015|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110325371|NCT01055015|Narcotics|narcotics|mesh-ancestor
110325372|NCT01055015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110325373|NCT01055015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110325374|NCT01055015|Analgesics|analgesics|mesh-ancestor
110325375|NCT01055015|Sensory System Agents|sensory system agents|mesh-ancestor
110325376|NCT01055015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110325378|NCT00472875|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110325379|NCT00472875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110325380|NCT00434291|Nemonoxacin|nemonoxacin|mesh-list
110325381|NCT00434291|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110325382|NCT00434291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110325383|NCT00434447|Zoledronic Acid|zoledronic acid|mesh-list
110325384|NCT00434447|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110325385|NCT00434447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110325386|NCT00472953|Insulin|insulin|mesh-list
110325387|NCT00472953|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110325388|NCT00472953|Insulin Aspart|insulin aspart|mesh-list
110325389|NCT00472953|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110325390|NCT00472953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110325391|NCT02957630|Drospirenone|drospirenone|mesh-list
110325392|NCT02957630|Levonorgestrel|levonorgestrel|mesh-list
110325393|NCT02957630|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110325394|NCT02957630|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110325395|NCT02957630|Contraceptive Agents|contraceptive agents|mesh-ancestor
110325396|NCT02957630|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110325397|NCT02957630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110325398|NCT02957630|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110325399|NCT02957630|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110325400|NCT02957630|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110325401|NCT02957630|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110325402|NCT02957630|Estrogens|estrogens|mesh-ancestor
110325403|NCT02957630|Hormones|hormones|mesh-ancestor
110325404|NCT02957630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110325405|NCT02957630|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110325406|NCT02957630|Hormone Antagonists|hormone antagonists|mesh-ancestor
110325407|NCT02957630|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110325408|NCT02957630|Diuretics|diuretics|mesh-ancestor
110325410|NCT00465036|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
110325411|NCT00465036|Cathartics|cathartics|mesh-ancestor
110325412|NCT00465036|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110325413|NCT04702061|Anesthetics|anesthetics|mesh-list
110325414|NCT04702061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110325415|NCT04702061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110325416|NCT00465075|Bazedoxifene|bazedoxifene|mesh-list
110325417|NCT00465075|Estrogens|estrogens|mesh-list
110325418|NCT00465075|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
110325419|NCT00465075|Hormones|hormones|mesh-ancestor
110325420|NCT00465075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110325421|NCT00465075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110325422|NCT00465075|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110325423|NCT00465075|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110325424|NCT00465075|Hormone Antagonists|hormone antagonists|mesh-ancestor
110325425|NCT00465075|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110325426|NCT00465192|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110325427|NCT00465192|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110325428|NCT00465192|Estradiol|estradiol|mesh-list
110325429|NCT00465192|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110325430|NCT00465192|Estrogens|estrogens|mesh-ancestor
110325432|NCT00465192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110325434|NCT00465192|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110325435|NCT00465192|Contraceptive Agents|contraceptive agents|mesh-ancestor
110325436|NCT00465192|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110325437|NCT00465192|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110325438|NCT00434681|Acetaminophen|acetaminophen|mesh-list
110325439|NCT00434681|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110325440|NCT00434681|Analgesics|analgesics|mesh-ancestor
110325441|NCT00434681|Sensory System Agents|sensory system agents|mesh-ancestor
110325442|NCT00434681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110325443|NCT00434681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110325444|NCT00434681|Antipyretics|antipyretics|mesh-ancestor
110325445|NCT00473070|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
110325446|NCT00473070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110325447|NCT00473070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110325448|NCT00473070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110325449|NCT00473070|Glucocorticoids|glucocorticoids|mesh-ancestor
110325450|NCT00473070|Hormones|hormones|mesh-ancestor
110325451|NCT00473070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110325452|NCT00473070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110325454|NCT00473070|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110325455|NCT03272568|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
110325456|NCT03272568|Immunologic Factors|immunologic factors|mesh-ancestor
110325457|NCT03272568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110325458|NCT04702334|Lidocaine|lidocaine|mesh-list
110325459|NCT04702334|Hyaluronic Acid|hyaluronic acid|mesh-list
110325460|NCT04702334|Anesthetics, Local|anesthetics, local|mesh-ancestor
110325461|NCT04702334|Anesthetics|anesthetics|mesh-ancestor
110325462|NCT04702334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110325463|NCT04702334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110325464|NCT04702334|Sensory System Agents|sensory system agents|mesh-ancestor
110325465|NCT04702334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110325466|NCT04702334|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110325467|NCT04702334|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110325468|NCT04702334|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110325469|NCT04702334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110325470|NCT04702334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110325471|NCT04702334|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110325472|NCT04702334|Immunologic Factors|immunologic factors|mesh-ancestor
110325473|NCT04702334|Viscosupplements|viscosupplements|mesh-ancestor
110325474|NCT04702334|Protective Agents|protective agents|mesh-ancestor
110325475|NCT00473460|Moxifloxacin|moxifloxacin|mesh-list
110325476|NCT00473460|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
110325477|NCT00473460|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110325478|NCT00473460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110325479|NCT00473460|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110325480|NCT00473460|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110325481|NCT00473460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110325482|NCT00473460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110325483|NCT00473460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110325484|NCT00473460|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110325485|NCT00473460|Contraceptive Agents|contraceptive agents|mesh-ancestor
110325486|NCT00473460|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110325487|NCT00473460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110325488|NCT00473460|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110325489|NCT00473460|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110325490|NCT00473460|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110325491|NCT00435305|Vancomycin|vancomycin|mesh-list
110325492|NCT00435305|Meropenem|meropenem|mesh-list
110325493|NCT00435305|Tazobactam|tazobactam|mesh-list
110325494|NCT00435305|Linezolid|linezolid|mesh-list
110325495|NCT00435305|Piperacillin|piperacillin|mesh-list
110325496|NCT00435305|Ceftazidime|ceftazidime|mesh-list
110325497|NCT00435305|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
110325498|NCT00435305|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110325499|NCT00435305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110325500|NCT00435305|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110325501|NCT00435305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110325502|NCT00435305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110325503|NCT00435305|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110325504|NCT00465543|Rosmarinic acid|rosmarinic acid|mesh-list
110325505|NCT00465543|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110325506|NCT00465543|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110325508|NCT00465543|Sensory System Agents|sensory system agents|mesh-ancestor
110171143|NCT00043888|Ritonavir|ritonavir|mesh-list
110325509|NCT00465543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110325510|NCT00465543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110325511|NCT00465543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110325512|NCT00465543|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110325513|NCT00465543|Antioxidants|antioxidants|mesh-ancestor
110325514|NCT00465543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110325515|NCT00465543|Protective Agents|protective agents|mesh-ancestor
110325516|NCT00465543|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110325517|NCT00465543|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110325518|NCT00465543|Protease Inhibitors|protease inhibitors|mesh-ancestor
110325519|NCT00465543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110325520|NCT00435500|Fluorides|fluorides|mesh-list
110325521|NCT00435500|Fluorides, Topical|fluorides, topical|mesh-list
110325522|NCT00435500|Cariostatic Agents|cariostatic agents|mesh-ancestor
110325523|NCT00435500|Protective Agents|protective agents|mesh-ancestor
110325524|NCT00435500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110325525|NCT03272412|Progesterone|progesterone|mesh-list
110325527|NCT03272412|Hormones|hormones|mesh-ancestor
110325528|NCT03272412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110325529|NCT03272412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110325530|NCT00473616|Irinotecan|irinotecan|mesh-list
110325531|NCT00473616|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110325532|NCT00473616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110325533|NCT00473616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110325534|NCT00473616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110325535|NCT00473616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110325536|NCT00435851|Hormones|hormones|mesh-list
110325537|NCT00435851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110325538|NCT00435851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110325539|NCT00436124|Oseltamivir|oseltamivir|mesh-list
110325540|NCT00436124|Antiviral Agents|antiviral agents|mesh-ancestor
110325541|NCT00436124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110325542|NCT00436124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110325543|NCT00436124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110325544|NCT02957474|Omeprazole|omeprazole|mesh-list
110325545|NCT02957474|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110325546|NCT02957474|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110325547|NCT02957474|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110325548|NCT02957474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110325549|NCT02957474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110325550|NCT00465231|Fentanyl|fentanyl|mesh-list
110325551|NCT00465231|Bupivacaine|bupivacaine|mesh-list
110325552|NCT00465231|Anesthetics, Local|anesthetics, local|mesh-ancestor
110325553|NCT00465231|Anesthetics|anesthetics|mesh-ancestor
110325554|NCT00465231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110325555|NCT00465231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110325556|NCT00465231|Sensory System Agents|sensory system agents|mesh-ancestor
110325557|NCT00465231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110325558|NCT00465231|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110325559|NCT00465231|Narcotics|narcotics|mesh-ancestor
110325560|NCT00465231|Analgesics|analgesics|mesh-ancestor
110325561|NCT00465231|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110325562|NCT00465231|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110325563|NCT00465231|Anesthetics, General|anesthetics, general|mesh-ancestor
110325564|NCT00436241|Capecitabine|capecitabine|mesh-list
110325565|NCT00436241|Oxaliplatin|oxaliplatin|mesh-list
110325566|NCT00436241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110325567|NCT00436241|Antimetabolites|antimetabolites|mesh-ancestor
110325568|NCT00436241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110325569|NCT00436241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110325570|NCT00481455|Temozolomide|temozolomide|mesh-list
110325571|NCT00481455|2-Methoxyestradiol|2-methoxyestradiol|mesh-list
110325572|NCT00481455|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110325573|NCT00481455|Alkylating Agents|alkylating agents|mesh-ancestor
110325574|NCT00481455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110325575|NCT00481455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110325576|NCT00481455|Tubulin Modulators|tubulin modulators|mesh-ancestor
110325577|NCT00481455|Antimitotic Agents|antimitotic agents|mesh-ancestor
110325578|NCT00481455|Mitosis Modulators|mitosis modulators|mesh-ancestor
110325580|NCT00481533|Ergonovine|ergonovine|mesh-list
110325581|NCT00481533|Oxytocics|oxytocics|mesh-ancestor
110325582|NCT00481533|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110325583|NCT00481533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110325584|NCT00481572|Terlipressin|terlipressin|mesh-list
110325585|NCT00481572|Vasopressins|vasopressins|mesh-list
110325586|NCT00481572|Arginine Vasopressin|arginine vasopressin|mesh-list
110325587|NCT00481572|Norepinephrine|norepinephrine|mesh-list
110325588|NCT00481572|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110325589|NCT00481572|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110325590|NCT00481572|Adrenergic Agents|adrenergic agents|mesh-ancestor
110325591|NCT00481572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110325592|NCT00481572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110325593|NCT00481572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110325594|NCT00481572|Sympathomimetics|sympathomimetics|mesh-ancestor
110325595|NCT00481572|Autonomic Agents|autonomic agents|mesh-ancestor
110325596|NCT00481572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110325597|NCT00481572|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110325598|NCT00481572|Hemostatics|hemostatics|mesh-ancestor
110325599|NCT00481572|Coagulants|coagulants|mesh-ancestor
110325600|NCT00481572|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
110325601|NCT00481572|Natriuretic Agents|natriuretic agents|mesh-ancestor
110325602|NCT00481572|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110325603|NCT00474006|Daunorubicin|daunorubicin|mesh-list
110325604|NCT00474006|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110325605|NCT00474006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110325606|NCT00474006|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110325607|NCT00474006|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110325608|NCT00474006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110325609|NCT00474006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110325610|NCT04697745|Dexamethasone|dexamethasone|mesh-list
110325611|NCT04697745|Dexmedetomidine|dexmedetomidine|mesh-list
110325612|NCT04697745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110325613|NCT04697745|Antiemetics|antiemetics|mesh-ancestor
110325614|NCT04697745|Autonomic Agents|autonomic agents|mesh-ancestor
110325615|NCT04697745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110325616|NCT04697745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110325617|NCT04697745|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110325618|NCT04697745|Glucocorticoids|glucocorticoids|mesh-ancestor
110325620|NCT04697745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110325621|NCT04697745|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110325622|NCT04697745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110325623|NCT04697745|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110325624|NCT04697745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110325625|NCT04697745|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110325626|NCT04697745|Analgesics|analgesics|mesh-ancestor
110325627|NCT04697745|Sensory System Agents|sensory system agents|mesh-ancestor
110325628|NCT04697745|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110325629|NCT04697745|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110325630|NCT04697745|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110325631|NCT04697745|Adrenergic Agents|adrenergic agents|mesh-ancestor
110325632|NCT04697745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110325633|NCT04697745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110325634|NCT00481689|Ciprofloxacin|ciprofloxacin|mesh-list
110325635|NCT00481689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110325636|NCT00481689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110325637|NCT00481689|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110325638|NCT00481689|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110325639|NCT00481689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110325640|NCT00481689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110325641|NCT00481689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110325642|NCT00481689|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110325643|NCT00481689|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110325644|NCT00436709|Paclitaxel|paclitaxel|mesh-list
110325645|NCT00436709|Cyclophosphamide|cyclophosphamide|mesh-list
110325646|NCT00436709|Bevacizumab|bevacizumab|mesh-list
110325647|NCT00436709|Doxorubicin|doxorubicin|mesh-list
110325648|NCT00436709|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110325649|NCT00436709|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110325650|NCT00436709|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110325651|NCT00436709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110325652|NCT00436709|Tubulin Modulators|tubulin modulators|mesh-ancestor
110325653|NCT00436709|Antimitotic Agents|antimitotic agents|mesh-ancestor
110325654|NCT00436709|Mitosis Modulators|mitosis modulators|mesh-ancestor
110325655|NCT00436709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110325656|NCT00436709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110325657|NCT00436709|Immunologic Factors|immunologic factors|mesh-ancestor
110325658|NCT00436709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110325659|NCT00436709|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110325660|NCT00436709|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110325661|NCT00436709|Alkylating Agents|alkylating agents|mesh-ancestor
110325662|NCT00436709|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110325663|NCT00436709|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110325664|NCT00436709|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110325665|NCT00436709|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110325666|NCT00436709|Growth Substances|growth substances|mesh-ancestor
110325667|NCT00436709|Growth Inhibitors|growth inhibitors|mesh-ancestor
110325668|NCT00436709|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110325669|NCT00436709|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110325670|NCT00436709|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110325671|NCT00436709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110325672|NCT00436787|PENTA|penta|mesh-list
110325673|NCT00436787|Fondaparinux|fondaparinux|mesh-list
110325674|NCT00436787|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110325675|NCT00436787|Antithrombins|antithrombins|mesh-ancestor
110325676|NCT00436787|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110325677|NCT00436787|Protease Inhibitors|protease inhibitors|mesh-ancestor
110325678|NCT00436787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110325679|NCT00436787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110325680|NCT00436787|Anticoagulants|anticoagulants|mesh-ancestor
110325681|NCT00436787|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110325682|NCT00436787|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110325683|NCT00481728|Tolterodine Tartrate|tolterodine tartrate|mesh-list
110325684|NCT00481728|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110325685|NCT00481728|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110325686|NCT00481728|Cholinergic Agents|cholinergic agents|mesh-ancestor
110325687|NCT00481728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110325688|NCT00481728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110325689|NCT00481728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110325692|NCT00436943|Nicotine|nicotine|mesh-list
110325693|NCT00436943|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110325694|NCT00436943|Autonomic Agents|autonomic agents|mesh-ancestor
110325695|NCT00436943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110325696|NCT00436943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110325697|NCT00436943|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110325698|NCT00436943|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110325699|NCT00436943|Cholinergic Agents|cholinergic agents|mesh-ancestor
110325700|NCT00436943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110171175|NCT00043927|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110325701|NCT00436943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110325702|NCT00436943|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110325703|NCT00436943|Antidepressive Agents|antidepressive agents|mesh-ancestor
110325704|NCT00436943|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110325705|NCT00436943|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110325706|NCT00436943|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110325707|NCT00436943|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110325709|NCT00436943|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110325710|NCT00436943|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110325711|NCT00436943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110325712|NCT00474162|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
110325713|NCT00474162|Plasma Substitutes|plasma substitutes|mesh-ancestor
110325714|NCT00474162|Blood Substitutes|blood substitutes|mesh-ancestor
110325715|NCT00481884|Petrolatum|petrolatum|mesh-list
110325716|NCT00481884|Emollients|emollients|mesh-ancestor
110325717|NCT00481884|Dermatologic Agents|dermatologic agents|mesh-ancestor
110325718|NCT00481923|Rimonabant|rimonabant|mesh-list
110325719|NCT00481923|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110325720|NCT00481923|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
110325721|NCT00481923|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110325722|NCT00481923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110325723|NCT00481923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110325724|NCT00481923|Hormones|hormones|mesh-ancestor
110325725|NCT00481923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110325726|NCT00481923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110325727|NCT00481962|Tigecycline|tigecycline|mesh-list
110325728|NCT00481962|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110325729|NCT00481962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110325730|NCT00481962|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110325731|NCT00481962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110325732|NCT00481962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110325733|NCT00437177|Apomorphine|apomorphine|mesh-list
110325734|NCT00437177|Emetics|emetics|mesh-ancestor
110325735|NCT00437177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110325736|NCT00437177|Autonomic Agents|autonomic agents|mesh-ancestor
110325737|NCT00437177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110325738|NCT00437177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110325739|NCT00437177|Dopamine Agonists|dopamine agonists|mesh-ancestor
110325740|NCT00437177|Dopamine Agents|dopamine agents|mesh-ancestor
110325741|NCT00437177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110325742|NCT00437177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110325743|NCT00437333|Metformin|metformin|mesh-list
110325744|NCT00437333|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110325745|NCT00437333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110325746|NCT00482079|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110325747|NCT00482079|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110325748|NCT00482079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110325750|NCT00482079|Hormones|hormones|mesh-ancestor
110325751|NCT00482079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110325752|NCT00482079|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110325753|NCT00482079|Protease Inhibitors|protease inhibitors|mesh-ancestor
110325754|NCT00482079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110325755|NCT00482079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110325756|NCT00437372|Sunitinib|sunitinib|mesh-list
110325757|NCT00437372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110325758|NCT00437372|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110325759|NCT00437372|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110325760|NCT00437372|Growth Substances|growth substances|mesh-ancestor
110325761|NCT00437372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110325762|NCT00437372|Growth Inhibitors|growth inhibitors|mesh-ancestor
110325763|NCT00437372|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110325764|NCT00437372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110325765|NCT00437372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110325766|NCT00437450|Epoetin Alfa|epoetin alfa|mesh-list
110325767|NCT00437450|Hematinics|hematinics|mesh-ancestor
110325768|NCT04701710|Ivermectin|ivermectin|mesh-list
110325769|NCT04701710|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110325770|NCT04701710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110325771|NCT00437606|Ethanol|ethanol|mesh-list
110171179|NCT00043966|Ritonavir|ritonavir|mesh-list
110325772|NCT00437606|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110325773|NCT00437606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110325774|NCT00437606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110325775|NCT00437606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110325776|NCT00482313|Methylphenidate|methylphenidate|mesh-list
110325777|NCT00482313|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110325778|NCT00482313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110325779|NCT00482313|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110325780|NCT00482313|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110325781|NCT00482313|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110325782|NCT00482313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110325783|NCT00482313|Dopamine Agents|dopamine agents|mesh-ancestor
110325784|NCT00482313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110325785|NCT00437684|Ribavirin|ribavirin|mesh-list
110325786|NCT00437684|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110325787|NCT00437684|Antimetabolites|antimetabolites|mesh-ancestor
110325788|NCT00437684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110325789|NCT00437684|Antiviral Agents|antiviral agents|mesh-ancestor
110325790|NCT00437684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110325792|NCT00437723|Hematinics|hematinics|mesh-ancestor
110325793|NCT00437762|Botulinum Toxins|botulinum toxins|mesh-list
110325794|NCT00437762|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110325795|NCT00437762|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110325796|NCT00437762|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110325797|NCT00437762|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110325798|NCT00437762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110325799|NCT00437762|Cholinergic Agents|cholinergic agents|mesh-ancestor
110325800|NCT00437762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110325801|NCT00437762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110325802|NCT00437762|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110325803|NCT00437762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110325804|NCT00482508|Omalizumab|omalizumab|mesh-list
110325805|NCT00482508|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110325806|NCT00482508|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110325807|NCT00482508|Respiratory System Agents|respiratory system agents|mesh-ancestor
110325808|NCT00437918|Acarbose|acarbose|mesh-list
110325809|NCT00437918|Nateglinide|nateglinide|mesh-list
110325810|NCT00437918|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
110325811|NCT00437918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110325812|NCT00437918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110325813|NCT00437918|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110325814|NCT00437918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110325815|NCT00437957|Temozolomide|temozolomide|mesh-list
110325816|NCT00437957|Valproic Acid|valproic acid|mesh-list
110325817|NCT00437957|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110325818|NCT00437957|Alkylating Agents|alkylating agents|mesh-ancestor
110325819|NCT00437957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110325820|NCT00437957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110325821|NCT00437957|Anticonvulsants|anticonvulsants|mesh-ancestor
110325822|NCT00437957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110325823|NCT00437957|GABA Agents|gaba agents|mesh-ancestor
110325824|NCT00437957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110325825|NCT00437957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110325826|NCT00437957|Antimanic Agents|antimanic agents|mesh-ancestor
110325827|NCT00437957|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110325828|NCT00437957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110325829|NCT00437957|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110325830|NCT03270176|Avelumab|avelumab|mesh-list
110325831|NCT03270176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110325832|NCT03270176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110325833|NCT00474279|Hormones|hormones|mesh-list
110325834|NCT00474279|Secretagogues|secretagogues|mesh-list
110325835|NCT00474279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110325836|NCT00474279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110325837|NCT03270696|Propofol|propofol|mesh-list
110325838|NCT03270696|Rocuronium|rocuronium|mesh-list
110325839|NCT03270696|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110325840|NCT03270696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110325841|NCT03270696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110325842|NCT03270696|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110325843|NCT03270696|Anesthetics, General|anesthetics, general|mesh-ancestor
110325844|NCT03270696|Anesthetics|anesthetics|mesh-ancestor
110325845|NCT03270696|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110325846|NCT03270696|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110325847|NCT03270696|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110325848|NCT03270696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110325849|NCT00437996|Clonidine|clonidine|mesh-list
110325850|NCT00437996|Sufentanil|sufentanil|mesh-list
110325851|NCT00437996|Levobupivacaine|levobupivacaine|mesh-list
110325852|NCT00437996|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110325853|NCT00437996|Narcotics|narcotics|mesh-ancestor
110325854|NCT00437996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110325855|NCT00437996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110325856|NCT00437996|Analgesics|analgesics|mesh-ancestor
110325857|NCT00437996|Sensory System Agents|sensory system agents|mesh-ancestor
110325858|NCT00437996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110325859|NCT00437996|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110325860|NCT00437996|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110325861|NCT00437996|Anesthetics, General|anesthetics, general|mesh-ancestor
110325862|NCT00437996|Anesthetics|anesthetics|mesh-ancestor
110325863|NCT00437996|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110325864|NCT00437996|Sympatholytics|sympatholytics|mesh-ancestor
110325865|NCT00437996|Autonomic Agents|autonomic agents|mesh-ancestor
110325866|NCT00437996|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110325867|NCT00437996|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110325868|NCT00437996|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110325869|NCT00437996|Adrenergic Agents|adrenergic agents|mesh-ancestor
110325870|NCT00437996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110325871|NCT00437996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110325872|NCT00437996|Anesthetics, Local|anesthetics, local|mesh-ancestor
110325873|NCT04701242|Ezetimibe|ezetimibe|mesh-list
110325874|NCT04701242|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110325875|NCT04701242|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110325876|NCT04701242|Antimetabolites|antimetabolites|mesh-ancestor
110325877|NCT04701242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110325878|NCT04701242|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110325879|NCT00474435|Tenofovir|tenofovir|mesh-list
110325880|NCT00474435|Emtricitabine|emtricitabine|mesh-list
110325881|NCT00474435|Efavirenz|efavirenz|mesh-list
110325882|NCT00474435|Antiviral Agents|antiviral agents|mesh-ancestor
110325883|NCT00474435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110325884|NCT00474435|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110325885|NCT00474435|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110325887|NCT00474435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110325888|NCT00474435|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110325889|NCT00474435|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110325890|NCT00474435|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110325891|NCT00474435|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110325892|NCT00474435|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110325893|NCT00474435|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110325894|NCT00474435|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110325895|NCT00474435|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110325897|NCT04701320|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110325898|NCT04701320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110325899|NCT04701320|Sympathomimetics|sympathomimetics|mesh-ancestor
110325900|NCT04701320|Autonomic Agents|autonomic agents|mesh-ancestor
110325901|NCT04701320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110325902|NCT04701320|Dopamine Agents|dopamine agents|mesh-ancestor
110325903|NCT04701320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110325904|NCT04701320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110325905|NCT04701320|Adrenergic Agents|adrenergic agents|mesh-ancestor
110325906|NCT04701320|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110325907|NCT04701320|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110325908|NCT04701320|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110325909|NCT04701320|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110325911|NCT00438113|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110325912|NCT00438113|Terazosin|terazosin|mesh-list
110325913|NCT00438113|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110325914|NCT00438113|Diuretics|diuretics|mesh-ancestor
110325915|NCT00438113|Natriuretic Agents|natriuretic agents|mesh-ancestor
110325916|NCT00438113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110325917|NCT00438113|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110325918|NCT00438113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110325919|NCT00438113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110325920|NCT00438113|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110325921|NCT00438113|Sympatholytics|sympatholytics|mesh-ancestor
110325922|NCT00438113|Autonomic Agents|autonomic agents|mesh-ancestor
110325923|NCT00438113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110325924|NCT00438113|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110325925|NCT00438113|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110325926|NCT00438113|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110325927|NCT00438113|Adrenergic Agents|adrenergic agents|mesh-ancestor
110325928|NCT00438113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110325930|NCT00438113|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110325931|NCT00438113|Urological Agents|urological agents|mesh-ancestor
110325932|NCT00438152|Ritonavir|ritonavir|mesh-list
110325933|NCT00438152|Lopinavir|lopinavir|mesh-list
110325934|NCT00438152|Saquinavir|saquinavir|mesh-list
110325935|NCT00438152|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110325936|NCT00438152|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110325937|NCT00438152|Protease Inhibitors|protease inhibitors|mesh-ancestor
110325938|NCT00438152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110325939|NCT00438152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110325940|NCT00438152|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110325941|NCT00438152|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110325942|NCT00438152|Antiviral Agents|antiviral agents|mesh-ancestor
110325943|NCT00438152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110325944|NCT00438152|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110325945|NCT00438152|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110325947|NCT00438230|Anticoagulants|anticoagulants|mesh-ancestor
110325948|NCT00438269|Metronidazole|metronidazole|mesh-list
110325949|NCT00438269|Ciprofloxacin|ciprofloxacin|mesh-list
110325950|NCT00438269|Meropenem|meropenem|mesh-list
110325951|NCT00438269|Cefazolin|cefazolin|mesh-list
110325952|NCT00438269|Tazobactam|tazobactam|mesh-list
110325953|NCT00438269|Piperacillin|piperacillin|mesh-list
110325954|NCT00438269|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
110325955|NCT00438269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110325956|NCT00438269|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110325957|NCT00438269|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110325958|NCT00438269|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110325959|NCT00438269|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110325960|NCT00438269|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110325961|NCT00438269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110325962|NCT00438269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110325963|NCT00438269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110325964|NCT00438269|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110325965|NCT00438269|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110325966|NCT00438269|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110325967|NCT00474591|PENTA|penta|mesh-list
110325968|NCT00474591|Fondaparinux|fondaparinux|mesh-list
110325969|NCT00474591|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110325970|NCT00474591|Antithrombins|antithrombins|mesh-ancestor
110325971|NCT00474591|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110325972|NCT00474591|Protease Inhibitors|protease inhibitors|mesh-ancestor
110325973|NCT00474591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110325974|NCT00474591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110325975|NCT00474591|Anticoagulants|anticoagulants|mesh-ancestor
110325976|NCT00474591|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110325977|NCT00474591|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110325978|NCT03279809|Aspirin|aspirin|mesh-list
110325979|NCT03279809|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110325980|NCT03279809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110325981|NCT03279809|Analgesics|analgesics|mesh-ancestor
110325982|NCT03279809|Sensory System Agents|sensory system agents|mesh-ancestor
110325983|NCT03279809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110325984|NCT03279809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110325985|NCT03279809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110325986|NCT03279809|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110325987|NCT03279809|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110325988|NCT03279809|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110325989|NCT03279809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110325990|NCT03279809|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110325991|NCT03279809|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110325992|NCT03279809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110325993|NCT03279809|Antipyretics|antipyretics|mesh-ancestor
110325994|NCT00438386|Aripiprazole|aripiprazole|mesh-list
110325995|NCT00438386|Antidepressive Agents|antidepressive agents|mesh-ancestor
110325996|NCT00438386|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110325997|NCT00438386|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110325998|NCT00438386|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110325999|NCT00438386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110326000|NCT00438386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110326001|NCT00438386|Dopamine Agonists|dopamine agonists|mesh-ancestor
110326003|NCT00438386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110326004|NCT00438386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110326005|NCT00438386|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110326006|NCT00438386|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110326008|NCT00438386|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110326009|NCT00438386|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110326010|NCT00438386|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110326011|NCT00438386|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110326012|NCT00475059|Cimetidine|cimetidine|mesh-list
110171236|NCT00044473|Levofloxacin|levofloxacin|mesh-list
110326013|NCT00475059|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110326014|NCT00475059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110326015|NCT00475059|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110326016|NCT00475059|Histamine Antagonists|histamine antagonists|mesh-ancestor
110326017|NCT00475059|Histamine Agents|histamine agents|mesh-ancestor
110326018|NCT00475059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110326019|NCT00475059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110326020|NCT00475059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110326021|NCT00475059|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110326022|NCT00475059|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110326023|NCT00475059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110326024|NCT00475098|Tinzaparin|tinzaparin|mesh-list
110326025|NCT00475098|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
110326026|NCT00475098|Dalteparin|dalteparin|mesh-list
110326027|NCT00475098|Anticoagulants|anticoagulants|mesh-ancestor
110326028|NCT00475098|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110326029|NCT00475098|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110326030|NCT00475098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110326031|NCT00475137|Lamotrigine|lamotrigine|mesh-list
110326032|NCT00475137|Anticonvulsants|anticonvulsants|mesh-list
110326033|NCT00475137|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110326034|NCT00475137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110326035|NCT00475137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110326036|NCT00475137|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110326037|NCT00475137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110326039|NCT00475137|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110326040|NCT00475137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110326041|NCT00475137|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110326042|NCT00475137|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110326043|NCT00438581|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110326044|NCT00438581|Immunologic Factors|immunologic factors|mesh-ancestor
110326045|NCT00438581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110326047|NCT00475293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110326048|NCT00475293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110326049|NCT00438737|Leucovorin|leucovorin|mesh-list
110326050|NCT00438737|Bevacizumab|bevacizumab|mesh-list
110326051|NCT00438737|Cetuximab|cetuximab|mesh-list
110326052|NCT00438737|Fluorouracil|fluorouracil|mesh-list
110326053|NCT00438737|Oxaliplatin|oxaliplatin|mesh-list
110326054|NCT00438737|Calcium|calcium|mesh-list
110326055|NCT00438737|Levoleucovorin|levoleucovorin|mesh-list
110326056|NCT00438737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110326057|NCT00438737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110326058|NCT00438737|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110326059|NCT00438737|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110326060|NCT00438737|Growth Substances|growth substances|mesh-ancestor
110326061|NCT00438737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110149915|NCT00006799|Megestrol|megestrol|mesh-list
110326063|NCT00438737|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110326064|NCT00438737|Antimetabolites|antimetabolites|mesh-ancestor
110326065|NCT00438737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110326066|NCT00438737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110326067|NCT00438737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110326068|NCT00438737|Immunologic Factors|immunologic factors|mesh-ancestor
110326069|NCT00438737|Antidotes|antidotes|mesh-ancestor
110326070|NCT00438737|Protective Agents|protective agents|mesh-ancestor
110326071|NCT00438737|Vitamin B Complex|vitamin b complex|mesh-ancestor
110326072|NCT00438737|Vitamins|vitamins|mesh-ancestor
110326073|NCT00438737|Micronutrients|micronutrients|mesh-ancestor
110326074|NCT00438776|Olanzapine|olanzapine|mesh-list
110326075|NCT00438776|Antiemetics|antiemetics|mesh-ancestor
110326076|NCT00438776|Autonomic Agents|autonomic agents|mesh-ancestor
110326077|NCT00438776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110326078|NCT00438776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110326079|NCT00438776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110326081|NCT00438776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110326082|NCT00438776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110326083|NCT00438776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110326084|NCT00438776|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110326085|NCT00438776|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110326086|NCT00438776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110326087|NCT00438776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110326088|NCT00438776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110326089|NCT00438776|Serotonin Agents|serotonin agents|mesh-ancestor
110326090|NCT00475410|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
110326091|NCT00475410|Hemostatics|hemostatics|mesh-ancestor
110326092|NCT00475410|Coagulants|coagulants|mesh-ancestor
110326093|NCT00475527|Amoxicillin|amoxicillin|mesh-list
110326094|NCT00475527|Metronidazole|metronidazole|mesh-list
110326095|NCT00475527|Clarithromycin|clarithromycin|mesh-list
110326096|NCT00475527|Omeprazole|omeprazole|mesh-list
110326097|NCT00475527|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110326098|NCT00475527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110326099|NCT00475527|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110326100|NCT00475527|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110326101|NCT00475527|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110326102|NCT00475527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110326103|NCT00475527|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110326104|NCT00475527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110326105|NCT00475527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110326106|NCT00475527|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110326108|NCT00475527|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110326109|NCT00439049|Naltrexone|naltrexone|mesh-list
110326110|NCT00439049|Modafinil|modafinil|mesh-list
110326111|NCT00439049|Amphetamine|amphetamine|mesh-list
110326112|NCT00439049|Dextroamphetamine|dextroamphetamine|mesh-list
110326113|NCT00439049|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110326114|NCT00439049|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110326115|NCT00439049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110326116|NCT00439049|Sensory System Agents|sensory system agents|mesh-ancestor
110326117|NCT00439049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110326118|NCT00439049|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110326119|NCT00439049|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
110326120|NCT00439049|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110326121|NCT00439049|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110326122|NCT00439049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110326123|NCT00439049|Sympathomimetics|sympathomimetics|mesh-ancestor
110326124|NCT00439049|Autonomic Agents|autonomic agents|mesh-ancestor
110326125|NCT00439049|Dopamine Agents|dopamine agents|mesh-ancestor
110326126|NCT00439049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110326127|NCT00439049|Adrenergic Agents|adrenergic agents|mesh-ancestor
110326128|NCT00439049|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110326129|NCT00439049|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110326130|NCT00439049|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110326131|NCT00439049|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110326132|NCT00475566|Everolimus|everolimus|mesh-list
110326133|NCT00475566|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110326134|NCT00475566|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110326135|NCT00475566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110326136|NCT00475566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110326137|NCT00475566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110326139|NCT00475566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110326140|NCT00475566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110326141|NCT00439166|Doxycycline|doxycycline|mesh-list
110326142|NCT00439166|Rifampin|rifampin|mesh-list
110326143|NCT00439166|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110326144|NCT00439166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110326145|NCT00439166|Antimalarials|antimalarials|mesh-ancestor
110326146|NCT00439166|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110326147|NCT00439166|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110326148|NCT00439166|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110326149|NCT00439166|Antitubercular Agents|antitubercular agents|mesh-ancestor
110326150|NCT00439166|Leprostatic Agents|leprostatic agents|mesh-ancestor
110326151|NCT00439166|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110326152|NCT00439166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110326153|NCT00439166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110326154|NCT00439166|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110326155|NCT00439166|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110326156|NCT00439166|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110326157|NCT00439166|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110326158|NCT00439166|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110326159|NCT00439166|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110326160|NCT00439283|Infliximab|infliximab|mesh-list
110326161|NCT00439283|Methotrexate|methotrexate|mesh-list
110326162|NCT00439283|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110326163|NCT00439283|Abortifacient Agents|abortifacient agents|mesh-ancestor
110326164|NCT00439283|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110326165|NCT00439283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110326166|NCT00439283|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110326167|NCT00439283|Antimetabolites|antimetabolites|mesh-ancestor
110326168|NCT00439283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110326169|NCT00439283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110326170|NCT00439283|Dermatologic Agents|dermatologic agents|mesh-ancestor
110326171|NCT00439283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110326172|NCT00439283|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110326173|NCT00439283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110326174|NCT00439283|Immunologic Factors|immunologic factors|mesh-ancestor
110326175|NCT00439283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110326176|NCT00439283|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110326177|NCT00439283|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110326178|NCT00439283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110326179|NCT00439283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110326180|NCT00475800|Lumiracoxib|lumiracoxib|mesh-list
110326181|NCT00475800|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110326182|NCT00475800|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110326183|NCT00475800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110326184|NCT00475800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110326185|NCT00475800|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110326186|NCT00475800|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110326187|NCT00475800|Analgesics|analgesics|mesh-ancestor
110326188|NCT00475800|Sensory System Agents|sensory system agents|mesh-ancestor
110326189|NCT00475800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110326190|NCT00475800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110326191|NCT00475800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110326192|NCT00475800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110326193|NCT00439361|Carboplatin|carboplatin|mesh-list
110326194|NCT00439361|Etoposide|etoposide|mesh-list
110326195|NCT00439361|Bortezomib|bortezomib|mesh-list
110326196|NCT00439361|Ifosfamide|ifosfamide|mesh-list
110326197|NCT00439361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110326198|NCT00439361|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110326199|NCT00439361|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110326200|NCT00439361|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110326201|NCT00439361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110326202|NCT00439361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110326203|NCT00439361|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110326204|NCT00439361|Alkylating Agents|alkylating agents|mesh-ancestor
110326205|NCT00475917|Gemcitabine|gemcitabine|mesh-list
110326206|NCT00475917|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110326207|NCT00475917|Antimetabolites|antimetabolites|mesh-ancestor
110326208|NCT00475917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110326209|NCT00475917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110326210|NCT00474669|Docetaxel|docetaxel|mesh-list
110326211|NCT00474669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110326212|NCT00474669|Tubulin Modulators|tubulin modulators|mesh-ancestor
110326213|NCT00474669|Antimitotic Agents|antimitotic agents|mesh-ancestor
110326214|NCT00474669|Mitosis Modulators|mitosis modulators|mesh-ancestor
110326215|NCT00474669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110326216|NCT00439400|Doxycycline|doxycycline|mesh-list
110326217|NCT00439400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110326218|NCT00439400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110326219|NCT00439400|Antimalarials|antimalarials|mesh-ancestor
110326220|NCT00439400|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110326221|NCT00439400|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110326222|NCT00475956|Cediranib|cediranib|mesh-list
110326223|NCT00475956|Saracatinib|saracatinib|mesh-list
110326224|NCT00475956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110326225|NCT00475956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110326226|NCT00475956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110326227|NCT00475956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110326228|NCT00476034|Lumiracoxib|lumiracoxib|mesh-list
110326229|NCT00476034|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110326230|NCT00476034|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110326231|NCT00476034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110326232|NCT00476034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110326233|NCT00476034|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110326234|NCT00476034|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110326235|NCT00476034|Analgesics|analgesics|mesh-ancestor
110326236|NCT00476034|Sensory System Agents|sensory system agents|mesh-ancestor
110326237|NCT00476034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110326238|NCT00476034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110326239|NCT00476034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110326240|NCT00476034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110326241|NCT00476073|Fluticasone|fluticasone|mesh-list
110326242|NCT00476073|Xhance|xhance|mesh-list
110326243|NCT00476073|Formoterol Fumarate|formoterol fumarate|mesh-list
110326244|NCT00476073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110326245|NCT00476073|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110326246|NCT00476073|Autonomic Agents|autonomic agents|mesh-ancestor
110326247|NCT00476073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110326248|NCT00476073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110326249|NCT00476073|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110326250|NCT00476073|Respiratory System Agents|respiratory system agents|mesh-ancestor
110326251|NCT00476073|Dermatologic Agents|dermatologic agents|mesh-ancestor
110326252|NCT00476073|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110326253|NCT00476073|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110326254|NCT00476073|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110326255|NCT00476073|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110326256|NCT00476073|Adrenergic Agents|adrenergic agents|mesh-ancestor
110326257|NCT00476073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110326258|NCT00476073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110326259|NCT00476268|Beclomethasone|beclomethasone|mesh-list
110326260|NCT00476268|Formoterol Fumarate|formoterol fumarate|mesh-list
110326261|NCT00476268|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110326262|NCT00476268|Autonomic Agents|autonomic agents|mesh-ancestor
110326263|NCT00476268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110326264|NCT00476268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110326265|NCT00476268|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110326266|NCT00476268|Respiratory System Agents|respiratory system agents|mesh-ancestor
110326267|NCT00476268|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110326268|NCT00476268|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110326269|NCT00476268|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110326270|NCT00476268|Adrenergic Agents|adrenergic agents|mesh-ancestor
110326271|NCT00476268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110326272|NCT00476268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110326273|NCT00476268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110326275|NCT00476268|Hormones|hormones|mesh-ancestor
110326276|NCT00476268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110326277|NCT00105989|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110326278|NCT00105989|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110326279|NCT00105989|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110326280|NCT00105989|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110326281|NCT00105989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110326282|NCT00105989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110326283|NCT00105989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110326284|NCT00105989|Analgesics|analgesics|mesh-ancestor
110326285|NCT00105989|Sensory System Agents|sensory system agents|mesh-ancestor
110326286|NCT00105989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110326287|NCT00105989|Antidepressive Agents|antidepressive agents|mesh-ancestor
110326288|NCT00105989|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110326289|NCT00105989|Dopamine Agents|dopamine agents|mesh-ancestor
110326290|NCT00476346|Vitamin D|vitamin d|mesh-list
110326291|NCT00476346|Calcium|calcium|mesh-list
110326292|NCT00476346|Vitamins|vitamins|mesh-ancestor
110326293|NCT00476346|Micronutrients|micronutrients|mesh-ancestor
110326294|NCT00476346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110326295|NCT00476346|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110326296|NCT00476346|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110326298|NCT00476424|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110326299|NCT00476424|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110326300|NCT00476424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110326301|NCT00476424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110326302|NCT00476424|Antiviral Agents|antiviral agents|mesh-ancestor
110326303|NCT00476424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110326304|NCT00476424|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110326305|NCT00476424|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110326306|NCT00476424|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110326307|NCT00476424|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110326308|NCT00476424|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110326309|NCT00476424|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110326310|NCT00439712|Levocetirizine|levocetirizine|mesh-list
110326311|NCT00439712|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110326312|NCT00439712|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110326313|NCT00439712|Histamine Antagonists|histamine antagonists|mesh-ancestor
110326314|NCT00439712|Histamine Agents|histamine agents|mesh-ancestor
110326315|NCT00439712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110326316|NCT00439712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110326317|NCT00439712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110326318|NCT00476463|Emtricitabine|emtricitabine|mesh-list
110326319|NCT00476463|Antiviral Agents|antiviral agents|mesh-ancestor
110326320|NCT00476463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110326321|NCT00476463|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110326322|NCT00476463|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110326323|NCT00476463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110326324|NCT00476463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110326325|NCT00476463|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110326326|NCT00476463|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110326328|NCT00439751|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110326329|NCT00439751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110326330|NCT00438243|Bromfenac|bromfenac|mesh-list
110326331|NCT00438243|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110326332|NCT00438243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110326333|NCT00438243|Analgesics|analgesics|mesh-ancestor
110326334|NCT00438243|Sensory System Agents|sensory system agents|mesh-ancestor
110326335|NCT00438243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110171281|NCT00397501|Methotrexate|methotrexate|mesh-list
110326336|NCT00438243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110326337|NCT00438243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110326338|NCT00438243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110326339|NCT00439829|Cetrorelix|cetrorelix|mesh-list
110326340|NCT00439829|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110326341|NCT00439829|Fertility Agents|fertility agents|mesh-ancestor
110326342|NCT00439829|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110326343|NCT00439829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110326344|NCT00439829|Hormone Antagonists|hormone antagonists|mesh-ancestor
110326345|NCT00439829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110326346|NCT03277248|Teriflunomide|teriflunomide|mesh-list
110326347|NCT03277248|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110326348|NCT03277248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110326349|NCT03277248|Analgesics|analgesics|mesh-ancestor
110326350|NCT03277248|Sensory System Agents|sensory system agents|mesh-ancestor
110326351|NCT03277248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110326352|NCT03277248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110326353|NCT03277248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110326354|NCT03277248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110326355|NCT03277248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110326356|NCT03277248|Immunologic Factors|immunologic factors|mesh-ancestor
110326357|NCT00440024|Tazarotene|tazarotene|mesh-list
110326358|NCT00440024|Dermatologic Agents|dermatologic agents|mesh-ancestor
110326359|NCT00440024|Keratolytic Agents|keratolytic agents|mesh-ancestor
110326360|NCT00440063|Epoetin Alfa|epoetin alfa|mesh-list
110326361|NCT00440063|Hematinics|hematinics|mesh-ancestor
110326362|NCT00440102|Ketamine|ketamine|mesh-list
110326363|NCT00440102|Etomidate|etomidate|mesh-list
110326364|NCT00440102|Analgesics|analgesics|mesh-ancestor
110326365|NCT00440102|Sensory System Agents|sensory system agents|mesh-ancestor
110326366|NCT00440102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110326367|NCT00440102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110326368|NCT00440102|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110326369|NCT00440102|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110326370|NCT00440102|Anesthetics, General|anesthetics, general|mesh-ancestor
110326371|NCT00440102|Anesthetics|anesthetics|mesh-ancestor
110326372|NCT00440102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110326373|NCT00440102|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110326374|NCT00440102|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110326375|NCT00440102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110326376|NCT00440102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110326377|NCT00440102|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110326378|NCT00476541|Gemtuzumab|gemtuzumab|mesh-list
110326379|NCT00476541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110326380|NCT00476541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110326381|NCT00476541|Immunotoxins|immunotoxins|mesh-ancestor
110326382|NCT00476541|Immunoconjugates|immunoconjugates|mesh-ancestor
110326383|NCT00476541|Immunologic Factors|immunologic factors|mesh-ancestor
110326384|NCT00476541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110326385|NCT00440141|Brimonidine Tartrate|brimonidine tartrate|mesh-list
110326386|NCT00440141|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110326387|NCT00440141|Latanoprost|latanoprost|mesh-list
110326388|NCT00440141|Brinzolamide|brinzolamide|mesh-list
110326389|NCT00440141|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110326390|NCT00440141|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110326391|NCT00440141|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110326392|NCT00440141|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110326393|NCT00440141|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110326394|NCT00440141|Adrenergic Agents|adrenergic agents|mesh-ancestor
110326395|NCT00440141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110326396|NCT00440141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110326397|NCT00440141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110326398|NCT00440141|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110326399|NCT00440141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110326400|NCT00438321|Anastrozole|anastrozole|mesh-list
110326401|NCT00438321|Goserelin|goserelin|mesh-list
110326402|NCT00438321|Testosterone|testosterone|mesh-list
110326403|NCT00438321|Androgens|androgens|mesh-ancestor
110326404|NCT00438321|Hormones|hormones|mesh-ancestor
110326405|NCT00438321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110326406|NCT00438321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110326407|NCT00438321|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110326409|NCT00438321|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110326410|NCT00438321|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110326411|NCT00438321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110326412|NCT00438321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110326413|NCT00438321|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110326414|NCT00438321|Hormone Antagonists|hormone antagonists|mesh-ancestor
110326415|NCT00476619|Epoetin Alfa|epoetin alfa|mesh-list
110326416|NCT00476619|Hematinics|hematinics|mesh-ancestor
110326417|NCT03279536|Lactoferrin|lactoferrin|mesh-list
110326418|NCT03279536|Dextrans|dextrans|mesh-list
110326419|NCT03279536|Iron-Dextran Complex|iron-dextran complex|mesh-list
110326421|NCT03279536|Anticoagulants|anticoagulants|mesh-ancestor
110326422|NCT03279536|Plasma Substitutes|plasma substitutes|mesh-ancestor
110326423|NCT03279536|Blood Substitutes|blood substitutes|mesh-ancestor
110326424|NCT03279536|Hematinics|hematinics|mesh-ancestor
110326425|NCT00440219|Prednisone|prednisone|mesh-list
110326426|NCT00440219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110326427|NCT00440219|Glucocorticoids|glucocorticoids|mesh-ancestor
110326428|NCT00440219|Hormones|hormones|mesh-ancestor
110326429|NCT00440219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110326430|NCT00440219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110326431|NCT00440219|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110326432|NCT00440219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110326433|NCT00438477|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
110326434|NCT00438477|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110326435|NCT00438477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110326436|NCT00440258|Cabergoline|cabergoline|mesh-list
110326437|NCT00440258|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110326438|NCT00440258|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110326439|NCT00440258|Dopamine Agonists|dopamine agonists|mesh-ancestor
110326440|NCT00440258|Dopamine Agents|dopamine agents|mesh-ancestor
110326441|NCT00440258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110326442|NCT00440258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110326443|NCT00440258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110326444|NCT00440336|Latanoprost|latanoprost|mesh-list
110326445|NCT00440336|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110326446|NCT00440336|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110326447|NCT00440375|Rosiglitazone|rosiglitazone|mesh-list
110326448|NCT00440375|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110326449|NCT00440375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110326450|NCT00440414|Pemetrexed|pemetrexed|mesh-list
110326451|NCT00440414|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110326452|NCT00440414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110326453|NCT00440414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110326454|NCT00440414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110326455|NCT00440414|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110326456|NCT00440414|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110326457|NCT00440414|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110326458|NCT03270462|Tacrolimus|tacrolimus|mesh-list
110326459|NCT03270462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110326460|NCT03270462|Immunologic Factors|immunologic factors|mesh-ancestor
110326461|NCT03270462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110326462|NCT03270462|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110326463|NCT03270462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110326464|NCT03270462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110326465|NCT00440609|Ranibizumab|ranibizumab|mesh-list
110326466|NCT00440609|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110326467|NCT00440609|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110326468|NCT00440609|Growth Substances|growth substances|mesh-ancestor
110326469|NCT00440609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110326470|NCT00440609|Growth Inhibitors|growth inhibitors|mesh-ancestor
110326471|NCT00440609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110326473|NCT00440648|Chelating Agents|chelating agents|mesh-ancestor
110326474|NCT00440648|Sequestering Agents|sequestering agents|mesh-ancestor
110326475|NCT00440648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110326476|NCT00440687|Fluticasone|fluticasone|mesh-list
110326477|NCT00440687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110326478|NCT00440687|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110326479|NCT00440687|Autonomic Agents|autonomic agents|mesh-ancestor
110326480|NCT00440687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110326481|NCT00440687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110326482|NCT00440687|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110326483|NCT00440687|Respiratory System Agents|respiratory system agents|mesh-ancestor
110326484|NCT00440687|Dermatologic Agents|dermatologic agents|mesh-ancestor
110326485|NCT00440687|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110326486|NCT03271047|Nivolumab|nivolumab|mesh-list
110326487|NCT03271047|Ipilimumab|ipilimumab|mesh-list
110326488|NCT03271047|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110326489|NCT03271047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110326490|NCT03271047|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110326491|NCT03271047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110326492|NCT00440765|Bortezomib|bortezomib|mesh-list
110326493|NCT00440765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110326494|NCT00440804|Ibuprofen|ibuprofen|mesh-list
110326495|NCT00440804|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110326496|NCT00440804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110326497|NCT00440804|Analgesics|analgesics|mesh-ancestor
110326498|NCT00440804|Sensory System Agents|sensory system agents|mesh-ancestor
110326499|NCT00440804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110326500|NCT00440804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110326501|NCT00440804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110326502|NCT00440804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110326503|NCT00440804|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110326504|NCT00440804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110326505|NCT00440804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110326506|NCT00440843|Olanzapine|olanzapine|mesh-list
110326507|NCT00440843|Antiemetics|antiemetics|mesh-ancestor
110326508|NCT00440843|Autonomic Agents|autonomic agents|mesh-ancestor
110326509|NCT00440843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110326510|NCT00440843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110326511|NCT00440843|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110326512|NCT00440843|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110326513|NCT00440843|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110326514|NCT00440843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110326516|NCT00440843|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110326517|NCT00440843|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110326518|NCT00440843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110326519|NCT00440843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110326520|NCT00440843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110326522|NCT00438789|Eculizumab|eculizumab|mesh-list
110326523|NCT00438789|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
110326524|NCT00438789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110326525|NCT00438789|Immunologic Factors|immunologic factors|mesh-ancestor
110326526|NCT00438789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110326527|NCT00440921|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
110326528|NCT00440921|Hemostatics|hemostatics|mesh-ancestor
110326529|NCT00440921|Coagulants|coagulants|mesh-ancestor
110326530|NCT00440960|Lidocaine|lidocaine|mesh-list
110326531|NCT00440960|Midazolam|midazolam|mesh-list
110326532|NCT00440960|Alfentanil|alfentanil|mesh-list
110326533|NCT00440960|Propofol|propofol|mesh-list
110326534|NCT00440960|Anesthetics, Local|anesthetics, local|mesh-ancestor
110326535|NCT00440960|Anesthetics|anesthetics|mesh-ancestor
110326536|NCT00440960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110326537|NCT00440960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110326538|NCT00440960|Sensory System Agents|sensory system agents|mesh-ancestor
110326539|NCT00440960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110326540|NCT00440960|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110326541|NCT00440960|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110326542|NCT00440960|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110326543|NCT00440960|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110326544|NCT00440960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110326545|NCT00440960|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110326546|NCT00440960|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110326547|NCT00440960|Anesthetics, General|anesthetics, general|mesh-ancestor
110326548|NCT00440960|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110326549|NCT00440960|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110326550|NCT00440960|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110326551|NCT00440960|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110326552|NCT00440960|GABA Modulators|gaba modulators|mesh-ancestor
110326553|NCT00440960|GABA Agents|gaba agents|mesh-ancestor
110326554|NCT00440960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110326555|NCT00440960|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110326556|NCT00440960|Narcotics|narcotics|mesh-ancestor
110326557|NCT00440960|Analgesics|analgesics|mesh-ancestor
110326558|NCT00438828|Dexamethasone|dexamethasone|mesh-list
110326559|NCT00438828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110326560|NCT00438828|Antiemetics|antiemetics|mesh-ancestor
110326561|NCT00438828|Autonomic Agents|autonomic agents|mesh-ancestor
110326562|NCT00438828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110326563|NCT00438828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110326564|NCT00438828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110326565|NCT00438828|Glucocorticoids|glucocorticoids|mesh-ancestor
110326567|NCT00438828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110326568|NCT00438828|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110326569|NCT00438828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110326570|NCT00441155|Imatinib Mesylate|imatinib mesylate|mesh-list
110326571|NCT00441155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110326572|NCT00441155|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110326573|NCT00441155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110326574|NCT00441155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110326576|NCT00106002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110326577|NCT00106002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110326578|NCT00106002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110326579|NCT00106002|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110326580|NCT00106002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110326582|NCT00476853|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110326583|NCT00476853|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110171336|NCT00044668|Hormones|hormones|mesh-ancestor
110326584|NCT00476853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110326585|NCT00476853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110326586|NCT00476853|Antiviral Agents|antiviral agents|mesh-ancestor
110326587|NCT00476853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110326588|NCT00476853|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110326589|NCT00476853|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110326590|NCT00476853|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110326591|NCT00476853|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110326592|NCT00438906|Secretin|secretin|mesh-list
110326593|NCT00438906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110326594|NCT00438906|Hormones|hormones|mesh-ancestor
110326595|NCT00438906|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110326596|NCT00438906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110326597|NCT00438945|Eprosartan|eprosartan|mesh-list
110326598|NCT00438945|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110326599|NCT00438945|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
110326600|NCT00438945|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110326601|NCT00438945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110326602|NCT00441428|Solifenacin Succinate|solifenacin succinate|mesh-list
110326603|NCT00441428|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110326604|NCT00441428|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110326605|NCT00441428|Cholinergic Agents|cholinergic agents|mesh-ancestor
110326606|NCT00441428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110326607|NCT00441428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110326608|NCT00441428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110326609|NCT00441428|Urological Agents|urological agents|mesh-ancestor
110326610|NCT00438984|Aldesleukin|aldesleukin|mesh-list
110326611|NCT00438984|Cyclophosphamide|cyclophosphamide|mesh-list
110326612|NCT00438984|Interleukin-2|interleukin-2|mesh-list
110326613|NCT00438984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110326614|NCT00438984|Immunologic Factors|immunologic factors|mesh-ancestor
110326615|NCT00438984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110326616|NCT00438984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110326617|NCT00438984|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110326618|NCT00438984|Alkylating Agents|alkylating agents|mesh-ancestor
110326619|NCT00438984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110326620|NCT00438984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110326621|NCT00438984|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110326622|NCT00438984|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110326623|NCT00438984|Analgesics|analgesics|mesh-ancestor
110326624|NCT00438984|Sensory System Agents|sensory system agents|mesh-ancestor
110326625|NCT00438984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110326626|NCT00438984|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110326627|NCT00438984|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110326628|NCT00438984|Antiviral Agents|antiviral agents|mesh-ancestor
110326629|NCT00438984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110326630|NCT00441506|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
110326631|NCT00441506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110326632|NCT00441506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110326634|NCT00441662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110326635|NCT00441662|Glucocorticoids|glucocorticoids|mesh-ancestor
110326636|NCT00441662|Hormones|hormones|mesh-ancestor
110326637|NCT00441662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110326638|NCT00441662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110326639|NCT00439062|Roxithromycin|roxithromycin|mesh-list
110326640|NCT00439062|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110326641|NCT00439062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110326642|NCT02957162|Atorvastatin|atorvastatin|mesh-list
110326643|NCT02957162|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110326644|NCT02957162|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110326646|NCT02957162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110326647|NCT02957162|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110326648|NCT02957162|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110326649|NCT02957162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110326650|NCT00441740|Gemcitabine|gemcitabine|mesh-list
110326651|NCT00441740|Docetaxel|docetaxel|mesh-list
110326652|NCT00441740|Vinorelbine|vinorelbine|mesh-list
110326653|NCT00441740|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110326654|NCT00441740|Antimetabolites|antimetabolites|mesh-ancestor
110326655|NCT00441740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110326656|NCT00441740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110326657|NCT00441740|Tubulin Modulators|tubulin modulators|mesh-ancestor
110326658|NCT00441740|Antimitotic Agents|antimitotic agents|mesh-ancestor
110326659|NCT00441740|Mitosis Modulators|mitosis modulators|mesh-ancestor
110326660|NCT00441740|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110326661|NCT02274012|Paclitaxel|paclitaxel|mesh-list
110326662|NCT02274012|Afatinib|afatinib|mesh-list
110326663|NCT02274012|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110326664|NCT02274012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110326665|NCT02274012|Tubulin Modulators|tubulin modulators|mesh-ancestor
110326666|NCT02274012|Antimitotic Agents|antimitotic agents|mesh-ancestor
110326667|NCT02274012|Mitosis Modulators|mitosis modulators|mesh-ancestor
110326668|NCT02274012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110326669|NCT02274012|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110326670|NCT02274012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110326671|NCT00477048|Saquinavir|saquinavir|mesh-list
110326672|NCT00477048|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110326673|NCT00477048|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110326674|NCT00477048|Protease Inhibitors|protease inhibitors|mesh-ancestor
110326675|NCT00477048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110326676|NCT00477048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110326677|NCT00477048|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110326678|NCT00477048|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110326679|NCT00477048|Antiviral Agents|antiviral agents|mesh-ancestor
110326680|NCT00477048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110326681|NCT00477048|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110326682|NCT00477048|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110326683|NCT00477126|Ritonavir|ritonavir|mesh-list
110326684|NCT00477126|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110326685|NCT00477126|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110326686|NCT00477126|Protease Inhibitors|protease inhibitors|mesh-ancestor
110326687|NCT00477126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110326688|NCT00477126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110326689|NCT00477126|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110326690|NCT00477126|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110326691|NCT00477126|Antiviral Agents|antiviral agents|mesh-ancestor
110326692|NCT00477126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110326693|NCT00477126|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110326694|NCT00477126|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110326695|NCT03279341|Prucalopride|prucalopride|mesh-list
110326696|NCT03279341|Bisacodyl|bisacodyl|mesh-list
110326697|NCT03279341|Laxatives|laxatives|mesh-ancestor
110326698|NCT03279341|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110326699|NCT03279341|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
110326700|NCT03279341|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110326701|NCT03279341|Serotonin Agents|serotonin agents|mesh-ancestor
110326702|NCT03279341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110326703|NCT03279341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110326704|NCT03279341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110326705|NCT03279341|Cathartics|cathartics|mesh-ancestor
110326706|NCT03279146|Tenofovir|tenofovir|mesh-list
110326707|NCT03279146|Antiviral Agents|antiviral agents|mesh-ancestor
110326708|NCT03279146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110326709|NCT03279146|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110171341|NCT00044746|Tazobactam|tazobactam|mesh-list
110326710|NCT03279146|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110326711|NCT03279146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110326712|NCT03279146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110326713|NCT03279146|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110326714|NCT03279146|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110326716|NCT00442052|Omeprazole|omeprazole|mesh-list
110326717|NCT00442052|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110326718|NCT00442052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110326719|NCT00442052|Analgesics|analgesics|mesh-ancestor
110326720|NCT00442052|Sensory System Agents|sensory system agents|mesh-ancestor
110326721|NCT00442052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110326722|NCT00442052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110326723|NCT00442052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110326725|NCT00442052|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110326726|NCT00442052|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110326727|NCT00442052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110326728|NCT00442052|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110326729|NCT00442052|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110326730|NCT00442052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110326731|NCT00442052|Antipyretics|antipyretics|mesh-ancestor
110326732|NCT00442052|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110326733|NCT00442052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110326734|NCT00442052|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110326735|NCT00477282|Topotecan|topotecan|mesh-list
110326736|NCT00477282|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110326737|NCT00477282|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110326738|NCT00477282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110326739|NCT00477282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110326740|NCT00477282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110326741|NCT00439530|Oseltamivir|oseltamivir|mesh-list
110326742|NCT00439530|Probenecid|probenecid|mesh-list
110326743|NCT00439530|Antiviral Agents|antiviral agents|mesh-ancestor
110326744|NCT00439530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110326745|NCT00439530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110326746|NCT00439530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110326747|NCT00439530|Uricosuric Agents|uricosuric agents|mesh-ancestor
110326748|NCT00439530|Gout Suppressants|gout suppressants|mesh-ancestor
110326749|NCT00439530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110326750|NCT00442325|Atorvastatin|atorvastatin|mesh-list
110326751|NCT00442325|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110326752|NCT00442325|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110326753|NCT00442325|Antimetabolites|antimetabolites|mesh-ancestor
110326754|NCT00442325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110326755|NCT00442325|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110326756|NCT00442325|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110326757|NCT00442325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110326758|NCT00477516|Dialysis Solutions|dialysis solutions|mesh-list
110326759|NCT00477516|Calcium|calcium|mesh-list
110326760|NCT00477516|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110326761|NCT00477516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110326762|NCT00477516|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110326763|NCT00477711|Capecitabine|capecitabine|mesh-list
110326764|NCT00477711|Cetuximab|cetuximab|mesh-list
110326765|NCT00477711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110326766|NCT00477711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110326767|NCT00477711|Antimetabolites|antimetabolites|mesh-ancestor
110326768|NCT00477711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110326769|NCT00477711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110326770|NCT00442403|Chloroquine|chloroquine|mesh-list
110326771|NCT00442403|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
110326772|NCT00442403|Amebicides|amebicides|mesh-ancestor
110326773|NCT00442403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110326774|NCT00442403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110326775|NCT00442403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110326776|NCT00442403|Antimalarials|antimalarials|mesh-ancestor
110326777|NCT00442403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110326778|NCT00442403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110326779|NCT00442403|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110326780|NCT00442403|Immunologic Factors|immunologic factors|mesh-ancestor
110326781|NCT00477789|Allopurinol|allopurinol|mesh-list
110326782|NCT00477789|Antimetabolites|antimetabolites|mesh-ancestor
110326783|NCT00477789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110326784|NCT00477789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110326785|NCT00477789|Gout Suppressants|gout suppressants|mesh-ancestor
110326786|NCT00477789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110326787|NCT00477789|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110326788|NCT00477789|Antioxidants|antioxidants|mesh-ancestor
110326789|NCT00477789|Protective Agents|protective agents|mesh-ancestor
110326790|NCT00477789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110326791|NCT00442481|Escitalopram|escitalopram|mesh-list
110326792|NCT00442481|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110326793|NCT00442481|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110326794|NCT00442481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110326795|NCT00442481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110326796|NCT00442481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110326797|NCT00442481|Serotonin Agents|serotonin agents|mesh-ancestor
110326798|NCT00442481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110326799|NCT00442637|Bevacizumab|bevacizumab|mesh-list
110326800|NCT00442637|Capecitabine|capecitabine|mesh-list
110326801|NCT00442637|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110326802|NCT00442637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110326803|NCT00442637|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110326804|NCT00442637|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110326805|NCT00442637|Growth Substances|growth substances|mesh-ancestor
110326806|NCT00442637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110326807|NCT00442637|Growth Inhibitors|growth inhibitors|mesh-ancestor
110326808|NCT00442637|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110326809|NCT00442637|Antimetabolites|antimetabolites|mesh-ancestor
110326810|NCT00442637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110326811|NCT00442676|Celecoxib|celecoxib|mesh-list
110326812|NCT00442676|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110326813|NCT00442676|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110326814|NCT00442676|Analgesics|analgesics|mesh-ancestor
110326815|NCT00442676|Sensory System Agents|sensory system agents|mesh-ancestor
110326816|NCT00442676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110326817|NCT00442676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110326818|NCT00442676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110326819|NCT00442676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110326820|NCT00442676|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110326821|NCT00442676|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110326822|NCT00442676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110326823|NCT00442676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110326824|NCT00477945|Clofarabine|clofarabine|mesh-list
110326825|NCT00477945|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110326826|NCT00477945|Antimetabolites|antimetabolites|mesh-ancestor
110326827|NCT00477945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110326828|NCT00477945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110326829|NCT00442793|Epoetin Alfa|epoetin alfa|mesh-list
110326830|NCT00442793|Hematinics|hematinics|mesh-ancestor
110326831|NCT00442832|Vancomycin|vancomycin|mesh-list
110326832|NCT00442832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110326833|NCT00442832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110326834|NCT00477984|Ethanol|ethanol|mesh-list
110326835|NCT00477984|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110326836|NCT00477984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110326837|NCT00477984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110326838|NCT00477984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110326840|NCT00478101|Oxycodone|oxycodone|mesh-list
110326841|NCT00478101|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110326842|NCT00478101|Narcotics|narcotics|mesh-ancestor
110326843|NCT00478101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110326844|NCT00478101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110326845|NCT00478101|Analgesics|analgesics|mesh-ancestor
110326846|NCT00478101|Sensory System Agents|sensory system agents|mesh-ancestor
110326847|NCT00478101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110326848|NCT00478101|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110326849|NCT00478101|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110326850|NCT00478101|Anesthetics, General|anesthetics, general|mesh-ancestor
110326852|NCT00440076|Bortezomib|bortezomib|mesh-list
110326853|NCT00440076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110326854|NCT00443105|Tacrolimus|tacrolimus|mesh-list
110326855|NCT00443105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110326856|NCT00443105|Immunologic Factors|immunologic factors|mesh-ancestor
110326857|NCT00443105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110326858|NCT00443105|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110326859|NCT00443105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110326860|NCT00443105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110326861|NCT00443144|Hormones|hormones|mesh-list
110326862|NCT00443144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110326863|NCT00443144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110326864|NCT00440154|Ezetimibe|ezetimibe|mesh-list
110326865|NCT00440154|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110326866|NCT00440154|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110326867|NCT00440154|Antimetabolites|antimetabolites|mesh-ancestor
110326868|NCT00440154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110326869|NCT00440154|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110326870|NCT00478374|Doxorubicin|doxorubicin|mesh-list
110326871|NCT00478374|Sorafenib|sorafenib|mesh-list
110326872|NCT00478374|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110326874|NCT00478374|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110326875|NCT00478374|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110326876|NCT00478374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110326877|NCT00478374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110326878|NCT00478374|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110326879|NCT00478452|Cyclophosphamide|cyclophosphamide|mesh-list
110326880|NCT00478452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110326881|NCT00478452|Immunologic Factors|immunologic factors|mesh-ancestor
110326882|NCT00478452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110326883|NCT00478452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110326884|NCT00478452|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110326885|NCT00478452|Alkylating Agents|alkylating agents|mesh-ancestor
110326886|NCT00478452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110326887|NCT00478452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110326888|NCT00478452|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110326889|NCT03279549|Mitogens|mitogens|mesh-list
110326890|NCT03279549|Mitosis Modulators|mitosis modulators|mesh-ancestor
110326891|NCT03279549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110326892|NCT03271983|Metronidazole|metronidazole|mesh-list
110326893|NCT03271983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110326894|NCT03271983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110326895|NCT03271983|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110326896|NCT03271983|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110326897|NCT00443222|Infliximab|infliximab|mesh-list
110326898|NCT00443222|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110326899|NCT00443222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110326900|NCT00443222|Dermatologic Agents|dermatologic agents|mesh-ancestor
110326901|NCT00443222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110326902|NCT00443222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110326903|NCT00440349|Tamoxifen|tamoxifen|mesh-list
110326904|NCT00440349|Prednisone|prednisone|mesh-list
110326905|NCT00440349|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110326906|NCT00440349|Glucocorticoids|glucocorticoids|mesh-ancestor
110326907|NCT00440349|Hormones|hormones|mesh-ancestor
110326908|NCT00440349|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110326909|NCT00440349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110326910|NCT00440349|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110326911|NCT00440349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110326912|NCT00440349|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110326913|NCT00440349|Hormone Antagonists|hormone antagonists|mesh-ancestor
110326914|NCT00440349|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110326915|NCT00440349|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110326916|NCT00440349|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110326917|NCT00443339|Darbepoetin alfa|darbepoetin alfa|mesh-list
110326918|NCT00443339|Hematinics|hematinics|mesh-ancestor
110326919|NCT04700228|Dexmedetomidine|dexmedetomidine|mesh-list
110326920|NCT04700228|Bupivacaine|bupivacaine|mesh-list
110326921|NCT04700228|Anesthetics, Local|anesthetics, local|mesh-ancestor
110326922|NCT04700228|Anesthetics|anesthetics|mesh-ancestor
110326923|NCT04700228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110326924|NCT04700228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110326925|NCT04700228|Sensory System Agents|sensory system agents|mesh-ancestor
110326926|NCT04700228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110326927|NCT04700228|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110326928|NCT04700228|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110326929|NCT04700228|Analgesics|analgesics|mesh-ancestor
110326930|NCT04700228|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110326931|NCT04700228|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110326932|NCT04700228|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110326933|NCT04700228|Adrenergic Agents|adrenergic agents|mesh-ancestor
110326934|NCT04700228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110326935|NCT04700228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110326936|NCT00440427|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
110326937|NCT00440427|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110326938|NCT00440427|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110326939|NCT00440427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110326940|NCT00440427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110326941|NCT00440427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110326942|NCT00440427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110326943|NCT00440427|Antidepressive Agents|antidepressive agents|mesh-ancestor
110326944|NCT00440427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110326945|NCT03278522|Ramosetron|ramosetron|mesh-list
110326946|NCT03278522|Antiemetics|antiemetics|mesh-ancestor
110326947|NCT03278522|Autonomic Agents|autonomic agents|mesh-ancestor
110326948|NCT03278522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110326949|NCT03278522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110326950|NCT03278522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110326951|NCT03278522|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110326952|NCT03278522|Serotonin Agents|serotonin agents|mesh-ancestor
110326953|NCT03278522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110326954|NCT03278522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110326955|NCT00440622|Gemcitabine|gemcitabine|mesh-list
110326956|NCT00440622|Capecitabine|capecitabine|mesh-list
110326957|NCT00440622|Trastuzumab|trastuzumab|mesh-list
110326958|NCT00440622|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110326959|NCT00440622|Antimetabolites|antimetabolites|mesh-ancestor
110326960|NCT00440622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110326961|NCT00440622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110326962|NCT00440622|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110326964|NCT00440661|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110326965|NCT03278444|Trimetazidine|trimetazidine|mesh-list
110326966|NCT03278444|Vasodilator Agents|vasodilator agents|mesh-ancestor
110326967|NCT00440739|Etoricoxib|etoricoxib|mesh-list
110326968|NCT00440739|Flavoxate|flavoxate|mesh-list
110326969|NCT00440739|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110326970|NCT00440739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110326971|NCT00440739|Analgesics|analgesics|mesh-ancestor
110326972|NCT00440739|Sensory System Agents|sensory system agents|mesh-ancestor
110326973|NCT00440739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110326974|NCT00440739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110326975|NCT00440739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110326977|NCT00440739|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110326978|NCT00440739|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110326979|NCT00440739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110326980|NCT00440739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110326981|NCT00440739|Parasympatholytics|parasympatholytics|mesh-ancestor
110326982|NCT00440739|Autonomic Agents|autonomic agents|mesh-ancestor
110326983|NCT00440739|Urological Agents|urological agents|mesh-ancestor
110326984|NCT00443573|Protein C|protein c|mesh-list
110326985|NCT00443573|Anticoagulants|anticoagulants|mesh-list
110326986|NCT00443573|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110326987|NCT00443573|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110326988|NCT00443573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110326989|NCT00478764|Triamcinolone|triamcinolone|mesh-list
110326990|NCT00478764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110326991|NCT00478764|Glucocorticoids|glucocorticoids|mesh-ancestor
110326992|NCT00478764|Hormones|hormones|mesh-ancestor
110326993|NCT00478764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110326994|NCT00478764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110326995|NCT00440778|Abciximab|abciximab|mesh-list
110326996|NCT00440778|Anticoagulants|anticoagulants|mesh-ancestor
110326997|NCT00440778|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110326998|NCT03278405|Avelumab|avelumab|mesh-list
110326999|NCT03278405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110327000|NCT03278405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110327001|NCT00443612|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110327002|NCT00443612|Irbesartan|irbesartan|mesh-list
110327003|NCT00443612|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110327004|NCT00443612|Diuretics|diuretics|mesh-ancestor
110327005|NCT00443612|Natriuretic Agents|natriuretic agents|mesh-ancestor
110327006|NCT00443612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110327007|NCT00443612|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110327008|NCT00443612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110327009|NCT00443612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110327010|NCT00443612|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110327011|NCT00443612|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110327012|NCT00443690|Rolofylline|rolofylline|mesh-list
110327013|NCT00443690|Diuretics|diuretics|mesh-ancestor
110327014|NCT00443690|Natriuretic Agents|natriuretic agents|mesh-ancestor
110327015|NCT00443690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110327016|NCT00440895|Abciximab|abciximab|mesh-list
110327017|NCT00440895|Anticoagulants|anticoagulants|mesh-ancestor
110327018|NCT00440895|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110327019|NCT00440973|Bevacizumab|bevacizumab|mesh-list
110327020|NCT00440973|Interleukin-2|interleukin-2|mesh-list
110327021|NCT00440973|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110327022|NCT00440973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110327023|NCT00440973|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110327024|NCT00440973|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110327025|NCT00440973|Growth Substances|growth substances|mesh-ancestor
110327026|NCT00440973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110327027|NCT00440973|Growth Inhibitors|growth inhibitors|mesh-ancestor
110327028|NCT00440973|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110327029|NCT00440973|Analgesics|analgesics|mesh-ancestor
110327030|NCT00440973|Sensory System Agents|sensory system agents|mesh-ancestor
110327031|NCT00440973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110327032|NCT00443924|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110327033|NCT00443924|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110327034|NCT00441051|Diclofenac|diclofenac|mesh-list
110327035|NCT00441051|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110327036|NCT00441051|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110327037|NCT00441051|Analgesics|analgesics|mesh-ancestor
110327038|NCT00441051|Sensory System Agents|sensory system agents|mesh-ancestor
110327039|NCT00441051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110171389|NCT00018213|Sensory System Agents|sensory system agents|mesh-ancestor
110327040|NCT00441051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110327041|NCT00441051|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110327042|NCT00441051|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110327043|NCT00441051|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110327044|NCT00441051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110327045|NCT00441051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110327046|NCT00443963|Esomeprazole|esomeprazole|mesh-list
110327048|NCT00443963|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110327049|NCT00443963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110327050|NCT00443963|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110327051|NCT00443963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110327052|NCT00443963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110327053|NCT00443963|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110327054|NCT00443963|Histamine Antagonists|histamine antagonists|mesh-ancestor
110327055|NCT00443963|Histamine Agents|histamine agents|mesh-ancestor
110327056|NCT00443963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110327057|NCT00443963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110327058|NCT00441207|Ascorbic Acid|ascorbic acid|mesh-list
110327059|NCT00441207|Antioxidants|antioxidants|mesh-ancestor
110327060|NCT00441207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110327061|NCT00441207|Protective Agents|protective agents|mesh-ancestor
110327062|NCT00441207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110327063|NCT00441207|Vitamins|vitamins|mesh-ancestor
110327064|NCT00441207|Micronutrients|micronutrients|mesh-ancestor
110327065|NCT00444041|Bevacizumab|bevacizumab|mesh-list
110327066|NCT00444041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110327067|NCT00444041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110327068|NCT00444041|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110327069|NCT00444041|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110327070|NCT00444041|Growth Substances|growth substances|mesh-ancestor
110327071|NCT00444041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110327072|NCT00444041|Growth Inhibitors|growth inhibitors|mesh-ancestor
110327073|NCT00441246|Phenylpropanolamine|phenylpropanolamine|mesh-list
110327074|NCT00441246|Pseudoephedrine|pseudoephedrine|mesh-list
110327075|NCT00441246|Ephedrine|ephedrine|mesh-list
110327076|NCT00441246|Guaifenesin|guaifenesin|mesh-list
110327077|NCT00441246|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
110327078|NCT00441246|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110327079|NCT00441246|Autonomic Agents|autonomic agents|mesh-ancestor
110327080|NCT00441246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110327081|NCT00441246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110327082|NCT00441246|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110327083|NCT00441246|Respiratory System Agents|respiratory system agents|mesh-ancestor
110327084|NCT00441246|Nasal Decongestants|nasal decongestants|mesh-ancestor
110327085|NCT00441246|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110327086|NCT00441246|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110327087|NCT00441246|Sympathomimetics|sympathomimetics|mesh-ancestor
110327088|NCT00441246|Adrenergic Agents|adrenergic agents|mesh-ancestor
110327089|NCT00441246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110327090|NCT00441246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110327091|NCT00441246|Expectorants|expectorants|mesh-ancestor
110327092|NCT00441246|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110327093|NCT00441246|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110327094|NCT00441246|Appetite Depressants|appetite depressants|mesh-ancestor
110327095|NCT00441246|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110327096|NCT00478959|Lenalidomide|lenalidomide|mesh-list
110327097|NCT00478959|Immunologic Factors|immunologic factors|mesh-ancestor
110327099|NCT00478959|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110327100|NCT00478959|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110327101|NCT00478959|Growth Substances|growth substances|mesh-ancestor
110327102|NCT00478959|Growth Inhibitors|growth inhibitors|mesh-ancestor
110327103|NCT00478959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110327104|NCT00444236|Esomeprazole|esomeprazole|mesh-list
110327105|NCT00444236|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110327106|NCT00444236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110327107|NCT00444236|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110327108|NCT00444236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110327109|NCT00444236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110327111|NCT00478998|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110327112|NCT00478998|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110327113|NCT00478998|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110327114|NCT00478998|Adrenergic Agents|adrenergic agents|mesh-ancestor
110327115|NCT00478998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110327116|NCT00478998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110327117|NCT00478998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110327118|NCT00478998|Urological Agents|urological agents|mesh-ancestor
110327119|NCT02957279|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110327120|NCT02957279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110327121|NCT00479076|Aflibercept|aflibercept|mesh-list
110327122|NCT00479076|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110327123|NCT00479076|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110327124|NCT00479076|Growth Substances|growth substances|mesh-ancestor
110327125|NCT00479076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110327126|NCT00479076|Growth Inhibitors|growth inhibitors|mesh-ancestor
110149965|NCT00007189|Gout Suppressants|gout suppressants|mesh-ancestor
110327127|NCT00479076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110327128|NCT00441519|Aspirin|aspirin|mesh-list
110327129|NCT00441519|Omeprazole|omeprazole|mesh-list
110327130|NCT00441519|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110327131|NCT00441519|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110327132|NCT00441519|Analgesics|analgesics|mesh-ancestor
110327133|NCT00441519|Sensory System Agents|sensory system agents|mesh-ancestor
110327134|NCT00441519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110327135|NCT00441519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110327136|NCT00441519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110327137|NCT00441519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110327138|NCT00441519|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110327139|NCT00441519|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110327140|NCT00441519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110327141|NCT00441519|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110327142|NCT00441519|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110327143|NCT00441519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110327144|NCT00441519|Antipyretics|antipyretics|mesh-ancestor
110327145|NCT00441519|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110327146|NCT00441519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110327147|NCT00441519|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110327148|NCT00441597|Atorvastatin|atorvastatin|mesh-list
110327149|NCT00441597|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110327150|NCT00441597|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110327151|NCT00441597|Antimetabolites|antimetabolites|mesh-ancestor
110327152|NCT00441597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110327153|NCT00441597|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110327154|NCT00441597|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110327155|NCT00441597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110327156|NCT00479193|Bacitracin|bacitracin|mesh-list
110327157|NCT00479193|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110327158|NCT00479193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110327159|NCT00479193|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110327160|NCT03278015|Paclitaxel|paclitaxel|mesh-list
110327161|NCT03278015|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110327162|NCT03278015|Gemcitabine|gemcitabine|mesh-list
110327163|NCT03278015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110327164|NCT03278015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110327165|NCT03278015|Tubulin Modulators|tubulin modulators|mesh-ancestor
110327166|NCT03278015|Antimitotic Agents|antimitotic agents|mesh-ancestor
110327167|NCT03278015|Mitosis Modulators|mitosis modulators|mesh-ancestor
110327168|NCT03278015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110327169|NCT03278015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110327170|NCT03278015|Antimetabolites|antimetabolites|mesh-ancestor
110327171|NCT00444314|Sunitinib|sunitinib|mesh-list
110327172|NCT00444314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110327173|NCT00444314|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110327174|NCT00444314|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110327175|NCT00444314|Growth Substances|growth substances|mesh-ancestor
110327176|NCT00444314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110327177|NCT00444314|Growth Inhibitors|growth inhibitors|mesh-ancestor
110327178|NCT00444314|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110327179|NCT00444314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110327180|NCT00444314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110327181|NCT02274051|Kinetin|kinetin|mesh-list
110327182|NCT02274051|Plant Growth Regulators|plant growth regulators|mesh-ancestor
110327184|NCT02274051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110327185|NCT00444470|Tranexamic Acid|tranexamic acid|mesh-list
110327186|NCT00444470|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110327187|NCT00444470|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110327188|NCT00444470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110327189|NCT00444470|Hemostatics|hemostatics|mesh-ancestor
110327190|NCT00444470|Coagulants|coagulants|mesh-ancestor
110327191|NCT00444548|Reboxetine|reboxetine|mesh-list
110327192|NCT00444548|Antidepressive Agents|antidepressive agents|mesh-ancestor
110327193|NCT00444548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110327194|NCT00444548|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110327195|NCT00444548|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110327196|NCT00444548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110327197|NCT00444548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110327198|NCT00444548|Adrenergic Agents|adrenergic agents|mesh-ancestor
110327199|NCT00444548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110327200|NCT00444548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110327201|NCT00444665|Travoprost|travoprost|mesh-list
110327202|NCT00444665|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110327203|NCT04699643|Pembrolizumab|pembrolizumab|mesh-list
110327204|NCT04699643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110327205|NCT04699643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110327206|NCT04699643|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110327207|NCT04699643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110327208|NCT02274090|Metformin|metformin|mesh-list
110327209|NCT02274090|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110327210|NCT02274090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110327211|NCT00479661|Dexmedetomidine|dexmedetomidine|mesh-list
110327212|NCT00479661|Propofol|propofol|mesh-list
110327213|NCT00479661|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110327214|NCT00479661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110327215|NCT00479661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110327216|NCT00479661|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110327217|NCT00479661|Analgesics|analgesics|mesh-ancestor
110327218|NCT00479661|Sensory System Agents|sensory system agents|mesh-ancestor
110327219|NCT00479661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110327220|NCT00479661|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110327221|NCT00479661|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110327222|NCT00479661|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110327223|NCT00479661|Adrenergic Agents|adrenergic agents|mesh-ancestor
110327224|NCT00479661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110327225|NCT00479661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110327226|NCT00479661|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110327227|NCT00479661|Anesthetics, General|anesthetics, general|mesh-ancestor
110327228|NCT00479661|Anesthetics|anesthetics|mesh-ancestor
110327229|NCT04700670|Platelet Factor 4|platelet factor 4|mesh-list
110327230|NCT04700670|Coagulants|coagulants|mesh-ancestor
110327231|NCT00441870|Folic Acid|folic acid|mesh-list
110327232|NCT00441870|Vitamin B Complex|vitamin b complex|mesh-list
110327233|NCT00441870|Hematinics|hematinics|mesh-ancestor
110327234|NCT00441870|Vitamins|vitamins|mesh-ancestor
110327235|NCT00441870|Micronutrients|micronutrients|mesh-ancestor
110327236|NCT00441870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110327237|NCT04700592|Ketamine|ketamine|mesh-list
110327238|NCT04700592|Gabapentin|gabapentin|mesh-list
110327239|NCT04700592|Analgesics|analgesics|mesh-ancestor
110327240|NCT04700592|Sensory System Agents|sensory system agents|mesh-ancestor
110327241|NCT04700592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110327242|NCT04700592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110327243|NCT04700592|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110327244|NCT04700592|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110327245|NCT04700592|Anesthetics, General|anesthetics, general|mesh-ancestor
110327247|NCT04700592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110327248|NCT04700592|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110327249|NCT04700592|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110327250|NCT04700592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110327251|NCT04700592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110327252|NCT04700592|Anticonvulsants|anticonvulsants|mesh-ancestor
110327253|NCT04700592|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110327254|NCT04700592|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110327255|NCT04700592|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110327256|NCT04700592|Antimanic Agents|antimanic agents|mesh-ancestor
110327257|NCT00441909|UC-781|uc-781|mesh-list
110327258|NCT00441909|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110327259|NCT00441909|Antiviral Agents|antiviral agents|mesh-ancestor
110327260|NCT00441909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110327261|NCT00445016|Anesthetics|anesthetics|mesh-list
110327262|NCT00445016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110327263|NCT00445016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110327264|NCT00445055|Droperidol|droperidol|mesh-list
110149971|NCT00388219|Analgesics|analgesics|mesh-ancestor
110327265|NCT00445055|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110327266|NCT00445055|Antiemetics|antiemetics|mesh-ancestor
110327267|NCT00445055|Autonomic Agents|autonomic agents|mesh-ancestor
110327268|NCT00445055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110327269|NCT00445055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110327270|NCT00445055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110327271|NCT00445055|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110327272|NCT00445055|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110327273|NCT00445055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110327274|NCT00445055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110327275|NCT00445055|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110327276|NCT00445055|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110327277|NCT00445055|Dopamine Agents|dopamine agents|mesh-ancestor
110327278|NCT00445055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110327279|NCT00445055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110327280|NCT00479739|Fluticasone|fluticasone|mesh-list
110327282|NCT00479739|Budesonide|budesonide|mesh-list
110327283|NCT00479739|Formoterol Fumarate|formoterol fumarate|mesh-list
110327284|NCT00479739|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110327285|NCT00479739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110327286|NCT00479739|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110327287|NCT00479739|Autonomic Agents|autonomic agents|mesh-ancestor
110327288|NCT00479739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110327289|NCT00479739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110327290|NCT00479739|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110327291|NCT00479739|Respiratory System Agents|respiratory system agents|mesh-ancestor
110327292|NCT00479739|Dermatologic Agents|dermatologic agents|mesh-ancestor
110327293|NCT00479739|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110327294|NCT00479739|Glucocorticoids|glucocorticoids|mesh-ancestor
110327295|NCT00479739|Hormones|hormones|mesh-ancestor
110327296|NCT00479739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110327297|NCT00479739|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110327298|NCT00479739|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110327299|NCT00479739|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110327300|NCT00479739|Adrenergic Agents|adrenergic agents|mesh-ancestor
110327301|NCT00479739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110327302|NCT00479739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110327303|NCT00445094|Vancomycin|vancomycin|mesh-list
110327304|NCT00445094|Imipenem|imipenem|mesh-list
110327305|NCT00445094|Amikacin|amikacin|mesh-list
110327306|NCT00445094|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
110327307|NCT00445094|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
110327309|NCT00445094|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110327310|NCT00445094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110327311|NCT00445094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110327312|NCT00445094|Protease Inhibitors|protease inhibitors|mesh-ancestor
110327313|NCT00445094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110327314|NCT00445094|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110327315|NCT00479778|Bazedoxifene|bazedoxifene|mesh-list
110327316|NCT00479778|Estrogens|estrogens|mesh-list
110327317|NCT00479778|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
110327318|NCT00479778|Hormones|hormones|mesh-ancestor
110327319|NCT00479778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110327320|NCT00479778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110327321|NCT00479778|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110327322|NCT00479778|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110327323|NCT00479778|Hormone Antagonists|hormone antagonists|mesh-ancestor
110327324|NCT00479778|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110327325|NCT00442026|Gemcitabine|gemcitabine|mesh-list
110327326|NCT00442026|Docetaxel|docetaxel|mesh-list
110327327|NCT00442026|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110327328|NCT00442026|Antimetabolites|antimetabolites|mesh-ancestor
110327329|NCT00442026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110327330|NCT00442026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110327331|NCT00442026|Tubulin Modulators|tubulin modulators|mesh-ancestor
110327332|NCT00442026|Antimitotic Agents|antimitotic agents|mesh-ancestor
110327333|NCT00442026|Mitosis Modulators|mitosis modulators|mesh-ancestor
110327334|NCT00479895|Chrysarobin|chrysarobin|mesh-list
110327335|NCT00479895|HBOC 201|hboc 201|mesh-list
110327336|NCT00479895|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110327337|NCT00479895|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110327338|NCT00479895|Analgesics|analgesics|mesh-ancestor
110327339|NCT00479895|Sensory System Agents|sensory system agents|mesh-ancestor
110327340|NCT00479895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110327341|NCT00479895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110327342|NCT00479895|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110327343|NCT00479895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110327344|NCT00479895|Blood Substitutes|blood substitutes|mesh-ancestor
110327345|NCT00445250|Calcipotriene|calcipotriene|mesh-list
110327346|NCT00445250|Dermatologic Agents|dermatologic agents|mesh-ancestor
110327347|NCT03279120|Tenofovir|tenofovir|mesh-list
110327348|NCT03279120|Levonorgestrel|levonorgestrel|mesh-list
110327349|NCT03279120|Antiviral Agents|antiviral agents|mesh-ancestor
110327350|NCT03279120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110327351|NCT03279120|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110327352|NCT03279120|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110327353|NCT03279120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110327354|NCT03279120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110327355|NCT03279120|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110327356|NCT03279120|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110327357|NCT03279120|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110327358|NCT03279120|Contraceptive Agents|contraceptive agents|mesh-ancestor
110327359|NCT03279120|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110327360|NCT03279120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110327361|NCT03279120|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110327362|NCT03279120|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110327363|NCT03279120|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110327364|NCT00479934|Imatinib Mesylate|imatinib mesylate|mesh-list
110327365|NCT00479934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110327366|NCT00479934|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110327367|NCT00479934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110327368|NCT00479934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110327369|NCT00442182|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
110327370|NCT00442182|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110327371|NCT00442182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110327372|NCT00442182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110327373|NCT03274700|Tamsulosin|tamsulosin|mesh-list
110327374|NCT03274700|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110327375|NCT03274700|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110327376|NCT03274700|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110327377|NCT03274700|Adrenergic Agents|adrenergic agents|mesh-ancestor
110327378|NCT03274700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110327379|NCT03274700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110327380|NCT03274700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110327381|NCT03274700|Urological Agents|urological agents|mesh-ancestor
110327382|NCT00442221|Naproxen|naproxen|mesh-list
110327383|NCT00442221|Sumatriptan|sumatriptan|mesh-list
110327384|NCT00442221|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110148390|NCT00006474|Temozolomide|temozolomide|mesh-list
110327385|NCT00442221|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110327386|NCT00442221|Analgesics|analgesics|mesh-ancestor
110327390|NCT00442221|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110327391|NCT00442221|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110327392|NCT00442221|Gout Suppressants|gout suppressants|mesh-ancestor
110327393|NCT00442221|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110327394|NCT00442221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110327395|NCT00442221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110327396|NCT00442221|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110327397|NCT00442221|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110327398|NCT00442221|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110327399|NCT00442221|Serotonin Agents|serotonin agents|mesh-ancestor
110327405|NCT00454259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110327406|NCT00454259|Analgesics|analgesics|mesh-ancestor
110327407|NCT00454259|Sensory System Agents|sensory system agents|mesh-ancestor
110327408|NCT00454259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110327409|NCT00454259|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110327410|NCT00454259|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110327411|NCT00454259|Anesthetics, General|anesthetics, general|mesh-ancestor
110327412|NCT00454259|Anesthetics|anesthetics|mesh-ancestor
110327414|NCT03278808|Chloroquine|chloroquine|mesh-list
110327415|NCT03278808|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
110327416|NCT03278808|Atovaquone|atovaquone|mesh-list
110327417|NCT03278808|Proguanil|proguanil|mesh-list
110327418|NCT03278808|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
110327419|NCT03278808|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110327420|NCT03278808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110327421|NCT03278808|Amebicides|amebicides|mesh-ancestor
110327422|NCT03278808|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110327423|NCT03278808|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110327424|NCT03278808|Antimalarials|antimalarials|mesh-ancestor
110327425|NCT03278808|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110327426|NCT03278808|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110327427|NCT03278808|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110327428|NCT03278808|Analgesics|analgesics|mesh-ancestor
110327429|NCT03278808|Sensory System Agents|sensory system agents|mesh-ancestor
110327430|NCT03278808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110327431|NCT03278808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110327432|NCT03278808|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110327433|NCT03278808|Filaricides|filaricides|mesh-ancestor
110327434|NCT03278808|Antinematodal Agents|antinematodal agents|mesh-ancestor
110327435|NCT03278808|Anthelmintics|anthelmintics|mesh-ancestor
110327436|NCT03278808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110327437|NCT03278808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110327438|NCT03278808|Antimetabolites|antimetabolites|mesh-ancestor
110327439|NCT00480090|Cytarabine|cytarabine|mesh-list
110327440|NCT00480090|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110327441|NCT00480090|Antimetabolites|antimetabolites|mesh-ancestor
110327442|NCT00480090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110327443|NCT00480090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110327444|NCT00480090|Antiviral Agents|antiviral agents|mesh-ancestor
110327445|NCT00480090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110327446|NCT00480090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110327447|NCT00480090|Immunologic Factors|immunologic factors|mesh-ancestor
110327448|NCT00480090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110327449|NCT00454883|Ziprasidone|ziprasidone|mesh-list
110327450|NCT00454883|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110327452|NCT00454883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110327453|NCT00454883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110327454|NCT00454883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110327455|NCT00454883|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110327456|NCT00454883|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110327457|NCT00454883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110327458|NCT00454883|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110327459|NCT00454883|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110327460|NCT00454883|Dopamine Agents|dopamine agents|mesh-ancestor
110327461|NCT03278652|Analgesics|analgesics|mesh-list
110327462|NCT03278652|Sensory System Agents|sensory system agents|mesh-ancestor
110327463|NCT03278652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110327464|NCT03278652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110327465|NCT00454961|Lumefantrine|lumefantrine|mesh-list
110327466|NCT00454961|Artemether|artemether|mesh-list
110327467|NCT00454961|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
110327468|NCT00454961|Antimalarials|antimalarials|mesh-ancestor
110327469|NCT00454961|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110327470|NCT00454961|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110327471|NCT00454961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110327472|NCT00480207|Folic Acid|folic acid|mesh-list
110327473|NCT00480207|Vitamin B Complex|vitamin b complex|mesh-list
110327474|NCT00480207|Hematinics|hematinics|mesh-ancestor
110327476|NCT00480207|Micronutrients|micronutrients|mesh-ancestor
110327477|NCT00480207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110327478|NCT00442455|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110327479|NCT00442455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110327480|NCT00442455|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110327481|NCT00442455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110327482|NCT00442455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110327483|NCT02956655|Insulin|insulin|mesh-list
110327484|NCT02956655|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110327485|NCT02956655|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110327486|NCT02956655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110327487|NCT00480246|Perphenazine|perphenazine|mesh-list
110327488|NCT00480246|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110327489|NCT00480246|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110327490|NCT00480246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110327491|NCT00480246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110327492|NCT00480246|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110327493|NCT00480246|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110327494|NCT00480246|Dopamine Agents|dopamine agents|mesh-ancestor
110327495|NCT00480246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110327496|NCT00480246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110327497|NCT00455117|Parecoxib|parecoxib|mesh-list
110327498|NCT00455117|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110327499|NCT00455117|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110327500|NCT00455117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110327501|NCT00455117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110327502|NCT00455117|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110327503|NCT00455117|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110327504|NCT00455117|Analgesics|analgesics|mesh-ancestor
110327505|NCT00455117|Sensory System Agents|sensory system agents|mesh-ancestor
110327506|NCT00455117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110327507|NCT00455117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110327508|NCT00455117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110327509|NCT00455117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110327510|NCT00442494|Hydrocortisone|hydrocortisone|mesh-list
110327511|NCT00442494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110327512|NCT03274427|Trimetazidine|trimetazidine|mesh-list
110327513|NCT03274427|Vasodilator Agents|vasodilator agents|mesh-ancestor
110327514|NCT00455234|Promethazine|promethazine|mesh-list
110327515|NCT00455234|Diphenhydramine|diphenhydramine|mesh-list
110327516|NCT00455234|Haloperidol|haloperidol|mesh-list
110327517|NCT00455234|Haloperidol decanoate|haloperidol decanoate|mesh-list
110327518|NCT00455234|Antiemetics|antiemetics|mesh-ancestor
110327519|NCT00455234|Autonomic Agents|autonomic agents|mesh-ancestor
110327520|NCT00455234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110327521|NCT00455234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110327522|NCT00455234|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110327523|NCT00455234|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110327524|NCT00455234|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110327525|NCT00455234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110327526|NCT00455234|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110327527|NCT00455234|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110327528|NCT00455234|Dopamine Agents|dopamine agents|mesh-ancestor
110327529|NCT00455234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110327530|NCT00455234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110327531|NCT00455234|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110327532|NCT00455234|Antipruritics|antipruritics|mesh-ancestor
110327533|NCT00455234|Dermatologic Agents|dermatologic agents|mesh-ancestor
110327534|NCT00455234|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110327535|NCT00455234|Histamine Antagonists|histamine antagonists|mesh-ancestor
110327536|NCT00455234|Histamine Agents|histamine agents|mesh-ancestor
110327537|NCT00455234|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110327538|NCT00455234|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110327539|NCT00455234|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110327540|NCT00455234|Anesthetics, Local|anesthetics, local|mesh-ancestor
110327541|NCT00455234|Anesthetics|anesthetics|mesh-ancestor
110327542|NCT00455234|Sensory System Agents|sensory system agents|mesh-ancestor
110327543|NCT00480363|Dexamethasone|dexamethasone|mesh-list
110327544|NCT00480363|Lenalidomide|lenalidomide|mesh-list
110327545|NCT00480363|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110327546|NCT00480363|Antiemetics|antiemetics|mesh-ancestor
110327547|NCT00480363|Autonomic Agents|autonomic agents|mesh-ancestor
110327548|NCT00480363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110327549|NCT00480363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110327550|NCT00480363|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110327551|NCT00480363|Glucocorticoids|glucocorticoids|mesh-ancestor
110327552|NCT00480363|Hormones|hormones|mesh-ancestor
110327553|NCT00480363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110327554|NCT00480363|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110327555|NCT00480363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110327556|NCT00480363|Immunologic Factors|immunologic factors|mesh-ancestor
110327557|NCT00480363|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110327558|NCT00480363|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110327559|NCT00480363|Growth Substances|growth substances|mesh-ancestor
110327560|NCT00480363|Growth Inhibitors|growth inhibitors|mesh-ancestor
110327561|NCT00455390|Psychotropic Drugs|psychotropic drugs|mesh-list
110327562|NCT00442845|Atorvastatin|atorvastatin|mesh-list
110327563|NCT00442845|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110327564|NCT00442845|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110327565|NCT00442845|Antimetabolites|antimetabolites|mesh-ancestor
110327566|NCT00442845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110327567|NCT00442845|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110327568|NCT00442845|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110327569|NCT00442845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110327570|NCT00455507|Istradefylline|istradefylline|mesh-list
110327571|NCT00455507|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
110327572|NCT00455507|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110327573|NCT00455507|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110327574|NCT00455507|Purinergic Agents|purinergic agents|mesh-ancestor
110171441|NCT00045370|Interferons|interferons|mesh-list
110327575|NCT00455507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110327576|NCT00455507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110327577|NCT00455507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110327578|NCT00480402|Progesterone|progesterone|mesh-list
110327579|NCT00480402|Progestins|progestins|mesh-ancestor
110327580|NCT00480402|Hormones|hormones|mesh-ancestor
110327581|NCT00480402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110327582|NCT00480402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110327583|NCT00455585|Lamivudine|lamivudine|mesh-list
110327584|NCT00455585|Nevirapine|nevirapine|mesh-list
110327585|NCT00455585|Stavudine|stavudine|mesh-list
110327586|NCT00455585|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110327587|NCT00455585|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110327588|NCT00455585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110327589|NCT00455585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110327590|NCT00455585|Antiviral Agents|antiviral agents|mesh-ancestor
110327591|NCT00455585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110327592|NCT00455585|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110327593|NCT00455585|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110327594|NCT00455585|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110327595|NCT00455585|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110327596|NCT00455585|Antimetabolites|antimetabolites|mesh-ancestor
110327597|NCT00455624|Androgens|androgens|mesh-list
110327598|NCT00455624|Hormones|hormones|mesh-ancestor
110327599|NCT00455624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110327600|NCT00455624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110327601|NCT00455897|Rituximab|rituximab|mesh-list
110327602|NCT00455897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110327603|NCT00455897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110327604|NCT00455897|Immunologic Factors|immunologic factors|mesh-ancestor
110327605|NCT00455897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110327606|NCT00455897|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110327607|NCT00455936|Gefitinib|gefitinib|mesh-list
110327608|NCT00455936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110327609|NCT00455936|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110327610|NCT00455936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110327611|NCT00455936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110327612|NCT00443235|Thalidomide|thalidomide|mesh-list
110327613|NCT00443235|Prednisone|prednisone|mesh-list
110327615|NCT00443235|Bortezomib|bortezomib|mesh-list
110327616|NCT00443235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110327617|NCT00443235|Glucocorticoids|glucocorticoids|mesh-ancestor
110327618|NCT00443235|Hormones|hormones|mesh-ancestor
110327619|NCT00443235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110327620|NCT00443235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110327621|NCT00443235|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110327622|NCT00443235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110327623|NCT00443235|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110327624|NCT00443235|Alkylating Agents|alkylating agents|mesh-ancestor
110327625|NCT00443235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110327626|NCT00443235|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110327627|NCT00443235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110327628|NCT00443235|Immunologic Factors|immunologic factors|mesh-ancestor
110327629|NCT00443235|Leprostatic Agents|leprostatic agents|mesh-ancestor
110327630|NCT00443235|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110327631|NCT00443235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110327632|NCT00443235|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110327633|NCT00443235|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110327634|NCT00443235|Growth Substances|growth substances|mesh-ancestor
110327635|NCT00443235|Growth Inhibitors|growth inhibitors|mesh-ancestor
110327636|NCT04700943|Anesthetics|anesthetics|mesh-list
110327637|NCT04700943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110327638|NCT04700943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110327639|NCT00456248|Ribavirin|ribavirin|mesh-list
110327640|NCT00456248|Interferon alfacon-1|interferon alfacon-1|mesh-list
110327641|NCT00456248|Antimetabolites|antimetabolites|mesh-ancestor
110327642|NCT00456248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110327643|NCT00456248|Antiviral Agents|antiviral agents|mesh-ancestor
110327644|NCT00456248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110327645|NCT00480558|Vaccines|vaccines|mesh-list
110327646|NCT00480558|Immunologic Factors|immunologic factors|mesh-ancestor
110327647|NCT00480558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110327648|NCT04700709|Mycophenolic Acid|mycophenolic acid|mesh-list
110327649|NCT04700709|Sirolimus|sirolimus|mesh-list
110327650|NCT04700709|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110327651|NCT04700709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110327652|NCT04700709|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110327653|NCT04700709|Antitubercular Agents|antitubercular agents|mesh-ancestor
110327654|NCT04700709|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110327655|NCT04700709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110327656|NCT04700709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110327657|NCT04700709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110327658|NCT04700709|Antifungal Agents|antifungal agents|mesh-ancestor
110327659|NCT04700709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110327660|NCT04700709|Immunologic Factors|immunologic factors|mesh-ancestor
110327661|NCT04700709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110327662|NCT04698317|Mitogens|mitogens|mesh-list
110327663|NCT04698317|Mitosis Modulators|mitosis modulators|mesh-ancestor
110327664|NCT04698317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110327665|NCT04700475|Citric Acid|citric acid|mesh-list
110327666|NCT04700475|Sodium Citrate|sodium citrate|mesh-list
110327667|NCT04700475|Anticoagulants|anticoagulants|mesh-ancestor
110327668|NCT04700475|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110327669|NCT04700475|Chelating Agents|chelating agents|mesh-ancestor
110327670|NCT04700475|Sequestering Agents|sequestering agents|mesh-ancestor
110327671|NCT04700475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110327672|NCT04700436|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110327673|NCT04700436|Ezetimibe|ezetimibe|mesh-list
110148391|NCT00006474|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
110327674|NCT04700436|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110327675|NCT04700436|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110327676|NCT04700436|Antimetabolites|antimetabolites|mesh-ancestor
110327677|NCT04700436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110327678|NCT04700436|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110171485|NCT00045448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110327679|NCT04700436|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110327680|NCT04700436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110327682|NCT00480597|Capecitabine|capecitabine|mesh-list
110327683|NCT00480597|Vinorelbine|vinorelbine|mesh-list
110327684|NCT00480597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110327685|NCT00480597|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110327686|NCT00480597|Antimetabolites|antimetabolites|mesh-ancestor
110327687|NCT00480597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110327688|NCT00480597|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110327690|NCT00480597|Antimitotic Agents|antimitotic agents|mesh-ancestor
110327691|NCT00480597|Mitosis Modulators|mitosis modulators|mesh-ancestor
110327692|NCT00456482|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
110327693|NCT00456482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110327694|NCT00456482|Glucocorticoids|glucocorticoids|mesh-ancestor
110327695|NCT00456482|Hormones|hormones|mesh-ancestor
110327696|NCT00456482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110327697|NCT00456482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110327698|NCT00480675|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110327699|NCT00480675|Methylprednisolone|methylprednisolone|mesh-list
110327700|NCT00480675|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110327701|NCT00480675|Prednisolone|prednisolone|mesh-list
110327702|NCT00480675|Prednisolone acetate|prednisolone acetate|mesh-list
110327703|NCT00480675|Bupivacaine|bupivacaine|mesh-list
110327704|NCT00480675|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110327705|NCT00480675|Prednisolone phosphate|prednisolone phosphate|mesh-list
110327706|NCT00480675|Anesthetics, Local|anesthetics, local|mesh-ancestor
110327707|NCT00480675|Anesthetics|anesthetics|mesh-ancestor
110327708|NCT00480675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110327709|NCT00480675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110327710|NCT00480675|Sensory System Agents|sensory system agents|mesh-ancestor
110327711|NCT00480675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110327712|NCT00480675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110327714|NCT00480675|Autonomic Agents|autonomic agents|mesh-ancestor
110327715|NCT00480675|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110327716|NCT00480675|Glucocorticoids|glucocorticoids|mesh-ancestor
110327717|NCT00480675|Hormones|hormones|mesh-ancestor
110327718|NCT00480675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110327719|NCT00480675|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110327720|NCT00480675|Protective Agents|protective agents|mesh-ancestor
110327721|NCT00480675|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110171501|NCT00045682|Paclitaxel|paclitaxel|mesh-list
110327722|NCT00480675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110327723|NCT00456560|Fluvoxamine|fluvoxamine|mesh-list
110327724|NCT00456560|Paroxetine|paroxetine|mesh-list
110327725|NCT00456560|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110327726|NCT00456560|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110327727|NCT00456560|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110327728|NCT00456560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110327729|NCT00456560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110327730|NCT00456560|Serotonin Agents|serotonin agents|mesh-ancestor
110327731|NCT00456560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110327732|NCT00456560|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110327733|NCT00456560|Antidepressive Agents|antidepressive agents|mesh-ancestor
110327734|NCT00456560|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110327735|NCT00456560|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110327736|NCT00456560|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110327737|NCT00456560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110327738|NCT00456560|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110327739|NCT00456560|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110327740|NCT00456560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110327741|NCT00456560|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110327742|NCT00456560|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110327743|NCT00456677|Minocycline|minocycline|mesh-list
110327744|NCT00456677|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110327745|NCT00456677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110327746|NCT00456716|Sorafenib|sorafenib|mesh-list
110327747|NCT00456716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110327748|NCT00456716|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110327749|NCT00456716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110327750|NCT00456716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110327751|NCT04700397|Nitroglycerin|nitroglycerin|mesh-list
110327752|NCT04700397|Vasodilator Agents|vasodilator agents|mesh-ancestor
110327753|NCT00456794|Istradefylline|istradefylline|mesh-list
110327754|NCT00456794|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
110327755|NCT00456794|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110327756|NCT00456794|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110327757|NCT00456794|Purinergic Agents|purinergic agents|mesh-ancestor
110327758|NCT00456794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110327759|NCT00456794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110327760|NCT00456794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110327761|NCT00456833|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110327762|NCT00456833|Everolimus|everolimus|mesh-list
110327763|NCT00456833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110327764|NCT00456833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110327765|NCT00456833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110327766|NCT00456833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110327767|NCT00456833|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110327768|NCT00456833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110327769|NCT00456833|Immunologic Factors|immunologic factors|mesh-ancestor
110327770|NCT00456833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110327771|NCT00456872|Lidocaine|lidocaine|mesh-list
110327772|NCT00456872|Anesthetics, Local|anesthetics, local|mesh-ancestor
110327773|NCT00456872|Anesthetics|anesthetics|mesh-ancestor
110327774|NCT00456872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110327775|NCT00456872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110327777|NCT00456872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110327778|NCT00456872|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110327779|NCT00456872|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110327780|NCT00456872|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110327781|NCT00456872|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110327782|NCT00456872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110327783|NCT00480753|Nitroglycerin|nitroglycerin|mesh-list
110327784|NCT00480753|Vasodilator Agents|vasodilator agents|mesh-ancestor
110327785|NCT04700046|Mexiletine|mexiletine|mesh-list
110327786|NCT04700046|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110327787|NCT04700046|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110327788|NCT04700046|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110327789|NCT04700046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110327790|NCT04700046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110327791|NCT00457067|Ranibizumab|ranibizumab|mesh-list
110327792|NCT00457067|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110327793|NCT00457067|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110327794|NCT00457067|Growth Substances|growth substances|mesh-ancestor
110327795|NCT00457067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110327796|NCT00457067|Growth Inhibitors|growth inhibitors|mesh-ancestor
110327797|NCT00457067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110327798|NCT00480870|Donepezil|donepezil|mesh-list
110327799|NCT00480870|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110327800|NCT00480870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110327801|NCT00480870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110327802|NCT00480870|Cholinergic Agents|cholinergic agents|mesh-ancestor
110327803|NCT00480870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110327804|NCT00480870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110327805|NCT00480870|Nootropic Agents|nootropic agents|mesh-ancestor
110327806|NCT00457106|Risperidone|risperidone|mesh-list
110327807|NCT00457106|Paroxetine|paroxetine|mesh-list
110327808|NCT00457106|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110171568|NCT00045799|Omeprazole|omeprazole|mesh-list
110327809|NCT00457106|Serotonin Agents|serotonin agents|mesh-ancestor
110327810|NCT00457106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110327811|NCT00457106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110327812|NCT00457106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110327813|NCT00457106|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110327814|NCT00457106|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110327815|NCT00457106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110327816|NCT00457106|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110327817|NCT00457106|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110327818|NCT00457106|Dopamine Agents|dopamine agents|mesh-ancestor
110327819|NCT00457106|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110327820|NCT00457106|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110327821|NCT00457106|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110327822|NCT00457106|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110327823|NCT00457106|Antidepressive Agents|antidepressive agents|mesh-ancestor
110327824|NCT00457106|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110327825|NCT00457106|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110327828|NCT00457145|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110327829|NCT00457145|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110327830|NCT00457145|Growth Substances|growth substances|mesh-ancestor
110150005|NCT00007774|Autonomic Agents|autonomic agents|mesh-ancestor
110327831|NCT00457145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110327832|NCT00457145|Growth Inhibitors|growth inhibitors|mesh-ancestor
110327833|NCT00457145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110327834|NCT00457223|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
110327835|NCT00457223|Hemostatics|hemostatics|mesh-ancestor
110327836|NCT00457223|Coagulants|coagulants|mesh-ancestor
110327838|NCT00443508|Tacrolimus|tacrolimus|mesh-list
110327839|NCT00443508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110327840|NCT00443508|Immunologic Factors|immunologic factors|mesh-ancestor
110327841|NCT00443508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110327842|NCT00443508|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110327843|NCT00443508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110327844|NCT00443508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110327845|NCT00443508|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110327846|NCT00443508|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110327848|NCT00457340|Atorvastatin|atorvastatin|mesh-list
110327849|NCT00457340|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110327850|NCT00457340|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110327852|NCT00457340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110327853|NCT00457340|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110327854|NCT00457340|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110327855|NCT00457340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110327857|NCT03278379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110327858|NCT03278379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110327860|NCT02956538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110327861|NCT02956538|Immunologic Factors|immunologic factors|mesh-ancestor
110327862|NCT02956538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110327863|NCT02956538|Leprostatic Agents|leprostatic agents|mesh-ancestor
110327864|NCT02956538|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110327865|NCT02956538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110327866|NCT02956538|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110327867|NCT02956538|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110327868|NCT02956538|Growth Substances|growth substances|mesh-ancestor
110327869|NCT02956538|Growth Inhibitors|growth inhibitors|mesh-ancestor
110327870|NCT02956538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110327871|NCT00457652|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110327872|NCT00457652|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110327873|NCT00457652|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110327874|NCT00457652|Antimetabolites|antimetabolites|mesh-ancestor
110327875|NCT00457652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110327876|NCT00457652|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110148392|NCT00006474|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110327877|NCT00457652|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110327879|NCT00457769|Donepezil|donepezil|mesh-list
110327880|NCT00457769|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110327881|NCT00457769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110327882|NCT00457769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110327883|NCT00457769|Cholinergic Agents|cholinergic agents|mesh-ancestor
110327884|NCT00457769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110327885|NCT00457769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110327886|NCT00457769|Nootropic Agents|nootropic agents|mesh-ancestor
110327888|NCT00457808|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110327889|NCT00457808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110148393|NCT00006474|Alkylating Agents|alkylating agents|mesh-ancestor
110327890|NCT00457808|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110327891|NCT00457808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110327892|NCT00457808|Antifungal Agents|antifungal agents|mesh-ancestor
110327893|NCT00457808|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110327894|NCT00457808|Immunologic Factors|immunologic factors|mesh-ancestor
110327895|NCT00457808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110327896|NCT00481143|Deferasirox|deferasirox|mesh-list
110327897|NCT00481143|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110327898|NCT00481143|Chelating Agents|chelating agents|mesh-ancestor
110327899|NCT00481143|Sequestering Agents|sequestering agents|mesh-ancestor
110327900|NCT00481143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110327901|NCT00457964|Everolimus|everolimus|mesh-list
110327902|NCT00457964|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110327904|NCT00457964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110327905|NCT00457964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110327906|NCT00457964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110327907|NCT00457964|Immunologic Factors|immunologic factors|mesh-ancestor
110327908|NCT00457964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110327909|NCT00457964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110327911|NCT00458042|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110327912|NCT00458081|Rimonabant|rimonabant|mesh-list
110327913|NCT00458081|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110327914|NCT00458081|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
110327915|NCT00458081|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110327916|NCT00458081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110327917|NCT00458081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110327918|NCT00458081|Hormones|hormones|mesh-ancestor
110327919|NCT00458081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110327920|NCT00458081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110327921|NCT00481182|Ritonavir|ritonavir|mesh-list
110327922|NCT00481182|Fosamprenavir|fosamprenavir|mesh-list
110327923|NCT00481182|Methadone|methadone|mesh-list
110327924|NCT00481182|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110327925|NCT00481182|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110327926|NCT00481182|Protease Inhibitors|protease inhibitors|mesh-ancestor
110327927|NCT00481182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110327928|NCT00481182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110327930|NCT00481182|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110327932|NCT00481182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110327933|NCT00481182|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110327934|NCT00481182|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110327935|NCT00481182|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110327936|NCT00481182|Narcotics|narcotics|mesh-ancestor
110327937|NCT00481182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110327938|NCT00481182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110327939|NCT00481182|Analgesics|analgesics|mesh-ancestor
110327940|NCT00481182|Sensory System Agents|sensory system agents|mesh-ancestor
110327941|NCT00481182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110327942|NCT00481182|Antitussive Agents|antitussive agents|mesh-ancestor
110327943|NCT00481182|Respiratory System Agents|respiratory system agents|mesh-ancestor
110327944|NCT00443937|Mycophenolic Acid|mycophenolic acid|mesh-list
110327945|NCT00443937|Everolimus|everolimus|mesh-list
110327947|NCT00443937|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110327948|NCT00443937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110327949|NCT00443937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110327950|NCT00443937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110327951|NCT00443937|Immunologic Factors|immunologic factors|mesh-ancestor
110327952|NCT00443937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110327953|NCT00443937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110327954|NCT00443937|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110327955|NCT00443937|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110327957|NCT00443937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110327958|NCT00443937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110327959|NCT00458315|Paclitaxel|paclitaxel|mesh-list
110327960|NCT00458315|Bevacizumab|bevacizumab|mesh-list
110327961|NCT00458315|Gemcitabine|gemcitabine|mesh-list
110327962|NCT00458315|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110327963|NCT00458315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110327964|NCT00458315|Tubulin Modulators|tubulin modulators|mesh-ancestor
110327965|NCT00458315|Antimitotic Agents|antimitotic agents|mesh-ancestor
110327966|NCT00458315|Mitosis Modulators|mitosis modulators|mesh-ancestor
110327967|NCT00458315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110327968|NCT00458315|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110327969|NCT00458315|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110327970|NCT00458315|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110327971|NCT00458315|Growth Substances|growth substances|mesh-ancestor
110327972|NCT00458315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110327973|NCT00458315|Growth Inhibitors|growth inhibitors|mesh-ancestor
110327974|NCT00458315|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110327976|NCT00444015|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110327978|NCT00444015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110327979|NCT00444015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110327980|NCT00444015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110327981|NCT00444015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110327982|NCT00458510|Fentanyl|fentanyl|mesh-list
110327983|NCT00458510|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110327984|NCT00458510|Narcotics|narcotics|mesh-ancestor
110327985|NCT00458510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110327986|NCT00458510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110327987|NCT00458510|Analgesics|analgesics|mesh-ancestor
110327988|NCT00458510|Sensory System Agents|sensory system agents|mesh-ancestor
110327989|NCT00458510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110327990|NCT00458510|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110327991|NCT00458510|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110327992|NCT00458510|Anesthetics, General|anesthetics, general|mesh-ancestor
110327993|NCT00458510|Anesthetics|anesthetics|mesh-ancestor
110327994|NCT00444132|Clopidogrel|clopidogrel|mesh-list
110327995|NCT00444132|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110327996|NCT00444132|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110327997|NCT00444132|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110327998|NCT00444132|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110327999|NCT00444132|Purinergic Agents|purinergic agents|mesh-ancestor
110328000|NCT00444132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110328001|NCT00444132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110328002|NCT00444132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110328003|NCT00444171|Insulin|insulin|mesh-list
110328004|NCT00444171|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110328005|NCT00444171|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110171607|NCT00045916|Nortriptyline|nortriptyline|mesh-list
110328006|NCT00444171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110328008|NCT00458900|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110328009|NCT00458900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110328010|NCT00458900|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110328011|NCT00458900|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110328012|NCT00458900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110328013|NCT00458900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110328014|NCT00458900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110328015|NCT00488163|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
110328016|NCT00488163|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110328017|NCT00488163|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110328018|NCT00488163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110328019|NCT00488163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110328020|NCT00488163|Adrenergic Agents|adrenergic agents|mesh-ancestor
110328021|NCT00488163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110328022|NCT00488163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110328023|NCT00459173|Rimonabant|rimonabant|mesh-list
110328024|NCT00459173|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110328025|NCT00459173|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
110328026|NCT00459173|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110328027|NCT00459173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110328028|NCT00459173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110328029|NCT00459173|Hormones|hormones|mesh-ancestor
110328030|NCT00459173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110328031|NCT00459173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110328032|NCT00444249|Dipivefrin|dipivefrin|mesh-list
110328033|NCT00444249|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110328034|NCT00444249|Adrenergic Agents|adrenergic agents|mesh-ancestor
110328035|NCT00444249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110328036|NCT00444249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110328037|NCT00444249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110328039|NCT00459407|Antioxidants|antioxidants|mesh-ancestor
110328040|NCT00459407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110328041|NCT00459407|Protective Agents|protective agents|mesh-ancestor
110328042|NCT00459407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110328043|NCT00459407|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
110328044|NCT00459407|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110328045|NCT00459407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110328046|NCT00459407|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110328047|NCT03278262|Aflibercept|aflibercept|mesh-list
110328048|NCT03278262|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110328049|NCT03278262|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110328051|NCT03278262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110328052|NCT03278262|Growth Inhibitors|growth inhibitors|mesh-ancestor
110328053|NCT03278262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110328054|NCT00459485|Zinc Sulfate|zinc sulfate|mesh-list
110328055|NCT00459485|Astringents|astringents|mesh-ancestor
110328056|NCT00459485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110328057|NCT00459485|Dermatologic Agents|dermatologic agents|mesh-ancestor
110328058|NCT00459563|Vitamin D|vitamin d|mesh-list
110328059|NCT00459563|Calcitriol|calcitriol|mesh-list
110328060|NCT00459563|Vitamins|vitamins|mesh-ancestor
110328061|NCT00459563|Micronutrients|micronutrients|mesh-ancestor
110328062|NCT00459563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110328063|NCT00459563|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110328064|NCT00459563|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110328065|NCT00459563|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
110328066|NCT00459563|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110328067|NCT00459563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110328068|NCT00459563|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110328069|NCT01242384|Silicon|silicon|mesh-list
110328070|NCT01242384|Trace Elements|trace elements|mesh-ancestor
110328071|NCT01242384|Micronutrients|micronutrients|mesh-ancestor
110328072|NCT01242384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110328073|NCT00488436|Cyclosporine|cyclosporine|mesh-list
110328074|NCT00488436|Cyclosporins|cyclosporins|mesh-list
110328075|NCT00488436|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110328076|NCT00488436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110328077|NCT00488436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110328078|NCT00488436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110328079|NCT00488436|Immunologic Factors|immunologic factors|mesh-ancestor
110328080|NCT00488436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110328081|NCT00488436|Antifungal Agents|antifungal agents|mesh-ancestor
110328082|NCT00488436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110328083|NCT00488436|Dermatologic Agents|dermatologic agents|mesh-ancestor
110328084|NCT00488436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110328085|NCT00488436|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110328086|NCT00459719|Tacrolimus|tacrolimus|mesh-list
110328087|NCT00459719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110328088|NCT00459719|Immunologic Factors|immunologic factors|mesh-ancestor
110328089|NCT00459719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110328091|NCT00459719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110328092|NCT00459719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110328095|NCT00495183|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110328096|NCT00495183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110328097|NCT00495183|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110328098|NCT00495183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110328099|NCT00495183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110328100|NCT00495183|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110328101|NCT00495183|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110328102|NCT00495183|Purinergic Agents|purinergic agents|mesh-ancestor
110328103|NCT00495183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110328104|NCT00495183|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110328105|NCT00495183|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110328106|NCT00495183|Parasympatholytics|parasympatholytics|mesh-ancestor
110328107|NCT00495183|Autonomic Agents|autonomic agents|mesh-ancestor
110328108|NCT00495183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110328109|NCT00495183|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110328110|NCT00495183|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110328111|NCT00495183|Cholinergic Agents|cholinergic agents|mesh-ancestor
110328113|NCT00488670|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110328114|NCT00488670|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110328115|NCT00488670|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110328116|NCT00488670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110328117|NCT00488670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110328118|NCT00488670|Serotonin Agents|serotonin agents|mesh-ancestor
110328119|NCT00488670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110328121|NCT00459836|Docetaxel|docetaxel|mesh-list
110328122|NCT00459836|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110328123|NCT00459836|Antimetabolites|antimetabolites|mesh-ancestor
110328124|NCT00459836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110328125|NCT00459836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110328126|NCT00459836|Tubulin Modulators|tubulin modulators|mesh-ancestor
110328127|NCT00459836|Antimitotic Agents|antimitotic agents|mesh-ancestor
110328128|NCT00459836|Mitosis Modulators|mitosis modulators|mesh-ancestor
110328129|NCT00488709|Cytarabine|cytarabine|mesh-list
110328131|NCT00488709|Topotecan|topotecan|mesh-list
110328132|NCT00488709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110328133|NCT00488709|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110328135|NCT00488709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110328136|NCT00488709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110328137|NCT00488709|Immunologic Factors|immunologic factors|mesh-ancestor
110328138|NCT00488709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110328139|NCT00488709|Antiviral Agents|antiviral agents|mesh-ancestor
110328141|NCT00488709|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110328142|NCT00488709|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110328143|NCT00488709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110328145|NCT00459992|Vasodilator Agents|vasodilator agents|mesh-ancestor
110328146|NCT00459992|Histamine Agonists|histamine agonists|mesh-ancestor
110328147|NCT00459992|Histamine Agents|histamine agents|mesh-ancestor
110328148|NCT00459992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110328149|NCT00459992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110328150|NCT00459992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110328151|NCT00495339|Levofloxacin|levofloxacin|mesh-list
110328152|NCT00495339|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110328153|NCT00495339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110328154|NCT00495339|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110328155|NCT00495339|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110328156|NCT00495339|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110328157|NCT00495339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110328158|NCT00495339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110328159|NCT00495339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110328160|NCT00495339|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110328161|NCT00495339|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110328163|NCT00460148|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110328164|NCT00460148|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110328165|NCT00460148|Dopamine Agonists|dopamine agonists|mesh-ancestor
110328166|NCT00460148|Dopamine Agents|dopamine agents|mesh-ancestor
110328167|NCT00460148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110328168|NCT00460148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110328169|NCT00460148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110328171|NCT00460226|Anticonvulsants|anticonvulsants|mesh-ancestor
110328172|NCT00460226|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110328173|NCT00460226|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110328174|NCT00460226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110328175|NCT00460226|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110328176|NCT00460226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110328178|NCT00460226|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110328179|NCT00460226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110328180|NCT00460226|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110328181|NCT00460226|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110328182|NCT00495378|Epoetin Alfa|epoetin alfa|mesh-list
110328183|NCT00495378|Hematinics|hematinics|mesh-ancestor
110328184|NCT00460304|Pramlintide|pramlintide|mesh-list
110328185|NCT00460304|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110328186|NCT00460304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110328189|NCT00460382|Raltegravir Potassium|raltegravir potassium|mesh-list
110328190|NCT00460382|Enfuvirtide|enfuvirtide|mesh-list
110328191|NCT00460382|Etravirine|etravirine|mesh-list
110328192|NCT00460382|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110328193|NCT00460382|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110328194|NCT00460382|Protease Inhibitors|protease inhibitors|mesh-ancestor
110328195|NCT00460382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110328196|NCT00460382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110328198|NCT00460382|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110328199|NCT00460382|Antiviral Agents|antiviral agents|mesh-ancestor
110328200|NCT00460382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110328201|NCT00460382|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110328202|NCT00460382|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110328204|NCT00460382|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110328205|NCT00460382|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110328206|NCT00460382|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110328207|NCT00460382|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110328208|NCT00460382|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110328210|NCT01242579|Dapivirine|dapivirine|mesh-list
110328211|NCT01242579|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110328212|NCT01242579|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110328213|NCT01242579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110328214|NCT01242579|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110328215|NCT01242579|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110328216|NCT01242579|Antiviral Agents|antiviral agents|mesh-ancestor
110328217|NCT01242579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110328218|NCT01242579|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
110328219|NCT00460499|Insulin|insulin|mesh-list
110328220|NCT00460499|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110328221|NCT00460499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110328222|NCT00495573|Acyclovir|acyclovir|mesh-list
110328223|NCT00495573|Antiviral Agents|antiviral agents|mesh-ancestor
110328224|NCT00495573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110328225|NCT00488787|Ketamine|ketamine|mesh-list
110328226|NCT00488787|Analgesics|analgesics|mesh-ancestor
110328227|NCT00488787|Sensory System Agents|sensory system agents|mesh-ancestor
110328228|NCT00488787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110328229|NCT00488787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110328230|NCT00488787|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110328231|NCT00488787|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110328233|NCT00488787|Anesthetics|anesthetics|mesh-ancestor
110328234|NCT00488787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110328235|NCT00488787|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110328236|NCT00488787|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110328237|NCT00488787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110328238|NCT00488787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110328239|NCT00460616|Cabergoline|cabergoline|mesh-list
110328240|NCT00460616|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110328241|NCT00460616|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110328242|NCT00460616|Dopamine Agonists|dopamine agonists|mesh-ancestor
110328243|NCT00460616|Dopamine Agents|dopamine agents|mesh-ancestor
110328244|NCT00460616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110328245|NCT00460616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110328246|NCT00460616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110328247|NCT00495651|Isoniazid|isoniazid|mesh-list
110328248|NCT00495651|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
110328249|NCT00495651|Antitubercular Agents|antitubercular agents|mesh-ancestor
110328250|NCT00495651|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110328251|NCT00495651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110150023|NCT00007813|Carboplatin|carboplatin|mesh-list
110328253|NCT00495651|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110328254|NCT00495651|Antimetabolites|antimetabolites|mesh-ancestor
110328255|NCT00495651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110328257|NCT00495651|Antiviral Agents|antiviral agents|mesh-ancestor
110328258|NCT00460733|Vitamin D|vitamin d|mesh-list
110328259|NCT00460733|Cholecalciferol|cholecalciferol|mesh-list
110328260|NCT00460733|Risedronic Acid|risedronic acid|mesh-list
110328261|NCT00460733|Calcium|calcium|mesh-list
110328262|NCT00460733|Vitamins|vitamins|mesh-ancestor
110328263|NCT00460733|Micronutrients|micronutrients|mesh-ancestor
110328264|NCT00460733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110328265|NCT00460733|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110328266|NCT00460733|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110328267|NCT00460733|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110328268|NCT00460733|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110328269|NCT00460733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110328270|NCT00460850|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110328271|NCT00460850|Antiviral Agents|antiviral agents|mesh-ancestor
110328272|NCT00460850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110328273|NCT00495729|Simvastatin|simvastatin|mesh-list
110328274|NCT00495729|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110328275|NCT00495729|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110328276|NCT00495729|Antimetabolites|antimetabolites|mesh-ancestor
110328277|NCT00495729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110328278|NCT00495729|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110328279|NCT00495729|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110328280|NCT00495729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110328281|NCT00460928|Immunoglobulins|immunoglobulins|mesh-list
110328282|NCT00460928|Antibodies|antibodies|mesh-list
110328283|NCT00460928|gamma-Globulins|gamma-globulins|mesh-list
110328284|NCT00460928|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110328285|NCT00460928|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110328286|NCT00460928|Immunologic Factors|immunologic factors|mesh-ancestor
110328287|NCT00460928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110328288|NCT00461084|Clarithromycin|clarithromycin|mesh-list
110328289|NCT00461084|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110328290|NCT00461084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110328291|NCT00461084|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110328292|NCT00461084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110328293|NCT00461084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110328294|NCT00461084|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110328295|NCT00461084|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110328296|NCT00495846|Octreotide|octreotide|mesh-list
110328297|NCT00495846|Lanreotide|lanreotide|mesh-list
110328298|NCT00495846|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110328299|NCT00495846|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110328300|NCT00495846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110328301|NCT00105482|Naltrexone|naltrexone|mesh-list
110328302|NCT00105482|Nicotine|nicotine|mesh-list
110328303|NCT00105482|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110171674|NCT00001724|Flurbiprofen|flurbiprofen|mesh-list
110328304|NCT00105482|Autonomic Agents|autonomic agents|mesh-ancestor
110328305|NCT00105482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110328306|NCT00105482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110328307|NCT00105482|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110328308|NCT00105482|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110328309|NCT00105482|Cholinergic Agents|cholinergic agents|mesh-ancestor
110328310|NCT00105482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110328311|NCT00105482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110328312|NCT00105482|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110328313|NCT00105482|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110328314|NCT00105482|Sensory System Agents|sensory system agents|mesh-ancestor
110328315|NCT00496002|Adefovir|adefovir|mesh-list
110328316|NCT00496002|Clevudine|clevudine|mesh-list
110328317|NCT00496002|Antiviral Agents|antiviral agents|mesh-ancestor
110328318|NCT00496002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110328319|NCT00496002|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110328320|NCT00496002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110328321|NCT00496002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110328322|NCT00496002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110328323|NCT00489099|Vaccines|vaccines|mesh-list
110328324|NCT00489099|Immunologic Factors|immunologic factors|mesh-ancestor
110328325|NCT00489099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110328327|NCT00496158|Clevudine|clevudine|mesh-list
110328328|NCT00496158|Antiviral Agents|antiviral agents|mesh-ancestor
110328330|NCT00496158|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110328331|NCT00496158|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110328332|NCT00496158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110328333|NCT00496158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110328334|NCT00489138|Ertapenem|ertapenem|mesh-list
110328335|NCT00489138|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110328336|NCT00489138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110328337|NCT00461396|Interferons|interferons|mesh-list
110328338|NCT00461396|Interferon beta-1b|interferon beta-1b|mesh-list
110328339|NCT00461396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110328340|NCT00461396|Antiviral Agents|antiviral agents|mesh-ancestor
110328341|NCT00461396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110328342|NCT00461396|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110328343|NCT00461396|Immunologic Factors|immunologic factors|mesh-ancestor
110328344|NCT00461396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110328345|NCT01327651|Tenofovir|tenofovir|mesh-list
110328346|NCT01327651|Emtricitabine|emtricitabine|mesh-list
110328347|NCT01327651|Antiviral Agents|antiviral agents|mesh-ancestor
110328348|NCT01327651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110328349|NCT01327651|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110328350|NCT01327651|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110328351|NCT01327651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110328352|NCT01327651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110328353|NCT01327651|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110328354|NCT01327651|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110328355|NCT00496275|Cisplatin|cisplatin|mesh-list
110328356|NCT00496275|Gemcitabine|gemcitabine|mesh-list
110328357|NCT00496275|Vinorelbine|vinorelbine|mesh-list
110328358|NCT00496275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110328359|NCT00496275|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110328360|NCT00496275|Antimetabolites|antimetabolites|mesh-ancestor
110328361|NCT00496275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110328362|NCT00496275|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110328363|NCT00496275|Tubulin Modulators|tubulin modulators|mesh-ancestor
110328364|NCT00496275|Antimitotic Agents|antimitotic agents|mesh-ancestor
110328365|NCT00496275|Mitosis Modulators|mitosis modulators|mesh-ancestor
110328366|NCT00591604|Vitamin D|vitamin d|mesh-list
110328369|NCT00591604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110328370|NCT00591604|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110328371|NCT00591643|Epinephrine|epinephrine|mesh-list
110328372|NCT00591643|Racepinephrine|racepinephrine|mesh-list
110328373|NCT00591643|Epinephryl borate|epinephryl borate|mesh-list
110328374|NCT00591643|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110328375|NCT00591643|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110328376|NCT00591643|Adrenergic Agents|adrenergic agents|mesh-ancestor
110328377|NCT00591643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110328378|NCT00591643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110328379|NCT00591643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110328380|NCT00591643|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110328381|NCT00591643|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110328382|NCT00591643|Autonomic Agents|autonomic agents|mesh-ancestor
110328383|NCT00591643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110328384|NCT00591643|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110328385|NCT00591643|Respiratory System Agents|respiratory system agents|mesh-ancestor
110328386|NCT00591643|Mydriatics|mydriatics|mesh-ancestor
110328387|NCT00591643|Sympathomimetics|sympathomimetics|mesh-ancestor
110328388|NCT00591643|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110328389|NCT00461747|Thalidomide|thalidomide|mesh-list
110328391|NCT00461747|Dexamethasone acetate|dexamethasone acetate|mesh-list
110328393|NCT00461747|BB 1101|bb 1101|mesh-list
110328394|NCT00461747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110328395|NCT00461747|Antiemetics|antiemetics|mesh-ancestor
110328396|NCT00461747|Autonomic Agents|autonomic agents|mesh-ancestor
110328397|NCT00461747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110328398|NCT00461747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110328399|NCT00461747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110328400|NCT00461747|Glucocorticoids|glucocorticoids|mesh-ancestor
110328401|NCT00461747|Hormones|hormones|mesh-ancestor
110328402|NCT00461747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110328403|NCT00461747|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110328404|NCT00461747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110328405|NCT00461747|Protease Inhibitors|protease inhibitors|mesh-ancestor
110328406|NCT00461747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110328407|NCT00461747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110328408|NCT00461747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110328409|NCT00461747|Immunologic Factors|immunologic factors|mesh-ancestor
110328410|NCT00461747|Leprostatic Agents|leprostatic agents|mesh-ancestor
110328411|NCT00461747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110328412|NCT00461747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110328413|NCT00461747|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110328414|NCT00461747|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110328415|NCT00461747|Growth Substances|growth substances|mesh-ancestor
110328416|NCT00461747|Growth Inhibitors|growth inhibitors|mesh-ancestor
110328417|NCT00461825|Cyclosporine|cyclosporine|mesh-list
110328419|NCT00461825|Azathioprine|azathioprine|mesh-list
110328420|NCT00461825|Cyclosporins|cyclosporins|mesh-list
110328421|NCT00461825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110328422|NCT00461825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110328423|NCT00461825|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110328424|NCT00461825|Immunologic Factors|immunologic factors|mesh-ancestor
110328425|NCT00461825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110328427|NCT00461825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110328428|NCT00461825|Dermatologic Agents|dermatologic agents|mesh-ancestor
110328429|NCT00461825|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110328430|NCT00461825|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110328431|NCT00461825|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110328432|NCT00461825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110328433|NCT00461825|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110328434|NCT00461825|Antitubercular Agents|antitubercular agents|mesh-ancestor
110328435|NCT00461825|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110328437|NCT00461825|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110328438|NCT04433026|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
110328439|NCT04433026|Natriuretic Agents|natriuretic agents|mesh-ancestor
110328440|NCT04433026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110328441|NCT00489372|Selenomethylselenocysteine|selenomethylselenocysteine|mesh-list
110328442|NCT00489372|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110328443|NCT00489372|Protective Agents|protective agents|mesh-ancestor
110328444|NCT00489372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110328445|NCT00489372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110328446|NCT00461903|Perindopril|perindopril|mesh-list
110328447|NCT00461903|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110328448|NCT00461903|Protease Inhibitors|protease inhibitors|mesh-ancestor
110328449|NCT00461903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110328450|NCT00461903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110328451|NCT00461903|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110328452|NCT00496392|Fentanyl|fentanyl|mesh-list
110328453|NCT00496392|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110328454|NCT00496392|Narcotics|narcotics|mesh-ancestor
110328455|NCT00496392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110328456|NCT00496392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110328457|NCT00496392|Analgesics|analgesics|mesh-ancestor
110328458|NCT00496392|Sensory System Agents|sensory system agents|mesh-ancestor
110328459|NCT00496392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110328460|NCT00496392|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110328461|NCT00496392|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110328462|NCT00496392|Anesthetics, General|anesthetics, general|mesh-ancestor
110328463|NCT00496392|Anesthetics|anesthetics|mesh-ancestor
110328464|NCT02893618|Diazoxide|diazoxide|mesh-list
110328465|NCT02893618|Choline|choline|mesh-list
110328466|NCT02893618|Lipotropic Agents|lipotropic agents|mesh-ancestor
110328467|NCT02893618|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110328468|NCT02893618|Antimetabolites|antimetabolites|mesh-ancestor
110328469|NCT02893618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110328470|NCT02893618|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110328471|NCT02893618|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110328472|NCT02893618|Nootropic Agents|nootropic agents|mesh-ancestor
110328473|NCT02893618|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110328474|NCT02893618|Vasodilator Agents|vasodilator agents|mesh-ancestor
110328475|NCT00496665|Cyclophosphamide|cyclophosphamide|mesh-list
110328476|NCT00496665|Methotrexate|methotrexate|mesh-list
110328477|NCT00496665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110328478|NCT00496665|Immunologic Factors|immunologic factors|mesh-ancestor
110328479|NCT00496665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110328480|NCT00496665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110328481|NCT00496665|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110328482|NCT00496665|Alkylating Agents|alkylating agents|mesh-ancestor
110328483|NCT00496665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110328484|NCT00496665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110328485|NCT00496665|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110328486|NCT00496665|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110328487|NCT00496665|Abortifacient Agents|abortifacient agents|mesh-ancestor
110328488|NCT00496665|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110328489|NCT00496665|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110328490|NCT00496665|Antimetabolites|antimetabolites|mesh-ancestor
110328491|NCT00496665|Dermatologic Agents|dermatologic agents|mesh-ancestor
110328492|NCT00496665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110328493|NCT00496665|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110328494|NCT00496665|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110328496|NCT00496704|Capecitabine|capecitabine|mesh-list
110328497|NCT00496704|Oxaliplatin|oxaliplatin|mesh-list
110328498|NCT00496704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110328499|NCT00496704|Antimetabolites|antimetabolites|mesh-ancestor
110328500|NCT00496704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110328501|NCT00496704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110328502|NCT00591916|Thrombin|thrombin|mesh-list
110328503|NCT00591916|Hyaluronic Acid|hyaluronic acid|mesh-list
110328504|NCT00591916|Hemostatics|hemostatics|mesh-ancestor
110328505|NCT00591916|Coagulants|coagulants|mesh-ancestor
110328506|NCT00591916|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110328507|NCT00591916|Immunologic Factors|immunologic factors|mesh-ancestor
110328508|NCT00591916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110328509|NCT00591916|Viscosupplements|viscosupplements|mesh-ancestor
110328510|NCT00591916|Protective Agents|protective agents|mesh-ancestor
110328512|NCT00462215|Immunologic Factors|immunologic factors|mesh-ancestor
110328513|NCT00462215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110328514|NCT00462371|Insulin|insulin|mesh-list
110328515|NCT00462371|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110328516|NCT00462371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110328517|NCT00497016|Atorvastatin|atorvastatin|mesh-list
110328518|NCT00497016|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110328519|NCT00497016|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110328520|NCT00497016|Antimetabolites|antimetabolites|mesh-ancestor
110328521|NCT00497016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110328522|NCT00497016|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110328523|NCT00497016|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110328525|NCT00222872|Hormones|hormones|mesh-list
110328526|NCT00222872|Parathyroid Hormone|parathyroid hormone|mesh-list
110328527|NCT00222872|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
110328528|NCT00222872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110328529|NCT00222872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110328530|NCT00222872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110328531|NCT00497172|Sirolimus|sirolimus|mesh-list
110328532|NCT00497172|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110328533|NCT00497172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110328535|NCT00497172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110328536|NCT00497172|Antifungal Agents|antifungal agents|mesh-ancestor
110328537|NCT00497172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110328538|NCT00497172|Immunologic Factors|immunologic factors|mesh-ancestor
110328539|NCT00497172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110328540|NCT03273296|Amoxicillin|amoxicillin|mesh-list
110328542|NCT03273296|Vancomycin|vancomycin|mesh-list
110328543|NCT03273296|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110328544|NCT03273296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110328545|NCT00497250|Gefitinib|gefitinib|mesh-list
110328546|NCT00497250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110328547|NCT00497250|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110328549|NCT00497250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110328550|NCT00462878|Vancomycin|vancomycin|mesh-list
110328551|NCT00462878|Meropenem|meropenem|mesh-list
110328552|NCT00462878|Teicoplanin|teicoplanin|mesh-list
110328553|NCT00462878|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110328554|NCT00462878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110328556|NCT00462956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110328557|NCT00462956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110328558|NCT00462956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110328559|NCT00462956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110328560|NCT00462995|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110328561|NCT00462995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110328562|NCT00462995|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110328563|NCT00462995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110328564|NCT00462995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110328565|NCT00489528|Hormones|hormones|mesh-list
110328566|NCT00489528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110328567|NCT00489528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110328568|NCT00463073|Bevacizumab|bevacizumab|mesh-list
110328569|NCT00463073|Cetuximab|cetuximab|mesh-list
110328570|NCT00463073|Irinotecan|irinotecan|mesh-list
110328571|NCT00463073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110328572|NCT00463073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110328573|NCT00463073|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110328574|NCT00463073|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110328575|NCT00463073|Growth Substances|growth substances|mesh-ancestor
110328576|NCT00463073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110328577|NCT00463073|Growth Inhibitors|growth inhibitors|mesh-ancestor
110328578|NCT00463073|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110328579|NCT00463073|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110328580|NCT00463073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110328581|NCT00463073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110328582|NCT00463112|Sibutramine|sibutramine|mesh-list
110328583|NCT00463112|Antidepressive Agents|antidepressive agents|mesh-ancestor
110328584|NCT00463112|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110328586|NCT00463112|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110328587|NCT00223028|Sirolimus|sirolimus|mesh-list
110328588|NCT00223028|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110328589|NCT00223028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110328590|NCT00223028|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110328591|NCT00223028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110328592|NCT00223028|Antifungal Agents|antifungal agents|mesh-ancestor
110328593|NCT00223028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110328594|NCT00223028|Immunologic Factors|immunologic factors|mesh-ancestor
110328595|NCT00223028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110328596|NCT00489645|Pramlintide|pramlintide|mesh-list
110328597|NCT00489645|Islet Amyloid Polypeptide|islet amyloid polypeptide|mesh-list
110328598|NCT00489645|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110328599|NCT00489645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110328600|NCT00489645|Appetite Depressants|appetite depressants|mesh-ancestor
110328601|NCT00489645|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110328602|NCT00489645|Amylin Receptor Agonists|amylin receptor agonists|mesh-ancestor
110328603|NCT00489645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110328604|NCT00463268|Vitamin D|vitamin d|mesh-list
110328605|NCT00463268|Alendronate|alendronate|mesh-list
110328606|NCT00463268|Calcium|calcium|mesh-list
110328607|NCT00463268|Vitamins|vitamins|mesh-ancestor
110328608|NCT00463268|Micronutrients|micronutrients|mesh-ancestor
110328609|NCT00463268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110328610|NCT00463268|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110328611|NCT00463268|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110328612|NCT00489723|Tamsulosin|tamsulosin|mesh-list
110328613|NCT00489723|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110328614|NCT00489723|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110328615|NCT00489723|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110328616|NCT00489723|Adrenergic Agents|adrenergic agents|mesh-ancestor
110328617|NCT00489723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110328618|NCT00489723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110328619|NCT00489723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110328620|NCT00489723|Urological Agents|urological agents|mesh-ancestor
110328621|NCT00105443|Sorafenib|sorafenib|mesh-list
110328623|NCT00105443|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110328624|NCT00105443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110328625|NCT00105443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110328627|NCT00489840|Anecortave|anecortave|mesh-list
110328628|NCT00489840|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110328629|NCT00489840|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110328630|NCT00489840|Growth Substances|growth substances|mesh-ancestor
110328631|NCT00489840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110328632|NCT00489840|Growth Inhibitors|growth inhibitors|mesh-ancestor
110328633|NCT00489840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110328634|NCT00489840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110328635|NCT00463502|Metformin|metformin|mesh-list
110328636|NCT00463502|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110328637|NCT00463502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110328638|NCT00489996|Gemcitabine|gemcitabine|mesh-list
110328639|NCT00489996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110328640|NCT00489996|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110328641|NCT00489996|Antimetabolites|antimetabolites|mesh-ancestor
110328642|NCT00489996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110328643|NCT00463541|Solifenacin Succinate|solifenacin succinate|mesh-list
110328644|NCT00463541|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110328645|NCT00463541|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110328646|NCT00463541|Cholinergic Agents|cholinergic agents|mesh-ancestor
110328647|NCT00463541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110328648|NCT00463541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110328649|NCT00463541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110328650|NCT00463541|Urological Agents|urological agents|mesh-ancestor
110328651|NCT00490113|Pyridoxamine|pyridoxamine|mesh-list
110328652|NCT00490113|Vitamin B Complex|vitamin b complex|mesh-ancestor
110328654|NCT00490113|Micronutrients|micronutrients|mesh-ancestor
110328655|NCT00490113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110328656|NCT01243203|Varenicline|varenicline|mesh-list
110328657|NCT01243203|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110328658|NCT01243203|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110328659|NCT01243203|Cholinergic Agents|cholinergic agents|mesh-ancestor
110328660|NCT01243203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110328661|NCT01243203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110328662|NCT01243203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110328663|NCT00497328|Acetylcysteine|acetylcysteine|mesh-list
110328664|NCT00497328|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110328665|NCT00497328|Antiviral Agents|antiviral agents|mesh-ancestor
110328666|NCT00497328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110328667|NCT00497328|Expectorants|expectorants|mesh-ancestor
110328668|NCT00497328|Respiratory System Agents|respiratory system agents|mesh-ancestor
110328669|NCT00497328|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110328670|NCT00497328|Antioxidants|antioxidants|mesh-ancestor
110328671|NCT00497328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110328672|NCT00497328|Protective Agents|protective agents|mesh-ancestor
110328673|NCT00497328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110328674|NCT00497328|Antidotes|antidotes|mesh-ancestor
110328675|NCT00466076|Glatiramer Acetate|glatiramer acetate|mesh-list
110328676|NCT00466076|(T,G)-A-L|(t,g)-a-l|mesh-list
110328677|NCT00466076|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110328678|NCT00466076|Immunologic Factors|immunologic factors|mesh-ancestor
110328679|NCT00466076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110328680|NCT00466076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110328682|NCT00466154|Aspirin|aspirin|mesh-list
110328683|NCT00466154|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110328684|NCT00466154|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110328685|NCT00466154|Analgesics|analgesics|mesh-ancestor
110328686|NCT00466154|Sensory System Agents|sensory system agents|mesh-ancestor
110328687|NCT00466154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110328688|NCT00466154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110328689|NCT00466154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110328690|NCT00466154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110328691|NCT00466154|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110328692|NCT00466154|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110328693|NCT00466154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110328694|NCT00466154|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110328695|NCT00466154|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110328696|NCT00466154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110328697|NCT00466154|Antipyretics|antipyretics|mesh-ancestor
110328698|NCT00490308|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110328700|NCT00490308|Estradiol|estradiol|mesh-list
110328701|NCT00490308|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110328702|NCT00490308|Estrogens|estrogens|mesh-ancestor
110328703|NCT00490308|Hormones|hormones|mesh-ancestor
110328704|NCT00490308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110328705|NCT00490308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110328706|NCT00490308|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110328707|NCT00490308|Contraceptive Agents|contraceptive agents|mesh-ancestor
110328708|NCT00490308|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110328710|NCT00463736|Magnesium Sulfate|magnesium sulfate|mesh-list
110328711|NCT00463736|Analgesics|analgesics|mesh-ancestor
110328712|NCT00463736|Sensory System Agents|sensory system agents|mesh-ancestor
110328713|NCT00463736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110328714|NCT00463736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110328715|NCT00463736|Anesthetics|anesthetics|mesh-ancestor
110328716|NCT00463736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110328717|NCT00463736|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110328718|NCT00463736|Anticonvulsants|anticonvulsants|mesh-ancestor
110328719|NCT00463736|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110328720|NCT00463736|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110328721|NCT00463736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110328722|NCT00463736|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110328723|NCT00463736|Tocolytic Agents|tocolytic agents|mesh-ancestor
110328724|NCT00463736|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110328725|NCT00490464|Nicardipine|nicardipine|mesh-list
110328726|NCT00490464|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110328727|NCT00490464|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110328728|NCT00490464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110328729|NCT00490464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110328730|NCT00490464|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110328731|NCT00490464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110328732|NCT00490464|Vasodilator Agents|vasodilator agents|mesh-ancestor
110328733|NCT00497523|Beclomethasone|beclomethasone|mesh-list
110328734|NCT00497523|Albuterol|albuterol|mesh-list
110328735|NCT00497523|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110328736|NCT00497523|Autonomic Agents|autonomic agents|mesh-ancestor
110328738|NCT00497523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110328739|NCT00497523|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110328740|NCT00497523|Respiratory System Agents|respiratory system agents|mesh-ancestor
110328741|NCT00497523|Tocolytic Agents|tocolytic agents|mesh-ancestor
110328742|NCT00497523|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110328743|NCT00497523|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110328744|NCT00497523|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110328746|NCT00497523|Adrenergic Agents|adrenergic agents|mesh-ancestor
110328747|NCT00497523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110328748|NCT00497523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110328749|NCT00497523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110328750|NCT00497523|Glucocorticoids|glucocorticoids|mesh-ancestor
110328752|NCT00497523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110328754|NCT00463775|Anticonvulsants|anticonvulsants|mesh-ancestor
110328755|NCT00463775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110328756|NCT00463775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110328757|NCT00490620|Antiviral Agents|antiviral agents|mesh-list
110328758|NCT00490620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110328760|NCT00466232|Topotecan|topotecan|mesh-list
110328761|NCT00466232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110328762|NCT00466232|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110328763|NCT00466232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110328764|NCT00466232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110328765|NCT00466232|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110328766|NCT00466232|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110328767|NCT00490659|Gemcitabine|gemcitabine|mesh-list
110328768|NCT00490659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110328769|NCT00490659|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110328770|NCT00490659|Antimetabolites|antimetabolites|mesh-ancestor
110328771|NCT00490659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110328772|NCT00490737|Daptomycin|daptomycin|mesh-list
110328773|NCT00490737|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110328774|NCT00490737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110328775|NCT00497562|Tramadol|tramadol|mesh-list
110328776|NCT00497562|Amitriptyline|amitriptyline|mesh-list
110328777|NCT00497562|Fluoxetine|fluoxetine|mesh-list
110328778|NCT00497562|Hormones|hormones|mesh-list
110328779|NCT00497562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110328780|NCT00497562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110328781|NCT00497562|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110328783|NCT00497562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110328784|NCT00497562|Analgesics|analgesics|mesh-ancestor
110328785|NCT00497562|Sensory System Agents|sensory system agents|mesh-ancestor
110328786|NCT00497562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110328787|NCT00497562|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110328788|NCT00497562|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110328789|NCT00497562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110328790|NCT00497562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110328791|NCT00497562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110328792|NCT00497562|Serotonin Agents|serotonin agents|mesh-ancestor
110328793|NCT00497562|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110328794|NCT00497562|Antidepressive Agents|antidepressive agents|mesh-ancestor
110328795|NCT00497562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110328796|NCT00497562|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110328797|NCT00497562|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110328798|NCT00497562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110328799|NCT00497562|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110328800|NCT00497562|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110328801|NCT00497562|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110328802|NCT00497562|Adrenergic Agents|adrenergic agents|mesh-ancestor
110328803|NCT00497601|Amphotericin B|amphotericin b|mesh-list
110328804|NCT00497601|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
110328805|NCT00497601|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
110328806|NCT00497601|Amebicides|amebicides|mesh-ancestor
110328807|NCT00497601|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110328808|NCT00497601|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110328809|NCT00497601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110328810|NCT00497601|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110328811|NCT00497601|Antifungal Agents|antifungal agents|mesh-ancestor
110328812|NCT00497601|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
110328813|NCT00497601|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
110328814|NCT00497601|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110328815|NCT00466388|Cevimeline|cevimeline|mesh-list
110328816|NCT00466388|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110328817|NCT00466388|Autonomic Agents|autonomic agents|mesh-ancestor
110171731|NCT00001763|Growth Substances|growth substances|mesh-ancestor
110328818|NCT00466388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110328819|NCT00466388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110328820|NCT00466388|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
110328821|NCT00466388|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110328822|NCT00466388|Cholinergic Agents|cholinergic agents|mesh-ancestor
110328823|NCT00466388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110328824|NCT00466388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110328825|NCT00466466|Everolimus|everolimus|mesh-list
110328826|NCT00466466|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110328827|NCT00466466|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110328828|NCT00466466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110328829|NCT00466466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110328830|NCT00466466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110328831|NCT00466466|Immunologic Factors|immunologic factors|mesh-ancestor
110328832|NCT00466466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110328833|NCT00466466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110328834|NCT00490854|Insulin|insulin|mesh-list
110328835|NCT00490854|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110328836|NCT00490854|Insulin, Isophane|insulin, isophane|mesh-list
110328837|NCT00490854|Isophane Insulin, Human|isophane insulin, human|mesh-list
110328838|NCT00490854|Isophane insulin, beef|isophane insulin, beef|mesh-list
110328839|NCT00490854|Protamines|protamines|mesh-list
110328840|NCT00490854|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110328841|NCT00490854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110328842|NCT00490854|Heparin Antagonists|heparin antagonists|mesh-ancestor
110328843|NCT00490854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110328844|NCT00490854|Coagulants|coagulants|mesh-ancestor
110328845|NCT00490893|Insulin Detemir|insulin detemir|mesh-list
110328846|NCT00490893|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110328847|NCT00490893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110328849|NCT03272126|Vitamins|vitamins|mesh-ancestor
110328850|NCT03272126|Micronutrients|micronutrients|mesh-ancestor
110328851|NCT03272126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110328852|NCT03272126|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110328853|NCT00491049|Levofloxacin|levofloxacin|mesh-list
110328854|NCT00491049|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110328855|NCT00491049|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110328856|NCT00491049|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110328858|NCT00491049|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110328859|NCT00491049|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110328860|NCT00491049|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110328861|NCT00491049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110328862|NCT00491049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110328863|NCT00491049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110328864|NCT00491049|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110328865|NCT00491049|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110328866|NCT00464165|Rimonabant|rimonabant|mesh-list
110328867|NCT00464165|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110328868|NCT00464165|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
110328869|NCT00464165|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110328870|NCT00464165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110328871|NCT00464165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110328872|NCT00464165|Hormones|hormones|mesh-ancestor
110328873|NCT00464165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110328874|NCT00464165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110328875|NCT00497913|Botulinum Toxins|botulinum toxins|mesh-list
110328876|NCT00497913|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110328877|NCT00497913|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110328878|NCT00497913|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110328879|NCT00497913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110328880|NCT00497913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110328881|NCT00497913|Cholinergic Agents|cholinergic agents|mesh-ancestor
110328882|NCT00497913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110328883|NCT00497913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110328884|NCT00497913|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110328885|NCT00497913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110328888|NCT03272321|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110328889|NCT03272321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110328890|NCT00491127|Dexamethasone|dexamethasone|mesh-list
110328891|NCT00491127|Gemcitabine|gemcitabine|mesh-list
110328892|NCT00491127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110328893|NCT00491127|Antiemetics|antiemetics|mesh-ancestor
110328894|NCT00491127|Autonomic Agents|autonomic agents|mesh-ancestor
110328895|NCT00491127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110328896|NCT00491127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110328897|NCT00491127|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110328898|NCT00491127|Glucocorticoids|glucocorticoids|mesh-ancestor
110328900|NCT00491127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110328901|NCT00491127|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110328902|NCT00491127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110328903|NCT00491127|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110328904|NCT00491127|Antimetabolites|antimetabolites|mesh-ancestor
110328905|NCT00491127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110328906|NCT00491166|Bromfenac|bromfenac|mesh-list
110328907|NCT00491166|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110328908|NCT00491166|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110328909|NCT00491166|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110328910|NCT00491166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110328911|NCT00491166|Analgesics|analgesics|mesh-ancestor
110328912|NCT00491166|Sensory System Agents|sensory system agents|mesh-ancestor
110328913|NCT00491166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110328914|NCT00491166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110328915|NCT00491166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110328916|NCT00491166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110328917|NCT03273062|Tolcapone|tolcapone|mesh-list
110328918|NCT03273062|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110328919|NCT03273062|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110328920|NCT03273062|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
110328921|NCT03273062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110328922|NCT03273062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110328923|NCT00498108|Rotigotine|rotigotine|mesh-list
110328924|NCT00498108|Dopamine Agonists|dopamine agonists|mesh-ancestor
110328925|NCT00498108|Dopamine Agents|dopamine agents|mesh-ancestor
110328926|NCT00498108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110328927|NCT00498108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110328929|NCT00464321|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110328930|NCT00464321|Immunologic Factors|immunologic factors|mesh-ancestor
110328931|NCT00464321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110328932|NCT00498225|Gemcitabine|gemcitabine|mesh-list
110328933|NCT00498225|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110328934|NCT00498225|Antimetabolites|antimetabolites|mesh-ancestor
110328935|NCT00498225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110328936|NCT00498225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110328937|NCT00466622|Metformin|metformin|mesh-list
110328938|NCT00466622|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110328939|NCT00466622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110328940|NCT01327612|Leucovorin|leucovorin|mesh-list
110328941|NCT01327612|Bevacizumab|bevacizumab|mesh-list
110328942|NCT01327612|Conatumumab|conatumumab|mesh-list
110328943|NCT01327612|Fluorouracil|fluorouracil|mesh-list
110328944|NCT01327612|Oxaliplatin|oxaliplatin|mesh-list
110328945|NCT01327612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110328946|NCT01327612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110328947|NCT01327612|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110328948|NCT01327612|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110328949|NCT01327612|Growth Substances|growth substances|mesh-ancestor
110328950|NCT01327612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110328951|NCT01327612|Growth Inhibitors|growth inhibitors|mesh-ancestor
110328952|NCT01327612|Antimetabolites|antimetabolites|mesh-ancestor
110328953|NCT01327612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110328954|NCT01327612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110328955|NCT01327612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110328956|NCT01327612|Immunologic Factors|immunologic factors|mesh-ancestor
110328957|NCT01327612|Antidotes|antidotes|mesh-ancestor
110328958|NCT01327612|Protective Agents|protective agents|mesh-ancestor
110328959|NCT01327612|Vitamin B Complex|vitamin b complex|mesh-ancestor
110328960|NCT01327612|Vitamins|vitamins|mesh-ancestor
110328961|NCT01327612|Micronutrients|micronutrients|mesh-ancestor
110328962|NCT01243281|Entecavir|entecavir|mesh-list
110328963|NCT01243281|Antiviral Agents|antiviral agents|mesh-ancestor
110328965|NCT00464399|Everolimus|everolimus|mesh-list
110328966|NCT00464399|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110328967|NCT00464399|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110328968|NCT00464399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110328969|NCT00464399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110328970|NCT00464399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110328971|NCT00464399|Immunologic Factors|immunologic factors|mesh-ancestor
110328972|NCT00464399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110328973|NCT00464399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110328974|NCT04132882|Sodium thiosulfate|sodium thiosulfate|mesh-list
110328975|NCT04132882|Antidotes|antidotes|mesh-ancestor
110328976|NCT04132882|Protective Agents|protective agents|mesh-ancestor
110328977|NCT04132882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110328978|NCT04132882|Antioxidants|antioxidants|mesh-ancestor
110328979|NCT04132882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110328980|NCT04132882|Antitubercular Agents|antitubercular agents|mesh-ancestor
110328981|NCT04132882|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110328982|NCT04132882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110328983|NCT04132882|Chelating Agents|chelating agents|mesh-ancestor
110328984|NCT04132882|Sequestering Agents|sequestering agents|mesh-ancestor
110328985|NCT01243359|Bevacizumab|bevacizumab|mesh-list
110328986|NCT01243359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110328988|NCT01243359|Antibodies|antibodies|mesh-list
110328989|NCT01243359|Immunoglobulins|immunoglobulins|mesh-list
110328990|NCT01243359|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110328991|NCT01243359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110328992|NCT01243359|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110328993|NCT01243359|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110328994|NCT01243359|Growth Substances|growth substances|mesh-ancestor
110328995|NCT01243359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110328997|NCT01243359|Immunologic Factors|immunologic factors|mesh-ancestor
110328998|NCT01243359|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110328999|NCT01243359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110329000|NCT01243359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110329001|NCT00498342|Acetylcysteine|acetylcysteine|mesh-list
110329002|NCT00498342|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110329003|NCT00498342|Antiviral Agents|antiviral agents|mesh-ancestor
110329004|NCT00498342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110329006|NCT00498342|Respiratory System Agents|respiratory system agents|mesh-ancestor
110329007|NCT00498342|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110329008|NCT00498342|Antioxidants|antioxidants|mesh-ancestor
110329009|NCT00498342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110329010|NCT00498342|Protective Agents|protective agents|mesh-ancestor
110329011|NCT00498342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110329012|NCT00498342|Antidotes|antidotes|mesh-ancestor
110329013|NCT00466856|Octreotide|octreotide|mesh-list
110329014|NCT00466856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110329015|NCT00466856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110329016|NCT00466856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110329018|NCT01243437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110329019|NCT01243437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110329020|NCT01243437|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110329021|NCT01243437|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110329022|NCT01243437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110329023|NCT01243437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110329024|NCT01243437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110329025|NCT01243437|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110329026|NCT01243437|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110329027|NCT00591994|Piribedil|piribedil|mesh-list
110329028|NCT00591994|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110329029|NCT00591994|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110329030|NCT00591994|Dopamine Agonists|dopamine agonists|mesh-ancestor
110329031|NCT00591994|Dopamine Agents|dopamine agents|mesh-ancestor
110329032|NCT00591994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110329033|NCT00591994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110329034|NCT00591994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110329035|NCT00464594|Metformin|metformin|mesh-list
110329037|NCT00464594|Gliclazide|gliclazide|mesh-list
110329038|NCT00464594|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110329039|NCT00464594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110329040|NCT00464594|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
110329041|NCT00464594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110329042|NCT00464594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110329043|NCT04397302|Valsartan|valsartan|mesh-list
110329044|NCT04397302|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
110329045|NCT04397302|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110150053|NCT00007852|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110329046|NCT04397302|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110329047|NCT04397302|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110329048|NCT04397302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110329049|NCT00466895|Lenalidomide|lenalidomide|mesh-list
110329050|NCT00466895|Immunologic Factors|immunologic factors|mesh-ancestor
110329051|NCT00466895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110329052|NCT00466895|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110329053|NCT00466895|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110329054|NCT00466895|Growth Substances|growth substances|mesh-ancestor
110329055|NCT00466895|Growth Inhibitors|growth inhibitors|mesh-ancestor
110329056|NCT00466895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110329058|NCT02893540|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110329059|NCT02893540|Antimetabolites|antimetabolites|mesh-ancestor
110329060|NCT02893540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110329061|NCT02893540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110329063|NCT01327573|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
110329064|NCT01327573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110329065|NCT01327573|Immunologic Factors|immunologic factors|mesh-ancestor
110329066|NCT01327573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110329067|NCT02893384|Anesthetics|anesthetics|mesh-list
110329068|NCT02893384|Anesthetics, Local|anesthetics, local|mesh-list
110329069|NCT02893384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110329070|NCT02893384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110329071|NCT02893384|Sensory System Agents|sensory system agents|mesh-ancestor
110329072|NCT02893384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110329073|NCT02893228|Levobupivacaine|levobupivacaine|mesh-list
110329074|NCT02893228|Anesthetics, Local|anesthetics, local|mesh-ancestor
110329075|NCT02893228|Anesthetics|anesthetics|mesh-ancestor
110329076|NCT02893228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110329077|NCT02893228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110329078|NCT02893228|Sensory System Agents|sensory system agents|mesh-ancestor
110329079|NCT02893228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110329080|NCT00498537|Spironolactone|spironolactone|mesh-list
110329081|NCT00498537|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110329082|NCT00498537|Hormone Antagonists|hormone antagonists|mesh-ancestor
110329083|NCT00498537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110329084|NCT00498537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110329085|NCT00498537|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110329086|NCT00498537|Diuretics|diuretics|mesh-ancestor
110329087|NCT00498537|Natriuretic Agents|natriuretic agents|mesh-ancestor
110329088|NCT00491478|Sertraline|sertraline|mesh-list
110329089|NCT00491478|Antidepressive Agents|antidepressive agents|mesh-ancestor
110329090|NCT00491478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110171748|NCT00046384|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110329091|NCT00491478|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110329092|NCT00491478|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110329093|NCT00491478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110329094|NCT00491478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110329095|NCT00491478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110329096|NCT00491478|Serotonin Agents|serotonin agents|mesh-ancestor
110329097|NCT00491478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110329098|NCT00491517|Sirolimus|sirolimus|mesh-list
110329099|NCT00491517|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110329100|NCT00491517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110329101|NCT00491517|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110329102|NCT00491517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110329103|NCT00491517|Antifungal Agents|antifungal agents|mesh-ancestor
110329104|NCT00491517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110329105|NCT00491517|Immunologic Factors|immunologic factors|mesh-ancestor
110329106|NCT00491517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110329107|NCT00464789|Bazedoxifene|bazedoxifene|mesh-list
110329108|NCT00464789|Estrogens|estrogens|mesh-list
110329110|NCT00464789|Hormones|hormones|mesh-ancestor
110329111|NCT00464789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110329112|NCT00464789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110329113|NCT00464789|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110329114|NCT00464789|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110329115|NCT00464789|Hormone Antagonists|hormone antagonists|mesh-ancestor
110329116|NCT00464789|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110329118|NCT00467012|Bevacizumab|bevacizumab|mesh-list
110329119|NCT00467012|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110329120|NCT00467012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110329121|NCT00467012|Tubulin Modulators|tubulin modulators|mesh-ancestor
110329122|NCT00467012|Antimitotic Agents|antimitotic agents|mesh-ancestor
110329123|NCT00467012|Mitosis Modulators|mitosis modulators|mesh-ancestor
110329124|NCT00467012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110329125|NCT00467012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110329126|NCT00467012|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110329127|NCT00467012|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110329128|NCT00467012|Growth Substances|growth substances|mesh-ancestor
110329129|NCT00467012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110329130|NCT00467012|Growth Inhibitors|growth inhibitors|mesh-ancestor
110329131|NCT03272867|Mannitol|mannitol|mesh-list
110329132|NCT03272867|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110329133|NCT03272867|Diuretics|diuretics|mesh-ancestor
110329134|NCT03272867|Natriuretic Agents|natriuretic agents|mesh-ancestor
110329135|NCT03272867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110329137|NCT01327495|Testosterone|testosterone|mesh-list
110329138|NCT01327495|Testosterone undecanoate|testosterone undecanoate|mesh-list
110329139|NCT01327495|Testosterone enanthate|testosterone enanthate|mesh-list
110329140|NCT01327495|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
110329141|NCT01327495|Acyline|acyline|mesh-list
110329142|NCT01327495|Androgens|androgens|mesh-ancestor
110329143|NCT01327495|Hormones|hormones|mesh-ancestor
110329144|NCT01327495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110329145|NCT01327495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110329146|NCT01327495|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110329147|NCT01327495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110329148|NCT01327495|Anabolic Agents|anabolic agents|mesh-ancestor
110329149|NCT01327495|Hormone Antagonists|hormone antagonists|mesh-ancestor
110329151|NCT00491634|Busulfan|busulfan|mesh-list
110329152|NCT00491634|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110329153|NCT00491634|Alkylating Agents|alkylating agents|mesh-ancestor
110329154|NCT00491634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110329155|NCT00491634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110329156|NCT00491634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110329158|NCT00491634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110329159|NCT00491634|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110329160|NCT01327339|Ropinirole|ropinirole|mesh-list
110329161|NCT01327339|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110329162|NCT01327339|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110329163|NCT01327339|Dopamine Agonists|dopamine agonists|mesh-ancestor
110329164|NCT01327339|Dopamine Agents|dopamine agents|mesh-ancestor
110329165|NCT01327339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110150112|NCT00008086|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110329166|NCT01327339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110329167|NCT01327339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110329168|NCT01327300|Mesalamine|mesalamine|mesh-list
110329169|NCT01327300|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110329170|NCT01327300|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110329171|NCT01327300|Analgesics|analgesics|mesh-ancestor
110329172|NCT01327300|Sensory System Agents|sensory system agents|mesh-ancestor
110329173|NCT01327300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110329174|NCT01327300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110329175|NCT01327300|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110329176|NCT01327300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110329177|NCT00467207|Botulinum Toxins|botulinum toxins|mesh-list
110329178|NCT00467207|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110329179|NCT00467207|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110329180|NCT00467207|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110329181|NCT00467207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110329182|NCT00467207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110329183|NCT00467207|Cholinergic Agents|cholinergic agents|mesh-ancestor
110329184|NCT00467207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110329185|NCT00467207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110329186|NCT00467207|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110329187|NCT00467207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110329190|NCT00592111|Etoposide|etoposide|mesh-list
110329191|NCT00592111|Vincristine|vincristine|mesh-list
110329192|NCT00592111|Doxorubicin|doxorubicin|mesh-list
110329193|NCT00592111|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110329194|NCT00592111|Bleomycin|bleomycin|mesh-list
110329195|NCT00592111|Vinblastine|vinblastine|mesh-list
110329196|NCT00592111|Procarbazine|procarbazine|mesh-list
110329197|NCT00592111|Mitogens|mitogens|mesh-list
110329198|NCT00592111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110329199|NCT00592111|Immunologic Factors|immunologic factors|mesh-ancestor
110329200|NCT00592111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110329201|NCT00592111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110329202|NCT00592111|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110329203|NCT00592111|Alkylating Agents|alkylating agents|mesh-ancestor
110329204|NCT00592111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110329205|NCT00592111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110329206|NCT00592111|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110329207|NCT00592111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110329208|NCT00592111|Glucocorticoids|glucocorticoids|mesh-ancestor
110329210|NCT00592111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110329211|NCT00592111|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110329212|NCT00592111|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110329213|NCT00592111|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110329214|NCT00592111|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110329215|NCT00592111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110329216|NCT00592111|Tubulin Modulators|tubulin modulators|mesh-ancestor
110329217|NCT00592111|Antimitotic Agents|antimitotic agents|mesh-ancestor
110329218|NCT00592111|Mitosis Modulators|mitosis modulators|mesh-ancestor
110329219|NCT00592111|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110329220|NCT00592150|Fenoldopam|fenoldopam|mesh-list
110329221|NCT00592150|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110329222|NCT00592150|Vasodilator Agents|vasodilator agents|mesh-ancestor
110329223|NCT00592150|Dopamine Agonists|dopamine agonists|mesh-ancestor
110329224|NCT00592150|Dopamine Agents|dopamine agents|mesh-ancestor
110329225|NCT00592150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110329226|NCT00592150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110329227|NCT00592150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110329229|NCT00592306|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110329230|NCT00592306|Immunologic Factors|immunologic factors|mesh-ancestor
110329231|NCT00592306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110329232|NCT00592306|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110329233|NCT00467246|Insulin Detemir|insulin detemir|mesh-list
110329234|NCT00467246|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110329235|NCT00467246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110329236|NCT04377295|Ranibizumab|ranibizumab|mesh-list
110329237|NCT04377295|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110329238|NCT04377295|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110329239|NCT04377295|Growth Substances|growth substances|mesh-ancestor
110329240|NCT04377295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110329241|NCT04377295|Growth Inhibitors|growth inhibitors|mesh-ancestor
110329242|NCT04377295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110329243|NCT00491712|Triamcinolone|triamcinolone|mesh-list
110329244|NCT00491712|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110329245|NCT00491712|Glucocorticoids|glucocorticoids|mesh-ancestor
110329246|NCT00491712|Hormones|hormones|mesh-ancestor
110329247|NCT00491712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110329248|NCT00491712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110329249|NCT02893111|Bortezomib|bortezomib|mesh-list
110329250|NCT02893111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110329251|NCT04328272|Azithromycin|azithromycin|mesh-list
110329252|NCT04328272|Hydroxychloroquine|hydroxychloroquine|mesh-list
110329253|NCT04328272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110329254|NCT04328272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110329255|NCT04328272|Antimalarials|antimalarials|mesh-ancestor
110329256|NCT04328272|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110329257|NCT04328272|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110329258|NCT04328272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110329259|NCT04328272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110329261|NCT04328194|Thrombin|thrombin|mesh-list
110329262|NCT04328194|Hemostatics|hemostatics|mesh-ancestor
110329263|NCT04328194|Coagulants|coagulants|mesh-ancestor
110329264|NCT00491790|Montelukast|montelukast|mesh-list
110329265|NCT00491790|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110329266|NCT00491790|Respiratory System Agents|respiratory system agents|mesh-ancestor
110329267|NCT00491790|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110329269|NCT00491790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110329270|NCT00491790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110329271|NCT00491790|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110329272|NCT00491790|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110329273|NCT00491790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110329274|NCT03272009|Interferons|interferons|mesh-list
110329275|NCT03272009|Interferon-alpha|interferon-alpha|mesh-list
110329276|NCT03272009|Interferon alpha-2|interferon alpha-2|mesh-list
110329277|NCT03272009|Entecavir|entecavir|mesh-list
110329278|NCT03272009|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110329279|NCT03272009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110329280|NCT03272009|Antiviral Agents|antiviral agents|mesh-ancestor
110329281|NCT03272009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110329282|NCT03272009|Immunologic Factors|immunologic factors|mesh-ancestor
110329283|NCT03272009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110329285|NCT00498888|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110329286|NCT00498888|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110329287|NCT00498888|Cholinergic Agents|cholinergic agents|mesh-ancestor
110329288|NCT00498888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110329289|NCT00498888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110329290|NCT00498888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110329291|NCT00498888|Urological Agents|urological agents|mesh-ancestor
110329292|NCT00491868|Epoetin Alfa|epoetin alfa|mesh-list
110329293|NCT00491868|Hematinics|hematinics|mesh-ancestor
110329294|NCT00491907|Folic Acid|folic acid|mesh-list
110329295|NCT00491907|Hematinics|hematinics|mesh-ancestor
110329296|NCT00491907|Vitamin B Complex|vitamin b complex|mesh-ancestor
110329297|NCT00491907|Vitamins|vitamins|mesh-ancestor
110329298|NCT00491907|Micronutrients|micronutrients|mesh-ancestor
110329299|NCT00491907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110329300|NCT00499005|Carbetocin|carbetocin|mesh-list
110329301|NCT00499005|Oxytocin|oxytocin|mesh-list
110329302|NCT00499005|Oxytocics|oxytocics|mesh-ancestor
110329303|NCT00499005|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110329304|NCT00499005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110329305|NCT00491946|Dactinomycin|dactinomycin|mesh-list
110329307|NCT00491946|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110329308|NCT00491946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110329309|NCT00491946|Tubulin Modulators|tubulin modulators|mesh-ancestor
110329310|NCT00491946|Antimitotic Agents|antimitotic agents|mesh-ancestor
110329311|NCT00491946|Mitosis Modulators|mitosis modulators|mesh-ancestor
110329312|NCT00491946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110329313|NCT00491946|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110329314|NCT00491946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110329315|NCT00491946|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110329316|NCT00491946|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110329318|NCT00491946|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110329320|NCT00491985|Immunologic Factors|immunologic factors|mesh-ancestor
110329321|NCT00491985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110329322|NCT02892916|Ketamine|ketamine|mesh-list
110329323|NCT02892916|Analgesics|analgesics|mesh-ancestor
110329324|NCT02892916|Sensory System Agents|sensory system agents|mesh-ancestor
110329325|NCT02892916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110329326|NCT02892916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110329327|NCT02892916|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110329328|NCT02892916|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110329329|NCT02892916|Anesthetics, General|anesthetics, general|mesh-ancestor
110329330|NCT02892916|Anesthetics|anesthetics|mesh-ancestor
110329331|NCT02892916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110329332|NCT02892916|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110329333|NCT02892916|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110329334|NCT02892916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110329335|NCT02892916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110329336|NCT00492102|Montelukast|montelukast|mesh-list
110329337|NCT00492102|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110329338|NCT00492102|Respiratory System Agents|respiratory system agents|mesh-ancestor
110329339|NCT00492102|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110329341|NCT00492102|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110329342|NCT00492102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110329343|NCT00492102|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110329344|NCT00492102|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110329345|NCT00492102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110329346|NCT00467636|Insulin glulisine|insulin glulisine|mesh-list
110329347|NCT00467636|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110329348|NCT00467636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110329349|NCT00492141|Temozolomide|temozolomide|mesh-list
110329350|NCT00492141|Camptothecin|camptothecin|mesh-list
110329351|NCT00492141|Rubitecan|rubitecan|mesh-list
110329352|NCT00492141|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110329353|NCT00492141|Alkylating Agents|alkylating agents|mesh-ancestor
110329354|NCT00492141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110329355|NCT00492141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110329356|NCT00492141|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110329357|NCT00492141|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110329358|NCT00492141|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110329359|NCT00492141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110329360|NCT04327726|Dexmedetomidine|dexmedetomidine|mesh-list
110329361|NCT04327726|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110329362|NCT04327726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110329363|NCT04327726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110329364|NCT04327726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110329366|NCT04327726|Sensory System Agents|sensory system agents|mesh-ancestor
110329367|NCT04327726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110329368|NCT04327726|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110329369|NCT04327726|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110329370|NCT04327726|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110329371|NCT04327726|Adrenergic Agents|adrenergic agents|mesh-ancestor
110329372|NCT04327726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110329373|NCT04327726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110329374|NCT00492219|Cimetidine|cimetidine|mesh-list
110329375|NCT00492219|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110329376|NCT00492219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110329377|NCT00492219|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110329378|NCT00492219|Histamine Antagonists|histamine antagonists|mesh-ancestor
110329379|NCT00492219|Histamine Agents|histamine agents|mesh-ancestor
110329380|NCT00492219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110329381|NCT00492219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110329382|NCT00492219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110329383|NCT00492219|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110329384|NCT00492219|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110329385|NCT00492219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110329387|NCT00465257|Amodiaquine|amodiaquine|mesh-list
110329388|NCT00465257|Antimalarials|antimalarials|mesh-ancestor
110329389|NCT00465257|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110329390|NCT00465257|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110329391|NCT00465257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110329392|NCT00465257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110329393|NCT00465257|Antiviral Agents|antiviral agents|mesh-ancestor
110329394|NCT00465257|Schistosomicides|schistosomicides|mesh-ancestor
110329395|NCT00465257|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110329396|NCT00465257|Anthelmintics|anthelmintics|mesh-ancestor
110329397|NCT04130776|Kallikreins|kallikreins|mesh-list
110329398|NCT04130776|Coagulants|coagulants|mesh-ancestor
110329399|NCT04130776|Fertility Agents, Male|fertility agents, male|mesh-ancestor
110329400|NCT04130776|Fertility Agents|fertility agents|mesh-ancestor
110329401|NCT04130776|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110329402|NCT04130776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110329404|NCT00492258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110329405|NCT00492258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110329406|NCT00492258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110329407|NCT00492258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110329408|NCT02955810|Dexamethasone|dexamethasone|mesh-list
110329409|NCT02955810|Cyclophosphamide|cyclophosphamide|mesh-list
110329410|NCT02955810|Bortezomib|bortezomib|mesh-list
110329411|NCT02955810|Daratumumab|daratumumab|mesh-list
110329412|NCT02955810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110329413|NCT02955810|Immunologic Factors|immunologic factors|mesh-ancestor
110329414|NCT02955810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110329415|NCT02955810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110329416|NCT02955810|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110329417|NCT02955810|Alkylating Agents|alkylating agents|mesh-ancestor
110329418|NCT02955810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110329419|NCT02955810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110329420|NCT02955810|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110329421|NCT02955810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110329423|NCT02955810|Autonomic Agents|autonomic agents|mesh-ancestor
110329424|NCT02955810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110329425|NCT02955810|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110329426|NCT02955810|Glucocorticoids|glucocorticoids|mesh-ancestor
110329427|NCT02955810|Hormones|hormones|mesh-ancestor
110329428|NCT02955810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110171780|NCT00001766|Abacavir|abacavir|mesh-list
110329429|NCT02955810|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110329430|NCT00465296|Rosiglitazone|rosiglitazone|mesh-list
110329432|NCT00465296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110329434|NCT00492414|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110329435|NCT00492414|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110329436|NCT00492414|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110329437|NCT00492414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110329438|NCT00492414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110329439|NCT00492414|Serotonin Agents|serotonin agents|mesh-ancestor
110329440|NCT00492414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110329441|NCT00492414|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110329442|NCT00492414|Antidepressive Agents|antidepressive agents|mesh-ancestor
110329443|NCT00492414|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110329444|NCT00492414|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110329445|NCT00492414|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110329446|NCT00492414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110329447|NCT01243632|Gemcitabine|gemcitabine|mesh-list
110329448|NCT01243632|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110329449|NCT01243632|Antimetabolites|antimetabolites|mesh-ancestor
110329450|NCT01243632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110329451|NCT01243632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110329452|NCT00467909|Micronutrients|micronutrients|mesh-list
110329453|NCT00467909|Trace Elements|trace elements|mesh-list
110329454|NCT00467909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110329455|NCT04327453|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110329456|NCT04327453|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
110329457|NCT04327453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110329458|NCT04327453|Antitubercular Agents|antitubercular agents|mesh-ancestor
110329459|NCT00467948|Cefazolin|cefazolin|mesh-list
110329460|NCT00467948|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110329461|NCT00467948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110329462|NCT00592579|2-Methoxyestradiol|2-methoxyestradiol|mesh-list
110329463|NCT00592579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110329464|NCT00592579|Tubulin Modulators|tubulin modulators|mesh-ancestor
110329465|NCT00592579|Antimitotic Agents|antimitotic agents|mesh-ancestor
110329466|NCT00592579|Mitosis Modulators|mitosis modulators|mesh-ancestor
110329467|NCT00592579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110329468|NCT00592618|Acetylcysteine|acetylcysteine|mesh-list
110329469|NCT00592618|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110329470|NCT00592618|Antiviral Agents|antiviral agents|mesh-ancestor
110329471|NCT00592618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110329472|NCT00592618|Expectorants|expectorants|mesh-ancestor
110329473|NCT00592618|Respiratory System Agents|respiratory system agents|mesh-ancestor
110329474|NCT00592618|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110329475|NCT00592618|Antioxidants|antioxidants|mesh-ancestor
110329476|NCT00592618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110329477|NCT00592618|Protective Agents|protective agents|mesh-ancestor
110329478|NCT00592618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110329479|NCT00592618|Antidotes|antidotes|mesh-ancestor
110329480|NCT01243710|Taurolidine|taurolidine|mesh-list
110329481|NCT01243710|Heparin|heparin|mesh-list
110329482|NCT01243710|Anticoagulants|anticoagulants|mesh-ancestor
110329483|NCT01243710|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110329484|NCT01243710|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110171787|NCT00001766|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110329485|NCT01243710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110329487|NCT01243710|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110329488|NCT01243710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110329490|NCT00622843|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110329491|NCT00622843|Immunologic Factors|immunologic factors|mesh-ancestor
110329492|NCT00622843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110329493|NCT01245543|Docetaxel|docetaxel|mesh-list
110329494|NCT01245543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110329495|NCT01245543|Tubulin Modulators|tubulin modulators|mesh-ancestor
110329496|NCT01245543|Antimitotic Agents|antimitotic agents|mesh-ancestor
110329497|NCT01245543|Mitosis Modulators|mitosis modulators|mesh-ancestor
110329498|NCT01245543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110329500|NCT00592930|Antiemetics|antiemetics|mesh-ancestor
110329501|NCT00592930|Autonomic Agents|autonomic agents|mesh-ancestor
110329502|NCT00592930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110329504|NCT00592930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110329505|NCT00592930|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110329506|NCT00592930|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110329507|NCT00592930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110329508|NCT00592930|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110329509|NCT00592930|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110329510|NCT00592930|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110329511|NCT00592930|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110329512|NCT00592930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110329513|NCT00592930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110329514|NCT00592930|Serotonin Agents|serotonin agents|mesh-ancestor
110329515|NCT00592969|Metformin|metformin|mesh-list
110329516|NCT00592969|Insulin Aspart|insulin aspart|mesh-list
110329517|NCT00592969|Biphasic Insulins|biphasic insulins|mesh-list
110329518|NCT00592969|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110329519|NCT00592969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110329521|NCT01245582|Oxaliplatin|oxaliplatin|mesh-list
110329522|NCT01245582|Sorafenib|sorafenib|mesh-list
110329523|NCT01245582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110329524|NCT01245582|Antimetabolites|antimetabolites|mesh-ancestor
110329525|NCT01245582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110329526|NCT01245582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110329527|NCT01245582|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110329528|NCT01245582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110329529|NCT00593008|Sirolimus|sirolimus|mesh-list
110329530|NCT00593008|Gemcitabine|gemcitabine|mesh-list
110329531|NCT00593008|Temsirolimus|temsirolimus|mesh-list
110329532|NCT00593008|MTOR Inhibitors|mtor inhibitors|mesh-list
110329533|NCT00593008|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110329534|NCT00593008|Antimetabolites|antimetabolites|mesh-ancestor
110329535|NCT00593008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110329536|NCT00593008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110329537|NCT00593008|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110329538|NCT00593008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110329539|NCT00593008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110329540|NCT00593008|Immunologic Factors|immunologic factors|mesh-ancestor
110329541|NCT00593008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110329543|NCT00593008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110329544|NCT00593008|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110329545|NCT00593008|Antifungal Agents|antifungal agents|mesh-ancestor
110329546|NCT02956200|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
110329547|NCT02956200|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
110329548|NCT02956200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110329549|NCT02956200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110329550|NCT02956200|Immunologic Factors|immunologic factors|mesh-ancestor
110329551|NCT02956200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110329552|NCT00593125|Levetiracetam|levetiracetam|mesh-list
110329553|NCT00593125|Anticonvulsants|anticonvulsants|mesh-ancestor
110329554|NCT00593125|Nootropic Agents|nootropic agents|mesh-ancestor
110329555|NCT00593164|Magnesium Sulfate|magnesium sulfate|mesh-list
110329556|NCT00593164|Analgesics|analgesics|mesh-ancestor
110329557|NCT00593164|Sensory System Agents|sensory system agents|mesh-ancestor
110329558|NCT00593164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110329559|NCT00593164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110329561|NCT00593164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110329562|NCT00593164|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110329564|NCT00593164|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110329565|NCT00593164|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110329566|NCT00593164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110329567|NCT00593164|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110329568|NCT00593164|Tocolytic Agents|tocolytic agents|mesh-ancestor
110329569|NCT00593164|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110329571|NCT01316107|Nateglinide|nateglinide|mesh-list
110329572|NCT01316107|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110329573|NCT01316107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110329574|NCT01316107|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110329575|NCT01316107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110329576|NCT05654194|Azacitidine|azacitidine|mesh-list
110329577|NCT05654194|Venetoclax|venetoclax|mesh-list
110329578|NCT05654194|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110329580|NCT05654194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110329581|NCT05654194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110329582|NCT05654194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110329583|NCT05653453|Paclitaxel|paclitaxel|mesh-list
110329584|NCT05653453|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110329585|NCT05653453|Gemcitabine|gemcitabine|mesh-list
110329586|NCT05653453|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110329587|NCT05653453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110329588|NCT05653453|Tubulin Modulators|tubulin modulators|mesh-ancestor
110329589|NCT05653453|Antimitotic Agents|antimitotic agents|mesh-ancestor
110329590|NCT05653453|Mitosis Modulators|mitosis modulators|mesh-ancestor
110329591|NCT05653453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110329592|NCT05653453|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110329593|NCT05653453|Antimetabolites|antimetabolites|mesh-ancestor
110329594|NCT00468182|Interferons|interferons|mesh-list
110329595|NCT00468182|Interferon-beta|interferon-beta|mesh-list
110329596|NCT00468182|Interferon beta-1b|interferon beta-1b|mesh-list
110329597|NCT00468182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110329598|NCT00468182|Antiviral Agents|antiviral agents|mesh-ancestor
110329599|NCT00468182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110329600|NCT00468182|Immunologic Factors|immunologic factors|mesh-ancestor
110329601|NCT00468182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110329602|NCT00468182|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110329603|NCT05649163|Disitamab vedotin|disitamab vedotin|mesh-list
110329604|NCT05649163|Immunoconjugates|immunoconjugates|mesh-ancestor
110329605|NCT05649163|Immunologic Factors|immunologic factors|mesh-ancestor
110329606|NCT05649163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110329608|NCT00465452|Dopamine Agonists|dopamine agonists|mesh-list
110329609|NCT00465452|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110329610|NCT00465452|Sympathomimetics|sympathomimetics|mesh-ancestor
110329611|NCT00465452|Autonomic Agents|autonomic agents|mesh-ancestor
110329612|NCT00465452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110329613|NCT00465452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110329614|NCT00465452|Dopamine Agents|dopamine agents|mesh-ancestor
110329615|NCT00465452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110329616|NCT00465452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110329617|NCT00465452|Protective Agents|protective agents|mesh-ancestor
110329619|NCT01379521|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110329620|NCT01379521|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110329621|NCT01379521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110329622|NCT01379521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110329623|NCT01379521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110329624|NCT01379521|Immunologic Factors|immunologic factors|mesh-ancestor
110171803|NCT00046501|Insulin|insulin|mesh-list
110329625|NCT01379521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110329626|NCT01379521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110329627|NCT00468260|Epothilone B|epothilone b|mesh-list
110329628|NCT00468260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110329629|NCT00468260|Tubulin Modulators|tubulin modulators|mesh-ancestor
110329630|NCT00468260|Antimitotic Agents|antimitotic agents|mesh-ancestor
110329631|NCT00468260|Mitosis Modulators|mitosis modulators|mesh-ancestor
110329632|NCT00468260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110329633|NCT01371994|Solifenacin Succinate|solifenacin succinate|mesh-list
110329634|NCT01371994|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110329635|NCT01371994|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110329637|NCT01371994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110329638|NCT01371994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110329639|NCT01371994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110329640|NCT01371994|Urological Agents|urological agents|mesh-ancestor
110329641|NCT00465608|Propranolol|propranolol|mesh-list
110329642|NCT00465608|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110329643|NCT00465608|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110329644|NCT00465608|Adrenergic Agents|adrenergic agents|mesh-ancestor
110329645|NCT00465608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110329646|NCT00465608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110329647|NCT00465608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110329648|NCT00465608|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110329649|NCT00465608|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110329650|NCT00465608|Vasodilator Agents|vasodilator agents|mesh-ancestor
110329651|NCT01371877|Vitamin D|vitamin d|mesh-list
110329652|NCT01371877|Ergocalciferols|ergocalciferols|mesh-list
110329653|NCT01371877|Cholecalciferol|cholecalciferol|mesh-list
110329654|NCT01371877|Vitamins|vitamins|mesh-list
110329655|NCT01371877|Micronutrients|micronutrients|mesh-ancestor
110329656|NCT01371877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110329657|NCT01371877|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110329658|NCT01371877|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110329659|NCT01245816|Eflornithine|eflornithine|mesh-list
110329660|NCT01245816|Sulindac|sulindac|mesh-list
110329661|NCT01245816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110329662|NCT01245816|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
110329663|NCT01245816|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110329664|NCT01245816|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110329665|NCT01245816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110329666|NCT01245816|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
110329668|NCT01245816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110329669|NCT01245816|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110329671|NCT01245816|Analgesics|analgesics|mesh-ancestor
110329672|NCT01245816|Sensory System Agents|sensory system agents|mesh-ancestor
110329673|NCT01245816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110329674|NCT01245816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110329675|NCT01245816|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110329676|NCT01245816|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110329677|NCT01245816|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110329678|NCT00492687|Tamoxifen|tamoxifen|mesh-list
110329679|NCT00492687|Carboplatin|carboplatin|mesh-list
110329681|NCT00492687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110329682|NCT00492687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110329683|NCT00492687|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110329685|NCT00492687|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110329686|NCT00492687|Hormone Antagonists|hormone antagonists|mesh-ancestor
110329687|NCT00492687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110329688|NCT00492687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110329689|NCT00492687|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110329690|NCT00492687|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110329691|NCT00492687|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110329692|NCT00492687|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110329694|NCT01371838|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
110329695|NCT01371838|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110329696|NCT01371838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110329697|NCT01245855|Alprostadil|alprostadil|mesh-list
110329698|NCT01245855|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110329699|NCT01245855|Vasodilator Agents|vasodilator agents|mesh-ancestor
110329700|NCT01245855|Urological Agents|urological agents|mesh-ancestor
110329701|NCT00473603|Heparin|heparin|mesh-list
110329702|NCT00473603|Anticoagulants|anticoagulants|mesh-ancestor
110329703|NCT00473603|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110329704|NCT00473603|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110329705|NCT00473603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110329707|NCT00492765|Interferon-beta|interferon-beta|mesh-list
110329708|NCT00492765|Interferon beta-1a|interferon beta-1a|mesh-list
110329709|NCT00492765|Simvastatin|simvastatin|mesh-list
110329710|NCT00492765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110329711|NCT00492765|Antiviral Agents|antiviral agents|mesh-ancestor
110329712|NCT00492765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110329713|NCT00492765|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110329714|NCT00492765|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110329715|NCT00492765|Antimetabolites|antimetabolites|mesh-ancestor
110329716|NCT00492765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110329717|NCT00492765|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110329718|NCT00492765|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110329719|NCT00492765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110329720|NCT00492765|Immunologic Factors|immunologic factors|mesh-ancestor
110329721|NCT00492765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110329722|NCT00492765|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110329723|NCT00468533|Aripiprazole|aripiprazole|mesh-list
110329724|NCT00468533|Antidepressive Agents|antidepressive agents|mesh-ancestor
110329725|NCT00468533|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110329726|NCT00468533|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110329727|NCT00468533|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110329728|NCT00468533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110329729|NCT00468533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110329730|NCT00468533|Dopamine Agonists|dopamine agonists|mesh-ancestor
110329731|NCT00468533|Dopamine Agents|dopamine agents|mesh-ancestor
110329732|NCT00468533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110329733|NCT00468533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110329734|NCT00468533|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110329735|NCT00468533|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110329736|NCT00468533|Serotonin Agents|serotonin agents|mesh-ancestor
110329737|NCT00468533|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110329738|NCT00468533|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110329739|NCT00468533|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110329740|NCT00468533|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110329741|NCT00473720|Paclitaxel|paclitaxel|mesh-list
110329742|NCT00473720|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110329743|NCT00473720|Satraplatin|satraplatin|mesh-list
110329744|NCT00473720|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110329745|NCT00473720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110329746|NCT00473720|Tubulin Modulators|tubulin modulators|mesh-ancestor
110329747|NCT00473720|Antimitotic Agents|antimitotic agents|mesh-ancestor
110329748|NCT00473720|Mitosis Modulators|mitosis modulators|mesh-ancestor
110329749|NCT00473720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110329750|NCT00499668|Ondansetron|ondansetron|mesh-list
110329751|NCT00499668|Aprepitant|aprepitant|mesh-list
110329753|NCT00499668|Autonomic Agents|autonomic agents|mesh-ancestor
110329754|NCT00499668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110329755|NCT00499668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110329756|NCT00499668|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110329757|NCT00499668|Antipruritics|antipruritics|mesh-ancestor
110329758|NCT00499668|Dermatologic Agents|dermatologic agents|mesh-ancestor
110329759|NCT00499668|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110329760|NCT00499668|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110329761|NCT00499668|Serotonin Agents|serotonin agents|mesh-ancestor
110329762|NCT00499668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110329763|NCT00499668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110329764|NCT00499668|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110329765|NCT00499707|Metformin|metformin|mesh-list
110329766|NCT00499707|Rosiglitazone|rosiglitazone|mesh-list
110329767|NCT00499707|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110329768|NCT00499707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110329769|NCT01366534|Vaccines|vaccines|mesh-list
110329770|NCT01366534|Immunologic Factors|immunologic factors|mesh-ancestor
110329771|NCT01366534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110329772|NCT00492843|Ibandronic Acid|ibandronic acid|mesh-list
110329773|NCT00492843|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110329774|NCT00492843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110329775|NCT01605487|Cyproheptadine|cyproheptadine|mesh-list
110329776|NCT01605487|Antipruritics|antipruritics|mesh-ancestor
110329777|NCT01605487|Dermatologic Agents|dermatologic agents|mesh-ancestor
110329778|NCT01605487|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110329779|NCT01605487|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110329780|NCT01605487|Histamine Antagonists|histamine antagonists|mesh-ancestor
110329781|NCT01605487|Histamine Agents|histamine agents|mesh-ancestor
110329782|NCT01605487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110329783|NCT01605487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110329784|NCT01605487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110329785|NCT01605487|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110150162|NCT00008242|Hormones|hormones|mesh-ancestor
110329786|NCT01605487|Serotonin Agents|serotonin agents|mesh-ancestor
110329787|NCT01605487|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110329788|NCT01365910|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
110329789|NCT01365910|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110329790|NCT01365910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110329791|NCT01365910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110329792|NCT01605526|Doxorubicin|doxorubicin|mesh-list
110329793|NCT01605526|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110329794|NCT01605526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110329795|NCT01605526|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110329796|NCT01605526|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110329797|NCT01605526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110329798|NCT01605526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110329799|NCT00468689|Ketoconazole|ketoconazole|mesh-list
110329800|NCT00468689|Antifungal Agents|antifungal agents|mesh-ancestor
110329801|NCT00468689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110329802|NCT00468689|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110171841|NCT00046852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110329803|NCT00468689|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110329804|NCT00468689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110329805|NCT00468689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110329806|NCT00468689|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110329807|NCT00468689|Hormone Antagonists|hormone antagonists|mesh-ancestor
110329808|NCT00468689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110329809|NCT00468689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110329810|NCT00468689|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110329811|NCT00473915|Fluticasone|fluticasone|mesh-list
110329812|NCT00473915|Xhance|xhance|mesh-list
110329813|NCT00473915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110329814|NCT00473915|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110329815|NCT00473915|Autonomic Agents|autonomic agents|mesh-ancestor
110329816|NCT00473915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110329817|NCT00473915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110329818|NCT00473915|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110329819|NCT00473915|Respiratory System Agents|respiratory system agents|mesh-ancestor
110329820|NCT00473915|Dermatologic Agents|dermatologic agents|mesh-ancestor
110329821|NCT00473915|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110329822|NCT00493077|Interferons|interferons|mesh-list
110329823|NCT00493077|Interferon-beta|interferon-beta|mesh-list
110329824|NCT00493077|Interferon beta-1a|interferon beta-1a|mesh-list
110329825|NCT00493077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110329826|NCT00493077|Antiviral Agents|antiviral agents|mesh-ancestor
110329827|NCT00493077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110329828|NCT00493077|Immunologic Factors|immunologic factors|mesh-ancestor
110329829|NCT00493077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110329830|NCT00493077|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110329831|NCT00474071|Remifentanil|remifentanil|mesh-list
110329832|NCT00474071|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110329833|NCT00474071|Narcotics|narcotics|mesh-ancestor
110329834|NCT00474071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110329835|NCT00474071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110329836|NCT00474071|Analgesics|analgesics|mesh-ancestor
110329837|NCT00474071|Sensory System Agents|sensory system agents|mesh-ancestor
110329838|NCT00474071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110329839|NCT00474110|Ketamine|ketamine|mesh-list
110329840|NCT00474110|Hydromorphone|hydromorphone|mesh-list
110329841|NCT00474110|Analgesics|analgesics|mesh-ancestor
110329842|NCT00474110|Sensory System Agents|sensory system agents|mesh-ancestor
110329843|NCT00474110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110329844|NCT00474110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110329845|NCT00474110|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110329846|NCT00474110|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110329847|NCT00474110|Anesthetics, General|anesthetics, general|mesh-ancestor
110329848|NCT00474110|Anesthetics|anesthetics|mesh-ancestor
110329849|NCT00474110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110329850|NCT00474110|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110329851|NCT00474110|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110329852|NCT00474110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110329853|NCT00474110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110329854|NCT00474110|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110329855|NCT00474110|Narcotics|narcotics|mesh-ancestor
110329856|NCT00500058|Rituximab|rituximab|mesh-list
110329857|NCT00500058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110329858|NCT00500058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110329859|NCT00500058|Immunologic Factors|immunologic factors|mesh-ancestor
110329860|NCT00500058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110329861|NCT00500058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110329862|NCT00468923|Candesartan|candesartan|mesh-list
110329863|NCT00468923|Candesartan cilexetil|candesartan cilexetil|mesh-list
110329864|NCT00468923|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110329865|NCT00468923|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110329866|NCT00468923|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110329867|NCT00468923|Antimetabolites|antimetabolites|mesh-ancestor
110329868|NCT00468923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110329869|NCT00468923|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110329870|NCT00468923|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110329871|NCT00468923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110329872|NCT00468923|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110329873|NCT00468923|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110329874|NCT00468923|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110329876|NCT01365481|Valsartan|valsartan|mesh-list
110329877|NCT01365481|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110329878|NCT01365481|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110329879|NCT01365481|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110329880|NCT01365481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110329881|NCT01365481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110329882|NCT01365481|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110329883|NCT01365481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110329884|NCT01365481|Vasodilator Agents|vasodilator agents|mesh-ancestor
110329885|NCT01365481|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110329886|NCT01365481|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110329887|NCT01365481|Diuretics|diuretics|mesh-ancestor
110329888|NCT01365481|Natriuretic Agents|natriuretic agents|mesh-ancestor
110329889|NCT01365481|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110329890|NCT00493116|Interferons|interferons|mesh-list
110329891|NCT00493116|Interferon-beta|interferon-beta|mesh-list
110329892|NCT00493116|Interferon beta-1a|interferon beta-1a|mesh-list
110329893|NCT00493116|Methylprednisolone|methylprednisolone|mesh-list
110329894|NCT00493116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110329895|NCT00493116|Antiviral Agents|antiviral agents|mesh-ancestor
110329896|NCT00493116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110329897|NCT00493116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110329898|NCT00493116|Antiemetics|antiemetics|mesh-ancestor
110329899|NCT00493116|Autonomic Agents|autonomic agents|mesh-ancestor
110329900|NCT00493116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110329901|NCT00493116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110329902|NCT00493116|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110329903|NCT00493116|Glucocorticoids|glucocorticoids|mesh-ancestor
110329904|NCT00493116|Hormones|hormones|mesh-ancestor
110329905|NCT00493116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110329906|NCT00493116|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110329907|NCT00493116|Protective Agents|protective agents|mesh-ancestor
110329908|NCT00493116|Immunologic Factors|immunologic factors|mesh-ancestor
110329909|NCT00493116|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110329910|NCT00493194|Cyclosporine|cyclosporine|mesh-list
110329911|NCT00493194|Sirolimus|sirolimus|mesh-list
110329912|NCT00493194|Cyclosporins|cyclosporins|mesh-list
110329913|NCT00493194|Daclizumab|daclizumab|mesh-list
110329914|NCT00493194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110329915|NCT00493194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110329916|NCT00493194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110329917|NCT00493194|Immunologic Factors|immunologic factors|mesh-ancestor
110329918|NCT00493194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110329919|NCT00493194|Antifungal Agents|antifungal agents|mesh-ancestor
110329920|NCT00493194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110329921|NCT00493194|Dermatologic Agents|dermatologic agents|mesh-ancestor
110329922|NCT00493194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110329923|NCT00493194|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110329924|NCT00493194|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110329925|NCT00493194|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110329926|NCT00493194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110329927|NCT01605721|Everolimus|everolimus|mesh-list
110329928|NCT01605721|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110329929|NCT01605721|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110329930|NCT01605721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110150164|NCT00008242|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110329931|NCT01605721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110329932|NCT01605721|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110329933|NCT01605721|Immunologic Factors|immunologic factors|mesh-ancestor
110329934|NCT01605721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110329935|NCT01605721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110329936|NCT01605760|Immunomodulating Agents|immunomodulating agents|mesh-list
110329937|NCT01605760|Immunologic Factors|immunologic factors|mesh-ancestor
110329938|NCT01605760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110329939|NCT01350271|Mebendazole|mebendazole|mesh-list
110329940|NCT01350271|Piperazine|piperazine|mesh-list
110329941|NCT01350271|Piperazine citrate|piperazine citrate|mesh-list
110329942|NCT01350271|DMP 777|dmp 777|mesh-list
110329943|NCT01350271|Antinematodal Agents|antinematodal agents|mesh-ancestor
110329944|NCT01350271|Anthelmintics|anthelmintics|mesh-ancestor
110171860|NCT04733781|Lidocaine|lidocaine|mesh-list
110329945|NCT01350271|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110329946|NCT01350271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110329947|NCT01350271|Tubulin Modulators|tubulin modulators|mesh-ancestor
110329948|NCT01350271|Antimitotic Agents|antimitotic agents|mesh-ancestor
110329949|NCT01350271|Mitosis Modulators|mitosis modulators|mesh-ancestor
110329950|NCT01350271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110329951|NCT01350271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110329952|NCT01350271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110329954|NCT00493233|Risperidone|risperidone|mesh-list
110329955|NCT00493233|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110329956|NCT00493233|Antipsychotic Agents|antipsychotic agents|mesh-list
110329957|NCT00493233|Clozapine|clozapine|mesh-list
110329958|NCT00493233|Perphenazine|perphenazine|mesh-list
110329959|NCT00493233|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110329960|NCT00493233|Serotonin Agents|serotonin agents|mesh-ancestor
110329961|NCT00493233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110329962|NCT00493233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110329963|NCT00493233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110329964|NCT00493233|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110329965|NCT00493233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110329966|NCT00493233|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110329967|NCT00493233|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110329968|NCT00493233|Dopamine Agents|dopamine agents|mesh-ancestor
110329969|NCT00493233|Antiemetics|antiemetics|mesh-ancestor
110329970|NCT00493233|Autonomic Agents|autonomic agents|mesh-ancestor
110329971|NCT00493233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110329972|NCT00493233|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110329973|NCT00493233|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110329974|NCT00493233|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110329975|NCT00493233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110329976|NCT00493233|Antidepressive Agents|antidepressive agents|mesh-ancestor
110329977|NCT00493233|GABA Antagonists|gaba antagonists|mesh-ancestor
110329978|NCT00493233|GABA Agents|gaba agents|mesh-ancestor
110329979|NCT00500253|Nitric Oxide|nitric oxide|mesh-list
110329980|NCT00500253|Methacholine Chloride|methacholine chloride|mesh-list
110329981|NCT00500253|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110329982|NCT00500253|Autonomic Agents|autonomic agents|mesh-ancestor
110329983|NCT00500253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110329984|NCT00500253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110329985|NCT00500253|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110329986|NCT00500253|Respiratory System Agents|respiratory system agents|mesh-ancestor
110329987|NCT00500253|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110329988|NCT00500253|Antioxidants|antioxidants|mesh-ancestor
110329989|NCT00500253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110329990|NCT00500253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110329991|NCT00500253|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
110329992|NCT00500253|Vasodilator Agents|vasodilator agents|mesh-ancestor
110329993|NCT00500253|Gasotransmitters|gasotransmitters|mesh-ancestor
110329994|NCT00500253|Protective Agents|protective agents|mesh-ancestor
110329995|NCT00500253|Miotics|miotics|mesh-ancestor
110329996|NCT00500253|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110329997|NCT00500253|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
110329998|NCT00500253|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
110329999|NCT00500253|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110330000|NCT00500253|Cholinergic Agents|cholinergic agents|mesh-ancestor
110330001|NCT01243788|Fluticasone|fluticasone|mesh-list
110330003|NCT01243788|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110330004|NCT01243788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110330006|NCT01243788|Autonomic Agents|autonomic agents|mesh-ancestor
110330007|NCT01243788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110330008|NCT01243788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110330009|NCT01243788|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110330010|NCT01243788|Respiratory System Agents|respiratory system agents|mesh-ancestor
110330011|NCT01243788|Dermatologic Agents|dermatologic agents|mesh-ancestor
110330012|NCT01243788|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110171863|NCT04733781|Anesthetics|anesthetics|mesh-ancestor
110330013|NCT01243788|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110330014|NCT01243788|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110330015|NCT01243788|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110330016|NCT01243788|Adrenergic Agents|adrenergic agents|mesh-ancestor
110330017|NCT01243788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110330018|NCT01243788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110330021|NCT01243827|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110330022|NCT01243827|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110330023|NCT01243827|Adrenergic Agents|adrenergic agents|mesh-ancestor
110330024|NCT01243827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110330025|NCT01243827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110330026|NCT01243827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110330027|NCT01243827|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110330028|NCT01243827|Antioxidants|antioxidants|mesh-ancestor
110330029|NCT01243827|Protective Agents|protective agents|mesh-ancestor
110330030|NCT01243827|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110330031|NCT01243827|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110330032|NCT01243827|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110330033|NCT01243827|Vasodilator Agents|vasodilator agents|mesh-ancestor
110330034|NCT01243827|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110330035|NCT01243827|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110330036|NCT01243827|Sympatholytics|sympatholytics|mesh-ancestor
110330037|NCT01243827|Autonomic Agents|autonomic agents|mesh-ancestor
110330038|NCT01243827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110330039|NCT01243827|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110330041|NCT00500409|Vitamins|vitamins|mesh-ancestor
110330042|NCT00500409|Micronutrients|micronutrients|mesh-ancestor
110330043|NCT00500409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110330044|NCT00500409|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110330045|NCT00469352|Ranibizumab|ranibizumab|mesh-list
110330046|NCT00469352|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110330047|NCT00469352|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110330048|NCT00469352|Growth Substances|growth substances|mesh-ancestor
110330049|NCT00469352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110330050|NCT00469352|Growth Inhibitors|growth inhibitors|mesh-ancestor
110330051|NCT00469352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110330052|NCT00469430|Metronidazole|metronidazole|mesh-list
110330053|NCT00469430|Cefotaxime|cefotaxime|mesh-list
110330054|NCT00469430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110330055|NCT00469430|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110330056|NCT00469430|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110330057|NCT00469430|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110330058|NCT00469469|Bevacizumab|bevacizumab|mesh-list
110330059|NCT00469469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110330060|NCT00469469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110330061|NCT00469469|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110330062|NCT00469469|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110330063|NCT00469469|Growth Substances|growth substances|mesh-ancestor
110330064|NCT00469469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110330065|NCT00469469|Growth Inhibitors|growth inhibitors|mesh-ancestor
110330066|NCT00500565|Bupivacaine|bupivacaine|mesh-list
110330067|NCT00500565|Anesthetics, Local|anesthetics, local|mesh-ancestor
110330068|NCT00500565|Anesthetics|anesthetics|mesh-ancestor
110330069|NCT00500565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110330070|NCT00500565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110330071|NCT00500565|Sensory System Agents|sensory system agents|mesh-ancestor
110330072|NCT00500565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110330073|NCT00469547|Ethanol|ethanol|mesh-list
110330074|NCT00469547|Anti-Infective Agents|anti-infective agents|mesh-list
110330075|NCT00469547|Emollients|emollients|mesh-list
110330076|NCT00469547|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110330077|NCT00469547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110330078|NCT00469547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110330079|NCT00469547|Dermatologic Agents|dermatologic agents|mesh-ancestor
110330080|NCT00500604|Valsartan|valsartan|mesh-list
110330081|NCT00500604|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110330082|NCT00500604|Irbesartan|irbesartan|mesh-list
110330083|NCT00500604|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110330084|NCT00500604|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110330085|NCT00500604|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110330086|NCT00500604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110330087|NCT00500604|Diuretics|diuretics|mesh-ancestor
110330088|NCT00500604|Natriuretic Agents|natriuretic agents|mesh-ancestor
110330089|NCT00500604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110330090|NCT00500604|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110330091|NCT00500604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110330092|NCT00493389|Hormones|hormones|mesh-list
110330093|NCT00493389|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
110330094|NCT00493389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110330095|NCT00493389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110330096|NCT01605994|Antacids|antacids|mesh-list
110330097|NCT01605994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110330098|NCT01605994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110330100|NCT00500721|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110330101|NCT00500721|Antidepressive Agents|antidepressive agents|mesh-ancestor
110330102|NCT00500721|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110330103|NCT00500721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110330104|NCT00500721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110330105|NCT00500721|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110330106|NCT00500721|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110330107|NCT00500721|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110330108|NCT00500721|Adrenergic Agents|adrenergic agents|mesh-ancestor
110330109|NCT00500721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110330110|NCT00500721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110330111|NCT00469586|Insulin|insulin|mesh-list
110330112|NCT00469586|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110330113|NCT00469586|Metformin|metformin|mesh-list
110330114|NCT00469586|Glimepiride|glimepiride|mesh-list
110330115|NCT00469586|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110330116|NCT00469586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110330117|NCT00469586|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110330118|NCT00469586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110330119|NCT00469586|Immunologic Factors|immunologic factors|mesh-ancestor
110330120|NCT01606111|Cerebrolysin|cerebrolysin|mesh-list
110330121|NCT01606111|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110330122|NCT01606111|Protective Agents|protective agents|mesh-ancestor
110330123|NCT01606111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110330124|NCT01606111|Nootropic Agents|nootropic agents|mesh-ancestor
110330125|NCT00493428|Baclofen|baclofen|mesh-list
110330126|NCT00493428|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110330127|NCT00493428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110330128|NCT00493428|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110330129|NCT00493428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110330130|NCT00493428|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
110330131|NCT00493428|GABA Agonists|gaba agonists|mesh-ancestor
110330132|NCT00493428|GABA Agents|gaba agents|mesh-ancestor
110330133|NCT00493428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110330134|NCT00493428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110330135|NCT01342510|Lidocaine|lidocaine|mesh-list
110330136|NCT01342510|Magnesium Sulfate|magnesium sulfate|mesh-list
110330137|NCT01342510|Anesthetics, Local|anesthetics, local|mesh-ancestor
110330138|NCT01342510|Anesthetics|anesthetics|mesh-ancestor
110330139|NCT01342510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110330140|NCT01342510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110330141|NCT01342510|Sensory System Agents|sensory system agents|mesh-ancestor
110330142|NCT01342510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110330143|NCT01342510|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110330144|NCT01342510|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110330145|NCT01342510|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110330146|NCT01342510|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110330147|NCT01342510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110018785|NCT01851174|Paclitaxel|paclitaxel|mesh-list
110330148|NCT01342510|Analgesics|analgesics|mesh-ancestor
110330149|NCT01342510|Anticonvulsants|anticonvulsants|mesh-ancestor
110330150|NCT01342510|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110330151|NCT01342510|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110330152|NCT01342510|Tocolytic Agents|tocolytic agents|mesh-ancestor
110330153|NCT01342510|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110330155|NCT01606345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110330156|NCT01606345|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110330157|NCT01606345|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110330158|NCT01606345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110330159|NCT01606345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110330160|NCT01245894|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110330161|NCT01245894|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110330162|NCT01245894|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110330163|NCT01245894|Antimetabolites|antimetabolites|mesh-ancestor
110330164|NCT01245894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110330165|NCT01245894|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110330166|NCT01245894|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110330167|NCT01245894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110330169|NCT00469664|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110330170|NCT00469664|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110330171|NCT00469664|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110330172|NCT00469664|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110330173|NCT00469664|Adrenergic Agents|adrenergic agents|mesh-ancestor
110330174|NCT00469664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110330175|NCT00469664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110330176|NCT00469664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110330177|NCT00469703|Thalidomide|thalidomide|mesh-list
110330178|NCT00469703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110330179|NCT00469703|Immunologic Factors|immunologic factors|mesh-ancestor
110330180|NCT00469703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110330181|NCT00469703|Leprostatic Agents|leprostatic agents|mesh-ancestor
110330182|NCT00469703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110330183|NCT00469703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110330184|NCT00469703|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110330185|NCT00469703|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110330186|NCT00469703|Growth Substances|growth substances|mesh-ancestor
110330187|NCT00469703|Growth Inhibitors|growth inhibitors|mesh-ancestor
110330188|NCT00469703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110330189|NCT01244100|Aspirin|aspirin|mesh-list
110330190|NCT01244100|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110330191|NCT01244100|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110330192|NCT01244100|Analgesics|analgesics|mesh-ancestor
110330193|NCT01244100|Sensory System Agents|sensory system agents|mesh-ancestor
110330194|NCT01244100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110330195|NCT01244100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110330196|NCT01244100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110330197|NCT01244100|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110330198|NCT01244100|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110330199|NCT01244100|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110330200|NCT01244100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110330201|NCT01244100|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110330202|NCT01244100|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110330203|NCT01244100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110330204|NCT01244100|Antipyretics|antipyretics|mesh-ancestor
110330205|NCT01340872|Ferric maltol|ferric maltol|mesh-list
110330206|NCT01340872|Hematinics|hematinics|mesh-ancestor
110330207|NCT00469781|Bromfenac|bromfenac|mesh-list
110330208|NCT00469781|Prednisolone acetate|prednisolone acetate|mesh-list
110330209|NCT00469781|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110330210|NCT00469781|Methylprednisolone|methylprednisolone|mesh-list
110330211|NCT00469781|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110330212|NCT00469781|Prednisolone|prednisolone|mesh-list
110330213|NCT00469781|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110330214|NCT00469781|Prednisolone phosphate|prednisolone phosphate|mesh-list
110330215|NCT00469781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110330216|NCT00469781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110330217|NCT00469781|Analgesics|analgesics|mesh-ancestor
110330218|NCT00469781|Sensory System Agents|sensory system agents|mesh-ancestor
110330219|NCT00469781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110330220|NCT00469781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110330221|NCT00469781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110330222|NCT00469781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110330223|NCT00469781|Antiemetics|antiemetics|mesh-ancestor
110330224|NCT00469781|Autonomic Agents|autonomic agents|mesh-ancestor
110330225|NCT00469781|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110330226|NCT00469781|Glucocorticoids|glucocorticoids|mesh-ancestor
110330227|NCT00469781|Hormones|hormones|mesh-ancestor
110330228|NCT00469781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110330229|NCT00469781|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110330230|NCT00469781|Protective Agents|protective agents|mesh-ancestor
110330231|NCT00469781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110330232|NCT00469781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110330234|NCT00474695|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110330235|NCT00474695|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110330236|NCT00474695|Growth Substances|growth substances|mesh-ancestor
110330237|NCT00474695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110330238|NCT00474695|Growth Inhibitors|growth inhibitors|mesh-ancestor
110330239|NCT00474695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110330241|NCT03271502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110330242|NCT03271502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110330243|NCT00500955|Rosiglitazone|rosiglitazone|mesh-list
110330244|NCT00500955|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110330245|NCT00500955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110330247|NCT00474773|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110330248|NCT00474773|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110330249|NCT00474773|Analgesics|analgesics|mesh-ancestor
110330250|NCT00474773|Sensory System Agents|sensory system agents|mesh-ancestor
110330251|NCT00474773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110330252|NCT00474773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110330253|NCT00474773|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110330254|NCT00474773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110330255|NCT00474773|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110330256|NCT00474773|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110330257|NCT00474773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110330258|NCT00474773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110330259|NCT00474890|Pseudoephedrine|pseudoephedrine|mesh-list
110330260|NCT00474890|Ephedrine|ephedrine|mesh-list
110330261|NCT00474890|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110330262|NCT00474890|Autonomic Agents|autonomic agents|mesh-ancestor
110330263|NCT00474890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110330264|NCT00474890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110330265|NCT00474890|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110330266|NCT00474890|Respiratory System Agents|respiratory system agents|mesh-ancestor
110330267|NCT00474890|Nasal Decongestants|nasal decongestants|mesh-ancestor
110330268|NCT00474890|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110330269|NCT00474890|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110330270|NCT00474890|Sympathomimetics|sympathomimetics|mesh-ancestor
110330271|NCT00474890|Adrenergic Agents|adrenergic agents|mesh-ancestor
110330272|NCT00474890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110330273|NCT00474890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110330274|NCT00501111|Donepezil|donepezil|mesh-list
110330275|NCT00501111|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110330276|NCT00501111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110330277|NCT00501111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110330278|NCT00501111|Cholinergic Agents|cholinergic agents|mesh-ancestor
110330279|NCT00501111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110330281|NCT00501111|Nootropic Agents|nootropic agents|mesh-ancestor
110330282|NCT00501150|Linezolid|linezolid|mesh-list
110330283|NCT00501150|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110330284|NCT00501150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110330285|NCT00501150|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110330286|NCT00501150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110330287|NCT00501150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110330288|NCT01340209|Tiotropium Bromide|tiotropium bromide|mesh-list
110330289|NCT01340209|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110330290|NCT01340209|Autonomic Agents|autonomic agents|mesh-ancestor
110330291|NCT01340209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110330292|NCT01340209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110330293|NCT01340209|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110330294|NCT01340209|Respiratory System Agents|respiratory system agents|mesh-ancestor
110330295|NCT01340209|Parasympatholytics|parasympatholytics|mesh-ancestor
110330296|NCT01340209|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110330297|NCT01340209|Cholinergic Agents|cholinergic agents|mesh-ancestor
110330298|NCT01340209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110330299|NCT01340209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110330300|NCT01246089|Ranibizumab|ranibizumab|mesh-list
110330302|NCT01246089|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110330303|NCT01246089|Growth Substances|growth substances|mesh-ancestor
110330304|NCT01246089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110330305|NCT01246089|Growth Inhibitors|growth inhibitors|mesh-ancestor
110330306|NCT01246089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110330307|NCT00598897|Clarithromycin|clarithromycin|mesh-list
110330309|NCT00598897|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110330310|NCT00598897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110330311|NCT00598897|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110330312|NCT00598897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110330313|NCT00598897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110330314|NCT00598897|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110330315|NCT00598897|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110330316|NCT00598897|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110330317|NCT00598897|Antitubercular Agents|antitubercular agents|mesh-ancestor
110330318|NCT04697732|Anesthetics|anesthetics|mesh-list
110330319|NCT04697732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110330320|NCT04697732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110330321|NCT00501267|Oxybutynin|oxybutynin|mesh-list
110330322|NCT00501267|Solabegron|solabegron|mesh-list
110330323|NCT00501267|Parasympatholytics|parasympatholytics|mesh-ancestor
110330324|NCT00501267|Autonomic Agents|autonomic agents|mesh-ancestor
110330325|NCT00501267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110330326|NCT00501267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110330327|NCT00501267|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110330328|NCT00501267|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110330329|NCT00501267|Cholinergic Agents|cholinergic agents|mesh-ancestor
110330330|NCT00501267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110330331|NCT00501267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110330332|NCT00501267|Urological Agents|urological agents|mesh-ancestor
110330333|NCT00501267|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
110330334|NCT00501267|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110330335|NCT00501267|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110330336|NCT00501267|Adrenergic Agents|adrenergic agents|mesh-ancestor
110330337|NCT00469937|Lithium Carbonate|lithium carbonate|mesh-list
110330338|NCT00469937|Antidepressive Agents|antidepressive agents|mesh-ancestor
110330339|NCT00469937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110330340|NCT00469937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110330341|NCT00469937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110330342|NCT00469937|Antimanic Agents|antimanic agents|mesh-ancestor
110330343|NCT00469937|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110330344|NCT00469937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110330345|NCT00469937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110330346|NCT00599287|Haloperidol|haloperidol|mesh-list
110330347|NCT00599287|Haloperidol decanoate|haloperidol decanoate|mesh-list
110330348|NCT00599287|Methylphenidate|methylphenidate|mesh-list
110330349|NCT00599287|Rivastigmine|rivastigmine|mesh-list
110330350|NCT00599287|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110330351|NCT00599287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110330352|NCT00599287|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110171902|NCT04163874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110330353|NCT00599287|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110330354|NCT00599287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110330355|NCT00599287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110330356|NCT00599287|Dopamine Agents|dopamine agents|mesh-ancestor
110330357|NCT00599287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110330358|NCT00599287|Antiemetics|antiemetics|mesh-ancestor
110330359|NCT00599287|Autonomic Agents|autonomic agents|mesh-ancestor
110330360|NCT00599287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110330361|NCT00599287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110330362|NCT00599287|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110330363|NCT00599287|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110330364|NCT00599287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110330365|NCT00599287|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110330366|NCT00599287|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110330367|NCT00599287|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110330368|NCT00599287|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110330369|NCT00599287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110330370|NCT00599287|Cholinergic Agents|cholinergic agents|mesh-ancestor
110330371|NCT00599287|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110330372|NCT00599287|Protective Agents|protective agents|mesh-ancestor
110330374|NCT04326166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110330375|NCT04326166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110330377|NCT00501384|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
110330378|NCT00501384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110330379|NCT00501384|Natriuretic Agents|natriuretic agents|mesh-ancestor
110330380|NCT00501384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110330381|NCT00599560|Vasopressins|vasopressins|mesh-list
110330382|NCT00599560|Arginine Vasopressin|arginine vasopressin|mesh-list
110330383|NCT00599560|Hemostatics|hemostatics|mesh-ancestor
110330384|NCT00599560|Coagulants|coagulants|mesh-ancestor
110330385|NCT00599560|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110330386|NCT00599560|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
110330387|NCT00599560|Natriuretic Agents|natriuretic agents|mesh-ancestor
110330388|NCT00599560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110330389|NCT00599716|Hyaluronic Acid|hyaluronic acid|mesh-list
110330390|NCT00599716|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110330391|NCT00599716|Immunologic Factors|immunologic factors|mesh-ancestor
110330392|NCT00599716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110330393|NCT00599716|Viscosupplements|viscosupplements|mesh-ancestor
110330394|NCT00599716|Protective Agents|protective agents|mesh-ancestor
110330395|NCT01246284|Triamcinolone|triamcinolone|mesh-list
110330396|NCT01246284|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110330397|NCT01246284|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110330398|NCT01246284|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110330399|NCT01246284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110330400|NCT01246284|Glucocorticoids|glucocorticoids|mesh-ancestor
110330401|NCT01246284|Hormones|hormones|mesh-ancestor
110330402|NCT01246284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110330403|NCT01246284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110330404|NCT01246284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110330405|NCT01246284|Immunologic Factors|immunologic factors|mesh-ancestor
110330406|NCT01246284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110330407|NCT01246284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110330408|NCT00599833|Cetuximab|cetuximab|mesh-list
110330409|NCT00599833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110330410|NCT00599833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110330411|NCT00469976|Bevacizumab|bevacizumab|mesh-list
110330412|NCT00469976|Carboplatin|carboplatin|mesh-list
110330413|NCT00469976|Gemcitabine|gemcitabine|mesh-list
110330414|NCT00469976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110330415|NCT00469976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110330416|NCT00469976|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110330417|NCT00469976|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110330418|NCT00469976|Growth Substances|growth substances|mesh-ancestor
110330419|NCT00469976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110330420|NCT00469976|Growth Inhibitors|growth inhibitors|mesh-ancestor
110171903|NCT00047242|Irinotecan|irinotecan|mesh-list
110330421|NCT00469976|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110330422|NCT00469976|Antimetabolites|antimetabolites|mesh-ancestor
110330423|NCT00469976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110330424|NCT00599911|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110330425|NCT00599911|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110330426|NCT00599911|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110330427|NCT00599911|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110330428|NCT00599911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110330429|NCT00599911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110330430|NCT00599911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110330431|NCT00599911|Analgesics|analgesics|mesh-ancestor
110330432|NCT00599911|Sensory System Agents|sensory system agents|mesh-ancestor
110330433|NCT00599911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110330434|NCT00599911|Antidepressive Agents|antidepressive agents|mesh-ancestor
110330435|NCT00599911|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110330436|NCT00599911|Dopamine Agents|dopamine agents|mesh-ancestor
110330438|NCT00599950|Mitomycin|mitomycin|mesh-list
110330439|NCT00599950|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110330440|NCT00599950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110330441|NCT00599950|Alkylating Agents|alkylating agents|mesh-ancestor
110330442|NCT00599950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110330443|NCT00599950|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110330444|NCT00599950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110330446|NCT00600145|Antidepressive Agents|antidepressive agents|mesh-ancestor
110330447|NCT00600145|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110330448|NCT00600145|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110330449|NCT00600145|Histamine Antagonists|histamine antagonists|mesh-ancestor
110330450|NCT00600145|Histamine Agents|histamine agents|mesh-ancestor
110330451|NCT00600145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110330452|NCT00600145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110330453|NCT00600145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110330454|NCT00600145|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110330455|NCT00600145|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110330456|NCT00600145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110330457|NCT00600145|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
110330458|NCT00600145|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110330459|NCT00600145|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110330460|NCT00600145|Adrenergic Agents|adrenergic agents|mesh-ancestor
110330461|NCT00600145|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110330462|NCT00600145|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110330463|NCT00600145|Serotonin Agents|serotonin agents|mesh-ancestor
110330464|NCT00600145|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110330465|NCT00470015|Aldesleukin|aldesleukin|mesh-list
110330466|NCT00470015|Interleukin-2|interleukin-2|mesh-list
110330467|NCT00470015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110330468|NCT00470015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110330469|NCT00470015|Analgesics|analgesics|mesh-ancestor
110330470|NCT00470015|Sensory System Agents|sensory system agents|mesh-ancestor
110330471|NCT00470015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110330472|NCT00470015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110330473|NCT00470015|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110330474|NCT00470015|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110330475|NCT00470015|Antiviral Agents|antiviral agents|mesh-ancestor
110330476|NCT00470015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110330477|NCT00600262|Bevacizumab|bevacizumab|mesh-list
110330478|NCT00600262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110330479|NCT00600262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110330480|NCT00600262|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110330481|NCT00600262|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110330482|NCT00600262|Growth Substances|growth substances|mesh-ancestor
110330483|NCT00600262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110330484|NCT00600262|Growth Inhibitors|growth inhibitors|mesh-ancestor
110330485|NCT00600301|Triamcinolone|triamcinolone|mesh-list
110330486|NCT00600301|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110330487|NCT00600301|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110330488|NCT00600301|Bevacizumab|bevacizumab|mesh-list
110330489|NCT00600301|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110330490|NCT00600301|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110330491|NCT00600301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110330492|NCT00600301|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110330493|NCT00600301|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110330494|NCT00600301|Growth Substances|growth substances|mesh-ancestor
110330495|NCT00600301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110330496|NCT00600301|Growth Inhibitors|growth inhibitors|mesh-ancestor
110330497|NCT00600301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110330498|NCT00600301|Glucocorticoids|glucocorticoids|mesh-ancestor
110330500|NCT00600301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110330501|NCT00600301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110330502|NCT00600301|Immunologic Factors|immunologic factors|mesh-ancestor
110330503|NCT00600301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110330504|NCT00600301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110330505|NCT00501579|Prednisolone|prednisolone|mesh-list
110330506|NCT00501579|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110330507|NCT00501579|Methylprednisolone|methylprednisolone|mesh-list
110330508|NCT00501579|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110330509|NCT00501579|Prednisolone acetate|prednisolone acetate|mesh-list
110330510|NCT00501579|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110330511|NCT00501579|Prednisolone phosphate|prednisolone phosphate|mesh-list
110330512|NCT00501579|Difluprednate|difluprednate|mesh-list
110330513|NCT00501579|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110330514|NCT00501579|Glucocorticoids|glucocorticoids|mesh-ancestor
110330515|NCT00501579|Hormones|hormones|mesh-ancestor
110330516|NCT00501579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110330517|NCT00501579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110330518|NCT00501579|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110330519|NCT00501579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110330520|NCT00501579|Antiemetics|antiemetics|mesh-ancestor
110330521|NCT00501579|Autonomic Agents|autonomic agents|mesh-ancestor
110330522|NCT00501579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110330523|NCT00501579|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110330524|NCT00501579|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110330525|NCT00501579|Protective Agents|protective agents|mesh-ancestor
110330526|NCT00501618|Clozapine|clozapine|mesh-list
110330527|NCT00501618|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110330528|NCT00501618|Serotonin Agents|serotonin agents|mesh-ancestor
110330529|NCT00501618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110330530|NCT00501618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110330531|NCT00501618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110330533|NCT00501618|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110330534|NCT00501618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110330535|NCT00501618|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110330536|NCT00501618|GABA Antagonists|gaba antagonists|mesh-ancestor
110330537|NCT00501618|GABA Agents|gaba agents|mesh-ancestor
110330538|NCT00600535|Abiraterone Acetate|abiraterone acetate|mesh-list
110330539|NCT00600535|Glucocorticoids|glucocorticoids|mesh-list
110330540|NCT00600535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110330541|NCT00600535|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110330542|NCT00600535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110330543|NCT00600535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110330544|NCT00600535|Hormone Antagonists|hormone antagonists|mesh-ancestor
110330545|NCT00600535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110330546|NCT00600535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110330547|NCT00600535|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110330548|NCT00600535|Hormones|hormones|mesh-ancestor
110330549|NCT00600691|Finasteride|finasteride|mesh-list
110330550|NCT00600691|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
110330551|NCT00600691|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110330552|NCT00600691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110330553|NCT00600691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110330554|NCT00600691|Hormone Antagonists|hormone antagonists|mesh-ancestor
110330555|NCT00600691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110330556|NCT00600691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110330557|NCT00600691|Urological Agents|urological agents|mesh-ancestor
110330558|NCT00623077|Etoposide|etoposide|mesh-list
110330559|NCT00623077|Melphalan|melphalan|mesh-list
110330560|NCT00623077|Busulfan|busulfan|mesh-list
110330561|NCT00623077|Ifosfamide|ifosfamide|mesh-list
110330562|NCT00623077|Thiotepa|thiotepa|mesh-list
110330563|NCT00623077|Sargramostim|sargramostim|mesh-list
110330564|NCT00623077|Mesna|mesna|mesh-list
110330565|NCT00623077|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110330566|NCT00623077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110330567|NCT00623077|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110330568|NCT00623077|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110330569|NCT00623077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110330570|NCT00623077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110330571|NCT00623077|Immunologic Factors|immunologic factors|mesh-ancestor
110330572|NCT00623077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110330573|NCT00623077|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110330574|NCT00623077|Alkylating Agents|alkylating agents|mesh-ancestor
110330575|NCT00623077|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110330576|NCT00623077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110330577|NCT00623077|Protective Agents|protective agents|mesh-ancestor
110330578|NCT00475358|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110330579|NCT00475358|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110330580|NCT00475358|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110330581|NCT00475358|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110330582|NCT00475358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110330583|NCT00475358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110330584|NCT00475358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110330585|NCT00475358|Analgesics|analgesics|mesh-ancestor
110330586|NCT00475358|Sensory System Agents|sensory system agents|mesh-ancestor
110330587|NCT00475358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110330588|NCT00475358|Antidepressive Agents|antidepressive agents|mesh-ancestor
110330589|NCT00475358|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110330590|NCT00475358|Dopamine Agents|dopamine agents|mesh-ancestor
110330591|NCT00623116|Testosterone|testosterone|mesh-list
110330592|NCT00623116|Estrogens|estrogens|mesh-list
110330593|NCT00623116|Androgens|androgens|mesh-ancestor
110330594|NCT00623116|Hormones|hormones|mesh-ancestor
110330595|NCT00623116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110330596|NCT00623116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110330597|NCT00623155|Pyrimethamine|pyrimethamine|mesh-list
110330598|NCT00623155|Sulfadoxine|sulfadoxine|mesh-list
110330599|NCT00623155|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
110330600|NCT00623155|Antimalarials|antimalarials|mesh-ancestor
110330601|NCT00623155|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110330602|NCT00623155|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110330603|NCT00623155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110330604|NCT00623155|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110330605|NCT00623155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110330606|NCT00623155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110330607|NCT00623155|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110330608|NCT00600730|Hypoglycemic Agents|hypoglycemic agents|mesh-list
110330609|NCT00600730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110330610|NCT00600769|Clarithromycin|clarithromycin|mesh-list
110330611|NCT00600769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110330612|NCT00600769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110330613|NCT00600769|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110330614|NCT00600769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110330615|NCT00600769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110330616|NCT00600769|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110330617|NCT00600769|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110330618|NCT00470210|Ribavirin|ribavirin|mesh-list
110330619|NCT00470210|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110330620|NCT00470210|Antimetabolites|antimetabolites|mesh-ancestor
110330621|NCT00470210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110330622|NCT00470210|Antiviral Agents|antiviral agents|mesh-ancestor
110330623|NCT00470210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110330624|NCT00600847|Loratadine|loratadine|mesh-list
110330625|NCT00600847|Desloratadine|desloratadine|mesh-list
110330626|NCT00600847|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110330627|NCT00600847|Cholinergic Agents|cholinergic agents|mesh-ancestor
110330628|NCT00600847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110330629|NCT00600847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110330630|NCT00600847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110330631|NCT00600847|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110330632|NCT00600847|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110330633|NCT00600847|Histamine Antagonists|histamine antagonists|mesh-ancestor
110330634|NCT00600847|Histamine Agents|histamine agents|mesh-ancestor
110330635|NCT00600847|Antipruritics|antipruritics|mesh-ancestor
110330636|NCT00600847|Dermatologic Agents|dermatologic agents|mesh-ancestor
110330637|NCT00600847|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110330638|NCT04325932|Kallikreins|kallikreins|mesh-list
110330639|NCT04325932|Coagulants|coagulants|mesh-ancestor
110330640|NCT04325932|Fertility Agents, Male|fertility agents, male|mesh-ancestor
110330641|NCT04325932|Fertility Agents|fertility agents|mesh-ancestor
110330642|NCT04325932|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110330643|NCT04325932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110330644|NCT00501657|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110330645|NCT00501657|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110330646|NCT00501657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110330647|NCT00501657|Incretins|incretins|mesh-ancestor
110330648|NCT00501657|Hormones|hormones|mesh-ancestor
110330649|NCT00501657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110330650|NCT00501657|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110330651|NCT00501657|Protease Inhibitors|protease inhibitors|mesh-ancestor
110330652|NCT00501657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110330653|NCT00501657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110330654|NCT00600964|Obatoclax|obatoclax|mesh-list
110330655|NCT00600964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110330656|NCT00600964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110330657|NCT00475397|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110330658|NCT00475397|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110330659|NCT00475397|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110330660|NCT00475397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110330661|NCT00475397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110330662|NCT00475397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110330663|NCT00475397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110330664|NCT00475397|Analgesics|analgesics|mesh-ancestor
110330665|NCT00475397|Sensory System Agents|sensory system agents|mesh-ancestor
110330666|NCT00475397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110330667|NCT00475397|Antidepressive Agents|antidepressive agents|mesh-ancestor
110330668|NCT00475397|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110330669|NCT00475397|Dopamine Agents|dopamine agents|mesh-ancestor
110330670|NCT00601042|Lobeline|lobeline|mesh-list
110330671|NCT00601042|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110330672|NCT00601042|Autonomic Agents|autonomic agents|mesh-ancestor
110330673|NCT00601042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110171946|NCT00047476|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110330674|NCT00601042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110330675|NCT00601042|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110330676|NCT00601042|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110330677|NCT00601042|Cholinergic Agents|cholinergic agents|mesh-ancestor
110330678|NCT00601042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110330679|NCT00601042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110330680|NCT00601042|Respiratory System Agents|respiratory system agents|mesh-ancestor
110330681|NCT00501696|Naltrexone|naltrexone|mesh-list
110330682|NCT00501696|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110330683|NCT00501696|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110330684|NCT00501696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110330685|NCT00501696|Sensory System Agents|sensory system agents|mesh-ancestor
110330686|NCT00501696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110330687|NCT00601276|Leuprolide|leuprolide|mesh-list
110330688|NCT00601276|Cyproterone Acetate|cyproterone acetate|mesh-list
110330689|NCT00601276|Cyproterone|cyproterone|mesh-list
110330690|NCT00601276|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110330691|NCT00601276|Fertility Agents|fertility agents|mesh-ancestor
110330692|NCT00601276|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110330693|NCT00601276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110330694|NCT00601276|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110330695|NCT00601276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110330696|NCT00601276|Androgen Antagonists|androgen antagonists|mesh-ancestor
110330697|NCT00601276|Hormone Antagonists|hormone antagonists|mesh-ancestor
110330698|NCT00601276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110330699|NCT00601276|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110330700|NCT00601276|Contraceptive Agents|contraceptive agents|mesh-ancestor
110330701|NCT00601315|Clarithromycin|clarithromycin|mesh-list
110330702|NCT00601315|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110330703|NCT00601315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110330704|NCT00601315|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110330705|NCT00601315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110330706|NCT00601315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110330707|NCT00601315|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110330708|NCT00601315|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110330709|NCT00470249|Carboplatin|carboplatin|mesh-list
110330710|NCT00470249|Gemcitabine|gemcitabine|mesh-list
110330711|NCT00470249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110330712|NCT00470249|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110330713|NCT00470249|Antimetabolites|antimetabolites|mesh-ancestor
110150196|NCT00008281|Vitamins|vitamins|mesh-ancestor
110330714|NCT00470249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110330715|NCT04325893|Hydroxychloroquine|hydroxychloroquine|mesh-list
110330716|NCT04325893|Antimalarials|antimalarials|mesh-ancestor
110330717|NCT04325893|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110330718|NCT04325893|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110330719|NCT04325893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110330720|NCT04325893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110330721|NCT04325893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110330722|NCT04325893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110330724|NCT00601432|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110330725|NCT00601432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110330726|NCT00601432|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110330727|NCT00601432|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110330728|NCT00601432|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110330729|NCT00601432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110330730|NCT00601432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110330731|NCT00601432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110330732|NCT00601432|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110330733|NCT00601432|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110330734|NCT00475514|Frovatriptan|frovatriptan|mesh-list
110330735|NCT00475514|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110330736|NCT00475514|Serotonin Agents|serotonin agents|mesh-ancestor
110330737|NCT00475514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110330738|NCT00475514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110330739|NCT00475514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110330740|NCT00601510|Capecitabine|capecitabine|mesh-list
110330741|NCT00601510|Imatinib Mesylate|imatinib mesylate|mesh-list
110330742|NCT00601510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110330743|NCT00601510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110330744|NCT00601510|Antimetabolites|antimetabolites|mesh-ancestor
110330745|NCT00601510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110330746|NCT00601510|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110330747|NCT00601510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110330749|NCT00601588|Antidepressive Agents|antidepressive agents|mesh-ancestor
110330750|NCT00601588|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110330751|NCT00601588|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110330752|NCT00601588|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110330753|NCT00601588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110330754|NCT00601588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110330755|NCT00601588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110330756|NCT00601588|Serotonin Agents|serotonin agents|mesh-ancestor
110330757|NCT00601588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110330758|NCT00601666|Zolpidem|zolpidem|mesh-list
110330759|NCT00601666|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110330760|NCT00601666|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110330761|NCT00601666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110330762|NCT00601666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110330763|NCT00601666|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
110330764|NCT00601666|GABA Agonists|gaba agonists|mesh-ancestor
110330765|NCT00601666|GABA Agents|gaba agents|mesh-ancestor
110330766|NCT00601666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110330767|NCT00601666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110330768|NCT01246362|Etoricoxib|etoricoxib|mesh-list
110330769|NCT01246362|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110330770|NCT01246362|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110330771|NCT01246362|Analgesics|analgesics|mesh-ancestor
110330772|NCT01246362|Sensory System Agents|sensory system agents|mesh-ancestor
110330773|NCT01246362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110330774|NCT01246362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110330775|NCT01246362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110330776|NCT01246362|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110330777|NCT01246362|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110330778|NCT01246362|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110330780|NCT01246362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110330781|NCT00470405|Oxaliplatin|oxaliplatin|mesh-list
110330782|NCT00470405|Pemetrexed|pemetrexed|mesh-list
110330783|NCT00470405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110330784|NCT00470405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110330785|NCT00470405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110330786|NCT00470405|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110330787|NCT00470405|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110330788|NCT00601978|Levodopa|levodopa|mesh-list
110330789|NCT00601978|Carbidopa|carbidopa|mesh-list
110330790|NCT00601978|Entacapone|entacapone|mesh-list
110330791|NCT00601978|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
110330792|NCT00601978|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110330793|NCT00601978|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110330794|NCT00601978|Dopamine Agents|dopamine agents|mesh-ancestor
110330795|NCT00601978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110330796|NCT00601978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110330797|NCT00601978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110330798|NCT00601978|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
110330799|NCT00601978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110330800|NCT00601978|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
110330801|NCT00601978|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110330802|NCT00601978|Immunologic Factors|immunologic factors|mesh-ancestor
110330803|NCT00601978|Dopamine Agonists|dopamine agonists|mesh-ancestor
110330804|NCT00601159|Gemcitabine|gemcitabine|mesh-list
110330805|NCT00601159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110330806|NCT00601159|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110330807|NCT00601159|Antimetabolites|antimetabolites|mesh-ancestor
110330808|NCT00601159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110330809|NCT00602017|Amlodipine|amlodipine|mesh-list
110330810|NCT00602017|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110330811|NCT00602017|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110330812|NCT00602017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110330813|NCT00602017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110330814|NCT00602017|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110330815|NCT00602017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110330816|NCT00602017|Vasodilator Agents|vasodilator agents|mesh-ancestor
110330817|NCT00470483|Paroxetine|paroxetine|mesh-list
110330818|NCT00470483|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110330819|NCT00470483|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110330820|NCT00470483|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110330821|NCT00470483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110330822|NCT00470483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110330823|NCT00470483|Serotonin Agents|serotonin agents|mesh-ancestor
110330824|NCT00470483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110330825|NCT00470483|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110330826|NCT00470483|Antidepressive Agents|antidepressive agents|mesh-ancestor
110330827|NCT00470483|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110330828|NCT00470483|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110330829|NCT00470483|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110330830|NCT00470483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110330831|NCT00602095|Misoprostol|misoprostol|mesh-list
110330832|NCT00602095|Dinoprostone|dinoprostone|mesh-list
110330833|NCT00602095|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110330834|NCT00602095|Abortifacient Agents|abortifacient agents|mesh-ancestor
110330835|NCT00602095|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110330836|NCT00602095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110330837|NCT00602095|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110330838|NCT00602095|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110330839|NCT00602095|Oxytocics|oxytocics|mesh-ancestor
110330840|NCT00475553|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110330841|NCT00475553|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110330842|NCT00475553|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110330843|NCT00475553|Etonogestrel|etonogestrel|mesh-list
110330844|NCT00475553|Desogestrel|desogestrel|mesh-list
110330845|NCT00475553|NuvaRing|nuvaring|mesh-list
110330846|NCT00475553|Estradiol|estradiol|mesh-list
110330847|NCT00475553|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110330848|NCT00475553|Estrogens|estrogens|mesh-ancestor
110330849|NCT00475553|Hormones|hormones|mesh-ancestor
110330850|NCT00475553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110330851|NCT00475553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110330852|NCT00475553|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110330853|NCT00475553|Contraceptive Agents|contraceptive agents|mesh-ancestor
110330854|NCT00475553|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110330855|NCT00475553|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110330856|NCT00475553|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110330857|NCT00475553|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110330858|NCT00475553|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110330859|NCT00475553|Progestins|progestins|mesh-ancestor
110330860|NCT01326481|Capecitabine|capecitabine|mesh-list
110330861|NCT01326481|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110330862|NCT01326481|Antimetabolites|antimetabolites|mesh-ancestor
110330863|NCT01326481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110330864|NCT01326481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110330866|NCT00502164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110330867|NCT00502164|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110330868|NCT00502164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110330869|NCT00502164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110330870|NCT00470522|Folic Acid|folic acid|mesh-list
110330871|NCT00470522|Methotrexate|methotrexate|mesh-list
110330872|NCT00470522|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110330873|NCT00470522|Abortifacient Agents|abortifacient agents|mesh-ancestor
110330874|NCT00470522|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110330875|NCT00470522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110330876|NCT00470522|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110330877|NCT00470522|Antimetabolites|antimetabolites|mesh-ancestor
110330878|NCT00470522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110330879|NCT00470522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110330880|NCT00470522|Dermatologic Agents|dermatologic agents|mesh-ancestor
110330881|NCT00470522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110330882|NCT00470522|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110330883|NCT00470522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110330884|NCT00470522|Immunologic Factors|immunologic factors|mesh-ancestor
110330885|NCT00470522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110330886|NCT00470522|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110330887|NCT00470522|Hematinics|hematinics|mesh-ancestor
110330888|NCT00470522|Vitamin B Complex|vitamin b complex|mesh-ancestor
110330889|NCT00470522|Vitamins|vitamins|mesh-ancestor
110330890|NCT00470522|Micronutrients|micronutrients|mesh-ancestor
110330891|NCT01244178|Insulin|insulin|mesh-list
110330892|NCT01244178|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110330893|NCT01244178|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110330894|NCT01244178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110330895|NCT00470561|Aspirin|aspirin|mesh-list
110330896|NCT00470561|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110330897|NCT00470561|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110330898|NCT00470561|Analgesics|analgesics|mesh-ancestor
110330899|NCT00470561|Sensory System Agents|sensory system agents|mesh-ancestor
110330900|NCT00470561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110330901|NCT00470561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110330902|NCT00470561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110330903|NCT00470561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110330904|NCT00470561|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110330905|NCT00470561|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110330906|NCT00470561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110330907|NCT00470561|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110330908|NCT00470561|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110330909|NCT00470561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110330912|NCT00475826|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110330913|NCT00475826|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110330914|NCT00475826|Antimetabolites|antimetabolites|mesh-ancestor
110330915|NCT00475826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110330916|NCT00475826|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110330917|NCT00502437|Granisetron|granisetron|mesh-list
110330918|NCT00502437|Antiemetics|antiemetics|mesh-ancestor
110330919|NCT00502437|Autonomic Agents|autonomic agents|mesh-ancestor
110330920|NCT00502437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110330921|NCT00502437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110330922|NCT00502437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110330923|NCT00502437|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110330924|NCT00502437|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110330925|NCT00502437|Serotonin Agents|serotonin agents|mesh-ancestor
110330926|NCT00502437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110330927|NCT00502437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110330928|NCT00470678|Ranibizumab|ranibizumab|mesh-list
110330929|NCT00470678|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110330930|NCT00470678|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110330931|NCT00470678|Growth Substances|growth substances|mesh-ancestor
110330932|NCT00470678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110330933|NCT00470678|Growth Inhibitors|growth inhibitors|mesh-ancestor
110330934|NCT00470678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110330935|NCT00502476|Chlorhexidine|chlorhexidine|mesh-list
110330936|NCT00502476|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110330937|NCT00502476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110330938|NCT00502476|Disinfectants|disinfectants|mesh-ancestor
110330939|NCT00493545|Poly ICLC|poly iclc|mesh-list
110330940|NCT00493545|Interferon Inducers|interferon inducers|mesh-ancestor
110330941|NCT00493545|Immunologic Factors|immunologic factors|mesh-ancestor
110330942|NCT00493545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110330943|NCT00470873|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
110330944|NCT00470873|Vasodilator Agents|vasodilator agents|mesh-ancestor
110330945|NCT00470873|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110330946|NCT00470873|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110330947|NCT00470873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110330948|NCT00470873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110330949|NCT00470873|Urological Agents|urological agents|mesh-ancestor
110330950|NCT00493623|Ibandronic Acid|ibandronic acid|mesh-list
110330951|NCT00493623|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110330952|NCT00493623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110330953|NCT00476099|Budesonide|budesonide|mesh-list
110330954|NCT00476099|Beclomethasone|beclomethasone|mesh-list
110330955|NCT00476099|Formoterol Fumarate|formoterol fumarate|mesh-list
110330956|NCT00476099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110330957|NCT00476099|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110330958|NCT00476099|Autonomic Agents|autonomic agents|mesh-ancestor
110330959|NCT00476099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110330960|NCT00476099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110330961|NCT00476099|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110330962|NCT00476099|Respiratory System Agents|respiratory system agents|mesh-ancestor
110330963|NCT00476099|Glucocorticoids|glucocorticoids|mesh-ancestor
110330964|NCT00476099|Hormones|hormones|mesh-ancestor
110330965|NCT00476099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110330966|NCT00476099|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110330967|NCT00476099|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110330968|NCT00476099|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110330969|NCT00476099|Adrenergic Agents|adrenergic agents|mesh-ancestor
110330970|NCT00476099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110330971|NCT00476099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110330972|NCT00493662|Hyaluronic Acid|hyaluronic acid|mesh-list
110330973|NCT00493662|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110330974|NCT00493662|Immunologic Factors|immunologic factors|mesh-ancestor
110330975|NCT00493662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110330976|NCT00493662|Viscosupplements|viscosupplements|mesh-ancestor
110330977|NCT00493662|Protective Agents|protective agents|mesh-ancestor
110330978|NCT00470912|Sunscreening Agents|sunscreening agents|mesh-list
110330979|NCT00470912|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110330980|NCT00470912|Protective Agents|protective agents|mesh-ancestor
110330981|NCT00470912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110330982|NCT00470912|Dermatologic Agents|dermatologic agents|mesh-ancestor
110330983|NCT00476138|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
110330984|NCT00476138|Antioxidants|antioxidants|mesh-ancestor
110330985|NCT00476138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110330986|NCT00476138|Protective Agents|protective agents|mesh-ancestor
110330987|NCT00476138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110330988|NCT00476138|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
110330989|NCT00476138|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110330990|NCT00476138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110330991|NCT00476138|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110330992|NCT02956083|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110330993|NCT02956083|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110330994|NCT00470990|Acyline|acyline|mesh-list
110330995|NCT00470990|Hormone Antagonists|hormone antagonists|mesh-ancestor
110330996|NCT00470990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110330997|NCT00470990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110330998|NCT01246440|Catumaxomab|catumaxomab|mesh-list
110330999|NCT01246440|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110331000|NCT00471029|Esomeprazole|esomeprazole|mesh-list
110331001|NCT00471029|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110331002|NCT00471029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110331003|NCT00471029|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110331004|NCT00471029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110331005|NCT00471029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110331006|NCT00476216|Fondaparinux|fondaparinux|mesh-list
110331007|NCT00476216|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110331008|NCT00476216|Antithrombins|antithrombins|mesh-ancestor
110331009|NCT00476216|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110331010|NCT00476216|Protease Inhibitors|protease inhibitors|mesh-ancestor
110331011|NCT00476216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110331012|NCT00476216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110331013|NCT00476216|Anticoagulants|anticoagulants|mesh-ancestor
110331014|NCT00471185|Acyline|acyline|mesh-list
110331015|NCT00471185|Hormone Antagonists|hormone antagonists|mesh-ancestor
110331016|NCT00471185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110331017|NCT00471185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110331018|NCT00493857|Nimotuzumab|nimotuzumab|mesh-list
110331019|NCT00493857|Antibodies|antibodies|mesh-list
110331020|NCT00493857|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110331021|NCT00493857|Immunologic Factors|immunologic factors|mesh-ancestor
110331022|NCT00493857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110331023|NCT00493857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110331024|NCT00493857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110331025|NCT00502788|Ribavirin|ribavirin|mesh-list
110331026|NCT00502788|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110331027|NCT00502788|Antimetabolites|antimetabolites|mesh-ancestor
110331028|NCT00502788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110331029|NCT00502788|Antiviral Agents|antiviral agents|mesh-ancestor
110331030|NCT00502788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110331031|NCT00602134|Mercaptopurine|mercaptopurine|mesh-list
110331032|NCT00602134|Antimetabolites|antimetabolites|mesh-ancestor
110331033|NCT00602134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110331034|NCT00602134|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110331035|NCT00602134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110331036|NCT00602134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110331037|NCT00602134|Immunologic Factors|immunologic factors|mesh-ancestor
110331038|NCT00602134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110331039|NCT00602134|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110331040|NCT00602134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110331041|NCT00494208|Testosterone|testosterone|mesh-list
110331042|NCT00494208|Androgens|androgens|mesh-ancestor
110331043|NCT00494208|Hormones|hormones|mesh-ancestor
110331044|NCT00494208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110331045|NCT00494208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110331046|NCT00471341|Celecoxib|celecoxib|mesh-list
110331047|NCT00471341|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110331048|NCT00471341|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110331050|NCT00471341|Sensory System Agents|sensory system agents|mesh-ancestor
110331051|NCT00471341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110331052|NCT00471341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110331053|NCT00471341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110331054|NCT00471341|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110331055|NCT00471341|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110331056|NCT00471341|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110331057|NCT00471341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110331058|NCT00471341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110331059|NCT01325428|Vinorelbine|vinorelbine|mesh-list
110331060|NCT01325428|Afatinib|afatinib|mesh-list
110331061|NCT01325428|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110331062|NCT01325428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110331063|NCT01325428|Tubulin Modulators|tubulin modulators|mesh-ancestor
110331064|NCT01325428|Antimitotic Agents|antimitotic agents|mesh-ancestor
110331065|NCT01325428|Mitosis Modulators|mitosis modulators|mesh-ancestor
110331066|NCT01325428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110331067|NCT01325428|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110331068|NCT01325428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110331069|NCT00494247|Antibodies|antibodies|mesh-list
110331070|NCT00494247|Immunologic Factors|immunologic factors|mesh-ancestor
110331071|NCT00494247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110331073|NCT00471419|Glucocorticoids|glucocorticoids|mesh-ancestor
110331074|NCT00471419|Hormones|hormones|mesh-ancestor
110331075|NCT00471419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110331076|NCT00471419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110331078|NCT01325350|Minoxidil|minoxidil|mesh-list
110331079|NCT01325350|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110331080|NCT01325350|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110331081|NCT01325350|Vasodilator Agents|vasodilator agents|mesh-ancestor
110331082|NCT01324999|Tadalafil|tadalafil|mesh-list
110331083|NCT01324999|Vasodilator Agents|vasodilator agents|mesh-ancestor
110331084|NCT01324999|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110331085|NCT01324999|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110331086|NCT01324999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110331087|NCT01324999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110331088|NCT01324999|Urological Agents|urological agents|mesh-ancestor
110331089|NCT01324570|Buprenorphine|buprenorphine|mesh-list
110331090|NCT01324570|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110331091|NCT01324570|Narcotics|narcotics|mesh-ancestor
110331092|NCT01324570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110331093|NCT01324570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110331094|NCT01324570|Analgesics|analgesics|mesh-ancestor
110331095|NCT01324570|Sensory System Agents|sensory system agents|mesh-ancestor
110331096|NCT01324570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110331097|NCT01324570|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110331099|NCT04325698|Bevacizumab|bevacizumab|mesh-list
110331100|NCT04325698|Carboplatin|carboplatin|mesh-list
110331101|NCT04325698|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110331102|NCT04325698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110331103|NCT04325698|Tubulin Modulators|tubulin modulators|mesh-ancestor
110331104|NCT04325698|Antimitotic Agents|antimitotic agents|mesh-ancestor
110331105|NCT04325698|Mitosis Modulators|mitosis modulators|mesh-ancestor
110331106|NCT04325698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110331107|NCT04325698|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110331108|NCT04325698|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110331109|NCT04325698|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110331110|NCT04325698|Growth Substances|growth substances|mesh-ancestor
110331111|NCT04325698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110331112|NCT04325698|Growth Inhibitors|growth inhibitors|mesh-ancestor
110331113|NCT01324141|Fluorouracil|fluorouracil|mesh-list
110331114|NCT01324141|Mitomycins|mitomycins|mesh-list
110331115|NCT01324141|Mitomycin|mitomycin|mesh-list
110331117|NCT01324141|Antimetabolites|antimetabolites|mesh-ancestor
110331118|NCT01324141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110331119|NCT01324141|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110331120|NCT01324141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110331121|NCT01324141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110331122|NCT01324141|Immunologic Factors|immunologic factors|mesh-ancestor
110331123|NCT01324141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110331124|NCT01324141|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110331125|NCT01324141|Alkylating Agents|alkylating agents|mesh-ancestor
110331126|NCT01324141|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110331127|NCT01324141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110331128|NCT01324141|Antioxidants|antioxidants|mesh-ancestor
110331129|NCT01324141|Protective Agents|protective agents|mesh-ancestor
110331130|NCT01324141|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110331131|NCT01324141|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110331132|NCT01324141|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110331133|NCT01324024|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
110331134|NCT01324024|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110331135|NCT01324024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110331136|NCT01324024|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110331137|NCT01324024|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110331138|NCT01324024|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110331139|NCT01324024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110331140|NCT01324024|Dopamine Agents|dopamine agents|mesh-ancestor
110331141|NCT01324024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110331142|NCT01244217|Fexofenadine|fexofenadine|mesh-list
110331143|NCT01244217|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110331144|NCT01244217|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110331145|NCT01244217|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110331146|NCT01244217|Histamine Antagonists|histamine antagonists|mesh-ancestor
110331148|NCT01244217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110331149|NCT01244217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110331150|NCT01244217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110331152|NCT00471653|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110331153|NCT00471653|Alkylating Agents|alkylating agents|mesh-ancestor
110331154|NCT00471653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110331155|NCT00471653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110331156|NCT00494559|Pioglitazone|pioglitazone|mesh-list
110331157|NCT00494559|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110331158|NCT00494559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110331159|NCT00494598|Sufentanil|sufentanil|mesh-list
110331160|NCT00494598|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110331161|NCT00494598|Narcotics|narcotics|mesh-ancestor
110331162|NCT00494598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110331163|NCT00494598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110331164|NCT00494598|Analgesics|analgesics|mesh-ancestor
110331165|NCT00494598|Sensory System Agents|sensory system agents|mesh-ancestor
110331166|NCT00494598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110331167|NCT00494598|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110331168|NCT00494598|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110331169|NCT00494598|Anesthetics, General|anesthetics, general|mesh-ancestor
110331170|NCT00494598|Anesthetics|anesthetics|mesh-ancestor
110331171|NCT00503412|Cediranib|cediranib|mesh-list
110331172|NCT00503412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110331173|NCT00503412|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110331174|NCT00503412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110331175|NCT00503412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110331176|NCT00503451|Panobinostat|panobinostat|mesh-list
110331177|NCT00503451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110331178|NCT00503451|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110331179|NCT00503451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110331180|NCT00503451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110331181|NCT00471809|Azithromycin|azithromycin|mesh-list
110331182|NCT00471809|Budesonide|budesonide|mesh-list
110331183|NCT00471809|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110331184|NCT00471809|Montelukast|montelukast|mesh-list
110331185|NCT00471809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110331186|NCT00471809|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110331187|NCT00471809|Autonomic Agents|autonomic agents|mesh-ancestor
110331188|NCT00471809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110331189|NCT00471809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110331190|NCT00471809|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110331191|NCT00471809|Respiratory System Agents|respiratory system agents|mesh-ancestor
110331192|NCT00471809|Glucocorticoids|glucocorticoids|mesh-ancestor
110331193|NCT00471809|Hormones|hormones|mesh-ancestor
110331194|NCT00471809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110331195|NCT00471809|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110331196|NCT00471809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110331197|NCT00471809|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110331198|NCT00471809|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110331199|NCT00471809|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110331200|NCT00471809|Adrenergic Agents|adrenergic agents|mesh-ancestor
110331201|NCT00471809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110331202|NCT00471809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110331203|NCT00471809|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110331204|NCT00471809|Hormone Antagonists|hormone antagonists|mesh-ancestor
110331205|NCT00471809|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110331206|NCT00471809|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110331207|NCT00503490|Levofloxacin|levofloxacin|mesh-list
110331208|NCT00503490|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110331209|NCT00503490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110331210|NCT00503490|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110331211|NCT00503490|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110331212|NCT00503490|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110331213|NCT00503490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110331214|NCT00503490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110331215|NCT00503490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110331216|NCT00503490|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110331217|NCT00503490|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110331219|NCT00471965|Doxorubicin|doxorubicin|mesh-list
110331220|NCT00471965|Fluorouracil|fluorouracil|mesh-list
110331221|NCT00471965|Oxaliplatin|oxaliplatin|mesh-list
110331222|NCT00471965|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110331223|NCT00471965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110331224|NCT00471965|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110331225|NCT00471965|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110331226|NCT00471965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110331227|NCT00471965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110331228|NCT00471965|Antimetabolites|antimetabolites|mesh-ancestor
110331229|NCT00471965|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110331230|NCT00471965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110331231|NCT00471965|Immunologic Factors|immunologic factors|mesh-ancestor
110331232|NCT00471965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110331233|NCT00471965|Antidotes|antidotes|mesh-ancestor
110331234|NCT00471965|Protective Agents|protective agents|mesh-ancestor
110331235|NCT00471965|Vitamin B Complex|vitamin b complex|mesh-ancestor
110331237|NCT00471965|Micronutrients|micronutrients|mesh-ancestor
110331238|NCT00472004|Tibolone|tibolone|mesh-list
110331239|NCT00472004|Estradiol|estradiol|mesh-list
110331240|NCT00472004|Estrogens|estrogens|mesh-ancestor
110331241|NCT00472004|Hormones|hormones|mesh-ancestor
110331242|NCT00472004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110331243|NCT00472004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110331244|NCT00472004|Androgen Antagonists|androgen antagonists|mesh-ancestor
110331245|NCT00472004|Hormone Antagonists|hormone antagonists|mesh-ancestor
110331246|NCT00472004|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110331247|NCT00472004|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110331248|NCT00472004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110331249|NCT00472004|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110331250|NCT00472004|Anabolic Agents|anabolic agents|mesh-ancestor
110331251|NCT00494715|Valsartan|valsartan|mesh-list
110331252|NCT00494715|Benazepril|benazepril|mesh-list
110331253|NCT00494715|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110331254|NCT00494715|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110331255|NCT00494715|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110331256|NCT00494715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110331257|NCT00494715|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110331258|NCT00494715|Protease Inhibitors|protease inhibitors|mesh-ancestor
110331259|NCT00494715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110331260|NCT00472043|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
110331261|NCT00472043|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110331262|NCT00472043|Dermatologic Agents|dermatologic agents|mesh-ancestor
110331263|NCT03271073|Apatinib|apatinib|mesh-list
110331264|NCT03271073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110331265|NCT03271073|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110331266|NCT03271073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110331267|NCT03271073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110331268|NCT01246557|Dexamethasone|dexamethasone|mesh-list
110331269|NCT01246557|Lenalidomide|lenalidomide|mesh-list
110331270|NCT01246557|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110331271|NCT01246557|Antiemetics|antiemetics|mesh-ancestor
110331272|NCT01246557|Autonomic Agents|autonomic agents|mesh-ancestor
110331273|NCT01246557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110331274|NCT01246557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110331275|NCT01246557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110331276|NCT01246557|Glucocorticoids|glucocorticoids|mesh-ancestor
110331277|NCT01246557|Hormones|hormones|mesh-ancestor
110331278|NCT01246557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110172012|NCT00048139|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110331279|NCT01246557|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110331280|NCT01246557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110331281|NCT01246557|Immunologic Factors|immunologic factors|mesh-ancestor
110331282|NCT01246557|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110374839|NCT00193050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110331283|NCT01246557|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110331284|NCT01246557|Growth Substances|growth substances|mesh-ancestor
110331285|NCT01246557|Growth Inhibitors|growth inhibitors|mesh-ancestor
110331286|NCT00476918|Triamcinolone|triamcinolone|mesh-list
110331287|NCT00476918|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110331288|NCT00476918|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110331289|NCT00476918|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110150220|NCT00008515|Glucocorticoids|glucocorticoids|mesh-ancestor
110331290|NCT00476918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110331291|NCT00476918|Glucocorticoids|glucocorticoids|mesh-ancestor
110331292|NCT00476918|Hormones|hormones|mesh-ancestor
110331293|NCT00476918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110331294|NCT00476918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110331295|NCT00476918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110331296|NCT00476918|Immunologic Factors|immunologic factors|mesh-ancestor
110331297|NCT00476918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110331298|NCT00476918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110331299|NCT01323790|Naloxegol|naloxegol|mesh-list
110331300|NCT01323790|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110331301|NCT01323790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110331302|NCT01323790|Sensory System Agents|sensory system agents|mesh-ancestor
110331303|NCT01323790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110331304|NCT00477035|Cyclophosphamide|cyclophosphamide|mesh-list
110331305|NCT00477035|Melphalan|melphalan|mesh-list
110331306|NCT00477035|Carmustine|carmustine|mesh-list
110331307|NCT00477035|Gemcitabine|gemcitabine|mesh-list
110331308|NCT00477035|Etoposide|etoposide|mesh-list
110331309|NCT00477035|Vinorelbine|vinorelbine|mesh-list
110331310|NCT00477035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110331311|NCT00477035|Immunologic Factors|immunologic factors|mesh-ancestor
110331312|NCT00477035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110331313|NCT00477035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110331314|NCT00477035|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110331315|NCT00477035|Alkylating Agents|alkylating agents|mesh-ancestor
110331316|NCT00477035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110331317|NCT00477035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110331318|NCT00477035|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110331319|NCT00477035|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110331320|NCT00477035|Antimetabolites|antimetabolites|mesh-ancestor
110331321|NCT00477035|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110331322|NCT00477035|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110331323|NCT00477035|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110331324|NCT00477035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110331325|NCT00477035|Tubulin Modulators|tubulin modulators|mesh-ancestor
110331326|NCT00477035|Antimitotic Agents|antimitotic agents|mesh-ancestor
110331327|NCT00477035|Mitosis Modulators|mitosis modulators|mesh-ancestor
110331328|NCT00494832|Dexmedetomidine|dexmedetomidine|mesh-list
110331329|NCT00494832|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110331330|NCT00494832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110331331|NCT00494832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110331332|NCT00494832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110331333|NCT00494832|Analgesics|analgesics|mesh-ancestor
110331334|NCT00494832|Sensory System Agents|sensory system agents|mesh-ancestor
110331335|NCT00494832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110331336|NCT00494832|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110331337|NCT00494832|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110331338|NCT00494832|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110331339|NCT00494832|Adrenergic Agents|adrenergic agents|mesh-ancestor
110331340|NCT00494832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110331341|NCT00494832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110331342|NCT00477074|Dimercaprol|dimercaprol|mesh-list
110331344|NCT00477074|Sequestering Agents|sequestering agents|mesh-ancestor
110331345|NCT00477074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110331346|NCT01323673|Clobetasol|clobetasol|mesh-list
110331347|NCT01323673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110331348|NCT01323673|Glucocorticoids|glucocorticoids|mesh-ancestor
110331349|NCT01323673|Hormones|hormones|mesh-ancestor
110331350|NCT01323673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110172018|NCT00048334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110331351|NCT01323673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110331352|NCT00494949|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110331354|NCT01246752|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110331355|NCT01246752|Antimetabolites|antimetabolites|mesh-ancestor
110331356|NCT01246752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110331357|NCT01246752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110331358|NCT01246752|Antiviral Agents|antiviral agents|mesh-ancestor
110331359|NCT01246752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110331360|NCT01246752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110331361|NCT01246752|Immunologic Factors|immunologic factors|mesh-ancestor
110331362|NCT01246752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110331363|NCT01323634|Fluticasone|fluticasone|mesh-list
110331364|NCT01323634|Xhance|xhance|mesh-list
110331365|NCT01323634|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110331366|NCT01323634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110331367|NCT01323634|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110331368|NCT01323634|Autonomic Agents|autonomic agents|mesh-ancestor
110331369|NCT01323634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110331370|NCT01323634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110331371|NCT01323634|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110331372|NCT01323634|Respiratory System Agents|respiratory system agents|mesh-ancestor
110331373|NCT01323634|Dermatologic Agents|dermatologic agents|mesh-ancestor
110331374|NCT01323634|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110331375|NCT01323634|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110331376|NCT01323634|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110331377|NCT01323634|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110331378|NCT01323634|Adrenergic Agents|adrenergic agents|mesh-ancestor
110331379|NCT01323634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110331380|NCT01323634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110331381|NCT05645302|Lidocaine|lidocaine|mesh-list
110331382|NCT05645302|Anesthetics, Local|anesthetics, local|mesh-ancestor
110331383|NCT05645302|Anesthetics|anesthetics|mesh-ancestor
110331384|NCT05645302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110331385|NCT05645302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110331386|NCT05645302|Sensory System Agents|sensory system agents|mesh-ancestor
110331387|NCT05645302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110331388|NCT05645302|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110331389|NCT05645302|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110331390|NCT05645302|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110331391|NCT05645302|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110331392|NCT05645302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110331393|NCT00494988|Insulin|insulin|mesh-list
110331394|NCT00494988|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110331395|NCT00494988|Insulin Aspart|insulin aspart|mesh-list
110331396|NCT00494988|Isophane Insulin, Human|isophane insulin, human|mesh-list
110331397|NCT00494988|Insulin, Isophane|insulin, isophane|mesh-list
110331398|NCT00494988|Isophane insulin, beef|isophane insulin, beef|mesh-list
110331399|NCT00494988|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110331400|NCT00494988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110331401|NCT01323478|Vortioxetine|vortioxetine|mesh-list
110331402|NCT01323478|Antidepressive Agents|antidepressive agents|mesh-ancestor
110331403|NCT01323478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110331404|NCT01323478|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110331405|NCT01323478|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110331406|NCT01323478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110331407|NCT01323478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110374850|NCT04608734|Anesthetics|anesthetics|mesh-ancestor
110331408|NCT01323478|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110331409|NCT01323478|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110331410|NCT01323478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110331411|NCT01323478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110331412|NCT01323478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110331413|NCT01323478|Serotonin Agents|serotonin agents|mesh-ancestor
110331414|NCT01323478|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110331415|NCT01323478|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110331416|NCT01323478|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110331417|NCT01323478|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110331419|NCT00472355|Emetics|emetics|mesh-ancestor
110331420|NCT00472355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110331421|NCT00472355|Autonomic Agents|autonomic agents|mesh-ancestor
110331422|NCT00472355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110331423|NCT00472355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110331424|NCT00472355|Dopamine Agonists|dopamine agonists|mesh-ancestor
110331425|NCT00472355|Dopamine Agents|dopamine agents|mesh-ancestor
110331426|NCT00472355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110331427|NCT00472355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110331428|NCT04325581|Liraglutide|liraglutide|mesh-list
110331429|NCT04325581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110331431|NCT04325581|Incretins|incretins|mesh-ancestor
110331432|NCT04325581|Hormones|hormones|mesh-ancestor
110331433|NCT04325581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110331434|NCT04325776|Zoledronic Acid|zoledronic acid|mesh-list
110331435|NCT04325776|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110331436|NCT04325776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110331437|NCT01322386|Vancomycin|vancomycin|mesh-list
110331438|NCT01322386|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110331439|NCT01322386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110331440|NCT00495066|Ipilimumab|ipilimumab|mesh-list
110331441|NCT00495066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110331442|NCT00495066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110331443|NCT00495066|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110331444|NCT00495066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110331445|NCT00472433|Alemtuzumab|alemtuzumab|mesh-list
110331446|NCT00472433|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110331447|NCT00472433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110331448|NCT00472472|Paclitaxel|paclitaxel|mesh-list
110331449|NCT00472472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110331450|NCT00472472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110331451|NCT00472472|Tubulin Modulators|tubulin modulators|mesh-ancestor
110331452|NCT00472472|Antimitotic Agents|antimitotic agents|mesh-ancestor
110331453|NCT00472472|Mitosis Modulators|mitosis modulators|mesh-ancestor
110331454|NCT00472472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110331455|NCT00503568|Vaccines|vaccines|mesh-list
110331456|NCT00503568|Immunologic Factors|immunologic factors|mesh-ancestor
110331457|NCT00503568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110331458|NCT00472550|Esomeprazole|esomeprazole|mesh-list
110331459|NCT00472550|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110331460|NCT00472550|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110331461|NCT00472550|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110331462|NCT00472550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110331463|NCT00472550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110331464|NCT00503607|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
110331465|NCT00503607|Laxatives|laxatives|mesh-ancestor
110331466|NCT00503607|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110331467|NCT00477503|Pentetic Acid|pentetic acid|mesh-list
110331468|NCT00477503|Gallium citrate|gallium citrate|mesh-list
110331469|NCT00477503|Chelating Agents|chelating agents|mesh-ancestor
110331470|NCT00477503|Sequestering Agents|sequestering agents|mesh-ancestor
110331471|NCT00477503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110331472|NCT00477503|Antidotes|antidotes|mesh-ancestor
110331473|NCT00477503|Protective Agents|protective agents|mesh-ancestor
110331474|NCT00477503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110331475|NCT00477503|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110331476|NCT00477503|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110331477|NCT01244334|Prednisolone|prednisolone|mesh-list
110331478|NCT01244334|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110331479|NCT01244334|Methylprednisolone|methylprednisolone|mesh-list
110331480|NCT01244334|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110331481|NCT01244334|Prednisolone acetate|prednisolone acetate|mesh-list
110331482|NCT01244334|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110331483|NCT01244334|Prednisolone phosphate|prednisolone phosphate|mesh-list
110331484|NCT01244334|Difluprednate|difluprednate|mesh-list
110331485|NCT01244334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110331486|NCT01244334|Glucocorticoids|glucocorticoids|mesh-ancestor
110331487|NCT01244334|Hormones|hormones|mesh-ancestor
110331488|NCT01244334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110331489|NCT01244334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110331490|NCT01244334|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110331491|NCT01244334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110331492|NCT01244334|Antiemetics|antiemetics|mesh-ancestor
110331493|NCT01244334|Autonomic Agents|autonomic agents|mesh-ancestor
110331494|NCT01244334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110331495|NCT01244334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110331496|NCT01244334|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110331497|NCT01244334|Protective Agents|protective agents|mesh-ancestor
110331498|NCT00477542|Clofarabine|clofarabine|mesh-list
110331499|NCT00477542|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110331500|NCT00477542|Antimetabolites|antimetabolites|mesh-ancestor
110331501|NCT00477542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110331502|NCT00477542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110331503|NCT00503763|Simvastatin|simvastatin|mesh-list
110331505|NCT00503763|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110331506|NCT00503763|Antimetabolites|antimetabolites|mesh-ancestor
110331507|NCT00503763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110331508|NCT00503763|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110331509|NCT00503763|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110331510|NCT00503763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110331511|NCT00477581|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110331512|NCT00477581|Exenatide|exenatide|mesh-list
110331513|NCT00477581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110331514|NCT00477581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110331515|NCT00477581|Incretins|incretins|mesh-ancestor
110331516|NCT00477581|Hormones|hormones|mesh-ancestor
110331517|NCT00477581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110331518|NCT00477581|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110331519|NCT00477581|Protease Inhibitors|protease inhibitors|mesh-ancestor
110331520|NCT00477581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110331521|NCT00477581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110331522|NCT00477581|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110331523|NCT00477737|Propofol|propofol|mesh-list
110331524|NCT00477737|Sevoflurane|sevoflurane|mesh-list
110331525|NCT00477737|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110331526|NCT00477737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110331527|NCT00477737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110331528|NCT00477737|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110331529|NCT00477737|Anesthetics, General|anesthetics, general|mesh-ancestor
110331530|NCT00477737|Anesthetics|anesthetics|mesh-ancestor
110331531|NCT00477737|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110331532|NCT00477737|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110331533|NCT00477776|Metoclopramide|metoclopramide|mesh-list
110331534|NCT00477776|Antiemetics|antiemetics|mesh-ancestor
110331535|NCT00477776|Autonomic Agents|autonomic agents|mesh-ancestor
110331536|NCT00477776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110331537|NCT00477776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110331538|NCT00477776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110331539|NCT00477776|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110331540|NCT00477776|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110331541|NCT00477776|Dopamine Agents|dopamine agents|mesh-ancestor
110331542|NCT00477776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110331543|NCT00477776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110331544|NCT00477815|Rituximab|rituximab|mesh-list
110331545|NCT00477815|Melphalan|melphalan|mesh-list
110331546|NCT00477815|Sargramostim|sargramostim|mesh-list
110331547|NCT00477815|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110331549|NCT00477815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110331550|NCT00477815|Immunologic Factors|immunologic factors|mesh-ancestor
110331551|NCT00477815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110331552|NCT00477815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110331553|NCT00477815|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110331555|NCT00477815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110331556|NCT00477815|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110331557|NCT00477815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110331558|NCT00477854|Chromium|chromium|mesh-list
110331559|NCT00477854|Picolinic acid|picolinic acid|mesh-list
110331560|NCT00477854|Trace Elements|trace elements|mesh-ancestor
110331561|NCT00477854|Micronutrients|micronutrients|mesh-ancestor
110331562|NCT00477854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110331563|NCT00477854|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110331564|NCT00477854|Chelating Agents|chelating agents|mesh-ancestor
110331565|NCT00477854|Sequestering Agents|sequestering agents|mesh-ancestor
110331566|NCT00477854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110331567|NCT00477893|Adalimumab|adalimumab|mesh-list
110331568|NCT00477893|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110331569|NCT00477893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110331570|NCT00477893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110331571|NCT01247337|Gemcitabine|gemcitabine|mesh-list
110331572|NCT01247337|Capecitabine|capecitabine|mesh-list
110331573|NCT01247337|Oxaliplatin|oxaliplatin|mesh-list
110331574|NCT01247337|Cetuximab|cetuximab|mesh-list
110331575|NCT01247337|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110331576|NCT01247337|Antimetabolites|antimetabolites|mesh-ancestor
110331577|NCT01247337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110331578|NCT01247337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110331579|NCT01247337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110331580|NCT00478049|Docetaxel|docetaxel|mesh-list
110331581|NCT00478049|Gefitinib|gefitinib|mesh-list
110331582|NCT00478049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110331583|NCT00478049|Tubulin Modulators|tubulin modulators|mesh-ancestor
110331584|NCT00478049|Antimitotic Agents|antimitotic agents|mesh-ancestor
110331585|NCT00478049|Mitosis Modulators|mitosis modulators|mesh-ancestor
110331586|NCT00478049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110331587|NCT00478049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110331588|NCT00478049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110331589|NCT01248975|Montelukast|montelukast|mesh-list
110331590|NCT01248975|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110331591|NCT01248975|Respiratory System Agents|respiratory system agents|mesh-ancestor
110331592|NCT01248975|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110331593|NCT01248975|Hormone Antagonists|hormone antagonists|mesh-ancestor
110331594|NCT01248975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110331595|NCT01248975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110331596|NCT01248975|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110331597|NCT01248975|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110331598|NCT01248975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110331599|NCT02955927|Atropine|atropine|mesh-list
110331600|NCT02955927|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110331601|NCT02955927|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110331602|NCT02955927|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110331603|NCT02955927|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110331604|NCT02955927|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110331605|NCT02955927|Autonomic Agents|autonomic agents|mesh-ancestor
110331606|NCT02955927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110331607|NCT02955927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110331608|NCT02955927|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110331609|NCT02955927|Respiratory System Agents|respiratory system agents|mesh-ancestor
110331610|NCT02955927|Mydriatics|mydriatics|mesh-ancestor
110331611|NCT02955927|Parasympatholytics|parasympatholytics|mesh-ancestor
110331612|NCT02955927|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110331613|NCT02955927|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110331614|NCT02955927|Cholinergic Agents|cholinergic agents|mesh-ancestor
110331615|NCT02955927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110331616|NCT02955927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110331617|NCT01322347|Dialysis Solutions|dialysis solutions|mesh-list
110331618|NCT01322347|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110331620|NCT01247493|Fludarabine|fludarabine|mesh-list
110331621|NCT01247493|Idarubicin|idarubicin|mesh-list
110331622|NCT01247493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110331623|NCT01247493|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110331624|NCT01247493|Antimetabolites|antimetabolites|mesh-ancestor
110331625|NCT01247493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110331626|NCT01247493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110331627|NCT01247493|Immunologic Factors|immunologic factors|mesh-ancestor
110331628|NCT01247493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110331629|NCT01247493|Antiviral Agents|antiviral agents|mesh-ancestor
110331630|NCT01247493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110331631|NCT01247493|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110331632|NCT01247493|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110331633|NCT01247493|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110331634|NCT01247493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110331635|NCT04325425|Carboplatin|carboplatin|mesh-list
110331636|NCT04325425|Etoposide|etoposide|mesh-list
110331637|NCT04325425|Folfirinox|folfirinox|mesh-list
110331638|NCT04325425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110331639|NCT04325425|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110331640|NCT04325425|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110331641|NCT04325425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110331642|NCT04325425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110331643|NCT04325425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110331644|NCT02891395|Imatinib Mesylate|imatinib mesylate|mesh-list
110331645|NCT02891395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110331646|NCT02891395|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110331647|NCT02891395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110331648|NCT02891395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110331649|NCT00478517|Epoetin Alfa|epoetin alfa|mesh-list
110331650|NCT00478517|Hematinics|hematinics|mesh-ancestor
110331651|NCT01321879|Telavancin|telavancin|mesh-list
110331652|NCT01321879|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110331653|NCT01321879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110331654|NCT01321723|Teriparatide|teriparatide|mesh-list
110331655|NCT01321723|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110331656|NCT01321723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110331657|NCT01321723|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110331659|NCT00478634|Cetuximab|cetuximab|mesh-list
110331660|NCT00478634|Everolimus|everolimus|mesh-list
110331661|NCT00478634|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110331662|NCT00478634|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110331663|NCT00478634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110331664|NCT00478634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110331665|NCT00478634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110331666|NCT00478634|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110331667|NCT00478634|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110331668|NCT00478634|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110331669|NCT00478634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110331670|NCT00478634|Immunologic Factors|immunologic factors|mesh-ancestor
110331671|NCT00478634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110331672|NCT01247688|Fludarabine|fludarabine|mesh-list
110331673|NCT01247688|Cyclophosphamide|cyclophosphamide|mesh-list
110331674|NCT01247688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110331675|NCT01247688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110331676|NCT01247688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110331677|NCT01247688|Immunologic Factors|immunologic factors|mesh-ancestor
110331678|NCT01247688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110331679|NCT01247688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110331680|NCT01247688|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110331681|NCT01247688|Alkylating Agents|alkylating agents|mesh-ancestor
110331682|NCT01247688|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110331684|NCT00478907|Thiopental|thiopental|mesh-list
110331685|NCT00478907|Propofol|propofol|mesh-list
110331686|NCT00478907|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110331687|NCT00478907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110331688|NCT00478907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110331689|NCT00478907|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110331690|NCT00478907|Anesthetics, General|anesthetics, general|mesh-ancestor
110331691|NCT00478907|Anesthetics|anesthetics|mesh-ancestor
110331692|NCT00478907|Analgesics|analgesics|mesh-ancestor
110331693|NCT00478907|Sensory System Agents|sensory system agents|mesh-ancestor
110331694|NCT00478907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110331695|NCT00478907|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110331696|NCT00478907|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110331697|NCT00478907|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110331698|NCT00478907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110331699|NCT00478907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110331700|NCT00478907|Anticonvulsants|anticonvulsants|mesh-ancestor
110331701|NCT00478907|GABA Modulators|gaba modulators|mesh-ancestor
110331702|NCT00478907|GABA Agents|gaba agents|mesh-ancestor
110331703|NCT00478946|Leucovorin|leucovorin|mesh-list
110331704|NCT00478946|Antidotes|antidotes|mesh-ancestor
110331705|NCT00478946|Protective Agents|protective agents|mesh-ancestor
110331706|NCT00478946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110331707|NCT00478946|Vitamin B Complex|vitamin b complex|mesh-ancestor
110331708|NCT00478946|Vitamins|vitamins|mesh-ancestor
110331709|NCT00478946|Micronutrients|micronutrients|mesh-ancestor
110331710|NCT01247961|Dexamethasone|dexamethasone|mesh-list
110331711|NCT01247961|Dexamethasone acetate|dexamethasone acetate|mesh-list
110331712|NCT01247961|BB 1101|bb 1101|mesh-list
110331713|NCT01247961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110331714|NCT01247961|Antiemetics|antiemetics|mesh-ancestor
110331715|NCT01247961|Autonomic Agents|autonomic agents|mesh-ancestor
110331716|NCT01247961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110331717|NCT01247961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110331718|NCT01247961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110331719|NCT01247961|Glucocorticoids|glucocorticoids|mesh-ancestor
110331720|NCT01247961|Hormones|hormones|mesh-ancestor
110331721|NCT01247961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110331722|NCT01247961|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110331723|NCT01247961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110331724|NCT01247961|Protease Inhibitors|protease inhibitors|mesh-ancestor
110331725|NCT01247961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110150234|NCT00008554|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110331726|NCT01247961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110331728|NCT01248078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110331729|NCT01248078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110331730|NCT00472823|Vitamin D|vitamin d|mesh-list
110331731|NCT00472823|Cholecalciferol|cholecalciferol|mesh-list
110331732|NCT00472823|Calcium|calcium|mesh-list
110331733|NCT00472823|Vitamins|vitamins|mesh-ancestor
110331734|NCT00472823|Micronutrients|micronutrients|mesh-ancestor
110331735|NCT00472823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110331736|NCT00472823|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110331737|NCT00472823|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110331738|NCT02275416|Ipilimumab|ipilimumab|mesh-list
110331739|NCT02275416|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110331740|NCT02275416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110331741|NCT02275416|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110331742|NCT02275416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110331743|NCT00472901|Afamelanotide|afamelanotide|mesh-list
110331744|NCT00472901|Dermatologic Agents|dermatologic agents|mesh-ancestor
110331745|NCT02483247|Paclitaxel|paclitaxel|mesh-list
110331746|NCT02483247|Doxorubicin|doxorubicin|mesh-list
110331747|NCT02483247|Pembrolizumab|pembrolizumab|mesh-list
110331748|NCT02483247|Capecitabine|capecitabine|mesh-list
110331749|NCT02483247|Nivolumab|nivolumab|mesh-list
110331750|NCT02483247|Sunitinib|sunitinib|mesh-list
110331751|NCT02483247|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110331752|NCT02483247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110331754|NCT02483247|Antimitotic Agents|antimitotic agents|mesh-ancestor
110331755|NCT02483247|Mitosis Modulators|mitosis modulators|mesh-ancestor
110331756|NCT02483247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110331757|NCT02483247|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110331758|NCT02483247|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110331759|NCT02483247|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110331760|NCT02483247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110331761|NCT02483247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110331762|NCT02483247|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110331763|NCT02483247|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110331765|NCT02483247|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110331766|NCT02483247|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110331767|NCT02483247|Growth Substances|growth substances|mesh-ancestor
110331768|NCT02483247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110331769|NCT02483247|Growth Inhibitors|growth inhibitors|mesh-ancestor
110331770|NCT02483247|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110331771|NCT02482233|Nicotine|nicotine|mesh-list
110331772|NCT02482233|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110331773|NCT02482233|Autonomic Agents|autonomic agents|mesh-ancestor
110331774|NCT02482233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110331775|NCT02482233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110331776|NCT02482233|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110331777|NCT02482233|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110331778|NCT02482233|Cholinergic Agents|cholinergic agents|mesh-ancestor
110331779|NCT02482233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110331780|NCT02482233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110331781|NCT01248117|Ranibizumab|ranibizumab|mesh-list
110331782|NCT01248117|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110331783|NCT01248117|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110331784|NCT01248117|Growth Substances|growth substances|mesh-ancestor
110331785|NCT01248117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110331786|NCT01248117|Growth Inhibitors|growth inhibitors|mesh-ancestor
110331787|NCT01248117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110331788|NCT01248234|Propofol|propofol|mesh-list
110331789|NCT01248234|Etomidate|etomidate|mesh-list
110331790|NCT01248234|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110331791|NCT01248234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110331792|NCT01248234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110331793|NCT01248234|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110331794|NCT01248234|Anesthetics, General|anesthetics, general|mesh-ancestor
110331795|NCT01248234|Anesthetics|anesthetics|mesh-ancestor
110331796|NCT01248273|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
110331797|NCT01248273|Immunologic Factors|immunologic factors|mesh-ancestor
110331798|NCT01248273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110331799|NCT00473174|Ramipril|ramipril|mesh-list
110331800|NCT00473174|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110331801|NCT00473174|Protease Inhibitors|protease inhibitors|mesh-ancestor
110331802|NCT00473174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110331803|NCT00473174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110331804|NCT00473174|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110331805|NCT00473213|Interferons|interferons|mesh-list
110331806|NCT00473213|Interferon-beta|interferon-beta|mesh-list
110331807|NCT00473213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110331808|NCT00473213|Antiviral Agents|antiviral agents|mesh-ancestor
110331809|NCT00473213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110331810|NCT00473213|Immunologic Factors|immunologic factors|mesh-ancestor
110331811|NCT00473213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110331812|NCT01320202|Dialysis Solutions|dialysis solutions|mesh-list
110331813|NCT01320202|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110331814|NCT01319383|Vorinostat|vorinostat|mesh-list
110331815|NCT01319383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110331816|NCT01319383|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110331817|NCT01319383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110331818|NCT01319383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110331819|NCT05645029|Chlorhexidine|chlorhexidine|mesh-list
110331820|NCT05645029|Methamphetamine|methamphetamine|mesh-list
110331821|NCT05645029|Titanium dioxide|titanium dioxide|mesh-list
110331822|NCT05645029|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110331823|NCT05645029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110331824|NCT05645029|Disinfectants|disinfectants|mesh-ancestor
110331825|NCT05645029|Dermatologic Agents|dermatologic agents|mesh-ancestor
110331826|NCT05645029|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110331827|NCT05645029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110331828|NCT05645029|Sympathomimetics|sympathomimetics|mesh-ancestor
110331829|NCT05645029|Autonomic Agents|autonomic agents|mesh-ancestor
110331830|NCT05645029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110331831|NCT05645029|Dopamine Agents|dopamine agents|mesh-ancestor
110331832|NCT05645029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110331833|NCT05645029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110331834|NCT05645029|Adrenergic Agents|adrenergic agents|mesh-ancestor
110331835|NCT05645029|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110331836|NCT05645029|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110331837|NCT05645029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110331838|NCT05645029|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110331839|NCT05645029|Sunscreening Agents|sunscreening agents|mesh-ancestor
110331840|NCT05645029|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110331841|NCT05645029|Protective Agents|protective agents|mesh-ancestor
110331842|NCT05645029|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110331843|NCT00479609|Testosterone|testosterone|mesh-list
110331844|NCT00479609|Androgens|androgens|mesh-ancestor
110331845|NCT00479609|Hormones|hormones|mesh-ancestor
110331846|NCT00479609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110331847|NCT00479609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110331848|NCT04325113|Levobupivacaine|levobupivacaine|mesh-list
110331849|NCT04325113|Anesthetics, Local|anesthetics, local|mesh-ancestor
110331850|NCT04325113|Anesthetics|anesthetics|mesh-ancestor
110331851|NCT04325113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110331852|NCT04325113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110331853|NCT04325113|Sensory System Agents|sensory system agents|mesh-ancestor
110331854|NCT04325113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110331855|NCT05644717|Ertugliflozin|ertugliflozin|mesh-list
110331856|NCT05644717|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110331857|NCT05644717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110331858|NCT05644717|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110331859|NCT05644717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110331860|NCT02891161|Durvalumab|durvalumab|mesh-list
110331861|NCT02891161|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110331862|NCT02891161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110331863|NCT00478985|Imatinib Mesylate|imatinib mesylate|mesh-list
110331864|NCT00478985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110331865|NCT00478985|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110331866|NCT00478985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110331867|NCT00478985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110331868|NCT02955732|Dexmedetomidine|dexmedetomidine|mesh-list
110331869|NCT02955732|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110331870|NCT02955732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110331871|NCT02955732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110331872|NCT02955732|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110331873|NCT02955732|Analgesics|analgesics|mesh-ancestor
110331874|NCT02955732|Sensory System Agents|sensory system agents|mesh-ancestor
110331875|NCT02955732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110331876|NCT02955732|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110331877|NCT02955732|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110331878|NCT02955732|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110331879|NCT02955732|Adrenergic Agents|adrenergic agents|mesh-ancestor
110331880|NCT02955732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110331881|NCT02955732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110331883|NCT01315678|Amikacin|amikacin|mesh-list
110331884|NCT01315678|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110331885|NCT01315678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110331886|NCT02955693|Dimethyl Fumarate|dimethyl fumarate|mesh-list
110331887|NCT02955693|Dermatologic Agents|dermatologic agents|mesh-ancestor
110331888|NCT02955693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110331889|NCT02955693|Immunologic Factors|immunologic factors|mesh-ancestor
110331890|NCT02955693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110331891|NCT00479726|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110331892|NCT00479726|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110331893|NCT00479726|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110331894|NCT00479726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110331895|NCT00479726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110331896|NCT00479726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110331897|NCT00479726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110331898|NCT00479726|Analgesics|analgesics|mesh-ancestor
110331899|NCT00479726|Sensory System Agents|sensory system agents|mesh-ancestor
110331900|NCT00479726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110331901|NCT00479726|Antidepressive Agents|antidepressive agents|mesh-ancestor
110331902|NCT00479726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110331903|NCT00479726|Dopamine Agents|dopamine agents|mesh-ancestor
110331904|NCT01315249|Fluticasone|fluticasone|mesh-list
110331905|NCT01315249|Xhance|xhance|mesh-list
110331906|NCT01315249|Glycopyrrolate|glycopyrrolate|mesh-list
110331907|NCT01315249|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110331908|NCT01315249|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
110331909|NCT01315249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110331910|NCT01315249|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110331911|NCT01315249|Autonomic Agents|autonomic agents|mesh-ancestor
110331912|NCT01315249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110331913|NCT01315249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110331914|NCT01315249|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110331915|NCT01315249|Respiratory System Agents|respiratory system agents|mesh-ancestor
110331916|NCT01315249|Dermatologic Agents|dermatologic agents|mesh-ancestor
110331917|NCT01315249|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110331918|NCT01315249|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110331919|NCT01315249|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110331920|NCT01315249|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110331921|NCT01315249|Adrenergic Agents|adrenergic agents|mesh-ancestor
110331922|NCT01315249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110331923|NCT01315249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110331924|NCT01315249|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110331925|NCT01315249|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110331926|NCT01315249|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110331927|NCT01315249|Cholinergic Agents|cholinergic agents|mesh-ancestor
110331928|NCT01315249|Glucocorticoids|glucocorticoids|mesh-ancestor
110331929|NCT01315249|Hormones|hormones|mesh-ancestor
110331930|NCT01315249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110331931|NCT01315249|Sympathomimetics|sympathomimetics|mesh-ancestor
110331932|NCT04207411|Lidocaine|lidocaine|mesh-list
110331933|NCT04207411|Bupivacaine|bupivacaine|mesh-list
110331934|NCT04207411|Anesthetics, Local|anesthetics, local|mesh-ancestor
110331935|NCT04207411|Anesthetics|anesthetics|mesh-ancestor
110331936|NCT04207411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110331937|NCT04207411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110331938|NCT04207411|Sensory System Agents|sensory system agents|mesh-ancestor
110331939|NCT04207411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110331940|NCT04207411|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110331941|NCT04207411|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110331942|NCT04207411|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110331943|NCT04207411|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110331944|NCT04207411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110331946|NCT00473486|Pemetrexed|pemetrexed|mesh-list
110331947|NCT00473486|Sorafenib|sorafenib|mesh-list
110331948|NCT00473486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110331949|NCT00473486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110331950|NCT00473486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110331952|NCT00473486|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110331953|NCT00473486|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110331954|NCT05644483|Propofol|propofol|mesh-list
110331955|NCT05644483|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110331956|NCT05644483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110331957|NCT05644483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110331958|NCT05644483|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110331959|NCT05644483|Anesthetics, General|anesthetics, general|mesh-ancestor
110331960|NCT05644483|Anesthetics|anesthetics|mesh-ancestor
110331961|NCT01248819|Ropivacaine|ropivacaine|mesh-list
110331962|NCT01248819|Anesthetics, Local|anesthetics, local|mesh-ancestor
110331963|NCT01248819|Anesthetics|anesthetics|mesh-ancestor
110331964|NCT01248819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110331965|NCT01248819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110331966|NCT01248819|Sensory System Agents|sensory system agents|mesh-ancestor
110331967|NCT01248819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110331968|NCT01313767|Botulinum Toxins|botulinum toxins|mesh-list
110331969|NCT01313767|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110331970|NCT01313767|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110331971|NCT01313767|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110331972|NCT01313767|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110331973|NCT01313767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110331974|NCT01313767|Cholinergic Agents|cholinergic agents|mesh-ancestor
110331975|NCT01313767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110331976|NCT01313767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110331977|NCT01313767|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110331978|NCT01313767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110331979|NCT01248858|Trametinib|trametinib|mesh-list
110331980|NCT01248858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110331981|NCT01248858|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110331982|NCT01248858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110331983|NCT01248858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110331984|NCT01313728|Dapsone|dapsone|mesh-list
110331985|NCT01313728|Tretinoin|tretinoin|mesh-list
110331986|NCT01313728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110331987|NCT01313728|Keratolytic Agents|keratolytic agents|mesh-ancestor
110331988|NCT01313728|Dermatologic Agents|dermatologic agents|mesh-ancestor
110331989|NCT01313728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110331990|NCT01313728|Antimalarials|antimalarials|mesh-ancestor
110331991|NCT01313728|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110331992|NCT01313728|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110331993|NCT01313728|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110331994|NCT01313728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110331995|NCT01313728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110331996|NCT01313728|Leprostatic Agents|leprostatic agents|mesh-ancestor
110331997|NCT01313728|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110331998|NCT00481364|Atorvastatin|atorvastatin|mesh-list
110331999|NCT00481364|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110332000|NCT00481364|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110332001|NCT00481364|Antimetabolites|antimetabolites|mesh-ancestor
110332002|NCT00481364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110332003|NCT00481364|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110332004|NCT00481364|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110332005|NCT00481364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110332006|NCT00481442|Phenylephrine|phenylephrine|mesh-list
110332007|NCT00481442|Oxymetazoline|oxymetazoline|mesh-list
110332008|NCT00481442|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110332009|NCT00481442|Mydriatics|mydriatics|mesh-ancestor
110332010|NCT00481442|Autonomic Agents|autonomic agents|mesh-ancestor
110332011|NCT00481442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110332012|NCT00481442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110332013|NCT00481442|Sympathomimetics|sympathomimetics|mesh-ancestor
110332014|NCT00481442|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110332016|NCT00481442|Respiratory System Agents|respiratory system agents|mesh-ancestor
110332017|NCT00481442|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110332018|NCT00481442|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110332019|NCT00481442|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110332020|NCT00481442|Adrenergic Agents|adrenergic agents|mesh-ancestor
110332021|NCT00481442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110332022|NCT00481442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110332023|NCT00481442|Protective Agents|protective agents|mesh-ancestor
110332024|NCT04697537|Dexmedetomidine|dexmedetomidine|mesh-list
110332025|NCT04697537|Ropivacaine|ropivacaine|mesh-list
110332026|NCT04697537|Anesthetics|anesthetics|mesh-ancestor
110332027|NCT04697537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110332028|NCT04697537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110332029|NCT04697537|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110332030|NCT04697537|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110332031|NCT04697537|Analgesics|analgesics|mesh-ancestor
110332032|NCT04697537|Sensory System Agents|sensory system agents|mesh-ancestor
110332033|NCT04697537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110332034|NCT04697537|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110332035|NCT04697537|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110332036|NCT04697537|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110332037|NCT04697537|Adrenergic Agents|adrenergic agents|mesh-ancestor
110332038|NCT04697537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110332039|NCT04697537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110332040|NCT04697537|Anesthetics, Local|anesthetics, local|mesh-ancestor
110332041|NCT00481481|Tacrolimus|tacrolimus|mesh-list
110332042|NCT00481481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110332043|NCT00481481|Immunologic Factors|immunologic factors|mesh-ancestor
110332044|NCT00481481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110332045|NCT00481481|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110332046|NCT00481481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110332047|NCT00481481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110332048|NCT04516317|Artesunate|artesunate|mesh-list
110332049|NCT04516317|Quinine|quinine|mesh-list
110332050|NCT04516317|Antimalarials|antimalarials|mesh-ancestor
110332051|NCT04516317|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110332052|NCT04516317|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110332053|NCT04516317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110332054|NCT04516317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110332055|NCT04516317|Antiviral Agents|antiviral agents|mesh-ancestor
110332056|NCT04516317|Schistosomicides|schistosomicides|mesh-ancestor
110332057|NCT04516317|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110332058|NCT04516317|Anthelmintics|anthelmintics|mesh-ancestor
110332059|NCT04516317|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110332060|NCT04516317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110332061|NCT04516317|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110332062|NCT04516317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110332063|NCT04516317|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110332064|NCT04516317|Analgesics|analgesics|mesh-ancestor
110332065|NCT04516317|Sensory System Agents|sensory system agents|mesh-ancestor
110332066|NCT02891083|Paclitaxel|paclitaxel|mesh-list
110332067|NCT02891083|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110332068|NCT02891083|Cisplatin|cisplatin|mesh-list
110332069|NCT02891083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110332070|NCT02891083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110332071|NCT02891083|Tubulin Modulators|tubulin modulators|mesh-ancestor
110332072|NCT02891083|Antimitotic Agents|antimitotic agents|mesh-ancestor
110332073|NCT02891083|Mitosis Modulators|mitosis modulators|mesh-ancestor
110332074|NCT02891083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110332081|NCT02891005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110332082|NCT02891005|Tubulin Modulators|tubulin modulators|mesh-ancestor
110332083|NCT02891005|Antimitotic Agents|antimitotic agents|mesh-ancestor
110332084|NCT02891005|Mitosis Modulators|mitosis modulators|mesh-ancestor
110332085|NCT02891005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110332086|NCT00504816|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
110332087|NCT00504816|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110332088|NCT00504816|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110332089|NCT00504816|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110332090|NCT00504816|Contraceptive Agents|contraceptive agents|mesh-ancestor
110332091|NCT00504816|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110332092|NCT00504816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110332093|NCT00504816|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110332094|NCT00504816|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110332095|NCT00504816|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
110332096|NCT00504816|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110332097|NCT00480116|Vaccines|vaccines|mesh-list
110332098|NCT00480116|Immunologic Factors|immunologic factors|mesh-ancestor
110332099|NCT00480116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110332100|NCT00504855|Calpastatin|calpastatin|mesh-list
110332101|NCT00504855|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
110332102|NCT00504855|Protease Inhibitors|protease inhibitors|mesh-ancestor
110332103|NCT00504855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110332104|NCT00504855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110332105|NCT00504933|Cetirizine|cetirizine|mesh-list
110332106|NCT00504933|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110332107|NCT00504933|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110332108|NCT00504933|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110332109|NCT00504933|Histamine Antagonists|histamine antagonists|mesh-ancestor
110332110|NCT00504933|Histamine Agents|histamine agents|mesh-ancestor
110332111|NCT00504933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110332112|NCT00504933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110332113|NCT00504933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110332114|NCT01313299|Botulinum Toxins|botulinum toxins|mesh-list
110332115|NCT01313299|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110332116|NCT01313299|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110332117|NCT01313299|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110332118|NCT01313299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110332119|NCT01313299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110332120|NCT01313299|Cholinergic Agents|cholinergic agents|mesh-ancestor
110332121|NCT01313299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110332122|NCT01313299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110332123|NCT01313299|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110332124|NCT01313299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110332125|NCT01313221|Etanercept|etanercept|mesh-list
110332126|NCT01313221|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110332127|NCT01313221|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110332128|NCT01313221|Analgesics|analgesics|mesh-ancestor
110332129|NCT01313221|Sensory System Agents|sensory system agents|mesh-ancestor
110332130|NCT01313221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110332131|NCT01313221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110332132|NCT01313221|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110332133|NCT01313221|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110332134|NCT01313221|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110332135|NCT01313221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110332136|NCT01313221|Immunologic Factors|immunologic factors|mesh-ancestor
110332137|NCT01313182|Povidone-Iodine|povidone-iodine|mesh-list
110332138|NCT01313182|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
110332139|NCT01313182|Mupirocin|mupirocin|mesh-list
110332140|NCT01313182|Povidone|povidone|mesh-list
110332141|NCT01313182|Calcium|calcium|mesh-list
110332142|NCT01313182|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110332143|NCT01313182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110332144|NCT01313182|Plasma Substitutes|plasma substitutes|mesh-ancestor
110332145|NCT01313182|Blood Substitutes|blood substitutes|mesh-ancestor
110332146|NCT01313182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110332147|NCT01313182|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110332148|NCT01313182|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110332149|NCT01313182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110332150|NCT01313182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110332151|NCT00480194|Xylometazoline|xylometazoline|mesh-list
110332152|NCT00480194|Bromides|bromides|mesh-list
110332153|NCT00480194|Ipratropium|ipratropium|mesh-list
110332154|NCT00480194|Anticonvulsants|anticonvulsants|mesh-ancestor
110332155|NCT00480194|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110332156|NCT00480194|Autonomic Agents|autonomic agents|mesh-ancestor
110332157|NCT00480194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110332158|NCT00480194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110332159|NCT00480194|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110332160|NCT00480194|Respiratory System Agents|respiratory system agents|mesh-ancestor
110332161|NCT00480194|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110332162|NCT00480194|Cholinergic Agents|cholinergic agents|mesh-ancestor
110332163|NCT00480194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110332164|NCT00480194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110332165|NCT00480194|Nasal Decongestants|nasal decongestants|mesh-ancestor
110332166|NCT00480194|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110332167|NCT00505089|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110332168|NCT00505089|Immunologic Factors|immunologic factors|mesh-ancestor
110332169|NCT00505089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110332170|NCT00505167|Memantine|memantine|mesh-list
110332171|NCT00505167|Donepezil|donepezil|mesh-list
110332172|NCT00505167|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110332173|NCT00505167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110332174|NCT00505167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110332175|NCT00505167|Cholinergic Agents|cholinergic agents|mesh-ancestor
110332176|NCT00505167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110332177|NCT00505167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110332178|NCT00505167|Nootropic Agents|nootropic agents|mesh-ancestor
110332179|NCT00505167|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110332180|NCT00505167|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110332181|NCT00505167|Dopamine Agents|dopamine agents|mesh-ancestor
110332182|NCT00505167|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110332183|NCT00505167|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110332185|NCT00480272|Adalimumab|adalimumab|mesh-list
110332186|NCT00480272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110332187|NCT00480272|Glucocorticoids|glucocorticoids|mesh-ancestor
110332188|NCT00480272|Hormones|hormones|mesh-ancestor
110332189|NCT00480272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110332190|NCT00480272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110332191|NCT00480272|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110332192|NCT00480272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110332193|NCT00480272|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110332194|NCT00480272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110332195|NCT04517058|Antidepressive Agents|antidepressive agents|mesh-list
110332196|NCT04517058|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110332197|NCT00480389|Sorafenib|sorafenib|mesh-list
110332198|NCT00480389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110332199|NCT00480389|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110332200|NCT00480389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110374910|NCT00191139|Docetaxel|docetaxel|mesh-list
110332201|NCT00480389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110332202|NCT04519710|Rituximab|rituximab|mesh-list
110332203|NCT04519710|Ocrelizumab|ocrelizumab|mesh-list
110332204|NCT04519710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110332205|NCT04519710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110332206|NCT04519710|Immunologic Factors|immunologic factors|mesh-ancestor
110332207|NCT04519710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110332208|NCT04519710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110332209|NCT00482027|Vaccines|vaccines|mesh-list
110332210|NCT00482027|Immunologic Factors|immunologic factors|mesh-ancestor
110172131|NCT00048880|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110332211|NCT00482027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110332213|NCT00482066|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110332214|NCT00482066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110332215|NCT00482066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110332216|NCT00482066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110332217|NCT00482066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110332218|NCT00482066|Immunologic Factors|immunologic factors|mesh-ancestor
110332219|NCT00482066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110332220|NCT00482066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110332221|NCT00482183|Pioglitazone|pioglitazone|mesh-list
110332222|NCT00482183|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110332223|NCT00482183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110332224|NCT01312909|Varenicline|varenicline|mesh-list
110332225|NCT01312909|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110332226|NCT01312909|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110332227|NCT01312909|Cholinergic Agents|cholinergic agents|mesh-ancestor
110332228|NCT01312909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110332229|NCT01312909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110332230|NCT01312909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110332231|NCT00482222|Leucovorin|leucovorin|mesh-list
110332232|NCT00482222|Fluorouracil|fluorouracil|mesh-list
110332233|NCT00482222|Capecitabine|capecitabine|mesh-list
110332234|NCT00482222|Oxaliplatin|oxaliplatin|mesh-list
110332235|NCT00482222|Cetuximab|cetuximab|mesh-list
110332236|NCT00482222|Calcium|calcium|mesh-list
110332237|NCT00482222|Levoleucovorin|levoleucovorin|mesh-list
110332238|NCT00482222|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110332239|NCT00482222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110332240|NCT00482222|Antimetabolites|antimetabolites|mesh-ancestor
110332241|NCT00482222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110332242|NCT00482222|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110332244|NCT00482222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110332245|NCT00482222|Immunologic Factors|immunologic factors|mesh-ancestor
110332246|NCT00482222|Antidotes|antidotes|mesh-ancestor
110332247|NCT00482222|Protective Agents|protective agents|mesh-ancestor
110332248|NCT00482222|Vitamin B Complex|vitamin b complex|mesh-ancestor
110332250|NCT00482222|Micronutrients|micronutrients|mesh-ancestor
110332251|NCT00482222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110332252|NCT01312129|Sulfasalazine|sulfasalazine|mesh-list
110332253|NCT01312129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110332254|NCT01312129|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110332255|NCT01312129|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110332256|NCT01312129|Analgesics|analgesics|mesh-ancestor
110332257|NCT01312129|Sensory System Agents|sensory system agents|mesh-ancestor
110332258|NCT01312129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110332259|NCT01312129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110332260|NCT01312129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110332261|NCT01312129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110374925|NCT00564512|Rituximab|rituximab|mesh-list
110332262|NCT01312129|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110332263|NCT04518852|Sorafenib|sorafenib|mesh-list
110332264|NCT04518852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110332265|NCT04518852|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110332266|NCT04518852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110332267|NCT04518852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110332268|NCT01311661|Olodaterol|olodaterol|mesh-list
110332269|NCT01311661|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110332270|NCT01311661|Autonomic Agents|autonomic agents|mesh-ancestor
110332271|NCT01311661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110332272|NCT01311661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110332273|NCT01311661|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110332274|NCT01311661|Respiratory System Agents|respiratory system agents|mesh-ancestor
110332275|NCT04518735|Anticoagulants|anticoagulants|mesh-list
110332276|NCT00482261|Aspirin|aspirin|mesh-list
110332277|NCT00482261|Dexamethasone|dexamethasone|mesh-list
110332278|NCT00482261|Lenalidomide|lenalidomide|mesh-list
110332279|NCT00482261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110332280|NCT00482261|Antiemetics|antiemetics|mesh-ancestor
110332281|NCT00482261|Autonomic Agents|autonomic agents|mesh-ancestor
110332282|NCT00482261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110332283|NCT00482261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110332284|NCT00482261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110332285|NCT00482261|Glucocorticoids|glucocorticoids|mesh-ancestor
110332286|NCT00482261|Hormones|hormones|mesh-ancestor
110332287|NCT00482261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110332288|NCT00482261|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110332289|NCT00482261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110332290|NCT00482261|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110332291|NCT00482261|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110332292|NCT00482261|Analgesics|analgesics|mesh-ancestor
110332293|NCT00482261|Sensory System Agents|sensory system agents|mesh-ancestor
110332294|NCT00482261|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110332295|NCT00482261|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110332296|NCT00482261|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110332297|NCT00482261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110332298|NCT00482261|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110332299|NCT00482261|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110332300|NCT00482261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110332301|NCT00482261|Antipyretics|antipyretics|mesh-ancestor
110332302|NCT00482261|Immunologic Factors|immunologic factors|mesh-ancestor
110332303|NCT00482261|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110332304|NCT00482261|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110332305|NCT00482261|Growth Substances|growth substances|mesh-ancestor
110332306|NCT00482261|Growth Inhibitors|growth inhibitors|mesh-ancestor
110332307|NCT04518618|Fentanyl|fentanyl|mesh-list
110332308|NCT04518618|Naloxone|naloxone|mesh-list
110332309|NCT04518618|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110332310|NCT04518618|Narcotics|narcotics|mesh-ancestor
110332311|NCT04518618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110332312|NCT04518618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110332313|NCT04518618|Analgesics|analgesics|mesh-ancestor
110332314|NCT04518618|Sensory System Agents|sensory system agents|mesh-ancestor
110332315|NCT04518618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110332316|NCT04518618|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110332317|NCT04518618|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110332318|NCT04518618|Anesthetics, General|anesthetics, general|mesh-ancestor
110332319|NCT04518618|Anesthetics|anesthetics|mesh-ancestor
110332320|NCT04518618|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110332321|NCT00480584|Gemcitabine|gemcitabine|mesh-list
110332322|NCT00480584|Capecitabine|capecitabine|mesh-list
110332323|NCT00480584|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110332324|NCT00480584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110332325|NCT00480584|Antimetabolites|antimetabolites|mesh-ancestor
110332326|NCT00480584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110332327|NCT00480584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110332328|NCT00480584|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110332329|NCT00480584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110332331|NCT01311505|Isoniazid|isoniazid|mesh-list
110332332|NCT01311505|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110332333|NCT01311505|Antitubercular Agents|antitubercular agents|mesh-ancestor
110332334|NCT01311505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110332335|NCT01311505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110332336|NCT01311505|Leprostatic Agents|leprostatic agents|mesh-ancestor
110332337|NCT01311505|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110332338|NCT01311505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110332339|NCT01311505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110332340|NCT01311505|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110332341|NCT01311505|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110332342|NCT01311505|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110332343|NCT01311505|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110332344|NCT01311505|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110332345|NCT01311505|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110332346|NCT01311505|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
110332347|NCT01311505|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110332348|NCT01311505|Antimetabolites|antimetabolites|mesh-ancestor
110332349|NCT01311505|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110332351|NCT01240538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110332352|NCT01240538|Immunologic Factors|immunologic factors|mesh-ancestor
110332353|NCT01240538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110332354|NCT01240538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110332355|NCT01240538|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110332356|NCT01240538|Alkylating Agents|alkylating agents|mesh-ancestor
110332357|NCT01240538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110332358|NCT01240538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110332359|NCT01240538|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110332360|NCT01310803|Valrubicin|valrubicin|mesh-list
110332361|NCT01310803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110332362|NCT01310803|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110332363|NCT01310803|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110332364|NCT01310803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110332365|NCT01310803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110332366|NCT04518540|Thioctic Acid|thioctic acid|mesh-list
110332367|NCT04518540|Antioxidants|antioxidants|mesh-ancestor
110332368|NCT04518540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110332369|NCT04518540|Protective Agents|protective agents|mesh-ancestor
110332370|NCT04518540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110332371|NCT04518540|Vitamin B Complex|vitamin b complex|mesh-ancestor
110332373|NCT04518540|Micronutrients|micronutrients|mesh-ancestor
110332374|NCT00480623|Satraplatin|satraplatin|mesh-list
110332375|NCT00480623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110332376|NCT01240655|Paclitaxel|paclitaxel|mesh-list
110332377|NCT01240655|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110332378|NCT01240655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110332379|NCT01240655|Tubulin Modulators|tubulin modulators|mesh-ancestor
110332380|NCT01240655|Antimitotic Agents|antimitotic agents|mesh-ancestor
110332381|NCT01240655|Mitosis Modulators|mitosis modulators|mesh-ancestor
110332382|NCT01240655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110332383|NCT04518189|Lidocaine|lidocaine|mesh-list
110332384|NCT04518189|Anesthetics, Local|anesthetics, local|mesh-ancestor
110332385|NCT04518189|Anesthetics|anesthetics|mesh-ancestor
110332386|NCT04518189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110332387|NCT04518189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110332388|NCT04518189|Sensory System Agents|sensory system agents|mesh-ancestor
110332389|NCT04518189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110332390|NCT04518189|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110332391|NCT04518189|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110332392|NCT04518189|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110332393|NCT04518189|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110332394|NCT04518189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110332395|NCT00482378|Zoledronic Acid|zoledronic acid|mesh-list
110332396|NCT00482378|Pamidronate|pamidronate|mesh-list
110332397|NCT00482378|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110332398|NCT00482378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110150384|NCT00000145|Zinc|zinc|mesh-list
110332401|NCT00482456|Anesthetics, General|anesthetics, general|mesh-ancestor
110332402|NCT00482456|Anesthetics|anesthetics|mesh-ancestor
110332403|NCT00482456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110332404|NCT00482456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110332405|NCT00482456|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110332406|NCT00482456|Analgesics|analgesics|mesh-ancestor
110332407|NCT00482456|Sensory System Agents|sensory system agents|mesh-ancestor
110332408|NCT00482456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110332409|NCT00480896|Tacrolimus|tacrolimus|mesh-list
110332410|NCT00480896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110332411|NCT00480896|Immunologic Factors|immunologic factors|mesh-ancestor
110332412|NCT00480896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110332413|NCT00480896|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110332414|NCT00480896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110332415|NCT00480896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110332416|NCT01309828|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110332417|NCT01309828|Olmesartan|olmesartan|mesh-list
110332418|NCT01309828|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
110332419|NCT01309828|Chlorthalidone|chlorthalidone|mesh-list
110332420|NCT01309828|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
110172148|NCT00049114|Immunologic Factors|immunologic factors|mesh-ancestor
110332421|NCT01309828|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110332422|NCT01309828|Diuretics|diuretics|mesh-ancestor
110332423|NCT01309828|Natriuretic Agents|natriuretic agents|mesh-ancestor
110332424|NCT01309828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110332425|NCT01309828|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110332426|NCT01309828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110332427|NCT01309828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110332428|NCT01309828|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110332429|NCT01309828|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110332430|NCT00482495|Bevacizumab|bevacizumab|mesh-list
110332431|NCT00482495|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110332432|NCT00482495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110332433|NCT00482495|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110332434|NCT00482495|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110332435|NCT00482495|Growth Substances|growth substances|mesh-ancestor
110332436|NCT00482495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110332437|NCT00482495|Growth Inhibitors|growth inhibitors|mesh-ancestor
110332439|NCT00480935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110332440|NCT00480935|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110332441|NCT00480935|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110332442|NCT00480935|Growth Substances|growth substances|mesh-ancestor
110150450|NCT00000187|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110332443|NCT00480935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110332444|NCT00480935|Growth Inhibitors|growth inhibitors|mesh-ancestor
110374978|NCT04607447|Hormones|hormones|mesh-ancestor
110332445|NCT00480935|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110332446|NCT00480935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110332447|NCT00480935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110332448|NCT00482573|Epinephrine|epinephrine|mesh-list
110332449|NCT00482573|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
110332450|NCT00482573|Anesthetics|anesthetics|mesh-list
110332451|NCT00482573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110332452|NCT00482573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110332453|NCT00482573|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110332454|NCT00482573|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110332455|NCT00482573|Adrenergic Agents|adrenergic agents|mesh-ancestor
110332456|NCT00482573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110332457|NCT00482573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110332458|NCT00482573|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110332459|NCT00482573|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110332460|NCT00482573|Autonomic Agents|autonomic agents|mesh-ancestor
110332461|NCT00482573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110332462|NCT00482573|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110332463|NCT00482573|Respiratory System Agents|respiratory system agents|mesh-ancestor
110332465|NCT00482573|Sympathomimetics|sympathomimetics|mesh-ancestor
110332466|NCT00482976|Ruboxistaurin|ruboxistaurin|mesh-list
110332467|NCT00482976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110332468|NCT00482976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110332469|NCT00481013|Valproic Acid|valproic acid|mesh-list
110332470|NCT00481013|Anticonvulsants|anticonvulsants|mesh-ancestor
110332472|NCT00481013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110332473|NCT00481013|GABA Agents|gaba agents|mesh-ancestor
110332474|NCT00481013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110332475|NCT00481013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110332476|NCT00481013|Antimanic Agents|antimanic agents|mesh-ancestor
110332477|NCT00481013|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110332478|NCT00481013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110332479|NCT00481013|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110332480|NCT01309243|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110150551|NCT00000466|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110332481|NCT01309243|Emtricitabine, Rilpivirine, Tenofovir Drug Combination|emtricitabine, rilpivirine, tenofovir drug combination|mesh-list
110332482|NCT01309243|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110332483|NCT01309243|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110332484|NCT01309243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110332485|NCT01309243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110332486|NCT01309243|Antiviral Agents|antiviral agents|mesh-ancestor
110332487|NCT01309243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110332488|NCT01309243|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110332489|NCT01309243|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110332490|NCT01240109|Remifentanil|remifentanil|mesh-list
110332491|NCT01240109|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110332492|NCT01240109|Narcotics|narcotics|mesh-ancestor
110332493|NCT01240109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110332494|NCT01240109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110332495|NCT01240109|Analgesics|analgesics|mesh-ancestor
110332496|NCT01240109|Sensory System Agents|sensory system agents|mesh-ancestor
110332497|NCT01240109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110332498|NCT04517526|Bevacizumab|bevacizumab|mesh-list
110332499|NCT04517526|Durvalumab|durvalumab|mesh-list
110332500|NCT04517526|Carboplatin|carboplatin|mesh-list
110332501|NCT04517526|Pemetrexed|pemetrexed|mesh-list
110332502|NCT04517526|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110332504|NCT04517526|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110332505|NCT04517526|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110332506|NCT04517526|Growth Substances|growth substances|mesh-ancestor
110332507|NCT04517526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110332508|NCT04517526|Growth Inhibitors|growth inhibitors|mesh-ancestor
110332509|NCT04517526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110332510|NCT04517526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110332511|NCT04517526|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110332512|NCT04517526|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110332513|NCT01309204|Brimonidine Tartrate|brimonidine tartrate|mesh-list
110332514|NCT01309204|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110332515|NCT01309204|Brinzolamide|brinzolamide|mesh-list
110332516|NCT01309204|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110332517|NCT01309204|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110150731|NCT00000553|Niacin|niacin|mesh-list
110332518|NCT01309204|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110332519|NCT01309204|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110332520|NCT01309204|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110332521|NCT01309204|Adrenergic Agents|adrenergic agents|mesh-ancestor
110332522|NCT01309204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110332523|NCT01309204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110332524|NCT01309204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110332525|NCT01309204|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110332526|NCT01309204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110332527|NCT00482807|Docetaxel|docetaxel|mesh-list
110332528|NCT00482807|Goserelin|goserelin|mesh-list
110332529|NCT00482807|Bicalutamide|bicalutamide|mesh-list
110332530|NCT00482807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110332531|NCT00482807|Tubulin Modulators|tubulin modulators|mesh-ancestor
110332532|NCT00482807|Antimitotic Agents|antimitotic agents|mesh-ancestor
110332533|NCT00482807|Mitosis Modulators|mitosis modulators|mesh-ancestor
110332534|NCT00482807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110332535|NCT00482807|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110332536|NCT00482807|Androgen Antagonists|androgen antagonists|mesh-ancestor
110332537|NCT00482807|Hormone Antagonists|hormone antagonists|mesh-ancestor
110332538|NCT00482807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110332539|NCT00482807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110332540|NCT01240148|Lidocaine|lidocaine|mesh-list
110332541|NCT01240148|Anesthetics, Local|anesthetics, local|mesh-ancestor
110332542|NCT01240148|Anesthetics|anesthetics|mesh-ancestor
110332543|NCT01240148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110332544|NCT01240148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110332545|NCT01240148|Sensory System Agents|sensory system agents|mesh-ancestor
110332546|NCT01240148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110332547|NCT01240148|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110332548|NCT01240148|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110332549|NCT01240148|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110332550|NCT01240148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110332551|NCT01240148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110332552|NCT04325191|Melatonin|melatonin|mesh-list
110332553|NCT04325191|Antioxidants|antioxidants|mesh-ancestor
110172160|NCT00049192|Imatinib Mesylate|imatinib mesylate|mesh-list
110332554|NCT04325191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110332556|NCT04325191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110332557|NCT04325191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110332558|NCT04517292|Cisplatin|cisplatin|mesh-list
110332559|NCT04517292|Gemcitabine|gemcitabine|mesh-list
110332560|NCT04517292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110332561|NCT04517292|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110332562|NCT04517292|Antimetabolites|antimetabolites|mesh-ancestor
110332563|NCT04517292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110332564|NCT00482846|Melphalan|melphalan|mesh-list
110332565|NCT00482846|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110332566|NCT00482846|Alkylating Agents|alkylating agents|mesh-ancestor
110332567|NCT00482846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110332568|NCT00482846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110332569|NCT00482846|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110332570|NCT00482846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110332571|NCT00482846|Immunologic Factors|immunologic factors|mesh-ancestor
110332572|NCT00482846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110332573|NCT01308736|Varenicline|varenicline|mesh-list
110332574|NCT01308736|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110332575|NCT01308736|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110332576|NCT01308736|Cholinergic Agents|cholinergic agents|mesh-ancestor
110332577|NCT01308736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110332578|NCT01308736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110332579|NCT01308736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110332580|NCT04517214|Gemcitabine|gemcitabine|mesh-list
110332581|NCT04517214|Capecitabine|capecitabine|mesh-list
110332582|NCT04517214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110332583|NCT04517214|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110332584|NCT04517214|Antimetabolites|antimetabolites|mesh-ancestor
110332585|NCT04517214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110332586|NCT00483054|Efavirenz|efavirenz|mesh-list
110332587|NCT00483054|Nevirapine|nevirapine|mesh-list
110332588|NCT00483054|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110150943|NCT00000679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110332590|NCT00483054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110332591|NCT00483054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110332592|NCT00483054|Antiviral Agents|antiviral agents|mesh-ancestor
110332593|NCT00483054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110332594|NCT00483054|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110332595|NCT00483054|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110332596|NCT00483054|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110332597|NCT00483054|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110332598|NCT00483054|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110332599|NCT00483054|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110332600|NCT00483054|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110332601|NCT00483054|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110332602|NCT01240226|Ketoconazole|ketoconazole|mesh-list
110332603|NCT01240226|Antifungal Agents|antifungal agents|mesh-ancestor
110332604|NCT01240226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110332605|NCT01240226|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110332606|NCT01240226|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110332607|NCT01240226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110332608|NCT01240226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110332609|NCT01240226|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110332610|NCT01240226|Hormone Antagonists|hormone antagonists|mesh-ancestor
110332611|NCT01240226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110332612|NCT01240226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110332613|NCT01240226|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110332616|NCT01240824|Autonomic Agents|autonomic agents|mesh-ancestor
110332617|NCT01240824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110332618|NCT01240824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110172168|NCT05576181|Etoposide|etoposide|mesh-list
110332619|NCT01240824|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110332620|NCT01240824|Respiratory System Agents|respiratory system agents|mesh-ancestor
110332621|NCT01240824|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110332622|NCT01240824|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110332623|NCT01240824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110332624|NCT01240824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110332625|NCT01240824|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110332626|NCT01240824|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110332627|NCT01240824|Purinergic Agents|purinergic agents|mesh-ancestor
110332628|NCT01240824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110332629|NCT01240824|Protective Agents|protective agents|mesh-ancestor
110332631|NCT01240941|Goserelin|goserelin|mesh-list
110332632|NCT01240941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110332633|NCT01240941|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110332634|NCT01240941|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110332635|NCT01240941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110332636|NCT01240941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110332637|NCT01240941|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110332638|NCT01240941|Hormone Antagonists|hormone antagonists|mesh-ancestor
110332639|NCT01240941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110332640|NCT01240941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110332641|NCT01240941|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110332642|NCT00482963|Efavirenz|efavirenz|mesh-list
110332643|NCT00482963|Levonorgestrel|levonorgestrel|mesh-list
110151131|NCT00000799|Probenecid|probenecid|mesh-list
110332644|NCT00482963|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110332645|NCT00482963|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110332646|NCT00482963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110332647|NCT00482963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110332648|NCT00482963|Antiviral Agents|antiviral agents|mesh-ancestor
110332649|NCT00482963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110332650|NCT00482963|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110332651|NCT00482963|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110332652|NCT00482963|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110332653|NCT00482963|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110332654|NCT00482963|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110332655|NCT00482963|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110332656|NCT00482963|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110332657|NCT00482963|Contraceptive Agents|contraceptive agents|mesh-ancestor
110332658|NCT00482963|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110332659|NCT00482963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110332660|NCT00482963|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110151177|NCT00000826|Hormone Antagonists|hormone antagonists|mesh-ancestor
110332661|NCT00482963|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110332663|NCT01241019|Topiramate|topiramate|mesh-list
110332664|NCT01241019|Anticonvulsants|anticonvulsants|mesh-ancestor
110332665|NCT01241019|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110332666|NCT01241019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110332667|NCT01240928|Exemestane|exemestane|mesh-list
110332668|NCT01240928|Goserelin|goserelin|mesh-list
110332669|NCT01240928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110332670|NCT01240928|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110332671|NCT01240928|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110332672|NCT01240928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110332673|NCT01240928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110332674|NCT01240928|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110332675|NCT01240928|Hormone Antagonists|hormone antagonists|mesh-ancestor
110332676|NCT01240928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110332677|NCT01240928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110332678|NCT01240928|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110332679|NCT00481169|Bazedoxifene|bazedoxifene|mesh-list
110332680|NCT00481169|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110332681|NCT00481169|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110332682|NCT00481169|Hormone Antagonists|hormone antagonists|mesh-ancestor
110332683|NCT00481169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110332684|NCT00481169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110332685|NCT00481169|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110332686|NCT00483093|Cisplatin|cisplatin|mesh-list
110332687|NCT00483093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110332689|NCT00483132|Interferon-alpha|interferon-alpha|mesh-list
110332690|NCT00483132|Interferon alpha-2|interferon alpha-2|mesh-list
110332691|NCT00483132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110332692|NCT00483132|Antiviral Agents|antiviral agents|mesh-ancestor
110332693|NCT00483132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110332694|NCT00483132|Immunologic Factors|immunologic factors|mesh-ancestor
110332695|NCT00483132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110332696|NCT00483210|Fenofibrate|fenofibrate|mesh-list
110332697|NCT00483210|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110332698|NCT00483210|Antimetabolites|antimetabolites|mesh-ancestor
110332699|NCT00483210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110332700|NCT00483210|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110332701|NCT00487994|Atorvastatin|atorvastatin|mesh-list
110332702|NCT00487994|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110332703|NCT00487994|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110332704|NCT00487994|Antimetabolites|antimetabolites|mesh-ancestor
110151358|NCT00000940|Lamivudine|lamivudine|mesh-list
110151359|NCT00000940|Abacavir|abacavir|mesh-list
110332705|NCT00487994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110332706|NCT00487994|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110332707|NCT00487994|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110332708|NCT00487994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110332709|NCT00483158|Finafloxacin|finafloxacin|mesh-list
110332710|NCT00483158|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110332711|NCT00483158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110332712|NCT00483158|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110332713|NCT00483158|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110332714|NCT00483158|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110332715|NCT00483158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110151426|NCT00000973|Leucovorin|leucovorin|mesh-list
110332716|NCT00483158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110332717|NCT00483158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110332719|NCT01308580|Prednisolone|prednisolone|mesh-list
110332720|NCT01308580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110332721|NCT01308580|Glucocorticoids|glucocorticoids|mesh-ancestor
110332722|NCT01308580|Hormones|hormones|mesh-ancestor
110332723|NCT01308580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110332724|NCT01308580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110332725|NCT01308580|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110332726|NCT01308580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110332727|NCT00483275|Alfacalcidol|alfacalcidol|mesh-list
110332728|NCT00483275|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
110332729|NCT00483275|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110332730|NCT00483275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110332731|NCT00483275|Vitamins|vitamins|mesh-ancestor
110332732|NCT00483275|Micronutrients|micronutrients|mesh-ancestor
110332733|NCT00483314|Acetylcysteine|acetylcysteine|mesh-list
110332734|NCT00483314|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110332735|NCT00483314|Antiviral Agents|antiviral agents|mesh-ancestor
110332736|NCT00483314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110332737|NCT00483314|Expectorants|expectorants|mesh-ancestor
110332738|NCT00483314|Respiratory System Agents|respiratory system agents|mesh-ancestor
110332739|NCT00483314|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110332740|NCT00483314|Antioxidants|antioxidants|mesh-ancestor
110332741|NCT00483314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110332742|NCT00483314|Protective Agents|protective agents|mesh-ancestor
110332743|NCT00483314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110332744|NCT00483314|Antidotes|antidotes|mesh-ancestor
110332746|NCT00483392|Rosiglitazone|rosiglitazone|mesh-list
110332747|NCT00483392|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110332748|NCT00483392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110332749|NCT00483431|Menaquinone 7|menaquinone 7|mesh-list
110332750|NCT00483431|Hemostatics|hemostatics|mesh-ancestor
110332751|NCT00483431|Coagulants|coagulants|mesh-ancestor
110332752|NCT00483600|PENTA|penta|mesh-list
110332753|NCT00483600|Fondaparinux|fondaparinux|mesh-list
110332754|NCT00483600|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110332755|NCT00483600|Antithrombins|antithrombins|mesh-ancestor
110332756|NCT00483600|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110332757|NCT00483600|Protease Inhibitors|protease inhibitors|mesh-ancestor
110332758|NCT00483600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110332759|NCT00483600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110332760|NCT00483600|Anticoagulants|anticoagulants|mesh-ancestor
110332761|NCT00483600|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110332762|NCT00483600|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110332763|NCT00488189|Tazobactam|tazobactam|mesh-list
110332764|NCT00488189|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
110332765|NCT00488189|Piperacillin|piperacillin|mesh-list
110332766|NCT00488189|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110332767|NCT00488189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110332768|NCT00488189|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110332769|NCT00488189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110332770|NCT00488189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110332771|NCT02956421|Vaccines|vaccines|mesh-list
110332772|NCT02956421|Immunologic Factors|immunologic factors|mesh-ancestor
110332773|NCT02956421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110332774|NCT00483470|Vaccines|vaccines|mesh-list
110332775|NCT00483470|Immunologic Factors|immunologic factors|mesh-ancestor
110332776|NCT00483470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110332777|NCT00488306|Tigecycline|tigecycline|mesh-list
110332778|NCT00488306|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110332779|NCT00488306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110332780|NCT00488306|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110332781|NCT00488306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110332782|NCT00488306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110332783|NCT00483626|Sildenafil Citrate|sildenafil citrate|mesh-list
110332784|NCT00483626|Vasodilator Agents|vasodilator agents|mesh-ancestor
110332785|NCT00483626|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110332786|NCT00483626|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110332787|NCT00483626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110332788|NCT00483626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110332789|NCT00483626|Urological Agents|urological agents|mesh-ancestor
110332791|NCT00483795|Sodium Citrate|sodium citrate|mesh-list
110332792|NCT00483795|Anticoagulants|anticoagulants|mesh-ancestor
110332793|NCT00483795|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110332794|NCT00483795|Chelating Agents|chelating agents|mesh-ancestor
110332795|NCT00483795|Sequestering Agents|sequestering agents|mesh-ancestor
110332796|NCT00483795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110332798|NCT05644210|Hydroxychloroquine|hydroxychloroquine|mesh-list
110332799|NCT05644210|Prednisone|prednisone|mesh-list
110332800|NCT05644210|Rituximab|rituximab|mesh-list
110332801|NCT05644210|Warfarin|warfarin|mesh-list
110332802|NCT05644210|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110332803|NCT05644210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110332804|NCT05644210|Immunologic Factors|immunologic factors|mesh-ancestor
110332805|NCT05644210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110332806|NCT05644210|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110332807|NCT05644210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110332808|NCT05644210|Glucocorticoids|glucocorticoids|mesh-ancestor
110332810|NCT05644210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110332811|NCT05644210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110332812|NCT05644210|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110332813|NCT05644210|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110332815|NCT05644210|Sensory System Agents|sensory system agents|mesh-ancestor
110332816|NCT05644210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110332817|NCT05644210|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110332818|NCT05644210|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110332819|NCT05644210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110332820|NCT05644210|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110332821|NCT05644210|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110332822|NCT05644210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110332823|NCT05644210|Antipyretics|antipyretics|mesh-ancestor
110332824|NCT05644210|Anticoagulants|anticoagulants|mesh-ancestor
110332825|NCT05644210|Antimalarials|antimalarials|mesh-ancestor
110332826|NCT05644210|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110332827|NCT05644210|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110332828|NCT05644210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110332829|NCT00488384|Acitretin|acitretin|mesh-list
110332830|NCT00488384|Keratolytic Agents|keratolytic agents|mesh-ancestor
110332831|NCT00488384|Dermatologic Agents|dermatologic agents|mesh-ancestor
110332832|NCT00483834|Bevacizumab|bevacizumab|mesh-list
110332833|NCT00483834|Capecitabine|capecitabine|mesh-list
110332834|NCT00483834|Irinotecan|irinotecan|mesh-list
110332835|NCT00483834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110332836|NCT00483834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110332837|NCT00483834|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110332838|NCT00483834|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110332839|NCT00483834|Growth Substances|growth substances|mesh-ancestor
110332840|NCT00483834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110332841|NCT00483834|Growth Inhibitors|growth inhibitors|mesh-ancestor
110332842|NCT00483834|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110332843|NCT00483834|Antimetabolites|antimetabolites|mesh-ancestor
110332844|NCT00483834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110332845|NCT00483834|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110151900|NCT00000147|Prednisolone|prednisolone|mesh-list
110332846|NCT00483834|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110332847|NCT00483834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110332848|NCT01307449|Vaccines|vaccines|mesh-list
110332849|NCT01307449|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110332850|NCT01307449|Immunologic Factors|immunologic factors|mesh-ancestor
110332851|NCT01307449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110332852|NCT01307020|Ibuprofen|ibuprofen|mesh-list
110332853|NCT01307020|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
110332854|NCT01307020|Ketoprofen|ketoprofen|mesh-list
110332855|NCT01307020|Tramadol|tramadol|mesh-list
110332856|NCT01307020|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110332857|NCT01307020|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110332858|NCT01307020|Analgesics|analgesics|mesh-ancestor
110332859|NCT01307020|Sensory System Agents|sensory system agents|mesh-ancestor
110332860|NCT01307020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110332861|NCT01307020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110332862|NCT01307020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110332863|NCT01307020|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110332864|NCT01307020|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110332865|NCT01307020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110332866|NCT01307020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110332867|NCT01307020|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110332868|NCT01307020|Narcotics|narcotics|mesh-ancestor
110332869|NCT01307020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110332870|NCT00483743|Budesonide|budesonide|mesh-list
110332871|NCT00483743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110332872|NCT00483743|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110332873|NCT00483743|Autonomic Agents|autonomic agents|mesh-ancestor
110332874|NCT00483743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110332875|NCT00483743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110332876|NCT00483743|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110332877|NCT00483743|Respiratory System Agents|respiratory system agents|mesh-ancestor
110332878|NCT00483743|Glucocorticoids|glucocorticoids|mesh-ancestor
110332879|NCT00483743|Hormones|hormones|mesh-ancestor
110332880|NCT00483743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110332882|NCT00483782|Bevacizumab|bevacizumab|mesh-list
110332883|NCT00483782|Carboplatin|carboplatin|mesh-list
110332884|NCT00483782|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110332885|NCT00483782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110332886|NCT00483782|Tubulin Modulators|tubulin modulators|mesh-ancestor
110332887|NCT00483782|Antimitotic Agents|antimitotic agents|mesh-ancestor
110332888|NCT00483782|Mitosis Modulators|mitosis modulators|mesh-ancestor
110332889|NCT00483782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110332890|NCT00483782|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110332891|NCT00483782|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110332892|NCT00483782|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110332893|NCT00483782|Growth Substances|growth substances|mesh-ancestor
110332894|NCT00483782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110332895|NCT00483782|Growth Inhibitors|growth inhibitors|mesh-ancestor
110332896|NCT02890771|Turmeric extract|turmeric extract|mesh-list
110332897|NCT02890771|Antioxidants|antioxidants|mesh-ancestor
110332898|NCT02890771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110332899|NCT02890771|Protective Agents|protective agents|mesh-ancestor
110332900|NCT02890771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110332901|NCT01306162|Dronedarone|dronedarone|mesh-list
110332902|NCT01306162|Dabigatran|dabigatran|mesh-list
110332903|NCT01306162|Antithrombins|antithrombins|mesh-ancestor
110332904|NCT01306162|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110332905|NCT01306162|Protease Inhibitors|protease inhibitors|mesh-ancestor
110332906|NCT01306162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110332907|NCT01306162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110332908|NCT01306162|Anticoagulants|anticoagulants|mesh-ancestor
110332909|NCT01306162|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110332910|NCT04515732|Apremilast|apremilast|mesh-list
110332911|NCT04515732|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110332912|NCT04515732|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110332913|NCT04515732|Analgesics|analgesics|mesh-ancestor
110332914|NCT04515732|Sensory System Agents|sensory system agents|mesh-ancestor
110332915|NCT04515732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110332916|NCT04515732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110332917|NCT04515732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110332919|NCT04515732|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
110332920|NCT04515732|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110332922|NCT04515732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110332923|NCT01305577|Deoxycholic Acid|deoxycholic acid|mesh-list
110332924|NCT01305577|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
110332925|NCT01305577|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110332926|NCT00483990|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
110332927|NCT00483990|Anesthetics, Local|anesthetics, local|mesh-ancestor
110332928|NCT00483990|Anesthetics|anesthetics|mesh-ancestor
110332929|NCT00483990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110332930|NCT00483990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110332931|NCT00483990|Sensory System Agents|sensory system agents|mesh-ancestor
110332932|NCT00483990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110332933|NCT00483990|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
110332934|NCT01304329|Empagliflozin|empagliflozin|mesh-list
110332935|NCT01304329|Simvastatin|simvastatin|mesh-list
110332936|NCT01304329|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110332937|NCT01304329|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110332938|NCT01304329|Antimetabolites|antimetabolites|mesh-ancestor
110332939|NCT01304329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110332940|NCT01304329|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110332941|NCT01304329|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110332942|NCT01304329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110332943|NCT01304329|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110332944|NCT01304329|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110332945|NCT01304329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110332947|NCT04515420|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110332948|NCT04515420|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110332949|NCT04515420|Adrenergic Agents|adrenergic agents|mesh-ancestor
110332950|NCT04515420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110332951|NCT04515420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110332952|NCT04515420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110332953|NCT04515420|Sympathomimetics|sympathomimetics|mesh-ancestor
110332954|NCT04515420|Autonomic Agents|autonomic agents|mesh-ancestor
110332955|NCT04515420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110332956|NCT04515420|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110332957|NCT00488540|Acetaminophen|acetaminophen|mesh-list
110332958|NCT00488540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110332959|NCT00488540|Analgesics|analgesics|mesh-ancestor
110332960|NCT00488540|Sensory System Agents|sensory system agents|mesh-ancestor
110332961|NCT00488540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110152219|NCT00389701|Glucocorticoids|glucocorticoids|mesh-ancestor
110332962|NCT00488540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110332964|NCT00484068|Enalapril|enalapril|mesh-list
110332965|NCT00484068|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110332966|NCT00484068|Protease Inhibitors|protease inhibitors|mesh-ancestor
110332967|NCT00484068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110332968|NCT00484068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110332969|NCT00484068|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110152271|NCT05448820|Doxorubicin|doxorubicin|mesh-list
110332971|NCT00483860|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110332972|NCT00483860|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110332973|NCT00483860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110332974|NCT00483860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110332975|NCT00483860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110332976|NCT01241097|Simvastatin|simvastatin|mesh-list
110332977|NCT01241097|Ezetimibe|ezetimibe|mesh-list
110332978|NCT01241097|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110332979|NCT01241097|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110332980|NCT01241097|Antimetabolites|antimetabolites|mesh-ancestor
110332981|NCT01241097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110332982|NCT01241097|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110332983|NCT01241097|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110332984|NCT01241097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110332986|NCT01303861|Nicotine|nicotine|mesh-list
110332987|NCT01303861|Varenicline|varenicline|mesh-list
110332988|NCT01303861|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110332989|NCT01303861|Autonomic Agents|autonomic agents|mesh-ancestor
110332990|NCT01303861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110332991|NCT01303861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110332992|NCT01303861|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110332993|NCT01303861|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110332994|NCT01303861|Cholinergic Agents|cholinergic agents|mesh-ancestor
110332995|NCT01303861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110332996|NCT01303861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110332997|NCT01303861|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110332998|NCT01303861|Antidepressive Agents|antidepressive agents|mesh-ancestor
110332999|NCT01303861|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110333000|NCT01303861|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110333001|NCT01303861|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110333002|NCT01303861|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110333003|NCT01303861|Dopamine Agents|dopamine agents|mesh-ancestor
110152389|NCT00000504|Adrenergic Agents|adrenergic agents|mesh-ancestor
110333004|NCT01303861|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110333005|NCT01303861|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110333006|NCT01303861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110333007|NCT01303627|Remifentanil|remifentanil|mesh-list
110333008|NCT01303627|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110333009|NCT01303627|Narcotics|narcotics|mesh-ancestor
110333010|NCT01303627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110333011|NCT01303627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110333012|NCT01303627|Analgesics|analgesics|mesh-ancestor
110333013|NCT01303627|Sensory System Agents|sensory system agents|mesh-ancestor
110333014|NCT01303627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110333015|NCT01241175|Magnesium Sulfate|magnesium sulfate|mesh-list
110333016|NCT01241175|Analgesics|analgesics|mesh-ancestor
110333017|NCT01241175|Sensory System Agents|sensory system agents|mesh-ancestor
110333018|NCT01241175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110333019|NCT01241175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110333020|NCT01241175|Anesthetics|anesthetics|mesh-ancestor
110152490|NCT00000531|Sotalol|sotalol|mesh-list
110333021|NCT01241175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110333022|NCT01241175|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110333023|NCT01241175|Anticonvulsants|anticonvulsants|mesh-ancestor
110333024|NCT01241175|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110333025|NCT01241175|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110333026|NCT01241175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110333027|NCT01241175|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110333028|NCT01241175|Tocolytic Agents|tocolytic agents|mesh-ancestor
110333029|NCT01241175|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110333030|NCT00484107|Estrogens|estrogens|mesh-list
110333031|NCT00484107|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
110333032|NCT00484107|Hormones|hormones|mesh-ancestor
110333033|NCT00484107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110333034|NCT00484107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110333035|NCT01302964|Mirtazapine|mirtazapine|mesh-list
110333036|NCT01302964|Antidepressive Agents|antidepressive agents|mesh-ancestor
110333037|NCT01302964|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110333038|NCT01302964|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110333039|NCT01302964|Histamine Antagonists|histamine antagonists|mesh-ancestor
110333040|NCT01302964|Histamine Agents|histamine agents|mesh-ancestor
110333041|NCT01302964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110333042|NCT01302964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110333043|NCT01302964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110333044|NCT01302964|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110333045|NCT01302964|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110333046|NCT01302964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110333047|NCT01302964|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
110333048|NCT01302964|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110333049|NCT01302964|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110333050|NCT01302964|Adrenergic Agents|adrenergic agents|mesh-ancestor
110333052|NCT01302964|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110333053|NCT01302964|Serotonin Agents|serotonin agents|mesh-ancestor
110333054|NCT01302964|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110333055|NCT00484055|Gentamicins|gentamicins|mesh-list
110333056|NCT00484055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110333057|NCT00484055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110333058|NCT00484055|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110333059|NCT00484055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110333060|NCT00484055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110333061|NCT01302691|Losartan|losartan|mesh-list
110333062|NCT01302691|Amlodipine|amlodipine|mesh-list
110333063|NCT01302691|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110333064|NCT01302691|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110333065|NCT01302691|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110333066|NCT01302691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110333067|NCT01302691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110333068|NCT01302691|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110333069|NCT01302691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110333070|NCT01302691|Vasodilator Agents|vasodilator agents|mesh-ancestor
110333071|NCT01302691|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110333072|NCT01302691|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110333073|NCT01302691|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110333075|NCT01302691|Natriuretic Agents|natriuretic agents|mesh-ancestor
110333076|NCT01302691|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110333077|NCT01241084|Leukotriene Antagonists|leukotriene antagonists|mesh-list
110333078|NCT01241084|Hormone Antagonists|hormone antagonists|mesh-ancestor
110333079|NCT01241084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110333080|NCT01241084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110333081|NCT01241084|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110333082|NCT01241084|Respiratory System Agents|respiratory system agents|mesh-ancestor
110333084|NCT05643820|Permethrin|permethrin|mesh-list
110333085|NCT05643820|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110333086|NCT05643820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110333087|NCT05643820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110333088|NCT05643820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110333089|NCT01242449|Trastuzumab|trastuzumab|mesh-list
110333090|NCT01242449|Vinorelbine|vinorelbine|mesh-list
110333091|NCT01242449|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110333092|NCT01242449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110333093|NCT01242449|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110333094|NCT01242449|Tubulin Modulators|tubulin modulators|mesh-ancestor
110333095|NCT01242449|Antimitotic Agents|antimitotic agents|mesh-ancestor
110333096|NCT01242449|Mitosis Modulators|mitosis modulators|mesh-ancestor
110333097|NCT01242449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110333098|NCT01241162|Decitabine|decitabine|mesh-list
110333099|NCT01241162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110333100|NCT01241162|Antimetabolites|antimetabolites|mesh-ancestor
110333101|NCT01241162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110333102|NCT01241162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110333103|NCT01241162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110333105|NCT00484133|Dopamine|dopamine|mesh-list
110333106|NCT00484133|Enoximone|enoximone|mesh-list
110333107|NCT00484133|Norepinephrine|norepinephrine|mesh-list
110333108|NCT00484133|Nitroglycerin|nitroglycerin|mesh-list
110333109|NCT00484133|Vasodilator Agents|vasodilator agents|mesh-ancestor
110333110|NCT00484133|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110333111|NCT00484133|Sympathomimetics|sympathomimetics|mesh-ancestor
110333112|NCT00484133|Autonomic Agents|autonomic agents|mesh-ancestor
110333113|NCT00484133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110333114|NCT00484133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110333115|NCT00484133|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
110333116|NCT00484133|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110333117|NCT00484133|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110333118|NCT00484133|Adrenergic Agents|adrenergic agents|mesh-ancestor
110333119|NCT00484133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110333120|NCT00484133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110333121|NCT00484133|Protective Agents|protective agents|mesh-ancestor
110333122|NCT00484133|Dopamine Agents|dopamine agents|mesh-ancestor
110333123|NCT00484133|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110333124|NCT00484133|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110333125|NCT00484133|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110333126|NCT00484133|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110333127|NCT00484133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110333129|NCT00484341|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110333130|NCT00484341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110333131|NCT00484341|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110333132|NCT00484341|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110333133|NCT00484341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110333134|NCT00484341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110333135|NCT01242566|Temozolomide|temozolomide|mesh-list
110333136|NCT01242566|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110333137|NCT01242566|Alkylating Agents|alkylating agents|mesh-ancestor
110333138|NCT01242566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110333139|NCT01242566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110333140|NCT04514835|Capecitabine|capecitabine|mesh-list
110333141|NCT04514835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110333142|NCT04514835|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110333144|NCT04514835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110333145|NCT00488813|Cephalosporins|cephalosporins|mesh-list
110333146|NCT00488813|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110333147|NCT00488813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110333148|NCT00484250|Metronidazole|metronidazole|mesh-list
110333149|NCT00484250|Doxycycline|doxycycline|mesh-list
110333150|NCT00484250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110333151|NCT00484250|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110333152|NCT00484250|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110333153|NCT00484250|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110333154|NCT00484250|Antimalarials|antimalarials|mesh-ancestor
110333155|NCT00488891|Paliperidone Palmitate|paliperidone palmitate|mesh-list
110333156|NCT00488891|Antipsychotic Agents|antipsychotic agents|mesh-list
110333157|NCT00488891|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110333158|NCT00488891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110333159|NCT00488891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110333160|NCT00488891|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110333161|NCT00488891|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110152818|NCT00000678|Zidovudine|zidovudine|mesh-list
110333162|NCT00488891|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110333164|NCT00488891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110333165|NCT00488891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110333166|NCT00488891|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110333167|NCT00488891|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110333168|NCT00488891|Dopamine Agents|dopamine agents|mesh-ancestor
110333169|NCT00484328|Ribavirin|ribavirin|mesh-list
110333170|NCT00484328|Antimetabolites|antimetabolites|mesh-ancestor
110333171|NCT00484328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110333172|NCT00484328|Antiviral Agents|antiviral agents|mesh-ancestor
110333173|NCT00484328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110333174|NCT00484575|Propofol|propofol|mesh-list
110333175|NCT00484575|Sevoflurane|sevoflurane|mesh-list
110333176|NCT00484575|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110172207|NCT00391911|Antioxidants|antioxidants|mesh-ancestor
110333177|NCT00484575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110333179|NCT00484575|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110333180|NCT00484575|Anesthetics, General|anesthetics, general|mesh-ancestor
110333181|NCT00484575|Anesthetics|anesthetics|mesh-ancestor
110333182|NCT00484575|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110333183|NCT00484575|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110333185|NCT04514796|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110333186|NCT04514796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110333187|NCT04514796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110333188|NCT00488969|Morphine|morphine|mesh-list
110333189|NCT00488969|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110333190|NCT00488969|Narcotics|narcotics|mesh-ancestor
110333191|NCT00488969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110333192|NCT00488969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110333193|NCT00488969|Analgesics|analgesics|mesh-ancestor
110333194|NCT00488969|Sensory System Agents|sensory system agents|mesh-ancestor
110333195|NCT00488969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110333196|NCT00484692|Bupropion|bupropion|mesh-list
110333197|NCT00484692|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110333198|NCT00484692|Antidepressive Agents|antidepressive agents|mesh-ancestor
110333199|NCT00484692|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110333200|NCT00484692|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110333201|NCT00484692|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110152961|NCT00000717|Clindamycin|clindamycin|mesh-list
110333202|NCT00484692|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110333203|NCT00484692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110333204|NCT00484692|Dopamine Agents|dopamine agents|mesh-ancestor
110333205|NCT00484692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110333206|NCT00484692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110333207|NCT00484692|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110333208|NCT00484692|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110333209|NCT00484692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110333210|NCT00484731|Bupivacaine|bupivacaine|mesh-list
110333211|NCT00484731|Anesthetics, Local|anesthetics, local|mesh-ancestor
110333212|NCT00484731|Anesthetics|anesthetics|mesh-ancestor
110333213|NCT00484731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110333214|NCT00484731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110333215|NCT00484731|Sensory System Agents|sensory system agents|mesh-ancestor
110333216|NCT00484731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110333217|NCT00484484|Ketamine|ketamine|mesh-list
110333218|NCT00484484|Analgesics|analgesics|mesh-ancestor
110333219|NCT00484484|Sensory System Agents|sensory system agents|mesh-ancestor
110333220|NCT00484484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110333221|NCT00484484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110333222|NCT00484484|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110333223|NCT00484484|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110333224|NCT00484484|Anesthetics, General|anesthetics, general|mesh-ancestor
110333225|NCT00484484|Anesthetics|anesthetics|mesh-ancestor
110333226|NCT00484484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110333227|NCT00484484|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110333228|NCT00484484|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110333229|NCT00484484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110333230|NCT00484484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110333231|NCT00484601|Doxorubicin|doxorubicin|mesh-list
110333232|NCT00484601|Ifosfamide|ifosfamide|mesh-list
110333233|NCT00484601|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110333234|NCT00484601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110333235|NCT00484601|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110333236|NCT00484601|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110333237|NCT00484601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110333238|NCT00484601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110333239|NCT00484601|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110333240|NCT00484601|Alkylating Agents|alkylating agents|mesh-ancestor
110333241|NCT00484770|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
110333242|NCT00484770|Natriuretic Agents|natriuretic agents|mesh-ancestor
110333243|NCT00484770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110333244|NCT00484640|Warfarin|warfarin|mesh-list
110333245|NCT00484640|Anticoagulants|anticoagulants|mesh-ancestor
110333246|NCT00489164|Sirolimus|sirolimus|mesh-list
110333247|NCT00489164|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110333248|NCT00489164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110333249|NCT00489164|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110333250|NCT00489164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110333251|NCT00489164|Antifungal Agents|antifungal agents|mesh-ancestor
110333252|NCT00489164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110333253|NCT00489164|Immunologic Factors|immunologic factors|mesh-ancestor
110333254|NCT00489164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110333255|NCT00484809|Etanercept|etanercept|mesh-list
110333256|NCT00484809|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110333257|NCT00484809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110333258|NCT00484809|Analgesics|analgesics|mesh-ancestor
110333259|NCT00484809|Sensory System Agents|sensory system agents|mesh-ancestor
110333260|NCT00484809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110333261|NCT00484809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110153101|NCT00000768|Ganciclovir|ganciclovir|mesh-list
110333262|NCT00484809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110333263|NCT00484809|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110333264|NCT00484809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110333265|NCT00484809|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110333266|NCT00484809|Immunologic Factors|immunologic factors|mesh-ancestor
110333267|NCT04514094|Fluorides|fluorides|mesh-list
110333268|NCT04514094|Cariostatic Agents|cariostatic agents|mesh-ancestor
110333269|NCT04514094|Protective Agents|protective agents|mesh-ancestor
110333270|NCT04514094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110333271|NCT04514289|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110333272|NCT00484926|Aspirin|aspirin|mesh-list
110333273|NCT00484926|Clopidogrel|clopidogrel|mesh-list
110333274|NCT00484926|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110333275|NCT00484926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110333276|NCT00484926|Analgesics|analgesics|mesh-ancestor
110333277|NCT00484926|Sensory System Agents|sensory system agents|mesh-ancestor
110333278|NCT00484926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110333279|NCT00484926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110333280|NCT00484926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110333281|NCT00484926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110333282|NCT00484926|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110333283|NCT00484926|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110333284|NCT00484926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110333285|NCT00484926|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110333286|NCT00484926|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110333287|NCT00484926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110333288|NCT00484926|Antipyretics|antipyretics|mesh-ancestor
110333289|NCT00484926|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110333290|NCT00484926|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110333291|NCT00484926|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110333292|NCT00484926|Purinergic Agents|purinergic agents|mesh-ancestor
110333293|NCT00484926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110333295|NCT02275806|Camptothecin|camptothecin|mesh-list
110333296|NCT02275806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110333297|NCT02275806|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110333298|NCT02275806|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110333299|NCT02275806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110333300|NCT02275806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110333301|NCT02275806|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110333302|NCT01241409|Rabeprazole|rabeprazole|mesh-list
110333303|NCT01241409|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110333304|NCT01241409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110333305|NCT01241409|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110333306|NCT01241409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110333307|NCT01241409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110333309|NCT02275845|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110333310|NCT02275845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110333311|NCT00489398|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
110333312|NCT00489398|Epinastine|epinastine|mesh-list
110333313|NCT00489398|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110333314|NCT00489398|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110333315|NCT00489398|Analgesics|analgesics|mesh-ancestor
110172214|NCT02970409|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110333316|NCT00489398|Sensory System Agents|sensory system agents|mesh-ancestor
110333317|NCT00489398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110333318|NCT00489398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110333319|NCT00489398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110333320|NCT00489398|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110333321|NCT00489398|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110333322|NCT00489398|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110333323|NCT00489398|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110333324|NCT00489398|Histamine Antagonists|histamine antagonists|mesh-ancestor
110333325|NCT00489398|Histamine Agents|histamine agents|mesh-ancestor
110333326|NCT00489398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110333327|NCT00489398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110333329|NCT00485004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110333330|NCT00485004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110333331|NCT00485004|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110333333|NCT00485004|Antifungal Agents|antifungal agents|mesh-ancestor
110333334|NCT00485004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110333335|NCT00485004|Immunologic Factors|immunologic factors|mesh-ancestor
110333336|NCT00485004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110333337|NCT00484991|Verapamil|verapamil|mesh-list
110333338|NCT00484991|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110333339|NCT00484991|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110333340|NCT00484991|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110333341|NCT00484991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110333342|NCT00484991|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110333343|NCT00484991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110333344|NCT00484991|Vasodilator Agents|vasodilator agents|mesh-ancestor
110333345|NCT00485121|Ezetimibe|ezetimibe|mesh-list
110333346|NCT00485121|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110153358|NCT00000882|Lamivudine|lamivudine|mesh-list
110333347|NCT00485121|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110333348|NCT00485121|Antimetabolites|antimetabolites|mesh-ancestor
110333349|NCT00485121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110333350|NCT00485121|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110333351|NCT00489437|Heparin|heparin|mesh-list
110333352|NCT00489437|Antibodies|antibodies|mesh-list
110333353|NCT00489437|Immunologic Factors|immunologic factors|mesh-ancestor
110333354|NCT00489437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110333355|NCT00489437|Anticoagulants|anticoagulants|mesh-ancestor
110333356|NCT00489437|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110333357|NCT00489437|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110333358|NCT00489437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110333359|NCT00485160|Ibuprofen|ibuprofen|mesh-list
110333360|NCT00485160|Indomethacin|indomethacin|mesh-list
110333361|NCT00485160|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110333362|NCT00485160|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110333363|NCT00485160|Analgesics|analgesics|mesh-ancestor
110333364|NCT00485160|Sensory System Agents|sensory system agents|mesh-ancestor
110333365|NCT00485160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110153397|NCT00000891|Didanosine|didanosine|mesh-list
110333366|NCT00485160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110333367|NCT00485160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110333368|NCT00485160|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110333369|NCT00485160|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110333370|NCT00485160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110333371|NCT00485160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110333372|NCT00485160|Gout Suppressants|gout suppressants|mesh-ancestor
110333373|NCT00485160|Tocolytic Agents|tocolytic agents|mesh-ancestor
110333374|NCT00485160|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110333377|NCT00485030|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110333378|NCT00485030|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110333379|NCT00485030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110333380|NCT00485030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110333381|NCT00485030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110333382|NCT00485030|Immunologic Factors|immunologic factors|mesh-ancestor
110333383|NCT00485030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110333384|NCT00485030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110333385|NCT00485030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110333386|NCT00485030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110333387|NCT00485030|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110333388|NCT00485030|Antifungal Agents|antifungal agents|mesh-ancestor
110333389|NCT04513821|Minocycline|minocycline|mesh-list
110333390|NCT04513821|Ethanol|ethanol|mesh-list
110333391|NCT04513821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110333392|NCT04513821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110333393|NCT04513821|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110333394|NCT04513821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110333395|NCT04513821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110333396|NCT00485108|Prednisolone|prednisolone|mesh-list
110333397|NCT00485108|Ketorolac|ketorolac|mesh-list
110333398|NCT00485108|Lubricant Eye Drops|lubricant eye drops|mesh-list
110333399|NCT00485108|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110333400|NCT00485108|Glucocorticoids|glucocorticoids|mesh-ancestor
110333401|NCT00485108|Hormones|hormones|mesh-ancestor
110333402|NCT00485108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110333403|NCT00485108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110333404|NCT00485108|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110333405|NCT00485108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110333406|NCT00485108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110333407|NCT00485108|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110333408|NCT00485108|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110333409|NCT00485108|Analgesics|analgesics|mesh-ancestor
110333410|NCT00485108|Sensory System Agents|sensory system agents|mesh-ancestor
110333411|NCT00485108|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110333412|NCT00485108|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110333413|NCT00485108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110333414|NCT00485108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110333415|NCT00485108|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110333416|NCT00485108|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110333417|NCT00485238|Acetazolamide|acetazolamide|mesh-list
110333418|NCT00485238|Anticonvulsants|anticonvulsants|mesh-ancestor
110333419|NCT00485238|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110333420|NCT00485238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110333421|NCT00485238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110333422|NCT00485238|Diuretics|diuretics|mesh-ancestor
110333423|NCT00485238|Natriuretic Agents|natriuretic agents|mesh-ancestor
110333424|NCT00485238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110333425|NCT00485277|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
110333426|NCT00485277|Antiviral Agents|antiviral agents|mesh-ancestor
110333427|NCT00485277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110333428|NCT04513509|Propranolol|propranolol|mesh-list
110333429|NCT04513509|Metoprolol|metoprolol|mesh-list
110333430|NCT04513509|Digoxin|digoxin|mesh-list
110333431|NCT04513509|Atenolol|atenolol|mesh-list
110333432|NCT04513509|Verapamil|verapamil|mesh-list
110333433|NCT04513509|Nebivolol|nebivolol|mesh-list
110333434|NCT04513509|Bisoprolol|bisoprolol|mesh-list
110333435|NCT04513509|Diltiazem|diltiazem|mesh-list
110333436|NCT04513509|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110333437|NCT04513509|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110333438|NCT04513509|Adrenergic Agents|adrenergic agents|mesh-ancestor
110333439|NCT04513509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110333440|NCT04513509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110333441|NCT04513509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110333442|NCT04513509|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110333443|NCT04513509|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110333444|NCT04513509|Vasodilator Agents|vasodilator agents|mesh-ancestor
110333445|NCT04513509|Sympatholytics|sympatholytics|mesh-ancestor
110333446|NCT04513509|Autonomic Agents|autonomic agents|mesh-ancestor
110333447|NCT04513509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110333448|NCT04513509|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110333449|NCT04513509|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110333450|NCT04513509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110333451|NCT04513509|Protective Agents|protective agents|mesh-ancestor
110333452|NCT04513509|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
110333453|NCT04513509|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110333454|NCT04513509|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110333455|NCT04513509|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110333456|NCT04513509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110333457|NCT04513509|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110333459|NCT00485342|Ribavirin|ribavirin|mesh-list
110333460|NCT00485342|Interferon-alpha|interferon-alpha|mesh-list
110333461|NCT00485342|Interferon alpha-2|interferon alpha-2|mesh-list
110333462|NCT00485342|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110333463|NCT00485342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110333464|NCT00485342|Antiviral Agents|antiviral agents|mesh-ancestor
110333465|NCT00485342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110153531|NCT00000978|Zidovudine|zidovudine|mesh-list
110333466|NCT00485342|Antimetabolites|antimetabolites|mesh-ancestor
110333467|NCT00485342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110333468|NCT00485342|Immunologic Factors|immunologic factors|mesh-ancestor
110333469|NCT00485342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110333470|NCT00489593|Olanzapine|olanzapine|mesh-list
110333471|NCT00489593|Fluoxetine|fluoxetine|mesh-list
110333472|NCT00489593|Antiemetics|antiemetics|mesh-ancestor
110333473|NCT00489593|Autonomic Agents|autonomic agents|mesh-ancestor
110333474|NCT00489593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110333475|NCT00489593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110333476|NCT00489593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110333477|NCT00489593|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110333478|NCT00489593|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110333479|NCT00489593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110333480|NCT00489593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110333481|NCT00489593|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110333482|NCT00489593|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110333483|NCT00489593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110333484|NCT00489593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110333485|NCT00489593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110333486|NCT00489593|Serotonin Agents|serotonin agents|mesh-ancestor
110153559|NCT00001002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110333487|NCT00489593|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110333488|NCT00489593|Antidepressive Agents|antidepressive agents|mesh-ancestor
110333489|NCT00489593|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110333490|NCT00489593|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110333491|NCT00489593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110333494|NCT01241487|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110333495|NCT01241487|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110333496|NCT01241487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110333497|NCT01241487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110333498|NCT01241487|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110333499|NCT01241487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110172235|NCT05640713|Fludarabine|fludarabine|mesh-list
110333501|NCT01241487|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110333502|NCT01241487|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110333503|NCT00505791|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
110333504|NCT00505791|Natriuretic Agents|natriuretic agents|mesh-ancestor
110333505|NCT00505791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110333506|NCT04513626|Raltegravir Potassium|raltegravir potassium|mesh-list
110333507|NCT04513626|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110333508|NCT04513626|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110333509|NCT04513626|Antiviral Agents|antiviral agents|mesh-ancestor
110333510|NCT04513626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110333511|NCT04513626|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110333512|NCT04513626|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110333513|NCT04513626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110333514|NCT04513626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110333515|NCT00485459|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
110333516|NCT00485459|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110333517|NCT00485459|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110333518|NCT00485459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110333519|NCT00485459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110153679|NCT00001014|Calcium|calcium|mesh-list
110333520|NCT00485459|Adrenergic Agents|adrenergic agents|mesh-ancestor
110333521|NCT00485459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110333522|NCT00485459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110333523|NCT04697511|Midazolam|midazolam|mesh-list
110333524|NCT04697511|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110333525|NCT04697511|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110333526|NCT04697511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110333527|NCT04697511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110333528|NCT04697511|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110333529|NCT04697511|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110333530|NCT04697511|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110333531|NCT04697511|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110333532|NCT04697511|Anesthetics, General|anesthetics, general|mesh-ancestor
110333533|NCT04697511|Anesthetics|anesthetics|mesh-ancestor
110333534|NCT04697511|GABA Modulators|gaba modulators|mesh-ancestor
110333535|NCT04697511|GABA Agents|gaba agents|mesh-ancestor
110333536|NCT04697511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110333537|NCT04697511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110333538|NCT00485511|Hydroxyurea|hydroxyurea|mesh-list
110333539|NCT00485511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110333540|NCT00485511|Antisickling Agents|antisickling agents|mesh-ancestor
110333541|NCT00485511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110333542|NCT00485511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110333543|NCT00485511|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110333545|NCT00485498|Risperidone|risperidone|mesh-list
110333546|NCT00485498|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110333547|NCT00485498|Serotonin Agents|serotonin agents|mesh-ancestor
110333548|NCT00485498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110333549|NCT00485498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110333550|NCT00485498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110333551|NCT00485498|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110333552|NCT00485498|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110333553|NCT00485498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110333554|NCT00485498|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110333555|NCT00485498|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110333556|NCT00485498|Dopamine Agents|dopamine agents|mesh-ancestor
110333557|NCT00485498|Antiemetics|antiemetics|mesh-ancestor
110333558|NCT00485498|Autonomic Agents|autonomic agents|mesh-ancestor
110333559|NCT00485498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110333560|NCT00485498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110333561|NCT00485498|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110333562|NCT00485498|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110333563|NCT00485498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110333564|NCT01302067|Fesoterodine|fesoterodine|mesh-list
110333565|NCT01302067|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110333566|NCT01302067|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110333567|NCT01302067|Cholinergic Agents|cholinergic agents|mesh-ancestor
110333568|NCT01302067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110333569|NCT01302067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110333570|NCT01302067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110333571|NCT01302067|Urological Agents|urological agents|mesh-ancestor
110333572|NCT00485550|Methylphenidate|methylphenidate|mesh-list
110333573|NCT00485550|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
110333574|NCT00485550|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110333575|NCT00485550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110333576|NCT00485550|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110333577|NCT00485550|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110333578|NCT00485550|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110333579|NCT00485550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110333580|NCT00485550|Dopamine Agents|dopamine agents|mesh-ancestor
110333581|NCT00485550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110333582|NCT00485550|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110333583|NCT00485550|Adrenergic Agents|adrenergic agents|mesh-ancestor
110333584|NCT00485628|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
110333585|NCT00485628|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110333586|NCT00485628|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110333587|NCT00485628|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110333588|NCT00485628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110333589|NCT00485628|Adrenergic Agents|adrenergic agents|mesh-ancestor
110333590|NCT00485628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110333591|NCT00485628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110333593|NCT00485576|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
110333594|NCT00485576|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110333595|NCT00485576|Immunologic Factors|immunologic factors|mesh-ancestor
110333596|NCT00485576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110333597|NCT00485667|Moxifloxacin|moxifloxacin|mesh-list
110333598|NCT00485667|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110333599|NCT00485667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110333601|NCT00485667|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110333602|NCT00485667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110333603|NCT00485667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110333604|NCT00485667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110333605|NCT00489905|Zoledronic Acid|zoledronic acid|mesh-list
110333606|NCT00489905|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110333607|NCT00489905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110333608|NCT00489944|Tamoxifen|tamoxifen|mesh-list
110333609|NCT00489944|Sunitinib|sunitinib|mesh-list
110333610|NCT00489944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110333611|NCT00489944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110333612|NCT00489944|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110333613|NCT00489944|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110333614|NCT00489944|Growth Substances|growth substances|mesh-ancestor
110333615|NCT00489944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110333616|NCT00489944|Growth Inhibitors|growth inhibitors|mesh-ancestor
110333617|NCT00489944|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110333618|NCT00489944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110333619|NCT00489944|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110333620|NCT00489944|Hormone Antagonists|hormone antagonists|mesh-ancestor
110333621|NCT00489944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110333622|NCT00489944|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110333623|NCT00489944|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110333624|NCT00489944|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110333625|NCT00489944|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110333626|NCT00485706|Dialysis Solutions|dialysis solutions|mesh-list
110333627|NCT00485706|Calcium|calcium|mesh-list
110333628|NCT00485706|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110333629|NCT00485706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110333630|NCT00485706|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110333631|NCT00505947|Infliximab|infliximab|mesh-list
110333632|NCT00505947|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110333633|NCT00505947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110333634|NCT00505947|Dermatologic Agents|dermatologic agents|mesh-ancestor
110333635|NCT00505947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110333636|NCT00505947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110333638|NCT00489983|Pemetrexed|pemetrexed|mesh-list
110333639|NCT00489983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110333640|NCT00489983|Antimetabolites|antimetabolites|mesh-ancestor
110333641|NCT00489983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110333642|NCT00489983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110333643|NCT00489983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110333644|NCT00489983|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110333645|NCT00489983|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110333646|NCT01241682|Cyclophosphamide|cyclophosphamide|mesh-list
110333647|NCT01241682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110333648|NCT01241682|Immunologic Factors|immunologic factors|mesh-ancestor
110333649|NCT01241682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110333650|NCT01241682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110333651|NCT01241682|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110333652|NCT01241682|Alkylating Agents|alkylating agents|mesh-ancestor
110333653|NCT01241682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110333654|NCT01241682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110333655|NCT01241682|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110333656|NCT00490178|Metformin|metformin|mesh-list
110333657|NCT00490178|Fenofibrate|fenofibrate|mesh-list
110333658|NCT00490178|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110333659|NCT00490178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110333660|NCT00490178|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110333661|NCT00490178|Antimetabolites|antimetabolites|mesh-ancestor
110333662|NCT00490178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110333663|NCT00490178|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110333664|NCT00485771|Lamotrigine|lamotrigine|mesh-list
110333665|NCT00485771|Olanzapine|olanzapine|mesh-list
110333666|NCT00485771|Fluoxetine|fluoxetine|mesh-list
110333667|NCT00485771|Antiemetics|antiemetics|mesh-ancestor
110333668|NCT00485771|Autonomic Agents|autonomic agents|mesh-ancestor
110333669|NCT00485771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110333670|NCT00485771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110333671|NCT00485771|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110333672|NCT00485771|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110333673|NCT00485771|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110333674|NCT00485771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110333675|NCT00485771|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110333676|NCT00485771|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110333677|NCT00485771|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110333678|NCT00485771|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110333679|NCT00485771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110333680|NCT00485771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110333681|NCT00485771|Serotonin Agents|serotonin agents|mesh-ancestor
110333682|NCT00485771|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110333683|NCT00485771|Antidepressive Agents|antidepressive agents|mesh-ancestor
110333684|NCT00485771|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110333685|NCT00485771|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110333686|NCT00485771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110333687|NCT00485771|Anticonvulsants|anticonvulsants|mesh-ancestor
110333688|NCT00485771|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110333689|NCT00485771|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110333690|NCT00485771|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110333691|NCT00485810|Olanzapine|olanzapine|mesh-list
110333692|NCT00485810|Antiemetics|antiemetics|mesh-ancestor
110333693|NCT00485810|Autonomic Agents|autonomic agents|mesh-ancestor
110333694|NCT00485810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110333695|NCT00485810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110333696|NCT00485810|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110333697|NCT00485810|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110333698|NCT00485810|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110333699|NCT00485810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110333700|NCT00485810|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110333701|NCT00485810|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110333702|NCT00485810|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110333703|NCT00485810|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110333704|NCT00485810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110333705|NCT00485810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110333706|NCT00485810|Serotonin Agents|serotonin agents|mesh-ancestor
110333707|NCT00490373|Pemetrexed|pemetrexed|mesh-list
110333708|NCT00490373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110333709|NCT00490373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110333710|NCT00490373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110333711|NCT00490373|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110333712|NCT00490373|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110333714|NCT00485823|Antiemetics|antiemetics|mesh-ancestor
110333715|NCT00485823|Autonomic Agents|autonomic agents|mesh-ancestor
110333716|NCT00485823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110333717|NCT00485823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110333718|NCT00485823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110333719|NCT00485823|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110333720|NCT00485823|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110333721|NCT00485823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110333722|NCT00485823|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110333723|NCT00485823|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110333724|NCT00485823|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110333725|NCT00485823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110333726|NCT00485823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110333727|NCT00485823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110333728|NCT00485823|Serotonin Agents|serotonin agents|mesh-ancestor
110333729|NCT00485849|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
110333730|NCT00485849|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110333731|NCT00485849|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110333732|NCT00485849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110333733|NCT00485849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110333734|NCT00485849|Adrenergic Agents|adrenergic agents|mesh-ancestor
110333735|NCT00485849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110333736|NCT00485849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110333737|NCT00485888|Escitalopram|escitalopram|mesh-list
110333738|NCT00485888|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110333739|NCT00485888|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110333740|NCT00485888|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110333741|NCT00485888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110333742|NCT00485888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110333743|NCT00485888|Serotonin Agents|serotonin agents|mesh-ancestor
110333744|NCT00485888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110333745|NCT00485862|Sertraline|sertraline|mesh-list
110333746|NCT00485862|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
110333747|NCT00485862|Antidepressive Agents|antidepressive agents|mesh-ancestor
110333748|NCT00485862|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110333749|NCT00485862|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110333750|NCT00485862|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110333751|NCT00485862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110333752|NCT00485862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110333753|NCT00485862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110333754|NCT00485862|Serotonin Agents|serotonin agents|mesh-ancestor
110154268|NCT00010075|Calcium|calcium|mesh-list
110333755|NCT00485862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110333756|NCT00485862|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110333757|NCT00485862|Adrenergic Agents|adrenergic agents|mesh-ancestor
110333758|NCT00485901|Haloperidol|haloperidol|mesh-list
110333759|NCT00485901|Olanzapine|olanzapine|mesh-list
110333760|NCT00485901|Haloperidol decanoate|haloperidol decanoate|mesh-list
110333761|NCT00485901|Antiemetics|antiemetics|mesh-ancestor
110333762|NCT00485901|Autonomic Agents|autonomic agents|mesh-ancestor
110333763|NCT00485901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110333764|NCT00485901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110333765|NCT00485901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110333766|NCT00485901|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110333767|NCT00485901|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110333768|NCT00485901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110333769|NCT00485901|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110333770|NCT00485901|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110333771|NCT00485901|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110333772|NCT00485901|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110333773|NCT00485901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110333774|NCT00485901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110333775|NCT00485901|Serotonin Agents|serotonin agents|mesh-ancestor
110333776|NCT00485901|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110333777|NCT00485901|Dopamine Agents|dopamine agents|mesh-ancestor
110333778|NCT00485901|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110333779|NCT00490412|Vitamin D|vitamin d|mesh-list
110333780|NCT00490412|Vitamins|vitamins|mesh-ancestor
110333781|NCT00490412|Micronutrients|micronutrients|mesh-ancestor
110333782|NCT00490412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110333783|NCT00490412|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110333784|NCT00485940|Prucalopride|prucalopride|mesh-list
110333785|NCT00485940|Laxatives|laxatives|mesh-ancestor
110333786|NCT00485940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110333788|NCT00485940|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110333790|NCT00485940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110333791|NCT00485940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110333792|NCT00485940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110333793|NCT00486005|Olanzapine|olanzapine|mesh-list
110333794|NCT00486005|Nizatidine|nizatidine|mesh-list
110333795|NCT00486005|Antiemetics|antiemetics|mesh-ancestor
110333796|NCT00486005|Autonomic Agents|autonomic agents|mesh-ancestor
110333797|NCT00486005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110333798|NCT00486005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110333799|NCT00486005|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110333800|NCT00486005|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110333801|NCT00486005|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110333802|NCT00486005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110333803|NCT00486005|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110333804|NCT00486005|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110333805|NCT00486005|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110333806|NCT00486005|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110333807|NCT00486005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110333808|NCT00486005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110333809|NCT00486005|Serotonin Agents|serotonin agents|mesh-ancestor
110333810|NCT00486005|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110333811|NCT00486005|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110154496|NCT00012103|Chelating Agents|chelating agents|mesh-ancestor
110333812|NCT00486005|Histamine Antagonists|histamine antagonists|mesh-ancestor
110333813|NCT00486005|Histamine Agents|histamine agents|mesh-ancestor
110333814|NCT00485979|Docetaxel|docetaxel|mesh-list
110333815|NCT00485979|Trastuzumab|trastuzumab|mesh-list
110333816|NCT00485979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110333817|NCT00485979|Tubulin Modulators|tubulin modulators|mesh-ancestor
110333818|NCT00485979|Antimitotic Agents|antimitotic agents|mesh-ancestor
110333819|NCT00485979|Mitosis Modulators|mitosis modulators|mesh-ancestor
110333820|NCT00485979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110333821|NCT00485979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110333822|NCT00486083|Methylphenidate|methylphenidate|mesh-list
110333823|NCT00486083|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
110333824|NCT00486083|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110333825|NCT00486083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110333826|NCT00486083|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110333827|NCT00486083|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110333829|NCT00486083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110333830|NCT00486083|Dopamine Agents|dopamine agents|mesh-ancestor
110333831|NCT00486083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110333832|NCT00486083|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110333833|NCT00486083|Adrenergic Agents|adrenergic agents|mesh-ancestor
110333834|NCT00490685|Sorafenib|sorafenib|mesh-list
110333835|NCT00490685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110333836|NCT00490685|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110333837|NCT00490685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110154560|NCT00005945|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110333838|NCT00490685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110333839|NCT00486122|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
110333840|NCT00486122|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110333841|NCT00486122|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110333842|NCT00486122|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110333843|NCT00486122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110333844|NCT00486122|Adrenergic Agents|adrenergic agents|mesh-ancestor
110333845|NCT00486122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110333846|NCT00486122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110333848|NCT04511715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110333849|NCT04511715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110333850|NCT04511715|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110333851|NCT04511715|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110333852|NCT04511715|Growth Substances|growth substances|mesh-ancestor
110333853|NCT04511715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110333854|NCT04511715|Growth Inhibitors|growth inhibitors|mesh-ancestor
110333855|NCT00486317|Calcitonin|calcitonin|mesh-list
110333856|NCT00486317|Salmon calcitonin|salmon calcitonin|mesh-list
110333857|NCT00486317|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
110333858|NCT00486317|Katacalcin|katacalcin|mesh-list
110333859|NCT00486317|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110333860|NCT00486317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110333861|NCT00486317|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110333862|NCT00486317|Vasodilator Agents|vasodilator agents|mesh-ancestor
110333863|NCT00490880|Gemcitabine|gemcitabine|mesh-list
110333864|NCT00490880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110333865|NCT00490880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110333866|NCT00490880|Antimetabolites|antimetabolites|mesh-ancestor
110333867|NCT00490880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110333868|NCT00486174|Methylene Blue|methylene blue|mesh-list
110333869|NCT00486174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110333870|NCT00486174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110333871|NCT00486356|Carboplatin|carboplatin|mesh-list
110333872|NCT00486356|Capecitabine|capecitabine|mesh-list
110333873|NCT00486356|Epirubicin|epirubicin|mesh-list
110333874|NCT00486356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110333875|NCT00486356|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110333876|NCT00486356|Antimetabolites|antimetabolites|mesh-ancestor
110333877|NCT00486356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110333878|NCT00486356|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110333879|NCT00486356|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110333880|NCT00486356|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110333881|NCT00486356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110333882|NCT00490958|Telmisartan|telmisartan|mesh-list
110333883|NCT00490958|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110333884|NCT00490958|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110333885|NCT00490958|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110333886|NCT00490958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110333888|NCT00486213|Vitamin B 6|vitamin b 6|mesh-list
110333889|NCT00486213|Vitamin B Complex|vitamin b complex|mesh-ancestor
110333890|NCT00486213|Vitamins|vitamins|mesh-ancestor
110333891|NCT00486213|Micronutrients|micronutrients|mesh-ancestor
110333892|NCT00486213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110333893|NCT00486369|Calcitonin|calcitonin|mesh-list
110333894|NCT00486369|Salmon calcitonin|salmon calcitonin|mesh-list
110333895|NCT00486369|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
110333897|NCT00486369|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110333898|NCT00486369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110333899|NCT00486369|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110333900|NCT00486369|Vasodilator Agents|vasodilator agents|mesh-ancestor
110333901|NCT00490997|Ketamine|ketamine|mesh-list
110333902|NCT00490997|Propofol|propofol|mesh-list
110333903|NCT00490997|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110333904|NCT00490997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110333905|NCT00490997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110333906|NCT00490997|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110333907|NCT00490997|Anesthetics, General|anesthetics, general|mesh-ancestor
110333908|NCT00490997|Anesthetics|anesthetics|mesh-ancestor
110333909|NCT00490997|Analgesics|analgesics|mesh-ancestor
110333910|NCT00490997|Sensory System Agents|sensory system agents|mesh-ancestor
110333911|NCT00490997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110333912|NCT00490997|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110333913|NCT00490997|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110333914|NCT00490997|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110333915|NCT00490997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110333916|NCT00490997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110333917|NCT04511637|Rivaroxaban|rivaroxaban|mesh-list
110333918|NCT04511637|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110333919|NCT04511637|Antithrombins|antithrombins|mesh-ancestor
110333920|NCT04511637|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110333921|NCT04511637|Protease Inhibitors|protease inhibitors|mesh-ancestor
110333922|NCT04511637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110333923|NCT04511637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110333924|NCT04511637|Anticoagulants|anticoagulants|mesh-ancestor
110333925|NCT00486486|Timolol|timolol|mesh-list
110333926|NCT00486486|Bimatoprost|bimatoprost|mesh-list
110333927|NCT00486486|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110333928|NCT00486486|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110333929|NCT00486486|Adrenergic Agents|adrenergic agents|mesh-ancestor
110333930|NCT00486486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110333931|NCT00486486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110333932|NCT00486486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110333933|NCT00486486|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110333934|NCT00486486|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110333935|NCT00491114|Gemcitabine|gemcitabine|mesh-list
110333936|NCT00491114|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110333937|NCT00491114|Antimetabolites|antimetabolites|mesh-ancestor
110333938|NCT00491114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110333939|NCT00491114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110333940|NCT00486564|Nifurtimox|nifurtimox|mesh-list
110333941|NCT00486564|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
110333942|NCT00486564|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110333943|NCT00486564|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110333944|NCT00486564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110333945|NCT00486668|Paclitaxel|paclitaxel|mesh-list
110333946|NCT00486668|Cyclophosphamide|cyclophosphamide|mesh-list
110333947|NCT00486668|Doxorubicin|doxorubicin|mesh-list
110333948|NCT00486668|Trastuzumab|trastuzumab|mesh-list
110333949|NCT00486668|Lapatinib|lapatinib|mesh-list
110333950|NCT00486668|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110333951|NCT00486668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110333952|NCT00486668|Tubulin Modulators|tubulin modulators|mesh-ancestor
110333953|NCT00486668|Antimitotic Agents|antimitotic agents|mesh-ancestor
110333955|NCT00486668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110333956|NCT00486668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110333957|NCT00486668|Immunologic Factors|immunologic factors|mesh-ancestor
110333958|NCT00486668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110333959|NCT00486668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110333960|NCT00486668|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110333961|NCT00486668|Alkylating Agents|alkylating agents|mesh-ancestor
110333962|NCT00486668|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110333963|NCT00486668|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110333964|NCT00486668|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110333965|NCT00486668|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110333966|NCT00486668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110333967|NCT00486668|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110333968|NCT00486668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110333969|NCT04510935|Anesthetics|anesthetics|mesh-list
110333970|NCT04510935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110333971|NCT04510935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110333972|NCT00491192|Diclofenac|diclofenac|mesh-list
110333973|NCT00491192|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110333974|NCT00491192|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110333975|NCT00491192|Analgesics|analgesics|mesh-ancestor
110333976|NCT00491192|Sensory System Agents|sensory system agents|mesh-ancestor
110333977|NCT00491192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110333978|NCT00491192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110333979|NCT00491192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110333980|NCT00491192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110333981|NCT00491192|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110333982|NCT00491192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110333983|NCT00491192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110333984|NCT00486798|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110333985|NCT00486798|Antidepressive Agents|antidepressive agents|mesh-ancestor
110333986|NCT00486798|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110333987|NCT00486798|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110333988|NCT00486798|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110333989|NCT00486798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110333990|NCT00486798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110333991|NCT01301833|Biguanides|biguanides|mesh-list
110333992|NCT01301833|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
110333993|NCT01301833|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110333994|NCT01301833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110333995|NCT01301833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110333996|NCT01301833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110333997|NCT00486785|Alfuzosin|alfuzosin|mesh-list
110333998|NCT00486785|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110333999|NCT00486785|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110334000|NCT00486785|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110334001|NCT00486785|Adrenergic Agents|adrenergic agents|mesh-ancestor
110334002|NCT00486785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110334003|NCT00486785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110334004|NCT00486785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110334005|NCT00486785|Urological Agents|urological agents|mesh-ancestor
110334007|NCT04324411|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110334008|NCT04324411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110334010|NCT04324411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110334011|NCT04324411|Antifungal Agents|antifungal agents|mesh-ancestor
110334012|NCT04324411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110334013|NCT04324411|Immunologic Factors|immunologic factors|mesh-ancestor
110334014|NCT04324411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110334015|NCT00486876|Tofisopam|tofisopam|mesh-list
110334016|NCT00486876|Antidepressive Agents|antidepressive agents|mesh-ancestor
110334017|NCT00486876|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110334018|NCT05643586|Ticagrelor|ticagrelor|mesh-list
110334019|NCT05643586|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
110334020|NCT05643586|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110334021|NCT05643586|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110334022|NCT05643586|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110334023|NCT05643586|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110334024|NCT05643586|Purinergic Agents|purinergic agents|mesh-ancestor
110334025|NCT05643586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110334026|NCT05643586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110334027|NCT05643586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110334028|NCT01242072|Isophosphamide mustard|isophosphamide mustard|mesh-list
110334030|NCT01242072|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110334031|NCT01242072|Alkylating Agents|alkylating agents|mesh-ancestor
110334032|NCT01242072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110334033|NCT01242072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110334034|NCT00491348|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110334035|NCT00491348|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110334036|NCT00491348|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110334037|NCT00491348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110334038|NCT00491348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110334039|NCT00491348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110155343|NCT00016744|Genistein|genistein|mesh-list
110334040|NCT00491348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110334041|NCT00491348|Analgesics|analgesics|mesh-ancestor
110334042|NCT00491348|Sensory System Agents|sensory system agents|mesh-ancestor
110334043|NCT00491348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110334044|NCT00491348|Antidepressive Agents|antidepressive agents|mesh-ancestor
110334045|NCT00491348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110334046|NCT00491348|Dopamine Agents|dopamine agents|mesh-ancestor
110334047|NCT01242098|Fluticasone|fluticasone|mesh-list
110334048|NCT01242098|Beclomethasone|beclomethasone|mesh-list
110334049|NCT01242098|Formoterol Fumarate|formoterol fumarate|mesh-list
110334050|NCT01242098|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110334051|NCT01242098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110334052|NCT01242098|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110334053|NCT01242098|Autonomic Agents|autonomic agents|mesh-ancestor
110334054|NCT01242098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110334055|NCT01242098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110334056|NCT01242098|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110334057|NCT01242098|Respiratory System Agents|respiratory system agents|mesh-ancestor
110334058|NCT01242098|Dermatologic Agents|dermatologic agents|mesh-ancestor
110334059|NCT01242098|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110334060|NCT01242098|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110334061|NCT01242098|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110334062|NCT01242098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110334063|NCT01242098|Adrenergic Agents|adrenergic agents|mesh-ancestor
110334064|NCT01242098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110334065|NCT01242098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110334066|NCT01242098|Glucocorticoids|glucocorticoids|mesh-ancestor
110334067|NCT01242098|Hormones|hormones|mesh-ancestor
110334068|NCT01242098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110334069|NCT01301092|Dulaglutide|dulaglutide|mesh-list
110334070|NCT01301092|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110334071|NCT01301092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110334072|NCT04510623|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
110334073|NCT04510623|Protease Inhibitors|protease inhibitors|mesh-ancestor
110334074|NCT04510623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110334075|NCT04510623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110334076|NCT04510818|Capecitabine|capecitabine|mesh-list
110334077|NCT04510818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110334078|NCT04510818|Antimetabolites|antimetabolites|mesh-ancestor
110334079|NCT04510818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110334080|NCT04510818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110334081|NCT05642845|Atorvastatin|atorvastatin|mesh-list
110334083|NCT05642845|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110334084|NCT05642845|Antimetabolites|antimetabolites|mesh-ancestor
110334085|NCT05642845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110334086|NCT05642845|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110155436|NCT00006029|Doxorubicin|doxorubicin|mesh-list
110334087|NCT05642845|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110334088|NCT05642845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110334089|NCT04510662|Telmisartan|telmisartan|mesh-list
110334090|NCT04510662|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110334091|NCT04510662|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110334092|NCT04510662|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110334093|NCT04510662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110334094|NCT05642689|Iron|iron|mesh-list
110334095|NCT05642689|Trace Elements|trace elements|mesh-ancestor
110334096|NCT05642689|Micronutrients|micronutrients|mesh-ancestor
110334097|NCT05642689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110334098|NCT01300819|Rotigotine|rotigotine|mesh-list
110334099|NCT01300819|Dopamine Agonists|dopamine agonists|mesh-ancestor
110334100|NCT01300819|Dopamine Agents|dopamine agents|mesh-ancestor
110334101|NCT01300819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110334102|NCT01300819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110334103|NCT01300819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110334104|NCT00486980|Peramivir|peramivir|mesh-list
110334105|NCT00486980|Antiviral Agents|antiviral agents|mesh-ancestor
110334106|NCT00486980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110334107|NCT00486980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110334108|NCT00486980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110334109|NCT01300741|Contact Lens Solutions|contact lens solutions|mesh-list
110334110|NCT01300741|Disinfectants|disinfectants|mesh-ancestor
110334111|NCT01300741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110334112|NCT02275962|Rifampin|rifampin|mesh-list
110334113|NCT02275962|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110334114|NCT02275962|Antitubercular Agents|antitubercular agents|mesh-ancestor
110334115|NCT02275962|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110334116|NCT02275962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110334117|NCT02275962|Leprostatic Agents|leprostatic agents|mesh-ancestor
110334118|NCT02275962|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110334119|NCT02275962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110334120|NCT02275962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110334121|NCT02275962|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110334122|NCT02275962|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110334123|NCT02275962|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110334124|NCT02275962|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110334125|NCT02275962|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110334126|NCT02275962|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110334127|NCT00487032|Fluticasone|fluticasone|mesh-list
110334128|NCT00487032|Xhance|xhance|mesh-list
110334129|NCT00487032|Prazosin|prazosin|mesh-list
110334130|NCT00487032|Phenylephrine|phenylephrine|mesh-list
110334131|NCT00487032|Oxymetazoline|oxymetazoline|mesh-list
110334132|NCT00487032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110334133|NCT00487032|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110334134|NCT00487032|Autonomic Agents|autonomic agents|mesh-ancestor
110334135|NCT00487032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110334136|NCT00487032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110334137|NCT00487032|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110334138|NCT00487032|Respiratory System Agents|respiratory system agents|mesh-ancestor
110334139|NCT00487032|Dermatologic Agents|dermatologic agents|mesh-ancestor
110334140|NCT00487032|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110334141|NCT00487032|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110334142|NCT00487032|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110334143|NCT00487032|Adrenergic Agents|adrenergic agents|mesh-ancestor
110334144|NCT00487032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110334145|NCT00487032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110334146|NCT00487032|Sympathomimetics|sympathomimetics|mesh-ancestor
110334147|NCT00487032|Nasal Decongestants|nasal decongestants|mesh-ancestor
110334148|NCT00487032|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110334149|NCT00487032|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110334150|NCT00487032|Mydriatics|mydriatics|mesh-ancestor
110334151|NCT00487032|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110334152|NCT00487032|Protective Agents|protective agents|mesh-ancestor
110334153|NCT00487032|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110334154|NCT00487032|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110334155|NCT00487032|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110334156|NCT00487032|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110334158|NCT00491426|Tazobactam|tazobactam|mesh-list
110334159|NCT00491426|Piperacillin|piperacillin|mesh-list
110334160|NCT00491426|Amphotericin B|amphotericin b|mesh-list
110334161|NCT00491426|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
110334162|NCT00491426|Acyclovir|acyclovir|mesh-list
110334163|NCT00491426|Ampicillin|ampicillin|mesh-list
110334164|NCT00491426|Caspofungin|caspofungin|mesh-list
110334165|NCT00491426|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
110334166|NCT00491426|Anidulafungin|anidulafungin|mesh-list
110334167|NCT00491426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110334168|NCT00491426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110334169|NCT00491426|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110334170|NCT00491426|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110334171|NCT00491426|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110334172|NCT00491426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110334173|NCT00491426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110334174|NCT00491426|Amebicides|amebicides|mesh-ancestor
110334175|NCT00491426|Antifungal Agents|antifungal agents|mesh-ancestor
110334176|NCT00491426|Antiviral Agents|antiviral agents|mesh-ancestor
110334177|NCT01300546|Naproxen|naproxen|mesh-list
110334179|NCT01300546|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110334180|NCT01300546|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110334181|NCT01300546|Analgesics|analgesics|mesh-ancestor
110334182|NCT01300546|Sensory System Agents|sensory system agents|mesh-ancestor
110334183|NCT01300546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110334184|NCT01300546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110334185|NCT01300546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110334186|NCT01300546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110334187|NCT01300546|Gout Suppressants|gout suppressants|mesh-ancestor
110334188|NCT01300546|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110334189|NCT01300546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110334190|NCT01300546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110334191|NCT01300546|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110334192|NCT01300546|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110334193|NCT01300546|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110334194|NCT01300546|Serotonin Agents|serotonin agents|mesh-ancestor
110334195|NCT01300546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110334196|NCT00487110|Acetaminophen|acetaminophen|mesh-list
110334197|NCT00487110|Tropisetron|tropisetron|mesh-list
110334198|NCT00487110|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110334199|NCT00487110|Analgesics|analgesics|mesh-ancestor
110334200|NCT00487110|Sensory System Agents|sensory system agents|mesh-ancestor
110334201|NCT00487110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110334202|NCT00487110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110334203|NCT00487110|Antipyretics|antipyretics|mesh-ancestor
110334204|NCT00487110|Antiemetics|antiemetics|mesh-ancestor
110334205|NCT00487110|Autonomic Agents|autonomic agents|mesh-ancestor
110334207|NCT00487110|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110334208|NCT00487110|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110334209|NCT00487110|Serotonin Agents|serotonin agents|mesh-ancestor
110334210|NCT00487110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110334211|NCT00487110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110334212|NCT00487136|Warfarin|warfarin|mesh-list
110334213|NCT00487136|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110334214|NCT00487136|Fenofibric acid|fenofibric acid|mesh-list
110334215|NCT00487136|Fenofibrate|fenofibrate|mesh-list
110334216|NCT00487136|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110334217|NCT00487136|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110334218|NCT00487136|Antimetabolites|antimetabolites|mesh-ancestor
110334219|NCT00487136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110334220|NCT00487136|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110334221|NCT00487136|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110334222|NCT00487136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110334223|NCT00487136|Anticoagulants|anticoagulants|mesh-ancestor
110334225|NCT02276001|Cyclosporins|cyclosporins|mesh-list
110334226|NCT02276001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110334227|NCT02276001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110334228|NCT02276001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110334229|NCT02276001|Immunologic Factors|immunologic factors|mesh-ancestor
110334230|NCT02276001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110334231|NCT02276001|Antifungal Agents|antifungal agents|mesh-ancestor
110334232|NCT02276001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110334233|NCT02276001|Dermatologic Agents|dermatologic agents|mesh-ancestor
110334234|NCT02276001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110334235|NCT02276001|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110334236|NCT00491582|Hormones|hormones|mesh-list
110334237|NCT00491582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110334238|NCT00491582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110334239|NCT00487175|Tramadol|tramadol|mesh-list
110334240|NCT00487175|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110334241|NCT00487175|Narcotics|narcotics|mesh-ancestor
110334242|NCT00487175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110334243|NCT00487175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110334244|NCT00487175|Analgesics|analgesics|mesh-ancestor
110334245|NCT00487175|Sensory System Agents|sensory system agents|mesh-ancestor
110334246|NCT00487175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110334247|NCT00487227|Caffeine|caffeine|mesh-list
110334248|NCT00487227|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110334249|NCT00487227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110334250|NCT00487227|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110334251|NCT00487227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110334252|NCT00487227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110334253|NCT00487227|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110334254|NCT00487227|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110334255|NCT00487227|Purinergic Agents|purinergic agents|mesh-ancestor
110334256|NCT00487227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110334257|NCT01300351|Fulvestrant|fulvestrant|mesh-list
110334258|NCT01300351|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110334259|NCT01300351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110334260|NCT01300351|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110334261|NCT01300351|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110156144|NCT04971343|Antibodies|antibodies|mesh-list
110334262|NCT01300351|Hormone Antagonists|hormone antagonists|mesh-ancestor
110334263|NCT01300351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110334264|NCT01300351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110334265|NCT00487253|Miltefosine|miltefosine|mesh-list
110334266|NCT00487253|Meglumine Antimoniate|meglumine antimoniate|mesh-list
110334267|NCT00487253|Antifungal Agents|antifungal agents|mesh-ancestor
110334268|NCT00487253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110334269|NCT00487253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110334270|NCT00487253|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110334271|NCT00487253|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110334272|NCT04510233|Ivermectin|ivermectin|mesh-list
110334273|NCT04510233|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110334274|NCT04510233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110334275|NCT05641909|Fentanyl|fentanyl|mesh-list
110334276|NCT05641909|Remifentanil|remifentanil|mesh-list
110334277|NCT05641909|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110334278|NCT05641909|Narcotics|narcotics|mesh-ancestor
110334279|NCT05641909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110334280|NCT05641909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110334281|NCT05641909|Analgesics|analgesics|mesh-ancestor
110334282|NCT05641909|Sensory System Agents|sensory system agents|mesh-ancestor
110334283|NCT05641909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110334284|NCT05641909|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110334285|NCT05641909|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110334286|NCT05641909|Anesthetics, General|anesthetics, general|mesh-ancestor
110334288|NCT02276196|Insulin glulisine|insulin glulisine|mesh-list
110334289|NCT02276196|Lixisenatide|lixisenatide|mesh-list
110334290|NCT02276196|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110334291|NCT02276196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110334292|NCT00487422|Prucalopride|prucalopride|mesh-list
110334293|NCT00487422|Laxatives|laxatives|mesh-ancestor
110334294|NCT00487422|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110334295|NCT00487422|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
110334296|NCT00487422|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110334297|NCT00487422|Serotonin Agents|serotonin agents|mesh-ancestor
110334298|NCT00487422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110334299|NCT00487422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110334300|NCT00487422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110334301|NCT04697355|Beta Carotene|beta carotene|mesh-list
110334302|NCT04697355|Naringenin|naringenin|mesh-list
110334303|NCT04697355|Carotenoids|carotenoids|mesh-list
110334304|NCT04697355|Antioxidants|antioxidants|mesh-ancestor
110334305|NCT04697355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110334306|NCT04697355|Protective Agents|protective agents|mesh-ancestor
110334307|NCT04697355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110334308|NCT04697355|Provitamins|provitamins|mesh-ancestor
110334309|NCT04697355|Vitamins|vitamins|mesh-ancestor
110334310|NCT04697355|Micronutrients|micronutrients|mesh-ancestor
110334311|NCT04697355|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110156397|NCT03958123|Moxifloxacin|moxifloxacin|mesh-list
110334312|NCT04697355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110334313|NCT04697355|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110334314|NCT04697355|Hormone Antagonists|hormone antagonists|mesh-ancestor
110334315|NCT04697355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110334316|NCT00491816|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110334317|NCT00491816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110334318|NCT00491816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110334319|NCT00491816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110334320|NCT00491816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110334322|NCT00491855|Bevacizumab|bevacizumab|mesh-list
110334323|NCT00491855|Oxaliplatin|oxaliplatin|mesh-list
110156520|NCT03151993|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110334324|NCT00491855|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110334325|NCT00491855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110334326|NCT00491855|Tubulin Modulators|tubulin modulators|mesh-ancestor
110334327|NCT00491855|Antimitotic Agents|antimitotic agents|mesh-ancestor
110334328|NCT00491855|Mitosis Modulators|mitosis modulators|mesh-ancestor
110334329|NCT00491855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110334330|NCT00491855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110334331|NCT00491855|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110334332|NCT00491855|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110334333|NCT00491855|Growth Substances|growth substances|mesh-ancestor
110334334|NCT00491855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110334335|NCT00491855|Growth Inhibitors|growth inhibitors|mesh-ancestor
110334336|NCT04697277|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110334337|NCT04697277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110334339|NCT00487448|Fludarabine|fludarabine|mesh-list
110334340|NCT00487448|Idarubicin|idarubicin|mesh-list
110334341|NCT00487448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110334342|NCT00487448|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110334343|NCT00487448|Antimetabolites|antimetabolites|mesh-ancestor
110334344|NCT00487448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110334345|NCT00487448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110334346|NCT00487448|Immunologic Factors|immunologic factors|mesh-ancestor
110334347|NCT00487448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110334348|NCT00487448|Antiviral Agents|antiviral agents|mesh-ancestor
110334349|NCT00487448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110334351|NCT00487448|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110334352|NCT00487448|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110334353|NCT00487448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110334355|NCT00506259|Antioxidants|antioxidants|mesh-ancestor
110334356|NCT00506259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110334357|NCT00506259|Protective Agents|protective agents|mesh-ancestor
110334358|NCT00506259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110334359|NCT00506259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110334360|NCT00506298|Diflunisal|diflunisal|mesh-list
110334361|NCT00506298|Bezafibrate|bezafibrate|mesh-list
110334362|NCT00506298|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110334363|NCT00506298|Antimetabolites|antimetabolites|mesh-ancestor
110334364|NCT00506298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110334365|NCT00506298|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110334366|NCT00506298|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110334367|NCT00506298|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110334368|NCT00506298|Analgesics|analgesics|mesh-ancestor
110334369|NCT00506298|Sensory System Agents|sensory system agents|mesh-ancestor
110334370|NCT00506298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110334371|NCT00506298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110334372|NCT00506298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110334373|NCT00506298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110334374|NCT00506298|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110334375|NCT00506298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110334377|NCT01242215|Gliclazide|gliclazide|mesh-list
110334378|NCT01242215|Glyburide|glyburide|mesh-list
110334379|NCT01242215|Ipragliflozin|ipragliflozin|mesh-list
110334380|NCT01242215|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110334381|NCT01242215|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110334382|NCT01242215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110334383|NCT01242215|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110334384|NCT01242215|Immunologic Factors|immunologic factors|mesh-ancestor
110334385|NCT01242215|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110334386|NCT01242215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110156863|NCT01807000|Prucalopride|prucalopride|mesh-list
110334387|NCT01242228|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110334388|NCT01242228|Vildagliptin|vildagliptin|mesh-list
110334389|NCT01242228|Saxagliptin|saxagliptin|mesh-list
110334391|NCT01242228|Ipragliflozin|ipragliflozin|mesh-list
110334392|NCT01242228|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
110334393|NCT01242228|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110334394|NCT01242228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110334395|NCT01242228|Incretins|incretins|mesh-ancestor
110334396|NCT01242228|Hormones|hormones|mesh-ancestor
110334397|NCT01242228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110334398|NCT01242228|Protease Inhibitors|protease inhibitors|mesh-ancestor
110334399|NCT01242228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110334400|NCT01242228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110334401|NCT01242228|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110334402|NCT01242306|Acetylcholine|acetylcholine|mesh-list
110334403|NCT01242306|Vasodilator Agents|vasodilator agents|mesh-ancestor
110334404|NCT01242306|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110334405|NCT01242306|Cholinergic Agents|cholinergic agents|mesh-ancestor
110334406|NCT01242306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110334407|NCT01242306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110334408|NCT01242306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110334410|NCT00492128|Amlodipine|amlodipine|mesh-list
110334411|NCT00492128|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110334412|NCT00492128|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110334413|NCT00492128|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110334414|NCT00492128|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110334415|NCT00492128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110334416|NCT00492128|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110334417|NCT00492128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110334418|NCT00492128|Vasodilator Agents|vasodilator agents|mesh-ancestor
110334419|NCT00492128|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110334420|NCT00492128|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110334421|NCT00492128|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110334422|NCT00492128|Diuretics|diuretics|mesh-ancestor
110334423|NCT00492128|Natriuretic Agents|natriuretic agents|mesh-ancestor
110334424|NCT00492128|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110334426|NCT00487734|Testosterone|testosterone|mesh-list
110334427|NCT00487734|Testosterone undecanoate|testosterone undecanoate|mesh-list
110334428|NCT00487734|Testosterone enanthate|testosterone enanthate|mesh-list
110334429|NCT00487734|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
110334430|NCT00487734|Androgens|androgens|mesh-ancestor
110334431|NCT00487734|Hormones|hormones|mesh-ancestor
110334432|NCT00487734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110334433|NCT00487734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110334434|NCT00487734|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110334435|NCT00487734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110334436|NCT00487734|Anabolic Agents|anabolic agents|mesh-ancestor
110334437|NCT01300234|Tenofovir|tenofovir|mesh-list
110334438|NCT01300234|Adefovir|adefovir|mesh-list
110334439|NCT01300234|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
110334440|NCT01300234|Antiviral Agents|antiviral agents|mesh-ancestor
110334441|NCT01300234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110334442|NCT01300234|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110334443|NCT01300234|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110334444|NCT01300234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110334445|NCT01300234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110334446|NCT01300234|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110334447|NCT01300234|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110334448|NCT01242332|Pregabalin|pregabalin|mesh-list
110334449|NCT01242332|Analgesics|analgesics|mesh-ancestor
110334450|NCT01242332|Sensory System Agents|sensory system agents|mesh-ancestor
110334451|NCT01242332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110334452|NCT01242332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110334453|NCT01242332|Anticonvulsants|anticonvulsants|mesh-ancestor
110334454|NCT01242332|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110334455|NCT01242332|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110157153|NCT00389766|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
110334456|NCT01242332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110334457|NCT01242332|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110334458|NCT01242332|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110334459|NCT01242332|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110334460|NCT01242332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110334461|NCT01242332|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110334462|NCT00487773|Cholecalciferol|cholecalciferol|mesh-list
110334464|NCT00487773|Albuterol|albuterol|mesh-list
110334465|NCT00487773|Montelukast|montelukast|mesh-list
110334466|NCT00487773|Vitamins|vitamins|mesh-ancestor
110334467|NCT00487773|Micronutrients|micronutrients|mesh-ancestor
110334468|NCT00487773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110334469|NCT00487773|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110334470|NCT00487773|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110334471|NCT00487773|Autonomic Agents|autonomic agents|mesh-ancestor
110334472|NCT00487773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110334473|NCT00487773|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110334474|NCT00487773|Respiratory System Agents|respiratory system agents|mesh-ancestor
110334475|NCT00487773|Glucocorticoids|glucocorticoids|mesh-ancestor
110334476|NCT00487773|Hormones|hormones|mesh-ancestor
110334477|NCT00487773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110157282|NCT00847366|Tamoxifen|tamoxifen|mesh-list
110334478|NCT00487773|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110334479|NCT00487773|Hormone Antagonists|hormone antagonists|mesh-ancestor
110334480|NCT00487773|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110334481|NCT00487773|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110334482|NCT00487773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110334483|NCT00487773|Tocolytic Agents|tocolytic agents|mesh-ancestor
110334484|NCT00487773|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110334485|NCT00487773|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110334486|NCT00487773|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110334487|NCT00487773|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110157347|NCT00847093|Anesthetics|anesthetics|mesh-ancestor
110334488|NCT00487773|Adrenergic Agents|adrenergic agents|mesh-ancestor
110334489|NCT00487773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110334490|NCT00487773|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110334491|NCT00487773|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110334492|NCT01299961|Abatacept|abatacept|mesh-list
110334493|NCT01299961|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110334494|NCT01299961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110334495|NCT01299961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110157405|NCT00846703|Immunologic Factors|immunologic factors|mesh-ancestor
110334496|NCT01299961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110334497|NCT01299961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110334498|NCT01299961|Immunologic Factors|immunologic factors|mesh-ancestor
110334499|NCT01299961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110334500|NCT01299961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110334501|NCT00492245|Mitomycins|mitomycins|mesh-list
110334502|NCT00492245|Mitomycin|mitomycin|mesh-list
110334503|NCT00492245|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110334504|NCT00492245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110334505|NCT00492245|Alkylating Agents|alkylating agents|mesh-ancestor
110334506|NCT00492245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110334507|NCT00492245|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110334508|NCT00492245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110334509|NCT00487812|Dobutamine|dobutamine|mesh-list
110334510|NCT00487812|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110334511|NCT00487812|Sympathomimetics|sympathomimetics|mesh-ancestor
110334512|NCT00487812|Autonomic Agents|autonomic agents|mesh-ancestor
110334513|NCT00487812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110334514|NCT00487812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110334515|NCT00487812|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
110334516|NCT00487812|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110334517|NCT00487812|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110334518|NCT00487812|Adrenergic Agents|adrenergic agents|mesh-ancestor
110334519|NCT00487812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110334520|NCT00487812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110334521|NCT00487812|Protective Agents|protective agents|mesh-ancestor
110334523|NCT01299805|Antidepressive Agents|antidepressive agents|mesh-ancestor
110334524|NCT01299805|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110334525|NCT01299805|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110334526|NCT01299805|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110334527|NCT01299805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110334528|NCT01299805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110334529|NCT01299805|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110334530|NCT01299805|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110334531|NCT01299805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110334532|NCT01299805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110334533|NCT01299805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110334534|NCT01299805|Serotonin Agents|serotonin agents|mesh-ancestor
110334535|NCT01299805|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110334536|NCT01299805|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110334537|NCT01299805|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110334538|NCT01299805|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110334539|NCT00487682|Valacyclovir|valacyclovir|mesh-list
110334540|NCT00487682|Antiviral Agents|antiviral agents|mesh-ancestor
110334541|NCT00487682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110334542|NCT04512261|Pembrolizumab|pembrolizumab|mesh-list
110334543|NCT04512261|Trastuzumab|trastuzumab|mesh-list
110334544|NCT04512261|Tucatinib|tucatinib|mesh-list
110334545|NCT04512261|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110334546|NCT04512261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110334547|NCT04512261|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110334548|NCT04512261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110334549|NCT04512261|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110334550|NCT04512261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110334551|NCT00487799|Ularitide|ularitide|mesh-list
110334552|NCT00487799|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110334553|NCT00487799|Autonomic Agents|autonomic agents|mesh-ancestor
110334554|NCT00487799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110334555|NCT00487799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110334556|NCT00487799|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110334557|NCT00487799|Respiratory System Agents|respiratory system agents|mesh-ancestor
110334558|NCT00487799|Diuretics|diuretics|mesh-ancestor
110334559|NCT00487799|Natriuretic Agents|natriuretic agents|mesh-ancestor
110334560|NCT05149170|Antibodies|antibodies|mesh-list
110334561|NCT05149170|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110334562|NCT05149170|Immunologic Factors|immunologic factors|mesh-ancestor
110157659|NCT00276523|Interferons|interferons|mesh-list
110334563|NCT05149170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110334564|NCT05149092|Caseins|caseins|mesh-list
110334565|NCT05149092|Chelating Agents|chelating agents|mesh-ancestor
110334566|NCT05149092|Sequestering Agents|sequestering agents|mesh-ancestor
110334567|NCT05149092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110334568|NCT04518501|Arsenic Trioxide|arsenic trioxide|mesh-list
110334569|NCT04518501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110334570|NCT00495287|Cytarabine|cytarabine|mesh-list
110334571|NCT00495287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110334572|NCT00495287|Antimetabolites|antimetabolites|mesh-ancestor
110334573|NCT00495287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110334574|NCT00495287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110334575|NCT00495287|Antiviral Agents|antiviral agents|mesh-ancestor
110157717|NCT00276172|Natalizumab|natalizumab|mesh-list
110334576|NCT00495287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110334577|NCT00495287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110334578|NCT00495287|Immunologic Factors|immunologic factors|mesh-ancestor
110334579|NCT00495287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110334581|NCT04696185|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110334582|NCT04696185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110334583|NCT04696185|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110334584|NCT04696185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110334586|NCT00495326|Nevirapine|nevirapine|mesh-list
110334587|NCT00495326|Rifampin|rifampin|mesh-list
110334588|NCT00495326|Isoniazid|isoniazid|mesh-list
110334589|NCT00495326|Ethambutol|ethambutol|mesh-list
110334590|NCT00495326|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110334591|NCT00495326|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110334592|NCT00495326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110334593|NCT00495326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110334594|NCT00495326|Antiviral Agents|antiviral agents|mesh-ancestor
110334595|NCT00495326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110334596|NCT00495326|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110334597|NCT00495326|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110334598|NCT00495326|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110334600|NCT00495326|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110334601|NCT00495326|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110334602|NCT00495326|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110334603|NCT00495326|Antitubercular Agents|antitubercular agents|mesh-ancestor
110334604|NCT00495326|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110334605|NCT00495326|Leprostatic Agents|leprostatic agents|mesh-ancestor
110334606|NCT00495326|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110334607|NCT00495326|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110334608|NCT00495326|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110334609|NCT00495326|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
110334610|NCT00495326|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110334611|NCT00495326|Antimetabolites|antimetabolites|mesh-ancestor
110334612|NCT00495326|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110334613|NCT00495326|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110334614|NCT00495326|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110334615|NCT00492479|Kinetin|kinetin|mesh-list
110334616|NCT00492479|Plant Growth Regulators|plant growth regulators|mesh-ancestor
110334617|NCT00492479|Growth Substances|growth substances|mesh-ancestor
110334618|NCT00492479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110334619|NCT00495365|Epoetin Alfa|epoetin alfa|mesh-list
110334620|NCT00495365|Hematinics|hematinics|mesh-ancestor
110334621|NCT00492518|Acetylcysteine|acetylcysteine|mesh-list
110334622|NCT00492518|Theophylline|theophylline|mesh-list
110334623|NCT00492518|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110334624|NCT00492518|Antiviral Agents|antiviral agents|mesh-ancestor
110334625|NCT00492518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110334626|NCT00492518|Expectorants|expectorants|mesh-ancestor
110334627|NCT00492518|Respiratory System Agents|respiratory system agents|mesh-ancestor
110334628|NCT00492518|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110334629|NCT00492518|Antioxidants|antioxidants|mesh-ancestor
110334630|NCT00492518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110334631|NCT00492518|Protective Agents|protective agents|mesh-ancestor
110334632|NCT00492518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110334633|NCT00492518|Antidotes|antidotes|mesh-ancestor
110334634|NCT00492518|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110334635|NCT00492518|Autonomic Agents|autonomic agents|mesh-ancestor
110334636|NCT00492518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110334637|NCT00492518|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110334638|NCT00492518|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110334639|NCT00492518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110334640|NCT00492518|Vasodilator Agents|vasodilator agents|mesh-ancestor
110334641|NCT00492518|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110334642|NCT00492518|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110334643|NCT00492518|Purinergic Agents|purinergic agents|mesh-ancestor
110334644|NCT00492518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110334646|NCT04513860|Anticonvulsants|anticonvulsants|mesh-ancestor
110334647|NCT00495560|Misoprostol|misoprostol|mesh-list
110334648|NCT00495560|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110334649|NCT00495560|Abortifacient Agents|abortifacient agents|mesh-ancestor
110334650|NCT00495560|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110334651|NCT00495560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110334652|NCT00495560|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110334654|NCT00495560|Oxytocics|oxytocics|mesh-ancestor
110334655|NCT00506844|Capecitabine|capecitabine|mesh-list
110334657|NCT00506844|Cetuximab|cetuximab|mesh-list
110334658|NCT00506844|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110334659|NCT00506844|Antimetabolites|antimetabolites|mesh-ancestor
110334660|NCT00506844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110334661|NCT00506844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110334662|NCT00506844|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110334663|NCT00506844|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110334664|NCT00506844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110334665|NCT00506844|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110334666|NCT00506961|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110334667|NCT00506961|Simvastatin|simvastatin|mesh-list
110334668|NCT00506961|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110334669|NCT00506961|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110334670|NCT00506961|Antimetabolites|antimetabolites|mesh-ancestor
110334671|NCT00506961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110334672|NCT00506961|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110334673|NCT00506961|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110334674|NCT00506961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110334675|NCT00492635|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
110334676|NCT00492635|Vasodilator Agents|vasodilator agents|mesh-ancestor
110334677|NCT00492635|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110334678|NCT00492635|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110334680|NCT00492635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110334681|NCT00492635|Urological Agents|urological agents|mesh-ancestor
110334682|NCT00507000|Vitamin D|vitamin d|mesh-list
110334683|NCT00507000|Cholecalciferol|cholecalciferol|mesh-list
110334684|NCT00507000|Vitamins|vitamins|mesh-ancestor
110334685|NCT00507000|Micronutrients|micronutrients|mesh-ancestor
110334686|NCT00507000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110334687|NCT00507000|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110334688|NCT00507000|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110334689|NCT00495872|Lenalidomide|lenalidomide|mesh-list
110334691|NCT00495872|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110334692|NCT00495872|Sorafenib|sorafenib|mesh-list
110334693|NCT00495872|Dasatinib|dasatinib|mesh-list
110334694|NCT00495872|Lapatinib|lapatinib|mesh-list
110334695|NCT00495872|Valproic Acid|valproic acid|mesh-list
110334696|NCT00495872|Immunologic Factors|immunologic factors|mesh-ancestor
110334697|NCT00495872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110334698|NCT00495872|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110334699|NCT00495872|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110334700|NCT00495872|Growth Substances|growth substances|mesh-ancestor
110334701|NCT00495872|Growth Inhibitors|growth inhibitors|mesh-ancestor
110334702|NCT00495872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110334703|NCT00495872|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110334704|NCT00495872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110334705|NCT00495872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110334706|NCT00495872|Anticonvulsants|anticonvulsants|mesh-ancestor
110334707|NCT00495872|GABA Agents|gaba agents|mesh-ancestor
110334708|NCT00495872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110334709|NCT00495872|Antimanic Agents|antimanic agents|mesh-ancestor
110334710|NCT00495872|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110334711|NCT00495872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110334712|NCT00495872|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110334713|NCT00507117|Eszopiclone|eszopiclone|mesh-list
110334714|NCT00507117|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110334715|NCT00507117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110334716|NCT00507117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110334717|NCT00492830|Antibodies|antibodies|mesh-list
110334718|NCT00492830|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110334719|NCT00492830|Immunologic Factors|immunologic factors|mesh-ancestor
110334720|NCT00492830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110334721|NCT01299571|Dutasteride|dutasteride|mesh-list
110334722|NCT01299571|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
110334723|NCT01299571|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110334724|NCT01299571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110334725|NCT01299571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110334726|NCT01299571|Hormone Antagonists|hormone antagonists|mesh-ancestor
110334727|NCT01299571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110334728|NCT01299571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110334729|NCT01243736|Metoclopramide|metoclopramide|mesh-list
110334730|NCT01243736|Simethicone|simethicone|mesh-list
110334731|NCT01243736|Antiemetics|antiemetics|mesh-ancestor
110334732|NCT01243736|Autonomic Agents|autonomic agents|mesh-ancestor
110334733|NCT01243736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110334734|NCT01243736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110334735|NCT01243736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110334736|NCT01243736|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110334737|NCT01243736|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110334738|NCT01243736|Dopamine Agents|dopamine agents|mesh-ancestor
110334739|NCT01243736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110334740|NCT01243736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110334741|NCT01243736|Antifoaming Agents|antifoaming agents|mesh-ancestor
110334742|NCT01243736|Emollients|emollients|mesh-ancestor
110334743|NCT01243736|Dermatologic Agents|dermatologic agents|mesh-ancestor
110334744|NCT00492986|Sorafenib|sorafenib|mesh-list
110334745|NCT00492986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110334746|NCT00492986|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110334747|NCT00492986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110334748|NCT00492986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110334749|NCT01243970|Phenylephrine|phenylephrine|mesh-list
110334750|NCT01243970|Oxymetazoline|oxymetazoline|mesh-list
110334751|NCT01243970|Ephedrine|ephedrine|mesh-list
110334752|NCT01243970|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110334753|NCT01243970|Mydriatics|mydriatics|mesh-ancestor
110334754|NCT01243970|Autonomic Agents|autonomic agents|mesh-ancestor
110334755|NCT01243970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110334756|NCT01243970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110334757|NCT01243970|Sympathomimetics|sympathomimetics|mesh-ancestor
110334758|NCT01243970|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110334759|NCT01243970|Nasal Decongestants|nasal decongestants|mesh-ancestor
110334760|NCT01243970|Respiratory System Agents|respiratory system agents|mesh-ancestor
110334761|NCT01243970|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110334762|NCT01243970|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110334763|NCT01243970|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110334764|NCT01243970|Adrenergic Agents|adrenergic agents|mesh-ancestor
110334765|NCT01243970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110334766|NCT01243970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110334767|NCT01243970|Protective Agents|protective agents|mesh-ancestor
110334768|NCT01243970|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110334769|NCT04515576|Dulaglutide|dulaglutide|mesh-list
110334770|NCT04515576|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110334771|NCT04515576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110334772|NCT01298362|Aromatase Inhibitors|aromatase inhibitors|mesh-list
110334773|NCT01298362|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110334774|NCT01298362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110334775|NCT01298362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110334777|NCT01298362|Hormone Antagonists|hormone antagonists|mesh-ancestor
110334778|NCT01298362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110334779|NCT01298362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110334781|NCT00493415|Vasodilator Agents|vasodilator agents|mesh-ancestor
110334782|NCT01244009|Niraparib|niraparib|mesh-list
110334783|NCT01244009|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110334784|NCT01244009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110334785|NCT01244009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110334786|NCT01244009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110334787|NCT04511832|Diclofenac|diclofenac|mesh-list
110334788|NCT04511832|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110334789|NCT04511832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110334791|NCT04511832|Sensory System Agents|sensory system agents|mesh-ancestor
110334792|NCT04511832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110334793|NCT04511832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110334794|NCT04511832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110334795|NCT04511832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110334796|NCT04511832|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110334797|NCT04511832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110334798|NCT04511832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110334800|NCT01244204|Vitamins|vitamins|mesh-ancestor
110334801|NCT01244204|Micronutrients|micronutrients|mesh-ancestor
110334802|NCT01244204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110334803|NCT01244204|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110334804|NCT00496028|Paclitaxel|paclitaxel|mesh-list
110334805|NCT00496028|Carboplatin|carboplatin|mesh-list
110334806|NCT00496028|Saracatinib|saracatinib|mesh-list
110334807|NCT00496028|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110334808|NCT00496028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110334809|NCT00496028|Tubulin Modulators|tubulin modulators|mesh-ancestor
110334810|NCT00496028|Antimitotic Agents|antimitotic agents|mesh-ancestor
110334811|NCT00496028|Mitosis Modulators|mitosis modulators|mesh-ancestor
110334812|NCT00496028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110334813|NCT00496028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110334814|NCT04516278|Bevacizumab|bevacizumab|mesh-list
110334815|NCT04516278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110334816|NCT04516278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110334817|NCT04516278|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110334818|NCT04516278|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110334819|NCT04516278|Growth Substances|growth substances|mesh-ancestor
110334820|NCT04516278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110334821|NCT04516278|Growth Inhibitors|growth inhibitors|mesh-ancestor
110334822|NCT00493532|Ibandronic Acid|ibandronic acid|mesh-list
110334823|NCT00493532|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110334824|NCT00493532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110334825|NCT01297465|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
110334826|NCT01297465|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
110334827|NCT01297465|Hormones|hormones|mesh-ancestor
110334828|NCT01297465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110334829|NCT01297465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110334830|NCT01297465|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110334831|NCT04518462|Bupivacaine|bupivacaine|mesh-list
110334832|NCT04518462|Anesthetics, Local|anesthetics, local|mesh-ancestor
110334833|NCT04518462|Anesthetics|anesthetics|mesh-ancestor
110334834|NCT04518462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110334835|NCT04518462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110334836|NCT04518462|Sensory System Agents|sensory system agents|mesh-ancestor
110158815|NCT00006122|Sensory System Agents|sensory system agents|mesh-ancestor
110334837|NCT04518462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110334838|NCT00496184|Nifedipine|nifedipine|mesh-list
110334839|NCT00496184|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110334840|NCT00496184|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110334841|NCT00496184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110334842|NCT00496184|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110334843|NCT00496184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110334844|NCT00496184|Vasodilator Agents|vasodilator agents|mesh-ancestor
110334845|NCT00496184|Tocolytic Agents|tocolytic agents|mesh-ancestor
110334847|NCT00493610|Acetylcysteine|acetylcysteine|mesh-list
110334848|NCT00493610|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110334849|NCT00493610|Antiviral Agents|antiviral agents|mesh-ancestor
110334850|NCT00493610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110334851|NCT00493610|Expectorants|expectorants|mesh-ancestor
110334852|NCT00493610|Respiratory System Agents|respiratory system agents|mesh-ancestor
110334853|NCT00493610|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110334854|NCT00493610|Antioxidants|antioxidants|mesh-ancestor
110334855|NCT00493610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110334856|NCT00493610|Protective Agents|protective agents|mesh-ancestor
110334857|NCT00493610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110334858|NCT00493610|Antidotes|antidotes|mesh-ancestor
110334859|NCT02274506|Cyclophosphamide|cyclophosphamide|mesh-list
110334860|NCT02274506|Fludarabine|fludarabine|mesh-list
110334861|NCT02274506|Fludarabine phosphate|fludarabine phosphate|mesh-list
110334862|NCT02274506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110334863|NCT02274506|Immunologic Factors|immunologic factors|mesh-ancestor
110334864|NCT02274506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110334865|NCT02274506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110334866|NCT02274506|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110334867|NCT02274506|Alkylating Agents|alkylating agents|mesh-ancestor
110334868|NCT02274506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110334869|NCT02274506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110334870|NCT02274506|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110334871|NCT02274506|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110334872|NCT02274506|Antimetabolites|antimetabolites|mesh-ancestor
110334873|NCT00496223|Sunitinib|sunitinib|mesh-list
110334874|NCT00496223|Dacarbazine|dacarbazine|mesh-list
110334875|NCT00496223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110334876|NCT00496223|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110159070|NCT00089167|Dexamethasone|dexamethasone|mesh-list
110334877|NCT00496223|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110334878|NCT00496223|Growth Substances|growth substances|mesh-ancestor
110334879|NCT00496223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110334880|NCT00496223|Growth Inhibitors|growth inhibitors|mesh-ancestor
110334881|NCT00496223|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110334882|NCT00496223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110334883|NCT00496223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110334884|NCT00496223|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110334885|NCT00496223|Alkylating Agents|alkylating agents|mesh-ancestor
110334886|NCT00496301|Gemcitabine|gemcitabine|mesh-list
110334887|NCT00496301|Capecitabine|capecitabine|mesh-list
110334888|NCT00496301|Sorafenib|sorafenib|mesh-list
110334889|NCT00496301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110334890|NCT00496301|Antimetabolites|antimetabolites|mesh-ancestor
110334891|NCT00496301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110334892|NCT00496301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110334893|NCT00496301|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110334894|NCT00496301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110334895|NCT05141838|Vitamin D|vitamin d|mesh-list
110334896|NCT05141838|Vitamins|vitamins|mesh-ancestor
110334897|NCT05141838|Micronutrients|micronutrients|mesh-ancestor
110334898|NCT05141838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110334899|NCT05141838|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110334900|NCT00493727|Acetylcysteine|acetylcysteine|mesh-list
110334901|NCT00493727|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110334902|NCT00493727|Antiviral Agents|antiviral agents|mesh-ancestor
110334903|NCT00493727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110334904|NCT00493727|Expectorants|expectorants|mesh-ancestor
110159188|NCT00390156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110334905|NCT00493727|Respiratory System Agents|respiratory system agents|mesh-ancestor
110334906|NCT00493727|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110334907|NCT00493727|Antioxidants|antioxidants|mesh-ancestor
110334908|NCT00493727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110334909|NCT00493727|Protective Agents|protective agents|mesh-ancestor
110172393|NCT00050830|Sensory System Agents|sensory system agents|mesh-ancestor
110334910|NCT00493727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110334912|NCT00493766|Panobinostat|panobinostat|mesh-list
110334913|NCT00493766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110159253|NCT00089830|Growth Substances|growth substances|mesh-ancestor
110334914|NCT00493766|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110334915|NCT00493766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110334916|NCT00493766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110334917|NCT05146479|Fluorides|fluorides|mesh-list
110334918|NCT05146479|Fluorides, Topical|fluorides, topical|mesh-list
110334919|NCT05146479|Cariostatic Agents|cariostatic agents|mesh-ancestor
110334920|NCT05146479|Protective Agents|protective agents|mesh-ancestor
110334921|NCT05146479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110334922|NCT05145621|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
110334923|NCT05145621|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
110334924|NCT05145621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110334925|NCT05145621|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110334926|NCT05145621|Immunologic Factors|immunologic factors|mesh-ancestor
110334927|NCT05145621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110334928|NCT01296568|Gemcitabine|gemcitabine|mesh-list
110334929|NCT01296568|Pemetrexed|pemetrexed|mesh-list
110334930|NCT01296568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110334931|NCT01296568|Antimetabolites|antimetabolites|mesh-ancestor
110334932|NCT01296568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110334933|NCT01296568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110334934|NCT01296568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110334935|NCT01296568|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110334936|NCT01296568|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110334937|NCT02598999|Lactoferrin|lactoferrin|mesh-list
110334938|NCT02598999|Hypothiocyanite ion|hypothiocyanite ion|mesh-list
110334940|NCT01296412|Metformin|metformin|mesh-list
110334941|NCT01296412|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110334942|NCT01296412|Liraglutide|liraglutide|mesh-list
110334943|NCT01296412|Glimepiride|glimepiride|mesh-list
110334944|NCT01296412|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110334945|NCT01296412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110334946|NCT01296412|Incretins|incretins|mesh-ancestor
110334947|NCT01296412|Hormones|hormones|mesh-ancestor
110334948|NCT01296412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110334949|NCT01296412|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110334950|NCT01296412|Protease Inhibitors|protease inhibitors|mesh-ancestor
110334951|NCT01296412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110334952|NCT01296412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110334953|NCT01296412|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110334954|NCT01296412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110334955|NCT01296412|Immunologic Factors|immunologic factors|mesh-ancestor
110334956|NCT00496652|Zalutumumab|zalutumumab|mesh-list
110334957|NCT00496652|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110334958|NCT00496652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110334959|NCT02597634|Ibuprofen|ibuprofen|mesh-list
110334960|NCT02597634|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110334961|NCT02597634|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110334962|NCT02597634|Analgesics|analgesics|mesh-ancestor
110334963|NCT02597634|Sensory System Agents|sensory system agents|mesh-ancestor
110334964|NCT02597634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110334965|NCT02597634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110334966|NCT02597634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110334968|NCT02597634|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110334969|NCT02597634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110334970|NCT02597634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110334971|NCT02591199|Lidocaine|lidocaine|mesh-list
110334972|NCT02591199|Heparin|heparin|mesh-list
110334973|NCT02591199|Anesthetics, Local|anesthetics, local|mesh-ancestor
110334974|NCT02591199|Anesthetics|anesthetics|mesh-ancestor
110334975|NCT02591199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110334976|NCT02591199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110334977|NCT02591199|Sensory System Agents|sensory system agents|mesh-ancestor
110334978|NCT02591199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110334979|NCT02591199|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110334980|NCT02591199|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110334981|NCT02591199|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110334982|NCT02591199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110334983|NCT02591199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110334984|NCT02591199|Anticoagulants|anticoagulants|mesh-ancestor
110334985|NCT02591199|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110334986|NCT02591199|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110334987|NCT00494078|Insulin Aspart|insulin aspart|mesh-list
110334988|NCT00494078|Insulin, Long-Acting|insulin, long-acting|mesh-list
110334989|NCT00494078|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
110334990|NCT00494078|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110334991|NCT00494078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110334992|NCT02596035|Nivolumab|nivolumab|mesh-list
110334993|NCT02596035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110334994|NCT02596035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110334995|NCT02596035|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110334996|NCT02596035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110334997|NCT00494156|Aspirin|aspirin|mesh-list
110334998|NCT00494156|Heparin|heparin|mesh-list
110334999|NCT00494156|Clopidogrel|clopidogrel|mesh-list
110335000|NCT00494156|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110335001|NCT00494156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110335003|NCT00494156|Sensory System Agents|sensory system agents|mesh-ancestor
110335004|NCT00494156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110335005|NCT00494156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110335006|NCT00494156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110335007|NCT00494156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110335008|NCT00494156|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110335009|NCT00494156|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110159820|NCT00094549|GABA Agents|gaba agents|mesh-ancestor
110335010|NCT00494156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110335011|NCT00494156|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110375280|NCT00474708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110335012|NCT00494156|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110335013|NCT00494156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110335014|NCT00494156|Antipyretics|antipyretics|mesh-ancestor
110335015|NCT00494156|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110335016|NCT00494156|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110335017|NCT00494156|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110335018|NCT00494156|Purinergic Agents|purinergic agents|mesh-ancestor
110335019|NCT00494156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110335020|NCT00494156|Anticoagulants|anticoagulants|mesh-ancestor
110335022|NCT02595489|Ergocalciferols|ergocalciferols|mesh-list
110335023|NCT02595489|Cholecalciferol|cholecalciferol|mesh-list
110335024|NCT02595489|Vitamins|vitamins|mesh-list
110335025|NCT02595489|Micronutrients|micronutrients|mesh-ancestor
110335026|NCT02595489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110335027|NCT02595489|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110159980|NCT00006269|Irinotecan|irinotecan|mesh-list
110335028|NCT02595489|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110335029|NCT00497003|Metoprolol|metoprolol|mesh-list
110335030|NCT00497003|Carvedilol|carvedilol|mesh-list
110335031|NCT00497003|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110335032|NCT00497003|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110335033|NCT00497003|Sympatholytics|sympatholytics|mesh-ancestor
110335034|NCT00497003|Autonomic Agents|autonomic agents|mesh-ancestor
110335035|NCT00497003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110335036|NCT00497003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110335037|NCT00497003|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110335039|NCT00497003|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110335040|NCT00497003|Adrenergic Agents|adrenergic agents|mesh-ancestor
110335041|NCT00497003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110335042|NCT00497003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110335043|NCT00497003|Antioxidants|antioxidants|mesh-ancestor
110335044|NCT00497003|Protective Agents|protective agents|mesh-ancestor
110172407|NCT00051142|Travoprost|travoprost|mesh-list
110335045|NCT00497003|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110335046|NCT00497003|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110335047|NCT00497003|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110335048|NCT00497003|Vasodilator Agents|vasodilator agents|mesh-ancestor
110335049|NCT00497003|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110335050|NCT00497003|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110335051|NCT00494312|Pioglitazone|pioglitazone|mesh-list
110335052|NCT00494312|Glyburide|glyburide|mesh-list
110335053|NCT00494312|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110335054|NCT00494312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110335055|NCT02595372|Omeprazole|omeprazole|mesh-list
110335056|NCT02595372|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110335057|NCT02595372|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110335058|NCT02595372|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110335059|NCT02595372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110335060|NCT02595372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110335061|NCT05142969|Chlorhexidine|chlorhexidine|mesh-list
110335062|NCT05142969|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110335063|NCT05142969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110335064|NCT05142969|Disinfectants|disinfectants|mesh-ancestor
110335065|NCT02596503|Cefixime|cefixime|mesh-list
110335066|NCT02596503|Irinotecan|irinotecan|mesh-list
110335067|NCT02596503|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110160206|NCT00096967|Bevacizumab|bevacizumab|mesh-list
110335068|NCT02596503|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110335069|NCT02596503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110335070|NCT02596503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110335071|NCT02596503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110335072|NCT02596503|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110335073|NCT02596503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110335074|NCT00494429|Morphine|morphine|mesh-list
110335075|NCT00494429|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110335076|NCT00494429|Narcotics|narcotics|mesh-ancestor
110335077|NCT00494429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110335078|NCT00494429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110335079|NCT00494429|Analgesics|analgesics|mesh-ancestor
110335080|NCT00494429|Sensory System Agents|sensory system agents|mesh-ancestor
110335081|NCT00494429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110335082|NCT00497120|Acetazolamide|acetazolamide|mesh-list
110335083|NCT00497120|Anticonvulsants|anticonvulsants|mesh-ancestor
110335084|NCT00497120|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110335085|NCT00497120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110335086|NCT00497120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110335087|NCT00497120|Diuretics|diuretics|mesh-ancestor
110335088|NCT00497120|Natriuretic Agents|natriuretic agents|mesh-ancestor
110335089|NCT00497120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110335091|NCT00494468|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110335092|NCT00494468|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110335093|NCT00494468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110335094|NCT00494468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110335095|NCT00494468|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
110335096|NCT00494468|GABA Agonists|gaba agonists|mesh-ancestor
110335097|NCT00494468|GABA Agents|gaba agents|mesh-ancestor
110335098|NCT00494468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110335099|NCT00494468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110335100|NCT00497237|Fluticasone|fluticasone|mesh-list
110335101|NCT00497237|Beclomethasone|beclomethasone|mesh-list
110335102|NCT00497237|Formoterol Fumarate|formoterol fumarate|mesh-list
110335103|NCT00497237|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110335104|NCT00497237|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110335105|NCT00497237|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110335106|NCT00497237|Autonomic Agents|autonomic agents|mesh-ancestor
110335107|NCT00497237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110335108|NCT00497237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110335109|NCT00497237|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110335110|NCT00497237|Respiratory System Agents|respiratory system agents|mesh-ancestor
110335111|NCT00497237|Dermatologic Agents|dermatologic agents|mesh-ancestor
110335112|NCT00497237|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110172412|NCT00051181|Travoprost|travoprost|mesh-list
110335113|NCT00497237|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110335114|NCT00497237|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110335115|NCT00497237|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110335116|NCT00497237|Adrenergic Agents|adrenergic agents|mesh-ancestor
110335117|NCT00497237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110335118|NCT00497237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110160451|NCT02888067|Bromides|bromides|mesh-list
110335119|NCT00497237|Glucocorticoids|glucocorticoids|mesh-ancestor
110335121|NCT00497237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110335122|NCT00497315|Pemetrexed|pemetrexed|mesh-list
110335123|NCT00497315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110335124|NCT00497315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110335125|NCT00497315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110335126|NCT00497315|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110335127|NCT00497315|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110335128|NCT05142072|Vitamin D|vitamin d|mesh-list
110335129|NCT05142072|Cholecalciferol|cholecalciferol|mesh-list
110335130|NCT05142072|Vitamins|vitamins|mesh-ancestor
110335131|NCT05142072|Micronutrients|micronutrients|mesh-ancestor
110335132|NCT05142072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110335133|NCT05142072|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110335134|NCT05142072|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110335135|NCT00497354|Anesthetics|anesthetics|mesh-list
110335136|NCT00497354|Anesthetics, Local|anesthetics, local|mesh-list
110160577|NCT00099970|Growth Inhibitors|growth inhibitors|mesh-ancestor
110335137|NCT00497354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110335138|NCT00497354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110335139|NCT00497354|Sensory System Agents|sensory system agents|mesh-ancestor
110335140|NCT00497354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110335141|NCT00494624|Prednisolone|prednisolone|mesh-list
110335142|NCT00494624|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110335143|NCT00494624|Glucocorticoids|glucocorticoids|mesh-ancestor
110335144|NCT00494624|Hormones|hormones|mesh-ancestor
110160640|NCT00006371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110160641|NCT00006371|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110160642|NCT00006371|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110335145|NCT00494624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110335146|NCT00494624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110335147|NCT00494624|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110335148|NCT00494624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110335149|NCT00494663|Ketoconazole|ketoconazole|mesh-list
110160709|NCT00424060|Sagopilone|sagopilone|mesh-list
110335150|NCT00494663|Antifungal Agents|antifungal agents|mesh-ancestor
110335151|NCT00494663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110335152|NCT00494663|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110335153|NCT00494663|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110335154|NCT00494663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110335155|NCT00494663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110335156|NCT00494663|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110335157|NCT00494663|Hormone Antagonists|hormone antagonists|mesh-ancestor
110335158|NCT00494663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110335159|NCT00494663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110335160|NCT00494663|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110335161|NCT05146674|Tadalafil|tadalafil|mesh-list
110335162|NCT05146674|Vasodilator Agents|vasodilator agents|mesh-ancestor
110335163|NCT05146674|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110335164|NCT05146674|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110335165|NCT05146674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110160837|NCT00006398|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110160838|NCT00006398|Adrenergic Agents|adrenergic agents|mesh-ancestor
110160839|NCT00006398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110335166|NCT05146674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110335167|NCT05146674|Urological Agents|urological agents|mesh-ancestor
110335169|NCT00507195|Propofol|propofol|mesh-list
110335170|NCT00507195|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
110335171|NCT00507195|Sevoflurane|sevoflurane|mesh-list
110335172|NCT00507195|Desflurane|desflurane|mesh-list
110335173|NCT00507195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110335174|NCT00507195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110335175|NCT00507195|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110335176|NCT00507195|Anesthetics, General|anesthetics, general|mesh-ancestor
110335177|NCT00507195|Anesthetics|anesthetics|mesh-ancestor
110188636|NCT00018668|Dopamine Agents|dopamine agents|mesh-ancestor
110335178|NCT00507195|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110335179|NCT00507195|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110335180|NCT00507195|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110335181|NCT00507195|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110335182|NCT00507195|GABA Modulators|gaba modulators|mesh-ancestor
110335183|NCT00507195|GABA Agents|gaba agents|mesh-ancestor
110335184|NCT00507195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110335185|NCT00507195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110335186|NCT00507195|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110335187|NCT00507195|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110335188|NCT00497471|Pyrimethamine|pyrimethamine|mesh-list
110335189|NCT00497471|Dapsone|dapsone|mesh-list
110335190|NCT00497471|Antimalarials|antimalarials|mesh-ancestor
110335191|NCT00497471|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110335192|NCT00497471|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110335193|NCT00497471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110335194|NCT00497471|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110160968|NCT00102583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110160974|NCT00102622|Paclitaxel|paclitaxel|mesh-list
110335195|NCT00497471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110335196|NCT00497471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110335197|NCT00497471|Leprostatic Agents|leprostatic agents|mesh-ancestor
110335198|NCT00497471|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110335199|NCT05146635|Epirubicin|epirubicin|mesh-list
110335200|NCT05146635|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110335201|NCT05146635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110335202|NCT05146635|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110335203|NCT05146635|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110335204|NCT05146635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110161027|NCT00101998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110335205|NCT05146635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110335206|NCT00494741|Mycophenolic Acid|mycophenolic acid|mesh-list
110335207|NCT00494741|Azathioprine|azathioprine|mesh-list
110335208|NCT00494741|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110335209|NCT00494741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110335210|NCT00494741|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110335211|NCT00494741|Antitubercular Agents|antitubercular agents|mesh-ancestor
110161092|NCT00103246|Silicon|silicon|mesh-list
110161093|NCT00103246|Silicon phthalocyanine|silicon phthalocyanine|mesh-list
110335212|NCT00494741|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110335213|NCT00494741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110335214|NCT00494741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110335215|NCT00494741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110335216|NCT00494741|Antimetabolites|antimetabolites|mesh-ancestor
110335217|NCT00494741|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110335218|NCT00494741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110335219|NCT00494741|Immunologic Factors|immunologic factors|mesh-ancestor
110335220|NCT00494741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110335221|NCT00494741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110161164|NCT00103948|Nootropic Agents|nootropic agents|mesh-ancestor
110335222|NCT00507234|Formoterol Fumarate|formoterol fumarate|mesh-list
110335223|NCT00507234|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110335224|NCT00507234|Autonomic Agents|autonomic agents|mesh-ancestor
110335225|NCT00507234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110335226|NCT00507234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110335227|NCT00507234|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110335228|NCT00507234|Respiratory System Agents|respiratory system agents|mesh-ancestor
110335229|NCT00507234|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110335230|NCT00507234|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110335231|NCT00507234|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110335232|NCT00507234|Adrenergic Agents|adrenergic agents|mesh-ancestor
110335233|NCT00507234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110172435|NCT05639777|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110161231|NCT00006461|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110161232|NCT00006461|Immunologic Factors|immunologic factors|mesh-ancestor
110161233|NCT00006461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110335234|NCT00507234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110335236|NCT05148546|Ipilimumab|ipilimumab|mesh-list
110335237|NCT05148546|Relatlimab|relatlimab|mesh-list
110335238|NCT05148546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110335239|NCT05148546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110335240|NCT05148546|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110335241|NCT05148546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110335242|NCT00506532|Pulmonary Surfactants|pulmonary surfactants|mesh-list
110335243|NCT00506532|Calfactant|calfactant|mesh-list
110335244|NCT00506532|Respiratory System Agents|respiratory system agents|mesh-ancestor
110335245|NCT05149560|Ticagrelor|ticagrelor|mesh-list
110335246|NCT05149560|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110161291|NCT00401167|Memantine|memantine|mesh-list
110335247|NCT05149560|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110335248|NCT05149560|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110335249|NCT05149560|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110335250|NCT05149560|Purinergic Agents|purinergic agents|mesh-ancestor
110335251|NCT05149560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110335252|NCT05149560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110335253|NCT05149560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110335254|NCT00494897|Cytarabine|cytarabine|mesh-list
110335255|NCT00494897|Prednisone|prednisone|mesh-list
110335256|NCT00494897|Cyclophosphamide|cyclophosphamide|mesh-list
110335257|NCT00494897|Methotrexate|methotrexate|mesh-list
110335258|NCT00494897|Vincristine|vincristine|mesh-list
110335259|NCT00494897|Daunorubicin|daunorubicin|mesh-list
110335260|NCT00494897|Asparaginase|asparaginase|mesh-list
110161355|NCT00105547|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110335261|NCT00494897|Mercaptopurine|mercaptopurine|mesh-list
110335262|NCT00494897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110335263|NCT00494897|Immunologic Factors|immunologic factors|mesh-ancestor
110335264|NCT00494897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110335265|NCT00494897|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110335266|NCT00494897|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110335267|NCT00494897|Alkylating Agents|alkylating agents|mesh-ancestor
110335268|NCT00494897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110161421|NCT00106054|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110335270|NCT00494897|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110335271|NCT00494897|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110335272|NCT00494897|Glucocorticoids|glucocorticoids|mesh-ancestor
110335273|NCT00494897|Hormones|hormones|mesh-ancestor
110335274|NCT00494897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110335275|NCT00494897|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110335276|NCT00494897|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110335277|NCT00494897|Abortifacient Agents|abortifacient agents|mesh-ancestor
110335278|NCT00494897|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110335279|NCT00494897|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110335280|NCT00494897|Antimetabolites|antimetabolites|mesh-ancestor
110335281|NCT00494897|Dermatologic Agents|dermatologic agents|mesh-ancestor
110335282|NCT00494897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110335283|NCT00494897|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110335284|NCT00494897|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110335285|NCT00494897|Antiviral Agents|antiviral agents|mesh-ancestor
110335286|NCT00494897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110335287|NCT00494897|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110335288|NCT00494897|Tubulin Modulators|tubulin modulators|mesh-ancestor
110335289|NCT00494897|Antimitotic Agents|antimitotic agents|mesh-ancestor
110161489|NCT00106522|Methotrexate|methotrexate|mesh-list
110161490|NCT00106522|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110161491|NCT00106522|Abortifacient Agents|abortifacient agents|mesh-ancestor
110335291|NCT00494897|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110335292|NCT00494897|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110335293|NCT00494897|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110335294|NCT00497744|Cefepime|cefepime|mesh-list
110335295|NCT00497744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110335296|NCT00497744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110335297|NCT00495092|Biperiden|biperiden|mesh-list
110335298|NCT00495092|Caffeine|caffeine|mesh-list
110335299|NCT00495092|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110335300|NCT00495092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110335301|NCT00495092|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110335302|NCT00495092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110335303|NCT00495092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110335304|NCT00495092|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110335306|NCT00495092|Purinergic Agents|purinergic agents|mesh-ancestor
110335307|NCT00495092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110335308|NCT00495092|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110335309|NCT00495092|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110335310|NCT00495092|Parasympatholytics|parasympatholytics|mesh-ancestor
110335311|NCT00495092|Autonomic Agents|autonomic agents|mesh-ancestor
110335312|NCT00495092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110335313|NCT00495092|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110161551|NCT00106834|Infliximab|infliximab|mesh-list
110335314|NCT00495092|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110335315|NCT00495092|Cholinergic Agents|cholinergic agents|mesh-ancestor
110335316|NCT01244360|Resveratrol|resveratrol|mesh-list
110335317|NCT01244360|Antioxidants|antioxidants|mesh-ancestor
110335318|NCT01244360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110335319|NCT01244360|Protective Agents|protective agents|mesh-ancestor
110335320|NCT01244360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110335321|NCT01244360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110335322|NCT01244360|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110335323|NCT00506571|Oxaliplatin|oxaliplatin|mesh-list
110335324|NCT00506571|Irinotecan|irinotecan|mesh-list
110335325|NCT00506571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110335326|NCT00506571|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110161664|NCT04712396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110161667|NCT04712396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110335327|NCT00506571|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110335328|NCT00506571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110335329|NCT00506571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110335330|NCT00497900|Vitamin D|vitamin d|mesh-list
110335331|NCT00497900|Vitamins|vitamins|mesh-ancestor
110335332|NCT00497900|Micronutrients|micronutrients|mesh-ancestor
110335333|NCT00497900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110335334|NCT00497900|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110335335|NCT05143125|Decitabine|decitabine|mesh-list
110335336|NCT05143125|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110335337|NCT05143125|Antimetabolites|antimetabolites|mesh-ancestor
110335338|NCT05143125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110335339|NCT05143125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110335340|NCT05143125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110161727|NCT00006695|Micronutrients|micronutrients|mesh-ancestor
110161728|NCT00108004|Pramlintide|pramlintide|mesh-list
110161729|NCT00108004|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110161730|NCT00108004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110161731|NCT00108238|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
110161732|NCT00108238|Estradiol|estradiol|mesh-list
110161733|NCT00108238|Progesterone|progesterone|mesh-list
110335341|NCT00497939|Saw palmetto extract|saw palmetto extract|mesh-list
110335342|NCT00497939|Urological Agents|urological agents|mesh-ancestor
110335343|NCT00498134|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
110335344|NCT00498134|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110335345|NCT00498134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110161779|NCT00401440|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110161780|NCT00401440|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110335346|NCT00498134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110335347|NCT00498134|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110335348|NCT00498134|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110335350|NCT00498134|Sensory System Agents|sensory system agents|mesh-ancestor
110161843|NCT00109057|Growth Substances|growth substances|mesh-ancestor
110335351|NCT00498134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110335352|NCT00498134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110335353|NCT00498134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110335354|NCT00498134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110335356|NCT00498251|Ipratropium|ipratropium|mesh-list
110335357|NCT00498251|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110335358|NCT00498251|Autonomic Agents|autonomic agents|mesh-ancestor
110335359|NCT00498251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110335360|NCT00498251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110335361|NCT00498251|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110335362|NCT00498251|Respiratory System Agents|respiratory system agents|mesh-ancestor
110335363|NCT00498251|Tocolytic Agents|tocolytic agents|mesh-ancestor
110335364|NCT00498251|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110335365|NCT00498251|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110335366|NCT00498251|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110335367|NCT00498251|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110161994|NCT00007202|Stavudine|stavudine|mesh-list
110335369|NCT00498251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110335370|NCT00498251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110335371|NCT00498251|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110335372|NCT00498251|Cholinergic Agents|cholinergic agents|mesh-ancestor
110335373|NCT00502658|Vitamins|vitamins|mesh-list
110335374|NCT00502658|Micronutrients|micronutrients|mesh-ancestor
110335375|NCT00502658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110335376|NCT00502736|Ibandronic Acid|ibandronic acid|mesh-list
110162048|NCT00110734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110335377|NCT00502736|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110335378|NCT00502736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110335379|NCT05146245|Risperidone|risperidone|mesh-list
110335380|NCT05146245|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110335381|NCT05146245|Serotonin Agents|serotonin agents|mesh-ancestor
110335382|NCT05146245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110335383|NCT05146245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110335384|NCT05146245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110335385|NCT05146245|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110162112|NCT00111124|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110162113|NCT00111124|Immunologic Factors|immunologic factors|mesh-ancestor
110162114|NCT00111163|Artesunate|artesunate|mesh-list
110335386|NCT05146245|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110335387|NCT05146245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110335388|NCT05146245|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110335389|NCT05146245|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110335390|NCT05146245|Dopamine Agents|dopamine agents|mesh-ancestor
110335391|NCT05146089|Bosentan|bosentan|mesh-list
110335392|NCT05146089|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110335393|NCT05146089|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
110335394|NCT05146089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110335395|NCT02954913|Liver Extracts|liver extracts|mesh-list
110335396|NCT02954913|Hematinics|hematinics|mesh-ancestor
110335397|NCT00502892|Carboplatin|carboplatin|mesh-list
110335398|NCT00502892|Topotecan|topotecan|mesh-list
110335399|NCT00502892|Ifosfamide|ifosfamide|mesh-list
110335400|NCT00502892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110162179|NCT00111748|Antiemetics|antiemetics|mesh-ancestor
110162180|NCT00111748|Autonomic Agents|autonomic agents|mesh-ancestor
110162183|NCT00111748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110335401|NCT00502892|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110335402|NCT00502892|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110335403|NCT00502892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110335404|NCT00502892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110335405|NCT00502892|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110335406|NCT00502892|Alkylating Agents|alkylating agents|mesh-ancestor
110335407|NCT00502970|Interferons|interferons|mesh-list
110335408|NCT00502970|Ribavirin|ribavirin|mesh-list
110335409|NCT00502970|Iron-Dextran Complex|iron-dextran complex|mesh-list
110335410|NCT00502970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110335411|NCT00502970|Antiviral Agents|antiviral agents|mesh-ancestor
110335412|NCT00502970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110335413|NCT00502970|Antimetabolites|antimetabolites|mesh-ancestor
110335414|NCT00502970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110335415|NCT00502970|Hematinics|hematinics|mesh-ancestor
110335416|NCT00498680|Sildenafil Citrate|sildenafil citrate|mesh-list
110335417|NCT00498680|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
110335418|NCT00498680|Vasodilator Agents|vasodilator agents|mesh-ancestor
110335419|NCT00498680|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110335420|NCT00498680|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110335421|NCT00498680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110335422|NCT00498680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110335423|NCT00498680|Urological Agents|urological agents|mesh-ancestor
110335424|NCT00498953|Carboplatin|carboplatin|mesh-list
110335425|NCT00498953|Docetaxel|docetaxel|mesh-list
110335426|NCT00498953|Fluorouracil|fluorouracil|mesh-list
110335427|NCT00498953|Lapatinib|lapatinib|mesh-list
110162242|NCT00401674|Tubulin Modulators|tubulin modulators|mesh-ancestor
110162243|NCT00401674|Antimitotic Agents|antimitotic agents|mesh-ancestor
110162246|NCT00112021|Pramlintide|pramlintide|mesh-list
110335429|NCT00498953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110335430|NCT00498953|Tubulin Modulators|tubulin modulators|mesh-ancestor
110335431|NCT00498953|Antimitotic Agents|antimitotic agents|mesh-ancestor
110335432|NCT00498953|Mitosis Modulators|mitosis modulators|mesh-ancestor
110335433|NCT00498953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110335434|NCT00498953|Antimetabolites|antimetabolites|mesh-ancestor
110335435|NCT00498953|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110335436|NCT00498953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110335438|NCT00498953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110335439|NCT00498953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110335440|NCT00498953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110335441|NCT00498953|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110162288|NCT00007436|Antiviral Agents|antiviral agents|mesh-ancestor
110162289|NCT00007436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110162290|NCT00007436|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110162292|NCT00007436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110335443|NCT00503126|Antithrombins|antithrombins|mesh-ancestor
110335444|NCT00503126|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110335445|NCT00503126|Protease Inhibitors|protease inhibitors|mesh-ancestor
110335446|NCT00503126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110335447|NCT00503126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110335448|NCT00503126|Anticoagulants|anticoagulants|mesh-ancestor
110335449|NCT05145543|Dexamethasone|dexamethasone|mesh-list
110335450|NCT05145543|Fentanyl|fentanyl|mesh-list
110335451|NCT05145543|Levobupivacaine|levobupivacaine|mesh-list
110335452|NCT05145543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110335454|NCT05145543|Autonomic Agents|autonomic agents|mesh-ancestor
110162348|NCT00112567|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110162349|NCT00112645|Cyclosporine|cyclosporine|mesh-list
110335455|NCT05145543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110335456|NCT05145543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110335457|NCT05145543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110335458|NCT05145543|Glucocorticoids|glucocorticoids|mesh-ancestor
110335459|NCT05145543|Hormones|hormones|mesh-ancestor
110335460|NCT05145543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110335461|NCT05145543|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110335462|NCT05145543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110335463|NCT05145543|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110335464|NCT05145543|Narcotics|narcotics|mesh-ancestor
110335465|NCT05145543|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110335466|NCT05145543|Analgesics|analgesics|mesh-ancestor
110335467|NCT05145543|Sensory System Agents|sensory system agents|mesh-ancestor
110162414|NCT00007670|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110162415|NCT00007670|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110162416|NCT00007670|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110335468|NCT05145543|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110335469|NCT05145543|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110335470|NCT05145543|Anesthetics, General|anesthetics, general|mesh-ancestor
110335471|NCT05145543|Anesthetics|anesthetics|mesh-ancestor
110335472|NCT05145543|Anesthetics, Local|anesthetics, local|mesh-ancestor
110335473|NCT00503204|Cediranib|cediranib|mesh-list
110335474|NCT00503204|Lomustine|lomustine|mesh-list
110335475|NCT00503204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110335476|NCT00503204|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110335477|NCT00503204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110335478|NCT00503204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110335479|NCT00503204|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110335480|NCT00503204|Alkylating Agents|alkylating agents|mesh-ancestor
110335481|NCT00503243|Mesalamine|mesalamine|mesh-list
110335482|NCT00503243|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110335483|NCT00503243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110335484|NCT00503243|Analgesics|analgesics|mesh-ancestor
110335485|NCT00503243|Sensory System Agents|sensory system agents|mesh-ancestor
110162474|NCT00113113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110162475|NCT00113113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110335486|NCT00503243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110335487|NCT00503243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110335488|NCT00503243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110335489|NCT00503243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110335490|NCT00498992|Vitamin E|vitamin e|mesh-list
110335491|NCT00498992|Lidocaine|lidocaine|mesh-list
110335492|NCT00498992|Vitamins|vitamins|mesh-ancestor
110335493|NCT00498992|Micronutrients|micronutrients|mesh-ancestor
110335494|NCT00498992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110335495|NCT00498992|Anesthetics, Local|anesthetics, local|mesh-ancestor
110335496|NCT00498992|Anesthetics|anesthetics|mesh-ancestor
110335497|NCT00498992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110335498|NCT00498992|Sensory System Agents|sensory system agents|mesh-ancestor
110335499|NCT00498992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110335500|NCT00498992|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110162533|NCT00007826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110162534|NCT00007826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110162537|NCT00007865|Etoposide|etoposide|mesh-list
110335501|NCT00498992|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110335502|NCT00498992|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110335503|NCT00498992|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110335504|NCT00498992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110335505|NCT00498992|Antioxidants|antioxidants|mesh-ancestor
110335506|NCT00498992|Protective Agents|protective agents|mesh-ancestor
110335507|NCT02276391|Telmisartan|telmisartan|mesh-list
110162596|NCT00007904|Immunologic Factors|immunologic factors|mesh-ancestor
110162597|NCT00007904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110162598|NCT00007904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110335508|NCT02276391|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110335509|NCT02276391|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110335510|NCT02276391|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110335511|NCT02276391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110335512|NCT05145270|Sulforaphane|sulforaphane|mesh-list
110335514|NCT05145270|Citalopram|citalopram|mesh-list
110335515|NCT05145270|Escitalopram|escitalopram|mesh-list
110162661|NCT00114283|Lapatinib|lapatinib|mesh-list
110335516|NCT05145270|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110335517|NCT05145270|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110335518|NCT05145270|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110335519|NCT05145270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110335520|NCT05145270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110335521|NCT05145270|Serotonin Agents|serotonin agents|mesh-ancestor
110335522|NCT05145270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110335523|NCT05145270|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110335524|NCT05145270|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110335525|NCT05145270|Parasympatholytics|parasympatholytics|mesh-ancestor
110162733|NCT00008021|Dermatologic Agents|dermatologic agents|mesh-ancestor
110162734|NCT00008021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110335526|NCT05145270|Autonomic Agents|autonomic agents|mesh-ancestor
110335527|NCT05145270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110335528|NCT05145270|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110335529|NCT05145270|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110335530|NCT05145270|Cholinergic Agents|cholinergic agents|mesh-ancestor
110335531|NCT05145270|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110335532|NCT05145270|Antidepressive Agents|antidepressive agents|mesh-ancestor
110162804|NCT00008177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110335533|NCT05145270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110335534|NCT05145270|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110335535|NCT05145270|Protective Agents|protective agents|mesh-ancestor
110335536|NCT05145270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110335537|NCT00503321|polysaccharide-K|polysaccharide-k|mesh-list
110335538|NCT00503321|Tegafur|tegafur|mesh-list
110335539|NCT00503321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110335540|NCT00503321|Antimetabolites|antimetabolites|mesh-ancestor
110335541|NCT00503321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110335542|NCT00503321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110162874|NCT00115414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110162875|NCT00115414|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110335543|NCT00503321|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110335544|NCT00503321|Immunologic Factors|immunologic factors|mesh-ancestor
110335545|NCT00503321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110375288|NCT00474240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110335546|NCT00503321|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110335547|NCT00503321|Antiviral Agents|antiviral agents|mesh-ancestor
110335548|NCT00503321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110335549|NCT00503321|Interferon Inducers|interferon inducers|mesh-ancestor
110335550|NCT00503321|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110335551|NCT00503321|Protective Agents|protective agents|mesh-ancestor
110335552|NCT00503477|Cediranib|cediranib|mesh-list
110335553|NCT00503477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110335554|NCT00503477|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110335555|NCT00503477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110162939|NCT00115609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110335556|NCT00503477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110335557|NCT05144295|Lactulose|lactulose|mesh-list
110335558|NCT05144295|Bisacodyl|bisacodyl|mesh-list
110335559|NCT05144295|Picosulfate sodium|picosulfate sodium|mesh-list
110335560|NCT05144295|Lubiprostone|lubiprostone|mesh-list
110335561|NCT05144295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110335562|NCT05144295|Cathartics|cathartics|mesh-ancestor
110335563|NCT05144295|Laxatives|laxatives|mesh-ancestor
110335565|NCT05144295|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110335566|NCT05144295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110335567|NCT01245452|Methotrexate|methotrexate|mesh-list
110335568|NCT01245452|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110335569|NCT01245452|Abortifacient Agents|abortifacient agents|mesh-ancestor
110335570|NCT01245452|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110335571|NCT01245452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110335572|NCT01245452|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110163073|NCT00116350|Oxytocin|oxytocin|mesh-list
110335574|NCT01245452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110335575|NCT01245452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110335576|NCT01245452|Dermatologic Agents|dermatologic agents|mesh-ancestor
110335577|NCT01245452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110335578|NCT01245452|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110335579|NCT01245452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110335580|NCT01245452|Immunologic Factors|immunologic factors|mesh-ancestor
110335581|NCT01245452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110335582|NCT01245452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110335584|NCT00503516|Megestrol Acetate|megestrol acetate|mesh-list
110335585|NCT00503516|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110163137|NCT02909322|Ropivacaine|ropivacaine|mesh-list
110163139|NCT02909322|Anesthetics|anesthetics|mesh-ancestor
110335586|NCT00503516|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110335587|NCT00503516|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110335588|NCT00503516|Contraceptive Agents|contraceptive agents|mesh-ancestor
110335589|NCT00503516|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110335590|NCT00503516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110335591|NCT00503516|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110335592|NCT00503516|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110335593|NCT00503516|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110335594|NCT00503516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110335595|NCT00503516|Appetite Stimulants|appetite stimulants|mesh-ancestor
110335596|NCT00503516|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110335597|NCT05148195|Leucovorin|leucovorin|mesh-list
110335598|NCT05148195|Docetaxel|docetaxel|mesh-list
110335599|NCT05148195|Irinotecan|irinotecan|mesh-list
110335600|NCT05148195|Calcium|calcium|mesh-list
110335601|NCT05148195|Levoleucovorin|levoleucovorin|mesh-list
110335602|NCT05148195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110335603|NCT05148195|Tubulin Modulators|tubulin modulators|mesh-ancestor
110163270|NCT04727515|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110335604|NCT05148195|Antimitotic Agents|antimitotic agents|mesh-ancestor
110335605|NCT05148195|Mitosis Modulators|mitosis modulators|mesh-ancestor
110335606|NCT05148195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110335607|NCT05148195|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110335608|NCT05148195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110335609|NCT05148195|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110335610|NCT05148195|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110163336|NCT00118105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110335611|NCT05148195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110335612|NCT05148195|Antidotes|antidotes|mesh-ancestor
110335613|NCT05148195|Protective Agents|protective agents|mesh-ancestor
110335614|NCT05148195|Vitamin B Complex|vitamin b complex|mesh-ancestor
110335616|NCT05148195|Micronutrients|micronutrients|mesh-ancestor
110335617|NCT00499265|Gemcitabine|gemcitabine|mesh-list
110335618|NCT00499265|Protease Inhibitors|protease inhibitors|mesh-list
110335619|NCT00499265|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-list
110335620|NCT00499265|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110335621|NCT00499265|Antimetabolites|antimetabolites|mesh-ancestor
110335622|NCT00499265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110335623|NCT00499265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110335624|NCT00499265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110335625|NCT01246622|Cytarabine|cytarabine|mesh-list
110335626|NCT01246622|Lenalidomide|lenalidomide|mesh-list
110335627|NCT01246622|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110335628|NCT01246622|Antimetabolites|antimetabolites|mesh-ancestor
110335629|NCT01246622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110335630|NCT01246622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110335631|NCT01246622|Antiviral Agents|antiviral agents|mesh-ancestor
110335632|NCT01246622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110335633|NCT01246622|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110335634|NCT01246622|Immunologic Factors|immunologic factors|mesh-ancestor
110335635|NCT01246622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110335636|NCT01246622|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110335637|NCT01246622|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110335638|NCT01246622|Growth Substances|growth substances|mesh-ancestor
110335639|NCT01246622|Growth Inhibitors|growth inhibitors|mesh-ancestor
110335640|NCT01245530|Donepezil|donepezil|mesh-list
110335641|NCT01245530|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110335642|NCT01245530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110335643|NCT01245530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110335644|NCT01245530|Cholinergic Agents|cholinergic agents|mesh-ancestor
110335645|NCT01245530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110335646|NCT01245530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110335647|NCT01245530|Nootropic Agents|nootropic agents|mesh-ancestor
110335649|NCT05148312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110335650|NCT05148312|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110335651|NCT05148312|Autonomic Agents|autonomic agents|mesh-ancestor
110163606|NCT00120367|Antiviral Agents|antiviral agents|mesh-ancestor
110335652|NCT05148312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110335653|NCT05148312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110335654|NCT05148312|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110335655|NCT05148312|Respiratory System Agents|respiratory system agents|mesh-ancestor
110335656|NCT05148312|Glucocorticoids|glucocorticoids|mesh-ancestor
110335657|NCT05148312|Hormones|hormones|mesh-ancestor
110335658|NCT05148312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110335659|NCT01246817|Sirolimus|sirolimus|mesh-list
110335660|NCT01246817|Temsirolimus|temsirolimus|mesh-list
110335661|NCT01246817|MTOR Inhibitors|mtor inhibitors|mesh-list
110335662|NCT01246817|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110335663|NCT01246817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110335664|NCT01246817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110335665|NCT01246817|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110335666|NCT01246817|Immunologic Factors|immunologic factors|mesh-ancestor
110335667|NCT01246817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110163673|NCT00120796|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110163675|NCT00120835|Interferons|interferons|mesh-list
110335668|NCT01246817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110335669|NCT01246817|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110335670|NCT01246817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110335671|NCT01246817|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110335672|NCT01246817|Antifungal Agents|antifungal agents|mesh-ancestor
110335673|NCT01245803|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110335674|NCT01245803|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110335675|NCT01245803|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110335676|NCT01245803|Antimetabolites|antimetabolites|mesh-ancestor
110335677|NCT01245803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110163731|NCT00121381|Tacrolimus|tacrolimus|mesh-list
110163732|NCT00121381|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110335678|NCT01245803|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110335679|NCT01245803|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110335680|NCT01245803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110335681|NCT05148975|Dimercaprol|dimercaprol|mesh-list
110335682|NCT05148975|Chelating Agents|chelating agents|mesh-ancestor
110335683|NCT05148975|Sequestering Agents|sequestering agents|mesh-ancestor
110335684|NCT05148975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110335685|NCT00499577|Vaccines|vaccines|mesh-list
110335686|NCT00499577|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110335687|NCT00499577|Immunologic Factors|immunologic factors|mesh-ancestor
110163797|NCT04705948|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110163798|NCT04705948|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110163799|NCT04705948|Anesthetics, General|anesthetics, general|mesh-ancestor
110163800|NCT04705948|Anesthetics|anesthetics|mesh-ancestor
110163801|NCT04705948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110335688|NCT00499577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110335689|NCT02274740|Metformin|metformin|mesh-list
110335690|NCT02274740|Lixisenatide|lixisenatide|mesh-list
110335691|NCT02274740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110335692|NCT02274740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110335693|NCT00499733|Cyclophosphamide|cyclophosphamide|mesh-list
110335694|NCT00499733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110335695|NCT00499733|Immunologic Factors|immunologic factors|mesh-ancestor
110335696|NCT00499733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110335697|NCT00499733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110163856|NCT00122356|Alendronate|alendronate|mesh-list
110163857|NCT00122356|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110335698|NCT00499733|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110335699|NCT00499733|Alkylating Agents|alkylating agents|mesh-ancestor
110335700|NCT00499733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110335701|NCT00499733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110335702|NCT00499733|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110335703|NCT00503594|Cytarabine|cytarabine|mesh-list
110335704|NCT00503594|Methotrexate|methotrexate|mesh-list
110335705|NCT00503594|Vincristine|vincristine|mesh-list
110163922|NCT00122629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110335706|NCT00503594|Temozolomide|temozolomide|mesh-list
110335707|NCT00503594|Procarbazine|procarbazine|mesh-list
110335708|NCT00503594|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110335709|NCT00503594|Abortifacient Agents|abortifacient agents|mesh-ancestor
110335710|NCT00503594|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110335711|NCT00503594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110335712|NCT00503594|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110335713|NCT00503594|Antimetabolites|antimetabolites|mesh-ancestor
110335714|NCT00503594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110335715|NCT00503594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110335716|NCT00503594|Dermatologic Agents|dermatologic agents|mesh-ancestor
110335717|NCT00503594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110335718|NCT00503594|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110335719|NCT00503594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110335720|NCT00503594|Immunologic Factors|immunologic factors|mesh-ancestor
110335721|NCT00503594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110335722|NCT00503594|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110335723|NCT00503594|Antiviral Agents|antiviral agents|mesh-ancestor
110335724|NCT00503594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110335725|NCT00503594|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110335726|NCT00503594|Tubulin Modulators|tubulin modulators|mesh-ancestor
110335727|NCT00503594|Antimitotic Agents|antimitotic agents|mesh-ancestor
110163988|NCT00129142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110335729|NCT00503594|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110335732|NCT00499811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110335733|NCT00499811|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110335734|NCT00499811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110335735|NCT00499811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110335736|NCT00499850|Leucovorin|leucovorin|mesh-list
110335737|NCT00499850|Fluorouracil|fluorouracil|mesh-list
110335738|NCT00499850|Oxaliplatin|oxaliplatin|mesh-list
110335739|NCT00499850|Antimetabolites|antimetabolites|mesh-ancestor
110335740|NCT00499850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110335741|NCT00499850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110335742|NCT00499850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110335743|NCT00499850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110335744|NCT00499850|Immunologic Factors|immunologic factors|mesh-ancestor
110335745|NCT00499850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110335746|NCT00499850|Antidotes|antidotes|mesh-ancestor
110335747|NCT00499850|Protective Agents|protective agents|mesh-ancestor
110335748|NCT00499850|Vitamin B Complex|vitamin b complex|mesh-ancestor
110335749|NCT00499850|Vitamins|vitamins|mesh-ancestor
110335750|NCT00499850|Micronutrients|micronutrients|mesh-ancestor
110335751|NCT05146713|Propolis|propolis|mesh-list
110335752|NCT05146713|Sodium Hypochlorite|sodium hypochlorite|mesh-list
110335754|NCT05146713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110335755|NCT05146713|Disinfectants|disinfectants|mesh-ancestor
110335756|NCT00503828|Naproxen|naproxen|mesh-list
110335757|NCT00503828|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110164041|NCT00063414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110164042|NCT05638451|Bevacizumab|bevacizumab|mesh-list
110335758|NCT00503828|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110335759|NCT00503828|Analgesics|analgesics|mesh-ancestor
110335760|NCT00503828|Sensory System Agents|sensory system agents|mesh-ancestor
110335761|NCT00503828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110335762|NCT00503828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110335763|NCT00503828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110335764|NCT00503828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110335765|NCT00503828|Gout Suppressants|gout suppressants|mesh-ancestor
110335766|NCT00503828|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110335767|NCT00503828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110164087|NCT00128557|Vitamins|vitamins|mesh-ancestor
110164088|NCT00128557|Micronutrients|micronutrients|mesh-ancestor
110164089|NCT00128557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110164090|NCT00128518|Perindopril|perindopril|mesh-list
110335768|NCT00503828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110335769|NCT00500006|Dasatinib|dasatinib|mesh-list
110335770|NCT00500006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110335771|NCT00500006|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110335772|NCT00500006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110335773|NCT00500006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110335774|NCT00506727|Amphetamine|amphetamine|mesh-list
110335775|NCT00506727|Adderall|adderall|mesh-list
110164149|NCT00128479|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110164150|NCT00128479|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110335776|NCT00506727|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
110335777|NCT00506727|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110335778|NCT00506727|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110335779|NCT00506727|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110343827|NCT06020755|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110335780|NCT00506727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110335781|NCT00506727|Adrenergic Agents|adrenergic agents|mesh-ancestor
110335782|NCT00506727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110335783|NCT00506727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110335784|NCT00506727|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110335785|NCT00506727|Sympathomimetics|sympathomimetics|mesh-ancestor
110335786|NCT00506727|Autonomic Agents|autonomic agents|mesh-ancestor
110335787|NCT00506727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110335788|NCT00506727|Dopamine Agents|dopamine agents|mesh-ancestor
110024492|NCT00004842|Budesonide|budesonide|mesh-list
110335789|NCT00506727|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110335790|NCT03455517|Rituximab|rituximab|mesh-list
110335791|NCT03455517|Venetoclax|venetoclax|mesh-list
110335792|NCT03455517|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110335793|NCT03455517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110335794|NCT03455517|Immunologic Factors|immunologic factors|mesh-ancestor
110335795|NCT03455517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110335796|NCT03455517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110335797|NCT04696536|Listerine|listerine|mesh-list
110335798|NCT04696536|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110335799|NCT04696536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110335800|NCT00500279|Celecoxib|celecoxib|mesh-list
110335801|NCT00500279|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110335802|NCT00500279|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110164215|NCT00018733|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110164216|NCT00018733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110164217|NCT00018733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110335804|NCT00500279|Sensory System Agents|sensory system agents|mesh-ancestor
110335805|NCT00500279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110335806|NCT00500279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110335807|NCT00500279|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110335808|NCT00500279|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110164259|NCT00009750|Antibodies|antibodies|mesh-list
110335809|NCT00500279|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110335810|NCT00500279|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110335811|NCT00500279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110335812|NCT00500279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110335813|NCT01245881|Sunscreening Agents|sunscreening agents|mesh-list
110335814|NCT01245881|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110335815|NCT01245881|Protective Agents|protective agents|mesh-ancestor
110335816|NCT01245881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110335817|NCT01245881|Dermatologic Agents|dermatologic agents|mesh-ancestor
110335818|NCT03458247|Abiraterone Acetate|abiraterone acetate|mesh-list
110335819|NCT03458247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110164331|NCT00009828|Mitosis Modulators|mitosis modulators|mesh-ancestor
110335820|NCT03458247|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110335821|NCT03458247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110335822|NCT03458247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110335823|NCT03458247|Hormone Antagonists|hormone antagonists|mesh-ancestor
110335824|NCT03458247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110335825|NCT03458247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110335826|NCT03458247|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110335827|NCT01247558|Vitamin B 12|vitamin b 12|mesh-list
110335828|NCT01247558|Vitamin B Complex|vitamin b complex|mesh-ancestor
110335829|NCT01247558|Vitamins|vitamins|mesh-ancestor
110335830|NCT01247558|Micronutrients|micronutrients|mesh-ancestor
110335831|NCT01247558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110335832|NCT00500552|Perhexiline|perhexiline|mesh-list
110335833|NCT00500552|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110335834|NCT00500552|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110335835|NCT00500552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110335836|NCT00500552|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110335837|NCT00500552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110335838|NCT00500552|Vasodilator Agents|vasodilator agents|mesh-ancestor
110335839|NCT00508209|Bortezomib|bortezomib|mesh-list
110335840|NCT00508209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110335841|NCT00500669|Povidone-Iodine|povidone-iodine|mesh-list
110335842|NCT00500669|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110335843|NCT00500669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110335844|NCT00507585|Leucovorin|leucovorin|mesh-list
110335845|NCT00507585|Bevacizumab|bevacizumab|mesh-list
110335846|NCT00507585|Fluorouracil|fluorouracil|mesh-list
110335847|NCT00507585|Oxaliplatin|oxaliplatin|mesh-list
110335848|NCT00507585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110335849|NCT00507585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110335850|NCT00507585|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110335851|NCT00507585|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110335852|NCT00507585|Growth Substances|growth substances|mesh-ancestor
110335853|NCT00507585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110335854|NCT00507585|Growth Inhibitors|growth inhibitors|mesh-ancestor
110335855|NCT00507585|Antimetabolites|antimetabolites|mesh-ancestor
110335856|NCT00507585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110335857|NCT00507585|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110335858|NCT00507585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110335859|NCT00507585|Immunologic Factors|immunologic factors|mesh-ancestor
110335860|NCT00507585|Antidotes|antidotes|mesh-ancestor
110335861|NCT00507585|Protective Agents|protective agents|mesh-ancestor
110335862|NCT00507585|Vitamin B Complex|vitamin b complex|mesh-ancestor
110335864|NCT00507585|Micronutrients|micronutrients|mesh-ancestor
110335865|NCT01247714|Phentermine|phentermine|mesh-list
110335866|NCT01247714|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110335867|NCT01247714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110335868|NCT01247714|Appetite Depressants|appetite depressants|mesh-ancestor
110335869|NCT01247714|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110335870|NCT01247714|Sympathomimetics|sympathomimetics|mesh-ancestor
110335871|NCT01247714|Autonomic Agents|autonomic agents|mesh-ancestor
110335872|NCT01247714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110335873|NCT01247714|Adrenergic Agents|adrenergic agents|mesh-ancestor
110335874|NCT01247714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110335875|NCT01247714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110335876|NCT00507663|Atenolol|atenolol|mesh-list
110335877|NCT00507663|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110335878|NCT00507663|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110335879|NCT00507663|Sympatholytics|sympatholytics|mesh-ancestor
110335880|NCT00507663|Autonomic Agents|autonomic agents|mesh-ancestor
110335881|NCT00507663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110335882|NCT00507663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110335883|NCT00507663|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110335884|NCT00507663|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110335885|NCT00507663|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110335886|NCT00507663|Adrenergic Agents|adrenergic agents|mesh-ancestor
110335887|NCT00507663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110335888|NCT00507663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110335890|NCT00508287|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110335891|NCT00508287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110335892|NCT00508287|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110335893|NCT00508287|Incretins|incretins|mesh-ancestor
110335894|NCT00508287|Hormones|hormones|mesh-ancestor
110335895|NCT00508287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110335896|NCT00508326|Paclitaxel|paclitaxel|mesh-list
110335897|NCT00508326|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110335898|NCT00508326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110335899|NCT00508326|Tubulin Modulators|tubulin modulators|mesh-ancestor
110335900|NCT00508326|Antimitotic Agents|antimitotic agents|mesh-ancestor
110335901|NCT00508326|Mitosis Modulators|mitosis modulators|mesh-ancestor
110335902|NCT00508326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110335903|NCT00507858|Dexamethasone|dexamethasone|mesh-list
110335904|NCT00507858|Pemetrexed|pemetrexed|mesh-list
110335905|NCT00507858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110335906|NCT00507858|Antiemetics|antiemetics|mesh-ancestor
110335907|NCT00507858|Autonomic Agents|autonomic agents|mesh-ancestor
110335908|NCT00507858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110335909|NCT00507858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110335910|NCT00507858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110335911|NCT00507858|Glucocorticoids|glucocorticoids|mesh-ancestor
110335913|NCT00507858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110335914|NCT00507858|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110335915|NCT00507858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110335916|NCT00507858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110335917|NCT00507858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110335918|NCT00507858|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110335919|NCT00507858|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110335920|NCT00508365|Carvedilol|carvedilol|mesh-list
110335921|NCT00508365|Lisinopril|lisinopril|mesh-list
110335922|NCT00508365|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110335923|NCT00508365|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110335924|NCT00508365|Adrenergic Agents|adrenergic agents|mesh-ancestor
110335925|NCT00508365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110335926|NCT00508365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110335927|NCT00508365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110335928|NCT00508365|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110335929|NCT00508365|Antioxidants|antioxidants|mesh-ancestor
110335930|NCT00508365|Protective Agents|protective agents|mesh-ancestor
110335931|NCT00508365|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110335932|NCT00508365|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110335933|NCT00508365|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110335934|NCT00508365|Vasodilator Agents|vasodilator agents|mesh-ancestor
110335935|NCT00508365|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110335936|NCT00508365|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110335937|NCT00508365|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110335938|NCT00508365|Protease Inhibitors|protease inhibitors|mesh-ancestor
110335939|NCT00508365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110335940|NCT00508365|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110335941|NCT00500864|Magnesium Sulfate|magnesium sulfate|mesh-list
110335942|NCT00500864|Analgesics|analgesics|mesh-ancestor
110335943|NCT00500864|Sensory System Agents|sensory system agents|mesh-ancestor
110335944|NCT00500864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110335945|NCT00500864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110335946|NCT00500864|Anesthetics|anesthetics|mesh-ancestor
110335947|NCT00500864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110335948|NCT00500864|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110335949|NCT00500864|Anticonvulsants|anticonvulsants|mesh-ancestor
110335950|NCT00500864|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110335951|NCT00500864|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110335952|NCT00500864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110335953|NCT00500864|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110335954|NCT00500864|Tocolytic Agents|tocolytic agents|mesh-ancestor
110335955|NCT00500864|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110335956|NCT00507975|Nicotine|nicotine|mesh-list
110335957|NCT00507975|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110335958|NCT00507975|Autonomic Agents|autonomic agents|mesh-ancestor
110335959|NCT00507975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110335960|NCT00507975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110335961|NCT00507975|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110335962|NCT00507975|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110335963|NCT00507975|Cholinergic Agents|cholinergic agents|mesh-ancestor
110335964|NCT00507975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110335965|NCT00507975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110335966|NCT01247909|Gentamicins|gentamicins|mesh-list
110335967|NCT01247909|Ceftriaxone|ceftriaxone|mesh-list
110335968|NCT01247909|Penicillins|penicillins|mesh-list
110335969|NCT01247909|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110164720|NCT00010179|Lurtotecan|lurtotecan|mesh-list
110335970|NCT01247909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110335971|NCT01247909|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110335972|NCT01247909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110335973|NCT01247909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110335974|NCT01245998|Dalteparin|dalteparin|mesh-list
110335975|NCT01245998|Tinzaparin|tinzaparin|mesh-list
110335976|NCT01245998|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
110335977|NCT01245998|Anticoagulants|anticoagulants|mesh-ancestor
110335978|NCT01245998|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110335979|NCT01245998|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110560342|NCT00638729|Analgesics|analgesics|mesh-ancestor
110335980|NCT01245998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110335981|NCT02954484|Acetaminophen|acetaminophen|mesh-list
110335982|NCT02954484|Etoricoxib|etoricoxib|mesh-list
110335983|NCT02954484|Pregabalin|pregabalin|mesh-list
110335984|NCT02954484|Morphine|morphine|mesh-list
110335985|NCT02954484|Ropivacaine|ropivacaine|mesh-list
110335986|NCT02954484|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110335987|NCT02954484|Narcotics|narcotics|mesh-ancestor
110335988|NCT02954484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110335989|NCT02954484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110335990|NCT02954484|Analgesics|analgesics|mesh-ancestor
110335991|NCT02954484|Sensory System Agents|sensory system agents|mesh-ancestor
110335992|NCT02954484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110335993|NCT02954484|Anesthetics, Local|anesthetics, local|mesh-ancestor
110335994|NCT02954484|Anesthetics|anesthetics|mesh-ancestor
110335995|NCT02954484|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110335996|NCT02954484|Antipyretics|antipyretics|mesh-ancestor
110335997|NCT02954484|Anticonvulsants|anticonvulsants|mesh-ancestor
110335998|NCT02954484|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110335999|NCT02954484|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110336000|NCT02954484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110172558|NCT00052312|Paclitaxel|paclitaxel|mesh-list
110336001|NCT02954484|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110336002|NCT02954484|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110336003|NCT02954484|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110336004|NCT02954484|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110336005|NCT02954484|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110336006|NCT02954484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110336007|NCT02954484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110336008|NCT02954484|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110336009|NCT02954484|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110336010|NCT02954484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110336011|NCT00501020|Rosiglitazone|rosiglitazone|mesh-list
110336012|NCT00501020|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110336013|NCT00501020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110336014|NCT00501098|Caspofungin|caspofungin|mesh-list
110336015|NCT00501098|Antifungal Agents|antifungal agents|mesh-ancestor
110336016|NCT00501098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110336017|NCT00501098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110336018|NCT00501098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110336019|NCT00501137|Vaccines|vaccines|mesh-list
110336021|NCT00501137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110336022|NCT01248260|Folic Acid|folic acid|mesh-list
110336023|NCT01248260|Hematinics|hematinics|mesh-ancestor
110336024|NCT01248260|Vitamin B Complex|vitamin b complex|mesh-ancestor
110336025|NCT01248260|Vitamins|vitamins|mesh-ancestor
110336026|NCT01248260|Micronutrients|micronutrients|mesh-ancestor
110336027|NCT01248260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110336028|NCT01246037|Bisoprolol|bisoprolol|mesh-list
110336029|NCT01246037|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110336031|NCT01246037|Autonomic Agents|autonomic agents|mesh-ancestor
110336032|NCT01246037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110336033|NCT01246037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110336034|NCT01246037|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110336035|NCT01246037|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110336036|NCT01246037|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110336037|NCT01246037|Adrenergic Agents|adrenergic agents|mesh-ancestor
110336038|NCT01246037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110336039|NCT01246037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110336040|NCT00501215|Parathyroid Hormone|parathyroid hormone|mesh-list
110336041|NCT00501215|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110336042|NCT00501215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110336043|NCT00509184|Rituximab|rituximab|mesh-list
110336044|NCT00509184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110336045|NCT00509184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110336046|NCT00509184|Immunologic Factors|immunologic factors|mesh-ancestor
110336047|NCT00509184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110336048|NCT00509184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110336049|NCT00501254|Aspirin|aspirin|mesh-list
110560579|NCT00782327|Losartan|losartan|mesh-list
110336050|NCT00501254|Salicylic Acid|salicylic acid|mesh-list
110336051|NCT00501254|Salicylates|salicylates|mesh-list
110336052|NCT00501254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110336053|NCT00501254|Antifungal Agents|antifungal agents|mesh-ancestor
110336054|NCT00501254|Keratolytic Agents|keratolytic agents|mesh-ancestor
110336055|NCT00501254|Dermatologic Agents|dermatologic agents|mesh-ancestor
110336056|NCT00501254|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110336057|NCT00501254|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110336058|NCT00501254|Analgesics|analgesics|mesh-ancestor
110336059|NCT00501254|Sensory System Agents|sensory system agents|mesh-ancestor
110336060|NCT00501254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110336061|NCT00501254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110336062|NCT00501254|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110336064|NCT00501254|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110336065|NCT00501254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110336066|NCT00501254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110336067|NCT00501254|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110336068|NCT00501254|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110336069|NCT00501254|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110336070|NCT00501254|Antipyretics|antipyretics|mesh-ancestor
110336071|NCT01248338|Metoprolol|metoprolol|mesh-list
110336072|NCT01248338|Nebivolol|nebivolol|mesh-list
110336073|NCT01248338|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110336074|NCT01248338|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110336075|NCT01248338|Sympatholytics|sympatholytics|mesh-ancestor
110336076|NCT01248338|Autonomic Agents|autonomic agents|mesh-ancestor
110336077|NCT01248338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110336078|NCT01248338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110336079|NCT01248338|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110336080|NCT01248338|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110336082|NCT01248338|Adrenergic Agents|adrenergic agents|mesh-ancestor
110336083|NCT01248338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110172680|NCT00052936|Hormones|hormones|mesh-ancestor
110336084|NCT01248338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110336085|NCT01248338|Vasodilator Agents|vasodilator agents|mesh-ancestor
110560700|NCT02681783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110336086|NCT01248338|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
110336087|NCT01248338|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110336088|NCT01248338|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110336090|NCT02953743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110336091|NCT02953743|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110336092|NCT02953743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110336093|NCT02953743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110336094|NCT00509379|Rituximab|rituximab|mesh-list
110336095|NCT00509379|Bortezomib|bortezomib|mesh-list
110336097|NCT00509379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110336098|NCT00509379|Immunologic Factors|immunologic factors|mesh-ancestor
110336099|NCT00509379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110336100|NCT00509379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110336101|NCT02274974|Lidocaine|lidocaine|mesh-list
110336102|NCT02274974|Epinephrine|epinephrine|mesh-list
110336103|NCT02274974|Anesthetics, Local|anesthetics, local|mesh-list
110336104|NCT02274974|Anesthetics|anesthetics|mesh-list
110336105|NCT02274974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110336106|NCT02274974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110336108|NCT02274974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110336109|NCT02274974|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110336110|NCT02274974|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110336111|NCT02274974|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110336112|NCT02274974|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110336113|NCT02274974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110336114|NCT02274974|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110336115|NCT02274974|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110336116|NCT02274974|Adrenergic Agents|adrenergic agents|mesh-ancestor
110336117|NCT02274974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110336118|NCT02274974|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110336119|NCT02274974|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110336120|NCT02274974|Autonomic Agents|autonomic agents|mesh-ancestor
110336121|NCT02274974|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110336122|NCT02274974|Respiratory System Agents|respiratory system agents|mesh-ancestor
110336123|NCT02274974|Mydriatics|mydriatics|mesh-ancestor
110336124|NCT02274974|Sympathomimetics|sympathomimetics|mesh-ancestor
110336125|NCT02274974|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110336127|NCT02274545|Immunologic Factors|immunologic factors|mesh-ancestor
110336128|NCT02274545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110336129|NCT02275013|Simendan|simendan|mesh-list
110336130|NCT02275013|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110336131|NCT02275013|Vasodilator Agents|vasodilator agents|mesh-ancestor
110336132|NCT02275013|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110336133|NCT02275013|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110336134|NCT02275013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110336135|NCT02275013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110336136|NCT02275013|Protective Agents|protective agents|mesh-ancestor
110336137|NCT02275013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110336138|NCT02274623|Calcifediol|calcifediol|mesh-list
110336139|NCT02274623|Vitamins|vitamins|mesh-ancestor
110336140|NCT02274623|Micronutrients|micronutrients|mesh-ancestor
110560804|NCT04102319|Hepcidins|hepcidins|mesh-list
110336141|NCT02274623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110336142|NCT02274623|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110336144|NCT00509613|Sorafenib|sorafenib|mesh-list
110336145|NCT00509613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110336146|NCT00509613|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110336147|NCT00509613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110336148|NCT00509613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110336149|NCT00509613|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110336150|NCT00509613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110336151|NCT00509613|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110336152|NCT00509613|Antifungal Agents|antifungal agents|mesh-ancestor
110336153|NCT00509613|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110336154|NCT00509613|Immunologic Factors|immunologic factors|mesh-ancestor
110336155|NCT00509613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110336156|NCT00501410|Leucovorin|leucovorin|mesh-list
110336157|NCT00501410|Fluorouracil|fluorouracil|mesh-list
110336158|NCT00501410|Oxaliplatin|oxaliplatin|mesh-list
110336159|NCT00501410|Cetuximab|cetuximab|mesh-list
110336160|NCT00501410|Dasatinib|dasatinib|mesh-list
110336161|NCT00501410|Antimetabolites|antimetabolites|mesh-ancestor
110336162|NCT00501410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110336163|NCT00501410|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110336164|NCT00501410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110336165|NCT00501410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110336166|NCT00501410|Immunologic Factors|immunologic factors|mesh-ancestor
110336167|NCT00501410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110336169|NCT00501410|Protective Agents|protective agents|mesh-ancestor
110336170|NCT00501410|Vitamin B Complex|vitamin b complex|mesh-ancestor
110336171|NCT00501410|Vitamins|vitamins|mesh-ancestor
110336172|NCT00501410|Micronutrients|micronutrients|mesh-ancestor
110336173|NCT00501410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110336174|NCT00501410|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110336175|NCT00501410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110336176|NCT02953275|Pentoxifylline|pentoxifylline|mesh-list
110336177|NCT02953275|Vedolizumab|vedolizumab|mesh-list
110336178|NCT02953275|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110336179|NCT02953275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110336180|NCT02953275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110336181|NCT02953275|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110336182|NCT02953275|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110336183|NCT02953275|Protective Agents|protective agents|mesh-ancestor
110336184|NCT02953275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110336185|NCT02953275|Vasodilator Agents|vasodilator agents|mesh-ancestor
110336186|NCT02953275|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110336187|NCT02953275|Antioxidants|antioxidants|mesh-ancestor
110336188|NCT02953275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110336189|NCT00501488|Rosiglitazone|rosiglitazone|mesh-list
110336190|NCT00501488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110336191|NCT00501488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110336192|NCT00508911|Contraceptive Agents|contraceptive agents|mesh-list
110336193|NCT00508911|Contraceptives, Oral|contraceptives, oral|mesh-list
110336194|NCT00508911|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110336195|NCT00508911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110336196|NCT00508911|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110336197|NCT02955719|Sertraline|sertraline|mesh-list
110336198|NCT02955719|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
110336199|NCT02955719|Antidepressive Agents|antidepressive agents|mesh-ancestor
110336200|NCT02955719|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110336201|NCT02955719|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110336202|NCT02955719|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110336203|NCT02955719|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110336204|NCT02955719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110336205|NCT02955719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110336206|NCT02955719|Serotonin Agents|serotonin agents|mesh-ancestor
110336207|NCT02955719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110336208|NCT02955719|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110336209|NCT02955719|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110336210|NCT00501527|Immunomodulating Agents|immunomodulating agents|mesh-list
110336211|NCT00501527|Immunologic Factors|immunologic factors|mesh-ancestor
110336212|NCT00501527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110336213|NCT02955524|Lidocaine|lidocaine|mesh-list
110336214|NCT02955524|Tetracaine|tetracaine|mesh-list
110336215|NCT02955524|Anesthetics, Local|anesthetics, local|mesh-ancestor
110336216|NCT02955524|Anesthetics|anesthetics|mesh-ancestor
110336217|NCT02955524|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110336218|NCT02955524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110336219|NCT02955524|Sensory System Agents|sensory system agents|mesh-ancestor
110336220|NCT02955524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110336221|NCT02955524|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110336222|NCT02955524|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110336223|NCT02955524|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110336224|NCT02955524|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110336225|NCT02955524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110336226|NCT02953041|Glycopyrrolate|glycopyrrolate|mesh-list
110336227|NCT02953041|Bromides|bromides|mesh-list
110336228|NCT02953041|Anticonvulsants|anticonvulsants|mesh-ancestor
110336229|NCT02953041|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110336230|NCT02953041|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110336231|NCT02953041|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110336232|NCT02953041|Cholinergic Agents|cholinergic agents|mesh-ancestor
110336233|NCT02953041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110336234|NCT02953041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110336235|NCT02953041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110336237|NCT00501566|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
110336238|NCT00501566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110336239|NCT00501566|Natriuretic Agents|natriuretic agents|mesh-ancestor
110336240|NCT00501566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110336241|NCT00501605|Cediranib|cediranib|mesh-list
110336242|NCT00501605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110336243|NCT00501605|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110336244|NCT00501605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110336245|NCT00501605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110336246|NCT00509847|Lactoferrin|lactoferrin|mesh-list
110336247|NCT00509847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110336248|NCT01248494|Letrozole|letrozole|mesh-list
110336249|NCT01248494|Dactolisib|dactolisib|mesh-list
110336250|NCT01248494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110336251|NCT01248494|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110336252|NCT01248494|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110336253|NCT01248494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110336254|NCT01248494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110336255|NCT01248494|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110336256|NCT01248494|Hormone Antagonists|hormone antagonists|mesh-ancestor
110336257|NCT01248494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110336258|NCT01248494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110336259|NCT02952573|Dexamethasone|dexamethasone|mesh-list
110336260|NCT02952573|Dexamethasone acetate|dexamethasone acetate|mesh-list
110336261|NCT02952573|BB 1101|bb 1101|mesh-list
110336262|NCT02952573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110336263|NCT02952573|Antiemetics|antiemetics|mesh-ancestor
110336264|NCT02952573|Autonomic Agents|autonomic agents|mesh-ancestor
110336265|NCT02952573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110336266|NCT02952573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110336267|NCT02952573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110336268|NCT02952573|Glucocorticoids|glucocorticoids|mesh-ancestor
110336270|NCT02952573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110336271|NCT02952573|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110336272|NCT02952573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110336273|NCT02952573|Protease Inhibitors|protease inhibitors|mesh-ancestor
110336274|NCT02952573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110336275|NCT02952573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110336276|NCT00501722|Satavaptan|satavaptan|mesh-list
110336277|NCT00501722|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
110336278|NCT00501722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110336279|NCT00501722|Natriuretic Agents|natriuretic agents|mesh-ancestor
110336280|NCT00501722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110336281|NCT01248611|Fentanyl|fentanyl|mesh-list
110336282|NCT01248611|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110336283|NCT01248611|Narcotics|narcotics|mesh-ancestor
110336284|NCT01248611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110336285|NCT01248611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110336286|NCT01248611|Analgesics|analgesics|mesh-ancestor
110336287|NCT01248611|Sensory System Agents|sensory system agents|mesh-ancestor
110375352|NCT02277678|Sensory System Agents|sensory system agents|mesh-ancestor
110336288|NCT01248611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110336289|NCT01248611|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110336290|NCT01248611|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110336291|NCT01248611|Anesthetics, General|anesthetics, general|mesh-ancestor
110336292|NCT01248611|Anesthetics|anesthetics|mesh-ancestor
110336293|NCT00509964|Irinotecan|irinotecan|mesh-list
110336294|NCT00509964|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110336295|NCT00509964|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110336296|NCT00509964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110336297|NCT00509964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110336298|NCT00509964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110336300|NCT00510471|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110336301|NCT00510471|Antibodies|antibodies|mesh-list
110336302|NCT00510471|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
110336303|NCT00510471|Immunologic Factors|immunologic factors|mesh-ancestor
110336304|NCT00510471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110336305|NCT00501839|Clomiphene|clomiphene|mesh-list
110336306|NCT00501839|Enclomiphene|enclomiphene|mesh-list
110336307|NCT00501839|Zuclomiphene|zuclomiphene|mesh-list
110336308|NCT00501839|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110336309|NCT00501839|Hormone Antagonists|hormone antagonists|mesh-ancestor
110336310|NCT00501839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110336311|NCT00501839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110336312|NCT00501839|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110336313|NCT00501839|Fertility Agents|fertility agents|mesh-ancestor
110336314|NCT00501839|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110336315|NCT00501839|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110336316|NCT00501839|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110336317|NCT00510003|Pimecrolimus|pimecrolimus|mesh-list
110336318|NCT00510003|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110336319|NCT00510003|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110336320|NCT00510003|Analgesics|analgesics|mesh-ancestor
110336321|NCT00510003|Sensory System Agents|sensory system agents|mesh-ancestor
110336322|NCT00510003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110561128|NCT02675309|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110336323|NCT00510003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110336324|NCT00510003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110336325|NCT00510003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110336326|NCT00510003|Dermatologic Agents|dermatologic agents|mesh-ancestor
110336327|NCT00510003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110336328|NCT00510003|Immunologic Factors|immunologic factors|mesh-ancestor
110336329|NCT00510003|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110336330|NCT00510003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110336331|NCT00510003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110336333|NCT00501878|Oxymetazoline|oxymetazoline|mesh-list
110336334|NCT00501878|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110336335|NCT00501878|Mydriatics|mydriatics|mesh-ancestor
110336336|NCT00501878|Autonomic Agents|autonomic agents|mesh-ancestor
110336337|NCT00501878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110336338|NCT00501878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110336339|NCT00501878|Sympathomimetics|sympathomimetics|mesh-ancestor
110336340|NCT00501878|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110336341|NCT00501878|Nasal Decongestants|nasal decongestants|mesh-ancestor
110336342|NCT00501878|Respiratory System Agents|respiratory system agents|mesh-ancestor
110336343|NCT00501878|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110336344|NCT00501878|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110336345|NCT00501878|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110336346|NCT00501878|Adrenergic Agents|adrenergic agents|mesh-ancestor
110336347|NCT00501878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110336348|NCT00501878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110336349|NCT00501878|Protective Agents|protective agents|mesh-ancestor
110336350|NCT00501917|Darbepoetin alfa|darbepoetin alfa|mesh-list
110336351|NCT00501917|Hematinics|hematinics|mesh-ancestor
110336352|NCT00510588|Metformin|metformin|mesh-list
110336353|NCT00510588|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110336354|NCT00510588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110172983|NCT00055042|Vitamin E|vitamin e|mesh-list
110336355|NCT00510627|Oxaliplatin|oxaliplatin|mesh-list
110336356|NCT00510627|Irinotecan|irinotecan|mesh-list
110336357|NCT00510627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110336358|NCT00510627|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110336359|NCT00510627|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110336360|NCT00510627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110336361|NCT00510627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110336362|NCT00502034|Interferons|interferons|mesh-list
110336363|NCT00502034|Interferon-alpha|interferon-alpha|mesh-list
110336364|NCT00502034|Interferon alpha-2|interferon alpha-2|mesh-list
110336366|NCT00502034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110336367|NCT00502034|Antiviral Agents|antiviral agents|mesh-ancestor
110336368|NCT00502034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110336369|NCT00502034|Immunologic Factors|immunologic factors|mesh-ancestor
110336370|NCT00502034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110336371|NCT00502034|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110336372|NCT00502034|Analgesics|analgesics|mesh-ancestor
110336373|NCT00502034|Sensory System Agents|sensory system agents|mesh-ancestor
110336374|NCT00502034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110336375|NCT00510666|Tramadol|tramadol|mesh-list
110336376|NCT00510666|Butorphanol|butorphanol|mesh-list
110336377|NCT00510666|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110336378|NCT00510666|Narcotics|narcotics|mesh-ancestor
110336379|NCT00510666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110336380|NCT00510666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110336381|NCT00510666|Analgesics|analgesics|mesh-ancestor
110336382|NCT00510666|Sensory System Agents|sensory system agents|mesh-ancestor
110336383|NCT00510666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110336384|NCT00510666|Antitussive Agents|antitussive agents|mesh-ancestor
110336385|NCT00510666|Respiratory System Agents|respiratory system agents|mesh-ancestor
110336386|NCT00510666|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110336387|NCT00508092|Anesthetics|anesthetics|mesh-list
110336388|NCT00508092|Anesthetics, Local|anesthetics, local|mesh-list
110336389|NCT00508092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110336390|NCT00508092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110336391|NCT00508092|Sensory System Agents|sensory system agents|mesh-ancestor
110336392|NCT00508092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110336393|NCT00510705|Metformin|metformin|mesh-list
110336394|NCT00510705|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110336395|NCT00510705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110336396|NCT00502073|Cyclosporine|cyclosporine|mesh-list
110336397|NCT00502073|Cyclosporins|cyclosporins|mesh-list
110336398|NCT00502073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110336399|NCT00502073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110336400|NCT00502073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110336401|NCT00502073|Immunologic Factors|immunologic factors|mesh-ancestor
110336402|NCT00502073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110336403|NCT00502073|Antifungal Agents|antifungal agents|mesh-ancestor
110336404|NCT00502073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110336405|NCT00502073|Dermatologic Agents|dermatologic agents|mesh-ancestor
110561290|NCT02676323|Leucovorin|leucovorin|mesh-list
110336407|NCT00502073|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110336408|NCT01248923|Dexamethasone|dexamethasone|mesh-list
110336409|NCT01248923|Bortezomib|bortezomib|mesh-list
110336410|NCT01248923|Filanesib|filanesib|mesh-list
110336411|NCT01248923|Lenograstim|lenograstim|mesh-list
110336412|NCT01248923|Proteasome Inhibitors|proteasome inhibitors|mesh-list
110336413|NCT01248923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110336414|NCT01248923|Antiemetics|antiemetics|mesh-ancestor
110336415|NCT01248923|Autonomic Agents|autonomic agents|mesh-ancestor
110336416|NCT01248923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110336417|NCT01248923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110336418|NCT01248923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110336419|NCT01248923|Glucocorticoids|glucocorticoids|mesh-ancestor
110336420|NCT01248923|Hormones|hormones|mesh-ancestor
110336421|NCT01248923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110336422|NCT01248923|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110336423|NCT01248923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110561368|NCT02674139|Copper|copper|mesh-list
110336425|NCT01248923|Immunologic Factors|immunologic factors|mesh-ancestor
110336426|NCT01248923|Protease Inhibitors|protease inhibitors|mesh-ancestor
110336427|NCT01248923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110336428|NCT01248923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110336429|NCT01248923|Antimitotic Agents|antimitotic agents|mesh-ancestor
110336430|NCT01248923|Mitosis Modulators|mitosis modulators|mesh-ancestor
110336432|NCT01249001|Fosaprepitant|fosaprepitant|mesh-list
110336433|NCT01249001|Antiemetics|antiemetics|mesh-ancestor
110336434|NCT01249001|Autonomic Agents|autonomic agents|mesh-ancestor
110336435|NCT01249001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110336436|NCT01249001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110336438|NCT01249001|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110336439|NCT01249001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110336440|NCT01249001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110336441|NCT00502112|Lenalidomide|lenalidomide|mesh-list
110336442|NCT00502112|Lintuzumab|lintuzumab|mesh-list
110336443|NCT00502112|Immunologic Factors|immunologic factors|mesh-ancestor
110336444|NCT00502112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110336445|NCT00502112|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110336446|NCT00502112|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110336447|NCT00502112|Growth Substances|growth substances|mesh-ancestor
110336448|NCT00502112|Growth Inhibitors|growth inhibitors|mesh-ancestor
110336449|NCT00502112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110336450|NCT00502112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110336451|NCT00502190|Silicon|silicon|mesh-list
110336452|NCT00502190|Trace Elements|trace elements|mesh-ancestor
110336453|NCT00502190|Micronutrients|micronutrients|mesh-ancestor
110336454|NCT00502190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110336455|NCT00502229|Metformin|metformin|mesh-list
110336456|NCT00502229|Clomiphene|clomiphene|mesh-list
110336457|NCT00502229|Enclomiphene|enclomiphene|mesh-list
110336458|NCT00502229|Zuclomiphene|zuclomiphene|mesh-list
110336459|NCT00502229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110336460|NCT00502229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110336461|NCT00502229|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110336462|NCT00502229|Hormone Antagonists|hormone antagonists|mesh-ancestor
110336463|NCT00502229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110336464|NCT00502229|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110336465|NCT00502229|Fertility Agents|fertility agents|mesh-ancestor
110336466|NCT00502229|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110336467|NCT00502229|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110336468|NCT00502229|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110336469|NCT00502268|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
110336470|NCT00502268|Ergocalciferols|ergocalciferols|mesh-list
110336471|NCT00502268|Vitamins|vitamins|mesh-ancestor
110336472|NCT00502268|Micronutrients|micronutrients|mesh-ancestor
110336473|NCT00502268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110336474|NCT00502268|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110336475|NCT00502268|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110336476|NCT00510081|Calcium|calcium|mesh-list
110336477|NCT00510081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110336478|NCT00510081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110336479|NCT00502385|Cediranib|cediranib|mesh-list
110336480|NCT00502385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110336481|NCT00502385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110336482|NCT00502385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110336483|NCT00502385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110336484|NCT00510159|Artesunate|artesunate|mesh-list
110336485|NCT00510159|Sulfalene|sulfalene|mesh-list
110336486|NCT00510159|Praziquantel|praziquantel|mesh-list
110336487|NCT00510159|Antimalarials|antimalarials|mesh-ancestor
110336488|NCT00510159|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110336489|NCT00510159|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110336490|NCT00510159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110336491|NCT00510159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110336492|NCT00510159|Antiviral Agents|antiviral agents|mesh-ancestor
110336493|NCT00510159|Schistosomicides|schistosomicides|mesh-ancestor
110336494|NCT00510159|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110336495|NCT00510159|Anthelmintics|anthelmintics|mesh-ancestor
110336496|NCT00510159|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110336497|NCT00502463|Immunomodulating Agents|immunomodulating agents|mesh-list
110336498|NCT00502463|Immunologic Factors|immunologic factors|mesh-ancestor
110336499|NCT00502463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110336500|NCT02952807|Misoprostol|misoprostol|mesh-list
110336501|NCT02952807|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110336502|NCT02952807|Abortifacient Agents|abortifacient agents|mesh-ancestor
110336503|NCT02952807|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110336504|NCT02952807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110336505|NCT02952807|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110336506|NCT02952807|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110336507|NCT02952807|Oxytocics|oxytocics|mesh-ancestor
110336508|NCT02275130|Calcium, Dietary|calcium, dietary|mesh-list
110336509|NCT02275130|Calcium|calcium|mesh-list
110336510|NCT02275130|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110336511|NCT02275130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110336512|NCT02275130|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110336513|NCT03459417|Morphine|morphine|mesh-list
110336514|NCT03459417|Sulpiride|sulpiride|mesh-list
110336515|NCT03459417|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110336516|NCT03459417|Narcotics|narcotics|mesh-ancestor
110336517|NCT03459417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110336518|NCT03459417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110336519|NCT03459417|Analgesics|analgesics|mesh-ancestor
110336520|NCT03459417|Sensory System Agents|sensory system agents|mesh-ancestor
110561474|NCT02670317|Prednisone|prednisone|mesh-list
110336521|NCT03459417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110336523|NCT03459417|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110336524|NCT03459417|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110336525|NCT03459417|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110336526|NCT03459417|Dopamine Agents|dopamine agents|mesh-ancestor
110336527|NCT03459417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110336528|NCT03459417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110336529|NCT03459417|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110336530|NCT03459417|Antidepressive Agents|antidepressive agents|mesh-ancestor
110336531|NCT00502541|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
110336532|NCT00502541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110336533|NCT00502541|Glucocorticoids|glucocorticoids|mesh-ancestor
110336535|NCT00502541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110336536|NCT00502541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110336537|NCT01249430|Cytarabine|cytarabine|mesh-list
110336538|NCT01249430|Etoposide|etoposide|mesh-list
110336539|NCT01249430|Mitoxantrone|mitoxantrone|mesh-list
110336540|NCT01249430|Azacitidine|azacitidine|mesh-list
110336541|NCT01249430|Etoposide phosphate|etoposide phosphate|mesh-list
110336542|NCT01249430|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110336543|NCT01249430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110336544|NCT01249430|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110336545|NCT01249430|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110336546|NCT01249430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110336547|NCT01249430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110336548|NCT01249430|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110336549|NCT01249430|Antimetabolites|antimetabolites|mesh-ancestor
110336550|NCT01249430|Antiviral Agents|antiviral agents|mesh-ancestor
110336551|NCT01249430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110336552|NCT01249430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110336553|NCT01249430|Immunologic Factors|immunologic factors|mesh-ancestor
110336554|NCT01249430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110336555|NCT01249430|Analgesics|analgesics|mesh-ancestor
110336556|NCT01249430|Sensory System Agents|sensory system agents|mesh-ancestor
110336557|NCT01249430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110189542|NCT00049101|Leucovorin|leucovorin|mesh-list
110336559|NCT02952963|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
110336560|NCT02952963|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110336561|NCT02952963|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110336562|NCT02952963|Antimetabolites|antimetabolites|mesh-ancestor
110336563|NCT02952963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110336564|NCT02952963|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110336565|NCT02952963|Cathartics|cathartics|mesh-ancestor
110336566|NCT02952963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110336567|NCT00510939|Bortezomib|bortezomib|mesh-list
110336568|NCT00510939|Tipifarnib|tipifarnib|mesh-list
110336569|NCT00510939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110172995|NCT00055120|Stavudine|stavudine|mesh-list
110336570|NCT00504062|Fluticasone|fluticasone|mesh-list
110336571|NCT00504062|Budesonide|budesonide|mesh-list
110336572|NCT00504062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110336573|NCT00504062|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110336574|NCT00504062|Autonomic Agents|autonomic agents|mesh-ancestor
110561566|NCT02669303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110336575|NCT00504062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110336576|NCT00504062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110336577|NCT00504062|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110336578|NCT00504062|Respiratory System Agents|respiratory system agents|mesh-ancestor
110336579|NCT00504062|Dermatologic Agents|dermatologic agents|mesh-ancestor
110336580|NCT00504062|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110336581|NCT00504062|Glucocorticoids|glucocorticoids|mesh-ancestor
110336582|NCT00504062|Hormones|hormones|mesh-ancestor
110336583|NCT00504062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110336584|NCT00504101|Bortezomib|bortezomib|mesh-list
110336585|NCT00504101|Melphalan|melphalan|mesh-list
110336586|NCT00504101|Arsenic Trioxide|arsenic trioxide|mesh-list
110336587|NCT00504101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110336588|NCT00504101|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110336589|NCT00504101|Alkylating Agents|alkylating agents|mesh-ancestor
110336590|NCT00504101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110336591|NCT00504101|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110336592|NCT00504101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110336593|NCT00504101|Immunologic Factors|immunologic factors|mesh-ancestor
110336594|NCT00504101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110336595|NCT00504140|Interferons|interferons|mesh-list
110336596|NCT00504140|Interferon-alpha|interferon-alpha|mesh-list
110336597|NCT00504140|Etoposide|etoposide|mesh-list
110336598|NCT00504140|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110336599|NCT00504140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110336600|NCT00504140|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110336601|NCT00504140|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110336602|NCT00504140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110336603|NCT00504140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110336604|NCT00504140|Antiviral Agents|antiviral agents|mesh-ancestor
110336605|NCT00504140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110336606|NCT00504140|Immunologic Factors|immunologic factors|mesh-ancestor
110336607|NCT00504140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110336608|NCT00511017|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
110336610|NCT00511017|Micronutrients|micronutrients|mesh-ancestor
110336611|NCT00511017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110336612|NCT00511017|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110336613|NCT00511212|Immunoglobulins|immunoglobulins|mesh-list
110336614|NCT00511212|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110336615|NCT00511212|Antibodies|antibodies|mesh-list
110336616|NCT00511212|gamma-Globulins|gamma-globulins|mesh-list
110336617|NCT00511212|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110336618|NCT00511212|Immunologic Factors|immunologic factors|mesh-ancestor
110336619|NCT00511212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110336620|NCT00510354|Imatinib Mesylate|imatinib mesylate|mesh-list
110336621|NCT00510354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110336622|NCT00510354|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110336623|NCT00510354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110336624|NCT00510354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110336625|NCT01241006|Dexamethasone|dexamethasone|mesh-list
110336626|NCT01241006|Prednisone|prednisone|mesh-list
110336627|NCT01241006|Glucocorticoids|glucocorticoids|mesh-list
110336628|NCT01241006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110336629|NCT01241006|Antiemetics|antiemetics|mesh-ancestor
110336630|NCT01241006|Autonomic Agents|autonomic agents|mesh-ancestor
110336631|NCT01241006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110336632|NCT01241006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110336633|NCT01241006|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110336634|NCT01241006|Hormones|hormones|mesh-ancestor
110336635|NCT01241006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110336636|NCT01241006|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110336637|NCT01241006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110336639|NCT00510393|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110336640|NCT00510393|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110561677|NCT00646841|Doxazosin|doxazosin|mesh-list
110336642|NCT00510393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110336643|NCT00510393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110336644|NCT00510393|Immunologic Factors|immunologic factors|mesh-ancestor
110336645|NCT00510393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110336646|NCT00510393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110336647|NCT01249547|Axitinib|axitinib|mesh-list
110336648|NCT01249547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110336649|NCT01249547|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110336650|NCT01249547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110336651|NCT01249547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110336653|NCT00511719|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110336654|NCT00511719|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110336655|NCT00511719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110336656|NCT01246232|Amisulpride|amisulpride|mesh-list
110336657|NCT01246232|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110336658|NCT01246232|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110336659|NCT01246232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110336660|NCT01246232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110336661|NCT01246232|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110336662|NCT01246232|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110336663|NCT01246232|Dopamine Agents|dopamine agents|mesh-ancestor
110336664|NCT01246232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110336665|NCT01246232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110336666|NCT01246232|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110336667|NCT01246232|Antidepressive Agents|antidepressive agents|mesh-ancestor
110336668|NCT01248962|Carboplatin|carboplatin|mesh-list
110336669|NCT01248962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110336670|NCT00511446|Docetaxel|docetaxel|mesh-list
110336671|NCT00511446|Capecitabine|capecitabine|mesh-list
110336672|NCT00511446|Oxaliplatin|oxaliplatin|mesh-list
110336673|NCT00511446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110336674|NCT00511446|Tubulin Modulators|tubulin modulators|mesh-ancestor
110336675|NCT00511446|Antimitotic Agents|antimitotic agents|mesh-ancestor
110336676|NCT00511446|Mitosis Modulators|mitosis modulators|mesh-ancestor
110336677|NCT00511446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110336678|NCT00511446|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110336679|NCT00511446|Antimetabolites|antimetabolites|mesh-ancestor
110336680|NCT02955446|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-list
110336682|NCT02955446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110336683|NCT02955446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110336684|NCT00511602|Insulin|insulin|mesh-list
110336685|NCT00511602|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110336686|NCT00511602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110336687|NCT00511953|Gabapentin|gabapentin|mesh-list
110336688|NCT00511953|Analgesics|analgesics|mesh-ancestor
110336689|NCT00511953|Sensory System Agents|sensory system agents|mesh-ancestor
110336690|NCT00511953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110336691|NCT00511953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110336692|NCT00511953|Anticonvulsants|anticonvulsants|mesh-ancestor
110336693|NCT00511953|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110336694|NCT00511953|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110336695|NCT00511953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110336696|NCT00511953|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110336697|NCT00511953|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110336698|NCT00511953|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110336699|NCT00511953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110336700|NCT00511953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110336701|NCT00511953|Antimanic Agents|antimanic agents|mesh-ancestor
110336702|NCT01249820|Anidulafungin|anidulafungin|mesh-list
110336703|NCT01249820|Antifungal Agents|antifungal agents|mesh-ancestor
110336704|NCT01249820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110336705|NCT01247090|Vasopressins|vasopressins|mesh-list
110336706|NCT01247090|Arginine Vasopressin|arginine vasopressin|mesh-list
110336707|NCT01247090|Hemostatics|hemostatics|mesh-ancestor
110336708|NCT01247090|Coagulants|coagulants|mesh-ancestor
110336709|NCT01247090|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110336711|NCT01247090|Natriuretic Agents|natriuretic agents|mesh-ancestor
110336712|NCT01247090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110336713|NCT00504764|Arsenic Trioxide|arsenic trioxide|mesh-list
110336714|NCT00504764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110336715|NCT02951754|Methylphenidate|methylphenidate|mesh-list
110336716|NCT02951754|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110336717|NCT02951754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110336718|NCT02951754|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110336719|NCT02951754|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110336721|NCT02951754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110336722|NCT02951754|Dopamine Agents|dopamine agents|mesh-ancestor
110336723|NCT02951754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110336724|NCT00504413|Digoxin|digoxin|mesh-list
110336725|NCT00504413|Midazolam|midazolam|mesh-list
110336726|NCT00504413|Methadone|methadone|mesh-list
110336727|NCT00504413|Bupropion|bupropion|mesh-list
110336728|NCT00504413|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110336729|NCT00504413|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110336730|NCT00504413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110336731|NCT00504413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110336732|NCT00504413|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110336733|NCT00504413|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110336734|NCT00504413|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110336735|NCT00504413|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110336736|NCT00504413|Anesthetics, General|anesthetics, general|mesh-ancestor
110336737|NCT00504413|Anesthetics|anesthetics|mesh-ancestor
110336738|NCT00504413|GABA Modulators|gaba modulators|mesh-ancestor
110336739|NCT00504413|GABA Agents|gaba agents|mesh-ancestor
110336740|NCT00504413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110336741|NCT00504413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110336742|NCT00504413|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110336743|NCT00504413|Antidepressive Agents|antidepressive agents|mesh-ancestor
110336744|NCT00504413|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110336745|NCT00504413|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110336746|NCT00504413|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110336747|NCT00504413|Dopamine Agents|dopamine agents|mesh-ancestor
110336748|NCT00504413|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110336749|NCT00504413|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110336750|NCT00504413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110336751|NCT00504413|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110336752|NCT00504413|Narcotics|narcotics|mesh-ancestor
110336753|NCT00504413|Analgesics|analgesics|mesh-ancestor
110336754|NCT00504413|Sensory System Agents|sensory system agents|mesh-ancestor
110336755|NCT00504413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110336756|NCT00504413|Antitussive Agents|antitussive agents|mesh-ancestor
110336757|NCT00504413|Respiratory System Agents|respiratory system agents|mesh-ancestor
110336758|NCT00504413|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110336759|NCT00504413|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110336760|NCT00504413|Protective Agents|protective agents|mesh-ancestor
110336761|NCT02951793|Psychotropic Drugs|psychotropic drugs|mesh-list
110336762|NCT01243658|Oxytocin|oxytocin|mesh-list
110336763|NCT01243658|Oxytocics|oxytocics|mesh-ancestor
110336764|NCT01243658|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110336765|NCT01243658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110336766|NCT01249664|Aflibercept|aflibercept|mesh-list
110336767|NCT01249664|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110336768|NCT01249664|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110336769|NCT01249664|Growth Substances|growth substances|mesh-ancestor
110561981|NCT02656121|Clomiphene|clomiphene|mesh-list
110336770|NCT01249664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110336771|NCT01249664|Growth Inhibitors|growth inhibitors|mesh-ancestor
110336772|NCT01249664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110336773|NCT00513162|Etoposide|etoposide|mesh-list
110336774|NCT00513162|Valproic Acid|valproic acid|mesh-list
110336775|NCT00513162|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110336776|NCT00513162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110562027|NCT02655965|Analgesics|analgesics|mesh-ancestor
110336777|NCT00513162|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110336778|NCT00513162|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110336779|NCT00513162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110336780|NCT00513162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110336781|NCT00513162|Anticonvulsants|anticonvulsants|mesh-ancestor
110336782|NCT00513162|GABA Agents|gaba agents|mesh-ancestor
110336783|NCT00513162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110336784|NCT00513162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110336785|NCT00513162|Antimanic Agents|antimanic agents|mesh-ancestor
110336786|NCT00513162|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110336787|NCT00513162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110336788|NCT00513162|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110336790|NCT00513201|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110336791|NCT00513201|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110336792|NCT00513201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110336793|NCT00512265|Acetylcysteine|acetylcysteine|mesh-list
110336794|NCT00512265|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110336795|NCT00512265|Antiviral Agents|antiviral agents|mesh-ancestor
110336796|NCT00512265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110336797|NCT00512265|Expectorants|expectorants|mesh-ancestor
110336798|NCT00512265|Respiratory System Agents|respiratory system agents|mesh-ancestor
110336799|NCT00512265|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110336800|NCT00512265|Antioxidants|antioxidants|mesh-ancestor
110336801|NCT00512265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110336802|NCT00512265|Protective Agents|protective agents|mesh-ancestor
110336803|NCT00512265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110336804|NCT00512265|Antidotes|antidotes|mesh-ancestor
110336805|NCT00513396|Isoniazid|isoniazid|mesh-list
110336806|NCT00513396|Antitubercular Agents|antitubercular agents|mesh-ancestor
110336807|NCT00513396|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110336808|NCT00513396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110336809|NCT00513396|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
110336810|NCT00513396|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110336811|NCT00513396|Antimetabolites|antimetabolites|mesh-ancestor
110562154|NCT04169867|Atezolizumab|atezolizumab|mesh-list
110336812|NCT00513396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110336813|NCT00513396|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110336814|NCT01249274|Progesterone|progesterone|mesh-list
110336815|NCT01249274|Progestins|progestins|mesh-ancestor
110336816|NCT01249274|Hormones|hormones|mesh-ancestor
110336817|NCT01249274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110336818|NCT01249274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110336819|NCT00513513|Ritonavir|ritonavir|mesh-list
110336820|NCT00513513|Darunavir|darunavir|mesh-list
110336821|NCT00513513|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110336822|NCT00513513|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110336823|NCT00513513|Protease Inhibitors|protease inhibitors|mesh-ancestor
110336824|NCT00513513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110336825|NCT00513513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110336826|NCT00513513|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110336827|NCT00513513|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110336828|NCT00513513|Antiviral Agents|antiviral agents|mesh-ancestor
110336829|NCT00513513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110336830|NCT00513513|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110336831|NCT00513513|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110336832|NCT00504959|Ranibizumab|ranibizumab|mesh-list
110336833|NCT00504959|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110336834|NCT00504959|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110336835|NCT00504959|Growth Substances|growth substances|mesh-ancestor
110336836|NCT00504959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110336837|NCT00504959|Growth Inhibitors|growth inhibitors|mesh-ancestor
110336838|NCT00504959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110336839|NCT00512616|Ceftriaxone|ceftriaxone|mesh-list
110336840|NCT00512616|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110336841|NCT00512616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110336842|NCT00505037|Sevelamer|sevelamer|mesh-list
110562265|NCT02654171|Ziresovir|ziresovir|mesh-list
110336843|NCT00505037|Chelating Agents|chelating agents|mesh-ancestor
110336844|NCT00505037|Sequestering Agents|sequestering agents|mesh-ancestor
110336845|NCT00505037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110336848|NCT00513552|Clofazimine|clofazimine|mesh-list
110336849|NCT00513552|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110336850|NCT00513552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110336851|NCT00513552|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110336852|NCT00513552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110336853|NCT00513552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110336854|NCT00513552|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110562322|NCT00699764|Vaccines|vaccines|mesh-list
110336855|NCT00513552|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110336856|NCT00513552|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110336857|NCT00513552|Antitubercular Agents|antitubercular agents|mesh-ancestor
110336858|NCT00513552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110336859|NCT00513552|Leprostatic Agents|leprostatic agents|mesh-ancestor
110336860|NCT00513630|Metformin|metformin|mesh-list
110336861|NCT00513630|Glipizide|glipizide|mesh-list
110336862|NCT00513630|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110336863|NCT00513630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110336864|NCT02275247|Ropivacaine|ropivacaine|mesh-list
110336865|NCT02275247|Anesthetics, Local|anesthetics, local|mesh-ancestor
110336866|NCT02275247|Anesthetics|anesthetics|mesh-ancestor
110562387|NCT00699920|Antimalarials|antimalarials|mesh-ancestor
110336867|NCT02275247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110336868|NCT02275247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110336869|NCT02275247|Sensory System Agents|sensory system agents|mesh-ancestor
110336870|NCT02275247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110336871|NCT04515719|Belimumab|belimumab|mesh-list
110336872|NCT04515719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110336873|NCT04515719|Immunologic Factors|immunologic factors|mesh-ancestor
110336874|NCT04515719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110336875|NCT00513786|Paclitaxel|paclitaxel|mesh-list
110336876|NCT00513786|Bevacizumab|bevacizumab|mesh-list
110336877|NCT00513786|Carboplatin|carboplatin|mesh-list
110336878|NCT00513786|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110336879|NCT00513786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110336880|NCT00513786|Tubulin Modulators|tubulin modulators|mesh-ancestor
110336881|NCT00513786|Antimitotic Agents|antimitotic agents|mesh-ancestor
110336882|NCT00513786|Mitosis Modulators|mitosis modulators|mesh-ancestor
110336883|NCT00513786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110336884|NCT00513786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110336885|NCT00513786|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110336886|NCT00513786|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110336888|NCT00513786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110336889|NCT00513786|Growth Inhibitors|growth inhibitors|mesh-ancestor
110336890|NCT00504491|Rituximab|rituximab|mesh-list
110336891|NCT00504491|Alemtuzumab|alemtuzumab|mesh-list
110336892|NCT00504491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110336893|NCT00504491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110336894|NCT00504491|Immunologic Factors|immunologic factors|mesh-ancestor
110336895|NCT00504491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110336896|NCT00504491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110336897|NCT00512811|Furosemide|furosemide|mesh-list
110336898|NCT00512811|Diuretics|diuretics|mesh-ancestor
110336899|NCT00512811|Natriuretic Agents|natriuretic agents|mesh-ancestor
110336900|NCT00512811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110336901|NCT00512811|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110336902|NCT00512811|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110336903|NCT00512811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110336904|NCT00513864|Morphine|morphine|mesh-list
110336905|NCT00513864|Codeine|codeine|mesh-list
110336906|NCT00513864|Dextromethorphan|dextromethorphan|mesh-list
110336907|NCT00513864|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110336908|NCT00513864|Narcotics|narcotics|mesh-ancestor
110336909|NCT00513864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110336910|NCT00513864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110336911|NCT00513864|Analgesics|analgesics|mesh-ancestor
110562566|NCT02661191|Vitamins|vitamins|mesh-ancestor
110336912|NCT00513864|Sensory System Agents|sensory system agents|mesh-ancestor
110173030|NCT00055393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110336913|NCT00513864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110336914|NCT00513864|Antitussive Agents|antitussive agents|mesh-ancestor
110336915|NCT00513864|Respiratory System Agents|respiratory system agents|mesh-ancestor
110336916|NCT00513864|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110336917|NCT00513864|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110336918|NCT00513864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110336919|NCT00513864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110336920|NCT01248884|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110336921|NCT01248884|Immunologic Factors|immunologic factors|mesh-ancestor
110336922|NCT01248884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110336923|NCT00512850|Folic Acid|folic acid|mesh-list
110336924|NCT00512850|Hematinics|hematinics|mesh-ancestor
110336925|NCT00512850|Vitamin B Complex|vitamin b complex|mesh-ancestor
110336926|NCT00512850|Vitamins|vitamins|mesh-ancestor
110336927|NCT00512850|Micronutrients|micronutrients|mesh-ancestor
110336928|NCT00512850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110336929|NCT00512928|Vitamin K 2|vitamin k 2|mesh-list
110336930|NCT00512928|Vitamin K|vitamin k|mesh-list
110336931|NCT00512928|Acenocoumarol|acenocoumarol|mesh-list
110336932|NCT00512928|Menaquinone 7|menaquinone 7|mesh-list
110336933|NCT00512928|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110336934|NCT00512928|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110336935|NCT00512928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110336936|NCT00512928|Hemostatics|hemostatics|mesh-ancestor
110336937|NCT00512928|Coagulants|coagulants|mesh-ancestor
110336938|NCT00512928|Vitamins|vitamins|mesh-ancestor
110336939|NCT00512928|Micronutrients|micronutrients|mesh-ancestor
110336940|NCT00512928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110336941|NCT00512928|Anticoagulants|anticoagulants|mesh-ancestor
110336942|NCT00505154|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110336943|NCT00505154|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110336944|NCT00505154|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110336945|NCT00505154|Antimetabolites|antimetabolites|mesh-ancestor
110336946|NCT00505154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110336947|NCT00505154|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110336948|NCT00505154|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110336949|NCT00505154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110336950|NCT01246973|Curcumin|curcumin|mesh-list
110562824|NCT00650897|Serotonin Agents|serotonin agents|mesh-ancestor
110336951|NCT01246973|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110336952|NCT01246973|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110336953|NCT01246973|Analgesics|analgesics|mesh-ancestor
110336954|NCT01246973|Sensory System Agents|sensory system agents|mesh-ancestor
110336955|NCT01246973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110336956|NCT01246973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110336957|NCT01246973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110336958|NCT01246973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110336959|NCT01246973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110336960|NCT01246973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110336961|NCT01246973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110336962|NCT00514605|Antibodies|antibodies|mesh-list
110336963|NCT00514605|Immunoglobulins|immunoglobulins|mesh-list
110336964|NCT00514605|Immunologic Factors|immunologic factors|mesh-ancestor
110336965|NCT00514605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110336966|NCT00513981|Leucovorin|leucovorin|mesh-list
110336967|NCT00513981|Methotrexate|methotrexate|mesh-list
110336968|NCT00513981|Calcium|calcium|mesh-list
110336969|NCT00513981|Levoleucovorin|levoleucovorin|mesh-list
110336970|NCT00513981|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110336971|NCT00513981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110336972|NCT00513981|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110336973|NCT00513981|Abortifacient Agents|abortifacient agents|mesh-ancestor
110336974|NCT00513981|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110562945|NCT02643563|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110336975|NCT00513981|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110336976|NCT00513981|Antimetabolites|antimetabolites|mesh-ancestor
110336977|NCT00513981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110336978|NCT00513981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110336979|NCT00513981|Dermatologic Agents|dermatologic agents|mesh-ancestor
110336980|NCT00513981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110336981|NCT00513981|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110336982|NCT00513981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110336983|NCT00513981|Immunologic Factors|immunologic factors|mesh-ancestor
110336985|NCT00513981|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110336986|NCT00513981|Antidotes|antidotes|mesh-ancestor
110336987|NCT00513981|Protective Agents|protective agents|mesh-ancestor
110336988|NCT00513981|Vitamin B Complex|vitamin b complex|mesh-ancestor
110336989|NCT00513981|Vitamins|vitamins|mesh-ancestor
110336990|NCT00513981|Micronutrients|micronutrients|mesh-ancestor
110336991|NCT00505232|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110336992|NCT00505232|Immunologic Factors|immunologic factors|mesh-ancestor
110563009|NCT02649101|Thalidomide|thalidomide|mesh-list
110336993|NCT00505232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110336994|NCT00514761|Capecitabine|capecitabine|mesh-list
110336995|NCT00514761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110336996|NCT00514761|Antimetabolites|antimetabolites|mesh-ancestor
110336997|NCT00514761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110336998|NCT00514761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110336999|NCT01245140|Alitretinoin|alitretinoin|mesh-list
110337000|NCT01245140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110337001|NCT01245140|Dermatologic Agents|dermatologic agents|mesh-ancestor
110337002|NCT02951637|Carboplatin|carboplatin|mesh-list
110337003|NCT02951637|Pemetrexed|pemetrexed|mesh-list
110337004|NCT02951637|Gefitinib|gefitinib|mesh-list
110337005|NCT02951637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110337006|NCT02951637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110337007|NCT02951637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110337008|NCT02951637|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110337009|NCT02951637|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110337010|NCT02951637|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110337011|NCT01245101|Raltegravir Potassium|raltegravir potassium|mesh-list
110337012|NCT01245101|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110337013|NCT01245101|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110337014|NCT01245101|Antiviral Agents|antiviral agents|mesh-ancestor
110337015|NCT01245101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110337016|NCT01245101|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110563136|NCT00653315|Tramadol|tramadol|mesh-list
110337018|NCT01245101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110337019|NCT01245101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110337021|NCT01245062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110337022|NCT01245062|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110337023|NCT01245062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110337024|NCT01245062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110337025|NCT01244984|Fluticasone|fluticasone|mesh-list
110337026|NCT01244984|Xhance|xhance|mesh-list
110337027|NCT01244984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110337028|NCT01244984|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110337029|NCT01244984|Autonomic Agents|autonomic agents|mesh-ancestor
110337030|NCT01244984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110337031|NCT01244984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110337032|NCT01244984|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110337033|NCT01244984|Respiratory System Agents|respiratory system agents|mesh-ancestor
110337034|NCT01244984|Dermatologic Agents|dermatologic agents|mesh-ancestor
110337035|NCT01244984|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110337036|NCT04695483|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
110337037|NCT04695483|Hormones|hormones|mesh-ancestor
110337038|NCT04695483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110337039|NCT04695483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110337040|NCT01244126|Fentanyl|fentanyl|mesh-list
110337041|NCT01244126|Morphine|morphine|mesh-list
110337042|NCT01244126|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110337043|NCT01244126|Narcotics|narcotics|mesh-ancestor
110337044|NCT01244126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110337045|NCT01244126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110337046|NCT01244126|Analgesics|analgesics|mesh-ancestor
110337047|NCT01244126|Sensory System Agents|sensory system agents|mesh-ancestor
110337048|NCT01244126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110337049|NCT01244126|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110337050|NCT01244126|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110337051|NCT01244126|Anesthetics, General|anesthetics, general|mesh-ancestor
110337052|NCT01244126|Anesthetics|anesthetics|mesh-ancestor
110337053|NCT01243775|Docetaxel|docetaxel|mesh-list
110337054|NCT01243775|Oxaliplatin|oxaliplatin|mesh-list
110337055|NCT01243775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110337056|NCT01243775|Tubulin Modulators|tubulin modulators|mesh-ancestor
110337057|NCT01243775|Antimitotic Agents|antimitotic agents|mesh-ancestor
110337058|NCT01243775|Mitosis Modulators|mitosis modulators|mesh-ancestor
110337059|NCT01243775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110337061|NCT00514293|Docetaxel|docetaxel|mesh-list
110337062|NCT00514293|Capecitabine|capecitabine|mesh-list
110337063|NCT00514293|Tretinoin|tretinoin|mesh-list
110337064|NCT00514293|Bexarotene|bexarotene|mesh-list
110337065|NCT00514293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110337066|NCT00514293|Tubulin Modulators|tubulin modulators|mesh-ancestor
110337067|NCT00514293|Antimitotic Agents|antimitotic agents|mesh-ancestor
110337068|NCT00514293|Mitosis Modulators|mitosis modulators|mesh-ancestor
110337069|NCT00514293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110337070|NCT00514293|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110563461|NCT02562118|Letrozole|letrozole|mesh-list
110337071|NCT00514293|Antimetabolites|antimetabolites|mesh-ancestor
110337072|NCT00514293|Keratolytic Agents|keratolytic agents|mesh-ancestor
110337073|NCT00514293|Dermatologic Agents|dermatologic agents|mesh-ancestor
110337074|NCT02955641|Dexamethasone|dexamethasone|mesh-list
110337075|NCT02955641|Nepafenac|nepafenac|mesh-list
110337076|NCT02955641|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110337077|NCT02955641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110337078|NCT02955641|Antiemetics|antiemetics|mesh-ancestor
110337079|NCT02955641|Autonomic Agents|autonomic agents|mesh-ancestor
110337080|NCT02955641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110337081|NCT02955641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110337082|NCT02955641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110337083|NCT02955641|Glucocorticoids|glucocorticoids|mesh-ancestor
110337084|NCT02955641|Hormones|hormones|mesh-ancestor
110337085|NCT02955641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110337086|NCT02955641|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110337087|NCT02955641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110337088|NCT02955641|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110337089|NCT02955641|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110337090|NCT02955641|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110337091|NCT02955641|Analgesics|analgesics|mesh-ancestor
110337092|NCT02955641|Sensory System Agents|sensory system agents|mesh-ancestor
110337093|NCT02955641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110337094|NCT01243268|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
110337095|NCT01243268|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110337096|NCT01243268|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110337097|NCT01243268|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110337098|NCT01243268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110337099|NCT00514995|Sodium Oxybate|sodium oxybate|mesh-list
110337100|NCT00514995|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110337101|NCT00514995|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110337102|NCT00514995|Anesthetics, General|anesthetics, general|mesh-ancestor
110337103|NCT00514995|Anesthetics|anesthetics|mesh-ancestor
110337104|NCT00514995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110337105|NCT00514995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110337106|NCT01242176|Empagliflozin|empagliflozin|mesh-list
110337107|NCT01242176|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110337108|NCT01242176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110337109|NCT01242176|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110337110|NCT01242176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110337111|NCT00515151|Ethanol|ethanol|mesh-list
110337112|NCT00515151|Octenidine|octenidine|mesh-list
110337113|NCT00515151|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110337114|NCT00515151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110337115|NCT00515151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110337116|NCT00515151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110563744|NCT02637167|Rifaximin|rifaximin|mesh-list
110337117|NCT01241786|Lenalidomide|lenalidomide|mesh-list
110337118|NCT01241786|Azacitidine|azacitidine|mesh-list
110337119|NCT01241786|Immunologic Factors|immunologic factors|mesh-ancestor
110337120|NCT01241786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110337121|NCT01241786|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110337122|NCT01241786|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110337123|NCT01241786|Growth Substances|growth substances|mesh-ancestor
110337124|NCT01241786|Growth Inhibitors|growth inhibitors|mesh-ancestor
110337125|NCT01241786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110337126|NCT01241786|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110337127|NCT01241786|Antimetabolites|antimetabolites|mesh-ancestor
110337128|NCT01241786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110337129|NCT01241786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110337132|NCT00514410|Vitamin B Complex|vitamin b complex|mesh-ancestor
110337133|NCT00514410|Vitamins|vitamins|mesh-ancestor
110337134|NCT00514410|Micronutrients|micronutrients|mesh-ancestor
110337135|NCT00514410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110337136|NCT01241318|Chlorhexidine|chlorhexidine|mesh-list
110337137|NCT01241318|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110337138|NCT01241318|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110337139|NCT01241318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110337140|NCT01241318|Disinfectants|disinfectants|mesh-ancestor
110337141|NCT01241318|Dermatologic Agents|dermatologic agents|mesh-ancestor
110337142|NCT00514488|Imatinib Mesylate|imatinib mesylate|mesh-list
110337143|NCT00514488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110337144|NCT00514488|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110337145|NCT00514488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110337146|NCT00514488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110337147|NCT00514527|Oritavancin|oritavancin|mesh-list
110337148|NCT00514527|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110563845|NCT04160195|Fludarabine|fludarabine|mesh-list
110337149|NCT00514527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110337150|NCT01241240|Timolol|timolol|mesh-list
110337151|NCT01241240|Brimonidine Tartrate|brimonidine tartrate|mesh-list
110337152|NCT01241240|Bimatoprost|bimatoprost|mesh-list
110337153|NCT01241240|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110337154|NCT01241240|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110337155|NCT01241240|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110337156|NCT01241240|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110337157|NCT01241240|Adrenergic Agents|adrenergic agents|mesh-ancestor
110337158|NCT01241240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110337159|NCT01241240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110337160|NCT01241240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110337161|NCT01241240|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110337162|NCT01241240|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110337163|NCT01241240|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110337164|NCT01241240|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110337165|NCT01241240|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110337166|NCT02950623|Titanium dioxide|titanium dioxide|mesh-list
110337167|NCT02950623|Sunscreening Agents|sunscreening agents|mesh-ancestor
110337168|NCT02950623|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110337169|NCT02950623|Protective Agents|protective agents|mesh-ancestor
110337170|NCT02950623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110337171|NCT02950623|Dermatologic Agents|dermatologic agents|mesh-ancestor
110337172|NCT02950623|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110337174|NCT00516009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110337175|NCT00516009|Antiemetics|antiemetics|mesh-ancestor
110337176|NCT00516009|Autonomic Agents|autonomic agents|mesh-ancestor
110337177|NCT00516009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110337178|NCT00516009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110337179|NCT00516009|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110337180|NCT00516009|Glucocorticoids|glucocorticoids|mesh-ancestor
110337181|NCT00516009|Hormones|hormones|mesh-ancestor
110337182|NCT00516009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110337183|NCT00516009|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110337184|NCT00516009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110337185|NCT02950584|Titanium dioxide|titanium dioxide|mesh-list
110337186|NCT02950584|Sunscreening Agents|sunscreening agents|mesh-ancestor
110337187|NCT02950584|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110337188|NCT02950584|Protective Agents|protective agents|mesh-ancestor
110337189|NCT02950584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110337190|NCT02950584|Dermatologic Agents|dermatologic agents|mesh-ancestor
110337191|NCT02950584|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110337192|NCT01240811|Copper|copper|mesh-list
110337193|NCT01240811|Levonorgestrel|levonorgestrel|mesh-list
110337194|NCT01240811|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110337195|NCT01240811|Contraceptive Agents|contraceptive agents|mesh-ancestor
110337196|NCT01240811|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110564085|NCT02612298|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110337197|NCT01240811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110337198|NCT01240811|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110337199|NCT01240811|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110337200|NCT01240811|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110337201|NCT01240811|Trace Elements|trace elements|mesh-ancestor
110337202|NCT01240811|Micronutrients|micronutrients|mesh-ancestor
110337204|NCT03459144|Verteporfin|verteporfin|mesh-list
110337205|NCT03459144|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110337206|NCT03459144|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110337207|NCT03459144|Growth Substances|growth substances|mesh-ancestor
110337208|NCT03459144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110337209|NCT03459144|Growth Inhibitors|growth inhibitors|mesh-ancestor
110337210|NCT03459144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110337211|NCT03459144|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110337212|NCT03459144|Dermatologic Agents|dermatologic agents|mesh-ancestor
110337213|NCT03459105|Bupivacaine|bupivacaine|mesh-list
110337214|NCT03459105|Anesthetics|anesthetics|mesh-list
110337215|NCT03459105|Anesthetics, Local|anesthetics, local|mesh-ancestor
110337216|NCT03459105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110337217|NCT03459105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110337218|NCT03459105|Sensory System Agents|sensory system agents|mesh-ancestor
110337219|NCT03459105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110337220|NCT01240382|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110337221|NCT01240382|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110337222|NCT01240382|Hyaluronic Acid|hyaluronic acid|mesh-list
110337223|NCT01240382|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110337224|NCT01240382|Immunologic Factors|immunologic factors|mesh-ancestor
110337225|NCT01240382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110337226|NCT01240382|Viscosupplements|viscosupplements|mesh-ancestor
110337227|NCT01240382|Protective Agents|protective agents|mesh-ancestor
110337228|NCT01244828|Asenapine|asenapine|mesh-list
110337229|NCT01244828|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110337230|NCT01244828|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110337231|NCT01244828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110337232|NCT01244828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110337233|NCT01244828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110337234|NCT00504192|Gemcitabine|gemcitabine|mesh-list
110337235|NCT00504192|Oxaliplatin|oxaliplatin|mesh-list
110337236|NCT00504192|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110337237|NCT00504192|Antimetabolites|antimetabolites|mesh-ancestor
110337238|NCT00504192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110337239|NCT00504192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110337240|NCT01243346|Crenolanib|crenolanib|mesh-list
110337241|NCT01243346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110337242|NCT01249443|Paclitaxel|paclitaxel|mesh-list
110337243|NCT01249443|Carboplatin|carboplatin|mesh-list
110337244|NCT01249443|Vorinostat|vorinostat|mesh-list
110337245|NCT01249443|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110337246|NCT01249443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110337248|NCT01249443|Antimitotic Agents|antimitotic agents|mesh-ancestor
110337249|NCT01249443|Mitosis Modulators|mitosis modulators|mesh-ancestor
110337250|NCT01249443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110337251|NCT01249443|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110337252|NCT01249443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110337253|NCT01243073|Imetelstat|imetelstat|mesh-list
110337254|NCT01243073|Motesanib diphosphate|motesanib diphosphate|mesh-list
110337255|NCT01243073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110337256|NCT01243073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110337257|NCT01243073|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110337258|NCT00516243|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
110337259|NCT00516243|Antioxidants|antioxidants|mesh-ancestor
110337260|NCT00516243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110337261|NCT00516243|Protective Agents|protective agents|mesh-ancestor
110337262|NCT00516243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110337263|NCT00516243|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
110337264|NCT00516243|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110337265|NCT00516243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110337266|NCT00516243|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110337268|NCT01240889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110337269|NCT01240889|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110337270|NCT01240889|Autonomic Agents|autonomic agents|mesh-ancestor
110337271|NCT01240889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110337272|NCT01240889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110337273|NCT01240889|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110337274|NCT01240889|Respiratory System Agents|respiratory system agents|mesh-ancestor
110337275|NCT01240889|Dermatologic Agents|dermatologic agents|mesh-ancestor
110337276|NCT01240889|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110337278|NCT00516282|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110337279|NCT00516282|Alkylating Agents|alkylating agents|mesh-ancestor
110337280|NCT00516282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110337281|NCT00516282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110337282|NCT01249521|Bevacizumab|bevacizumab|mesh-list
110337283|NCT01249521|Trebananib|trebananib|mesh-list
110337284|NCT01249521|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110337285|NCT01249521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110337286|NCT01249521|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110337287|NCT01249521|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110337288|NCT01249521|Growth Substances|growth substances|mesh-ancestor
110337289|NCT01249521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110337290|NCT01249521|Growth Inhibitors|growth inhibitors|mesh-ancestor
110337291|NCT01249677|Insulin Glargine|insulin glargine|mesh-list
110337292|NCT01249677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110337293|NCT01249677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110337294|NCT04511975|Azacitidine|azacitidine|mesh-list
110337295|NCT04511975|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110337296|NCT04511975|Antimetabolites|antimetabolites|mesh-ancestor
110337297|NCT04511975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110337298|NCT04511975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110337299|NCT04511975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110337300|NCT04511897|Expectorants|expectorants|mesh-list
110337301|NCT04511897|Respiratory System Agents|respiratory system agents|mesh-ancestor
110337302|NCT04519463|Lidocaine|lidocaine|mesh-list
110337303|NCT04519463|Anesthetics, Local|anesthetics, local|mesh-ancestor
110337304|NCT04519463|Anesthetics|anesthetics|mesh-ancestor
110337305|NCT04519463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110337306|NCT04519463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110337307|NCT04519463|Sensory System Agents|sensory system agents|mesh-ancestor
110337308|NCT04519463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110337309|NCT04519463|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110337310|NCT04519463|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110337311|NCT04519463|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110337312|NCT04519463|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110337313|NCT04519463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110337315|NCT04696848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110337316|NCT04696848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110337317|NCT01244256|Gentamicins|gentamicins|mesh-list
110337318|NCT01244256|Clotrimazole|clotrimazole|mesh-list
110337320|NCT01244256|Beclomethasone|beclomethasone|mesh-list
110337321|NCT01244256|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110337322|NCT01244256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110337323|NCT01244256|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110337324|NCT01244256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110337325|NCT01244256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110337326|NCT01244256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110337327|NCT01244256|Glucocorticoids|glucocorticoids|mesh-ancestor
110337329|NCT01244256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110337330|NCT01244256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110337331|NCT01244256|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110337332|NCT01244256|Respiratory System Agents|respiratory system agents|mesh-ancestor
110173065|NCT00055666|Beclomethasone|beclomethasone|mesh-list
110337333|NCT01244256|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110337334|NCT01244256|Antifungal Agents|antifungal agents|mesh-ancestor
110337335|NCT01244256|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110337336|NCT01244256|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110337338|NCT01244256|Hormone Antagonists|hormone antagonists|mesh-ancestor
110337339|NCT01244256|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110564551|NCT05370313|Nicotine|nicotine|mesh-list
110337340|NCT01244256|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110337341|NCT01249833|Oseltamivir|oseltamivir|mesh-list
110337342|NCT01249833|Antiviral Agents|antiviral agents|mesh-ancestor
110337343|NCT01249833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110337344|NCT01249833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110337345|NCT01249833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110337346|NCT02950233|N-Methylaspartate|n-methylaspartate|mesh-list
110337347|NCT02950233|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
110337348|NCT02950233|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110337349|NCT02950233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110337350|NCT02950233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110337351|NCT02950233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110337352|NCT01249404|Botulinum Toxins|botulinum toxins|mesh-list
110337353|NCT01249404|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110337354|NCT01249404|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110337355|NCT01249404|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110337356|NCT01249404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110337357|NCT01249404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110337358|NCT01249404|Cholinergic Agents|cholinergic agents|mesh-ancestor
110337359|NCT01249404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110337360|NCT01249404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110337361|NCT01249404|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110337362|NCT01249404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110337363|NCT04511000|Atorvastatin|atorvastatin|mesh-list
110337364|NCT04511000|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110337365|NCT04511000|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110337366|NCT04511000|Antimetabolites|antimetabolites|mesh-ancestor
110337367|NCT04511000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110337368|NCT04511000|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110337369|NCT04511000|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110337370|NCT04511000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110337371|NCT04519385|Dexamethasone|dexamethasone|mesh-list
110337372|NCT04519385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110337373|NCT04519385|Antiemetics|antiemetics|mesh-ancestor
110337374|NCT04519385|Autonomic Agents|autonomic agents|mesh-ancestor
110337375|NCT04519385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110337376|NCT04519385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110337377|NCT04519385|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110337378|NCT04519385|Glucocorticoids|glucocorticoids|mesh-ancestor
110337380|NCT04519385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110564815|NCT04517435|Immunologic Factors|immunologic factors|mesh-ancestor
110337381|NCT04519385|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110337382|NCT04519385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110337383|NCT00506051|Pemetrexed|pemetrexed|mesh-list
110337384|NCT00506051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110337385|NCT00506051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110337386|NCT00506051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110337387|NCT00506051|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110337388|NCT00506051|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110337389|NCT00504465|Dinoprostone|dinoprostone|mesh-list
110337390|NCT00504465|Oxytocics|oxytocics|mesh-ancestor
110337391|NCT00504465|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110337392|NCT00504465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110337393|NCT00516360|Chlorhexidine|chlorhexidine|mesh-list
110337394|NCT00516360|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
110337395|NCT00516360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110337396|NCT00516360|Disinfectants|disinfectants|mesh-ancestor
110337398|NCT04510649|Rabeprazole|rabeprazole|mesh-list
110337399|NCT04510649|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110337400|NCT04510649|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110337401|NCT04510649|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110337402|NCT04510649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110337403|NCT04510649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110564945|NCT03950674|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110564946|NCT03950674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110564951|NCT03909477|Xenon|xenon|mesh-list
110337404|NCT04510649|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110337405|NCT04510649|Antitubercular Agents|antitubercular agents|mesh-ancestor
110337406|NCT04510649|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110337407|NCT04510649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110337408|NCT04510649|Leprostatic Agents|leprostatic agents|mesh-ancestor
110337409|NCT04510649|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110337410|NCT04510649|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110337411|NCT04510649|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110337412|NCT04510649|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110337413|NCT04510649|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110337414|NCT04510649|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110337415|NCT04510649|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110337417|NCT01249092|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110337418|NCT01249092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110337419|NCT01249092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110337420|NCT01249092|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110337421|NCT01249092|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110337422|NCT01249092|Protective Agents|protective agents|mesh-ancestor
110337423|NCT01249092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110337424|NCT01249092|Vasodilator Agents|vasodilator agents|mesh-ancestor
110337425|NCT01249092|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110337426|NCT01249092|Antioxidants|antioxidants|mesh-ancestor
110337427|NCT02275182|Dexmedetomidine|dexmedetomidine|mesh-list
110337428|NCT02275182|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110337429|NCT02275182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110337430|NCT02275182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110337431|NCT02275182|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110337432|NCT02275182|Analgesics|analgesics|mesh-ancestor
110337433|NCT02275182|Sensory System Agents|sensory system agents|mesh-ancestor
110337434|NCT02275182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110337435|NCT02275182|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110337436|NCT02275182|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110337437|NCT02275182|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110337438|NCT02275182|Adrenergic Agents|adrenergic agents|mesh-ancestor
110337439|NCT02275182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110337440|NCT02275182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110337441|NCT01248780|Golimumab|golimumab|mesh-list
110565207|NCT02251431|Hormones|hormones|mesh-ancestor
110337442|NCT01248780|Methotrexate|methotrexate|mesh-list
110337443|NCT01248780|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110337444|NCT01248780|Abortifacient Agents|abortifacient agents|mesh-ancestor
110337445|NCT01248780|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110337446|NCT01248780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110337447|NCT01248780|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110337448|NCT01248780|Antimetabolites|antimetabolites|mesh-ancestor
110337449|NCT01248780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110337450|NCT01248780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110337451|NCT01248780|Dermatologic Agents|dermatologic agents|mesh-ancestor
110337452|NCT01248780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110337453|NCT01248780|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110337454|NCT01248780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110337456|NCT01248780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110337457|NCT01248780|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110337458|NCT01248780|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110337459|NCT01248780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110337460|NCT01248468|Aspirin|aspirin|mesh-list
110337461|NCT01248468|Acetaminophen|acetaminophen|mesh-list
110337462|NCT01248468|Sumatriptan|sumatriptan|mesh-list
110337463|NCT01248468|Caffeine|caffeine|mesh-list
110337464|NCT01248468|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110337465|NCT01248468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110337466|NCT01248468|Analgesics|analgesics|mesh-ancestor
110337467|NCT01248468|Sensory System Agents|sensory system agents|mesh-ancestor
110337468|NCT01248468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110337469|NCT01248468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110337470|NCT01248468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110337471|NCT01248468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110337472|NCT01248468|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110337473|NCT01248468|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110337474|NCT01248468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110337475|NCT01248468|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110337476|NCT01248468|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110337477|NCT01248468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110337478|NCT01248468|Antipyretics|antipyretics|mesh-ancestor
110337479|NCT01248468|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110337480|NCT01248468|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110337481|NCT01248468|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110337482|NCT01248468|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110337483|NCT01248468|Purinergic Agents|purinergic agents|mesh-ancestor
110337484|NCT01248468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110337485|NCT01248468|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110337486|NCT01248468|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110337487|NCT01248468|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110337488|NCT01248468|Serotonin Agents|serotonin agents|mesh-ancestor
110337489|NCT02275299|Methotrexate|methotrexate|mesh-list
110337490|NCT02275299|Leflunomide|leflunomide|mesh-list
110337491|NCT02275299|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110337492|NCT02275299|Abortifacient Agents|abortifacient agents|mesh-ancestor
110337493|NCT02275299|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110337494|NCT02275299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110337495|NCT02275299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110337496|NCT02275299|Antimetabolites|antimetabolites|mesh-ancestor
110337497|NCT02275299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110337498|NCT02275299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110337499|NCT02275299|Dermatologic Agents|dermatologic agents|mesh-ancestor
110337500|NCT02275299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110337501|NCT02275299|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110337502|NCT02275299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110337503|NCT02275299|Immunologic Factors|immunologic factors|mesh-ancestor
110337504|NCT02275299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110337505|NCT02275299|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110337506|NCT01247922|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110337507|NCT01247922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110337508|NCT01247922|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110337509|NCT01247922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110337510|NCT01247922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110337511|NCT01246206|Tacrolimus|tacrolimus|mesh-list
110337512|NCT01246206|Thymoglobulin|thymoglobulin|mesh-list
110337514|NCT01246206|Immunologic Factors|immunologic factors|mesh-ancestor
110337515|NCT01246206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110337516|NCT01246206|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110337517|NCT01246206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110337518|NCT01246206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110337519|NCT04510610|Decitabine|decitabine|mesh-list
110337520|NCT04510610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110337521|NCT04510610|Antimetabolites|antimetabolites|mesh-ancestor
110337522|NCT04510610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110337523|NCT04510610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110337524|NCT04510610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110337525|NCT01246011|Warfarin|warfarin|mesh-list
110337526|NCT01246011|Argatroban|argatroban|mesh-list
110337527|NCT01246011|Anticoagulants|anticoagulants|mesh-ancestor
110337528|NCT01246011|Antithrombins|antithrombins|mesh-ancestor
110337529|NCT01246011|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110337530|NCT01246011|Protease Inhibitors|protease inhibitors|mesh-ancestor
110337532|NCT01246011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110337533|NCT01246011|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110337534|NCT01244490|Guanfacine|guanfacine|mesh-list
110337535|NCT01244490|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
110565559|NCT02631473|Ritonavir|ritonavir|mesh-list
110337536|NCT01244490|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110337537|NCT01244490|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110337538|NCT01244490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110337539|NCT01244490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110337540|NCT01244490|Adrenergic Agents|adrenergic agents|mesh-ancestor
110337541|NCT01244490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110337542|NCT01244490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110337543|NCT01244490|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110337544|NCT01244490|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110337545|NCT01244490|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110337546|NCT01244490|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110337547|NCT01243944|Lenalidomide|lenalidomide|mesh-list
110337548|NCT01243944|Pomalidomide|pomalidomide|mesh-list
110337549|NCT01243944|Hydroxyurea|hydroxyurea|mesh-list
110337550|NCT01243944|Pipobroman|pipobroman|mesh-list
110337551|NCT01243944|Anagrelide|anagrelide|mesh-list
110337552|NCT01243944|Immunologic Factors|immunologic factors|mesh-ancestor
110337553|NCT01243944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110337554|NCT01243944|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110337555|NCT01243944|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110337556|NCT01243944|Growth Substances|growth substances|mesh-ancestor
110337557|NCT01243944|Growth Inhibitors|growth inhibitors|mesh-ancestor
110337558|NCT01243944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110337559|NCT01243944|Antisickling Agents|antisickling agents|mesh-ancestor
110337560|NCT01243944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110337561|NCT01243944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110337562|NCT01243944|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110337563|NCT01243944|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110337564|NCT01243944|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110337565|NCT01243944|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110337566|NCT01243944|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110337567|NCT01243944|Alkylating Agents|alkylating agents|mesh-ancestor
110337568|NCT00516399|Povidone-Iodine|povidone-iodine|mesh-list
110337569|NCT00516399|Natamycin|natamycin|mesh-list
110337570|NCT00516399|Povidone|povidone|mesh-list
110337571|NCT00516399|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110337572|NCT00516399|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110337573|NCT00516399|Plasma Substitutes|plasma substitutes|mesh-ancestor
110337574|NCT00516399|Blood Substitutes|blood substitutes|mesh-ancestor
110565811|NCT00669773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110337575|NCT00516399|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110337576|NCT00516399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110337577|NCT00516399|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110337578|NCT00516399|Antifungal Agents|antifungal agents|mesh-ancestor
110337579|NCT00516438|Topotecan|topotecan|mesh-list
110337580|NCT00516438|Olaparib|olaparib|mesh-list
110337581|NCT00516438|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
110337582|NCT00516438|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110337583|NCT00516438|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110337584|NCT00516438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110337585|NCT00516438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110337586|NCT00516438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110337587|NCT02275988|Clarithromycin|clarithromycin|mesh-list
110337588|NCT02275988|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110337589|NCT02275988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110337590|NCT02275988|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110337591|NCT02275988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110337592|NCT02275988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110337593|NCT02275988|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110337594|NCT02275988|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110337595|NCT02950155|Rituximab|rituximab|mesh-list
110337596|NCT02950155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110337597|NCT02950155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110337598|NCT02950155|Immunologic Factors|immunologic factors|mesh-ancestor
110565943|NCT00664469|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110337599|NCT02950155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110173094|NCT00055861|Docetaxel|docetaxel|mesh-list
110337600|NCT02950155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110337601|NCT00516672|Lapatinib|lapatinib|mesh-list
110337602|NCT00516672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110337603|NCT00516672|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110337604|NCT00516672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110337605|NCT00516672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110337606|NCT00516711|Sevoflurane|sevoflurane|mesh-list
110337607|NCT00516711|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110337608|NCT00516711|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110337609|NCT00516711|Anesthetics, General|anesthetics, general|mesh-ancestor
110337610|NCT00516711|Anesthetics|anesthetics|mesh-ancestor
110337611|NCT00516711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110337612|NCT00516711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110337613|NCT00516750|Doxorubicin|doxorubicin|mesh-list
110337614|NCT00516750|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110337615|NCT00516750|Methotrexate|methotrexate|mesh-list
110337616|NCT00516750|Vinblastine|vinblastine|mesh-list
110337617|NCT00516750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110337618|NCT00516750|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110337619|NCT00516750|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110337620|NCT00516750|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110337621|NCT00516750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110337622|NCT00516750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110337623|NCT00516750|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110337624|NCT00516750|Abortifacient Agents|abortifacient agents|mesh-ancestor
110337625|NCT00516750|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110566064|NCT00911651|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110337626|NCT00516750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110337627|NCT00516750|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110337628|NCT00516750|Antimetabolites|antimetabolites|mesh-ancestor
110337629|NCT00516750|Dermatologic Agents|dermatologic agents|mesh-ancestor
110337630|NCT00516750|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110337631|NCT00516750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110337632|NCT00516750|Immunologic Factors|immunologic factors|mesh-ancestor
110337633|NCT00516750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110337634|NCT00516750|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110337635|NCT00516750|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110337636|NCT00516750|Tubulin Modulators|tubulin modulators|mesh-ancestor
110337637|NCT00516750|Antimitotic Agents|antimitotic agents|mesh-ancestor
110337638|NCT00516750|Mitosis Modulators|mitosis modulators|mesh-ancestor
110337639|NCT00505427|Thioctic Acid|thioctic acid|mesh-list
110337640|NCT00505427|Antioxidants|antioxidants|mesh-ancestor
110337641|NCT00505427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110337642|NCT00505427|Protective Agents|protective agents|mesh-ancestor
110337643|NCT00505427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110337644|NCT00505427|Vitamin B Complex|vitamin b complex|mesh-ancestor
110337645|NCT00505427|Vitamins|vitamins|mesh-ancestor
110337646|NCT00505427|Micronutrients|micronutrients|mesh-ancestor
110337647|NCT00506168|Capecitabine|capecitabine|mesh-list
110337648|NCT00506168|Irinotecan|irinotecan|mesh-list
110337649|NCT00506168|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110337650|NCT00506168|Antimetabolites|antimetabolites|mesh-ancestor
110337651|NCT00506168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110337652|NCT00506168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110337653|NCT00506168|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110337654|NCT00506168|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110337655|NCT00506168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110337656|NCT02950038|Nivolumab|nivolumab|mesh-list
110337657|NCT02950038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110337658|NCT02950038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110337659|NCT02950038|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110337660|NCT02950038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110337661|NCT04510220|Ofatumumab|ofatumumab|mesh-list
110337662|NCT04510220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110337663|NCT02949648|Nicotine|nicotine|mesh-list
110337664|NCT02949648|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110337665|NCT02949648|Autonomic Agents|autonomic agents|mesh-ancestor
110337666|NCT02949648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110566247|NCT00595127|Cyclophosphamide|cyclophosphamide|mesh-list
110337667|NCT02949648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110337669|NCT02949648|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110337670|NCT02949648|Cholinergic Agents|cholinergic agents|mesh-ancestor
110337671|NCT02949648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110337672|NCT02949648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110337673|NCT04510337|Magnesium Sulfate|magnesium sulfate|mesh-list
110337675|NCT04510337|Analgesics|analgesics|mesh-ancestor
110566303|NCT00912119|Hemostatics|hemostatics|mesh-ancestor
110337677|NCT04510337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110337678|NCT04510337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110337679|NCT04510337|Anesthetics|anesthetics|mesh-ancestor
110337680|NCT04510337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110337681|NCT04510337|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110337682|NCT04510337|Anticonvulsants|anticonvulsants|mesh-ancestor
110337683|NCT04510337|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110337684|NCT04510337|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110337685|NCT04510337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110337686|NCT04510337|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110337687|NCT04510337|Tocolytic Agents|tocolytic agents|mesh-ancestor
110337688|NCT04510337|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110337689|NCT04510337|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110337690|NCT04510337|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110337691|NCT04510337|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110337693|NCT02949765|Trace Elements|trace elements|mesh-ancestor
110337694|NCT02949765|Micronutrients|micronutrients|mesh-ancestor
110337695|NCT02949765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110337697|NCT04518176|Oxytocics|oxytocics|mesh-ancestor
110337698|NCT04518176|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110337699|NCT04518176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110337700|NCT00516945|Lamivudine|lamivudine|mesh-list
110337701|NCT00516945|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110337702|NCT00516945|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110337703|NCT00516945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110337704|NCT00516945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110337705|NCT00516945|Antiviral Agents|antiviral agents|mesh-ancestor
110337706|NCT00516945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110337707|NCT00516945|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110566567|NCT00675545|Carboplatin|carboplatin|mesh-list
110337708|NCT00516945|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110337709|NCT02275598|Brentuximab Vedotin|brentuximab vedotin|mesh-list
110337710|NCT02275598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110566627|NCT00808509|Adalimumab|adalimumab|mesh-list
110337711|NCT02275598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110337713|NCT02275598|Immunoconjugates|immunoconjugates|mesh-ancestor
110337714|NCT02275598|Immunologic Factors|immunologic factors|mesh-ancestor
110337715|NCT02275598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110337716|NCT00517062|Hormones|hormones|mesh-list
110337717|NCT00517062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110337718|NCT00517062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110337719|NCT00517179|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
110337720|NCT00517179|Vasodilator Agents|vasodilator agents|mesh-ancestor
110337721|NCT00517179|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110337722|NCT00517179|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110337723|NCT00517179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110337724|NCT00517179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110337725|NCT00517179|Urological Agents|urological agents|mesh-ancestor
110337727|NCT00517218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110337728|NCT00506207|Oxaliplatin|oxaliplatin|mesh-list
110337729|NCT00506207|Irinotecan|irinotecan|mesh-list
110337730|NCT00506207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110337731|NCT00506207|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110337732|NCT00506207|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110337733|NCT00506207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110337734|NCT00506207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110337735|NCT00517257|Atorvastatin|atorvastatin|mesh-list
110337736|NCT00517257|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110337737|NCT00517257|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110337738|NCT00517257|Antimetabolites|antimetabolites|mesh-ancestor
110337739|NCT00517257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110337740|NCT00517257|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110337741|NCT00517257|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110337742|NCT00517257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110337743|NCT00506246|Propofol|propofol|mesh-list
110337744|NCT00506246|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110337745|NCT00506246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110337746|NCT00506246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110337747|NCT00506246|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110337748|NCT00506246|Anesthetics, General|anesthetics, general|mesh-ancestor
110337749|NCT00506246|Anesthetics|anesthetics|mesh-ancestor
110337750|NCT01243242|Metadoxine|metadoxine|mesh-list
110337751|NCT01243242|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110337752|NCT00517491|Lanreotide|lanreotide|mesh-list
110337753|NCT00517491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110337754|NCT04517201|Insulin|insulin|mesh-list
110337755|NCT04517201|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110337756|NCT04517201|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110337757|NCT04517201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110337758|NCT01241292|Elotuzumab|elotuzumab|mesh-list
110337759|NCT01241292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110337760|NCT00517725|Carvedilol|carvedilol|mesh-list
110337762|NCT00517725|Bisoprolol|bisoprolol|mesh-list
110337763|NCT00517725|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110337764|NCT00517725|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110337765|NCT00517725|Adrenergic Agents|adrenergic agents|mesh-ancestor
110337766|NCT00517725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110337767|NCT00517725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110337768|NCT00517725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110337769|NCT00517725|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110337770|NCT00517725|Antioxidants|antioxidants|mesh-ancestor
110337771|NCT00517725|Protective Agents|protective agents|mesh-ancestor
110337772|NCT00517725|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110337773|NCT00517725|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110337774|NCT00517725|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110337775|NCT00517725|Vasodilator Agents|vasodilator agents|mesh-ancestor
110337776|NCT00517725|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110337777|NCT00517725|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110337778|NCT00517725|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
110337779|NCT00517725|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110337780|NCT00517725|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110337781|NCT00517725|Sympatholytics|sympatholytics|mesh-ancestor
110337782|NCT00517725|Autonomic Agents|autonomic agents|mesh-ancestor
110337783|NCT00517725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110337784|NCT00517725|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110337785|NCT01240863|Hydrocodone|hydrocodone|mesh-list
110337786|NCT01240863|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110337787|NCT01240863|Narcotics|narcotics|mesh-ancestor
110337788|NCT01240863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110337789|NCT01240863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110337790|NCT01240863|Analgesics|analgesics|mesh-ancestor
110337791|NCT01240863|Sensory System Agents|sensory system agents|mesh-ancestor
110337792|NCT01240863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110337793|NCT01240863|Antitussive Agents|antitussive agents|mesh-ancestor
110567072|NCT05951595|Anthelmintics|anthelmintics|mesh-ancestor
110337794|NCT01240863|Respiratory System Agents|respiratory system agents|mesh-ancestor
110337795|NCT01240746|Vaccines|vaccines|mesh-list
110337796|NCT01240746|Immunologic Factors|immunologic factors|mesh-ancestor
110337797|NCT01240746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110337798|NCT01240590|Cisplatin|cisplatin|mesh-list
110337799|NCT01240590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110337800|NCT01240200|Insulin Glargine|insulin glargine|mesh-list
110337801|NCT01240200|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110337802|NCT01240200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110337803|NCT00504543|Everolimus|everolimus|mesh-list
110337804|NCT00504543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110337805|NCT00504543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110337806|NCT00504543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110337807|NCT00504543|Immunologic Factors|immunologic factors|mesh-ancestor
110337808|NCT00504543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110337809|NCT00504543|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110337810|NCT00504543|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110337811|NCT00504543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110337812|NCT02949843|Pembrolizumab|pembrolizumab|mesh-list
110337813|NCT02949843|Nivolumab|nivolumab|mesh-list
110337814|NCT02949843|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
110337815|NCT02949843|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110337816|NCT02949843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110337817|NCT02949843|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110337818|NCT02949843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110337819|NCT02949843|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110337820|NCT02949843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110337821|NCT00517764|Citalopram|citalopram|mesh-list
110337822|NCT00517764|Escitalopram|escitalopram|mesh-list
110337823|NCT00517764|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110337824|NCT00517764|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110337825|NCT00517764|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110337826|NCT00517764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110337827|NCT00517764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110337828|NCT00517764|Serotonin Agents|serotonin agents|mesh-ancestor
110337829|NCT00517764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110337830|NCT00517764|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110337831|NCT00517764|Antidepressive Agents|antidepressive agents|mesh-ancestor
110337832|NCT00517764|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110337833|NCT00517803|Micronutrients|micronutrients|mesh-list
110337834|NCT00517803|Trace Elements|trace elements|mesh-list
110337835|NCT00517803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110337836|NCT04516304|Equol|equol|mesh-list
110337837|NCT04516304|Phytoestrogens|phytoestrogens|mesh-ancestor
110337838|NCT04516304|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
110337839|NCT04516304|Estrogens|estrogens|mesh-ancestor
110337840|NCT04516304|Hormones|hormones|mesh-ancestor
110337841|NCT04516304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110337842|NCT04516304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110337843|NCT01242930|Niacinamide|niacinamide|mesh-list
110337844|NCT01242930|Lenalidomide|lenalidomide|mesh-list
110337845|NCT01242930|Imetelstat|imetelstat|mesh-list
110190620|NCT00053001|Hematinics|hematinics|mesh-ancestor
110337846|NCT01242930|Motesanib diphosphate|motesanib diphosphate|mesh-list
110337847|NCT01242930|Immunologic Factors|immunologic factors|mesh-ancestor
110337848|NCT01242930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110337849|NCT01242930|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110337850|NCT01242930|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110337851|NCT01242930|Growth Substances|growth substances|mesh-ancestor
110337852|NCT01242930|Growth Inhibitors|growth inhibitors|mesh-ancestor
110337853|NCT01242930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110337854|NCT01242930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110337855|NCT01242930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110337856|NCT01242930|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110337857|NCT01242930|Vitamin B Complex|vitamin b complex|mesh-ancestor
110337858|NCT01242930|Vitamins|vitamins|mesh-ancestor
110337859|NCT01242930|Micronutrients|micronutrients|mesh-ancestor
110337860|NCT01241214|Cetirizine|cetirizine|mesh-list
110337861|NCT01241214|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110337862|NCT01241214|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110337863|NCT01241214|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110337864|NCT01241214|Histamine Antagonists|histamine antagonists|mesh-ancestor
110337865|NCT01241214|Histamine Agents|histamine agents|mesh-ancestor
110337866|NCT01241214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110337867|NCT01241214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110337868|NCT01241214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110337869|NCT01240512|Vitamin D|vitamin d|mesh-list
110337870|NCT01240512|Cholecalciferol|cholecalciferol|mesh-list
110337871|NCT01240512|Vitamins|vitamins|mesh-ancestor
110337872|NCT01240512|Micronutrients|micronutrients|mesh-ancestor
110567433|NCT05256719|Abatacept|abatacept|mesh-list
110337873|NCT01240512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110337874|NCT01240512|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110337875|NCT01240512|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110337876|NCT01240629|Doxorubicin|doxorubicin|mesh-list
110337877|NCT01240629|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110337878|NCT01240629|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110337879|NCT01240629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110337880|NCT01240629|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110337881|NCT01240629|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110337882|NCT01240629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110567466|NCT05176223|Edetic Acid|edetic acid|mesh-list
110337883|NCT01240629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110337884|NCT00518232|Methylphenidate|methylphenidate|mesh-list
110337885|NCT00518232|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110337886|NCT00518232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110337887|NCT00518232|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110337888|NCT00518232|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110337889|NCT00518232|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110337890|NCT00518232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110337891|NCT00518232|Dopamine Agents|dopamine agents|mesh-ancestor
110337892|NCT00518232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110337894|NCT00505505|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110337895|NCT00505505|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110337896|NCT00505505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110337897|NCT00518271|Sirolimus|sirolimus|mesh-list
110337898|NCT00518271|Tacrolimus|tacrolimus|mesh-list
110337899|NCT00518271|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110337900|NCT00518271|Immunologic Factors|immunologic factors|mesh-ancestor
110337901|NCT00518271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110337902|NCT00518271|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110337903|NCT00518271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110337904|NCT00518271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110337905|NCT00518271|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110337906|NCT00518271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110337907|NCT00518271|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110337908|NCT00518271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110337909|NCT00518271|Antifungal Agents|antifungal agents|mesh-ancestor
110337910|NCT00518193|Cetuximab|cetuximab|mesh-list
110337911|NCT00518193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110337912|NCT00518193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110337914|NCT00518427|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110337915|NCT00518427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110337916|NCT00518466|Topiramate|topiramate|mesh-list
110337917|NCT00518466|Phentermine|phentermine|mesh-list
110337918|NCT00518466|Anticonvulsants|anticonvulsants|mesh-ancestor
110337919|NCT00518466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110337920|NCT00518466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110337921|NCT00518466|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110337922|NCT00518466|Appetite Depressants|appetite depressants|mesh-ancestor
110337923|NCT00518466|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110337924|NCT00518466|Sympathomimetics|sympathomimetics|mesh-ancestor
110337925|NCT00518466|Autonomic Agents|autonomic agents|mesh-ancestor
110337926|NCT00518466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110337927|NCT00518466|Adrenergic Agents|adrenergic agents|mesh-ancestor
110337928|NCT00518466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110337929|NCT00518466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110337931|NCT00518583|Doxorubicin|doxorubicin|mesh-list
110337932|NCT00518583|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110337933|NCT00518583|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110337934|NCT00518583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110337936|NCT00518583|Antimitotic Agents|antimitotic agents|mesh-ancestor
110337937|NCT00518583|Mitosis Modulators|mitosis modulators|mesh-ancestor
110337938|NCT00518583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110337939|NCT00518583|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110337940|NCT00518583|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110337941|NCT00518583|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110337942|NCT00518583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110337943|NCT00519753|Timolol|timolol|mesh-list
110337945|NCT00519753|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110337946|NCT00519753|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110173126|NCT00055939|Exatecan|exatecan|mesh-list
110337947|NCT00519753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110337948|NCT00519753|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110337949|NCT00519753|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110337950|NCT00519753|Adrenergic Agents|adrenergic agents|mesh-ancestor
110337951|NCT00519753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110337952|NCT00519753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110337953|NCT00519753|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110567789|NCT04085315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110337954|NCT00519753|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110337955|NCT00519870|Losartan|losartan|mesh-list
110337956|NCT00519870|Nifedipine|nifedipine|mesh-list
110337957|NCT00519870|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110337958|NCT00519870|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110337959|NCT00519870|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110337960|NCT00519870|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110337961|NCT00519870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110337962|NCT00519870|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110337963|NCT00519870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110337964|NCT00519870|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110337965|NCT00519870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110337966|NCT00519870|Vasodilator Agents|vasodilator agents|mesh-ancestor
110337967|NCT00519870|Tocolytic Agents|tocolytic agents|mesh-ancestor
110337968|NCT00519870|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110337969|NCT00519909|Calcium|calcium|mesh-list
110337970|NCT00519909|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110337971|NCT00519909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110337972|NCT02949492|Interleukin-2|interleukin-2|mesh-list
110337973|NCT02949492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110337974|NCT02949492|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110337975|NCT02949492|Analgesics|analgesics|mesh-ancestor
110337976|NCT02949492|Sensory System Agents|sensory system agents|mesh-ancestor
110337977|NCT02949492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110337978|NCT02949492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110337979|NCT04514588|Caffeine|caffeine|mesh-list
110337980|NCT04514588|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110337981|NCT04514588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110337982|NCT04514588|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110337983|NCT04514588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110567921|NCT03539900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110567922|NCT03539900|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110567923|NCT03539900|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110567924|NCT03539900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110567925|NCT03539900|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110567931|NCT03479476|Metformin|metformin|mesh-list
110567932|NCT03479476|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110567933|NCT03479476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110567934|NCT03399539|Dexamethasone|dexamethasone|mesh-list
110567935|NCT03399539|Dexamethasone acetate|dexamethasone acetate|mesh-list
110567936|NCT03399539|Venetoclax|venetoclax|mesh-list
110567937|NCT03399539|Ixazomib|ixazomib|mesh-list
110567938|NCT03399539|Ichthammol|ichthammol|mesh-list
110567939|NCT03399539|BB 1101|bb 1101|mesh-list
110567940|NCT03399539|Glycine|glycine|mesh-list
110567941|NCT03399539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110567942|NCT03399539|Antiemetics|antiemetics|mesh-ancestor
110567943|NCT03399539|Autonomic Agents|autonomic agents|mesh-ancestor
110567944|NCT03399539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110567945|NCT03399539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110567946|NCT03399539|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110567947|NCT03399539|Glucocorticoids|glucocorticoids|mesh-ancestor
110567948|NCT03399539|Hormones|hormones|mesh-ancestor
110337984|NCT04514588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110337985|NCT04514588|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110337986|NCT04514588|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110337987|NCT04514588|Purinergic Agents|purinergic agents|mesh-ancestor
110337988|NCT04514588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110337989|NCT02276300|Cyclophosphamide|cyclophosphamide|mesh-list
110337991|NCT02276300|Sargramostim|sargramostim|mesh-list
110337992|NCT02276300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110337993|NCT02276300|Immunologic Factors|immunologic factors|mesh-ancestor
110337994|NCT02276300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110337995|NCT02276300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110337996|NCT02276300|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110337997|NCT02276300|Alkylating Agents|alkylating agents|mesh-ancestor
110567981|NCT03358706|Midazolam|midazolam|mesh-list
110337998|NCT02276300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110337999|NCT02276300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110338000|NCT02276300|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110338001|NCT02276300|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110338003|NCT00520026|Lithium Carbonate|lithium carbonate|mesh-list
110338004|NCT00520026|Antidepressive Agents|antidepressive agents|mesh-ancestor
110338005|NCT00520026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110338006|NCT00520026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110338007|NCT00520026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110338008|NCT00520026|Antimanic Agents|antimanic agents|mesh-ancestor
110338009|NCT00520026|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110568043|NCT03220776|Analgesics|analgesics|mesh-ancestor
110338010|NCT00520026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110338011|NCT00520026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110338012|NCT02955251|Nivolumab|nivolumab|mesh-list
110338013|NCT02955251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110338014|NCT02955251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110173129|NCT00055939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110338015|NCT02955251|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110338016|NCT02955251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110338018|NCT00518895|Oblimersen|oblimersen|mesh-list
110338019|NCT00518895|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110338020|NCT00518895|Alkylating Agents|alkylating agents|mesh-ancestor
110338021|NCT00518895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110338022|NCT00518895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110338023|NCT00520104|Ketamine|ketamine|mesh-list
110338024|NCT00520104|Analgesics|analgesics|mesh-ancestor
110338025|NCT00520104|Sensory System Agents|sensory system agents|mesh-ancestor
110338026|NCT00520104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110338027|NCT00520104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110338028|NCT00520104|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110338029|NCT00520104|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110338030|NCT00520104|Anesthetics, General|anesthetics, general|mesh-ancestor
110338031|NCT00520104|Anesthetics|anesthetics|mesh-ancestor
110338032|NCT00520104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110338033|NCT00520104|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110338034|NCT00520104|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110338035|NCT00520104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110338036|NCT00520104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110338037|NCT00519012|Sertraline|sertraline|mesh-list
110338038|NCT00519012|Paroxetine|paroxetine|mesh-list
110338039|NCT00519012|Antidepressive Agents|antidepressive agents|mesh-ancestor
110338040|NCT00519012|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110338041|NCT00519012|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110338042|NCT00519012|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110338043|NCT00519012|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110338044|NCT00519012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110338045|NCT00519012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110338046|NCT00519012|Serotonin Agents|serotonin agents|mesh-ancestor
110338047|NCT00519012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110338048|NCT00519012|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110338049|NCT00519012|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110338050|NCT00519012|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110338051|NCT00519012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110338052|NCT00520260|Ketorolac|ketorolac|mesh-list
110338053|NCT00520260|Bromfenac|bromfenac|mesh-list
110338054|NCT00520260|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110338055|NCT00520260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110338056|NCT00520260|Analgesics|analgesics|mesh-ancestor
110338057|NCT00520260|Sensory System Agents|sensory system agents|mesh-ancestor
110338058|NCT00520260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110338059|NCT00520260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110338060|NCT00520260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110338061|NCT00520260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110338062|NCT00520260|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110338063|NCT00520260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110338064|NCT00520260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110338065|NCT00520338|Celecoxib|celecoxib|mesh-list
110338066|NCT00520338|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110338067|NCT00520338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110338068|NCT00520338|Analgesics|analgesics|mesh-ancestor
110338069|NCT00520338|Sensory System Agents|sensory system agents|mesh-ancestor
110338070|NCT00520338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110338071|NCT00520338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110338072|NCT00520338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110338073|NCT00520338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110338074|NCT00520338|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110338075|NCT00520338|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110338077|NCT00520338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110338078|NCT02594072|Goserelin|goserelin|mesh-list
110338079|NCT02594072|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110568489|NCT00705822|Prednisone|prednisone|mesh-list
110338080|NCT02594072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110338081|NCT00519051|Fluoxetine|fluoxetine|mesh-list
110338082|NCT00519051|Antidepressive Agents|antidepressive agents|mesh-list
110338083|NCT00519051|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110338084|NCT00519051|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110338085|NCT00519051|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110338086|NCT00519051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110338087|NCT00519051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110338088|NCT00519051|Serotonin Agents|serotonin agents|mesh-ancestor
110338089|NCT00519051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110338090|NCT00519051|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110338091|NCT00519051|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110338092|NCT00519051|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110338093|NCT00519051|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110338094|NCT00519051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110338095|NCT02275832|Minoxidil|minoxidil|mesh-list
110338096|NCT02275832|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110338097|NCT02275832|Vasodilator Agents|vasodilator agents|mesh-ancestor
110338098|NCT00519207|Lidocaine|lidocaine|mesh-list
110338099|NCT00519207|Anesthetics, Local|anesthetics, local|mesh-ancestor
110338100|NCT00519207|Anesthetics|anesthetics|mesh-ancestor
110568566|NCT00758368|Apomorphine|apomorphine|mesh-list
110338101|NCT00519207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110338102|NCT00519207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110338103|NCT00519207|Sensory System Agents|sensory system agents|mesh-ancestor
110338104|NCT00519207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110338105|NCT00519207|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110338106|NCT00519207|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110338107|NCT00519207|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110338108|NCT00519207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110338109|NCT00519207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110338110|NCT02590094|Bevacizumab|bevacizumab|mesh-list
110338111|NCT02590094|Aflibercept|aflibercept|mesh-list
110338112|NCT02590094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110338113|NCT02590094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110338114|NCT02590094|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110338115|NCT02590094|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110338116|NCT02590094|Growth Substances|growth substances|mesh-ancestor
110338117|NCT02590094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110338118|NCT02590094|Growth Inhibitors|growth inhibitors|mesh-ancestor
110338119|NCT00520455|Levonorgestrel|levonorgestrel|mesh-list
110338120|NCT00520455|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110338121|NCT00520455|Contraceptive Agents|contraceptive agents|mesh-ancestor
110338122|NCT00520455|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110338123|NCT00520455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110338124|NCT00520455|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110338125|NCT00520455|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110338126|NCT00520455|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110338127|NCT02949258|Oxaliplatin|oxaliplatin|mesh-list
110338128|NCT02949258|Etoposide|etoposide|mesh-list
110338129|NCT02949258|Epirubicin|epirubicin|mesh-list
110338130|NCT02949258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110338131|NCT02949258|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110338133|NCT02949258|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110338134|NCT02949258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110338135|NCT02949258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110338136|NCT02949258|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110338138|NCT04514081|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110338139|NCT04514081|Antimetabolites|antimetabolites|mesh-ancestor
110568800|NCT04627246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110338140|NCT04514081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110338141|NCT04514081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110338142|NCT04514081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110173213|NCT00056641|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110338143|NCT00519246|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
110338144|NCT00519246|Analgesics, Opioid|analgesics, opioid|mesh-list
110338145|NCT00519246|Narcotics|narcotics|mesh-ancestor
110338146|NCT00519246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110338147|NCT00519246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110338148|NCT00519246|Analgesics|analgesics|mesh-ancestor
110338149|NCT00519246|Sensory System Agents|sensory system agents|mesh-ancestor
110338150|NCT00519246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110338151|NCT00519246|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110338152|NCT00519246|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110338153|NCT00519246|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110338154|NCT00519987|Ketamine|ketamine|mesh-list
110338155|NCT00519987|Analgesics|analgesics|mesh-ancestor
110338156|NCT00519987|Sensory System Agents|sensory system agents|mesh-ancestor
110338157|NCT00519987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110338158|NCT00519987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110338159|NCT00519987|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110338160|NCT00519987|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110338161|NCT00519987|Anesthetics, General|anesthetics, general|mesh-ancestor
110338163|NCT00519987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110338164|NCT00519987|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110338165|NCT00519987|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110338166|NCT00519987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110338167|NCT00519987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110338168|NCT00519324|Everolimus|everolimus|mesh-list
110338169|NCT00519324|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110568998|NCT00759070|Antiviral Agents|antiviral agents|mesh-ancestor
110338170|NCT00519324|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110338171|NCT00519324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110338172|NCT00519324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110338173|NCT00519324|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110338174|NCT00519324|Immunologic Factors|immunologic factors|mesh-ancestor
110338175|NCT00519324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110338176|NCT00519324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110338178|NCT00520650|Antidepressive Agents|antidepressive agents|mesh-ancestor
110338179|NCT00520650|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110338180|NCT00520650|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110569066|NCT00759460|Olanzapine|olanzapine|mesh-list
110338181|NCT00520650|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110338182|NCT00520650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110338183|NCT00520650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110338184|NCT00520650|Dopamine Agonists|dopamine agonists|mesh-ancestor
110338185|NCT00520650|Dopamine Agents|dopamine agents|mesh-ancestor
110338186|NCT00520650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110338187|NCT00520650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110338188|NCT00520650|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110338189|NCT00520650|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110338190|NCT00520650|Serotonin Agents|serotonin agents|mesh-ancestor
110569131|NCT00759928|Sorafenib|sorafenib|mesh-list
110338191|NCT00520650|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110338192|NCT00520650|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110338193|NCT00520650|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110338194|NCT00520650|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110338196|NCT00519363|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110338197|NCT00519363|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110338198|NCT00519363|Antimetabolites|antimetabolites|mesh-ancestor
110338199|NCT00519363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110338200|NCT00519363|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110338201|NCT00519363|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110338202|NCT00519363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110338203|NCT00519480|Metformin|metformin|mesh-list
110338204|NCT00519480|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110338205|NCT00519480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110338207|NCT02955056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110338208|NCT02955056|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110338209|NCT02955056|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110338211|NCT02954939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110338212|NCT02954939|Glucocorticoids|glucocorticoids|mesh-ancestor
110338214|NCT02954939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110338215|NCT02954939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110338216|NCT02954939|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110338217|NCT02954939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110338218|NCT00519519|Omeprazole|omeprazole|mesh-list
110338219|NCT00519519|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110338220|NCT00519519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110338221|NCT00519519|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110338222|NCT00519519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110338223|NCT00519519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110338224|NCT00520806|Methocarbamol|methocarbamol|mesh-list
110338225|NCT00520806|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110338226|NCT00520806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110338227|NCT00520806|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110338228|NCT00520806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110338229|NCT00505739|Mifepristone|mifepristone|mesh-list
110338230|NCT00505739|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
110338231|NCT00505739|Abortifacient Agents|abortifacient agents|mesh-ancestor
110338232|NCT00505739|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110338233|NCT00505739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110338234|NCT00505739|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110569393|NCT04047940|Metformin|metformin|mesh-list
110338235|NCT00505739|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110338236|NCT00505739|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110338237|NCT00505739|Contraceptive Agents|contraceptive agents|mesh-ancestor
110338238|NCT00505739|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
110338239|NCT00505739|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
110338240|NCT00505739|Hormone Antagonists|hormone antagonists|mesh-ancestor
110338241|NCT00505739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110338242|NCT00505739|Luteolytic Agents|luteolytic agents|mesh-ancestor
110338243|NCT00505739|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110338244|NCT00505739|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
110338245|NCT02948985|Cetuximab|cetuximab|mesh-list
110338246|NCT02948985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110338247|NCT02948985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110338248|NCT04513457|Liver Extracts|liver extracts|mesh-list
110338249|NCT04513457|Hematinics|hematinics|mesh-ancestor
110338250|NCT00521040|Levocetirizine|levocetirizine|mesh-list
110338251|NCT00521040|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110338252|NCT00521040|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110338253|NCT00521040|Histamine Antagonists|histamine antagonists|mesh-ancestor
110338254|NCT00521040|Histamine Agents|histamine agents|mesh-ancestor
110338255|NCT00521040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110338256|NCT00521040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110569504|NCT00773812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110338257|NCT00521040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110338258|NCT04513340|Levodopa|levodopa|mesh-list
110338259|NCT04513340|Carbidopa|carbidopa|mesh-list
110338260|NCT04513340|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110338261|NCT04513340|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110338262|NCT04513340|Dopamine Agents|dopamine agents|mesh-ancestor
110338263|NCT04513340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110338264|NCT04513340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110338265|NCT04513340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110338266|NCT04513340|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
110338267|NCT04513340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110338271|NCT04513379|Efavirenz|efavirenz|mesh-list
110338272|NCT04513379|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110338273|NCT04513379|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110338274|NCT04513379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110338275|NCT04513379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110338276|NCT04513379|Antiviral Agents|antiviral agents|mesh-ancestor
110338277|NCT04513379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110338278|NCT04513379|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110338279|NCT04513379|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110338280|NCT04513379|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110338281|NCT04513379|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110338282|NCT04513379|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110338283|NCT04513379|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110338285|NCT00521157|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110338286|NCT00521157|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110338287|NCT00521157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110338288|NCT00521157|Sensory System Agents|sensory system agents|mesh-ancestor
110338289|NCT00521157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110338290|NCT00505817|Leuprolide|leuprolide|mesh-list
110338291|NCT00505817|Cetrorelix|cetrorelix|mesh-list
110375383|NCT01580865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110338292|NCT00505817|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110338293|NCT00505817|Fertility Agents|fertility agents|mesh-ancestor
110338294|NCT00505817|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110338295|NCT00505817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110338296|NCT00505817|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110338297|NCT00505817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110338298|NCT00505817|Hormone Antagonists|hormone antagonists|mesh-ancestor
110338299|NCT00505817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110338300|NCT00521430|Cyclosporine|cyclosporine|mesh-list
110338301|NCT00521430|Methylprednisolone|methylprednisolone|mesh-list
110338302|NCT00521430|Methotrexate|methotrexate|mesh-list
110338303|NCT00521430|Fludarabine phosphate|fludarabine phosphate|mesh-list
110338304|NCT00521430|Fludarabine|fludarabine|mesh-list
110338305|NCT00521430|Busulfan|busulfan|mesh-list
110338306|NCT00521430|Cyclosporins|cyclosporins|mesh-list
110338307|NCT00521430|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110338308|NCT00521430|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110338309|NCT00521430|Abortifacient Agents|abortifacient agents|mesh-ancestor
110338310|NCT00521430|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110338311|NCT00521430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110338312|NCT00521430|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110338313|NCT00521430|Antimetabolites|antimetabolites|mesh-ancestor
110569748|NCT00776542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110338314|NCT00521430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110338315|NCT00521430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110338316|NCT00521430|Dermatologic Agents|dermatologic agents|mesh-ancestor
110338317|NCT00521430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110338318|NCT00521430|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110338319|NCT00521430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110338320|NCT00521430|Immunologic Factors|immunologic factors|mesh-ancestor
110338321|NCT00521430|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110338322|NCT00521430|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110338323|NCT00521430|Antifungal Agents|antifungal agents|mesh-ancestor
110338324|NCT00521430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110338325|NCT00521430|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110338326|NCT00521430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110338327|NCT00521430|Antiemetics|antiemetics|mesh-ancestor
110338328|NCT00521430|Autonomic Agents|autonomic agents|mesh-ancestor
110338329|NCT00521430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110338330|NCT00521430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110338331|NCT00521430|Glucocorticoids|glucocorticoids|mesh-ancestor
110338333|NCT00521430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110338334|NCT00521430|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110338335|NCT00521430|Protective Agents|protective agents|mesh-ancestor
110338336|NCT00521430|Alkylating Agents|alkylating agents|mesh-ancestor
110338337|NCT00521430|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110338338|NCT00521430|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110338339|NCT00521274|Docetaxel|docetaxel|mesh-list
110338340|NCT00521274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110338341|NCT00521274|Tubulin Modulators|tubulin modulators|mesh-ancestor
110338342|NCT00521274|Antimitotic Agents|antimitotic agents|mesh-ancestor
110338343|NCT00521274|Mitosis Modulators|mitosis modulators|mesh-ancestor
110338344|NCT00521274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110338345|NCT05146778|Lidocaine|lidocaine|mesh-list
110338346|NCT05146778|Fentanyl|fentanyl|mesh-list
110338347|NCT05146778|Dexmedetomidine|dexmedetomidine|mesh-list
110338348|NCT05146778|Analgesics, Opioid|analgesics, opioid|mesh-list
110338349|NCT05146778|Anesthetics|anesthetics|mesh-list
110338350|NCT05146778|Anesthetics, Local|anesthetics, local|mesh-ancestor
110338351|NCT05146778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110338352|NCT05146778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110338353|NCT05146778|Sensory System Agents|sensory system agents|mesh-ancestor
110338354|NCT05146778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110338355|NCT05146778|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110338356|NCT05146778|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110569867|NCT00709332|Contraceptive Agents|contraceptive agents|mesh-ancestor
110338357|NCT05146778|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110338358|NCT05146778|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110338359|NCT05146778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110338361|NCT05146778|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110338362|NCT05146778|Analgesics|analgesics|mesh-ancestor
110338363|NCT05146778|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110338364|NCT05146778|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110338365|NCT05146778|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110338366|NCT05146778|Adrenergic Agents|adrenergic agents|mesh-ancestor
110338367|NCT05146778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110338368|NCT05146778|Narcotics|narcotics|mesh-ancestor
110338369|NCT05146778|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110338370|NCT05146778|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110338371|NCT05146778|Anesthetics, General|anesthetics, general|mesh-ancestor
110338372|NCT00505700|Cytarabine|cytarabine|mesh-list
110338373|NCT00505700|Bortezomib|bortezomib|mesh-list
110338374|NCT00505700|Idarubicin|idarubicin|mesh-list
110338375|NCT00505700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110338376|NCT00505700|Antimetabolites|antimetabolites|mesh-ancestor
110338377|NCT00505700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110338378|NCT00505700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110338379|NCT00505700|Antiviral Agents|antiviral agents|mesh-ancestor
110338380|NCT00505700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110338381|NCT00505700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110338382|NCT00505700|Immunologic Factors|immunologic factors|mesh-ancestor
110338383|NCT00505700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110338384|NCT00505700|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110569918|NCT00828984|Laxatives|laxatives|mesh-list
110338385|NCT00505700|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110338386|NCT00505700|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110338387|NCT00505700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110338389|NCT02948283|Ritonavir|ritonavir|mesh-list
110338390|NCT02948283|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110338391|NCT02948283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110338392|NCT02948283|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110338393|NCT02948283|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110338394|NCT02948283|Protease Inhibitors|protease inhibitors|mesh-ancestor
110338395|NCT02948283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110338396|NCT02948283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110338397|NCT02948283|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110338398|NCT02948283|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110338399|NCT02948283|Antiviral Agents|antiviral agents|mesh-ancestor
110338400|NCT02948283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110338401|NCT02948283|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110338402|NCT02948283|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110338403|NCT04512872|Denosumab|denosumab|mesh-list
110338404|NCT04512872|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110338405|NCT04512872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110338406|NCT00523185|Diazepam|diazepam|mesh-list
110338407|NCT00523185|Lorazepam|lorazepam|mesh-list
110338408|NCT00523185|Anticonvulsants|anticonvulsants|mesh-ancestor
110338409|NCT00523185|Antiemetics|antiemetics|mesh-ancestor
110338410|NCT00523185|Autonomic Agents|autonomic agents|mesh-ancestor
110173246|NCT00056836|Growth Inhibitors|growth inhibitors|mesh-ancestor
110338411|NCT00523185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110338412|NCT00523185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110338413|NCT00523185|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110338414|NCT00523185|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110570030|NCT00685607|Simethicone|simethicone|mesh-list
110338415|NCT00523185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110338417|NCT00523185|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110338418|NCT00523185|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110338419|NCT00523185|GABA Modulators|gaba modulators|mesh-ancestor
110338420|NCT00523185|GABA Agents|gaba agents|mesh-ancestor
110338421|NCT00523185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110338422|NCT00523185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110338423|NCT00523185|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110338424|NCT00523185|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110338425|NCT00523185|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110338426|NCT00523185|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110338427|NCT00523185|Anesthetics, General|anesthetics, general|mesh-ancestor
110338428|NCT00523185|Anesthetics|anesthetics|mesh-ancestor
110338429|NCT04512404|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
110338430|NCT04512404|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110338431|NCT04512404|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110338432|NCT04512404|Antimetabolites|antimetabolites|mesh-ancestor
110570104|NCT00681785|Dalteparin|dalteparin|mesh-list
110338433|NCT04512404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110338434|NCT04512404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110338435|NCT04512404|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110338437|NCT04693962|Mitosis Modulators|mitosis modulators|mesh-ancestor
110338438|NCT04693962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110338439|NCT05144399|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110338440|NCT05144399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110338441|NCT00521703|Lidocaine|lidocaine|mesh-list
110338442|NCT00521703|Anesthetics, Local|anesthetics, local|mesh-ancestor
110338443|NCT00521703|Anesthetics|anesthetics|mesh-ancestor
110570143|NCT00657137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110338444|NCT00521703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110338445|NCT00521703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110338446|NCT00521703|Sensory System Agents|sensory system agents|mesh-ancestor
110338447|NCT00521703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110338448|NCT00521703|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110338449|NCT00521703|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110338450|NCT00521703|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110338451|NCT00521703|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110338452|NCT00521703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110338453|NCT00521742|Pioglitazone|pioglitazone|mesh-list
110570208|NCT00768508|Naltrexone|naltrexone|mesh-list
110338456|NCT00521742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110338457|NCT00521781|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110338458|NCT00521781|Leuprolide|leuprolide|mesh-list
110338459|NCT00521781|Bicalutamide|bicalutamide|mesh-list
110338460|NCT00521781|Androgens|androgens|mesh-list
110338461|NCT00521781|Androgen Antagonists|androgen antagonists|mesh-list
110338462|NCT00521781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110338463|NCT00521781|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110338464|NCT00521781|Fertility Agents|fertility agents|mesh-ancestor
110338465|NCT00521781|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110338466|NCT00521781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110338467|NCT00521781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110338468|NCT00521781|Hormones|hormones|mesh-ancestor
110338469|NCT00521781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110338470|NCT00521781|Hormone Antagonists|hormone antagonists|mesh-ancestor
110338471|NCT00521820|Pioglitazone|pioglitazone|mesh-list
110338472|NCT00521820|Glyburide|glyburide|mesh-list
110338473|NCT00521820|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110338474|NCT00521820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110338475|NCT00523263|Heparin|heparin|mesh-list
110338476|NCT00523263|Anticoagulants|anticoagulants|mesh-ancestor
110338477|NCT00523263|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110338478|NCT00523263|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110173253|NCT05495321|Sensory System Agents|sensory system agents|mesh-ancestor
110338479|NCT00523263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110338480|NCT00521859|Fludarabine|fludarabine|mesh-list
110338481|NCT00521859|Fludarabine phosphate|fludarabine phosphate|mesh-list
110338482|NCT00521859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110338483|NCT00521859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110338484|NCT00521859|Antimetabolites|antimetabolites|mesh-ancestor
110338485|NCT00521859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110338486|NCT00521859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110338487|NCT00521859|Immunologic Factors|immunologic factors|mesh-ancestor
110338488|NCT00521859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110338489|NCT02954822|Glimepiride|glimepiride|mesh-list
110338490|NCT02954822|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110338491|NCT02954822|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110338492|NCT02954822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110338493|NCT02954822|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110338494|NCT02954822|Immunologic Factors|immunologic factors|mesh-ancestor
110338495|NCT00522015|Rivastigmine|rivastigmine|mesh-list
110338496|NCT00522015|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110338497|NCT00522015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110338498|NCT00522015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110338499|NCT00522015|Cholinergic Agents|cholinergic agents|mesh-ancestor
110338500|NCT00522015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110338501|NCT00522015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110338502|NCT00522015|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110338503|NCT00522015|Protective Agents|protective agents|mesh-ancestor
110338504|NCT00523380|Doxorubicin|doxorubicin|mesh-list
110338505|NCT00523380|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110338506|NCT00523380|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110338507|NCT00523380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110570328|NCT00683111|Famotidine|famotidine|mesh-list
110338508|NCT00523380|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110338509|NCT00523380|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110338510|NCT00523380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110338511|NCT00523380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110338512|NCT00523458|Efavirenz|efavirenz|mesh-list
110338513|NCT00523458|Nevirapine|nevirapine|mesh-list
110338514|NCT00523458|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110338515|NCT00523458|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110338516|NCT00523458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110338517|NCT00523458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110338518|NCT00523458|Antiviral Agents|antiviral agents|mesh-ancestor
110338519|NCT00523458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110338520|NCT00523458|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110338521|NCT00523458|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110338522|NCT00523458|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110338523|NCT00523458|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110338524|NCT00523458|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110338525|NCT00523458|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110338526|NCT00523458|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110338527|NCT00523458|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110338528|NCT00507065|Amphetamine|amphetamine|mesh-list
110338529|NCT00507065|Adderall|adderall|mesh-list
110338530|NCT00507065|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110338531|NCT00507065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110338532|NCT00507065|Sympathomimetics|sympathomimetics|mesh-ancestor
110338533|NCT00507065|Autonomic Agents|autonomic agents|mesh-ancestor
110338534|NCT00507065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110338535|NCT00507065|Dopamine Agents|dopamine agents|mesh-ancestor
110338536|NCT00507065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110338537|NCT00507065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110338538|NCT00507065|Adrenergic Agents|adrenergic agents|mesh-ancestor
110338539|NCT00507065|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110570366|NCT04141787|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110338540|NCT00507065|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110338541|NCT00507065|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110338542|NCT00507065|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110338543|NCT00522132|Artesunate|artesunate|mesh-list
110338544|NCT00522132|Antimalarials|antimalarials|mesh-ancestor
110338545|NCT00522132|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110338546|NCT00522132|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110338547|NCT00522132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110338548|NCT00522132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110338549|NCT00522132|Antiviral Agents|antiviral agents|mesh-ancestor
110338550|NCT00522132|Schistosomicides|schistosomicides|mesh-ancestor
110338551|NCT00522132|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110338553|NCT00522210|Insulin|insulin|mesh-list
110338554|NCT00522210|Isophane Insulin, Human|isophane insulin, human|mesh-list
110338555|NCT00522210|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110338556|NCT00522210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110338557|NCT00522249|Interferons|interferons|mesh-list
110338558|NCT00522249|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110338559|NCT00522249|Interferon-alpha|interferon-alpha|mesh-list
110338560|NCT00522249|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
110338561|NCT00522249|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110338562|NCT00522249|Sunitinib|sunitinib|mesh-list
110338563|NCT00522249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110338564|NCT00522249|Antiviral Agents|antiviral agents|mesh-ancestor
110338565|NCT00522249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110338566|NCT00522249|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110338567|NCT00522249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110338568|NCT00522249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110338569|NCT00522249|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110338570|NCT00522249|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110338571|NCT00522249|Growth Substances|growth substances|mesh-ancestor
110338572|NCT00522249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110338573|NCT00522249|Growth Inhibitors|growth inhibitors|mesh-ancestor
110338574|NCT00522249|Immunologic Factors|immunologic factors|mesh-ancestor
110338575|NCT05148767|Irinotecan|irinotecan|mesh-list
110338576|NCT05148767|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110338577|NCT05148767|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110338578|NCT05148767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110338579|NCT05148767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110338580|NCT05148767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110338581|NCT00523692|Etanercept|etanercept|mesh-list
110338582|NCT00523692|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110338583|NCT00523692|Methylprednisolone|methylprednisolone|mesh-list
110338584|NCT00523692|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110338585|NCT00523692|Prednisolone|prednisolone|mesh-list
110338586|NCT00523692|Prednisolone acetate|prednisolone acetate|mesh-list
110338587|NCT00523692|Methotrexate|methotrexate|mesh-list
110338588|NCT00523692|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110338589|NCT00523692|Prednisolone phosphate|prednisolone phosphate|mesh-list
110338590|NCT00523692|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110570534|NCT00853658|Enalapril|enalapril|mesh-list
110338591|NCT00523692|Abortifacient Agents|abortifacient agents|mesh-ancestor
110338592|NCT00523692|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110338593|NCT00523692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110338594|NCT00523692|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110338596|NCT00523692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110338597|NCT00523692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110338598|NCT00523692|Dermatologic Agents|dermatologic agents|mesh-ancestor
110338599|NCT00523692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110338600|NCT00523692|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110338601|NCT00523692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110338602|NCT00523692|Immunologic Factors|immunologic factors|mesh-ancestor
110338603|NCT00523692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110338604|NCT00523692|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110338605|NCT00523692|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110338606|NCT00523692|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110338607|NCT00523692|Analgesics|analgesics|mesh-ancestor
110338608|NCT00523692|Sensory System Agents|sensory system agents|mesh-ancestor
110338609|NCT00523692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110338610|NCT00523692|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110338611|NCT00523692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110338612|NCT00523692|Antiemetics|antiemetics|mesh-ancestor
110338613|NCT00523692|Autonomic Agents|autonomic agents|mesh-ancestor
110338614|NCT00523692|Glucocorticoids|glucocorticoids|mesh-ancestor
110338615|NCT00523692|Hormones|hormones|mesh-ancestor
110338616|NCT00523692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110338617|NCT00523692|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110338618|NCT00523692|Protective Agents|protective agents|mesh-ancestor
110338619|NCT00523692|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110338621|NCT05148689|Oxymetazoline|oxymetazoline|mesh-list
110338622|NCT05148689|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110338623|NCT05148689|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110338624|NCT05148689|Adrenergic Agents|adrenergic agents|mesh-ancestor
110338625|NCT05148689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110338626|NCT05148689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110338627|NCT05148689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110338628|NCT05148689|Sympathomimetics|sympathomimetics|mesh-ancestor
110338629|NCT05148689|Autonomic Agents|autonomic agents|mesh-ancestor
110338630|NCT05148689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110338631|NCT05148689|Nasal Decongestants|nasal decongestants|mesh-ancestor
110338632|NCT05148689|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110338633|NCT05148689|Respiratory System Agents|respiratory system agents|mesh-ancestor
110338634|NCT05148689|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110338635|NCT05148689|Mydriatics|mydriatics|mesh-ancestor
110338636|NCT05148689|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110338637|NCT05148689|Protective Agents|protective agents|mesh-ancestor
110338638|NCT00522444|Magnesium Sulfate|magnesium sulfate|mesh-list
110338639|NCT00522444|Analgesics|analgesics|mesh-ancestor
110338640|NCT00522444|Sensory System Agents|sensory system agents|mesh-ancestor
110338641|NCT00522444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110338642|NCT00522444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110338643|NCT00522444|Anesthetics|anesthetics|mesh-ancestor
110338644|NCT00522444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110338645|NCT00522444|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110338646|NCT00522444|Anticonvulsants|anticonvulsants|mesh-ancestor
110338647|NCT00522444|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110338648|NCT00522444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110338649|NCT00522444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110338650|NCT00522444|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110338651|NCT00522444|Tocolytic Agents|tocolytic agents|mesh-ancestor
110338652|NCT00522444|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110338653|NCT05148143|Raltitrexed|raltitrexed|mesh-list
110338654|NCT05148143|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110338655|NCT05148143|Antimetabolites|antimetabolites|mesh-ancestor
110570765|NCT00688961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110338656|NCT05148143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110338657|NCT05148143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110338658|NCT05148143|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110338659|NCT05148143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110338660|NCT00523887|Fentanyl|fentanyl|mesh-list
110338661|NCT00523887|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110338662|NCT00523887|Narcotics|narcotics|mesh-ancestor
110338663|NCT00523887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110338664|NCT00523887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110338665|NCT00523887|Analgesics|analgesics|mesh-ancestor
110338666|NCT00523887|Sensory System Agents|sensory system agents|mesh-ancestor
110338667|NCT00523887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110338668|NCT00523887|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110338669|NCT00523887|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110338670|NCT00523887|Anesthetics, General|anesthetics, general|mesh-ancestor
110338671|NCT00523887|Anesthetics|anesthetics|mesh-ancestor
110338672|NCT05145218|Paclitaxel|paclitaxel|mesh-list
110338673|NCT05145218|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110338674|NCT05145218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110338675|NCT05145218|Tubulin Modulators|tubulin modulators|mesh-ancestor
110338676|NCT05145218|Antimitotic Agents|antimitotic agents|mesh-ancestor
110338677|NCT05145218|Mitosis Modulators|mitosis modulators|mesh-ancestor
110338678|NCT05145218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110338679|NCT00523926|Bedaquiline|bedaquiline|mesh-list
110338680|NCT00523926|Antitubercular Agents|antitubercular agents|mesh-ancestor
110338681|NCT00523926|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110338682|NCT00523926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110338683|NCT05146271|Anesthetics|anesthetics|mesh-list
110338684|NCT05146271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110338685|NCT05146271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110338686|NCT00522639|Deoxyglucose|deoxyglucose|mesh-list
110338687|NCT00522639|Antimetabolites|antimetabolites|mesh-ancestor
110570864|NCT02624453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110338688|NCT00522639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110338689|NCT00522639|Antiviral Agents|antiviral agents|mesh-ancestor
110338690|NCT00522639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110338691|NCT05142098|Dexamethasone|dexamethasone|mesh-list
110338692|NCT05142098|Etoricoxib|etoricoxib|mesh-list
110338693|NCT05142098|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
110338694|NCT05142098|Glucocorticoids|glucocorticoids|mesh-list
110338695|NCT05142098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110338696|NCT05142098|Antiemetics|antiemetics|mesh-ancestor
110338697|NCT05142098|Autonomic Agents|autonomic agents|mesh-ancestor
110338698|NCT05142098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110338699|NCT05142098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110338700|NCT05142098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110338701|NCT05142098|Hormones|hormones|mesh-ancestor
110338702|NCT05142098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110338703|NCT05142098|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110338704|NCT05142098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110338705|NCT05142098|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110338706|NCT05142098|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110338707|NCT05142098|Analgesics|analgesics|mesh-ancestor
110338708|NCT05142098|Sensory System Agents|sensory system agents|mesh-ancestor
110338709|NCT05142098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110338710|NCT05142098|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110338711|NCT05142098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110338712|NCT05142098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110338713|NCT00523965|Amphotericin B|amphotericin b|mesh-list
110338714|NCT00523965|Paromomycin|paromomycin|mesh-list
110338715|NCT00523965|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
110338716|NCT00523965|Miltefosine|miltefosine|mesh-list
110338717|NCT00523965|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
110338718|NCT00523965|Deoxycholic Acid|deoxycholic acid|mesh-list
110338719|NCT00523965|Amebicides|amebicides|mesh-ancestor
110338720|NCT00523965|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110338721|NCT00523965|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110338722|NCT00523965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110338723|NCT00523965|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110338724|NCT00523965|Antifungal Agents|antifungal agents|mesh-ancestor
110338725|NCT00523965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110338726|NCT00523965|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
110338727|NCT00523965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110338728|NCT05141669|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
110338729|NCT05141669|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
110338730|NCT05141669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110338731|NCT05141669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110338732|NCT05141669|Immunologic Factors|immunologic factors|mesh-ancestor
110338733|NCT05141669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110338735|NCT05141240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110338736|NCT05141240|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110338737|NCT05141240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110338738|NCT05141240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110338739|NCT00524004|Immunoglobulin G|immunoglobulin g|mesh-list
110338740|NCT00524004|Immunologic Factors|immunologic factors|mesh-ancestor
110338741|NCT00524004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110338743|NCT05148377|Anticoagulants|anticoagulants|mesh-ancestor
110338744|NCT05148377|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110338745|NCT05148377|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110338746|NCT05148377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110338748|NCT00524160|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110338749|NCT00524160|Narcotics|narcotics|mesh-ancestor
110338750|NCT00524160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110338751|NCT00524160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110338752|NCT00524160|Analgesics|analgesics|mesh-ancestor
110338753|NCT00524160|Sensory System Agents|sensory system agents|mesh-ancestor
110338754|NCT00524160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110338755|NCT00524160|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110338756|NCT00524160|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110338757|NCT00524160|Anesthetics, General|anesthetics, general|mesh-ancestor
110338758|NCT00524160|Anesthetics|anesthetics|mesh-ancestor
110338760|NCT00524199|Protective Agents|protective agents|mesh-ancestor
110338761|NCT00524199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110338762|NCT00523068|Tolterodine Tartrate|tolterodine tartrate|mesh-list
110338763|NCT00523068|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110338764|NCT00523068|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110338765|NCT00523068|Cholinergic Agents|cholinergic agents|mesh-ancestor
110338766|NCT00523068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110571311|NCT00784966|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110338767|NCT00523068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110338768|NCT00523068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110338769|NCT00523068|Urological Agents|urological agents|mesh-ancestor
110338770|NCT02276378|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110338771|NCT02276378|Telmisartan|telmisartan|mesh-list
110338772|NCT02276378|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110338773|NCT02276378|Diuretics|diuretics|mesh-ancestor
110338774|NCT02276378|Natriuretic Agents|natriuretic agents|mesh-ancestor
110169121|NCT00000893|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110338775|NCT02276378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110338776|NCT02276378|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110338777|NCT02276378|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110338778|NCT02276378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110338779|NCT02276378|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110338780|NCT02276378|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110338781|NCT04696250|Antineoplastic Agents|antineoplastic agents|mesh-list
110338782|NCT04696250|Immunomodulating Agents|immunomodulating agents|mesh-list
110338783|NCT04696250|Immunologic Factors|immunologic factors|mesh-ancestor
110338784|NCT04696250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110338785|NCT00524433|Tezosentan|tezosentan|mesh-list
110338786|NCT00524433|Vasodilator Agents|vasodilator agents|mesh-ancestor
110338787|NCT02947932|Indomethacin|indomethacin|mesh-list
110338789|NCT02947932|Antioxidants|antioxidants|mesh-ancestor
110338790|NCT02947932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110338791|NCT02947932|Protective Agents|protective agents|mesh-ancestor
110338792|NCT02947932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110338793|NCT02947932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110173311|NCT00057343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110338794|NCT02947932|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110338795|NCT02947932|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110338797|NCT02947932|Analgesics|analgesics|mesh-ancestor
110338798|NCT02947932|Sensory System Agents|sensory system agents|mesh-ancestor
110338799|NCT02947932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110338800|NCT02947932|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110338802|NCT02947932|Gout Suppressants|gout suppressants|mesh-ancestor
110338804|NCT02947932|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110338805|NCT02947932|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110338807|NCT05146154|Relebactam|relebactam|mesh-list
110338808|NCT05146154|Cilastatin|cilastatin|mesh-list
110338809|NCT05146154|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110338810|NCT05146154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110338811|NCT05146154|Protease Inhibitors|protease inhibitors|mesh-ancestor
110338812|NCT05146154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110338813|NCT05146154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110338814|NCT05146154|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110338815|NCT00524667|Fludarabine|fludarabine|mesh-list
110338816|NCT00524667|Valproic Acid|valproic acid|mesh-list
110338817|NCT00524667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110338818|NCT00524667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110338819|NCT00524667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110338820|NCT00524667|Anticonvulsants|anticonvulsants|mesh-ancestor
110338821|NCT00524667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110338822|NCT00524667|GABA Agents|gaba agents|mesh-ancestor
110338823|NCT00524667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110338824|NCT00524667|Antimanic Agents|antimanic agents|mesh-ancestor
110338825|NCT00524667|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110338826|NCT00524667|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110338827|NCT00524667|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110338828|NCT00524706|Leucovorin|leucovorin|mesh-list
110338829|NCT00524706|Oxaliplatin|oxaliplatin|mesh-list
110338830|NCT00524706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110338831|NCT00524706|Antidotes|antidotes|mesh-ancestor
110338832|NCT00524706|Protective Agents|protective agents|mesh-ancestor
110338833|NCT00524706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110338834|NCT00524706|Vitamin B Complex|vitamin b complex|mesh-ancestor
110338835|NCT00524706|Vitamins|vitamins|mesh-ancestor
110338836|NCT00524706|Micronutrients|micronutrients|mesh-ancestor
110338837|NCT00507143|Irinotecan|irinotecan|mesh-list
110338838|NCT00507143|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110338839|NCT00507143|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110169446|NCT00000986|Zidovudine|zidovudine|mesh-list
110338841|NCT00507143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110338842|NCT00507143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110338843|NCT00525993|Etoricoxib|etoricoxib|mesh-list
110338844|NCT00525993|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110338845|NCT00525993|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110338846|NCT00525993|Analgesics|analgesics|mesh-ancestor
110338847|NCT00525993|Sensory System Agents|sensory system agents|mesh-ancestor
110338848|NCT00525993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110338849|NCT00525993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110169500|NCT00000998|Leucovorin|leucovorin|mesh-list
110338850|NCT00525993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110338851|NCT00525993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110338852|NCT00525993|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110338853|NCT00525993|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110338854|NCT00525993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110338855|NCT00525993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110338856|NCT02947854|Photosensitizing Agents|photosensitizing agents|mesh-list
110338857|NCT02947854|Poly ICLC|poly iclc|mesh-list
110338858|NCT02947854|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
110338859|NCT02947854|Interferon Inducers|interferon inducers|mesh-ancestor
110338860|NCT02947854|Immunologic Factors|immunologic factors|mesh-ancestor
110338861|NCT02947854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110338862|NCT02947854|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110338863|NCT02947854|Dermatologic Agents|dermatologic agents|mesh-ancestor
110338864|NCT02947815|Botulinum Toxins|botulinum toxins|mesh-list
110338865|NCT02947815|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110338866|NCT02947815|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110338867|NCT02947815|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110173317|NCT00057382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110338868|NCT02947815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110338869|NCT02947815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110338870|NCT02947815|Cholinergic Agents|cholinergic agents|mesh-ancestor
110338871|NCT02947815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110338872|NCT02947815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110338873|NCT02947815|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110338874|NCT02947815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110338875|NCT00507221|Albendazole|albendazole|mesh-list
110338876|NCT00507221|Praziquantel|praziquantel|mesh-list
110338877|NCT00507221|Anthelmintics|anthelmintics|mesh-ancestor
110338878|NCT00507221|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110338879|NCT00507221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110338880|NCT00507221|Anticestodal Agents|anticestodal agents|mesh-ancestor
110169690|NCT00001040|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110338881|NCT00507221|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110338882|NCT00507221|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110338883|NCT00507221|Tubulin Modulators|tubulin modulators|mesh-ancestor
110338884|NCT00507221|Antimitotic Agents|antimitotic agents|mesh-ancestor
110338885|NCT00507221|Mitosis Modulators|mitosis modulators|mesh-ancestor
110338886|NCT00507221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110338887|NCT00507221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110338888|NCT02947737|Gentamicins|gentamicins|mesh-list
110338889|NCT02947737|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110338890|NCT02947737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110338891|NCT02947737|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110338892|NCT02947737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110338893|NCT02947737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110338894|NCT05146895|Imiquimod|imiquimod|mesh-list
110338895|NCT05146895|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110338896|NCT05146895|Immunologic Factors|immunologic factors|mesh-ancestor
110338897|NCT05146895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110338898|NCT05146895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110338899|NCT05146895|Interferon Inducers|interferon inducers|mesh-ancestor
110338900|NCT05143073|Ethanol|ethanol|mesh-list
110338901|NCT05143073|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110338902|NCT05143073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110338903|NCT05143073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110338904|NCT05143073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110338905|NCT00524901|Epoetin Alfa|epoetin alfa|mesh-list
110338906|NCT00524901|Hematinics|hematinics|mesh-ancestor
110338907|NCT02954588|Pyridoxamine|pyridoxamine|mesh-list
110338908|NCT02954588|Vitamin B Complex|vitamin b complex|mesh-ancestor
110338909|NCT02954588|Vitamins|vitamins|mesh-ancestor
110338910|NCT02954588|Micronutrients|micronutrients|mesh-ancestor
110338911|NCT02954588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110338912|NCT02954549|Vitamin D|vitamin d|mesh-list
110338913|NCT02954549|Cholecalciferol|cholecalciferol|mesh-list
110338914|NCT02954549|Vitamins|vitamins|mesh-ancestor
110338915|NCT02954549|Micronutrients|micronutrients|mesh-ancestor
110169894|NCT00016224|Thalidomide|thalidomide|mesh-list
110338916|NCT02954549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110338917|NCT02954549|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110338918|NCT02954549|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110338919|NCT05145608|Lamotrigine|lamotrigine|mesh-list
110338920|NCT05145608|Anticonvulsants|anticonvulsants|mesh-list
110338921|NCT05145608|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110338922|NCT05145608|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110338923|NCT05145608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110338924|NCT05145608|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110338925|NCT05145608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110338926|NCT05145608|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110338927|NCT05145608|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110338928|NCT05145608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110338929|NCT05145608|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110338930|NCT05145608|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110338931|NCT02946294|Epinephrine|epinephrine|mesh-list
110338932|NCT02946294|Racepinephrine|racepinephrine|mesh-list
110338933|NCT02946294|Bupivacaine|bupivacaine|mesh-list
110338934|NCT02946294|Epinephryl borate|epinephryl borate|mesh-list
110338935|NCT02946294|Anesthetics, Local|anesthetics, local|mesh-ancestor
110338936|NCT02946294|Anesthetics|anesthetics|mesh-ancestor
110338937|NCT02946294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110173321|NCT00057421|Glucocorticoids|glucocorticoids|mesh-ancestor
110338938|NCT02946294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110338939|NCT02946294|Sensory System Agents|sensory system agents|mesh-ancestor
110338940|NCT02946294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110338941|NCT02946294|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110338942|NCT02946294|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110338943|NCT02946294|Adrenergic Agents|adrenergic agents|mesh-ancestor
110338944|NCT02946294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110338945|NCT02946294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110338946|NCT02946294|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110338947|NCT02946294|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110338948|NCT02946294|Autonomic Agents|autonomic agents|mesh-ancestor
110338949|NCT02946294|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110338950|NCT02946294|Respiratory System Agents|respiratory system agents|mesh-ancestor
110338951|NCT02946294|Mydriatics|mydriatics|mesh-ancestor
110338952|NCT02946294|Sympathomimetics|sympathomimetics|mesh-ancestor
110338953|NCT02946294|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110338954|NCT05146232|Anesthetics|anesthetics|mesh-list
110170012|NCT00016380|Antiemetics|antiemetics|mesh-ancestor
110338955|NCT05146232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110338956|NCT05146232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110338959|NCT00525096|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110338960|NCT00525096|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110338961|NCT00525096|Analgesics|analgesics|mesh-ancestor
110338962|NCT00525096|Sensory System Agents|sensory system agents|mesh-ancestor
110338963|NCT00525096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110338964|NCT00525096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110338965|NCT00525096|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110338966|NCT00525096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110338967|NCT00525096|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110338968|NCT00525096|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110338969|NCT00525096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110338970|NCT00525096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110338971|NCT00525096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110338972|NCT00525096|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110338973|NCT00525096|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110338974|NCT00525096|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110338975|NCT00525096|Hormone Antagonists|hormone antagonists|mesh-ancestor
110338976|NCT00525096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110338977|NCT04693026|Remdesivir|remdesivir|mesh-list
110338978|NCT04693026|Antimetabolites|antimetabolites|mesh-ancestor
110338979|NCT04693026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110338980|NCT04693026|Antiviral Agents|antiviral agents|mesh-ancestor
110338981|NCT04693026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110338982|NCT02276859|Insulin|insulin|mesh-list
110338983|NCT02276859|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110338984|NCT02276859|Insulin Aspart|insulin aspart|mesh-list
110338985|NCT02276859|Insulin Lispro|insulin lispro|mesh-list
110338986|NCT02276859|Insulin glulisine|insulin glulisine|mesh-list
110338987|NCT02276859|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110338988|NCT02276859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110338989|NCT05143970|Trastuzumab|trastuzumab|mesh-list
110338990|NCT05143970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110338991|NCT05143970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110338992|NCT05147090|Empagliflozin|empagliflozin|mesh-list
110338993|NCT05147090|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110338994|NCT05147090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110338995|NCT05147090|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110338996|NCT05147090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110338997|NCT00525252|Baclofen|baclofen|mesh-list
110338998|NCT00525252|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110338999|NCT00525252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110339000|NCT00525252|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110339001|NCT00525252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110170173|NCT00038506|Zidovudine|zidovudine|mesh-list
110339002|NCT00525252|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
110339003|NCT00525252|GABA Agonists|gaba agonists|mesh-ancestor
110339004|NCT00525252|GABA Agents|gaba agents|mesh-ancestor
110339005|NCT00525252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110339006|NCT00525252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110339007|NCT02947113|Etoposide|etoposide|mesh-list
110339008|NCT02947113|Pemetrexed|pemetrexed|mesh-list
110339009|NCT02947113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110339010|NCT02947113|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110339011|NCT02947113|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110339012|NCT02947113|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110339013|NCT02947113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110339014|NCT02947113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110339015|NCT02947113|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110339016|NCT02947113|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110339017|NCT05149274|Fexuprazan|fexuprazan|mesh-list
110339018|NCT05149274|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110339019|NCT02276690|Hepcidins|hepcidins|mesh-list
110339020|NCT02276690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110339021|NCT02947269|Prucalopride|prucalopride|mesh-list
110339022|NCT02947269|Laxatives|laxatives|mesh-ancestor
110339023|NCT02947269|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110339024|NCT02947269|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
110339025|NCT02947269|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110339026|NCT02947269|Serotonin Agents|serotonin agents|mesh-ancestor
110339027|NCT02947269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110339028|NCT02947269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110170375|NCT00039520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110339029|NCT02947269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110339031|NCT00526305|Dexamethasone|dexamethasone|mesh-list
110339032|NCT00526305|Prednisone|prednisone|mesh-list
110339033|NCT00526305|Hydrocortisone|hydrocortisone|mesh-list
110170442|NCT00001343|Hormones|hormones|mesh-ancestor
110339034|NCT00526305|Cyclophosphamide|cyclophosphamide|mesh-list
110339035|NCT00526305|Vincristine|vincristine|mesh-list
110339036|NCT00526305|Daunorubicin|daunorubicin|mesh-list
110339037|NCT00526305|Asparaginase|asparaginase|mesh-list
110339038|NCT00526305|Mitoxantrone|mitoxantrone|mesh-list
110339039|NCT00526305|Mercaptopurine|mercaptopurine|mesh-list
110339040|NCT00526305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110339041|NCT00526305|Immunologic Factors|immunologic factors|mesh-ancestor
110339042|NCT00526305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110339043|NCT00526305|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110339044|NCT00526305|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110339045|NCT00526305|Alkylating Agents|alkylating agents|mesh-ancestor
110339046|NCT00526305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110339047|NCT00526305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110339048|NCT00526305|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110339049|NCT00526305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110339050|NCT00526305|Antiemetics|antiemetics|mesh-ancestor
110339051|NCT00526305|Autonomic Agents|autonomic agents|mesh-ancestor
110339052|NCT00526305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110339053|NCT00526305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110339054|NCT00526305|Glucocorticoids|glucocorticoids|mesh-ancestor
110339055|NCT00526305|Hormones|hormones|mesh-ancestor
110339056|NCT00526305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110339057|NCT00526305|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110339058|NCT00526305|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110339059|NCT00526305|Tubulin Modulators|tubulin modulators|mesh-ancestor
110339060|NCT00526305|Antimitotic Agents|antimitotic agents|mesh-ancestor
110339061|NCT00526305|Mitosis Modulators|mitosis modulators|mesh-ancestor
110339062|NCT00526305|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110339063|NCT00526305|Antimetabolites|antimetabolites|mesh-ancestor
110339064|NCT00526305|Antiviral Agents|antiviral agents|mesh-ancestor
110339065|NCT00526305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110339066|NCT00526305|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110339067|NCT00526305|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110339068|NCT00526305|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110339069|NCT00526305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110173339|NCT00057850|Cisplatin|cisplatin|mesh-list
110339070|NCT00526305|Analgesics|analgesics|mesh-ancestor
110170714|NCT00041782|Tinzaparin|tinzaparin|mesh-list
110339071|NCT00526305|Sensory System Agents|sensory system agents|mesh-ancestor
110339072|NCT00526305|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110339073|NCT02276768|Trimebutine|trimebutine|mesh-list
110339074|NCT02276768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110339075|NCT02276768|Parasympatholytics|parasympatholytics|mesh-ancestor
110339076|NCT02276768|Autonomic Agents|autonomic agents|mesh-ancestor
110339077|NCT02276768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110339078|NCT02276768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110339079|NCT00526383|Antidepressive Agents|antidepressive agents|mesh-list
110339080|NCT00526383|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-list
110339081|NCT00526383|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110339082|NCT05147753|Moxonidine|moxonidine|mesh-list
110339083|NCT05147753|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110339084|NCT00525408|Docetaxel|docetaxel|mesh-list
110339085|NCT00525408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110339086|NCT00525408|Tubulin Modulators|tubulin modulators|mesh-ancestor
110339087|NCT00525408|Antimitotic Agents|antimitotic agents|mesh-ancestor
110339088|NCT00525408|Mitosis Modulators|mitosis modulators|mesh-ancestor
110339089|NCT00525408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110339090|NCT00525447|Dexamethasone|dexamethasone|mesh-list
110339091|NCT00525447|Lenalidomide|lenalidomide|mesh-list
110339092|NCT00525447|Dacetuzumab|dacetuzumab|mesh-list
110170804|NCT02970643|Olanzapine|olanzapine|mesh-list
110339093|NCT00525447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110339094|NCT00525447|Antiemetics|antiemetics|mesh-ancestor
110339095|NCT00525447|Autonomic Agents|autonomic agents|mesh-ancestor
110339096|NCT00525447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110339097|NCT00525447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110339098|NCT00525447|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110339099|NCT00525447|Glucocorticoids|glucocorticoids|mesh-ancestor
110339100|NCT00525447|Hormones|hormones|mesh-ancestor
110339101|NCT00525447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110339102|NCT00525447|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110339103|NCT00525447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110339104|NCT00525447|Immunologic Factors|immunologic factors|mesh-ancestor
110339105|NCT00525447|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110339106|NCT00525447|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110339107|NCT00525447|Growth Substances|growth substances|mesh-ancestor
110339108|NCT00525447|Growth Inhibitors|growth inhibitors|mesh-ancestor
110339109|NCT00525447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110339110|NCT00525486|Nifedipine|nifedipine|mesh-list
110170894|NCT00042796|Decitabine|decitabine|mesh-list
110339111|NCT00525486|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110339112|NCT00525486|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110339113|NCT00525486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110339114|NCT00525486|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110339115|NCT00525486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110339116|NCT00525486|Vasodilator Agents|vasodilator agents|mesh-ancestor
110339117|NCT00525486|Tocolytic Agents|tocolytic agents|mesh-ancestor
110170962|NCT00043069|Micronutrients|micronutrients|mesh-ancestor
110339118|NCT00525486|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110339119|NCT05145101|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110339120|NCT05145101|Immunologic Factors|immunologic factors|mesh-ancestor
110339121|NCT05145101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110339123|NCT02946060|Antioxidants|antioxidants|mesh-ancestor
110339124|NCT02946060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110339125|NCT02946060|Protective Agents|protective agents|mesh-ancestor
110339126|NCT02946060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110339127|NCT00525564|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110339128|NCT00525564|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110339129|NCT00525564|Autonomic Agents|autonomic agents|mesh-ancestor
110339130|NCT00525564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110339131|NCT00525564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110339132|NCT00525564|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110339133|NCT00525564|Respiratory System Agents|respiratory system agents|mesh-ancestor
110339134|NCT00525564|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110339135|NCT00525564|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110339136|NCT00525564|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110339137|NCT00525564|Adrenergic Agents|adrenergic agents|mesh-ancestor
110339138|NCT00525564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110339139|NCT00525564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110339140|NCT00525642|Cyclophosphamide|cyclophosphamide|mesh-list
110339141|NCT00525642|Docetaxel|docetaxel|mesh-list
110339142|NCT00525642|Doxorubicin|doxorubicin|mesh-list
110339143|NCT00525642|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110339144|NCT00525642|Epirubicin|epirubicin|mesh-list
110339145|NCT00525642|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110339146|NCT00525642|Immunologic Factors|immunologic factors|mesh-ancestor
110339147|NCT00525642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110339148|NCT00525642|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110339149|NCT00525642|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110339150|NCT00525642|Alkylating Agents|alkylating agents|mesh-ancestor
110339151|NCT00525642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110339152|NCT00525642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110339153|NCT00525642|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110339154|NCT00525642|Tubulin Modulators|tubulin modulators|mesh-ancestor
110339155|NCT00525642|Antimitotic Agents|antimitotic agents|mesh-ancestor
110339156|NCT00525642|Mitosis Modulators|mitosis modulators|mesh-ancestor
110339157|NCT00525642|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110339158|NCT00525642|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110339159|NCT00525642|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110339160|NCT00525642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110339161|NCT00525681|Cyclosporine|cyclosporine|mesh-list
110339162|NCT00525681|Tacrolimus|tacrolimus|mesh-list
110339163|NCT00525681|Cyclosporins|cyclosporins|mesh-list
110339164|NCT00525681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110339165|NCT00525681|Immunologic Factors|immunologic factors|mesh-ancestor
110339166|NCT00525681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110339167|NCT00525681|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110339168|NCT00525681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110339169|NCT00525681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110339170|NCT00525681|Antifungal Agents|antifungal agents|mesh-ancestor
110339171|NCT00525681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110339172|NCT00525681|Dermatologic Agents|dermatologic agents|mesh-ancestor
110339173|NCT00525681|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110339174|NCT03456635|Anti-Infective Agents|anti-infective agents|mesh-list
110339175|NCT03456635|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110339176|NCT02945982|Entecavir|entecavir|mesh-list
110339177|NCT02945982|Carvedilol|carvedilol|mesh-list
110339178|NCT02945982|Antiviral Agents|antiviral agents|mesh-ancestor
110339179|NCT02945982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110339180|NCT02945982|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110339181|NCT02945982|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110339182|NCT02945982|Adrenergic Agents|adrenergic agents|mesh-ancestor
110339183|NCT02945982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110171194|NCT00043966|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110339184|NCT02945982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110339185|NCT02945982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110339186|NCT02945982|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110339188|NCT02945982|Protective Agents|protective agents|mesh-ancestor
110339189|NCT02945982|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110339190|NCT02945982|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110339191|NCT02945982|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110339192|NCT02945982|Vasodilator Agents|vasodilator agents|mesh-ancestor
110339193|NCT02945982|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110339194|NCT02945982|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110339195|NCT02954393|Amoxicillin|amoxicillin|mesh-list
110339196|NCT02954393|Metronidazole|metronidazole|mesh-list
110339197|NCT02954393|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110339198|NCT02954393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110339199|NCT02954393|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110339200|NCT02954393|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110339201|NCT02954276|Sumatriptan|sumatriptan|mesh-list
110339202|NCT02954276|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110339203|NCT02954276|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110339205|NCT02954276|Serotonin Agents|serotonin agents|mesh-ancestor
110339206|NCT02954276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110171259|NCT00018135|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110339207|NCT02954276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110339208|NCT02954276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110339209|NCT00507494|Pioglitazone|pioglitazone|mesh-list
110339210|NCT00507494|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110339211|NCT00507494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110339212|NCT00526617|Temozolomide|temozolomide|mesh-list
110339214|NCT00526617|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110339215|NCT00526617|Alkylating Agents|alkylating agents|mesh-ancestor
110339216|NCT00526617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110339217|NCT00526617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110339218|NCT00526617|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110339219|NCT00526617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110339221|NCT00507845|Ramipril|ramipril|mesh-list
110339222|NCT00507845|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110339223|NCT00507845|Protease Inhibitors|protease inhibitors|mesh-ancestor
110339224|NCT00507845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110339225|NCT00507845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110339226|NCT00507845|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110339227|NCT00507845|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110339228|NCT00507845|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110339229|NCT00507845|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110339230|NCT00507845|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110339231|NCT00507845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110339232|NCT00507845|Vasodilator Agents|vasodilator agents|mesh-ancestor
110339233|NCT00525759|Zoledronic Acid|zoledronic acid|mesh-list
110339234|NCT00525759|Cyclophosphamide|cyclophosphamide|mesh-list
110339235|NCT00525759|Docetaxel|docetaxel|mesh-list
110339236|NCT00525759|Fluorouracil|fluorouracil|mesh-list
110339237|NCT00525759|Epirubicin|epirubicin|mesh-list
110339238|NCT00525759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110339239|NCT00525759|Immunologic Factors|immunologic factors|mesh-ancestor
110339240|NCT00525759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110339241|NCT00525759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110339242|NCT00525759|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110339243|NCT00525759|Alkylating Agents|alkylating agents|mesh-ancestor
110339244|NCT00525759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110339245|NCT00525759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110339246|NCT00525759|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110339247|NCT00525759|Tubulin Modulators|tubulin modulators|mesh-ancestor
110339248|NCT00525759|Antimitotic Agents|antimitotic agents|mesh-ancestor
110339249|NCT00525759|Mitosis Modulators|mitosis modulators|mesh-ancestor
110339250|NCT00525759|Antimetabolites|antimetabolites|mesh-ancestor
110339251|NCT00525759|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110339252|NCT00525759|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110339253|NCT00525759|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110339254|NCT00525759|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110339255|NCT00525759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110171342|NCT00044746|Piperacillin|piperacillin|mesh-list
110339256|NCT00525759|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110339258|NCT00507962|Doxorubicin|doxorubicin|mesh-list
110339259|NCT00507962|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110339260|NCT00507962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110339261|NCT00507962|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110339262|NCT00507962|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110339263|NCT00507962|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110339264|NCT00507962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110339265|NCT00507962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110339266|NCT00508040|Interferons|interferons|mesh-list
110339267|NCT00508040|Interferon-alpha|interferon-alpha|mesh-list
110339268|NCT00508040|Interferon alpha-2|interferon alpha-2|mesh-list
110339269|NCT00508040|Prednisone|prednisone|mesh-list
110339270|NCT00508040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110339271|NCT00508040|Glucocorticoids|glucocorticoids|mesh-ancestor
110339273|NCT00508040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110339274|NCT00508040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110339275|NCT00508040|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110339276|NCT00508040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110339277|NCT00508040|Antiviral Agents|antiviral agents|mesh-ancestor
110339278|NCT00508040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110339279|NCT00508040|Immunologic Factors|immunologic factors|mesh-ancestor
110339280|NCT00508664|Docetaxel|docetaxel|mesh-list
110339281|NCT00508664|Fluorouracil|fluorouracil|mesh-list
110339282|NCT00508664|Cetuximab|cetuximab|mesh-list
110339283|NCT00508664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110339284|NCT00508664|Tubulin Modulators|tubulin modulators|mesh-ancestor
110339285|NCT00508664|Antimitotic Agents|antimitotic agents|mesh-ancestor
110339286|NCT00508664|Mitosis Modulators|mitosis modulators|mesh-ancestor
110339287|NCT00508664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110339288|NCT00508664|Antimetabolites|antimetabolites|mesh-ancestor
110339289|NCT00508664|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110339290|NCT00508664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110339291|NCT00508664|Immunologic Factors|immunologic factors|mesh-ancestor
110339292|NCT00508664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110171620|NCT04380207|QPX7728|qpx7728|mesh-list
110339293|NCT00508664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110339294|NCT02946684|Letrozole|letrozole|mesh-list
110339295|NCT02946684|Aromatase Inhibitors|aromatase inhibitors|mesh-list
110339296|NCT02946684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110339297|NCT02946684|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110339298|NCT02946684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110339299|NCT02946684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110339300|NCT02946684|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110339301|NCT02946684|Hormone Antagonists|hormone antagonists|mesh-ancestor
110339302|NCT02946684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110339303|NCT02946684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110339305|NCT02953379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110339306|NCT02953379|Dermatologic Agents|dermatologic agents|mesh-ancestor
110339307|NCT02953379|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110339308|NCT02946801|Listerine|listerine|mesh-list
110339309|NCT02946801|Sodium Fluoride|sodium fluoride|mesh-list
110339310|NCT02946801|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110339311|NCT02946801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110339312|NCT02946801|Cariostatic Agents|cariostatic agents|mesh-ancestor
110339313|NCT02946801|Protective Agents|protective agents|mesh-ancestor
110339314|NCT02946801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110339315|NCT02953847|Rifampin|rifampin|mesh-list
110339316|NCT02953847|Isoniazid|isoniazid|mesh-list
110339317|NCT02953847|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110339318|NCT02953847|Antitubercular Agents|antitubercular agents|mesh-ancestor
110339319|NCT02953847|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110339320|NCT02953847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110339321|NCT02953847|Leprostatic Agents|leprostatic agents|mesh-ancestor
110339322|NCT02953847|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110339324|NCT02953847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110339325|NCT02953847|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110339326|NCT02953847|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110339327|NCT02953847|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110339328|NCT02953847|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110339329|NCT02953847|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110339330|NCT02953847|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110339331|NCT02953847|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
110339332|NCT02953847|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110339333|NCT02953847|Antimetabolites|antimetabolites|mesh-ancestor
110339334|NCT02953847|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110339335|NCT00526695|Sevoflurane|sevoflurane|mesh-list
110171941|NCT00047281|Growth Substances|growth substances|mesh-ancestor
110339336|NCT00526695|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110339337|NCT00526695|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110339338|NCT00526695|Anesthetics, General|anesthetics, general|mesh-ancestor
110339340|NCT00526695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110339341|NCT00526695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110339342|NCT00526929|Darbepoetin alfa|darbepoetin alfa|mesh-list
110339343|NCT00526929|Hematinics|hematinics|mesh-ancestor
110339344|NCT02953535|Sofosbuvir|sofosbuvir|mesh-list
110339345|NCT02953535|Antiviral Agents|antiviral agents|mesh-ancestor
110339346|NCT02953535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110339347|NCT00526734|Melphalan|melphalan|mesh-list
110339348|NCT00526734|Immunologic Factors|immunologic factors|mesh-ancestor
110339349|NCT00526734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110339350|NCT00526734|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110339351|NCT00526734|Alkylating Agents|alkylating agents|mesh-ancestor
110339352|NCT00526734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110339353|NCT00526734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110339354|NCT00526734|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110339355|NCT00526734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110339357|NCT00508859|Antidepressive Agents|antidepressive agents|mesh-ancestor
110339358|NCT00508859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110339359|NCT00508859|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110339360|NCT00508859|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110339361|NCT00508859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110172134|NCT00049075|Fludarabine|fludarabine|mesh-list
110339362|NCT00508859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110339363|NCT00508859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110339364|NCT00508859|Serotonin Agents|serotonin agents|mesh-ancestor
110339365|NCT00508859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110339366|NCT00508898|Calcitriol|calcitriol|mesh-list
110339367|NCT00508898|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110339368|NCT00508898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110339369|NCT00508898|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
110339370|NCT00508898|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110339371|NCT00508898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110339372|NCT00508898|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110339373|NCT00508898|Vitamins|vitamins|mesh-ancestor
110339374|NCT00508898|Micronutrients|micronutrients|mesh-ancestor
110339375|NCT00508898|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110339376|NCT04692558|Hyaluronic Acid|hyaluronic acid|mesh-list
110339377|NCT04692558|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110339378|NCT04692558|Immunologic Factors|immunologic factors|mesh-ancestor
110339379|NCT04692558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110339380|NCT04692558|Viscosupplements|viscosupplements|mesh-ancestor
110339381|NCT04692558|Protective Agents|protective agents|mesh-ancestor
110339382|NCT02952599|Edoxaban|edoxaban|mesh-list
110339383|NCT02952599|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110339384|NCT02952599|Antithrombins|antithrombins|mesh-ancestor
110339385|NCT02952599|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110339386|NCT02952599|Protease Inhibitors|protease inhibitors|mesh-ancestor
110339387|NCT02952599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110339388|NCT02952599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110339389|NCT02952599|Anticoagulants|anticoagulants|mesh-ancestor
110339390|NCT00510419|Sumatriptan|sumatriptan|mesh-list
110339391|NCT00510419|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110339392|NCT00510419|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110339393|NCT00510419|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110172259|NCT00392028|Ertapenem|ertapenem|mesh-list
110339396|NCT00510419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110339397|NCT00510419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110339398|NCT00510536|Acetaminophen|acetaminophen|mesh-list
110339399|NCT00510536|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110339400|NCT00510536|Analgesics|analgesics|mesh-ancestor
110339401|NCT00510536|Sensory System Agents|sensory system agents|mesh-ancestor
110339402|NCT00510536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110339403|NCT00510536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110339404|NCT00510536|Antipyretics|antipyretics|mesh-ancestor
110339405|NCT03458715|Empagliflozin|empagliflozin|mesh-list
110339406|NCT03458715|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
110339407|NCT03458715|Linagliptin|linagliptin|mesh-list
110339408|NCT03458715|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
110339409|NCT03458715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110339410|NCT03458715|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110339411|NCT03458715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110339412|NCT03458715|Incretins|incretins|mesh-ancestor
110339413|NCT03458715|Hormones|hormones|mesh-ancestor
110339414|NCT03458715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110339415|NCT03458715|Protease Inhibitors|protease inhibitors|mesh-ancestor
110339416|NCT03458715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110339417|NCT00510614|Tinidazole|tinidazole|mesh-list
110339418|NCT00510614|Alkylating Agents|alkylating agents|mesh-ancestor
110339419|NCT00510614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110339420|NCT00510614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110339421|NCT00510614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110339422|NCT00510614|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
110339423|NCT00510614|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110339424|NCT00510614|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110339425|NCT00508976|Lidocaine|lidocaine|mesh-list
110339426|NCT00508976|Bupivacaine|bupivacaine|mesh-list
110172443|NCT05639777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110339427|NCT00508976|Anesthetics, Local|anesthetics, local|mesh-ancestor
110339428|NCT00508976|Anesthetics|anesthetics|mesh-ancestor
110339429|NCT00508976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110339430|NCT00508976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110339431|NCT00508976|Sensory System Agents|sensory system agents|mesh-ancestor
110339432|NCT00508976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110339433|NCT00508976|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110339434|NCT00508976|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110339435|NCT00508976|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110339436|NCT00508976|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110339437|NCT00508976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110339438|NCT04692285|Zolpidem|zolpidem|mesh-list
110339439|NCT04692285|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110339440|NCT04692285|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110339441|NCT04692285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110339442|NCT04692285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110339443|NCT04692285|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
110339444|NCT04692285|GABA Agonists|gaba agonists|mesh-ancestor
110339445|NCT04692285|GABA Agents|gaba agents|mesh-ancestor
110339446|NCT04692285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110339447|NCT04692285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110339448|NCT00509015|Artesunate|artesunate|mesh-list
110339449|NCT00509015|Pyrimethamine|pyrimethamine|mesh-list
110339450|NCT00509015|Primaquine|primaquine|mesh-list
110339451|NCT00509015|Sulfadoxine|sulfadoxine|mesh-list
110339452|NCT00509015|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
110339453|NCT00509015|Antimalarials|antimalarials|mesh-ancestor
110339454|NCT00509015|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110339455|NCT00509015|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110339456|NCT00509015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110339457|NCT00509015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110339458|NCT00509015|Antiviral Agents|antiviral agents|mesh-ancestor
110339459|NCT00509015|Schistosomicides|schistosomicides|mesh-ancestor
110339460|NCT00509015|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110339461|NCT00509015|Anthelmintics|anthelmintics|mesh-ancestor
110339462|NCT00509015|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110339463|NCT00509015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110339464|NCT00509015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110339465|NCT00509015|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110339467|NCT00528060|Atazanavir Sulfate|atazanavir sulfate|mesh-list
110339468|NCT00528060|Tenofovir|tenofovir|mesh-list
110339469|NCT00528060|Emtricitabine|emtricitabine|mesh-list
110172571|NCT00052351|Metronidazole|metronidazole|mesh-list
110339470|NCT00528060|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110339471|NCT00528060|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110339473|NCT00528060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110339474|NCT00528060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110339475|NCT00528060|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110339476|NCT00528060|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110339477|NCT00528060|Antiviral Agents|antiviral agents|mesh-ancestor
110339478|NCT00528060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110339479|NCT00528060|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110339480|NCT00528060|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110339481|NCT00528060|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110339482|NCT00528060|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110339483|NCT00527085|Cinacalcet|cinacalcet|mesh-list
110339484|NCT00527085|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110339485|NCT00527085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110339486|NCT00527085|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
110339487|NCT00527085|Hormone Antagonists|hormone antagonists|mesh-ancestor
110339488|NCT00527085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110339489|NCT00509327|Bisacodyl|bisacodyl|mesh-list
110339490|NCT00509327|Cathartics|cathartics|mesh-ancestor
110339491|NCT00509327|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110339492|NCT00509327|Laxatives|laxatives|mesh-ancestor
110339493|NCT00509405|Potassium Citrate|potassium citrate|mesh-list
110339494|NCT00509405|Diuretics|diuretics|mesh-ancestor
110339495|NCT00509405|Natriuretic Agents|natriuretic agents|mesh-ancestor
110339496|NCT00509405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110339497|NCT00509405|Expectorants|expectorants|mesh-ancestor
110339498|NCT00509405|Respiratory System Agents|respiratory system agents|mesh-ancestor
110339499|NCT00509561|Capecitabine|capecitabine|mesh-list
110339500|NCT00509561|Cetuximab|cetuximab|mesh-list
110339501|NCT00509561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110339502|NCT00509561|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110339503|NCT00509561|Antimetabolites|antimetabolites|mesh-ancestor
110339504|NCT00509561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110172689|NCT00053092|Fludarabine|fludarabine|mesh-list
110339505|NCT00509561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110339507|NCT00509639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110339508|NCT00509639|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110339509|NCT00509639|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110339510|NCT00509639|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110339511|NCT00528177|Morphine|morphine|mesh-list
110339512|NCT00528177|Oxycodone|oxycodone|mesh-list
110339513|NCT00528177|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110339514|NCT00528177|Narcotics|narcotics|mesh-ancestor
110339515|NCT00528177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110339516|NCT00528177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110339517|NCT00528177|Analgesics|analgesics|mesh-ancestor
110339518|NCT00528177|Sensory System Agents|sensory system agents|mesh-ancestor
110339519|NCT00528177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110339520|NCT00509678|Rituximab|rituximab|mesh-list
110339521|NCT00509678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110339522|NCT00509678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110339523|NCT00509678|Immunologic Factors|immunologic factors|mesh-ancestor
110339524|NCT00509678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110339525|NCT00509678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110339526|NCT00528216|Capsaicin|capsaicin|mesh-list
110339527|NCT00528216|Antipruritics|antipruritics|mesh-ancestor
110339528|NCT00528216|Dermatologic Agents|dermatologic agents|mesh-ancestor
110339529|NCT00528216|Sensory System Agents|sensory system agents|mesh-ancestor
110339530|NCT00528216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110339531|NCT00528216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110339532|NCT00528255|Misoprostol|misoprostol|mesh-list
110339533|NCT00528255|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110172798|NCT00053872|Lomustine|lomustine|mesh-list
110339534|NCT00528255|Abortifacient Agents|abortifacient agents|mesh-ancestor
110339535|NCT00528255|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110339536|NCT00528255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110339537|NCT00528255|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110339538|NCT00528255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110339539|NCT00528255|Oxytocics|oxytocics|mesh-ancestor
110339540|NCT02953106|Fluticasone|fluticasone|mesh-list
110339542|NCT02953106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110339543|NCT02953106|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110339544|NCT02953106|Autonomic Agents|autonomic agents|mesh-ancestor
110339545|NCT02953106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110339546|NCT02953106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110339547|NCT02953106|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110339548|NCT02953106|Respiratory System Agents|respiratory system agents|mesh-ancestor
110339549|NCT02953106|Dermatologic Agents|dermatologic agents|mesh-ancestor
110339550|NCT02953106|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110339551|NCT02953106|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
110339552|NCT02953106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110339553|NCT02953106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110339554|NCT02953106|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110339555|NCT02953106|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110339557|NCT02953106|Histamine Agents|histamine agents|mesh-ancestor
110339558|NCT02953106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110339559|NCT02952989|Pembrolizumab|pembrolizumab|mesh-list
110339560|NCT02952989|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110339561|NCT02952989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110172881|NCT00054418|Vitamin D|vitamin d|mesh-list
110339562|NCT02952989|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110339563|NCT02952989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110339564|NCT00510926|Imatinib Mesylate|imatinib mesylate|mesh-list
110339565|NCT00510926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110339566|NCT00510926|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110339567|NCT00510926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110339568|NCT00510926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110339569|NCT00509834|Lactoferrin|lactoferrin|mesh-list
110339570|NCT00509834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110339571|NCT03459404|Sufentanil|sufentanil|mesh-list
110339572|NCT03459404|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110339573|NCT03459404|Narcotics|narcotics|mesh-ancestor
110339574|NCT03459404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110339575|NCT03459404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110339576|NCT03459404|Analgesics|analgesics|mesh-ancestor
110339577|NCT03459404|Sensory System Agents|sensory system agents|mesh-ancestor
110339578|NCT03459404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110339579|NCT03459404|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110339580|NCT03459404|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110339581|NCT03459404|Anesthetics, General|anesthetics, general|mesh-ancestor
110339582|NCT03459404|Anesthetics|anesthetics|mesh-ancestor
110339583|NCT00527202|Botulinum Toxins|botulinum toxins|mesh-list
110339584|NCT00527202|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110339585|NCT00527202|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110339586|NCT00527202|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110339587|NCT00527202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110339588|NCT00527202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110339589|NCT00527202|Cholinergic Agents|cholinergic agents|mesh-ancestor
110339590|NCT00527202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110339591|NCT00527202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110339592|NCT00527202|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110339593|NCT00527202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110339594|NCT00510965|Ranibizumab|ranibizumab|mesh-list
110339595|NCT00510965|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110339596|NCT00510965|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110339597|NCT00510965|Growth Substances|growth substances|mesh-ancestor
110339598|NCT00510965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110339599|NCT00510965|Growth Inhibitors|growth inhibitors|mesh-ancestor
110339600|NCT00510965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110339601|NCT00509990|Pimecrolimus|pimecrolimus|mesh-list
110339602|NCT00509990|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110339603|NCT00509990|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110339604|NCT00509990|Analgesics|analgesics|mesh-ancestor
110339605|NCT00509990|Sensory System Agents|sensory system agents|mesh-ancestor
110339606|NCT00509990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110339607|NCT00509990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110339608|NCT00509990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110339609|NCT00509990|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110339610|NCT00509990|Dermatologic Agents|dermatologic agents|mesh-ancestor
110339611|NCT00509990|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110339612|NCT00509990|Immunologic Factors|immunologic factors|mesh-ancestor
110339613|NCT00509990|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110339614|NCT00509990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110339615|NCT00509990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110339617|NCT03459911|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110339618|NCT03459911|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110339619|NCT03459911|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110339620|NCT03459911|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110339621|NCT03459911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110339622|NCT03459833|Hyaluronic Acid|hyaluronic acid|mesh-list
110339623|NCT03459833|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110339625|NCT03459833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110339626|NCT03459833|Viscosupplements|viscosupplements|mesh-ancestor
110339627|NCT03459833|Protective Agents|protective agents|mesh-ancestor
110339629|NCT05648487|Immunologic Factors|immunologic factors|mesh-ancestor
110339630|NCT05648487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110339631|NCT00511121|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110339632|NCT00511121|Imatinib Mesylate|imatinib mesylate|mesh-list
110339633|NCT00511121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110173067|NCT00055666|Glucocorticoids|glucocorticoids|mesh-ancestor
110339634|NCT00511121|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110339635|NCT00511121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110339636|NCT00511121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110339638|NCT00511121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110339639|NCT04692051|Paclitaxel|paclitaxel|mesh-list
110339640|NCT04692051|Cisplatin|cisplatin|mesh-list
110339641|NCT04692051|Gemcitabine|gemcitabine|mesh-list
110339642|NCT04692051|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110339643|NCT04692051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110339644|NCT04692051|Tubulin Modulators|tubulin modulators|mesh-ancestor
110339645|NCT04692051|Antimitotic Agents|antimitotic agents|mesh-ancestor
110339646|NCT04692051|Mitosis Modulators|mitosis modulators|mesh-ancestor
110339647|NCT04692051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110339648|NCT04692051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110339649|NCT04692051|Antimetabolites|antimetabolites|mesh-ancestor
110339650|NCT00528723|Albuterol|albuterol|mesh-list
110339651|NCT00528723|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110339652|NCT00528723|Autonomic Agents|autonomic agents|mesh-ancestor
110339653|NCT00528723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110339654|NCT00528723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110339655|NCT00528723|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110173134|NCT00055978|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110339656|NCT00528723|Respiratory System Agents|respiratory system agents|mesh-ancestor
110339657|NCT00528723|Tocolytic Agents|tocolytic agents|mesh-ancestor
110339658|NCT00528723|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110339659|NCT00528723|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110339660|NCT00528723|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110339661|NCT00528723|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110339662|NCT00528723|Adrenergic Agents|adrenergic agents|mesh-ancestor
110339663|NCT00528723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110339664|NCT00528723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110339665|NCT00510107|Oxaliplatin|oxaliplatin|mesh-list
110339666|NCT00510107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110339667|NCT01580514|Exenatide|exenatide|mesh-list
110339668|NCT01580514|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110339669|NCT01580514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110339670|NCT01580514|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110339671|NCT01580514|Incretins|incretins|mesh-ancestor
110339672|NCT01580514|Hormones|hormones|mesh-ancestor
110339673|NCT01580514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110339674|NCT00528918|Insulin glulisine|insulin glulisine|mesh-list
110339675|NCT00528918|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110339676|NCT00528918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110339678|NCT00515190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110339679|NCT00511277|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110339680|NCT00511277|Antidepressive Agents|antidepressive agents|mesh-ancestor
110339681|NCT00511277|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110339682|NCT00511277|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110339683|NCT00511277|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110339684|NCT00511277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110339685|NCT00511277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110339686|NCT02953184|Vitamins|vitamins|mesh-list
110339687|NCT02953184|Vitamin B Complex|vitamin b complex|mesh-list
110339689|NCT02953184|Docetaxel|docetaxel|mesh-list
110339690|NCT02953184|Doxorubicin|doxorubicin|mesh-list
110339691|NCT02953184|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110339692|NCT02953184|Dexrazoxane|dexrazoxane|mesh-list
110339693|NCT02953184|Razoxane|razoxane|mesh-list
110339695|NCT02953184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110339696|NCT02953184|Immunologic Factors|immunologic factors|mesh-ancestor
110339697|NCT02953184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110339698|NCT02953184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110339699|NCT02953184|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110339700|NCT02953184|Alkylating Agents|alkylating agents|mesh-ancestor
110339701|NCT02953184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110339702|NCT02953184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110339703|NCT02953184|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110339704|NCT02953184|Micronutrients|micronutrients|mesh-ancestor
110339705|NCT02953184|Tubulin Modulators|tubulin modulators|mesh-ancestor
110339707|NCT02953184|Mitosis Modulators|mitosis modulators|mesh-ancestor
110339708|NCT02953184|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110339709|NCT02953184|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110339710|NCT02953184|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110339711|NCT02953184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110339712|NCT02953184|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110339713|NCT02953184|Protective Agents|protective agents|mesh-ancestor
110339714|NCT00515229|Amitriptyline|amitriptyline|mesh-list
110339715|NCT00515229|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110339716|NCT00515229|Antidepressive Agents|antidepressive agents|mesh-ancestor
110339717|NCT00515229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110339718|NCT00515229|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110339719|NCT00515229|Analgesics|analgesics|mesh-ancestor
110339720|NCT00515229|Sensory System Agents|sensory system agents|mesh-ancestor
110339721|NCT00515229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110339722|NCT00515229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110339723|NCT00515229|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110339724|NCT00515229|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110339725|NCT00515229|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110339726|NCT00515229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110339727|NCT00515229|Adrenergic Agents|adrenergic agents|mesh-ancestor
110339728|NCT00515229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110339729|NCT00511316|Montelukast|montelukast|mesh-list
110339730|NCT00511316|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110339731|NCT00511316|Respiratory System Agents|respiratory system agents|mesh-ancestor
110339732|NCT00511316|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110339733|NCT00511316|Hormone Antagonists|hormone antagonists|mesh-ancestor
110339734|NCT00511316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110339735|NCT00511316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110339736|NCT00511316|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110339737|NCT00511316|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110339738|NCT00511316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110339739|NCT00529269|Mycophenolic Acid|mycophenolic acid|mesh-list
110339740|NCT00529269|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110339741|NCT00529269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110339742|NCT00529269|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110173498|NCT02969473|Docetaxel|docetaxel|mesh-list
110339743|NCT00529269|Antitubercular Agents|antitubercular agents|mesh-ancestor
110339744|NCT00529269|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110339745|NCT00529269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110339746|NCT00529269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110339747|NCT00529269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110339748|NCT00515268|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|mesh-list
110339749|NCT00515268|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
110339750|NCT00515268|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110339752|NCT00515268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110339754|NCT01356966|Hematinics|hematinics|mesh-ancestor
110339755|NCT01356966|Vitamin B Complex|vitamin b complex|mesh-ancestor
110339756|NCT01356966|Vitamins|vitamins|mesh-ancestor
110339757|NCT01356966|Micronutrients|micronutrients|mesh-ancestor
110339758|NCT01356966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110339759|NCT02944734|Amlodipine|amlodipine|mesh-list
110339760|NCT02944734|Candesartan|candesartan|mesh-list
110339761|NCT02944734|Candesartan cilexetil|candesartan cilexetil|mesh-list
110339762|NCT02944734|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110339763|NCT02944734|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110339764|NCT02944734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110339765|NCT02944734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110339766|NCT02944734|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110339767|NCT02944734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110339768|NCT02944734|Vasodilator Agents|vasodilator agents|mesh-ancestor
110339769|NCT02944734|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110339770|NCT02944734|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110339772|NCT00510263|Prednisolone|prednisolone|mesh-list
110339773|NCT00510263|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110339774|NCT00510263|Methylprednisolone|methylprednisolone|mesh-list
110339775|NCT00510263|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110339776|NCT00510263|Prednisolone acetate|prednisolone acetate|mesh-list
110339778|NCT00510263|Prednisolone phosphate|prednisolone phosphate|mesh-list
110339779|NCT00510263|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110339780|NCT00510263|Glucocorticoids|glucocorticoids|mesh-ancestor
110339781|NCT00510263|Hormones|hormones|mesh-ancestor
110339782|NCT00510263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110339783|NCT00510263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110339784|NCT00510263|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110339785|NCT00510263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110339786|NCT00510263|Antiemetics|antiemetics|mesh-ancestor
110339787|NCT00510263|Autonomic Agents|autonomic agents|mesh-ancestor
110339788|NCT00510263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110339789|NCT00510263|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110339790|NCT00510263|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110339791|NCT00510263|Protective Agents|protective agents|mesh-ancestor
110339792|NCT00510263|Antiviral Agents|antiviral agents|mesh-ancestor
110339793|NCT00510263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110339794|NCT00511628|Risperidone|risperidone|mesh-list
110339795|NCT00511628|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110339796|NCT00511628|Serotonin Agents|serotonin agents|mesh-ancestor
110339797|NCT00511628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110339798|NCT00511628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110339799|NCT00511628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110339800|NCT00511628|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110339801|NCT00511628|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110339802|NCT00511628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110339803|NCT00511628|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110339804|NCT00511628|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110339805|NCT00511628|Dopamine Agents|dopamine agents|mesh-ancestor
110339806|NCT00529425|Ropivacaine|ropivacaine|mesh-list
110339807|NCT00529425|Anesthetics, Local|anesthetics, local|mesh-ancestor
110339808|NCT00529425|Anesthetics|anesthetics|mesh-ancestor
110339809|NCT00529425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110339810|NCT00529425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110339811|NCT00529425|Sensory System Agents|sensory system agents|mesh-ancestor
110339812|NCT00529425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110339813|NCT02950935|Progesterone|progesterone|mesh-list
110339814|NCT02950935|Progestins|progestins|mesh-ancestor
110339815|NCT02950935|Hormones|hormones|mesh-ancestor
110339816|NCT02950935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110339817|NCT02950935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110339818|NCT00529620|Pyrimethamine|pyrimethamine|mesh-list
110339820|NCT00529620|Sulfadoxine|sulfadoxine|mesh-list
110339821|NCT00529620|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
110339822|NCT00529620|Amodiaquine|amodiaquine|mesh-list
110339823|NCT00529620|Artenimol|artenimol|mesh-list
110339824|NCT00529620|Sulfalene|sulfalene|mesh-list
110339825|NCT00529620|Antimalarials|antimalarials|mesh-ancestor
110339826|NCT00529620|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110339827|NCT00529620|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110339828|NCT00529620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110339829|NCT00529620|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110339830|NCT00529620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110339831|NCT00529620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110339832|NCT00529620|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110339833|NCT00512993|Zoledronic Acid|zoledronic acid|mesh-list
110339834|NCT00512993|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110339835|NCT00512993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110339836|NCT00513032|Methylene Blue|methylene blue|mesh-list
110339837|NCT00513032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110339838|NCT00513032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110339839|NCT00513110|Caffeine|caffeine|mesh-list
110339840|NCT00513110|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110339841|NCT00513110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110174210|NCT00064129|Ipilimumab|ipilimumab|mesh-list
110366065|NCT04941105|Protease Inhibitors|protease inhibitors|mesh-ancestor
110366066|NCT04941105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110366067|NCT04941105|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110366068|NCT04933695|Sotorasib|sotorasib|mesh-list
110366069|NCT04933695|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110366070|NCT04933695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110366071|NCT04933695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110366072|NCT04933695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110366073|NCT04873102|Danazol|danazol|mesh-list
110366074|NCT04873102|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110375411|NCT04601324|Fluticasone|fluticasone|mesh-list
110366075|NCT04873102|Hormone Antagonists|hormone antagonists|mesh-ancestor
110366076|NCT04873102|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110366077|NCT04873102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110366078|NCT04860141|Gabapentin|gabapentin|mesh-list
110366079|NCT04860141|Analgesics|analgesics|mesh-ancestor
110366080|NCT04860141|Sensory System Agents|sensory system agents|mesh-ancestor
110366081|NCT04860141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110366082|NCT04860141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110366083|NCT04860141|Anticonvulsants|anticonvulsants|mesh-ancestor
110366084|NCT04860141|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110366085|NCT04860141|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110366086|NCT04860141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110366087|NCT04860141|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110366088|NCT04860141|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110366089|NCT04860141|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110366090|NCT04860141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110366091|NCT04860141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110366092|NCT04860141|Antimanic Agents|antimanic agents|mesh-ancestor
110366094|NCT04823156|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110366095|NCT04823156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110366096|NCT04813653|Cyclosporine|cyclosporine|mesh-list
110366097|NCT04813653|Dexamethasone|dexamethasone|mesh-list
110366098|NCT04813653|Cyclosporins|cyclosporins|mesh-list
110366099|NCT04813653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110366100|NCT04813653|Antiemetics|antiemetics|mesh-ancestor
110366101|NCT04813653|Autonomic Agents|autonomic agents|mesh-ancestor
110366102|NCT04813653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110366103|NCT04813653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110366104|NCT04813653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110366105|NCT04813653|Glucocorticoids|glucocorticoids|mesh-ancestor
110366106|NCT04813653|Hormones|hormones|mesh-ancestor
110366107|NCT04813653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110366108|NCT04813653|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110366109|NCT04813653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110366110|NCT04813653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110366111|NCT04813653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110375612|NCT04570449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110366112|NCT04813653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110366114|NCT04813653|Antifungal Agents|antifungal agents|mesh-ancestor
110366115|NCT04813653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110366116|NCT04813653|Dermatologic Agents|dermatologic agents|mesh-ancestor
110366117|NCT04813653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110366118|NCT04813653|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110366119|NCT04803747|Tranexamic Acid|tranexamic acid|mesh-list
110366120|NCT04803747|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110366121|NCT04803747|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110366122|NCT04803747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110366123|NCT04803747|Hemostatics|hemostatics|mesh-ancestor
110366124|NCT04803747|Coagulants|coagulants|mesh-ancestor
110366125|NCT04790474|Dexamethasone|dexamethasone|mesh-list
110375675|NCT04570254|Vitamins|vitamins|mesh-list
110375676|NCT04570254|Vitamin E|vitamin e|mesh-list
110375677|NCT04570254|Acetylcysteine|acetylcysteine|mesh-list
110375678|NCT04570254|Pentoxifylline|pentoxifylline|mesh-list
110366126|NCT04790474|Pomalidomide|pomalidomide|mesh-list
110366127|NCT04790474|Ixazomib|ixazomib|mesh-list
110366128|NCT04790474|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110366129|NCT04790474|Antiemetics|antiemetics|mesh-ancestor
110366130|NCT04790474|Autonomic Agents|autonomic agents|mesh-ancestor
110366131|NCT04790474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110366132|NCT04790474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110366133|NCT04790474|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110366134|NCT04790474|Glucocorticoids|glucocorticoids|mesh-ancestor
110366135|NCT04790474|Hormones|hormones|mesh-ancestor
110375738|NCT04575194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110375739|NCT04575194|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110375740|NCT04575194|Incretins|incretins|mesh-ancestor
110375741|NCT04575194|Hormones|hormones|mesh-ancestor
110366136|NCT04790474|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110366137|NCT04790474|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110366138|NCT04790474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110366139|NCT04790474|Immunologic Factors|immunologic factors|mesh-ancestor
110366140|NCT04790474|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110366141|NCT04790474|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110366142|NCT04790474|Growth Substances|growth substances|mesh-ancestor
110366143|NCT04790474|Growth Inhibitors|growth inhibitors|mesh-ancestor
110366144|NCT04790474|Protease Inhibitors|protease inhibitors|mesh-ancestor
110366145|NCT04790474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110366146|NCT04790474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110366147|NCT04743570|Methylnaltrexone|methylnaltrexone|mesh-list
110366148|NCT04743570|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110366149|NCT04743570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110366150|NCT04743570|Sensory System Agents|sensory system agents|mesh-ancestor
110366151|NCT04743570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110366152|NCT04718025|Aspirin|aspirin|mesh-list
110366153|NCT04718025|Ticagrelor|ticagrelor|mesh-list
110366154|NCT04718025|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110366155|NCT04718025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110375798|NCT00585455|Serotonin Agents|serotonin agents|mesh-ancestor
110366156|NCT04718025|Analgesics|analgesics|mesh-ancestor
110366157|NCT04718025|Sensory System Agents|sensory system agents|mesh-ancestor
110366158|NCT04718025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110366159|NCT04718025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110366160|NCT04718025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110366161|NCT04718025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110366162|NCT04718025|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110366163|NCT04718025|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110366164|NCT04718025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110366165|NCT04718025|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110366166|NCT04718025|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110366167|NCT04718025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110366168|NCT04718025|Antipyretics|antipyretics|mesh-ancestor
110366169|NCT04718025|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110366170|NCT04718025|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110366171|NCT04718025|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110366173|NCT04718025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110366175|NCT04666948|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110366176|NCT04666948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110366177|NCT04642430|Rivaroxaban|rivaroxaban|mesh-list
110366178|NCT04642430|Apixaban|apixaban|mesh-list
110366179|NCT04642430|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110366180|NCT04642430|Antithrombins|antithrombins|mesh-ancestor
110366181|NCT04642430|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110375853|NCT01089504|Phenobarbital|phenobarbital|mesh-list
110375854|NCT01089504|Anticonvulsants|anticonvulsants|mesh-ancestor
110366182|NCT04642430|Protease Inhibitors|protease inhibitors|mesh-ancestor
110366183|NCT04642430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110366184|NCT04642430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110366186|NCT04609176|Apatinib|apatinib|mesh-list
110366187|NCT04609176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110366188|NCT04609176|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110366189|NCT04609176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110366190|NCT04609176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110366191|NCT04562090|Mirabegron|mirabegron|mesh-list
110366192|NCT04562090|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
110366193|NCT04562090|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110375903|NCT01088529|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110375904|NCT01088529|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110375905|NCT01088529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110366194|NCT04562090|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110366195|NCT04562090|Adrenergic Agents|adrenergic agents|mesh-ancestor
110366196|NCT04562090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110366197|NCT04562090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110366198|NCT04562090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110366199|NCT04562090|Urological Agents|urological agents|mesh-ancestor
110366200|NCT04557189|Ondansetron|ondansetron|mesh-list
110366201|NCT04557189|Antiemetics|antiemetics|mesh-ancestor
110375963|NCT04312282|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110375964|NCT04312282|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110366202|NCT04557189|Autonomic Agents|autonomic agents|mesh-ancestor
110366203|NCT04557189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110366204|NCT04557189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110366205|NCT04557189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110366206|NCT04557189|Antipruritics|antipruritics|mesh-ancestor
110366207|NCT04557189|Dermatologic Agents|dermatologic agents|mesh-ancestor
110366208|NCT04557189|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110366209|NCT04557189|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110366211|NCT04557189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110366212|NCT04557189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110366213|NCT04530838|Vaccines|vaccines|mesh-list
110177871|NCT00142051|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110366214|NCT04530838|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110366215|NCT04530838|Immunologic Factors|immunologic factors|mesh-ancestor
110366216|NCT04530838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110366217|NCT04442919|Morphine|morphine|mesh-list
110366218|NCT04442919|Methoxyflurane|methoxyflurane|mesh-list
110366219|NCT04442919|Ticagrelor|ticagrelor|mesh-list
110366220|NCT04442919|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110366221|NCT04442919|Narcotics|narcotics|mesh-ancestor
110366222|NCT04442919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110366223|NCT04442919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110366224|NCT04442919|Analgesics|analgesics|mesh-ancestor
110366225|NCT04442919|Sensory System Agents|sensory system agents|mesh-ancestor
110366226|NCT04442919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110366227|NCT04442919|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110366228|NCT04442919|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110366229|NCT04442919|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110366231|NCT04442919|Purinergic Agents|purinergic agents|mesh-ancestor
110366232|NCT04442919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110366233|NCT04442919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110366234|NCT04442919|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110366235|NCT04442919|Anesthetics, General|anesthetics, general|mesh-ancestor
110366236|NCT04442919|Anesthetics|anesthetics|mesh-ancestor
110366237|NCT04435197|Pembrolizumab|pembrolizumab|mesh-list
110366238|NCT04435197|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110366239|NCT04435197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110366240|NCT04435197|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110366241|NCT04435197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110366242|NCT04424901|Dipyridamole|dipyridamole|mesh-list
110366243|NCT04424901|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110366244|NCT04424901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110366245|NCT04424901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110366246|NCT04424901|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110366247|NCT04424901|Vasodilator Agents|vasodilator agents|mesh-ancestor
110366248|NCT04415060|Sevoflurane|sevoflurane|mesh-list
110366249|NCT04415060|Isoflurane|isoflurane|mesh-list
110376153|NCT00588926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110376158|NCT00589082|Daunorubicin|daunorubicin|mesh-list
110366250|NCT04415060|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110366251|NCT04415060|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110366252|NCT04415060|Anesthetics, General|anesthetics, general|mesh-ancestor
110366254|NCT04415060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110366255|NCT04415060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110366256|NCT04410445|Nivolumab|nivolumab|mesh-list
110366257|NCT04410445|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110366258|NCT04410445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110366259|NCT04410445|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110376205|NCT04568304|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110376208|NCT01082640|Febuxostat|febuxostat|mesh-list
110366260|NCT04410445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110366261|NCT04381091|Idebenone|idebenone|mesh-list
110366262|NCT04381091|Antioxidants|antioxidants|mesh-ancestor
110366263|NCT04381091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110366264|NCT04381091|Protective Agents|protective agents|mesh-ancestor
110366265|NCT04381091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110366266|NCT04225312|Natalizumab|natalizumab|mesh-list
110366267|NCT04225312|Immunologic Factors|immunologic factors|mesh-ancestor
110366268|NCT04225312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110366269|NCT04209205|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110366270|NCT04209205|Immunologic Factors|immunologic factors|mesh-ancestor
110366271|NCT04209205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110366272|NCT04156347|Topotecan|topotecan|mesh-list
110366273|NCT04156347|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110366274|NCT04156347|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110376266|NCT00590447|Rituximab|rituximab|mesh-list
110376273|NCT01081626|Hormones|hormones|mesh-ancestor
110366275|NCT04156347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110366276|NCT04156347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110366277|NCT04156347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110366279|NCT04129086|Analgesics|analgesics|mesh-ancestor
110366280|NCT04129086|Sensory System Agents|sensory system agents|mesh-ancestor
110366281|NCT04129086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110366282|NCT04129086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110366283|NCT04129086|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110366284|NCT04129086|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110366285|NCT04129086|Anesthetics, General|anesthetics, general|mesh-ancestor
110366286|NCT04129086|Anesthetics|anesthetics|mesh-ancestor
110366287|NCT04129086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110366288|NCT04129086|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110366289|NCT04129086|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110366290|NCT04129086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110366291|NCT04129086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110366292|NCT04062448|Rituximab|rituximab|mesh-list
110376324|NCT00590603|Antioxidants|antioxidants|mesh-ancestor
110366293|NCT04062448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110366294|NCT04062448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110366295|NCT04062448|Immunologic Factors|immunologic factors|mesh-ancestor
110366296|NCT04062448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110366297|NCT04062448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110366298|NCT04003285|Pregnanolone|pregnanolone|mesh-list
110366299|NCT04003285|Anesthetics|anesthetics|mesh-ancestor
110366300|NCT04003285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110366301|NCT04003285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110366302|NCT04000555|Vancomycin|vancomycin|mesh-list
110366303|NCT04000555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110366304|NCT04000555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110366306|NCT03994393|Tremelimumab|tremelimumab|mesh-list
110366307|NCT03994393|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110366308|NCT03994393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110366309|NCT03961438|Monophosphoryl lipid A|monophosphoryl lipid a|mesh-list
110366310|NCT03961438|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110366311|NCT03961438|Immunologic Factors|immunologic factors|mesh-ancestor
110366312|NCT03961438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110366313|NCT03798639|Nivolumab|nivolumab|mesh-list
110376381|NCT01084161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110376383|NCT01084161|Analgesics|analgesics|mesh-ancestor
110366315|NCT03798639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110366316|NCT03798639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110366317|NCT03798639|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110366318|NCT03798639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110366319|NCT03774901|Avelumab|avelumab|mesh-list
110366320|NCT03774901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110366321|NCT03774901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110366322|NCT03762018|Bevacizumab|bevacizumab|mesh-list
110366323|NCT03762018|Atezolizumab|atezolizumab|mesh-list
110366324|NCT03762018|Carboplatin|carboplatin|mesh-list
110366325|NCT03762018|Pemetrexed|pemetrexed|mesh-list
110366326|NCT03762018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110376434|NCT03451682|Antioxidants|antioxidants|mesh-ancestor
110376439|NCT02210754|Nicotine|nicotine|mesh-list
110366327|NCT03762018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110366328|NCT03762018|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110366329|NCT03762018|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110366330|NCT03762018|Growth Substances|growth substances|mesh-ancestor
110366331|NCT03762018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110366332|NCT03762018|Growth Inhibitors|growth inhibitors|mesh-ancestor
110366333|NCT03762018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110366334|NCT03762018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110366335|NCT03762018|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110366336|NCT03762018|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110366337|NCT03762018|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110366338|NCT03456882|RNS60|rns60|mesh-list
110366339|NCT03456882|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110366340|NCT03456882|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110366341|NCT03456882|Analgesics|analgesics|mesh-ancestor
110366342|NCT03456882|Sensory System Agents|sensory system agents|mesh-ancestor
110366343|NCT03456882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110376496|NCT04991103|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110376497|NCT04991103|Glucocorticoids|glucocorticoids|mesh-ancestor
110366344|NCT03456882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110366345|NCT03456882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110366346|NCT03456882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110177881|NCT00142129|Bortezomib|bortezomib|mesh-list
110366347|NCT03456882|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110366348|NCT03433807|Idebenone|idebenone|mesh-list
110366349|NCT03433807|Antioxidants|antioxidants|mesh-ancestor
110366350|NCT03433807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110366351|NCT03433807|Protective Agents|protective agents|mesh-ancestor
110366352|NCT03433807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110366353|NCT03416179|Cytarabine|cytarabine|mesh-list
110366354|NCT03416179|Azacitidine|azacitidine|mesh-list
110366355|NCT03416179|Daunorubicin|daunorubicin|mesh-list
110366356|NCT03416179|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110366357|NCT03416179|Antimetabolites|antimetabolites|mesh-ancestor
110376555|NCT03450161|Fentanyl|fentanyl|mesh-list
110366358|NCT03416179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110366359|NCT03416179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110366360|NCT03416179|Antiviral Agents|antiviral agents|mesh-ancestor
110366361|NCT03416179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110366362|NCT03416179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110366363|NCT03416179|Immunologic Factors|immunologic factors|mesh-ancestor
110366364|NCT03416179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110376615|NCT03456947|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110376616|NCT03456947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110376626|NCT04564638|Cyclosporine|cyclosporine|mesh-list
110366365|NCT03416179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110366366|NCT03416179|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110366367|NCT03416179|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110366368|NCT03416179|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110366370|NCT03313544|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110366371|NCT03313544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110366372|NCT03313544|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110366373|NCT03313544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110366374|NCT03309150|Paclitaxel|paclitaxel|mesh-list
110366375|NCT03309150|Carboplatin|carboplatin|mesh-list
110376683|NCT00196976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110366376|NCT03309150|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110366377|NCT03309150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110366378|NCT03309150|Tubulin Modulators|tubulin modulators|mesh-ancestor
110366379|NCT03309150|Antimitotic Agents|antimitotic agents|mesh-ancestor
110366380|NCT03309150|Mitosis Modulators|mitosis modulators|mesh-ancestor
110366381|NCT03309150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110366382|NCT03266783|Rivaroxaban|rivaroxaban|mesh-list
110366383|NCT03266783|Apixaban|apixaban|mesh-list
110366384|NCT03266783|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110376746|NCT00195494|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110376747|NCT00195494|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110366385|NCT03266783|Antithrombins|antithrombins|mesh-ancestor
110366386|NCT03266783|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110366387|NCT03266783|Protease Inhibitors|protease inhibitors|mesh-ancestor
110366388|NCT03266783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110366389|NCT03266783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110366390|NCT03266783|Anticoagulants|anticoagulants|mesh-ancestor
110366392|NCT03251859|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110366393|NCT03251859|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110366394|NCT03251859|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110366395|NCT03251859|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110366396|NCT03251859|Purinergic Agents|purinergic agents|mesh-ancestor
110366397|NCT03251859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110376810|NCT02486367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110376811|NCT02486367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110376813|NCT00194675|Dutasteride|dutasteride|mesh-list
110366398|NCT03251859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110366399|NCT03251859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110366401|NCT02918409|Colistin|colistin|mesh-list
110366402|NCT02918409|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110366403|NCT02918409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110366404|NCT02859792|Riluzole|riluzole|mesh-list
110366405|NCT02859792|Anticonvulsants|anticonvulsants|mesh-ancestor
110366406|NCT02859792|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110366407|NCT02859792|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110366408|NCT02859792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110366409|NCT02859792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110366410|NCT02859792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110366411|NCT02859792|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110376871|NCT00191984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110376873|NCT00191984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110366412|NCT02859792|Protective Agents|protective agents|mesh-ancestor
110366413|NCT02852213|Dopa Decarboxylase|dopa decarboxylase|mesh-list
110366414|NCT02852213|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110366415|NCT02852213|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110366417|NCT02774005|Antioxidants|antioxidants|mesh-ancestor
110366418|NCT02774005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110366419|NCT02774005|Protective Agents|protective agents|mesh-ancestor
110366420|NCT02774005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110366421|NCT02700828|Hydrocortisone|hydrocortisone|mesh-list
110376928|NCT00198107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110366422|NCT02700828|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
110366423|NCT02700828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110366424|NCT02695771|Gemcitabine|gemcitabine|mesh-list
110366425|NCT02695771|Mitomycins|mitomycins|mesh-list
110366426|NCT02695771|Mitomycin|mitomycin|mesh-list
110366427|NCT02695771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110366428|NCT02695771|Antimetabolites|antimetabolites|mesh-ancestor
110366429|NCT02695771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110366430|NCT02695771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110366431|NCT02695771|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110366432|NCT02695771|Alkylating Agents|alkylating agents|mesh-ancestor
110366433|NCT02695771|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110366434|NCT02695771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110366435|NCT02293954|Antibodies|antibodies|mesh-list
110366436|NCT02293954|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110366437|NCT02293954|Immunologic Factors|immunologic factors|mesh-ancestor
110366438|NCT02293954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110366439|NCT02259621|Paclitaxel|paclitaxel|mesh-list
110366440|NCT02259621|Carboplatin|carboplatin|mesh-list
110366441|NCT02259621|Nivolumab|nivolumab|mesh-list
110366442|NCT02259621|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110366443|NCT02259621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110366444|NCT02259621|Tubulin Modulators|tubulin modulators|mesh-ancestor
110366445|NCT02259621|Antimitotic Agents|antimitotic agents|mesh-ancestor
110366446|NCT02259621|Mitosis Modulators|mitosis modulators|mesh-ancestor
110366447|NCT02259621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110377055|NCT00176462|Abortifacient Agents|abortifacient agents|mesh-ancestor
110377058|NCT00176462|Antimetabolites|antimetabolites|mesh-ancestor
110366448|NCT02259621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110366449|NCT02259621|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110366450|NCT02190305|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
110366451|NCT02190305|Immunologic Factors|immunologic factors|mesh-ancestor
110366452|NCT02190305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110366454|NCT01941641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110366455|NCT01941641|Antimetabolites|antimetabolites|mesh-ancestor
110366456|NCT01941641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110366457|NCT01941641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110366458|NCT01804634|Cyclophosphamide|cyclophosphamide|mesh-list
110366459|NCT01804634|Melphalan|melphalan|mesh-list
110366460|NCT01804634|Fludarabine|fludarabine|mesh-list
110366461|NCT01804634|Tacrolimus|tacrolimus|mesh-list
110366462|NCT01804634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110366463|NCT01804634|Immunologic Factors|immunologic factors|mesh-ancestor
110366464|NCT01804634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110366465|NCT01804634|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110366466|NCT01804634|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110366467|NCT01804634|Alkylating Agents|alkylating agents|mesh-ancestor
110366468|NCT01804634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110366469|NCT01804634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110366470|NCT01804634|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110366471|NCT01804634|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110366472|NCT01804634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110366473|NCT01792934|Bevacizumab|bevacizumab|mesh-list
110366474|NCT01792934|Irinotecan|irinotecan|mesh-list
110366475|NCT01792934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110366476|NCT01792934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110366477|NCT01792934|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110366478|NCT01792934|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110366479|NCT01792934|Growth Substances|growth substances|mesh-ancestor
110366480|NCT01792934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110366481|NCT01792934|Growth Inhibitors|growth inhibitors|mesh-ancestor
110377173|NCT04562103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110377174|NCT04562103|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110366482|NCT01792934|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110366483|NCT01792934|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110366484|NCT01792934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110366485|NCT01792934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110366486|NCT01669915|Vitamin D|vitamin d|mesh-list
110366487|NCT01669915|Ergocalciferols|ergocalciferols|mesh-list
110366488|NCT01669915|Cholecalciferol|cholecalciferol|mesh-list
110366489|NCT01669915|Vitamins|vitamins|mesh-list
110366490|NCT01669915|Micronutrients|micronutrients|mesh-ancestor
110366491|NCT01669915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110366492|NCT01669915|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110366493|NCT01669915|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110377236|NCT00478205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110366495|NCT01653223|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110366496|NCT01653223|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110366497|NCT01653223|Antimetabolites|antimetabolites|mesh-ancestor
110366498|NCT01653223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110366499|NCT01653223|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110366500|NCT01653223|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110366501|NCT01653223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110366502|NCT01549587|Listerine|listerine|mesh-list
110366503|NCT01549587|Cetylpyridinium|cetylpyridinium|mesh-list
110366504|NCT01549587|Fluorides|fluorides|mesh-list
110366505|NCT01549587|Sodium Fluoride|sodium fluoride|mesh-list
110366506|NCT01549587|Tin Fluorides|tin fluorides|mesh-list
110377300|NCT00476957|Antifungal Agents|antifungal agents|mesh-ancestor
110377301|NCT00476957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110366507|NCT01549587|Cariostatic Agents|cariostatic agents|mesh-ancestor
110366508|NCT01549587|Protective Agents|protective agents|mesh-ancestor
110366509|NCT01549587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110366510|NCT01549587|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110366511|NCT01549587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110366513|NCT01356290|Thalidomide|thalidomide|mesh-list
110366514|NCT01356290|Celecoxib|celecoxib|mesh-list
110366515|NCT01356290|Cyclophosphamide|cyclophosphamide|mesh-list
110366516|NCT01356290|Bevacizumab|bevacizumab|mesh-list
110366517|NCT01356290|Etoposide|etoposide|mesh-list
110366518|NCT01356290|Etoposide phosphate|etoposide phosphate|mesh-list
110366519|NCT01356290|Fenofibric acid|fenofibric acid|mesh-list
110366520|NCT01356290|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110377366|NCT00472199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110377372|NCT00472199|Dopamine Agents|dopamine agents|mesh-ancestor
110366522|NCT01356290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110366523|NCT01356290|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110366524|NCT01356290|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110366525|NCT01356290|Alkylating Agents|alkylating agents|mesh-ancestor
110366526|NCT01356290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110366527|NCT01356290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110366528|NCT01356290|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110366529|NCT01356290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110366530|NCT01356290|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110366531|NCT01356290|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110366532|NCT01356290|Growth Substances|growth substances|mesh-ancestor
110366533|NCT01356290|Growth Inhibitors|growth inhibitors|mesh-ancestor
110366534|NCT01356290|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110366535|NCT01356290|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110366536|NCT01356290|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110366537|NCT01356290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110366538|NCT01356290|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110366539|NCT01356290|Antimetabolites|antimetabolites|mesh-ancestor
110366540|NCT01356290|Antiviral Agents|antiviral agents|mesh-ancestor
110377489|NCT01089647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110366541|NCT01356290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110366542|NCT01356290|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110366543|NCT01356290|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110366544|NCT01356290|Analgesics|analgesics|mesh-ancestor
110366545|NCT01356290|Sensory System Agents|sensory system agents|mesh-ancestor
110366546|NCT01356290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110366547|NCT01356290|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110366548|NCT01356290|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110366549|NCT01356290|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110366550|NCT01356290|Leprostatic Agents|leprostatic agents|mesh-ancestor
110366551|NCT01356290|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110366552|NCT01356290|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110366553|NCT01356290|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110366554|NCT01356290|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110366555|NCT01047540|Pritelivir|pritelivir|mesh-list
110366556|NCT01047540|Antiviral Agents|antiviral agents|mesh-ancestor
110366557|NCT01047540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110366558|NCT01047540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110366559|NCT01047540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110366560|NCT00521222|Fluticasone|fluticasone|mesh-list
110377551|NCT01088243|Analgesics|analgesics|mesh-ancestor
110377552|NCT01088243|Sensory System Agents|sensory system agents|mesh-ancestor
110377557|NCT04672499|Cortisone|cortisone|mesh-list
110366561|NCT00521222|Xhance|xhance|mesh-list
110366562|NCT00521222|Albuterol|albuterol|mesh-list
110366563|NCT00521222|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110366564|NCT00521222|Ipratropium|ipratropium|mesh-list
110366565|NCT00521222|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
110366566|NCT00521222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110366567|NCT00521222|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110366568|NCT00521222|Autonomic Agents|autonomic agents|mesh-ancestor
110366569|NCT00521222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110366570|NCT00521222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110366571|NCT00521222|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110366572|NCT00521222|Respiratory System Agents|respiratory system agents|mesh-ancestor
110366573|NCT00521222|Dermatologic Agents|dermatologic agents|mesh-ancestor
110366574|NCT00521222|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110366575|NCT00521222|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110366576|NCT00521222|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110366577|NCT00521222|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110366578|NCT00521222|Adrenergic Agents|adrenergic agents|mesh-ancestor
110366579|NCT00521222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110366580|NCT00521222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110366581|NCT00521222|Tocolytic Agents|tocolytic agents|mesh-ancestor
110366582|NCT00521222|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110377606|NCT01087814|Antiviral Agents|antiviral agents|mesh-ancestor
110377607|NCT01087814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110377614|NCT04554030|Immunomodulating Agents|immunomodulating agents|mesh-list
110366583|NCT00521222|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110366584|NCT00521222|Cholinergic Agents|cholinergic agents|mesh-ancestor
110366585|NCT00521222|Glucocorticoids|glucocorticoids|mesh-ancestor
110366586|NCT00521222|Hormones|hormones|mesh-ancestor
110366587|NCT00521222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110366588|NCT00521222|Sympathomimetics|sympathomimetics|mesh-ancestor
110366589|NCT00545012|Levetiracetam|levetiracetam|mesh-list
110366590|NCT00545012|Anticonvulsants|anticonvulsants|mesh-ancestor
110366591|NCT00545012|Nootropic Agents|nootropic agents|mesh-ancestor
110366592|NCT00545090|Ibandronic Acid|ibandronic acid|mesh-list
110366593|NCT00545090|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110366594|NCT00545090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110377657|NCT04553601|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110366595|NCT00545207|Ibandronic Acid|ibandronic acid|mesh-list
110366596|NCT00545207|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110366597|NCT00545207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110366598|NCT00545246|Docetaxel|docetaxel|mesh-list
110366599|NCT00545246|Aflibercept|aflibercept|mesh-list
110366600|NCT00545246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110366601|NCT00545246|Tubulin Modulators|tubulin modulators|mesh-ancestor
110366603|NCT00545246|Mitosis Modulators|mitosis modulators|mesh-ancestor
110366604|NCT00545246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110366605|NCT00545246|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110366606|NCT00545246|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110366607|NCT00545246|Growth Substances|growth substances|mesh-ancestor
110366608|NCT00545246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110366609|NCT00545246|Growth Inhibitors|growth inhibitors|mesh-ancestor
110366610|NCT03456401|Sorafenib|sorafenib|mesh-list
110366611|NCT03456401|Sunitinib|sunitinib|mesh-list
110366612|NCT03456401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110366613|NCT03456401|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110366614|NCT03456401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110366615|NCT03456401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110377791|NCT00179010|Purinergic Agents|purinergic agents|mesh-ancestor
110377792|NCT00179010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110366617|NCT03456401|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110366618|NCT03456401|Growth Substances|growth substances|mesh-ancestor
110366619|NCT03456401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110366620|NCT03456401|Growth Inhibitors|growth inhibitors|mesh-ancestor
110366621|NCT00545480|Ibandronic Acid|ibandronic acid|mesh-list
110366622|NCT00545480|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110366623|NCT00545480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110366624|NCT00545519|Thymoglobulin|thymoglobulin|mesh-list
110366625|NCT00545519|Immunologic Factors|immunologic factors|mesh-ancestor
110366626|NCT00545519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110366627|NCT00545519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110366628|NCT00545558|Tenofovir|tenofovir|mesh-list
110366629|NCT00545558|Emtricitabine|emtricitabine|mesh-list
110366630|NCT00545558|Efavirenz|efavirenz|mesh-list
110366631|NCT00545558|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110366632|NCT00545558|Antiviral Agents|antiviral agents|mesh-ancestor
110366633|NCT00545558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110366634|NCT00545558|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110366635|NCT00545558|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110366636|NCT00545558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110366637|NCT00545558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110366638|NCT00545558|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110366639|NCT00545558|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110366640|NCT00545558|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110366641|NCT00545558|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110366642|NCT00545558|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110366643|NCT00545558|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110366644|NCT00545558|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110366645|NCT00545558|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110366646|NCT04684667|Propranolol|propranolol|mesh-list
110366647|NCT04684667|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110366648|NCT04684667|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110366649|NCT04684667|Adrenergic Agents|adrenergic agents|mesh-ancestor
110366650|NCT04684667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110377906|NCT00177216|Serotonin Agents|serotonin agents|mesh-ancestor
110366651|NCT04684667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110366652|NCT04684667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110366653|NCT04684667|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110366654|NCT04684667|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110366655|NCT04684667|Vasodilator Agents|vasodilator agents|mesh-ancestor
110366657|NCT00545675|Aripiprazole|aripiprazole|mesh-list
110377964|NCT01081145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110377968|NCT00174915|Febuxostat|febuxostat|mesh-list
110366658|NCT00545675|Antidepressive Agents|antidepressive agents|mesh-ancestor
110366659|NCT00545675|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110366660|NCT00545675|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110366661|NCT00545675|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110366662|NCT00545675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110366663|NCT00545675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110366664|NCT00545675|Dopamine Agonists|dopamine agonists|mesh-ancestor
110366665|NCT00545675|Dopamine Agents|dopamine agents|mesh-ancestor
110366666|NCT00545675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110366667|NCT00545675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110366668|NCT00545675|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110366669|NCT00545675|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110366670|NCT00545675|Serotonin Agents|serotonin agents|mesh-ancestor
110366671|NCT00545675|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110366672|NCT00545675|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110378035|NCT04571996|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110378036|NCT04571996|Analgesics|analgesics|mesh-ancestor
110378037|NCT04571996|Sensory System Agents|sensory system agents|mesh-ancestor
110366673|NCT00545675|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110366674|NCT00545675|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110366675|NCT00545675|Anticonvulsants|anticonvulsants|mesh-ancestor
110366676|NCT00545675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110366677|NCT00545675|GABA Agents|gaba agents|mesh-ancestor
110366678|NCT00545675|Antimanic Agents|antimanic agents|mesh-ancestor
110366679|NCT00545831|Taurolidine|taurolidine|mesh-list
110366680|NCT00545831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110366681|NCT00545831|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110366682|NCT00545831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110366683|NCT00545870|Bevacizumab|bevacizumab|mesh-list
110366684|NCT00545870|Ranibizumab|ranibizumab|mesh-list
110378092|NCT04550793|Botulinum Toxins|botulinum toxins|mesh-list
110378093|NCT04550793|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110378094|NCT04550793|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110378096|NCT04550793|Cholinergic Agents|cholinergic agents|mesh-ancestor
110366685|NCT00545870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110366686|NCT00545870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110366687|NCT00545870|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110366688|NCT00545870|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110366689|NCT00545870|Growth Substances|growth substances|mesh-ancestor
110366690|NCT00545870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110366691|NCT00545870|Growth Inhibitors|growth inhibitors|mesh-ancestor
110366692|NCT00545909|Ibandronic Acid|ibandronic acid|mesh-list
110366693|NCT00545909|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110366694|NCT00545909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110366696|NCT04645914|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110366697|NCT04645914|Autonomic Agents|autonomic agents|mesh-ancestor
110366698|NCT04645914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110378153|NCT00479232|Antimetabolites|antimetabolites|mesh-ancestor
110378154|NCT00479232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110366699|NCT04645914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110366700|NCT04645914|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110366701|NCT04645914|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110366702|NCT04645914|Cholinergic Agents|cholinergic agents|mesh-ancestor
110366703|NCT04645914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110366704|NCT04645914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110366706|NCT00546065|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110366707|NCT00546065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110366708|NCT00546065|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110366709|NCT00546065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110378215|NCT00556205|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110378216|NCT00556205|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110366710|NCT00546065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110366711|NCT00546143|Omalizumab|omalizumab|mesh-list
110366712|NCT00546143|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110366713|NCT00546143|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110366714|NCT00546143|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110366715|NCT00546143|Respiratory System Agents|respiratory system agents|mesh-ancestor
110366716|NCT00546143|Immunologic Factors|immunologic factors|mesh-ancestor
110366717|NCT00546143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110366718|NCT00560079|Allopurinol|allopurinol|mesh-list
110366719|NCT00560079|Dipyridamole|dipyridamole|mesh-list
110366720|NCT00560079|Antimetabolites|antimetabolites|mesh-ancestor
110366721|NCT00560079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110366722|NCT00560079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110366723|NCT00560079|Gout Suppressants|gout suppressants|mesh-ancestor
110366724|NCT00560079|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110366725|NCT00560079|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110366726|NCT00560079|Antioxidants|antioxidants|mesh-ancestor
110366727|NCT00560079|Protective Agents|protective agents|mesh-ancestor
110378278|NCT00477672|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110366728|NCT00560079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110366729|NCT00560079|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110366730|NCT00560079|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110366731|NCT00560079|Vasodilator Agents|vasodilator agents|mesh-ancestor
110366732|NCT00560118|Fotemustine|fotemustine|mesh-list
110366733|NCT00560118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110366734|NCT00546494|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
110366735|NCT00546494|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110366736|NCT00546494|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110366737|NCT00546494|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110366738|NCT00546494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110366739|NCT00546494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110366740|NCT00546494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110366741|NCT00546494|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110366742|NCT00546494|Antidepressive Agents|antidepressive agents|mesh-ancestor
110366743|NCT00546494|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110366744|NCT00546533|Etanercept|etanercept|mesh-list
110366745|NCT00546533|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110366746|NCT00546533|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110366747|NCT00546533|Analgesics|analgesics|mesh-ancestor
110177931|NCT00142480|Bevacizumab|bevacizumab|mesh-list
110378399|NCT04570865|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110366748|NCT00546533|Sensory System Agents|sensory system agents|mesh-ancestor
110366749|NCT00546533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110366750|NCT00546533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110366751|NCT00546533|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110366752|NCT00546533|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110366753|NCT00546533|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110366754|NCT00546533|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110366755|NCT00546533|Immunologic Factors|immunologic factors|mesh-ancestor
110366756|NCT00558480|Vitamins|vitamins|mesh-list
110366757|NCT00558480|Vitamin A|vitamin a|mesh-list
110366758|NCT00558480|Retinol palmitate|retinol palmitate|mesh-list
110366759|NCT00558480|Micronutrients|micronutrients|mesh-ancestor
110366760|NCT00558480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110366761|NCT00558480|Antioxidants|antioxidants|mesh-ancestor
110366762|NCT00558480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110366763|NCT00558480|Protective Agents|protective agents|mesh-ancestor
110366764|NCT00558480|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110366765|NCT00558480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110366766|NCT00546650|Sumatriptan|sumatriptan|mesh-list
110366767|NCT00546650|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110366768|NCT00546650|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110366769|NCT00546650|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110366770|NCT00546650|Serotonin Agents|serotonin agents|mesh-ancestor
110366771|NCT00546650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110366772|NCT00546650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110378528|NCT01129960|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
110366773|NCT00546650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110366774|NCT00546923|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
110366775|NCT00546923|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110366776|NCT00546923|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110366777|NCT00546923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110366778|NCT00546923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110366779|NCT00546923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110366780|NCT00546923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110366781|NCT00546923|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110366782|NCT00546923|Antidepressive Agents|antidepressive agents|mesh-ancestor
110366784|NCT00547001|Estradiol|estradiol|mesh-list
110366785|NCT00547001|Estrogens|estrogens|mesh-ancestor
110366786|NCT00547001|Hormones|hormones|mesh-ancestor
110366787|NCT00547001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110366788|NCT00547001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110366789|NCT00547352|Sildenafil Citrate|sildenafil citrate|mesh-list
110366790|NCT00547352|Tadalafil|tadalafil|mesh-list
110366791|NCT00547352|Vasodilator Agents|vasodilator agents|mesh-ancestor
110366792|NCT00547352|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110378657|NCT04539054|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110366793|NCT00547352|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110366795|NCT00547352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110366796|NCT00547352|Urological Agents|urological agents|mesh-ancestor
110366797|NCT00547508|Tadalafil|tadalafil|mesh-list
110366798|NCT00547508|Vasodilator Agents|vasodilator agents|mesh-ancestor
110366799|NCT00547508|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110366800|NCT00547508|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110366801|NCT00547508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110366802|NCT00547508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110366803|NCT00547508|Urological Agents|urological agents|mesh-ancestor
110366804|NCT00560274|Ribavirin|ribavirin|mesh-list
110366805|NCT00560274|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110378721|NCT00576173|Sensory System Agents|sensory system agents|mesh-ancestor
110366806|NCT00560274|Antimetabolites|antimetabolites|mesh-ancestor
110366807|NCT00560274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110366808|NCT00560274|Antiviral Agents|antiviral agents|mesh-ancestor
110366809|NCT00560274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110366810|NCT00547547|Selenium|selenium|mesh-list
110366811|NCT00547547|Capecitabine|capecitabine|mesh-list
110366812|NCT00547547|Irinotecan|irinotecan|mesh-list
110366813|NCT00547547|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110366814|NCT00547547|Antimetabolites|antimetabolites|mesh-ancestor
110366815|NCT00547547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110366816|NCT00547547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110378782|NCT04539444|Tislelizumab|tislelizumab|mesh-list
110378783|NCT04539444|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
110366817|NCT00547547|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110366818|NCT00547547|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110366819|NCT00547547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110366820|NCT00547547|Antioxidants|antioxidants|mesh-ancestor
110366821|NCT00547547|Protective Agents|protective agents|mesh-ancestor
110366822|NCT00547547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110366823|NCT00547547|Trace Elements|trace elements|mesh-ancestor
110366824|NCT00547547|Micronutrients|micronutrients|mesh-ancestor
110366825|NCT00547625|Tadalafil|tadalafil|mesh-list
110366826|NCT00547625|Vasodilator Agents|vasodilator agents|mesh-ancestor
110378845|NCT01126060|Coagulants|coagulants|mesh-ancestor
110366827|NCT00547625|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110366828|NCT00547625|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110366829|NCT00547625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110366830|NCT00547625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110366831|NCT00547625|Urological Agents|urological agents|mesh-ancestor
110366833|NCT00547664|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110366834|NCT00547664|Narcotics|narcotics|mesh-ancestor
110366835|NCT00547664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110366836|NCT00547664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110366837|NCT00547664|Analgesics|analgesics|mesh-ancestor
110366838|NCT00547664|Sensory System Agents|sensory system agents|mesh-ancestor
110366839|NCT00547664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110366840|NCT00560430|Telmisartan|telmisartan|mesh-list
110366841|NCT00560430|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110366842|NCT00560430|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110366843|NCT00560430|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110366844|NCT00560430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110366845|NCT00560547|Epoetin Alfa|epoetin alfa|mesh-list
110366846|NCT00560547|Hematinics|hematinics|mesh-ancestor
110366847|NCT04636125|Doxycycline|doxycycline|mesh-list
110366848|NCT04636125|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110366849|NCT04636125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110366850|NCT04636125|Antimalarials|antimalarials|mesh-ancestor
110366851|NCT04636125|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110366852|NCT04636125|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110366853|NCT04684628|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
110366854|NCT04684628|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110366855|NCT04684628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110378914|NCT04558424|Ascorbic Acid|ascorbic acid|mesh-list
110366856|NCT04636242|Aminolevulinic Acid|aminolevulinic acid|mesh-list
110366857|NCT04636242|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110366858|NCT04636242|Dermatologic Agents|dermatologic agents|mesh-ancestor
110366859|NCT00548288|Pamidronate|pamidronate|mesh-list
110366860|NCT00548288|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110366861|NCT00548288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110366863|NCT04644354|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110366864|NCT04644354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110366865|NCT04644354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110366866|NCT04644354|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110366867|NCT04644354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110366868|NCT04644354|Vasodilator Agents|vasodilator agents|mesh-ancestor
110366869|NCT04644354|Tocolytic Agents|tocolytic agents|mesh-ancestor
110366870|NCT04644354|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110366871|NCT00548483|Dexamethasone|dexamethasone|mesh-list
110366872|NCT00548483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110366873|NCT00548483|Antiemetics|antiemetics|mesh-ancestor
110378961|NCT01124734|Temozolomide|temozolomide|mesh-list
110366874|NCT00548483|Autonomic Agents|autonomic agents|mesh-ancestor
110366875|NCT00548483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110366876|NCT00548483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110366877|NCT00548483|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110366878|NCT00548483|Glucocorticoids|glucocorticoids|mesh-ancestor
110366879|NCT00548483|Hormones|hormones|mesh-ancestor
110366880|NCT00548483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110366881|NCT00548483|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110379017|NCT02212340|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110379018|NCT02212340|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110366882|NCT00548483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110366883|NCT04635852|Fentanyl|fentanyl|mesh-list
110366884|NCT04635852|Morphine|morphine|mesh-list
110366885|NCT04635852|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110366887|NCT04635852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110366888|NCT04635852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110366889|NCT04635852|Analgesics|analgesics|mesh-ancestor
110366890|NCT04635852|Sensory System Agents|sensory system agents|mesh-ancestor
110366891|NCT04635852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110366892|NCT04635852|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110366893|NCT04635852|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110366894|NCT04635852|Anesthetics, General|anesthetics, general|mesh-ancestor
110366895|NCT04635852|Anesthetics|anesthetics|mesh-ancestor
110366896|NCT00548561|Dexrazoxane|dexrazoxane|mesh-list
110366897|NCT00548561|Razoxane|razoxane|mesh-list
110366898|NCT00548561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110366899|NCT00548561|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110366900|NCT00548561|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110366901|NCT00548561|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110366902|NCT00548561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110366903|NCT00548561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110366904|NCT00548561|Protective Agents|protective agents|mesh-ancestor
110379158|NCT00577694|Clofarabine|clofarabine|mesh-list
110366905|NCT00548561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110366906|NCT00548561|Antimitotic Agents|antimitotic agents|mesh-ancestor
110366907|NCT00548561|Mitosis Modulators|mitosis modulators|mesh-ancestor
110366908|NCT04635696|Ethyl Chloride|ethyl chloride|mesh-list
110366909|NCT04635696|Anesthetics, Local|anesthetics, local|mesh-ancestor
110366910|NCT04635696|Anesthetics|anesthetics|mesh-ancestor
110366911|NCT04635696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110366912|NCT04635696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110366913|NCT04635696|Sensory System Agents|sensory system agents|mesh-ancestor
110366914|NCT04635696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110366915|NCT00548678|Aspirin|aspirin|mesh-list
110366916|NCT00548678|Diclofenac|diclofenac|mesh-list
110366917|NCT00548678|Ketorolac|ketorolac|mesh-list
110366918|NCT00548678|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110366919|NCT00548678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110366920|NCT00548678|Analgesics|analgesics|mesh-ancestor
110366921|NCT00548678|Sensory System Agents|sensory system agents|mesh-ancestor
110366922|NCT00548678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110366923|NCT00548678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110366924|NCT00548678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110366925|NCT00548678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110366926|NCT00548678|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110366927|NCT00548678|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110366928|NCT00548678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110366929|NCT00548678|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110379215|NCT04578470|Vitamin D|vitamin d|mesh-list
110366930|NCT00548678|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110366931|NCT00548678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110366932|NCT00548678|Antipyretics|antipyretics|mesh-ancestor
110366933|NCT00548834|Certolizumab Pegol|certolizumab pegol|mesh-list
110366934|NCT00548834|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110366935|NCT00548834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110366936|NCT00548834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110366937|NCT00548834|Immunologic Factors|immunologic factors|mesh-ancestor
110366938|NCT00548834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110366939|NCT00548834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110366940|NCT04684199|Melatonin|melatonin|mesh-list
110366941|NCT04684199|Antioxidants|antioxidants|mesh-ancestor
110366942|NCT04684199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110366943|NCT04684199|Protective Agents|protective agents|mesh-ancestor
110366944|NCT04684199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110366945|NCT04684199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110366946|NCT00560586|Budesonide|budesonide|mesh-list
110366947|NCT00560586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110366948|NCT00560586|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110366949|NCT00560586|Autonomic Agents|autonomic agents|mesh-ancestor
110366950|NCT00560586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110366951|NCT00560586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110366952|NCT00560586|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110366953|NCT00560586|Respiratory System Agents|respiratory system agents|mesh-ancestor
110366954|NCT00560586|Glucocorticoids|glucocorticoids|mesh-ancestor
110366956|NCT00560586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110366957|NCT00549068|Risedronic Acid|risedronic acid|mesh-list
110366958|NCT00549068|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110379321|NCT00578825|Lopinavir|lopinavir|mesh-list
110366959|NCT00549068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110366960|NCT00549068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110366961|NCT00549068|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110366962|NCT00549068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110366963|NCT00549068|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110366965|NCT00549107|Milrinone|milrinone|mesh-list
110366966|NCT00549107|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110366967|NCT00549107|Vasodilator Agents|vasodilator agents|mesh-ancestor
110366968|NCT00549107|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110366969|NCT00549107|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110366970|NCT00549107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110366971|NCT00549107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110366972|NCT00549107|Protective Agents|protective agents|mesh-ancestor
110366973|NCT00549107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110366974|NCT00549107|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110366975|NCT00549146|Fluticasone|fluticasone|mesh-list
110366976|NCT00549146|Xhance|xhance|mesh-list
110366977|NCT00549146|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110366978|NCT00549146|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
110366979|NCT00549146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110366980|NCT00549146|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110366981|NCT00549146|Autonomic Agents|autonomic agents|mesh-ancestor
110366982|NCT00549146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110366983|NCT00549146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110366984|NCT00549146|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110366985|NCT00549146|Respiratory System Agents|respiratory system agents|mesh-ancestor
110366986|NCT00549146|Dermatologic Agents|dermatologic agents|mesh-ancestor
110366987|NCT00549146|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110366988|NCT00549146|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110366989|NCT00549146|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110379442|NCT04555694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110366990|NCT00549146|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110366991|NCT00549146|Adrenergic Agents|adrenergic agents|mesh-ancestor
110366992|NCT00549146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110366993|NCT00549146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110366994|NCT00549146|Glucocorticoids|glucocorticoids|mesh-ancestor
110366996|NCT00549146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110366997|NCT00549146|Sympathomimetics|sympathomimetics|mesh-ancestor
110366998|NCT00549341|Botulinum Toxins|botulinum toxins|mesh-list
110366999|NCT00549341|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110367000|NCT00549341|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110367001|NCT00549341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110367003|NCT00549341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110367004|NCT00549341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110367005|NCT00549419|Dobutamine|dobutamine|mesh-list
110367006|NCT00549419|Norepinephrine|norepinephrine|mesh-list
110367007|NCT00549419|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110367008|NCT00549419|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110367009|NCT00549419|Adrenergic Agents|adrenergic agents|mesh-ancestor
110367010|NCT00549419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110367011|NCT00549419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110367012|NCT00549419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110367013|NCT00549419|Sympathomimetics|sympathomimetics|mesh-ancestor
110367014|NCT00549419|Autonomic Agents|autonomic agents|mesh-ancestor
110367015|NCT00549419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110367016|NCT00549419|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110367017|NCT00549419|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110367018|NCT00549419|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
110367019|NCT00549419|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110367020|NCT00549419|Protective Agents|protective agents|mesh-ancestor
110367021|NCT04643691|Losartan|losartan|mesh-list
110367022|NCT04643691|Spironolactone|spironolactone|mesh-list
110367023|NCT04643691|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110379560|NCT02216994|Lactulose|lactulose|mesh-list
110367024|NCT04643691|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110367025|NCT04643691|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110367026|NCT04643691|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110367027|NCT04643691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110367028|NCT04643691|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110367029|NCT04643691|Hormone Antagonists|hormone antagonists|mesh-ancestor
110367030|NCT04643691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110367031|NCT04643691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110367032|NCT04643691|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110367033|NCT04643691|Diuretics|diuretics|mesh-ancestor
110367034|NCT04643691|Natriuretic Agents|natriuretic agents|mesh-ancestor
110367035|NCT03455972|Immunomodulating Agents|immunomodulating agents|mesh-list
110367036|NCT03455972|Immunologic Factors|immunologic factors|mesh-ancestor
110367037|NCT03455972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110367038|NCT00549536|Calcium, Dietary|calcium, dietary|mesh-list
110367039|NCT00549536|Calcium|calcium|mesh-list
110367040|NCT00549536|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110367042|NCT00549536|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110367043|NCT00549614|Acipimox|acipimox|mesh-list
110367044|NCT00549614|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110367045|NCT00549614|Antimetabolites|antimetabolites|mesh-ancestor
110367046|NCT00549614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110367047|NCT00549614|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110367048|NCT00559026|Dacarbazine|dacarbazine|mesh-list
110367049|NCT00559026|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110367050|NCT00559026|Alkylating Agents|alkylating agents|mesh-ancestor
110367051|NCT00559026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110379749|NCT00580619|Cholinergic Agents|cholinergic agents|mesh-ancestor
110367052|NCT00559026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110367053|NCT00549887|Insulin|insulin|mesh-list
110367054|NCT00549887|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110367055|NCT00549887|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110367056|NCT00549887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110367058|NCT00549926|Pravastatin|pravastatin|mesh-list
110367059|NCT00549926|Pitavastatin|pitavastatin|mesh-list
110367060|NCT00549926|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110367061|NCT00549926|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110367062|NCT00549926|Antimetabolites|antimetabolites|mesh-ancestor
110367063|NCT00549926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110367064|NCT00549926|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110367065|NCT00549926|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110367066|NCT00549926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110367067|NCT00549965|Risedronic Acid|risedronic acid|mesh-list
110367068|NCT00549965|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110379827|NCT01120600|Vitamin D|vitamin d|mesh-list
110367069|NCT00549965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110367070|NCT00549965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110367071|NCT00549965|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110367072|NCT00549965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110367073|NCT00549965|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110367074|NCT00550004|Gemcitabine|gemcitabine|mesh-list
110367075|NCT00550004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110367076|NCT00550004|Antimetabolites|antimetabolites|mesh-ancestor
110367077|NCT00550004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110367078|NCT00550004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110367079|NCT04634721|Bupivacaine|bupivacaine|mesh-list
110367080|NCT04634721|Anesthetics, Local|anesthetics, local|mesh-ancestor
110367081|NCT04634721|Anesthetics|anesthetics|mesh-ancestor
110367082|NCT04634721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110367083|NCT04634721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110367084|NCT04634721|Sensory System Agents|sensory system agents|mesh-ancestor
110367085|NCT04634721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110367086|NCT00550160|Artesunate|artesunate|mesh-list
110367087|NCT00550160|Amodiaquine|amodiaquine|mesh-list
110367088|NCT00550160|Antimalarials|antimalarials|mesh-ancestor
110367089|NCT00550160|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110367090|NCT00550160|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110367091|NCT00550160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110367092|NCT00550160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110379870|NCT01120093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110367094|NCT00550160|Schistosomicides|schistosomicides|mesh-ancestor
110367095|NCT00550160|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110367096|NCT00550160|Anthelmintics|anthelmintics|mesh-ancestor
110367097|NCT00550199|Gemcitabine|gemcitabine|mesh-list
110367098|NCT00550199|Panobinostat|panobinostat|mesh-list
110367099|NCT00550199|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110367100|NCT00550199|Antimetabolites|antimetabolites|mesh-ancestor
110367101|NCT00550199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110367102|NCT00550199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110367103|NCT00550199|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110367104|NCT00550199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110367105|NCT04643301|Liraglutide|liraglutide|mesh-list
110367106|NCT04643301|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110367107|NCT04643301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110367108|NCT04643301|Incretins|incretins|mesh-ancestor
110367109|NCT04643301|Hormones|hormones|mesh-ancestor
110367110|NCT04643301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110367111|NCT00550433|Bazedoxifene|bazedoxifene|mesh-list
110367112|NCT00550433|Estrogens|estrogens|mesh-list
110367113|NCT00550433|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
110367114|NCT00550433|Hormones|hormones|mesh-ancestor
110367115|NCT00550433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110367116|NCT00550433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110367117|NCT00550433|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110367118|NCT00550433|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110367119|NCT00550433|Hormone Antagonists|hormone antagonists|mesh-ancestor
110367120|NCT00550433|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110367121|NCT04642989|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110367122|NCT04642989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110367123|NCT04634058|Antibodies|antibodies|mesh-list
110367124|NCT04634058|Immunoglobulins|immunoglobulins|mesh-list
110367125|NCT04634058|Immunologic Factors|immunologic factors|mesh-ancestor
110367126|NCT04634058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110367127|NCT00550628|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110367128|NCT00550628|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110367129|NCT00550628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110367130|NCT00560820|Deferasirox|deferasirox|mesh-list
110367131|NCT00560820|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110367132|NCT00560820|Chelating Agents|chelating agents|mesh-ancestor
110367133|NCT00560820|Sequestering Agents|sequestering agents|mesh-ancestor
110367134|NCT00560820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110367135|NCT00550784|Paclitaxel|paclitaxel|mesh-list
110367136|NCT00550784|Cyclophosphamide|cyclophosphamide|mesh-list
110367137|NCT00550784|Melphalan|melphalan|mesh-list
110367138|NCT00550784|Topotecan|topotecan|mesh-list
110367139|NCT00550784|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110367140|NCT00550784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110367141|NCT00550784|Tubulin Modulators|tubulin modulators|mesh-ancestor
110367142|NCT00550784|Antimitotic Agents|antimitotic agents|mesh-ancestor
110367143|NCT00550784|Mitosis Modulators|mitosis modulators|mesh-ancestor
110367144|NCT00550784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110367145|NCT00550784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110367146|NCT00550784|Immunologic Factors|immunologic factors|mesh-ancestor
110379963|NCT01119703|Immunologic Factors|immunologic factors|mesh-ancestor
110367147|NCT00550784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110367148|NCT00550784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110367149|NCT00550784|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110367150|NCT00550784|Alkylating Agents|alkylating agents|mesh-ancestor
110367151|NCT00550784|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110367152|NCT00550784|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110367153|NCT00550784|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110367154|NCT00550784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110367155|NCT00550901|Dexrazoxane|dexrazoxane|mesh-list
110367156|NCT00550901|Razoxane|razoxane|mesh-list
110367157|NCT00550901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110367158|NCT00550901|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110367159|NCT00550901|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110367160|NCT00550901|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110367161|NCT00550901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110367162|NCT00550901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110367163|NCT00550901|Protective Agents|protective agents|mesh-ancestor
110367164|NCT00550901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110367165|NCT00550901|Antimitotic Agents|antimitotic agents|mesh-ancestor
110367166|NCT00550901|Mitosis Modulators|mitosis modulators|mesh-ancestor
110367167|NCT04633746|Endostatins|endostatins|mesh-list
110367168|NCT04633746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110367169|NCT04633746|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110367170|NCT04633746|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110367171|NCT04633746|Growth Substances|growth substances|mesh-ancestor
110367172|NCT04633746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110367173|NCT04633746|Growth Inhibitors|growth inhibitors|mesh-ancestor
110367174|NCT00551018|Tenofovir|tenofovir|mesh-list
110367175|NCT00551018|Emtricitabine|emtricitabine|mesh-list
110367176|NCT00551018|Antiviral Agents|antiviral agents|mesh-ancestor
110367177|NCT00551018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110380145|NCT02211690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110367178|NCT00551018|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110367179|NCT00551018|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110367180|NCT00551018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110367181|NCT00551018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110367182|NCT00551018|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110367183|NCT00551018|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110367184|NCT00551096|Gemcitabine|gemcitabine|mesh-list
110367185|NCT00551096|Capecitabine|capecitabine|mesh-list
110367186|NCT00551096|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110367187|NCT00551096|Antimetabolites|antimetabolites|mesh-ancestor
110367188|NCT00551096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110367189|NCT00551096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110367190|NCT00551252|Gemcitabine|gemcitabine|mesh-list
110367191|NCT00551252|Imatinib Mesylate|imatinib mesylate|mesh-list
110367192|NCT00551252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110367193|NCT00551252|Antimetabolites|antimetabolites|mesh-ancestor
110367194|NCT00551252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110367195|NCT00551252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110367196|NCT00551252|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110367197|NCT00551252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110367198|NCT01125761|Clemastine|clemastine|mesh-list
110367199|NCT01125761|Dexamethasone|dexamethasone|mesh-list
110367200|NCT01125761|Dexamethasone acetate|dexamethasone acetate|mesh-list
110367201|NCT01125761|BB 1101|bb 1101|mesh-list
110367202|NCT01125761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110367203|NCT01125761|Antiemetics|antiemetics|mesh-ancestor
110367204|NCT01125761|Autonomic Agents|autonomic agents|mesh-ancestor
110367205|NCT01125761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110367206|NCT01125761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110367207|NCT01125761|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110367208|NCT01125761|Glucocorticoids|glucocorticoids|mesh-ancestor
110367209|NCT01125761|Hormones|hormones|mesh-ancestor
110380343|NCT01643499|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110367210|NCT01125761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110367211|NCT01125761|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110367212|NCT01125761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110367213|NCT01125761|Protease Inhibitors|protease inhibitors|mesh-ancestor
110367214|NCT01125761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110367215|NCT01125761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110177986|NCT02780427|Analgesics|analgesics|mesh-ancestor
110367216|NCT01125761|Antipruritics|antipruritics|mesh-ancestor
110367217|NCT01125761|Dermatologic Agents|dermatologic agents|mesh-ancestor
110367218|NCT01125761|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110367219|NCT01125761|Histamine Antagonists|histamine antagonists|mesh-ancestor
110367220|NCT01125761|Histamine Agents|histamine agents|mesh-ancestor
110367221|NCT01125761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110367222|NCT01125761|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110367223|NCT04641780|Brexpiprazole|brexpiprazole|mesh-list
110367224|NCT04641780|Serotonin Agents|serotonin agents|mesh-ancestor
110367225|NCT04641780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110367226|NCT04641780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110367227|NCT04641780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110367228|NCT04641780|Dopamine Agonists|dopamine agonists|mesh-ancestor
110380470|NCT04550702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110380471|NCT04550702|Urological Agents|urological agents|mesh-ancestor
110367230|NCT05408312|Vaccines|vaccines|mesh-list
110367231|NCT05408312|Immunologic Factors|immunologic factors|mesh-ancestor
110367232|NCT05408312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110367233|NCT00559338|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
110367234|NCT00559338|Natriuretic Agents|natriuretic agents|mesh-ancestor
110367235|NCT00559338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110367236|NCT05340374|177Lu-PSMA-617|177lu-psma-617|mesh-list
110367237|NCT05340374|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110367238|NCT05340374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110367239|NCT04640883|8-chloro-cyclic adenosine monophosphate|8-chloro-cyclic adenosine monophosphate|mesh-list
110367240|NCT04640883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110367241|NCT04640883|Immunologic Factors|immunologic factors|mesh-ancestor
110367242|NCT04640883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110367243|NCT00553124|Vitamin E|vitamin e|mesh-list
110367244|NCT00553124|Selenium|selenium|mesh-list
110367245|NCT00553124|Vitamins|vitamins|mesh-ancestor
110367246|NCT00553124|Micronutrients|micronutrients|mesh-ancestor
110367247|NCT00553124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110367248|NCT00553124|Antioxidants|antioxidants|mesh-ancestor
110367249|NCT00553124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110367250|NCT00553124|Protective Agents|protective agents|mesh-ancestor
110367251|NCT00553124|Trace Elements|trace elements|mesh-ancestor
110367252|NCT04640181|Enoxaparin|enoxaparin|mesh-list
110367253|NCT04640181|Rivaroxaban|rivaroxaban|mesh-list
110367254|NCT04640181|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110367255|NCT04640181|Antithrombins|antithrombins|mesh-ancestor
110367256|NCT04640181|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110367257|NCT04640181|Protease Inhibitors|protease inhibitors|mesh-ancestor
110367258|NCT04640181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110367259|NCT04640181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110367260|NCT04640181|Anticoagulants|anticoagulants|mesh-ancestor
110367261|NCT04640181|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110367262|NCT04640181|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110367263|NCT00559455|Leucovorin|leucovorin|mesh-list
110367264|NCT00559455|Fluorouracil|fluorouracil|mesh-list
110367265|NCT00559455|Oxaliplatin|oxaliplatin|mesh-list
110367266|NCT00559455|Antimetabolites|antimetabolites|mesh-ancestor
110367267|NCT00559455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110367268|NCT00559455|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110367269|NCT00559455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110367270|NCT00559455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110380668|NCT04548284|Hormones|hormones|mesh-ancestor
110380671|NCT04547894|TMC-310911|tmc-310911|mesh-list
110367271|NCT00559455|Immunologic Factors|immunologic factors|mesh-ancestor
110367272|NCT00559455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110367273|NCT00559455|Antidotes|antidotes|mesh-ancestor
110367274|NCT00559455|Protective Agents|protective agents|mesh-ancestor
110367275|NCT00559455|Vitamin B Complex|vitamin b complex|mesh-ancestor
110367276|NCT00559455|Vitamins|vitamins|mesh-ancestor
110367277|NCT00559455|Micronutrients|micronutrients|mesh-ancestor
110367278|NCT00559494|Minocycline|minocycline|mesh-list
110367279|NCT00559494|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110367280|NCT00559494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110367281|NCT05209412|Aspirin|aspirin|mesh-list
110367282|NCT05209412|Paclitaxel|paclitaxel|mesh-list
110367283|NCT05209412|Clopidogrel|clopidogrel|mesh-list
110367285|NCT05209412|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110367286|NCT05209412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110367287|NCT05209412|Tubulin Modulators|tubulin modulators|mesh-ancestor
110367288|NCT05209412|Antimitotic Agents|antimitotic agents|mesh-ancestor
110367289|NCT05209412|Mitosis Modulators|mitosis modulators|mesh-ancestor
110367290|NCT05209412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110367291|NCT05209412|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110367292|NCT05209412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110367293|NCT05209412|Analgesics|analgesics|mesh-ancestor
110367294|NCT05209412|Sensory System Agents|sensory system agents|mesh-ancestor
110367295|NCT05209412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110367296|NCT05209412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110367297|NCT05209412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110367298|NCT05209412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110367299|NCT05209412|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110367300|NCT05209412|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110380781|NCT01646580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110367301|NCT05209412|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110367302|NCT05209412|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110367303|NCT05209412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110367304|NCT05209412|Antipyretics|antipyretics|mesh-ancestor
110367305|NCT05209412|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110367306|NCT05209412|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110367307|NCT05209412|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110367308|NCT05209412|Purinergic Agents|purinergic agents|mesh-ancestor
110367309|NCT05209412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110367310|NCT05186675|Epinephrine|epinephrine|mesh-list
110367311|NCT05186675|Racepinephrine|racepinephrine|mesh-list
110367312|NCT05186675|Epinephryl borate|epinephryl borate|mesh-list
110367313|NCT05186675|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110367314|NCT05186675|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110367315|NCT05186675|Adrenergic Agents|adrenergic agents|mesh-ancestor
110367316|NCT05186675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110367317|NCT05186675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110367318|NCT05186675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110367320|NCT05186675|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110367321|NCT05186675|Autonomic Agents|autonomic agents|mesh-ancestor
110367322|NCT05186675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110367323|NCT05186675|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110367324|NCT05186675|Respiratory System Agents|respiratory system agents|mesh-ancestor
110380927|NCT04544969|Cisplatin|cisplatin|mesh-list
110367326|NCT05186675|Sympathomimetics|sympathomimetics|mesh-ancestor
110367327|NCT05186675|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110367328|NCT04639362|Venetoclax|venetoclax|mesh-list
110367329|NCT04639362|Obinutuzumab|obinutuzumab|mesh-list
110367330|NCT04639362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110367331|NCT04639362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110367332|NCT04639284|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
110367333|NCT04639284|Antibodies|antibodies|mesh-list
110367334|NCT04639284|Immunologic Factors|immunologic factors|mesh-ancestor
110367335|NCT04639284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110367336|NCT04639284|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110367337|NCT04639284|Growth Substances|growth substances|mesh-ancestor
110367338|NCT04639284|Growth Inhibitors|growth inhibitors|mesh-ancestor
110367339|NCT04639284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110367340|NCT00559689|Budesonide|budesonide|mesh-list
110367341|NCT00559689|Beclomethasone|beclomethasone|mesh-list
110367342|NCT00559689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110367343|NCT00559689|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110367344|NCT00559689|Autonomic Agents|autonomic agents|mesh-ancestor
110367345|NCT00559689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110367346|NCT00559689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110367347|NCT00559689|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110367348|NCT00559689|Respiratory System Agents|respiratory system agents|mesh-ancestor
110367349|NCT00559689|Glucocorticoids|glucocorticoids|mesh-ancestor
110367350|NCT00559689|Hormones|hormones|mesh-ancestor
110367351|NCT00559689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110367352|NCT04629027|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
110367353|NCT04629027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110367354|NCT04629027|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110367355|NCT04629027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110367356|NCT00561288|Acetaminophen|acetaminophen|mesh-list
110367357|NCT00561288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110367358|NCT00561288|Analgesics|analgesics|mesh-ancestor
110367359|NCT00561288|Sensory System Agents|sensory system agents|mesh-ancestor
110367360|NCT00561288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110367361|NCT00561288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110367362|NCT00561288|Antipyretics|antipyretics|mesh-ancestor
110367363|NCT00561327|Losartan|losartan|mesh-list
110367364|NCT00561327|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110381041|NCT01647165|Bortezomib|bortezomib|mesh-list
110367365|NCT00561327|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110367366|NCT00561327|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110367367|NCT00561327|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110367368|NCT00561327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110367369|NCT00561522|Capecitabine|capecitabine|mesh-list
110367370|NCT00561522|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110367371|NCT00561522|Antimetabolites|antimetabolites|mesh-ancestor
110367372|NCT00561522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110367373|NCT00561522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110367374|NCT03454620|Irinotecan|irinotecan|mesh-list
110367375|NCT03454620|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110367376|NCT03454620|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110367377|NCT03454620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110367378|NCT03454620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110367379|NCT03454620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110367380|NCT04628559|Dexmedetomidine|dexmedetomidine|mesh-list
110367381|NCT04628559|Ketamine|ketamine|mesh-list
110367382|NCT04628559|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110367383|NCT04628559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110367384|NCT04628559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110367385|NCT04628559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110367386|NCT04628559|Analgesics|analgesics|mesh-ancestor
110367387|NCT04628559|Sensory System Agents|sensory system agents|mesh-ancestor
110367388|NCT04628559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110367389|NCT04628559|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110367390|NCT04628559|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110367391|NCT04628559|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110367392|NCT04628559|Adrenergic Agents|adrenergic agents|mesh-ancestor
110367393|NCT04628559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110367394|NCT04628559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110367395|NCT04628559|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110367396|NCT04628559|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110367397|NCT04628559|Anesthetics, General|anesthetics, general|mesh-ancestor
110367399|NCT04628559|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110367400|NCT04628559|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110367401|NCT04683341|Tenofovir|tenofovir|mesh-list
110367402|NCT04683341|Antiviral Agents|antiviral agents|mesh-ancestor
110367403|NCT04683341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110367404|NCT04683341|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110367405|NCT04683341|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110367406|NCT04683341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110367407|NCT04683341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110367408|NCT04683341|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110375431|NCT00565331|Rituximab|rituximab|mesh-list
110367409|NCT04683341|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110367410|NCT04628676|Epinephrine|epinephrine|mesh-list
110367411|NCT04628676|Tranylcypromine|tranylcypromine|mesh-list
110367412|NCT04628676|Tranexamic Acid|tranexamic acid|mesh-list
110367413|NCT04628676|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110367414|NCT04628676|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110367415|NCT04628676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110367416|NCT04628676|Hemostatics|hemostatics|mesh-ancestor
110367417|NCT04628676|Coagulants|coagulants|mesh-ancestor
110367418|NCT04628676|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110367419|NCT04628676|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110367420|NCT04628676|Adrenergic Agents|adrenergic agents|mesh-ancestor
110367421|NCT04628676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110367422|NCT04628676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110367423|NCT04628676|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110367424|NCT04628676|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110367425|NCT04628676|Autonomic Agents|autonomic agents|mesh-ancestor
110367426|NCT04628676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110367427|NCT04628676|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110367428|NCT04628676|Respiratory System Agents|respiratory system agents|mesh-ancestor
110367429|NCT04628676|Mydriatics|mydriatics|mesh-ancestor
110367431|NCT04628676|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110367432|NCT04628676|Antidepressive Agents|antidepressive agents|mesh-ancestor
110367433|NCT04628676|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110367434|NCT04628676|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
110367435|NCT04628676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110381326|NCT01202227|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110381331|NCT01202227|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110367437|NCT04628676|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110367438|NCT04628676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110367439|NCT04628325|Furosemide|furosemide|mesh-list
110367440|NCT04628325|Diuretics|diuretics|mesh-ancestor
110367441|NCT04628325|Natriuretic Agents|natriuretic agents|mesh-ancestor
110367442|NCT04628325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110367443|NCT04628325|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110381384|NCT02279511|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
110367444|NCT04628325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110367445|NCT04628325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110367446|NCT04657497|Camostat|camostat|mesh-list
110367447|NCT04657497|Protease Inhibitors|protease inhibitors|mesh-ancestor
110367448|NCT04657497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110367449|NCT04657497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110367450|NCT04657497|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
110367451|NCT04657497|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110367452|NCT01214434|Emollients|emollients|mesh-list
110367453|NCT01214434|Dermatologic Agents|dermatologic agents|mesh-ancestor
110367454|NCT04971356|Aspirin|aspirin|mesh-list
110367455|NCT04971356|Ticagrelor|ticagrelor|mesh-list
110367456|NCT04971356|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110381450|NCT01201798|Prednisolone|prednisolone|mesh-list
110381457|NCT01201798|Difluprednate|difluprednate|mesh-list
110367457|NCT04971356|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110367458|NCT04971356|Analgesics|analgesics|mesh-ancestor
110367459|NCT04971356|Sensory System Agents|sensory system agents|mesh-ancestor
110367460|NCT04971356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110367461|NCT04971356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110367462|NCT04971356|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110367463|NCT04971356|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110367464|NCT04971356|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110367465|NCT04971356|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110367466|NCT04971356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110367467|NCT04971356|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110367468|NCT04971356|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110367469|NCT04971356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110367470|NCT04971356|Antipyretics|antipyretics|mesh-ancestor
110367471|NCT04971356|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110367472|NCT04971356|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110367473|NCT04971356|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110367474|NCT04971356|Purinergic Agents|purinergic agents|mesh-ancestor
110367475|NCT04971356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110367476|NCT01214395|Tea Tree Oil|tea tree oil|mesh-list
110367477|NCT01214395|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110367478|NCT01214395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110367479|NCT01214239|Linagliptin|linagliptin|mesh-list
110367480|NCT01214239|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110367481|NCT01214239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110367482|NCT01214239|Incretins|incretins|mesh-ancestor
110381572|NCT01683747|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110367483|NCT01214239|Hormones|hormones|mesh-ancestor
110367484|NCT01214239|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110367485|NCT01214239|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110367486|NCT01214239|Protease Inhibitors|protease inhibitors|mesh-ancestor
110367487|NCT01214239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110367488|NCT01214239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110367489|NCT01214044|Dexetimide|dexetimide|mesh-list
110367490|NCT01214044|Citalopram|citalopram|mesh-list
110367491|NCT01214044|Escitalopram|escitalopram|mesh-list
110367492|NCT01214044|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110367493|NCT01214044|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110367494|NCT01214044|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110367495|NCT01214044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110367496|NCT01214044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110367497|NCT01214044|Serotonin Agents|serotonin agents|mesh-ancestor
110367498|NCT01214044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110367499|NCT01214044|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110367500|NCT01214044|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110367501|NCT01214044|Parasympatholytics|parasympatholytics|mesh-ancestor
110367502|NCT01214044|Autonomic Agents|autonomic agents|mesh-ancestor
110367503|NCT01214044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110367504|NCT01214044|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110367505|NCT01214044|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110367506|NCT01214044|Cholinergic Agents|cholinergic agents|mesh-ancestor
110367507|NCT01214044|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110367508|NCT01214044|Antidepressive Agents|antidepressive agents|mesh-ancestor
110367509|NCT01214044|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110367511|NCT01213966|Antimalarials|antimalarials|mesh-ancestor
110367512|NCT01213966|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110367513|NCT01213966|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110367514|NCT01213966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110367515|NCT01213264|Anesthetics|anesthetics|mesh-list
110367516|NCT01213264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110367517|NCT01213264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110367518|NCT04657107|Ketamine|ketamine|mesh-list
110367519|NCT04657107|Esketamine|esketamine|mesh-list
110367520|NCT04657107|Analgesics|analgesics|mesh-ancestor
110367521|NCT04657107|Sensory System Agents|sensory system agents|mesh-ancestor
110367522|NCT04657107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110367523|NCT04657107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110367524|NCT04657107|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110367525|NCT04657107|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110367526|NCT04657107|Anesthetics, General|anesthetics, general|mesh-ancestor
110367527|NCT04657107|Anesthetics|anesthetics|mesh-ancestor
110367528|NCT04657107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110367529|NCT04657107|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110367530|NCT04657107|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110367531|NCT04657107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110381743|NCT04537403|Chelating Agents|chelating agents|mesh-ancestor
110367532|NCT04657107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110367533|NCT04657107|Antidepressive Agents|antidepressive agents|mesh-ancestor
110367534|NCT04657107|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110367535|NCT00561717|Cetirizine|cetirizine|mesh-list
110367536|NCT00561717|Loratadine|loratadine|mesh-list
110367537|NCT00561717|Azelastine|azelastine|mesh-list
110367538|NCT00561717|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110367540|NCT00561717|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110367541|NCT00561717|Histamine Antagonists|histamine antagonists|mesh-ancestor
110367542|NCT00561717|Histamine Agents|histamine agents|mesh-ancestor
110367543|NCT00561717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110367544|NCT00561717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110367545|NCT00561717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110367546|NCT00561717|Antipruritics|antipruritics|mesh-ancestor
110367547|NCT00561717|Dermatologic Agents|dermatologic agents|mesh-ancestor
110367548|NCT00561717|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110367549|NCT00561717|Autonomic Agents|autonomic agents|mesh-ancestor
110367550|NCT00561717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110381808|NCT01200355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110367551|NCT00561717|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110367552|NCT00561717|Respiratory System Agents|respiratory system agents|mesh-ancestor
110367553|NCT00561717|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
110367554|NCT00561717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110367556|NCT00561756|Immunologic Factors|immunologic factors|mesh-ancestor
110367557|NCT00561756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110367558|NCT04683146|Chlorhexidine|chlorhexidine|mesh-list
110367559|NCT04683146|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110367560|NCT04683146|Propranolol|propranolol|mesh-list
110367561|NCT04683146|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110367562|NCT04683146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110367563|NCT04683146|Disinfectants|disinfectants|mesh-ancestor
110367564|NCT04683146|Dermatologic Agents|dermatologic agents|mesh-ancestor
110367565|NCT04683146|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110367566|NCT04683146|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110367567|NCT04683146|Adrenergic Agents|adrenergic agents|mesh-ancestor
110367568|NCT04683146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110381868|NCT01685892|Venetoclax|venetoclax|mesh-list
110367569|NCT04683146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110367570|NCT04683146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110367571|NCT04683146|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110367572|NCT04683146|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110367573|NCT04683146|Vasodilator Agents|vasodilator agents|mesh-ancestor
110367574|NCT04816877|Analgesics, Opioid|analgesics, opioid|mesh-list
110367575|NCT04816877|Narcotics|narcotics|mesh-ancestor
110367576|NCT04816877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110367577|NCT04816877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110367578|NCT04816877|Analgesics|analgesics|mesh-ancestor
110367579|NCT04816877|Sensory System Agents|sensory system agents|mesh-ancestor
110367580|NCT04816877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110367582|NCT04800302|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110381922|NCT01686009|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110381923|NCT01686009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110367583|NCT04800302|Narcotics|narcotics|mesh-ancestor
110367584|NCT04800302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110367585|NCT04800302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110367586|NCT04800302|Analgesics|analgesics|mesh-ancestor
110367587|NCT04800302|Sensory System Agents|sensory system agents|mesh-ancestor
110367588|NCT04800302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110367589|NCT04711304|Hyaluronic Acid|hyaluronic acid|mesh-list
110367590|NCT04711304|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110367591|NCT04711304|Immunologic Factors|immunologic factors|mesh-ancestor
110367592|NCT04711304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110367593|NCT04711304|Viscosupplements|viscosupplements|mesh-ancestor
110367594|NCT04711304|Protective Agents|protective agents|mesh-ancestor
110367595|NCT04710719|Triamcinolone|triamcinolone|mesh-list
110367596|NCT04710719|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110367597|NCT04710719|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110367598|NCT04710719|Fluorouracil|fluorouracil|mesh-list
110367599|NCT04710719|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110367600|NCT04710719|Antimetabolites|antimetabolites|mesh-ancestor
110367601|NCT04710719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110367602|NCT04710719|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110367604|NCT04710719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110367605|NCT04710719|Immunologic Factors|immunologic factors|mesh-ancestor
110367606|NCT04710719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110367607|NCT04710719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110367608|NCT04710719|Glucocorticoids|glucocorticoids|mesh-ancestor
110367609|NCT04710719|Hormones|hormones|mesh-ancestor
110367610|NCT04710719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110367611|NCT04710719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110367612|NCT04627779|Flurbiprofen|flurbiprofen|mesh-list
110367613|NCT04627779|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
110367614|NCT04627779|Analgesics|analgesics|mesh-ancestor
110367615|NCT04627779|Sensory System Agents|sensory system agents|mesh-ancestor
110367616|NCT04627779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110367617|NCT04627779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110367618|NCT04627779|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110367619|NCT04627779|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110367620|NCT04627779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110367621|NCT04627779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110382040|NCT04530188|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110382041|NCT01687491|Enoxaparin|enoxaparin|mesh-list
110367622|NCT04627779|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110367623|NCT04627779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110367624|NCT04627779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110367625|NCT04537598|Morphine|morphine|mesh-list
110367626|NCT04537598|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110367628|NCT04537598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110367629|NCT04537598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110367630|NCT04537598|Analgesics|analgesics|mesh-ancestor
110367631|NCT04537598|Sensory System Agents|sensory system agents|mesh-ancestor
110367632|NCT04537598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110367633|NCT04627467|Chloroquine|chloroquine|mesh-list
110367634|NCT04627467|Amebicides|amebicides|mesh-ancestor
110367635|NCT04627467|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110367636|NCT04627467|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110367637|NCT04627467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110367638|NCT04627467|Antimalarials|antimalarials|mesh-ancestor
110367639|NCT04627467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110367640|NCT04627623|Antibodies|antibodies|mesh-list
110367641|NCT04627623|Immunoglobulin G|immunoglobulin g|mesh-list
110367642|NCT04627623|Immunologic Factors|immunologic factors|mesh-ancestor
110367643|NCT04627623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110382096|NCT04535804|Analgesics|analgesics|mesh-ancestor
110367644|NCT04656249|Lenvatinib|lenvatinib|mesh-list
110367645|NCT04656249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110367646|NCT04656249|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110367647|NCT04656249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110367648|NCT04656249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110367649|NCT04682795|Insulin|insulin|mesh-list
110367650|NCT04682795|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110367651|NCT04682795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110367652|NCT04655664|Vitamin D|vitamin d|mesh-list
110367653|NCT04655664|Ergocalciferols|ergocalciferols|mesh-list
110367654|NCT04655664|Cholecalciferol|cholecalciferol|mesh-list
110367655|NCT04655664|Vitamins|vitamins|mesh-list
110367656|NCT04655664|Micronutrients|micronutrients|mesh-ancestor
110367657|NCT04655664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110367658|NCT04655664|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110367659|NCT04655664|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110367660|NCT04655508|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
110367661|NCT04655508|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110367662|NCT04655508|Autonomic Agents|autonomic agents|mesh-ancestor
110382149|NCT01199068|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110367663|NCT04655508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110367664|NCT04655508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110367665|NCT04655508|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110367666|NCT04655508|Respiratory System Agents|respiratory system agents|mesh-ancestor
110367668|NCT04655508|Hormones|hormones|mesh-ancestor
110367669|NCT04655508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110367670|NCT04655508|Sympathomimetics|sympathomimetics|mesh-ancestor
110367671|NCT04655040|Caffeine|caffeine|mesh-list
110367672|NCT04655040|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110367673|NCT04655040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110367674|NCT04655040|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110367675|NCT04655040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110367676|NCT04655040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110367677|NCT04655040|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110367678|NCT04655040|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110367679|NCT04655040|Purinergic Agents|purinergic agents|mesh-ancestor
110367680|NCT04655040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110367681|NCT04626765|Cyclophosphamide|cyclophosphamide|mesh-list
110367682|NCT04626765|Fludarabine|fludarabine|mesh-list
110382205|NCT04534803|BCG Vaccine|bcg vaccine|mesh-list
110382206|NCT04534803|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110367683|NCT04626765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110367684|NCT04626765|Immunologic Factors|immunologic factors|mesh-ancestor
110367685|NCT04626765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110367686|NCT04626765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110367687|NCT04626765|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110367688|NCT04626765|Alkylating Agents|alkylating agents|mesh-ancestor
110367689|NCT04626765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110367690|NCT04626765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110367691|NCT04626765|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110367692|NCT04626726|Cyclophosphamide|cyclophosphamide|mesh-list
110367693|NCT04626726|Fludarabine|fludarabine|mesh-list
110367694|NCT04626726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110367695|NCT04626726|Immunologic Factors|immunologic factors|mesh-ancestor
110367696|NCT04626726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110367697|NCT04626726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110367698|NCT04626726|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110367699|NCT04626726|Alkylating Agents|alkylating agents|mesh-ancestor
110382256|NCT01196416|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110382257|NCT01196416|Alkylating Agents|alkylating agents|mesh-ancestor
110367700|NCT04626726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110367701|NCT04626726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110367702|NCT04626726|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110367704|NCT04654962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110367705|NCT04654962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110367706|NCT04626414|Ferric maltol|ferric maltol|mesh-list
110367707|NCT04626414|Ferric Compounds|ferric compounds|mesh-list
110367708|NCT04626414|Hematinics|hematinics|mesh-ancestor
110367709|NCT04654416|Colchicine|colchicine|mesh-list
110367710|NCT04654416|Gout Suppressants|gout suppressants|mesh-ancestor
110367711|NCT04654416|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110367712|NCT04654416|Tubulin Modulators|tubulin modulators|mesh-ancestor
110367713|NCT04654416|Antimitotic Agents|antimitotic agents|mesh-ancestor
110367714|NCT04654416|Mitosis Modulators|mitosis modulators|mesh-ancestor
110382312|NCT02219672|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110367715|NCT04654416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110367716|NCT04654416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110367717|NCT02906150|Cisplatin|cisplatin|mesh-list
110367718|NCT02906150|Carboplatin|carboplatin|mesh-list
110367719|NCT02906150|Pemetrexed|pemetrexed|mesh-list
110367720|NCT02906150|Thymalfasin|thymalfasin|mesh-list
110367721|NCT02906150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110367722|NCT02906150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110367723|NCT02906150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110367724|NCT02906150|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110367725|NCT02906150|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110367726|NCT02906150|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110367727|NCT02906150|Immunologic Factors|immunologic factors|mesh-ancestor
110367728|NCT02906150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110367729|NCT00561990|Nimotuzumab|nimotuzumab|mesh-list
110367730|NCT00561990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110367731|NCT00561990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110367732|NCT02905994|Cytarabine|cytarabine|mesh-list
110367733|NCT02905994|Idarubicin|idarubicin|mesh-list
110367734|NCT02905994|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110367735|NCT02905994|Antimetabolites|antimetabolites|mesh-ancestor
110382373|NCT02219867|Analgesics|analgesics|mesh-ancestor
110367736|NCT02905994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110367737|NCT02905994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110367738|NCT02905994|Antiviral Agents|antiviral agents|mesh-ancestor
110367739|NCT02905994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110367740|NCT02905994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110367741|NCT02905994|Immunologic Factors|immunologic factors|mesh-ancestor
110367742|NCT02905994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110367743|NCT02905994|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110367744|NCT02905994|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110367745|NCT02905994|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110367746|NCT02905994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110367747|NCT02905682|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
110367748|NCT02905682|Hemostatics|hemostatics|mesh-ancestor
110367749|NCT02905682|Coagulants|coagulants|mesh-ancestor
110367750|NCT02905682|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
110367751|NCT02905682|Natriuretic Agents|natriuretic agents|mesh-ancestor
110367752|NCT02905682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110367753|NCT04626258|Fluconazole|fluconazole|mesh-list
110367754|NCT04626258|Antifungal Agents|antifungal agents|mesh-ancestor
110367755|NCT04626258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110367756|NCT04626258|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110367757|NCT04626258|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110367758|NCT04626258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110367759|NCT04626258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110367760|NCT04626258|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110367761|NCT04626258|Hormone Antagonists|hormone antagonists|mesh-ancestor
110367762|NCT04626258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110367763|NCT04626258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110367764|NCT04626258|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110367765|NCT04626258|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110367766|NCT04626063|Acetaminophen|acetaminophen|mesh-list
110367767|NCT04626063|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
110367768|NCT04626063|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
110367769|NCT04626063|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110367770|NCT04626063|Analgesics|analgesics|mesh-ancestor
110367771|NCT04626063|Sensory System Agents|sensory system agents|mesh-ancestor
110367772|NCT04626063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110367773|NCT04626063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110367774|NCT04626063|Antipyretics|antipyretics|mesh-ancestor
110367775|NCT04626063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110367776|NCT04625985|Metformin|metformin|mesh-list
110367777|NCT04625985|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110367778|NCT04625985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110367779|NCT02905760|Furosemide|furosemide|mesh-list
110367780|NCT02905760|Diuretics|diuretics|mesh-list
110382549|NCT01177540|Decitabine|decitabine|mesh-list
110367782|NCT02905760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110367783|NCT02905760|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110367784|NCT02905760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110367785|NCT02905760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110367786|NCT02905526|Contraceptive Agents|contraceptive agents|mesh-list
110367787|NCT02905526|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110367788|NCT02905526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110367789|NCT04654182|Chlorhexidine|chlorhexidine|mesh-list
110367790|NCT04654182|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110367791|NCT04654182|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110367792|NCT04654182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110367793|NCT04654182|Disinfectants|disinfectants|mesh-ancestor
110382611|NCT01642472|Ulipristal acetate|ulipristal acetate|mesh-list
110367794|NCT04654182|Dermatologic Agents|dermatologic agents|mesh-ancestor
110367795|NCT04654026|Aspirin|aspirin|mesh-list
110367796|NCT04654026|Clopidogrel|clopidogrel|mesh-list
110367797|NCT04654026|Ticagrelor|ticagrelor|mesh-list
110367798|NCT04654026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110367799|NCT04654026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110367800|NCT04654026|Analgesics|analgesics|mesh-ancestor
110367801|NCT04654026|Sensory System Agents|sensory system agents|mesh-ancestor
110367802|NCT04654026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110367803|NCT04654026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110367804|NCT04654026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110367805|NCT04654026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110367806|NCT04654026|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110367807|NCT04654026|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110367808|NCT04654026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110367809|NCT04654026|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110367810|NCT04654026|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110367811|NCT04654026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110367813|NCT04654026|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110367814|NCT04654026|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110367815|NCT04654026|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110367816|NCT04654026|Purinergic Agents|purinergic agents|mesh-ancestor
110367817|NCT04654026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110367819|NCT04625595|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110367820|NCT04625595|Sympatholytics|sympatholytics|mesh-ancestor
110367821|NCT04625595|Autonomic Agents|autonomic agents|mesh-ancestor
110367822|NCT04625595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110367823|NCT04625595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110367824|NCT04625595|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110367825|NCT04625595|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110367826|NCT04625595|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110367827|NCT04625595|Adrenergic Agents|adrenergic agents|mesh-ancestor
110367828|NCT04625595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110367829|NCT04625595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110367830|NCT02905058|Ketoprofen|ketoprofen|mesh-list
110367831|NCT02905058|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110367832|NCT02905058|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110367833|NCT02905058|Analgesics|analgesics|mesh-ancestor
110367834|NCT02905058|Sensory System Agents|sensory system agents|mesh-ancestor
110367835|NCT02905058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110367836|NCT02905058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110367837|NCT02905058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110367838|NCT02905058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110367839|NCT02905058|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110367840|NCT02905058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110367841|NCT02905058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110367843|NCT04653792|Analgesics|analgesics|mesh-ancestor
110367844|NCT04653792|Sensory System Agents|sensory system agents|mesh-ancestor
110367845|NCT04653792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110367846|NCT04653792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110367847|NCT04653792|Anticonvulsants|anticonvulsants|mesh-ancestor
110367848|NCT04653792|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110367849|NCT04653792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110367850|NCT04653792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110367851|NCT04653792|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110367852|NCT04653792|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110367853|NCT04653792|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110367854|NCT04653792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110367855|NCT04653792|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110367856|NCT00557700|Bromides|bromides|mesh-list
110367857|NCT00557700|Tiotropium Bromide|tiotropium bromide|mesh-list
110367858|NCT00557700|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110367859|NCT00557700|Autonomic Agents|autonomic agents|mesh-ancestor
110367860|NCT00557700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110367861|NCT00557700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110367862|NCT00557700|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110367863|NCT00557700|Respiratory System Agents|respiratory system agents|mesh-ancestor
110367864|NCT00557700|Parasympatholytics|parasympatholytics|mesh-ancestor
110367865|NCT00557700|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110367866|NCT00557700|Cholinergic Agents|cholinergic agents|mesh-ancestor
110367867|NCT00557700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110367868|NCT00557700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110367869|NCT00557700|Anticonvulsants|anticonvulsants|mesh-ancestor
110367870|NCT00557739|Mometasone Furoate|mometasone furoate|mesh-list
110367871|NCT00557739|Nortriptyline|nortriptyline|mesh-list
110367872|NCT00557739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110367873|NCT00557739|Dermatologic Agents|dermatologic agents|mesh-ancestor
110367874|NCT00557739|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110367875|NCT00557739|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110367876|NCT00557739|Antidepressive Agents|antidepressive agents|mesh-ancestor
110367877|NCT00557739|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110367878|NCT00557739|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110367879|NCT00557739|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110367880|NCT00557739|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110367881|NCT00557739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110367882|NCT00557739|Adrenergic Agents|adrenergic agents|mesh-ancestor
110367883|NCT00557739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110367884|NCT00557739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110367885|NCT02903888|Levonorgestrel|levonorgestrel|mesh-list
110367886|NCT02903888|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110367887|NCT02903888|Contraceptive Agents|contraceptive agents|mesh-ancestor
110367888|NCT02903888|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110367889|NCT02903888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110367890|NCT02903888|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110367891|NCT02903888|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110367892|NCT02903888|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110367893|NCT04624269|Hydroxychloroquine|hydroxychloroquine|mesh-list
110367894|NCT04624269|Antimalarials|antimalarials|mesh-ancestor
110367895|NCT04624269|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110367896|NCT04624269|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110367897|NCT04624269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110367898|NCT04624269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110367899|NCT04624269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110367900|NCT04624269|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110367901|NCT04652739|Prednisolone|prednisolone|mesh-list
110367902|NCT04652739|Lycopene|lycopene|mesh-list
110367903|NCT04652739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110367904|NCT04652739|Glucocorticoids|glucocorticoids|mesh-ancestor
110367905|NCT04652739|Hormones|hormones|mesh-ancestor
110382966|NCT06047834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110382967|NCT06047834|Analgesics|analgesics|mesh-ancestor
110382968|NCT06047834|Sympatholytics|sympatholytics|mesh-ancestor
110382969|NCT06047834|Autonomic Agents|autonomic agents|mesh-ancestor
110382970|NCT06047548|Tirzepatide|tirzepatide|mesh-list
110382971|NCT06047548|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110382972|NCT06047548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110382973|NCT06047548|Incretins|incretins|mesh-ancestor
110382974|NCT06047548|Hormones|hormones|mesh-ancestor
110382975|NCT06047548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110382976|NCT06047535|Isotretinoin|isotretinoin|mesh-list
110382977|NCT06047535|Dermatologic Agents|dermatologic agents|mesh-ancestor
110382978|NCT06047483|Loxoprofen|loxoprofen|mesh-list
110382979|NCT06047483|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110382980|NCT06047483|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110382981|NCT06047483|Analgesics|analgesics|mesh-ancestor
110382982|NCT06047483|Sensory System Agents|sensory system agents|mesh-ancestor
110383008|NCT06047379|Bevacizumab|bevacizumab|mesh-list
110383009|NCT06047379|Carboplatin|carboplatin|mesh-list
110383010|NCT06047379|Pembrolizumab|pembrolizumab|mesh-list
110367906|NCT04652739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110367907|NCT04652739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110367908|NCT04652739|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110367909|NCT04652739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110367910|NCT04652739|Protective Agents|protective agents|mesh-ancestor
110367911|NCT04652739|Antioxidants|antioxidants|mesh-ancestor
110367912|NCT04652739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110367913|NCT04652739|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110367914|NCT04652739|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110367915|NCT02903498|Tegafur|tegafur|mesh-list
110367916|NCT02903498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110367917|NCT02903498|Antimetabolites|antimetabolites|mesh-ancestor
110367918|NCT02903498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110367919|NCT02903498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110367920|NCT04652427|Dexmedetomidine|dexmedetomidine|mesh-list
110367921|NCT04652427|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110367922|NCT04652427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110367923|NCT04652427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110367924|NCT04652427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110367925|NCT04652427|Analgesics|analgesics|mesh-ancestor
110367926|NCT04652427|Sensory System Agents|sensory system agents|mesh-ancestor
110367927|NCT04652427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110367928|NCT04652427|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110367929|NCT04652427|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110367930|NCT04652427|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110367931|NCT04652427|Adrenergic Agents|adrenergic agents|mesh-ancestor
110367932|NCT04652427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110367933|NCT04652427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110367934|NCT04623879|Ivacaftor|ivacaftor|mesh-list
110367935|NCT04623879|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
110367936|NCT04623879|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110367937|NCT04623879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110367939|NCT00562068|Cyclophosphamide|cyclophosphamide|mesh-list
110367940|NCT00562068|Doxorubicin|doxorubicin|mesh-list
110367941|NCT00562068|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110367942|NCT00562068|Vincristine|vincristine|mesh-list
110367943|NCT00562068|Alemtuzumab|alemtuzumab|mesh-list
110367944|NCT00562068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110367945|NCT00562068|Immunologic Factors|immunologic factors|mesh-ancestor
110367946|NCT00562068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110367947|NCT00562068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110367948|NCT00562068|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110367949|NCT00562068|Alkylating Agents|alkylating agents|mesh-ancestor
110367950|NCT00562068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110367951|NCT00562068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110367952|NCT00562068|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110367953|NCT00562068|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110367954|NCT00562068|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110367955|NCT00562068|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110367957|NCT00562068|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110367958|NCT00562068|Tubulin Modulators|tubulin modulators|mesh-ancestor
110367959|NCT00562068|Antimitotic Agents|antimitotic agents|mesh-ancestor
110367960|NCT00562068|Mitosis Modulators|mitosis modulators|mesh-ancestor
110367961|NCT00562068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110367963|NCT00562068|Hormones|hormones|mesh-ancestor
110367964|NCT00562068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110367965|NCT00562068|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110367966|NCT00562068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110367967|NCT00562185|Carboplatin|carboplatin|mesh-list
110367968|NCT00562185|Doxorubicin|doxorubicin|mesh-list
110367969|NCT00562185|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110367970|NCT00562185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110367971|NCT00562185|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110367972|NCT00562185|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110367973|NCT00562185|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110367974|NCT00562185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110367975|NCT00562185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110367976|NCT00562224|Abexinostat|abexinostat|mesh-list
110367977|NCT00562224|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110367978|NCT00562224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110367979|NCT00562224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110367980|NCT02903069|Temozolomide|temozolomide|mesh-list
110367981|NCT02903069|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110367982|NCT02903069|Alkylating Agents|alkylating agents|mesh-ancestor
110367983|NCT02903069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110367984|NCT02903069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110367986|NCT04623840|Vasodilator Agents|vasodilator agents|mesh-ancestor
110367987|NCT04623840|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110367988|NCT04623840|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110367989|NCT04623840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110367990|NCT04623840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110383502|NCT06044467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110383503|NCT06044311|Carboplatin|carboplatin|mesh-list
110383504|NCT06044311|Vactosertib|vactosertib|mesh-list
110383505|NCT06044311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110383506|NCT06044311|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110383507|NCT06044311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110383508|NCT06044311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110383509|NCT06044142|Curcumin|curcumin|mesh-list
110383510|NCT06044142|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110383511|NCT06044142|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110383512|NCT06044142|Analgesics|analgesics|mesh-ancestor
110383513|NCT06044142|Sensory System Agents|sensory system agents|mesh-ancestor
110367991|NCT04623840|Urological Agents|urological agents|mesh-ancestor
110367992|NCT02902640|Trimethoprim|trimethoprim|mesh-list
110367993|NCT02902640|Sulfamethoxazole|sulfamethoxazole|mesh-list
110367994|NCT02902640|Phenylpropanolamine|phenylpropanolamine|mesh-list
110367995|NCT02902640|Guaifenesin|guaifenesin|mesh-list
110367996|NCT02902640|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
110367997|NCT02902640|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110367998|NCT02902640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110367999|NCT02902640|Antimalarials|antimalarials|mesh-ancestor
110368000|NCT02902640|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110368001|NCT02902640|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110368002|NCT02902640|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110368003|NCT02902640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110368004|NCT02902640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110178094|NCT00143533|Cefpodoxime|cefpodoxime|mesh-list
110368005|NCT02902640|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110368006|NCT02902640|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
110368007|NCT02902640|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110383566|NCT06043674|Atezolizumab|atezolizumab|mesh-list
110368009|NCT02902640|Respiratory System Agents|respiratory system agents|mesh-ancestor
110368010|NCT02902640|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110368011|NCT02902640|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110368012|NCT02902640|Adrenergic Agents|adrenergic agents|mesh-ancestor
110368013|NCT02902640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110368014|NCT02902640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110368015|NCT02902640|Appetite Depressants|appetite depressants|mesh-ancestor
110368016|NCT02902640|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110368017|NCT02902640|Sympathomimetics|sympathomimetics|mesh-ancestor
110368018|NCT02902640|Autonomic Agents|autonomic agents|mesh-ancestor
110368019|NCT02902640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110368020|NCT02902640|Nasal Decongestants|nasal decongestants|mesh-ancestor
110368021|NCT02902640|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110368022|NCT04624893|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
110368023|NCT04624893|Immunoconjugates|immunoconjugates|mesh-list
110368024|NCT04624893|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110383660|NCT06042985|Citric Acid|citric acid|mesh-list
110368025|NCT04624893|Immunologic Factors|immunologic factors|mesh-ancestor
110368026|NCT04624893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110368027|NCT02902523|Tenofovir|tenofovir|mesh-list
110368028|NCT02902523|Antiviral Agents|antiviral agents|mesh-ancestor
110368029|NCT02902523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110368030|NCT02902523|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110368031|NCT02902523|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110368032|NCT02902523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110368033|NCT02902523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110368034|NCT02902523|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110368035|NCT02902523|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110368036|NCT02902289|Ibuprofen|ibuprofen|mesh-list
110368037|NCT02902289|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110368038|NCT02902289|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110368039|NCT02902289|Analgesics|analgesics|mesh-ancestor
110368040|NCT02902289|Sensory System Agents|sensory system agents|mesh-ancestor
110368041|NCT02902289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110368042|NCT02902289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110368043|NCT02902289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110368044|NCT02902289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110368045|NCT02902289|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110368046|NCT02902289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110368047|NCT02902289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110368048|NCT02902133|Acetazolamide|acetazolamide|mesh-list
110368049|NCT02902133|Anticonvulsants|anticonvulsants|mesh-ancestor
110368050|NCT02902133|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110368051|NCT02902133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110368052|NCT02902133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110368053|NCT02902133|Diuretics|diuretics|mesh-ancestor
110368054|NCT02902133|Natriuretic Agents|natriuretic agents|mesh-ancestor
110368055|NCT02902133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110368056|NCT04623021|Nafamostat|nafamostat|mesh-list
110368057|NCT04623021|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110368058|NCT04623021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110368059|NCT04623021|Analgesics|analgesics|mesh-ancestor
110368060|NCT04623021|Sensory System Agents|sensory system agents|mesh-ancestor
110368061|NCT04623021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110368062|NCT04623021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110368063|NCT04623021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110368064|NCT04623021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110368065|NCT04623021|Anticoagulants|anticoagulants|mesh-ancestor
110368066|NCT04623021|Protease Inhibitors|protease inhibitors|mesh-ancestor
110368067|NCT04623021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110368068|NCT04623021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110368069|NCT04623021|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
110368070|NCT04623021|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110368071|NCT04623021|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
110368072|NCT04623021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110368074|NCT02902055|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
110368075|NCT02902055|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110368076|NCT02902055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110368077|NCT02902055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110368079|NCT02901977|Doxazosin|doxazosin|mesh-list
110368080|NCT02901977|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110368081|NCT02901977|Protease Inhibitors|protease inhibitors|mesh-ancestor
110368082|NCT02901977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110368083|NCT02901977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110368084|NCT02901977|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110368085|NCT02901977|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110368086|NCT02901977|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110368087|NCT02901977|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110368088|NCT02901977|Adrenergic Agents|adrenergic agents|mesh-ancestor
110368089|NCT02901977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110368090|NCT02901977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110368091|NCT00553553|Morphine|morphine|mesh-list
110368092|NCT00553553|Remifentanil|remifentanil|mesh-list
110368093|NCT00553553|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110368094|NCT00553553|Narcotics|narcotics|mesh-ancestor
110368095|NCT00553553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110368096|NCT00553553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110368097|NCT00553553|Analgesics|analgesics|mesh-ancestor
110368098|NCT00553553|Sensory System Agents|sensory system agents|mesh-ancestor
110368099|NCT00553553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110368100|NCT04622982|Vitamin D|vitamin d|mesh-list
110368101|NCT04622982|Vitamins|vitamins|mesh-ancestor
110368102|NCT04622982|Micronutrients|micronutrients|mesh-ancestor
110368103|NCT04622982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110368104|NCT04622982|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110368105|NCT04622202|Pregabalin|pregabalin|mesh-list
110368106|NCT04622202|Analgesics|analgesics|mesh-ancestor
110368107|NCT04622202|Sensory System Agents|sensory system agents|mesh-ancestor
110368108|NCT04622202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110368109|NCT04622202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110368110|NCT04622202|Anticonvulsants|anticonvulsants|mesh-ancestor
110368111|NCT04622202|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110368112|NCT04622202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110368113|NCT04622202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110368114|NCT04622202|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110368115|NCT04622202|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110368116|NCT04622202|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110368117|NCT04622202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110368118|NCT04622202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110368120|NCT04622358|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110368121|NCT04622358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110368122|NCT04622358|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110368123|NCT04622358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110368124|NCT04622358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110368125|NCT02901587|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110368126|NCT02901587|Antidepressive Agents|antidepressive agents|mesh-ancestor
110368127|NCT02901587|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110368128|NCT02901587|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110368129|NCT02901587|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110368130|NCT02901587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110368131|NCT02901587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110368132|NCT04622397|Tranexamic Acid|tranexamic acid|mesh-list
110368133|NCT04622397|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110368134|NCT04622397|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110368135|NCT04622397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110368136|NCT04622397|Hemostatics|hemostatics|mesh-ancestor
110368137|NCT04622397|Coagulants|coagulants|mesh-ancestor
110368138|NCT02901353|Sirolimus|sirolimus|mesh-list
110368139|NCT02901353|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110368140|NCT02901353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110368141|NCT02901353|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110368142|NCT02901353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110368143|NCT02901353|Antifungal Agents|antifungal agents|mesh-ancestor
110368144|NCT02901353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110368145|NCT02901353|Immunologic Factors|immunologic factors|mesh-ancestor
110368146|NCT02901353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110368148|NCT04621461|Astringents|astringents|mesh-ancestor
110368149|NCT04621461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110368150|NCT04621461|Dermatologic Agents|dermatologic agents|mesh-ancestor
110368151|NCT02901236|Antifibrotic Agents|antifibrotic agents|mesh-list
110368152|NCT02901236|Bevacizumab|bevacizumab|mesh-list
110368153|NCT02901236|Mitomycins|mitomycins|mesh-list
110368154|NCT02901236|Mitomycin|mitomycin|mesh-list
110368155|NCT02901236|Antimetabolites|antimetabolites|mesh-list
110368156|NCT02901236|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110368157|NCT02901236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110368158|NCT02901236|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110368159|NCT02901236|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110368160|NCT02901236|Growth Substances|growth substances|mesh-ancestor
110368161|NCT02901236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110368162|NCT02901236|Growth Inhibitors|growth inhibitors|mesh-ancestor
110368163|NCT02901236|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110368164|NCT02901236|Alkylating Agents|alkylating agents|mesh-ancestor
110368165|NCT02901236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110368166|NCT02901236|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110368167|NCT02901236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110368168|NCT02901236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110368169|NCT04621617|Midodrine|midodrine|mesh-list
110368170|NCT04621617|Sympathomimetics|sympathomimetics|mesh-ancestor
110368171|NCT04621617|Autonomic Agents|autonomic agents|mesh-ancestor
110368172|NCT04621617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110368173|NCT04621617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110368174|NCT04621617|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110368175|NCT04621617|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110368176|NCT04621617|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110368177|NCT04621617|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110368178|NCT04621617|Adrenergic Agents|adrenergic agents|mesh-ancestor
110368179|NCT04621617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110368180|NCT04621617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110368181|NCT01212757|Thalidomide|thalidomide|mesh-list
110368182|NCT01212757|Apremilast|apremilast|mesh-list
110368183|NCT01212757|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110368184|NCT01212757|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110368185|NCT01212757|Analgesics|analgesics|mesh-ancestor
110368186|NCT01212757|Sensory System Agents|sensory system agents|mesh-ancestor
110368187|NCT01212757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110368188|NCT01212757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110368189|NCT01212757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110368190|NCT01212757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110368191|NCT01212757|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
110368192|NCT01212757|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110368193|NCT01212757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110368194|NCT01212757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110178110|NCT00393315|Paclitaxel|paclitaxel|mesh-list
110368195|NCT01212757|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110368196|NCT01212757|Immunologic Factors|immunologic factors|mesh-ancestor
110368197|NCT01212757|Leprostatic Agents|leprostatic agents|mesh-ancestor
110368198|NCT01212757|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110368199|NCT01212757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110368200|NCT01212757|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110368201|NCT01212757|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110368202|NCT01212757|Growth Substances|growth substances|mesh-ancestor
110368203|NCT01212757|Growth Inhibitors|growth inhibitors|mesh-ancestor
110368204|NCT01212757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110368206|NCT00562419|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110368207|NCT00562419|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110368208|NCT00562419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110368209|NCT00562419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110368210|NCT00562419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110368211|NCT00562458|Anastrozole|anastrozole|mesh-list
110368212|NCT00562458|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110368213|NCT00562458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110368214|NCT00562458|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110368215|NCT00562458|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110368216|NCT00562458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110368217|NCT00562458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110368218|NCT00562458|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110368219|NCT00562458|Hormone Antagonists|hormone antagonists|mesh-ancestor
110368220|NCT00562458|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110383907|NCT06007846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110383908|NCT06007846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110383909|NCT06007846|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110383910|NCT06007846|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110383911|NCT06005532|Adalimumab|adalimumab|mesh-list
110383912|NCT06005532|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110383913|NCT06005532|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110383914|NCT06005532|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110383946|NCT05995769|Psilocybin|psilocybin|mesh-list
110383947|NCT05995769|Hallucinogens|hallucinogens|mesh-ancestor
110383948|NCT05995769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110383949|NCT05995769|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110383950|NCT05986331|Pembrolizumab|pembrolizumab|mesh-list
110383951|NCT05986331|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110383952|NCT05986331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110383953|NCT05986331|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110383954|NCT05986331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110383955|NCT05983367|Bevacizumab|bevacizumab|mesh-list
110383956|NCT05983367|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110383957|NCT05983367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110383958|NCT05983367|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110375466|NCT00472641|Serotonin Agents|serotonin agents|mesh-ancestor
110383959|NCT05983367|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110383960|NCT05983367|Growth Substances|growth substances|mesh-ancestor
110383961|NCT05983367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110383962|NCT05983367|Growth Inhibitors|growth inhibitors|mesh-ancestor
110383963|NCT05976464|Magnesium Sulfate|magnesium sulfate|mesh-list
110383964|NCT05976464|Analgesics|analgesics|mesh-ancestor
110368221|NCT00562458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110368223|NCT02900729|Amlodipine|amlodipine|mesh-list
110368224|NCT02900729|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110368225|NCT02900729|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110368226|NCT02900729|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110368227|NCT02900729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110368228|NCT02900729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110368229|NCT02900729|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110368230|NCT02900729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110368231|NCT02900729|Vasodilator Agents|vasodilator agents|mesh-ancestor
110368232|NCT02900729|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110368233|NCT02900729|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110368234|NCT02900729|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110368235|NCT02900729|Diuretics|diuretics|mesh-ancestor
110368236|NCT02900729|Natriuretic Agents|natriuretic agents|mesh-ancestor
110368237|NCT02900729|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110368238|NCT04621227|Midazolam|midazolam|mesh-list
110368239|NCT04621227|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110368240|NCT04621227|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110368241|NCT04621227|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110368242|NCT04621227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110368243|NCT04621227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110368244|NCT04621227|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110368245|NCT04621227|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110368246|NCT04621227|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110368247|NCT04621227|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110368248|NCT04621227|Anesthetics, General|anesthetics, general|mesh-ancestor
110368250|NCT04621227|GABA Modulators|gaba modulators|mesh-ancestor
110368251|NCT04621227|GABA Agents|gaba agents|mesh-ancestor
110368252|NCT04621227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110368253|NCT04621227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110368254|NCT04621227|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110368255|NCT04621227|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110368256|NCT04621227|Antimetabolites|antimetabolites|mesh-ancestor
110368257|NCT04621227|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110368258|NCT04621227|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110368260|NCT01190410|Certolizumab Pegol|certolizumab pegol|mesh-list
110368261|NCT01190410|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110368262|NCT01190410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110368263|NCT01190410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110368264|NCT01190410|Immunologic Factors|immunologic factors|mesh-ancestor
110368265|NCT01190410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110368266|NCT01190410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110368267|NCT01190254|Asenapine|asenapine|mesh-list
110368268|NCT01190254|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110368269|NCT01190254|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110368270|NCT01190254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110368271|NCT01190254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110368272|NCT01190254|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110368273|NCT04620954|Nivolumab|nivolumab|mesh-list
110368274|NCT04620954|Oregovomab|oregovomab|mesh-list
110368275|NCT04620954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110368276|NCT04620954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110368277|NCT04620954|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110368278|NCT04620954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110368279|NCT00562692|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
110368280|NCT00562692|Natriuretic Agents|natriuretic agents|mesh-ancestor
110368281|NCT00562692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110368282|NCT04621110|Fentanyl|fentanyl|mesh-list
110368283|NCT04621110|Midazolam|midazolam|mesh-list
110368284|NCT04621110|Dexmedetomidine|dexmedetomidine|mesh-list
110368285|NCT04621110|Ketamine|ketamine|mesh-list
110368286|NCT04621110|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110368287|NCT04621110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110368288|NCT04621110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110368289|NCT04621110|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110368290|NCT04621110|Analgesics|analgesics|mesh-ancestor
110368291|NCT04621110|Sensory System Agents|sensory system agents|mesh-ancestor
110368292|NCT04621110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110368293|NCT04621110|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110368294|NCT04621110|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110368295|NCT04621110|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110368296|NCT04621110|Adrenergic Agents|adrenergic agents|mesh-ancestor
110368297|NCT04621110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110368298|NCT04621110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110368299|NCT04621110|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110368300|NCT04621110|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110368301|NCT04621110|Anesthetics, General|anesthetics, general|mesh-ancestor
110368302|NCT04621110|Anesthetics|anesthetics|mesh-ancestor
110368303|NCT04621110|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110368304|NCT04621110|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110368305|NCT04621110|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110368306|NCT04621110|Narcotics|narcotics|mesh-ancestor
110368307|NCT04621110|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110368308|NCT04621110|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110368309|NCT04621110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110368310|NCT04621110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110368311|NCT04621110|GABA Modulators|gaba modulators|mesh-ancestor
110368312|NCT04621110|GABA Agents|gaba agents|mesh-ancestor
110368313|NCT04620720|Gabapentin|gabapentin|mesh-list
110368314|NCT04620720|Analgesics|analgesics|mesh-ancestor
110368315|NCT04620720|Sensory System Agents|sensory system agents|mesh-ancestor
110368316|NCT04620720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110368317|NCT04620720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110368318|NCT04620720|Anticonvulsants|anticonvulsants|mesh-ancestor
110368319|NCT04620720|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110368320|NCT04620720|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110368321|NCT04620720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110368322|NCT04620720|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110368323|NCT04620720|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110368324|NCT04620720|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110368325|NCT04620720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110368807|NCT04616352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110368326|NCT04620720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110368327|NCT04620720|Antimanic Agents|antimanic agents|mesh-ancestor
110368328|NCT02900417|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110368329|NCT02900417|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110368330|NCT02900417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110368331|NCT02900417|Incretins|incretins|mesh-ancestor
110368333|NCT02900417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110368334|NCT02900417|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110368335|NCT02900417|Protease Inhibitors|protease inhibitors|mesh-ancestor
110368336|NCT02900417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110368337|NCT02900417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110368338|NCT04620837|Tislelizumab|tislelizumab|mesh-list
110368339|NCT04620837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110368340|NCT04620837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110368341|NCT04620018|Amoxicillin|amoxicillin|mesh-list
110368342|NCT04620018|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110368343|NCT04620018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110368344|NCT02900105|Letrozole|letrozole|mesh-list
110368345|NCT02900105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110368346|NCT02900105|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110368347|NCT02900105|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110368348|NCT02900105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110368349|NCT02900105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110368350|NCT02900105|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110368351|NCT02900105|Hormone Antagonists|hormone antagonists|mesh-ancestor
110368352|NCT02900105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110368353|NCT02900105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110368355|NCT04619862|Analgesics|analgesics|mesh-ancestor
110368356|NCT04619862|Sensory System Agents|sensory system agents|mesh-ancestor
110368357|NCT04619862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110368358|NCT04619862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110368359|NCT04619862|Anticonvulsants|anticonvulsants|mesh-ancestor
110368360|NCT04619862|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110368361|NCT04619862|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110368362|NCT04619862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110368363|NCT04619862|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110368364|NCT04619862|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110384077|NCT05935306|Ibuprofen|ibuprofen|mesh-list
110368365|NCT04619862|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110368366|NCT04619862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110368367|NCT04619862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110368368|NCT04619862|Antimanic Agents|antimanic agents|mesh-ancestor
110368369|NCT01190839|Infliximab|infliximab|mesh-list
110368370|NCT01190839|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110368371|NCT01190839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110368372|NCT01190839|Dermatologic Agents|dermatologic agents|mesh-ancestor
110368373|NCT01190839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110368374|NCT01190839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110368376|NCT00562770|Valganciclovir|valganciclovir|mesh-list
110368377|NCT00562770|Antiviral Agents|antiviral agents|mesh-ancestor
110368378|NCT00562770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110368379|NCT05424692|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
110368380|NCT05424692|Fluorouracil|fluorouracil|mesh-list
110368381|NCT05424692|Oxaliplatin|oxaliplatin|mesh-list
110368382|NCT05424692|Irinotecan|irinotecan|mesh-list
110368383|NCT05424692|Cetuximab|cetuximab|mesh-list
110368384|NCT05424692|Antimetabolites|antimetabolites|mesh-ancestor
110368385|NCT05424692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110368386|NCT05424692|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110368387|NCT05424692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110368388|NCT05424692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110368389|NCT05424692|Immunologic Factors|immunologic factors|mesh-ancestor
110368390|NCT05424692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110368391|NCT05424692|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110368392|NCT05424692|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110368393|NCT05424692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110368394|NCT05424692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110368395|NCT05424692|Vitamin B Complex|vitamin b complex|mesh-ancestor
110368396|NCT05424692|Vitamins|vitamins|mesh-ancestor
110368397|NCT05424692|Micronutrients|micronutrients|mesh-ancestor
110368398|NCT04618965|Dexmedetomidine|dexmedetomidine|mesh-list
110368399|NCT04618965|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110368400|NCT04618965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110368401|NCT04618965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110368402|NCT04618965|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110368403|NCT04618965|Analgesics|analgesics|mesh-ancestor
110368404|NCT04618965|Sensory System Agents|sensory system agents|mesh-ancestor
110368405|NCT04618965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110368406|NCT04618965|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110368407|NCT04618965|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110368408|NCT04618965|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110368409|NCT04618965|Adrenergic Agents|adrenergic agents|mesh-ancestor
110384122|NCT05918822|Maribavir|maribavir|mesh-list
110368410|NCT04618965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110368411|NCT04618965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110368413|NCT01190449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110368414|NCT00562809|Irbesartan|irbesartan|mesh-list
110368415|NCT00562809|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110368416|NCT00562809|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110368417|NCT00562809|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110368418|NCT00562809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110368419|NCT01190098|Lacosamide|lacosamide|mesh-list
110368420|NCT01190098|Anticonvulsants|anticonvulsants|mesh-ancestor
110368421|NCT01190098|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110368422|NCT01190098|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110368423|NCT01190098|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110368424|NCT01190098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110368425|NCT04314739|Resveratrol|resveratrol|mesh-list
110368426|NCT04314739|Antioxidants|antioxidants|mesh-ancestor
110368427|NCT04314739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110368428|NCT04314739|Protective Agents|protective agents|mesh-ancestor
110368429|NCT04314739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110368430|NCT04314739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110368431|NCT04314739|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110368432|NCT02885740|Adenosine|adenosine|mesh-list
110368433|NCT02885740|Analgesics|analgesics|mesh-ancestor
110368434|NCT02885740|Sensory System Agents|sensory system agents|mesh-ancestor
110368435|NCT02885740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110368436|NCT02885740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110368437|NCT02885740|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110368438|NCT02885740|Vasodilator Agents|vasodilator agents|mesh-ancestor
110368439|NCT02885740|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
110368440|NCT02885740|Purinergic Agonists|purinergic agonists|mesh-ancestor
110368441|NCT02885740|Purinergic Agents|purinergic agents|mesh-ancestor
110368442|NCT02885740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110368443|NCT02885740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110368444|NCT05309785|Canagliflozin|canagliflozin|mesh-list
110368445|NCT05309785|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110368446|NCT05309785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110368447|NCT05309785|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110368448|NCT05309785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110368449|NCT01190020|Lubiprostone|lubiprostone|mesh-list
110368450|NCT01190020|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
110368451|NCT01190020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110368452|NCT01190020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110368454|NCT01189435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110368455|NCT01189435|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110368456|NCT01189435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110368457|NCT01189435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110368458|NCT01165996|Decitabine|decitabine|mesh-list
110368459|NCT01165996|Azacitidine|azacitidine|mesh-list
110368460|NCT01165996|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110368461|NCT01165996|Antimetabolites|antimetabolites|mesh-ancestor
110368462|NCT01165996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110368463|NCT01165996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110368464|NCT01165996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110368466|NCT04619433|Pemetrexed|pemetrexed|mesh-list
110368467|NCT04619433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110368468|NCT04619433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110368469|NCT04619433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110368470|NCT04619433|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110368471|NCT04619433|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110368472|NCT04619160|Propofol|propofol|mesh-list
110368473|NCT04619160|Sevoflurane|sevoflurane|mesh-list
110368474|NCT04619160|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110368475|NCT04619160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110368476|NCT04619160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110368477|NCT04619160|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110368478|NCT04619160|Anesthetics, General|anesthetics, general|mesh-ancestor
110368479|NCT04619160|Anesthetics|anesthetics|mesh-ancestor
110368480|NCT04619160|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110368481|NCT04619160|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110368482|NCT01165684|Insulin|insulin|mesh-list
110368483|NCT01165684|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110368484|NCT01165684|Insulin Aspart|insulin aspart|mesh-list
110368485|NCT01165684|Insulin, Long-Acting|insulin, long-acting|mesh-list
110368486|NCT01165684|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
110368487|NCT01165684|Insulin Detemir|insulin detemir|mesh-list
110368488|NCT01165684|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110368489|NCT01165684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110368490|NCT01189201|Linagliptin|linagliptin|mesh-list
110368491|NCT01189201|Empagliflozin|empagliflozin|mesh-list
110368492|NCT01189201|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110368493|NCT01189201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110368494|NCT01189201|Incretins|incretins|mesh-ancestor
110368495|NCT01189201|Hormones|hormones|mesh-ancestor
110368496|NCT01189201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110368497|NCT01189201|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110368498|NCT01189201|Protease Inhibitors|protease inhibitors|mesh-ancestor
110368499|NCT01189201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110368500|NCT01189201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110368501|NCT01189201|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110368502|NCT01188811|Thioctic Acid|thioctic acid|mesh-list
110368503|NCT01188811|Antioxidants|antioxidants|mesh-ancestor
110368504|NCT01188811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110368505|NCT01188811|Protective Agents|protective agents|mesh-ancestor
110368506|NCT01188811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110368507|NCT01188811|Vitamin B Complex|vitamin b complex|mesh-ancestor
110368508|NCT01188811|Vitamins|vitamins|mesh-ancestor
110368509|NCT01188811|Micronutrients|micronutrients|mesh-ancestor
110368510|NCT01183234|Methylphenidate|methylphenidate|mesh-list
110368511|NCT01183234|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110178169|NCT00143806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110375470|NCT00472641|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110368512|NCT01183234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110368513|NCT01183234|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110368514|NCT01183234|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110368515|NCT01183234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110368516|NCT01183234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110368517|NCT01183234|Dopamine Agents|dopamine agents|mesh-ancestor
110368518|NCT01183234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110368519|NCT04618497|Ketorolac|ketorolac|mesh-list
110368520|NCT04618497|Methoxyflurane|methoxyflurane|mesh-list
110368521|NCT04618497|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110368522|NCT04618497|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110368523|NCT04618497|Analgesics|analgesics|mesh-ancestor
110368524|NCT04618497|Sensory System Agents|sensory system agents|mesh-ancestor
110368525|NCT04618497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110368526|NCT04618497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110368527|NCT04618497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110368528|NCT04618497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110368529|NCT04618497|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110368530|NCT04618497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110368531|NCT04618497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110368532|NCT04618497|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110368533|NCT04618497|Anesthetics, General|anesthetics, general|mesh-ancestor
110368534|NCT04618497|Anesthetics|anesthetics|mesh-ancestor
110368535|NCT04618497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110368536|NCT04618575|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
110368537|NCT04618575|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
110368538|NCT04618575|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110368539|NCT04618536|Sunscreening Agents|sunscreening agents|mesh-list
110368540|NCT04618536|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110368541|NCT04618536|Protective Agents|protective agents|mesh-ancestor
110368542|NCT04618536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110368543|NCT04618536|Dermatologic Agents|dermatologic agents|mesh-ancestor
110368544|NCT04651959|Favipiravir|favipiravir|mesh-list
110368545|NCT04651959|Antiviral Agents|antiviral agents|mesh-ancestor
110368546|NCT04651959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110368547|NCT01165216|Paclitaxel|paclitaxel|mesh-list
110368548|NCT01165216|Carboplatin|carboplatin|mesh-list
110063980|NCT01525043|Naproxen|naproxen|mesh-list
110063981|NCT01525043|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110063982|NCT01525043|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110063983|NCT01525043|Analgesics|analgesics|mesh-ancestor
110063984|NCT01525043|Sensory System Agents|sensory system agents|mesh-ancestor
110063985|NCT01525043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110063986|NCT01525043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110063987|NCT01525043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110063988|NCT01525043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110063989|NCT01525043|Gout Suppressants|gout suppressants|mesh-ancestor
110063990|NCT01525043|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110063991|NCT01525043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110063992|NCT01525043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110063993|NCT01525290|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
110063994|NCT01525290|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110063995|NCT01525290|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110063996|NCT01525290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110063997|NCT01525537|Sufentanil|sufentanil|mesh-list
110063998|NCT01525537|Dsuvia|dsuvia|mesh-list
110063999|NCT01525537|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110064000|NCT01525537|Narcotics|narcotics|mesh-ancestor
110064001|NCT01525537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110064002|NCT01525537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110064003|NCT01525537|Analgesics|analgesics|mesh-ancestor
110064004|NCT01525537|Sensory System Agents|sensory system agents|mesh-ancestor
110064005|NCT01525537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110064006|NCT01525537|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110064007|NCT01525537|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110064008|NCT01525537|Anesthetics, General|anesthetics, general|mesh-ancestor
110064009|NCT01525537|Anesthetics|anesthetics|mesh-ancestor
110064010|NCT01525680|Hydrocortisone|hydrocortisone|mesh-list
110064011|NCT01525680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110064012|NCT01525706|Ethanol|ethanol|mesh-list
110064013|NCT01525706|Paclitaxel|paclitaxel|mesh-list
110064014|NCT01525706|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110178186|NCT00144157|Zidovudine|zidovudine|mesh-list
110064015|NCT01525706|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110064016|NCT01525706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110064017|NCT01525706|Tubulin Modulators|tubulin modulators|mesh-ancestor
110064018|NCT01525706|Antimitotic Agents|antimitotic agents|mesh-ancestor
110064019|NCT01525706|Mitosis Modulators|mitosis modulators|mesh-ancestor
110064020|NCT01525706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110064021|NCT01525706|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110064022|NCT01525706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110064023|NCT01525706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110064024|NCT01525706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110064025|NCT01525719|Everolimus|everolimus|mesh-list
110064026|NCT01525719|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110064027|NCT01525719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110064028|NCT01525719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110064029|NCT01525719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110064030|NCT01525719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110064031|NCT01525719|Immunologic Factors|immunologic factors|mesh-ancestor
110064032|NCT01525719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110064033|NCT01525719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110064034|NCT01525771|Cisplatin|cisplatin|mesh-list
110064035|NCT01525771|Docetaxel|docetaxel|mesh-list
110064036|NCT01525771|Capecitabine|capecitabine|mesh-list
110064037|NCT01525771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110064038|NCT01525771|Tubulin Modulators|tubulin modulators|mesh-ancestor
110064039|NCT01525771|Antimitotic Agents|antimitotic agents|mesh-ancestor
110064040|NCT01525771|Mitosis Modulators|mitosis modulators|mesh-ancestor
110064041|NCT01525771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110064042|NCT01525771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110064043|NCT01525771|Antimetabolites|antimetabolites|mesh-ancestor
110064044|NCT01525823|Metformin|metformin|mesh-list
110064045|NCT01525823|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110064046|NCT01525823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110064047|NCT01525836|Rituximab|rituximab|mesh-list
110064048|NCT01525836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110064049|NCT01525836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110064050|NCT01525836|Immunologic Factors|immunologic factors|mesh-ancestor
110064051|NCT01525836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110064052|NCT01525836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110064053|NCT01525888|Enzyme Inhibitors|enzyme inhibitors|mesh-list
110064054|NCT01525888|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
110064055|NCT01525888|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
110064056|NCT01525888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110064057|NCT01525888|Protease Inhibitors|protease inhibitors|mesh-ancestor
110064058|NCT01525914|Dutasteride|dutasteride|mesh-list
110064059|NCT01525914|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
110064060|NCT01525914|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110064061|NCT01525914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110064062|NCT01525914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110064063|NCT01525914|Hormone Antagonists|hormone antagonists|mesh-ancestor
110064064|NCT01525914|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110384312|NCT05846568|Immunologic Factors|immunologic factors|mesh-ancestor
110064065|NCT01525914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110064067|NCT01526005|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110064068|NCT01526005|Autonomic Agents|autonomic agents|mesh-ancestor
110064069|NCT01526005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110064070|NCT01526005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110064071|NCT01526005|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110064072|NCT01526005|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110064073|NCT01526005|Cholinergic Agents|cholinergic agents|mesh-ancestor
110064074|NCT01526005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110064075|NCT01526005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110064076|NCT01526070|Aflibercept|aflibercept|mesh-list
110064077|NCT01526070|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110384365|NCT05799079|Decitabine|decitabine|mesh-list
110064078|NCT01526070|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110064079|NCT01526070|Growth Substances|growth substances|mesh-ancestor
110064080|NCT01526070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110178193|NCT00144157|Antiviral Agents|antiviral agents|mesh-ancestor
110064081|NCT01526070|Growth Inhibitors|growth inhibitors|mesh-ancestor
110064082|NCT01526070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110064084|NCT01526083|Warfarin|warfarin|mesh-list
110064085|NCT01526083|Anticoagulants|anticoagulants|mesh-ancestor
110064086|NCT01526083|Anticonvulsants|anticonvulsants|mesh-ancestor
110064087|NCT01526083|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110064088|NCT01526083|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110064089|NCT01526083|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110064090|NCT01526083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110064091|NCT01526122|Aspirin|aspirin|mesh-list
110064092|NCT01526122|Clopidogrel|clopidogrel|mesh-list
110064093|NCT01526122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110064094|NCT01526122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110064095|NCT01526122|Analgesics|analgesics|mesh-ancestor
110064096|NCT01526122|Sensory System Agents|sensory system agents|mesh-ancestor
110064097|NCT01526122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110064098|NCT01526122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110064099|NCT01526122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110064100|NCT01526122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110064101|NCT01526122|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110064102|NCT01526122|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110064103|NCT01526122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110064104|NCT01526122|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110064105|NCT01526122|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110064106|NCT01526122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110064107|NCT01526122|Antipyretics|antipyretics|mesh-ancestor
110384476|NCT05752734|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110064108|NCT01526122|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110064109|NCT01526122|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110064110|NCT01526122|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110064111|NCT01526122|Purinergic Agents|purinergic agents|mesh-ancestor
110064112|NCT01526122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110064113|NCT01526161|Fluticasone|fluticasone|mesh-list
110064115|NCT01526161|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110064116|NCT01526161|Montelukast|montelukast|mesh-list
110064117|NCT01526161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110064118|NCT01526161|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110064119|NCT01526161|Autonomic Agents|autonomic agents|mesh-ancestor
110064120|NCT01526161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110064121|NCT01526161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110064122|NCT01526161|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110064123|NCT01526161|Respiratory System Agents|respiratory system agents|mesh-ancestor
110064124|NCT01526161|Dermatologic Agents|dermatologic agents|mesh-ancestor
110064125|NCT01526161|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110064126|NCT01526161|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110064127|NCT01526161|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110064128|NCT01526161|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110064129|NCT01526161|Adrenergic Agents|adrenergic agents|mesh-ancestor
110064130|NCT01526161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110064131|NCT01526161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110064132|NCT01526161|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110064133|NCT01526161|Hormone Antagonists|hormone antagonists|mesh-ancestor
110064134|NCT01526161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110384565|NCT05698147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110384566|NCT05698147|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110384567|NCT05698147|Abortifacient Agents|abortifacient agents|mesh-ancestor
110064135|NCT01526161|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110064136|NCT01526161|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110064138|NCT01526174|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110064139|NCT01526174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110064140|NCT01526174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110064142|NCT01526174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110064143|NCT01526278|Alendronate|alendronate|mesh-list
110064144|NCT01526278|Calcitriol|calcitriol|mesh-list
110064145|NCT01526278|Maxmarvil|maxmarvil|mesh-list
110064146|NCT01526278|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110384613|NCT05691400|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110384614|NCT05691400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110384615|NCT05691400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110384616|NCT05688475|Dexamethasone|dexamethasone|mesh-list
110384617|NCT05688475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110384618|NCT05688475|Antiemetics|antiemetics|mesh-ancestor
110384619|NCT05688475|Autonomic Agents|autonomic agents|mesh-ancestor
110384620|NCT05688475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110384621|NCT05688475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110384622|NCT05688475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110384623|NCT05688475|Glucocorticoids|glucocorticoids|mesh-ancestor
110384624|NCT05688475|Hormones|hormones|mesh-ancestor
110064147|NCT01526278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110064148|NCT01526278|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110064149|NCT01526278|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
110064150|NCT01526278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110064151|NCT01526278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110064152|NCT01526278|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110064153|NCT01526278|Vitamins|vitamins|mesh-ancestor
110064154|NCT01526278|Micronutrients|micronutrients|mesh-ancestor
110064155|NCT01526317|Metformin|metformin|mesh-list
110064156|NCT01526317|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110064157|NCT01526317|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110064158|NCT01526317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110064159|NCT01526317|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110064160|NCT01526317|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110064161|NCT01526317|Antimetabolites|antimetabolites|mesh-ancestor
110384697|NCT05653401|Diclofenac|diclofenac|mesh-list
110064162|NCT01526317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110064163|NCT01526317|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110064164|NCT01526317|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110064165|NCT01526317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110064166|NCT01526369|Paclitaxel|paclitaxel|mesh-list
110064167|NCT01526369|Trastuzumab|trastuzumab|mesh-list
110064168|NCT01526369|Lapatinib|lapatinib|mesh-list
110064169|NCT01526369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110064170|NCT01526369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110064171|NCT01526369|Tubulin Modulators|tubulin modulators|mesh-ancestor
110064172|NCT01526369|Antimitotic Agents|antimitotic agents|mesh-ancestor
110064173|NCT01526369|Mitosis Modulators|mitosis modulators|mesh-ancestor
110064174|NCT01526369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110064175|NCT01526369|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110064176|NCT01526369|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110064177|NCT01526369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110064178|NCT01526395|Propofol|propofol|mesh-list
110064179|NCT01526395|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110384754|NCT05635708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110064180|NCT01526395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110064181|NCT01526395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110064182|NCT01526395|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110064183|NCT01526395|Anesthetics, General|anesthetics, general|mesh-ancestor
110064184|NCT01526395|Anesthetics|anesthetics|mesh-ancestor
110064185|NCT01526460|Atorvastatin|atorvastatin|mesh-list
110064186|NCT01526460|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110064187|NCT01526460|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110064188|NCT01526460|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110064189|NCT01526460|Antimetabolites|antimetabolites|mesh-ancestor
110064190|NCT01526460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110064191|NCT01526460|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110064192|NCT01526460|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110064194|NCT01526499|Cyclophosphamide|cyclophosphamide|mesh-list
110064195|NCT01526499|Docetaxel|docetaxel|mesh-list
110064196|NCT01526499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110064197|NCT01526499|Immunologic Factors|immunologic factors|mesh-ancestor
110064198|NCT01526499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110064199|NCT01526499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110064200|NCT01526499|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110064201|NCT01526499|Alkylating Agents|alkylating agents|mesh-ancestor
110384810|NCT05624996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110384811|NCT05624996|Immunologic Factors|immunologic factors|mesh-ancestor
110384812|NCT05624996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110384813|NCT05624996|Keratolytic Agents|keratolytic agents|mesh-ancestor
110384814|NCT05624996|Dermatologic Agents|dermatologic agents|mesh-ancestor
110384815|NCT05619653|Prednisolone|prednisolone|mesh-list
110384816|NCT05619653|Losartan|losartan|mesh-list
110064202|NCT01526499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110064203|NCT01526499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110064204|NCT01526499|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110064206|NCT01526499|Antimitotic Agents|antimitotic agents|mesh-ancestor
110064207|NCT01526499|Mitosis Modulators|mitosis modulators|mesh-ancestor
110064208|NCT01526525|Acetaminophen|acetaminophen|mesh-list
110064209|NCT01526525|Parecoxib|parecoxib|mesh-list
110064210|NCT01526525|Ketamine|ketamine|mesh-list
110064211|NCT01526525|Morphine|morphine|mesh-list
110064212|NCT01526525|Tramadol|tramadol|mesh-list
110064213|NCT01526525|Analgesics|analgesics|mesh-ancestor
110064214|NCT01526525|Sensory System Agents|sensory system agents|mesh-ancestor
110064215|NCT01526525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110064216|NCT01526525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110064217|NCT01526525|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110064218|NCT01526525|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110064219|NCT01526525|Anesthetics, General|anesthetics, general|mesh-ancestor
110064221|NCT01526525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110064222|NCT01526525|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110064223|NCT01526525|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110064224|NCT01526525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110064225|NCT01526525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110064226|NCT01526525|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110064227|NCT01526525|Narcotics|narcotics|mesh-ancestor
110064228|NCT01526525|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110064229|NCT01526525|Antipyretics|antipyretics|mesh-ancestor
110064230|NCT01526525|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110064231|NCT01526525|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110064232|NCT01526525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110064233|NCT01526525|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110064234|NCT01526525|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110064235|NCT01526525|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110064236|NCT01526564|Acetylcarnitine|acetylcarnitine|mesh-list
110064237|NCT01526564|Vitamin B Complex|vitamin b complex|mesh-ancestor
110064238|NCT01526564|Vitamins|vitamins|mesh-ancestor
110385064|NCT05515796|Trastuzumab|trastuzumab|mesh-list
110385065|NCT05515796|Tislelizumab|tislelizumab|mesh-list
110385066|NCT05515796|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110385067|NCT05515796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110385068|NCT05514535|Insulin Glargine|insulin glargine|mesh-list
110385069|NCT05514535|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110385070|NCT05514535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110385071|NCT05513209|Anesthetics|anesthetics|mesh-list
110064239|NCT01526564|Micronutrients|micronutrients|mesh-ancestor
110064240|NCT01526564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110064241|NCT01526564|Nootropic Agents|nootropic agents|mesh-ancestor
110064242|NCT01526616|Metformin|metformin|mesh-list
110064243|NCT01526616|Spironolactone|spironolactone|mesh-list
110064244|NCT01526616|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110064245|NCT01526616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110064246|NCT01526616|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110064247|NCT01526616|Hormone Antagonists|hormone antagonists|mesh-ancestor
110064248|NCT01526616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110064249|NCT01526616|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110064250|NCT01526616|Diuretics|diuretics|mesh-ancestor
110064251|NCT01526616|Natriuretic Agents|natriuretic agents|mesh-ancestor
110064252|NCT01526694|Thalidomide|thalidomide|mesh-list
110064253|NCT01526694|Dexamethasone|dexamethasone|mesh-list
110064254|NCT01526694|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110064255|NCT01526694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110064256|NCT01526694|Antiemetics|antiemetics|mesh-ancestor
110064257|NCT01526694|Autonomic Agents|autonomic agents|mesh-ancestor
110064258|NCT01526694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110064259|NCT01526694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110064260|NCT01526694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110064261|NCT01526694|Glucocorticoids|glucocorticoids|mesh-ancestor
110064262|NCT01526694|Hormones|hormones|mesh-ancestor
110064263|NCT01526694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110064264|NCT01526694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110064265|NCT01526694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110064266|NCT01526694|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110385129|NCT05500170|Niacinamide|niacinamide|mesh-list
110064267|NCT01526694|Alkylating Agents|alkylating agents|mesh-ancestor
110064268|NCT01526694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110064269|NCT01526694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110064270|NCT01526694|Immunologic Factors|immunologic factors|mesh-ancestor
110064271|NCT01526694|Leprostatic Agents|leprostatic agents|mesh-ancestor
110064272|NCT01526694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110064273|NCT01526694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110064274|NCT01526694|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110064275|NCT01526694|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110064276|NCT01526694|Growth Substances|growth substances|mesh-ancestor
110178218|NCT00144352|Sulfadoxine|sulfadoxine|mesh-list
110064277|NCT01526694|Growth Inhibitors|growth inhibitors|mesh-ancestor
110064278|NCT01526837|Bevacizumab|bevacizumab|mesh-list
110064279|NCT01526837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110064280|NCT01526837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110064281|NCT01526837|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110064282|NCT01526837|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110064283|NCT01526837|Growth Substances|growth substances|mesh-ancestor
110064284|NCT01526837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110064285|NCT01526837|Growth Inhibitors|growth inhibitors|mesh-ancestor
110064286|NCT01526850|Cyclosporine|cyclosporine|mesh-list
110064287|NCT01526850|Cyclosporins|cyclosporins|mesh-list
110064288|NCT01526850|Glucocorticoids|glucocorticoids|mesh-list
110064289|NCT01526850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110064290|NCT01526850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110064291|NCT01526850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110064292|NCT01526850|Immunologic Factors|immunologic factors|mesh-ancestor
110064293|NCT01526850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110064294|NCT01526850|Antifungal Agents|antifungal agents|mesh-ancestor
110064295|NCT01526850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110064296|NCT01526850|Dermatologic Agents|dermatologic agents|mesh-ancestor
110064297|NCT01526850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110064298|NCT01526850|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110064299|NCT01526850|Hormones|hormones|mesh-ancestor
110064300|NCT01526850|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110064301|NCT01526876|Clevidipine|clevidipine|mesh-list
110064302|NCT01526876|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110064303|NCT01526876|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110064304|NCT01526876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110064305|NCT01526876|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110064306|NCT01526876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110064308|NCT01526941|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110064309|NCT01526941|Insulin Aspart|insulin aspart|mesh-list
110064310|NCT01526941|Insulin, Long-Acting|insulin, long-acting|mesh-list
110064311|NCT01526941|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
110064312|NCT01526941|Biphasic Insulins|biphasic insulins|mesh-list
110064313|NCT01526941|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
110064314|NCT01526941|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110064315|NCT01526941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110064316|NCT01526980|Insulin|insulin|mesh-list
110064317|NCT01526980|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110064318|NCT01526980|Insulin Aspart|insulin aspart|mesh-list
110064319|NCT01526980|Insulin, Long-Acting|insulin, long-acting|mesh-list
110064320|NCT01526980|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
110064321|NCT01526980|Biphasic Insulins|biphasic insulins|mesh-list
110064322|NCT01526980|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
110064323|NCT01526980|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110064324|NCT01526980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110064325|NCT01527019|Cephalosporins|cephalosporins|mesh-list
110064326|NCT01527019|Norfloxacin|norfloxacin|mesh-list
110064327|NCT01527019|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110064328|NCT01527019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110064329|NCT01527019|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110064330|NCT01527019|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110064332|NCT01527019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110064333|NCT01527019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110064334|NCT01527019|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110064335|NCT01527019|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110064336|NCT01527032|Thalidomide|thalidomide|mesh-list
110064337|NCT01527032|Dexamethasone|dexamethasone|mesh-list
110064339|NCT01527032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110064340|NCT01527032|Antiemetics|antiemetics|mesh-ancestor
110064341|NCT01527032|Autonomic Agents|autonomic agents|mesh-ancestor
110064342|NCT01527032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110064343|NCT01527032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110064344|NCT01527032|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110064345|NCT01527032|Glucocorticoids|glucocorticoids|mesh-ancestor
110064346|NCT01527032|Hormones|hormones|mesh-ancestor
110064347|NCT01527032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110064348|NCT01527032|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110064349|NCT01527032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110385263|NCT05408845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110064350|NCT01527032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110064351|NCT01527032|Alkylating Agents|alkylating agents|mesh-ancestor
110064352|NCT01527032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110064353|NCT01527032|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110064354|NCT01527032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110064355|NCT01527032|Immunologic Factors|immunologic factors|mesh-ancestor
110064356|NCT01527032|Leprostatic Agents|leprostatic agents|mesh-ancestor
110064357|NCT01527032|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110064358|NCT01527032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110064359|NCT01527032|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110064360|NCT01527032|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110064361|NCT01527032|Growth Substances|growth substances|mesh-ancestor
110064362|NCT01527032|Growth Inhibitors|growth inhibitors|mesh-ancestor
110064364|NCT01527097|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110064365|NCT01527097|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110064366|NCT01527097|Antimetabolites|antimetabolites|mesh-ancestor
110064367|NCT01527097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110064368|NCT01527097|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110064369|NCT01527097|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110064370|NCT01527097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110064371|NCT01527279|Antazoline|antazoline|mesh-list
110064372|NCT01527279|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110064373|NCT01527279|Histamine Antagonists|histamine antagonists|mesh-ancestor
110064374|NCT01527279|Histamine Agents|histamine agents|mesh-ancestor
110064375|NCT01527279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110064376|NCT01527279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110064377|NCT01527279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110064378|NCT01527279|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110064379|NCT01527305|Paliperidone Palmitate|paliperidone palmitate|mesh-list
110064380|NCT01527305|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110064381|NCT01527305|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110064382|NCT01527305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110385315|NCT05395052|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110064383|NCT01527305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110064384|NCT01527305|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110064385|NCT01527305|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110064386|NCT01527305|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110064387|NCT01527305|Serotonin Agents|serotonin agents|mesh-ancestor
110064388|NCT01527305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110064389|NCT01527305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110064390|NCT01527305|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110064391|NCT01527305|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110064392|NCT01527305|Dopamine Agents|dopamine agents|mesh-ancestor
110064394|NCT01527318|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110064395|NCT01527318|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110064396|NCT01527318|Antimetabolites|antimetabolites|mesh-ancestor
110064397|NCT01527318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110064398|NCT01527318|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110064399|NCT01527422|Prednisone|prednisone|mesh-list
110064400|NCT01527422|Cyclophosphamide|cyclophosphamide|mesh-list
110064401|NCT01527422|Doxorubicin|doxorubicin|mesh-list
110064402|NCT01527422|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110064403|NCT01527422|Vincristine|vincristine|mesh-list
110064404|NCT01527422|Sargramostim|sargramostim|mesh-list
110064405|NCT01527422|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110064407|NCT01527422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110064408|NCT01527422|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110064409|NCT01527422|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110064410|NCT01527422|Alkylating Agents|alkylating agents|mesh-ancestor
110064411|NCT01527422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110064412|NCT01527422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110064413|NCT01527422|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110064414|NCT01527422|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110064415|NCT01527422|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110064416|NCT01527422|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110064417|NCT01527422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110064418|NCT01527422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110064420|NCT01527422|Hormones|hormones|mesh-ancestor
110064421|NCT01527422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110064422|NCT01527422|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110385407|NCT05361720|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110064423|NCT01527422|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110064424|NCT01527422|Tubulin Modulators|tubulin modulators|mesh-ancestor
110064425|NCT01527422|Antimitotic Agents|antimitotic agents|mesh-ancestor
110064426|NCT01527422|Mitosis Modulators|mitosis modulators|mesh-ancestor
110064427|NCT01527448|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110064428|NCT01527448|Antidepressive Agents|antidepressive agents|mesh-ancestor
110064429|NCT01527448|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110064430|NCT01527448|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110064431|NCT01527448|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110064432|NCT01527448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110064433|NCT01527448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110064434|NCT01527474|Escitalopram|escitalopram|mesh-list
110064435|NCT01527474|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110064436|NCT01527474|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110064437|NCT01527474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110064438|NCT01527474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110064439|NCT01527474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110064440|NCT01527474|Serotonin Agents|serotonin agents|mesh-ancestor
110064441|NCT01527474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110064442|NCT01527539|Insulin Aspart|insulin aspart|mesh-list
110064443|NCT01527539|Biphasic Insulins|biphasic insulins|mesh-list
110064444|NCT01527539|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
110064445|NCT01527539|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110064446|NCT01527539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110064447|NCT01527552|Insulin Aspart|insulin aspart|mesh-list
110064448|NCT01527552|Biphasic Insulins|biphasic insulins|mesh-list
110064449|NCT01527552|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110064450|NCT01527552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110064451|NCT01527565|Insulin Aspart|insulin aspart|mesh-list
110064452|NCT01527565|Biphasic Insulins|biphasic insulins|mesh-list
110385467|NCT05316168|Dexamethasone|dexamethasone|mesh-list
110385468|NCT05316168|Bupivacaine|bupivacaine|mesh-list
110385469|NCT05316168|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110385470|NCT05316168|Antiemetics|antiemetics|mesh-ancestor
110385471|NCT05316168|Autonomic Agents|autonomic agents|mesh-ancestor
110385472|NCT05316168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110385473|NCT05316168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110385474|NCT05316168|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110385475|NCT05316168|Glucocorticoids|glucocorticoids|mesh-ancestor
110385476|NCT05316168|Hormones|hormones|mesh-ancestor
110385478|NCT05316168|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110064453|NCT01527565|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110064454|NCT01527565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110064455|NCT01527630|Insulin Aspart|insulin aspart|mesh-list
110064456|NCT01527630|Biphasic Insulins|biphasic insulins|mesh-list
110064457|NCT01527630|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110064458|NCT01527630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110064459|NCT01527643|Insulin Aspart|insulin aspart|mesh-list
110064460|NCT01527643|Biphasic Insulins|biphasic insulins|mesh-list
110064461|NCT01527643|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110064462|NCT01527643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110064463|NCT01527656|Insulin Aspart|insulin aspart|mesh-list
110064464|NCT01527656|Biphasic Insulins|biphasic insulins|mesh-list
110064465|NCT01527656|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110064466|NCT01527656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110064467|NCT01527669|Lovastatin|lovastatin|mesh-list
110064468|NCT01527669|L 647318|l 647318|mesh-list
110064469|NCT01527669|Dihydromevinolin|dihydromevinolin|mesh-list
110064470|NCT01527669|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110064471|NCT01527669|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110064472|NCT01527669|Antimetabolites|antimetabolites|mesh-ancestor
110064473|NCT01527669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110064474|NCT01527669|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110064475|NCT01527669|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110064476|NCT01527669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110064477|NCT01527734|Tetrodotoxin|tetrodotoxin|mesh-list
110064478|NCT01527734|Anesthetics, Local|anesthetics, local|mesh-ancestor
110064479|NCT01527734|Anesthetics|anesthetics|mesh-ancestor
110064480|NCT01527734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110064481|NCT01527734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110064482|NCT01527734|Sensory System Agents|sensory system agents|mesh-ancestor
110064483|NCT01527734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110064484|NCT01527734|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110064485|NCT01527734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110064486|NCT01527734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110064487|NCT01527786|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
110064488|NCT01527786|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110064489|NCT01527786|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110064490|NCT01527786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110064491|NCT01527786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110064492|NCT01527786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110064493|NCT01527786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110064494|NCT01527786|Antidepressive Agents|antidepressive agents|mesh-ancestor
110064495|NCT01527786|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110064497|NCT01527864|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110064498|NCT01527864|Carboplatin|carboplatin|mesh-list
110385653|NCT05231629|Growth Substances|growth substances|mesh-ancestor
110385654|NCT05231629|Growth Inhibitors|growth inhibitors|mesh-ancestor
110385655|NCT05227937|Amikacin|amikacin|mesh-list
110385656|NCT05227937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110385657|NCT05227937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110385658|NCT05208879|Carotenoids|carotenoids|mesh-list
110385659|NCT05208879|Antioxidants|antioxidants|mesh-ancestor
110385660|NCT05208879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110385661|NCT05208879|Protective Agents|protective agents|mesh-ancestor
110385662|NCT05208879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110385673|NCT05201313|Lidocaine|lidocaine|mesh-list
110064499|NCT01527864|Endostatins|endostatins|mesh-list
110064500|NCT01527864|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110064501|NCT01527864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110064502|NCT01527864|Tubulin Modulators|tubulin modulators|mesh-ancestor
110064503|NCT01527864|Antimitotic Agents|antimitotic agents|mesh-ancestor
110064504|NCT01527864|Mitosis Modulators|mitosis modulators|mesh-ancestor
110064505|NCT01527864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110064506|NCT01527864|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110064507|NCT01527864|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110064508|NCT01527864|Growth Substances|growth substances|mesh-ancestor
110064509|NCT01527864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110064510|NCT01527864|Growth Inhibitors|growth inhibitors|mesh-ancestor
110064512|NCT01527890|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110064513|NCT01527890|Narcotics|narcotics|mesh-ancestor
110064514|NCT01527890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110064516|NCT01527890|Analgesics|analgesics|mesh-ancestor
110064517|NCT01527890|Sensory System Agents|sensory system agents|mesh-ancestor
110064518|NCT01527890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110064519|NCT01527890|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110064520|NCT01527890|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110064521|NCT01527890|Anesthetics, General|anesthetics, general|mesh-ancestor
110064522|NCT01527890|Anesthetics|anesthetics|mesh-ancestor
110064523|NCT01527903|Midazolam|midazolam|mesh-list
110064524|NCT01527903|Propofol|propofol|mesh-list
110064526|NCT01527903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110064527|NCT01527903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110064528|NCT01527903|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110064529|NCT01527903|Anesthetics, General|anesthetics, general|mesh-ancestor
110064530|NCT01527903|Anesthetics|anesthetics|mesh-ancestor
110064531|NCT01527903|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110064532|NCT01527903|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110064533|NCT01527903|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110064534|NCT01527903|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110064535|NCT01527903|GABA Modulators|gaba modulators|mesh-ancestor
110064536|NCT01527903|GABA Agents|gaba agents|mesh-ancestor
110064537|NCT01527903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110064538|NCT01527903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110064539|NCT01527968|Tranexamic Acid|tranexamic acid|mesh-list
110064540|NCT01527968|Aminocaproic Acid|aminocaproic acid|mesh-list
110064541|NCT01527968|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110385844|NCT05146739|Vitamins|vitamins|mesh-ancestor
110064542|NCT01527968|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110064543|NCT01527968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110064544|NCT01527968|Hemostatics|hemostatics|mesh-ancestor
110064545|NCT01527968|Coagulants|coagulants|mesh-ancestor
110064546|NCT01527994|Aprepitant|aprepitant|mesh-list
110064547|NCT01527994|Antiemetics|antiemetics|mesh-ancestor
110064548|NCT01527994|Autonomic Agents|autonomic agents|mesh-ancestor
110064549|NCT01527994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110064550|NCT01527994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110064551|NCT01527994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110385909|NCT05083312|Dermatologic Agents|dermatologic agents|mesh-ancestor
110064552|NCT01527994|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110064553|NCT01527994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110064554|NCT01527994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110064555|NCT01528007|Naltrexone|naltrexone|mesh-list
110386014|NCT05050162|Cisplatin|cisplatin|mesh-list
110064556|NCT01528007|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110064557|NCT01528007|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110064558|NCT01528007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110064559|NCT01528007|Sensory System Agents|sensory system agents|mesh-ancestor
110064560|NCT01528007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110064562|NCT01528137|Talactoferrin alfa|talactoferrin alfa|mesh-list
110064563|NCT01528137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110064564|NCT01528137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110064565|NCT01528163|Methotrexate|methotrexate|mesh-list
110064566|NCT01528163|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110064567|NCT01528163|Abortifacient Agents|abortifacient agents|mesh-ancestor
110064568|NCT01528163|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110064569|NCT01528163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110064570|NCT01528163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110064571|NCT01528163|Antimetabolites|antimetabolites|mesh-ancestor
110064572|NCT01528163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110064574|NCT01528163|Dermatologic Agents|dermatologic agents|mesh-ancestor
110064575|NCT01528163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110064576|NCT01528163|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110064577|NCT01528163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110064578|NCT01528163|Immunologic Factors|immunologic factors|mesh-ancestor
110064579|NCT01528163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110064580|NCT01528163|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110064581|NCT01528176|Cholecalciferol|cholecalciferol|mesh-list
110064582|NCT01528176|Vitamin D|vitamin d|mesh-list
110064583|NCT01528176|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110064584|NCT01528176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110064585|NCT01528176|Vitamins|vitamins|mesh-ancestor
110064586|NCT01528176|Micronutrients|micronutrients|mesh-ancestor
110064587|NCT01528176|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110064588|NCT01528371|Midazolam|midazolam|mesh-list
110064589|NCT01528371|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110064590|NCT01528371|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110064591|NCT01528371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110064592|NCT01528371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110064593|NCT01528371|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110064594|NCT01528371|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110064595|NCT01528371|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110064596|NCT01528371|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110064597|NCT01528371|Anesthetics, General|anesthetics, general|mesh-ancestor
110064598|NCT01528371|Anesthetics|anesthetics|mesh-ancestor
110064599|NCT01528371|GABA Modulators|gaba modulators|mesh-ancestor
110064600|NCT01528371|GABA Agents|gaba agents|mesh-ancestor
110386139|NCT05013229|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110386140|NCT05013229|Insulin Glargine|insulin glargine|mesh-list
110386141|NCT05013229|Insulin Aspart|insulin aspart|mesh-list
110386142|NCT05013229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110386143|NCT05013229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110386144|NCT05010434|Bevacizumab|bevacizumab|mesh-list
110386145|NCT05010434|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110386146|NCT05010434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110386147|NCT05010434|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110386148|NCT05010434|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110386149|NCT05010434|Growth Substances|growth substances|mesh-ancestor
110386151|NCT05010434|Growth Inhibitors|growth inhibitors|mesh-ancestor
110064601|NCT01528371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110064602|NCT01528371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110064604|NCT01528501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110064605|NCT01528501|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110064606|NCT01528501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110064607|NCT01528501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110064608|NCT01528540|Pregabalin|pregabalin|mesh-list
110064609|NCT01528540|Antioxidants|antioxidants|mesh-list
110064610|NCT01528540|Analgesics|analgesics|mesh-ancestor
110064611|NCT01528540|Sensory System Agents|sensory system agents|mesh-ancestor
110064612|NCT01528540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110064613|NCT01528540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110064614|NCT01528540|Anticonvulsants|anticonvulsants|mesh-ancestor
110064615|NCT01528540|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110064616|NCT01528540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110064617|NCT01528540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110064618|NCT01528540|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110064619|NCT01528540|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110064620|NCT01528540|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110064621|NCT01528540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110064622|NCT01528540|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110064623|NCT01528540|Protective Agents|protective agents|mesh-ancestor
110064624|NCT01528618|Cisplatin|cisplatin|mesh-list
110064625|NCT01528618|Gemcitabine|gemcitabine|mesh-list
110064626|NCT01528618|Fluorouracil|fluorouracil|mesh-list
110064627|NCT01528618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110064628|NCT01528618|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110064629|NCT01528618|Antimetabolites|antimetabolites|mesh-ancestor
110064630|NCT01528618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110064631|NCT01528618|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110064632|NCT01528618|Immunologic Factors|immunologic factors|mesh-ancestor
110064633|NCT01528618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110064634|NCT01528644|Calcium, Dietary|calcium, dietary|mesh-list
110064636|NCT01528644|Ferrous gluconate|ferrous gluconate|mesh-list
110064638|NCT01528644|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110064639|NCT01528644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110064640|NCT01528644|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110064641|NCT01528644|Trace Elements|trace elements|mesh-ancestor
110064642|NCT01528644|Micronutrients|micronutrients|mesh-ancestor
110064643|NCT01528644|Hematinics|hematinics|mesh-ancestor
110064644|NCT01528722|Bupivacaine|bupivacaine|mesh-list
110064645|NCT01528722|Anesthetics, Local|anesthetics, local|mesh-ancestor
110064646|NCT01528722|Anesthetics|anesthetics|mesh-ancestor
110064647|NCT01528722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110064648|NCT01528722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110064649|NCT01528722|Sensory System Agents|sensory system agents|mesh-ancestor
110064650|NCT01528722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110064652|NCT01528800|Vitamin K 1|vitamin k 1|mesh-list
110064653|NCT01528800|Vitamins|vitamins|mesh-ancestor
110064654|NCT01528800|Micronutrients|micronutrients|mesh-ancestor
110064655|NCT01528800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110064656|NCT01528800|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110064657|NCT01528800|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110064658|NCT01528800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110064659|NCT01528800|Hemostatics|hemostatics|mesh-ancestor
110064660|NCT01528800|Coagulants|coagulants|mesh-ancestor
110064661|NCT01528813|Amorolfine|amorolfine|mesh-list
110064662|NCT01528813|Antifungal Agents|antifungal agents|mesh-ancestor
110064663|NCT01528813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110064664|NCT01528826|Oxaliplatin|oxaliplatin|mesh-list
110064665|NCT01528826|Vinorelbine|vinorelbine|mesh-list
110386345|NCT04890470|Hemostatics|hemostatics|mesh-ancestor
110064666|NCT01528826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110064667|NCT01528826|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110064668|NCT01528826|Tubulin Modulators|tubulin modulators|mesh-ancestor
110064669|NCT01528826|Antimitotic Agents|antimitotic agents|mesh-ancestor
110064670|NCT01528826|Mitosis Modulators|mitosis modulators|mesh-ancestor
110064671|NCT01528826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110064672|NCT01528865|Tenofovir|tenofovir|mesh-list
110064674|NCT01528865|Antiviral Agents|antiviral agents|mesh-ancestor
110064675|NCT01528865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110064676|NCT01528865|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110064677|NCT01528865|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110064678|NCT01528865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110064679|NCT01528865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110064680|NCT01528865|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110064681|NCT01528865|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110064682|NCT01528930|Amikacin|amikacin|mesh-list
110064683|NCT01528930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110064684|NCT01528930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110064685|NCT01528943|Epoprostenol|epoprostenol|mesh-list
110064686|NCT01528943|Tezosentan|tezosentan|mesh-list
110064687|NCT01528943|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110064688|NCT01528943|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110064689|NCT01528943|Vasodilator Agents|vasodilator agents|mesh-ancestor
110064691|NCT01529073|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110064692|NCT01529073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110064693|NCT01529125|Lamivudine|lamivudine|mesh-list
110064694|NCT01529125|Zidovudine|zidovudine|mesh-list
110064695|NCT01529125|Nevirapine|nevirapine|mesh-list
110064696|NCT01529125|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110064697|NCT01529125|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110064698|NCT01529125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110064699|NCT01529125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110064700|NCT01529125|Antiviral Agents|antiviral agents|mesh-ancestor
110064701|NCT01529125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110064702|NCT01529125|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110064703|NCT01529125|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110064704|NCT01529125|Antimetabolites|antimetabolites|mesh-ancestor
110064705|NCT01529125|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110064706|NCT01529125|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110064708|NCT01529138|Temsirolimus|temsirolimus|mesh-list
110064709|NCT01529138|MTOR Inhibitors|mtor inhibitors|mesh-list
110064711|NCT01529138|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110064712|NCT01529138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110064713|NCT01529138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110064714|NCT01529138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110064715|NCT01529138|Immunologic Factors|immunologic factors|mesh-ancestor
110064716|NCT01529138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110064717|NCT01529138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110064718|NCT01529138|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110064719|NCT01529138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110386570|NCT04721132|Bevacizumab|bevacizumab|mesh-list
110064720|NCT01529138|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110064721|NCT01529138|Antifungal Agents|antifungal agents|mesh-ancestor
110064723|NCT01529164|Fluorouracil|fluorouracil|mesh-list
110064724|NCT01529164|Oxaliplatin|oxaliplatin|mesh-list
110064725|NCT01529164|Endostar protein|endostar protein|mesh-list
110064726|NCT01529164|Endostatins|endostatins|mesh-list
110064727|NCT01529164|Antimetabolites|antimetabolites|mesh-ancestor
110368549|NCT01165216|Ipilimumab|ipilimumab|mesh-list
110064728|NCT01529164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110064729|NCT01529164|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110064730|NCT01529164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110064731|NCT01529164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110064732|NCT01529164|Immunologic Factors|immunologic factors|mesh-ancestor
110064733|NCT01529164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110064734|NCT01529164|Antidotes|antidotes|mesh-ancestor
110064735|NCT01529164|Protective Agents|protective agents|mesh-ancestor
110386627|NCT04674813|Alkylating Agents|alkylating agents|mesh-ancestor
110386628|NCT04674813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110386629|NCT04674813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110386630|NCT04674813|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110386631|NCT04670679|Pembrolizumab|pembrolizumab|mesh-list
110386632|NCT04670679|Cetuximab|cetuximab|mesh-list
110386633|NCT04670679|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110386634|NCT04670679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110386635|NCT04670679|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110386636|NCT04670679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110386637|NCT04633551|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
110386651|NCT04620746|Penicillins|penicillins|mesh-list
110386652|NCT04620746|Penicillin G|penicillin g|mesh-list
110064736|NCT01529164|Vitamin B Complex|vitamin b complex|mesh-ancestor
110064737|NCT01529164|Vitamins|vitamins|mesh-ancestor
110064738|NCT01529164|Micronutrients|micronutrients|mesh-ancestor
110064739|NCT01529164|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110064740|NCT01529164|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110064741|NCT01529164|Growth Substances|growth substances|mesh-ancestor
110064742|NCT01529164|Growth Inhibitors|growth inhibitors|mesh-ancestor
110064743|NCT01529177|Metformin|metformin|mesh-list
110064744|NCT01529177|Citric Acid|citric acid|mesh-list
110064745|NCT01529177|Sodium Citrate|sodium citrate|mesh-list
110064746|NCT01529177|Clomiphene|clomiphene|mesh-list
110064747|NCT01529177|Enclomiphene|enclomiphene|mesh-list
110064748|NCT01529177|Zuclomiphene|zuclomiphene|mesh-list
110064749|NCT01529177|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110064750|NCT01529177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110064751|NCT01529177|Anticoagulants|anticoagulants|mesh-ancestor
110064752|NCT01529177|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110064753|NCT01529177|Chelating Agents|chelating agents|mesh-ancestor
110064754|NCT01529177|Sequestering Agents|sequestering agents|mesh-ancestor
110386685|NCT04596995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110386686|NCT04593927|Siponimod|siponimod|mesh-list
110386687|NCT04593927|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
110386692|NCT04592809|Midazolam|midazolam|mesh-list
110064755|NCT01529177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110064757|NCT01529177|Hormone Antagonists|hormone antagonists|mesh-ancestor
110064758|NCT01529177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110064759|NCT01529177|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110064760|NCT01529177|Fertility Agents|fertility agents|mesh-ancestor
110064761|NCT01529177|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110178247|NCT00404716|Vasodilator Agents|vasodilator agents|mesh-ancestor
110064762|NCT01529177|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110064763|NCT01529177|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110064764|NCT01529190|Pregabalin|pregabalin|mesh-list
110064765|NCT01529190|Analgesics|analgesics|mesh-ancestor
110064766|NCT01529190|Sensory System Agents|sensory system agents|mesh-ancestor
110064767|NCT01529190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110064768|NCT01529190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110064769|NCT01529190|Anticonvulsants|anticonvulsants|mesh-ancestor
110064770|NCT01529190|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110386769|NCT04553666|Vitamins|vitamins|mesh-list
110386770|NCT04553666|Ascorbic Acid|ascorbic acid|mesh-list
110386771|NCT04553666|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
110386772|NCT04553666|Micronutrients|micronutrients|mesh-ancestor
110386773|NCT04553666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110386774|NCT04553666|Antioxidants|antioxidants|mesh-ancestor
110386775|NCT04553666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110386776|NCT04553666|Protective Agents|protective agents|mesh-ancestor
110386777|NCT04553666|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
110386778|NCT04553666|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110386779|NCT04553666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110386780|NCT04553666|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110386781|NCT04551885|Aldesleukin|aldesleukin|mesh-list
110386782|NCT04551885|Cyclophosphamide|cyclophosphamide|mesh-list
110386783|NCT04551885|Fludarabine|fludarabine|mesh-list
110386784|NCT04551885|Avelumab|avelumab|mesh-list
110386785|NCT04551885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110386786|NCT04551885|Immunologic Factors|immunologic factors|mesh-ancestor
110386787|NCT04551885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110386788|NCT04551885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110386789|NCT04551885|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110386790|NCT04551885|Alkylating Agents|alkylating agents|mesh-ancestor
110386791|NCT04551885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110386792|NCT04551885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110064771|NCT01529190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110064772|NCT01529190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110064773|NCT01529190|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110064774|NCT01529190|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110064775|NCT01529190|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110064776|NCT01529190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110064777|NCT01529190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110064780|NCT01529229|Desloratadine|desloratadine|mesh-list
110064781|NCT01529229|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
110064782|NCT01529229|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110064783|NCT01529229|Glucocorticoids|glucocorticoids|mesh-ancestor
110064784|NCT01529229|Hormones|hormones|mesh-ancestor
110094946|NCT01711814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110064785|NCT01529229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110064786|NCT01529229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110064787|NCT01529229|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110064788|NCT01529229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110064789|NCT01529229|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110064790|NCT01529229|Respiratory System Agents|respiratory system agents|mesh-ancestor
110064791|NCT01529229|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110064792|NCT01529229|Cholinergic Agents|cholinergic agents|mesh-ancestor
110064793|NCT01529229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110064794|NCT01529229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110064795|NCT01529229|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110064796|NCT01529229|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110064797|NCT01529229|Histamine Antagonists|histamine antagonists|mesh-ancestor
110386964|NCT04513717|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110386968|NCT04505254|Acalabrutinib|acalabrutinib|mesh-list
110064799|NCT01529242|Prednisolone|prednisolone|mesh-list
110064800|NCT01529242|Betamethasone|betamethasone|mesh-list
110064801|NCT01529242|Desloratadine|desloratadine|mesh-list
110064802|NCT01529242|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
110064803|NCT01529242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110064805|NCT01529242|Hormones|hormones|mesh-ancestor
110064806|NCT01529242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110064807|NCT01529242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110064808|NCT01529242|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110064809|NCT01529242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110064810|NCT01529242|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110064811|NCT01529242|Respiratory System Agents|respiratory system agents|mesh-ancestor
110064812|NCT01529242|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110064813|NCT01529242|Cholinergic Agents|cholinergic agents|mesh-ancestor
110064814|NCT01529242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110064815|NCT01529242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110387024|NCT04448184|Coagulants|coagulants|mesh-ancestor
110064816|NCT01529242|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110064817|NCT01529242|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110064818|NCT01529242|Histamine Antagonists|histamine antagonists|mesh-ancestor
110064819|NCT01529242|Histamine Agents|histamine agents|mesh-ancestor
110064820|NCT01529255|Telbivudine|telbivudine|mesh-list
110064821|NCT01529255|Antiviral Agents|antiviral agents|mesh-ancestor
110064822|NCT01529255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110064823|NCT01529255|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110064824|NCT01529255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110064825|NCT01529255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110064826|NCT01529294|Iloperidone|iloperidone|mesh-list
110064827|NCT01529294|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110064828|NCT01529294|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110064829|NCT01529294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110064830|NCT01529294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110064831|NCT01529294|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110064832|NCT01529320|Methylprednisolone|methylprednisolone|mesh-list
110064833|NCT01529320|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110064834|NCT01529320|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110064835|NCT01529320|Prednisolone|prednisolone|mesh-list
110064836|NCT01529320|Prednisolone acetate|prednisolone acetate|mesh-list
110064837|NCT01529320|Methylprednisolone aceponate|methylprednisolone aceponate|mesh-list
110064838|NCT01529320|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110064839|NCT01529320|Prednisolone phosphate|prednisolone phosphate|mesh-list
110064840|NCT01529320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110064841|NCT01529320|Antiemetics|antiemetics|mesh-ancestor
110064842|NCT01529320|Autonomic Agents|autonomic agents|mesh-ancestor
110064843|NCT01529320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110064844|NCT01529320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110064845|NCT01529320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110064846|NCT01529320|Glucocorticoids|glucocorticoids|mesh-ancestor
110064847|NCT01529320|Hormones|hormones|mesh-ancestor
110064848|NCT01529320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110064849|NCT01529320|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110064850|NCT01529320|Protective Agents|protective agents|mesh-ancestor
110064851|NCT01529320|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110064852|NCT01529320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110064853|NCT01529437|Immunomodulating Agents|immunomodulating agents|mesh-list
110064854|NCT01529437|Immunologic Factors|immunologic factors|mesh-list
110064855|NCT01529437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110064857|NCT01529476|Nemonoxacin|nemonoxacin|mesh-list
110064858|NCT01529476|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110064859|NCT01529476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110064860|NCT01529476|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110064861|NCT01529476|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110064862|NCT01529476|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110064863|NCT01529476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110064864|NCT01529476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110064865|NCT01529476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110064866|NCT01529476|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110064867|NCT01529476|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110064869|NCT01529528|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110064870|NCT01529528|Protease Inhibitors|protease inhibitors|mesh-ancestor
110064871|NCT01529528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110064872|NCT01529528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110064873|NCT01529528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110064874|NCT01529528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110064875|NCT01529541|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110064876|NCT01529541|Anagliptin|anagliptin|mesh-list
110064877|NCT01529541|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110064878|NCT01529541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110064879|NCT01529541|Incretins|incretins|mesh-ancestor
110064880|NCT01529541|Hormones|hormones|mesh-ancestor
110064881|NCT01529541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110064882|NCT01529541|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110064883|NCT01529541|Protease Inhibitors|protease inhibitors|mesh-ancestor
110064884|NCT01529541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110064885|NCT01529541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110064886|NCT01529554|Everolimus|everolimus|mesh-list
110064887|NCT01529554|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110387273|NCT04257500|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110064888|NCT01529554|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110064889|NCT01529554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110064890|NCT01529554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110064891|NCT01529554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110064892|NCT01529554|Immunologic Factors|immunologic factors|mesh-ancestor
110064893|NCT01529554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110064894|NCT01529554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110064895|NCT01529619|Rivastigmine|rivastigmine|mesh-list
110064896|NCT01529619|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110064897|NCT01529619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110064898|NCT01529619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110064899|NCT01529619|Cholinergic Agents|cholinergic agents|mesh-ancestor
110387385|NCT04171843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110387386|NCT04170283|Tislelizumab|tislelizumab|mesh-list
110387387|NCT04170283|Zanubrutinib|zanubrutinib|mesh-list
110064900|NCT01529619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110064901|NCT01529619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110064902|NCT01529619|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110064903|NCT01529619|Protective Agents|protective agents|mesh-ancestor
110064904|NCT01529710|Praziquantel|praziquantel|mesh-list
110064905|NCT01529710|Anthelmintics|anthelmintics|mesh-ancestor
110064906|NCT01529710|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110064907|NCT01529710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110064908|NCT01529788|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110064909|NCT01529788|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110064910|NCT01529788|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110064911|NCT01529788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110064912|NCT01529788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110064913|NCT01529788|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110064914|NCT01529788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110064915|NCT01529788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110064916|NCT01529788|Cholinergic Agents|cholinergic agents|mesh-ancestor
110064917|NCT01529788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110064918|NCT01529892|Methamphetamine|methamphetamine|mesh-list
110064919|NCT01529892|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110064920|NCT01529892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110064921|NCT01529892|Sympathomimetics|sympathomimetics|mesh-ancestor
110064922|NCT01529892|Autonomic Agents|autonomic agents|mesh-ancestor
110064923|NCT01529892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110064924|NCT01529892|Dopamine Agents|dopamine agents|mesh-ancestor
110064925|NCT01529892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110387479|NCT04082780|Rifamycins|rifamycins|mesh-list
110387480|NCT04082780|Rifamycin SV|rifamycin sv|mesh-list
110387481|NCT04082780|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110387482|NCT04082780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110064926|NCT01529892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110064927|NCT01529892|Adrenergic Agents|adrenergic agents|mesh-ancestor
110064928|NCT01529892|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110064929|NCT01529892|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110064930|NCT01529892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110064931|NCT01529892|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110064932|NCT01529957|Nemonoxacin|nemonoxacin|mesh-list
110064933|NCT01529957|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110064934|NCT01529957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110064935|NCT01530022|Lacosamide|lacosamide|mesh-list
110064936|NCT01530022|Carbamazepine|carbamazepine|mesh-list
110064937|NCT01530022|Anticonvulsants|anticonvulsants|mesh-ancestor
110064938|NCT01530022|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110064939|NCT01530022|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110064940|NCT01530022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110064941|NCT01530022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110064942|NCT01530022|Antimanic Agents|antimanic agents|mesh-ancestor
110064943|NCT01530022|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110064944|NCT01530022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110064945|NCT01530022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110064946|NCT01530022|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110064947|NCT01530022|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110064948|NCT01530022|Analgesics|analgesics|mesh-ancestor
110387526|NCT04047628|Immunologic Factors|immunologic factors|mesh-ancestor
110064949|NCT01530022|Sensory System Agents|sensory system agents|mesh-ancestor
110064950|NCT01530022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110064951|NCT01530022|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110064952|NCT01530022|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110064954|NCT01530048|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110064955|NCT01530048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110064956|NCT01530126|Becaplermin|becaplermin|mesh-list
110064957|NCT01530126|Anticoagulants|anticoagulants|mesh-ancestor
110064958|NCT01530126|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
110064959|NCT01530126|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110064960|NCT01530126|Growth Substances|growth substances|mesh-ancestor
110064961|NCT01530126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110064963|NCT01530152|Anesthetics, Local|anesthetics, local|mesh-ancestor
110064964|NCT01530152|Anesthetics|anesthetics|mesh-ancestor
110064965|NCT01530152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110064966|NCT01530152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110064967|NCT01530152|Sensory System Agents|sensory system agents|mesh-ancestor
110064968|NCT01530152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110064969|NCT01530152|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110064970|NCT01530152|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110064971|NCT01530152|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110064972|NCT01530152|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110064973|NCT01530152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110064975|NCT01530217|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110064976|NCT01530217|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110064977|NCT01530217|Analgesics|analgesics|mesh-ancestor
110064978|NCT01530217|Sensory System Agents|sensory system agents|mesh-ancestor
110064979|NCT01530217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110064980|NCT01530217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110064981|NCT01530217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110064982|NCT01530217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110064983|NCT01530217|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110387644|NCT03950817|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110387645|NCT03950817|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110387646|NCT03950817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110387647|NCT03950817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110387649|NCT03943901|Cyclophosphamide|cyclophosphamide|mesh-list
110387650|NCT03943901|Rituximab|rituximab|mesh-list
110387651|NCT03943901|Doxorubicin|doxorubicin|mesh-list
110387652|NCT03943901|Vincristine|vincristine|mesh-list
110387653|NCT03943901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110387654|NCT03943901|Immunologic Factors|immunologic factors|mesh-ancestor
110387655|NCT03943901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110387656|NCT03943901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110387657|NCT03943901|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110387658|NCT03943901|Alkylating Agents|alkylating agents|mesh-ancestor
110387660|NCT03943901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110064985|NCT01530217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110064987|NCT01530230|Oxytocics|oxytocics|mesh-ancestor
110064988|NCT01530230|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110064989|NCT01530230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110064990|NCT01530295|Docetaxel|docetaxel|mesh-list
110064991|NCT01530295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110064992|NCT01530295|Tubulin Modulators|tubulin modulators|mesh-ancestor
110064993|NCT01530295|Antimitotic Agents|antimitotic agents|mesh-ancestor
110064994|NCT01530295|Mitosis Modulators|mitosis modulators|mesh-ancestor
110064995|NCT01530295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110064996|NCT01530308|Dopamine|dopamine|mesh-list
110064997|NCT01530308|Haloperidol|haloperidol|mesh-list
110064998|NCT01530308|Haloperidol decanoate|haloperidol decanoate|mesh-list
110064999|NCT01530308|Antipsychotic Agents|antipsychotic agents|mesh-list
110065000|NCT01530308|Dopamine Antagonists|dopamine antagonists|mesh-list
110065001|NCT01530308|Antiemetics|antiemetics|mesh-ancestor
110065002|NCT01530308|Autonomic Agents|autonomic agents|mesh-ancestor
110065003|NCT01530308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110065004|NCT01530308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110065005|NCT01530308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110065006|NCT01530308|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110065007|NCT01530308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110065008|NCT01530308|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110065009|NCT01530308|Dopamine Agents|dopamine agents|mesh-ancestor
110065010|NCT01530308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110065011|NCT01530308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110065012|NCT01530308|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110065013|NCT01530308|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110387704|NCT03913195|Ibalizumab|ibalizumab|mesh-list
110387705|NCT03913195|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110387709|NCT03912428|Celecoxib|celecoxib|mesh-list
110065014|NCT01530308|Sympathomimetics|sympathomimetics|mesh-ancestor
110065015|NCT01530308|Protective Agents|protective agents|mesh-ancestor
110065016|NCT01530386|Lacosamide|lacosamide|mesh-list
110065017|NCT01530386|Anticonvulsants|anticonvulsants|mesh-ancestor
110065018|NCT01530386|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110065019|NCT01530386|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110368808|NCT00553943|Cytarabine|cytarabine|mesh-list
110065020|NCT01530386|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110065021|NCT01530386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110065022|NCT01530438|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110065023|NCT01530438|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110065024|NCT01530438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110065025|NCT01530451|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
110065026|NCT01530451|Hemostatics|hemostatics|mesh-ancestor
110065027|NCT01530451|Coagulants|coagulants|mesh-ancestor
110065028|NCT01530451|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
110065029|NCT01530451|Natriuretic Agents|natriuretic agents|mesh-ancestor
110065030|NCT01530451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110065031|NCT01530490|Cabergoline|cabergoline|mesh-list
110065032|NCT01530490|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
110065033|NCT01530490|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110065034|NCT01530490|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110065035|NCT01530490|Dopamine Agonists|dopamine agonists|mesh-ancestor
110065037|NCT01530490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110065038|NCT01530490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110065039|NCT01530490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110065040|NCT01530490|Plasma Substitutes|plasma substitutes|mesh-ancestor
110065041|NCT01530490|Blood Substitutes|blood substitutes|mesh-ancestor
110065042|NCT01530503|Capecitabine|capecitabine|mesh-list
110065043|NCT01530503|Mitomycins|mitomycins|mesh-list
110065044|NCT01530503|Mitomycin|mitomycin|mesh-list
110065045|NCT01530503|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110065046|NCT01530503|Antimetabolites|antimetabolites|mesh-ancestor
110065047|NCT01530503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110387883|NCT03704688|Trametinib|trametinib|mesh-list
110065048|NCT01530503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110065049|NCT01530503|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110065050|NCT01530503|Alkylating Agents|alkylating agents|mesh-ancestor
110065051|NCT01530503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110065052|NCT01530503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110065054|NCT01530542|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110065055|NCT01530542|Narcotics|narcotics|mesh-ancestor
110065056|NCT01530542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110065057|NCT01530542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110065058|NCT01530542|Analgesics|analgesics|mesh-ancestor
110065059|NCT01530542|Sensory System Agents|sensory system agents|mesh-ancestor
110065060|NCT01530542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110065061|NCT01530555|Thymoglobulin|thymoglobulin|mesh-list
110065062|NCT01530555|Immunologic Factors|immunologic factors|mesh-ancestor
110065063|NCT01530555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110065064|NCT01530555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110065065|NCT01530594|Lenalidomide|lenalidomide|mesh-list
110065066|NCT01530594|Bortezomib|bortezomib|mesh-list
110065067|NCT01530594|Immunologic Factors|immunologic factors|mesh-ancestor
110065068|NCT01530594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110065069|NCT01530594|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110065070|NCT01530594|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110065071|NCT01530594|Growth Substances|growth substances|mesh-ancestor
110065072|NCT01530594|Growth Inhibitors|growth inhibitors|mesh-ancestor
110065073|NCT01530594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110065074|NCT01530607|Cyclophosphamide|cyclophosphamide|mesh-list
110065076|NCT01530607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110065077|NCT01530607|Immunologic Factors|immunologic factors|mesh-ancestor
110065078|NCT01530607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110065079|NCT01530607|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110065080|NCT01530607|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110065081|NCT01530607|Alkylating Agents|alkylating agents|mesh-ancestor
110065082|NCT01530607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110065083|NCT01530607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110065084|NCT01530607|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110065085|NCT01530607|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110065086|NCT01530620|Propiverine|propiverine|mesh-list
110065087|NCT01530620|Parasympatholytics|parasympatholytics|mesh-ancestor
110065088|NCT01530620|Autonomic Agents|autonomic agents|mesh-ancestor
110065089|NCT01530620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110065090|NCT01530620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110065091|NCT01530620|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110065092|NCT01530620|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110065093|NCT01530620|Cholinergic Agents|cholinergic agents|mesh-ancestor
110065094|NCT01530620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110368809|NCT00553943|Rituximab|rituximab|mesh-list
110065095|NCT01530620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110065097|NCT01530698|Vaccines|vaccines|mesh-list
110388022|NCT03562507|Nivolumab|nivolumab|mesh-list
110065098|NCT01530698|Immunologic Factors|immunologic factors|mesh-ancestor
110065099|NCT01530698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110065100|NCT01530711|Terlipressin|terlipressin|mesh-list
110065101|NCT01530711|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110065102|NCT01530711|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110065103|NCT01530737|Antithrombins|antithrombins|mesh-list
110065104|NCT01530737|Antithrombin III|antithrombin iii|mesh-list
110065105|NCT01530737|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110065106|NCT01530737|Protease Inhibitors|protease inhibitors|mesh-ancestor
110065107|NCT01530737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110065108|NCT01530737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110065109|NCT01530737|Anticoagulants|anticoagulants|mesh-ancestor
110065110|NCT01530763|Amoxicillin|amoxicillin|mesh-list
110065111|NCT01530763|Ceftriaxone|ceftriaxone|mesh-list
110065112|NCT01530763|Clavulanic Acid|clavulanic acid|mesh-list
110065113|NCT01530763|Clavulanic Acids|clavulanic acids|mesh-list
110065114|NCT01530763|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
110065115|NCT01530763|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
110065116|NCT01530763|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110065117|NCT01530763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110065118|NCT01530763|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110065119|NCT01530763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110065120|NCT01530763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110065121|NCT01530815|Bupivacaine|bupivacaine|mesh-list
110065122|NCT01530815|Anesthetics, Local|anesthetics, local|mesh-ancestor
110065123|NCT01530815|Anesthetics|anesthetics|mesh-ancestor
110065124|NCT01530815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110065125|NCT01530815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110065126|NCT01530815|Sensory System Agents|sensory system agents|mesh-ancestor
110065127|NCT01530815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110065128|NCT01530984|Ipilimumab|ipilimumab|mesh-list
110065129|NCT01530984|Sargramostim|sargramostim|mesh-list
110065130|NCT01530984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110065131|NCT01530984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110065132|NCT01530984|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110065133|NCT01530984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110065134|NCT01530984|Immunologic Factors|immunologic factors|mesh-ancestor
110065135|NCT01530984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110065136|NCT01531049|Nicotine|nicotine|mesh-list
110065137|NCT01531049|Varenicline|varenicline|mesh-list
110065138|NCT01531049|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110065139|NCT01531049|Autonomic Agents|autonomic agents|mesh-ancestor
110065140|NCT01531049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110065141|NCT01531049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110065142|NCT01531049|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110065143|NCT01531049|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110065144|NCT01531049|Cholinergic Agents|cholinergic agents|mesh-ancestor
110065145|NCT01531049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110065146|NCT01531049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110065147|NCT01531114|Ticagrelor|ticagrelor|mesh-list
110065148|NCT01531114|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
110065149|NCT01531114|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110065150|NCT01531114|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110065151|NCT01531114|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110065152|NCT01531114|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110388119|NCT03457142|Hormones|hormones|mesh-ancestor
110065153|NCT01531114|Purinergic Agents|purinergic agents|mesh-ancestor
110065154|NCT01531114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110065155|NCT01531114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110065156|NCT01531114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110065158|NCT01531140|Senna Extract|senna extract|mesh-list
110065159|NCT01531140|Sennosides|sennosides|mesh-list
110065160|NCT01531140|Cathartics|cathartics|mesh-ancestor
110065161|NCT01531140|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110065162|NCT01531140|Laxatives|laxatives|mesh-ancestor
110065163|NCT01531166|Interferons|interferons|mesh-list
110065164|NCT01531166|Interferon-alpha|interferon-alpha|mesh-list
110065165|NCT01531166|Interferon alpha-2|interferon alpha-2|mesh-list
110065166|NCT01531166|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110065167|NCT01531166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110065168|NCT01531166|Antiviral Agents|antiviral agents|mesh-ancestor
110065169|NCT01531166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110065170|NCT01531166|Immunologic Factors|immunologic factors|mesh-ancestor
110065171|NCT01531166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110065172|NCT01531192|Nystatin|nystatin|mesh-list
110065173|NCT01531192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110388162|NCT03399773|Alkylating Agents|alkylating agents|mesh-ancestor
110065174|NCT01531192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110065175|NCT01531192|Antifungal Agents|antifungal agents|mesh-ancestor
110065176|NCT01531192|Ionophores|ionophores|mesh-ancestor
110065177|NCT01531192|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110065178|NCT01531192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110065179|NCT01531218|Azithromycin|azithromycin|mesh-list
110065180|NCT01531218|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110065181|NCT01531218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110065182|NCT01531244|Dactinomycin|dactinomycin|mesh-list
110065183|NCT01531244|Cactinomycin|cactinomycin|mesh-list
110065184|NCT01531244|Melphalan|melphalan|mesh-list
110065185|NCT01531244|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110065186|NCT01531244|Alkylating Agents|alkylating agents|mesh-ancestor
110065187|NCT01531244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110065188|NCT01531244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110065189|NCT01531244|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110065190|NCT01531244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110065191|NCT01531244|Immunologic Factors|immunologic factors|mesh-ancestor
110065192|NCT01531244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110065193|NCT01531244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110065194|NCT01531244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110065195|NCT01531244|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110065196|NCT01531244|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110065197|NCT01531244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110065198|NCT01531244|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110065199|NCT01531309|Agomelatine|agomelatine|mesh-list
110065200|NCT01531309|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110065201|NCT01531309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110065202|NCT01531309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110065203|NCT01531322|Vaccines|vaccines|mesh-list
110065204|NCT01531322|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110065205|NCT01531322|Immunologic Factors|immunologic factors|mesh-ancestor
110065206|NCT01531322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110065207|NCT01531361|Sorafenib|sorafenib|mesh-list
110065208|NCT01531361|Vemurafenib|vemurafenib|mesh-list
110065209|NCT01531361|Crizotinib|crizotinib|mesh-list
110065210|NCT01531361|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
110065211|NCT01531361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110065212|NCT01531361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110065213|NCT01531361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110065214|NCT01531361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110065215|NCT01531452|Oxaliplatin|oxaliplatin|mesh-list
110065216|NCT01531452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110065217|NCT01531517|Pantothenic Acid|pantothenic acid|mesh-list
110065218|NCT01531517|Propolis|propolis|mesh-list
110065219|NCT01531517|Vitamin B Complex|vitamin b complex|mesh-ancestor
110065220|NCT01531517|Vitamins|vitamins|mesh-ancestor
110065221|NCT01531517|Micronutrients|micronutrients|mesh-ancestor
110065222|NCT01531517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110065223|NCT01531517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110065224|NCT01531569|Secoisolariciresinol|secoisolariciresinol|mesh-list
110065225|NCT01531569|Phytoestrogens|phytoestrogens|mesh-ancestor
110065226|NCT01531569|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
110065227|NCT01531569|Estrogens|estrogens|mesh-ancestor
110065228|NCT01531569|Hormones|hormones|mesh-ancestor
110065229|NCT01531569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110065230|NCT01531569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110065231|NCT01531595|Bevacizumab|bevacizumab|mesh-list
110065232|NCT01531595|Oxaliplatin|oxaliplatin|mesh-list
110065233|NCT01531595|Irinotecan|irinotecan|mesh-list
110065234|NCT01531595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110065235|NCT01531595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110065236|NCT01531595|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110065237|NCT01531595|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110065238|NCT01531595|Growth Substances|growth substances|mesh-ancestor
110065239|NCT01531595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110065240|NCT01531595|Growth Inhibitors|growth inhibitors|mesh-ancestor
110065241|NCT01531595|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110065242|NCT01531595|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110065243|NCT01531595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110065244|NCT01531595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110065245|NCT01531647|Ritonavir|ritonavir|mesh-list
110065246|NCT01531647|Raltegravir Potassium|raltegravir potassium|mesh-list
110065247|NCT01531647|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110065248|NCT01531647|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110065249|NCT01531647|Protease Inhibitors|protease inhibitors|mesh-ancestor
110065250|NCT01531647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110065251|NCT01531647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110065252|NCT01531647|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110065253|NCT01531647|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110065254|NCT01531647|Antiviral Agents|antiviral agents|mesh-ancestor
110065255|NCT01531647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110065256|NCT01531647|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110065257|NCT01531647|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110065258|NCT01531647|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110065259|NCT01531647|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110065260|NCT01531712|Gemcitabine|gemcitabine|mesh-list
110065261|NCT01531712|Oxaliplatin|oxaliplatin|mesh-list
110388367|NCT03202628|Antiemetics|antiemetics|mesh-ancestor
110065262|NCT01531712|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110065263|NCT01531712|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110065264|NCT01531712|Antimetabolites|antimetabolites|mesh-ancestor
110065265|NCT01531712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110065266|NCT01531712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110065267|NCT01531712|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110065268|NCT01531712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110065270|NCT01531764|Afatinib|afatinib|mesh-list
110065271|NCT01531764|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110065272|NCT01531764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110065273|NCT01531764|Tubulin Modulators|tubulin modulators|mesh-ancestor
110065274|NCT01531764|Antimitotic Agents|antimitotic agents|mesh-ancestor
110065275|NCT01531764|Mitosis Modulators|mitosis modulators|mesh-ancestor
110065276|NCT01531764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110065277|NCT01531764|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110065278|NCT01531764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110065279|NCT01531777|Apatinib|apatinib|mesh-list
110065280|NCT01531777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110065281|NCT01531777|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110065282|NCT01531777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110065283|NCT01531777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110065284|NCT01531790|Carboplatin|carboplatin|mesh-list
110065285|NCT01531790|Pemetrexed|pemetrexed|mesh-list
110065286|NCT01531790|Endostar protein|endostar protein|mesh-list
110065287|NCT01531790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110065288|NCT01531790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110065289|NCT01531790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110065290|NCT01531790|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110065291|NCT01531790|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110065292|NCT01531790|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110065293|NCT01531790|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110065294|NCT01531790|Growth Substances|growth substances|mesh-ancestor
110065295|NCT01531790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110065296|NCT01531790|Growth Inhibitors|growth inhibitors|mesh-ancestor
110065297|NCT01531829|Heparin|heparin|mesh-list
110065298|NCT01531829|Plasminogen|plasminogen|mesh-list
110065299|NCT01531829|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
110065300|NCT01531829|Tinzaparin|tinzaparin|mesh-list
110065301|NCT01531829|Dalteparin|dalteparin|mesh-list
110065302|NCT01531829|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
110065303|NCT01531829|Nadroparin|nadroparin|mesh-list
110065304|NCT01531829|Anticoagulants|anticoagulants|mesh-ancestor
110065305|NCT01531829|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110065306|NCT01531829|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110065307|NCT01531829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110065308|NCT01531842|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110065309|NCT01531842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110065310|NCT01531855|Insulin|insulin|mesh-list
110065311|NCT01531855|Insulin Lispro|insulin lispro|mesh-list
110065312|NCT01531855|Insulin, Short-Acting|insulin, short-acting|mesh-list
110065313|NCT01531855|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110065314|NCT01531855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110065315|NCT01531920|Ethanol|ethanol|mesh-list
110065316|NCT01531920|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110065317|NCT01531920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110065318|NCT01531920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110065319|NCT01531920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110065320|NCT01532011|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110065321|NCT01532011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110388575|NCT02964182|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110388576|NCT02964182|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110388577|NCT02964182|Cholinergic Agents|cholinergic agents|mesh-ancestor
110065322|NCT01532011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110065324|NCT01532011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110065325|NCT01532076|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
110065326|NCT01532076|Hemostatics|hemostatics|mesh-ancestor
110065327|NCT01532076|Coagulants|coagulants|mesh-ancestor
110065328|NCT01532102|Antiviral Agents|antiviral agents|mesh-list
110065329|NCT01532102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110065330|NCT01532115|Moxifloxacin|moxifloxacin|mesh-list
110065331|NCT01532115|Opicapone|opicapone|mesh-list
110065332|NCT01532115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110065333|NCT01532115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110065334|NCT01532115|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110065335|NCT01532115|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110065336|NCT01532115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110065337|NCT01532115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110065338|NCT01532115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110065339|NCT01532115|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
110065340|NCT01532115|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110065341|NCT01532115|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110065342|NCT01532154|4-Aminopyridine|4-aminopyridine|mesh-list
110065343|NCT01532154|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
110065344|NCT01532154|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110065345|NCT01532154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110065346|NCT01532232|Varenicline|varenicline|mesh-list
110065347|NCT01532232|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110065348|NCT01532232|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110065349|NCT01532232|Cholinergic Agents|cholinergic agents|mesh-ancestor
110065350|NCT01532232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110065351|NCT01532232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110065352|NCT01532232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110065353|NCT01532297|Dialysis Solutions|dialysis solutions|mesh-list
110065354|NCT01532297|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110065355|NCT01532336|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110065356|NCT01532466|Rocuronium|rocuronium|mesh-list
110065357|NCT01532466|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110065358|NCT01532466|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110065359|NCT01532466|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110065360|NCT01532466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110065361|NCT01532466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110065362|NCT01532544|Heparin|heparin|mesh-list
110065363|NCT01532544|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
110065364|NCT01532544|Tinzaparin|tinzaparin|mesh-list
110065365|NCT01532544|Dalteparin|dalteparin|mesh-list
110065366|NCT01532544|Eptifibatide|eptifibatide|mesh-list
110388772|NCT02784496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110388773|NCT02784496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110388779|NCT02763566|Letrozole|letrozole|mesh-list
110388780|NCT02763566|Fulvestrant|fulvestrant|mesh-list
110388781|NCT02763566|Anastrozole|anastrozole|mesh-list
110388782|NCT02763566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110065367|NCT01532544|Anticoagulants|anticoagulants|mesh-ancestor
110065368|NCT01532544|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110065369|NCT01532544|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110065370|NCT01532544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110065371|NCT01532544|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110065372|NCT01532674|Anti-Infective Agents|anti-infective agents|mesh-list
110065373|NCT01532674|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110065374|NCT01532726|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
110065376|NCT01532726|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110065377|NCT01532726|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110065378|NCT01532726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110065379|NCT01532726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110065381|NCT01532804|Oxaliplatin|oxaliplatin|mesh-list
110065382|NCT01532804|Raltitrexed|raltitrexed|mesh-list
110388827|NCT02739035|Dexamethasone|dexamethasone|mesh-list
110065383|NCT01532804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110065384|NCT01532804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110065385|NCT01532804|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110065386|NCT01532804|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110065387|NCT01532804|Growth Substances|growth substances|mesh-ancestor
110065388|NCT01532804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110065389|NCT01532804|Growth Inhibitors|growth inhibitors|mesh-ancestor
110065390|NCT01532804|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110065391|NCT01532804|Antimetabolites|antimetabolites|mesh-ancestor
110065392|NCT01532804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110065393|NCT01532804|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110065394|NCT01532804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110065395|NCT01532843|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110065396|NCT01532843|Antiviral Agents|antiviral agents|mesh-ancestor
110065397|NCT01532843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110065400|NCT01532856|Dexamethasone acetate|dexamethasone acetate|mesh-list
110065401|NCT01532856|Prednisone|prednisone|mesh-list
110065402|NCT01532856|Cyclophosphamide|cyclophosphamide|mesh-list
110065403|NCT01532856|Melphalan|melphalan|mesh-list
110065404|NCT01532856|BB 1101|bb 1101|mesh-list
110065405|NCT01532856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110065406|NCT01532856|Immunologic Factors|immunologic factors|mesh-ancestor
110065407|NCT01532856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110065408|NCT01532856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110065409|NCT01532856|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110065410|NCT01532856|Alkylating Agents|alkylating agents|mesh-ancestor
110065411|NCT01532856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110065412|NCT01532856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110065413|NCT01532856|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110065414|NCT01532856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110065415|NCT01532856|Antiemetics|antiemetics|mesh-ancestor
110065416|NCT01532856|Autonomic Agents|autonomic agents|mesh-ancestor
110065417|NCT01532856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110065418|NCT01532856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110065419|NCT01532856|Glucocorticoids|glucocorticoids|mesh-ancestor
110065420|NCT01532856|Hormones|hormones|mesh-ancestor
110065421|NCT01532856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110065422|NCT01532856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110388954|NCT02627846|Epinephryl borate|epinephryl borate|mesh-list
110065423|NCT01532856|Protease Inhibitors|protease inhibitors|mesh-ancestor
110065424|NCT01532856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110065425|NCT01532856|Leprostatic Agents|leprostatic agents|mesh-ancestor
110065426|NCT01532856|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110065427|NCT01532856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110065428|NCT01532856|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110065429|NCT01532856|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110065431|NCT01532856|Growth Inhibitors|growth inhibitors|mesh-ancestor
110065432|NCT01532895|Hydromorphone|hydromorphone|mesh-list
110065433|NCT01532895|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110065434|NCT01532895|Narcotics|narcotics|mesh-ancestor
110065435|NCT01532895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110065436|NCT01532895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110065437|NCT01532895|Analgesics|analgesics|mesh-ancestor
110065438|NCT01532895|Sensory System Agents|sensory system agents|mesh-ancestor
110065439|NCT01532895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110065440|NCT01532960|Poly ICLC|poly iclc|mesh-list
110065441|NCT01532960|Interferon Inducers|interferon inducers|mesh-ancestor
110065442|NCT01532960|Immunologic Factors|immunologic factors|mesh-ancestor
110065443|NCT01532960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110065444|NCT01533090|Bisacodyl|bisacodyl|mesh-list
110065445|NCT01533090|Cathartics|cathartics|mesh-ancestor
110065446|NCT01533090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110065447|NCT01533090|Laxatives|laxatives|mesh-ancestor
110065448|NCT01533129|Testosterone|testosterone|mesh-list
110065449|NCT01533129|Androgens|androgens|mesh-ancestor
110065450|NCT01533129|Hormones|hormones|mesh-ancestor
110065451|NCT01533129|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110065452|NCT01533129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110065453|NCT01533155|Quinidine|quinidine|mesh-list
110065454|NCT01533155|Quinidine gluconate|quinidine gluconate|mesh-list
110065455|NCT01533155|Morphine|morphine|mesh-list
110065456|NCT01533155|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110065457|NCT01533155|Narcotics|narcotics|mesh-ancestor
110065458|NCT01533155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110389077|NCT02542293|Cisplatin|cisplatin|mesh-list
110065459|NCT01533155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110065460|NCT01533155|Analgesics|analgesics|mesh-ancestor
110065461|NCT01533155|Sensory System Agents|sensory system agents|mesh-ancestor
110065462|NCT01533155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110065463|NCT01533155|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110065464|NCT01533155|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110065465|NCT01533155|Adrenergic Agents|adrenergic agents|mesh-ancestor
110065466|NCT01533155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110065467|NCT01533155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110065468|NCT01533155|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110065469|NCT01533155|Antimalarials|antimalarials|mesh-ancestor
110065470|NCT01533155|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110065471|NCT01533155|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110065472|NCT01533155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110065473|NCT01533155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110065474|NCT01533155|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110065475|NCT01533155|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110065476|NCT01533155|Cholinergic Agents|cholinergic agents|mesh-ancestor
110065477|NCT01533155|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110065478|NCT01533155|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110065479|NCT01533155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110065480|NCT01533155|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110065481|NCT01533155|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110065482|NCT01533220|Pheniramine|pheniramine|mesh-list
110065483|NCT01533220|Naphazoline|naphazoline|mesh-list
110065484|NCT01533220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110065485|NCT01533220|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110065486|NCT01533220|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110065487|NCT01533220|Adrenergic Agents|adrenergic agents|mesh-ancestor
110065488|NCT01533220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110065489|NCT01533220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110065490|NCT01533220|Nasal Decongestants|nasal decongestants|mesh-ancestor
110065491|NCT01533220|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110065492|NCT01533220|Respiratory System Agents|respiratory system agents|mesh-ancestor
110065493|NCT01533220|Antipruritics|antipruritics|mesh-ancestor
110389135|NCT02443077|Carmustine|carmustine|mesh-list
110065494|NCT01533220|Dermatologic Agents|dermatologic agents|mesh-ancestor
110065495|NCT01533220|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110065496|NCT01533220|Histamine Antagonists|histamine antagonists|mesh-ancestor
110065497|NCT01533220|Histamine Agents|histamine agents|mesh-ancestor
110065498|NCT01533220|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110065499|NCT01533272|Tenofovir|tenofovir|mesh-list
110065500|NCT01533272|Emtricitabine|emtricitabine|mesh-list
110065501|NCT01533272|Lopinavir|lopinavir|mesh-list
110065502|NCT01533272|Maraviroc|maraviroc|mesh-list
110065503|NCT01533272|Antiviral Agents|antiviral agents|mesh-ancestor
110065504|NCT01533272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110065505|NCT01533272|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110065506|NCT01533272|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110065507|NCT01533272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110065508|NCT01533272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110065509|NCT01533272|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110065510|NCT01533272|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110065511|NCT01533272|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110065512|NCT01533272|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110065513|NCT01533272|Protease Inhibitors|protease inhibitors|mesh-ancestor
110065514|NCT01533272|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110065515|NCT01533272|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110065516|NCT01533272|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110065517|NCT01533272|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110065518|NCT01533272|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
110065519|NCT01533324|Leucovorin|leucovorin|mesh-list
110065520|NCT01533324|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
110065521|NCT01533324|Antidotes|antidotes|mesh-ancestor
110065522|NCT01533324|Protective Agents|protective agents|mesh-ancestor
110065523|NCT01533324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110065524|NCT01533324|Vitamin B Complex|vitamin b complex|mesh-ancestor
110065525|NCT01533324|Vitamins|vitamins|mesh-ancestor
110065526|NCT01533324|Micronutrients|micronutrients|mesh-ancestor
110065527|NCT01533376|Timolol|timolol|mesh-list
110065528|NCT01533376|Lubricant Eye Drops|lubricant eye drops|mesh-list
110065529|NCT01533376|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110065530|NCT01533376|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110065531|NCT01533376|Adrenergic Agents|adrenergic agents|mesh-ancestor
110065532|NCT01533376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110065533|NCT01533376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110065534|NCT01533376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110065535|NCT01533376|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110065536|NCT01533376|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110065537|NCT01533376|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110065538|NCT01533376|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110065539|NCT01533389|Silodosin|silodosin|mesh-list
110065540|NCT01533389|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110065541|NCT01533389|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110065542|NCT01533389|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110065543|NCT01533389|Adrenergic Agents|adrenergic agents|mesh-ancestor
110065544|NCT01533389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110065545|NCT01533389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110065546|NCT01533389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110065547|NCT01533389|Urological Agents|urological agents|mesh-ancestor
110065548|NCT01533441|Vitamin K|vitamin k|mesh-list
110065549|NCT01533441|Vitamin K 2|vitamin k 2|mesh-list
110065550|NCT01533441|Vitamin K 1|vitamin k 1|mesh-list
110065551|NCT01533441|Vitamins|vitamins|mesh-ancestor
110065552|NCT01533441|Micronutrients|micronutrients|mesh-ancestor
110065553|NCT01533441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110065554|NCT01533441|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110065555|NCT01533441|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110065556|NCT01533441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110065557|NCT01533441|Hemostatics|hemostatics|mesh-ancestor
110065558|NCT01533441|Coagulants|coagulants|mesh-ancestor
110389174|NCT02437136|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110389175|NCT02437136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110389176|NCT02437136|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110065560|NCT01533506|Anticonvulsants|anticonvulsants|mesh-ancestor
110065561|NCT01533545|Epinephrine|epinephrine|mesh-list
110065562|NCT01533545|Mepivacaine|mepivacaine|mesh-list
110065563|NCT01533545|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110065564|NCT01533545|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110065565|NCT01533545|Adrenergic Agents|adrenergic agents|mesh-ancestor
110065566|NCT01533545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110065567|NCT01533545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110065568|NCT01533545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110065569|NCT01533545|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110065570|NCT01533545|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110065571|NCT01533545|Autonomic Agents|autonomic agents|mesh-ancestor
110065572|NCT01533545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110065573|NCT01533545|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110065574|NCT01533545|Respiratory System Agents|respiratory system agents|mesh-ancestor
110065575|NCT01533545|Mydriatics|mydriatics|mesh-ancestor
110065576|NCT01533545|Sympathomimetics|sympathomimetics|mesh-ancestor
110065577|NCT01533545|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110065578|NCT01533545|Anesthetics, Local|anesthetics, local|mesh-ancestor
110065579|NCT01533545|Anesthetics|anesthetics|mesh-ancestor
110065580|NCT01533545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110065581|NCT01533545|Sensory System Agents|sensory system agents|mesh-ancestor
110065582|NCT01533558|Caspofungin|caspofungin|mesh-list
110065583|NCT01533558|Antifungal Agents|antifungal agents|mesh-ancestor
110065584|NCT01533558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110065585|NCT01533558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110065586|NCT01533558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110065587|NCT01533662|Phenylephrine|phenylephrine|mesh-list
110065588|NCT01533662|Oxymetazoline|oxymetazoline|mesh-list
110065589|NCT01533662|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110065590|NCT01533662|Mydriatics|mydriatics|mesh-ancestor
110065591|NCT01533662|Autonomic Agents|autonomic agents|mesh-ancestor
110065592|NCT01533662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110065593|NCT01533662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110065594|NCT01533662|Sympathomimetics|sympathomimetics|mesh-ancestor
110065595|NCT01533662|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110065596|NCT01533662|Nasal Decongestants|nasal decongestants|mesh-ancestor
110065597|NCT01533662|Respiratory System Agents|respiratory system agents|mesh-ancestor
110065598|NCT01533662|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110065599|NCT01533662|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110065600|NCT01533662|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110065601|NCT01533662|Adrenergic Agents|adrenergic agents|mesh-ancestor
110065602|NCT01533662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110065603|NCT01533662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110065604|NCT01533662|Protective Agents|protective agents|mesh-ancestor
110065605|NCT01533675|Hydrogen Peroxide|hydrogen peroxide|mesh-list
110065606|NCT01533675|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110065607|NCT01533675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110065609|NCT01533740|Folic Acid|folic acid|mesh-list
110065610|NCT01533740|Bevacizumab|bevacizumab|mesh-list
110065611|NCT01533740|Fluorouracil|fluorouracil|mesh-list
110065612|NCT01533740|Irinotecan|irinotecan|mesh-list
110065613|NCT01533740|Levoleucovorin|levoleucovorin|mesh-list
110065614|NCT01533740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110065615|NCT01533740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110065616|NCT01533740|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110065617|NCT01533740|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110065618|NCT01533740|Growth Substances|growth substances|mesh-ancestor
110065619|NCT01533740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110065620|NCT01533740|Growth Inhibitors|growth inhibitors|mesh-ancestor
110065621|NCT01533740|Antimetabolites|antimetabolites|mesh-ancestor
110065622|NCT01533740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110065623|NCT01533740|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110065624|NCT01533740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110065625|NCT01533740|Immunologic Factors|immunologic factors|mesh-ancestor
110065626|NCT01533740|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110065627|NCT01533740|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110065628|NCT01533740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110065629|NCT01533740|Antidotes|antidotes|mesh-ancestor
110065630|NCT01533740|Protective Agents|protective agents|mesh-ancestor
110065631|NCT01533740|Vitamin B Complex|vitamin b complex|mesh-ancestor
110065632|NCT01533740|Vitamins|vitamins|mesh-ancestor
110065633|NCT01533740|Micronutrients|micronutrients|mesh-ancestor
110389186|NCT02421939|Cytarabine|cytarabine|mesh-list
110389187|NCT02421939|Fludarabine|fludarabine|mesh-list
110065634|NCT01533740|Hematinics|hematinics|mesh-ancestor
110065635|NCT01533818|Amoxicillin|amoxicillin|mesh-list
110065636|NCT01533818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110065637|NCT01533818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110065638|NCT01533870|Rifampin|rifampin|mesh-list
110065639|NCT01533870|Naloxegol|naloxegol|mesh-list
110065640|NCT01533870|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110065641|NCT01533870|Antitubercular Agents|antitubercular agents|mesh-ancestor
110065642|NCT01533870|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110065643|NCT01533870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110065644|NCT01533870|Leprostatic Agents|leprostatic agents|mesh-ancestor
110065645|NCT01533870|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110065646|NCT01533870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110065647|NCT01533870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110065648|NCT01533870|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110065649|NCT01533870|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110065650|NCT01533870|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110178350|NCT01807455|Lidocaine|lidocaine|mesh-list
110065651|NCT01533870|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110065652|NCT01533870|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110065653|NCT01533870|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110065654|NCT01533870|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110065655|NCT01533870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110065656|NCT01533870|Sensory System Agents|sensory system agents|mesh-ancestor
110065657|NCT01533870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110065658|NCT01534026|Aspirin|aspirin|mesh-list
110065659|NCT01534026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110065660|NCT01534026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110065661|NCT01534026|Analgesics|analgesics|mesh-ancestor
110065662|NCT01534026|Sensory System Agents|sensory system agents|mesh-ancestor
110065663|NCT01534026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110065664|NCT01534026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110065665|NCT01534026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110065666|NCT01534026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110065667|NCT01534026|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110065668|NCT01534026|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110065669|NCT01534026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110065670|NCT01534026|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110065671|NCT01534026|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110065672|NCT01534026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110065673|NCT01534026|Antipyretics|antipyretics|mesh-ancestor
110065674|NCT01534169|Dexamethasone|dexamethasone|mesh-list
110065675|NCT01534169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110065676|NCT01534169|Antiemetics|antiemetics|mesh-ancestor
110065677|NCT01534169|Autonomic Agents|autonomic agents|mesh-ancestor
110065678|NCT01534169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110065679|NCT01534169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110065680|NCT01534169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110065681|NCT01534169|Glucocorticoids|glucocorticoids|mesh-ancestor
110065682|NCT01534169|Hormones|hormones|mesh-ancestor
110065683|NCT01534169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110065684|NCT01534169|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110065685|NCT01534169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110065686|NCT01534247|Metronidazole|metronidazole|mesh-list
110065687|NCT01534247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110065688|NCT01534247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110065689|NCT01534247|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110065690|NCT01534247|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110065691|NCT01534312|Mesalamine|mesalamine|mesh-list
110065692|NCT01534312|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110065693|NCT01534312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110065694|NCT01534312|Analgesics|analgesics|mesh-ancestor
110065695|NCT01534312|Sensory System Agents|sensory system agents|mesh-ancestor
110065696|NCT01534312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110065697|NCT01534312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110065698|NCT01534312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110065699|NCT01534312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110065701|NCT01534442|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110065702|NCT01534442|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110065703|NCT01534442|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110065708|NCT01534442|Respiratory System Agents|respiratory system agents|mesh-ancestor
110065709|NCT01534442|Mydriatics|mydriatics|mesh-ancestor
110065710|NCT01534442|Parasympatholytics|parasympatholytics|mesh-ancestor
110065711|NCT01534442|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110065712|NCT01534442|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110065713|NCT01534442|Cholinergic Agents|cholinergic agents|mesh-ancestor
110065714|NCT01534442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110065715|NCT01534442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110065716|NCT01534455|Lapatinib|lapatinib|mesh-list
110065717|NCT01534455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110065718|NCT01534455|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110065719|NCT01534455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110065720|NCT01534455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110065725|NCT01534546|Capecitabine|capecitabine|mesh-list
110065727|NCT01534546|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110065728|NCT01534546|Antimetabolites|antimetabolites|mesh-ancestor
110065729|NCT01534546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110065730|NCT01534546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110065731|NCT01534585|Paclitaxel|paclitaxel|mesh-list
110065732|NCT01534585|Mitogens|mitogens|mesh-list
110065733|NCT01534585|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110065734|NCT01534585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110065735|NCT01534585|Tubulin Modulators|tubulin modulators|mesh-ancestor
110065736|NCT01534585|Antimitotic Agents|antimitotic agents|mesh-ancestor
110065737|NCT01534585|Mitosis Modulators|mitosis modulators|mesh-ancestor
110065738|NCT01534585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110065739|NCT01534702|Cytarabine|cytarabine|mesh-list
110065740|NCT01534702|Clofarabine|clofarabine|mesh-list
110065741|NCT01534702|Idarubicin|idarubicin|mesh-list
110065742|NCT01534702|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110065743|NCT01534702|Antimetabolites|antimetabolites|mesh-ancestor
110065744|NCT01534702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110065745|NCT01534702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110065747|NCT01534702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110065748|NCT01534702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110065749|NCT01534702|Immunologic Factors|immunologic factors|mesh-ancestor
110065750|NCT01534702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110065751|NCT01534702|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110065752|NCT01534702|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110065753|NCT01534702|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110065754|NCT01534702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110065755|NCT01534754|Mesalamine|mesalamine|mesh-list
110065756|NCT01534754|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110065757|NCT01534754|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110065758|NCT01534754|Analgesics|analgesics|mesh-ancestor
110065759|NCT01534754|Sensory System Agents|sensory system agents|mesh-ancestor
110065760|NCT01534754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110065761|NCT01534754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110065762|NCT01534754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110065763|NCT01534754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110065764|NCT01534806|Ketorolac|ketorolac|mesh-list
110065765|NCT01534806|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110065766|NCT01534806|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110065767|NCT01534806|Analgesics|analgesics|mesh-ancestor
110065768|NCT01534806|Sensory System Agents|sensory system agents|mesh-ancestor
110065769|NCT01534806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110065770|NCT01534806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110065771|NCT01534806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110389206|NCT02421939|Analgesics|analgesics|mesh-ancestor
110065772|NCT01534806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110065773|NCT01534806|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110065774|NCT01534806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110065775|NCT01534806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110065776|NCT01534845|Temozolomide|temozolomide|mesh-list
110065777|NCT01534845|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110065778|NCT01534845|Alkylating Agents|alkylating agents|mesh-ancestor
110065779|NCT01534845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110065780|NCT01534845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110065781|NCT01534858|Polihexanide|polihexanide|mesh-list
110065782|NCT01534858|Betaine|betaine|mesh-list
110065783|NCT01534858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110065784|NCT01534858|Lipotropic Agents|lipotropic agents|mesh-ancestor
110065785|NCT01534858|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110065786|NCT01534858|Antimetabolites|antimetabolites|mesh-ancestor
110065787|NCT01534858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110065788|NCT01534858|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110065789|NCT01534858|Disinfectants|disinfectants|mesh-ancestor
110065790|NCT01534858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110065791|NCT01534884|Rituximab|rituximab|mesh-list
110065792|NCT01534884|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110065793|NCT01534884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110065794|NCT01534884|Immunologic Factors|immunologic factors|mesh-ancestor
110065795|NCT01534884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110065796|NCT01534884|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110065798|NCT01534949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110065799|NCT01534949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110065800|NCT01534949|Immunologic Factors|immunologic factors|mesh-ancestor
110065801|NCT01534949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110065802|NCT01534949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110065803|NCT01535027|Alendronate|alendronate|mesh-list
110065804|NCT01535027|Teriparatide|teriparatide|mesh-list
110065805|NCT01535027|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
110065806|NCT01535027|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110065808|NCT01535027|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110065809|NCT01535027|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110065810|NCT01535027|Hormone Antagonists|hormone antagonists|mesh-ancestor
110065811|NCT01535027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110065812|NCT01535027|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110065813|NCT01535027|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110065814|NCT01535079|Ibuprofen|ibuprofen|mesh-list
110065815|NCT01535079|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110065816|NCT01535079|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110065817|NCT01535079|Analgesics|analgesics|mesh-ancestor
110065818|NCT01535079|Sensory System Agents|sensory system agents|mesh-ancestor
110065819|NCT01535079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110065820|NCT01535079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110065821|NCT01535079|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110065822|NCT01535079|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110065823|NCT01535079|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110065824|NCT01535079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110065825|NCT01535079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110065826|NCT01535092|Silybin|silybin|mesh-list
110065827|NCT01535092|Protective Agents|protective agents|mesh-ancestor
110065828|NCT01535092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110065829|NCT01535092|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110065830|NCT01535092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110065831|NCT01535157|Ketoconazole|ketoconazole|mesh-list
110065832|NCT01535157|Fenretinide|fenretinide|mesh-list
110065833|NCT01535157|Retinamide|retinamide|mesh-list
110065834|NCT01535157|Antifungal Agents|antifungal agents|mesh-ancestor
110065835|NCT01535157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110065836|NCT01535157|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110065837|NCT01535157|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110065838|NCT01535157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110065839|NCT01535157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110065840|NCT01535157|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110065841|NCT01535157|Hormone Antagonists|hormone antagonists|mesh-ancestor
110065842|NCT01535157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110065843|NCT01535157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110065844|NCT01535157|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110065845|NCT01535157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110065846|NCT01535157|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110065847|NCT01535157|Protective Agents|protective agents|mesh-ancestor
110065848|NCT01535170|Lactoferrin|lactoferrin|mesh-list
110065849|NCT01535170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110065851|NCT01535183|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110065852|NCT01535183|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110065854|NCT01535183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110065855|NCT01535183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110065856|NCT01535417|Celecoxib|celecoxib|mesh-list
110065857|NCT01535417|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110065858|NCT01535417|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110065859|NCT01535417|Analgesics|analgesics|mesh-ancestor
110065860|NCT01535417|Sensory System Agents|sensory system agents|mesh-ancestor
110065861|NCT01535417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110065862|NCT01535417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110065863|NCT01535417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110065864|NCT01535417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110065865|NCT01535417|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110065866|NCT01535417|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110065867|NCT01535417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110065868|NCT01535417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110065869|NCT01535469|Fluconazole|fluconazole|mesh-list
110065870|NCT01535469|Antifungal Agents|antifungal agents|mesh-ancestor
110065871|NCT01535469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110065872|NCT01535469|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110065873|NCT01535469|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110065874|NCT01535469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110065875|NCT01535469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110065876|NCT01535469|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110065877|NCT01535469|Hormone Antagonists|hormone antagonists|mesh-ancestor
110065878|NCT01535469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110065879|NCT01535469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110065880|NCT01535469|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110065881|NCT01535469|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110065882|NCT01535495|Propranolol|propranolol|mesh-list
110065883|NCT01535495|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110065884|NCT01535495|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110065885|NCT01535495|Adrenergic Agents|adrenergic agents|mesh-ancestor
110065886|NCT01535495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110065887|NCT01535495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110065888|NCT01535495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110065889|NCT01535495|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110065890|NCT01535495|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110065891|NCT01535495|Vasodilator Agents|vasodilator agents|mesh-ancestor
110065893|NCT01535547|Tacrolimus|tacrolimus|mesh-list
110065894|NCT01535547|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110065895|NCT01535547|Immunologic Factors|immunologic factors|mesh-ancestor
110065896|NCT01535547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110065897|NCT01535547|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110065898|NCT01535547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110065899|NCT01535547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110065900|NCT01535547|Antifungal Agents|antifungal agents|mesh-ancestor
110065901|NCT01535547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110065902|NCT01535612|Insulin|insulin|mesh-list
110065903|NCT01535612|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110065904|NCT01535612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110065905|NCT01535677|Metformin|metformin|mesh-list
110065906|NCT01535677|Dapagliflozin|dapagliflozin|mesh-list
110065907|NCT01535677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110065908|NCT01535677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110065909|NCT01535677|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110065910|NCT01535677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110065911|NCT01535690|Methylene Blue|methylene blue|mesh-list
110065912|NCT01535690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110065913|NCT01535690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110065914|NCT01535768|Travoprost|travoprost|mesh-list
110065915|NCT01535768|Brimonidine Tartrate|brimonidine tartrate|mesh-list
110065916|NCT01535768|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110065917|NCT01535768|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110065918|NCT01535768|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110065919|NCT01535768|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110065920|NCT01535768|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110065921|NCT01535768|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110065922|NCT01535768|Adrenergic Agents|adrenergic agents|mesh-ancestor
110065923|NCT01535768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110065924|NCT01535768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110065925|NCT01535768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110065927|NCT01535781|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110065928|NCT01535781|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110065929|NCT01535781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110065930|NCT01535781|Hemostatics|hemostatics|mesh-ancestor
110065931|NCT01535781|Coagulants|coagulants|mesh-ancestor
110065932|NCT01535820|Ortho Evra|ortho evra|mesh-list
110065933|NCT01535820|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110065934|NCT01535820|Contraceptive Agents|contraceptive agents|mesh-ancestor
110065935|NCT01535820|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110065936|NCT01535820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110065938|NCT01535859|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110065939|NCT01535859|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110065940|NCT01535859|Dopamine Agonists|dopamine agonists|mesh-ancestor
110065941|NCT01535859|Dopamine Agents|dopamine agents|mesh-ancestor
110065942|NCT01535859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110065943|NCT01535859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110065944|NCT01535859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110065945|NCT01535872|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
110065946|NCT01535872|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110065947|NCT01535872|Immunologic Factors|immunologic factors|mesh-ancestor
110065948|NCT01535872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110065949|NCT01535989|Sirolimus|sirolimus|mesh-list
110065950|NCT01535989|Temsirolimus|temsirolimus|mesh-list
110065951|NCT01535989|MTOR Inhibitors|mtor inhibitors|mesh-list
110065952|NCT01535989|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
110065953|NCT01535989|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110065954|NCT01535989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110065955|NCT01535989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110065956|NCT01535989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110065957|NCT01535989|Immunologic Factors|immunologic factors|mesh-ancestor
110065958|NCT01535989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110065959|NCT01535989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110065960|NCT01535989|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110065961|NCT01535989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110065962|NCT01535989|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110065963|NCT01535989|Antifungal Agents|antifungal agents|mesh-ancestor
110065964|NCT01535989|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110065965|NCT01535989|Immunotoxins|immunotoxins|mesh-ancestor
110065966|NCT01535989|Immunoconjugates|immunoconjugates|mesh-ancestor
110065967|NCT01536002|Propofol|propofol|mesh-list
110065968|NCT01536002|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110065969|NCT01536002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110065970|NCT01536002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110065971|NCT01536002|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110065972|NCT01536002|Anesthetics, General|anesthetics, general|mesh-ancestor
110065973|NCT01536002|Anesthetics|anesthetics|mesh-ancestor
110065974|NCT01536028|Insulin|insulin|mesh-list
110065975|NCT01536028|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110065976|NCT01536028|Insulin Aspart|insulin aspart|mesh-list
110065977|NCT01536028|Insulin, Long-Acting|insulin, long-acting|mesh-list
110065978|NCT01536028|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
110065979|NCT01536028|Biphasic Insulins|biphasic insulins|mesh-list
110065980|NCT01536028|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
110065981|NCT01536028|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110065982|NCT01536028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110065983|NCT01536054|Sirolimus|sirolimus|mesh-list
110065984|NCT01536054|Sargramostim|sargramostim|mesh-list
110065985|NCT01536054|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110065986|NCT01536054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110065987|NCT01536054|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110065988|NCT01536054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110065989|NCT01536054|Antifungal Agents|antifungal agents|mesh-ancestor
110065990|NCT01536054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110065991|NCT01536054|Immunologic Factors|immunologic factors|mesh-ancestor
110065992|NCT01536054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110065993|NCT01536132|Simendan|simendan|mesh-list
110065994|NCT01536132|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110065995|NCT01536132|Vasodilator Agents|vasodilator agents|mesh-ancestor
110065996|NCT01536132|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110065997|NCT01536132|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110065998|NCT01536132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110065999|NCT01536132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110066000|NCT01536132|Protective Agents|protective agents|mesh-ancestor
110066001|NCT01536132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110066003|NCT01536158|Ibuprofen|ibuprofen|mesh-list
110066004|NCT01536158|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110066005|NCT01536158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110066006|NCT01536158|Analgesics|analgesics|mesh-ancestor
110066007|NCT01536158|Sensory System Agents|sensory system agents|mesh-ancestor
110066008|NCT01536158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110066009|NCT01536158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110066010|NCT01536158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110066011|NCT01536158|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110066012|NCT01536158|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110066013|NCT01536158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110066014|NCT01536158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110066016|NCT01536223|Cisplatin|cisplatin|mesh-list
110066017|NCT01536223|Docetaxel|docetaxel|mesh-list
110066018|NCT01536223|Fluorouracil|fluorouracil|mesh-list
110066019|NCT01536223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110066020|NCT01536223|Tubulin Modulators|tubulin modulators|mesh-ancestor
110066021|NCT01536223|Antimitotic Agents|antimitotic agents|mesh-ancestor
110066022|NCT01536223|Mitosis Modulators|mitosis modulators|mesh-ancestor
110066023|NCT01536223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110066024|NCT01536223|Antimetabolites|antimetabolites|mesh-ancestor
110066025|NCT01536223|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110066026|NCT01536223|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110066027|NCT01536223|Immunologic Factors|immunologic factors|mesh-ancestor
110066028|NCT01536223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110066029|NCT01536249|Pramipexole|pramipexole|mesh-list
110066030|NCT01536249|Cimetidine|cimetidine|mesh-list
110066031|NCT01536249|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110066032|NCT01536249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110066033|NCT01536249|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110066034|NCT01536249|Histamine Antagonists|histamine antagonists|mesh-ancestor
110066035|NCT01536249|Histamine Agents|histamine agents|mesh-ancestor
110389240|NCT02390284|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110066036|NCT01536249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110066037|NCT01536249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110066038|NCT01536249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110066039|NCT01536249|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110066040|NCT01536249|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110066041|NCT01536249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110066043|NCT01536249|Protective Agents|protective agents|mesh-ancestor
110066044|NCT01536249|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110066045|NCT01536249|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110066046|NCT01536249|Dopamine Agonists|dopamine agonists|mesh-ancestor
110066047|NCT01536249|Dopamine Agents|dopamine agents|mesh-ancestor
110066048|NCT01536301|Morphine|morphine|mesh-list
110066049|NCT01536301|Oxycodone|oxycodone|mesh-list
110066050|NCT01536301|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110066051|NCT01536301|Narcotics|narcotics|mesh-ancestor
110066052|NCT01536301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110066053|NCT01536301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110066054|NCT01536301|Analgesics|analgesics|mesh-ancestor
110066055|NCT01536301|Sensory System Agents|sensory system agents|mesh-ancestor
110066056|NCT01536301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110066057|NCT01536314|Memantine|memantine|mesh-list
110066058|NCT01536314|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110066059|NCT01536314|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110066060|NCT01536314|Dopamine Agents|dopamine agents|mesh-ancestor
110066061|NCT01536314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110066062|NCT01536314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110066063|NCT01536314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110066064|NCT01536314|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110066065|NCT01536314|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110066066|NCT01536353|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
110066067|NCT01536353|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110066068|NCT01536431|Insulin|insulin|mesh-list
110066070|NCT01536431|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110066071|NCT01536431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110066072|NCT01536470|Norepinephrine|norepinephrine|mesh-list
110066073|NCT01536470|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110066074|NCT01536470|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110066075|NCT01536470|Adrenergic Agents|adrenergic agents|mesh-ancestor
110066076|NCT01536470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110066077|NCT01536470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110066078|NCT01536470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110066079|NCT01536470|Sympathomimetics|sympathomimetics|mesh-ancestor
110066080|NCT01536470|Autonomic Agents|autonomic agents|mesh-ancestor
110066081|NCT01536470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110066082|NCT01536470|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110066084|NCT01536600|Biphasic Insulins|biphasic insulins|mesh-list
110066085|NCT01536600|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
110066086|NCT01536600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110066087|NCT01536600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110066088|NCT01536613|Insulin Aspart|insulin aspart|mesh-list
110066089|NCT01536613|Biphasic Insulins|biphasic insulins|mesh-list
110066090|NCT01536613|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
110066091|NCT01536613|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110066092|NCT01536613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110066093|NCT01536626|Insulin Aspart|insulin aspart|mesh-list
110066094|NCT01536626|Biphasic Insulins|biphasic insulins|mesh-list
110066095|NCT01536626|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
110066096|NCT01536626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110066097|NCT01536626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110066098|NCT01536639|Insulin Aspart|insulin aspart|mesh-list
110066099|NCT01536639|Biphasic Insulins|biphasic insulins|mesh-list
110066100|NCT01536639|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
110066101|NCT01536639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110066102|NCT01536639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110066103|NCT01536652|Insulin Aspart|insulin aspart|mesh-list
110066104|NCT01536652|Biphasic Insulins|biphasic insulins|mesh-list
110066105|NCT01536652|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
110066106|NCT01536652|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110066107|NCT01536652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110066108|NCT01536665|Liraglutide|liraglutide|mesh-list
110066109|NCT01536665|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110066110|NCT01536665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110066111|NCT01536665|Incretins|incretins|mesh-ancestor
110066112|NCT01536665|Hormones|hormones|mesh-ancestor
110066113|NCT01536665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110066114|NCT01536691|Ondansetron|ondansetron|mesh-list
110066115|NCT01536691|Aprepitant|aprepitant|mesh-list
110066116|NCT01536691|Fosaprepitant|fosaprepitant|mesh-list
110066117|NCT01536691|Ramosetron|ramosetron|mesh-list
110066118|NCT01536691|Antiemetics|antiemetics|mesh-ancestor
110066119|NCT01536691|Autonomic Agents|autonomic agents|mesh-ancestor
110066120|NCT01536691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110066121|NCT01536691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110066122|NCT01536691|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110066123|NCT01536691|Antipruritics|antipruritics|mesh-ancestor
110066124|NCT01536691|Dermatologic Agents|dermatologic agents|mesh-ancestor
110066125|NCT01536691|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110066126|NCT01536691|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110066127|NCT01536691|Serotonin Agents|serotonin agents|mesh-ancestor
110066128|NCT01536691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110066129|NCT01536691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110066130|NCT01536691|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110066131|NCT01536717|Carticaine|carticaine|mesh-list
110066132|NCT01536717|Anesthetics, Local|anesthetics, local|mesh-ancestor
110066133|NCT01536717|Anesthetics|anesthetics|mesh-ancestor
110066134|NCT01536717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110066135|NCT01536717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110066136|NCT01536717|Sensory System Agents|sensory system agents|mesh-ancestor
110066137|NCT01536717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110066138|NCT01536743|Palbociclib|palbociclib|mesh-list
110066139|NCT01536743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110066140|NCT01536743|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110066141|NCT01536743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110066142|NCT01536743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110066143|NCT01536873|Dolutegravir|dolutegravir|mesh-list
110066144|NCT01536873|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110066145|NCT01536873|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110066146|NCT01536873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110066147|NCT01536873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110066148|NCT01536873|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110066149|NCT01536873|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110066150|NCT01536873|Antiviral Agents|antiviral agents|mesh-ancestor
110066151|NCT01536873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110066152|NCT01537055|Amoxicillin|amoxicillin|mesh-list
110066153|NCT01537055|Levofloxacin|levofloxacin|mesh-list
110066154|NCT01537055|Ofloxacin|ofloxacin|mesh-list
110066155|NCT01537055|Lansoprazole|lansoprazole|mesh-list
110066156|NCT01537055|Dexlansoprazole|dexlansoprazole|mesh-list
110066157|NCT01537055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110066158|NCT01537055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110066159|NCT01537055|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110066160|NCT01537055|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110066161|NCT01537055|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110066162|NCT01537055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110066163|NCT01537055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110066164|NCT01537055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110066165|NCT01537055|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110389258|NCT02356159|Immunologic Factors|immunologic factors|mesh-ancestor
110066166|NCT01537055|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110066167|NCT01537055|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110066168|NCT01537055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110066169|NCT01537055|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110066170|NCT01537094|Vitamins|vitamins|mesh-list
110066171|NCT01537094|Ascorbic Acid|ascorbic acid|mesh-list
110066172|NCT01537094|Micronutrients|micronutrients|mesh-ancestor
110066173|NCT01537094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110066174|NCT01537094|Antioxidants|antioxidants|mesh-ancestor
110066175|NCT01537094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110066176|NCT01537094|Protective Agents|protective agents|mesh-ancestor
110066177|NCT01537107|Sirolimus|sirolimus|mesh-list
110066178|NCT01537107|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110066179|NCT01537107|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110066180|NCT01537107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110066181|NCT01537107|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110066182|NCT01537107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110066183|NCT01537107|Antifungal Agents|antifungal agents|mesh-ancestor
110066184|NCT01537107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110066185|NCT01537107|Immunologic Factors|immunologic factors|mesh-ancestor
110066186|NCT01537107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110066187|NCT01537107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110066188|NCT01537107|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110066189|NCT01537146|Ropivacaine|ropivacaine|mesh-list
110066190|NCT01537146|Anesthetics, Local|anesthetics, local|mesh-ancestor
110066191|NCT01537146|Anesthetics|anesthetics|mesh-ancestor
110066192|NCT01537146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110066193|NCT01537146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110066194|NCT01537146|Sensory System Agents|sensory system agents|mesh-ancestor
110066195|NCT01537146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110066196|NCT01537250|Levofloxacin|levofloxacin|mesh-list
110066198|NCT01537250|Nemonoxacin|nemonoxacin|mesh-list
110066199|NCT01537250|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110066200|NCT01537250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110066201|NCT01537250|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110066202|NCT01537250|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110066203|NCT01537250|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110066204|NCT01537250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110066205|NCT01537250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110066206|NCT01537250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110066207|NCT01537250|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110066208|NCT01537250|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110066209|NCT01537354|Poractant alfa|poractant alfa|mesh-list
110066210|NCT01537354|Beractant|beractant|mesh-list
110066211|NCT01537354|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
110066212|NCT01537354|Respiratory System Agents|respiratory system agents|mesh-ancestor
110066213|NCT01537380|Cefazolin|cefazolin|mesh-list
110066214|NCT01537380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110066215|NCT01537380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110066216|NCT01537471|Meclizine|meclizine|mesh-list
110066217|NCT01537471|Dimenhydrinate|dimenhydrinate|mesh-list
110066218|NCT01537471|Antiemetics|antiemetics|mesh-ancestor
110066220|NCT01537471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110066221|NCT01537471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110066222|NCT01537471|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110066223|NCT01537471|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110066224|NCT01537471|Histamine Antagonists|histamine antagonists|mesh-ancestor
110066225|NCT01537471|Histamine Agents|histamine agents|mesh-ancestor
110066226|NCT01537471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110066227|NCT01537471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110066228|NCT01537471|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110066229|NCT01537471|Cholinergic Agents|cholinergic agents|mesh-ancestor
110066230|NCT01537471|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110066231|NCT01537575|Immunoglobulins|immunoglobulins|mesh-list
110066232|NCT01537575|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110066233|NCT01537575|Antibodies|antibodies|mesh-list
110066234|NCT01537575|gamma-Globulins|gamma-globulins|mesh-list
110066235|NCT01537575|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110066236|NCT01537575|Immunologic Factors|immunologic factors|mesh-ancestor
110066237|NCT01537575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110066238|NCT01537640|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110066239|NCT01537640|Immunologic Factors|immunologic factors|mesh-ancestor
110066240|NCT01537640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110066241|NCT01537744|Azacitidine|azacitidine|mesh-list
110066242|NCT01537744|Romidepsin|romidepsin|mesh-list
110066243|NCT01537744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110066244|NCT01537744|Antimetabolites|antimetabolites|mesh-ancestor
110066245|NCT01537744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110066246|NCT01537744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110066247|NCT01537744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110066248|NCT01537744|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110066249|NCT01537744|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110066250|NCT01537770|Lidocaine|lidocaine|mesh-list
110066251|NCT01537770|Anesthetics, Local|anesthetics, local|mesh-ancestor
110066252|NCT01537770|Anesthetics|anesthetics|mesh-ancestor
110066253|NCT01537770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110066254|NCT01537770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110066255|NCT01537770|Sensory System Agents|sensory system agents|mesh-ancestor
110066256|NCT01537770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110066257|NCT01537770|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110178501|NCT00424138|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110066258|NCT01537770|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110066259|NCT01537770|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110066260|NCT01537770|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110066261|NCT01537770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110066262|NCT01537809|Vitamin D|vitamin d|mesh-list
110066263|NCT01537809|Ergocalciferols|ergocalciferols|mesh-list
110066264|NCT01537809|Cholecalciferol|cholecalciferol|mesh-list
110066265|NCT01537809|Vitamins|vitamins|mesh-list
110066266|NCT01537809|Micronutrients|micronutrients|mesh-ancestor
110066267|NCT01537809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110066268|NCT01537809|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110066269|NCT01537809|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110066270|NCT01537861|Thalidomide|thalidomide|mesh-list
110066271|NCT01537861|Dexamethasone|dexamethasone|mesh-list
110066272|NCT01537861|Cyclophosphamide|cyclophosphamide|mesh-list
110066273|NCT01537861|Lenalidomide|lenalidomide|mesh-list
110066274|NCT01537861|Bortezomib|bortezomib|mesh-list
110066275|NCT01537861|Pomalidomide|pomalidomide|mesh-list
110066276|NCT01537861|Lenograstim|lenograstim|mesh-list
110066277|NCT01537861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110066278|NCT01537861|Immunologic Factors|immunologic factors|mesh-ancestor
110066279|NCT01537861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110066281|NCT01537861|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110066282|NCT01537861|Alkylating Agents|alkylating agents|mesh-ancestor
110066283|NCT01537861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110066284|NCT01537861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110066285|NCT01537861|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110066286|NCT01537861|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110066287|NCT01537861|Antiemetics|antiemetics|mesh-ancestor
110066288|NCT01537861|Autonomic Agents|autonomic agents|mesh-ancestor
110066289|NCT01537861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110066290|NCT01537861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110066291|NCT01537861|Glucocorticoids|glucocorticoids|mesh-ancestor
110066292|NCT01537861|Hormones|hormones|mesh-ancestor
110066293|NCT01537861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110066294|NCT01537861|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110066295|NCT01537861|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110066296|NCT01537861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110066297|NCT01537861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110066298|NCT01537861|Growth Substances|growth substances|mesh-ancestor
110066299|NCT01537861|Growth Inhibitors|growth inhibitors|mesh-ancestor
110066300|NCT01537861|Leprostatic Agents|leprostatic agents|mesh-ancestor
110066301|NCT01537861|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110066302|NCT01537861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110066304|NCT01538095|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110066305|NCT01538095|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110066306|NCT01538095|Growth Substances|growth substances|mesh-ancestor
110066307|NCT01538095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110066308|NCT01538095|Growth Inhibitors|growth inhibitors|mesh-ancestor
110066309|NCT01538095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110066311|NCT01538108|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110066312|NCT01538108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110066313|NCT01538108|Tubulin Modulators|tubulin modulators|mesh-ancestor
110066314|NCT01538108|Antimitotic Agents|antimitotic agents|mesh-ancestor
110066315|NCT01538108|Mitosis Modulators|mitosis modulators|mesh-ancestor
110066316|NCT01538108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110066317|NCT01538225|Nabiximols|nabiximols|mesh-list
110066318|NCT01538225|Analgesics|analgesics|mesh-ancestor
110066319|NCT01538225|Sensory System Agents|sensory system agents|mesh-ancestor
110178511|NCT01806792|Vitamins|vitamins|mesh-ancestor
110066320|NCT01538225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110066321|NCT01538225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110066322|NCT01538316|Genistein|genistein|mesh-list
110066323|NCT01538316|Quercetin|quercetin|mesh-list
110066324|NCT01538316|Antioxidants|antioxidants|mesh-ancestor
110066325|NCT01538316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110066326|NCT01538316|Protective Agents|protective agents|mesh-ancestor
110066327|NCT01538316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110066328|NCT01538316|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110066329|NCT01538316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110066330|NCT01538316|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110066331|NCT01538316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110066332|NCT01538316|Phytoestrogens|phytoestrogens|mesh-ancestor
110066333|NCT01538316|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
110066334|NCT01538316|Estrogens|estrogens|mesh-ancestor
110066335|NCT01538316|Hormones|hormones|mesh-ancestor
110066336|NCT01538316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110066337|NCT01538329|Amantadine|amantadine|mesh-list
110066338|NCT01538329|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110066339|NCT01538329|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110066340|NCT01538329|Antiviral Agents|antiviral agents|mesh-ancestor
110066341|NCT01538329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110066342|NCT01538329|Dopamine Agents|dopamine agents|mesh-ancestor
110066343|NCT01538329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110066344|NCT01538329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110066345|NCT01538329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110066346|NCT01538329|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110066347|NCT01538329|Analgesics|analgesics|mesh-ancestor
110066348|NCT01538329|Sensory System Agents|sensory system agents|mesh-ancestor
110066349|NCT01538329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110066350|NCT01538381|Afatinib|afatinib|mesh-list
110066351|NCT01538381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110066352|NCT01538381|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110066353|NCT01538381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110066354|NCT01538381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110066355|NCT01538394|Nicotine|nicotine|mesh-list
110066356|NCT01538394|Varenicline|varenicline|mesh-list
110066357|NCT01538394|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110066358|NCT01538394|Autonomic Agents|autonomic agents|mesh-ancestor
110066359|NCT01538394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110066360|NCT01538394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110066361|NCT01538394|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110066362|NCT01538394|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110066363|NCT01538394|Cholinergic Agents|cholinergic agents|mesh-ancestor
110066364|NCT01538394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110389284|NCT02203526|Cytarabine|cytarabine|mesh-list
110066365|NCT01538394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110066367|NCT01538446|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
110066368|NCT01538446|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110066369|NCT01538446|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110066370|NCT01538446|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110066371|NCT01538446|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110066372|NCT01538446|Purinergic Agents|purinergic agents|mesh-ancestor
110066373|NCT01538446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110368550|NCT01165216|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110225452|NCT05962151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110066374|NCT01538446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110066375|NCT01538446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110066377|NCT01538459|Bupivacaine|bupivacaine|mesh-list
110066378|NCT01538459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110066379|NCT01538459|Antiemetics|antiemetics|mesh-ancestor
110066380|NCT01538459|Autonomic Agents|autonomic agents|mesh-ancestor
110066381|NCT01538459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110066382|NCT01538459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110066383|NCT01538459|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110066384|NCT01538459|Glucocorticoids|glucocorticoids|mesh-ancestor
110066385|NCT01538459|Hormones|hormones|mesh-ancestor
110066386|NCT01538459|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110066387|NCT01538459|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110066388|NCT01538459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110066389|NCT01538459|Anesthetics, Local|anesthetics, local|mesh-ancestor
110066391|NCT01538459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110066392|NCT01538459|Sensory System Agents|sensory system agents|mesh-ancestor
110066393|NCT01538485|Cholecalciferol|cholecalciferol|mesh-list
110066394|NCT01538485|Vitamin D|vitamin d|mesh-list
110066395|NCT01538485|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110066396|NCT01538485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110066397|NCT01538485|Vitamins|vitamins|mesh-ancestor
110066398|NCT01538485|Micronutrients|micronutrients|mesh-ancestor
110066399|NCT01538485|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110066400|NCT01538511|Insulin|insulin|mesh-list
110066401|NCT01538511|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110066402|NCT01538511|Insulin Aspart|insulin aspart|mesh-list
110066403|NCT01538511|Insulin, Long-Acting|insulin, long-acting|mesh-list
110066404|NCT01538511|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
110066405|NCT01538511|Biphasic Insulins|biphasic insulins|mesh-list
110066406|NCT01538511|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
110066407|NCT01538511|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110066408|NCT01538511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110066409|NCT01538537|ON 01910|on 01910|mesh-list
110066410|NCT01538537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110066411|NCT01538537|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110066412|NCT01538537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110066413|NCT01538537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110066414|NCT01538563|ON 01910|on 01910|mesh-list
110066416|NCT01538563|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110066417|NCT01538563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110066418|NCT01538563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110066419|NCT01538576|Insulin Aspart|insulin aspart|mesh-list
110066420|NCT01538576|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110066421|NCT01538576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110066422|NCT01538589|Insulin Aspart|insulin aspart|mesh-list
110066423|NCT01538589|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110066424|NCT01538589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110066425|NCT01538641|Rituximab|rituximab|mesh-list
110066426|NCT01538641|Gemcitabine|gemcitabine|mesh-list
110066427|NCT01538641|Oxaliplatin|oxaliplatin|mesh-list
110066428|NCT01538641|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110066429|NCT01538641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110066430|NCT01538641|Immunologic Factors|immunologic factors|mesh-ancestor
110066431|NCT01538641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110066432|NCT01538641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110066433|NCT01538641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110066434|NCT01538641|Antimetabolites|antimetabolites|mesh-ancestor
110066435|NCT01538641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110066436|NCT01538667|Ciprofloxacin|ciprofloxacin|mesh-list
110066437|NCT01538667|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110066438|NCT01538667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110066439|NCT01538667|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110066440|NCT01538667|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110066441|NCT01538667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110066442|NCT01538667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110066443|NCT01538667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110066444|NCT01538667|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110066445|NCT01538667|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110066446|NCT01538693|Cyproheptadine|cyproheptadine|mesh-list
110066447|NCT01538693|Dexetimide|dexetimide|mesh-list
110066448|NCT01538693|Citalopram|citalopram|mesh-list
110066449|NCT01538693|Escitalopram|escitalopram|mesh-list
110066450|NCT01538693|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110066451|NCT01538693|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110066452|NCT01538693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110066453|NCT01538693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110066455|NCT01538693|Serotonin Agents|serotonin agents|mesh-ancestor
110066456|NCT01538693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110066457|NCT01538693|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110066458|NCT01538693|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110066459|NCT01538693|Parasympatholytics|parasympatholytics|mesh-ancestor
110066460|NCT01538693|Autonomic Agents|autonomic agents|mesh-ancestor
110066461|NCT01538693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110066462|NCT01538693|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110066463|NCT01538693|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110066464|NCT01538693|Cholinergic Agents|cholinergic agents|mesh-ancestor
110066465|NCT01538693|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110066466|NCT01538693|Antidepressive Agents|antidepressive agents|mesh-ancestor
110066467|NCT01538693|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110066468|NCT01538693|Antipruritics|antipruritics|mesh-ancestor
110066469|NCT01538693|Dermatologic Agents|dermatologic agents|mesh-ancestor
110066470|NCT01538693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110066471|NCT01538693|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110066472|NCT01538693|Histamine Antagonists|histamine antagonists|mesh-ancestor
110066473|NCT01538693|Histamine Agents|histamine agents|mesh-ancestor
110066474|NCT01538693|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110066475|NCT01538693|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110066476|NCT01538732|Alitretinoin|alitretinoin|mesh-list
110066477|NCT01538732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110389316|NCT02199184|Ofatumumab|ofatumumab|mesh-list
110066478|NCT01538732|Dermatologic Agents|dermatologic agents|mesh-ancestor
110066479|NCT01538771|Darbepoetin alfa|darbepoetin alfa|mesh-list
110066480|NCT01538771|Hematinics|hematinics|mesh-ancestor
110066481|NCT01538797|Ranitidine|ranitidine|mesh-list
110066482|NCT01538797|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
110066483|NCT01538797|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110066484|NCT01538797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110066485|NCT01538797|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110066486|NCT01538797|Histamine Antagonists|histamine antagonists|mesh-ancestor
110066487|NCT01538797|Histamine Agents|histamine agents|mesh-ancestor
110066488|NCT01538797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110066489|NCT01538797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110066490|NCT01538797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110066492|NCT01538849|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110066493|NCT01538849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110066494|NCT01538849|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110066495|NCT01538849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110066496|NCT01538849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110066497|NCT01538875|Labetalol|labetalol|mesh-list
110066498|NCT01538875|Hydralazine|hydralazine|mesh-list
110066499|NCT01538875|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110066500|NCT01538875|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110066501|NCT01538875|Adrenergic Agents|adrenergic agents|mesh-ancestor
110066502|NCT01538875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110066503|NCT01538875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110066504|NCT01538875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110066505|NCT01538875|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110066506|NCT01538875|Sympathomimetics|sympathomimetics|mesh-ancestor
110066507|NCT01538875|Autonomic Agents|autonomic agents|mesh-ancestor
110066508|NCT01538875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110066509|NCT01538875|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110066510|NCT01538875|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110066511|NCT01538875|Vasodilator Agents|vasodilator agents|mesh-ancestor
110066513|NCT01538901|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110066514|NCT01538901|Immunologic Factors|immunologic factors|mesh-ancestor
110066515|NCT01538901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110066516|NCT01538901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110066517|NCT01538901|Interferon Inducers|interferon inducers|mesh-ancestor
110066518|NCT01538927|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
110066519|NCT01538927|Hemostatics|hemostatics|mesh-ancestor
110066520|NCT01538927|Coagulants|coagulants|mesh-ancestor
110066521|NCT01538940|Vaccines|vaccines|mesh-list
110066522|NCT01538940|Immunologic Factors|immunologic factors|mesh-ancestor
110066523|NCT01538940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110066524|NCT01538953|Sodium Hypochlorite|sodium hypochlorite|mesh-list
110066525|NCT01538953|Disinfectants|disinfectants|mesh-list
110066527|NCT01538953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110066528|NCT01539018|Sorafenib|sorafenib|mesh-list
110066529|NCT01539018|Tegafur|tegafur|mesh-list
110066530|NCT01539018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110066531|NCT01539018|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110066532|NCT01539018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110225453|NCT05962151|Analgesics|analgesics|mesh-ancestor
110066533|NCT01539018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110066534|NCT01539018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110066536|NCT01539044|Atropine|atropine|mesh-list
110066537|NCT01539044|Neostigmine|neostigmine|mesh-list
110066538|NCT01539044|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110066539|NCT01539044|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110066540|NCT01539044|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110066541|NCT01539044|Autonomic Agents|autonomic agents|mesh-ancestor
110066542|NCT01539044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110066543|NCT01539044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110066544|NCT01539044|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110066545|NCT01539044|Respiratory System Agents|respiratory system agents|mesh-ancestor
110066546|NCT01539044|Mydriatics|mydriatics|mesh-ancestor
110066547|NCT01539044|Parasympatholytics|parasympatholytics|mesh-ancestor
110066548|NCT01539044|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110066549|NCT01539044|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110066550|NCT01539044|Cholinergic Agents|cholinergic agents|mesh-ancestor
110066551|NCT01539044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110066552|NCT01539044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110066553|NCT01539044|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110066554|NCT01539044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110066555|NCT01539044|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110066556|NCT01539174|Prednisone|prednisone|mesh-list
110066557|NCT01539174|Cyclophosphamide|cyclophosphamide|mesh-list
110066558|NCT01539174|Rituximab|rituximab|mesh-list
110066559|NCT01539174|Doxorubicin|doxorubicin|mesh-list
110066560|NCT01539174|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110066561|NCT01539174|Vincristine|vincristine|mesh-list
110066562|NCT01539174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110066563|NCT01539174|Immunologic Factors|immunologic factors|mesh-ancestor
110066564|NCT01539174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110066565|NCT01539174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110066566|NCT01539174|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110066567|NCT01539174|Alkylating Agents|alkylating agents|mesh-ancestor
110066568|NCT01539174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110066569|NCT01539174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110066570|NCT01539174|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110066571|NCT01539174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110066572|NCT01539174|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110066573|NCT01539174|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110066574|NCT01539174|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110066575|NCT01539174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110066576|NCT01539174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110066577|NCT01539174|Glucocorticoids|glucocorticoids|mesh-ancestor
110066578|NCT01539174|Hormones|hormones|mesh-ancestor
110066579|NCT01539174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110066580|NCT01539174|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110066581|NCT01539174|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110066582|NCT01539174|Tubulin Modulators|tubulin modulators|mesh-ancestor
110066583|NCT01539174|Antimitotic Agents|antimitotic agents|mesh-ancestor
110066584|NCT01539174|Mitosis Modulators|mitosis modulators|mesh-ancestor
110066586|NCT01539265|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110066587|NCT01539265|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110066588|NCT01539265|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110066590|NCT01539265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110066591|NCT01539265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110066592|NCT01539265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110066593|NCT01539265|Urological Agents|urological agents|mesh-ancestor
110066594|NCT01539330|Voriconazole|voriconazole|mesh-list
110066595|NCT01539330|Antifungal Agents|antifungal agents|mesh-ancestor
110066596|NCT01539330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110066597|NCT01539330|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110389346|NCT02165007|Sirolimus|sirolimus|mesh-list
110066598|NCT01539330|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110066599|NCT01539330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110368551|NCT01165216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110066600|NCT01539330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110066601|NCT01539330|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110066602|NCT01539330|Hormone Antagonists|hormone antagonists|mesh-ancestor
110066603|NCT01539330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110066604|NCT01539330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110066605|NCT01539330|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110066606|NCT01539343|Anti-Infective Agents|anti-infective agents|mesh-list
110066607|NCT01539343|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110066609|NCT01539408|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110066610|NCT01539408|Abortifacient Agents|abortifacient agents|mesh-ancestor
110066611|NCT01539408|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110066612|NCT01539408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110066613|NCT01539408|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110066614|NCT01539408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110066615|NCT01539408|Oxytocics|oxytocics|mesh-ancestor
110066616|NCT01539473|Tedizolid phosphate|tedizolid phosphate|mesh-list
110066618|NCT01539473|Tyramine|tyramine|mesh-list
110066619|NCT01539473|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110066620|NCT01539473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110066621|NCT01539473|Sympathomimetics|sympathomimetics|mesh-ancestor
110066622|NCT01539473|Autonomic Agents|autonomic agents|mesh-ancestor
110066623|NCT01539473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110066624|NCT01539473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110066625|NCT01539473|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110066626|NCT01539473|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110066627|NCT01539473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110066628|NCT01539473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110066629|NCT01539473|Adrenergic Agents|adrenergic agents|mesh-ancestor
110066630|NCT01539473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110066631|NCT01539564|Minocycline|minocycline|mesh-list
110066632|NCT01539564|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110066633|NCT01539564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110066634|NCT01539577|Dexamethasone|dexamethasone|mesh-list
110066635|NCT01539577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110066636|NCT01539577|Antiemetics|antiemetics|mesh-ancestor
110066637|NCT01539577|Autonomic Agents|autonomic agents|mesh-ancestor
110066638|NCT01539577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110066639|NCT01539577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110066640|NCT01539577|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110066641|NCT01539577|Glucocorticoids|glucocorticoids|mesh-ancestor
110066642|NCT01539577|Hormones|hormones|mesh-ancestor
110066643|NCT01539577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110066644|NCT01539577|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110066645|NCT01539577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110066646|NCT01539603|Sirolimus|sirolimus|mesh-list
110066647|NCT01539603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110066648|NCT01539603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110066649|NCT01539603|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110066650|NCT01539603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110066651|NCT01539603|Antifungal Agents|antifungal agents|mesh-ancestor
110066652|NCT01539603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110066653|NCT01539603|Immunologic Factors|immunologic factors|mesh-ancestor
110066654|NCT01539603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110066655|NCT01539616|Fenofibrate|fenofibrate|mesh-list
110066656|NCT01539616|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110066657|NCT01539616|Antimetabolites|antimetabolites|mesh-ancestor
110066658|NCT01539616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110066659|NCT01539616|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110066661|NCT01539655|Ranitidine|ranitidine|mesh-list
110066662|NCT01539655|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
110066663|NCT01539655|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110066664|NCT01539655|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110066665|NCT01539655|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110066666|NCT01539655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110066667|NCT01539655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110066668|NCT01539655|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110066669|NCT01539655|Histamine Antagonists|histamine antagonists|mesh-ancestor
110066670|NCT01539655|Histamine Agents|histamine agents|mesh-ancestor
110066671|NCT01539655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110066672|NCT01539655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110066673|NCT01539681|Sorafenib|sorafenib|mesh-list
110066674|NCT01539681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110066675|NCT01539681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110066676|NCT01539681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110066677|NCT01539681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110066678|NCT01539707|Solifenacin Succinate|solifenacin succinate|mesh-list
110066679|NCT01539707|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110066680|NCT01539707|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110066681|NCT01539707|Cholinergic Agents|cholinergic agents|mesh-ancestor
110066682|NCT01539707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110066683|NCT01539707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110066684|NCT01539707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110066685|NCT01539707|Urological Agents|urological agents|mesh-ancestor
110066686|NCT01539720|Levonorgestrel|levonorgestrel|mesh-list
110066687|NCT01539720|Ulipristal acetate|ulipristal acetate|mesh-list
110066688|NCT01539720|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110066689|NCT01539720|Contraceptive Agents|contraceptive agents|mesh-ancestor
110066690|NCT01539720|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110066691|NCT01539720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110066692|NCT01539720|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110066693|NCT01539720|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110066694|NCT01539720|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110066695|NCT01539733|Haloperidol|haloperidol|mesh-list
110066696|NCT01539733|Olanzapine|olanzapine|mesh-list
110066697|NCT01539733|Haloperidol decanoate|haloperidol decanoate|mesh-list
110066698|NCT01539733|Antiemetics|antiemetics|mesh-ancestor
110066699|NCT01539733|Autonomic Agents|autonomic agents|mesh-ancestor
110066700|NCT01539733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110066701|NCT01539733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110066702|NCT01539733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110066703|NCT01539733|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110066704|NCT01539733|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110066705|NCT01539733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110066706|NCT01539733|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110066707|NCT01539733|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110066708|NCT01539733|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110066709|NCT01539733|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110066710|NCT01539733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110066711|NCT01539733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110066712|NCT01539733|Serotonin Agents|serotonin agents|mesh-ancestor
110066713|NCT01539733|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110066714|NCT01539733|Dopamine Agents|dopamine agents|mesh-ancestor
110066715|NCT01539733|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110066716|NCT01539798|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110066717|NCT01539902|Cyclophosphamide|cyclophosphamide|mesh-list
110066718|NCT01539902|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110066719|NCT01539902|Immunologic Factors|immunologic factors|mesh-ancestor
110066720|NCT01539902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110066721|NCT01539902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110066722|NCT01539902|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110066723|NCT01539902|Alkylating Agents|alkylating agents|mesh-ancestor
110066724|NCT01539902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110066725|NCT01539902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110066726|NCT01539902|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110066728|NCT01540032|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110066729|NCT01540032|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110066730|NCT01540032|Analgesics|analgesics|mesh-ancestor
110066731|NCT01540032|Sensory System Agents|sensory system agents|mesh-ancestor
110066732|NCT01540032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110066733|NCT01540032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110066734|NCT01540032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110066735|NCT01540032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110066736|NCT01540032|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110066737|NCT01540032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110066738|NCT01540032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110066739|NCT01540084|Propofol|propofol|mesh-list
110066740|NCT01540084|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110066741|NCT01540084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110066742|NCT01540084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110066743|NCT01540084|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110066744|NCT01540084|Anesthetics, General|anesthetics, general|mesh-ancestor
110066745|NCT01540084|Anesthetics|anesthetics|mesh-ancestor
110066746|NCT01540110|Cyclophosphamide|cyclophosphamide|mesh-list
110066747|NCT01540110|Docetaxel|docetaxel|mesh-list
110066748|NCT01540110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110066749|NCT01540110|Immunologic Factors|immunologic factors|mesh-ancestor
110066750|NCT01540110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110066751|NCT01540110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110066752|NCT01540110|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110066753|NCT01540110|Alkylating Agents|alkylating agents|mesh-ancestor
110066754|NCT01540110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110066755|NCT01540110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110066756|NCT01540110|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110066757|NCT01540110|Tubulin Modulators|tubulin modulators|mesh-ancestor
110066758|NCT01540110|Antimitotic Agents|antimitotic agents|mesh-ancestor
110066759|NCT01540110|Mitosis Modulators|mitosis modulators|mesh-ancestor
110066760|NCT01540136|Nedaplatin|nedaplatin|mesh-list
110066761|NCT01540136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110066762|NCT01540240|Zidovudine|zidovudine|mesh-list
110066763|NCT01540240|Antimetabolites|antimetabolites|mesh-ancestor
110066764|NCT01540240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110066765|NCT01540240|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110066766|NCT01540240|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110066767|NCT01540240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110066768|NCT01540240|Antiviral Agents|antiviral agents|mesh-ancestor
110066769|NCT01540240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110066770|NCT01540240|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110066771|NCT01540240|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110066772|NCT01540435|Bevacizumab|bevacizumab|mesh-list
110066773|NCT01540435|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110066774|NCT01540435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110066775|NCT01540435|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110066776|NCT01540435|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110066777|NCT01540435|Growth Substances|growth substances|mesh-ancestor
110066778|NCT01540435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110066779|NCT01540435|Growth Inhibitors|growth inhibitors|mesh-ancestor
110066780|NCT01540500|Fluvoxamine|fluvoxamine|mesh-list
110066781|NCT01540500|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110066782|NCT01540500|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110066783|NCT01540500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110066784|NCT01540500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110066785|NCT01540500|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110066786|NCT01540500|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110066787|NCT01540500|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110066788|NCT01540500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110066789|NCT01540500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110066791|NCT01540500|Serotonin Agents|serotonin agents|mesh-ancestor
110066792|NCT01540500|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110066793|NCT01540500|Antidepressive Agents|antidepressive agents|mesh-ancestor
110066794|NCT01540500|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110066795|NCT01540500|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110066796|NCT01540500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110066797|NCT01540500|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110066798|NCT01540526|Axitinib|axitinib|mesh-list
110066799|NCT01540526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110066800|NCT01540526|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110066801|NCT01540526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110066802|NCT01540526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110066803|NCT01540591|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
110066805|NCT01540591|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
110066806|NCT01540591|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110066807|NCT01540682|Cetuximab|cetuximab|mesh-list
110066808|NCT01540682|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110066809|NCT01540682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110066810|NCT01540708|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
110066811|NCT01540708|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110066812|NCT01540708|Autonomic Agents|autonomic agents|mesh-ancestor
110066813|NCT01540708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110066814|NCT01540708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110066815|NCT01540708|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110066816|NCT01540708|Respiratory System Agents|respiratory system agents|mesh-ancestor
110066817|NCT01540708|Glucocorticoids|glucocorticoids|mesh-ancestor
110066818|NCT01540708|Hormones|hormones|mesh-ancestor
110368552|NCT01165216|Tubulin Modulators|tubulin modulators|mesh-ancestor
110066819|NCT01540708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110066821|NCT01540721|Acetaminophen|acetaminophen|mesh-list
110066822|NCT01540721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110066823|NCT01540721|Analgesics|analgesics|mesh-ancestor
110066824|NCT01540721|Sensory System Agents|sensory system agents|mesh-ancestor
110066825|NCT01540721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110066826|NCT01540721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110066827|NCT01540721|Antipyretics|antipyretics|mesh-ancestor
110066828|NCT01540734|Acetaminophen|acetaminophen|mesh-list
110066829|NCT01540734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110066830|NCT01540734|Analgesics|analgesics|mesh-ancestor
110066831|NCT01540734|Sensory System Agents|sensory system agents|mesh-ancestor
110066832|NCT01540734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110066833|NCT01540734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110066834|NCT01540734|Antipyretics|antipyretics|mesh-ancestor
110066835|NCT01540747|Folic Acid|folic acid|mesh-list
110066836|NCT01540747|Vitamin B Complex|vitamin b complex|mesh-list
110066837|NCT01540747|Inositol|inositol|mesh-list
110066838|NCT01540747|Melatonin|melatonin|mesh-list
110066839|NCT01540747|Antioxidants|antioxidants|mesh-ancestor
110066840|NCT01540747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110066841|NCT01540747|Protective Agents|protective agents|mesh-ancestor
110066842|NCT01540747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110066843|NCT01540747|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110066844|NCT01540747|Hematinics|hematinics|mesh-ancestor
110066845|NCT01540747|Vitamins|vitamins|mesh-ancestor
110066846|NCT01540747|Micronutrients|micronutrients|mesh-ancestor
110066847|NCT01540812|Cytarabine|cytarabine|mesh-list
110066848|NCT01540812|Dexamethasone|dexamethasone|mesh-list
110066849|NCT01540812|Dexamethasone acetate|dexamethasone acetate|mesh-list
110066850|NCT01540812|Prednisone|prednisone|mesh-list
110066851|NCT01540812|Hydrocortisone|hydrocortisone|mesh-list
110066852|NCT01540812|Fludarabine|fludarabine|mesh-list
110066853|NCT01540812|Vincristine|vincristine|mesh-list
110066855|NCT01540812|Idarubicin|idarubicin|mesh-list
110066856|NCT01540812|Methotrexate|methotrexate|mesh-list
110066857|NCT01540812|Pegaspargase|pegaspargase|mesh-list
110066858|NCT01540812|Asparaginase|asparaginase|mesh-list
110066859|NCT01540812|BB 1101|bb 1101|mesh-list
110066860|NCT01540812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110066861|NCT01540812|Antiemetics|antiemetics|mesh-ancestor
110066862|NCT01540812|Autonomic Agents|autonomic agents|mesh-ancestor
110066863|NCT01540812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110066864|NCT01540812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110066865|NCT01540812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110066866|NCT01540812|Glucocorticoids|glucocorticoids|mesh-ancestor
110066867|NCT01540812|Hormones|hormones|mesh-ancestor
110066868|NCT01540812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110066869|NCT01540812|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110066870|NCT01540812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110066871|NCT01540812|Protease Inhibitors|protease inhibitors|mesh-ancestor
110066872|NCT01540812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110066873|NCT01540812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110066874|NCT01540812|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110066875|NCT01540812|Antimetabolites|antimetabolites|mesh-ancestor
110066876|NCT01540812|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110066877|NCT01540812|Immunologic Factors|immunologic factors|mesh-ancestor
110066878|NCT01540812|Antiviral Agents|antiviral agents|mesh-ancestor
110066879|NCT01540812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110066880|NCT01540812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110066881|NCT01540812|Tubulin Modulators|tubulin modulators|mesh-ancestor
110066882|NCT01540812|Antimitotic Agents|antimitotic agents|mesh-ancestor
110066883|NCT01540812|Mitosis Modulators|mitosis modulators|mesh-ancestor
110066884|NCT01540812|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110066885|NCT01540812|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110066886|NCT01540812|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110066887|NCT01540812|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110066888|NCT01540812|Abortifacient Agents|abortifacient agents|mesh-ancestor
110066889|NCT01540812|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110066890|NCT01540812|Dermatologic Agents|dermatologic agents|mesh-ancestor
110066891|NCT01540812|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110066892|NCT01540812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110066893|NCT01540812|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110066894|NCT01540877|Anesthetics|anesthetics|mesh-list
110066895|NCT01540877|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
110066896|NCT01540877|Anesthetics, Local|anesthetics, local|mesh-list
110066897|NCT01540877|Capsaicin|capsaicin|mesh-list
110066898|NCT01540877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110066899|NCT01540877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110066900|NCT01540877|Sensory System Agents|sensory system agents|mesh-ancestor
110066901|NCT01540877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110066902|NCT01540877|Antipruritics|antipruritics|mesh-ancestor
110066903|NCT01540877|Dermatologic Agents|dermatologic agents|mesh-ancestor
110066904|NCT01540877|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
110066905|NCT01541059|Ropivacaine|ropivacaine|mesh-list
110066906|NCT01541059|Anesthetics, Local|anesthetics, local|mesh-ancestor
110066907|NCT01541059|Anesthetics|anesthetics|mesh-ancestor
110066908|NCT01541059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110066909|NCT01541059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110066910|NCT01541059|Sensory System Agents|sensory system agents|mesh-ancestor
110066911|NCT01541059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110066912|NCT01541072|Lenograstim|lenograstim|mesh-list
110066913|NCT01541072|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110066914|NCT01541072|Immunologic Factors|immunologic factors|mesh-ancestor
110066915|NCT01541072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110066916|NCT01541124|Morphine|morphine|mesh-list
110066917|NCT01541124|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110066918|NCT01541124|Narcotics|narcotics|mesh-ancestor
110066919|NCT01541124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110066920|NCT01541124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110066921|NCT01541124|Analgesics|analgesics|mesh-ancestor
110066922|NCT01541124|Sensory System Agents|sensory system agents|mesh-ancestor
110066923|NCT01541124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110066924|NCT01541137|Diclofenac|diclofenac|mesh-list
110066925|NCT01541137|Parecoxib|parecoxib|mesh-list
110066926|NCT01541137|Valdecoxib|valdecoxib|mesh-list
110066928|NCT01541137|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110066929|NCT01541137|Analgesics|analgesics|mesh-ancestor
110066930|NCT01541137|Sensory System Agents|sensory system agents|mesh-ancestor
110066931|NCT01541137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110066932|NCT01541137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110066933|NCT01541137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110066934|NCT01541137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110066935|NCT01541137|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110066936|NCT01541137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110066937|NCT01541137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110066938|NCT01541137|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110066939|NCT01541189|Valsartan|valsartan|mesh-list
110066940|NCT01541189|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110066941|NCT01541189|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110066942|NCT01541189|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110066943|NCT01541189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110066944|NCT01541267|Telmisartan|telmisartan|mesh-list
110066945|NCT01541267|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110066946|NCT01541267|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110066947|NCT01541267|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110066948|NCT01541267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110066949|NCT01541280|Azacitidine|azacitidine|mesh-list
110066950|NCT01541280|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110066951|NCT01541280|Antimetabolites|antimetabolites|mesh-ancestor
110066952|NCT01541280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110066953|NCT01541280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110066954|NCT01541280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110066956|NCT01541293|Anesthetics, Local|anesthetics, local|mesh-ancestor
110066957|NCT01541293|Anesthetics|anesthetics|mesh-ancestor
110066958|NCT01541293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110066959|NCT01541293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110066960|NCT01541293|Sensory System Agents|sensory system agents|mesh-ancestor
110066961|NCT01541293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110066962|NCT01541293|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110066963|NCT01541293|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110066964|NCT01541293|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110066965|NCT01541293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110066966|NCT01541293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110066967|NCT01541332|Dexamethasone|dexamethasone|mesh-list
110066968|NCT01541332|Doxorubicin|doxorubicin|mesh-list
110066969|NCT01541332|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110066970|NCT01541332|Pomalidomide|pomalidomide|mesh-list
110066971|NCT01541332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110066972|NCT01541332|Antiemetics|antiemetics|mesh-ancestor
110066973|NCT01541332|Autonomic Agents|autonomic agents|mesh-ancestor
110066974|NCT01541332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110066975|NCT01541332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110066976|NCT01541332|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110066977|NCT01541332|Glucocorticoids|glucocorticoids|mesh-ancestor
110066978|NCT01541332|Hormones|hormones|mesh-ancestor
110066979|NCT01541332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110066980|NCT01541332|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110066981|NCT01541332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110066982|NCT01541332|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110066983|NCT01541332|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110066984|NCT01541332|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110066985|NCT01541332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110066986|NCT01541332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110066987|NCT01541332|Immunologic Factors|immunologic factors|mesh-ancestor
110066988|NCT01541332|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110066989|NCT01541332|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110066990|NCT01541332|Growth Substances|growth substances|mesh-ancestor
110066991|NCT01541332|Growth Inhibitors|growth inhibitors|mesh-ancestor
110066993|NCT01541436|Antipruritics|antipruritics|mesh-ancestor
110066994|NCT01541436|Dermatologic Agents|dermatologic agents|mesh-ancestor
110066995|NCT01541436|Sensory System Agents|sensory system agents|mesh-ancestor
110066996|NCT01541436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110066997|NCT01541436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110066998|NCT01541475|Dexetimide|dexetimide|mesh-list
110066999|NCT01541475|Citalopram|citalopram|mesh-list
110067000|NCT01541475|Bupropion|bupropion|mesh-list
110067001|NCT01541475|Escitalopram|escitalopram|mesh-list
110067002|NCT01541475|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110067003|NCT01541475|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110067004|NCT01541475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110067005|NCT01541475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110067006|NCT01541475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110067007|NCT01541475|Serotonin Agents|serotonin agents|mesh-ancestor
110067008|NCT01541475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110067009|NCT01541475|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110067010|NCT01541475|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110067011|NCT01541475|Parasympatholytics|parasympatholytics|mesh-ancestor
110067012|NCT01541475|Autonomic Agents|autonomic agents|mesh-ancestor
110067013|NCT01541475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110067014|NCT01541475|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110067015|NCT01541475|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110067016|NCT01541475|Cholinergic Agents|cholinergic agents|mesh-ancestor
110067017|NCT01541475|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110067018|NCT01541475|Antidepressive Agents|antidepressive agents|mesh-ancestor
110067019|NCT01541475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110067020|NCT01541475|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110067021|NCT01541475|Dopamine Agents|dopamine agents|mesh-ancestor
110067022|NCT01541475|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110067023|NCT01541475|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110067024|NCT01541475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110067025|NCT01541605|Methylphenidate|methylphenidate|mesh-list
110067026|NCT01541605|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110067027|NCT01541605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110067028|NCT01541605|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110067029|NCT01541605|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110067030|NCT01541605|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110067031|NCT01541605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110067032|NCT01541605|Dopamine Agents|dopamine agents|mesh-ancestor
110067033|NCT01541605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110067034|NCT01541631|Albendazole|albendazole|mesh-list
110067036|NCT01541631|Anthelmintics|anthelmintics|mesh-ancestor
110067037|NCT01541631|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110067038|NCT01541631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110067039|NCT01541631|Anticestodal Agents|anticestodal agents|mesh-ancestor
110067040|NCT01541631|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110067041|NCT01541631|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110067042|NCT01541631|Tubulin Modulators|tubulin modulators|mesh-ancestor
110067043|NCT01541631|Antimitotic Agents|antimitotic agents|mesh-ancestor
110067044|NCT01541631|Mitosis Modulators|mitosis modulators|mesh-ancestor
110067045|NCT01541631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110067046|NCT01541631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110067047|NCT01541670|Antibodies|antibodies|mesh-list
110067048|NCT01541670|Immunologic Factors|immunologic factors|mesh-ancestor
110067049|NCT01541670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110067050|NCT01541683|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110067051|NCT01541904|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110067052|NCT01541904|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110067053|NCT01541085|Ritonavir|ritonavir|mesh-list
110067054|NCT01541085|Darunavir|darunavir|mesh-list
110067055|NCT01541085|Efavirenz|efavirenz|mesh-list
110067056|NCT01541085|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110067057|NCT01541085|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110067058|NCT01541085|Protease Inhibitors|protease inhibitors|mesh-ancestor
110067059|NCT01541085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110067060|NCT01541085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110067061|NCT01541085|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110067062|NCT01541085|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110067063|NCT01541085|Antiviral Agents|antiviral agents|mesh-ancestor
110067064|NCT01541085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110067065|NCT01541085|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110067066|NCT01541085|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110067067|NCT01541085|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110067068|NCT01541085|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110067069|NCT01541085|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110067070|NCT01541085|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110067071|NCT01541085|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110067072|NCT01541085|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110067073|NCT01541085|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110067074|NCT01541943|Losartan|losartan|mesh-list
110067075|NCT01541943|Atorvastatin|atorvastatin|mesh-list
110067076|NCT01541943|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110067077|NCT01541943|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110067078|NCT01541943|Antimetabolites|antimetabolites|mesh-ancestor
110067079|NCT01541943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110067080|NCT01541943|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110067081|NCT01541943|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110067082|NCT01541943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110067083|NCT01541943|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110067084|NCT01541943|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110067085|NCT01541943|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110067086|NCT01541943|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110067087|NCT01541956|Metformin|metformin|mesh-list
110067088|NCT01541956|Vildagliptin|vildagliptin|mesh-list
110067089|NCT01541956|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110067090|NCT01541956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110067091|NCT01541956|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110067092|NCT01541956|Protease Inhibitors|protease inhibitors|mesh-ancestor
110067093|NCT01541956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110067094|NCT01541956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110067095|NCT01542047|Carboplatin|carboplatin|mesh-list
110067096|NCT01542047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110067097|NCT01542060|Insulin Aspart|insulin aspart|mesh-list
110067098|NCT01542060|Biphasic Insulins|biphasic insulins|mesh-list
110067099|NCT01542060|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
110067101|NCT01542060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110067103|NCT01542099|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110067104|NCT01542099|Narcotics|narcotics|mesh-ancestor
110067105|NCT01542099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110067106|NCT01542099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110067107|NCT01542099|Analgesics|analgesics|mesh-ancestor
110067108|NCT01542099|Sensory System Agents|sensory system agents|mesh-ancestor
110067109|NCT01542099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110067110|NCT01542138|Niacinamide|niacinamide|mesh-list
110067112|NCT01542138|Nicotinic Acids|nicotinic acids|mesh-list
110067114|NCT01542138|Vitamin B Complex|vitamin b complex|mesh-ancestor
110067115|NCT01542138|Vitamins|vitamins|mesh-ancestor
110067116|NCT01542138|Micronutrients|micronutrients|mesh-ancestor
110067117|NCT01542138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110067118|NCT01542138|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110067119|NCT01542138|Antimetabolites|antimetabolites|mesh-ancestor
110368553|NCT01165216|Antimitotic Agents|antimitotic agents|mesh-ancestor
110067120|NCT01542138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110067121|NCT01542138|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110067122|NCT01542138|Vasodilator Agents|vasodilator agents|mesh-ancestor
110067123|NCT01542138|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110067125|NCT01542190|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
110067126|NCT01542190|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110067127|NCT01542190|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110067128|NCT01542190|Analgesics|analgesics|mesh-ancestor
110067129|NCT01542190|Sensory System Agents|sensory system agents|mesh-ancestor
110067130|NCT01542190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110067131|NCT01542190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110067132|NCT01542190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110067133|NCT01542190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110067134|NCT01542190|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110067135|NCT01542190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110067136|NCT01542190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110067137|NCT01542242|Liraglutide|liraglutide|mesh-list
110067138|NCT01542242|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110067139|NCT01542242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110067140|NCT01542242|Incretins|incretins|mesh-ancestor
110067141|NCT01542242|Hormones|hormones|mesh-ancestor
110067142|NCT01542242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110067143|NCT01542268|Pentoxifylline|pentoxifylline|mesh-list
110067144|NCT01542268|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110067145|NCT01542268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110067146|NCT01542268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110067147|NCT01542268|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110067148|NCT01542268|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110067149|NCT01542268|Protective Agents|protective agents|mesh-ancestor
110067150|NCT01542268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110067151|NCT01542268|Vasodilator Agents|vasodilator agents|mesh-ancestor
110067152|NCT01542268|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110067153|NCT01542268|Antioxidants|antioxidants|mesh-ancestor
110067154|NCT01542294|Oxaliplatin|oxaliplatin|mesh-list
110178640|NCT04749043|Nitrous Oxide|nitrous oxide|mesh-list
110067155|NCT01542294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110067156|NCT01542424|Insulin|insulin|mesh-list
110067157|NCT01542424|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110067158|NCT01542424|Insulin Aspart|insulin aspart|mesh-list
110067159|NCT01542424|Insulin Detemir|insulin detemir|mesh-list
110067160|NCT01542424|Biphasic Insulins|biphasic insulins|mesh-list
110067161|NCT01542424|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
110067162|NCT01542424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110067163|NCT01542424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110067164|NCT01542437|Afatinib|afatinib|mesh-list
110067165|NCT01542437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110067166|NCT01542437|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110067167|NCT01542437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110067168|NCT01542437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110067169|NCT01542450|Insulin|insulin|mesh-list
110067170|NCT01542450|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110067171|NCT01542450|Insulin Detemir|insulin detemir|mesh-list
110067172|NCT01542450|Isophane Insulin, Human|isophane insulin, human|mesh-list
110067173|NCT01542450|Insulin, Isophane|insulin, isophane|mesh-list
110067174|NCT01542450|Isophane insulin, beef|isophane insulin, beef|mesh-list
110067175|NCT01542450|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110067176|NCT01542450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110067177|NCT01542463|Insulin Detemir|insulin detemir|mesh-list
110067178|NCT01542463|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110067179|NCT01542463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110067180|NCT01542476|Insulin Detemir|insulin detemir|mesh-list
110067181|NCT01542476|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110067182|NCT01542476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110067183|NCT01542489|Insulin|insulin|mesh-list
110067184|NCT01542489|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110067185|NCT01542489|Insulin Aspart|insulin aspart|mesh-list
110067186|NCT01542489|Insulin Detemir|insulin detemir|mesh-list
110067187|NCT01542489|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110067188|NCT01542489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110067189|NCT01542697|Magnesium Sulfate|magnesium sulfate|mesh-list
110067190|NCT01542697|Analgesics|analgesics|mesh-ancestor
110067191|NCT01542697|Sensory System Agents|sensory system agents|mesh-ancestor
110067192|NCT01542697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110067193|NCT01542697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110067194|NCT01542697|Anesthetics|anesthetics|mesh-ancestor
110067195|NCT01542697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110067196|NCT01542697|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110067197|NCT01542697|Anticonvulsants|anticonvulsants|mesh-ancestor
110067198|NCT01542697|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110067199|NCT01542697|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110067200|NCT01542697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110067201|NCT01542697|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110067202|NCT01542697|Tocolytic Agents|tocolytic agents|mesh-ancestor
110067203|NCT01542697|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110067204|NCT01542710|Timolol|timolol|mesh-list
110067205|NCT01542710|Bimatoprost|bimatoprost|mesh-list
110067206|NCT01542710|Travoprost|travoprost|mesh-list
110067207|NCT01542710|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110067208|NCT01542710|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110067209|NCT01542710|Adrenergic Agents|adrenergic agents|mesh-ancestor
110067210|NCT01542710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110067211|NCT01542710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110067212|NCT01542710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110067213|NCT01542710|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110067214|NCT01542710|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110067215|NCT01542723|Nadroparin|nadroparin|mesh-list
110067216|NCT01542723|Anticoagulants|anticoagulants|mesh-ancestor
110067217|NCT01542723|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110067218|NCT01542723|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110067219|NCT01542723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110067220|NCT01542762|Nadroparin|nadroparin|mesh-list
110067221|NCT01542762|Anticoagulants|anticoagulants|mesh-ancestor
110067222|NCT01542762|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110067223|NCT01542762|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110067224|NCT01542762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110067225|NCT01542801|Ciprofloxacin|ciprofloxacin|mesh-list
110067226|NCT01542801|Norfloxacin|norfloxacin|mesh-list
110067227|NCT01542801|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110067228|NCT01542801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110067229|NCT01542801|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110067230|NCT01542801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110067232|NCT01542801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110067233|NCT01542801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110067234|NCT01542801|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110067235|NCT01542801|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110067236|NCT01542827|Analgesics|analgesics|mesh-list
110067237|NCT01542827|Sensory System Agents|sensory system agents|mesh-ancestor
110067238|NCT01542827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110067239|NCT01542827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110067240|NCT01542918|Rituximab|rituximab|mesh-list
110067241|NCT01542918|Lenalidomide|lenalidomide|mesh-list
110067242|NCT01542918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110067243|NCT01542918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110067244|NCT01542918|Immunologic Factors|immunologic factors|mesh-ancestor
110067245|NCT01542918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110067246|NCT01542918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110067247|NCT01542918|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110067248|NCT01542918|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110067249|NCT01542918|Growth Substances|growth substances|mesh-ancestor
110067250|NCT01542918|Growth Inhibitors|growth inhibitors|mesh-ancestor
110067251|NCT01543035|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
110067252|NCT01543035|Antiviral Agents|antiviral agents|mesh-ancestor
110067253|NCT01543035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110067254|NCT01543061|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110067255|NCT01543061|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110067256|NCT01543139|Valproic Acid|valproic acid|mesh-list
110067257|NCT01543139|Anticonvulsants|anticonvulsants|mesh-ancestor
110067258|NCT01543139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110067259|NCT01543139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110067260|NCT01543139|GABA Agents|gaba agents|mesh-ancestor
110067261|NCT01543139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110067262|NCT01543139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110067263|NCT01543139|Antimanic Agents|antimanic agents|mesh-ancestor
110067264|NCT01543139|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110067265|NCT01543139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110067266|NCT01543139|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110067267|NCT01543165|Ketorolac|ketorolac|mesh-list
110067268|NCT01543165|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
110067269|NCT01543165|Morphine|morphine|mesh-list
110067270|NCT01543165|Analgesics|analgesics|mesh-list
110067271|NCT01543165|Nefopam|nefopam|mesh-list
110067272|NCT01543165|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110067273|NCT01543165|Narcotics|narcotics|mesh-ancestor
110067274|NCT01543165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110067275|NCT01543165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110067276|NCT01543165|Sensory System Agents|sensory system agents|mesh-ancestor
110067277|NCT01543165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110067278|NCT01543165|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110067279|NCT01543165|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110067280|NCT01543165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110067281|NCT01543165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110067282|NCT01543165|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110067283|NCT01543165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110067284|NCT01543165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110067285|NCT01543321|Tetrabenazine|tetrabenazine|mesh-list
110067286|NCT01543321|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110067287|NCT01543321|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110067288|NCT01543321|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110225454|NCT05962151|Sensory System Agents|sensory system agents|mesh-ancestor
110067289|NCT01543321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110067291|NCT01543321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110067292|NCT01543321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110067293|NCT01543347|Temocillin|temocillin|mesh-list
110067294|NCT01543347|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110067295|NCT01543347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110067296|NCT01543386|Curcumin|curcumin|mesh-list
110067297|NCT01543386|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110067298|NCT01543386|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110067299|NCT01543386|Analgesics|analgesics|mesh-ancestor
110067300|NCT01543386|Sensory System Agents|sensory system agents|mesh-ancestor
110067301|NCT01543386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110067302|NCT01543386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110067303|NCT01543386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110067304|NCT01543386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110067305|NCT01543386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110067306|NCT01543386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110067307|NCT01543386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110067308|NCT01543399|Tibolone|tibolone|mesh-list
110067309|NCT01543399|Androgen Antagonists|androgen antagonists|mesh-ancestor
110067310|NCT01543399|Hormone Antagonists|hormone antagonists|mesh-ancestor
110067311|NCT01543399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110067312|NCT01543399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110067313|NCT01543399|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110067314|NCT01543399|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110067315|NCT01543399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110067316|NCT01543399|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110067318|NCT01543399|Hormones|hormones|mesh-ancestor
110067319|NCT01543464|Temozolomide|temozolomide|mesh-list
110067320|NCT01543464|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110067321|NCT01543464|Alkylating Agents|alkylating agents|mesh-ancestor
110067322|NCT01543464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110067323|NCT01543464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110067324|NCT01543555|Atorvastatin|atorvastatin|mesh-list
110067325|NCT01543555|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110067326|NCT01543555|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110067327|NCT01543555|Antimetabolites|antimetabolites|mesh-ancestor
110067328|NCT01543555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110067329|NCT01543555|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110067330|NCT01543555|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110067331|NCT01543555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110067332|NCT01543724|Lithium Carbonate|lithium carbonate|mesh-list
110067333|NCT01543724|Antidepressive Agents|antidepressive agents|mesh-ancestor
110067334|NCT01543724|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110067335|NCT01543724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110067336|NCT01543724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110067337|NCT01543724|Antimanic Agents|antimanic agents|mesh-ancestor
110067338|NCT01543724|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110067339|NCT01543724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110067340|NCT01543724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110067341|NCT01543737|Hyaluronic Acid|hyaluronic acid|mesh-list
110067342|NCT01543737|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110067343|NCT01543737|Immunologic Factors|immunologic factors|mesh-ancestor
110067344|NCT01543737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110067345|NCT01543737|Viscosupplements|viscosupplements|mesh-ancestor
110067346|NCT01543737|Protective Agents|protective agents|mesh-ancestor
110067347|NCT01543750|4-Aminopyridine|4-aminopyridine|mesh-list
110067348|NCT01543750|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
110067349|NCT01543750|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110067350|NCT01543750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110067351|NCT01543906|Retinol acetate|retinol acetate|mesh-list
110067352|NCT01543906|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110067353|NCT01543906|Immunologic Factors|immunologic factors|mesh-ancestor
110067354|NCT01543906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110067355|NCT01543906|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110067356|NCT01543906|Protective Agents|protective agents|mesh-ancestor
110067357|NCT01543906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110067360|NCT01543932|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
110067361|NCT01543932|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110067362|NCT01543932|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110067363|NCT01543932|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110067364|NCT01543932|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110067365|NCT01543932|Purinergic Agents|purinergic agents|mesh-ancestor
110067366|NCT01543932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110067367|NCT01543932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110067368|NCT01543932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110067369|NCT01543945|Dexamethasone|dexamethasone|mesh-list
110067370|NCT01543945|Dexamethasone acetate|dexamethasone acetate|mesh-list
110067371|NCT01543945|Ondansetron|ondansetron|mesh-list
110067372|NCT01543945|Antiemetics|antiemetics|mesh-list
110067373|NCT01543945|Dimenhydrinate|dimenhydrinate|mesh-list
110067375|NCT01543945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110067376|NCT01543945|Autonomic Agents|autonomic agents|mesh-ancestor
110067377|NCT01543945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110067378|NCT01543945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110067379|NCT01543945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110067380|NCT01543945|Glucocorticoids|glucocorticoids|mesh-ancestor
110067381|NCT01543945|Hormones|hormones|mesh-ancestor
110067382|NCT01543945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110067383|NCT01543945|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110067384|NCT01543945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110067385|NCT01543945|Protease Inhibitors|protease inhibitors|mesh-ancestor
110067386|NCT01543945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110067387|NCT01543945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110067388|NCT01543945|Antipruritics|antipruritics|mesh-ancestor
110067389|NCT01543945|Dermatologic Agents|dermatologic agents|mesh-ancestor
110067390|NCT01543945|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110067391|NCT01543945|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110067392|NCT01543945|Serotonin Agents|serotonin agents|mesh-ancestor
110067393|NCT01543945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110067394|NCT01543945|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110067395|NCT01543945|Histamine Antagonists|histamine antagonists|mesh-ancestor
110067396|NCT01543945|Histamine Agents|histamine agents|mesh-ancestor
110067397|NCT01543971|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
110067398|NCT01543971|Lenograstim|lenograstim|mesh-list
110067399|NCT01543971|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110067400|NCT01543971|Immunologic Factors|immunologic factors|mesh-ancestor
110067401|NCT01543971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110067402|NCT01543971|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110067403|NCT01543971|Vasodilator Agents|vasodilator agents|mesh-ancestor
110067404|NCT01544140|Midazolam|midazolam|mesh-list
110067405|NCT01544140|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110067406|NCT01544140|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110067407|NCT01544140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110067408|NCT01544140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110067409|NCT01544140|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110067410|NCT01544140|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110067411|NCT01544140|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110067412|NCT01544140|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110067413|NCT01544140|Anesthetics, General|anesthetics, general|mesh-ancestor
110067414|NCT01544140|Anesthetics|anesthetics|mesh-ancestor
110067415|NCT01544140|GABA Modulators|gaba modulators|mesh-ancestor
110067416|NCT01544140|GABA Agents|gaba agents|mesh-ancestor
110067417|NCT01544140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110067418|NCT01544140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110067419|NCT01544192|Tocopherols|tocopherols|mesh-list
110067420|NCT01544192|Vitamin E|vitamin e|mesh-list
110067421|NCT01544192|Tocotrienols|tocotrienols|mesh-list
110067422|NCT01544192|alpha-Tocopherol|alpha-tocopherol|mesh-list
110067423|NCT01544192|Antioxidants|antioxidants|mesh-list
110067424|NCT01544192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110067425|NCT01544192|Protective Agents|protective agents|mesh-ancestor
110067426|NCT01544192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110067428|NCT01544192|Micronutrients|micronutrients|mesh-ancestor
110067429|NCT01544283|Triamcinolone|triamcinolone|mesh-list
110067430|NCT01544283|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110067431|NCT01544283|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110067432|NCT01544283|Lidocaine|lidocaine|mesh-list
110067433|NCT01544283|Tetracaine|tetracaine|mesh-list
110067434|NCT01544283|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110067435|NCT01544283|Anesthetics, Local|anesthetics, local|mesh-ancestor
110067436|NCT01544283|Anesthetics|anesthetics|mesh-ancestor
110067437|NCT01544283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110067438|NCT01544283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110067439|NCT01544283|Sensory System Agents|sensory system agents|mesh-ancestor
110067440|NCT01544283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110067441|NCT01544283|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110067442|NCT01544283|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110067443|NCT01544283|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110067444|NCT01544283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110067445|NCT01544283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110067446|NCT01544283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110067447|NCT01544283|Glucocorticoids|glucocorticoids|mesh-ancestor
110067448|NCT01544283|Hormones|hormones|mesh-ancestor
110067449|NCT01544283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110067450|NCT01544283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110067451|NCT01544283|Immunologic Factors|immunologic factors|mesh-ancestor
110067452|NCT01544283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110067453|NCT01544439|Salicylic Acid|salicylic acid|mesh-list
110067454|NCT01544439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110067455|NCT01544439|Antifungal Agents|antifungal agents|mesh-ancestor
110067456|NCT01544439|Keratolytic Agents|keratolytic agents|mesh-ancestor
110067457|NCT01544439|Dermatologic Agents|dermatologic agents|mesh-ancestor
110067458|NCT01544504|Norepinephrine|norepinephrine|mesh-list
110067459|NCT01544504|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110067460|NCT01544504|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110067461|NCT01544504|Adrenergic Agents|adrenergic agents|mesh-ancestor
110067462|NCT01544504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110067463|NCT01544504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110067464|NCT01544504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110067465|NCT01544504|Sympathomimetics|sympathomimetics|mesh-ancestor
110067466|NCT01544504|Autonomic Agents|autonomic agents|mesh-ancestor
110067467|NCT01544504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110067468|NCT01544504|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110067469|NCT01544517|Amoxicillin|amoxicillin|mesh-list
110067470|NCT01544517|Levofloxacin|levofloxacin|mesh-list
110067471|NCT01544517|Tinidazole|tinidazole|mesh-list
110067472|NCT01544517|Esomeprazole|esomeprazole|mesh-list
110067473|NCT01544517|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
110067474|NCT01544517|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110067475|NCT01544517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110067476|NCT01544517|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110067477|NCT01544517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110067478|NCT01544517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110067479|NCT01544517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110067480|NCT01544517|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110067481|NCT01544517|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110067482|NCT01544517|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110067483|NCT01544517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110067484|NCT01544517|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110067485|NCT01544517|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110067486|NCT01544517|Alkylating Agents|alkylating agents|mesh-ancestor
110067487|NCT01544517|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
110067488|NCT01544517|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110067489|NCT01544517|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110067490|NCT01544634|Beclomethasone|beclomethasone|mesh-list
110067491|NCT01544634|Propranolol|propranolol|mesh-list
110067492|NCT01544634|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110067493|NCT01544634|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110067494|NCT01544634|Adrenergic Agents|adrenergic agents|mesh-ancestor
110067495|NCT01544634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110067496|NCT01544634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110067497|NCT01544634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110067498|NCT01544634|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110067499|NCT01544634|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110067500|NCT01544634|Vasodilator Agents|vasodilator agents|mesh-ancestor
110067501|NCT01544634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110067502|NCT01544634|Glucocorticoids|glucocorticoids|mesh-ancestor
110067503|NCT01544634|Hormones|hormones|mesh-ancestor
110067504|NCT01544634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110067505|NCT01544634|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110067506|NCT01544634|Respiratory System Agents|respiratory system agents|mesh-ancestor
110067507|NCT01544673|Linezolid|linezolid|mesh-list
110067508|NCT01544673|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110067509|NCT01544673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110067510|NCT01544673|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110067511|NCT01544673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110067512|NCT01544673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110067513|NCT01544725|Ketamine|ketamine|mesh-list
110067514|NCT01544725|Propofol|propofol|mesh-list
110067515|NCT01544725|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110067516|NCT01544725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110067517|NCT01544725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110067518|NCT01544725|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110067519|NCT01544725|Anesthetics, General|anesthetics, general|mesh-ancestor
110067520|NCT01544725|Anesthetics|anesthetics|mesh-ancestor
110067521|NCT01544725|Analgesics|analgesics|mesh-ancestor
110067522|NCT01544725|Sensory System Agents|sensory system agents|mesh-ancestor
110067523|NCT01544725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110067524|NCT01544725|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110067525|NCT01544725|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110067526|NCT01544725|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110067527|NCT01544725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110178788|NCT01805895|Minocycline|minocycline|mesh-list
110067528|NCT01544725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110067529|NCT01544751|Metformin|metformin|mesh-list
110067530|NCT01544751|Atorvastatin|atorvastatin|mesh-list
110067531|NCT01544751|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110067532|NCT01544751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110067533|NCT01544751|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110067534|NCT01544751|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110067535|NCT01544751|Antimetabolites|antimetabolites|mesh-ancestor
110067536|NCT01544751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110067538|NCT01544751|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110067539|NCT01544751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110067540|NCT01544829|Theobromine|theobromine|mesh-list
110067541|NCT01544829|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110067542|NCT01544829|Autonomic Agents|autonomic agents|mesh-ancestor
110067543|NCT01544829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110067544|NCT01544829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110067545|NCT01544829|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110067546|NCT01544829|Respiratory System Agents|respiratory system agents|mesh-ancestor
110067547|NCT01544829|Vasodilator Agents|vasodilator agents|mesh-ancestor
110067548|NCT01544842|Triamcinolone|triamcinolone|mesh-list
110067549|NCT01544842|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110067550|NCT01544842|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110067551|NCT01544842|Tacrolimus|tacrolimus|mesh-list
110067552|NCT01544842|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110067553|NCT01544842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110067554|NCT01544842|Immunologic Factors|immunologic factors|mesh-ancestor
110067555|NCT01544842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110067556|NCT01544842|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110067557|NCT01544842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110389517|NCT01619176|Leflunomide|leflunomide|mesh-list
110067558|NCT01544842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110067559|NCT01544842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110067560|NCT01544842|Glucocorticoids|glucocorticoids|mesh-ancestor
110067561|NCT01544842|Hormones|hormones|mesh-ancestor
110067562|NCT01544842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110067563|NCT01544881|Insulin|insulin|mesh-list
110067564|NCT01544881|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110067565|NCT01544881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110067566|NCT01544894|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
110067567|NCT01544894|Strontium ranelate|strontium ranelate|mesh-list
110067568|NCT01544894|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110067569|NCT01544894|Hormone Antagonists|hormone antagonists|mesh-ancestor
110067570|NCT01544894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110067571|NCT01544894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110067572|NCT01544894|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110067573|NCT01544894|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110067574|NCT01544894|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110067575|NCT01544907|Paclitaxel|paclitaxel|mesh-list
110067576|NCT01544907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110067577|NCT01544907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110067578|NCT01544907|Tubulin Modulators|tubulin modulators|mesh-ancestor
110067579|NCT01544907|Antimitotic Agents|antimitotic agents|mesh-ancestor
110067581|NCT01544907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110067582|NCT01544959|Fentanyl|fentanyl|mesh-list
110067583|NCT01544959|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
110067584|NCT01544959|Esmolol|esmolol|mesh-list
110067585|NCT01544959|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110067586|NCT01544959|Narcotics|narcotics|mesh-ancestor
110067587|NCT01544959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110067588|NCT01544959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110067589|NCT01544959|Analgesics|analgesics|mesh-ancestor
110067590|NCT01544959|Sensory System Agents|sensory system agents|mesh-ancestor
110067591|NCT01544959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110067592|NCT01544959|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110067593|NCT01544959|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110067594|NCT01544959|Anesthetics, General|anesthetics, general|mesh-ancestor
110067595|NCT01544959|Anesthetics|anesthetics|mesh-ancestor
110067596|NCT01544959|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110067597|NCT01544959|Adrenergic Agents|adrenergic agents|mesh-ancestor
110067598|NCT01544959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110067599|NCT01544959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110067600|NCT01544959|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110067601|NCT01544972|Acetaminophen|acetaminophen|mesh-list
110067603|NCT01544972|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110067604|NCT01544972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110067605|NCT01544972|Analgesics|analgesics|mesh-ancestor
110067606|NCT01544972|Sensory System Agents|sensory system agents|mesh-ancestor
110067607|NCT01544972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110067608|NCT01544972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110067609|NCT01544972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110067610|NCT01544972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110067611|NCT01544972|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110067612|NCT01544972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110067613|NCT01544972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110067614|NCT01544972|Antipyretics|antipyretics|mesh-ancestor
110067615|NCT01545024|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110067616|NCT01545024|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110067617|NCT01545024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110067618|NCT01545024|Incretins|incretins|mesh-ancestor
110067619|NCT01545024|Hormones|hormones|mesh-ancestor
110067620|NCT01545024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110067621|NCT01545024|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110067622|NCT01545024|Protease Inhibitors|protease inhibitors|mesh-ancestor
110067623|NCT01545024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110067624|NCT01545024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110067625|NCT01545284|Acitretin|acitretin|mesh-list
110067626|NCT01545284|Keratolytic Agents|keratolytic agents|mesh-ancestor
110067627|NCT01545284|Dermatologic Agents|dermatologic agents|mesh-ancestor
110067628|NCT01545297|Dexmedetomidine|dexmedetomidine|mesh-list
110067629|NCT01545297|Remifentanil|remifentanil|mesh-list
110067630|NCT01545297|Propofol|propofol|mesh-list
110067631|NCT01545297|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110067632|NCT01545297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110067633|NCT01545297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110067634|NCT01545297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110067635|NCT01545297|Analgesics|analgesics|mesh-ancestor
110067636|NCT01545297|Sensory System Agents|sensory system agents|mesh-ancestor
110067637|NCT01545297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110067638|NCT01545297|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110067639|NCT01545297|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110067640|NCT01545297|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110067641|NCT01545297|Adrenergic Agents|adrenergic agents|mesh-ancestor
110067642|NCT01545297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110067643|NCT01545297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110067644|NCT01545297|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110067645|NCT01545297|Anesthetics, General|anesthetics, general|mesh-ancestor
110067646|NCT01545297|Anesthetics|anesthetics|mesh-ancestor
110067647|NCT01545297|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110067648|NCT01545297|Narcotics|narcotics|mesh-ancestor
110067649|NCT01545427|Imatinib Mesylate|imatinib mesylate|mesh-list
110067650|NCT01545427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110067651|NCT01545427|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110067652|NCT01545427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110067653|NCT01545427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110067654|NCT01545440|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110067655|NCT01545440|Immunologic Factors|immunologic factors|mesh-ancestor
110067656|NCT01545440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110067657|NCT01545479|Captopril|captopril|mesh-list
110067658|NCT01545479|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110067659|NCT01545479|Protease Inhibitors|protease inhibitors|mesh-ancestor
110067660|NCT01545479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110067661|NCT01545479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110067662|NCT01545479|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110067663|NCT01545635|Thrombin|thrombin|mesh-list
110067664|NCT01545635|Hemostatics|hemostatics|mesh-ancestor
110067665|NCT01545635|Coagulants|coagulants|mesh-ancestor
110067666|NCT01545778|Oxycodone|oxycodone|mesh-list
110067667|NCT01545778|Tapentadol|tapentadol|mesh-list
110067668|NCT01545778|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110067669|NCT01545778|Narcotics|narcotics|mesh-ancestor
110067670|NCT01545778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110067671|NCT01545778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110067672|NCT01545778|Analgesics|analgesics|mesh-ancestor
110067673|NCT01545778|Sensory System Agents|sensory system agents|mesh-ancestor
110067674|NCT01545778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110067675|NCT01545778|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110067676|NCT01545778|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110067677|NCT01545778|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110067678|NCT01545778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110067679|NCT01545778|Adrenergic Agents|adrenergic agents|mesh-ancestor
110067680|NCT01545778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110067681|NCT01545791|Insulin Detemir|insulin detemir|mesh-list
110067682|NCT01545791|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110067683|NCT01545791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110067684|NCT01545804|Lenalidomide|lenalidomide|mesh-list
110067685|NCT01545804|Immunologic Factors|immunologic factors|mesh-ancestor
110067686|NCT01545804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110067687|NCT01545804|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110067688|NCT01545804|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110067689|NCT01545804|Growth Substances|growth substances|mesh-ancestor
110067690|NCT01545804|Growth Inhibitors|growth inhibitors|mesh-ancestor
110067691|NCT01545804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110067692|NCT01545830|Vitamin D|vitamin d|mesh-list
110067693|NCT01545830|Cholecalciferol|cholecalciferol|mesh-list
110067694|NCT01545830|Vitamins|vitamins|mesh-ancestor
110067695|NCT01545830|Micronutrients|micronutrients|mesh-ancestor
110067696|NCT01545830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110067697|NCT01545830|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110067698|NCT01545830|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110067699|NCT01545856|Levodopa|levodopa|mesh-list
110067700|NCT01545856|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110067701|NCT01545856|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110067702|NCT01545856|Dopamine Agents|dopamine agents|mesh-ancestor
110067703|NCT01545856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110067704|NCT01545856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110067705|NCT01545856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110067706|NCT01545947|Azacitidine|azacitidine|mesh-list
110067707|NCT01545947|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110067708|NCT01545947|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110067709|NCT01545947|Antimetabolites|antimetabolites|mesh-ancestor
110067710|NCT01545947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110067711|NCT01545947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110067712|NCT01545947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110067713|NCT01545947|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110067714|NCT01546051|BCI-838|bci-838|mesh-list
110067715|NCT01546051|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110067716|NCT01546051|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110067717|NCT01546051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110368554|NCT01165216|Mitosis Modulators|mitosis modulators|mesh-ancestor
110067718|NCT01546051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110067719|NCT01546051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110067721|NCT01546090|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110067722|NCT01546090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110067723|NCT01546090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110067724|NCT01546090|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110067725|NCT01546090|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110067726|NCT01546090|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110067727|NCT01546090|GABA Modulators|gaba modulators|mesh-ancestor
110067728|NCT01546090|GABA Agents|gaba agents|mesh-ancestor
110067729|NCT01546090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110067730|NCT01546090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110067731|NCT01546103|Vitamin D|vitamin d|mesh-list
110067732|NCT01546103|Ergocalciferols|ergocalciferols|mesh-list
110067733|NCT01546103|Cholecalciferol|cholecalciferol|mesh-list
110067734|NCT01546103|Vitamins|vitamins|mesh-list
110067735|NCT01546103|Micronutrients|micronutrients|mesh-ancestor
110067736|NCT01546103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110067737|NCT01546103|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110067738|NCT01546103|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110067739|NCT01546116|Lamivudine|lamivudine|mesh-list
110067740|NCT01546116|Adefovir|adefovir|mesh-list
110067741|NCT01546116|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
110067742|NCT01546116|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110067743|NCT01546116|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110067744|NCT01546116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110067745|NCT01546116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110067746|NCT01546116|Antiviral Agents|antiviral agents|mesh-ancestor
110067747|NCT01546116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110067748|NCT01546116|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110067749|NCT01546116|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110067750|NCT01546389|Chloroquine|chloroquine|mesh-list
110067751|NCT01546389|Amebicides|amebicides|mesh-ancestor
110067752|NCT01546389|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110067753|NCT01546389|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110067754|NCT01546389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110067755|NCT01546389|Antimalarials|antimalarials|mesh-ancestor
110067756|NCT01546389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110067757|NCT01546558|Metformin|metformin|mesh-list
110067758|NCT01546558|Ranolazine|ranolazine|mesh-list
110067759|NCT01546558|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110067760|NCT01546558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110067761|NCT01546558|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110067762|NCT01546558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110067763|NCT01546558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110067764|NCT01546597|Metformin|metformin|mesh-list
110067765|NCT01546597|Ranolazine|ranolazine|mesh-list
110067766|NCT01546597|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110067767|NCT01546597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110067768|NCT01546597|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110067769|NCT01546597|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110067770|NCT01546597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110067771|NCT01546701|Morphine|morphine|mesh-list
110067772|NCT01546701|Buprenorphine|buprenorphine|mesh-list
110067773|NCT01546701|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110067774|NCT01546701|Narcotics|narcotics|mesh-ancestor
110067775|NCT01546701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110067776|NCT01546701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110067777|NCT01546701|Analgesics|analgesics|mesh-ancestor
110067778|NCT01546701|Sensory System Agents|sensory system agents|mesh-ancestor
110067779|NCT01546701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110067780|NCT01546701|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110067781|NCT01546896|Alprazolam|alprazolam|mesh-list
110067782|NCT01546896|Buspirone|buspirone|mesh-list
110067783|NCT01546896|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110067784|NCT01546896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110067785|NCT01546896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110067786|NCT01546896|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110067787|NCT01546896|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110067788|NCT01546896|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110067789|NCT01546896|GABA Modulators|gaba modulators|mesh-ancestor
110067790|NCT01546896|GABA Agents|gaba agents|mesh-ancestor
110067791|NCT01546896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110067792|NCT01546896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110067793|NCT01546896|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110067794|NCT01546896|Serotonin Agents|serotonin agents|mesh-ancestor
110067795|NCT01546935|Oseltamivir|oseltamivir|mesh-list
110067796|NCT01546935|Antiviral Agents|antiviral agents|mesh-ancestor
110067797|NCT01546935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110067798|NCT01546935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110067799|NCT01546935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110067800|NCT01546961|Chloroquine|chloroquine|mesh-list
110067801|NCT01546961|Amebicides|amebicides|mesh-ancestor
110067802|NCT01546961|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110067803|NCT01546961|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110067804|NCT01546961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110067805|NCT01546961|Antimalarials|antimalarials|mesh-ancestor
110067806|NCT01546961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110067807|NCT01547091|Antirheumatic Agents|antirheumatic agents|mesh-list
110067808|NCT01547104|Glimepiride|glimepiride|mesh-list
110067809|NCT01547104|Linagliptin|linagliptin|mesh-list
110067810|NCT01547104|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110067811|NCT01547104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110067812|NCT01547104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110067813|NCT01547104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110067814|NCT01547104|Immunologic Factors|immunologic factors|mesh-ancestor
110067815|NCT01547104|Incretins|incretins|mesh-ancestor
110067816|NCT01547104|Hormones|hormones|mesh-ancestor
110067817|NCT01547104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110067818|NCT01547104|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110067819|NCT01547104|Protease Inhibitors|protease inhibitors|mesh-ancestor
110067820|NCT01547104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110067821|NCT01547104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110067822|NCT01547143|Cyclosporine|cyclosporine|mesh-list
110067823|NCT01547143|Dexamethasone|dexamethasone|mesh-list
110067824|NCT01547143|Etoposide|etoposide|mesh-list
110067825|NCT01547143|Cyclosporins|cyclosporins|mesh-list
110067826|NCT01547143|gamma-Globulins|gamma-globulins|mesh-list
110067827|NCT01547143|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110067828|NCT01547143|Antiemetics|antiemetics|mesh-ancestor
110067829|NCT01547143|Autonomic Agents|autonomic agents|mesh-ancestor
110067830|NCT01547143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110067831|NCT01547143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110067832|NCT01547143|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110067833|NCT01547143|Glucocorticoids|glucocorticoids|mesh-ancestor
110067835|NCT01547143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110067836|NCT01547143|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110067837|NCT01547143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110067838|NCT01547143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110067839|NCT01547143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110067840|NCT01547143|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110067841|NCT01547143|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110067842|NCT01547143|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110067843|NCT01547143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110067844|NCT01547143|Immunologic Factors|immunologic factors|mesh-ancestor
110067845|NCT01547143|Antifungal Agents|antifungal agents|mesh-ancestor
110067846|NCT01547143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110067847|NCT01547143|Dermatologic Agents|dermatologic agents|mesh-ancestor
110067848|NCT01547143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110067849|NCT01547143|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110067850|NCT01547169|Insulin|insulin|mesh-list
110067851|NCT01547169|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110067852|NCT01547169|Insulin Detemir|insulin detemir|mesh-list
110067853|NCT01547169|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110067854|NCT01547169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110067856|NCT01547221|Miconazole|miconazole|mesh-list
110067857|NCT01547221|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110067858|NCT01547221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110067859|NCT01547221|Antifungal Agents|antifungal agents|mesh-ancestor
110067860|NCT01547221|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110067861|NCT01547221|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110067862|NCT01547221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110067863|NCT01547221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110067864|NCT01547221|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110067865|NCT01547221|Hormone Antagonists|hormone antagonists|mesh-ancestor
110067866|NCT01547221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110067867|NCT01547221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110067868|NCT01547221|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110067869|NCT01547221|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110067870|NCT01547312|Interferons|interferons|mesh-list
110067871|NCT01547312|Ribavirin|ribavirin|mesh-list
110067872|NCT01547312|Grazoprevir|grazoprevir|mesh-list
110067873|NCT01547312|Liver Extracts|liver extracts|mesh-list
110067874|NCT01547312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110067875|NCT01547312|Antiviral Agents|antiviral agents|mesh-ancestor
110067876|NCT01547312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110067877|NCT01547312|Antimetabolites|antimetabolites|mesh-ancestor
110067878|NCT01547312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110067879|NCT01547312|Hematinics|hematinics|mesh-ancestor
110067880|NCT01547325|Doxycycline|doxycycline|mesh-list
110067881|NCT01547325|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110067882|NCT01547325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110067883|NCT01547325|Antimalarials|antimalarials|mesh-ancestor
110067884|NCT01547325|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110067885|NCT01547325|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110067886|NCT01547377|Zinc|zinc|mesh-list
110067887|NCT01547377|Selenium|selenium|mesh-list
110067888|NCT01547377|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110067889|NCT01547377|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110067890|NCT01547377|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110067891|NCT01547377|Antimetabolites|antimetabolites|mesh-ancestor
110067892|NCT01547377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110067893|NCT01547377|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110067894|NCT01547377|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110067895|NCT01547377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110067896|NCT01547377|Trace Elements|trace elements|mesh-ancestor
110067897|NCT01547377|Micronutrients|micronutrients|mesh-ancestor
110067898|NCT01547377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110067899|NCT01547377|Antioxidants|antioxidants|mesh-ancestor
110067900|NCT01547377|Protective Agents|protective agents|mesh-ancestor
110067902|NCT01547416|Ropivacaine|ropivacaine|mesh-list
110067903|NCT01547416|Anesthetics, Local|anesthetics, local|mesh-ancestor
110067904|NCT01547416|Anesthetics|anesthetics|mesh-ancestor
110067905|NCT01547416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110067906|NCT01547416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110067907|NCT01547416|Sensory System Agents|sensory system agents|mesh-ancestor
110067908|NCT01547416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110067909|NCT01547416|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110067910|NCT01547416|Narcotics|narcotics|mesh-ancestor
110067911|NCT01547416|Analgesics|analgesics|mesh-ancestor
110067912|NCT01547416|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110067913|NCT01547416|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110067914|NCT01547416|Anesthetics, General|anesthetics, general|mesh-ancestor
110067915|NCT01547455|Atorvastatin|atorvastatin|mesh-list
110067916|NCT01547455|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110067917|NCT01547455|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110067918|NCT01547455|Antimetabolites|antimetabolites|mesh-ancestor
110067919|NCT01547455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110067920|NCT01547455|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110067921|NCT01547455|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110067922|NCT01547455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110067923|NCT01547494|Vitamins|vitamins|mesh-list
110067924|NCT01547494|Micronutrients|micronutrients|mesh-ancestor
110067925|NCT01547494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110067926|NCT01547520|Meperidine|meperidine|mesh-list
110067927|NCT01547520|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110067928|NCT01547520|Narcotics|narcotics|mesh-ancestor
110067929|NCT01547520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110067930|NCT01547520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110067931|NCT01547520|Analgesics|analgesics|mesh-ancestor
110067932|NCT01547520|Sensory System Agents|sensory system agents|mesh-ancestor
110067933|NCT01547520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110067934|NCT01547520|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110067935|NCT01547546|GDC-0084|gdc-0084|mesh-list
110067936|NCT01547546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110067937|NCT01547546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110067938|NCT01547559|Geranylgeranylacetone|geranylgeranylacetone|mesh-list
110067939|NCT01547559|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110067940|NCT01547559|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110067941|NCT01547559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110067942|NCT01548001|Methotrexate|methotrexate|mesh-list
110067943|NCT01548001|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110067944|NCT01548001|Abortifacient Agents|abortifacient agents|mesh-ancestor
110067945|NCT01548001|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110067946|NCT01548001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110067947|NCT01548001|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110067948|NCT01548001|Antimetabolites|antimetabolites|mesh-ancestor
110067949|NCT01548001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110067950|NCT01548001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110067951|NCT01548001|Dermatologic Agents|dermatologic agents|mesh-ancestor
110067952|NCT01548001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110067953|NCT01548001|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110067954|NCT01548001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110067955|NCT01548001|Immunologic Factors|immunologic factors|mesh-ancestor
110067956|NCT01548001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110067957|NCT01548001|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110067958|NCT01548027|Anesthetics|anesthetics|mesh-list
110067959|NCT01548027|Anesthetics, Local|anesthetics, local|mesh-list
110067960|NCT01548027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110067961|NCT01548027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110067962|NCT01548027|Sensory System Agents|sensory system agents|mesh-ancestor
110067963|NCT01548027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110067964|NCT01548066|Valproic Acid|valproic acid|mesh-list
110067965|NCT01548066|Anticonvulsants|anticonvulsants|mesh-ancestor
110067966|NCT01548066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110067967|NCT01548066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110067968|NCT01548066|GABA Agents|gaba agents|mesh-ancestor
110067969|NCT01548066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110067970|NCT01548066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110067971|NCT01548066|Antimanic Agents|antimanic agents|mesh-ancestor
110067972|NCT01548066|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110067973|NCT01548066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110067974|NCT01548066|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110067975|NCT01548079|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
110067976|NCT01548079|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
110067977|NCT01548079|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110067978|NCT01548118|Vaccines|vaccines|mesh-list
110067979|NCT01548118|Immunologic Factors|immunologic factors|mesh-ancestor
110067980|NCT01548118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110067981|NCT01548144|Pemetrexed|pemetrexed|mesh-list
110067982|NCT01548144|Crizotinib|crizotinib|mesh-list
110067983|NCT01548144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110067984|NCT01548144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110067985|NCT01548144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110067986|NCT01548144|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110067987|NCT01548144|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110067988|NCT01548144|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110067989|NCT01548157|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110067990|NCT01548157|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110067991|NCT01548157|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110067992|NCT01548157|Antimetabolites|antimetabolites|mesh-ancestor
110067993|NCT01548157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110067994|NCT01548157|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110067995|NCT01548157|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110067996|NCT01548157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110067997|NCT01548170|Ketoconazole|ketoconazole|mesh-list
110067998|NCT01548170|Sunitinib|sunitinib|mesh-list
110067999|NCT01548170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110068000|NCT01548170|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110068001|NCT01548170|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110068002|NCT01548170|Growth Substances|growth substances|mesh-ancestor
110068003|NCT01548170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110068004|NCT01548170|Growth Inhibitors|growth inhibitors|mesh-ancestor
110068005|NCT01548170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110068006|NCT01548170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110068007|NCT01548170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110068008|NCT01548170|Antifungal Agents|antifungal agents|mesh-ancestor
110068009|NCT01548170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110068010|NCT01548170|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110068011|NCT01548170|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110068012|NCT01548170|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110068013|NCT01548170|Hormone Antagonists|hormone antagonists|mesh-ancestor
110225455|NCT05962151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110068014|NCT01548170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110068015|NCT01548170|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110068016|NCT01548209|Dexmedetomidine|dexmedetomidine|mesh-list
110068017|NCT01548209|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110068018|NCT01548209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110068019|NCT01548209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110068021|NCT01548209|Analgesics|analgesics|mesh-ancestor
110068022|NCT01548209|Sensory System Agents|sensory system agents|mesh-ancestor
110068023|NCT01548209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110068024|NCT01548209|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110068025|NCT01548209|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110068026|NCT01548209|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110068027|NCT01548209|Adrenergic Agents|adrenergic agents|mesh-ancestor
110068028|NCT01548209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110068029|NCT01548209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110068030|NCT01548235|Insulin Aspart|insulin aspart|mesh-list
110068031|NCT01548235|Biphasic Insulins|biphasic insulins|mesh-list
110068032|NCT01548235|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
110068033|NCT01548235|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110068034|NCT01548235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110068035|NCT01548248|Insulin|insulin|mesh-list
110068036|NCT01548248|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110068037|NCT01548248|Insulin Aspart|insulin aspart|mesh-list
110068038|NCT01548248|Insulin Detemir|insulin detemir|mesh-list
110068039|NCT01548248|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110068040|NCT01548248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110068041|NCT01548274|Sarpogrelate|sarpogrelate|mesh-list
110068042|NCT01548274|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110068043|NCT01548274|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110068044|NCT01548274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110068045|NCT01548274|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110068046|NCT01548274|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110068047|NCT01548274|Serotonin Agents|serotonin agents|mesh-ancestor
110068048|NCT01548274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110068049|NCT01548274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110068050|NCT01548326|Atorvastatin|atorvastatin|mesh-list
110068051|NCT01548326|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110068052|NCT01548326|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110068053|NCT01548326|Antimetabolites|antimetabolites|mesh-ancestor
110068054|NCT01548326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110068055|NCT01548326|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110068056|NCT01548326|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110068057|NCT01548326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110068058|NCT01548482|Sirolimus|sirolimus|mesh-list
110068059|NCT01548482|Temsirolimus|temsirolimus|mesh-list
110068060|NCT01548482|Trebananib|trebananib|mesh-list
110068061|NCT01548482|MTOR Inhibitors|mtor inhibitors|mesh-list
110068062|NCT01548482|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110068063|NCT01548482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110068064|NCT01548482|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110068065|NCT01548482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110068066|NCT01548482|Antifungal Agents|antifungal agents|mesh-ancestor
110068067|NCT01548482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110068068|NCT01548482|Immunologic Factors|immunologic factors|mesh-ancestor
110068069|NCT01548482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110068070|NCT01548482|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110068071|NCT01548482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110068072|NCT01548482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110068073|NCT01548482|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110068074|NCT01548482|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110068075|NCT01548482|Growth Substances|growth substances|mesh-ancestor
110068076|NCT01548482|Growth Inhibitors|growth inhibitors|mesh-ancestor
110068077|NCT01548521|Oxytocin|oxytocin|mesh-list
110068078|NCT01548521|Oxytocics|oxytocics|mesh-ancestor
110068079|NCT01548521|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110068080|NCT01548521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110068081|NCT01548560|Dapivirine|dapivirine|mesh-list
110068082|NCT01548560|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110068083|NCT01548560|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110068084|NCT01548560|Antiviral Agents|antiviral agents|mesh-ancestor
110068085|NCT01548560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110068086|NCT01548612|Nitroprusside|nitroprusside|mesh-list
110068087|NCT01548612|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110068088|NCT01548612|Vasodilator Agents|vasodilator agents|mesh-ancestor
110068089|NCT01548612|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
110068090|NCT01548612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110068091|NCT01548677|Trastuzumab|trastuzumab|mesh-list
110068092|NCT01548677|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110068093|NCT01548677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110068094|NCT01548703|BCI-838|bci-838|mesh-list
110068095|NCT01548703|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110068096|NCT01548703|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110068097|NCT01548703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110068098|NCT01548703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110068099|NCT01548703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110068101|NCT01548794|Bupivacaine|bupivacaine|mesh-list
110068102|NCT01548794|Anesthetics|anesthetics|mesh-list
110068103|NCT01548794|Anesthetics, Local|anesthetics, local|mesh-ancestor
110068104|NCT01548794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110068105|NCT01548794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110068106|NCT01548794|Sensory System Agents|sensory system agents|mesh-ancestor
110068107|NCT01548794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110068108|NCT01548794|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110068109|NCT01548794|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110068110|NCT01548794|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110068111|NCT01548794|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110068112|NCT01548794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110068113|NCT01548807|Everolimus|everolimus|mesh-list
110068114|NCT01548807|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110068115|NCT01548807|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110068116|NCT01548807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110068117|NCT01548807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110068118|NCT01548807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110068119|NCT01548807|Immunologic Factors|immunologic factors|mesh-ancestor
110068120|NCT01548807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110068121|NCT01548807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110068122|NCT01548859|Midazolam|midazolam|mesh-list
110068123|NCT01548859|Sevoflurane|sevoflurane|mesh-list
110068124|NCT01548859|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110068125|NCT01548859|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110068126|NCT01548859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110068127|NCT01548859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110068128|NCT01548859|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110068129|NCT01548859|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110068130|NCT01548859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110068131|NCT01548859|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110068132|NCT01548859|Anesthetics, General|anesthetics, general|mesh-ancestor
110068133|NCT01548859|Anesthetics|anesthetics|mesh-ancestor
110068134|NCT01548859|GABA Modulators|gaba modulators|mesh-ancestor
110068135|NCT01548859|GABA Agents|gaba agents|mesh-ancestor
110068136|NCT01548859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110068137|NCT01548859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110068139|NCT01548859|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110068140|NCT01548872|Cardioplegic Solutions|cardioplegic solutions|mesh-list
110068141|NCT01548872|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110068142|NCT01548911|Gemtuzumab|gemtuzumab|mesh-list
110068143|NCT01548911|Calicheamicins|calicheamicins|mesh-list
110068144|NCT01548911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110068145|NCT01548911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110068146|NCT01548911|Immunotoxins|immunotoxins|mesh-ancestor
110068147|NCT01548911|Immunoconjugates|immunoconjugates|mesh-ancestor
110068148|NCT01548911|Immunologic Factors|immunologic factors|mesh-ancestor
110068149|NCT01548911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110068150|NCT01548911|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110068151|NCT01548924|Paclitaxel|paclitaxel|mesh-list
110068152|NCT01548924|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110068153|NCT01548924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110068154|NCT01548924|Tubulin Modulators|tubulin modulators|mesh-ancestor
110068155|NCT01548924|Antimitotic Agents|antimitotic agents|mesh-ancestor
110068156|NCT01548924|Mitosis Modulators|mitosis modulators|mesh-ancestor
110068157|NCT01548924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110068158|NCT01548950|Bosentan|bosentan|mesh-list
110068159|NCT01548950|Sildenafil Citrate|sildenafil citrate|mesh-list
110068160|NCT01548950|Vasodilator Agents|vasodilator agents|mesh-ancestor
110068161|NCT01548950|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110068162|NCT01548950|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110068163|NCT01548950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110068164|NCT01548950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110068165|NCT01548950|Urological Agents|urological agents|mesh-ancestor
110068166|NCT01548950|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110068167|NCT01548950|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
110068168|NCT01549093|Carboplatin|carboplatin|mesh-list
110068169|NCT01549093|Gemcitabine|gemcitabine|mesh-list
110068170|NCT01549093|Endostar protein|endostar protein|mesh-list
110068171|NCT01549093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110068172|NCT01549093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110068173|NCT01549093|Antimetabolites|antimetabolites|mesh-ancestor
110068174|NCT01549093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110068175|NCT01549093|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110068176|NCT01549093|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110068177|NCT01549093|Growth Substances|growth substances|mesh-ancestor
110068178|NCT01549093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110068179|NCT01549093|Growth Inhibitors|growth inhibitors|mesh-ancestor
110068180|NCT01549158|Torsemide|torsemide|mesh-list
110068181|NCT01549158|Furosemide|furosemide|mesh-list
110068182|NCT01549158|Diuretics|diuretics|mesh-ancestor
110068183|NCT01549158|Natriuretic Agents|natriuretic agents|mesh-ancestor
110068184|NCT01549158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110068185|NCT01549158|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110068186|NCT01549158|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110068187|NCT01549158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110068188|NCT01549158|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110068189|NCT01549171|Iloprost|iloprost|mesh-list
110068190|NCT01549171|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110068191|NCT01549171|Vasodilator Agents|vasodilator agents|mesh-ancestor
110068192|NCT01549236|Benzonidazole|benzonidazole|mesh-list
110068193|NCT01549236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110068194|NCT01549236|Immunologic Factors|immunologic factors|mesh-ancestor
110068195|NCT01549236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110068196|NCT01549236|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
110068197|NCT01549236|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110068198|NCT01549236|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110068200|NCT01549301|Lenograstim|lenograstim|mesh-list
110068201|NCT01549301|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110068202|NCT01549301|Immunologic Factors|immunologic factors|mesh-ancestor
110068203|NCT01549301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110068205|NCT01549418|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110068206|NCT01549418|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110068207|NCT01549418|Analgesics|analgesics|mesh-ancestor
110068208|NCT01549418|Sensory System Agents|sensory system agents|mesh-ancestor
110068209|NCT01549418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110068210|NCT01549418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110068211|NCT01549418|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110068212|NCT01549418|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110068213|NCT01549418|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110068214|NCT01549418|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110068215|NCT01549418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110068216|NCT01549418|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110068217|NCT01549418|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110068218|NCT01549418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110068219|NCT01549418|Antipyretics|antipyretics|mesh-ancestor
110068220|NCT01549431|Dexamethasone|dexamethasone|mesh-list
110068221|NCT01549431|Panobinostat|panobinostat|mesh-list
110068222|NCT01549431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110068223|NCT01549431|Antiemetics|antiemetics|mesh-ancestor
110068224|NCT01549431|Autonomic Agents|autonomic agents|mesh-ancestor
110068225|NCT01549431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110068226|NCT01549431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110068228|NCT01549431|Glucocorticoids|glucocorticoids|mesh-ancestor
110068229|NCT01549431|Hormones|hormones|mesh-ancestor
110068230|NCT01549431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110068231|NCT01549431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110068232|NCT01549431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110068233|NCT01549431|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110068234|NCT01549431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110068235|NCT01549431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110068236|NCT01549496|Amlodipine|amlodipine|mesh-list
110068237|NCT01549496|Diltiazem|diltiazem|mesh-list
110068238|NCT01549496|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110068239|NCT01549496|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110068240|NCT01549496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110068241|NCT01549496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110068242|NCT01549496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110068243|NCT01549496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110068244|NCT01549496|Vasodilator Agents|vasodilator agents|mesh-ancestor
110068245|NCT01549548|Ponatinib|ponatinib|mesh-list
110068246|NCT01549548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110068247|NCT01549548|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110068248|NCT01549548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110068249|NCT01549548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110068250|NCT01549574|Crizotinib|crizotinib|mesh-list
110068251|NCT01549574|Esomeprazole|esomeprazole|mesh-list
110068252|NCT01549574|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110068253|NCT01549574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110068254|NCT01549574|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110068255|NCT01549574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110068256|NCT01549574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110068257|NCT01549574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110068258|NCT01549574|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110068259|NCT01549600|Psyllium|psyllium|mesh-list
110068260|NCT01549600|Cathartics|cathartics|mesh-ancestor
110068261|NCT01549600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110068262|NCT01549691|Alprazolam|alprazolam|mesh-list
110068263|NCT01549691|Zopiclone|zopiclone|mesh-list
110068264|NCT01549691|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110068265|NCT01549691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110068266|NCT01549691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110068267|NCT01549691|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110068268|NCT01549691|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110068269|NCT01549691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110068270|NCT01549691|GABA Modulators|gaba modulators|mesh-ancestor
110068271|NCT01549691|GABA Agents|gaba agents|mesh-ancestor
110068272|NCT01549691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110068273|NCT01549691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110068274|NCT01549704|Ropivacaine|ropivacaine|mesh-list
110068275|NCT01549704|Anesthetics, Local|anesthetics, local|mesh-ancestor
110068276|NCT01549704|Anesthetics|anesthetics|mesh-ancestor
110068277|NCT01549704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110068278|NCT01549704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110068279|NCT01549704|Sensory System Agents|sensory system agents|mesh-ancestor
110068280|NCT01549704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110068281|NCT01549743|Celecoxib|celecoxib|mesh-list
110068282|NCT01549743|Rebamipide|rebamipide|mesh-list
110068283|NCT01549743|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110068284|NCT01549743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110068285|NCT01549743|Analgesics|analgesics|mesh-ancestor
110068286|NCT01549743|Sensory System Agents|sensory system agents|mesh-ancestor
110068287|NCT01549743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110068288|NCT01549743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110068289|NCT01549743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110068290|NCT01549743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110068291|NCT01549743|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110068292|NCT01549743|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110068293|NCT01549743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110068294|NCT01549743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110068295|NCT01549743|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110068296|NCT01549743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110068298|NCT01549743|Protective Agents|protective agents|mesh-ancestor
110068299|NCT01549795|Capecitabine|capecitabine|mesh-list
110068300|NCT01549795|Liver Extracts|liver extracts|mesh-list
110068301|NCT01549795|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110068302|NCT01549795|Antimetabolites|antimetabolites|mesh-ancestor
110068303|NCT01549795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110068304|NCT01549795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110068305|NCT01549795|Hematinics|hematinics|mesh-ancestor
110068306|NCT01549847|Piracetam|piracetam|mesh-list
110068307|NCT01549847|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110068308|NCT01549847|Protective Agents|protective agents|mesh-ancestor
110068309|NCT01549847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110068310|NCT01549847|Nootropic Agents|nootropic agents|mesh-ancestor
110068311|NCT01549938|Cholecalciferol|cholecalciferol|mesh-list
110068312|NCT01549938|Vitamin D|vitamin d|mesh-list
110068313|NCT01549938|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110068314|NCT01549938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110068315|NCT01549938|Vitamins|vitamins|mesh-ancestor
110068316|NCT01549938|Micronutrients|micronutrients|mesh-ancestor
110068317|NCT01549938|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110068318|NCT01549990|Sevoflurane|sevoflurane|mesh-list
110068319|NCT01549990|Desflurane|desflurane|mesh-list
110068320|NCT01549990|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110068321|NCT01549990|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110068322|NCT01549990|Anesthetics, General|anesthetics, general|mesh-ancestor
110068323|NCT01549990|Anesthetics|anesthetics|mesh-ancestor
110068324|NCT01549990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110068325|NCT01549990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110068327|NCT01550055|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110068328|NCT01550055|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110068329|NCT01550055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110068330|NCT01550055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110068331|NCT01550055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110068332|NCT01550107|Allopurinol|allopurinol|mesh-list
110068333|NCT01550107|Antimetabolites|antimetabolites|mesh-ancestor
110068334|NCT01550107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110068335|NCT01550107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110068336|NCT01550107|Gout Suppressants|gout suppressants|mesh-ancestor
110068337|NCT01550107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110068338|NCT01550107|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110068339|NCT01550107|Antioxidants|antioxidants|mesh-ancestor
110068340|NCT01550107|Protective Agents|protective agents|mesh-ancestor
110068341|NCT01550107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110068342|NCT01550146|Dexamethasone|dexamethasone|mesh-list
110068343|NCT01550146|Dexamethasone acetate|dexamethasone acetate|mesh-list
110068345|NCT01550146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110068346|NCT01550146|Antiemetics|antiemetics|mesh-ancestor
110068347|NCT01550146|Autonomic Agents|autonomic agents|mesh-ancestor
110068348|NCT01550146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110068349|NCT01550146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110068350|NCT01550146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110068351|NCT01550146|Glucocorticoids|glucocorticoids|mesh-ancestor
110068352|NCT01550146|Hormones|hormones|mesh-ancestor
110068353|NCT01550146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110068354|NCT01550146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110068355|NCT01550146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110068356|NCT01550146|Protease Inhibitors|protease inhibitors|mesh-ancestor
110068357|NCT01550146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110178946|NCT03341143|Pembrolizumab|pembrolizumab|mesh-list
110068358|NCT01550146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110068360|NCT01550302|Anesthetics, Local|anesthetics, local|mesh-ancestor
110068361|NCT01550302|Anesthetics|anesthetics|mesh-ancestor
110068362|NCT01550302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110068363|NCT01550302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110068364|NCT01550302|Sensory System Agents|sensory system agents|mesh-ancestor
110068365|NCT01550302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110068366|NCT01550354|Alfentanil|alfentanil|mesh-list
110068367|NCT01550354|Propofol|propofol|mesh-list
110068368|NCT01550354|Rocuronium|rocuronium|mesh-list
110068369|NCT01550354|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110068370|NCT01550354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110068371|NCT01550354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110068372|NCT01550354|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110068373|NCT01550354|Anesthetics, General|anesthetics, general|mesh-ancestor
110068374|NCT01550354|Anesthetics|anesthetics|mesh-ancestor
110068375|NCT01550354|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110068376|NCT01550354|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110068377|NCT01550354|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110068378|NCT01550354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110068379|NCT01550354|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110068380|NCT01550354|Narcotics|narcotics|mesh-ancestor
110068381|NCT01550354|Analgesics|analgesics|mesh-ancestor
110068382|NCT01550354|Sensory System Agents|sensory system agents|mesh-ancestor
110068383|NCT01550419|Atorvastatin|atorvastatin|mesh-list
110068384|NCT01550419|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110068385|NCT01550419|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110068386|NCT01550419|Antimetabolites|antimetabolites|mesh-ancestor
110068387|NCT01550419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110068388|NCT01550419|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110068389|NCT01550419|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110068390|NCT01550419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110068391|NCT01550445|Prednisolone|prednisolone|mesh-list
110068392|NCT01550445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110068393|NCT01550445|Glucocorticoids|glucocorticoids|mesh-ancestor
110068394|NCT01550445|Hormones|hormones|mesh-ancestor
110068395|NCT01550445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110068396|NCT01550445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110068397|NCT01550445|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110068398|NCT01550445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110068399|NCT01550640|Remifentanil|remifentanil|mesh-list
110068400|NCT01550640|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110068401|NCT01550640|Narcotics|narcotics|mesh-ancestor
110068402|NCT01550640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110068403|NCT01550640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110068404|NCT01550640|Analgesics|analgesics|mesh-ancestor
110068405|NCT01550640|Sensory System Agents|sensory system agents|mesh-ancestor
110068406|NCT01550640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110068407|NCT01550653|Liraglutide|liraglutide|mesh-list
110068408|NCT01550653|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110068409|NCT01550653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110068410|NCT01550653|Incretins|incretins|mesh-ancestor
110068412|NCT01550653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110068413|NCT01550770|Propofol|propofol|mesh-list
110068414|NCT01550770|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110068415|NCT01550770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110068416|NCT01550770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110068417|NCT01550770|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110068418|NCT01550770|Anesthetics, General|anesthetics, general|mesh-ancestor
110068419|NCT01550770|Anesthetics|anesthetics|mesh-ancestor
110068420|NCT01550848|Gemcitabine|gemcitabine|mesh-list
110068421|NCT01550848|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110068422|NCT01550848|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110068423|NCT01550848|Antimetabolites|antimetabolites|mesh-ancestor
110068424|NCT01550848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110068425|NCT01550848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110068426|NCT01550900|Metformin|metformin|mesh-list
110068427|NCT01550900|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110068428|NCT01550900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110068429|NCT01550926|Orlistat|orlistat|mesh-list
110068430|NCT01550926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110068431|NCT01550926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110068432|NCT01550926|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110068433|NCT01550926|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110068434|NCT01551004|REP 3123|rep 3123|mesh-list
110068435|NCT01551004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110068436|NCT01551004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110068437|NCT01551069|Hydroxychloroquine|hydroxychloroquine|mesh-list
110068438|NCT01551069|Antimalarials|antimalarials|mesh-ancestor
110068439|NCT01551069|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110068440|NCT01551069|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110068441|NCT01551069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110068442|NCT01551069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110068443|NCT01551069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110068444|NCT01551069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110068445|NCT01550458|Mibefradil|mibefradil|mesh-list
110068446|NCT01550458|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110068447|NCT01550458|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110068448|NCT01550458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110068449|NCT01550458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110068450|NCT01550458|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110068451|NCT01550458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110068452|NCT01550458|Vasodilator Agents|vasodilator agents|mesh-ancestor
110068453|NCT01550458|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110068454|NCT01550458|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110068455|NCT01550458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110068457|NCT01551147|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110068458|NCT01551147|Respiratory System Agents|respiratory system agents|mesh-ancestor
110068459|NCT01551147|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110068460|NCT01551147|Hormone Antagonists|hormone antagonists|mesh-ancestor
110068461|NCT01551147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110068462|NCT01551147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110068463|NCT01551147|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110068464|NCT01551147|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110094947|NCT01711814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110068465|NCT01551147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110068466|NCT01551225|Escitalopram|escitalopram|mesh-list
110068467|NCT01551225|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110068468|NCT01551225|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110068469|NCT01551225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110068470|NCT01551225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110068471|NCT01551225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110068472|NCT01551225|Serotonin Agents|serotonin agents|mesh-ancestor
110068473|NCT01551225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110068474|NCT01551290|Infliximab|infliximab|mesh-list
110068475|NCT01551290|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110068476|NCT01551290|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110068477|NCT01551290|Dermatologic Agents|dermatologic agents|mesh-ancestor
110068478|NCT01551290|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110068479|NCT01551290|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110068480|NCT01551329|Ketamine|ketamine|mesh-list
110068481|NCT01551329|Analgesics|analgesics|mesh-ancestor
110068482|NCT01551329|Sensory System Agents|sensory system agents|mesh-ancestor
110068483|NCT01551329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110068484|NCT01551329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110068485|NCT01551329|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110068486|NCT01551329|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110068487|NCT01551329|Anesthetics, General|anesthetics, general|mesh-ancestor
110068488|NCT01551329|Anesthetics|anesthetics|mesh-ancestor
110068489|NCT01551329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110178959|NCT00405535|Glycine|glycine|mesh-list
110068490|NCT01551329|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110068491|NCT01551329|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110068492|NCT01551329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110068493|NCT01551329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110068494|NCT01551368|Nimodipine|nimodipine|mesh-list
110068495|NCT01551368|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110068496|NCT01551368|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110068497|NCT01551368|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110068498|NCT01551368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110068499|NCT01551368|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110068500|NCT01551368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110068501|NCT01551368|Vasodilator Agents|vasodilator agents|mesh-ancestor
110068502|NCT01551394|Gentamicins|gentamicins|mesh-list
110068503|NCT01551394|Meropenem|meropenem|mesh-list
110068504|NCT01551394|Ampicillin|ampicillin|mesh-list
110068505|NCT01551394|Cefotaxime|cefotaxime|mesh-list
110068507|NCT01551394|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110068508|NCT01551394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110068509|NCT01551394|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110068510|NCT01551394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110068511|NCT01551394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110068512|NCT01551459|Sunitinib|sunitinib|mesh-list
110068513|NCT01551459|Dacarbazine|dacarbazine|mesh-list
110068514|NCT01551459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110068515|NCT01551459|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110068516|NCT01551459|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110068517|NCT01551459|Growth Substances|growth substances|mesh-ancestor
110068518|NCT01551459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110068519|NCT01551459|Growth Inhibitors|growth inhibitors|mesh-ancestor
110068520|NCT01551459|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110068521|NCT01551459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110068522|NCT01551459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110068523|NCT01551459|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110068524|NCT01551459|Alkylating Agents|alkylating agents|mesh-ancestor
110068525|NCT01551485|Zolpidem|zolpidem|mesh-list
110068526|NCT01551485|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110068527|NCT01551485|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110068528|NCT01551485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110068529|NCT01551485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110068530|NCT01551485|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
110068531|NCT01551485|GABA Agonists|gaba agonists|mesh-ancestor
110068532|NCT01551485|GABA Agents|gaba agents|mesh-ancestor
110068533|NCT01551485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110068534|NCT01551485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110068535|NCT01551511|Dronabinol|dronabinol|mesh-list
110068536|NCT01551511|Hallucinogens|hallucinogens|mesh-ancestor
110068537|NCT01551511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110068538|NCT01551511|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110068539|NCT01551511|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110068540|NCT01551511|Analgesics|analgesics|mesh-ancestor
110068541|NCT01551511|Sensory System Agents|sensory system agents|mesh-ancestor
110068542|NCT01551511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110068543|NCT01551511|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
110068544|NCT01551511|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110068545|NCT01551511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110068546|NCT01551511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110068548|NCT01551511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110068549|NCT01551589|Docetaxel|docetaxel|mesh-list
110068550|NCT01551589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110068551|NCT01551589|Tubulin Modulators|tubulin modulators|mesh-ancestor
110068552|NCT01551589|Antimitotic Agents|antimitotic agents|mesh-ancestor
110068553|NCT01551589|Mitosis Modulators|mitosis modulators|mesh-ancestor
110068554|NCT01551589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110068555|NCT01551615|Metformin|metformin|mesh-list
110068556|NCT01551615|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110068557|NCT01551615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110068558|NCT01551628|BCT-100|bct-100|mesh-list
110068559|NCT01551628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110068560|NCT01551641|Thalidomide|thalidomide|mesh-list
110068561|NCT01551641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110068562|NCT01551641|Immunologic Factors|immunologic factors|mesh-ancestor
110068563|NCT01551641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110068564|NCT01551641|Leprostatic Agents|leprostatic agents|mesh-ancestor
110068565|NCT01551641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110068566|NCT01551641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110068567|NCT01551641|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110068568|NCT01551641|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110068569|NCT01551641|Growth Substances|growth substances|mesh-ancestor
110068570|NCT01551641|Growth Inhibitors|growth inhibitors|mesh-ancestor
110068571|NCT01551641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110068572|NCT01551667|Antibodies|antibodies|mesh-list
110068573|NCT01551667|Immunologic Factors|immunologic factors|mesh-ancestor
110068574|NCT01551667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110068575|NCT01551680|Iniparib|iniparib|mesh-list
110068576|NCT01551680|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110068577|NCT01551680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110068578|NCT01551680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110068579|NCT01551680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110068580|NCT01551719|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110068581|NCT01551719|Vancomycin|vancomycin|mesh-list
110068582|NCT01551719|Linezolid|linezolid|mesh-list
110068583|NCT01551719|Daptomycin|daptomycin|mesh-list
110068584|NCT01551719|Penicillins|penicillins|mesh-list
110068585|NCT01551719|Tigecycline|tigecycline|mesh-list
110068586|NCT01551719|Cephalosporins|cephalosporins|mesh-list
110068587|NCT01551719|Teicoplanin|teicoplanin|mesh-list
110068588|NCT01551719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110068589|NCT01551719|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110068590|NCT01551719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110068591|NCT01551719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110068592|NCT01551797|Acetaminophen|acetaminophen|mesh-list
110068593|NCT01551797|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110068594|NCT01551797|Analgesics|analgesics|mesh-ancestor
110068595|NCT01551797|Sensory System Agents|sensory system agents|mesh-ancestor
110068596|NCT01551797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110068597|NCT01551797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110068598|NCT01551797|Antipyretics|antipyretics|mesh-ancestor
110068600|NCT01551810|Immunologic Factors|immunologic factors|mesh-ancestor
110068601|NCT01551810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110068603|NCT01551823|Immunologic Factors|immunologic factors|mesh-ancestor
110068604|NCT01551823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110068605|NCT01551836|Acetaminophen|acetaminophen|mesh-list
110068606|NCT01551836|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110068607|NCT01551836|Analgesics|analgesics|mesh-ancestor
110068608|NCT01551836|Sensory System Agents|sensory system agents|mesh-ancestor
110068609|NCT01551836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110068610|NCT01551836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110068611|NCT01551836|Antipyretics|antipyretics|mesh-ancestor
110068612|NCT01552005|Saxagliptin|saxagliptin|mesh-list
110068613|NCT01552005|Incretins|incretins|mesh-ancestor
110068614|NCT01552005|Hormones|hormones|mesh-ancestor
110068615|NCT01552005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110068616|NCT01552005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110068617|NCT01552005|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110068618|NCT01552005|Protease Inhibitors|protease inhibitors|mesh-ancestor
110068619|NCT01552005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110225456|NCT05959356|Leucovorin|leucovorin|mesh-list
110068621|NCT01552005|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110068622|NCT01552018|Saxagliptin|saxagliptin|mesh-list
110068623|NCT01552018|Incretins|incretins|mesh-ancestor
110068624|NCT01552018|Hormones|hormones|mesh-ancestor
110068625|NCT01552018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110068626|NCT01552018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110068627|NCT01552018|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110068628|NCT01552018|Protease Inhibitors|protease inhibitors|mesh-ancestor
110068629|NCT01552018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110068630|NCT01552018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110068631|NCT01552018|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110068632|NCT01552044|Spironolactone|spironolactone|mesh-list
110068633|NCT01552044|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110068635|NCT01552044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110068636|NCT01552044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110068637|NCT01552044|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110068638|NCT01552044|Diuretics|diuretics|mesh-ancestor
110068639|NCT01552044|Natriuretic Agents|natriuretic agents|mesh-ancestor
110068640|NCT01552122|Vitamin D|vitamin d|mesh-list
110068641|NCT01552122|Cholecalciferol|cholecalciferol|mesh-list
110068642|NCT01552122|Alendronate|alendronate|mesh-list
110068643|NCT01552122|Calcium Carbonate|calcium carbonate|mesh-list
110068644|NCT01552122|Calcium|calcium|mesh-list
110068645|NCT01552122|Vitamins|vitamins|mesh-ancestor
110068646|NCT01552122|Micronutrients|micronutrients|mesh-ancestor
110068647|NCT01552122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110068648|NCT01552122|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110068649|NCT01552122|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110068650|NCT01552122|Antacids|antacids|mesh-ancestor
110068651|NCT01552122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110068652|NCT01552122|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110068653|NCT01552148|Morphine|morphine|mesh-list
110068654|NCT01552148|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110068655|NCT01552148|Narcotics|narcotics|mesh-ancestor
110068656|NCT01552148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110068657|NCT01552148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110068658|NCT01552148|Analgesics|analgesics|mesh-ancestor
110068659|NCT01552148|Sensory System Agents|sensory system agents|mesh-ancestor
110068660|NCT01552148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110068661|NCT01552187|Colchicine|colchicine|mesh-list
110068662|NCT01552187|Gout Suppressants|gout suppressants|mesh-ancestor
110068663|NCT01552187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110068664|NCT01552187|Tubulin Modulators|tubulin modulators|mesh-ancestor
110068665|NCT01552187|Antimitotic Agents|antimitotic agents|mesh-ancestor
110068666|NCT01552187|Mitosis Modulators|mitosis modulators|mesh-ancestor
110068667|NCT01552187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110068668|NCT01552187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110068670|NCT01552330|Primaquine|primaquine|mesh-list
110068671|NCT01552330|Pyronaridine|pyronaridine|mesh-list
110068672|NCT01552330|Pyronaridine tetraphosphate, artesunate drug combination|pyronaridine tetraphosphate, artesunate drug combination|mesh-list
110068673|NCT01552330|Antimalarials|antimalarials|mesh-ancestor
110068674|NCT01552330|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110068675|NCT01552330|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110068676|NCT01552330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110068677|NCT01552330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110068678|NCT01552330|Antiviral Agents|antiviral agents|mesh-ancestor
110068679|NCT01552330|Schistosomicides|schistosomicides|mesh-ancestor
110068680|NCT01552330|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110068681|NCT01552330|Anthelmintics|anthelmintics|mesh-ancestor
110068683|NCT01552629|Cyclosporins|cyclosporins|mesh-list
110068684|NCT01552629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110068685|NCT01552629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110068686|NCT01552629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110068687|NCT01552629|Immunologic Factors|immunologic factors|mesh-ancestor
110068688|NCT01552629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110068689|NCT01552629|Antifungal Agents|antifungal agents|mesh-ancestor
110068690|NCT01552629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110068691|NCT01552629|Dermatologic Agents|dermatologic agents|mesh-ancestor
110068692|NCT01552629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110068693|NCT01552629|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110068694|NCT01552668|Fidaxomicin|fidaxomicin|mesh-list
110068695|NCT01552668|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110068696|NCT01552668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110068697|NCT01552798|Aspirin|aspirin|mesh-list
110068698|NCT01552798|Acetaminophen|acetaminophen|mesh-list
110068699|NCT01552798|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110068700|NCT01552798|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110068701|NCT01552798|Analgesics|analgesics|mesh-ancestor
110068702|NCT01552798|Sensory System Agents|sensory system agents|mesh-ancestor
110068704|NCT01552798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110068705|NCT01552798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110068706|NCT01552798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110068707|NCT01552798|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110068708|NCT01552798|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110068709|NCT01552798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110068710|NCT01552798|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110068711|NCT01552798|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110068712|NCT01552798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110068713|NCT01552798|Antipyretics|antipyretics|mesh-ancestor
110068714|NCT01552837|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110068715|NCT01552837|Antidepressive Agents|antidepressive agents|mesh-ancestor
110068716|NCT01552837|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110068717|NCT01552837|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110068718|NCT01552837|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110389721|NCT00954226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110068719|NCT01552837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110068720|NCT01552837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110068722|NCT01552850|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110068723|NCT01552850|Narcotics|narcotics|mesh-ancestor
110068724|NCT01552850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110068725|NCT01552850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110068726|NCT01552850|Analgesics|analgesics|mesh-ancestor
110068727|NCT01552850|Sensory System Agents|sensory system agents|mesh-ancestor
110068728|NCT01552850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110068729|NCT01552863|Oxycodone|oxycodone|mesh-list
110068730|NCT01552863|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110068731|NCT01552863|Narcotics|narcotics|mesh-ancestor
110068732|NCT01552863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110068733|NCT01552863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110068734|NCT01552863|Analgesics|analgesics|mesh-ancestor
110068735|NCT01552863|Sensory System Agents|sensory system agents|mesh-ancestor
110068736|NCT01552863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110068737|NCT01552967|Capecitabine|capecitabine|mesh-list
110068738|NCT01552967|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110068739|NCT01552967|Antimetabolites|antimetabolites|mesh-ancestor
110068740|NCT01552967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110068741|NCT01552967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110068743|NCT01552980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110068745|NCT01552993|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110068746|NCT01552993|Analgesics|analgesics|mesh-ancestor
110068747|NCT01552993|Sensory System Agents|sensory system agents|mesh-ancestor
110068748|NCT01552993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110068749|NCT01552993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110068750|NCT01552993|Antipyretics|antipyretics|mesh-ancestor
110068751|NCT01553006|Cefditoren pivoxil|cefditoren pivoxil|mesh-list
110068752|NCT01553006|Cefditoren|cefditoren|mesh-list
110068753|NCT01553006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110068754|NCT01553006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110068755|NCT01553019|Gemcitabine|gemcitabine|mesh-list
110068756|NCT01553019|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110068757|NCT01553019|Antimetabolites|antimetabolites|mesh-ancestor
110068758|NCT01553019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110068759|NCT01553019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110068760|NCT01553123|Ulipristal acetate|ulipristal acetate|mesh-list
110068761|NCT01553123|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110068762|NCT01553123|Contraceptive Agents|contraceptive agents|mesh-ancestor
110068763|NCT01553123|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110068764|NCT01553123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110389801|NCT00217737|Antimetabolites|antimetabolites|mesh-ancestor
110068765|NCT01553123|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110068766|NCT01553357|Dexamethasone|dexamethasone|mesh-list
110068767|NCT01553357|Lenalidomide|lenalidomide|mesh-list
110068768|NCT01553357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110068769|NCT01553357|Antiemetics|antiemetics|mesh-ancestor
110068770|NCT01553357|Autonomic Agents|autonomic agents|mesh-ancestor
110068771|NCT01553357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110068772|NCT01553357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110068773|NCT01553357|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110068774|NCT01553357|Glucocorticoids|glucocorticoids|mesh-ancestor
110068776|NCT01553357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110068777|NCT01553357|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110068778|NCT01553357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110068779|NCT01553357|Immunologic Factors|immunologic factors|mesh-ancestor
110068780|NCT01553357|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110068781|NCT01553357|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110068782|NCT01553357|Growth Substances|growth substances|mesh-ancestor
110068783|NCT01553357|Growth Inhibitors|growth inhibitors|mesh-ancestor
110068784|NCT01553435|Dextromethorphan|dextromethorphan|mesh-list
110068785|NCT01553435|Antitussive Agents|antitussive agents|mesh-ancestor
110068786|NCT01553435|Respiratory System Agents|respiratory system agents|mesh-ancestor
110068787|NCT01553435|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110068788|NCT01553435|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110068789|NCT01553435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110068790|NCT01553435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110068791|NCT01553435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110068792|NCT01553500|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
110068793|NCT01553500|Cathartics|cathartics|mesh-ancestor
110068794|NCT01553500|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110068795|NCT01553617|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
110068796|NCT01553617|Plasma Substitutes|plasma substitutes|mesh-ancestor
110068797|NCT01553617|Blood Substitutes|blood substitutes|mesh-ancestor
110068798|NCT01553721|Udenafil|udenafil|mesh-list
110068799|NCT01553721|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110068800|NCT01553721|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110068801|NCT01553721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110179068|NCT01466361|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110068802|NCT01553721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110068803|NCT01553773|Estradiol|estradiol|mesh-list
110068804|NCT01553773|Estrogens|estrogens|mesh-ancestor
110068805|NCT01553773|Hormones|hormones|mesh-ancestor
110225457|NCT05959356|Oxaliplatin|oxaliplatin|mesh-list
110225458|NCT05959356|Irinotecan|irinotecan|mesh-list
110068806|NCT01553773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110068807|NCT01553773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110068809|NCT01553786|Immunologic Factors|immunologic factors|mesh-ancestor
110068810|NCT01553786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110068811|NCT01553786|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110068812|NCT01553786|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110068813|NCT01553786|Growth Substances|growth substances|mesh-ancestor
110068814|NCT01553786|Growth Inhibitors|growth inhibitors|mesh-ancestor
110389877|NCT00003838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110389878|NCT00003838|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110389879|NCT00003838|Antifungal Agents|antifungal agents|mesh-ancestor
110389880|NCT00003838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110389881|NCT00003838|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110389882|NCT00003838|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110389893|NCT06031454|Verapamil|verapamil|mesh-list
110389894|NCT06031454|Midazolam|midazolam|mesh-list
110389895|NCT06031454|Omeprazole|omeprazole|mesh-list
110068815|NCT01553786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110068817|NCT01553903|Letrozole|letrozole|mesh-list
110068818|NCT01553903|Anastrozole|anastrozole|mesh-list
110068819|NCT01553903|Exemestane|exemestane|mesh-list
110068820|NCT01553903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110068821|NCT01553903|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110068822|NCT01553903|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110068823|NCT01553903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110068824|NCT01553903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110068825|NCT01553903|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110068826|NCT01553903|Hormone Antagonists|hormone antagonists|mesh-ancestor
110068827|NCT01553903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110068828|NCT01553903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110068829|NCT01553903|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110068830|NCT01553903|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110068831|NCT01553903|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110068832|NCT01553903|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110068833|NCT01553942|Pemetrexed|pemetrexed|mesh-list
110068834|NCT01553942|Afatinib|afatinib|mesh-list
110068835|NCT01553942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110068836|NCT01553942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110068837|NCT01553942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110068838|NCT01553942|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110068839|NCT01553942|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110068840|NCT01553942|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110068841|NCT01553981|Tadalafil|tadalafil|mesh-list
110068842|NCT01553981|Vasodilator Agents|vasodilator agents|mesh-ancestor
110068843|NCT01553981|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110068844|NCT01553981|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110068845|NCT01553981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110068846|NCT01553981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110068847|NCT01553981|Urological Agents|urological agents|mesh-ancestor
110068849|NCT01554059|Oxaliplatin|oxaliplatin|mesh-list
110068850|NCT01554059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110068851|NCT01554059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110068852|NCT01554059|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110068853|NCT01554059|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110068854|NCT01554059|Growth Substances|growth substances|mesh-ancestor
110068855|NCT01554059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110068856|NCT01554059|Growth Inhibitors|growth inhibitors|mesh-ancestor
110068857|NCT01554111|Picosulfate sodium|picosulfate sodium|mesh-list
110068858|NCT01554111|Cathartics|cathartics|mesh-ancestor
110068859|NCT01554111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110068860|NCT01554124|Meropenem|meropenem|mesh-list
110389906|NCT06031454|Anesthetics|anesthetics|mesh-ancestor
110068861|NCT01554124|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110068862|NCT01554124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110068863|NCT01554254|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
110068864|NCT01554254|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110068865|NCT01554254|Vasodilator Agents|vasodilator agents|mesh-ancestor
110068866|NCT01554345|Vitamin E|vitamin e|mesh-list
110068867|NCT01554345|Selenium|selenium|mesh-list
110068868|NCT01554345|Vitamins|vitamins|mesh-ancestor
110068869|NCT01554345|Micronutrients|micronutrients|mesh-ancestor
110068870|NCT01554345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110068871|NCT01554345|Antioxidants|antioxidants|mesh-ancestor
110068872|NCT01554345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110068873|NCT01554345|Protective Agents|protective agents|mesh-ancestor
110068874|NCT01554345|Trace Elements|trace elements|mesh-ancestor
110068875|NCT01554397|Cisplatin|cisplatin|mesh-list
110068876|NCT01554397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110068877|NCT01554540|Treprostinil|treprostinil|mesh-list
110068878|NCT01554540|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110068879|NCT01554592|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
110068880|NCT01554592|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110068881|NCT01554592|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110068882|NCT01554592|Antimetabolites|antimetabolites|mesh-ancestor
110068883|NCT01554592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110068884|NCT01554592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110068885|NCT01554592|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110068886|NCT01554631|Acarbose|acarbose|mesh-list
110068887|NCT01554631|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
110068888|NCT01554631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110068889|NCT01554631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110068890|NCT01554631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110068891|NCT01554631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110068892|NCT01554657|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110068893|NCT01554657|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
110068894|NCT01554657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110068895|NCT01554657|Antitubercular Agents|antitubercular agents|mesh-ancestor
110068896|NCT01554813|Vaccines|vaccines|mesh-list
110068897|NCT01554813|Immunologic Factors|immunologic factors|mesh-ancestor
110068898|NCT01554813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110068899|NCT01554826|Vaccines|vaccines|mesh-list
110068900|NCT01554826|Immunologic Factors|immunologic factors|mesh-ancestor
110068901|NCT01554826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110068902|NCT01554852|Thalidomide|thalidomide|mesh-list
110068903|NCT01554852|Dexamethasone|dexamethasone|mesh-list
110068904|NCT01554852|Dexamethasone acetate|dexamethasone acetate|mesh-list
110068905|NCT01554852|Cyclophosphamide|cyclophosphamide|mesh-list
110068906|NCT01554852|Melphalan|melphalan|mesh-list
110068907|NCT01554852|Lenalidomide|lenalidomide|mesh-list
110068908|NCT01554852|Bortezomib|bortezomib|mesh-list
110068909|NCT01554852|Vorinostat|vorinostat|mesh-list
110068910|NCT01554852|BB 1101|bb 1101|mesh-list
110068911|NCT01554852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110068912|NCT01554852|Immunologic Factors|immunologic factors|mesh-ancestor
110068913|NCT01554852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110068914|NCT01554852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110068915|NCT01554852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110068916|NCT01554852|Alkylating Agents|alkylating agents|mesh-ancestor
110068917|NCT01554852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110068918|NCT01554852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110068919|NCT01554852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110068920|NCT01554852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110068921|NCT01554852|Antiemetics|antiemetics|mesh-ancestor
110068922|NCT01554852|Autonomic Agents|autonomic agents|mesh-ancestor
110068923|NCT01554852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110068924|NCT01554852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110068925|NCT01554852|Glucocorticoids|glucocorticoids|mesh-ancestor
110068926|NCT01554852|Hormones|hormones|mesh-ancestor
110068927|NCT01554852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110389932|NCT06031454|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110068928|NCT01554852|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110068929|NCT01554852|Protease Inhibitors|protease inhibitors|mesh-ancestor
110068930|NCT01554852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110068931|NCT01554852|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110068932|NCT01554852|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110068933|NCT01554852|Growth Substances|growth substances|mesh-ancestor
110068934|NCT01554852|Growth Inhibitors|growth inhibitors|mesh-ancestor
110068935|NCT01554852|Leprostatic Agents|leprostatic agents|mesh-ancestor
110068936|NCT01554852|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110068937|NCT01554852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110068938|NCT01554852|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110068939|NCT01554930|Methylprednisolone|methylprednisolone|mesh-list
110068940|NCT01554930|Mannitol|mannitol|mesh-list
110068941|NCT01554930|Immunoglobulins|immunoglobulins|mesh-list
110068942|NCT01554930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110068943|NCT01554930|Antiemetics|antiemetics|mesh-ancestor
110068944|NCT01554930|Autonomic Agents|autonomic agents|mesh-ancestor
110068945|NCT01554930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110068946|NCT01554930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110068947|NCT01554930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110068948|NCT01554930|Glucocorticoids|glucocorticoids|mesh-ancestor
110068949|NCT01554930|Hormones|hormones|mesh-ancestor
110068950|NCT01554930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110068951|NCT01554930|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110068952|NCT01554930|Protective Agents|protective agents|mesh-ancestor
110068953|NCT01554930|Immunologic Factors|immunologic factors|mesh-ancestor
110068954|NCT01554930|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110068955|NCT01554930|Diuretics|diuretics|mesh-ancestor
110068956|NCT01554930|Natriuretic Agents|natriuretic agents|mesh-ancestor
110068957|NCT01554969|Capecitabine|capecitabine|mesh-list
110068958|NCT01554969|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110068959|NCT01554969|Antimetabolites|antimetabolites|mesh-ancestor
110068960|NCT01554969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110068961|NCT01554969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110068962|NCT01554995|Linezolid|linezolid|mesh-list
110068963|NCT01554995|Delpazolid|delpazolid|mesh-list
110068964|NCT01554995|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110068965|NCT01554995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110068966|NCT01554995|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110068967|NCT01554995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110068968|NCT01554995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110068969|NCT01555008|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
110068970|NCT01555008|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110068971|NCT01555008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110068972|NCT01555008|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110068973|NCT01555008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110068975|NCT01555060|Hematinics|hematinics|mesh-ancestor
110068976|NCT01555099|Budesonide|budesonide|mesh-list
110068977|NCT01555099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110068978|NCT01555099|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110068979|NCT01555099|Autonomic Agents|autonomic agents|mesh-ancestor
110068980|NCT01555099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110068981|NCT01555099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110068982|NCT01555099|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110068983|NCT01555099|Respiratory System Agents|respiratory system agents|mesh-ancestor
110068984|NCT01555099|Glucocorticoids|glucocorticoids|mesh-ancestor
110068985|NCT01555099|Hormones|hormones|mesh-ancestor
110068986|NCT01555099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110068987|NCT01555112|Ammonium trichloro(dioxoethylene-O,O'-)tellurate|ammonium trichloro(dioxoethylene-o,o'-)tellurate|mesh-list
110068988|NCT01555112|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110068989|NCT01555112|Immunologic Factors|immunologic factors|mesh-ancestor
110068990|NCT01555112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110068991|NCT01555112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110068992|NCT01555112|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110068993|NCT01555112|Protective Agents|protective agents|mesh-ancestor
110068994|NCT01555112|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110068995|NCT01555112|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110068996|NCT01555112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110068997|NCT01555112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110068998|NCT01555112|Antiviral Agents|antiviral agents|mesh-ancestor
110068999|NCT01555112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110069002|NCT01555190|Hematinics|hematinics|mesh-ancestor
110069003|NCT01555190|Vitamin B Complex|vitamin b complex|mesh-ancestor
110069004|NCT01555190|Vitamins|vitamins|mesh-ancestor
110069005|NCT01555190|Micronutrients|micronutrients|mesh-ancestor
110069006|NCT01555190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110069007|NCT01555216|Ropivacaine|ropivacaine|mesh-list
110069008|NCT01555216|Anesthetics, Local|anesthetics, local|mesh-ancestor
110069009|NCT01555216|Anesthetics|anesthetics|mesh-ancestor
110069010|NCT01555216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110069011|NCT01555216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110069012|NCT01555216|Sensory System Agents|sensory system agents|mesh-ancestor
110069013|NCT01555216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110069014|NCT01555398|Fenofibric acid|fenofibric acid|mesh-list
110069015|NCT01555398|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110069016|NCT01555398|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110069017|NCT01555398|Antimetabolites|antimetabolites|mesh-ancestor
110069018|NCT01555398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110069019|NCT01555398|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110069020|NCT01555476|Ibuprofen|ibuprofen|mesh-list
110069021|NCT01555476|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110069022|NCT01555476|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110069023|NCT01555476|Analgesics|analgesics|mesh-ancestor
110069024|NCT01555476|Sensory System Agents|sensory system agents|mesh-ancestor
110069025|NCT01555476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110069026|NCT01555476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110069027|NCT01555476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110069028|NCT01555476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110069029|NCT01555476|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110069030|NCT01555476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110069031|NCT01555476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110069032|NCT01555580|Molgramostim|molgramostim|mesh-list
110069033|NCT01555580|Sargramostim|sargramostim|mesh-list
110069034|NCT01555580|Immunologic Factors|immunologic factors|mesh-ancestor
110069035|NCT01555580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110069036|NCT01555580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110069037|NCT01555658|Heparin|heparin|mesh-list
110069038|NCT01555658|Bivalirudin|bivalirudin|mesh-list
110069039|NCT01555658|Anticoagulants|anticoagulants|mesh-ancestor
110069040|NCT01555658|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110069041|NCT01555658|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110069042|NCT01555658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110069043|NCT01555658|Antithrombins|antithrombins|mesh-ancestor
110069044|NCT01555658|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110069045|NCT01555658|Protease Inhibitors|protease inhibitors|mesh-ancestor
110069046|NCT01555658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110069047|NCT01555710|Carboplatin|carboplatin|mesh-list
110069048|NCT01555710|Etoposide|etoposide|mesh-list
110069049|NCT01555710|Isophosphamide mustard|isophosphamide mustard|mesh-list
110069050|NCT01555710|Ifosfamide|ifosfamide|mesh-list
110069051|NCT01555710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110069052|NCT01555710|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110069053|NCT01555710|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110069054|NCT01555710|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110069055|NCT01555710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110069056|NCT01555710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110069057|NCT01555710|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110069058|NCT01555710|Alkylating Agents|alkylating agents|mesh-ancestor
110069060|NCT01555788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110069061|NCT01555814|Amisulpride|amisulpride|mesh-list
110069062|NCT01555814|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110069063|NCT01555814|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110069064|NCT01555814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110069065|NCT01555814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110069066|NCT01555814|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110069067|NCT01555814|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110069068|NCT01555814|Dopamine Agents|dopamine agents|mesh-ancestor
110069069|NCT01555814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110069070|NCT01555814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110069071|NCT01555814|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110069072|NCT01555814|Antidepressive Agents|antidepressive agents|mesh-ancestor
110069073|NCT01555853|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110069074|NCT01555853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110069075|NCT01555866|Isavuconazole|isavuconazole|mesh-list
110069076|NCT01555866|Antifungal Agents|antifungal agents|mesh-ancestor
110069077|NCT01555866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110069079|NCT01555879|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110069080|NCT01555879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110069081|NCT01555879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110069082|NCT01555879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110069083|NCT01555879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110069084|NCT01555879|Immunologic Factors|immunologic factors|mesh-ancestor
110069085|NCT01555879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110069086|NCT01555879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110069087|NCT01555918|Isavuconazole|isavuconazole|mesh-list
110069088|NCT01555918|Antifungal Agents|antifungal agents|mesh-ancestor
110069089|NCT01555918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110069091|NCT01555970|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110069092|NCT01555970|Antiviral Agents|antiviral agents|mesh-ancestor
110069093|NCT01555970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110069094|NCT01555970|Expectorants|expectorants|mesh-ancestor
110069095|NCT01555970|Respiratory System Agents|respiratory system agents|mesh-ancestor
110069096|NCT01555970|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110069097|NCT01555970|Antioxidants|antioxidants|mesh-ancestor
110069098|NCT01555970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110069099|NCT01555970|Protective Agents|protective agents|mesh-ancestor
110069100|NCT01555970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110069101|NCT01555970|Antidotes|antidotes|mesh-ancestor
110069102|NCT01556035|Lenalidomide|lenalidomide|mesh-list
110069103|NCT01556035|Immunologic Factors|immunologic factors|mesh-ancestor
110069104|NCT01556035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110069105|NCT01556035|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110069106|NCT01556035|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110069107|NCT01556035|Growth Substances|growth substances|mesh-ancestor
110069108|NCT01556035|Growth Inhibitors|growth inhibitors|mesh-ancestor
110069109|NCT01556035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110069110|NCT01556191|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110069111|NCT01556191|Fulvestrant|fulvestrant|mesh-list
110069113|NCT01556191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110069114|NCT01556191|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110069115|NCT01556191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110069116|NCT01556191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110069117|NCT01556191|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110069118|NCT01556191|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110069119|NCT01556191|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110069120|NCT01556191|Hormone Antagonists|hormone antagonists|mesh-ancestor
110069121|NCT01556191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110069122|NCT01556191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110069123|NCT01556321|Caffeine|caffeine|mesh-list
110069124|NCT01556321|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110069125|NCT01556321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110069126|NCT01556321|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110069127|NCT01556321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110069128|NCT01556321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110069129|NCT01556321|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110069130|NCT01556321|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110069131|NCT01556321|Purinergic Agents|purinergic agents|mesh-ancestor
110069132|NCT01556321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110069133|NCT01556334|Azithromycin|azithromycin|mesh-list
110069134|NCT01556334|Erythromycin|erythromycin|mesh-list
110069135|NCT01556334|Erythromycin Estolate|erythromycin estolate|mesh-list
110069136|NCT01556334|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
110069137|NCT01556334|Erythromycin stearate|erythromycin stearate|mesh-list
110069138|NCT01556334|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110069139|NCT01556334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110069140|NCT01556334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110069141|NCT01556334|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110069142|NCT01556334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110069143|NCT01556334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110069144|NCT01556477|Lenalidomide|lenalidomide|mesh-list
110069145|NCT01556477|Azacitidine|azacitidine|mesh-list
110069146|NCT01556477|Immunologic Factors|immunologic factors|mesh-ancestor
110069147|NCT01556477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110069148|NCT01556477|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110069149|NCT01556477|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110069150|NCT01556477|Growth Substances|growth substances|mesh-ancestor
110069151|NCT01556477|Growth Inhibitors|growth inhibitors|mesh-ancestor
110069152|NCT01556477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110069153|NCT01556477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110069154|NCT01556477|Antimetabolites|antimetabolites|mesh-ancestor
110069155|NCT01556477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110069156|NCT01556477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110069157|NCT01556529|Unithiol|unithiol|mesh-list
110069158|NCT01556529|Antidotes|antidotes|mesh-ancestor
110069159|NCT01556529|Protective Agents|protective agents|mesh-ancestor
110069160|NCT01556529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110069161|NCT01556529|Chelating Agents|chelating agents|mesh-ancestor
110069162|NCT01556529|Sequestering Agents|sequestering agents|mesh-ancestor
110069163|NCT01556529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110069164|NCT01556542|Paclitaxel|paclitaxel|mesh-list
110069165|NCT01556542|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110069166|NCT01556542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110069167|NCT01556542|Tubulin Modulators|tubulin modulators|mesh-ancestor
110069168|NCT01556542|Antimitotic Agents|antimitotic agents|mesh-ancestor
110069169|NCT01556542|Mitosis Modulators|mitosis modulators|mesh-ancestor
110069170|NCT01556542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110069171|NCT05847660|Cetrorelix|cetrorelix|mesh-list
110069172|NCT05847660|Progesterone|progesterone|mesh-list
110069173|NCT05847660|Dydrogesterone|dydrogesterone|mesh-list
110069174|NCT05847660|Progestins|progestins|mesh-ancestor
110069175|NCT05847660|Hormones|hormones|mesh-ancestor
110069176|NCT05847660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110069177|NCT05847660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110069178|NCT05847660|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110069179|NCT05847660|Fertility Agents|fertility agents|mesh-ancestor
110069180|NCT05847660|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110069181|NCT05847660|Hormone Antagonists|hormone antagonists|mesh-ancestor
110069182|NCT05847413|Verapamil|verapamil|mesh-list
110069183|NCT05847413|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110069184|NCT05847413|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110069185|NCT05847413|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110069186|NCT05847413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110069187|NCT05847413|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110069188|NCT05847413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110069189|NCT05847413|Vasodilator Agents|vasodilator agents|mesh-ancestor
110069190|NCT05847322|Azithromycin|azithromycin|mesh-list
110069191|NCT05847322|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110069192|NCT05847322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110069193|NCT05847257|Ubiquinone|ubiquinone|mesh-list
110069194|NCT05847257|Coenzyme Q10|coenzyme q10|mesh-list
110069195|NCT05847257|Letrozole|letrozole|mesh-list
110069196|NCT05847257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110069197|NCT05847257|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110069198|NCT05847257|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110069199|NCT05847257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110069200|NCT05847257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110069201|NCT05847257|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110069202|NCT05847257|Hormone Antagonists|hormone antagonists|mesh-ancestor
110069203|NCT05847257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110069204|NCT05847257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110069205|NCT05847257|Micronutrients|micronutrients|mesh-ancestor
110069206|NCT05847257|Vitamins|vitamins|mesh-ancestor
110069207|NCT05847205|Hirudins|hirudins|mesh-list
110069208|NCT05847205|Antithrombins|antithrombins|mesh-ancestor
110069209|NCT05847205|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110069210|NCT05847205|Protease Inhibitors|protease inhibitors|mesh-ancestor
110069211|NCT05847205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110069212|NCT05847205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110069213|NCT05847205|Anticoagulants|anticoagulants|mesh-ancestor
110069214|NCT05847205|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110069215|NCT05847205|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110069216|NCT05847088|Dexamethasone|dexamethasone|mesh-list
110069217|NCT05847088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110069218|NCT05847088|Antiemetics|antiemetics|mesh-ancestor
110069219|NCT05847088|Autonomic Agents|autonomic agents|mesh-ancestor
110069220|NCT05847088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110069221|NCT05847088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110069222|NCT05847088|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110069223|NCT05847088|Glucocorticoids|glucocorticoids|mesh-ancestor
110069225|NCT05847088|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110069226|NCT05847088|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110069227|NCT05847088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110069228|NCT05847049|Nepafenac|nepafenac|mesh-list
110069229|NCT05847049|Aflibercept|aflibercept|mesh-list
110069230|NCT05847049|Eplerenone|eplerenone|mesh-list
110069231|NCT05847049|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110069232|NCT05847049|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110069233|NCT05847049|Growth Substances|growth substances|mesh-ancestor
110069234|NCT05847049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110069235|NCT05847049|Growth Inhibitors|growth inhibitors|mesh-ancestor
110069236|NCT05847049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110069237|NCT05847049|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110069238|NCT05847049|Hormone Antagonists|hormone antagonists|mesh-ancestor
110069239|NCT05847049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110069240|NCT05847049|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110069241|NCT05847049|Diuretics|diuretics|mesh-ancestor
110069242|NCT05847049|Natriuretic Agents|natriuretic agents|mesh-ancestor
110069243|NCT05847049|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110069244|NCT05847049|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110069245|NCT05847049|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110069246|NCT05847049|Analgesics|analgesics|mesh-ancestor
110069247|NCT05847049|Sensory System Agents|sensory system agents|mesh-ancestor
110069248|NCT05847049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110069249|NCT05847049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110069250|NCT05847049|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110069251|NCT05846867|Leucovorin|leucovorin|mesh-list
110069252|NCT05846867|Fluorouracil|fluorouracil|mesh-list
110069253|NCT05846867|Oxaliplatin|oxaliplatin|mesh-list
110069254|NCT05846867|Irinotecan|irinotecan|mesh-list
110069255|NCT05846867|Calcium|calcium|mesh-list
110069256|NCT05846867|Levoleucovorin|levoleucovorin|mesh-list
110069257|NCT05846867|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110069259|NCT05846867|Antimetabolites|antimetabolites|mesh-ancestor
110069260|NCT05846867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110069261|NCT05846867|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110069262|NCT05846867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110069263|NCT05846867|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110069264|NCT05846867|Immunologic Factors|immunologic factors|mesh-ancestor
110069265|NCT05846867|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110069266|NCT05846867|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110069267|NCT05846867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110069268|NCT05846867|Antidotes|antidotes|mesh-ancestor
110069269|NCT05846867|Protective Agents|protective agents|mesh-ancestor
110069270|NCT05846867|Vitamin B Complex|vitamin b complex|mesh-ancestor
110069271|NCT05846867|Vitamins|vitamins|mesh-ancestor
110069272|NCT05846867|Micronutrients|micronutrients|mesh-ancestor
110069273|NCT05845736|Antihypertensive Agents|antihypertensive agents|mesh-list
110069274|NCT05840744|Antithrombins|antithrombins|mesh-list
110069275|NCT05840744|Thrombin|thrombin|mesh-list
110069276|NCT05840744|Hemostatics|hemostatics|mesh-ancestor
110069277|NCT05840744|Coagulants|coagulants|mesh-ancestor
110069278|NCT05840744|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110069279|NCT05840744|Protease Inhibitors|protease inhibitors|mesh-ancestor
110069280|NCT05840744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110069281|NCT05840744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110069282|NCT05840744|Anticoagulants|anticoagulants|mesh-ancestor
110069283|NCT05840692|Escitalopram|escitalopram|mesh-list
110069284|NCT05840692|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110069285|NCT05840692|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110069286|NCT05840692|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110069287|NCT05840692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110069288|NCT05840692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110069289|NCT05840692|Serotonin Agents|serotonin agents|mesh-ancestor
110069290|NCT05840692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110069291|NCT05840653|Psychotropic Drugs|psychotropic drugs|mesh-list
110069292|NCT05840640|Lenograstim|lenograstim|mesh-list
110069293|NCT05840640|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110069294|NCT05840640|Immunologic Factors|immunologic factors|mesh-ancestor
110069295|NCT05840640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110069296|NCT05840588|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110069297|NCT05840588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110069300|NCT05840536|Diuretics|diuretics|mesh-ancestor
110069301|NCT05840536|Natriuretic Agents|natriuretic agents|mesh-ancestor
110069302|NCT05840536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110052965|NCT01483300|Cisplatin|cisplatin|mesh-list
110069303|NCT05840536|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110069304|NCT05840536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110069305|NCT05840536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110069306|NCT05840536|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110069307|NCT05840536|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110069308|NCT05840406|Acetaminophen|acetaminophen|mesh-list
110069309|NCT05840406|Ibuprofen|ibuprofen|mesh-list
110069310|NCT05840406|Ketoprofen|ketoprofen|mesh-list
110069311|NCT05840406|Dexmedetomidine|dexmedetomidine|mesh-list
110069312|NCT05840406|Tramadol|tramadol|mesh-list
110069313|NCT05840406|Levobupivacaine|levobupivacaine|mesh-list
110069314|NCT05840406|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110069315|NCT05840406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110389988|NCT06031233|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110069316|NCT05840406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110069317|NCT05840406|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110069318|NCT05840406|Analgesics|analgesics|mesh-ancestor
110069319|NCT05840406|Sensory System Agents|sensory system agents|mesh-ancestor
110069320|NCT05840406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110069321|NCT05840406|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110069322|NCT05840406|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110069323|NCT05840406|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110069324|NCT05840406|Adrenergic Agents|adrenergic agents|mesh-ancestor
110069325|NCT05840406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110069326|NCT05840406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110069327|NCT05840406|Antipyretics|antipyretics|mesh-ancestor
110069328|NCT05840406|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110069329|NCT05840406|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110069330|NCT05840406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110069331|NCT05840406|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110069332|NCT05840406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110069333|NCT05840406|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110069334|NCT05840406|Narcotics|narcotics|mesh-ancestor
110069335|NCT05840406|Anesthetics, Local|anesthetics, local|mesh-ancestor
110069336|NCT05840406|Anesthetics|anesthetics|mesh-ancestor
110069337|NCT05840328|Dexmedetomidine|dexmedetomidine|mesh-list
110069338|NCT05840328|Bupivacaine|bupivacaine|mesh-list
110069339|NCT05840328|Anesthetics, Local|anesthetics, local|mesh-ancestor
110069340|NCT05840328|Anesthetics|anesthetics|mesh-ancestor
110069341|NCT05840328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110069342|NCT05840328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110069343|NCT05840328|Sensory System Agents|sensory system agents|mesh-ancestor
110069344|NCT05840328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110069345|NCT05840328|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110069346|NCT05840328|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110069347|NCT05840328|Analgesics|analgesics|mesh-ancestor
110069348|NCT05840328|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110069349|NCT05840328|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110069350|NCT05840328|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110069351|NCT05840328|Adrenergic Agents|adrenergic agents|mesh-ancestor
110069352|NCT05840328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110069353|NCT05840328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110069354|NCT05840172|Benzocaine|benzocaine|mesh-list
110069355|NCT05840172|Anesthetics, Local|anesthetics, local|mesh-ancestor
110069356|NCT05840172|Anesthetics|anesthetics|mesh-ancestor
110069357|NCT05840172|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110069358|NCT05840172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110069359|NCT05840172|Sensory System Agents|sensory system agents|mesh-ancestor
110069360|NCT05840172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110069361|NCT05840094|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110069362|NCT05840094|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110069363|NCT05840094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110069364|NCT05839652|Midodrine|midodrine|mesh-list
110069365|NCT05839652|Droxidopa|droxidopa|mesh-list
110069366|NCT05839652|Sympathomimetics|sympathomimetics|mesh-ancestor
110069367|NCT05839652|Autonomic Agents|autonomic agents|mesh-ancestor
110069368|NCT05839652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110069369|NCT05839652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110069370|NCT05839652|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110179208|NCT00009815|Leucovorin|leucovorin|mesh-list
110069371|NCT05839652|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110069372|NCT05839652|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110069373|NCT05839652|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110069374|NCT05839652|Adrenergic Agents|adrenergic agents|mesh-ancestor
110069375|NCT05839652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110069376|NCT05839652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110069377|NCT05839652|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110069378|NCT05839652|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110069379|NCT05839574|Letrozole|letrozole|mesh-list
110069380|NCT05839574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110069381|NCT05839574|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110069382|NCT05839574|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110069383|NCT05839574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110069384|NCT05839574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110069385|NCT05839574|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110069386|NCT05839574|Hormone Antagonists|hormone antagonists|mesh-ancestor
110069387|NCT05839574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110069388|NCT05839574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110069389|NCT05839561|Letrozole|letrozole|mesh-list
110069390|NCT05839561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110069391|NCT05839561|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110069392|NCT05839561|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110069393|NCT05839561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110069394|NCT05839561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110069395|NCT05839561|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110069396|NCT05839561|Hormone Antagonists|hormone antagonists|mesh-ancestor
110069397|NCT05839561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110069398|NCT05839561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110069399|NCT05839548|Epinephrine|epinephrine|mesh-list
110069400|NCT05839548|Racepinephrine|racepinephrine|mesh-list
110069401|NCT05839548|Carticaine|carticaine|mesh-list
110069402|NCT05839548|Mepivacaine|mepivacaine|mesh-list
110069403|NCT05839548|Epinephryl borate|epinephryl borate|mesh-list
110069404|NCT05839548|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110069405|NCT05839548|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110069406|NCT05839548|Adrenergic Agents|adrenergic agents|mesh-ancestor
110069407|NCT05839548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110069408|NCT05839548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110069409|NCT05839548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110069410|NCT05839548|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110069411|NCT05839548|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110069412|NCT05839548|Autonomic Agents|autonomic agents|mesh-ancestor
110069414|NCT05839548|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110069415|NCT05839548|Respiratory System Agents|respiratory system agents|mesh-ancestor
110069416|NCT05839548|Mydriatics|mydriatics|mesh-ancestor
110069417|NCT05839548|Sympathomimetics|sympathomimetics|mesh-ancestor
110069418|NCT05839548|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110069419|NCT05839548|Anesthetics, Local|anesthetics, local|mesh-ancestor
110069420|NCT05839548|Anesthetics|anesthetics|mesh-ancestor
110069421|NCT05839548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110069422|NCT05839548|Sensory System Agents|sensory system agents|mesh-ancestor
110069423|NCT05839522|Antibodies|antibodies|mesh-list
110069424|NCT05839522|Immunoglobulins|immunoglobulins|mesh-list
110069425|NCT05839522|HIV Antibodies|hiv antibodies|mesh-list
110069426|NCT05839522|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
110069427|NCT05839522|Immunologic Factors|immunologic factors|mesh-ancestor
110069428|NCT05839522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110069429|NCT05839509|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
110069430|NCT05839509|Hallucinogens|hallucinogens|mesh-ancestor
110069431|NCT05839509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110069432|NCT05839509|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110069433|NCT05839509|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110069434|NCT05839509|Serotonin Agents|serotonin agents|mesh-ancestor
110069435|NCT05839509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110069436|NCT05839509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110069437|NCT05839509|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110069438|NCT05839470|Leucovorin|leucovorin|mesh-list
110069439|NCT05839470|Oxaliplatin|oxaliplatin|mesh-list
110069440|NCT05839470|Irinotecan|irinotecan|mesh-list
110069441|NCT05839470|Levoleucovorin|levoleucovorin|mesh-list
110069442|NCT05839470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110069443|NCT05839470|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110069444|NCT05839470|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110069445|NCT05839470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110094949|NCT01711814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110069446|NCT05839470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110069448|NCT05839470|Protective Agents|protective agents|mesh-ancestor
110069449|NCT05839470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110069450|NCT05839470|Vitamin B Complex|vitamin b complex|mesh-ancestor
110069451|NCT05839470|Vitamins|vitamins|mesh-ancestor
110069452|NCT05839470|Micronutrients|micronutrients|mesh-ancestor
110069453|NCT05839236|Atorvastatin|atorvastatin|mesh-list
110069454|NCT05839236|Calcium|calcium|mesh-list
110069455|NCT05839236|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110069456|NCT05839236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110069457|NCT05839236|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110069458|NCT05839236|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110069459|NCT05839236|Antimetabolites|antimetabolites|mesh-ancestor
110069460|NCT05839236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110069461|NCT05839236|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110069462|NCT05839236|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110069463|NCT05839236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110069464|NCT05839197|Apatinib|apatinib|mesh-list
110069465|NCT05839197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110069466|NCT05839197|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110069467|NCT05839197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110069468|NCT05839197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110069469|NCT05839054|Methamphetamine|methamphetamine|mesh-list
110069470|NCT05839054|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110069471|NCT05839054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110069472|NCT05839054|Sympathomimetics|sympathomimetics|mesh-ancestor
110069473|NCT05839054|Autonomic Agents|autonomic agents|mesh-ancestor
110069474|NCT05839054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110069475|NCT05839054|Dopamine Agents|dopamine agents|mesh-ancestor
110069476|NCT05839054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110069477|NCT05839054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110069478|NCT05839054|Adrenergic Agents|adrenergic agents|mesh-ancestor
110069479|NCT05839054|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110069480|NCT05839054|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110069481|NCT05839054|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110069482|NCT05839054|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110069484|NCT05838846|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110069485|NCT05838846|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110069486|NCT05838846|Vasodilator Agents|vasodilator agents|mesh-ancestor
110069487|NCT05838846|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110069488|NCT05838846|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110069489|NCT05838846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110069490|NCT05838846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110069491|NCT05838846|Protective Agents|protective agents|mesh-ancestor
110069492|NCT05838846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110069493|NCT05837403|Nitroglycerin|nitroglycerin|mesh-list
110069494|NCT05837403|Vasodilator Agents|vasodilator agents|mesh-ancestor
110069495|NCT05836610|Hydrocortisone|hydrocortisone|mesh-list
110069496|NCT05836610|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
110069497|NCT05836610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110069498|NCT05830630|Bupivacaine|bupivacaine|mesh-list
110069499|NCT05830630|Methylene Blue|methylene blue|mesh-list
110069500|NCT05830630|Anesthetics, Local|anesthetics, local|mesh-ancestor
110069501|NCT05830630|Anesthetics|anesthetics|mesh-ancestor
110069502|NCT05830630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110069503|NCT05830630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110069504|NCT05830630|Sensory System Agents|sensory system agents|mesh-ancestor
110069505|NCT05830630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110069506|NCT05830630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110069507|NCT05830630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110069508|NCT05823753|Cannabidiol|cannabidiol|mesh-list
110069509|NCT05823753|Anticonvulsants|anticonvulsants|mesh-ancestor
110069511|NCT05823311|Gemcitabine|gemcitabine|mesh-list
110069512|NCT05823311|Lenvatinib|lenvatinib|mesh-list
110069513|NCT05823311|Tislelizumab|tislelizumab|mesh-list
110069514|NCT05823311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110069515|NCT05823311|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110069516|NCT05823311|Antimetabolites|antimetabolites|mesh-ancestor
110069517|NCT05823311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110069518|NCT05823311|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110069519|NCT05823311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110069520|NCT05823311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110069522|NCT05813158|Anesthetics, Local|anesthetics, local|mesh-ancestor
110069523|NCT05813158|Anesthetics|anesthetics|mesh-ancestor
110069524|NCT05813158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110069525|NCT05813158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110069526|NCT05813158|Sensory System Agents|sensory system agents|mesh-ancestor
110069527|NCT05813158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110069528|NCT05805683|Calcitonin|calcitonin|mesh-list
110069529|NCT05805683|Salmon calcitonin|salmon calcitonin|mesh-list
110069530|NCT05805683|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
110069531|NCT05805683|Katacalcin|katacalcin|mesh-list
110069532|NCT05805683|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110069533|NCT05805683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110069534|NCT05805683|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110069535|NCT05805683|Vasodilator Agents|vasodilator agents|mesh-ancestor
110069536|NCT05782361|Pembrolizumab|pembrolizumab|mesh-list
110069537|NCT05782361|Tepotinib|tepotinib|mesh-list
110069538|NCT05782361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110069539|NCT05782361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110069540|NCT05782361|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110069541|NCT05782361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110069542|NCT05753670|Tamsulosin|tamsulosin|mesh-list
110069543|NCT05753670|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110069544|NCT05753670|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110069545|NCT05753670|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110069546|NCT05753670|Adrenergic Agents|adrenergic agents|mesh-ancestor
110069547|NCT05753670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110069548|NCT05753670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110069549|NCT05753670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110069550|NCT05753670|Urological Agents|urological agents|mesh-ancestor
110179240|NCT00009854|Alkylating Agents|alkylating agents|mesh-ancestor
110069573|NCT05686005|Hemostatics|hemostatics|mesh-ancestor
110069574|NCT05686005|Coagulants|coagulants|mesh-ancestor
110069575|NCT05671991|Empagliflozin|empagliflozin|mesh-list
110069576|NCT05671991|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110069577|NCT05671991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110069578|NCT05671991|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110069579|NCT05671991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110069580|NCT05585151|Evolocumab|evolocumab|mesh-list
110069581|NCT05585151|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
110069582|NCT05585151|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110069583|NCT05585151|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110069584|NCT05585151|Antimetabolites|antimetabolites|mesh-ancestor
110069585|NCT05585151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110069586|NCT05585151|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110069587|NCT05585151|Protease Inhibitors|protease inhibitors|mesh-ancestor
110069588|NCT05585151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110069589|NCT05585151|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110069590|NCT05585112|Lidocaine|lidocaine|mesh-list
110069591|NCT05585112|Carticaine|carticaine|mesh-list
110069592|NCT05585112|Anesthetics, Local|anesthetics, local|mesh-ancestor
110069593|NCT05585112|Anesthetics|anesthetics|mesh-ancestor
110069594|NCT05585112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110069595|NCT05585112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110069596|NCT05585112|Sensory System Agents|sensory system agents|mesh-ancestor
110069597|NCT05585112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110069598|NCT05585112|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110069599|NCT05585112|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110069600|NCT05585112|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110069601|NCT05585112|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110069602|NCT05585112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110069604|NCT05552443|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110069605|NCT05552443|Narcotics|narcotics|mesh-ancestor
110069606|NCT05552443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110069607|NCT05552443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110069608|NCT05552443|Analgesics|analgesics|mesh-ancestor
110069609|NCT05552443|Sensory System Agents|sensory system agents|mesh-ancestor
110069610|NCT05552443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110069611|NCT05527483|Listerine|listerine|mesh-list
110069612|NCT05527483|Fluorides|fluorides|mesh-list
110069613|NCT05527483|Sodium Fluoride|sodium fluoride|mesh-list
110069614|NCT05527483|Cariostatic Agents|cariostatic agents|mesh-ancestor
110069615|NCT05527483|Protective Agents|protective agents|mesh-ancestor
110069616|NCT05527483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110069617|NCT05527483|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110069618|NCT05527483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110069619|NCT05527470|Cisplatin|cisplatin|mesh-list
110069620|NCT05527470|Gemcitabine|gemcitabine|mesh-list
110069621|NCT05527470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110069622|NCT05527470|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110069623|NCT05527470|Antimetabolites|antimetabolites|mesh-ancestor
110069624|NCT05527470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110069625|NCT05477485|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
110069626|NCT05477485|Antiviral Agents|antiviral agents|mesh-ancestor
110069627|NCT05477485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110069628|NCT05458102|Voriconazole|voriconazole|mesh-list
110069629|NCT05458102|Cobicistat|cobicistat|mesh-list
110069630|NCT05458102|Rifabutin|rifabutin|mesh-list
110069631|NCT05458102|Vesatolimod|vesatolimod|mesh-list
110069632|NCT05458102|Antifungal Agents|antifungal agents|mesh-ancestor
110069633|NCT05458102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110069634|NCT05458102|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110069635|NCT05458102|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110069636|NCT05458102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110069637|NCT05458102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110069638|NCT05458102|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110069639|NCT05458102|Hormone Antagonists|hormone antagonists|mesh-ancestor
110069640|NCT05458102|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110069641|NCT05458102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110069642|NCT05458102|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110069643|NCT05458102|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110069644|NCT05458102|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110069645|NCT05458102|Antiviral Agents|antiviral agents|mesh-ancestor
110069646|NCT05458102|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110069647|NCT05458102|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110069648|NCT05458102|Antitubercular Agents|antitubercular agents|mesh-ancestor
110069649|NCT05439356|Colchicine|colchicine|mesh-list
110069650|NCT05439356|Gout Suppressants|gout suppressants|mesh-ancestor
110069651|NCT05439356|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110069652|NCT05439356|Tubulin Modulators|tubulin modulators|mesh-ancestor
110069653|NCT05439356|Antimitotic Agents|antimitotic agents|mesh-ancestor
110069654|NCT05439356|Mitosis Modulators|mitosis modulators|mesh-ancestor
110069655|NCT05439356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110069656|NCT05439356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110069657|NCT05335356|Ustekinumab|ustekinumab|mesh-list
110069658|NCT05335356|Dermatologic Agents|dermatologic agents|mesh-ancestor
110069659|NCT05323487|Bumetanide|bumetanide|mesh-list
110069660|NCT05323487|Diuretics|diuretics|mesh-ancestor
110069661|NCT05323487|Natriuretic Agents|natriuretic agents|mesh-ancestor
110069662|NCT05323487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110225459|NCT05959356|Cetuximab|cetuximab|mesh-list
110069663|NCT05323487|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110069664|NCT05323487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110069665|NCT05323487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110069666|NCT05301322|Vaccines|vaccines|mesh-list
110069676|NCT05224050|Nicotine|nicotine|mesh-list
110069677|NCT05224050|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110069678|NCT05224050|Autonomic Agents|autonomic agents|mesh-ancestor
110069679|NCT05224050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110069680|NCT05224050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110069681|NCT05224050|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110069682|NCT05224050|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110069683|NCT05224050|Cholinergic Agents|cholinergic agents|mesh-ancestor
110069684|NCT05224050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110069685|NCT05224050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110069686|NCT05117866|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
110069687|NCT05117866|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110069688|NCT05095259|Insulin|insulin|mesh-list
110069689|NCT05095259|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110069690|NCT05095259|Epinephrine|epinephrine|mesh-list
110069691|NCT05095259|Glucagon|glucagon|mesh-list
110069692|NCT05095259|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110069693|NCT05095259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110069694|NCT05095259|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110069695|NCT05095259|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110069696|NCT05095259|Adrenergic Agents|adrenergic agents|mesh-ancestor
110069697|NCT05095259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110069698|NCT05095259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110069699|NCT05095259|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110069700|NCT05095259|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110069701|NCT05095259|Autonomic Agents|autonomic agents|mesh-ancestor
110069702|NCT05095259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110069703|NCT05095259|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110069704|NCT05095259|Respiratory System Agents|respiratory system agents|mesh-ancestor
110069705|NCT05095259|Mydriatics|mydriatics|mesh-ancestor
110069706|NCT05095259|Sympathomimetics|sympathomimetics|mesh-ancestor
110069707|NCT05095259|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110069708|NCT05095259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110069709|NCT05095259|Hormones|hormones|mesh-ancestor
110069710|NCT05095259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110069719|NCT05049278|Phenylephrine|phenylephrine|mesh-list
110069720|NCT05049278|Oxymetazoline|oxymetazoline|mesh-list
110069721|NCT05049278|Norepinephrine|norepinephrine|mesh-list
110069722|NCT05049278|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110069723|NCT05049278|Mydriatics|mydriatics|mesh-ancestor
110069724|NCT05049278|Autonomic Agents|autonomic agents|mesh-ancestor
110069725|NCT05049278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110069726|NCT05049278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110069727|NCT05049278|Sympathomimetics|sympathomimetics|mesh-ancestor
110069728|NCT05049278|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110069729|NCT05049278|Nasal Decongestants|nasal decongestants|mesh-ancestor
110069730|NCT05049278|Respiratory System Agents|respiratory system agents|mesh-ancestor
110069731|NCT05049278|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110069732|NCT05049278|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110069733|NCT05049278|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110069734|NCT05049278|Adrenergic Agents|adrenergic agents|mesh-ancestor
110069736|NCT05049278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110069737|NCT05049278|Protective Agents|protective agents|mesh-ancestor
110069738|NCT05040282|Etonogestrel|etonogestrel|mesh-list
110069739|NCT05040282|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110069740|NCT05040282|Contraceptive Agents|contraceptive agents|mesh-ancestor
110069741|NCT05040282|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110069742|NCT05040282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110069743|NCT05040282|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110069744|NCT04982354|Fludarabine|fludarabine|mesh-list
110069745|NCT04982354|Melphalan|melphalan|mesh-list
110069746|NCT04982354|Busulfan|busulfan|mesh-list
110069747|NCT04982354|Midostaurin|midostaurin|mesh-list
110094950|NCT01711827|Isavuconazole|isavuconazole|mesh-list
110069748|NCT04982354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110069749|NCT04982354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110069750|NCT04982354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110069751|NCT04982354|Immunologic Factors|immunologic factors|mesh-ancestor
110069752|NCT04982354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110069753|NCT04982354|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110069754|NCT04982354|Alkylating Agents|alkylating agents|mesh-ancestor
110069755|NCT04982354|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110069756|NCT04982354|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110069757|NCT04982354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110069758|NCT04953754|Melatonin|melatonin|mesh-list
110069759|NCT04953754|Antioxidants|antioxidants|mesh-ancestor
110069760|NCT04953754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110069761|NCT04953754|Protective Agents|protective agents|mesh-ancestor
110069762|NCT04953754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110069763|NCT04953754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110069764|NCT04932382|Misoprostol|misoprostol|mesh-list
110069765|NCT04932382|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110069766|NCT04932382|Abortifacient Agents|abortifacient agents|mesh-ancestor
110069767|NCT04932382|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110069768|NCT04932382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110069769|NCT04932382|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110069770|NCT04932382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110069771|NCT04932382|Oxytocics|oxytocics|mesh-ancestor
110069772|NCT04901715|Albuterol|albuterol|mesh-list
110069773|NCT04901715|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110069774|NCT04901715|Autonomic Agents|autonomic agents|mesh-ancestor
110069775|NCT04901715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110069776|NCT04901715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110069777|NCT04901715|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110069778|NCT04901715|Respiratory System Agents|respiratory system agents|mesh-ancestor
110069779|NCT04901715|Tocolytic Agents|tocolytic agents|mesh-ancestor
110069780|NCT04901715|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110069781|NCT04901715|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110069782|NCT04901715|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110069783|NCT04901715|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110069784|NCT04901715|Adrenergic Agents|adrenergic agents|mesh-ancestor
110069785|NCT04901715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110069786|NCT04901715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110069787|NCT04895592|Dexamethasone|dexamethasone|mesh-list
110069788|NCT04895592|Dexamethasone acetate|dexamethasone acetate|mesh-list
110069789|NCT04895592|Ichthammol|ichthammol|mesh-list
110069790|NCT04895592|BB 1101|bb 1101|mesh-list
110069791|NCT04895592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110069792|NCT04895592|Antiemetics|antiemetics|mesh-ancestor
110069793|NCT04895592|Autonomic Agents|autonomic agents|mesh-ancestor
110069794|NCT04895592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110069795|NCT04895592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110069796|NCT04895592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110069797|NCT04895592|Glucocorticoids|glucocorticoids|mesh-ancestor
110069798|NCT04895592|Hormones|hormones|mesh-ancestor
110069799|NCT04895592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110069800|NCT04895592|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110069801|NCT04895592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110069802|NCT04895592|Protease Inhibitors|protease inhibitors|mesh-ancestor
110069803|NCT04895592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110069804|NCT04895592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110069805|NCT04895592|Dermatologic Agents|dermatologic agents|mesh-ancestor
110069806|NCT04861103|Enoxaparin|enoxaparin|mesh-list
110069807|NCT04861103|Anticoagulants|anticoagulants|mesh-ancestor
110069808|NCT04861103|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110069809|NCT04861103|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110069810|NCT04861103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110069811|NCT04843761|Remdesivir|remdesivir|mesh-list
110179299|NCT00010088|Vitamins|vitamins|mesh-ancestor
110069812|NCT04843761|Phentolamine|phentolamine|mesh-list
110069813|NCT04843761|Vasoactive Intestinal Peptide|vasoactive intestinal peptide|mesh-list
110069814|NCT04843761|Antimetabolites|antimetabolites|mesh-ancestor
110069815|NCT04843761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110069816|NCT04843761|Antiviral Agents|antiviral agents|mesh-ancestor
110069817|NCT04843761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110069818|NCT04843761|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110069819|NCT04843761|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110069820|NCT04843761|Adrenergic Agents|adrenergic agents|mesh-ancestor
110069821|NCT04843761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110069822|NCT04843761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110069823|NCT04843761|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110069824|NCT04843761|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110069825|NCT04843761|Vasodilator Agents|vasodilator agents|mesh-ancestor
110069826|NCT04843761|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110069827|NCT04843761|Protective Agents|protective agents|mesh-ancestor
110069828|NCT04835129|Dexamethasone|dexamethasone|mesh-list
110069829|NCT04835129|Pomalidomide|pomalidomide|mesh-list
110069831|NCT04835129|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110069832|NCT04835129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110069833|NCT04835129|Antiemetics|antiemetics|mesh-ancestor
110069834|NCT04835129|Autonomic Agents|autonomic agents|mesh-ancestor
110069835|NCT04835129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110069836|NCT04835129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110069837|NCT04835129|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110069838|NCT04835129|Glucocorticoids|glucocorticoids|mesh-ancestor
110069840|NCT04835129|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110069841|NCT04835129|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110069842|NCT04835129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110069843|NCT04835129|Immunologic Factors|immunologic factors|mesh-ancestor
110069844|NCT04835129|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110069845|NCT04835129|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110069846|NCT04835129|Growth Substances|growth substances|mesh-ancestor
110069847|NCT04835129|Growth Inhibitors|growth inhibitors|mesh-ancestor
110069848|NCT04799249|Carboplatin|carboplatin|mesh-list
110069849|NCT04799249|Gemcitabine|gemcitabine|mesh-list
110069850|NCT04799249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110069851|NCT04799249|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110069852|NCT04799249|Antimetabolites|antimetabolites|mesh-ancestor
110069853|NCT04799249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110069855|NCT04710368|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
110069856|NCT04710368|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110069857|NCT04710368|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110069858|NCT04710368|Antimetabolites|antimetabolites|mesh-ancestor
110069859|NCT04710368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110179313|NCT00010166|Gemcitabine|gemcitabine|mesh-list
110069860|NCT04710368|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110069861|NCT04710368|Protease Inhibitors|protease inhibitors|mesh-ancestor
110069862|NCT04710368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110069863|NCT04710368|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110069864|NCT04699604|Levocetirizine|levocetirizine|mesh-list
110069865|NCT04699604|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110069866|NCT04699604|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110069867|NCT04699604|Histamine Antagonists|histamine antagonists|mesh-ancestor
110069868|NCT04699604|Histamine Agents|histamine agents|mesh-ancestor
110069869|NCT04699604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110069870|NCT04699604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110069871|NCT04699604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110069872|NCT04614974|Famotidine|famotidine|mesh-list
110069873|NCT04614974|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110069874|NCT04614974|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110069875|NCT04614974|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110069876|NCT04614974|Histamine Antagonists|histamine antagonists|mesh-ancestor
110069877|NCT04614974|Histamine Agents|histamine agents|mesh-ancestor
110069878|NCT04614974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110069879|NCT04614974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110069880|NCT04614974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110069881|NCT04603066|Ondansetron|ondansetron|mesh-list
110069882|NCT04603066|Antiemetics|antiemetics|mesh-ancestor
110069883|NCT04603066|Autonomic Agents|autonomic agents|mesh-ancestor
110069884|NCT04603066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110069885|NCT04603066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110069886|NCT04603066|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110069887|NCT04603066|Antipruritics|antipruritics|mesh-ancestor
110069888|NCT04603066|Dermatologic Agents|dermatologic agents|mesh-ancestor
110069889|NCT04603066|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110069890|NCT04603066|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110069891|NCT04603066|Serotonin Agents|serotonin agents|mesh-ancestor
110069892|NCT04603066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110069893|NCT04603066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110069894|NCT04591431|Nivolumab|nivolumab|mesh-list
110069895|NCT04591431|Trastuzumab|trastuzumab|mesh-list
110069896|NCT04591431|Ipilimumab|ipilimumab|mesh-list
110069897|NCT04591431|Atezolizumab|atezolizumab|mesh-list
110069898|NCT04591431|Pertuzumab|pertuzumab|mesh-list
110069899|NCT04591431|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
110069900|NCT04591431|Everolimus|everolimus|mesh-list
110069901|NCT04591431|Palbociclib|palbociclib|mesh-list
110069902|NCT04591431|Lapatinib|lapatinib|mesh-list
110069903|NCT04591431|Vemurafenib|vemurafenib|mesh-list
110069904|NCT04591431|Maytansine|maytansine|mesh-list
110069905|NCT04591431|Talazoparib|talazoparib|mesh-list
110069906|NCT04591431|Ponatinib|ponatinib|mesh-list
110069907|NCT04591431|Ipatasertib|ipatasertib|mesh-list
110069908|NCT04591431|Tepotinib|tepotinib|mesh-list
110069909|NCT04591431|Pralsetinib|pralsetinib|mesh-list
110069910|NCT04591431|Entrectinib|entrectinib|mesh-list
110069911|NCT04591431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110069912|NCT04591431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110069913|NCT04591431|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110069914|NCT04591431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110069915|NCT04591431|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110069916|NCT04591431|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110069917|NCT04591431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110069918|NCT04591431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110069919|NCT04591431|Immunologic Factors|immunologic factors|mesh-ancestor
110069920|NCT04591431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110069921|NCT04591431|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110069922|NCT04591431|Tubulin Modulators|tubulin modulators|mesh-ancestor
110069924|NCT04591431|Mitosis Modulators|mitosis modulators|mesh-ancestor
110069925|NCT04591431|Immunotoxins|immunotoxins|mesh-ancestor
110069926|NCT04591431|Immunoconjugates|immunoconjugates|mesh-ancestor
110069927|NCT04591431|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110069928|NCT04571164|Rotigotine|rotigotine|mesh-list
110069929|NCT04571164|Dopamine Agonists|dopamine agonists|mesh-ancestor
110069930|NCT04571164|Dopamine Agents|dopamine agents|mesh-ancestor
110069931|NCT04571164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110069932|NCT04571164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110069933|NCT04571164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110069934|NCT04559880|Tranexamic Acid|tranexamic acid|mesh-list
110069935|NCT04559880|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110069936|NCT04559880|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110069937|NCT04559880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110069938|NCT04559880|Hemostatics|hemostatics|mesh-ancestor
110069939|NCT04559880|Coagulants|coagulants|mesh-ancestor
110069940|NCT04542369|Carboplatin|carboplatin|mesh-list
110069941|NCT04542369|Etoposide|etoposide|mesh-list
110069942|NCT04542369|Tislelizumab|tislelizumab|mesh-list
110069943|NCT04542369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110069944|NCT04542369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110069945|NCT04542369|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110069946|NCT04542369|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110069947|NCT04542369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110069948|NCT04542369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110069949|NCT04542369|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110069950|NCT04496596|Suramin|suramin|mesh-list
110069951|NCT04496596|Antinematodal Agents|antinematodal agents|mesh-ancestor
110069952|NCT04496596|Anthelmintics|anthelmintics|mesh-ancestor
110390101|NCT06029998|Bortezomib|bortezomib|mesh-list
110069953|NCT04496596|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110069954|NCT04496596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110069955|NCT04496596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110069956|NCT04496596|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
110069957|NCT04496596|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110069958|NCT04477850|Luspatercept|luspatercept|mesh-list
110069959|NCT04477850|Hematinics|hematinics|mesh-ancestor
110069960|NCT04346654|Dexamethasone|dexamethasone|mesh-list
110069961|NCT04346654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110069962|NCT04346654|Antiemetics|antiemetics|mesh-ancestor
110069963|NCT04346654|Autonomic Agents|autonomic agents|mesh-ancestor
110069964|NCT04346654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110069965|NCT04346654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110069966|NCT04346654|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110069967|NCT04346654|Glucocorticoids|glucocorticoids|mesh-ancestor
110069968|NCT04346654|Hormones|hormones|mesh-ancestor
110069969|NCT04346654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110069970|NCT04346654|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110069971|NCT04346654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110069972|NCT04312503|Olanzapine|olanzapine|mesh-list
110069973|NCT04312503|Risperidone|risperidone|mesh-list
110069974|NCT04312503|Aripiprazole|aripiprazole|mesh-list
110069975|NCT04312503|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110069976|NCT04312503|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
110069977|NCT04312503|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110069978|NCT04312503|Serotonin Agents|serotonin agents|mesh-ancestor
110069979|NCT04312503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110069980|NCT04312503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110069981|NCT04312503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110069982|NCT04312503|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110069983|NCT04312503|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110069984|NCT04312503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110069985|NCT04312503|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110069986|NCT04312503|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110069987|NCT04312503|Dopamine Agents|dopamine agents|mesh-ancestor
110069988|NCT04312503|Antiemetics|antiemetics|mesh-ancestor
110069989|NCT04312503|Autonomic Agents|autonomic agents|mesh-ancestor
110069990|NCT04312503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110069991|NCT04312503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110069992|NCT04312503|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110069993|NCT04312503|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110069994|NCT04312503|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110069995|NCT04312503|Antidepressive Agents|antidepressive agents|mesh-ancestor
110069996|NCT04312503|Dopamine Agonists|dopamine agonists|mesh-ancestor
110069997|NCT04312503|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110069998|NCT04312503|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110069999|NCT04312503|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110070000|NCT04312503|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110070001|NCT04312503|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
110070002|NCT04312503|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110070003|NCT04312503|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110070004|NCT04312503|Adrenergic Agents|adrenergic agents|mesh-ancestor
110070005|NCT04310540|Edetic Acid|edetic acid|mesh-list
110070006|NCT04310540|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
110070007|NCT04310540|Chelating Agents|chelating agents|mesh-ancestor
110070008|NCT04310540|Sequestering Agents|sequestering agents|mesh-ancestor
110070009|NCT04310540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110070010|NCT04310540|Anticoagulants|anticoagulants|mesh-ancestor
110070011|NCT04310540|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110070012|NCT04310540|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110070013|NCT04305444|Everolimus|everolimus|mesh-list
110070014|NCT04305444|Pomalidomide|pomalidomide|mesh-list
110070015|NCT04305444|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110070016|NCT04305444|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110070017|NCT04305444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110070018|NCT04305444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110070019|NCT04305444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110070020|NCT04305444|Immunologic Factors|immunologic factors|mesh-ancestor
110070021|NCT04305444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110070022|NCT04305444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110070023|NCT04305444|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110070024|NCT04305444|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110070025|NCT04305444|Growth Substances|growth substances|mesh-ancestor
110070026|NCT04305444|Growth Inhibitors|growth inhibitors|mesh-ancestor
110070028|NCT04297332|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110070029|NCT04297332|Autonomic Agents|autonomic agents|mesh-ancestor
110070030|NCT04297332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110070031|NCT04297332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110070032|NCT04297332|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110070033|NCT04297332|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110070034|NCT04297332|Cholinergic Agents|cholinergic agents|mesh-ancestor
110070035|NCT04297332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110070036|NCT04297332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110070037|NCT04273776|Zolpidem|zolpidem|mesh-list
110070038|NCT04273776|Suvorexant|suvorexant|mesh-list
110070039|NCT04273776|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110070040|NCT04273776|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110070041|NCT04273776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110070042|NCT04273776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110070043|NCT04273776|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
110070044|NCT04273776|GABA Agonists|gaba agonists|mesh-ancestor
110070045|NCT04273776|GABA Agents|gaba agents|mesh-ancestor
110070046|NCT04273776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110070047|NCT04273776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110070048|NCT04273776|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
110070050|NCT04249063|Anesthetics|anesthetics|mesh-list
110070051|NCT04249063|Anesthetics, Local|anesthetics, local|mesh-list
110070052|NCT04249063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110070053|NCT04249063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110070054|NCT04249063|Sensory System Agents|sensory system agents|mesh-ancestor
110070055|NCT04249063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110070056|NCT04249063|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110070057|NCT04249063|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110070058|NCT04249063|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110070059|NCT04249063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110070060|NCT04249063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110070061|NCT04245722|Cyclophosphamide|cyclophosphamide|mesh-list
110070062|NCT04245722|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110070063|NCT04245722|Rituximab|rituximab|mesh-list
110070064|NCT04245722|Fludarabine|fludarabine|mesh-list
110070065|NCT04245722|Obinutuzumab|obinutuzumab|mesh-list
110070066|NCT04245722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110070067|NCT04245722|Immunologic Factors|immunologic factors|mesh-ancestor
110070068|NCT04245722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110070069|NCT04245722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110070070|NCT04245722|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110070071|NCT04245722|Alkylating Agents|alkylating agents|mesh-ancestor
110070072|NCT04245722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110070073|NCT04245722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110070074|NCT04245722|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110070075|NCT04245722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110070077|NCT04239040|Ipilimumab|ipilimumab|mesh-list
110070078|NCT04239040|Vaccines|vaccines|mesh-list
110070079|NCT04239040|Immunologic Factors|immunologic factors|mesh-ancestor
110070080|NCT04239040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110070081|NCT04239040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110070082|NCT04239040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110070083|NCT04239040|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110225460|NCT05959356|Levoleucovorin|levoleucovorin|mesh-list
110070084|NCT04239040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110070086|NCT04204252|Protein C Inhibitor|protein c inhibitor|mesh-list
110070087|NCT04204252|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
110070088|NCT04204252|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110070089|NCT04204252|Protease Inhibitors|protease inhibitors|mesh-ancestor
110070090|NCT04204252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110070091|NCT04204252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110070092|NCT04198116|Guanfacine|guanfacine|mesh-list
110070093|NCT04198116|Varenicline|varenicline|mesh-list
110070094|NCT04198116|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110070095|NCT04198116|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110070096|NCT04198116|Cholinergic Agents|cholinergic agents|mesh-ancestor
110070097|NCT04198116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110070098|NCT04198116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110070099|NCT04198116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110070100|NCT04198116|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110070101|NCT04198116|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110070102|NCT04198116|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110070103|NCT04198116|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110070104|NCT04198116|Adrenergic Agents|adrenergic agents|mesh-ancestor
110070105|NCT04192955|Salicylates|salicylates|mesh-list
110070106|NCT04192955|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110070107|NCT04192955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110070108|NCT04192955|Analgesics|analgesics|mesh-ancestor
110070109|NCT04192955|Sensory System Agents|sensory system agents|mesh-ancestor
110070110|NCT04192955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110070111|NCT04192955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110070112|NCT04192955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110070113|NCT04192955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110070114|NCT04192955|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110070115|NCT04192955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110070116|NCT04192955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110070117|NCT04184869|Atazanavir Sulfate|atazanavir sulfate|mesh-list
110070118|NCT04184869|Belinostat|belinostat|mesh-list
110070119|NCT04184869|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110070120|NCT04184869|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110070121|NCT04184869|Protease Inhibitors|protease inhibitors|mesh-ancestor
110070122|NCT04184869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110070123|NCT04184869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110070124|NCT04184869|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110070125|NCT04184869|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110070126|NCT04184869|Antiviral Agents|antiviral agents|mesh-ancestor
110070127|NCT04184869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110070128|NCT04184869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110070129|NCT04184869|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110070131|NCT04175262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110070132|NCT04175262|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110070133|NCT04175262|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110070134|NCT04175262|Growth Substances|growth substances|mesh-ancestor
110070135|NCT04175262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110070136|NCT04175262|Growth Inhibitors|growth inhibitors|mesh-ancestor
110070137|NCT04175262|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110070138|NCT04175262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110070139|NCT04175262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110070141|NCT04149899|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110070142|NCT04149899|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110070143|NCT04149899|Adrenergic Agents|adrenergic agents|mesh-ancestor
110070144|NCT04149899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110070145|NCT04149899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110179354|NCT00010283|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110070146|NCT04149899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110070147|NCT04149899|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110070148|NCT04149899|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110070150|NCT04137536|Antibodies, Bispecific|antibodies, bispecific|mesh-list
110070151|NCT04137536|Immunologic Factors|immunologic factors|mesh-ancestor
110070152|NCT04137536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110070153|NCT04087421|Glycerol|glycerol|mesh-list
110070154|NCT04087421|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
110070155|NCT04087421|Protective Agents|protective agents|mesh-ancestor
110070156|NCT04087421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110070157|NCT04080531|Vaccines|vaccines|mesh-list
110070158|NCT04080531|Immunologic Factors|immunologic factors|mesh-ancestor
110070159|NCT04080531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110070160|NCT04070378|Daratumumab|daratumumab|mesh-list
110070161|NCT04070378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110070162|NCT04023071|Cyclophosphamide|cyclophosphamide|mesh-list
110070163|NCT04023071|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110070164|NCT04023071|Rituximab|rituximab|mesh-list
110070165|NCT04023071|Fludarabine|fludarabine|mesh-list
110070166|NCT04023071|Obinutuzumab|obinutuzumab|mesh-list
110070167|NCT04023071|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110070168|NCT04023071|Immunologic Factors|immunologic factors|mesh-ancestor
110070169|NCT04023071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110070170|NCT04023071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110070171|NCT04023071|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110070172|NCT04023071|Alkylating Agents|alkylating agents|mesh-ancestor
110070173|NCT04023071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110070174|NCT04023071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110070175|NCT04023071|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110070176|NCT04023071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110070177|NCT04014075|Trastuzumab|trastuzumab|mesh-list
110070202|NCT04009109|Growth Substances|growth substances|mesh-ancestor
110070203|NCT04009109|Growth Inhibitors|growth inhibitors|mesh-ancestor
110070204|NCT04009109|Protease Inhibitors|protease inhibitors|mesh-ancestor
110070205|NCT04009109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110070206|NCT04009109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110070207|NCT03983993|Panitumumab|panitumumab|mesh-list
110070208|NCT03983993|Niraparib|niraparib|mesh-list
110070209|NCT03983993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110070210|NCT03983993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110179357|NCT00010322|Atamestane|atamestane|mesh-list
110070211|NCT03983993|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110070213|NCT03983993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110070250|NCT03909152|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110070252|NCT03909152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110070253|NCT03909152|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110070254|NCT03909152|Hormone Antagonists|hormone antagonists|mesh-ancestor
110070255|NCT03909152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110070256|NCT03909152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110070257|NCT03909152|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110070258|NCT03909152|Fertility Agents|fertility agents|mesh-ancestor
110070259|NCT03909152|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110070260|NCT03797001|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
110070261|NCT03797001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110070262|NCT03778424|Rufinamide|rufinamide|mesh-list
110070263|NCT03778424|Anticonvulsants|anticonvulsants|mesh-ancestor
110070264|NCT03778424|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110094951|NCT01711827|Prednisone|prednisone|mesh-list
110070265|NCT03778424|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110070266|NCT03778424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110070267|NCT03778424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110070268|NCT03777215|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
110070269|NCT03777215|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110070270|NCT03777215|Vasodilator Agents|vasodilator agents|mesh-ancestor
110070271|NCT03776864|Pembrolizumab|pembrolizumab|mesh-list
110070272|NCT03776864|Immunoglobulins|immunoglobulins|mesh-list
110070273|NCT03776864|Immunoglobulin G|immunoglobulin g|mesh-list
110070274|NCT03776864|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110070275|NCT03776864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110070276|NCT03776864|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110070277|NCT03776864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110070278|NCT03776864|Immunologic Factors|immunologic factors|mesh-ancestor
110070279|NCT03776864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110070280|NCT03762759|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
110070281|NCT03762759|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110070282|NCT03762759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110070283|NCT03675412|Caffeine|caffeine|mesh-list
110070284|NCT03675412|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110070285|NCT03675412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110070286|NCT03675412|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110070287|NCT03675412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110070288|NCT03675412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110070289|NCT03675412|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110070290|NCT03675412|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110070291|NCT03675412|Purinergic Agents|purinergic agents|mesh-ancestor
110070292|NCT03675412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110070293|NCT03664180|Heparin|heparin|mesh-list
110070294|NCT03664180|Calcium heparin|calcium heparin|mesh-list
110070295|NCT03664180|Enoxaparin|enoxaparin|mesh-list
110070296|NCT03664180|Hirudins|hirudins|mesh-list
110070297|NCT03664180|Enoxaparin sodium|enoxaparin sodium|mesh-list
110070298|NCT03664180|Bivalirudin|bivalirudin|mesh-list
110070299|NCT03664180|Anticoagulants|anticoagulants|mesh-ancestor
110070300|NCT03664180|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110070301|NCT03664180|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110070302|NCT03664180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110070303|NCT03664180|Antithrombins|antithrombins|mesh-ancestor
110070304|NCT03664180|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110070305|NCT03664180|Protease Inhibitors|protease inhibitors|mesh-ancestor
110070306|NCT03664180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110070307|NCT03652870|Dexetimide|dexetimide|mesh-list
110070308|NCT03652870|Citalopram|citalopram|mesh-list
110070309|NCT03652870|Nortriptyline|nortriptyline|mesh-list
110070310|NCT03652870|Escitalopram|escitalopram|mesh-list
110070311|NCT03652870|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110070312|NCT03652870|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110070313|NCT03652870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110070314|NCT03652870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110070315|NCT03652870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110070316|NCT03652870|Serotonin Agents|serotonin agents|mesh-ancestor
110070317|NCT03652870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110070318|NCT03652870|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110070319|NCT03652870|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110070320|NCT03652870|Parasympatholytics|parasympatholytics|mesh-ancestor
110070321|NCT03652870|Autonomic Agents|autonomic agents|mesh-ancestor
110070322|NCT03652870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110070323|NCT03652870|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110070324|NCT03652870|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110070325|NCT03652870|Cholinergic Agents|cholinergic agents|mesh-ancestor
110070326|NCT03652870|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110070327|NCT03652870|Antidepressive Agents|antidepressive agents|mesh-ancestor
110070328|NCT03652870|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110070329|NCT03652870|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110070330|NCT03652870|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110070331|NCT03652870|Adrenergic Agents|adrenergic agents|mesh-ancestor
110070333|NCT03648905|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110070334|NCT03648905|Sympathomimetics|sympathomimetics|mesh-ancestor
110070335|NCT03648905|Autonomic Agents|autonomic agents|mesh-ancestor
110070336|NCT03648905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110070337|NCT03648905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110070338|NCT03648905|Dopamine Agents|dopamine agents|mesh-ancestor
110070339|NCT03648905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110070340|NCT03648905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110070341|NCT03648905|Protective Agents|protective agents|mesh-ancestor
110070342|NCT03634852|Moxifloxacin|moxifloxacin|mesh-list
110070343|NCT03634852|Dexamethasone|dexamethasone|mesh-list
110070344|NCT03634852|Triamcinolone|triamcinolone|mesh-list
110070345|NCT03634852|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110070346|NCT03634852|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110070347|NCT03634852|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110070348|NCT03634852|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
110070349|NCT03634852|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110070350|NCT03634852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110070351|NCT03634852|Antiemetics|antiemetics|mesh-ancestor
110070352|NCT03634852|Autonomic Agents|autonomic agents|mesh-ancestor
110070353|NCT03634852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110070354|NCT03634852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110070355|NCT03634852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110070356|NCT03634852|Glucocorticoids|glucocorticoids|mesh-ancestor
110070357|NCT03634852|Hormones|hormones|mesh-ancestor
110070358|NCT03634852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110070359|NCT03634852|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110070361|NCT03634852|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110070362|NCT03634852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110070363|NCT03634852|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110070364|NCT03634852|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110070365|NCT03634852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110070366|NCT03634852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110070367|NCT03634852|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110070368|NCT03634852|Contraceptive Agents|contraceptive agents|mesh-ancestor
110070369|NCT03634852|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110070370|NCT03634852|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110070371|NCT03634852|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110070372|NCT03634852|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110070373|NCT03634852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110070374|NCT03634852|Immunologic Factors|immunologic factors|mesh-ancestor
110070375|NCT03634852|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110070376|NCT03625986|Nicotine|nicotine|mesh-list
110070377|NCT03625986|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110070378|NCT03625986|Autonomic Agents|autonomic agents|mesh-ancestor
110070379|NCT03625986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110070380|NCT03625986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110070381|NCT03625986|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110070382|NCT03625986|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110070383|NCT03625986|Cholinergic Agents|cholinergic agents|mesh-ancestor
110070384|NCT03625986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110070385|NCT03625986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110070386|NCT03604289|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
110070387|NCT03604289|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110070388|NCT03604289|Vasodilator Agents|vasodilator agents|mesh-ancestor
110070389|NCT03593811|Cyproheptadine|cyproheptadine|mesh-list
110070390|NCT03593811|Ondansetron|ondansetron|mesh-list
110070391|NCT03593811|Antiemetics|antiemetics|mesh-ancestor
110070392|NCT03593811|Autonomic Agents|autonomic agents|mesh-ancestor
110070393|NCT03593811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110070394|NCT03593811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110070395|NCT03593811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110070396|NCT03593811|Antipruritics|antipruritics|mesh-ancestor
110070397|NCT03593811|Dermatologic Agents|dermatologic agents|mesh-ancestor
110070398|NCT03593811|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110070399|NCT03593811|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110070400|NCT03593811|Serotonin Agents|serotonin agents|mesh-ancestor
110070401|NCT03593811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110070402|NCT03593811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110070403|NCT03593811|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110070404|NCT03593811|Histamine Antagonists|histamine antagonists|mesh-ancestor
110070405|NCT03593811|Histamine Agents|histamine agents|mesh-ancestor
110070406|NCT03593811|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110070407|NCT03588754|Propranolol|propranolol|mesh-list
110070418|NCT03569085|Isoflurane|isoflurane|mesh-list
110070419|NCT03569085|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110070420|NCT03569085|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110070421|NCT03569085|Anesthetics, General|anesthetics, general|mesh-ancestor
110070422|NCT03569085|Anesthetics|anesthetics|mesh-ancestor
110070423|NCT03569085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110070424|NCT03569085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110070425|NCT03552575|Valsartan|valsartan|mesh-list
110070426|NCT03552575|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
110070427|NCT03552575|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110070428|NCT03552575|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110070429|NCT03552575|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110070430|NCT03552575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110070431|NCT03528902|Tamoxifen|tamoxifen|mesh-list
110070432|NCT03528902|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110070433|NCT03528902|Hormone Antagonists|hormone antagonists|mesh-ancestor
110070434|NCT03528902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110070435|NCT03528902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110070436|NCT03528902|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110070437|NCT03528902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110070438|NCT03528902|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110070439|NCT03528902|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110070440|NCT03528902|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110070441|NCT03523156|Azithromycin|azithromycin|mesh-list
110070442|NCT03523156|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110070443|NCT03523156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110070444|NCT03495388|Oxycodone|oxycodone|mesh-list
110070445|NCT03495388|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110070446|NCT03495388|Narcotics|narcotics|mesh-ancestor
110070447|NCT03495388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110070448|NCT03495388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110070449|NCT03495388|Analgesics|analgesics|mesh-ancestor
110070450|NCT03495388|Sensory System Agents|sensory system agents|mesh-ancestor
110070451|NCT03495388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110070452|NCT03463408|Nivolumab|nivolumab|mesh-list
110070453|NCT03463408|Ipilimumab|ipilimumab|mesh-list
110070454|NCT03463408|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110070455|NCT03463408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110070456|NCT03463408|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110070457|NCT03463408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110070458|NCT03420144|Hormones|hormones|mesh-list
110070459|NCT03420144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110070460|NCT03420144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110070537|NCT03344419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110070538|NCT03344419|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110070539|NCT03344419|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110070540|NCT03344419|Anesthetics, General|anesthetics, general|mesh-ancestor
110070541|NCT03344419|Anesthetics|anesthetics|mesh-ancestor
110070542|NCT03344419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110070543|NCT03344419|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110390167|NCT06014073|Antimetabolites|antimetabolites|mesh-ancestor
110070544|NCT03344419|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110070545|NCT03344419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110070546|NCT03344419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110070548|NCT03321526|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110070549|NCT03321526|Serotonin|serotonin|mesh-list
110070550|NCT03321526|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
110070551|NCT03321526|Antidepressive Agents|antidepressive agents|mesh-ancestor
110070552|NCT03321526|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110070553|NCT03321526|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110070554|NCT03321526|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110070555|NCT03321526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110070556|NCT03321526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110070557|NCT03321526|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110070559|NCT03321526|Adrenergic Agents|adrenergic agents|mesh-ancestor
110070560|NCT03321526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110070561|NCT03321526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110070562|NCT03321526|Sympathomimetics|sympathomimetics|mesh-ancestor
110070563|NCT03321526|Autonomic Agents|autonomic agents|mesh-ancestor
110070564|NCT03321526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110070565|NCT03321526|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110070566|NCT03321526|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110070567|NCT03321526|Serotonin Agents|serotonin agents|mesh-ancestor
110070568|NCT03321526|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110070569|NCT03321526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110070570|NCT03297593|Nivolumab|nivolumab|mesh-list
110070571|NCT03297593|Ipilimumab|ipilimumab|mesh-list
110070572|NCT03297593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110070573|NCT03297593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110070574|NCT03297593|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110070575|NCT03297593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110070576|NCT03263650|Prednisone|prednisone|mesh-list
110070577|NCT03263650|Carboplatin|carboplatin|mesh-list
110070578|NCT03263650|Olaparib|olaparib|mesh-list
110070579|NCT03263650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110070580|NCT03263650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110070581|NCT03263650|Glucocorticoids|glucocorticoids|mesh-ancestor
110070582|NCT03263650|Hormones|hormones|mesh-ancestor
110070583|NCT03263650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110070584|NCT03263650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110070585|NCT03263650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110070586|NCT03263650|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110070587|NCT03263650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110070588|NCT03263650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110070589|NCT03217669|Sirolimus|sirolimus|mesh-list
110070590|NCT03217669|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110070591|NCT03217669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110070592|NCT03217669|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110070593|NCT03217669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110070594|NCT03217669|Antifungal Agents|antifungal agents|mesh-ancestor
110070595|NCT03217669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110070596|NCT03217669|Immunologic Factors|immunologic factors|mesh-ancestor
110070597|NCT03217669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110070598|NCT03196427|Vedolizumab|vedolizumab|mesh-list
110070599|NCT03196427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110070600|NCT03185819|Midazolam|midazolam|mesh-list
110070601|NCT03185819|Esketamine|esketamine|mesh-list
110070602|NCT03185819|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110070603|NCT03185819|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110070604|NCT03185819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110070605|NCT03185819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110070607|NCT03185819|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110070608|NCT03185819|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110070609|NCT03185819|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110070610|NCT03185819|Anesthetics, General|anesthetics, general|mesh-ancestor
110070611|NCT03185819|Anesthetics|anesthetics|mesh-ancestor
110070612|NCT03185819|GABA Modulators|gaba modulators|mesh-ancestor
110070613|NCT03185819|GABA Agents|gaba agents|mesh-ancestor
110070614|NCT03185819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110070615|NCT03185819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110070616|NCT03185819|Antidepressive Agents|antidepressive agents|mesh-ancestor
110070617|NCT03153111|Macitentan|macitentan|mesh-list
110070618|NCT03153111|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
110070619|NCT03153111|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
110070620|NCT03153111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110070621|NCT03153111|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
110070622|NCT03126435|Gemcitabine|gemcitabine|mesh-list
110070623|NCT03126435|Paclitaxel|paclitaxel|mesh-list
110070624|NCT03126435|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110070625|NCT03126435|Antimetabolites|antimetabolites|mesh-ancestor
110070626|NCT03126435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110070627|NCT03126435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110070628|NCT03126435|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110070629|NCT03126435|Tubulin Modulators|tubulin modulators|mesh-ancestor
110070630|NCT03126435|Antimitotic Agents|antimitotic agents|mesh-ancestor
110070631|NCT03126435|Mitosis Modulators|mitosis modulators|mesh-ancestor
110070632|NCT03119584|Linaclotide|linaclotide|mesh-list
110070633|NCT03119584|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
110070634|NCT03119584|Enzyme Activators|enzyme activators|mesh-ancestor
110070635|NCT03119584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110070636|NCT03119584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110070637|NCT03095781|Pembrolizumab|pembrolizumab|mesh-list
110070638|NCT03095781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110070639|NCT03095781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110070640|NCT03095781|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110070641|NCT03095781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110070642|NCT03084939|Capecitabine|capecitabine|mesh-list
110070643|NCT03084939|Trastuzumab|trastuzumab|mesh-list
110070644|NCT03084939|Lapatinib|lapatinib|mesh-list
110070645|NCT03084939|Maytansine|maytansine|mesh-list
110070646|NCT03084939|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
110070647|NCT03084939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110070648|NCT03084939|Antimetabolites|antimetabolites|mesh-ancestor
110070649|NCT03084939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110070650|NCT03084939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110070651|NCT03084939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110070652|NCT03084939|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110070653|NCT03084939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110070654|NCT03084939|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110070655|NCT03084939|Tubulin Modulators|tubulin modulators|mesh-ancestor
110070656|NCT03084939|Antimitotic Agents|antimitotic agents|mesh-ancestor
110070657|NCT03084939|Mitosis Modulators|mitosis modulators|mesh-ancestor
110070658|NCT03084939|Immunotoxins|immunotoxins|mesh-ancestor
110070659|NCT03084939|Immunoconjugates|immunoconjugates|mesh-ancestor
110070660|NCT03084939|Immunologic Factors|immunologic factors|mesh-ancestor
110070661|NCT03084939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110070662|NCT03047005|Naltrexone|naltrexone|mesh-list
110070663|NCT03047005|Bupropion|bupropion|mesh-list
110070664|NCT03047005|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110070665|NCT03047005|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110070666|NCT03047005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110070667|NCT03047005|Sensory System Agents|sensory system agents|mesh-ancestor
110070668|NCT03047005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110070669|NCT03047005|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110070670|NCT03047005|Antidepressive Agents|antidepressive agents|mesh-ancestor
110070671|NCT03047005|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110070672|NCT03047005|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110070673|NCT03047005|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110070674|NCT03047005|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110070675|NCT03047005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110070676|NCT03047005|Dopamine Agents|dopamine agents|mesh-ancestor
110070677|NCT03047005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110070678|NCT03047005|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110070679|NCT03047005|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110070680|NCT03047005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110070681|NCT03020030|Leucovorin|leucovorin|mesh-list
110070682|NCT03020030|Cytarabine|cytarabine|mesh-list
110070683|NCT03020030|Dexamethasone|dexamethasone|mesh-list
110070684|NCT03020030|Hydrocortisone|hydrocortisone|mesh-list
110070685|NCT03020030|Cyclophosphamide|cyclophosphamide|mesh-list
110070686|NCT03020030|Doxorubicin|doxorubicin|mesh-list
110070687|NCT03020030|Methotrexate|methotrexate|mesh-list
110070688|NCT03020030|Etoposide|etoposide|mesh-list
110070689|NCT03020030|Vincristine|vincristine|mesh-list
110070690|NCT03020030|Asparaginase|asparaginase|mesh-list
110070691|NCT03020030|Dasatinib|dasatinib|mesh-list
110070692|NCT03020030|Mercaptopurine|mercaptopurine|mesh-list
110070693|NCT03020030|Pegaspargase|pegaspargase|mesh-list
110070694|NCT03020030|Dexrazoxane|dexrazoxane|mesh-list
110070695|NCT03020030|Razoxane|razoxane|mesh-list
110070696|NCT03020030|Levoleucovorin|levoleucovorin|mesh-list
110070697|NCT03020030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110070698|NCT03020030|Immunologic Factors|immunologic factors|mesh-ancestor
110070699|NCT03020030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110070700|NCT03020030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110070701|NCT03020030|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110070702|NCT03020030|Alkylating Agents|alkylating agents|mesh-ancestor
110070703|NCT03020030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110070704|NCT03020030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110070705|NCT03020030|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110070706|NCT03020030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110070707|NCT03020030|Antiemetics|antiemetics|mesh-ancestor
110070708|NCT03020030|Autonomic Agents|autonomic agents|mesh-ancestor
110070709|NCT03020030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110070710|NCT03020030|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110070711|NCT03020030|Glucocorticoids|glucocorticoids|mesh-ancestor
110070712|NCT03020030|Hormones|hormones|mesh-ancestor
110070713|NCT03020030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110070714|NCT03020030|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110070715|NCT03020030|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110070716|NCT03020030|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110070717|NCT03020030|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110070718|NCT03020030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110070719|NCT03020030|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110070720|NCT03020030|Abortifacient Agents|abortifacient agents|mesh-ancestor
110070721|NCT03020030|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110070722|NCT03020030|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110070723|NCT03020030|Antimetabolites|antimetabolites|mesh-ancestor
110070724|NCT03020030|Dermatologic Agents|dermatologic agents|mesh-ancestor
110070725|NCT03020030|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110070726|NCT03020030|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110070727|NCT03020030|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110070728|NCT03020030|Antiviral Agents|antiviral agents|mesh-ancestor
110070729|NCT03020030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110070730|NCT03020030|Antidotes|antidotes|mesh-ancestor
110070731|NCT03020030|Protective Agents|protective agents|mesh-ancestor
110070732|NCT03020030|Vitamin B Complex|vitamin b complex|mesh-ancestor
110070733|NCT03020030|Vitamins|vitamins|mesh-ancestor
110070734|NCT03020030|Micronutrients|micronutrients|mesh-ancestor
110070735|NCT03020030|Tubulin Modulators|tubulin modulators|mesh-ancestor
110070736|NCT03020030|Antimitotic Agents|antimitotic agents|mesh-ancestor
110070737|NCT03020030|Mitosis Modulators|mitosis modulators|mesh-ancestor
110070738|NCT03020030|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110070739|NCT03020030|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110070740|NCT03011684|Tamoxifen|tamoxifen|mesh-list
110070741|NCT03011684|Letrozole|letrozole|mesh-list
110070742|NCT03011684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110070743|NCT03011684|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110070744|NCT03011684|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110070745|NCT03011684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110070746|NCT03011684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110070747|NCT03011684|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110070748|NCT03011684|Hormone Antagonists|hormone antagonists|mesh-ancestor
110070749|NCT03011684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110070750|NCT03011684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110070751|NCT03011684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110070752|NCT03011684|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110070753|NCT03011684|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110070754|NCT03011684|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110070755|NCT02968108|Ustekinumab|ustekinumab|mesh-list
110070756|NCT02968108|Dermatologic Agents|dermatologic agents|mesh-ancestor
110070757|NCT02947347|Rituximab|rituximab|mesh-list
110070758|NCT02947347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110070759|NCT02947347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110070760|NCT02947347|Immunologic Factors|immunologic factors|mesh-ancestor
110070761|NCT02947347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110070762|NCT02947347|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110070763|NCT02946996|Metformin|metformin|mesh-list
110070764|NCT02946996|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110070765|NCT02946996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110070766|NCT02870907|Cyclophosphamide|cyclophosphamide|mesh-list
110070767|NCT02870907|Thiotepa|thiotepa|mesh-list
110070768|NCT02870907|Carboplatin|carboplatin|mesh-list
110070770|NCT02870907|Etoposide phosphate|etoposide phosphate|mesh-list
110070771|NCT02870907|Vincristine|vincristine|mesh-list
110070772|NCT02870907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110070773|NCT02870907|Immunologic Factors|immunologic factors|mesh-ancestor
110070774|NCT02870907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110070775|NCT02870907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110070776|NCT02870907|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110070777|NCT02870907|Alkylating Agents|alkylating agents|mesh-ancestor
110070778|NCT02870907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110070779|NCT02870907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110070780|NCT02870907|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110070781|NCT02870907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110070782|NCT02870907|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110070783|NCT02870907|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110070784|NCT02870907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110070785|NCT02870907|Tubulin Modulators|tubulin modulators|mesh-ancestor
110070786|NCT02870907|Antimitotic Agents|antimitotic agents|mesh-ancestor
110070787|NCT02870907|Mitosis Modulators|mitosis modulators|mesh-ancestor
110070788|NCT02823574|Nivolumab|nivolumab|mesh-list
110070789|NCT02823574|Ipilimumab|ipilimumab|mesh-list
110070790|NCT02823574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110070791|NCT02823574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110070792|NCT02823574|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110070793|NCT02823574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110070794|NCT02641028|Aticaprant|aticaprant|mesh-list
110070795|NCT02641028|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110070796|NCT02641028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110070797|NCT02641028|Sensory System Agents|sensory system agents|mesh-ancestor
110070798|NCT02641028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110070799|NCT02525796|Eplerenone|eplerenone|mesh-list
110070801|NCT02525796|Cinacalcet|cinacalcet|mesh-list
110070802|NCT02525796|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110070803|NCT02525796|Hormone Antagonists|hormone antagonists|mesh-ancestor
110094952|NCT01711827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110070804|NCT02525796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110070805|NCT02525796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110070806|NCT02525796|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110070807|NCT02525796|Diuretics|diuretics|mesh-ancestor
110070808|NCT02525796|Natriuretic Agents|natriuretic agents|mesh-ancestor
110070809|NCT02525796|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110070810|NCT02525796|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110070811|NCT02525796|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
110070812|NCT02525796|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
110070813|NCT02525796|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110070814|NCT02525796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110070815|NCT02525796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110070816|NCT02525796|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
110070817|NCT02360280|Midazolam|midazolam|mesh-list
110070818|NCT02360280|Ketamine|ketamine|mesh-list
110070819|NCT02360280|Analgesics|analgesics|mesh-ancestor
110070820|NCT02360280|Sensory System Agents|sensory system agents|mesh-ancestor
110070821|NCT02360280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110070822|NCT02360280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110070823|NCT02360280|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110070824|NCT02360280|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110070825|NCT02360280|Anesthetics, General|anesthetics, general|mesh-ancestor
110070826|NCT02360280|Anesthetics|anesthetics|mesh-ancestor
110070827|NCT02360280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110070828|NCT02360280|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110070829|NCT02360280|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110070830|NCT02360280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110070831|NCT02360280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110070832|NCT02360280|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110070833|NCT02360280|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110070834|NCT02360280|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110070835|NCT02360280|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110070836|NCT02360280|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110070837|NCT02360280|GABA Modulators|gaba modulators|mesh-ancestor
110070838|NCT02360280|GABA Agents|gaba agents|mesh-ancestor
110070839|NCT02201251|Topiramate|topiramate|mesh-list
110070840|NCT02201251|Levetiracetam|levetiracetam|mesh-list
110070841|NCT02201251|Anticonvulsants|anticonvulsants|mesh-ancestor
110070842|NCT02201251|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110070843|NCT02201251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110070845|NCT02192021|Doxorubicin|doxorubicin|mesh-list
110070846|NCT02192021|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110070847|NCT02192021|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110070848|NCT02192021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110070849|NCT02192021|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110070850|NCT02192021|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110070851|NCT02192021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110070852|NCT02192021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110070853|NCT02174575|Sevoflurane|sevoflurane|mesh-list
110070854|NCT02174575|Desflurane|desflurane|mesh-list
110070855|NCT02174575|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110070856|NCT02174575|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110070857|NCT02174575|Anesthetics, General|anesthetics, general|mesh-ancestor
110070858|NCT02174575|Anesthetics|anesthetics|mesh-ancestor
110070859|NCT02174575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110070860|NCT02174575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110070862|NCT01889810|Cholecalciferol|cholecalciferol|mesh-list
110070863|NCT01889810|Vitamins|vitamins|mesh-ancestor
110070864|NCT01889810|Micronutrients|micronutrients|mesh-ancestor
110070865|NCT01889810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110070866|NCT01889810|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110070867|NCT01889810|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110070868|NCT01840592|Doxorubicin|doxorubicin|mesh-list
110070869|NCT01840592|Sorafenib|sorafenib|mesh-list
110070870|NCT01840592|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110070871|NCT01840592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110070872|NCT01840592|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110070873|NCT01840592|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110070874|NCT01840592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110070875|NCT01840592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110070876|NCT01840592|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110070878|NCT01734694|Linezolid|linezolid|mesh-list
110070879|NCT01734694|Daptomycin|daptomycin|mesh-list
110070880|NCT01734694|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
110070881|NCT01734694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110070882|NCT01734694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110070883|NCT01734694|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110179504|NCT00847860|Analgesics|analgesics|mesh-ancestor
110070884|NCT01734694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110070885|NCT01734694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110070886|NCT01703949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110070888|NCT01703949|Brentuximab Vedotin|brentuximab vedotin|mesh-list
110070890|NCT01703949|Immunoglobulins|immunoglobulins|mesh-list
110070891|NCT01703949|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110070892|NCT01703949|Immunoconjugates|immunoconjugates|mesh-list
110070893|NCT01703949|Immunologic Factors|immunologic factors|mesh-ancestor
110179595|NCT00011960|Paclitaxel|paclitaxel|mesh-list
110070894|NCT01703949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110070895|NCT01703949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110070896|NCT01703949|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110070897|NCT01703949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110070899|NCT01599234|Nabiximols|nabiximols|mesh-list
110070900|NCT01599234|Analgesics|analgesics|mesh-ancestor
110070901|NCT01599234|Sensory System Agents|sensory system agents|mesh-ancestor
110070902|NCT01599234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110179660|NCT01818323|Immunomodulating Agents|immunomodulating agents|mesh-list
110070903|NCT01599234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110070904|NCT01468896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110070905|NCT01468896|Cetuximab|cetuximab|mesh-list
110070906|NCT01468896|Interleukin-12|interleukin-12|mesh-list
110070907|NCT01468896|Antibodies|antibodies|mesh-list
110070908|NCT01468896|Immunoglobulins|immunoglobulins|mesh-list
110070909|NCT01468896|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110179798|NCT00846690|Mydriatics|mydriatics|mesh-ancestor
110070910|NCT01468896|Immunologic Factors|immunologic factors|mesh-ancestor
110070911|NCT01468896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110070912|NCT01468896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110070913|NCT01468896|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110070914|NCT01468896|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110070915|NCT01468896|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110070916|NCT01468896|Growth Substances|growth substances|mesh-ancestor
110070917|NCT01468896|Growth Inhibitors|growth inhibitors|mesh-ancestor
110070918|NCT01251861|Bicalutamide|bicalutamide|mesh-list
110070919|NCT01251861|Androgen Antagonists|androgen antagonists|mesh-ancestor
110070920|NCT01251861|Hormone Antagonists|hormone antagonists|mesh-ancestor
110070921|NCT01251861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110070922|NCT01251861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110070923|NCT01251861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110070924|NCT00843882|Lenalidomide|lenalidomide|mesh-list
110070925|NCT00843882|Epoetin Alfa|epoetin alfa|mesh-list
110070926|NCT00843882|Immunologic Factors|immunologic factors|mesh-ancestor
110070927|NCT00843882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110070928|NCT00843882|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110070929|NCT00843882|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110070930|NCT00843882|Growth Substances|growth substances|mesh-ancestor
110070931|NCT00843882|Growth Inhibitors|growth inhibitors|mesh-ancestor
110070933|NCT00843882|Hematinics|hematinics|mesh-ancestor
110070934|NCT00716625|Sunitinib|sunitinib|mesh-list
110070935|NCT00716625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110070936|NCT00716625|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110070937|NCT00716625|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110070938|NCT00716625|Growth Substances|growth substances|mesh-ancestor
110070939|NCT00716625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110070940|NCT00716625|Growth Inhibitors|growth inhibitors|mesh-ancestor
110070941|NCT00716625|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110070942|NCT00716625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110070943|NCT00716625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110070944|NCT00713817|Nabiximols|nabiximols|mesh-list
110070945|NCT00713817|Analgesics|analgesics|mesh-ancestor
110070946|NCT00713817|Sensory System Agents|sensory system agents|mesh-ancestor
110070947|NCT00713817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110070948|NCT00713817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110070949|NCT00713323|Nabiximols|nabiximols|mesh-list
110070950|NCT00713323|Analgesics|analgesics|mesh-ancestor
110070951|NCT00713323|Sensory System Agents|sensory system agents|mesh-ancestor
110070952|NCT00713323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110070953|NCT00713323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110070954|NCT00713193|Cyclosporine|cyclosporine|mesh-list
110070955|NCT00713193|Prednisone|prednisone|mesh-list
110070956|NCT00713193|Cyclosporins|cyclosporins|mesh-list
110070957|NCT00713193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110070958|NCT00713193|Glucocorticoids|glucocorticoids|mesh-ancestor
110070959|NCT00713193|Hormones|hormones|mesh-ancestor
110070960|NCT00713193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110070961|NCT00713193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110070962|NCT00713193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110070963|NCT00713193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110070964|NCT00713193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110070965|NCT00713193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110070966|NCT00713193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110070967|NCT00713193|Immunologic Factors|immunologic factors|mesh-ancestor
110070968|NCT00713193|Antifungal Agents|antifungal agents|mesh-ancestor
110070969|NCT00713193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110070970|NCT00713193|Dermatologic Agents|dermatologic agents|mesh-ancestor
110070971|NCT00713193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110070972|NCT00713193|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110070973|NCT00710554|Nabiximols|nabiximols|mesh-list
110070974|NCT00710554|Analgesics|analgesics|mesh-ancestor
110070975|NCT00710554|Sensory System Agents|sensory system agents|mesh-ancestor
110070976|NCT00710554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110070977|NCT00710554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110070978|NCT00710424|Nabiximols|nabiximols|mesh-list
110070979|NCT00710424|Analgesics|analgesics|mesh-ancestor
110070980|NCT00710424|Sensory System Agents|sensory system agents|mesh-ancestor
110070981|NCT00710424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110070982|NCT00710424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110070983|NCT00674609|Nabiximols|nabiximols|mesh-list
110070984|NCT00674609|Analgesics|analgesics|mesh-ancestor
110070985|NCT00674609|Sensory System Agents|sensory system agents|mesh-ancestor
110070986|NCT00674609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110070987|NCT00674609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110070988|NCT01556646|Tolvaptan|tolvaptan|mesh-list
110070989|NCT01556646|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
110070990|NCT01556646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110070991|NCT01556646|Natriuretic Agents|natriuretic agents|mesh-ancestor
110070992|NCT01556646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110070993|NCT01556659|Acenocoumarol|acenocoumarol|mesh-list
110070994|NCT01556659|Anticoagulants|anticoagulants|mesh-ancestor
110070995|NCT01556672|Adalimumab|adalimumab|mesh-list
110070996|NCT01556672|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110070998|NCT01556672|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110070999|NCT01556698|Nitric Oxide|nitric oxide|mesh-list
110071000|NCT01556698|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110071001|NCT01556698|Autonomic Agents|autonomic agents|mesh-ancestor
110071002|NCT01556698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110071003|NCT01556698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110071004|NCT01556698|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110071005|NCT01556698|Respiratory System Agents|respiratory system agents|mesh-ancestor
110071006|NCT01556698|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110071007|NCT01556698|Antioxidants|antioxidants|mesh-ancestor
110071008|NCT01556698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110071009|NCT01556698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110071010|NCT01556698|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
110071011|NCT01556698|Vasodilator Agents|vasodilator agents|mesh-ancestor
110071012|NCT01556698|Gasotransmitters|gasotransmitters|mesh-ancestor
110071013|NCT01556698|Protective Agents|protective agents|mesh-ancestor
110071016|NCT01556737|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110071017|NCT01556737|Protective Agents|protective agents|mesh-ancestor
110071018|NCT01556737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110071019|NCT01556737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110071020|NCT01556737|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110071021|NCT01556737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110071022|NCT01556737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110071023|NCT01556737|Phytoestrogens|phytoestrogens|mesh-ancestor
110071024|NCT01556737|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
110071025|NCT01556737|Estrogens|estrogens|mesh-ancestor
110071026|NCT01556737|Hormones|hormones|mesh-ancestor
110071027|NCT01556737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110071028|NCT01556815|Sorafenib|sorafenib|mesh-list
110071029|NCT01556815|Chlorotrianisene|chlorotrianisene|mesh-list
110071030|NCT01556815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110071031|NCT01556815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110071032|NCT01556815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110071033|NCT01556815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110071034|NCT01556815|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
110071035|NCT01556815|Estrogens|estrogens|mesh-ancestor
110071036|NCT01556815|Hormones|hormones|mesh-ancestor
110180137|NCT00014534|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110071037|NCT01556815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110071038|NCT01556815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110071039|NCT01556815|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110071040|NCT01556867|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
110071041|NCT01556867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110071042|NCT01557075|Atorvastatin|atorvastatin|mesh-list
110071043|NCT01557075|Pravastatin|pravastatin|mesh-list
110071044|NCT01557075|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
110071045|NCT01557075|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110071046|NCT01557075|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110071047|NCT01557075|Antimetabolites|antimetabolites|mesh-ancestor
110071048|NCT01557075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110071049|NCT01557075|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110071050|NCT01557075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110071051|NCT01557114|Ipilimumab|ipilimumab|mesh-list
110071052|NCT01557114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110071053|NCT01557114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110071054|NCT01557114|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110071055|NCT01557114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110071056|NCT01557127|Sorafenib|sorafenib|mesh-list
110071057|NCT01557127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110071058|NCT01557127|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110071059|NCT01557127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110071060|NCT01557127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110071061|NCT01557140|Carvedilol|carvedilol|mesh-list
110071062|NCT01557140|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110071063|NCT01557140|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110071064|NCT01557140|Adrenergic Agents|adrenergic agents|mesh-ancestor
110071065|NCT01557140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110180196|NCT00014690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110071066|NCT01557140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110071067|NCT01557140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110071068|NCT01557140|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110071070|NCT01557140|Protective Agents|protective agents|mesh-ancestor
110071071|NCT01557140|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110071072|NCT01557140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110071073|NCT01557140|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110071074|NCT01557140|Vasodilator Agents|vasodilator agents|mesh-ancestor
110071075|NCT01557140|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110071076|NCT01557140|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110071077|NCT01557153|Amlodipine|amlodipine|mesh-list
110180239|NCT00275925|Oxcarbazepine|oxcarbazepine|mesh-list
110071078|NCT01557153|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110071079|NCT01557153|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110071080|NCT01557153|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110225461|NCT05959356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110071081|NCT01557153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110071082|NCT01557153|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110071083|NCT01557153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110071084|NCT01557153|Vasodilator Agents|vasodilator agents|mesh-ancestor
110071085|NCT01557257|Naltrexone|naltrexone|mesh-list
110071086|NCT01557257|Oxycodone|oxycodone|mesh-list
110071087|NCT01557257|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110071088|NCT01557257|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110071089|NCT01557257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110071090|NCT01557257|Sensory System Agents|sensory system agents|mesh-ancestor
110071091|NCT01557257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110071092|NCT01557257|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110071093|NCT01557257|Narcotics|narcotics|mesh-ancestor
110071094|NCT01557257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110071095|NCT01557257|Analgesics|analgesics|mesh-ancestor
110071096|NCT01557270|Dexmedetomidine|dexmedetomidine|mesh-list
110071097|NCT01557270|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110071098|NCT01557270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110071099|NCT01557270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110071100|NCT01557270|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110071102|NCT01557270|Sensory System Agents|sensory system agents|mesh-ancestor
110071103|NCT01557270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110071104|NCT01557270|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110071105|NCT01557270|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110071106|NCT01557270|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110071107|NCT01557270|Adrenergic Agents|adrenergic agents|mesh-ancestor
110071108|NCT01557270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110071109|NCT01557270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110071111|NCT01557335|Omeprazole|omeprazole|mesh-list
110071112|NCT01557335|Clopidogrel|clopidogrel|mesh-list
110071113|NCT01557335|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110071114|NCT01557335|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110071115|NCT01557335|Analgesics|analgesics|mesh-ancestor
110071116|NCT01557335|Sensory System Agents|sensory system agents|mesh-ancestor
110071117|NCT01557335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110071118|NCT01557335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110071119|NCT01557335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110071120|NCT01557335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110071121|NCT01557335|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110071123|NCT01557335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110071124|NCT01557335|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110071125|NCT01557335|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110071126|NCT01557335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110071127|NCT01557335|Antipyretics|antipyretics|mesh-ancestor
110071128|NCT01557335|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110071129|NCT01557335|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110071130|NCT01557335|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110071131|NCT01557335|Purinergic Agents|purinergic agents|mesh-ancestor
110071132|NCT01557335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110071133|NCT01557335|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110071134|NCT01557335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110071135|NCT01557335|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110071136|NCT01557374|Abatacept|abatacept|mesh-list
110071137|NCT01557374|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110071138|NCT01557374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110071139|NCT01557374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110071140|NCT01557374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110071141|NCT01557374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110071142|NCT01557374|Immunologic Factors|immunologic factors|mesh-ancestor
110071143|NCT01557374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110071144|NCT01557374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110071145|NCT01557439|Levocetirizine|levocetirizine|mesh-list
110071146|NCT01557439|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110071147|NCT01557439|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110071148|NCT01557439|Histamine Antagonists|histamine antagonists|mesh-ancestor
110071149|NCT01557439|Histamine Agents|histamine agents|mesh-ancestor
110180481|NCT00275106|Antiemetics|antiemetics|mesh-ancestor
110071150|NCT01557439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110071151|NCT01557439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110071152|NCT01557439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110071153|NCT01557478|Melatonin|melatonin|mesh-list
110071154|NCT01557478|Antioxidants|antioxidants|mesh-ancestor
110071155|NCT01557478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110071156|NCT01557478|Protective Agents|protective agents|mesh-ancestor
110071157|NCT01557478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110071158|NCT01557478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110071159|NCT01557634|Insulin|insulin|mesh-list
110071160|NCT01557634|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110071161|NCT01557634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110071162|NCT01557647|Treprostinil|treprostinil|mesh-list
110071163|NCT01557647|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110071164|NCT01557660|Treprostinil|treprostinil|mesh-list
110071165|NCT01557660|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110071166|NCT01557712|Ketamine|ketamine|mesh-list
110071167|NCT01557712|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
110071168|NCT01557712|Analgesics|analgesics|mesh-ancestor
110071169|NCT01557712|Sensory System Agents|sensory system agents|mesh-ancestor
110071170|NCT01557712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110071171|NCT01557712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110071172|NCT01557712|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110071173|NCT01557712|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110071174|NCT01557712|Anesthetics, General|anesthetics, general|mesh-ancestor
110071175|NCT01557712|Anesthetics|anesthetics|mesh-ancestor
110071176|NCT01557712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110071177|NCT01557712|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110071178|NCT01557712|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110071179|NCT01557712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110071180|NCT01557712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110071181|NCT01557712|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110071182|NCT01557712|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110071183|NCT01557712|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110071184|NCT01557712|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110071185|NCT01557712|Antidepressive Agents|antidepressive agents|mesh-ancestor
110071186|NCT01557712|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110071187|NCT01557764|Trastuzumab|trastuzumab|mesh-list
110071188|NCT01557764|Lapatinib|lapatinib|mesh-list
110071189|NCT01557764|Antibodies|antibodies|mesh-list
110071190|NCT01557764|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110071191|NCT01557764|Immunologic Factors|immunologic factors|mesh-ancestor
110071192|NCT01557764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110071193|NCT01557764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110071194|NCT01557764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110071195|NCT01557764|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110071196|NCT01557764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110071197|NCT01557764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110071198|NCT01557816|Naproxen|naproxen|mesh-list
110071199|NCT01557816|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110071200|NCT01557816|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110071201|NCT01557816|Analgesics|analgesics|mesh-ancestor
110071202|NCT01557816|Sensory System Agents|sensory system agents|mesh-ancestor
110071203|NCT01557816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110071204|NCT01557816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110071205|NCT01557816|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110071206|NCT01557816|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110071207|NCT01557816|Gout Suppressants|gout suppressants|mesh-ancestor
110071208|NCT01557816|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110071209|NCT01557816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110071210|NCT01557816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110071211|NCT01557829|Silicon|silicon|mesh-list
110071212|NCT01557829|Trace Elements|trace elements|mesh-ancestor
110071213|NCT01557829|Micronutrients|micronutrients|mesh-ancestor
110071214|NCT01557829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110071216|NCT01557907|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110071217|NCT01557907|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110071218|NCT01557907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110071219|NCT01557985|Bupivacaine|bupivacaine|mesh-list
110071220|NCT01557985|Anesthetics, Local|anesthetics, local|mesh-ancestor
110071221|NCT01557985|Anesthetics|anesthetics|mesh-ancestor
110071222|NCT01557985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110071223|NCT01557985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110071224|NCT01557985|Sensory System Agents|sensory system agents|mesh-ancestor
110071225|NCT01557985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110071226|NCT01558011|Docetaxel|docetaxel|mesh-list
110071227|NCT01558011|Capecitabine|capecitabine|mesh-list
110071228|NCT01558011|Oxaliplatin|oxaliplatin|mesh-list
110071229|NCT01558011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110071230|NCT01558011|Tubulin Modulators|tubulin modulators|mesh-ancestor
110071231|NCT01558011|Antimitotic Agents|antimitotic agents|mesh-ancestor
110071232|NCT01558011|Mitosis Modulators|mitosis modulators|mesh-ancestor
110071233|NCT01558011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110071234|NCT01558011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110071235|NCT01558011|Antimetabolites|antimetabolites|mesh-ancestor
110071236|NCT01558167|Rituximab|rituximab|mesh-list
110071237|NCT01558167|Lenalidomide|lenalidomide|mesh-list
110071238|NCT01558167|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110071239|NCT01558167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110071240|NCT01558167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110071241|NCT01558167|Immunologic Factors|immunologic factors|mesh-ancestor
110071242|NCT01558167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110071243|NCT01558167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110071244|NCT01558167|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110071245|NCT01558167|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110071246|NCT01558167|Growth Substances|growth substances|mesh-ancestor
110071247|NCT01558167|Growth Inhibitors|growth inhibitors|mesh-ancestor
110071248|NCT01558167|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110071249|NCT01558167|Alkylating Agents|alkylating agents|mesh-ancestor
110071250|NCT01558167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110071251|NCT01558193|Vitamins|vitamins|mesh-list
110071252|NCT01558193|Evening primrose oil|evening primrose oil|mesh-list
110071253|NCT01558193|Micronutrients|micronutrients|mesh-ancestor
110071254|NCT01558193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110071255|NCT01558193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110071256|NCT01558193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110071257|NCT01558193|Analgesics|analgesics|mesh-ancestor
110071258|NCT01558193|Sensory System Agents|sensory system agents|mesh-ancestor
110071259|NCT01558193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110071260|NCT01558193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110071261|NCT01558193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110071262|NCT01558193|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110071263|NCT01558193|Antimetabolites|antimetabolites|mesh-ancestor
110071264|NCT01558193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110071265|NCT01558193|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110071266|NCT01558193|Dermatologic Agents|dermatologic agents|mesh-ancestor
110071267|NCT01558245|Kallikreins|kallikreins|mesh-list
110071268|NCT01558245|Coagulants|coagulants|mesh-ancestor
110071269|NCT01558245|Fertility Agents, Male|fertility agents, male|mesh-ancestor
110071270|NCT01558245|Fertility Agents|fertility agents|mesh-ancestor
110071271|NCT01558245|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110071272|NCT01558245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110071273|NCT01558310|Ustekinumab|ustekinumab|mesh-list
110071274|NCT01558310|Dermatologic Agents|dermatologic agents|mesh-ancestor
110071275|NCT01558336|Praziquantel|praziquantel|mesh-list
110071276|NCT01558336|Anthelmintics|anthelmintics|mesh-ancestor
110071277|NCT01558336|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110071278|NCT01558336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110071279|NCT01558375|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
110071280|NCT01558375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110071281|NCT01558453|Oxaliplatin|oxaliplatin|mesh-list
110071282|NCT01558453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110071283|NCT01558466|Sildenafil Citrate|sildenafil citrate|mesh-list
110071284|NCT01558466|Vasodilator Agents|vasodilator agents|mesh-ancestor
110071285|NCT01558466|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110071286|NCT01558466|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110071287|NCT01558466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110071288|NCT01558466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110071290|NCT01558622|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
110071291|NCT01558622|Ketoprofen|ketoprofen|mesh-list
110071292|NCT01558622|Meperidine|meperidine|mesh-list
110071293|NCT01558622|Tramadol|tramadol|mesh-list
110071294|NCT01558622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110071295|NCT01558622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110071296|NCT01558622|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110071297|NCT01558622|Narcotics|narcotics|mesh-ancestor
110071298|NCT01558622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110071299|NCT01558622|Analgesics|analgesics|mesh-ancestor
110071300|NCT01558622|Sensory System Agents|sensory system agents|mesh-ancestor
110071301|NCT01558622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110071302|NCT01558622|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110071303|NCT01558622|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110071304|NCT01558622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110071305|NCT01558622|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110071306|NCT01558622|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110071307|NCT01558622|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110071308|NCT01558622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110071309|NCT01558648|Analgesics|analgesics|mesh-list
110071310|NCT01558648|Sensory System Agents|sensory system agents|mesh-ancestor
110071311|NCT01558648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110071312|NCT01558648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110071313|NCT01558713|Fentanyl|fentanyl|mesh-list
110071314|NCT01558713|Bupivacaine|bupivacaine|mesh-list
110071315|NCT01558713|Ropivacaine|ropivacaine|mesh-list
110071316|NCT01558713|Levobupivacaine|levobupivacaine|mesh-list
110071317|NCT01558713|Anesthetics, Local|anesthetics, local|mesh-ancestor
110071318|NCT01558713|Anesthetics|anesthetics|mesh-ancestor
110071319|NCT01558713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110071320|NCT01558713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110071321|NCT01558713|Sensory System Agents|sensory system agents|mesh-ancestor
110071322|NCT01558713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110071323|NCT01558713|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110071324|NCT01558713|Narcotics|narcotics|mesh-ancestor
110071325|NCT01558713|Analgesics|analgesics|mesh-ancestor
110071326|NCT01558713|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110071327|NCT01558713|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110071328|NCT01558713|Anesthetics, General|anesthetics, general|mesh-ancestor
110071329|NCT01558830|Ranolazine|ranolazine|mesh-list
110071330|NCT01558830|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110071331|NCT01558830|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110071332|NCT01558830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110071334|NCT01558869|Oxaliplatin|oxaliplatin|mesh-list
110071335|NCT01558869|Irinotecan|irinotecan|mesh-list
110071336|NCT01558869|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110071337|NCT01558869|Antimetabolites|antimetabolites|mesh-ancestor
110071338|NCT01558869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110071339|NCT01558869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110071340|NCT01558869|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110071341|NCT01558869|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110071342|NCT01558869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110071343|NCT01558934|Lofexidine|lofexidine|mesh-list
110071344|NCT01558934|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110071345|NCT01558934|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110071346|NCT01558934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110071347|NCT01558934|Sensory System Agents|sensory system agents|mesh-ancestor
110071348|NCT01558934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110071349|NCT01558934|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110071350|NCT01558934|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110071351|NCT01558934|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110071352|NCT01558934|Adrenergic Agents|adrenergic agents|mesh-ancestor
110071353|NCT01558934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110071354|NCT01558934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110071355|NCT01558960|Melphalan|melphalan|mesh-list
110071356|NCT01558960|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110071357|NCT01558960|Alkylating Agents|alkylating agents|mesh-ancestor
110071358|NCT01558960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110071359|NCT01558960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110071360|NCT01558960|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110071361|NCT01558960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110071362|NCT01558960|Immunologic Factors|immunologic factors|mesh-ancestor
110071363|NCT01558960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110071364|NCT01558986|Cefazolin|cefazolin|mesh-list
110071365|NCT01558986|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110071366|NCT01558986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110071367|NCT01559025|Vildagliptin|vildagliptin|mesh-list
110071368|NCT01559025|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
110071369|NCT01559025|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110071370|NCT01559025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110071371|NCT01559025|Protease Inhibitors|protease inhibitors|mesh-ancestor
110071372|NCT01559025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110071373|NCT01559025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110071374|NCT01559051|Anesthetics|anesthetics|mesh-list
110071375|NCT01559051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110071376|NCT01559051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110071377|NCT01559142|Infliximab|infliximab|mesh-list
110071378|NCT01559142|Azathioprine|azathioprine|mesh-list
110071379|NCT01559142|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110071380|NCT01559142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110071381|NCT01559142|Dermatologic Agents|dermatologic agents|mesh-ancestor
110071382|NCT01559142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110071383|NCT01559142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110071384|NCT01559142|Antimetabolites|antimetabolites|mesh-ancestor
110071385|NCT01559142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110071386|NCT01559142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110071388|NCT01559142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110071389|NCT01559142|Immunologic Factors|immunologic factors|mesh-ancestor
110071390|NCT01559142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110071391|NCT01559272|Paliperidone Palmitate|paliperidone palmitate|mesh-list
110071392|NCT01559272|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110071393|NCT01559272|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110071394|NCT01559272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110071395|NCT01559272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110071396|NCT01559272|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110071397|NCT01559272|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110071398|NCT01559272|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110071399|NCT01559272|Serotonin Agents|serotonin agents|mesh-ancestor
110071400|NCT01559272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110071401|NCT01559272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110071402|NCT01559272|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110071403|NCT01559272|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110071404|NCT01559272|Dopamine Agents|dopamine agents|mesh-ancestor
110071405|NCT01559285|Ropivacaine|ropivacaine|mesh-list
110071406|NCT01559285|Anesthetics, Local|anesthetics, local|mesh-ancestor
110071407|NCT01559285|Anesthetics|anesthetics|mesh-ancestor
110071408|NCT01559285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110071409|NCT01559285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110071410|NCT01559285|Sensory System Agents|sensory system agents|mesh-ancestor
110071411|NCT01559285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110071412|NCT01559298|Aspirin|aspirin|mesh-list
110071413|NCT01559298|Clopidogrel|clopidogrel|mesh-list
110071414|NCT01559298|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110071415|NCT01559298|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110071416|NCT01559298|Analgesics|analgesics|mesh-ancestor
110071417|NCT01559298|Sensory System Agents|sensory system agents|mesh-ancestor
110071418|NCT01559298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110071419|NCT01559298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110071420|NCT01559298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110071421|NCT01559298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110071422|NCT01559298|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110071423|NCT01559298|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110180915|NCT00016952|Vitamin B Complex|vitamin b complex|mesh-ancestor
110071424|NCT01559298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110071425|NCT01559298|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110071426|NCT01559298|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110071427|NCT01559298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110071428|NCT01559298|Antipyretics|antipyretics|mesh-ancestor
110071429|NCT01559298|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110071430|NCT01559298|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110071431|NCT01559298|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110071432|NCT01559298|Purinergic Agents|purinergic agents|mesh-ancestor
110071433|NCT01559298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110071434|NCT01559480|Desogestrel|desogestrel|mesh-list
110071435|NCT01559480|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110071436|NCT01559480|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110071437|NCT01559480|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110071438|NCT01559480|Contraceptive Agents|contraceptive agents|mesh-ancestor
110071439|NCT01559480|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110071440|NCT01559480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110071441|NCT01559480|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110071442|NCT01559480|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110071443|NCT01559480|Progestins|progestins|mesh-ancestor
110071445|NCT01559480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110071446|NCT01559545|Metronidazole|metronidazole|mesh-list
110071447|NCT01559545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110071448|NCT01559545|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110071449|NCT01559545|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110071450|NCT01559545|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110071451|NCT01559584|Triamcinolone|triamcinolone|mesh-list
110071452|NCT01559584|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110071453|NCT01559584|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110071454|NCT01559584|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110071455|NCT01559584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110071456|NCT01559584|Glucocorticoids|glucocorticoids|mesh-ancestor
110071457|NCT01559584|Hormones|hormones|mesh-ancestor
110071458|NCT01559584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110071459|NCT01559584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110071460|NCT01559584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110071461|NCT01559584|Immunologic Factors|immunologic factors|mesh-ancestor
110071462|NCT01559584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110071463|NCT01559584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110071464|NCT01559727|Prednisone|prednisone|mesh-list
110071465|NCT01559727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110071466|NCT01559727|Glucocorticoids|glucocorticoids|mesh-ancestor
110071467|NCT01559727|Hormones|hormones|mesh-ancestor
110071468|NCT01559727|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110071469|NCT01559727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110071470|NCT01559727|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110071471|NCT01559727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110071472|NCT01559740|Bupivacaine|bupivacaine|mesh-list
110071473|NCT01559740|Anesthetics, Local|anesthetics, local|mesh-ancestor
110071474|NCT01559740|Anesthetics|anesthetics|mesh-ancestor
110071475|NCT01559740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110071476|NCT01559740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110071477|NCT01559740|Sensory System Agents|sensory system agents|mesh-ancestor
110071478|NCT01559740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110071479|NCT01559753|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110071480|NCT01559753|Amoxicillin|amoxicillin|mesh-list
110071481|NCT01559753|Ceftriaxone|ceftriaxone|mesh-list
110071482|NCT01559753|Tobramycin|tobramycin|mesh-list
110071483|NCT01559753|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
110071484|NCT01559753|Clavulanic Acids|clavulanic acids|mesh-list
110071485|NCT01559753|Clavulanic Acid|clavulanic acid|mesh-list
110071486|NCT01559753|Cefotaxime|cefotaxime|mesh-list
110071487|NCT01559753|Cefoxitin|cefoxitin|mesh-list
110071488|NCT01559753|Netilmicin|netilmicin|mesh-list
110071489|NCT01559753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110071490|NCT01559753|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110071491|NCT01559753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110071492|NCT01559753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110071493|NCT01559753|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110071494|NCT01559974|Cholecalciferol|cholecalciferol|mesh-list
110071495|NCT01559974|Vitamin D|vitamin d|mesh-list
110071496|NCT01559974|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110071497|NCT01559974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110071498|NCT01559974|Vitamins|vitamins|mesh-ancestor
110071499|NCT01559974|Micronutrients|micronutrients|mesh-ancestor
110071500|NCT01559974|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110071502|NCT01560117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110071503|NCT01560117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110071504|NCT01560117|Immunologic Factors|immunologic factors|mesh-ancestor
110071505|NCT01560117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110071506|NCT01560117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110071507|NCT05570669|Simethicone|simethicone|mesh-list
110071508|NCT05570669|Sodium sulfate|sodium sulfate|mesh-list
110071509|NCT05570669|Antifoaming Agents|antifoaming agents|mesh-ancestor
110071510|NCT05570669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110071511|NCT05570669|Emollients|emollients|mesh-ancestor
110071512|NCT05570669|Dermatologic Agents|dermatologic agents|mesh-ancestor
110071513|NCT05570669|Cathartics|cathartics|mesh-ancestor
110071514|NCT05570669|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110071515|NCT05570383|Antacids|antacids|mesh-list
110071516|NCT05570383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110071517|NCT05570383|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110071518|NCT05570110|Glycyrrhetinic Acid|glycyrrhetinic acid|mesh-list
110071519|NCT05570110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110071520|NCT05570084|Tamsulosin|tamsulosin|mesh-list
110071521|NCT05570084|Silodosin|silodosin|mesh-list
110071522|NCT05570084|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110071523|NCT05570084|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110071525|NCT05570084|Adrenergic Agents|adrenergic agents|mesh-ancestor
110071526|NCT05570084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110071527|NCT05570084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110071528|NCT05570084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110071529|NCT05570084|Urological Agents|urological agents|mesh-ancestor
110071530|NCT05569668|Paclitaxel|paclitaxel|mesh-list
110071531|NCT05569668|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110071532|NCT05569668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110071533|NCT05569668|Tubulin Modulators|tubulin modulators|mesh-ancestor
110071534|NCT05569668|Antimitotic Agents|antimitotic agents|mesh-ancestor
110071535|NCT05569668|Mitosis Modulators|mitosis modulators|mesh-ancestor
110071536|NCT05569668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110071537|NCT05569655|Furosemide|furosemide|mesh-list
110071538|NCT05569655|Tolvaptan|tolvaptan|mesh-list
110071539|NCT05569655|Diuretics|diuretics|mesh-ancestor
110071540|NCT05569655|Natriuretic Agents|natriuretic agents|mesh-ancestor
110071541|NCT05569655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110071542|NCT05569655|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110071543|NCT05569655|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110071544|NCT05569655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110071545|NCT05569655|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
110071546|NCT05569590|Hydrogen Peroxide|hydrogen peroxide|mesh-list
110071548|NCT05569590|Fluorides|fluorides|mesh-list
110071549|NCT05569590|Fluorides, Topical|fluorides, topical|mesh-list
110071550|NCT05569590|Cariostatic Agents|cariostatic agents|mesh-ancestor
110071551|NCT05569590|Protective Agents|protective agents|mesh-ancestor
110071552|NCT05569590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110071553|NCT05569590|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110071554|NCT05569590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110071555|NCT05569577|Estrogens|estrogens|mesh-list
110071556|NCT05569577|Dydrogesterone|dydrogesterone|mesh-list
110071557|NCT05569577|Hormones|hormones|mesh-ancestor
110071558|NCT05569577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110071559|NCT05569577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110071560|NCT05569577|Progestins|progestins|mesh-ancestor
110071561|NCT05569031|Lofexidine|lofexidine|mesh-list
110071562|NCT05569031|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
110071563|NCT05569031|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110071564|NCT05569031|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110071565|NCT05569031|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110071566|NCT05569031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110071567|NCT05569031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110071568|NCT05569031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110071569|NCT05569031|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110071570|NCT05569031|Antidepressive Agents|antidepressive agents|mesh-ancestor
110071571|NCT05569031|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110071572|NCT05569031|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110071573|NCT05569031|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110071574|NCT05569031|Sensory System Agents|sensory system agents|mesh-ancestor
110071575|NCT05569031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110071576|NCT05569031|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110071577|NCT05569031|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110071578|NCT05569031|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110071579|NCT05569031|Adrenergic Agents|adrenergic agents|mesh-ancestor
110071580|NCT05564741|Norepinephrine|norepinephrine|mesh-list
110071581|NCT05564741|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110071582|NCT05564741|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110071583|NCT05564741|Adrenergic Agents|adrenergic agents|mesh-ancestor
110071584|NCT05564741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110071585|NCT05564741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110071586|NCT05564741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110071587|NCT05564741|Sympathomimetics|sympathomimetics|mesh-ancestor
110071588|NCT05564741|Autonomic Agents|autonomic agents|mesh-ancestor
110071589|NCT05564741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110071590|NCT05564741|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110071591|NCT05522582|Methotrexate|methotrexate|mesh-list
110071592|NCT05522582|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
110071593|NCT05522582|Antibodies|antibodies|mesh-list
110071594|NCT05522582|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110071595|NCT05522582|Immunologic Factors|immunologic factors|mesh-ancestor
110071596|NCT05522582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110071597|NCT05522582|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110071599|NCT05522582|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110071600|NCT05522582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110071601|NCT05522582|Antimetabolites|antimetabolites|mesh-ancestor
110071602|NCT05522582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110071603|NCT05522582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110071604|NCT05522582|Dermatologic Agents|dermatologic agents|mesh-ancestor
110071605|NCT05522582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110071606|NCT05522582|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110071607|NCT05522582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110071608|NCT05522582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110071609|NCT05522582|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110071610|NCT05522582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110071612|NCT05491304|Etoposide|etoposide|mesh-list
110071613|NCT05491304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110071614|NCT05491304|Antiemetics|antiemetics|mesh-ancestor
110071615|NCT05491304|Autonomic Agents|autonomic agents|mesh-ancestor
110071616|NCT05491304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110071617|NCT05491304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110071618|NCT05491304|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110071619|NCT05491304|Glucocorticoids|glucocorticoids|mesh-ancestor
110071620|NCT05491304|Hormones|hormones|mesh-ancestor
110071621|NCT05491304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110071622|NCT05491304|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110071623|NCT05491304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110071624|NCT05491304|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110071625|NCT05491304|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110071626|NCT05491304|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110071627|NCT05491304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110071628|NCT05491304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110071629|NCT05391555|Remifentanil|remifentanil|mesh-list
110071630|NCT05391555|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110071631|NCT05391555|Narcotics|narcotics|mesh-ancestor
110071632|NCT05391555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110071633|NCT05391555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110071634|NCT05391555|Analgesics|analgesics|mesh-ancestor
110071635|NCT05391555|Sensory System Agents|sensory system agents|mesh-ancestor
110071636|NCT05391555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110071637|NCT05388656|Estradiol|estradiol|mesh-list
110071638|NCT05388656|Progesterone|progesterone|mesh-list
110071639|NCT05388656|Estrogens|estrogens|mesh-ancestor
110071640|NCT05388656|Hormones|hormones|mesh-ancestor
110071641|NCT05388656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110071642|NCT05388656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110071643|NCT05388656|Progestins|progestins|mesh-ancestor
110071644|NCT05372393|Anesthetics|anesthetics|mesh-list
110071645|NCT05372393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110071646|NCT05372393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110071647|NCT05219604|Diphenhydramine|diphenhydramine|mesh-list
110071648|NCT05219604|Promethazine|promethazine|mesh-list
110071649|NCT05219604|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110071650|NCT05219604|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110071651|NCT05219604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110071652|NCT05219604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110071653|NCT05219604|Anesthetics, Local|anesthetics, local|mesh-ancestor
110071654|NCT05219604|Anesthetics|anesthetics|mesh-ancestor
110071655|NCT05219604|Sensory System Agents|sensory system agents|mesh-ancestor
110071656|NCT05219604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110071657|NCT05219604|Antiemetics|antiemetics|mesh-ancestor
110071658|NCT05219604|Autonomic Agents|autonomic agents|mesh-ancestor
110071659|NCT05219604|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110071660|NCT05219604|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110071661|NCT05219604|Histamine Antagonists|histamine antagonists|mesh-ancestor
110071662|NCT05219604|Histamine Agents|histamine agents|mesh-ancestor
110071663|NCT05219604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110071664|NCT05219604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110071665|NCT05219604|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110071666|NCT05219604|Antipruritics|antipruritics|mesh-ancestor
110071667|NCT05219604|Dermatologic Agents|dermatologic agents|mesh-ancestor
110071668|NCT05137080|Dexamethasone|dexamethasone|mesh-list
110071669|NCT05137080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110071670|NCT05137080|Antiemetics|antiemetics|mesh-ancestor
110071671|NCT05137080|Autonomic Agents|autonomic agents|mesh-ancestor
110071672|NCT05137080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110071673|NCT05137080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110071674|NCT05137080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110071675|NCT05137080|Glucocorticoids|glucocorticoids|mesh-ancestor
110071676|NCT05137080|Hormones|hormones|mesh-ancestor
110071677|NCT05137080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110071678|NCT05137080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110071679|NCT05137080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110071680|NCT04873323|Moxifloxacin|moxifloxacin|mesh-list
110071681|NCT04873323|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110071682|NCT04873323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110071683|NCT04873323|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110071684|NCT04873323|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110071685|NCT04873323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110071686|NCT04873323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110071687|NCT04873323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110071688|NCT04787731|Lidocaine|lidocaine|mesh-list
110071689|NCT04787731|Bupivacaine|bupivacaine|mesh-list
110071690|NCT04787731|Anesthetics, Local|anesthetics, local|mesh-list
110071691|NCT04787731|Anesthetics|anesthetics|mesh-list
110071692|NCT04787731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110071693|NCT04787731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110071694|NCT04787731|Sensory System Agents|sensory system agents|mesh-ancestor
110071695|NCT04787731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110181076|NCT00017264|Atrasentan|atrasentan|mesh-list
110071696|NCT04787731|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110071697|NCT04787731|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110071698|NCT04787731|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110071699|NCT04787731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110071700|NCT04787731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110071701|NCT04713358|Nalmefene|nalmefene|mesh-list
110071702|NCT04713358|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110071703|NCT04713358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110071704|NCT04713358|Sensory System Agents|sensory system agents|mesh-ancestor
110071705|NCT04713358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110071706|NCT04705051|Venglustat|venglustat|mesh-list
110071707|NCT04705051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110071708|NCT04705051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110071709|NCT04696952|Zopiclone|zopiclone|mesh-list
110071710|NCT04696952|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110071711|NCT04696952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110071712|NCT04696952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110071713|NCT04496999|Midostaurin|midostaurin|mesh-list
110071714|NCT04496999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110071715|NCT04496999|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110071716|NCT04496999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110071717|NCT04496999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110071718|NCT04492722|Dapagliflozin|dapagliflozin|mesh-list
110071719|NCT04492722|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110071720|NCT04492722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110071721|NCT04492722|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110071722|NCT04492722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110071723|NCT04424511|Azithromycin|azithromycin|mesh-list
110071724|NCT04424511|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110071725|NCT04424511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110071726|NCT04410406|Ivermectin|ivermectin|mesh-list
110071727|NCT04410406|Albendazole|albendazole|mesh-list
110071728|NCT04410406|Moxidectin|moxidectin|mesh-list
110071729|NCT04410406|Diethylcarbamazine|diethylcarbamazine|mesh-list
110071730|NCT04410406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110071731|NCT04410406|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110071732|NCT04410406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110071733|NCT04410406|Anthelmintics|anthelmintics|mesh-ancestor
110071734|NCT04410406|Anticestodal Agents|anticestodal agents|mesh-ancestor
110071735|NCT04410406|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110071736|NCT04410406|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110071737|NCT04410406|Tubulin Modulators|tubulin modulators|mesh-ancestor
110071738|NCT04410406|Antimitotic Agents|antimitotic agents|mesh-ancestor
110071739|NCT04410406|Mitosis Modulators|mitosis modulators|mesh-ancestor
110071740|NCT04410406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110071741|NCT04410406|Antinematodal Agents|antinematodal agents|mesh-ancestor
110071743|NCT04410406|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
110071744|NCT04410406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110071745|NCT04393506|Apatinib|apatinib|mesh-list
110071746|NCT04393506|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
110071747|NCT04393506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110071748|NCT04393506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110071749|NCT04393506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110071750|NCT04393506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110071751|NCT04393506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110071752|NCT04349826|Azithromycin|azithromycin|mesh-list
110071754|NCT04349826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110071755|NCT04349826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110071756|NCT04298853|Morphine|morphine|mesh-list
110071757|NCT04298853|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110071758|NCT04298853|Narcotics|narcotics|mesh-ancestor
110071759|NCT04298853|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110071760|NCT04298853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110071761|NCT04298853|Analgesics|analgesics|mesh-ancestor
110071762|NCT04298853|Sensory System Agents|sensory system agents|mesh-ancestor
110071763|NCT04298853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110071764|NCT04232683|Tamsulosin|tamsulosin|mesh-list
110071765|NCT04232683|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110071766|NCT04232683|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110071767|NCT04232683|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110071768|NCT04232683|Adrenergic Agents|adrenergic agents|mesh-ancestor
110071769|NCT04232683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110071770|NCT04232683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110071771|NCT04232683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110071772|NCT04232683|Urological Agents|urological agents|mesh-ancestor
110071774|NCT04227483|Deflazacort|deflazacort|mesh-list
110071775|NCT04227483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110071776|NCT04227483|Glucocorticoids|glucocorticoids|mesh-ancestor
110071778|NCT04227483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110071779|NCT04227483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110071780|NCT04227483|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110071781|NCT04227483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110071782|NCT04227483|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110071783|NCT04227483|Immunologic Factors|immunologic factors|mesh-ancestor
110071784|NCT04182672|Triamcinolone|triamcinolone|mesh-list
110071785|NCT04182672|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110071786|NCT04182672|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110071787|NCT04182672|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110071788|NCT04182672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110071789|NCT04182672|Glucocorticoids|glucocorticoids|mesh-ancestor
110071790|NCT04182672|Hormones|hormones|mesh-ancestor
110071791|NCT04182672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110071792|NCT04182672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110071793|NCT04182672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110071794|NCT04182672|Immunologic Factors|immunologic factors|mesh-ancestor
110071795|NCT04182672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110071796|NCT04182672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110071797|NCT04101227|Ondansetron|ondansetron|mesh-list
110071798|NCT04101227|Antiemetics|antiemetics|mesh-ancestor
110071799|NCT04101227|Autonomic Agents|autonomic agents|mesh-ancestor
110071800|NCT04101227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110071801|NCT04101227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110071802|NCT04101227|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110071803|NCT04101227|Antipruritics|antipruritics|mesh-ancestor
110071804|NCT04101227|Dermatologic Agents|dermatologic agents|mesh-ancestor
110071805|NCT04101227|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110071806|NCT04101227|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110071807|NCT04101227|Serotonin Agents|serotonin agents|mesh-ancestor
110071808|NCT04101227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110071809|NCT04101227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110071810|NCT04047004|Doxorubicin|doxorubicin|mesh-list
110071811|NCT04047004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110071812|NCT04047004|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110071813|NCT04047004|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110071814|NCT04047004|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110071815|NCT04047004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110071816|NCT04047004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110071818|NCT03893435|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
110071819|NCT03893435|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110071820|NCT03893435|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110071821|NCT03893435|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110071822|NCT03893435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110071824|NCT03813121|Ketamine|ketamine|mesh-list
110071825|NCT03813121|Analgesics|analgesics|mesh-ancestor
110071826|NCT03813121|Sensory System Agents|sensory system agents|mesh-ancestor
110071827|NCT03813121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110071828|NCT03813121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110071829|NCT03813121|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110071830|NCT03813121|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110071831|NCT03813121|Anesthetics, General|anesthetics, general|mesh-ancestor
110071832|NCT03813121|Anesthetics|anesthetics|mesh-ancestor
110071833|NCT03813121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110071834|NCT03813121|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110071835|NCT03813121|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110071836|NCT03813121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110071837|NCT03813121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110071838|NCT03813121|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110071839|NCT03813121|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110071840|NCT03813121|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110071841|NCT03813121|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110071842|NCT03813121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110071843|NCT03813121|GABA Modulators|gaba modulators|mesh-ancestor
110071844|NCT03813121|GABA Agents|gaba agents|mesh-ancestor
110071845|NCT03710590|Nicotine|nicotine|mesh-list
110071846|NCT03710590|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110071847|NCT03710590|Autonomic Agents|autonomic agents|mesh-ancestor
110071848|NCT03710590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110071849|NCT03710590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110071850|NCT03710590|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110071851|NCT03710590|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110071852|NCT03710590|Cholinergic Agents|cholinergic agents|mesh-ancestor
110071853|NCT03710590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110181286|NCT00018642|Dopamine Agents|dopamine agents|mesh-ancestor
110071854|NCT03710590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110071856|NCT03676725|Anesthetics, Local|anesthetics, local|mesh-ancestor
110071857|NCT03676725|Anesthetics|anesthetics|mesh-ancestor
110071858|NCT03676725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110071859|NCT03676725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110071860|NCT03676725|Sensory System Agents|sensory system agents|mesh-ancestor
110071861|NCT03676725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110071862|NCT03676725|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110071863|NCT03676725|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110071864|NCT03676725|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110071865|NCT03676725|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110071866|NCT03676725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110071867|NCT03468335|Irinotecan|irinotecan|mesh-list
110071868|NCT03468335|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110071869|NCT03468335|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110071870|NCT03468335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110071871|NCT03468335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110071872|NCT03468335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110071873|NCT03280511|Oxaliplatin|oxaliplatin|mesh-list
110071874|NCT03280511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110071875|NCT03205423|Gabapentin|gabapentin|mesh-list
110071876|NCT03205423|Analgesics|analgesics|mesh-ancestor
110071877|NCT03205423|Sensory System Agents|sensory system agents|mesh-ancestor
110071878|NCT03205423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110071879|NCT03205423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110071880|NCT03205423|Anticonvulsants|anticonvulsants|mesh-ancestor
110071881|NCT03205423|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110071882|NCT03205423|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110071883|NCT03205423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110071884|NCT03205423|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110071885|NCT03205423|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110071886|NCT03205423|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110071887|NCT03205423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110071888|NCT03205423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110071889|NCT03205423|Antimanic Agents|antimanic agents|mesh-ancestor
110071890|NCT03104400|Adalimumab|adalimumab|mesh-list
110071891|NCT03104400|Upadacitinib|upadacitinib|mesh-list
110071892|NCT03104400|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110071893|NCT03104400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110071894|NCT03104400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110071895|NCT03104400|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
110071896|NCT03104400|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110071897|NCT03104400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110071898|NCT03104400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110071899|NCT03104374|Upadacitinib|upadacitinib|mesh-list
110071900|NCT03104374|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
110071901|NCT03104374|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110071902|NCT03104374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110071903|NCT03104374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110071904|NCT03104374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110071905|NCT03008369|Lenvatinib|lenvatinib|mesh-list
110071906|NCT03008369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110071907|NCT03008369|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110071908|NCT03008369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110071909|NCT03008369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110071910|NCT02965716|Pembrolizumab|pembrolizumab|mesh-list
110071911|NCT02965716|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
110071912|NCT02965716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110071913|NCT02965716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110071914|NCT02965716|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110094953|NCT01711827|Glucocorticoids|glucocorticoids|mesh-ancestor
110071915|NCT02965716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110071917|NCT02918006|Immunologic Factors|immunologic factors|mesh-ancestor
110071918|NCT02918006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110071919|NCT02917772|Nivolumab|nivolumab|mesh-list
110071920|NCT02917772|Ipilimumab|ipilimumab|mesh-list
110071921|NCT02917772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110071922|NCT02917772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110071923|NCT02917772|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110071924|NCT02917772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110071926|NCT02909686|Resveratrol|resveratrol|mesh-list
110071927|NCT02909686|Pycnogenols|pycnogenols|mesh-list
110071928|NCT02909686|Turmeric extract|turmeric extract|mesh-list
110071929|NCT02909686|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110071930|NCT02909686|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110071931|NCT02909686|Analgesics|analgesics|mesh-ancestor
110071932|NCT02909686|Sensory System Agents|sensory system agents|mesh-ancestor
110071933|NCT02909686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110071934|NCT02909686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110071935|NCT02909686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110071936|NCT02909686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110071937|NCT02909686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110071938|NCT02909686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110071939|NCT02909686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110071940|NCT02909686|Antioxidants|antioxidants|mesh-ancestor
110071941|NCT02909686|Protective Agents|protective agents|mesh-ancestor
110071942|NCT02909686|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110071943|NCT02909686|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110071944|NCT02909686|Immunologic Factors|immunologic factors|mesh-ancestor
110071945|NCT02713373|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110071946|NCT02713373|Pembrolizumab|pembrolizumab|mesh-list
110071947|NCT02713373|Cetuximab|cetuximab|mesh-list
110071948|NCT02713373|Antibodies|antibodies|mesh-list
110071949|NCT02713373|Immunoglobulins|immunoglobulins|mesh-list
110071950|NCT02713373|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110071951|NCT02713373|Immunologic Factors|immunologic factors|mesh-ancestor
110071952|NCT02713373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110071953|NCT02713373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110071954|NCT02713373|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110181342|NCT00018759|Paroxetine|paroxetine|mesh-list
110071965|NCT02686593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110071966|NCT02686593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110071967|NCT02686593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110071968|NCT02686593|Antimetabolites|antimetabolites|mesh-ancestor
110071979|NCT02583282|Doxycycline|doxycycline|mesh-list
110071980|NCT02583282|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110071981|NCT02583282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110071982|NCT02583282|Antimalarials|antimalarials|mesh-ancestor
110071983|NCT02583282|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110071984|NCT02583282|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110071985|NCT02553941|Azacitidine|azacitidine|mesh-list
110071986|NCT02553941|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110071987|NCT02553941|Antimetabolites|antimetabolites|mesh-ancestor
110071988|NCT02553941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110071989|NCT02553941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110071990|NCT02553941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110071991|NCT02546492|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
110071992|NCT02546492|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
110071993|NCT02546492|beta-Endorphin|beta-endorphin|mesh-list
110071994|NCT02546492|Hormones|hormones|mesh-ancestor
110368811|NCT00553943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110071995|NCT02546492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110071996|NCT02546492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110071997|NCT02546492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110071998|NCT02546492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110071999|NCT02527564|Suvorexant|suvorexant|mesh-list
110072000|NCT02527564|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110072001|NCT02527564|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110072002|NCT02527564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110072003|NCT02527564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110072004|NCT02527564|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
110072005|NCT02527564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110072006|NCT02527564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110072007|NCT02179749|Mifepristone|mifepristone|mesh-list
110072008|NCT02179749|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
110072009|NCT02179749|Abortifacient Agents|abortifacient agents|mesh-ancestor
110072010|NCT02179749|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110072011|NCT02179749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110072012|NCT02179749|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110072013|NCT02179749|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110072014|NCT02179749|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110072015|NCT02179749|Contraceptive Agents|contraceptive agents|mesh-ancestor
110072016|NCT02179749|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
110072017|NCT02179749|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
110072018|NCT02179749|Hormone Antagonists|hormone antagonists|mesh-ancestor
110072019|NCT02179749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110072020|NCT02179749|Luteolytic Agents|luteolytic agents|mesh-ancestor
110072021|NCT02179749|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110072022|NCT02179749|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
110072024|NCT02065609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110072025|NCT02065609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110072026|NCT00641186|Sodium Oxybate|sodium oxybate|mesh-list
110072027|NCT00641186|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110072028|NCT00641186|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110072029|NCT00641186|Anesthetics, General|anesthetics, general|mesh-ancestor
110072030|NCT00641186|Anesthetics|anesthetics|mesh-ancestor
110072031|NCT00641186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110072032|NCT00641186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110072034|NCT01561482|Simvastatin|simvastatin|mesh-list
110072035|NCT01561482|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110072036|NCT01561482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110072037|NCT01561482|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110072038|NCT01561482|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110072039|NCT01561482|Antimetabolites|antimetabolites|mesh-ancestor
110072040|NCT01561482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110072041|NCT01561482|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110072042|NCT01561482|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110072043|NCT01561482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110072044|NCT01561586|Cisplatin|cisplatin|mesh-list
110072045|NCT01561586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110072046|NCT01562704|Acetaminophen|acetaminophen|mesh-list
110072047|NCT01562704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110072048|NCT01562704|Analgesics|analgesics|mesh-ancestor
110072049|NCT01562704|Sensory System Agents|sensory system agents|mesh-ancestor
110072050|NCT01562704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110181393|NCT00018954|Hormones|hormones|mesh-ancestor
110072051|NCT01562704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110072053|NCT01564095|Tryptophan|tryptophan|mesh-list
110072054|NCT01564095|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110072055|NCT01564095|Tacrolimus|tacrolimus|mesh-list
110072056|NCT01564095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110072057|NCT01564095|Immunologic Factors|immunologic factors|mesh-ancestor
110072058|NCT01564095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110072059|NCT01564095|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110072060|NCT01564095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110072061|NCT01564095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110072062|NCT01564095|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110072063|NCT01564095|Antidepressive Agents|antidepressive agents|mesh-ancestor
110072064|NCT01564095|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110072065|NCT01564238|Calcium, Dietary|calcium, dietary|mesh-list
110072066|NCT01564238|Calcium|calcium|mesh-list
110072067|NCT01564238|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110072068|NCT01564238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110072069|NCT01564238|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110072070|NCT01564576|Bromides|bromides|mesh-list
110072071|NCT01564576|Rocuronium|rocuronium|mesh-list
110072072|NCT01564576|Anticonvulsants|anticonvulsants|mesh-ancestor
110072073|NCT01564576|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110072074|NCT01564576|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110072075|NCT01564576|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110072076|NCT01564576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110072077|NCT01564576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110072078|NCT01564823|Metronidazole|metronidazole|mesh-list
110072079|NCT01564823|Adalimumab|adalimumab|mesh-list
110072080|NCT01564823|Azathioprine|azathioprine|mesh-list
110072081|NCT01564823|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110072082|NCT01564823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110072083|NCT01564823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110072084|NCT01564823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110072085|NCT01564823|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110072086|NCT01564823|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110072087|NCT01564823|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110072088|NCT01564823|Antimetabolites|antimetabolites|mesh-ancestor
110072089|NCT01564823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110072090|NCT01564823|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110072091|NCT01564823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110072092|NCT01564823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110072093|NCT01564823|Immunologic Factors|immunologic factors|mesh-ancestor
110072094|NCT01564823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110072095|NCT01565239|Thrombin|thrombin|mesh-list
110072096|NCT01565239|Hemostatics|hemostatics|mesh-ancestor
110072097|NCT01565239|Coagulants|coagulants|mesh-ancestor
110072098|NCT01565265|Cetrorelix|cetrorelix|mesh-list
110072099|NCT01565265|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
110072100|NCT01565265|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
110072101|NCT01565265|Hormones|hormones|mesh-ancestor
110164774|NCT00021307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110072102|NCT01565265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110072103|NCT01565265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110072104|NCT01565265|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110072105|NCT01565265|Fertility Agents|fertility agents|mesh-ancestor
110072106|NCT01565265|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110072107|NCT01565265|Hormone Antagonists|hormone antagonists|mesh-ancestor
110072108|NCT01566292|Botulinum Toxins|botulinum toxins|mesh-list
110072109|NCT01566292|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110072110|NCT01566292|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110072111|NCT01566292|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110072112|NCT01566292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110072113|NCT01566292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110072114|NCT01566292|Cholinergic Agents|cholinergic agents|mesh-ancestor
110072115|NCT01566292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110072116|NCT01566292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110072117|NCT01566292|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110072118|NCT01566292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110072119|NCT01566422|Vancomycin|vancomycin|mesh-list
110072120|NCT01566422|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110072121|NCT01566422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110072122|NCT01566760|Fesoterodine|fesoterodine|mesh-list
110072123|NCT01566760|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110072124|NCT01566760|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110072125|NCT01566760|Cholinergic Agents|cholinergic agents|mesh-ancestor
110072126|NCT01566760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110072127|NCT01566760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110072128|NCT01566760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110072129|NCT01566760|Urological Agents|urological agents|mesh-ancestor
110072130|NCT01566890|Regadenoson|regadenoson|mesh-list
110072131|NCT01566890|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
110072132|NCT01566890|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
110072133|NCT01566890|Purinergic Agonists|purinergic agonists|mesh-ancestor
110072134|NCT01566890|Purinergic Agents|purinergic agents|mesh-ancestor
110072135|NCT01566890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110072136|NCT01566890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110072137|NCT01566890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110072138|NCT01567072|Ibuprofen|ibuprofen|mesh-list
110072139|NCT01567072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110072140|NCT01567072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110072141|NCT01567072|Analgesics|analgesics|mesh-ancestor
110072142|NCT01567072|Sensory System Agents|sensory system agents|mesh-ancestor
110072143|NCT01567072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110072144|NCT01567072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110072145|NCT01567072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110072146|NCT01567072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110072147|NCT01567072|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110072148|NCT01567072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110072149|NCT01567072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110072150|NCT01567423|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
110072151|NCT01567423|Antimalarials|antimalarials|mesh-ancestor
110072152|NCT01567423|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110072153|NCT01567423|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110072154|NCT01567423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110072155|NCT01568632|Imetelstat|imetelstat|mesh-list
110072156|NCT01568632|Motesanib diphosphate|motesanib diphosphate|mesh-list
110072157|NCT01568632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110072158|NCT01568632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110072159|NCT01568632|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110072160|NCT01568645|Imatinib Mesylate|imatinib mesylate|mesh-list
110072161|NCT01568645|Carvedilol|carvedilol|mesh-list
110072162|NCT01568645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110072163|NCT01568645|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110072164|NCT01568645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110072165|NCT01568645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110072166|NCT01568645|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110072167|NCT01568645|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110072168|NCT01568645|Adrenergic Agents|adrenergic agents|mesh-ancestor
110072169|NCT01568645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110072170|NCT01568645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110072171|NCT01568645|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110072172|NCT01568645|Antioxidants|antioxidants|mesh-ancestor
110072173|NCT01568645|Protective Agents|protective agents|mesh-ancestor
110072174|NCT01568645|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110072175|NCT01568645|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110072176|NCT01568645|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110072177|NCT01568645|Vasodilator Agents|vasodilator agents|mesh-ancestor
110072178|NCT01568645|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110072179|NCT01568645|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110072180|NCT01568684|Citalopram|citalopram|mesh-list
110072181|NCT01568684|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110072182|NCT01568684|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110072183|NCT01568684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110072184|NCT01568684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110072185|NCT01568684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110072186|NCT01568684|Serotonin Agents|serotonin agents|mesh-ancestor
110072187|NCT01568684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110072188|NCT01568684|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110072189|NCT01568684|Antidepressive Agents|antidepressive agents|mesh-ancestor
110072190|NCT01568684|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110072191|NCT01569685|Sertraline|sertraline|mesh-list
110072192|NCT01569685|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
110072193|NCT01569685|Antidepressive Agents|antidepressive agents|mesh-ancestor
110072194|NCT01569685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110072195|NCT01569685|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110072196|NCT01569685|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110072197|NCT01569685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110072198|NCT01569685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110072199|NCT01569685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110072201|NCT01569685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110072202|NCT01569685|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110072203|NCT01569685|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110072204|NCT01570049|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110072205|NCT01570049|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110072206|NCT01570049|Alkylating Agents|alkylating agents|mesh-ancestor
110072207|NCT01570049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110072208|NCT01570049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110072209|NCT01570088|Folic Acid|folic acid|mesh-list
110072210|NCT01570088|Hematinics|hematinics|mesh-ancestor
110072211|NCT01570088|Vitamin B Complex|vitamin b complex|mesh-ancestor
110072212|NCT01570088|Vitamins|vitamins|mesh-ancestor
110072213|NCT01570088|Micronutrients|micronutrients|mesh-ancestor
110072214|NCT01570088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110072215|NCT01570478|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
110072216|NCT01570478|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110072218|NCT01570478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110072219|NCT01570478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110072220|NCT01570478|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110072221|NCT01570478|Respiratory System Agents|respiratory system agents|mesh-ancestor
110072222|NCT01570478|Glucocorticoids|glucocorticoids|mesh-ancestor
110072223|NCT01570478|Hormones|hormones|mesh-ancestor
110072224|NCT01570478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110072225|NCT01570478|Sympathomimetics|sympathomimetics|mesh-ancestor
110072226|NCT01570504|Ivermectin|ivermectin|mesh-list
110072227|NCT01570504|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110072228|NCT01570504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110072229|NCT01570556|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110072230|NCT01570556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110072231|NCT01570569|Losartan|losartan|mesh-list
110072232|NCT01570569|Midazolam|midazolam|mesh-list
110072233|NCT01570569|Dextromethorphan|dextromethorphan|mesh-list
110072234|NCT01570569|Caffeine|caffeine|mesh-list
110072235|NCT01570569|Omeprazole|omeprazole|mesh-list
110072236|NCT01570569|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110072237|NCT01570569|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110072238|NCT01570569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110072240|NCT01570569|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110072241|NCT01570569|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110072242|NCT01570569|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110072243|NCT01570569|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110072244|NCT01570569|Anesthetics, General|anesthetics, general|mesh-ancestor
110072245|NCT01570569|Anesthetics|anesthetics|mesh-ancestor
110072246|NCT01570569|GABA Modulators|gaba modulators|mesh-ancestor
110072247|NCT01570569|GABA Agents|gaba agents|mesh-ancestor
110072248|NCT01570569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110072249|NCT01570569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110072250|NCT01570569|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110072251|NCT01570569|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110072252|NCT01570569|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110072253|NCT01570569|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110072254|NCT01570569|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110072255|NCT01570569|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110072256|NCT01570569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110164775|NCT00021346|Carboplatin|carboplatin|mesh-list
110072257|NCT01570569|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110072258|NCT01570569|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110072259|NCT01570569|Purinergic Agents|purinergic agents|mesh-ancestor
110072260|NCT01570569|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110072261|NCT01570569|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110072262|NCT01570569|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110072263|NCT01570569|Antitussive Agents|antitussive agents|mesh-ancestor
110072264|NCT01570569|Respiratory System Agents|respiratory system agents|mesh-ancestor
110072265|NCT01570569|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110072266|NCT01570569|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110072267|NCT01570582|Paclitaxel|paclitaxel|mesh-list
110072268|NCT01570582|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110072269|NCT01570582|Carboplatin|carboplatin|mesh-list
110072270|NCT01570582|Gemcitabine|gemcitabine|mesh-list
110072271|NCT01570582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110072272|NCT01570582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110072273|NCT01570582|Tubulin Modulators|tubulin modulators|mesh-ancestor
110072274|NCT01570582|Antimitotic Agents|antimitotic agents|mesh-ancestor
110072275|NCT01570582|Mitosis Modulators|mitosis modulators|mesh-ancestor
110072276|NCT01570582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110072277|NCT01570582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110072278|NCT01570582|Antimetabolites|antimetabolites|mesh-ancestor
110072279|NCT01570608|Ranibizumab|ranibizumab|mesh-list
110072280|NCT01570608|Verteporfin|verteporfin|mesh-list
110072281|NCT01570608|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110072282|NCT01570608|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110072283|NCT01570608|Growth Substances|growth substances|mesh-ancestor
110072284|NCT01570608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110072285|NCT01570608|Growth Inhibitors|growth inhibitors|mesh-ancestor
110072286|NCT01570608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110072287|NCT01570608|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110072288|NCT01570608|Dermatologic Agents|dermatologic agents|mesh-ancestor
110072289|NCT01570660|Pioglitazone|pioglitazone|mesh-list
110072290|NCT01570660|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110072291|NCT01570660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110072292|NCT01570764|Cyclophosphamide|cyclophosphamide|mesh-list
110072293|NCT01570764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110072294|NCT01570764|Immunologic Factors|immunologic factors|mesh-ancestor
110072295|NCT01570764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110072296|NCT01570764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110072297|NCT01570764|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110072298|NCT01570764|Alkylating Agents|alkylating agents|mesh-ancestor
110072299|NCT01570764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110072300|NCT01570764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110072301|NCT01570764|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110072302|NCT01570790|Fosbretabulin|fosbretabulin|mesh-list
110072303|NCT01570790|Combretastatin|combretastatin|mesh-list
110072304|NCT01570790|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110072305|NCT01570790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110072306|NCT01570790|Tubulin Modulators|tubulin modulators|mesh-ancestor
110072307|NCT01570790|Antimitotic Agents|antimitotic agents|mesh-ancestor
110390521|NCT05511025|Analgesics|analgesics|mesh-ancestor
110072308|NCT01570790|Mitosis Modulators|mitosis modulators|mesh-ancestor
110072309|NCT01570790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110072310|NCT01570894|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110072311|NCT01570894|Antidepressive Agents|antidepressive agents|mesh-ancestor
110072312|NCT01570894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110072313|NCT01570894|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110072314|NCT01570894|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110072315|NCT01570894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110072316|NCT01570894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110072317|NCT01570907|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110072318|NCT01570907|Antidepressive Agents|antidepressive agents|mesh-ancestor
110072319|NCT01570907|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110072320|NCT01570907|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110072321|NCT01570907|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110072322|NCT01570907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110072323|NCT01570907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110072324|NCT01570959|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110072325|NCT01570959|Antidepressive Agents|antidepressive agents|mesh-ancestor
110072326|NCT01570959|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110072327|NCT01570959|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110072328|NCT01570959|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110072329|NCT01570959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110072330|NCT01570959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110072331|NCT01570985|Triamcinolone|triamcinolone|mesh-list
110072332|NCT01570985|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110072333|NCT01570985|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110072334|NCT01570985|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110072335|NCT01570985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110072336|NCT01570985|Glucocorticoids|glucocorticoids|mesh-ancestor
110072337|NCT01570985|Hormones|hormones|mesh-ancestor
110072338|NCT01570985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110072339|NCT01570985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110072340|NCT01570985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110072341|NCT01570985|Immunologic Factors|immunologic factors|mesh-ancestor
110072342|NCT01570985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110072343|NCT01570985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110072345|NCT01571024|Fluorouracil|fluorouracil|mesh-list
110072346|NCT01571024|Oxaliplatin|oxaliplatin|mesh-list
110072347|NCT01571024|Antimetabolites|antimetabolites|mesh-ancestor
110072348|NCT01571024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110072349|NCT01571024|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110072350|NCT01571024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110072351|NCT01571024|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110072352|NCT01571024|Immunologic Factors|immunologic factors|mesh-ancestor
110072353|NCT01571024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110072354|NCT01571024|Antidotes|antidotes|mesh-ancestor
110072355|NCT01571024|Protective Agents|protective agents|mesh-ancestor
110072356|NCT01571024|Vitamin B Complex|vitamin b complex|mesh-ancestor
110072357|NCT01571024|Vitamins|vitamins|mesh-ancestor
110072358|NCT01571024|Micronutrients|micronutrients|mesh-ancestor
110072359|NCT01571050|Calcium Carbonate|calcium carbonate|mesh-list
110072360|NCT01571050|Antacids|antacids|mesh-ancestor
110072361|NCT01571050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110072362|NCT01571050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110072363|NCT01571063|Vitamin D|vitamin d|mesh-list
110072364|NCT01571063|Cholecalciferol|cholecalciferol|mesh-list
110072365|NCT01571063|Vitamins|vitamins|mesh-ancestor
110072366|NCT01571063|Micronutrients|micronutrients|mesh-ancestor
110072367|NCT01571063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110072368|NCT01571063|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110072369|NCT01571063|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110072370|NCT01571167|Varenicline|varenicline|mesh-list
110072371|NCT01571167|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110072372|NCT01571167|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110072373|NCT01571167|Cholinergic Agents|cholinergic agents|mesh-ancestor
110072374|NCT01571167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110072375|NCT01571167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110072376|NCT01571167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110072378|NCT01571206|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110072379|NCT01571206|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110072380|NCT01571206|Dermatologic Agents|dermatologic agents|mesh-ancestor
110072381|NCT01571206|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110072382|NCT01571206|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110072383|NCT01571219|Infliximab|infliximab|mesh-list
110072384|NCT01571219|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110072385|NCT01571219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110072386|NCT01571219|Dermatologic Agents|dermatologic agents|mesh-ancestor
110072387|NCT01571219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110072388|NCT01571219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110072390|NCT01571323|Oxytocin|oxytocin|mesh-list
110072391|NCT01571323|Oxytocics|oxytocics|mesh-ancestor
110181571|NCT00142454|Imiquimod|imiquimod|mesh-list
110072392|NCT01571323|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110072393|NCT01571323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110072394|NCT01571323|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110072395|NCT01571323|Abortifacient Agents|abortifacient agents|mesh-ancestor
110072396|NCT01571323|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110072397|NCT01571323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110072398|NCT01571414|Ritonavir|ritonavir|mesh-list
110072399|NCT01571414|Lopinavir|lopinavir|mesh-list
110072400|NCT01571414|Efavirenz|efavirenz|mesh-list
110072401|NCT01571414|Rifampin|rifampin|mesh-list
110072402|NCT01571414|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110072403|NCT01571414|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110072404|NCT01571414|Protease Inhibitors|protease inhibitors|mesh-ancestor
110072405|NCT01571414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110072406|NCT01571414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110072407|NCT01571414|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110072408|NCT01571414|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110072409|NCT01571414|Antiviral Agents|antiviral agents|mesh-ancestor
110072410|NCT01571414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110072411|NCT01571414|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110072412|NCT01571414|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110072413|NCT01571414|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110072414|NCT01571414|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110072415|NCT01571414|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110072416|NCT01571414|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110072417|NCT01571414|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110072418|NCT01571414|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110072419|NCT01571414|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110072420|NCT01571414|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110072421|NCT01571414|Antitubercular Agents|antitubercular agents|mesh-ancestor
110072422|NCT01571414|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110072423|NCT01571414|Leprostatic Agents|leprostatic agents|mesh-ancestor
110072424|NCT01571414|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110072425|NCT01571414|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110072426|NCT01571414|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110072428|NCT01571570|Antiviral Agents|antiviral agents|mesh-ancestor
110072429|NCT01571570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110072430|NCT01571570|Protease Inhibitors|protease inhibitors|mesh-ancestor
110072431|NCT01571570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110072432|NCT01571570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110072433|NCT01571583|Interferons|interferons|mesh-list
110072435|NCT01571583|Interferon-alpha|interferon-alpha|mesh-list
110072436|NCT01571583|Interferon alpha-2|interferon alpha-2|mesh-list
110072437|NCT01571583|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110072438|NCT01571583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110072439|NCT01571583|Antiviral Agents|antiviral agents|mesh-ancestor
110072440|NCT01571583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110072441|NCT01571583|Antimetabolites|antimetabolites|mesh-ancestor
110072442|NCT01571583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110072443|NCT01571583|Immunologic Factors|immunologic factors|mesh-ancestor
110072444|NCT01571583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110072445|NCT01571609|Insulin|insulin|mesh-list
110072446|NCT01571609|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110072447|NCT01571609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110072448|NCT01571648|Azacitidine|azacitidine|mesh-list
110072449|NCT01571648|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110072450|NCT01571648|Antimetabolites|antimetabolites|mesh-ancestor
110072451|NCT01571648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110072452|NCT01571648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110072453|NCT01571648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110072454|NCT01571687|Antioxidants|antioxidants|mesh-list
110072455|NCT01571687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110072456|NCT01571687|Protective Agents|protective agents|mesh-ancestor
110072457|NCT01571687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110072458|NCT01571791|Ketorolac|ketorolac|mesh-list
110072459|NCT01571791|Lidocaine|lidocaine|mesh-list
110072460|NCT01571791|Anesthetics, Local|anesthetics, local|mesh-ancestor
110072461|NCT01571791|Anesthetics|anesthetics|mesh-ancestor
110072462|NCT01571791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110072463|NCT01571791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110072464|NCT01571791|Sensory System Agents|sensory system agents|mesh-ancestor
110072465|NCT01571791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110072466|NCT01571791|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110072467|NCT01571791|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110072468|NCT01571791|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110072469|NCT01571791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110072470|NCT01571791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110072471|NCT01571791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110164776|NCT00021346|Gemcitabine|gemcitabine|mesh-list
110072472|NCT01571791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110072474|NCT01571791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110072475|NCT01571791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110072476|NCT01571791|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110072477|NCT01571791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110072478|NCT01571804|Pregabalin|pregabalin|mesh-list
110072479|NCT01571804|Analgesics|analgesics|mesh-ancestor
110072480|NCT01571804|Sensory System Agents|sensory system agents|mesh-ancestor
110072481|NCT01571804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110072482|NCT01571804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110072483|NCT01571804|Anticonvulsants|anticonvulsants|mesh-ancestor
110072484|NCT01571804|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110072485|NCT01571804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110072486|NCT01571804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110072487|NCT01571804|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110072488|NCT01571804|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110072489|NCT01571804|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110072490|NCT01571804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110072491|NCT01571804|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110072492|NCT01571856|Zinc Sulfate|zinc sulfate|mesh-list
110072493|NCT01571856|Astringents|astringents|mesh-ancestor
110072494|NCT01571856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110072495|NCT01571856|Dermatologic Agents|dermatologic agents|mesh-ancestor
110072496|NCT01571882|Policosanol|policosanol|mesh-list
110072497|NCT01571882|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110072498|NCT01571882|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110072499|NCT01571882|Antimetabolites|antimetabolites|mesh-ancestor
110072500|NCT01571882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110072501|NCT01571882|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110072502|NCT01571882|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110072503|NCT01571921|Tocotrienols|tocotrienols|mesh-list
110072504|NCT01571921|Vitamin E|vitamin e|mesh-list
110072505|NCT01571921|Tocopherols|tocopherols|mesh-list
110072507|NCT01571921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110072508|NCT01571921|Protective Agents|protective agents|mesh-ancestor
110072509|NCT01571921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110072510|NCT01571921|Vitamins|vitamins|mesh-ancestor
110072511|NCT01571921|Micronutrients|micronutrients|mesh-ancestor
110072512|NCT01571960|Vaccines|vaccines|mesh-list
110072513|NCT01571960|Immunologic Factors|immunologic factors|mesh-ancestor
110072514|NCT01571960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110072515|NCT01572012|Ondansetron|ondansetron|mesh-list
110072516|NCT01572012|Antiemetics|antiemetics|mesh-ancestor
110072517|NCT01572012|Autonomic Agents|autonomic agents|mesh-ancestor
110072518|NCT01572012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110072519|NCT01572012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110072520|NCT01572012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110072521|NCT01572012|Antipruritics|antipruritics|mesh-ancestor
110072522|NCT01572012|Dermatologic Agents|dermatologic agents|mesh-ancestor
110072523|NCT01572012|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110072524|NCT01572012|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110072525|NCT01572012|Serotonin Agents|serotonin agents|mesh-ancestor
110072526|NCT01572012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110072527|NCT01572012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110072528|NCT01572025|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
110072529|NCT01572025|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110072530|NCT01572025|Immunologic Factors|immunologic factors|mesh-ancestor
110072531|NCT01572025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110072532|NCT01572090|Hypoglycemic Agents|hypoglycemic agents|mesh-list
110072533|NCT01572090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110072534|NCT01571908|Rocuronium|rocuronium|mesh-list
110072535|NCT01571908|Succinylcholine|succinylcholine|mesh-list
110072536|NCT01571908|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110072537|NCT01571908|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110072538|NCT01571908|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110072539|NCT01571908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110072540|NCT01571908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110072541|NCT01571908|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
110072542|NCT01572116|Lidocaine|lidocaine|mesh-list
110072543|NCT01572116|Epinephrine|epinephrine|mesh-list
110072544|NCT01572116|Racepinephrine|racepinephrine|mesh-list
110072545|NCT01572116|Sufentanil|sufentanil|mesh-list
110072547|NCT01572116|Anesthetics, Local|anesthetics, local|mesh-ancestor
110072548|NCT01572116|Anesthetics|anesthetics|mesh-ancestor
110072549|NCT01572116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110072550|NCT01572116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110072551|NCT01572116|Sensory System Agents|sensory system agents|mesh-ancestor
110072552|NCT01572116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110072553|NCT01572116|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110072554|NCT01572116|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110072555|NCT01572116|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110072556|NCT01572116|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110072557|NCT01572116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110072558|NCT01572116|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110390555|NCT05405270|Imiquimod|imiquimod|mesh-list
110072559|NCT01572116|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110072560|NCT01572116|Adrenergic Agents|adrenergic agents|mesh-ancestor
110072561|NCT01572116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110072562|NCT01572116|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110072563|NCT01572116|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110072564|NCT01572116|Autonomic Agents|autonomic agents|mesh-ancestor
110072565|NCT01572116|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110072566|NCT01572116|Respiratory System Agents|respiratory system agents|mesh-ancestor
110072567|NCT01572116|Mydriatics|mydriatics|mesh-ancestor
110072568|NCT01572116|Sympathomimetics|sympathomimetics|mesh-ancestor
110072569|NCT01572116|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110072570|NCT01572116|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110072571|NCT01572116|Narcotics|narcotics|mesh-ancestor
110072572|NCT01572116|Analgesics|analgesics|mesh-ancestor
110072573|NCT01572116|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110072574|NCT01572116|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110072575|NCT01572116|Anesthetics, General|anesthetics, general|mesh-ancestor
110072576|NCT01572129|Clopidogrel|clopidogrel|mesh-list
110072577|NCT01572129|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110072578|NCT01572129|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110072579|NCT01572129|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110072580|NCT01572129|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110072581|NCT01572129|Purinergic Agents|purinergic agents|mesh-ancestor
110072582|NCT01572129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110072583|NCT01572129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110072584|NCT01572129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110072585|NCT01572181|Fludarabine|fludarabine|mesh-list
110072587|NCT01572181|Thymoglobulin|thymoglobulin|mesh-list
110072588|NCT01572181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110072589|NCT01572181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110072590|NCT01572181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110072591|NCT01572181|Immunologic Factors|immunologic factors|mesh-ancestor
110072592|NCT01572181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110072593|NCT01572181|Alkylating Agents|alkylating agents|mesh-ancestor
110072594|NCT01572181|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110072595|NCT01572181|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110072596|NCT01572259|Hormones|hormones|mesh-list
110072597|NCT01572259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110072598|NCT01572259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110072599|NCT01572285|Dexamethasone|dexamethasone|mesh-list
110072600|NCT01572285|Dexamethasone acetate|dexamethasone acetate|mesh-list
110072601|NCT01572285|BB 1101|bb 1101|mesh-list
110072602|NCT01572285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110072603|NCT01572285|Antiemetics|antiemetics|mesh-ancestor
110072604|NCT01572285|Autonomic Agents|autonomic agents|mesh-ancestor
110072605|NCT01572285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110072606|NCT01572285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110072607|NCT01572285|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110072608|NCT01572285|Glucocorticoids|glucocorticoids|mesh-ancestor
110072609|NCT01572285|Hormones|hormones|mesh-ancestor
110072610|NCT01572285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110072611|NCT01572285|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110072612|NCT01572285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110072613|NCT01572285|Protease Inhibitors|protease inhibitors|mesh-ancestor
110072615|NCT01572285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110072616|NCT01572324|Leucovorin|leucovorin|mesh-list
110072617|NCT01572324|Fluorouracil|fluorouracil|mesh-list
110072618|NCT01572324|Capecitabine|capecitabine|mesh-list
110072619|NCT01572324|Oxaliplatin|oxaliplatin|mesh-list
110072620|NCT01572324|Antimetabolites|antimetabolites|mesh-ancestor
110072621|NCT01572324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110072622|NCT01572324|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110072623|NCT01572324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110072624|NCT01572324|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110072625|NCT01572324|Immunologic Factors|immunologic factors|mesh-ancestor
110072626|NCT01572324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110072628|NCT01572324|Protective Agents|protective agents|mesh-ancestor
110072629|NCT01572324|Vitamin B Complex|vitamin b complex|mesh-ancestor
110072630|NCT01572324|Vitamins|vitamins|mesh-ancestor
110072631|NCT01572324|Micronutrients|micronutrients|mesh-ancestor
110072632|NCT01572350|Triamcinolone|triamcinolone|mesh-list
110072633|NCT01572350|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110072634|NCT01572350|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110072635|NCT01572350|Bevacizumab|bevacizumab|mesh-list
110072636|NCT01572350|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110072637|NCT01572350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110072638|NCT01572350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110072639|NCT01572350|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110072640|NCT01572350|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110072641|NCT01572350|Growth Substances|growth substances|mesh-ancestor
110072642|NCT01572350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110072643|NCT01572350|Growth Inhibitors|growth inhibitors|mesh-ancestor
110072644|NCT01572350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110072645|NCT01572350|Glucocorticoids|glucocorticoids|mesh-ancestor
110072646|NCT01572350|Hormones|hormones|mesh-ancestor
110072647|NCT01572350|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110072648|NCT01572350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110072649|NCT01572350|Immunologic Factors|immunologic factors|mesh-ancestor
110072650|NCT01572350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110072651|NCT01572350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110072652|NCT01572363|Sildenafil Citrate|sildenafil citrate|mesh-list
110072653|NCT01572363|Vasodilator Agents|vasodilator agents|mesh-ancestor
110072654|NCT01572363|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110072655|NCT01572363|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110072656|NCT01572363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110072657|NCT01572363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110072658|NCT01572363|Urological Agents|urological agents|mesh-ancestor
110072659|NCT01572454|Dexmedetomidine|dexmedetomidine|mesh-list
110072660|NCT01572454|Remifentanil|remifentanil|mesh-list
110072661|NCT01572454|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110072662|NCT01572454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110072663|NCT01572454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110072664|NCT01572454|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110072665|NCT01572454|Analgesics|analgesics|mesh-ancestor
110072666|NCT01572454|Sensory System Agents|sensory system agents|mesh-ancestor
110072667|NCT01572454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110072668|NCT01572454|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110072669|NCT01572454|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110072670|NCT01572454|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110072671|NCT01572454|Adrenergic Agents|adrenergic agents|mesh-ancestor
110072672|NCT01572454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110072673|NCT01572454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110072674|NCT01572454|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110072675|NCT01572454|Narcotics|narcotics|mesh-ancestor
110072676|NCT01572545|Zoledronic Acid|zoledronic acid|mesh-list
110072677|NCT01572545|Denosumab|denosumab|mesh-list
110072678|NCT01572545|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110072679|NCT01572545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110072680|NCT01572558|Ciprofloxacin|ciprofloxacin|mesh-list
110072681|NCT01572558|Meropenem|meropenem|mesh-list
110072682|NCT01572558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110072683|NCT01572558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110072684|NCT01572558|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110072685|NCT01572558|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110072686|NCT01572558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110072687|NCT01572558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110072688|NCT01572558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110072689|NCT01572558|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110072690|NCT01572558|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110072691|NCT01572597|Metronidazole|metronidazole|mesh-list
110072692|NCT01572597|Clarithromycin|clarithromycin|mesh-list
110072693|NCT01572597|Acetylcysteine|acetylcysteine|mesh-list
110072694|NCT01572597|Rabeprazole|rabeprazole|mesh-list
110072695|NCT01572597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110072696|NCT01572597|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110072697|NCT01572597|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110072698|NCT01572597|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110072699|NCT01572597|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110072700|NCT01572597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110072701|NCT01572597|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110072702|NCT01572597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110072703|NCT01572597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110072704|NCT01572597|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110072705|NCT01572597|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110072706|NCT01572597|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110072707|NCT01572597|Antiviral Agents|antiviral agents|mesh-ancestor
110072708|NCT01572597|Expectorants|expectorants|mesh-ancestor
110072709|NCT01572597|Respiratory System Agents|respiratory system agents|mesh-ancestor
110072710|NCT01572597|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110072711|NCT01572597|Antioxidants|antioxidants|mesh-ancestor
110072712|NCT01572597|Protective Agents|protective agents|mesh-ancestor
110072713|NCT01572597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110072714|NCT01572623|Clopidogrel|clopidogrel|mesh-list
110072715|NCT01572623|Atorvastatin|atorvastatin|mesh-list
110072716|NCT01572623|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110072717|NCT01572623|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110072718|NCT01572623|Antimetabolites|antimetabolites|mesh-ancestor
110072719|NCT01572623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110072720|NCT01572623|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110072721|NCT01572623|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110072722|NCT01572623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110072723|NCT01572623|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110072724|NCT01572623|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110072725|NCT01572623|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110072726|NCT01572623|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110072727|NCT01572623|Purinergic Agents|purinergic agents|mesh-ancestor
110072728|NCT01572623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110072729|NCT01572623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110072731|NCT01572649|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110072732|NCT01572649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110072734|NCT01572688|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110072735|NCT01572688|Alkylating Agents|alkylating agents|mesh-ancestor
110072736|NCT01572688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110072737|NCT01572688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110072738|NCT01572688|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110072739|NCT01572688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110072740|NCT01572688|Immunologic Factors|immunologic factors|mesh-ancestor
110072741|NCT01572688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110072742|NCT01572805|Melatonin|melatonin|mesh-list
110072743|NCT01572805|Antioxidants|antioxidants|mesh-ancestor
110072744|NCT01572805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110072745|NCT01572805|Protective Agents|protective agents|mesh-ancestor
110072746|NCT01572805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110072747|NCT01572805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110072749|NCT01572831|Cariostatic Agents|cariostatic agents|mesh-ancestor
110072750|NCT01572831|Protective Agents|protective agents|mesh-ancestor
110072751|NCT01572831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110072752|NCT01572857|Immunoglobulins|immunoglobulins|mesh-list
110072753|NCT01572857|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110072754|NCT01572857|Antibodies|antibodies|mesh-list
110072755|NCT01572857|Immunologic Factors|immunologic factors|mesh-ancestor
110072756|NCT01572857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110072757|NCT01572961|Aspirin|aspirin|mesh-list
110072758|NCT01572961|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110072759|NCT01572961|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110072760|NCT01572961|Analgesics|analgesics|mesh-ancestor
110072761|NCT01572961|Sensory System Agents|sensory system agents|mesh-ancestor
110072762|NCT01572961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110072763|NCT01572961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110072764|NCT01572961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110072765|NCT01572961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110072766|NCT01572961|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110072767|NCT01572961|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110072768|NCT01572961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110072769|NCT01572961|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110072770|NCT01572961|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110072771|NCT01572961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110072772|NCT01572961|Antipyretics|antipyretics|mesh-ancestor
110072773|NCT01573013|Iron|iron|mesh-list
110072774|NCT01573013|Trace Elements|trace elements|mesh-ancestor
110072775|NCT01573013|Micronutrients|micronutrients|mesh-ancestor
110072776|NCT01573013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110072777|NCT01573143|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110072778|NCT01573143|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110072779|NCT01573143|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110072780|NCT01573143|Antimetabolites|antimetabolites|mesh-ancestor
110072781|NCT01573143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110072782|NCT01573143|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110072783|NCT01573143|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110072784|NCT01573143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110072785|NCT01573286|Glucagon|glucagon|mesh-list
110072786|NCT01573286|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
110072787|NCT01573286|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110072788|NCT01573286|Hormones|hormones|mesh-ancestor
110072789|NCT01573286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110072790|NCT01573286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110072791|NCT01573286|Incretins|incretins|mesh-ancestor
110072792|NCT01573338|Carboplatin|carboplatin|mesh-list
110072793|NCT01573338|Etoposide|etoposide|mesh-list
110072794|NCT01573338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110072795|NCT01573338|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110072796|NCT01573338|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110072797|NCT01573338|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110072798|NCT01573338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110072799|NCT01573338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110072800|NCT01573377|Metformin|metformin|mesh-list
110072801|NCT01573377|Cyproterone Acetate|cyproterone acetate|mesh-list
110072802|NCT01573377|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110072803|NCT01573377|Cyproterone|cyproterone|mesh-list
110072804|NCT01573377|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110072805|NCT01573377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110072806|NCT01573377|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110072807|NCT01573377|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110072808|NCT01573377|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110072809|NCT01573377|Contraceptive Agents|contraceptive agents|mesh-ancestor
110072810|NCT01573377|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110072811|NCT01573377|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110072812|NCT01573377|Estrogens|estrogens|mesh-ancestor
110072813|NCT01573377|Hormones|hormones|mesh-ancestor
110072814|NCT01573377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110072815|NCT01573377|Androgen Antagonists|androgen antagonists|mesh-ancestor
110072816|NCT01573377|Hormone Antagonists|hormone antagonists|mesh-ancestor
110072817|NCT01573377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110072818|NCT01573377|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110072819|NCT01573468|Capecitabine|capecitabine|mesh-list
110072820|NCT01573468|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110072821|NCT01573468|Antimetabolites|antimetabolites|mesh-ancestor
110072822|NCT01573468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110072823|NCT01573468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110072824|NCT01573598|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
110072825|NCT01573598|Antidepressive Agents|antidepressive agents|mesh-ancestor
110072826|NCT01573598|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110072827|NCT01573598|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110072828|NCT01573598|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110072829|NCT01573598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110072830|NCT01573598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110072831|NCT01573598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110072832|NCT01573598|Serotonin Agents|serotonin agents|mesh-ancestor
110072833|NCT01573598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110072834|NCT01573598|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110072835|NCT01573598|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110072836|NCT01573637|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
110072837|NCT01573637|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110072838|NCT01573637|Hormone Antagonists|hormone antagonists|mesh-ancestor
110072839|NCT01573637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110072840|NCT01573637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110072841|NCT01573637|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110072842|NCT01573637|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110072843|NCT01573637|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110072844|NCT01573663|Dipropizine|dipropizine|mesh-list
110072845|NCT01573663|Ambroxol|ambroxol|mesh-list
110072846|NCT01573663|Expectorants|expectorants|mesh-ancestor
110072847|NCT01573663|Respiratory System Agents|respiratory system agents|mesh-ancestor
110072848|NCT01573663|Antitussive Agents|antitussive agents|mesh-ancestor
110072849|NCT01573715|Cisatracurium|cisatracurium|mesh-list
110072850|NCT01573715|Atracurium|atracurium|mesh-list
110072851|NCT01573715|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110072852|NCT01573715|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110072853|NCT01573715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110072854|NCT01573715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110072855|NCT01573715|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110072856|NCT01573715|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
110072857|NCT01573715|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110072858|NCT01573715|Cholinergic Agents|cholinergic agents|mesh-ancestor
110072859|NCT01573715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110072860|NCT01573715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110072861|NCT01573741|Ketamine|ketamine|mesh-list
110072862|NCT01573741|Analgesics|analgesics|mesh-ancestor
110072863|NCT01573741|Sensory System Agents|sensory system agents|mesh-ancestor
110072864|NCT01573741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110072865|NCT01573741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110072866|NCT01573741|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110072867|NCT01573741|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110072868|NCT01573741|Anesthetics, General|anesthetics, general|mesh-ancestor
110072869|NCT01573741|Anesthetics|anesthetics|mesh-ancestor
110072870|NCT01573741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110072871|NCT01573741|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110072872|NCT01573741|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110072873|NCT01573741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110368812|NCT00553943|Immunologic Factors|immunologic factors|mesh-ancestor
110072874|NCT01573741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110072876|NCT01573806|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110072877|NCT01573806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110072878|NCT01573806|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110072879|NCT01573806|Incretins|incretins|mesh-ancestor
110072880|NCT01573806|Hormones|hormones|mesh-ancestor
110072881|NCT01573806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110072882|NCT01573975|Clarithromycin|clarithromycin|mesh-list
110072883|NCT01573975|Rabeprazole|rabeprazole|mesh-list
110072884|NCT01573975|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110072885|NCT01573975|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110072886|NCT01573975|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110072887|NCT01573975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110072888|NCT01573975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110072889|NCT01573975|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110072890|NCT01573975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110072891|NCT01573975|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110072892|NCT01573975|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110072893|NCT01573975|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110072894|NCT01574014|Hydrocortisone|hydrocortisone|mesh-list
110072895|NCT01574014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110072896|NCT01574027|Vitamin D|vitamin d|mesh-list
110072897|NCT01574027|Cholecalciferol|cholecalciferol|mesh-list
110072898|NCT01574027|Vitamins|vitamins|mesh-ancestor
110072899|NCT01574027|Micronutrients|micronutrients|mesh-ancestor
110072900|NCT01574027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110072901|NCT01574027|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110072902|NCT01574027|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110072905|NCT01574092|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110072906|NCT01574092|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110072907|NCT01574092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110072908|NCT01574092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110072909|NCT01574131|Fenofibrate|fenofibrate|mesh-list
110072910|NCT01574131|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110072911|NCT01574131|Antimetabolites|antimetabolites|mesh-ancestor
110072912|NCT01574131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110072913|NCT01574131|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110072915|NCT01574261|Vitamin B Complex|vitamin b complex|mesh-ancestor
110072916|NCT01574261|Vitamins|vitamins|mesh-ancestor
110072917|NCT01574261|Micronutrients|micronutrients|mesh-ancestor
110072918|NCT01574261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110072919|NCT01574313|Tocopherols|tocopherols|mesh-list
110072920|NCT01574313|Vitamin E|vitamin e|mesh-list
110072921|NCT01574313|Tocotrienols|tocotrienols|mesh-list
110072922|NCT01574313|alpha-Tocopherol|alpha-tocopherol|mesh-list
110072923|NCT01574313|Niacin|niacin|mesh-list
110072924|NCT01574313|Diphenidol|diphenidol|mesh-list
110072925|NCT01574313|Antioxidants|antioxidants|mesh-ancestor
110072926|NCT01574313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110072927|NCT01574313|Protective Agents|protective agents|mesh-ancestor
110072928|NCT01574313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110072929|NCT01574313|Vitamins|vitamins|mesh-ancestor
110072930|NCT01574313|Micronutrients|micronutrients|mesh-ancestor
110072931|NCT01574313|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110072932|NCT01574313|Antimetabolites|antimetabolites|mesh-ancestor
110072933|NCT01574313|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110072934|NCT01574313|Vasodilator Agents|vasodilator agents|mesh-ancestor
110072935|NCT01574313|Vitamin B Complex|vitamin b complex|mesh-ancestor
110072936|NCT01574313|Antiemetics|antiemetics|mesh-ancestor
110072937|NCT01574313|Autonomic Agents|autonomic agents|mesh-ancestor
110072938|NCT01574313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110072939|NCT01574313|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110072940|NCT01574508|Insulin|insulin|mesh-list
110072941|NCT01574508|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110072942|NCT01574508|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110072943|NCT01574508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110072945|NCT01574638|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110072946|NCT01574638|Antitubercular Agents|antitubercular agents|mesh-ancestor
110072947|NCT01574638|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110072948|NCT01574638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110072949|NCT01574638|Leprostatic Agents|leprostatic agents|mesh-ancestor
110072950|NCT01574742|Minocycline|minocycline|mesh-list
110072951|NCT01574742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110072952|NCT01574742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110072953|NCT01574820|Rosiglitazone|rosiglitazone|mesh-list
110072954|NCT01574820|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110072955|NCT01574820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110072956|NCT01575158|Citalopram|citalopram|mesh-list
110072957|NCT01575158|Clomipramine|clomipramine|mesh-list
110072958|NCT01575158|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110072959|NCT01575158|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110072960|NCT01575158|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110072961|NCT01575158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110072962|NCT01575158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110072963|NCT01575158|Serotonin Agents|serotonin agents|mesh-ancestor
110072964|NCT01575158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110072965|NCT01575158|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110072966|NCT01575158|Antidepressive Agents|antidepressive agents|mesh-ancestor
110072967|NCT01575158|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110072968|NCT01575158|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110072969|NCT01575236|Chlorhexidine|chlorhexidine|mesh-list
110072970|NCT01575236|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110072971|NCT01575236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110072972|NCT01575236|Disinfectants|disinfectants|mesh-ancestor
110072973|NCT01575301|Liraglutide|liraglutide|mesh-list
110072974|NCT01575301|Exenatide|exenatide|mesh-list
110072975|NCT01575301|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110072976|NCT01575301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110072977|NCT01575301|Incretins|incretins|mesh-ancestor
110072978|NCT01575301|Hormones|hormones|mesh-ancestor
110072979|NCT01575301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110072980|NCT01575301|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110072983|NCT01575405|Antiviral Agents|antiviral agents|mesh-ancestor
110072984|NCT01575405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110072985|NCT01575405|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110072986|NCT01575405|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110072987|NCT01575405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110072988|NCT01575405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110072989|NCT01575405|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110072990|NCT01575405|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110072991|NCT01575405|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
110072992|NCT01575405|Protective Agents|protective agents|mesh-ancestor
110072993|NCT01575405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110072994|NCT01575418|Tenofovir|tenofovir|mesh-list
110072995|NCT01575418|Glycerol|glycerol|mesh-list
110072996|NCT01575418|Antiviral Agents|antiviral agents|mesh-ancestor
110072997|NCT01575418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110072998|NCT01575418|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110072999|NCT01575418|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110073000|NCT01575418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110073001|NCT01575418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110073002|NCT01575418|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110073003|NCT01575418|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110073004|NCT01575418|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
110073005|NCT01575418|Protective Agents|protective agents|mesh-ancestor
110073006|NCT01575418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110073007|NCT01575483|Saxagliptin|saxagliptin|mesh-list
110073008|NCT01575483|Incretins|incretins|mesh-ancestor
110073009|NCT01575483|Hormones|hormones|mesh-ancestor
110073010|NCT01575483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110073011|NCT01575483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110073012|NCT01575483|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110073013|NCT01575483|Protease Inhibitors|protease inhibitors|mesh-ancestor
110073014|NCT01575483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110073015|NCT01575483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110073016|NCT01575483|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110073017|NCT01575509|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110073019|NCT01575613|Artemether|artemether|mesh-list
110073020|NCT01575613|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
110073021|NCT01575613|Antimalarials|antimalarials|mesh-ancestor
110073022|NCT01575613|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110073023|NCT01575613|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110073024|NCT01575613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110073025|NCT01575626|Sevoflurane|sevoflurane|mesh-list
110073026|NCT01575626|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110073027|NCT01575626|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110073029|NCT01575626|Anesthetics|anesthetics|mesh-ancestor
110073030|NCT01575626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110073031|NCT01575626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110073032|NCT01575639|Prednisolone|prednisolone|mesh-list
110073033|NCT01575639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110073034|NCT01575639|Glucocorticoids|glucocorticoids|mesh-ancestor
110073035|NCT01575639|Hormones|hormones|mesh-ancestor
110073036|NCT01575639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110073037|NCT01575639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110073038|NCT01575639|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110073039|NCT01575639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110073040|NCT01575652|Lisinopril|lisinopril|mesh-list
110073041|NCT01575652|Perindopril|perindopril|mesh-list
110073042|NCT01575652|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
110073043|NCT01575652|Enzyme Inhibitors|enzyme inhibitors|mesh-list
110073044|NCT01575652|Protease Inhibitors|protease inhibitors|mesh-ancestor
110073045|NCT01575652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110073046|NCT01575652|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110073047|NCT01575652|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110073048|NCT01575652|Protective Agents|protective agents|mesh-ancestor
110073049|NCT01575652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110073050|NCT01575678|Melatonin|melatonin|mesh-list
110073051|NCT01575678|Antioxidants|antioxidants|mesh-ancestor
110073052|NCT01575678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110073053|NCT01575678|Protective Agents|protective agents|mesh-ancestor
110073054|NCT01575678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110073055|NCT01575678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110073057|NCT01575717|Ergocalciferols|ergocalciferols|mesh-list
110073058|NCT01575717|Cholecalciferol|cholecalciferol|mesh-list
110073059|NCT01575717|Vitamins|vitamins|mesh-list
110073060|NCT01575717|Micronutrients|micronutrients|mesh-ancestor
110073061|NCT01575717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110073062|NCT01575717|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110073063|NCT01575717|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110073064|NCT01575782|Chloroquine|chloroquine|mesh-list
110073065|NCT01575782|Amebicides|amebicides|mesh-ancestor
110073066|NCT01575782|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110073067|NCT01575782|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110073068|NCT01575782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110073069|NCT01575782|Antimalarials|antimalarials|mesh-ancestor
110073070|NCT01575782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110073072|NCT01575795|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110073073|NCT01575795|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110073074|NCT01575795|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110073075|NCT01575795|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110073076|NCT01575795|Purinergic Agents|purinergic agents|mesh-ancestor
110073077|NCT01575795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110073078|NCT01575795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110073079|NCT01575795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110073080|NCT01576029|Docetaxel|docetaxel|mesh-list
110073081|NCT01576029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110073082|NCT01576029|Tubulin Modulators|tubulin modulators|mesh-ancestor
110073083|NCT01576029|Antimitotic Agents|antimitotic agents|mesh-ancestor
110073084|NCT01576029|Mitosis Modulators|mitosis modulators|mesh-ancestor
110073085|NCT01576029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110073086|NCT01576094|Simendan|simendan|mesh-list
110073087|NCT01576094|Milrinone|milrinone|mesh-list
110073088|NCT01576094|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110073089|NCT01576094|Vasodilator Agents|vasodilator agents|mesh-ancestor
110073090|NCT01576094|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110073091|NCT01576094|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110073092|NCT01576094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110073093|NCT01576094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110073094|NCT01576094|Protective Agents|protective agents|mesh-ancestor
110073095|NCT01576094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110073096|NCT01576094|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110073097|NCT01576185|Sorafenib|sorafenib|mesh-list
110073098|NCT01576185|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
110182231|NCT00395031|Ziprasidone|ziprasidone|mesh-list
110073099|NCT01576185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110073100|NCT01576185|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110073101|NCT01576185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110073102|NCT01576185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110073103|NCT01576263|Ropivacaine|ropivacaine|mesh-list
110073104|NCT01576263|Anesthetics, Local|anesthetics, local|mesh-ancestor
110073105|NCT01576263|Anesthetics|anesthetics|mesh-ancestor
110073106|NCT01576263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110073107|NCT01576263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110073108|NCT01576263|Sensory System Agents|sensory system agents|mesh-ancestor
110073109|NCT01576263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110073110|NCT01576354|4-Aminopyridine|4-aminopyridine|mesh-list
110073111|NCT01576354|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
110073112|NCT01576354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110073113|NCT01576354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110073114|NCT01576419|Celecoxib|celecoxib|mesh-list
110073115|NCT01576419|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110073116|NCT01576419|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110073117|NCT01576419|Analgesics|analgesics|mesh-ancestor
110073118|NCT01576419|Sensory System Agents|sensory system agents|mesh-ancestor
110073119|NCT01576419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110073120|NCT01576419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110073121|NCT01576419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110073122|NCT01576419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110073123|NCT01576419|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110073124|NCT01576419|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110073125|NCT01576419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110073126|NCT01576419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110073127|NCT01576458|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
110073128|NCT01576458|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
110073129|NCT01576458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110073131|NCT01576627|Zinc Oxide|zinc oxide|mesh-list
110073132|NCT01576627|Trace Elements|trace elements|mesh-ancestor
110073133|NCT01576627|Micronutrients|micronutrients|mesh-ancestor
110073134|NCT01576627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110073135|NCT01576627|Dermatologic Agents|dermatologic agents|mesh-ancestor
110073136|NCT01576627|Sunscreening Agents|sunscreening agents|mesh-ancestor
110073137|NCT01576627|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110073138|NCT01576627|Protective Agents|protective agents|mesh-ancestor
110073139|NCT01576640|Bupropion|bupropion|mesh-list
110073140|NCT01576640|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110073141|NCT01576640|Antidepressive Agents|antidepressive agents|mesh-ancestor
110073142|NCT01576640|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110073143|NCT01576640|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110073144|NCT01576640|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110073145|NCT01576640|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110073146|NCT01576640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110073147|NCT01576640|Dopamine Agents|dopamine agents|mesh-ancestor
110073148|NCT01576640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110073149|NCT01576640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110073150|NCT01576640|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110073151|NCT01576640|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110073152|NCT01576640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110073153|NCT01576679|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
110073154|NCT01576679|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110073155|NCT01576679|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110073156|NCT01576679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110073157|NCT01576692|Aldesleukin|aldesleukin|mesh-list
110073158|NCT01576692|Antibodies|antibodies|mesh-list
110073159|NCT01576692|Immunoglobulins|immunoglobulins|mesh-list
110073160|NCT01576692|Sargramostim|sargramostim|mesh-list
110073161|NCT01576692|Immunologic Factors|immunologic factors|mesh-ancestor
110073162|NCT01576692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110073163|NCT01576692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110073164|NCT01576692|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110073165|NCT01576692|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110073166|NCT01576692|Antiviral Agents|antiviral agents|mesh-ancestor
110073167|NCT01576692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110073168|NCT01576731|Tenofovir|tenofovir|mesh-list
110073169|NCT01576731|Emtricitabine|emtricitabine|mesh-list
110073170|NCT01576731|Lopinavir|lopinavir|mesh-list
110073171|NCT01576731|Raltegravir Potassium|raltegravir potassium|mesh-list
110073172|NCT01576731|Antiviral Agents|antiviral agents|mesh-ancestor
110073173|NCT01576731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110073174|NCT01576731|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110073175|NCT01576731|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110073176|NCT01576731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110073177|NCT01576731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110073178|NCT01576731|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110073179|NCT01576731|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110073180|NCT01576731|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110073181|NCT01576731|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110073182|NCT01576731|Protease Inhibitors|protease inhibitors|mesh-ancestor
110073183|NCT01576731|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110073184|NCT01576731|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110073185|NCT01576731|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110073186|NCT01576731|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110073187|NCT01576770|Lidocaine|lidocaine|mesh-list
110073188|NCT01576770|Tetracaine|tetracaine|mesh-list
110073189|NCT01576770|Ethyl Chloride|ethyl chloride|mesh-list
110073190|NCT01576770|Anesthetics, Local|anesthetics, local|mesh-ancestor
110073191|NCT01576770|Anesthetics|anesthetics|mesh-ancestor
110073192|NCT01576770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110073193|NCT01576770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110073194|NCT01576770|Sensory System Agents|sensory system agents|mesh-ancestor
110073195|NCT01576770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110073196|NCT01576770|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110073197|NCT01576770|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110073198|NCT01576770|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110073199|NCT01576770|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110073200|NCT01576770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110073201|NCT01576848|Caseins|caseins|mesh-list
110073202|NCT01576848|Chelating Agents|chelating agents|mesh-ancestor
110073203|NCT01576848|Sequestering Agents|sequestering agents|mesh-ancestor
110073204|NCT01576848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110073206|NCT01577017|Aromatase Inhibitors|aromatase inhibitors|mesh-list
110073207|NCT01577017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110073208|NCT01577017|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110073209|NCT01577017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110073210|NCT01577017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110073211|NCT01577017|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110073212|NCT01577017|Hormone Antagonists|hormone antagonists|mesh-ancestor
110073213|NCT01577017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110073214|NCT01577017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110073215|NCT01577043|Racecadotril|racecadotril|mesh-list
110073216|NCT01577043|Antidiarrheals|antidiarrheals|mesh-ancestor
110073217|NCT01577043|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110073218|NCT01577043|Protease Inhibitors|protease inhibitors|mesh-ancestor
110073219|NCT01577043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110073220|NCT01577043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110073221|NCT01577121|Indomethacin|indomethacin|mesh-list
110073222|NCT01577121|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110073223|NCT01577121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110073224|NCT01577121|Analgesics|analgesics|mesh-ancestor
110073225|NCT01577121|Sensory System Agents|sensory system agents|mesh-ancestor
110073226|NCT01577121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110073227|NCT01577121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110073228|NCT01577121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110073229|NCT01577121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110073230|NCT01577121|Gout Suppressants|gout suppressants|mesh-ancestor
110073231|NCT01577121|Tocolytic Agents|tocolytic agents|mesh-ancestor
110073232|NCT01577121|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110073233|NCT01577121|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110073234|NCT01577121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110073235|NCT01577121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110073236|NCT01577095|Rosiglitazone|rosiglitazone|mesh-list
110073237|NCT01577095|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110073238|NCT01577095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110073239|NCT01577199|Clomiphene|clomiphene|mesh-list
110073240|NCT01577199|Enclomiphene|enclomiphene|mesh-list
110073241|NCT01577199|Zuclomiphene|zuclomiphene|mesh-list
110073242|NCT01577199|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110073243|NCT01577199|Hormone Antagonists|hormone antagonists|mesh-ancestor
110073244|NCT01577199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110073245|NCT01577199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110073246|NCT01577199|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110073247|NCT01577199|Fertility Agents|fertility agents|mesh-ancestor
110073248|NCT01577199|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110073249|NCT01577199|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110073250|NCT01577199|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110073251|NCT01577342|Moxifloxacin|moxifloxacin|mesh-list
110073252|NCT01577342|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110073253|NCT01577342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110073254|NCT01577342|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110073255|NCT01577342|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110073256|NCT01577342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110073257|NCT01577342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110073258|NCT01577342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110073259|NCT01577368|Tazobactam|tazobactam|mesh-list
110073260|NCT01577368|Piperacillin|piperacillin|mesh-list
110073261|NCT01577368|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
110073262|NCT01577368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110073263|NCT01577368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110073264|NCT01577368|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110073265|NCT01577368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110073266|NCT01577368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110073267|NCT01577407|Nefopam|nefopam|mesh-list
110073268|NCT01577407|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110073269|NCT01577407|Analgesics|analgesics|mesh-ancestor
110073270|NCT01577407|Sensory System Agents|sensory system agents|mesh-ancestor
110073271|NCT01577407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110073272|NCT01577407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110073274|NCT01577459|Tedizolid|tedizolid|mesh-list
110073275|NCT01577459|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110073276|NCT01577459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110073277|NCT01577524|Povidone-Iodine|povidone-iodine|mesh-list
110073278|NCT01577524|Povidone|povidone|mesh-list
110073279|NCT01577524|Plasma Substitutes|plasma substitutes|mesh-ancestor
110073280|NCT01577524|Blood Substitutes|blood substitutes|mesh-ancestor
110073281|NCT01577524|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110073282|NCT01577524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110073283|NCT01577550|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110073284|NCT01577550|Immunologic Factors|immunologic factors|mesh-ancestor
110073285|NCT01577550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110073286|NCT01577589|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
110073287|NCT01577589|Cephalosporins|cephalosporins|mesh-list
110073288|NCT01577589|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110073289|NCT01577589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110073290|NCT01577693|Dutasteride|dutasteride|mesh-list
110073291|NCT01577693|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
110073292|NCT01577693|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110073293|NCT01577693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110073294|NCT01577693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110073295|NCT01577693|Hormone Antagonists|hormone antagonists|mesh-ancestor
110073296|NCT01577693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110073297|NCT01577693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110073298|NCT01577771|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110073299|NCT01577771|Immunologic Factors|immunologic factors|mesh-ancestor
110073300|NCT01577771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110073301|NCT01577849|Vitamin D|vitamin d|mesh-list
110073302|NCT01577849|Cholecalciferol|cholecalciferol|mesh-list
110073303|NCT01577849|Vitamins|vitamins|mesh-ancestor
110073304|NCT01577849|Micronutrients|micronutrients|mesh-ancestor
110073305|NCT01577849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110073306|NCT01577849|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110073307|NCT01577849|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110073308|NCT01577862|Rifampin|rifampin|mesh-list
110073309|NCT01577862|Colistin|colistin|mesh-list
110073310|NCT01577862|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110073311|NCT01577862|Antitubercular Agents|antitubercular agents|mesh-ancestor
110073312|NCT01577862|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110073313|NCT01577862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110073314|NCT01577862|Leprostatic Agents|leprostatic agents|mesh-ancestor
110073315|NCT01577862|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110073316|NCT01577862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110073317|NCT01577862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110073318|NCT01577862|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110073319|NCT01577862|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110073320|NCT01577862|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110073321|NCT01577862|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110073322|NCT01577862|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110073323|NCT01577862|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110073324|NCT01577914|Carvedilol|carvedilol|mesh-list
110073325|NCT01577914|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110073326|NCT01577914|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110073327|NCT01577914|Adrenergic Agents|adrenergic agents|mesh-ancestor
110073328|NCT01577914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110073329|NCT01577914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110073330|NCT01577914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110073331|NCT01577914|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110073332|NCT01577914|Antioxidants|antioxidants|mesh-ancestor
110073333|NCT01577914|Protective Agents|protective agents|mesh-ancestor
110073334|NCT01577914|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110073335|NCT01577914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110073336|NCT01577914|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110073337|NCT01577914|Vasodilator Agents|vasodilator agents|mesh-ancestor
110073338|NCT01577914|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110073339|NCT01577914|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110073340|NCT01577940|Ropivacaine|ropivacaine|mesh-list
110073341|NCT01577940|Anesthetics, Local|anesthetics, local|mesh-ancestor
110073342|NCT01577940|Anesthetics|anesthetics|mesh-ancestor
110073343|NCT01577940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110073344|NCT01577940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110073345|NCT01577940|Sensory System Agents|sensory system agents|mesh-ancestor
110073346|NCT01577940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110073347|NCT01577992|Levodopa|levodopa|mesh-list
110073348|NCT01577992|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110073349|NCT01577992|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110073350|NCT01577992|Dopamine Agents|dopamine agents|mesh-ancestor
110073351|NCT01577992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110073352|NCT01577992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110073353|NCT01577992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110073354|NCT01578057|Ethanol|ethanol|mesh-list
110073355|NCT01578057|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110073356|NCT01578057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110073357|NCT01578057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110073358|NCT01578057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110073359|NCT01578070|Salicylic Acid|salicylic acid|mesh-list
110073360|NCT01578070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110073361|NCT01578070|Antifungal Agents|antifungal agents|mesh-ancestor
110073362|NCT01578070|Keratolytic Agents|keratolytic agents|mesh-ancestor
110073363|NCT01578070|Dermatologic Agents|dermatologic agents|mesh-ancestor
110073364|NCT01578109|Sorafenib|sorafenib|mesh-list
110073365|NCT01578109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110073366|NCT01578109|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110073367|NCT01578109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110073368|NCT01578109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110073369|NCT01578161|Dexmedetomidine|dexmedetomidine|mesh-list
110073370|NCT01578161|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110073371|NCT01578161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110073372|NCT01578161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110073373|NCT01578161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110073374|NCT01578161|Analgesics|analgesics|mesh-ancestor
110073375|NCT01578161|Sensory System Agents|sensory system agents|mesh-ancestor
110073376|NCT01578161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110073377|NCT01578161|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110073378|NCT01578161|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110073379|NCT01578161|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110073380|NCT01578161|Adrenergic Agents|adrenergic agents|mesh-ancestor
110073381|NCT01578161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110073382|NCT01578161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110073383|NCT01578174|Dexmedetomidine|dexmedetomidine|mesh-list
110073384|NCT01578174|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110073385|NCT01578174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110073386|NCT01578174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110073387|NCT01578174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110073388|NCT01578174|Analgesics|analgesics|mesh-ancestor
110073389|NCT01578174|Sensory System Agents|sensory system agents|mesh-ancestor
110073390|NCT01578174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110073391|NCT01578174|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110073392|NCT01578174|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110073393|NCT01578174|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110073394|NCT01578174|Adrenergic Agents|adrenergic agents|mesh-ancestor
110073395|NCT01578174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110073396|NCT01578174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110073397|NCT01578200|Calcium Carbonate|calcium carbonate|mesh-list
110073399|NCT01578200|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110073400|NCT01578200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110073401|NCT01578200|Antacids|antacids|mesh-ancestor
110073402|NCT01578200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110073403|NCT01578200|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110073404|NCT01578213|Imatinib Mesylate|imatinib mesylate|mesh-list
110073405|NCT01578213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110073406|NCT01578213|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110073407|NCT01578213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110073408|NCT01578213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110073409|NCT01578252|Ondansetron|ondansetron|mesh-list
110073410|NCT01578252|Antiemetics|antiemetics|mesh-ancestor
110073411|NCT01578252|Autonomic Agents|autonomic agents|mesh-ancestor
110073412|NCT01578252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110073413|NCT01578252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110073414|NCT01578252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110073415|NCT01578252|Antipruritics|antipruritics|mesh-ancestor
110073416|NCT01578252|Dermatologic Agents|dermatologic agents|mesh-ancestor
110073417|NCT01578252|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110073418|NCT01578252|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110073419|NCT01578252|Serotonin Agents|serotonin agents|mesh-ancestor
110073420|NCT01578252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110073421|NCT01578252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110073422|NCT01578265|Ondansetron|ondansetron|mesh-list
110073423|NCT01578265|Antiemetics|antiemetics|mesh-ancestor
110073424|NCT01578265|Autonomic Agents|autonomic agents|mesh-ancestor
110073425|NCT01578265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110073426|NCT01578265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110073427|NCT01578265|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110073428|NCT01578265|Antipruritics|antipruritics|mesh-ancestor
110073429|NCT01578265|Dermatologic Agents|dermatologic agents|mesh-ancestor
110073430|NCT01578265|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110073431|NCT01578265|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110073432|NCT01578265|Serotonin Agents|serotonin agents|mesh-ancestor
110073433|NCT01578265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110073434|NCT01578265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110073435|NCT01578304|Fesoterodine|fesoterodine|mesh-list
110073436|NCT01578304|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110073437|NCT01578304|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110073438|NCT01578304|Cholinergic Agents|cholinergic agents|mesh-ancestor
110073439|NCT01578304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110073440|NCT01578304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110073441|NCT01578304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110073442|NCT01578304|Urological Agents|urological agents|mesh-ancestor
110073443|NCT01578343|Dexamethasone|dexamethasone|mesh-list
110073444|NCT01578343|Dexamethasone acetate|dexamethasone acetate|mesh-list
110073445|NCT01578343|Fludarabine|fludarabine|mesh-list
110073446|NCT01578343|Fludarabine phosphate|fludarabine phosphate|mesh-list
110073447|NCT01578343|Mitoxantrone|mitoxantrone|mesh-list
110073449|NCT01578343|BB 1101|bb 1101|mesh-list
110073450|NCT01578343|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110073451|NCT01578343|Antiemetics|antiemetics|mesh-ancestor
110073452|NCT01578343|Autonomic Agents|autonomic agents|mesh-ancestor
110073453|NCT01578343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110073454|NCT01578343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110073455|NCT01578343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110073456|NCT01578343|Glucocorticoids|glucocorticoids|mesh-ancestor
110073458|NCT01578343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110073459|NCT01578343|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110073460|NCT01578343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110073461|NCT01578343|Protease Inhibitors|protease inhibitors|mesh-ancestor
110073462|NCT01578343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110073463|NCT01578343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110073464|NCT01578343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110073465|NCT01578343|Antimetabolites|antimetabolites|mesh-ancestor
110073466|NCT01578343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110073467|NCT01578343|Immunologic Factors|immunologic factors|mesh-ancestor
110073468|NCT01578343|Analgesics|analgesics|mesh-ancestor
110073469|NCT01578343|Sensory System Agents|sensory system agents|mesh-ancestor
110073470|NCT01578343|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110073471|NCT01578343|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110073472|NCT01578343|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110073473|NCT01578434|Calcium, Dietary|calcium, dietary|mesh-list
110073474|NCT01578434|Vitamin D|vitamin d|mesh-list
110073475|NCT01578434|Ergocalciferols|ergocalciferols|mesh-list
110073476|NCT01578434|Cholecalciferol|cholecalciferol|mesh-list
110073477|NCT01578434|Vitamins|vitamins|mesh-list
110073478|NCT01578434|Calcium Carbonate|calcium carbonate|mesh-list
110073480|NCT01578434|Micronutrients|micronutrients|mesh-ancestor
110073481|NCT01578434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110073482|NCT01578434|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110073483|NCT01578434|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110073484|NCT01578434|Antacids|antacids|mesh-ancestor
110073485|NCT01578434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110073486|NCT01578434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110073487|NCT01578447|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
110073488|NCT01578447|Medroxyprogesterone|medroxyprogesterone|mesh-list
110073489|NCT01578447|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110073491|NCT01578447|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110073492|NCT01578447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110073493|NCT01578447|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110073494|NCT01578447|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110073495|NCT01578447|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110073497|NCT01578447|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110073498|NCT01578447|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110182488|NCT00024453|Teicoplanin|teicoplanin|mesh-list
110073499|NCT01578447|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110073500|NCT01578473|Vitamin D|vitamin d|mesh-list
110073501|NCT01578473|Ergocalciferols|ergocalciferols|mesh-list
110073502|NCT01578473|Vitamins|vitamins|mesh-list
110073503|NCT01578473|Vitamin E|vitamin e|mesh-list
110073504|NCT01578473|Methyltestosterone|methyltestosterone|mesh-list
110073505|NCT01578473|Testosterone|testosterone|mesh-list
110073506|NCT01578473|Testosterone undecanoate|testosterone undecanoate|mesh-list
110073507|NCT01578473|Testosterone enanthate|testosterone enanthate|mesh-list
110073508|NCT01578473|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
110073509|NCT01578473|Micronutrients|micronutrients|mesh-ancestor
110073510|NCT01578473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110073511|NCT01578473|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110073512|NCT01578473|Androgens|androgens|mesh-ancestor
110073513|NCT01578473|Hormones|hormones|mesh-ancestor
110073514|NCT01578473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110073515|NCT01578473|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110073516|NCT01578473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110073517|NCT01578473|Anabolic Agents|anabolic agents|mesh-ancestor
110073518|NCT01578473|Antioxidants|antioxidants|mesh-ancestor
110073519|NCT01578473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110073520|NCT01578473|Protective Agents|protective agents|mesh-ancestor
110073521|NCT01578473|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110073522|NCT01578564|SOR-C13|sor-c13|mesh-list
110073523|NCT01578564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110073524|NCT01578564|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110073525|NCT01578564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110073526|NCT01578564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110073527|NCT01578564|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110073528|NCT01578564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110073529|NCT01578603|Calcium|calcium|mesh-list
110073530|NCT01578603|Caseins|caseins|mesh-list
110073531|NCT01578603|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110073532|NCT01578603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110073533|NCT01578603|Chelating Agents|chelating agents|mesh-ancestor
110073534|NCT01578603|Sequestering Agents|sequestering agents|mesh-ancestor
110073535|NCT01578603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110073536|NCT01578629|Aspirin|aspirin|mesh-list
110073537|NCT01578629|Vitamin E|vitamin e|mesh-list
110073538|NCT01578629|Tocopherols|tocopherols|mesh-list
110073539|NCT01578629|Tocotrienols|tocotrienols|mesh-list
110073540|NCT01578629|Vitamins|vitamins|mesh-ancestor
110073541|NCT01578629|Micronutrients|micronutrients|mesh-ancestor
110073542|NCT01578629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110073543|NCT01578629|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110073544|NCT01578629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110073545|NCT01578629|Analgesics|analgesics|mesh-ancestor
110073546|NCT01578629|Sensory System Agents|sensory system agents|mesh-ancestor
110073547|NCT01578629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110073548|NCT01578629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110073549|NCT01578629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110073550|NCT01578629|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110073551|NCT01578629|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110073552|NCT01578629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110073553|NCT01578629|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110073554|NCT01578629|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110073555|NCT01578629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110073556|NCT01578629|Antipyretics|antipyretics|mesh-ancestor
110073557|NCT01578629|Antioxidants|antioxidants|mesh-ancestor
110073558|NCT01578629|Protective Agents|protective agents|mesh-ancestor
110073559|NCT01578668|Pemetrexed|pemetrexed|mesh-list
110073560|NCT01578668|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110073561|NCT01578668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110073562|NCT01578668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110073563|NCT01578668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110073564|NCT01578668|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110073565|NCT01578668|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110073566|NCT01578668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110073568|NCT01578720|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110073569|NCT01578720|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110073570|NCT01578720|Growth Substances|growth substances|mesh-ancestor
110073571|NCT01578720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110073572|NCT01578720|Growth Inhibitors|growth inhibitors|mesh-ancestor
110073573|NCT01578720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110073574|NCT01578824|Methacholine Chloride|methacholine chloride|mesh-list
110073575|NCT01578824|Miotics|miotics|mesh-ancestor
110073576|NCT01578824|Autonomic Agents|autonomic agents|mesh-ancestor
110073577|NCT01578824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110073578|NCT01578824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110073579|NCT01578824|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110073580|NCT01578824|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
110073581|NCT01578824|Respiratory System Agents|respiratory system agents|mesh-ancestor
110073582|NCT01578824|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
110073583|NCT01578824|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110073584|NCT01578824|Cholinergic Agents|cholinergic agents|mesh-ancestor
110073585|NCT01578824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110073586|NCT01578824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110073587|NCT01578889|Vaccines|vaccines|mesh-list
110073588|NCT01578889|Immunologic Factors|immunologic factors|mesh-ancestor
110073589|NCT01578889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110073590|NCT01578928|Pasireotide|pasireotide|mesh-list
110073591|NCT01578928|Hormones|hormones|mesh-ancestor
110073592|NCT01578928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110073593|NCT01578928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110073594|NCT01579019|Ritonavir|ritonavir|mesh-list
110073595|NCT01579019|Ribavirin|ribavirin|mesh-list
110073596|NCT01579019|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110073597|NCT01579019|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110073598|NCT01579019|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110182545|NCT00025038|Antimetabolites|antimetabolites|mesh-ancestor
110073599|NCT01579019|Protease Inhibitors|protease inhibitors|mesh-ancestor
110073600|NCT01579019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110073601|NCT01579019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110073602|NCT01579019|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110073603|NCT01579019|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110073604|NCT01579019|Antiviral Agents|antiviral agents|mesh-ancestor
110073605|NCT01579019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110073606|NCT01579019|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110073607|NCT01579019|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110073608|NCT01579019|Antimetabolites|antimetabolites|mesh-ancestor
110073609|NCT01579058|Bisoprolol|bisoprolol|mesh-list
110073610|NCT01579058|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110073611|NCT01579058|Sympatholytics|sympatholytics|mesh-ancestor
110073612|NCT01579058|Autonomic Agents|autonomic agents|mesh-ancestor
110073613|NCT01579058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110073614|NCT01579058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110073615|NCT01579058|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110073616|NCT01579058|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110073618|NCT01579058|Adrenergic Agents|adrenergic agents|mesh-ancestor
110073619|NCT01579058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110073620|NCT01579058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110073622|NCT01579110|Prednisone|prednisone|mesh-list
110073623|NCT01579110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110073624|NCT01579110|Glucocorticoids|glucocorticoids|mesh-ancestor
110073625|NCT01579110|Hormones|hormones|mesh-ancestor
110073626|NCT01579110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110073627|NCT01579110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110073628|NCT01579110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110073629|NCT01579110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110073630|NCT01579110|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110073631|NCT01579110|Immunologic Factors|immunologic factors|mesh-ancestor
110073632|NCT01579110|Antinematodal Agents|antinematodal agents|mesh-ancestor
110073633|NCT01579110|Anthelmintics|anthelmintics|mesh-ancestor
110073634|NCT01579110|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110073635|NCT01579110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110073636|NCT01579110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110073637|NCT01579149|Plerixafor|plerixafor|mesh-list
110073638|NCT01579149|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110073639|NCT01579149|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110073640|NCT01579149|Antiviral Agents|antiviral agents|mesh-ancestor
110073641|NCT01579149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110073642|NCT01579201|Carbetocin|carbetocin|mesh-list
110073643|NCT01579201|Oxytocics|oxytocics|mesh-ancestor
110073644|NCT01579201|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110073645|NCT01579201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110073646|NCT01579227|Tamoxifen|tamoxifen|mesh-list
110073647|NCT01579227|Tocotrienols|tocotrienols|mesh-list
110073648|NCT01579227|Vitamin E|vitamin e|mesh-list
110073649|NCT01579227|Tocopherols|tocopherols|mesh-list
110073650|NCT01579227|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110073651|NCT01579227|Hormone Antagonists|hormone antagonists|mesh-ancestor
110073652|NCT01579227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110073653|NCT01579227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110073654|NCT01579227|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110073655|NCT01579227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110073656|NCT01579227|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110073657|NCT01579227|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110073658|NCT01579227|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110073659|NCT01579227|Antioxidants|antioxidants|mesh-ancestor
110073660|NCT01579227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110073661|NCT01579227|Protective Agents|protective agents|mesh-ancestor
110073662|NCT01579227|Vitamins|vitamins|mesh-ancestor
110073663|NCT01579227|Micronutrients|micronutrients|mesh-ancestor
110073664|NCT01579279|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110073665|NCT01579279|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110073666|NCT01579279|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110073667|NCT01579279|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110073668|NCT01579279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110073669|NCT01579279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110073670|NCT01579279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110073671|NCT01579279|Analgesics|analgesics|mesh-ancestor
110073672|NCT01579279|Sensory System Agents|sensory system agents|mesh-ancestor
110073673|NCT01579279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110073674|NCT01579279|Antidepressive Agents|antidepressive agents|mesh-ancestor
110073675|NCT01579279|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110073676|NCT01579279|Dopamine Agents|dopamine agents|mesh-ancestor
110073677|NCT01579383|Sumatriptan|sumatriptan|mesh-list
110073678|NCT01579383|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110073679|NCT01579383|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110073680|NCT01579383|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110073681|NCT01579383|Serotonin Agents|serotonin agents|mesh-ancestor
110073682|NCT01579383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110073683|NCT01579383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110073684|NCT01579383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110073685|NCT01579448|Vaccines|vaccines|mesh-list
110073686|NCT01579448|Immunologic Factors|immunologic factors|mesh-ancestor
110073687|NCT01579448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110073688|NCT01579461|Mirabegron|mirabegron|mesh-list
110073689|NCT01579461|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
110073690|NCT01579461|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110073691|NCT01579461|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110073692|NCT01579461|Adrenergic Agents|adrenergic agents|mesh-ancestor
110073693|NCT01579461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110073694|NCT01579461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110073695|NCT01579461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110073696|NCT01579461|Urological Agents|urological agents|mesh-ancestor
110073697|NCT01579500|Botulinum Toxins|botulinum toxins|mesh-list
110073698|NCT01579500|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110073699|NCT01579500|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110073700|NCT01579500|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110073701|NCT01579500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110073702|NCT01579500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110073703|NCT01579500|Cholinergic Agents|cholinergic agents|mesh-ancestor
110073704|NCT01579500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110073705|NCT01579500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110073706|NCT01579500|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110073707|NCT01579500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110073708|NCT01579539|Methylprednisolone|methylprednisolone|mesh-list
110073709|NCT01579539|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110073710|NCT01579539|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110073711|NCT01579539|Prednisolone|prednisolone|mesh-list
110073712|NCT01579539|Prednisolone acetate|prednisolone acetate|mesh-list
110073713|NCT01579539|Esomeprazole|esomeprazole|mesh-list
110073714|NCT01579539|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110073715|NCT01579539|Prednisolone phosphate|prednisolone phosphate|mesh-list
110073716|NCT01579539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110073717|NCT01579539|Antiemetics|antiemetics|mesh-ancestor
110073718|NCT01579539|Autonomic Agents|autonomic agents|mesh-ancestor
110073719|NCT01579539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110073720|NCT01579539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110073721|NCT01579539|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110073722|NCT01579539|Glucocorticoids|glucocorticoids|mesh-ancestor
110073723|NCT01579539|Hormones|hormones|mesh-ancestor
110073724|NCT01579539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110073725|NCT01579539|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110073726|NCT01579539|Protective Agents|protective agents|mesh-ancestor
110073727|NCT01579539|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110073728|NCT01579539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110073729|NCT01579539|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110073730|NCT01579539|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110073731|NCT01579539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110073732|NCT01579539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110073734|NCT01579630|Gefitinib|gefitinib|mesh-list
110073735|NCT01579630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110073736|NCT01579630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110073737|NCT01579630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110073738|NCT01579630|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110073739|NCT01579630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110073740|NCT01579630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110073741|NCT01579695|Tesamorelin|tesamorelin|mesh-list
110073742|NCT01579695|Growth Substances|growth substances|mesh-ancestor
110073743|NCT01579695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110073744|NCT01579760|Aflibercept|aflibercept|mesh-list
110073745|NCT01579760|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110073746|NCT01579760|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110073747|NCT01579760|Growth Substances|growth substances|mesh-ancestor
110073748|NCT01579760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110073749|NCT01579760|Growth Inhibitors|growth inhibitors|mesh-ancestor
110073750|NCT01579760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110073751|NCT01579786|Acetaminophen|acetaminophen|mesh-list
110073752|NCT01579786|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110073753|NCT01579786|Analgesics|analgesics|mesh-ancestor
110073754|NCT01579786|Sensory System Agents|sensory system agents|mesh-ancestor
110073755|NCT01579786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110073756|NCT01579786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110073757|NCT01579786|Antipyretics|antipyretics|mesh-ancestor
110073758|NCT01579838|Eculizumab|eculizumab|mesh-list
110073759|NCT01579838|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
110073760|NCT01579838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110073761|NCT01579838|Immunologic Factors|immunologic factors|mesh-ancestor
110073762|NCT01579838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110073763|NCT01579864|Rocuronium|rocuronium|mesh-list
110073764|NCT01579864|Succinylcholine|succinylcholine|mesh-list
110073765|NCT01579864|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110073766|NCT01579864|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110073767|NCT01579864|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110073768|NCT01579864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110073769|NCT01579864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110073770|NCT01579864|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
110073771|NCT01579890|Diclofenac|diclofenac|mesh-list
110073772|NCT01579890|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110073773|NCT01579890|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110073774|NCT01579890|Analgesics|analgesics|mesh-ancestor
110073775|NCT01579890|Sensory System Agents|sensory system agents|mesh-ancestor
110073776|NCT01579890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110073777|NCT01579890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110073778|NCT01579890|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110073779|NCT01579890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110073780|NCT01579890|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110073781|NCT01579890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110073782|NCT01579890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110073783|NCT01579903|Factor VIII|factor viii|mesh-list
110073784|NCT01579903|Coagulants|coagulants|mesh-ancestor
110073785|NCT01579929|Etoposide|etoposide|mesh-list
110073786|NCT01579929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110073787|NCT01579929|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110073788|NCT01579929|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110073789|NCT01579929|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110073790|NCT01579929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110073791|NCT01579929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110073792|NCT01579994|Crizotinib|crizotinib|mesh-list
110073793|NCT01579994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110073794|NCT01579994|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110073795|NCT01579994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110073796|NCT01579994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110073797|NCT01580228|Ofatumumab|ofatumumab|mesh-list
110073798|NCT01580228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110073799|NCT01581333|Anti-Infective Agents|anti-infective agents|mesh-list
110073800|NCT01581333|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110073801|NCT01581359|Triptorelin Pamoate|triptorelin pamoate|mesh-list
110073802|NCT01581359|Luteolytic Agents|luteolytic agents|mesh-ancestor
110073803|NCT01581359|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110073804|NCT01581359|Contraceptive Agents|contraceptive agents|mesh-ancestor
110073805|NCT01581359|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110073806|NCT01581359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110073807|NCT01581359|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110073808|NCT01581359|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110073809|NCT01581359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110073810|NCT01581476|Quinapril|quinapril|mesh-list
110073811|NCT01581476|Atorvastatin|atorvastatin|mesh-list
110073812|NCT01581476|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
110073813|NCT01581476|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110073814|NCT01581476|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110073815|NCT01581476|Antimetabolites|antimetabolites|mesh-ancestor
110073816|NCT01581476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110073817|NCT01581476|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110073818|NCT01581476|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110073819|NCT01581476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110073820|NCT01581476|Protease Inhibitors|protease inhibitors|mesh-ancestor
110073821|NCT01581476|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110073822|NCT01582321|Cantharidin|cantharidin|mesh-list
110073823|NCT01582321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110073824|NCT01582321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110073825|NCT01582438|Sildenafil Citrate|sildenafil citrate|mesh-list
110073826|NCT01582438|Citric Acid|citric acid|mesh-list
110073827|NCT01582438|Sodium Citrate|sodium citrate|mesh-list
110073828|NCT01582438|Anticoagulants|anticoagulants|mesh-ancestor
110073829|NCT01582438|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110073830|NCT01582438|Chelating Agents|chelating agents|mesh-ancestor
110073831|NCT01582438|Sequestering Agents|sequestering agents|mesh-ancestor
110073832|NCT01582438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110073833|NCT01582438|Vasodilator Agents|vasodilator agents|mesh-ancestor
110073834|NCT01582438|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110073835|NCT01582438|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110073836|NCT01582438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110073837|NCT01582438|Urological Agents|urological agents|mesh-ancestor
110073838|NCT01582711|Isoniazid|isoniazid|mesh-list
110073839|NCT01582711|Rifapentine|rifapentine|mesh-list
110073840|NCT01582711|Antitubercular Agents|antitubercular agents|mesh-ancestor
110073841|NCT01582711|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110073842|NCT01582711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110073843|NCT01582711|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
110073844|NCT01582711|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110073845|NCT01582711|Antimetabolites|antimetabolites|mesh-ancestor
110073846|NCT01582711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110073847|NCT01582711|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110073848|NCT01582711|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110073849|NCT01582711|Leprostatic Agents|leprostatic agents|mesh-ancestor
110073850|NCT01583062|Amoxicillin|amoxicillin|mesh-list
110073851|NCT01583062|Clavulanic Acids|clavulanic acids|mesh-list
110073852|NCT01583062|Clavulanic Acid|clavulanic acid|mesh-list
110073853|NCT01583062|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110073854|NCT01583062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110073855|NCT01583062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110073856|NCT01583062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110073857|NCT01583062|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110073859|NCT01583426|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110073860|NCT01583426|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110073861|NCT01583426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110073862|NCT01583426|Tubulin Modulators|tubulin modulators|mesh-ancestor
110073863|NCT01583426|Antimitotic Agents|antimitotic agents|mesh-ancestor
110073864|NCT01583426|Mitosis Modulators|mitosis modulators|mesh-ancestor
110073865|NCT01583426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110073866|NCT01583972|Vitamin A|vitamin a|mesh-list
110073868|NCT01583972|Vitamins|vitamins|mesh-ancestor
110073869|NCT01583972|Micronutrients|micronutrients|mesh-ancestor
110073870|NCT01583972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110073871|NCT01583972|Antioxidants|antioxidants|mesh-ancestor
110073872|NCT01583972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110073873|NCT01583972|Protective Agents|protective agents|mesh-ancestor
110073874|NCT01583972|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110073875|NCT01583972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110073876|NCT01584362|Oxfendazole|oxfendazole|mesh-list
110073877|NCT01584362|Anthelmintics|anthelmintics|mesh-ancestor
110073878|NCT01584362|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110073879|NCT01584362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110073880|NCT01584362|Antinematodal Agents|antinematodal agents|mesh-ancestor
110073881|NCT01584921|Epoetin Alfa|epoetin alfa|mesh-list
110073882|NCT01584921|Hematinics|hematinics|mesh-ancestor
110073883|NCT01586013|Propofol|propofol|mesh-list
110073884|NCT01586013|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110073885|NCT01586013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110073886|NCT01586013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110073887|NCT01586013|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110073888|NCT01586013|Anesthetics, General|anesthetics, general|mesh-ancestor
110073889|NCT01586013|Anesthetics|anesthetics|mesh-ancestor
110073890|NCT01586845|Cyclosporine|cyclosporine|mesh-list
110073891|NCT01586845|Tacrolimus|tacrolimus|mesh-list
110073892|NCT01586845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110073893|NCT01586845|Immunologic Factors|immunologic factors|mesh-ancestor
110073894|NCT01586845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110073895|NCT01586845|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110073896|NCT01586845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110073897|NCT01586845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110073898|NCT01586845|Antifungal Agents|antifungal agents|mesh-ancestor
110073899|NCT01586845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110073900|NCT01586845|Dermatologic Agents|dermatologic agents|mesh-ancestor
110073901|NCT01586845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110073902|NCT01587339|Pregabalin|pregabalin|mesh-list
110073903|NCT01587339|Zonisamide|zonisamide|mesh-list
110073904|NCT01587339|Lacosamide|lacosamide|mesh-list
110073905|NCT01587339|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
110073906|NCT01587339|Ezogabine|ezogabine|mesh-list
110073907|NCT01587339|Analgesics|analgesics|mesh-ancestor
110073908|NCT01587339|Sensory System Agents|sensory system agents|mesh-ancestor
110073909|NCT01587339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110073910|NCT01587339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110073911|NCT01587339|Anticonvulsants|anticonvulsants|mesh-ancestor
110073912|NCT01587339|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110073913|NCT01587339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110182810|NCT00026130|Antimetabolites|antimetabolites|mesh-ancestor
110073914|NCT01587339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110073915|NCT01587339|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110073916|NCT01587339|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110073917|NCT01587339|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110073918|NCT01587339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110073919|NCT01587339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110073920|NCT01587339|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110073921|NCT01587339|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110073922|NCT01587378|Metformin|metformin|mesh-list
110073923|NCT01587378|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110073924|NCT01587378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110073925|NCT01587482|Paclitaxel|paclitaxel|mesh-list
110073926|NCT01587482|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110073927|NCT01587482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110073928|NCT01587482|Tubulin Modulators|tubulin modulators|mesh-ancestor
110073929|NCT01587482|Antimitotic Agents|antimitotic agents|mesh-ancestor
110073930|NCT01587482|Mitosis Modulators|mitosis modulators|mesh-ancestor
110073931|NCT01587482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110073932|NCT01587625|Oxytocin|oxytocin|mesh-list
110073933|NCT01587625|Oxytocics|oxytocics|mesh-ancestor
110073934|NCT01587625|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110073935|NCT01587625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110073936|NCT01587820|Cisplatin|cisplatin|mesh-list
110073937|NCT01587820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110073938|NCT01587937|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110073939|NCT01587937|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
110073940|NCT01587937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110073941|NCT01587937|Antitubercular Agents|antitubercular agents|mesh-ancestor
110073942|NCT01588171|Enoxaparin|enoxaparin|mesh-list
110073943|NCT01588171|Bemiparin|bemiparin|mesh-list
110073944|NCT01588171|Anticoagulants|anticoagulants|mesh-ancestor
110073945|NCT01588171|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110073946|NCT01588171|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110073947|NCT01588171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110073948|NCT01588873|Desogestrel|desogestrel|mesh-list
110073950|NCT01588873|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110073951|NCT01588873|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110073952|NCT01588873|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110073953|NCT01588873|Contraceptive Agents|contraceptive agents|mesh-ancestor
110073954|NCT01588873|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110073955|NCT01588873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110073956|NCT01588873|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110073957|NCT01588873|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110073958|NCT01588873|Progestins|progestins|mesh-ancestor
110073959|NCT01588873|Hormones|hormones|mesh-ancestor
110073960|NCT01588873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110073961|NCT01589367|Metformin|metformin|mesh-list
110073962|NCT01589367|Letrozole|letrozole|mesh-list
110073963|NCT01589367|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110073964|NCT01589367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110073965|NCT01589367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110073966|NCT01589367|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110073967|NCT01589367|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110073968|NCT01589367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110073969|NCT01589367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110073970|NCT01589367|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110073971|NCT01589367|Hormone Antagonists|hormone antagonists|mesh-ancestor
110073972|NCT01589367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110073973|NCT01589432|Lidocaine|lidocaine|mesh-list
110073974|NCT01589432|Anesthetics, Local|anesthetics, local|mesh-ancestor
110073975|NCT01589432|Anesthetics|anesthetics|mesh-ancestor
110073976|NCT01589432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110073977|NCT01589432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110073978|NCT01589432|Sensory System Agents|sensory system agents|mesh-ancestor
110073979|NCT01589432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110073980|NCT01589432|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110073981|NCT01589432|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110073982|NCT01589432|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110073983|NCT01589432|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110073984|NCT01589432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110073985|NCT01589614|Erythromycin|erythromycin|mesh-list
110073986|NCT01589614|Erythromycin Estolate|erythromycin estolate|mesh-list
110073987|NCT01589614|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
110073988|NCT01589614|Erythromycin stearate|erythromycin stearate|mesh-list
110073989|NCT01589614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110073990|NCT01589614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110073991|NCT01589614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110073992|NCT01589614|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110073993|NCT01589614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110073994|NCT01589614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110182860|NCT04726280|Anesthetics|anesthetics|mesh-ancestor
110073995|NCT01589861|Lapatinib|lapatinib|mesh-list
110073996|NCT01589861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110073997|NCT01589861|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110073998|NCT01589861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110073999|NCT01589861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110074000|NCT01590173|Prednisolone|prednisolone|mesh-list
110074001|NCT01590173|Heparin|heparin|mesh-list
110074002|NCT01590173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110074003|NCT01590173|Glucocorticoids|glucocorticoids|mesh-ancestor
110074004|NCT01590173|Hormones|hormones|mesh-ancestor
110074005|NCT01590173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110074006|NCT01590173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110074007|NCT01590173|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110074008|NCT01590173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110074009|NCT01590173|Anticoagulants|anticoagulants|mesh-ancestor
110074010|NCT01590173|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110074011|NCT01590173|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110074012|NCT01590173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110074014|NCT01590199|Pasireotide|pasireotide|mesh-list
110074015|NCT01590199|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110074016|NCT01590199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110074017|NCT01590199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110074018|NCT01590199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110074019|NCT01590199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110074020|NCT01590199|Immunologic Factors|immunologic factors|mesh-ancestor
110074021|NCT01590199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110074022|NCT01590199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110074023|NCT01590199|Hormones|hormones|mesh-ancestor
110074024|NCT01590199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110074025|NCT01590225|Ribavirin|ribavirin|mesh-list
110074026|NCT01590225|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110074027|NCT01590225|Interferon-alpha|interferon-alpha|mesh-list
110074028|NCT01590225|Antimetabolites|antimetabolites|mesh-ancestor
110074029|NCT01590225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110074030|NCT01590225|Antiviral Agents|antiviral agents|mesh-ancestor
110074031|NCT01590225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110074032|NCT01590225|Immunologic Factors|immunologic factors|mesh-ancestor
110074033|NCT01590225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110074034|NCT01590342|Diclofenac|diclofenac|mesh-list
110182911|NCT00027066|Analgesics|analgesics|mesh-ancestor
110074035|NCT01590342|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110074036|NCT01590342|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110074037|NCT01590342|Analgesics|analgesics|mesh-ancestor
110074038|NCT01590342|Sensory System Agents|sensory system agents|mesh-ancestor
110074039|NCT01590342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110074040|NCT01590342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110074041|NCT01590342|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110074042|NCT01590342|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110074043|NCT01590342|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110074044|NCT01590342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110074045|NCT01590342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110074046|NCT01590537|Copper|copper|mesh-list
110074047|NCT01590537|Levonorgestrel|levonorgestrel|mesh-list
110074048|NCT01590537|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110074049|NCT01590537|Contraceptive Agents|contraceptive agents|mesh-ancestor
110074050|NCT01590537|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110074051|NCT01590537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110074052|NCT01590537|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110074053|NCT01590537|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110074054|NCT01590537|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110074055|NCT01590537|Trace Elements|trace elements|mesh-ancestor
110074056|NCT01590537|Micronutrients|micronutrients|mesh-ancestor
110074057|NCT01590641|Vesatolimod|vesatolimod|mesh-list
110074058|NCT01590641|Antiviral Agents|antiviral agents|mesh-ancestor
110074059|NCT01590641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110074060|NCT01590654|Vesatolimod|vesatolimod|mesh-list
110074061|NCT01590654|Antiviral Agents|antiviral agents|mesh-ancestor
110074062|NCT01590654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110074063|NCT01590693|Botulinum Toxins|botulinum toxins|mesh-list
110074064|NCT01590693|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110074065|NCT01590693|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110074066|NCT01590693|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110074067|NCT01590693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110074068|NCT01590693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110182954|NCT04206488|Digoxin|digoxin|mesh-list
110074069|NCT01590693|Cholinergic Agents|cholinergic agents|mesh-ancestor
110074070|NCT01590693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110074071|NCT01590693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110074072|NCT01590693|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110074073|NCT01590693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110074074|NCT01590732|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110074076|NCT01590732|Etoposide|etoposide|mesh-list
110074077|NCT01590732|Etoposide phosphate|etoposide phosphate|mesh-list
110074078|NCT01590732|Ifosfamide|ifosfamide|mesh-list
110074079|NCT01590732|Isophosphamide mustard|isophosphamide mustard|mesh-list
110074080|NCT01590732|Podophyllotoxin|podophyllotoxin|mesh-list
110074081|NCT01590732|Romidepsin|romidepsin|mesh-list
110074082|NCT01590732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110074083|NCT01590732|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110074084|NCT01590732|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110074085|NCT01590732|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110074086|NCT01590732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110074087|NCT01590732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110074088|NCT01590732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110074089|NCT01590732|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110074090|NCT01590732|Alkylating Agents|alkylating agents|mesh-ancestor
110074091|NCT01590732|Keratolytic Agents|keratolytic agents|mesh-ancestor
110074092|NCT01590732|Dermatologic Agents|dermatologic agents|mesh-ancestor
110074093|NCT01590732|Tubulin Modulators|tubulin modulators|mesh-ancestor
110074094|NCT01590732|Antimitotic Agents|antimitotic agents|mesh-ancestor
110074095|NCT01590732|Mitosis Modulators|mitosis modulators|mesh-ancestor
110074096|NCT01590732|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110074097|NCT01590732|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110074098|NCT01590823|Dabigatran|dabigatran|mesh-list
110074099|NCT01590823|Antithrombins|antithrombins|mesh-ancestor
110074100|NCT01590823|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110074101|NCT01590823|Protease Inhibitors|protease inhibitors|mesh-ancestor
110074102|NCT01590823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110074103|NCT01590823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110074104|NCT01590823|Anticoagulants|anticoagulants|mesh-ancestor
110074105|NCT01590836|Insulin|insulin|mesh-list
110074106|NCT01590836|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110074107|NCT01590836|Insulin Aspart|insulin aspart|mesh-list
110074108|NCT01590836|Insulin, Long-Acting|insulin, long-acting|mesh-list
110074109|NCT01590836|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110074110|NCT01590836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110074111|NCT01590849|Contraceptive Agents|contraceptive agents|mesh-list
110074112|NCT01590849|Contraceptives, Oral|contraceptives, oral|mesh-list
110074113|NCT01590849|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
110074114|NCT01590849|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110074115|NCT01590849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110074116|NCT01590849|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110074117|NCT01590901|Probucol|probucol|mesh-list
110074118|NCT01590901|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110074119|NCT01590901|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110074120|NCT01590901|Antimetabolites|antimetabolites|mesh-ancestor
110074121|NCT01590901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110074122|NCT01590901|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110074123|NCT01590901|Antioxidants|antioxidants|mesh-ancestor
110074124|NCT01590901|Protective Agents|protective agents|mesh-ancestor
110074125|NCT01590901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110074126|NCT01590966|Certolizumab Pegol|certolizumab pegol|mesh-list
110074127|NCT01590966|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110074128|NCT01590966|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110074129|NCT01590966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110074130|NCT01590966|Immunologic Factors|immunologic factors|mesh-ancestor
110094954|NCT01711827|Hormones|hormones|mesh-ancestor
110074131|NCT01590966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110074132|NCT01590966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110074133|NCT01591031|Sevoflurane|sevoflurane|mesh-list
110074135|NCT01591031|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110074136|NCT01591031|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110074137|NCT01591031|Anesthetics, General|anesthetics, general|mesh-ancestor
110074138|NCT01591031|Anesthetics|anesthetics|mesh-ancestor
110074139|NCT01591031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110074140|NCT01591031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110074141|NCT01591031|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110074142|NCT01591031|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110074143|NCT01591031|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110074144|NCT01591031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110074145|NCT01591070|Tacrolimus|tacrolimus|mesh-list
110074146|NCT01591070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110074147|NCT01591070|Immunologic Factors|immunologic factors|mesh-ancestor
110074148|NCT01591070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110074149|NCT01591070|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110074150|NCT01591070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110074151|NCT01591070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110074152|NCT01591083|Esomeprazole|esomeprazole|mesh-list
110074153|NCT01591083|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110074154|NCT01591083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110074155|NCT01591083|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110074156|NCT01591083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110074157|NCT01591083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110074158|NCT01591122|Prednisone|prednisone|mesh-list
110074159|NCT01591122|Abiraterone Acetate|abiraterone acetate|mesh-list
110074160|NCT01591122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110074161|NCT01591122|Glucocorticoids|glucocorticoids|mesh-ancestor
110074162|NCT01591122|Hormones|hormones|mesh-ancestor
110074163|NCT01591122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110074164|NCT01591122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110074165|NCT01591122|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110074166|NCT01591122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110074167|NCT01591122|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110074168|NCT01591122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110074169|NCT01591122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110074170|NCT01591122|Hormone Antagonists|hormone antagonists|mesh-ancestor
110074171|NCT01591122|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110074172|NCT01591135|Paclitaxel|paclitaxel|mesh-list
110074173|NCT01591135|Fluorouracil|fluorouracil|mesh-list
110074174|NCT01591135|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110074175|NCT01591135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110074176|NCT01591135|Tubulin Modulators|tubulin modulators|mesh-ancestor
110074177|NCT01591135|Antimitotic Agents|antimitotic agents|mesh-ancestor
110074178|NCT01591135|Mitosis Modulators|mitosis modulators|mesh-ancestor
110074179|NCT01591135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110074180|NCT01591135|Antimetabolites|antimetabolites|mesh-ancestor
110074181|NCT01591135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110074182|NCT01591135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110074183|NCT01591135|Immunologic Factors|immunologic factors|mesh-ancestor
110074184|NCT01591135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110074185|NCT01591148|Propofol|propofol|mesh-list
110074186|NCT01591148|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110074187|NCT01591148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110074188|NCT01591148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110074189|NCT01591148|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110074190|NCT01591148|Anesthetics, General|anesthetics, general|mesh-ancestor
110074191|NCT01591148|Anesthetics|anesthetics|mesh-ancestor
110074192|NCT01591226|Mannitol|mannitol|mesh-list
110074193|NCT01591226|Caffeine|caffeine|mesh-list
110074194|NCT01591226|Citric Acid|citric acid|mesh-list
110074195|NCT01591226|Sodium Citrate|sodium citrate|mesh-list
110074196|NCT01591226|Anticoagulants|anticoagulants|mesh-ancestor
110074197|NCT01591226|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110074198|NCT01591226|Chelating Agents|chelating agents|mesh-ancestor
110074199|NCT01591226|Sequestering Agents|sequestering agents|mesh-ancestor
110074200|NCT01591226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110074201|NCT01591226|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110074202|NCT01591226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110074203|NCT01591226|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110074204|NCT01591226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110074205|NCT01591226|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110074206|NCT01591226|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110074207|NCT01591226|Purinergic Agents|purinergic agents|mesh-ancestor
110074208|NCT01591226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110074209|NCT01591226|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110074210|NCT01591226|Diuretics|diuretics|mesh-ancestor
110074211|NCT01591226|Natriuretic Agents|natriuretic agents|mesh-ancestor
110074212|NCT01591434|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
110074213|NCT01591434|Laxatives|laxatives|mesh-ancestor
110074214|NCT01591434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110074215|NCT01591551|Natalizumab|natalizumab|mesh-list
110074216|NCT01591551|Immunologic Factors|immunologic factors|mesh-ancestor
110074217|NCT01591551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110074218|NCT01591668|Vesatolimod|vesatolimod|mesh-list
110074219|NCT01591668|Antiviral Agents|antiviral agents|mesh-ancestor
110074220|NCT01591668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110074221|NCT01591759|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
110074222|NCT01591759|Nootropic Agents|nootropic agents|mesh-ancestor
110074223|NCT01591850|Ritonavir|ritonavir|mesh-list
110074224|NCT01591850|Atazanavir Sulfate|atazanavir sulfate|mesh-list
110074225|NCT01591850|Rifampin|rifampin|mesh-list
110074226|NCT01591850|Ketoconazole|ketoconazole|mesh-list
110074227|NCT01591850|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110074228|NCT01591850|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110074229|NCT01591850|Protease Inhibitors|protease inhibitors|mesh-ancestor
110074230|NCT01591850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110074231|NCT01591850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110074232|NCT01591850|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110074233|NCT01591850|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110074234|NCT01591850|Antiviral Agents|antiviral agents|mesh-ancestor
110074235|NCT01591850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110074236|NCT01591850|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110074237|NCT01591850|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110074238|NCT01591850|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110074239|NCT01591850|Antitubercular Agents|antitubercular agents|mesh-ancestor
110074240|NCT01591850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110074241|NCT01591850|Leprostatic Agents|leprostatic agents|mesh-ancestor
110074242|NCT01591850|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110074243|NCT01591850|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110074244|NCT01591850|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110074245|NCT01591850|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110074246|NCT01591850|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110074247|NCT01591850|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110074248|NCT01591850|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110074250|NCT01591850|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110074251|NCT01591850|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110074252|NCT01591850|Hormone Antagonists|hormone antagonists|mesh-ancestor
110074253|NCT01591850|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110074254|NCT01591850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110074256|NCT01591889|Alkylating Agents|alkylating agents|mesh-ancestor
110074257|NCT01591889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110074258|NCT01591889|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110074259|NCT01591889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110074260|NCT01591889|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
110074261|NCT01591889|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110074262|NCT01591889|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110074264|NCT01591902|Growth Substances|growth substances|mesh-ancestor
110074265|NCT01591902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110074266|NCT01591980|Pregabalin|pregabalin|mesh-list
110074267|NCT01591980|Analgesics|analgesics|mesh-ancestor
110074268|NCT01591980|Sensory System Agents|sensory system agents|mesh-ancestor
110074269|NCT01591980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110074270|NCT01591980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110074271|NCT01591980|Anticonvulsants|anticonvulsants|mesh-ancestor
110074272|NCT01591980|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110074273|NCT01591980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110074274|NCT01591980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110074275|NCT01591980|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110074276|NCT01591980|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110074277|NCT01591980|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110074278|NCT01591980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110074279|NCT01591980|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110074280|NCT01592019|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
110074281|NCT01592019|Diclofenac|diclofenac|mesh-list
110074282|NCT01592019|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110074283|NCT01592019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110074284|NCT01592019|Analgesics|analgesics|mesh-ancestor
110074285|NCT01592019|Sensory System Agents|sensory system agents|mesh-ancestor
110074286|NCT01592019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110074287|NCT01592019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110074288|NCT01592019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110074289|NCT01592019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110074290|NCT01592019|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110074291|NCT01592019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110074292|NCT01592019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110074293|NCT01592032|Vancomycin|vancomycin|mesh-list
110074294|NCT01592032|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110074295|NCT01592032|Linezolid|linezolid|mesh-list
110074296|NCT01592032|Daptomycin|daptomycin|mesh-list
110074297|NCT01592032|Tigecycline|tigecycline|mesh-list
110074298|NCT01592032|Teicoplanin|teicoplanin|mesh-list
110074300|NCT01592032|Heparin|heparin|mesh-list
110074301|NCT01592032|Calcium heparin|calcium heparin|mesh-list
110074302|NCT01592032|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110074303|NCT01592032|Anticoagulants|anticoagulants|mesh-ancestor
110074304|NCT01592032|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110074305|NCT01592032|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110074306|NCT01592032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110074307|NCT01592032|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110074308|NCT01592032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110074309|NCT01592136|Ponatinib|ponatinib|mesh-list
110074310|NCT01592136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110074311|NCT01592136|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110074312|NCT01592136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110074313|NCT01592136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110074314|NCT01592162|Remifentanil|remifentanil|mesh-list
110074315|NCT01592162|Propofol|propofol|mesh-list
110074316|NCT01592162|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110390908|NCT04751370|Ipilimumab|ipilimumab|mesh-list
110074317|NCT01592162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110074318|NCT01592162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110074319|NCT01592162|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110074320|NCT01592162|Anesthetics, General|anesthetics, general|mesh-ancestor
110074322|NCT01592162|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110074323|NCT01592162|Narcotics|narcotics|mesh-ancestor
110074324|NCT01592162|Analgesics|analgesics|mesh-ancestor
110074325|NCT01592162|Sensory System Agents|sensory system agents|mesh-ancestor
110074326|NCT01592162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110074327|NCT01592201|Olanzapine|olanzapine|mesh-list
110074328|NCT01592201|Risperidone|risperidone|mesh-list
110074329|NCT01592201|Aripiprazole|aripiprazole|mesh-list
110074330|NCT01592201|Antipsychotic Agents|antipsychotic agents|mesh-list
110074331|NCT01592201|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110074332|NCT01592201|Serotonin Agents|serotonin agents|mesh-ancestor
110074333|NCT01592201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110074334|NCT01592201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110074335|NCT01592201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110074336|NCT01592201|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110074337|NCT01592201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110074338|NCT01592201|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110074339|NCT01592201|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110074340|NCT01592201|Dopamine Agents|dopamine agents|mesh-ancestor
110074341|NCT01592201|Antiemetics|antiemetics|mesh-ancestor
110074342|NCT01592201|Autonomic Agents|autonomic agents|mesh-ancestor
110074343|NCT01592201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110074344|NCT01592201|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110074345|NCT01592201|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110074346|NCT01592201|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110074347|NCT01592201|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110074348|NCT01592201|Antidepressive Agents|antidepressive agents|mesh-ancestor
110074349|NCT01592201|Dopamine Agonists|dopamine agonists|mesh-ancestor
110074350|NCT01592201|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110074351|NCT01592201|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110074352|NCT01592201|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110074353|NCT01592201|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110074354|NCT01592214|Benzocaine|benzocaine|mesh-list
110074355|NCT01592214|Anesthetics, Local|anesthetics, local|mesh-ancestor
110074356|NCT01592214|Anesthetics|anesthetics|mesh-ancestor
110074357|NCT01592214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110074358|NCT01592214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110074359|NCT01592214|Sensory System Agents|sensory system agents|mesh-ancestor
110074360|NCT01592214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110074361|NCT01592227|Acetaminophen|acetaminophen|mesh-list
110074362|NCT01592227|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110074363|NCT01592227|Analgesics|analgesics|mesh-ancestor
110074364|NCT01592227|Sensory System Agents|sensory system agents|mesh-ancestor
110074365|NCT01592227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110074366|NCT01592227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110074367|NCT01592227|Antipyretics|antipyretics|mesh-ancestor
110074368|NCT01592253|Sirolimus|sirolimus|mesh-list
110074369|NCT01592253|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110074370|NCT01592253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110074371|NCT01592253|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110074372|NCT01592253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110074374|NCT01592253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110074375|NCT01592253|Immunologic Factors|immunologic factors|mesh-ancestor
110074376|NCT01592253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110074377|NCT01592279|Liraglutide|liraglutide|mesh-list
110074378|NCT01592279|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110074379|NCT01592279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110074380|NCT01592279|Incretins|incretins|mesh-ancestor
110074381|NCT01592279|Hormones|hormones|mesh-ancestor
110074382|NCT01592279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110074383|NCT01592305|Ritonavir|ritonavir|mesh-list
110074384|NCT01592305|Atazanavir Sulfate|atazanavir sulfate|mesh-list
110074385|NCT01592305|Tenofovir|tenofovir|mesh-list
110074386|NCT01592305|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110074387|NCT01592305|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110074388|NCT01592305|Protease Inhibitors|protease inhibitors|mesh-ancestor
110074389|NCT01592305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110074390|NCT01592305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110074391|NCT01592305|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110074392|NCT01592305|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110074393|NCT01592305|Antiviral Agents|antiviral agents|mesh-ancestor
110074394|NCT01592305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110074395|NCT01592305|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110074396|NCT01592305|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110074397|NCT01592305|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110074398|NCT01592305|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110074399|NCT01592318|Ritonavir|ritonavir|mesh-list
110074400|NCT01592318|Lactams|lactams|mesh-list
110074401|NCT01592318|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110074402|NCT01592318|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110074403|NCT01592318|Protease Inhibitors|protease inhibitors|mesh-ancestor
110074404|NCT01592318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110074405|NCT01592318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110074406|NCT01592318|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110074407|NCT01592318|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110074408|NCT01592318|Antiviral Agents|antiviral agents|mesh-ancestor
110074409|NCT01592318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110074410|NCT01592318|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110074411|NCT01592318|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110074412|NCT01592318|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110074413|NCT01592526|Nicotine|nicotine|mesh-list
110074414|NCT01592526|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110074415|NCT01592526|Autonomic Agents|autonomic agents|mesh-ancestor
110074416|NCT01592526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110074417|NCT01592526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110074418|NCT01592526|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110074419|NCT01592526|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110074420|NCT01592526|Cholinergic Agents|cholinergic agents|mesh-ancestor
110074421|NCT01592526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110074422|NCT01592526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110074423|NCT01592630|Ropivacaine|ropivacaine|mesh-list
110074424|NCT01592630|Anesthetics, Local|anesthetics, local|mesh-ancestor
110074425|NCT01592630|Anesthetics|anesthetics|mesh-ancestor
110074426|NCT01592630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110074427|NCT01592630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110074428|NCT01592630|Sensory System Agents|sensory system agents|mesh-ancestor
110074429|NCT01592630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110074430|NCT01592981|Cyclophosphamide|cyclophosphamide|mesh-list
110074432|NCT01592981|Fludarabine|fludarabine|mesh-list
110074433|NCT01592981|Bortezomib|bortezomib|mesh-list
110074434|NCT01592981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110074435|NCT01592981|Immunologic Factors|immunologic factors|mesh-ancestor
110074436|NCT01592981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110074437|NCT01592981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110074438|NCT01592981|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110074439|NCT01592981|Alkylating Agents|alkylating agents|mesh-ancestor
110074440|NCT01592981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110074441|NCT01592981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110074442|NCT01592981|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110074443|NCT01592981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110074445|NCT01593033|Trace Elements|trace elements|mesh-list
110074446|NCT01593033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110074447|NCT01593046|Cabotegravir|cabotegravir|mesh-list
110074449|NCT01593046|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110074450|NCT01593046|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110074451|NCT01593046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110390923|NCT04699630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110074452|NCT01593046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110074453|NCT01593046|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110074454|NCT01593046|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110074455|NCT01593046|Antiviral Agents|antiviral agents|mesh-ancestor
110074456|NCT01593046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110074457|NCT01593046|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110074458|NCT01593046|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110074459|NCT01593124|Imiquimod|imiquimod|mesh-list
110074460|NCT01593124|Nonoxynol|nonoxynol|mesh-list
110074461|NCT01593124|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110074462|NCT01593124|Immunologic Factors|immunologic factors|mesh-ancestor
110074463|NCT01593124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110074464|NCT01593124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110074465|NCT01593124|Interferon Inducers|interferon inducers|mesh-ancestor
110074466|NCT01593124|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
110074467|NCT01593124|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
110074468|NCT01593124|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110074469|NCT01593124|Contraceptive Agents|contraceptive agents|mesh-ancestor
110074470|NCT01593124|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110074471|NCT01593124|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110074472|NCT01593137|Metformin|metformin|mesh-list
110074473|NCT01593137|Liraglutide|liraglutide|mesh-list
110074474|NCT01593137|Glimepiride|glimepiride|mesh-list
110074475|NCT01593137|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110074476|NCT01593137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110074477|NCT01593137|Incretins|incretins|mesh-ancestor
110074478|NCT01593137|Hormones|hormones|mesh-ancestor
110074479|NCT01593137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110074480|NCT01593137|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110074481|NCT01593137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110074482|NCT01593137|Immunologic Factors|immunologic factors|mesh-ancestor
110074483|NCT01593150|Dabigatran|dabigatran|mesh-list
110074484|NCT01593150|Antithrombins|antithrombins|mesh-ancestor
110074485|NCT01593150|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110074486|NCT01593150|Protease Inhibitors|protease inhibitors|mesh-ancestor
110074487|NCT01593150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110074488|NCT01593150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110074489|NCT01593150|Anticoagulants|anticoagulants|mesh-ancestor
110074490|NCT01593163|Ibuprofen|ibuprofen|mesh-list
110074491|NCT01593163|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110074492|NCT01593163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110074493|NCT01593163|Analgesics|analgesics|mesh-ancestor
110074494|NCT01593163|Sensory System Agents|sensory system agents|mesh-ancestor
110074495|NCT01593163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110074496|NCT01593163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110074497|NCT01593163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110074498|NCT01593163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110074499|NCT01593163|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110074500|NCT01593163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110074501|NCT01593163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110074502|NCT01593280|Morphine|morphine|mesh-list
110074503|NCT01593280|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110074504|NCT01593280|Narcotics|narcotics|mesh-ancestor
110074505|NCT01593280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110074506|NCT01593280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110074507|NCT01593280|Analgesics|analgesics|mesh-ancestor
110074509|NCT01593280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110074510|NCT01593293|Pemetrexed|pemetrexed|mesh-list
110074511|NCT01593293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110074512|NCT01593293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110074513|NCT01593293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110074514|NCT01593293|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110390935|NCT04691986|Vasodilator Agents|vasodilator agents|mesh-ancestor
110074515|NCT01593293|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110074517|NCT01593306|Cisplatin|cisplatin|mesh-list
110074518|NCT01593306|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110074519|NCT01593306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110074520|NCT01593306|Tubulin Modulators|tubulin modulators|mesh-ancestor
110074521|NCT01593306|Antimitotic Agents|antimitotic agents|mesh-ancestor
110074522|NCT01593306|Mitosis Modulators|mitosis modulators|mesh-ancestor
110074523|NCT01593306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110074524|NCT01593319|Ropivacaine|ropivacaine|mesh-list
110074525|NCT01593319|Anesthetics, Local|anesthetics, local|mesh-ancestor
110074526|NCT01593319|Anesthetics|anesthetics|mesh-ancestor
110074527|NCT01593319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110074528|NCT01593319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110074529|NCT01593319|Sensory System Agents|sensory system agents|mesh-ancestor
110074530|NCT01593319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110074532|NCT01593332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110074533|NCT01593332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110074534|NCT01593332|Immunologic Factors|immunologic factors|mesh-ancestor
110074535|NCT01593332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110074536|NCT01593332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110074537|NCT01593371|Metformin|metformin|mesh-list
110074538|NCT01593371|Pioglitazone|pioglitazone|mesh-list
110074539|NCT01593371|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110074540|NCT01593371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110074541|NCT01593397|Fentanyl|fentanyl|mesh-list
110074542|NCT01593397|Propofol|propofol|mesh-list
110074543|NCT01593397|Anesthetics|anesthetics|mesh-list
110074544|NCT01593397|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110074545|NCT01593397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110074546|NCT01593397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110074547|NCT01593397|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110074548|NCT01593397|Anesthetics, General|anesthetics, general|mesh-ancestor
110074549|NCT01593397|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110074550|NCT01593397|Narcotics|narcotics|mesh-ancestor
110074551|NCT01593397|Analgesics|analgesics|mesh-ancestor
110074552|NCT01593397|Sensory System Agents|sensory system agents|mesh-ancestor
110074553|NCT01593397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110074554|NCT01593397|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110074555|NCT01593410|Dexamethasone|dexamethasone|mesh-list
110074556|NCT01593410|Lenalidomide|lenalidomide|mesh-list
110074557|NCT01593410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110074558|NCT01593410|Antiemetics|antiemetics|mesh-ancestor
110074559|NCT01593410|Autonomic Agents|autonomic agents|mesh-ancestor
110074560|NCT01593410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110074561|NCT01593410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110074562|NCT01593410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110074563|NCT01593410|Glucocorticoids|glucocorticoids|mesh-ancestor
110074564|NCT01593410|Hormones|hormones|mesh-ancestor
110074565|NCT01593410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110074566|NCT01593410|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110074567|NCT01593410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110074568|NCT01593410|Immunologic Factors|immunologic factors|mesh-ancestor
110074569|NCT01593410|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110074570|NCT01593410|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110074571|NCT01593410|Growth Substances|growth substances|mesh-ancestor
110074572|NCT01593410|Growth Inhibitors|growth inhibitors|mesh-ancestor
110074573|NCT01593501|Vitamin D|vitamin d|mesh-list
110074574|NCT01593501|Cholecalciferol|cholecalciferol|mesh-list
110074576|NCT01593501|Micronutrients|micronutrients|mesh-ancestor
110074577|NCT01593501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110074578|NCT01593501|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110074579|NCT01593501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110074580|NCT01593514|Lactitol|lactitol|mesh-list
110074581|NCT01593514|Vaccines|vaccines|mesh-list
110074582|NCT01593514|Immunologic Factors|immunologic factors|mesh-ancestor
110074583|NCT01593514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110074584|NCT01593514|Cathartics|cathartics|mesh-ancestor
110074585|NCT01593514|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110074586|NCT01593566|Bupivacaine|bupivacaine|mesh-list
110074587|NCT01593566|Anesthetics, Local|anesthetics, local|mesh-ancestor
110074588|NCT01593566|Anesthetics|anesthetics|mesh-ancestor
110074589|NCT01593566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110074590|NCT01593566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110074591|NCT01593566|Sensory System Agents|sensory system agents|mesh-ancestor
110074592|NCT01593566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110074593|NCT01593605|Resveratrol|resveratrol|mesh-list
110074594|NCT01593605|Antioxidants|antioxidants|mesh-ancestor
110074595|NCT01593605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110074596|NCT01593605|Protective Agents|protective agents|mesh-ancestor
110074597|NCT01593605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110074598|NCT01593605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110074599|NCT01593605|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110074600|NCT01593644|Adenosine|adenosine|mesh-list
110074601|NCT01593644|Dipyridamole|dipyridamole|mesh-list
110074602|NCT01593644|Analgesics|analgesics|mesh-ancestor
110074603|NCT01593644|Sensory System Agents|sensory system agents|mesh-ancestor
110074604|NCT01593644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110074605|NCT01593644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110074606|NCT01593644|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110074607|NCT01593644|Vasodilator Agents|vasodilator agents|mesh-ancestor
110074608|NCT01593644|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
110074609|NCT01593644|Purinergic Agonists|purinergic agonists|mesh-ancestor
110074610|NCT01593644|Purinergic Agents|purinergic agents|mesh-ancestor
110074611|NCT01593644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110074612|NCT01593644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110074613|NCT01593644|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110074614|NCT01593644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110074615|NCT01593644|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110074616|NCT01593774|Melatonin|melatonin|mesh-list
110074617|NCT01593774|Antioxidants|antioxidants|mesh-ancestor
110074618|NCT01593774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110074619|NCT01593774|Protective Agents|protective agents|mesh-ancestor
110074620|NCT01593774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110074621|NCT01593774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110074622|NCT01593826|Budesonide|budesonide|mesh-list
110074623|NCT01593826|Formoterol Fumarate|formoterol fumarate|mesh-list
110074624|NCT01593826|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
110074625|NCT01593826|Charcoal|charcoal|mesh-list
110074626|NCT01593826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110074627|NCT01593826|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110074628|NCT01593826|Autonomic Agents|autonomic agents|mesh-ancestor
110074629|NCT01593826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110074630|NCT01593826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110074631|NCT01593826|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110074632|NCT01593826|Respiratory System Agents|respiratory system agents|mesh-ancestor
110074633|NCT01593826|Glucocorticoids|glucocorticoids|mesh-ancestor
110074634|NCT01593826|Hormones|hormones|mesh-ancestor
110074635|NCT01593826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110074636|NCT01593826|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110074637|NCT01593826|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110074638|NCT01593826|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110074639|NCT01593826|Adrenergic Agents|adrenergic agents|mesh-ancestor
110074640|NCT01593826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110074641|NCT01593826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110074642|NCT01593826|Antidotes|antidotes|mesh-ancestor
110074643|NCT01593826|Protective Agents|protective agents|mesh-ancestor
110074644|NCT01593930|Lidocaine|lidocaine|mesh-list
110074645|NCT01593930|Carticaine|carticaine|mesh-list
110074646|NCT01593930|Anesthetics, Local|anesthetics, local|mesh-ancestor
110074647|NCT01593930|Anesthetics|anesthetics|mesh-ancestor
110074648|NCT01593930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110074649|NCT01593930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110074650|NCT01593930|Sensory System Agents|sensory system agents|mesh-ancestor
110183153|NCT00395655|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110074651|NCT01593930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110074652|NCT01593930|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110074653|NCT01593930|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110074654|NCT01593930|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110074655|NCT01593930|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110074656|NCT01593930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110074658|NCT01593995|Mitosis Modulators|mitosis modulators|mesh-ancestor
110074659|NCT01593995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110074660|NCT01594047|Ketamine|ketamine|mesh-list
110074661|NCT01594047|Methadone|methadone|mesh-list
110074662|NCT01594047|Analgesics|analgesics|mesh-ancestor
110074663|NCT01594047|Sensory System Agents|sensory system agents|mesh-ancestor
110074664|NCT01594047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110074665|NCT01594047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110074666|NCT01594047|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110074667|NCT01594047|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110074668|NCT01594047|Anesthetics, General|anesthetics, general|mesh-ancestor
110074669|NCT01594047|Anesthetics|anesthetics|mesh-ancestor
110074670|NCT01594047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110074671|NCT01594047|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110074672|NCT01594047|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110074673|NCT01594047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110074674|NCT01594047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110074675|NCT01594047|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110074676|NCT01594047|Narcotics|narcotics|mesh-ancestor
110074677|NCT01594047|Antitussive Agents|antitussive agents|mesh-ancestor
110074678|NCT01594047|Respiratory System Agents|respiratory system agents|mesh-ancestor
110074679|NCT01594060|Insulin|insulin|mesh-list
110074680|NCT01594060|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110074681|NCT01594060|Insulin Glargine|insulin glargine|mesh-list
110074682|NCT01594060|Insulin glulisine|insulin glulisine|mesh-list
110074683|NCT01594060|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110074684|NCT01594060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110074685|NCT01594099|Paclitaxel|paclitaxel|mesh-list
110074686|NCT01594099|Cisplatin|cisplatin|mesh-list
110074687|NCT01594099|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110074688|NCT01594099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110074689|NCT01594099|Tubulin Modulators|tubulin modulators|mesh-ancestor
110074690|NCT01594099|Antimitotic Agents|antimitotic agents|mesh-ancestor
110074691|NCT01594099|Mitosis Modulators|mitosis modulators|mesh-ancestor
110074692|NCT01594099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110074693|NCT01594177|Paclitaxel|paclitaxel|mesh-list
110074694|NCT01594177|Cyclophosphamide|cyclophosphamide|mesh-list
110074695|NCT01594177|Trastuzumab|trastuzumab|mesh-list
110074696|NCT01594177|Epirubicin|epirubicin|mesh-list
110074697|NCT01594177|Afatinib|afatinib|mesh-list
110074698|NCT01594177|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110074699|NCT01594177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110074700|NCT01594177|Tubulin Modulators|tubulin modulators|mesh-ancestor
110074701|NCT01594177|Antimitotic Agents|antimitotic agents|mesh-ancestor
110074702|NCT01594177|Mitosis Modulators|mitosis modulators|mesh-ancestor
110074703|NCT01594177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110074704|NCT01594177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110074705|NCT01594177|Immunologic Factors|immunologic factors|mesh-ancestor
110074706|NCT01594177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110074707|NCT01594177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110074708|NCT01594177|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110074709|NCT01594177|Alkylating Agents|alkylating agents|mesh-ancestor
110074710|NCT01594177|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110074711|NCT01594177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110074712|NCT01594177|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110074713|NCT01594177|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110074714|NCT01594177|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110074715|NCT01594177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110074716|NCT01594177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110074717|NCT01594229|Rituximab|rituximab|mesh-list
110183161|NCT00392561|Antioxidants|antioxidants|mesh-ancestor
110074718|NCT01594229|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110074719|NCT01594229|Venetoclax|venetoclax|mesh-list
110074720|NCT01594229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110074721|NCT01594229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110074722|NCT01594229|Immunologic Factors|immunologic factors|mesh-ancestor
110074723|NCT01594229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110074724|NCT01594229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110074725|NCT01594229|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110074726|NCT01594229|Alkylating Agents|alkylating agents|mesh-ancestor
110074727|NCT01594229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110074728|NCT01594242|Bortezomib|bortezomib|mesh-list
110074729|NCT01594242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110074730|NCT01594255|Moxifloxacin|moxifloxacin|mesh-list
110074731|NCT01594255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110074732|NCT01594255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110074733|NCT01594255|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110074734|NCT01594255|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110074735|NCT01594255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110074736|NCT01594255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110074737|NCT01594255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110074738|NCT01594268|Everolimus|everolimus|mesh-list
110074739|NCT01594268|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110074740|NCT01594268|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110074741|NCT01594268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110074742|NCT01594268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110074743|NCT01594268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110074744|NCT01594268|Immunologic Factors|immunologic factors|mesh-ancestor
110074745|NCT01594268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110074746|NCT01594268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110074747|NCT01594346|Vitamin E|vitamin e|mesh-list
110074748|NCT01594346|Tocopherols|tocopherols|mesh-list
110074749|NCT01594346|Tocotrienols|tocotrienols|mesh-list
110074750|NCT01594346|alpha-Tocopherol|alpha-tocopherol|mesh-list
110074751|NCT01594346|Vitamins|vitamins|mesh-ancestor
110074753|NCT01594346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110074754|NCT01594346|Antioxidants|antioxidants|mesh-ancestor
110074755|NCT01594346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110074756|NCT01594346|Protective Agents|protective agents|mesh-ancestor
110074757|NCT01594489|Aminophylline|aminophylline|mesh-list
110074758|NCT01594489|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110074759|NCT01594489|Autonomic Agents|autonomic agents|mesh-ancestor
110074760|NCT01594489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110074761|NCT01594489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110074762|NCT01594489|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110074763|NCT01594489|Respiratory System Agents|respiratory system agents|mesh-ancestor
110074764|NCT01594489|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110074765|NCT01594489|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110074766|NCT01594489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110074768|NCT01594489|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110074769|NCT01594489|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110074770|NCT01594489|Purinergic Agents|purinergic agents|mesh-ancestor
110074771|NCT01594489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110074772|NCT01594489|Protective Agents|protective agents|mesh-ancestor
110074773|NCT01594502|Dutasteride|dutasteride|mesh-list
110074774|NCT01594502|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
110074775|NCT01594502|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110074776|NCT01594502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110074777|NCT01594502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110074778|NCT01594502|Hormone Antagonists|hormone antagonists|mesh-ancestor
110074779|NCT01594502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110074780|NCT01594502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110074782|NCT01594619|Naloxegol|naloxegol|mesh-list
110074783|NCT01594619|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110074784|NCT01594619|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110074785|NCT01594619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110074786|NCT01594619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110074787|NCT01594619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110074788|NCT01594619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110074789|NCT01594619|Vasodilator Agents|vasodilator agents|mesh-ancestor
110074790|NCT01594619|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110074791|NCT01594619|Sensory System Agents|sensory system agents|mesh-ancestor
110074792|NCT01594619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110074793|NCT01594671|Tranexamic Acid|tranexamic acid|mesh-list
110074794|NCT01594671|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110074795|NCT01594671|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110074796|NCT01594671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110074797|NCT01594671|Hemostatics|hemostatics|mesh-ancestor
110074798|NCT01594671|Coagulants|coagulants|mesh-ancestor
110074799|NCT01594697|Metformin|metformin|mesh-list
110074800|NCT01594697|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110074801|NCT01594697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110074802|NCT01594775|Oxytocin|oxytocin|mesh-list
110074803|NCT01594775|Oxytocics|oxytocics|mesh-ancestor
110074804|NCT01594775|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110074805|NCT01594775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110074806|NCT01594866|Dexetimide|dexetimide|mesh-list
110074807|NCT01594866|Citalopram|citalopram|mesh-list
110074808|NCT01594866|Escitalopram|escitalopram|mesh-list
110074809|NCT01594866|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110074810|NCT01594866|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110074811|NCT01594866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110074812|NCT01594866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110074813|NCT01594866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110074814|NCT01594866|Serotonin Agents|serotonin agents|mesh-ancestor
110074815|NCT01594866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110074816|NCT01594866|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110074817|NCT01594866|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110074818|NCT01594866|Parasympatholytics|parasympatholytics|mesh-ancestor
110074819|NCT01594866|Autonomic Agents|autonomic agents|mesh-ancestor
110074820|NCT01594866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110074821|NCT01594866|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110074822|NCT01594866|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110074823|NCT01594866|Cholinergic Agents|cholinergic agents|mesh-ancestor
110074824|NCT01594866|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110074826|NCT01594866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110074827|NCT01594879|Levonorgestrel|levonorgestrel|mesh-list
110074828|NCT01594879|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110074829|NCT01594879|Contraceptive Agents|contraceptive agents|mesh-ancestor
110074830|NCT01594879|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110074831|NCT01594879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110074832|NCT01594879|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110074833|NCT01594879|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110074834|NCT01594879|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110074835|NCT01594905|Tenofovir|tenofovir|mesh-list
110074836|NCT01594905|Entecavir|entecavir|mesh-list
110074837|NCT01594905|Antiviral Agents|antiviral agents|mesh-ancestor
110074838|NCT01594905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110074839|NCT01594905|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110074840|NCT01594905|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110074841|NCT01594905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110183190|NCT00028314|Abacavir|abacavir|mesh-list
110074842|NCT01594905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110074843|NCT01594905|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110074844|NCT01594905|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110074846|NCT01594918|Mitoxantrone|mitoxantrone|mesh-list
110074847|NCT01594918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110074848|NCT01594918|Glucocorticoids|glucocorticoids|mesh-ancestor
110074849|NCT01594918|Hormones|hormones|mesh-ancestor
110074850|NCT01594918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110074851|NCT01594918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110074852|NCT01594918|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110074853|NCT01594918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110074854|NCT01594918|Analgesics|analgesics|mesh-ancestor
110074855|NCT01594918|Sensory System Agents|sensory system agents|mesh-ancestor
110074856|NCT01594918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110074857|NCT01594918|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110074858|NCT01594918|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110074859|NCT01594918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110074860|NCT01594918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110074861|NCT01595009|Everolimus|everolimus|mesh-list
110074862|NCT01595009|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110074863|NCT01595009|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110074864|NCT01595009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110074865|NCT01595009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110074866|NCT01595009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110074867|NCT01595009|Immunologic Factors|immunologic factors|mesh-ancestor
110074868|NCT01595009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110074869|NCT01595009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110074870|NCT01595022|Contraceptive Agents|contraceptive agents|mesh-list
110074871|NCT01595022|Levonorgestrel|levonorgestrel|mesh-list
110074872|NCT01595022|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110074873|NCT01595022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110391014|NCT04535362|Autonomic Agents|autonomic agents|mesh-ancestor
110074874|NCT01595022|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110074875|NCT01595022|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110074876|NCT01595022|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110074878|NCT01595152|Solifenacin Succinate|solifenacin succinate|mesh-list
110074879|NCT01595152|Fesoterodine|fesoterodine|mesh-list
110074880|NCT01595152|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110074881|NCT01595152|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110074882|NCT01595152|Cholinergic Agents|cholinergic agents|mesh-ancestor
110074883|NCT01595152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110074884|NCT01595152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110074885|NCT01595152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110074886|NCT01595152|Urological Agents|urological agents|mesh-ancestor
110074887|NCT01595334|Cetrorelix|cetrorelix|mesh-list
110074888|NCT01595334|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110074889|NCT01595334|Fertility Agents|fertility agents|mesh-ancestor
110074890|NCT01595334|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110074891|NCT01595334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110074892|NCT01595334|Hormone Antagonists|hormone antagonists|mesh-ancestor
110074893|NCT01595334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110074894|NCT01595399|Atropine|atropine|mesh-list
110074895|NCT01595399|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110074896|NCT01595399|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110074897|NCT01595399|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110074898|NCT01595399|Autonomic Agents|autonomic agents|mesh-ancestor
110074899|NCT01595399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110074900|NCT01595399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110074901|NCT01595399|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110074902|NCT01595399|Respiratory System Agents|respiratory system agents|mesh-ancestor
110074903|NCT01595399|Mydriatics|mydriatics|mesh-ancestor
110074904|NCT01595399|Parasympatholytics|parasympatholytics|mesh-ancestor
110074905|NCT01595399|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110074906|NCT01595399|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110074907|NCT01595399|Cholinergic Agents|cholinergic agents|mesh-ancestor
110074908|NCT01595399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110074909|NCT01595399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110074910|NCT01595425|Esomeprazole|esomeprazole|mesh-list
110074911|NCT01595425|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110074912|NCT01595425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110074913|NCT01595425|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110074914|NCT01595425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110074915|NCT01595425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110074917|NCT01595594|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110074918|NCT01595594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110074919|NCT01595594|Antimalarials|antimalarials|mesh-ancestor
110074920|NCT01595594|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110074921|NCT01595594|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110074922|NCT01595633|Tenofovir|tenofovir|mesh-list
110074923|NCT01595633|Adefovir|adefovir|mesh-list
110074924|NCT01595633|Antiviral Agents|antiviral agents|mesh-ancestor
110074925|NCT01595633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110074926|NCT01595633|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110074927|NCT01595633|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110074928|NCT01595633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110391040|NCT04467723|Analgesics|analgesics|mesh-ancestor
110074929|NCT01595633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110074930|NCT01595633|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110074931|NCT01595633|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110074933|NCT01595685|Telbivudine|telbivudine|mesh-list
110074934|NCT01595685|Antiviral Agents|antiviral agents|mesh-ancestor
110074935|NCT01595685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110074936|NCT01595685|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110074937|NCT01595685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110074938|NCT01595685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110074939|NCT01595724|Dienogest|dienogest|mesh-list
110074940|NCT01595724|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110074941|NCT01595724|Contraceptive Agents|contraceptive agents|mesh-ancestor
110074942|NCT01595724|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110074943|NCT01595724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110074944|NCT01595724|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110074945|NCT01595724|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110074946|NCT01595724|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110074947|NCT01595724|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110074948|NCT01595724|Hormone Antagonists|hormone antagonists|mesh-ancestor
110225462|NCT05959356|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110074949|NCT01595724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110074950|NCT01595724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110074951|NCT01595724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110074954|NCT01595737|Vasodilator Agents|vasodilator agents|mesh-ancestor
110074955|NCT01595737|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110074956|NCT01595737|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110074957|NCT01595737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110074958|NCT01595737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110074959|NCT01595737|Protective Agents|protective agents|mesh-ancestor
110074960|NCT01595737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110074961|NCT01595763|Fibrin fragment D|fibrin fragment d|mesh-list
110074962|NCT01595763|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110074963|NCT01595763|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110074964|NCT01595763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110074966|NCT01595763|Coagulants|coagulants|mesh-ancestor
110074967|NCT01595789|Liraglutide|liraglutide|mesh-list
110074968|NCT01595789|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110074969|NCT01595789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110074970|NCT01595789|Incretins|incretins|mesh-ancestor
110074971|NCT01595789|Hormones|hormones|mesh-ancestor
110074972|NCT01595789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110074973|NCT01595815|Calcium|calcium|mesh-list
110074974|NCT01595815|Ionophores|ionophores|mesh-list
110074975|NCT01595815|Calcium Ionophores|calcium ionophores|mesh-list
110074976|NCT01595815|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110074977|NCT01595815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110074978|NCT01595815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110074979|NCT01595815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110074980|NCT01595828|Pitavastatin|pitavastatin|mesh-list
110074981|NCT01595828|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110074982|NCT01595828|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110074983|NCT01595828|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110074984|NCT01595828|Antimetabolites|antimetabolites|mesh-ancestor
110074985|NCT01595828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110074986|NCT01595828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110074987|NCT01595828|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110074988|NCT01595867|Naltrexone|naltrexone|mesh-list
110074989|NCT01595867|Morphine|morphine|mesh-list
110074990|NCT01595867|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110074991|NCT01595867|Narcotics|narcotics|mesh-ancestor
110074992|NCT01595867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110074993|NCT01595867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110074994|NCT01595867|Analgesics|analgesics|mesh-ancestor
110074995|NCT01595867|Sensory System Agents|sensory system agents|mesh-ancestor
110074996|NCT01595867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110074997|NCT01595867|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110074998|NCT01595867|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110074999|NCT01595880|Metformin|metformin|mesh-list
110075000|NCT01595880|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110075001|NCT01595880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110075002|NCT01595893|Vitamin D|vitamin d|mesh-list
110075003|NCT01595893|Cholecalciferol|cholecalciferol|mesh-list
110075004|NCT01595893|Vitamins|vitamins|mesh-ancestor
110075005|NCT01595893|Micronutrients|micronutrients|mesh-ancestor
110075006|NCT01595893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110075007|NCT01595893|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110075008|NCT01595893|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110075010|NCT01595958|Cyclosporins|cyclosporins|mesh-list
110075011|NCT01595958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110075012|NCT01595958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110075013|NCT01595958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110075014|NCT01595958|Immunologic Factors|immunologic factors|mesh-ancestor
110075015|NCT01595958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110075016|NCT01595958|Antifungal Agents|antifungal agents|mesh-ancestor
110075017|NCT01595958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110075018|NCT01595958|Dermatologic Agents|dermatologic agents|mesh-ancestor
110075019|NCT01595958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110075020|NCT01595958|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110075021|NCT01595984|Cyclosporine|cyclosporine|mesh-list
110075022|NCT01595984|Mycophenolic Acid|mycophenolic acid|mesh-list
110075023|NCT01595984|Everolimus|everolimus|mesh-list
110075024|NCT01595984|Cyclosporins|cyclosporins|mesh-list
110075025|NCT01595984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110075026|NCT01595984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110075027|NCT01595984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110075028|NCT01595984|Immunologic Factors|immunologic factors|mesh-ancestor
110075029|NCT01595984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110075030|NCT01595984|Antifungal Agents|antifungal agents|mesh-ancestor
110075031|NCT01595984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110075032|NCT01595984|Dermatologic Agents|dermatologic agents|mesh-ancestor
110075033|NCT01595984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110075034|NCT01595984|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110075035|NCT01595984|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110075036|NCT01595984|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110075037|NCT01595984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110075038|NCT01595984|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110075039|NCT01595984|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110075040|NCT01595984|Antitubercular Agents|antitubercular agents|mesh-ancestor
110075041|NCT01595984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110075042|NCT01596010|Norethindrone|norethindrone|mesh-list
110075043|NCT01596010|Norethindrone Acetate|norethindrone acetate|mesh-list
110075045|NCT01596010|Estrogens|estrogens|mesh-ancestor
110075046|NCT01596010|Hormones|hormones|mesh-ancestor
110075047|NCT01596010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110075048|NCT01596010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110075049|NCT01596010|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110075050|NCT01596010|Contraceptive Agents|contraceptive agents|mesh-ancestor
110075051|NCT01596010|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110075052|NCT01596010|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110075053|NCT01596010|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110075054|NCT01596010|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110075055|NCT01596010|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110075056|NCT01596075|Cannabidiol|cannabidiol|mesh-list
110075057|NCT01596075|Anticonvulsants|anticonvulsants|mesh-ancestor
110075058|NCT01596114|Tin Fluorides|tin fluorides|mesh-list
110075059|NCT01596114|Cariostatic Agents|cariostatic agents|mesh-ancestor
110075060|NCT01596114|Protective Agents|protective agents|mesh-ancestor
110075061|NCT01596114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110075062|NCT01596140|Sirolimus|sirolimus|mesh-list
110075063|NCT01596140|Everolimus|everolimus|mesh-list
110075064|NCT01596140|Temsirolimus|temsirolimus|mesh-list
110075065|NCT01596140|MTOR Inhibitors|mtor inhibitors|mesh-list
110075066|NCT01596140|Vemurafenib|vemurafenib|mesh-list
110075067|NCT01596140|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110075068|NCT01596140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110075069|NCT01596140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110075070|NCT01596140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110075071|NCT01596140|Immunologic Factors|immunologic factors|mesh-ancestor
110075072|NCT01596140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110075073|NCT01596140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110075074|NCT01596140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110075075|NCT01596140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110075076|NCT01596140|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110075077|NCT01596140|Antifungal Agents|antifungal agents|mesh-ancestor
110075078|NCT01596166|Ketorolac|ketorolac|mesh-list
110075079|NCT01596166|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
110075080|NCT01596166|Metoclopramide|metoclopramide|mesh-list
110075081|NCT01596166|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110075083|NCT01596166|Analgesics|analgesics|mesh-ancestor
110075084|NCT01596166|Sensory System Agents|sensory system agents|mesh-ancestor
110075085|NCT01596166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110075086|NCT01596166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110075087|NCT01596166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110075088|NCT01596166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110075089|NCT01596166|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110075090|NCT01596166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110075091|NCT01596166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110075092|NCT01596166|Antiemetics|antiemetics|mesh-ancestor
110075093|NCT01596166|Autonomic Agents|autonomic agents|mesh-ancestor
110075094|NCT01596166|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110075095|NCT01596166|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110075096|NCT01596166|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110075097|NCT01596166|Dopamine Agents|dopamine agents|mesh-ancestor
110075098|NCT01596166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110075099|NCT01596218|Brentuximab Vedotin|brentuximab vedotin|mesh-list
110075100|NCT01596218|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110075101|NCT01596218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110075102|NCT01596218|Immunotoxins|immunotoxins|mesh-ancestor
110075103|NCT01596218|Immunoconjugates|immunoconjugates|mesh-ancestor
110075104|NCT01596218|Immunologic Factors|immunologic factors|mesh-ancestor
110075105|NCT01596218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110075106|NCT01596296|Dinoprostone|dinoprostone|mesh-list
110075107|NCT01596296|Oxytocics|oxytocics|mesh-ancestor
110075108|NCT01596296|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110075109|NCT01596296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110075110|NCT01596387|Propofol|propofol|mesh-list
110075111|NCT01596387|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110075112|NCT01596387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110075113|NCT01596387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110075114|NCT01596387|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110075115|NCT01596387|Anesthetics, General|anesthetics, general|mesh-ancestor
110075116|NCT01596387|Anesthetics|anesthetics|mesh-ancestor
110075117|NCT01596400|Granisetron|granisetron|mesh-list
110075118|NCT01596400|Antiemetics|antiemetics|mesh-ancestor
110075119|NCT01596400|Autonomic Agents|autonomic agents|mesh-ancestor
110075120|NCT01596400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110075121|NCT01596400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110075122|NCT01596400|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110075123|NCT01596400|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110075124|NCT01596400|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110075125|NCT01596400|Serotonin Agents|serotonin agents|mesh-ancestor
110075126|NCT01596400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110075127|NCT01596400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110075128|NCT01596413|Granisetron|granisetron|mesh-list
110075129|NCT01596413|Antiemetics|antiemetics|mesh-ancestor
110075130|NCT01596413|Autonomic Agents|autonomic agents|mesh-ancestor
110075131|NCT01596413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110075132|NCT01596413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110075133|NCT01596413|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110075134|NCT01596413|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110075135|NCT01596413|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110075136|NCT01596413|Serotonin Agents|serotonin agents|mesh-ancestor
110075137|NCT01596413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110075138|NCT01596413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110075139|NCT01596426|Granisetron|granisetron|mesh-list
110075140|NCT01596426|Antiemetics|antiemetics|mesh-ancestor
110075141|NCT01596426|Autonomic Agents|autonomic agents|mesh-ancestor
110075142|NCT01596426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110075143|NCT01596426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110075144|NCT01596426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110075145|NCT01596426|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110075146|NCT01596426|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110075147|NCT01596426|Serotonin Agents|serotonin agents|mesh-ancestor
110075148|NCT01596426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110075149|NCT01596426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110075150|NCT01596517|Ribavirin|ribavirin|mesh-list
110075151|NCT01596517|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110075152|NCT01596517|Interferon-alpha|interferon-alpha|mesh-list
110075153|NCT01596517|Antimetabolites|antimetabolites|mesh-ancestor
110075154|NCT01596517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110075155|NCT01596517|Antiviral Agents|antiviral agents|mesh-ancestor
110075156|NCT01596517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110075157|NCT01596517|Immunologic Factors|immunologic factors|mesh-ancestor
110075158|NCT01596517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110075160|NCT01596556|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110075161|NCT01596556|Autonomic Agents|autonomic agents|mesh-ancestor
110075162|NCT01596556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110075163|NCT01596556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110075164|NCT01596556|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110075165|NCT01596556|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110075166|NCT01596556|Cholinergic Agents|cholinergic agents|mesh-ancestor
110075167|NCT01596556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110075168|NCT01596556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110075169|NCT01596634|Lactoferrin|lactoferrin|mesh-list
110075170|NCT01596634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110075171|NCT01596647|Diclofenac|diclofenac|mesh-list
110075172|NCT01596647|Midazolam|midazolam|mesh-list
110075173|NCT01596647|Caffeine|caffeine|mesh-list
110075174|NCT01596647|Omeprazole|omeprazole|mesh-list
110075175|NCT01596647|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110075176|NCT01596647|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110075177|NCT01596647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110075178|NCT01596647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110075179|NCT01596647|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110075180|NCT01596647|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110075181|NCT01596647|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110075182|NCT01596647|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110075183|NCT01596647|Anesthetics, General|anesthetics, general|mesh-ancestor
110075184|NCT01596647|Anesthetics|anesthetics|mesh-ancestor
110075185|NCT01596647|GABA Modulators|gaba modulators|mesh-ancestor
110075186|NCT01596647|GABA Agents|gaba agents|mesh-ancestor
110075187|NCT01596647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110075188|NCT01596647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110075189|NCT01596647|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110075190|NCT01596647|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110075191|NCT01596647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110075192|NCT01596647|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110075193|NCT01596647|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110075194|NCT01596647|Purinergic Agents|purinergic agents|mesh-ancestor
110075195|NCT01596647|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110075196|NCT01596647|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110075197|NCT01596647|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110075198|NCT01596647|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110075199|NCT01596647|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110075200|NCT01596647|Analgesics|analgesics|mesh-ancestor
110075201|NCT01596647|Sensory System Agents|sensory system agents|mesh-ancestor
110075202|NCT01596647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110075203|NCT01596647|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110075205|NCT01596647|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110075206|NCT01596660|Bupivacaine|bupivacaine|mesh-list
110075207|NCT01596660|Anesthetics, Local|anesthetics, local|mesh-ancestor
110075208|NCT01596660|Anesthetics|anesthetics|mesh-ancestor
110075209|NCT01596660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110075210|NCT01596660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110075211|NCT01596660|Sensory System Agents|sensory system agents|mesh-ancestor
110075212|NCT01596660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110075213|NCT01596673|Hydrocodone|hydrocodone|mesh-list
110075214|NCT01596673|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110075215|NCT01596673|Narcotics|narcotics|mesh-ancestor
110075216|NCT01596673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110075217|NCT01596673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110075218|NCT01596673|Analgesics|analgesics|mesh-ancestor
110075219|NCT01596673|Sensory System Agents|sensory system agents|mesh-ancestor
110075220|NCT01596673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110075221|NCT01596673|Antitussive Agents|antitussive agents|mesh-ancestor
110075222|NCT01596673|Respiratory System Agents|respiratory system agents|mesh-ancestor
110075223|NCT01596686|Picosulfate sodium|picosulfate sodium|mesh-list
110075224|NCT01596686|Cathartics|cathartics|mesh-ancestor
110075225|NCT01596686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110075226|NCT01596738|Tranexamic Acid|tranexamic acid|mesh-list
110075227|NCT01596738|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110075228|NCT01596738|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110075229|NCT01596738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110075230|NCT01596738|Hemostatics|hemostatics|mesh-ancestor
110075231|NCT01596738|Coagulants|coagulants|mesh-ancestor
110075232|NCT01596764|Sulfasalazine|sulfasalazine|mesh-list
110075234|NCT01596764|Methylnaltrexone|methylnaltrexone|mesh-list
110075236|NCT01596764|Antidiarrheals|antidiarrheals|mesh-list
110075237|NCT01596764|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110075238|NCT01596764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110075239|NCT01596764|Sensory System Agents|sensory system agents|mesh-ancestor
110075240|NCT01596764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110075241|NCT01596764|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110075242|NCT01596764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110075243|NCT01596764|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110075244|NCT01596764|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110075245|NCT01596764|Analgesics|analgesics|mesh-ancestor
110075246|NCT01596764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110075247|NCT01596764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110075248|NCT01596777|Sulfasalazine|sulfasalazine|mesh-list
110075249|NCT01596777|Naltrexone|naltrexone|mesh-list
110075250|NCT01596777|Methylnaltrexone|methylnaltrexone|mesh-list
110075251|NCT01596777|Loperamide|loperamide|mesh-list
110075252|NCT01596777|Antidiarrheals|antidiarrheals|mesh-list
110075253|NCT01596777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110075254|NCT01596777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110391158|NCT04283669|Crizotinib|crizotinib|mesh-list
110075255|NCT01596777|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110075256|NCT01596777|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110075257|NCT01596777|Analgesics|analgesics|mesh-ancestor
110075258|NCT01596777|Sensory System Agents|sensory system agents|mesh-ancestor
110075259|NCT01596777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110075260|NCT01596777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110075261|NCT01596777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110075262|NCT01596777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110075263|NCT01596777|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110075264|NCT01596777|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110075265|NCT01596803|Ascorbic Acid|ascorbic acid|mesh-list
110075266|NCT01596803|Vitamin E|vitamin e|mesh-list
110075267|NCT01596803|alpha-Tocopherol|alpha-tocopherol|mesh-list
110075268|NCT01596803|Tocopherols|tocopherols|mesh-list
110075269|NCT01596803|Antioxidants|antioxidants|mesh-list
110075270|NCT01596803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110075271|NCT01596803|Protective Agents|protective agents|mesh-ancestor
110075272|NCT01596803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110075273|NCT01596803|Vitamins|vitamins|mesh-ancestor
110075274|NCT01596803|Micronutrients|micronutrients|mesh-ancestor
110075275|NCT01596855|Epoetin Alfa|epoetin alfa|mesh-list
110075276|NCT01596855|Hematinics|hematinics|mesh-ancestor
110075277|NCT01596868|Cisplatin|cisplatin|mesh-list
110075278|NCT01596868|Gemcitabine|gemcitabine|mesh-list
110075279|NCT01596868|Docetaxel|docetaxel|mesh-list
110075280|NCT01596868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110075281|NCT01596868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110075282|NCT01596868|Antimetabolites|antimetabolites|mesh-ancestor
110075283|NCT01596868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110075284|NCT01596868|Tubulin Modulators|tubulin modulators|mesh-ancestor
110075285|NCT01596868|Antimitotic Agents|antimitotic agents|mesh-ancestor
110075286|NCT01596868|Mitosis Modulators|mitosis modulators|mesh-ancestor
110075287|NCT01596894|Azithromycin|azithromycin|mesh-list
110075288|NCT01596894|Metronidazole|metronidazole|mesh-list
110075289|NCT01596894|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110075290|NCT01596894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110075291|NCT01596894|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110075292|NCT01596894|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110075293|NCT01596907|Ephedrine|ephedrine|mesh-list
110075294|NCT01596907|Pseudoephedrine|pseudoephedrine|mesh-list
110075295|NCT01596907|Caffeine|caffeine|mesh-list
110075296|NCT01596907|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110075297|NCT01596907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110075298|NCT01596907|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110075299|NCT01596907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110075300|NCT01596907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110075301|NCT01596907|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110075302|NCT01596907|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110075303|NCT01596907|Purinergic Agents|purinergic agents|mesh-ancestor
110075304|NCT01596907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110075305|NCT01596907|Sympathomimetics|sympathomimetics|mesh-ancestor
110075306|NCT01596907|Autonomic Agents|autonomic agents|mesh-ancestor
110075307|NCT01596907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110075308|NCT01596907|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110075309|NCT01596907|Adrenergic Agents|adrenergic agents|mesh-ancestor
110075310|NCT01596907|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110075311|NCT01596907|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110075312|NCT01596907|Respiratory System Agents|respiratory system agents|mesh-ancestor
110075313|NCT01596907|Nasal Decongestants|nasal decongestants|mesh-ancestor
110075315|NCT01596998|Racepinephrine|racepinephrine|mesh-list
110075316|NCT01596998|Levobupivacaine|levobupivacaine|mesh-list
110075317|NCT01596998|Epinephryl borate|epinephryl borate|mesh-list
110075318|NCT01596998|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110075319|NCT01596998|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110075320|NCT01596998|Adrenergic Agents|adrenergic agents|mesh-ancestor
110075321|NCT01596998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110075322|NCT01596998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110075323|NCT01596998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110075324|NCT01596998|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110075325|NCT01596998|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110075326|NCT01596998|Autonomic Agents|autonomic agents|mesh-ancestor
110075327|NCT01596998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110075328|NCT01596998|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110075329|NCT01596998|Respiratory System Agents|respiratory system agents|mesh-ancestor
110075330|NCT01596998|Mydriatics|mydriatics|mesh-ancestor
110075331|NCT01596998|Sympathomimetics|sympathomimetics|mesh-ancestor
110075332|NCT01596998|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110075333|NCT01596998|Anesthetics, Local|anesthetics, local|mesh-ancestor
110075334|NCT01596998|Anesthetics|anesthetics|mesh-ancestor
110075335|NCT01596998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110075336|NCT01596998|Sensory System Agents|sensory system agents|mesh-ancestor
110075337|NCT01597011|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
110075338|NCT01597011|Hemostatics|hemostatics|mesh-ancestor
110075339|NCT01597011|Coagulants|coagulants|mesh-ancestor
110075340|NCT01597167|Magnesium Sulfate|magnesium sulfate|mesh-list
110075341|NCT01597167|Analgesics|analgesics|mesh-ancestor
110075342|NCT01597167|Sensory System Agents|sensory system agents|mesh-ancestor
110075343|NCT01597167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110075344|NCT01597167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110075345|NCT01597167|Anesthetics|anesthetics|mesh-ancestor
110075346|NCT01597167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110075347|NCT01597167|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110075348|NCT01597167|Anticonvulsants|anticonvulsants|mesh-ancestor
110075349|NCT01597167|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110075350|NCT01597167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110075351|NCT01597167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110075352|NCT01597167|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110075353|NCT01597167|Tocolytic Agents|tocolytic agents|mesh-ancestor
110075354|NCT01597167|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110075356|NCT01597206|Trace Elements|trace elements|mesh-ancestor
110075357|NCT01597206|Micronutrients|micronutrients|mesh-ancestor
110075358|NCT01597206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110075359|NCT01597232|Chrysarobin|chrysarobin|mesh-list
110075360|NCT01597232|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110075361|NCT01597232|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110075362|NCT01597232|Analgesics|analgesics|mesh-ancestor
110075363|NCT01597232|Sensory System Agents|sensory system agents|mesh-ancestor
110075364|NCT01597232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110075365|NCT01597232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110075366|NCT01597232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110075367|NCT01597232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110075368|NCT01597297|4-Aminopyridine|4-aminopyridine|mesh-list
110075369|NCT01597297|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
110075370|NCT01597297|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110075371|NCT01597297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110075372|NCT01597310|Pramipexole|pramipexole|mesh-list
110075373|NCT01597310|Warfarin|warfarin|mesh-list
110391223|NCT04212416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110075374|NCT01597310|Anticoagulants|anticoagulants|mesh-ancestor
110075375|NCT01597310|Antioxidants|antioxidants|mesh-ancestor
110075376|NCT01597310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110075377|NCT01597310|Protective Agents|protective agents|mesh-ancestor
110075378|NCT01597310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110075379|NCT01597310|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110075380|NCT01597310|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110075381|NCT01597310|Dopamine Agonists|dopamine agonists|mesh-ancestor
110075382|NCT01597310|Dopamine Agents|dopamine agents|mesh-ancestor
110075383|NCT01597310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110075384|NCT01597336|Plasminogen|plasminogen|mesh-list
110075385|NCT01597336|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
110075386|NCT01597336|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110075387|NCT01597336|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110075388|NCT01597336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110075389|NCT01597427|Clonidine|clonidine|mesh-list
110075390|NCT01597427|Analgesics|analgesics|mesh-ancestor
110075391|NCT01597427|Sensory System Agents|sensory system agents|mesh-ancestor
110075392|NCT01597427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110075393|NCT01597427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110075394|NCT01597427|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110075395|NCT01597427|Sympatholytics|sympatholytics|mesh-ancestor
110075396|NCT01597427|Autonomic Agents|autonomic agents|mesh-ancestor
110075397|NCT01597427|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110075398|NCT01597427|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110075399|NCT01597427|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110075400|NCT01597427|Adrenergic Agents|adrenergic agents|mesh-ancestor
110075401|NCT01597427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110075402|NCT01597427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110075403|NCT01597518|Riluzole|riluzole|mesh-list
110075404|NCT01597518|Anticonvulsants|anticonvulsants|mesh-ancestor
110075405|NCT01597518|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110075406|NCT01597518|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110075407|NCT01597518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110075408|NCT01597518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110075409|NCT01597518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110075410|NCT01597518|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110075411|NCT01597518|Protective Agents|protective agents|mesh-ancestor
110075412|NCT01597531|Liraglutide|liraglutide|mesh-list
110075413|NCT01597531|Orlistat|orlistat|mesh-list
110075414|NCT01597531|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110075415|NCT01597531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110075416|NCT01597531|Incretins|incretins|mesh-ancestor
110075417|NCT01597531|Hormones|hormones|mesh-ancestor
110075418|NCT01597531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110075419|NCT01597531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110075420|NCT01597531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110075421|NCT01597531|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110075422|NCT01597531|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110075423|NCT01597609|Sibutramine|sibutramine|mesh-list
110075424|NCT01597609|Antidepressive Agents|antidepressive agents|mesh-ancestor
110075425|NCT01597609|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110075426|NCT01597609|Appetite Depressants|appetite depressants|mesh-ancestor
110075427|NCT01597609|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110075428|NCT01597648|Maraviroc|maraviroc|mesh-list
110075429|NCT01597648|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
110075430|NCT01597648|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110075431|NCT01597648|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110075432|NCT01597648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110075433|NCT01597648|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110075434|NCT01597648|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110075435|NCT01597648|Antiviral Agents|antiviral agents|mesh-ancestor
110075436|NCT01597648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110075437|NCT01597648|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
110075438|NCT01597648|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110075439|NCT01597648|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110075440|NCT01597648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110075441|NCT01597661|Bupropion|bupropion|mesh-list
110075442|NCT01597661|Antidepressive Agents|antidepressive agents|mesh-list
110075443|NCT01597661|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110075444|NCT01597661|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110075445|NCT01597661|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110075446|NCT01597661|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110075447|NCT01597661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110075448|NCT01597661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110075449|NCT01597661|Dopamine Agents|dopamine agents|mesh-ancestor
110075450|NCT01597661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110075451|NCT01597661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110075452|NCT01597661|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110075453|NCT01597661|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110075454|NCT01597661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110075455|NCT01597700|Ezetimibe|ezetimibe|mesh-list
110075456|NCT01597700|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110075457|NCT01597700|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110075458|NCT01597700|Antimetabolites|antimetabolites|mesh-ancestor
110075459|NCT01597700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110075460|NCT01597700|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110075461|NCT01597713|Insulin Glargine|insulin glargine|mesh-list
110075462|NCT01597713|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110075463|NCT01597713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110075464|NCT01597726|Misoprostol|misoprostol|mesh-list
110075465|NCT01597726|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110075466|NCT01597726|Abortifacient Agents|abortifacient agents|mesh-ancestor
110075467|NCT01597726|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110075468|NCT01597726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110075469|NCT01597726|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110075470|NCT01597726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110075471|NCT01597726|Oxytocics|oxytocics|mesh-ancestor
110075472|NCT01597765|Vitamins|vitamins|mesh-list
110075473|NCT01597765|Vitamin E|vitamin e|mesh-list
110075474|NCT01597765|Tocopherols|tocopherols|mesh-list
110075475|NCT01597765|Tocotrienols|tocotrienols|mesh-list
110075476|NCT01597765|alpha-Tocopherol|alpha-tocopherol|mesh-list
110075477|NCT01597765|Acetylcysteine|acetylcysteine|mesh-list
110075478|NCT01597765|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110075479|NCT01597765|Deferiprone|deferiprone|mesh-list
110075480|NCT01597765|Micronutrients|micronutrients|mesh-ancestor
110075481|NCT01597765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110075482|NCT01597765|Antiviral Agents|antiviral agents|mesh-ancestor
110075483|NCT01597765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110075484|NCT01597765|Expectorants|expectorants|mesh-ancestor
110075485|NCT01597765|Respiratory System Agents|respiratory system agents|mesh-ancestor
110075486|NCT01597765|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110075487|NCT01597765|Antioxidants|antioxidants|mesh-ancestor
110164777|NCT00021346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110075488|NCT01597765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110075489|NCT01597765|Protective Agents|protective agents|mesh-ancestor
110075490|NCT01597765|Antidotes|antidotes|mesh-ancestor
110075491|NCT01597765|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110075492|NCT01597765|Chelating Agents|chelating agents|mesh-ancestor
110075493|NCT01597765|Sequestering Agents|sequestering agents|mesh-ancestor
110075494|NCT01597817|Chitosan|chitosan|mesh-list
110075495|NCT01597817|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110075496|NCT01597817|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110075497|NCT01597817|Antimetabolites|antimetabolites|mesh-ancestor
110075498|NCT01597817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110075499|NCT01597817|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110075500|NCT01597817|Chelating Agents|chelating agents|mesh-ancestor
110075501|NCT01597817|Sequestering Agents|sequestering agents|mesh-ancestor
110075502|NCT01597817|Hemostatics|hemostatics|mesh-ancestor
110075503|NCT01597817|Coagulants|coagulants|mesh-ancestor
110075504|NCT01597895|Maraviroc|maraviroc|mesh-list
110391259|NCT04117945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110075505|NCT01597895|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110075506|NCT01597895|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110075507|NCT01597895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110075509|NCT01597895|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110075510|NCT01597895|Antiviral Agents|antiviral agents|mesh-ancestor
110075511|NCT01597895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110075512|NCT01597895|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
110075513|NCT01597934|Tenofovir|tenofovir|mesh-list
110075514|NCT01597934|Entecavir|entecavir|mesh-list
110075515|NCT01597934|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
110075516|NCT01597934|Adefovir|adefovir|mesh-list
110075517|NCT01597934|Lamivudine|lamivudine|mesh-list
110075518|NCT01597934|Telbivudine|telbivudine|mesh-list
110075519|NCT01597934|Antiviral Agents|antiviral agents|mesh-ancestor
110075520|NCT01597934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110075521|NCT01597934|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110075522|NCT01597934|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110075523|NCT01597934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110075524|NCT01597934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110075525|NCT01597934|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110075526|NCT01597934|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110075527|NCT01597986|Isavuconazole|isavuconazole|mesh-list
110075528|NCT01597986|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110075529|NCT01597986|Norethindrone|norethindrone|mesh-list
110075530|NCT01597986|Norethindrone Acetate|norethindrone acetate|mesh-list
110075532|NCT01597986|Contraceptive Agents|contraceptive agents|mesh-list
110075533|NCT01597986|Contraceptives, Oral|contraceptives, oral|mesh-list
110075535|NCT01597986|Estrogens|estrogens|mesh-ancestor
110075536|NCT01597986|Hormones|hormones|mesh-ancestor
110075537|NCT01597986|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110075538|NCT01597986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110075539|NCT01597986|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110075540|NCT01597986|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110075541|NCT01597986|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110075542|NCT01597986|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110075543|NCT01597986|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110075544|NCT01597986|Antifungal Agents|antifungal agents|mesh-ancestor
110075545|NCT01597986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110075546|NCT01597986|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110075547|NCT01598012|Mefenamic Acid|mefenamic acid|mesh-list
110075548|NCT01598012|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110075549|NCT01598012|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110075550|NCT01598012|Analgesics|analgesics|mesh-ancestor
110075551|NCT01598012|Sensory System Agents|sensory system agents|mesh-ancestor
110075552|NCT01598012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110075553|NCT01598012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110075554|NCT01598012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110075555|NCT01598012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110075556|NCT01598012|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110075557|NCT01598012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110075558|NCT01598012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110075559|NCT01598051|Rivaroxaban|rivaroxaban|mesh-list
110075560|NCT01598051|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110183298|NCT03959501|Dapagliflozin|dapagliflozin|mesh-list
110075562|NCT01598051|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110075563|NCT01598051|Protease Inhibitors|protease inhibitors|mesh-ancestor
110075564|NCT01598051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110075565|NCT01598051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110075566|NCT01598051|Anticoagulants|anticoagulants|mesh-ancestor
110075567|NCT01598168|Rivaroxaban|rivaroxaban|mesh-list
110075568|NCT01598168|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110075569|NCT01598168|Antithrombins|antithrombins|mesh-ancestor
110075570|NCT01598168|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110075572|NCT01598168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110075573|NCT01598168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110075574|NCT01598168|Anticoagulants|anticoagulants|mesh-ancestor
110075575|NCT01598259|Melatonin|melatonin|mesh-list
110075576|NCT01598259|Antioxidants|antioxidants|mesh-ancestor
110075577|NCT01598259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110075578|NCT01598259|Protective Agents|protective agents|mesh-ancestor
110075579|NCT01598259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110075580|NCT01598259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110075581|NCT01598337|Aspirin|aspirin|mesh-list
110075582|NCT01598337|Tirofiban|tirofiban|mesh-list
110075583|NCT01598337|Clopidogrel|clopidogrel|mesh-list
110075584|NCT01598337|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
110075585|NCT01598337|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110075586|NCT01598337|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110075587|NCT01598337|Analgesics|analgesics|mesh-ancestor
110075588|NCT01598337|Sensory System Agents|sensory system agents|mesh-ancestor
110075589|NCT01598337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110075590|NCT01598337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110075591|NCT01598337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110075592|NCT01598337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110075593|NCT01598337|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110075594|NCT01598337|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110075595|NCT01598337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110075596|NCT01598337|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110075597|NCT01598337|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110075598|NCT01598337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110075599|NCT01598337|Antipyretics|antipyretics|mesh-ancestor
110075600|NCT01598337|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110075601|NCT01598337|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110075602|NCT01598337|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110075603|NCT01598337|Purinergic Agents|purinergic agents|mesh-ancestor
110075604|NCT01598337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110075605|NCT01598363|Digoxin|digoxin|mesh-list
110075607|NCT01598363|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110075608|NCT01598363|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110075609|NCT01598363|Antimetabolites|antimetabolites|mesh-ancestor
110075610|NCT01598363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110075611|NCT01598363|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110075612|NCT01598363|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110075613|NCT01598363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110075614|NCT01598363|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110075615|NCT01598363|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110075616|NCT01598363|Protective Agents|protective agents|mesh-ancestor
110075617|NCT01598363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110075618|NCT01598402|Amoxicillin|amoxicillin|mesh-list
110075619|NCT01598402|Clavulanic Acids|clavulanic acids|mesh-list
110075620|NCT01598402|Clavulanic Acid|clavulanic acid|mesh-list
110075621|NCT01598402|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110075622|NCT01598402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110075623|NCT01598402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110075624|NCT01598402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110075625|NCT01598402|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110075626|NCT01598441|Iloprost|iloprost|mesh-list
110075627|NCT01598441|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110075628|NCT01598441|Vasodilator Agents|vasodilator agents|mesh-ancestor
110075629|NCT01598480|Anti-Infective Agents|anti-infective agents|mesh-list
110075630|NCT01598480|Silver Sulfadiazine|silver sulfadiazine|mesh-list
110075631|NCT01598480|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110075632|NCT01598480|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110075633|NCT01598493|Anti-Infective Agents|anti-infective agents|mesh-list
110075634|NCT01598493|Silver Sulfadiazine|silver sulfadiazine|mesh-list
110075635|NCT01598493|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110075636|NCT01598493|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110075637|NCT01598558|Rituximab|rituximab|mesh-list
110075638|NCT01598558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110075639|NCT01598558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110075640|NCT01598558|Immunologic Factors|immunologic factors|mesh-ancestor
110075641|NCT01598558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110075642|NCT01598558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110075644|NCT01598584|Mirtazapine|mirtazapine|mesh-list
110075645|NCT01598584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110075646|NCT01598584|Antimetabolites|antimetabolites|mesh-ancestor
110075647|NCT01598584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110075648|NCT01598584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110075649|NCT01598584|Antidepressive Agents|antidepressive agents|mesh-ancestor
110075650|NCT01598584|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110075651|NCT01598584|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110075652|NCT01598584|Histamine Antagonists|histamine antagonists|mesh-ancestor
110075653|NCT01598584|Histamine Agents|histamine agents|mesh-ancestor
110075654|NCT01598584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110075655|NCT01598584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110075656|NCT01598584|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110075657|NCT01598584|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110075658|NCT01598584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110075659|NCT01598584|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
110075660|NCT01598584|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110075661|NCT01598584|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110075662|NCT01598584|Adrenergic Agents|adrenergic agents|mesh-ancestor
110075663|NCT01598584|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110075664|NCT01598584|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110075665|NCT01598584|Serotonin Agents|serotonin agents|mesh-ancestor
110075666|NCT01598584|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110075668|NCT01598623|Oxytocics|oxytocics|mesh-ancestor
110075669|NCT01598623|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110075670|NCT01598623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110075671|NCT01598649|Mannitol|mannitol|mesh-list
110075672|NCT01598649|Caseins|caseins|mesh-list
110075673|NCT01598649|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110075674|NCT01598649|Diuretics|diuretics|mesh-ancestor
110075675|NCT01598649|Natriuretic Agents|natriuretic agents|mesh-ancestor
110075676|NCT01598649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110075677|NCT01598649|Chelating Agents|chelating agents|mesh-ancestor
110075678|NCT01598649|Sequestering Agents|sequestering agents|mesh-ancestor
110075679|NCT01598649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110075680|NCT01598675|Methamphetamine|methamphetamine|mesh-list
110075681|NCT01598675|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110075682|NCT01598675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110075683|NCT01598675|Sympathomimetics|sympathomimetics|mesh-ancestor
110075684|NCT01598675|Autonomic Agents|autonomic agents|mesh-ancestor
110075685|NCT01598675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110075686|NCT01598675|Dopamine Agents|dopamine agents|mesh-ancestor
110075687|NCT01598675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110075688|NCT01598675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110075689|NCT01598675|Adrenergic Agents|adrenergic agents|mesh-ancestor
110075690|NCT01598675|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110075691|NCT01598675|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110075692|NCT01598675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110075693|NCT01598675|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110075694|NCT01598883|Heparin|heparin|mesh-list
110075695|NCT01598883|Calcium heparin|calcium heparin|mesh-list
110075696|NCT01598883|Antithrombins|antithrombins|mesh-list
110075697|NCT01598883|Anticoagulants|anticoagulants|mesh-ancestor
110075698|NCT01598883|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110075699|NCT01598883|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110075700|NCT01598883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110075701|NCT01598883|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110075702|NCT01598883|Protease Inhibitors|protease inhibitors|mesh-ancestor
110075703|NCT01598883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110075704|NCT01598948|Mipomersen|mipomersen|mesh-list
110075705|NCT01598948|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110075706|NCT01598948|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110075707|NCT01598948|Antimetabolites|antimetabolites|mesh-ancestor
110075708|NCT01598948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110075709|NCT01598948|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110075710|NCT01599000|Lumefantrine|lumefantrine|mesh-list
110075711|NCT01599000|Artemether|artemether|mesh-list
110075712|NCT01599000|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
110075713|NCT01599000|Antimalarials|antimalarials|mesh-ancestor
110075714|NCT01599000|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110075715|NCT01599000|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110075716|NCT01599000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110075717|NCT01599013|Carboplatin|carboplatin|mesh-list
110075718|NCT01599013|Gemcitabine|gemcitabine|mesh-list
110075719|NCT01599013|Vinblastine|vinblastine|mesh-list
110075720|NCT01599013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110075721|NCT01599013|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110075722|NCT01599013|Antimetabolites|antimetabolites|mesh-ancestor
110075723|NCT01599013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110075724|NCT01599013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110075725|NCT01599013|Tubulin Modulators|tubulin modulators|mesh-ancestor
110075726|NCT01599013|Antimitotic Agents|antimitotic agents|mesh-ancestor
110075727|NCT01599013|Mitosis Modulators|mitosis modulators|mesh-ancestor
110075729|NCT01599078|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110075730|NCT01599078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110075731|NCT01599078|Tubulin Modulators|tubulin modulators|mesh-ancestor
110075732|NCT01599078|Antimitotic Agents|antimitotic agents|mesh-ancestor
110075733|NCT01599078|Mitosis Modulators|mitosis modulators|mesh-ancestor
110075734|NCT01599078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110075735|NCT01599117|Udenafil|udenafil|mesh-list
110075736|NCT01599117|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110075737|NCT01599117|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110075738|NCT01599117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110075739|NCT01599117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110075740|NCT01599130|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110075741|NCT01599130|Entecavir|entecavir|mesh-list
110075742|NCT01599130|Antiviral Agents|antiviral agents|mesh-ancestor
110075743|NCT01599130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110075744|NCT01599273|Triamcinolone|triamcinolone|mesh-list
110075745|NCT01599273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110075746|NCT01599273|Glucocorticoids|glucocorticoids|mesh-ancestor
110075747|NCT01599273|Hormones|hormones|mesh-ancestor
110075748|NCT01599273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110075749|NCT01599273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110075750|NCT01599312|Cobalt|cobalt|mesh-list
110075751|NCT01599312|Trace Elements|trace elements|mesh-ancestor
110075752|NCT01599312|Micronutrients|micronutrients|mesh-ancestor
110075753|NCT01599312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110075754|NCT01599338|Liraglutide|liraglutide|mesh-list
110075755|NCT01599338|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110075756|NCT01599338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110075758|NCT01599338|Hormones|hormones|mesh-ancestor
110075759|NCT01599338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110075760|NCT01599364|Ritonavir|ritonavir|mesh-list
110075761|NCT01599364|Atazanavir Sulfate|atazanavir sulfate|mesh-list
110075762|NCT01599364|Lamivudine|lamivudine|mesh-list
110075763|NCT01599364|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110075764|NCT01599364|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110075765|NCT01599364|Protease Inhibitors|protease inhibitors|mesh-ancestor
110075766|NCT01599364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110075767|NCT01599364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110075768|NCT01599364|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110075769|NCT01599364|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110075770|NCT01599364|Antiviral Agents|antiviral agents|mesh-ancestor
110075771|NCT01599364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110075772|NCT01599364|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110075773|NCT01599364|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110075774|NCT01599364|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110075775|NCT01599364|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110075776|NCT01599377|Tofacitinib|tofacitinib|mesh-list
110075777|NCT01599377|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
110075778|NCT01599377|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110075779|NCT01599377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110075780|NCT01599377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110075781|NCT05691088|Acetaminophen|acetaminophen|mesh-list
110075782|NCT05691088|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110075783|NCT05691088|Analgesics|analgesics|mesh-ancestor
110075784|NCT05691088|Sensory System Agents|sensory system agents|mesh-ancestor
110075785|NCT05691088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110075786|NCT05691088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110075787|NCT05691088|Antipyretics|antipyretics|mesh-ancestor
110075788|NCT05690802|Palonosetron|palonosetron|mesh-list
110075789|NCT05690802|Antiemetics|antiemetics|mesh-ancestor
110075790|NCT05690802|Autonomic Agents|autonomic agents|mesh-ancestor
110075791|NCT05690802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110075792|NCT05690802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110075793|NCT05690802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110075794|NCT05690802|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110183366|NCT00028938|Paclitaxel|paclitaxel|mesh-list
110075795|NCT05690802|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110075796|NCT05690802|Serotonin Agents|serotonin agents|mesh-ancestor
110075797|NCT05690802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110075798|NCT05690802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110075799|NCT05690321|Opium|opium|mesh-list
110075800|NCT05690321|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110075801|NCT05690321|Narcotics|narcotics|mesh-ancestor
110075802|NCT05690321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110075803|NCT05690321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110075804|NCT05690321|Analgesics|analgesics|mesh-ancestor
110075805|NCT05690321|Sensory System Agents|sensory system agents|mesh-ancestor
110075806|NCT05690321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110075807|NCT05690321|Antidiarrheals|antidiarrheals|mesh-ancestor
110075808|NCT05690321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110075809|NCT05690321|Antitussive Agents|antitussive agents|mesh-ancestor
110075810|NCT05690321|Respiratory System Agents|respiratory system agents|mesh-ancestor
110075811|NCT05690191|Rituximab|rituximab|mesh-list
110075812|NCT05690191|Lenalidomide|lenalidomide|mesh-list
110075813|NCT05690191|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110075814|NCT05690191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110075815|NCT05690191|Immunologic Factors|immunologic factors|mesh-ancestor
110075816|NCT05690191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110075817|NCT05690191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110075818|NCT05690191|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110075819|NCT05690191|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110075820|NCT05690191|Growth Substances|growth substances|mesh-ancestor
110075821|NCT05690191|Growth Inhibitors|growth inhibitors|mesh-ancestor
110075822|NCT05689996|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110075823|NCT05689996|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110075824|NCT05689983|Budesonide|budesonide|mesh-list
110075825|NCT05689983|Formoterol Fumarate|formoterol fumarate|mesh-list
110075826|NCT05689983|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110075827|NCT05689983|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110075828|NCT05689983|Autonomic Agents|autonomic agents|mesh-ancestor
110075829|NCT05689983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110075830|NCT05689983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110075832|NCT05689983|Respiratory System Agents|respiratory system agents|mesh-ancestor
110075833|NCT05689983|Glucocorticoids|glucocorticoids|mesh-ancestor
110075835|NCT05689983|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110075836|NCT05689983|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110075837|NCT05689983|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110075838|NCT05689983|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110075839|NCT05689983|Adrenergic Agents|adrenergic agents|mesh-ancestor
110075840|NCT05689983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110075841|NCT05689983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110075842|NCT05689957|Rocuronium|rocuronium|mesh-list
110075843|NCT05689957|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110075844|NCT05689957|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110075845|NCT05689957|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110075846|NCT05689957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110075847|NCT05689957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110075849|NCT05689671|Carboplatin|carboplatin|mesh-list
110075850|NCT05689671|Pembrolizumab|pembrolizumab|mesh-list
110075851|NCT05689671|Pemetrexed|pemetrexed|mesh-list
110075852|NCT05689671|Atezolizumab|atezolizumab|mesh-list
110075853|NCT05689671|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110075854|NCT05689671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110075855|NCT05689671|Tubulin Modulators|tubulin modulators|mesh-ancestor
110075856|NCT05689671|Antimitotic Agents|antimitotic agents|mesh-ancestor
110075857|NCT05689671|Mitosis Modulators|mitosis modulators|mesh-ancestor
110075858|NCT05689671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110075859|NCT05689671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110075860|NCT05689671|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110075861|NCT05689671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110075862|NCT05689671|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110075863|NCT05689671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110075864|NCT05689632|Vitamin D|vitamin d|mesh-list
110075865|NCT05689632|Ergocalciferols|ergocalciferols|mesh-list
110075866|NCT05689632|Cholecalciferol|cholecalciferol|mesh-list
110075867|NCT05689632|Vitamins|vitamins|mesh-list
110075868|NCT05689632|Micronutrients|micronutrients|mesh-ancestor
110075869|NCT05689632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110075870|NCT05689632|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110075871|NCT05689632|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110075872|NCT05689619|Silybin|silybin|mesh-list
110075873|NCT05689619|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110075874|NCT05689619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110075875|NCT05689619|Protective Agents|protective agents|mesh-ancestor
110075876|NCT05689619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110075877|NCT05689242|Dexmedetomidine|dexmedetomidine|mesh-list
110075878|NCT05689242|Nalbuphine|nalbuphine|mesh-list
110075879|NCT05689242|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110391335|NCT04022005|Rituximab|rituximab|mesh-list
110075880|NCT05689242|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110075881|NCT05689242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110075882|NCT05689242|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110075883|NCT05689242|Analgesics|analgesics|mesh-ancestor
110075884|NCT05689242|Sensory System Agents|sensory system agents|mesh-ancestor
110075885|NCT05689242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110075886|NCT05689242|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110075887|NCT05689242|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110075888|NCT05689242|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110075889|NCT05689242|Adrenergic Agents|adrenergic agents|mesh-ancestor
110075890|NCT05689242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110075891|NCT05689242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110075892|NCT05689242|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110075893|NCT05689242|Narcotics|narcotics|mesh-ancestor
110075894|NCT05689229|Colistin|colistin|mesh-list
110075895|NCT05689229|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110075896|NCT05689229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110075897|NCT05688046|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
110075898|NCT05688046|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
110075899|NCT05688046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110075900|NCT05688046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110075902|NCT05688046|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110075903|NCT05688046|Growth Substances|growth substances|mesh-ancestor
110075904|NCT05688046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110075905|NCT05688046|Growth Inhibitors|growth inhibitors|mesh-ancestor
110075907|NCT05618132|Vasodilator Agents|vasodilator agents|mesh-ancestor
110075908|NCT05618132|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110075909|NCT05618132|Cholinergic Agents|cholinergic agents|mesh-ancestor
110075910|NCT05618132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110075911|NCT05618132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110075912|NCT05618132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110075913|NCT05553808|Docetaxel|docetaxel|mesh-list
110075914|NCT05553808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110075915|NCT05553808|Tubulin Modulators|tubulin modulators|mesh-ancestor
110075916|NCT05553808|Antimitotic Agents|antimitotic agents|mesh-ancestor
110075917|NCT05553808|Mitosis Modulators|mitosis modulators|mesh-ancestor
110075918|NCT05553808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110075919|NCT05540184|Allopurinol|allopurinol|mesh-list
110075920|NCT05540184|Trimetazidine|trimetazidine|mesh-list
110075921|NCT05540184|Antimetabolites|antimetabolites|mesh-ancestor
110075922|NCT05540184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110075923|NCT05540184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110075924|NCT05540184|Gout Suppressants|gout suppressants|mesh-ancestor
110075925|NCT05540184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110075926|NCT05540184|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110075928|NCT05540184|Protective Agents|protective agents|mesh-ancestor
110075929|NCT05540184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110075930|NCT05540184|Vasodilator Agents|vasodilator agents|mesh-ancestor
110075932|NCT05473195|Ethionamide|ethionamide|mesh-list
110075933|NCT05473195|Antitubercular Agents|antitubercular agents|mesh-ancestor
110075934|NCT05473195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110075935|NCT05473195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110075936|NCT05473195|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
110075937|NCT05473195|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110075938|NCT05473195|Antimetabolites|antimetabolites|mesh-ancestor
110075939|NCT05473195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110075940|NCT05473195|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110075941|NCT05422053|Insulin|insulin|mesh-list
110075942|NCT05422053|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110075943|NCT05422053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110075944|NCT05344911|Remifentanil|remifentanil|mesh-list
110075945|NCT05344911|Alfentanil|alfentanil|mesh-list
110075946|NCT05344911|Propofol|propofol|mesh-list
110075947|NCT05344911|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110075957|NCT05344911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110075958|NCT05344417|Iodine|iodine|mesh-list
110075959|NCT05344417|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110075960|NCT05344417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110075961|NCT05344417|Trace Elements|trace elements|mesh-ancestor
110075962|NCT05344417|Micronutrients|micronutrients|mesh-ancestor
110075963|NCT05344417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110075964|NCT05338021|Vancomycin|vancomycin|mesh-list
110075965|NCT05338021|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110075966|NCT05338021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110075967|NCT05338008|Vancomycin|vancomycin|mesh-list
110075968|NCT05338008|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110075969|NCT05338008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110075970|NCT05281328|Octreotide|octreotide|mesh-list
110075971|NCT05281328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110075972|NCT05281328|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110075973|NCT05281328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110075974|NCT05251376|Morphine|morphine|mesh-list
110075975|NCT05251376|Methadone|methadone|mesh-list
110075976|NCT05251376|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110075977|NCT05251376|Narcotics|narcotics|mesh-ancestor
110075978|NCT05251376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110075979|NCT05251376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110075980|NCT05251376|Analgesics|analgesics|mesh-ancestor
110075981|NCT05251376|Sensory System Agents|sensory system agents|mesh-ancestor
110075982|NCT05251376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110075983|NCT05251376|Antitussive Agents|antitussive agents|mesh-ancestor
110075984|NCT05251376|Respiratory System Agents|respiratory system agents|mesh-ancestor
110075985|NCT05191446|Ethanol|ethanol|mesh-list
110075986|NCT05191446|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110075987|NCT05191446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110075988|NCT05191446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110075989|NCT05191446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110075991|NCT05189483|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110075992|NCT05189483|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110075993|NCT05189483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110075995|NCT05189483|Antimitotic Agents|antimitotic agents|mesh-ancestor
110075996|NCT05189483|Mitosis Modulators|mitosis modulators|mesh-ancestor
110075997|NCT05189483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110075998|NCT05188820|Cortisone|cortisone|mesh-list
110075999|NCT05188820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110076000|NCT05149313|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110076001|NCT05149313|Immunologic Factors|immunologic factors|mesh-ancestor
110076002|NCT05149313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110076003|NCT05070247|Pembrolizumab|pembrolizumab|mesh-list
110076004|NCT05070247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110076005|NCT05070247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110076006|NCT05070247|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110076007|NCT05070247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110076016|NCT04969250|Vaccines|vaccines|mesh-list
110076017|NCT04969250|Immunologic Factors|immunologic factors|mesh-ancestor
110076018|NCT04969250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110076019|NCT04938609|Pembrolizumab|pembrolizumab|mesh-list
110076020|NCT04938609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110076021|NCT04938609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110076022|NCT04938609|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110076023|NCT04938609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110076025|NCT04873557|Trace Elements|trace elements|mesh-ancestor
110076026|NCT04873557|Micronutrients|micronutrients|mesh-ancestor
110076027|NCT04873557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110076028|NCT04812457|Povidone-Iodine|povidone-iodine|mesh-list
110076029|NCT04812457|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110076030|NCT04812457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110076031|NCT04789616|Maraviroc|maraviroc|mesh-list
110076032|NCT04789616|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110076033|NCT04789616|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110076034|NCT04789616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110076035|NCT04789616|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110076036|NCT04789616|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110076037|NCT04789616|Antiviral Agents|antiviral agents|mesh-ancestor
110076038|NCT04789616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110076039|NCT04789616|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
110076040|NCT04785300|Dasatinib|dasatinib|mesh-list
110076041|NCT04785300|Quercetin|quercetin|mesh-list
110076042|NCT04785300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110076043|NCT04785300|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110076044|NCT04785300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110076045|NCT04785300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110076046|NCT04785300|Antioxidants|antioxidants|mesh-ancestor
110076047|NCT04785300|Protective Agents|protective agents|mesh-ancestor
110076048|NCT04785300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110076049|NCT04753216|Bevacizumab|bevacizumab|mesh-list
110076050|NCT04753216|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110076051|NCT04753216|Irinotecan|irinotecan|mesh-list
110076052|NCT04753216|Endothelial Growth Factors|endothelial growth factors|mesh-list
110076053|NCT04753216|Antibodies|antibodies|mesh-list
110076054|NCT04753216|Immunoglobulins|immunoglobulins|mesh-list
110076055|NCT04753216|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110076056|NCT04753216|Immunoglobulin G|immunoglobulin g|mesh-list
110076057|NCT04753216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110076058|NCT04753216|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110076059|NCT04753216|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110076060|NCT04753216|Growth Substances|growth substances|mesh-ancestor
110076061|NCT04753216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110076062|NCT04753216|Growth Inhibitors|growth inhibitors|mesh-ancestor
110076063|NCT04753216|Immunologic Factors|immunologic factors|mesh-ancestor
110076064|NCT04753216|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110076065|NCT04753216|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110076066|NCT04753216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110076067|NCT04753216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110076068|NCT04714619|Letrozole|letrozole|mesh-list
110076069|NCT04714619|Anastrozole|anastrozole|mesh-list
110076070|NCT04714619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110076072|NCT04714619|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110076073|NCT04714619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110076074|NCT04714619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110076075|NCT04714619|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110076076|NCT04714619|Hormone Antagonists|hormone antagonists|mesh-ancestor
110076077|NCT04714619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110076078|NCT04714619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110076079|NCT04714619|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110076080|NCT04690855|Atezolizumab|atezolizumab|mesh-list
110076081|NCT04690855|Talazoparib|talazoparib|mesh-list
110076082|NCT04690855|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110076083|NCT04690855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110076084|NCT04690855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110076085|NCT04690855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110076086|NCT04690855|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110076087|NCT04690855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110076088|NCT04689945|Morphine|morphine|mesh-list
110076089|NCT04689945|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110076090|NCT04689945|Narcotics|narcotics|mesh-ancestor
110076091|NCT04689945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110076092|NCT04689945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110076093|NCT04689945|Analgesics|analgesics|mesh-ancestor
110076094|NCT04689945|Sensory System Agents|sensory system agents|mesh-ancestor
110076095|NCT04689945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110076096|NCT04682483|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
110076097|NCT04643574|Cyclophosphamide|cyclophosphamide|mesh-list
110076098|NCT04643574|Fludarabine|fludarabine|mesh-list
110076099|NCT04643574|Interleukin-2|interleukin-2|mesh-list
110076100|NCT04643574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110076101|NCT04643574|Immunologic Factors|immunologic factors|mesh-ancestor
110076102|NCT04643574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110076103|NCT04643574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110076104|NCT04643574|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110076105|NCT04643574|Alkylating Agents|alkylating agents|mesh-ancestor
110076106|NCT04643574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110076107|NCT04643574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110076108|NCT04643574|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110076109|NCT04643574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110076110|NCT04643574|Analgesics|analgesics|mesh-ancestor
110076111|NCT04643574|Sensory System Agents|sensory system agents|mesh-ancestor
110076112|NCT04643574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110076113|NCT04563494|Dexamethasone|dexamethasone|mesh-list
110076114|NCT04563494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110076115|NCT04563494|Antiemetics|antiemetics|mesh-ancestor
110391378|NCT03924895|Pembrolizumab|pembrolizumab|mesh-list
110076117|NCT04563494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110076118|NCT04563494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110076119|NCT04563494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110076120|NCT04563494|Glucocorticoids|glucocorticoids|mesh-ancestor
110076121|NCT04563494|Hormones|hormones|mesh-ancestor
110076122|NCT04563494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110076123|NCT04563494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110183436|NCT00029757|Estrogens|estrogens|mesh-list
110076124|NCT04563494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110076126|NCT04541173|Atezolizumab|atezolizumab|mesh-list
110076127|NCT04541173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110076128|NCT04541173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110076129|NCT04541173|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110076130|NCT04541173|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110076131|NCT04541173|Growth Substances|growth substances|mesh-ancestor
110076132|NCT04541173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110076133|NCT04541173|Growth Inhibitors|growth inhibitors|mesh-ancestor
110076134|NCT04541173|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110076135|NCT04541173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110076136|NCT04530747|Metformin|metformin|mesh-list
110076137|NCT04530747|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110076138|NCT04530747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110076139|NCT04464174|Carboplatin|carboplatin|mesh-list
110076140|NCT04464174|Gemcitabine|gemcitabine|mesh-list
110076141|NCT04464174|Capecitabine|capecitabine|mesh-list
110076142|NCT04464174|Ipatasertib|ipatasertib|mesh-list
110076143|NCT04464174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110076144|NCT04464174|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110076145|NCT04464174|Antimetabolites|antimetabolites|mesh-ancestor
110076146|NCT04464174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110076147|NCT04464174|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110076148|NCT04464174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110076149|NCT04456296|Methyltestosterone|methyltestosterone|mesh-list
110076150|NCT04456296|Testosterone|testosterone|mesh-list
110076151|NCT04456296|Testosterone undecanoate|testosterone undecanoate|mesh-list
110076152|NCT04456296|Testosterone enanthate|testosterone enanthate|mesh-list
110076153|NCT04456296|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
110076154|NCT04456296|Androgens|androgens|mesh-ancestor
110076155|NCT04456296|Hormones|hormones|mesh-ancestor
110076156|NCT04456296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110076157|NCT04456296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110076158|NCT04456296|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110076159|NCT04456296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110076160|NCT04456296|Anabolic Agents|anabolic agents|mesh-ancestor
110076161|NCT04408118|Paclitaxel|paclitaxel|mesh-list
110076162|NCT04408118|Atezolizumab|atezolizumab|mesh-list
110076163|NCT04408118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110076164|NCT04408118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110076165|NCT04408118|Tubulin Modulators|tubulin modulators|mesh-ancestor
110076166|NCT04408118|Antimitotic Agents|antimitotic agents|mesh-ancestor
110076167|NCT04408118|Mitosis Modulators|mitosis modulators|mesh-ancestor
110076168|NCT04408118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110076169|NCT04408118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110076170|NCT04408118|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110076172|NCT04403321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110076173|NCT04403321|Immunologic Factors|immunologic factors|mesh-ancestor
110076174|NCT04403321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110076175|NCT04403321|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110076176|NCT04403321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110076177|NCT04403321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110076179|NCT04265755|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
110076180|NCT04265755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110076181|NCT04265755|Analgesics|analgesics|mesh-ancestor
110076182|NCT04265755|Sensory System Agents|sensory system agents|mesh-ancestor
110076183|NCT04265755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110076184|NCT04265755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110076185|NCT04246372|Tofacitinib|tofacitinib|mesh-list
110076186|NCT04246372|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
110076187|NCT04246372|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110076188|NCT04246372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110076189|NCT04246372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110076190|NCT04229771|Proxymetacaine|proxymetacaine|mesh-list
110076191|NCT04229771|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110076192|NCT04229771|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110076193|NCT04229771|Anesthetics, Local|anesthetics, local|mesh-ancestor
110076194|NCT04229771|Anesthetics|anesthetics|mesh-ancestor
110076195|NCT04229771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110076196|NCT04229771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110076197|NCT04229771|Sensory System Agents|sensory system agents|mesh-ancestor
110076198|NCT04229771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110076199|NCT04182334|TEMPO|tempo|mesh-list
110076200|NCT04182334|Antioxidants|antioxidants|mesh-ancestor
110076201|NCT04182334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110076202|NCT04182334|Protective Agents|protective agents|mesh-ancestor
110076203|NCT04182334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110076204|NCT04123444|Iloprost|iloprost|mesh-list
110076205|NCT04123444|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110076206|NCT04123444|Vasodilator Agents|vasodilator agents|mesh-ancestor
110076207|NCT03987503|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
110076208|NCT03987503|Antiviral Agents|antiviral agents|mesh-ancestor
110076209|NCT03987503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110076210|NCT03967197|Lidocaine|lidocaine|mesh-list
110076211|NCT03967197|Anesthetics, Local|anesthetics, local|mesh-ancestor
110076212|NCT03967197|Anesthetics|anesthetics|mesh-ancestor
110076213|NCT03967197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110076214|NCT03967197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110076215|NCT03967197|Sensory System Agents|sensory system agents|mesh-ancestor
110076216|NCT03967197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110076217|NCT03967197|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110076218|NCT03967197|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110076219|NCT03967197|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110076220|NCT03967197|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110076221|NCT03967197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110076222|NCT03935646|Adderall|adderall|mesh-list
110076223|NCT03935646|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110076224|NCT03935646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110076226|NCT03871153|Carboplatin|carboplatin|mesh-list
110076227|NCT03871153|Durvalumab|durvalumab|mesh-list
110076228|NCT03871153|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110076229|NCT03871153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110076230|NCT03871153|Tubulin Modulators|tubulin modulators|mesh-ancestor
110076231|NCT03871153|Antimitotic Agents|antimitotic agents|mesh-ancestor
110076232|NCT03871153|Mitosis Modulators|mitosis modulators|mesh-ancestor
110076233|NCT03871153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110076234|NCT03871153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110076236|NCT03547999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110076237|NCT03547999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110076238|NCT03547999|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110076239|NCT03547999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110076240|NCT03536728|Eflornithine|eflornithine|mesh-list
110076241|NCT03536728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110076242|NCT03536728|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
110076243|NCT03536728|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110076244|NCT03536728|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110076245|NCT03536728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110076246|NCT03536728|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
110076247|NCT03536728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110076248|NCT03536728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110076249|NCT03517423|Brivaracetam|brivaracetam|mesh-list
110076250|NCT03517423|Anticonvulsants|anticonvulsants|mesh-ancestor
110076251|NCT03470675|Ketamine|ketamine|mesh-list
110076252|NCT03470675|Morphine|morphine|mesh-list
110076253|NCT03470675|Analgesics|analgesics|mesh-ancestor
110076254|NCT03470675|Sensory System Agents|sensory system agents|mesh-ancestor
110076255|NCT03470675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110076256|NCT03470675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110076257|NCT03470675|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110076258|NCT03470675|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110076259|NCT03470675|Anesthetics, General|anesthetics, general|mesh-ancestor
110076260|NCT03470675|Anesthetics|anesthetics|mesh-ancestor
110076261|NCT03470675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110076262|NCT03470675|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110076263|NCT03470675|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110076264|NCT03470675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110076265|NCT03470675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110076266|NCT03470675|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110076267|NCT03470675|Narcotics|narcotics|mesh-ancestor
110076268|NCT03462251|Paclitaxel|paclitaxel|mesh-list
110076269|NCT03462251|Bevacizumab|bevacizumab|mesh-list
110076270|NCT03462251|Capecitabine|capecitabine|mesh-list
110076271|NCT03462251|Fulvestrant|fulvestrant|mesh-list
110076272|NCT03462251|Aromatase Inhibitors|aromatase inhibitors|mesh-list
110076273|NCT03462251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110076274|NCT03462251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110076275|NCT03462251|Tubulin Modulators|tubulin modulators|mesh-ancestor
110076276|NCT03462251|Antimitotic Agents|antimitotic agents|mesh-ancestor
110076277|NCT03462251|Mitosis Modulators|mitosis modulators|mesh-ancestor
110076278|NCT03462251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110076279|NCT03462251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110076280|NCT03462251|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110076281|NCT03462251|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110076282|NCT03462251|Growth Substances|growth substances|mesh-ancestor
110076283|NCT03462251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110076284|NCT03462251|Growth Inhibitors|growth inhibitors|mesh-ancestor
110076285|NCT03462251|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110076286|NCT03462251|Antimetabolites|antimetabolites|mesh-ancestor
110076287|NCT03462251|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110076288|NCT03462251|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110076290|NCT03462251|Hormone Antagonists|hormone antagonists|mesh-ancestor
110076291|NCT03462251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110076292|NCT03462251|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110076293|NCT03462251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110076294|NCT03294954|Cyclophosphamide|cyclophosphamide|mesh-list
110076296|NCT03294954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110076297|NCT03294954|Immunologic Factors|immunologic factors|mesh-ancestor
110076298|NCT03294954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110076299|NCT03294954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110076300|NCT03294954|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110076301|NCT03294954|Alkylating Agents|alkylating agents|mesh-ancestor
110076302|NCT03294954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110076303|NCT03294954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110076304|NCT03294954|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110076305|NCT03274414|Cisplatin|cisplatin|mesh-list
110076306|NCT03274414|Etoposide|etoposide|mesh-list
110076307|NCT03274414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110076308|NCT03274414|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110076309|NCT03274414|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110076310|NCT03274414|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110076311|NCT03274414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110076312|NCT03274414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110076313|NCT03272685|Nicotine|nicotine|mesh-list
110076314|NCT03272685|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110076315|NCT03272685|Autonomic Agents|autonomic agents|mesh-ancestor
110076316|NCT03272685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110076317|NCT03272685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110076318|NCT03272685|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110076319|NCT03272685|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110076320|NCT03272685|Cholinergic Agents|cholinergic agents|mesh-ancestor
110076321|NCT03272685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110076322|NCT03272685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110076323|NCT03272334|Pembrolizumab|pembrolizumab|mesh-list
110076324|NCT03272334|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110076325|NCT03272334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110076326|NCT03272334|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110076327|NCT03272334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110076328|NCT03258281|Evolocumab|evolocumab|mesh-list
110076329|NCT03258281|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
110076330|NCT03258281|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110076331|NCT03258281|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110076332|NCT03258281|Antimetabolites|antimetabolites|mesh-ancestor
110076333|NCT03258281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110076334|NCT03258281|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110076335|NCT03258281|Protease Inhibitors|protease inhibitors|mesh-ancestor
110076336|NCT03258281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110076337|NCT03258281|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110076338|NCT05705466|Pembrolizumab|pembrolizumab|mesh-list
110076339|NCT05705466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110076340|NCT05705466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110076341|NCT05705466|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110076342|NCT05705466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110076343|NCT05705388|Liraglutide|liraglutide|mesh-list
110076344|NCT05705388|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110076345|NCT05705388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110076346|NCT05705388|Incretins|incretins|mesh-ancestor
110076347|NCT05705388|Hormones|hormones|mesh-ancestor
110076348|NCT05705388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110076349|NCT05705336|Tranexamic Acid|tranexamic acid|mesh-list
110076350|NCT05705336|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110076351|NCT05705336|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110076352|NCT05705336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110076353|NCT05705336|Hemostatics|hemostatics|mesh-ancestor
110076354|NCT05705336|Coagulants|coagulants|mesh-ancestor
110076355|NCT05705037|6-chloro-2-(1-piperazinyl)pyrazine|6-chloro-2-(1-piperazinyl)pyrazine|mesh-list
110076356|NCT05705037|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110076357|NCT05705037|Serotonin Agents|serotonin agents|mesh-ancestor
110076358|NCT05705037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110076359|NCT05705037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110076360|NCT05705037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110076361|NCT05704959|Povidone-Iodine|povidone-iodine|mesh-list
110076362|NCT05704959|Povidone|povidone|mesh-list
110076363|NCT05704959|Plasma Substitutes|plasma substitutes|mesh-ancestor
110076364|NCT05704959|Blood Substitutes|blood substitutes|mesh-ancestor
110076365|NCT05704959|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110076366|NCT05704959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110076367|NCT05704894|Epoetin Alfa|epoetin alfa|mesh-list
110076368|NCT05704894|Hematinics|hematinics|mesh-ancestor
110076369|NCT05704816|Anesthetics|anesthetics|mesh-list
110076370|NCT05704816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110076371|NCT05704816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110076372|NCT05704595|Diuretics|diuretics|mesh-list
110076373|NCT05704595|Natriuretic Agents|natriuretic agents|mesh-ancestor
110076374|NCT05704595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110076375|NCT05704400|Rituximab|rituximab|mesh-list
110076376|NCT05704400|Daratumumab|daratumumab|mesh-list
110076377|NCT05704400|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110076378|NCT05704400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110076379|NCT05704400|Immunologic Factors|immunologic factors|mesh-ancestor
110076380|NCT05704400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110076381|NCT05704400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110076382|NCT05704114|Tazarotene|tazarotene|mesh-list
110076383|NCT05704114|Dermatologic Agents|dermatologic agents|mesh-ancestor
110076384|NCT05704114|Keratolytic Agents|keratolytic agents|mesh-ancestor
110076385|NCT05704088|Dapagliflozin|dapagliflozin|mesh-list
110076386|NCT05704088|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110076387|NCT05704088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110076388|NCT05704088|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110076389|NCT05704088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110076390|NCT05703997|Atezolizumab|atezolizumab|mesh-list
110076391|NCT05703997|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110076392|NCT05703997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110076393|NCT05703997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110076394|NCT05703997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110076395|NCT05703984|Metformin|metformin|mesh-list
110076396|NCT05703984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110076397|NCT05703984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110076398|NCT05703555|Maytansine|maytansine|mesh-list
110076399|NCT05703555|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110076400|NCT05703555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110076401|NCT05703555|Tubulin Modulators|tubulin modulators|mesh-ancestor
110076402|NCT05703555|Antimitotic Agents|antimitotic agents|mesh-ancestor
110076403|NCT05703555|Mitosis Modulators|mitosis modulators|mesh-ancestor
110076404|NCT05703555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110076405|NCT05703373|Micronutrients|micronutrients|mesh-list
110076406|NCT05703373|Trace Elements|trace elements|mesh-list
110076407|NCT05703373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110076408|NCT05702190|Opium|opium|mesh-list
110076409|NCT05702190|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110076410|NCT05702190|Narcotics|narcotics|mesh-ancestor
110076411|NCT05702190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110076412|NCT05702190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110076414|NCT05702190|Sensory System Agents|sensory system agents|mesh-ancestor
110076415|NCT05702190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110076416|NCT05702190|Antidiarrheals|antidiarrheals|mesh-ancestor
110076417|NCT05702190|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110076418|NCT05702190|Antitussive Agents|antitussive agents|mesh-ancestor
110076419|NCT05702190|Respiratory System Agents|respiratory system agents|mesh-ancestor
110076420|NCT05701124|Ranibizumab|ranibizumab|mesh-list
110076421|NCT05701124|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110076422|NCT05701124|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110076424|NCT05701124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110076425|NCT05701124|Growth Inhibitors|growth inhibitors|mesh-ancestor
110076426|NCT05701124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110076427|NCT05645380|Cyclophosphamide|cyclophosphamide|mesh-list
110076428|NCT05645380|Carboplatin|carboplatin|mesh-list
110076429|NCT05645380|Docetaxel|docetaxel|mesh-list
110076430|NCT05645380|Doxorubicin|doxorubicin|mesh-list
110076431|NCT05645380|Pembrolizumab|pembrolizumab|mesh-list
110076432|NCT05645380|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110076433|NCT05645380|Immunologic Factors|immunologic factors|mesh-ancestor
110076434|NCT05645380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110076435|NCT05645380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110076436|NCT05645380|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110076437|NCT05645380|Alkylating Agents|alkylating agents|mesh-ancestor
110076438|NCT05645380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110076439|NCT05645380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110076440|NCT05645380|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110076441|NCT05645380|Tubulin Modulators|tubulin modulators|mesh-ancestor
110076442|NCT05645380|Antimitotic Agents|antimitotic agents|mesh-ancestor
110076443|NCT05645380|Mitosis Modulators|mitosis modulators|mesh-ancestor
110076444|NCT05645380|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110076445|NCT05645380|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110076446|NCT05645380|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110076447|NCT05645380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110076448|NCT05645380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110076449|NCT05645380|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110076450|NCT05584709|Immunoconjugates|immunoconjugates|mesh-list
110076451|NCT05584709|Immunologic Factors|immunologic factors|mesh-ancestor
110076452|NCT05584709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110076453|NCT05504486|Brexpiprazole|brexpiprazole|mesh-list
110076454|NCT05504486|Serotonin Agents|serotonin agents|mesh-ancestor
110076455|NCT05504486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110076456|NCT05504486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110076457|NCT05504486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110076458|NCT05504486|Dopamine Agonists|dopamine agonists|mesh-ancestor
110076459|NCT05504486|Dopamine Agents|dopamine agents|mesh-ancestor
110076460|NCT05476939|Everolimus|everolimus|mesh-list
110076461|NCT05476939|TIC10 compound|tic10 compound|mesh-list
110076462|NCT05476939|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110076463|NCT05476939|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110076464|NCT05476939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110076465|NCT05476939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110076466|NCT05476939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110076467|NCT05476939|Immunologic Factors|immunologic factors|mesh-ancestor
110076468|NCT05476939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110076469|NCT05476939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110076471|NCT05458232|Vasodilator Agents|vasodilator agents|mesh-ancestor
110076472|NCT05458232|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110076473|NCT05458232|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110076474|NCT05458232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110076475|NCT05458232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110076476|NCT05458232|Urological Agents|urological agents|mesh-ancestor
110076478|NCT05274243|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110076479|NCT05274243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110076480|NCT05274243|Disinfectants|disinfectants|mesh-ancestor
110076481|NCT05274243|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
110076482|NCT05274243|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110076484|NCT05271799|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110076485|NCT05271799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110076486|NCT05271799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110076487|NCT05271799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110076488|NCT05270733|Ustekinumab|ustekinumab|mesh-list
110076489|NCT05270733|Dermatologic Agents|dermatologic agents|mesh-ancestor
110076490|NCT05253417|Cannabidiol|cannabidiol|mesh-list
110076491|NCT05253417|Anticonvulsants|anticonvulsants|mesh-ancestor
110076492|NCT05184803|Docetaxel|docetaxel|mesh-list
110076493|NCT05184803|Oxaliplatin|oxaliplatin|mesh-list
110076494|NCT05184803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110076495|NCT05184803|Tubulin Modulators|tubulin modulators|mesh-ancestor
110076496|NCT05184803|Antimitotic Agents|antimitotic agents|mesh-ancestor
110076497|NCT05184803|Mitosis Modulators|mitosis modulators|mesh-ancestor
110076498|NCT05184803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110076499|NCT05030506|Pembrolizumab|pembrolizumab|mesh-list
110076500|NCT05030506|Lenvatinib|lenvatinib|mesh-list
110076501|NCT05030506|Belzutifan|belzutifan|mesh-list
110076502|NCT05030506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110076503|NCT05030506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110076504|NCT05030506|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110076505|NCT05030506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110076506|NCT05030506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110076507|NCT05030506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110076508|NCT04911621|Temozolomide|temozolomide|mesh-list
110076509|NCT04911621|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110076510|NCT04911621|Alkylating Agents|alkylating agents|mesh-ancestor
110076511|NCT04911621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110076512|NCT04911621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110076513|NCT04764643|Acetylcysteine|acetylcysteine|mesh-list
110076514|NCT04764643|Sodium thiosulfate|sodium thiosulfate|mesh-list
110076515|NCT04764643|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110076516|NCT04764643|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110076517|NCT04764643|Antiviral Agents|antiviral agents|mesh-ancestor
110076518|NCT04764643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110076519|NCT04764643|Expectorants|expectorants|mesh-ancestor
110076520|NCT04764643|Respiratory System Agents|respiratory system agents|mesh-ancestor
110076521|NCT04764643|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110076522|NCT04764643|Antioxidants|antioxidants|mesh-ancestor
110076523|NCT04764643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110076524|NCT04764643|Protective Agents|protective agents|mesh-ancestor
110076525|NCT04764643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110076526|NCT04764643|Antidotes|antidotes|mesh-ancestor
110076527|NCT04764643|Antitubercular Agents|antitubercular agents|mesh-ancestor
110076528|NCT04764643|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110076529|NCT04764643|Chelating Agents|chelating agents|mesh-ancestor
110076530|NCT04764643|Sequestering Agents|sequestering agents|mesh-ancestor
110076531|NCT04706429|Trientine|trientine|mesh-list
110076532|NCT04706429|Chelating Agents|chelating agents|mesh-ancestor
110076533|NCT04706429|Sequestering Agents|sequestering agents|mesh-ancestor
110076534|NCT04706429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110076535|NCT04558892|Enoxaparin|enoxaparin|mesh-list
110076536|NCT04558892|Anticoagulants|anticoagulants|mesh-ancestor
110076537|NCT04558892|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110076548|NCT04077515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110076549|NCT04077515|Immunologic Factors|immunologic factors|mesh-ancestor
110076550|NCT04077515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110076551|NCT04077515|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110076552|NCT04077515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110076553|NCT04077515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110076563|NCT03970200|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110076564|NCT03970200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110076565|NCT03958461|Anti-Infective Agents|anti-infective agents|mesh-list
110076566|NCT03919773|Immunoglobulins|immunoglobulins|mesh-list
110076567|NCT03919773|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110076568|NCT03919773|gamma-Globulins|gamma-globulins|mesh-list
110076569|NCT03919773|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110076571|NCT03919773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110076572|NCT03841110|Aldesleukin|aldesleukin|mesh-list
110076573|NCT03841110|Cyclophosphamide|cyclophosphamide|mesh-list
110076574|NCT03841110|Pembrolizumab|pembrolizumab|mesh-list
110076575|NCT03841110|Nivolumab|nivolumab|mesh-list
110076576|NCT03841110|Fludarabine|fludarabine|mesh-list
110076577|NCT03841110|Atezolizumab|atezolizumab|mesh-list
110076578|NCT03841110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110076579|NCT03841110|Immunologic Factors|immunologic factors|mesh-ancestor
110076580|NCT03841110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110076581|NCT03841110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110076582|NCT03841110|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110076583|NCT03841110|Alkylating Agents|alkylating agents|mesh-ancestor
110076584|NCT03841110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110076585|NCT03841110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110076586|NCT03841110|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110076587|NCT03841110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110076588|NCT03841110|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110076589|NCT03841110|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110076590|NCT03841110|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110076591|NCT03841110|Antiviral Agents|antiviral agents|mesh-ancestor
110076592|NCT03841110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110076593|NCT03810313|Aflibercept|aflibercept|mesh-list
110076594|NCT03810313|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110076595|NCT03810313|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110076596|NCT03810313|Growth Substances|growth substances|mesh-ancestor
110076597|NCT03810313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110076598|NCT03810313|Growth Inhibitors|growth inhibitors|mesh-ancestor
110076599|NCT03810313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110076600|NCT03802630|Aflibercept|aflibercept|mesh-list
110076601|NCT03802630|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110076602|NCT03802630|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110076603|NCT03802630|Growth Substances|growth substances|mesh-ancestor
110076604|NCT03802630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110076605|NCT03802630|Growth Inhibitors|growth inhibitors|mesh-ancestor
110076606|NCT03802630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110076607|NCT03785691|Ondansetron|ondansetron|mesh-list
110076608|NCT03785691|Mirtazapine|mirtazapine|mesh-list
110076609|NCT03785691|Antiemetics|antiemetics|mesh-ancestor
110076610|NCT03785691|Autonomic Agents|autonomic agents|mesh-ancestor
110076611|NCT03785691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110076612|NCT03785691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110076613|NCT03785691|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110076614|NCT03785691|Antipruritics|antipruritics|mesh-ancestor
110076615|NCT03785691|Dermatologic Agents|dermatologic agents|mesh-ancestor
110076616|NCT03785691|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110076617|NCT03785691|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110076618|NCT03785691|Serotonin Agents|serotonin agents|mesh-ancestor
110076619|NCT03785691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110076620|NCT03785691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110076621|NCT03785691|Antidepressive Agents|antidepressive agents|mesh-ancestor
110076622|NCT03785691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110076623|NCT03785691|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110076624|NCT03785691|Histamine Antagonists|histamine antagonists|mesh-ancestor
110076625|NCT03785691|Histamine Agents|histamine agents|mesh-ancestor
110076626|NCT03785691|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110076627|NCT03785691|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110076628|NCT03785691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110076629|NCT03785691|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
110076630|NCT03785691|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110076631|NCT03785691|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110076632|NCT03785691|Adrenergic Agents|adrenergic agents|mesh-ancestor
110076633|NCT03785691|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110076634|NCT03780829|Cycloserine|cycloserine|mesh-list
110076635|NCT03780829|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110076636|NCT03780829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110076637|NCT03780829|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110076638|NCT03780829|Antitubercular Agents|antitubercular agents|mesh-ancestor
110076639|NCT03780829|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110076640|NCT03780829|Antimetabolites|antimetabolites|mesh-ancestor
110076641|NCT03780829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110076644|NCT03736863|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110076645|NCT03736863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110076646|NCT03736863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110076647|NCT03710564|Aflibercept|aflibercept|mesh-list
110076648|NCT03710564|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110076649|NCT03710564|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110076650|NCT03710564|Growth Substances|growth substances|mesh-ancestor
110076651|NCT03710564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110076652|NCT03710564|Growth Inhibitors|growth inhibitors|mesh-ancestor
110076653|NCT03710564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110076655|NCT03703492|Estrogens|estrogens|mesh-ancestor
110076656|NCT03703492|Hormones|hormones|mesh-ancestor
110076657|NCT03703492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110076658|NCT03703492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110076660|NCT03624127|Deucravacitinib|deucravacitinib|mesh-list
110076661|NCT03624127|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110076662|NCT03624127|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110076663|NCT03624127|Analgesics|analgesics|mesh-ancestor
110076664|NCT03624127|Sensory System Agents|sensory system agents|mesh-ancestor
110076665|NCT03624127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110076666|NCT03624127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110076667|NCT03624127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110076668|NCT03624127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110076669|NCT03624127|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
110076670|NCT03624127|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110076671|NCT03624127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110076672|NCT03624127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110076673|NCT03624127|Dermatologic Agents|dermatologic agents|mesh-ancestor
110076674|NCT03624127|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110076675|NCT03499899|Carboplatin|carboplatin|mesh-list
110076676|NCT03499899|Spartalizumab|spartalizumab|mesh-list
110076677|NCT03499899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110076678|NCT03499899|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110391509|NCT03630211|Thymoglobulin|thymoglobulin|mesh-list
110076679|NCT03499899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110076680|NCT03499899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110076682|NCT03481634|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110076683|NCT03481634|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110076684|NCT03481634|Growth Substances|growth substances|mesh-ancestor
110076685|NCT03481634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110076686|NCT03481634|Growth Inhibitors|growth inhibitors|mesh-ancestor
110076687|NCT03481634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110076688|NCT03476642|Epinephrine|epinephrine|mesh-list
110076689|NCT03476642|Ropivacaine|ropivacaine|mesh-list
110076690|NCT03476642|Anesthetics, Local|anesthetics, local|mesh-ancestor
110076692|NCT03476642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110076693|NCT03476642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110076694|NCT03476642|Sensory System Agents|sensory system agents|mesh-ancestor
110076695|NCT03476642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110076696|NCT03476642|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110076697|NCT03476642|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110076698|NCT03476642|Adrenergic Agents|adrenergic agents|mesh-ancestor
110076700|NCT03476642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110076701|NCT03476642|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110076702|NCT03476642|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110076703|NCT03476642|Autonomic Agents|autonomic agents|mesh-ancestor
110076704|NCT03476642|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110076705|NCT03476642|Respiratory System Agents|respiratory system agents|mesh-ancestor
110076706|NCT03476642|Mydriatics|mydriatics|mesh-ancestor
110076707|NCT03476642|Sympathomimetics|sympathomimetics|mesh-ancestor
110076708|NCT03476642|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110076709|NCT03430700|Pembrolizumab|pembrolizumab|mesh-list
110076710|NCT03430700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110076711|NCT03430700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110076712|NCT03430700|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110076713|NCT03430700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110076714|NCT03171025|Nivolumab|nivolumab|mesh-list
110076715|NCT03171025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110076716|NCT03171025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110076717|NCT03171025|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110076718|NCT03171025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110076719|NCT03149003|Bevacizumab|bevacizumab|mesh-list
110076720|NCT03149003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110076721|NCT03149003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110076722|NCT03149003|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110076723|NCT03149003|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110076724|NCT03149003|Growth Substances|growth substances|mesh-ancestor
110076725|NCT03149003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110076726|NCT03149003|Growth Inhibitors|growth inhibitors|mesh-ancestor
110076727|NCT03106454|Ferrous fumarate|ferrous fumarate|mesh-list
110076728|NCT03106454|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110076729|NCT03106454|Norethindrone|norethindrone|mesh-list
110076730|NCT03106454|Norethindrone Acetate|norethindrone acetate|mesh-list
110076732|NCT03106454|Estrogens|estrogens|mesh-ancestor
110076733|NCT03106454|Hormones|hormones|mesh-ancestor
110076734|NCT03106454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110076735|NCT03106454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110076736|NCT03106454|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110076737|NCT03106454|Contraceptive Agents|contraceptive agents|mesh-ancestor
110076738|NCT03106454|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110076739|NCT03106454|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110076740|NCT03106454|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110391548|NCT03587961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110391549|NCT03534453|Olaparib|olaparib|mesh-list
110391550|NCT03534453|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110076741|NCT03106454|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110076742|NCT03106454|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110076745|NCT02990806|Infliximab|infliximab|mesh-list
110076746|NCT02990806|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110076747|NCT02990806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110076748|NCT02990806|Dermatologic Agents|dermatologic agents|mesh-ancestor
110076749|NCT02990806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110076750|NCT02990806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110076751|NCT02965703|Aspirin|aspirin|mesh-list
110076752|NCT02965703|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110076753|NCT02965703|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110076754|NCT02965703|Analgesics|analgesics|mesh-ancestor
110076755|NCT02965703|Sensory System Agents|sensory system agents|mesh-ancestor
110076756|NCT02965703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110076757|NCT02965703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110076758|NCT02965703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110076759|NCT02965703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110076760|NCT02965703|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110076761|NCT02965703|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110076762|NCT02965703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110076763|NCT02965703|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110076764|NCT02965703|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110076765|NCT02965703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110076766|NCT02965703|Antipyretics|antipyretics|mesh-ancestor
110076767|NCT02938442|Paclitaxel|paclitaxel|mesh-list
110076768|NCT02938442|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110076769|NCT02938442|Cyclophosphamide|cyclophosphamide|mesh-list
110076770|NCT02938442|Doxorubicin|doxorubicin|mesh-list
110076771|NCT02938442|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110076772|NCT02938442|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
110076773|NCT02938442|Freund's Adjuvant|freund's adjuvant|mesh-list
110076779|NCT02938442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110076780|NCT02938442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110076781|NCT02938442|Immunologic Factors|immunologic factors|mesh-ancestor
110076782|NCT02938442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110076783|NCT02938442|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110076784|NCT02938442|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110076785|NCT02938442|Alkylating Agents|alkylating agents|mesh-ancestor
110076786|NCT02938442|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110076787|NCT02938442|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110076788|NCT02938442|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110076789|NCT02938442|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110076790|NCT02938442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110076791|NCT02938442|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110076792|NCT02650271|Tenofovir|tenofovir|mesh-list
110076793|NCT02650271|Entecavir|entecavir|mesh-list
110076794|NCT02650271|Antiviral Agents|antiviral agents|mesh-ancestor
110076795|NCT02650271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110076796|NCT02650271|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110076797|NCT02650271|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110076798|NCT02650271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110076799|NCT02650271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110076800|NCT02650271|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110076801|NCT02650271|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110076802|NCT02420821|Bevacizumab|bevacizumab|mesh-list
110076803|NCT02420821|Atezolizumab|atezolizumab|mesh-list
110076804|NCT02420821|Sunitinib|sunitinib|mesh-list
110076805|NCT02420821|Antibodies|antibodies|mesh-list
110076806|NCT02420821|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110076807|NCT02420821|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110076808|NCT02420821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110076809|NCT02420821|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110076810|NCT02420821|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110076811|NCT02420821|Growth Substances|growth substances|mesh-ancestor
110076812|NCT02420821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110076813|NCT02420821|Growth Inhibitors|growth inhibitors|mesh-ancestor
110076814|NCT02420821|Immunologic Factors|immunologic factors|mesh-ancestor
110076815|NCT02420821|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110076816|NCT02420821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110076817|NCT02420821|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110076818|NCT02420821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110076819|NCT02811263|Epoetin Alfa|epoetin alfa|mesh-list
110076820|NCT02811263|Hematinics|hematinics|mesh-ancestor
110076826|NCT02229084|Paclitaxel|paclitaxel|mesh-list
110076827|NCT02229084|Docetaxel|docetaxel|mesh-list
110076828|NCT02229084|Cyclophosphamide|cyclophosphamide|mesh-list
110076829|NCT02229084|Doxorubicin|doxorubicin|mesh-list
110076830|NCT02229084|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
110076831|NCT02229084|Freund's Adjuvant|freund's adjuvant|mesh-list
110076832|NCT02229084|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110076833|NCT02229084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110076834|NCT02229084|Tubulin Modulators|tubulin modulators|mesh-ancestor
110076835|NCT02229084|Antimitotic Agents|antimitotic agents|mesh-ancestor
110076836|NCT02229084|Mitosis Modulators|mitosis modulators|mesh-ancestor
110076837|NCT02229084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110076838|NCT02229084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110076839|NCT02229084|Immunologic Factors|immunologic factors|mesh-ancestor
110076840|NCT02229084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110076841|NCT02229084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110076842|NCT02229084|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110076843|NCT02229084|Alkylating Agents|alkylating agents|mesh-ancestor
110076844|NCT02229084|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110076845|NCT02229084|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110076846|NCT02229084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110076847|NCT02229084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110076848|NCT02229084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110076849|NCT02229084|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110076851|NCT02188121|Simvastatin|simvastatin|mesh-list
110076852|NCT02188121|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110076853|NCT02188121|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110076854|NCT02188121|Antimetabolites|antimetabolites|mesh-ancestor
110076855|NCT02188121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110076856|NCT02188121|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110076857|NCT02188121|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110076858|NCT02188121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110076859|NCT02188121|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110076860|NCT02188121|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110076861|NCT02188121|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110076862|NCT02188121|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110076863|NCT02039063|Quetmolimab|quetmolimab|mesh-list
110076864|NCT02039063|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110076865|NCT02039063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110076866|NCT02039063|Immunologic Factors|immunologic factors|mesh-ancestor
110076867|NCT02039063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110076868|NCT01970410|Teriflunomide|teriflunomide|mesh-list
110076869|NCT01970410|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110076870|NCT01970410|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110076871|NCT01970410|Analgesics|analgesics|mesh-ancestor
110076872|NCT01970410|Sensory System Agents|sensory system agents|mesh-ancestor
110076873|NCT01970410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110076874|NCT01970410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110076875|NCT01970410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110076876|NCT01970410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110076877|NCT01970410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110076878|NCT01970410|Immunologic Factors|immunologic factors|mesh-ancestor
110076881|NCT01746173|Cyclophosphamide|cyclophosphamide|mesh-list
110076882|NCT01746173|Melphalan|melphalan|mesh-list
110076883|NCT01746173|Busulfan|busulfan|mesh-list
110076884|NCT01746173|Gemcitabine|gemcitabine|mesh-list
110076885|NCT01746173|Doxorubicin|doxorubicin|mesh-list
110076886|NCT01746173|Etoposide|etoposide|mesh-list
110076887|NCT01746173|Etoposide phosphate|etoposide phosphate|mesh-list
110076888|NCT01746173|Vincristine|vincristine|mesh-list
110076889|NCT01746173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110076890|NCT01746173|Immunologic Factors|immunologic factors|mesh-ancestor
110076891|NCT01746173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110076892|NCT01746173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110076893|NCT01746173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110076894|NCT01746173|Alkylating Agents|alkylating agents|mesh-ancestor
110076895|NCT01746173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110076896|NCT01746173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110076897|NCT01746173|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110076898|NCT01746173|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110076899|NCT01746173|Antimetabolites|antimetabolites|mesh-ancestor
110076900|NCT01746173|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110076901|NCT01746173|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110076902|NCT01746173|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110076903|NCT01746173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110076904|NCT01746173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110076905|NCT01746173|Glucocorticoids|glucocorticoids|mesh-ancestor
110076906|NCT01746173|Hormones|hormones|mesh-ancestor
110076907|NCT01746173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110076908|NCT01746173|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110076909|NCT01746173|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110076910|NCT01746173|Tubulin Modulators|tubulin modulators|mesh-ancestor
110076911|NCT01746173|Antimitotic Agents|antimitotic agents|mesh-ancestor
110076912|NCT01746173|Mitosis Modulators|mitosis modulators|mesh-ancestor
110076913|NCT01746173|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110076914|NCT01746173|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110076915|NCT01746173|Antiviral Agents|antiviral agents|mesh-ancestor
110076916|NCT01746173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110076917|NCT01694004|Benzocaine|benzocaine|mesh-list
110076918|NCT01694004|Anesthetics, Local|anesthetics, local|mesh-ancestor
110076919|NCT01694004|Anesthetics|anesthetics|mesh-ancestor
110076920|NCT01694004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110076921|NCT01694004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110076922|NCT01694004|Sensory System Agents|sensory system agents|mesh-ancestor
110076923|NCT01694004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110076924|NCT01545843|Fluoxetine|fluoxetine|mesh-list
110076925|NCT01545843|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110076926|NCT01545843|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110076927|NCT01545843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110076928|NCT01545843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110076929|NCT01545843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110076930|NCT01545843|Serotonin Agents|serotonin agents|mesh-ancestor
110076931|NCT01545843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110076932|NCT01545843|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110076933|NCT01545843|Antidepressive Agents|antidepressive agents|mesh-ancestor
110076934|NCT01545843|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110076935|NCT01545843|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110076936|NCT01545843|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110076937|NCT01545843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110076938|NCT00843791|Pioglitazone|pioglitazone|mesh-list
110076939|NCT00843791|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
110076940|NCT00843791|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110076941|NCT00843791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110076944|NCT03187769|Autonomic Agents|autonomic agents|mesh-ancestor
110076945|NCT03187769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110076946|NCT03187769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110076947|NCT03187769|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110076948|NCT03187769|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110076949|NCT03187769|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110076950|NCT03187769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110076951|NCT03187769|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110076952|NCT03187769|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110076953|NCT03187769|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110076954|NCT03187769|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110076955|NCT03187769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110076956|NCT03187769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110076957|NCT03187769|Serotonin Agents|serotonin agents|mesh-ancestor
110076958|NCT03161353|Tamoxifen|tamoxifen|mesh-list
110076959|NCT03161353|Carboplatin|carboplatin|mesh-list
110076960|NCT03161353|Docetaxel|docetaxel|mesh-list
110076961|NCT03161353|Trastuzumab|trastuzumab|mesh-list
110076962|NCT03161353|Letrozole|letrozole|mesh-list
110076963|NCT03161353|Pertuzumab|pertuzumab|mesh-list
110076964|NCT03161353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110076965|NCT03161353|Tubulin Modulators|tubulin modulators|mesh-ancestor
110076966|NCT03161353|Antimitotic Agents|antimitotic agents|mesh-ancestor
110076967|NCT03161353|Mitosis Modulators|mitosis modulators|mesh-ancestor
110076968|NCT03161353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110076969|NCT03161353|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110076970|NCT03161353|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110076971|NCT03161353|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110076972|NCT03161353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110076973|NCT03161353|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110076974|NCT03161353|Hormone Antagonists|hormone antagonists|mesh-ancestor
110076975|NCT03161353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110076976|NCT03161353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110076977|NCT03161353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110076978|NCT03161353|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110076979|NCT03161353|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110076980|NCT03161353|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110076981|NCT03136731|Antibodies|antibodies|mesh-list
110076982|NCT03136731|Immunologic Factors|immunologic factors|mesh-ancestor
110076983|NCT03136731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110076985|NCT03134196|Antiviral Agents|antiviral agents|mesh-ancestor
110076986|NCT03134196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110076987|NCT02956382|Venetoclax|venetoclax|mesh-list
110076988|NCT02956382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110076989|NCT02939573|Dapsone|dapsone|mesh-list
110076990|NCT02939573|Colchicine|colchicine|mesh-list
110076991|NCT02939573|Azathioprine|azathioprine|mesh-list
110076992|NCT02939573|Gout Suppressants|gout suppressants|mesh-ancestor
110076993|NCT02939573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110076994|NCT02939573|Tubulin Modulators|tubulin modulators|mesh-ancestor
110076995|NCT02939573|Antimitotic Agents|antimitotic agents|mesh-ancestor
110076996|NCT02939573|Mitosis Modulators|mitosis modulators|mesh-ancestor
110076997|NCT02939573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110076998|NCT02939573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110076999|NCT02939573|Antimetabolites|antimetabolites|mesh-ancestor
110077000|NCT02939573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110077001|NCT02939573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110077002|NCT02939573|Immunologic Factors|immunologic factors|mesh-ancestor
110077003|NCT02939573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110077004|NCT02939573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110077005|NCT02939573|Antimalarials|antimalarials|mesh-ancestor
110077006|NCT02939573|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110077007|NCT02939573|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110077008|NCT02939573|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110077009|NCT02939573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110077010|NCT02939573|Leprostatic Agents|leprostatic agents|mesh-ancestor
110077011|NCT02939573|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110077012|NCT02855229|Methylphenidate|methylphenidate|mesh-list
110077014|NCT02855229|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110077015|NCT02855229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110077016|NCT02855229|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110077017|NCT02855229|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110077018|NCT02855229|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110077019|NCT02855229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110077020|NCT02855229|Dopamine Agents|dopamine agents|mesh-ancestor
110077021|NCT02855229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110077022|NCT02855229|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
110077023|NCT02855229|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110077024|NCT02855229|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110077025|NCT02829931|Bevacizumab|bevacizumab|mesh-list
110077027|NCT02829931|Ipilimumab|ipilimumab|mesh-list
110077028|NCT02829931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110077030|NCT02829931|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110077031|NCT02829931|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110077032|NCT02829931|Growth Substances|growth substances|mesh-ancestor
110077033|NCT02829931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110077034|NCT02829931|Growth Inhibitors|growth inhibitors|mesh-ancestor
110077035|NCT02829931|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110077036|NCT02829931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110077037|NCT02815566|Tenofovir|tenofovir|mesh-list
110077038|NCT02815566|Emtricitabine|emtricitabine|mesh-list
110077039|NCT02815566|Antiviral Agents|antiviral agents|mesh-ancestor
110077040|NCT02815566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110077041|NCT02815566|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110077042|NCT02815566|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110077043|NCT02815566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110077044|NCT02815566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110077045|NCT02815566|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110077046|NCT02815566|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110077047|NCT02769845|Hydroxyurea|hydroxyurea|mesh-list
110077048|NCT02769845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110077049|NCT02769845|Antisickling Agents|antisickling agents|mesh-ancestor
110077050|NCT02769845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110077051|NCT02769845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110077052|NCT02769845|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110077053|NCT02702492|Niacin|niacin|mesh-list
110077054|NCT02702492|Nivolumab|nivolumab|mesh-list
110077055|NCT02702492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110077056|NCT02702492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110077057|NCT02702492|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110077058|NCT02702492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110077060|NCT02702492|Antimetabolites|antimetabolites|mesh-ancestor
110077061|NCT02702492|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110077062|NCT02702492|Vasodilator Agents|vasodilator agents|mesh-ancestor
110077063|NCT02702492|Vitamin B Complex|vitamin b complex|mesh-ancestor
110077064|NCT02702492|Vitamins|vitamins|mesh-ancestor
110077065|NCT02702492|Micronutrients|micronutrients|mesh-ancestor
110077066|NCT02702492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110077067|NCT02652455|Aldesleukin|aldesleukin|mesh-list
110077068|NCT02652455|Cyclophosphamide|cyclophosphamide|mesh-list
110077069|NCT02652455|Nivolumab|nivolumab|mesh-list
110077070|NCT02652455|Fludarabine|fludarabine|mesh-list
110077071|NCT02652455|Interleukin-2|interleukin-2|mesh-list
110077072|NCT02652455|Antibodies|antibodies|mesh-list
110077073|NCT02652455|Immunoglobulins|immunoglobulins|mesh-list
110077074|NCT02652455|Antibodies, Blocking|antibodies, blocking|mesh-list
110077075|NCT02652455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110077077|NCT02652455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110077078|NCT02652455|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110077079|NCT02652455|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110077080|NCT02652455|Alkylating Agents|alkylating agents|mesh-ancestor
110077081|NCT02652455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110077082|NCT02652455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110077083|NCT02652455|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110077084|NCT02652455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110077085|NCT02652455|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110077086|NCT02652455|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110077087|NCT02652455|Analgesics|analgesics|mesh-ancestor
110077088|NCT02652455|Sensory System Agents|sensory system agents|mesh-ancestor
110077089|NCT02652455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110077090|NCT02652455|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110077091|NCT02652455|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110077092|NCT02652455|Antiviral Agents|antiviral agents|mesh-ancestor
110077093|NCT02652455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110077094|NCT02491983|Letrozole|letrozole|mesh-list
110077095|NCT02491983|Fulvestrant|fulvestrant|mesh-list
110077097|NCT02491983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110077098|NCT02491983|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110077099|NCT02491983|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110077100|NCT02491983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110077101|NCT02491983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110077102|NCT02491983|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110077103|NCT02491983|Hormone Antagonists|hormone antagonists|mesh-ancestor
110077104|NCT02491983|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110077105|NCT02491983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110077106|NCT02491983|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110077107|NCT02491983|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110077108|NCT02491983|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110077109|NCT02467478|Linagliptin|linagliptin|mesh-list
110077110|NCT02467478|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110077111|NCT02467478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110077112|NCT02467478|Incretins|incretins|mesh-ancestor
110077113|NCT02467478|Hormones|hormones|mesh-ancestor
110077114|NCT02467478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110077115|NCT02467478|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110077116|NCT02467478|Protease Inhibitors|protease inhibitors|mesh-ancestor
110077117|NCT02467478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110077118|NCT02467478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110077120|NCT02466243|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
110077121|NCT02466243|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110077122|NCT02466243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110077123|NCT02466243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110077124|NCT02466243|Hormones|hormones|mesh-ancestor
110077125|NCT02466243|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110077126|NCT02466243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110077127|NCT02321098|Amorolfine|amorolfine|mesh-list
110077128|NCT02321098|Antifungal Agents|antifungal agents|mesh-ancestor
110077129|NCT02321098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110077130|NCT02185417|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110077131|NCT02185417|Chlorthalidone|chlorthalidone|mesh-list
110077132|NCT02185417|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110077133|NCT02185417|Diuretics|diuretics|mesh-ancestor
110077134|NCT02185417|Natriuretic Agents|natriuretic agents|mesh-ancestor
110077135|NCT02185417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110077136|NCT02185417|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110077137|NCT02185417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110077138|NCT02185417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110077139|NCT02158234|Cisplatin|cisplatin|mesh-list
110077140|NCT02158234|Alkylating Agents|alkylating agents|mesh-list
110077141|NCT02158234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110077142|NCT02158234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110077143|NCT01966731|Hydroxyurea|hydroxyurea|mesh-list
110077144|NCT01966731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110077145|NCT01966731|Antisickling Agents|antisickling agents|mesh-ancestor
110077146|NCT01966731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110077147|NCT01966731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110077148|NCT01966731|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110077150|NCT01953926|Fulvestrant|fulvestrant|mesh-list
110077151|NCT01953926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110077152|NCT01953926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110077153|NCT01953926|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110077154|NCT01953926|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110077155|NCT01953926|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110077156|NCT01953926|Hormone Antagonists|hormone antagonists|mesh-ancestor
110077157|NCT01953926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110077158|NCT01953926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110077159|NCT01859026|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110077161|NCT01859026|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
110077162|NCT01859026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110077163|NCT01859026|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110077164|NCT01859026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110077165|NCT01859026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110077166|NCT01859026|Mitosis Modulators|mitosis modulators|mesh-ancestor
110077168|NCT01843374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110077169|NCT01657591|Vemurafenib|vemurafenib|mesh-list
110077170|NCT01657591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110077171|NCT01657591|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110077172|NCT01657591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110077173|NCT01657591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110077174|NCT01599468|Tranexamic Acid|tranexamic acid|mesh-list
110077175|NCT01599468|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110077176|NCT01599468|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110077177|NCT01599468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110077178|NCT01599468|Hemostatics|hemostatics|mesh-ancestor
110077179|NCT01599468|Coagulants|coagulants|mesh-ancestor
110077180|NCT01599572|Zinc|zinc|mesh-list
110077181|NCT01599572|Trace Elements|trace elements|mesh-ancestor
110077182|NCT01599572|Micronutrients|micronutrients|mesh-ancestor
110077183|NCT01599572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110077184|NCT01599598|Imidacloprid|imidacloprid|mesh-list
110077185|NCT01599598|Cholinergic Agents|cholinergic agents|mesh-ancestor
110077186|NCT01599598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110077187|NCT01599598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110077188|NCT01599598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110077189|NCT01599702|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
110077190|NCT01599702|Hematinics|hematinics|mesh-ancestor
110077191|NCT01599728|Substance P|substance p|mesh-list
110077192|NCT01599728|Neurokinin A|neurokinin a|mesh-list
110077193|NCT01599728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110077194|NCT01599728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110077195|NCT01599728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110077196|NCT01599819|Factor VIII|factor viii|mesh-list
110077197|NCT01599819|BAX 855|bax 855|mesh-list
110077198|NCT01599819|Coagulants|coagulants|mesh-ancestor
110077199|NCT01599858|Omeprazole|omeprazole|mesh-list
110077200|NCT01599858|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110077201|NCT01599858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110077202|NCT01599858|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110077203|NCT01599858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110077204|NCT01599858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110077205|NCT01599871|Theophylline|theophylline|mesh-list
110077206|NCT01599871|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110077207|NCT01599871|Autonomic Agents|autonomic agents|mesh-ancestor
110077208|NCT01599871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110077209|NCT01599871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110077210|NCT01599871|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110077211|NCT01599871|Respiratory System Agents|respiratory system agents|mesh-ancestor
110077212|NCT01599871|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110077213|NCT01599871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110077214|NCT01599871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110077215|NCT01599871|Vasodilator Agents|vasodilator agents|mesh-ancestor
110077216|NCT01599871|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110077217|NCT01599871|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110077219|NCT01599871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110077220|NCT01599884|Acetylcysteine|acetylcysteine|mesh-list
110077221|NCT01599884|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110077222|NCT01599884|Antiviral Agents|antiviral agents|mesh-ancestor
110077223|NCT01599884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110077224|NCT01599884|Expectorants|expectorants|mesh-ancestor
110077225|NCT01599884|Respiratory System Agents|respiratory system agents|mesh-ancestor
110077226|NCT01599884|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110077227|NCT01599884|Antioxidants|antioxidants|mesh-ancestor
110077228|NCT01599884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110077229|NCT01599884|Protective Agents|protective agents|mesh-ancestor
110077230|NCT01599884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110077231|NCT01599884|Antidotes|antidotes|mesh-ancestor
110077232|NCT01599923|Antivenins|antivenins|mesh-list
110077233|NCT01599923|Immunologic Factors|immunologic factors|mesh-ancestor
110077234|NCT01599923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110077235|NCT01599936|Antivenins|antivenins|mesh-list
110077236|NCT01599936|Immunologic Factors|immunologic factors|mesh-ancestor
110077237|NCT01599936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110077238|NCT01599962|Cinacalcet|cinacalcet|mesh-list
110077239|NCT01599962|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110077240|NCT01599962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110077241|NCT01599962|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
110077242|NCT01599962|Hormone Antagonists|hormone antagonists|mesh-ancestor
110077243|NCT01599962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110077244|NCT01599975|Methylphenidate|methylphenidate|mesh-list
110077245|NCT01599975|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110077246|NCT01599975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110077247|NCT01599975|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110077248|NCT01599975|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110077249|NCT01599975|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110077250|NCT01599975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110077251|NCT01599975|Dopamine Agents|dopamine agents|mesh-ancestor
110077252|NCT01599975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110077254|NCT01599988|Chelating Agents|chelating agents|mesh-ancestor
110077255|NCT01599988|Sequestering Agents|sequestering agents|mesh-ancestor
110077256|NCT01599988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110077258|NCT01600430|Ergocalciferols|ergocalciferols|mesh-list
110077259|NCT01600430|Cholecalciferol|cholecalciferol|mesh-list
110077260|NCT01600430|Vitamins|vitamins|mesh-list
110077261|NCT01600430|Micronutrients|micronutrients|mesh-ancestor
110077262|NCT01600430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110077263|NCT01600430|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110077264|NCT01600430|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110077265|NCT01600599|Tranexamic Acid|tranexamic acid|mesh-list
110077266|NCT01600599|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110077267|NCT01600599|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110077268|NCT01600599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110077269|NCT01600599|Hemostatics|hemostatics|mesh-ancestor
110077270|NCT01600599|Coagulants|coagulants|mesh-ancestor
110077271|NCT01601028|Hydroxychloroquine|hydroxychloroquine|mesh-list
110077272|NCT01601028|Antimalarials|antimalarials|mesh-ancestor
110077273|NCT01601028|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110077274|NCT01601028|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110077275|NCT01601028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110077276|NCT01601028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110077277|NCT01601028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110077279|NCT01602029|Ondansetron|ondansetron|mesh-list
110077280|NCT01602029|Simvastatin|simvastatin|mesh-list
110077281|NCT01602029|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110077282|NCT01602029|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110077283|NCT01602029|Antimetabolites|antimetabolites|mesh-ancestor
110077284|NCT01602029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110077285|NCT01602029|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110077286|NCT01602029|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110077287|NCT01602029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110077288|NCT01602029|Antiemetics|antiemetics|mesh-ancestor
110077289|NCT01602029|Autonomic Agents|autonomic agents|mesh-ancestor
110077290|NCT01602029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110077291|NCT01602029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110077292|NCT01602029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110077293|NCT01602029|Antipruritics|antipruritics|mesh-ancestor
110077294|NCT01602029|Dermatologic Agents|dermatologic agents|mesh-ancestor
110077295|NCT01602029|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110077296|NCT01602029|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110077297|NCT01602029|Serotonin Agents|serotonin agents|mesh-ancestor
110077298|NCT01602029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110077299|NCT01602874|Metronidazole|metronidazole|mesh-list
110077300|NCT01602874|Clarithromycin|clarithromycin|mesh-list
110077301|NCT01602874|Ceftriaxone|ceftriaxone|mesh-list
110077302|NCT01602874|Tigecycline|tigecycline|mesh-list
110077303|NCT01602874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110077304|NCT01602874|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110077305|NCT01602874|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110077306|NCT01602874|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110077307|NCT01602874|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110077308|NCT01602874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110077309|NCT01602874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110077310|NCT01602874|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110077311|NCT01602874|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110077312|NCT01602887|Palbociclib|palbociclib|mesh-list
110077313|NCT01602887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110077314|NCT01602887|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110077315|NCT01602887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110077316|NCT01602887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110077317|NCT01603264|Trastuzumab|trastuzumab|mesh-list
110077318|NCT01603264|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110077319|NCT01603264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110077320|NCT01603680|Anesthetics|anesthetics|mesh-list
110077321|NCT01603680|Mepivacaine|mepivacaine|mesh-list
110077322|NCT01603680|Anesthetics, Local|anesthetics, local|mesh-list
110077323|NCT01603680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110077324|NCT01603680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110077325|NCT01603680|Sensory System Agents|sensory system agents|mesh-ancestor
110077326|NCT01603680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110077328|NCT01604213|Vildagliptin|vildagliptin|mesh-list
110077329|NCT01604213|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110077330|NCT01604213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110077331|NCT01604213|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110077332|NCT01604213|Protease Inhibitors|protease inhibitors|mesh-ancestor
110077333|NCT01604213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110077334|NCT01604213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110077335|NCT01605240|Acetaminophen|acetaminophen|mesh-list
110077336|NCT01605240|Ibuprofen|ibuprofen|mesh-list
110077337|NCT01605240|Codeine|codeine|mesh-list
110077338|NCT01605240|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110077339|NCT01605240|Analgesics|analgesics|mesh-ancestor
110077340|NCT01605240|Sensory System Agents|sensory system agents|mesh-ancestor
110183662|NCT00030732|Gemcitabine|gemcitabine|mesh-list
110077341|NCT01605240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110077342|NCT01605240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110077343|NCT01605240|Antipyretics|antipyretics|mesh-ancestor
110077344|NCT01605240|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110077345|NCT01605240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110077346|NCT01605240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110077347|NCT01605240|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110077348|NCT01605240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110077349|NCT01605240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110077350|NCT01605240|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110077351|NCT01605240|Narcotics|narcotics|mesh-ancestor
110077352|NCT01605240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110077353|NCT01605240|Antitussive Agents|antitussive agents|mesh-ancestor
110077354|NCT01605240|Respiratory System Agents|respiratory system agents|mesh-ancestor
110077355|NCT01605279|Dobutamine|dobutamine|mesh-list
110077356|NCT01605279|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110077357|NCT01605279|Sympathomimetics|sympathomimetics|mesh-ancestor
110077358|NCT01605279|Autonomic Agents|autonomic agents|mesh-ancestor
110077359|NCT01605279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110077360|NCT01605279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110077361|NCT01605279|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
110077362|NCT01605279|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110077363|NCT01605279|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110077364|NCT01605279|Adrenergic Agents|adrenergic agents|mesh-ancestor
110077365|NCT01605279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110077366|NCT01605279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110077367|NCT01605279|Protective Agents|protective agents|mesh-ancestor
110077368|NCT01606072|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
110077369|NCT01606072|Hemostatics|hemostatics|mesh-ancestor
110077370|NCT01606072|Coagulants|coagulants|mesh-ancestor
110077371|NCT01606072|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
110077373|NCT01606072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110077374|NCT01606722|Ritonavir|ritonavir|mesh-list
110077375|NCT01606722|Darunavir|darunavir|mesh-list
110077376|NCT01606722|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110077377|NCT01606722|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110077378|NCT01606722|Protease Inhibitors|protease inhibitors|mesh-ancestor
110077379|NCT01606722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110077380|NCT01606722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110077381|NCT01606722|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110077382|NCT01606722|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110077383|NCT01606722|Antiviral Agents|antiviral agents|mesh-ancestor
110077384|NCT01606722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110077385|NCT01606722|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110077386|NCT01606722|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110077387|NCT01607983|Nitric Oxide|nitric oxide|mesh-list
110077388|NCT01607983|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110077389|NCT01607983|Autonomic Agents|autonomic agents|mesh-ancestor
110077390|NCT01607983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110077391|NCT01607983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110077392|NCT01607983|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110077393|NCT01607983|Respiratory System Agents|respiratory system agents|mesh-ancestor
110077394|NCT01607983|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110077395|NCT01607983|Antioxidants|antioxidants|mesh-ancestor
110077396|NCT01607983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110077397|NCT01607983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110077398|NCT01607983|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
110077399|NCT01607983|Vasodilator Agents|vasodilator agents|mesh-ancestor
110077400|NCT01607983|Gasotransmitters|gasotransmitters|mesh-ancestor
110077401|NCT01607983|Protective Agents|protective agents|mesh-ancestor
110077402|NCT01608217|Acetaminophen|acetaminophen|mesh-list
110077403|NCT01608217|Dronabinol|dronabinol|mesh-list
110077404|NCT01608217|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110077405|NCT01608217|Analgesics|analgesics|mesh-ancestor
110077406|NCT01608217|Sensory System Agents|sensory system agents|mesh-ancestor
110077407|NCT01608217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110077408|NCT01608217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110077409|NCT01608217|Antipyretics|antipyretics|mesh-ancestor
110077410|NCT01608217|Hallucinogens|hallucinogens|mesh-ancestor
110077411|NCT01608217|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110077412|NCT01608217|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
110077413|NCT01608217|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110077414|NCT01608217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110077415|NCT01608217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110077416|NCT01608217|Hormones|hormones|mesh-ancestor
110077417|NCT01608217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110077418|NCT01608594|Ipilimumab|ipilimumab|mesh-list
110077419|NCT01608594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110077420|NCT01608594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110077421|NCT01608594|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110077422|NCT01608594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110077423|NCT01608854|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110077424|NCT01608854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110077425|NCT01608880|Nitroglycerin|nitroglycerin|mesh-list
110077426|NCT01608880|Vasodilator Agents|vasodilator agents|mesh-ancestor
110077427|NCT01608958|Oxytocin|oxytocin|mesh-list
110077428|NCT01608958|Oxytocics|oxytocics|mesh-ancestor
110077429|NCT01608958|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110077430|NCT01608958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110077431|NCT01609153|Olanzapine|olanzapine|mesh-list
110077432|NCT01609153|Amisulpride|amisulpride|mesh-list
110077433|NCT01609153|Antiemetics|antiemetics|mesh-ancestor
110077434|NCT01609153|Autonomic Agents|autonomic agents|mesh-ancestor
110077435|NCT01609153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110077436|NCT01609153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110077437|NCT01609153|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110077438|NCT01609153|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110077439|NCT01609153|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110077440|NCT01609153|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110077441|NCT01609153|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110077442|NCT01609153|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110077443|NCT01609153|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110077444|NCT01609153|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110077445|NCT01609153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110077446|NCT01609153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110077447|NCT01609153|Serotonin Agents|serotonin agents|mesh-ancestor
110077448|NCT01609153|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110077449|NCT01609153|Dopamine Agents|dopamine agents|mesh-ancestor
110077450|NCT01609153|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110077451|NCT01609153|Antidepressive Agents|antidepressive agents|mesh-ancestor
110077453|NCT01610141|Anticoagulants|anticoagulants|mesh-ancestor
110077454|NCT01610310|Interferon-beta|interferon-beta|mesh-list
110077455|NCT01610310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110077456|NCT01610310|Antiviral Agents|antiviral agents|mesh-ancestor
110077457|NCT01610310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110077458|NCT01610310|Immunologic Factors|immunologic factors|mesh-ancestor
110077459|NCT01610310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110077460|NCT01610362|Immunoglobulins|immunoglobulins|mesh-list
110077461|NCT01610362|Antibodies|antibodies|mesh-list
110077462|NCT01610362|gamma-Globulins|gamma-globulins|mesh-list
110077463|NCT01610362|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110077464|NCT01610362|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110077465|NCT01610362|Immunoglobulin G|immunoglobulin g|mesh-list
110077466|NCT01610362|Immunologic Factors|immunologic factors|mesh-ancestor
110077467|NCT01610362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110077469|NCT01610401|Caffeine|caffeine|mesh-list
110077470|NCT01610401|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110077471|NCT01610401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110077472|NCT01610401|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110077473|NCT01610401|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110077474|NCT01610401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110077475|NCT01610401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110077476|NCT01610401|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110077477|NCT01610401|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110077478|NCT01610401|Purinergic Agents|purinergic agents|mesh-ancestor
110077479|NCT01610401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110077480|NCT01610765|Antiviral Agents|antiviral agents|mesh-list
110077481|NCT01610765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110077483|NCT01610778|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110077484|NCT01610778|Dermatologic Agents|dermatologic agents|mesh-ancestor
110077485|NCT01610869|Nintedanib|nintedanib|mesh-list
110077486|NCT01610869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110077487|NCT01610869|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110077488|NCT01610869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110077489|NCT01610869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110077490|NCT01610921|Adenosine|adenosine|mesh-list
110077491|NCT01610921|Analgesics|analgesics|mesh-ancestor
110077492|NCT01610921|Sensory System Agents|sensory system agents|mesh-ancestor
110077493|NCT01610921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110077494|NCT01610921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110077495|NCT01610921|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110077496|NCT01610921|Vasodilator Agents|vasodilator agents|mesh-ancestor
110077497|NCT01610921|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
110077498|NCT01610921|Purinergic Agonists|purinergic agonists|mesh-ancestor
110077499|NCT01610921|Purinergic Agents|purinergic agents|mesh-ancestor
110077500|NCT01610921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110077501|NCT01610921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110077502|NCT01610934|Liraglutide|liraglutide|mesh-list
110077503|NCT01610934|Glimepiride|glimepiride|mesh-list
110077504|NCT01610934|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110077505|NCT01610934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110077506|NCT01610934|Incretins|incretins|mesh-ancestor
110077507|NCT01610934|Hormones|hormones|mesh-ancestor
110077508|NCT01610934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110077509|NCT01610934|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110077510|NCT01610934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110077511|NCT01610934|Immunologic Factors|immunologic factors|mesh-ancestor
110077512|NCT01610947|Adalimumab|adalimumab|mesh-list
110077513|NCT01610947|Infliximab|infliximab|mesh-list
110077514|NCT01610947|Golimumab|golimumab|mesh-list
110077515|NCT01610947|Etanercept|etanercept|mesh-list
110077516|NCT01610947|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110077517|NCT01610947|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110077518|NCT01610947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110077519|NCT01610947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110077520|NCT01610947|Dermatologic Agents|dermatologic agents|mesh-ancestor
110077521|NCT01610947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110077522|NCT01610947|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110077523|NCT01610947|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110077524|NCT01610947|Analgesics|analgesics|mesh-ancestor
110077525|NCT01610947|Sensory System Agents|sensory system agents|mesh-ancestor
110077526|NCT01610947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110077527|NCT01610947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110077528|NCT01610947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110077529|NCT01610947|Immunologic Factors|immunologic factors|mesh-ancestor
110077530|NCT01610999|Plerixafor|plerixafor|mesh-list
110077531|NCT01610999|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110077532|NCT01610999|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110077533|NCT01610999|Antiviral Agents|antiviral agents|mesh-ancestor
110077534|NCT01610999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110077535|NCT01611038|Selenomethylselenocysteine|selenomethylselenocysteine|mesh-list
110077536|NCT01611038|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110077537|NCT01611038|Protective Agents|protective agents|mesh-ancestor
110077538|NCT01611038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110077539|NCT01611038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110077540|NCT01611077|Amlodipine|amlodipine|mesh-list
110077541|NCT01611077|Candesartan|candesartan|mesh-list
110077542|NCT01611077|Candesartan cilexetil|candesartan cilexetil|mesh-list
110077543|NCT01611077|Olmesartan|olmesartan|mesh-list
110077544|NCT01611077|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
110077545|NCT01611077|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110077546|NCT01611077|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110077547|NCT01611077|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110077548|NCT01611077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110164778|NCT00021346|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110077549|NCT01611077|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110077550|NCT01611077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110077551|NCT01611077|Vasodilator Agents|vasodilator agents|mesh-ancestor
110077552|NCT01611077|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110077553|NCT01611077|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110077555|NCT01611142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110077556|NCT01611311|BI 409306|bi 409306|mesh-list
110077557|NCT01611311|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110077558|NCT01611311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110077559|NCT01611311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110077560|NCT01611324|Epinephrine|epinephrine|mesh-list
110077561|NCT01611324|Mepivacaine|mepivacaine|mesh-list
110077562|NCT01611324|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110077563|NCT01611324|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110077564|NCT01611324|Adrenergic Agents|adrenergic agents|mesh-ancestor
110077565|NCT01611324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110077566|NCT01611324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110077567|NCT01611324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110077568|NCT01611324|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110077569|NCT01611324|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110077570|NCT01611324|Autonomic Agents|autonomic agents|mesh-ancestor
110077571|NCT01611324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110077572|NCT01611324|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110077573|NCT01611324|Respiratory System Agents|respiratory system agents|mesh-ancestor
110077574|NCT01611324|Mydriatics|mydriatics|mesh-ancestor
110077575|NCT01611324|Sympathomimetics|sympathomimetics|mesh-ancestor
110077576|NCT01611324|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110077577|NCT01611324|Anesthetics, Local|anesthetics, local|mesh-ancestor
110077578|NCT01611324|Anesthetics|anesthetics|mesh-ancestor
110077579|NCT01611324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110077580|NCT01611324|Sensory System Agents|sensory system agents|mesh-ancestor
110077581|NCT01611363|Ipragliflozin|ipragliflozin|mesh-list
110077582|NCT01611363|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110077583|NCT01611363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110077584|NCT01611363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110077585|NCT01611363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110077586|NCT01611415|Ipragliflozin|ipragliflozin|mesh-list
110077587|NCT01611415|Furosemide|furosemide|mesh-list
110077588|NCT01611415|Diuretics|diuretics|mesh-ancestor
110077589|NCT01611415|Natriuretic Agents|natriuretic agents|mesh-ancestor
110077590|NCT01611415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110077591|NCT01611415|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110077592|NCT01611415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110077593|NCT01611415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110077594|NCT01611415|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110077595|NCT01611415|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110077596|NCT01611428|Ipragliflozin|ipragliflozin|mesh-list
110077597|NCT01611428|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110077598|NCT01611428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110077599|NCT01611428|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110077600|NCT01611428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110077602|NCT01611480|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110077603|NCT01611480|Immunologic Factors|immunologic factors|mesh-ancestor
110077604|NCT01611480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110077605|NCT01611480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110077606|NCT01611480|Interferon Inducers|interferon inducers|mesh-ancestor
110077607|NCT01611506|Capecitabine|capecitabine|mesh-list
110077608|NCT01611506|Cetuximab|cetuximab|mesh-list
110077609|NCT01611506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110077610|NCT01611506|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110077611|NCT01611506|Antimetabolites|antimetabolites|mesh-ancestor
110077612|NCT01611506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110077613|NCT01611506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110077614|NCT01611675|Vemurafenib|vemurafenib|mesh-list
110077615|NCT01611675|Leflunomide|leflunomide|mesh-list
110077616|NCT01611675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110077617|NCT01611675|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110077618|NCT01611675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110077619|NCT01611675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110077620|NCT01611675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110077621|NCT01611675|Immunologic Factors|immunologic factors|mesh-ancestor
110077622|NCT01611675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110077623|NCT01611688|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110077624|NCT01611688|Immunologic Factors|immunologic factors|mesh-ancestor
110077625|NCT01611688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110077626|NCT01611727|Cisplatin|cisplatin|mesh-list
110077627|NCT01611727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110077628|NCT01611896|Selenium|selenium|mesh-list
110077629|NCT01611896|Antioxidants|antioxidants|mesh-ancestor
110077630|NCT01611896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110077631|NCT01611896|Protective Agents|protective agents|mesh-ancestor
110077632|NCT01611896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110077633|NCT01611896|Trace Elements|trace elements|mesh-ancestor
110077634|NCT01611896|Micronutrients|micronutrients|mesh-ancestor
110077636|NCT01611909|Expectorants|expectorants|mesh-ancestor
110077637|NCT01611909|Respiratory System Agents|respiratory system agents|mesh-ancestor
110077638|NCT01611961|Docetaxel|docetaxel|mesh-list
110077639|NCT01611961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110077640|NCT01611961|Tubulin Modulators|tubulin modulators|mesh-ancestor
110077641|NCT01611961|Antimitotic Agents|antimitotic agents|mesh-ancestor
110077642|NCT01611961|Mitosis Modulators|mitosis modulators|mesh-ancestor
110077643|NCT01611961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110077644|NCT01612052|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110077645|NCT01612052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110077646|NCT01612065|Misoprostol|misoprostol|mesh-list
110077647|NCT01612065|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110077648|NCT01612065|Abortifacient Agents|abortifacient agents|mesh-ancestor
110077649|NCT01612065|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110077650|NCT01612065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110077651|NCT01612065|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110077652|NCT01612065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110077653|NCT01612065|Oxytocics|oxytocics|mesh-ancestor
110077655|NCT01612078|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110077656|NCT01612078|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110077657|NCT01612247|Aspirin|aspirin|mesh-list
110077658|NCT01612247|Cyclophosphamide|cyclophosphamide|mesh-list
110077659|NCT01612247|Methotrexate|methotrexate|mesh-list
110077660|NCT01612247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110077661|NCT01612247|Immunologic Factors|immunologic factors|mesh-ancestor
110077662|NCT01612247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110077663|NCT01612247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110077664|NCT01612247|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110077665|NCT01612247|Alkylating Agents|alkylating agents|mesh-ancestor
110077666|NCT01612247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110077667|NCT01612247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110077668|NCT01612247|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110077669|NCT01612247|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110077670|NCT01612247|Abortifacient Agents|abortifacient agents|mesh-ancestor
110077671|NCT01612247|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110077672|NCT01612247|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110077673|NCT01612247|Antimetabolites|antimetabolites|mesh-ancestor
110077674|NCT01612247|Dermatologic Agents|dermatologic agents|mesh-ancestor
110077675|NCT01612247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110077676|NCT01612247|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110077677|NCT01612247|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110077678|NCT01612247|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110077679|NCT01612247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110077680|NCT01612247|Analgesics|analgesics|mesh-ancestor
110077681|NCT01612247|Sensory System Agents|sensory system agents|mesh-ancestor
110077682|NCT01612247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110077683|NCT01612247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110077684|NCT01612247|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110077686|NCT01612247|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110077687|NCT01612247|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110077688|NCT01612247|Antipyretics|antipyretics|mesh-ancestor
110077689|NCT01612273|Aspirin|aspirin|mesh-list
110077690|NCT01612273|Triflusal|triflusal|mesh-list
110077691|NCT01612273|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110077692|NCT01612273|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110077693|NCT01612273|Analgesics|analgesics|mesh-ancestor
110077694|NCT01612273|Sensory System Agents|sensory system agents|mesh-ancestor
110077695|NCT01612273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110077696|NCT01612273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110077697|NCT01612273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110077698|NCT01612273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110077699|NCT01612273|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110077700|NCT01612273|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110077701|NCT01612273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110077702|NCT01612273|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110077703|NCT01612273|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110077704|NCT01612273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110077705|NCT01612273|Antipyretics|antipyretics|mesh-ancestor
110077706|NCT01612286|Endostatins|endostatins|mesh-list
110077707|NCT01612286|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110077708|NCT01612286|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110077709|NCT01612286|Growth Substances|growth substances|mesh-ancestor
110077710|NCT01612286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110077711|NCT01612286|Growth Inhibitors|growth inhibitors|mesh-ancestor
110077712|NCT01612286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110077714|NCT01612299|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110077715|NCT01612299|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110077716|NCT01612299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110077717|NCT01612299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110077718|NCT01612299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110077719|NCT01612299|Immunologic Factors|immunologic factors|mesh-ancestor
110077720|NCT01612299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110077721|NCT01612299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110077722|NCT01612377|Prednisone|prednisone|mesh-list
110077723|NCT01612377|Prednisolone|prednisolone|mesh-list
110077724|NCT01612377|Dipyridamole|dipyridamole|mesh-list
110077725|NCT01612377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110077726|NCT01612377|Glucocorticoids|glucocorticoids|mesh-ancestor
110077727|NCT01612377|Hormones|hormones|mesh-ancestor
110077728|NCT01612377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110077729|NCT01612377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110077730|NCT01612377|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110077731|NCT01612377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110077732|NCT01612377|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110077733|NCT01612377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110077734|NCT01612377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110077735|NCT01612377|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110077736|NCT01612377|Vasodilator Agents|vasodilator agents|mesh-ancestor
110077737|NCT01612403|Zinc Sulfate|zinc sulfate|mesh-list
110077738|NCT01612403|Astringents|astringents|mesh-ancestor
110077739|NCT01612403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110077740|NCT01612403|Dermatologic Agents|dermatologic agents|mesh-ancestor
110077741|NCT01612468|Liraglutide|liraglutide|mesh-list
110077742|NCT01612468|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110077743|NCT01612468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110077744|NCT01612468|Incretins|incretins|mesh-ancestor
110077745|NCT01612468|Hormones|hormones|mesh-ancestor
110077746|NCT01612468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110077747|NCT01612507|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
110077748|NCT01612507|Cephalosporins|cephalosporins|mesh-list
110077749|NCT01612507|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110077750|NCT01612507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110077751|NCT01612728|Aromatase Inhibitors|aromatase inhibitors|mesh-list
110077752|NCT01612728|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110077753|NCT01612728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110077754|NCT01612728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110077755|NCT01612728|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110077756|NCT01612728|Hormone Antagonists|hormone antagonists|mesh-ancestor
110077757|NCT01612728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110077758|NCT01612728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110077760|NCT01612741|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
110077761|NCT01612741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110077762|NCT01612741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110077763|NCT01612741|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110077764|NCT01612741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110077765|NCT01612832|Pregabalin|pregabalin|mesh-list
110077766|NCT01612832|Analgesics|analgesics|mesh-ancestor
110077767|NCT01612832|Sensory System Agents|sensory system agents|mesh-ancestor
110077768|NCT01612832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110077769|NCT01612832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110077770|NCT01612832|Anticonvulsants|anticonvulsants|mesh-ancestor
110077771|NCT01612832|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110077772|NCT01612832|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110077773|NCT01612832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110077774|NCT01612832|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110077775|NCT01612832|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110077776|NCT01612832|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110077777|NCT01612832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110077778|NCT01612832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110077779|NCT01612871|Tamoxifen|tamoxifen|mesh-list
110077780|NCT01612871|Letrozole|letrozole|mesh-list
110077781|NCT01612871|Anastrozole|anastrozole|mesh-list
110077782|NCT01612871|Exemestane|exemestane|mesh-list
110077783|NCT01612871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110077784|NCT01612871|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110077785|NCT01612871|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110077786|NCT01612871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110077787|NCT01612871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110077788|NCT01612871|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110077789|NCT01612871|Hormone Antagonists|hormone antagonists|mesh-ancestor
110077790|NCT01612871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110077791|NCT01612871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110077792|NCT01612871|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110077793|NCT01612871|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110077794|NCT01612871|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110077795|NCT01612871|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110077796|NCT01612910|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
110077797|NCT01612910|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110077798|NCT01612910|Protective Agents|protective agents|mesh-ancestor
110077799|NCT01612910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110077800|NCT01612910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110077801|NCT01612936|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110077802|NCT01612936|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110077803|NCT01612936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110077804|NCT01612975|Naproxen|naproxen|mesh-list
110077805|NCT01612975|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110077806|NCT01612975|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110077807|NCT01612975|Analgesics|analgesics|mesh-ancestor
110077808|NCT01612975|Sensory System Agents|sensory system agents|mesh-ancestor
110077809|NCT01612975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110077810|NCT01612975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110077811|NCT01612975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110077812|NCT01612975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110077813|NCT01612975|Gout Suppressants|gout suppressants|mesh-ancestor
110077814|NCT01612975|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110077815|NCT01612975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110077816|NCT01612975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110077817|NCT01613040|Moxifloxacin|moxifloxacin|mesh-list
110368813|NCT00553943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110077818|NCT01613040|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
110077819|NCT01613040|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110077820|NCT01613040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110077821|NCT01613040|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110077822|NCT01613040|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110077823|NCT01613040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110077824|NCT01613040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110077825|NCT01613040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110077826|NCT01613040|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110077827|NCT01613040|Contraceptive Agents|contraceptive agents|mesh-ancestor
110077828|NCT01613040|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110077829|NCT01613040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110077830|NCT01613040|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110077831|NCT01613040|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110077832|NCT01613040|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110077834|NCT01613053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110077835|NCT01613053|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110077836|NCT01613053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110077837|NCT01613053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110077838|NCT01613079|Methotrexate|methotrexate|mesh-list
110077839|NCT01613079|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110077840|NCT01613079|Abortifacient Agents|abortifacient agents|mesh-ancestor
110077841|NCT01613079|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110077842|NCT01613079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110077843|NCT01613079|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110077844|NCT01613079|Antimetabolites|antimetabolites|mesh-ancestor
110077845|NCT01613079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110077846|NCT01613079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110077847|NCT01613079|Dermatologic Agents|dermatologic agents|mesh-ancestor
110077848|NCT01613079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110077849|NCT01613079|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110077850|NCT01613079|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110077851|NCT01613079|Immunologic Factors|immunologic factors|mesh-ancestor
110077852|NCT01613079|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110077853|NCT01613079|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110077854|NCT01613092|Vancomycin|vancomycin|mesh-list
110077855|NCT01613092|Clindamycin|clindamycin|mesh-list
110077856|NCT01613092|Cefazolin|cefazolin|mesh-list
110077857|NCT01613092|Cephalexin|cephalexin|mesh-list
110077858|NCT01613092|Bacitracin|bacitracin|mesh-list
110077859|NCT01613092|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110077860|NCT01613092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110077861|NCT01613092|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110077862|NCT01613092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110077863|NCT01613092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110077864|NCT01613092|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110077865|NCT01613105|Acarbose|acarbose|mesh-list
110077866|NCT01613105|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
110077867|NCT01613105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110077868|NCT01613105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110077869|NCT01613105|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110077870|NCT01613105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110077871|NCT01613170|Estrogens|estrogens|mesh-list
110077872|NCT01613170|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
110077873|NCT01613170|Hormones|hormones|mesh-ancestor
110077874|NCT01613170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110077875|NCT01613170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110077876|NCT01613196|Deoxyglucose|deoxyglucose|mesh-list
110077877|NCT01613196|Antimetabolites|antimetabolites|mesh-ancestor
110077878|NCT01613196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110077879|NCT01613196|Antiviral Agents|antiviral agents|mesh-ancestor
110077880|NCT01613196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110077881|NCT01613209|Candesartan|candesartan|mesh-list
110077882|NCT01613209|Candesartan cilexetil|candesartan cilexetil|mesh-list
110077883|NCT01613209|Olmesartan|olmesartan|mesh-list
110077884|NCT01613209|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110077885|NCT01613209|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110077886|NCT01613209|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110077887|NCT01613209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110077888|NCT01613300|Ofatumumab|ofatumumab|mesh-list
110077889|NCT01613300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110077890|NCT01613365|Chlorhexidine|chlorhexidine|mesh-list
110077891|NCT01613365|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110077892|NCT01613365|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110077893|NCT01613365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110077894|NCT01613365|Disinfectants|disinfectants|mesh-ancestor
110077895|NCT01613365|Dermatologic Agents|dermatologic agents|mesh-ancestor
110077896|NCT01613469|Leucovorin|leucovorin|mesh-list
110077897|NCT01613469|Antidotes|antidotes|mesh-ancestor
110077898|NCT01613469|Protective Agents|protective agents|mesh-ancestor
110077899|NCT01613469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110077900|NCT01613469|Vitamin B Complex|vitamin b complex|mesh-ancestor
110077901|NCT01613469|Vitamins|vitamins|mesh-ancestor
110077902|NCT01613469|Micronutrients|micronutrients|mesh-ancestor
110077903|NCT01613482|Trastuzumab|trastuzumab|mesh-list
110077904|NCT01613482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110077905|NCT01613482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110077906|NCT01613534|Sucralfate|sucralfate|mesh-list
110077907|NCT01613534|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110077908|NCT01613534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110077909|NCT01613547|Amoxicillin|amoxicillin|mesh-list
110077910|NCT01613547|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110077911|NCT01613547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110077912|NCT01613573|Hormones|hormones|mesh-list
110077913|NCT01613573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110077914|NCT01613573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110077915|NCT01613664|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
110077916|NCT01613664|Hemostatics|hemostatics|mesh-ancestor
110077917|NCT01613664|Coagulants|coagulants|mesh-ancestor
110077918|NCT01613690|Glycopyrrolate|glycopyrrolate|mesh-list
110077919|NCT01613690|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110077920|NCT01613690|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110077921|NCT01613690|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110077922|NCT01613690|Cholinergic Agents|cholinergic agents|mesh-ancestor
110077923|NCT01613690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110077924|NCT01613690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110077925|NCT01613690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110077926|NCT01613755|Metformin|metformin|mesh-list
110077927|NCT01613755|Dipyridamole|dipyridamole|mesh-list
110077928|NCT01613755|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110077929|NCT01613755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110077930|NCT01613755|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110077931|NCT01613755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110077932|NCT01613755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110077933|NCT01613755|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110077934|NCT01613755|Vasodilator Agents|vasodilator agents|mesh-ancestor
110077935|NCT01613794|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110077936|NCT01613794|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110077937|NCT01613794|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110077938|NCT01613794|Antimetabolites|antimetabolites|mesh-ancestor
110077939|NCT01613794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110077940|NCT01613794|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110077941|NCT01613794|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110077942|NCT01613794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110077943|NCT01613807|Insulin|insulin|mesh-list
110077944|NCT01613807|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110077945|NCT01613807|Insulin Lispro|insulin lispro|mesh-list
110164779|NCT00021346|Antimetabolites|antimetabolites|mesh-ancestor
110077946|NCT01613807|Isophane insulin, insulin lispro drug combination 50:50|isophane insulin, insulin lispro drug combination 50:50|mesh-list
110077947|NCT01613807|Insulin, Long-Acting|insulin, long-acting|mesh-list
110077948|NCT01613807|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110077949|NCT01613807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110077950|NCT01613820|Scopolamine|scopolamine|mesh-list
110077951|NCT01613820|Ketamine|ketamine|mesh-list
110077952|NCT01613820|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
110077953|NCT01613820|Analgesics|analgesics|mesh-ancestor
110077954|NCT01613820|Sensory System Agents|sensory system agents|mesh-ancestor
110077955|NCT01613820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110077956|NCT01613820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110077957|NCT01613820|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110077958|NCT01613820|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110077959|NCT01613820|Anesthetics, General|anesthetics, general|mesh-ancestor
110077960|NCT01613820|Anesthetics|anesthetics|mesh-ancestor
110077961|NCT01613820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110077962|NCT01613820|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110077963|NCT01613820|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110077964|NCT01613820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110077965|NCT01613820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110077966|NCT01613820|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110077967|NCT01613820|Antiemetics|antiemetics|mesh-ancestor
110077969|NCT01613820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110077970|NCT01613820|Mydriatics|mydriatics|mesh-ancestor
110077971|NCT01613820|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110077972|NCT01613820|Cholinergic Agents|cholinergic agents|mesh-ancestor
110077973|NCT01613820|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110077974|NCT01613820|Parasympatholytics|parasympatholytics|mesh-ancestor
110077976|NCT01613846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110077977|NCT01613846|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110077978|NCT01613846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110077979|NCT01613846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110077980|NCT01613924|Benzoyl Peroxide|benzoyl peroxide|mesh-list
110077981|NCT01613924|Dermatologic Agents|dermatologic agents|mesh-ancestor
110077982|NCT01613963|Cyclosporine|cyclosporine|mesh-list
110077983|NCT01613963|Mycophenolic Acid|mycophenolic acid|mesh-list
110077984|NCT01613963|Prednisolone|prednisolone|mesh-list
110077985|NCT01613963|Adalimumab|adalimumab|mesh-list
110077986|NCT01613963|Infliximab|infliximab|mesh-list
110077987|NCT01613963|Etanercept|etanercept|mesh-list
110077988|NCT01613963|Methotrexate|methotrexate|mesh-list
110077989|NCT01613963|Azathioprine|azathioprine|mesh-list
110077990|NCT01613963|Cyclosporins|cyclosporins|mesh-list
110077991|NCT01613963|Immunosuppressive Agents|immunosuppressive agents|mesh-list
110077992|NCT01613963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110077993|NCT01613963|Immunologic Factors|immunologic factors|mesh-ancestor
110077994|NCT01613963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110077995|NCT01613963|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110077996|NCT01613963|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110077997|NCT01613963|Abortifacient Agents|abortifacient agents|mesh-ancestor
110077998|NCT01613963|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110077999|NCT01613963|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110078000|NCT01613963|Antimetabolites|antimetabolites|mesh-ancestor
110078001|NCT01613963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110078002|NCT01613963|Dermatologic Agents|dermatologic agents|mesh-ancestor
110078003|NCT01613963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110078004|NCT01613963|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110078005|NCT01613963|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110078006|NCT01613963|Antifungal Agents|antifungal agents|mesh-ancestor
110078007|NCT01613963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110078008|NCT01613963|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110078009|NCT01613963|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110078010|NCT01613963|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110078011|NCT01613963|Antitubercular Agents|antitubercular agents|mesh-ancestor
110078012|NCT01613963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110078013|NCT01613963|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110078014|NCT01613963|Glucocorticoids|glucocorticoids|mesh-ancestor
110078015|NCT01613963|Hormones|hormones|mesh-ancestor
110078016|NCT01613963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110078017|NCT01613963|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110078018|NCT01613963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110078019|NCT01613963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110078020|NCT01613963|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110078021|NCT01613963|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110078022|NCT01613963|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110078024|NCT01613963|Sensory System Agents|sensory system agents|mesh-ancestor
110078025|NCT01613976|Panobinostat|panobinostat|mesh-list
110078026|NCT01613976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110078027|NCT01613976|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110078028|NCT01613976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110078029|NCT01613976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110078030|NCT01614041|Tandospirone|tandospirone|mesh-list
110078031|NCT01614041|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110078032|NCT01614041|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110078033|NCT01614041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110078034|NCT01614041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110078035|NCT01614041|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110078036|NCT01614041|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110078037|NCT01614041|Serotonin Agents|serotonin agents|mesh-ancestor
110078038|NCT01614041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110078039|NCT01614041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110078041|NCT01614132|Vincristine|vincristine|mesh-list
110078042|NCT01614132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110078043|NCT01614132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110078044|NCT01614132|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110078045|NCT01614132|Tubulin Modulators|tubulin modulators|mesh-ancestor
110078046|NCT01614132|Antimitotic Agents|antimitotic agents|mesh-ancestor
110078047|NCT01614132|Mitosis Modulators|mitosis modulators|mesh-ancestor
110078049|NCT01614223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110078050|NCT01614223|Glucocorticoids|glucocorticoids|mesh-ancestor
110078052|NCT01614223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110078053|NCT01614223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110078054|NCT01614223|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110078055|NCT01614223|Respiratory System Agents|respiratory system agents|mesh-ancestor
110078056|NCT01614236|Pregabalin|pregabalin|mesh-list
110078057|NCT01614236|Analgesics|analgesics|mesh-ancestor
110078058|NCT01614236|Sensory System Agents|sensory system agents|mesh-ancestor
110078059|NCT01614236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110078060|NCT01614236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110078061|NCT01614236|Anticonvulsants|anticonvulsants|mesh-ancestor
110078062|NCT01614236|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110078063|NCT01614236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110078064|NCT01614236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110078065|NCT01614236|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110078066|NCT01614236|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110078067|NCT01614236|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110078068|NCT01614236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110078069|NCT01614236|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110078070|NCT01614301|Pioglitazone|pioglitazone|mesh-list
110078071|NCT01614301|Sirolimus|sirolimus|mesh-list
110078072|NCT01614301|Etoricoxib|etoricoxib|mesh-list
110078073|NCT01614301|Temsirolimus|temsirolimus|mesh-list
110078074|NCT01614301|MTOR Inhibitors|mtor inhibitors|mesh-list
110078075|NCT01614301|Dacarbazine|dacarbazine|mesh-list
110078076|NCT01614301|Trofosfamide|trofosfamide|mesh-list
110078077|NCT01614301|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110183738|NCT04711863|Antidepressive Agents|antidepressive agents|mesh-ancestor
110078078|NCT01614301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110078079|NCT01614301|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110078080|NCT01614301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110078081|NCT01614301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110078082|NCT01614301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110078083|NCT01614301|Immunologic Factors|immunologic factors|mesh-ancestor
110078084|NCT01614301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110078085|NCT01614301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110078086|NCT01614301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110078087|NCT01614301|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110078088|NCT01614301|Antifungal Agents|antifungal agents|mesh-ancestor
110078089|NCT01614301|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110078090|NCT01614301|Alkylating Agents|alkylating agents|mesh-ancestor
110078091|NCT01614301|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110078092|NCT01614301|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110078093|NCT01614301|Analgesics|analgesics|mesh-ancestor
110078094|NCT01614301|Sensory System Agents|sensory system agents|mesh-ancestor
110078095|NCT01614301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110078096|NCT01614301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110078097|NCT01614301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110078098|NCT01614301|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110078099|NCT01614301|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110078100|NCT01614366|Amlodipine|amlodipine|mesh-list
110078101|NCT01614366|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110078102|NCT01614366|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110078103|NCT01614366|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110078104|NCT01614366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110078105|NCT01614366|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110078106|NCT01614366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110078107|NCT01614366|Vasodilator Agents|vasodilator agents|mesh-ancestor
110078109|NCT01614405|Lopinavir|lopinavir|mesh-list
110078110|NCT01614405|Tenofovir|tenofovir|mesh-list
110078111|NCT01614405|Emtricitabine|emtricitabine|mesh-list
110078112|NCT01614405|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110078113|NCT01614405|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110078114|NCT01614405|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110078115|NCT01614405|Protease Inhibitors|protease inhibitors|mesh-ancestor
110078116|NCT01614405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110368814|NCT00553943|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110078117|NCT01614405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110078118|NCT01614405|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110078119|NCT01614405|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110078120|NCT01614405|Antiviral Agents|antiviral agents|mesh-ancestor
110078122|NCT01614405|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110078123|NCT01614405|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110078124|NCT01614405|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110078125|NCT01614405|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110078126|NCT01614431|Acetylcysteine|acetylcysteine|mesh-list
110078127|NCT01614431|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110078128|NCT01614431|Antiviral Agents|antiviral agents|mesh-ancestor
110078129|NCT01614431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110078130|NCT01614431|Expectorants|expectorants|mesh-ancestor
110078131|NCT01614431|Respiratory System Agents|respiratory system agents|mesh-ancestor
110078132|NCT01614431|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110078133|NCT01614431|Antioxidants|antioxidants|mesh-ancestor
110078134|NCT01614431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110078135|NCT01614431|Protective Agents|protective agents|mesh-ancestor
110078136|NCT01614431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110078137|NCT01614431|Antidotes|antidotes|mesh-ancestor
110078138|NCT01614496|Insulin|insulin|mesh-list
110078139|NCT01614496|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110078140|NCT01614496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110078141|NCT01614535|Remifentanil|remifentanil|mesh-list
110078142|NCT01614535|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110078143|NCT01614535|Narcotics|narcotics|mesh-ancestor
110078144|NCT01614535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110078145|NCT01614535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110078146|NCT01614535|Analgesics|analgesics|mesh-ancestor
110078147|NCT01614535|Sensory System Agents|sensory system agents|mesh-ancestor
110078148|NCT01614535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110078149|NCT01614938|Cisplatin|cisplatin|mesh-list
110078150|NCT01614938|Docetaxel|docetaxel|mesh-list
110078151|NCT01614938|Cetuximab|cetuximab|mesh-list
110078152|NCT01614938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110078153|NCT01614938|Tubulin Modulators|tubulin modulators|mesh-ancestor
110078154|NCT01614938|Antimitotic Agents|antimitotic agents|mesh-ancestor
110078155|NCT01614938|Mitosis Modulators|mitosis modulators|mesh-ancestor
110078156|NCT01614938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110078157|NCT01614938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110078158|NCT01614964|Lumefantrine|lumefantrine|mesh-list
110078159|NCT01614964|Artemether|artemether|mesh-list
110078160|NCT01614964|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
110183792|NCT04711668|Analgesics|analgesics|mesh-ancestor
110078162|NCT01614964|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110078163|NCT01614964|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110078164|NCT01614964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110078165|NCT01613729|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110078166|NCT01613729|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110078167|NCT01613729|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110078168|NCT01613729|Antimetabolites|antimetabolites|mesh-ancestor
110078169|NCT01613729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110078170|NCT01613729|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110078171|NCT01613729|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110078172|NCT01613729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110078173|NCT01615016|Pulmonary Surfactants|pulmonary surfactants|mesh-list
110078174|NCT01615016|Respiratory System Agents|respiratory system agents|mesh-ancestor
110078175|NCT01615042|Lenalidomide|lenalidomide|mesh-list
110078176|NCT01615042|Immunologic Factors|immunologic factors|mesh-ancestor
110078177|NCT01615042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110078178|NCT01615042|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110078179|NCT01615042|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110078180|NCT01615042|Growth Substances|growth substances|mesh-ancestor
110078181|NCT01615042|Growth Inhibitors|growth inhibitors|mesh-ancestor
110078182|NCT01615042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110078183|NCT01615055|Fluoxetine|fluoxetine|mesh-list
110078184|NCT01615055|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110078185|NCT01615055|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110078186|NCT01615055|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110078187|NCT01615055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110078188|NCT01615055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110078189|NCT01615055|Serotonin Agents|serotonin agents|mesh-ancestor
110078190|NCT01615055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110078191|NCT01615055|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110078192|NCT01615055|Antidepressive Agents|antidepressive agents|mesh-ancestor
110078193|NCT01615055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110078194|NCT01615055|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110078195|NCT01615055|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110078196|NCT01615055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110078197|NCT01615081|Insulin|insulin|mesh-list
110078198|NCT01615081|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110078199|NCT01615081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110078200|NCT01615107|Oxytocin|oxytocin|mesh-list
110078201|NCT01615107|Oxytocics|oxytocics|mesh-ancestor
110078202|NCT01615107|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110078203|NCT01615107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110078204|NCT01615185|Amisulpride|amisulpride|mesh-list
110078205|NCT01615185|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110078206|NCT01615185|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110078207|NCT01615185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110078208|NCT01615185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110078209|NCT01615185|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110078210|NCT01615185|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110078211|NCT01615185|Dopamine Agents|dopamine agents|mesh-ancestor
110078212|NCT01615185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110078213|NCT01615185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110078214|NCT01615185|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110078215|NCT01615185|Antidepressive Agents|antidepressive agents|mesh-ancestor
110078216|NCT01615211|Letrozole|letrozole|mesh-list
110078217|NCT01615211|Trilostane|trilostane|mesh-list
110078218|NCT01615211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110078219|NCT01615211|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110078220|NCT01615211|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110078221|NCT01615211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110078222|NCT01615211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110078223|NCT01615211|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110078224|NCT01615211|Hormone Antagonists|hormone antagonists|mesh-ancestor
110078225|NCT01615211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110078226|NCT01615211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110078227|NCT01615211|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
110078228|NCT01615211|Abortifacient Agents|abortifacient agents|mesh-ancestor
110078229|NCT01615211|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110078230|NCT01615224|Misoprostol|misoprostol|mesh-list
110078231|NCT01615224|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110078232|NCT01615224|Abortifacient Agents|abortifacient agents|mesh-ancestor
110078233|NCT01615224|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110078234|NCT01615224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110078235|NCT01615224|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110078236|NCT01615224|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110078237|NCT01615224|Oxytocics|oxytocics|mesh-ancestor
110078238|NCT01615289|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110078239|NCT01615354|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
110078240|NCT01615354|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
110078241|NCT01615354|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110078242|NCT01615354|Contraceptive Agents|contraceptive agents|mesh-ancestor
110078243|NCT01615354|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110078244|NCT01615354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110078245|NCT01615354|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110078246|NCT01615354|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110078247|NCT01615354|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110078248|NCT01615354|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110078249|NCT01615354|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110078250|NCT01615354|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
110078251|NCT01615354|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
110078252|NCT01615354|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
110078253|NCT01615393|Ribavirin|ribavirin|mesh-list
110078254|NCT01615393|Antimetabolites|antimetabolites|mesh-ancestor
110078255|NCT01615393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110078256|NCT01615393|Antiviral Agents|antiviral agents|mesh-ancestor
110078257|NCT01615393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110078258|NCT01615445|Resveratrol|resveratrol|mesh-list
110078259|NCT01615445|Antioxidants|antioxidants|mesh-ancestor
110078260|NCT01615445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110078261|NCT01615445|Protective Agents|protective agents|mesh-ancestor
110078262|NCT01615445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110078263|NCT01615445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110078264|NCT01615445|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110078265|NCT01615601|Ritonavir|ritonavir|mesh-list
110078267|NCT01615601|Etravirine|etravirine|mesh-list
110078268|NCT01615601|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
110078269|NCT01615601|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110078270|NCT01615601|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110078271|NCT01615601|Protease Inhibitors|protease inhibitors|mesh-ancestor
110078272|NCT01615601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110078273|NCT01615601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110078274|NCT01615601|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110078275|NCT01615601|Antiviral Agents|antiviral agents|mesh-ancestor
110078276|NCT01615601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110078277|NCT01615601|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110078278|NCT01615601|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110078279|NCT01615601|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110078280|NCT01615601|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110078281|NCT01615614|Rilpivirine|rilpivirine|mesh-list
110078282|NCT01615614|Rifabutin|rifabutin|mesh-list
110078283|NCT01615614|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110078284|NCT01615614|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110078285|NCT01615614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110078286|NCT01615614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110078287|NCT01615614|Antiviral Agents|antiviral agents|mesh-ancestor
110078288|NCT01615614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110078289|NCT01615614|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110078290|NCT01615614|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110078291|NCT01615614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110078292|NCT01615614|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110078293|NCT01615614|Antitubercular Agents|antitubercular agents|mesh-ancestor
110078294|NCT01615627|Treprostinil|treprostinil|mesh-list
110078295|NCT01615627|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110078296|NCT01615627|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110078298|NCT01615757|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110078299|NCT01615757|Antimetabolites|antimetabolites|mesh-ancestor
110078300|NCT01615757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110078301|NCT01615757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110078302|NCT01615757|Antiviral Agents|antiviral agents|mesh-ancestor
110078303|NCT01615757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110078304|NCT01615757|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110078305|NCT01615757|Immunologic Factors|immunologic factors|mesh-ancestor
110078306|NCT01615757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110078307|NCT01615796|Gepotidacin|gepotidacin|mesh-list
110078308|NCT01615796|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110078309|NCT01615796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110078310|NCT01615796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110078311|NCT01615796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110078312|NCT01615913|Ketoconazole|ketoconazole|mesh-list
110078313|NCT01615913|Terbinafine|terbinafine|mesh-list
110078314|NCT01615913|Antifungal Agents|antifungal agents|mesh-ancestor
110078315|NCT01615913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110078316|NCT01615913|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110078317|NCT01615913|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110078318|NCT01615913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110078319|NCT01615913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110078320|NCT01615913|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110078321|NCT01615913|Hormone Antagonists|hormone antagonists|mesh-ancestor
110078322|NCT01615913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110078323|NCT01615913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110078324|NCT01615913|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110078325|NCT01615978|Liraglutide|liraglutide|mesh-list
110078326|NCT01615978|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110078327|NCT01615978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110078328|NCT01615978|Incretins|incretins|mesh-ancestor
110078329|NCT01615978|Hormones|hormones|mesh-ancestor
110078330|NCT01615978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110078331|NCT01616004|Nitrous Oxide|nitrous oxide|mesh-list
110078332|NCT01616004|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110078333|NCT01616004|Anesthetics, General|anesthetics, general|mesh-ancestor
110078334|NCT01616004|Anesthetics|anesthetics|mesh-ancestor
110078335|NCT01616004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110078336|NCT01616004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110078337|NCT01616004|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110078338|NCT01616004|Analgesics|analgesics|mesh-ancestor
110078339|NCT01616004|Sensory System Agents|sensory system agents|mesh-ancestor
110078340|NCT01616004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110078341|NCT01616069|Simendan|simendan|mesh-list
110078342|NCT01616069|Epinephrine|epinephrine|mesh-list
110078343|NCT01616069|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110078344|NCT01616069|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110078345|NCT01616069|Adrenergic Agents|adrenergic agents|mesh-ancestor
110078346|NCT01616069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110078347|NCT01616069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110078348|NCT01616069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110078349|NCT01616069|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110078350|NCT01616069|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110078352|NCT01616069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110078353|NCT01616069|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110078354|NCT01616069|Respiratory System Agents|respiratory system agents|mesh-ancestor
110078356|NCT01616069|Sympathomimetics|sympathomimetics|mesh-ancestor
110078357|NCT01616069|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110078358|NCT01616069|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110078359|NCT01616069|Vasodilator Agents|vasodilator agents|mesh-ancestor
110078360|NCT01616069|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110078361|NCT01616069|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110078362|NCT01616069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110078363|NCT01616069|Protective Agents|protective agents|mesh-ancestor
110078364|NCT01616108|Bupivacaine|bupivacaine|mesh-list
110078365|NCT01616108|Anesthetics, Local|anesthetics, local|mesh-ancestor
110078366|NCT01616108|Anesthetics|anesthetics|mesh-ancestor
110078367|NCT01616108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110078368|NCT01616108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110078369|NCT01616108|Sensory System Agents|sensory system agents|mesh-ancestor
110078370|NCT01616108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110078371|NCT01616186|Everolimus|everolimus|mesh-list
110078372|NCT01616186|Sorafenib|sorafenib|mesh-list
110078373|NCT01616186|Sunitinib|sunitinib|mesh-list
110078374|NCT01616186|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110078375|NCT01616186|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110078376|NCT01616186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110078377|NCT01616186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110078378|NCT01616186|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110078379|NCT01616186|Immunologic Factors|immunologic factors|mesh-ancestor
110078380|NCT01616186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110078381|NCT01616186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110078382|NCT01616186|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110078383|NCT01616186|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110078384|NCT01616186|Growth Substances|growth substances|mesh-ancestor
110078385|NCT01616186|Growth Inhibitors|growth inhibitors|mesh-ancestor
110078386|NCT01616225|Hormones|hormones|mesh-list
110078387|NCT01616225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110078388|NCT01616225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110078389|NCT01616355|Sodium Hypochlorite|sodium hypochlorite|mesh-list
110078391|NCT01616355|Disinfectants|disinfectants|mesh-ancestor
110078392|NCT01616355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110078393|NCT01616381|Sildenafil Citrate|sildenafil citrate|mesh-list
110078394|NCT01616381|Vasodilator Agents|vasodilator agents|mesh-ancestor
110078395|NCT01616381|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110078396|NCT01616381|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110078397|NCT01616381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110078398|NCT01616381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110078399|NCT01616381|Urological Agents|urological agents|mesh-ancestor
110078400|NCT01616407|Methylphenidate|methylphenidate|mesh-list
110078401|NCT01616407|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
110078402|NCT01616407|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110078403|NCT01616407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110078404|NCT01616407|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110078405|NCT01616407|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110078406|NCT01616407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110078407|NCT01616407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110078409|NCT01616407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110078410|NCT01616407|Hallucinogens|hallucinogens|mesh-ancestor
110078411|NCT01616407|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110078412|NCT01616407|Serotonin Agents|serotonin agents|mesh-ancestor
110078413|NCT01616407|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110078414|NCT01616407|Adrenergic Agents|adrenergic agents|mesh-ancestor
110078415|NCT01616485|Sildenafil Citrate|sildenafil citrate|mesh-list
110078416|NCT01616485|Nitroglycerin|nitroglycerin|mesh-list
110078417|NCT01616485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110078418|NCT01616485|Vasodilator Agents|vasodilator agents|mesh-ancestor
110078419|NCT01616485|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110078420|NCT01616485|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110078421|NCT01616485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110078422|NCT01616485|Urological Agents|urological agents|mesh-ancestor
110078424|NCT01616615|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110078425|NCT01616615|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110078426|NCT01616615|Analgesics|analgesics|mesh-ancestor
110078427|NCT01616615|Sensory System Agents|sensory system agents|mesh-ancestor
110078428|NCT01616615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110078429|NCT01616615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110078430|NCT01616615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110078431|NCT01616615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110078432|NCT01616615|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110078433|NCT01616615|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110078434|NCT01616615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110078435|NCT01616615|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110078436|NCT01616615|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110078437|NCT01616615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110078438|NCT01616615|Antipyretics|antipyretics|mesh-ancestor
110078439|NCT01616680|Brentuximab Vedotin|brentuximab vedotin|mesh-list
110078440|NCT01616680|Antibodies|antibodies|mesh-list
110078441|NCT01616680|Immunoglobulins|immunoglobulins|mesh-list
110078442|NCT01616680|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110078443|NCT01616680|Immunoconjugates|immunoconjugates|mesh-list
110078444|NCT01616680|Immunologic Factors|immunologic factors|mesh-ancestor
110078445|NCT01616680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110078446|NCT01616680|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110078447|NCT01616680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110078448|NCT01616680|Immunotoxins|immunotoxins|mesh-ancestor
110078449|NCT01616732|Testosterone|testosterone|mesh-list
110078450|NCT01616732|Androgens|androgens|mesh-ancestor
110078451|NCT01616732|Hormones|hormones|mesh-ancestor
110078452|NCT01616732|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110078453|NCT01616732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110078454|NCT01616784|Insulin|insulin|mesh-list
110078455|NCT01616784|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110078456|NCT01616784|Insulin Detemir|insulin detemir|mesh-list
110078457|NCT01616784|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110078458|NCT01616784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110078459|NCT01616849|Nimotuzumab|nimotuzumab|mesh-list
110078460|NCT01616849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110078461|NCT01616849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110078462|NCT01616875|Cisplatin|cisplatin|mesh-list
110078463|NCT01616875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110078464|NCT01616888|Paclitaxel|paclitaxel|mesh-list
110078465|NCT01616888|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110078466|NCT01616888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110078467|NCT01616888|Tubulin Modulators|tubulin modulators|mesh-ancestor
110078468|NCT01616888|Antimitotic Agents|antimitotic agents|mesh-ancestor
110078469|NCT01616888|Mitosis Modulators|mitosis modulators|mesh-ancestor
110078470|NCT01616888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110078471|NCT01616927|Lanreotide|lanreotide|mesh-list
110078472|NCT01616927|Somatostatin|somatostatin|mesh-list
110078473|NCT01616927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110078474|NCT01616927|Hormones|hormones|mesh-ancestor
110078475|NCT01616927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110078476|NCT01616927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110078477|NCT01616966|Remifentanil|remifentanil|mesh-list
110078478|NCT01616966|Propofol|propofol|mesh-list
110078479|NCT01616966|Sevoflurane|sevoflurane|mesh-list
110078480|NCT01616966|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110078481|NCT01616966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110078482|NCT01616966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110078483|NCT01616966|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110078484|NCT01616966|Anesthetics, General|anesthetics, general|mesh-ancestor
110078485|NCT01616966|Anesthetics|anesthetics|mesh-ancestor
110078486|NCT01616966|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110078487|NCT01616966|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110078488|NCT01616966|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110078491|NCT01616966|Sensory System Agents|sensory system agents|mesh-ancestor
110078492|NCT01616966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110078494|NCT01616992|Anesthetics, Local|anesthetics, local|mesh-ancestor
110078496|NCT01616992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110078497|NCT01616992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110078498|NCT01616992|Sensory System Agents|sensory system agents|mesh-ancestor
110078499|NCT01616992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110078500|NCT01617057|Tiludronic acid|tiludronic acid|mesh-list
110078501|NCT01617057|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110078502|NCT01617057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110078503|NCT01617135|Levodopa|levodopa|mesh-list
110078504|NCT01617135|Carbidopa|carbidopa|mesh-list
110078505|NCT01617135|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
110078506|NCT01617135|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110078507|NCT01617135|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110078508|NCT01617135|Dopamine Agents|dopamine agents|mesh-ancestor
110078509|NCT01617135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110078510|NCT01617135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110078511|NCT01617135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110078512|NCT01617135|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
110078513|NCT01617135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110078514|NCT01617135|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110078515|NCT01617135|Immunologic Factors|immunologic factors|mesh-ancestor
110078516|NCT01617135|Dopamine Agonists|dopamine agonists|mesh-ancestor
110078517|NCT01617200|Olanzapine|olanzapine|mesh-list
110078518|NCT01617200|Asenapine|asenapine|mesh-list
110078519|NCT01617200|Antiemetics|antiemetics|mesh-ancestor
110078520|NCT01617200|Autonomic Agents|autonomic agents|mesh-ancestor
110078521|NCT01617200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110078522|NCT01617200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110078523|NCT01617200|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110078524|NCT01617200|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110078525|NCT01617200|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110078526|NCT01617200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110078527|NCT01617200|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110078528|NCT01617200|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110078529|NCT01617200|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110078530|NCT01617200|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110078531|NCT01617200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110078532|NCT01617200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110078533|NCT01617200|Serotonin Agents|serotonin agents|mesh-ancestor
110078534|NCT01617213|Lenalidomide|lenalidomide|mesh-list
110078535|NCT01617213|Melphalan|melphalan|mesh-list
110078536|NCT01617213|Immunologic Factors|immunologic factors|mesh-ancestor
110078537|NCT01617213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110078538|NCT01617213|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110078539|NCT01617213|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110078540|NCT01617213|Growth Substances|growth substances|mesh-ancestor
110078541|NCT01617213|Growth Inhibitors|growth inhibitors|mesh-ancestor
110078542|NCT01617213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110078543|NCT01617213|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110078544|NCT01617213|Alkylating Agents|alkylating agents|mesh-ancestor
110078545|NCT01617213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110078546|NCT01617213|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110078547|NCT01617213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110078548|NCT01617226|Azacitidine|azacitidine|mesh-list
110078549|NCT01617226|Vorinostat|vorinostat|mesh-list
110078550|NCT01617226|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110078551|NCT01617226|Antimetabolites|antimetabolites|mesh-ancestor
110078552|NCT01617226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110078553|NCT01617226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110078554|NCT01617226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110078555|NCT01617226|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110078556|NCT01617317|Immunoglobulins|immunoglobulins|mesh-list
110078557|NCT01617317|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110078558|NCT01617317|Antibodies|antibodies|mesh-list
110078559|NCT01617317|gamma-Globulins|gamma-globulins|mesh-list
110078560|NCT01617317|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110078561|NCT01617317|Immunologic Factors|immunologic factors|mesh-ancestor
110078562|NCT01617317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110078564|NCT01617356|Anesthetics, Local|anesthetics, local|mesh-ancestor
110078565|NCT01617356|Anesthetics|anesthetics|mesh-ancestor
110078566|NCT01617356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110078567|NCT01617356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110078568|NCT01617356|Sensory System Agents|sensory system agents|mesh-ancestor
110078569|NCT01617356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110078570|NCT01617356|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110078571|NCT01617356|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110078572|NCT01617356|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110078573|NCT01617356|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110078574|NCT01617356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110078575|NCT01617538|Atorvastatin|atorvastatin|mesh-list
110078576|NCT01617538|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110078577|NCT01617538|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110078578|NCT01617538|Antimetabolites|antimetabolites|mesh-ancestor
110078579|NCT01617538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110078580|NCT01617538|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110078581|NCT01617538|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110078582|NCT01617538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110078583|NCT01617551|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
110078584|NCT01617551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110078585|NCT01617551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110078586|NCT01617564|Bupivacaine|bupivacaine|mesh-list
110078587|NCT01617564|Anesthetics, Local|anesthetics, local|mesh-ancestor
110078588|NCT01617564|Anesthetics|anesthetics|mesh-ancestor
110078589|NCT01617564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110078590|NCT01617564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110078591|NCT01617564|Sensory System Agents|sensory system agents|mesh-ancestor
110078592|NCT01617564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110078593|NCT01617590|Methotrexate|methotrexate|mesh-list
110078594|NCT01617590|Leflunomide|leflunomide|mesh-list
110078595|NCT01617590|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110078596|NCT01617590|Abortifacient Agents|abortifacient agents|mesh-ancestor
110078597|NCT01617590|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110078598|NCT01617590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110078599|NCT01617590|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110078600|NCT01617590|Antimetabolites|antimetabolites|mesh-ancestor
110078601|NCT01617590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110078602|NCT01617590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110078603|NCT01617590|Dermatologic Agents|dermatologic agents|mesh-ancestor
110078604|NCT01617590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110078605|NCT01617590|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110078606|NCT01617590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110078607|NCT01617590|Immunologic Factors|immunologic factors|mesh-ancestor
110078608|NCT01617590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110078609|NCT01617590|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110078610|NCT01617694|Dexmedetomidine|dexmedetomidine|mesh-list
110078611|NCT01617694|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110078612|NCT01617694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110078613|NCT01617694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110078614|NCT01617694|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110078615|NCT01617694|Analgesics|analgesics|mesh-ancestor
110078616|NCT01617694|Sensory System Agents|sensory system agents|mesh-ancestor
110078617|NCT01617694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110078618|NCT01617694|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110078619|NCT01617694|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110078620|NCT01617694|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110078621|NCT01617694|Adrenergic Agents|adrenergic agents|mesh-ancestor
110078622|NCT01617694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110078623|NCT01617694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110078625|NCT01617707|Propofol|propofol|mesh-list
110183862|NCT00031434|Valganciclovir|valganciclovir|mesh-list
110078626|NCT01617707|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110078627|NCT01617707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110078628|NCT01617707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110078629|NCT01617707|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110078630|NCT01617707|Anesthetics, General|anesthetics, general|mesh-ancestor
110078631|NCT01617707|Anesthetics|anesthetics|mesh-ancestor
110078632|NCT01617707|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110078633|NCT01617707|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110078634|NCT01617707|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110078635|NCT01617707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110078636|NCT01617707|GABA Modulators|gaba modulators|mesh-ancestor
110078638|NCT01617707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110078639|NCT01617707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110078640|NCT01617733|Pasireotide|pasireotide|mesh-list
110078642|NCT01617733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110078643|NCT01617733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110078644|NCT01617746|Bosentan|bosentan|mesh-list
110078645|NCT01617746|Ambrisentan|ambrisentan|mesh-list
110078646|NCT01617746|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110078647|NCT01617746|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
110078648|NCT01617746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110078649|NCT01617772|Atorvastatin|atorvastatin|mesh-list
110078650|NCT01617772|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110078651|NCT01617772|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110078652|NCT01617772|Antimetabolites|antimetabolites|mesh-ancestor
110078653|NCT01617772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110078654|NCT01617772|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110078655|NCT01617772|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110078656|NCT01617772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110078657|NCT01617798|Metolazone|metolazone|mesh-list
110078658|NCT01617798|Furosemide|furosemide|mesh-list
110078659|NCT01617798|Diuretics|diuretics|mesh-ancestor
110078660|NCT01617798|Natriuretic Agents|natriuretic agents|mesh-ancestor
110078661|NCT01617798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110078662|NCT01617798|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110078663|NCT01617798|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110078664|NCT01617798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110078665|NCT01617798|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110078666|NCT01617798|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110078667|NCT01617811|Anesthetics|anesthetics|mesh-list
110078668|NCT01617811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110078669|NCT01617811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110078670|NCT01617824|Linagliptin|linagliptin|mesh-list
110078671|NCT01617824|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110078672|NCT01617824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110078673|NCT01617824|Incretins|incretins|mesh-ancestor
110078674|NCT01617824|Hormones|hormones|mesh-ancestor
110078675|NCT01617824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110078676|NCT01617824|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110078677|NCT01617824|Protease Inhibitors|protease inhibitors|mesh-ancestor
110078678|NCT01617824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110078679|NCT01617824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110078680|NCT01617928|Paclitaxel|paclitaxel|mesh-list
110078681|NCT01617928|Carboplatin|carboplatin|mesh-list
110078682|NCT01617928|Veliparib|veliparib|mesh-list
110078683|NCT01617928|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110078684|NCT01617928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110078685|NCT01617928|Tubulin Modulators|tubulin modulators|mesh-ancestor
110078686|NCT01617928|Antimitotic Agents|antimitotic agents|mesh-ancestor
110078687|NCT01617928|Mitosis Modulators|mitosis modulators|mesh-ancestor
110078688|NCT01617928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110078689|NCT01617928|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110078690|NCT01617928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110078691|NCT01618006|Aspirin|aspirin|mesh-list
110078692|NCT01618006|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110078693|NCT01618006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110078694|NCT01618006|Analgesics|analgesics|mesh-ancestor
110078695|NCT01618006|Sensory System Agents|sensory system agents|mesh-ancestor
110078696|NCT01618006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110078697|NCT01618006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110078698|NCT01618006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110078699|NCT01618006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110078700|NCT01618006|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110078701|NCT01618006|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110078702|NCT01618006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110078703|NCT01618006|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110078704|NCT01618006|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110078705|NCT01618006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110078706|NCT01618006|Antipyretics|antipyretics|mesh-ancestor
110078707|NCT01618253|Sorafenib|sorafenib|mesh-list
110078708|NCT01618253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110078709|NCT01618253|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110078710|NCT01618253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110078711|NCT01618253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110078712|NCT01618370|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
110078713|NCT01618370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110078714|NCT01618396|Midazolam|midazolam|mesh-list
110078715|NCT01618396|Propofol|propofol|mesh-list
110078716|NCT01618396|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110078717|NCT01618396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110078718|NCT01618396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110078719|NCT01618396|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110078720|NCT01618396|Anesthetics, General|anesthetics, general|mesh-ancestor
110078721|NCT01618396|Anesthetics|anesthetics|mesh-ancestor
110078722|NCT01618396|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110078723|NCT01618396|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110078724|NCT01618396|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110078725|NCT01618396|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110078726|NCT01618396|GABA Modulators|gaba modulators|mesh-ancestor
110078727|NCT01618396|GABA Agents|gaba agents|mesh-ancestor
110078728|NCT01618396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110078729|NCT01618396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110078730|NCT01618188|Insulin|insulin|mesh-list
110078731|NCT01618188|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110078732|NCT01618188|Insulin Aspart|insulin aspart|mesh-list
110078733|NCT01618188|Insulin, Long-Acting|insulin, long-acting|mesh-list
110078734|NCT01618188|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
110078735|NCT01618188|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110078736|NCT01618188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110078737|NCT01618448|Tolvaptan|tolvaptan|mesh-list
110078738|NCT01618448|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
110078739|NCT01618448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110078740|NCT01618448|Natriuretic Agents|natriuretic agents|mesh-ancestor
110078741|NCT01618448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110078742|NCT01618474|Docetaxel|docetaxel|mesh-list
110078743|NCT01618474|Capecitabine|capecitabine|mesh-list
110078744|NCT01618474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110078745|NCT01618474|Tubulin Modulators|tubulin modulators|mesh-ancestor
110078746|NCT01618474|Antimitotic Agents|antimitotic agents|mesh-ancestor
110078747|NCT01618474|Mitosis Modulators|mitosis modulators|mesh-ancestor
110078748|NCT01618474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110078749|NCT01618474|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110078750|NCT01618474|Antimetabolites|antimetabolites|mesh-ancestor
110078752|NCT01618513|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110078753|NCT01618513|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110078754|NCT01618513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110078755|NCT01618539|Propofol|propofol|mesh-list
110078756|NCT01618539|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110078757|NCT01618539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110078758|NCT01618539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110078759|NCT01618539|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110078760|NCT01618539|Anesthetics, General|anesthetics, general|mesh-ancestor
110078761|NCT01618539|Anesthetics|anesthetics|mesh-ancestor
110078762|NCT01618591|Azithromycin|azithromycin|mesh-list
110078763|NCT01618591|Levofloxacin|levofloxacin|mesh-list
110078764|NCT01618591|Rifaximin|rifaximin|mesh-list
110078765|NCT01618591|Loperamide|loperamide|mesh-list
110078766|NCT01618591|Antidiarrheals|antidiarrheals|mesh-list
110078767|NCT01618591|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110078768|NCT01618591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110078769|NCT01618591|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110078770|NCT01618591|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110078771|NCT01618591|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110078772|NCT01618591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110078773|NCT01618591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110078774|NCT01618591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110078775|NCT01618591|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110078776|NCT01618591|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110078777|NCT01618591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110078778|NCT01618643|Acetic Acid|acetic acid|mesh-list
110078779|NCT01618643|Retinol acetate|retinol acetate|mesh-list
110078780|NCT01618643|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110078781|NCT01618643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110078782|NCT01618643|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110078783|NCT01618643|Immunologic Factors|immunologic factors|mesh-ancestor
110078784|NCT01618643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110078785|NCT01618643|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110078787|NCT01618643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110078788|NCT01618760|Risperidone|risperidone|mesh-list
110078789|NCT01618760|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110078790|NCT01618760|Serotonin Agents|serotonin agents|mesh-ancestor
110078791|NCT01618760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110078792|NCT01618760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110078793|NCT01618760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110078794|NCT01618760|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110078795|NCT01618760|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110078796|NCT01618760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110078797|NCT01618760|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110078798|NCT01618760|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110078799|NCT01618760|Dopamine Agents|dopamine agents|mesh-ancestor
110078801|NCT01618773|Benzoyl Peroxide|benzoyl peroxide|mesh-list
110078802|NCT01618773|Dermatologic Agents|dermatologic agents|mesh-ancestor
110078803|NCT01618773|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110078804|NCT01618773|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110078805|NCT01618773|Analgesics|analgesics|mesh-ancestor
110078806|NCT01618773|Sensory System Agents|sensory system agents|mesh-ancestor
110078807|NCT01618773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110078808|NCT01618773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110078809|NCT01618773|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110078810|NCT01618773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110078811|NCT01618799|Lamotrigine|lamotrigine|mesh-list
110078812|NCT01618799|Anticonvulsants|anticonvulsants|mesh-list
110078813|NCT01618799|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110078814|NCT01618799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110078815|NCT01618799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110078816|NCT01618799|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110078817|NCT01618799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110078818|NCT01618799|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110078819|NCT01618799|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110078820|NCT01618799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110078821|NCT01618799|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110078822|NCT01618799|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110078823|NCT01618825|Lamotrigine|lamotrigine|mesh-list
110078824|NCT01618825|Anticonvulsants|anticonvulsants|mesh-list
110078825|NCT01618825|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110078826|NCT01618825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110078827|NCT01618825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110078828|NCT01618825|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110078829|NCT01618825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110078830|NCT01618825|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110078831|NCT01618825|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110078832|NCT01618825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110078833|NCT01618825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110078834|NCT01618825|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110078837|NCT01618877|Nootropic Agents|nootropic agents|mesh-ancestor
110078838|NCT01618890|Propranolol|propranolol|mesh-list
110078839|NCT01618890|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110078840|NCT01618890|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110078841|NCT01618890|Adrenergic Agents|adrenergic agents|mesh-ancestor
110078842|NCT01618890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110078843|NCT01618890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110078844|NCT01618890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110078845|NCT01618890|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110078846|NCT01618890|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110078847|NCT01618890|Vasodilator Agents|vasodilator agents|mesh-ancestor
110078848|NCT01618903|Levetiracetam|levetiracetam|mesh-list
110078849|NCT01618903|Anticonvulsants|anticonvulsants|mesh-ancestor
110078850|NCT01618903|Nootropic Agents|nootropic agents|mesh-ancestor
110078851|NCT01618929|Montelukast|montelukast|mesh-list
110078852|NCT01618929|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110078853|NCT01618929|Respiratory System Agents|respiratory system agents|mesh-ancestor
110078854|NCT01618929|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110078855|NCT01618929|Hormone Antagonists|hormone antagonists|mesh-ancestor
110078856|NCT01618929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110078857|NCT01618929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110078858|NCT01618929|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110078859|NCT01618929|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110078860|NCT01618929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110078861|NCT01619007|Rivaroxaban|rivaroxaban|mesh-list
110078862|NCT01619007|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110078863|NCT01619007|Antithrombins|antithrombins|mesh-ancestor
110078864|NCT01619007|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110078865|NCT01619007|Protease Inhibitors|protease inhibitors|mesh-ancestor
110078866|NCT01619007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110078867|NCT01619007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110078868|NCT01619007|Anticoagulants|anticoagulants|mesh-ancestor
110078869|NCT01619046|Factor VIII|factor viii|mesh-list
110078870|NCT01619046|Coagulants|coagulants|mesh-ancestor
110078871|NCT01619072|Misoprostol|misoprostol|mesh-list
110078872|NCT01619072|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110078873|NCT01619072|Abortifacient Agents|abortifacient agents|mesh-ancestor
110078874|NCT01619072|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110078875|NCT01619072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110078876|NCT01619072|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110078877|NCT01619072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110078878|NCT01619072|Oxytocics|oxytocics|mesh-ancestor
110078879|NCT01619137|Povidone-Iodine|povidone-iodine|mesh-list
110078880|NCT01619137|Povidone|povidone|mesh-list
110078881|NCT01619137|Plasma Substitutes|plasma substitutes|mesh-ancestor
110078882|NCT01619137|Blood Substitutes|blood substitutes|mesh-ancestor
110078883|NCT01619137|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110078884|NCT01619137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110078885|NCT01619150|Etoricoxib|etoricoxib|mesh-list
110078886|NCT01619150|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110078887|NCT01619150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110078888|NCT01619150|Analgesics|analgesics|mesh-ancestor
110078889|NCT01619150|Sensory System Agents|sensory system agents|mesh-ancestor
110078890|NCT01619150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110078891|NCT01619150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110078892|NCT01619150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110078893|NCT01619150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110078894|NCT01619150|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110078895|NCT01619150|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110078896|NCT01619150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110078897|NCT01619150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110078899|NCT01619163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110078900|NCT01619163|Glucocorticoids|glucocorticoids|mesh-ancestor
110078901|NCT01619163|Hormones|hormones|mesh-ancestor
110078902|NCT01619163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110078903|NCT01619163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110078904|NCT01619163|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110078905|NCT01619163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110078906|NCT01619280|Nitroprusside|nitroprusside|mesh-list
110078907|NCT01619280|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110078908|NCT01619280|Vasodilator Agents|vasodilator agents|mesh-ancestor
110078909|NCT01619280|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
110078910|NCT01619280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110078912|NCT01619436|Analgesics|analgesics|mesh-ancestor
110078913|NCT01619436|Sensory System Agents|sensory system agents|mesh-ancestor
110078914|NCT01619436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110078915|NCT01619436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110078916|NCT01619436|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110078917|NCT01619436|Sympatholytics|sympatholytics|mesh-ancestor
110078918|NCT01619436|Autonomic Agents|autonomic agents|mesh-ancestor
110078919|NCT01619436|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110078920|NCT01619436|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110078921|NCT01619436|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110078922|NCT01619436|Adrenergic Agents|adrenergic agents|mesh-ancestor
110078923|NCT01619436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110078924|NCT01619436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110078925|NCT01619462|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110078926|NCT01619462|Immunologic Factors|immunologic factors|mesh-ancestor
110078927|NCT01619462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110078928|NCT01619527|Darunavir|darunavir|mesh-list
110078929|NCT01619527|Cobicistat|cobicistat|mesh-list
110078930|NCT01619527|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110078931|NCT01619527|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110078932|NCT01619527|Protease Inhibitors|protease inhibitors|mesh-ancestor
110078933|NCT01619527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110078934|NCT01619527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110078935|NCT01619527|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110078936|NCT01619527|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110078937|NCT01619527|Antiviral Agents|antiviral agents|mesh-ancestor
110078938|NCT01619527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110078939|NCT01619527|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110078940|NCT01619527|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110078941|NCT01619566|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110078942|NCT01619566|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110078943|NCT01619566|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110078944|NCT01619566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110078945|NCT01619566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110078946|NCT01619566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110078947|NCT01619566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110078949|NCT01619566|Sensory System Agents|sensory system agents|mesh-ancestor
110078950|NCT01619566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110078951|NCT01619566|Antidepressive Agents|antidepressive agents|mesh-ancestor
110078952|NCT01619566|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110078953|NCT01619566|Dopamine Agents|dopamine agents|mesh-ancestor
110078954|NCT01619644|Valproic Acid|valproic acid|mesh-list
110078955|NCT01619644|Anticonvulsants|anticonvulsants|mesh-ancestor
110078956|NCT01619644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110078957|NCT01619644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110078958|NCT01619644|GABA Agents|gaba agents|mesh-ancestor
110078959|NCT01619644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110078960|NCT01619644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110078961|NCT01619644|Antimanic Agents|antimanic agents|mesh-ancestor
110078962|NCT01619644|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110078963|NCT01619644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110078964|NCT01619644|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110078965|NCT01619683|Enclomiphene|enclomiphene|mesh-list
110078966|NCT01619683|Clomiphene|clomiphene|mesh-list
110078967|NCT01619683|Zuclomiphene|zuclomiphene|mesh-list
110078968|NCT01619683|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110078969|NCT01619683|Hormone Antagonists|hormone antagonists|mesh-ancestor
110078970|NCT01619683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110078971|NCT01619683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110078972|NCT01619683|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110078973|NCT01619683|Fertility Agents|fertility agents|mesh-ancestor
110078974|NCT01619683|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110078975|NCT01619683|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110078976|NCT01619683|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110078977|NCT01619761|Mycophenolic Acid|mycophenolic acid|mesh-list
110078978|NCT01619761|Cyclophosphamide|cyclophosphamide|mesh-list
110078979|NCT01619761|Melphalan|melphalan|mesh-list
110078980|NCT01619761|Mechlorethamine|mechlorethamine|mesh-list
110078981|NCT01619761|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
110078982|NCT01619761|Rituximab|rituximab|mesh-list
110078983|NCT01619761|Fludarabine|fludarabine|mesh-list
110078984|NCT01619761|Fludarabine phosphate|fludarabine phosphate|mesh-list
110078985|NCT01619761|Lenalidomide|lenalidomide|mesh-list
110078986|NCT01619761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110078987|NCT01619761|Tacrolimus|tacrolimus|mesh-list
110078988|NCT01619761|Antibodies|antibodies|mesh-list
110078989|NCT01619761|Immunoglobulins|immunoglobulins|mesh-list
110078990|NCT01619761|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110078991|NCT01619761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110078992|NCT01619761|Immunologic Factors|immunologic factors|mesh-ancestor
110078993|NCT01619761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110078994|NCT01619761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110078995|NCT01619761|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110078996|NCT01619761|Alkylating Agents|alkylating agents|mesh-ancestor
110078997|NCT01619761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110078998|NCT01619761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110078999|NCT01619761|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110079000|NCT01619761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110079001|NCT01619761|Antimetabolites|antimetabolites|mesh-ancestor
110079002|NCT01619761|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110079003|NCT01619761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110079004|NCT01619761|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110079005|NCT01619761|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110079006|NCT01619761|Growth Substances|growth substances|mesh-ancestor
110079007|NCT01619761|Growth Inhibitors|growth inhibitors|mesh-ancestor
110079008|NCT01619761|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110079009|NCT01619761|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110079010|NCT01619761|Antitubercular Agents|antitubercular agents|mesh-ancestor
110079011|NCT01619761|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110079012|NCT01619761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110079014|NCT01619891|Vitamins|vitamins|mesh-ancestor
110079015|NCT01619891|Micronutrients|micronutrients|mesh-ancestor
110079016|NCT01619891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110079018|NCT01620112|Lidocaine|lidocaine|mesh-list
110079019|NCT01620112|Clonidine|clonidine|mesh-list
110079020|NCT01620112|Anesthetics, Local|anesthetics, local|mesh-ancestor
110079021|NCT01620112|Anesthetics|anesthetics|mesh-ancestor
110079022|NCT01620112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110079023|NCT01620112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110079024|NCT01620112|Sensory System Agents|sensory system agents|mesh-ancestor
110079025|NCT01620112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110079026|NCT01620112|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110079027|NCT01620112|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110079028|NCT01620112|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110079029|NCT01620112|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110079030|NCT01620112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110079031|NCT01620112|Analgesics|analgesics|mesh-ancestor
110079032|NCT01620112|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110079033|NCT01620112|Sympatholytics|sympatholytics|mesh-ancestor
110079034|NCT01620112|Autonomic Agents|autonomic agents|mesh-ancestor
110079035|NCT01620112|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110079036|NCT01620112|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110079037|NCT01620112|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110079038|NCT01620112|Adrenergic Agents|adrenergic agents|mesh-ancestor
110079039|NCT01620112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110079040|NCT01620229|Brentuximab Vedotin|brentuximab vedotin|mesh-list
110079041|NCT01620229|Antibodies|antibodies|mesh-list
110079042|NCT01620229|Immunoglobulins|immunoglobulins|mesh-list
110079043|NCT01620229|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110079044|NCT01620229|Immunoconjugates|immunoconjugates|mesh-list
110079045|NCT01620229|Immunologic Factors|immunologic factors|mesh-ancestor
110079046|NCT01620229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110079047|NCT01620229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110079048|NCT01620229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110079049|NCT01620229|Immunotoxins|immunotoxins|mesh-ancestor
110079050|NCT01620268|Leflunomide|leflunomide|mesh-list
110079051|NCT01620268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110079052|NCT01620268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110079053|NCT01620268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110079054|NCT01620268|Immunologic Factors|immunologic factors|mesh-ancestor
110079055|NCT01620268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110079057|NCT01620307|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110079058|NCT01620307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110079059|NCT01620307|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110079060|NCT01620307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110079061|NCT01620307|Antifungal Agents|antifungal agents|mesh-ancestor
110079062|NCT01620307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110079063|NCT01620307|Immunologic Factors|immunologic factors|mesh-ancestor
110079064|NCT01620307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110079065|NCT01620320|Dobutamine|dobutamine|mesh-list
110079066|NCT01620320|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110079067|NCT01620320|Sympathomimetics|sympathomimetics|mesh-ancestor
110079068|NCT01620320|Autonomic Agents|autonomic agents|mesh-ancestor
110079069|NCT01620320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110079070|NCT01620320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110079071|NCT01620320|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
110079072|NCT01620320|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110079073|NCT01620320|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110079074|NCT01620320|Adrenergic Agents|adrenergic agents|mesh-ancestor
110079075|NCT01620320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110079076|NCT01620320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110079077|NCT01620320|Protective Agents|protective agents|mesh-ancestor
110079079|NCT01620333|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110079081|NCT01620333|Insulin, Long-Acting|insulin, long-acting|mesh-list
110079082|NCT01620333|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
110079083|NCT01620333|Biphasic Insulins|biphasic insulins|mesh-list
110079084|NCT01620333|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110079085|NCT01620333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110079086|NCT01620424|Insulin|insulin|mesh-list
110079087|NCT01620424|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110079088|NCT01620424|Insulin Aspart|insulin aspart|mesh-list
110079089|NCT01620424|Insulin, Long-Acting|insulin, long-acting|mesh-list
110079090|NCT01620424|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
110079091|NCT01620424|Biphasic Insulins|biphasic insulins|mesh-list
110079092|NCT01620424|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
110079093|NCT01620424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110079094|NCT01620424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110079095|NCT01620437|Insulin Aspart|insulin aspart|mesh-list
110079096|NCT01620437|Biphasic Insulins|biphasic insulins|mesh-list
110079097|NCT01620437|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110079098|NCT01620437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110079099|NCT01620450|Insulin|insulin|mesh-list
110079100|NCT01620450|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110079101|NCT01620450|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110079102|NCT01620450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110079103|NCT01620463|Liraglutide|liraglutide|mesh-list
110079104|NCT01620463|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110079105|NCT01620463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110079106|NCT01620463|Incretins|incretins|mesh-ancestor
110079107|NCT01620463|Hormones|hormones|mesh-ancestor
110079108|NCT01620463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110079109|NCT01620476|Liraglutide|liraglutide|mesh-list
110079110|NCT01620476|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110079111|NCT01620476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110079112|NCT01620476|Incretins|incretins|mesh-ancestor
110079113|NCT01620476|Hormones|hormones|mesh-ancestor
110079114|NCT01620476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110079115|NCT01620684|Metyrapone|metyrapone|mesh-list
110079116|NCT01620684|Antimetabolites|antimetabolites|mesh-ancestor
110079117|NCT01620684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110079118|NCT01620684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110079119|NCT01620736|Raltegravir Potassium|raltegravir potassium|mesh-list
110079120|NCT01620736|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110079121|NCT01620736|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110079122|NCT01620736|Antiviral Agents|antiviral agents|mesh-ancestor
110079123|NCT01620736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110183899|NCT03152084|Dapagliflozin|dapagliflozin|mesh-list
110079124|NCT01620736|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110079125|NCT01620736|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110079126|NCT01620736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110079127|NCT01620736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110079128|NCT01620814|Misoprostol|misoprostol|mesh-list
110079129|NCT01620814|Dinoprostone|dinoprostone|mesh-list
110079130|NCT01620814|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110079131|NCT01620814|Abortifacient Agents|abortifacient agents|mesh-ancestor
110079132|NCT01620814|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110079133|NCT01620814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110079134|NCT01620814|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110079135|NCT01620814|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110079136|NCT01620814|Oxytocics|oxytocics|mesh-ancestor
110079137|NCT01620840|Lacosamide|lacosamide|mesh-list
110079138|NCT01620840|Anticonvulsants|anticonvulsants|mesh-ancestor
110079139|NCT01620840|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110079140|NCT01620840|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110079141|NCT01620840|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110079142|NCT01620840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110079143|NCT01620944|Ritonavir|ritonavir|mesh-list
110079144|NCT01620944|Atazanavir Sulfate|atazanavir sulfate|mesh-list
110079145|NCT01620944|Tenofovir|tenofovir|mesh-list
110079146|NCT01620944|Lamivudine|lamivudine|mesh-list
110079147|NCT01620944|Emtricitabine|emtricitabine|mesh-list
110079148|NCT01620944|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110079149|NCT01620944|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110079150|NCT01620944|Protease Inhibitors|protease inhibitors|mesh-ancestor
110079151|NCT01620944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110079152|NCT01620944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110079154|NCT01620944|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110079155|NCT01620944|Antiviral Agents|antiviral agents|mesh-ancestor
110079156|NCT01620944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110079157|NCT01620944|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110079158|NCT01620944|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110079159|NCT01620944|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110079160|NCT01620944|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110079161|NCT01621022|Bupropion|bupropion|mesh-list
110079162|NCT01621022|Nicotine|nicotine|mesh-list
110079163|NCT01621022|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110079164|NCT01621022|Autonomic Agents|autonomic agents|mesh-ancestor
110079165|NCT01621022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110079166|NCT01621022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110079167|NCT01621022|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110079168|NCT01621022|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110079169|NCT01621022|Cholinergic Agents|cholinergic agents|mesh-ancestor
110079170|NCT01621022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110079171|NCT01621022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110079172|NCT01621022|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110079173|NCT01621022|Antidepressive Agents|antidepressive agents|mesh-ancestor
110079174|NCT01621022|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110079175|NCT01621022|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110079176|NCT01621022|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110079177|NCT01621022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110079178|NCT01621022|Dopamine Agents|dopamine agents|mesh-ancestor
110079179|NCT01621022|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110079180|NCT01621022|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110079181|NCT01621022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110079182|NCT01621100|Hydromorphone|hydromorphone|mesh-list
110079183|NCT01621100|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110079184|NCT01621100|Narcotics|narcotics|mesh-ancestor
110079185|NCT01621100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110079186|NCT01621100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110079187|NCT01621100|Analgesics|analgesics|mesh-ancestor
110079188|NCT01621100|Sensory System Agents|sensory system agents|mesh-ancestor
110079189|NCT01621100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110079190|NCT01621113|4-Aminopyridine|4-aminopyridine|mesh-list
110079191|NCT01621113|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
110079192|NCT01621113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110079193|NCT01621113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110079194|NCT01621165|Prazosin|prazosin|mesh-list
110079195|NCT01621165|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110079196|NCT01621165|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110079197|NCT01621165|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110079198|NCT01621165|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110079199|NCT01621165|Adrenergic Agents|adrenergic agents|mesh-ancestor
110079200|NCT01621165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110079201|NCT01621165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110079202|NCT01621165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110079203|NCT01621204|Immunoglobulins|immunoglobulins|mesh-list
110079204|NCT01621204|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110079205|NCT01621204|gamma-Globulins|gamma-globulins|mesh-list
110079206|NCT01621204|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110079207|NCT01621204|Immunologic Factors|immunologic factors|mesh-ancestor
110079208|NCT01621204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110079209|NCT01621217|Cetuximab|cetuximab|mesh-list
110079210|NCT01621217|Mitomycins|mitomycins|mesh-list
110079211|NCT01621217|Mitomycin|mitomycin|mesh-list
110079212|NCT01621217|Fluorouracil|fluorouracil|mesh-list
110079213|NCT01621217|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110079214|NCT01621217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110079215|NCT01621217|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110079216|NCT01621217|Alkylating Agents|alkylating agents|mesh-ancestor
110079217|NCT01621217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110079218|NCT01621217|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110079219|NCT01621217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110079221|NCT01621217|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110079222|NCT01621217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110079223|NCT01621217|Immunologic Factors|immunologic factors|mesh-ancestor
110079224|NCT01621217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110079226|NCT01621256|Anticoagulants|anticoagulants|mesh-ancestor
110079227|NCT01621256|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110079228|NCT01621256|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110079229|NCT01621256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110079230|NCT01621269|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
110079231|NCT01621269|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
110368815|NCT00553943|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110079232|NCT01621269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110079233|NCT01621269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110079234|NCT01621269|Immunologic Factors|immunologic factors|mesh-ancestor
110079235|NCT01621269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110079236|NCT01621308|Insulin|insulin|mesh-list
110079237|NCT01621308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110079238|NCT01621308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110079239|NCT01621321|Voriconazole|voriconazole|mesh-list
110079240|NCT01621321|Prednisolone|prednisolone|mesh-list
110079241|NCT01621321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110079242|NCT01621321|Glucocorticoids|glucocorticoids|mesh-ancestor
110079243|NCT01621321|Hormones|hormones|mesh-ancestor
110079244|NCT01621321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110079245|NCT01621321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110079246|NCT01621321|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110079247|NCT01621321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110079248|NCT01621321|Antifungal Agents|antifungal agents|mesh-ancestor
110079249|NCT01621321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110079250|NCT01621321|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110079251|NCT01621321|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110079252|NCT01621321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110079253|NCT01621321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110079254|NCT01621321|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110079255|NCT01621321|Hormone Antagonists|hormone antagonists|mesh-ancestor
110079256|NCT01621321|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110079257|NCT01621373|Propofol|propofol|mesh-list
110079258|NCT01621373|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110079259|NCT01621373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110183904|NCT00031707|Megestrol|megestrol|mesh-list
110079260|NCT01621373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110079261|NCT01621373|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110079262|NCT01621373|Anesthetics, General|anesthetics, general|mesh-ancestor
110079263|NCT01621373|Anesthetics|anesthetics|mesh-ancestor
110079264|NCT01621386|Prednisone|prednisone|mesh-list
110079265|NCT01621386|Montelukast|montelukast|mesh-list
110079266|NCT01621386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110079267|NCT01621386|Glucocorticoids|glucocorticoids|mesh-ancestor
110079268|NCT01621386|Hormones|hormones|mesh-ancestor
110079269|NCT01621386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110079270|NCT01621386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110079271|NCT01621386|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110079272|NCT01621386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110079273|NCT01621386|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110079274|NCT01621386|Respiratory System Agents|respiratory system agents|mesh-ancestor
110079275|NCT01621386|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110079276|NCT01621386|Hormone Antagonists|hormone antagonists|mesh-ancestor
110079277|NCT01621386|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110079278|NCT01621386|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110079279|NCT01621386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110079280|NCT01621451|Aspirin|aspirin|mesh-list
110079281|NCT01621451|Clopidogrel|clopidogrel|mesh-list
110079282|NCT01621451|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110079283|NCT01621451|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110079284|NCT01621451|Analgesics|analgesics|mesh-ancestor
110079285|NCT01621451|Sensory System Agents|sensory system agents|mesh-ancestor
110079286|NCT01621451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110079287|NCT01621451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110079288|NCT01621451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110079289|NCT01621451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110079290|NCT01621451|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110079291|NCT01621451|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110079292|NCT01621451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110079293|NCT01621451|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110079294|NCT01621451|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110079295|NCT01621451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110079296|NCT01621451|Antipyretics|antipyretics|mesh-ancestor
110079297|NCT01621451|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110079298|NCT01621451|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110079299|NCT01621451|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110079300|NCT01621451|Purinergic Agents|purinergic agents|mesh-ancestor
110079301|NCT01621451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110079302|NCT01621620|Yohimbine|yohimbine|mesh-list
110079303|NCT01621620|Mydriatics|mydriatics|mesh-ancestor
110079304|NCT01621620|Autonomic Agents|autonomic agents|mesh-ancestor
110079305|NCT01621620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110079306|NCT01621620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110079307|NCT01621620|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
110079308|NCT01621620|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110079309|NCT01621620|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110079310|NCT01621620|Adrenergic Agents|adrenergic agents|mesh-ancestor
110079311|NCT01621620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110079312|NCT01621620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110079313|NCT01621620|Urological Agents|urological agents|mesh-ancestor
110079314|NCT01621698|Fentanyl|fentanyl|mesh-list
110079315|NCT01621698|Bupivacaine|bupivacaine|mesh-list
110079316|NCT01621698|Propofol|propofol|mesh-list
110079317|NCT01621698|Atracurium|atracurium|mesh-list
110079318|NCT01621698|Anesthetics, Local|anesthetics, local|mesh-ancestor
110079319|NCT01621698|Anesthetics|anesthetics|mesh-ancestor
110079320|NCT01621698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110079321|NCT01621698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110079322|NCT01621698|Sensory System Agents|sensory system agents|mesh-ancestor
110183909|NCT00031707|Contraceptive Agents|contraceptive agents|mesh-ancestor
110079323|NCT01621698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110079324|NCT01621698|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110079325|NCT01621698|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110079326|NCT01621698|Anesthetics, General|anesthetics, general|mesh-ancestor
110079327|NCT01621698|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110079328|NCT01621698|Narcotics|narcotics|mesh-ancestor
110079329|NCT01621698|Analgesics|analgesics|mesh-ancestor
110079330|NCT01621698|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110079331|NCT01621698|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110079332|NCT01621698|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110079333|NCT01621698|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110079334|NCT01621698|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
110079335|NCT01621698|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110079336|NCT01621698|Cholinergic Agents|cholinergic agents|mesh-ancestor
110079337|NCT01621698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110079338|NCT01621698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110079339|NCT01621750|Clopidogrel|clopidogrel|mesh-list
110079340|NCT01621750|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110079341|NCT01621750|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110079342|NCT01621750|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110079343|NCT01621750|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110079344|NCT01621750|Purinergic Agents|purinergic agents|mesh-ancestor
110079345|NCT01621750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110079346|NCT01621750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110079347|NCT01621750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110079348|NCT01621763|Clopidogrel|clopidogrel|mesh-list
110079349|NCT01621763|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110079350|NCT01621763|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110079351|NCT01621763|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110079352|NCT01621763|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110079353|NCT01621763|Purinergic Agents|purinergic agents|mesh-ancestor
110079354|NCT01621763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110079355|NCT01621763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110079356|NCT01621763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110079357|NCT01621789|Diminazene aceturate|diminazene aceturate|mesh-list
110079358|NCT01621789|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110079359|NCT01621789|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110079360|NCT01621789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110079361|NCT01621789|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
110079362|NCT01621893|Calcium|calcium|mesh-list
110079363|NCT01621893|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110079364|NCT01621893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110079366|NCT01621971|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110079367|NCT01621971|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110079368|NCT01621971|Vasodilator Agents|vasodilator agents|mesh-ancestor
110079369|NCT01621971|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110079370|NCT01621971|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110079371|NCT01621971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110079372|NCT01621971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110079373|NCT01621971|Protective Agents|protective agents|mesh-ancestor
110079374|NCT01621971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110079375|NCT01622075|Paclitaxel|paclitaxel|mesh-list
110079376|NCT01622075|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110079377|NCT01622075|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110079378|NCT01622075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110079379|NCT01622075|Tubulin Modulators|tubulin modulators|mesh-ancestor
110079380|NCT01622075|Antimitotic Agents|antimitotic agents|mesh-ancestor
110079381|NCT01622075|Mitosis Modulators|mitosis modulators|mesh-ancestor
110079382|NCT01622075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110079383|NCT01622283|Cetirizine|cetirizine|mesh-list
110079384|NCT01622283|Levocetirizine|levocetirizine|mesh-list
110079385|NCT01622283|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110079386|NCT01622283|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110079387|NCT01622283|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110079388|NCT01622283|Histamine Antagonists|histamine antagonists|mesh-ancestor
110079389|NCT01622283|Histamine Agents|histamine agents|mesh-ancestor
110079390|NCT01622283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110079391|NCT01622283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110079392|NCT01622283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110079393|NCT01622361|Tamoxifen|tamoxifen|mesh-list
110079394|NCT01622361|Cyclophosphamide|cyclophosphamide|mesh-list
110079395|NCT01622361|Docetaxel|docetaxel|mesh-list
110079396|NCT01622361|Doxorubicin|doxorubicin|mesh-list
110079397|NCT01622361|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110079398|NCT01622361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110079399|NCT01622361|Immunologic Factors|immunologic factors|mesh-ancestor
110079400|NCT01622361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110079401|NCT01622361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110079402|NCT01622361|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110079403|NCT01622361|Alkylating Agents|alkylating agents|mesh-ancestor
110079404|NCT01622361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110079405|NCT01622361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110079406|NCT01622361|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110079407|NCT01622361|Tubulin Modulators|tubulin modulators|mesh-ancestor
110079408|NCT01622361|Antimitotic Agents|antimitotic agents|mesh-ancestor
110079409|NCT01622361|Mitosis Modulators|mitosis modulators|mesh-ancestor
110079410|NCT01622361|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110079411|NCT01622361|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110079412|NCT01622361|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110079413|NCT01622361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110079414|NCT01622361|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110079415|NCT01622361|Hormone Antagonists|hormone antagonists|mesh-ancestor
110079416|NCT01622361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110079417|NCT01622361|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110079418|NCT01622361|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110079419|NCT01622361|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110079420|NCT01622361|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110079421|NCT01622439|Prednisone|prednisone|mesh-list
110079422|NCT01622439|Cyclophosphamide|cyclophosphamide|mesh-list
110079423|NCT01622439|Rituximab|rituximab|mesh-list
110079424|NCT01622439|Doxorubicin|doxorubicin|mesh-list
110079425|NCT01622439|Vincristine|vincristine|mesh-list
110079426|NCT01622439|Valproic Acid|valproic acid|mesh-list
110079427|NCT01622439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110079428|NCT01622439|Immunologic Factors|immunologic factors|mesh-ancestor
110079429|NCT01622439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110079430|NCT01622439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110079431|NCT01622439|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110079432|NCT01622439|Alkylating Agents|alkylating agents|mesh-ancestor
110079433|NCT01622439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110079434|NCT01622439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110079435|NCT01622439|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110079436|NCT01622439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110079437|NCT01622439|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110079438|NCT01622439|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110079439|NCT01622439|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110079440|NCT01622439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110079441|NCT01622439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110079442|NCT01622439|Glucocorticoids|glucocorticoids|mesh-ancestor
110079443|NCT01622439|Hormones|hormones|mesh-ancestor
110079444|NCT01622439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110079445|NCT01622439|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110079446|NCT01622439|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110079447|NCT01622439|Tubulin Modulators|tubulin modulators|mesh-ancestor
110079448|NCT01622439|Antimitotic Agents|antimitotic agents|mesh-ancestor
110079449|NCT01622439|Mitosis Modulators|mitosis modulators|mesh-ancestor
110079450|NCT01622439|Anticonvulsants|anticonvulsants|mesh-ancestor
110079451|NCT01622439|GABA Agents|gaba agents|mesh-ancestor
110079452|NCT01622439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110079454|NCT01622439|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110079455|NCT01622439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110079456|NCT01622439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110079457|NCT01622504|Naloxone|naloxone|mesh-list
110079458|NCT01622504|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110079459|NCT01622504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110079460|NCT01622504|Sensory System Agents|sensory system agents|mesh-ancestor
110079461|NCT01622504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110079462|NCT01622556|Fludarabine|fludarabine|mesh-list
110079463|NCT01622556|Busulfan|busulfan|mesh-list
110079464|NCT01622556|Thymoglobulin|thymoglobulin|mesh-list
110079465|NCT01622556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110079466|NCT01622556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110079467|NCT01622556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110079468|NCT01622556|Immunologic Factors|immunologic factors|mesh-ancestor
110079469|NCT01622556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110079470|NCT01622556|Alkylating Agents|alkylating agents|mesh-ancestor
110079471|NCT01622556|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110079472|NCT01622556|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110079473|NCT01622777|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110079474|NCT01622777|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110079475|NCT01622777|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110079476|NCT01622777|Antimetabolites|antimetabolites|mesh-ancestor
110079477|NCT01622777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110079478|NCT01622777|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110079479|NCT01622777|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110079480|NCT01622777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110079482|NCT01622790|Abacavir|abacavir|mesh-list
110079483|NCT01622790|Dideoxynucleosides|dideoxynucleosides|mesh-list
110079484|NCT01622790|Dolutegravir|dolutegravir|mesh-list
110079485|NCT01622790|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110079486|NCT01622790|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110079487|NCT01622790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110079488|NCT01622790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110079489|NCT01622790|Antiviral Agents|antiviral agents|mesh-ancestor
110079490|NCT01622790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110079491|NCT01622790|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110079492|NCT01622790|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110079493|NCT01622790|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110079494|NCT01622790|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110079495|NCT01622790|Antimetabolites|antimetabolites|mesh-ancestor
110079496|NCT01622881|Nefopam|nefopam|mesh-list
110079497|NCT01622881|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110079498|NCT01622881|Analgesics|analgesics|mesh-ancestor
110079499|NCT01622881|Sensory System Agents|sensory system agents|mesh-ancestor
110079500|NCT01622881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110079501|NCT01622881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110079502|NCT01622933|Interferons|interferons|mesh-list
110079503|NCT01622933|Interferon-alpha|interferon-alpha|mesh-list
110079504|NCT01622933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110079505|NCT01622933|Antiviral Agents|antiviral agents|mesh-ancestor
110079506|NCT01622933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110079507|NCT01622933|Immunologic Factors|immunologic factors|mesh-ancestor
110079508|NCT01622933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110079509|NCT01622946|Tranexamic Acid|tranexamic acid|mesh-list
110079510|NCT01622946|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110079511|NCT01622946|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110079512|NCT01622946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110079513|NCT01622946|Hemostatics|hemostatics|mesh-ancestor
110079515|NCT01622972|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
110079516|NCT01622972|Laxatives|laxatives|mesh-ancestor
110079517|NCT01622972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110079518|NCT01623024|Vitamin D|vitamin d|mesh-list
110079519|NCT01623024|Vitamins|vitamins|mesh-ancestor
110079520|NCT01623024|Micronutrients|micronutrients|mesh-ancestor
110079521|NCT01623024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110079522|NCT01623024|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110079523|NCT01623102|Bevacizumab|bevacizumab|mesh-list
110079524|NCT01623102|Cisplatin|cisplatin|mesh-list
110079525|NCT01623102|Gemcitabine|gemcitabine|mesh-list
110079526|NCT01623102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110079527|NCT01623102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110079528|NCT01623102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110079529|NCT01623102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110079530|NCT01623102|Growth Substances|growth substances|mesh-ancestor
110079531|NCT01623102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110079532|NCT01623102|Growth Inhibitors|growth inhibitors|mesh-ancestor
110079533|NCT01623102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110079534|NCT01623102|Antimetabolites|antimetabolites|mesh-ancestor
110079535|NCT01623102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110079536|NCT01623206|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
110079537|NCT01623206|Hemostatics|hemostatics|mesh-ancestor
110079538|NCT01623206|Coagulants|coagulants|mesh-ancestor
110079539|NCT01623206|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
110079540|NCT01623206|Natriuretic Agents|natriuretic agents|mesh-ancestor
110079541|NCT01623206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110079542|NCT01623284|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110079543|NCT01623284|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110079544|NCT01623284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110079545|NCT01623336|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110079546|NCT01623336|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110079548|NCT01623336|Antiviral Agents|antiviral agents|mesh-ancestor
110079549|NCT01623336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110079550|NCT01623336|Immunologic Factors|immunologic factors|mesh-ancestor
110079551|NCT01623336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110079552|NCT01623349|Olaparib|olaparib|mesh-list
110079553|NCT01623349|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110079554|NCT01623349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110079555|NCT01623349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110079556|NCT01623349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110079557|NCT01623362|Fluorides|fluorides|mesh-list
110079558|NCT01623362|Cariostatic Agents|cariostatic agents|mesh-ancestor
110079559|NCT01623362|Protective Agents|protective agents|mesh-ancestor
110079560|NCT01623362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110079561|NCT01623375|Insulin|insulin|mesh-list
110079562|NCT01623375|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110079563|NCT01623375|Insulin, Long-Acting|insulin, long-acting|mesh-list
110079564|NCT01623375|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110079565|NCT01623375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110079566|NCT01623401|Tedizolid phosphate|tedizolid phosphate|mesh-list
110079567|NCT01623401|Tedizolid|tedizolid|mesh-list
110079568|NCT01623401|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110079569|NCT01623401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110079570|NCT01623440|Naltrexone|naltrexone|mesh-list
110079571|NCT01623440|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110079572|NCT01623440|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110079573|NCT01623440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110079574|NCT01623440|Sensory System Agents|sensory system agents|mesh-ancestor
110079575|NCT01623440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110079576|NCT01623505|Varenicline|varenicline|mesh-list
110079577|NCT01623505|Nicotine|nicotine|mesh-list
110079578|NCT01623505|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110079579|NCT01623505|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110079580|NCT01623505|Cholinergic Agents|cholinergic agents|mesh-ancestor
110079581|NCT01623505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110079582|NCT01623505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110079583|NCT01623505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110079584|NCT01623505|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110079585|NCT01623505|Autonomic Agents|autonomic agents|mesh-ancestor
110079586|NCT01623505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110079587|NCT01623570|Menotropins|menotropins|mesh-list
110079588|NCT01623570|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110079589|NCT01623570|Fertility Agents|fertility agents|mesh-ancestor
110079590|NCT01623570|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110079591|NCT01623570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110079592|NCT01623609|Naloxegol|naloxegol|mesh-list
110079593|NCT01623609|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110079594|NCT01623609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110079595|NCT01623609|Sensory System Agents|sensory system agents|mesh-ancestor
110183944|NCT02971644|Cobalt|cobalt|mesh-list
110079596|NCT01623609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110079597|NCT01623635|Ropivacaine|ropivacaine|mesh-list
110079598|NCT01623635|Anesthetics, Local|anesthetics, local|mesh-ancestor
110079599|NCT01623635|Anesthetics|anesthetics|mesh-ancestor
110079600|NCT01623635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110079601|NCT01623635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110079602|NCT01623635|Sensory System Agents|sensory system agents|mesh-ancestor
110079603|NCT01623635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110079604|NCT01623713|Risperidone|risperidone|mesh-list
110079605|NCT01623713|Iloperidone|iloperidone|mesh-list
110079606|NCT01623713|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110079607|NCT01623713|Serotonin Agents|serotonin agents|mesh-ancestor
110079608|NCT01623713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110079609|NCT01623713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110079610|NCT01623713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110079611|NCT01623713|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110079612|NCT01623713|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110079613|NCT01623713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110079614|NCT01623713|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110079615|NCT01623713|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110079616|NCT01623713|Dopamine Agents|dopamine agents|mesh-ancestor
110079618|NCT01623778|Interferon-alpha|interferon-alpha|mesh-list
110079619|NCT01623778|Interferon alpha-2|interferon alpha-2|mesh-list
110079620|NCT01623778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110079621|NCT01623778|Antiviral Agents|antiviral agents|mesh-ancestor
110079622|NCT01623778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110079623|NCT01623778|Immunologic Factors|immunologic factors|mesh-ancestor
110079624|NCT01623778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110079625|NCT01623817|Vancomycin|vancomycin|mesh-list
110079626|NCT01623817|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110079627|NCT01623817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110079628|NCT01623908|Zoledronic Acid|zoledronic acid|mesh-list
110079629|NCT01623908|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110079630|NCT01623908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110079631|NCT01623921|Celecoxib|celecoxib|mesh-list
110079632|NCT01623921|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110079633|NCT01623921|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110079634|NCT01623921|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110079635|NCT01623921|Antimetabolites|antimetabolites|mesh-ancestor
110079636|NCT01623921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110079637|NCT01623921|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110079638|NCT01623921|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110079639|NCT01623921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110079640|NCT01623921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110079641|NCT01623921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110079642|NCT01623921|Analgesics|analgesics|mesh-ancestor
110079643|NCT01623921|Sensory System Agents|sensory system agents|mesh-ancestor
110079644|NCT01623921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110079645|NCT01623921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110079646|NCT01623921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110079647|NCT01623921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110079648|NCT01623921|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110079649|NCT01623921|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110079650|NCT01624025|Docetaxel|docetaxel|mesh-list
110079651|NCT01624025|Epirubicin|epirubicin|mesh-list
110079652|NCT01624025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110079653|NCT01624025|Tubulin Modulators|tubulin modulators|mesh-ancestor
110079654|NCT01624025|Antimitotic Agents|antimitotic agents|mesh-ancestor
110079655|NCT01624025|Mitosis Modulators|mitosis modulators|mesh-ancestor
110079656|NCT01624025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110079657|NCT01624025|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110079658|NCT01624025|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110079659|NCT01624025|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110079660|NCT01624025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110079661|NCT01624038|Hydroxyurea|hydroxyurea|mesh-list
110079662|NCT01624038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110079663|NCT01624038|Antisickling Agents|antisickling agents|mesh-ancestor
110183950|NCT00031824|Prednisone|prednisone|mesh-list
110079664|NCT01624038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110079665|NCT01624038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110079666|NCT01624038|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110079667|NCT01624051|Cisplatin|cisplatin|mesh-list
110079668|NCT01624051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110079669|NCT01624064|Calcium, Dietary|calcium, dietary|mesh-list
110079670|NCT01624064|Enalapril|enalapril|mesh-list
110079671|NCT01624064|Calcium|calcium|mesh-list
110079672|NCT01624064|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
110079673|NCT01624064|Enzyme Inhibitors|enzyme inhibitors|mesh-list
110079674|NCT01624064|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110079675|NCT01624064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110079676|NCT01624064|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110079677|NCT01624064|Protease Inhibitors|protease inhibitors|mesh-ancestor
110079678|NCT01624064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110079679|NCT01624064|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110079680|NCT01624103|Lidocaine|lidocaine|mesh-list
110079681|NCT01624103|Levobupivacaine|levobupivacaine|mesh-list
110079682|NCT01624103|Anesthetics, Local|anesthetics, local|mesh-ancestor
110079683|NCT01624103|Anesthetics|anesthetics|mesh-ancestor
110079684|NCT01624103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110079685|NCT01624103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110079686|NCT01624103|Sensory System Agents|sensory system agents|mesh-ancestor
110079687|NCT01624103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110079688|NCT01624103|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110079689|NCT01624103|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110079690|NCT01624103|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110079691|NCT01624103|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110079692|NCT01624103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110079693|NCT01624116|Metformin|metformin|mesh-list
110079694|NCT01624116|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110079695|NCT01624116|Acarbose|acarbose|mesh-list
110079696|NCT01624116|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110079697|NCT01624116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110079698|NCT01624116|Incretins|incretins|mesh-ancestor
110079699|NCT01624116|Hormones|hormones|mesh-ancestor
110079700|NCT01624116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110079701|NCT01624116|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110079702|NCT01624116|Protease Inhibitors|protease inhibitors|mesh-ancestor
110079703|NCT01624116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110079704|NCT01624116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110079705|NCT01624116|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
110079706|NCT01624129|Fluticasone|fluticasone|mesh-list
110079707|NCT01624129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110079708|NCT01624129|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110079709|NCT01624129|Autonomic Agents|autonomic agents|mesh-ancestor
110079710|NCT01624129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110079711|NCT01624129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110079712|NCT01624129|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110079713|NCT01624129|Respiratory System Agents|respiratory system agents|mesh-ancestor
110079714|NCT01624129|Dermatologic Agents|dermatologic agents|mesh-ancestor
110079715|NCT01624129|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110079716|NCT01624207|Atorvastatin|atorvastatin|mesh-list
110079717|NCT01624207|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110079718|NCT01624207|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110079719|NCT01624207|Antimetabolites|antimetabolites|mesh-ancestor
110079720|NCT01624207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110079721|NCT01624207|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110079722|NCT01624207|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110079723|NCT01624207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110079724|NCT01624246|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
110079725|NCT01624246|Avibactam|avibactam|mesh-list
110079726|NCT01624246|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110079727|NCT01624246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110079728|NCT01624246|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110079729|NCT01624246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110079730|NCT01624246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110079731|NCT01624337|Piperaquine|piperaquine|mesh-list
110079732|NCT01624337|Antimalarials|antimalarials|mesh-ancestor
110079733|NCT01624337|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110079734|NCT01624337|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110079735|NCT01624337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110079736|NCT01624428|Varenicline|varenicline|mesh-list
110079737|NCT01624428|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110079738|NCT01624428|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110079739|NCT01624428|Cholinergic Agents|cholinergic agents|mesh-ancestor
110079740|NCT01624428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110079741|NCT01624428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110079742|NCT01624428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110079744|NCT01624441|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110079745|NCT01624441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110079746|NCT01624441|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110079747|NCT01624441|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110079748|NCT01624441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110079749|NCT01624441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110079750|NCT01624493|Carboplatin|carboplatin|mesh-list
110079751|NCT01624493|Gemcitabine|gemcitabine|mesh-list
110079752|NCT01624493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110079753|NCT01624493|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110079754|NCT01624493|Antimetabolites|antimetabolites|mesh-ancestor
110079755|NCT01624493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110079757|NCT01624649|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
110079758|NCT01624649|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110079759|NCT01624649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110079760|NCT01624649|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110079761|NCT01624649|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110079762|NCT01624649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110079763|NCT01624649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110079764|NCT01624649|Dopamine Agents|dopamine agents|mesh-ancestor
110079765|NCT01624649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110079766|NCT01624649|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110079767|NCT01624649|Adrenergic Agents|adrenergic agents|mesh-ancestor
110079768|NCT01624675|Risperidone|risperidone|mesh-list
110079769|NCT01624675|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110079770|NCT01624675|Serotonin Agents|serotonin agents|mesh-ancestor
110079771|NCT01624675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110079772|NCT01624675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110079773|NCT01624675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110079774|NCT01624675|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110079775|NCT01624675|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110079776|NCT01624675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110079777|NCT01624675|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110079778|NCT01624675|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110079779|NCT01624675|Dopamine Agents|dopamine agents|mesh-ancestor
110079780|NCT01624714|Alemtuzumab|alemtuzumab|mesh-list
110079781|NCT01624714|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110079782|NCT01624714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110079783|NCT01624766|Denosumab|denosumab|mesh-list
110079784|NCT01624766|Everolimus|everolimus|mesh-list
110079785|NCT01624766|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
110079786|NCT01624766|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110079787|NCT01624766|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110079788|NCT01624766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110079789|NCT01624766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110079790|NCT01624766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110079791|NCT01624766|Immunologic Factors|immunologic factors|mesh-ancestor
110079792|NCT01624766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110079793|NCT01624766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110079794|NCT01624766|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110079795|NCT01624766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110079796|NCT01624857|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110079797|NCT01624857|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110079798|NCT01624857|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110079799|NCT01624857|Antimetabolites|antimetabolites|mesh-ancestor
110079800|NCT01624857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110079801|NCT01624857|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110079802|NCT01624857|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110079803|NCT01624857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110079804|NCT01625026|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
110079805|NCT01625026|Cathartics|cathartics|mesh-ancestor
110079806|NCT01625026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110079807|NCT01625260|Gemcitabine|gemcitabine|mesh-list
110079808|NCT01625260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110079810|NCT01625260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110079811|NCT01625260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110079812|NCT01625351|Sirolimus|sirolimus|mesh-list
110079813|NCT01625351|Fludarabine|fludarabine|mesh-list
110079814|NCT01625351|Melphalan|melphalan|mesh-list
110079815|NCT01625351|Busulfan|busulfan|mesh-list
110079816|NCT01625351|Mechlorethamine|mechlorethamine|mesh-list
110079817|NCT01625351|Alemtuzumab|alemtuzumab|mesh-list
110079818|NCT01625351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110079819|NCT01625351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110079820|NCT01625351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110079821|NCT01625351|Immunologic Factors|immunologic factors|mesh-ancestor
110079822|NCT01625351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110079823|NCT01625351|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110079824|NCT01625351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110079825|NCT01625351|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110079826|NCT01625351|Antifungal Agents|antifungal agents|mesh-ancestor
110079827|NCT01625351|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110079828|NCT01625351|Alkylating Agents|alkylating agents|mesh-ancestor
110079829|NCT01625351|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110079830|NCT01625351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110079831|NCT01625429|Paclitaxel|paclitaxel|mesh-list
110079832|NCT01625429|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110079833|NCT01625429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110079834|NCT01625429|Tubulin Modulators|tubulin modulators|mesh-ancestor
110079835|NCT01625429|Antimitotic Agents|antimitotic agents|mesh-ancestor
110079836|NCT01625429|Mitosis Modulators|mitosis modulators|mesh-ancestor
110079837|NCT01625429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110079838|NCT01625494|Amlodipine|amlodipine|mesh-list
110079839|NCT01625494|Irbesartan|irbesartan|mesh-list
110079840|NCT01625494|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110079841|NCT01625494|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110079842|NCT01625494|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110079843|NCT01625494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110079844|NCT01625494|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110079845|NCT01625494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110079847|NCT01625494|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110079848|NCT01625494|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110079849|NCT01625520|Everolimus|everolimus|mesh-list
110079850|NCT01625520|Pasireotide|pasireotide|mesh-list
110079851|NCT01625520|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110079852|NCT01625520|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110079853|NCT01625520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110079854|NCT01625520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110079855|NCT01625520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110079856|NCT01625520|Immunologic Factors|immunologic factors|mesh-ancestor
110079857|NCT01625520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110079858|NCT01625520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110079859|NCT01625520|Hormones|hormones|mesh-ancestor
110079860|NCT01625520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110079861|NCT01625572|Morphine|morphine|mesh-list
110079862|NCT01625572|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110079863|NCT01625572|Narcotics|narcotics|mesh-ancestor
110079864|NCT01625572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110079865|NCT01625572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110079866|NCT01625572|Analgesics|analgesics|mesh-ancestor
110079867|NCT01625572|Sensory System Agents|sensory system agents|mesh-ancestor
110079868|NCT01625572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110079870|NCT01625715|Antipruritics|antipruritics|mesh-ancestor
110079871|NCT01625715|Dermatologic Agents|dermatologic agents|mesh-ancestor
110079872|NCT01625715|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110079873|NCT01625715|Histamine Antagonists|histamine antagonists|mesh-ancestor
110079874|NCT01625715|Histamine Agents|histamine agents|mesh-ancestor
110079875|NCT01625715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110079876|NCT01625715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110079877|NCT01625715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110079878|NCT01625715|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110079879|NCT01625741|Rituximab|rituximab|mesh-list
110079880|NCT01625741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110079881|NCT01625741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110079882|NCT01625741|Immunologic Factors|immunologic factors|mesh-ancestor
110079883|NCT01625741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110079884|NCT01625741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110079886|NCT01625793|Interferon-alpha|interferon-alpha|mesh-list
110079887|NCT01625793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110079888|NCT01625793|Antiviral Agents|antiviral agents|mesh-ancestor
110079889|NCT01625793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110079890|NCT01625793|Immunologic Factors|immunologic factors|mesh-ancestor
110079891|NCT01625793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110079892|NCT01625806|Ketoconazole|ketoconazole|mesh-list
110079893|NCT01625806|Antifungal Agents|antifungal agents|mesh-ancestor
110079894|NCT01625806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110079895|NCT01625806|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110079896|NCT01625806|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110079897|NCT01625806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110079898|NCT01625806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110079899|NCT01625806|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110079900|NCT01625806|Hormone Antagonists|hormone antagonists|mesh-ancestor
110079901|NCT01625806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110079902|NCT01625806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110368816|NCT00553943|Antimetabolites|antimetabolites|mesh-ancestor
110079905|NCT01625871|Artemether|artemether|mesh-list
110079906|NCT01625871|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
110079907|NCT01625871|Antimalarials|antimalarials|mesh-ancestor
110079908|NCT01625871|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110079909|NCT01625871|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110079910|NCT01625871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110079911|NCT01625936|Bevacizumab|bevacizumab|mesh-list
110079912|NCT01625936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110079913|NCT01625936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110079914|NCT01625936|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110079915|NCT01625936|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110079916|NCT01625936|Growth Substances|growth substances|mesh-ancestor
110079917|NCT01625936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110079918|NCT01625936|Growth Inhibitors|growth inhibitors|mesh-ancestor
110079919|NCT01625156|Sirolimus|sirolimus|mesh-list
110079920|NCT01625156|Temsirolimus|temsirolimus|mesh-list
110079921|NCT01625156|MTOR Inhibitors|mtor inhibitors|mesh-list
110079922|NCT01625156|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110079923|NCT01625156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110079924|NCT01625156|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110079925|NCT01625156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110079926|NCT01625156|Antifungal Agents|antifungal agents|mesh-ancestor
110079927|NCT01625156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110079928|NCT01625156|Immunologic Factors|immunologic factors|mesh-ancestor
110079929|NCT01625156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110079930|NCT01625156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110079931|NCT01625156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110079932|NCT01625156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110079933|NCT01626222|Everolimus|everolimus|mesh-list
110079934|NCT01626222|Exemestane|exemestane|mesh-list
110183979|NCT00031863|Analgesics|analgesics|mesh-ancestor
110079936|NCT01626222|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110079937|NCT01626222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110079938|NCT01626222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110079939|NCT01626222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110079940|NCT01626222|Immunologic Factors|immunologic factors|mesh-ancestor
110079941|NCT01626222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110079942|NCT01626222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110079943|NCT01626222|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110079944|NCT01626222|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110079945|NCT01626222|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110079946|NCT01626222|Hormone Antagonists|hormone antagonists|mesh-ancestor
110079947|NCT01626222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110079948|NCT01626339|Bevacizumab|bevacizumab|mesh-list
110079949|NCT01626339|Ranibizumab|ranibizumab|mesh-list
110079950|NCT01626339|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110079951|NCT01626339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110079952|NCT01626339|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110079953|NCT01626339|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110079954|NCT01626339|Growth Substances|growth substances|mesh-ancestor
110079955|NCT01626339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110079956|NCT01626339|Growth Inhibitors|growth inhibitors|mesh-ancestor
110079958|NCT01626443|Vitamin B Complex|vitamin b complex|mesh-list
110079959|NCT01626443|Inositol|inositol|mesh-list
110079960|NCT01626443|Hematinics|hematinics|mesh-ancestor
110079961|NCT01626443|Vitamins|vitamins|mesh-ancestor
110079962|NCT01626443|Micronutrients|micronutrients|mesh-ancestor
110079963|NCT01626443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110079964|NCT01626469|Captopril|captopril|mesh-list
110079965|NCT01626469|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110079966|NCT01626469|Protease Inhibitors|protease inhibitors|mesh-ancestor
110079967|NCT01626469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110079968|NCT01626469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110079969|NCT01626469|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110079971|NCT01626534|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110079972|NCT01626534|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110079973|NCT01626534|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110079974|NCT01626534|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110079975|NCT01626534|Purinergic Agents|purinergic agents|mesh-ancestor
110079976|NCT01626534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110079977|NCT01626534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110079978|NCT01626534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110079979|NCT01626560|Vancomycin|vancomycin|mesh-list
110079980|NCT01626560|Daptomycin|daptomycin|mesh-list
110079981|NCT01626560|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110079982|NCT01626560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110079983|NCT01626612|Anti-Infective Agents|anti-infective agents|mesh-list
110079984|NCT01626612|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110079985|NCT01626651|Ketoconazole|ketoconazole|mesh-list
110079986|NCT01626651|Antifungal Agents|antifungal agents|mesh-ancestor
110079987|NCT01626651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110079988|NCT01626651|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110079989|NCT01626651|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110079990|NCT01626651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110079991|NCT01626651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110079992|NCT01626651|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110079993|NCT01626651|Hormone Antagonists|hormone antagonists|mesh-ancestor
110079994|NCT01626651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110079995|NCT01626651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110079996|NCT01626651|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110079997|NCT01626911|Heparin|heparin|mesh-list
110079998|NCT01626911|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
110079999|NCT01626911|Tinzaparin|tinzaparin|mesh-list
110080000|NCT01626911|Dalteparin|dalteparin|mesh-list
110080001|NCT01626911|Anticoagulants|anticoagulants|mesh-ancestor
110080002|NCT01626911|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110080003|NCT01626911|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110080004|NCT01626911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110080005|NCT01627041|Cytarabine|cytarabine|mesh-list
110080006|NCT01627041|Decitabine|decitabine|mesh-list
110080007|NCT01627041|Daunorubicin|daunorubicin|mesh-list
110080008|NCT01627041|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110080009|NCT01627041|Antimetabolites|antimetabolites|mesh-ancestor
110080010|NCT01627041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110080011|NCT01627041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110080012|NCT01627041|Antiviral Agents|antiviral agents|mesh-ancestor
110080013|NCT01627041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110080014|NCT01627041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110080015|NCT01627041|Immunologic Factors|immunologic factors|mesh-ancestor
110080016|NCT01627041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110080017|NCT01627041|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110080018|NCT01627041|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110080019|NCT01627041|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110080020|NCT01627041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110080021|NCT01627106|Amiodarone|amiodarone|mesh-list
110080022|NCT01627106|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110080023|NCT01627106|Vasodilator Agents|vasodilator agents|mesh-ancestor
110080024|NCT01627106|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
110080025|NCT01627106|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110080026|NCT01627106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110080027|NCT01627106|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110080028|NCT01627106|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110080029|NCT01627106|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110080030|NCT01627106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110080031|NCT01627106|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110080032|NCT01627106|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110080033|NCT01627106|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110080035|NCT01627132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110080036|NCT01627132|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110080037|NCT01627132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110080038|NCT01627132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110080039|NCT01627145|Solifenacin Succinate|solifenacin succinate|mesh-list
110080040|NCT01627145|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110080041|NCT01627145|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110080042|NCT01627145|Cholinergic Agents|cholinergic agents|mesh-ancestor
110080043|NCT01627145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110080044|NCT01627145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110080045|NCT01627145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110080046|NCT01627145|Urological Agents|urological agents|mesh-ancestor
110080047|NCT01627158|Budesonide|budesonide|mesh-list
110080048|NCT01627158|Formoterol Fumarate|formoterol fumarate|mesh-list
110080049|NCT01627158|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
110080050|NCT01627158|Charcoal|charcoal|mesh-list
110080051|NCT01627158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110080052|NCT01627158|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110080053|NCT01627158|Autonomic Agents|autonomic agents|mesh-ancestor
110080054|NCT01627158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110080055|NCT01627158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110080056|NCT01627158|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110080057|NCT01627158|Respiratory System Agents|respiratory system agents|mesh-ancestor
110080058|NCT01627158|Glucocorticoids|glucocorticoids|mesh-ancestor
110080060|NCT01627158|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110080061|NCT01627158|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110080062|NCT01627158|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110080063|NCT01627158|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110080064|NCT01627158|Adrenergic Agents|adrenergic agents|mesh-ancestor
110080065|NCT01627158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110080066|NCT01627158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110080067|NCT01627158|Antidotes|antidotes|mesh-ancestor
110080068|NCT01627158|Protective Agents|protective agents|mesh-ancestor
110080069|NCT01627171|Bisacodyl|bisacodyl|mesh-list
110080070|NCT01627171|Picosulfate sodium|picosulfate sodium|mesh-list
110080071|NCT01627171|Cathartics|cathartics|mesh-ancestor
110080072|NCT01627171|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110080073|NCT01627171|Laxatives|laxatives|mesh-ancestor
110080074|NCT01627223|Lamivudine|lamivudine|mesh-list
110080076|NCT01627223|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110080077|NCT01627223|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110080078|NCT01627223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110080079|NCT01627223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110080080|NCT01627223|Antiviral Agents|antiviral agents|mesh-ancestor
110080081|NCT01627223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110080082|NCT01627223|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110080083|NCT01627223|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110080084|NCT01627236|Methylprednisolone|methylprednisolone|mesh-list
110080085|NCT01627236|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110080086|NCT01627236|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110080087|NCT01627236|Prednisolone|prednisolone|mesh-list
110080088|NCT01627236|Prednisolone acetate|prednisolone acetate|mesh-list
110080089|NCT01627236|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110080090|NCT01627236|Prednisolone phosphate|prednisolone phosphate|mesh-list
110080091|NCT01627236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110080092|NCT01627236|Antiemetics|antiemetics|mesh-ancestor
110080093|NCT01627236|Autonomic Agents|autonomic agents|mesh-ancestor
110080094|NCT01627236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110080095|NCT01627236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110080096|NCT01627236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110080098|NCT01627236|Hormones|hormones|mesh-ancestor
110080099|NCT01627236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110080100|NCT01627236|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110080101|NCT01627236|Protective Agents|protective agents|mesh-ancestor
110080102|NCT01627236|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110080103|NCT01627236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110080104|NCT01627262|Mesalamine|mesalamine|mesh-list
110080105|NCT01627262|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110080106|NCT01627262|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110080107|NCT01627262|Analgesics|analgesics|mesh-ancestor
110080108|NCT01627262|Sensory System Agents|sensory system agents|mesh-ancestor
110080109|NCT01627262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110080110|NCT01627262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110080111|NCT01627262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110080112|NCT01627262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110080113|NCT01627353|Dexamethasone|dexamethasone|mesh-list
110080114|NCT01627353|Lidocaine|lidocaine|mesh-list
110080115|NCT01627353|Magnesium Sulfate|magnesium sulfate|mesh-list
110080116|NCT01627353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110080117|NCT01627353|Antiemetics|antiemetics|mesh-ancestor
110080118|NCT01627353|Autonomic Agents|autonomic agents|mesh-ancestor
110080119|NCT01627353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110080120|NCT01627353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110080121|NCT01627353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110080122|NCT01627353|Glucocorticoids|glucocorticoids|mesh-ancestor
110080123|NCT01627353|Hormones|hormones|mesh-ancestor
110080124|NCT01627353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110080125|NCT01627353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110080126|NCT01627353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110080127|NCT01627353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110080129|NCT01627353|Anesthetics|anesthetics|mesh-ancestor
110080130|NCT01627353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110080131|NCT01627353|Sensory System Agents|sensory system agents|mesh-ancestor
110080132|NCT01627353|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110080133|NCT01627353|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110080134|NCT01627353|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110080135|NCT01627353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110080136|NCT01627353|Analgesics|analgesics|mesh-ancestor
110080137|NCT01627353|Anticonvulsants|anticonvulsants|mesh-ancestor
110080138|NCT01627353|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110080139|NCT01627353|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110080140|NCT01627353|Tocolytic Agents|tocolytic agents|mesh-ancestor
110080141|NCT01627353|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110080142|NCT01627379|Panitumumab|panitumumab|mesh-list
110080143|NCT01627379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110183993|NCT00031902|Bleomycin|bleomycin|mesh-list
110080144|NCT01627379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110080145|NCT01627431|Aspirin|aspirin|mesh-list
110080146|NCT01627431|Clopidogrel|clopidogrel|mesh-list
110080147|NCT01627431|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110080148|NCT01627431|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110080149|NCT01627431|Analgesics|analgesics|mesh-ancestor
110080150|NCT01627431|Sensory System Agents|sensory system agents|mesh-ancestor
110080151|NCT01627431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110080152|NCT01627431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110080153|NCT01627431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110080154|NCT01627431|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110080155|NCT01627431|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110080156|NCT01627431|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110080157|NCT01627431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110080158|NCT01627431|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110080159|NCT01627431|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110080160|NCT01627431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110080161|NCT01627431|Antipyretics|antipyretics|mesh-ancestor
110080162|NCT01627431|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110080163|NCT01627431|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110080164|NCT01627431|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110080165|NCT01627431|Purinergic Agents|purinergic agents|mesh-ancestor
110080166|NCT01627431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110080167|NCT01627587|Ketoconazole|ketoconazole|mesh-list
110080168|NCT01627587|Antifungal Agents|antifungal agents|mesh-ancestor
110080169|NCT01627587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110080170|NCT01627587|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110080171|NCT01627587|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110080172|NCT01627587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110080173|NCT01627587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110080174|NCT01627587|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110080175|NCT01627587|Hormone Antagonists|hormone antagonists|mesh-ancestor
110080176|NCT01627587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110080177|NCT01627587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110080178|NCT01627587|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110080179|NCT01627626|Pilocarpine|pilocarpine|mesh-list
110080180|NCT01627626|Miotics|miotics|mesh-ancestor
110080181|NCT01627626|Autonomic Agents|autonomic agents|mesh-ancestor
110080182|NCT01627626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110080183|NCT01627626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110080184|NCT01627626|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
110080185|NCT01627626|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110080186|NCT01627626|Cholinergic Agents|cholinergic agents|mesh-ancestor
110080187|NCT01627626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110080188|NCT01627626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110080189|NCT01627639|Acetazolamide|acetazolamide|mesh-list
110080190|NCT01627639|Anticonvulsants|anticonvulsants|mesh-ancestor
110080191|NCT01627639|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110080192|NCT01627639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110080193|NCT01627639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110080194|NCT01627639|Diuretics|diuretics|mesh-ancestor
110080195|NCT01627639|Natriuretic Agents|natriuretic agents|mesh-ancestor
110080196|NCT01627639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110080197|NCT01627678|Molgramostim|molgramostim|mesh-list
110080198|NCT01627678|Aluminum Hydroxide|aluminum hydroxide|mesh-list
110080200|NCT01627678|Immunologic Factors|immunologic factors|mesh-ancestor
110080201|NCT01627678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110080202|NCT01627678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110080203|NCT01627678|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110080204|NCT01627678|Antacids|antacids|mesh-ancestor
110080205|NCT01627678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110080206|NCT01627678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110080207|NCT01627717|Maraviroc|maraviroc|mesh-list
110080208|NCT01627717|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110080209|NCT01627717|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110080210|NCT01627717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110080212|NCT01627717|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110080213|NCT01627717|Antiviral Agents|antiviral agents|mesh-ancestor
110080214|NCT01627717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110080215|NCT01627717|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
110080216|NCT01627834|Ropinirole|ropinirole|mesh-list
110080217|NCT01627834|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110080218|NCT01627834|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110080219|NCT01627834|Dopamine Agonists|dopamine agonists|mesh-ancestor
110080220|NCT01627834|Dopamine Agents|dopamine agents|mesh-ancestor
110080221|NCT01627834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110080222|NCT01627834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110080223|NCT01627834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110080224|NCT01627847|Ropinirole|ropinirole|mesh-list
110080225|NCT01627847|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110080226|NCT01627847|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110080227|NCT01627847|Dopamine Agonists|dopamine agonists|mesh-ancestor
110080228|NCT01627847|Dopamine Agents|dopamine agents|mesh-ancestor
110080229|NCT01627847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110080230|NCT01627847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110080231|NCT01627847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110080232|NCT01627873|Fentanyl|fentanyl|mesh-list
110080233|NCT01627873|Remifentanil|remifentanil|mesh-list
110080234|NCT01627873|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110080235|NCT01627873|Narcotics|narcotics|mesh-ancestor
110080236|NCT01627873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110080237|NCT01627873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110080238|NCT01627873|Analgesics|analgesics|mesh-ancestor
110080239|NCT01627873|Sensory System Agents|sensory system agents|mesh-ancestor
110080240|NCT01627873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110080241|NCT01627873|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110080242|NCT01627873|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110080243|NCT01627873|Anesthetics, General|anesthetics, general|mesh-ancestor
110080244|NCT01627873|Anesthetics|anesthetics|mesh-ancestor
110080245|NCT01627886|Ibandronic Acid|ibandronic acid|mesh-list
110080246|NCT01627886|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110080247|NCT01627886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110080248|NCT01627938|Mitoxantrone|mitoxantrone|mesh-list
110080249|NCT01627938|Dexrazoxane|dexrazoxane|mesh-list
110080250|NCT01627938|Razoxane|razoxane|mesh-list
110080251|NCT01627938|Analgesics|analgesics|mesh-ancestor
110080252|NCT01627938|Sensory System Agents|sensory system agents|mesh-ancestor
110080253|NCT01627938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110080254|NCT01627938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110080255|NCT01627938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110080256|NCT01627938|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110080257|NCT01627938|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110080258|NCT01627938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110080259|NCT01627938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110080260|NCT01627938|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110080261|NCT01627938|Protective Agents|protective agents|mesh-ancestor
110080262|NCT01627938|Antimitotic Agents|antimitotic agents|mesh-ancestor
110080263|NCT01627938|Mitosis Modulators|mitosis modulators|mesh-ancestor
110080264|NCT01628055|Immunoglobulins|immunoglobulins|mesh-list
110080265|NCT01628055|Antibodies|antibodies|mesh-list
110080266|NCT01628055|gamma-Globulins|gamma-globulins|mesh-list
110080267|NCT01628055|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110080268|NCT01628055|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110080269|NCT01628055|Immunoglobulin G|immunoglobulin g|mesh-list
110080270|NCT01628055|Immunologic Factors|immunologic factors|mesh-ancestor
110080271|NCT01628055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110080272|NCT01628341|Insulin|insulin|mesh-list
110080273|NCT01628341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110080274|NCT01628341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110080275|NCT01628354|Ranibizumab|ranibizumab|mesh-list
110080276|NCT01628354|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110080277|NCT01628354|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110080278|NCT01628354|Growth Substances|growth substances|mesh-ancestor
110080279|NCT01628354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110080280|NCT01628354|Growth Inhibitors|growth inhibitors|mesh-ancestor
110080281|NCT01628354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110080283|NCT01628445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110080284|NCT01628445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110080285|NCT01628445|Incretins|incretins|mesh-ancestor
110080286|NCT01628445|Hormones|hormones|mesh-ancestor
110080287|NCT01628445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110080288|NCT01628471|Decitabine|decitabine|mesh-list
110080289|NCT01628471|Genistein|genistein|mesh-list
110080290|NCT01628471|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110080291|NCT01628471|Antimetabolites|antimetabolites|mesh-ancestor
110080292|NCT01628471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110080293|NCT01628471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110080294|NCT01628471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110080295|NCT01628471|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110080296|NCT01628471|Protective Agents|protective agents|mesh-ancestor
110080297|NCT01628471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110080298|NCT01628471|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110080299|NCT01628471|Phytoestrogens|phytoestrogens|mesh-ancestor
110080300|NCT01628471|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
110080301|NCT01628471|Estrogens|estrogens|mesh-ancestor
110080302|NCT01628471|Hormones|hormones|mesh-ancestor
110080303|NCT01628471|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110080304|NCT01628562|Remifentanil|remifentanil|mesh-list
110080305|NCT01628562|Esmolol|esmolol|mesh-list
110080306|NCT01628562|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110080307|NCT01628562|Narcotics|narcotics|mesh-ancestor
110080308|NCT01628562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110080309|NCT01628562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110080310|NCT01628562|Analgesics|analgesics|mesh-ancestor
110080311|NCT01628562|Sensory System Agents|sensory system agents|mesh-ancestor
110080312|NCT01628562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110080313|NCT01628562|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110080314|NCT01628562|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110080315|NCT01628562|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110080316|NCT01628562|Adrenergic Agents|adrenergic agents|mesh-ancestor
110080317|NCT01628562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110080318|NCT01628562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110080319|NCT01628666|Vancomycin|vancomycin|mesh-list
110080320|NCT01628666|Cefazolin|cefazolin|mesh-list
110080321|NCT01628666|Cephalexin|cephalexin|mesh-list
110080322|NCT01628666|Bacitracin|bacitracin|mesh-list
110080323|NCT01628666|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110080324|NCT01628666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110080325|NCT01628666|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110080326|NCT01628731|Furosemide|furosemide|mesh-list
110080327|NCT01628731|Ethacrynic Acid|ethacrynic acid|mesh-list
110080328|NCT01628731|Diuretics|diuretics|mesh-ancestor
110080329|NCT01628731|Natriuretic Agents|natriuretic agents|mesh-ancestor
110080330|NCT01628731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110080331|NCT01628731|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110080332|NCT01628731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110080333|NCT01628731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110080334|NCT01628731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110080335|NCT01628770|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
110080336|NCT01628770|Hematinics|hematinics|mesh-ancestor
110080337|NCT01628783|Escitalopram|escitalopram|mesh-list
110080338|NCT01628783|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110080339|NCT01628783|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110080340|NCT01628783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110080341|NCT01628783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110080342|NCT01628783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110080343|NCT01628783|Serotonin Agents|serotonin agents|mesh-ancestor
110080344|NCT01628783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110080346|NCT01628952|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110080347|NCT01628952|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110080348|NCT01628952|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110080349|NCT01628952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110080350|NCT01628952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110080351|NCT01628952|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
110080352|NCT01628952|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110080353|NCT01628952|Cholinergic Agents|cholinergic agents|mesh-ancestor
110080354|NCT01628952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110080355|NCT01628952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110080356|NCT01629082|Lenalidomide|lenalidomide|mesh-list
110080357|NCT01629082|Clofarabine|clofarabine|mesh-list
110080358|NCT01629082|Immunologic Factors|immunologic factors|mesh-ancestor
110080359|NCT01629082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110080360|NCT01629082|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110080361|NCT01629082|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110080362|NCT01629082|Growth Substances|growth substances|mesh-ancestor
110080363|NCT01629082|Growth Inhibitors|growth inhibitors|mesh-ancestor
110080364|NCT01629082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110080365|NCT01629082|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110080366|NCT01629082|Antimetabolites|antimetabolites|mesh-ancestor
110080367|NCT01629082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110080368|NCT01629173|Ethylene|ethylene|mesh-list
110080369|NCT01629173|Plant Growth Regulators|plant growth regulators|mesh-ancestor
110080370|NCT01629173|Growth Substances|growth substances|mesh-ancestor
110080371|NCT01629173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110080372|NCT01629199|Mitogens|mitogens|mesh-list
110080373|NCT01629199|Mitosis Modulators|mitosis modulators|mesh-ancestor
110080374|NCT01629199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110080375|NCT01629212|Octylonium|octylonium|mesh-list
110080376|NCT01629212|Bromides|bromides|mesh-list
110080377|NCT01629212|Tiropramide|tiropramide|mesh-list
110080378|NCT01629212|Anticonvulsants|anticonvulsants|mesh-ancestor
110080379|NCT01629212|Parasympatholytics|parasympatholytics|mesh-ancestor
110080380|NCT01629212|Autonomic Agents|autonomic agents|mesh-ancestor
110080381|NCT01629212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110080382|NCT01629212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110080383|NCT01629212|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110080384|NCT01629212|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110080385|NCT01629212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110080386|NCT01629212|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110080387|NCT01629212|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110080388|NCT01629212|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110080389|NCT01629212|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110080390|NCT01629212|Cholinergic Agents|cholinergic agents|mesh-ancestor
110080391|NCT01629212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110080392|NCT01629225|Candesartan|candesartan|mesh-list
110080393|NCT01629225|Candesartan cilexetil|candesartan cilexetil|mesh-list
110080394|NCT01629225|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110080395|NCT01629225|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110080396|NCT01629225|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110080397|NCT01629225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110080398|NCT01629251|Insulin|insulin|mesh-list
110080399|NCT01629251|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110080400|NCT01629251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110080401|NCT01629277|Insulin|insulin|mesh-list
110080402|NCT01629277|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110080403|NCT01629277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110080404|NCT01629368|Carbamazepine|carbamazepine|mesh-list
110080405|NCT01629368|Anticonvulsants|anticonvulsants|mesh-ancestor
110080406|NCT01629368|Antimanic Agents|antimanic agents|mesh-ancestor
110080407|NCT01629368|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110080408|NCT01629368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110080409|NCT01629368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110080411|NCT01629368|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110080412|NCT01629368|Analgesics|analgesics|mesh-ancestor
110080413|NCT01629368|Sensory System Agents|sensory system agents|mesh-ancestor
110080414|NCT01629368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110080415|NCT01629368|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110080416|NCT01629368|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110080417|NCT01629368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110080418|NCT01629368|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110080419|NCT01629368|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110080420|NCT01629394|Neostigmine|neostigmine|mesh-list
110080421|NCT01629394|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110080422|NCT01629394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110080423|NCT01629394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110080424|NCT01629394|Cholinergic Agents|cholinergic agents|mesh-ancestor
110080425|NCT01629394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110080426|NCT01629394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110080427|NCT01629394|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110080428|NCT01629394|Autonomic Agents|autonomic agents|mesh-ancestor
110080429|NCT01629394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110080431|NCT01629446|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110080432|NCT01629446|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110080433|NCT01629446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110080434|NCT01629446|Sensory System Agents|sensory system agents|mesh-ancestor
110080435|NCT01629446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110080436|NCT01629446|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110080437|NCT01629446|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110080438|NCT01629446|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110080439|NCT01629446|Adrenergic Agents|adrenergic agents|mesh-ancestor
110080440|NCT01629446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110080441|NCT01629446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110080442|NCT01629511|Gemcitabine|gemcitabine|mesh-list
110080443|NCT01629511|Methotrexate|methotrexate|mesh-list
110080444|NCT01629511|Clofarabine|clofarabine|mesh-list
110080445|NCT01629511|Busulfan|busulfan|mesh-list
110080446|NCT01629511|Tacrolimus|tacrolimus|mesh-list
110080447|NCT01629511|Thymoglobulin|thymoglobulin|mesh-list
110080448|NCT01629511|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110080449|NCT01629511|Lenograstim|lenograstim|mesh-list
110080450|NCT01629511|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110080451|NCT01629511|Antimetabolites|antimetabolites|mesh-ancestor
110080452|NCT01629511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110080453|NCT01629511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110080454|NCT01629511|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110080455|NCT01629511|Abortifacient Agents|abortifacient agents|mesh-ancestor
110080456|NCT01629511|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110080457|NCT01629511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110080458|NCT01629511|Dermatologic Agents|dermatologic agents|mesh-ancestor
110080459|NCT01629511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110080460|NCT01629511|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110080461|NCT01629511|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110080462|NCT01629511|Immunologic Factors|immunologic factors|mesh-ancestor
110080463|NCT01629511|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110080464|NCT01629511|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110080465|NCT01629511|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110080466|NCT01629511|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110080467|NCT01629511|Alkylating Agents|alkylating agents|mesh-ancestor
110080468|NCT01629511|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110080469|NCT01629511|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110080470|NCT01629628|Adalimumab|adalimumab|mesh-list
110080471|NCT01629628|Mercaptopurine|mercaptopurine|mesh-list
110080472|NCT01629628|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110080473|NCT01629628|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110080474|NCT01629628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110080475|NCT01629628|Antimetabolites|antimetabolites|mesh-ancestor
110080476|NCT01629628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110080477|NCT01629628|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110080478|NCT01629628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110080479|NCT01629628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110080480|NCT01629628|Immunologic Factors|immunologic factors|mesh-ancestor
110080481|NCT01629628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110080482|NCT01629628|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110080483|NCT01629628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110080485|NCT01629680|Parasympatholytics|parasympatholytics|mesh-ancestor
110080486|NCT01629680|Autonomic Agents|autonomic agents|mesh-ancestor
110080487|NCT01629680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110080488|NCT01629680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110080489|NCT01629732|Ribavirin|ribavirin|mesh-list
110080490|NCT01629732|Antimetabolites|antimetabolites|mesh-ancestor
110080491|NCT01629732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110080492|NCT01629732|Antiviral Agents|antiviral agents|mesh-ancestor
110080493|NCT01629732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110080494|NCT01629758|Nivolumab|nivolumab|mesh-list
110080495|NCT01629758|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110080496|NCT01629758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110080497|NCT01629758|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110080498|NCT01629758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110080499|NCT01629875|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110080500|NCT01629875|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110080501|NCT01629875|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110080502|NCT01629875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110080503|NCT01629875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110080504|NCT01629875|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110080505|NCT01629875|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110080506|NCT01629875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110080507|NCT01629875|Cholinergic Agents|cholinergic agents|mesh-ancestor
110080508|NCT01629875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110080509|NCT01630018|Topotecan|topotecan|mesh-list
110080510|NCT01630018|Belotecan|belotecan|mesh-list
110080511|NCT01630018|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110080512|NCT01630018|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110080513|NCT01630018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110080514|NCT01630018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110080515|NCT01630018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110080516|NCT01630057|Zonisamide|zonisamide|mesh-list
110080517|NCT01630057|Anticonvulsants|anticonvulsants|mesh-ancestor
110080518|NCT01630057|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110080519|NCT01630057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110080520|NCT01630057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110080521|NCT01630057|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110080522|NCT01630057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110080523|NCT01630070|Paclitaxel|paclitaxel|mesh-list
110080524|NCT01630070|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110080525|NCT01630070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110080526|NCT01630070|Tubulin Modulators|tubulin modulators|mesh-ancestor
110080527|NCT01630070|Antimitotic Agents|antimitotic agents|mesh-ancestor
110080528|NCT01630070|Mitosis Modulators|mitosis modulators|mesh-ancestor
110080529|NCT01630070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110080530|NCT01630083|Capecitabine|capecitabine|mesh-list
110080531|NCT01630083|Oxaliplatin|oxaliplatin|mesh-list
110080532|NCT01630083|Epirubicin|epirubicin|mesh-list
110080533|NCT01630083|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110080534|NCT01630083|Antimetabolites|antimetabolites|mesh-ancestor
110080535|NCT01630083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110080536|NCT01630083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110080537|NCT01630083|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110080538|NCT01630083|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110080539|NCT01630083|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110080540|NCT01630083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110080541|NCT01630096|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
110080542|NCT01630096|Laxatives|laxatives|mesh-ancestor
110080543|NCT01630096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110080544|NCT01630148|Bemiparin|bemiparin|mesh-list
110080545|NCT01630148|Anticoagulants|anticoagulants|mesh-ancestor
110080546|NCT01630187|Carbetocin|carbetocin|mesh-list
110080547|NCT01630187|Oxytocin|oxytocin|mesh-list
110080548|NCT01630187|Oxytocics|oxytocics|mesh-ancestor
110080549|NCT01630187|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110080550|NCT01630187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110080551|NCT01630226|Cisplatin|cisplatin|mesh-list
110080552|NCT01630226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110080553|NCT01630278|Ibuprofen|ibuprofen|mesh-list
110080554|NCT01630278|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110080555|NCT01630278|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110080556|NCT01630278|Analgesics|analgesics|mesh-ancestor
110080557|NCT01630278|Sensory System Agents|sensory system agents|mesh-ancestor
110080558|NCT01630278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110080559|NCT01630278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110080560|NCT01630278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110080561|NCT01630278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110080562|NCT01630278|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110080563|NCT01630278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110080564|NCT01630278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110080565|NCT01630343|Acetaminophen|acetaminophen|mesh-list
110080566|NCT01630343|Tramadol|tramadol|mesh-list
110080567|NCT01630343|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110080568|NCT01630343|Analgesics|analgesics|mesh-ancestor
110080569|NCT01630343|Sensory System Agents|sensory system agents|mesh-ancestor
110080570|NCT01630343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110080571|NCT01630343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110080572|NCT01630343|Antipyretics|antipyretics|mesh-ancestor
110080573|NCT01630343|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110080574|NCT01630343|Narcotics|narcotics|mesh-ancestor
110080575|NCT01630343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110080576|NCT01630369|Insulin|insulin|mesh-list
110080577|NCT01630369|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110080578|NCT01630369|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110080579|NCT01630369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110080580|NCT01630538|Cyclophosphamide|cyclophosphamide|mesh-list
110080581|NCT01630538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110080582|NCT01630538|Immunologic Factors|immunologic factors|mesh-ancestor
110080583|NCT01630538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110080584|NCT01630538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110080585|NCT01630538|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110080586|NCT01630538|Alkylating Agents|alkylating agents|mesh-ancestor
110080587|NCT01630538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110080588|NCT01630538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110080589|NCT01630538|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110080590|NCT01630564|Aldesleukin|aldesleukin|mesh-list
110080591|NCT01630564|Interleukin-2|interleukin-2|mesh-list
110080592|NCT01630564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110080593|NCT01630564|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110080594|NCT01630564|Analgesics|analgesics|mesh-ancestor
110080595|NCT01630564|Sensory System Agents|sensory system agents|mesh-ancestor
110080596|NCT01630564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110080597|NCT01630564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110080598|NCT01630564|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110080599|NCT01630564|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110080600|NCT01630564|Antiviral Agents|antiviral agents|mesh-ancestor
110080601|NCT01630564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110080602|NCT01630642|Clopidogrel|clopidogrel|mesh-list
110080603|NCT01630642|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110080604|NCT01630642|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110080605|NCT01630642|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110080606|NCT01630642|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110080607|NCT01630642|Purinergic Agents|purinergic agents|mesh-ancestor
110080608|NCT01630642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110080609|NCT01630642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110080610|NCT01630642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110080611|NCT01630655|Felodipine|felodipine|mesh-list
110080612|NCT01630655|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110080613|NCT01630655|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110080614|NCT01630655|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110080615|NCT01630655|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110080616|NCT01630655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110080617|NCT01630655|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110080618|NCT01630655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110080619|NCT01630655|Vasodilator Agents|vasodilator agents|mesh-ancestor
110080621|NCT01630720|Vitamins|vitamins|mesh-list
110080622|NCT01630720|Micronutrients|micronutrients|mesh-ancestor
110080623|NCT01630720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110080624|NCT01630720|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110080625|NCT01630733|Docetaxel|docetaxel|mesh-list
110080626|NCT01630733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110080627|NCT01630733|Tubulin Modulators|tubulin modulators|mesh-ancestor
110080628|NCT01630733|Antimitotic Agents|antimitotic agents|mesh-ancestor
110080629|NCT01630733|Mitosis Modulators|mitosis modulators|mesh-ancestor
110080630|NCT01630733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110080631|NCT01630902|Felodipine|felodipine|mesh-list
110080632|NCT01630902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110080633|NCT01630902|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110080634|NCT01630902|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110080635|NCT01630902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110080636|NCT01630902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110080637|NCT01630902|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110080638|NCT01630902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110080639|NCT01630902|Vasodilator Agents|vasodilator agents|mesh-ancestor
110080640|NCT01630915|Clopidogrel|clopidogrel|mesh-list
110080641|NCT01630915|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110080642|NCT01630915|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110080643|NCT01630915|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110080644|NCT01630915|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110080645|NCT01630915|Purinergic Agents|purinergic agents|mesh-ancestor
110080646|NCT01630915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110080647|NCT01630915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110080648|NCT01630915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110080649|NCT01630941|Denosumab|denosumab|mesh-list
110080650|NCT01630941|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110080651|NCT01630941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110080652|NCT01631058|Prednisone|prednisone|mesh-list
110080653|NCT01631058|Everolimus|everolimus|mesh-list
110080654|NCT01631058|Lactitol|lactitol|mesh-list
110080655|NCT01631058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110080656|NCT01631058|Glucocorticoids|glucocorticoids|mesh-ancestor
110080657|NCT01631058|Hormones|hormones|mesh-ancestor
110080658|NCT01631058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110080659|NCT01631058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110080660|NCT01631058|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110080661|NCT01631058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110080662|NCT01631058|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110080663|NCT01631058|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110080664|NCT01631058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110080666|NCT01631058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110080667|NCT01631058|Immunologic Factors|immunologic factors|mesh-ancestor
110080668|NCT01631058|Cathartics|cathartics|mesh-ancestor
110080669|NCT01631058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110080670|NCT01631097|Tivozanib|tivozanib|mesh-list
110080671|NCT01631097|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110080672|NCT01631097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110080673|NCT01631097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110080674|NCT01631136|Cisplatin|cisplatin|mesh-list
110080675|NCT01631136|Gemcitabine|gemcitabine|mesh-list
110080676|NCT01631136|Pemetrexed|pemetrexed|mesh-list
110080677|NCT01631136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110080678|NCT01631136|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110080679|NCT01631136|Antimetabolites|antimetabolites|mesh-ancestor
110080680|NCT01631136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110080681|NCT01631136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110080682|NCT01631136|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110080683|NCT01631136|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110080684|NCT01631201|Azithromycin|azithromycin|mesh-list
110080685|NCT01631201|KRM 1648|krm 1648|mesh-list
110080686|NCT01631201|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110080687|NCT01631201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110080688|NCT01631201|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110080689|NCT01631201|Antitubercular Agents|antitubercular agents|mesh-ancestor
110184047|NCT00032019|Prednisone|prednisone|mesh-list
110080690|NCT01631201|Leprostatic Agents|leprostatic agents|mesh-ancestor
110080691|NCT01631305|Magnesium Oxide|magnesium oxide|mesh-list
110080692|NCT01631305|Calcium|calcium|mesh-list
110080693|NCT01631305|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110080694|NCT01631305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110080695|NCT01631305|Antacids|antacids|mesh-ancestor
110080696|NCT01631305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110080697|NCT01631305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110080698|NCT01631357|Cisplatin|cisplatin|mesh-list
110080699|NCT01631357|Gemcitabine|gemcitabine|mesh-list
110080700|NCT01631357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110080701|NCT01631357|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110080702|NCT01631357|Antimetabolites|antimetabolites|mesh-ancestor
110080703|NCT01631357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110080704|NCT01631383|Tetrahydropalmatine|tetrahydropalmatine|mesh-list
110080705|NCT01631383|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110080706|NCT01631383|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110080707|NCT01631383|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110080708|NCT01631383|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110080709|NCT01631383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110080710|NCT01631383|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110080711|NCT01631383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110080712|NCT01631383|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110080713|NCT01631383|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110080714|NCT01631383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110080715|NCT01631383|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110080716|NCT01631383|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110080718|NCT01631383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110080719|NCT01631383|Adrenergic Agents|adrenergic agents|mesh-ancestor
110080720|NCT01631383|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110080721|NCT01631383|Analgesics|analgesics|mesh-ancestor
110080722|NCT01631383|Sensory System Agents|sensory system agents|mesh-ancestor
110080723|NCT01631383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110080724|NCT01631396|Neostigmine|neostigmine|mesh-list
110080725|NCT01631396|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110080726|NCT01631396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110080727|NCT01631396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110080728|NCT01631396|Cholinergic Agents|cholinergic agents|mesh-ancestor
110080729|NCT01631396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110080730|NCT01631396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110080731|NCT01631396|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110080732|NCT01631396|Autonomic Agents|autonomic agents|mesh-ancestor
110080733|NCT01631396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110080734|NCT01631409|Aspirin|aspirin|mesh-list
110080735|NCT01631409|Atenolol|atenolol|mesh-list
110080736|NCT01631409|Enalapril|enalapril|mesh-list
110080737|NCT01631409|Enalaprilat|enalaprilat|mesh-list
110080738|NCT01631409|Amlodipine|amlodipine|mesh-list
110080739|NCT01631409|Isosorbide|isosorbide|mesh-list
110080740|NCT01631409|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
110080741|NCT01631409|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
110080742|NCT01631409|Nitroglycerin|nitroglycerin|mesh-list
110080743|NCT01631409|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110080744|NCT01631409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110080745|NCT01631409|Analgesics|analgesics|mesh-ancestor
110080746|NCT01631409|Sensory System Agents|sensory system agents|mesh-ancestor
110080747|NCT01631409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110080748|NCT01631409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110080749|NCT01631409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110080750|NCT01631409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110080751|NCT01631409|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110080752|NCT01631409|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110080753|NCT01631409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110080754|NCT01631409|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110080755|NCT01631409|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110080756|NCT01631409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110080757|NCT01631409|Antipyretics|antipyretics|mesh-ancestor
110080758|NCT01631409|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110080759|NCT01631409|Protease Inhibitors|protease inhibitors|mesh-ancestor
110080760|NCT01631409|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110080761|NCT01631409|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110080762|NCT01631409|Sympatholytics|sympatholytics|mesh-ancestor
110080763|NCT01631409|Autonomic Agents|autonomic agents|mesh-ancestor
110080764|NCT01631409|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110080765|NCT01631409|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110080766|NCT01631409|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110080767|NCT01631409|Adrenergic Agents|adrenergic agents|mesh-ancestor
110080768|NCT01631409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110080769|NCT01631409|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110080770|NCT01631409|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110080771|NCT01631409|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110080772|NCT01631409|Vasodilator Agents|vasodilator agents|mesh-ancestor
110080773|NCT01631409|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110080774|NCT01631409|Diuretics|diuretics|mesh-ancestor
110080775|NCT01631409|Natriuretic Agents|natriuretic agents|mesh-ancestor
110080776|NCT01631409|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
110080777|NCT01631448|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
110080778|NCT01631448|Hemostatics|hemostatics|mesh-ancestor
110080779|NCT01631448|Coagulants|coagulants|mesh-ancestor
110080780|NCT01631513|Tapentadol|tapentadol|mesh-list
110080781|NCT01631513|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110080782|NCT01631513|Narcotics|narcotics|mesh-ancestor
110080783|NCT01631513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110080784|NCT01631513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110080785|NCT01631513|Analgesics|analgesics|mesh-ancestor
110080786|NCT01631513|Sensory System Agents|sensory system agents|mesh-ancestor
110080787|NCT01631513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110080788|NCT01631513|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110080789|NCT01631513|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110080790|NCT01631513|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110080791|NCT01631513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110080792|NCT01631513|Adrenergic Agents|adrenergic agents|mesh-ancestor
110080793|NCT01631513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110080794|NCT01631526|Vitamin D|vitamin d|mesh-list
110080795|NCT01631526|Vitamins|vitamins|mesh-ancestor
110080796|NCT01631526|Micronutrients|micronutrients|mesh-ancestor
110080797|NCT01631526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110080798|NCT01631526|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110080799|NCT01631539|Irinotecan|irinotecan|mesh-list
110080800|NCT01631539|Cetuximab|cetuximab|mesh-list
110080801|NCT01631539|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110080802|NCT01631539|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110080803|NCT01631539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110080804|NCT01631539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110080805|NCT01631539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110080806|NCT01631539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110080807|NCT01631604|Botulinum Toxins|botulinum toxins|mesh-list
110080808|NCT01631604|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110080809|NCT01631604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110080810|NCT01631604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110080811|NCT01631604|Cholinergic Agents|cholinergic agents|mesh-ancestor
110080812|NCT01631604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110080813|NCT01631604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110080814|NCT01631669|Celecoxib|celecoxib|mesh-list
110080815|NCT01631669|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110080816|NCT01631669|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110080817|NCT01631669|Analgesics|analgesics|mesh-ancestor
110080818|NCT01631669|Sensory System Agents|sensory system agents|mesh-ancestor
110080819|NCT01631669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110080820|NCT01631669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110080821|NCT01631669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110080822|NCT01631669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110080823|NCT01631669|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110080824|NCT01631669|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110080825|NCT01631669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110080826|NCT01631669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110080827|NCT01631838|Tocotrienols|tocotrienols|mesh-list
110080828|NCT01631838|Vitamin E|vitamin e|mesh-list
110080829|NCT01631838|Tocopherols|tocopherols|mesh-list
110080831|NCT01631838|Antioxidants|antioxidants|mesh-ancestor
110080832|NCT01631838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110080833|NCT01631838|Protective Agents|protective agents|mesh-ancestor
110080834|NCT01631838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110080835|NCT01631838|Vitamins|vitamins|mesh-ancestor
110080836|NCT01631838|Micronutrients|micronutrients|mesh-ancestor
110080837|NCT01631877|Enoxaparin|enoxaparin|mesh-list
110080838|NCT01631877|Acenocoumarol|acenocoumarol|mesh-list
110080839|NCT01631877|Anticoagulants|anticoagulants|mesh-ancestor
110080840|NCT01631877|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110080841|NCT01631877|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110080842|NCT01631877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110080843|NCT01631968|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110080844|NCT01631968|Colistin|colistin|mesh-list
110080845|NCT01631968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110080846|NCT01631994|Metoclopramide|metoclopramide|mesh-list
110080847|NCT01631994|Antiemetics|antiemetics|mesh-ancestor
110080849|NCT01631994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110080850|NCT01631994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110080851|NCT01631994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110080852|NCT01631994|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110080853|NCT01631994|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110080854|NCT01631994|Dopamine Agents|dopamine agents|mesh-ancestor
110080855|NCT01631994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110080856|NCT01631994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110080857|NCT01632007|Alogliptin|alogliptin|mesh-list
110080858|NCT01632007|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110080859|NCT01632007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110080860|NCT01632007|Incretins|incretins|mesh-ancestor
110080861|NCT01632007|Hormones|hormones|mesh-ancestor
110080862|NCT01632007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110080863|NCT01632007|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110080864|NCT01632007|Protease Inhibitors|protease inhibitors|mesh-ancestor
110080865|NCT01632007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110080866|NCT01632007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110080868|NCT01632046|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110080869|NCT01632163|Lixisenatide|lixisenatide|mesh-list
110080870|NCT01632163|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110080871|NCT01632163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110080872|NCT01632189|Varenicline|varenicline|mesh-list
110080873|NCT01632189|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110080875|NCT01632189|Cholinergic Agents|cholinergic agents|mesh-ancestor
110080876|NCT01632189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110080877|NCT01632189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110080878|NCT01632189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110080879|NCT01632371|Paclitaxel|paclitaxel|mesh-list
110080880|NCT01632371|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110080881|NCT01632371|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110080882|NCT01632371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110080883|NCT01632371|Tubulin Modulators|tubulin modulators|mesh-ancestor
110080884|NCT01632371|Antimitotic Agents|antimitotic agents|mesh-ancestor
110080885|NCT01632371|Mitosis Modulators|mitosis modulators|mesh-ancestor
110080886|NCT01632371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110080887|NCT01632436|Pixantrone|pixantrone|mesh-list
110080888|NCT01632436|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110080889|NCT01632436|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110080890|NCT01632436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110080891|NCT01632436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110080892|NCT01632436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110080893|NCT01632514|Cholecalciferol|cholecalciferol|mesh-list
110080894|NCT01632514|Vitamin D|vitamin d|mesh-list
110080895|NCT01632514|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110080896|NCT01632514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110080897|NCT01632514|Vitamins|vitamins|mesh-ancestor
110080898|NCT01632514|Micronutrients|micronutrients|mesh-ancestor
110080899|NCT01632514|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110080900|NCT01632540|Beclomethasone|beclomethasone|mesh-list
110080901|NCT01632540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110080902|NCT01632540|Glucocorticoids|glucocorticoids|mesh-ancestor
110080903|NCT01632540|Hormones|hormones|mesh-ancestor
110080904|NCT01632540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110080905|NCT01632540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110080907|NCT01632540|Respiratory System Agents|respiratory system agents|mesh-ancestor
110080909|NCT01632592|Growth Substances|growth substances|mesh-ancestor
110080910|NCT01632592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110080911|NCT01632605|Sirolimus|sirolimus|mesh-list
110080912|NCT01632605|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110080913|NCT01632605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110080914|NCT01632605|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110080915|NCT01632605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110080916|NCT01632605|Antifungal Agents|antifungal agents|mesh-ancestor
110080917|NCT01632605|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110080918|NCT01632605|Immunologic Factors|immunologic factors|mesh-ancestor
110080919|NCT01632605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110080920|NCT01632722|Bevacizumab|bevacizumab|mesh-list
110080921|NCT01632722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110080922|NCT01632722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110080923|NCT01632722|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110080924|NCT01632722|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110080925|NCT01632722|Growth Substances|growth substances|mesh-ancestor
110080926|NCT01632722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110080927|NCT01632722|Growth Inhibitors|growth inhibitors|mesh-ancestor
110080928|NCT01632761|Vitamin D|vitamin d|mesh-list
110080929|NCT01632761|Ergocalciferols|ergocalciferols|mesh-list
110080930|NCT01632761|Cholecalciferol|cholecalciferol|mesh-list
110080931|NCT01632761|Vitamins|vitamins|mesh-list
110080932|NCT01632761|Micronutrients|micronutrients|mesh-ancestor
110080933|NCT01632761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110080934|NCT01632761|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110080935|NCT01632761|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110080936|NCT01632826|Pomalidomide|pomalidomide|mesh-list
110080937|NCT01632826|Immunologic Factors|immunologic factors|mesh-ancestor
110080938|NCT01632826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110080939|NCT01632826|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110184095|NCT03151382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110080940|NCT01632826|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110080941|NCT01632826|Growth Substances|growth substances|mesh-ancestor
110080942|NCT01632826|Growth Inhibitors|growth inhibitors|mesh-ancestor
110080943|NCT01632826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110080944|NCT01633086|Nitric Oxide|nitric oxide|mesh-list
110080945|NCT01633086|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110080946|NCT01633086|Autonomic Agents|autonomic agents|mesh-ancestor
110080947|NCT01633086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110080948|NCT01633086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110080949|NCT01633086|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110080950|NCT01633086|Respiratory System Agents|respiratory system agents|mesh-ancestor
110080951|NCT01633086|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110080952|NCT01633086|Antioxidants|antioxidants|mesh-ancestor
110080953|NCT01633086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110080954|NCT01633086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110080955|NCT01633086|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
110080956|NCT01633086|Vasodilator Agents|vasodilator agents|mesh-ancestor
110080957|NCT01633086|Gasotransmitters|gasotransmitters|mesh-ancestor
110080958|NCT01633086|Protective Agents|protective agents|mesh-ancestor
110080959|NCT01633099|Decitabine|decitabine|mesh-list
110080960|NCT01633099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110080961|NCT01633099|Antimetabolites|antimetabolites|mesh-ancestor
110080962|NCT01633099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110080963|NCT01633099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110080964|NCT01633099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110080965|NCT01633203|Capecitabine|capecitabine|mesh-list
110080966|NCT01633203|Epirubicin|epirubicin|mesh-list
110080967|NCT01633203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110080968|NCT01633203|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110080969|NCT01633203|Antimetabolites|antimetabolites|mesh-ancestor
110080970|NCT01633203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110080971|NCT01633203|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110080972|NCT01633203|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110080973|NCT01633203|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110080974|NCT01633203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110080975|NCT01633294|Gentamicins|gentamicins|mesh-list
110080976|NCT01633294|Ampicillin|ampicillin|mesh-list
110080977|NCT01633294|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110080978|NCT01633294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110080979|NCT01633294|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110080980|NCT01633294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110080981|NCT01633294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110080982|NCT01633359|Atorvastatin|atorvastatin|mesh-list
110080983|NCT01633359|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
110080984|NCT01633359|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110080985|NCT01633359|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110080986|NCT01633359|Antimetabolites|antimetabolites|mesh-ancestor
110080987|NCT01633359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110080988|NCT01633359|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110080989|NCT01633359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110080990|NCT01633450|Zinc|zinc|mesh-list
110080991|NCT01633450|Trace Elements|trace elements|mesh-ancestor
110080992|NCT01633450|Micronutrients|micronutrients|mesh-ancestor
110080993|NCT01633450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110080994|NCT01633476|Valacyclovir|valacyclovir|mesh-list
110080995|NCT01633476|Antiviral Agents|antiviral agents|mesh-ancestor
110080996|NCT01633476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110080997|NCT01633593|Donepezil|donepezil|mesh-list
110080998|NCT01633593|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110080999|NCT01633593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110081000|NCT01633593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110081001|NCT01633593|Cholinergic Agents|cholinergic agents|mesh-ancestor
110081002|NCT01633593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110081003|NCT01633593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110081004|NCT01633593|Nootropic Agents|nootropic agents|mesh-ancestor
110081005|NCT01633645|Gemcitabine|gemcitabine|mesh-list
110081006|NCT01633645|Bortezomib|bortezomib|mesh-list
110081007|NCT01633645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110081008|NCT01633645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110081009|NCT01633645|Antimetabolites|antimetabolites|mesh-ancestor
110081010|NCT01633645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110081011|NCT01633658|Cholecalciferol|cholecalciferol|mesh-list
110081012|NCT01633658|Vitamin D|vitamin d|mesh-list
110081013|NCT01633658|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110081014|NCT01633658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110081015|NCT01633658|Vitamins|vitamins|mesh-ancestor
110081016|NCT01633658|Micronutrients|micronutrients|mesh-ancestor
110081017|NCT01633658|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110081019|NCT01633749|Immunologic Factors|immunologic factors|mesh-ancestor
110081020|NCT01633749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110081021|NCT01633762|Vancomycin|vancomycin|mesh-list
110081022|NCT01633762|Gentamicins|gentamicins|mesh-list
110081023|NCT01633762|Meropenem|meropenem|mesh-list
110081024|NCT01633762|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110081025|NCT01633762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110081026|NCT01633762|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110081027|NCT01633762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110081028|NCT01633762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110081029|NCT01633957|Warfarin|warfarin|mesh-list
110081030|NCT01633957|Anticoagulants|anticoagulants|mesh-ancestor
110081031|NCT01633970|Leucovorin|leucovorin|mesh-list
110081032|NCT01633970|Paclitaxel|paclitaxel|mesh-list
110081033|NCT01633970|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110081034|NCT01633970|Bevacizumab|bevacizumab|mesh-list
110081035|NCT01633970|Carboplatin|carboplatin|mesh-list
110081036|NCT01633970|Oxaliplatin|oxaliplatin|mesh-list
110081037|NCT01633970|Pemetrexed|pemetrexed|mesh-list
110081038|NCT01633970|Atezolizumab|atezolizumab|mesh-list
110081039|NCT01633970|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110081040|NCT01633970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110081041|NCT01633970|Tubulin Modulators|tubulin modulators|mesh-ancestor
110081042|NCT01633970|Antimitotic Agents|antimitotic agents|mesh-ancestor
110081043|NCT01633970|Mitosis Modulators|mitosis modulators|mesh-ancestor
110081044|NCT01633970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110081045|NCT01633970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110081046|NCT01633970|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110081047|NCT01633970|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110081048|NCT01633970|Growth Substances|growth substances|mesh-ancestor
110081049|NCT01633970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110081050|NCT01633970|Growth Inhibitors|growth inhibitors|mesh-ancestor
110081051|NCT01633970|Antidotes|antidotes|mesh-ancestor
110081052|NCT01633970|Protective Agents|protective agents|mesh-ancestor
110081053|NCT01633970|Vitamin B Complex|vitamin b complex|mesh-ancestor
110081054|NCT01633970|Vitamins|vitamins|mesh-ancestor
110081055|NCT01633970|Micronutrients|micronutrients|mesh-ancestor
110081057|NCT01633970|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110081058|NCT01633970|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110081059|NCT01633970|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110081060|NCT01633983|Methotrexate|methotrexate|mesh-list
110081061|NCT01633983|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110081062|NCT01633983|Abortifacient Agents|abortifacient agents|mesh-ancestor
110081063|NCT01633983|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110081064|NCT01633983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110081065|NCT01633983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110081066|NCT01633983|Antimetabolites|antimetabolites|mesh-ancestor
110081067|NCT01633983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110081068|NCT01633983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110081069|NCT01633983|Dermatologic Agents|dermatologic agents|mesh-ancestor
110081070|NCT01633983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110081071|NCT01633983|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110081072|NCT01633983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110081073|NCT01633983|Immunologic Factors|immunologic factors|mesh-ancestor
110081074|NCT01633983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110081075|NCT01633983|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110081076|NCT01634061|Dactolisib|dactolisib|mesh-list
110081077|NCT01634061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110081078|NCT01634230|Phenylacetic acid|phenylacetic acid|mesh-list
110081079|NCT01634230|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110081080|NCT01634230|Antimetabolites|antimetabolites|mesh-ancestor
110081081|NCT01634230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110081082|NCT01634230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110081083|NCT01634295|Niacin|niacin|mesh-list
110081084|NCT01634295|Amlodipine|amlodipine|mesh-list
110081085|NCT01634295|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110081086|NCT01634295|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110081087|NCT01634295|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110081088|NCT01634295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110081089|NCT01634295|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110081090|NCT01634295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110081091|NCT01634295|Vasodilator Agents|vasodilator agents|mesh-ancestor
110081092|NCT01634295|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110081093|NCT01634295|Antimetabolites|antimetabolites|mesh-ancestor
110081094|NCT01634295|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110081095|NCT01634295|Vitamin B Complex|vitamin b complex|mesh-ancestor
110081097|NCT01634295|Micronutrients|micronutrients|mesh-ancestor
110081098|NCT01634321|Leuprolide|leuprolide|mesh-list
110081099|NCT01634321|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110081100|NCT01634321|Fertility Agents|fertility agents|mesh-ancestor
110081101|NCT01634321|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110081102|NCT01634321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110081103|NCT01634321|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110081104|NCT01634321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110081106|NCT01634347|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110081107|NCT01634347|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110081108|NCT01634347|Adrenergic Agents|adrenergic agents|mesh-ancestor
110081109|NCT01634347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110081110|NCT01634347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110081111|NCT01634347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110081112|NCT01634347|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110081113|NCT01634347|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110081114|NCT01634347|Vasodilator Agents|vasodilator agents|mesh-ancestor
110081115|NCT01634373|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110081116|NCT01634373|Antidepressive Agents|antidepressive agents|mesh-ancestor
110081117|NCT01634373|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110081118|NCT01634373|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110081119|NCT01634373|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110081120|NCT01634373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110081121|NCT01634373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110081122|NCT01634386|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110081123|NCT01634386|Antidepressive Agents|antidepressive agents|mesh-ancestor
110081124|NCT01634386|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110081125|NCT01634386|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110081126|NCT01634386|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110081127|NCT01634386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110081128|NCT01634386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110081129|NCT01634399|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110081130|NCT01634399|Antidepressive Agents|antidepressive agents|mesh-ancestor
110081131|NCT01634399|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110081132|NCT01634399|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110081133|NCT01634399|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110081134|NCT01634399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110081135|NCT01634399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110081136|NCT01634412|Amitriptyline|amitriptyline|mesh-list
110081137|NCT01634412|Cyclobenzaprine|cyclobenzaprine|mesh-list
110081138|NCT01634412|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110081139|NCT01634412|Antidepressive Agents|antidepressive agents|mesh-ancestor
110081140|NCT01634412|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110081141|NCT01634412|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110081142|NCT01634412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110081143|NCT01634412|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110081144|NCT01634412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110081145|NCT01634412|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110081146|NCT01634412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110081147|NCT01634412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110081148|NCT01634412|Analgesics|analgesics|mesh-ancestor
110081149|NCT01634412|Sensory System Agents|sensory system agents|mesh-ancestor
110081150|NCT01634412|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110081151|NCT01634412|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110081152|NCT01634412|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110081153|NCT01634412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110081154|NCT01634412|Adrenergic Agents|adrenergic agents|mesh-ancestor
110081155|NCT01634412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110081156|NCT01634438|Heparin|heparin|mesh-list
110081157|NCT01634438|Calcium heparin|calcium heparin|mesh-list
110081158|NCT01634438|Anticoagulants|anticoagulants|mesh-ancestor
110081159|NCT01634438|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110081160|NCT01634438|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110081161|NCT01634438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110081162|NCT01634594|Nicardipine|nicardipine|mesh-list
110081163|NCT01634594|Dexmedetomidine|dexmedetomidine|mesh-list
110081164|NCT01634594|Remifentanil|remifentanil|mesh-list
110081165|NCT01634594|Sevoflurane|sevoflurane|mesh-list
110081166|NCT01634594|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110081167|NCT01634594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110081168|NCT01634594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110081169|NCT01634594|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110081170|NCT01634594|Analgesics|analgesics|mesh-ancestor
110081171|NCT01634594|Sensory System Agents|sensory system agents|mesh-ancestor
110081172|NCT01634594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110081173|NCT01634594|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110081174|NCT01634594|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110081175|NCT01634594|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110081176|NCT01634594|Adrenergic Agents|adrenergic agents|mesh-ancestor
110081177|NCT01634594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110081178|NCT01634594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110081179|NCT01634594|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110081180|NCT01634594|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110081181|NCT01634594|Anesthetics, General|anesthetics, general|mesh-ancestor
110081182|NCT01634594|Anesthetics|anesthetics|mesh-ancestor
110081183|NCT01634594|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110081184|NCT01634594|Narcotics|narcotics|mesh-ancestor
110081185|NCT01634594|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110081186|NCT01634594|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110081187|NCT01634594|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110081188|NCT01634594|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110081189|NCT01634594|Vasodilator Agents|vasodilator agents|mesh-ancestor
110081190|NCT01634685|Capecitabine|capecitabine|mesh-list
110081191|NCT01634685|Bavituximab|bavituximab|mesh-list
110081192|NCT01634685|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110081193|NCT01634685|Antimetabolites|antimetabolites|mesh-ancestor
110081194|NCT01634685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110081195|NCT01634685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110081196|NCT01634685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110081197|NCT01634698|Vitamin A|vitamin a|mesh-list
110081198|NCT01634698|Retinol palmitate|retinol palmitate|mesh-list
110081200|NCT01634698|Micronutrients|micronutrients|mesh-ancestor
110081201|NCT01634698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110081203|NCT01634698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110081204|NCT01634698|Protective Agents|protective agents|mesh-ancestor
110081205|NCT01634698|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110081206|NCT01634698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110081207|NCT01634763|Ceritinib|ceritinib|mesh-list
110081208|NCT01634763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110081209|NCT01634763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110081210|NCT01634763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110081211|NCT01634763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110081213|NCT01634789|Estrogens|estrogens|mesh-list
110081214|NCT01634789|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
110081215|NCT01634789|Hormones|hormones|mesh-ancestor
110081216|NCT01634789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110081217|NCT01634789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110081218|NCT01634789|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110081219|NCT01634789|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110081220|NCT01634789|Hormone Antagonists|hormone antagonists|mesh-ancestor
110081221|NCT01634789|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110081222|NCT01634880|Panitumumab|panitumumab|mesh-list
110081223|NCT01634880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110081224|NCT01634880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110081225|NCT01634893|Hydroxychloroquine|hydroxychloroquine|mesh-list
110081226|NCT01634893|Sorafenib|sorafenib|mesh-list
110081227|NCT01634893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110081228|NCT01634893|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110081229|NCT01634893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110081230|NCT01634893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110081231|NCT01634893|Antimalarials|antimalarials|mesh-ancestor
110081232|NCT01634893|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110081233|NCT01634893|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110081234|NCT01634893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110081235|NCT01634893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110081236|NCT01634906|Atorvastatin|atorvastatin|mesh-list
110081237|NCT01634906|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110081238|NCT01634906|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110081239|NCT01634906|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110081240|NCT01634906|Antimetabolites|antimetabolites|mesh-ancestor
110081241|NCT01634906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110081242|NCT01634906|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110081243|NCT01634906|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110081244|NCT01634906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110081245|NCT01634932|Iron|iron|mesh-list
110081246|NCT01634932|Trace Elements|trace elements|mesh-ancestor
110081247|NCT01634932|Micronutrients|micronutrients|mesh-ancestor
110081248|NCT01634932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110081249|NCT01634945|Amodiaquine|amodiaquine|mesh-list
110081250|NCT01634945|Antimalarials|antimalarials|mesh-ancestor
110081251|NCT01634945|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110081252|NCT01634945|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110081253|NCT01634945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110081254|NCT01634958|Aluminum Hydroxide|aluminum hydroxide|mesh-list
110081255|NCT01634958|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110081256|NCT01634958|Immunologic Factors|immunologic factors|mesh-ancestor
110081257|NCT01634958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110081258|NCT01634958|Antacids|antacids|mesh-ancestor
110081259|NCT01634958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110081260|NCT01634958|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110081261|NCT01635088|Mometasone Furoate|mometasone furoate|mesh-list
110081262|NCT01635088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110081263|NCT01635088|Dermatologic Agents|dermatologic agents|mesh-ancestor
110081264|NCT01635088|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110081266|NCT01635114|Antioxidants|antioxidants|mesh-ancestor
110081267|NCT01635114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110081268|NCT01635114|Protective Agents|protective agents|mesh-ancestor
110184141|NCT00032292|Visilizumab|visilizumab|mesh-list
110081269|NCT01635114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110081270|NCT01635114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110081271|NCT01635114|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110081272|NCT01635205|Anesthetics|anesthetics|mesh-list
110081273|NCT01635205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110081274|NCT01635205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110081275|NCT01635296|Cytarabine|cytarabine|mesh-list
110081276|NCT01635296|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110081277|NCT01635296|Antimetabolites|antimetabolites|mesh-ancestor
110081278|NCT01635296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110081279|NCT01635296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110081280|NCT01635296|Antiviral Agents|antiviral agents|mesh-ancestor
110081281|NCT01635296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110081282|NCT01635296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110081283|NCT01635296|Immunologic Factors|immunologic factors|mesh-ancestor
110081284|NCT01635296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110081285|NCT01635400|Irinotecan|irinotecan|mesh-list
110081286|NCT01635400|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110081287|NCT01635400|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110081288|NCT01635400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110081289|NCT01635400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110081290|NCT01635400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110081291|NCT01635530|Doxycycline|doxycycline|mesh-list
110081292|NCT01635530|Ceftriaxone|ceftriaxone|mesh-list
110081293|NCT01635530|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110081294|NCT01635530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110081295|NCT01635530|Antimalarials|antimalarials|mesh-ancestor
110081296|NCT01635530|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110081297|NCT01635530|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110081298|NCT01635608|Acetaminophen|acetaminophen|mesh-list
110081299|NCT01635608|Amoxicillin|amoxicillin|mesh-list
110081300|NCT01635608|Talinolol|talinolol|mesh-list
110081301|NCT01635608|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110081302|NCT01635608|Analgesics|analgesics|mesh-ancestor
110081303|NCT01635608|Sensory System Agents|sensory system agents|mesh-ancestor
110081304|NCT01635608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110081305|NCT01635608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110081306|NCT01635608|Antipyretics|antipyretics|mesh-ancestor
110081307|NCT01635608|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110081308|NCT01635608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110081309|NCT01635608|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110081310|NCT01635608|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110081311|NCT01635608|Adrenergic Agents|adrenergic agents|mesh-ancestor
110081312|NCT01635608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110081313|NCT01635608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110081314|NCT01635608|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110081315|NCT01635608|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110081316|NCT01635686|Etanercept|etanercept|mesh-list
110081317|NCT01635686|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110081318|NCT01635686|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110081319|NCT01635686|Analgesics|analgesics|mesh-ancestor
110081320|NCT01635686|Sensory System Agents|sensory system agents|mesh-ancestor
110081321|NCT01635686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110081322|NCT01635686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110081323|NCT01635686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110081324|NCT01635686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110081325|NCT01635686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110081326|NCT01635686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110081327|NCT01635686|Immunologic Factors|immunologic factors|mesh-ancestor
110081328|NCT01635751|Pregabalin|pregabalin|mesh-list
110081329|NCT01635751|Analgesics|analgesics|mesh-ancestor
110081330|NCT01635751|Sensory System Agents|sensory system agents|mesh-ancestor
110081331|NCT01635751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110081332|NCT01635751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110081333|NCT01635751|Anticonvulsants|anticonvulsants|mesh-ancestor
110081334|NCT01635751|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110081335|NCT01635751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110081336|NCT01635751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110081337|NCT01635751|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110081338|NCT01635751|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110081339|NCT01635751|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110081340|NCT01635751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110081341|NCT01635751|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110081342|NCT01635777|Miltefosine|miltefosine|mesh-list
110081343|NCT01635777|Antifungal Agents|antifungal agents|mesh-ancestor
110081344|NCT01635777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110081345|NCT01635777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110081346|NCT01635777|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110081347|NCT01635777|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110081348|NCT01635790|Bevacizumab|bevacizumab|mesh-list
110081349|NCT01635790|Ranibizumab|ranibizumab|mesh-list
110081350|NCT01635790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110081351|NCT01635790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110081352|NCT01635790|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110081353|NCT01635790|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110081354|NCT01635790|Growth Substances|growth substances|mesh-ancestor
110081355|NCT01635790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110081356|NCT01635790|Growth Inhibitors|growth inhibitors|mesh-ancestor
110081357|NCT01635803|Bevacizumab|bevacizumab|mesh-list
110081358|NCT01635803|Ranibizumab|ranibizumab|mesh-list
110081359|NCT01635803|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110081360|NCT01635803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110081361|NCT01635803|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110081362|NCT01635803|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110081363|NCT01635803|Growth Substances|growth substances|mesh-ancestor
110081364|NCT01635803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110081365|NCT01635803|Growth Inhibitors|growth inhibitors|mesh-ancestor
110081366|NCT01635816|Vaccines|vaccines|mesh-list
110081367|NCT01635816|Immunologic Factors|immunologic factors|mesh-ancestor
110081368|NCT01635816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110081369|NCT01635829|Carbamazepine|carbamazepine|mesh-list
110081370|NCT01635829|Phenytoin|phenytoin|mesh-list
110081371|NCT01635829|Anticonvulsants|anticonvulsants|mesh-ancestor
110081372|NCT01635829|Antimanic Agents|antimanic agents|mesh-ancestor
110081373|NCT01635829|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110081374|NCT01635829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110081375|NCT01635829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110081376|NCT01635829|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110081377|NCT01635829|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110081378|NCT01635829|Analgesics|analgesics|mesh-ancestor
110081379|NCT01635829|Sensory System Agents|sensory system agents|mesh-ancestor
110081380|NCT01635829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110081381|NCT01635829|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110081382|NCT01635829|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110081383|NCT01635829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110081384|NCT01635829|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110081385|NCT01635829|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110081386|NCT01635829|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110081387|NCT01635829|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110081388|NCT01635946|Isavuconazole|isavuconazole|mesh-list
110081389|NCT01635946|Atorvastatin|atorvastatin|mesh-list
110081390|NCT01635946|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110081391|NCT01635946|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110081392|NCT01635946|Antimetabolites|antimetabolites|mesh-ancestor
110081393|NCT01635946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110081394|NCT01635946|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110081395|NCT01635946|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110081396|NCT01635946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110081397|NCT01635946|Antifungal Agents|antifungal agents|mesh-ancestor
110081398|NCT01635946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110081399|NCT01635972|Isavuconazole|isavuconazole|mesh-list
110081400|NCT01635972|Bupropion|bupropion|mesh-list
110081401|NCT01635972|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110081402|NCT01635972|Antidepressive Agents|antidepressive agents|mesh-ancestor
110081403|NCT01635972|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110081404|NCT01635972|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110081405|NCT01635972|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110081406|NCT01635972|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110081407|NCT01635972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110081408|NCT01635972|Dopamine Agents|dopamine agents|mesh-ancestor
110081409|NCT01635972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110081410|NCT01635972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110081411|NCT01635972|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110081412|NCT01635972|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110081413|NCT01635972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110081414|NCT01635972|Antifungal Agents|antifungal agents|mesh-ancestor
110081415|NCT01635972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110081416|NCT01636037|Levodopa|levodopa|mesh-list
110081417|NCT01636037|Carbidopa|carbidopa|mesh-list
110081418|NCT01636037|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
110081419|NCT01636037|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110081420|NCT01636037|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110081421|NCT01636037|Dopamine Agents|dopamine agents|mesh-ancestor
110081422|NCT01636037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110081423|NCT01636037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110081424|NCT01636037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110081425|NCT01636037|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
110081426|NCT01636037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110081427|NCT01636037|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110081428|NCT01636037|Immunologic Factors|immunologic factors|mesh-ancestor
110081429|NCT01636037|Dopamine Agonists|dopamine agonists|mesh-ancestor
110081430|NCT01636128|Eflornithine|eflornithine|mesh-list
110081431|NCT01636128|Sulindac|sulindac|mesh-list
110081432|NCT01636128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110081433|NCT01636128|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
110081434|NCT01636128|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110081435|NCT01636128|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110081436|NCT01636128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110081437|NCT01636128|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
110081438|NCT01636128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110081439|NCT01636128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110081440|NCT01636128|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110081441|NCT01636128|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110081442|NCT01636128|Analgesics|analgesics|mesh-ancestor
110081443|NCT01636128|Sensory System Agents|sensory system agents|mesh-ancestor
110081444|NCT01636128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110081445|NCT01636128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110081446|NCT01636128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110081447|NCT01636128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110081448|NCT01636128|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110081449|NCT01636141|Dapansutrile|dapansutrile|mesh-list
110081450|NCT01636141|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110081451|NCT01636180|Clopidogrel|clopidogrel|mesh-list
110081452|NCT01636180|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110081453|NCT01636180|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110081454|NCT01636180|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110081455|NCT01636180|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110081456|NCT01636180|Purinergic Agents|purinergic agents|mesh-ancestor
110081457|NCT01636180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110081458|NCT01636180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110081459|NCT01636180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110081461|NCT01636245|Immunologic Factors|immunologic factors|mesh-ancestor
110081462|NCT01636245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110081463|NCT01636271|Darapladib|darapladib|mesh-list
110081464|NCT01636271|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
110081465|NCT01636271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110184167|NCT00032838|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110081466|NCT01636271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110081467|NCT01636310|Nicotine|nicotine|mesh-list
110081468|NCT01636310|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110081469|NCT01636310|Autonomic Agents|autonomic agents|mesh-ancestor
110081470|NCT01636310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110081471|NCT01636310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110081472|NCT01636310|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110081473|NCT01636310|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110081474|NCT01636310|Cholinergic Agents|cholinergic agents|mesh-ancestor
110081475|NCT01636310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110081476|NCT01636310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110081478|NCT01636323|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110081479|NCT01636323|Autonomic Agents|autonomic agents|mesh-ancestor
110081480|NCT01636323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110081481|NCT01636323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110081482|NCT01636323|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110081483|NCT01636323|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110081484|NCT01636323|Cholinergic Agents|cholinergic agents|mesh-ancestor
110081485|NCT01636323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110081486|NCT01636323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110081487|NCT01636336|Nicotine|nicotine|mesh-list
110081488|NCT01636336|Progesterone|progesterone|mesh-list
110081489|NCT01636336|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110081490|NCT01636336|Autonomic Agents|autonomic agents|mesh-ancestor
110081491|NCT01636336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110081492|NCT01636336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110081493|NCT01636336|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110081494|NCT01636336|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110081495|NCT01636336|Cholinergic Agents|cholinergic agents|mesh-ancestor
110081496|NCT01636336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110081497|NCT01636336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110081498|NCT01636336|Progestins|progestins|mesh-ancestor
110081499|NCT01636336|Hormones|hormones|mesh-ancestor
110081500|NCT01636336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110081501|NCT01636401|Bromides|bromides|mesh-list
110081502|NCT01636401|Anticonvulsants|anticonvulsants|mesh-ancestor
110081503|NCT01636505|Cetrorelix|cetrorelix|mesh-list
110081504|NCT01636505|Buserelin|buserelin|mesh-list
110081505|NCT01636505|Ganirelix|ganirelix|mesh-list
110081506|NCT01636505|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110081507|NCT01636505|Fertility Agents|fertility agents|mesh-ancestor
110081508|NCT01636505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110081509|NCT01636505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110081510|NCT01636505|Hormone Antagonists|hormone antagonists|mesh-ancestor
110081511|NCT01636505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110081512|NCT01636531|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110081513|NCT01636531|Immunologic Factors|immunologic factors|mesh-ancestor
110081514|NCT01636531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110081515|NCT01636557|Vitamin K|vitamin k|mesh-list
110081516|NCT01636557|Midazolam|midazolam|mesh-list
110081517|NCT01636557|Caffeine|caffeine|mesh-list
110081518|NCT01636557|Omeprazole|omeprazole|mesh-list
110081519|NCT01636557|Warfarin|warfarin|mesh-list
110081520|NCT01636557|Vitamins|vitamins|mesh-ancestor
110081521|NCT01636557|Micronutrients|micronutrients|mesh-ancestor
110081522|NCT01636557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110081523|NCT01636557|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110081524|NCT01636557|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110081525|NCT01636557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110081526|NCT01636557|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110081527|NCT01636557|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110081528|NCT01636557|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110081529|NCT01636557|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110081530|NCT01636557|Anesthetics, General|anesthetics, general|mesh-ancestor
110081531|NCT01636557|Anesthetics|anesthetics|mesh-ancestor
110081532|NCT01636557|GABA Modulators|gaba modulators|mesh-ancestor
110081533|NCT01636557|GABA Agents|gaba agents|mesh-ancestor
110081534|NCT01636557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110081535|NCT01636557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110081536|NCT01636557|Anticoagulants|anticoagulants|mesh-ancestor
110081537|NCT01636557|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110081538|NCT01636557|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110081539|NCT01636557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110081540|NCT01636557|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110081541|NCT01636557|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110081542|NCT01636557|Purinergic Agents|purinergic agents|mesh-ancestor
110081543|NCT01636557|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110081544|NCT01636557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110081545|NCT01636557|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110081546|NCT01636557|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110081547|NCT01636557|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110081548|NCT01636557|Hemostatics|hemostatics|mesh-ancestor
110081549|NCT01636557|Coagulants|coagulants|mesh-ancestor
110081550|NCT01636570|Vitamin D|vitamin d|mesh-list
110081551|NCT01636570|Cholecalciferol|cholecalciferol|mesh-list
110081552|NCT01636570|Vitamins|vitamins|mesh-ancestor
110081553|NCT01636570|Micronutrients|micronutrients|mesh-ancestor
110081554|NCT01636570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110081555|NCT01636570|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110081556|NCT01636570|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110081557|NCT01636596|Insulin Lispro|insulin lispro|mesh-list
110081558|NCT01636596|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110081559|NCT01636596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110081560|NCT01636609|Cytarabine|cytarabine|mesh-list
110081561|NCT01636609|Azacitidine|azacitidine|mesh-list
110081562|NCT01636609|Tosedostat|tosedostat|mesh-list
110081563|NCT01636609|Glycine|glycine|mesh-list
110081564|NCT01636609|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110081565|NCT01636609|Antimetabolites|antimetabolites|mesh-ancestor
110081566|NCT01636609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110081567|NCT01636609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110081568|NCT01636609|Antiviral Agents|antiviral agents|mesh-ancestor
110081569|NCT01636609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110081570|NCT01636609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110081571|NCT01636609|Immunologic Factors|immunologic factors|mesh-ancestor
110081572|NCT01636609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110081573|NCT01636609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110081574|NCT01636609|Glycine Agents|glycine agents|mesh-ancestor
110081575|NCT01636609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110081576|NCT01636622|Paclitaxel|paclitaxel|mesh-list
110081577|NCT01636622|Carboplatin|carboplatin|mesh-list
110081578|NCT01636622|Vemurafenib|vemurafenib|mesh-list
110081579|NCT01636622|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110081580|NCT01636622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110081581|NCT01636622|Tubulin Modulators|tubulin modulators|mesh-ancestor
110081582|NCT01636622|Antimitotic Agents|antimitotic agents|mesh-ancestor
110081583|NCT01636622|Mitosis Modulators|mitosis modulators|mesh-ancestor
110081584|NCT01636622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110081585|NCT01636622|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110081586|NCT01636622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110081587|NCT01636700|Tramadol|tramadol|mesh-list
110081588|NCT01636700|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110081589|NCT01636700|Narcotics|narcotics|mesh-ancestor
110081590|NCT01636700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110081591|NCT01636700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110081592|NCT01636700|Analgesics|analgesics|mesh-ancestor
110081593|NCT01636700|Sensory System Agents|sensory system agents|mesh-ancestor
110081594|NCT01636700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110081595|NCT01635426|Aspirin|aspirin|mesh-list
110081596|NCT01635426|Clopidogrel|clopidogrel|mesh-list
110081597|NCT01635426|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110081598|NCT01635426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110081599|NCT01635426|Analgesics|analgesics|mesh-ancestor
110081600|NCT01635426|Sensory System Agents|sensory system agents|mesh-ancestor
110081601|NCT01635426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110081602|NCT01635426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110081603|NCT01635426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110081604|NCT01635426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110081605|NCT01635426|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110081606|NCT01635426|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110081607|NCT01635426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110081608|NCT01635426|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110081609|NCT01635426|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110081610|NCT01635426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110081611|NCT01635426|Antipyretics|antipyretics|mesh-ancestor
110081612|NCT01635426|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110081613|NCT01635426|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110081614|NCT01635426|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110081615|NCT01635426|Purinergic Agents|purinergic agents|mesh-ancestor
110081616|NCT01635426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110081617|NCT01636869|Bupivacaine|bupivacaine|mesh-list
110081618|NCT01636869|Anesthetics, Local|anesthetics, local|mesh-ancestor
110081619|NCT01636869|Anesthetics|anesthetics|mesh-ancestor
110081620|NCT01636869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110081621|NCT01636869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110081622|NCT01636869|Sensory System Agents|sensory system agents|mesh-ancestor
110081623|NCT01636869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110081624|NCT01636895|Pyrimethamine|pyrimethamine|mesh-list
110081625|NCT01636895|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
110081626|NCT01636895|Sulfadoxine|sulfadoxine|mesh-list
110081627|NCT01636895|Antimalarials|antimalarials|mesh-ancestor
110081628|NCT01636895|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110081629|NCT01636895|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110081630|NCT01636895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110081631|NCT01636895|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110081632|NCT01636895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110081633|NCT01636895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110081634|NCT01636895|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110081635|NCT01636908|Everolimus|everolimus|mesh-list
110081636|NCT01636908|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110081637|NCT01636908|Sorafenib|sorafenib|mesh-list
110081638|NCT01636908|Sunitinib|sunitinib|mesh-list
110081639|NCT01636908|Dasatinib|dasatinib|mesh-list
110081640|NCT01636908|Lapatinib|lapatinib|mesh-list
110081641|NCT01636908|Vemurafenib|vemurafenib|mesh-list
110081642|NCT01636908|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110081643|NCT01636908|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110081644|NCT01636908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110081645|NCT01636908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110081646|NCT01636908|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110081647|NCT01636908|Immunologic Factors|immunologic factors|mesh-ancestor
110081648|NCT01636908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110081649|NCT01636908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110081651|NCT01636908|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110081652|NCT01636908|Growth Substances|growth substances|mesh-ancestor
110081653|NCT01636908|Growth Inhibitors|growth inhibitors|mesh-ancestor
110081654|NCT01636999|Nitrous Oxide|nitrous oxide|mesh-list
110081655|NCT01636999|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110081656|NCT01636999|Anesthetics, General|anesthetics, general|mesh-ancestor
110081657|NCT01636999|Anesthetics|anesthetics|mesh-ancestor
110081658|NCT01636999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110081659|NCT01636999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110081661|NCT01636999|Analgesics|analgesics|mesh-ancestor
110081662|NCT01636999|Sensory System Agents|sensory system agents|mesh-ancestor
110081663|NCT01636999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110081664|NCT01637025|Cellulose, Oxidized|cellulose, oxidized|mesh-list
110081665|NCT01637025|Hemostatics|hemostatics|mesh-ancestor
110081666|NCT01637025|Coagulants|coagulants|mesh-ancestor
110081667|NCT01637155|Vitamin D|vitamin d|mesh-list
110081668|NCT01637155|Cholecalciferol|cholecalciferol|mesh-list
110081669|NCT01637155|Vitamins|vitamins|mesh-ancestor
110081670|NCT01637155|Micronutrients|micronutrients|mesh-ancestor
110081671|NCT01637155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110081672|NCT01637155|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110081673|NCT01637155|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110081674|NCT01637194|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110081675|NCT01637194|Cetuximab|cetuximab|mesh-list
110081676|NCT01637194|Everolimus|everolimus|mesh-list
110081677|NCT01637194|Antibodies|antibodies|mesh-list
110081678|NCT01637194|Immunoglobulins|immunoglobulins|mesh-list
110081679|NCT01637194|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110081680|NCT01637194|Immunologic Factors|immunologic factors|mesh-ancestor
110081681|NCT01637194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110081682|NCT01637194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110081683|NCT01637194|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110081684|NCT01637194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110081685|NCT01637194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110081686|NCT01637194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110081687|NCT01637194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110081688|NCT01637233|Ritonavir|ritonavir|mesh-list
110081689|NCT01637233|Lopinavir|lopinavir|mesh-list
110081690|NCT01637233|Atazanavir Sulfate|atazanavir sulfate|mesh-list
110081691|NCT01637233|Darunavir|darunavir|mesh-list
110081692|NCT01637233|Fosamprenavir|fosamprenavir|mesh-list
110081693|NCT01637233|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
110081694|NCT01637233|Tenofovir|tenofovir|mesh-list
110081695|NCT01637233|Lamivudine|lamivudine|mesh-list
110081696|NCT01637233|Emtricitabine|emtricitabine|mesh-list
110081697|NCT01637233|Zidovudine|zidovudine|mesh-list
110081698|NCT01637233|Maraviroc|maraviroc|mesh-list
110081699|NCT01637233|Abacavir|abacavir|mesh-list
110081700|NCT01637233|Dideoxynucleosides|dideoxynucleosides|mesh-list
110081701|NCT01637233|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
110081702|NCT01637233|Protease Inhibitors|protease inhibitors|mesh-list
110081703|NCT01637233|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110081704|NCT01637233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110081705|NCT01637233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110081706|NCT01637233|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110081707|NCT01637233|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110081708|NCT01637233|Antiviral Agents|antiviral agents|mesh-ancestor
110081709|NCT01637233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110081710|NCT01637233|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110081711|NCT01637233|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110081712|NCT01637233|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110081714|NCT01637233|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110081715|NCT01637233|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110081716|NCT01637233|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
110081717|NCT01637259|Ritonavir|ritonavir|mesh-list
110081718|NCT01637259|Lopinavir|lopinavir|mesh-list
110081719|NCT01637259|Atazanavir Sulfate|atazanavir sulfate|mesh-list
110081720|NCT01637259|Darunavir|darunavir|mesh-list
110081721|NCT01637259|Fosamprenavir|fosamprenavir|mesh-list
110081722|NCT01637259|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
110081724|NCT01637259|Lamivudine|lamivudine|mesh-list
110081725|NCT01637259|Emtricitabine|emtricitabine|mesh-list
110081726|NCT01637259|Zidovudine|zidovudine|mesh-list
110081727|NCT01637259|Maraviroc|maraviroc|mesh-list
110081728|NCT01637259|Abacavir|abacavir|mesh-list
110081729|NCT01637259|Dideoxynucleosides|dideoxynucleosides|mesh-list
110081730|NCT01637259|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
110081731|NCT01637259|Protease Inhibitors|protease inhibitors|mesh-list
110081732|NCT01637259|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110081733|NCT01637259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110081734|NCT01637259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110081735|NCT01637259|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110081736|NCT01637259|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110081737|NCT01637259|Antiviral Agents|antiviral agents|mesh-ancestor
110081738|NCT01637259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110081739|NCT01637259|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110081740|NCT01637259|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110081741|NCT01637259|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110081742|NCT01637259|Antimetabolites|antimetabolites|mesh-ancestor
110081743|NCT01637259|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110081744|NCT01637259|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110081745|NCT01637259|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
110081746|NCT01637376|Temoporfin|temoporfin|mesh-list
110081747|NCT01637376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110081748|NCT01637376|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110081749|NCT01637376|Dermatologic Agents|dermatologic agents|mesh-ancestor
110081750|NCT01637454|Terlipressin|terlipressin|mesh-list
110081751|NCT01637454|Norepinephrine|norepinephrine|mesh-list
110081752|NCT01637454|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110081753|NCT01637454|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110081754|NCT01637454|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110081755|NCT01637454|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110081756|NCT01637454|Adrenergic Agents|adrenergic agents|mesh-ancestor
110081757|NCT01637454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110081758|NCT01637454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110081759|NCT01637454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110081761|NCT01637454|Autonomic Agents|autonomic agents|mesh-ancestor
110081762|NCT01637454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110081763|NCT01637532|Interferons|interferons|mesh-list
110081764|NCT01637532|Interferon-alpha|interferon-alpha|mesh-list
110081765|NCT01637532|Interferon alpha-2|interferon alpha-2|mesh-list
110081766|NCT01637532|Carboplatin|carboplatin|mesh-list
110081767|NCT01637532|Doxorubicin|doxorubicin|mesh-list
110081768|NCT01637532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110081769|NCT01637532|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110081770|NCT01637532|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110081771|NCT01637532|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110081772|NCT01637532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110081773|NCT01637532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110081774|NCT01637532|Antiviral Agents|antiviral agents|mesh-ancestor
110081775|NCT01637532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110081776|NCT01637532|Immunologic Factors|immunologic factors|mesh-ancestor
110081777|NCT01637532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110081778|NCT01637545|Ramosetron|ramosetron|mesh-list
110081779|NCT01637545|Antiemetics|antiemetics|mesh-ancestor
110081780|NCT01637545|Autonomic Agents|autonomic agents|mesh-ancestor
110081782|NCT01637545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110081783|NCT01637545|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110081784|NCT01637545|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110081785|NCT01637545|Serotonin Agents|serotonin agents|mesh-ancestor
110081786|NCT01637545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110081787|NCT01637545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110081788|NCT01637558|Ritonavir|ritonavir|mesh-list
110081789|NCT01637558|Lopinavir|lopinavir|mesh-list
110081790|NCT01637558|Nevirapine|nevirapine|mesh-list
110081791|NCT01637558|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110081792|NCT01637558|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110081794|NCT01637558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110081795|NCT01637558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110081797|NCT01637558|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110081798|NCT01637558|Antiviral Agents|antiviral agents|mesh-ancestor
110081799|NCT01637558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110081800|NCT01637558|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110081801|NCT01637558|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110081802|NCT01637558|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110081803|NCT01637558|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110081804|NCT01637558|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110081805|NCT01637558|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110081806|NCT01637571|Dexlansoprazole|dexlansoprazole|mesh-list
110081807|NCT01637571|Lansoprazole|lansoprazole|mesh-list
110081808|NCT01637571|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110081809|NCT01637571|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110081810|NCT01637571|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110081811|NCT01637571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110081812|NCT01637571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110081813|NCT01637636|Rifampin|rifampin|mesh-list
110081815|NCT01637636|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110081816|NCT01637636|Antitubercular Agents|antitubercular agents|mesh-ancestor
110081817|NCT01637636|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110081818|NCT01637636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110081819|NCT01637636|Leprostatic Agents|leprostatic agents|mesh-ancestor
110081820|NCT01637636|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110081821|NCT01637636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110081822|NCT01637636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110081823|NCT01637636|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110081824|NCT01637636|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110081825|NCT01637636|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110081826|NCT01637636|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110081827|NCT01637636|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110081828|NCT01637636|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110081829|NCT01637636|Antifungal Agents|antifungal agents|mesh-ancestor
110081830|NCT01637636|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110081831|NCT01637636|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110081832|NCT01637636|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110081833|NCT01637636|Hormone Antagonists|hormone antagonists|mesh-ancestor
110081834|NCT01637636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110081835|NCT01637636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110081836|NCT01637636|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110081837|NCT01637675|Tanshinone|tanshinone|mesh-list
110081838|NCT01637675|Sildenafil Citrate|sildenafil citrate|mesh-list
110081839|NCT01637675|Citric Acid|citric acid|mesh-list
110081840|NCT01637675|Sodium Citrate|sodium citrate|mesh-list
110081841|NCT01637675|Anticoagulants|anticoagulants|mesh-ancestor
110081842|NCT01637675|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110081843|NCT01637675|Chelating Agents|chelating agents|mesh-ancestor
110081844|NCT01637675|Sequestering Agents|sequestering agents|mesh-ancestor
110081845|NCT01637675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110081846|NCT01637675|Vasodilator Agents|vasodilator agents|mesh-ancestor
110081847|NCT01637675|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110184233|NCT03150368|Docetaxel|docetaxel|mesh-list
110081848|NCT01637675|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110081849|NCT01637675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110081850|NCT01637675|Urological Agents|urological agents|mesh-ancestor
110081851|NCT01637675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110081852|NCT01637675|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110081853|NCT01637675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110081854|NCT01637675|Analgesics|analgesics|mesh-ancestor
110081855|NCT01637675|Sensory System Agents|sensory system agents|mesh-ancestor
110081856|NCT01637675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110081857|NCT01637675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110081858|NCT01637675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110081859|NCT01637675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110081860|NCT01637675|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110081861|NCT01637675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110081862|NCT01637675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110081863|NCT01637675|Immunologic Factors|immunologic factors|mesh-ancestor
110081864|NCT01637753|Carmustine|carmustine|mesh-list
110081865|NCT01637753|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110081866|NCT01637753|Alkylating Agents|alkylating agents|mesh-ancestor
110081867|NCT01637753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110081868|NCT01637753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110081869|NCT01637766|Melphalan|melphalan|mesh-list
110081870|NCT01637766|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110081871|NCT01637766|Alkylating Agents|alkylating agents|mesh-ancestor
110081872|NCT01637766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110081873|NCT01637766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110081874|NCT01637766|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110081875|NCT01637766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110081876|NCT01637766|Immunologic Factors|immunologic factors|mesh-ancestor
110081877|NCT01637766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110081878|NCT01637818|Acetaminophen|acetaminophen|mesh-list
110081879|NCT01637818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
110081880|NCT01637818|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
110081881|NCT01637818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110081882|NCT01637818|Analgesics|analgesics|mesh-ancestor
110081883|NCT01637818|Sensory System Agents|sensory system agents|mesh-ancestor
110081884|NCT01637818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110081885|NCT01637818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110081886|NCT01637818|Antipyretics|antipyretics|mesh-ancestor
110081887|NCT01637818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110081888|NCT01637844|Telbivudine|telbivudine|mesh-list
110081889|NCT01637844|Antiviral Agents|antiviral agents|mesh-ancestor
110081890|NCT01637844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110081891|NCT01637844|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110081892|NCT01637844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110081893|NCT01637844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110081894|NCT01637883|Benzydamine|benzydamine|mesh-list
110081895|NCT01637883|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110081896|NCT01637948|Listerine|listerine|mesh-list
110081897|NCT01637948|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110081898|NCT01637948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110081899|NCT01638026|Triptorelin Pamoate|triptorelin pamoate|mesh-list
110081900|NCT01638026|Luteolytic Agents|luteolytic agents|mesh-ancestor
110081901|NCT01638026|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110081902|NCT01638026|Contraceptive Agents|contraceptive agents|mesh-ancestor
110081903|NCT01638026|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110081904|NCT01638026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110081905|NCT01638026|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110081906|NCT01638026|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110081907|NCT01638026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110081908|NCT01638078|Thalidomide|thalidomide|mesh-list
110081909|NCT01638078|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110081910|NCT01638078|Immunologic Factors|immunologic factors|mesh-ancestor
110081911|NCT01638078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110081912|NCT01638078|Leprostatic Agents|leprostatic agents|mesh-ancestor
110081913|NCT01638078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110081914|NCT01638078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110081915|NCT01638078|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110081916|NCT01638078|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110081917|NCT01638078|Growth Substances|growth substances|mesh-ancestor
110081918|NCT01638078|Growth Inhibitors|growth inhibitors|mesh-ancestor
110081919|NCT01638078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110081920|NCT01638182|Vitamins|vitamins|mesh-list
110081921|NCT01638182|Vitamin K|vitamin k|mesh-list
110081922|NCT01638182|Vitamin K 2|vitamin k 2|mesh-list
110081923|NCT01638182|Vitamin K 1|vitamin k 1|mesh-list
110081924|NCT01638182|Micronutrients|micronutrients|mesh-ancestor
110081925|NCT01638182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110081926|NCT01638182|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110081927|NCT01638182|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110081928|NCT01638182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110081929|NCT01638182|Hemostatics|hemostatics|mesh-ancestor
110081930|NCT01638182|Coagulants|coagulants|mesh-ancestor
110081931|NCT01638234|Melatonin|melatonin|mesh-list
110081932|NCT01638234|Antioxidants|antioxidants|mesh-ancestor
110081933|NCT01638234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110081934|NCT01638234|Protective Agents|protective agents|mesh-ancestor
110081935|NCT01638234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110081936|NCT01638234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110081937|NCT01638247|Tamoxifen|tamoxifen|mesh-list
110081938|NCT01638247|Goserelin|goserelin|mesh-list
110081939|NCT01638247|Exemestane|exemestane|mesh-list
110081940|NCT01638247|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
110081941|NCT01638247|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110081942|NCT01638247|Hormone Antagonists|hormone antagonists|mesh-ancestor
110081943|NCT01638247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110081944|NCT01638247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110081945|NCT01638247|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110081946|NCT01638247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110081947|NCT01638247|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110081948|NCT01638247|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110081949|NCT01638247|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110081950|NCT01638247|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110081951|NCT01638247|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110081952|NCT01638247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110081953|NCT01638247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110081954|NCT01638247|Hormones|hormones|mesh-ancestor
110081955|NCT01638260|Liraglutide|liraglutide|mesh-list
110081956|NCT01638260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110081957|NCT01638260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110081958|NCT01638260|Incretins|incretins|mesh-ancestor
110081959|NCT01638260|Hormones|hormones|mesh-ancestor
110081960|NCT01638260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110081961|NCT01638273|Pregabalin|pregabalin|mesh-list
110081962|NCT01638273|Analgesics|analgesics|mesh-ancestor
110081963|NCT01638273|Sensory System Agents|sensory system agents|mesh-ancestor
110081964|NCT01638273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110081965|NCT01638273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110081966|NCT01638273|Anticonvulsants|anticonvulsants|mesh-ancestor
110081967|NCT01638273|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110184253|NCT00033111|Cabergoline|cabergoline|mesh-list
110081968|NCT01638273|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110081969|NCT01638273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110081970|NCT01638273|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110081971|NCT01638273|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110081972|NCT01638273|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110081973|NCT01638273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110081974|NCT01638273|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110081975|NCT01638299|Insulin|insulin|mesh-list
110081976|NCT01638299|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110081977|NCT01638299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110081978|NCT01638325|Insulin|insulin|mesh-list
110081979|NCT01638325|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110081980|NCT01638325|Insulin Lispro|insulin lispro|mesh-list
110081981|NCT01638325|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110081982|NCT01638325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110081983|NCT01638364|Ethanol|ethanol|mesh-list
110081984|NCT01638364|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110081985|NCT01638364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110081986|NCT01638364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110081987|NCT01638364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110081988|NCT01638377|Naltrexone|naltrexone|mesh-list
110081989|NCT01638377|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110081990|NCT01638377|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110081991|NCT01638377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110081992|NCT01638377|Sensory System Agents|sensory system agents|mesh-ancestor
110081993|NCT01638377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110081994|NCT01638403|Modafinil|modafinil|mesh-list
110081995|NCT01638403|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110081996|NCT01638403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110081997|NCT01638403|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
110081998|NCT01638403|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110081999|NCT01638403|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110082000|NCT01638403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110082001|NCT01638624|Propofol|propofol|mesh-list
110082002|NCT01638624|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110082003|NCT01638624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110082004|NCT01638624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110082006|NCT01638624|Anesthetics, General|anesthetics, general|mesh-ancestor
110082007|NCT01638624|Anesthetics|anesthetics|mesh-ancestor
110082008|NCT01638650|Ritonavir|ritonavir|mesh-list
110082010|NCT01638650|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
110082011|NCT01638650|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110082012|NCT01638650|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110082013|NCT01638650|Protease Inhibitors|protease inhibitors|mesh-ancestor
110082014|NCT01638650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110082015|NCT01638650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110082016|NCT01638650|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110082017|NCT01638650|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110082018|NCT01638650|Antiviral Agents|antiviral agents|mesh-ancestor
110082019|NCT01638650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110082020|NCT01638650|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110082021|NCT01638650|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110184258|NCT00033111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110082022|NCT01638650|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110082024|NCT01638663|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
110082025|NCT01638663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110082026|NCT01638663|Natriuretic Agents|natriuretic agents|mesh-ancestor
110082027|NCT01638663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110082028|NCT01638676|Metformin|metformin|mesh-list
110082029|NCT01638676|Vemurafenib|vemurafenib|mesh-list
110082030|NCT01638676|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110082031|NCT01638676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110082032|NCT01638676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110082033|NCT01638676|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110082034|NCT01638676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110082035|NCT01638676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110082036|NCT01638689|Escitalopram|escitalopram|mesh-list
110082037|NCT01638689|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110082038|NCT01638689|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110082039|NCT01638689|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110082040|NCT01638689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110082041|NCT01638689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110082042|NCT01638689|Serotonin Agents|serotonin agents|mesh-ancestor
110082043|NCT01638689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110082044|NCT01638715|Infliximab|infliximab|mesh-list
110082045|NCT01638715|Rituximab|rituximab|mesh-list
110082046|NCT01638715|Abatacept|abatacept|mesh-list
110082047|NCT01638715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110082048|NCT01638715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110082049|NCT01638715|Immunologic Factors|immunologic factors|mesh-ancestor
110082050|NCT01638715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110082051|NCT01638715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110082052|NCT01638715|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110082053|NCT01638715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110082054|NCT01638715|Dermatologic Agents|dermatologic agents|mesh-ancestor
110082055|NCT01638715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110082056|NCT01638715|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110082057|NCT01638715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110082058|NCT01638715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110082059|NCT01638767|Contraceptive Agents|contraceptive agents|mesh-list
110082060|NCT01638767|NuvaRing|nuvaring|mesh-list
110082061|NCT01638767|Contraceptives, Oral|contraceptives, oral|mesh-list
110082062|NCT01638767|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110082063|NCT01638767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110082064|NCT01638767|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110082065|NCT01638767|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110082066|NCT01638780|Resveratrol|resveratrol|mesh-list
110082067|NCT01638780|Antioxidants|antioxidants|mesh-ancestor
110082068|NCT01638780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110082069|NCT01638780|Protective Agents|protective agents|mesh-ancestor
110082070|NCT01638780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110082071|NCT01638780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110082072|NCT01638780|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110082073|NCT01638858|Ranibizumab|ranibizumab|mesh-list
110184286|NCT02984384|Aspirin|aspirin|mesh-list
110082074|NCT01638858|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110082075|NCT01638858|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110082076|NCT01638858|Growth Substances|growth substances|mesh-ancestor
110082077|NCT01638858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110082078|NCT01638858|Growth Inhibitors|growth inhibitors|mesh-ancestor
110082079|NCT01638858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110082080|NCT01638936|Indatuximab ravtansine|indatuximab ravtansine|mesh-list
110082082|NCT01638936|Immunologic Factors|immunologic factors|mesh-ancestor
110082083|NCT01638936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110082084|NCT01638962|Acetaminophen|acetaminophen|mesh-list
110082085|NCT01638962|Aspirin|aspirin|mesh-list
110082086|NCT01638962|Ibuprofen|ibuprofen|mesh-list
110082087|NCT01638962|Celecoxib|celecoxib|mesh-list
110082088|NCT01638962|Diclofenac|diclofenac|mesh-list
110082089|NCT01638962|Naproxen|naproxen|mesh-list
110082090|NCT01638962|Indomethacin|indomethacin|mesh-list
110082091|NCT01638962|Etoricoxib|etoricoxib|mesh-list
110082092|NCT01638962|Meloxicam|meloxicam|mesh-list
110082093|NCT01638962|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
110082094|NCT01638962|Etodolac|etodolac|mesh-list
110082095|NCT01638962|Lornoxicam|lornoxicam|mesh-list
110082096|NCT01638962|Nabumetone|nabumetone|mesh-list
110082097|NCT01638962|Tenoxicam|tenoxicam|mesh-list
110082098|NCT01638962|Tiaprofenic acid|tiaprofenic acid|mesh-list
110082099|NCT01638962|Analgesics|analgesics|mesh-list
110082100|NCT01638962|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110082101|NCT01638962|Sensory System Agents|sensory system agents|mesh-ancestor
110082102|NCT01638962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110082103|NCT01638962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110082104|NCT01638962|Antipyretics|antipyretics|mesh-ancestor
110082105|NCT01638962|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110082106|NCT01638962|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110082107|NCT01638962|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110082108|NCT01638962|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110082109|NCT01638962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110082110|NCT01638962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110082111|NCT01638962|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110082112|NCT01638962|Gout Suppressants|gout suppressants|mesh-ancestor
110082113|NCT01638962|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110082114|NCT01638962|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110082115|NCT01638962|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110082116|NCT01638962|Tocolytic Agents|tocolytic agents|mesh-ancestor
110082117|NCT01638962|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110082118|NCT01638988|Metformin|metformin|mesh-list
110082119|NCT01638988|Clomiphene|clomiphene|mesh-list
110082120|NCT01638988|Enclomiphene|enclomiphene|mesh-list
110082121|NCT01638988|Zuclomiphene|zuclomiphene|mesh-list
110082122|NCT01638988|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110082123|NCT01638988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110082124|NCT01638988|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110082125|NCT01638988|Hormone Antagonists|hormone antagonists|mesh-ancestor
110082126|NCT01638988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110082127|NCT01638988|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110082128|NCT01638988|Fertility Agents|fertility agents|mesh-ancestor
110082129|NCT01638988|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110082130|NCT01638988|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110082131|NCT01638988|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110082132|NCT01639027|Drotaverin|drotaverin|mesh-list
110082133|NCT01639027|Analgesics|analgesics|mesh-ancestor
110082134|NCT01639027|Sensory System Agents|sensory system agents|mesh-ancestor
110082135|NCT01639027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110082136|NCT01639027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110082137|NCT01639027|Parasympatholytics|parasympatholytics|mesh-ancestor
110082138|NCT01639027|Autonomic Agents|autonomic agents|mesh-ancestor
110082139|NCT01639027|Vasodilator Agents|vasodilator agents|mesh-ancestor
110082140|NCT01639066|Tenofovir|tenofovir|mesh-list
110082141|NCT01639066|Entecavir|entecavir|mesh-list
110082142|NCT01639066|Antiviral Agents|antiviral agents|mesh-ancestor
110082143|NCT01639066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110082144|NCT01639066|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110082145|NCT01639066|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110082146|NCT01639066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110082147|NCT01639066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110082148|NCT01639066|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110082149|NCT01639066|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110082150|NCT01639092|Tenofovir|tenofovir|mesh-list
110082151|NCT01639092|Entecavir|entecavir|mesh-list
110082152|NCT01639092|Antiviral Agents|antiviral agents|mesh-ancestor
110082153|NCT01639092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110082154|NCT01639092|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110082155|NCT01639092|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110082156|NCT01639092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110082157|NCT01639092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110082158|NCT01639092|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110082159|NCT01639092|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110082161|NCT01639261|Interferon-gamma|interferon-gamma|mesh-list
110082162|NCT01639261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110082163|NCT01639261|Antiviral Agents|antiviral agents|mesh-ancestor
110082164|NCT01639261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110082166|NCT01639326|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110082167|NCT01639326|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110082168|NCT01639326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110082169|NCT01639326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110082170|NCT01639326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110082171|NCT01639456|Aldesleukin|aldesleukin|mesh-list
110082172|NCT01639456|Cyclophosphamide|cyclophosphamide|mesh-list
110082173|NCT01639456|Fludarabine|fludarabine|mesh-list
110082174|NCT01639456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110082175|NCT01639456|Immunologic Factors|immunologic factors|mesh-ancestor
110082176|NCT01639456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110082177|NCT01639456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110082178|NCT01639456|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110082179|NCT01639456|Alkylating Agents|alkylating agents|mesh-ancestor
110082180|NCT01639456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110082181|NCT01639456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110082182|NCT01639456|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110082183|NCT01639456|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110082184|NCT01639456|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110082185|NCT01639456|Antiviral Agents|antiviral agents|mesh-ancestor
110082186|NCT01639456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110082187|NCT01639521|Gemcitabine|gemcitabine|mesh-list
110082188|NCT01639521|Doxorubicin|doxorubicin|mesh-list
110082189|NCT01639521|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110082190|NCT01639521|Methotrexate|methotrexate|mesh-list
110082191|NCT01639521|Vinblastine|vinblastine|mesh-list
110082192|NCT01639521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110082193|NCT01639521|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110082194|NCT01639521|Antimetabolites|antimetabolites|mesh-ancestor
110082195|NCT01639521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110082196|NCT01639521|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110082197|NCT01639521|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110082198|NCT01639521|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110082199|NCT01639521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110082200|NCT01639521|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110082201|NCT01639521|Abortifacient Agents|abortifacient agents|mesh-ancestor
110082202|NCT01639521|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110082203|NCT01639521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110082204|NCT01639521|Dermatologic Agents|dermatologic agents|mesh-ancestor
110082205|NCT01639521|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110082206|NCT01639521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110082207|NCT01639521|Immunologic Factors|immunologic factors|mesh-ancestor
110082208|NCT01639521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110082209|NCT01639521|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110184315|NCT00033423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110082210|NCT01639521|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110082211|NCT01639521|Tubulin Modulators|tubulin modulators|mesh-ancestor
110082212|NCT01639521|Antimitotic Agents|antimitotic agents|mesh-ancestor
110082213|NCT01639521|Mitosis Modulators|mitosis modulators|mesh-ancestor
110082215|NCT01639547|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110082216|NCT01639547|Antimetabolites|antimetabolites|mesh-ancestor
110082217|NCT01639547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110082218|NCT01639547|Antiviral Agents|antiviral agents|mesh-ancestor
110082219|NCT01639547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110082220|NCT01639794|Solifenacin Succinate|solifenacin succinate|mesh-list
110082221|NCT01639794|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110082222|NCT01639794|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110082223|NCT01639794|Cholinergic Agents|cholinergic agents|mesh-ancestor
110082224|NCT01639794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110082225|NCT01639794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110082226|NCT01639794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110082227|NCT01639794|Urological Agents|urological agents|mesh-ancestor
110082228|NCT01639807|Latanoprost|latanoprost|mesh-list
110082229|NCT01639807|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110082230|NCT01639807|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110082231|NCT01639885|Interferons|interferons|mesh-list
110082232|NCT01639885|Interferon-alpha|interferon-alpha|mesh-list
110082233|NCT01639885|Interferon alpha-2|interferon alpha-2|mesh-list
110082234|NCT01639885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110082235|NCT01639885|Antiviral Agents|antiviral agents|mesh-ancestor
110082236|NCT01639885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110082237|NCT01639885|Immunologic Factors|immunologic factors|mesh-ancestor
110082238|NCT01639885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110082239|NCT01639898|Dexamethasone|dexamethasone|mesh-list
110082240|NCT01639898|Dexamethasone acetate|dexamethasone acetate|mesh-list
110082242|NCT01639898|BB 1101|bb 1101|mesh-list
110082243|NCT01639898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110082244|NCT01639898|Antiemetics|antiemetics|mesh-ancestor
110082245|NCT01639898|Autonomic Agents|autonomic agents|mesh-ancestor
110082246|NCT01639898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110082247|NCT01639898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110082248|NCT01639898|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110082249|NCT01639898|Glucocorticoids|glucocorticoids|mesh-ancestor
110082250|NCT01639898|Hormones|hormones|mesh-ancestor
110082251|NCT01639898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110082252|NCT01639898|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110082253|NCT01639898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110082254|NCT01639898|Protease Inhibitors|protease inhibitors|mesh-ancestor
110082255|NCT01639898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110082256|NCT01639898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110082257|NCT01639898|Immunologic Factors|immunologic factors|mesh-ancestor
110082258|NCT01639898|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110082259|NCT01639898|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110082260|NCT01639898|Growth Substances|growth substances|mesh-ancestor
110082261|NCT01639898|Growth Inhibitors|growth inhibitors|mesh-ancestor
110082262|NCT01640743|Methylprednisolone|methylprednisolone|mesh-list
110082263|NCT01640743|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110082264|NCT01640743|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110082265|NCT01640743|Prednisolone|prednisolone|mesh-list
110082266|NCT01640743|Prednisolone acetate|prednisolone acetate|mesh-list
110082267|NCT01640743|Everolimus|everolimus|mesh-list
110082268|NCT01640743|Tacrolimus|tacrolimus|mesh-list
110082269|NCT01640743|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110082270|NCT01640743|Prednisolone phosphate|prednisolone phosphate|mesh-list
110082271|NCT01640743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110082272|NCT01640743|Immunologic Factors|immunologic factors|mesh-ancestor
110082273|NCT01640743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110082274|NCT01640743|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110082275|NCT01640743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110082276|NCT01640743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110082277|NCT01640743|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110082278|NCT01640743|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110082279|NCT01640743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110082280|NCT01640743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110082281|NCT01640743|Antiemetics|antiemetics|mesh-ancestor
110082282|NCT01640743|Autonomic Agents|autonomic agents|mesh-ancestor
110082283|NCT01640743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110082284|NCT01640743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110082285|NCT01640743|Glucocorticoids|glucocorticoids|mesh-ancestor
110082286|NCT01640743|Hormones|hormones|mesh-ancestor
110082287|NCT01640743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110082288|NCT01640743|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110082289|NCT01640743|Protective Agents|protective agents|mesh-ancestor
110082290|NCT01640743|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110082291|NCT01641016|Efavirenz|efavirenz|mesh-list
110082292|NCT01641016|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110082293|NCT01641016|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110082294|NCT01641016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110082295|NCT01641016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110082296|NCT01641016|Antiviral Agents|antiviral agents|mesh-ancestor
110082297|NCT01641016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110082298|NCT01641016|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110082299|NCT01641016|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110082300|NCT01641016|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110082301|NCT01641016|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110082302|NCT01641016|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110082303|NCT01641016|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110082304|NCT01642771|Docetaxel|docetaxel|mesh-list
110082305|NCT01642771|Fluorouracil|fluorouracil|mesh-list
110082306|NCT01642771|Capecitabine|capecitabine|mesh-list
110082307|NCT01642771|Epirubicin|epirubicin|mesh-list
110082308|NCT01642771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110082309|NCT01642771|Tubulin Modulators|tubulin modulators|mesh-ancestor
110082310|NCT01642771|Antimitotic Agents|antimitotic agents|mesh-ancestor
110082311|NCT01642771|Mitosis Modulators|mitosis modulators|mesh-ancestor
110082312|NCT01642771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110082313|NCT01642771|Antimetabolites|antimetabolites|mesh-ancestor
110082314|NCT01642771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110082315|NCT01642771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110082316|NCT01642771|Immunologic Factors|immunologic factors|mesh-ancestor
110082317|NCT01642771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110082318|NCT01642771|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110082319|NCT01642771|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110082320|NCT01642771|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110082321|NCT01642771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110082322|NCT01642979|Cyclosporine|cyclosporine|mesh-list
110082323|NCT01642979|Levamisole|levamisole|mesh-list
110082324|NCT01642979|Cyclosporins|cyclosporins|mesh-list
110082325|NCT01642979|Glucocorticoids|glucocorticoids|mesh-list
110082326|NCT01642979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110082327|NCT01642979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110082328|NCT01642979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110082329|NCT01642979|Immunologic Factors|immunologic factors|mesh-ancestor
110082330|NCT01642979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110082331|NCT01642979|Antifungal Agents|antifungal agents|mesh-ancestor
110082332|NCT01642979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110082333|NCT01642979|Dermatologic Agents|dermatologic agents|mesh-ancestor
110082334|NCT01642979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110082335|NCT01642979|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110082336|NCT01642979|Hormones|hormones|mesh-ancestor
110082337|NCT01642979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110082338|NCT01642979|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110082339|NCT01642979|Antinematodal Agents|antinematodal agents|mesh-ancestor
110082340|NCT01642979|Anthelmintics|anthelmintics|mesh-ancestor
110082341|NCT01642979|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110082342|NCT01643031|Clopidogrel|clopidogrel|mesh-list
110082343|NCT01643031|Ticagrelor|ticagrelor|mesh-list
110082344|NCT01643031|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110082345|NCT01643031|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110082346|NCT01643031|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110082347|NCT01643031|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110082348|NCT01643031|Purinergic Agents|purinergic agents|mesh-ancestor
110082349|NCT01643031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110082350|NCT01643031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110082351|NCT01643031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110082352|NCT01643434|Clonidine|clonidine|mesh-list
110082353|NCT01643434|Spironolactone|spironolactone|mesh-list
110082354|NCT01643434|Analgesics|analgesics|mesh-ancestor
110082355|NCT01643434|Sensory System Agents|sensory system agents|mesh-ancestor
110082356|NCT01643434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110082357|NCT01643434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110082358|NCT01643434|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110082359|NCT01643434|Sympatholytics|sympatholytics|mesh-ancestor
110082360|NCT01643434|Autonomic Agents|autonomic agents|mesh-ancestor
110082361|NCT01643434|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110082362|NCT01643434|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110082363|NCT01643434|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110082364|NCT01643434|Adrenergic Agents|adrenergic agents|mesh-ancestor
110082365|NCT01643434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110082366|NCT01643434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110082367|NCT01643434|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110082368|NCT01643434|Hormone Antagonists|hormone antagonists|mesh-ancestor
110082369|NCT01643434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110082370|NCT01643434|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110082371|NCT01643434|Diuretics|diuretics|mesh-ancestor
110082372|NCT01643434|Natriuretic Agents|natriuretic agents|mesh-ancestor
110082373|NCT01643941|Vaccines|vaccines|mesh-list
110082374|NCT01643941|Immunologic Factors|immunologic factors|mesh-ancestor
110082375|NCT01643941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110082376|NCT01643980|Progesterone|progesterone|mesh-list
110082377|NCT01643980|Progestins|progestins|mesh-ancestor
110082378|NCT01643980|Hormones|hormones|mesh-ancestor
110082379|NCT01643980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110082380|NCT01643980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110082381|NCT01645228|Calcium|calcium|mesh-list
110082382|NCT01645228|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110082383|NCT01645228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110082385|NCT01645839|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110082387|NCT01645839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110082388|NCT01645839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110082389|NCT01645839|Antiviral Agents|antiviral agents|mesh-ancestor
110082390|NCT01645839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110082391|NCT01645839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110082392|NCT01645839|Immunologic Factors|immunologic factors|mesh-ancestor
110082393|NCT01645839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110082394|NCT01646437|Aspirin|aspirin|mesh-list
110082395|NCT01646437|Vitamin D|vitamin d|mesh-list
110082396|NCT01646437|Cholecalciferol|cholecalciferol|mesh-list
110082397|NCT01646437|Vitamins|vitamins|mesh-ancestor
110082398|NCT01646437|Micronutrients|micronutrients|mesh-ancestor
110082399|NCT01646437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110082400|NCT01646437|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110082401|NCT01646437|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110082402|NCT01646437|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110082403|NCT01646437|Analgesics|analgesics|mesh-ancestor
110082404|NCT01646437|Sensory System Agents|sensory system agents|mesh-ancestor
110082405|NCT01646437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110082406|NCT01646437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110082407|NCT01646437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110082408|NCT01646437|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110082409|NCT01646437|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110082410|NCT01646437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110082411|NCT01646437|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110082412|NCT01646437|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110082413|NCT01646437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110082414|NCT01646437|Antipyretics|antipyretics|mesh-ancestor
110082415|NCT01646437|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110082416|NCT01646619|Magnesium Sulfate|magnesium sulfate|mesh-list
110082417|NCT01646619|Analgesics|analgesics|mesh-ancestor
110082418|NCT01646619|Sensory System Agents|sensory system agents|mesh-ancestor
110082419|NCT01646619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110082420|NCT01646619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110082421|NCT01646619|Anesthetics|anesthetics|mesh-ancestor
110184332|NCT00393263|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110082422|NCT01646619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110082423|NCT01646619|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110082424|NCT01646619|Anticonvulsants|anticonvulsants|mesh-ancestor
110082425|NCT01646619|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110082426|NCT01646619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110082427|NCT01646619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110082428|NCT01646619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110082429|NCT01646619|Tocolytic Agents|tocolytic agents|mesh-ancestor
110082430|NCT01646619|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110082431|NCT01647880|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
110082432|NCT01647880|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
110082433|NCT01647880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110082434|NCT01647880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110082435|NCT01647880|Immunologic Factors|immunologic factors|mesh-ancestor
110082436|NCT01647880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110082438|NCT01648218|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110082439|NCT01648218|Insulin Glargine|insulin glargine|mesh-list
110082440|NCT01648218|Insulin Aspart|insulin aspart|mesh-list
110082441|NCT01648218|Insulin, Isophane|insulin, isophane|mesh-list
110082442|NCT01648218|Isophane Insulin, Human|isophane insulin, human|mesh-list
110082443|NCT01648218|Protamines|protamines|mesh-list
110082444|NCT01648218|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110082445|NCT01648218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110082446|NCT01648218|Heparin Antagonists|heparin antagonists|mesh-ancestor
110082447|NCT01648218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110082448|NCT01648218|Coagulants|coagulants|mesh-ancestor
110082449|NCT01648465|Everolimus|everolimus|mesh-list
110082450|NCT01648465|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110082451|NCT01648465|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110082452|NCT01648465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110082453|NCT01648465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110082454|NCT01648465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110082455|NCT01648465|Immunologic Factors|immunologic factors|mesh-ancestor
110082456|NCT01648465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110082457|NCT01648465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110082459|NCT01648777|Anesthetics, Local|anesthetics, local|mesh-ancestor
110082461|NCT01648777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110082462|NCT01648777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110082463|NCT01648777|Sensory System Agents|sensory system agents|mesh-ancestor
110082464|NCT01648777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110082465|NCT01648998|Fludrocortisone|fludrocortisone|mesh-list
110082466|NCT01648998|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110082467|NCT01649024|Tremelimumab|tremelimumab|mesh-list
110082468|NCT01649024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110082469|NCT01649960|Sirolimus|sirolimus|mesh-list
110082470|NCT01649960|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110082471|NCT01649960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110082472|NCT01649960|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110082473|NCT01649960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110082474|NCT01649960|Antifungal Agents|antifungal agents|mesh-ancestor
110082475|NCT01649960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110082476|NCT01649960|Immunologic Factors|immunologic factors|mesh-ancestor
110082477|NCT01649960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110082478|NCT01650012|Eplerenone|eplerenone|mesh-list
110082479|NCT01650012|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110082480|NCT01650012|Hormone Antagonists|hormone antagonists|mesh-ancestor
110082481|NCT01650012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110082482|NCT01650012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110082483|NCT01650012|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110082484|NCT01650012|Diuretics|diuretics|mesh-ancestor
110082485|NCT01650012|Natriuretic Agents|natriuretic agents|mesh-ancestor
110082486|NCT01650012|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110082487|NCT01650090|Cisplatin|cisplatin|mesh-list
110082488|NCT01650090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110082489|NCT01650129|Insulin|insulin|mesh-list
110082490|NCT01650129|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110082491|NCT01650129|Insulin Aspart|insulin aspart|mesh-list
110082492|NCT01650129|Biphasic Insulins|biphasic insulins|mesh-list
110082493|NCT01650129|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110082494|NCT01650129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110082495|NCT01650181|Selenium|selenium|mesh-list
110082496|NCT01650181|Thioctic Acid|thioctic acid|mesh-list
110082497|NCT01650181|Metformin|metformin|mesh-list
110082498|NCT01650181|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110082499|NCT01650181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110082500|NCT01650181|Antioxidants|antioxidants|mesh-ancestor
110082501|NCT01650181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110082502|NCT01650181|Protective Agents|protective agents|mesh-ancestor
110082503|NCT01650181|Trace Elements|trace elements|mesh-ancestor
110082504|NCT01650181|Micronutrients|micronutrients|mesh-ancestor
110082505|NCT01650181|Vitamin B Complex|vitamin b complex|mesh-ancestor
110082506|NCT01650181|Vitamins|vitamins|mesh-ancestor
110082507|NCT01650272|Minoxidil|minoxidil|mesh-list
110082508|NCT01650272|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110082509|NCT01650272|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110082510|NCT01650272|Vasodilator Agents|vasodilator agents|mesh-ancestor
110082511|NCT01650376|Paclitaxel|paclitaxel|mesh-list
110082512|NCT01650376|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110082513|NCT01650376|Carboplatin|carboplatin|mesh-list
110082514|NCT01650376|Olaparib|olaparib|mesh-list
110082515|NCT01650376|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110082516|NCT01650376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110082517|NCT01650376|Tubulin Modulators|tubulin modulators|mesh-ancestor
110082518|NCT01650376|Antimitotic Agents|antimitotic agents|mesh-ancestor
110082519|NCT01650376|Mitosis Modulators|mitosis modulators|mesh-ancestor
110082520|NCT01650376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110082521|NCT01650376|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110082522|NCT01650376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110082523|NCT01650389|BCG Vaccine|bcg vaccine|mesh-list
110082524|NCT01650389|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110082525|NCT01650389|Immunologic Factors|immunologic factors|mesh-ancestor
110082526|NCT01650389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110082527|NCT01650415|Epoetin Alfa|epoetin alfa|mesh-list
110082528|NCT01650415|Hematinics|hematinics|mesh-ancestor
110082529|NCT01650428|Bevacizumab|bevacizumab|mesh-list
110082530|NCT01650428|Fluorouracil|fluorouracil|mesh-list
110082531|NCT01650428|Oxaliplatin|oxaliplatin|mesh-list
110082532|NCT01650428|Irinotecan|irinotecan|mesh-list
110082533|NCT01650428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110082534|NCT01650428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110082535|NCT01650428|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110082536|NCT01650428|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110082537|NCT01650428|Growth Substances|growth substances|mesh-ancestor
110082538|NCT01650428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110082539|NCT01650428|Growth Inhibitors|growth inhibitors|mesh-ancestor
110082540|NCT01650428|Antimetabolites|antimetabolites|mesh-ancestor
110082541|NCT01650428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110082542|NCT01650428|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110082543|NCT01650428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110082544|NCT01650428|Immunologic Factors|immunologic factors|mesh-ancestor
110082545|NCT01650428|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110082546|NCT01650428|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110082547|NCT01650428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110082548|NCT01650441|Beclomethasone|beclomethasone|mesh-list
110082549|NCT01650441|Formoterol Fumarate|formoterol fumarate|mesh-list
110082550|NCT01650441|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110082551|NCT01650441|Autonomic Agents|autonomic agents|mesh-ancestor
110082552|NCT01650441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110082553|NCT01650441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110082554|NCT01650441|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110082555|NCT01650441|Respiratory System Agents|respiratory system agents|mesh-ancestor
110082556|NCT01650441|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110082557|NCT01650441|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110082558|NCT01650441|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110082559|NCT01650441|Adrenergic Agents|adrenergic agents|mesh-ancestor
110082560|NCT01650441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110082561|NCT01650441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110082562|NCT01650441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110082563|NCT01650441|Glucocorticoids|glucocorticoids|mesh-ancestor
110082565|NCT01650441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110082566|NCT01650493|Listerine|listerine|mesh-list
110082567|NCT01650493|Sodium Fluoride|sodium fluoride|mesh-list
110082568|NCT01650493|Cariostatic Agents|cariostatic agents|mesh-ancestor
110082569|NCT01650493|Protective Agents|protective agents|mesh-ancestor
110082570|NCT01650493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110082571|NCT01650493|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110082572|NCT01650493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110082574|NCT01650506|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110082575|NCT01650506|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110082576|NCT01650506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110082577|NCT01650506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110082578|NCT01650506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110082579|NCT01650506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110082580|NCT01650506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110082581|NCT01650597|JNJ-42165279|jnj-42165279|mesh-list
110082582|NCT01650597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110082583|NCT01650597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110082584|NCT01650649|Lofexidine|lofexidine|mesh-list
110082585|NCT01650649|Clonidine|clonidine|mesh-list
110082586|NCT01650649|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110082587|NCT01650649|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110082588|NCT01650649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110082589|NCT01650649|Sensory System Agents|sensory system agents|mesh-ancestor
110082590|NCT01650649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110082591|NCT01650649|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110082592|NCT01650649|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110082593|NCT01650649|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110082594|NCT01650649|Adrenergic Agents|adrenergic agents|mesh-ancestor
110082595|NCT01650649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110082596|NCT01650649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110082597|NCT01650649|Analgesics|analgesics|mesh-ancestor
110082598|NCT01650649|Sympatholytics|sympatholytics|mesh-ancestor
110082599|NCT01650649|Autonomic Agents|autonomic agents|mesh-ancestor
110082600|NCT01650662|Cyclosporine|cyclosporine|mesh-list
110082601|NCT01650662|Cyclosporins|cyclosporins|mesh-list
110082602|NCT01650662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110082603|NCT01650662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110082604|NCT01650662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110082606|NCT01650662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110082607|NCT01650662|Antifungal Agents|antifungal agents|mesh-ancestor
110082608|NCT01650662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110082609|NCT01650662|Dermatologic Agents|dermatologic agents|mesh-ancestor
110082610|NCT01650662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110082611|NCT01650662|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110082612|NCT01650727|Rituximab|rituximab|mesh-list
110082613|NCT01650727|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110082614|NCT01650727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110082615|NCT01650727|Immunologic Factors|immunologic factors|mesh-ancestor
110082616|NCT01650727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110082617|NCT01650727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110082618|NCT01650740|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110082619|NCT01650740|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110082620|NCT01650740|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110082621|NCT01650740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110082622|NCT01650740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110082623|NCT01650740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110082624|NCT01650740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110082625|NCT01650740|Analgesics|analgesics|mesh-ancestor
110082626|NCT01650740|Sensory System Agents|sensory system agents|mesh-ancestor
110082627|NCT01650740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110082628|NCT01650740|Antidepressive Agents|antidepressive agents|mesh-ancestor
110082629|NCT01650740|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110082630|NCT01650740|Dopamine Agents|dopamine agents|mesh-ancestor
110082632|NCT01650870|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110082633|NCT01650883|Vitamin D|vitamin d|mesh-list
110082634|NCT01650883|Ergocalciferols|ergocalciferols|mesh-list
110082635|NCT01650883|Cholecalciferol|cholecalciferol|mesh-list
110082636|NCT01650883|Vitamins|vitamins|mesh-list
110082637|NCT01650883|Micronutrients|micronutrients|mesh-ancestor
110082638|NCT01650883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110082639|NCT01650883|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110082640|NCT01650883|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110082641|NCT01650961|Palonosetron|palonosetron|mesh-list
110082642|NCT01650961|Antiemetics|antiemetics|mesh-ancestor
110082643|NCT01650961|Autonomic Agents|autonomic agents|mesh-ancestor
110082644|NCT01650961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110082645|NCT01650961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110082646|NCT01650961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110082647|NCT01650961|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110082648|NCT01650961|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110082649|NCT01650961|Serotonin Agents|serotonin agents|mesh-ancestor
110082650|NCT01650961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110082651|NCT01650961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110082652|NCT01651130|Carbetocin|carbetocin|mesh-list
110082653|NCT01651130|Oxytocics|oxytocics|mesh-ancestor
110082654|NCT01651130|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110082655|NCT01651130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110082656|NCT01651156|Tolvaptan|tolvaptan|mesh-list
110082657|NCT01651156|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
110082658|NCT01651156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110082659|NCT01651156|Natriuretic Agents|natriuretic agents|mesh-ancestor
110082660|NCT01651156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110082661|NCT01651169|Methylphenidate|methylphenidate|mesh-list
110082662|NCT01651169|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110082663|NCT01651169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110082664|NCT01651169|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110082665|NCT01651169|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110082666|NCT01651169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110082667|NCT01651169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110082668|NCT01651169|Dopamine Agents|dopamine agents|mesh-ancestor
110082669|NCT01651169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110082670|NCT01651182|Tranexamic Acid|tranexamic acid|mesh-list
110082671|NCT01651182|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110082672|NCT01651182|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110082673|NCT01651182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110082674|NCT01651182|Hemostatics|hemostatics|mesh-ancestor
110082675|NCT01651182|Coagulants|coagulants|mesh-ancestor
110082676|NCT01651312|Mirabegron|mirabegron|mesh-list
110082677|NCT01651312|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
110082678|NCT01651312|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110082679|NCT01651312|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110082680|NCT01651312|Adrenergic Agents|adrenergic agents|mesh-ancestor
110082681|NCT01651312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110082682|NCT01651312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110082683|NCT01651312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110082684|NCT01651312|Urological Agents|urological agents|mesh-ancestor
110082687|NCT01651325|Antitussive Agents|antitussive agents|mesh-ancestor
110082688|NCT01651325|Respiratory System Agents|respiratory system agents|mesh-ancestor
110082689|NCT01651325|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110082690|NCT01651325|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110082691|NCT01651325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110082692|NCT01651325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110082693|NCT01651325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110082694|NCT01651325|Antifungal Agents|antifungal agents|mesh-ancestor
110082695|NCT01651325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110082696|NCT01651364|Cabergoline|cabergoline|mesh-list
110082697|NCT01651364|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110082698|NCT01651364|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110082699|NCT01651364|Dopamine Agonists|dopamine agonists|mesh-ancestor
110082700|NCT01651364|Dopamine Agents|dopamine agents|mesh-ancestor
110082701|NCT01651364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110082702|NCT01651364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110082703|NCT01651364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110082704|NCT01651377|Pramipexole|pramipexole|mesh-list
110082705|NCT01651377|Antioxidants|antioxidants|mesh-ancestor
110082706|NCT01651377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110082707|NCT01651377|Protective Agents|protective agents|mesh-ancestor
110082708|NCT01651377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110082709|NCT01651377|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110082710|NCT01651377|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110082711|NCT01651377|Dopamine Agonists|dopamine agonists|mesh-ancestor
110082712|NCT01651377|Dopamine Agents|dopamine agents|mesh-ancestor
110082713|NCT01651377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110082714|NCT01651390|Sirolimus|sirolimus|mesh-list
110082715|NCT01651390|Paclitaxel|paclitaxel|mesh-list
110082716|NCT01651390|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110082717|NCT01651390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110082718|NCT01651390|Tubulin Modulators|tubulin modulators|mesh-ancestor
110082719|NCT01651390|Antimitotic Agents|antimitotic agents|mesh-ancestor
110082720|NCT01651390|Mitosis Modulators|mitosis modulators|mesh-ancestor
110082721|NCT01651390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110082722|NCT01651390|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110082723|NCT01651390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110082724|NCT01651390|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110082725|NCT01651390|Antifungal Agents|antifungal agents|mesh-ancestor
110082726|NCT01651390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110082727|NCT01651390|Immunologic Factors|immunologic factors|mesh-ancestor
110082728|NCT01651390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110082729|NCT01651416|Lumefantrine|lumefantrine|mesh-list
110082730|NCT01651416|Artemether|artemether|mesh-list
110082731|NCT01651416|Pyrimethamine|pyrimethamine|mesh-list
110082732|NCT01651416|Piperaquine|piperaquine|mesh-list
110082733|NCT01651416|Sulfadoxine|sulfadoxine|mesh-list
110082734|NCT01651416|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
110082735|NCT01651416|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
110082736|NCT01651416|Amodiaquine|amodiaquine|mesh-list
110082737|NCT01651416|Artenimol|artenimol|mesh-list
110082738|NCT01651416|Antimalarials|antimalarials|mesh-ancestor
110082739|NCT01651416|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110082740|NCT01651416|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110082741|NCT01651416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110082742|NCT01651416|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110082743|NCT01651416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110082744|NCT01651416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110082745|NCT01651416|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110082746|NCT01651481|Montelukast|montelukast|mesh-list
110082747|NCT01651481|Levocetirizine|levocetirizine|mesh-list
110082748|NCT01651481|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110082749|NCT01651481|Respiratory System Agents|respiratory system agents|mesh-ancestor
110082750|NCT01651481|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110082751|NCT01651481|Hormone Antagonists|hormone antagonists|mesh-ancestor
110082752|NCT01651481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110082753|NCT01651481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110082754|NCT01651481|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110082755|NCT01651481|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110082756|NCT01651481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110082757|NCT01651481|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110082758|NCT01651481|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110082759|NCT01651481|Histamine Antagonists|histamine antagonists|mesh-ancestor
110082761|NCT01651481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110082763|NCT01651520|Antidotes|antidotes|mesh-ancestor
110082764|NCT01651520|Protective Agents|protective agents|mesh-ancestor
110082765|NCT01651520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110082766|NCT01651520|GABA Modulators|gaba modulators|mesh-ancestor
110082768|NCT01651520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110082769|NCT01651520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110082770|NCT01651572|Rocuronium|rocuronium|mesh-list
110082771|NCT01651572|Cisatracurium|cisatracurium|mesh-list
110082772|NCT01651572|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110082773|NCT01651572|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110082774|NCT01651572|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110082775|NCT01651572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110082776|NCT01651572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110082777|NCT01651585|Valacyclovir|valacyclovir|mesh-list
110082778|NCT01651585|Antiviral Agents|antiviral agents|mesh-ancestor
110082779|NCT01651585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110082780|NCT01651637|Pulmonary Surfactants|pulmonary surfactants|mesh-list
110082781|NCT01651637|Respiratory System Agents|respiratory system agents|mesh-ancestor
110082782|NCT01651715|Antibodies|antibodies|mesh-list
110082783|NCT01651715|Immunologic Factors|immunologic factors|mesh-ancestor
110082784|NCT01651715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110082785|NCT01651728|Simvastatin|simvastatin|mesh-list
110082786|NCT01651728|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110082787|NCT01651728|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110082788|NCT01651728|Antimetabolites|antimetabolites|mesh-ancestor
110082789|NCT01651728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110082790|NCT01651728|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110082791|NCT01651728|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110082792|NCT01651728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110082793|NCT01651923|Heparin|heparin|mesh-list
110082794|NCT01651923|Calcium heparin|calcium heparin|mesh-list
110082795|NCT01651923|Anticoagulants|anticoagulants|mesh-ancestor
110082796|NCT01651923|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110082797|NCT01651923|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110082798|NCT01651923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110082799|NCT01651962|Fentanyl|fentanyl|mesh-list
110082800|NCT01651962|Terbutaline|terbutaline|mesh-list
110082802|NCT01651962|Narcotics|narcotics|mesh-ancestor
110082803|NCT01651962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110082804|NCT01651962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110082805|NCT01651962|Analgesics|analgesics|mesh-ancestor
110082806|NCT01651962|Sensory System Agents|sensory system agents|mesh-ancestor
110082807|NCT01651962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110082808|NCT01651962|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110082809|NCT01651962|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110082810|NCT01651962|Anesthetics, General|anesthetics, general|mesh-ancestor
110082811|NCT01651962|Anesthetics|anesthetics|mesh-ancestor
110082812|NCT01651962|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110082813|NCT01651962|Autonomic Agents|autonomic agents|mesh-ancestor
110082814|NCT01651962|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110082815|NCT01651962|Respiratory System Agents|respiratory system agents|mesh-ancestor
110082816|NCT01651962|Sympathomimetics|sympathomimetics|mesh-ancestor
110082817|NCT01651962|Tocolytic Agents|tocolytic agents|mesh-ancestor
110082818|NCT01651962|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110082819|NCT01651962|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110082820|NCT01651962|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110082821|NCT01651962|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110082822|NCT01651962|Adrenergic Agents|adrenergic agents|mesh-ancestor
110082823|NCT01651962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110082824|NCT01651962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110082825|NCT01651988|Propofol|propofol|mesh-list
110082826|NCT01651988|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110082827|NCT01651988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110082828|NCT01651988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110082829|NCT01651988|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110082830|NCT01651988|Anesthetics, General|anesthetics, general|mesh-ancestor
110082832|NCT01652014|Mycophenolic Acid|mycophenolic acid|mesh-list
110082833|NCT01652014|Cyclophosphamide|cyclophosphamide|mesh-list
110082834|NCT01652014|Fludarabine|fludarabine|mesh-list
110082835|NCT01652014|Fludarabine phosphate|fludarabine phosphate|mesh-list
110082836|NCT01652014|Tacrolimus|tacrolimus|mesh-list
110082837|NCT01652014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110082838|NCT01652014|Immunologic Factors|immunologic factors|mesh-ancestor
110082839|NCT01652014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110082840|NCT01652014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110082841|NCT01652014|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110082842|NCT01652014|Alkylating Agents|alkylating agents|mesh-ancestor
110082843|NCT01652014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110082844|NCT01652014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110082845|NCT01652014|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110082846|NCT01652014|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110082847|NCT01652014|Antimetabolites|antimetabolites|mesh-ancestor
110082848|NCT01652014|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110082849|NCT01652014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110082850|NCT01652014|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110082851|NCT01652014|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110082852|NCT01652014|Antitubercular Agents|antitubercular agents|mesh-ancestor
110082853|NCT01652014|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110082854|NCT01652014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110082855|NCT01652118|Clarithromycin|clarithromycin|mesh-list
110082856|NCT01652118|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110082857|NCT01652118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110082858|NCT01652118|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110082860|NCT01652118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110082861|NCT01652118|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110082862|NCT01652118|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110082863|NCT01652157|Pancrelipase|pancrelipase|mesh-list
110082865|NCT01652157|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110082866|NCT01652183|Acetaminophen|acetaminophen|mesh-list
110082867|NCT01652183|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110082868|NCT01652183|Analgesics|analgesics|mesh-ancestor
110082869|NCT01652183|Sensory System Agents|sensory system agents|mesh-ancestor
110082870|NCT01652183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110082871|NCT01652183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110082872|NCT01652183|Antipyretics|antipyretics|mesh-ancestor
110082873|NCT01652196|Leucovorin|leucovorin|mesh-list
110082874|NCT01652196|Fluorouracil|fluorouracil|mesh-list
110082875|NCT01652196|Oxaliplatin|oxaliplatin|mesh-list
110082876|NCT01652196|Aflibercept|aflibercept|mesh-list
110082877|NCT01652196|Endothelial Growth Factors|endothelial growth factors|mesh-list
110082878|NCT01652196|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110082879|NCT01652196|Antimetabolites|antimetabolites|mesh-ancestor
110082880|NCT01652196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110082881|NCT01652196|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110082882|NCT01652196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110082883|NCT01652196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110082884|NCT01652196|Immunologic Factors|immunologic factors|mesh-ancestor
110082885|NCT01652196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110082886|NCT01652196|Antidotes|antidotes|mesh-ancestor
110082887|NCT01652196|Protective Agents|protective agents|mesh-ancestor
110082888|NCT01652196|Vitamin B Complex|vitamin b complex|mesh-ancestor
110082889|NCT01652196|Vitamins|vitamins|mesh-ancestor
110082890|NCT01652196|Micronutrients|micronutrients|mesh-ancestor
110082891|NCT01652196|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110082892|NCT01652196|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110082893|NCT01652196|Growth Substances|growth substances|mesh-ancestor
110082894|NCT01652196|Growth Inhibitors|growth inhibitors|mesh-ancestor
110082895|NCT01652196|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110082896|NCT01652313|Rasagiline|rasagiline|mesh-list
110082897|NCT01652313|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
110082898|NCT01652313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110082899|NCT01652313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110082900|NCT01652313|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110082901|NCT01652313|Protective Agents|protective agents|mesh-ancestor
110082902|NCT01652313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110082903|NCT01652326|Diazepam|diazepam|mesh-list
110082904|NCT01652326|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110082905|NCT01652326|Anticonvulsants|anticonvulsants|mesh-ancestor
110082906|NCT01652326|Antiemetics|antiemetics|mesh-ancestor
110082907|NCT01652326|Autonomic Agents|autonomic agents|mesh-ancestor
110082908|NCT01652326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110082909|NCT01652326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110082910|NCT01652326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110082911|NCT01652326|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110082912|NCT01652326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110082913|NCT01652326|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110082914|NCT01652326|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110082915|NCT01652326|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110082916|NCT01652326|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110082917|NCT01652326|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110082918|NCT01652326|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110082919|NCT01652326|Anesthetics, General|anesthetics, general|mesh-ancestor
110082922|NCT01652326|GABA Agents|gaba agents|mesh-ancestor
110082923|NCT01652326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110082924|NCT01652326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110082926|NCT01652339|Valsartan|valsartan|mesh-list
110082927|NCT01652339|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
110082928|NCT01652339|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110082929|NCT01652339|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110082930|NCT01652339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110082931|NCT01652339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110082932|NCT01652339|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110082933|NCT01652339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110082934|NCT01652339|Vasodilator Agents|vasodilator agents|mesh-ancestor
110082935|NCT01652339|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110082936|NCT01652339|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110082937|NCT01652378|Lidocaine|lidocaine|mesh-list
110082938|NCT01652378|Ondansetron|ondansetron|mesh-list
110082939|NCT01652378|Anesthetics, Local|anesthetics, local|mesh-ancestor
110082940|NCT01652378|Anesthetics|anesthetics|mesh-ancestor
110082941|NCT01652378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110082942|NCT01652378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110082943|NCT01652378|Sensory System Agents|sensory system agents|mesh-ancestor
110082944|NCT01652378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110082945|NCT01652378|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110082946|NCT01652378|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110082947|NCT01652378|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110082948|NCT01652378|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110082949|NCT01652378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110082950|NCT01652378|Antiemetics|antiemetics|mesh-ancestor
110082951|NCT01652378|Autonomic Agents|autonomic agents|mesh-ancestor
110082952|NCT01652378|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110082953|NCT01652378|Antipruritics|antipruritics|mesh-ancestor
110082954|NCT01652378|Dermatologic Agents|dermatologic agents|mesh-ancestor
110082955|NCT01652378|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110082956|NCT01652378|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110082957|NCT01652378|Serotonin Agents|serotonin agents|mesh-ancestor
110082958|NCT01652378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110082959|NCT01652417|Methylprednisolone|methylprednisolone|mesh-list
110082960|NCT01652417|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110082961|NCT01652417|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110082962|NCT01652417|Prednisolone|prednisolone|mesh-list
110082963|NCT01652417|Prednisolone acetate|prednisolone acetate|mesh-list
110082964|NCT01652417|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110082965|NCT01652417|Prednisolone phosphate|prednisolone phosphate|mesh-list
110082966|NCT01652417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110082967|NCT01652417|Antiemetics|antiemetics|mesh-ancestor
110082968|NCT01652417|Autonomic Agents|autonomic agents|mesh-ancestor
110082969|NCT01652417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110082970|NCT01652417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110082971|NCT01652417|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110082972|NCT01652417|Glucocorticoids|glucocorticoids|mesh-ancestor
110082973|NCT01652417|Hormones|hormones|mesh-ancestor
110082974|NCT01652417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110082975|NCT01652417|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110082976|NCT01652417|Protective Agents|protective agents|mesh-ancestor
110082977|NCT01652417|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110082978|NCT01652417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110082979|NCT01652534|Amantadine|amantadine|mesh-list
110082980|NCT01652534|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110082981|NCT01652534|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110082982|NCT01652534|Antiviral Agents|antiviral agents|mesh-ancestor
110082983|NCT01652534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110082984|NCT01652534|Dopamine Agents|dopamine agents|mesh-ancestor
110082985|NCT01652534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110082986|NCT01652534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110082987|NCT01652534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110082988|NCT01652534|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110082989|NCT01652534|Analgesics|analgesics|mesh-ancestor
110082990|NCT01652534|Sensory System Agents|sensory system agents|mesh-ancestor
110082991|NCT01652534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110082992|NCT01652547|Pasireotide|pasireotide|mesh-list
110082993|NCT01652547|Somatostatin|somatostatin|mesh-list
110082994|NCT01652547|Hormones|hormones|mesh-ancestor
110082995|NCT01652547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110082996|NCT01652547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110082997|NCT01652560|Bevacizumab|bevacizumab|mesh-list
110082998|NCT01652560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110082999|NCT01652560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110083000|NCT01652560|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110083001|NCT01652560|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110083002|NCT01652560|Growth Substances|growth substances|mesh-ancestor
110083003|NCT01652560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110083004|NCT01652560|Growth Inhibitors|growth inhibitors|mesh-ancestor
110083005|NCT01652586|Midazolam|midazolam|mesh-list
110083006|NCT01652586|Dexmedetomidine|dexmedetomidine|mesh-list
110083007|NCT01652586|Remifentanil|remifentanil|mesh-list
110083008|NCT01652586|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110083009|NCT01652586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110083010|NCT01652586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110083011|NCT01652586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110083012|NCT01652586|Analgesics|analgesics|mesh-ancestor
110083013|NCT01652586|Sensory System Agents|sensory system agents|mesh-ancestor
110083014|NCT01652586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110083015|NCT01652586|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110083016|NCT01652586|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110083017|NCT01652586|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110083018|NCT01652586|Adrenergic Agents|adrenergic agents|mesh-ancestor
110083019|NCT01652586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110083020|NCT01652586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110083021|NCT01652586|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110083022|NCT01652586|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110083023|NCT01652586|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110083024|NCT01652586|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110083025|NCT01652586|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110083026|NCT01652586|Anesthetics, General|anesthetics, general|mesh-ancestor
110083027|NCT01652586|Anesthetics|anesthetics|mesh-ancestor
110083028|NCT01652586|GABA Modulators|gaba modulators|mesh-ancestor
110083029|NCT01652586|GABA Agents|gaba agents|mesh-ancestor
110083030|NCT01652586|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110083031|NCT01652586|Narcotics|narcotics|mesh-ancestor
110083032|NCT01652599|Dexamethasone|dexamethasone|mesh-list
110083033|NCT01652599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110083034|NCT01652599|Antiemetics|antiemetics|mesh-ancestor
110083035|NCT01652599|Autonomic Agents|autonomic agents|mesh-ancestor
110083036|NCT01652599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110083037|NCT01652599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110083038|NCT01652599|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110083039|NCT01652599|Glucocorticoids|glucocorticoids|mesh-ancestor
110083040|NCT01652599|Hormones|hormones|mesh-ancestor
110083041|NCT01652599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110184401|NCT02149823|Oxytocin|oxytocin|mesh-list
110083042|NCT01652599|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110083043|NCT01652599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110083044|NCT01652638|Heparin|heparin|mesh-list
110083045|NCT01652638|Calcium heparin|calcium heparin|mesh-list
110083046|NCT01652638|Anticoagulants|anticoagulants|mesh-ancestor
110083047|NCT01652638|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110083048|NCT01652638|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110083049|NCT01652638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110083050|NCT01652781|Azacitidine|azacitidine|mesh-list
110083051|NCT01652781|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110083052|NCT01652781|Antimetabolites|antimetabolites|mesh-ancestor
110083053|NCT01652781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110083054|NCT01652781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110083055|NCT01652781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110083057|NCT01652794|Gemcitabine|gemcitabine|mesh-list
110083058|NCT01652794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110083059|NCT01652794|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110083060|NCT01652794|Antimetabolites|antimetabolites|mesh-ancestor
110083061|NCT01652794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110083062|NCT01652820|Carboplatin|carboplatin|mesh-list
110083063|NCT01652820|Gemcitabine|gemcitabine|mesh-list
110083064|NCT01652820|Docetaxel|docetaxel|mesh-list
110083065|NCT01652820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110083066|NCT01652820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110083067|NCT01652820|Antimetabolites|antimetabolites|mesh-ancestor
110083068|NCT01652820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110083069|NCT01652820|Tubulin Modulators|tubulin modulators|mesh-ancestor
110083070|NCT01652820|Antimitotic Agents|antimitotic agents|mesh-ancestor
110083071|NCT01652820|Mitosis Modulators|mitosis modulators|mesh-ancestor
110083073|NCT01652859|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
110083074|NCT01652859|Amebicides|amebicides|mesh-ancestor
110083075|NCT01652859|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110083076|NCT01652859|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110083077|NCT01652859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110083078|NCT01652859|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110083079|NCT01652859|Antifungal Agents|antifungal agents|mesh-ancestor
110083080|NCT01652898|Esmolol|esmolol|mesh-list
110083081|NCT01652898|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110083082|NCT01652898|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110083083|NCT01652898|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110083084|NCT01652898|Adrenergic Agents|adrenergic agents|mesh-ancestor
110083085|NCT01652898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110083086|NCT01652898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110083087|NCT01652898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110083088|NCT01652924|Anesthetics|anesthetics|mesh-list
110083089|NCT01652924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110083090|NCT01652924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110083091|NCT01653015|Vaccines|vaccines|mesh-list
110083092|NCT01653015|Immunologic Factors|immunologic factors|mesh-ancestor
110083093|NCT01653015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110083094|NCT01653041|Everolimus|everolimus|mesh-list
110083095|NCT01653041|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110083096|NCT01653041|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110083097|NCT01653041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110083098|NCT01653041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110083099|NCT01653041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110083100|NCT01653041|Immunologic Factors|immunologic factors|mesh-ancestor
110083101|NCT01653041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110083102|NCT01653041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110083103|NCT01653067|Cytarabine|cytarabine|mesh-list
110083104|NCT01653067|Sirolimus|sirolimus|mesh-list
110083106|NCT01653067|Dexamethasone acetate|dexamethasone acetate|mesh-list
110083107|NCT01653067|Rituximab|rituximab|mesh-list
110083108|NCT01653067|Temsirolimus|temsirolimus|mesh-list
110083109|NCT01653067|MTOR Inhibitors|mtor inhibitors|mesh-list
110083110|NCT01653067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110083111|NCT01653067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110083112|NCT01653067|Immunologic Factors|immunologic factors|mesh-ancestor
110083113|NCT01653067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110083114|NCT01653067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110083115|NCT01653067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110083116|NCT01653067|Antiemetics|antiemetics|mesh-ancestor
110083117|NCT01653067|Autonomic Agents|autonomic agents|mesh-ancestor
110083118|NCT01653067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110083119|NCT01653067|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110083120|NCT01653067|Glucocorticoids|glucocorticoids|mesh-ancestor
110083121|NCT01653067|Hormones|hormones|mesh-ancestor
110083122|NCT01653067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110083123|NCT01653067|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110083124|NCT01653067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110083125|NCT01653067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110083126|NCT01653067|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110083127|NCT01653067|Antimetabolites|antimetabolites|mesh-ancestor
110083128|NCT01653067|Antiviral Agents|antiviral agents|mesh-ancestor
110083129|NCT01653067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110083130|NCT01653067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110083131|NCT01653067|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110083132|NCT01653067|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110083133|NCT01653067|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110083134|NCT01653067|Antifungal Agents|antifungal agents|mesh-ancestor
110083135|NCT01653119|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110083136|NCT01653119|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110083137|NCT01653119|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110083138|NCT01653119|Antimetabolites|antimetabolites|mesh-ancestor
110083139|NCT01653119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110083140|NCT01653119|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110083141|NCT01653119|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110083142|NCT01653119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110083143|NCT01653171|Acetylcysteine|acetylcysteine|mesh-list
110083144|NCT01653171|Simethicone|simethicone|mesh-list
110083145|NCT01653171|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110083146|NCT01653171|Antiviral Agents|antiviral agents|mesh-ancestor
110083147|NCT01653171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110083149|NCT01653171|Respiratory System Agents|respiratory system agents|mesh-ancestor
110083150|NCT01653171|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110083151|NCT01653171|Antioxidants|antioxidants|mesh-ancestor
110083152|NCT01653171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110083153|NCT01653171|Protective Agents|protective agents|mesh-ancestor
110083154|NCT01653171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110083155|NCT01653171|Antidotes|antidotes|mesh-ancestor
110083156|NCT01653171|Antifoaming Agents|antifoaming agents|mesh-ancestor
110083157|NCT01653171|Emollients|emollients|mesh-ancestor
110083158|NCT01653171|Dermatologic Agents|dermatologic agents|mesh-ancestor
110083159|NCT01653236|Ribavirin|ribavirin|mesh-list
110083160|NCT01653236|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110083161|NCT01653236|Antimetabolites|antimetabolites|mesh-ancestor
110083162|NCT01653236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110083163|NCT01653236|Antiviral Agents|antiviral agents|mesh-ancestor
110083164|NCT01653236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110083165|NCT01653314|Imatinib Mesylate|imatinib mesylate|mesh-list
110083166|NCT01653314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110083167|NCT01653314|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110083168|NCT01653314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110083169|NCT01653314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110083170|NCT01653457|Memantine|memantine|mesh-list
110083171|NCT01653457|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110083172|NCT01653457|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110083174|NCT01653457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110083175|NCT01653457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110083176|NCT01653457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110083177|NCT01653457|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110083178|NCT01653457|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110083179|NCT01653470|Leucovorin|leucovorin|mesh-list
110083180|NCT01653470|Paclitaxel|paclitaxel|mesh-list
110083181|NCT01653470|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110083182|NCT01653470|Carboplatin|carboplatin|mesh-list
110083183|NCT01653470|Fluorouracil|fluorouracil|mesh-list
110083184|NCT01653470|Irinotecan|irinotecan|mesh-list
110083185|NCT01653470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110083186|NCT01653470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110083187|NCT01653470|Tubulin Modulators|tubulin modulators|mesh-ancestor
110083188|NCT01653470|Antimitotic Agents|antimitotic agents|mesh-ancestor
110083189|NCT01653470|Mitosis Modulators|mitosis modulators|mesh-ancestor
110083190|NCT01653470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110083191|NCT01653470|Antimetabolites|antimetabolites|mesh-ancestor
110083192|NCT01653470|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110083193|NCT01653470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110083194|NCT01653470|Immunologic Factors|immunologic factors|mesh-ancestor
110083195|NCT01653470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110083196|NCT01653470|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110083197|NCT01653470|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110083198|NCT01653470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110083200|NCT01653470|Protective Agents|protective agents|mesh-ancestor
110083201|NCT01653470|Vitamin B Complex|vitamin b complex|mesh-ancestor
110083202|NCT01653470|Vitamins|vitamins|mesh-ancestor
110083203|NCT01653470|Micronutrients|micronutrients|mesh-ancestor
110083204|NCT01653522|Doxycycline|doxycycline|mesh-list
110083205|NCT01653522|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110083206|NCT01653522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110083207|NCT01653522|Antimalarials|antimalarials|mesh-ancestor
110083208|NCT01653522|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110083209|NCT01653522|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110083210|NCT01653561|Apatinib|apatinib|mesh-list
110083211|NCT01653561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110083212|NCT01653561|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110083213|NCT01653561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110083214|NCT01653561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110083215|NCT01653639|Factor VIII|factor viii|mesh-list
110083216|NCT01653639|Coagulants|coagulants|mesh-ancestor
110083217|NCT01653665|Sargramostim|sargramostim|mesh-list
110083218|NCT01653665|Immunologic Factors|immunologic factors|mesh-ancestor
110083219|NCT01653665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110083220|NCT01653717|Cyclophosphamide|cyclophosphamide|mesh-list
110083221|NCT01653717|Fludarabine|fludarabine|mesh-list
110083222|NCT01653717|Fludarabine phosphate|fludarabine phosphate|mesh-list
110083223|NCT01653717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110083224|NCT01653717|Immunologic Factors|immunologic factors|mesh-ancestor
110083225|NCT01653717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110083226|NCT01653717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110083227|NCT01653717|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110083228|NCT01653717|Alkylating Agents|alkylating agents|mesh-ancestor
110083229|NCT01653717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110083230|NCT01653717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110083231|NCT01653717|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110083232|NCT01653717|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110083233|NCT01653717|Antimetabolites|antimetabolites|mesh-ancestor
110083234|NCT01653977|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
110083236|NCT01653990|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
110083237|NCT01653990|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110083238|NCT01653990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110083239|NCT01653990|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110083240|NCT01653990|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110083241|NCT01653990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110083242|NCT01653990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110083243|NCT01653990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110083244|NCT01653990|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110083245|NCT01653990|Contraceptive Agents|contraceptive agents|mesh-ancestor
110083246|NCT01653990|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110083247|NCT01653990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110083248|NCT01653990|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110083249|NCT01653990|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110083250|NCT01653990|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110083251|NCT01654003|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
110083252|NCT01654081|Irinotecan|irinotecan|mesh-list
110083253|NCT01654081|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110083254|NCT01654081|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110083255|NCT01654081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110083256|NCT01654081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110083257|NCT01654081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110083258|NCT01654120|Liraglutide|liraglutide|mesh-list
110083259|NCT01654120|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110083260|NCT01654120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110083261|NCT01654120|Incretins|incretins|mesh-ancestor
110083262|NCT01654120|Hormones|hormones|mesh-ancestor
110083263|NCT01654120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110083264|NCT01654146|Paclitaxel|paclitaxel|mesh-list
110083265|NCT01654146|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110083266|NCT01654146|Carboplatin|carboplatin|mesh-list
110083267|NCT01654146|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110083268|NCT01654146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110083269|NCT01654146|Tubulin Modulators|tubulin modulators|mesh-ancestor
110083270|NCT01654146|Antimitotic Agents|antimitotic agents|mesh-ancestor
110083271|NCT01654146|Mitosis Modulators|mitosis modulators|mesh-ancestor
110083272|NCT01654146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110083273|NCT01654185|Letrozole|letrozole|mesh-list
110083274|NCT01654185|Exemestane|exemestane|mesh-list
110083275|NCT01654185|Aromatase Inhibitors|aromatase inhibitors|mesh-list
110083276|NCT01654185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110083277|NCT01654185|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110083278|NCT01654185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110083279|NCT01654185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110083280|NCT01654185|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110083281|NCT01654185|Hormone Antagonists|hormone antagonists|mesh-ancestor
110083282|NCT01654185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110083283|NCT01654185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110083285|NCT01654211|Lactams|lactams|mesh-list
110083286|NCT01654211|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110083287|NCT01654211|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110083288|NCT01654211|Protease Inhibitors|protease inhibitors|mesh-ancestor
110083289|NCT01654211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110083290|NCT01654211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110083291|NCT01654211|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110083292|NCT01654211|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110083293|NCT01654211|Antiviral Agents|antiviral agents|mesh-ancestor
110083294|NCT01654211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110083295|NCT01654211|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110083296|NCT01654211|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110083297|NCT01654211|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110083299|NCT01654367|Aromatase Inhibitors|aromatase inhibitors|mesh-list
110083300|NCT01654367|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110083301|NCT01654367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110083302|NCT01654367|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110083303|NCT01654367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110083304|NCT01654367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110083305|NCT01654367|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110083306|NCT01654367|Hormone Antagonists|hormone antagonists|mesh-ancestor
110083307|NCT01654367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110083308|NCT01654497|HU 211|hu 211|mesh-list
110083309|NCT01654497|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110083310|NCT01654497|Antiemetics|antiemetics|mesh-ancestor
110083311|NCT01654497|Autonomic Agents|autonomic agents|mesh-ancestor
110083312|NCT01654497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110083313|NCT01654497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110083314|NCT01654497|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110083315|NCT01654497|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110083316|NCT01654497|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110083317|NCT01654497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110083318|NCT01654497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110083319|NCT01654497|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110083320|NCT01654497|Protective Agents|protective agents|mesh-ancestor
110083321|NCT01654562|Simvastatin|simvastatin|mesh-list
110083322|NCT01654562|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110083323|NCT01654562|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110083324|NCT01654562|Antimetabolites|antimetabolites|mesh-ancestor
110083325|NCT01654562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110083326|NCT01654562|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110083327|NCT01654562|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110083328|NCT01654562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110083329|NCT01654575|Methotrexate|methotrexate|mesh-list
110083330|NCT01654575|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110083331|NCT01654575|Abortifacient Agents|abortifacient agents|mesh-ancestor
110083332|NCT01654575|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110083333|NCT01654575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110083334|NCT01654575|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110083335|NCT01654575|Antimetabolites|antimetabolites|mesh-ancestor
110083336|NCT01654575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110083337|NCT01654575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110083338|NCT01654575|Dermatologic Agents|dermatologic agents|mesh-ancestor
110083339|NCT01654575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110083340|NCT01654575|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110083341|NCT01654575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110083342|NCT01654575|Immunologic Factors|immunologic factors|mesh-ancestor
110083343|NCT01654575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110083344|NCT01654575|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110083346|NCT01654640|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110083347|NCT01654640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110083348|NCT01654692|Ipilimumab|ipilimumab|mesh-list
110083349|NCT01654692|Fotemustine|fotemustine|mesh-list
110083350|NCT01654692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110083351|NCT01654692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110083352|NCT01654692|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110083353|NCT01654692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110083354|NCT01654705|Pantoprazole|pantoprazole|mesh-list
110083355|NCT01654705|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110083356|NCT01654705|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110083357|NCT01654705|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110083358|NCT01654705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110083359|NCT01654705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110083360|NCT01654718|Pantoprazole|pantoprazole|mesh-list
110083361|NCT01654718|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110083362|NCT01654718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110083363|NCT01654718|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110083364|NCT01654718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110083365|NCT01654718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110083366|NCT01654809|Vaccines|vaccines|mesh-list
110083367|NCT01654809|Immunologic Factors|immunologic factors|mesh-ancestor
110083368|NCT01654809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110083369|NCT01654913|Chrysarobin|chrysarobin|mesh-list
110083370|NCT01654913|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110083371|NCT01654913|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110083372|NCT01654913|Analgesics|analgesics|mesh-ancestor
110083373|NCT01654913|Sensory System Agents|sensory system agents|mesh-ancestor
110083374|NCT01654913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110083375|NCT01654913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110083376|NCT01654913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110083377|NCT01654913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110083378|NCT01654939|Rifaximin|rifaximin|mesh-list
110083379|NCT01654939|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110083380|NCT01654939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110083381|NCT01654939|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110083382|NCT01654965|Topotecan|topotecan|mesh-list
110083383|NCT01654965|Lenograstim|lenograstim|mesh-list
110083384|NCT01654965|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110083385|NCT01654965|Immunologic Factors|immunologic factors|mesh-ancestor
110083386|NCT01654965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110083387|NCT01654965|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110083388|NCT01654965|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110083389|NCT01654965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110083390|NCT01654965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110083391|NCT01654965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110083392|NCT01655004|Exemestane|exemestane|mesh-list
110083393|NCT01655004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110083394|NCT01655004|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110083395|NCT01655004|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110083396|NCT01655004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110083397|NCT01655004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110083398|NCT01655004|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110083399|NCT01655004|Hormone Antagonists|hormone antagonists|mesh-ancestor
110083400|NCT01655004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110083401|NCT01655004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110083402|NCT01655056|Darexaban|darexaban|mesh-list
110083403|NCT01655056|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110083404|NCT01655056|Antithrombins|antithrombins|mesh-ancestor
110083405|NCT01655056|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110083406|NCT01655056|Protease Inhibitors|protease inhibitors|mesh-ancestor
110083407|NCT01655056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110083408|NCT01655056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110083409|NCT01655056|Anticoagulants|anticoagulants|mesh-ancestor
110083410|NCT01655082|Nicotine|nicotine|mesh-list
110083411|NCT01655082|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110083412|NCT01655082|Autonomic Agents|autonomic agents|mesh-ancestor
110083413|NCT01655082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110083414|NCT01655082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110083415|NCT01655082|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110083416|NCT01655082|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110083417|NCT01655082|Cholinergic Agents|cholinergic agents|mesh-ancestor
110083418|NCT01655082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110083419|NCT01655082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110083420|NCT01655095|Prucalopride|prucalopride|mesh-list
110083421|NCT01655095|Bisacodyl|bisacodyl|mesh-list
110083422|NCT01655095|Laxatives|laxatives|mesh-ancestor
110083423|NCT01655095|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110083424|NCT01655095|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
110083425|NCT01655095|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110083426|NCT01655095|Serotonin Agents|serotonin agents|mesh-ancestor
110083427|NCT01655095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110083428|NCT01655095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110083429|NCT01655095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110083430|NCT01655095|Cathartics|cathartics|mesh-ancestor
110083432|NCT01655108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110083433|NCT01655108|Vasodilator Agents|vasodilator agents|mesh-ancestor
110083434|NCT01655147|Rifampin|rifampin|mesh-list
110083435|NCT01655147|Abiraterone Acetate|abiraterone acetate|mesh-list
110083436|NCT01655147|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110083437|NCT01655147|Antitubercular Agents|antitubercular agents|mesh-ancestor
110083438|NCT01655147|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110083439|NCT01655147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110083440|NCT01655147|Leprostatic Agents|leprostatic agents|mesh-ancestor
110083441|NCT01655147|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110083442|NCT01655147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110083443|NCT01655147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110083444|NCT01655147|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110083445|NCT01655147|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110083446|NCT01655147|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110083447|NCT01655147|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110083448|NCT01655147|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110083449|NCT01655147|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110083450|NCT01655147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110083451|NCT01655147|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110083452|NCT01655147|Hormone Antagonists|hormone antagonists|mesh-ancestor
110083453|NCT01655147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110083454|NCT01655147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110083455|NCT01655147|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110083456|NCT01655199|Albuterol|albuterol|mesh-list
110083457|NCT01655199|Ipratropium|ipratropium|mesh-list
110083458|NCT01655199|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110083459|NCT01655199|Autonomic Agents|autonomic agents|mesh-ancestor
110083460|NCT01655199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110083461|NCT01655199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110083462|NCT01655199|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110083463|NCT01655199|Respiratory System Agents|respiratory system agents|mesh-ancestor
110083464|NCT01655199|Tocolytic Agents|tocolytic agents|mesh-ancestor
110083465|NCT01655199|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110083466|NCT01655199|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110083467|NCT01655199|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110083468|NCT01655199|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110083469|NCT01655199|Adrenergic Agents|adrenergic agents|mesh-ancestor
110083470|NCT01655199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110083471|NCT01655199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110083472|NCT01655199|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110083473|NCT01655199|Cholinergic Agents|cholinergic agents|mesh-ancestor
110083474|NCT01655212|Valganciclovir|valganciclovir|mesh-list
110083476|NCT01655212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110083477|NCT01655303|Propranolol|propranolol|mesh-list
110083478|NCT01655303|Metoprolol|metoprolol|mesh-list
110083479|NCT01655303|Verapamil|verapamil|mesh-list
110083480|NCT01655303|Diltiazem|diltiazem|mesh-list
110083481|NCT01655303|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110083482|NCT01655303|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110083483|NCT01655303|Adrenergic Agents|adrenergic agents|mesh-ancestor
110083484|NCT01655303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110083485|NCT01655303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110083486|NCT01655303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110083487|NCT01655303|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110083488|NCT01655303|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110083489|NCT01655303|Vasodilator Agents|vasodilator agents|mesh-ancestor
110083490|NCT01655303|Sympatholytics|sympatholytics|mesh-ancestor
110083491|NCT01655303|Autonomic Agents|autonomic agents|mesh-ancestor
110083492|NCT01655303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110083493|NCT01655303|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110083494|NCT01655303|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110083495|NCT01655303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110083496|NCT01655303|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110083497|NCT01655316|Verapamil|verapamil|mesh-list
110083498|NCT01655316|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110083499|NCT01655316|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110083500|NCT01655316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110083501|NCT01655316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110083502|NCT01655316|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110083503|NCT01655316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110083504|NCT01655316|Vasodilator Agents|vasodilator agents|mesh-ancestor
110083505|NCT01655368|Psychotropic Drugs|psychotropic drugs|mesh-list
110083507|NCT01655524|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110083508|NCT01655524|Autonomic Agents|autonomic agents|mesh-ancestor
110083509|NCT01655524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110083510|NCT01655524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110083511|NCT01655524|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110083512|NCT01655524|Respiratory System Agents|respiratory system agents|mesh-ancestor
110083513|NCT01655524|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110083514|NCT01655524|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110083515|NCT01655524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110083516|NCT01655524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110083517|NCT01655524|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110083518|NCT01655524|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110083519|NCT01655524|Purinergic Agents|purinergic agents|mesh-ancestor
110083520|NCT01655524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110083521|NCT01655524|Protective Agents|protective agents|mesh-ancestor
110083523|NCT01655628|Gemcitabine|gemcitabine|mesh-list
110083524|NCT01655628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110083525|NCT01655628|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110083526|NCT01655628|Antimetabolites|antimetabolites|mesh-ancestor
110083527|NCT01655628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110083528|NCT01655641|Tranexamic Acid|tranexamic acid|mesh-list
110083529|NCT01655641|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110083530|NCT01655641|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110083531|NCT01655641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110083532|NCT01655641|Hemostatics|hemostatics|mesh-ancestor
110083533|NCT01655641|Coagulants|coagulants|mesh-ancestor
110083534|NCT01655706|Aripiprazole|aripiprazole|mesh-list
110083535|NCT01655706|Escitalopram|escitalopram|mesh-list
110083536|NCT01655706|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110083537|NCT01655706|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110083538|NCT01655706|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110083539|NCT01655706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110083540|NCT01655706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110083541|NCT01655706|Serotonin Agents|serotonin agents|mesh-ancestor
110083542|NCT01655706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110083543|NCT01655706|Antidepressive Agents|antidepressive agents|mesh-ancestor
110083544|NCT01655706|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110083545|NCT01655706|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110083546|NCT01655706|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110083547|NCT01655706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110083548|NCT01655706|Dopamine Agonists|dopamine agonists|mesh-ancestor
110083549|NCT01655706|Dopamine Agents|dopamine agents|mesh-ancestor
110083550|NCT01655706|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110083551|NCT01655706|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110083552|NCT01655706|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110083553|NCT01655706|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110083554|NCT01655706|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110083556|NCT01655745|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110083557|NCT01655745|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110083558|NCT01655745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110083559|NCT01655758|Timolol|timolol|mesh-list
110083560|NCT01655758|Bimatoprost|bimatoprost|mesh-list
110083561|NCT01655758|Travoprost|travoprost|mesh-list
110083562|NCT01655758|Dorzolamide|dorzolamide|mesh-list
110083563|NCT01655758|Latanoprost|latanoprost|mesh-list
110083564|NCT01655758|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110083565|NCT01655758|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110083566|NCT01655758|Adrenergic Agents|adrenergic agents|mesh-ancestor
110083567|NCT01655758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110083568|NCT01655758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110083569|NCT01655758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110083570|NCT01655758|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110083571|NCT01655758|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110083572|NCT01655758|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110083573|NCT01655758|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110083574|NCT01655758|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110083575|NCT01655758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110083576|NCT01655810|Vitamin D|vitamin d|mesh-list
110083577|NCT01655810|Ergocalciferols|ergocalciferols|mesh-list
110083578|NCT01655810|Cholecalciferol|cholecalciferol|mesh-list
110083579|NCT01655810|Vitamins|vitamins|mesh-list
110083580|NCT01655810|Calcium Carbonate|calcium carbonate|mesh-list
110083581|NCT01655810|Micronutrients|micronutrients|mesh-ancestor
110083582|NCT01655810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110083583|NCT01655810|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110083584|NCT01655810|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110083585|NCT01655810|Antacids|antacids|mesh-ancestor
110083586|NCT01655810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110083587|NCT01655810|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110083588|NCT01655862|Botulinum Toxins|botulinum toxins|mesh-list
110083589|NCT01655862|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110083590|NCT01655862|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110083591|NCT01655862|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110083592|NCT01655862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110083593|NCT01655862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110083594|NCT01655862|Cholinergic Agents|cholinergic agents|mesh-ancestor
110083595|NCT01655862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110083596|NCT01655862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110083597|NCT01655862|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110083598|NCT01655862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110083599|NCT01655875|Plerixafor|plerixafor|mesh-list
110083600|NCT01655875|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110083601|NCT01655875|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110083602|NCT01655875|Antiviral Agents|antiviral agents|mesh-ancestor
110083603|NCT01655875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110083604|NCT01655888|Tremelimumab|tremelimumab|mesh-list
110083605|NCT01655888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110083606|NCT01655914|Flumazenil|flumazenil|mesh-list
110083607|NCT01655914|Antidotes|antidotes|mesh-ancestor
110083608|NCT01655914|Protective Agents|protective agents|mesh-ancestor
110083609|NCT01655914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110083610|NCT01655914|GABA Modulators|gaba modulators|mesh-ancestor
110083611|NCT01655914|GABA Agents|gaba agents|mesh-ancestor
110083612|NCT01655914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110184624|NCT01806311|Candesartan cilexetil|candesartan cilexetil|mesh-list
110083613|NCT01655914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110083614|NCT01655927|Tranexamic Acid|tranexamic acid|mesh-list
110083615|NCT01655927|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110083616|NCT01655927|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110083617|NCT01655927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110083619|NCT01655927|Coagulants|coagulants|mesh-ancestor
110083620|NCT01655966|Vitamin D|vitamin d|mesh-list
110083621|NCT01655966|Interferons|interferons|mesh-list
110083622|NCT01655966|Ribavirin|ribavirin|mesh-list
110083623|NCT01655966|Vitamins|vitamins|mesh-ancestor
110083624|NCT01655966|Micronutrients|micronutrients|mesh-ancestor
110083625|NCT01655966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110083626|NCT01655966|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110083627|NCT01655966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110083628|NCT01655966|Antiviral Agents|antiviral agents|mesh-ancestor
110083629|NCT01655966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110083630|NCT01655966|Antimetabolites|antimetabolites|mesh-ancestor
110083631|NCT01655966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110083632|NCT01655992|Capecitabine|capecitabine|mesh-list
110083633|NCT01655992|Tegafur|tegafur|mesh-list
110083634|NCT01655992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110083635|NCT01655992|Antimetabolites|antimetabolites|mesh-ancestor
110083636|NCT01655992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110083637|NCT01655992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110083638|NCT01656005|Beclomethasone|beclomethasone|mesh-list
110083639|NCT01656005|Carvedilol|carvedilol|mesh-list
110083640|NCT01656005|Bisoprolol|bisoprolol|mesh-list
110083641|NCT01656005|Formoterol Fumarate|formoterol fumarate|mesh-list
110083642|NCT01656005|Tiotropium Bromide|tiotropium bromide|mesh-list
110083643|NCT01656005|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110083644|NCT01656005|Autonomic Agents|autonomic agents|mesh-ancestor
110083645|NCT01656005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110083646|NCT01656005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110083647|NCT01656005|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110083648|NCT01656005|Respiratory System Agents|respiratory system agents|mesh-ancestor
110083649|NCT01656005|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110083650|NCT01656005|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110083651|NCT01656005|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110083652|NCT01656005|Adrenergic Agents|adrenergic agents|mesh-ancestor
110083653|NCT01656005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110083654|NCT01656005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110083655|NCT01656005|Parasympatholytics|parasympatholytics|mesh-ancestor
110083656|NCT01656005|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110083657|NCT01656005|Cholinergic Agents|cholinergic agents|mesh-ancestor
110083658|NCT01656005|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110083659|NCT01656005|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110083660|NCT01656005|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110083662|NCT01656005|Protective Agents|protective agents|mesh-ancestor
110083663|NCT01656005|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110083664|NCT01656005|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110083665|NCT01656005|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110083666|NCT01656005|Vasodilator Agents|vasodilator agents|mesh-ancestor
110083667|NCT01656005|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110083668|NCT01656005|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110083669|NCT01656005|Sympatholytics|sympatholytics|mesh-ancestor
110083670|NCT01656005|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110083671|NCT01656005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110083672|NCT01656005|Glucocorticoids|glucocorticoids|mesh-ancestor
110083674|NCT01656005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110083675|NCT01656018|Rilpivirine|rilpivirine|mesh-list
110083676|NCT01656018|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110083677|NCT01656018|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110083678|NCT01656018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110083679|NCT01656018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110083680|NCT01656018|Antiviral Agents|antiviral agents|mesh-ancestor
110083681|NCT01656018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110083682|NCT01656018|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110083683|NCT01656018|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110083684|NCT01656057|Acetaminophen|acetaminophen|mesh-list
110083685|NCT01656057|Metformin|metformin|mesh-list
110083686|NCT01656057|Cholecystokinin|cholecystokinin|mesh-list
110083687|NCT01656057|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
110083688|NCT01656057|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110083689|NCT01656057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110083690|NCT01656057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110083691|NCT01656057|Analgesics|analgesics|mesh-ancestor
110083692|NCT01656057|Sensory System Agents|sensory system agents|mesh-ancestor
110083693|NCT01656057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110083694|NCT01656057|Antipyretics|antipyretics|mesh-ancestor
110083695|NCT01656057|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110083696|NCT01656057|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110083697|NCT01656057|Antimetabolites|antimetabolites|mesh-ancestor
110083698|NCT01656057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110083699|NCT01656057|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110083700|NCT01656057|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
110083701|NCT01656057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110083703|NCT01656070|Cholecalciferol|cholecalciferol|mesh-list
110083704|NCT01656070|Vitamins|vitamins|mesh-ancestor
110083705|NCT01656070|Micronutrients|micronutrients|mesh-ancestor
110083706|NCT01656070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110083707|NCT01656070|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110083708|NCT01656070|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110083709|NCT01656109|Atazanavir Sulfate|atazanavir sulfate|mesh-list
110083710|NCT01656109|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110083711|NCT01656109|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110083712|NCT01656109|Protease Inhibitors|protease inhibitors|mesh-ancestor
110083713|NCT01656109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110083714|NCT01656109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110083715|NCT01656109|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110083716|NCT01656109|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110083717|NCT01656109|Antiviral Agents|antiviral agents|mesh-ancestor
110083718|NCT01656109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110083720|NCT01656122|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110083721|NCT01656122|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110083722|NCT01656122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110083723|NCT01656122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110083724|NCT01656122|Antiviral Agents|antiviral agents|mesh-ancestor
110083725|NCT01656122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110083727|NCT01656122|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110083728|NCT01656148|4-Aminopyridine|4-aminopyridine|mesh-list
110083729|NCT01656148|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
110083730|NCT01656148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110083731|NCT01656148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110083732|NCT01656226|Sunscreening Agents|sunscreening agents|mesh-list
110083733|NCT01656226|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110083734|NCT01656226|Protective Agents|protective agents|mesh-ancestor
110184716|NCT00035256|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110083735|NCT01656226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110083736|NCT01656226|Dermatologic Agents|dermatologic agents|mesh-ancestor
110083737|NCT01656330|Rivaroxaban|rivaroxaban|mesh-list
110083738|NCT01656330|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110083739|NCT01656330|Antithrombins|antithrombins|mesh-ancestor
110083740|NCT01656330|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110083741|NCT01656330|Protease Inhibitors|protease inhibitors|mesh-ancestor
110083742|NCT01656330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110083743|NCT01656330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110083745|NCT01656512|Vitamin D|vitamin d|mesh-list
110083746|NCT01656512|Diphosphonates|diphosphonates|mesh-list
110083747|NCT01656512|Calcium|calcium|mesh-list
110083748|NCT01656512|Vitamins|vitamins|mesh-ancestor
110083749|NCT01656512|Micronutrients|micronutrients|mesh-ancestor
110083750|NCT01656512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110083751|NCT01656512|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110083752|NCT01656512|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110083753|NCT01656525|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110083754|NCT01656525|Immunologic Factors|immunologic factors|mesh-ancestor
110083755|NCT01656525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110083756|NCT01656616|Antidotes|antidotes|mesh-list
110083757|NCT01656616|Protective Agents|protective agents|mesh-ancestor
110083758|NCT01656616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110083759|NCT01656642|Atezolizumab|atezolizumab|mesh-list
110083760|NCT01656642|Vemurafenib|vemurafenib|mesh-list
110083761|NCT01656642|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110083762|NCT01656642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110083763|NCT01656642|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110083764|NCT01656642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110083765|NCT01656642|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110083766|NCT01656642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110083767|NCT01656668|Theobromine|theobromine|mesh-list
110083768|NCT01656668|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110083769|NCT01656668|Autonomic Agents|autonomic agents|mesh-ancestor
110083770|NCT01656668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110083771|NCT01656668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110083772|NCT01656668|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110083773|NCT01656668|Respiratory System Agents|respiratory system agents|mesh-ancestor
110083774|NCT01656668|Vasodilator Agents|vasodilator agents|mesh-ancestor
110083775|NCT01656720|Methoxamine|methoxamine|mesh-list
110083776|NCT01656720|Sympathomimetics|sympathomimetics|mesh-ancestor
110083777|NCT01656720|Autonomic Agents|autonomic agents|mesh-ancestor
110083778|NCT01656720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110083779|NCT01656720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110083780|NCT01656720|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110083781|NCT01656720|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110083782|NCT01656720|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110083783|NCT01656720|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110083784|NCT01656720|Adrenergic Agents|adrenergic agents|mesh-ancestor
110083785|NCT01656720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110083786|NCT01656720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110083787|NCT01656798|Sildenafil Citrate|sildenafil citrate|mesh-list
110083788|NCT01656798|Citric Acid|citric acid|mesh-list
110083789|NCT01656798|Sodium Citrate|sodium citrate|mesh-list
110083790|NCT01656798|Anticoagulants|anticoagulants|mesh-ancestor
110083791|NCT01656798|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110083792|NCT01656798|Chelating Agents|chelating agents|mesh-ancestor
110083793|NCT01656798|Sequestering Agents|sequestering agents|mesh-ancestor
110083794|NCT01656798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110083795|NCT01656798|Vasodilator Agents|vasodilator agents|mesh-ancestor
110083796|NCT01656798|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110083797|NCT01656798|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110083798|NCT01656798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110083799|NCT01656798|Urological Agents|urological agents|mesh-ancestor
110083801|NCT01656811|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110083802|NCT01656811|Autonomic Agents|autonomic agents|mesh-ancestor
110083803|NCT01656811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110083804|NCT01656811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110083805|NCT01656811|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110083806|NCT01656811|Respiratory System Agents|respiratory system agents|mesh-ancestor
110083807|NCT01656811|Tocolytic Agents|tocolytic agents|mesh-ancestor
110083808|NCT01656811|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110083809|NCT01656811|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110083810|NCT01656811|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110083811|NCT01656811|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110083812|NCT01656811|Adrenergic Agents|adrenergic agents|mesh-ancestor
110083813|NCT01656811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110083814|NCT01656811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110083815|NCT01656980|Carmustine|carmustine|mesh-list
110083816|NCT01656980|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110083817|NCT01656980|Alkylating Agents|alkylating agents|mesh-ancestor
110083818|NCT01656980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110083819|NCT01656980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110083820|NCT01657058|Dimenhydrinate|dimenhydrinate|mesh-list
110083821|NCT01657058|Antiemetics|antiemetics|mesh-ancestor
110083822|NCT01657058|Autonomic Agents|autonomic agents|mesh-ancestor
110083823|NCT01657058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110083824|NCT01657058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110083825|NCT01657058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110083826|NCT01657058|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110083827|NCT01657058|Histamine Antagonists|histamine antagonists|mesh-ancestor
110083828|NCT01657058|Histamine Agents|histamine agents|mesh-ancestor
110083829|NCT01657058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110083830|NCT01657058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110083832|NCT01657071|Clopidogrel|clopidogrel|mesh-list
110083833|NCT01657071|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110083834|NCT01657071|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110083835|NCT01657071|Analgesics|analgesics|mesh-ancestor
110083836|NCT01657071|Sensory System Agents|sensory system agents|mesh-ancestor
110083837|NCT01657071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110083838|NCT01657071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110083839|NCT01657071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110083840|NCT01657071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110083841|NCT01657071|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110083842|NCT01657071|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110083843|NCT01657071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110083844|NCT01657071|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110083845|NCT01657071|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110083846|NCT01657071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110083847|NCT01657071|Antipyretics|antipyretics|mesh-ancestor
110083848|NCT01657071|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110083850|NCT01657071|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110083851|NCT01657071|Purinergic Agents|purinergic agents|mesh-ancestor
110083852|NCT01657071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110083853|NCT01657110|Tea Tree Oil|tea tree oil|mesh-list
110083854|NCT01657110|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110083855|NCT01657110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110083856|NCT01657136|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
110083857|NCT01657136|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110083858|NCT01657136|Adrenergic Agents|adrenergic agents|mesh-ancestor
110083859|NCT01657136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110083860|NCT01657136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110184770|NCT02971254|Anesthetics|anesthetics|mesh-ancestor
110083861|NCT01657136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110083862|NCT01657201|Voriconazole|voriconazole|mesh-list
110083863|NCT01657201|Antifungal Agents|antifungal agents|mesh-ancestor
110083864|NCT01657201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110083865|NCT01657201|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110083866|NCT01657201|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110083867|NCT01657201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110083868|NCT01657201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110083869|NCT01657201|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110083870|NCT01657201|Hormone Antagonists|hormone antagonists|mesh-ancestor
110083871|NCT01657201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110083872|NCT01657201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110083873|NCT01657201|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110083874|NCT01657240|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
110083875|NCT01657240|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110083876|NCT01657240|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110083877|NCT01657240|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110083878|NCT01657240|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110083879|NCT01657240|Analgesics|analgesics|mesh-ancestor
110083880|NCT01657240|Sensory System Agents|sensory system agents|mesh-ancestor
110083881|NCT01657240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110083882|NCT01657240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110083883|NCT01657240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110083884|NCT01657240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110083885|NCT01657240|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110083886|NCT01657240|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110083887|NCT01657240|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110083888|NCT01657240|Histamine Antagonists|histamine antagonists|mesh-ancestor
110083889|NCT01657240|Histamine Agents|histamine agents|mesh-ancestor
110083890|NCT01657240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110083891|NCT01657240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110083892|NCT01657318|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
110083893|NCT01657318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110083894|NCT01657331|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110083895|NCT01657331|Brentuximab Vedotin|brentuximab vedotin|mesh-list
110083896|NCT01657331|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110083897|NCT01657331|Alkylating Agents|alkylating agents|mesh-ancestor
110083898|NCT01657331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110083899|NCT01657331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110083900|NCT01657331|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110083902|NCT01657331|Immunoconjugates|immunoconjugates|mesh-ancestor
110083903|NCT01657331|Immunologic Factors|immunologic factors|mesh-ancestor
110083904|NCT01657331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110083905|NCT01657409|Botulinum Toxins|botulinum toxins|mesh-list
110083906|NCT01657409|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110083907|NCT01657409|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110083908|NCT01657409|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
110083909|NCT01657409|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110083910|NCT01657409|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110083911|NCT01657409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110083912|NCT01657409|Cholinergic Agents|cholinergic agents|mesh-ancestor
110083913|NCT01657409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110083914|NCT01657409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110083915|NCT01657409|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110083916|NCT01657409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110083917|NCT01657448|Methenamine|methenamine|mesh-list
110083919|NCT01657448|Methenamine mandelate|methenamine mandelate|mesh-list
110083920|NCT01657448|Methylene Blue|methylene blue|mesh-list
110083921|NCT01657448|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110083922|NCT01657448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110083923|NCT01657448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110083924|NCT01657448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110083925|NCT01657448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110083926|NCT01657487|Fluticasone|fluticasone|mesh-list
110083928|NCT01657487|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110083929|NCT01657487|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
110083930|NCT01657487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110083931|NCT01657487|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110083932|NCT01657487|Autonomic Agents|autonomic agents|mesh-ancestor
110083933|NCT01657487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110083934|NCT01657487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110083935|NCT01657487|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110083936|NCT01657487|Respiratory System Agents|respiratory system agents|mesh-ancestor
110083937|NCT01657487|Dermatologic Agents|dermatologic agents|mesh-ancestor
110083938|NCT01657487|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110083939|NCT01657487|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110083940|NCT01657487|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110083941|NCT01657487|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110083942|NCT01657487|Adrenergic Agents|adrenergic agents|mesh-ancestor
110083943|NCT01657487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110083944|NCT01657487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110083945|NCT01657487|Glucocorticoids|glucocorticoids|mesh-ancestor
110083946|NCT01657487|Hormones|hormones|mesh-ancestor
110083947|NCT01657487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110083948|NCT01657487|Sympathomimetics|sympathomimetics|mesh-ancestor
110083949|NCT01657578|Omeprazole|omeprazole|mesh-list
110083950|NCT01657578|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110083951|NCT01657578|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110083952|NCT01657578|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110083953|NCT01657578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110083954|NCT01657578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110083955|NCT01657656|Vitamin D|vitamin d|mesh-list
110083956|NCT01657656|Vitamins|vitamins|mesh-ancestor
110083957|NCT01657656|Micronutrients|micronutrients|mesh-ancestor
110083958|NCT01657656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110083959|NCT01657656|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110083960|NCT01657669|Aflibercept|aflibercept|mesh-list
110083961|NCT01657669|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110083962|NCT01657669|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110083963|NCT01657669|Growth Substances|growth substances|mesh-ancestor
110083964|NCT01657669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110083965|NCT01657669|Growth Inhibitors|growth inhibitors|mesh-ancestor
110083966|NCT01657669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110083968|NCT01657682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110083969|NCT01657747|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
110083970|NCT01657747|Parasympatholytics|parasympatholytics|mesh-ancestor
110083971|NCT01657747|Autonomic Agents|autonomic agents|mesh-ancestor
110083972|NCT01657747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110083973|NCT01657747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110083974|NCT01657747|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110083975|NCT01657747|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110083976|NCT01657747|Cholinergic Agents|cholinergic agents|mesh-ancestor
110083977|NCT01657747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110083978|NCT01657747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110083979|NCT01657812|Dexmedetomidine|dexmedetomidine|mesh-list
110083980|NCT01657812|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110083981|NCT01657812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110083982|NCT01657812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110083983|NCT01657812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110083984|NCT01657812|Analgesics|analgesics|mesh-ancestor
110083985|NCT01657812|Sensory System Agents|sensory system agents|mesh-ancestor
110184865|NCT01805570|Ticagrelor|ticagrelor|mesh-list
110083986|NCT01657812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110083987|NCT01657812|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110083988|NCT01657812|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110083989|NCT01657812|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110083990|NCT01657812|Adrenergic Agents|adrenergic agents|mesh-ancestor
110083991|NCT01657812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110083992|NCT01657812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110083995|NCT01657825|Anticoagulants|anticoagulants|mesh-ancestor
110083996|NCT01657825|Antifungal Agents|antifungal agents|mesh-ancestor
110083997|NCT01657825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110083998|NCT01657838|Ketoconazole|ketoconazole|mesh-list
110083999|NCT01657838|Isavuconazole|isavuconazole|mesh-list
110084000|NCT01657838|Antifungal Agents|antifungal agents|mesh-ancestor
110084001|NCT01657838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110084002|NCT01657838|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110084003|NCT01657838|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110084004|NCT01657838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110084005|NCT01657838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110084006|NCT01657838|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110084007|NCT01657838|Hormone Antagonists|hormone antagonists|mesh-ancestor
110084008|NCT01657838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110084009|NCT01657838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110084010|NCT01657838|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110084011|NCT01657851|Tamsulosin|tamsulosin|mesh-list
110084012|NCT01657851|Dutasteride|dutasteride|mesh-list
110084013|NCT01657851|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110084014|NCT01657851|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110084015|NCT01657851|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110084016|NCT01657851|Adrenergic Agents|adrenergic agents|mesh-ancestor
110084017|NCT01657851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110084018|NCT01657851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110084019|NCT01657851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110084020|NCT01657851|Urological Agents|urological agents|mesh-ancestor
110084021|NCT01657851|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
110084022|NCT01657851|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110084023|NCT01657851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110084024|NCT01657851|Hormone Antagonists|hormone antagonists|mesh-ancestor
110084025|NCT01657851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110084026|NCT01657864|Lamotrigine|lamotrigine|mesh-list
110084027|NCT01657864|Anticonvulsants|anticonvulsants|mesh-ancestor
110084028|NCT01657864|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110084029|NCT01657864|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110084030|NCT01657864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110084031|NCT01657864|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110084032|NCT01657864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110084033|NCT01657864|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110084034|NCT01657864|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110084035|NCT01657864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110084036|NCT01657864|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110084037|NCT01657864|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110084038|NCT01657890|Isavuconazole|isavuconazole|mesh-list
110084039|NCT01657890|Antifungal Agents|antifungal agents|mesh-ancestor
110084040|NCT01657890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110084043|NCT01657929|Immunologic Factors|immunologic factors|mesh-ancestor
110084044|NCT01657929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110084045|NCT01657929|Antacids|antacids|mesh-ancestor
110084046|NCT01657929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110084047|NCT01657929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110084048|NCT01657955|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110084049|NCT01657955|Chlorambucil|chlorambucil|mesh-list
110084050|NCT01657955|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110084051|NCT01657955|Alkylating Agents|alkylating agents|mesh-ancestor
110084052|NCT01657955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110084053|NCT01657955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110084054|NCT01657513|Adalimumab|adalimumab|mesh-list
110084055|NCT01657513|Infliximab|infliximab|mesh-list
110084056|NCT01657513|Etanercept|etanercept|mesh-list
110084057|NCT01657513|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110084058|NCT01657513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110084059|NCT01657513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110084060|NCT01657513|Dermatologic Agents|dermatologic agents|mesh-ancestor
110084061|NCT01657513|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110084062|NCT01657513|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110084063|NCT01657513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110084065|NCT01657513|Sensory System Agents|sensory system agents|mesh-ancestor
110084066|NCT01657513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110084067|NCT01657513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110084068|NCT01657513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110184925|NCT00036231|Secretin|secretin|mesh-list
110084069|NCT01657513|Immunologic Factors|immunologic factors|mesh-ancestor
110084070|NCT01657981|Darexaban|darexaban|mesh-list
110084071|NCT01657981|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110084072|NCT01657981|Antithrombins|antithrombins|mesh-ancestor
110084073|NCT01657981|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110084074|NCT01657981|Protease Inhibitors|protease inhibitors|mesh-ancestor
110084075|NCT01657981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110084076|NCT01657981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110084077|NCT01657981|Anticoagulants|anticoagulants|mesh-ancestor
110084078|NCT01658007|Sirolimus|sirolimus|mesh-list
110084079|NCT01658007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110084080|NCT01658007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110084081|NCT01658007|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110084082|NCT01658007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110084083|NCT01658007|Antifungal Agents|antifungal agents|mesh-ancestor
110084084|NCT01658007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110084085|NCT01658007|Immunologic Factors|immunologic factors|mesh-ancestor
110084086|NCT01658007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110084087|NCT01658033|Leucovorin|leucovorin|mesh-list
110084088|NCT01658033|Oxaliplatin|oxaliplatin|mesh-list
110084089|NCT01658033|Bevacizumab|bevacizumab|mesh-list
110084090|NCT01658033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110084091|NCT01658033|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110084092|NCT01658033|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110084093|NCT01658033|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110084095|NCT01658033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110084096|NCT01658033|Growth Inhibitors|growth inhibitors|mesh-ancestor
110084097|NCT01658033|Antidotes|antidotes|mesh-ancestor
110084098|NCT01658033|Protective Agents|protective agents|mesh-ancestor
110084099|NCT01658033|Vitamin B Complex|vitamin b complex|mesh-ancestor
110084100|NCT01658033|Vitamins|vitamins|mesh-ancestor
110084101|NCT01658033|Micronutrients|micronutrients|mesh-ancestor
110084102|NCT01658124|Tranexamic Acid|tranexamic acid|mesh-list
110084103|NCT01658124|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110084104|NCT01658124|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110084105|NCT01658124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110084106|NCT01658124|Hemostatics|hemostatics|mesh-ancestor
110084107|NCT01658124|Coagulants|coagulants|mesh-ancestor
110084108|NCT01658176|Exemestane|exemestane|mesh-list
110084109|NCT01658176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110084110|NCT01658176|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110084111|NCT01658176|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110084112|NCT01658176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110084113|NCT01658176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110084114|NCT01658176|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110084115|NCT01658176|Hormone Antagonists|hormone antagonists|mesh-ancestor
110084116|NCT01658176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110084117|NCT01658176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110084118|NCT01658202|Nicotine|nicotine|mesh-list
110084119|NCT01658202|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110084120|NCT01658202|Autonomic Agents|autonomic agents|mesh-ancestor
110084121|NCT01658202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110084122|NCT01658202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110084123|NCT01658202|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110084124|NCT01658202|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110084125|NCT01658202|Cholinergic Agents|cholinergic agents|mesh-ancestor
110084126|NCT01658202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110084127|NCT01658202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110084128|NCT01658215|Nicotine|nicotine|mesh-list
110084129|NCT01658215|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110084130|NCT01658215|Autonomic Agents|autonomic agents|mesh-ancestor
110084131|NCT01658215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110084132|NCT01658215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110084133|NCT01658215|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110084134|NCT01658215|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110084135|NCT01658215|Cholinergic Agents|cholinergic agents|mesh-ancestor
110084136|NCT01658215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110084137|NCT01658215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110084138|NCT01657396|Chlorhexidine|chlorhexidine|mesh-list
110084139|NCT01657396|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110084140|NCT01657396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110084142|NCT01658319|Fludarabine|fludarabine|mesh-list
110084143|NCT01658319|Fludarabine phosphate|fludarabine phosphate|mesh-list
110084144|NCT01658319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110084145|NCT01658319|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110084146|NCT01658319|Antimetabolites|antimetabolites|mesh-ancestor
110084147|NCT01658319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110084148|NCT01658319|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110084149|NCT01658319|Immunologic Factors|immunologic factors|mesh-ancestor
110084150|NCT01658319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110084151|NCT01658358|Doxorubicin|doxorubicin|mesh-list
110084152|NCT01658358|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110084153|NCT01658358|Lapatinib|lapatinib|mesh-list
110084154|NCT01658358|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110084155|NCT01658358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110084156|NCT01658358|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110084157|NCT01658358|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110084158|NCT01658358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110084159|NCT01658358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110084160|NCT01658358|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110084161|NCT01658410|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
110084162|NCT01658410|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110084163|NCT01658410|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
110084164|NCT01658410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110084166|NCT01658449|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110084167|NCT01658449|Immunologic Factors|immunologic factors|mesh-ancestor
110084168|NCT01658449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110084169|NCT01658449|Viscosupplements|viscosupplements|mesh-ancestor
110084170|NCT01658449|Protective Agents|protective agents|mesh-ancestor
110084171|NCT01658462|Docetaxel|docetaxel|mesh-list
110084172|NCT01658462|Nintedanib|nintedanib|mesh-list
110084173|NCT01658462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110084174|NCT01658462|Tubulin Modulators|tubulin modulators|mesh-ancestor
110084175|NCT01658462|Antimitotic Agents|antimitotic agents|mesh-ancestor
110084176|NCT01658462|Mitosis Modulators|mitosis modulators|mesh-ancestor
110084177|NCT01658462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110084178|NCT01658462|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110084179|NCT01658462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110084180|NCT01658527|Bicalutamide|bicalutamide|mesh-list
110084181|NCT01658527|Androgen Antagonists|androgen antagonists|mesh-ancestor
110084182|NCT01658527|Hormone Antagonists|hormone antagonists|mesh-ancestor
110084183|NCT01658527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110084184|NCT01658527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110084185|NCT01658527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110084187|NCT01658553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110084188|NCT01658553|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110084189|NCT01658553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110084190|NCT01658553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110084191|NCT01658774|Albendazole|albendazole|mesh-list
110084192|NCT01658774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110084193|NCT01658774|Anthelmintics|anthelmintics|mesh-ancestor
110084194|NCT01658774|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110084195|NCT01658774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110084196|NCT01658774|Anticestodal Agents|anticestodal agents|mesh-ancestor
110084197|NCT01658774|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110084198|NCT01658774|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110084199|NCT01658774|Tubulin Modulators|tubulin modulators|mesh-ancestor
110084200|NCT01658774|Antimitotic Agents|antimitotic agents|mesh-ancestor
110084201|NCT01658774|Mitosis Modulators|mitosis modulators|mesh-ancestor
110084202|NCT01658774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110084203|NCT01658852|Metronidazole|metronidazole|mesh-list
110084204|NCT01658852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110084205|NCT01658852|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110084206|NCT01658852|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110084207|NCT01658852|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110084208|NCT01658891|Beclomethasone|beclomethasone|mesh-list
110084209|NCT01658891|Formoterol Fumarate|formoterol fumarate|mesh-list
110084210|NCT01658891|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110084211|NCT01658891|Autonomic Agents|autonomic agents|mesh-ancestor
110084212|NCT01658891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110084213|NCT01658891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110084214|NCT01658891|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110084215|NCT01658891|Respiratory System Agents|respiratory system agents|mesh-ancestor
110084216|NCT01658891|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110084217|NCT01658891|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110084218|NCT01658891|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110084219|NCT01658891|Adrenergic Agents|adrenergic agents|mesh-ancestor
110084220|NCT01658891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110084221|NCT01658891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110084222|NCT01658891|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110084223|NCT01658891|Glucocorticoids|glucocorticoids|mesh-ancestor
110084225|NCT01658891|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110084226|NCT01659008|Estradiol|estradiol|mesh-list
110084227|NCT01659008|Estrogens|estrogens|mesh-ancestor
110084228|NCT01659008|Hormones|hormones|mesh-ancestor
110084229|NCT01659008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110084230|NCT01659008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110084231|NCT01659047|Idelalisib|idelalisib|mesh-list
110084232|NCT01659047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110084233|NCT01659047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110225463|NCT05959356|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110084234|NCT01659047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110084235|NCT01659086|Vaccines|vaccines|mesh-list
110084236|NCT01659086|Immunologic Factors|immunologic factors|mesh-ancestor
110084237|NCT01659086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110084238|NCT01659099|Prednisone|prednisone|mesh-list
110084239|NCT01659099|Cyclophosphamide|cyclophosphamide|mesh-list
110084240|NCT01659099|Rituximab|rituximab|mesh-list
110084241|NCT01659099|Doxorubicin|doxorubicin|mesh-list
110084242|NCT01659099|Vincristine|vincristine|mesh-list
110084243|NCT01659099|Obinutuzumab|obinutuzumab|mesh-list
110084244|NCT01659099|Bleomycin|bleomycin|mesh-list
110084245|NCT01659099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110084246|NCT01659099|Immunologic Factors|immunologic factors|mesh-ancestor
110084247|NCT01659099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110084248|NCT01659099|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110084249|NCT01659099|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110084250|NCT01659099|Alkylating Agents|alkylating agents|mesh-ancestor
110084251|NCT01659099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110084252|NCT01659099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110084253|NCT01659099|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110084254|NCT01659099|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110084255|NCT01659099|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110084256|NCT01659099|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110084257|NCT01659099|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110084258|NCT01659099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110084259|NCT01659099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110084260|NCT01659099|Glucocorticoids|glucocorticoids|mesh-ancestor
110084261|NCT01659099|Hormones|hormones|mesh-ancestor
110084262|NCT01659099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110084263|NCT01659099|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110084264|NCT01659099|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110084265|NCT01659099|Tubulin Modulators|tubulin modulators|mesh-ancestor
110084266|NCT01659099|Antimitotic Agents|antimitotic agents|mesh-ancestor
110084267|NCT01659099|Mitosis Modulators|mitosis modulators|mesh-ancestor
110084268|NCT01659190|Calcium Carbonate|calcium carbonate|mesh-list
110084269|NCT01659190|Antacids|antacids|mesh-ancestor
110084270|NCT01659190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110084271|NCT01659190|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110084272|NCT01659242|Sulfasalazine|sulfasalazine|mesh-list
110084273|NCT01659242|Methotrexate|methotrexate|mesh-list
110084274|NCT01659242|Leflunomide|leflunomide|mesh-list
110084275|NCT01659242|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110084276|NCT01659242|Abortifacient Agents|abortifacient agents|mesh-ancestor
110084277|NCT01659242|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110084278|NCT01659242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110084279|NCT01659242|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110084280|NCT01659242|Antimetabolites|antimetabolites|mesh-ancestor
110084281|NCT01659242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110084282|NCT01659242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110084283|NCT01659242|Dermatologic Agents|dermatologic agents|mesh-ancestor
110084284|NCT01659242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110084285|NCT01659242|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110084286|NCT01659242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110084287|NCT01659242|Immunologic Factors|immunologic factors|mesh-ancestor
110084288|NCT01659242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110084289|NCT01659242|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110084290|NCT01659242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110084291|NCT01659242|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110084292|NCT01659242|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110084293|NCT01659242|Analgesics|analgesics|mesh-ancestor
110084294|NCT01659242|Sensory System Agents|sensory system agents|mesh-ancestor
110084295|NCT01659242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110084296|NCT01659242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110084297|NCT01659242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110084298|NCT01659281|Artesunate|artesunate|mesh-list
110084299|NCT01659281|Mefloquine|mefloquine|mesh-list
110084300|NCT01659281|Antimalarials|antimalarials|mesh-ancestor
110084301|NCT01659281|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110084302|NCT01659281|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110084303|NCT01659281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110084304|NCT01659281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110084305|NCT01659281|Antiviral Agents|antiviral agents|mesh-ancestor
110084306|NCT01659281|Schistosomicides|schistosomicides|mesh-ancestor
110084307|NCT01659281|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110084308|NCT01659281|Anthelmintics|anthelmintics|mesh-ancestor
110084309|NCT01659346|Carvedilol|carvedilol|mesh-list
110084310|NCT01659346|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110084311|NCT01659346|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110084312|NCT01659346|Adrenergic Agents|adrenergic agents|mesh-ancestor
110084313|NCT01659346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110084314|NCT01659346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110084315|NCT01659346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110084316|NCT01659346|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110084318|NCT01659346|Protective Agents|protective agents|mesh-ancestor
110084319|NCT01659346|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110084320|NCT01659346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110084321|NCT01659346|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110084322|NCT01659346|Vasodilator Agents|vasodilator agents|mesh-ancestor
110084323|NCT01659346|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110084324|NCT01659346|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110084325|NCT01659359|Lidocaine|lidocaine|mesh-list
110084326|NCT01659359|Anesthetics, Local|anesthetics, local|mesh-ancestor
110084327|NCT01659359|Anesthetics|anesthetics|mesh-ancestor
110084328|NCT01659359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110084329|NCT01659359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110084330|NCT01659359|Sensory System Agents|sensory system agents|mesh-ancestor
110084331|NCT01659359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110084332|NCT01659359|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110084333|NCT01659359|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110225464|NCT05959356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110084334|NCT01659359|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110084335|NCT01659359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110084336|NCT01659359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110084337|NCT01659372|Naproxen|naproxen|mesh-list
110084338|NCT01659372|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110084339|NCT01659372|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110084340|NCT01659372|Analgesics|analgesics|mesh-ancestor
110084341|NCT01659372|Sensory System Agents|sensory system agents|mesh-ancestor
110084342|NCT01659372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110084343|NCT01659372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110084344|NCT01659372|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110084345|NCT01659372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110084346|NCT01659372|Gout Suppressants|gout suppressants|mesh-ancestor
110084347|NCT01659372|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110084348|NCT01659372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110084349|NCT01659372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110084350|NCT01659437|Clarithromycin|clarithromycin|mesh-list
110084351|NCT01659437|Streptomycin|streptomycin|mesh-list
110084352|NCT01659437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110084353|NCT01659437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110084354|NCT01659437|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110084355|NCT01659437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110084356|NCT01659437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110084357|NCT01659437|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110084358|NCT01659437|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110084359|NCT01659476|Methacholine Chloride|methacholine chloride|mesh-list
110084360|NCT01659476|Miotics|miotics|mesh-ancestor
110084361|NCT01659476|Autonomic Agents|autonomic agents|mesh-ancestor
110084362|NCT01659476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110084363|NCT01659476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110084364|NCT01659476|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110084365|NCT01659476|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
110084366|NCT01659476|Respiratory System Agents|respiratory system agents|mesh-ancestor
110084367|NCT01659476|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
110084368|NCT01659476|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110084369|NCT01659476|Cholinergic Agents|cholinergic agents|mesh-ancestor
110084370|NCT01659476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110084371|NCT01659476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110084372|NCT01659515|Arbekacin|arbekacin|mesh-list
110084373|NCT01659515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110084374|NCT01659515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110084375|NCT01659619|Erythromycin|erythromycin|mesh-list
110084376|NCT01659619|Erythromycin Estolate|erythromycin estolate|mesh-list
110084377|NCT01659619|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
110084378|NCT01659619|Erythromycin stearate|erythromycin stearate|mesh-list
110084379|NCT01659619|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110084380|NCT01659619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110084381|NCT01659619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110084382|NCT01659619|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110084383|NCT01659619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110084384|NCT01659619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110084385|NCT01659684|Immunoglobulins|immunoglobulins|mesh-list
110084386|NCT01659684|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110084387|NCT01659684|Antibodies|antibodies|mesh-list
110084388|NCT01659684|gamma-Globulins|gamma-globulins|mesh-list
110084389|NCT01659684|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110084390|NCT01659684|Immunologic Factors|immunologic factors|mesh-ancestor
110084391|NCT01659684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110084392|NCT01659788|Ubiquinone|ubiquinone|mesh-list
110084393|NCT01659788|Coenzyme Q10|coenzyme q10|mesh-list
110084394|NCT01659788|Micronutrients|micronutrients|mesh-ancestor
110084395|NCT01659788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110084396|NCT01659788|Vitamins|vitamins|mesh-ancestor
110084397|NCT01659827|Bupivacaine|bupivacaine|mesh-list
110084398|NCT01659827|Anesthetics, Local|anesthetics, local|mesh-ancestor
110084399|NCT01659827|Anesthetics|anesthetics|mesh-ancestor
110084400|NCT01659827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110084401|NCT01659827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110084402|NCT01659827|Sensory System Agents|sensory system agents|mesh-ancestor
110084403|NCT01659827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110084404|NCT01659892|Montelukast|montelukast|mesh-list
110084405|NCT01659892|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110084406|NCT01659892|Respiratory System Agents|respiratory system agents|mesh-ancestor
110084407|NCT01659892|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110084408|NCT01659892|Hormone Antagonists|hormone antagonists|mesh-ancestor
110084409|NCT01659892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110084410|NCT01659892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110084411|NCT01659892|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110084412|NCT01659892|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110084413|NCT01659892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110084414|NCT01659905|Montelukast|montelukast|mesh-list
110084415|NCT01659905|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110084416|NCT01659905|Respiratory System Agents|respiratory system agents|mesh-ancestor
110084417|NCT01659905|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110084418|NCT01659905|Hormone Antagonists|hormone antagonists|mesh-ancestor
110254722|NCT00467116|Gemcitabine|gemcitabine|mesh-list
110084419|NCT01659905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110084420|NCT01659905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110084421|NCT01659905|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110084422|NCT01659905|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110084423|NCT01659905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110084424|NCT01659918|Montelukast|montelukast|mesh-list
110084425|NCT01659918|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110084426|NCT01659918|Respiratory System Agents|respiratory system agents|mesh-ancestor
110084427|NCT01659918|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110084428|NCT01659918|Hormone Antagonists|hormone antagonists|mesh-ancestor
110084429|NCT01659918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110084430|NCT01659918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110084431|NCT01659918|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110084432|NCT01659918|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110084433|NCT01659918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110084434|NCT01659931|Montelukast|montelukast|mesh-list
110084435|NCT01659931|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110084436|NCT01659931|Respiratory System Agents|respiratory system agents|mesh-ancestor
110084437|NCT01659931|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110084438|NCT01659931|Hormone Antagonists|hormone antagonists|mesh-ancestor
110084439|NCT01659931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110084440|NCT01659931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110084441|NCT01659931|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110084442|NCT01659931|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110084443|NCT01659931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110084444|NCT01659944|Metoprolol|metoprolol|mesh-list
110084445|NCT01659944|Eliglustat|eliglustat|mesh-list
110084446|NCT01659944|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110084447|NCT01659944|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110084448|NCT01659944|Sympatholytics|sympatholytics|mesh-ancestor
110084449|NCT01659944|Autonomic Agents|autonomic agents|mesh-ancestor
110084450|NCT01659944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110084451|NCT01659944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110084452|NCT01659944|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110084453|NCT01659944|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110084454|NCT01659944|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110084455|NCT01659944|Adrenergic Agents|adrenergic agents|mesh-ancestor
110084456|NCT01659944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110084457|NCT01659944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110084458|NCT01659944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110084459|NCT01659775|Ondansetron|ondansetron|mesh-list
110084460|NCT01659775|Antiemetics|antiemetics|mesh-ancestor
110084461|NCT01659775|Autonomic Agents|autonomic agents|mesh-ancestor
110084462|NCT01659775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110084463|NCT01659775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110084464|NCT01659775|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110084465|NCT01659775|Antipruritics|antipruritics|mesh-ancestor
110084466|NCT01659775|Dermatologic Agents|dermatologic agents|mesh-ancestor
110084467|NCT01659775|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110084468|NCT01659775|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110084469|NCT01659775|Serotonin Agents|serotonin agents|mesh-ancestor
110084470|NCT01659775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110084471|NCT01659775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110084472|NCT01660295|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
110084473|NCT01660295|Dihydroergotamine|dihydroergotamine|mesh-list
110084475|NCT01660295|Anticoagulants|anticoagulants|mesh-ancestor
110084476|NCT01660295|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110084477|NCT01660295|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110084478|NCT01660295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110084479|NCT01660295|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110084480|NCT01660295|Dopamine Agonists|dopamine agonists|mesh-ancestor
110084481|NCT01660295|Dopamine Agents|dopamine agents|mesh-ancestor
110084482|NCT01660295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110084483|NCT01660295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110084484|NCT01660295|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110084485|NCT01660295|Analgesics|analgesics|mesh-ancestor
110084486|NCT01660295|Sensory System Agents|sensory system agents|mesh-ancestor
110084487|NCT01660295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110084488|NCT01660373|Tirofiban|tirofiban|mesh-list
110084489|NCT01660373|Ticagrelor|ticagrelor|mesh-list
110084490|NCT01660373|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110084491|NCT01660373|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110084492|NCT01660373|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110084493|NCT01660373|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110084494|NCT01660373|Purinergic Agents|purinergic agents|mesh-ancestor
110084495|NCT01660373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110084496|NCT01660373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110084497|NCT01660373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110084498|NCT01660373|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110084499|NCT01660373|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110084500|NCT01660386|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110084501|NCT01660386|Glimepiride|glimepiride|mesh-list
110084502|NCT01660386|Saxagliptin|saxagliptin|mesh-list
110084503|NCT01660386|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110084504|NCT01660386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110084505|NCT01660386|Incretins|incretins|mesh-ancestor
110084506|NCT01660386|Hormones|hormones|mesh-ancestor
110084507|NCT01660386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110084508|NCT01660386|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110084509|NCT01660386|Protease Inhibitors|protease inhibitors|mesh-ancestor
110084510|NCT01660386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110084511|NCT01660386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110084512|NCT01660386|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110084513|NCT01660386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110084514|NCT01660386|Immunologic Factors|immunologic factors|mesh-ancestor
110084515|NCT01660399|Docetaxel|docetaxel|mesh-list
110084516|NCT01660399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110084517|NCT01660399|Tubulin Modulators|tubulin modulators|mesh-ancestor
110084518|NCT01660399|Antimitotic Agents|antimitotic agents|mesh-ancestor
110084519|NCT01660399|Mitosis Modulators|mitosis modulators|mesh-ancestor
110084520|NCT01660399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110084521|NCT01660477|Ritonavir|ritonavir|mesh-list
110084522|NCT01660477|Lopinavir|lopinavir|mesh-list
110084523|NCT01660477|Isavuconazole|isavuconazole|mesh-list
110084525|NCT01660477|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110084526|NCT01660477|Protease Inhibitors|protease inhibitors|mesh-ancestor
110084527|NCT01660477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110084528|NCT01660477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110084529|NCT01660477|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110084530|NCT01660477|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110084531|NCT01660477|Antiviral Agents|antiviral agents|mesh-ancestor
110084532|NCT01660477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110084533|NCT01660477|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110084534|NCT01660477|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110084535|NCT01660477|Antifungal Agents|antifungal agents|mesh-ancestor
110084536|NCT01660542|Docetaxel|docetaxel|mesh-list
110084537|NCT01660542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110084538|NCT01660542|Tubulin Modulators|tubulin modulators|mesh-ancestor
110084539|NCT01660542|Antimitotic Agents|antimitotic agents|mesh-ancestor
110084540|NCT01660542|Mitosis Modulators|mitosis modulators|mesh-ancestor
110184985|NCT00036543|Atrasentan|atrasentan|mesh-list
110084541|NCT01660542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110084542|NCT01660594|Calcium|calcium|mesh-list
110084543|NCT01660594|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110084544|NCT01660594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110084545|NCT01660620|Betaxolol|betaxolol|mesh-list
110084546|NCT01660620|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110084547|NCT01660620|Sympatholytics|sympatholytics|mesh-ancestor
110084548|NCT01660620|Autonomic Agents|autonomic agents|mesh-ancestor
110084549|NCT01660620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110084550|NCT01660620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110084551|NCT01660620|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110084552|NCT01660620|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110084553|NCT01660620|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110084554|NCT01660620|Adrenergic Agents|adrenergic agents|mesh-ancestor
110084555|NCT01660620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110084556|NCT01660620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110084557|NCT01660750|Dexamethasone|dexamethasone|mesh-list
110084558|NCT01660750|Cyclophosphamide|cyclophosphamide|mesh-list
110084559|NCT01660750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110084560|NCT01660750|Immunologic Factors|immunologic factors|mesh-ancestor
110084561|NCT01660750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110084562|NCT01660750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110084563|NCT01660750|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110084564|NCT01660750|Alkylating Agents|alkylating agents|mesh-ancestor
110084565|NCT01660750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110084566|NCT01660750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110084567|NCT01660750|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110084568|NCT01660750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110084569|NCT01660750|Antiemetics|antiemetics|mesh-ancestor
110084570|NCT01660750|Autonomic Agents|autonomic agents|mesh-ancestor
110084571|NCT01660750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110084572|NCT01660750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110084573|NCT01660750|Glucocorticoids|glucocorticoids|mesh-ancestor
110084574|NCT01660750|Hormones|hormones|mesh-ancestor
110084575|NCT01660750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110084576|NCT01660750|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110084577|NCT01660854|Proguanil|proguanil|mesh-list
110084578|NCT01660854|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
110084579|NCT01660854|Antimalarials|antimalarials|mesh-ancestor
110084580|NCT01660854|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110084581|NCT01660854|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110084582|NCT01660854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110084583|NCT01660854|Antimetabolites|antimetabolites|mesh-ancestor
110084584|NCT01660854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110084585|NCT01660867|Dexamethasone|dexamethasone|mesh-list
110084586|NCT01660867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110084587|NCT01660867|Antiemetics|antiemetics|mesh-ancestor
110084588|NCT01660867|Autonomic Agents|autonomic agents|mesh-ancestor
110084589|NCT01660867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110084590|NCT01660867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110084591|NCT01660867|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110084592|NCT01660867|Glucocorticoids|glucocorticoids|mesh-ancestor
110084593|NCT01660867|Hormones|hormones|mesh-ancestor
110084594|NCT01660867|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110084595|NCT01660867|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110084596|NCT01660867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110084597|NCT01660919|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110084598|NCT01660919|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110084599|NCT01660919|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110084600|NCT01660919|Antimetabolites|antimetabolites|mesh-ancestor
110084601|NCT01660919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110084602|NCT01660919|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110084603|NCT01660919|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110084604|NCT01660919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110084605|NCT01660945|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
110084606|NCT01660945|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110084607|NCT01660945|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110084608|NCT01660945|Antimetabolites|antimetabolites|mesh-ancestor
110084609|NCT01660945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110084610|NCT01660945|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110084611|NCT01660997|Dexamethasone|dexamethasone|mesh-list
110084612|NCT01660997|Ixazomib|ixazomib|mesh-list
110084613|NCT01660997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110084614|NCT01660997|Antiemetics|antiemetics|mesh-ancestor
110084615|NCT01660997|Autonomic Agents|autonomic agents|mesh-ancestor
110084616|NCT01660997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110084617|NCT01660997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110084618|NCT01660997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110084619|NCT01660997|Glucocorticoids|glucocorticoids|mesh-ancestor
110084620|NCT01660997|Hormones|hormones|mesh-ancestor
110084621|NCT01660997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110084622|NCT01660997|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110084623|NCT01660997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110084624|NCT01660997|Protease Inhibitors|protease inhibitors|mesh-ancestor
110084625|NCT01660997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110084626|NCT01660997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110084627|NCT01661101|Omeprazole|omeprazole|mesh-list
110084628|NCT01661101|Dabigatran|dabigatran|mesh-list
110084629|NCT01661101|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110084630|NCT01661101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110084631|NCT01661101|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110084632|NCT01661101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110084633|NCT01661101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110084634|NCT01661101|Antithrombins|antithrombins|mesh-ancestor
110084635|NCT01661101|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110084636|NCT01661101|Protease Inhibitors|protease inhibitors|mesh-ancestor
110084637|NCT01661101|Anticoagulants|anticoagulants|mesh-ancestor
110084638|NCT01661192|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
110084639|NCT01661192|Protein C Inhibitor|protein c inhibitor|mesh-list
110084640|NCT01661192|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
110084641|NCT01661192|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110084642|NCT01661192|Protease Inhibitors|protease inhibitors|mesh-ancestor
110084643|NCT01661192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110084644|NCT01661192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110084645|NCT01661257|Infliximab|infliximab|mesh-list
110084646|NCT01661257|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110084647|NCT01661257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110084648|NCT01661257|Dermatologic Agents|dermatologic agents|mesh-ancestor
110084649|NCT01661257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110084650|NCT01661257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110084651|NCT01661296|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
110084652|NCT01661296|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110084653|NCT01661296|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110084654|NCT01661296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110084655|NCT01661296|Schistosomicides|schistosomicides|mesh-ancestor
110084656|NCT01661296|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110084657|NCT01661296|Anthelmintics|anthelmintics|mesh-ancestor
110084658|NCT01661309|Vitamin B 12|vitamin b 12|mesh-list
110084659|NCT01661309|Vitamins|vitamins|mesh-ancestor
110084660|NCT01661309|Micronutrients|micronutrients|mesh-ancestor
110084661|NCT01661309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110084662|NCT01661309|Vitamin B Complex|vitamin b complex|mesh-ancestor
110084663|NCT01661322|Aspirin|aspirin|mesh-list
110084664|NCT01661322|Clopidogrel|clopidogrel|mesh-list
110084665|NCT01661322|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110084666|NCT01661322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110084667|NCT01661322|Analgesics|analgesics|mesh-ancestor
110084668|NCT01661322|Sensory System Agents|sensory system agents|mesh-ancestor
110084669|NCT01661322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110084670|NCT01661322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110084671|NCT01661322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110084672|NCT01661322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110084673|NCT01661322|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110084674|NCT01661322|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110084675|NCT01661322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110084676|NCT01661322|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110084677|NCT01661322|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110084678|NCT01661322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110084679|NCT01661322|Antipyretics|antipyretics|mesh-ancestor
110084680|NCT01661322|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110084681|NCT01661322|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110084682|NCT01661322|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110084684|NCT01661322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110084686|NCT01661335|Dexamethasone acetate|dexamethasone acetate|mesh-list
110084687|NCT01661335|Ondansetron|ondansetron|mesh-list
110084688|NCT01661335|Aprepitant|aprepitant|mesh-list
110084689|NCT01661335|Fosaprepitant|fosaprepitant|mesh-list
110084690|NCT01661335|BB 1101|bb 1101|mesh-list
110084691|NCT01661335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110084692|NCT01661335|Antiemetics|antiemetics|mesh-ancestor
110084693|NCT01661335|Autonomic Agents|autonomic agents|mesh-ancestor
110084694|NCT01661335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110084695|NCT01661335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110084696|NCT01661335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110084697|NCT01661335|Glucocorticoids|glucocorticoids|mesh-ancestor
110084698|NCT01661335|Hormones|hormones|mesh-ancestor
110084699|NCT01661335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110084700|NCT01661335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110084701|NCT01661335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110084702|NCT01661335|Protease Inhibitors|protease inhibitors|mesh-ancestor
110084703|NCT01661335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110084704|NCT01661335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110084705|NCT01661335|Antipruritics|antipruritics|mesh-ancestor
110084706|NCT01661335|Dermatologic Agents|dermatologic agents|mesh-ancestor
110084707|NCT01661335|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110084708|NCT01661335|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110084709|NCT01661335|Serotonin Agents|serotonin agents|mesh-ancestor
110084710|NCT01661335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110084711|NCT01661335|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110084712|NCT01661439|Heparin|heparin|mesh-list
110084713|NCT01661439|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
110084714|NCT01661439|Tinzaparin|tinzaparin|mesh-list
110084715|NCT01661439|Dalteparin|dalteparin|mesh-list
110084716|NCT01661439|Anticoagulants|anticoagulants|mesh-ancestor
110084717|NCT01661439|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110084718|NCT01661439|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110084719|NCT01661439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110084721|NCT01661530|Vitamins|vitamins|mesh-ancestor
110084722|NCT01661530|Micronutrients|micronutrients|mesh-ancestor
110084723|NCT01661530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110084724|NCT01661530|Antioxidants|antioxidants|mesh-ancestor
110084725|NCT01661530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110084726|NCT01661530|Protective Agents|protective agents|mesh-ancestor
110084727|NCT01661556|Miconazole|miconazole|mesh-list
110084728|NCT01661556|Hydroquinone|hydroquinone|mesh-list
110084729|NCT01661556|Antifungal Agents|antifungal agents|mesh-ancestor
110084730|NCT01661556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110084731|NCT01661556|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110084732|NCT01661556|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110084733|NCT01661556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110084734|NCT01661556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110084735|NCT01661556|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110084736|NCT01661556|Hormone Antagonists|hormone antagonists|mesh-ancestor
110084737|NCT01661556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110084738|NCT01661556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110084739|NCT01661556|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110084740|NCT01661556|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110084741|NCT01661556|Antioxidants|antioxidants|mesh-ancestor
110084742|NCT01661556|Protective Agents|protective agents|mesh-ancestor
110084743|NCT01661556|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110084744|NCT01661751|Vaccines|vaccines|mesh-list
110084745|NCT01661751|Immunologic Factors|immunologic factors|mesh-ancestor
110084746|NCT01661751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110084748|NCT01661777|Histamine Antagonists|histamine antagonists|mesh-list
110084749|NCT01661777|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
110084750|NCT01661777|Natriuretic Agents|natriuretic agents|mesh-ancestor
110084751|NCT01661777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110084752|NCT01661777|Histamine Agents|histamine agents|mesh-ancestor
110084753|NCT01661777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110084754|NCT01661777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110084755|NCT01661855|Riluzole|riluzole|mesh-list
110084756|NCT01661855|Anticonvulsants|anticonvulsants|mesh-ancestor
110084757|NCT01661855|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110084758|NCT01661855|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110084759|NCT01661855|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110084760|NCT01661855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110084761|NCT01661855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110084762|NCT01661855|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110084763|NCT01661855|Protective Agents|protective agents|mesh-ancestor
110084764|NCT01661868|Olaparib|olaparib|mesh-list
110084765|NCT01661868|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110084766|NCT01661868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110084767|NCT01661868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110084768|NCT01661868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110084769|NCT01662037|Bosentan|bosentan|mesh-list
110084770|NCT01662037|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110084771|NCT01662037|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
110084772|NCT01662037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110084774|NCT01662089|Trace Elements|trace elements|mesh-ancestor
110084775|NCT01662089|Micronutrients|micronutrients|mesh-ancestor
110084776|NCT01662089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110084777|NCT01662128|Capecitabine|capecitabine|mesh-list
110084778|NCT01662128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110084779|NCT01662128|Antimetabolites|antimetabolites|mesh-ancestor
110084780|NCT01662128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110084781|NCT01662128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110084782|NCT01662180|Hormones|hormones|mesh-list
110084783|NCT01662180|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
110084784|NCT01662180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110084785|NCT01662180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110084786|NCT01662193|Calcium, Dietary|calcium, dietary|mesh-list
110084787|NCT01662193|Vitamin D|vitamin d|mesh-list
110084788|NCT01662193|Ergocalciferols|ergocalciferols|mesh-list
110084789|NCT01662193|Cholecalciferol|cholecalciferol|mesh-list
110084790|NCT01662193|Vitamins|vitamins|mesh-list
110084791|NCT01662193|Calcium Carbonate|calcium carbonate|mesh-list
110084792|NCT01662193|Calcium|calcium|mesh-list
110084793|NCT01662193|Micronutrients|micronutrients|mesh-ancestor
110084794|NCT01662193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110084795|NCT01662193|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110084796|NCT01662193|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110084797|NCT01662193|Antacids|antacids|mesh-ancestor
110084798|NCT01662193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110084799|NCT01662193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110084800|NCT01662349|Anti-Infective Agents|anti-infective agents|mesh-list
110084801|NCT01662349|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110084802|NCT01662401|Bupivacaine|bupivacaine|mesh-list
110084803|NCT01662401|Anesthetics, Local|anesthetics, local|mesh-ancestor
110084804|NCT01662401|Anesthetics|anesthetics|mesh-ancestor
110084805|NCT01662401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110084806|NCT01662401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110084807|NCT01662401|Sensory System Agents|sensory system agents|mesh-ancestor
110084808|NCT01662401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110084809|NCT01662466|Methyltestosterone|methyltestosterone|mesh-list
110084810|NCT01662466|Testosterone|testosterone|mesh-list
110084811|NCT01662466|Testosterone undecanoate|testosterone undecanoate|mesh-list
110084812|NCT01662466|Testosterone enanthate|testosterone enanthate|mesh-list
110084813|NCT01662466|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
110084814|NCT01662466|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
110084815|NCT01662466|Androgens|androgens|mesh-ancestor
110084816|NCT01662466|Hormones|hormones|mesh-ancestor
110084817|NCT01662466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110084818|NCT01662466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110084819|NCT01662466|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110084820|NCT01662466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110084821|NCT01662466|Anabolic Agents|anabolic agents|mesh-ancestor
110084822|NCT01662466|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110084823|NCT01662466|Immunologic Factors|immunologic factors|mesh-ancestor
110084825|NCT01662518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110084826|NCT01662518|Antiemetics|antiemetics|mesh-ancestor
110084827|NCT01662518|Autonomic Agents|autonomic agents|mesh-ancestor
110084828|NCT01662518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110084829|NCT01662518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110084830|NCT01662518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110084831|NCT01662518|Glucocorticoids|glucocorticoids|mesh-ancestor
110084832|NCT01662518|Hormones|hormones|mesh-ancestor
110084833|NCT01662518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110084834|NCT01662518|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110084835|NCT01662518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110084836|NCT01662622|Sevoflurane|sevoflurane|mesh-list
110084837|NCT01662622|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110084838|NCT01662622|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110084839|NCT01662622|Anesthetics, General|anesthetics, general|mesh-ancestor
110084840|NCT01662622|Anesthetics|anesthetics|mesh-ancestor
110084841|NCT01662622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110084842|NCT01662622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110084843|NCT01662674|Metformin|metformin|mesh-list
110084844|NCT01662674|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110084845|NCT01662674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110084846|NCT01662687|Granisetron|granisetron|mesh-list
110084847|NCT01662687|Antiemetics|antiemetics|mesh-ancestor
110084848|NCT01662687|Autonomic Agents|autonomic agents|mesh-ancestor
110084849|NCT01662687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110084850|NCT01662687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110084851|NCT01662687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110084852|NCT01662687|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110084853|NCT01662687|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110084854|NCT01662687|Serotonin Agents|serotonin agents|mesh-ancestor
110084855|NCT01662687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110084856|NCT01662687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110084857|NCT01662700|Artesunate|artesunate|mesh-list
110084858|NCT01662700|Chloroquine|chloroquine|mesh-list
110084859|NCT01662700|Antimalarials|antimalarials|mesh-ancestor
110084860|NCT01662700|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110084861|NCT01662700|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110084862|NCT01662700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110084863|NCT01662700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110084864|NCT01662700|Antiviral Agents|antiviral agents|mesh-ancestor
110084865|NCT01662700|Schistosomicides|schistosomicides|mesh-ancestor
110084866|NCT01662700|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110084867|NCT01662700|Anthelmintics|anthelmintics|mesh-ancestor
110084868|NCT01662700|Amebicides|amebicides|mesh-ancestor
110084869|NCT01662700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110084871|NCT01662804|Antibodies|antibodies|mesh-list
110084872|NCT01662804|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110084873|NCT01662804|Immunologic Factors|immunologic factors|mesh-ancestor
110084874|NCT01662804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110084875|NCT01662804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110084876|NCT01662804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110084877|NCT01662804|Analgesics|analgesics|mesh-ancestor
110084878|NCT01662804|Sensory System Agents|sensory system agents|mesh-ancestor
110084879|NCT01662804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110084880|NCT01662869|Leucovorin|leucovorin|mesh-list
110084881|NCT01662869|Folic Acid|folic acid|mesh-list
110084882|NCT01662869|Oxaliplatin|oxaliplatin|mesh-list
110084883|NCT01662869|Fluorouracil|fluorouracil|mesh-list
110084884|NCT01662869|Levoleucovorin|levoleucovorin|mesh-list
110084885|NCT01662869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110084886|NCT01662869|Antidotes|antidotes|mesh-ancestor
110084887|NCT01662869|Protective Agents|protective agents|mesh-ancestor
110084888|NCT01662869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110084889|NCT01662869|Vitamin B Complex|vitamin b complex|mesh-ancestor
110084890|NCT01662869|Vitamins|vitamins|mesh-ancestor
110084891|NCT01662869|Micronutrients|micronutrients|mesh-ancestor
110084892|NCT01662869|Hematinics|hematinics|mesh-ancestor
110084893|NCT01662869|Antimetabolites|antimetabolites|mesh-ancestor
110084894|NCT01662869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110084895|NCT01662869|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110084896|NCT01662869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110084897|NCT01662869|Immunologic Factors|immunologic factors|mesh-ancestor
110084898|NCT01662921|Insulin|insulin|mesh-list
110084899|NCT01662921|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110084900|NCT01662921|Insulin Lispro|insulin lispro|mesh-list
110084901|NCT01662921|Insulin glulisine|insulin glulisine|mesh-list
110084902|NCT01662921|Isophane Insulin, Human|isophane insulin, human|mesh-list
110084903|NCT01662921|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110084904|NCT01662921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110084905|NCT01663038|Aspirin|aspirin|mesh-list
110084906|NCT01663038|Clopidogrel|clopidogrel|mesh-list
110084907|NCT01663038|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110084908|NCT01663038|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110084909|NCT01663038|Analgesics|analgesics|mesh-ancestor
110084910|NCT01663038|Sensory System Agents|sensory system agents|mesh-ancestor
110084911|NCT01663038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110084912|NCT01663038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110084913|NCT01663038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110084914|NCT01663038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110084915|NCT01663038|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110084916|NCT01663038|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110084917|NCT01663038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110084918|NCT01663038|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110084919|NCT01663038|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110084920|NCT01663038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110084921|NCT01663038|Antipyretics|antipyretics|mesh-ancestor
110084922|NCT01663038|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110084923|NCT01663038|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110084924|NCT01663038|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110084925|NCT01663038|Purinergic Agents|purinergic agents|mesh-ancestor
110084926|NCT01663038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110084928|NCT01663077|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110084929|NCT01663077|Serotonin Agents|serotonin agents|mesh-ancestor
110084930|NCT01663077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110084931|NCT01663077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110084932|NCT01663077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110084933|NCT01663077|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110084934|NCT01663077|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110084935|NCT01663077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110084936|NCT01663077|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110084937|NCT01663077|GABA Antagonists|gaba antagonists|mesh-ancestor
110084938|NCT01663077|GABA Agents|gaba agents|mesh-ancestor
110084939|NCT01663090|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
110084940|NCT01663090|Hematinics|hematinics|mesh-ancestor
110084941|NCT01663090|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
110084942|NCT01663090|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110084943|NCT01663168|Rifabutin|rifabutin|mesh-list
110084944|NCT01663168|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110084945|NCT01663168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110084946|NCT01663168|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110084947|NCT01663168|Antitubercular Agents|antitubercular agents|mesh-ancestor
110084948|NCT01663441|Oprelvekin|oprelvekin|mesh-list
110084949|NCT01663441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110084950|NCT01661985|Azithromycin|azithromycin|mesh-list
110084951|NCT01661985|Doxycycline|doxycycline|mesh-list
110084952|NCT01661985|Lymecycline|lymecycline|mesh-list
110084953|NCT01661985|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110084954|NCT01661985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110084955|NCT01661985|Antimalarials|antimalarials|mesh-ancestor
110084956|NCT01661985|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110084957|NCT01661985|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110084958|NCT01663558|Imiquimod|imiquimod|mesh-list
110084959|NCT01663558|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110084960|NCT01663558|Immunologic Factors|immunologic factors|mesh-ancestor
110084961|NCT01663558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110084962|NCT01663558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110084963|NCT01663558|Interferon Inducers|interferon inducers|mesh-ancestor
110084964|NCT01663662|Tolvaptan|tolvaptan|mesh-list
110084965|NCT01663662|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
110084966|NCT01663662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110084967|NCT01663662|Natriuretic Agents|natriuretic agents|mesh-ancestor
110084968|NCT01663662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110084969|NCT01663753|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110084970|NCT01663753|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110084971|NCT01663753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110084972|NCT01663805|Everolimus|everolimus|mesh-list
110084973|NCT01663805|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110084974|NCT01663805|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110084975|NCT01663805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110084976|NCT01663805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110084977|NCT01663805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110084978|NCT01663805|Immunologic Factors|immunologic factors|mesh-ancestor
110084979|NCT01663805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110084980|NCT01663805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110084982|NCT01663961|Mirabegron|mirabegron|mesh-list
110084983|NCT01663961|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110084984|NCT01663961|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110084985|NCT01663961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110084986|NCT01663961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110084987|NCT01663961|Protective Agents|protective agents|mesh-ancestor
110084988|NCT01663961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110084989|NCT01663961|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
110084990|NCT01663961|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110084991|NCT01663961|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110084992|NCT01663961|Adrenergic Agents|adrenergic agents|mesh-ancestor
110084993|NCT01663961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110084994|NCT01663961|Urological Agents|urological agents|mesh-ancestor
110084995|NCT01664013|Botulinum Toxins|botulinum toxins|mesh-list
110084996|NCT01664013|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110084997|NCT01664013|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110084998|NCT01664013|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110084999|NCT01664013|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110085000|NCT01664013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110085001|NCT01664013|Cholinergic Agents|cholinergic agents|mesh-ancestor
110085002|NCT01664013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110085003|NCT01664013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110085004|NCT01664013|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110085005|NCT01664013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110085006|NCT01664065|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
110085007|NCT01664065|Cephalosporins|cephalosporins|mesh-list
110085008|NCT01664065|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110085009|NCT01664065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110085010|NCT01664195|Epoetin Alfa|epoetin alfa|mesh-list
110085011|NCT01664195|Hematinics|hematinics|mesh-ancestor
110085012|NCT01664221|Epoetin Alfa|epoetin alfa|mesh-list
110085013|NCT01664221|Hematinics|hematinics|mesh-ancestor
110085014|NCT01664260|Acetylcysteine|acetylcysteine|mesh-list
110085015|NCT01664260|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110085016|NCT01664260|Antiviral Agents|antiviral agents|mesh-ancestor
110085017|NCT01664260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110085018|NCT01664260|Expectorants|expectorants|mesh-ancestor
110085019|NCT01664260|Respiratory System Agents|respiratory system agents|mesh-ancestor
110085020|NCT01664260|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110085021|NCT01664260|Antioxidants|antioxidants|mesh-ancestor
110085022|NCT01664260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110085024|NCT01664260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110085025|NCT01664260|Antidotes|antidotes|mesh-ancestor
110085026|NCT01664520|Dexmedetomidine|dexmedetomidine|mesh-list
110085027|NCT01664520|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110085028|NCT01664520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110085029|NCT01664520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110085030|NCT01664520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110085031|NCT01664520|Analgesics|analgesics|mesh-ancestor
110085032|NCT01664520|Sensory System Agents|sensory system agents|mesh-ancestor
110085033|NCT01664520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110085034|NCT01664520|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110085035|NCT01664520|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110085036|NCT01664520|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110085037|NCT01664520|Adrenergic Agents|adrenergic agents|mesh-ancestor
110085038|NCT01664520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110085039|NCT01664520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110085040|NCT01664650|Genistein|genistein|mesh-list
110085041|NCT01664650|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110085042|NCT01664650|Protective Agents|protective agents|mesh-ancestor
110085043|NCT01664650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110085044|NCT01664650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110085045|NCT01664650|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110085046|NCT01664650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110085047|NCT01664650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110085048|NCT01664650|Phytoestrogens|phytoestrogens|mesh-ancestor
110085049|NCT01664650|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
110085050|NCT01664650|Estrogens|estrogens|mesh-ancestor
110085051|NCT01664650|Hormones|hormones|mesh-ancestor
110085052|NCT01664650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110085053|NCT01664676|Liraglutide|liraglutide|mesh-list
110085054|NCT01664676|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110085055|NCT01664676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110085056|NCT01664676|Incretins|incretins|mesh-ancestor
110085057|NCT01664676|Hormones|hormones|mesh-ancestor
110085058|NCT01664676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110085059|NCT01664728|Abiraterone Acetate|abiraterone acetate|mesh-list
110085060|NCT01664728|Glucocorticoids|glucocorticoids|mesh-list
110085061|NCT01664728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110085062|NCT01664728|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110085063|NCT01664728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110085064|NCT01664728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110085065|NCT01664728|Hormone Antagonists|hormone antagonists|mesh-ancestor
110085066|NCT01664728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110085067|NCT01664728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110085068|NCT01664728|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110085069|NCT01664728|Hormones|hormones|mesh-ancestor
110085070|NCT01664754|Carboplatin|carboplatin|mesh-list
110085071|NCT01664754|Pemetrexed|pemetrexed|mesh-list
110085072|NCT01664754|Exemestane|exemestane|mesh-list
110085073|NCT01664754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110085074|NCT01664754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110085075|NCT01664754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110085076|NCT01664754|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110085077|NCT01664754|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110085078|NCT01664754|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110085079|NCT01664754|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110085080|NCT01664754|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110085081|NCT01664754|Hormone Antagonists|hormone antagonists|mesh-ancestor
110085082|NCT01664754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110085083|NCT01664754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110085084|NCT01664819|Antioxidants|antioxidants|mesh-list
110085085|NCT01664819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110085086|NCT01664819|Protective Agents|protective agents|mesh-ancestor
110085087|NCT01664819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110085089|NCT01664845|Ribavirin|ribavirin|mesh-list
110085090|NCT01664845|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110085091|NCT01664845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110085092|NCT01664845|Antimetabolites|antimetabolites|mesh-ancestor
110085093|NCT01664845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110085094|NCT01664845|Antiviral Agents|antiviral agents|mesh-ancestor
110085095|NCT01664845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110085098|NCT01664871|Protective Agents|protective agents|mesh-ancestor
110085099|NCT01664871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110085100|NCT01664936|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110085101|NCT01664936|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110085102|NCT01664936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110085103|NCT01665066|Nicotine|nicotine|mesh-list
110085104|NCT01665066|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110085105|NCT01665066|Autonomic Agents|autonomic agents|mesh-ancestor
110085106|NCT01665066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110085107|NCT01665066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110085108|NCT01665066|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110085109|NCT01665066|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110085110|NCT01665066|Cholinergic Agents|cholinergic agents|mesh-ancestor
110085111|NCT01665066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110085112|NCT01665066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110085113|NCT01665079|Propofol|propofol|mesh-list
110085114|NCT01665079|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110085115|NCT01665079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110085116|NCT01665079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110085117|NCT01665079|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110085118|NCT01665079|Anesthetics, General|anesthetics, general|mesh-ancestor
110085119|NCT01665079|Anesthetics|anesthetics|mesh-ancestor
110085120|NCT01665196|Deoxyglucose|deoxyglucose|mesh-list
110085121|NCT01665196|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110085122|NCT01665196|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110085123|NCT01665196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110085124|NCT01665196|Antimetabolites|antimetabolites|mesh-ancestor
110085125|NCT01665196|Antiviral Agents|antiviral agents|mesh-ancestor
110085126|NCT01665196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110085127|NCT01665209|Morphine|morphine|mesh-list
110085128|NCT01665209|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110085129|NCT01665209|Narcotics|narcotics|mesh-ancestor
110085130|NCT01665209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110085131|NCT01665209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110085132|NCT01665209|Analgesics|analgesics|mesh-ancestor
110085133|NCT01665209|Sensory System Agents|sensory system agents|mesh-ancestor
110085134|NCT01665209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110085135|NCT01665222|Morphine|morphine|mesh-list
110085136|NCT01665222|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110085137|NCT01665222|Narcotics|narcotics|mesh-ancestor
110085138|NCT01665222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110085139|NCT01665222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110085140|NCT01665222|Analgesics|analgesics|mesh-ancestor
110085141|NCT01665222|Sensory System Agents|sensory system agents|mesh-ancestor
110085142|NCT01665222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110085143|NCT01665235|Aspirin|aspirin|mesh-list
110085144|NCT01665235|Amlodipine|amlodipine|mesh-list
110085145|NCT01665235|Clopidogrel|clopidogrel|mesh-list
110085146|NCT01665235|Atorvastatin|atorvastatin|mesh-list
110085147|NCT01665235|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110085148|NCT01665235|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110085149|NCT01665235|Analgesics|analgesics|mesh-ancestor
110085150|NCT01665235|Sensory System Agents|sensory system agents|mesh-ancestor
110085151|NCT01665235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110085152|NCT01665235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110085153|NCT01665235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110085154|NCT01665235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110085155|NCT01665235|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110085156|NCT01665235|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110085157|NCT01665235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110085158|NCT01665235|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110085160|NCT01665235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110085161|NCT01665235|Antipyretics|antipyretics|mesh-ancestor
110085162|NCT01665235|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110085163|NCT01665235|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110085164|NCT01665235|Antimetabolites|antimetabolites|mesh-ancestor
110085165|NCT01665235|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110085166|NCT01665235|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110085167|NCT01665235|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110085168|NCT01665235|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110085169|NCT01665235|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110085170|NCT01665235|Purinergic Agents|purinergic agents|mesh-ancestor
110085171|NCT01665235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110085172|NCT01665235|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110085173|NCT01665235|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110085174|NCT01665235|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110085175|NCT01665235|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110085176|NCT01665235|Vasodilator Agents|vasodilator agents|mesh-ancestor
110085179|NCT01665248|Sodium Fluoride|sodium fluoride|mesh-list
110085180|NCT01665248|Cariostatic Agents|cariostatic agents|mesh-ancestor
110085181|NCT01665248|Protective Agents|protective agents|mesh-ancestor
110085182|NCT01665248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110085183|NCT01665248|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110085184|NCT01665248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110085185|NCT01665378|Folic Acid|folic acid|mesh-list
110085186|NCT01665378|Vitamin B Complex|vitamin b complex|mesh-list
110085187|NCT01665378|Micronutrients|micronutrients|mesh-list
110085188|NCT01665378|Trace Elements|trace elements|mesh-list
110085189|NCT01665378|Hematinics|hematinics|mesh-ancestor
110085190|NCT01665378|Vitamins|vitamins|mesh-ancestor
110085191|NCT01665378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110085192|NCT01665404|Fluvoxamine|fluvoxamine|mesh-list
110085193|NCT01665404|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110085194|NCT01665404|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110085195|NCT01665404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110085196|NCT01665404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110085197|NCT01665404|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110085198|NCT01665404|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110085199|NCT01665404|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110085200|NCT01665404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110085201|NCT01665404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110085202|NCT01665404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110085203|NCT01665404|Serotonin Agents|serotonin agents|mesh-ancestor
110085204|NCT01665404|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110085205|NCT01665404|Antidepressive Agents|antidepressive agents|mesh-ancestor
110085206|NCT01665404|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110085207|NCT01665404|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110085208|NCT01665404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110085209|NCT01665404|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110085210|NCT01665417|Docetaxel|docetaxel|mesh-list
110085211|NCT01665417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110085212|NCT01665417|Tubulin Modulators|tubulin modulators|mesh-ancestor
110085213|NCT01665417|Antimitotic Agents|antimitotic agents|mesh-ancestor
110085214|NCT01665417|Mitosis Modulators|mitosis modulators|mesh-ancestor
110085215|NCT01665417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110085216|NCT01665469|Lycopene|lycopene|mesh-list
110085217|NCT01665469|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110085218|NCT01665469|Antioxidants|antioxidants|mesh-ancestor
110085219|NCT01665469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110085220|NCT01665469|Protective Agents|protective agents|mesh-ancestor
110085221|NCT01665469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110085222|NCT01665469|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110085223|NCT01665469|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110085224|NCT01665469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110085225|NCT01664507|Epinephrine|epinephrine|mesh-list
110085226|NCT01664507|Racepinephrine|racepinephrine|mesh-list
110085227|NCT01664507|Epinephryl borate|epinephryl borate|mesh-list
110085228|NCT01664507|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110085229|NCT01664507|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110085230|NCT01664507|Adrenergic Agents|adrenergic agents|mesh-ancestor
110085231|NCT01664507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110085232|NCT01664507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110085233|NCT01664507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110085234|NCT01664507|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110085235|NCT01664507|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110085237|NCT01664507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110085238|NCT01664507|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110085239|NCT01664507|Respiratory System Agents|respiratory system agents|mesh-ancestor
110085240|NCT01664507|Mydriatics|mydriatics|mesh-ancestor
110085241|NCT01664507|Sympathomimetics|sympathomimetics|mesh-ancestor
110085242|NCT01664507|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110085243|NCT01665586|Dexmedetomidine|dexmedetomidine|mesh-list
110085244|NCT01665586|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110085245|NCT01665586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110085246|NCT01665586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110085247|NCT01665586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110085248|NCT01665586|Analgesics|analgesics|mesh-ancestor
110085249|NCT01665586|Sensory System Agents|sensory system agents|mesh-ancestor
110085250|NCT01665586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110085251|NCT01665586|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110085252|NCT01665586|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110085253|NCT01665586|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110085254|NCT01665586|Adrenergic Agents|adrenergic agents|mesh-ancestor
110085255|NCT01665586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110085256|NCT01665586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110085257|NCT01665638|Canagliflozin|canagliflozin|mesh-list
110085258|NCT01665638|Somatostatin|somatostatin|mesh-list
110085259|NCT01665638|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110085260|NCT01665638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110085261|NCT01665638|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110085262|NCT01665638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110085263|NCT01665638|Hormones|hormones|mesh-ancestor
110085264|NCT01665638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110085265|NCT01665703|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110085266|NCT01665703|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110085267|NCT01665703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110085269|NCT01665742|Vitamin E|vitamin e|mesh-list
110085270|NCT01665742|alpha-Tocopherol|alpha-tocopherol|mesh-list
110085271|NCT01665742|Lycopene|lycopene|mesh-list
110085272|NCT01665742|Vitamins|vitamins|mesh-ancestor
110085273|NCT01665742|Micronutrients|micronutrients|mesh-ancestor
110085274|NCT01665742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110085275|NCT01665742|Antioxidants|antioxidants|mesh-ancestor
110085276|NCT01665742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110085277|NCT01665742|Protective Agents|protective agents|mesh-ancestor
110085278|NCT01665742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110085279|NCT01665742|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110085280|NCT01665742|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110085281|NCT01665742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110085282|NCT01665781|Epoetin Alfa|epoetin alfa|mesh-list
110085283|NCT01665781|Hematinics|hematinics|mesh-ancestor
110085284|NCT01665846|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
110085285|NCT01665846|Hematinics|hematinics|mesh-ancestor
110085286|NCT01665846|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
110085287|NCT01665846|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110085288|NCT01666041|Fenofibrate|fenofibrate|mesh-list
110085289|NCT01666041|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110085290|NCT01666041|Antimetabolites|antimetabolites|mesh-ancestor
110085291|NCT01666041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110085292|NCT01666041|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110085293|NCT01666067|Simvastatin|simvastatin|mesh-list
110085294|NCT01666067|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
110085295|NCT01666067|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110085296|NCT01666067|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110085297|NCT01666067|Antimetabolites|antimetabolites|mesh-ancestor
110085298|NCT01666067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110085299|NCT01666067|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110085300|NCT01666067|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110085301|NCT01666067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110085302|NCT01666171|Metformin|metformin|mesh-list
110085303|NCT01666171|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110085304|NCT01666171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110085305|NCT01666223|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
110085306|NCT01666223|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
110085307|NCT01666223|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110085308|NCT01666223|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110085309|NCT01666223|Antimetabolites|antimetabolites|mesh-ancestor
110085310|NCT01666223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110085311|NCT01666223|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110085314|NCT01666236|Triamcinolone|triamcinolone|mesh-list
110085315|NCT01666236|Ranibizumab|ranibizumab|mesh-list
110085316|NCT01666236|Verteporfin|verteporfin|mesh-list
110085317|NCT01666236|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110085318|NCT01666236|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110085319|NCT01666236|Growth Substances|growth substances|mesh-ancestor
110085320|NCT01666236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110085321|NCT01666236|Growth Inhibitors|growth inhibitors|mesh-ancestor
110085322|NCT01666236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110085323|NCT01666236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110085324|NCT01666236|Glucocorticoids|glucocorticoids|mesh-ancestor
110085325|NCT01666236|Hormones|hormones|mesh-ancestor
110085326|NCT01666236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110085327|NCT01666236|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110085328|NCT01666236|Dermatologic Agents|dermatologic agents|mesh-ancestor
110085329|NCT01666249|Immunoglobulins|immunoglobulins|mesh-list
110085330|NCT01666249|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110085331|NCT01666249|Antibodies|antibodies|mesh-list
110085332|NCT01666249|Immunologic Factors|immunologic factors|mesh-ancestor
110085333|NCT01666249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110085334|NCT01666262|Vaccines|vaccines|mesh-list
110085335|NCT01666262|Immunologic Factors|immunologic factors|mesh-ancestor
110085336|NCT01666262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110085337|NCT01666301|Darbepoetin alfa|darbepoetin alfa|mesh-list
110085338|NCT01666301|Hematinics|hematinics|mesh-ancestor
110085339|NCT01666353|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110085340|NCT01666353|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110085341|NCT01666353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110085342|NCT01666379|Fentanyl|fentanyl|mesh-list
110085343|NCT01666379|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110085344|NCT01666379|Narcotics|narcotics|mesh-ancestor
110085345|NCT01666379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110085346|NCT01666379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110085347|NCT01666379|Analgesics|analgesics|mesh-ancestor
110085348|NCT01666379|Sensory System Agents|sensory system agents|mesh-ancestor
110085349|NCT01666379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110085350|NCT01666379|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110085351|NCT01666379|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110085352|NCT01666379|Anesthetics, General|anesthetics, general|mesh-ancestor
110085353|NCT01666379|Anesthetics|anesthetics|mesh-ancestor
110085354|NCT01666418|Paclitaxel|paclitaxel|mesh-list
110085355|NCT01666418|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110085356|NCT01666418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110085357|NCT01666418|Tubulin Modulators|tubulin modulators|mesh-ancestor
110085358|NCT01666418|Antimitotic Agents|antimitotic agents|mesh-ancestor
110085359|NCT01666418|Mitosis Modulators|mitosis modulators|mesh-ancestor
110085360|NCT01666418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110085361|NCT01666431|Lapatinib|lapatinib|mesh-list
110085362|NCT01666431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110085363|NCT01666431|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110085364|NCT01666431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110085365|NCT01666431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110085366|NCT01666522|Vitamin D|vitamin d|mesh-list
110085367|NCT01666522|Cholecalciferol|cholecalciferol|mesh-list
110085368|NCT01666522|Vitamins|vitamins|mesh-ancestor
110085369|NCT01666522|Micronutrients|micronutrients|mesh-ancestor
110085370|NCT01666522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110085371|NCT01666522|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110085372|NCT01666522|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110085373|NCT01666587|Ibuprofen|ibuprofen|mesh-list
110085374|NCT01666587|Antioxidants|antioxidants|mesh-list
110085375|NCT01666587|Prostaglandin Antagonists|prostaglandin antagonists|mesh-list
110085376|NCT01666587|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110085377|NCT01666587|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110085378|NCT01666587|Analgesics|analgesics|mesh-ancestor
110085379|NCT01666587|Sensory System Agents|sensory system agents|mesh-ancestor
110085380|NCT01666587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110085381|NCT01666587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110085382|NCT01666587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110085383|NCT01666587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110085384|NCT01666587|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110085385|NCT01666587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110085386|NCT01666587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110085387|NCT01666587|Protective Agents|protective agents|mesh-ancestor
110085388|NCT01666587|Hormone Antagonists|hormone antagonists|mesh-ancestor
110085389|NCT01666587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110085391|NCT01666600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110085392|NCT01666600|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110085393|NCT01666600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110085394|NCT01666600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110085395|NCT01666665|Metformin|metformin|mesh-list
110085396|NCT01666665|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110085397|NCT01666665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110085398|NCT01666678|Diphenhydramine|diphenhydramine|mesh-list
110085399|NCT01666678|Promethazine|promethazine|mesh-list
110085400|NCT01666678|Naproxen|naproxen|mesh-list
110085401|NCT01666678|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110085402|NCT01666678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110085403|NCT01666678|Analgesics|analgesics|mesh-ancestor
110085404|NCT01666678|Sensory System Agents|sensory system agents|mesh-ancestor
110085405|NCT01666678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110085406|NCT01666678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110085407|NCT01666678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110085408|NCT01666678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110085409|NCT01666678|Gout Suppressants|gout suppressants|mesh-ancestor
110085410|NCT01666678|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110085411|NCT01666678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110085412|NCT01666678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110085413|NCT01666678|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110085414|NCT01666678|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110085415|NCT01666678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110085416|NCT01666678|Anesthetics, Local|anesthetics, local|mesh-ancestor
110085417|NCT01666678|Anesthetics|anesthetics|mesh-ancestor
110085418|NCT01666678|Antiemetics|antiemetics|mesh-ancestor
110085419|NCT01666678|Autonomic Agents|autonomic agents|mesh-ancestor
110085420|NCT01666678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110085421|NCT01666678|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110085422|NCT01666678|Histamine Antagonists|histamine antagonists|mesh-ancestor
110085423|NCT01666678|Histamine Agents|histamine agents|mesh-ancestor
110085424|NCT01666678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110085425|NCT01666678|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110085426|NCT01666678|Antipruritics|antipruritics|mesh-ancestor
110085427|NCT01666678|Dermatologic Agents|dermatologic agents|mesh-ancestor
110085429|NCT01666691|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110085430|NCT01666691|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110085431|NCT01666691|Growth Substances|growth substances|mesh-ancestor
110085432|NCT01666691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110085433|NCT01666691|Growth Inhibitors|growth inhibitors|mesh-ancestor
110085434|NCT01666691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110085435|NCT01666743|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
110085436|NCT01666743|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110085437|NCT01666743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110085438|NCT01666756|Sorafenib|sorafenib|mesh-list
110085439|NCT01666756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110085440|NCT01666756|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110085441|NCT01666756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110085442|NCT01666756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110085443|NCT01666769|Micafungin|micafungin|mesh-list
110085444|NCT01666769|Antifungal Agents|antifungal agents|mesh-ancestor
110085445|NCT01666769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110085446|NCT01667094|Meropenem|meropenem|mesh-list
110085447|NCT01667094|Tazobactam|tazobactam|mesh-list
110085448|NCT01667094|Piperacillin|piperacillin|mesh-list
110085449|NCT01667094|Clavulanic Acid|clavulanic acid|mesh-list
110085450|NCT01667094|Clavulanic Acids|clavulanic acids|mesh-list
110085451|NCT01667094|Ceftazidime|ceftazidime|mesh-list
110085452|NCT01667094|Cefepime|cefepime|mesh-list
110085453|NCT01667094|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
110085454|NCT01667094|Ticarcillin|ticarcillin|mesh-list
110085455|NCT01667094|Ticarcillin-clavulanic acid|ticarcillin-clavulanic acid|mesh-list
110085456|NCT01667094|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110085457|NCT01667094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110085458|NCT01667094|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110085459|NCT01667094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110085460|NCT01667094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110085461|NCT01667211|Paclitaxel|paclitaxel|mesh-list
110085462|NCT01667211|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110085463|NCT01667211|Nedaplatin|nedaplatin|mesh-list
110085464|NCT01667211|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110085465|NCT01667211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110085466|NCT01667211|Tubulin Modulators|tubulin modulators|mesh-ancestor
110085467|NCT01667211|Antimitotic Agents|antimitotic agents|mesh-ancestor
110085468|NCT01667211|Mitosis Modulators|mitosis modulators|mesh-ancestor
110085469|NCT01667211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110085471|NCT01667263|Danazol|danazol|mesh-list
110085472|NCT01667263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110085473|NCT01667263|Keratolytic Agents|keratolytic agents|mesh-ancestor
110085474|NCT01667263|Dermatologic Agents|dermatologic agents|mesh-ancestor
110085475|NCT01667263|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110085476|NCT01667263|Hormone Antagonists|hormone antagonists|mesh-ancestor
110085477|NCT01667263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110085478|NCT01667263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110085479|NCT01667315|Bupivacaine|bupivacaine|mesh-list
110085480|NCT01667315|Anesthetics, Local|anesthetics, local|mesh-ancestor
110085481|NCT01667315|Anesthetics|anesthetics|mesh-ancestor
110085482|NCT01667315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110085483|NCT01667315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110085484|NCT01667315|Sensory System Agents|sensory system agents|mesh-ancestor
110085485|NCT01667315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110085486|NCT01667445|Morphine|morphine|mesh-list
110085487|NCT01667445|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110085488|NCT01667445|Narcotics|narcotics|mesh-ancestor
110085489|NCT01667445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110085490|NCT01667445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110085491|NCT01667445|Analgesics|analgesics|mesh-ancestor
110085492|NCT01667445|Sensory System Agents|sensory system agents|mesh-ancestor
110085493|NCT01667445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110085494|NCT01667484|Adderall|adderall|mesh-list
110085495|NCT01667484|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110085496|NCT01667484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110085497|NCT01667497|4-Aminopyridine|4-aminopyridine|mesh-list
110085498|NCT01667497|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
110085499|NCT01667497|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110085500|NCT01667497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110085501|NCT01667523|Cinnamaldehyde|cinnamaldehyde|mesh-list
110085502|NCT01667523|Capsaicin|capsaicin|mesh-list
110085503|NCT01667523|Antipruritics|antipruritics|mesh-ancestor
110085504|NCT01667523|Dermatologic Agents|dermatologic agents|mesh-ancestor
110085505|NCT01667523|Sensory System Agents|sensory system agents|mesh-ancestor
110085506|NCT01667523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110085507|NCT01667523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110085508|NCT01667523|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110085509|NCT01667523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110085510|NCT01667523|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
110085511|NCT01667523|Protective Agents|protective agents|mesh-ancestor
110085512|NCT01667575|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110085513|NCT01667575|Amoxicillin|amoxicillin|mesh-list
110085514|NCT01667575|Clarithromycin|clarithromycin|mesh-list
110085515|NCT01667575|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
110085516|NCT01667575|Potassium Citrate|potassium citrate|mesh-list
110085517|NCT01667575|Esomeprazole|esomeprazole|mesh-list
110085518|NCT01667575|Bismuth|bismuth|mesh-list
110085519|NCT01667575|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
110085520|NCT01667575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110085521|NCT01667575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110085522|NCT01667575|Antitubercular Agents|antitubercular agents|mesh-ancestor
110085523|NCT01667575|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110085524|NCT01667575|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110085525|NCT01667575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110085526|NCT01667575|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110085527|NCT01667575|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110085528|NCT01667575|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110085529|NCT01667575|Antacids|antacids|mesh-ancestor
110085530|NCT01667575|Diuretics|diuretics|mesh-ancestor
110085531|NCT01667575|Natriuretic Agents|natriuretic agents|mesh-ancestor
110085532|NCT01667575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110085533|NCT01667575|Expectorants|expectorants|mesh-ancestor
110085534|NCT01667575|Respiratory System Agents|respiratory system agents|mesh-ancestor
110085536|NCT01667614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110085537|NCT01667614|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110085538|NCT01667614|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110085539|NCT01667614|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110085540|NCT01667614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110085541|NCT01667692|Azithromycin|azithromycin|mesh-list
110085542|NCT01667692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110085543|NCT01667692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110085544|NCT01667718|Amoxicillin|amoxicillin|mesh-list
110085545|NCT01667718|Levofloxacin|levofloxacin|mesh-list
110085546|NCT01667718|Potassium Citrate|potassium citrate|mesh-list
110085547|NCT01667718|Lansoprazole|lansoprazole|mesh-list
110085548|NCT01667718|Dexlansoprazole|dexlansoprazole|mesh-list
110085549|NCT01667718|Bismuth|bismuth|mesh-list
110085550|NCT01667718|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
110085551|NCT01667718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110085552|NCT01667718|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110085553|NCT01667718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110085554|NCT01667718|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110085555|NCT01667718|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110085556|NCT01667718|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110085557|NCT01667718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110085558|NCT01667718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110085559|NCT01667718|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110085560|NCT01667718|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110085561|NCT01667718|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110085562|NCT01667718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110085563|NCT01667718|Antacids|antacids|mesh-ancestor
110085564|NCT01667718|Diuretics|diuretics|mesh-ancestor
110085565|NCT01667718|Natriuretic Agents|natriuretic agents|mesh-ancestor
110085566|NCT01667718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110085567|NCT01667718|Expectorants|expectorants|mesh-ancestor
110085568|NCT01667718|Respiratory System Agents|respiratory system agents|mesh-ancestor
110085569|NCT01667874|Gentamicins|gentamicins|mesh-list
110085570|NCT01667874|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110085571|NCT01667874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110085572|NCT01667874|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110085573|NCT01667874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110085574|NCT01667874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110085575|NCT01668043|UB-421|ub-421|mesh-list
110085576|NCT01668043|Antibodies|antibodies|mesh-list
110085577|NCT01668043|Immunologic Factors|immunologic factors|mesh-ancestor
110085578|NCT01668043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110085579|NCT01668043|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110085580|NCT01668043|Antiviral Agents|antiviral agents|mesh-ancestor
110085581|NCT01668043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110085582|NCT01668056|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
110085583|NCT01668056|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110085584|NCT01668056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110085585|NCT01668069|Ondansetron|ondansetron|mesh-list
110085586|NCT01668069|Antiemetics|antiemetics|mesh-ancestor
110085587|NCT01668069|Autonomic Agents|autonomic agents|mesh-ancestor
110085588|NCT01668069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110085589|NCT01668069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110085590|NCT01668069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110085591|NCT01668069|Antipruritics|antipruritics|mesh-ancestor
110085592|NCT01668069|Dermatologic Agents|dermatologic agents|mesh-ancestor
110085593|NCT01668069|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110085594|NCT01668069|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110085595|NCT01668069|Serotonin Agents|serotonin agents|mesh-ancestor
110085596|NCT01668069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110085597|NCT01668069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110085598|NCT01668121|Budesonide|budesonide|mesh-list
110085599|NCT01668121|Formoterol Fumarate|formoterol fumarate|mesh-list
110085600|NCT01668121|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
110085601|NCT01668121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110085602|NCT01668121|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110085603|NCT01668121|Autonomic Agents|autonomic agents|mesh-ancestor
110085604|NCT01668121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110085605|NCT01668121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110085606|NCT01668121|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110085607|NCT01668121|Respiratory System Agents|respiratory system agents|mesh-ancestor
110085608|NCT01668121|Glucocorticoids|glucocorticoids|mesh-ancestor
110085610|NCT01668121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110085611|NCT01668121|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110085613|NCT01668121|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110085614|NCT01668121|Adrenergic Agents|adrenergic agents|mesh-ancestor
110085615|NCT01668121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110085616|NCT01668121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110085617|NCT01668433|Primaquine|primaquine|mesh-list
110085618|NCT01668433|Methylene Blue|methylene blue|mesh-list
110085619|NCT01668433|Antimalarials|antimalarials|mesh-ancestor
110085620|NCT01668433|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110085621|NCT01668433|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110085622|NCT01668433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110085623|NCT01668433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110085624|NCT01668433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110085625|NCT01668446|Sildenafil Citrate|sildenafil citrate|mesh-list
110085626|NCT01668446|Estradiol|estradiol|mesh-list
110085627|NCT01668446|Estrogens|estrogens|mesh-ancestor
110085628|NCT01668446|Hormones|hormones|mesh-ancestor
110085629|NCT01668446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110085630|NCT01668446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110085631|NCT01668446|Vasodilator Agents|vasodilator agents|mesh-ancestor
110085632|NCT01668446|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110085633|NCT01668446|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110085634|NCT01668446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110085635|NCT01668446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110085636|NCT01668446|Urological Agents|urological agents|mesh-ancestor
110085637|NCT01668485|Hypoglycemic Agents|hypoglycemic agents|mesh-list
110085638|NCT01668485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110085639|NCT01668498|Doxycycline|doxycycline|mesh-list
110085640|NCT01668498|Erythromycin|erythromycin|mesh-list
110085641|NCT01668498|Erythromycin Estolate|erythromycin estolate|mesh-list
110085642|NCT01668498|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
110085643|NCT01668498|Erythromycin stearate|erythromycin stearate|mesh-list
110085644|NCT01668498|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110085645|NCT01668498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110085646|NCT01668498|Antimalarials|antimalarials|mesh-ancestor
110085647|NCT01668498|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110085648|NCT01668498|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110085649|NCT01668498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110085650|NCT01668498|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110085651|NCT01668498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110085652|NCT01668498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110085653|NCT01668550|AZD-0424|azd-0424|mesh-list
110085654|NCT01668550|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110085655|NCT01668550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110085656|NCT01668550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110085657|NCT01668615|Tretinoin|tretinoin|mesh-list
110085658|NCT01668615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110085659|NCT01668615|Keratolytic Agents|keratolytic agents|mesh-ancestor
110085660|NCT01668615|Dermatologic Agents|dermatologic agents|mesh-ancestor
110085661|NCT01668680|Celecoxib|celecoxib|mesh-list
110085662|NCT01668680|Capecitabine|capecitabine|mesh-list
110085663|NCT01668680|Methotrexate|methotrexate|mesh-list
110085664|NCT01668680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110085665|NCT01668680|Antimetabolites|antimetabolites|mesh-ancestor
110085666|NCT01668680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110085667|NCT01668680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110085668|NCT01668680|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110085669|NCT01668680|Abortifacient Agents|abortifacient agents|mesh-ancestor
110085670|NCT01668680|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110085671|NCT01668680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110085672|NCT01668680|Dermatologic Agents|dermatologic agents|mesh-ancestor
110085673|NCT01668680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110085674|NCT01668680|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110085675|NCT01668680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110085676|NCT01668680|Immunologic Factors|immunologic factors|mesh-ancestor
110085677|NCT01668680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110085678|NCT01668680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110085679|NCT01668680|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110085680|NCT01668680|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110085682|NCT01668680|Sensory System Agents|sensory system agents|mesh-ancestor
110085683|NCT01668680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110085684|NCT01668680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110085685|NCT01668680|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110085686|NCT01668680|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110085687|NCT01668901|Aspirin|aspirin|mesh-list
110085688|NCT01668901|Warfarin|warfarin|mesh-list
110085689|NCT01668901|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110085690|NCT01668901|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110085692|NCT01668901|Sensory System Agents|sensory system agents|mesh-ancestor
110085693|NCT01668901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110085694|NCT01668901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110085695|NCT01668901|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110085696|NCT01668901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110085697|NCT01668901|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110085698|NCT01668901|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110085699|NCT01668901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110085700|NCT01668901|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110085701|NCT01668901|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110085702|NCT01668901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110085704|NCT01668901|Anticoagulants|anticoagulants|mesh-ancestor
110085705|NCT01668927|Amoxicillin|amoxicillin|mesh-list
110085706|NCT01668927|Metronidazole|metronidazole|mesh-list
110085707|NCT01668927|Tetracycline|tetracycline|mesh-list
110085708|NCT01668927|Furazolidone|furazolidone|mesh-list
110085709|NCT01668927|Potassium Citrate|potassium citrate|mesh-list
110085710|NCT01668927|Lansoprazole|lansoprazole|mesh-list
110085711|NCT01668927|Bismuth|bismuth|mesh-list
110085712|NCT01668927|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
110085713|NCT01668927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110085714|NCT01668927|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110085715|NCT01668927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110085716|NCT01668927|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110085717|NCT01668927|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110085718|NCT01668927|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110085719|NCT01668927|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110085720|NCT01668927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110085721|NCT01668927|Antacids|antacids|mesh-ancestor
110085722|NCT01668927|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110085723|NCT01668927|Diuretics|diuretics|mesh-ancestor
110085724|NCT01668927|Natriuretic Agents|natriuretic agents|mesh-ancestor
110085725|NCT01668927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110085726|NCT01668927|Expectorants|expectorants|mesh-ancestor
110085727|NCT01668927|Respiratory System Agents|respiratory system agents|mesh-ancestor
110085728|NCT01668927|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110085729|NCT01668927|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110085730|NCT01668927|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
110085731|NCT01668927|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
110085732|NCT01669044|Dexmedetomidine|dexmedetomidine|mesh-list
110085733|NCT01669044|Propofol|propofol|mesh-list
110085734|NCT01669044|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110085735|NCT01669044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110085736|NCT01669044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110085737|NCT01669044|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110085738|NCT01669044|Analgesics|analgesics|mesh-ancestor
110085739|NCT01669044|Sensory System Agents|sensory system agents|mesh-ancestor
110085740|NCT01669044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110085741|NCT01669044|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110085742|NCT01669044|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110085743|NCT01669044|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110085744|NCT01669044|Adrenergic Agents|adrenergic agents|mesh-ancestor
110085745|NCT01669044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110085746|NCT01669044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110085747|NCT01669044|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110085748|NCT01669044|Anesthetics, General|anesthetics, general|mesh-ancestor
110085749|NCT01669044|Anesthetics|anesthetics|mesh-ancestor
110085750|NCT01669083|Diketopiperazines|diketopiperazines|mesh-list
110085751|NCT01669083|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110085752|NCT01669083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110085753|NCT01669135|Anesthetics|anesthetics|mesh-list
110085754|NCT01669135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110085755|NCT01669135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110085756|NCT01669213|Ondansetron|ondansetron|mesh-list
110085757|NCT01669213|Ramosetron|ramosetron|mesh-list
110085758|NCT01669213|Antiemetics|antiemetics|mesh-ancestor
110085759|NCT01669213|Autonomic Agents|autonomic agents|mesh-ancestor
110085760|NCT01669213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110085761|NCT01669213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110085762|NCT01669213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110085763|NCT01669213|Antipruritics|antipruritics|mesh-ancestor
110085764|NCT01669213|Dermatologic Agents|dermatologic agents|mesh-ancestor
110085765|NCT01669213|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110085766|NCT01669213|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110085767|NCT01669213|Serotonin Agents|serotonin agents|mesh-ancestor
110085769|NCT01669213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110085771|NCT01669226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110085772|NCT01669239|Doxorubicin|doxorubicin|mesh-list
110085773|NCT01669239|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110085774|NCT01669239|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110085775|NCT01669239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110085776|NCT01669239|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110085777|NCT01669239|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110085778|NCT01669239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110085779|NCT01669239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110085780|NCT01669291|Leuprolide|leuprolide|mesh-list
110085781|NCT01669291|Cetrorelix|cetrorelix|mesh-list
110085782|NCT01669291|Menotropins|menotropins|mesh-list
110085783|NCT01669291|Ganirelix|ganirelix|mesh-list
110085784|NCT01669291|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110085785|NCT01669291|Fertility Agents|fertility agents|mesh-ancestor
110085786|NCT01669291|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110085787|NCT01669291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110085788|NCT01669291|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110085789|NCT01669291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110085790|NCT01669291|Hormone Antagonists|hormone antagonists|mesh-ancestor
110085791|NCT01669291|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110085792|NCT01669304|Verapamil|verapamil|mesh-list
110085793|NCT01669304|Sertraline|sertraline|mesh-list
110085794|NCT01669304|Antidepressive Agents|antidepressive agents|mesh-ancestor
110085795|NCT01669304|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110085796|NCT01669304|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110085797|NCT01669304|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110085798|NCT01669304|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110085799|NCT01669304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110085800|NCT01669304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110085801|NCT01669304|Serotonin Agents|serotonin agents|mesh-ancestor
110085802|NCT01669304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110085803|NCT01669304|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110085804|NCT01669304|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110085805|NCT01669304|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110085806|NCT01669304|Vasodilator Agents|vasodilator agents|mesh-ancestor
110085807|NCT01669369|Lithium Carbonate|lithium carbonate|mesh-list
110085808|NCT01669369|Antidepressive Agents|antidepressive agents|mesh-ancestor
110085809|NCT01669369|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110085810|NCT01669369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110085811|NCT01669369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110085812|NCT01669369|Antimanic Agents|antimanic agents|mesh-ancestor
110085813|NCT01669369|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110085814|NCT01669369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110085815|NCT01669369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110085816|NCT01669447|Ranibizumab|ranibizumab|mesh-list
110085817|NCT01669447|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110085818|NCT01669447|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110085819|NCT01669447|Growth Substances|growth substances|mesh-ancestor
110085820|NCT01669447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110085821|NCT01669447|Growth Inhibitors|growth inhibitors|mesh-ancestor
110085822|NCT01669447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110085823|NCT01669499|Dexamethasone|dexamethasone|mesh-list
110085824|NCT01669499|Dexamethasone acetate|dexamethasone acetate|mesh-list
110085825|NCT01669499|BB 1101|bb 1101|mesh-list
110085826|NCT01669499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110085827|NCT01669499|Antiemetics|antiemetics|mesh-ancestor
110085828|NCT01669499|Autonomic Agents|autonomic agents|mesh-ancestor
110085829|NCT01669499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110085830|NCT01669499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110085831|NCT01669499|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110085832|NCT01669499|Glucocorticoids|glucocorticoids|mesh-ancestor
110085833|NCT01669499|Hormones|hormones|mesh-ancestor
110085834|NCT01669499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110085835|NCT01669499|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110085836|NCT01669499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110085837|NCT01669499|Protease Inhibitors|protease inhibitors|mesh-ancestor
110085838|NCT01669499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110085839|NCT01669499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110085841|NCT01669707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110085842|NCT01669707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110085843|NCT01669707|Growth Substances|growth substances|mesh-ancestor
110085844|NCT01669707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110085845|NCT01669707|Growth Inhibitors|growth inhibitors|mesh-ancestor
110085846|NCT01669707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110085847|NCT01669941|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
110085848|NCT01669941|Antimalarials|antimalarials|mesh-ancestor
110085849|NCT01669941|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110085850|NCT01669941|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110085851|NCT01669941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110085852|NCT01669967|Diphenhydramine|diphenhydramine|mesh-list
110085853|NCT01669967|Promethazine|promethazine|mesh-list
110085854|NCT01669967|Lidocaine|lidocaine|mesh-list
110085855|NCT01669967|Anesthetics, Local|anesthetics, local|mesh-ancestor
110085856|NCT01669967|Anesthetics|anesthetics|mesh-ancestor
110085857|NCT01669967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110085858|NCT01669967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110085859|NCT01669967|Sensory System Agents|sensory system agents|mesh-ancestor
110085860|NCT01669967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110085861|NCT01669967|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110085862|NCT01669967|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110085863|NCT01669967|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110085864|NCT01669967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110085865|NCT01669967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110085866|NCT01669967|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110085867|NCT01669967|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110085868|NCT01669967|Antiemetics|antiemetics|mesh-ancestor
110085869|NCT01669967|Autonomic Agents|autonomic agents|mesh-ancestor
110085870|NCT01669967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110085871|NCT01669967|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110085872|NCT01669967|Histamine Antagonists|histamine antagonists|mesh-ancestor
110085873|NCT01669967|Histamine Agents|histamine agents|mesh-ancestor
110085874|NCT01669967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110085875|NCT01669967|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110085876|NCT01669967|Antipruritics|antipruritics|mesh-ancestor
110085877|NCT01669967|Dermatologic Agents|dermatologic agents|mesh-ancestor
110085878|NCT01670149|Rifaximin|rifaximin|mesh-list
110085879|NCT01670149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110085880|NCT01670149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110085881|NCT01670149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110085882|NCT01670370|Gemcitabine|gemcitabine|mesh-list
110085883|NCT01670370|Oxaliplatin|oxaliplatin|mesh-list
110085884|NCT01670370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110085885|NCT01670370|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110085886|NCT01670370|Antimetabolites|antimetabolites|mesh-ancestor
110085887|NCT01670370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110085888|NCT01670552|Naproxen|naproxen|mesh-list
110085889|NCT01670552|Nimesulide|nimesulide|mesh-list
110085890|NCT01670552|Esomeprazole|esomeprazole|mesh-list
110085891|NCT01670552|Pantoprazole|pantoprazole|mesh-list
110085892|NCT01670552|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110085893|NCT01670552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110085894|NCT01670552|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110085895|NCT01670552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110085896|NCT01670552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110085897|NCT01670552|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110085898|NCT01670552|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110085899|NCT01670552|Analgesics|analgesics|mesh-ancestor
110085900|NCT01670552|Sensory System Agents|sensory system agents|mesh-ancestor
110085901|NCT01670552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110085902|NCT01670552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110085903|NCT01670552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110085904|NCT01670552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110085905|NCT01670552|Gout Suppressants|gout suppressants|mesh-ancestor
110085906|NCT01670552|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110085907|NCT01670578|Hyaluronic Acid|hyaluronic acid|mesh-list
110085908|NCT01670578|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110085909|NCT01670578|Immunologic Factors|immunologic factors|mesh-ancestor
110085910|NCT01670578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110085911|NCT01670578|Viscosupplements|viscosupplements|mesh-ancestor
110085912|NCT01670578|Protective Agents|protective agents|mesh-ancestor
110085913|NCT01670812|Methylprednisolone|methylprednisolone|mesh-list
110085915|NCT01670812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110085916|NCT01670812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110085917|NCT01670812|Immunologic Factors|immunologic factors|mesh-ancestor
110085918|NCT01670812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110085920|NCT01670812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110085921|NCT01670812|Antiemetics|antiemetics|mesh-ancestor
110085922|NCT01670812|Autonomic Agents|autonomic agents|mesh-ancestor
110085923|NCT01670812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110085924|NCT01670812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110085925|NCT01670812|Glucocorticoids|glucocorticoids|mesh-ancestor
110085926|NCT01670812|Hormones|hormones|mesh-ancestor
110085927|NCT01670812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110085928|NCT01670812|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110085929|NCT01670812|Protective Agents|protective agents|mesh-ancestor
110085930|NCT01671449|Oxaliplatin|oxaliplatin|mesh-list
110085931|NCT01671449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110085932|NCT01671800|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
110085933|NCT01671800|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110085934|NCT01671800|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110085935|NCT01671800|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110085936|NCT01671800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110085937|NCT01671800|Cholinergic Agents|cholinergic agents|mesh-ancestor
110085938|NCT01671800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110085939|NCT01671800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110085940|NCT01672359|Choline|choline|mesh-list
110085941|NCT01672359|Lipotropic Agents|lipotropic agents|mesh-ancestor
110085942|NCT01672359|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110085943|NCT01672359|Antimetabolites|antimetabolites|mesh-ancestor
110085944|NCT01672359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110085945|NCT01672359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110085946|NCT01672359|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110085947|NCT01672359|Nootropic Agents|nootropic agents|mesh-ancestor
110085948|NCT01673308|Lenalidomide|lenalidomide|mesh-list
110085949|NCT01673308|Immunologic Factors|immunologic factors|mesh-ancestor
110085950|NCT01673308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110085951|NCT01673308|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110085952|NCT01673308|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110085953|NCT01673308|Growth Substances|growth substances|mesh-ancestor
110085954|NCT01673308|Growth Inhibitors|growth inhibitors|mesh-ancestor
110085955|NCT01673308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110085956|NCT01673737|Vemurafenib|vemurafenib|mesh-list
110085957|NCT01673737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110085958|NCT01673737|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110085959|NCT01673737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110085960|NCT01673737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110085961|NCT01674556|Gemcitabine|gemcitabine|mesh-list
110085962|NCT01674556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110085963|NCT01674556|Antimetabolites|antimetabolites|mesh-ancestor
110085964|NCT01674556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110085965|NCT01674556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110085966|NCT01675115|Aspirin|aspirin|mesh-list
110085967|NCT01675115|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110085968|NCT01675115|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110085969|NCT01675115|Analgesics|analgesics|mesh-ancestor
110085970|NCT01675115|Sensory System Agents|sensory system agents|mesh-ancestor
110085971|NCT01675115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110085972|NCT01675115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110085973|NCT01675115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110085974|NCT01675115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110085975|NCT01675115|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110085976|NCT01675115|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110085977|NCT01675115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110185175|NCT01464944|Aspirin|aspirin|mesh-list
110085978|NCT01675115|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110085979|NCT01675115|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110085980|NCT01675115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110085982|NCT01675310|Metformin|metformin|mesh-list
110085983|NCT01675310|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110085984|NCT01675310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110085985|NCT01676649|Paclitaxel|paclitaxel|mesh-list
110085986|NCT01676649|Carboplatin|carboplatin|mesh-list
110085987|NCT01676649|Ipilimumab|ipilimumab|mesh-list
110085988|NCT01676649|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110085989|NCT01676649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110085990|NCT01676649|Tubulin Modulators|tubulin modulators|mesh-ancestor
110085991|NCT01676649|Antimitotic Agents|antimitotic agents|mesh-ancestor
110085992|NCT01676649|Mitosis Modulators|mitosis modulators|mesh-ancestor
110085993|NCT01676649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110085994|NCT01676649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110085995|NCT01676649|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110085996|NCT01676987|Budesonide|budesonide|mesh-list
110085997|NCT01676987|Formoterol Fumarate|formoterol fumarate|mesh-list
110085998|NCT01676987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110085999|NCT01676987|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110086000|NCT01676987|Autonomic Agents|autonomic agents|mesh-ancestor
110086001|NCT01676987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110086002|NCT01676987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110086003|NCT01676987|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110086004|NCT01676987|Respiratory System Agents|respiratory system agents|mesh-ancestor
110086005|NCT01676987|Glucocorticoids|glucocorticoids|mesh-ancestor
110086006|NCT01676987|Hormones|hormones|mesh-ancestor
110086007|NCT01676987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110086008|NCT01676987|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110086009|NCT01676987|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110086010|NCT01676987|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110086011|NCT01676987|Adrenergic Agents|adrenergic agents|mesh-ancestor
110086012|NCT01676987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110086013|NCT01676987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110086014|NCT01677039|Ethanol|ethanol|mesh-list
110086015|NCT01677039|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110086016|NCT01677039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110086017|NCT01677039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110086018|NCT01677039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110086019|NCT01677065|Oxycodone|oxycodone|mesh-list
110086020|NCT01677065|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110086021|NCT01677065|Narcotics|narcotics|mesh-ancestor
110086022|NCT01677065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110086023|NCT01677065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110086024|NCT01677065|Analgesics|analgesics|mesh-ancestor
110086025|NCT01677065|Sensory System Agents|sensory system agents|mesh-ancestor
110086026|NCT01677065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110086027|NCT01677247|Glimepiride|glimepiride|mesh-list
110086028|NCT01677247|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110086029|NCT01677247|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110086030|NCT01677247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110086031|NCT01677247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110086032|NCT01677247|Immunologic Factors|immunologic factors|mesh-ancestor
110086033|NCT01677260|Metformin|metformin|mesh-list
110086034|NCT01677260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110086035|NCT01677260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110086036|NCT01677572|Immunoglobulin G|immunoglobulin g|mesh-list
110086037|NCT01677572|Immunologic Factors|immunologic factors|mesh-ancestor
110086038|NCT01677572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110086039|NCT01677650|Methadone|methadone|mesh-list
110086040|NCT01677650|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110086041|NCT01677650|Narcotics|narcotics|mesh-ancestor
110086042|NCT01677650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110086043|NCT01677650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110086044|NCT01677650|Analgesics|analgesics|mesh-ancestor
110086045|NCT01677650|Sensory System Agents|sensory system agents|mesh-ancestor
110185183|NCT01464944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110086046|NCT01677650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110086047|NCT01677650|Antitussive Agents|antitussive agents|mesh-ancestor
110086048|NCT01677650|Respiratory System Agents|respiratory system agents|mesh-ancestor
110086049|NCT01678053|Omeprazole|omeprazole|mesh-list
110086051|NCT01678053|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110086053|NCT01678053|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
110086054|NCT01678053|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110086055|NCT01678053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110086056|NCT01678053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110086057|NCT01678053|Cholinergic Agents|cholinergic agents|mesh-ancestor
110086058|NCT01678053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110086059|NCT01678053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110086060|NCT01678053|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110086061|NCT01678053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110086062|NCT01678053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110086063|NCT01678053|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110086064|NCT01678053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110086065|NCT01678937|Cyclosporine|cyclosporine|mesh-list
110086066|NCT01678937|Sirolimus|sirolimus|mesh-list
110086067|NCT01678937|Mycophenolic Acid|mycophenolic acid|mesh-list
110086068|NCT01678937|Temsirolimus|temsirolimus|mesh-list
110086069|NCT01678937|MTOR Inhibitors|mtor inhibitors|mesh-list
110086070|NCT01678937|Tacrolimus|tacrolimus|mesh-list
110086071|NCT01678937|Cyclosporins|cyclosporins|mesh-list
110086072|NCT01678937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110086073|NCT01678937|Immunologic Factors|immunologic factors|mesh-ancestor
110086074|NCT01678937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110086075|NCT01678937|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110086076|NCT01678937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110086077|NCT01678937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110086078|NCT01678937|Antifungal Agents|antifungal agents|mesh-ancestor
110086079|NCT01678937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110086080|NCT01678937|Dermatologic Agents|dermatologic agents|mesh-ancestor
110086081|NCT01678937|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110086082|NCT01678937|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110086083|NCT01678937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110086084|NCT01678937|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110086085|NCT01678937|Antitubercular Agents|antitubercular agents|mesh-ancestor
110086086|NCT01678937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110086087|NCT01678937|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110086088|NCT01679041|Cyclophosphamide|cyclophosphamide|mesh-list
110086089|NCT01679041|Fludarabine|fludarabine|mesh-list
110086090|NCT01679041|Alemtuzumab|alemtuzumab|mesh-list
110086091|NCT01679041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110086092|NCT01679041|Immunologic Factors|immunologic factors|mesh-ancestor
110086093|NCT01679041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110086094|NCT01679041|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110086095|NCT01679041|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110086096|NCT01679041|Alkylating Agents|alkylating agents|mesh-ancestor
110086097|NCT01679041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110086098|NCT01679041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110086099|NCT01679041|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110086100|NCT01679041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110086101|NCT01679093|Dexamethasone|dexamethasone|mesh-list
110086102|NCT01679093|Droperidol|droperidol|mesh-list
110086103|NCT01679093|Ondansetron|ondansetron|mesh-list
110086104|NCT01679093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110086106|NCT01679093|Autonomic Agents|autonomic agents|mesh-ancestor
110086107|NCT01679093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110086108|NCT01679093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110086109|NCT01679093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110086110|NCT01679093|Glucocorticoids|glucocorticoids|mesh-ancestor
110086111|NCT01679093|Hormones|hormones|mesh-ancestor
110086112|NCT01679093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110086113|NCT01679093|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110086114|NCT01679093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110086115|NCT01679093|Antipruritics|antipruritics|mesh-ancestor
110086116|NCT01679093|Dermatologic Agents|dermatologic agents|mesh-ancestor
110086117|NCT01679093|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110086118|NCT01679093|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110086119|NCT01679093|Serotonin Agents|serotonin agents|mesh-ancestor
110086120|NCT01679093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110086121|NCT01679093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110086122|NCT01679093|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110086123|NCT01679093|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110086124|NCT01679093|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110086125|NCT01679093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110086126|NCT01679093|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110086127|NCT01679093|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110086128|NCT01679093|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110086130|NCT01679743|Trastuzumab|trastuzumab|mesh-list
110086131|NCT01679743|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110086132|NCT01679743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110086133|NCT01680094|Panobinostat|panobinostat|mesh-list
110086134|NCT01680094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110086135|NCT01680094|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110086136|NCT01680094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110086137|NCT01680094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110086138|NCT01680120|Anesthetics|anesthetics|mesh-list
110086139|NCT01680120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110086140|NCT01680120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110086141|NCT01680198|Vitamin D|vitamin d|mesh-list
110086142|NCT01680198|Vitamins|vitamins|mesh-ancestor
110086143|NCT01680198|Micronutrients|micronutrients|mesh-ancestor
110086144|NCT01680198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110086145|NCT01680198|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110086146|NCT05597215|Technetium Tc 99m Medronate|technetium tc 99m medronate|mesh-list
110086147|NCT05597215|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110086148|NCT05597215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110086149|NCT05596981|Sorafenib|sorafenib|mesh-list
110086150|NCT05596981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110086151|NCT05596981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110086152|NCT05596981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110086153|NCT05596981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110086154|NCT05596968|Sorafenib|sorafenib|mesh-list
110086155|NCT05596968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110086156|NCT05596968|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110086157|NCT05596968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110086158|NCT05596968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110086159|NCT05596890|Paclitaxel|paclitaxel|mesh-list
110086160|NCT05596890|Carboplatin|carboplatin|mesh-list
110086161|NCT05596890|Tislelizumab|tislelizumab|mesh-list
110086162|NCT05596890|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110086163|NCT05596890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110086164|NCT05596890|Tubulin Modulators|tubulin modulators|mesh-ancestor
110086165|NCT05596890|Antimitotic Agents|antimitotic agents|mesh-ancestor
110086166|NCT05596890|Mitosis Modulators|mitosis modulators|mesh-ancestor
110086167|NCT05596890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110185209|NCT00037635|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
110086168|NCT05596890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110086170|NCT05596669|Morphine|morphine|mesh-list
110086171|NCT05596669|Analgesics|analgesics|mesh-ancestor
110086172|NCT05596669|Sensory System Agents|sensory system agents|mesh-ancestor
110086173|NCT05596669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110086174|NCT05596669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110086175|NCT05596669|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110086176|NCT05596669|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110086177|NCT05596669|Anesthetics, General|anesthetics, general|mesh-ancestor
110086178|NCT05596669|Anesthetics|anesthetics|mesh-ancestor
110086179|NCT05596669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110086180|NCT05596669|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110086181|NCT05596669|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110086182|NCT05596669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110086183|NCT05596669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110086184|NCT05596669|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110086185|NCT05596669|Narcotics|narcotics|mesh-ancestor
110086186|NCT05596617|Melatonin|melatonin|mesh-list
110086187|NCT05596617|Antioxidants|antioxidants|mesh-ancestor
110086188|NCT05596617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110086189|NCT05596617|Protective Agents|protective agents|mesh-ancestor
110086190|NCT05596617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110086191|NCT05596617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110086192|NCT05596552|Fentanyl|fentanyl|mesh-list
110086193|NCT05596552|Dexmedetomidine|dexmedetomidine|mesh-list
110086194|NCT05596552|Bupivacaine|bupivacaine|mesh-list
110086195|NCT05596552|Anesthetics, Local|anesthetics, local|mesh-ancestor
110086196|NCT05596552|Anesthetics|anesthetics|mesh-ancestor
110086197|NCT05596552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110086198|NCT05596552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110086199|NCT05596552|Sensory System Agents|sensory system agents|mesh-ancestor
110086200|NCT05596552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110086201|NCT05596552|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110086202|NCT05596552|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110086203|NCT05596552|Analgesics|analgesics|mesh-ancestor
110086204|NCT05596552|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110086205|NCT05596552|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110086206|NCT05596552|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110086207|NCT05596552|Adrenergic Agents|adrenergic agents|mesh-ancestor
110086208|NCT05596552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110086209|NCT05596552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110086210|NCT05596552|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110086211|NCT05596552|Narcotics|narcotics|mesh-ancestor
110086212|NCT05596552|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110086213|NCT05596552|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110086214|NCT05596552|Anesthetics, General|anesthetics, general|mesh-ancestor
110086215|NCT05596227|Fentanyl|fentanyl|mesh-list
110086216|NCT05596227|Narcotics|narcotics|mesh-list
110086217|NCT05596227|Propofol|propofol|mesh-list
110086218|NCT05596227|Anesthetics|anesthetics|mesh-list
110086219|NCT05596227|Sevoflurane|sevoflurane|mesh-list
110086220|NCT05596227|Rocuronium|rocuronium|mesh-list
110086221|NCT05596227|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110086222|NCT05596227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110086223|NCT05596227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110086224|NCT05596227|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110086225|NCT05596227|Anesthetics, General|anesthetics, general|mesh-ancestor
110086226|NCT05596227|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110086227|NCT05596227|Analgesics|analgesics|mesh-ancestor
110086228|NCT05596227|Sensory System Agents|sensory system agents|mesh-ancestor
110086229|NCT05596227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110086230|NCT05596227|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110086231|NCT05596227|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110086232|NCT05596227|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110086233|NCT05596227|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110086234|NCT05596227|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110086235|NCT05596227|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110086236|NCT05596214|Curcumin|curcumin|mesh-list
110086237|NCT05596214|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110086238|NCT05596214|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110086239|NCT05596214|Analgesics|analgesics|mesh-ancestor
110086240|NCT05596214|Sensory System Agents|sensory system agents|mesh-ancestor
110086241|NCT05596214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110086242|NCT05596214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110086243|NCT05596214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110086244|NCT05596214|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110086245|NCT05596214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110086246|NCT05596214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110086247|NCT05596214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110086248|NCT05596149|Listerine|listerine|mesh-list
110086249|NCT05596149|Fluorides|fluorides|mesh-list
110086250|NCT05596149|Sodium Fluoride|sodium fluoride|mesh-list
110086251|NCT05596149|Fluorophosphate|fluorophosphate|mesh-list
110086252|NCT05596149|Cariostatic Agents|cariostatic agents|mesh-ancestor
110086253|NCT05596149|Protective Agents|protective agents|mesh-ancestor
110086254|NCT05596149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110086255|NCT05596149|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110086256|NCT05596149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110086257|NCT05596097|Zanubrutinib|zanubrutinib|mesh-list
110086258|NCT05596097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110086259|NCT05596097|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110086260|NCT05596097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110086261|NCT05596097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110086262|NCT05596071|Sufentanil|sufentanil|mesh-list
110086264|NCT05596071|Ropivacaine|ropivacaine|mesh-list
110086265|NCT05596071|Anesthetics, Local|anesthetics, local|mesh-ancestor
110086266|NCT05596071|Anesthetics|anesthetics|mesh-ancestor
110086267|NCT05596071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110086268|NCT05596071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110086269|NCT05596071|Sensory System Agents|sensory system agents|mesh-ancestor
110086270|NCT05596071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110086271|NCT05596071|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110086272|NCT05596071|Narcotics|narcotics|mesh-ancestor
110086273|NCT05596071|Analgesics|analgesics|mesh-ancestor
110086274|NCT05596071|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110086275|NCT05596071|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110086276|NCT05596071|Anesthetics, General|anesthetics, general|mesh-ancestor
110086277|NCT05595824|Molnupiravir|molnupiravir|mesh-list
110086278|NCT05595824|Antiviral Agents|antiviral agents|mesh-ancestor
110086279|NCT05595824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110086280|NCT05595590|Tislelizumab|tislelizumab|mesh-list
110086281|NCT05595590|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110086282|NCT05595590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110086283|NCT05595447|Pembrolizumab|pembrolizumab|mesh-list
110086284|NCT05595447|Nivolumab|nivolumab|mesh-list
110086285|NCT05595447|Brentuximab Vedotin|brentuximab vedotin|mesh-list
110086286|NCT05595447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110086287|NCT05595447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110086288|NCT05595447|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110086289|NCT05595447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110086290|NCT05595447|Immunotoxins|immunotoxins|mesh-ancestor
110086291|NCT05595447|Immunoconjugates|immunoconjugates|mesh-ancestor
110086292|NCT05595447|Immunologic Factors|immunologic factors|mesh-ancestor
110086293|NCT05595447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110086294|NCT05595408|Immunomodulating Agents|immunomodulating agents|mesh-list
110086295|NCT05595408|Immunologic Factors|immunologic factors|mesh-ancestor
110086296|NCT05595408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110086297|NCT05567822|Esmolol|esmolol|mesh-list
110086298|NCT05567822|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110086299|NCT05567822|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110086300|NCT05567822|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110086301|NCT05567822|Adrenergic Agents|adrenergic agents|mesh-ancestor
110086302|NCT05567822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110086303|NCT05567822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110086304|NCT05567822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110086305|NCT05557253|Anesthetics|anesthetics|mesh-list
110086306|NCT05557253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110086307|NCT05557253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110086308|NCT05539924|Vitamin B 12|vitamin b 12|mesh-list
110086309|NCT05539924|Pregabalin|pregabalin|mesh-list
110086310|NCT05539924|Gabapentin|gabapentin|mesh-list
110086311|NCT05539924|Vitamins|vitamins|mesh-ancestor
110086312|NCT05539924|Micronutrients|micronutrients|mesh-ancestor
110086313|NCT05539924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110086314|NCT05539924|Analgesics|analgesics|mesh-ancestor
110086315|NCT05539924|Sensory System Agents|sensory system agents|mesh-ancestor
110086316|NCT05539924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110086317|NCT05539924|Anticonvulsants|anticonvulsants|mesh-ancestor
110086318|NCT05539924|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110086319|NCT05539924|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110086320|NCT05539924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110086321|NCT05539924|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110086323|NCT05539924|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110086324|NCT05539924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110086325|NCT05539924|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110086326|NCT05539924|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110086327|NCT05539924|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110086328|NCT05539924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110086329|NCT05539924|Antimanic Agents|antimanic agents|mesh-ancestor
110086330|NCT05539924|Vitamin B Complex|vitamin b complex|mesh-ancestor
110086331|NCT05514782|Sunscreening Agents|sunscreening agents|mesh-list
110086332|NCT05514782|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110086333|NCT05514782|Protective Agents|protective agents|mesh-ancestor
110086334|NCT05514782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110086335|NCT05514782|Dermatologic Agents|dermatologic agents|mesh-ancestor
110086336|NCT05479370|Vaccines|vaccines|mesh-list
110086337|NCT05479370|Immunologic Factors|immunologic factors|mesh-ancestor
110086338|NCT05479370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110086339|NCT05468242|Bevacizumab|bevacizumab|mesh-list
110086340|NCT05468242|Tislelizumab|tislelizumab|mesh-list
110086341|NCT05468242|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110086342|NCT05468242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110086343|NCT05468242|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110086344|NCT05468242|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110086345|NCT05468242|Growth Substances|growth substances|mesh-ancestor
110086346|NCT05468242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110086347|NCT05468242|Growth Inhibitors|growth inhibitors|mesh-ancestor
110086348|NCT05433402|Chlorpromazine|chlorpromazine|mesh-list
110086349|NCT05433402|Antiemetics|antiemetics|mesh-ancestor
110086350|NCT05433402|Autonomic Agents|autonomic agents|mesh-ancestor
110086351|NCT05433402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110086352|NCT05433402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110086353|NCT05433402|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110086354|NCT05433402|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110086355|NCT05433402|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110086356|NCT05433402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110086357|NCT05433402|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110086358|NCT05433402|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110086359|NCT05433402|Dopamine Agents|dopamine agents|mesh-ancestor
110086360|NCT05433402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110086361|NCT05433402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110086362|NCT05423951|Sufentanil|sufentanil|mesh-list
110086363|NCT05423951|Propofol|propofol|mesh-list
110086364|NCT05423951|Rocuronium|rocuronium|mesh-list
110086365|NCT05423951|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110086366|NCT05423951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110086367|NCT05423951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110086368|NCT05423951|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110086369|NCT05423951|Anesthetics, General|anesthetics, general|mesh-ancestor
110086370|NCT05423951|Anesthetics|anesthetics|mesh-ancestor
110086371|NCT05423951|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110086372|NCT05423951|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110086373|NCT05423951|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110086374|NCT05423951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110086375|NCT05423951|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110086376|NCT05423951|Narcotics|narcotics|mesh-ancestor
110086377|NCT05423951|Analgesics|analgesics|mesh-ancestor
110086378|NCT05423951|Sensory System Agents|sensory system agents|mesh-ancestor
110086379|NCT05423951|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110086380|NCT05405621|Exatecan|exatecan|mesh-list
110086381|NCT05405621|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110086382|NCT05405621|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110086383|NCT05405621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110086384|NCT05405621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110086385|NCT05405621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110086386|NCT05350696|Morphine|morphine|mesh-list
110086387|NCT05350696|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110086388|NCT05350696|Narcotics|narcotics|mesh-ancestor
110086389|NCT05350696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110086390|NCT05350696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110086391|NCT05350696|Analgesics|analgesics|mesh-ancestor
110086392|NCT05350696|Sensory System Agents|sensory system agents|mesh-ancestor
110086393|NCT05350696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110086395|NCT05291156|Avelumab|avelumab|mesh-list
110086396|NCT05291156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110086397|NCT05291156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110086398|NCT05253118|Pemetrexed|pemetrexed|mesh-list
110086399|NCT05253118|Tislelizumab|tislelizumab|mesh-list
110086400|NCT05253118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110086401|NCT05253118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110086402|NCT05253118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110086403|NCT05253118|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110086404|NCT05253118|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110086405|NCT05253118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110086406|NCT05226923|Meropenem|meropenem|mesh-list
110086407|NCT05226923|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110086408|NCT05226923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110086409|NCT05076838|Diazepam|diazepam|mesh-list
110086410|NCT05076838|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110086412|NCT05076838|Antiemetics|antiemetics|mesh-ancestor
110086413|NCT05076838|Autonomic Agents|autonomic agents|mesh-ancestor
110086414|NCT05076838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110086415|NCT05076838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110086416|NCT05076838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110086417|NCT05076838|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110086418|NCT05076838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110086419|NCT05076838|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110086420|NCT05076838|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110086421|NCT05076838|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110086422|NCT05076838|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110086423|NCT05076838|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110086424|NCT05076838|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110086425|NCT05076838|Anesthetics, General|anesthetics, general|mesh-ancestor
110086426|NCT05076838|Anesthetics|anesthetics|mesh-ancestor
110086427|NCT05076838|GABA Modulators|gaba modulators|mesh-ancestor
110086428|NCT05076838|GABA Agents|gaba agents|mesh-ancestor
110086429|NCT05076838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110086430|NCT05076838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110086431|NCT05057949|Itraconazole|itraconazole|mesh-list
110086432|NCT05057949|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
110086433|NCT05057949|Rifampin|rifampin|mesh-list
110086434|NCT05057949|Antifungal Agents|antifungal agents|mesh-ancestor
110086435|NCT05057949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110086436|NCT05057949|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110086437|NCT05057949|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110086438|NCT05057949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110086439|NCT05057949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110086440|NCT05057949|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110086441|NCT05057949|Hormone Antagonists|hormone antagonists|mesh-ancestor
110086442|NCT05057949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110086443|NCT05057949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110086444|NCT05057949|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110086445|NCT05057949|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110086446|NCT05057949|Antitubercular Agents|antitubercular agents|mesh-ancestor
110086447|NCT05057949|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110086448|NCT05057949|Leprostatic Agents|leprostatic agents|mesh-ancestor
110086449|NCT05057949|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110086450|NCT05057949|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110086451|NCT05057949|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110086452|NCT05057949|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110086453|NCT05057949|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110086454|NCT05057949|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110086455|NCT05057949|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110086456|NCT04925960|Epalrestat|epalrestat|mesh-list
110086457|NCT04925960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110086458|NCT04925960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110086459|NCT04901312|Analgesics, Opioid|analgesics, opioid|mesh-list
110086460|NCT04901312|Narcotics|narcotics|mesh-ancestor
110086461|NCT04901312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110086462|NCT04901312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110086463|NCT04901312|Analgesics|analgesics|mesh-ancestor
110086464|NCT04901312|Sensory System Agents|sensory system agents|mesh-ancestor
110086465|NCT04901312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110086466|NCT04886297|Resveratrol|resveratrol|mesh-list
110086467|NCT04886297|Antioxidants|antioxidants|mesh-ancestor
110086468|NCT04886297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110086469|NCT04886297|Protective Agents|protective agents|mesh-ancestor
110086470|NCT04886297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110086471|NCT04886297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110086472|NCT04886297|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110086473|NCT04830410|Levan|levan|mesh-list
110086474|NCT04830410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110086475|NCT04810793|Amoxicillin|amoxicillin|mesh-list
110086476|NCT04810793|Levofloxacin|levofloxacin|mesh-list
110086477|NCT04810793|Ofloxacin|ofloxacin|mesh-list
110086478|NCT04810793|Tetracycline|tetracycline|mesh-list
110086479|NCT04810793|Furazolidone|furazolidone|mesh-list
110086480|NCT04810793|Esomeprazole|esomeprazole|mesh-list
110086481|NCT04810793|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110086482|NCT04810793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110086483|NCT04810793|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110086484|NCT04810793|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110086485|NCT04810793|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110086486|NCT04810793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110086487|NCT04810793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110086488|NCT04810793|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110086489|NCT04810793|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110086490|NCT04810793|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110086491|NCT04810793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110086492|NCT04810793|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110185265|NCT00038181|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110086493|NCT04810793|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110086494|NCT04810793|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110086495|NCT04810793|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110086496|NCT04810793|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
110086497|NCT04810793|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110086498|NCT04810793|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110086499|NCT04810793|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
110086500|NCT04797832|Ferric gluconate|ferric gluconate|mesh-list
110086501|NCT04797832|Hematinics|hematinics|mesh-ancestor
110086502|NCT04684511|Rofecoxib|rofecoxib|mesh-list
110086503|NCT04684511|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110086504|NCT04684511|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110086505|NCT04684511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110086506|NCT04684511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110086507|NCT04684511|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110086508|NCT04684511|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110086509|NCT04684511|Analgesics|analgesics|mesh-ancestor
110086510|NCT04684511|Sensory System Agents|sensory system agents|mesh-ancestor
110086511|NCT04684511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110086512|NCT04684511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110086513|NCT04684511|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110086514|NCT04684511|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110086515|NCT04650841|Naloxone|naloxone|mesh-list
110086516|NCT04650841|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110086517|NCT04650841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110086518|NCT04650841|Sensory System Agents|sensory system agents|mesh-ancestor
110086519|NCT04650841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110086520|NCT04624854|Aspirin|aspirin|mesh-list
110086521|NCT04624854|Clopidogrel|clopidogrel|mesh-list
110086522|NCT04624854|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110086523|NCT04624854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110086524|NCT04624854|Analgesics|analgesics|mesh-ancestor
110086525|NCT04624854|Sensory System Agents|sensory system agents|mesh-ancestor
110086526|NCT04624854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110086527|NCT04624854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110086528|NCT04624854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110086529|NCT04624854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110086530|NCT04624854|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110086531|NCT04624854|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110086532|NCT04624854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110086533|NCT04624854|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110086534|NCT04624854|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110086535|NCT04624854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110086536|NCT04624854|Antipyretics|antipyretics|mesh-ancestor
110086537|NCT04624854|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110086538|NCT04624854|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110086539|NCT04624854|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110086540|NCT04624854|Purinergic Agents|purinergic agents|mesh-ancestor
110086541|NCT04624854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110086542|NCT04602598|Zanubrutinib|zanubrutinib|mesh-list
110086543|NCT04602598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110086544|NCT04602598|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110086545|NCT04602598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110086546|NCT04602598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110086547|NCT04565171|Yimitasvir|yimitasvir|mesh-list
110086548|NCT04565171|Antiviral Agents|antiviral agents|mesh-ancestor
110086549|NCT04565171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110086550|NCT04463368|Nivolumab|nivolumab|mesh-list
110086551|NCT04463368|Ipilimumab|ipilimumab|mesh-list
110086552|NCT04463368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110086553|NCT04463368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110086554|NCT04463368|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110086555|NCT04463368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110086556|NCT04450407|Insulin|insulin|mesh-list
110086557|NCT04450407|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110086558|NCT04450407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110086559|NCT04231838|Nicotine|nicotine|mesh-list
110086560|NCT04231838|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110185271|NCT00038220|Lopinavir|lopinavir|mesh-list
110086561|NCT04231838|Autonomic Agents|autonomic agents|mesh-ancestor
110086562|NCT04231838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110086563|NCT04231838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110086564|NCT04231838|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110086565|NCT04231838|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110086566|NCT04231838|Cholinergic Agents|cholinergic agents|mesh-ancestor
110086567|NCT04231838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110086568|NCT04231838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110086569|NCT04218266|Apixaban|apixaban|mesh-list
110086570|NCT04218266|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110086571|NCT04218266|Antithrombins|antithrombins|mesh-ancestor
110086572|NCT04218266|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110086573|NCT04218266|Protease Inhibitors|protease inhibitors|mesh-ancestor
110086574|NCT04218266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110086575|NCT04218266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110086576|NCT04218266|Anticoagulants|anticoagulants|mesh-ancestor
110086577|NCT04172363|Octenidine|octenidine|mesh-list
110086578|NCT04172363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110086579|NCT04172363|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110086580|NCT04074603|Insulin|insulin|mesh-list
110086581|NCT04074603|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110086582|NCT04074603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110086583|NCT04068246|Metformin|metformin|mesh-list
110086584|NCT04068246|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110086585|NCT04068246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110086586|NCT04063033|Ferric gluconate|ferric gluconate|mesh-list
110086587|NCT04063033|Hematinics|hematinics|mesh-ancestor
110086588|NCT04037605|Ketoconazole|ketoconazole|mesh-list
110086589|NCT04037605|Dexamethasone|dexamethasone|mesh-list
110086590|NCT04037605|Dexamethasone acetate|dexamethasone acetate|mesh-list
110086591|NCT04037605|Hydrocortisone|hydrocortisone|mesh-list
110086592|NCT04037605|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
110086593|NCT04037605|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110086594|NCT04037605|Hormones|hormones|mesh-list
110086595|NCT04037605|Cosyntropin|cosyntropin|mesh-list
110086596|NCT04037605|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
110086597|NCT04037605|BB 1101|bb 1101|mesh-list
110086598|NCT04037605|Ganirelix|ganirelix|mesh-list
110086599|NCT04037605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110086600|NCT04037605|Antiemetics|antiemetics|mesh-ancestor
110086601|NCT04037605|Autonomic Agents|autonomic agents|mesh-ancestor
110086602|NCT04037605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110086603|NCT04037605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110086604|NCT04037605|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110086605|NCT04037605|Glucocorticoids|glucocorticoids|mesh-ancestor
110086606|NCT04037605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110086607|NCT04037605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110086608|NCT04037605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110086609|NCT04037605|Protease Inhibitors|protease inhibitors|mesh-ancestor
110086610|NCT04037605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110086611|NCT04037605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110086612|NCT04037605|Antifungal Agents|antifungal agents|mesh-ancestor
110086613|NCT04037605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110086614|NCT04037605|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110086615|NCT04037605|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110086616|NCT04037605|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110086617|NCT04037605|Hormone Antagonists|hormone antagonists|mesh-ancestor
110086618|NCT04037605|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110086619|NCT04002258|Antipsychotic Agents|antipsychotic agents|mesh-list
110086620|NCT04002258|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110086621|NCT04002258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110086623|NCT04002258|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110086625|NCT03928093|Analgesics|analgesics|mesh-ancestor
110086626|NCT03928093|Sensory System Agents|sensory system agents|mesh-ancestor
110086627|NCT03928093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110086628|NCT03928093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110086629|NCT03928093|Anticonvulsants|anticonvulsants|mesh-ancestor
110086630|NCT03928093|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110086631|NCT03928093|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110086632|NCT03928093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110086633|NCT03928093|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110086634|NCT03928093|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110086635|NCT03928093|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110086636|NCT03928093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110086637|NCT03928093|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110086638|NCT03907800|Paclitaxel|paclitaxel|mesh-list
110086639|NCT03907800|Carboplatin|carboplatin|mesh-list
110086640|NCT03907800|Trastuzumab|trastuzumab|mesh-list
110086641|NCT03907800|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110086642|NCT03907800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110086643|NCT03907800|Tubulin Modulators|tubulin modulators|mesh-ancestor
110086644|NCT03907800|Antimitotic Agents|antimitotic agents|mesh-ancestor
110086645|NCT03907800|Mitosis Modulators|mitosis modulators|mesh-ancestor
110086646|NCT03907800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110086647|NCT03907800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110086648|NCT03894904|Heparin|heparin|mesh-list
110086649|NCT03894904|Papaverine|papaverine|mesh-list
110086650|NCT03894904|Anticoagulants|anticoagulants|mesh-ancestor
110086651|NCT03894904|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110086652|NCT03894904|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110086653|NCT03894904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110086654|NCT03894904|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110086655|NCT03894904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110086656|NCT03894904|Vasodilator Agents|vasodilator agents|mesh-ancestor
110086657|NCT03894904|Urological Agents|urological agents|mesh-ancestor
110086658|NCT03797833|Anesthetics|anesthetics|mesh-list
110086659|NCT03797833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110086660|NCT03797833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110086661|NCT03749174|Anesthetics|anesthetics|mesh-list
110086662|NCT03749174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110086663|NCT03749174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110086664|NCT03722927|Bupivacaine|bupivacaine|mesh-list
110086665|NCT03722927|Anesthetics, Local|anesthetics, local|mesh-ancestor
110086666|NCT03722927|Anesthetics|anesthetics|mesh-ancestor
110086667|NCT03722927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110086668|NCT03722927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110086669|NCT03722927|Sensory System Agents|sensory system agents|mesh-ancestor
110086670|NCT03722927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110086671|NCT03681652|Azathioprine|azathioprine|mesh-list
110086672|NCT03681652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110086673|NCT03681652|Antimetabolites|antimetabolites|mesh-ancestor
110086674|NCT03681652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110086675|NCT03681652|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110086676|NCT03681652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110086677|NCT03681652|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110086678|NCT03681652|Immunologic Factors|immunologic factors|mesh-ancestor
110086679|NCT03681652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110086680|NCT03578198|Rituximab|rituximab|mesh-list
110086681|NCT03578198|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110086682|NCT03578198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110086683|NCT03578198|Immunologic Factors|immunologic factors|mesh-ancestor
110086684|NCT03578198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110086685|NCT03578198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110086737|NCT03517176|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110086738|NCT03517176|Antimetabolites|antimetabolites|mesh-ancestor
110086739|NCT03512964|Tenofovir|tenofovir|mesh-list
110086740|NCT03512964|Emtricitabine|emtricitabine|mesh-list
110086741|NCT03512964|Dolutegravir|dolutegravir|mesh-list
110086742|NCT03512964|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
110086743|NCT03512964|Antiviral Agents|antiviral agents|mesh-ancestor
110086744|NCT03512964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110086745|NCT03512964|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110086746|NCT03512964|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110086747|NCT03512964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110086748|NCT03512964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110086749|NCT03512964|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110086750|NCT03512964|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110086751|NCT03512964|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110086752|NCT03512964|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110086753|NCT03476109|Omalizumab|omalizumab|mesh-list
110086754|NCT03476109|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110086755|NCT03476109|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110086756|NCT03476109|Respiratory System Agents|respiratory system agents|mesh-ancestor
110086757|NCT03463499|Hyaluronic Acid|hyaluronic acid|mesh-list
110086758|NCT03463499|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110086759|NCT03463499|Immunologic Factors|immunologic factors|mesh-ancestor
110086760|NCT03463499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110086761|NCT03463499|Viscosupplements|viscosupplements|mesh-ancestor
110086762|NCT03463499|Protective Agents|protective agents|mesh-ancestor
110086763|NCT03366974|Clarithromycin|clarithromycin|mesh-list
110086765|NCT03366974|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110086766|NCT03366974|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110086767|NCT03366974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110086768|NCT03366974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110086769|NCT03366974|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110086770|NCT03366974|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110086771|NCT03366974|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110086772|NCT03366974|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110086773|NCT03366974|Anesthetics, General|anesthetics, general|mesh-ancestor
110086774|NCT03366974|Anesthetics|anesthetics|mesh-ancestor
110086775|NCT03366974|GABA Modulators|gaba modulators|mesh-ancestor
110086776|NCT03366974|GABA Agents|gaba agents|mesh-ancestor
110086777|NCT03366974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110086778|NCT03366974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110086779|NCT03366974|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110086780|NCT03366974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110086781|NCT03366974|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110086782|NCT03366974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110086783|NCT03366974|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110086784|NCT03366974|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110086785|NCT03340129|Nivolumab|nivolumab|mesh-list
110086786|NCT03340129|Ipilimumab|ipilimumab|mesh-list
110086787|NCT03340129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110086788|NCT03340129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110086789|NCT03340129|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110086790|NCT03340129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110086791|NCT03307746|Rituximab|rituximab|mesh-list
110086792|NCT03307746|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110086793|NCT03307746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110086794|NCT03307746|Immunologic Factors|immunologic factors|mesh-ancestor
110086795|NCT03307746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110086796|NCT03307746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110086797|NCT03294083|Cemiplimab|cemiplimab|mesh-list
110086798|NCT03294083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110086799|NCT03294083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110086800|NCT03128398|Domperidone|domperidone|mesh-list
110086801|NCT03128398|Antiemetics|antiemetics|mesh-ancestor
110086802|NCT03128398|Autonomic Agents|autonomic agents|mesh-ancestor
110086803|NCT03128398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110086804|NCT03128398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110086805|NCT03128398|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110086806|NCT03128398|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110086807|NCT03128398|Dopamine Agents|dopamine agents|mesh-ancestor
110086808|NCT03128398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110086809|NCT03128398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110086810|NCT03119038|Ketorolac|ketorolac|mesh-list
110086811|NCT03119038|Clonidine|clonidine|mesh-list
110086812|NCT03119038|Epinephrine|epinephrine|mesh-list
110086813|NCT03119038|Bupivacaine|bupivacaine|mesh-list
110086814|NCT03119038|Ropivacaine|ropivacaine|mesh-list
110086815|NCT03119038|Anesthetics, Local|anesthetics, local|mesh-ancestor
110086816|NCT03119038|Anesthetics|anesthetics|mesh-ancestor
110086817|NCT03119038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110086818|NCT03119038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110086819|NCT03119038|Sensory System Agents|sensory system agents|mesh-ancestor
110086820|NCT03119038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110086821|NCT03119038|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110086822|NCT03119038|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110086823|NCT03119038|Adrenergic Agents|adrenergic agents|mesh-ancestor
110086824|NCT03119038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110185310|NCT00847262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110086825|NCT03119038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110086826|NCT03119038|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110086827|NCT03119038|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110086828|NCT03119038|Autonomic Agents|autonomic agents|mesh-ancestor
110086829|NCT03119038|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110086830|NCT03119038|Respiratory System Agents|respiratory system agents|mesh-ancestor
110086832|NCT03119038|Sympathomimetics|sympathomimetics|mesh-ancestor
110086833|NCT03119038|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110086834|NCT03119038|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110086835|NCT03119038|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110086836|NCT03119038|Analgesics|analgesics|mesh-ancestor
110086837|NCT03119038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110086838|NCT03119038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110086839|NCT03119038|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110086841|NCT03119038|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110086842|NCT03119038|Sympatholytics|sympatholytics|mesh-ancestor
110086843|NCT03119038|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110086844|NCT03099265|Leucovorin|leucovorin|mesh-list
110086845|NCT03099265|Fluorouracil|fluorouracil|mesh-list
110086846|NCT03099265|Oxaliplatin|oxaliplatin|mesh-list
110086847|NCT03099265|Irinotecan|irinotecan|mesh-list
110086848|NCT03099265|Antimetabolites|antimetabolites|mesh-ancestor
110086849|NCT03099265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110086850|NCT03099265|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110086851|NCT03099265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110086852|NCT03099265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110086853|NCT03099265|Immunologic Factors|immunologic factors|mesh-ancestor
110086854|NCT03099265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110086855|NCT03099265|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110086856|NCT03099265|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110086857|NCT03099265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110086858|NCT03099265|Antidotes|antidotes|mesh-ancestor
110086859|NCT03099265|Protective Agents|protective agents|mesh-ancestor
110086860|NCT03099265|Vitamin B Complex|vitamin b complex|mesh-ancestor
110086861|NCT03099265|Vitamins|vitamins|mesh-ancestor
110086862|NCT03099265|Micronutrients|micronutrients|mesh-ancestor
110086863|NCT03063749|Sirolimus|sirolimus|mesh-list
110086864|NCT03063749|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110086865|NCT03063749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110086866|NCT03063749|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110086867|NCT03063749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110086868|NCT03063749|Antifungal Agents|antifungal agents|mesh-ancestor
110086869|NCT03063749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110086870|NCT03063749|Immunologic Factors|immunologic factors|mesh-ancestor
110086871|NCT03063749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110086872|NCT03007589|Sunscreening Agents|sunscreening agents|mesh-list
110086873|NCT03007589|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110086874|NCT03007589|Protective Agents|protective agents|mesh-ancestor
110086875|NCT03007589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110086876|NCT03007589|Dermatologic Agents|dermatologic agents|mesh-ancestor
110086877|NCT02975037|Clarithromycin|clarithromycin|mesh-list
110086878|NCT02975037|Itraconazole|itraconazole|mesh-list
110086879|NCT02975037|Sildenafil Citrate|sildenafil citrate|mesh-list
110086880|NCT02975037|Vasodilator Agents|vasodilator agents|mesh-ancestor
110086881|NCT02975037|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110086882|NCT02975037|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110086883|NCT02975037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110086884|NCT02975037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110086885|NCT02975037|Urological Agents|urological agents|mesh-ancestor
110086886|NCT02975037|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110086887|NCT02975037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110086888|NCT02975037|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110086889|NCT02975037|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110086890|NCT02975037|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110086891|NCT02975037|Antifungal Agents|antifungal agents|mesh-ancestor
110086892|NCT02975037|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110086893|NCT02975037|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110086894|NCT02975037|Hormone Antagonists|hormone antagonists|mesh-ancestor
110086895|NCT02975037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110086896|NCT02975037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110086897|NCT02931890|Paclitaxel|paclitaxel|mesh-list
110086898|NCT02931890|Docetaxel|docetaxel|mesh-list
110086900|NCT02931890|Capecitabine|capecitabine|mesh-list
110086901|NCT02931890|Oxaliplatin|oxaliplatin|mesh-list
110086902|NCT02931890|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110086903|NCT02931890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110086904|NCT02931890|Tubulin Modulators|tubulin modulators|mesh-ancestor
110086905|NCT02931890|Antimitotic Agents|antimitotic agents|mesh-ancestor
110086906|NCT02931890|Mitosis Modulators|mitosis modulators|mesh-ancestor
110086907|NCT02931890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110086908|NCT02931890|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110086909|NCT02931890|Antimetabolites|antimetabolites|mesh-ancestor
110086910|NCT02812862|Tiotropium Bromide|tiotropium bromide|mesh-list
110086912|NCT02812862|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110086913|NCT02812862|Autonomic Agents|autonomic agents|mesh-ancestor
110086914|NCT02812862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110086915|NCT02812862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110086916|NCT02812862|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110086917|NCT02812862|Respiratory System Agents|respiratory system agents|mesh-ancestor
110086918|NCT02812862|Parasympatholytics|parasympatholytics|mesh-ancestor
110086919|NCT02812862|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110086920|NCT02812862|Cholinergic Agents|cholinergic agents|mesh-ancestor
110086921|NCT02812862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110086922|NCT02812862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110086924|NCT02587312|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110086925|NCT02587312|Autonomic Agents|autonomic agents|mesh-ancestor
110086926|NCT02587312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110086927|NCT02587312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110086928|NCT02587312|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110086929|NCT02587312|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110086930|NCT02587312|Cholinergic Agents|cholinergic agents|mesh-ancestor
110086931|NCT02587312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110086932|NCT02587312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110086933|NCT02549677|Cyclophosphamide|cyclophosphamide|mesh-list
110086934|NCT02549677|Docetaxel|docetaxel|mesh-list
110086935|NCT02549677|Epirubicin|epirubicin|mesh-list
110086936|NCT02549677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110086937|NCT02549677|Immunologic Factors|immunologic factors|mesh-ancestor
110086938|NCT02549677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110086939|NCT02549677|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110086940|NCT02549677|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110086941|NCT02549677|Alkylating Agents|alkylating agents|mesh-ancestor
110086942|NCT02549677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110086943|NCT02549677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110086944|NCT02549677|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110086945|NCT02549677|Tubulin Modulators|tubulin modulators|mesh-ancestor
110086946|NCT02549677|Antimitotic Agents|antimitotic agents|mesh-ancestor
110086947|NCT02549677|Mitosis Modulators|mitosis modulators|mesh-ancestor
110086948|NCT02549677|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110086949|NCT02549677|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110086950|NCT02549677|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110086951|NCT02549677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110086952|NCT02450253|Tadalafil|tadalafil|mesh-list
110086953|NCT02450253|Vasodilator Agents|vasodilator agents|mesh-ancestor
110086954|NCT02450253|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110086955|NCT02450253|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110086956|NCT02450253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110086957|NCT02450253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110086958|NCT02450253|Urological Agents|urological agents|mesh-ancestor
110086959|NCT02257970|Ketoprofen|ketoprofen|mesh-list
110086960|NCT02257970|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110086961|NCT02257970|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110086962|NCT02257970|Analgesics|analgesics|mesh-ancestor
110086963|NCT02257970|Sensory System Agents|sensory system agents|mesh-ancestor
110086964|NCT02257970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110086965|NCT02257970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110086966|NCT02257970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110086967|NCT02257970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110086968|NCT02257970|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110086969|NCT02257970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110086970|NCT02257970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110086971|NCT05838729|Pembrolizumab|pembrolizumab|mesh-list
110086972|NCT05838729|Nivolumab|nivolumab|mesh-list
110086973|NCT05838729|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
110086974|NCT05838729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110086975|NCT05838729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110086976|NCT05838729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110086977|NCT05838599|Imiquimod|imiquimod|mesh-list
110086978|NCT05838599|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110086979|NCT05838599|Immunologic Factors|immunologic factors|mesh-ancestor
110086980|NCT05838599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110086981|NCT05838599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110086982|NCT05838599|Interferon Inducers|interferon inducers|mesh-ancestor
110086983|NCT05838248|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110086984|NCT05838248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110086985|NCT05838105|Progesterone|progesterone|mesh-list
110086987|NCT05838105|Hormones|hormones|mesh-ancestor
110086988|NCT05838105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110086989|NCT05838105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110086990|NCT05838066|Docetaxel|docetaxel|mesh-list
110086991|NCT05838066|Trastuzumab|trastuzumab|mesh-list
110086992|NCT05838066|Pertuzumab|pertuzumab|mesh-list
110086993|NCT05838066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110086994|NCT05838066|Tubulin Modulators|tubulin modulators|mesh-ancestor
110086995|NCT05838066|Antimitotic Agents|antimitotic agents|mesh-ancestor
110086996|NCT05838066|Mitosis Modulators|mitosis modulators|mesh-ancestor
110086997|NCT05838066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110086998|NCT05838066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110086999|NCT05838001|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
110087000|NCT05838001|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
110087001|NCT05838001|beta-Endorphin|beta-endorphin|mesh-list
110087002|NCT05838001|Hormones|hormones|mesh-ancestor
110087003|NCT05838001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110087004|NCT05838001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110087005|NCT05838001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110087006|NCT05838001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110087007|NCT05837936|Anesthetics|anesthetics|mesh-list
110087008|NCT05837936|Sevoflurane|sevoflurane|mesh-list
110087009|NCT05837936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110087010|NCT05837936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110087011|NCT05837936|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110087012|NCT05837936|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110087013|NCT05837936|Anesthetics, General|anesthetics, general|mesh-ancestor
110087014|NCT05837845|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
110087015|NCT05837845|Hallucinogens|hallucinogens|mesh-ancestor
110087016|NCT05837845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110087017|NCT05837845|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110087018|NCT05837845|Serotonin Agents|serotonin agents|mesh-ancestor
110087019|NCT05837845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110087020|NCT05837845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110087021|NCT05837845|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110087022|NCT05837845|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110087023|NCT05837845|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110087024|NCT05837845|Adrenergic Agents|adrenergic agents|mesh-ancestor
110087025|NCT05837806|Tislelizumab|tislelizumab|mesh-list
110087026|NCT05837806|Disitamab vedotin|disitamab vedotin|mesh-list
110087027|NCT05837806|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110087028|NCT05837806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110087029|NCT05837806|Immunoconjugates|immunoconjugates|mesh-ancestor
110087030|NCT05837806|Immunologic Factors|immunologic factors|mesh-ancestor
110087031|NCT05837806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110087033|NCT05837689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110087034|NCT05837286|Cortisone|cortisone|mesh-list
110087035|NCT05837286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110087036|NCT05836857|Cannabidiol|cannabidiol|mesh-list
110087037|NCT05836857|Anticonvulsants|anticonvulsants|mesh-ancestor
110087038|NCT05836831|Tranexamic Acid|tranexamic acid|mesh-list
110087039|NCT05836831|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110087040|NCT05836831|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110087041|NCT05836831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110087042|NCT05836831|Hemostatics|hemostatics|mesh-ancestor
110087043|NCT05836831|Coagulants|coagulants|mesh-ancestor
110087044|NCT05836545|Midazolam|midazolam|mesh-list
110087045|NCT05836545|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110087046|NCT05836545|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110087047|NCT05836545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110087048|NCT05836545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110087049|NCT05836545|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110087050|NCT05836545|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110087051|NCT05836545|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110087052|NCT05836545|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110087053|NCT05836545|Anesthetics, General|anesthetics, general|mesh-ancestor
110087054|NCT05836545|Anesthetics|anesthetics|mesh-ancestor
110087055|NCT05836545|GABA Modulators|gaba modulators|mesh-ancestor
110087056|NCT05836545|GABA Agents|gaba agents|mesh-ancestor
110087057|NCT05836545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110087058|NCT05836545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110087059|NCT05836441|Tacrolimus|tacrolimus|mesh-list
110087060|NCT05836441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110087061|NCT05836441|Immunologic Factors|immunologic factors|mesh-ancestor
110087062|NCT05836441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110087063|NCT05836441|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110087064|NCT05836441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110087065|NCT05836441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110087066|NCT05836233|Vasodilator Agents|vasodilator agents|mesh-list
110087067|NCT05835999|Everolimus|everolimus|mesh-list
110087068|NCT05835999|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110087069|NCT05835999|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110087070|NCT05835999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110087071|NCT05835999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110087072|NCT05835999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110087073|NCT05835999|Immunologic Factors|immunologic factors|mesh-ancestor
110087074|NCT05835999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110087075|NCT05835999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110087076|NCT05835726|Daratumumab|daratumumab|mesh-list
110087077|NCT05835726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110087078|NCT05834049|Midazolam|midazolam|mesh-list
110087079|NCT05834049|Anesthetics|anesthetics|mesh-ancestor
110087080|NCT05834049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110087081|NCT05834049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110087082|NCT05834049|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110087083|NCT05834049|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110087084|NCT05834049|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110087085|NCT05834049|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110087086|NCT05834049|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110087087|NCT05834049|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110087088|NCT05834049|Anesthetics, General|anesthetics, general|mesh-ancestor
110087089|NCT05834049|GABA Modulators|gaba modulators|mesh-ancestor
110087090|NCT05834049|GABA Agents|gaba agents|mesh-ancestor
110087091|NCT05834049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110087092|NCT05834049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110087093|NCT05833217|Insulin|insulin|mesh-list
110087094|NCT05833217|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110087095|NCT05833217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110087096|NCT05814744|Dexmedetomidine|dexmedetomidine|mesh-list
110087097|NCT05814744|Bupivacaine|bupivacaine|mesh-list
110087098|NCT05814744|Anesthetics, Local|anesthetics, local|mesh-ancestor
110087099|NCT05814744|Anesthetics|anesthetics|mesh-ancestor
110087100|NCT05814744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110087101|NCT05814744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110087102|NCT05814744|Sensory System Agents|sensory system agents|mesh-ancestor
110087103|NCT05814744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110087104|NCT05814744|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110087105|NCT05814744|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110087106|NCT05814744|Analgesics|analgesics|mesh-ancestor
110087107|NCT05814744|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110087108|NCT05814744|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110087109|NCT05814744|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110087110|NCT05814744|Adrenergic Agents|adrenergic agents|mesh-ancestor
110087111|NCT05814744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110087112|NCT05814744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110087114|NCT05797558|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
110087115|NCT05797558|Mineralocorticoids|mineralocorticoids|mesh-list
110087116|NCT05797558|Hormone Antagonists|hormone antagonists|mesh-ancestor
110087117|NCT05797558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110087118|NCT05797558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110087119|NCT05797558|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110087120|NCT05797558|Diuretics|diuretics|mesh-ancestor
110087121|NCT05797558|Natriuretic Agents|natriuretic agents|mesh-ancestor
110087122|NCT05797558|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110087124|NCT05786820|Pycnogenols|pycnogenols|mesh-list
110087125|NCT05786820|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110087127|NCT05786820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110087128|NCT05786820|Antioxidants|antioxidants|mesh-ancestor
110087129|NCT05786820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110087130|NCT05786820|Protective Agents|protective agents|mesh-ancestor
110087131|NCT05786820|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110087132|NCT05781308|Paclitaxel|paclitaxel|mesh-list
110087133|NCT05781308|Bevacizumab|bevacizumab|mesh-list
110087134|NCT05781308|Atezolizumab|atezolizumab|mesh-list
110087135|NCT05781308|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110087136|NCT05781308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110087137|NCT05781308|Tubulin Modulators|tubulin modulators|mesh-ancestor
110087138|NCT05781308|Antimitotic Agents|antimitotic agents|mesh-ancestor
110087139|NCT05781308|Mitosis Modulators|mitosis modulators|mesh-ancestor
110087140|NCT05781308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110087141|NCT05781308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110087142|NCT05781308|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110087143|NCT05781308|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110087144|NCT05781308|Growth Substances|growth substances|mesh-ancestor
110087145|NCT05781308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110087146|NCT05781308|Growth Inhibitors|growth inhibitors|mesh-ancestor
110087147|NCT05781308|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110087148|NCT05772156|Methylergonovine|methylergonovine|mesh-list
110087149|NCT05772156|Oxytocics|oxytocics|mesh-ancestor
110087150|NCT05772156|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110087151|NCT05772156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110087152|NCT05769868|Esmolol|esmolol|mesh-list
110087153|NCT05769868|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110087154|NCT05769868|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110087155|NCT05769868|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110087156|NCT05769868|Adrenergic Agents|adrenergic agents|mesh-ancestor
110087157|NCT05769868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110087158|NCT05769868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110087159|NCT05769868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110087160|NCT05727579|Ertugliflozin|ertugliflozin|mesh-list
110087161|NCT05727579|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110087162|NCT05727579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110087163|NCT05727579|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110087164|NCT05727579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110087165|NCT05685615|Polymyxins|polymyxins|mesh-list
110087166|NCT05685615|Polymyxin B|polymyxin b|mesh-list
110087167|NCT05685615|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110087168|NCT05685615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110087169|NCT05652764|Immunomodulating Agents|immunomodulating agents|mesh-list
110087170|NCT05652764|Immunologic Factors|immunologic factors|mesh-ancestor
110087171|NCT05652764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110087172|NCT05650996|Calpastatin|calpastatin|mesh-list
110087173|NCT05650996|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
110087174|NCT05650996|Protease Inhibitors|protease inhibitors|mesh-ancestor
110087175|NCT05650996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110087176|NCT05650996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110087177|NCT05597254|Niacin|niacin|mesh-list
110087178|NCT05597254|Niacinamide|niacinamide|mesh-list
110087179|NCT05597254|Nicotinic Acids|nicotinic acids|mesh-list
110087180|NCT05597254|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110087181|NCT05597254|Antimetabolites|antimetabolites|mesh-ancestor
110087182|NCT05597254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110087183|NCT05597254|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110087184|NCT05597254|Vasodilator Agents|vasodilator agents|mesh-ancestor
110087185|NCT05597254|Vitamin B Complex|vitamin b complex|mesh-ancestor
110087186|NCT05597254|Vitamins|vitamins|mesh-ancestor
110087187|NCT05597254|Micronutrients|micronutrients|mesh-ancestor
110087188|NCT05597254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110087189|NCT05576415|Varenicline|varenicline|mesh-list
110087190|NCT05576415|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110087191|NCT05576415|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110087192|NCT05576415|Cholinergic Agents|cholinergic agents|mesh-ancestor
110087193|NCT05576415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110087194|NCT05576415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110087195|NCT05576415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110087197|NCT05324761|Gabapentin|gabapentin|mesh-list
110087198|NCT05324761|Analgesics|analgesics|mesh-ancestor
110087199|NCT05324761|Sensory System Agents|sensory system agents|mesh-ancestor
110087200|NCT05324761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110087201|NCT05324761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110087202|NCT05324761|Anticonvulsants|anticonvulsants|mesh-ancestor
110087203|NCT05324761|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110087204|NCT05324761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110087205|NCT05324761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110087206|NCT05324761|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110087207|NCT05324761|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110087208|NCT05324761|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110087209|NCT05324761|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110087210|NCT05324761|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110087211|NCT05324761|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110087212|NCT05324761|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110087213|NCT05324761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110087214|NCT05324761|Antimanic Agents|antimanic agents|mesh-ancestor
110087215|NCT05317403|Cytarabine|cytarabine|mesh-list
110087216|NCT05317403|Fludarabine|fludarabine|mesh-list
110087217|NCT05317403|Venetoclax|venetoclax|mesh-list
110087218|NCT05317403|Vorinostat|vorinostat|mesh-list
110087219|NCT05317403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110087220|NCT05317403|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110087221|NCT05317403|Antimetabolites|antimetabolites|mesh-ancestor
110087222|NCT05317403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110087223|NCT05317403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110087224|NCT05317403|Immunologic Factors|immunologic factors|mesh-ancestor
110087225|NCT05317403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110087226|NCT05317403|Antiviral Agents|antiviral agents|mesh-ancestor
110087227|NCT05317403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110087228|NCT05317403|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110087229|NCT05317403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110087230|NCT05312242|Folic Acid|folic acid|mesh-list
110087231|NCT05312242|Micronutrients|micronutrients|mesh-list
110087232|NCT05312242|Trace Elements|trace elements|mesh-list
110087233|NCT05312242|Hematinics|hematinics|mesh-ancestor
110087234|NCT05312242|Vitamin B Complex|vitamin b complex|mesh-ancestor
110087235|NCT05312242|Vitamins|vitamins|mesh-ancestor
110087236|NCT05312242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110087237|NCT05288829|Ravulizumab|ravulizumab|mesh-list
110087238|NCT05288829|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
110087239|NCT05288829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110087240|NCT05288829|Immunologic Factors|immunologic factors|mesh-ancestor
110087241|NCT05288829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110087242|NCT05233566|Ketamine|ketamine|mesh-list
110087243|NCT05233566|Analgesics|analgesics|mesh-ancestor
110087244|NCT05233566|Sensory System Agents|sensory system agents|mesh-ancestor
110087245|NCT05233566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110087246|NCT05233566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110087247|NCT05233566|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110087248|NCT05233566|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110087249|NCT05233566|Anesthetics, General|anesthetics, general|mesh-ancestor
110087250|NCT05233566|Anesthetics|anesthetics|mesh-ancestor
110087251|NCT05233566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110087252|NCT05233566|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110087253|NCT05233566|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110087254|NCT05233566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110087255|NCT05233566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110087256|NCT05232344|Estradiol|estradiol|mesh-list
110087257|NCT05232344|Progesterone|progesterone|mesh-list
110087258|NCT05232344|Estrogens|estrogens|mesh-ancestor
110087260|NCT05232344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110087261|NCT05232344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110087262|NCT05232344|Progestins|progestins|mesh-ancestor
110087263|NCT05210517|Empagliflozin|empagliflozin|mesh-list
110087264|NCT05210517|Benzbromarone|benzbromarone|mesh-list
110087265|NCT05210517|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110087266|NCT05210517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110087267|NCT05210517|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110087268|NCT05210517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110087269|NCT05210517|Uricosuric Agents|uricosuric agents|mesh-ancestor
110087270|NCT05210517|Gout Suppressants|gout suppressants|mesh-ancestor
110087271|NCT05210517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110087272|NCT05180994|Infliximab|infliximab|mesh-list
110087273|NCT05180994|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110087274|NCT05180994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110087275|NCT05180994|Dermatologic Agents|dermatologic agents|mesh-ancestor
110087276|NCT05180994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110087277|NCT05180994|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110087279|NCT05118685|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
110087280|NCT05118685|Hormones|hormones|mesh-ancestor
110087281|NCT05118685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110087282|NCT05118685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110087283|NCT05109650|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110087284|NCT05109650|Antibodies|antibodies|mesh-list
110087285|NCT05109650|Immunoglobulins|immunoglobulins|mesh-list
110087286|NCT05109650|Immunologic Factors|immunologic factors|mesh-ancestor
110087287|NCT05109650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110087288|NCT05108259|Adalimumab|adalimumab|mesh-list
110087289|NCT05108259|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110087290|NCT05108259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110087291|NCT05108259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110087292|NCT05040217|Mitogens|mitogens|mesh-list
110087293|NCT05040217|Mitosis Modulators|mitosis modulators|mesh-ancestor
110087294|NCT05040217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110087295|NCT05032118|Ketamine|ketamine|mesh-list
110087296|NCT05032118|Propofol|propofol|mesh-list
110087297|NCT05032118|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110087298|NCT05032118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110087299|NCT05032118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110087300|NCT05032118|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110087301|NCT05032118|Anesthetics, General|anesthetics, general|mesh-ancestor
110087302|NCT05032118|Anesthetics|anesthetics|mesh-ancestor
110087303|NCT05032118|Analgesics|analgesics|mesh-ancestor
110087304|NCT05032118|Sensory System Agents|sensory system agents|mesh-ancestor
110087305|NCT05032118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110087306|NCT05032118|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110087307|NCT05032118|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110087308|NCT05032118|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110087309|NCT05032118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110087310|NCT05032118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110087311|NCT04977908|Insulin|insulin|mesh-list
110087312|NCT04977908|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110087313|NCT04977908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110087314|NCT04874597|Ocrelizumab|ocrelizumab|mesh-list
110087315|NCT04874597|Immunologic Factors|immunologic factors|mesh-ancestor
110087316|NCT04874597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110087317|NCT04862234|Dulaglutide|dulaglutide|mesh-list
110087318|NCT04862234|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110087319|NCT04862234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110087320|NCT04842643|Immunoglobulins|immunoglobulins|mesh-list
110087321|NCT04842643|Immunologic Factors|immunologic factors|mesh-ancestor
110087322|NCT04842643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110087324|NCT04745234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110087325|NCT04701151|BCG Vaccine|bcg vaccine|mesh-list
110087326|NCT04701151|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110087327|NCT04701151|Immunologic Factors|immunologic factors|mesh-ancestor
110087328|NCT04701151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110087329|NCT04573920|Atrasentan|atrasentan|mesh-list
110087330|NCT04573920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110087331|NCT04573920|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
110087332|NCT04573920|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
110087333|NCT04573920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110087334|NCT04505878|Ascorbic Acid|ascorbic acid|mesh-list
110087335|NCT04505878|Vitamins|vitamins|mesh-ancestor
110087336|NCT04505878|Micronutrients|micronutrients|mesh-ancestor
110087337|NCT04505878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110087338|NCT04505878|Antioxidants|antioxidants|mesh-ancestor
110087339|NCT04505878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110087340|NCT04505878|Protective Agents|protective agents|mesh-ancestor
110087341|NCT04505189|Psilocybin|psilocybin|mesh-list
110087342|NCT04505189|Hallucinogens|hallucinogens|mesh-ancestor
110087343|NCT04505189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110087344|NCT04505189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110087345|NCT04404881|Bevacizumab|bevacizumab|mesh-list
110087346|NCT04404881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110087347|NCT04404881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110087348|NCT04404881|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110087349|NCT04404881|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110087350|NCT04404881|Growth Substances|growth substances|mesh-ancestor
110087351|NCT04404881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110087352|NCT04404881|Growth Inhibitors|growth inhibitors|mesh-ancestor
110087353|NCT04370509|Pembrolizumab|pembrolizumab|mesh-list
110087354|NCT04370509|Axitinib|axitinib|mesh-list
110087355|NCT04370509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110087356|NCT04370509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110087357|NCT04370509|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110087358|NCT04370509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110087359|NCT04370509|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110087360|NCT04370509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110087361|NCT04335058|Iron|iron|mesh-list
110087362|NCT04335058|Lactoferrin|lactoferrin|mesh-list
110087363|NCT04335058|Trace Elements|trace elements|mesh-ancestor
110087364|NCT04335058|Micronutrients|micronutrients|mesh-ancestor
110087365|NCT04335058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110087366|NCT04335058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110087367|NCT04319224|Nivolumab|nivolumab|mesh-list
110087368|NCT04319224|Ipilimumab|ipilimumab|mesh-list
110087369|NCT04319224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110087370|NCT04319224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110087371|NCT04319224|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110087372|NCT04319224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110087373|NCT04280562|Acetaminophen|acetaminophen|mesh-list
110087374|NCT04280562|Analgesics|analgesics|mesh-list
110087375|NCT04280562|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110087376|NCT04280562|Sensory System Agents|sensory system agents|mesh-ancestor
110087377|NCT04280562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110087378|NCT04280562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110087380|NCT04257448|Paclitaxel|paclitaxel|mesh-list
110087381|NCT04257448|Gemcitabine|gemcitabine|mesh-list
110087382|NCT04257448|Lenalidomide|lenalidomide|mesh-list
110087383|NCT04257448|Azacitidine|azacitidine|mesh-list
110087384|NCT04257448|Durvalumab|durvalumab|mesh-list
110087385|NCT04257448|Romidepsin|romidepsin|mesh-list
110087386|NCT04257448|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110087387|NCT04257448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110087388|NCT04257448|Tubulin Modulators|tubulin modulators|mesh-ancestor
110087389|NCT04257448|Antimitotic Agents|antimitotic agents|mesh-ancestor
110087390|NCT04257448|Mitosis Modulators|mitosis modulators|mesh-ancestor
110087391|NCT04257448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110087392|NCT04257448|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110087393|NCT04257448|Antimetabolites|antimetabolites|mesh-ancestor
110087394|NCT04257448|Immunologic Factors|immunologic factors|mesh-ancestor
110087395|NCT04257448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110087396|NCT04257448|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110087397|NCT04257448|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110087398|NCT04257448|Growth Substances|growth substances|mesh-ancestor
110087399|NCT04257448|Growth Inhibitors|growth inhibitors|mesh-ancestor
110087400|NCT04257448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110087401|NCT04257448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110087402|NCT04257448|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110087403|NCT04257448|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110087404|NCT04075136|Triamcinolone|triamcinolone|mesh-list
110087405|NCT04075136|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110087406|NCT04075136|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110087407|NCT04075136|Ranibizumab|ranibizumab|mesh-list
110087408|NCT04075136|Verteporfin|verteporfin|mesh-list
110087409|NCT04075136|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110087410|NCT04075136|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110087411|NCT04075136|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110087412|NCT04075136|Growth Substances|growth substances|mesh-ancestor
110087413|NCT04075136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110087414|NCT04075136|Growth Inhibitors|growth inhibitors|mesh-ancestor
110087415|NCT04075136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110087416|NCT04075136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110087417|NCT04075136|Glucocorticoids|glucocorticoids|mesh-ancestor
110087418|NCT04075136|Hormones|hormones|mesh-ancestor
110087419|NCT04075136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110087420|NCT04075136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110087421|NCT04075136|Immunologic Factors|immunologic factors|mesh-ancestor
110087422|NCT04075136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110087423|NCT04075136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110087424|NCT04075136|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110087425|NCT04075136|Dermatologic Agents|dermatologic agents|mesh-ancestor
110087426|NCT03959566|Moxifloxacin|moxifloxacin|mesh-list
110087428|NCT03959566|Midazolam|midazolam|mesh-list
110087429|NCT03959566|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110087430|NCT03959566|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110087431|NCT03959566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110087432|NCT03959566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110087433|NCT03959566|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110087434|NCT03959566|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110087435|NCT03959566|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110087436|NCT03959566|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110087437|NCT03959566|Anesthetics, General|anesthetics, general|mesh-ancestor
110087438|NCT03959566|Anesthetics|anesthetics|mesh-ancestor
110087439|NCT03959566|GABA Modulators|gaba modulators|mesh-ancestor
110087440|NCT03959566|GABA Agents|gaba agents|mesh-ancestor
110087441|NCT03959566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110087442|NCT03959566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110087443|NCT03959566|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110087444|NCT03959566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110087445|NCT03959566|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110087446|NCT03959566|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110087447|NCT03959566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110087448|NCT03959566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110087449|NCT03959566|Antitubercular Agents|antitubercular agents|mesh-ancestor
110087451|NCT03909529|Spironolactone|spironolactone|mesh-list
110087452|NCT03909529|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110087453|NCT03909529|Hormone Antagonists|hormone antagonists|mesh-ancestor
110087454|NCT03909529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110087455|NCT03909529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110087456|NCT03909529|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110087457|NCT03909529|Diuretics|diuretics|mesh-ancestor
110087458|NCT03909529|Natriuretic Agents|natriuretic agents|mesh-ancestor
110087459|NCT03909529|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110087460|NCT03909529|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110087461|NCT03909529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110087462|NCT03909529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110087463|NCT03909529|Protective Agents|protective agents|mesh-ancestor
110087464|NCT03875755|Inositol|inositol|mesh-list
110087465|NCT03875755|Vitamin B Complex|vitamin b complex|mesh-ancestor
110087466|NCT03875755|Vitamins|vitamins|mesh-ancestor
110087467|NCT03875755|Micronutrients|micronutrients|mesh-ancestor
110087468|NCT03875755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110087469|NCT03380546|Insulin|insulin|mesh-list
110087470|NCT03380546|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110087471|NCT03380546|Acarbose|acarbose|mesh-list
110087472|NCT03380546|Insulin, Short-Acting|insulin, short-acting|mesh-list
110087473|NCT03380546|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110087474|NCT03380546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110087475|NCT03380546|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
110087476|NCT03380546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110087477|NCT03380546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110087478|NCT03318094|Nitroprusside|nitroprusside|mesh-list
110087479|NCT03318094|Phentolamine|phentolamine|mesh-list
110087480|NCT03318094|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
110087481|NCT03318094|Adrenergic Antagonists|adrenergic antagonists|mesh-list
110087482|NCT03318094|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110087483|NCT03318094|Vasodilator Agents|vasodilator agents|mesh-ancestor
110087484|NCT03318094|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
110087485|NCT03318094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110087486|NCT03318094|Adrenergic Agents|adrenergic agents|mesh-ancestor
110087487|NCT03318094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110087488|NCT03318094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110087489|NCT03268499|Cisplatin|cisplatin|mesh-list
110087490|NCT03268499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110087491|NCT03250624|Ivermectin|ivermectin|mesh-list
110087492|NCT03250624|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110087493|NCT03250624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110087494|NCT03204955|Plasma-lyte 148|plasma-lyte 148|mesh-list
110087495|NCT03204955|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110087496|NCT03204955|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110087497|NCT03187353|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
110087498|NCT03187353|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110087499|NCT03187353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110087500|NCT03187353|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110087501|NCT03187353|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110087502|NCT03187353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110087503|NCT03187353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110087504|NCT03187353|Dopamine Agents|dopamine agents|mesh-ancestor
110087505|NCT03187353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110087506|NCT03122717|Gefitinib|gefitinib|mesh-list
110087507|NCT03122717|Osimertinib|osimertinib|mesh-list
110087509|NCT03122717|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110087510|NCT03122717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110087511|NCT03122717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110087512|NCT03069326|Thalidomide|thalidomide|mesh-list
110087513|NCT03069326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110087514|NCT03069326|Immunologic Factors|immunologic factors|mesh-ancestor
110087515|NCT03069326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110087516|NCT03069326|Leprostatic Agents|leprostatic agents|mesh-ancestor
110087517|NCT03069326|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110087518|NCT03069326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110087519|NCT03069326|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110087520|NCT03069326|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110087521|NCT03069326|Growth Substances|growth substances|mesh-ancestor
110087522|NCT03069326|Growth Inhibitors|growth inhibitors|mesh-ancestor
110087523|NCT03069326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110087524|NCT03015740|Nivolumab|nivolumab|mesh-list
110087525|NCT03015740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110087526|NCT03015740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110087527|NCT03015740|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110087528|NCT03015740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110087529|NCT02881242|Trametinib|trametinib|mesh-list
110087530|NCT02881242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110087531|NCT02881242|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110087532|NCT02881242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110087533|NCT02881242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110087534|NCT02638519|Xenon|xenon|mesh-list
110087535|NCT02638519|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110087536|NCT02638519|Anesthetics, General|anesthetics, general|mesh-ancestor
110087537|NCT02638519|Anesthetics|anesthetics|mesh-ancestor
110087538|NCT02638519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110087539|NCT02638519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110087540|NCT02408549|Lacosamide|lacosamide|mesh-list
110087541|NCT02408549|Anticonvulsants|anticonvulsants|mesh-ancestor
110087542|NCT02408549|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110087543|NCT02408549|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110087544|NCT02408549|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110087545|NCT02408549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110087546|NCT02376699|Paclitaxel|paclitaxel|mesh-list
110087547|NCT02376699|Gemcitabine|gemcitabine|mesh-list
110087548|NCT02376699|Pembrolizumab|pembrolizumab|mesh-list
110087549|NCT02376699|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110087550|NCT02376699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110087551|NCT02376699|Tubulin Modulators|tubulin modulators|mesh-ancestor
110087552|NCT02376699|Antimitotic Agents|antimitotic agents|mesh-ancestor
110087553|NCT02376699|Mitosis Modulators|mitosis modulators|mesh-ancestor
110087554|NCT02376699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110087555|NCT02376699|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110087556|NCT02376699|Antimetabolites|antimetabolites|mesh-ancestor
110087557|NCT02376699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110087558|NCT02376699|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110087559|NCT02141542|Tremelimumab|tremelimumab|mesh-list
110087560|NCT02141542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110087561|NCT01930955|Amoxicillin|amoxicillin|mesh-list
110087562|NCT01930955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110087563|NCT01930955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110087564|NCT01333514|Insulin Aspart|insulin aspart|mesh-list
110087565|NCT01333514|Insulin, Long-Acting|insulin, long-acting|mesh-list
110087566|NCT01333514|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
110087567|NCT01333514|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110087568|NCT01333514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110087569|NCT02098512|Brentuximab Vedotin|brentuximab vedotin|mesh-list
110087570|NCT02098512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110087571|NCT02098512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110087572|NCT02098512|Immunotoxins|immunotoxins|mesh-ancestor
110087573|NCT02098512|Immunoconjugates|immunoconjugates|mesh-ancestor
110087574|NCT02098512|Immunologic Factors|immunologic factors|mesh-ancestor
110087575|NCT02098512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110087576|NCT02066636|Nivolumab|nivolumab|mesh-list
110087577|NCT02066636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110087578|NCT02066636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110087579|NCT02066636|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110087580|NCT02066636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110087582|NCT02036086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110087583|NCT02036086|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110087584|NCT02036086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110087585|NCT02036086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110087586|NCT01486264|Botulinum Toxins|botulinum toxins|mesh-list
110087587|NCT01486264|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110087588|NCT01486264|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110087589|NCT01486264|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110087590|NCT01486264|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110087591|NCT01486264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110087592|NCT01486264|Cholinergic Agents|cholinergic agents|mesh-ancestor
110087593|NCT01486264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110087594|NCT01486264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110087595|NCT01486264|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110087596|NCT01486264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110087597|NCT01299480|Vaccines|vaccines|mesh-list
110087598|NCT01299480|Immunologic Factors|immunologic factors|mesh-ancestor
110087599|NCT01299480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110087600|NCT01681446|Interferons|interferons|mesh-list
110087601|NCT01681446|Interferon-alpha|interferon-alpha|mesh-list
110087602|NCT01681446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110087603|NCT01681446|Antiviral Agents|antiviral agents|mesh-ancestor
110087604|NCT01681446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110087605|NCT01681446|Immunologic Factors|immunologic factors|mesh-ancestor
110087606|NCT01681446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110087607|NCT01681875|Nicotine|nicotine|mesh-list
110087608|NCT01681875|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110087609|NCT01681875|Autonomic Agents|autonomic agents|mesh-ancestor
110087610|NCT01681875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110087612|NCT01681875|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110087613|NCT01681875|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110087614|NCT01681875|Cholinergic Agents|cholinergic agents|mesh-ancestor
110087615|NCT01681875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110087616|NCT01681875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110087617|NCT01682577|Perindopril|perindopril|mesh-list
110087618|NCT01682577|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110087619|NCT01682577|Protease Inhibitors|protease inhibitors|mesh-ancestor
110087620|NCT01682577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110087621|NCT01682577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110087622|NCT01682577|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110087623|NCT01683760|Fluconazole|fluconazole|mesh-list
110087624|NCT01683760|Antifungal Agents|antifungal agents|mesh-ancestor
110087625|NCT01683760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110087626|NCT01683760|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110087627|NCT01683760|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110087628|NCT01683760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110087629|NCT01683760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110087630|NCT01683760|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110087631|NCT01683760|Hormone Antagonists|hormone antagonists|mesh-ancestor
110087632|NCT01683760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110087633|NCT01683760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110087634|NCT01683760|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110087635|NCT01683760|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110087636|NCT01684813|Clopidogrel|clopidogrel|mesh-list
110087637|NCT01684813|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
110087638|NCT01684813|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110087639|NCT01684813|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110087640|NCT01684813|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110087641|NCT01684813|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110087642|NCT01684813|Purinergic Agents|purinergic agents|mesh-ancestor
110087643|NCT01684813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110087644|NCT01684813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110087645|NCT01684813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110087646|NCT01684982|Sirolimus|sirolimus|mesh-list
110087647|NCT01684982|Everolimus|everolimus|mesh-list
110087648|NCT01684982|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110087649|NCT01684982|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110087650|NCT01684982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110087651|NCT01684982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110087652|NCT01684982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110087653|NCT01684982|Immunologic Factors|immunologic factors|mesh-ancestor
110087654|NCT01684982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110087655|NCT01684982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110087656|NCT01684982|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110087657|NCT01684982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110087658|NCT01684982|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110087659|NCT01684982|Antifungal Agents|antifungal agents|mesh-ancestor
110087660|NCT01685034|Immunomodulating Agents|immunomodulating agents|mesh-list
110087661|NCT01685034|Immunologic Factors|immunologic factors|mesh-ancestor
110087662|NCT01685034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110087663|NCT01685489|polysaccharide-K|polysaccharide-k|mesh-list
110087665|NCT01685489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110087666|NCT01685489|Tubulin Modulators|tubulin modulators|mesh-ancestor
110087667|NCT01685489|Antimitotic Agents|antimitotic agents|mesh-ancestor
110087668|NCT01685489|Mitosis Modulators|mitosis modulators|mesh-ancestor
110087669|NCT01685489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110087670|NCT01685489|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110087671|NCT01685489|Immunologic Factors|immunologic factors|mesh-ancestor
110087672|NCT01685489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110087673|NCT01685489|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110087674|NCT01685489|Antiviral Agents|antiviral agents|mesh-ancestor
110087675|NCT01685489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110087676|NCT01685489|Interferon Inducers|interferon inducers|mesh-ancestor
110087677|NCT01685489|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110087678|NCT01685489|Protective Agents|protective agents|mesh-ancestor
110087679|NCT01686386|Dexamethasone|dexamethasone|mesh-list
110087680|NCT01686386|Lenalidomide|lenalidomide|mesh-list
110087681|NCT01686386|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110087682|NCT01686386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110087683|NCT01686386|Antiemetics|antiemetics|mesh-ancestor
110087684|NCT01686386|Autonomic Agents|autonomic agents|mesh-ancestor
110087685|NCT01686386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110087686|NCT01686386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110087687|NCT01686386|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110087688|NCT01686386|Glucocorticoids|glucocorticoids|mesh-ancestor
110087689|NCT01686386|Hormones|hormones|mesh-ancestor
110087690|NCT01686386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110087691|NCT01686386|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110087692|NCT01686386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110087693|NCT01686386|Immunologic Factors|immunologic factors|mesh-ancestor
110087694|NCT01686386|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110087695|NCT01686386|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110087696|NCT01686386|Growth Substances|growth substances|mesh-ancestor
110087697|NCT01686386|Growth Inhibitors|growth inhibitors|mesh-ancestor
110087698|NCT01686386|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110087699|NCT01686386|Alkylating Agents|alkylating agents|mesh-ancestor
110087700|NCT01686386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110087701|NCT01686594|Methoxsalen|methoxsalen|mesh-list
110087702|NCT01686594|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110087703|NCT01686594|Dermatologic Agents|dermatologic agents|mesh-ancestor
110087704|NCT01687517|Vaccines|vaccines|mesh-list
110087705|NCT01687517|Immunologic Factors|immunologic factors|mesh-ancestor
110087706|NCT01687517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110087707|NCT01687751|Midazolam|midazolam|mesh-list
110087708|NCT01687751|Dexmedetomidine|dexmedetomidine|mesh-list
110087709|NCT01687751|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110087710|NCT01687751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110087711|NCT01687751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110087712|NCT01687751|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110087713|NCT01687751|Analgesics|analgesics|mesh-ancestor
110087714|NCT01687751|Sensory System Agents|sensory system agents|mesh-ancestor
110087715|NCT01687751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110087716|NCT01687751|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110087717|NCT01687751|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110087718|NCT01687751|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110087719|NCT01687751|Adrenergic Agents|adrenergic agents|mesh-ancestor
110087720|NCT01687751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110087721|NCT01687751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110087722|NCT01687751|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110087723|NCT01687751|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110087724|NCT01687751|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110087725|NCT01687751|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110087726|NCT01687751|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110087727|NCT01687751|Anesthetics, General|anesthetics, general|mesh-ancestor
110087730|NCT01687751|GABA Agents|gaba agents|mesh-ancestor
110087731|NCT01688362|Dexamethasone|dexamethasone|mesh-list
110087732|NCT01688362|Bupivacaine|bupivacaine|mesh-list
110087733|NCT01688362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110087734|NCT01688362|Antiemetics|antiemetics|mesh-ancestor
110087735|NCT01688362|Autonomic Agents|autonomic agents|mesh-ancestor
110087736|NCT01688362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110087737|NCT01688362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110087738|NCT01688362|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110087739|NCT01688362|Glucocorticoids|glucocorticoids|mesh-ancestor
110087740|NCT01688362|Hormones|hormones|mesh-ancestor
110087741|NCT01688362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110087742|NCT01688362|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110087743|NCT01688362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110087744|NCT01688362|Anesthetics, Local|anesthetics, local|mesh-ancestor
110087745|NCT01688362|Anesthetics|anesthetics|mesh-ancestor
110087746|NCT01688362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110087747|NCT01688362|Sensory System Agents|sensory system agents|mesh-ancestor
110087748|NCT01688375|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
110087749|NCT01688375|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
110087750|NCT01688375|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110087751|NCT01689753|Citric Acid|citric acid|mesh-list
110087752|NCT01689753|Sodium Citrate|sodium citrate|mesh-list
110087753|NCT01689753|Anticoagulants|anticoagulants|mesh-ancestor
110087754|NCT01689753|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110087755|NCT01689753|Chelating Agents|chelating agents|mesh-ancestor
110087756|NCT01689753|Sequestering Agents|sequestering agents|mesh-ancestor
110087757|NCT01689753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110087758|NCT01690039|Fludrocortisone|fludrocortisone|mesh-list
110087759|NCT01690039|Furosemide|furosemide|mesh-list
110087760|NCT01690039|Diuretics|diuretics|mesh-ancestor
110087761|NCT01690039|Natriuretic Agents|natriuretic agents|mesh-ancestor
110087762|NCT01690039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110087763|NCT01690039|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110087764|NCT01690039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110087765|NCT01690039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110087766|NCT01690039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110087767|NCT01690091|Metformin|metformin|mesh-list
110087768|NCT01690091|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110087769|NCT01690091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110087770|NCT01690104|Rifampin|rifampin|mesh-list
110087771|NCT01690104|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110087772|NCT01690104|Antitubercular Agents|antitubercular agents|mesh-ancestor
110087773|NCT01690104|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110087774|NCT01690104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110087775|NCT01690104|Leprostatic Agents|leprostatic agents|mesh-ancestor
110087776|NCT01690104|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110087777|NCT01690104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110087778|NCT01690104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110087779|NCT01690104|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110087780|NCT01690104|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110087781|NCT01690104|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110087782|NCT01690104|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110087783|NCT01690104|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110087784|NCT01690104|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110087785|NCT01690221|Diltiazem|diltiazem|mesh-list
110087786|NCT01690221|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110087787|NCT01690221|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110087788|NCT01690221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110087789|NCT01690221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110087790|NCT01690221|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110087791|NCT01690221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110087793|NCT01690247|Immunosuppressive Agents|immunosuppressive agents|mesh-list
110087794|NCT01690247|Immunologic Factors|immunologic factors|mesh-ancestor
110087795|NCT01690247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110087796|NCT01690286|Ketoconazole|ketoconazole|mesh-list
110087797|NCT01690286|Antifungal Agents|antifungal agents|mesh-ancestor
110087798|NCT01690286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110087799|NCT01690286|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110087800|NCT01690286|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110087801|NCT01690286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110087802|NCT01690286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110087803|NCT01690286|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110087804|NCT01690286|Hormone Antagonists|hormone antagonists|mesh-ancestor
110087805|NCT01690286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110087806|NCT01690286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110087807|NCT01690286|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110087808|NCT01690325|Cyclophosphamide|cyclophosphamide|mesh-list
110087809|NCT01690325|Bevacizumab|bevacizumab|mesh-list
110087810|NCT01690325|Docetaxel|docetaxel|mesh-list
110087811|NCT01690325|Trastuzumab|trastuzumab|mesh-list
110087812|NCT01690325|Epirubicin|epirubicin|mesh-list
110087813|NCT01690325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110087814|NCT01690325|Immunologic Factors|immunologic factors|mesh-ancestor
110087815|NCT01690325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110087816|NCT01690325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110087817|NCT01690325|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110087818|NCT01690325|Alkylating Agents|alkylating agents|mesh-ancestor
110087819|NCT01690325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110087820|NCT01690325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110087821|NCT01690325|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110087822|NCT01690325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110087823|NCT01690325|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110087824|NCT01690325|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110087825|NCT01690325|Growth Substances|growth substances|mesh-ancestor
110087826|NCT01690325|Growth Inhibitors|growth inhibitors|mesh-ancestor
110087827|NCT01690325|Tubulin Modulators|tubulin modulators|mesh-ancestor
110087828|NCT01690325|Antimitotic Agents|antimitotic agents|mesh-ancestor
110087829|NCT01690325|Mitosis Modulators|mitosis modulators|mesh-ancestor
110087830|NCT01690325|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110087831|NCT01690325|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110087832|NCT01690325|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110087833|NCT01690325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110087834|NCT01690338|Bromides|bromides|mesh-list
110087835|NCT01690338|Rocuronium|rocuronium|mesh-list
110087836|NCT01690338|Vecuronium Bromide|vecuronium bromide|mesh-list
110087837|NCT01690338|Cisatracurium|cisatracurium|mesh-list
110087838|NCT01690338|Anticonvulsants|anticonvulsants|mesh-ancestor
110087839|NCT01690338|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110087840|NCT01690338|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110087841|NCT01690338|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110087842|NCT01690338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110087843|NCT01690338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110087844|NCT01690338|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
110087845|NCT01690338|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110087846|NCT01690338|Cholinergic Agents|cholinergic agents|mesh-ancestor
110087847|NCT01690338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110087848|NCT01690338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110087849|NCT01690364|Anesthetics|anesthetics|mesh-list
110087850|NCT01690364|Cisatracurium|cisatracurium|mesh-list
110087851|NCT01690364|Vecuronium Bromide|vecuronium bromide|mesh-list
110087852|NCT01690364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110087853|NCT01690364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110087854|NCT01690364|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110087855|NCT01690364|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110087856|NCT01690364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110087857|NCT01690364|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110087858|NCT01690364|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
110087859|NCT01690364|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110087860|NCT01690364|Cholinergic Agents|cholinergic agents|mesh-ancestor
110087861|NCT01690364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110087862|NCT01690364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110087863|NCT01690403|Rifapentine|rifapentine|mesh-list
110087864|NCT01690403|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110087865|NCT01690403|Antitubercular Agents|antitubercular agents|mesh-ancestor
110087866|NCT01690403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110087867|NCT01690403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110087868|NCT01690403|Leprostatic Agents|leprostatic agents|mesh-ancestor
110087869|NCT01690468|Carboplatin|carboplatin|mesh-list
110087870|NCT01690468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110087871|NCT01690507|Cytarabine|cytarabine|mesh-list
110087872|NCT01690507|Decitabine|decitabine|mesh-list
110087874|NCT01690507|Lenograstim|lenograstim|mesh-list
110087875|NCT01690507|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110087876|NCT01690507|Antimetabolites|antimetabolites|mesh-ancestor
110087877|NCT01690507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110087878|NCT01690507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110087879|NCT01690507|Antiviral Agents|antiviral agents|mesh-ancestor
110087880|NCT01690507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110087881|NCT01690507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110087882|NCT01690507|Immunologic Factors|immunologic factors|mesh-ancestor
110087883|NCT01690507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110087884|NCT01690507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110087885|NCT01690507|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110087886|NCT01690507|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110087887|NCT01690533|Moxifloxacin|moxifloxacin|mesh-list
110087888|NCT01690533|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
110087889|NCT01690533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110087890|NCT01690533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110087891|NCT01690533|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110087892|NCT01690533|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110087893|NCT01690533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110087894|NCT01690533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110087895|NCT01690533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110087896|NCT01690533|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110087897|NCT01690533|Contraceptive Agents|contraceptive agents|mesh-ancestor
110087898|NCT01690533|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110087899|NCT01690533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110087900|NCT01690533|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110087901|NCT01690533|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110087902|NCT01690533|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110087903|NCT01690559|Ciprofloxacin|ciprofloxacin|mesh-list
110087904|NCT01690559|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110087905|NCT01690559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110087906|NCT01690559|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110087907|NCT01690559|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110087908|NCT01690559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110087909|NCT01690559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110087910|NCT01690559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110087911|NCT01690559|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110087912|NCT01690559|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110087913|NCT01690572|Paclitaxel|paclitaxel|mesh-list
110087914|NCT01690572|Hyaluronic Acid|hyaluronic acid|mesh-list
110087915|NCT01690572|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110087916|NCT01690572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110087917|NCT01690572|Tubulin Modulators|tubulin modulators|mesh-ancestor
110087918|NCT01690572|Antimitotic Agents|antimitotic agents|mesh-ancestor
110087919|NCT01690572|Mitosis Modulators|mitosis modulators|mesh-ancestor
110087920|NCT01690572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110087921|NCT01690572|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110087922|NCT01690572|Immunologic Factors|immunologic factors|mesh-ancestor
110087923|NCT01690572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110087924|NCT01690572|Viscosupplements|viscosupplements|mesh-ancestor
110087925|NCT01690572|Protective Agents|protective agents|mesh-ancestor
110087926|NCT01690598|Topotecan|topotecan|mesh-list
110087927|NCT01690598|Veliparib|veliparib|mesh-list
110087928|NCT01690598|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110087929|NCT01690598|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110087930|NCT01690598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110087931|NCT01690598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110087932|NCT01690598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110087933|NCT01690598|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110087934|NCT01690637|Oseltamivir|oseltamivir|mesh-list
110087935|NCT01690637|Antiviral Agents|antiviral agents|mesh-ancestor
110087936|NCT01690637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110087937|NCT01690637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110087938|NCT01690637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110087939|NCT01690702|Paclitaxel|paclitaxel|mesh-list
110087940|NCT01690702|Docetaxel|docetaxel|mesh-list
110087941|NCT01690702|Cyclophosphamide|cyclophosphamide|mesh-list
110087942|NCT01690702|Epirubicin|epirubicin|mesh-list
110087943|NCT01690702|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110087944|NCT01690702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110087945|NCT01690702|Tubulin Modulators|tubulin modulators|mesh-ancestor
110087946|NCT01690702|Antimitotic Agents|antimitotic agents|mesh-ancestor
110087947|NCT01690702|Mitosis Modulators|mitosis modulators|mesh-ancestor
110087948|NCT01690702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110087949|NCT01690702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110087950|NCT01690702|Immunologic Factors|immunologic factors|mesh-ancestor
110087951|NCT01690702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110087952|NCT01690702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110087953|NCT01690702|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110087954|NCT01690702|Alkylating Agents|alkylating agents|mesh-ancestor
110087955|NCT01690702|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110087956|NCT01690702|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110087957|NCT01690702|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110087958|NCT01690702|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110087959|NCT01690702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110087961|NCT01690767|Anesthetics, Local|anesthetics, local|mesh-ancestor
110087962|NCT01690767|Anesthetics|anesthetics|mesh-ancestor
110087963|NCT01690767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110087964|NCT01690767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110087965|NCT01690767|Sensory System Agents|sensory system agents|mesh-ancestor
110087966|NCT01690767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110087967|NCT01690767|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110087968|NCT01690767|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110087969|NCT01690767|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110087970|NCT01690767|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110087971|NCT01690767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110087972|NCT01690780|Ibuprofen|ibuprofen|mesh-list
110087973|NCT01690780|Morphine|morphine|mesh-list
110087974|NCT01690780|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110087975|NCT01690780|Narcotics|narcotics|mesh-ancestor
110087976|NCT01690780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110087977|NCT01690780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110087978|NCT01690780|Analgesics|analgesics|mesh-ancestor
110087979|NCT01690780|Sensory System Agents|sensory system agents|mesh-ancestor
110087980|NCT01690780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110087981|NCT01690780|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110087982|NCT01690780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110087983|NCT01690780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110087984|NCT01690780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110087985|NCT01690780|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110087986|NCT01690780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110087987|NCT01690780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110087988|NCT01690832|Fenoldopam|fenoldopam|mesh-list
110087989|NCT01690832|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110087990|NCT01690832|Vasodilator Agents|vasodilator agents|mesh-ancestor
110087991|NCT01690832|Dopamine Agonists|dopamine agonists|mesh-ancestor
110087992|NCT01690832|Dopamine Agents|dopamine agents|mesh-ancestor
110087993|NCT01690832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110087994|NCT01690832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110087995|NCT01690832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110087996|NCT01690871|Dactolisib|dactolisib|mesh-list
110087997|NCT01690871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110087998|NCT01690884|Adenosine|adenosine|mesh-list
110087999|NCT01690884|Analgesics|analgesics|mesh-ancestor
110088000|NCT01690884|Sensory System Agents|sensory system agents|mesh-ancestor
110088001|NCT01690884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110088002|NCT01690884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110088003|NCT01690884|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110088004|NCT01690884|Vasodilator Agents|vasodilator agents|mesh-ancestor
110088005|NCT01690884|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
110088006|NCT01690884|Purinergic Agonists|purinergic agonists|mesh-ancestor
110088007|NCT01690884|Purinergic Agents|purinergic agents|mesh-ancestor
110088008|NCT01690884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110088009|NCT01690884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110088011|NCT01690962|Hydroxocobalamin|hydroxocobalamin|mesh-list
110088012|NCT01690962|Vitamin B 12|vitamin b 12|mesh-list
110088013|NCT01690962|Vitamin B Complex|vitamin b complex|mesh-list
110088014|NCT01690962|Micronutrients|micronutrients|mesh-ancestor
110088015|NCT01690962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110088016|NCT01690962|Hematinics|hematinics|mesh-ancestor
110088017|NCT01690975|Benzonatate|benzonatate|mesh-list
110088018|NCT01690975|Antitussive Agents|antitussive agents|mesh-ancestor
110088019|NCT01690975|Respiratory System Agents|respiratory system agents|mesh-ancestor
110088020|NCT01691001|Dexmedetomidine|dexmedetomidine|mesh-list
110088021|NCT01691001|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110088022|NCT01691001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110088023|NCT01691001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110088025|NCT01691001|Analgesics|analgesics|mesh-ancestor
110088026|NCT01691001|Sensory System Agents|sensory system agents|mesh-ancestor
110088027|NCT01691001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110088028|NCT01691001|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110088029|NCT01691001|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110088030|NCT01691001|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110088031|NCT01691001|Adrenergic Agents|adrenergic agents|mesh-ancestor
110088032|NCT01691001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110088033|NCT01691001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110088034|NCT01691053|Spironolactone|spironolactone|mesh-list
110088035|NCT01691053|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110088036|NCT01691053|Hormone Antagonists|hormone antagonists|mesh-ancestor
110088037|NCT01691053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110088038|NCT01691053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110088039|NCT01691053|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110088040|NCT01691053|Diuretics|diuretics|mesh-ancestor
110088041|NCT01691053|Natriuretic Agents|natriuretic agents|mesh-ancestor
110088042|NCT01691118|Antihypertensive Agents|antihypertensive agents|mesh-list
110088043|NCT01691209|Hydrocortisone|hydrocortisone|mesh-list
110088044|NCT01691209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110088045|NCT01691365|Vitamins|vitamins|mesh-list
110088046|NCT01691365|Vitamin B Complex|vitamin b complex|mesh-list
110088047|NCT01691365|Antioxidants|antioxidants|mesh-list
110088048|NCT01691365|Micronutrients|micronutrients|mesh-ancestor
110088049|NCT01691365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110088050|NCT01691365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110088051|NCT01691365|Protective Agents|protective agents|mesh-ancestor
110088052|NCT01691404|Quercetin|quercetin|mesh-list
110088053|NCT01691404|Antioxidants|antioxidants|mesh-ancestor
110088054|NCT01691404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110088055|NCT01691404|Protective Agents|protective agents|mesh-ancestor
110185420|NCT00846911|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110088056|NCT01691404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110088057|NCT01691456|Montelukast|montelukast|mesh-list
110088058|NCT01691456|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110088059|NCT01691456|Respiratory System Agents|respiratory system agents|mesh-ancestor
110088060|NCT01691456|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110088061|NCT01691456|Hormone Antagonists|hormone antagonists|mesh-ancestor
110088062|NCT01691456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110088063|NCT01691456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110088064|NCT01691456|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110088065|NCT01691456|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110088066|NCT01691456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110088067|NCT01691469|Montelukast|montelukast|mesh-list
110088068|NCT01691469|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110088069|NCT01691469|Respiratory System Agents|respiratory system agents|mesh-ancestor
110088070|NCT01691469|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110088071|NCT01691469|Hormone Antagonists|hormone antagonists|mesh-ancestor
110088072|NCT01691469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110088073|NCT01691469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110088074|NCT01691469|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110088075|NCT01691469|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110088076|NCT01691469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110088077|NCT01691495|PENTA|penta|mesh-list
110088078|NCT01691495|Fondaparinux|fondaparinux|mesh-list
110088079|NCT01691495|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110088080|NCT01691495|Antithrombins|antithrombins|mesh-ancestor
110088081|NCT01691495|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110088082|NCT01691495|Protease Inhibitors|protease inhibitors|mesh-ancestor
110088083|NCT01691495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110088084|NCT01691495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110088085|NCT01691495|Anticoagulants|anticoagulants|mesh-ancestor
110088086|NCT01691495|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110088087|NCT01691495|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110088088|NCT01691625|Immunomodulating Agents|immunomodulating agents|mesh-list
110088089|NCT01691625|Immunologic Factors|immunologic factors|mesh-ancestor
110088090|NCT01691625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110088091|NCT01691651|Botulinum Toxins|botulinum toxins|mesh-list
110088092|NCT01691651|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110088093|NCT01691651|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110088094|NCT01691651|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110088095|NCT01691651|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110088096|NCT01691651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110088097|NCT01691651|Cholinergic Agents|cholinergic agents|mesh-ancestor
110088098|NCT01691651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110088099|NCT01691651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110088100|NCT01691651|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110088101|NCT01691651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110088103|NCT01691677|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110088104|NCT01691677|Glucocorticoids|glucocorticoids|mesh-ancestor
110088105|NCT01691677|Hormones|hormones|mesh-ancestor
110088106|NCT01691677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110088107|NCT01691677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110088108|NCT01691677|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110088109|NCT01691677|Respiratory System Agents|respiratory system agents|mesh-ancestor
110088110|NCT01691742|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
110088111|NCT01691742|Laxatives|laxatives|mesh-list
110088112|NCT01691742|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110088113|NCT01691807|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110088114|NCT01691807|Ofatumumab|ofatumumab|mesh-list
110088115|NCT01691807|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110088116|NCT01691807|Alkylating Agents|alkylating agents|mesh-ancestor
110088117|NCT01691807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110088118|NCT01691807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110088119|NCT01691872|Ezogabine|ezogabine|mesh-list
110088120|NCT01691872|Anticonvulsants|anticonvulsants|mesh-ancestor
110088121|NCT01691872|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110088122|NCT01691872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110088123|NCT01691937|Sufentanil|sufentanil|mesh-list
110088124|NCT01691937|Ropivacaine|ropivacaine|mesh-list
110088125|NCT01691937|Anesthetics, Local|anesthetics, local|mesh-ancestor
110088126|NCT01691937|Anesthetics|anesthetics|mesh-ancestor
110088127|NCT01691937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110088128|NCT01691937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110088129|NCT01691937|Sensory System Agents|sensory system agents|mesh-ancestor
110088130|NCT01691937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110088131|NCT01691937|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110088132|NCT01691937|Narcotics|narcotics|mesh-ancestor
110088133|NCT01691937|Analgesics|analgesics|mesh-ancestor
110088134|NCT01691937|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110088135|NCT01691937|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110088136|NCT01691937|Anesthetics, General|anesthetics, general|mesh-ancestor
110088137|NCT01691976|Estrogens|estrogens|mesh-list
110088138|NCT01691976|Hormones|hormones|mesh-ancestor
110088139|NCT01691976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110088140|NCT01691976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110088141|NCT01692132|Prucalopride|prucalopride|mesh-list
110088142|NCT01692132|Laxatives|laxatives|mesh-ancestor
110088143|NCT01692132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110088144|NCT01692132|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
110088145|NCT01692132|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110088146|NCT01692132|Serotonin Agents|serotonin agents|mesh-ancestor
110088147|NCT01692132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110088148|NCT01692132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110088149|NCT01692132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110088150|NCT01692210|Dexmedetomidine|dexmedetomidine|mesh-list
110088151|NCT01692210|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110088152|NCT01692210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110088153|NCT01692210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110088154|NCT01692210|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110088155|NCT01692210|Analgesics|analgesics|mesh-ancestor
110088156|NCT01692210|Sensory System Agents|sensory system agents|mesh-ancestor
110088157|NCT01692210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110088158|NCT01692210|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110088159|NCT01692210|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110088160|NCT01692210|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110088161|NCT01692210|Adrenergic Agents|adrenergic agents|mesh-ancestor
110088162|NCT01692210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110088163|NCT01692210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110088165|NCT01692457|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110088166|NCT01692457|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110088167|NCT01692457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110088168|NCT01692457|Immunologic Factors|immunologic factors|mesh-ancestor
110088169|NCT01692457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110088170|NCT01692483|Prednisone|prednisone|mesh-list
110088171|NCT01692483|Abiraterone Acetate|abiraterone acetate|mesh-list
110088172|NCT01692483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110088173|NCT01692483|Glucocorticoids|glucocorticoids|mesh-ancestor
110088174|NCT01692483|Hormones|hormones|mesh-ancestor
110088175|NCT01692483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110088176|NCT01692483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110088177|NCT01692483|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110088178|NCT01692483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110088179|NCT01692483|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110088180|NCT01692483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110088181|NCT01692483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110088182|NCT01692483|Hormone Antagonists|hormone antagonists|mesh-ancestor
110088183|NCT01692483|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110088184|NCT01692652|Loteprednol Etabonate|loteprednol etabonate|mesh-list
110088185|NCT01692652|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110088186|NCT01692678|Dacarbazine|dacarbazine|mesh-list
110088187|NCT01692678|Trabectedin|trabectedin|mesh-list
110088188|NCT01692678|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110185445|NCT00846716|Biguanides|biguanides|mesh-list
110088189|NCT01692678|Alkylating Agents|alkylating agents|mesh-ancestor
110088190|NCT01692678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110088191|NCT01692678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110088192|NCT01692704|Gemcitabine|gemcitabine|mesh-list
110088193|NCT01692704|Floxuridine|floxuridine|mesh-list
110088194|NCT01692704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110088195|NCT01692704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110088196|NCT01692704|Antimetabolites|antimetabolites|mesh-ancestor
110088197|NCT01692704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110088199|NCT01692808|Ergocalciferols|ergocalciferols|mesh-list
110088200|NCT01692808|Cholecalciferol|cholecalciferol|mesh-list
110088201|NCT01692808|Vitamins|vitamins|mesh-list
110088202|NCT01692808|Micronutrients|micronutrients|mesh-ancestor
110088203|NCT01692808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110088204|NCT01692808|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110088205|NCT01692808|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110088206|NCT01692834|Cyclosporine|cyclosporine|mesh-list
110088207|NCT01692834|Cyclosporins|cyclosporins|mesh-list
110088208|NCT01692834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110088209|NCT01692834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110088210|NCT01692834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110088211|NCT01692834|Immunologic Factors|immunologic factors|mesh-ancestor
110088212|NCT01692834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110088213|NCT01692834|Antifungal Agents|antifungal agents|mesh-ancestor
110088214|NCT01692834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110088215|NCT01692834|Dermatologic Agents|dermatologic agents|mesh-ancestor
110088216|NCT01692834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110088217|NCT01692834|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110088218|NCT01692886|Vaccines|vaccines|mesh-list
110088219|NCT01692886|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110088220|NCT01692886|Immunologic Factors|immunologic factors|mesh-ancestor
110088221|NCT01692886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110088222|NCT01692925|Factor VIII|factor viii|mesh-list
110088223|NCT01692925|Coagulants|coagulants|mesh-ancestor
110088224|NCT01693003|Tiotropium Bromide|tiotropium bromide|mesh-list
110088225|NCT01693003|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110088226|NCT01693003|Autonomic Agents|autonomic agents|mesh-ancestor
110088227|NCT01693003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110088228|NCT01693003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110088229|NCT01693003|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110088230|NCT01693003|Respiratory System Agents|respiratory system agents|mesh-ancestor
110088231|NCT01693003|Parasympatholytics|parasympatholytics|mesh-ancestor
110088232|NCT01693003|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110088233|NCT01693003|Cholinergic Agents|cholinergic agents|mesh-ancestor
110088234|NCT01693003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110088235|NCT01693003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110088237|NCT01693081|Emetics|emetics|mesh-ancestor
110088238|NCT01693081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110088239|NCT01693081|Autonomic Agents|autonomic agents|mesh-ancestor
110088240|NCT01693081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110088241|NCT01693081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110088242|NCT01693081|Dopamine Agonists|dopamine agonists|mesh-ancestor
110088243|NCT01693081|Dopamine Agents|dopamine agents|mesh-ancestor
110088244|NCT01693081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110088245|NCT01693081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110088247|NCT01693159|Hemostatics|hemostatics|mesh-ancestor
110088248|NCT01693159|Coagulants|coagulants|mesh-ancestor
110088249|NCT01693276|Paclitaxel|paclitaxel|mesh-list
110088250|NCT01693276|Gemcitabine|gemcitabine|mesh-list
110088251|NCT01693276|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110185451|NCT00846677|Vitamin D|vitamin d|mesh-list
110088252|NCT01693276|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110088253|NCT01693276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110088254|NCT01693276|Tubulin Modulators|tubulin modulators|mesh-ancestor
110088255|NCT01693276|Antimitotic Agents|antimitotic agents|mesh-ancestor
110088256|NCT01693276|Mitosis Modulators|mitosis modulators|mesh-ancestor
110088257|NCT01693276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110088258|NCT01693276|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110088259|NCT01693276|Antimetabolites|antimetabolites|mesh-ancestor
110088260|NCT01693289|Metformin|metformin|mesh-list
110088261|NCT01693289|Letrozole|letrozole|mesh-list
110088262|NCT01693289|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110088263|NCT01693289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110088264|NCT01693289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110088265|NCT01693289|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110088266|NCT01693289|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110088267|NCT01693289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110088268|NCT01693289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110088269|NCT01693289|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110088270|NCT01693289|Hormone Antagonists|hormone antagonists|mesh-ancestor
110225465|NCT05959356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110088271|NCT01693289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110088273|NCT01693302|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110088274|NCT01693302|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110088275|NCT01693302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110088276|NCT01693328|Fentanyl|fentanyl|mesh-list
110088277|NCT01693328|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110088278|NCT01693328|Narcotics|narcotics|mesh-ancestor
110088279|NCT01693328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110088280|NCT01693328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110088281|NCT01693328|Analgesics|analgesics|mesh-ancestor
110088282|NCT01693328|Sensory System Agents|sensory system agents|mesh-ancestor
110088283|NCT01693328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110088284|NCT01693328|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110088285|NCT01693328|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110088286|NCT01693328|Anesthetics, General|anesthetics, general|mesh-ancestor
110088287|NCT01693328|Anesthetics|anesthetics|mesh-ancestor
110088288|NCT01693393|Cyclosporine|cyclosporine|mesh-list
110088289|NCT01693393|Cyclosporins|cyclosporins|mesh-list
110088290|NCT01693393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110088291|NCT01693393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110088292|NCT01693393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110088293|NCT01693393|Immunologic Factors|immunologic factors|mesh-ancestor
110088294|NCT01693393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110088295|NCT01693393|Antifungal Agents|antifungal agents|mesh-ancestor
110088296|NCT01693393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110088297|NCT01693393|Dermatologic Agents|dermatologic agents|mesh-ancestor
110088298|NCT01693393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110088299|NCT01693393|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110088300|NCT01693419|Gemcitabine|gemcitabine|mesh-list
110088301|NCT01693419|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110088302|NCT01693419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110088303|NCT01693419|Antimetabolites|antimetabolites|mesh-ancestor
110088304|NCT01693419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110088305|NCT01693419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110088306|NCT01693419|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110088307|NCT01693419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110088308|NCT01693432|Docetaxel|docetaxel|mesh-list
110088309|NCT01693432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110088310|NCT01693432|Tubulin Modulators|tubulin modulators|mesh-ancestor
110088311|NCT01693432|Antimitotic Agents|antimitotic agents|mesh-ancestor
110088312|NCT01693432|Mitosis Modulators|mitosis modulators|mesh-ancestor
110088313|NCT01693432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110088314|NCT01693445|Oxaliplatin|oxaliplatin|mesh-list
110088315|NCT01693445|Irinotecan|irinotecan|mesh-list
110088316|NCT01693445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110088317|NCT01693445|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110088318|NCT01693445|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110088319|NCT01693445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110088320|NCT01693445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110088322|NCT01693601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110088323|NCT01693601|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110088324|NCT01693601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110088325|NCT01693601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110088326|NCT01693640|Abatacept|abatacept|mesh-list
110088327|NCT01693640|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110225467|NCT05959356|Protective Agents|protective agents|mesh-ancestor
110088328|NCT01693640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110088329|NCT01693640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110088330|NCT01693640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110088331|NCT01693640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110088332|NCT01693640|Immunologic Factors|immunologic factors|mesh-ancestor
110088333|NCT01693640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110088334|NCT01693640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110088336|NCT01693679|Adefovir|adefovir|mesh-list
110088337|NCT01693679|Telbivudine|telbivudine|mesh-list
110088338|NCT01693679|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110088339|NCT01693679|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110088340|NCT01693679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110088341|NCT01693679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110088342|NCT01693679|Antiviral Agents|antiviral agents|mesh-ancestor
110088343|NCT01693679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110088344|NCT01693679|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110088345|NCT01693679|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110088346|NCT01693718|Fluorouracil|fluorouracil|mesh-list
110088347|NCT01693718|Hydroxyurea|hydroxyurea|mesh-list
110088348|NCT01693718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110088349|NCT01693718|Antimetabolites|antimetabolites|mesh-ancestor
110088350|NCT01693718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110088351|NCT01693718|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110088352|NCT01693718|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110088353|NCT01693718|Immunologic Factors|immunologic factors|mesh-ancestor
110088354|NCT01693718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110088355|NCT01693718|Antisickling Agents|antisickling agents|mesh-ancestor
110088356|NCT01693718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110088357|NCT01693718|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110088358|NCT01693809|Caffeine|caffeine|mesh-list
110088359|NCT01693809|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110088360|NCT01693809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110088361|NCT01693809|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110088362|NCT01693809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110088363|NCT01693809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110088364|NCT01693809|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110088365|NCT01693809|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110088366|NCT01693809|Purinergic Agents|purinergic agents|mesh-ancestor
110088367|NCT01693809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110088368|NCT01693822|Axitinib|axitinib|mesh-list
110088369|NCT01693822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110088370|NCT01693822|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110088371|NCT01693822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110088372|NCT01693822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110088373|NCT01694017|Tenofovir|tenofovir|mesh-list
110088374|NCT01694017|Zidovudine|zidovudine|mesh-list
110088375|NCT01694017|Antiviral Agents|antiviral agents|mesh-ancestor
110088376|NCT01694017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110088377|NCT01694017|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110088378|NCT01694017|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110088379|NCT01694017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110088380|NCT01694017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110088381|NCT01694017|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110088382|NCT01694017|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110088383|NCT01694017|Antimetabolites|antimetabolites|mesh-ancestor
110088384|NCT05288816|Ravulizumab|ravulizumab|mesh-list
110088385|NCT05288816|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
110088386|NCT05288816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110088387|NCT05288816|Immunologic Factors|immunologic factors|mesh-ancestor
110088388|NCT05288816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110088389|NCT05288738|Dexmedetomidine|dexmedetomidine|mesh-list
110088390|NCT05288738|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110088391|NCT05288738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110088392|NCT05288738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110088393|NCT05288738|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110088395|NCT05288738|Sensory System Agents|sensory system agents|mesh-ancestor
110088396|NCT05288738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110088397|NCT05288738|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110088398|NCT05288738|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110088399|NCT05288738|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110088400|NCT05288738|Adrenergic Agents|adrenergic agents|mesh-ancestor
110088401|NCT05288738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110088402|NCT05288738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110088403|NCT05288725|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110088404|NCT05288725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110088405|NCT05288725|Glucocorticoids|glucocorticoids|mesh-ancestor
110088406|NCT05288725|Hormones|hormones|mesh-ancestor
110088407|NCT05288725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110088408|NCT05288725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110088409|NCT05288725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110088410|NCT05288725|Immunologic Factors|immunologic factors|mesh-ancestor
110088411|NCT05288465|Cerebrolysin|cerebrolysin|mesh-list
110088412|NCT05288465|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110088413|NCT05288465|Protective Agents|protective agents|mesh-ancestor
110088414|NCT05288465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110088415|NCT05288465|Nootropic Agents|nootropic agents|mesh-ancestor
110088416|NCT05288192|Triamcinolone|triamcinolone|mesh-list
110088417|NCT05288192|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110088418|NCT05288192|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110088419|NCT05288192|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110088420|NCT05288192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110088421|NCT05288192|Glucocorticoids|glucocorticoids|mesh-ancestor
110088422|NCT05288192|Hormones|hormones|mesh-ancestor
110088423|NCT05288192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110088424|NCT05288192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110088425|NCT05288192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110088426|NCT05288192|Immunologic Factors|immunologic factors|mesh-ancestor
110088427|NCT05288192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110088428|NCT05288192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110088429|NCT05288179|Pirfenidone|pirfenidone|mesh-list
110088430|NCT05288179|Analgesics|analgesics|mesh-ancestor
110088431|NCT05288179|Sensory System Agents|sensory system agents|mesh-ancestor
110088432|NCT05288179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110088433|NCT05288179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110088434|NCT05288179|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110088435|NCT05288179|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110088436|NCT05288179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110088437|NCT05288179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110088438|NCT05288179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110088439|NCT05288127|Talazoparib|talazoparib|mesh-list
110088440|NCT05288127|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110088441|NCT05288127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110088442|NCT05288127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110088443|NCT05288127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110088444|NCT05291455|Lacosamide|lacosamide|mesh-list
110088445|NCT05291455|Phenobarbital|phenobarbital|mesh-list
110088446|NCT05291455|Anticonvulsants|anticonvulsants|mesh-ancestor
110088447|NCT05291455|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110088448|NCT05291455|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110088449|NCT05291455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110088450|NCT05291455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110088451|NCT05291455|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110088452|NCT05291455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110088453|NCT05291455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110088454|NCT05291455|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110088455|NCT05291455|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110185476|NCT05424549|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110088456|NCT05291455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110088457|NCT05291455|GABA Modulators|gaba modulators|mesh-ancestor
110088458|NCT05291455|GABA Agents|gaba agents|mesh-ancestor
110088459|NCT05291455|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110088460|NCT05291455|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110088461|NCT05291455|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110088462|NCT05291195|Sodium Hypochlorite|sodium hypochlorite|mesh-list
110088464|NCT05291195|Disinfectants|disinfectants|mesh-ancestor
110088465|NCT05291195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110088466|NCT05291104|Folic Acid|folic acid|mesh-list
110088467|NCT05291104|Choline|choline|mesh-list
110088468|NCT05291104|Hematinics|hematinics|mesh-ancestor
110088469|NCT05291104|Vitamin B Complex|vitamin b complex|mesh-ancestor
110088470|NCT05291104|Vitamins|vitamins|mesh-ancestor
110088471|NCT05291104|Micronutrients|micronutrients|mesh-ancestor
110088472|NCT05291104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110088473|NCT05291104|Lipotropic Agents|lipotropic agents|mesh-ancestor
110088474|NCT05291104|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110088475|NCT05291104|Antimetabolites|antimetabolites|mesh-ancestor
110088476|NCT05291104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110088477|NCT05291104|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110088478|NCT05291104|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110088479|NCT05291104|Nootropic Agents|nootropic agents|mesh-ancestor
110088480|NCT05291052|Capecitabine|capecitabine|mesh-list
110088481|NCT05291052|Oxaliplatin|oxaliplatin|mesh-list
110088482|NCT05291052|Lenvatinib|lenvatinib|mesh-list
110088483|NCT05291052|Tislelizumab|tislelizumab|mesh-list
110088484|NCT05291052|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110088485|NCT05291052|Antimetabolites|antimetabolites|mesh-ancestor
110088486|NCT05291052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110088487|NCT05291052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110088488|NCT05291052|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110088489|NCT05291052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110088490|NCT05291052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110088491|NCT05290948|Bevacizumab|bevacizumab|mesh-list
110088492|NCT05290948|Acetazolamide|acetazolamide|mesh-list
110088493|NCT05290948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110088494|NCT05290948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110088495|NCT05290948|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110088496|NCT05290948|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110088497|NCT05290948|Growth Substances|growth substances|mesh-ancestor
110088498|NCT05290948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110088499|NCT05290948|Growth Inhibitors|growth inhibitors|mesh-ancestor
110088500|NCT05290948|Anticonvulsants|anticonvulsants|mesh-ancestor
110088501|NCT05290948|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110088502|NCT05290948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110088503|NCT05290948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110088504|NCT05290948|Diuretics|diuretics|mesh-ancestor
110088505|NCT05290948|Natriuretic Agents|natriuretic agents|mesh-ancestor
110088506|NCT05290935|Paclitaxel|paclitaxel|mesh-list
110088507|NCT05290935|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110088508|NCT05290935|Antibodies|antibodies|mesh-list
110088509|NCT05290935|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110088510|NCT05290935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110088511|NCT05290935|Tubulin Modulators|tubulin modulators|mesh-ancestor
110088512|NCT05290935|Antimitotic Agents|antimitotic agents|mesh-ancestor
110088513|NCT05290935|Mitosis Modulators|mitosis modulators|mesh-ancestor
110088514|NCT05290935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110088515|NCT05290935|Immunologic Factors|immunologic factors|mesh-ancestor
110088516|NCT05290935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110088518|NCT05290857|Coagulants|coagulants|mesh-ancestor
110088519|NCT05290506|Linagliptin|linagliptin|mesh-list
110088520|NCT05290506|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
110088521|NCT05290506|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110088522|NCT05290506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110088523|NCT05290506|Incretins|incretins|mesh-ancestor
110088524|NCT05290506|Hormones|hormones|mesh-ancestor
110088525|NCT05290506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110088526|NCT05290506|Protease Inhibitors|protease inhibitors|mesh-ancestor
110088527|NCT05290506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110088528|NCT05290506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110088529|NCT05290337|Zanubrutinib|zanubrutinib|mesh-list
110088530|NCT05290337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110088531|NCT05290337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110088532|NCT05290337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110088533|NCT05290337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110088534|NCT05290324|Midazolam|midazolam|mesh-list
110088535|NCT05290324|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110088536|NCT05290324|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110088537|NCT05290324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110088538|NCT05290324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110088539|NCT05290324|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110088540|NCT05290324|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110088541|NCT05290324|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110088542|NCT05290324|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110088543|NCT05290324|Anesthetics, General|anesthetics, general|mesh-ancestor
110088545|NCT05290324|GABA Modulators|gaba modulators|mesh-ancestor
110088546|NCT05290324|GABA Agents|gaba agents|mesh-ancestor
110088547|NCT05290324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110088548|NCT05290324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110088549|NCT05292742|Capecitabine|capecitabine|mesh-list
110088550|NCT05292742|Trastuzumab|trastuzumab|mesh-list
110088551|NCT05292742|Pertuzumab|pertuzumab|mesh-list
110088552|NCT05292742|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110088553|NCT05292742|Antimetabolites|antimetabolites|mesh-ancestor
110088554|NCT05292742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110088555|NCT05292742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110088556|NCT05292742|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110088557|NCT05292677|Anesthetics|anesthetics|mesh-list
110088558|NCT05292677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110088559|NCT05292677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110088560|NCT05292573|Metformin|metformin|mesh-list
110088561|NCT05292573|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110088562|NCT05292573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110088563|NCT05291910|Paclitaxel|paclitaxel|mesh-list
110088564|NCT05291910|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110088565|NCT05291910|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110088566|NCT05291910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110088567|NCT05291910|Tubulin Modulators|tubulin modulators|mesh-ancestor
110088568|NCT05291910|Antimitotic Agents|antimitotic agents|mesh-ancestor
110088569|NCT05291910|Mitosis Modulators|mitosis modulators|mesh-ancestor
110088570|NCT05291910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110088571|NCT05291793|Methylprednisolone|methylprednisolone|mesh-list
110088572|NCT05291793|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110088573|NCT05291793|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110088574|NCT05291793|Prednisolone|prednisolone|mesh-list
110088575|NCT05291793|Prednisolone acetate|prednisolone acetate|mesh-list
110088576|NCT05291793|Tenoxicam|tenoxicam|mesh-list
110088577|NCT05291793|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110088578|NCT05291793|Prednisolone phosphate|prednisolone phosphate|mesh-list
110088579|NCT05291793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110088580|NCT05291793|Antiemetics|antiemetics|mesh-ancestor
110088581|NCT05291793|Autonomic Agents|autonomic agents|mesh-ancestor
110088582|NCT05291793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110088583|NCT05291793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110088584|NCT05291793|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110088585|NCT05291793|Glucocorticoids|glucocorticoids|mesh-ancestor
110088586|NCT05291793|Hormones|hormones|mesh-ancestor
110088587|NCT05291793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110088588|NCT05291793|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110088589|NCT05291793|Protective Agents|protective agents|mesh-ancestor
110088590|NCT05291793|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110185495|NCT00846326|Dermatologic Agents|dermatologic agents|mesh-ancestor
110088591|NCT05291793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110088592|NCT05291793|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110088593|NCT05291793|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110088595|NCT05291793|Sensory System Agents|sensory system agents|mesh-ancestor
110088596|NCT05291793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110088597|NCT05291793|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110088598|NCT05291793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110088599|NCT05291793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110088600|NCT05294926|Rocuronium|rocuronium|mesh-list
110088601|NCT05294926|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110088602|NCT05294926|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110088603|NCT05294926|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110088604|NCT05294926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110088605|NCT05294926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110088606|NCT05294887|Bisoprolol|bisoprolol|mesh-list
110088607|NCT05294887|Diltiazem|diltiazem|mesh-list
110088608|NCT05294887|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110088609|NCT05294887|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110088610|NCT05294887|Adrenergic Agents|adrenergic agents|mesh-ancestor
110088611|NCT05294887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110088612|NCT05294887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110088613|NCT05294887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110088614|NCT05294887|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110088615|NCT05294887|Sympatholytics|sympatholytics|mesh-ancestor
110088616|NCT05294887|Autonomic Agents|autonomic agents|mesh-ancestor
110088617|NCT05294887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110088618|NCT05294887|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110088619|NCT05294887|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110088620|NCT05294887|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110088621|NCT05294887|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110088623|NCT05294822|Insulin|insulin|mesh-list
110088624|NCT05294822|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110088625|NCT05294822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110088626|NCT05294744|Acetylcysteine|acetylcysteine|mesh-list
110088627|NCT05294744|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110088628|NCT05294744|Antiviral Agents|antiviral agents|mesh-ancestor
110088629|NCT05294744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110088630|NCT05294744|Expectorants|expectorants|mesh-ancestor
110088631|NCT05294744|Respiratory System Agents|respiratory system agents|mesh-ancestor
110088632|NCT05294744|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110088633|NCT05294744|Antioxidants|antioxidants|mesh-ancestor
110088634|NCT05294744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110088635|NCT05294744|Protective Agents|protective agents|mesh-ancestor
110088636|NCT05294744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110088637|NCT05294744|Antidotes|antidotes|mesh-ancestor
110088638|NCT05294679|Propofol|propofol|mesh-list
110088639|NCT05294679|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110088640|NCT05294679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110088641|NCT05294679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110088642|NCT05294679|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110088643|NCT05294679|Anesthetics, General|anesthetics, general|mesh-ancestor
110088644|NCT05294679|Anesthetics|anesthetics|mesh-ancestor
110088645|NCT05294666|Cyclosporine|cyclosporine|mesh-list
110088646|NCT05294666|Tacrolimus|tacrolimus|mesh-list
110088647|NCT05294666|Cyclosporins|cyclosporins|mesh-list
110088648|NCT05294666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110088649|NCT05294666|Immunologic Factors|immunologic factors|mesh-ancestor
110088650|NCT05294666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110088651|NCT05294666|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110088652|NCT05294666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110088653|NCT05294666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110185502|NCT00846326|Sympathomimetics|sympathomimetics|mesh-ancestor
110088654|NCT05294666|Antifungal Agents|antifungal agents|mesh-ancestor
110088655|NCT05294666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110088656|NCT05294666|Dermatologic Agents|dermatologic agents|mesh-ancestor
110088657|NCT05294666|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110088658|NCT05294640|Lidocaine|lidocaine|mesh-list
110088659|NCT05294640|Epinephrine|epinephrine|mesh-list
110088660|NCT05294640|Anesthetics, Local|anesthetics, local|mesh-list
110088661|NCT05294640|Anesthetics|anesthetics|mesh-list
110088662|NCT05294640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110088663|NCT05294640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110088665|NCT05294640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110088666|NCT05294640|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110088667|NCT05294640|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110088668|NCT05294640|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110088669|NCT05294640|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110088670|NCT05294640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110088671|NCT05294640|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110088672|NCT05294640|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110088673|NCT05294640|Adrenergic Agents|adrenergic agents|mesh-ancestor
110088674|NCT05294640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110088675|NCT05294640|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110088676|NCT05294640|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110088677|NCT05294640|Autonomic Agents|autonomic agents|mesh-ancestor
110088678|NCT05294640|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110088679|NCT05294640|Respiratory System Agents|respiratory system agents|mesh-ancestor
110088681|NCT05294640|Sympathomimetics|sympathomimetics|mesh-ancestor
110088682|NCT05294640|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110088683|NCT05294536|Liraglutide|liraglutide|mesh-list
110088684|NCT05294536|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110088685|NCT05294536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110088686|NCT05294536|Incretins|incretins|mesh-ancestor
110088687|NCT05294536|Hormones|hormones|mesh-ancestor
110088688|NCT05294536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110088689|NCT05294484|Indapamide|indapamide|mesh-list
110088690|NCT05294484|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110088691|NCT05294484|Diuretics|diuretics|mesh-ancestor
110088692|NCT05294484|Natriuretic Agents|natriuretic agents|mesh-ancestor
110088693|NCT05294484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110088694|NCT05294484|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110088695|NCT05294484|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110088696|NCT05294484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110088697|NCT05294406|Piperaquine|piperaquine|mesh-list
110088699|NCT05294406|Antimalarials|antimalarials|mesh-ancestor
110088700|NCT05294406|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110088701|NCT05294406|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110088702|NCT05294406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110088703|NCT05294393|Magnesium Sulfate|magnesium sulfate|mesh-list
110088704|NCT05294393|Ropivacaine|ropivacaine|mesh-list
110088705|NCT05294393|Anesthetics, Local|anesthetics, local|mesh-ancestor
110088706|NCT05294393|Anesthetics|anesthetics|mesh-ancestor
110088707|NCT05294393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110088708|NCT05294393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110088709|NCT05294393|Sensory System Agents|sensory system agents|mesh-ancestor
110088710|NCT05294393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110088711|NCT05294393|Analgesics|analgesics|mesh-ancestor
110088712|NCT05294393|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110088713|NCT05294393|Anticonvulsants|anticonvulsants|mesh-ancestor
110088714|NCT05294393|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110088715|NCT05294393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110088716|NCT05294393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110088717|NCT05294393|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110088718|NCT05294393|Tocolytic Agents|tocolytic agents|mesh-ancestor
110088719|NCT05294393|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110088720|NCT05293977|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110088721|NCT05293977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110088722|NCT05293808|Aspirin|aspirin|mesh-list
110088723|NCT05293808|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110088724|NCT05293808|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110088725|NCT05293808|Analgesics|analgesics|mesh-ancestor
110088726|NCT05293808|Sensory System Agents|sensory system agents|mesh-ancestor
110088727|NCT05293808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110088728|NCT05293808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110088729|NCT05293808|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110088730|NCT05293808|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110088731|NCT05293808|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110088732|NCT05293808|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110088733|NCT05293808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110088734|NCT05293808|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110088735|NCT05293808|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110088736|NCT05293808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110088737|NCT05293808|Antipyretics|antipyretics|mesh-ancestor
110088738|NCT05293704|Mizoribine|mizoribine|mesh-list
110088739|NCT05293704|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110088740|NCT05293704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110088741|NCT05293704|Analgesics|analgesics|mesh-ancestor
110088742|NCT05293704|Sensory System Agents|sensory system agents|mesh-ancestor
110088743|NCT05293704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110088744|NCT05293704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110088745|NCT05293704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110088746|NCT05293704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110088747|NCT05293704|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110088748|NCT05293704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110088749|NCT05293704|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110088750|NCT05293704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110088751|NCT05293704|Antimalarials|antimalarials|mesh-ancestor
110088752|NCT05293704|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110088753|NCT05293704|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110088755|NCT05293704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110088756|NCT05293704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110088757|NCT05293704|Immunologic Factors|immunologic factors|mesh-ancestor
110088758|NCT05293574|Norethindrone|norethindrone|mesh-list
110088759|NCT05293574|Norethindrone Acetate|norethindrone acetate|mesh-list
110088760|NCT05293574|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110088761|NCT05293574|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110088762|NCT05293574|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110088763|NCT05293574|Contraceptive Agents|contraceptive agents|mesh-ancestor
110088764|NCT05293574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110088765|NCT05293574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110088766|NCT05293574|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110088767|NCT05293574|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110088768|NCT05293119|Mometasone Furoate|mometasone furoate|mesh-list
110088769|NCT05293119|Tofacitinib|tofacitinib|mesh-list
110088770|NCT05293119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110088771|NCT05293119|Dermatologic Agents|dermatologic agents|mesh-ancestor
110088772|NCT05293119|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110088773|NCT05293119|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
110088774|NCT05293119|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110088775|NCT05293119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110088776|NCT05293119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110088777|NCT05293080|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
110088778|NCT05296863|Minoxidil|minoxidil|mesh-list
110088779|NCT05296863|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110088780|NCT05296863|Vasodilator Agents|vasodilator agents|mesh-ancestor
110088781|NCT05296369|Folic Acid|folic acid|mesh-list
110088782|NCT05296369|Hematinics|hematinics|mesh-ancestor
110088783|NCT05296369|Vitamin B Complex|vitamin b complex|mesh-ancestor
110088784|NCT05296369|Vitamins|vitamins|mesh-ancestor
110088785|NCT05296369|Micronutrients|micronutrients|mesh-ancestor
110088786|NCT05296369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110088787|NCT05296317|Cyclophosphamide|cyclophosphamide|mesh-list
110088788|NCT05296317|Epirubicin|epirubicin|mesh-list
110088789|NCT05296317|Lenograstim|lenograstim|mesh-list
110088790|NCT05296317|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110088791|NCT05296317|Immunologic Factors|immunologic factors|mesh-ancestor
110088792|NCT05296317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110088793|NCT05296317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110088794|NCT05296317|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110088795|NCT05296317|Alkylating Agents|alkylating agents|mesh-ancestor
110088796|NCT05296317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110088797|NCT05296317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110088798|NCT05296317|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110088799|NCT05296317|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110088800|NCT05296317|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110088801|NCT05296317|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110088802|NCT05296317|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110088803|NCT05296317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110088804|NCT05296005|Leucovorin|leucovorin|mesh-list
110088805|NCT05296005|Docetaxel|docetaxel|mesh-list
110088806|NCT05296005|Fluorouracil|fluorouracil|mesh-list
110088807|NCT05296005|Capecitabine|capecitabine|mesh-list
110088808|NCT05296005|Oxaliplatin|oxaliplatin|mesh-list
110088809|NCT05296005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110088810|NCT05296005|Tubulin Modulators|tubulin modulators|mesh-ancestor
110088811|NCT05296005|Antimitotic Agents|antimitotic agents|mesh-ancestor
110088812|NCT05296005|Mitosis Modulators|mitosis modulators|mesh-ancestor
110088813|NCT05296005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110088814|NCT05296005|Antimetabolites|antimetabolites|mesh-ancestor
110088815|NCT05296005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110088816|NCT05296005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110088817|NCT05296005|Immunologic Factors|immunologic factors|mesh-ancestor
110088818|NCT05296005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110088819|NCT05296005|Antidotes|antidotes|mesh-ancestor
110088820|NCT05296005|Protective Agents|protective agents|mesh-ancestor
110088821|NCT05296005|Vitamin B Complex|vitamin b complex|mesh-ancestor
110088822|NCT05296005|Vitamins|vitamins|mesh-ancestor
110088823|NCT05296005|Micronutrients|micronutrients|mesh-ancestor
110088824|NCT05295836|Glycerol|glycerol|mesh-list
110088825|NCT05295836|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
110088826|NCT05295836|Protective Agents|protective agents|mesh-ancestor
110088827|NCT05295836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110088828|NCT05294900|Paclitaxel|paclitaxel|mesh-list
110088829|NCT05294900|Carboplatin|carboplatin|mesh-list
110088831|NCT05294900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110088832|NCT05294900|Tubulin Modulators|tubulin modulators|mesh-ancestor
110088833|NCT05294900|Antimitotic Agents|antimitotic agents|mesh-ancestor
110088834|NCT05294900|Mitosis Modulators|mitosis modulators|mesh-ancestor
110088835|NCT05294900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110088836|NCT05275647|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110088837|NCT05275647|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110088838|NCT05275647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110088839|NCT05275647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110088840|NCT05275647|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110088841|NCT05275647|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110088842|NCT05275647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110088843|NCT05275647|Cholinergic Agents|cholinergic agents|mesh-ancestor
110088844|NCT05275647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110088845|NCT05273242|Artesunate|artesunate|mesh-list
110088846|NCT05273242|Infliximab|infliximab|mesh-list
110088847|NCT05273242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110088848|NCT05273242|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110088849|NCT05273242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110088850|NCT05273242|Dermatologic Agents|dermatologic agents|mesh-ancestor
110088851|NCT05273242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110088852|NCT05273242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110088853|NCT05273242|Antimalarials|antimalarials|mesh-ancestor
110088854|NCT05273242|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110088855|NCT05273242|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110088856|NCT05273242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110088857|NCT05273242|Antiviral Agents|antiviral agents|mesh-ancestor
110088858|NCT05273242|Schistosomicides|schistosomicides|mesh-ancestor
110088859|NCT05273242|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110088860|NCT05273242|Anthelmintics|anthelmintics|mesh-ancestor
110088861|NCT05269095|Anesthetics|anesthetics|mesh-list
110088862|NCT05269095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110088863|NCT05269095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110088864|NCT05267938|Lidocaine|lidocaine|mesh-list
110088865|NCT05267938|Epinephrine|epinephrine|mesh-list
110088866|NCT05267938|Anesthetics, Local|anesthetics, local|mesh-list
110088867|NCT05267938|Anesthetics|anesthetics|mesh-list
110088868|NCT05267938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110088869|NCT05267938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110088870|NCT05267938|Sensory System Agents|sensory system agents|mesh-ancestor
110088871|NCT05267938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110088872|NCT05267938|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110088873|NCT05267938|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110088874|NCT05267938|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110088875|NCT05267938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110088876|NCT05267938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110088877|NCT05267938|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110088878|NCT05267938|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110088879|NCT05267938|Adrenergic Agents|adrenergic agents|mesh-ancestor
110088880|NCT05267938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110088881|NCT05267938|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110088882|NCT05267938|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110088883|NCT05267938|Autonomic Agents|autonomic agents|mesh-ancestor
110088884|NCT05267938|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110088885|NCT05267938|Respiratory System Agents|respiratory system agents|mesh-ancestor
110088886|NCT05267938|Mydriatics|mydriatics|mesh-ancestor
110088887|NCT05267938|Sympathomimetics|sympathomimetics|mesh-ancestor
110088888|NCT05267938|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110088889|NCT05267431|Methotrexate|methotrexate|mesh-list
110088890|NCT05267431|Hydroquinone|hydroquinone|mesh-list
110088891|NCT05267431|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110088892|NCT05267431|Abortifacient Agents|abortifacient agents|mesh-ancestor
110088893|NCT05267431|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110088894|NCT05267431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110088895|NCT05267431|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110088896|NCT05267431|Antimetabolites|antimetabolites|mesh-ancestor
110088897|NCT05267431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110088898|NCT05267431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110088899|NCT05267431|Dermatologic Agents|dermatologic agents|mesh-ancestor
110088900|NCT05267431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110088901|NCT05267431|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110088902|NCT05267431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110088903|NCT05267431|Immunologic Factors|immunologic factors|mesh-ancestor
110088904|NCT05267431|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110088905|NCT05267431|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110088906|NCT05267431|Antioxidants|antioxidants|mesh-ancestor
110088907|NCT05267431|Protective Agents|protective agents|mesh-ancestor
110088908|NCT05267431|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110088909|NCT05266248|Caffeine|caffeine|mesh-list
110088910|NCT05266248|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110088911|NCT05266248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110088912|NCT05266248|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110088913|NCT05266248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110088914|NCT05266248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110088915|NCT05266248|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110088916|NCT05266248|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110088917|NCT05266248|Purinergic Agents|purinergic agents|mesh-ancestor
110088918|NCT05266248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110088919|NCT05264584|Acetylcysteine|acetylcysteine|mesh-list
110088920|NCT05264584|Febuxostat|febuxostat|mesh-list
110088925|NCT05264584|Respiratory System Agents|respiratory system agents|mesh-ancestor
110088926|NCT05264584|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110088927|NCT05264584|Antioxidants|antioxidants|mesh-ancestor
110088928|NCT05264584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110088929|NCT05264584|Protective Agents|protective agents|mesh-ancestor
110088930|NCT05264584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110088931|NCT05264584|Antidotes|antidotes|mesh-ancestor
110088932|NCT05264584|Gout Suppressants|gout suppressants|mesh-ancestor
110088933|NCT05264584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110088934|NCT05262686|Aldesleukin|aldesleukin|mesh-list
110088935|NCT05262686|Interleukin-2|interleukin-2|mesh-list
110088936|NCT05262686|Belimumab|belimumab|mesh-list
110088937|NCT05262686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110088938|NCT05262686|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110088939|NCT05262686|Analgesics|analgesics|mesh-ancestor
110088940|NCT05262686|Sensory System Agents|sensory system agents|mesh-ancestor
110088941|NCT05262686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110088942|NCT05262686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110088943|NCT05262686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110088944|NCT05262686|Immunologic Factors|immunologic factors|mesh-ancestor
110088945|NCT05262686|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110088946|NCT05262686|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110088947|NCT05262686|Antiviral Agents|antiviral agents|mesh-ancestor
110088948|NCT05262686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110088952|NCT05238506|Lidocaine|lidocaine|mesh-list
110088953|NCT05238506|Anesthetics, Local|anesthetics, local|mesh-ancestor
110088954|NCT05238506|Anesthetics|anesthetics|mesh-ancestor
110088955|NCT05238506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110088956|NCT05238506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110088957|NCT05238506|Sensory System Agents|sensory system agents|mesh-ancestor
110088958|NCT05238506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110088959|NCT05238506|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110088960|NCT05238506|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110088961|NCT05238506|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110088962|NCT05238506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110088963|NCT05238506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110088964|NCT05236608|Nivolumab|nivolumab|mesh-list
110088965|NCT05236608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110088966|NCT05236608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110088967|NCT05236608|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110088968|NCT05236608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110088969|NCT05225402|Norepinephrine|norepinephrine|mesh-list
110088970|NCT05225402|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110088971|NCT05225402|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110088972|NCT05225402|Adrenergic Agents|adrenergic agents|mesh-ancestor
110088973|NCT05225402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110088974|NCT05225402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110088975|NCT05225402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110088976|NCT05225402|Sympathomimetics|sympathomimetics|mesh-ancestor
110088977|NCT05225402|Autonomic Agents|autonomic agents|mesh-ancestor
110088978|NCT05225402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110088979|NCT05225402|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110088980|NCT05220826|Ethanol|ethanol|mesh-list
110088981|NCT05220826|Ethylene|ethylene|mesh-list
110088982|NCT05220826|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110088984|NCT05220826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110088985|NCT05220826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110088986|NCT05220826|Plant Growth Regulators|plant growth regulators|mesh-ancestor
110088987|NCT05220826|Growth Substances|growth substances|mesh-ancestor
110088988|NCT05210413|Spartalizumab|spartalizumab|mesh-list
110088989|NCT05210413|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110088990|NCT05210413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110088991|NCT05210413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110088992|NCT05210413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110088993|NCT05203705|Enoxaparin|enoxaparin|mesh-list
110088994|NCT05203705|Anticoagulants|anticoagulants|mesh-ancestor
110088995|NCT05203705|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110088996|NCT05203705|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110088997|NCT05203705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110088998|NCT05202561|Vaccines|vaccines|mesh-list
110088999|NCT05202561|Immunologic Factors|immunologic factors|mesh-ancestor
110089000|NCT05202561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110089001|NCT05192629|Midazolam|midazolam|mesh-list
110089002|NCT05192629|Dexmedetomidine|dexmedetomidine|mesh-list
110089003|NCT05192629|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110089004|NCT05192629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110089005|NCT05192629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110089006|NCT05192629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110089008|NCT05192629|Sensory System Agents|sensory system agents|mesh-ancestor
110089009|NCT05192629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110089010|NCT05192629|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110089011|NCT05192629|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110089012|NCT05192629|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110089013|NCT05192629|Adrenergic Agents|adrenergic agents|mesh-ancestor
110089014|NCT05192629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110089015|NCT05192629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110089016|NCT05192629|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110089017|NCT05192629|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110089018|NCT05192629|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110089019|NCT05192629|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110089020|NCT05192629|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110089021|NCT05192629|Anesthetics, General|anesthetics, general|mesh-ancestor
110089023|NCT05192629|GABA Modulators|gaba modulators|mesh-ancestor
110089024|NCT05192629|GABA Agents|gaba agents|mesh-ancestor
110089025|NCT05189444|Amoxicillin|amoxicillin|mesh-list
110089026|NCT05189444|Clarithromycin|clarithromycin|mesh-list
110089027|NCT05189444|Potassium Citrate|potassium citrate|mesh-list
110089028|NCT05189444|Esomeprazole|esomeprazole|mesh-list
110089029|NCT05189444|Bismuth|bismuth|mesh-list
110089030|NCT05189444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110089031|NCT05189444|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110089032|NCT05189444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110089033|NCT05189444|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110089034|NCT05189444|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110089035|NCT05189444|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110089036|NCT05189444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110089037|NCT05189444|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110089038|NCT05189444|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110089039|NCT05189444|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110089040|NCT05189444|Antacids|antacids|mesh-ancestor
110089041|NCT05189444|Diuretics|diuretics|mesh-ancestor
110089042|NCT05189444|Natriuretic Agents|natriuretic agents|mesh-ancestor
110089043|NCT05189444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110089044|NCT05189444|Expectorants|expectorants|mesh-ancestor
110089045|NCT05189444|Respiratory System Agents|respiratory system agents|mesh-ancestor
110089046|NCT05175274|Colchicine|colchicine|mesh-list
110089047|NCT05175274|Gout Suppressants|gout suppressants|mesh-ancestor
110089048|NCT05175274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110089049|NCT05175274|Tubulin Modulators|tubulin modulators|mesh-ancestor
110089050|NCT05175274|Antimitotic Agents|antimitotic agents|mesh-ancestor
110089051|NCT05175274|Mitosis Modulators|mitosis modulators|mesh-ancestor
110089052|NCT05175274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110089053|NCT05175274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110089054|NCT05129137|Acetaminophen|acetaminophen|mesh-list
110089055|NCT05129137|Nefopam|nefopam|mesh-list
110089056|NCT05129137|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110089057|NCT05129137|Analgesics|analgesics|mesh-ancestor
110089058|NCT05129137|Sensory System Agents|sensory system agents|mesh-ancestor
110089059|NCT05129137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110089060|NCT05129137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110089062|NCT05110898|Olmesartan|olmesartan|mesh-list
110089063|NCT05110898|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
110089064|NCT05110898|Indapamide|indapamide|mesh-list
110089065|NCT05110898|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110089066|NCT05110898|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110089067|NCT05110898|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110089068|NCT05110898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110089069|NCT05110898|Diuretics|diuretics|mesh-ancestor
110089070|NCT05110898|Natriuretic Agents|natriuretic agents|mesh-ancestor
110089071|NCT05110898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110089072|NCT05110898|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110089073|NCT05110898|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110185549|NCT04888377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110089075|NCT05098041|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110089076|NCT05098041|Antitubercular Agents|antitubercular agents|mesh-ancestor
110089077|NCT05098041|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110089078|NCT05098041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110089079|NCT05098041|Leprostatic Agents|leprostatic agents|mesh-ancestor
110089080|NCT05098041|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110089081|NCT05098041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110089082|NCT05098041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110089083|NCT05098041|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110089084|NCT05098041|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110089085|NCT05098041|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110089086|NCT05098041|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110089087|NCT05098041|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110089088|NCT05098041|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110089089|NCT05096325|Insulin|insulin|mesh-list
110089090|NCT05096325|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110089091|NCT05096325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110089092|NCT05096065|Leuprolide|leuprolide|mesh-list
110089093|NCT05096065|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110089094|NCT05096065|Fertility Agents|fertility agents|mesh-ancestor
110089095|NCT05096065|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110089096|NCT05096065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110089097|NCT05096065|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110089098|NCT05096065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110089099|NCT05083572|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110089100|NCT05083572|Rifaximin|rifaximin|mesh-list
110089101|NCT05083572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110089102|NCT05083572|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110089103|NCT05030025|Lamivudine|lamivudine|mesh-list
110089104|NCT05030025|Abacavir|abacavir|mesh-list
110089105|NCT05030025|Dideoxynucleosides|dideoxynucleosides|mesh-list
110089106|NCT05030025|Dolutegravir|dolutegravir|mesh-list
110089107|NCT05030025|Abacavir, dolutegravir, and lamivudine drug combination|abacavir, dolutegravir, and lamivudine drug combination|mesh-list
110089108|NCT05030025|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110089109|NCT05030025|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110089110|NCT05030025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110089111|NCT05030025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110089112|NCT05030025|Antiviral Agents|antiviral agents|mesh-ancestor
110089113|NCT05030025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110089114|NCT05030025|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110089115|NCT05030025|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110089117|NCT05030025|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110089118|NCT05030025|Antimetabolites|antimetabolites|mesh-ancestor
110089119|NCT05013567|Ibuprofen|ibuprofen|mesh-list
110089120|NCT05013567|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110089121|NCT05013567|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110089122|NCT05013567|Analgesics|analgesics|mesh-ancestor
110089123|NCT05013567|Sensory System Agents|sensory system agents|mesh-ancestor
110089124|NCT05013567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110089125|NCT05013567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110089126|NCT05013567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110089127|NCT05013567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110089128|NCT05013567|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110089129|NCT05013567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110089130|NCT05013567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110089132|NCT05008926|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110089133|NCT05008926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110089134|NCT05008926|Sensory System Agents|sensory system agents|mesh-ancestor
110089135|NCT05008926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110089136|NCT04989621|Rituximab|rituximab|mesh-list
110089137|NCT04989621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110089138|NCT04989621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110089139|NCT04989621|Immunologic Factors|immunologic factors|mesh-ancestor
110089140|NCT04989621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110089141|NCT04989621|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110089142|NCT04989049|Folic Acid|folic acid|mesh-list
110089143|NCT04989049|Hematinics|hematinics|mesh-ancestor
110089144|NCT04989049|Vitamin B Complex|vitamin b complex|mesh-ancestor
110089145|NCT04989049|Vitamins|vitamins|mesh-ancestor
110089146|NCT04989049|Micronutrients|micronutrients|mesh-ancestor
110089147|NCT04989049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110089148|NCT04984044|Vitamin D|vitamin d|mesh-list
110089149|NCT04984044|Cholecalciferol|cholecalciferol|mesh-list
110089150|NCT04984044|Vitamins|vitamins|mesh-ancestor
110089151|NCT04984044|Micronutrients|micronutrients|mesh-ancestor
110089152|NCT04984044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110089153|NCT04984044|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110089154|NCT04984044|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110089155|NCT04975802|Caffeine|caffeine|mesh-list
110089156|NCT04975802|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110089157|NCT04975802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110089158|NCT04975802|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110089159|NCT04975802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110089160|NCT04975802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110089161|NCT04975802|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110089162|NCT04975802|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110089163|NCT04975802|Purinergic Agents|purinergic agents|mesh-ancestor
110089164|NCT04975802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110089165|NCT04964700|Natalizumab|natalizumab|mesh-list
110089166|NCT04964700|Immunologic Factors|immunologic factors|mesh-ancestor
110089167|NCT04964700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110089168|NCT04950868|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110089169|NCT04950868|Antidepressive Agents|antidepressive agents|mesh-ancestor
110089170|NCT04950868|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110089171|NCT04950868|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110089172|NCT04950868|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110089173|NCT04950868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110089174|NCT04950868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110089175|NCT04899843|Zinc Sulfate|zinc sulfate|mesh-list
110089176|NCT04899843|Astringents|astringents|mesh-ancestor
110089177|NCT04899843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110089178|NCT04899843|Dermatologic Agents|dermatologic agents|mesh-ancestor
110089179|NCT04897802|Exenatide|exenatide|mesh-list
110089180|NCT04897802|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110089181|NCT04897802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110089182|NCT04897802|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110089183|NCT04897802|Incretins|incretins|mesh-ancestor
110089184|NCT04897802|Hormones|hormones|mesh-ancestor
110089185|NCT04897802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110089186|NCT04882332|Vitamin B 12|vitamin b 12|mesh-list
110089187|NCT04882332|Hydroxocobalamin|hydroxocobalamin|mesh-list
110089188|NCT04882332|Vitamins|vitamins|mesh-ancestor
110089189|NCT04882332|Micronutrients|micronutrients|mesh-ancestor
110089190|NCT04882332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110089191|NCT04882332|Vitamin B Complex|vitamin b complex|mesh-ancestor
110089192|NCT04882332|Hematinics|hematinics|mesh-ancestor
110089194|NCT04871425|Ketamine|ketamine|mesh-list
110089195|NCT04871425|Analgesics|analgesics|mesh-ancestor
110089196|NCT04871425|Sensory System Agents|sensory system agents|mesh-ancestor
110089197|NCT04871425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110089198|NCT04871425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110089199|NCT04871425|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110089200|NCT04871425|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110089201|NCT04871425|Anesthetics, General|anesthetics, general|mesh-ancestor
110089202|NCT04871425|Anesthetics|anesthetics|mesh-ancestor
110089203|NCT04871425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110089204|NCT04871425|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110089205|NCT04871425|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110089206|NCT04871425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110089207|NCT04871425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110089208|NCT04871425|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110089210|NCT04871425|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110089211|NCT04869605|Chrysarobin|chrysarobin|mesh-list
110185563|NCT00277043|Antimitotic Agents|antimitotic agents|mesh-ancestor
110089212|NCT04869605|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110089213|NCT04869605|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110089215|NCT04869605|Sensory System Agents|sensory system agents|mesh-ancestor
110089216|NCT04869605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110089217|NCT04869605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110089218|NCT04869605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110089219|NCT04869605|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110089220|NCT04835584|Dasatinib|dasatinib|mesh-list
110089221|NCT04835584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110089222|NCT04835584|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110089224|NCT04835584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110089225|NCT04774315|Omalizumab|omalizumab|mesh-list
110089226|NCT04774315|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110089227|NCT04774315|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110089228|NCT04774315|Respiratory System Agents|respiratory system agents|mesh-ancestor
110089229|NCT04767503|Propofol|propofol|mesh-list
110089230|NCT04767503|Desflurane|desflurane|mesh-list
110089231|NCT04767503|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110089232|NCT04767503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110089233|NCT04767503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110089234|NCT04767503|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110089235|NCT04767503|Anesthetics, General|anesthetics, general|mesh-ancestor
110089236|NCT04767503|Anesthetics|anesthetics|mesh-ancestor
110089237|NCT04767503|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110089238|NCT04722679|Anticoagulants|anticoagulants|mesh-list
110089239|NCT04696380|Nicotine|nicotine|mesh-list
110089240|NCT04696380|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110089241|NCT04696380|Autonomic Agents|autonomic agents|mesh-ancestor
110089242|NCT04696380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110089243|NCT04696380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110089244|NCT04696380|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110089245|NCT04696380|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110089246|NCT04696380|Cholinergic Agents|cholinergic agents|mesh-ancestor
110089247|NCT04696380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110089248|NCT04696380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110089249|NCT04672772|Paclitaxel|paclitaxel|mesh-list
110089250|NCT04672772|Cetuximab|cetuximab|mesh-list
110089251|NCT04672772|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110089252|NCT04672772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110089253|NCT04672772|Tubulin Modulators|tubulin modulators|mesh-ancestor
110089254|NCT04672772|Antimitotic Agents|antimitotic agents|mesh-ancestor
110089255|NCT04672772|Mitosis Modulators|mitosis modulators|mesh-ancestor
110089256|NCT04672772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110089257|NCT04672772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110089258|NCT04671082|Tolperisone|tolperisone|mesh-list
110089259|NCT04671082|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110089260|NCT04671082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110089261|NCT04671082|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110089262|NCT04671082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110089263|NCT04669587|Palbociclib|palbociclib|mesh-list
110089264|NCT04669587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110089265|NCT04669587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110089266|NCT04669587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110089267|NCT04669587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110089269|NCT04659941|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110089270|NCT04659941|Immunologic Factors|immunologic factors|mesh-ancestor
110089271|NCT04659941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110089272|NCT04658823|Vitamin E|vitamin e|mesh-list
110089273|NCT04658823|Tocopherols|tocopherols|mesh-list
110089274|NCT04658823|Tocotrienols|tocotrienols|mesh-list
110089275|NCT04658823|Tocovid|tocovid|mesh-list
110089276|NCT04658823|Vitamins|vitamins|mesh-ancestor
110089277|NCT04658823|Micronutrients|micronutrients|mesh-ancestor
110089278|NCT04658823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110089279|NCT04658823|Antioxidants|antioxidants|mesh-ancestor
110089280|NCT04658823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110089281|NCT04658823|Protective Agents|protective agents|mesh-ancestor
110089282|NCT04648241|Vaccines|vaccines|mesh-list
110089283|NCT04648241|Immunologic Factors|immunologic factors|mesh-ancestor
110089284|NCT04648241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110089285|NCT04640818|Rituximab|rituximab|mesh-list
110089286|NCT04640818|Cladribine|cladribine|mesh-list
110089287|NCT04640818|Ocrelizumab|ocrelizumab|mesh-list
110089288|NCT04640818|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110089289|NCT04640818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110089290|NCT04640818|Immunologic Factors|immunologic factors|mesh-ancestor
110089291|NCT04640818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110089292|NCT04640818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110089293|NCT04640818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110089294|NCT04602078|Gemcitabine|gemcitabine|mesh-list
110089295|NCT04602078|Atezolizumab|atezolizumab|mesh-list
110089296|NCT04602078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110089297|NCT04602078|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110089298|NCT04602078|Antimetabolites|antimetabolites|mesh-ancestor
110089299|NCT04602078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110089300|NCT04602078|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110089301|NCT04602078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110089302|NCT04588857|Dexamethasone|dexamethasone|mesh-list
110089303|NCT04588857|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110089304|NCT04588857|Antiemetics|antiemetics|mesh-ancestor
110089305|NCT04588857|Autonomic Agents|autonomic agents|mesh-ancestor
110089306|NCT04588857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110089307|NCT04588857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110089308|NCT04588857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110089309|NCT04588857|Glucocorticoids|glucocorticoids|mesh-ancestor
110089310|NCT04588857|Hormones|hormones|mesh-ancestor
110089311|NCT04588857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110089312|NCT04588857|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110089313|NCT04588857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110089314|NCT04569448|Brexpiprazole|brexpiprazole|mesh-list
110089315|NCT04569448|Serotonin Agents|serotonin agents|mesh-ancestor
110089316|NCT04569448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110089317|NCT04569448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110089318|NCT04569448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110089319|NCT04569448|Dopamine Agonists|dopamine agonists|mesh-ancestor
110089320|NCT04569448|Dopamine Agents|dopamine agents|mesh-ancestor
110089321|NCT04542980|Autoantibodies|autoantibodies|mesh-list
110089322|NCT04542980|Immunologic Factors|immunologic factors|mesh-ancestor
110089323|NCT04542980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110089324|NCT04529499|Favipiravir|favipiravir|mesh-list
110089325|NCT04529499|Antiviral Agents|antiviral agents|mesh-ancestor
110089326|NCT04529499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110089327|NCT04523428|Venetoclax|venetoclax|mesh-list
110089328|NCT04523428|Acalabrutinib|acalabrutinib|mesh-list
110089329|NCT04523428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110089330|NCT04508504|Ropivacaine|ropivacaine|mesh-list
110089331|NCT04508504|Anesthetics, Local|anesthetics, local|mesh-ancestor
110089332|NCT04508504|Anesthetics|anesthetics|mesh-ancestor
110089333|NCT04508504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110089334|NCT04508504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110089335|NCT04508504|Sensory System Agents|sensory system agents|mesh-ancestor
110089336|NCT04508504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110089337|NCT04490707|Lenalidomide|lenalidomide|mesh-list
110089338|NCT04490707|Azacitidine|azacitidine|mesh-list
110089339|NCT04490707|Immunologic Factors|immunologic factors|mesh-ancestor
110089340|NCT04490707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110089341|NCT04490707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110089342|NCT04490707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110089343|NCT04490707|Growth Substances|growth substances|mesh-ancestor
110089344|NCT04490707|Growth Inhibitors|growth inhibitors|mesh-ancestor
110089345|NCT04490707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110089346|NCT04490707|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110089347|NCT04490707|Antimetabolites|antimetabolites|mesh-ancestor
110089348|NCT04490707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110089349|NCT04490707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110089350|NCT04464577|Itraconazole|itraconazole|mesh-list
110089351|NCT04464577|Fluconazole|fluconazole|mesh-list
110089352|NCT04464577|Bupropion|bupropion|mesh-list
110089353|NCT04464577|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110089354|NCT04464577|Antidepressive Agents|antidepressive agents|mesh-ancestor
110089355|NCT04464577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110089356|NCT04464577|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110089357|NCT04464577|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110089358|NCT04464577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110089359|NCT04464577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110089360|NCT04464577|Dopamine Agents|dopamine agents|mesh-ancestor
110089361|NCT04464577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110089362|NCT04464577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110089363|NCT04464577|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110089364|NCT04464577|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110089365|NCT04464577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110089366|NCT04464577|Antifungal Agents|antifungal agents|mesh-ancestor
110089367|NCT04464577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110089368|NCT04464577|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110089369|NCT04464577|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110089370|NCT04464577|Hormone Antagonists|hormone antagonists|mesh-ancestor
110089371|NCT04464577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110089372|NCT04464577|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110089373|NCT04464577|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110089374|NCT04464577|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110089375|NCT04402658|Albuterol|albuterol|mesh-list
110089376|NCT04402658|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110089377|NCT04402658|Autonomic Agents|autonomic agents|mesh-ancestor
110089378|NCT04402658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110089379|NCT04402658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110089380|NCT04402658|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110089381|NCT04402658|Respiratory System Agents|respiratory system agents|mesh-ancestor
110089382|NCT04402658|Tocolytic Agents|tocolytic agents|mesh-ancestor
110089383|NCT04402658|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110089384|NCT04402658|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110089385|NCT04402658|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110089386|NCT04402658|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110089387|NCT04402658|Adrenergic Agents|adrenergic agents|mesh-ancestor
110089388|NCT04402658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110089389|NCT04402658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110089390|NCT04391179|Dipyridamole|dipyridamole|mesh-list
110089391|NCT04391179|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110089392|NCT04391179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110089393|NCT04391179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110089394|NCT04391179|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110089395|NCT04391179|Vasodilator Agents|vasodilator agents|mesh-ancestor
110089396|NCT04375683|Flumatinib|flumatinib|mesh-list
110089397|NCT04375683|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110089398|NCT04375683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110089399|NCT04375683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110089400|NCT04356742|Metformin|metformin|mesh-list
110089401|NCT04356742|Dapagliflozin|dapagliflozin|mesh-list
110089402|NCT04356742|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110089403|NCT04356742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110089404|NCT04356742|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110089405|NCT04356742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110089406|NCT04353284|Gabexate|gabexate|mesh-list
110089407|NCT04353284|Camostat|camostat|mesh-list
110089408|NCT04353284|Protease Inhibitors|protease inhibitors|mesh-ancestor
110089409|NCT04353284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110089410|NCT04353284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110089411|NCT04353284|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
110089412|NCT04353284|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110089413|NCT04353284|Anticoagulants|anticoagulants|mesh-ancestor
110089414|NCT04348864|Antibodies|antibodies|mesh-list
110089415|NCT04348864|Immunologic Factors|immunologic factors|mesh-ancestor
110089416|NCT04348864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110089417|NCT04328012|Losartan|losartan|mesh-list
110089418|NCT04328012|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110089419|NCT04328012|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110089420|NCT04328012|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110089421|NCT04328012|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110089422|NCT04328012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110089423|NCT04310150|Hemostatics|hemostatics|mesh-list
110089424|NCT04310150|Coagulants|coagulants|mesh-ancestor
110089425|NCT04294914|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
110089426|NCT04294147|Erenumab|erenumab|mesh-list
110089427|NCT04294147|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
110089428|NCT04294147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110089429|NCT04294147|Analgesics|analgesics|mesh-ancestor
110089430|NCT04294147|Sensory System Agents|sensory system agents|mesh-ancestor
110089431|NCT04294147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110089432|NCT04294147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110089433|NCT04292873|Vitamin D|vitamin d|mesh-list
110089434|NCT04292873|Vitamins|vitamins|mesh-ancestor
110089435|NCT04292873|Micronutrients|micronutrients|mesh-ancestor
110089436|NCT04292873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110089437|NCT04292873|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110089438|NCT04264637|Azelastine|azelastine|mesh-list
110089439|NCT04264637|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110089440|NCT04264637|Autonomic Agents|autonomic agents|mesh-ancestor
110089441|NCT04264637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110089442|NCT04264637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110089443|NCT04264637|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110089444|NCT04264637|Respiratory System Agents|respiratory system agents|mesh-ancestor
110089445|NCT04264637|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
110089446|NCT04264637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110089447|NCT04264637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110089448|NCT04264637|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110089449|NCT04264637|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110089450|NCT04264637|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110089451|NCT04264637|Histamine Antagonists|histamine antagonists|mesh-ancestor
110089452|NCT04264637|Histamine Agents|histamine agents|mesh-ancestor
110089453|NCT04264637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110089454|NCT04238091|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110089455|NCT04238091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110089456|NCT04233801|Empagliflozin|empagliflozin|mesh-list
110089457|NCT04233801|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110089458|NCT04233801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110089459|NCT04233801|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110089460|NCT04233801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110089461|NCT04180085|Abatacept|abatacept|mesh-list
110089462|NCT04180085|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110089463|NCT04180085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110089464|NCT04180085|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110089465|NCT04180085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110089466|NCT04180085|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110089467|NCT04180085|Immunologic Factors|immunologic factors|mesh-ancestor
110089468|NCT04180085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110089469|NCT04180085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110089470|NCT04169451|Letrozole|letrozole|mesh-list
110089471|NCT04169451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110089472|NCT04169451|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110089473|NCT04169451|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110089474|NCT04169451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110089475|NCT04169451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110089476|NCT04169451|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110089477|NCT04169451|Hormone Antagonists|hormone antagonists|mesh-ancestor
110089478|NCT04169451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110089479|NCT04169451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110089480|NCT04169438|Petrolatum|petrolatum|mesh-list
110089481|NCT04169438|Emollients|emollients|mesh-ancestor
110089482|NCT04169438|Dermatologic Agents|dermatologic agents|mesh-ancestor
110089484|NCT04159818|Nivolumab|nivolumab|mesh-list
110089485|NCT04159818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110089486|NCT04159818|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110089487|NCT04159818|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110089488|NCT04159818|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110089489|NCT04159818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110089490|NCT04159818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110089491|NCT04159818|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110089492|NCT04159818|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110089493|NCT04157881|Rabeprazole|rabeprazole|mesh-list
110089494|NCT04157881|Dabigatran|dabigatran|mesh-list
110089495|NCT04157881|Antithrombins|antithrombins|mesh-ancestor
110089496|NCT04157881|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110089497|NCT04157881|Protease Inhibitors|protease inhibitors|mesh-ancestor
110089498|NCT04157881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110089499|NCT04157881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110089500|NCT04157881|Anticoagulants|anticoagulants|mesh-ancestor
110089501|NCT04157881|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110089502|NCT04157881|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110089503|NCT04157881|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110089504|NCT04151563|Docetaxel|docetaxel|mesh-list
110089505|NCT04151563|Nivolumab|nivolumab|mesh-list
110089506|NCT04151563|Ipilimumab|ipilimumab|mesh-list
110089507|NCT04151563|Ramucirumab|ramucirumab|mesh-list
110089508|NCT04151563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110089509|NCT04151563|Tubulin Modulators|tubulin modulators|mesh-ancestor
110089510|NCT04151563|Antimitotic Agents|antimitotic agents|mesh-ancestor
110089511|NCT04151563|Mitosis Modulators|mitosis modulators|mesh-ancestor
110089512|NCT04151563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110089513|NCT04151563|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110089514|NCT04151563|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110089515|NCT04136262|Methotrexate|methotrexate|mesh-list
110089516|NCT04136262|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110089517|NCT04136262|Abortifacient Agents|abortifacient agents|mesh-ancestor
110089518|NCT04136262|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110089519|NCT04136262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110089520|NCT04136262|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110089521|NCT04136262|Antimetabolites|antimetabolites|mesh-ancestor
110089522|NCT04136262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110089523|NCT04136262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110089524|NCT04136262|Dermatologic Agents|dermatologic agents|mesh-ancestor
110089525|NCT04136262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110089526|NCT04136262|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110089527|NCT04136262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110089528|NCT04136262|Immunologic Factors|immunologic factors|mesh-ancestor
110089529|NCT04136262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110089530|NCT04136262|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110089531|NCT04133922|Insulin|insulin|mesh-list
110089532|NCT04133922|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110089533|NCT04133922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110089534|NCT04115059|Dasatinib|dasatinib|mesh-list
110089535|NCT04115059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110089536|NCT04115059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110089537|NCT04115059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110089538|NCT04115059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110089539|NCT04114890|Tenofovir|tenofovir|mesh-list
110089540|NCT04114890|Antiviral Agents|antiviral agents|mesh-ancestor
110089541|NCT04114890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110089542|NCT04114890|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110089543|NCT04114890|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110089544|NCT04114890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110089545|NCT04114890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110089546|NCT04114890|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110089547|NCT04114890|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110089549|NCT04096066|Lenalidomide|lenalidomide|mesh-list
110089550|NCT04096066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110089551|NCT04096066|Antiemetics|antiemetics|mesh-ancestor
110089552|NCT04096066|Autonomic Agents|autonomic agents|mesh-ancestor
110089553|NCT04096066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110089554|NCT04096066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110089555|NCT04096066|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110089557|NCT04096066|Hormones|hormones|mesh-ancestor
110089558|NCT04096066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110089559|NCT04096066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110089560|NCT04096066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110089561|NCT04096066|Immunologic Factors|immunologic factors|mesh-ancestor
110089562|NCT04096066|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110089563|NCT04096066|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110089564|NCT04096066|Growth Substances|growth substances|mesh-ancestor
110089565|NCT04096066|Growth Inhibitors|growth inhibitors|mesh-ancestor
110089566|NCT04082676|Bupivacaine|bupivacaine|mesh-list
110089567|NCT04082676|Anesthetics, Local|anesthetics, local|mesh-ancestor
110089568|NCT04082676|Anesthetics|anesthetics|mesh-ancestor
110089569|NCT04082676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110089570|NCT04082676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110089571|NCT04082676|Sensory System Agents|sensory system agents|mesh-ancestor
110089572|NCT04082676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110089573|NCT04012177|Niacinamide|niacinamide|mesh-list
110089575|NCT04012177|Nicotinic Acids|nicotinic acids|mesh-list
110089576|NCT04012177|Azithromycin|azithromycin|mesh-list
110089577|NCT04012177|Choline|choline|mesh-list
110089578|NCT04012177|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110089579|NCT04012177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110089580|NCT04012177|Lipotropic Agents|lipotropic agents|mesh-ancestor
110089582|NCT04012177|Antimetabolites|antimetabolites|mesh-ancestor
110089583|NCT04012177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110089584|NCT04012177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110089585|NCT04012177|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110089586|NCT04012177|Nootropic Agents|nootropic agents|mesh-ancestor
110089587|NCT04012177|Vitamin B Complex|vitamin b complex|mesh-ancestor
110089588|NCT04012177|Vitamins|vitamins|mesh-ancestor
110089589|NCT04012177|Micronutrients|micronutrients|mesh-ancestor
110089590|NCT04012177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110089591|NCT04012177|Vasodilator Agents|vasodilator agents|mesh-ancestor
110089592|NCT04007289|Apixaban|apixaban|mesh-list
110089593|NCT04007289|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110089594|NCT04007289|Antithrombins|antithrombins|mesh-ancestor
110089595|NCT04007289|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110089596|NCT04007289|Protease Inhibitors|protease inhibitors|mesh-ancestor
110089597|NCT04007289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110089598|NCT04007289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110089623|NCT03990883|Sensory System Agents|sensory system agents|mesh-ancestor
110089624|NCT03990883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110089625|NCT03990883|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110089626|NCT03990883|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110089627|NCT03990883|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110089628|NCT03990883|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110089629|NCT03990883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110089630|NCT03984890|Vitamin D|vitamin d|mesh-list
110089631|NCT03984890|Cholecalciferol|cholecalciferol|mesh-list
110089632|NCT03984890|Vitamins|vitamins|mesh-ancestor
110089633|NCT03984890|Micronutrients|micronutrients|mesh-ancestor
110089634|NCT03984890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110089635|NCT03984890|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110089636|NCT03984890|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110089637|NCT03926091|Cyclophosphamide|cyclophosphamide|mesh-list
110089638|NCT03926091|Docetaxel|docetaxel|mesh-list
110089639|NCT03926091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110089640|NCT03926091|Immunologic Factors|immunologic factors|mesh-ancestor
110089641|NCT03926091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110089642|NCT03926091|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110089643|NCT03926091|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110089644|NCT03926091|Alkylating Agents|alkylating agents|mesh-ancestor
110089645|NCT03926091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110089646|NCT03926091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110089647|NCT03926091|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110089648|NCT03926091|Tubulin Modulators|tubulin modulators|mesh-ancestor
110089649|NCT03926091|Antimitotic Agents|antimitotic agents|mesh-ancestor
110089650|NCT03926091|Mitosis Modulators|mitosis modulators|mesh-ancestor
110089651|NCT03924427|Deucravacitinib|deucravacitinib|mesh-list
110089652|NCT03924427|Dermatologic Agents|dermatologic agents|mesh-ancestor
110089653|NCT03924427|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110089654|NCT03924427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110089655|NCT03924427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110089657|NCT03922451|Tazobactam|tazobactam|mesh-list
110089658|NCT03922451|Piperacillin|piperacillin|mesh-list
110089659|NCT03922451|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
110089661|NCT03922451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110089662|NCT03922451|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110089663|NCT03922451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110089664|NCT03922451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110089665|NCT05802433|Vitamin D|vitamin d|mesh-list
110089666|NCT05802433|Cholecalciferol|cholecalciferol|mesh-list
110089667|NCT05802433|Vitamins|vitamins|mesh-ancestor
110089668|NCT05802433|Micronutrients|micronutrients|mesh-ancestor
110089669|NCT05802433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110089670|NCT05802433|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110089671|NCT05802433|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110089672|NCT05802303|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110089673|NCT05802303|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110089674|NCT05802303|Estradiol|estradiol|mesh-list
110089675|NCT05802303|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110089676|NCT05802303|Estrogens|estrogens|mesh-ancestor
110089677|NCT05802303|Hormones|hormones|mesh-ancestor
110089678|NCT05802303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110089679|NCT05802303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110089680|NCT05802303|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110089681|NCT05802303|Contraceptive Agents|contraceptive agents|mesh-ancestor
110089682|NCT05802303|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110089683|NCT05802303|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110089684|NCT05802290|Nivolumab|nivolumab|mesh-list
110089685|NCT05802290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110089686|NCT05802290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110089687|NCT05802290|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110089688|NCT05802290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110089689|NCT05802212|Metformin|metformin|mesh-list
110089690|NCT05802212|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110089691|NCT05802212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110089692|NCT05802121|Acetic Acid|acetic acid|mesh-list
110089693|NCT05802121|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110089694|NCT05802121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110089695|NCT05802108|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
110089696|NCT05802108|Evolocumab|evolocumab|mesh-list
110089697|NCT05802108|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110089698|NCT05802108|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110089699|NCT05802108|Antimetabolites|antimetabolites|mesh-ancestor
110089700|NCT05802108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110089701|NCT05802108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110089702|NCT05802108|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110089703|NCT05802108|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
110089704|NCT05802108|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110089705|NCT05802108|Protease Inhibitors|protease inhibitors|mesh-ancestor
110089706|NCT05802082|Anesthetics|anesthetics|mesh-list
110089707|NCT05802082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110089708|NCT05802082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110089709|NCT05801900|Ibuprofen|ibuprofen|mesh-list
110089710|NCT05801900|Ketorolac|ketorolac|mesh-list
110089711|NCT05801900|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110089712|NCT05801900|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110089713|NCT05801900|Analgesics|analgesics|mesh-ancestor
110089714|NCT05801900|Sensory System Agents|sensory system agents|mesh-ancestor
110089715|NCT05801900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110089716|NCT05801900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110089717|NCT05801900|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110089718|NCT05801900|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110089719|NCT05801900|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110089720|NCT05801900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110089721|NCT05801900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110089722|NCT05801523|Ethanol|ethanol|mesh-list
110089723|NCT05801523|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110089724|NCT05801523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110089725|NCT05801523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110089726|NCT05801523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110089727|NCT05801484|Linezolid|linezolid|mesh-list
110089728|NCT05801484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110089729|NCT05801484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110089730|NCT05801484|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110089731|NCT05801484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110089732|NCT05801484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110089734|NCT05801380|Donepezil|donepezil|mesh-list
110089735|NCT05801380|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110089736|NCT05801380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110089737|NCT05801380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110089738|NCT05801380|Cholinergic Agents|cholinergic agents|mesh-ancestor
110089739|NCT05801380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110089740|NCT05801380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110089741|NCT05801380|Nootropic Agents|nootropic agents|mesh-ancestor
110089742|NCT05801380|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110089743|NCT05801380|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110089744|NCT05801380|Dopamine Agents|dopamine agents|mesh-ancestor
110089745|NCT05801380|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110089746|NCT05801380|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110089747|NCT05801367|Allyl sulfide|allyl sulfide|mesh-list
110089748|NCT05801367|Antioxidants|antioxidants|mesh-ancestor
110089749|NCT05801367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110089750|NCT05801367|Protective Agents|protective agents|mesh-ancestor
110089751|NCT05801367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110089752|NCT05801367|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110089753|NCT05801367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110089754|NCT05801367|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110089755|NCT05801367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110089756|NCT05801328|Salicylic Acid|salicylic acid|mesh-list
110089757|NCT05801328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110089758|NCT05801328|Antifungal Agents|antifungal agents|mesh-ancestor
110089759|NCT05801328|Keratolytic Agents|keratolytic agents|mesh-ancestor
110089760|NCT05801328|Dermatologic Agents|dermatologic agents|mesh-ancestor
110089761|NCT05801289|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110089762|NCT05801289|Antidepressive Agents|antidepressive agents|mesh-ancestor
110089763|NCT05801289|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110089764|NCT05801289|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110089765|NCT05801289|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110089766|NCT05801289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110089767|NCT05801289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110089768|NCT05801237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110089769|NCT05801237|Antibodies|antibodies|mesh-list
110089770|NCT05801237|Immunoglobulins|immunoglobulins|mesh-list
110089771|NCT05801237|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110089772|NCT05801237|Immunologic Factors|immunologic factors|mesh-ancestor
110089773|NCT05801237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110089774|NCT05801237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110089775|NCT05801133|Pirfenidone|pirfenidone|mesh-list
110089776|NCT05801133|Analgesics|analgesics|mesh-ancestor
110089777|NCT05801133|Sensory System Agents|sensory system agents|mesh-ancestor
110089778|NCT05801133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110089779|NCT05801133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110089780|NCT05801133|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110089781|NCT05801133|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110185611|NCT00276848|Antimetabolites|antimetabolites|mesh-ancestor
110089782|NCT05801133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110089783|NCT05801133|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110089784|NCT05801133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110089785|NCT05801068|Factor Xa Inhibitors|factor xa inhibitors|mesh-list
110089786|NCT05801068|Antithrombins|antithrombins|mesh-ancestor
110089787|NCT05801068|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110089788|NCT05801068|Protease Inhibitors|protease inhibitors|mesh-ancestor
110089789|NCT05801068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110089790|NCT05801068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110089791|NCT05801068|Anticoagulants|anticoagulants|mesh-ancestor
110089792|NCT05800847|Gabapentin|gabapentin|mesh-list
110089793|NCT05800847|Analgesics|analgesics|mesh-ancestor
110089794|NCT05800847|Sensory System Agents|sensory system agents|mesh-ancestor
110089795|NCT05800847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110089796|NCT05800847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110089797|NCT05800847|Anticonvulsants|anticonvulsants|mesh-ancestor
110089798|NCT05800847|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110089799|NCT05800847|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110089800|NCT05800847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110089801|NCT05800847|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110089802|NCT05800847|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110089803|NCT05800847|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110089804|NCT05800847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110089805|NCT05800847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110089806|NCT05800847|Antimanic Agents|antimanic agents|mesh-ancestor
110089823|NCT05800756|Trastuzumab|trastuzumab|mesh-list
110089825|NCT05800756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110089826|NCT05800756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110089827|NCT05800756|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110089828|NCT05800756|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110089829|NCT05800756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110089830|NCT05800756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110089831|NCT05800756|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110089832|NCT05800756|Hormone Antagonists|hormone antagonists|mesh-ancestor
110089833|NCT05800756|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110089834|NCT05800756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110089835|NCT05800197|Tamoxifen|tamoxifen|mesh-list
110089836|NCT05800197|Letrozole|letrozole|mesh-list
110089837|NCT05800197|Anastrozole|anastrozole|mesh-list
110089838|NCT05800197|Goserelin|goserelin|mesh-list
110089839|NCT05800197|Triptorelin Pamoate|triptorelin pamoate|mesh-list
110089840|NCT05800197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110089841|NCT05800197|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110089842|NCT05800197|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110089843|NCT05800197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110089844|NCT05800197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110089845|NCT05800197|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110089846|NCT05800197|Hormone Antagonists|hormone antagonists|mesh-ancestor
110089847|NCT05800197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110185621|NCT00276809|Etoposide|etoposide|mesh-list
110089850|NCT05800197|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110089851|NCT05800197|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110089852|NCT05800197|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110089853|NCT05800197|Luteolytic Agents|luteolytic agents|mesh-ancestor
110089854|NCT05800197|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110089855|NCT05800197|Contraceptive Agents|contraceptive agents|mesh-ancestor
110089856|NCT05800197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110089857|NCT05800197|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110089858|NCT05797597|Aspirin|aspirin|mesh-list
110089859|NCT05797597|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110089860|NCT05797597|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110089861|NCT05797597|Analgesics|analgesics|mesh-ancestor
110089862|NCT05797597|Sensory System Agents|sensory system agents|mesh-ancestor
110089863|NCT05797597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110089864|NCT05797597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110089865|NCT05797597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110089866|NCT05797597|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110089867|NCT05797597|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110089868|NCT05797597|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110089869|NCT05797597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110089870|NCT05797597|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110089871|NCT05797597|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110089872|NCT05797597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110089873|NCT05797597|Antipyretics|antipyretics|mesh-ancestor
110089874|NCT05794750|Capecitabine|capecitabine|mesh-list
110089875|NCT05794750|Oxaliplatin|oxaliplatin|mesh-list
110089876|NCT05794750|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110089877|NCT05794750|Antimetabolites|antimetabolites|mesh-ancestor
110089878|NCT05794750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110089879|NCT05794750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110089880|NCT05792293|Atorvastatin|atorvastatin|mesh-list
110089881|NCT05792293|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110089882|NCT05792293|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110089883|NCT05792293|Antimetabolites|antimetabolites|mesh-ancestor
110089884|NCT05792293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110089885|NCT05792293|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110225468|NCT05959356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110089886|NCT05792293|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110089887|NCT05792293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110089888|NCT05785689|Dexmedetomidine|dexmedetomidine|mesh-list
110089889|NCT05785689|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110089890|NCT05785689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110089891|NCT05785689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110089892|NCT05785689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110089893|NCT05785689|Analgesics|analgesics|mesh-ancestor
110089894|NCT05785689|Sensory System Agents|sensory system agents|mesh-ancestor
110089895|NCT05785689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110089896|NCT05785689|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110089897|NCT05785689|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110089898|NCT05785689|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110089899|NCT05785689|Adrenergic Agents|adrenergic agents|mesh-ancestor
110089900|NCT05785689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110089901|NCT05785689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110089902|NCT05753644|Ropivacaine|ropivacaine|mesh-list
110089903|NCT05753644|Anesthetics, Local|anesthetics, local|mesh-ancestor
110089904|NCT05753644|Anesthetics|anesthetics|mesh-ancestor
110089905|NCT05753644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110089906|NCT05753644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110089907|NCT05753644|Sensory System Agents|sensory system agents|mesh-ancestor
110089908|NCT05753644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110089912|NCT05756504|Ketorolac|ketorolac|mesh-list
110089913|NCT05756504|Tramadol|tramadol|mesh-list
110089914|NCT05756504|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110089915|NCT05756504|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110089916|NCT05756504|Analgesics|analgesics|mesh-ancestor
110089917|NCT05756504|Sensory System Agents|sensory system agents|mesh-ancestor
110089918|NCT05756504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110089919|NCT05756504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110089920|NCT05756504|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110089921|NCT05756504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110089922|NCT05756504|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110089923|NCT05756504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110089924|NCT05756504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110089925|NCT05756504|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110089926|NCT05756504|Narcotics|narcotics|mesh-ancestor
110089927|NCT05756504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110089928|NCT05699603|Fluorouracil|fluorouracil|mesh-list
110089929|NCT05699603|Calcipotriene|calcipotriene|mesh-list
110089930|NCT05699603|Antimetabolites|antimetabolites|mesh-ancestor
110089931|NCT05699603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110089932|NCT05699603|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110089933|NCT05699603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110089934|NCT05699603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110089935|NCT05699603|Immunologic Factors|immunologic factors|mesh-ancestor
110089936|NCT05699603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110089937|NCT05699603|Dermatologic Agents|dermatologic agents|mesh-ancestor
110089938|NCT05697510|Siltuximab|siltuximab|mesh-list
110089939|NCT05697510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110089940|NCT05657925|Ondansetron|ondansetron|mesh-list
110089941|NCT05657925|Antiemetics|antiemetics|mesh-ancestor
110089942|NCT05657925|Autonomic Agents|autonomic agents|mesh-ancestor
110089943|NCT05657925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110089944|NCT05657925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110089945|NCT05657925|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110089946|NCT05657925|Antipruritics|antipruritics|mesh-ancestor
110089947|NCT05657925|Dermatologic Agents|dermatologic agents|mesh-ancestor
110089948|NCT05657925|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110089949|NCT05657925|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110089950|NCT05657925|Serotonin Agents|serotonin agents|mesh-ancestor
110089951|NCT05657925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110089952|NCT05657925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110089953|NCT05656508|Vaccines|vaccines|mesh-list
110089954|NCT05656508|Immunologic Factors|immunologic factors|mesh-ancestor
110089955|NCT05656508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110089956|NCT05622812|Lidocaine|lidocaine|mesh-list
110089957|NCT05622812|Anesthetics, Local|anesthetics, local|mesh-ancestor
110089958|NCT05622812|Anesthetics|anesthetics|mesh-ancestor
110089959|NCT05622812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110089960|NCT05622812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110089961|NCT05622812|Sensory System Agents|sensory system agents|mesh-ancestor
110089962|NCT05622812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110089963|NCT05622812|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110089964|NCT05622812|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110089965|NCT05622812|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110089966|NCT05622812|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110089967|NCT05622812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110089968|NCT05611229|Pembrolizumab|pembrolizumab|mesh-list
110089969|NCT05611229|Nivolumab|nivolumab|mesh-list
110089970|NCT05611229|Ipilimumab|ipilimumab|mesh-list
110089971|NCT05611229|Trametinib|trametinib|mesh-list
110089972|NCT05611229|Vemurafenib|vemurafenib|mesh-list
110089973|NCT05611229|Dabrafenib|dabrafenib|mesh-list
110089974|NCT05611229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110089975|NCT05611229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110089976|NCT05611229|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110089977|NCT05611229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110089978|NCT05611229|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110089979|NCT05611229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110089981|NCT05601154|Fluorides|fluorides|mesh-list
110089982|NCT05601154|Sodium Fluoride|sodium fluoride|mesh-list
110089983|NCT05601154|Cariostatic Agents|cariostatic agents|mesh-ancestor
110089984|NCT05601154|Protective Agents|protective agents|mesh-ancestor
110089985|NCT05601154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110089986|NCT05601154|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110089987|NCT05601154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110089988|NCT05566665|Meropenem|meropenem|mesh-list
110089989|NCT05566665|Tazobactam|tazobactam|mesh-list
110089990|NCT05566665|Ceftazidime|ceftazidime|mesh-list
110089991|NCT05566665|Avibactam|avibactam|mesh-list
110089992|NCT05566665|Ceftolozane|ceftolozane|mesh-list
110089993|NCT05566665|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
110089994|NCT05566665|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
110089995|NCT05566665|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110089996|NCT05566665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110089997|NCT05566665|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110089998|NCT05566665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110089999|NCT05566665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110090000|NCT05566665|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110090002|NCT05559476|Immunologic Factors|immunologic factors|mesh-ancestor
110090003|NCT05559476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110090004|NCT05544565|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110090005|NCT05544565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110090006|NCT05521984|Dapagliflozin|dapagliflozin|mesh-list
110090007|NCT05521984|Carmustine|carmustine|mesh-list
110090008|NCT05521984|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110090009|NCT05521984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110090011|NCT05521984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110090012|NCT05521984|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110090013|NCT05521984|Alkylating Agents|alkylating agents|mesh-ancestor
110090014|NCT05521984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110090015|NCT05497323|Adapalene|adapalene|mesh-list
110090016|NCT05497323|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110090017|NCT05497323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110090018|NCT05497323|Analgesics|analgesics|mesh-ancestor
110090019|NCT05497323|Sensory System Agents|sensory system agents|mesh-ancestor
110090020|NCT05497323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110090021|NCT05497323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110090022|NCT05497323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110090023|NCT05497323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110090024|NCT05497323|Dermatologic Agents|dermatologic agents|mesh-ancestor
110090025|NCT05463965|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110090026|NCT05463965|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110090027|NCT05463965|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110090028|NCT05463965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110090029|NCT05463965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110090030|NCT05463965|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110090031|NCT05463965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110090032|NCT05463965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110090033|NCT05463965|Cholinergic Agents|cholinergic agents|mesh-ancestor
110090034|NCT05463965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110090035|NCT05371886|Midazolam|midazolam|mesh-list
110090036|NCT05371886|Morphine|morphine|mesh-list
110090037|NCT05371886|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110090038|NCT05371886|Narcotics|narcotics|mesh-ancestor
110090039|NCT05371886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110090040|NCT05371886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110090041|NCT05371886|Analgesics|analgesics|mesh-ancestor
110090042|NCT05371886|Sensory System Agents|sensory system agents|mesh-ancestor
110090043|NCT05371886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110090044|NCT05371886|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110090045|NCT05371886|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110090046|NCT05371886|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110090047|NCT05371886|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110090048|NCT05371886|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110090049|NCT05371886|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110090050|NCT05371886|Anesthetics, General|anesthetics, general|mesh-ancestor
110090051|NCT05371886|Anesthetics|anesthetics|mesh-ancestor
110090052|NCT05371886|GABA Modulators|gaba modulators|mesh-ancestor
110090053|NCT05371886|GABA Agents|gaba agents|mesh-ancestor
110090054|NCT05371886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110090055|NCT05371886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110090056|NCT05345782|Bupivacaine|bupivacaine|mesh-list
110090057|NCT05345782|Anesthetics, Local|anesthetics, local|mesh-ancestor
110090058|NCT05345782|Anesthetics|anesthetics|mesh-ancestor
110090059|NCT05345782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110090060|NCT05345782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110090061|NCT05345782|Sensory System Agents|sensory system agents|mesh-ancestor
110090062|NCT05345782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110090063|NCT05309655|Adenosine|adenosine|mesh-list
110090064|NCT05309655|Analgesics|analgesics|mesh-ancestor
110090065|NCT05309655|Sensory System Agents|sensory system agents|mesh-ancestor
110090066|NCT05309655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110090067|NCT05309655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110090068|NCT05309655|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110090069|NCT05309655|Vasodilator Agents|vasodilator agents|mesh-ancestor
110090070|NCT05309655|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
110090071|NCT05309655|Purinergic Agonists|purinergic agonists|mesh-ancestor
110090072|NCT05309655|Purinergic Agents|purinergic agents|mesh-ancestor
110090073|NCT05309655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110090074|NCT05309655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110090075|NCT05297903|Antibodies, Bispecific|antibodies, bispecific|mesh-list
110090076|NCT05297903|Immunologic Factors|immunologic factors|mesh-ancestor
110090077|NCT05297903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110090078|NCT05265767|Factor VIII|factor viii|mesh-list
110090079|NCT05265767|Coagulants|coagulants|mesh-ancestor
110090080|NCT05219799|Propranolol|propranolol|mesh-list
110090081|NCT05219799|Phentolamine|phentolamine|mesh-list
110090082|NCT05219799|Isoproterenol|isoproterenol|mesh-list
110090083|NCT05219799|Norepinephrine|norepinephrine|mesh-list
110090084|NCT05219799|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110090085|NCT05219799|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110090086|NCT05219799|Adrenergic Agents|adrenergic agents|mesh-ancestor
110090087|NCT05219799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110090088|NCT05219799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110090089|NCT05219799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110090090|NCT05219799|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110090091|NCT05219799|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110090092|NCT05219799|Vasodilator Agents|vasodilator agents|mesh-ancestor
110090093|NCT05219799|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110090094|NCT05219799|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110090095|NCT05219799|Sympathomimetics|sympathomimetics|mesh-ancestor
110090096|NCT05219799|Autonomic Agents|autonomic agents|mesh-ancestor
110090097|NCT05219799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110090098|NCT05219799|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110090099|NCT05219799|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110090100|NCT05219799|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110090101|NCT05219799|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110090102|NCT05219799|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110090103|NCT05219799|Respiratory System Agents|respiratory system agents|mesh-ancestor
110090104|NCT05219799|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110090105|NCT05219799|Protective Agents|protective agents|mesh-ancestor
110090106|NCT05215951|Osimertinib|osimertinib|mesh-list
110090107|NCT05215951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110090108|NCT05215951|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110090109|NCT05215951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110090110|NCT05215951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110090111|NCT05161468|Triamcinolone|triamcinolone|mesh-list
110090112|NCT05161468|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110090113|NCT05161468|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110090114|NCT05161468|Lidocaine|lidocaine|mesh-list
110090115|NCT05161468|Acid citrate dextrose|acid citrate dextrose|mesh-list
110090116|NCT05161468|Glucocorticoids|glucocorticoids|mesh-list
110090117|NCT05161468|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110090118|NCT05161468|Anesthetics, Local|anesthetics, local|mesh-ancestor
110090119|NCT05161468|Anesthetics|anesthetics|mesh-ancestor
110090120|NCT05161468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110090121|NCT05161468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110090122|NCT05161468|Sensory System Agents|sensory system agents|mesh-ancestor
110090123|NCT05161468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110090124|NCT05161468|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110090125|NCT05161468|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110090126|NCT05161468|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110090127|NCT05161468|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110090128|NCT05161468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110090129|NCT05161468|Anticoagulants|anticoagulants|mesh-ancestor
110090130|NCT05161468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110090131|NCT05161468|Hormones|hormones|mesh-ancestor
110090132|NCT05161468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110090133|NCT05161468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110090134|NCT05161468|Immunologic Factors|immunologic factors|mesh-ancestor
110090135|NCT05161468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110090136|NCT05108389|Hemostatics|hemostatics|mesh-list
110090137|NCT05108389|Coagulants|coagulants|mesh-ancestor
110090138|NCT05104762|Immunoglobulins|immunoglobulins|mesh-list
110090139|NCT05104762|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110090140|NCT05104762|Antibodies|antibodies|mesh-list
110090141|NCT05104762|gamma-Globulins|gamma-globulins|mesh-list
110090142|NCT05104762|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110090143|NCT05104762|Immunologic Factors|immunologic factors|mesh-ancestor
110090144|NCT05104762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110090145|NCT05027425|Durvalumab|durvalumab|mesh-list
110090146|NCT05027425|Tremelimumab|tremelimumab|mesh-list
110090147|NCT05027425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110090148|NCT05027425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110090149|NCT05003648|Pramipexole|pramipexole|mesh-list
110090150|NCT05003648|Antioxidants|antioxidants|mesh-ancestor
110090151|NCT05003648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110090152|NCT05003648|Protective Agents|protective agents|mesh-ancestor
110090153|NCT05003648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110090154|NCT05003648|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110090155|NCT05003648|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110090156|NCT05003648|Dopamine Agonists|dopamine agonists|mesh-ancestor
110090157|NCT05003648|Dopamine Agents|dopamine agents|mesh-ancestor
110090158|NCT05003648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110090159|NCT04991480|Niraparib|niraparib|mesh-list
110090160|NCT04991480|Talazoparib|talazoparib|mesh-list
110090161|NCT04991480|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110090162|NCT04991480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110090163|NCT04991480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110090164|NCT04991480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110090165|NCT04892043|Nivolumab|nivolumab|mesh-list
110090166|NCT04892043|Ipilimumab|ipilimumab|mesh-list
110090167|NCT04892043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110090168|NCT04892043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110090169|NCT04892043|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110090170|NCT04892043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110090171|NCT04880278|Nabilone|nabilone|mesh-list
110090172|NCT04880278|Antiemetics|antiemetics|mesh-ancestor
110090173|NCT04880278|Autonomic Agents|autonomic agents|mesh-ancestor
110090174|NCT04880278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110090175|NCT04880278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110090176|NCT04880278|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110090177|NCT04880278|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110090178|NCT04880278|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110090179|NCT04880278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110090180|NCT04880278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110090181|NCT04858425|Niclosamide|niclosamide|mesh-list
110090182|NCT04858425|Anticestodal Agents|anticestodal agents|mesh-ancestor
110090183|NCT04858425|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110090184|NCT04858425|Anthelmintics|anthelmintics|mesh-ancestor
110090185|NCT04858425|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110090186|NCT04858425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110090187|NCT04858425|Antinematodal Agents|antinematodal agents|mesh-ancestor
110090189|NCT04835506|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110090190|NCT04835506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110090191|NCT04835506|Dermatologic Agents|dermatologic agents|mesh-ancestor
110090192|NCT04835506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110090193|NCT04835506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110090194|NCT04824092|Prednisone|prednisone|mesh-list
110090195|NCT04824092|Cyclophosphamide|cyclophosphamide|mesh-list
110090196|NCT04824092|Rituximab|rituximab|mesh-list
110090197|NCT04824092|Doxorubicin|doxorubicin|mesh-list
110090198|NCT04824092|Vincristine|vincristine|mesh-list
110090199|NCT04824092|Lenalidomide|lenalidomide|mesh-list
110090200|NCT04824092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110090201|NCT04824092|Immunologic Factors|immunologic factors|mesh-ancestor
110090202|NCT04824092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110090203|NCT04824092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110090204|NCT04824092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110090205|NCT04824092|Alkylating Agents|alkylating agents|mesh-ancestor
110090206|NCT04824092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110090207|NCT04824092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110090208|NCT04824092|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110090209|NCT04824092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110090210|NCT04824092|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110090211|NCT04824092|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110090212|NCT04824092|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110090213|NCT04824092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110090214|NCT04824092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110090215|NCT04824092|Glucocorticoids|glucocorticoids|mesh-ancestor
110090216|NCT04824092|Hormones|hormones|mesh-ancestor
110090217|NCT04824092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110090218|NCT04824092|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110225469|NCT05959356|Vitamin B Complex|vitamin b complex|mesh-ancestor
110090219|NCT04824092|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110090220|NCT04824092|Tubulin Modulators|tubulin modulators|mesh-ancestor
110090221|NCT04824092|Antimitotic Agents|antimitotic agents|mesh-ancestor
110090222|NCT04824092|Mitosis Modulators|mitosis modulators|mesh-ancestor
110090223|NCT04824092|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110090224|NCT04824092|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110090225|NCT04824092|Growth Substances|growth substances|mesh-ancestor
110090226|NCT04824092|Growth Inhibitors|growth inhibitors|mesh-ancestor
110090227|NCT04762758|Naltrexone|naltrexone|mesh-list
110090228|NCT04762758|Baclofen|baclofen|mesh-list
110090229|NCT04762758|Sorbitol|sorbitol|mesh-list
110090230|NCT04762758|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110090231|NCT04762758|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110090232|NCT04762758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110090233|NCT04762758|Sensory System Agents|sensory system agents|mesh-ancestor
110090234|NCT04762758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110090235|NCT04762758|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110090236|NCT04762758|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110090237|NCT04762758|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
110090238|NCT04762758|GABA Agonists|gaba agonists|mesh-ancestor
110090239|NCT04762758|GABA Agents|gaba agents|mesh-ancestor
110090240|NCT04762758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110090241|NCT04762758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110090242|NCT04762758|Cathartics|cathartics|mesh-ancestor
110090243|NCT04762758|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110090244|NCT04732065|Dopamine|dopamine|mesh-list
110090245|NCT04732065|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110090246|NCT04732065|Sympathomimetics|sympathomimetics|mesh-ancestor
110090247|NCT04732065|Autonomic Agents|autonomic agents|mesh-ancestor
110090248|NCT04732065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110090249|NCT04732065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110090250|NCT04732065|Dopamine Agents|dopamine agents|mesh-ancestor
110090251|NCT04732065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110090252|NCT04732065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110090253|NCT04732065|Protective Agents|protective agents|mesh-ancestor
110090254|NCT04717908|Linezolid|linezolid|mesh-list
110090255|NCT04717908|Cycloserine|cycloserine|mesh-list
110090256|NCT04717908|Pyrazinamide|pyrazinamide|mesh-list
110090257|NCT04717908|Bedaquiline|bedaquiline|mesh-list
110090258|NCT04717908|Clofazimine|clofazimine|mesh-list
110090259|NCT04717908|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110090260|NCT04717908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110090261|NCT04717908|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110090262|NCT04717908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110090263|NCT04717908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110090264|NCT04717908|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110090265|NCT04717908|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110090266|NCT04717908|Antitubercular Agents|antitubercular agents|mesh-ancestor
110090267|NCT04717908|Antimetabolites|antimetabolites|mesh-ancestor
110090268|NCT04717908|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110090269|NCT04717908|Leprostatic Agents|leprostatic agents|mesh-ancestor
110090270|NCT04665895|Fluticasone|fluticasone|mesh-list
110090272|NCT04665895|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110090273|NCT04665895|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110090274|NCT04665895|Autonomic Agents|autonomic agents|mesh-ancestor
110090275|NCT04665895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110090276|NCT04665895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110090277|NCT04665895|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110090278|NCT04665895|Respiratory System Agents|respiratory system agents|mesh-ancestor
110090279|NCT04665895|Dermatologic Agents|dermatologic agents|mesh-ancestor
110090280|NCT04665895|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110090281|NCT04594187|Immunomodulating Agents|immunomodulating agents|mesh-list
110090282|NCT04594187|Immunologic Factors|immunologic factors|mesh-ancestor
110090283|NCT04594187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110090284|NCT04559230|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
110090285|NCT04559230|Immunoconjugates|immunoconjugates|mesh-ancestor
110090286|NCT04559230|Immunologic Factors|immunologic factors|mesh-ancestor
110090287|NCT04559230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110090289|NCT04549792|Dermatologic Agents|dermatologic agents|mesh-ancestor
110090291|NCT04545554|Calcium|calcium|mesh-list
110090292|NCT04545554|Vitamins|vitamins|mesh-ancestor
110090293|NCT04545554|Micronutrients|micronutrients|mesh-ancestor
110090294|NCT04545554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110090295|NCT04545554|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110090296|NCT04545554|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110090297|NCT04530058|Metformin|metformin|mesh-list
110090298|NCT04530058|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110090299|NCT04530058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110090300|NCT04500574|Latanoprost|latanoprost|mesh-list
110090301|NCT04500574|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110090302|NCT04500574|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110090303|NCT04483505|Fulvestrant|fulvestrant|mesh-list
110090304|NCT04483505|Palbociclib|palbociclib|mesh-list
110090305|NCT04483505|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110090306|NCT04483505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110090307|NCT04483505|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110090308|NCT04483505|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110090309|NCT04483505|Hormone Antagonists|hormone antagonists|mesh-ancestor
110090310|NCT04483505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110090311|NCT04483505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110090312|NCT04483505|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110090313|NCT04483505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110090314|NCT04483505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110090315|NCT04445662|Varenicline|varenicline|mesh-list
110090316|NCT04445662|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110090317|NCT04445662|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110090318|NCT04445662|Cholinergic Agents|cholinergic agents|mesh-ancestor
110090319|NCT04445662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110090320|NCT04445662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110090321|NCT04445662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110090322|NCT04416282|Terlipressin|terlipressin|mesh-list
110090323|NCT04416282|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110090324|NCT04416282|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110090325|NCT04395469|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
110090326|NCT04395469|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110090327|NCT04395469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110090328|NCT04375150|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
110090329|NCT04375150|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110090330|NCT04375150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110090331|NCT04375150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110090332|NCT04359784|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
110090333|NCT04359784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110090334|NCT04323046|Nivolumab|nivolumab|mesh-list
110090335|NCT04323046|Ipilimumab|ipilimumab|mesh-list
110090336|NCT04323046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110090337|NCT04323046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110090338|NCT04323046|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110090339|NCT04323046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110090340|NCT04170946|Talazoparib|talazoparib|mesh-list
110090341|NCT04170946|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110090342|NCT04170946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110090343|NCT04170946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110090344|NCT04170946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110090345|NCT04152551|Risedronic Acid|risedronic acid|mesh-list
110090346|NCT04152551|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110090347|NCT04152551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110090348|NCT04152551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110090349|NCT04152551|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110090350|NCT04152551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110090351|NCT04152551|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110090353|NCT04112498|Relatlimab|relatlimab|mesh-list
110090354|NCT04112498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110090355|NCT04112498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110090356|NCT04112498|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110090357|NCT04112498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110090358|NCT04104893|Pembrolizumab|pembrolizumab|mesh-list
110090359|NCT04104893|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110090360|NCT04104893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110090361|NCT04104893|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110090362|NCT04104893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110090363|NCT04042051|Trastuzumab|trastuzumab|mesh-list
110090364|NCT04042051|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
110090365|NCT04042051|Maytansine|maytansine|mesh-list
110090366|NCT04042051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110090367|NCT04042051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110090368|NCT04042051|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110090369|NCT04042051|Tubulin Modulators|tubulin modulators|mesh-ancestor
110090370|NCT04042051|Antimitotic Agents|antimitotic agents|mesh-ancestor
110090371|NCT04042051|Mitosis Modulators|mitosis modulators|mesh-ancestor
110090372|NCT04042051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110090373|NCT04042051|Immunotoxins|immunotoxins|mesh-ancestor
110090374|NCT04042051|Immunoconjugates|immunoconjugates|mesh-ancestor
110090375|NCT04042051|Immunologic Factors|immunologic factors|mesh-ancestor
110090376|NCT04042051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110090377|NCT04033991|Sunitinib|sunitinib|mesh-list
110090378|NCT04033991|Axitinib|axitinib|mesh-list
110090379|NCT04033991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110090380|NCT04033991|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110090381|NCT04033991|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110090382|NCT04033991|Growth Substances|growth substances|mesh-ancestor
110090383|NCT04033991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110090384|NCT04033991|Growth Inhibitors|growth inhibitors|mesh-ancestor
110090385|NCT04033991|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110090386|NCT04033991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110090387|NCT04033991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110090389|NCT03961360|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110090390|NCT03961360|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110090391|NCT03961360|Analgesics|analgesics|mesh-ancestor
110090392|NCT03961360|Sensory System Agents|sensory system agents|mesh-ancestor
110090393|NCT03961360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110090394|NCT03961360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110090395|NCT03961360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110090396|NCT03961360|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110090397|NCT03961360|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110090398|NCT03961360|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110090399|NCT03961360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110090400|NCT03961360|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110090401|NCT03961360|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110090402|NCT03961360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110090403|NCT03961360|Antipyretics|antipyretics|mesh-ancestor
110090404|NCT03924401|Abatacept|abatacept|mesh-list
110090405|NCT03924401|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110090406|NCT03924401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110090407|NCT03924401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110090408|NCT03924401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110090409|NCT03924401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110090410|NCT03924401|Immunologic Factors|immunologic factors|mesh-ancestor
110090411|NCT03924401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110090412|NCT03924401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110090413|NCT03769285|Niacinamide|niacinamide|mesh-list
110090414|NCT03769285|Niacin|niacin|mesh-list
110090415|NCT03769285|Nicotinic Acids|nicotinic acids|mesh-list
110090416|NCT03769285|Vitamin B Complex|vitamin b complex|mesh-ancestor
110090417|NCT03769285|Vitamins|vitamins|mesh-ancestor
110090418|NCT03769285|Micronutrients|micronutrients|mesh-ancestor
110090419|NCT03769285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110090420|NCT03769285|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110090421|NCT03769285|Antimetabolites|antimetabolites|mesh-ancestor
110090422|NCT03769285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110090423|NCT03769285|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110090424|NCT03769285|Vasodilator Agents|vasodilator agents|mesh-ancestor
110090425|NCT03749187|Temozolomide|temozolomide|mesh-list
110090426|NCT03749187|Pamiparib|pamiparib|mesh-list
110090427|NCT03749187|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
110090428|NCT03749187|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110090429|NCT03749187|Alkylating Agents|alkylating agents|mesh-ancestor
110090430|NCT03749187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110090431|NCT03749187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110090432|NCT03749187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110090433|NCT03738553|Trastuzumab|trastuzumab|mesh-list
110090434|NCT03738553|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110090435|NCT03738553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110090436|NCT03710902|Antihypertensive Agents|antihypertensive agents|mesh-list
110090437|NCT03705806|Immunomodulating Agents|immunomodulating agents|mesh-list
110090438|NCT03705806|Immunologic Factors|immunologic factors|mesh-ancestor
110185707|NCT04430790|Doxapram|doxapram|mesh-list
110090439|NCT03705806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110090440|NCT03642132|Bevacizumab|bevacizumab|mesh-list
110090441|NCT03642132|Avelumab|avelumab|mesh-list
110090442|NCT03642132|Talazoparib|talazoparib|mesh-list
110090443|NCT03642132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110090444|NCT03642132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110090445|NCT03642132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110090446|NCT03642132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110090447|NCT03642132|Growth Substances|growth substances|mesh-ancestor
110090448|NCT03642132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110090449|NCT03642132|Growth Inhibitors|growth inhibitors|mesh-ancestor
110090450|NCT03642132|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110090451|NCT03642132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110090452|NCT03642132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110090453|NCT03632330|Midazolam|midazolam|mesh-list
110090454|NCT03632330|Dexmedetomidine|dexmedetomidine|mesh-list
110090455|NCT03632330|Propofol|propofol|mesh-list
110090456|NCT03632330|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110090457|NCT03632330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110090458|NCT03632330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110090459|NCT03632330|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110090460|NCT03632330|Analgesics|analgesics|mesh-ancestor
110090461|NCT03632330|Sensory System Agents|sensory system agents|mesh-ancestor
110090462|NCT03632330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110090463|NCT03632330|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110090464|NCT03632330|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110090465|NCT03632330|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110090466|NCT03632330|Adrenergic Agents|adrenergic agents|mesh-ancestor
110090467|NCT03632330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110090468|NCT03632330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110090469|NCT03632330|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110090470|NCT03632330|Anesthetics, General|anesthetics, general|mesh-ancestor
110090471|NCT03632330|Anesthetics|anesthetics|mesh-ancestor
110090472|NCT03632330|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110090473|NCT03632330|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110090474|NCT03632330|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110090475|NCT03632330|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110090476|NCT03632330|GABA Modulators|gaba modulators|mesh-ancestor
110090477|NCT03632330|GABA Agents|gaba agents|mesh-ancestor
110090478|NCT03575949|Deoxyglucose|deoxyglucose|mesh-list
110090479|NCT03575949|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110090480|NCT03575949|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110090481|NCT03575949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110090482|NCT03575949|Antimetabolites|antimetabolites|mesh-ancestor
110090483|NCT03575949|Antiviral Agents|antiviral agents|mesh-ancestor
110090484|NCT03575949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110090485|NCT03572764|Cytarabine|cytarabine|mesh-list
110090486|NCT03572764|Daunorubicin|daunorubicin|mesh-list
110090487|NCT03572764|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110090488|NCT03572764|Antimetabolites|antimetabolites|mesh-ancestor
110090489|NCT03572764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110090490|NCT03572764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110090491|NCT03572764|Antiviral Agents|antiviral agents|mesh-ancestor
110090492|NCT03572764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110090493|NCT03572764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110090494|NCT03572764|Immunologic Factors|immunologic factors|mesh-ancestor
110090495|NCT03572764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110090496|NCT03572764|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110090497|NCT03572764|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110090498|NCT03572764|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110090499|NCT03572764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110090500|NCT03560752|Vaccines|vaccines|mesh-list
110090501|NCT03560752|Immunologic Factors|immunologic factors|mesh-ancestor
110090502|NCT03560752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110090503|NCT03506061|Ivacaftor|ivacaftor|mesh-list
110090504|NCT03506061|Elexacaftor|elexacaftor|mesh-list
110090505|NCT03506061|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
110090506|NCT03506061|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110090507|NCT03506061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110090508|NCT03475342|Tranexamic Acid|tranexamic acid|mesh-list
110090509|NCT03475342|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110090510|NCT03475342|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110090511|NCT03475342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110090512|NCT03475342|Hemostatics|hemostatics|mesh-ancestor
110090513|NCT03475342|Coagulants|coagulants|mesh-ancestor
110090514|NCT03466151|Sirolimus|sirolimus|mesh-list
110090515|NCT03466151|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110090516|NCT03466151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110090517|NCT03466151|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110090518|NCT03466151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110090519|NCT03466151|Antifungal Agents|antifungal agents|mesh-ancestor
110090520|NCT03466151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110090521|NCT03466151|Immunologic Factors|immunologic factors|mesh-ancestor
110090522|NCT03466151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110090523|NCT03452930|Benzimidazole|benzimidazole|mesh-list
110090524|NCT03452930|Anthelmintics|anthelmintics|mesh-ancestor
110090525|NCT03452930|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110090526|NCT03452930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110225470|NCT05959356|Vitamins|vitamins|mesh-ancestor
110090527|NCT03418818|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
110090528|NCT03418818|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110090529|NCT03418818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110090530|NCT03253289|Meclizine|meclizine|mesh-list
110090531|NCT03253289|Antiemetics|antiemetics|mesh-ancestor
110090532|NCT03253289|Autonomic Agents|autonomic agents|mesh-ancestor
110090533|NCT03253289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110090534|NCT03253289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110090535|NCT03253289|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110090536|NCT03253289|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110090537|NCT03253289|Histamine Antagonists|histamine antagonists|mesh-ancestor
110090538|NCT03253289|Histamine Agents|histamine agents|mesh-ancestor
110090539|NCT03253289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110090540|NCT03253289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110090541|NCT03253289|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110090542|NCT03253289|Cholinergic Agents|cholinergic agents|mesh-ancestor
110090543|NCT03253289|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110090545|NCT03227705|Progestins|progestins|mesh-ancestor
110090546|NCT03227705|Hormones|hormones|mesh-ancestor
110090547|NCT03227705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110090548|NCT03227705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110090549|NCT03176953|Topiramate|topiramate|mesh-list
110090550|NCT03176953|Anticonvulsants|anticonvulsants|mesh-ancestor
110090551|NCT03176953|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110090552|NCT03176953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110090553|NCT03150004|Cytarabine|cytarabine|mesh-list
110090554|NCT03150004|Mitoxantrone|mitoxantrone|mesh-list
110090555|NCT03150004|Cladribine|cladribine|mesh-list
110090556|NCT03150004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110090557|NCT03150004|Antimetabolites|antimetabolites|mesh-ancestor
110090558|NCT03150004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110090559|NCT03150004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110090560|NCT03150004|Antiviral Agents|antiviral agents|mesh-ancestor
110090561|NCT03150004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110090562|NCT03150004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110090563|NCT03150004|Immunologic Factors|immunologic factors|mesh-ancestor
110090564|NCT03150004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110090565|NCT03150004|Analgesics|analgesics|mesh-ancestor
110090566|NCT03150004|Sensory System Agents|sensory system agents|mesh-ancestor
110090567|NCT03150004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110090568|NCT03150004|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110090569|NCT03150004|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110090570|NCT03150004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110090571|NCT03149822|Pembrolizumab|pembrolizumab|mesh-list
110225471|NCT05959356|Micronutrients|micronutrients|mesh-ancestor
110090572|NCT03149822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110090573|NCT03149822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110090574|NCT03149822|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110090575|NCT03149822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110090577|NCT03082534|Cetuximab|cetuximab|mesh-list
110090578|NCT03082534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110090579|NCT03082534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110090580|NCT03082534|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110090581|NCT03082534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110090582|NCT03056339|Cyclophosphamide|cyclophosphamide|mesh-list
110090583|NCT03056339|Fludarabine|fludarabine|mesh-list
110090584|NCT03056339|Fludarabine phosphate|fludarabine phosphate|mesh-list
110090585|NCT03056339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110090586|NCT03056339|Immunologic Factors|immunologic factors|mesh-ancestor
110090587|NCT03056339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110090588|NCT03056339|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110090589|NCT03056339|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110090590|NCT03056339|Alkylating Agents|alkylating agents|mesh-ancestor
110090591|NCT03056339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110090592|NCT03056339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110090593|NCT03056339|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110090594|NCT03056339|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110090595|NCT03056339|Antimetabolites|antimetabolites|mesh-ancestor
110090596|NCT02960230|Nivolumab|nivolumab|mesh-list
110090612|NCT02701699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110090613|NCT02682511|Ifetroban|ifetroban|mesh-list
110090614|NCT02682511|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110090615|NCT02351869|Midazolam|midazolam|mesh-list
110090617|NCT02351869|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110090618|NCT02351869|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110090619|NCT02351869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110090620|NCT02351869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110090621|NCT02351869|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110090622|NCT02351869|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110090623|NCT02351869|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110090624|NCT02351869|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110090625|NCT02351869|Anesthetics, General|anesthetics, general|mesh-ancestor
110090626|NCT02351869|Anesthetics|anesthetics|mesh-ancestor
110090627|NCT02351869|GABA Modulators|gaba modulators|mesh-ancestor
110090628|NCT02351869|GABA Agents|gaba agents|mesh-ancestor
110090629|NCT02351869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110090630|NCT02351869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110090631|NCT02351869|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110090632|NCT02351869|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110090633|NCT02351869|Analgesics|analgesics|mesh-ancestor
110090634|NCT02351869|Sensory System Agents|sensory system agents|mesh-ancestor
110090635|NCT02351869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110090636|NCT02311582|Pembrolizumab|pembrolizumab|mesh-list
110185733|NCT04201665|Carbetocin|carbetocin|mesh-list
110090637|NCT02311582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110090638|NCT02311582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110090639|NCT02311582|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110090640|NCT02311582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110090641|NCT02237820|Dexamethasone|dexamethasone|mesh-list
110090642|NCT02237820|Prednisone|prednisone|mesh-list
110090643|NCT02237820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110090644|NCT02237820|Antiemetics|antiemetics|mesh-ancestor
110090645|NCT02237820|Autonomic Agents|autonomic agents|mesh-ancestor
110090646|NCT02237820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110090647|NCT02237820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110090648|NCT02237820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110090649|NCT02237820|Glucocorticoids|glucocorticoids|mesh-ancestor
110090650|NCT02237820|Hormones|hormones|mesh-ancestor
110090651|NCT02237820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110090652|NCT02237820|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110090653|NCT02237820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110090654|NCT02160353|Prednisolone|prednisolone|mesh-list
110090655|NCT02160353|Abiraterone Acetate|abiraterone acetate|mesh-list
110090656|NCT02160353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110090657|NCT02160353|Glucocorticoids|glucocorticoids|mesh-ancestor
110090658|NCT02160353|Hormones|hormones|mesh-ancestor
110090659|NCT02160353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110090660|NCT02160353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110090661|NCT02160353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110090662|NCT02160353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110090663|NCT02160353|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110090664|NCT02160353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110090665|NCT02160353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110090666|NCT02160353|Hormone Antagonists|hormone antagonists|mesh-ancestor
110090667|NCT02160353|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110090668|NCT02152358|Acyclovir|acyclovir|mesh-list
110090669|NCT02152358|Ganciclovir|ganciclovir|mesh-list
110090670|NCT02152358|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
110090671|NCT02152358|Antiviral Agents|antiviral agents|mesh-ancestor
110090672|NCT02152358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110090673|NCT02152358|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110090674|NCT02152358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110090675|NCT02152358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110090676|NCT01819064|Atropine|atropine|mesh-list
110090677|NCT01819064|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110090678|NCT01819064|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110090679|NCT01819064|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110090680|NCT01819064|Autonomic Agents|autonomic agents|mesh-ancestor
110090681|NCT01819064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110090682|NCT01819064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110090683|NCT01819064|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110090684|NCT01819064|Respiratory System Agents|respiratory system agents|mesh-ancestor
110090685|NCT01819064|Mydriatics|mydriatics|mesh-ancestor
110090686|NCT01819064|Parasympatholytics|parasympatholytics|mesh-ancestor
110090687|NCT01819064|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110090688|NCT01819064|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110090689|NCT01819064|Cholinergic Agents|cholinergic agents|mesh-ancestor
110090690|NCT01819064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110090691|NCT01819064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110090692|NCT01817751|Sorafenib|sorafenib|mesh-list
110090693|NCT01817751|Sildenafil Citrate|sildenafil citrate|mesh-list
110090694|NCT01817751|Valproic Acid|valproic acid|mesh-list
110090695|NCT01817751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110090696|NCT01817751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110090697|NCT01817751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110090698|NCT01817751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110090699|NCT01817751|Vasodilator Agents|vasodilator agents|mesh-ancestor
110090700|NCT01817751|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110090706|NCT01817751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110090708|NCT01817751|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110090709|NCT01817751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110090710|NCT01817751|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110090711|NCT02744053|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
110090712|NCT02744053|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110090713|NCT02744053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110090719|NCT01549730|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
110090720|NCT01549730|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110090721|NCT01549730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110090722|NCT00812669|Cyclophosphamide|cyclophosphamide|mesh-list
110090723|NCT00812669|Rituximab|rituximab|mesh-list
110090724|NCT00812669|Fludarabine|fludarabine|mesh-list
110090725|NCT00812669|Fludarabine phosphate|fludarabine phosphate|mesh-list
110090726|NCT00812669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110090727|NCT00812669|Immunologic Factors|immunologic factors|mesh-ancestor
110090728|NCT00812669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110090729|NCT00812669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110090730|NCT00812669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110090731|NCT00812669|Alkylating Agents|alkylating agents|mesh-ancestor
110090732|NCT00812669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110090733|NCT00812669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110090734|NCT00812669|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110090735|NCT00812669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110090736|NCT00812669|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110090737|NCT00812669|Antimetabolites|antimetabolites|mesh-ancestor
110090738|NCT00188539|Anesthetics|anesthetics|mesh-list
110090739|NCT00188539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110090740|NCT00188539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110090741|NCT03889314|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110090742|NCT03889314|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110090743|NCT03889314|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110090744|NCT03889314|Antimetabolites|antimetabolites|mesh-ancestor
110090745|NCT03889314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110090747|NCT03889314|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110090748|NCT03889314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110090749|NCT03870880|Risperidone|risperidone|mesh-list
110090750|NCT03870880|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110090751|NCT03870880|Serotonin Agents|serotonin agents|mesh-ancestor
110090752|NCT03870880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110090753|NCT03870880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110090754|NCT03870880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110090755|NCT03870880|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110090756|NCT03870880|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110090757|NCT03870880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110090758|NCT03870880|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110090759|NCT03870880|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110090760|NCT03870880|Dopamine Agents|dopamine agents|mesh-ancestor
110090761|NCT03861377|Remifentanil|remifentanil|mesh-list
110090762|NCT03861377|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110090763|NCT03861377|Narcotics|narcotics|mesh-ancestor
110090764|NCT03861377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110090765|NCT03861377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110090766|NCT03861377|Analgesics|analgesics|mesh-ancestor
110090767|NCT03861377|Sensory System Agents|sensory system agents|mesh-ancestor
110090768|NCT03861377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110090769|NCT03844100|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
110090770|NCT03844100|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
110090771|NCT03844100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110090772|NCT03836144|Potassium Citrate|potassium citrate|mesh-list
110090773|NCT03836144|Diuretics|diuretics|mesh-ancestor
110090774|NCT03836144|Natriuretic Agents|natriuretic agents|mesh-ancestor
110090775|NCT03836144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110090777|NCT03836144|Respiratory System Agents|respiratory system agents|mesh-ancestor
110090778|NCT03796416|Misoprostol|misoprostol|mesh-list
110090779|NCT03796416|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110090780|NCT03796416|Abortifacient Agents|abortifacient agents|mesh-ancestor
110090781|NCT03796416|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110090782|NCT03796416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110090783|NCT03796416|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110090784|NCT03796416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110090785|NCT03796416|Oxytocics|oxytocics|mesh-ancestor
110090786|NCT03785106|Vitamins|vitamins|mesh-list
110090788|NCT03785106|Pyridoxal|pyridoxal|mesh-list
110090789|NCT03785106|Vitamin B 6|vitamin b 6|mesh-list
110090790|NCT03785106|Vitamin B Complex|vitamin b complex|mesh-list
110090791|NCT03785106|Isoniazid|isoniazid|mesh-list
110090792|NCT03785106|Rifapentine|rifapentine|mesh-list
110090793|NCT03785106|Rifampin|rifampin|mesh-list
110090794|NCT03785106|Micronutrients|micronutrients|mesh-ancestor
110090795|NCT03785106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110090796|NCT03785106|Antitubercular Agents|antitubercular agents|mesh-ancestor
110090797|NCT03785106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110090798|NCT03785106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110090799|NCT03785106|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
110090800|NCT03785106|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110090801|NCT03785106|Antimetabolites|antimetabolites|mesh-ancestor
110090802|NCT03785106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110090803|NCT03785106|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110090804|NCT03785106|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110090805|NCT03785106|Leprostatic Agents|leprostatic agents|mesh-ancestor
110090806|NCT03785106|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110090807|NCT03785106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110090808|NCT03785106|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110090809|NCT03785106|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110090810|NCT03785106|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110090811|NCT03785106|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110090812|NCT03785106|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110090813|NCT03785106|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110090814|NCT03782142|Tenofovir|tenofovir|mesh-list
110090815|NCT03782142|Dolutegravir|dolutegravir|mesh-list
110090816|NCT03782142|Rilpivirine|rilpivirine|mesh-list
110090817|NCT03782142|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
110090818|NCT03782142|Antiviral Agents|antiviral agents|mesh-ancestor
110090819|NCT03782142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110090820|NCT03782142|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110090821|NCT03782142|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110090822|NCT03782142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110090823|NCT03782142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110090824|NCT03782142|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110090825|NCT03782142|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110090826|NCT03782142|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110090827|NCT03782142|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110090828|NCT03782142|Protease Inhibitors|protease inhibitors|mesh-ancestor
110090829|NCT03782142|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110090830|NCT03782142|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110090832|NCT03770299|Vinorelbine|vinorelbine|mesh-list
110090833|NCT03770299|Docetaxel|docetaxel|mesh-list
110090834|NCT03770299|Carboplatin|carboplatin|mesh-list
110090835|NCT03770299|Gemcitabine|gemcitabine|mesh-list
110090836|NCT03770299|Nivolumab|nivolumab|mesh-list
110090837|NCT03770299|Pemetrexed|pemetrexed|mesh-list
110090838|NCT03770299|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110090839|NCT03770299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110090840|NCT03770299|Tubulin Modulators|tubulin modulators|mesh-ancestor
110090841|NCT03770299|Antimitotic Agents|antimitotic agents|mesh-ancestor
110090842|NCT03770299|Mitosis Modulators|mitosis modulators|mesh-ancestor
110090843|NCT03770299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110090844|NCT03770299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110090845|NCT03770299|Antimetabolites|antimetabolites|mesh-ancestor
110090846|NCT03770299|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110090847|NCT03770299|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110090848|NCT03770299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110090849|NCT03770299|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110090850|NCT03770299|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110090851|NCT03760835|Dexamethasone|dexamethasone|mesh-list
110090852|NCT03760835|Prednisone|prednisone|mesh-list
110090853|NCT03760835|Prednisolone|prednisolone|mesh-list
110090854|NCT03760835|Hydrocortisone|hydrocortisone|mesh-list
110090855|NCT03760835|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
110090856|NCT03760835|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
110090857|NCT03760835|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
110090858|NCT03760835|Cortisone|cortisone|mesh-list
110090859|NCT03760835|Glucocorticoids|glucocorticoids|mesh-list
110090860|NCT03760835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110090861|NCT03760835|Antiemetics|antiemetics|mesh-ancestor
110090862|NCT03760835|Autonomic Agents|autonomic agents|mesh-ancestor
110090863|NCT03760835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110090864|NCT03760835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110090865|NCT03760835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110090866|NCT03760835|Hormones|hormones|mesh-ancestor
110090867|NCT03760835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110090868|NCT03760835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110090869|NCT03760835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110090870|NCT03759496|Durvalumab|durvalumab|mesh-list
110090871|NCT03759496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110090872|NCT03759496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110090873|NCT03759184|Obinutuzumab|obinutuzumab|mesh-list
110090874|NCT03759184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110090875|NCT03759184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110090876|NCT03727750|Gemtuzumab|gemtuzumab|mesh-list
110090877|NCT03727750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110090878|NCT03727750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110090879|NCT03727750|Immunotoxins|immunotoxins|mesh-ancestor
110090880|NCT03727750|Immunoconjugates|immunoconjugates|mesh-ancestor
110090881|NCT03727750|Immunologic Factors|immunologic factors|mesh-ancestor
110090882|NCT03727750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110090883|NCT03724409|Octreotide|octreotide|mesh-list
110090884|NCT03724409|Edotreotide|edotreotide|mesh-list
110090885|NCT03724409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110090886|NCT03724409|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110090887|NCT03724409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110090888|NCT03724409|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110090889|NCT03724409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110090890|NCT03715829|PF-06700841|pf-06700841|mesh-list
110090891|NCT03715829|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110090892|NCT03715829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110090893|NCT03715829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110090895|NCT03712254|Anticonvulsants|anticonvulsants|mesh-ancestor
110090896|NCT03712254|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110090897|NCT03712254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110090898|NCT03712254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110090899|NCT03704441|Bupivacaine|bupivacaine|mesh-list
110090900|NCT03704441|Anesthetics, Local|anesthetics, local|mesh-ancestor
110090901|NCT03704441|Anesthetics|anesthetics|mesh-ancestor
110090902|NCT03704441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110090903|NCT03704441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110090904|NCT03704441|Sensory System Agents|sensory system agents|mesh-ancestor
110090905|NCT03704441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110090906|NCT03673826|Dexamethasone|dexamethasone|mesh-list
110090907|NCT03673826|Lenalidomide|lenalidomide|mesh-list
110090908|NCT03673826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110090909|NCT03673826|Antiemetics|antiemetics|mesh-ancestor
110090910|NCT03673826|Autonomic Agents|autonomic agents|mesh-ancestor
110090911|NCT03673826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110090912|NCT03673826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110090913|NCT03673826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110090914|NCT03673826|Glucocorticoids|glucocorticoids|mesh-ancestor
110090916|NCT03673826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110090917|NCT03673826|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110090918|NCT03673826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110090919|NCT03673826|Immunologic Factors|immunologic factors|mesh-ancestor
110090920|NCT03673826|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110090921|NCT03673826|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110090922|NCT03673826|Growth Substances|growth substances|mesh-ancestor
110090923|NCT03673826|Growth Inhibitors|growth inhibitors|mesh-ancestor
110090924|NCT03660839|Artefenomel|artefenomel|mesh-list
110090925|NCT03660839|Ferroquine|ferroquine|mesh-list
110090926|NCT03660839|Antimalarials|antimalarials|mesh-ancestor
110090927|NCT03660839|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110090928|NCT03660839|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110090929|NCT03660839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110090931|NCT03660241|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110090932|NCT03660241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110090933|NCT03660241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110090934|NCT03651102|Thalidomide|thalidomide|mesh-list
110090935|NCT03651102|Hydroxyurea|hydroxyurea|mesh-list
110090936|NCT03651102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110090937|NCT03651102|Immunologic Factors|immunologic factors|mesh-ancestor
110090938|NCT03651102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110090939|NCT03651102|Leprostatic Agents|leprostatic agents|mesh-ancestor
110090940|NCT03651102|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110090941|NCT03651102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110090942|NCT03651102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110090943|NCT03651102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110090944|NCT03651102|Growth Substances|growth substances|mesh-ancestor
110090945|NCT03651102|Growth Inhibitors|growth inhibitors|mesh-ancestor
110090946|NCT03651102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110090947|NCT03651102|Antisickling Agents|antisickling agents|mesh-ancestor
110090948|NCT03651102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110090949|NCT03651102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110090950|NCT03651102|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110090951|NCT03649802|Vitamin D|vitamin d|mesh-list
110090952|NCT03649802|Ergocalciferols|ergocalciferols|mesh-list
110090953|NCT03649802|Cholecalciferol|cholecalciferol|mesh-list
110090954|NCT03649802|Vitamins|vitamins|mesh-list
110090955|NCT03649802|Micronutrients|micronutrients|mesh-ancestor
110090956|NCT03649802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110090957|NCT03649802|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110090958|NCT03649802|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110090959|NCT03573115|Adapalene|adapalene|mesh-list
110090960|NCT03573115|Benzoyl Peroxide|benzoyl peroxide|mesh-list
110090961|NCT03573115|Dermatologic Agents|dermatologic agents|mesh-ancestor
110090962|NCT03573115|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110090963|NCT03573115|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110090964|NCT03573115|Analgesics|analgesics|mesh-ancestor
110090965|NCT03573115|Sensory System Agents|sensory system agents|mesh-ancestor
110090966|NCT03573115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110090967|NCT03573115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110090968|NCT03573115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110090969|NCT03573115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110090970|NCT03569475|Milnacipran|milnacipran|mesh-list
110090972|NCT03569475|Levomilnacipran|levomilnacipran|mesh-list
110090973|NCT03569475|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110090974|NCT03569475|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110090975|NCT03569475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110090976|NCT03569475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110090977|NCT03569475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110090978|NCT03569475|Serotonin Agents|serotonin agents|mesh-ancestor
110090979|NCT03569475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110090980|NCT03569475|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110090981|NCT03569475|Antidepressive Agents|antidepressive agents|mesh-ancestor
110090982|NCT03569475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110090983|NCT03569475|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110090984|NCT03569475|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110090985|NCT03569475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110090986|NCT03569475|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110090987|NCT03569475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110090988|NCT03569475|Analgesics|analgesics|mesh-ancestor
110090989|NCT03569475|Sensory System Agents|sensory system agents|mesh-ancestor
110090990|NCT03569475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110090991|NCT03546556|Alovudine|alovudine|mesh-list
110090992|NCT03546556|Dideoxynucleosides|dideoxynucleosides|mesh-list
110090993|NCT03546556|Antiviral Agents|antiviral agents|mesh-ancestor
110090994|NCT03546556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110090995|NCT03546556|Antimetabolites|antimetabolites|mesh-ancestor
110090996|NCT03546556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110090997|NCT03546556|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110090998|NCT03546556|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110090999|NCT03546556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110091000|NCT03533712|Folic Acid|folic acid|mesh-list
110091001|NCT03533712|Hematinics|hematinics|mesh-ancestor
110091002|NCT03533712|Vitamin B Complex|vitamin b complex|mesh-ancestor
110091004|NCT03533712|Micronutrients|micronutrients|mesh-ancestor
110091005|NCT03533712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110091006|NCT03523520|Naltrexone|naltrexone|mesh-list
110091007|NCT03523520|Bromides|bromides|mesh-list
110091008|NCT03523520|Methylnaltrexone|methylnaltrexone|mesh-list
110091009|NCT03523520|Naloxegol|naloxegol|mesh-list
110091010|NCT03523520|Anticonvulsants|anticonvulsants|mesh-ancestor
110091011|NCT03523520|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110091012|NCT03523520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110091013|NCT03523520|Sensory System Agents|sensory system agents|mesh-ancestor
110091014|NCT03523520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110091015|NCT03523520|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110091016|NCT03518242|Cyclophosphamide|cyclophosphamide|mesh-list
110091018|NCT03518242|Methotrexate|methotrexate|mesh-list
110091019|NCT03518242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110091020|NCT03518242|Immunologic Factors|immunologic factors|mesh-ancestor
110091021|NCT03518242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110091022|NCT03518242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110091023|NCT03518242|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110091024|NCT03518242|Alkylating Agents|alkylating agents|mesh-ancestor
110091025|NCT03518242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110091026|NCT03518242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110091027|NCT03518242|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110091028|NCT03518242|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110091029|NCT03518242|Antimetabolites|antimetabolites|mesh-ancestor
110091030|NCT03518242|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110091031|NCT03518242|Abortifacient Agents|abortifacient agents|mesh-ancestor
110091032|NCT03518242|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110091033|NCT03518242|Dermatologic Agents|dermatologic agents|mesh-ancestor
110091034|NCT03518242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110091035|NCT03518242|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110091036|NCT03518242|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110091037|NCT03500549|Eculizumab|eculizumab|mesh-list
110091038|NCT03500549|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
110091039|NCT03500549|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110091040|NCT03500549|Immunologic Factors|immunologic factors|mesh-ancestor
110091041|NCT03500549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110091042|NCT03435185|Lidocaine|lidocaine|mesh-list
110091043|NCT03435185|Anesthetics, Local|anesthetics, local|mesh-ancestor
110091044|NCT03435185|Anesthetics|anesthetics|mesh-ancestor
110091045|NCT03435185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110091046|NCT03435185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110091047|NCT03435185|Sensory System Agents|sensory system agents|mesh-ancestor
110091048|NCT03435185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110091049|NCT03435185|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110091050|NCT03435185|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110091051|NCT03435185|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110091052|NCT03435185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110091053|NCT03435185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110091054|NCT03383380|Sirolimus|sirolimus|mesh-list
110091055|NCT03383380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110091056|NCT03383380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110091057|NCT03383380|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110091058|NCT03383380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110091059|NCT03383380|Antifungal Agents|antifungal agents|mesh-ancestor
110091060|NCT03383380|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110091061|NCT03383380|Immunologic Factors|immunologic factors|mesh-ancestor
110091062|NCT03383380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110091063|NCT03325439|Brivaracetam|brivaracetam|mesh-list
110091064|NCT03325439|Anticonvulsants|anticonvulsants|mesh-ancestor
110091065|NCT03242772|Amphetamine|amphetamine|mesh-list
110091066|NCT03242772|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110091067|NCT03242772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110091068|NCT03242772|Sympathomimetics|sympathomimetics|mesh-ancestor
110091069|NCT03242772|Autonomic Agents|autonomic agents|mesh-ancestor
110091070|NCT03242772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110091071|NCT03242772|Dopamine Agents|dopamine agents|mesh-ancestor
110091072|NCT03242772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110091073|NCT03242772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110091074|NCT03242772|Adrenergic Agents|adrenergic agents|mesh-ancestor
110091075|NCT03242772|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110091076|NCT03242772|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110091077|NCT03242772|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110091078|NCT03242772|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110091079|NCT03236311|Adenosine|adenosine|mesh-list
110091080|NCT03236311|Regadenoson|regadenoson|mesh-list
110091081|NCT03236311|Analgesics|analgesics|mesh-ancestor
110091082|NCT03236311|Sensory System Agents|sensory system agents|mesh-ancestor
110091083|NCT03236311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110091084|NCT03236311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110091085|NCT03236311|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110091086|NCT03236311|Vasodilator Agents|vasodilator agents|mesh-ancestor
110091087|NCT03236311|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
110091088|NCT03236311|Purinergic Agonists|purinergic agonists|mesh-ancestor
110091089|NCT03236311|Purinergic Agents|purinergic agents|mesh-ancestor
110091090|NCT03236311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110091091|NCT03236311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110091092|NCT03236311|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
110091093|NCT03234686|Deferiprone|deferiprone|mesh-list
110091094|NCT03234686|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110091095|NCT03234686|Chelating Agents|chelating agents|mesh-ancestor
110091096|NCT03234686|Sequestering Agents|sequestering agents|mesh-ancestor
110091097|NCT03234686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110091098|NCT03223974|Paclitaxel|paclitaxel|mesh-list
110091099|NCT03223974|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110091100|NCT03223974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110091101|NCT03223974|Tubulin Modulators|tubulin modulators|mesh-ancestor
110091102|NCT03223974|Antimitotic Agents|antimitotic agents|mesh-ancestor
110091103|NCT03223974|Mitosis Modulators|mitosis modulators|mesh-ancestor
110091104|NCT03223974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110091105|NCT03192046|Carbon Fiber|carbon fiber|mesh-list
110091106|NCT03192046|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110091107|NCT03192046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110091108|NCT03190369|Hylan|hylan|mesh-list
110091109|NCT03190369|Viscosupplements|viscosupplements|mesh-ancestor
110091110|NCT03190369|Protective Agents|protective agents|mesh-ancestor
110091111|NCT03190369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110091112|NCT05438342|Immunomodulating Agents|immunomodulating agents|mesh-list
110091113|NCT05438342|Immunologic Factors|immunologic factors|mesh-ancestor
110091114|NCT05438342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110091115|NCT05438108|Bevacizumab|bevacizumab|mesh-list
110091116|NCT05438108|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110091117|NCT05438108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110091118|NCT05438108|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110091119|NCT05438108|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110091120|NCT05438108|Growth Substances|growth substances|mesh-ancestor
110091121|NCT05438108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110091122|NCT05438108|Growth Inhibitors|growth inhibitors|mesh-ancestor
110091123|NCT05437783|Azithromycin|azithromycin|mesh-list
110091124|NCT05437783|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110091125|NCT05437783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110091126|NCT05437718|Ropivacaine|ropivacaine|mesh-list
110091127|NCT05437718|Anesthetics, Local|anesthetics, local|mesh-ancestor
110091128|NCT05437718|Anesthetics|anesthetics|mesh-ancestor
110091129|NCT05437718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110091130|NCT05437718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110091131|NCT05437718|Sensory System Agents|sensory system agents|mesh-ancestor
110091132|NCT05437718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110091134|NCT05437497|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110091135|NCT05437497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110091136|NCT05437497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110091137|NCT05437497|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110091138|NCT05437497|Anesthetics, General|anesthetics, general|mesh-ancestor
110091139|NCT05437497|Anesthetics|anesthetics|mesh-ancestor
110091140|NCT05437471|Letrozole|letrozole|mesh-list
110091141|NCT05437471|Dydrogesterone|dydrogesterone|mesh-list
110091142|NCT05437471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110091143|NCT05437471|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110091144|NCT05437471|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110091145|NCT05437471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110091146|NCT05437471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110091147|NCT05437471|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110091148|NCT05437471|Hormone Antagonists|hormone antagonists|mesh-ancestor
110091149|NCT05437471|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110091150|NCT05437471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110091151|NCT05437471|Progestins|progestins|mesh-ancestor
110091152|NCT05437471|Hormones|hormones|mesh-ancestor
110091153|NCT05437432|Lithium Carbonate|lithium carbonate|mesh-list
110091154|NCT05437432|Methamphetamine|methamphetamine|mesh-list
110091155|NCT05437432|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110091156|NCT05437432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110091157|NCT05437432|Sympathomimetics|sympathomimetics|mesh-ancestor
110091158|NCT05437432|Autonomic Agents|autonomic agents|mesh-ancestor
110091159|NCT05437432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110091160|NCT05437432|Dopamine Agents|dopamine agents|mesh-ancestor
110091161|NCT05437432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110091162|NCT05437432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110091163|NCT05437432|Adrenergic Agents|adrenergic agents|mesh-ancestor
110091164|NCT05437432|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110091165|NCT05437432|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110185798|NCT00275834|Zonisamide|zonisamide|mesh-list
110091166|NCT05437432|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110091167|NCT05437432|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110091168|NCT05437432|Antidepressive Agents|antidepressive agents|mesh-ancestor
110091169|NCT05437432|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110091170|NCT05437432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110091171|NCT05437432|Antimanic Agents|antimanic agents|mesh-ancestor
110091172|NCT05437432|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110091173|NCT05437432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110091174|NCT05437224|Ambrisentan|ambrisentan|mesh-list
110091175|NCT05437224|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110091176|NCT05436990|Pembrolizumab|pembrolizumab|mesh-list
110091177|NCT05436990|Vactosertib|vactosertib|mesh-list
110091178|NCT05436990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110091179|NCT05436990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110091180|NCT05436990|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110091181|NCT05436990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110091182|NCT05436990|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110091183|NCT05436990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110091184|NCT05426811|Raltitrexed|raltitrexed|mesh-list
110091185|NCT05426811|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110091186|NCT05426811|Antimetabolites|antimetabolites|mesh-ancestor
110091187|NCT05426811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110091188|NCT05426811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110091189|NCT05426811|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110091190|NCT05426811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110091192|NCT05357859|Cholecalciferol|cholecalciferol|mesh-list
110091193|NCT05357859|Vitamins|vitamins|mesh-ancestor
110091194|NCT05357859|Micronutrients|micronutrients|mesh-ancestor
110091195|NCT05357859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110091196|NCT05357859|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110091197|NCT05357859|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110091198|NCT04970381|Rivaroxaban|rivaroxaban|mesh-list
110091199|NCT04970381|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110091200|NCT04970381|Antithrombins|antithrombins|mesh-ancestor
110091201|NCT04970381|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110091202|NCT04970381|Protease Inhibitors|protease inhibitors|mesh-ancestor
110091203|NCT04970381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110091204|NCT04970381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110091205|NCT04970381|Anticoagulants|anticoagulants|mesh-ancestor
110091206|NCT04895046|Niraparib|niraparib|mesh-list
110091207|NCT04895046|Dostarlimab|dostarlimab|mesh-list
110091208|NCT04895046|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110091209|NCT04895046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110091210|NCT04895046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110091211|NCT04895046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110091212|NCT04765514|Temozolomide|temozolomide|mesh-list
110091213|NCT04765514|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110091214|NCT04765514|Alkylating Agents|alkylating agents|mesh-ancestor
110091215|NCT04765514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110091216|NCT04765514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110091217|NCT04590586|Thalidomide|thalidomide|mesh-list
110091218|NCT04590586|Apremilast|apremilast|mesh-list
110091219|NCT04590586|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110091220|NCT04590586|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110091221|NCT04590586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110091222|NCT04590586|Analgesics|analgesics|mesh-ancestor
110091223|NCT04590586|Sensory System Agents|sensory system agents|mesh-ancestor
110091224|NCT04590586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110091225|NCT04590586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110091226|NCT04590586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110091227|NCT04590586|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110091228|NCT04590586|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
110091229|NCT04590586|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110091230|NCT04590586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110091231|NCT04590586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110091232|NCT04590586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110091233|NCT04590586|Immunologic Factors|immunologic factors|mesh-ancestor
110091234|NCT04590586|Leprostatic Agents|leprostatic agents|mesh-ancestor
110091235|NCT04590586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110091236|NCT04590586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110091237|NCT04590586|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110091238|NCT04590586|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110091239|NCT04590586|Growth Substances|growth substances|mesh-ancestor
110091240|NCT04590586|Growth Inhibitors|growth inhibitors|mesh-ancestor
110091241|NCT04590586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110091242|NCT04312009|Losartan|losartan|mesh-list
110091243|NCT04312009|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110091244|NCT04312009|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110091245|NCT04312009|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110091246|NCT04312009|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110091247|NCT04312009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110091248|NCT04100096|Brexpiprazole|brexpiprazole|mesh-list
110091249|NCT04100096|Serotonin Agents|serotonin agents|mesh-ancestor
110091250|NCT04100096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110091251|NCT04100096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110091252|NCT04100096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110091253|NCT04100096|Dopamine Agonists|dopamine agonists|mesh-ancestor
110091254|NCT04100096|Dopamine Agents|dopamine agents|mesh-ancestor
110091255|NCT03850483|PF-06700841|pf-06700841|mesh-list
110091256|NCT03850483|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110091257|NCT03850483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110091258|NCT03850483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110091259|NCT03563742|Tenofovir|tenofovir|mesh-list
110091260|NCT03563742|Lamivudine|lamivudine|mesh-list
110091261|NCT03563742|Rilpivirine|rilpivirine|mesh-list
110091262|NCT03563742|Antiviral Agents|antiviral agents|mesh-ancestor
110091263|NCT03563742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110091264|NCT03563742|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110091265|NCT03563742|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110091266|NCT03563742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110091267|NCT03563742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110091268|NCT03563742|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110091269|NCT03563742|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110091270|NCT03473925|Pembrolizumab|pembrolizumab|mesh-list
110091271|NCT03473925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110091272|NCT03473925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110091273|NCT03473925|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110091274|NCT03473925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110091275|NCT03424122|Rituximab|rituximab|mesh-list
110091276|NCT03424122|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110091277|NCT03424122|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110091278|NCT03424122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110091279|NCT03424122|Immunologic Factors|immunologic factors|mesh-ancestor
110091280|NCT03424122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110091281|NCT03424122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110091282|NCT03424122|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110091283|NCT03424122|Alkylating Agents|alkylating agents|mesh-ancestor
110091284|NCT03424122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110091285|NCT03230097|BI 409306|bi 409306|mesh-list
110091286|NCT03230097|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110091287|NCT03230097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110091288|NCT03230097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110091289|NCT02968940|Avelumab|avelumab|mesh-list
110091290|NCT02968940|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110091291|NCT02968940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110091292|NCT02663908|Leuprolide|leuprolide|mesh-list
110091293|NCT02663908|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110091294|NCT02663908|Fertility Agents|fertility agents|mesh-ancestor
110091295|NCT02663908|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110091296|NCT02663908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110091297|NCT02663908|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110185813|NCT00397176|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110091298|NCT02663908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110091299|NCT02333292|Ritonavir|ritonavir|mesh-list
110091300|NCT02333292|Sofosbuvir|sofosbuvir|mesh-list
110091301|NCT02333292|Grazoprevir|grazoprevir|mesh-list
110091302|NCT02333292|Ledipasvir|ledipasvir|mesh-list
110091303|NCT02333292|Velpatasvir|velpatasvir|mesh-list
110091304|NCT02333292|Simeprevir|simeprevir|mesh-list
110091305|NCT02333292|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110091306|NCT02333292|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110091307|NCT02333292|Protease Inhibitors|protease inhibitors|mesh-ancestor
110091308|NCT02333292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110091309|NCT02333292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110091310|NCT02333292|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110091311|NCT02333292|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110091312|NCT02333292|Antiviral Agents|antiviral agents|mesh-ancestor
110091313|NCT02333292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110091314|NCT02333292|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110091315|NCT02333292|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110091316|NCT02203773|Posaconazole|posaconazole|mesh-list
110091317|NCT02203773|Azacitidine|azacitidine|mesh-list
110091318|NCT02203773|Decitabine|decitabine|mesh-list
110091319|NCT02203773|Venetoclax|venetoclax|mesh-list
110091320|NCT02203773|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110091321|NCT02203773|Antimetabolites|antimetabolites|mesh-ancestor
110091322|NCT02203773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110091323|NCT02203773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110091324|NCT02203773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110091325|NCT02203773|Antifungal Agents|antifungal agents|mesh-ancestor
110091326|NCT02203773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110091327|NCT02203773|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
110091328|NCT02203773|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110091329|NCT02203773|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110091330|NCT02203773|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110091331|NCT02203773|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110091332|NCT02203773|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110091333|NCT02203773|Hormone Antagonists|hormone antagonists|mesh-ancestor
110091334|NCT02203773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110091335|NCT02203773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110091336|NCT02175030|Copper|copper|mesh-list
110091337|NCT02175030|Levonorgestrel|levonorgestrel|mesh-list
110091338|NCT02175030|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110091339|NCT02175030|Contraceptive Agents|contraceptive agents|mesh-ancestor
110091340|NCT02175030|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110091341|NCT02175030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110091342|NCT02175030|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110091343|NCT02175030|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110091344|NCT02175030|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110091345|NCT02175030|Trace Elements|trace elements|mesh-ancestor
110091346|NCT02175030|Micronutrients|micronutrients|mesh-ancestor
110091347|NCT01555541|Cytarabine|cytarabine|mesh-list
110091348|NCT01555541|Etoposide|etoposide|mesh-list
110091349|NCT01555541|Ofatumumab|ofatumumab|mesh-list
110091350|NCT01555541|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110091351|NCT01555541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110091352|NCT01555541|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110091353|NCT01555541|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110091354|NCT01555541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110091355|NCT01555541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110091356|NCT01555541|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110091357|NCT01555541|Antimetabolites|antimetabolites|mesh-ancestor
110091358|NCT01555541|Antiviral Agents|antiviral agents|mesh-ancestor
110091359|NCT01555541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110091360|NCT01555541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110091361|NCT01555541|Immunologic Factors|immunologic factors|mesh-ancestor
110091362|NCT01555541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110091363|NCT01398852|Riboflavin|riboflavin|mesh-list
110091364|NCT01398852|Vitamin B Complex|vitamin b complex|mesh-ancestor
110091365|NCT01398852|Vitamins|vitamins|mesh-ancestor
110091366|NCT01398852|Micronutrients|micronutrients|mesh-ancestor
110091367|NCT01398852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110091368|NCT01398852|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110091369|NCT01398852|Dermatologic Agents|dermatologic agents|mesh-ancestor
110091370|NCT01398839|Riboflavin|riboflavin|mesh-list
110091371|NCT01398839|Vitamin B Complex|vitamin b complex|mesh-ancestor
110091373|NCT01398839|Micronutrients|micronutrients|mesh-ancestor
110091374|NCT01398839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110091375|NCT01398839|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110091376|NCT01398839|Dermatologic Agents|dermatologic agents|mesh-ancestor
110091377|NCT00496795|Docetaxel|docetaxel|mesh-list
110091378|NCT00496795|Epirubicin|epirubicin|mesh-list
110091379|NCT00496795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110091380|NCT00496795|Tubulin Modulators|tubulin modulators|mesh-ancestor
110091381|NCT00496795|Antimitotic Agents|antimitotic agents|mesh-ancestor
110091382|NCT00496795|Mitosis Modulators|mitosis modulators|mesh-ancestor
110091383|NCT00496795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110091384|NCT00496795|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110091385|NCT00496795|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110091386|NCT00496795|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110091387|NCT00496795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110091388|NCT03164889|Entecavir|entecavir|mesh-list
110091389|NCT03164889|Molgramostim|molgramostim|mesh-list
110091390|NCT03164889|Sargramostim|sargramostim|mesh-list
110091391|NCT03164889|Antiviral Agents|antiviral agents|mesh-ancestor
110091392|NCT03164889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110091393|NCT03164889|Immunologic Factors|immunologic factors|mesh-ancestor
110091394|NCT03164889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110091395|NCT03164889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110091396|NCT03133260|Aspirin|aspirin|mesh-list
110091397|NCT03133260|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110091398|NCT03133260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110091399|NCT03133260|Analgesics|analgesics|mesh-ancestor
110091400|NCT03133260|Sensory System Agents|sensory system agents|mesh-ancestor
110091401|NCT03133260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110091402|NCT03133260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110091404|NCT03133260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110091405|NCT03133260|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110091406|NCT03133260|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110091407|NCT03133260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110091408|NCT03133260|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110091409|NCT03133260|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110091411|NCT03133260|Antipyretics|antipyretics|mesh-ancestor
110091412|NCT03096834|Erenumab|erenumab|mesh-list
110091413|NCT03096834|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
110091414|NCT03096834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110091415|NCT03096834|Analgesics|analgesics|mesh-ancestor
110091416|NCT03096834|Sensory System Agents|sensory system agents|mesh-ancestor
110091417|NCT03096834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110091418|NCT03096834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110091419|NCT03056014|Acetylcysteine|acetylcysteine|mesh-list
110091420|NCT03056014|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110091421|NCT03056014|Antiviral Agents|antiviral agents|mesh-ancestor
110091422|NCT03056014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110091423|NCT03056014|Expectorants|expectorants|mesh-ancestor
110091424|NCT03056014|Respiratory System Agents|respiratory system agents|mesh-ancestor
110091425|NCT03056014|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110091426|NCT03056014|Antioxidants|antioxidants|mesh-ancestor
110091427|NCT03056014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110091428|NCT03056014|Protective Agents|protective agents|mesh-ancestor
110091429|NCT03056014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110091430|NCT03056014|Antidotes|antidotes|mesh-ancestor
110091431|NCT03126812|Paclitaxel|paclitaxel|mesh-list
110091432|NCT03126812|Carboplatin|carboplatin|mesh-list
110091433|NCT03126812|Pembrolizumab|pembrolizumab|mesh-list
110091434|NCT03126812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110091435|NCT03126812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110091436|NCT03126812|Tubulin Modulators|tubulin modulators|mesh-ancestor
110091437|NCT03126812|Antimitotic Agents|antimitotic agents|mesh-ancestor
110091438|NCT03126812|Mitosis Modulators|mitosis modulators|mesh-ancestor
110091439|NCT03126812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110091440|NCT03126812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110091441|NCT03126812|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110091442|NCT03026972|Vaccines|vaccines|mesh-list
110091443|NCT03026972|Immunologic Factors|immunologic factors|mesh-ancestor
110091444|NCT03026972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110091445|NCT03012815|Chlordiazepoxide|chlordiazepoxide|mesh-list
110091446|NCT03012815|Gabapentin|gabapentin|mesh-list
110091447|NCT03012815|Lorazepam|lorazepam|mesh-list
110091448|NCT03012815|Valproic Acid|valproic acid|mesh-list
110091449|NCT03012815|Analgesics|analgesics|mesh-ancestor
110091450|NCT03012815|Sensory System Agents|sensory system agents|mesh-ancestor
110091452|NCT03012815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110091453|NCT03012815|Anticonvulsants|anticonvulsants|mesh-ancestor
110091454|NCT03012815|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110091455|NCT03012815|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110091456|NCT03012815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110091457|NCT03012815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110091458|NCT03012815|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110091459|NCT03012815|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110091460|NCT03012815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110091461|NCT03012815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110091462|NCT03012815|Antimanic Agents|antimanic agents|mesh-ancestor
110091463|NCT03012815|Antiemetics|antiemetics|mesh-ancestor
110091464|NCT03012815|Autonomic Agents|autonomic agents|mesh-ancestor
110091465|NCT03012815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110091466|NCT03012815|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110091467|NCT03012815|GABA Modulators|gaba modulators|mesh-ancestor
110091468|NCT03012815|GABA Agents|gaba agents|mesh-ancestor
110091469|NCT03012815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110091470|NCT03012815|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110091471|NCT03001011|Sevelamer|sevelamer|mesh-list
110091472|NCT03001011|Chelating Agents|chelating agents|mesh-ancestor
110091473|NCT03001011|Sequestering Agents|sequestering agents|mesh-ancestor
110091474|NCT03001011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110091475|NCT02993757|Vaccines|vaccines|mesh-list
110091476|NCT02993757|Immunologic Factors|immunologic factors|mesh-ancestor
110091477|NCT02993757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110091478|NCT02979535|Vaccines|vaccines|mesh-list
110091479|NCT02979535|Immunologic Factors|immunologic factors|mesh-ancestor
110091480|NCT02979535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110091481|NCT02978716|Carboplatin|carboplatin|mesh-list
110091482|NCT02978716|Gemcitabine|gemcitabine|mesh-list
110091483|NCT02978716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110091484|NCT02978716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110091485|NCT02978716|Antimetabolites|antimetabolites|mesh-ancestor
110091486|NCT02978716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110091487|NCT02973321|Metformin|metformin|mesh-list
110091488|NCT02973321|Liraglutide|liraglutide|mesh-list
110091489|NCT02973321|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110091490|NCT02973321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110091491|NCT02973321|Incretins|incretins|mesh-ancestor
110091492|NCT02973321|Hormones|hormones|mesh-ancestor
110091493|NCT02973321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110091494|NCT02967250|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
110091495|NCT02967250|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
110091496|NCT02967250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110091497|NCT02943785|Edoxaban|edoxaban|mesh-list
110091498|NCT02943785|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110091499|NCT02943785|Antithrombins|antithrombins|mesh-ancestor
110091500|NCT02943785|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110091501|NCT02943785|Protease Inhibitors|protease inhibitors|mesh-ancestor
110091502|NCT02943785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110091503|NCT02943785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110091504|NCT02943785|Anticoagulants|anticoagulants|mesh-ancestor
110091505|NCT02908334|Sertraline|sertraline|mesh-list
110091506|NCT02908334|Antidepressive Agents|antidepressive agents|mesh-ancestor
110091507|NCT02908334|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110091508|NCT02908334|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110091509|NCT02908334|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110091510|NCT02908334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110091511|NCT02908334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110091512|NCT02908334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110091513|NCT02908334|Serotonin Agents|serotonin agents|mesh-ancestor
110091514|NCT02908334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110091515|NCT02886286|Fentanyl|fentanyl|mesh-list
110091516|NCT02886286|Morphine|morphine|mesh-list
110091517|NCT02886286|Hydromorphone|hydromorphone|mesh-list
110091518|NCT02886286|Bupivacaine|bupivacaine|mesh-list
110091519|NCT02886286|Anesthetics, Local|anesthetics, local|mesh-ancestor
110091520|NCT02886286|Anesthetics|anesthetics|mesh-ancestor
110091521|NCT02886286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110091522|NCT02886286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110091523|NCT02886286|Sensory System Agents|sensory system agents|mesh-ancestor
110091524|NCT02886286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110091525|NCT02886286|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110091526|NCT02886286|Narcotics|narcotics|mesh-ancestor
110091527|NCT02886286|Analgesics|analgesics|mesh-ancestor
110091528|NCT02886286|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110091529|NCT02886286|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110091530|NCT02886286|Anesthetics, General|anesthetics, general|mesh-ancestor
110091531|NCT02865187|Vitamin D|vitamin d|mesh-list
110091532|NCT02865187|Vitamins|vitamins|mesh-ancestor
110091533|NCT02865187|Micronutrients|micronutrients|mesh-ancestor
110091534|NCT02865187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110091535|NCT02865187|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110091536|NCT02787551|Metformin|metformin|mesh-list
110091537|NCT02787551|Insulin Glargine|insulin glargine|mesh-list
110091538|NCT02787551|Pioglitazone|pioglitazone|mesh-list
110091539|NCT02787551|Liraglutide|liraglutide|mesh-list
110091540|NCT02787551|Exenatide|exenatide|mesh-list
110091541|NCT02787551|Dulaglutide|dulaglutide|mesh-list
110091542|NCT02787551|Lixisenatide|lixisenatide|mesh-list
110091543|NCT02787551|Hypoglycemic Agents|hypoglycemic agents|mesh-list
110091544|NCT02787551|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
110091545|NCT02787551|rGLP-1 protein|rglp-1 protein|mesh-list
110091546|NCT02787551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110091547|NCT02787551|Incretins|incretins|mesh-ancestor
110091548|NCT02787551|Hormones|hormones|mesh-ancestor
110091549|NCT02787551|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110091550|NCT02787551|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110091551|NCT02787551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110091552|NCT02735044|Insulin|insulin|mesh-list
110091553|NCT02735044|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110091554|NCT02735044|Insulin Glargine|insulin glargine|mesh-list
110091555|NCT02735044|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110091556|NCT02735044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110091557|NCT02692651|Vancomycin|vancomycin|mesh-list
110091558|NCT02692651|Fidaxomicin|fidaxomicin|mesh-list
110091559|NCT02692651|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110091560|NCT02692651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110091561|NCT02674061|Pembrolizumab|pembrolizumab|mesh-list
110091562|NCT02674061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110091563|NCT02674061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110091564|NCT02674061|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110091565|NCT02674061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110091566|NCT02654314|Melatonin|melatonin|mesh-list
110091567|NCT02654314|Antioxidants|antioxidants|mesh-ancestor
110091568|NCT02654314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110091569|NCT02654314|Protective Agents|protective agents|mesh-ancestor
110091570|NCT02654314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110091571|NCT02654314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110091572|NCT02626962|Nivolumab|nivolumab|mesh-list
110091573|NCT02626962|Ipilimumab|ipilimumab|mesh-list
110091574|NCT02626962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110091575|NCT02626962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110091576|NCT02626962|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110091577|NCT02626962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110091578|NCT02623998|Metformin|metformin|mesh-list
110091579|NCT02623998|Insulin Glargine|insulin glargine|mesh-list
110091580|NCT02623998|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110091581|NCT02623998|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110091582|NCT02623998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110091583|NCT02623998|Incretins|incretins|mesh-ancestor
110091584|NCT02623998|Hormones|hormones|mesh-ancestor
110091585|NCT02623998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110091586|NCT02623998|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110091587|NCT02623998|Protease Inhibitors|protease inhibitors|mesh-ancestor
110091588|NCT02623998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110091589|NCT02623998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110091590|NCT02608684|Gemcitabine|gemcitabine|mesh-list
110091591|NCT02608684|Pembrolizumab|pembrolizumab|mesh-list
110091592|NCT02608684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110091593|NCT02608684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110091594|NCT02608684|Antimetabolites|antimetabolites|mesh-ancestor
110091595|NCT02608684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110091596|NCT02608684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110091597|NCT02608684|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110091598|NCT02587520|Vaccines|vaccines|mesh-list
110091599|NCT02587520|Immunologic Factors|immunologic factors|mesh-ancestor
110091600|NCT02587520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110091601|NCT02584829|Interferons|interferons|mesh-list
110091602|NCT02584829|Interferon-beta|interferon-beta|mesh-list
110091603|NCT02584829|Avelumab|avelumab|mesh-list
110091604|NCT02584829|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110091605|NCT02584829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110091606|NCT02584829|Antiviral Agents|antiviral agents|mesh-ancestor
110091607|NCT02584829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110091608|NCT02584829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110091609|NCT02584829|Immunologic Factors|immunologic factors|mesh-ancestor
110091610|NCT02584829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110091611|NCT02557321|Pembrolizumab|pembrolizumab|mesh-list
110091612|NCT02557321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110091613|NCT02557321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110091614|NCT02557321|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110091615|NCT02557321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110091616|NCT02512172|Pembrolizumab|pembrolizumab|mesh-list
110091617|NCT02512172|Azacitidine|azacitidine|mesh-list
110091618|NCT02512172|Romidepsin|romidepsin|mesh-list
110091620|NCT02512172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110091621|NCT02512172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110091622|NCT02512172|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110091623|NCT02512172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110091624|NCT02512172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110091625|NCT02512172|Antimetabolites|antimetabolites|mesh-ancestor
110091626|NCT02512172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110091627|NCT02512172|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110091628|NCT02512172|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110091629|NCT02499367|Cyclophosphamide|cyclophosphamide|mesh-list
110091630|NCT02499367|Doxorubicin|doxorubicin|mesh-list
110091631|NCT02499367|Nivolumab|nivolumab|mesh-list
110091632|NCT02499367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110091633|NCT02499367|Immunologic Factors|immunologic factors|mesh-ancestor
110091634|NCT02499367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110091635|NCT02499367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110091636|NCT02499367|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110091638|NCT02499367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110091639|NCT02499367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110091640|NCT02499367|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110091641|NCT02499367|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110091642|NCT02499367|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110091643|NCT02499367|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110091644|NCT02499367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110091645|NCT02499367|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110091646|NCT02499367|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110091647|NCT02497612|Artefenomel|artefenomel|mesh-list
110091648|NCT02497612|Ferroquine|ferroquine|mesh-list
110091649|NCT02497612|Antimalarials|antimalarials|mesh-ancestor
110091650|NCT02497612|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110091651|NCT02497612|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110091652|NCT02497612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110091653|NCT02497131|Brentuximab Vedotin|brentuximab vedotin|mesh-list
110185848|NCT00275600|Protective Agents|protective agents|mesh-ancestor
110091654|NCT02497131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110091655|NCT02497131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110091656|NCT02497131|Immunotoxins|immunotoxins|mesh-ancestor
110091657|NCT02497131|Immunoconjugates|immunoconjugates|mesh-ancestor
110091658|NCT02497131|Immunologic Factors|immunologic factors|mesh-ancestor
110091659|NCT02497131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110091660|NCT02491333|Metformin|metformin|mesh-list
110091661|NCT02491333|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110091662|NCT02491333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110091663|NCT02469987|Bevacizumab|bevacizumab|mesh-list
110091664|NCT02469987|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110091665|NCT02469987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110091666|NCT02469987|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110091667|NCT02469987|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110091668|NCT02469987|Growth Substances|growth substances|mesh-ancestor
110091669|NCT02469987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110091670|NCT02469987|Growth Inhibitors|growth inhibitors|mesh-ancestor
110091671|NCT02439307|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110091672|NCT02439307|Rifaximin|rifaximin|mesh-list
110091673|NCT02439307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110091674|NCT02439307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110091675|NCT02381652|Triamcinolone|triamcinolone|mesh-list
110091676|NCT02381652|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110091677|NCT02381652|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110091678|NCT02381652|Hyaluronic Acid|hyaluronic acid|mesh-list
110091679|NCT02381652|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110091680|NCT02381652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110091681|NCT02381652|Glucocorticoids|glucocorticoids|mesh-ancestor
110091682|NCT02381652|Hormones|hormones|mesh-ancestor
110091683|NCT02381652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110091684|NCT02381652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110091685|NCT02381652|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110091686|NCT02381652|Immunologic Factors|immunologic factors|mesh-ancestor
110091687|NCT02381652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110091688|NCT02381652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110091689|NCT02381652|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110091690|NCT02381652|Viscosupplements|viscosupplements|mesh-ancestor
110091691|NCT02381652|Protective Agents|protective agents|mesh-ancestor
110091692|NCT02368301|Dexamethasone|dexamethasone|mesh-list
110091693|NCT02368301|Lenalidomide|lenalidomide|mesh-list
110091694|NCT02368301|Elotuzumab|elotuzumab|mesh-list
110091695|NCT02368301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110091696|NCT02368301|Antiemetics|antiemetics|mesh-ancestor
110091697|NCT02368301|Autonomic Agents|autonomic agents|mesh-ancestor
110091698|NCT02368301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110091699|NCT02368301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110091700|NCT02368301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110091701|NCT02368301|Glucocorticoids|glucocorticoids|mesh-ancestor
110091702|NCT02368301|Hormones|hormones|mesh-ancestor
110091703|NCT02368301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110091704|NCT02368301|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110091705|NCT02368301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110091706|NCT02368301|Immunologic Factors|immunologic factors|mesh-ancestor
110091707|NCT02368301|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110091708|NCT02368301|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110091709|NCT02368301|Growth Substances|growth substances|mesh-ancestor
110091710|NCT02368301|Growth Inhibitors|growth inhibitors|mesh-ancestor
110091711|NCT02367794|Paclitaxel|paclitaxel|mesh-list
110091712|NCT02367794|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110091713|NCT02367794|Carboplatin|carboplatin|mesh-list
110091714|NCT02367794|Atezolizumab|atezolizumab|mesh-list
110091715|NCT02367794|Antibodies|antibodies|mesh-list
110091716|NCT02367794|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110091717|NCT02367794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110091718|NCT02367794|Tubulin Modulators|tubulin modulators|mesh-ancestor
110091719|NCT02367794|Antimitotic Agents|antimitotic agents|mesh-ancestor
110091720|NCT02367794|Mitosis Modulators|mitosis modulators|mesh-ancestor
110091721|NCT02367794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110185849|NCT00275522|Sirolimus|sirolimus|mesh-list
110091722|NCT02367794|Immunologic Factors|immunologic factors|mesh-ancestor
110091723|NCT02367794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110091724|NCT02367794|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110091725|NCT02367794|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110091726|NCT02363998|Lofexidine|lofexidine|mesh-list
110091727|NCT02363998|Clonidine|clonidine|mesh-list
110091728|NCT02363998|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110091729|NCT02363998|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110091730|NCT02363998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110091731|NCT02363998|Sensory System Agents|sensory system agents|mesh-ancestor
110091732|NCT02363998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110091733|NCT02363998|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110091734|NCT02363998|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110091735|NCT02363998|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110091736|NCT02363998|Adrenergic Agents|adrenergic agents|mesh-ancestor
110091737|NCT02363998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110091738|NCT02363998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110091739|NCT02363998|Analgesics|analgesics|mesh-ancestor
110091740|NCT02363998|Sympatholytics|sympatholytics|mesh-ancestor
110091741|NCT02363998|Autonomic Agents|autonomic agents|mesh-ancestor
110091742|NCT02325466|Aspirin|aspirin|mesh-list
110091743|NCT02325466|Ticagrelor|ticagrelor|mesh-list
110091744|NCT02325466|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110091745|NCT02325466|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110091746|NCT02325466|Analgesics|analgesics|mesh-ancestor
110091747|NCT02325466|Sensory System Agents|sensory system agents|mesh-ancestor
110091748|NCT02325466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110091749|NCT02325466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110091750|NCT02325466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110091751|NCT02325466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110091752|NCT02325466|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110091753|NCT02325466|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110091754|NCT02325466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110091755|NCT02325466|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110091756|NCT02325466|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110091757|NCT02325466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110091758|NCT02325466|Antipyretics|antipyretics|mesh-ancestor
110091759|NCT02325466|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110091760|NCT02325466|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110091761|NCT02325466|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110091762|NCT02325466|Purinergic Agents|purinergic agents|mesh-ancestor
110091763|NCT02325466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110091764|NCT02323100|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
110091766|NCT02323100|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
110091767|NCT02323100|Protective Agents|protective agents|mesh-ancestor
110091768|NCT02323100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110091769|NCT02323100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110091770|NCT02322710|Petrolatum|petrolatum|mesh-list
110091771|NCT02322710|Emollients|emollients|mesh-ancestor
110091772|NCT02322710|Dermatologic Agents|dermatologic agents|mesh-ancestor
110091773|NCT02283281|Dronabinol|dronabinol|mesh-list
110091774|NCT02283281|Hallucinogens|hallucinogens|mesh-ancestor
110091775|NCT02283281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110091776|NCT02283281|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110091777|NCT02283281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110091778|NCT02283281|Analgesics|analgesics|mesh-ancestor
110091779|NCT02283281|Sensory System Agents|sensory system agents|mesh-ancestor
110091780|NCT02283281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110091781|NCT02283281|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
110091782|NCT02283281|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110091783|NCT02283281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110091784|NCT02283281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110091785|NCT02283281|Hormones|hormones|mesh-ancestor
110091786|NCT02283281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110091787|NCT02162563|Leucovorin|leucovorin|mesh-list
110091788|NCT02162563|Bevacizumab|bevacizumab|mesh-list
110091789|NCT02162563|Panitumumab|panitumumab|mesh-list
110091790|NCT02162563|Fluorouracil|fluorouracil|mesh-list
110091791|NCT02162563|Oxaliplatin|oxaliplatin|mesh-list
110091793|NCT02162563|Levoleucovorin|levoleucovorin|mesh-list
110091794|NCT02162563|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110091795|NCT02162563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110091796|NCT02162563|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110091797|NCT02162563|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110091798|NCT02162563|Growth Substances|growth substances|mesh-ancestor
110091799|NCT02162563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110091800|NCT02162563|Growth Inhibitors|growth inhibitors|mesh-ancestor
110091801|NCT02162563|Antimetabolites|antimetabolites|mesh-ancestor
110091802|NCT02162563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110091803|NCT02162563|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110091804|NCT02162563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110091805|NCT02162563|Immunologic Factors|immunologic factors|mesh-ancestor
110091806|NCT02162563|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110091807|NCT02162563|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110091808|NCT02162563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110091809|NCT02162563|Antidotes|antidotes|mesh-ancestor
110091810|NCT02162563|Protective Agents|protective agents|mesh-ancestor
110091811|NCT02162563|Vitamin B Complex|vitamin b complex|mesh-ancestor
110091812|NCT02162563|Vitamins|vitamins|mesh-ancestor
110091813|NCT02162563|Micronutrients|micronutrients|mesh-ancestor
110091814|NCT02127086|Analgesics|analgesics|mesh-list
110091815|NCT02127086|Sensory System Agents|sensory system agents|mesh-ancestor
110091816|NCT02127086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110091817|NCT02127086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110091818|NCT02120079|Loteprednol Etabonate|loteprednol etabonate|mesh-list
110091819|NCT02120079|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110091820|NCT02120079|Lubricant Eye Drops|lubricant eye drops|mesh-list
110091821|NCT02120079|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110091822|NCT02120079|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110091823|NCT02106195|Belumosudil|belumosudil|mesh-list
110091824|NCT02106195|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110091825|NCT02106195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110091826|NCT02106195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110091827|NCT02075177|Ketoconazole|ketoconazole|mesh-list
110091828|NCT02075177|Fenretinide|fenretinide|mesh-list
110091829|NCT02075177|Antifungal Agents|antifungal agents|mesh-ancestor
110091830|NCT02075177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110091831|NCT02075177|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110091832|NCT02075177|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110091833|NCT02075177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110091834|NCT02075177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110091835|NCT02075177|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110091836|NCT02075177|Hormone Antagonists|hormone antagonists|mesh-ancestor
110091837|NCT02075177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110091838|NCT02075177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110091839|NCT02075177|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110091840|NCT02075177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110091841|NCT02075177|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110091842|NCT02075177|Protective Agents|protective agents|mesh-ancestor
110091843|NCT02050919|Sorafenib|sorafenib|mesh-list
110091844|NCT02050919|Epirubicin|epirubicin|mesh-list
110091845|NCT02050919|Ifosfamide|ifosfamide|mesh-list
110091846|NCT02050919|Isophosphamide mustard|isophosphamide mustard|mesh-list
110091847|NCT02050919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110091848|NCT02050919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110091849|NCT02050919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110091850|NCT02050919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110091851|NCT02050919|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110091852|NCT02050919|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110091853|NCT02050919|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110091854|NCT02050919|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110091855|NCT02050919|Alkylating Agents|alkylating agents|mesh-ancestor
110091856|NCT02040857|Tamoxifen|tamoxifen|mesh-list
110091857|NCT02040857|Letrozole|letrozole|mesh-list
110091858|NCT02040857|Palbociclib|palbociclib|mesh-list
110091859|NCT02040857|Anastrozole|anastrozole|mesh-list
110091861|NCT02040857|Aromatase Inhibitors|aromatase inhibitors|mesh-list
110091862|NCT02040857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110091863|NCT02040857|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110091864|NCT02040857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110091865|NCT02040857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110091866|NCT02040857|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110091867|NCT02040857|Hormone Antagonists|hormone antagonists|mesh-ancestor
110091868|NCT02040857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110091869|NCT02040857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110091870|NCT02040857|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110091871|NCT02040857|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110091872|NCT02040857|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110091873|NCT02040857|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110091874|NCT02040857|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110091875|NCT01997463|Albuterol|albuterol|mesh-list
110091876|NCT01997463|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110091877|NCT01997463|Autonomic Agents|autonomic agents|mesh-ancestor
110091878|NCT01997463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110091879|NCT01997463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110091880|NCT01997463|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110091881|NCT01997463|Respiratory System Agents|respiratory system agents|mesh-ancestor
110091882|NCT01997463|Tocolytic Agents|tocolytic agents|mesh-ancestor
110091883|NCT01997463|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110091884|NCT01997463|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110091885|NCT01997463|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110091886|NCT01997463|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110091887|NCT01997463|Adrenergic Agents|adrenergic agents|mesh-ancestor
110091888|NCT01997463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110091889|NCT01997463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110091890|NCT01976754|Dexmedetomidine|dexmedetomidine|mesh-list
110091891|NCT01976754|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110091892|NCT01976754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110091893|NCT01976754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110091894|NCT01976754|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110091895|NCT01976754|Analgesics|analgesics|mesh-ancestor
110091896|NCT01976754|Sensory System Agents|sensory system agents|mesh-ancestor
110091897|NCT01976754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110091898|NCT01976754|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110091899|NCT01976754|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110091900|NCT01976754|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110091901|NCT01976754|Adrenergic Agents|adrenergic agents|mesh-ancestor
110091902|NCT01976754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110091903|NCT01976754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110091904|NCT01943825|Vaccines|vaccines|mesh-list
110091905|NCT01943825|Immunologic Factors|immunologic factors|mesh-ancestor
110091906|NCT01943825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110091907|NCT01916317|Lidocaine|lidocaine|mesh-list
110091908|NCT01916317|Anesthetics, Local|anesthetics, local|mesh-ancestor
110091909|NCT01916317|Anesthetics|anesthetics|mesh-ancestor
110091910|NCT01916317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110091911|NCT01916317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110091912|NCT01916317|Sensory System Agents|sensory system agents|mesh-ancestor
110091913|NCT01916317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110091914|NCT01916317|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110091915|NCT01916317|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110091916|NCT01916317|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110091917|NCT01916317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110091918|NCT01916317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110091919|NCT01863186|Lofexidine|lofexidine|mesh-list
110091920|NCT01863186|Clonidine|clonidine|mesh-list
110091921|NCT01863186|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110091922|NCT01863186|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110091923|NCT01863186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110091924|NCT01863186|Sensory System Agents|sensory system agents|mesh-ancestor
110091925|NCT01863186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110091926|NCT01863186|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110091927|NCT01863186|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110091928|NCT01863186|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110091929|NCT01863186|Adrenergic Agents|adrenergic agents|mesh-ancestor
110091930|NCT01863186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110091931|NCT01863186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110091932|NCT01863186|Analgesics|analgesics|mesh-ancestor
110091933|NCT01863186|Sympatholytics|sympatholytics|mesh-ancestor
110091934|NCT01863186|Autonomic Agents|autonomic agents|mesh-ancestor
110091935|NCT01828840|Fentanyl|fentanyl|mesh-list
110091936|NCT01828840|Morphine|morphine|mesh-list
110091937|NCT01828840|Methadone|methadone|mesh-list
110091938|NCT01828840|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110091939|NCT01828840|Narcotics|narcotics|mesh-ancestor
110091940|NCT01828840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110091941|NCT01828840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110091942|NCT01828840|Analgesics|analgesics|mesh-ancestor
110091943|NCT01828840|Sensory System Agents|sensory system agents|mesh-ancestor
110091944|NCT01828840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110091945|NCT01828840|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110091946|NCT01828840|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110091947|NCT01828840|Anesthetics, General|anesthetics, general|mesh-ancestor
110091948|NCT01828840|Anesthetics|anesthetics|mesh-ancestor
110091949|NCT01828840|Antitussive Agents|antitussive agents|mesh-ancestor
110091950|NCT01828840|Respiratory System Agents|respiratory system agents|mesh-ancestor
110091951|NCT01817426|Infliximab|infliximab|mesh-list
110091952|NCT01817426|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110091953|NCT01817426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110091954|NCT01817426|Dermatologic Agents|dermatologic agents|mesh-ancestor
110091955|NCT01817426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110091956|NCT01817426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110091957|NCT01741103|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110091958|NCT01741103|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110091959|NCT01741103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110091960|NCT01741103|Incretins|incretins|mesh-ancestor
110091961|NCT01741103|Hormones|hormones|mesh-ancestor
110091962|NCT01741103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110091963|NCT01741103|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110091964|NCT01741103|Protease Inhibitors|protease inhibitors|mesh-ancestor
110091965|NCT01741103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110091966|NCT01741103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110091967|NCT01722331|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110091968|NCT01722331|Immunologic Factors|immunologic factors|mesh-ancestor
110091969|NCT01722331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110091970|NCT01630590|Androgens|androgens|mesh-list
110091971|NCT01630590|Hormones|hormones|mesh-ancestor
110091972|NCT01630590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110091973|NCT01630590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110091974|NCT01619085|Nintedanib|nintedanib|mesh-list
110091975|NCT01619085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110091976|NCT01619085|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110091977|NCT01619085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110091978|NCT01619085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110091979|NCT01499095|Insulin|insulin|mesh-list
110091980|NCT01499095|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110091981|NCT01499095|Insulin Glargine|insulin glargine|mesh-list
110091982|NCT01499095|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110091983|NCT01499095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110091984|NCT01499082|Insulin|insulin|mesh-list
110091985|NCT01499082|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110091986|NCT01499082|Insulin Glargine|insulin glargine|mesh-list
110091987|NCT01499082|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110091988|NCT01499082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110091989|NCT01488890|Vaccines|vaccines|mesh-list
110091990|NCT01488890|Immunologic Factors|immunologic factors|mesh-ancestor
110091991|NCT01488890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110091992|NCT01436396|Vaccines|vaccines|mesh-list
110091993|NCT01436396|Immunologic Factors|immunologic factors|mesh-ancestor
110091994|NCT01436396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110091995|NCT01414777|Ondansetron|ondansetron|mesh-list
110091996|NCT01414777|Antiemetics|antiemetics|mesh-ancestor
110091997|NCT01414777|Autonomic Agents|autonomic agents|mesh-ancestor
110091998|NCT01414777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110091999|NCT01414777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110092000|NCT01414777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110092001|NCT01414777|Antipruritics|antipruritics|mesh-ancestor
110092002|NCT01414777|Dermatologic Agents|dermatologic agents|mesh-ancestor
110092003|NCT01414777|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110092004|NCT01414777|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110092005|NCT01414777|Serotonin Agents|serotonin agents|mesh-ancestor
110092006|NCT01414777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110092007|NCT01414777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110092008|NCT01411241|Vaccines|vaccines|mesh-list
110092009|NCT01411241|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110092010|NCT01411241|Immunologic Factors|immunologic factors|mesh-ancestor
110092011|NCT01411241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110092012|NCT01380938|Ribavirin|ribavirin|mesh-list
110092013|NCT01380938|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110092014|NCT01380938|Interferon-alpha|interferon-alpha|mesh-list
110092015|NCT01380938|Antimetabolites|antimetabolites|mesh-ancestor
110092016|NCT01380938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110092017|NCT01380938|Antiviral Agents|antiviral agents|mesh-ancestor
110092018|NCT01380938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110092019|NCT01380938|Immunologic Factors|immunologic factors|mesh-ancestor
110092020|NCT01380938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110092021|NCT01374516|Vaccines|vaccines|mesh-list
110092022|NCT01374516|Immunologic Factors|immunologic factors|mesh-ancestor
110092023|NCT01374516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110092024|NCT01373281|Vaccines|vaccines|mesh-list
110092025|NCT01373281|Immunologic Factors|immunologic factors|mesh-ancestor
110092026|NCT01373281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110092027|NCT01254422|Vaccines|vaccines|mesh-list
110092028|NCT01254422|Immunologic Factors|immunologic factors|mesh-ancestor
110092029|NCT01254422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110092030|NCT01204242|Lidocaine|lidocaine|mesh-list
110092031|NCT01204242|Anesthetics, Local|anesthetics, local|mesh-ancestor
110092032|NCT01204242|Anesthetics|anesthetics|mesh-ancestor
110092033|NCT01204242|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110092034|NCT01204242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110092035|NCT01204242|Sensory System Agents|sensory system agents|mesh-ancestor
110092036|NCT01204242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110092037|NCT01204242|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110092038|NCT01204242|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110092039|NCT01204242|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110092040|NCT01204242|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110092041|NCT01204242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110092042|NCT01187433|Vaccines|vaccines|mesh-list
110092043|NCT01187433|Immunologic Factors|immunologic factors|mesh-ancestor
110092044|NCT01187433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110092045|NCT01150045|Leucovorin|leucovorin|mesh-list
110092046|NCT01150045|Celecoxib|celecoxib|mesh-list
110092047|NCT01150045|Fluorouracil|fluorouracil|mesh-list
110092048|NCT01150045|Oxaliplatin|oxaliplatin|mesh-list
110092049|NCT01150045|Antimetabolites|antimetabolites|mesh-ancestor
110092050|NCT01150045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110092051|NCT01150045|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110092052|NCT01150045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110092053|NCT01150045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110092054|NCT01150045|Immunologic Factors|immunologic factors|mesh-ancestor
110092055|NCT01150045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110092056|NCT01150045|Antidotes|antidotes|mesh-ancestor
110092057|NCT01150045|Protective Agents|protective agents|mesh-ancestor
110092058|NCT01150045|Vitamin B Complex|vitamin b complex|mesh-ancestor
110092059|NCT01150045|Vitamins|vitamins|mesh-ancestor
110092060|NCT01150045|Micronutrients|micronutrients|mesh-ancestor
110092061|NCT01150045|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110092062|NCT01150045|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110092063|NCT01150045|Analgesics|analgesics|mesh-ancestor
110092064|NCT01150045|Sensory System Agents|sensory system agents|mesh-ancestor
110092065|NCT01150045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110092066|NCT01150045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110092067|NCT01150045|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110092068|NCT01150045|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110092069|NCT01150045|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110092070|NCT01150045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110092071|NCT01098032|Acetylcysteine|acetylcysteine|mesh-list
110092072|NCT01098032|Antiviral Agents|antiviral agents|mesh-ancestor
110092073|NCT01098032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110092074|NCT01098032|Expectorants|expectorants|mesh-ancestor
110092075|NCT01098032|Respiratory System Agents|respiratory system agents|mesh-ancestor
110092076|NCT01098032|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110092077|NCT01098032|Antioxidants|antioxidants|mesh-ancestor
110092078|NCT01098032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110092079|NCT01098032|Protective Agents|protective agents|mesh-ancestor
110092080|NCT01098032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110092081|NCT00945009|Dactinomycin|dactinomycin|mesh-list
110092082|NCT00945009|Cactinomycin|cactinomycin|mesh-list
110092083|NCT00945009|Doxorubicin|doxorubicin|mesh-list
110092084|NCT00945009|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110092085|NCT00945009|Vincristine|vincristine|mesh-list
110092086|NCT00945009|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110092087|NCT00945009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110092088|NCT00945009|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110092089|NCT00945009|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110092090|NCT00945009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110092091|NCT00945009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110092092|NCT00945009|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110092093|NCT00945009|Tubulin Modulators|tubulin modulators|mesh-ancestor
110092094|NCT00945009|Antimitotic Agents|antimitotic agents|mesh-ancestor
110092095|NCT00945009|Mitosis Modulators|mitosis modulators|mesh-ancestor
110092096|NCT00945009|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110092097|NCT00945009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110092098|NCT00945009|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110092099|NCT00945009|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110092101|NCT00942877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110092102|NCT00942877|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110092103|NCT00942877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110092104|NCT00942877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110092105|NCT00896389|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110092106|NCT00896389|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110092107|NCT00896389|Diuretics|diuretics|mesh-ancestor
110092108|NCT00896389|Natriuretic Agents|natriuretic agents|mesh-ancestor
110092109|NCT00896389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110092110|NCT00896389|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110092111|NCT00896389|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110092112|NCT00896389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110092113|NCT00880893|Vaccines|vaccines|mesh-list
110092114|NCT00880893|Immunologic Factors|immunologic factors|mesh-ancestor
110092115|NCT00880893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110092116|NCT00579527|Cyclosporine|cyclosporine|mesh-list
110092117|NCT00579527|Mycophenolic Acid|mycophenolic acid|mesh-list
110092119|NCT00579527|Prednisolone|prednisolone|mesh-list
110092120|NCT00579527|Tacrolimus|tacrolimus|mesh-list
110092121|NCT00579527|Cyclosporins|cyclosporins|mesh-list
110092122|NCT00579527|Thymoglobulin|thymoglobulin|mesh-list
110092123|NCT00579527|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110092124|NCT00579527|Daclizumab|daclizumab|mesh-list
110092125|NCT00579527|Parathyroid Hormone|parathyroid hormone|mesh-list
110092126|NCT00579527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110092127|NCT00579527|Immunologic Factors|immunologic factors|mesh-ancestor
110092128|NCT00579527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110092129|NCT00579527|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110092130|NCT00579527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110092131|NCT00579527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110092132|NCT00579527|Antifungal Agents|antifungal agents|mesh-ancestor
110092133|NCT00579527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110092134|NCT00579527|Dermatologic Agents|dermatologic agents|mesh-ancestor
110092135|NCT00579527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110092136|NCT00579527|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110092137|NCT00579527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110092138|NCT00579527|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110092139|NCT00579527|Antitubercular Agents|antitubercular agents|mesh-ancestor
110092140|NCT00579527|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110092141|NCT00579527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110092143|NCT00579527|Autonomic Agents|autonomic agents|mesh-ancestor
110092144|NCT00579527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110092145|NCT00579527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110092146|NCT00579527|Glucocorticoids|glucocorticoids|mesh-ancestor
110092148|NCT00579527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110092149|NCT00579527|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110092150|NCT00579527|Protective Agents|protective agents|mesh-ancestor
110092151|NCT00579527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110092152|NCT00579527|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110092153|NCT01904123|Tyrphostins|tyrphostins|mesh-list
110092154|NCT01904123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110092155|NCT01904123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110092156|NCT01904123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110092157|NCT00576836|Parathyroid Hormone|parathyroid hormone|mesh-list
110092158|NCT00576836|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110092159|NCT00576836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110092160|NCT00531232|Clofarabine|clofarabine|mesh-list
110092161|NCT00531232|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110092162|NCT00531232|Antimetabolites|antimetabolites|mesh-ancestor
110092163|NCT00531232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110092164|NCT00531232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110092165|NCT00066950|Chlorhexidine|chlorhexidine|mesh-list
110092166|NCT00066950|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110092167|NCT00066950|Fluorides|fluorides|mesh-list
110092168|NCT00066950|Fluorides, Topical|fluorides, topical|mesh-list
110092169|NCT00066950|Cariostatic Agents|cariostatic agents|mesh-ancestor
110092170|NCT00066950|Protective Agents|protective agents|mesh-ancestor
110092171|NCT00066950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110092172|NCT00066950|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110092173|NCT00066950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110092174|NCT00066950|Disinfectants|disinfectants|mesh-ancestor
110092175|NCT00066950|Dermatologic Agents|dermatologic agents|mesh-ancestor
110092176|NCT01694134|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110092177|NCT01694134|Methylprednisolone|methylprednisolone|mesh-list
110092178|NCT01694134|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110092179|NCT01694134|Prednisolone|prednisolone|mesh-list
110092180|NCT01694134|Prednisolone acetate|prednisolone acetate|mesh-list
110092181|NCT01694134|Lidocaine|lidocaine|mesh-list
110092182|NCT01694134|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110092183|NCT01694134|Prednisolone phosphate|prednisolone phosphate|mesh-list
110092184|NCT01694134|Anesthetics, Local|anesthetics, local|mesh-ancestor
110092185|NCT01694134|Anesthetics|anesthetics|mesh-ancestor
110092186|NCT01694134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110092187|NCT01694134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110092188|NCT01694134|Sensory System Agents|sensory system agents|mesh-ancestor
110092189|NCT01694134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110092190|NCT01694134|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110092191|NCT01694134|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110092192|NCT01694134|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110092193|NCT01694134|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110092194|NCT01694134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110092195|NCT01694134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110092197|NCT01694134|Autonomic Agents|autonomic agents|mesh-ancestor
110092198|NCT01694134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110092199|NCT01694134|Glucocorticoids|glucocorticoids|mesh-ancestor
110092200|NCT01694134|Hormones|hormones|mesh-ancestor
110092201|NCT01694134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110092202|NCT01694134|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110092203|NCT01694134|Protective Agents|protective agents|mesh-ancestor
110092204|NCT01694134|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110092205|NCT01694134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110092206|NCT01694212|Diclofenac|diclofenac|mesh-list
110092207|NCT01694212|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110092208|NCT01694212|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110092209|NCT01694212|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110092210|NCT01694212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110092211|NCT01694212|Analgesics|analgesics|mesh-ancestor
110092212|NCT01694212|Sensory System Agents|sensory system agents|mesh-ancestor
110092213|NCT01694212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110092214|NCT01694212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110092215|NCT01694212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110092216|NCT01694212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110092217|NCT01694212|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110092218|NCT01694212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110092219|NCT01694212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110092220|NCT01694264|Entecavir|entecavir|mesh-list
110092221|NCT01694264|Antiviral Agents|antiviral agents|mesh-ancestor
110092222|NCT01694264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110092223|NCT01694355|Vitamin D|vitamin d|mesh-list
110092224|NCT01694355|Vitamins|vitamins|mesh-ancestor
110092225|NCT01694355|Micronutrients|micronutrients|mesh-ancestor
110092226|NCT01694355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110092227|NCT01694355|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110092228|NCT01694381|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
110092229|NCT01694381|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
110092230|NCT01694381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110092231|NCT01694381|Immunologic Factors|immunologic factors|mesh-ancestor
110092232|NCT01694381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110092233|NCT01694407|Tenofovir|tenofovir|mesh-list
110092234|NCT01694407|Emtricitabine|emtricitabine|mesh-list
110092235|NCT01694407|Antiviral Agents|antiviral agents|mesh-ancestor
110092236|NCT01694407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110092237|NCT01694407|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110092238|NCT01694407|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110092239|NCT01694407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110092240|NCT01694407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110092241|NCT01694407|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110092242|NCT01694407|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110092243|NCT01694459|Heparin|heparin|mesh-list
110092244|NCT01694459|Calcium heparin|calcium heparin|mesh-list
110092245|NCT01694459|Anticoagulants|anticoagulants|mesh-ancestor
110092246|NCT01694459|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110092247|NCT01694459|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110092248|NCT01694459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110092249|NCT01694498|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
110092250|NCT01694498|Hemostatics|hemostatics|mesh-ancestor
110092251|NCT01694498|Coagulants|coagulants|mesh-ancestor
110092252|NCT01694498|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
110092253|NCT01694498|Natriuretic Agents|natriuretic agents|mesh-ancestor
110092254|NCT01694498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110092255|NCT01694576|Paclitaxel|paclitaxel|mesh-list
110092256|NCT01694576|Nedaplatin|nedaplatin|mesh-list
110092257|NCT01694576|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110092258|NCT01694576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110092259|NCT01694576|Tubulin Modulators|tubulin modulators|mesh-ancestor
110092260|NCT01694576|Antimitotic Agents|antimitotic agents|mesh-ancestor
110092261|NCT01694576|Mitosis Modulators|mitosis modulators|mesh-ancestor
110092262|NCT01694576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110092263|NCT01694693|Abatacept|abatacept|mesh-list
110092264|NCT01694693|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110092265|NCT01694693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110092266|NCT01694693|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110092267|NCT01694693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110092268|NCT01694693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110092269|NCT01694693|Immunologic Factors|immunologic factors|mesh-ancestor
110092270|NCT01694693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110092271|NCT01694693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110092272|NCT01694732|Varenicline|varenicline|mesh-list
110092273|NCT01694732|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110092275|NCT01694732|Cholinergic Agents|cholinergic agents|mesh-ancestor
110092276|NCT01694732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110092277|NCT01694732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110092278|NCT01694732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110092279|NCT01694797|Metoprolol|metoprolol|mesh-list
110092280|NCT01694797|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110092281|NCT01694797|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110092283|NCT01694797|Autonomic Agents|autonomic agents|mesh-ancestor
110092284|NCT01694797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110092285|NCT01694797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110092286|NCT01694797|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110092287|NCT01694797|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110092288|NCT01694797|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110092289|NCT01694797|Adrenergic Agents|adrenergic agents|mesh-ancestor
110092290|NCT01694797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110092291|NCT01694797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110092292|NCT01695005|Prednisone|prednisone|mesh-list
110092293|NCT01695005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110092294|NCT01695005|Glucocorticoids|glucocorticoids|mesh-ancestor
110092295|NCT01695005|Hormones|hormones|mesh-ancestor
110092296|NCT01695005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110092297|NCT01695005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110092298|NCT01695005|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110092299|NCT01695005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110092300|NCT01695057|Vorinostat|vorinostat|mesh-list
110092301|NCT01695057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110092302|NCT01695057|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110092303|NCT01695057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110092304|NCT01695057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110092305|NCT01695070|Melatonin|melatonin|mesh-list
110092306|NCT01695070|Antioxidants|antioxidants|mesh-ancestor
110092307|NCT01695070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110092308|NCT01695070|Protective Agents|protective agents|mesh-ancestor
110092309|NCT01695070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110092310|NCT01695070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110092311|NCT01695109|Liraglutide|liraglutide|mesh-list
110092312|NCT01695109|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110092313|NCT01695109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110092314|NCT01695109|Incretins|incretins|mesh-ancestor
110092315|NCT01695109|Hormones|hormones|mesh-ancestor
110092316|NCT01695109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110092317|NCT01695122|Valproic Acid|valproic acid|mesh-list
110092318|NCT01695122|Anticonvulsants|anticonvulsants|mesh-ancestor
110092319|NCT01695122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110092320|NCT01695122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110092321|NCT01695122|GABA Agents|gaba agents|mesh-ancestor
110092322|NCT01695122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110092323|NCT01695122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110092324|NCT01695122|Antimanic Agents|antimanic agents|mesh-ancestor
110092325|NCT01695122|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110092326|NCT01695122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110092327|NCT01695122|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110092328|NCT01695148|Carotenoids|carotenoids|mesh-list
110092329|NCT01695148|Antioxidants|antioxidants|mesh-ancestor
110092330|NCT01695148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110092331|NCT01695148|Protective Agents|protective agents|mesh-ancestor
110092332|NCT01695148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110092334|NCT01695174|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110092335|NCT01695174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110092336|NCT01695174|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110092337|NCT01695187|5-((2-(6-Amino-9H-purin-9-yl) ethyl) amino)-1-pentanol|5-((2-(6-amino-9h-purin-9-yl) ethyl) amino)-1-pentanol|mesh-list
110092338|NCT01695187|Adenylyl Cyclase Inhibitors|adenylyl cyclase inhibitors|mesh-ancestor
110092339|NCT01695187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110092340|NCT01695187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110092341|NCT01695226|Celecoxib|celecoxib|mesh-list
110185910|NCT00275132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110092342|NCT01695226|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110092343|NCT01695226|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110092344|NCT01695226|Analgesics|analgesics|mesh-ancestor
110092345|NCT01695226|Sensory System Agents|sensory system agents|mesh-ancestor
110092346|NCT01695226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110092347|NCT01695226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110092348|NCT01695226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110092349|NCT01695226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110092350|NCT01695226|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110092351|NCT01695226|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110092352|NCT01695226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110092353|NCT01695226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110092354|NCT01695356|Sunscreening Agents|sunscreening agents|mesh-list
110092355|NCT01695356|Zinc Oxide|zinc oxide|mesh-list
110092356|NCT01695356|Titanium dioxide|titanium dioxide|mesh-list
110092357|NCT01695356|Avobenzone|avobenzone|mesh-list
110092358|NCT01695356|Terephthalylidene dicamphor sulfonic acid|terephthalylidene dicamphor sulfonic acid|mesh-list
110092359|NCT01695356|Benzophenone|benzophenone|mesh-list
110092360|NCT01695356|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110092361|NCT01695356|Protective Agents|protective agents|mesh-ancestor
110092362|NCT01695356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110092363|NCT01695356|Dermatologic Agents|dermatologic agents|mesh-ancestor
110092364|NCT01695356|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110092365|NCT01695460|Cholecalciferol|cholecalciferol|mesh-list
110092366|NCT01695460|Vitamins|vitamins|mesh-list
110092367|NCT01695460|Micronutrients|micronutrients|mesh-ancestor
110092368|NCT01695460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110092369|NCT01695460|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110092370|NCT01695460|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110092371|NCT01695707|Pioglitazone|pioglitazone|mesh-list
110092372|NCT01695707|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110092373|NCT01695707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110092374|NCT01695733|Vaccines|vaccines|mesh-list
110092375|NCT01695733|Immunologic Factors|immunologic factors|mesh-ancestor
110092376|NCT01695733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110092377|NCT01695759|Epoetin Alfa|epoetin alfa|mesh-list
110092378|NCT01695759|Hematinics|hematinics|mesh-ancestor
110092379|NCT01695798|Vaccines|vaccines|mesh-list
110092380|NCT01695798|Immunologic Factors|immunologic factors|mesh-ancestor
110092381|NCT01695798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110092382|NCT01695824|Warfarin|warfarin|mesh-list
110092383|NCT01695824|Anticoagulants|anticoagulants|mesh-ancestor
110092384|NCT01695850|Sennosides|sennosides|mesh-list
110092385|NCT01695850|Laxatives|laxatives|mesh-ancestor
110092386|NCT01695850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110092387|NCT01695902|Levonorgestrel|levonorgestrel|mesh-list
110092388|NCT01695902|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110092389|NCT01695902|Contraceptive Agents|contraceptive agents|mesh-ancestor
110092390|NCT01695902|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110092391|NCT01695902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110092392|NCT01695902|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110092393|NCT01695902|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110092394|NCT01695902|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110092395|NCT01696110|Heparin|heparin|mesh-list
110092396|NCT01696110|Calcium heparin|calcium heparin|mesh-list
110092397|NCT01696110|Tirofiban|tirofiban|mesh-list
110092398|NCT01696110|Bivalirudin|bivalirudin|mesh-list
110092399|NCT01696110|Anticoagulants|anticoagulants|mesh-ancestor
110092400|NCT01696110|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110092401|NCT01696110|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110092402|NCT01696110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110092403|NCT01696110|Antithrombins|antithrombins|mesh-ancestor
110092404|NCT01696110|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110092405|NCT01696110|Protease Inhibitors|protease inhibitors|mesh-ancestor
110092406|NCT01696110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110092407|NCT01696110|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110092408|NCT01696240|Udenafil|udenafil|mesh-list
110092409|NCT01696240|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110092410|NCT01696240|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110092411|NCT01696240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110092412|NCT01696240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110092413|NCT01696370|Trimetazidine|trimetazidine|mesh-list
110092414|NCT01696370|Vasodilator Agents|vasodilator agents|mesh-ancestor
110092415|NCT01696383|Timolol|timolol|mesh-list
110092416|NCT01696383|Travoprost|travoprost|mesh-list
110092417|NCT01696383|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110092418|NCT01696383|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110092419|NCT01696383|Adrenergic Agents|adrenergic agents|mesh-ancestor
110092420|NCT01696383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110092421|NCT01696383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110092422|NCT01696383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110092423|NCT01696383|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110092424|NCT01696383|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110092426|NCT01696409|Ergocalciferols|ergocalciferols|mesh-list
110092427|NCT01696409|Cholecalciferol|cholecalciferol|mesh-list
110092428|NCT01696409|Vitamins|vitamins|mesh-list
110092429|NCT01696409|Micronutrients|micronutrients|mesh-ancestor
110092430|NCT01696409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110092431|NCT01696409|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110092432|NCT01696409|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110092434|NCT01696422|Immunologic Factors|immunologic factors|mesh-ancestor
110092435|NCT01696422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110092436|NCT01696448|Thioctic Acid|thioctic acid|mesh-list
110092437|NCT01696448|Antioxidants|antioxidants|mesh-ancestor
110092438|NCT01696448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110092439|NCT01696448|Protective Agents|protective agents|mesh-ancestor
110092440|NCT01696448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110092441|NCT01696448|Vitamin B Complex|vitamin b complex|mesh-ancestor
110092442|NCT01696448|Vitamins|vitamins|mesh-ancestor
110092443|NCT01696448|Micronutrients|micronutrients|mesh-ancestor
110092444|NCT01696474|Bortezomib|bortezomib|mesh-list
110092445|NCT01696474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110092446|NCT01696500|Immunoglobulins|immunoglobulins|mesh-list
110092447|NCT01696500|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110092448|NCT01696500|Antibodies|antibodies|mesh-list
110092449|NCT01696500|gamma-Globulins|gamma-globulins|mesh-list
110092450|NCT01696500|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110092451|NCT01696500|Immunologic Factors|immunologic factors|mesh-ancestor
110092452|NCT01696500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110092453|NCT01696526|Vitamin D|vitamin d|mesh-list
110092454|NCT01696526|Vitamins|vitamins|mesh-ancestor
110092455|NCT01696526|Micronutrients|micronutrients|mesh-ancestor
110092456|NCT01696526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110092457|NCT01696526|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110092458|NCT01696552|Cimetidine|cimetidine|mesh-list
110092459|NCT01696552|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110092460|NCT01696552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110092461|NCT01696552|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110092462|NCT01696552|Histamine Antagonists|histamine antagonists|mesh-ancestor
110092463|NCT01696552|Histamine Agents|histamine agents|mesh-ancestor
110092464|NCT01696552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110092465|NCT01696552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110092466|NCT01696552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110092467|NCT01696552|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110092468|NCT01696552|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110092469|NCT01696552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110092470|NCT01696617|Aripiprazole|aripiprazole|mesh-list
110092471|NCT01696617|Antidepressive Agents|antidepressive agents|mesh-ancestor
110092472|NCT01696617|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110092473|NCT01696617|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110092474|NCT01696617|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110092475|NCT01696617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110092476|NCT01696617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110092477|NCT01696617|Dopamine Agonists|dopamine agonists|mesh-ancestor
110092478|NCT01696617|Dopamine Agents|dopamine agents|mesh-ancestor
110092479|NCT01696617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110092480|NCT01696617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110092481|NCT01696617|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110092483|NCT01696617|Serotonin Agents|serotonin agents|mesh-ancestor
110092484|NCT01696617|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110092485|NCT01696617|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110092486|NCT01696617|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110092487|NCT01696617|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110092489|NCT01696630|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110092490|NCT01696630|Anesthetics, General|anesthetics, general|mesh-ancestor
110092491|NCT01696630|Anesthetics|anesthetics|mesh-ancestor
110092492|NCT01696630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110092493|NCT01696630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110092495|NCT01696656|Gastrointestinal Agents|gastrointestinal agents|mesh-list
110092496|NCT01696656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110092497|NCT01696799|Econazole|econazole|mesh-list
110092498|NCT01696799|Antifungal Agents|antifungal agents|mesh-ancestor
110092499|NCT01696799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110092500|NCT01696799|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110092501|NCT01696799|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110092502|NCT01696799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110092503|NCT01696799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110092504|NCT01696799|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110092505|NCT01696799|Hormone Antagonists|hormone antagonists|mesh-ancestor
110092506|NCT01696799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110092507|NCT01696799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110092508|NCT01696825|Diazepam|diazepam|mesh-list
110092509|NCT01696825|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110092510|NCT01696825|Anticonvulsants|anticonvulsants|mesh-ancestor
110092511|NCT01696825|Antiemetics|antiemetics|mesh-ancestor
110092512|NCT01696825|Autonomic Agents|autonomic agents|mesh-ancestor
110092513|NCT01696825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110092514|NCT01696825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110092515|NCT01696825|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110092516|NCT01696825|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110092517|NCT01696825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110092518|NCT01696825|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110092519|NCT01696825|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110092520|NCT01696825|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110092521|NCT01696825|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110092522|NCT01696825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110092523|NCT01696825|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110092524|NCT01696825|Anesthetics, General|anesthetics, general|mesh-ancestor
110092525|NCT01696825|Anesthetics|anesthetics|mesh-ancestor
110092526|NCT01696825|GABA Modulators|gaba modulators|mesh-ancestor
110092527|NCT01696825|GABA Agents|gaba agents|mesh-ancestor
110092528|NCT01696825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110092529|NCT01696825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110092530|NCT01697020|Mercaptopurine|mercaptopurine|mesh-list
110092531|NCT01697020|Antimetabolites|antimetabolites|mesh-ancestor
110092532|NCT01697020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110092533|NCT01697020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110092534|NCT01697020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110092535|NCT01697020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110092536|NCT01697020|Immunologic Factors|immunologic factors|mesh-ancestor
110092537|NCT01697020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110092538|NCT01697020|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110092539|NCT01697020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110368555|NCT01165216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110092540|NCT01697046|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110092541|NCT01697046|Raltegravir Potassium|raltegravir potassium|mesh-list
110092542|NCT01697046|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110092543|NCT01697046|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110092544|NCT01697046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110092545|NCT01697046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110092546|NCT01697046|Antiviral Agents|antiviral agents|mesh-ancestor
110092547|NCT01697046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110092548|NCT01697046|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110092549|NCT01697046|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110092550|NCT01697046|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110092551|NCT01697046|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110092552|NCT01697059|Amoxicillin|amoxicillin|mesh-list
110092553|NCT01697059|Piperacillin|piperacillin|mesh-list
110092554|NCT01697059|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
110092555|NCT01697059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110092556|NCT01697059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110092557|NCT01697059|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110092558|NCT01697059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110092559|NCT01697059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110092560|NCT01697098|Dexamethasone|dexamethasone|mesh-list
110092561|NCT01697098|Dexamethasone acetate|dexamethasone acetate|mesh-list
110092562|NCT01697098|Glucocorticoids|glucocorticoids|mesh-list
110092563|NCT01697098|BB 1101|bb 1101|mesh-list
110092564|NCT01697098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110092565|NCT01697098|Antiemetics|antiemetics|mesh-ancestor
110092566|NCT01697098|Autonomic Agents|autonomic agents|mesh-ancestor
110092567|NCT01697098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110092568|NCT01697098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110092569|NCT01697098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110092570|NCT01697098|Hormones|hormones|mesh-ancestor
110092571|NCT01697098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110092572|NCT01697098|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110092573|NCT01697098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110092574|NCT01697098|Protease Inhibitors|protease inhibitors|mesh-ancestor
110092575|NCT01697098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110092576|NCT01697098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110092578|NCT01697111|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110092579|NCT01697111|Contraceptive Agents|contraceptive agents|mesh-ancestor
110092580|NCT01697111|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110092581|NCT01697111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110092582|NCT01697111|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110092583|NCT01697111|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110092584|NCT01697111|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110092585|NCT01697111|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110092586|NCT01697111|Hormone Antagonists|hormone antagonists|mesh-ancestor
110092587|NCT01697111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110092588|NCT01697111|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110092589|NCT01697111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110092590|NCT01697150|Pancrelipase|pancrelipase|mesh-list
110092591|NCT01697150|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110092592|NCT01697228|Vitamin D|vitamin d|mesh-list
110092593|NCT01697228|Vitamins|vitamins|mesh-ancestor
110092594|NCT01697228|Micronutrients|micronutrients|mesh-ancestor
110092595|NCT01697228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110092596|NCT01697228|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110092598|NCT01697293|Cyclophosphamide|cyclophosphamide|mesh-list
110092599|NCT01697293|Doxorubicin|doxorubicin|mesh-list
110092600|NCT01697293|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110092601|NCT01697293|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110092602|NCT01697293|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110092603|NCT01697293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110092604|NCT01697293|Tubulin Modulators|tubulin modulators|mesh-ancestor
110092605|NCT01697293|Antimitotic Agents|antimitotic agents|mesh-ancestor
110092606|NCT01697293|Mitosis Modulators|mitosis modulators|mesh-ancestor
110092607|NCT01697293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110092608|NCT01697293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110092609|NCT01697293|Immunologic Factors|immunologic factors|mesh-ancestor
110092610|NCT01697293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110092611|NCT01697293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110092612|NCT01697293|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110092613|NCT01697293|Alkylating Agents|alkylating agents|mesh-ancestor
110092615|NCT01697293|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110092616|NCT01697293|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110092617|NCT01697293|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110092618|NCT01697293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110092619|NCT01697306|Gemcitabine|gemcitabine|mesh-list
110092620|NCT01697306|BCG Vaccine|bcg vaccine|mesh-list
110092621|NCT01697306|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110092622|NCT01697306|Antimetabolites|antimetabolites|mesh-ancestor
110092623|NCT01697306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110092624|NCT01697306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110092625|NCT01697306|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110092626|NCT01697306|Immunologic Factors|immunologic factors|mesh-ancestor
110092627|NCT01697306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110092628|NCT01697410|Terlipressin|terlipressin|mesh-list
110092629|NCT01697410|Norepinephrine|norepinephrine|mesh-list
110092630|NCT01697410|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110092631|NCT01697410|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110092632|NCT01697410|Adrenergic Agents|adrenergic agents|mesh-ancestor
110092633|NCT01697410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110092634|NCT01697410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110092635|NCT01697410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110092636|NCT01697410|Sympathomimetics|sympathomimetics|mesh-ancestor
110092637|NCT01697410|Autonomic Agents|autonomic agents|mesh-ancestor
110092638|NCT01697410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110092639|NCT01697410|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110092640|NCT01697410|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110092641|NCT01697436|Ribavirin|ribavirin|mesh-list
110092642|NCT01697436|Antimetabolites|antimetabolites|mesh-ancestor
110092643|NCT01697436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110092644|NCT01697436|Antiviral Agents|antiviral agents|mesh-ancestor
110092645|NCT01697436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110092646|NCT01697605|Infigratinib|infigratinib|mesh-list
110092647|NCT01697605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110092648|NCT01697618|Insulin|insulin|mesh-list
110092649|NCT01697618|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110092650|NCT01697618|Insulin Aspart|insulin aspart|mesh-list
110092651|NCT01697618|Biphasic Insulins|biphasic insulins|mesh-list
110260174|NCT02944201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110092652|NCT01697618|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
110092653|NCT01697618|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110092654|NCT01697618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110092655|NCT01697631|Insulin|insulin|mesh-list
110092656|NCT01697631|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110092657|NCT01697631|Insulin Aspart|insulin aspart|mesh-list
110092658|NCT01697631|Insulin, Long-Acting|insulin, long-acting|mesh-list
110092659|NCT01697631|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
110092660|NCT01697631|Biphasic Insulins|biphasic insulins|mesh-list
110092661|NCT01697631|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
110092662|NCT01697631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110092663|NCT01697631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110092664|NCT01697657|Insulin|insulin|mesh-list
110092665|NCT01697657|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110092666|NCT01697657|Insulin Aspart|insulin aspart|mesh-list
110092667|NCT01697657|Insulin Detemir|insulin detemir|mesh-list
110092668|NCT01697657|Isophane Insulin, Human|isophane insulin, human|mesh-list
110092669|NCT01697657|Insulin, Isophane|insulin, isophane|mesh-list
110092670|NCT01697657|Isophane insulin, beef|isophane insulin, beef|mesh-list
110092671|NCT01697657|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110092672|NCT01697657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110092673|NCT01697670|Aminolevulinic Acid|aminolevulinic acid|mesh-list
110092674|NCT01697670|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110092675|NCT01697670|Dermatologic Agents|dermatologic agents|mesh-ancestor
110092676|NCT01697722|Beclomethasone|beclomethasone|mesh-list
110092677|NCT01697722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110092678|NCT01697722|Glucocorticoids|glucocorticoids|mesh-ancestor
110092679|NCT01697722|Hormones|hormones|mesh-ancestor
110092680|NCT01697722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110092681|NCT01697722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110092682|NCT01697722|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110185942|NCT03430596|Cholinergic Agents|cholinergic agents|mesh-ancestor
110092683|NCT01697722|Respiratory System Agents|respiratory system agents|mesh-ancestor
110092684|NCT01697735|Atorvastatin|atorvastatin|mesh-list
110092685|NCT01697735|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110092686|NCT01697735|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110092687|NCT01697735|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110092688|NCT01697735|Antimetabolites|antimetabolites|mesh-ancestor
110092689|NCT01697735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110092690|NCT01697735|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110092691|NCT01697735|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110092692|NCT01697735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110092694|NCT01697787|Lumefantrine|lumefantrine|mesh-list
110092695|NCT01697787|Artemether|artemether|mesh-list
110092696|NCT01697787|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
110092697|NCT01697787|Amodiaquine|amodiaquine|mesh-list
110092698|NCT01697787|Antimalarials|antimalarials|mesh-ancestor
110092699|NCT01697787|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110092700|NCT01697787|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110092701|NCT01697787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110092702|NCT01697787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110092703|NCT01697787|Antiviral Agents|antiviral agents|mesh-ancestor
110092704|NCT01697787|Schistosomicides|schistosomicides|mesh-ancestor
110092705|NCT01697787|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110092706|NCT01697787|Anthelmintics|anthelmintics|mesh-ancestor
110092707|NCT01697826|Clindamycin|clindamycin|mesh-list
110092708|NCT01697826|Clindamycin palmitate|clindamycin palmitate|mesh-list
110092709|NCT01697826|Clindamycin phosphate|clindamycin phosphate|mesh-list
110092710|NCT01697826|Clotrimazole|clotrimazole|mesh-list
110092711|NCT01697826|Miconazole|miconazole|mesh-list
110092712|NCT01697826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110092713|NCT01697826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110092714|NCT01697826|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110092715|NCT01697826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110092716|NCT01697826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110092717|NCT01697826|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110092718|NCT01697826|Antifungal Agents|antifungal agents|mesh-ancestor
110092719|NCT01697826|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110092720|NCT01697826|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110092721|NCT01697826|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110092722|NCT01697826|Hormone Antagonists|hormone antagonists|mesh-ancestor
110092723|NCT01697826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110092724|NCT01697826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110092725|NCT01697826|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110092726|NCT01697826|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110092727|NCT01698164|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110092728|NCT01698164|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110092729|NCT01698164|Estradiol|estradiol|mesh-list
110092730|NCT01698164|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110092731|NCT01698164|Progesterone|progesterone|mesh-list
110092732|NCT01698164|Estrogens|estrogens|mesh-ancestor
110092733|NCT01698164|Hormones|hormones|mesh-ancestor
110092734|NCT01698164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110092735|NCT01698164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110092736|NCT01698164|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110092737|NCT01698164|Contraceptive Agents|contraceptive agents|mesh-ancestor
110092738|NCT01698164|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110092739|NCT01698164|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110092740|NCT01698164|Progestins|progestins|mesh-ancestor
110092741|NCT01698177|Vaccines|vaccines|mesh-list
110092742|NCT01698177|Immunologic Factors|immunologic factors|mesh-ancestor
110092743|NCT01698177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110092744|NCT01698203|Ropivacaine|ropivacaine|mesh-list
110092745|NCT01698203|Anesthetics, Local|anesthetics, local|mesh-ancestor
110092746|NCT01698203|Anesthetics|anesthetics|mesh-ancestor
110092747|NCT01698203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110092748|NCT01698203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110092749|NCT01698203|Sensory System Agents|sensory system agents|mesh-ancestor
110092750|NCT01698203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110092751|NCT01698476|Vitamin D|vitamin d|mesh-list
110092752|NCT01698476|Cholecalciferol|cholecalciferol|mesh-list
110092753|NCT01698476|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
110092754|NCT01698476|Vitamins|vitamins|mesh-ancestor
110092755|NCT01698476|Micronutrients|micronutrients|mesh-ancestor
110092756|NCT01698476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110092757|NCT01698476|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110092758|NCT01698476|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110092759|NCT01698476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110092760|NCT01698541|Tacrolimus|tacrolimus|mesh-list
110092761|NCT01698541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110092762|NCT01698541|Immunologic Factors|immunologic factors|mesh-ancestor
110092763|NCT01698541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110092764|NCT01698541|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110092766|NCT01698541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110092767|NCT01698567|Antithrombins|antithrombins|mesh-list
110092768|NCT01698567|Antithrombin III|antithrombin iii|mesh-list
110092769|NCT01698567|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110092770|NCT01698567|Protease Inhibitors|protease inhibitors|mesh-ancestor
110092771|NCT01698567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110092772|NCT01698567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110092773|NCT01698567|Anticoagulants|anticoagulants|mesh-ancestor
110092774|NCT01698593|Epinephrine|epinephrine|mesh-list
110092775|NCT01698593|Bupivacaine|bupivacaine|mesh-list
110092776|NCT01698593|Anesthetics, Local|anesthetics, local|mesh-ancestor
110092777|NCT01698593|Anesthetics|anesthetics|mesh-ancestor
110092778|NCT01698593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110092779|NCT01698593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110092780|NCT01698593|Sensory System Agents|sensory system agents|mesh-ancestor
110092781|NCT01698593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110092782|NCT01698593|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110092783|NCT01698593|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110092784|NCT01698593|Adrenergic Agents|adrenergic agents|mesh-ancestor
110092785|NCT01698593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110092786|NCT01698593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110092787|NCT01698593|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110092788|NCT01698593|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110092789|NCT01698593|Autonomic Agents|autonomic agents|mesh-ancestor
110092790|NCT01698593|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110092791|NCT01698593|Respiratory System Agents|respiratory system agents|mesh-ancestor
110092792|NCT01698593|Mydriatics|mydriatics|mesh-ancestor
110092793|NCT01698593|Sympathomimetics|sympathomimetics|mesh-ancestor
110092794|NCT01698593|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110092795|NCT01698645|Fentanyl|fentanyl|mesh-list
110092796|NCT01698645|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110092797|NCT01698645|Narcotics|narcotics|mesh-ancestor
110092798|NCT01698645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110092799|NCT01698645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110092800|NCT01698645|Analgesics|analgesics|mesh-ancestor
110092801|NCT01698645|Sensory System Agents|sensory system agents|mesh-ancestor
110092802|NCT01698645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110092803|NCT01698645|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110092804|NCT01698645|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110092805|NCT01698645|Anesthetics, General|anesthetics, general|mesh-ancestor
110092806|NCT01698645|Anesthetics|anesthetics|mesh-ancestor
110092807|NCT01698697|Insulin Aspart|insulin aspart|mesh-list
110092808|NCT01698697|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110092809|NCT01698697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110092810|NCT01698723|Ribavirin|ribavirin|mesh-list
110092811|NCT01698723|Antimetabolites|antimetabolites|mesh-ancestor
110092812|NCT01698723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110092813|NCT01698723|Antiviral Agents|antiviral agents|mesh-ancestor
110092814|NCT01698723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110092815|NCT01698749|Dexamethasone|dexamethasone|mesh-list
110092816|NCT01698749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110092817|NCT01698749|Antiemetics|antiemetics|mesh-ancestor
110092818|NCT01698749|Autonomic Agents|autonomic agents|mesh-ancestor
110092819|NCT01698749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110092820|NCT01698749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110092821|NCT01698749|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110092822|NCT01698749|Glucocorticoids|glucocorticoids|mesh-ancestor
110092823|NCT01698749|Hormones|hormones|mesh-ancestor
110092824|NCT01698749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110092825|NCT01698749|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110092826|NCT01698749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110092827|NCT01698788|Dexamethasone|dexamethasone|mesh-list
110092828|NCT01698788|Dexamethasone acetate|dexamethasone acetate|mesh-list
110092830|NCT01698788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110092831|NCT01698788|Antiemetics|antiemetics|mesh-ancestor
110092832|NCT01698788|Autonomic Agents|autonomic agents|mesh-ancestor
110092833|NCT01698788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110092834|NCT01698788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110092836|NCT01698788|Glucocorticoids|glucocorticoids|mesh-ancestor
110092837|NCT01698788|Hormones|hormones|mesh-ancestor
110092838|NCT01698788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110092839|NCT01698788|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110092840|NCT01698788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110092841|NCT01698788|Protease Inhibitors|protease inhibitors|mesh-ancestor
110092842|NCT01698788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110092843|NCT01698788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110092844|NCT01698931|Glyburide|glyburide|mesh-list
110092845|NCT01698931|Repaglinide|repaglinide|mesh-list
110092846|NCT01698931|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110092847|NCT01698931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110092848|NCT01699113|Rabeprazole|rabeprazole|mesh-list
110092849|NCT01699113|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110092850|NCT01699113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110092851|NCT01699113|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110092852|NCT01699113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110092853|NCT01699113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110092854|NCT01699126|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110092855|NCT01699126|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110092856|NCT01699126|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110092857|NCT01699126|Antimetabolites|antimetabolites|mesh-ancestor
110092858|NCT01699126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110092859|NCT01699126|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110092860|NCT01699126|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110092861|NCT01699126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110092862|NCT01699204|Acetylcysteine|acetylcysteine|mesh-list
110092863|NCT01699204|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110092864|NCT01699204|Antiviral Agents|antiviral agents|mesh-ancestor
110092865|NCT01699204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110092866|NCT01699204|Expectorants|expectorants|mesh-ancestor
110092867|NCT01699204|Respiratory System Agents|respiratory system agents|mesh-ancestor
110092868|NCT01699204|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110092869|NCT01699204|Antioxidants|antioxidants|mesh-ancestor
110092870|NCT01699204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110092871|NCT01699204|Protective Agents|protective agents|mesh-ancestor
110092872|NCT01699204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110092873|NCT01699204|Antidotes|antidotes|mesh-ancestor
110092874|NCT01699282|Antivitamins K|antivitamins k|mesh-list
110092875|NCT01699282|Anticoagulants|anticoagulants|mesh-ancestor
110092876|NCT01699347|Picibanil|picibanil|mesh-list
110092877|NCT01699347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110092878|NCT01699360|Cyclosporine|cyclosporine|mesh-list
110092879|NCT01699360|Sirolimus|sirolimus|mesh-list
110092880|NCT01699360|Tacrolimus|tacrolimus|mesh-list
110092881|NCT01699360|Cyclosporins|cyclosporins|mesh-list
110092882|NCT01699360|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110092883|NCT01699360|Immunologic Factors|immunologic factors|mesh-ancestor
110092884|NCT01699360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110092885|NCT01699360|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110092886|NCT01699360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110092887|NCT01699360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110092888|NCT01699360|Antifungal Agents|antifungal agents|mesh-ancestor
110092889|NCT01699360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110092890|NCT01699360|Dermatologic Agents|dermatologic agents|mesh-ancestor
110092891|NCT01699360|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110092892|NCT01699360|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110092893|NCT01699360|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110092894|NCT01699360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110092896|NCT01699412|Clobetasol|clobetasol|mesh-list
110092898|NCT01699412|Antiemetics|antiemetics|mesh-ancestor
110092899|NCT01699412|Autonomic Agents|autonomic agents|mesh-ancestor
110092900|NCT01699412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110092901|NCT01699412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110092902|NCT01699412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110092903|NCT01699412|Glucocorticoids|glucocorticoids|mesh-ancestor
110092904|NCT01699412|Hormones|hormones|mesh-ancestor
110092905|NCT01699412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110092906|NCT01699412|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110092907|NCT01699412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110092908|NCT01699438|Mesalamine|mesalamine|mesh-list
110092909|NCT01699438|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110092910|NCT01699438|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110092911|NCT01699438|Analgesics|analgesics|mesh-ancestor
110092912|NCT01699438|Sensory System Agents|sensory system agents|mesh-ancestor
110092913|NCT01699438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110092914|NCT01699438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110092915|NCT01699438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110092916|NCT01699438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110092917|NCT01699490|Valsartan|valsartan|mesh-list
110092918|NCT01699490|Fluoxetine|fluoxetine|mesh-list
110092919|NCT01699490|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110092920|NCT01699490|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110092921|NCT01699490|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110092922|NCT01699490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110092923|NCT01699490|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110092924|NCT01699490|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110092925|NCT01699490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110092926|NCT01699490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110092927|NCT01699490|Serotonin Agents|serotonin agents|mesh-ancestor
110092928|NCT01699490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110092929|NCT01699490|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110092930|NCT01699490|Antidepressive Agents|antidepressive agents|mesh-ancestor
110092931|NCT01699490|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110092932|NCT01699490|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110092933|NCT01699490|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110092934|NCT01699490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110092936|NCT01699594|Methacholine Chloride|methacholine chloride|mesh-list
110092937|NCT01699594|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110092938|NCT01699594|Diuretics|diuretics|mesh-ancestor
110092939|NCT01699594|Natriuretic Agents|natriuretic agents|mesh-ancestor
110092940|NCT01699594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110092941|NCT01699594|Miotics|miotics|mesh-ancestor
110092942|NCT01699594|Autonomic Agents|autonomic agents|mesh-ancestor
110092943|NCT01699594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110092944|NCT01699594|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110092945|NCT01699594|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
110092946|NCT01699594|Respiratory System Agents|respiratory system agents|mesh-ancestor
110092947|NCT01699594|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
110092948|NCT01699594|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110092949|NCT01699594|Cholinergic Agents|cholinergic agents|mesh-ancestor
110092950|NCT01699594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110092951|NCT01699594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110092952|NCT01699659|Immunomodulating Agents|immunomodulating agents|mesh-list
110092953|NCT01699659|Immunologic Factors|immunologic factors|mesh-ancestor
110092954|NCT01699659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110092955|NCT01699711|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
110092956|NCT01699711|Antioxidants|antioxidants|mesh-ancestor
110092957|NCT01699711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110092958|NCT01699711|Protective Agents|protective agents|mesh-ancestor
110092959|NCT01699711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110092960|NCT01699711|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
110092961|NCT01699711|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110092962|NCT01699711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110092963|NCT01699711|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110092964|NCT01699724|Sertraline|sertraline|mesh-list
110092965|NCT01699724|Antidepressive Agents|antidepressive agents|mesh-ancestor
110092966|NCT01699724|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110092967|NCT01699724|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110092968|NCT01699724|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110092969|NCT01699724|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110092970|NCT01699724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110092971|NCT01699724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110092972|NCT01699724|Serotonin Agents|serotonin agents|mesh-ancestor
110092973|NCT01699724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110092974|NCT01699776|Digoxin|digoxin|mesh-list
110092975|NCT01699776|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110092976|NCT01699776|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110092977|NCT01699776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110092978|NCT01699776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110092979|NCT01699776|Protective Agents|protective agents|mesh-ancestor
110092980|NCT01699776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110092981|NCT01699802|Anesthetics|anesthetics|mesh-list
110092982|NCT01699802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110092983|NCT01699802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110092984|NCT01699828|Buspirone|buspirone|mesh-list
110092985|NCT01699828|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110092986|NCT01699828|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110092987|NCT01699828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110092988|NCT01699828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110092989|NCT01699828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110092990|NCT01699828|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110092992|NCT01699828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110092993|NCT01699828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110092994|NCT01699854|Capsaicin|capsaicin|mesh-list
110092995|NCT01699854|Antipruritics|antipruritics|mesh-ancestor
110092996|NCT01699854|Dermatologic Agents|dermatologic agents|mesh-ancestor
110092997|NCT01699854|Sensory System Agents|sensory system agents|mesh-ancestor
110092998|NCT01699854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110092999|NCT01699854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110093000|NCT01699919|Lidocaine|lidocaine|mesh-list
110093001|NCT01699919|Anesthetics, Local|anesthetics, local|mesh-ancestor
110093002|NCT01699919|Anesthetics|anesthetics|mesh-ancestor
110093003|NCT01699919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110093004|NCT01699919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110093005|NCT01699919|Sensory System Agents|sensory system agents|mesh-ancestor
110093006|NCT01699919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110093007|NCT01699919|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110093008|NCT01699919|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110093009|NCT01699919|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110093010|NCT01699919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110093011|NCT01699919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110093012|NCT01699932|Metformin|metformin|mesh-list
110093013|NCT01699932|Glimepiride|glimepiride|mesh-list
110093014|NCT01699932|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110093015|NCT01699932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110093016|NCT01699932|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110093017|NCT01699932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110093018|NCT01699932|Immunologic Factors|immunologic factors|mesh-ancestor
110093019|NCT01699997|Oxytocin|oxytocin|mesh-list
110093020|NCT01699997|Oxytocics|oxytocics|mesh-ancestor
110093021|NCT01699997|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110093022|NCT01699997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110093023|NCT01700010|Paclitaxel|paclitaxel|mesh-list
110093024|NCT01700010|Lapatinib|lapatinib|mesh-list
110093025|NCT01700010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110093026|NCT01700010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110093027|NCT01700010|Tubulin Modulators|tubulin modulators|mesh-ancestor
110093028|NCT01700010|Antimitotic Agents|antimitotic agents|mesh-ancestor
110093029|NCT01700010|Mitosis Modulators|mitosis modulators|mesh-ancestor
110093030|NCT01700010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110093031|NCT01700010|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110093032|NCT01700010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110093033|NCT01700270|Fluvoxamine|fluvoxamine|mesh-list
110093034|NCT01700270|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110093035|NCT01700270|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110093036|NCT01700270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110093037|NCT01700270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110093038|NCT01700270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110093039|NCT01700270|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110093040|NCT01700270|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110093041|NCT01700270|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110093042|NCT01700270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110093043|NCT01700270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110093044|NCT01700270|Serotonin Agents|serotonin agents|mesh-ancestor
110093045|NCT01700270|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110093046|NCT01700270|Antidepressive Agents|antidepressive agents|mesh-ancestor
110093047|NCT01700270|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110093048|NCT01700270|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110093049|NCT01700270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110093050|NCT01700270|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110093051|NCT01700322|Clopidogrel|clopidogrel|mesh-list
110093052|NCT01700322|Ticagrelor|ticagrelor|mesh-list
110093053|NCT01700322|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
110093054|NCT01700322|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110093055|NCT01700322|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110093056|NCT01700322|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110093057|NCT01700322|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110093058|NCT01700322|Purinergic Agents|purinergic agents|mesh-ancestor
110093059|NCT01700322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110093060|NCT01700322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110093061|NCT01700322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110093062|NCT01700400|Bevacizumab|bevacizumab|mesh-list
110093063|NCT01700400|Carboplatin|carboplatin|mesh-list
110093064|NCT01700400|Pemetrexed|pemetrexed|mesh-list
110093065|NCT01700400|Everolimus|everolimus|mesh-list
110093066|NCT01700400|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110093067|NCT01700400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110093068|NCT01700400|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110093069|NCT01700400|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110093070|NCT01700400|Growth Substances|growth substances|mesh-ancestor
110093071|NCT01700400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110093072|NCT01700400|Growth Inhibitors|growth inhibitors|mesh-ancestor
110093073|NCT01700400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110093074|NCT01700400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110093075|NCT01700400|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110093076|NCT01700400|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110093077|NCT01700400|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110093078|NCT01700400|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110093079|NCT01700400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110093080|NCT01700400|Immunologic Factors|immunologic factors|mesh-ancestor
110093082|NCT01700413|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110093083|NCT01700413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110093084|NCT01700413|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110093085|NCT01700413|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110093086|NCT01700413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110093087|NCT01700413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110093088|NCT01700426|Vitamins|vitamins|mesh-list
110093089|NCT01700426|Vitamin E|vitamin e|mesh-list
110093090|NCT01700426|Tocopherols|tocopherols|mesh-list
110093091|NCT01700426|Tocotrienols|tocotrienols|mesh-list
110093092|NCT01700426|alpha-Tocopherol|alpha-tocopherol|mesh-list
110093093|NCT01700426|Micronutrients|micronutrients|mesh-ancestor
110093094|NCT01700426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110093095|NCT01700426|Antioxidants|antioxidants|mesh-ancestor
110093096|NCT01700426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110093097|NCT01700426|Protective Agents|protective agents|mesh-ancestor
110093098|NCT01700478|Vasopressins|vasopressins|mesh-list
110093099|NCT01700478|Arginine Vasopressin|arginine vasopressin|mesh-list
110093100|NCT01700478|Misoprostol|misoprostol|mesh-list
110093101|NCT01700478|Diuretics|diuretics|mesh-list
110093102|NCT01700478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110093103|NCT01700478|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110093104|NCT01700478|Abortifacient Agents|abortifacient agents|mesh-ancestor
110093105|NCT01700478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110093106|NCT01700478|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110093107|NCT01700478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110093108|NCT01700478|Oxytocics|oxytocics|mesh-ancestor
110093109|NCT01700478|Natriuretic Agents|natriuretic agents|mesh-ancestor
110093110|NCT01700478|Hemostatics|hemostatics|mesh-ancestor
110093111|NCT01700478|Coagulants|coagulants|mesh-ancestor
110093112|NCT01700478|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110093113|NCT01700478|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
110093114|NCT01700491|Ropivacaine|ropivacaine|mesh-list
110093115|NCT01700491|Anesthetics, Local|anesthetics, local|mesh-ancestor
110093116|NCT01700491|Anesthetics|anesthetics|mesh-ancestor
110093117|NCT01700491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110093118|NCT01700491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110093119|NCT01700491|Sensory System Agents|sensory system agents|mesh-ancestor
110093120|NCT01700491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110093121|NCT01700504|Gentamicins|gentamicins|mesh-list
110093122|NCT01700504|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110093123|NCT01700504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110093124|NCT01700504|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110093125|NCT01700504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110093126|NCT01700504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110093127|NCT01700608|Plerixafor|plerixafor|mesh-list
110093128|NCT01700608|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110093129|NCT01700608|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110093130|NCT01700608|Antiviral Agents|antiviral agents|mesh-ancestor
110093131|NCT01700608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110093132|NCT01700751|Brentuximab Vedotin|brentuximab vedotin|mesh-list
110093133|NCT01700751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110093134|NCT01700751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110093135|NCT01700751|Immunotoxins|immunotoxins|mesh-ancestor
110093136|NCT01700751|Immunoconjugates|immunoconjugates|mesh-ancestor
110093137|NCT01700751|Immunologic Factors|immunologic factors|mesh-ancestor
110093138|NCT01700751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110093139|NCT01700790|Ritonavir|ritonavir|mesh-list
110093140|NCT01700790|Lopinavir|lopinavir|mesh-list
110093141|NCT01700790|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110093142|NCT01700790|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110093143|NCT01700790|Protease Inhibitors|protease inhibitors|mesh-ancestor
110093144|NCT01700790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110093145|NCT01700790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110093146|NCT01700790|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110093147|NCT01700790|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110093148|NCT01700790|Antiviral Agents|antiviral agents|mesh-ancestor
110093149|NCT01700790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110093150|NCT01700790|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110093151|NCT01700790|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110093152|NCT01700803|Iodine|iodine|mesh-list
110093154|NCT01700803|Povidone-Iodine|povidone-iodine|mesh-list
110093155|NCT01700803|Povidone|povidone|mesh-list
110093156|NCT01700803|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110093157|NCT01700803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110093158|NCT01700803|Trace Elements|trace elements|mesh-ancestor
110093159|NCT01700803|Micronutrients|micronutrients|mesh-ancestor
110093160|NCT01700803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110093161|NCT01700803|Plasma Substitutes|plasma substitutes|mesh-ancestor
110093162|NCT01700803|Blood Substitutes|blood substitutes|mesh-ancestor
110093163|NCT01700881|Vitamin E|vitamin e|mesh-list
110093164|NCT01700881|Vitamins|vitamins|mesh-ancestor
110093165|NCT01700881|Micronutrients|micronutrients|mesh-ancestor
110093166|NCT01700881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110093167|NCT01700881|Antioxidants|antioxidants|mesh-ancestor
110093168|NCT01700881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110093169|NCT01700881|Protective Agents|protective agents|mesh-ancestor
110093170|NCT01701076|Dexamethasone|dexamethasone|mesh-list
110093171|NCT01701076|Lenalidomide|lenalidomide|mesh-list
110093172|NCT01701076|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110093173|NCT01701076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110093174|NCT01701076|Antiemetics|antiemetics|mesh-ancestor
110093175|NCT01701076|Autonomic Agents|autonomic agents|mesh-ancestor
110093176|NCT01701076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110093177|NCT01701076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110093178|NCT01701076|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110093179|NCT01701076|Glucocorticoids|glucocorticoids|mesh-ancestor
110093180|NCT01701076|Hormones|hormones|mesh-ancestor
110093181|NCT01701076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110093182|NCT01701076|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110093183|NCT01701076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110093184|NCT01701076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110093185|NCT01701076|Immunologic Factors|immunologic factors|mesh-ancestor
110093186|NCT01701076|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110093187|NCT01701076|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110093188|NCT01701076|Growth Substances|growth substances|mesh-ancestor
110093189|NCT01701076|Growth Inhibitors|growth inhibitors|mesh-ancestor
110093190|NCT01701076|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110093191|NCT01701076|Alkylating Agents|alkylating agents|mesh-ancestor
110093192|NCT01701089|Selegiline|selegiline|mesh-list
110093193|NCT01701089|Antidepressive Agents|antidepressive agents|mesh-ancestor
110093194|NCT01701089|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110093195|NCT01701089|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110093196|NCT01701089|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110093197|NCT01701089|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
110093198|NCT01701089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110093199|NCT01701089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110093200|NCT01701089|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110093201|NCT01701089|Protective Agents|protective agents|mesh-ancestor
110093202|NCT01701089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110093203|NCT01701180|Oxytocin|oxytocin|mesh-list
110093204|NCT01701180|Oxytocics|oxytocics|mesh-ancestor
110093205|NCT01701180|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110093206|NCT01701180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110093207|NCT01701219|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
110093208|NCT01701219|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110093209|NCT01701219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110093210|NCT01701232|Rituximab|rituximab|mesh-list
110093211|NCT01701232|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110093212|NCT01701232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110093213|NCT01701232|Immunologic Factors|immunologic factors|mesh-ancestor
110093214|NCT01701232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110093215|NCT01701232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110093216|NCT01701297|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
110093217|NCT01701297|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110093218|NCT01701297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110093219|NCT01701297|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110093220|NCT01701297|Antimalarials|antimalarials|mesh-ancestor
110093221|NCT01701297|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110093222|NCT01701297|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110093225|NCT01701323|Fludarabine phosphate|fludarabine phosphate|mesh-list
110093226|NCT01701323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110093227|NCT01701323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110093228|NCT01701323|Antimetabolites|antimetabolites|mesh-ancestor
110093229|NCT01701323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110093230|NCT01701323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110093231|NCT01701323|Immunologic Factors|immunologic factors|mesh-ancestor
110093232|NCT01701323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110093233|NCT01701323|Antiviral Agents|antiviral agents|mesh-ancestor
110093234|NCT01701323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110093235|NCT01701336|Cloricromen|cloricromen|mesh-list
110093236|NCT01701336|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110093237|NCT01701349|Paclitaxel|paclitaxel|mesh-list
110093238|NCT01701349|Fosbretabulin|fosbretabulin|mesh-list
110093239|NCT01701349|Combretastatin|combretastatin|mesh-list
110093240|NCT01701349|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110093241|NCT01701349|Carboplatin|carboplatin|mesh-list
110093242|NCT01701349|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110093244|NCT01701349|Tubulin Modulators|tubulin modulators|mesh-ancestor
110093245|NCT01701349|Antimitotic Agents|antimitotic agents|mesh-ancestor
110093246|NCT01701349|Mitosis Modulators|mitosis modulators|mesh-ancestor
110093247|NCT01701349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110093248|NCT01701453|Clopidogrel|clopidogrel|mesh-list
110093249|NCT01701453|Ticagrelor|ticagrelor|mesh-list
110093250|NCT01701453|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
110093251|NCT01701453|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110093252|NCT01701453|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110093253|NCT01701453|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110093254|NCT01701453|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110093255|NCT01701453|Purinergic Agents|purinergic agents|mesh-ancestor
110093256|NCT01701453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110093257|NCT01701453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110093258|NCT01701453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110093259|NCT01701466|Silver Sulfadiazine|silver sulfadiazine|mesh-list
110093260|NCT01701466|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110093261|NCT01701466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110093262|NCT01701479|Aldesleukin|aldesleukin|mesh-list
110093263|NCT01701479|Interleukin-2|interleukin-2|mesh-list
110093264|NCT01701479|Dinutuximab|dinutuximab|mesh-list
110093265|NCT01701479|Isotretinoin|isotretinoin|mesh-list
110093266|NCT01701479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110093267|NCT01701479|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110093268|NCT01701479|Analgesics|analgesics|mesh-ancestor
110093269|NCT01701479|Sensory System Agents|sensory system agents|mesh-ancestor
110093270|NCT01701479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110093271|NCT01701479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110093272|NCT01701479|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110093273|NCT01701479|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110093274|NCT01701479|Antiviral Agents|antiviral agents|mesh-ancestor
110093275|NCT01701479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110093276|NCT01701479|Dermatologic Agents|dermatologic agents|mesh-ancestor
110093277|NCT01701518|Dexamethasone|dexamethasone|mesh-list
110093278|NCT01701518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110093279|NCT01701518|Antiemetics|antiemetics|mesh-ancestor
110093280|NCT01701518|Autonomic Agents|autonomic agents|mesh-ancestor
110093281|NCT01701518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110093282|NCT01701518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110093283|NCT01701518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110093284|NCT01701518|Glucocorticoids|glucocorticoids|mesh-ancestor
110093285|NCT01701518|Hormones|hormones|mesh-ancestor
110093286|NCT01701518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110093287|NCT01701518|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110093288|NCT01701518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110093289|NCT01701583|Omalizumab|omalizumab|mesh-list
110093290|NCT01701583|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110093291|NCT01701583|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110093292|NCT01701583|Respiratory System Agents|respiratory system agents|mesh-ancestor
110093294|NCT01701739|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110093295|NCT01701739|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110093296|NCT01701739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110093297|NCT01701739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110093298|NCT01701739|Protective Agents|protective agents|mesh-ancestor
110093299|NCT01701739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110093300|NCT01701778|Dexmedetomidine|dexmedetomidine|mesh-list
110093301|NCT01701778|Sevoflurane|sevoflurane|mesh-list
110093302|NCT01701778|Levobupivacaine|levobupivacaine|mesh-list
110093303|NCT01701778|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110093304|NCT01701778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110093305|NCT01701778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110093306|NCT01701778|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110093307|NCT01701778|Analgesics|analgesics|mesh-ancestor
110093308|NCT01701778|Sensory System Agents|sensory system agents|mesh-ancestor
110093309|NCT01701778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110093310|NCT01701778|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110093311|NCT01701778|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110093312|NCT01701778|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110093313|NCT01701778|Adrenergic Agents|adrenergic agents|mesh-ancestor
110093314|NCT01701778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110093315|NCT01701778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110093316|NCT01701778|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110093317|NCT01701778|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110093318|NCT01701778|Anesthetics, General|anesthetics, general|mesh-ancestor
110093319|NCT01701778|Anesthetics|anesthetics|mesh-ancestor
110093320|NCT01701778|Anesthetics, Local|anesthetics, local|mesh-ancestor
110093321|NCT01701843|Cromolyn Sodium|cromolyn sodium|mesh-list
110093322|NCT01701843|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
110093323|NCT01701843|Immunologic Factors|immunologic factors|mesh-ancestor
110093324|NCT01701843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110093325|NCT01701843|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110093326|NCT01701843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110093327|NCT01701843|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110093328|NCT01701843|Respiratory System Agents|respiratory system agents|mesh-ancestor
110093329|NCT01701856|Interferons|interferons|mesh-list
110093330|NCT01701856|Interferon-beta|interferon-beta|mesh-list
110093331|NCT01701856|Interferon beta-1b|interferon beta-1b|mesh-list
110093332|NCT01701856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110093333|NCT01701856|Antiviral Agents|antiviral agents|mesh-ancestor
110093334|NCT01701856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110093335|NCT01701856|Immunologic Factors|immunologic factors|mesh-ancestor
110093336|NCT01701856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110093337|NCT01701856|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110093338|NCT01701882|Tenofovir|tenofovir|mesh-list
110093339|NCT01701882|Emtricitabine|emtricitabine|mesh-list
110093340|NCT01701882|Rilpivirine|rilpivirine|mesh-list
110093341|NCT01701882|Antiviral Agents|antiviral agents|mesh-ancestor
110093342|NCT01701882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110093343|NCT01701882|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110093344|NCT01701882|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110093345|NCT01701882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110093346|NCT01701882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110093347|NCT01701882|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110093348|NCT01701882|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110093349|NCT01701921|Pregabalin|pregabalin|mesh-list
110093350|NCT01701921|Analgesics|analgesics|mesh-ancestor
110093351|NCT01701921|Sensory System Agents|sensory system agents|mesh-ancestor
110093352|NCT01701921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110093353|NCT01701921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110093354|NCT01701921|Anticonvulsants|anticonvulsants|mesh-ancestor
110093355|NCT01701921|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110093356|NCT01701921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110093357|NCT01701921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110093358|NCT01701921|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110093359|NCT01701921|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110093360|NCT01701921|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110093361|NCT01701921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110093362|NCT01701921|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110093363|NCT01702038|Rituximab|rituximab|mesh-list
110093364|NCT01702038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110093365|NCT01702038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110093366|NCT01702038|Immunologic Factors|immunologic factors|mesh-ancestor
110093367|NCT01702038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110093368|NCT01702038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110093370|NCT01702090|Darunavir|darunavir|mesh-list
110093371|NCT01702090|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110093372|NCT01702090|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110093373|NCT01702090|Protease Inhibitors|protease inhibitors|mesh-ancestor
110093374|NCT01702090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110093375|NCT01702090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110093376|NCT01702090|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110093377|NCT01702090|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110093378|NCT01702090|Antiviral Agents|antiviral agents|mesh-ancestor
110093379|NCT01702090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110093380|NCT01702090|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110093381|NCT01702090|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110093382|NCT01702103|Mometasone Furoate|mometasone furoate|mesh-list
110093383|NCT01702103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110093384|NCT01702103|Dermatologic Agents|dermatologic agents|mesh-ancestor
110093385|NCT01702103|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110093386|NCT01702129|Doxorubicin|doxorubicin|mesh-list
110093387|NCT01702129|Cetuximab|cetuximab|mesh-list
110093388|NCT01702129|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110093389|NCT01702129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110093390|NCT01702129|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110093391|NCT01702129|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110093392|NCT01702129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110093393|NCT01702129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110093394|NCT01702129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110093395|NCT01702181|Tacrolimus|tacrolimus|mesh-list
110093396|NCT01702181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110093397|NCT01702181|Immunologic Factors|immunologic factors|mesh-ancestor
110093398|NCT01702181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110093399|NCT01702181|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110093401|NCT01702181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110093402|NCT01702207|Tacrolimus|tacrolimus|mesh-list
110093403|NCT01702207|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110093404|NCT01702207|Immunologic Factors|immunologic factors|mesh-ancestor
110093405|NCT01702207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110093406|NCT01702207|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110093407|NCT01702207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110093408|NCT01702207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110093409|NCT01702376|Moxifloxacin|moxifloxacin|mesh-list
110093410|NCT01702376|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110093411|NCT01702376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110093412|NCT01702376|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110093413|NCT01702376|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110093414|NCT01702376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110093415|NCT01702376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110093416|NCT01702376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110093417|NCT01702389|Remifentanil|remifentanil|mesh-list
110093418|NCT01702389|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110093419|NCT01702389|Narcotics|narcotics|mesh-ancestor
110093420|NCT01702389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110093421|NCT01702389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110093422|NCT01702389|Analgesics|analgesics|mesh-ancestor
110093423|NCT01702389|Sensory System Agents|sensory system agents|mesh-ancestor
110093424|NCT01702389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110093425|NCT01702415|Zoledronic Acid|zoledronic acid|mesh-list
110093426|NCT01702415|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110093427|NCT01702415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110093428|NCT01702506|Antacids|antacids|mesh-list
110093429|NCT01702506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110093430|NCT01702506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110093431|NCT01702610|Temozolomide|temozolomide|mesh-list
110093432|NCT01702610|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110093433|NCT01702610|Alkylating Agents|alkylating agents|mesh-ancestor
110093434|NCT01702610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110093435|NCT01702610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110093436|NCT01702623|Oxcarbazepine|oxcarbazepine|mesh-list
110093437|NCT01702623|Anticonvulsants|anticonvulsants|mesh-ancestor
110093438|NCT01702623|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110093439|NCT01702623|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110093440|NCT01702623|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110093441|NCT01702623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110186016|NCT03062826|Aspirin|aspirin|mesh-list
110093442|NCT01702623|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110093443|NCT01702623|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110093445|NCT01702636|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110093446|NCT01702636|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110093447|NCT01702636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110093448|NCT01702636|Hemostatics|hemostatics|mesh-ancestor
110093449|NCT01702636|Coagulants|coagulants|mesh-ancestor
110093450|NCT01702649|Biapenem|biapenem|mesh-list
110093451|NCT01702649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110093452|NCT01702688|Angiotensin II|angiotensin ii|mesh-list
110093453|NCT01702688|Giapreza|giapreza|mesh-list
110093454|NCT01702688|Angiotensinogen|angiotensinogen|mesh-list
110093455|NCT01702688|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110093456|NCT01702688|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110093457|NCT01702688|Protease Inhibitors|protease inhibitors|mesh-ancestor
110093458|NCT01702688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110093459|NCT01702688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110093461|NCT01702701|Montelukast|montelukast|mesh-list
110093462|NCT01702701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110093463|NCT01702701|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110093464|NCT01702701|Autonomic Agents|autonomic agents|mesh-ancestor
110093465|NCT01702701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110093466|NCT01702701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110093467|NCT01702701|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110093468|NCT01702701|Respiratory System Agents|respiratory system agents|mesh-ancestor
110093469|NCT01702701|Dermatologic Agents|dermatologic agents|mesh-ancestor
110093470|NCT01702701|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110093471|NCT01702701|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110093472|NCT01702701|Hormone Antagonists|hormone antagonists|mesh-ancestor
110093473|NCT01702701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110093474|NCT01702701|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110093475|NCT01702701|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110093476|NCT01702701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110093477|NCT01702714|Paclitaxel|paclitaxel|mesh-list
110093478|NCT01702714|Carboplatin|carboplatin|mesh-list
110093479|NCT01702714|Gemcitabine|gemcitabine|mesh-list
110093480|NCT01702714|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110093481|NCT01702714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110093482|NCT01702714|Tubulin Modulators|tubulin modulators|mesh-ancestor
110038032|NCT01422317|Tocopherols|tocopherols|mesh-list
110093483|NCT01702714|Antimitotic Agents|antimitotic agents|mesh-ancestor
110093484|NCT01702714|Mitosis Modulators|mitosis modulators|mesh-ancestor
110093485|NCT01702714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110093486|NCT01702714|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110093487|NCT01702714|Antimetabolites|antimetabolites|mesh-ancestor
110093488|NCT01702792|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
110093489|NCT01702792|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110093490|NCT01702792|Immunologic Factors|immunologic factors|mesh-ancestor
110093491|NCT01702792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110093492|NCT01702857|Aluminum Hydroxide|aluminum hydroxide|mesh-list
110093493|NCT01702857|Vaccines|vaccines|mesh-list
110093494|NCT01702857|Aluminum sulfate|aluminum sulfate|mesh-list
110093495|NCT01702857|Immunologic Factors|immunologic factors|mesh-ancestor
110093496|NCT01702857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110093497|NCT01702857|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110093498|NCT01702857|Antacids|antacids|mesh-ancestor
110093499|NCT01702857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110093500|NCT01702857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110093501|NCT01702974|Vitamin D|vitamin d|mesh-list
110093502|NCT01702974|Cholecalciferol|cholecalciferol|mesh-list
110093503|NCT01702974|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
110093504|NCT01702974|Vitamins|vitamins|mesh-ancestor
110093505|NCT01702974|Micronutrients|micronutrients|mesh-ancestor
110093506|NCT01702974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110093507|NCT01702974|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110093508|NCT01702974|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110093509|NCT01702974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110093510|NCT01703104|Folic Acid|folic acid|mesh-list
110093511|NCT01703104|Vitamin B Complex|vitamin b complex|mesh-list
110093512|NCT01703104|Proguanil|proguanil|mesh-list
110093513|NCT01703104|Hematinics|hematinics|mesh-ancestor
110093515|NCT01703104|Micronutrients|micronutrients|mesh-ancestor
110093516|NCT01703104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110093517|NCT01703104|Antimalarials|antimalarials|mesh-ancestor
110093518|NCT01703104|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110093519|NCT01703104|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110093520|NCT01703104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110093521|NCT01703104|Antimetabolites|antimetabolites|mesh-ancestor
110093522|NCT01703104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110093523|NCT01703130|Ropivacaine|ropivacaine|mesh-list
110093524|NCT01703130|Anesthetics, Local|anesthetics, local|mesh-ancestor
110093525|NCT01703130|Anesthetics|anesthetics|mesh-ancestor
110093526|NCT01703130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110093527|NCT01703130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110093528|NCT01703130|Sensory System Agents|sensory system agents|mesh-ancestor
110093529|NCT01703130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110093531|NCT01703234|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110093532|NCT01703234|Protease Inhibitors|protease inhibitors|mesh-ancestor
110093533|NCT01703234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110093534|NCT01703234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110093535|NCT01703234|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110093536|NCT01703312|Omalizumab|omalizumab|mesh-list
110093537|NCT01703312|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110093538|NCT01703312|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110093539|NCT01703312|Respiratory System Agents|respiratory system agents|mesh-ancestor
110093540|NCT01703325|Triamcinolone|triamcinolone|mesh-list
110093541|NCT01703325|Clobetasol|clobetasol|mesh-list
110093542|NCT01703325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110093543|NCT01703325|Glucocorticoids|glucocorticoids|mesh-ancestor
110093544|NCT01703325|Hormones|hormones|mesh-ancestor
110093545|NCT01703325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110093546|NCT01703325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110093547|NCT01703351|Fentanyl|fentanyl|mesh-list
110093548|NCT01703351|Ropivacaine|ropivacaine|mesh-list
110093549|NCT01703351|Anesthetics, Local|anesthetics, local|mesh-ancestor
110093550|NCT01703351|Anesthetics|anesthetics|mesh-ancestor
110093551|NCT01703351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110093552|NCT01703351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110093553|NCT01703351|Sensory System Agents|sensory system agents|mesh-ancestor
110093554|NCT01703351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110093555|NCT01703351|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110093556|NCT01703351|Narcotics|narcotics|mesh-ancestor
110093557|NCT01703351|Analgesics|analgesics|mesh-ancestor
110093558|NCT01703351|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110093559|NCT01703351|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110093560|NCT01703351|Anesthetics, General|anesthetics, general|mesh-ancestor
110093561|NCT01703364|Lenalidomide|lenalidomide|mesh-list
110093562|NCT01703364|Immunologic Factors|immunologic factors|mesh-ancestor
110093563|NCT01703364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110093564|NCT01703364|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110093565|NCT01703364|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110093566|NCT01703364|Growth Substances|growth substances|mesh-ancestor
110093567|NCT01703364|Growth Inhibitors|growth inhibitors|mesh-ancestor
110093568|NCT01703364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110093569|NCT01703390|Cetuximab|cetuximab|mesh-list
110093570|NCT01703390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110093571|NCT01703390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110093572|NCT01703455|Sorafenib|sorafenib|mesh-list
110093573|NCT01703455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110093574|NCT01703455|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110093575|NCT01703455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110093576|NCT01703455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110093577|NCT01703468|Oxcarbazepine|oxcarbazepine|mesh-list
110093578|NCT01703468|Anticonvulsants|anticonvulsants|mesh-ancestor
110093579|NCT01703468|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110093580|NCT01703468|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110093581|NCT01703468|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110093582|NCT01703468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110093583|NCT01703468|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110093584|NCT01703468|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110093585|NCT01703559|Phentolamine|phentolamine|mesh-list
110093586|NCT01703559|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110093587|NCT01703559|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110093588|NCT01703559|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110093589|NCT01703559|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110093591|NCT01703559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110093592|NCT01703559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110093593|NCT01703559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110093594|NCT01703559|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110093595|NCT01703624|Glycopyrrolate|glycopyrrolate|mesh-list
110093596|NCT01703624|Bromides|bromides|mesh-list
110093597|NCT01703624|Anticonvulsants|anticonvulsants|mesh-ancestor
110093598|NCT01703624|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110093599|NCT01703624|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110093600|NCT01703624|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110093601|NCT01703624|Cholinergic Agents|cholinergic agents|mesh-ancestor
110093602|NCT01703624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110093603|NCT01703624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110093604|NCT01703624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110093605|NCT01703637|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110093606|NCT01703637|Vildagliptin|vildagliptin|mesh-list
110093607|NCT01703637|Saxagliptin|saxagliptin|mesh-list
110093608|NCT01703637|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110093609|NCT01703637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110093610|NCT01703637|Incretins|incretins|mesh-ancestor
110093611|NCT01703637|Hormones|hormones|mesh-ancestor
110093612|NCT01703637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110093613|NCT01703637|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110093614|NCT01703637|Protease Inhibitors|protease inhibitors|mesh-ancestor
110093615|NCT01703637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110093616|NCT01703637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110093617|NCT01703728|Menotropins|menotropins|mesh-list
110093618|NCT01703728|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110093619|NCT01703728|Fertility Agents|fertility agents|mesh-ancestor
110093620|NCT01703728|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110093621|NCT01703728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110093622|NCT01703754|Isophosphamide mustard|isophosphamide mustard|mesh-list
110093623|NCT01703754|Ifosfamide|ifosfamide|mesh-list
110093624|NCT01703754|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110093625|NCT01703754|Alkylating Agents|alkylating agents|mesh-ancestor
110093626|NCT01703754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110093627|NCT01703754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110093629|NCT01703910|Etoposide|etoposide|mesh-list
110093630|NCT01703910|Vinorelbine|vinorelbine|mesh-list
110093631|NCT01703910|Docetaxel|docetaxel|mesh-list
110093632|NCT01703910|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110093633|NCT01703910|Cisplatin|cisplatin|mesh-list
110093634|NCT01703910|Gemcitabine|gemcitabine|mesh-list
110093635|NCT01703910|Doxorubicin|doxorubicin|mesh-list
110093636|NCT01703910|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110093637|NCT01703910|Fluorouracil|fluorouracil|mesh-list
110093638|NCT01703910|Capecitabine|capecitabine|mesh-list
110093639|NCT01703910|Oxaliplatin|oxaliplatin|mesh-list
110093640|NCT01703910|Irinotecan|irinotecan|mesh-list
110093641|NCT01703910|Etoposide phosphate|etoposide phosphate|mesh-list
110093642|NCT01703910|Pemetrexed|pemetrexed|mesh-list
110093643|NCT01703910|Cetuximab|cetuximab|mesh-list
110093644|NCT01703910|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110093645|NCT01703910|Sorafenib|sorafenib|mesh-list
110093646|NCT01703910|Topotecan|topotecan|mesh-list
110093647|NCT01703910|Dasatinib|dasatinib|mesh-list
110093648|NCT01703910|Mitomycins|mitomycins|mesh-list
110093649|NCT01703910|Mitomycin|mitomycin|mesh-list
110093650|NCT01703910|Raltitrexed|raltitrexed|mesh-list
110093651|NCT01703910|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110093652|NCT01703910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110093653|NCT01703910|Tubulin Modulators|tubulin modulators|mesh-ancestor
110093654|NCT01703910|Antimitotic Agents|antimitotic agents|mesh-ancestor
110093655|NCT01703910|Mitosis Modulators|mitosis modulators|mesh-ancestor
110093656|NCT01703910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110093657|NCT01703910|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110093658|NCT01703910|Antimetabolites|antimetabolites|mesh-ancestor
110093659|NCT01703910|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110093660|NCT01703910|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110093661|NCT01703910|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110093662|NCT01703910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110093663|NCT01703910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110093664|NCT01703910|Immunologic Factors|immunologic factors|mesh-ancestor
110093665|NCT01703910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110093667|NCT01703910|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110093668|NCT01703910|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110093669|NCT01703910|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110093670|NCT01703910|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110093671|NCT01703910|Alkylating Agents|alkylating agents|mesh-ancestor
110093673|NCT01704027|Hormones|hormones|mesh-ancestor
110093674|NCT01704027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110093675|NCT01704027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110093676|NCT01704092|Dexmedetomidine|dexmedetomidine|mesh-list
110093677|NCT01704092|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110093678|NCT01704092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110093679|NCT01704092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110093680|NCT01704092|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110093681|NCT01704092|Analgesics|analgesics|mesh-ancestor
110093682|NCT01704092|Sensory System Agents|sensory system agents|mesh-ancestor
110093683|NCT01704092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110093684|NCT01704092|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110093685|NCT01704092|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110093687|NCT01704092|Adrenergic Agents|adrenergic agents|mesh-ancestor
110093688|NCT01704092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110093689|NCT01704092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110093690|NCT01704248|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110093691|NCT01704248|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110093692|NCT01704339|Capsaicin|capsaicin|mesh-list
110093693|NCT01704339|Antipruritics|antipruritics|mesh-ancestor
110093694|NCT01704339|Dermatologic Agents|dermatologic agents|mesh-ancestor
110093695|NCT01704339|Sensory System Agents|sensory system agents|mesh-ancestor
110093696|NCT01704339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110093697|NCT01704339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110093698|NCT01704378|Insulin Aspart|insulin aspart|mesh-list
110093699|NCT01704378|Biphasic Insulins|biphasic insulins|mesh-list
110093700|NCT01704378|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110093701|NCT01704378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110093702|NCT01704417|Insulin|insulin|mesh-list
110093703|NCT01704417|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110093704|NCT01704417|Insulin Glargine|insulin glargine|mesh-list
110093705|NCT01704417|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110093706|NCT01704417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110093707|NCT01704469|Anesthetics|anesthetics|mesh-list
110093708|NCT01704469|Anesthetics, Local|anesthetics, local|mesh-list
110093709|NCT01704469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110093710|NCT01704469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110093711|NCT01704469|Sensory System Agents|sensory system agents|mesh-ancestor
110093712|NCT01704469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110093713|NCT01704482|Acetylcysteine|acetylcysteine|mesh-list
110093714|NCT01704482|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110093715|NCT01704482|Antiviral Agents|antiviral agents|mesh-ancestor
110093716|NCT01704482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110093717|NCT01704482|Expectorants|expectorants|mesh-ancestor
110093718|NCT01704482|Respiratory System Agents|respiratory system agents|mesh-ancestor
110093719|NCT01704482|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110093720|NCT01704482|Antioxidants|antioxidants|mesh-ancestor
110186044|NCT00130364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110093721|NCT01704482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110093722|NCT01704482|Protective Agents|protective agents|mesh-ancestor
110093723|NCT01704482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110093725|NCT01704508|Lumefantrine|lumefantrine|mesh-list
110093726|NCT01704508|Artemether|artemether|mesh-list
110093727|NCT01704508|Piperaquine|piperaquine|mesh-list
110093728|NCT01704508|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
110093729|NCT01704508|Artenimol|artenimol|mesh-list
110093730|NCT01704508|Antimalarials|antimalarials|mesh-ancestor
110093731|NCT01704508|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110093732|NCT01704508|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110093733|NCT01704508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110093734|NCT01704534|Ustekinumab|ustekinumab|mesh-list
110093735|NCT01704534|Dermatologic Agents|dermatologic agents|mesh-ancestor
110093736|NCT01704612|Ropivacaine|ropivacaine|mesh-list
110093737|NCT01704612|Anesthetics, Local|anesthetics, local|mesh-ancestor
110093738|NCT01704612|Anesthetics|anesthetics|mesh-ancestor
110093739|NCT01704612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110093740|NCT01704612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110093741|NCT01704612|Sensory System Agents|sensory system agents|mesh-ancestor
110093743|NCT01704638|Digoxin|digoxin|mesh-list
110093744|NCT01704638|Fluvoxamine|fluvoxamine|mesh-list
110093745|NCT01704638|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110093746|NCT01704638|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110093747|NCT01704638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110093748|NCT01704638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110093749|NCT01704638|Protective Agents|protective agents|mesh-ancestor
110093750|NCT01704638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110093751|NCT01704638|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110093752|NCT01704638|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110093753|NCT01704638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110093754|NCT01704638|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110093755|NCT01704638|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110093756|NCT01704638|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110093757|NCT01704638|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110093758|NCT01704638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110093759|NCT01704638|Serotonin Agents|serotonin agents|mesh-ancestor
110093760|NCT01704638|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110093761|NCT01704638|Antidepressive Agents|antidepressive agents|mesh-ancestor
110093762|NCT01704638|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110093763|NCT01704638|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110093764|NCT01704638|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110093765|NCT01704690|Paclitaxel|paclitaxel|mesh-list
110093766|NCT01704690|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110093767|NCT01704690|Cisplatin|cisplatin|mesh-list
110093768|NCT01704690|Fluorouracil|fluorouracil|mesh-list
110093769|NCT01704690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110093770|NCT01704690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110093771|NCT01704690|Tubulin Modulators|tubulin modulators|mesh-ancestor
110093772|NCT01704690|Antimitotic Agents|antimitotic agents|mesh-ancestor
110093773|NCT01704690|Mitosis Modulators|mitosis modulators|mesh-ancestor
110093774|NCT01704690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110093775|NCT01704690|Antimetabolites|antimetabolites|mesh-ancestor
110093776|NCT01704690|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110093777|NCT01704690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110093778|NCT01704690|Immunologic Factors|immunologic factors|mesh-ancestor
110093779|NCT01704690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110093780|NCT01704703|Panitumumab|panitumumab|mesh-list
110093781|NCT01704703|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110093782|NCT01704703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110093783|NCT01704716|Aldesleukin|aldesleukin|mesh-list
110093784|NCT01704716|Cyclophosphamide|cyclophosphamide|mesh-list
110093785|NCT01704716|Melphalan|melphalan|mesh-list
110093786|NCT01704716|Busulfan|busulfan|mesh-list
110093787|NCT01704716|Carboplatin|carboplatin|mesh-list
110093788|NCT01704716|Doxorubicin|doxorubicin|mesh-list
110093789|NCT01704716|Etoposide|etoposide|mesh-list
110093790|NCT01704716|Vincristine|vincristine|mesh-list
110093791|NCT01704716|Interleukin-2|interleukin-2|mesh-list
110093792|NCT01704716|Dinutuximab|dinutuximab|mesh-list
110093793|NCT01704716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110093794|NCT01704716|Immunologic Factors|immunologic factors|mesh-ancestor
110093795|NCT01704716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110093796|NCT01704716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110093797|NCT01704716|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110093798|NCT01704716|Alkylating Agents|alkylating agents|mesh-ancestor
110093799|NCT01704716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110093800|NCT01704716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110093801|NCT01704716|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110093802|NCT01704716|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110093803|NCT01704716|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110093804|NCT01704716|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110093805|NCT01704716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110093806|NCT01704716|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110093807|NCT01704716|Tubulin Modulators|tubulin modulators|mesh-ancestor
110093808|NCT01704716|Antimitotic Agents|antimitotic agents|mesh-ancestor
110093809|NCT01704716|Mitosis Modulators|mitosis modulators|mesh-ancestor
110093810|NCT01704716|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110093811|NCT01704716|Analgesics|analgesics|mesh-ancestor
110093812|NCT01704716|Sensory System Agents|sensory system agents|mesh-ancestor
110093813|NCT01704716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110093814|NCT01704716|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110093815|NCT01704716|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110093816|NCT01704716|Antiviral Agents|antiviral agents|mesh-ancestor
110093817|NCT01704716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110093818|NCT01704794|Folic Acid|folic acid|mesh-list
110093819|NCT01704794|Vitamin B Complex|vitamin b complex|mesh-list
110093820|NCT01704794|Proguanil|proguanil|mesh-list
110093821|NCT01704794|Hematinics|hematinics|mesh-ancestor
110093822|NCT01704794|Vitamins|vitamins|mesh-ancestor
110093823|NCT01704794|Micronutrients|micronutrients|mesh-ancestor
110093824|NCT01704794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110093825|NCT01704794|Antimalarials|antimalarials|mesh-ancestor
110093826|NCT01704794|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110093827|NCT01704794|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110093828|NCT01704794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110093829|NCT01704794|Antimetabolites|antimetabolites|mesh-ancestor
110093830|NCT01704794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110093832|NCT01704872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110093833|NCT01704898|Efavirenz|efavirenz|mesh-list
110093834|NCT01704898|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110093835|NCT01704898|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110093836|NCT01704898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110093837|NCT01704898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110093838|NCT01704898|Antiviral Agents|antiviral agents|mesh-ancestor
110093839|NCT01704898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110093840|NCT01704898|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110093841|NCT01704898|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110093842|NCT01704898|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110093843|NCT01704898|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110093844|NCT01704898|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110093845|NCT01704898|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110093846|NCT01705002|Bevacizumab|bevacizumab|mesh-list
110093847|NCT01705002|Capecitabine|capecitabine|mesh-list
110093848|NCT01705002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110093849|NCT01705002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110093850|NCT01705002|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110093851|NCT01705002|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110093853|NCT01705002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110093854|NCT01705002|Growth Inhibitors|growth inhibitors|mesh-ancestor
110093855|NCT01705002|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110093856|NCT01705002|Antimetabolites|antimetabolites|mesh-ancestor
110093857|NCT01705002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110093858|NCT01705041|Liver Extracts|liver extracts|mesh-list
110093859|NCT01705041|Hematinics|hematinics|mesh-ancestor
110093860|NCT01705223|Vaccines|vaccines|mesh-list
110093861|NCT01705223|Immunologic Factors|immunologic factors|mesh-ancestor
110093862|NCT01705223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110093863|NCT01705249|Norethindrone|norethindrone|mesh-list
110093864|NCT01705249|Norethindrone Acetate|norethindrone acetate|mesh-list
110093865|NCT01705249|Estradiol|estradiol|mesh-list
110093866|NCT01705249|Estrogens|estrogens|mesh-ancestor
110093867|NCT01705249|Hormones|hormones|mesh-ancestor
110093868|NCT01705249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110093869|NCT01705249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110093870|NCT01705249|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110093871|NCT01705249|Contraceptive Agents|contraceptive agents|mesh-ancestor
110093872|NCT01705249|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110093873|NCT01705249|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110093874|NCT01705249|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110093875|NCT01705249|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110093876|NCT01705249|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110093877|NCT01705314|Vitamin D|vitamin d|mesh-list
110093878|NCT01705314|Vitamins|vitamins|mesh-ancestor
110093879|NCT01705314|Micronutrients|micronutrients|mesh-ancestor
110093880|NCT01705314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110093881|NCT01705314|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110093882|NCT01705340|Trastuzumab|trastuzumab|mesh-list
110093883|NCT01705340|Lapatinib|lapatinib|mesh-list
110093884|NCT01705340|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110093885|NCT01705340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110093886|NCT01705340|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110093887|NCT01705340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110093888|NCT01705340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110093889|NCT01705379|Lactitol|lactitol|mesh-list
110093890|NCT01705379|Cathartics|cathartics|mesh-ancestor
110093891|NCT01705379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110093893|NCT01705392|Dacarbazine|dacarbazine|mesh-list
110093894|NCT01705392|Propranolol|propranolol|mesh-list
110093895|NCT01705392|Enalapril|enalapril|mesh-list
110093896|NCT01705392|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110093897|NCT01705392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110093898|NCT01705392|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110093899|NCT01705392|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110093900|NCT01705392|Growth Substances|growth substances|mesh-ancestor
110093901|NCT01705392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110093902|NCT01705392|Growth Inhibitors|growth inhibitors|mesh-ancestor
110093903|NCT01705392|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110093904|NCT01705392|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110093905|NCT01705392|Adrenergic Agents|adrenergic agents|mesh-ancestor
110093906|NCT01705392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110093907|NCT01705392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110093908|NCT01705392|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110093909|NCT01705392|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110093910|NCT01705392|Vasodilator Agents|vasodilator agents|mesh-ancestor
110093911|NCT01705392|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110093912|NCT01705392|Alkylating Agents|alkylating agents|mesh-ancestor
110093913|NCT01705392|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110093914|NCT01705392|Protease Inhibitors|protease inhibitors|mesh-ancestor
110093915|NCT01705392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110093916|NCT01705457|Vitamin A|vitamin a|mesh-list
110093917|NCT01705457|Retinol palmitate|retinol palmitate|mesh-list
110093918|NCT01705457|Vitamins|vitamins|mesh-ancestor
110093919|NCT01705457|Micronutrients|micronutrients|mesh-ancestor
110093920|NCT01705457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110093921|NCT01705457|Antioxidants|antioxidants|mesh-ancestor
110093922|NCT01705457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110093923|NCT01705457|Protective Agents|protective agents|mesh-ancestor
110093924|NCT01705457|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110093925|NCT01705457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110093926|NCT01705470|Furosemide|furosemide|mesh-list
110093927|NCT01705470|Diuretics|diuretics|mesh-ancestor
110093928|NCT01705470|Natriuretic Agents|natriuretic agents|mesh-ancestor
110093929|NCT01705470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110093930|NCT01705470|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110093931|NCT01705470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110093932|NCT01705470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110093933|NCT01705483|Paclitaxel|paclitaxel|mesh-list
110093934|NCT01705483|Docetaxel|docetaxel|mesh-list
110093935|NCT01705483|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110093936|NCT01705483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110093937|NCT01705483|Tubulin Modulators|tubulin modulators|mesh-ancestor
110093938|NCT01705483|Antimitotic Agents|antimitotic agents|mesh-ancestor
110040007|NCT01430689|Vaccines|vaccines|mesh-list
110093939|NCT01705483|Mitosis Modulators|mitosis modulators|mesh-ancestor
110093940|NCT01705483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110093941|NCT01705639|Melatonin|melatonin|mesh-list
110093942|NCT01705639|Antioxidants|antioxidants|mesh-ancestor
110093943|NCT01705639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110093944|NCT01705639|Protective Agents|protective agents|mesh-ancestor
110093945|NCT01705639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110093946|NCT01705639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110093947|NCT01705743|Nitrous Oxide|nitrous oxide|mesh-list
110093948|NCT01705743|Sevoflurane|sevoflurane|mesh-list
110093949|NCT01705743|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110093950|NCT01705743|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110093951|NCT01705743|Anesthetics, General|anesthetics, general|mesh-ancestor
110093952|NCT01705743|Anesthetics|anesthetics|mesh-ancestor
110093953|NCT01705743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110093954|NCT01705743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110093955|NCT01705743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110093956|NCT01705743|Analgesics|analgesics|mesh-ancestor
110093957|NCT01705743|Sensory System Agents|sensory system agents|mesh-ancestor
110093958|NCT01705743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110093959|NCT01705756|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
110093960|NCT01705756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110093961|NCT01705769|Micronutrients|micronutrients|mesh-list
110093962|NCT01705769|Trace Elements|trace elements|mesh-list
110093963|NCT01705769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110093964|NCT01705795|Antibodies|antibodies|mesh-list
110093965|NCT01705795|Immunologic Factors|immunologic factors|mesh-ancestor
110093966|NCT01705795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110093969|NCT01705808|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110093970|NCT01705808|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110093971|NCT01705808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110093972|NCT01705938|Dolcanatide|dolcanatide|mesh-list
110093973|NCT01705938|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
110093974|NCT01705938|Enzyme Activators|enzyme activators|mesh-ancestor
110093975|NCT01705938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110093976|NCT01705938|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110093977|NCT01705951|Nicotine|nicotine|mesh-list
110093978|NCT01705951|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110093979|NCT01705951|Autonomic Agents|autonomic agents|mesh-ancestor
110093980|NCT01705951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110093981|NCT01705951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110093982|NCT01705951|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110093983|NCT01705951|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110093984|NCT01705951|Cholinergic Agents|cholinergic agents|mesh-ancestor
110093985|NCT01705951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110093986|NCT01705951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110093987|NCT01706055|Interferons|interferons|mesh-list
110093988|NCT01706055|Interferon-beta|interferon-beta|mesh-list
110093989|NCT01706055|Interferon beta-1b|interferon beta-1b|mesh-list
110093990|NCT01706055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110093991|NCT01706055|Antiviral Agents|antiviral agents|mesh-ancestor
110093992|NCT01706055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110093993|NCT01706055|Immunologic Factors|immunologic factors|mesh-ancestor
110093994|NCT01706055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110093995|NCT01706055|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110093996|NCT01706172|Lidocaine|lidocaine|mesh-list
110093997|NCT01706172|Anesthetics, Local|anesthetics, local|mesh-ancestor
110093998|NCT01706172|Anesthetics|anesthetics|mesh-ancestor
110093999|NCT01706172|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110094000|NCT01706172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110094001|NCT01706172|Sensory System Agents|sensory system agents|mesh-ancestor
110094002|NCT01706172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110094003|NCT01706172|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110186066|NCT00394394|Enalapril|enalapril|mesh-list
110094004|NCT01706172|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110094005|NCT01706172|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110094006|NCT01706172|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110094007|NCT01706172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110094008|NCT01706211|Rosiglitazone|rosiglitazone|mesh-list
110094009|NCT01706211|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110094010|NCT01706211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110094011|NCT01706315|Gepotidacin|gepotidacin|mesh-list
110094012|NCT01706315|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110094013|NCT01706315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110094014|NCT01706315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110094015|NCT01706315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110094016|NCT01706341|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110094017|NCT01706354|Anesthetics|anesthetics|mesh-list
110094018|NCT01706354|Anesthetics, Local|anesthetics, local|mesh-list
110094019|NCT01706354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110094020|NCT01706354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110094021|NCT01706354|Sensory System Agents|sensory system agents|mesh-ancestor
110094022|NCT01706354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110094023|NCT01706367|Vaccines|vaccines|mesh-list
110094024|NCT01706367|Immunologic Factors|immunologic factors|mesh-ancestor
110094025|NCT01706367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110094026|NCT01706471|Mycophenolic Acid|mycophenolic acid|mesh-list
110094027|NCT01706471|Everolimus|everolimus|mesh-list
110094028|NCT01706471|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110094029|NCT01706471|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110094030|NCT01706471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110094031|NCT01706471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110094032|NCT01706471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110094033|NCT01706471|Immunologic Factors|immunologic factors|mesh-ancestor
110094034|NCT01706471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110094035|NCT01706471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110094036|NCT01706471|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110094037|NCT01706471|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110094038|NCT01706471|Antitubercular Agents|antitubercular agents|mesh-ancestor
110094039|NCT01706471|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110094040|NCT01706471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110094041|NCT01706510|Clopidogrel|clopidogrel|mesh-list
110094042|NCT01706510|Ticagrelor|ticagrelor|mesh-list
110094043|NCT01706510|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110094044|NCT01706510|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110094045|NCT01706510|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110094046|NCT01706510|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110094047|NCT01706510|Purinergic Agents|purinergic agents|mesh-ancestor
110094048|NCT01706510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110094049|NCT01706510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110094050|NCT01706510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110094051|NCT01706562|Itraconazole|itraconazole|mesh-list
110094052|NCT01706562|Antifungal Agents|antifungal agents|mesh-ancestor
110094053|NCT01706562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110094054|NCT01706562|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110094055|NCT01706562|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110094056|NCT01706562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110094057|NCT01706562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110094058|NCT01706562|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110094059|NCT01706562|Hormone Antagonists|hormone antagonists|mesh-ancestor
110094060|NCT01706562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110094061|NCT01706562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110094062|NCT01706562|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110094063|NCT01706627|Melatonin|melatonin|mesh-list
110094064|NCT01706627|Antioxidants|antioxidants|mesh-ancestor
110094065|NCT01706627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110094066|NCT01706627|Protective Agents|protective agents|mesh-ancestor
110094067|NCT01706627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110094068|NCT01706627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110094069|NCT01706679|Moxifloxacin|moxifloxacin|mesh-list
110094070|NCT01706679|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110094071|NCT01706679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110094072|NCT01706679|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110094073|NCT01706679|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110094074|NCT01706679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110094075|NCT01706679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110094076|NCT01706679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110094078|NCT01706874|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110094079|NCT01706874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110094080|NCT01706887|Amiloride|amiloride|mesh-list
110094081|NCT01706887|Diuretics|diuretics|mesh-ancestor
110094082|NCT01706887|Natriuretic Agents|natriuretic agents|mesh-ancestor
110094083|NCT01706887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110094084|NCT01706887|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
110094085|NCT01706887|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110094086|NCT01706887|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110040276|NCT01432249|Etanercept|etanercept|mesh-list
110094087|NCT01706887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110094088|NCT01706887|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
110094089|NCT01706887|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110094090|NCT01707082|Midazolam|midazolam|mesh-list
110094091|NCT01707082|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110094092|NCT01707082|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110094093|NCT01707082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110094094|NCT01707082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110094095|NCT01707082|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110094096|NCT01707082|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110094097|NCT01707082|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110094098|NCT01707082|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110094099|NCT01707082|Anesthetics, General|anesthetics, general|mesh-ancestor
110094100|NCT01707082|Anesthetics|anesthetics|mesh-ancestor
110094101|NCT01707082|GABA Modulators|gaba modulators|mesh-ancestor
110094102|NCT01707082|GABA Agents|gaba agents|mesh-ancestor
110094103|NCT01707082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110094104|NCT01707082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110094105|NCT01707134|Insulin|insulin|mesh-list
110094106|NCT01707134|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110094107|NCT01707134|Insulin Aspart|insulin aspart|mesh-list
110094108|NCT01707134|Isophane Insulin, Human|isophane insulin, human|mesh-list
110094109|NCT01707134|Insulin, Isophane|insulin, isophane|mesh-list
110094110|NCT01707134|Isophane insulin, beef|isophane insulin, beef|mesh-list
110094111|NCT01707134|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110094112|NCT01707134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110094113|NCT01707160|Insulin|insulin|mesh-list
110094114|NCT01707160|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110094115|NCT01707160|Insulin Aspart|insulin aspart|mesh-list
110094116|NCT01707160|Biphasic Insulins|biphasic insulins|mesh-list
110094117|NCT01707160|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
110094118|NCT01707160|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110094119|NCT01707160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110094121|NCT01707199|Pyrimethamine|pyrimethamine|mesh-list
110094122|NCT01707199|Sulfadoxine|sulfadoxine|mesh-list
110094123|NCT01707199|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
110094124|NCT01707199|Antimalarials|antimalarials|mesh-ancestor
110094125|NCT01707199|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110094126|NCT01707199|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110094127|NCT01707199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110094128|NCT01707199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110094129|NCT01707199|Antiviral Agents|antiviral agents|mesh-ancestor
110094130|NCT01707199|Schistosomicides|schistosomicides|mesh-ancestor
110094131|NCT01707199|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110094132|NCT01707199|Anthelmintics|anthelmintics|mesh-ancestor
110094133|NCT01707199|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110094134|NCT01707199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110094135|NCT01707199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110094136|NCT01707199|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110094138|NCT01707251|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110094139|NCT01707251|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110094140|NCT01707251|Analgesics|analgesics|mesh-ancestor
110094141|NCT01707251|Sensory System Agents|sensory system agents|mesh-ancestor
110094142|NCT01707251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110094143|NCT01707251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110094144|NCT01707251|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110094145|NCT01707251|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110094146|NCT01707251|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110094147|NCT01707251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110094148|NCT01707251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110094149|NCT01707316|Canagliflozin|canagliflozin|mesh-list
110094150|NCT01707316|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110094151|NCT01707316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110094152|NCT01707316|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110094153|NCT01707316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110094154|NCT01707342|Simeprevir|simeprevir|mesh-list
110094155|NCT01707342|Antiviral Agents|antiviral agents|mesh-ancestor
110094156|NCT01707342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110094157|NCT01707342|Protease Inhibitors|protease inhibitors|mesh-ancestor
110094158|NCT01707342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110094159|NCT01707342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110094160|NCT01707394|Apixaban|apixaban|mesh-list
110040540|NCT01434147|Bevacizumab|bevacizumab|mesh-list
110094161|NCT01707394|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110094162|NCT01707394|Antithrombins|antithrombins|mesh-ancestor
110094163|NCT01707394|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110094164|NCT01707394|Protease Inhibitors|protease inhibitors|mesh-ancestor
110094165|NCT01707394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110094166|NCT01707394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110094167|NCT01707394|Anticoagulants|anticoagulants|mesh-ancestor
110094168|NCT01707407|Ketoconazole|ketoconazole|mesh-list
110094169|NCT01707407|Pomalidomide|pomalidomide|mesh-list
110094170|NCT01707407|Carbamazepine|carbamazepine|mesh-list
110094171|NCT01707407|Fluvoxamine|fluvoxamine|mesh-list
110094172|NCT01707407|Immunologic Factors|immunologic factors|mesh-ancestor
110094173|NCT01707407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110094174|NCT01707407|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110094175|NCT01707407|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110094176|NCT01707407|Growth Substances|growth substances|mesh-ancestor
110094177|NCT01707407|Growth Inhibitors|growth inhibitors|mesh-ancestor
110094178|NCT01707407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110094179|NCT01707407|Antifungal Agents|antifungal agents|mesh-ancestor
110094180|NCT01707407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110094181|NCT01707407|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110094182|NCT01707407|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110094183|NCT01707407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110094184|NCT01707407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110094185|NCT01707407|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110094186|NCT01707407|Hormone Antagonists|hormone antagonists|mesh-ancestor
110094187|NCT01707407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110094188|NCT01707407|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110094189|NCT01707407|Anticonvulsants|anticonvulsants|mesh-ancestor
110094190|NCT01707407|Antimanic Agents|antimanic agents|mesh-ancestor
110094191|NCT01707407|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110094192|NCT01707407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110094193|NCT01707407|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110094194|NCT01707407|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110094195|NCT01707407|Analgesics|analgesics|mesh-ancestor
110094196|NCT01707407|Sensory System Agents|sensory system agents|mesh-ancestor
110094197|NCT01707407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110094198|NCT01707407|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110094199|NCT01707407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110094200|NCT01707407|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110094201|NCT01707407|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110094203|NCT01707407|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110094204|NCT01707407|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110094205|NCT01707407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110094206|NCT01707407|Serotonin Agents|serotonin agents|mesh-ancestor
110094207|NCT01707407|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110094208|NCT01707407|Antidepressive Agents|antidepressive agents|mesh-ancestor
110094209|NCT01707407|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110094210|NCT01707407|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110094212|NCT01707537|Immunologic Factors|immunologic factors|mesh-ancestor
110094213|NCT01707537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110094214|NCT01707615|Proanthocyanidin|proanthocyanidin|mesh-list
110094215|NCT01707615|Antioxidants|antioxidants|mesh-ancestor
110094216|NCT01707615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110094217|NCT01707615|Protective Agents|protective agents|mesh-ancestor
110094218|NCT01707615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110094219|NCT01707615|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110094220|NCT01707615|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110094221|NCT01707615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110094222|NCT01707732|Enoxaparin|enoxaparin|mesh-list
110094223|NCT01707732|Anticoagulants|anticoagulants|mesh-ancestor
110094224|NCT01707732|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110094225|NCT01707732|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110094226|NCT01707732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110094227|NCT01707745|Bevacizumab|bevacizumab|mesh-list
110094228|NCT01707745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110094229|NCT01707745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110094231|NCT01707745|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110094232|NCT01707745|Growth Substances|growth substances|mesh-ancestor
110094233|NCT01707745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110094234|NCT01707745|Growth Inhibitors|growth inhibitors|mesh-ancestor
110094235|NCT01707823|Aspirin|aspirin|mesh-list
110094236|NCT01707823|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110094237|NCT01707823|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110094238|NCT01707823|Analgesics|analgesics|mesh-ancestor
110094239|NCT01707823|Sensory System Agents|sensory system agents|mesh-ancestor
110094240|NCT01707823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110094241|NCT01707823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110094242|NCT01707823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110094243|NCT01707823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110094244|NCT01707823|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110094245|NCT01707823|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110094246|NCT01707823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110094247|NCT01707823|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110094248|NCT01707823|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110094249|NCT01707823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110094250|NCT01707823|Antipyretics|antipyretics|mesh-ancestor
110094251|NCT01707849|Everolimus|everolimus|mesh-list
110094252|NCT01707849|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110094253|NCT01707849|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110094254|NCT01707849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110094255|NCT01707849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110094256|NCT01707849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110094257|NCT01707849|Immunologic Factors|immunologic factors|mesh-ancestor
110094258|NCT01707849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110094259|NCT01707849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110094260|NCT01707940|Ketoconazole|ketoconazole|mesh-list
110094261|NCT01707940|Antifungal Agents|antifungal agents|mesh-ancestor
110094262|NCT01707940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110094263|NCT01707940|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110094264|NCT01707940|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110094265|NCT01707940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110094266|NCT01707940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110186093|NCT00130091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110094267|NCT01707940|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110094268|NCT01707940|Hormone Antagonists|hormone antagonists|mesh-ancestor
110094269|NCT01707940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110094270|NCT01707940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110094271|NCT01707940|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110094273|NCT01707953|Sympathomimetics|sympathomimetics|mesh-ancestor
110094274|NCT01707953|Autonomic Agents|autonomic agents|mesh-ancestor
110094275|NCT01707953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110094276|NCT01707953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110094277|NCT01707953|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110094278|NCT01707953|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110094279|NCT01707953|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110094280|NCT01707953|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110094281|NCT01707953|Adrenergic Agents|adrenergic agents|mesh-ancestor
110094282|NCT01707953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110094283|NCT01707953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110094284|NCT01708005|Vitamin D|vitamin d|mesh-list
110094285|NCT01708005|Cholecalciferol|cholecalciferol|mesh-list
110094286|NCT01708005|Vitamins|vitamins|mesh-ancestor
110094287|NCT01708005|Micronutrients|micronutrients|mesh-ancestor
110094288|NCT01708005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110094289|NCT01708005|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110094290|NCT01708005|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110094291|NCT01708044|Pramlintide|pramlintide|mesh-list
110094292|NCT01708044|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110094293|NCT01708044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110094294|NCT01708239|Fibrin fragment D|fibrin fragment d|mesh-list
110094295|NCT01708239|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110094296|NCT01708239|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110094297|NCT01708239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110094298|NCT01708239|Hemostatics|hemostatics|mesh-ancestor
110094299|NCT01708239|Coagulants|coagulants|mesh-ancestor
110094300|NCT01708330|Lidocaine|lidocaine|mesh-list
110094301|NCT01708330|Anesthetics, Local|anesthetics, local|mesh-ancestor
110094302|NCT01708330|Anesthetics|anesthetics|mesh-ancestor
110094303|NCT01708330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110094304|NCT01708330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110094305|NCT01708330|Sensory System Agents|sensory system agents|mesh-ancestor
110094306|NCT01708330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110094307|NCT01708330|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110094308|NCT01708330|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110094309|NCT01708330|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110094310|NCT01708330|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110094311|NCT01708330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110094312|NCT01708369|Aspirin|aspirin|mesh-list
110094313|NCT01708369|Ethanol|ethanol|mesh-list
110094314|NCT01708369|Oseltamivir|oseltamivir|mesh-list
110094315|NCT01708369|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110094316|NCT01708369|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110094317|NCT01708369|Analgesics|analgesics|mesh-ancestor
110094318|NCT01708369|Sensory System Agents|sensory system agents|mesh-ancestor
110094319|NCT01708369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110094320|NCT01708369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110094321|NCT01708369|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110094322|NCT01708369|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110094323|NCT01708369|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110094324|NCT01708369|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110094325|NCT01708369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110094326|NCT01708369|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110094327|NCT01708369|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110094328|NCT01708369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110094329|NCT01708369|Antipyretics|antipyretics|mesh-ancestor
110094330|NCT01708369|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110094331|NCT01708369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110094332|NCT01708369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110094333|NCT01708369|Antiviral Agents|antiviral agents|mesh-ancestor
110094334|NCT01708447|Lidocaine|lidocaine|mesh-list
110094335|NCT01708447|Anesthetics, Local|anesthetics, local|mesh-list
110094336|NCT01708447|Anesthetics|anesthetics|mesh-list
110094337|NCT01708447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110094338|NCT01708447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110094339|NCT01708447|Sensory System Agents|sensory system agents|mesh-ancestor
110094340|NCT01708447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110094341|NCT01708447|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110094342|NCT01708447|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110094343|NCT01708447|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110094344|NCT01708447|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110094345|NCT01708447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110094347|NCT01708616|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110094348|NCT01708616|Serotonin Agents|serotonin agents|mesh-ancestor
110094349|NCT01708616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110094350|NCT01708616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110094351|NCT01708616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110094352|NCT01708616|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110094353|NCT01708616|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110094354|NCT01708616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110094355|NCT01708616|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110094356|NCT01708616|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110094357|NCT01708616|Dopamine Agents|dopamine agents|mesh-ancestor
110094358|NCT01708642|Epinephrine|epinephrine|mesh-list
110094359|NCT01708642|Racepinephrine|racepinephrine|mesh-list
110094360|NCT01708642|Epinephryl borate|epinephryl borate|mesh-list
110094361|NCT01708642|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110094362|NCT01708642|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110094363|NCT01708642|Adrenergic Agents|adrenergic agents|mesh-ancestor
110094364|NCT01708642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110094365|NCT01708642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110094366|NCT01708642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110094367|NCT01708642|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110094368|NCT01708642|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110094369|NCT01708642|Autonomic Agents|autonomic agents|mesh-ancestor
110094370|NCT01708642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110094371|NCT01708642|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110094372|NCT01708642|Respiratory System Agents|respiratory system agents|mesh-ancestor
110094373|NCT01708642|Mydriatics|mydriatics|mesh-ancestor
110094374|NCT01708642|Sympathomimetics|sympathomimetics|mesh-ancestor
110094375|NCT01708642|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110094376|NCT01708707|Morphine|morphine|mesh-list
110094377|NCT01708707|Buprenorphine|buprenorphine|mesh-list
110094378|NCT01708707|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110094379|NCT01708707|Narcotics|narcotics|mesh-ancestor
110094380|NCT01708707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110094381|NCT01708707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110094382|NCT01708707|Analgesics|analgesics|mesh-ancestor
110094383|NCT01708707|Sensory System Agents|sensory system agents|mesh-ancestor
110094384|NCT01708707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110094385|NCT01708707|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110094386|NCT01708720|Vaccines|vaccines|mesh-list
110094387|NCT01708720|Immunologic Factors|immunologic factors|mesh-ancestor
110094388|NCT01708720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110094389|NCT01708798|Eplerenone|eplerenone|mesh-list
110094390|NCT01708798|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110094391|NCT01708798|Hormone Antagonists|hormone antagonists|mesh-ancestor
110094392|NCT01708798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110094393|NCT01708798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110094394|NCT01708798|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110094395|NCT01708798|Diuretics|diuretics|mesh-ancestor
110094396|NCT01708798|Natriuretic Agents|natriuretic agents|mesh-ancestor
110094397|NCT01708798|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110094398|NCT01708837|Propofol|propofol|mesh-list
110094399|NCT01708837|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110094400|NCT01708837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110094401|NCT01708837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110094402|NCT01708837|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110094403|NCT01708837|Anesthetics, General|anesthetics, general|mesh-ancestor
110094404|NCT01708837|Anesthetics|anesthetics|mesh-ancestor
110094405|NCT01708850|Rivaroxaban|rivaroxaban|mesh-list
110094406|NCT01708850|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110094407|NCT01708850|Antithrombins|antithrombins|mesh-ancestor
110094408|NCT01708850|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110094409|NCT01708850|Protease Inhibitors|protease inhibitors|mesh-ancestor
110094410|NCT01708850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110094411|NCT01708850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110094412|NCT01708850|Anticoagulants|anticoagulants|mesh-ancestor
110094413|NCT01708876|Artesunate|artesunate|mesh-list
110094414|NCT01708876|Chloroquine|chloroquine|mesh-list
110094415|NCT01708876|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
110094417|NCT01708876|Mefloquine|mefloquine|mesh-list
110094418|NCT01708876|Antimalarials|antimalarials|mesh-ancestor
110094419|NCT01708876|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110094420|NCT01708876|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110094421|NCT01708876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110094422|NCT01708876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110094423|NCT01708876|Antiviral Agents|antiviral agents|mesh-ancestor
110094424|NCT01708876|Schistosomicides|schistosomicides|mesh-ancestor
110094425|NCT01708876|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110094426|NCT01708876|Anthelmintics|anthelmintics|mesh-ancestor
110094427|NCT01708876|Amebicides|amebicides|mesh-ancestor
110094428|NCT01708876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110094429|NCT01708876|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110094430|NCT01708876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110094431|NCT01708876|Analgesics|analgesics|mesh-ancestor
110094432|NCT01708876|Sensory System Agents|sensory system agents|mesh-ancestor
110094433|NCT01708876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110094434|NCT01708876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110094435|NCT01708876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110094436|NCT01708876|Filaricides|filaricides|mesh-ancestor
110094437|NCT01708876|Antinematodal Agents|antinematodal agents|mesh-ancestor
110094438|NCT01709019|Vaccines|vaccines|mesh-list
110094439|NCT01709019|Immunologic Factors|immunologic factors|mesh-ancestor
110094440|NCT01709019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110094441|NCT01709071|Vaccines|vaccines|mesh-list
110094442|NCT01709071|Immunologic Factors|immunologic factors|mesh-ancestor
110094443|NCT01709071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110094444|NCT01709292|Vemurafenib|vemurafenib|mesh-list
110094445|NCT01709292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110094446|NCT01709292|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110094447|NCT01709292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110094448|NCT01709292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110094449|NCT01709370|Letrozole|letrozole|mesh-list
110094450|NCT01709370|Palbociclib|palbociclib|mesh-list
110094451|NCT01709370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110094452|NCT01709370|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110094453|NCT01709370|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110094455|NCT01709370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110094456|NCT01709370|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110094457|NCT01709370|Hormone Antagonists|hormone antagonists|mesh-ancestor
110094458|NCT01709370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110094459|NCT01709370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110041088|NCT01437696|Vitamin D|vitamin d|mesh-list
110094460|NCT01709370|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110094461|NCT01709630|Magnesium Sulfate|magnesium sulfate|mesh-list
110094462|NCT01709630|Analgesics|analgesics|mesh-ancestor
110094463|NCT01709630|Sensory System Agents|sensory system agents|mesh-ancestor
110094464|NCT01709630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110094465|NCT01709630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110094466|NCT01709630|Anesthetics|anesthetics|mesh-ancestor
110094467|NCT01709630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110094468|NCT01709630|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110094469|NCT01709630|Anticonvulsants|anticonvulsants|mesh-ancestor
110094470|NCT01709630|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110094471|NCT01709630|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110094472|NCT01709630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110094473|NCT01709630|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110094474|NCT01709630|Tocolytic Agents|tocolytic agents|mesh-ancestor
110094475|NCT01709630|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110094476|NCT01709656|Celecoxib|celecoxib|mesh-list
110094477|NCT01709656|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110094478|NCT01709656|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110094479|NCT01709656|Analgesics|analgesics|mesh-ancestor
110094480|NCT01709656|Sensory System Agents|sensory system agents|mesh-ancestor
110094481|NCT01709656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110094482|NCT01709656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110094483|NCT01709656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110094484|NCT01709656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110094485|NCT01709656|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110094486|NCT01709656|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110094487|NCT01709656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110094488|NCT01709656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110094489|NCT01709682|Amiodarone|amiodarone|mesh-list
110094490|NCT01709682|Sotalol|sotalol|mesh-list
110094491|NCT01709682|Flecainide|flecainide|mesh-list
110094492|NCT01709682|Propafenone|propafenone|mesh-list
110094493|NCT01709682|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
110094494|NCT01709682|Vasodilator Agents|vasodilator agents|mesh-ancestor
110094495|NCT01709682|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
110094496|NCT01709682|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110094497|NCT01709682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110094498|NCT01709682|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110094499|NCT01709682|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110094500|NCT01709682|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110094501|NCT01709682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110094502|NCT01709682|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110094503|NCT01709682|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110094504|NCT01709682|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110094505|NCT01709682|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110094506|NCT01709682|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110094507|NCT01709682|Adrenergic Agents|adrenergic agents|mesh-ancestor
110094508|NCT01709682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110094509|NCT01709682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110094510|NCT01709682|Sympatholytics|sympatholytics|mesh-ancestor
110094511|NCT01709682|Autonomic Agents|autonomic agents|mesh-ancestor
110094512|NCT01709682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110094513|NCT01709682|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110094514|NCT01709760|Methotrexate|methotrexate|mesh-list
110094515|NCT01709760|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110094516|NCT01709760|Abortifacient Agents|abortifacient agents|mesh-ancestor
110094517|NCT01709760|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110094518|NCT01709760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110094519|NCT01709760|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110094520|NCT01709760|Antimetabolites|antimetabolites|mesh-ancestor
110094521|NCT01709760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110094522|NCT01709760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110094523|NCT01709760|Dermatologic Agents|dermatologic agents|mesh-ancestor
110094524|NCT01709760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110094525|NCT01709760|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110094526|NCT01709760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110094527|NCT01709760|Immunologic Factors|immunologic factors|mesh-ancestor
110094528|NCT01709760|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110094529|NCT01709760|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110094530|NCT01709825|Sulfalene|sulfalene|mesh-list
110041283|NCT05343507|Ketamine|ketamine|mesh-list
110094531|NCT01709825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110094532|NCT01709825|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110094533|NCT01709825|Antimalarials|antimalarials|mesh-ancestor
110094534|NCT01709825|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110094535|NCT01709825|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110094536|NCT01709929|Insulin Detemir|insulin detemir|mesh-list
110094537|NCT01709929|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110094538|NCT01709929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110094539|NCT01709942|Cetrorelix|cetrorelix|mesh-list
110094540|NCT01709942|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110094541|NCT01709942|Fertility Agents|fertility agents|mesh-ancestor
110094542|NCT01709942|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110094543|NCT01709942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110094544|NCT01709942|Hormone Antagonists|hormone antagonists|mesh-ancestor
110094545|NCT01709942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110094546|NCT01709955|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
110094547|NCT01709955|Cathartics|cathartics|mesh-ancestor
110094548|NCT01709955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110094549|NCT01709994|Aspirin|aspirin|mesh-list
110094550|NCT01709994|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110094551|NCT01709994|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110094552|NCT01709994|Analgesics|analgesics|mesh-ancestor
110094553|NCT01709994|Sensory System Agents|sensory system agents|mesh-ancestor
110094554|NCT01709994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110094555|NCT01709994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110094556|NCT01709994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110094557|NCT01709994|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110094558|NCT01709994|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110094559|NCT01709994|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110094560|NCT01709994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110094561|NCT01709994|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110094562|NCT01709994|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110094563|NCT01709994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110094564|NCT01709994|Antipyretics|antipyretics|mesh-ancestor
110094565|NCT01710059|Adrenergic Agents|adrenergic agents|mesh-list
110094566|NCT01710059|Adrenergic Agonists|adrenergic agonists|mesh-list
110094567|NCT01710059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110094568|NCT01710059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110094569|NCT01710059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110094571|NCT01710072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110094572|NCT01710072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110094573|NCT01710072|Analgesics|analgesics|mesh-ancestor
110094574|NCT01710072|Sensory System Agents|sensory system agents|mesh-ancestor
110094575|NCT01710072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110094576|NCT01710072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110094577|NCT01710072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110094578|NCT01710072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110094579|NCT01710072|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110094580|NCT01710072|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110094581|NCT01710072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110094582|NCT01710072|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110094583|NCT01710072|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110094584|NCT01710072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110094585|NCT01710072|Antipyretics|antipyretics|mesh-ancestor
110094586|NCT01710163|Aripiprazole|aripiprazole|mesh-list
110094587|NCT01710163|Antidepressive Agents|antidepressive agents|mesh-ancestor
110094588|NCT01710163|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110094589|NCT01710163|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110094590|NCT01710163|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110094591|NCT01710163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110094592|NCT01710163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110094593|NCT01710163|Dopamine Agonists|dopamine agonists|mesh-ancestor
110094594|NCT01710163|Dopamine Agents|dopamine agents|mesh-ancestor
110094595|NCT01710163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110094596|NCT01710163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110094597|NCT01710163|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110094598|NCT01710163|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110094599|NCT01710163|Serotonin Agents|serotonin agents|mesh-ancestor
110094600|NCT01710163|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110094601|NCT01710163|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110094602|NCT01710163|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110094603|NCT01710163|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110094604|NCT01710202|Hydrocortisone|hydrocortisone|mesh-list
110094605|NCT01710202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110094606|NCT01710228|Methylprednisolone|methylprednisolone|mesh-list
110094607|NCT01710228|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110094608|NCT01710228|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110094609|NCT01710228|Prednisolone|prednisolone|mesh-list
110094610|NCT01710228|Prednisolone acetate|prednisolone acetate|mesh-list
110094611|NCT01710228|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110094612|NCT01710228|Prednisolone phosphate|prednisolone phosphate|mesh-list
110094613|NCT01710228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110094614|NCT01710228|Antiemetics|antiemetics|mesh-ancestor
110094615|NCT01710228|Autonomic Agents|autonomic agents|mesh-ancestor
110094616|NCT01710228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110094617|NCT01710228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110094618|NCT01710228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110094619|NCT01710228|Glucocorticoids|glucocorticoids|mesh-ancestor
110094620|NCT01710228|Hormones|hormones|mesh-ancestor
110094621|NCT01710228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110094622|NCT01710228|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110094623|NCT01710228|Protective Agents|protective agents|mesh-ancestor
110094624|NCT01710228|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110094625|NCT01710228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110094626|NCT01710384|Betamethasone|betamethasone|mesh-list
110094627|NCT01710384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110094628|NCT01710384|Glucocorticoids|glucocorticoids|mesh-ancestor
110094629|NCT01710384|Hormones|hormones|mesh-ancestor
110094630|NCT01710384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110094631|NCT01710384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110094632|NCT01710384|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110094633|NCT01710384|Respiratory System Agents|respiratory system agents|mesh-ancestor
110094634|NCT01710462|Domperidone|domperidone|mesh-list
110094635|NCT01710462|Pantoprazole|pantoprazole|mesh-list
110094636|NCT01710462|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110094637|NCT01710462|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110094638|NCT01710462|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110094639|NCT01710462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110094640|NCT01710462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110094641|NCT01710462|Antiemetics|antiemetics|mesh-ancestor
110094642|NCT01710462|Autonomic Agents|autonomic agents|mesh-ancestor
110094643|NCT01710462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110094644|NCT01710462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110094645|NCT01710462|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110094646|NCT01710462|Dopamine Agents|dopamine agents|mesh-ancestor
110094647|NCT01710462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110094649|NCT01710488|Prulifloxacin|prulifloxacin|mesh-list
110094650|NCT01710488|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110094651|NCT01710488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110094652|NCT01710488|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110094653|NCT01710488|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110094654|NCT01710488|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110094655|NCT01710488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110094656|NCT01710488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110094657|NCT01710488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110094658|NCT01710488|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110094659|NCT01710488|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110094660|NCT01710540|Metformin|metformin|mesh-list
110094661|NCT01710540|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110094662|NCT01710540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110094663|NCT01710553|Metformin|metformin|mesh-list
110094664|NCT01710553|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110094665|NCT01710553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110094666|NCT01710566|Misoprostol|misoprostol|mesh-list
110094667|NCT01710566|Oxytocin|oxytocin|mesh-list
110094668|NCT01710566|Oxytocics|oxytocics|mesh-ancestor
110094669|NCT01710566|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110094670|NCT01710566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110094671|NCT01710566|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110094672|NCT01710566|Abortifacient Agents|abortifacient agents|mesh-ancestor
110094673|NCT01710566|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110094674|NCT01710566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110094675|NCT01710592|Docetaxel|docetaxel|mesh-list
110094676|NCT01710592|Capecitabine|capecitabine|mesh-list
110094677|NCT01710592|Oxaliplatin|oxaliplatin|mesh-list
110094678|NCT01710592|Epirubicin|epirubicin|mesh-list
110094679|NCT01710592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110094680|NCT01710592|Tubulin Modulators|tubulin modulators|mesh-ancestor
110094681|NCT01710592|Antimitotic Agents|antimitotic agents|mesh-ancestor
110094682|NCT01710592|Mitosis Modulators|mitosis modulators|mesh-ancestor
110094683|NCT01710592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110094684|NCT01710592|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110094685|NCT01710592|Antimetabolites|antimetabolites|mesh-ancestor
110094686|NCT01710592|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110094687|NCT01710592|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110094688|NCT01710592|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110094689|NCT01710592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110094690|NCT01710631|Eszopiclone|eszopiclone|mesh-list
110094691|NCT01710631|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110094692|NCT01710631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110094693|NCT01710631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110094694|NCT01710670|Ethanol|ethanol|mesh-list
110094695|NCT01710670|Brivaracetam|brivaracetam|mesh-list
110094696|NCT01710670|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110094697|NCT01710670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110094698|NCT01710670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110094699|NCT01710670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110094700|NCT01710670|Anticonvulsants|anticonvulsants|mesh-ancestor
110094701|NCT01710696|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110094702|NCT01710696|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110094703|NCT01710696|Estradiol|estradiol|mesh-list
110094704|NCT01710696|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110094705|NCT01710696|Estrogens|estrogens|mesh-ancestor
110094706|NCT01710696|Hormones|hormones|mesh-ancestor
110094707|NCT01710696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110094708|NCT01710696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110094709|NCT01710696|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110094710|NCT01710696|Contraceptive Agents|contraceptive agents|mesh-ancestor
110094711|NCT01710696|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110094712|NCT01710696|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110094713|NCT01710722|Ephedrine|ephedrine|mesh-list
110094714|NCT01710722|Pseudoephedrine|pseudoephedrine|mesh-list
110094715|NCT01710722|Caffeine|caffeine|mesh-list
110094716|NCT01710722|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110094717|NCT01710722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110094718|NCT01710722|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110094719|NCT01710722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110094720|NCT01710722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110094721|NCT01710722|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110094722|NCT01710722|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110094723|NCT01710722|Purinergic Agents|purinergic agents|mesh-ancestor
110094724|NCT01710722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110094725|NCT01710722|Sympathomimetics|sympathomimetics|mesh-ancestor
110094726|NCT01710722|Autonomic Agents|autonomic agents|mesh-ancestor
110094727|NCT01710722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110094728|NCT01710722|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110094729|NCT01710722|Adrenergic Agents|adrenergic agents|mesh-ancestor
110094730|NCT01710722|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110094731|NCT01710722|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110094732|NCT01710722|Respiratory System Agents|respiratory system agents|mesh-ancestor
110094733|NCT01710722|Nasal Decongestants|nasal decongestants|mesh-ancestor
110094734|NCT01710748|Everolimus|everolimus|mesh-list
110094735|NCT01710748|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110094736|NCT01710748|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110094737|NCT01710748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110094738|NCT01710748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110094739|NCT01710748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110094740|NCT01710748|Immunologic Factors|immunologic factors|mesh-ancestor
110094741|NCT01710748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110094742|NCT01710748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110094743|NCT01710826|Venglustat|venglustat|mesh-list
110094744|NCT01710826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110094745|NCT01710826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110094746|NCT01710904|Oxycodone|oxycodone|mesh-list
110094747|NCT01710904|Naloxone|naloxone|mesh-list
110094748|NCT01710904|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110094749|NCT01710904|Narcotics|narcotics|mesh-ancestor
110042376|NCT01441908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110094750|NCT01710904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110094751|NCT01710904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110094752|NCT01710904|Analgesics|analgesics|mesh-ancestor
110094753|NCT01710904|Sensory System Agents|sensory system agents|mesh-ancestor
110094754|NCT01710904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110094755|NCT01710904|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110094756|NCT01710995|Omeprazole, sodium bicarbonate drug combination|omeprazole, sodium bicarbonate drug combination|mesh-list
110094757|NCT01710995|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110094758|NCT01710995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110094759|NCT01710995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110094760|NCT01711060|Oxytocin|oxytocin|mesh-list
110094761|NCT01711060|Oxytocics|oxytocics|mesh-ancestor
110094762|NCT01711060|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110094763|NCT01711060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110094764|NCT01711073|Plerixafor|plerixafor|mesh-list
110094765|NCT01711073|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110094766|NCT01711073|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110094767|NCT01711073|Antiviral Agents|antiviral agents|mesh-ancestor
110094768|NCT01711073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110094769|NCT01711086|Formoterol Fumarate|formoterol fumarate|mesh-list
110094770|NCT01711086|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110094771|NCT01711086|Autonomic Agents|autonomic agents|mesh-ancestor
110094772|NCT01711086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110094773|NCT01711086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110094774|NCT01711086|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110094775|NCT01711086|Respiratory System Agents|respiratory system agents|mesh-ancestor
110094776|NCT01711086|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110094777|NCT01711086|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110094778|NCT01711086|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110094779|NCT01711086|Adrenergic Agents|adrenergic agents|mesh-ancestor
110094780|NCT01711086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110094781|NCT01711086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110094783|NCT01711112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110094784|NCT01711112|Tubulin Modulators|tubulin modulators|mesh-ancestor
110094785|NCT01711112|Antimitotic Agents|antimitotic agents|mesh-ancestor
110094786|NCT01711112|Mitosis Modulators|mitosis modulators|mesh-ancestor
110094787|NCT01711112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110094788|NCT01711125|Baclofen|baclofen|mesh-list
110094789|NCT01711125|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110094790|NCT01711125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110094791|NCT01711125|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110094792|NCT01711125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110094793|NCT01711125|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
110094794|NCT01711125|GABA Agonists|gaba agonists|mesh-ancestor
110094795|NCT01711125|GABA Agents|gaba agents|mesh-ancestor
110094796|NCT01711125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110094797|NCT01711125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110094798|NCT01711229|Acetaminophen|acetaminophen|mesh-list
110094799|NCT01711229|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110094800|NCT01711229|Analgesics|analgesics|mesh-ancestor
110094801|NCT01711229|Sensory System Agents|sensory system agents|mesh-ancestor
110094802|NCT01711229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110094803|NCT01711229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110094804|NCT01711229|Antipyretics|antipyretics|mesh-ancestor
110094805|NCT01711320|Omeprazole|omeprazole|mesh-list
110094806|NCT01711320|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110094807|NCT01711320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110094808|NCT01711320|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110094809|NCT01711320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110094810|NCT01711320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110094811|NCT01711437|Ascorbic Acid|ascorbic acid|mesh-list
110094812|NCT01711437|Simethicone|simethicone|mesh-list
110094813|NCT01711437|Picosulfate sodium|picosulfate sodium|mesh-list
110094814|NCT01711437|Magnesium Oxide|magnesium oxide|mesh-list
110094815|NCT01711437|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
110094816|NCT01711437|Citric Acid|citric acid|mesh-list
110094817|NCT01711437|Sodium Citrate|sodium citrate|mesh-list
110094818|NCT01711437|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110094819|NCT01711437|Anticoagulants|anticoagulants|mesh-ancestor
110094820|NCT01711437|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110094821|NCT01711437|Chelating Agents|chelating agents|mesh-ancestor
110094822|NCT01711437|Sequestering Agents|sequestering agents|mesh-ancestor
110042908|NCT01444885|Amlodipine|amlodipine|mesh-list
110094823|NCT01711437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110094824|NCT01711437|Antioxidants|antioxidants|mesh-ancestor
110094826|NCT01711437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110094827|NCT01711437|Vitamins|vitamins|mesh-ancestor
110094828|NCT01711437|Micronutrients|micronutrients|mesh-ancestor
110094829|NCT01711437|Antifoaming Agents|antifoaming agents|mesh-ancestor
110094830|NCT01711437|Emollients|emollients|mesh-ancestor
110094831|NCT01711437|Dermatologic Agents|dermatologic agents|mesh-ancestor
110094832|NCT01711437|Cathartics|cathartics|mesh-ancestor
110094833|NCT01711437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110094834|NCT01711437|Antacids|antacids|mesh-ancestor
110094835|NCT01711437|Laxatives|laxatives|mesh-ancestor
110094836|NCT01711463|Fluticasone|fluticasone|mesh-list
110094837|NCT01711463|Xhance|xhance|mesh-list
110094838|NCT01711463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110094839|NCT01711463|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110094840|NCT01711463|Autonomic Agents|autonomic agents|mesh-ancestor
110094841|NCT01711463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110094842|NCT01711463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110094843|NCT01711463|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110094844|NCT01711463|Respiratory System Agents|respiratory system agents|mesh-ancestor
110094845|NCT01711463|Dermatologic Agents|dermatologic agents|mesh-ancestor
110094846|NCT01711463|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110094847|NCT01711476|Complement Factor H|complement factor h|mesh-list
110094848|NCT01711476|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
110094849|NCT01711476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110094850|NCT01711476|Immunologic Factors|immunologic factors|mesh-ancestor
110094851|NCT01711476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110094852|NCT01711489|Mycophenolic Acid|mycophenolic acid|mesh-list
110094853|NCT01711489|Isavuconazole|isavuconazole|mesh-list
110094854|NCT01711489|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110094855|NCT01711489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110094856|NCT01711489|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110094857|NCT01711489|Antitubercular Agents|antitubercular agents|mesh-ancestor
110094858|NCT01711489|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110094859|NCT01711489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110094861|NCT01711489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110094862|NCT01711489|Antifungal Agents|antifungal agents|mesh-ancestor
110094863|NCT01711515|Cisplatin|cisplatin|mesh-list
110094864|NCT01711515|Ipilimumab|ipilimumab|mesh-list
110094865|NCT01711515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110094866|NCT01711515|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110094867|NCT01711515|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110094868|NCT01711515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110094869|NCT01711528|Dexamethasone|dexamethasone|mesh-list
110094870|NCT01711528|Dexamethasone acetate|dexamethasone acetate|mesh-list
110094871|NCT01711528|Bortezomib|bortezomib|mesh-list
110094872|NCT01711528|Ichthammol|ichthammol|mesh-list
110094873|NCT01711528|BB 1101|bb 1101|mesh-list
110094874|NCT01711528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110094875|NCT01711528|Antiemetics|antiemetics|mesh-ancestor
110094876|NCT01711528|Autonomic Agents|autonomic agents|mesh-ancestor
110094877|NCT01711528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110094878|NCT01711528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110094879|NCT01711528|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110094880|NCT01711528|Glucocorticoids|glucocorticoids|mesh-ancestor
110094882|NCT01711528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110094883|NCT01711528|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110094884|NCT01711528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110094886|NCT01711528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110094887|NCT01711528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110094888|NCT01711528|Dermatologic Agents|dermatologic agents|mesh-ancestor
110094889|NCT01711567|Tenofovir|tenofovir|mesh-list
110094890|NCT01711567|Entecavir|entecavir|mesh-list
110094891|NCT01711567|Antiviral Agents|antiviral agents|mesh-ancestor
110094892|NCT01711567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110094893|NCT01711567|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110094894|NCT01711567|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110094895|NCT01711567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110094896|NCT01711567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110094897|NCT01711567|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110094898|NCT01711567|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110094899|NCT01711593|Dimercaprol|dimercaprol|mesh-list
110094900|NCT01711593|Chelating Agents|chelating agents|mesh-ancestor
110094901|NCT01711593|Sequestering Agents|sequestering agents|mesh-ancestor
110094902|NCT01711593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110094903|NCT01711671|Dexamethasone|dexamethasone|mesh-list
110094904|NCT01711671|Lenalidomide|lenalidomide|mesh-list
110094905|NCT01711671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110094906|NCT01711671|Antiemetics|antiemetics|mesh-ancestor
110094907|NCT01711671|Autonomic Agents|autonomic agents|mesh-ancestor
110094908|NCT01711671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110094909|NCT01711671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110094910|NCT01711671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110094911|NCT01711671|Glucocorticoids|glucocorticoids|mesh-ancestor
110094913|NCT01711671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110094914|NCT01711671|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110094915|NCT01711671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110094916|NCT01711671|Immunologic Factors|immunologic factors|mesh-ancestor
110094917|NCT01711671|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110094918|NCT01711671|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110094919|NCT01711671|Growth Substances|growth substances|mesh-ancestor
110094920|NCT01711671|Growth Inhibitors|growth inhibitors|mesh-ancestor
110094921|NCT01711697|Paclitaxel|paclitaxel|mesh-list
110094922|NCT01711697|Carboplatin|carboplatin|mesh-list
110094923|NCT01711697|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110094924|NCT01711697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110094925|NCT01711697|Tubulin Modulators|tubulin modulators|mesh-ancestor
110094926|NCT01711697|Antimitotic Agents|antimitotic agents|mesh-ancestor
110094927|NCT01711697|Mitosis Modulators|mitosis modulators|mesh-ancestor
110094928|NCT01711697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110094929|NCT01711723|Darapladib|darapladib|mesh-list
110094930|NCT01711723|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
110094931|NCT01711723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110094932|NCT01711723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110094933|NCT01711749|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110094934|NCT01711749|Calcium|calcium|mesh-list
110094935|NCT01711749|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110442367|NCT00680329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110442368|NCT00680329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110442369|NCT00680329|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110442370|NCT00680329|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110442371|NCT02811016|Budesonide|budesonide|mesh-list
110442372|NCT02811016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110442373|NCT02811016|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110442374|NCT02811016|Autonomic Agents|autonomic agents|mesh-ancestor
110442375|NCT02811016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110442376|NCT02811016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110442377|NCT02811016|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110442378|NCT02811016|Respiratory System Agents|respiratory system agents|mesh-ancestor
110442379|NCT02811016|Glucocorticoids|glucocorticoids|mesh-ancestor
110442380|NCT02811016|Hormones|hormones|mesh-ancestor
110442381|NCT02811016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110442382|NCT00690313|Moxifloxacin|moxifloxacin|mesh-list
110442383|NCT00690313|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
110442384|NCT00690313|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110442385|NCT00690313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110442386|NCT00690313|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110442387|NCT00690313|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110442388|NCT00690313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110442389|NCT00690313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110442390|NCT00690313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110442391|NCT00690313|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110442392|NCT00690313|Contraceptive Agents|contraceptive agents|mesh-ancestor
110442393|NCT00690313|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110442394|NCT00690313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110442395|NCT00690313|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110442396|NCT00690313|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110442397|NCT00690313|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110442398|NCT04237480|Vitamin D|vitamin d|mesh-list
110442399|NCT04237480|Ergocalciferols|ergocalciferols|mesh-list
110442400|NCT04237480|Cholecalciferol|cholecalciferol|mesh-list
110442401|NCT04237480|Vitamins|vitamins|mesh-list
110442402|NCT04237480|Micronutrients|micronutrients|mesh-ancestor
110442403|NCT04237480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110442404|NCT04237480|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110329667|NCT01245816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110442405|NCT04237480|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110442406|NCT02810782|Morphine|morphine|mesh-list
110442407|NCT02810782|Phenobarbital|phenobarbital|mesh-list
110442408|NCT02810782|Chlorpromazine|chlorpromazine|mesh-list
110442409|NCT02810782|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110442410|NCT02810782|Narcotics|narcotics|mesh-ancestor
110442411|NCT02810782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110442412|NCT02810782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110442413|NCT02810782|Analgesics|analgesics|mesh-ancestor
110442414|NCT02810782|Sensory System Agents|sensory system agents|mesh-ancestor
110442415|NCT02810782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110442416|NCT02810782|Anticonvulsants|anticonvulsants|mesh-ancestor
110442417|NCT02810782|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110442418|NCT02810782|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110442419|NCT02810782|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110442420|NCT02810782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110442421|NCT02810782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110442422|NCT02810782|GABA Modulators|gaba modulators|mesh-ancestor
110442423|NCT02810782|GABA Agents|gaba agents|mesh-ancestor
110442424|NCT02810782|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110442425|NCT02810782|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110442426|NCT02810782|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110442427|NCT02810782|Antiemetics|antiemetics|mesh-ancestor
110442428|NCT02810782|Autonomic Agents|autonomic agents|mesh-ancestor
110442429|NCT02810782|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110442430|NCT02810782|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110442431|NCT02810782|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110442432|NCT02810782|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110442433|NCT02810782|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110442434|NCT02810782|Dopamine Agents|dopamine agents|mesh-ancestor
110442435|NCT02810548|Mitogens|mitogens|mesh-list
110442436|NCT02810548|Mitosis Modulators|mitosis modulators|mesh-ancestor
110442437|NCT02810548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110442438|NCT01155869|Naltrexone|naltrexone|mesh-list
110442439|NCT01155869|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110442440|NCT01155869|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110442441|NCT01155869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110442442|NCT01155869|Sensory System Agents|sensory system agents|mesh-ancestor
110442443|NCT01155869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110442444|NCT00687037|Cetylpyridinium|cetylpyridinium|mesh-list
110442445|NCT00687037|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110442446|NCT00687037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110442447|NCT02625415|Vitamins|vitamins|mesh-list
110442448|NCT02625415|Vitamin B 6|vitamin b 6|mesh-list
110442449|NCT02625415|Pyridoxal|pyridoxal|mesh-list
110442450|NCT02625415|Pyridoxine|pyridoxine|mesh-list
110442451|NCT02625415|Vitamin B Complex|vitamin b complex|mesh-list
110442452|NCT02625415|Micronutrients|micronutrients|mesh-ancestor
110442453|NCT02625415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110442454|NCT02809768|Itraconazole|itraconazole|mesh-list
110442455|NCT02809768|Fluconazole|fluconazole|mesh-list
110442457|NCT02809768|Antifungal Agents|antifungal agents|mesh-ancestor
110442458|NCT02809768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110442459|NCT02809768|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110442460|NCT02809768|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110442461|NCT02809768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110442462|NCT02809768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110442463|NCT02809768|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110442464|NCT02809768|Hormone Antagonists|hormone antagonists|mesh-ancestor
110442465|NCT02809768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110442466|NCT02809768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110442467|NCT02809768|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110442468|NCT02809768|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110442469|NCT02809768|Antitubercular Agents|antitubercular agents|mesh-ancestor
110442470|NCT02809768|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110442471|NCT02809768|Leprostatic Agents|leprostatic agents|mesh-ancestor
110442472|NCT02809768|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110442473|NCT02809768|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110442474|NCT02809768|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110442475|NCT02809768|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110044877|NCT05269849|Sirolimus|sirolimus|mesh-list
110442476|NCT02809768|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110329670|NCT01245816|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110442477|NCT02809768|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110442478|NCT02809768|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110442479|NCT02809768|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110442480|NCT02809768|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110442481|NCT04237090|Diphenhydramine|diphenhydramine|mesh-list
110442482|NCT04237090|Promethazine|promethazine|mesh-list
110442483|NCT04237090|Cetirizine|cetirizine|mesh-list
110442484|NCT04237090|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110442485|NCT04237090|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110442486|NCT04237090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110442487|NCT04237090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110442488|NCT04237090|Anesthetics, Local|anesthetics, local|mesh-ancestor
110442489|NCT04237090|Anesthetics|anesthetics|mesh-ancestor
110442490|NCT04237090|Sensory System Agents|sensory system agents|mesh-ancestor
110442491|NCT04237090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110442492|NCT04237090|Antiemetics|antiemetics|mesh-ancestor
110442493|NCT04237090|Autonomic Agents|autonomic agents|mesh-ancestor
110442494|NCT04237090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110442495|NCT04237090|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110442496|NCT04237090|Histamine Antagonists|histamine antagonists|mesh-ancestor
110442497|NCT04237090|Histamine Agents|histamine agents|mesh-ancestor
110442498|NCT04237090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110442499|NCT04237090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110442500|NCT04237090|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110442501|NCT04237090|Antipruritics|antipruritics|mesh-ancestor
110442502|NCT04237090|Dermatologic Agents|dermatologic agents|mesh-ancestor
110442503|NCT04237090|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110442504|NCT00690781|Caseins|caseins|mesh-list
110442505|NCT00690781|Chelating Agents|chelating agents|mesh-ancestor
110442506|NCT00690781|Sequestering Agents|sequestering agents|mesh-ancestor
110442507|NCT00690781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110442508|NCT00682825|Anesthetics|anesthetics|mesh-list
110442509|NCT00682825|Anesthetics, Inhalation|anesthetics, inhalation|mesh-list
110442510|NCT00682825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110442511|NCT00682825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110442512|NCT00682825|Anesthetics, General|anesthetics, general|mesh-ancestor
110442514|NCT00912379|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110442515|NCT00912379|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110442516|NCT00912379|Analgesics|analgesics|mesh-ancestor
110442517|NCT00912379|Sensory System Agents|sensory system agents|mesh-ancestor
110442518|NCT00912379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110442519|NCT00912379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110442520|NCT00912379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110442521|NCT00912379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110442522|NCT02809378|Remifentanil|remifentanil|mesh-list
110442523|NCT02809378|Thiopental|thiopental|mesh-list
110442524|NCT02809378|Palonosetron|palonosetron|mesh-list
110442525|NCT02809378|Propofol|propofol|mesh-list
110442526|NCT02809378|Sevoflurane|sevoflurane|mesh-list
110442527|NCT02809378|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110442528|NCT02809378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110442529|NCT02809378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110442530|NCT02809378|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110442531|NCT02809378|Anesthetics, General|anesthetics, general|mesh-ancestor
110442532|NCT02809378|Anesthetics|anesthetics|mesh-ancestor
110442533|NCT02809378|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110442534|NCT02809378|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110442535|NCT02809378|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110442536|NCT02809378|Narcotics|narcotics|mesh-ancestor
110442537|NCT02809378|Analgesics|analgesics|mesh-ancestor
110442538|NCT02809378|Sensory System Agents|sensory system agents|mesh-ancestor
110442539|NCT02809378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110442541|NCT02809378|Autonomic Agents|autonomic agents|mesh-ancestor
110442542|NCT02809378|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110442543|NCT02809378|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110442544|NCT02809378|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110442545|NCT02809378|Serotonin Agents|serotonin agents|mesh-ancestor
110442546|NCT02809378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110442547|NCT02809378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110442548|NCT02809378|Anticonvulsants|anticonvulsants|mesh-ancestor
110442549|NCT02809378|GABA Modulators|gaba modulators|mesh-ancestor
110442550|NCT02809378|GABA Agents|gaba agents|mesh-ancestor
110442551|NCT00683059|Paclitaxel|paclitaxel|mesh-list
110442552|NCT00683059|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110442553|NCT00683059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110442554|NCT00683059|Tubulin Modulators|tubulin modulators|mesh-ancestor
110442555|NCT00683059|Antimitotic Agents|antimitotic agents|mesh-ancestor
110442556|NCT00683059|Mitosis Modulators|mitosis modulators|mesh-ancestor
110442557|NCT00683059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110442559|NCT01185353|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110442560|NCT01185353|Abortifacient Agents|abortifacient agents|mesh-ancestor
110442561|NCT01185353|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110442562|NCT01185353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110442563|NCT01185353|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110442564|NCT01185353|Antimetabolites|antimetabolites|mesh-ancestor
110442565|NCT01185353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110442566|NCT01185353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110442567|NCT01185353|Dermatologic Agents|dermatologic agents|mesh-ancestor
110442568|NCT01185353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110442569|NCT01185353|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110442570|NCT01185353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110442571|NCT01185353|Immunologic Factors|immunologic factors|mesh-ancestor
110442572|NCT01185353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110442573|NCT01185353|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110442574|NCT00683137|Valdecoxib|valdecoxib|mesh-list
110442575|NCT00683137|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110373260|NCT04593108|Abortifacient Agents|abortifacient agents|mesh-ancestor
110442576|NCT00683137|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110442577|NCT00683137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110442578|NCT00683137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110442579|NCT00683137|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110442580|NCT00683137|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110442581|NCT00683137|Analgesics|analgesics|mesh-ancestor
110442582|NCT00683137|Sensory System Agents|sensory system agents|mesh-ancestor
110442583|NCT00683137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110442584|NCT00683137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110442585|NCT00683137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110442586|NCT00683137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110442587|NCT02809456|Nicorandil|nicorandil|mesh-list
110442588|NCT02809456|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110442589|NCT02809456|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110442590|NCT02809456|Vasodilator Agents|vasodilator agents|mesh-ancestor
110442591|NCT02809456|Vitamin B Complex|vitamin b complex|mesh-ancestor
110442592|NCT02809456|Vitamins|vitamins|mesh-ancestor
110442593|NCT02809456|Micronutrients|micronutrients|mesh-ancestor
110442594|NCT02809456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110442595|NCT05576740|Contraceptive Agents|contraceptive agents|mesh-list
110442596|NCT05576740|Hormones|hormones|mesh-list
110442597|NCT05576740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110442598|NCT05576740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110442599|NCT05576740|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110442600|NCT04139629|Antibodies|antibodies|mesh-list
110089599|NCT04007289|Anticoagulants|anticoagulants|mesh-ancestor
110089600|NCT04004910|Antineoplastic Agents|antineoplastic agents|mesh-list
110089613|NCT03993249|Nivolumab|nivolumab|mesh-list
110089614|NCT03993249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110046063|NCT05740982|Antiviral Agents|antiviral agents|mesh-ancestor
110089615|NCT03993249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110089616|NCT03993249|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110089617|NCT03993249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110089618|NCT03990883|Lidocaine|lidocaine|mesh-list
110089619|NCT03990883|Anesthetics, Local|anesthetics, local|mesh-ancestor
110089620|NCT03990883|Anesthetics|anesthetics|mesh-ancestor
110089621|NCT03990883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110089622|NCT03990883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110442601|NCT04139629|Immunologic Factors|immunologic factors|mesh-ancestor
110442602|NCT04139629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110442603|NCT02813044|Anesthetics|anesthetics|mesh-list
110442604|NCT02813044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110442605|NCT02813044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110442606|NCT04236778|Vancomycin|vancomycin|mesh-list
110442607|NCT04236778|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110442608|NCT04236778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110442609|NCT02812888|Propranolol|propranolol|mesh-list
110442610|NCT02812888|Methimazole|methimazole|mesh-list
110442611|NCT02812888|Propylthiouracil|propylthiouracil|mesh-list
110442612|NCT02812888|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110442613|NCT02812888|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110442614|NCT02812888|Adrenergic Agents|adrenergic agents|mesh-ancestor
110442615|NCT02812888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110442616|NCT02812888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110442617|NCT02812888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110442618|NCT02812888|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110442619|NCT02812888|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110442620|NCT02812888|Vasodilator Agents|vasodilator agents|mesh-ancestor
110442621|NCT02812888|Antithyroid Agents|antithyroid agents|mesh-ancestor
110442622|NCT02812888|Hormone Antagonists|hormone antagonists|mesh-ancestor
110442623|NCT02812888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110442624|NCT02812888|Antimetabolites|antimetabolites|mesh-ancestor
110442625|NCT00687661|Diphosphonates|diphosphonates|mesh-list
110442626|NCT00687661|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110442627|NCT00687661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110442629|NCT00687817|Carboplatin|carboplatin|mesh-list
110442630|NCT00687817|Bavituximab|bavituximab|mesh-list
110442631|NCT00687817|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110442632|NCT00687817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110442633|NCT00687817|Tubulin Modulators|tubulin modulators|mesh-ancestor
110442634|NCT00687817|Antimitotic Agents|antimitotic agents|mesh-ancestor
110442635|NCT00687817|Mitosis Modulators|mitosis modulators|mesh-ancestor
110442636|NCT00687817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110442637|NCT00687817|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110442639|NCT02808988|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110442640|NCT02808988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110442641|NCT02625805|Methylphenidate|methylphenidate|mesh-list
110442642|NCT02625805|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110442643|NCT02625805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110442644|NCT02625805|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110442645|NCT02625805|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110442646|NCT02625805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110442647|NCT02625805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110442648|NCT02625805|Dopamine Agents|dopamine agents|mesh-ancestor
110442649|NCT02625805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110442650|NCT00688207|Rosiglitazone|rosiglitazone|mesh-list
110442652|NCT00688207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110442653|NCT02880462|Sulforaphane|sulforaphane|mesh-list
110442654|NCT02880462|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110442655|NCT02880462|Protective Agents|protective agents|mesh-ancestor
110442656|NCT02880462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110442657|NCT02880462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110442658|NCT00688363|Chrysarobin|chrysarobin|mesh-list
110442659|NCT00688363|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110442660|NCT00688363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110442661|NCT00688363|Analgesics|analgesics|mesh-ancestor
110442662|NCT00688363|Sensory System Agents|sensory system agents|mesh-ancestor
110442663|NCT00688363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110442664|NCT00688363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110442665|NCT00688363|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110442666|NCT00688363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110442667|NCT02812654|Doxorubicin|doxorubicin|mesh-list
110442668|NCT02812654|Ifosfamide|ifosfamide|mesh-list
110442669|NCT02812654|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110442670|NCT02812654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110442671|NCT02812654|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110442672|NCT02812654|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110442673|NCT02812654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110442674|NCT02812654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110442675|NCT02812654|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110442676|NCT02812654|Alkylating Agents|alkylating agents|mesh-ancestor
110442677|NCT02809066|Calcium, Dietary|calcium, dietary|mesh-list
110329680|NCT00492687|Temozolomide|temozolomide|mesh-list
110442679|NCT02809066|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110442680|NCT02809066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110442681|NCT02809066|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110442682|NCT01097694|Imatinib Mesylate|imatinib mesylate|mesh-list
110442683|NCT01097694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110442684|NCT01097694|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110442685|NCT01097694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110442686|NCT01097694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110442687|NCT00688987|Hydrocortisone|hydrocortisone|mesh-list
110442688|NCT00688987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110442689|NCT02808676|Vitamin D|vitamin d|mesh-list
110442690|NCT02808676|Cholecalciferol|cholecalciferol|mesh-list
110442691|NCT02808676|Vitamins|vitamins|mesh-ancestor
110442692|NCT02808676|Micronutrients|micronutrients|mesh-ancestor
110442693|NCT02808676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110442694|NCT02808676|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110442695|NCT02808676|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110442696|NCT00690937|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
110442697|NCT00690937|Sevelamer|sevelamer|mesh-list
110442698|NCT00690937|Chelating Agents|chelating agents|mesh-ancestor
110442699|NCT00690937|Sequestering Agents|sequestering agents|mesh-ancestor
110442700|NCT00690937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110442701|NCT00690937|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110442702|NCT00690937|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110442703|NCT00690937|Antimetabolites|antimetabolites|mesh-ancestor
110442704|NCT00690937|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110442706|NCT00689143|Immunologic Factors|immunologic factors|mesh-ancestor
110442707|NCT00689143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110442708|NCT00912457|Donepezil|donepezil|mesh-list
110442709|NCT00912457|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110442710|NCT00912457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110442711|NCT00912457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110442712|NCT00912457|Cholinergic Agents|cholinergic agents|mesh-ancestor
110442713|NCT00912457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110442714|NCT00912457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110442715|NCT00912457|Nootropic Agents|nootropic agents|mesh-ancestor
110442716|NCT04200586|Dapagliflozin|dapagliflozin|mesh-list
110442717|NCT04200586|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110442718|NCT04200586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110442719|NCT04200586|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110442720|NCT04200586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110442721|NCT02625103|Clozapine|clozapine|mesh-list
110442722|NCT02625103|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110442723|NCT02625103|Serotonin Agents|serotonin agents|mesh-ancestor
110442724|NCT02625103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110442725|NCT02625103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110442726|NCT02625103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110442727|NCT02625103|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110442728|NCT02625103|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110442729|NCT02625103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110442730|NCT02625103|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110442731|NCT02625103|GABA Antagonists|gaba antagonists|mesh-ancestor
110442732|NCT02625103|GABA Agents|gaba agents|mesh-ancestor
110442733|NCT01155479|Rasagiline|rasagiline|mesh-list
110442734|NCT01155479|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
110442735|NCT01155479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110442736|NCT01155479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110442737|NCT01155479|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110442738|NCT01155479|Protective Agents|protective agents|mesh-ancestor
110442739|NCT01155479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110442740|NCT02807272|Tipifarnib|tipifarnib|mesh-list
110442741|NCT02807272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110442742|NCT02807194|Anesthetics|anesthetics|mesh-list
110442743|NCT02807194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110442744|NCT02807194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110442745|NCT00912535|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110442746|NCT00912535|Antidepressive Agents|antidepressive agents|mesh-ancestor
110442747|NCT00912535|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110442748|NCT00912535|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110442749|NCT00912535|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110442750|NCT00912535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110442751|NCT00912535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110442752|NCT02625727|Hyaluronic Acid|hyaluronic acid|mesh-list
110442753|NCT02625727|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110442754|NCT02625727|Immunologic Factors|immunologic factors|mesh-ancestor
110442755|NCT02625727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110442756|NCT02625727|Viscosupplements|viscosupplements|mesh-ancestor
110442757|NCT02625727|Protective Agents|protective agents|mesh-ancestor
110442758|NCT04313699|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
110442759|NCT04313699|Antiviral Agents|antiviral agents|mesh-ancestor
110442760|NCT04313699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110442762|NCT01155167|Nitroglycerin|nitroglycerin|mesh-list
110442763|NCT01155167|Anesthetics, Local|anesthetics, local|mesh-ancestor
110442764|NCT01155167|Anesthetics|anesthetics|mesh-ancestor
110442765|NCT01155167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110442766|NCT01155167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110373290|NCT00567866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110442767|NCT01155167|Sensory System Agents|sensory system agents|mesh-ancestor
110442768|NCT01155167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110442769|NCT01155167|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110442770|NCT01155167|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110442771|NCT01155167|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110442772|NCT01155167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110442773|NCT01155167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110442774|NCT01155167|Vasodilator Agents|vasodilator agents|mesh-ancestor
110442775|NCT05238155|Antimetabolites|antimetabolites|mesh-list
110048402|NCT04705727|Budesonide|budesonide|mesh-list
110442776|NCT05238155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110442777|NCT01106586|Ritonavir|ritonavir|mesh-list
110442778|NCT01106586|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110442779|NCT01106586|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110442780|NCT01106586|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110442781|NCT01106586|Protease Inhibitors|protease inhibitors|mesh-ancestor
110442782|NCT01106586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110442783|NCT01106586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110442784|NCT01106586|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110442785|NCT01106586|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110442786|NCT01106586|Antiviral Agents|antiviral agents|mesh-ancestor
110442787|NCT01106586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110442788|NCT01106586|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110442789|NCT01106586|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110442790|NCT00683995|Fentanyl|fentanyl|mesh-list
110442791|NCT00683995|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110442792|NCT00683995|Narcotics|narcotics|mesh-ancestor
110442793|NCT00683995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110442794|NCT00683995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110442796|NCT00683995|Sensory System Agents|sensory system agents|mesh-ancestor
110442797|NCT00683995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110442798|NCT00683995|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110442799|NCT00683995|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110442800|NCT00683995|Anesthetics, General|anesthetics, general|mesh-ancestor
110442801|NCT00683995|Anesthetics|anesthetics|mesh-ancestor
110442802|NCT02806882|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
110442803|NCT02806882|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110442804|NCT02806882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110442805|NCT02884817|Listerine|listerine|mesh-list
110442806|NCT02884817|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110442807|NCT02884817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110442808|NCT02806804|Vaccines|vaccines|mesh-list
110442809|NCT02806804|Immunologic Factors|immunologic factors|mesh-ancestor
110442810|NCT02806804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110442811|NCT02879292|Anesthetics|anesthetics|mesh-list
110442812|NCT02879292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110442813|NCT02879292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110442814|NCT02806648|Palbociclib|palbociclib|mesh-list
110442815|NCT02806648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110442816|NCT02806648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110442817|NCT02806648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110442818|NCT02806648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110442819|NCT00689845|Cytarabine|cytarabine|mesh-list
110442820|NCT00689845|Prednisone|prednisone|mesh-list
110442821|NCT00689845|Prednisolone|prednisolone|mesh-list
110442822|NCT00689845|Cyclophosphamide|cyclophosphamide|mesh-list
110442823|NCT00689845|Ifosfamide|ifosfamide|mesh-list
110442824|NCT00689845|Rituximab|rituximab|mesh-list
110442825|NCT00689845|Doxorubicin|doxorubicin|mesh-list
110442826|NCT00689845|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110442827|NCT00689845|Methotrexate|methotrexate|mesh-list
110442829|NCT00689845|Vincristine|vincristine|mesh-list
110442830|NCT00689845|Bleomycin|bleomycin|mesh-list
110442831|NCT00689845|Etoposide phosphate|etoposide phosphate|mesh-list
110442832|NCT00689845|Vindesine|vindesine|mesh-list
110442833|NCT00689845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110442834|NCT00689845|Immunologic Factors|immunologic factors|mesh-ancestor
110442835|NCT00689845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110442836|NCT00689845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110442837|NCT00689845|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110442838|NCT00689845|Alkylating Agents|alkylating agents|mesh-ancestor
110442839|NCT00689845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110442840|NCT00689845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110442841|NCT00689845|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110442842|NCT00689845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110442843|NCT00689845|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110442844|NCT00689845|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110442845|NCT00689845|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110442846|NCT00689845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110442847|NCT00689845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110442848|NCT00689845|Glucocorticoids|glucocorticoids|mesh-ancestor
110442849|NCT00689845|Hormones|hormones|mesh-ancestor
110442850|NCT00689845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110442851|NCT00689845|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110442852|NCT00689845|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110442853|NCT00689845|Abortifacient Agents|abortifacient agents|mesh-ancestor
110442854|NCT00689845|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110442855|NCT00689845|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110442856|NCT00689845|Antimetabolites|antimetabolites|mesh-ancestor
110442857|NCT00689845|Dermatologic Agents|dermatologic agents|mesh-ancestor
110442858|NCT00689845|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110442859|NCT00689845|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110442860|NCT00689845|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110442861|NCT00689845|Antiviral Agents|antiviral agents|mesh-ancestor
110442862|NCT00689845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110442863|NCT00689845|Tubulin Modulators|tubulin modulators|mesh-ancestor
110442864|NCT00689845|Antimitotic Agents|antimitotic agents|mesh-ancestor
110442865|NCT00689845|Mitosis Modulators|mitosis modulators|mesh-ancestor
110442866|NCT00624767|Insulin|insulin|mesh-list
110442867|NCT00624767|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110442868|NCT00624767|Insulin Aspart|insulin aspart|mesh-list
110442869|NCT00624767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110442870|NCT00624767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110442872|NCT02806492|Oxymetazoline|oxymetazoline|mesh-list
110442873|NCT02806492|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110442874|NCT02806492|Mydriatics|mydriatics|mesh-ancestor
110442875|NCT02806492|Autonomic Agents|autonomic agents|mesh-ancestor
110442876|NCT02806492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110442877|NCT02806492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110442878|NCT02806492|Sympathomimetics|sympathomimetics|mesh-ancestor
110442879|NCT02806492|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110442880|NCT02806492|Nasal Decongestants|nasal decongestants|mesh-ancestor
110442881|NCT02806492|Respiratory System Agents|respiratory system agents|mesh-ancestor
110442882|NCT02806492|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110442883|NCT02806492|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110442884|NCT02806492|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110442885|NCT02806492|Adrenergic Agents|adrenergic agents|mesh-ancestor
110442886|NCT02806492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110442887|NCT02806492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110442888|NCT02806492|Protective Agents|protective agents|mesh-ancestor
110442889|NCT00691405|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110442890|NCT00691405|Formoterol Fumarate|formoterol fumarate|mesh-list
110442891|NCT00691405|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110442892|NCT00691405|Autonomic Agents|autonomic agents|mesh-ancestor
110442893|NCT00691405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110442894|NCT00691405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110373313|NCT00582582|Micronutrients|micronutrients|mesh-ancestor
110442895|NCT00691405|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110442896|NCT00691405|Respiratory System Agents|respiratory system agents|mesh-ancestor
110442897|NCT00691405|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110442898|NCT00691405|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110442900|NCT00691405|Adrenergic Agents|adrenergic agents|mesh-ancestor
110442901|NCT00691405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110442902|NCT00691405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110442903|NCT01106430|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
110442904|NCT01106430|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
110442905|NCT01106430|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110442906|NCT01106430|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110442907|NCT01106430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110442908|NCT01106430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110442909|NCT01106430|Adrenergic Agents|adrenergic agents|mesh-ancestor
110442910|NCT01106430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110442911|NCT01106430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110442912|NCT01106430|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110442913|NCT01106430|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110442914|NCT01106430|Dopamine Agents|dopamine agents|mesh-ancestor
110442916|NCT02804776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110442917|NCT02804776|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110442918|NCT02804776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110442919|NCT02804776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110442920|NCT01154153|Loratadine|loratadine|mesh-list
110442921|NCT01154153|Triamcinolone|triamcinolone|mesh-list
110442922|NCT01154153|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110442923|NCT01154153|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110442924|NCT01154153|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110442925|NCT01154153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110442926|NCT01154153|Glucocorticoids|glucocorticoids|mesh-ancestor
110442927|NCT01154153|Hormones|hormones|mesh-ancestor
110442928|NCT01154153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110442929|NCT01154153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110442930|NCT01154153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110442931|NCT01154153|Immunologic Factors|immunologic factors|mesh-ancestor
110442932|NCT01154153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110442933|NCT01154153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110442934|NCT01154153|Antipruritics|antipruritics|mesh-ancestor
110442935|NCT01154153|Dermatologic Agents|dermatologic agents|mesh-ancestor
110442936|NCT01154153|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110442937|NCT01154153|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110442938|NCT01154153|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110442939|NCT01154153|Histamine Antagonists|histamine antagonists|mesh-ancestor
110442940|NCT01154153|Histamine Agents|histamine agents|mesh-ancestor
110442941|NCT01154153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110442942|NCT00684229|Anesthetics|anesthetics|mesh-list
110442943|NCT00684229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110442944|NCT00684229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110442946|NCT00874237|Loxapine|loxapine|mesh-list
110442947|NCT00874237|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110442948|NCT00874237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110442949|NCT00874237|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110442950|NCT00874237|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110442951|NCT00874237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110442952|NCT00874237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110442953|NCT00874237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110442954|NCT00874237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110442955|NCT00874237|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110442956|NCT00874237|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110442957|NCT00874237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110442958|NCT00874237|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110442959|NCT00874237|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110442960|NCT00874237|Dopamine Agents|dopamine agents|mesh-ancestor
110442961|NCT00874237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110442962|NCT02805946|Posaconazole|posaconazole|mesh-list
110442963|NCT02805946|Antifungal Agents|antifungal agents|mesh-ancestor
110329693|NCT01371838|Ceftriaxone|ceftriaxone|mesh-list
110442964|NCT02805946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110442965|NCT02805946|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
110442966|NCT02805946|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110442967|NCT02805946|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110442968|NCT02805946|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110442969|NCT02805946|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110442970|NCT02805946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110442971|NCT02805946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110442972|NCT02805946|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110442973|NCT02805946|Hormone Antagonists|hormone antagonists|mesh-ancestor
110442974|NCT02805946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110442975|NCT02805946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110442977|NCT02804386|Antiviral Agents|antiviral agents|mesh-ancestor
110442978|NCT02804386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110442979|NCT02805868|Siltuximab|siltuximab|mesh-list
110442980|NCT02805868|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110442981|NCT02805868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110442982|NCT02805868|Immunologic Factors|immunologic factors|mesh-ancestor
110442983|NCT02805868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110442984|NCT00684385|Gefitinib|gefitinib|mesh-list
110442985|NCT00684385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110442986|NCT00684385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110442987|NCT00684385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110442988|NCT00684385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110442989|NCT02690038|Immunoglobulins|immunoglobulins|mesh-list
110442990|NCT02690038|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110442991|NCT02690038|Antibodies|antibodies|mesh-list
110442992|NCT02690038|gamma-Globulins|gamma-globulins|mesh-list
110442993|NCT02690038|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110442994|NCT02690038|Immunologic Factors|immunologic factors|mesh-ancestor
110442995|NCT02690038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110442996|NCT00691795|Clonidine|clonidine|mesh-list
110442997|NCT00691795|Fentanyl|fentanyl|mesh-list
110442998|NCT00691795|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110442999|NCT00691795|Narcotics|narcotics|mesh-ancestor
110443000|NCT00691795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110443001|NCT00691795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110443002|NCT00691795|Analgesics|analgesics|mesh-ancestor
110443003|NCT00691795|Sensory System Agents|sensory system agents|mesh-ancestor
110443004|NCT00691795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110443005|NCT00691795|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110443006|NCT00691795|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110443007|NCT00691795|Anesthetics, General|anesthetics, general|mesh-ancestor
110443008|NCT00691795|Anesthetics|anesthetics|mesh-ancestor
110443009|NCT00691795|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110443010|NCT00691795|Sympatholytics|sympatholytics|mesh-ancestor
110443011|NCT00691795|Autonomic Agents|autonomic agents|mesh-ancestor
110443012|NCT00691795|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110443013|NCT00691795|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110443014|NCT00691795|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110443015|NCT00691795|Adrenergic Agents|adrenergic agents|mesh-ancestor
110443016|NCT00691795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110443017|NCT00691795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110443018|NCT02805556|Fostemsavir|fostemsavir|mesh-list
110443019|NCT02805556|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110443020|NCT02805556|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110443021|NCT02805556|Antiviral Agents|antiviral agents|mesh-ancestor
110443022|NCT02805556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110443023|NCT02805556|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110443024|NCT02805556|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110443025|NCT02805556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110443026|NCT04032964|Doxorubicin|doxorubicin|mesh-list
110443027|NCT04032964|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110443028|NCT04032964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110443029|NCT04032964|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110443030|NCT04032964|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110443031|NCT04032964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110443032|NCT04032964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110443033|NCT00694291|Sorafenib|sorafenib|mesh-list
110443034|NCT00694291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110443035|NCT00694291|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110443036|NCT00694291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110443037|NCT00694291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110443038|NCT01153763|Dabrafenib|dabrafenib|mesh-list
110443039|NCT01153763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110443040|NCT01153763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110443041|NCT01153763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110443042|NCT01153763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110443043|NCT00691873|Omalizumab|omalizumab|mesh-list
110443044|NCT00691873|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110443045|NCT00691873|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110443046|NCT00691873|Respiratory System Agents|respiratory system agents|mesh-ancestor
110443047|NCT05538052|Lidocaine|lidocaine|mesh-list
110443048|NCT05538052|Tramadol|tramadol|mesh-list
110443049|NCT05538052|Anesthetics, Local|anesthetics, local|mesh-ancestor
110443050|NCT05538052|Anesthetics|anesthetics|mesh-ancestor
110443051|NCT05538052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110443052|NCT05538052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110443053|NCT05538052|Sensory System Agents|sensory system agents|mesh-ancestor
110443054|NCT05538052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110443055|NCT05538052|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110443056|NCT05538052|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110443057|NCT05538052|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110443058|NCT05538052|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110443059|NCT05538052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110443060|NCT05538052|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110443061|NCT05538052|Narcotics|narcotics|mesh-ancestor
110443062|NCT05538052|Analgesics|analgesics|mesh-ancestor
110443063|NCT05298475|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-list
110443064|NCT05298475|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110053169|NCT01485211|Vitamins|vitamins|mesh-ancestor
110443065|NCT05298475|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110443066|NCT05298475|Antimetabolites|antimetabolites|mesh-ancestor
110443067|NCT05298475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110443068|NCT05298475|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110443069|NCT05298475|Protease Inhibitors|protease inhibitors|mesh-ancestor
110443070|NCT05298475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110443071|NCT05298475|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110443072|NCT00691951|Budesonide|budesonide|mesh-list
110443073|NCT00691951|Formoterol Fumarate|formoterol fumarate|mesh-list
110443074|NCT00691951|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110443075|NCT00691951|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110443076|NCT00691951|Autonomic Agents|autonomic agents|mesh-ancestor
110443077|NCT00691951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110373348|NCT04584983|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110443078|NCT00691951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110443079|NCT00691951|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110443080|NCT00691951|Respiratory System Agents|respiratory system agents|mesh-ancestor
110443081|NCT00691951|Glucocorticoids|glucocorticoids|mesh-ancestor
110443082|NCT00691951|Hormones|hormones|mesh-ancestor
110443083|NCT00691951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110443084|NCT00691951|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110443085|NCT00691951|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110443086|NCT00691951|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110443087|NCT00691951|Adrenergic Agents|adrenergic agents|mesh-ancestor
110443088|NCT00691951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110443089|NCT00691951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110443090|NCT04316351|Pemetrexed|pemetrexed|mesh-list
110443091|NCT04316351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110443092|NCT04316351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110443093|NCT04316351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110443094|NCT04316351|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110443095|NCT04316351|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110443096|NCT02625337|Pembrolizumab|pembrolizumab|mesh-list
110443097|NCT02625337|Trametinib|trametinib|mesh-list
110443098|NCT02625337|Dabrafenib|dabrafenib|mesh-list
110443099|NCT02625337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110443100|NCT02625337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110443101|NCT02625337|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110443102|NCT02625337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110443103|NCT02625337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110443104|NCT02625337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110443105|NCT04236310|Trastuzumab|trastuzumab|mesh-list
110443106|NCT04236310|Anastrozole|anastrozole|mesh-list
110443107|NCT04236310|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110443108|NCT04236310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110443109|NCT04236310|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110443110|NCT04236310|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110443111|NCT04236310|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110443112|NCT04236310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110443113|NCT04236310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110443114|NCT04236310|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110443115|NCT04236310|Hormone Antagonists|hormone antagonists|mesh-ancestor
110443116|NCT04236310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110443117|NCT04236310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110443118|NCT02621515|Nivolumab|nivolumab|mesh-list
110443119|NCT02621515|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110443120|NCT02621515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110443121|NCT02621515|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110443122|NCT02621515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110443123|NCT02803918|Metformin|metformin|mesh-list
110443124|NCT02803918|Lixisenatide|lixisenatide|mesh-list
110443125|NCT02803918|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110443126|NCT02803918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110443128|NCT02805010|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110443129|NCT02805010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110443130|NCT02805010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110443131|NCT02805010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110443132|NCT02805010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110443133|NCT02805010|Immunologic Factors|immunologic factors|mesh-ancestor
110443134|NCT02805010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110443135|NCT02805010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110443136|NCT02800408|Beta-Cryptoxanthin|beta-cryptoxanthin|mesh-list
110443137|NCT02800408|Provitamins|provitamins|mesh-ancestor
110443138|NCT02800408|Vitamins|vitamins|mesh-ancestor
110443139|NCT02800408|Micronutrients|micronutrients|mesh-ancestor
110443140|NCT02800408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110443141|NCT00692263|Tramadol|tramadol|mesh-list
110443142|NCT00692263|Escitalopram|escitalopram|mesh-list
110443143|NCT00692263|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110443144|NCT00692263|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110443145|NCT00692263|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110443146|NCT00692263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110443147|NCT00692263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110443148|NCT00692263|Serotonin Agents|serotonin agents|mesh-ancestor
110443149|NCT00692263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110443150|NCT00692263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110443151|NCT00692263|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110443152|NCT00692263|Narcotics|narcotics|mesh-ancestor
110443153|NCT00692263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110443154|NCT00692263|Analgesics|analgesics|mesh-ancestor
110443155|NCT00692263|Sensory System Agents|sensory system agents|mesh-ancestor
110443156|NCT02800486|Cetuximab|cetuximab|mesh-list
110443157|NCT02800486|Mannitol|mannitol|mesh-list
110443158|NCT02800486|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110443159|NCT02800486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110443160|NCT02800486|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110443161|NCT02800486|Diuretics|diuretics|mesh-ancestor
110443162|NCT02800486|Natriuretic Agents|natriuretic agents|mesh-ancestor
110443163|NCT02800486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110443164|NCT00694759|Metformin|metformin|mesh-list
110443165|NCT00694759|Pioglitazone|pioglitazone|mesh-list
110443166|NCT00694759|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110443167|NCT00694759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110443168|NCT00694837|Nelfinavir|nelfinavir|mesh-list
110443169|NCT00694837|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110443170|NCT00694837|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110443171|NCT00694837|Protease Inhibitors|protease inhibitors|mesh-ancestor
110443172|NCT00694837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110443173|NCT00694837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110443174|NCT00694837|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110443175|NCT00694837|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110443176|NCT00694837|Antiviral Agents|antiviral agents|mesh-ancestor
110443177|NCT00694837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110443178|NCT02800252|Aspirin|aspirin|mesh-list
110443179|NCT02800252|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110443180|NCT02800252|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110443181|NCT02800252|Analgesics|analgesics|mesh-ancestor
110373383|NCT04584008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110443182|NCT02800252|Sensory System Agents|sensory system agents|mesh-ancestor
110443183|NCT02800252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110443184|NCT02800252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110443185|NCT02800252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110443186|NCT02800252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110443187|NCT02800252|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110443188|NCT02800252|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110443189|NCT02800252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110443190|NCT02800252|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110443191|NCT02800252|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110443192|NCT02800252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110443195|NCT02621359|Levofloxacin|levofloxacin|mesh-list
110443196|NCT02621359|Nitazoxanide|nitazoxanide|mesh-list
110443197|NCT02621359|Omeprazole|omeprazole|mesh-list
110443198|NCT02621359|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110090271|NCT04665895|Xhance|xhance|mesh-list
110443199|NCT02621359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110443200|NCT02621359|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110443201|NCT02621359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110443202|NCT02621359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110443203|NCT02621359|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110443204|NCT02621359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110443205|NCT02621359|Antimalarials|antimalarials|mesh-ancestor
110443206|NCT02621359|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110443207|NCT02621359|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110443208|NCT02621359|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110054094|NCT01489982|Doxepin|doxepin|mesh-list
110443209|NCT02621359|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110443210|NCT02621359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110443211|NCT02621359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110443212|NCT02621359|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110443213|NCT02621359|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110443214|NCT01152437|Cetuximab|cetuximab|mesh-list
110443215|NCT01152437|Afatinib|afatinib|mesh-list
110443216|NCT01152437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110443217|NCT01152437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110443218|NCT01152437|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110443219|NCT01152437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110443220|NCT01152437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110443221|NCT02800174|Clopidogrel|clopidogrel|mesh-list
110443222|NCT02800174|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
110443223|NCT02800174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110443224|NCT02800174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110443225|NCT02800174|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110443226|NCT02800174|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110443227|NCT02800174|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110443228|NCT02800174|Purinergic Agents|purinergic agents|mesh-ancestor
110443229|NCT02800174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110443230|NCT02800330|Esomeprazole|esomeprazole|mesh-list
110443231|NCT02800330|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110443232|NCT02800330|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110443233|NCT02800330|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110443234|NCT02800330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110443235|NCT02800330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110443236|NCT02799862|Paclitaxel|paclitaxel|mesh-list
110443237|NCT02799862|Carboplatin|carboplatin|mesh-list
110443238|NCT02799862|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110443239|NCT02799862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110443240|NCT02799862|Tubulin Modulators|tubulin modulators|mesh-ancestor
110443241|NCT02799862|Antimitotic Agents|antimitotic agents|mesh-ancestor
110443242|NCT02799862|Mitosis Modulators|mitosis modulators|mesh-ancestor
110443243|NCT02799862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110443244|NCT01151579|Albuterol|albuterol|mesh-list
110443245|NCT01151579|Ipratropium|ipratropium|mesh-list
110443246|NCT01151579|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110443247|NCT01151579|Autonomic Agents|autonomic agents|mesh-ancestor
110443248|NCT01151579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110443249|NCT01151579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110443250|NCT01151579|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110443251|NCT01151579|Respiratory System Agents|respiratory system agents|mesh-ancestor
110443252|NCT01151579|Tocolytic Agents|tocolytic agents|mesh-ancestor
110443253|NCT01151579|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110443254|NCT01151579|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110443255|NCT01151579|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110443256|NCT01151579|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110443257|NCT01151579|Adrenergic Agents|adrenergic agents|mesh-ancestor
110443258|NCT01151579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110443259|NCT01151579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110443260|NCT01151579|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110443261|NCT01151579|Cholinergic Agents|cholinergic agents|mesh-ancestor
110443262|NCT00694915|BCG Vaccine|bcg vaccine|mesh-list
110443263|NCT00694915|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110443264|NCT00694915|Immunologic Factors|immunologic factors|mesh-ancestor
110443265|NCT00694915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110443266|NCT01097616|Suvorexant|suvorexant|mesh-list
110443267|NCT01097616|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110443268|NCT01097616|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110443269|NCT01097616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110443270|NCT01097616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110443271|NCT01097616|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
110443272|NCT01097616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110090290|NCT04545554|Vitamin D|vitamin d|mesh-list
110443273|NCT01097616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110443274|NCT00695071|Itraconazole|itraconazole|mesh-list
110443275|NCT00695071|Antifungal Agents|antifungal agents|mesh-ancestor
110443276|NCT00695071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110443277|NCT00695071|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110443278|NCT00695071|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110443279|NCT00695071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110443280|NCT00695071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110443281|NCT00695071|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110443282|NCT00695071|Hormone Antagonists|hormone antagonists|mesh-ancestor
110443283|NCT00695071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110443284|NCT00695071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110443285|NCT00695071|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110443286|NCT04939428|Molnupiravir|molnupiravir|mesh-list
110443287|NCT04939428|Antiviral Agents|antiviral agents|mesh-ancestor
110443288|NCT04939428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110443289|NCT02803216|Amoxicillin|amoxicillin|mesh-list
110443290|NCT02803216|Clarithromycin|clarithromycin|mesh-list
110443291|NCT02803216|Omeprazole|omeprazole|mesh-list
110443292|NCT02803216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110443293|NCT02803216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110443294|NCT02803216|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110443295|NCT02803216|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110443296|NCT02803216|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110443297|NCT02803216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110443298|NCT02803216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110443299|NCT02803216|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110443300|NCT02803216|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110443301|NCT02803216|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110443302|NCT02799316|Antibodies|antibodies|mesh-list
110443303|NCT02799316|Immunologic Factors|immunologic factors|mesh-ancestor
110443304|NCT02799316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110443305|NCT02620969|Dialysis Solutions|dialysis solutions|mesh-list
110443306|NCT02620969|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110443307|NCT02799238|Temozolomide|temozolomide|mesh-list
110443308|NCT02799238|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110443309|NCT02799238|Alkylating Agents|alkylating agents|mesh-ancestor
110443310|NCT02799238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110443311|NCT02799238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110443312|NCT02620813|Tretinoin|tretinoin|mesh-list
110443313|NCT02620813|Isotretinoin|isotretinoin|mesh-list
110443314|NCT02620813|Dermatologic Agents|dermatologic agents|mesh-ancestor
110443315|NCT02620813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110443316|NCT02620813|Keratolytic Agents|keratolytic agents|mesh-ancestor
110443317|NCT00692731|Caffeine|caffeine|mesh-list
110443318|NCT00692731|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110443319|NCT00692731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110443320|NCT00692731|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110443321|NCT00692731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110443322|NCT00692731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110443323|NCT00692731|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110443324|NCT00692731|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110329706|NCT00492765|Interferons|interferons|mesh-list
110443325|NCT00692731|Purinergic Agents|purinergic agents|mesh-ancestor
110443326|NCT00692731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110443327|NCT02624401|Dexmedetomidine|dexmedetomidine|mesh-list
110443328|NCT02624401|Ketamine|ketamine|mesh-list
110443329|NCT02624401|Propofol|propofol|mesh-list
110443330|NCT02624401|Sevoflurane|sevoflurane|mesh-list
110443331|NCT02624401|Esketamine|esketamine|mesh-list
110443332|NCT02624401|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110443333|NCT02624401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110443334|NCT02624401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110443335|NCT02624401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110443336|NCT02624401|Analgesics|analgesics|mesh-ancestor
110443337|NCT02624401|Sensory System Agents|sensory system agents|mesh-ancestor
110443338|NCT02624401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110443339|NCT02624401|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110443340|NCT02624401|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110443341|NCT02624401|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110443342|NCT02624401|Adrenergic Agents|adrenergic agents|mesh-ancestor
110443343|NCT02624401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110443344|NCT02624401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110443345|NCT02624401|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110443346|NCT02624401|Anesthetics, General|anesthetics, general|mesh-ancestor
110443347|NCT02624401|Anesthetics|anesthetics|mesh-ancestor
110443348|NCT02624401|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110443349|NCT02624401|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110443350|NCT02624401|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110443351|NCT02624401|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110443352|NCT02624401|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110443353|NCT02624401|Antidepressive Agents|antidepressive agents|mesh-ancestor
110443354|NCT02624401|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110443355|NCT02802748|Letrozole|letrozole|mesh-list
110443356|NCT02802748|Vinorelbine|vinorelbine|mesh-list
110443357|NCT02802748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110443358|NCT02802748|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110443359|NCT02802748|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110443360|NCT02802748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110443361|NCT02802748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110443362|NCT02802748|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110443363|NCT02802748|Hormone Antagonists|hormone antagonists|mesh-ancestor
110443364|NCT02802748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110443365|NCT02802748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110443366|NCT02802748|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110443367|NCT02802748|Tubulin Modulators|tubulin modulators|mesh-ancestor
110443368|NCT02802748|Antimitotic Agents|antimitotic agents|mesh-ancestor
110443369|NCT02802748|Mitosis Modulators|mitosis modulators|mesh-ancestor
110443370|NCT02798068|Methylprednisolone|methylprednisolone|mesh-list
110443371|NCT02798068|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110443372|NCT02798068|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110443373|NCT02798068|Prednisolone|prednisolone|mesh-list
110443374|NCT02798068|Prednisolone acetate|prednisolone acetate|mesh-list
110443375|NCT02798068|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110443376|NCT02798068|Prednisolone phosphate|prednisolone phosphate|mesh-list
110443377|NCT02798068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110443378|NCT02798068|Antiemetics|antiemetics|mesh-ancestor
110443379|NCT02798068|Autonomic Agents|autonomic agents|mesh-ancestor
110443380|NCT02798068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110443381|NCT02798068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110443382|NCT02798068|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110443383|NCT02798068|Glucocorticoids|glucocorticoids|mesh-ancestor
110443384|NCT02798068|Hormones|hormones|mesh-ancestor
110443385|NCT02798068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110443386|NCT02798068|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110443387|NCT02798068|Protective Agents|protective agents|mesh-ancestor
110443388|NCT02798068|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110443389|NCT02798068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110443391|NCT00593827|Tubulin Modulators|tubulin modulators|mesh-ancestor
110443392|NCT00593827|Antimitotic Agents|antimitotic agents|mesh-ancestor
110443393|NCT00593827|Mitosis Modulators|mitosis modulators|mesh-ancestor
110443394|NCT00593827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110443395|NCT00593827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110443397|NCT04135885|Hematinics|hematinics|mesh-ancestor
110443398|NCT04135885|Vitamin B Complex|vitamin b complex|mesh-ancestor
110443399|NCT04135885|Vitamins|vitamins|mesh-ancestor
110443400|NCT04135885|Micronutrients|micronutrients|mesh-ancestor
110443401|NCT04135885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110443402|NCT00693043|Lidocaine|lidocaine|mesh-list
110443403|NCT00693043|Anesthetics, Local|anesthetics, local|mesh-ancestor
110443404|NCT00693043|Anesthetics|anesthetics|mesh-ancestor
110443405|NCT00693043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110443406|NCT00693043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110443407|NCT00693043|Sensory System Agents|sensory system agents|mesh-ancestor
110443408|NCT00693043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110443409|NCT00693043|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110443410|NCT00693043|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110443411|NCT00693043|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110443412|NCT00693043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110443413|NCT00693043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110443414|NCT00695929|Simendan|simendan|mesh-list
110443415|NCT00695929|Milrinone|milrinone|mesh-list
110443416|NCT00695929|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110443417|NCT00695929|Vasodilator Agents|vasodilator agents|mesh-ancestor
110443418|NCT00695929|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110443419|NCT00695929|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110443420|NCT00695929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110443421|NCT00695929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110443422|NCT00695929|Protective Agents|protective agents|mesh-ancestor
110443423|NCT00695929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110443424|NCT00695929|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110443425|NCT04235296|Mitogens|mitogens|mesh-list
110443426|NCT04235296|Mitosis Modulators|mitosis modulators|mesh-ancestor
110443427|NCT04235296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110443428|NCT02620501|Lidocaine|lidocaine|mesh-list
110443429|NCT02620501|Anesthetics, Local|anesthetics, local|mesh-ancestor
110443430|NCT02620501|Anesthetics|anesthetics|mesh-ancestor
110443431|NCT02620501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110443432|NCT02620501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110443433|NCT02620501|Sensory System Agents|sensory system agents|mesh-ancestor
110443434|NCT02620501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110443435|NCT02620501|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110443436|NCT02620501|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110443437|NCT02620501|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110443438|NCT02620501|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110443439|NCT02620501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110443440|NCT00693121|Amantadine|amantadine|mesh-list
110443441|NCT00693121|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110443442|NCT00693121|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110443443|NCT00693121|Antiviral Agents|antiviral agents|mesh-ancestor
110443444|NCT00693121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110443445|NCT00693121|Dopamine Agents|dopamine agents|mesh-ancestor
110443446|NCT00693121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110443447|NCT00693121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110443448|NCT00693121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110443449|NCT00693121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110443450|NCT00693121|Analgesics|analgesics|mesh-ancestor
110443451|NCT00693121|Sensory System Agents|sensory system agents|mesh-ancestor
110443452|NCT00693121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110443453|NCT02620423|Leucovorin|leucovorin|mesh-list
110443454|NCT02620423|Gemcitabine|gemcitabine|mesh-list
110443455|NCT02620423|Fluorouracil|fluorouracil|mesh-list
110443456|NCT02620423|Pembrolizumab|pembrolizumab|mesh-list
110443457|NCT02620423|Irinotecan|irinotecan|mesh-list
110443458|NCT02620423|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110443460|NCT02620423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110443461|NCT02620423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110443462|NCT02620423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110443463|NCT02620423|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110443464|NCT02620423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110443465|NCT02620423|Immunologic Factors|immunologic factors|mesh-ancestor
110443466|NCT02620423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110443467|NCT02620423|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110443468|NCT02620423|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110443469|NCT02620423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110443470|NCT02620423|Antidotes|antidotes|mesh-ancestor
110443471|NCT02620423|Protective Agents|protective agents|mesh-ancestor
110443472|NCT02620423|Vitamin B Complex|vitamin b complex|mesh-ancestor
110443473|NCT02620423|Vitamins|vitamins|mesh-ancestor
110443474|NCT02620423|Micronutrients|micronutrients|mesh-ancestor
110443475|NCT00696007|Gemcitabine|gemcitabine|mesh-list
110443476|NCT00696007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110443477|NCT00696007|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110443478|NCT00696007|Antimetabolites|antimetabolites|mesh-ancestor
110443479|NCT00696007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110443480|NCT02624089|Ropivacaine|ropivacaine|mesh-list
110443481|NCT02624089|Anesthetics, Local|anesthetics, local|mesh-ancestor
110443482|NCT02624089|Anesthetics|anesthetics|mesh-ancestor
110443483|NCT02624089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110443484|NCT02624089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110443485|NCT02624089|Sensory System Agents|sensory system agents|mesh-ancestor
110443486|NCT02624089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110443487|NCT02796196|Coal Tar|coal tar|mesh-list
110443488|NCT02796196|Keratolytic Agents|keratolytic agents|mesh-ancestor
110443489|NCT02796196|Dermatologic Agents|dermatologic agents|mesh-ancestor
110443490|NCT00693199|Amlodipine|amlodipine|mesh-list
110443491|NCT00693199|Prazosin|prazosin|mesh-list
110443492|NCT00693199|Terazosin|terazosin|mesh-list
110443493|NCT00693199|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110443495|NCT00693199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110443496|NCT00693199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110443497|NCT00693199|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110443498|NCT00693199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110330308|NCT00598897|Rifabutin|rifabutin|mesh-list
110443499|NCT00693199|Vasodilator Agents|vasodilator agents|mesh-ancestor
110443500|NCT00693199|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110443501|NCT00693199|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110443502|NCT00693199|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110443503|NCT00693199|Adrenergic Agents|adrenergic agents|mesh-ancestor
110443504|NCT00693199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110443505|NCT00693199|Urological Agents|urological agents|mesh-ancestor
110443506|NCT02795884|Cisplatin|cisplatin|mesh-list
110443507|NCT02795884|Pemetrexed|pemetrexed|mesh-list
110443508|NCT02795884|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110443509|NCT02795884|Vinorelbine|vinorelbine|mesh-list
110443510|NCT02795884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110443511|NCT02795884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110443512|NCT02795884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110443513|NCT02795884|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110443514|NCT02795884|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110330437|NCT00599950|Mitomycins|mitomycins|mesh-list
110443515|NCT02795884|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110330499|NCT00600301|Hormones|hormones|mesh-ancestor
110443516|NCT02795884|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110443518|NCT02795884|Antimitotic Agents|antimitotic agents|mesh-ancestor
110443519|NCT02795884|Mitosis Modulators|mitosis modulators|mesh-ancestor
110443521|NCT02795572|Vitamins|vitamins|mesh-list
110443522|NCT02795572|Vitamin B 12|vitamin b 12|mesh-list
110443523|NCT02795572|Vitamin B 6|vitamin b 6|mesh-list
110443524|NCT02795572|Pyridoxal|pyridoxal|mesh-list
110443526|NCT02795572|Vitamin B Complex|vitamin b complex|mesh-list
110330865|NCT00502164|Cediranib|cediranib|mesh-list
110443527|NCT02795572|Micronutrients|micronutrients|mesh-ancestor
110443528|NCT02795572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110443529|NCT02795572|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110443530|NCT02801188|Dexmedetomidine|dexmedetomidine|mesh-list
110443531|NCT02801188|Bupivacaine|bupivacaine|mesh-list
110331077|NCT01325350|Bimatoprost|bimatoprost|mesh-list
110443532|NCT02801188|Anesthetics, Local|anesthetics, local|mesh-ancestor
110443533|NCT02801188|Anesthetics|anesthetics|mesh-ancestor
110331151|NCT00471653|Temozolomide|temozolomide|mesh-list
110443534|NCT02801188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110331218|NCT00471965|Leucovorin|leucovorin|mesh-list
110443535|NCT02801188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110443536|NCT02801188|Sensory System Agents|sensory system agents|mesh-ancestor
110443537|NCT02801188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110443538|NCT02801188|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110443539|NCT02801188|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110443540|NCT02801188|Analgesics|analgesics|mesh-ancestor
110443541|NCT02801188|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110443542|NCT02801188|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110443543|NCT02801188|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110443544|NCT02801188|Adrenergic Agents|adrenergic agents|mesh-ancestor
110443545|NCT02801188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110331430|NCT04325581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110331504|NCT00503763|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110443546|NCT02801188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110443547|NCT02801032|Tadalafil|tadalafil|mesh-list
110443548|NCT02801032|Vasodilator Agents|vasodilator agents|mesh-ancestor
110443549|NCT02801032|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110443550|NCT02801032|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110443551|NCT02801032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110443552|NCT02801032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110443553|NCT02801032|Urological Agents|urological agents|mesh-ancestor
110443554|NCT05442190|Hypericin|hypericin|mesh-list
110443555|NCT05442190|Antidepressive Agents|antidepressive agents|mesh-ancestor
110443556|NCT05442190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110443557|NCT05442190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110443558|NCT05442190|Antiviral Agents|antiviral agents|mesh-ancestor
110443559|NCT05442190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110443560|NCT05442190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110443561|NCT05442190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110332015|NCT00481442|Nasal Decongestants|nasal decongestants|mesh-ancestor
110443562|NCT05442190|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110443563|NCT05442190|Immunologic Factors|immunologic factors|mesh-ancestor
110443564|NCT05442190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110443565|NCT02689960|Prednisone|prednisone|mesh-list
110443566|NCT02689960|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110443567|NCT02689960|Glucocorticoids|glucocorticoids|mesh-ancestor
110443568|NCT02689960|Hormones|hormones|mesh-ancestor
110443569|NCT02689960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110443570|NCT02689960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110443571|NCT02689960|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110443572|NCT02689960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110443573|NCT01150097|Everolimus|everolimus|mesh-list
110443574|NCT01150097|Tacrolimus|tacrolimus|mesh-list
110443575|NCT01150097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110443576|NCT01150097|Immunologic Factors|immunologic factors|mesh-ancestor
110443577|NCT01150097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110443578|NCT01150097|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110443579|NCT01150097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110443580|NCT01150097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110443582|NCT01150097|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110443583|NCT01150097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110443584|NCT02794948|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
110443585|NCT02794948|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110443586|NCT02794948|Immunologic Factors|immunologic factors|mesh-ancestor
110443587|NCT02794948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110443589|NCT01149863|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110443590|NCT01149863|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110443591|NCT01149863|Antiviral Agents|antiviral agents|mesh-ancestor
110443592|NCT01149863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110443594|NCT02794792|Ipragliflozin|ipragliflozin|mesh-list
110443595|NCT02794792|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110332372|NCT04518540|Vitamins|vitamins|mesh-ancestor
110443596|NCT02794792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110443597|NCT02794792|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110443598|NCT02794792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110443599|NCT01149473|Losartan|losartan|mesh-list
110443600|NCT01149473|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110443601|NCT01149473|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110443602|NCT01149473|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110443603|NCT01149473|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110443604|NCT01149473|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110443605|NCT01149473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110443606|NCT01149473|Diuretics|diuretics|mesh-ancestor
110443607|NCT01149473|Natriuretic Agents|natriuretic agents|mesh-ancestor
110443608|NCT01149473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110443609|NCT01149473|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110443610|NCT01149473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110443611|NCT00872989|Docetaxel|docetaxel|mesh-list
110443612|NCT00872989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110443613|NCT00872989|Tubulin Modulators|tubulin modulators|mesh-ancestor
110443614|NCT00872989|Antimitotic Agents|antimitotic agents|mesh-ancestor
110443615|NCT00872989|Mitosis Modulators|mitosis modulators|mesh-ancestor
110443616|NCT00872989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110443617|NCT02794714|Rocuronium|rocuronium|mesh-list
110333083|NCT05643820|Ivermectin|ivermectin|mesh-list
110443618|NCT02794714|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110443619|NCT02794714|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110443620|NCT02794714|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110443621|NCT02794714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110443622|NCT02794714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110443623|NCT01148771|Ertapenem|ertapenem|mesh-list
110443624|NCT01148771|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110443625|NCT01148771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110333294|NCT02275806|Irinotecan|irinotecan|mesh-list
110443627|NCT01148693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110443628|NCT01148693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110443629|NCT01148693|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110443630|NCT01148693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110333458|NCT00485342|Interferons|interferons|mesh-list
110443631|NCT01148693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110443632|NCT00693355|Butyric Acid|butyric acid|mesh-list
110443633|NCT00693355|Histamine Antagonists|histamine antagonists|mesh-ancestor
110443634|NCT00693355|Histamine Agents|histamine agents|mesh-ancestor
110443635|NCT00693355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110443636|NCT00693355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110443637|NCT00693355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110443638|NCT00693433|Sirolimus|sirolimus|mesh-list
110443639|NCT00693433|Dexamethasone|dexamethasone|mesh-list
110443640|NCT00693433|Temsirolimus|temsirolimus|mesh-list
110443641|NCT00693433|MTOR Inhibitors|mtor inhibitors|mesh-list
110443642|NCT00693433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110443643|NCT00693433|Antiemetics|antiemetics|mesh-ancestor
110443644|NCT00693433|Autonomic Agents|autonomic agents|mesh-ancestor
110443645|NCT00693433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110443646|NCT00693433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110443647|NCT00693433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110443648|NCT00693433|Glucocorticoids|glucocorticoids|mesh-ancestor
110443649|NCT00693433|Hormones|hormones|mesh-ancestor
110443650|NCT00693433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110443651|NCT00693433|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110443652|NCT00693433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110443653|NCT00693433|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110443654|NCT00693433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110443655|NCT00693433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110443657|NCT00693433|Immunologic Factors|immunologic factors|mesh-ancestor
110443658|NCT00693433|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110443659|NCT00693433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110443660|NCT00693433|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110443662|NCT05414422|Ketamine|ketamine|mesh-list
110443664|NCT05414422|Sensory System Agents|sensory system agents|mesh-ancestor
110443665|NCT05414422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110443666|NCT05414422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110443667|NCT05414422|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110443668|NCT05414422|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110443669|NCT05414422|Anesthetics, General|anesthetics, general|mesh-ancestor
110443670|NCT05414422|Anesthetics|anesthetics|mesh-ancestor
110334350|NCT00487448|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110443671|NCT05414422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110443672|NCT05414422|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110443673|NCT05414422|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110334580|NCT04696185|Dapagliflozin|dapagliflozin|mesh-list
110443674|NCT05414422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110334645|NCT04513860|Cenobamate|cenobamate|mesh-list
110443675|NCT05414422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110443678|NCT00872599|Antimetabolites|antimetabolites|mesh-ancestor
110334939|NCT02598999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110443679|NCT00872599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110443680|NCT00872599|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110443681|NCT02623621|Bevacizumab|bevacizumab|mesh-list
110443682|NCT02623621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110443683|NCT02623621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110443684|NCT02623621|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110443685|NCT02623621|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110443686|NCT02623621|Growth Substances|growth substances|mesh-ancestor
110443687|NCT02623621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110335453|NCT05145543|Antiemetics|antiemetics|mesh-ancestor
110443688|NCT02623621|Growth Inhibitors|growth inhibitors|mesh-ancestor
110443690|NCT00693589|Vitamin B 12|vitamin b 12|mesh-list
110443691|NCT00693589|Hydroxocobalamin|hydroxocobalamin|mesh-list
110443692|NCT00693589|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110443693|NCT00693589|Vitamins|vitamins|mesh-ancestor
110443694|NCT00693589|Micronutrients|micronutrients|mesh-ancestor
110443695|NCT00693589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110443696|NCT00693589|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110443697|NCT00693589|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110443698|NCT00693589|Antimetabolites|antimetabolites|mesh-ancestor
110443699|NCT00693589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110443700|NCT00693589|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110443701|NCT00693589|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110443702|NCT00693589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110443703|NCT00693589|Hematinics|hematinics|mesh-ancestor
110443704|NCT00693589|Vitamin B Complex|vitamin b complex|mesh-ancestor
110443705|NCT01148537|Moxifloxacin|moxifloxacin|mesh-list
110443706|NCT01148537|Buprenorphine|buprenorphine|mesh-list
110443707|NCT01148537|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
110443708|NCT01148537|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110443709|NCT01148537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110443710|NCT01148537|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110443711|NCT01148537|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110443712|NCT01148537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110443713|NCT01148537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110443714|NCT01148537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110443715|NCT01148537|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110443716|NCT01148537|Contraceptive Agents|contraceptive agents|mesh-ancestor
110443717|NCT01148537|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110443718|NCT01148537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110443719|NCT01148537|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110443720|NCT01148537|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110443721|NCT01148537|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110443722|NCT01148537|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110443723|NCT01148537|Narcotics|narcotics|mesh-ancestor
110443724|NCT01148537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110443725|NCT01148537|Analgesics|analgesics|mesh-ancestor
110443726|NCT01148537|Sensory System Agents|sensory system agents|mesh-ancestor
110443727|NCT01148537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110443728|NCT01148537|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110443730|NCT02793544|Sirolimus|sirolimus|mesh-list
110443731|NCT02793544|Cyclophosphamide|cyclophosphamide|mesh-list
110443733|NCT02793544|Fludarabine|fludarabine|mesh-list
110443734|NCT02793544|Mesna|mesna|mesh-list
110443735|NCT02793544|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110443736|NCT02793544|Immunologic Factors|immunologic factors|mesh-ancestor
110443737|NCT02793544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110443738|NCT02793544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110336081|NCT01248338|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110443739|NCT02793544|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110443740|NCT02793544|Alkylating Agents|alkylating agents|mesh-ancestor
110443741|NCT02793544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110443742|NCT02793544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110443743|NCT02793544|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110443744|NCT02793544|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110443745|NCT02793544|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110336609|NCT00511017|Vitamins|vitamins|mesh-ancestor
110443746|NCT02793544|Antitubercular Agents|antitubercular agents|mesh-ancestor
110336681|NCT02955446|Nirogacestat|nirogacestat|mesh-list
110443748|NCT02793544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110443749|NCT02793544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110443750|NCT02793544|Antifungal Agents|antifungal agents|mesh-ancestor
110443751|NCT02793544|Protective Agents|protective agents|mesh-ancestor
110443752|NCT02793388|Primaquine|primaquine|mesh-list
110443753|NCT02793388|Antimalarials|antimalarials|mesh-ancestor
110443754|NCT02793388|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110443755|NCT02793388|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110443756|NCT02793388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110443757|NCT02689882|Niacinamide|niacinamide|mesh-list
110443758|NCT02689882|Niacin|niacin|mesh-list
110443759|NCT02689882|Nicotinic Acids|nicotinic acids|mesh-list
110443760|NCT02689882|Vitamin B Complex|vitamin b complex|mesh-ancestor
110443761|NCT02689882|Vitamins|vitamins|mesh-ancestor
110443762|NCT02689882|Micronutrients|micronutrients|mesh-ancestor
110443763|NCT02689882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110443764|NCT02689882|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110443765|NCT02689882|Antimetabolites|antimetabolites|mesh-ancestor
110443766|NCT02689882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110443767|NCT02689882|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110443768|NCT02689882|Vasodilator Agents|vasodilator agents|mesh-ancestor
110443769|NCT02789644|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
110443770|NCT02789644|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
110443771|NCT02789644|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110443772|NCT04234594|Panitumumab|panitumumab|mesh-list
110443773|NCT04234594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110443774|NCT04234594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110443775|NCT02789488|Fenugreek seed meal|fenugreek seed meal|mesh-list
110443776|NCT02789488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110443777|NCT02789488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110443778|NCT04233346|Ponatinib|ponatinib|mesh-list
110443779|NCT04233346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110443780|NCT04233346|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110443781|NCT04233346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110443782|NCT04233346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110443783|NCT01148459|Vaccines|vaccines|mesh-list
110443784|NCT01148459|Immunologic Factors|immunologic factors|mesh-ancestor
110337935|NCT00518583|Tubulin Modulators|tubulin modulators|mesh-ancestor
110338002|NCT02276300|Interferon Inducers|interferon inducers|mesh-ancestor
110338076|NCT00520338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110443785|NCT01148459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110443787|NCT03913234|Letrozole|letrozole|mesh-list
110443788|NCT03913234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110443789|NCT03913234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110443790|NCT03913234|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110443791|NCT03913234|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110443792|NCT03913234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110338284|NCT00521157|Naltrexone|naltrexone|mesh-list
110338360|NCT05146778|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110443793|NCT03913234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110443794|NCT03913234|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110443795|NCT03913234|Hormone Antagonists|hormone antagonists|mesh-ancestor
110560287|NCT02615288|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110560288|NCT02618096|Oxytocin|oxytocin|mesh-list
110560289|NCT02618096|Dinoprostone|dinoprostone|mesh-list
110560290|NCT02618096|Oxytocics|oxytocics|mesh-ancestor
110338747|NCT00524160|Fentanyl|fentanyl|mesh-list
110338801|NCT02947932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110443796|NCT03913234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110443797|NCT03913234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110443798|NCT02789332|Paclitaxel|paclitaxel|mesh-list
110443799|NCT02789332|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110443800|NCT02789332|Cyclophosphamide|cyclophosphamide|mesh-list
110443801|NCT02789332|Carboplatin|carboplatin|mesh-list
110443802|NCT02789332|Epirubicin|epirubicin|mesh-list
110443803|NCT02789332|Olaparib|olaparib|mesh-list
110339323|NCT02953847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110339395|NCT00510419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110443804|NCT02789332|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110443805|NCT02789332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110443806|NCT02789332|Tubulin Modulators|tubulin modulators|mesh-ancestor
110443807|NCT02789332|Antimitotic Agents|antimitotic agents|mesh-ancestor
110443808|NCT02789332|Mitosis Modulators|mitosis modulators|mesh-ancestor
110560291|NCT02618096|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110443809|NCT02789332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110339916|NCT00513188|Alkylating Agents|alkylating agents|mesh-ancestor
110443810|NCT02789332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110340075|NCT00512291|Serotonin Agents|serotonin agents|mesh-ancestor
110443811|NCT02789332|Immunologic Factors|immunologic factors|mesh-ancestor
110443812|NCT02789332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110340369|NCT00531999|Ritonavir|ritonavir|mesh-list
110443813|NCT02789332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110443814|NCT02789332|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110443815|NCT02789332|Alkylating Agents|alkylating agents|mesh-ancestor
110443816|NCT02789332|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110443817|NCT02789332|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110443818|NCT02789332|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110443819|NCT02789332|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110443820|NCT02789332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110443821|NCT02789332|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110443822|NCT02792140|Naltrexone|naltrexone|mesh-list
110443823|NCT02792140|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110443824|NCT02792140|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110443825|NCT02792140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110443826|NCT02792140|Sensory System Agents|sensory system agents|mesh-ancestor
110443827|NCT02792140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110443828|NCT02791594|Pembrolizumab|pembrolizumab|mesh-list
110443829|NCT02791594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110443830|NCT02791594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110443831|NCT02791594|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110443832|NCT02791594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110443833|NCT04234516|Morphine|morphine|mesh-list
110443834|NCT04234516|Buprenorphine|buprenorphine|mesh-list
110443835|NCT04234516|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
110443836|NCT04234516|Naloxone|naloxone|mesh-list
110443837|NCT04234516|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110443838|NCT04234516|Narcotics|narcotics|mesh-ancestor
110443839|NCT04234516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110443840|NCT04234516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110443841|NCT04234516|Analgesics|analgesics|mesh-ancestor
110443842|NCT04234516|Sensory System Agents|sensory system agents|mesh-ancestor
110443843|NCT04234516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110443844|NCT04234516|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110443845|NCT02789566|Primaquine|primaquine|mesh-list
110443846|NCT02789566|Antimalarials|antimalarials|mesh-ancestor
110443847|NCT02789566|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110443848|NCT02789566|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110443849|NCT02789566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110443850|NCT00697021|Aspirin|aspirin|mesh-list
110443851|NCT00697021|Clopidogrel|clopidogrel|mesh-list
110443852|NCT00697021|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110443853|NCT00697021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110443854|NCT00697021|Analgesics|analgesics|mesh-ancestor
110443855|NCT00697021|Sensory System Agents|sensory system agents|mesh-ancestor
110443856|NCT00697021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110443857|NCT00697021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110340634|NCT00516425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110443858|NCT00697021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110443859|NCT00697021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110443860|NCT00697021|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110443861|NCT00697021|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110443862|NCT00697021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110341001|NCT02938962|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110443863|NCT00697021|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110443864|NCT00697021|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110443865|NCT00697021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110443866|NCT00697021|Antipyretics|antipyretics|mesh-ancestor
110341224|NCT00520754|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110341297|NCT00521261|Antibodies, Bispecific|antibodies, bispecific|mesh-list
110443867|NCT00697021|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110443868|NCT00697021|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110341448|NCT00522782|Budesonide|budesonide|mesh-list
110443869|NCT00697021|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110443870|NCT00697021|Purinergic Agents|purinergic agents|mesh-ancestor
110341521|NCT00523055|Lidocaine|lidocaine|mesh-list
110443871|NCT00697021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110443872|NCT02620345|Dydrogesterone|dydrogesterone|mesh-list
110443873|NCT02620345|Progestins|progestins|mesh-ancestor
110443874|NCT02620345|Hormones|hormones|mesh-ancestor
110341667|NCT00523952|Tacrolimus|tacrolimus|mesh-list
110443875|NCT02620345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110341739|NCT02935764|Immunologic Factors|immunologic factors|mesh-ancestor
110443876|NCT02620345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110443877|NCT00696163|Insulin Aspart|insulin aspart|mesh-list
110443878|NCT00696163|Biphasic Insulins|biphasic insulins|mesh-list
110443879|NCT00696163|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
110341909|NCT00526175|Cytarabine|cytarabine|mesh-list
110341960|NCT02930031|Antidotes|antidotes|mesh-ancestor
110443880|NCT00696163|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110443881|NCT00696163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110443882|NCT02790580|Cyclophosphamide|cyclophosphamide|mesh-list
110443883|NCT02790580|Doxorubicin|doxorubicin|mesh-list
110443884|NCT02790580|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110443885|NCT02790580|Sunitinib|sunitinib|mesh-list
110443886|NCT02790580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110443887|NCT02790580|Immunologic Factors|immunologic factors|mesh-ancestor
110443888|NCT02790580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110443890|NCT02790580|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110443891|NCT02790580|Alkylating Agents|alkylating agents|mesh-ancestor
110443892|NCT02790580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110443893|NCT02790580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110342791|NCT00531167|Lamivudine|lamivudine|mesh-list
110443894|NCT02790580|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110443895|NCT02790580|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110443897|NCT02790580|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110443898|NCT02790580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110443899|NCT02790580|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110443900|NCT02790580|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110443901|NCT02790580|Growth Substances|growth substances|mesh-ancestor
110443902|NCT02790580|Growth Inhibitors|growth inhibitors|mesh-ancestor
110443903|NCT02790580|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110443904|NCT02788864|Piperaquine|piperaquine|mesh-list
110443905|NCT02788864|Antimalarials|antimalarials|mesh-ancestor
110443906|NCT02788864|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110443907|NCT02788864|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110443908|NCT02788864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110443909|NCT02788786|Chlorhexidine|chlorhexidine|mesh-list
110443910|NCT02788786|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110443912|NCT02788786|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110443913|NCT02788786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110443914|NCT02788786|Disinfectants|disinfectants|mesh-ancestor
110443916|NCT02623465|Insulin Lispro|insulin lispro|mesh-list
110443917|NCT02623465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110443918|NCT02623465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110443919|NCT00693979|Paclitaxel|paclitaxel|mesh-list
110443920|NCT00693979|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110443921|NCT00693979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110443922|NCT00693979|Tubulin Modulators|tubulin modulators|mesh-ancestor
110443923|NCT00693979|Antimitotic Agents|antimitotic agents|mesh-ancestor
110443924|NCT00693979|Mitosis Modulators|mitosis modulators|mesh-ancestor
110344110|NCT05911906|Remdesivir|remdesivir|mesh-list
110443925|NCT00693979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110443926|NCT04232800|Riboflavin|riboflavin|mesh-list
110443927|NCT04232800|Vitamins|vitamins|mesh-ancestor
110443928|NCT04232800|Micronutrients|micronutrients|mesh-ancestor
110344338|NCT05855798|Anticonvulsants|anticonvulsants|mesh-ancestor
110443929|NCT04232800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110344455|NCT05813327|Mesna|mesna|mesh-list
110443930|NCT04232800|Vitamin B Complex|vitamin b complex|mesh-ancestor
110443931|NCT04232800|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110443932|NCT04232800|Dermatologic Agents|dermatologic agents|mesh-ancestor
110443933|NCT01148225|Adalimumab|adalimumab|mesh-list
110344697|NCT05683691|Analgesics|analgesics|mesh-ancestor
110443934|NCT01148225|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110443935|NCT01148225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110443936|NCT01148225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110443937|NCT02788240|Meropenem|meropenem|mesh-list
110443938|NCT02788240|Terlipressin|terlipressin|mesh-list
110443939|NCT02788240|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110443941|NCT02788240|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110443942|NCT02788240|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110443943|NCT04134715|Contraceptive Agents|contraceptive agents|mesh-list
110443944|NCT04134715|Contraceptives, Oral|contraceptives, oral|mesh-list
110443945|NCT04134715|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110443946|NCT04134715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110443947|NCT04134715|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110443948|NCT02884115|Penicillins|penicillins|mesh-list
110344988|NCT05415215|Pertuzumab|pertuzumab|mesh-list
110443949|NCT02884115|Penicillin G Benzathine|penicillin g benzathine|mesh-list
110443950|NCT02884115|Penicillin G|penicillin g|mesh-list
110443951|NCT02884115|Penicillin G Procaine|penicillin g procaine|mesh-list
110443952|NCT02884115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110443953|NCT02884115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110443954|NCT01190813|Levodopa|levodopa|mesh-list
110443955|NCT01190813|Carbidopa|carbidopa|mesh-list
110443956|NCT01190813|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110443957|NCT01190813|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110345268|NCT05230368|Decitabine|decitabine|mesh-list
110443958|NCT01190813|Dopamine Agents|dopamine agents|mesh-ancestor
110443959|NCT01190813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110560292|NCT02618096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110443960|NCT01190813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110345413|NCT05139017|Oxaliplatin|oxaliplatin|mesh-list
110443961|NCT01190813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110345492|NCT05084222|Hormones|hormones|mesh-ancestor
110443962|NCT01190813|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
110443963|NCT01190813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110443964|NCT03641326|Sunitinib|sunitinib|mesh-list
110443965|NCT03641326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110443966|NCT03641326|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110443967|NCT03641326|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110443968|NCT03641326|Growth Substances|growth substances|mesh-ancestor
110443969|NCT03641326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110443970|NCT03641326|Growth Inhibitors|growth inhibitors|mesh-ancestor
110443971|NCT03641326|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110443972|NCT03641326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110345635|NCT05018585|Vitamins|vitamins|mesh-ancestor
110345700|NCT05004519|Analgesics|analgesics|mesh-ancestor
110443973|NCT03641326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110345777|NCT04956692|Pemetrexed|pemetrexed|mesh-list
110443975|NCT00870727|Antidepressive Agents|antidepressive agents|mesh-ancestor
110345851|NCT04895358|Paclitaxel|paclitaxel|mesh-list
110443976|NCT00870727|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110443977|NCT00870727|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110443979|NCT00870727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110443980|NCT00870727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110443982|NCT00870727|Dopamine Agents|dopamine agents|mesh-ancestor
110443983|NCT00870727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110443984|NCT00870727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110443985|NCT00870727|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110443986|NCT00870727|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110443987|NCT00870727|Serotonin Agents|serotonin agents|mesh-ancestor
110560293|NCT04134026|Epoetin Alfa|epoetin alfa|mesh-list
110443988|NCT00870727|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110443989|NCT00870727|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110443990|NCT00870727|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110443991|NCT00870727|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110443992|NCT02787928|Hydromorphone|hydromorphone|mesh-list
110443993|NCT02787928|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110560294|NCT04134026|Hematinics|hematinics|mesh-ancestor
110560295|NCT02963831|Cyclophosphamide|cyclophosphamide|mesh-list
110346890|NCT04293562|Analgesics|analgesics|mesh-ancestor
110443995|NCT02787928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110443996|NCT02787928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110443997|NCT02787928|Analgesics|analgesics|mesh-ancestor
110443998|NCT02787928|Sensory System Agents|sensory system agents|mesh-ancestor
110443999|NCT02787928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110444000|NCT02617069|Botulinum Toxins|botulinum toxins|mesh-list
110444001|NCT02617069|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110444002|NCT02617069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110444003|NCT02617069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110444004|NCT02617069|Cholinergic Agents|cholinergic agents|mesh-ancestor
110347255|NCT04068103|Oxaliplatin|oxaliplatin|mesh-list
110444005|NCT02617069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110444006|NCT02617069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110444008|NCT02788552|Thiamine|thiamine|mesh-list
110444009|NCT02788552|Micronutrients|micronutrients|mesh-ancestor
110347700|NCT03625648|Antioxidants|antioxidants|mesh-ancestor
110444010|NCT02788552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110444011|NCT02788552|Vitamin B Complex|vitamin b complex|mesh-ancestor
110347849|NCT03518606|Durvalumab|durvalumab|mesh-list
110444012|NCT01147055|Rifampin|rifampin|mesh-list
110444013|NCT01147055|Crizotinib|crizotinib|mesh-list
110444014|NCT01147055|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110347923|NCT03407144|Bleomycin|bleomycin|mesh-list
110444015|NCT01147055|Antitubercular Agents|antitubercular agents|mesh-ancestor
110444016|NCT01147055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110348041|NCT03306264|Antimetabolites|antimetabolites|mesh-ancestor
110444017|NCT01147055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110444018|NCT01147055|Leprostatic Agents|leprostatic agents|mesh-ancestor
110348096|NCT03268954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110444019|NCT01147055|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110348169|NCT03210688|Glucocorticoids|glucocorticoids|mesh-ancestor
110444020|NCT01147055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110444021|NCT01147055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110444022|NCT01147055|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110444023|NCT01147055|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110444024|NCT01147055|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110444025|NCT01147055|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110444026|NCT01147055|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110444027|NCT01147055|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110444028|NCT01147055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110444029|NCT01147055|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110444030|NCT02623231|Escitalopram|escitalopram|mesh-list
110560297|NCT02963831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110444031|NCT02623231|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110444032|NCT02623231|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110444033|NCT02623231|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110444034|NCT02623231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110444035|NCT02623231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110444036|NCT02623231|Serotonin Agents|serotonin agents|mesh-ancestor
110444037|NCT02623231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110444038|NCT02623153|Docetaxel|docetaxel|mesh-list
110444039|NCT02623153|Capecitabine|capecitabine|mesh-list
110444040|NCT02623153|Oxaliplatin|oxaliplatin|mesh-list
110348747|NCT02152995|Iodine|iodine|mesh-list
110348902|NCT02030028|beta-Endorphin|beta-endorphin|mesh-list
110444042|NCT02623153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110348978|NCT01583322|Nintedanib|nintedanib|mesh-list
110444043|NCT02623153|Tubulin Modulators|tubulin modulators|mesh-ancestor
110444044|NCT02623153|Antimitotic Agents|antimitotic agents|mesh-ancestor
110444045|NCT02623153|Mitosis Modulators|mitosis modulators|mesh-ancestor
110349056|NCT01431326|Hormones|hormones|mesh-ancestor
110444046|NCT02623153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110444047|NCT02623153|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110444048|NCT02623153|Antimetabolites|antimetabolites|mesh-ancestor
110444049|NCT02616913|Moxifloxacin|moxifloxacin|mesh-list
110444050|NCT02616913|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110444051|NCT02616913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110444052|NCT02616913|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110349588|NCT02915055|Ibuprofen|ibuprofen|mesh-list
110444053|NCT02616913|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110444054|NCT02616913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110444055|NCT02616913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110444056|NCT02616913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110373519|NCT00590928|Histamine Agents|histamine agents|mesh-ancestor
110444058|NCT02884037|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110444060|NCT02884037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110444061|NCT04233502|Melatonin|melatonin|mesh-list
110444062|NCT04233502|Antioxidants|antioxidants|mesh-ancestor
110350032|NCT01289821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110560299|NCT02963831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110350183|NCT02912676|Mercaptopurine|mercaptopurine|mesh-list
110444063|NCT04233502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110444065|NCT04233502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110444066|NCT04233502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110444067|NCT00696475|Diazoxide|diazoxide|mesh-list
110444068|NCT00696475|Choline|choline|mesh-list
110350408|NCT02933645|Insulin|insulin|mesh-list
110444069|NCT00696475|Lipotropic Agents|lipotropic agents|mesh-ancestor
110444070|NCT00696475|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110444071|NCT00696475|Antimetabolites|antimetabolites|mesh-ancestor
110560300|NCT02963831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110444072|NCT00696475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110444073|NCT00696475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110444074|NCT00696475|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110444075|NCT00696475|Nootropic Agents|nootropic agents|mesh-ancestor
110350852|NCT03981341|Estrogens|estrogens|mesh-list
110444076|NCT00696475|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110444077|NCT00696475|Vasodilator Agents|vasodilator agents|mesh-ancestor
110444079|NCT03628066|Palbociclib|palbociclib|mesh-list
110444080|NCT03628066|Goserelin|goserelin|mesh-list
110351137|NCT00623857|Zinc|zinc|mesh-list
110444081|NCT03628066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110444082|NCT03628066|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110444083|NCT03628066|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110444084|NCT03628066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110444085|NCT03628066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110444086|NCT03628066|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110444087|NCT03628066|Hormone Antagonists|hormone antagonists|mesh-ancestor
110560301|NCT02963831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110444088|NCT03628066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110351519|NCT05467436|Analgesics|analgesics|mesh-list
110444089|NCT03628066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110444090|NCT03628066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110444091|NCT03628066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110444093|NCT00625079|Vasodilator Agents|vasodilator agents|mesh-ancestor
110444094|NCT00625079|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110444095|NCT00625079|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110444096|NCT00625079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110444097|NCT00625079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110444098|NCT00625079|Urological Agents|urological agents|mesh-ancestor
110444100|NCT02786992|Oxytocin|oxytocin|mesh-list
110444101|NCT02786992|Carbetocin|carbetocin|mesh-list
110444103|NCT02786992|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110444104|NCT02786992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110444105|NCT02786992|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110444106|NCT02786992|Abortifacient Agents|abortifacient agents|mesh-ancestor
110444107|NCT02786992|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110444108|NCT02786992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110444109|NCT04232644|Amphetamine|amphetamine|mesh-list
110352249|NCT02690064|Tocotrienols|tocotrienols|mesh-list
110444110|NCT04232644|Dextroamphetamine|dextroamphetamine|mesh-list
110444111|NCT04232644|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110444112|NCT04232644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110444114|NCT04232644|Autonomic Agents|autonomic agents|mesh-ancestor
110444115|NCT04232644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110444116|NCT04232644|Dopamine Agents|dopamine agents|mesh-ancestor
110444117|NCT04232644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110560302|NCT02963831|Alkylating Agents|alkylating agents|mesh-ancestor
110444118|NCT04232644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110444120|NCT04232644|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110444121|NCT04232644|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110352687|NCT05470530|Glucocorticoids|glucocorticoids|mesh-ancestor
110444122|NCT04232644|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110444123|NCT04232644|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110444124|NCT03557788|Rifaximin|rifaximin|mesh-list
110444125|NCT03557788|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110444126|NCT03557788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110444127|NCT03557788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110444128|NCT04133155|Paclitaxel|paclitaxel|mesh-list
110444129|NCT04133155|Gemcitabine|gemcitabine|mesh-list
110352760|NCT00598858|Antimitotic Agents|antimitotic agents|mesh-ancestor
110444130|NCT04133155|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110444131|NCT04133155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110444132|NCT04133155|Tubulin Modulators|tubulin modulators|mesh-ancestor
110444133|NCT04133155|Antimitotic Agents|antimitotic agents|mesh-ancestor
110444134|NCT04133155|Mitosis Modulators|mitosis modulators|mesh-ancestor
110444135|NCT04133155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110444136|NCT04133155|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110444137|NCT04133155|Antimetabolites|antimetabolites|mesh-ancestor
110444138|NCT01190267|Asenapine|asenapine|mesh-list
110352845|NCT04685642|Aspirin|aspirin|mesh-list
110444139|NCT01190267|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110444140|NCT01190267|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110352893|NCT05312190|Progesterone|progesterone|mesh-list
110061586|NCT05715216|Nivolumab|nivolumab|mesh-list
110444141|NCT01190267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110444142|NCT01190267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110444143|NCT01190267|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110444144|NCT00869089|Apremilast|apremilast|mesh-list
110444145|NCT00869089|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110444146|NCT00869089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110444147|NCT00869089|Analgesics|analgesics|mesh-ancestor
110444148|NCT00869089|Sensory System Agents|sensory system agents|mesh-ancestor
110444149|NCT00869089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110444150|NCT00869089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110444151|NCT00869089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110444152|NCT00869089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110444153|NCT00869089|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
110444154|NCT00869089|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110444155|NCT00869089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110444156|NCT00869089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110444157|NCT02616367|Bupivacaine|bupivacaine|mesh-list
110444159|NCT02616367|Anesthetics, Local|anesthetics, local|mesh-ancestor
110444160|NCT02616367|Anesthetics|anesthetics|mesh-ancestor
110444161|NCT02616367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110444162|NCT02616367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110444163|NCT02616367|Sensory System Agents|sensory system agents|mesh-ancestor
110444164|NCT02616367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110444165|NCT04200040|Dacarbazine|dacarbazine|mesh-list
110444166|NCT04200040|Molgramostim|molgramostim|mesh-list
110444167|NCT04200040|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110444168|NCT04200040|Alkylating Agents|alkylating agents|mesh-ancestor
110444169|NCT04200040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110444170|NCT04200040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110444171|NCT04232722|Sorafenib|sorafenib|mesh-list
110444172|NCT04232722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110353166|NCT01258738|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110444173|NCT04232722|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110353304|NCT04687566|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110444175|NCT04232722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110444177|NCT02622685|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
110444178|NCT02622685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110444179|NCT02622607|Zoledronic Acid|zoledronic acid|mesh-list
110444180|NCT02622607|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110353519|NCT04319770|Immunologic Factors|immunologic factors|mesh-ancestor
110444181|NCT02622607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110444182|NCT02787226|Bupivacaine|bupivacaine|mesh-list
110353672|NCT01199978|Losartan|losartan|mesh-list
110444183|NCT02787226|Anesthetics, Local|anesthetics, local|mesh-ancestor
110353743|NCT04246684|Vitamins|vitamins|mesh-ancestor
110444184|NCT02787226|Anesthetics|anesthetics|mesh-ancestor
110444185|NCT02787226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110444186|NCT02787226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110444188|NCT02787226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110444189|NCT00697567|Vaccines|vaccines|mesh-list
110354122|NCT01266148|Everolimus|everolimus|mesh-list
110444190|NCT00697567|Immunologic Factors|immunologic factors|mesh-ancestor
110444191|NCT00697567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110444192|NCT02616289|Emollients|emollients|mesh-list
110444193|NCT02616289|Dermatologic Agents|dermatologic agents|mesh-ancestor
110444194|NCT03421756|Sirolimus|sirolimus|mesh-list
110444195|NCT03421756|Alemtuzumab|alemtuzumab|mesh-list
110444196|NCT03421756|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110444197|NCT03421756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110444198|NCT03421756|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110444199|NCT03421756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110444200|NCT03421756|Antifungal Agents|antifungal agents|mesh-ancestor
110444201|NCT03421756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110444202|NCT03421756|Immunologic Factors|immunologic factors|mesh-ancestor
110444203|NCT03421756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110444204|NCT03421756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110444205|NCT00870103|Moxifloxacin|moxifloxacin|mesh-list
110444206|NCT00870103|Dexamethasone|dexamethasone|mesh-list
110444207|NCT00870103|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110444208|NCT00870103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110444210|NCT00870103|Autonomic Agents|autonomic agents|mesh-ancestor
110444211|NCT00870103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110444212|NCT00870103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110444213|NCT00870103|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110444214|NCT00870103|Glucocorticoids|glucocorticoids|mesh-ancestor
110355416|NCT00553748|Alovudine|alovudine|mesh-list
110355566|NCT02894957|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110444216|NCT00870103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110444217|NCT00870103|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110444218|NCT00870103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110444219|NCT00870103|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110444220|NCT00870103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110444221|NCT00870103|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110444222|NCT00870103|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110444223|NCT00870103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110355944|NCT01232296|Sorafenib|sorafenib|mesh-list
110444224|NCT00870103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110444225|NCT00870103|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110356096|NCT03540758|Niacin|niacin|mesh-list
110444227|NCT03365752|Mepivacaine|mepivacaine|mesh-list
110444228|NCT03365752|Chloroprocaine|chloroprocaine|mesh-list
110356254|NCT05073627|Dabigatran|dabigatran|mesh-list
110444229|NCT03365752|Anesthetics, General|anesthetics, general|mesh-list
110444230|NCT03365752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110444231|NCT03365752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110444232|NCT03365752|Anesthetics, Local|anesthetics, local|mesh-ancestor
110444233|NCT03365752|Sensory System Agents|sensory system agents|mesh-ancestor
110444234|NCT03365752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110444235|NCT02785666|Ribavirin|ribavirin|mesh-list
110444236|NCT02785666|Grazoprevir|grazoprevir|mesh-list
110444237|NCT02785666|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
110356600|NCT01209949|Adapalene|adapalene|mesh-list
110444238|NCT02785666|Antimetabolites|antimetabolites|mesh-ancestor
110444239|NCT02785666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110444240|NCT02785666|Antiviral Agents|antiviral agents|mesh-ancestor
110444241|NCT02785666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110444242|NCT01145417|Pregabalin|pregabalin|mesh-list
110444243|NCT01145417|Analgesics|analgesics|mesh-ancestor
110444244|NCT01145417|Sensory System Agents|sensory system agents|mesh-ancestor
110356893|NCT04682691|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110356969|NCT03986424|Memantine|memantine|mesh-list
110444245|NCT01145417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110357042|NCT00557219|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110444246|NCT01145417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110444247|NCT01145417|Anticonvulsants|anticonvulsants|mesh-ancestor
110444248|NCT01145417|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110444249|NCT01145417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110444250|NCT01145417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110444251|NCT01145417|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110444252|NCT01145417|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110444253|NCT01145417|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110444254|NCT01145417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110444255|NCT01145417|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110444256|NCT04232332|Mitogens|mitogens|mesh-list
110357266|NCT04658420|Ketamine|ketamine|mesh-list
110444257|NCT04232332|Mitosis Modulators|mitosis modulators|mesh-ancestor
110444258|NCT04232332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110444259|NCT02785276|Ropivacaine|ropivacaine|mesh-list
110444260|NCT02785276|Anesthetics, Local|anesthetics, local|mesh-ancestor
110444261|NCT02785276|Anesthetics|anesthetics|mesh-ancestor
110444262|NCT02785276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110357415|NCT04657172|Pilocarpine|pilocarpine|mesh-list
110444263|NCT02785276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110444264|NCT02785276|Sensory System Agents|sensory system agents|mesh-ancestor
110444265|NCT02785276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110444266|NCT04316039|Temozolomide|temozolomide|mesh-list
110444267|NCT04316039|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110444268|NCT04316039|Alkylating Agents|alkylating agents|mesh-ancestor
110444269|NCT04316039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110444270|NCT04316039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110444271|NCT00696631|Dronedarone|dronedarone|mesh-list
110444272|NCT00696631|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110444273|NCT02615977|Ethanol|ethanol|mesh-list
110444274|NCT02615977|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110444275|NCT02615977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110444276|NCT02615977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110444277|NCT02615977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110444278|NCT01189487|Ampicillin|ampicillin|mesh-list
110444279|NCT01189487|Sulbactam|sulbactam|mesh-list
110444280|NCT01189487|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110444281|NCT01189487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110444282|NCT01189487|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110444283|NCT01189487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110357907|NCT00543933|Nitric Oxide|nitric oxide|mesh-list
110444284|NCT01189487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110444285|NCT02621905|Itraconazole|itraconazole|mesh-list
110444286|NCT02621905|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
110444287|NCT02621905|Antifungal Agents|antifungal agents|mesh-ancestor
110444288|NCT02621905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110444289|NCT02621905|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110444290|NCT02621905|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110444291|NCT02621905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110444292|NCT02621905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110444293|NCT02621905|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110444294|NCT02621905|Hormone Antagonists|hormone antagonists|mesh-ancestor
110444295|NCT02621905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110444296|NCT02621905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110444297|NCT02621905|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110444298|NCT01106352|Docetaxel|docetaxel|mesh-list
110444299|NCT01106352|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
110444300|NCT01106352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110444301|NCT01106352|Tubulin Modulators|tubulin modulators|mesh-ancestor
110444302|NCT01106352|Antimitotic Agents|antimitotic agents|mesh-ancestor
110373561|NCT00591201|Infliximab|infliximab|mesh-list
110444303|NCT01106352|Mitosis Modulators|mitosis modulators|mesh-ancestor
110444304|NCT01106352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110444305|NCT01144403|Cyclophosphamide|cyclophosphamide|mesh-list
110444306|NCT01144403|Rituximab|rituximab|mesh-list
110444307|NCT01144403|Fludarabine|fludarabine|mesh-list
110444308|NCT01144403|Mitoxantrone|mitoxantrone|mesh-list
110444309|NCT01144403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110358198|NCT06021717|Anesthetics|anesthetics|mesh-ancestor
110444310|NCT01144403|Immunologic Factors|immunologic factors|mesh-ancestor
110444311|NCT01144403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110444312|NCT01144403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110444313|NCT01144403|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110444314|NCT01144403|Alkylating Agents|alkylating agents|mesh-ancestor
110358318|NCT06016972|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110444315|NCT01144403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110444316|NCT01144403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110444317|NCT01144403|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110444318|NCT01144403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110444319|NCT01144403|Analgesics|analgesics|mesh-ancestor
110444320|NCT01144403|Sensory System Agents|sensory system agents|mesh-ancestor
110444321|NCT01144403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110444322|NCT01144403|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110444323|NCT01144403|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110444324|NCT01144403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110444325|NCT03071926|Doxorubicin|doxorubicin|mesh-list
110444326|NCT03071926|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110444327|NCT03071926|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110444328|NCT03071926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110444329|NCT03071926|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110444330|NCT03071926|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110444331|NCT03071926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110444332|NCT03071926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110444333|NCT02883647|Tenofovir|tenofovir|mesh-list
110444334|NCT02883647|Entecavir|entecavir|mesh-list
110444335|NCT02883647|Antiviral Agents|antiviral agents|mesh-ancestor
110444336|NCT02883647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110444337|NCT02883647|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110444338|NCT02883647|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110444339|NCT02883647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110444340|NCT02883647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110444341|NCT02883647|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110444342|NCT02883647|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110444343|NCT02621827|Calcifediol|calcifediol|mesh-list
110444344|NCT02621827|Vitamins|vitamins|mesh-ancestor
110444345|NCT02621827|Micronutrients|micronutrients|mesh-ancestor
110444346|NCT02621827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110444347|NCT02621827|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110444348|NCT01143389|Riboflavin|riboflavin|mesh-list
110444349|NCT01143389|Vitamin B Complex|vitamin b complex|mesh-ancestor
110444350|NCT01143389|Vitamins|vitamins|mesh-ancestor
110444351|NCT01143389|Micronutrients|micronutrients|mesh-ancestor
110444352|NCT01143389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110444353|NCT01143389|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110444354|NCT01143389|Dermatologic Agents|dermatologic agents|mesh-ancestor
110444355|NCT00868231|Bromides|bromides|mesh-list
110444356|NCT00868231|Tiotropium Bromide|tiotropium bromide|mesh-list
110444357|NCT00868231|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110444358|NCT00868231|Autonomic Agents|autonomic agents|mesh-ancestor
110444359|NCT00868231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110444360|NCT00868231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110444361|NCT00868231|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110444362|NCT00868231|Respiratory System Agents|respiratory system agents|mesh-ancestor
110444363|NCT00868231|Parasympatholytics|parasympatholytics|mesh-ancestor
110444364|NCT00868231|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110444365|NCT00868231|Cholinergic Agents|cholinergic agents|mesh-ancestor
110444366|NCT00868231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110358717|NCT05528588|Furosemide|furosemide|mesh-list
110444367|NCT00868231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110444368|NCT00868231|Anticonvulsants|anticonvulsants|mesh-ancestor
110444369|NCT04231864|Durvalumab|durvalumab|mesh-list
110444370|NCT04231864|Immunoglobulins|immunoglobulins|mesh-list
110444371|NCT04231864|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110444372|NCT04231864|Immunoglobulin G|immunoglobulin g|mesh-list
110444373|NCT04231864|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110373567|NCT04582097|Ramipril|ramipril|mesh-list
110444374|NCT04231864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110444375|NCT04231864|Immunologic Factors|immunologic factors|mesh-ancestor
110444376|NCT04231864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110444377|NCT01143077|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
110444380|NCT01143077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110444381|NCT01143077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110444382|NCT01143077|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110444383|NCT01143077|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
110444384|NCT01143077|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110444385|NCT01143077|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110444386|NCT01143077|Adrenergic Agents|adrenergic agents|mesh-ancestor
110444387|NCT01143077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110444388|NCT01143077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110444389|NCT01143077|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110444390|NCT01143077|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110444392|NCT01143077|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110444393|NCT01143077|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110444394|NCT01143077|Dopamine Agents|dopamine agents|mesh-ancestor
110359137|NCT04324307|Mitosis Modulators|mitosis modulators|mesh-ancestor
110444396|NCT02786446|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
110444397|NCT02786446|Lidocaine|lidocaine|mesh-list
110444398|NCT02786446|Anesthetics, Local|anesthetics, local|mesh-ancestor
110444399|NCT02786446|Anesthetics|anesthetics|mesh-ancestor
110444400|NCT02786446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110444401|NCT02786446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110444402|NCT02786446|Sensory System Agents|sensory system agents|mesh-ancestor
110444403|NCT02786446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110444404|NCT02786446|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110444405|NCT02786446|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110444406|NCT02786446|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110444407|NCT02786446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110444408|NCT02786446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110444409|NCT02786446|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110444411|NCT02786446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110444412|NCT02786446|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110444413|NCT02786446|Gout Suppressants|gout suppressants|mesh-ancestor
110444414|NCT02786446|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110444415|NCT02786446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110444416|NCT02619019|Dexamethasone|dexamethasone|mesh-list
110444417|NCT02619019|Meperidine|meperidine|mesh-list
110444418|NCT02619019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110444419|NCT02619019|Antiemetics|antiemetics|mesh-ancestor
110444420|NCT02619019|Autonomic Agents|autonomic agents|mesh-ancestor
110444421|NCT02619019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110444422|NCT02619019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110444423|NCT02619019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110444424|NCT02619019|Glucocorticoids|glucocorticoids|mesh-ancestor
110444425|NCT02619019|Hormones|hormones|mesh-ancestor
110444426|NCT02619019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110444427|NCT02619019|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110444428|NCT02619019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110444429|NCT02619019|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110444430|NCT02619019|Narcotics|narcotics|mesh-ancestor
110444431|NCT02619019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110444432|NCT02619019|Analgesics|analgesics|mesh-ancestor
110444433|NCT02619019|Sensory System Agents|sensory system agents|mesh-ancestor
110444434|NCT02619019|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110444436|NCT02957032|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110444437|NCT02957032|Antimetabolites|antimetabolites|mesh-ancestor
110359561|NCT03281369|Atezolizumab|atezolizumab|mesh-list
110444438|NCT02957032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110444439|NCT02957032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110444440|NCT02957032|Antiviral Agents|antiviral agents|mesh-ancestor
110444441|NCT02957032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110359764|NCT02133196|Alkylating Agents|alkylating agents|mesh-ancestor
110359838|NCT01316523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110444442|NCT02957032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110444443|NCT02957032|Immunologic Factors|immunologic factors|mesh-ancestor
110444444|NCT02957032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110444445|NCT02947516|Liver Extracts|liver extracts|mesh-list
110444446|NCT02947516|Hematinics|hematinics|mesh-ancestor
110444447|NCT01096446|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
110444448|NCT01096446|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
110444449|NCT01096446|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
110444450|NCT01096446|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110444452|NCT00864721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110444453|NCT00864721|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110444454|NCT00864721|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110444455|NCT00864721|Growth Substances|growth substances|mesh-ancestor
110444456|NCT00864721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110360053|NCT01237327|Exemestane|exemestane|mesh-list
110444458|NCT00864721|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110444459|NCT00864721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110444460|NCT00864721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110444461|NCT05308420|Morphine|morphine|mesh-list
110444462|NCT05308420|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110444463|NCT05308420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110444464|NCT05308420|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110444465|NCT05308420|Narcotics|narcotics|mesh-ancestor
110444466|NCT05308420|Analgesics|analgesics|mesh-ancestor
110444467|NCT05308420|Sensory System Agents|sensory system agents|mesh-ancestor
110444468|NCT05308420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110360346|NCT04643132|Ketamine|ketamine|mesh-list
110444469|NCT02897050|Cyclophosphamide|cyclophosphamide|mesh-list
110444470|NCT02897050|Docetaxel|docetaxel|mesh-list
110444471|NCT02897050|Fluorouracil|fluorouracil|mesh-list
110444472|NCT02897050|Capecitabine|capecitabine|mesh-list
110444473|NCT02897050|Epirubicin|epirubicin|mesh-list
110444474|NCT02897050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110444475|NCT02897050|Immunologic Factors|immunologic factors|mesh-ancestor
110444476|NCT02897050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110444477|NCT02897050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110444478|NCT02897050|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110444479|NCT02897050|Alkylating Agents|alkylating agents|mesh-ancestor
110360421|NCT00559286|Telmisartan|telmisartan|mesh-list
110444480|NCT02897050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110444481|NCT02897050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110444482|NCT02897050|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110444483|NCT02897050|Tubulin Modulators|tubulin modulators|mesh-ancestor
110444484|NCT02897050|Antimitotic Agents|antimitotic agents|mesh-ancestor
110444485|NCT02897050|Mitosis Modulators|mitosis modulators|mesh-ancestor
110444486|NCT02897050|Antimetabolites|antimetabolites|mesh-ancestor
110444487|NCT02897050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110444488|NCT02897050|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110444489|NCT02897050|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110360624|NCT00559676|Vitamins|vitamins|mesh-ancestor
110444491|NCT02897050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110444493|NCT01095666|Pioglitazone|pioglitazone|mesh-list
110444495|NCT01095666|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110444496|NCT01095666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110444497|NCT01095666|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110444498|NCT01095666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110444499|NCT01100658|Methylphenidate|methylphenidate|mesh-list
110444500|NCT01100658|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110444501|NCT01100658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110444502|NCT01100658|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110444503|NCT01100658|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110444504|NCT01100658|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110360966|NCT00624676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110444505|NCT01100658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110444506|NCT01100658|Dopamine Agents|dopamine agents|mesh-ancestor
110444507|NCT01100658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110444508|NCT05276908|Bupivacaine|bupivacaine|mesh-list
110444509|NCT05276908|Anesthetics|anesthetics|mesh-list
110444510|NCT05276908|Anesthetics, Local|anesthetics, local|mesh-ancestor
110444511|NCT05276908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110444512|NCT05276908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110444513|NCT05276908|Sensory System Agents|sensory system agents|mesh-ancestor
110444514|NCT05276908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110444515|NCT02785978|Levodopa|levodopa|mesh-list
110444516|NCT02785978|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110444517|NCT02785978|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110444519|NCT02785978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110444520|NCT02785978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110444521|NCT02785978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110361485|NCT05425368|Fluorides|fluorides|mesh-list
110444522|NCT02786212|Dexmedetomidine|dexmedetomidine|mesh-list
110444523|NCT02786212|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110444524|NCT02786212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110444525|NCT02786212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110444526|NCT02786212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110444527|NCT02786212|Analgesics|analgesics|mesh-ancestor
110444528|NCT02786212|Sensory System Agents|sensory system agents|mesh-ancestor
110444529|NCT02786212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110361771|NCT01188655|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110444530|NCT02786212|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110444531|NCT02786212|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110444532|NCT02786212|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110444533|NCT02786212|Adrenergic Agents|adrenergic agents|mesh-ancestor
110444534|NCT02786212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110444535|NCT02786212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110444538|NCT05273710|Vitamin B Complex|vitamin b complex|mesh-ancestor
110444540|NCT05273710|Micronutrients|micronutrients|mesh-ancestor
110444541|NCT05273710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110444542|NCT02784808|Antirheumatic Agents|antirheumatic agents|mesh-list
110444543|NCT02784652|Zoledronic Acid|zoledronic acid|mesh-list
110444544|NCT02784652|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110444545|NCT02784652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110444547|NCT01100502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110444548|NCT01100502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110444549|NCT01100502|Immunotoxins|immunotoxins|mesh-ancestor
110444550|NCT01100502|Immunoconjugates|immunoconjugates|mesh-ancestor
110444551|NCT01100502|Immunologic Factors|immunologic factors|mesh-ancestor
110444552|NCT01100502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110444553|NCT02784340|Dexamethasone|dexamethasone|mesh-list
110444554|NCT02784340|Dexamethasone acetate|dexamethasone acetate|mesh-list
110444555|NCT02784340|Bupivacaine|bupivacaine|mesh-list
110444556|NCT02784340|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
110444557|NCT02784340|BB 1101|bb 1101|mesh-list
110444558|NCT02784340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110444559|NCT02784340|Antiemetics|antiemetics|mesh-ancestor
110444560|NCT02784340|Autonomic Agents|autonomic agents|mesh-ancestor
110444561|NCT02784340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110444562|NCT02784340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110444563|NCT02784340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110444564|NCT02784340|Glucocorticoids|glucocorticoids|mesh-ancestor
110444565|NCT02784340|Hormones|hormones|mesh-ancestor
110444566|NCT02784340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110444567|NCT02784340|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110444568|NCT02784340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110444569|NCT02784340|Protease Inhibitors|protease inhibitors|mesh-ancestor
110444570|NCT02784340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110362777|NCT01661166|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110444571|NCT02784340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110362852|NCT02077881|Antimetabolites|antimetabolites|mesh-ancestor
110444572|NCT02784340|Anesthetics, Local|anesthetics, local|mesh-ancestor
110444574|NCT02784340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110363001|NCT02044341|Anesthetics|anesthetics|mesh-ancestor
110444575|NCT02784340|Sensory System Agents|sensory system agents|mesh-ancestor
110444576|NCT02878512|Anesthetics|anesthetics|mesh-list
110444577|NCT02878512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110444578|NCT02878512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110444579|NCT01094886|Rivaroxaban|rivaroxaban|mesh-list
110363220|NCT01972854|Vitamins|vitamins|mesh-ancestor
110444580|NCT01094886|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110444581|NCT01094886|Antithrombins|antithrombins|mesh-ancestor
110444582|NCT01094886|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110444583|NCT01094886|Protease Inhibitors|protease inhibitors|mesh-ancestor
110444584|NCT01094886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110444585|NCT01094886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110444586|NCT01094886|Anticoagulants|anticoagulants|mesh-ancestor
110444588|NCT01094808|Analgesics|analgesics|mesh-ancestor
110444589|NCT01094808|Sensory System Agents|sensory system agents|mesh-ancestor
110444590|NCT01094808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110444591|NCT01094808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110444592|NCT01094808|Anticonvulsants|anticonvulsants|mesh-ancestor
110444593|NCT01094808|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110444594|NCT01094808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110444595|NCT01094808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110444596|NCT01094808|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110444597|NCT01094808|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110444598|NCT01094808|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110363440|NCT01185301|Methotrexate|methotrexate|mesh-list
110444599|NCT01094808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110444601|NCT00864253|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110444602|NCT00864253|Dacarbazine|dacarbazine|mesh-list
110444603|NCT00864253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110444604|NCT00864253|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110444605|NCT00864253|Alkylating Agents|alkylating agents|mesh-ancestor
110444606|NCT00864253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110444607|NCT02782312|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
110444608|NCT02782312|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110444609|NCT02782312|Autonomic Agents|autonomic agents|mesh-ancestor
110444610|NCT02782312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110444611|NCT02782312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110444612|NCT02782312|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110444613|NCT02782312|Respiratory System Agents|respiratory system agents|mesh-ancestor
110444615|NCT02782312|Hormones|hormones|mesh-ancestor
110444616|NCT02782312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110444617|NCT02782312|Sympathomimetics|sympathomimetics|mesh-ancestor
110444619|NCT00698425|Citric Acid|citric acid|mesh-list
110444620|NCT00698425|Sodium Citrate|sodium citrate|mesh-list
110444621|NCT00698425|Anticoagulants|anticoagulants|mesh-ancestor
110444622|NCT00698425|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110444623|NCT00698425|Chelating Agents|chelating agents|mesh-ancestor
110444624|NCT00698425|Sequestering Agents|sequestering agents|mesh-ancestor
110364007|NCT04669392|Ethanol|ethanol|mesh-list
110444625|NCT00698425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110444627|NCT05342272|Muramidase|muramidase|mesh-list
110091637|NCT02499367|Alkylating Agents|alkylating agents|mesh-ancestor
110444628|NCT05342272|Betaine|betaine|mesh-list
110364170|NCT00533741|Antacids|antacids|mesh-ancestor
110444629|NCT05342272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110444630|NCT05342272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110364222|NCT00557544|Antiemetics|antiemetics|mesh-ancestor
110444631|NCT05342272|Lipotropic Agents|lipotropic agents|mesh-ancestor
110444632|NCT05342272|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110444633|NCT05342272|Antimetabolites|antimetabolites|mesh-ancestor
110444634|NCT05342272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110444635|NCT05342272|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110444636|NCT04230460|Ethanol|ethanol|mesh-list
110444637|NCT04230460|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110444638|NCT04230460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110444639|NCT04230460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110444640|NCT04230460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110444641|NCT02783638|Pregabalin|pregabalin|mesh-list
110444642|NCT02783638|Analgesics|analgesics|mesh-ancestor
110444643|NCT02783638|Sensory System Agents|sensory system agents|mesh-ancestor
110444644|NCT02783638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110444645|NCT02783638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110444646|NCT02783638|Anticonvulsants|anticonvulsants|mesh-ancestor
110444647|NCT02783638|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110444648|NCT02783638|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110444649|NCT02783638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110444650|NCT02783638|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110444651|NCT02783638|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110444652|NCT02783638|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110444653|NCT02783638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110444654|NCT02783638|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110444655|NCT04230070|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110444656|NCT04230070|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110444657|NCT04230070|Levonorgestrel|levonorgestrel|mesh-list
110444658|NCT04230070|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110444659|NCT04230070|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
110444660|NCT04230070|Estradiol|estradiol|mesh-list
110364569|NCT00535418|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110444661|NCT04230070|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110444662|NCT04230070|Estrogens|estrogens|mesh-ancestor
110444663|NCT04230070|Hormones|hormones|mesh-ancestor
110444664|NCT04230070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110444665|NCT04230070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110444666|NCT04230070|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110444667|NCT04230070|Contraceptive Agents|contraceptive agents|mesh-ancestor
110444668|NCT04230070|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110444669|NCT04230070|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110444670|NCT04230070|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110444671|NCT04230070|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110444672|NCT04230070|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110444673|NCT04230070|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110444675|NCT02782078|Clindamycin palmitate|clindamycin palmitate|mesh-list
110444676|NCT02782078|Clindamycin phosphate|clindamycin phosphate|mesh-list
110444677|NCT02782078|Rifampin|rifampin|mesh-list
110444678|NCT02782078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110444680|NCT02782078|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110444681|NCT02782078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110365235|NCT00541112|Antimetabolites|antimetabolites|mesh-ancestor
110444682|NCT02782078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110365309|NCT04659642|Narcotics|narcotics|mesh-ancestor
110444683|NCT02782078|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110444684|NCT02782078|Antitubercular Agents|antitubercular agents|mesh-ancestor
110444685|NCT02782078|Leprostatic Agents|leprostatic agents|mesh-ancestor
110444686|NCT02782078|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110444687|NCT02782078|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110365451|NCT00543218|Calcitonin|calcitonin|mesh-list
110365527|NCT00543608|Vancomycin|vancomycin|mesh-list
110444689|NCT02782078|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110444690|NCT02782078|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110444691|NCT02782078|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110444692|NCT02782078|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110444693|NCT01293682|Calcitriol|calcitriol|mesh-list
110444694|NCT01293682|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110444695|NCT01293682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110444696|NCT01293682|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
110444697|NCT01293682|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110444698|NCT01293682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110444699|NCT01293682|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110444700|NCT01293682|Vitamins|vitamins|mesh-ancestor
110444701|NCT01293682|Micronutrients|micronutrients|mesh-ancestor
110444702|NCT01293682|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110444703|NCT00864097|Diclofenac|diclofenac|mesh-list
110444704|NCT00864097|Tanezumab|tanezumab|mesh-list
110444705|NCT00864097|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110366032|NCT04968899|Antiemetics|antiemetics|mesh-ancestor
110444706|NCT00864097|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110444707|NCT00864097|Analgesics|analgesics|mesh-ancestor
110444708|NCT00864097|Sensory System Agents|sensory system agents|mesh-ancestor
110444709|NCT00864097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110444710|NCT00864097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110444711|NCT00864097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110366172|NCT04718025|Purinergic Agents|purinergic agents|mesh-ancestor
110444713|NCT00864097|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110444714|NCT00864097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110260175|NCT02944201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110444715|NCT00864097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110444716|NCT02782624|Empagliflozin|empagliflozin|mesh-list
110444717|NCT02782624|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110444718|NCT02782624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110444719|NCT02782624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110444720|NCT02782624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110444721|NCT02781766|Thrombin|thrombin|mesh-list
110444722|NCT02781766|Hemostatics|hemostatics|mesh-ancestor
110444723|NCT02781766|Coagulants|coagulants|mesh-ancestor
110444724|NCT00887536|Cyclophosphamide|cyclophosphamide|mesh-list
110444725|NCT00887536|Bevacizumab|bevacizumab|mesh-list
110444726|NCT00887536|Docetaxel|docetaxel|mesh-list
110444727|NCT00887536|Doxorubicin|doxorubicin|mesh-list
110444728|NCT00887536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110444729|NCT00887536|Immunologic Factors|immunologic factors|mesh-ancestor
110444730|NCT00887536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110444731|NCT00887536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110444732|NCT00887536|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110373649|NCT00583869|Pregabalin|pregabalin|mesh-list
110444733|NCT00887536|Alkylating Agents|alkylating agents|mesh-ancestor
110444734|NCT00887536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110444735|NCT00887536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110444736|NCT00887536|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110444737|NCT00887536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110444738|NCT00887536|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110444739|NCT00887536|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110444740|NCT00887536|Growth Substances|growth substances|mesh-ancestor
110444741|NCT00887536|Growth Inhibitors|growth inhibitors|mesh-ancestor
110444742|NCT00887536|Tubulin Modulators|tubulin modulators|mesh-ancestor
110444743|NCT00887536|Antimitotic Agents|antimitotic agents|mesh-ancestor
110444744|NCT00887536|Mitosis Modulators|mitosis modulators|mesh-ancestor
110444745|NCT00887536|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110444746|NCT00887536|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110444747|NCT00887536|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110444748|NCT00887536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110444749|NCT02614339|Metformin|metformin|mesh-list
110366886|NCT04635852|Narcotics|narcotics|mesh-ancestor
110444750|NCT02614339|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110444751|NCT02614339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110444752|NCT02618395|Hydrocodone|hydrocodone|mesh-list
110444753|NCT02618395|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110444754|NCT02618395|Narcotics|narcotics|mesh-ancestor
110444755|NCT02618395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110444756|NCT02618395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110444757|NCT02618395|Analgesics|analgesics|mesh-ancestor
110444758|NCT02618395|Sensory System Agents|sensory system agents|mesh-ancestor
110444759|NCT02618395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110444760|NCT02618395|Antitussive Agents|antitussive agents|mesh-ancestor
110444761|NCT02618395|Respiratory System Agents|respiratory system agents|mesh-ancestor
110444762|NCT01183013|Pioglitazone|pioglitazone|mesh-list
110444763|NCT01183013|Linagliptin|linagliptin|mesh-list
110444764|NCT01183013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110444765|NCT01183013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110444766|NCT01183013|Incretins|incretins|mesh-ancestor
110444768|NCT01183013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110367319|NCT05186675|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110444769|NCT01183013|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110444770|NCT01183013|Protease Inhibitors|protease inhibitors|mesh-ancestor
110367398|NCT04628559|Anesthetics|anesthetics|mesh-ancestor
110444771|NCT01183013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110367539|NCT00561717|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110444772|NCT01183013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110444773|NCT04229212|Cimetidine|cimetidine|mesh-list
110444774|NCT04229212|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110444775|NCT04229212|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110091792|NCT02162563|Irinotecan|irinotecan|mesh-list
110444776|NCT04229212|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110444777|NCT04229212|Histamine Antagonists|histamine antagonists|mesh-ancestor
110444778|NCT04229212|Histamine Agents|histamine agents|mesh-ancestor
110444779|NCT04229212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110444780|NCT04229212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110444781|NCT04229212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110444782|NCT04229212|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110444783|NCT04229212|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110444784|NCT04229212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110444785|NCT02615041|Meropenem|meropenem|mesh-list
110444786|NCT02615041|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110444787|NCT02615041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110444789|NCT04229602|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110444790|NCT04229602|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110444791|NCT04229602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110444792|NCT04229602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110444793|NCT04229602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110444794|NCT04229602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110444795|NCT04229602|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110444796|NCT04229602|Antidepressive Agents|antidepressive agents|mesh-ancestor
110444797|NCT04229602|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110368119|NCT04622358|Rabeprazole|rabeprazole|mesh-list
110444799|NCT05298163|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110444800|NCT05298163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110444801|NCT05298163|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
110444802|NCT05298163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110444803|NCT05298163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110444804|NCT05298163|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110444805|NCT05298163|Vitamins|vitamins|mesh-ancestor
110444806|NCT05298163|Micronutrients|micronutrients|mesh-ancestor
110368465|NCT04619433|Carboplatin|carboplatin|mesh-list
110444807|NCT05298163|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110444808|NCT01141283|Buprenorphine|buprenorphine|mesh-list
110444809|NCT01141283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110444810|NCT01141283|Narcotics|narcotics|mesh-ancestor
110064193|NCT01526460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110444812|NCT01141283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110444813|NCT01141283|Analgesics|analgesics|mesh-ancestor
110444814|NCT01141283|Sensory System Agents|sensory system agents|mesh-ancestor
110444815|NCT01141283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110064419|NCT01527422|Glucocorticoids|glucocorticoids|mesh-ancestor
110444816|NCT01141283|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110444818|NCT05340946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110444819|NCT05340946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110444820|NCT00863707|Regadenoson|regadenoson|mesh-list
110064707|NCT01529138|Sirolimus|sirolimus|mesh-list
110064779|NCT01529229|Betamethasone|betamethasone|mesh-list
110064856|NCT01529476|Levofloxacin|levofloxacin|mesh-list
110444821|NCT00863707|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
110444822|NCT00863707|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
110444823|NCT00863707|Purinergic Agonists|purinergic agonists|mesh-ancestor
110444824|NCT00863707|Purinergic Agents|purinergic agents|mesh-ancestor
110444825|NCT00863707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110444826|NCT00863707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110444827|NCT00863707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110444828|NCT05340634|Contraceptive Agents|contraceptive agents|mesh-list
110444829|NCT05340634|Contraceptives, Oral|contraceptives, oral|mesh-list
110444830|NCT05340634|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110444831|NCT05340634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110444832|NCT05340634|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110444833|NCT05367479|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110444834|NCT05367479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110444837|NCT04187807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110444838|NCT04187807|Protective Agents|protective agents|mesh-ancestor
110444839|NCT04187807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110444840|NCT04187807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110444841|NCT01094184|Paclitaxel|paclitaxel|mesh-list
110444842|NCT01094184|Docetaxel|docetaxel|mesh-list
110444843|NCT01094184|Bevacizumab|bevacizumab|mesh-list
110444844|NCT01094184|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110444845|NCT01094184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110444846|NCT01094184|Tubulin Modulators|tubulin modulators|mesh-ancestor
110444847|NCT01094184|Antimitotic Agents|antimitotic agents|mesh-ancestor
110444848|NCT01094184|Mitosis Modulators|mitosis modulators|mesh-ancestor
110444849|NCT01094184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110444850|NCT01094184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110444851|NCT01094184|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110444852|NCT01094184|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110444853|NCT01094184|Growth Substances|growth substances|mesh-ancestor
110444854|NCT01094184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110444855|NCT01094184|Growth Inhibitors|growth inhibitors|mesh-ancestor
110373659|NCT00583869|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110444856|NCT00697879|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
110444857|NCT00697879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110444858|NCT00697879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110444859|NCT01134731|Paliperidone Palmitate|paliperidone palmitate|mesh-list
110444860|NCT01134731|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110444861|NCT01134731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110444862|NCT01134731|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110444863|NCT01134731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110444864|NCT01134731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110444865|NCT01134731|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110444866|NCT01134731|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110444867|NCT01134731|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110444868|NCT01134731|Serotonin Agents|serotonin agents|mesh-ancestor
110444869|NCT01134731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110444870|NCT01134731|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110444871|NCT01134731|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110444872|NCT01134731|Dopamine Agents|dopamine agents|mesh-ancestor
110444874|NCT04132063|Anticonvulsants|anticonvulsants|mesh-ancestor
110444875|NCT04132063|Nootropic Agents|nootropic agents|mesh-ancestor
110444876|NCT02618317|Minocycline|minocycline|mesh-list
110444877|NCT02618317|Heparin|heparin|mesh-list
110444878|NCT02618317|Anticoagulants|anticoagulants|mesh-ancestor
110444879|NCT02618317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110444880|NCT02618317|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110444881|NCT02618317|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110444882|NCT02618317|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110066083|NCT01536600|Insulin Aspart|insulin aspart|mesh-list
110444883|NCT02618317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110066219|NCT01537471|Autonomic Agents|autonomic agents|mesh-ancestor
110066303|NCT01538095|Trebananib|trebananib|mesh-list
110444885|NCT01140503|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110444886|NCT01140503|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110444887|NCT01140503|Analgesics|analgesics|mesh-ancestor
110444888|NCT01140503|Sensory System Agents|sensory system agents|mesh-ancestor
110444889|NCT01140503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110066512|NCT01538901|Imiquimod|imiquimod|mesh-list
110066589|NCT01539265|Adrenergic Agents|adrenergic agents|mesh-ancestor
110066660|NCT01539655|Omeprazole|omeprazole|mesh-list
110444890|NCT01140503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110444891|NCT01140503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110444892|NCT01140503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110066804|NCT01540591|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
110444893|NCT01140503|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
110444894|NCT01140503|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110444895|NCT01140503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110066955|NCT01541293|Lidocaine|lidocaine|mesh-list
110444896|NCT01140503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110444897|NCT02689726|Imiquimod|imiquimod|mesh-list
110444898|NCT02689726|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110067111|NCT01542138|Niacin|niacin|mesh-list
110444899|NCT02689726|Immunologic Factors|immunologic factors|mesh-ancestor
110444900|NCT02689726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110444901|NCT02689726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110444902|NCT02689726|Interferon Inducers|interferon inducers|mesh-ancestor
110444903|NCT00863317|Montelukast|montelukast|mesh-list
110444904|NCT00863317|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110067317|NCT01543399|Anabolic Agents|anabolic agents|mesh-ancestor
110444905|NCT00863317|Respiratory System Agents|respiratory system agents|mesh-ancestor
110444906|NCT00863317|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110444907|NCT00863317|Hormone Antagonists|hormone antagonists|mesh-ancestor
110067537|NCT01544751|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110444908|NCT00863317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110444909|NCT00863317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110444910|NCT00863317|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110444911|NCT00863317|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110444912|NCT00863317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110444913|NCT02744092|Enoxaparin|enoxaparin|mesh-list
110444914|NCT02744092|Dalteparin|dalteparin|mesh-list
110444915|NCT02744092|PENTA|penta|mesh-list
110444916|NCT02744092|Warfarin|warfarin|mesh-list
110444917|NCT02744092|Rivaroxaban|rivaroxaban|mesh-list
110444918|NCT02744092|Dabigatran|dabigatran|mesh-list
110444919|NCT02744092|Apixaban|apixaban|mesh-list
110444921|NCT02744092|Fondaparinux|fondaparinux|mesh-list
110444922|NCT02744092|Anticoagulants|anticoagulants|mesh-ancestor
110444923|NCT02744092|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110444924|NCT02744092|Antithrombins|antithrombins|mesh-ancestor
110444925|NCT02744092|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110444926|NCT02744092|Protease Inhibitors|protease inhibitors|mesh-ancestor
110444927|NCT02744092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110067901|NCT01547416|Fentanyl|fentanyl|mesh-list
110444928|NCT02744092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110444929|NCT02744092|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110444930|NCT02744092|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110444932|NCT01200368|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110444933|NCT01200368|Immunologic Factors|immunologic factors|mesh-ancestor
110444934|NCT01200368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110444937|NCT04125121|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110068634|NCT01552044|Hormone Antagonists|hormone antagonists|mesh-ancestor
110444938|NCT04125121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110444939|NCT04125121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110444940|NCT04125121|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110444941|NCT04125121|Anesthetics, General|anesthetics, general|mesh-ancestor
110444942|NCT04125121|Anesthetics|anesthetics|mesh-ancestor
110444943|NCT04125121|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110444944|NCT04125121|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110444945|NCT01079130|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110444946|NCT01079130|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110444947|NCT01079130|Autonomic Agents|autonomic agents|mesh-ancestor
110444948|NCT01079130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110444949|NCT01079130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110444950|NCT01079130|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110444951|NCT01079130|Respiratory System Agents|respiratory system agents|mesh-ancestor
110444952|NCT01079130|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110444953|NCT01079130|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110444954|NCT01079130|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110444955|NCT01079130|Adrenergic Agents|adrenergic agents|mesh-ancestor
110444956|NCT01079130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110444957|NCT01079130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110444958|NCT01078974|Dexamethasone|dexamethasone|mesh-list
110444959|NCT01078974|Rituximab|rituximab|mesh-list
110444960|NCT01078974|Pomalidomide|pomalidomide|mesh-list
110444961|NCT01078974|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110444962|NCT01078974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110444963|NCT01078974|Immunologic Factors|immunologic factors|mesh-ancestor
110444964|NCT01078974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110444965|NCT01078974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110444966|NCT01078974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110069078|NCT01555879|Abatacept|abatacept|mesh-list
110444968|NCT01078974|Autonomic Agents|autonomic agents|mesh-ancestor
110444969|NCT01078974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110444970|NCT01078974|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110444971|NCT01078974|Glucocorticoids|glucocorticoids|mesh-ancestor
110444972|NCT01078974|Hormones|hormones|mesh-ancestor
110444973|NCT01078974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110444974|NCT01078974|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110444975|NCT01078974|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110444976|NCT01078974|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110444977|NCT01078974|Growth Substances|growth substances|mesh-ancestor
110444978|NCT01078974|Growth Inhibitors|growth inhibitors|mesh-ancestor
110444980|NCT04307082|Antifungal Agents|antifungal agents|mesh-ancestor
110444981|NCT04307082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110444982|NCT02878200|Piperaquine|piperaquine|mesh-list
110444983|NCT02878200|Artenimol|artenimol|mesh-list
110444984|NCT02878200|Antimalarials|antimalarials|mesh-ancestor
110444985|NCT02878200|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110444986|NCT02878200|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110069510|NCT05823311|Cisplatin|cisplatin|mesh-list
110444987|NCT02878200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110444988|NCT04302012|Mydriatics|mydriatics|mesh-list
110444989|NCT04302012|Autonomic Agents|autonomic agents|mesh-ancestor
110444990|NCT04302012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110444991|NCT04302012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110444992|NCT00869557|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110444993|NCT00869557|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110444995|NCT00869557|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110444996|NCT00869557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110444997|NCT00869557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110444998|NCT00869557|Antiviral Agents|antiviral agents|mesh-ancestor
110444999|NCT00869557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110445000|NCT00869557|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110445001|NCT00869557|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110445002|NCT02781064|Atorvastatin|atorvastatin|mesh-list
110445003|NCT02781064|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110445004|NCT02781064|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110445005|NCT02781064|Antimetabolites|antimetabolites|mesh-ancestor
110445006|NCT02781064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110445008|NCT02781064|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110445009|NCT02781064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110445010|NCT04205682|Cannabidiol|cannabidiol|mesh-list
110445011|NCT04205682|Anticonvulsants|anticonvulsants|mesh-ancestor
110445012|NCT01134263|Vaccines|vaccines|mesh-list
110069854|NCT04710368|Evolocumab|evolocumab|mesh-list
110445013|NCT01134263|Immunologic Factors|immunologic factors|mesh-ancestor
110445014|NCT01134263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110445015|NCT01199822|Olaratumab|olaratumab|mesh-list
110445016|NCT01199822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110445017|NCT01096056|Vaccines|vaccines|mesh-list
110445018|NCT01096056|Immunologic Factors|immunologic factors|mesh-ancestor
110445019|NCT01096056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110445020|NCT00866359|Apremilast|apremilast|mesh-list
110445021|NCT00866359|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110445022|NCT00866359|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110445023|NCT00866359|Analgesics|analgesics|mesh-ancestor
110445024|NCT00866359|Sensory System Agents|sensory system agents|mesh-ancestor
110445025|NCT00866359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110445026|NCT00866359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110445027|NCT00866359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110445028|NCT00866359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110445029|NCT00866359|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
110445030|NCT00866359|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110445031|NCT00866359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110445032|NCT00866359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110445033|NCT01199198|Tolvaptan|tolvaptan|mesh-list
110445034|NCT01199198|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
110445035|NCT01199198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110445036|NCT01199198|Natriuretic Agents|natriuretic agents|mesh-ancestor
110445037|NCT01199198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110445038|NCT05089708|Trifarotene|trifarotene|mesh-list
110445039|NCT05089708|Dermatologic Agents|dermatologic agents|mesh-ancestor
110445040|NCT01095978|Clarithromycin|clarithromycin|mesh-list
110445041|NCT01095978|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110445042|NCT01095978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110445043|NCT01095978|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110445044|NCT01095978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110445045|NCT01095978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110445046|NCT01095978|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110070140|NCT04149899|Timolol|timolol|mesh-list
110445047|NCT01095978|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110445048|NCT01134107|Insulin|insulin|mesh-list
110445049|NCT01134107|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110445050|NCT01134107|Insulin Aspart|insulin aspart|mesh-list
110445051|NCT01134107|Insulin Lispro|insulin lispro|mesh-list
110445052|NCT01134107|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110445053|NCT01134107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110445054|NCT01198574|Vitamins|vitamins|mesh-list
110445055|NCT01198574|Folic Acid|folic acid|mesh-list
110445056|NCT01198574|Vitamin A|vitamin a|mesh-list
110445057|NCT01198574|Iron|iron|mesh-list
110445058|NCT01198574|Retinol palmitate|retinol palmitate|mesh-list
110445059|NCT01198574|Micronutrients|micronutrients|mesh-ancestor
110445060|NCT01198574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110445061|NCT01198574|Trace Elements|trace elements|mesh-ancestor
110445062|NCT01198574|Hematinics|hematinics|mesh-ancestor
110445063|NCT01198574|Vitamin B Complex|vitamin b complex|mesh-ancestor
110445064|NCT01198574|Antioxidants|antioxidants|mesh-ancestor
110445065|NCT01198574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110070547|NCT03321526|Norepinephrine|norepinephrine|mesh-list
110445067|NCT01198574|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110445068|NCT01198574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110445069|NCT02580994|Carboplatin|carboplatin|mesh-list
110445070|NCT02580994|Pembrolizumab|pembrolizumab|mesh-list
110445071|NCT02580994|Etoposide|etoposide|mesh-list
110070769|NCT02870907|Etoposide|etoposide|mesh-list
110445072|NCT02580994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110070844|NCT02201251|Nootropic Agents|nootropic agents|mesh-ancestor
110070997|NCT01556672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110445073|NCT02580994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110445074|NCT02580994|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110445075|NCT02580994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110071289|NCT01558466|Urological Agents|urological agents|mesh-ancestor
110445076|NCT02580994|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110445077|NCT02580994|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110445078|NCT02580994|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110445079|NCT02580994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110445080|NCT01198028|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110445081|NCT01198028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110445082|NCT01198028|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110445083|NCT01198028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110445084|NCT01198028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110445086|NCT01092780|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110445087|NCT01092780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110072033|NCT01561482|Metformin|metformin|mesh-list
110445088|NCT01092780|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
110445089|NCT01092780|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110445090|NCT01092780|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110072239|NCT01570569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110445091|NCT01092780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110072389|NCT01571323|Misoprostol|misoprostol|mesh-list
110445092|NCT05338606|Bimatoprost|bimatoprost|mesh-list
110445093|NCT05338606|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110445094|NCT01092546|Flutemetamol|flutemetamol|mesh-list
110445095|NCT01092546|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110445096|NCT01092546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110445097|NCT02779348|Warfarin|warfarin|mesh-list
110445098|NCT02779348|Anticoagulants|anticoagulants|mesh-ancestor
110445099|NCT02779582|Progesterone|progesterone|mesh-list
110445100|NCT02779582|Progestins|progestins|mesh-ancestor
110445102|NCT02779582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110445103|NCT02779582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110445104|NCT00634894|Letrozole|letrozole|mesh-list
110445105|NCT00634894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110445106|NCT00634894|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110445107|NCT00634894|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110445108|NCT00634894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110445109|NCT00634894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110445110|NCT00634894|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110445111|NCT00634894|Hormone Antagonists|hormone antagonists|mesh-ancestor
110445112|NCT00634894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110445113|NCT00634894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110445114|NCT02779270|Sunscreening Agents|sunscreening agents|mesh-list
110445115|NCT02779270|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110445116|NCT02779270|Protective Agents|protective agents|mesh-ancestor
110445117|NCT02779270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110445118|NCT02779270|Dermatologic Agents|dermatologic agents|mesh-ancestor
110445119|NCT01078662|Olaparib|olaparib|mesh-list
110445120|NCT01078662|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110445121|NCT01078662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110445122|NCT01078662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110445123|NCT01078662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110445124|NCT04227886|Capecitabine|capecitabine|mesh-list
110445125|NCT04227886|Irinotecan|irinotecan|mesh-list
110445126|NCT04227886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110445127|NCT04227886|Antimetabolites|antimetabolites|mesh-ancestor
110445128|NCT04227886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110445129|NCT04227886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110445130|NCT04227886|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110445131|NCT04227886|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110445132|NCT04227886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110445133|NCT02200978|Cytarabine|cytarabine|mesh-list
110445134|NCT02200978|Methotrexate|methotrexate|mesh-list
110445135|NCT02200978|Mercaptopurine|mercaptopurine|mesh-list
110445136|NCT02200978|Mitoxantrone|mitoxantrone|mesh-list
110445137|NCT02200978|Tretinoin|tretinoin|mesh-list
110445138|NCT02200978|Arsenic Trioxide|arsenic trioxide|mesh-list
110445139|NCT02200978|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110445140|NCT02200978|Abortifacient Agents|abortifacient agents|mesh-ancestor
110445141|NCT02200978|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110445142|NCT02200978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110445143|NCT02200978|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110445144|NCT02200978|Antimetabolites|antimetabolites|mesh-ancestor
110445145|NCT02200978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110445146|NCT02200978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110445147|NCT02200978|Dermatologic Agents|dermatologic agents|mesh-ancestor
110445148|NCT02200978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110445149|NCT02200978|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110445150|NCT02200978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110445151|NCT02200978|Immunologic Factors|immunologic factors|mesh-ancestor
110445152|NCT02200978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110445153|NCT02200978|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110445154|NCT02200978|Antiviral Agents|antiviral agents|mesh-ancestor
110445155|NCT02200978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110445156|NCT02200978|Analgesics|analgesics|mesh-ancestor
110445157|NCT02200978|Sensory System Agents|sensory system agents|mesh-ancestor
110445158|NCT02200978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110445159|NCT02200978|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110072903|NCT01574092|Irinotecan|irinotecan|mesh-list
110445160|NCT02200978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110073056|NCT01575717|Vitamin D|vitamin d|mesh-list
110445161|NCT02200978|Keratolytic Agents|keratolytic agents|mesh-ancestor
110445162|NCT02779192|Ebselen|ebselen|mesh-list
110445163|NCT02779192|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110073273|NCT01577459|Tedizolid phosphate|tedizolid phosphate|mesh-list
110445164|NCT02779192|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110445165|NCT02779192|Analgesics|analgesics|mesh-ancestor
110445166|NCT02779192|Sensory System Agents|sensory system agents|mesh-ancestor
110445167|NCT02779192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110073448|NCT01578343|Vorinostat|vorinostat|mesh-list
110445168|NCT02779192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110445169|NCT02779192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110073567|NCT01578720|Aflibercept|aflibercept|mesh-list
110445170|NCT02779192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110445171|NCT02779192|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110445172|NCT02779192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110445173|NCT02779192|Antioxidants|antioxidants|mesh-ancestor
110445174|NCT02779192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110445175|NCT02779192|Protective Agents|protective agents|mesh-ancestor
110445176|NCT02779192|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110445177|NCT02779192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110445178|NCT02779192|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110445179|NCT05020210|Sivelestat|sivelestat|mesh-list
110445180|NCT05020210|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110445181|NCT05020210|Protease Inhibitors|protease inhibitors|mesh-ancestor
110445182|NCT05020210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110445183|NCT05020210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110074255|NCT01591889|Tinidazole|tinidazole|mesh-list
110445185|NCT04227808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110074299|NCT01592032|Anti-Infective Agents|anti-infective agents|mesh-list
110445186|NCT04227808|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110445187|NCT04227808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110445188|NCT04227808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110445190|NCT01091454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110445191|NCT01140347|Ramucirumab|ramucirumab|mesh-list
110445192|NCT01140347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110445193|NCT04227652|Ibuprofen|ibuprofen|mesh-list
110445194|NCT04227652|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110445195|NCT04227652|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110445196|NCT04227652|Analgesics|analgesics|mesh-ancestor
110445197|NCT04227652|Sensory System Agents|sensory system agents|mesh-ancestor
110445198|NCT04227652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110445199|NCT04227652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110445200|NCT04227652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110445201|NCT04227652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110074448|NCT01593046|Rilpivirine|rilpivirine|mesh-list
110074508|NCT01593280|Sensory System Agents|sensory system agents|mesh-ancestor
110445202|NCT04227652|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110445203|NCT04227652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110074657|NCT01593995|Mitogens|mitogens|mesh-list
110445204|NCT04227652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110445207|NCT02883569|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
110445208|NCT02883569|Tramadol|tramadol|mesh-list
110445209|NCT02883569|Codeine|codeine|mesh-list
110074877|NCT01595022|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110445210|NCT02883569|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110445211|NCT02883569|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110445212|NCT02883569|Analgesics|analgesics|mesh-ancestor
110445213|NCT02883569|Sensory System Agents|sensory system agents|mesh-ancestor
110445214|NCT02883569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110445215|NCT02883569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110445216|NCT02883569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110445217|NCT02883569|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110445218|NCT02883569|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110445219|NCT02883569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110445220|NCT02883569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110445221|NCT02883569|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110445222|NCT02883569|Narcotics|narcotics|mesh-ancestor
110445223|NCT02883569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110445224|NCT02883569|Antitussive Agents|antitussive agents|mesh-ancestor
110075314|NCT01596998|Epinephrine|epinephrine|mesh-list
110445225|NCT02883569|Respiratory System Agents|respiratory system agents|mesh-ancestor
110445227|NCT02883023|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110075606|NCT01598363|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110445229|NCT02778958|Acetaminophen|acetaminophen|mesh-list
110445230|NCT02778958|Ibuprofen|ibuprofen|mesh-list
110075834|NCT05689983|Hormones|hormones|mesh-ancestor
110445231|NCT02778958|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110445232|NCT02778958|Analgesics|analgesics|mesh-ancestor
110445233|NCT02778958|Sensory System Agents|sensory system agents|mesh-ancestor
110445234|NCT02778958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110075990|NCT05189483|Paclitaxel|paclitaxel|mesh-list
110076071|NCT04714619|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110445235|NCT02778958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110445236|NCT02778958|Antipyretics|antipyretics|mesh-ancestor
110445237|NCT02778958|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110076289|NCT03462251|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110445238|NCT02778958|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110445239|NCT02778958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110445240|NCT02778958|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110445241|NCT02778958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110373708|NCT00569621|Moxaverine|moxaverine|mesh-list
110445242|NCT02778958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110445244|NCT01197560|Gemcitabine|gemcitabine|mesh-list
110445245|NCT01197560|Oxaliplatin|oxaliplatin|mesh-list
110445246|NCT01197560|Etoposide|etoposide|mesh-list
110445247|NCT01197560|Lenalidomide|lenalidomide|mesh-list
110445248|NCT01197560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110445249|NCT01197560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110445250|NCT01197560|Immunologic Factors|immunologic factors|mesh-ancestor
110076423|NCT05701124|Growth Substances|growth substances|mesh-ancestor
110445251|NCT01197560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110445252|NCT01197560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110445253|NCT01197560|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110445254|NCT01197560|Antimetabolites|antimetabolites|mesh-ancestor
110076570|NCT03919773|Immunologic Factors|immunologic factors|mesh-ancestor
110445255|NCT01197560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110076643|NCT03736863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110076731|NCT03106454|Estradiol|estradiol|mesh-list
110445256|NCT01197560|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110445257|NCT01197560|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110445258|NCT01197560|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110445259|NCT01197560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110445260|NCT01197560|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110445261|NCT01197560|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110445262|NCT01197560|Growth Substances|growth substances|mesh-ancestor
110445263|NCT01197560|Growth Inhibitors|growth inhibitors|mesh-ancestor
110445265|NCT04940572|Anticonvulsants|anticonvulsants|mesh-ancestor
110445266|NCT04940572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110077029|NCT02829931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110445267|NCT04940572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110445268|NCT04940572|GABA Agents|gaba agents|mesh-ancestor
110077096|NCT02491983|Palbociclib|palbociclib|mesh-list
110077167|NCT01843374|Tremelimumab|tremelimumab|mesh-list
110445269|NCT04940572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110077253|NCT01599988|Caseins|caseins|mesh-list
110445270|NCT04940572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110445271|NCT04940572|Antimanic Agents|antimanic agents|mesh-ancestor
110445272|NCT04940572|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110445273|NCT04940572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110445274|NCT04940572|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110077685|NCT01612247|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110445275|NCT01196078|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110445276|NCT01196078|Vinorelbine|vinorelbine|mesh-list
110445277|NCT01196078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110077833|NCT01613053|Imatinib Mesylate|imatinib mesylate|mesh-list
110445278|NCT01196078|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110445280|NCT01196078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110078051|NCT01614223|Hormones|hormones|mesh-ancestor
110078121|NCT01614405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110445281|NCT01196078|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110445282|NCT01196078|Tubulin Modulators|tubulin modulators|mesh-ancestor
110445283|NCT01196078|Antimitotic Agents|antimitotic agents|mesh-ancestor
110445284|NCT01196078|Mitosis Modulators|mitosis modulators|mesh-ancestor
110445285|NCT05314660|Fluorides|fluorides|mesh-list
110445286|NCT05314660|Cariostatic Agents|cariostatic agents|mesh-ancestor
110445287|NCT05314660|Protective Agents|protective agents|mesh-ancestor
110445288|NCT05314660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110445290|NCT04920292|Anthelmintics|anthelmintics|mesh-ancestor
110078637|NCT01617707|GABA Agents|gaba agents|mesh-ancestor
110445291|NCT04920292|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110445292|NCT04920292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110445293|NCT04920292|Antinematodal Agents|antinematodal agents|mesh-ancestor
110445294|NCT04317872|Dexamethasone|dexamethasone|mesh-list
110078800|NCT01618773|Adapalene|adapalene|mesh-list
110445295|NCT04317872|Dexamethasone acetate|dexamethasone acetate|mesh-list
110445296|NCT04317872|BB 1101|bb 1101|mesh-list
110445297|NCT04317872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110445298|NCT04317872|Antiemetics|antiemetics|mesh-ancestor
110445299|NCT04317872|Autonomic Agents|autonomic agents|mesh-ancestor
110079078|NCT01620333|Insulin|insulin|mesh-list
110079153|NCT01620944|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110445300|NCT04317872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110445301|NCT04317872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110445302|NCT04317872|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110445304|NCT04317872|Hormones|hormones|mesh-ancestor
110445305|NCT04317872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110445306|NCT04317872|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110445307|NCT04317872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110445308|NCT04317872|Protease Inhibitors|protease inhibitors|mesh-ancestor
110445309|NCT04317872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110079743|NCT01624441|Epirubicin|epirubicin|mesh-list
110079809|NCT01625260|Antimetabolites|antimetabolites|mesh-ancestor
110445310|NCT04317872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110445311|NCT01132547|Cyproheptadine|cyproheptadine|mesh-list
110445312|NCT01132547|Antipruritics|antipruritics|mesh-ancestor
110079885|NCT01625793|Interferons|interferons|mesh-list
110445313|NCT01132547|Dermatologic Agents|dermatologic agents|mesh-ancestor
110445314|NCT01132547|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110079957|NCT01626443|Folic Acid|folic acid|mesh-list
110445316|NCT01132547|Histamine Antagonists|histamine antagonists|mesh-ancestor
110445317|NCT01132547|Histamine Agents|histamine agents|mesh-ancestor
110445318|NCT01132547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110445319|NCT01132547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110445321|NCT01132547|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110445322|NCT01132547|Serotonin Agents|serotonin agents|mesh-ancestor
110445323|NCT01132547|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110445324|NCT01194830|Linagliptin|linagliptin|mesh-list
110445325|NCT01194830|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110445326|NCT01194830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110080620|NCT01630720|Vitamin D|vitamin d|mesh-list
110445328|NCT01194830|Hormones|hormones|mesh-ancestor
110445329|NCT01194830|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110445330|NCT01194830|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110445331|NCT01194830|Protease Inhibitors|protease inhibitors|mesh-ancestor
110445332|NCT01194830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110080908|NCT01632592|Tesamorelin|tesamorelin|mesh-list
110445333|NCT01194830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110445334|NCT02778178|Clonidine|clonidine|mesh-list
110445335|NCT02778178|Ropivacaine|ropivacaine|mesh-list
110445336|NCT02778178|Anesthetics, Local|anesthetics, local|mesh-ancestor
110445337|NCT02778178|Anesthetics|anesthetics|mesh-ancestor
110445338|NCT02778178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110445339|NCT02778178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110445340|NCT02778178|Sensory System Agents|sensory system agents|mesh-ancestor
110081056|NCT01633970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110445341|NCT02778178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110445342|NCT02778178|Analgesics|analgesics|mesh-ancestor
110445343|NCT02778178|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110445344|NCT02778178|Sympatholytics|sympatholytics|mesh-ancestor
110445345|NCT02778178|Autonomic Agents|autonomic agents|mesh-ancestor
110445346|NCT02778178|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110445347|NCT02778178|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110445348|NCT02778178|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110445349|NCT02778178|Adrenergic Agents|adrenergic agents|mesh-ancestor
110081199|NCT01634698|Vitamins|vitamins|mesh-ancestor
110445350|NCT02778178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110445351|NCT02778178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110445352|NCT01194440|Zoledronic Acid|zoledronic acid|mesh-list
110445353|NCT01194440|Letrozole|letrozole|mesh-list
110445354|NCT01194440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110445355|NCT01194440|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110445356|NCT01194440|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110445357|NCT01194440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110445358|NCT01194440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110445359|NCT01194440|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110445360|NCT01194440|Hormone Antagonists|hormone antagonists|mesh-ancestor
110445361|NCT01194440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110081793|NCT01637558|Protease Inhibitors|protease inhibitors|mesh-ancestor
110445362|NCT01194440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110082009|NCT01638650|Saquinavir|saquinavir|mesh-list
110082081|NCT01638936|Immunoconjugates|immunoconjugates|mesh-ancestor
110082160|NCT01639261|Interferons|interferons|mesh-list
110445363|NCT01194440|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110445364|NCT04823052|Sulindac|sulindac|mesh-list
110445366|NCT04823052|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110445367|NCT04823052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110445368|NCT04823052|Analgesics|analgesics|mesh-ancestor
110445369|NCT04823052|Sensory System Agents|sensory system agents|mesh-ancestor
110445370|NCT04823052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110082458|NCT01648777|Bupivacaine|bupivacaine|mesh-list
110445371|NCT04823052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110445372|NCT04823052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110445373|NCT04823052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110445374|NCT04823052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110082605|NCT01650662|Immunologic Factors|immunologic factors|mesh-ancestor
110082760|NCT01651481|Histamine Agents|histamine agents|mesh-ancestor
110445375|NCT04823052|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110445376|NCT04823052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110445377|NCT04823052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110445378|NCT04823052|Anticonvulsants|anticonvulsants|mesh-ancestor
110445379|NCT04823052|GABA Agonists|gaba agonists|mesh-ancestor
110445380|NCT04823052|GABA Agents|gaba agents|mesh-ancestor
110445381|NCT04823052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110445383|NCT00951015|Dolutegravir|dolutegravir|mesh-list
110445384|NCT00951015|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110445385|NCT00951015|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110445386|NCT00951015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110445387|NCT00951015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110445388|NCT00951015|Antiviral Agents|antiviral agents|mesh-ancestor
110083199|NCT01653470|Antidotes|antidotes|mesh-ancestor
110445389|NCT00951015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110445390|NCT00951015|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110445391|NCT00951015|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110445392|NCT00951015|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110445393|NCT00951015|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110445394|NCT00951015|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110445395|NCT00951015|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110445396|NCT00951015|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110445397|NCT00951015|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110445398|NCT00951015|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110445399|NCT00951015|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110445400|NCT02777866|Bupivacaine|bupivacaine|mesh-list
110445401|NCT02777866|Anesthetics, Local|anesthetics, local|mesh-ancestor
110445402|NCT02777866|Anesthetics|anesthetics|mesh-ancestor
110445403|NCT02777866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110445404|NCT02777866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110445405|NCT02777866|Sensory System Agents|sensory system agents|mesh-ancestor
110445406|NCT02777866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110445407|NCT00626262|Esomeprazole|esomeprazole|mesh-list
110445408|NCT00626262|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110083555|NCT01655706|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110445409|NCT00626262|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110083702|NCT01656070|Vitamin D|vitamin d|mesh-list
110445410|NCT00626262|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110445411|NCT00626262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110083849|NCT01657071|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110083918|NCT01657448|Methenamine hippurate|methenamine hippurate|mesh-list
110083993|NCT01657825|Isavuconazole|isavuconazole|mesh-list
110445412|NCT00626262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110445413|NCT02876796|Firsocostat|firsocostat|mesh-list
110084141|NCT01657396|Disinfectants|disinfectants|mesh-ancestor
110445414|NCT02876796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110445415|NCT02876796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110445416|NCT01193660|Epoetin Alfa|epoetin alfa|mesh-list
110445418|NCT02777788|Paclitaxel|paclitaxel|mesh-list
110445419|NCT02777788|Vinorelbine|vinorelbine|mesh-list
110445420|NCT02777788|Docetaxel|docetaxel|mesh-list
110445422|NCT02777788|Gemcitabine|gemcitabine|mesh-list
110445423|NCT02777788|Pemetrexed|pemetrexed|mesh-list
110445424|NCT02777788|Cisplatin|cisplatin|mesh-list
110445426|NCT02777788|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110445427|NCT02777788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110445428|NCT02777788|Tubulin Modulators|tubulin modulators|mesh-ancestor
110445429|NCT02777788|Antimitotic Agents|antimitotic agents|mesh-ancestor
110445430|NCT02777788|Mitosis Modulators|mitosis modulators|mesh-ancestor
110084773|NCT01662089|Zinc|zinc|mesh-list
110445431|NCT02777788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110445432|NCT02777788|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110445433|NCT02777788|Antimetabolites|antimetabolites|mesh-ancestor
110445434|NCT02777788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110445435|NCT02777788|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110445436|NCT02777788|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110445437|NCT01076166|Clarithromycin|clarithromycin|mesh-list
110445438|NCT01076166|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110445439|NCT01076166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110445440|NCT01076166|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110445441|NCT01076166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110445442|NCT01076166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110085236|NCT01664507|Autonomic Agents|autonomic agents|mesh-ancestor
110445443|NCT01076166|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110445444|NCT01076166|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110445445|NCT02777710|Durvalumab|durvalumab|mesh-list
110085535|NCT01667614|Losartan|losartan|mesh-list
110445446|NCT02777710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110445447|NCT02777710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110085612|NCT01668121|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110445448|NCT01193582|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110445449|NCT01193582|Immunologic Factors|immunologic factors|mesh-ancestor
110445450|NCT01193582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110445451|NCT00602901|Naproxen|naproxen|mesh-list
110445452|NCT00602901|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110445453|NCT00602901|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110445454|NCT00602901|Analgesics|analgesics|mesh-ancestor
110445455|NCT00602901|Sensory System Agents|sensory system agents|mesh-ancestor
110085914|NCT01670812|Rituximab|rituximab|mesh-list
110445456|NCT00602901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110445457|NCT00602901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110086052|NCT01678053|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110445458|NCT00602901|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110445459|NCT00602901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110445460|NCT00602901|Gout Suppressants|gout suppressants|mesh-ancestor
110445461|NCT00602901|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110445462|NCT00602901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110445463|NCT00602901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110445464|NCT01076088|Metformin|metformin|mesh-list
110445465|NCT01076088|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110445466|NCT01076088|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110445467|NCT01076088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110445468|NCT01076088|Incretins|incretins|mesh-ancestor
110445469|NCT01076088|Hormones|hormones|mesh-ancestor
110445470|NCT01076088|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110445471|NCT01076088|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110445472|NCT01076088|Protease Inhibitors|protease inhibitors|mesh-ancestor
110445473|NCT01076088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110445474|NCT01076088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110445475|NCT02777320|Acetaminophen|acetaminophen|mesh-list
110445476|NCT02777320|Ibuprofen|ibuprofen|mesh-list
110445477|NCT02777320|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110445478|NCT02777320|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110445479|NCT02777320|Analgesics|analgesics|mesh-ancestor
110445480|NCT02777320|Sensory System Agents|sensory system agents|mesh-ancestor
110445481|NCT02777320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110445482|NCT02777320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110445483|NCT02777320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110445484|NCT02777320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110445485|NCT02777320|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110445486|NCT02777320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110445487|NCT02777320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110445488|NCT02777320|Antipyretics|antipyretics|mesh-ancestor
110445490|NCT01193348|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
110445491|NCT01193348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110445492|NCT01193348|Immunologic Factors|immunologic factors|mesh-ancestor
110086322|NCT05539924|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110086394|NCT05291156|Cetuximab|cetuximab|mesh-list
110445493|NCT01193348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110445494|NCT00945321|Aprepitant|aprepitant|mesh-list
110445495|NCT00945321|Fosaprepitant|fosaprepitant|mesh-list
110445497|NCT00945321|Autonomic Agents|autonomic agents|mesh-ancestor
110445498|NCT00945321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110445499|NCT00945321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110086840|NCT03119038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110445500|NCT00945321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110445501|NCT00945321|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110086923|NCT02587312|Nicotine|nicotine|mesh-list
110445502|NCT00945321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110086986|NCT05838105|Progestins|progestins|mesh-ancestor
110445503|NCT00945321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110445505|NCT02776228|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110445506|NCT02776228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110445507|NCT02776228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110445509|NCT05382728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110087450|NCT03909529|Digoxin|digoxin|mesh-list
110445510|NCT05382728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110445511|NCT05382728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110087508|NCT03122717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110087581|NCT02036086|Vemurafenib|vemurafenib|mesh-list
110445512|NCT05382728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110445513|NCT01192178|Fluticasone|fluticasone|mesh-list
110445515|NCT01192178|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110445516|NCT01192178|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
110445517|NCT01192178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110087728|NCT01687751|Anesthetics|anesthetics|mesh-ancestor
110445518|NCT01192178|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110445519|NCT01192178|Autonomic Agents|autonomic agents|mesh-ancestor
110445520|NCT01192178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110445521|NCT01192178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110445522|NCT01192178|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110445523|NCT01192178|Respiratory System Agents|respiratory system agents|mesh-ancestor
110445525|NCT01192178|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110088102|NCT01691677|Beclomethasone|beclomethasone|mesh-list
110088164|NCT01692457|Golimumab|golimumab|mesh-list
110088236|NCT01693081|Apomorphine|apomorphine|mesh-list
110445526|NCT01192178|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110445527|NCT01192178|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110445528|NCT01192178|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110445529|NCT01192178|Adrenergic Agents|adrenergic agents|mesh-ancestor
110445530|NCT01192178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110445531|NCT01192178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110445532|NCT01192178|Glucocorticoids|glucocorticoids|mesh-ancestor
110445534|NCT01192178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110445535|NCT01192178|Sympathomimetics|sympathomimetics|mesh-ancestor
110445536|NCT04193566|Dapagliflozin|dapagliflozin|mesh-list
110088754|NCT05293704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110088830|NCT05294900|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110445537|NCT04193566|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110088983|NCT05220826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110445538|NCT04193566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110089061|NCT05129137|Antipyretics|antipyretics|mesh-ancestor
110445539|NCT04193566|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110445540|NCT04193566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110089209|NCT04871425|Narcotics|narcotics|mesh-ancestor
110445541|NCT00869401|Temozolomide|temozolomide|mesh-list
110445543|NCT00869401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110445544|NCT00869401|Alkylating Agents|alkylating agents|mesh-ancestor
110445545|NCT00869401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110445546|NCT00869401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110445547|NCT00869401|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110445548|NCT00869401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110445549|NCT01076010|Sorafenib|sorafenib|mesh-list
110445550|NCT01076010|Tivozanib|tivozanib|mesh-list
110445551|NCT01076010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110445552|NCT01076010|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110445553|NCT01076010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110445554|NCT01076010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110445555|NCT04225780|Ganciclovir|ganciclovir|mesh-list
110445556|NCT04225780|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
110445557|NCT04225780|Antiviral Agents|antiviral agents|mesh-ancestor
110445558|NCT04225780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110445559|NCT04225780|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110445560|NCT04225780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110445561|NCT04225780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110445562|NCT04045171|Tacrolimus|tacrolimus|mesh-list
110445563|NCT04045171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110445564|NCT04045171|Immunologic Factors|immunologic factors|mesh-ancestor
110445565|NCT04045171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110445566|NCT04045171|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110445567|NCT04045171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110445568|NCT04045171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110445569|NCT01075152|Lamivudine|lamivudine|mesh-list
110445570|NCT01075152|Zidovudine|zidovudine|mesh-list
110445571|NCT01075152|Efavirenz|efavirenz|mesh-list
110445572|NCT01075152|Stavudine|stavudine|mesh-list
110445573|NCT01075152|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110089548|NCT04096066|Dexamethasone|dexamethasone|mesh-list
110445574|NCT01075152|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110445575|NCT01075152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110089656|NCT03922451|Cefazolin|cefazolin|mesh-list
110445576|NCT01075152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110445577|NCT01075152|Antiviral Agents|antiviral agents|mesh-ancestor
110445578|NCT01075152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110445579|NCT01075152|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110445580|NCT01075152|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110445581|NCT01075152|Antimetabolites|antimetabolites|mesh-ancestor
110445582|NCT01075152|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110445583|NCT01075152|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110445584|NCT01075152|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110090010|NCT05521984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110445585|NCT01075152|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110445586|NCT01075152|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110445587|NCT01075152|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110445589|NCT04134637|Anesthetics, Local|anesthetics, local|mesh-ancestor
110445590|NCT04134637|Anesthetics|anesthetics|mesh-ancestor
110445591|NCT04134637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110445592|NCT04134637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110445593|NCT04134637|Sensory System Agents|sensory system agents|mesh-ancestor
110445594|NCT04134637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110445596|NCT02617849|Carboplatin|carboplatin|mesh-list
110092614|NCT01697293|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110090746|NCT03889314|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110445598|NCT02617849|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110445599|NCT02617849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110445600|NCT02617849|Tubulin Modulators|tubulin modulators|mesh-ancestor
110090894|NCT03712254|Fosphenytoin|fosphenytoin|mesh-list
110445601|NCT02617849|Antimitotic Agents|antimitotic agents|mesh-ancestor
110445602|NCT02617849|Mitosis Modulators|mitosis modulators|mesh-ancestor
110445603|NCT02617849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110445604|NCT02617849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110445605|NCT02617849|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110091133|NCT05437497|Propofol|propofol|mesh-list
110373750|NCT00570284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110445607|NCT00950859|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110445609|NCT00950859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110445610|NCT00950859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110445611|NCT00950859|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110445612|NCT00950859|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110445613|NCT00950859|Antiviral Agents|antiviral agents|mesh-ancestor
110445614|NCT00950859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110445615|NCT02775292|Aldesleukin|aldesleukin|mesh-list
110445616|NCT02775292|Cyclophosphamide|cyclophosphamide|mesh-list
110445617|NCT02775292|Nivolumab|nivolumab|mesh-list
110445618|NCT02775292|Fludarabine|fludarabine|mesh-list
110445619|NCT02775292|Fludarabine phosphate|fludarabine phosphate|mesh-list
110445620|NCT02775292|Interleukin-2|interleukin-2|mesh-list
110445621|NCT02775292|Vaccines|vaccines|mesh-list
110445622|NCT02775292|Immunologic Factors|immunologic factors|mesh-ancestor
110445623|NCT02775292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110445624|NCT02775292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110445625|NCT02775292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110445626|NCT02775292|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110445627|NCT02775292|Alkylating Agents|alkylating agents|mesh-ancestor
110091410|NCT03133260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110445628|NCT02775292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110445629|NCT02775292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110445630|NCT02775292|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110445631|NCT02775292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110091619|NCT02512172|Cc-486|cc-486|mesh-list
110445632|NCT02775292|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110445633|NCT02775292|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110445634|NCT02775292|Antimetabolites|antimetabolites|mesh-ancestor
110445635|NCT02775292|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110445636|NCT02775292|Analgesics|analgesics|mesh-ancestor
110445637|NCT02775292|Sensory System Agents|sensory system agents|mesh-ancestor
110445638|NCT02775292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110445639|NCT02775292|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110445640|NCT02775292|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110445641|NCT02775292|Antiviral Agents|antiviral agents|mesh-ancestor
110445642|NCT02775292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110445643|NCT00862849|Insulin|insulin|mesh-list
110445644|NCT00862849|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110445645|NCT00862849|Insulin Lispro|insulin lispro|mesh-list
110445646|NCT00862849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110092147|NCT00579527|Hormones|hormones|mesh-ancestor
110445647|NCT00862849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110445648|NCT01090050|Naproxen|naproxen|mesh-list
110445649|NCT01090050|Sumatriptan|sumatriptan|mesh-list
110445650|NCT01090050|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110092433|NCT01696422|Vaccines|vaccines|mesh-list
110445651|NCT01090050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110445652|NCT01090050|Analgesics|analgesics|mesh-ancestor
110445653|NCT01090050|Sensory System Agents|sensory system agents|mesh-ancestor
110445654|NCT01090050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110445655|NCT01090050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110445656|NCT01090050|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110445657|NCT01090050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110445658|NCT01090050|Gout Suppressants|gout suppressants|mesh-ancestor
110445659|NCT01090050|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110092577|NCT01697111|Dienogest|dienogest|mesh-list
110445660|NCT01090050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110445661|NCT01090050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110445662|NCT01090050|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110445663|NCT01090050|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110445664|NCT01090050|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110445665|NCT01090050|Serotonin Agents|serotonin agents|mesh-ancestor
110445666|NCT01090050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110445668|NCT02775370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110445669|NCT02775370|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110445670|NCT02775370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110445671|NCT02775370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110445672|NCT04225468|Analgesics, Opioid|analgesics, opioid|mesh-list
110445673|NCT04225468|Narcotics|narcotics|mesh-ancestor
110445674|NCT04225468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110445675|NCT04225468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110445676|NCT04225468|Analgesics|analgesics|mesh-ancestor
110445677|NCT04225468|Sensory System Agents|sensory system agents|mesh-ancestor
110445678|NCT04225468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110445680|NCT02855307|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110445681|NCT02855307|Hormones|hormones|mesh-list
110445682|NCT02855307|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110445683|NCT02855307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110445684|NCT02855307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110445685|NCT01077960|Hormones|hormones|mesh-list
110445686|NCT01077960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110445687|NCT01077960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110445688|NCT04269369|Fluorouracil|fluorouracil|mesh-list
110445689|NCT04269369|Antimetabolites|antimetabolites|mesh-ancestor
110093081|NCT01700413|Idarubicin|idarubicin|mesh-list
110445690|NCT04269369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110445691|NCT04269369|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110445692|NCT04269369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110445693|NCT04269369|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110093224|NCT01701323|Fludarabine|fludarabine|mesh-list
110093293|NCT01701739|Digoxin|digoxin|mesh-list
110093369|NCT01702090|Ritonavir|ritonavir|mesh-list
110445694|NCT04269369|Immunologic Factors|immunologic factors|mesh-ancestor
110445695|NCT04269369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110445696|NCT02776540|Aspirin|aspirin|mesh-list
110093514|NCT01703104|Vitamins|vitamins|mesh-ancestor
110093590|NCT01703559|Adrenergic Agents|adrenergic agents|mesh-ancestor
110093666|NCT01703910|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110093742|NCT01704612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110445698|NCT02776540|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110093892|NCT01705392|Bevacizumab|bevacizumab|mesh-list
110445699|NCT02776540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110445700|NCT02776540|Analgesics|analgesics|mesh-ancestor
110445701|NCT02776540|Sensory System Agents|sensory system agents|mesh-ancestor
110445702|NCT02776540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110445703|NCT02776540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110445704|NCT02776540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110445705|NCT02776540|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110445706|NCT02776540|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110445707|NCT02776540|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110445708|NCT02776540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110445709|NCT02776540|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110445710|NCT02776540|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110445711|NCT02776540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110445712|NCT02776540|Antipyretics|antipyretics|mesh-ancestor
110445713|NCT02776540|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110445714|NCT02776540|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110445715|NCT02776540|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110445716|NCT02776540|Purinergic Agents|purinergic agents|mesh-ancestor
110445717|NCT02776540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110445718|NCT00944697|Oxycodone|oxycodone|mesh-list
110445719|NCT00944697|Naloxone|naloxone|mesh-list
110445720|NCT00944697|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110445721|NCT00944697|Narcotics|narcotics|mesh-ancestor
110445722|NCT00944697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110445723|NCT00944697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110445724|NCT00944697|Analgesics|analgesics|mesh-ancestor
110445725|NCT00944697|Sensory System Agents|sensory system agents|mesh-ancestor
110373766|NCT00570479|Anecortave|anecortave|mesh-list
110445726|NCT00944697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110445727|NCT00944697|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110445729|NCT02878122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110445730|NCT04807348|Metformin|metformin|mesh-list
110445731|NCT04807348|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110445732|NCT04807348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110445733|NCT04224922|Paclitaxel|paclitaxel|mesh-list
110445734|NCT04224922|Cyclophosphamide|cyclophosphamide|mesh-list
110445735|NCT04224922|Epirubicin|epirubicin|mesh-list
110445736|NCT04224922|Carboplatin|carboplatin|mesh-list
110445737|NCT04224922|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110445738|NCT04224922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110445739|NCT04224922|Tubulin Modulators|tubulin modulators|mesh-ancestor
110445740|NCT04224922|Antimitotic Agents|antimitotic agents|mesh-ancestor
110445741|NCT04224922|Mitosis Modulators|mitosis modulators|mesh-ancestor
110445742|NCT04224922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110445743|NCT04224922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110445745|NCT04224922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110445746|NCT04224922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110092765|NCT01698541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110445747|NCT04224922|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110445748|NCT04224922|Alkylating Agents|alkylating agents|mesh-ancestor
110445749|NCT04224922|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110445750|NCT04224922|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110445751|NCT04224922|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110445752|NCT04224922|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110445753|NCT04224922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110445754|NCT02877888|Fluorides|fluorides|mesh-list
110445755|NCT02877888|Fluorides, Topical|fluorides, topical|mesh-list
110445757|NCT02877888|Protective Agents|protective agents|mesh-ancestor
110094885|NCT01711528|Protease Inhibitors|protease inhibitors|mesh-ancestor
110094961|NCT01711905|Vitamin D|vitamin d|mesh-list
110445758|NCT02877888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110445759|NCT02772640|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110445761|NCT02772640|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110445762|NCT02772640|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110445763|NCT02772640|Antimetabolites|antimetabolites|mesh-ancestor
110445764|NCT02772640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110445765|NCT02772640|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110445766|NCT02772640|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110445767|NCT02772640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110445768|NCT02772718|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110445769|NCT02772718|Immunologic Factors|immunologic factors|mesh-ancestor
110095099|NCT01712828|Sirolimus|sirolimus|mesh-list
110095211|NCT01713179|Ambroxol|ambroxol|mesh-list
110445770|NCT02772718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110445771|NCT00866281|Midostaurin|midostaurin|mesh-list
110445772|NCT00866281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110095393|NCT01714128|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110445773|NCT00866281|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110445774|NCT00866281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110445775|NCT00866281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110445776|NCT04121611|Aspirin|aspirin|mesh-list
110445777|NCT04121611|Heparin|heparin|mesh-list
110445778|NCT04121611|Calcium heparin|calcium heparin|mesh-list
110445779|NCT04121611|Anticoagulants|anticoagulants|mesh-ancestor
110445780|NCT04121611|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110445781|NCT04121611|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110445782|NCT04121611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110445783|NCT04121611|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110445784|NCT04121611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110445786|NCT04121611|Sensory System Agents|sensory system agents|mesh-ancestor
110445787|NCT04121611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110445788|NCT04121611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110445789|NCT04121611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110445790|NCT04121611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110445791|NCT04121611|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110445792|NCT04121611|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110445793|NCT04121611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110445794|NCT04121611|Antipyretics|antipyretics|mesh-ancestor
110445795|NCT02771860|Denosumab|denosumab|mesh-list
110445796|NCT02771860|Calcium|calcium|mesh-list
110445797|NCT02771860|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110445798|NCT02771860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110445799|NCT02771860|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110445800|NCT02771782|Vaccines|vaccines|mesh-list
110445801|NCT02771782|BCG Vaccine|bcg vaccine|mesh-list
110445802|NCT02771782|Immunologic Factors|immunologic factors|mesh-ancestor
110445803|NCT02771782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110445804|NCT02771782|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110445806|NCT02771392|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110095675|NCT01715597|Vitamins|vitamins|mesh-ancestor
110445807|NCT02771392|Anesthetics, Local|anesthetics, local|mesh-ancestor
110445808|NCT02771392|Anesthetics|anesthetics|mesh-ancestor
110445809|NCT02771392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110445810|NCT02771392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110445811|NCT02771392|Sensory System Agents|sensory system agents|mesh-ancestor
110096101|NCT01718327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110445812|NCT02771392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110445814|NCT02771704|Chlorhexidine|chlorhexidine|mesh-list
110445815|NCT02771704|Fluorides|fluorides|mesh-list
110445816|NCT02771704|Cariostatic Agents|cariostatic agents|mesh-ancestor
110096404|NCT01719835|Antiemetics|antiemetics|mesh-ancestor
110096475|NCT01720719|Vitamins|vitamins|mesh-ancestor
110445817|NCT02771704|Protective Agents|protective agents|mesh-ancestor
110445818|NCT02771704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110445819|NCT02771704|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110445820|NCT02771704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110445821|NCT02771704|Disinfectants|disinfectants|mesh-ancestor
110445822|NCT02771704|Trace Elements|trace elements|mesh-ancestor
110445825|NCT02771314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110096777|NCT01731132|Copper|copper|mesh-list
110445826|NCT02771314|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110445827|NCT02771314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110445828|NCT02771314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110445829|NCT02771158|Midodrine|midodrine|mesh-list
110445830|NCT02771158|Sympathomimetics|sympathomimetics|mesh-ancestor
110096995|NCT01732328|Micronutrients|micronutrients|mesh-ancestor
110445832|NCT02771158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110445833|NCT02771158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110445834|NCT02771158|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110445835|NCT02771158|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110097373|NCT01735318|Lisinopril|lisinopril|mesh-list
110445836|NCT02771158|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110445837|NCT02771158|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110445838|NCT02771158|Adrenergic Agents|adrenergic agents|mesh-ancestor
110445839|NCT02771158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110445840|NCT02771158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110445841|NCT02770690|Lidocaine|lidocaine|mesh-list
110445842|NCT02770690|Ethyl Chloride|ethyl chloride|mesh-list
110445843|NCT02770690|Anesthetics, Local|anesthetics, local|mesh-ancestor
110445844|NCT02770690|Anesthetics|anesthetics|mesh-ancestor
110445845|NCT02770690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110445846|NCT02770690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110445847|NCT02770690|Sensory System Agents|sensory system agents|mesh-ancestor
110445848|NCT02770690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110445849|NCT02770690|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110445850|NCT02770690|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110098022|NCT01739673|Riboflavin|riboflavin|mesh-list
110445851|NCT02770690|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110445852|NCT02770690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110445853|NCT02770690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110445855|NCT02770378|Itraconazole|itraconazole|mesh-list
110445856|NCT02770378|Minocycline|minocycline|mesh-list
110445857|NCT02770378|Celecoxib|celecoxib|mesh-list
110445858|NCT02770378|Temozolomide|temozolomide|mesh-list
110445859|NCT02770378|Auranofin|auranofin|mesh-list
110445860|NCT02770378|Captopril|captopril|mesh-list
110445861|NCT02770378|Disulfiram|disulfiram|mesh-list
110445862|NCT02770378|Aprepitant|aprepitant|mesh-list
110445864|NCT02770378|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110445865|NCT02770378|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110445866|NCT02770378|Protease Inhibitors|protease inhibitors|mesh-ancestor
110445867|NCT02770378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110445868|NCT02770378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110445869|NCT02770378|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110445871|NCT02770378|Antiviral Agents|antiviral agents|mesh-ancestor
110445872|NCT02770378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110098529|NCT01742988|Venetoclax|venetoclax|mesh-list
110571348|NCT00851630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110571349|NCT00851630|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110571350|NCT00851630|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110571351|NCT00851630|Antimetabolites|antimetabolites|mesh-ancestor
110571352|NCT05298761|Lidocaine|lidocaine|mesh-list
110571353|NCT05298761|Nalbuphine|nalbuphine|mesh-list
110571354|NCT05298761|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110571355|NCT05298761|Narcotics|narcotics|mesh-ancestor
110571356|NCT05298761|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110571357|NCT05298761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110571358|NCT05298761|Analgesics|analgesics|mesh-ancestor
110571359|NCT05298761|Sensory System Agents|sensory system agents|mesh-ancestor
110218856|NCT00281944|Leucovorin|leucovorin|mesh-list
110571360|NCT05298761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110571361|NCT05298761|Anesthetics, Local|anesthetics, local|mesh-ancestor
110571362|NCT05298761|Anesthetics|anesthetics|mesh-ancestor
110571363|NCT05298761|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110571364|NCT05298761|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110571365|NCT05298761|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110571366|NCT05298761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110571367|NCT05298761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110571368|NCT00459667|Interferons|interferons|mesh-list
110571369|NCT00459667|Interferon-beta|interferon-beta|mesh-list
110571370|NCT00459667|Interferon beta-1b|interferon beta-1b|mesh-list
110571371|NCT00459667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110571372|NCT00459667|Antiviral Agents|antiviral agents|mesh-ancestor
110571373|NCT00459667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110571374|NCT00459667|Immunologic Factors|immunologic factors|mesh-ancestor
110571375|NCT00459667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110571376|NCT00459667|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110571377|NCT02621255|Bupivacaine|bupivacaine|mesh-list
110571378|NCT02621255|Anesthetics|anesthetics|mesh-list
110571379|NCT02621255|Sevoflurane|sevoflurane|mesh-list
110571380|NCT02621255|Anesthetics, Local|anesthetics, local|mesh-ancestor
110571381|NCT02621255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110571382|NCT02621255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110571383|NCT02621255|Sensory System Agents|sensory system agents|mesh-ancestor
110571384|NCT02621255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110571385|NCT02621255|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110571386|NCT02621255|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110571387|NCT02621255|Anesthetics, General|anesthetics, general|mesh-ancestor
110571388|NCT00828204|Interferons|interferons|mesh-list
110571389|NCT00828204|Interferon-beta|interferon-beta|mesh-list
110571390|NCT00828204|Interferon beta-1a|interferon beta-1a|mesh-list
110571391|NCT00828204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110571392|NCT00828204|Antiviral Agents|antiviral agents|mesh-ancestor
110571393|NCT00828204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110571394|NCT00828204|Immunologic Factors|immunologic factors|mesh-ancestor
110571395|NCT00828204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110571396|NCT00828204|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110571398|NCT00696215|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
110571399|NCT00696215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110571400|NCT00696215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110571401|NCT00696215|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110571402|NCT00696215|Protective Agents|protective agents|mesh-ancestor
110571403|NCT00696215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110571404|NCT00784186|Misoprostol|misoprostol|mesh-list
110571405|NCT00784186|Mifepristone|mifepristone|mesh-list
110571406|NCT00784186|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110571407|NCT00784186|Abortifacient Agents|abortifacient agents|mesh-ancestor
110571408|NCT00784186|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110571409|NCT00784186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110571410|NCT00784186|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110571411|NCT00784186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110571412|NCT00784186|Oxytocics|oxytocics|mesh-ancestor
110571413|NCT00784186|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
110571414|NCT00784186|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110571415|NCT00784186|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110571416|NCT00784186|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110571417|NCT00784186|Contraceptive Agents|contraceptive agents|mesh-ancestor
110571418|NCT00784186|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
110571419|NCT00784186|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
110571420|NCT00784186|Hormone Antagonists|hormone antagonists|mesh-ancestor
110571421|NCT00784186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110571422|NCT00784186|Luteolytic Agents|luteolytic agents|mesh-ancestor
110571423|NCT00784186|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110571424|NCT00784186|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
110571426|NCT00851552|Doxorubicin|doxorubicin|mesh-list
110571427|NCT00851552|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110571428|NCT00851552|Bortezomib|bortezomib|mesh-list
110571429|NCT00851552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110571430|NCT00851552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110571431|NCT00851552|Immunologic Factors|immunologic factors|mesh-ancestor
110571432|NCT00851552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110571433|NCT00851552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110571434|NCT00851552|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110571435|NCT00851552|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110571436|NCT00851552|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110571437|NCT00851552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110571438|NCT00851552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110571439|NCT00785122|Cyclophosphamide|cyclophosphamide|mesh-list
110571440|NCT00785122|Molgramostim|molgramostim|mesh-list
110571441|NCT00785122|Imiquimod|imiquimod|mesh-list
110571442|NCT00785122|Sargramostim|sargramostim|mesh-list
110571443|NCT00785122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110571444|NCT00785122|Immunologic Factors|immunologic factors|mesh-ancestor
110571445|NCT00785122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110571446|NCT00785122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110571447|NCT00785122|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110571448|NCT00785122|Alkylating Agents|alkylating agents|mesh-ancestor
110571449|NCT00785122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110571450|NCT00785122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110373824|NCT00571142|GABA Agents|gaba agents|mesh-ancestor
110571451|NCT00785122|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110571452|NCT00785122|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110571453|NCT00785122|Interferon Inducers|interferon inducers|mesh-ancestor
110571454|NCT04116554|Bupivacaine|bupivacaine|mesh-list
110571455|NCT04116554|Anesthetics, Local|anesthetics, local|mesh-ancestor
110571456|NCT04116554|Anesthetics|anesthetics|mesh-ancestor
110571457|NCT04116554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110571458|NCT04116554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110571459|NCT04116554|Sensory System Agents|sensory system agents|mesh-ancestor
110571460|NCT04116554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110571461|NCT00700856|Pioglitazone|pioglitazone|mesh-list
110571462|NCT00700856|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110571463|NCT00700856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110571464|NCT00790114|Midazolam|midazolam|mesh-list
110571465|NCT00790114|Caffeine|caffeine|mesh-list
110571466|NCT00790114|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110571467|NCT00790114|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110571468|NCT00790114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110571469|NCT00790114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110571470|NCT00790114|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110571471|NCT00790114|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110571472|NCT00790114|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110571473|NCT00790114|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110571474|NCT00790114|Anesthetics, General|anesthetics, general|mesh-ancestor
110571475|NCT00790114|Anesthetics|anesthetics|mesh-ancestor
110571476|NCT00790114|GABA Modulators|gaba modulators|mesh-ancestor
110571477|NCT00790114|GABA Agents|gaba agents|mesh-ancestor
110571478|NCT00790114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110571479|NCT00790114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110571480|NCT00790114|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110571481|NCT00790114|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110571482|NCT00790114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110571483|NCT00790114|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110571484|NCT00790114|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110571485|NCT00790114|Purinergic Agents|purinergic agents|mesh-ancestor
110571486|NCT01023139|Sibutramine|sibutramine|mesh-list
110148399|NCT04201834|Serotonin Agents|serotonin agents|mesh-ancestor
110571488|NCT01023139|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110571489|NCT01023139|Appetite Depressants|appetite depressants|mesh-ancestor
110571490|NCT01023139|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110571491|NCT00459043|Docetaxel|docetaxel|mesh-list
110571492|NCT00459043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110571493|NCT00459043|Tubulin Modulators|tubulin modulators|mesh-ancestor
110571494|NCT00459043|Antimitotic Agents|antimitotic agents|mesh-ancestor
110571495|NCT00459043|Mitosis Modulators|mitosis modulators|mesh-ancestor
110571496|NCT00459043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110571497|NCT00795262|Thioctic Acid|thioctic acid|mesh-list
110571498|NCT00795262|Quinapril|quinapril|mesh-list
110571499|NCT00795262|Antioxidants|antioxidants|mesh-ancestor
110571500|NCT00795262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110571501|NCT00795262|Protective Agents|protective agents|mesh-ancestor
110571502|NCT00795262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110571503|NCT00795262|Vitamin B Complex|vitamin b complex|mesh-ancestor
110571504|NCT00795262|Vitamins|vitamins|mesh-ancestor
110571505|NCT00795262|Micronutrients|micronutrients|mesh-ancestor
110571506|NCT00795262|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110219008|NCT00282997|Pregabalin|pregabalin|mesh-list
110571507|NCT00795262|Protease Inhibitors|protease inhibitors|mesh-ancestor
110571508|NCT00795262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110571509|NCT00795262|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110571510|NCT00785200|Chlorhexidine|chlorhexidine|mesh-list
110571511|NCT00785200|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110571512|NCT00785200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110571513|NCT00785200|Disinfectants|disinfectants|mesh-ancestor
110571514|NCT00817206|Tacrolimus|tacrolimus|mesh-list
110571515|NCT00817206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110571516|NCT00817206|Immunologic Factors|immunologic factors|mesh-ancestor
110571517|NCT00817206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110571518|NCT00817206|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110571519|NCT00817206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110571520|NCT00817206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110571521|NCT02611518|Metformin|metformin|mesh-list
110571522|NCT02611518|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110571523|NCT02611518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110571524|NCT02611518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110571525|NCT02611518|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110571526|NCT02611518|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110571527|NCT02611518|Antimetabolites|antimetabolites|mesh-ancestor
110571528|NCT02611518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110571529|NCT02611518|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110571530|NCT02611518|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110571531|NCT02611518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110571532|NCT01023607|Atorvastatin|atorvastatin|mesh-list
110571533|NCT01023607|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110571534|NCT01023607|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110571535|NCT01023607|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110571536|NCT01023607|Antimetabolites|antimetabolites|mesh-ancestor
110571537|NCT01023607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110571538|NCT01023607|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110571539|NCT01023607|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110571540|NCT01023607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110571541|NCT00665002|Sargramostim|sargramostim|mesh-list
110571542|NCT00665002|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
110571543|NCT00665002|Immunologic Factors|immunologic factors|mesh-ancestor
110571544|NCT00665002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110571545|NCT00665002|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110571546|NCT00660010|Leuprolide|leuprolide|mesh-list
110571547|NCT00660010|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110571548|NCT00660010|Fertility Agents|fertility agents|mesh-ancestor
110571549|NCT00660010|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110571550|NCT00660010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110571551|NCT00660010|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110571552|NCT00660010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110571553|NCT04015908|Acetaminophen|acetaminophen|mesh-list
110571554|NCT04015908|Celecoxib|celecoxib|mesh-list
110571555|NCT04015908|Pregabalin|pregabalin|mesh-list
110571556|NCT04015908|Oxycodone|oxycodone|mesh-list
110571557|NCT04015908|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110571558|NCT04015908|Analgesics|analgesics|mesh-ancestor
110571559|NCT04015908|Sensory System Agents|sensory system agents|mesh-ancestor
110571560|NCT04015908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110571561|NCT04015908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110571562|NCT04015908|Antipyretics|antipyretics|mesh-ancestor
110571563|NCT04015908|Anticonvulsants|anticonvulsants|mesh-ancestor
110571564|NCT04015908|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110571565|NCT04015908|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110571566|NCT04015908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110571567|NCT04015908|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110571568|NCT04015908|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110571569|NCT04015908|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110571570|NCT04015908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110571571|NCT04015908|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110571572|NCT04015908|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110571573|NCT04015908|Narcotics|narcotics|mesh-ancestor
110571574|NCT04015908|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110571575|NCT04015908|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110571576|NCT04015908|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110571577|NCT04015908|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110571578|NCT04015908|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110571579|NCT04015908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110571580|NCT00790816|Lapatinib|lapatinib|mesh-list
110571581|NCT00790816|Antineoplastic Agents|antineoplastic agents|mesh-list
110571582|NCT00790816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110571583|NCT00790816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110571584|NCT00790816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110571585|NCT00873041|Deferasirox|deferasirox|mesh-list
110571586|NCT00873041|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110571587|NCT00873041|Chelating Agents|chelating agents|mesh-ancestor
110571588|NCT00873041|Sequestering Agents|sequestering agents|mesh-ancestor
110571589|NCT00873041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110571590|NCT00795496|Histamine|histamine|mesh-list
110571591|NCT00795496|Histamine Agonists|histamine agonists|mesh-ancestor
110571592|NCT00795496|Histamine Agents|histamine agents|mesh-ancestor
110571593|NCT00795496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110571594|NCT00795496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110571595|NCT00795496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110571596|NCT00795574|Infliximab|infliximab|mesh-list
110571597|NCT00795574|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110571598|NCT00795574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110571599|NCT00795574|Dermatologic Agents|dermatologic agents|mesh-ancestor
110571600|NCT00795574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110571601|NCT00795574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110571602|NCT00785434|Escitalopram|escitalopram|mesh-list
110571603|NCT00785434|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110571604|NCT00785434|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110571605|NCT00785434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110571606|NCT00785434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110571607|NCT00785434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110571608|NCT00785434|Serotonin Agents|serotonin agents|mesh-ancestor
110571609|NCT00785434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110571610|NCT00790894|Epothilones|epothilones|mesh-list
110571611|NCT00790894|Tubulin Modulators|tubulin modulators|mesh-ancestor
110571612|NCT00790894|Antimitotic Agents|antimitotic agents|mesh-ancestor
110571613|NCT00790894|Mitosis Modulators|mitosis modulators|mesh-ancestor
110571614|NCT00790894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110571615|NCT00790894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110571616|NCT02623127|Sunitinib|sunitinib|mesh-list
110571617|NCT02623127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110571618|NCT02623127|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110571619|NCT02623127|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110571620|NCT02623127|Growth Substances|growth substances|mesh-ancestor
110571621|NCT02623127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110571622|NCT02623127|Growth Inhibitors|growth inhibitors|mesh-ancestor
110571623|NCT02623127|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110571624|NCT02623127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110571625|NCT02623127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110571626|NCT05263492|Pembrolizumab|pembrolizumab|mesh-list
110571627|NCT05263492|Lenvatinib|lenvatinib|mesh-list
110571628|NCT05263492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110571629|NCT05263492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110571630|NCT05263492|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110571631|NCT05263492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110571632|NCT05263492|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110571633|NCT05263492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110571634|NCT04134611|Hyaluronic Acid|hyaluronic acid|mesh-list
110571635|NCT04134611|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110571636|NCT04134611|Immunologic Factors|immunologic factors|mesh-ancestor
110571637|NCT04134611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110571638|NCT04134611|Viscosupplements|viscosupplements|mesh-ancestor
110571639|NCT04134611|Protective Agents|protective agents|mesh-ancestor
110571640|NCT02620631|Morphine|morphine|mesh-list
110571641|NCT02620631|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110571642|NCT02620631|Narcotics|narcotics|mesh-ancestor
110571643|NCT02620631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110571644|NCT02620631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110571645|NCT02620631|Analgesics|analgesics|mesh-ancestor
110571646|NCT02620631|Sensory System Agents|sensory system agents|mesh-ancestor
110571647|NCT02620631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110571648|NCT04030572|Clonidine|clonidine|mesh-list
110571649|NCT04030572|Analgesics|analgesics|mesh-ancestor
110571650|NCT04030572|Sensory System Agents|sensory system agents|mesh-ancestor
110571651|NCT04030572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110571652|NCT04030572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110571653|NCT04030572|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110571654|NCT04030572|Sympatholytics|sympatholytics|mesh-ancestor
110571655|NCT04030572|Autonomic Agents|autonomic agents|mesh-ancestor
110571656|NCT04030572|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110571657|NCT04030572|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110571658|NCT04030572|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110571659|NCT04030572|Adrenergic Agents|adrenergic agents|mesh-ancestor
110219158|NCT04718701|Paclitaxel|paclitaxel|mesh-list
110571661|NCT04030572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110571662|NCT00795808|Metformin|metformin|mesh-list
110571663|NCT00795808|Clomiphene|clomiphene|mesh-list
110571664|NCT00795808|Enclomiphene|enclomiphene|mesh-list
110571665|NCT00795808|Zuclomiphene|zuclomiphene|mesh-list
110571666|NCT00795808|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110571667|NCT00795808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110571668|NCT00795808|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110571669|NCT00795808|Hormone Antagonists|hormone antagonists|mesh-ancestor
110571670|NCT00795808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110571671|NCT00795808|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110571672|NCT00795808|Fertility Agents|fertility agents|mesh-ancestor
110571673|NCT00795808|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110571674|NCT00795808|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110571675|NCT00795808|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110571676|NCT04135781|Paclitaxel|paclitaxel|mesh-list
110571677|NCT04135781|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110571678|NCT04135781|Capecitabine|capecitabine|mesh-list
110571679|NCT04135781|Oxaliplatin|oxaliplatin|mesh-list
110571680|NCT04135781|Tegafur|tegafur|mesh-list
110571681|NCT04135781|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110571682|NCT04135781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110571683|NCT04135781|Tubulin Modulators|tubulin modulators|mesh-ancestor
110571684|NCT04135781|Antimitotic Agents|antimitotic agents|mesh-ancestor
110571685|NCT04135781|Mitosis Modulators|mitosis modulators|mesh-ancestor
110571686|NCT04135781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110571687|NCT04135781|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110571688|NCT04135781|Antimetabolites|antimetabolites|mesh-ancestor
110571689|NCT04135313|Capecitabine|capecitabine|mesh-list
110571690|NCT04135313|Oxaliplatin|oxaliplatin|mesh-list
110571691|NCT04135313|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110571692|NCT04135313|Antimetabolites|antimetabolites|mesh-ancestor
110571693|NCT04135313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110571694|NCT04135313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110571695|NCT00692159|Pemetrexed|pemetrexed|mesh-list
110571696|NCT00692159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110571697|NCT00692159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110571698|NCT00692159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110571699|NCT00692159|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110148414|NCT04192435|Coagulants|coagulants|mesh-ancestor
110571700|NCT00692159|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110571701|NCT00692315|Vitamin B 12|vitamin b 12|mesh-list
110571702|NCT00692315|Vitamins|vitamins|mesh-ancestor
110571703|NCT00692315|Micronutrients|micronutrients|mesh-ancestor
110571704|NCT00692315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110571705|NCT00692315|Vitamin B Complex|vitamin b complex|mesh-ancestor
110571706|NCT02623049|Anticoagulants|anticoagulants|mesh-list
110571707|NCT02608944|Adenosine|adenosine|mesh-list
110571708|NCT02608944|Regadenoson|regadenoson|mesh-list
110571709|NCT02608944|Analgesics|analgesics|mesh-ancestor
110571710|NCT02608944|Sensory System Agents|sensory system agents|mesh-ancestor
110571711|NCT02608944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110571712|NCT02608944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110571713|NCT02608944|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110571714|NCT02608944|Vasodilator Agents|vasodilator agents|mesh-ancestor
110571715|NCT02608944|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
110571716|NCT02608944|Purinergic Agonists|purinergic agonists|mesh-ancestor
110571717|NCT02608944|Purinergic Agents|purinergic agents|mesh-ancestor
110571718|NCT02608944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110571719|NCT02608944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110571720|NCT02608944|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
110571721|NCT00913614|SR 46349B|sr 46349b|mesh-list
110571722|NCT00913614|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110571723|NCT00913614|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110571724|NCT00913614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110571725|NCT00913614|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110571726|NCT00913614|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110571727|NCT00913614|Serotonin Agents|serotonin agents|mesh-ancestor
110571728|NCT00913614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110571729|NCT00913614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110571730|NCT00664534|Insulin|insulin|mesh-list
110571731|NCT00664534|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110571732|NCT00664534|Insulin Glargine|insulin glargine|mesh-list
110219225|NCT00284947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110571733|NCT00664534|Insulin Lispro|insulin lispro|mesh-list
110571734|NCT00664534|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110571735|NCT00664534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110571736|NCT00913848|Valproic Acid|valproic acid|mesh-list
110571737|NCT00913848|Anticonvulsants|anticonvulsants|mesh-ancestor
110571738|NCT00913848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110571739|NCT00913848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110571740|NCT00913848|GABA Agents|gaba agents|mesh-ancestor
110571741|NCT00913848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110571742|NCT00913848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110571743|NCT00913848|Antimanic Agents|antimanic agents|mesh-ancestor
110571744|NCT00913848|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110571745|NCT00913848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110571746|NCT00913848|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110571748|NCT02620163|Telmisartan|telmisartan|mesh-list
110571749|NCT02620163|Chlorthalidone|chlorthalidone|mesh-list
110571750|NCT02620163|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
110571751|NCT02620163|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110571752|NCT02620163|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110571753|NCT02620163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110571754|NCT02620163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110571755|NCT02620163|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110571756|NCT02620163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110571757|NCT02620163|Vasodilator Agents|vasodilator agents|mesh-ancestor
110571758|NCT02620163|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110373875|NCT00584610|Copper|copper|mesh-list
110571759|NCT02620163|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110571760|NCT02620163|Diuretics|diuretics|mesh-ancestor
110571761|NCT02620163|Natriuretic Agents|natriuretic agents|mesh-ancestor
110571762|NCT02620163|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110571763|NCT05758116|Tislelizumab|tislelizumab|mesh-list
110571764|NCT05758116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110571765|NCT05758116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110571766|NCT00912821|Dialysis Solutions|dialysis solutions|mesh-list
110571767|NCT00912821|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110571768|NCT00570310|Pregabalin|pregabalin|mesh-list
110571769|NCT00570310|Analgesics|analgesics|mesh-ancestor
110571770|NCT00570310|Sensory System Agents|sensory system agents|mesh-ancestor
110571771|NCT00570310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110571772|NCT00570310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110571773|NCT00570310|Anticonvulsants|anticonvulsants|mesh-ancestor
110571774|NCT00570310|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110571775|NCT00570310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110571776|NCT00570310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110571777|NCT00570310|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110571778|NCT00570310|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110571779|NCT00570310|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110571780|NCT00570310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110571781|NCT00570310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110571782|NCT00696995|Insulin Aspart|insulin aspart|mesh-list
110571783|NCT00696995|Biphasic Insulins|biphasic insulins|mesh-list
110571784|NCT00696995|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
110571785|NCT00696995|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110571786|NCT00696995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110571787|NCT00664066|Epoetin Alfa|epoetin alfa|mesh-list
110571788|NCT00664066|Hematinics|hematinics|mesh-ancestor
110571789|NCT04676958|Vitamin K|vitamin k|mesh-list
110571790|NCT04676958|Vitamin K 2|vitamin k 2|mesh-list
110571791|NCT04676958|Vitamins|vitamins|mesh-ancestor
110571792|NCT04676958|Micronutrients|micronutrients|mesh-ancestor
110571793|NCT04676958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110571794|NCT04676958|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110571795|NCT04676958|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110571796|NCT04676958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110571797|NCT04676958|Hemostatics|hemostatics|mesh-ancestor
110571798|NCT04676958|Coagulants|coagulants|mesh-ancestor
110571799|NCT02619929|Vinorelbine|vinorelbine|mesh-list
110571800|NCT02619929|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110571801|NCT02619929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110571802|NCT02619929|Tubulin Modulators|tubulin modulators|mesh-ancestor
110571803|NCT02619929|Antimitotic Agents|antimitotic agents|mesh-ancestor
110571804|NCT02619929|Mitosis Modulators|mitosis modulators|mesh-ancestor
110571805|NCT02619929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110571806|NCT00796198|Latanoprost|latanoprost|mesh-list
110571807|NCT00796198|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110571808|NCT00796198|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110571809|NCT02622503|Rituximab|rituximab|mesh-list
110571810|NCT02622503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110571811|NCT02622503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110571812|NCT02622503|Immunologic Factors|immunologic factors|mesh-ancestor
110571813|NCT02622503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110571814|NCT02622503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110571815|NCT00814710|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110571816|NCT00814710|Immunologic Factors|immunologic factors|mesh-ancestor
110571817|NCT00814710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110571818|NCT00796276|Paliperidone Palmitate|paliperidone palmitate|mesh-list
110571819|NCT00796276|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110571820|NCT00796276|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110571821|NCT00796276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110571822|NCT00796276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110571823|NCT00796276|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110571824|NCT00796276|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110571825|NCT00796276|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110571826|NCT00796276|Serotonin Agents|serotonin agents|mesh-ancestor
110373896|NCT00571298|Antidotes|antidotes|mesh-ancestor
110571828|NCT00796276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110571829|NCT00796276|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110571830|NCT00796276|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110571831|NCT00796276|Dopamine Agents|dopamine agents|mesh-ancestor
110571832|NCT00796432|Paliperidone Palmitate|paliperidone palmitate|mesh-list
110571833|NCT00796432|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110571834|NCT00796432|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110148424|NCT00423397|Interferon alpha-2|interferon alpha-2|mesh-list
110571835|NCT00796432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110571836|NCT00796432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110571837|NCT00796432|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110571838|NCT00796432|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110571839|NCT00796432|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110571840|NCT00796432|Serotonin Agents|serotonin agents|mesh-ancestor
110571841|NCT00796432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110571842|NCT00796432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110571843|NCT00796432|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110571844|NCT00796432|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110571845|NCT00796432|Dopamine Agents|dopamine agents|mesh-ancestor
110571846|NCT00786058|Fluorouracil|fluorouracil|mesh-list
110571847|NCT00786058|Antimetabolites|antimetabolites|mesh-ancestor
110571848|NCT00786058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110571849|NCT00786058|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110571850|NCT00786058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110571851|NCT00786058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110571852|NCT00786058|Immunologic Factors|immunologic factors|mesh-ancestor
110571853|NCT00786058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110571854|NCT00871169|Oxaliplatin|oxaliplatin|mesh-list
110571855|NCT00871169|Irinotecan|irinotecan|mesh-list
110571856|NCT00871169|Cetuximab|cetuximab|mesh-list
110571857|NCT00871169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110571858|NCT00871169|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110571859|NCT00871169|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110571860|NCT00871169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110094936|NCT01711749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110571861|NCT00871169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110571862|NCT00871169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110571863|NCT00791284|Paliperidone Palmitate|paliperidone palmitate|mesh-list
110571864|NCT00791284|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110571865|NCT00791284|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110571866|NCT00791284|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110571867|NCT00791284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110571868|NCT00791284|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110571869|NCT00791284|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110571870|NCT00791284|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110571871|NCT00791284|Serotonin Agents|serotonin agents|mesh-ancestor
110571872|NCT00791284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110571873|NCT00791284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110571874|NCT00791284|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110571875|NCT00791284|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110571876|NCT00791284|Dopamine Agents|dopamine agents|mesh-ancestor
110571877|NCT00814632|Apremilast|apremilast|mesh-list
110571878|NCT00814632|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110571879|NCT00814632|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110571880|NCT00814632|Analgesics|analgesics|mesh-ancestor
110571881|NCT00814632|Sensory System Agents|sensory system agents|mesh-ancestor
110571882|NCT00814632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110571883|NCT00814632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110571884|NCT00814632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110571885|NCT00814632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110571886|NCT00814632|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
110571887|NCT00814632|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110571888|NCT00814632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110571889|NCT00814632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110571890|NCT00786136|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110571891|NCT00786136|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110571892|NCT00786136|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110571893|NCT00786136|Antimetabolites|antimetabolites|mesh-ancestor
110571894|NCT00786136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110571895|NCT00786136|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110571896|NCT00786136|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110571897|NCT00786136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110571899|NCT02554942|Hematinics|hematinics|mesh-ancestor
110571900|NCT02619773|Mupirocin|mupirocin|mesh-list
110571901|NCT02619773|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110571902|NCT02619773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110571903|NCT02619773|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110571904|NCT02619773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110571905|NCT02619773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110571907|NCT02555488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110571908|NCT02555488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110571909|NCT02554864|Lidocaine|lidocaine|mesh-list
110571910|NCT02554864|Ropivacaine|ropivacaine|mesh-list
110571911|NCT02554864|Anesthetics, Local|anesthetics, local|mesh-ancestor
110571912|NCT02554864|Anesthetics|anesthetics|mesh-ancestor
110571913|NCT02554864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110571914|NCT02554864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110571915|NCT02554864|Sensory System Agents|sensory system agents|mesh-ancestor
110571916|NCT02554864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110571917|NCT02554864|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110571918|NCT02554864|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110571919|NCT02554864|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110571920|NCT02554864|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110571921|NCT02554864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110571922|NCT00851318|Certolizumab Pegol|certolizumab pegol|mesh-list
110571923|NCT00851318|Methotrexate|methotrexate|mesh-list
110571924|NCT00851318|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110571925|NCT00851318|Abortifacient Agents|abortifacient agents|mesh-ancestor
110571926|NCT00851318|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110571927|NCT00851318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110571928|NCT00851318|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110571929|NCT00851318|Antimetabolites|antimetabolites|mesh-ancestor
110571930|NCT00851318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110571931|NCT00851318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110571932|NCT00851318|Dermatologic Agents|dermatologic agents|mesh-ancestor
110571933|NCT00851318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110571934|NCT00851318|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110571935|NCT00851318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110571936|NCT00851318|Immunologic Factors|immunologic factors|mesh-ancestor
110571937|NCT00851318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110571938|NCT00851318|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110571939|NCT00851318|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110571940|NCT00851318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110571941|NCT00786370|Dexmedetomidine|dexmedetomidine|mesh-list
110571942|NCT00786370|Propofol|propofol|mesh-list
110571943|NCT00786370|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110571944|NCT00786370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110571945|NCT00786370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110571946|NCT00786370|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110571947|NCT00786370|Analgesics|analgesics|mesh-ancestor
110571948|NCT00786370|Sensory System Agents|sensory system agents|mesh-ancestor
110571949|NCT00786370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110571950|NCT00786370|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110571951|NCT00786370|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110571952|NCT00786370|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110571953|NCT00786370|Adrenergic Agents|adrenergic agents|mesh-ancestor
110571954|NCT00786370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110571955|NCT00786370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110571957|NCT00786370|Anesthetics, General|anesthetics, general|mesh-ancestor
110571958|NCT00786370|Anesthetics|anesthetics|mesh-ancestor
110571959|NCT00796900|Dantrolene|dantrolene|mesh-list
110571960|NCT00796900|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110571961|NCT00796900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110571962|NCT00796900|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110571963|NCT00796900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110571965|NCT00791830|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110571966|NCT00791830|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110571967|NCT00791830|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110571968|NCT00791830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110571969|NCT00786448|Darifenacin|darifenacin|mesh-list
110571970|NCT00786448|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110571971|NCT00786448|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110571972|NCT00786448|Cholinergic Agents|cholinergic agents|mesh-ancestor
110571973|NCT00786448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110571974|NCT00786448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110571975|NCT00786448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110571976|NCT00786448|Urological Agents|urological agents|mesh-ancestor
110571977|NCT04137653|Paclitaxel|paclitaxel|mesh-list
110571978|NCT04137653|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110571979|NCT04137653|Carboplatin|carboplatin|mesh-list
110571980|NCT04137653|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110571981|NCT04137653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110571982|NCT04137653|Tubulin Modulators|tubulin modulators|mesh-ancestor
110571983|NCT04137653|Antimitotic Agents|antimitotic agents|mesh-ancestor
110571984|NCT04137653|Mitosis Modulators|mitosis modulators|mesh-ancestor
110571985|NCT04137653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110571986|NCT00797056|Aspirin|aspirin|mesh-list
110571987|NCT00797056|Clopidogrel|clopidogrel|mesh-list
110571988|NCT00797056|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110571989|NCT00797056|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110571990|NCT00797056|Analgesics|analgesics|mesh-ancestor
110571991|NCT00797056|Sensory System Agents|sensory system agents|mesh-ancestor
110571992|NCT00797056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110571993|NCT00797056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110571994|NCT00797056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110571995|NCT00797056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110571996|NCT00797056|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110571997|NCT00797056|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110571998|NCT00797056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110571999|NCT00797056|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110572000|NCT00797056|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110572001|NCT00797056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110572002|NCT00797056|Antipyretics|antipyretics|mesh-ancestor
110572003|NCT00797056|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110572004|NCT00797056|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110572005|NCT00797056|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110572006|NCT00797056|Purinergic Agents|purinergic agents|mesh-ancestor
110572007|NCT00797056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110572008|NCT00593957|Dextromethorphan|dextromethorphan|mesh-list
110572009|NCT00593957|Antitussive Agents|antitussive agents|mesh-ancestor
110572010|NCT00593957|Respiratory System Agents|respiratory system agents|mesh-ancestor
110572011|NCT00593957|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110572012|NCT00593957|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110572013|NCT00593957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110572014|NCT00593957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110572015|NCT00593957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110572016|NCT00697151|Aspirin|aspirin|mesh-list
110572017|NCT00697151|Warfarin|warfarin|mesh-list
110572018|NCT00697151|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110572019|NCT00697151|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110572020|NCT00697151|Analgesics|analgesics|mesh-ancestor
110572021|NCT00697151|Sensory System Agents|sensory system agents|mesh-ancestor
110572022|NCT00697151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110572023|NCT00697151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110572024|NCT00697151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110572025|NCT00697151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110572026|NCT00697151|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110572027|NCT00697151|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110219519|NCT00077714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110572028|NCT00697151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110572029|NCT00697151|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110572030|NCT00697151|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110572031|NCT00697151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110572032|NCT00697151|Antipyretics|antipyretics|mesh-ancestor
110572033|NCT00697151|Anticoagulants|anticoagulants|mesh-ancestor
110572034|NCT02621957|Pravastatin|pravastatin|mesh-list
110572035|NCT02621957|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110572036|NCT02621957|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110572037|NCT02621957|Antimetabolites|antimetabolites|mesh-ancestor
110572038|NCT02621957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110572039|NCT02621957|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110572040|NCT02621957|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110572041|NCT02621957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110572043|NCT00851084|Folic Acid|folic acid|mesh-list
110572044|NCT00851084|Oxaliplatin|oxaliplatin|mesh-list
110572045|NCT00851084|Aflibercept|aflibercept|mesh-list
110572046|NCT00851084|Levoleucovorin|levoleucovorin|mesh-list
110572047|NCT00851084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110572048|NCT00851084|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110572049|NCT00851084|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110572050|NCT00851084|Growth Substances|growth substances|mesh-ancestor
110572051|NCT00851084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110572052|NCT00851084|Growth Inhibitors|growth inhibitors|mesh-ancestor
110572053|NCT00851084|Antidotes|antidotes|mesh-ancestor
110572054|NCT00851084|Protective Agents|protective agents|mesh-ancestor
110572055|NCT00851084|Vitamin B Complex|vitamin b complex|mesh-ancestor
110572056|NCT00851084|Vitamins|vitamins|mesh-ancestor
110572057|NCT00851084|Micronutrients|micronutrients|mesh-ancestor
110572058|NCT00851084|Hematinics|hematinics|mesh-ancestor
110572059|NCT02617199|Fentanyl|fentanyl|mesh-list
110572060|NCT02617199|Analgesics|analgesics|mesh-list
110572061|NCT02617199|Ropivacaine|ropivacaine|mesh-list
110572062|NCT02617199|Anesthetics|anesthetics|mesh-ancestor
110572063|NCT02617199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110572064|NCT02617199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110572065|NCT02617199|Anesthetics, Local|anesthetics, local|mesh-ancestor
110572066|NCT02617199|Sensory System Agents|sensory system agents|mesh-ancestor
110572067|NCT02617199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110572068|NCT02617199|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110572069|NCT02617199|Narcotics|narcotics|mesh-ancestor
110572070|NCT02617199|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110572071|NCT02617199|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110572072|NCT02617199|Anesthetics, General|anesthetics, general|mesh-ancestor
110572073|NCT00845858|Metoclopramide|metoclopramide|mesh-list
110572074|NCT00845858|Antiemetics|antiemetics|mesh-ancestor
110572075|NCT00845858|Autonomic Agents|autonomic agents|mesh-ancestor
110572076|NCT00845858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110572077|NCT00845858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110572078|NCT00845858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110572079|NCT00845858|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110572080|NCT00845858|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110572081|NCT00845858|Dopamine Agents|dopamine agents|mesh-ancestor
110572082|NCT00845858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110572083|NCT00845858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110572084|NCT02619149|Tazobactam|tazobactam|mesh-list
110572085|NCT02619149|Piperacillin|piperacillin|mesh-list
110572086|NCT02619149|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
110572087|NCT02619149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110572088|NCT02619149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110572089|NCT02619149|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110572090|NCT02619149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110572091|NCT02619149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110572093|NCT04134065|Vitamins|vitamins|mesh-ancestor
110572094|NCT04134065|Micronutrients|micronutrients|mesh-ancestor
110572095|NCT04134065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110572096|NCT04134065|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110572098|NCT02616731|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110572099|NCT02616731|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110572100|NCT02616731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110572101|NCT02616731|Hemostatics|hemostatics|mesh-ancestor
110219599|NCT00287170|Vitamins|vitamins|mesh-ancestor
110572102|NCT02616731|Coagulants|coagulants|mesh-ancestor
110572103|NCT00850460|Atorvastatin|atorvastatin|mesh-list
110572104|NCT00850460|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110572105|NCT00850460|Simvastatin|simvastatin|mesh-list
110572106|NCT00850460|Pravastatin|pravastatin|mesh-list
110572107|NCT00850460|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110572108|NCT00850460|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110572109|NCT00850460|Antimetabolites|antimetabolites|mesh-ancestor
110572110|NCT00850460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110572111|NCT00850460|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110572112|NCT00850460|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110572113|NCT00850460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110572115|NCT00661492|Mitoxantrone|mitoxantrone|mesh-list
110572116|NCT00661492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110572117|NCT00661492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110572118|NCT00661492|Analgesics|analgesics|mesh-ancestor
110572119|NCT00661492|Sensory System Agents|sensory system agents|mesh-ancestor
110572120|NCT00661492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110572121|NCT00661492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110572122|NCT00661492|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110572123|NCT00661492|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110572124|NCT00661492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110572125|NCT00661492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110572126|NCT00693251|Sirolimus|sirolimus|mesh-list
110572127|NCT00693251|Paclitaxel|paclitaxel|mesh-list
110572128|NCT00693251|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110572129|NCT00693251|Everolimus|everolimus|mesh-list
110572130|NCT00693251|Temsirolimus|temsirolimus|mesh-list
110572131|NCT00693251|MTOR Inhibitors|mtor inhibitors|mesh-list
110572132|NCT00693251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110572133|NCT00693251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110572134|NCT00693251|Tubulin Modulators|tubulin modulators|mesh-ancestor
110572135|NCT00693251|Antimitotic Agents|antimitotic agents|mesh-ancestor
110572136|NCT00693251|Mitosis Modulators|mitosis modulators|mesh-ancestor
110572137|NCT00693251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110572138|NCT00693251|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110572139|NCT00693251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110572140|NCT00693251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110572141|NCT00693251|Immunologic Factors|immunologic factors|mesh-ancestor
110572142|NCT00693251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110572143|NCT00693251|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110572144|NCT00693251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110572145|NCT00693251|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110572146|NCT00693251|Antifungal Agents|antifungal agents|mesh-ancestor
110572147|NCT00792376|Diclofenac|diclofenac|mesh-list
110572148|NCT00792376|Etoricoxib|etoricoxib|mesh-list
110572149|NCT00792376|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110572150|NCT00792376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110572151|NCT00792376|Analgesics|analgesics|mesh-ancestor
110572152|NCT00792376|Sensory System Agents|sensory system agents|mesh-ancestor
110572153|NCT00792376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110572154|NCT00792376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110572155|NCT00792376|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110572156|NCT00792376|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110572157|NCT00792376|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110572158|NCT00792376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110572159|NCT00792376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110572160|NCT00792376|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110572161|NCT00592358|Paliperidone Palmitate|paliperidone palmitate|mesh-list
110572162|NCT00592358|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110572163|NCT00592358|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110572164|NCT00592358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110572165|NCT00592358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110572166|NCT00592358|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110572167|NCT00592358|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110572168|NCT00592358|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110572169|NCT00592358|Serotonin Agents|serotonin agents|mesh-ancestor
110572170|NCT00592358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110572171|NCT00592358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110572172|NCT00592358|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110572173|NCT00592358|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110572174|NCT00592358|Dopamine Agents|dopamine agents|mesh-ancestor
110572175|NCT00814320|Immunoglobulins|immunoglobulins|mesh-list
110572176|NCT00814320|Antibodies|antibodies|mesh-list
110572177|NCT00814320|gamma-Globulins|gamma-globulins|mesh-list
110572178|NCT00814320|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110572179|NCT00814320|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110219667|NCT00287326|Sympatholytics|sympatholytics|mesh-ancestor
110572180|NCT00814320|Immunoglobulin G|immunoglobulin g|mesh-list
110572181|NCT00814320|Immunologic Factors|immunologic factors|mesh-ancestor
110572182|NCT00814320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110572183|NCT00869999|Rituximab|rituximab|mesh-list
110572184|NCT00869999|Everolimus|everolimus|mesh-list
110572185|NCT00869999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110572186|NCT00869999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110572187|NCT00869999|Immunologic Factors|immunologic factors|mesh-ancestor
110572188|NCT00869999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110572189|NCT00869999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110572190|NCT00869999|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110572191|NCT00869999|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110572192|NCT00869999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110572193|NCT00869999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110572194|NCT00869999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110572195|NCT04030988|Dexamethasone|dexamethasone|mesh-list
110572196|NCT04030988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110572197|NCT04030988|Antiemetics|antiemetics|mesh-ancestor
110572198|NCT04030988|Autonomic Agents|autonomic agents|mesh-ancestor
110572199|NCT04030988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110572200|NCT04030988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110572201|NCT04030988|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110572202|NCT04030988|Glucocorticoids|glucocorticoids|mesh-ancestor
110572203|NCT04030988|Hormones|hormones|mesh-ancestor
110572204|NCT04030988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110572205|NCT04030988|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110572206|NCT04030988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110572207|NCT00703352|Eplerenone|eplerenone|mesh-list
110572208|NCT00703352|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110572209|NCT00703352|Hormone Antagonists|hormone antagonists|mesh-ancestor
110572210|NCT00703352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110572211|NCT00703352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110572212|NCT00703352|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110572213|NCT00703352|Diuretics|diuretics|mesh-ancestor
110572214|NCT00703352|Natriuretic Agents|natriuretic agents|mesh-ancestor
110572215|NCT00703352|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110572216|NCT00703430|Memantine|memantine|mesh-list
110572217|NCT00703430|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110572218|NCT00703430|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110572219|NCT00703430|Dopamine Agents|dopamine agents|mesh-ancestor
110572220|NCT00703430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110572221|NCT00703430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110572222|NCT00703430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110572223|NCT00703430|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110572224|NCT00703430|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110572225|NCT00797836|Interferons|interferons|mesh-list
110572226|NCT00797836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110572227|NCT00797836|Antiviral Agents|antiviral agents|mesh-ancestor
110572228|NCT00797836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110572229|NCT00693407|Capsaicin|capsaicin|mesh-list
110572230|NCT00693407|Antipruritics|antipruritics|mesh-ancestor
110572231|NCT00693407|Dermatologic Agents|dermatologic agents|mesh-ancestor
110572232|NCT00693407|Sensory System Agents|sensory system agents|mesh-ancestor
110572233|NCT00693407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110572234|NCT00693407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110572235|NCT02618603|Triamcinolone|triamcinolone|mesh-list
110572236|NCT02618603|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110572237|NCT02618603|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110572238|NCT02618603|Botulinum Toxins|botulinum toxins|mesh-list
110572239|NCT02618603|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110572240|NCT02618603|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110572241|NCT02618603|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110572242|NCT02618603|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110572243|NCT02618603|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110572244|NCT02618603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110572245|NCT02618603|Cholinergic Agents|cholinergic agents|mesh-ancestor
110572246|NCT02618603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110572247|NCT02618603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110572248|NCT02618603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110572249|NCT02618603|Glucocorticoids|glucocorticoids|mesh-ancestor
110572250|NCT02618603|Hormones|hormones|mesh-ancestor
110572251|NCT02618603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110572252|NCT02618603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110572253|NCT02618603|Immunologic Factors|immunologic factors|mesh-ancestor
110572254|NCT02618603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110572255|NCT02618603|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110572256|NCT02618603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110572257|NCT02616497|Aspirin|aspirin|mesh-list
110572258|NCT02616497|Triflusal|triflusal|mesh-list
110572259|NCT02616497|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110572260|NCT02616497|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110572262|NCT02616497|Sensory System Agents|sensory system agents|mesh-ancestor
110572263|NCT02616497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110572264|NCT02616497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110572265|NCT02616497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110572266|NCT02616497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110572267|NCT02616497|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110572268|NCT02616497|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110572269|NCT02616497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110572270|NCT02616497|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110572271|NCT02616497|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110572272|NCT02616497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110572273|NCT02616497|Antipyretics|antipyretics|mesh-ancestor
110572274|NCT00570232|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110572275|NCT00570232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110572276|NCT00570232|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110572277|NCT00570232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110572278|NCT00570232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110572279|NCT05755854|Cyclophosphamide|cyclophosphamide|mesh-list
110572280|NCT05755854|Fludarabine|fludarabine|mesh-list
110572281|NCT05755854|Fludarabine phosphate|fludarabine phosphate|mesh-list
110572282|NCT05755854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110572283|NCT05755854|Immunologic Factors|immunologic factors|mesh-ancestor
110572284|NCT05755854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110572285|NCT05755854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110572286|NCT05755854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110572287|NCT05755854|Alkylating Agents|alkylating agents|mesh-ancestor
110572288|NCT05755854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110572289|NCT05755854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110572290|NCT05755854|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110572291|NCT05755854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110572292|NCT05755854|Antimetabolites|antimetabolites|mesh-ancestor
110572293|NCT00787384|Imatinib Mesylate|imatinib mesylate|mesh-list
110572294|NCT00787384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110572295|NCT00787384|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110572296|NCT00787384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110373951|NCT01143337|Antimetabolites|antimetabolites|mesh-ancestor
110572297|NCT00787384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110572298|NCT02616419|Lidocaine|lidocaine|mesh-list
110572299|NCT02616419|Anesthetics, Local|anesthetics, local|mesh-ancestor
110572300|NCT02616419|Anesthetics|anesthetics|mesh-ancestor
110572301|NCT02616419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110572302|NCT02616419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110572303|NCT02616419|Sensory System Agents|sensory system agents|mesh-ancestor
110572304|NCT02616419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110572305|NCT02616419|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110572306|NCT02616419|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110572307|NCT02616419|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110572308|NCT02616419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110572309|NCT02616419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110572310|NCT00798070|Cyclophosphamide|cyclophosphamide|mesh-list
110572311|NCT00798070|Fluorouracil|fluorouracil|mesh-list
110572312|NCT00798070|Docetaxel|docetaxel|mesh-list
110572313|NCT00798070|Epirubicin|epirubicin|mesh-list
110572314|NCT00798070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110572315|NCT00798070|Immunologic Factors|immunologic factors|mesh-ancestor
110572316|NCT00798070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110572317|NCT00798070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110572318|NCT00798070|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110572319|NCT00798070|Alkylating Agents|alkylating agents|mesh-ancestor
110572320|NCT00798070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110572321|NCT00798070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110572322|NCT00798070|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110572323|NCT00798070|Antimetabolites|antimetabolites|mesh-ancestor
110572324|NCT00798070|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110572325|NCT00798070|Tubulin Modulators|tubulin modulators|mesh-ancestor
110572326|NCT00798070|Antimitotic Agents|antimitotic agents|mesh-ancestor
110572327|NCT00798070|Mitosis Modulators|mitosis modulators|mesh-ancestor
110219818|NCT00111618|Vadimezan|vadimezan|mesh-list
110572328|NCT00798070|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110148454|NCT03265405|Prednisolone phosphate|prednisolone phosphate|mesh-list
110572329|NCT00798070|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110572330|NCT00798070|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110572331|NCT00798070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110572333|NCT00809328|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110572334|NCT00809328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110572335|NCT00798148|Carboplatin|carboplatin|mesh-list
110572337|NCT00798148|Melphalan|melphalan|mesh-list
110572338|NCT00798148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110572339|NCT00798148|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110572340|NCT00798148|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110572341|NCT00798148|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110572342|NCT00798148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110572343|NCT00798148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110572344|NCT00798148|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110572345|NCT00798148|Alkylating Agents|alkylating agents|mesh-ancestor
110572346|NCT00798148|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110572347|NCT00798148|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110572348|NCT00798148|Immunologic Factors|immunologic factors|mesh-ancestor
110572349|NCT00798148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110572350|NCT00787462|Pregabalin|pregabalin|mesh-list
110572351|NCT00787462|Analgesics|analgesics|mesh-ancestor
110572352|NCT00787462|Sensory System Agents|sensory system agents|mesh-ancestor
110572353|NCT00787462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110572354|NCT00787462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110572355|NCT00787462|Anticonvulsants|anticonvulsants|mesh-ancestor
110572356|NCT00787462|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110572357|NCT00787462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110572358|NCT00787462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110572359|NCT00787462|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110572360|NCT00787462|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110572361|NCT00787462|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110572362|NCT00787462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110572363|NCT00787462|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110572364|NCT00792766|Everolimus|everolimus|mesh-list
110572365|NCT00792766|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110572366|NCT00792766|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110572367|NCT00792766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110572368|NCT00792766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110572369|NCT00792766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110572370|NCT00792766|Immunologic Factors|immunologic factors|mesh-ancestor
110572371|NCT00792766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110572372|NCT00792766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110572373|NCT00798460|Lamivudine|lamivudine|mesh-list
110572374|NCT00798460|Adefovir|adefovir|mesh-list
110572375|NCT00798460|Clevudine|clevudine|mesh-list
110572376|NCT00798460|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110572377|NCT00798460|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110572378|NCT00798460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110572379|NCT00798460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110572381|NCT00798460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110572382|NCT00798460|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110572383|NCT00798460|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110572384|NCT02615873|Levodopa|levodopa|mesh-list
110572385|NCT02615873|Carbidopa|carbidopa|mesh-list
110572386|NCT02615873|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
110572387|NCT02615873|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110572388|NCT02615873|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110572389|NCT02615873|Dopamine Agents|dopamine agents|mesh-ancestor
110572390|NCT02615873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110572391|NCT02615873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110572392|NCT02615873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110572393|NCT02615873|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
110572394|NCT02615873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110572395|NCT02615873|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110572396|NCT02615873|Immunologic Factors|immunologic factors|mesh-ancestor
110572397|NCT02615873|Dopamine Agonists|dopamine agonists|mesh-ancestor
110572398|NCT00814164|Daunorubicin|daunorubicin|mesh-list
110572399|NCT00814164|Clofarabine|clofarabine|mesh-list
110572400|NCT00814164|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110572402|NCT00814164|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110572403|NCT00814164|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110572404|NCT00814164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110572405|NCT00814164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110572406|NCT00814164|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110572407|NCT00814164|Antimetabolites|antimetabolites|mesh-ancestor
110572409|NCT02609334|Histamine Antagonists|histamine antagonists|mesh-ancestor
110572410|NCT02609334|Histamine Agents|histamine agents|mesh-ancestor
110572411|NCT02609334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110572412|NCT02609334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110572413|NCT02609334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110572414|NCT00659230|Dopamine|dopamine|mesh-list
110572415|NCT00659230|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110373967|NCT01143259|Alvimopan|alvimopan|mesh-list
110572417|NCT00659230|Autonomic Agents|autonomic agents|mesh-ancestor
110572418|NCT00659230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110572419|NCT00659230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110572420|NCT00659230|Dopamine Agents|dopamine agents|mesh-ancestor
110572421|NCT00659230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110572422|NCT00659230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110572423|NCT00659230|Protective Agents|protective agents|mesh-ancestor
110572424|NCT00809094|Acetylcysteine|acetylcysteine|mesh-list
110572425|NCT00809094|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110572426|NCT00809094|Antiviral Agents|antiviral agents|mesh-ancestor
110572427|NCT00809094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110572428|NCT00809094|Expectorants|expectorants|mesh-ancestor
110572429|NCT00809094|Respiratory System Agents|respiratory system agents|mesh-ancestor
110572430|NCT00809094|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110572431|NCT00809094|Antioxidants|antioxidants|mesh-ancestor
110572432|NCT00809094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110572433|NCT00809094|Protective Agents|protective agents|mesh-ancestor
110572434|NCT00809094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110572435|NCT00809094|Antidotes|antidotes|mesh-ancestor
110572436|NCT02615639|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110572437|NCT02615639|Interferon-alpha|interferon-alpha|mesh-list
110572438|NCT02615639|Entecavir|entecavir|mesh-list
110572439|NCT02615639|Telbivudine|telbivudine|mesh-list
110572440|NCT02615639|Interferon alpha-2|interferon alpha-2|mesh-list
110572441|NCT02615639|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
110572442|NCT02615639|Vaccines|vaccines|mesh-list
110572443|NCT02615639|Immunologic Factors|immunologic factors|mesh-ancestor
110572444|NCT02615639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110572445|NCT02615639|Antiviral Agents|antiviral agents|mesh-ancestor
110572446|NCT02615639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110572447|NCT02615639|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110572448|NCT02615639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110572449|NCT02615639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110572450|NCT02615639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110572451|NCT00798616|Methylprednisolone|methylprednisolone|mesh-list
110572452|NCT00798616|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110572453|NCT00798616|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110572454|NCT00798616|Prednisolone|prednisolone|mesh-list
110572455|NCT00798616|Prednisolone acetate|prednisolone acetate|mesh-list
110572456|NCT00798616|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110572457|NCT00798616|Prednisolone phosphate|prednisolone phosphate|mesh-list
110572458|NCT00798616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110572459|NCT00798616|Antiemetics|antiemetics|mesh-ancestor
110572460|NCT00798616|Autonomic Agents|autonomic agents|mesh-ancestor
110572461|NCT00798616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110572462|NCT00798616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110572463|NCT00798616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110572464|NCT00798616|Glucocorticoids|glucocorticoids|mesh-ancestor
110572465|NCT00798616|Hormones|hormones|mesh-ancestor
110572466|NCT00798616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110373996|NCT00585156|Celecoxib|celecoxib|mesh-list
110572467|NCT00798616|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110572468|NCT00798616|Protective Agents|protective agents|mesh-ancestor
110572469|NCT00798616|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110572470|NCT00798616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110572471|NCT02618057|Levofloxacin|levofloxacin|mesh-list
110572472|NCT02618057|Prednisolone|prednisolone|mesh-list
110572473|NCT02618057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110572474|NCT02618057|Glucocorticoids|glucocorticoids|mesh-ancestor
110572475|NCT02618057|Hormones|hormones|mesh-ancestor
110572476|NCT02618057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110572477|NCT02618057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110572478|NCT02618057|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110572479|NCT02618057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110572480|NCT02618057|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110572481|NCT02618057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110572482|NCT02618057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110572483|NCT02618057|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110572484|NCT02618057|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110572485|NCT02618057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110572486|NCT02618057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110572487|NCT02618057|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110572488|NCT02618057|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110572489|NCT04137029|Bromides|bromides|mesh-list
110572490|NCT04137029|Formoterol Fumarate|formoterol fumarate|mesh-list
110572491|NCT04137029|Tiotropium Bromide|tiotropium bromide|mesh-list
110572492|NCT04137029|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110572493|NCT04137029|Autonomic Agents|autonomic agents|mesh-ancestor
110572494|NCT04137029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110572495|NCT04137029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110572496|NCT04137029|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110572497|NCT04137029|Respiratory System Agents|respiratory system agents|mesh-ancestor
110572498|NCT04137029|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110572499|NCT04137029|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110572500|NCT04137029|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110572501|NCT04137029|Adrenergic Agents|adrenergic agents|mesh-ancestor
110572502|NCT04137029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110572503|NCT04137029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110572504|NCT04137029|Parasympatholytics|parasympatholytics|mesh-ancestor
110572505|NCT04137029|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110572506|NCT04137029|Cholinergic Agents|cholinergic agents|mesh-ancestor
110572507|NCT04137029|Anticonvulsants|anticonvulsants|mesh-ancestor
110572508|NCT00787774|Raltegravir Potassium|raltegravir potassium|mesh-list
110572509|NCT00787774|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110572510|NCT00787774|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110572511|NCT00787774|Antiviral Agents|antiviral agents|mesh-ancestor
110572512|NCT00787774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110572513|NCT00787774|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110572514|NCT00787774|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110572515|NCT00787774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110572516|NCT00787774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110572517|NCT00452413|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110572518|NCT00452413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110572519|NCT00452413|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110572520|NCT00452413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110148483|NCT02890069|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110572521|NCT00452413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110572522|NCT00798772|Micronutrients|micronutrients|mesh-list
110572523|NCT00798772|Trace Elements|trace elements|mesh-list
110572524|NCT00798772|Antioxidants|antioxidants|mesh-list
110572525|NCT00798772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110572526|NCT00798772|Protective Agents|protective agents|mesh-ancestor
110572527|NCT00798772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110572528|NCT00867503|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110572529|NCT00867503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110572530|NCT00867503|Alkylating Agents|alkylating agents|mesh-ancestor
110572531|NCT00867503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110572532|NCT00867503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110572533|NCT02615561|Pantothenic Acid|pantothenic acid|mesh-list
110572534|NCT02615561|Vitamin B Complex|vitamin b complex|mesh-ancestor
110572536|NCT02615561|Micronutrients|micronutrients|mesh-ancestor
110572537|NCT02615561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110572538|NCT00793234|Enoxaparin|enoxaparin|mesh-list
110572539|NCT00793234|Anticoagulants|anticoagulants|mesh-ancestor
110572540|NCT00793234|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110572541|NCT00793234|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110572542|NCT00793234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110572543|NCT00697775|Vaccines|vaccines|mesh-list
110572544|NCT00697775|Immunologic Factors|immunologic factors|mesh-ancestor
110572545|NCT00697775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110572546|NCT04133051|Bupivacaine|bupivacaine|mesh-list
110572547|NCT04133051|Anesthetics, Local|anesthetics, local|mesh-ancestor
110572548|NCT04133051|Anesthetics|anesthetics|mesh-ancestor
110572549|NCT04133051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110572550|NCT04133051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110572551|NCT04133051|Sensory System Agents|sensory system agents|mesh-ancestor
110572552|NCT04133051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110572553|NCT00788242|Insulin|insulin|mesh-list
110572554|NCT00788242|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110572555|NCT00788242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110572556|NCT04031027|Apremilast|apremilast|mesh-list
110572557|NCT04031027|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110572558|NCT04031027|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110572559|NCT04031027|Analgesics|analgesics|mesh-ancestor
110572560|NCT04031027|Sensory System Agents|sensory system agents|mesh-ancestor
110572561|NCT04031027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110572562|NCT04031027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110572563|NCT04031027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110572564|NCT04031027|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110572565|NCT04031027|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
110572566|NCT04031027|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110572567|NCT04031027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110572568|NCT04031027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110572569|NCT02609802|Sevoflurane|sevoflurane|mesh-list
110572570|NCT02609802|Desflurane|desflurane|mesh-list
110572571|NCT02609802|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110572572|NCT02609802|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110572573|NCT02609802|Anesthetics, General|anesthetics, general|mesh-ancestor
110572574|NCT02609802|Anesthetics|anesthetics|mesh-ancestor
110572575|NCT02609802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110572576|NCT02609802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110572577|NCT02609646|Vancomycin|vancomycin|mesh-list
110572578|NCT02609646|Meropenem|meropenem|mesh-list
110572580|NCT02609646|Linezolid|linezolid|mesh-list
110572581|NCT02609646|Piperacillin|piperacillin|mesh-list
110572582|NCT02609646|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
110572583|NCT02609646|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110572584|NCT02609646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110572585|NCT02609646|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110572586|NCT02609646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110572587|NCT02609646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110572588|NCT02609646|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110572589|NCT02610504|Hyaluronic Acid|hyaluronic acid|mesh-list
110572590|NCT02610504|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110572591|NCT02610504|Immunologic Factors|immunologic factors|mesh-ancestor
110572592|NCT02610504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110572593|NCT02610504|Viscosupplements|viscosupplements|mesh-ancestor
110572594|NCT02610504|Protective Agents|protective agents|mesh-ancestor
110572595|NCT04132583|Diclofenac|diclofenac|mesh-list
110572596|NCT04132583|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110572597|NCT04132583|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110572599|NCT04132583|Sensory System Agents|sensory system agents|mesh-ancestor
110572600|NCT04132583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110572601|NCT04132583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110572602|NCT04132583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110572603|NCT04132583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110572604|NCT04132583|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110572605|NCT04132583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110572606|NCT04132583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110572607|NCT05754762|Remifentanil|remifentanil|mesh-list
110572608|NCT05754762|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110572609|NCT05754762|Narcotics|narcotics|mesh-ancestor
110572610|NCT05754762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110572611|NCT05754762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110572612|NCT05754762|Analgesics|analgesics|mesh-ancestor
110572613|NCT05754762|Sensory System Agents|sensory system agents|mesh-ancestor
110572614|NCT05754762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110572615|NCT05326152|Immunomodulating Agents|immunomodulating agents|mesh-list
110572616|NCT05326152|Immunologic Factors|immunologic factors|mesh-ancestor
110572617|NCT05326152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110572618|NCT00914004|Desipramine|desipramine|mesh-list
110572619|NCT00914004|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110572620|NCT00914004|Antidepressive Agents|antidepressive agents|mesh-ancestor
110572621|NCT00914004|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110572622|NCT00914004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110572623|NCT00914004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110572624|NCT00914004|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110572625|NCT00914004|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110572626|NCT00914004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110572627|NCT00914004|Adrenergic Agents|adrenergic agents|mesh-ancestor
110572628|NCT00914004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110572629|NCT00914004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110572631|NCT00867113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110572632|NCT00867113|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110572633|NCT00867113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110572634|NCT00867113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110572635|NCT02608710|Verinurad|verinurad|mesh-list
110572636|NCT02608710|Gout Suppressants|gout suppressants|mesh-ancestor
110572637|NCT02608710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110572638|NCT04030260|Antibodies|antibodies|mesh-list
110572639|NCT04030260|Immunoglobulins|immunoglobulins|mesh-list
110572640|NCT04030260|Immunologic Factors|immunologic factors|mesh-ancestor
110572641|NCT04030260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110572642|NCT00697385|Tranexamic Acid|tranexamic acid|mesh-list
110572643|NCT00697385|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110572644|NCT00697385|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110572645|NCT00697385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110572646|NCT00697385|Hemostatics|hemostatics|mesh-ancestor
110572647|NCT00697385|Coagulants|coagulants|mesh-ancestor
110572648|NCT00451555|Fulvestrant|fulvestrant|mesh-list
110572649|NCT00451555|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110572650|NCT00451555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110572651|NCT00451555|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110572652|NCT00451555|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110572653|NCT00451555|Hormone Antagonists|hormone antagonists|mesh-ancestor
110572654|NCT00451555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110572655|NCT00451555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110572656|NCT00867035|Chlorhexidine|chlorhexidine|mesh-list
110572657|NCT00867035|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110572658|NCT00867035|Chlorine dioxide|chlorine dioxide|mesh-list
110572659|NCT00867035|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110572660|NCT00867035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110572661|NCT00867035|Disinfectants|disinfectants|mesh-ancestor
110572662|NCT00867035|Dermatologic Agents|dermatologic agents|mesh-ancestor
110572663|NCT00867035|Dental Disinfectants|dental disinfectants|mesh-ancestor
110572664|NCT05754684|Aldesleukin|aldesleukin|mesh-list
110572665|NCT05754684|Interleukin-2|interleukin-2|mesh-list
110572666|NCT05754684|Molgramostim|molgramostim|mesh-list
110572667|NCT05754684|Dinutuximab|dinutuximab|mesh-list
110572668|NCT05754684|Spironolactone|spironolactone|mesh-list
110572669|NCT05754684|Sargramostim|sargramostim|mesh-list
110572670|NCT05754684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110572671|NCT05754684|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110572672|NCT05754684|Analgesics|analgesics|mesh-ancestor
110572673|NCT05754684|Sensory System Agents|sensory system agents|mesh-ancestor
110572674|NCT05754684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110572675|NCT05754684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110572676|NCT05754684|Immunologic Factors|immunologic factors|mesh-ancestor
110572677|NCT05754684|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110572678|NCT05754684|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110572679|NCT05754684|Antiviral Agents|antiviral agents|mesh-ancestor
110572680|NCT05754684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110572681|NCT05754684|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110572682|NCT05754684|Hormone Antagonists|hormone antagonists|mesh-ancestor
110572683|NCT05754684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110572684|NCT05754684|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110572685|NCT05754684|Diuretics|diuretics|mesh-ancestor
110572686|NCT05754684|Natriuretic Agents|natriuretic agents|mesh-ancestor
110572687|NCT00694187|Zaleplon|zaleplon|mesh-list
110572688|NCT00694187|Anticonvulsants|anticonvulsants|mesh-ancestor
110572689|NCT00694187|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110572690|NCT00694187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110572691|NCT00694187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110572692|NCT00694187|GABA Modulators|gaba modulators|mesh-ancestor
110572693|NCT00694187|GABA Agents|gaba agents|mesh-ancestor
110572694|NCT00694187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110572695|NCT00694187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110572696|NCT02617121|Gabapentin|gabapentin|mesh-list
110572697|NCT02617121|Ramosetron|ramosetron|mesh-list
110572698|NCT02617121|Analgesics|analgesics|mesh-ancestor
110572699|NCT02617121|Sensory System Agents|sensory system agents|mesh-ancestor
110572700|NCT02617121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110572701|NCT02617121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110572702|NCT02617121|Anticonvulsants|anticonvulsants|mesh-ancestor
110572703|NCT02617121|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110572704|NCT02617121|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110572705|NCT02617121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110572706|NCT02617121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110572707|NCT02617121|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110572708|NCT02617121|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110572709|NCT02617121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110572710|NCT02617121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110572711|NCT02617121|Antimanic Agents|antimanic agents|mesh-ancestor
110572712|NCT02617121|Antiemetics|antiemetics|mesh-ancestor
110572713|NCT02617121|Autonomic Agents|autonomic agents|mesh-ancestor
110572714|NCT02617121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110572715|NCT02617121|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110572716|NCT02617121|Serotonin Agents|serotonin agents|mesh-ancestor
110572717|NCT02609490|Olmesartan|olmesartan|mesh-list
110572718|NCT02609490|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
110572719|NCT02609490|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
110572720|NCT02609490|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110572721|NCT02609490|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110572722|NCT02609490|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110148514|NCT00006483|Sargramostim|sargramostim|mesh-list
110572723|NCT02609490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110572724|NCT02610348|Vaccines|vaccines|mesh-list
110572725|NCT02610348|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110572726|NCT02610348|Immunologic Factors|immunologic factors|mesh-ancestor
110374038|NCT00572663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110572727|NCT02610348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110572729|NCT05757336|Bevacizumab|bevacizumab|mesh-list
110572730|NCT05757336|Gemcitabine|gemcitabine|mesh-list
110572731|NCT05757336|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110572732|NCT05757336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110572733|NCT05757336|Tubulin Modulators|tubulin modulators|mesh-ancestor
110572734|NCT05757336|Antimitotic Agents|antimitotic agents|mesh-ancestor
110572735|NCT05757336|Mitosis Modulators|mitosis modulators|mesh-ancestor
110572736|NCT05757336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110572737|NCT05757336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110572738|NCT05757336|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110572739|NCT05757336|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110572740|NCT05757336|Growth Substances|growth substances|mesh-ancestor
110572741|NCT05757336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110572742|NCT05757336|Growth Inhibitors|growth inhibitors|mesh-ancestor
110572743|NCT05757336|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110572744|NCT05757336|Antimetabolites|antimetabolites|mesh-ancestor
110572745|NCT00871871|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110572746|NCT00871871|Isosorbide|isosorbide|mesh-list
110572747|NCT00871871|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
110572748|NCT00871871|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
110572749|NCT00871871|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110572750|NCT00871871|Diuretics|diuretics|mesh-ancestor
110572751|NCT00871871|Natriuretic Agents|natriuretic agents|mesh-ancestor
110572752|NCT00871871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110572753|NCT00871871|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110572754|NCT00871871|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110572755|NCT00871871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110572756|NCT00871871|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110572757|NCT00871871|Vasodilator Agents|vasodilator agents|mesh-ancestor
110572758|NCT00871871|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
110572759|NCT02608788|Ketorolac|ketorolac|mesh-list
110572760|NCT02608788|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110572761|NCT02608788|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110572762|NCT02608788|Analgesics|analgesics|mesh-ancestor
110572763|NCT02608788|Sensory System Agents|sensory system agents|mesh-ancestor
110572764|NCT02608788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110572765|NCT02608788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110572766|NCT02608788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110572767|NCT02608788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110572768|NCT02608788|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110572769|NCT02608788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110572770|NCT02608788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110572771|NCT04132349|Ulipristal acetate|ulipristal acetate|mesh-list
110572772|NCT04132349|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110572773|NCT04132349|Contraceptive Agents|contraceptive agents|mesh-ancestor
110572774|NCT04132349|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110572775|NCT04132349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110572776|NCT04132349|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110572777|NCT04961190|Paroxetine|paroxetine|mesh-list
110572778|NCT04961190|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
110572779|NCT04961190|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110572780|NCT04961190|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110572781|NCT04961190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110572782|NCT04961190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110572783|NCT04961190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110572784|NCT04961190|Serotonin Agents|serotonin agents|mesh-ancestor
110572785|NCT04961190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110572786|NCT04961190|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110572787|NCT04961190|Antidepressive Agents|antidepressive agents|mesh-ancestor
110572788|NCT04961190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110572789|NCT04961190|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110572790|NCT04961190|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110572791|NCT04961190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110572792|NCT04961190|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110572793|NCT00849680|Vaccines|vaccines|mesh-list
110572794|NCT00849680|Immunologic Factors|immunologic factors|mesh-ancestor
110572795|NCT00849680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110572796|NCT00866723|Bevacizumab|bevacizumab|mesh-list
110572797|NCT00866723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110572798|NCT00866723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110572799|NCT00866723|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110572800|NCT00866723|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110572801|NCT00866723|Growth Substances|growth substances|mesh-ancestor
110572802|NCT00866723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110572803|NCT00866723|Growth Inhibitors|growth inhibitors|mesh-ancestor
110572804|NCT02613455|Triamcinolone|triamcinolone|mesh-list
110572805|NCT02613455|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110572806|NCT02613455|Lidocaine|lidocaine|mesh-list
110572807|NCT02613455|Anesthetics, Local|anesthetics, local|mesh-ancestor
110572808|NCT02613455|Anesthetics|anesthetics|mesh-ancestor
110572809|NCT02613455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110572810|NCT02613455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110572811|NCT02613455|Sensory System Agents|sensory system agents|mesh-ancestor
110572812|NCT02613455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110572813|NCT02613455|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110572814|NCT02613455|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110572815|NCT02613455|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110572816|NCT02613455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110572817|NCT02613455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110572818|NCT02613455|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110572819|NCT02613455|Glucocorticoids|glucocorticoids|mesh-ancestor
110572820|NCT02613455|Hormones|hormones|mesh-ancestor
110572821|NCT02613455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110572822|NCT02613455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110572823|NCT02613455|Immunologic Factors|immunologic factors|mesh-ancestor
110572824|NCT00703586|Maraviroc|maraviroc|mesh-list
110572825|NCT00703586|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110572826|NCT00703586|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110572827|NCT00703586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110572828|NCT00703586|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110572829|NCT00703586|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110572830|NCT00703586|Antiviral Agents|antiviral agents|mesh-ancestor
110572831|NCT00703586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110572832|NCT00703586|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
110572833|NCT04130399|Folfirinox|folfirinox|mesh-list
110572834|NCT04130399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110572835|NCT00849056|rGLP-1 protein|rglp-1 protein|mesh-list
110572836|NCT00849056|Incretins|incretins|mesh-ancestor
110572837|NCT00849056|Hormones|hormones|mesh-ancestor
110572838|NCT00849056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110572839|NCT00849056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110572840|NCT02612948|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110572841|NCT02612948|Antidepressive Agents|antidepressive agents|mesh-ancestor
110572842|NCT02612948|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110572843|NCT02612948|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110572844|NCT02612948|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110572845|NCT02612948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110572846|NCT02612948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110572847|NCT00706862|Lactoferrin|lactoferrin|mesh-list
110572848|NCT00706862|Talactoferrin alfa|talactoferrin alfa|mesh-list
110572849|NCT00706862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110572850|NCT00706862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110572851|NCT02612714|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110572852|NCT02612714|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110572853|NCT02612714|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110572855|NCT02612714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110572856|NCT02612714|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110572857|NCT02612714|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110572858|NCT02612714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110572859|NCT00837434|Adalimumab|adalimumab|mesh-list
110572860|NCT00837434|Etanercept|etanercept|mesh-list
110572861|NCT00837434|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110572862|NCT00837434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110572864|NCT00837434|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110572865|NCT00837434|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110572866|NCT00837434|Analgesics|analgesics|mesh-ancestor
110572867|NCT00837434|Sensory System Agents|sensory system agents|mesh-ancestor
110572868|NCT00837434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110572869|NCT00837434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110572870|NCT00837434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110572871|NCT00837434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110572872|NCT00837434|Immunologic Factors|immunologic factors|mesh-ancestor
110572873|NCT00703742|Escitalopram|escitalopram|mesh-list
110572874|NCT00703742|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110572875|NCT00703742|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110572876|NCT00703742|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110572877|NCT00703742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110572878|NCT00703742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110572879|NCT00703742|Serotonin Agents|serotonin agents|mesh-ancestor
110572880|NCT00703742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110572881|NCT00702182|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110572882|NCT00702182|Vinorelbine|vinorelbine|mesh-list
110572883|NCT00702182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110572884|NCT00702182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110572885|NCT00702182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110572886|NCT00702182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110572887|NCT00702182|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110572888|NCT00702182|Tubulin Modulators|tubulin modulators|mesh-ancestor
110572889|NCT00702182|Antimitotic Agents|antimitotic agents|mesh-ancestor
110572890|NCT00702182|Mitosis Modulators|mitosis modulators|mesh-ancestor
110572891|NCT00702260|Ramipril|ramipril|mesh-list
110572892|NCT00702260|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110572893|NCT00702260|Protease Inhibitors|protease inhibitors|mesh-ancestor
110572894|NCT00702260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110572895|NCT00702260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110572896|NCT00702260|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110572897|NCT00702416|Acetaminophen|acetaminophen|mesh-list
110572898|NCT00702416|Fentanyl|fentanyl|mesh-list
110572899|NCT00702416|Morphine|morphine|mesh-list
110572900|NCT00702416|Analgesics, Opioid|analgesics, opioid|mesh-list
110572901|NCT00702416|Narcotics|narcotics|mesh-list
110572902|NCT00702416|Analgesics|analgesics|mesh-list
110572903|NCT00702416|Anesthetics|anesthetics|mesh-list
110572904|NCT00702416|Ropivacaine|ropivacaine|mesh-list
110572905|NCT00702416|Anesthetics, Local|anesthetics, local|mesh-list
110572906|NCT00702416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110572907|NCT00702416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110572908|NCT00702416|Sensory System Agents|sensory system agents|mesh-ancestor
110572909|NCT00702416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110572910|NCT00702416|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110572911|NCT00702416|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110572912|NCT00702416|Anesthetics, General|anesthetics, general|mesh-ancestor
110572913|NCT00702416|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110572914|NCT00702416|Antipyretics|antipyretics|mesh-ancestor
110572915|NCT00827918|Olanzapine|olanzapine|mesh-list
110572916|NCT00827918|Antiemetics|antiemetics|mesh-ancestor
110572917|NCT00827918|Autonomic Agents|autonomic agents|mesh-ancestor
110572918|NCT00827918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110572919|NCT00827918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110572920|NCT00827918|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110572921|NCT00827918|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110572922|NCT00827918|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110572923|NCT00827918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110572924|NCT00827918|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110572925|NCT00827918|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110220407|NCT00130195|Alkylating Agents|alkylating agents|mesh-ancestor
110572926|NCT00827918|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110572927|NCT00827918|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110572928|NCT00827918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110572929|NCT00827918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110572930|NCT00827918|Serotonin Agents|serotonin agents|mesh-ancestor
110572931|NCT00813150|Dexamethasone|dexamethasone|mesh-list
110572932|NCT00813150|Cyclophosphamide|cyclophosphamide|mesh-list
110572934|NCT00813150|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110572935|NCT00813150|Immunologic Factors|immunologic factors|mesh-ancestor
110572936|NCT00813150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110572937|NCT00813150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110572938|NCT00813150|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110572939|NCT00813150|Alkylating Agents|alkylating agents|mesh-ancestor
110572940|NCT00813150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110572941|NCT00813150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110572942|NCT00813150|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110572943|NCT00813150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110572944|NCT00813150|Antiemetics|antiemetics|mesh-ancestor
110572945|NCT00813150|Autonomic Agents|autonomic agents|mesh-ancestor
110572946|NCT00813150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110572947|NCT00813150|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110572948|NCT00813150|Glucocorticoids|glucocorticoids|mesh-ancestor
110572949|NCT00813150|Hormones|hormones|mesh-ancestor
110572950|NCT00813150|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110572951|NCT00813150|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110572952|NCT00807846|Celecoxib|celecoxib|mesh-list
110572953|NCT00807846|Naproxen|naproxen|mesh-list
110572954|NCT00807846|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110572955|NCT00807846|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110572956|NCT00807846|Analgesics|analgesics|mesh-ancestor
110572957|NCT00807846|Sensory System Agents|sensory system agents|mesh-ancestor
110572958|NCT00807846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110572959|NCT00807846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110572960|NCT00807846|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110572961|NCT00807846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110572962|NCT00807846|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110572963|NCT00807846|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110572964|NCT00807846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110572965|NCT00807846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110572966|NCT00807846|Gout Suppressants|gout suppressants|mesh-ancestor
110572967|NCT00810108|Ritonavir|ritonavir|mesh-list
110572968|NCT00810108|Lopinavir|lopinavir|mesh-list
110572969|NCT00810108|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110572970|NCT00810108|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110572971|NCT00810108|Protease Inhibitors|protease inhibitors|mesh-ancestor
110572972|NCT00810108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110572973|NCT00810108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110572974|NCT00810108|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110572975|NCT00810108|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110572976|NCT00810108|Antiviral Agents|antiviral agents|mesh-ancestor
110572977|NCT00810108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110572978|NCT00810108|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110572979|NCT00810108|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110572980|NCT00827606|Atorvastatin|atorvastatin|mesh-list
110572981|NCT00827606|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110572982|NCT00827606|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110572983|NCT00827606|Antimetabolites|antimetabolites|mesh-ancestor
110572984|NCT00827606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110572985|NCT00827606|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110572986|NCT00827606|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110572987|NCT00827606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110572988|NCT04016220|Budesonide|budesonide|mesh-list
110572989|NCT04016220|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110572990|NCT04016220|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110572991|NCT04016220|Autonomic Agents|autonomic agents|mesh-ancestor
110572992|NCT04016220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110572993|NCT04016220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110572995|NCT04016220|Respiratory System Agents|respiratory system agents|mesh-ancestor
110572996|NCT04016220|Glucocorticoids|glucocorticoids|mesh-ancestor
110572997|NCT04016220|Hormones|hormones|mesh-ancestor
110572998|NCT04016220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110572999|NCT00663052|Etanercept|etanercept|mesh-list
110573000|NCT00663052|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110573001|NCT00663052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110573002|NCT00663052|Analgesics|analgesics|mesh-ancestor
110573003|NCT00663052|Sensory System Agents|sensory system agents|mesh-ancestor
110573004|NCT00663052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110573005|NCT00663052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110573006|NCT00663052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110573007|NCT00663052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110573008|NCT00663052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110573009|NCT00663052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110573010|NCT00663052|Immunologic Factors|immunologic factors|mesh-ancestor
110573011|NCT05599880|Bortezomib|bortezomib|mesh-list
110573012|NCT05599880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110573013|NCT00707252|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110573014|NCT00707252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110573015|NCT00707252|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110573016|NCT00707252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110573017|NCT00707252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110573018|NCT00826748|Beclomethasone|beclomethasone|mesh-list
110573019|NCT00826748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110573020|NCT00826748|Glucocorticoids|glucocorticoids|mesh-ancestor
110573021|NCT00826748|Hormones|hormones|mesh-ancestor
110573022|NCT00826748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110573023|NCT00826748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110573024|NCT00826748|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110573025|NCT00826748|Respiratory System Agents|respiratory system agents|mesh-ancestor
110573026|NCT00922844|Sevoflurane|sevoflurane|mesh-list
110573027|NCT00922844|Isoflurane|isoflurane|mesh-list
110573028|NCT00922844|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110573029|NCT00922844|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110573030|NCT00922844|Anesthetics, General|anesthetics, general|mesh-ancestor
110573031|NCT00922844|Anesthetics|anesthetics|mesh-ancestor
110573032|NCT00922844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110573033|NCT00922844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110573034|NCT00707330|Clarithromycin|clarithromycin|mesh-list
110573035|NCT00707330|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110573036|NCT00707330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110573037|NCT00707330|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110573038|NCT00707330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110573039|NCT00707330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110573040|NCT00707330|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110573041|NCT00707330|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110573042|NCT00707408|Imatinib Mesylate|imatinib mesylate|mesh-list
110573043|NCT00707408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110573044|NCT00707408|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110573045|NCT00707408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110573046|NCT00707408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110573047|NCT00788320|Vitamin D|vitamin d|mesh-list
110573048|NCT00788320|Cholecalciferol|cholecalciferol|mesh-list
110573049|NCT00788320|Vitamins|vitamins|mesh-ancestor
110573050|NCT00788320|Micronutrients|micronutrients|mesh-ancestor
110573051|NCT00788320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110573052|NCT00788320|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110573053|NCT00788320|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110573054|NCT00807144|Tacrolimus|tacrolimus|mesh-list
110573055|NCT00807144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110573056|NCT00807144|Immunologic Factors|immunologic factors|mesh-ancestor
110573057|NCT00807144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110573058|NCT00807144|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110573059|NCT00807144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110573060|NCT00807144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110573061|NCT00799240|Cisplatin|cisplatin|mesh-list
110573062|NCT00799240|Pemetrexed|pemetrexed|mesh-list
110573063|NCT00799240|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110573064|NCT00799240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110573065|NCT00799240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110573066|NCT00799240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110573067|NCT00799240|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110573068|NCT00799240|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110573069|NCT00799240|Immunologic Factors|immunologic factors|mesh-ancestor
110573070|NCT00799240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110573071|NCT00591006|Hydrocortisone|hydrocortisone|mesh-list
110573072|NCT00591006|Phenytoin|phenytoin|mesh-list
110573073|NCT00591006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110573074|NCT00591006|Anticonvulsants|anticonvulsants|mesh-ancestor
110573075|NCT00591006|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110573076|NCT00591006|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110573077|NCT00591006|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110573078|NCT00591006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110573079|NCT00591006|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110573080|NCT00591006|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110573081|NCT00788398|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110573082|NCT00844844|Eculizumab|eculizumab|mesh-list
110573083|NCT00844844|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
110573084|NCT00844844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110573085|NCT00844844|Immunologic Factors|immunologic factors|mesh-ancestor
110573086|NCT00844844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110573087|NCT05748054|Fluorides|fluorides|mesh-list
110573088|NCT05748054|Cariostatic Agents|cariostatic agents|mesh-ancestor
110573089|NCT05748054|Protective Agents|protective agents|mesh-ancestor
110573090|NCT05748054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110573091|NCT00702572|Paclitaxel|paclitaxel|mesh-list
110573092|NCT00702572|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110573093|NCT00702572|Bevacizumab|bevacizumab|mesh-list
110573094|NCT00702572|Carboplatin|carboplatin|mesh-list
110573095|NCT00702572|Vorinostat|vorinostat|mesh-list
110573096|NCT00702572|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110573097|NCT00702572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110573098|NCT00702572|Tubulin Modulators|tubulin modulators|mesh-ancestor
110573099|NCT00702572|Antimitotic Agents|antimitotic agents|mesh-ancestor
110573100|NCT00702572|Mitosis Modulators|mitosis modulators|mesh-ancestor
110573101|NCT00702572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110573102|NCT00702572|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110573103|NCT00702572|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110573104|NCT00702572|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110573105|NCT00702572|Growth Substances|growth substances|mesh-ancestor
110573106|NCT00702572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110573107|NCT00702572|Growth Inhibitors|growth inhibitors|mesh-ancestor
110573108|NCT00702572|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110573109|NCT00702572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110573110|NCT00793468|Nicotine|nicotine|mesh-list
110573111|NCT00793468|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110573112|NCT00793468|Autonomic Agents|autonomic agents|mesh-ancestor
110573113|NCT00793468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110573114|NCT00793468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110573115|NCT00793468|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110573116|NCT00793468|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110573117|NCT00793468|Cholinergic Agents|cholinergic agents|mesh-ancestor
110573118|NCT00793468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110573119|NCT00793468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110573120|NCT00836810|Prednisone|prednisone|mesh-list
110573121|NCT00836810|Prednisolone|prednisolone|mesh-list
110573122|NCT00836810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110573123|NCT00836810|Glucocorticoids|glucocorticoids|mesh-ancestor
110573124|NCT00836810|Hormones|hormones|mesh-ancestor
110573125|NCT00836810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110573126|NCT00836810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110573127|NCT00836810|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110573128|NCT00836810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110573129|NCT00658684|Fesoterodine|fesoterodine|mesh-list
110573130|NCT00658684|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110573131|NCT00658684|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110573132|NCT00658684|Cholinergic Agents|cholinergic agents|mesh-ancestor
110573133|NCT00658684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110573134|NCT00658684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110573135|NCT00658684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110573136|NCT00658684|Urological Agents|urological agents|mesh-ancestor
110573137|NCT00660400|Azacitidine|azacitidine|mesh-list
110573138|NCT00660400|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110573139|NCT00660400|Antimetabolites|antimetabolites|mesh-ancestor
110573140|NCT00660400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110573141|NCT00660400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110573142|NCT00660400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110573143|NCT00826514|Tanezumab|tanezumab|mesh-list
110573144|NCT00826514|Analgesics|analgesics|mesh-ancestor
110573145|NCT00826514|Sensory System Agents|sensory system agents|mesh-ancestor
110573146|NCT00826514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110573147|NCT00826514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110573148|NCT00800566|Clofarabine|clofarabine|mesh-list
110573149|NCT00800566|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110573150|NCT00800566|Antimetabolites|antimetabolites|mesh-ancestor
110573151|NCT00800566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110573152|NCT00800566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110573153|NCT00793858|Ciclesonide|ciclesonide|mesh-list
110573154|NCT00793858|Glucocorticoids|glucocorticoids|mesh-ancestor
110573155|NCT00793858|Hormones|hormones|mesh-ancestor
110573156|NCT00793858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110573157|NCT00793858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110573158|NCT00793858|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110573159|NCT00800722|Sirolimus|sirolimus|mesh-list
110573160|NCT00800722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110573161|NCT00800722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110573162|NCT00800722|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110573163|NCT00800722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110573164|NCT00800722|Antifungal Agents|antifungal agents|mesh-ancestor
110573165|NCT00800722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110573166|NCT00800722|Immunologic Factors|immunologic factors|mesh-ancestor
110573167|NCT00800722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110573168|NCT00826280|Caffeine|caffeine|mesh-list
110573169|NCT00826280|Regadenoson|regadenoson|mesh-list
110573170|NCT00826280|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110573171|NCT00826280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110573172|NCT00826280|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110573173|NCT00826280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110573174|NCT00826280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110573175|NCT00826280|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110573176|NCT00826280|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110573177|NCT00826280|Purinergic Agents|purinergic agents|mesh-ancestor
110573178|NCT00826280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110573179|NCT00826280|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
110573180|NCT00826280|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
110573181|NCT00826280|Purinergic Agonists|purinergic agonists|mesh-ancestor
110573182|NCT00800800|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110573183|NCT00800800|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110573184|NCT00800800|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110573185|NCT00800800|Antimetabolites|antimetabolites|mesh-ancestor
110573186|NCT00800800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110573187|NCT00800800|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110573188|NCT00800800|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110573189|NCT00800800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110573191|NCT00703898|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110573192|NCT00703898|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110573193|NCT00703898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110374090|NCT03451110|Histamine Agents|histamine agents|mesh-ancestor
110573194|NCT00703898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110573196|NCT00703898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110573197|NCT00703898|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110573198|NCT00703898|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110573199|NCT00703898|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110573200|NCT00703898|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110573201|NCT04030442|Morphine|morphine|mesh-list
110573202|NCT04030442|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110573203|NCT04030442|Narcotics|narcotics|mesh-ancestor
110573204|NCT04030442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110573205|NCT04030442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110573206|NCT04030442|Analgesics|analgesics|mesh-ancestor
110573207|NCT04030442|Sensory System Agents|sensory system agents|mesh-ancestor
110573208|NCT04030442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110573209|NCT00801034|Calcium|calcium|mesh-list
110573210|NCT00801034|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110573211|NCT00801034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110573212|NCT04130477|Nickel|nickel|mesh-list
110573213|NCT04130477|Trace Elements|trace elements|mesh-ancestor
110573214|NCT04130477|Micronutrients|micronutrients|mesh-ancestor
110573215|NCT04130477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110573216|NCT00794326|Dialysis Solutions|dialysis solutions|mesh-list
110573217|NCT00794326|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110573218|NCT00702728|Furosemide|furosemide|mesh-list
110573219|NCT00702728|Diuretics|diuretics|mesh-ancestor
110573220|NCT00702728|Natriuretic Agents|natriuretic agents|mesh-ancestor
110573221|NCT00702728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110573222|NCT00702728|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110573223|NCT00702728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110573224|NCT00702728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110573225|NCT04132115|Vancomycin|vancomycin|mesh-list
110573226|NCT04132115|Gentamicins|gentamicins|mesh-list
110573227|NCT04132115|Meropenem|meropenem|mesh-list
110573228|NCT04132115|Tazobactam|tazobactam|mesh-list
110573229|NCT04132115|Linezolid|linezolid|mesh-list
110573230|NCT04132115|Piperacillin|piperacillin|mesh-list
110573231|NCT04132115|Daptomycin|daptomycin|mesh-list
110573232|NCT04132115|Amikacin|amikacin|mesh-list
110573233|NCT04132115|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
110573234|NCT04132115|Ceftobiprole|ceftobiprole|mesh-list
110573235|NCT04132115|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
110573236|NCT04132115|Acyclovir|acyclovir|mesh-list
110573237|NCT04132115|Ganciclovir|ganciclovir|mesh-list
110573238|NCT04132115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110573239|NCT04132115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110573240|NCT04132115|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110573241|NCT04132115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110573242|NCT04132115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110573243|NCT04132115|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110573244|NCT04132115|Antiviral Agents|antiviral agents|mesh-ancestor
110573245|NCT00801268|Emodin|emodin|mesh-list
110573246|NCT00801268|Cathartics|cathartics|mesh-ancestor
110573247|NCT00801268|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110573248|NCT00801268|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110573249|NCT00801268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110573250|NCT00801268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110573251|NCT02614937|Squalamine|squalamine|mesh-list
110573252|NCT02614937|Ranibizumab|ranibizumab|mesh-list
110573253|NCT02614937|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110573254|NCT02614937|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110573255|NCT02614937|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110573256|NCT02614937|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110573257|NCT02614937|Growth Substances|growth substances|mesh-ancestor
110573258|NCT02614937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110573259|NCT02614937|Growth Inhibitors|growth inhibitors|mesh-ancestor
110573260|NCT02614937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110573261|NCT02614937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110573262|NCT02614937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110573263|NCT02614937|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110573265|NCT00707642|Vaccines|vaccines|mesh-list
110573266|NCT00707642|Immunologic Factors|immunologic factors|mesh-ancestor
110573267|NCT00707642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110573268|NCT00789568|Moxifloxacin|moxifloxacin|mesh-list
110573269|NCT00789568|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
110573270|NCT00789568|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110573271|NCT00789568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110573272|NCT00789568|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110573273|NCT00789568|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110573274|NCT00789568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110573275|NCT00789568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110573276|NCT00789568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110573277|NCT00789568|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110573278|NCT00789568|Contraceptive Agents|contraceptive agents|mesh-ancestor
110573279|NCT00789568|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110573280|NCT00789568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110573281|NCT00789568|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110573282|NCT00789568|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110573283|NCT00789568|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110573284|NCT00789646|Lidocaine|lidocaine|mesh-list
110573285|NCT00789646|Anesthetics, Local|anesthetics, local|mesh-ancestor
110573286|NCT00789646|Anesthetics|anesthetics|mesh-ancestor
110573287|NCT00789646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110573288|NCT00789646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110573289|NCT00789646|Sensory System Agents|sensory system agents|mesh-ancestor
110573290|NCT00789646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110573291|NCT00789646|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110573292|NCT00789646|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110573293|NCT00789646|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110573294|NCT00789646|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110573295|NCT00789646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110573296|NCT00856973|Eszopiclone|eszopiclone|mesh-list
110573297|NCT00856973|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110573298|NCT00856973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110573299|NCT00856973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110573300|NCT00794638|Rituximab|rituximab|mesh-list
110573301|NCT00794638|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110573302|NCT00794638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110573303|NCT00794638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110573304|NCT00794638|Immunologic Factors|immunologic factors|mesh-ancestor
110573305|NCT00794638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110573306|NCT00794638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110573307|NCT00794638|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110573308|NCT00794638|Alkylating Agents|alkylating agents|mesh-ancestor
110573309|NCT00794638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110573310|NCT00801580|Doxorubicin|doxorubicin|mesh-list
110573311|NCT00801580|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110573312|NCT00801580|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110573313|NCT00801580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110573314|NCT00801580|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110573315|NCT00801580|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110573316|NCT00801580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110573317|NCT00801580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110573318|NCT00805194|Docetaxel|docetaxel|mesh-list
110573319|NCT00805194|Nintedanib|nintedanib|mesh-list
110573320|NCT00805194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110573321|NCT00805194|Tubulin Modulators|tubulin modulators|mesh-ancestor
110573322|NCT00805194|Antimitotic Agents|antimitotic agents|mesh-ancestor
110573323|NCT00805194|Mitosis Modulators|mitosis modulators|mesh-ancestor
110573324|NCT00805194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110573326|NCT00805194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110573327|NCT00657046|Droxidopa|droxidopa|mesh-list
110573328|NCT00657046|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110573329|NCT00657046|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110573330|NCT00707798|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110573332|NCT00707798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110573333|NCT00801736|Paclitaxel|paclitaxel|mesh-list
110573334|NCT00801736|Cisplatin|cisplatin|mesh-list
110573335|NCT00801736|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110573336|NCT00801736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110573337|NCT00801736|Tubulin Modulators|tubulin modulators|mesh-ancestor
110573338|NCT00801736|Antimitotic Agents|antimitotic agents|mesh-ancestor
110573339|NCT00801736|Mitosis Modulators|mitosis modulators|mesh-ancestor
110573340|NCT00801736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110573341|NCT00856661|Salivary plasminogen activator alpha 1, Desmodus rotundus|salivary plasminogen activator alpha 1, desmodus rotundus|mesh-list
110573342|NCT00856661|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110573343|NCT00856661|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110573344|NCT00856661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110573345|NCT02606994|Diphenhydramine|diphenhydramine|mesh-list
110573346|NCT02606994|Lidocaine|lidocaine|mesh-list
110573347|NCT02606994|Anesthetics, Local|anesthetics, local|mesh-ancestor
110573348|NCT02606994|Anesthetics|anesthetics|mesh-ancestor
110573349|NCT02606994|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110573350|NCT02606994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110573351|NCT02606994|Sensory System Agents|sensory system agents|mesh-ancestor
110573352|NCT02606994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110573353|NCT02606994|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110573354|NCT02606994|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110573355|NCT02606994|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110573356|NCT02606994|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110573357|NCT02606994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110573358|NCT02606994|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110573359|NCT02606994|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110573360|NCT02606994|Antiemetics|antiemetics|mesh-ancestor
110573361|NCT02606994|Autonomic Agents|autonomic agents|mesh-ancestor
110573362|NCT02606994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110573363|NCT02606994|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110573364|NCT02606994|Histamine Antagonists|histamine antagonists|mesh-ancestor
110573365|NCT02606994|Histamine Agents|histamine agents|mesh-ancestor
110573366|NCT02606994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110573367|NCT02606994|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110573368|NCT00844376|Atorvastatin|atorvastatin|mesh-list
110573369|NCT00844376|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110573370|NCT00844376|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110573371|NCT00844376|Antimetabolites|antimetabolites|mesh-ancestor
110573372|NCT00844376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110573373|NCT00844376|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110573374|NCT00844376|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110573375|NCT00844376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110573377|NCT04046302|Oxytocics|oxytocics|mesh-ancestor
110573378|NCT04046302|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110573379|NCT04046302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110573380|NCT00914394|Phenylephrine|phenylephrine|mesh-list
110573381|NCT00914394|Oxymetazoline|oxymetazoline|mesh-list
110573382|NCT00914394|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
110573383|NCT00914394|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110573384|NCT00914394|Mydriatics|mydriatics|mesh-ancestor
110573385|NCT00914394|Autonomic Agents|autonomic agents|mesh-ancestor
110573386|NCT00914394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110573387|NCT00914394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110573388|NCT00914394|Sympathomimetics|sympathomimetics|mesh-ancestor
110573389|NCT00914394|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110573390|NCT00914394|Nasal Decongestants|nasal decongestants|mesh-ancestor
110573391|NCT00914394|Respiratory System Agents|respiratory system agents|mesh-ancestor
110573392|NCT00914394|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110573393|NCT00914394|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110573394|NCT00914394|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110573395|NCT00914394|Adrenergic Agents|adrenergic agents|mesh-ancestor
110573396|NCT00914394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110573397|NCT00914394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110374116|NCT01140061|MK 0873|mk 0873|mesh-list
110573398|NCT00914394|Protective Agents|protective agents|mesh-ancestor
110573399|NCT00914394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110573401|NCT04045678|Dopamine Agonists|dopamine agonists|mesh-ancestor
110573402|NCT04045678|Dopamine Agents|dopamine agents|mesh-ancestor
110573403|NCT04045678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110573404|NCT04045678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110573405|NCT04045678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110573406|NCT00658606|Alefacept|alefacept|mesh-list
110573407|NCT00658606|Dermatologic Agents|dermatologic agents|mesh-ancestor
110573408|NCT00658606|Immunologic Factors|immunologic factors|mesh-ancestor
110573409|NCT00658606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110573410|NCT00795106|Capsaicin|capsaicin|mesh-list
110573411|NCT00795106|Antipruritics|antipruritics|mesh-ancestor
110573412|NCT00795106|Dermatologic Agents|dermatologic agents|mesh-ancestor
110573413|NCT00795106|Sensory System Agents|sensory system agents|mesh-ancestor
110573414|NCT00795106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110573415|NCT00795106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110573417|NCT00589290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110573418|NCT00589290|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110573419|NCT00589290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110573420|NCT00589290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110573421|NCT00802048|Ropivacaine|ropivacaine|mesh-list
110573422|NCT00802048|Anesthetics, Local|anesthetics, local|mesh-list
110573423|NCT00802048|Anesthetics|anesthetics|mesh-list
110573424|NCT00802048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110573425|NCT00802048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110573426|NCT00802048|Sensory System Agents|sensory system agents|mesh-ancestor
110573427|NCT00802048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110573428|NCT00809536|Metformin|metformin|mesh-list
110573429|NCT00809536|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110573430|NCT00809536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110573431|NCT00809692|Histamine|histamine|mesh-list
110573432|NCT00809692|Histamine phosphate|histamine phosphate|mesh-list
110573433|NCT00809692|Histamine Agonists|histamine agonists|mesh-ancestor
110573434|NCT00809692|Histamine Agents|histamine agents|mesh-ancestor
110573435|NCT00809692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110573436|NCT00809692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110573437|NCT00809692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110573438|NCT00843284|Pregabalin|pregabalin|mesh-list
110573439|NCT00843284|Analgesics|analgesics|mesh-ancestor
110573440|NCT00843284|Sensory System Agents|sensory system agents|mesh-ancestor
110573441|NCT00843284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110573442|NCT00843284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110573443|NCT00843284|Anticonvulsants|anticonvulsants|mesh-ancestor
110573444|NCT00843284|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110573445|NCT00843284|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110573446|NCT00843284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110573447|NCT00843284|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110573448|NCT00843284|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110573449|NCT00843284|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110573450|NCT00843284|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110573451|NCT00843284|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110573453|NCT00802282|Hallucinogens|hallucinogens|mesh-ancestor
110573454|NCT00802282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110573455|NCT00802282|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110573456|NCT00652834|Mycophenolic Acid|mycophenolic acid|mesh-list
110573457|NCT00652834|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110573458|NCT00652834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110573459|NCT00652834|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110573460|NCT00652834|Antitubercular Agents|antitubercular agents|mesh-ancestor
110573461|NCT00652834|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110573462|NCT00652834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110573463|NCT00652834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110573464|NCT00652834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110573465|NCT00825812|Atropine|atropine|mesh-list
110573466|NCT00825812|Neostigmine|neostigmine|mesh-list
110573467|NCT00825812|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110573468|NCT00825812|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110573469|NCT00825812|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110573470|NCT00825812|Autonomic Agents|autonomic agents|mesh-ancestor
110573471|NCT00825812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110573472|NCT00825812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110573473|NCT00825812|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110573474|NCT00825812|Respiratory System Agents|respiratory system agents|mesh-ancestor
110573475|NCT00825812|Mydriatics|mydriatics|mesh-ancestor
110573476|NCT00825812|Parasympatholytics|parasympatholytics|mesh-ancestor
110573477|NCT00825812|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110573478|NCT00825812|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110573479|NCT00825812|Cholinergic Agents|cholinergic agents|mesh-ancestor
110573480|NCT00825812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110573481|NCT00825812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110573482|NCT00825812|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110573483|NCT00825812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110573484|NCT00825812|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110573485|NCT00802594|Pafuramidine|pafuramidine|mesh-list
110573486|NCT00802594|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
110573487|NCT00802594|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110573488|NCT00802594|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110573489|NCT00802594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110573490|NCT00707876|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
110573491|NCT00707876|Hematinics|hematinics|mesh-ancestor
110573492|NCT00707876|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
110573493|NCT00707876|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110573494|NCT02606448|Bupivacaine|bupivacaine|mesh-list
110573495|NCT02606448|Anesthetics, Local|anesthetics, local|mesh-ancestor
110573496|NCT02606448|Anesthetics|anesthetics|mesh-ancestor
110573497|NCT02606448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110573498|NCT02606448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110573499|NCT02606448|Sensory System Agents|sensory system agents|mesh-ancestor
110573500|NCT02606448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110573501|NCT00802828|Famotidine|famotidine|mesh-list
110573502|NCT00802828|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110573503|NCT00802828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110573504|NCT00802828|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110573505|NCT00802828|Histamine Antagonists|histamine antagonists|mesh-ancestor
110573506|NCT00802828|Histamine Agents|histamine agents|mesh-ancestor
110573507|NCT00802828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110573508|NCT00802828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110573509|NCT00802828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110573510|NCT00802906|Bevacizumab|bevacizumab|mesh-list
110573511|NCT00802906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110573512|NCT00802906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110573513|NCT00802906|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110573514|NCT00802906|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110573515|NCT00802906|Growth Substances|growth substances|mesh-ancestor
110573516|NCT00802906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110573517|NCT00802906|Growth Inhibitors|growth inhibitors|mesh-ancestor
110573518|NCT00803218|Fluticasone|fluticasone|mesh-list
110573519|NCT00803218|Xhance|xhance|mesh-list
110573520|NCT00803218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110573521|NCT00803218|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110573522|NCT00803218|Autonomic Agents|autonomic agents|mesh-ancestor
110573523|NCT00803218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110573524|NCT00803218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110573525|NCT00803218|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110573526|NCT00803218|Respiratory System Agents|respiratory system agents|mesh-ancestor
110573527|NCT00803218|Dermatologic Agents|dermatologic agents|mesh-ancestor
110573528|NCT00803218|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110573529|NCT00824564|Tranexamic Acid|tranexamic acid|mesh-list
110573530|NCT00824564|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110573531|NCT00824564|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110573532|NCT00824564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110573533|NCT00824564|Hemostatics|hemostatics|mesh-ancestor
110573534|NCT00824564|Coagulants|coagulants|mesh-ancestor
110573535|NCT00803374|Ipilimumab|ipilimumab|mesh-list
110573536|NCT00803374|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110573537|NCT00803374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110573538|NCT00803374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110573539|NCT00803374|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110573540|NCT00803374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110573541|NCT00803374|Immunologic Factors|immunologic factors|mesh-ancestor
110573542|NCT00803374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110573543|NCT00803530|Ascorbic Acid|ascorbic acid|mesh-list
110573544|NCT00803530|Antioxidants|antioxidants|mesh-ancestor
110573545|NCT00803530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110573546|NCT00803530|Protective Agents|protective agents|mesh-ancestor
110573547|NCT00803530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110573548|NCT00803530|Vitamins|vitamins|mesh-ancestor
110573549|NCT00803530|Micronutrients|micronutrients|mesh-ancestor
110573550|NCT00803764|Naproxen|naproxen|mesh-list
110573551|NCT00803764|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110573552|NCT00803764|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110573553|NCT00803764|Analgesics|analgesics|mesh-ancestor
110573554|NCT00803764|Sensory System Agents|sensory system agents|mesh-ancestor
110573555|NCT00803764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110573556|NCT00803764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110573557|NCT00803764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110573558|NCT00803764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110573559|NCT00803764|Gout Suppressants|gout suppressants|mesh-ancestor
110573560|NCT00803764|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110573561|NCT00803764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110573562|NCT00803764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110573563|NCT00704366|Saracatinib|saracatinib|mesh-list
110573564|NCT00704366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110573565|NCT00704366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110573566|NCT00704366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110573567|NCT00708266|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
110573568|NCT00708266|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
110573569|NCT00708266|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
110573570|NCT00708266|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110573571|NCT00803842|Doxycycline|doxycycline|mesh-list
110573572|NCT00803842|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110573573|NCT00803842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110573574|NCT00803842|Antimalarials|antimalarials|mesh-ancestor
110573575|NCT00803842|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110573576|NCT00803842|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110573577|NCT00658528|Esomeprazole|esomeprazole|mesh-list
110573578|NCT00658528|Rabeprazole|rabeprazole|mesh-list
110573579|NCT00658528|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110573580|NCT00658528|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110573581|NCT00658528|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110573582|NCT00658528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110573583|NCT00658528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110573584|NCT00856583|Risperidone|risperidone|mesh-list
110573585|NCT00856583|Sertindole|sertindole|mesh-list
110573586|NCT00856583|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110573587|NCT00856583|Serotonin Agents|serotonin agents|mesh-ancestor
110573588|NCT00856583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110573589|NCT00856583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110573590|NCT00856583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110573591|NCT00856583|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110573592|NCT00856583|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110573593|NCT00856583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110573594|NCT00856583|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110573595|NCT00856583|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110573596|NCT00856583|Dopamine Agents|dopamine agents|mesh-ancestor
110573597|NCT00803244|Immunomodulating Agents|immunomodulating agents|mesh-list
110573598|NCT00803244|Immunologic Factors|immunologic factors|mesh-ancestor
110573599|NCT00803244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110573601|NCT05753280|Vitamins|vitamins|mesh-ancestor
110573602|NCT05753280|Micronutrients|micronutrients|mesh-ancestor
110573603|NCT05753280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110573604|NCT05753280|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110573605|NCT00824408|Pemetrexed|pemetrexed|mesh-list
110573606|NCT00824408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110573607|NCT00824408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110573608|NCT00824408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110573609|NCT00824408|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110573610|NCT00824408|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110573611|NCT02611700|Paclitaxel|paclitaxel|mesh-list
110573612|NCT02611700|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110573613|NCT02611700|Cisplatin|cisplatin|mesh-list
110573614|NCT02611700|Nimotuzumab|nimotuzumab|mesh-list
110573615|NCT02611700|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110573616|NCT02611700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110573617|NCT02611700|Tubulin Modulators|tubulin modulators|mesh-ancestor
110573618|NCT02611700|Antimitotic Agents|antimitotic agents|mesh-ancestor
110573619|NCT02611700|Mitosis Modulators|mitosis modulators|mesh-ancestor
110573620|NCT02611700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110573621|NCT02611700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110573622|NCT00708344|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110573623|NCT00708344|Irbesartan|irbesartan|mesh-list
110573624|NCT00708344|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110573625|NCT00708344|Diuretics|diuretics|mesh-ancestor
110573626|NCT00708344|Natriuretic Agents|natriuretic agents|mesh-ancestor
110573627|NCT00708344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110573628|NCT00708344|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110573629|NCT00708344|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110573630|NCT00708344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110573631|NCT00708344|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110573632|NCT00708344|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110573633|NCT00866333|Entinostat|entinostat|mesh-list
110573634|NCT00866333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110573635|NCT00866333|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110573636|NCT00866333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110573637|NCT00866333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110573638|NCT00834080|Naltrexone|naltrexone|mesh-list
110573639|NCT00834080|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110573640|NCT00834080|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110573641|NCT00834080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110573642|NCT00834080|Sensory System Agents|sensory system agents|mesh-ancestor
110573643|NCT00834080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110573644|NCT00823472|Ganirelix|ganirelix|mesh-list
110573645|NCT00823472|Hormone Antagonists|hormone antagonists|mesh-ancestor
110573646|NCT00823472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110573647|NCT00823472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110573648|NCT04118699|Rifaximin|rifaximin|mesh-list
110573649|NCT04118699|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110573650|NCT04118699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110573651|NCT04118699|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110573652|NCT00856193|Glycopyrrolate|glycopyrrolate|mesh-list
110573653|NCT00856193|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110573654|NCT00856193|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110573655|NCT00856193|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110573656|NCT00856193|Cholinergic Agents|cholinergic agents|mesh-ancestor
110573657|NCT00856193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110573658|NCT00856193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110573659|NCT00856193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110573660|NCT04130087|Selegiline|selegiline|mesh-list
110573661|NCT04130087|Antidepressive Agents|antidepressive agents|mesh-ancestor
110573662|NCT04130087|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110573663|NCT04130087|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110573664|NCT04130087|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110573665|NCT04130087|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
110573666|NCT04130087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110573667|NCT04130087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110573668|NCT04130087|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110573669|NCT04130087|Protective Agents|protective agents|mesh-ancestor
110573670|NCT04130087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110573671|NCT00652366|Gemcitabine|gemcitabine|mesh-list
110573672|NCT00652366|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110573673|NCT00652366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110573674|NCT00652366|Antimetabolites|antimetabolites|mesh-ancestor
110573675|NCT00652366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110573676|NCT00652366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110573677|NCT00652366|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110573678|NCT00652366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110573680|NCT00841568|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
110573681|NCT00841568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110573682|NCT00841568|Natriuretic Agents|natriuretic agents|mesh-ancestor
110573683|NCT00841568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110573684|NCT00855959|Budesonide|budesonide|mesh-list
110573685|NCT00855959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110573686|NCT00855959|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110573687|NCT00855959|Autonomic Agents|autonomic agents|mesh-ancestor
110573688|NCT00855959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110573689|NCT00855959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110573690|NCT00855959|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110573691|NCT00855959|Respiratory System Agents|respiratory system agents|mesh-ancestor
110573692|NCT00855959|Glucocorticoids|glucocorticoids|mesh-ancestor
110573693|NCT00855959|Hormones|hormones|mesh-ancestor
110573694|NCT00855959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110573696|NCT00704600|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110573697|NCT00704600|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110573698|NCT00704600|Protease Inhibitors|protease inhibitors|mesh-ancestor
110573699|NCT00704600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110573700|NCT00704600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110573701|NCT00704600|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110573702|NCT00704600|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110573703|NCT00704600|Antiviral Agents|antiviral agents|mesh-ancestor
110573704|NCT00704600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110573705|NCT00699881|Cetuximab|cetuximab|mesh-list
110573706|NCT00699881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110573707|NCT00699881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110573708|NCT00708578|Metformin|metformin|mesh-list
110573709|NCT00708578|Insulin Glargine|insulin glargine|mesh-list
110573710|NCT00708578|Glimepiride|glimepiride|mesh-list
110573711|NCT00708578|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110573712|NCT00708578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110573713|NCT00708578|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110573714|NCT00708578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110573715|NCT00708578|Immunologic Factors|immunologic factors|mesh-ancestor
110573716|NCT00704678|Sevelamer|sevelamer|mesh-list
110573717|NCT00704678|Chelating Agents|chelating agents|mesh-ancestor
110573718|NCT00704678|Sequestering Agents|sequestering agents|mesh-ancestor
110573719|NCT00704678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110573720|NCT00708656|Mesalamine|mesalamine|mesh-list
110573721|NCT00708656|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110573722|NCT00708656|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110573723|NCT00708656|Analgesics|analgesics|mesh-ancestor
110573724|NCT00708656|Sensory System Agents|sensory system agents|mesh-ancestor
110573725|NCT00708656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110573726|NCT00708656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110573727|NCT00708656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110573728|NCT00708656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110573729|NCT00913328|Montelukast|montelukast|mesh-list
110573730|NCT00913328|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110573731|NCT00913328|Respiratory System Agents|respiratory system agents|mesh-ancestor
110573732|NCT00913328|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110573733|NCT00913328|Hormone Antagonists|hormone antagonists|mesh-ancestor
110573734|NCT00913328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110573735|NCT00913328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110573736|NCT00913328|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110573737|NCT00913328|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110573738|NCT00913328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110573739|NCT00804310|Lapatinib|lapatinib|mesh-list
110573740|NCT00804310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110573741|NCT00804310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110573742|NCT00804310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110573743|NCT00804310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110573744|NCT04118777|Ropivacaine|ropivacaine|mesh-list
110573745|NCT04118777|Anesthetics, Local|anesthetics, local|mesh-ancestor
110221164|NCT00080444|Hormones|hormones|mesh-ancestor
110573746|NCT04118777|Anesthetics|anesthetics|mesh-ancestor
110573747|NCT04118777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110573748|NCT04118777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110573749|NCT04118777|Sensory System Agents|sensory system agents|mesh-ancestor
110573750|NCT04118777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110573751|NCT00708812|Paclitaxel|paclitaxel|mesh-list
110573752|NCT00708812|Carboplatin|carboplatin|mesh-list
110573753|NCT00708812|Endostar protein|endostar protein|mesh-list
110573754|NCT00708812|Endostatins|endostatins|mesh-list
110573755|NCT00708812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110573756|NCT00708812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110573757|NCT00708812|Tubulin Modulators|tubulin modulators|mesh-ancestor
110573758|NCT00708812|Antimitotic Agents|antimitotic agents|mesh-ancestor
110573759|NCT00708812|Mitosis Modulators|mitosis modulators|mesh-ancestor
110573760|NCT00708812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110573761|NCT00708812|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110573762|NCT00708812|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110573763|NCT00708812|Growth Substances|growth substances|mesh-ancestor
110573764|NCT00708812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110573765|NCT00708812|Growth Inhibitors|growth inhibitors|mesh-ancestor
110573766|NCT04127747|Rituximab|rituximab|mesh-list
110573767|NCT04127747|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110573768|NCT04127747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110573769|NCT04127747|Immunologic Factors|immunologic factors|mesh-ancestor
110573770|NCT04127747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110573771|NCT04127747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110573772|NCT00822926|Botulinum Toxins|botulinum toxins|mesh-list
110573773|NCT00822926|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110573774|NCT00822926|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110573775|NCT00822926|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110573776|NCT00822926|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110573777|NCT00822926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110573778|NCT00822926|Cholinergic Agents|cholinergic agents|mesh-ancestor
110573779|NCT00822926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110573780|NCT00822926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110573781|NCT00822926|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110573782|NCT00822926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110573783|NCT00822770|Plerixafor|plerixafor|mesh-list
110573784|NCT00822770|Fludarabine|fludarabine|mesh-list
110573785|NCT00822770|Fludarabine phosphate|fludarabine phosphate|mesh-list
110573786|NCT00822770|Busulfan|busulfan|mesh-list
110573787|NCT00822770|Thymoglobulin|thymoglobulin|mesh-list
110573788|NCT00822770|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110573789|NCT00822770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110573790|NCT00822770|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110573791|NCT00822770|Antimetabolites|antimetabolites|mesh-ancestor
110573792|NCT00822770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110573793|NCT00822770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110573794|NCT00822770|Immunologic Factors|immunologic factors|mesh-ancestor
110573795|NCT00822770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110573796|NCT00822770|Antiviral Agents|antiviral agents|mesh-ancestor
110573797|NCT00822770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110573798|NCT00822770|Alkylating Agents|alkylating agents|mesh-ancestor
110573799|NCT00822770|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110573800|NCT00822770|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110573801|NCT00822770|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110573802|NCT00822770|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110573803|NCT02842086|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110573804|NCT02842086|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
110573805|NCT02842086|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110573806|NCT02842086|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110573807|NCT02842086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110573808|NCT02842086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110573809|NCT02842086|Antiviral Agents|antiviral agents|mesh-ancestor
110573810|NCT02842086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110573811|NCT02842086|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110573812|NCT02842086|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110573813|NCT00822692|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
110573814|NCT00822692|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110573815|NCT00822692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110573816|NCT00822692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110573817|NCT00822692|Antimalarials|antimalarials|mesh-ancestor
110573818|NCT00822692|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110573819|NCT00822692|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110573821|NCT02607111|Tinzaparin|tinzaparin|mesh-list
110573822|NCT02607111|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
110573823|NCT02607111|Anticoagulants|anticoagulants|mesh-ancestor
110573824|NCT02607111|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110573825|NCT02607111|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110573826|NCT02607111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110573827|NCT00703196|Folic Acid|folic acid|mesh-list
110573828|NCT00703196|Hematinics|hematinics|mesh-ancestor
110573829|NCT00703196|Vitamin B Complex|vitamin b complex|mesh-ancestor
110573830|NCT00703196|Vitamins|vitamins|mesh-ancestor
110573831|NCT00703196|Micronutrients|micronutrients|mesh-ancestor
110573832|NCT00703196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110573833|NCT00913250|Interferon beta-1a|interferon beta-1a|mesh-list
110573834|NCT00913250|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110573835|NCT00913250|Immunologic Factors|immunologic factors|mesh-ancestor
110573836|NCT00913250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110573837|NCT00913250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110573838|NCT00913250|Antiviral Agents|antiviral agents|mesh-ancestor
110573839|NCT00913250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110573840|NCT00914277|Sildenafil Citrate|sildenafil citrate|mesh-list
110573841|NCT00914277|Vasodilator Agents|vasodilator agents|mesh-ancestor
110573842|NCT00914277|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110573843|NCT00914277|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110573844|NCT00914277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110573845|NCT00914277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110573846|NCT00914277|Urological Agents|urological agents|mesh-ancestor
110573847|NCT00704756|Ribavirin|ribavirin|mesh-list
110573848|NCT00704756|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110573849|NCT00704756|Interferon-alpha|interferon-alpha|mesh-list
110573850|NCT00704756|Antimetabolites|antimetabolites|mesh-ancestor
110573851|NCT00704756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110573852|NCT00704756|Antiviral Agents|antiviral agents|mesh-ancestor
110573853|NCT00704756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110573854|NCT00704756|Immunologic Factors|immunologic factors|mesh-ancestor
110573855|NCT00704756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110573856|NCT00806442|Borage oil|borage oil|mesh-list
110573857|NCT00806442|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110573858|NCT02608242|Amlodipine|amlodipine|mesh-list
110573859|NCT02608242|Telmisartan|telmisartan|mesh-list
110573860|NCT02608242|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
110573861|NCT02608242|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110573862|NCT02608242|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110573863|NCT02608242|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110573864|NCT02608242|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110573865|NCT02608242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110573866|NCT02608242|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110573867|NCT02608242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110573868|NCT02608242|Vasodilator Agents|vasodilator agents|mesh-ancestor
110573869|NCT02608242|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110573870|NCT02608242|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110573871|NCT02608242|Antimetabolites|antimetabolites|mesh-ancestor
110573872|NCT02608242|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110573873|NCT02608242|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110573874|NCT02608242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110573875|NCT02608242|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110573876|NCT02608242|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110573877|NCT02607696|Zolpidem|zolpidem|mesh-list
110573878|NCT02607696|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110573879|NCT02607696|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110573880|NCT02607696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110573881|NCT02607696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110573882|NCT02607696|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
110573883|NCT02607696|GABA Agonists|gaba agonists|mesh-ancestor
110573884|NCT02607696|GABA Agents|gaba agents|mesh-ancestor
110573885|NCT02607696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110573886|NCT02607696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110573887|NCT00839852|Cariprazine|cariprazine|mesh-list
110573888|NCT00839852|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110573889|NCT00839852|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110573890|NCT00839852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110573891|NCT00839852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110573892|NCT00839852|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110573893|NCT02604849|Gentamicins|gentamicins|mesh-list
110573894|NCT02604849|Neomycin|neomycin|mesh-list
110573895|NCT02604849|Streptomycin|streptomycin|mesh-list
110573896|NCT02604849|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110573897|NCT02604849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110573898|NCT02604849|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110573899|NCT02604849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110573900|NCT02604849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110573901|NCT00709046|Pantoprazole|pantoprazole|mesh-list
110573902|NCT00709046|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110573903|NCT00709046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110573904|NCT00709046|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110573905|NCT00709046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110573906|NCT00709046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110573907|NCT00820898|Gemcitabine|gemcitabine|mesh-list
110573908|NCT00820898|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110573909|NCT00820898|Antimetabolites|antimetabolites|mesh-ancestor
110573910|NCT00820898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110573911|NCT00820898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110573912|NCT00865709|Leucovorin|leucovorin|mesh-list
110573913|NCT00865709|Oxaliplatin|oxaliplatin|mesh-list
110573914|NCT00865709|Fluorouracil|fluorouracil|mesh-list
110573915|NCT00865709|Sorafenib|sorafenib|mesh-list
110573916|NCT00865709|Levoleucovorin|levoleucovorin|mesh-list
110573917|NCT00865709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110573918|NCT00865709|Antidotes|antidotes|mesh-ancestor
110573919|NCT00865709|Protective Agents|protective agents|mesh-ancestor
110573920|NCT00865709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110573921|NCT00865709|Vitamin B Complex|vitamin b complex|mesh-ancestor
110573922|NCT00865709|Vitamins|vitamins|mesh-ancestor
110573923|NCT00865709|Micronutrients|micronutrients|mesh-ancestor
110573924|NCT00865709|Antimetabolites|antimetabolites|mesh-ancestor
110573925|NCT00865709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110573926|NCT00865709|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110573927|NCT00865709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110573928|NCT00865709|Immunologic Factors|immunologic factors|mesh-ancestor
110573929|NCT00865709|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110573930|NCT00865709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110573931|NCT00839306|Rabeprazole|rabeprazole|mesh-list
110573932|NCT00839306|Ranitidine|ranitidine|mesh-list
110573933|NCT00839306|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
110573934|NCT00839306|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110573935|NCT00839306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110573936|NCT00839306|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110573937|NCT00839306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110573938|NCT00839306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110573939|NCT00839306|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110573940|NCT00839306|Histamine Antagonists|histamine antagonists|mesh-ancestor
110573941|NCT00839306|Histamine Agents|histamine agents|mesh-ancestor
110573942|NCT00839306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110573943|NCT00839306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110573944|NCT04131335|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110573945|NCT04131335|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110573946|NCT00839072|Trazodone|trazodone|mesh-list
110573947|NCT00839072|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110573948|NCT00839072|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110573949|NCT00839072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110573950|NCT00839072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110573951|NCT00839072|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110573952|NCT00839072|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110573953|NCT00839072|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110573954|NCT00839072|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110573955|NCT00839072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110573956|NCT00839072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110573957|NCT00839072|Serotonin Agents|serotonin agents|mesh-ancestor
110573958|NCT00839072|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110573959|NCT00839072|Antidepressive Agents|antidepressive agents|mesh-ancestor
110573960|NCT00704990|Vitamins|vitamins|mesh-list
110573961|NCT00704990|Ascorbic Acid|ascorbic acid|mesh-list
110573962|NCT00704990|Vitamin B 6|vitamin b 6|mesh-list
110573963|NCT00704990|Pyridoxal|pyridoxal|mesh-list
110573964|NCT00704990|Pyridoxine|pyridoxine|mesh-list
110573966|NCT00704990|Vitamin B Complex|vitamin b complex|mesh-list
110573967|NCT00704990|Micronutrients|micronutrients|mesh-ancestor
110573968|NCT00704990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110573969|NCT00704990|Trace Elements|trace elements|mesh-ancestor
110573970|NCT00704990|Antioxidants|antioxidants|mesh-ancestor
110573971|NCT00704990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110221393|NCT00306358|Vitamin B 12|vitamin b 12|mesh-list
110573973|NCT02607774|Midazolam|midazolam|mesh-list
110573974|NCT02607774|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110573975|NCT02607774|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110573976|NCT02607774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110573977|NCT02607774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110573978|NCT02607774|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110573979|NCT02607774|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110573980|NCT02607774|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110573981|NCT02607774|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110573982|NCT02607774|Anesthetics, General|anesthetics, general|mesh-ancestor
110573983|NCT02607774|Anesthetics|anesthetics|mesh-ancestor
110573984|NCT02607774|GABA Modulators|gaba modulators|mesh-ancestor
110573985|NCT02607774|GABA Agents|gaba agents|mesh-ancestor
110573986|NCT02607774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110573987|NCT02607774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110573988|NCT00838916|Insulin Glargine|insulin glargine|mesh-list
110573989|NCT00838916|rGLP-1 protein|rglp-1 protein|mesh-list
110573990|NCT00838916|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110573991|NCT00838916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110573993|NCT00838916|Hormones|hormones|mesh-ancestor
110573994|NCT00838916|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110573995|NCT00838682|Omeprazole|omeprazole|mesh-list
110573996|NCT00838682|Rabeprazole|rabeprazole|mesh-list
110573997|NCT00838682|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110573998|NCT00838682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110573999|NCT00838682|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110574000|NCT00838682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110574001|NCT00838682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110574002|NCT00913484|Disulfiram|disulfiram|mesh-list
110574003|NCT00913484|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110574004|NCT00913484|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
110574005|NCT00913484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110574006|NCT00913484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110574007|NCT00803712|Vitamin D|vitamin d|mesh-list
110574008|NCT00803712|Ergocalciferols|ergocalciferols|mesh-list
110574009|NCT00803712|Cholecalciferol|cholecalciferol|mesh-list
110574010|NCT00803712|Vitamins|vitamins|mesh-list
110574011|NCT00803712|Cinacalcet|cinacalcet|mesh-list
110574012|NCT00803712|Micronutrients|micronutrients|mesh-ancestor
110574013|NCT00803712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110574014|NCT00803712|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110574015|NCT00803712|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110574016|NCT00803712|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
110574017|NCT00803712|Hormone Antagonists|hormone antagonists|mesh-ancestor
110574018|NCT00803712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110574019|NCT00803634|Antihypertensive Agents|antihypertensive agents|mesh-list
110574020|NCT00803634|Diltiazem|diltiazem|mesh-list
110574021|NCT00803634|Nitroprusside|nitroprusside|mesh-list
110574022|NCT00803634|Nicardipine|nicardipine|mesh-list
110574023|NCT00803634|Clevidipine|clevidipine|mesh-list
110574024|NCT00803634|Isosorbide|isosorbide|mesh-list
110574025|NCT00803634|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
110574026|NCT00803634|Nitroglycerin|nitroglycerin|mesh-list
110574027|NCT00803634|Vasodilator Agents|vasodilator agents|mesh-ancestor
110574028|NCT00803634|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110574029|NCT00803634|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110574030|NCT00803634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110574031|NCT00803634|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110574032|NCT00803634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110574033|NCT00803634|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110574034|NCT00803634|Diuretics|diuretics|mesh-ancestor
110574035|NCT00803634|Natriuretic Agents|natriuretic agents|mesh-ancestor
110574036|NCT00803634|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
110574037|NCT00838526|Rabeprazole|rabeprazole|mesh-list
110574038|NCT00838526|Ranitidine|ranitidine|mesh-list
110574039|NCT00838526|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
110574040|NCT00838526|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110574041|NCT00838526|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110574042|NCT00838526|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110574043|NCT00838526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110574044|NCT00838526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110574045|NCT00838526|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110574046|NCT00838526|Histamine Antagonists|histamine antagonists|mesh-ancestor
110574047|NCT00838526|Histamine Agents|histamine agents|mesh-ancestor
110574048|NCT00838526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110574049|NCT00838526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110574051|NCT00914472|Calcium heparin|calcium heparin|mesh-list
110574052|NCT00914472|Anticoagulants|anticoagulants|mesh-ancestor
110574053|NCT00914472|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110574054|NCT00914472|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110574055|NCT00914472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110574056|NCT02611466|Naproxen|naproxen|mesh-list
110574057|NCT02611466|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110574058|NCT02611466|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110574059|NCT02611466|Analgesics|analgesics|mesh-ancestor
110574060|NCT02611466|Sensory System Agents|sensory system agents|mesh-ancestor
110574061|NCT02611466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110574062|NCT02611466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110574063|NCT02611466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110574064|NCT02611466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110574065|NCT02611466|Gout Suppressants|gout suppressants|mesh-ancestor
110574066|NCT02611466|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110574067|NCT02611466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110574068|NCT02611466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110574069|NCT02688270|Nitroglycerin|nitroglycerin|mesh-list
110574070|NCT02688270|Vasodilator Agents|vasodilator agents|mesh-ancestor
110574071|NCT02610920|Iron|iron|mesh-list
110574072|NCT02610920|Trace Elements|trace elements|mesh-ancestor
110574073|NCT02610920|Micronutrients|micronutrients|mesh-ancestor
110574074|NCT02610920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110574075|NCT00913562|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110574076|NCT00913562|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110574077|NCT00913562|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110574078|NCT00913562|Antimetabolites|antimetabolites|mesh-ancestor
110574079|NCT00913562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110574080|NCT00913562|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110574081|NCT00913562|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110574082|NCT00913562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110574083|NCT00818168|Infliximab|infliximab|mesh-list
110574084|NCT00818168|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110574085|NCT00818168|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110574086|NCT00818168|Dermatologic Agents|dermatologic agents|mesh-ancestor
110574087|NCT00818168|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110574088|NCT00818168|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110574089|NCT02607540|Cisplatin|cisplatin|mesh-list
110574091|NCT02607540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110574092|NCT02607540|Antimetabolites|antimetabolites|mesh-ancestor
110574093|NCT02607540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110574094|NCT02607540|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110574095|NCT02607540|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110574096|NCT02607540|Immunologic Factors|immunologic factors|mesh-ancestor
110574097|NCT02607540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110574098|NCT00705692|Levamisole|levamisole|mesh-list
110574099|NCT00705692|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110574100|NCT00705692|Immunologic Factors|immunologic factors|mesh-ancestor
110574101|NCT00705692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110574102|NCT00705692|Antinematodal Agents|antinematodal agents|mesh-ancestor
110574103|NCT00705692|Anthelmintics|anthelmintics|mesh-ancestor
110574104|NCT00705692|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110574105|NCT00705692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110574107|NCT00705770|Hydrocortisone|hydrocortisone|mesh-list
110574108|NCT00705770|Anecortave|anecortave|mesh-list
110574109|NCT00705770|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110574110|NCT00705770|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110574111|NCT00705770|Growth Substances|growth substances|mesh-ancestor
110574112|NCT00705770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110574113|NCT00705770|Growth Inhibitors|growth inhibitors|mesh-ancestor
110574114|NCT00705770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110574115|NCT00705770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110574116|NCT00796653|Formoterol Fumarate|formoterol fumarate|mesh-list
110574117|NCT00796653|Olodaterol|olodaterol|mesh-list
110574118|NCT00796653|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110574119|NCT00796653|Autonomic Agents|autonomic agents|mesh-ancestor
110574120|NCT00796653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110574121|NCT00796653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110574122|NCT00796653|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110574123|NCT00796653|Respiratory System Agents|respiratory system agents|mesh-ancestor
110574124|NCT00796653|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110574125|NCT00796653|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110574126|NCT00796653|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110574127|NCT00796653|Adrenergic Agents|adrenergic agents|mesh-ancestor
110574128|NCT00796653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110574129|NCT00796653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110574131|NCT00806286|Carboplatin|carboplatin|mesh-list
110574132|NCT00806286|Efatutazone|efatutazone|mesh-list
110574133|NCT00806286|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110574134|NCT00806286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110574135|NCT00806286|Tubulin Modulators|tubulin modulators|mesh-ancestor
110574136|NCT00806286|Antimitotic Agents|antimitotic agents|mesh-ancestor
110574137|NCT00806286|Mitosis Modulators|mitosis modulators|mesh-ancestor
110574138|NCT00806286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110574139|NCT03537924|Acetazolamide|acetazolamide|mesh-list
110574140|NCT03537924|Anticonvulsants|anticonvulsants|mesh-ancestor
110574141|NCT03537924|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110574142|NCT03537924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110574143|NCT03537924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110574145|NCT03537924|Natriuretic Agents|natriuretic agents|mesh-ancestor
110574146|NCT03537924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110574147|NCT00590538|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
110574148|NCT00590538|Genistein|genistein|mesh-list
110574149|NCT00590538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110574150|NCT00590538|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110574151|NCT00590538|Protective Agents|protective agents|mesh-ancestor
110574152|NCT00590538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110574153|NCT00590538|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110574154|NCT00590538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110574155|NCT00590538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110574156|NCT00590538|Phytoestrogens|phytoestrogens|mesh-ancestor
110574157|NCT00590538|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
110574158|NCT00590538|Estrogens|estrogens|mesh-ancestor
110574159|NCT00590538|Hormones|hormones|mesh-ancestor
110374260|NCT00573950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110574160|NCT00590538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110574161|NCT02608320|Fentanyl|fentanyl|mesh-list
110574162|NCT02608320|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110574163|NCT02608320|Narcotics|narcotics|mesh-ancestor
110574164|NCT02608320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110574165|NCT02608320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110574166|NCT02608320|Analgesics|analgesics|mesh-ancestor
110574167|NCT02608320|Sensory System Agents|sensory system agents|mesh-ancestor
110574168|NCT02608320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110574169|NCT02608320|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110574170|NCT02608320|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110574171|NCT02608320|Anesthetics, General|anesthetics, general|mesh-ancestor
110574172|NCT02608320|Anesthetics|anesthetics|mesh-ancestor
110574173|NCT01731444|Phenylephrine|phenylephrine|mesh-list
110574174|NCT01731444|Oxymetazoline|oxymetazoline|mesh-list
110574175|NCT01731444|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110574176|NCT01731444|Mydriatics|mydriatics|mesh-ancestor
110574177|NCT01731444|Autonomic Agents|autonomic agents|mesh-ancestor
110574178|NCT01731444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110574179|NCT01731444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110574180|NCT01731444|Sympathomimetics|sympathomimetics|mesh-ancestor
110574181|NCT01731444|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110574182|NCT01731444|Nasal Decongestants|nasal decongestants|mesh-ancestor
110574183|NCT01731444|Respiratory System Agents|respiratory system agents|mesh-ancestor
110574184|NCT01731444|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110574185|NCT01731444|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110574186|NCT01731444|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110574187|NCT01731444|Adrenergic Agents|adrenergic agents|mesh-ancestor
110574188|NCT01731444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110574189|NCT01731444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110574190|NCT01731444|Protective Agents|protective agents|mesh-ancestor
110574191|NCT05728788|Antineoplastic Agents|antineoplastic agents|mesh-list
110574192|NCT02608164|Vitamin D|vitamin d|mesh-list
110574193|NCT02608164|Cholecalciferol|cholecalciferol|mesh-list
110574194|NCT02608164|Vitamins|vitamins|mesh-ancestor
110574195|NCT02608164|Micronutrients|micronutrients|mesh-ancestor
110574196|NCT02608164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110574197|NCT02608164|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110574198|NCT02608164|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110574199|NCT00796419|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
110221618|NCT00081107|Epothilones|epothilones|mesh-list
110574201|NCT00796419|Blood Substitutes|blood substitutes|mesh-ancestor
110574202|NCT04110873|Ubiquinone|ubiquinone|mesh-list
110574203|NCT04110873|Micronutrients|micronutrients|mesh-ancestor
110574204|NCT04110873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110574205|NCT02604615|Capecitabine|capecitabine|mesh-list
110574206|NCT02604615|Oxaliplatin|oxaliplatin|mesh-list
110574207|NCT02604615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110574208|NCT02604615|Antimetabolites|antimetabolites|mesh-ancestor
110574209|NCT02604615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110574210|NCT02604615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110574211|NCT00796107|Letrozole|letrozole|mesh-list
110574212|NCT00796107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110574213|NCT00796107|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110574214|NCT00796107|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110574215|NCT00796107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110574216|NCT00796107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110574217|NCT00796107|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110574218|NCT00796107|Hormone Antagonists|hormone antagonists|mesh-ancestor
110574219|NCT00796107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110574220|NCT00796107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110574221|NCT00805740|Caspofungin|caspofungin|mesh-list
110574222|NCT00805740|Anidulafungin|anidulafungin|mesh-list
110574223|NCT00805740|Antifungal Agents|antifungal agents|mesh-ancestor
110574224|NCT00805740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110574225|NCT00805740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110574226|NCT00805740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110574227|NCT05613075|Hyaluronic Acid|hyaluronic acid|mesh-list
110574228|NCT05613075|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110574229|NCT05613075|Immunologic Factors|immunologic factors|mesh-ancestor
110574230|NCT05613075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110574231|NCT05613075|Viscosupplements|viscosupplements|mesh-ancestor
110574232|NCT05613075|Protective Agents|protective agents|mesh-ancestor
110574233|NCT01227876|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110574234|NCT01227876|Methylprednisolone|methylprednisolone|mesh-list
110574235|NCT01227876|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110574236|NCT01227876|Prednisolone|prednisolone|mesh-list
110574237|NCT01227876|Prednisolone acetate|prednisolone acetate|mesh-list
110574238|NCT01227876|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110574239|NCT01227876|Prednisolone phosphate|prednisolone phosphate|mesh-list
110574240|NCT01227876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110574241|NCT01227876|Antiemetics|antiemetics|mesh-ancestor
110574242|NCT01227876|Autonomic Agents|autonomic agents|mesh-ancestor
110574243|NCT01227876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110574244|NCT01227876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110574245|NCT01227876|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110574246|NCT01227876|Glucocorticoids|glucocorticoids|mesh-ancestor
110574247|NCT01227876|Hormones|hormones|mesh-ancestor
110574248|NCT01227876|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110574249|NCT01227876|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110574250|NCT01227876|Protective Agents|protective agents|mesh-ancestor
110574251|NCT01227876|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110574252|NCT01227876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110574254|NCT00795639|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
110574255|NCT00795639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110574256|NCT05297292|Ranibizumab|ranibizumab|mesh-list
110574257|NCT05297292|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110574258|NCT05297292|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110574259|NCT05297292|Growth Substances|growth substances|mesh-ancestor
110574260|NCT05297292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110574261|NCT05297292|Growth Inhibitors|growth inhibitors|mesh-ancestor
110574262|NCT05297292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110574263|NCT02604459|Fentanyl|fentanyl|mesh-list
110574264|NCT02604459|Anesthetics|anesthetics|mesh-list
110574265|NCT02604459|Propofol|propofol|mesh-list
110574266|NCT02604459|Sevoflurane|sevoflurane|mesh-list
110574267|NCT02604459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110574268|NCT02604459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110574269|NCT02604459|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110574270|NCT02604459|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110574271|NCT02604459|Anesthetics, General|anesthetics, general|mesh-ancestor
110574272|NCT02604459|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110574273|NCT02604459|Narcotics|narcotics|mesh-ancestor
110574274|NCT02604459|Analgesics|analgesics|mesh-ancestor
110574275|NCT02604459|Sensory System Agents|sensory system agents|mesh-ancestor
110574276|NCT02604459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110574277|NCT02604459|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110574278|NCT02604459|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110574279|NCT02604459|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110574281|NCT02604225|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110574282|NCT02604225|Anesthetics, General|anesthetics, general|mesh-ancestor
110574283|NCT02604225|Anesthetics|anesthetics|mesh-ancestor
110574284|NCT02604225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110574285|NCT02604225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110574286|NCT02607072|Aspirin|aspirin|mesh-list
110574287|NCT02607072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110574288|NCT02607072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110574289|NCT02607072|Analgesics|analgesics|mesh-ancestor
110574290|NCT02607072|Sensory System Agents|sensory system agents|mesh-ancestor
110574291|NCT02607072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110574292|NCT02607072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110574293|NCT02607072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110574295|NCT02607072|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110574296|NCT02607072|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110574297|NCT02607072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110574298|NCT02607072|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110574299|NCT02607072|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110574300|NCT02607072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110574302|NCT04110093|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
110574303|NCT04110093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110574304|NCT04110093|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110574305|NCT04110093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110574306|NCT00588237|Paclitaxel|paclitaxel|mesh-list
110574307|NCT00588237|Bevacizumab|bevacizumab|mesh-list
110574308|NCT00588237|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110574309|NCT00588237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110574310|NCT00588237|Tubulin Modulators|tubulin modulators|mesh-ancestor
110574311|NCT00588237|Antimitotic Agents|antimitotic agents|mesh-ancestor
110574312|NCT00588237|Mitosis Modulators|mitosis modulators|mesh-ancestor
110574313|NCT00588237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110148644|NCT00006786|Growth Substances|growth substances|mesh-ancestor
110574314|NCT00588237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110574315|NCT00588237|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110574316|NCT00588237|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110574317|NCT00588237|Growth Substances|growth substances|mesh-ancestor
110574318|NCT00588237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110574319|NCT00588237|Growth Inhibitors|growth inhibitors|mesh-ancestor
110574320|NCT02605746|Ceritinib|ceritinib|mesh-list
110574321|NCT02605746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110574322|NCT02605746|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110574323|NCT02605746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110574324|NCT02605746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110574325|NCT04109859|Methylene Blue|methylene blue|mesh-list
110574326|NCT04109859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110574327|NCT04109859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110574328|NCT00790023|Ciclesonide|ciclesonide|mesh-list
110574329|NCT00790023|Glucocorticoids|glucocorticoids|mesh-ancestor
110574330|NCT00790023|Hormones|hormones|mesh-ancestor
110574331|NCT00790023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110574332|NCT00790023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110574333|NCT00790023|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110574334|NCT00588822|Rituximab|rituximab|mesh-list
110574335|NCT00588822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110574336|NCT00588822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110574337|NCT00588822|Immunologic Factors|immunologic factors|mesh-ancestor
110574338|NCT00588822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110574339|NCT00588822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110574340|NCT05563467|Pembrolizumab|pembrolizumab|mesh-list
110574341|NCT05563467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110574342|NCT05563467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110574343|NCT05563467|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110574344|NCT05563467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110574345|NCT00589914|Paliperidone Palmitate|paliperidone palmitate|mesh-list
110574346|NCT00589914|Risperidone|risperidone|mesh-list
110574347|NCT00589914|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110574348|NCT00589914|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110574349|NCT00589914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110574350|NCT00589914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110574351|NCT00589914|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110374281|NCT00586365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110574352|NCT00589914|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110574353|NCT00589914|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110574354|NCT00589914|Serotonin Agents|serotonin agents|mesh-ancestor
110574355|NCT00589914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110574356|NCT00589914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110574357|NCT00589914|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110574358|NCT00589914|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110574359|NCT00589914|Dopamine Agents|dopamine agents|mesh-ancestor
110574360|NCT00789555|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
110574361|NCT00789555|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110574362|NCT00789555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110574363|NCT00789555|Analgesics|analgesics|mesh-ancestor
110574364|NCT00789555|Sensory System Agents|sensory system agents|mesh-ancestor
110574365|NCT00789555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110574366|NCT00789555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110574367|NCT00789555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110574368|NCT00789555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110574369|NCT00789555|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110574370|NCT00789555|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110574371|NCT00789555|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110574372|NCT00789555|Histamine Antagonists|histamine antagonists|mesh-ancestor
110574373|NCT00789555|Histamine Agents|histamine agents|mesh-ancestor
110574374|NCT00789555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110574375|NCT00789555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110574377|NCT03770455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110574378|NCT03770455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110574379|NCT01026337|Sunitinib|sunitinib|mesh-list
110574380|NCT01026337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110574381|NCT01026337|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110574382|NCT01026337|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110574384|NCT01026337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110574385|NCT01026337|Growth Inhibitors|growth inhibitors|mesh-ancestor
110574386|NCT01026337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110574387|NCT01026337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110574388|NCT01026337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110574389|NCT03746275|Aspirin|aspirin|mesh-list
110574390|NCT03746275|Rivaroxaban|rivaroxaban|mesh-list
110574391|NCT03746275|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110574392|NCT03746275|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110574393|NCT03746275|Analgesics|analgesics|mesh-ancestor
110574394|NCT03746275|Sensory System Agents|sensory system agents|mesh-ancestor
110574395|NCT03746275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110574396|NCT03746275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110574397|NCT03746275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110574398|NCT03746275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110574399|NCT03746275|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110574400|NCT03746275|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110574401|NCT03746275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110574402|NCT03746275|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110574403|NCT03746275|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110574404|NCT03746275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110574405|NCT03746275|Antipyretics|antipyretics|mesh-ancestor
110574406|NCT03746275|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110574407|NCT03746275|Antithrombins|antithrombins|mesh-ancestor
110574408|NCT03746275|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110574409|NCT03746275|Protease Inhibitors|protease inhibitors|mesh-ancestor
110574410|NCT03746275|Anticoagulants|anticoagulants|mesh-ancestor
110574411|NCT01026415|Rifampin|rifampin|mesh-list
110574412|NCT01026415|Ketoconazole|ketoconazole|mesh-list
110574413|NCT01026415|Brentuximab Vedotin|brentuximab vedotin|mesh-list
110574414|NCT01026415|Midazolam|midazolam|mesh-list
110574415|NCT01026415|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110574416|NCT01026415|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110574417|NCT01026415|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110574418|NCT01026415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110374299|NCT00574769|Tubulin Modulators|tubulin modulators|mesh-ancestor
110574419|NCT01026415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110574420|NCT01026415|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110574421|NCT01026415|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110574422|NCT01026415|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110221841|NCT00399698|Risperidone|risperidone|mesh-list
110574423|NCT01026415|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110574424|NCT01026415|Anesthetics, General|anesthetics, general|mesh-ancestor
110574425|NCT01026415|Anesthetics|anesthetics|mesh-ancestor
110574426|NCT01026415|GABA Modulators|gaba modulators|mesh-ancestor
110574427|NCT01026415|GABA Agents|gaba agents|mesh-ancestor
110574428|NCT01026415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110574429|NCT01026415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110574430|NCT01026415|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110574431|NCT01026415|Antitubercular Agents|antitubercular agents|mesh-ancestor
110574432|NCT01026415|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110574433|NCT01026415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110574434|NCT01026415|Leprostatic Agents|leprostatic agents|mesh-ancestor
110574435|NCT01026415|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110574436|NCT01026415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110574437|NCT01026415|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110574438|NCT01026415|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110574440|NCT01026415|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110574441|NCT01026415|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110574442|NCT01026415|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110574443|NCT01026415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110574444|NCT01026415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110574445|NCT01026415|Immunotoxins|immunotoxins|mesh-ancestor
110574446|NCT01026415|Immunoconjugates|immunoconjugates|mesh-ancestor
110574447|NCT01026415|Immunologic Factors|immunologic factors|mesh-ancestor
110574448|NCT01026415|Antifungal Agents|antifungal agents|mesh-ancestor
110574449|NCT01026415|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110574450|NCT01026415|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110574451|NCT01026415|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110574452|NCT01026415|Hormone Antagonists|hormone antagonists|mesh-ancestor
110574453|NCT01026415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110574454|NCT01026415|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110574455|NCT01026727|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
110574456|NCT01026727|Antiviral Agents|antiviral agents|mesh-ancestor
110574457|NCT01026727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110574458|NCT02604966|Artesunate|artesunate|mesh-list
110574459|NCT02604966|Antimalarials|antimalarials|mesh-ancestor
110574460|NCT02604966|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110574461|NCT02604966|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110574462|NCT02604966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110574463|NCT02604966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110574464|NCT02604966|Antiviral Agents|antiviral agents|mesh-ancestor
110574465|NCT02604966|Schistosomicides|schistosomicides|mesh-ancestor
110574466|NCT02604966|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110574467|NCT02604966|Anthelmintics|anthelmintics|mesh-ancestor
110574468|NCT00914160|Diclofenac|diclofenac|mesh-list
110574469|NCT00914160|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110574470|NCT00914160|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110574471|NCT00914160|Analgesics|analgesics|mesh-ancestor
110574472|NCT00914160|Sensory System Agents|sensory system agents|mesh-ancestor
110574473|NCT00914160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110574474|NCT00914160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110574475|NCT00914160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110574476|NCT00914160|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110574477|NCT00914160|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110574478|NCT00914160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110574479|NCT00914160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110574480|NCT00450619|Metronidazole|metronidazole|mesh-list
110574481|NCT00450619|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
110574482|NCT00450619|Vaccines|vaccines|mesh-list
110574483|NCT00450619|Sargramostim|sargramostim|mesh-list
110574484|NCT00450619|Immunologic Factors|immunologic factors|mesh-ancestor
110574485|NCT00450619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110574486|NCT00450619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110574487|NCT00450619|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110574488|NCT00450619|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110574489|NCT00450619|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110574490|NCT00450619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110574491|NCT00450619|Analgesics|analgesics|mesh-ancestor
110574492|NCT00450619|Sensory System Agents|sensory system agents|mesh-ancestor
110574493|NCT00450619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110574494|NCT00802074|Ritonavir|ritonavir|mesh-list
110574495|NCT00802074|Fosamprenavir|fosamprenavir|mesh-list
110574496|NCT00802074|Raltegravir Potassium|raltegravir potassium|mesh-list
110574497|NCT00802074|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110574498|NCT00802074|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110574499|NCT00802074|Protease Inhibitors|protease inhibitors|mesh-ancestor
110574500|NCT00802074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110574501|NCT00802074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110574502|NCT00802074|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110574503|NCT00802074|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110148671|NCT00006864|Aldesleukin|aldesleukin|mesh-list
110574504|NCT00802074|Antiviral Agents|antiviral agents|mesh-ancestor
110574505|NCT00802074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110574506|NCT00802074|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110574507|NCT00802074|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110574508|NCT00802074|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110574509|NCT00802074|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110574510|NCT04112394|Anesthetics|anesthetics|mesh-list
110574511|NCT04112394|Anesthetics, Local|anesthetics, local|mesh-list
110574512|NCT04112394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110574513|NCT04112394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110574514|NCT04112394|Sensory System Agents|sensory system agents|mesh-ancestor
110574515|NCT04112394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110574516|NCT00450385|Prednisone|prednisone|mesh-list
110574517|NCT00450385|Cyclophosphamide|cyclophosphamide|mesh-list
110574518|NCT00450385|Rituximab|rituximab|mesh-list
110574519|NCT00450385|Doxorubicin|doxorubicin|mesh-list
110574520|NCT00450385|Vincristine|vincristine|mesh-list
110574521|NCT00450385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110574522|NCT00450385|Immunologic Factors|immunologic factors|mesh-ancestor
110574523|NCT00450385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110574524|NCT00450385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110574525|NCT00450385|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110574526|NCT00450385|Alkylating Agents|alkylating agents|mesh-ancestor
110574527|NCT00450385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110574528|NCT00450385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110574529|NCT00450385|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110574530|NCT00450385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110574531|NCT00450385|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110574532|NCT00450385|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110574533|NCT00450385|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110574534|NCT00450385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110574535|NCT00450385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110574536|NCT00450385|Glucocorticoids|glucocorticoids|mesh-ancestor
110574537|NCT00450385|Hormones|hormones|mesh-ancestor
110574538|NCT00450385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110574539|NCT00450385|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110574540|NCT00450385|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110574541|NCT00450385|Tubulin Modulators|tubulin modulators|mesh-ancestor
110574542|NCT00450385|Antimitotic Agents|antimitotic agents|mesh-ancestor
110574543|NCT00450385|Mitosis Modulators|mitosis modulators|mesh-ancestor
110574544|NCT00588354|Triamcinolone|triamcinolone|mesh-list
110574545|NCT00588354|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110574546|NCT00588354|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110574547|NCT00588354|Lidocaine|lidocaine|mesh-list
110574548|NCT00588354|Clonidine|clonidine|mesh-list
110574549|NCT00588354|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110574550|NCT00588354|Anesthetics, Local|anesthetics, local|mesh-ancestor
110574551|NCT00588354|Anesthetics|anesthetics|mesh-ancestor
110574552|NCT00588354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110574553|NCT00588354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110574554|NCT00588354|Sensory System Agents|sensory system agents|mesh-ancestor
110574555|NCT00588354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110574556|NCT00588354|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110148686|NCT00007059|Mycophenolic Acid|mycophenolic acid|mesh-list
110574557|NCT00588354|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110574559|NCT00588354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110574560|NCT00588354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110574561|NCT00588354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110574562|NCT00588354|Glucocorticoids|glucocorticoids|mesh-ancestor
110574563|NCT00588354|Hormones|hormones|mesh-ancestor
110574564|NCT00588354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110574565|NCT00588354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110574566|NCT00588354|Immunologic Factors|immunologic factors|mesh-ancestor
110574567|NCT00588354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110574568|NCT00588354|Analgesics|analgesics|mesh-ancestor
110574569|NCT00588354|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110574570|NCT00588354|Sympatholytics|sympatholytics|mesh-ancestor
110574571|NCT00588354|Autonomic Agents|autonomic agents|mesh-ancestor
110221987|NCT00082043|Dutasteride|dutasteride|mesh-list
110574572|NCT00588354|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110574573|NCT00588354|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110574574|NCT00588354|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110574575|NCT00588354|Adrenergic Agents|adrenergic agents|mesh-ancestor
110574576|NCT00588354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110574577|NCT00449761|Panobinostat|panobinostat|mesh-list
110574578|NCT00449761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110574579|NCT00449761|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110574580|NCT00449761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110574581|NCT00449761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110574582|NCT00800982|Etanercept|etanercept|mesh-list
110574583|NCT00800982|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110574584|NCT00800982|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110574585|NCT00800982|Analgesics|analgesics|mesh-ancestor
110574586|NCT00800982|Sensory System Agents|sensory system agents|mesh-ancestor
110574587|NCT00800982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110574588|NCT00800982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110574589|NCT00800982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110574590|NCT00800982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110574591|NCT00800982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110574592|NCT00800982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110574593|NCT00800982|Immunologic Factors|immunologic factors|mesh-ancestor
110574594|NCT01019395|Daptomycin|daptomycin|mesh-list
110574595|NCT01019395|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110574596|NCT01019395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110574597|NCT00830960|Clopidogrel|clopidogrel|mesh-list
110574598|NCT00830960|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
110574599|NCT00830960|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110574600|NCT00830960|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110574601|NCT00830960|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110574602|NCT00830960|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110574603|NCT00830960|Purinergic Agents|purinergic agents|mesh-ancestor
110574604|NCT00830960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110574605|NCT00830960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110574606|NCT00830960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110574607|NCT01026961|Acetaminophen|acetaminophen|mesh-list
110574608|NCT01026961|Dimethindene|dimethindene|mesh-list
110574609|NCT01026961|Phenylephrine|phenylephrine|mesh-list
110574610|NCT01026961|Oxymetazoline|oxymetazoline|mesh-list
110574611|NCT01026961|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110574612|NCT01026961|Analgesics|analgesics|mesh-ancestor
110574613|NCT01026961|Sensory System Agents|sensory system agents|mesh-ancestor
110574614|NCT01026961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110574615|NCT01026961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110574616|NCT01026961|Antipyretics|antipyretics|mesh-ancestor
110574617|NCT01026961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110574618|NCT01026961|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110574619|NCT01026961|Mydriatics|mydriatics|mesh-ancestor
110574620|NCT01026961|Autonomic Agents|autonomic agents|mesh-ancestor
110574621|NCT01026961|Sympathomimetics|sympathomimetics|mesh-ancestor
110574622|NCT01026961|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110574623|NCT01026961|Nasal Decongestants|nasal decongestants|mesh-ancestor
110574624|NCT01026961|Respiratory System Agents|respiratory system agents|mesh-ancestor
110574625|NCT01026961|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110574626|NCT01026961|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110574627|NCT01026961|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110574628|NCT01026961|Adrenergic Agents|adrenergic agents|mesh-ancestor
110574629|NCT01026961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110574630|NCT01026961|Protective Agents|protective agents|mesh-ancestor
110574631|NCT01026961|Antipruritics|antipruritics|mesh-ancestor
110574632|NCT01026961|Dermatologic Agents|dermatologic agents|mesh-ancestor
110574633|NCT01026961|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110574634|NCT01026961|Histamine Antagonists|histamine antagonists|mesh-ancestor
110574635|NCT01026961|Histamine Agents|histamine agents|mesh-ancestor
110574636|NCT01026961|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110574637|NCT01566253|Acetaminophen|acetaminophen|mesh-list
110574638|NCT01566253|Ketoprofen|ketoprofen|mesh-list
110574639|NCT01566253|Morphine|morphine|mesh-list
110574640|NCT01566253|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110574641|NCT01566253|Narcotics|narcotics|mesh-ancestor
110574642|NCT01566253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110574643|NCT01566253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110574644|NCT01566253|Analgesics|analgesics|mesh-ancestor
110574645|NCT01566253|Sensory System Agents|sensory system agents|mesh-ancestor
110574646|NCT01566253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110574647|NCT01566253|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110574648|NCT01566253|Antipyretics|antipyretics|mesh-ancestor
110574649|NCT01566253|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110574650|NCT01566253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110574651|NCT01566253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110574652|NCT01566253|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110574653|NCT01566253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110574654|NCT01566253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110574656|NCT03849313|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110574657|NCT03849313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110574658|NCT03849313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110574659|NCT04111614|Tofacitinib|tofacitinib|mesh-list
110574660|NCT04111614|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
110574661|NCT04111614|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110574662|NCT04111614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110574663|NCT04111614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110574665|NCT01023919|Paclitaxel|paclitaxel|mesh-list
110574666|NCT01023919|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110574667|NCT01023919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110574668|NCT01023919|Tubulin Modulators|tubulin modulators|mesh-ancestor
110574669|NCT01023919|Antimitotic Agents|antimitotic agents|mesh-ancestor
110574670|NCT01023919|Mitosis Modulators|mitosis modulators|mesh-ancestor
110574671|NCT01023919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110574672|NCT01023919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110574673|NCT01023919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110574674|NCT01023919|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110574675|NCT01023919|Antifungal Agents|antifungal agents|mesh-ancestor
110574676|NCT01023919|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110574677|NCT01023919|Immunologic Factors|immunologic factors|mesh-ancestor
110574678|NCT01023919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110574679|NCT04028622|Anesthetics|anesthetics|mesh-list
110574680|NCT04028622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110574681|NCT04028622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110574682|NCT00830804|Ritonavir|ritonavir|mesh-list
110574683|NCT00830804|Darunavir|darunavir|mesh-list
110574684|NCT00830804|Raltegravir Potassium|raltegravir potassium|mesh-list
110574685|NCT00830804|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110574686|NCT00830804|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110574687|NCT00830804|Protease Inhibitors|protease inhibitors|mesh-ancestor
110574688|NCT00830804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110574689|NCT00830804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110574690|NCT00830804|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110574691|NCT00830804|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110574692|NCT00830804|Antiviral Agents|antiviral agents|mesh-ancestor
110574693|NCT00830804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110574694|NCT00830804|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110574695|NCT00830804|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110574696|NCT00830804|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110574697|NCT00830804|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110574698|NCT00789477|Aflibercept|aflibercept|mesh-list
110574699|NCT00789477|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110574700|NCT00789477|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110574701|NCT00789477|Growth Substances|growth substances|mesh-ancestor
110574702|NCT00789477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110574703|NCT00789477|Growth Inhibitors|growth inhibitors|mesh-ancestor
110574704|NCT00789477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110574705|NCT01024075|Dexamethasone|dexamethasone|mesh-list
110574706|NCT01024075|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110574707|NCT01024075|Antiemetics|antiemetics|mesh-ancestor
110574708|NCT01024075|Autonomic Agents|autonomic agents|mesh-ancestor
110574709|NCT01024075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110574710|NCT01024075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110574711|NCT01024075|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110574712|NCT01024075|Glucocorticoids|glucocorticoids|mesh-ancestor
110574714|NCT01024075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110574715|NCT01024075|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110574716|NCT01024075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110574717|NCT05756348|Protective Agents|protective agents|mesh-list
110574718|NCT05756348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110574719|NCT00913874|Valproic Acid|valproic acid|mesh-list
110574720|NCT00913874|Anticonvulsants|anticonvulsants|mesh-ancestor
110574721|NCT00913874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110574722|NCT00913874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110574723|NCT00913874|GABA Agents|gaba agents|mesh-ancestor
110574724|NCT00913874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110574725|NCT00913874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110574726|NCT00913874|Antimanic Agents|antimanic agents|mesh-ancestor
110574727|NCT00913874|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110574728|NCT00913874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110574729|NCT00913874|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110574730|NCT00796614|Tamsulosin|tamsulosin|mesh-list
110574731|NCT00796614|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110574732|NCT00796614|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110574733|NCT00796614|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110574734|NCT00796614|Adrenergic Agents|adrenergic agents|mesh-ancestor
110574735|NCT00796614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110574736|NCT00796614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110574737|NCT00796614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110574738|NCT00796614|Urological Agents|urological agents|mesh-ancestor
110574739|NCT02603445|Idelalisib|idelalisib|mesh-list
110574740|NCT02603445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110574741|NCT02603445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110574742|NCT02603445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110574743|NCT02603679|Tamoxifen|tamoxifen|mesh-list
110574744|NCT02603679|Paclitaxel|paclitaxel|mesh-list
110574745|NCT02603679|Letrozole|letrozole|mesh-list
110574746|NCT02603679|Palbociclib|palbociclib|mesh-list
110574747|NCT02603679|Anastrozole|anastrozole|mesh-list
110574748|NCT02603679|Exemestane|exemestane|mesh-list
110574749|NCT02603679|Goserelin|goserelin|mesh-list
110574750|NCT02603679|Aromatase Inhibitors|aromatase inhibitors|mesh-list
110574751|NCT02603679|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110574752|NCT02603679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110574753|NCT02603679|Tubulin Modulators|tubulin modulators|mesh-ancestor
110574754|NCT02603679|Antimitotic Agents|antimitotic agents|mesh-ancestor
110574755|NCT02603679|Mitosis Modulators|mitosis modulators|mesh-ancestor
110574756|NCT02603679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110574757|NCT02603679|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110574758|NCT02603679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110574759|NCT02603679|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110574760|NCT02603679|Hormone Antagonists|hormone antagonists|mesh-ancestor
110574761|NCT02603679|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110574762|NCT02603679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110574763|NCT02603679|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110574764|NCT02603679|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110574765|NCT02603679|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110574766|NCT02603679|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110574767|NCT02603679|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110574769|NCT03995485|Antiviral Agents|antiviral agents|mesh-ancestor
110574770|NCT03995485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110574771|NCT02605434|Levodopa|levodopa|mesh-list
110574772|NCT02605434|Carbidopa|carbidopa|mesh-list
110574773|NCT02605434|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
110574774|NCT02605434|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110574775|NCT02605434|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110574776|NCT02605434|Dopamine Agents|dopamine agents|mesh-ancestor
110574777|NCT02605434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110574778|NCT02605434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110574779|NCT02605434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110574780|NCT02605434|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
110574781|NCT02605434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110574782|NCT02605434|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110574783|NCT02605434|Immunologic Factors|immunologic factors|mesh-ancestor
110574784|NCT02605434|Dopamine Agonists|dopamine agonists|mesh-ancestor
110574785|NCT00863681|Riociguat|riociguat|mesh-list
110574786|NCT00863681|Enzyme Activators|enzyme activators|mesh-ancestor
110574787|NCT00863681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110574788|NCT05758298|Nicotine|nicotine|mesh-list
110574789|NCT05758298|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110574790|NCT05758298|Autonomic Agents|autonomic agents|mesh-ancestor
110574791|NCT05758298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110574792|NCT05758298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110574793|NCT05758298|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110574794|NCT05758298|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110574795|NCT05758298|Cholinergic Agents|cholinergic agents|mesh-ancestor
110574796|NCT05758298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110574797|NCT05758298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110574798|NCT00789321|Amlodipine|amlodipine|mesh-list
110574799|NCT00789321|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110574800|NCT00789321|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110574801|NCT00789321|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110574802|NCT00789321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110574803|NCT00789321|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110574804|NCT00789321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110574805|NCT00789321|Vasodilator Agents|vasodilator agents|mesh-ancestor
110574806|NCT00811928|Fluconazole|fluconazole|mesh-list
110574807|NCT00811928|Posaconazole|posaconazole|mesh-list
110574808|NCT00811928|Antifungal Agents|antifungal agents|mesh-ancestor
110574809|NCT00811928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110574810|NCT00811928|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110574811|NCT00811928|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110574812|NCT00811928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110574813|NCT00811928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110574814|NCT00811928|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110574815|NCT00811928|Hormone Antagonists|hormone antagonists|mesh-ancestor
110574816|NCT00811928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110574817|NCT00811928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110574818|NCT00811928|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110574819|NCT00811928|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110574820|NCT00811928|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
110574821|NCT00811928|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110574822|NCT00811928|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110574823|NCT00448669|Tenofovir|tenofovir|mesh-list
110574824|NCT00448669|Emtricitabine|emtricitabine|mesh-list
110574825|NCT00448669|Antiviral Agents|antiviral agents|mesh-ancestor
110574826|NCT00448669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110574827|NCT00448669|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110574828|NCT00448669|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110574829|NCT00448669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110574830|NCT00448669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110574831|NCT00448669|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110574832|NCT00448669|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110574833|NCT00591734|Bevacizumab|bevacizumab|mesh-list
110574834|NCT00591734|Everolimus|everolimus|mesh-list
110574835|NCT00591734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110574836|NCT00591734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110574837|NCT00591734|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110574838|NCT00591734|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110574839|NCT00591734|Growth Substances|growth substances|mesh-ancestor
110574840|NCT00591734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110574841|NCT00591734|Growth Inhibitors|growth inhibitors|mesh-ancestor
110574842|NCT00591734|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110574843|NCT00591734|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110574844|NCT00591734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110574845|NCT00591734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110574846|NCT00591734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110574847|NCT00591734|Immunologic Factors|immunologic factors|mesh-ancestor
110574848|NCT00848549|Carbamazepine|carbamazepine|mesh-list
110574849|NCT00848549|Zonisamide|zonisamide|mesh-list
110574850|NCT00848549|Anticonvulsants|anticonvulsants|mesh-ancestor
110574851|NCT00848549|Antimanic Agents|antimanic agents|mesh-ancestor
110574852|NCT00848549|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110574853|NCT00848549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110574854|NCT00848549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110574855|NCT00848549|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110574856|NCT00848549|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110574857|NCT00848549|Analgesics|analgesics|mesh-ancestor
110574858|NCT00848549|Sensory System Agents|sensory system agents|mesh-ancestor
110574859|NCT00848549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110574860|NCT00848549|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110574861|NCT00848549|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110574862|NCT00848549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110574863|NCT00848549|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110574864|NCT00848549|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110574865|NCT00848549|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110574866|NCT00848549|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110574867|NCT00788151|Vaccines|vaccines|mesh-list
110574868|NCT00788151|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110574869|NCT00788151|Immunologic Factors|immunologic factors|mesh-ancestor
110574870|NCT00788151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110574871|NCT04116359|Cisplatin|cisplatin|mesh-list
110574872|NCT04116359|Etoposide|etoposide|mesh-list
110574873|NCT04116359|Etoposide phosphate|etoposide phosphate|mesh-list
110574874|NCT04116359|Podophyllotoxin|podophyllotoxin|mesh-list
110574875|NCT04116359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110574876|NCT04116359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110574877|NCT04116359|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110574878|NCT04116359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110574879|NCT04116359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110574880|NCT04116359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110574881|NCT04116359|Keratolytic Agents|keratolytic agents|mesh-ancestor
110574882|NCT04116359|Dermatologic Agents|dermatologic agents|mesh-ancestor
110574883|NCT04116359|Tubulin Modulators|tubulin modulators|mesh-ancestor
110574884|NCT04116359|Antimitotic Agents|antimitotic agents|mesh-ancestor
110574885|NCT04116359|Mitosis Modulators|mitosis modulators|mesh-ancestor
110574886|NCT04118153|Abatacept|abatacept|mesh-list
110574887|NCT04118153|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110574888|NCT04118153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110574889|NCT04118153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110574890|NCT04118153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110574891|NCT04118153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110574892|NCT04118153|Immunologic Factors|immunologic factors|mesh-ancestor
110574893|NCT04118153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110574894|NCT04118153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110574895|NCT00848393|Fentanyl|fentanyl|mesh-list
110574896|NCT00848393|Dexmedetomidine|dexmedetomidine|mesh-list
110574897|NCT00848393|Citric Acid|citric acid|mesh-list
110574898|NCT00848393|Sodium Citrate|sodium citrate|mesh-list
110574899|NCT00848393|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110574900|NCT00848393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110574901|NCT00848393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110574902|NCT00848393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110574903|NCT00848393|Analgesics|analgesics|mesh-ancestor
110574904|NCT00848393|Sensory System Agents|sensory system agents|mesh-ancestor
110574905|NCT00848393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110574906|NCT00848393|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110574907|NCT00848393|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110574908|NCT00848393|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110574909|NCT00848393|Adrenergic Agents|adrenergic agents|mesh-ancestor
110574910|NCT00848393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110574911|NCT00848393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110574912|NCT00848393|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110574913|NCT00848393|Narcotics|narcotics|mesh-ancestor
110574914|NCT00848393|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110574915|NCT00848393|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110574916|NCT00848393|Anesthetics, General|anesthetics, general|mesh-ancestor
110574917|NCT00848393|Anesthetics|anesthetics|mesh-ancestor
110574918|NCT00848393|Anticoagulants|anticoagulants|mesh-ancestor
110574919|NCT00848393|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110574920|NCT00848393|Chelating Agents|chelating agents|mesh-ancestor
110574921|NCT00848393|Sequestering Agents|sequestering agents|mesh-ancestor
110574922|NCT00815516|Amphotericin B|amphotericin b|mesh-list
110574923|NCT00815516|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
110574924|NCT00815516|Micafungin|micafungin|mesh-list
110574925|NCT00815516|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
110574926|NCT00815516|Deoxycholic Acid|deoxycholic acid|mesh-list
110574927|NCT00815516|Amebicides|amebicides|mesh-ancestor
110574928|NCT00815516|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110574929|NCT00815516|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110574930|NCT00815516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110574931|NCT00815516|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110574932|NCT00815516|Antifungal Agents|antifungal agents|mesh-ancestor
110574933|NCT00815516|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
110574934|NCT00815516|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110574935|NCT00705926|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
110574936|NCT00705926|Antiviral Agents|antiviral agents|mesh-ancestor
110574937|NCT00705926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110574938|NCT00787917|Omalizumab|omalizumab|mesh-list
110574939|NCT00787917|Itraconazole|itraconazole|mesh-list
110574940|NCT00787917|Antifungal Agents|antifungal agents|mesh-ancestor
110574941|NCT00787917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110574942|NCT00787917|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110574943|NCT00787917|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110574944|NCT00787917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110574945|NCT00787917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110574946|NCT00787917|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110574947|NCT00787917|Hormone Antagonists|hormone antagonists|mesh-ancestor
110574948|NCT00787917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110574949|NCT00787917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110574950|NCT00787917|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110574951|NCT00787917|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110574952|NCT00787917|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110574953|NCT00787917|Respiratory System Agents|respiratory system agents|mesh-ancestor
110574954|NCT05758064|Dydrogesterone|dydrogesterone|mesh-list
110574955|NCT05758064|Progestins|progestins|mesh-ancestor
110574956|NCT05758064|Hormones|hormones|mesh-ancestor
110574957|NCT05758064|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110574958|NCT05758064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110574959|NCT00829244|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
110574960|NCT00829244|Hormones|hormones|mesh-ancestor
110574961|NCT00829244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110574962|NCT00829244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110574963|NCT00787605|Amlodipine|amlodipine|mesh-list
110574964|NCT00787605|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110574965|NCT00787605|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110574966|NCT00787605|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110574967|NCT00787605|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110374352|NCT01137682|Hormones|hormones|mesh-ancestor
110574968|NCT00787605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110574969|NCT00787605|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110574970|NCT00787605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110574971|NCT00787605|Vasodilator Agents|vasodilator agents|mesh-ancestor
110574972|NCT00787605|Diuretics|diuretics|mesh-ancestor
110574973|NCT00787605|Natriuretic Agents|natriuretic agents|mesh-ancestor
110574974|NCT00787605|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110574975|NCT00448591|Bevacizumab|bevacizumab|mesh-list
110574976|NCT00448591|Taxane|taxane|mesh-list
110574977|NCT00448591|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110574978|NCT00448591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110574979|NCT00448591|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110574980|NCT00448591|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110574981|NCT00448591|Growth Substances|growth substances|mesh-ancestor
110574982|NCT00448591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110574983|NCT00448591|Growth Inhibitors|growth inhibitors|mesh-ancestor
110574984|NCT00787527|Prednisone|prednisone|mesh-list
110574985|NCT00787527|Cyclophosphamide|cyclophosphamide|mesh-list
110574986|NCT00787527|Doxorubicin|doxorubicin|mesh-list
110574987|NCT00787527|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110574988|NCT00787527|Vincristine|vincristine|mesh-list
110574989|NCT00787527|Vorinostat|vorinostat|mesh-list
110574990|NCT00787527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110574991|NCT00787527|Immunologic Factors|immunologic factors|mesh-ancestor
110574992|NCT00787527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110574993|NCT00787527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110574994|NCT00787527|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110574995|NCT00787527|Alkylating Agents|alkylating agents|mesh-ancestor
110574996|NCT00787527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110574997|NCT00787527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110574998|NCT00787527|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110574999|NCT00787527|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110575000|NCT00787527|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110575001|NCT00787527|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110575002|NCT00787527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110575003|NCT00787527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110575004|NCT00787527|Glucocorticoids|glucocorticoids|mesh-ancestor
110575005|NCT00787527|Hormones|hormones|mesh-ancestor
110575006|NCT00787527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110575007|NCT00787527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110575008|NCT00787527|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110575009|NCT00787527|Tubulin Modulators|tubulin modulators|mesh-ancestor
110575010|NCT00787527|Antimitotic Agents|antimitotic agents|mesh-ancestor
110575011|NCT00787527|Mitosis Modulators|mitosis modulators|mesh-ancestor
110575012|NCT00787527|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110575013|NCT00804388|Vitamin E|vitamin e|mesh-list
110575014|NCT00804388|Vitamins|vitamins|mesh-ancestor
110575015|NCT00804388|Micronutrients|micronutrients|mesh-ancestor
110575016|NCT00804388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110575017|NCT00804388|Antioxidants|antioxidants|mesh-ancestor
110575018|NCT00804388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110575019|NCT00804388|Protective Agents|protective agents|mesh-ancestor
110575020|NCT00806962|Vaccines|vaccines|mesh-list
110575021|NCT00806962|Immunologic Factors|immunologic factors|mesh-ancestor
110575022|NCT00806962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110222438|NCT00307723|Bevacizumab|bevacizumab|mesh-list
110575023|NCT02553226|Oxytocin|oxytocin|mesh-list
110575024|NCT02553226|Oxytocics|oxytocics|mesh-ancestor
110575025|NCT02553226|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110575026|NCT02553226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110575027|NCT00810316|Clonazepam|clonazepam|mesh-list
110575028|NCT00810316|Alprazolam|alprazolam|mesh-list
110575029|NCT00810316|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110575030|NCT00810316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110575031|NCT00810316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110575032|NCT00810316|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110575033|NCT00810316|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110575034|NCT00810316|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110575035|NCT00810316|GABA Modulators|gaba modulators|mesh-ancestor
110575036|NCT00810316|GABA Agents|gaba agents|mesh-ancestor
110575037|NCT00810316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110575038|NCT00810316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110575039|NCT00810316|Anticonvulsants|anticonvulsants|mesh-ancestor
110575040|NCT00448435|Fluticasone|fluticasone|mesh-list
110575042|NCT00448435|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110575043|NCT00448435|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
110575044|NCT00448435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110575045|NCT00448435|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110575046|NCT00448435|Autonomic Agents|autonomic agents|mesh-ancestor
110575047|NCT00448435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110575048|NCT00448435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110575049|NCT00448435|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110575050|NCT00448435|Respiratory System Agents|respiratory system agents|mesh-ancestor
110575051|NCT00448435|Dermatologic Agents|dermatologic agents|mesh-ancestor
110575052|NCT00448435|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110575053|NCT00448435|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110575054|NCT00448435|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110575055|NCT00448435|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110575056|NCT00448435|Adrenergic Agents|adrenergic agents|mesh-ancestor
110575057|NCT00448435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110575058|NCT00448435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110575059|NCT00448435|Glucocorticoids|glucocorticoids|mesh-ancestor
110575060|NCT00448435|Hormones|hormones|mesh-ancestor
110575061|NCT00448435|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110575062|NCT00448435|Sympathomimetics|sympathomimetics|mesh-ancestor
110575063|NCT00804622|Tenofovir|tenofovir|mesh-list
110575064|NCT00804622|Telbivudine|telbivudine|mesh-list
110575065|NCT00804622|Antiviral Agents|antiviral agents|mesh-ancestor
110575066|NCT00804622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110575067|NCT00804622|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110575068|NCT00804622|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110575069|NCT00804622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110575070|NCT00804622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110575071|NCT00804622|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110575072|NCT00804622|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110575073|NCT02603055|Vaccines|vaccines|mesh-list
110575074|NCT02603055|Immunologic Factors|immunologic factors|mesh-ancestor
110575075|NCT02603055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110575076|NCT02602743|Ketamine|ketamine|mesh-list
110575077|NCT02602743|Remifentanil|remifentanil|mesh-list
110575078|NCT02602743|Propofol|propofol|mesh-list
110575079|NCT02602743|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110575080|NCT02602743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110575081|NCT02602743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110575082|NCT02602743|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110575083|NCT02602743|Anesthetics, General|anesthetics, general|mesh-ancestor
110575084|NCT02602743|Anesthetics|anesthetics|mesh-ancestor
110575085|NCT02602743|Analgesics|analgesics|mesh-ancestor
110575086|NCT02602743|Sensory System Agents|sensory system agents|mesh-ancestor
110575087|NCT02602743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110575088|NCT02602743|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110374373|NCT00586911|Betaine|betaine|mesh-list
110575089|NCT02602743|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110575091|NCT02602743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110575092|NCT02602743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110575093|NCT02602743|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110575094|NCT02602743|Narcotics|narcotics|mesh-ancestor
110575095|NCT00807118|Fesoterodine|fesoterodine|mesh-list
110575096|NCT00807118|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110575097|NCT00807118|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110575098|NCT00807118|Cholinergic Agents|cholinergic agents|mesh-ancestor
110575099|NCT00807118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110575100|NCT00807118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110575101|NCT00807118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110575102|NCT00807118|Urological Agents|urological agents|mesh-ancestor
110575103|NCT00448279|Trastuzumab|trastuzumab|mesh-list
110575104|NCT00448279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110575105|NCT00448279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110575106|NCT00804856|Cytarabine|cytarabine|mesh-list
110575107|NCT00804856|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110575108|NCT00804856|Antimetabolites|antimetabolites|mesh-ancestor
110575109|NCT00804856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110575110|NCT00804856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110575111|NCT00804856|Antiviral Agents|antiviral agents|mesh-ancestor
110575112|NCT00804856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110575113|NCT00804856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110575114|NCT00804856|Immunologic Factors|immunologic factors|mesh-ancestor
110575115|NCT00804856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110575116|NCT00810706|Exemestane|exemestane|mesh-list
110575117|NCT00810706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110575118|NCT00810706|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110575119|NCT00810706|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110575120|NCT00810706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110575121|NCT00810706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110575122|NCT00810706|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110575123|NCT00810706|Hormone Antagonists|hormone antagonists|mesh-ancestor
110575124|NCT00810706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110575125|NCT00810706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110575126|NCT00807196|Cyclophosphamide|cyclophosphamide|mesh-list
110575127|NCT00807196|Rituximab|rituximab|mesh-list
110575128|NCT00807196|Fludarabine|fludarabine|mesh-list
110575129|NCT00807196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110575130|NCT00807196|Immunologic Factors|immunologic factors|mesh-ancestor
110575131|NCT00807196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110575132|NCT00807196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110575133|NCT00807196|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110575134|NCT00807196|Alkylating Agents|alkylating agents|mesh-ancestor
110575135|NCT00807196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110575136|NCT00807196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110575137|NCT00807196|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110575138|NCT00807196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110575139|NCT00448123|Tamsulosin|tamsulosin|mesh-list
110575140|NCT00448123|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110575141|NCT00448123|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110575142|NCT00448123|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110575144|NCT00448123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110575145|NCT00448123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110575146|NCT00448123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110575147|NCT00448123|Urological Agents|urological agents|mesh-ancestor
110575148|NCT00804934|Ranibizumab|ranibizumab|mesh-list
110575149|NCT00804934|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110575150|NCT00804934|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110575151|NCT00804934|Growth Substances|growth substances|mesh-ancestor
110575152|NCT00804934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110575153|NCT00804934|Growth Inhibitors|growth inhibitors|mesh-ancestor
110575154|NCT00804934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110575155|NCT00805012|Docetaxel|docetaxel|mesh-list
110575156|NCT00805012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110575157|NCT00805012|Tubulin Modulators|tubulin modulators|mesh-ancestor
110575158|NCT00805012|Antimitotic Agents|antimitotic agents|mesh-ancestor
110575159|NCT00805012|Mitosis Modulators|mitosis modulators|mesh-ancestor
110575160|NCT00805012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110575161|NCT00447499|Lanreotide|lanreotide|mesh-list
110575162|NCT00447499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110575163|NCT00805090|Itraconazole|itraconazole|mesh-list
110575164|NCT00805090|Diclofenac|diclofenac|mesh-list
110575165|NCT00805090|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110575166|NCT00805090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110575167|NCT00805090|Analgesics|analgesics|mesh-ancestor
110575168|NCT00805090|Sensory System Agents|sensory system agents|mesh-ancestor
110575169|NCT00805090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110575170|NCT00805090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110575171|NCT00805090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110575172|NCT00805090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110575173|NCT00805090|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110575174|NCT00805090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110575175|NCT00805090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110575176|NCT00805090|Antifungal Agents|antifungal agents|mesh-ancestor
110575177|NCT00805090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110575178|NCT00805090|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110575179|NCT00805090|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110575180|NCT00805090|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110575181|NCT00805090|Hormone Antagonists|hormone antagonists|mesh-ancestor
110575182|NCT00805090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110575183|NCT00805090|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110575184|NCT00810862|Pimecrolimus|pimecrolimus|mesh-list
110575185|NCT00810862|Lactitol|lactitol|mesh-list
110575186|NCT00810862|Cathartics|cathartics|mesh-ancestor
110575187|NCT00810862|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110575188|NCT00810862|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110575189|NCT00810862|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110575190|NCT00810862|Analgesics|analgesics|mesh-ancestor
110575191|NCT00810862|Sensory System Agents|sensory system agents|mesh-ancestor
110575192|NCT00810862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110575193|NCT00810862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110575194|NCT00810862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110575195|NCT00810862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110575196|NCT00810862|Dermatologic Agents|dermatologic agents|mesh-ancestor
110575197|NCT00810862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110575198|NCT00810862|Immunologic Factors|immunologic factors|mesh-ancestor
110575199|NCT00810862|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110575200|NCT00810862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110575201|NCT00810862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110575202|NCT00800436|Trastuzumab|trastuzumab|mesh-list
110575203|NCT00800436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110575204|NCT00800436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110575205|NCT00810940|Mannitol|mannitol|mesh-list
110575206|NCT00810940|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110575207|NCT00810940|Diuretics|diuretics|mesh-ancestor
110575208|NCT00810940|Natriuretic Agents|natriuretic agents|mesh-ancestor
110575209|NCT00810940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110575210|NCT00655564|Alefacept|alefacept|mesh-list
110575211|NCT00655564|Dermatologic Agents|dermatologic agents|mesh-ancestor
110575212|NCT00655564|Immunologic Factors|immunologic factors|mesh-ancestor
110575213|NCT00655564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110575214|NCT00447421|Pemetrexed|pemetrexed|mesh-list
110575215|NCT00447421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110575216|NCT00447421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110575217|NCT00447421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110575218|NCT00447421|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110575219|NCT00447421|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110575220|NCT00651118|Fluticasone|fluticasone|mesh-list
110575222|NCT00651118|Azelastine|azelastine|mesh-list
110575223|NCT00651118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110575224|NCT00651118|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110575225|NCT00651118|Autonomic Agents|autonomic agents|mesh-ancestor
110575226|NCT00651118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110575227|NCT00651118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110575228|NCT00651118|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110575229|NCT00651118|Respiratory System Agents|respiratory system agents|mesh-ancestor
110575230|NCT00651118|Dermatologic Agents|dermatologic agents|mesh-ancestor
110575231|NCT00651118|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110575232|NCT00651118|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
110575233|NCT00651118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110575234|NCT00651118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110575235|NCT00651118|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110575236|NCT00651118|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110575237|NCT00651118|Histamine Antagonists|histamine antagonists|mesh-ancestor
110575238|NCT00651118|Histamine Agents|histamine agents|mesh-ancestor
110575239|NCT00651118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110575240|NCT00447265|Etanercept|etanercept|mesh-list
110575241|NCT00447265|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110575242|NCT00447265|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110575243|NCT00447265|Analgesics|analgesics|mesh-ancestor
110575244|NCT00447265|Sensory System Agents|sensory system agents|mesh-ancestor
110575245|NCT00447265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110575246|NCT00447265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110575247|NCT00447265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110222671|NCT00088491|Olanzapine|olanzapine|mesh-list
110575248|NCT00447265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110575249|NCT00447265|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110575250|NCT00447265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110575251|NCT00447265|Immunologic Factors|immunologic factors|mesh-ancestor
110575252|NCT03641755|Olaparib|olaparib|mesh-list
110575253|NCT03641755|Sapacitabine|sapacitabine|mesh-list
110575254|NCT03641755|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110575255|NCT03641755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110575256|NCT03641755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110575257|NCT03641755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110575258|NCT00657358|Lidocaine|lidocaine|mesh-list
110575259|NCT00657358|Anesthetics, Local|anesthetics, local|mesh-ancestor
110575260|NCT00657358|Anesthetics|anesthetics|mesh-ancestor
110575261|NCT00657358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110575262|NCT00657358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110575263|NCT00657358|Sensory System Agents|sensory system agents|mesh-ancestor
110575264|NCT00657358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110575265|NCT00657358|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110575266|NCT00657358|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110575267|NCT00657358|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110575268|NCT00657358|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110575269|NCT00657358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110575270|NCT00457639|Cholic Acids|cholic acids|mesh-list
110575271|NCT00457639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110575272|NCT00800202|Paclitaxel|paclitaxel|mesh-list
110575273|NCT00800202|Bevacizumab|bevacizumab|mesh-list
110575274|NCT00800202|Carboplatin|carboplatin|mesh-list
110575275|NCT00800202|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110575276|NCT00800202|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110575277|NCT00800202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110575278|NCT00800202|Tubulin Modulators|tubulin modulators|mesh-ancestor
110575279|NCT00800202|Antimitotic Agents|antimitotic agents|mesh-ancestor
110575280|NCT00800202|Mitosis Modulators|mitosis modulators|mesh-ancestor
110575281|NCT00800202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110575282|NCT00800202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110575283|NCT00800202|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110575284|NCT00800202|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110575285|NCT00800202|Growth Substances|growth substances|mesh-ancestor
110575286|NCT00800202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110575287|NCT00800202|Growth Inhibitors|growth inhibitors|mesh-ancestor
110575288|NCT00800202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110575289|NCT00800202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110575290|NCT00811096|Chloroquine|chloroquine|mesh-list
110575292|NCT00811096|Amebicides|amebicides|mesh-ancestor
110575293|NCT00811096|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110575294|NCT00811096|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110575295|NCT00811096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110575296|NCT00811096|Antimalarials|antimalarials|mesh-ancestor
110575297|NCT00811096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110575298|NCT00811096|Alkylating Agents|alkylating agents|mesh-ancestor
110575299|NCT00811096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110575300|NCT00811096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110575301|NCT00811096|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
110575302|NCT05146804|Sulforaphane|sulforaphane|mesh-list
110575303|NCT05146804|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110575304|NCT05146804|Protective Agents|protective agents|mesh-ancestor
110575305|NCT05146804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110575306|NCT05146804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110575307|NCT00655486|Lacosamide|lacosamide|mesh-list
110575308|NCT00655486|Anticonvulsants|anticonvulsants|mesh-ancestor
110575309|NCT00655486|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110575310|NCT00655486|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110575311|NCT00655486|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110575312|NCT00655486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110575313|NCT04111302|Dezocine|dezocine|mesh-list
110575314|NCT04111302|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110575315|NCT04111302|Narcotics|narcotics|mesh-ancestor
110575316|NCT04111302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110575317|NCT04111302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110575318|NCT04111302|Analgesics|analgesics|mesh-ancestor
110575319|NCT04111302|Sensory System Agents|sensory system agents|mesh-ancestor
110575320|NCT04111302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110575321|NCT04111848|Ketamine|ketamine|mesh-list
110222749|NCT00402207|Hormones|hormones|mesh-ancestor
110575322|NCT04111848|Analgesics|analgesics|mesh-ancestor
110575323|NCT04111848|Sensory System Agents|sensory system agents|mesh-ancestor
110575324|NCT04111848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110575325|NCT04111848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110575326|NCT04111848|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110575327|NCT04111848|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110575328|NCT04111848|Anesthetics, General|anesthetics, general|mesh-ancestor
110575329|NCT04111848|Anesthetics|anesthetics|mesh-ancestor
110575330|NCT04111848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110575331|NCT04111848|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110575332|NCT04111848|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110575333|NCT04111848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110575334|NCT04111848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110575335|NCT00457015|Ecallantide|ecallantide|mesh-list
110575336|NCT00457015|Analgesics|analgesics|mesh-ancestor
110575337|NCT00457015|Sensory System Agents|sensory system agents|mesh-ancestor
110575338|NCT00457015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110575339|NCT00457015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110575340|NCT00457015|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110575341|NCT00457015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110575342|NCT00457015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110575343|NCT00457015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110575344|NCT00654940|Pregabalin|pregabalin|mesh-list
110575345|NCT00654940|Analgesics|analgesics|mesh-ancestor
110575346|NCT00654940|Sensory System Agents|sensory system agents|mesh-ancestor
110575347|NCT00654940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110575348|NCT00654940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110575349|NCT00654940|Anticonvulsants|anticonvulsants|mesh-ancestor
110575350|NCT00654940|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110575351|NCT00654940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110575352|NCT00654940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110575353|NCT00654940|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110575354|NCT00654940|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110575355|NCT00654940|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110575356|NCT00654940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110575357|NCT00654940|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110575358|NCT00588666|Bevacizumab|bevacizumab|mesh-list
110575359|NCT00588666|Carboplatin|carboplatin|mesh-list
110575360|NCT00588666|Gemcitabine|gemcitabine|mesh-list
110575361|NCT00588666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110575362|NCT00588666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110575363|NCT00588666|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110575364|NCT00588666|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110575365|NCT00588666|Growth Substances|growth substances|mesh-ancestor
110575366|NCT00588666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110575367|NCT00588666|Growth Inhibitors|growth inhibitors|mesh-ancestor
110575368|NCT00588666|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110575369|NCT00588666|Antimetabolites|antimetabolites|mesh-ancestor
110575370|NCT00588666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110575371|NCT00805558|Moxifloxacin|moxifloxacin|mesh-list
110575372|NCT00805558|Metronidazole|metronidazole|mesh-list
110575373|NCT00805558|Ciprofloxacin|ciprofloxacin|mesh-list
110575374|NCT00805558|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
110575375|NCT00805558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110575376|NCT00805558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110575377|NCT00805558|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110575378|NCT00805558|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110575379|NCT00805558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110575380|NCT00805558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110575381|NCT00805558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110575382|NCT00805558|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110575383|NCT00805558|Contraceptive Agents|contraceptive agents|mesh-ancestor
110575384|NCT00805558|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110575385|NCT00805558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110575386|NCT00805558|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110575387|NCT00805558|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110575388|NCT00805558|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110575389|NCT00805558|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110575390|NCT00805558|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110575391|NCT00805558|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110575392|NCT00805558|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110575393|NCT01019785|Ergocalciferols|ergocalciferols|mesh-list
110575394|NCT01019785|Vitamin D|vitamin d|mesh-list
110575395|NCT01019785|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110575396|NCT01019785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110575397|NCT01019785|Vitamins|vitamins|mesh-ancestor
110575398|NCT01019785|Micronutrients|micronutrients|mesh-ancestor
110575399|NCT01019785|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110575400|NCT02604186|Botulinum Toxins|botulinum toxins|mesh-list
110575401|NCT02604186|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110575402|NCT02604186|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110575403|NCT02604186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110575404|NCT02604186|Cholinergic Agents|cholinergic agents|mesh-ancestor
110575405|NCT02604186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110575406|NCT02604186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110575407|NCT01024543|Phenylephrine|phenylephrine|mesh-list
110575408|NCT01024543|Oxymetazoline|oxymetazoline|mesh-list
110575409|NCT01024543|Angiotensin II|angiotensin ii|mesh-list
110575411|NCT01024543|Angiotensinogen|angiotensinogen|mesh-list
110575412|NCT01024543|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110575413|NCT01024543|Mydriatics|mydriatics|mesh-ancestor
110575414|NCT01024543|Autonomic Agents|autonomic agents|mesh-ancestor
110575415|NCT01024543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110575416|NCT01024543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110575417|NCT01024543|Sympathomimetics|sympathomimetics|mesh-ancestor
110575418|NCT01024543|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110575419|NCT01024543|Nasal Decongestants|nasal decongestants|mesh-ancestor
110575420|NCT01024543|Respiratory System Agents|respiratory system agents|mesh-ancestor
110575421|NCT01024543|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110575422|NCT01024543|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110575423|NCT01024543|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110575424|NCT01024543|Adrenergic Agents|adrenergic agents|mesh-ancestor
110575425|NCT01024543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110374420|NCT00587145|Docetaxel|docetaxel|mesh-list
110575426|NCT01024543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110575427|NCT01024543|Protective Agents|protective agents|mesh-ancestor
110575428|NCT01024543|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110575429|NCT01024543|Protease Inhibitors|protease inhibitors|mesh-ancestor
110575430|NCT01024543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110575431|NCT00811330|Atorvastatin|atorvastatin|mesh-list
110575432|NCT00811330|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110575433|NCT00811330|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110575434|NCT00811330|Antimetabolites|antimetabolites|mesh-ancestor
110575435|NCT00811330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110575436|NCT00811330|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110575437|NCT00811330|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110575438|NCT00811330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110575439|NCT00811408|Cidofovir|cidofovir|mesh-list
110575440|NCT00811408|Carboplatin|carboplatin|mesh-list
110575441|NCT00811408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110575442|NCT00811408|Antiviral Agents|antiviral agents|mesh-ancestor
110575443|NCT00811408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110575444|NCT00811408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110575445|NCT00811408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110575446|NCT00446797|Celecoxib|celecoxib|mesh-list
110575447|NCT00446797|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110575448|NCT00446797|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110575449|NCT00446797|Analgesics|analgesics|mesh-ancestor
110575450|NCT00446797|Sensory System Agents|sensory system agents|mesh-ancestor
110575451|NCT00446797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110575452|NCT00446797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110575453|NCT00446797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110575454|NCT00446797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110575455|NCT00446797|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110575456|NCT00446797|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110575457|NCT00446797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110575458|NCT00446797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110575459|NCT00855335|Ritonavir|ritonavir|mesh-list
110575460|NCT00855335|Darunavir|darunavir|mesh-list
110575461|NCT00855335|Cobicistat|cobicistat|mesh-list
110575462|NCT00855335|Rilpivirine|rilpivirine|mesh-list
110575463|NCT00855335|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
110575464|NCT00855335|Etravirine|etravirine|mesh-list
110575465|NCT00855335|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110575466|NCT00855335|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110575467|NCT00855335|Protease Inhibitors|protease inhibitors|mesh-ancestor
110575468|NCT00855335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110222891|NCT05568602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110575469|NCT00855335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110575470|NCT00855335|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110575471|NCT00855335|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110575472|NCT00855335|Antiviral Agents|antiviral agents|mesh-ancestor
110575473|NCT00855335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110575474|NCT00855335|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110575475|NCT00855335|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110575476|NCT00855335|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110575477|NCT00855335|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110575478|NCT00811486|Spironolactone|spironolactone|mesh-list
110575479|NCT00811486|Conivaptan|conivaptan|mesh-list
110575480|NCT00811486|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110575481|NCT00811486|Hormone Antagonists|hormone antagonists|mesh-ancestor
110575482|NCT00811486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110575483|NCT00811486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110575484|NCT00811486|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110575485|NCT00811486|Diuretics|diuretics|mesh-ancestor
110575486|NCT00811486|Natriuretic Agents|natriuretic agents|mesh-ancestor
110575487|NCT00811486|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
110374424|NCT00587145|Mitosis Modulators|mitosis modulators|mesh-ancestor
110575488|NCT00811486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110575489|NCT04114188|Prednisolone|prednisolone|mesh-list
110575490|NCT04114188|Infliximab|infliximab|mesh-list
110575491|NCT04114188|Tacrolimus|tacrolimus|mesh-list
110575492|NCT04114188|Thymoglobulin|thymoglobulin|mesh-list
110575493|NCT04114188|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110575494|NCT04114188|Immunoglobulins|immunoglobulins|mesh-list
110575495|NCT04114188|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110575496|NCT04114188|Antibodies|antibodies|mesh-list
110575497|NCT04114188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110575498|NCT04114188|Immunologic Factors|immunologic factors|mesh-ancestor
110575499|NCT04114188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110575500|NCT04114188|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110575501|NCT04114188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110575502|NCT04114188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110575503|NCT04114188|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110575504|NCT04114188|Glucocorticoids|glucocorticoids|mesh-ancestor
110575505|NCT04114188|Hormones|hormones|mesh-ancestor
110575506|NCT04114188|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110575507|NCT04114188|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110575508|NCT04114188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110575509|NCT04114188|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110575510|NCT04114188|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110575511|NCT04114188|Dermatologic Agents|dermatologic agents|mesh-ancestor
110575512|NCT04114188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110575513|NCT00811876|Leuprolide|leuprolide|mesh-list
110575514|NCT00811876|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110575515|NCT00811876|Fertility Agents|fertility agents|mesh-ancestor
110575516|NCT00811876|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110575517|NCT00811876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110575518|NCT00811876|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110575519|NCT00811876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110575520|NCT00915252|Cytarabine|cytarabine|mesh-list
110575521|NCT00915252|Azacitidine|azacitidine|mesh-list
110575522|NCT00915252|Daunorubicin|daunorubicin|mesh-list
110575523|NCT00915252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110575524|NCT00915252|Antimetabolites|antimetabolites|mesh-ancestor
110575525|NCT00915252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110575526|NCT00915252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110575527|NCT00915252|Antiviral Agents|antiviral agents|mesh-ancestor
110575528|NCT00915252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110575529|NCT00915252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110575530|NCT00915252|Immunologic Factors|immunologic factors|mesh-ancestor
110575531|NCT00915252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110575532|NCT00915252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110575533|NCT00915252|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110575534|NCT00915252|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110575535|NCT00915252|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110575536|NCT00593489|Insulin|insulin|mesh-list
110575537|NCT00593489|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110575538|NCT00593489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110575539|NCT00446641|Cilostazol|cilostazol|mesh-list
110575541|NCT00446641|Autonomic Agents|autonomic agents|mesh-ancestor
110575542|NCT00446641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110575543|NCT00446641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110575544|NCT00446641|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110575545|NCT00446641|Respiratory System Agents|respiratory system agents|mesh-ancestor
110575546|NCT00446641|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110575547|NCT00446641|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110575548|NCT00446641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110575549|NCT00446641|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110575550|NCT00446641|Vasodilator Agents|vasodilator agents|mesh-ancestor
110575551|NCT00446641|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110575552|NCT00446641|Protective Agents|protective agents|mesh-ancestor
110575553|NCT00446641|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110575554|NCT00446641|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110575555|NCT00446641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110575556|NCT00646282|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
110575557|NCT00646282|Vitamins|vitamins|mesh-ancestor
110575558|NCT00646282|Micronutrients|micronutrients|mesh-ancestor
110575559|NCT00646282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110575560|NCT00646282|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110575561|NCT00792636|Naproxen|naproxen|mesh-list
110575562|NCT00792636|Sumatriptan|sumatriptan|mesh-list
110575563|NCT00792636|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110575564|NCT00792636|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110575565|NCT00792636|Analgesics|analgesics|mesh-ancestor
110575566|NCT00792636|Sensory System Agents|sensory system agents|mesh-ancestor
110575567|NCT00792636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110575568|NCT00792636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110575569|NCT00792636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110575570|NCT00792636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110575571|NCT00792636|Gout Suppressants|gout suppressants|mesh-ancestor
110575572|NCT00792636|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110575573|NCT00792636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110575574|NCT00792636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110148862|NCT00006112|Fluorouracil|fluorouracil|mesh-list
110575575|NCT00792636|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110575576|NCT00792636|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110575577|NCT00792636|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110575578|NCT00792636|Serotonin Agents|serotonin agents|mesh-ancestor
110575579|NCT00792636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110575580|NCT00446563|Losartan|losartan|mesh-list
110575581|NCT00446563|Amlodipine|amlodipine|mesh-list
110575582|NCT00446563|Valsartan|valsartan|mesh-list
110575583|NCT00446563|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110575584|NCT00446563|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110575585|NCT00446563|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110575586|NCT00446563|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110575587|NCT00446563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110575588|NCT00446563|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110575589|NCT00446563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110575590|NCT00446563|Vasodilator Agents|vasodilator agents|mesh-ancestor
110575591|NCT00446563|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110575592|NCT00446563|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110575593|NCT00446563|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110575594|NCT00446563|Diuretics|diuretics|mesh-ancestor
110575595|NCT00446563|Natriuretic Agents|natriuretic agents|mesh-ancestor
110575596|NCT00446563|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110575597|NCT00650806|Canagliflozin|canagliflozin|mesh-list
110575598|NCT00650806|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110575599|NCT00650806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110575600|NCT00650806|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110575601|NCT00650806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110575602|NCT00863057|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110575603|NCT00863057|Methadone|methadone|mesh-list
110575604|NCT00863057|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110575605|NCT00863057|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110575606|NCT00863057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110575607|NCT00863057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110575608|NCT00863057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110575609|NCT00863057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110575610|NCT00863057|Analgesics|analgesics|mesh-ancestor
110575611|NCT00863057|Sensory System Agents|sensory system agents|mesh-ancestor
110575612|NCT00863057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110575613|NCT00863057|Antidepressive Agents|antidepressive agents|mesh-ancestor
110575614|NCT00863057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110575615|NCT00863057|Dopamine Agents|dopamine agents|mesh-ancestor
110575616|NCT00863057|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110575617|NCT00863057|Narcotics|narcotics|mesh-ancestor
110223037|NCT00088998|Growth Inhibitors|growth inhibitors|mesh-ancestor
110575618|NCT00863057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110575619|NCT00863057|Antitussive Agents|antitussive agents|mesh-ancestor
110575620|NCT00863057|Respiratory System Agents|respiratory system agents|mesh-ancestor
110575621|NCT00814216|Fluticasone|fluticasone|mesh-list
110575622|NCT00814216|Xhance|xhance|mesh-list
110575623|NCT00814216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110575624|NCT00814216|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110575625|NCT00814216|Autonomic Agents|autonomic agents|mesh-ancestor
110575626|NCT00814216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110575627|NCT00814216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110575628|NCT00814216|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110575629|NCT00814216|Respiratory System Agents|respiratory system agents|mesh-ancestor
110575630|NCT00814216|Dermatologic Agents|dermatologic agents|mesh-ancestor
110575631|NCT00814216|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110575632|NCT00829166|Capecitabine|capecitabine|mesh-list
110575633|NCT00829166|Trastuzumab|trastuzumab|mesh-list
110575634|NCT00829166|Lapatinib|lapatinib|mesh-list
110575635|NCT00829166|Maytansine|maytansine|mesh-list
110575636|NCT00829166|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
110575637|NCT00829166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110575638|NCT00829166|Antimetabolites|antimetabolites|mesh-ancestor
110575639|NCT00829166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110575640|NCT00829166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110575641|NCT00829166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110575642|NCT00829166|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110575643|NCT00829166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110575644|NCT00829166|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110575645|NCT00829166|Tubulin Modulators|tubulin modulators|mesh-ancestor
110575646|NCT00829166|Antimitotic Agents|antimitotic agents|mesh-ancestor
110575647|NCT00829166|Mitosis Modulators|mitosis modulators|mesh-ancestor
110575648|NCT00829166|Immunotoxins|immunotoxins|mesh-ancestor
110575649|NCT00829166|Immunoconjugates|immunoconjugates|mesh-ancestor
110575650|NCT00829166|Immunologic Factors|immunologic factors|mesh-ancestor
110575651|NCT00829166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110575652|NCT00799266|Zoledronic Acid|zoledronic acid|mesh-list
110575653|NCT00799266|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110575654|NCT00799266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110575655|NCT00650104|Ropinirole|ropinirole|mesh-list
110575656|NCT00650104|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110575657|NCT00650104|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110575658|NCT00650104|Dopamine Agonists|dopamine agonists|mesh-ancestor
110575659|NCT00650104|Dopamine Agents|dopamine agents|mesh-ancestor
110575660|NCT00650104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110575661|NCT00650104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110575662|NCT00650104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110575663|NCT00808054|Lidocaine|lidocaine|mesh-list
110575664|NCT00808054|Prilocaine|prilocaine|mesh-list
110575665|NCT00808054|Anesthetics, Local|anesthetics, local|mesh-ancestor
110575666|NCT00808054|Anesthetics|anesthetics|mesh-ancestor
110575667|NCT00808054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110575668|NCT00808054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110575669|NCT00808054|Sensory System Agents|sensory system agents|mesh-ancestor
110575670|NCT00808054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110575671|NCT00808054|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110575672|NCT00808054|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110575673|NCT00808054|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110575674|NCT00808054|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110575675|NCT00808054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110575676|NCT05102734|Nitroglycerin|nitroglycerin|mesh-list
110575677|NCT05102734|Vasodilator Agents|vasodilator agents|mesh-ancestor
110575678|NCT00814528|Imiquimod|imiquimod|mesh-list
110575679|NCT00814528|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110575680|NCT00814528|Immunologic Factors|immunologic factors|mesh-ancestor
110575681|NCT00814528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110575682|NCT00814528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110575683|NCT00814528|Interferon Inducers|interferon inducers|mesh-ancestor
110575684|NCT00814606|Ribavirin|ribavirin|mesh-list
110575685|NCT00814606|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110575686|NCT00814606|Antimetabolites|antimetabolites|mesh-ancestor
110575687|NCT00814606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110575688|NCT00814606|Antiviral Agents|antiviral agents|mesh-ancestor
110575689|NCT00814606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110575690|NCT00814762|Vaccines|vaccines|mesh-list
110575691|NCT00814762|Immunologic Factors|immunologic factors|mesh-ancestor
110575692|NCT00814762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110575693|NCT00654238|Sorafenib|sorafenib|mesh-list
110223114|NCT00121446|Anticoagulants|anticoagulants|mesh-ancestor
110575694|NCT00654238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110575695|NCT00654238|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110575697|NCT00654238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110575698|NCT00862979|Cyclosporine|cyclosporine|mesh-list
110575699|NCT00862979|Mycophenolic Acid|mycophenolic acid|mesh-list
110575701|NCT00862979|Tacrolimus|tacrolimus|mesh-list
110575702|NCT00862979|Cyclosporins|cyclosporins|mesh-list
110575703|NCT00862979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110575704|NCT00862979|Immunologic Factors|immunologic factors|mesh-ancestor
110575705|NCT00862979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110575706|NCT00862979|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110575707|NCT00862979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110575708|NCT00862979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110575709|NCT00862979|Antifungal Agents|antifungal agents|mesh-ancestor
110575710|NCT00862979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110575711|NCT00862979|Dermatologic Agents|dermatologic agents|mesh-ancestor
110575712|NCT00862979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110575713|NCT00862979|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110575714|NCT00862979|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110575715|NCT00862979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110575716|NCT00862979|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110575717|NCT00862979|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110575718|NCT00862979|Antitubercular Agents|antitubercular agents|mesh-ancestor
110575719|NCT00862979|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110575720|NCT02605356|Dexamethasone|dexamethasone|mesh-list
110575721|NCT02605356|Bortezomib|bortezomib|mesh-list
110575722|NCT02605356|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
110575723|NCT02605356|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110575724|NCT02605356|Antiemetics|antiemetics|mesh-ancestor
110575725|NCT02605356|Autonomic Agents|autonomic agents|mesh-ancestor
110575726|NCT02605356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110575727|NCT02605356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110575728|NCT02605356|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110575729|NCT02605356|Glucocorticoids|glucocorticoids|mesh-ancestor
110575730|NCT02605356|Hormones|hormones|mesh-ancestor
110575731|NCT02605356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110575732|NCT02605356|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110575733|NCT02605356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110575734|NCT00812266|Carboplatin|carboplatin|mesh-list
110575735|NCT00812266|Etoposide|etoposide|mesh-list
110575736|NCT00812266|Topotecan|topotecan|mesh-list
110575737|NCT00812266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110575738|NCT00812266|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110575739|NCT00812266|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110575740|NCT00812266|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110575741|NCT00812266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110575742|NCT00812266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110575743|NCT00812266|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110575744|NCT00814918|Aminolevulinic Acid|aminolevulinic acid|mesh-list
110575745|NCT00814918|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110575746|NCT00814918|Dermatologic Agents|dermatologic agents|mesh-ancestor
110575747|NCT04113954|Prilocaine|prilocaine|mesh-list
110575748|NCT04113954|Mepivacaine|mepivacaine|mesh-list
110575749|NCT04113954|Anesthetics, Local|anesthetics, local|mesh-ancestor
110575750|NCT04113954|Anesthetics|anesthetics|mesh-ancestor
110575751|NCT04113954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110575752|NCT04113954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110575753|NCT04113954|Sensory System Agents|sensory system agents|mesh-ancestor
110575754|NCT04113954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110575755|NCT00812344|Ketoconazole|ketoconazole|mesh-list
110575756|NCT00812344|Antifungal Agents|antifungal agents|mesh-ancestor
110575757|NCT00812344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110575758|NCT00812344|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110575759|NCT00812344|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110575760|NCT00812344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110575761|NCT00812344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110575762|NCT00812344|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110575763|NCT00812344|Hormone Antagonists|hormone antagonists|mesh-ancestor
110575764|NCT00812344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110374451|NCT00199797|Vitamin B Complex|vitamin b complex|mesh-ancestor
110575765|NCT00812344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110575766|NCT00812344|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110575767|NCT00446251|Mycophenolic Acid|mycophenolic acid|mesh-list
110575769|NCT00446251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110575770|NCT00446251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110575771|NCT00446251|Immunologic Factors|immunologic factors|mesh-ancestor
110575772|NCT00446251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110575773|NCT00446251|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110575774|NCT00446251|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110575775|NCT00446251|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110575776|NCT00446251|Antitubercular Agents|antitubercular agents|mesh-ancestor
110575777|NCT00446251|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110575778|NCT00446251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110575779|NCT00446251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110575780|NCT00446251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110575781|NCT00812422|Ibuprofen|ibuprofen|mesh-list
110575782|NCT00812422|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110575783|NCT00812422|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110575784|NCT00812422|Analgesics|analgesics|mesh-ancestor
110575785|NCT00812422|Sensory System Agents|sensory system agents|mesh-ancestor
110575786|NCT00812422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110575787|NCT00812422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110575788|NCT00812422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110575789|NCT00812422|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110575790|NCT00812422|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110575791|NCT00812422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110575792|NCT00812422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110575793|NCT04110834|Itraconazole|itraconazole|mesh-list
110575794|NCT04110834|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
110575795|NCT04110834|Antifungal Agents|antifungal agents|mesh-ancestor
110575796|NCT04110834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110575797|NCT04110834|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110575798|NCT04110834|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110575799|NCT04110834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110575800|NCT04110834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110575801|NCT04110834|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110575802|NCT04110834|Hormone Antagonists|hormone antagonists|mesh-ancestor
110575803|NCT04110834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110575804|NCT04110834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110575805|NCT04110834|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110575806|NCT00812578|Cholecalciferol|cholecalciferol|mesh-list
110575807|NCT00812578|Vitamin D|vitamin d|mesh-list
110575808|NCT00812578|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110575809|NCT00812578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110575810|NCT00812578|Vitamins|vitamins|mesh-ancestor
110575811|NCT00812578|Micronutrients|micronutrients|mesh-ancestor
110575812|NCT00812578|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110575813|NCT00796224|Azithromycin|azithromycin|mesh-list
110575814|NCT00796224|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110575815|NCT00796224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110575816|NCT00808366|Antifungal Agents|antifungal agents|mesh-list
110575817|NCT00808366|Clotrimazole|clotrimazole|mesh-list
110575818|NCT00808366|Miconazole|miconazole|mesh-list
110575819|NCT00808366|Keratolytic Agents|keratolytic agents|mesh-list
110575820|NCT00808366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110575821|NCT00808366|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110575822|NCT00808366|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110575823|NCT00808366|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110575824|NCT00808366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110575825|NCT00808366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110575826|NCT00808366|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110575827|NCT00808366|Hormone Antagonists|hormone antagonists|mesh-ancestor
110575828|NCT00808366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110575829|NCT00808366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110575830|NCT00808366|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110575831|NCT00808366|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110575833|NCT04045522|Zoledronic Acid|zoledronic acid|mesh-list
110575834|NCT04045522|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110575835|NCT04045522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110575836|NCT02551276|Albuterol|albuterol|mesh-list
110575837|NCT02551276|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110575838|NCT02551276|Autonomic Agents|autonomic agents|mesh-ancestor
110575839|NCT02551276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110223262|NCT00121563|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110575841|NCT02551276|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110575842|NCT02551276|Respiratory System Agents|respiratory system agents|mesh-ancestor
110575843|NCT02551276|Tocolytic Agents|tocolytic agents|mesh-ancestor
110575844|NCT02551276|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110575845|NCT02551276|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110575846|NCT02551276|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110575847|NCT02551276|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110575848|NCT02551276|Adrenergic Agents|adrenergic agents|mesh-ancestor
110575849|NCT02551276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110575850|NCT02551276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110575851|NCT00848081|Tadalafil|tadalafil|mesh-list
110148884|NCT00006115|Leucovorin|leucovorin|mesh-list
110575852|NCT00848081|Vasodilator Agents|vasodilator agents|mesh-ancestor
110575853|NCT00848081|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110575854|NCT00848081|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110575855|NCT00848081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110575856|NCT00848081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110575857|NCT00848081|Urological Agents|urological agents|mesh-ancestor
110575858|NCT00815464|Antiviral Agents|antiviral agents|mesh-list
110575859|NCT00815464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110575860|NCT04111380|Paclitaxel|paclitaxel|mesh-list
110575861|NCT04111380|Cisplatin|cisplatin|mesh-list
110575862|NCT04111380|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110575863|NCT04111380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110575864|NCT04111380|Tubulin Modulators|tubulin modulators|mesh-ancestor
110575865|NCT04111380|Antimitotic Agents|antimitotic agents|mesh-ancestor
110575866|NCT04111380|Mitosis Modulators|mitosis modulators|mesh-ancestor
110575867|NCT04111380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110575868|NCT04117919|Triamcinolone|triamcinolone|mesh-list
110575869|NCT04117919|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110575870|NCT04117919|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110575871|NCT04117919|Hydrocortisone|hydrocortisone|mesh-list
110575872|NCT04117919|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
110575873|NCT04117919|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
110575874|NCT04117919|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
110575875|NCT04117919|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110575876|NCT04117919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110575877|NCT04117919|Glucocorticoids|glucocorticoids|mesh-ancestor
110575878|NCT04117919|Hormones|hormones|mesh-ancestor
110575879|NCT04117919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110575880|NCT04117919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110575881|NCT04117919|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110575883|NCT04117919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110575884|NCT04117919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110575885|NCT00701285|Pravastatin|pravastatin|mesh-list
110575886|NCT00701285|Pitavastatin|pitavastatin|mesh-list
110575887|NCT00701285|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110575888|NCT00701285|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110575889|NCT00701285|Antimetabolites|antimetabolites|mesh-ancestor
110575890|NCT00701285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110575891|NCT00701285|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110575892|NCT00701285|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110575893|NCT00701285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110575894|NCT02604498|Nemonoxacin|nemonoxacin|mesh-list
110575895|NCT02604498|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110575896|NCT02604498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110575897|NCT00700037|Atorvastatin|atorvastatin|mesh-list
110575898|NCT00700037|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110575899|NCT00700037|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110575900|NCT00700037|Antimetabolites|antimetabolites|mesh-ancestor
110575901|NCT00700037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110575902|NCT00700037|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110094937|NCT01711749|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110575903|NCT00700037|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110575904|NCT00700037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110575905|NCT00815542|Dinoprostone|dinoprostone|mesh-list
110575906|NCT00815542|Oxytocics|oxytocics|mesh-ancestor
110575907|NCT00815542|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110575908|NCT00815542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110575909|NCT00791778|Sorafenib|sorafenib|mesh-list
110575910|NCT00791778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110575911|NCT00791778|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110575912|NCT00791778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110223340|NCT04711161|Paclitaxel|paclitaxel|mesh-list
110148888|NCT00006115|Calcium|calcium|mesh-list
110575913|NCT00791778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110575914|NCT02604576|Bromopride|bromopride|mesh-list
110575915|NCT02604576|Metoclopramide|metoclopramide|mesh-list
110575916|NCT02604576|Simethicone|simethicone|mesh-list
110575917|NCT02604576|Antifoaming Agents|antifoaming agents|mesh-ancestor
110575918|NCT02604576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110575919|NCT02604576|Emollients|emollients|mesh-ancestor
110575920|NCT02604576|Dermatologic Agents|dermatologic agents|mesh-ancestor
110575921|NCT02604576|Antiemetics|antiemetics|mesh-ancestor
110575922|NCT02604576|Autonomic Agents|autonomic agents|mesh-ancestor
110575923|NCT02604576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110575924|NCT02604576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110575925|NCT02604576|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110575926|NCT02604576|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110575927|NCT02604576|Dopamine Agents|dopamine agents|mesh-ancestor
110575928|NCT02604576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110575929|NCT02604576|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110575930|NCT04110132|Bupivacaine|bupivacaine|mesh-list
110575931|NCT04110132|Anesthetics, Local|anesthetics, local|mesh-ancestor
110575932|NCT04110132|Anesthetics|anesthetics|mesh-ancestor
110575933|NCT04110132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110575934|NCT04110132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110575935|NCT04110132|Sensory System Agents|sensory system agents|mesh-ancestor
110575936|NCT04110132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110575937|NCT00795600|Insulin|insulin|mesh-list
110575938|NCT00795600|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110575939|NCT00795600|Insulin Detemir|insulin detemir|mesh-list
110575940|NCT00795600|Isophane Insulin, Human|isophane insulin, human|mesh-list
110575941|NCT00795600|Insulin, Isophane|insulin, isophane|mesh-list
110575942|NCT00795600|Isophane insulin, beef|isophane insulin, beef|mesh-list
110575943|NCT00795600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110575944|NCT00795600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110575945|NCT00795132|Cyclosporine|cyclosporine|mesh-list
110575946|NCT00795132|Mycophenolic Acid|mycophenolic acid|mesh-list
110575947|NCT00795132|Fludarabine|fludarabine|mesh-list
110575948|NCT00795132|Busulfan|busulfan|mesh-list
110575949|NCT00795132|Cyclosporins|cyclosporins|mesh-list
110575950|NCT00795132|Thymoglobulin|thymoglobulin|mesh-list
110575951|NCT00795132|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110575952|NCT00795132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110575953|NCT00795132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110575954|NCT00795132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110575955|NCT00795132|Immunologic Factors|immunologic factors|mesh-ancestor
110575956|NCT00795132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110575957|NCT00795132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110575958|NCT00795132|Antifungal Agents|antifungal agents|mesh-ancestor
110575959|NCT00795132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110575960|NCT00795132|Dermatologic Agents|dermatologic agents|mesh-ancestor
110575961|NCT00795132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110575962|NCT00795132|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110575963|NCT00795132|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110575964|NCT00795132|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110575965|NCT00795132|Antitubercular Agents|antitubercular agents|mesh-ancestor
110575966|NCT00795132|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110575967|NCT00795132|Alkylating Agents|alkylating agents|mesh-ancestor
110575968|NCT00795132|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110575969|NCT00795132|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110575971|NCT02604420|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
110575972|NCT02604420|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110575973|NCT02604420|Immunologic Factors|immunologic factors|mesh-ancestor
110575974|NCT02604420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110575975|NCT04110210|Morphine|morphine|mesh-list
110575976|NCT04110210|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110575977|NCT04110210|Narcotics|narcotics|mesh-ancestor
110575978|NCT04110210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110575979|NCT04110210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110575980|NCT04110210|Analgesics|analgesics|mesh-ancestor
110575981|NCT04110210|Sensory System Agents|sensory system agents|mesh-ancestor
110575982|NCT04110210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110575983|NCT00647296|Pramipexole|pramipexole|mesh-list
110575984|NCT00647296|Antioxidants|antioxidants|mesh-ancestor
110575985|NCT00647296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110223412|NCT05567081|Glucocorticoids|glucocorticoids|mesh-ancestor
110575986|NCT00647296|Protective Agents|protective agents|mesh-ancestor
110575987|NCT00647296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110575988|NCT00647296|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110575989|NCT00647296|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110575990|NCT00647296|Dopamine Agonists|dopamine agonists|mesh-ancestor
110575992|NCT00647296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110575993|NCT00813202|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
110575994|NCT00813202|Natriuretic Agents|natriuretic agents|mesh-ancestor
110575995|NCT00813202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110575997|NCT00646906|Acetaminophen|acetaminophen|mesh-list
110575998|NCT00646906|Ibuprofen|ibuprofen|mesh-list
110575999|NCT00646906|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110576000|NCT00646906|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110576001|NCT00646906|Analgesics|analgesics|mesh-ancestor
110576002|NCT00646906|Sensory System Agents|sensory system agents|mesh-ancestor
110576003|NCT00646906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110576004|NCT00646906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110576005|NCT00646906|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110576006|NCT00646906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110576007|NCT00646906|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110576008|NCT00646906|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110576009|NCT00646906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110576010|NCT00646906|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110576011|NCT00646906|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110576012|NCT00646906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110576013|NCT00646906|Antipyretics|antipyretics|mesh-ancestor
110576014|NCT00813436|Oxytocin|oxytocin|mesh-list
110576015|NCT00813436|Oxytocics|oxytocics|mesh-ancestor
110576016|NCT00813436|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110576017|NCT00813436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110576018|NCT00808678|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110576019|NCT00808678|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110576020|NCT00808678|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110576021|NCT00808678|Antimetabolites|antimetabolites|mesh-ancestor
110576022|NCT00808678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110576023|NCT00808678|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110576024|NCT00808678|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110576025|NCT00808678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110576026|NCT00815854|Folic Acid|folic acid|mesh-list
110576027|NCT00815854|Hematinics|hematinics|mesh-ancestor
110576028|NCT00815854|Vitamin B Complex|vitamin b complex|mesh-ancestor
110576029|NCT00815854|Vitamins|vitamins|mesh-ancestor
110576030|NCT00815854|Micronutrients|micronutrients|mesh-ancestor
110576031|NCT00815854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110576032|NCT00817648|Risperidone|risperidone|mesh-list
110576033|NCT00817648|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110576034|NCT00817648|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110576035|NCT00817648|Serotonin Agents|serotonin agents|mesh-ancestor
110576036|NCT00817648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110576037|NCT00817648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110576038|NCT00817648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110576039|NCT00817648|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110576040|NCT00817648|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110576041|NCT00817648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110576042|NCT00817648|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110576043|NCT00817648|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110576044|NCT00817648|Dopamine Agents|dopamine agents|mesh-ancestor
110576045|NCT00817648|Antidepressive Agents|antidepressive agents|mesh-ancestor
110576046|NCT00829010|Vaccines|vaccines|mesh-list
110576047|NCT00829010|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110576048|NCT00829010|Immunologic Factors|immunologic factors|mesh-ancestor
110576049|NCT00829010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110576050|NCT00644332|Ranolazine|ranolazine|mesh-list
110576051|NCT00644332|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110576052|NCT00644332|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110576053|NCT00644332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110576054|NCT00808912|Sildenafil Citrate|sildenafil citrate|mesh-list
110576055|NCT00808912|Vasodilator Agents|vasodilator agents|mesh-ancestor
110576056|NCT00808912|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110576057|NCT00808912|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110576058|NCT00808912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110576059|NCT00808912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110576060|NCT00808912|Urological Agents|urological agents|mesh-ancestor
110576062|NCT02551042|Coagulants|coagulants|mesh-ancestor
110576063|NCT00445939|Adalimumab|adalimumab|mesh-list
110576064|NCT00445939|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110576065|NCT00445939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110576066|NCT00445939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110576067|NCT00816244|Atorvastatin|atorvastatin|mesh-list
110576068|NCT00816244|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110576069|NCT00816244|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110576070|NCT00816244|Antimetabolites|antimetabolites|mesh-ancestor
110576071|NCT00816244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110576072|NCT00816244|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110576073|NCT00816244|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110576074|NCT00816244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110576075|NCT00817960|Methylphenidate|methylphenidate|mesh-list
110576076|NCT00817960|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110576077|NCT00817960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110576078|NCT00817960|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110576079|NCT00817960|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110576080|NCT00817960|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110576081|NCT00817960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110576082|NCT00817960|Dopamine Agents|dopamine agents|mesh-ancestor
110576083|NCT00817960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110576084|NCT00818038|Natalizumab|natalizumab|mesh-list
110576085|NCT00818038|Immunologic Factors|immunologic factors|mesh-ancestor
110576086|NCT00818038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110576087|NCT00482053|Acetaminophen|acetaminophen|mesh-list
110576088|NCT00482053|Diphenhydramine|diphenhydramine|mesh-list
110576089|NCT00482053|Promethazine|promethazine|mesh-list
110576090|NCT00482053|Cyclosporine|cyclosporine|mesh-list
110576091|NCT00482053|Mycophenolic Acid|mycophenolic acid|mesh-list
110576092|NCT00482053|Methylprednisolone|methylprednisolone|mesh-list
110576093|NCT00482053|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110576094|NCT00482053|Hydrocortisone|hydrocortisone|mesh-list
110576095|NCT00482053|Cyclophosphamide|cyclophosphamide|mesh-list
110576096|NCT00482053|Carmustine|carmustine|mesh-list
110576097|NCT00482053|Rituximab|rituximab|mesh-list
110576098|NCT00482053|Etoposide|etoposide|mesh-list
110576099|NCT00482053|Cyclosporins|cyclosporins|mesh-list
110576100|NCT00482053|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110576101|NCT00482053|Lenograstim|lenograstim|mesh-list
110576102|NCT00482053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110576103|NCT00482053|Immunologic Factors|immunologic factors|mesh-ancestor
110576104|NCT00482053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110576105|NCT00482053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110576106|NCT00482053|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110576107|NCT00482053|Alkylating Agents|alkylating agents|mesh-ancestor
110576108|NCT00482053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110576109|NCT00482053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110576110|NCT00482053|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110576111|NCT00482053|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110576112|NCT00482053|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110576113|NCT00482053|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110576114|NCT00482053|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110576115|NCT00482053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110576116|NCT00482053|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110576117|NCT00482053|Antifungal Agents|antifungal agents|mesh-ancestor
110576118|NCT00482053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110576119|NCT00482053|Dermatologic Agents|dermatologic agents|mesh-ancestor
110576120|NCT00482053|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110576121|NCT00482053|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110576122|NCT00482053|Analgesics|analgesics|mesh-ancestor
110576123|NCT00482053|Sensory System Agents|sensory system agents|mesh-ancestor
110576124|NCT00482053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110576125|NCT00482053|Antipyretics|antipyretics|mesh-ancestor
110576126|NCT00482053|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110576127|NCT00482053|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110576128|NCT00482053|Antitubercular Agents|antitubercular agents|mesh-ancestor
110576129|NCT00482053|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110576130|NCT00482053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110576131|NCT00482053|Antiemetics|antiemetics|mesh-ancestor
110576132|NCT00482053|Autonomic Agents|autonomic agents|mesh-ancestor
110576133|NCT00482053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110576134|NCT00482053|Glucocorticoids|glucocorticoids|mesh-ancestor
110576135|NCT00482053|Hormones|hormones|mesh-ancestor
110576136|NCT00482053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110576137|NCT00482053|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110576138|NCT00482053|Protective Agents|protective agents|mesh-ancestor
110576139|NCT00482053|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110576140|NCT00482053|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110576141|NCT00482053|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110576142|NCT00482053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110576143|NCT00482053|Anesthetics, Local|anesthetics, local|mesh-ancestor
110576144|NCT00482053|Anesthetics|anesthetics|mesh-ancestor
110576145|NCT00482053|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110576146|NCT00482053|Histamine Antagonists|histamine antagonists|mesh-ancestor
110576147|NCT00482053|Histamine Agents|histamine agents|mesh-ancestor
110576148|NCT00482053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110576149|NCT00482053|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110576150|NCT00482053|Antipruritics|antipruritics|mesh-ancestor
110576151|NCT00455923|Fluticasone|fluticasone|mesh-list
110576152|NCT00455923|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
110576153|NCT00455923|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110576154|NCT00455923|Autonomic Agents|autonomic agents|mesh-ancestor
110576155|NCT00455923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110576156|NCT00455923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110576157|NCT00455923|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110374505|NCT01137292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110576158|NCT00455923|Respiratory System Agents|respiratory system agents|mesh-ancestor
110576159|NCT00455923|Glucocorticoids|glucocorticoids|mesh-ancestor
110576160|NCT00455923|Hormones|hormones|mesh-ancestor
110576161|NCT00455923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110576162|NCT00455923|Sympathomimetics|sympathomimetics|mesh-ancestor
110576163|NCT00455923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110576164|NCT00455923|Dermatologic Agents|dermatologic agents|mesh-ancestor
110576165|NCT00455923|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110576166|NCT00642616|Insulin|insulin|mesh-list
110576167|NCT00642616|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110576168|NCT00642616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110576169|NCT00809068|Tibolone|tibolone|mesh-list
110576170|NCT00809068|Fenofibrate|fenofibrate|mesh-list
110576171|NCT00809068|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110576172|NCT00809068|Antimetabolites|antimetabolites|mesh-ancestor
110576173|NCT00809068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110576174|NCT00809068|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110576175|NCT00809068|Androgen Antagonists|androgen antagonists|mesh-ancestor
110576176|NCT00809068|Hormone Antagonists|hormone antagonists|mesh-ancestor
110576177|NCT00809068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110576178|NCT00809068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110576179|NCT00809068|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110148931|NCT00006127|Amifostine|amifostine|mesh-list
110576180|NCT00809068|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110576181|NCT00809068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110576182|NCT00809068|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110576183|NCT00809068|Anabolic Agents|anabolic agents|mesh-ancestor
110576184|NCT00809068|Hormones|hormones|mesh-ancestor
110576185|NCT03844945|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110576186|NCT03844945|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110576187|NCT01027117|Sildenafil Citrate|sildenafil citrate|mesh-list
110576188|NCT01027117|Vasodilator Agents|vasodilator agents|mesh-ancestor
110576189|NCT01027117|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110576190|NCT01027117|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110576191|NCT01027117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110576192|NCT01027117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110576193|NCT01027117|Urological Agents|urological agents|mesh-ancestor
110576194|NCT03995563|Dexamethasone|dexamethasone|mesh-list
110576195|NCT03995563|Ropivacaine|ropivacaine|mesh-list
110576196|NCT03995563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110576197|NCT03995563|Antiemetics|antiemetics|mesh-ancestor
110576198|NCT03995563|Autonomic Agents|autonomic agents|mesh-ancestor
110576199|NCT03995563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110576200|NCT03995563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110576201|NCT03995563|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110576202|NCT03995563|Glucocorticoids|glucocorticoids|mesh-ancestor
110576203|NCT03995563|Hormones|hormones|mesh-ancestor
110576204|NCT03995563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110576205|NCT03995563|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110576206|NCT03995563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110576207|NCT03995563|Anesthetics, Local|anesthetics, local|mesh-ancestor
110576208|NCT03995563|Anesthetics|anesthetics|mesh-ancestor
110576209|NCT03995563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110576210|NCT03995563|Sensory System Agents|sensory system agents|mesh-ancestor
110576211|NCT00445003|Triamcinolone|triamcinolone|mesh-list
110576212|NCT00445003|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110576213|NCT00445003|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110576214|NCT00445003|Ranibizumab|ranibizumab|mesh-list
110576215|NCT00445003|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110576216|NCT00445003|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110576218|NCT00445003|Growth Substances|growth substances|mesh-ancestor
110576219|NCT00445003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110576220|NCT00445003|Growth Inhibitors|growth inhibitors|mesh-ancestor
110576221|NCT00445003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110576222|NCT00445003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110576223|NCT00445003|Glucocorticoids|glucocorticoids|mesh-ancestor
110576224|NCT00445003|Hormones|hormones|mesh-ancestor
110576225|NCT00445003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110576226|NCT00445003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110576227|NCT00445003|Immunologic Factors|immunologic factors|mesh-ancestor
110576228|NCT00445003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110576229|NCT00445003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110576230|NCT00642460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
110576231|NCT00642460|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
110576232|NCT00642460|Methotrexate|methotrexate|mesh-list
110576233|NCT00642460|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110576234|NCT00642460|Abortifacient Agents|abortifacient agents|mesh-ancestor
110576235|NCT00642460|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110576236|NCT00642460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110576237|NCT00642460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110576238|NCT00642460|Antimetabolites|antimetabolites|mesh-ancestor
110576239|NCT00642460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110576240|NCT00642460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110576241|NCT00642460|Dermatologic Agents|dermatologic agents|mesh-ancestor
110576242|NCT00642460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110576243|NCT00642460|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110576244|NCT00642460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110576245|NCT00642460|Immunologic Factors|immunologic factors|mesh-ancestor
110576246|NCT00642460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110576247|NCT00642460|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110148937|NCT00006133|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110576248|NCT00642460|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110576249|NCT00642460|Analgesics|analgesics|mesh-ancestor
110576250|NCT00642460|Sensory System Agents|sensory system agents|mesh-ancestor
110576251|NCT00642460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110576253|NCT00814658|Galantamine|galantamine|mesh-list
110576254|NCT00814658|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110576255|NCT00814658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110576256|NCT00814658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110576257|NCT00814658|Cholinergic Agents|cholinergic agents|mesh-ancestor
110576258|NCT00814658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110576259|NCT00814658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110576260|NCT00814658|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110576261|NCT00814658|Autonomic Agents|autonomic agents|mesh-ancestor
110576262|NCT00814658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110576263|NCT00814658|Nootropic Agents|nootropic agents|mesh-ancestor
110576264|NCT00814658|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110576265|NCT00814658|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110576266|NCT00814658|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110576267|NCT00814658|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110576268|NCT00814658|Vasodilator Agents|vasodilator agents|mesh-ancestor
110576269|NCT00816634|Paclitaxel|paclitaxel|mesh-list
110576270|NCT00816634|Capecitabine|capecitabine|mesh-list
110576271|NCT00816634|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110576272|NCT00816634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110576273|NCT00816634|Tubulin Modulators|tubulin modulators|mesh-ancestor
110576274|NCT00816634|Antimitotic Agents|antimitotic agents|mesh-ancestor
110576275|NCT00816634|Mitosis Modulators|mitosis modulators|mesh-ancestor
110576276|NCT00816634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110576277|NCT00816634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110576278|NCT00816634|Antimetabolites|antimetabolites|mesh-ancestor
110576279|NCT00642304|Epoetin Alfa|epoetin alfa|mesh-list
110576280|NCT00642304|Hematinics|hematinics|mesh-ancestor
110576281|NCT00814580|Oxycodone|oxycodone|mesh-list
110576282|NCT00814580|Tapentadol|tapentadol|mesh-list
110576283|NCT00814580|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110576284|NCT00814580|Narcotics|narcotics|mesh-ancestor
110576285|NCT00814580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110576286|NCT00814580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110576287|NCT00814580|Analgesics|analgesics|mesh-ancestor
110576288|NCT00814580|Sensory System Agents|sensory system agents|mesh-ancestor
110576289|NCT00814580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110576290|NCT00814580|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110576291|NCT00814580|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110576292|NCT00814580|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110576293|NCT00814580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110576294|NCT00814580|Adrenergic Agents|adrenergic agents|mesh-ancestor
110576295|NCT00814580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110576296|NCT00643162|Escitalopram|escitalopram|mesh-list
110576297|NCT00643162|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110576298|NCT00643162|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110576299|NCT00643162|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110576300|NCT00643162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110576301|NCT00643162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110576302|NCT00643162|Serotonin Agents|serotonin agents|mesh-ancestor
110576303|NCT00643162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110576305|NCT00814502|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110576306|NCT00814502|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110576307|NCT00814502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110576308|NCT00814502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110576309|NCT00814502|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
110576310|NCT00814502|GABA Agonists|gaba agonists|mesh-ancestor
110576311|NCT00814502|GABA Agents|gaba agents|mesh-ancestor
110576312|NCT00814502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110576313|NCT00814502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110576314|NCT00653224|Levocetirizine|levocetirizine|mesh-list
110576315|NCT00653224|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110576316|NCT00653224|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110576317|NCT00653224|Histamine Antagonists|histamine antagonists|mesh-ancestor
110576318|NCT00653224|Histamine Agents|histamine agents|mesh-ancestor
110576319|NCT00653224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110576320|NCT00653224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110576321|NCT00653224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110576322|NCT00444925|Tolterodine Tartrate|tolterodine tartrate|mesh-list
110576323|NCT00444925|Fesoterodine|fesoterodine|mesh-list
110576324|NCT00444925|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110576325|NCT00444925|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110576326|NCT00444925|Cholinergic Agents|cholinergic agents|mesh-ancestor
110576327|NCT00444925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110576328|NCT00444925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110576329|NCT00444925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110576330|NCT00444925|Urological Agents|urological agents|mesh-ancestor
110576331|NCT00641056|Insulin Glargine|insulin glargine|mesh-list
110576332|NCT00641056|Exenatide|exenatide|mesh-list
110576333|NCT00641056|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110576334|NCT00641056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110576335|NCT00641056|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110576336|NCT00641056|Incretins|incretins|mesh-ancestor
110576337|NCT00641056|Hormones|hormones|mesh-ancestor
110576338|NCT00641056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110576339|NCT00569374|Modafinil|modafinil|mesh-list
110576340|NCT00569374|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110576341|NCT00569374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110576342|NCT00569374|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
110576343|NCT00569374|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110576344|NCT00569374|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110576345|NCT00569374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110576347|NCT00828464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110576348|NCT00828464|Glucocorticoids|glucocorticoids|mesh-ancestor
110576349|NCT00828464|Hormones|hormones|mesh-ancestor
110576350|NCT00828464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110576351|NCT00828464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110576352|NCT00816712|Methyltestosterone|methyltestosterone|mesh-list
110576353|NCT00816712|Testosterone|testosterone|mesh-list
110576354|NCT00816712|Testosterone undecanoate|testosterone undecanoate|mesh-list
110576355|NCT00816712|Testosterone enanthate|testosterone enanthate|mesh-list
110576356|NCT00816712|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
110576357|NCT00816712|Androgens|androgens|mesh-ancestor
110576358|NCT00816712|Hormones|hormones|mesh-ancestor
110576359|NCT00816712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110374528|NCT04674137|Glutarimide|glutarimide|mesh-list
110576360|NCT00816712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110576361|NCT00816712|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110576362|NCT00816712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110576363|NCT00816712|Anabolic Agents|anabolic agents|mesh-ancestor
110576364|NCT00818194|Cyclosporine|cyclosporine|mesh-list
110576365|NCT00818194|Tacrolimus|tacrolimus|mesh-list
110576366|NCT00818194|Cyclosporins|cyclosporins|mesh-list
110576367|NCT00818194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110576368|NCT00818194|Immunologic Factors|immunologic factors|mesh-ancestor
110576369|NCT00818194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110148965|NCT00006154|Ritonavir|ritonavir|mesh-list
110576370|NCT00818194|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110576371|NCT00818194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110576372|NCT00818194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110576373|NCT00818194|Antifungal Agents|antifungal agents|mesh-ancestor
110576374|NCT00818194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110576375|NCT00818194|Dermatologic Agents|dermatologic agents|mesh-ancestor
110576376|NCT00818194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110576377|NCT02610686|Chloroquine|chloroquine|mesh-list
110576378|NCT02610686|Amebicides|amebicides|mesh-ancestor
110576379|NCT02610686|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110576380|NCT02610686|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110576381|NCT02610686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110576382|NCT02610686|Antimalarials|antimalarials|mesh-ancestor
110576383|NCT02610686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110576384|NCT00816790|Tazobactam|tazobactam|mesh-list
110576385|NCT00816790|Piperacillin|piperacillin|mesh-list
110576386|NCT00816790|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
110576387|NCT00816790|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110576388|NCT00816790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110576389|NCT00816790|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110576390|NCT00816790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110576391|NCT00816790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110576392|NCT00818350|Sunitinib|sunitinib|mesh-list
110576393|NCT00818350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110576394|NCT00818350|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110576395|NCT00818350|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110576396|NCT00818350|Growth Substances|growth substances|mesh-ancestor
110576397|NCT00818350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110576398|NCT00818350|Growth Inhibitors|growth inhibitors|mesh-ancestor
110576399|NCT00818350|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110576400|NCT00818350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110576401|NCT00818350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110576402|NCT00810602|Vorinostat|vorinostat|mesh-list
110576403|NCT00810602|Tacrolimus|tacrolimus|mesh-list
110576404|NCT00810602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110576405|NCT00810602|Immunologic Factors|immunologic factors|mesh-ancestor
110576406|NCT00810602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110576407|NCT00810602|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110576408|NCT00810602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110576409|NCT00810602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110576410|NCT00810602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110576411|NCT00810602|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110576412|NCT00816868|Capecitabine|capecitabine|mesh-list
110576413|NCT00816868|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110576414|NCT00816868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110576415|NCT00816868|Antimetabolites|antimetabolites|mesh-ancestor
110576416|NCT00816868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110576417|NCT00816868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110576418|NCT00816868|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110576419|NCT00816868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110576420|NCT05500586|Glucagon|glucagon|mesh-list
110576421|NCT05500586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110576422|NCT05500586|Hormones|hormones|mesh-ancestor
110576423|NCT05500586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110374534|NCT04674137|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110576424|NCT05500586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110576425|NCT00791700|Maraviroc|maraviroc|mesh-list
110576426|NCT00791700|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110576427|NCT00791700|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110576428|NCT00791700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110576429|NCT00791700|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110576430|NCT00791700|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110576431|NCT00791700|Antiviral Agents|antiviral agents|mesh-ancestor
110576432|NCT00791700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110576433|NCT00791700|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
110576434|NCT00628108|Levocetirizine|levocetirizine|mesh-list
110576435|NCT00628108|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110576436|NCT00628108|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110576437|NCT00628108|Histamine Antagonists|histamine antagonists|mesh-ancestor
110576438|NCT00628108|Histamine Agents|histamine agents|mesh-ancestor
110576439|NCT00628108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110576440|NCT00628108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110576441|NCT00628108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110576443|NCT00821392|Gout Suppressants|gout suppressants|mesh-ancestor
110576444|NCT00821392|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110576445|NCT00591578|Valsartan|valsartan|mesh-list
110576446|NCT00591578|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
110576447|NCT00591578|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110576448|NCT00591578|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110576449|NCT00591578|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110576450|NCT00591578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110576451|NCT00797862|Amlodipine|amlodipine|mesh-list
110576452|NCT00797862|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110576453|NCT00797862|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110576454|NCT00797862|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110576455|NCT00797862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110576456|NCT00797862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110576457|NCT00797862|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110576458|NCT00797862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110576459|NCT00797862|Vasodilator Agents|vasodilator agents|mesh-ancestor
110576460|NCT00797862|Diuretics|diuretics|mesh-ancestor
110576461|NCT00797862|Natriuretic Agents|natriuretic agents|mesh-ancestor
110576462|NCT00797862|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110576463|NCT00817258|Cisplatin|cisplatin|mesh-list
110576464|NCT00817258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110576465|NCT00794820|Cyclophosphamide|cyclophosphamide|mesh-list
110576466|NCT00794820|Rituximab|rituximab|mesh-list
110576467|NCT00794820|Fludarabine|fludarabine|mesh-list
110576468|NCT00794820|Fludarabine phosphate|fludarabine phosphate|mesh-list
110576469|NCT00794820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110576470|NCT00794820|Immunologic Factors|immunologic factors|mesh-ancestor
110576471|NCT00794820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110576472|NCT00794820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110576473|NCT00794820|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110576474|NCT00794820|Alkylating Agents|alkylating agents|mesh-ancestor
110576475|NCT00794820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110576476|NCT00794820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110576477|NCT00794820|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110576478|NCT00794820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110576479|NCT00794820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110576480|NCT00794820|Antimetabolites|antimetabolites|mesh-ancestor
110576481|NCT00455533|Paclitaxel|paclitaxel|mesh-list
110576482|NCT00455533|Epothilones|epothilones|mesh-list
110576483|NCT00455533|Cyclophosphamide|cyclophosphamide|mesh-list
110576484|NCT00455533|Doxorubicin|doxorubicin|mesh-list
110576485|NCT00455533|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110576486|NCT00455533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110576487|NCT00455533|Tubulin Modulators|tubulin modulators|mesh-ancestor
110576488|NCT00455533|Antimitotic Agents|antimitotic agents|mesh-ancestor
110576489|NCT00455533|Mitosis Modulators|mitosis modulators|mesh-ancestor
110576490|NCT00455533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110576491|NCT00455533|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110576492|NCT00455533|Immunologic Factors|immunologic factors|mesh-ancestor
110576493|NCT00455533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110576494|NCT00455533|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110576495|NCT00455533|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110576496|NCT00455533|Alkylating Agents|alkylating agents|mesh-ancestor
110576497|NCT00455533|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110576498|NCT00455533|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110576499|NCT00455533|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110576500|NCT00455533|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110576501|NCT00455533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110576503|NCT00818584|Antifungal Agents|antifungal agents|mesh-ancestor
110576504|NCT00818584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110576505|NCT02610530|Hypoglycemic Agents|hypoglycemic agents|mesh-list
110576506|NCT02610530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110576507|NCT00923000|Morphine|morphine|mesh-list
110576508|NCT00923000|Nalbuphine|nalbuphine|mesh-list
110576509|NCT00923000|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110576510|NCT00923000|Narcotics|narcotics|mesh-ancestor
110576511|NCT00923000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110576512|NCT00923000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110576513|NCT00923000|Analgesics|analgesics|mesh-ancestor
110576514|NCT00923000|Sensory System Agents|sensory system agents|mesh-ancestor
110576515|NCT00923000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110576516|NCT01019863|Oxaliplatin|oxaliplatin|mesh-list
110576517|NCT01019863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110576518|NCT00642850|Epoetin Alfa|epoetin alfa|mesh-list
110576519|NCT00642850|Hematinics|hematinics|mesh-ancestor
110576520|NCT00455455|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110576521|NCT00913952|Clomipramine|clomipramine|mesh-list
110576522|NCT00913952|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110576523|NCT00913952|Antidepressive Agents|antidepressive agents|mesh-ancestor
110576524|NCT00913952|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110576525|NCT00913952|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110576526|NCT00913952|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110576527|NCT00913952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110576528|NCT00913952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110576529|NCT00913952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110576530|NCT00913952|Serotonin Agents|serotonin agents|mesh-ancestor
110576531|NCT00913952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110576532|NCT04581382|Pembrolizumab|pembrolizumab|mesh-list
110576533|NCT04581382|Nivolumab|nivolumab|mesh-list
110576534|NCT04581382|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110576535|NCT04581382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110576536|NCT04581382|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110576537|NCT04581382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110576538|NCT00818818|Meglumine Antimoniate|meglumine antimoniate|mesh-list
110576539|NCT00818818|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110576540|NCT00818818|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110576541|NCT00818818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110576542|NCT03840811|Ciprofloxacin|ciprofloxacin|mesh-list
110576543|NCT03840811|Ceftriaxone|ceftriaxone|mesh-list
110576544|NCT03840811|Cefixime|cefixime|mesh-list
110576545|NCT03840811|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110576546|NCT03840811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110576547|NCT03840811|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110576548|NCT03840811|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110576549|NCT03840811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110576550|NCT03840811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110576551|NCT03840811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110576552|NCT03840811|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110576553|NCT03840811|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110576554|NCT00640510|Olanzapine|olanzapine|mesh-list
110576555|NCT00640510|Antiemetics|antiemetics|mesh-ancestor
110576556|NCT00640510|Autonomic Agents|autonomic agents|mesh-ancestor
110576557|NCT00640510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110576558|NCT00640510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110576559|NCT00640510|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110576560|NCT00640510|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110576561|NCT00640510|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110576562|NCT00640510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110576563|NCT00640510|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110576564|NCT00640510|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110576565|NCT00640510|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110576566|NCT00640510|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110576567|NCT00640510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110576569|NCT00640510|Serotonin Agents|serotonin agents|mesh-ancestor
110576570|NCT00913718|Fluoxetine|fluoxetine|mesh-list
110576571|NCT00913718|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110576572|NCT00913718|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110576573|NCT00913718|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110576574|NCT00913718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110576575|NCT00913718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110576576|NCT00913718|Serotonin Agents|serotonin agents|mesh-ancestor
110576577|NCT00913718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110576578|NCT00913718|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110576579|NCT00913718|Antidepressive Agents|antidepressive agents|mesh-ancestor
110576580|NCT00913718|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110576581|NCT00913718|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110576582|NCT00913718|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110576583|NCT00913718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110576584|NCT00813800|Varenicline|varenicline|mesh-list
110576585|NCT00813800|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110223996|NCT00090246|Dermatologic Agents|dermatologic agents|mesh-ancestor
110576586|NCT00813800|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110576587|NCT00813800|Cholinergic Agents|cholinergic agents|mesh-ancestor
110576588|NCT00813800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110576589|NCT00813800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110576590|NCT00813800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110576591|NCT00627016|Dexlansoprazole|dexlansoprazole|mesh-list
110576592|NCT00627016|Lansoprazole|lansoprazole|mesh-list
110576593|NCT00627016|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110576594|NCT00627016|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110576595|NCT00627016|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110576596|NCT00627016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110576597|NCT00627016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110576598|NCT00794664|Mipomersen|mipomersen|mesh-list
110576599|NCT00794664|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110576600|NCT00794664|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110576601|NCT00794664|Antimetabolites|antimetabolites|mesh-ancestor
110576602|NCT00794664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110576603|NCT00794664|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110576604|NCT00444535|Bevacizumab|bevacizumab|mesh-list
110576605|NCT00444535|Lapatinib|lapatinib|mesh-list
110576606|NCT00444535|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110576607|NCT00444535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110576608|NCT00444535|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110576609|NCT00444535|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110576610|NCT00444535|Growth Substances|growth substances|mesh-ancestor
110576611|NCT00444535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110576612|NCT00444535|Growth Inhibitors|growth inhibitors|mesh-ancestor
110576613|NCT00444535|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110576614|NCT00444535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110576615|NCT00444535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110576616|NCT04110288|Paclitaxel|paclitaxel|mesh-list
110576617|NCT04110288|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110576618|NCT04110288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110576619|NCT04110288|Tubulin Modulators|tubulin modulators|mesh-ancestor
110576620|NCT04110288|Antimitotic Agents|antimitotic agents|mesh-ancestor
110576621|NCT04110288|Mitosis Modulators|mitosis modulators|mesh-ancestor
110576622|NCT04110288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110576623|NCT00826306|Sunscreening Agents|sunscreening agents|mesh-list
110576624|NCT00826306|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110576625|NCT00826306|Protective Agents|protective agents|mesh-ancestor
110576626|NCT00826306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110576627|NCT00826306|Dermatologic Agents|dermatologic agents|mesh-ancestor
110576628|NCT05753852|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
110576629|NCT05753852|Antiviral Agents|antiviral agents|mesh-ancestor
110576630|NCT05753852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110576631|NCT05753852|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
110576632|NCT05753852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110576633|NCT00821782|Azithromycin|azithromycin|mesh-list
110576634|NCT00821782|Levofloxacin|levofloxacin|mesh-list
110576635|NCT00821782|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110576636|NCT00821782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110576637|NCT00821782|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110576638|NCT00821782|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110094938|NCT01711749|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110576640|NCT00821782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110576641|NCT00821782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110576642|NCT00821782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110576643|NCT00821782|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110576644|NCT00821782|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110576645|NCT00847613|Tofacitinib|tofacitinib|mesh-list
110576646|NCT00847613|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
110576647|NCT00847613|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110576648|NCT00847613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110576649|NCT00847613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110576650|NCT00794196|Antidepressive Agents|antidepressive agents|mesh-list
110576651|NCT00794196|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110576653|NCT00807092|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110576654|NCT00807092|Metformin|metformin|mesh-list
110576655|NCT00807092|Insulin Aspart|insulin aspart|mesh-list
110576656|NCT00807092|Biphasic Insulins|biphasic insulins|mesh-list
110576657|NCT00807092|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
110576658|NCT00807092|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110576659|NCT00807092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110576660|NCT04112550|Acetaminophen|acetaminophen|mesh-list
110576661|NCT04112550|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
110576663|NCT04112550|Methadone|methadone|mesh-list
110576664|NCT04112550|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110576665|NCT04112550|Analgesics|analgesics|mesh-ancestor
110576666|NCT04112550|Sensory System Agents|sensory system agents|mesh-ancestor
110576667|NCT04112550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110576668|NCT04112550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110576669|NCT04112550|Antipyretics|antipyretics|mesh-ancestor
110576670|NCT04112550|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110576671|NCT04112550|Narcotics|narcotics|mesh-ancestor
110576672|NCT04112550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110576673|NCT04112550|Antitussive Agents|antitussive agents|mesh-ancestor
110576674|NCT04112550|Respiratory System Agents|respiratory system agents|mesh-ancestor
110576675|NCT04112550|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110576676|NCT04112550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110576677|NCT04112550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110576678|NCT00640042|Morphine|morphine|mesh-list
110576679|NCT00640042|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110576680|NCT00640042|Narcotics|narcotics|mesh-ancestor
110576681|NCT00640042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110576682|NCT00640042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110576683|NCT00640042|Analgesics|analgesics|mesh-ancestor
110576684|NCT00640042|Sensory System Agents|sensory system agents|mesh-ancestor
110576685|NCT00640042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110576686|NCT00807014|Adapalene|adapalene|mesh-list
110576687|NCT00807014|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110576688|NCT00807014|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110576689|NCT00807014|Analgesics|analgesics|mesh-ancestor
110576690|NCT00807014|Sensory System Agents|sensory system agents|mesh-ancestor
110576691|NCT00807014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110576692|NCT00807014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110576693|NCT00807014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110576694|NCT00807014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110576695|NCT00807014|Dermatologic Agents|dermatologic agents|mesh-ancestor
110576696|NCT00794040|Methylphenidate|methylphenidate|mesh-list
110576697|NCT00794040|Citalopram|citalopram|mesh-list
110576698|NCT00794040|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110149006|NCT00006190|Stavudine|stavudine|mesh-list
110576699|NCT00794040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110576700|NCT00794040|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110576701|NCT00794040|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110576702|NCT00794040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110576703|NCT00794040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110576704|NCT00794040|Dopamine Agents|dopamine agents|mesh-ancestor
110576705|NCT00794040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110576706|NCT00794040|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110576707|NCT00794040|Serotonin Agents|serotonin agents|mesh-ancestor
110576708|NCT00794040|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110576709|NCT00794040|Antidepressive Agents|antidepressive agents|mesh-ancestor
110576710|NCT00794040|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110576711|NCT04109742|Curcumin|curcumin|mesh-list
110576712|NCT04109742|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110576714|NCT04109742|Analgesics|analgesics|mesh-ancestor
110576715|NCT04109742|Sensory System Agents|sensory system agents|mesh-ancestor
110576716|NCT04109742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110576717|NCT04109742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110576718|NCT04109742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110576719|NCT04109742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110576720|NCT04109742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110576721|NCT04109742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110576722|NCT04109742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110576723|NCT00813488|Fentanyl|fentanyl|mesh-list
110576724|NCT00813488|Oxycodone|oxycodone|mesh-list
110576725|NCT00813488|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110576726|NCT00813488|Narcotics|narcotics|mesh-ancestor
110576727|NCT00813488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110576728|NCT00813488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110576729|NCT00813488|Analgesics|analgesics|mesh-ancestor
110576730|NCT00813488|Sensory System Agents|sensory system agents|mesh-ancestor
110576731|NCT00813488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110576732|NCT00813488|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110576733|NCT00813488|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110576734|NCT00813488|Anesthetics, General|anesthetics, general|mesh-ancestor
110576736|NCT00797316|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110576737|NCT00797316|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110576738|NCT00797316|Diuretics|diuretics|mesh-ancestor
110576739|NCT00797316|Natriuretic Agents|natriuretic agents|mesh-ancestor
110576740|NCT00797316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110576741|NCT00797316|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110576742|NCT00797316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110576743|NCT00797316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110576744|NCT05640336|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110576745|NCT05640336|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
110576746|NCT05640336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110576747|NCT05640336|Antitubercular Agents|antitubercular agents|mesh-ancestor
110576748|NCT05753696|Losartan|losartan|mesh-list
110576749|NCT05753696|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
110576750|NCT05753696|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110576751|NCT05753696|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110576752|NCT05753696|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110576753|NCT05753696|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110576754|NCT05753696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110576755|NCT04107480|Dopamine|dopamine|mesh-list
110576756|NCT04107480|Dopamine Agonists|dopamine agonists|mesh-list
110576757|NCT04107480|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110576758|NCT04107480|Sympathomimetics|sympathomimetics|mesh-ancestor
110576759|NCT04107480|Autonomic Agents|autonomic agents|mesh-ancestor
110576760|NCT04107480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110576761|NCT04107480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110576762|NCT04107480|Dopamine Agents|dopamine agents|mesh-ancestor
110576763|NCT04107480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110576764|NCT04107480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110576765|NCT04107480|Protective Agents|protective agents|mesh-ancestor
110576766|NCT00915408|Dexamethasone|dexamethasone|mesh-list
110576767|NCT00915408|Cyclophosphamide|cyclophosphamide|mesh-list
110576768|NCT00915408|Lenalidomide|lenalidomide|mesh-list
110576769|NCT00915408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110576770|NCT00915408|Immunologic Factors|immunologic factors|mesh-ancestor
110576771|NCT00915408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110576772|NCT00915408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110576773|NCT00915408|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110576774|NCT00915408|Alkylating Agents|alkylating agents|mesh-ancestor
110576775|NCT00915408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110576776|NCT00915408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110576777|NCT00915408|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110576778|NCT00915408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110576779|NCT00915408|Antiemetics|antiemetics|mesh-ancestor
110576780|NCT00915408|Autonomic Agents|autonomic agents|mesh-ancestor
110576781|NCT00915408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110576782|NCT00915408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110576783|NCT00915408|Glucocorticoids|glucocorticoids|mesh-ancestor
110576784|NCT00915408|Hormones|hormones|mesh-ancestor
110576785|NCT00915408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110576786|NCT00915408|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110576787|NCT00915408|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110576789|NCT00915408|Growth Substances|growth substances|mesh-ancestor
110576790|NCT00915408|Growth Inhibitors|growth inhibitors|mesh-ancestor
110576791|NCT00791076|Pancreatic Polypeptide|pancreatic polypeptide|mesh-list
110576792|NCT00791076|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110576793|NCT00791076|Hormones|hormones|mesh-ancestor
110576794|NCT00791076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110576795|NCT00791076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110576797|NCT02610062|Immunoconjugates|immunoconjugates|mesh-ancestor
110576798|NCT02610062|Immunologic Factors|immunologic factors|mesh-ancestor
110576799|NCT02610062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110576800|NCT00625378|Sorafenib|sorafenib|mesh-list
110576801|NCT00625378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110576802|NCT00625378|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110576803|NCT00625378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110576804|NCT00625378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110576805|NCT00806624|Warfarin|warfarin|mesh-list
110576806|NCT00806624|Edoxaban|edoxaban|mesh-list
110576807|NCT00806624|Anticoagulants|anticoagulants|mesh-ancestor
110576808|NCT00806624|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110576809|NCT00806624|Antithrombins|antithrombins|mesh-ancestor
110576810|NCT00806624|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110576811|NCT00806624|Protease Inhibitors|protease inhibitors|mesh-ancestor
110576812|NCT00806624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110576813|NCT00806624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110576814|NCT00624832|Omalizumab|omalizumab|mesh-list
110576815|NCT00624832|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110576816|NCT00624832|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110576817|NCT00624832|Respiratory System Agents|respiratory system agents|mesh-ancestor
110576818|NCT05753150|Primaquine|primaquine|mesh-list
110576819|NCT05753150|Tafenoquine|tafenoquine|mesh-list
110576820|NCT05753150|Antimalarials|antimalarials|mesh-ancestor
110576821|NCT05753150|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110576822|NCT05753150|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110576823|NCT05753150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110576824|NCT00826852|Carboplatin|carboplatin|mesh-list
110576825|NCT00826852|Docetaxel|docetaxel|mesh-list
110576826|NCT00826852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110576827|NCT00826852|Tubulin Modulators|tubulin modulators|mesh-ancestor
110374591|NCT00196326|Estradiol|estradiol|mesh-list
110576828|NCT00826852|Antimitotic Agents|antimitotic agents|mesh-ancestor
110576829|NCT00826852|Mitosis Modulators|mitosis modulators|mesh-ancestor
110576830|NCT00826852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110576831|NCT00826930|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
110576833|NCT00826930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110576834|NCT00826930|Protective Agents|protective agents|mesh-ancestor
110576835|NCT00826930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110576836|NCT00826930|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110576837|NCT00826930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110576838|NCT00913796|Potassium Citrate|potassium citrate|mesh-list
110576839|NCT00913796|Diuretics|diuretics|mesh-ancestor
110576840|NCT00913796|Natriuretic Agents|natriuretic agents|mesh-ancestor
110576841|NCT00913796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110576842|NCT00913796|Expectorants|expectorants|mesh-ancestor
110576843|NCT00913796|Respiratory System Agents|respiratory system agents|mesh-ancestor
110576844|NCT00633880|Droxidopa|droxidopa|mesh-list
110576845|NCT00633880|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110576846|NCT00633880|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110576847|NCT04029428|Octreotide|octreotide|mesh-list
110576848|NCT04029428|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
110576849|NCT04029428|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110576850|NCT04029428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110576851|NCT04029428|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110576852|NCT04029428|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110576853|NCT04029428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110576854|NCT00819520|Ivermectin|ivermectin|mesh-list
110576855|NCT00819520|Malathion|malathion|mesh-list
110576856|NCT00819520|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110576857|NCT00819520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110576858|NCT00819520|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110576859|NCT00819520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110576860|NCT00819520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110576861|NCT00819520|Cholinergic Agents|cholinergic agents|mesh-ancestor
110576862|NCT00819520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110576863|NCT00819520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110576864|NCT00631696|Pregabalin|pregabalin|mesh-list
110576865|NCT00631696|Analgesics|analgesics|mesh-ancestor
110576866|NCT00631696|Sensory System Agents|sensory system agents|mesh-ancestor
110576867|NCT00631696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110576868|NCT00631696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110576870|NCT00631696|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110576871|NCT00631696|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110576872|NCT00631696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110576873|NCT00631696|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110576874|NCT00631696|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110576875|NCT00631696|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110576876|NCT00631696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110576877|NCT00631696|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110576878|NCT02608112|Methotrexate|methotrexate|mesh-list
110576879|NCT02608112|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110576880|NCT02608112|Abortifacient Agents|abortifacient agents|mesh-ancestor
110576881|NCT02608112|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110576882|NCT02608112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110576883|NCT02608112|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110576884|NCT02608112|Antimetabolites|antimetabolites|mesh-ancestor
110576885|NCT02608112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110576887|NCT02608112|Dermatologic Agents|dermatologic agents|mesh-ancestor
110576888|NCT02608112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110576889|NCT02608112|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110576890|NCT02608112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110576891|NCT02608112|Immunologic Factors|immunologic factors|mesh-ancestor
110576892|NCT02608112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110576893|NCT02608112|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110576894|NCT02549326|Vitamin D|vitamin d|mesh-list
110576895|NCT02549326|Cholecalciferol|cholecalciferol|mesh-list
110576896|NCT02549326|Vitamins|vitamins|mesh-ancestor
110576897|NCT02549326|Micronutrients|micronutrients|mesh-ancestor
110576898|NCT02549326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110576899|NCT02549326|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110576900|NCT02549326|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110576901|NCT00819676|Nitric Oxide|nitric oxide|mesh-list
110576902|NCT00819676|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110576903|NCT00819676|Autonomic Agents|autonomic agents|mesh-ancestor
110576904|NCT00819676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110576905|NCT00819676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110576906|NCT00819676|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110576907|NCT00819676|Respiratory System Agents|respiratory system agents|mesh-ancestor
110576908|NCT00819676|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110576909|NCT00819676|Antioxidants|antioxidants|mesh-ancestor
110576910|NCT00819676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110576911|NCT00819676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110576912|NCT00819676|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
110576913|NCT00819676|Vasodilator Agents|vasodilator agents|mesh-ancestor
110576914|NCT00819676|Gasotransmitters|gasotransmitters|mesh-ancestor
110576915|NCT00819676|Protective Agents|protective agents|mesh-ancestor
110576916|NCT00827320|Levetiracetam|levetiracetam|mesh-list
110576917|NCT00827320|Anticonvulsants|anticonvulsants|mesh-ancestor
110576918|NCT00827320|Nootropic Agents|nootropic agents|mesh-ancestor
110576919|NCT00819754|Bevacizumab|bevacizumab|mesh-list
110576920|NCT00819754|Capecitabine|capecitabine|mesh-list
110576921|NCT00819754|Oxaliplatin|oxaliplatin|mesh-list
110576922|NCT00819754|Irinotecan|irinotecan|mesh-list
110576923|NCT00819754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110576924|NCT00819754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110576925|NCT00819754|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110576926|NCT00819754|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110576927|NCT00819754|Growth Substances|growth substances|mesh-ancestor
110576928|NCT00819754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110576929|NCT00819754|Growth Inhibitors|growth inhibitors|mesh-ancestor
110576930|NCT00819754|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110576931|NCT00819754|Antimetabolites|antimetabolites|mesh-ancestor
110576932|NCT00819754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110576933|NCT00819754|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110576934|NCT00819754|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110576935|NCT00819754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110576936|NCT00819988|Pregabalin|pregabalin|mesh-list
110576937|NCT00819988|Analgesics|analgesics|mesh-ancestor
110576938|NCT00819988|Sensory System Agents|sensory system agents|mesh-ancestor
110576939|NCT00819988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110576940|NCT00819988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110576941|NCT00819988|Anticonvulsants|anticonvulsants|mesh-ancestor
110576942|NCT00819988|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110576943|NCT00819988|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110576944|NCT00819988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110576945|NCT00819988|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110576946|NCT00819988|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110576947|NCT00819988|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110576948|NCT00819988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110576949|NCT00819988|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110576950|NCT00827554|Nadroparin|nadroparin|mesh-list
110576951|NCT00827554|Anticoagulants|anticoagulants|mesh-ancestor
110576952|NCT00827554|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110576953|NCT00827554|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110576954|NCT00827554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110576955|NCT00847145|Vaccines|vaccines|mesh-list
110576956|NCT00847145|Immunologic Factors|immunologic factors|mesh-ancestor
110576957|NCT00847145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110576958|NCT00701597|Bosentan|bosentan|mesh-list
110576959|NCT00701597|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110576960|NCT00701597|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
110576961|NCT00701597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110576963|NCT00700193|Immunologic Factors|immunologic factors|mesh-ancestor
110576964|NCT00700193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110576965|NCT00846521|Acarbose|acarbose|mesh-list
110576966|NCT00846521|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
110576967|NCT00846521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110576968|NCT00846521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110576969|NCT00846521|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110576970|NCT00846521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110576971|NCT00698945|Brimonidine Tartrate|brimonidine tartrate|mesh-list
110576972|NCT00698945|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110576973|NCT00698945|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110576974|NCT00698945|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110576975|NCT00698945|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110576976|NCT00698945|Adrenergic Agents|adrenergic agents|mesh-ancestor
110576977|NCT00698945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110576978|NCT00698945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110576979|NCT00698945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110576980|NCT00862823|Tenofovir|tenofovir|mesh-list
110576981|NCT00862823|Emtricitabine|emtricitabine|mesh-list
110576982|NCT00862823|Efavirenz|efavirenz|mesh-list
110576983|NCT00862823|Antiviral Agents|antiviral agents|mesh-ancestor
110576984|NCT00862823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110576985|NCT00862823|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110576986|NCT00862823|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110576987|NCT00862823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110576988|NCT00862823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110576989|NCT00862823|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110576990|NCT00862823|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110576991|NCT00862823|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110576992|NCT00862823|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110576993|NCT00862823|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110576994|NCT00862823|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110576995|NCT00862823|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110576996|NCT00862823|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110576997|NCT00790842|Dexamethasone|dexamethasone|mesh-list
110576998|NCT00790842|Lenalidomide|lenalidomide|mesh-list
110576999|NCT00790842|Heparin|heparin|mesh-list
110577000|NCT00790842|Calcium heparin|calcium heparin|mesh-list
110577001|NCT00790842|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
110577002|NCT00790842|Tinzaparin|tinzaparin|mesh-list
110577003|NCT00790842|Dalteparin|dalteparin|mesh-list
110577004|NCT00790842|Anticoagulants|anticoagulants|mesh-list
110577005|NCT00790842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110577006|NCT00790842|Antiemetics|antiemetics|mesh-ancestor
110577007|NCT00790842|Autonomic Agents|autonomic agents|mesh-ancestor
110577008|NCT00790842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110577009|NCT00790842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110577010|NCT00790842|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110577011|NCT00790842|Glucocorticoids|glucocorticoids|mesh-ancestor
110577012|NCT00790842|Hormones|hormones|mesh-ancestor
110094939|NCT01711749|Antimetabolites|antimetabolites|mesh-ancestor
110577013|NCT00790842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110577014|NCT00790842|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110577015|NCT00790842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110577016|NCT00790842|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110577017|NCT00790842|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110577018|NCT00790842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110577019|NCT00790842|Immunologic Factors|immunologic factors|mesh-ancestor
110577020|NCT00790842|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110577021|NCT00790842|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110577022|NCT00790842|Growth Substances|growth substances|mesh-ancestor
110577023|NCT00790842|Growth Inhibitors|growth inhibitors|mesh-ancestor
110577024|NCT04104204|Morphine|morphine|mesh-list
110577025|NCT04104204|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110577026|NCT04104204|Narcotics|narcotics|mesh-ancestor
110577027|NCT04104204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110577028|NCT04104204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110577029|NCT04104204|Analgesics|analgesics|mesh-ancestor
110577030|NCT04104204|Sensory System Agents|sensory system agents|mesh-ancestor
110577031|NCT04104204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110577033|NCT05572476|Etoposide|etoposide|mesh-list
110577034|NCT05572476|Durvalumab|durvalumab|mesh-list
110577035|NCT05572476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110577036|NCT05572476|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110577037|NCT05572476|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110577038|NCT05572476|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110577040|NCT05572476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110577041|NCT05572476|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110577042|NCT00574288|Dexamethasone|dexamethasone|mesh-list
110577043|NCT00574288|Methylprednisolone|methylprednisolone|mesh-list
110577044|NCT00574288|Daratumumab|daratumumab|mesh-list
110577045|NCT00574288|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110577046|NCT00574288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110577047|NCT00574288|Antiemetics|antiemetics|mesh-ancestor
110577048|NCT00574288|Autonomic Agents|autonomic agents|mesh-ancestor
110577049|NCT00574288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110577050|NCT00574288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110577051|NCT00574288|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110577052|NCT00574288|Glucocorticoids|glucocorticoids|mesh-ancestor
110577053|NCT00574288|Hormones|hormones|mesh-ancestor
110577054|NCT00574288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110577055|NCT00574288|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110577056|NCT00574288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110577057|NCT00574288|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110577058|NCT00574288|Protective Agents|protective agents|mesh-ancestor
110577059|NCT00574288|Immunologic Factors|immunologic factors|mesh-ancestor
110577060|NCT00790452|Aspirin|aspirin|mesh-list
110577061|NCT00790452|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110577062|NCT00790452|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110577063|NCT00790452|Analgesics|analgesics|mesh-ancestor
110577064|NCT00790452|Sensory System Agents|sensory system agents|mesh-ancestor
110577065|NCT00790452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110577066|NCT00790452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110577067|NCT00790452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110577068|NCT00790452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110577069|NCT00790452|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110577070|NCT00790452|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110577071|NCT00790452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110577072|NCT00790452|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110577073|NCT00790452|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110577074|NCT00790452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110577075|NCT00790452|Antipyretics|antipyretics|mesh-ancestor
110577076|NCT00823030|Lidocaine|lidocaine|mesh-list
110577077|NCT00823030|Anesthetics, Local|anesthetics, local|mesh-ancestor
110577078|NCT00823030|Anesthetics|anesthetics|mesh-ancestor
110577079|NCT00823030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110577080|NCT00823030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110577081|NCT00823030|Sensory System Agents|sensory system agents|mesh-ancestor
110577082|NCT00823030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110577083|NCT00823030|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110577084|NCT00823030|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110577085|NCT00823030|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110577086|NCT00823030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110577087|NCT00823030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110577088|NCT00823186|Paclitaxel|paclitaxel|mesh-list
110577089|NCT00823186|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110577090|NCT00823186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110577091|NCT00823186|Tubulin Modulators|tubulin modulators|mesh-ancestor
110577092|NCT00823186|Antimitotic Agents|antimitotic agents|mesh-ancestor
110577093|NCT00823186|Mitosis Modulators|mitosis modulators|mesh-ancestor
110577094|NCT00823186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110577095|NCT00626392|Aspirin|aspirin|mesh-list
110577096|NCT00626392|Niacin|niacin|mesh-list
110577097|NCT00626392|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110577098|NCT00626392|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110577099|NCT00626392|Analgesics|analgesics|mesh-ancestor
110577100|NCT00626392|Sensory System Agents|sensory system agents|mesh-ancestor
110577101|NCT00626392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110149064|NCT00006208|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110577102|NCT00626392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110577103|NCT00626392|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110577105|NCT00626392|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110577106|NCT00626392|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110577107|NCT00626392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110577108|NCT00626392|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110577109|NCT00626392|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110577110|NCT00626392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110577112|NCT00626392|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110577113|NCT00626392|Antimetabolites|antimetabolites|mesh-ancestor
110577114|NCT00626392|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110577115|NCT00626392|Vasodilator Agents|vasodilator agents|mesh-ancestor
110577116|NCT00626392|Vitamin B Complex|vitamin b complex|mesh-ancestor
110577117|NCT00626392|Vitamins|vitamins|mesh-ancestor
110577118|NCT00626392|Micronutrients|micronutrients|mesh-ancestor
110577119|NCT00820690|Paclitaxel|paclitaxel|mesh-list
110577120|NCT00820690|Cyclophosphamide|cyclophosphamide|mesh-list
110577121|NCT00820690|Doxorubicin|doxorubicin|mesh-list
110577122|NCT00820690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110577123|NCT00820690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110577124|NCT00820690|Tubulin Modulators|tubulin modulators|mesh-ancestor
110577125|NCT00820690|Antimitotic Agents|antimitotic agents|mesh-ancestor
110577126|NCT00820690|Mitosis Modulators|mitosis modulators|mesh-ancestor
110577127|NCT00820690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110577128|NCT00820690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110577129|NCT00820690|Immunologic Factors|immunologic factors|mesh-ancestor
110577130|NCT00820690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110577131|NCT00820690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110577132|NCT00820690|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110577133|NCT00820690|Alkylating Agents|alkylating agents|mesh-ancestor
110577134|NCT00820690|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110577135|NCT00820690|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110577136|NCT00820690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110577137|NCT00820690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110577138|NCT00820690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110577139|NCT00820768|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110577140|NCT00820768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110577141|NCT00624052|Amlodipine|amlodipine|mesh-list
110577142|NCT00624052|Telmisartan|telmisartan|mesh-list
110577143|NCT00624052|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110577144|NCT00624052|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110577145|NCT00624052|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110577146|NCT00624052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110577147|NCT00624052|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110577148|NCT00624052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110577149|NCT00624052|Vasodilator Agents|vasodilator agents|mesh-ancestor
110577150|NCT00624052|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110577151|NCT00624052|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110577152|NCT00821080|Sirolimus|sirolimus|mesh-list
110577153|NCT00821080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110577154|NCT00821080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110577155|NCT00821080|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110577156|NCT00821080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110577157|NCT00821080|Antifungal Agents|antifungal agents|mesh-ancestor
110577158|NCT00821080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110577159|NCT00821080|Immunologic Factors|immunologic factors|mesh-ancestor
110577160|NCT00821080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110577161|NCT04044430|Nivolumab|nivolumab|mesh-list
110577162|NCT04044430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110577163|NCT04044430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110577164|NCT04044430|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110374623|NCT00195663|Methotrexate|methotrexate|mesh-list
110577165|NCT04044430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110577166|NCT00821158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
110577167|NCT00821158|Antioxidants|antioxidants|mesh-list
110577168|NCT00821158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110577169|NCT00821158|Protective Agents|protective agents|mesh-ancestor
110577170|NCT00821158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110577171|NCT00828646|BMS 708163|bms 708163|mesh-list
110577172|NCT00828646|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
110577173|NCT00828646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110577174|NCT00828646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110577176|NCT02548936|Ezetimibe|ezetimibe|mesh-list
110577177|NCT02548936|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
110577178|NCT02548936|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110577179|NCT02548936|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110577180|NCT02548936|Antimetabolites|antimetabolites|mesh-ancestor
110577181|NCT02548936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110577182|NCT02548936|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110577183|NCT02548936|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110577184|NCT02548936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110577185|NCT00828802|Lenalidomide|lenalidomide|mesh-list
110577186|NCT00828802|Decitabine|decitabine|mesh-list
110577187|NCT00828802|Immunologic Factors|immunologic factors|mesh-ancestor
110577188|NCT00828802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110577189|NCT00828802|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110577190|NCT00828802|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110577191|NCT00828802|Growth Substances|growth substances|mesh-ancestor
110577192|NCT00828802|Growth Inhibitors|growth inhibitors|mesh-ancestor
110577193|NCT00828802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110577194|NCT00828802|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110577195|NCT00828802|Antimetabolites|antimetabolites|mesh-ancestor
110260176|NCT02944201|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110577196|NCT00828802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110577197|NCT00828802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110577198|NCT00785577|Pregabalin|pregabalin|mesh-list
110577199|NCT00785577|Analgesics|analgesics|mesh-ancestor
110577200|NCT00785577|Sensory System Agents|sensory system agents|mesh-ancestor
110577201|NCT00785577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110577202|NCT00785577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110577203|NCT00785577|Anticonvulsants|anticonvulsants|mesh-ancestor
110577204|NCT00785577|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110577205|NCT00785577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110577206|NCT00785577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110577207|NCT00785577|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110577208|NCT00785577|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110577209|NCT00785577|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110577210|NCT00785577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110577211|NCT00785577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110577212|NCT00830830|Hyaluronic Acid|hyaluronic acid|mesh-list
110577213|NCT00830830|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110577214|NCT00830830|Immunologic Factors|immunologic factors|mesh-ancestor
110577215|NCT00830830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110577216|NCT00830830|Viscosupplements|viscosupplements|mesh-ancestor
110577217|NCT00830830|Protective Agents|protective agents|mesh-ancestor
110577218|NCT00828958|Risperidone|risperidone|mesh-list
110577219|NCT00828958|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110577220|NCT00828958|Serotonin Agents|serotonin agents|mesh-ancestor
110577221|NCT00828958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110577222|NCT00828958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110577223|NCT00828958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110577224|NCT00828958|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110577225|NCT00828958|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110577226|NCT00828958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110577227|NCT00828958|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110577228|NCT00828958|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110577229|NCT00828958|Dopamine Agents|dopamine agents|mesh-ancestor
110577230|NCT02548780|Doxorubicin|doxorubicin|mesh-list
110374633|NCT00195663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110577231|NCT02548780|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110577232|NCT02548780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110577233|NCT02548780|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110577234|NCT02548780|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110577236|NCT02548780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110577237|NCT04105023|Genistein|genistein|mesh-list
110577238|NCT04105023|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110577239|NCT04105023|Protective Agents|protective agents|mesh-ancestor
110577240|NCT04105023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110577241|NCT04105023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110577242|NCT04105023|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110577243|NCT04105023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110577244|NCT04105023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110577245|NCT04105023|Phytoestrogens|phytoestrogens|mesh-ancestor
110577246|NCT04105023|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
110577247|NCT04105023|Estrogens|estrogens|mesh-ancestor
110577248|NCT04105023|Hormones|hormones|mesh-ancestor
110577249|NCT04105023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110577250|NCT04104867|Domperidone|domperidone|mesh-list
110577251|NCT04104867|Antiemetics|antiemetics|mesh-ancestor
110577252|NCT04104867|Autonomic Agents|autonomic agents|mesh-ancestor
110577253|NCT04104867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110577254|NCT04104867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110577255|NCT04104867|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110577256|NCT04104867|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110224682|NCT05999994|Temozolomide|temozolomide|mesh-list
110577257|NCT04104867|Dopamine Agents|dopamine agents|mesh-ancestor
110577258|NCT04104867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110577259|NCT04104867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110577260|NCT00789828|Everolimus|everolimus|mesh-list
110577261|NCT00789828|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110577262|NCT00789828|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110577263|NCT00789828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110577264|NCT00789828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110577265|NCT00789828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110577266|NCT00789828|Immunologic Factors|immunologic factors|mesh-ancestor
110577267|NCT00789828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110577268|NCT00789828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110577269|NCT02550262|Fentanyl|fentanyl|mesh-list
110577270|NCT02550262|Bupivacaine|bupivacaine|mesh-list
110577271|NCT02550262|Anesthetics, Local|anesthetics, local|mesh-ancestor
110577272|NCT02550262|Anesthetics|anesthetics|mesh-ancestor
110577273|NCT02550262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110577274|NCT02550262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110577275|NCT02550262|Sensory System Agents|sensory system agents|mesh-ancestor
110577276|NCT02550262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110577277|NCT02550262|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110577278|NCT02550262|Narcotics|narcotics|mesh-ancestor
110577279|NCT02550262|Analgesics|analgesics|mesh-ancestor
110577280|NCT02550262|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110577281|NCT02550262|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110577282|NCT02550262|Anesthetics, General|anesthetics, general|mesh-ancestor
110577283|NCT02550418|Budesonide|budesonide|mesh-list
110577284|NCT02550418|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110577285|NCT02550418|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110577286|NCT02550418|Autonomic Agents|autonomic agents|mesh-ancestor
110577287|NCT02550418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110577288|NCT02550418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110577289|NCT02550418|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110577290|NCT02550418|Respiratory System Agents|respiratory system agents|mesh-ancestor
110577291|NCT02550418|Glucocorticoids|glucocorticoids|mesh-ancestor
110577292|NCT02550418|Hormones|hormones|mesh-ancestor
110577293|NCT02550418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110577294|NCT00829114|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110577295|NCT00829114|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110577296|NCT00829114|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110577297|NCT00829114|Estradiol|estradiol|mesh-list
110577298|NCT00829114|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110577299|NCT00829114|Estrogens|estrogens|mesh-ancestor
110577300|NCT00829114|Hormones|hormones|mesh-ancestor
110577301|NCT00829114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110577302|NCT00829114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110577303|NCT00829114|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110577305|NCT00829114|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110577306|NCT00829114|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110577307|NCT00829114|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110577308|NCT00829114|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110577309|NCT00790296|Hormones|hormones|mesh-list
110577310|NCT00790296|Thyrotropin-Releasing Hormone|thyrotropin-releasing hormone|mesh-list
110577311|NCT00790296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110577312|NCT00790296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110577313|NCT00829192|Afamelanotide|afamelanotide|mesh-list
110577314|NCT00829192|Dermatologic Agents|dermatologic agents|mesh-ancestor
110577315|NCT00623194|Insulin|insulin|mesh-list
110577316|NCT00623194|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110577317|NCT00623194|Insulin Aspart|insulin aspart|mesh-list
110577318|NCT00623194|Insulin Detemir|insulin detemir|mesh-list
110577319|NCT00623194|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110577320|NCT00623194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110577321|NCT00784368|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110577322|NCT02548468|Mycophenolic Acid|mycophenolic acid|mesh-list
110577323|NCT02548468|Cyclophosphamide|cyclophosphamide|mesh-list
110577324|NCT02548468|Fludarabine|fludarabine|mesh-list
110577325|NCT02548468|Fludarabine phosphate|fludarabine phosphate|mesh-list
110577326|NCT02548468|Tacrolimus|tacrolimus|mesh-list
110577327|NCT02548468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110577328|NCT02548468|Immunologic Factors|immunologic factors|mesh-ancestor
110577329|NCT02548468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110224777|NCT05999487|Dobutamine|dobutamine|mesh-list
110577330|NCT02548468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110577331|NCT02548468|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110577332|NCT02548468|Alkylating Agents|alkylating agents|mesh-ancestor
110577333|NCT02548468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110577334|NCT02548468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110577335|NCT02548468|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110577336|NCT02548468|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110577337|NCT02548468|Antimetabolites|antimetabolites|mesh-ancestor
110577338|NCT02548468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110577339|NCT02548468|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110577340|NCT02548468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110577341|NCT02548468|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110577342|NCT02548468|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110577343|NCT02548468|Antitubercular Agents|antitubercular agents|mesh-ancestor
110577344|NCT02548468|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110577345|NCT00829660|Acarbose|acarbose|mesh-list
110577346|NCT00829660|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
110577347|NCT00829660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110577348|NCT00829660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110577349|NCT00829660|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110577350|NCT00829660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110577351|NCT00915564|Simeprevir|simeprevir|mesh-list
110577352|NCT00915564|Methadone|methadone|mesh-list
110577353|NCT00915564|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110577354|NCT00915564|Narcotics|narcotics|mesh-ancestor
110577355|NCT00915564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110577356|NCT00915564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110577357|NCT00915564|Analgesics|analgesics|mesh-ancestor
110577358|NCT00915564|Sensory System Agents|sensory system agents|mesh-ancestor
110577359|NCT00915564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110577360|NCT00915564|Antitussive Agents|antitussive agents|mesh-ancestor
110577361|NCT00915564|Respiratory System Agents|respiratory system agents|mesh-ancestor
110577362|NCT00915564|Antiviral Agents|antiviral agents|mesh-ancestor
110577363|NCT00915564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110577364|NCT00915564|Protease Inhibitors|protease inhibitors|mesh-ancestor
110577365|NCT00915564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110577366|NCT00915564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110577367|NCT02603406|Epoetin Alfa|epoetin alfa|mesh-list
110577368|NCT02603406|Hematinics|hematinics|mesh-ancestor
110577369|NCT04106700|Apixaban|apixaban|mesh-list
110577370|NCT04106700|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110577371|NCT04106700|Antithrombins|antithrombins|mesh-ancestor
110577372|NCT04106700|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110577373|NCT04106700|Protease Inhibitors|protease inhibitors|mesh-ancestor
110577374|NCT04106700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110577375|NCT04106700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110577376|NCT04106700|Anticoagulants|anticoagulants|mesh-ancestor
110577378|NCT00831376|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110577379|NCT00831376|Autonomic Agents|autonomic agents|mesh-ancestor
110577380|NCT00831376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110577381|NCT00831376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110149078|NCT00006211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110577382|NCT00831376|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110577383|NCT00831376|Respiratory System Agents|respiratory system agents|mesh-ancestor
110577384|NCT00831376|Tocolytic Agents|tocolytic agents|mesh-ancestor
110577385|NCT00831376|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110577386|NCT00831376|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110577387|NCT00831376|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110577388|NCT00831376|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110577389|NCT00831376|Adrenergic Agents|adrenergic agents|mesh-ancestor
110577390|NCT00831376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110577391|NCT00831376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110577392|NCT02602470|Metronidazole|metronidazole|mesh-list
110577393|NCT02602470|Azelaic acid|azelaic acid|mesh-list
110577394|NCT02602470|Brimonidine Tartrate|brimonidine tartrate|mesh-list
110577395|NCT02602470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110577396|NCT02602470|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110577397|NCT02602470|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110577398|NCT02602470|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110577399|NCT02602470|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110577400|NCT02602470|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110577401|NCT02602470|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110577402|NCT02602470|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110577403|NCT02602470|Adrenergic Agents|adrenergic agents|mesh-ancestor
110577404|NCT02602470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110577405|NCT02602470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110577406|NCT02602470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110577407|NCT02602470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110577408|NCT02602470|Dermatologic Agents|dermatologic agents|mesh-ancestor
110577410|NCT00824200|Adrenergic Agents|adrenergic agents|mesh-list
110577411|NCT00824200|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
110577412|NCT00824200|Adrenergic Antagonists|adrenergic antagonists|mesh-list
110577413|NCT00824200|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110577414|NCT00824200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110577415|NCT00824200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110577416|NCT00824200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110577417|NCT00824200|Urological Agents|urological agents|mesh-ancestor
110577418|NCT00829894|Risperidone|risperidone|mesh-list
110577419|NCT00829894|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110577420|NCT00829894|Serotonin Agents|serotonin agents|mesh-ancestor
110577421|NCT00829894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110577422|NCT00829894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110577423|NCT00829894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110577424|NCT00829894|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110577425|NCT00829894|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110577426|NCT00829894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110577427|NCT00829894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110577428|NCT00829894|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110577429|NCT00829894|Dopamine Agents|dopamine agents|mesh-ancestor
110577430|NCT00622726|Bevacizumab|bevacizumab|mesh-list
110577431|NCT00622726|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110577432|NCT00622726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110577433|NCT00622726|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110577434|NCT00622726|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110577435|NCT00622726|Growth Substances|growth substances|mesh-ancestor
110577436|NCT00622726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110374653|NCT01135498|Antimetabolites|antimetabolites|mesh-ancestor
110577437|NCT00622726|Growth Inhibitors|growth inhibitors|mesh-ancestor
110577438|NCT00830050|Naproxen|naproxen|mesh-list
110577439|NCT00830050|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110577440|NCT00830050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110577441|NCT00830050|Analgesics|analgesics|mesh-ancestor
110577442|NCT00830050|Sensory System Agents|sensory system agents|mesh-ancestor
110577443|NCT00830050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110577444|NCT00830050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110577445|NCT00830050|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110577446|NCT00830050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110577447|NCT00830050|Gout Suppressants|gout suppressants|mesh-ancestor
110577448|NCT00830050|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110577449|NCT00830050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110149086|NCT00006214|Flutamide|flutamide|mesh-list
110577450|NCT00830050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110577452|NCT00623428|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110577453|NCT00623428|Antimetabolites|antimetabolites|mesh-ancestor
110577454|NCT00623428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110577455|NCT00623428|Antiviral Agents|antiviral agents|mesh-ancestor
110577456|NCT00623428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110577457|NCT00824668|Insulin|insulin|mesh-list
110577458|NCT00824668|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110577459|NCT00824668|Insulin Glargine|insulin glargine|mesh-list
110577460|NCT00824668|Insulin Aspart|insulin aspart|mesh-list
110577461|NCT00824668|Biphasic Insulins|biphasic insulins|mesh-list
110577462|NCT00824668|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
110577463|NCT00824668|Insulin glulisine|insulin glulisine|mesh-list
110577464|NCT00824668|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110577465|NCT00824668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110577466|NCT00832234|Dexamethasone|dexamethasone|mesh-list
110577467|NCT00832234|Rituximab|rituximab|mesh-list
110577468|NCT00832234|Bortezomib|bortezomib|mesh-list
110577469|NCT00832234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110577470|NCT00832234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110577471|NCT00832234|Immunologic Factors|immunologic factors|mesh-ancestor
110577472|NCT00832234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110577473|NCT00832234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110577474|NCT00832234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110577475|NCT00832234|Antiemetics|antiemetics|mesh-ancestor
110577476|NCT00832234|Autonomic Agents|autonomic agents|mesh-ancestor
110577477|NCT00832234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110577478|NCT00832234|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110577479|NCT00832234|Glucocorticoids|glucocorticoids|mesh-ancestor
110577480|NCT00832234|Hormones|hormones|mesh-ancestor
110577481|NCT00832234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110577482|NCT00832234|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110577483|NCT05036980|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
110577484|NCT05036980|Antioxidants|antioxidants|mesh-ancestor
110577485|NCT05036980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110577486|NCT05036980|Protective Agents|protective agents|mesh-ancestor
110577487|NCT05036980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110577488|NCT05036980|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110577489|NCT05036980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110577490|NCT00837850|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
110577491|NCT00837850|Vasodilator Agents|vasodilator agents|mesh-ancestor
110577492|NCT00837850|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
110577493|NCT00837850|Protective Agents|protective agents|mesh-ancestor
110577494|NCT00837850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110577495|NCT00784134|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
110577496|NCT00784134|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110374657|NCT04610567|Methotrexate|methotrexate|mesh-list
110577497|NCT00784134|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110577498|NCT00784134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110577499|NCT00837928|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110577500|NCT00837928|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110577501|NCT00837928|Alkylating Agents|alkylating agents|mesh-ancestor
110577502|NCT00837928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110577503|NCT00837928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110577505|NCT04102566|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110577506|NCT04102566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110577507|NCT04102566|Analgesics|analgesics|mesh-ancestor
110577508|NCT04102566|Sensory System Agents|sensory system agents|mesh-ancestor
110577509|NCT04102566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110577510|NCT04102566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110577511|NCT04102566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110577512|NCT04102566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110577513|NCT04102566|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110577514|NCT04102566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110577515|NCT04102566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110577516|NCT04102176|Tin Fluorides|tin fluorides|mesh-list
110577517|NCT04102176|Cariostatic Agents|cariostatic agents|mesh-ancestor
110577518|NCT04102176|Protective Agents|protective agents|mesh-ancestor
110577519|NCT04102176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110577520|NCT00783432|Azelastine|azelastine|mesh-list
110577521|NCT00783432|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110577522|NCT00783432|Autonomic Agents|autonomic agents|mesh-ancestor
110577523|NCT00783432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110577524|NCT00783432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110577525|NCT00783432|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110577526|NCT00783432|Respiratory System Agents|respiratory system agents|mesh-ancestor
110577527|NCT00783432|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
110577528|NCT00783432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110577529|NCT00783432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110577530|NCT00783432|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110577531|NCT00783432|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110577532|NCT00783432|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110577533|NCT00783432|Histamine Antagonists|histamine antagonists|mesh-ancestor
110577534|NCT00783432|Histamine Agents|histamine agents|mesh-ancestor
110577535|NCT00783432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110577536|NCT00789360|Loxapine|loxapine|mesh-list
110577537|NCT00789360|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110577538|NCT00789360|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110577539|NCT00789360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110577540|NCT00789360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110577541|NCT00789360|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110577542|NCT00789360|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110577543|NCT00789360|Dopamine Agents|dopamine agents|mesh-ancestor
110577544|NCT00789360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110577545|NCT00789360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110577546|NCT05526924|Fluorouracil|fluorouracil|mesh-list
110577547|NCT05526924|Tislelizumab|tislelizumab|mesh-list
110577548|NCT05526924|Hydroxyurea|hydroxyurea|mesh-list
110577549|NCT05526924|Pamiparib|pamiparib|mesh-list
110577550|NCT05526924|Antimetabolites|antimetabolites|mesh-ancestor
110577551|NCT05526924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110577552|NCT05526924|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110577553|NCT05526924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110577554|NCT05526924|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110577555|NCT05526924|Immunologic Factors|immunologic factors|mesh-ancestor
110577556|NCT05526924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110577558|NCT05526924|Antisickling Agents|antisickling agents|mesh-ancestor
110577559|NCT05526924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110577560|NCT05526924|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110577561|NCT05526924|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110577562|NCT00782418|Exenatide|exenatide|mesh-list
110577563|NCT00782418|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110577564|NCT00782418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110577565|NCT00782418|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110577566|NCT00782418|Incretins|incretins|mesh-ancestor
110577567|NCT00782418|Hormones|hormones|mesh-ancestor
110577568|NCT00782418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110577569|NCT00782340|Droxidopa|droxidopa|mesh-list
110577570|NCT00782340|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110577571|NCT00782340|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110577572|NCT00774852|Prednisone|prednisone|mesh-list
110577573|NCT00774852|Cyclophosphamide|cyclophosphamide|mesh-list
110577574|NCT00774852|Abatacept|abatacept|mesh-list
110577575|NCT00774852|Azathioprine|azathioprine|mesh-list
110577576|NCT00774852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110577577|NCT00774852|Immunologic Factors|immunologic factors|mesh-ancestor
110577578|NCT00774852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110577579|NCT00774852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110577580|NCT00774852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110577581|NCT00774852|Alkylating Agents|alkylating agents|mesh-ancestor
110577582|NCT00774852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110577583|NCT00774852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110577584|NCT00774852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110577585|NCT00774852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110577586|NCT00774852|Glucocorticoids|glucocorticoids|mesh-ancestor
110577587|NCT00774852|Hormones|hormones|mesh-ancestor
110577588|NCT00774852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110577589|NCT00774852|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110577590|NCT00774852|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110577591|NCT00774852|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110577592|NCT00774852|Antimetabolites|antimetabolites|mesh-ancestor
110577593|NCT00774852|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110577594|NCT00774306|Phenytoin|phenytoin|mesh-list
110577595|NCT00774306|Levetiracetam|levetiracetam|mesh-list
110577596|NCT00774306|Valproic Acid|valproic acid|mesh-list
110577597|NCT00774306|Anticonvulsants|anticonvulsants|mesh-ancestor
110577598|NCT00774306|Nootropic Agents|nootropic agents|mesh-ancestor
110577599|NCT00774306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110577600|NCT00774306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110577601|NCT00774306|GABA Agents|gaba agents|mesh-ancestor
110577602|NCT00774306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110577603|NCT00774306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110577604|NCT00774306|Antimanic Agents|antimanic agents|mesh-ancestor
110577605|NCT00774306|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110577606|NCT00774306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110577607|NCT00774306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110577608|NCT00774306|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110577609|NCT00774306|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110577610|NCT00774306|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110577611|NCT00774306|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110577612|NCT00774306|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110577619|NCT04105764|Bromides|bromides|mesh-list
110577620|NCT04105764|Rocuronium|rocuronium|mesh-list
110577621|NCT04105764|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
110577622|NCT04105764|Anticonvulsants|anticonvulsants|mesh-ancestor
110577623|NCT04105764|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110577624|NCT04105764|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110577625|NCT04105764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110577626|NCT04105764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110577627|NCT00781326|Nimodipine|nimodipine|mesh-list
110577628|NCT00781326|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110577629|NCT00781326|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110577630|NCT00781326|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110225046|NCT05997485|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110577631|NCT00781326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110577632|NCT00781326|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110577633|NCT00781326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110577634|NCT00781326|Vasodilator Agents|vasodilator agents|mesh-ancestor
110577635|NCT00773838|Dexamethasone|dexamethasone|mesh-list
110577636|NCT00773838|Bortezomib|bortezomib|mesh-list
110577637|NCT00773838|Vorinostat|vorinostat|mesh-list
110577638|NCT00773838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110577639|NCT00773838|Antiemetics|antiemetics|mesh-ancestor
110577640|NCT00773838|Autonomic Agents|autonomic agents|mesh-ancestor
110577641|NCT00773838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110577642|NCT00773838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110577643|NCT00773838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110577644|NCT00773838|Glucocorticoids|glucocorticoids|mesh-ancestor
110577645|NCT00773838|Hormones|hormones|mesh-ancestor
110577646|NCT00773838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110577647|NCT00773838|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110577648|NCT00773838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110577649|NCT00773838|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110577650|NCT00773838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110577651|NCT00773838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110577652|NCT00787644|Pioglitazone|pioglitazone|mesh-list
110577653|NCT00787644|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110577654|NCT00787644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110577655|NCT02602002|Remifentanil|remifentanil|mesh-list
110577656|NCT02602002|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110577657|NCT02602002|Narcotics|narcotics|mesh-ancestor
110577658|NCT02602002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110577659|NCT02602002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110577660|NCT02602002|Analgesics|analgesics|mesh-ancestor
110577661|NCT02602002|Sensory System Agents|sensory system agents|mesh-ancestor
110577662|NCT02602002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110577663|NCT00787566|Granisetron|granisetron|mesh-list
110577664|NCT00787566|Antiemetics|antiemetics|mesh-ancestor
110577665|NCT00787566|Autonomic Agents|autonomic agents|mesh-ancestor
110577666|NCT00787566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110577667|NCT00787566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110577668|NCT00787566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110577669|NCT00787566|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110577670|NCT00787566|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110577671|NCT00787566|Serotonin Agents|serotonin agents|mesh-ancestor
110577672|NCT00787566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110577673|NCT00787566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110577675|NCT02602938|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110577676|NCT02602938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110577677|NCT02602938|Analgesics|analgesics|mesh-ancestor
110577678|NCT02602938|Sensory System Agents|sensory system agents|mesh-ancestor
110577679|NCT02602938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110577680|NCT02602938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110577681|NCT02602938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110577682|NCT02602938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110577683|NCT02602938|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110577684|NCT02602938|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110577685|NCT02602938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110577686|NCT02602938|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110577687|NCT02602938|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110577688|NCT02602938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110577689|NCT02602938|Antipyretics|antipyretics|mesh-ancestor
110577690|NCT00787254|Lansoprazole|lansoprazole|mesh-list
110577691|NCT00787254|Dexlansoprazole|dexlansoprazole|mesh-list
110577692|NCT00787254|Gefarnate|gefarnate|mesh-list
110577693|NCT00787254|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110577694|NCT00787254|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110577695|NCT00787254|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110577696|NCT00787254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110577697|NCT00787254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110577698|NCT00922402|Insulin|insulin|mesh-list
110577699|NCT00922402|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110577700|NCT00922402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110577701|NCT04105374|Flucytosine|flucytosine|mesh-list
110577702|NCT04105374|Temozolomide|temozolomide|mesh-list
110577703|NCT04105374|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110577704|NCT04105374|Alkylating Agents|alkylating agents|mesh-ancestor
110577705|NCT04105374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110577706|NCT04105374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110577707|NCT04105374|Antifungal Agents|antifungal agents|mesh-ancestor
110577708|NCT04105374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110577709|NCT04105374|Antimetabolites|antimetabolites|mesh-ancestor
110577710|NCT04102878|Anesthetics|anesthetics|mesh-list
110577711|NCT04102878|Anesthetics, Local|anesthetics, local|mesh-list
110577712|NCT04102878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110577713|NCT04102878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110577714|NCT04102878|Sensory System Agents|sensory system agents|mesh-ancestor
110577715|NCT04102878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110577717|NCT00838240|Clofarabine|clofarabine|mesh-list
110577718|NCT00838240|Idarubicin|idarubicin|mesh-list
110577719|NCT00838240|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110577720|NCT00838240|Antimetabolites|antimetabolites|mesh-ancestor
110577721|NCT00838240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110577722|NCT00838240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110577723|NCT00838240|Antiviral Agents|antiviral agents|mesh-ancestor
110577724|NCT00838240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110577725|NCT00838240|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110577726|NCT00838240|Immunologic Factors|immunologic factors|mesh-ancestor
110577727|NCT00838240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110577728|NCT00838240|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110577729|NCT00838240|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110577730|NCT00838240|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110577731|NCT00838240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110577732|NCT00773292|Cyclosporine|cyclosporine|mesh-list
110577733|NCT00773292|Cyclosporins|cyclosporins|mesh-list
110577734|NCT00773292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110577735|NCT00773292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110577736|NCT00773292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110577737|NCT00773292|Immunologic Factors|immunologic factors|mesh-ancestor
110577738|NCT00773292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110577739|NCT00773292|Antifungal Agents|antifungal agents|mesh-ancestor
110577740|NCT00773292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110577741|NCT00773292|Dermatologic Agents|dermatologic agents|mesh-ancestor
110577742|NCT00773292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110577743|NCT00773292|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110577744|NCT00838396|Arbaclofen placarbil|arbaclofen placarbil|mesh-list
110577746|NCT00838396|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110577747|NCT00838396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110577748|NCT00838396|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110577749|NCT00838396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110577750|NCT00838396|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
110577751|NCT00838396|GABA Agonists|gaba agonists|mesh-ancestor
110577752|NCT00838396|GABA Agents|gaba agents|mesh-ancestor
110577753|NCT00838396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110577754|NCT00838396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110577755|NCT00838864|Ceftriaxone|ceftriaxone|mesh-list
110577756|NCT00838864|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110577757|NCT00838864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110577758|NCT00833326|Docetaxel|docetaxel|mesh-list
110577759|NCT00833326|Antimitotic Agents|antimitotic agents|mesh-list
110577760|NCT00833326|Mitogens|mitogens|mesh-list
110577761|NCT00833326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110577762|NCT00833326|Tubulin Modulators|tubulin modulators|mesh-ancestor
110577763|NCT00833326|Mitosis Modulators|mitosis modulators|mesh-ancestor
110577764|NCT00833326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110577765|NCT00833404|Nicotine|nicotine|mesh-list
110577766|NCT00833404|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110577767|NCT00833404|Autonomic Agents|autonomic agents|mesh-ancestor
110577768|NCT00833404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110577769|NCT00833404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110577770|NCT00833404|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110577771|NCT00833404|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110577772|NCT00833404|Cholinergic Agents|cholinergic agents|mesh-ancestor
110577773|NCT00833404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110577774|NCT00833404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110577775|NCT00621322|Vaccines|vaccines|mesh-list
110577776|NCT00621322|Immunologic Factors|immunologic factors|mesh-ancestor
110577777|NCT00621322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110577778|NCT00839488|Pantoprazole|pantoprazole|mesh-list
110577779|NCT00839488|Famotidine|famotidine|mesh-list
110577780|NCT00839488|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110577781|NCT00839488|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110577782|NCT00839488|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110577783|NCT00839488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110577784|NCT00839488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110577785|NCT00839488|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110577786|NCT00839488|Histamine Antagonists|histamine antagonists|mesh-ancestor
110577787|NCT00839488|Histamine Agents|histamine agents|mesh-ancestor
110577788|NCT00839488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110577789|NCT00839488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110577790|NCT00834184|Nikkomycin|nikkomycin|mesh-list
110577791|NCT00834184|Antifungal Agents|antifungal agents|mesh-ancestor
110577792|NCT00834184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110577793|NCT00834184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110577794|NCT00834184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110577795|NCT00834262|Insulin|insulin|mesh-list
110577796|NCT00834262|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110577797|NCT00834262|Insulin Aspart|insulin aspart|mesh-list
110577798|NCT00834262|Insulin, Long-Acting|insulin, long-acting|mesh-list
110577799|NCT00834262|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
110577800|NCT00834262|Biphasic Insulins|biphasic insulins|mesh-list
110577801|NCT00834262|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
110577802|NCT00834262|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110577803|NCT00834262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110577804|NCT00853385|Adalimumab|adalimumab|mesh-list
110577805|NCT00853385|Tofacitinib|tofacitinib|mesh-list
110577806|NCT00853385|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110577807|NCT00853385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110577808|NCT00853385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110577809|NCT00853385|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
110577810|NCT00853385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110577811|NCT00853385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110577812|NCT00853385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110577813|NCT00622336|Lenalidomide|lenalidomide|mesh-list
110577814|NCT00622336|Immunologic Factors|immunologic factors|mesh-ancestor
110577815|NCT00622336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110577816|NCT00622336|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110577817|NCT00622336|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110577818|NCT00622336|Growth Substances|growth substances|mesh-ancestor
110577819|NCT00622336|Growth Inhibitors|growth inhibitors|mesh-ancestor
110577820|NCT00622336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110577821|NCT00846365|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110577822|NCT00846365|Olmesartan|olmesartan|mesh-list
110577823|NCT00846365|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
110577824|NCT00846365|Chlorthalidone|chlorthalidone|mesh-list
110577825|NCT00846365|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
110577826|NCT00846365|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110577828|NCT00846365|Natriuretic Agents|natriuretic agents|mesh-ancestor
110577829|NCT00846365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110577830|NCT00846365|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110577831|NCT00846365|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110577832|NCT00846365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110577833|NCT00846365|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110577834|NCT00846365|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110577835|NCT00834730|Ketamine|ketamine|mesh-list
110577836|NCT00834730|Analgesics|analgesics|mesh-ancestor
110577837|NCT00834730|Sensory System Agents|sensory system agents|mesh-ancestor
110577838|NCT00834730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110577839|NCT00834730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110577840|NCT00834730|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110577841|NCT00834730|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110577842|NCT00834730|Anesthetics, General|anesthetics, general|mesh-ancestor
110577843|NCT00834730|Anesthetics|anesthetics|mesh-ancestor
110577844|NCT00834730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110577845|NCT00834730|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110577846|NCT00834730|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110577847|NCT00834730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110577848|NCT00834730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110577849|NCT02601924|Anesthetics|anesthetics|mesh-list
110577850|NCT02601924|Anesthetics, Local|anesthetics, local|mesh-list
110577851|NCT02601924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110577852|NCT02601924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110577853|NCT02601924|Sensory System Agents|sensory system agents|mesh-ancestor
110577854|NCT02601924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110577855|NCT00840112|Vitamin E|vitamin e|mesh-list
110577856|NCT00840112|Tocopherols|tocopherols|mesh-list
110577857|NCT00840112|alpha-Tocopherol|alpha-tocopherol|mesh-list
110577858|NCT00840112|Vitamins|vitamins|mesh-ancestor
110577859|NCT00840112|Micronutrients|micronutrients|mesh-ancestor
110577860|NCT00840112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110577861|NCT00840112|Antioxidants|antioxidants|mesh-ancestor
110577862|NCT00840112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110577863|NCT00840112|Protective Agents|protective agents|mesh-ancestor
110577864|NCT04101474|Ketamine|ketamine|mesh-list
110577865|NCT04101474|Analgesics|analgesics|mesh-ancestor
110577866|NCT04101474|Sensory System Agents|sensory system agents|mesh-ancestor
110577867|NCT04101474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110577868|NCT04101474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110577869|NCT04101474|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110577870|NCT04101474|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110577871|NCT04101474|Anesthetics, General|anesthetics, general|mesh-ancestor
110577872|NCT04101474|Anesthetics|anesthetics|mesh-ancestor
110577873|NCT04101474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110577874|NCT04101474|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110577875|NCT04101474|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110577876|NCT04101474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110577877|NCT04101474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110577878|NCT04101708|Amoxicillin|amoxicillin|mesh-list
110577879|NCT04101708|Clarithromycin|clarithromycin|mesh-list
110577880|NCT04101708|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
110577881|NCT04101708|Lansoprazole|lansoprazole|mesh-list
110577882|NCT04101708|Dexlansoprazole|dexlansoprazole|mesh-list
110577883|NCT04101708|Bismuth|bismuth|mesh-list
110577884|NCT04101708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110577885|NCT04101708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110577886|NCT04101708|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110577887|NCT04101708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110577888|NCT04101708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110577889|NCT04101708|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110577890|NCT04101708|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110577891|NCT04101708|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110577892|NCT04101708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110577893|NCT04101708|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110577894|NCT04101708|Antacids|antacids|mesh-ancestor
110577895|NCT00779142|Methotrexate|methotrexate|mesh-list
110577896|NCT00779142|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110577897|NCT00779142|Abortifacient Agents|abortifacient agents|mesh-ancestor
110577898|NCT00779142|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110577899|NCT00779142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110577900|NCT00779142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110577901|NCT00779142|Antimetabolites|antimetabolites|mesh-ancestor
110577902|NCT00779142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110577903|NCT00779142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110577904|NCT00779142|Dermatologic Agents|dermatologic agents|mesh-ancestor
110577905|NCT00779142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110577906|NCT00779142|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110577907|NCT00779142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110577908|NCT00779142|Immunologic Factors|immunologic factors|mesh-ancestor
110577909|NCT00779142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110577910|NCT00779142|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110577911|NCT00840346|Panobinostat|panobinostat|mesh-list
110577912|NCT00840346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110577913|NCT00840346|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110577914|NCT00840346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110577915|NCT00840346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110577916|NCT04105140|Oxytocin|oxytocin|mesh-list
110577917|NCT04105140|Oxytocics|oxytocics|mesh-ancestor
110577918|NCT04105140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110577919|NCT04105140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110577920|NCT00840580|Moxifloxacin|moxifloxacin|mesh-list
110577921|NCT00840580|Levofloxacin|levofloxacin|mesh-list
110577922|NCT00840580|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110577923|NCT00840580|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110577924|NCT00840580|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
110577925|NCT00840580|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110577926|NCT00840580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110577927|NCT00840580|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110577928|NCT00840580|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110577929|NCT00840580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110577930|NCT00840580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110225347|NCT05989503|Valsartan|valsartan|mesh-list
110577931|NCT00840580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110577932|NCT00840580|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110577933|NCT00840580|Contraceptive Agents|contraceptive agents|mesh-ancestor
110577934|NCT00840580|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110577935|NCT00840580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110577936|NCT00840580|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110577937|NCT00840580|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110577938|NCT00840580|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110577939|NCT00840580|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110577940|NCT00840580|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110577941|NCT00840580|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110577942|NCT00773136|Bimatoprost|bimatoprost|mesh-list
110577943|NCT00773136|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110577945|NCT02602860|Brivaracetam|brivaracetam|mesh-list
110577946|NCT02602860|Anticonvulsants|anticonvulsants|mesh-ancestor
110577947|NCT02602860|Nootropic Agents|nootropic agents|mesh-ancestor
110577948|NCT00825058|Paroxetine|paroxetine|mesh-list
110577949|NCT00825058|Amibegron|amibegron|mesh-list
110577950|NCT00825058|Amibegron hydrochloride|amibegron hydrochloride|mesh-list
110577951|NCT00825058|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110577952|NCT00825058|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110577953|NCT00825058|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110577954|NCT00825058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110577955|NCT00825058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110577956|NCT00825058|Serotonin Agents|serotonin agents|mesh-ancestor
110577957|NCT00825058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110577958|NCT00825058|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110577959|NCT00825058|Antidepressive Agents|antidepressive agents|mesh-ancestor
110577960|NCT00825058|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110577961|NCT00825058|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110577962|NCT00825058|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110577963|NCT00825058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110577964|NCT00825058|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110577965|NCT00825058|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110577966|NCT00825058|Adrenergic Agents|adrenergic agents|mesh-ancestor
110577967|NCT00825058|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
110577968|NCT00701831|Insulin Glargine|insulin glargine|mesh-list
110577969|NCT00701831|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110577970|NCT00701831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110577971|NCT00835744|Clomiphene|clomiphene|mesh-list
110577972|NCT00835744|Enclomiphene|enclomiphene|mesh-list
110577973|NCT00835744|Zuclomiphene|zuclomiphene|mesh-list
110577974|NCT00835744|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110577975|NCT00835744|Hormone Antagonists|hormone antagonists|mesh-ancestor
110577976|NCT00835744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110577977|NCT00835744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110577978|NCT00835744|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110577979|NCT00835744|Fertility Agents|fertility agents|mesh-ancestor
110577980|NCT00835744|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110577981|NCT00835744|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110577982|NCT00835744|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110577983|NCT00778830|Cetuximab|cetuximab|mesh-list
110577984|NCT00778830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110577985|NCT00778830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110577986|NCT00772668|Prednisone|prednisone|mesh-list
110577987|NCT00772668|Cyclophosphamide|cyclophosphamide|mesh-list
110577988|NCT00772668|Rituximab|rituximab|mesh-list
110577989|NCT00772668|Bortezomib|bortezomib|mesh-list
110577990|NCT00772668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110577991|NCT00772668|Immunologic Factors|immunologic factors|mesh-ancestor
110577992|NCT00772668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110577993|NCT00772668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110577994|NCT00772668|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110577995|NCT00772668|Alkylating Agents|alkylating agents|mesh-ancestor
110577996|NCT00772668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110577997|NCT00772668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110577998|NCT00772668|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110577999|NCT00772668|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110578000|NCT00772668|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110578001|NCT00772668|Glucocorticoids|glucocorticoids|mesh-ancestor
110578002|NCT00772668|Hormones|hormones|mesh-ancestor
110578003|NCT00772668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110225437|NCT05966246|Mosapride|mosapride|mesh-list
110578004|NCT00772668|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110578005|NCT00786474|Dalteparin|dalteparin|mesh-list
110578006|NCT00786474|Tinzaparin|tinzaparin|mesh-list
110578007|NCT00786474|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
110578008|NCT00786474|Anticoagulants|anticoagulants|mesh-ancestor
110578009|NCT00786474|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110578010|NCT00786474|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110578011|NCT00786474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110578013|NCT00784875|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110578014|NCT00784875|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110578015|NCT00784875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110578016|NCT00784875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110578017|NCT00784875|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
110578018|NCT00784875|GABA Agonists|gaba agonists|mesh-ancestor
110578019|NCT00784875|GABA Agents|gaba agents|mesh-ancestor
110578020|NCT00784875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110578021|NCT00784875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110578022|NCT00701909|Ketamine|ketamine|mesh-list
110578023|NCT00701909|Morphine|morphine|mesh-list
110578024|NCT00701909|Analgesics|analgesics|mesh-ancestor
110578025|NCT00701909|Sensory System Agents|sensory system agents|mesh-ancestor
110578026|NCT00701909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110578027|NCT00701909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110578028|NCT00701909|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110578029|NCT00701909|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110578030|NCT00701909|Anesthetics, General|anesthetics, general|mesh-ancestor
110578031|NCT00701909|Anesthetics|anesthetics|mesh-ancestor
110578032|NCT00701909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110578033|NCT00701909|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110578034|NCT00701909|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110578035|NCT00701909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110578036|NCT00701909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110578037|NCT00701909|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110578038|NCT00701909|Narcotics|narcotics|mesh-ancestor
110578039|NCT00699023|Simvastatin|simvastatin|mesh-list
110578040|NCT00699023|Ezetimibe|ezetimibe|mesh-list
110578041|NCT00699023|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110578042|NCT00699023|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110578043|NCT00699023|Antimetabolites|antimetabolites|mesh-ancestor
110578044|NCT00699023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110578045|NCT00699023|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110578046|NCT00699023|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110578047|NCT00699023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110578048|NCT00853229|Pregabalin|pregabalin|mesh-list
110578049|NCT00853229|Analgesics|analgesics|mesh-ancestor
110578050|NCT00853229|Sensory System Agents|sensory system agents|mesh-ancestor
110578051|NCT00853229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110578052|NCT00853229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110578053|NCT00853229|Anticonvulsants|anticonvulsants|mesh-ancestor
110578054|NCT00853229|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110578055|NCT00853229|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110578056|NCT00853229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110578057|NCT00853229|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110578058|NCT00853229|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110578059|NCT00853229|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110578060|NCT00853229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110578061|NCT00853229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110578062|NCT00853073|Bevacizumab|bevacizumab|mesh-list
110578063|NCT00853073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110578064|NCT00853073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110578065|NCT00853073|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110578066|NCT00853073|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110578067|NCT00853073|Growth Substances|growth substances|mesh-ancestor
110578068|NCT00853073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110578069|NCT00853073|Growth Inhibitors|growth inhibitors|mesh-ancestor
110578070|NCT00845897|Botulinum Toxins|botulinum toxins|mesh-list
110578071|NCT00845897|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110578072|NCT00845897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110578073|NCT00845897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110578074|NCT00845897|Cholinergic Agents|cholinergic agents|mesh-ancestor
110578075|NCT00845897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110578076|NCT00845897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110578077|NCT04120337|Lidocaine|lidocaine|mesh-list
110578078|NCT04120337|Anesthetics, Local|anesthetics, local|mesh-ancestor
110578079|NCT04120337|Anesthetics|anesthetics|mesh-ancestor
110578080|NCT04120337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110578081|NCT04120337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110578082|NCT04120337|Sensory System Agents|sensory system agents|mesh-ancestor
110149125|NCT00006232|Antiemetics|antiemetics|mesh-ancestor
110578083|NCT04120337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110578084|NCT04120337|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110578085|NCT04120337|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110578086|NCT04120337|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110578087|NCT04120337|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110578088|NCT04120337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110578089|NCT00592319|Celecoxib|celecoxib|mesh-list
110578090|NCT00592319|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110578091|NCT00592319|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110578092|NCT00592319|Analgesics|analgesics|mesh-ancestor
110578093|NCT00592319|Sensory System Agents|sensory system agents|mesh-ancestor
110578094|NCT00592319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110578095|NCT00592319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110578096|NCT00592319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110578097|NCT00592319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110578098|NCT00592319|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110578099|NCT00592319|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110578100|NCT00592319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110260177|NCT02944201|Antioxidants|antioxidants|mesh-ancestor
110578101|NCT00592319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110578102|NCT00862121|Mesalamine|mesalamine|mesh-list
110578103|NCT00862121|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110578104|NCT00862121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110578105|NCT00862121|Analgesics|analgesics|mesh-ancestor
110578106|NCT00862121|Sensory System Agents|sensory system agents|mesh-ancestor
110578107|NCT00862121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110578108|NCT00862121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110578109|NCT00862121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110578110|NCT00862121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110578111|NCT00784719|Cyclosporine|cyclosporine|mesh-list
110578112|NCT00784719|Cyclosporins|cyclosporins|mesh-list
110578113|NCT00784719|Tofacitinib|tofacitinib|mesh-list
110578114|NCT00784719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110578115|NCT00784719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110578116|NCT00784719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110578117|NCT00784719|Immunologic Factors|immunologic factors|mesh-ancestor
110578118|NCT00784719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110578119|NCT00784719|Antifungal Agents|antifungal agents|mesh-ancestor
110578120|NCT00784719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110578121|NCT00784719|Dermatologic Agents|dermatologic agents|mesh-ancestor
110578122|NCT00784719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110578123|NCT00784719|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110578124|NCT00784719|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
110578125|NCT00784719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110578126|NCT00852917|Tramadol|tramadol|mesh-list
110578127|NCT00852917|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110578128|NCT00852917|Narcotics|narcotics|mesh-ancestor
110578129|NCT00852917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110578130|NCT00852917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110578131|NCT00852917|Analgesics|analgesics|mesh-ancestor
110578132|NCT00852917|Sensory System Agents|sensory system agents|mesh-ancestor
110578133|NCT00852917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110578134|NCT00700583|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110578135|NCT00700583|Terazosin|terazosin|mesh-list
110578136|NCT00700583|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110578137|NCT00700583|Diuretics|diuretics|mesh-ancestor
110578138|NCT00700583|Natriuretic Agents|natriuretic agents|mesh-ancestor
110578139|NCT00700583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110374775|NCT00564200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110578140|NCT00700583|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110578141|NCT00700583|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110578142|NCT00700583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110578143|NCT00700583|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110578144|NCT00700583|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110578146|NCT00700583|Adrenergic Agents|adrenergic agents|mesh-ancestor
110578147|NCT00700583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110578148|NCT00700583|Urological Agents|urological agents|mesh-ancestor
110578149|NCT00913055|Octreotide|octreotide|mesh-list
110578150|NCT00913055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110225567|NCT05896566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110578151|NCT00913055|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110578152|NCT00913055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110578153|NCT04117139|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110578154|NCT04117139|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110578155|NCT04117139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110578157|NCT00845429|Immunologic Factors|immunologic factors|mesh-ancestor
110578158|NCT00845429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110578159|NCT00844883|Sorafenib|sorafenib|mesh-list
110578160|NCT00844883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110578161|NCT00844883|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110578162|NCT00844883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110578163|NCT00844883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110578164|NCT00851903|Metformin|metformin|mesh-list
110578165|NCT00851903|Insulin Glargine|insulin glargine|mesh-list
110578166|NCT00851903|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110578167|NCT00851903|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110578168|NCT00851903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110578169|NCT00851903|Incretins|incretins|mesh-ancestor
110578170|NCT00851903|Hormones|hormones|mesh-ancestor
110578171|NCT00851903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110578172|NCT00851903|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110578173|NCT00851903|Protease Inhibitors|protease inhibitors|mesh-ancestor
110578174|NCT00851903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110260178|NCT02944201|Protective Agents|protective agents|mesh-ancestor
110578175|NCT00851903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110578176|NCT00587457|Immunotoxin HA22|immunotoxin ha22|mesh-list
110578177|NCT00587457|Immunotoxins|immunotoxins|mesh-ancestor
110578178|NCT00587457|Immunoconjugates|immunoconjugates|mesh-ancestor
110578179|NCT00587457|Immunologic Factors|immunologic factors|mesh-ancestor
110578180|NCT00587457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110578181|NCT00587457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110578182|NCT00851747|Deoxycholic Acid|deoxycholic acid|mesh-list
110578183|NCT00851747|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
110578184|NCT00851747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110578185|NCT04099563|Abrocitinib|abrocitinib|mesh-list
110578186|NCT04099563|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110578187|NCT04099563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110578188|NCT04099563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110578189|NCT00767325|Methotrexate|methotrexate|mesh-list
110578190|NCT00767325|Abatacept|abatacept|mesh-list
110578191|NCT00767325|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110578192|NCT00767325|Abortifacient Agents|abortifacient agents|mesh-ancestor
110578193|NCT00767325|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110578194|NCT00767325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110578195|NCT00767325|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110578196|NCT00767325|Antimetabolites|antimetabolites|mesh-ancestor
110578197|NCT00767325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110374786|NCT00193479|Immunologic Factors|immunologic factors|mesh-ancestor
110578198|NCT00767325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110578199|NCT00767325|Dermatologic Agents|dermatologic agents|mesh-ancestor
110578200|NCT00767325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110578201|NCT00767325|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110578202|NCT00767325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110578203|NCT00767325|Immunologic Factors|immunologic factors|mesh-ancestor
110578204|NCT00767325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110578205|NCT00767325|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110578206|NCT00767325|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110578207|NCT00767325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110578208|NCT00851591|Psyllium|psyllium|mesh-list
110578209|NCT00851591|Cathartics|cathartics|mesh-ancestor
110578210|NCT00851591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110578211|NCT02612363|Dexmedetomidine|dexmedetomidine|mesh-list
110578212|NCT02612363|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110578213|NCT02612363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110578214|NCT02612363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110578215|NCT02612363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110578216|NCT02612363|Analgesics|analgesics|mesh-ancestor
110578217|NCT02612363|Sensory System Agents|sensory system agents|mesh-ancestor
110578218|NCT02612363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110578219|NCT02612363|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110578220|NCT02612363|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110578221|NCT02612363|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110578222|NCT02612363|Adrenergic Agents|adrenergic agents|mesh-ancestor
110578223|NCT02612363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110578224|NCT02612363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110578225|NCT00702767|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
110578226|NCT00702767|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
110578227|NCT00702767|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
110578228|NCT00702767|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110578229|NCT00912899|Noscapine|noscapine|mesh-list
110578230|NCT00912899|Antitussive Agents|antitussive agents|mesh-ancestor
110578231|NCT00912899|Respiratory System Agents|respiratory system agents|mesh-ancestor
110578232|NCT00700895|Warfarin|warfarin|mesh-list
110578233|NCT00700895|Anticoagulants|anticoagulants|mesh-ancestor
110578234|NCT00861341|Aspirin|aspirin|mesh-list
110578235|NCT00861341|Pioglitazone|pioglitazone|mesh-list
110578236|NCT00861341|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110578237|NCT00861341|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110578238|NCT00861341|Analgesics|analgesics|mesh-ancestor
110578239|NCT00861341|Sensory System Agents|sensory system agents|mesh-ancestor
110578240|NCT00861341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110578241|NCT00861341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110578242|NCT00861341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110578243|NCT00861341|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110578244|NCT00861341|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110578245|NCT00861341|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110578246|NCT00861341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110578247|NCT00861341|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110578248|NCT00861341|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110578249|NCT00861341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110578250|NCT00861341|Antipyretics|antipyretics|mesh-ancestor
110578251|NCT00861341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110578252|NCT00766467|Modafinil|modafinil|mesh-list
110578253|NCT00766467|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110578254|NCT00766467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110578255|NCT00766467|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
110578256|NCT00766467|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110578257|NCT00766467|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110578258|NCT00766467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110578259|NCT00850499|Rituximab|rituximab|mesh-list
110578260|NCT00850499|Fludarabine|fludarabine|mesh-list
110578261|NCT00850499|Bortezomib|bortezomib|mesh-list
110578262|NCT00850499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110578263|NCT00850499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110578264|NCT00850499|Immunologic Factors|immunologic factors|mesh-ancestor
110578265|NCT00850499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110578266|NCT00850499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110578267|NCT00844805|Infliximab|infliximab|mesh-list
110578268|NCT00844805|Naproxen|naproxen|mesh-list
110578269|NCT00844805|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110578270|NCT00844805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110578271|NCT00844805|Dermatologic Agents|dermatologic agents|mesh-ancestor
110578272|NCT00844805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110578273|NCT00844805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110578274|NCT00844805|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110578275|NCT00844805|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110578276|NCT00844805|Analgesics|analgesics|mesh-ancestor
110578277|NCT00844805|Sensory System Agents|sensory system agents|mesh-ancestor
110578278|NCT00844805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110578279|NCT00844805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110578280|NCT00844805|Gout Suppressants|gout suppressants|mesh-ancestor
110578281|NCT00844805|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110578282|NCT00844805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110578283|NCT00844805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110578284|NCT00765999|Linaclotide|linaclotide|mesh-list
110578285|NCT00765999|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
110578286|NCT00765999|Enzyme Activators|enzyme activators|mesh-ancestor
110578287|NCT00765999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110578288|NCT00765999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110578289|NCT04099407|Pirfenidone|pirfenidone|mesh-list
110578290|NCT04099407|Analgesics|analgesics|mesh-ancestor
110578291|NCT04099407|Sensory System Agents|sensory system agents|mesh-ancestor
110578292|NCT04099407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110578293|NCT04099407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110578294|NCT04099407|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110578295|NCT04099407|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110578296|NCT04099407|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110578297|NCT04099407|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110578298|NCT04099407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110225775|NCT05826964|Elafin|elafin|mesh-list
110578299|NCT00765063|Dalteparin|dalteparin|mesh-list
110578300|NCT00765063|Anticoagulants|anticoagulants|mesh-ancestor
110578301|NCT00765063|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110578302|NCT00765063|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110578303|NCT00765063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110578304|NCT00764751|Calcipotriene|calcipotriene|mesh-list
110578305|NCT00764751|Dermatologic Agents|dermatologic agents|mesh-ancestor
110578306|NCT00764517|Rituximab|rituximab|mesh-list
110578307|NCT00764517|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110578308|NCT00764517|Vorinostat|vorinostat|mesh-list
110578309|NCT00764517|Cladribine|cladribine|mesh-list
110578310|NCT00764517|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
110578311|NCT00764517|Antibodies|antibodies|mesh-list
110578312|NCT00764517|Immunoglobulins|immunoglobulins|mesh-list
110578313|NCT00764517|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110578314|NCT00764517|Immunologic Factors|immunologic factors|mesh-ancestor
110578315|NCT00764517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110578316|NCT00764517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110578317|NCT00764517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110578318|NCT00764517|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110578319|NCT00764517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110578320|NCT00764517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110578321|NCT00764517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110578322|NCT00764517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110578323|NCT00764517|Antimetabolites|antimetabolites|mesh-ancestor
110578324|NCT00764361|Doxycycline|doxycycline|mesh-list
110578325|NCT00764361|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110578326|NCT00764361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110578327|NCT00764361|Antimalarials|antimalarials|mesh-ancestor
110578328|NCT00764361|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110578329|NCT00764361|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110578330|NCT00763971|Methylphenidate|methylphenidate|mesh-list
110578331|NCT00763971|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
110578332|NCT00763971|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110578333|NCT00763971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110578334|NCT00763971|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110578335|NCT00763971|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110578336|NCT00763971|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110578337|NCT00763971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110578338|NCT00763971|Dopamine Agents|dopamine agents|mesh-ancestor
110578339|NCT00763971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110578340|NCT00763815|Metformin|metformin|mesh-list
110578341|NCT00763815|Pioglitazone|pioglitazone|mesh-list
110578342|NCT00763815|Lixisenatide|lixisenatide|mesh-list
110578343|NCT00763815|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110578344|NCT00763815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110578345|NCT00763269|Silicon|silicon|mesh-list
110578346|NCT00763269|Triclosan|triclosan|mesh-list
110578347|NCT00763269|Fluorides|fluorides|mesh-list
110578348|NCT00763269|Cariostatic Agents|cariostatic agents|mesh-ancestor
110578349|NCT00763269|Protective Agents|protective agents|mesh-ancestor
110578350|NCT00763269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110578351|NCT00763269|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110578352|NCT00763269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110578353|NCT00763269|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
110578354|NCT00763269|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110578355|NCT00763269|Antimetabolites|antimetabolites|mesh-ancestor
110578356|NCT00763269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110578357|NCT00763269|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110578358|NCT00763269|Trace Elements|trace elements|mesh-ancestor
110578359|NCT00763269|Micronutrients|micronutrients|mesh-ancestor
110578361|NCT00763035|Regadenoson|regadenoson|mesh-list
110578362|NCT00763035|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110578363|NCT00763035|Sympathomimetics|sympathomimetics|mesh-ancestor
110578364|NCT00763035|Autonomic Agents|autonomic agents|mesh-ancestor
110578365|NCT00763035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110578366|NCT00763035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110578367|NCT00763035|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
110578368|NCT00763035|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110578369|NCT00763035|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110225793|NCT05826964|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110578370|NCT00763035|Adrenergic Agents|adrenergic agents|mesh-ancestor
110578371|NCT00763035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110578372|NCT00763035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110578373|NCT00763035|Protective Agents|protective agents|mesh-ancestor
110578374|NCT00763035|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
110578375|NCT00763035|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
110578377|NCT00763035|Purinergic Agents|purinergic agents|mesh-ancestor
110578378|NCT00844649|Paclitaxel|paclitaxel|mesh-list
110578379|NCT00844649|Gemcitabine|gemcitabine|mesh-list
110578380|NCT00844649|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110578381|NCT00844649|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110578382|NCT00844649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110578383|NCT00844649|Tubulin Modulators|tubulin modulators|mesh-ancestor
110578384|NCT00844649|Antimitotic Agents|antimitotic agents|mesh-ancestor
110578385|NCT00844649|Mitosis Modulators|mitosis modulators|mesh-ancestor
110578386|NCT00844649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110578387|NCT00844649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110578388|NCT00844649|Antimetabolites|antimetabolites|mesh-ancestor
110578389|NCT04098861|Timolol|timolol|mesh-list
110578390|NCT04098861|Latanoprost|latanoprost|mesh-list
110578391|NCT04098861|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110578392|NCT04098861|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110578393|NCT04098861|Adrenergic Agents|adrenergic agents|mesh-ancestor
110578394|NCT04098861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110578395|NCT04098861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110578396|NCT04098861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110578397|NCT04098861|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110578398|NCT04098861|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110578399|NCT04098861|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110578400|NCT04098861|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110578402|NCT00850343|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110578403|NCT00850343|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110578404|NCT00850343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110578405|NCT00850343|Immunologic Factors|immunologic factors|mesh-ancestor
110578406|NCT00850343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110578407|NCT00850343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110578408|NCT00849875|Dacarbazine|dacarbazine|mesh-list
110578409|NCT00849875|Imidazole|imidazole|mesh-list
110578410|NCT00849875|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110578411|NCT00849875|Alkylating Agents|alkylating agents|mesh-ancestor
110578412|NCT00849875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110578413|NCT00849875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110578414|NCT00849875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110578415|NCT00844415|Dabigatran|dabigatran|mesh-list
110578416|NCT00844415|Antithrombins|antithrombins|mesh-ancestor
110578417|NCT00844415|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110578418|NCT00844415|Protease Inhibitors|protease inhibitors|mesh-ancestor
110578419|NCT00844415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110578420|NCT00844415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110578421|NCT00844415|Anticoagulants|anticoagulants|mesh-ancestor
110578422|NCT00843635|Tadalafil|tadalafil|mesh-list
110578423|NCT00843635|Vasodilator Agents|vasodilator agents|mesh-ancestor
110578424|NCT00843635|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110578425|NCT00843635|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110578426|NCT00843635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110578427|NCT00843635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110578428|NCT00843635|Urological Agents|urological agents|mesh-ancestor
110578429|NCT00699179|Insulin Aspart|insulin aspart|mesh-list
110578430|NCT00699179|Biphasic Insulins|biphasic insulins|mesh-list
110578431|NCT00699179|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
110578432|NCT00699179|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110578433|NCT00699179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110578434|NCT04116827|Tamoxifen|tamoxifen|mesh-list
110578435|NCT04116827|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110578436|NCT04116827|Hormone Antagonists|hormone antagonists|mesh-ancestor
110578437|NCT04116827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110578438|NCT04116827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110578439|NCT04116827|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110578440|NCT04116827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110578441|NCT04116827|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110578442|NCT04116827|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110578443|NCT04116827|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110578444|NCT00849017|rGLP-1 protein|rglp-1 protein|mesh-list
110578445|NCT00849017|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
110578446|NCT00849017|Incretins|incretins|mesh-ancestor
110578447|NCT00849017|Hormones|hormones|mesh-ancestor
110225866|NCT05776056|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110578448|NCT00849017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110578449|NCT00849017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110578451|NCT00842309|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110578452|NCT00842309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110578453|NCT00842309|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110578454|NCT00842309|Antitubercular Agents|antitubercular agents|mesh-ancestor
110578455|NCT00842309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110578456|NCT00842309|Antimetabolites|antimetabolites|mesh-ancestor
110578457|NCT00842309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110578458|NCT00842153|Clobetasol|clobetasol|mesh-list
110578459|NCT00842153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110578460|NCT00842153|Glucocorticoids|glucocorticoids|mesh-ancestor
110578461|NCT00842153|Hormones|hormones|mesh-ancestor
110578462|NCT00842153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110578463|NCT00842153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110374824|NCT00193206|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110578464|NCT00762411|N2-((2S)-2-(3,5-difluorophenyl)-2-hydroxyethanoyl)-N1-((7S)-5-methyl-6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-L-alaninamide|n2-((2s)-2-(3,5-difluorophenyl)-2-hydroxyethanoyl)-n1-((7s)-5-methyl-6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-l-alaninamide|mesh-list
110578465|NCT00762411|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
110578466|NCT00762411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110578467|NCT00762411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110578468|NCT00841763|Vaccines|vaccines|mesh-list
110578469|NCT00841763|Immunologic Factors|immunologic factors|mesh-ancestor
110578470|NCT00841763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110578471|NCT00785538|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110578472|NCT00785538|Immunologic Factors|immunologic factors|mesh-ancestor
110578473|NCT00785538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110578474|NCT02602704|Bazedoxifene|bazedoxifene|mesh-list
110578475|NCT02602704|Calcium|calcium|mesh-list
110578476|NCT02602704|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110578477|NCT02602704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110578478|NCT02602704|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110578479|NCT02602704|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110578480|NCT02602704|Hormone Antagonists|hormone antagonists|mesh-ancestor
110578481|NCT02602704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110578482|NCT02602704|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110578483|NCT00860405|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
110578484|NCT00860405|Plasma Substitutes|plasma substitutes|mesh-ancestor
110578485|NCT00860405|Blood Substitutes|blood substitutes|mesh-ancestor
110578486|NCT00703313|Moxifloxacin|moxifloxacin|mesh-list
110578488|NCT00703313|Gatifloxacin|gatifloxacin|mesh-list
110149162|NCT00006247|Growth Inhibitors|growth inhibitors|mesh-ancestor
110578489|NCT00703313|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110578490|NCT00703313|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110578491|NCT00703313|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
110578492|NCT00703313|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110578493|NCT00703313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110578494|NCT00703313|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110578495|NCT00703313|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110578496|NCT00703313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110578497|NCT00703313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110578498|NCT00703313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110578499|NCT00703313|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110578500|NCT00703313|Contraceptive Agents|contraceptive agents|mesh-ancestor
110578501|NCT00703313|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110578502|NCT00703313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110578503|NCT00703313|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110578504|NCT00703313|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110578505|NCT00703313|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110578506|NCT00703313|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110578507|NCT00703313|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110578508|NCT00703313|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110578509|NCT00703079|Octreotide|octreotide|mesh-list
110578510|NCT00703079|Lanreotide|lanreotide|mesh-list
110578511|NCT00703079|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110578512|NCT00703079|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110578513|NCT00703079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110578514|NCT00840827|Cyclosporine|cyclosporine|mesh-list
110578515|NCT00840827|Lenalidomide|lenalidomide|mesh-list
110578516|NCT00840827|Cyclosporins|cyclosporins|mesh-list
110578517|NCT00840827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110578518|NCT00840827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110578520|NCT00840827|Immunologic Factors|immunologic factors|mesh-ancestor
110578521|NCT00840827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110578522|NCT00840827|Antifungal Agents|antifungal agents|mesh-ancestor
110578523|NCT00840827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110578524|NCT00840827|Dermatologic Agents|dermatologic agents|mesh-ancestor
110578525|NCT00840827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110578527|NCT00840827|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110578528|NCT00840827|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110578529|NCT00840827|Growth Substances|growth substances|mesh-ancestor
110578530|NCT00840827|Growth Inhibitors|growth inhibitors|mesh-ancestor
110578531|NCT00840827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110578532|NCT00703469|Nivolumab|nivolumab|mesh-list
110578533|NCT00703469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110578534|NCT00703469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110578535|NCT00703469|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110578536|NCT00703469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110578537|NCT02612207|Bilirubin|bilirubin|mesh-list
110578538|NCT02612207|Antioxidants|antioxidants|mesh-ancestor
110578539|NCT02612207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110578540|NCT02612207|Protective Agents|protective agents|mesh-ancestor
110578541|NCT02612207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110578542|NCT00859937|Dasatinib|dasatinib|mesh-list
110578543|NCT00859937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110578544|NCT00859937|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110578545|NCT00859937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110578546|NCT00859937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110578547|NCT04030715|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110578548|NCT04030715|Bismuth|bismuth|mesh-list
110578549|NCT04030715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110578550|NCT04030715|Antacids|antacids|mesh-ancestor
110578551|NCT04030715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110578552|NCT04030715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110578553|NCT00592007|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110578554|NCT00592007|Fulvestrant|fulvestrant|mesh-list
110578555|NCT00592007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110578556|NCT00592007|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110578557|NCT00592007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110578558|NCT00592007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110578559|NCT00592007|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110578560|NCT00592007|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110578561|NCT00592007|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110578562|NCT00592007|Hormone Antagonists|hormone antagonists|mesh-ancestor
110578563|NCT00592007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110578564|NCT00592007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110578565|NCT00839423|Vortioxetine|vortioxetine|mesh-list
110578566|NCT00839423|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
110578567|NCT00839423|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110578568|NCT00839423|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110578569|NCT00839423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110578570|NCT00839423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110578571|NCT00839423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110578572|NCT00839423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110578573|NCT00839423|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110578574|NCT00839423|Antidepressive Agents|antidepressive agents|mesh-ancestor
110578575|NCT00839423|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110578576|NCT00839423|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110578577|NCT00839423|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110578578|NCT00839423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110578579|NCT00839423|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110578580|NCT00839423|Serotonin Agents|serotonin agents|mesh-ancestor
110578581|NCT00839423|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110578582|NCT00839423|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110578583|NCT00839423|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110578584|NCT00839423|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110578585|NCT00859469|Gemcitabine|gemcitabine|mesh-list
110578586|NCT00859469|Oxaliplatin|oxaliplatin|mesh-list
110578587|NCT00859469|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110578588|NCT00859469|Antimetabolites|antimetabolites|mesh-ancestor
110578589|NCT00859469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110578590|NCT00859469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110578591|NCT00703625|Sirolimus|sirolimus|mesh-list
110578592|NCT00703625|Docetaxel|docetaxel|mesh-list
110578593|NCT00703625|Temsirolimus|temsirolimus|mesh-list
110578595|NCT00703625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110578596|NCT00703625|Tubulin Modulators|tubulin modulators|mesh-ancestor
110578597|NCT00703625|Antimitotic Agents|antimitotic agents|mesh-ancestor
110578598|NCT00703625|Mitosis Modulators|mitosis modulators|mesh-ancestor
110578599|NCT00703625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110578600|NCT00703625|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110578601|NCT00703625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110578602|NCT00703625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110578603|NCT00703625|Immunologic Factors|immunologic factors|mesh-ancestor
110578604|NCT00703625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110578605|NCT00703625|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110578606|NCT00703625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110578607|NCT00703625|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110578608|NCT00703625|Antifungal Agents|antifungal agents|mesh-ancestor
110578609|NCT00703703|Tolterodine Tartrate|tolterodine tartrate|mesh-list
110578610|NCT00703703|Darifenacin|darifenacin|mesh-list
110578611|NCT00703703|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110578612|NCT00703703|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110578613|NCT00703703|Cholinergic Agents|cholinergic agents|mesh-ancestor
110578614|NCT00703703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110578615|NCT00703703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110578616|NCT00703703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110578617|NCT00703703|Urological Agents|urological agents|mesh-ancestor
110578618|NCT00859313|Sufentanil|sufentanil|mesh-list
110578619|NCT00859313|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110578620|NCT00859313|Narcotics|narcotics|mesh-ancestor
110578621|NCT00859313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110578622|NCT00859313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110578623|NCT00859313|Analgesics|analgesics|mesh-ancestor
110578624|NCT00859313|Sensory System Agents|sensory system agents|mesh-ancestor
110578625|NCT00859313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110578626|NCT00859313|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110578627|NCT00859313|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110578628|NCT00859313|Anesthetics, General|anesthetics, general|mesh-ancestor
110578629|NCT00859313|Anesthetics|anesthetics|mesh-ancestor
110578630|NCT02611973|Aspirin|aspirin|mesh-list
110578631|NCT02611973|Hydroxyurea|hydroxyurea|mesh-list
110578632|NCT02611973|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110578633|NCT02611973|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110578635|NCT02611973|Sensory System Agents|sensory system agents|mesh-ancestor
110578636|NCT02611973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110578637|NCT02611973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110578638|NCT02611973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110578639|NCT02611973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110578640|NCT02611973|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110578641|NCT02611973|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110578642|NCT02611973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110578643|NCT02611973|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110578644|NCT02611973|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110578645|NCT02611973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110578646|NCT02611973|Antipyretics|antipyretics|mesh-ancestor
110374847|NCT04608734|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110578647|NCT02611973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110578648|NCT02611973|Antisickling Agents|antisickling agents|mesh-ancestor
110578649|NCT02611973|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110578650|NCT00771810|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
110578651|NCT00771810|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110578652|NCT00771810|Vasodilator Agents|vasodilator agents|mesh-ancestor
110578653|NCT00836927|Sirolimus|sirolimus|mesh-list
110578654|NCT00836927|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110578655|NCT00836927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110578656|NCT00836927|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110578657|NCT00836927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110578658|NCT00836927|Antifungal Agents|antifungal agents|mesh-ancestor
110578659|NCT00836927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110578660|NCT00836927|Immunologic Factors|immunologic factors|mesh-ancestor
110578661|NCT00836927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110578662|NCT00703235|Bevacizumab|bevacizumab|mesh-list
110578663|NCT00703235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110578664|NCT00703235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110578665|NCT00703235|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110578666|NCT00703235|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110578667|NCT00703235|Growth Substances|growth substances|mesh-ancestor
110578668|NCT00703235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110578669|NCT00703235|Growth Inhibitors|growth inhibitors|mesh-ancestor
110578670|NCT02612051|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110578671|NCT00771030|Brodalumab|brodalumab|mesh-list
110578672|NCT00771030|Dermatologic Agents|dermatologic agents|mesh-ancestor
110578673|NCT00768300|Ambrisentan|ambrisentan|mesh-list
110578674|NCT00768300|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110578675|NCT00768222|Triclosan|triclosan|mesh-list
110578676|NCT00768222|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110578677|NCT00768222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110578678|NCT00768222|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
110578679|NCT00768222|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110578680|NCT00768222|Antimetabolites|antimetabolites|mesh-ancestor
110578681|NCT00768222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110578682|NCT00768222|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110578683|NCT00768144|Sunitinib|sunitinib|mesh-list
110578684|NCT00768144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110578685|NCT00768144|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110578686|NCT00768144|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110578687|NCT00768144|Growth Substances|growth substances|mesh-ancestor
110578688|NCT00768144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110578689|NCT00768144|Growth Inhibitors|growth inhibitors|mesh-ancestor
110578690|NCT00768144|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110578691|NCT00768144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110578692|NCT00768144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110149179|NCT00006250|Hormones|hormones|mesh-ancestor
110578694|NCT00784836|Interferon-beta|interferon-beta|mesh-list
110578695|NCT00784836|Interferon beta-1a|interferon beta-1a|mesh-list
110578696|NCT00784836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110578697|NCT00784836|Antiviral Agents|antiviral agents|mesh-ancestor
110578698|NCT00784836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110578699|NCT00784836|Immunologic Factors|immunologic factors|mesh-ancestor
110578700|NCT00784836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110578701|NCT00784836|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110578702|NCT04104984|Tocolytic Agents|tocolytic agents|mesh-list
110578703|NCT04104984|Progesterone|progesterone|mesh-list
110578704|NCT04104984|Progestins|progestins|mesh-ancestor
110578705|NCT04104984|Hormones|hormones|mesh-ancestor
110578706|NCT04104984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110578707|NCT04104984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110578708|NCT04104984|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110578709|NCT00767520|Dasatinib|dasatinib|mesh-list
110578710|NCT00767520|Exemestane|exemestane|mesh-list
110578711|NCT00767520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110578712|NCT00767520|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110578713|NCT00767520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110578714|NCT00767520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110578715|NCT00767520|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110578716|NCT00767520|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110578717|NCT00767520|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110578718|NCT00767520|Hormone Antagonists|hormone antagonists|mesh-ancestor
110578719|NCT00767520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110578720|NCT00767520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110578721|NCT00858845|Clonidine|clonidine|mesh-list
110578722|NCT00858845|Analgesics|analgesics|mesh-ancestor
110578723|NCT00858845|Sensory System Agents|sensory system agents|mesh-ancestor
110578724|NCT00858845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110578725|NCT00858845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110578726|NCT00858845|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110578727|NCT00858845|Sympatholytics|sympatholytics|mesh-ancestor
110578728|NCT00858845|Autonomic Agents|autonomic agents|mesh-ancestor
110578729|NCT00858845|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110578730|NCT00858845|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110578731|NCT00858845|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110578732|NCT00858845|Adrenergic Agents|adrenergic agents|mesh-ancestor
110578733|NCT00858845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110578734|NCT00858845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110578735|NCT05591339|BCG Vaccine|bcg vaccine|mesh-list
110578736|NCT05591339|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110578737|NCT05591339|Immunologic Factors|immunologic factors|mesh-ancestor
110578738|NCT05591339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110578739|NCT00770562|Dexamethasone|dexamethasone|mesh-list
110578740|NCT00770562|Rituximab|rituximab|mesh-list
110578741|NCT00770562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110578742|NCT00770562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110578743|NCT00770562|Immunologic Factors|immunologic factors|mesh-ancestor
110578744|NCT00770562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110578745|NCT00770562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110578746|NCT00770562|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110578748|NCT00770562|Autonomic Agents|autonomic agents|mesh-ancestor
110578749|NCT00770562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110578750|NCT00770562|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110578751|NCT00770562|Glucocorticoids|glucocorticoids|mesh-ancestor
110578752|NCT00770562|Hormones|hormones|mesh-ancestor
110578753|NCT00770562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110578754|NCT00770562|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110578755|NCT00836693|Tadalafil|tadalafil|mesh-list
110578756|NCT00836693|Vasodilator Agents|vasodilator agents|mesh-ancestor
110578757|NCT00836693|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110578758|NCT00836693|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110578759|NCT00836693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110578760|NCT00836693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110578761|NCT00836693|Urological Agents|urological agents|mesh-ancestor
110578762|NCT00770484|Propranolol|propranolol|mesh-list
110578763|NCT00770484|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110578764|NCT00770484|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110578765|NCT00770484|Adrenergic Agents|adrenergic agents|mesh-ancestor
110578766|NCT00770484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110578767|NCT00770484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110578768|NCT00770484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110578769|NCT00770484|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110578770|NCT00770484|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110578771|NCT00770484|Vasodilator Agents|vasodilator agents|mesh-ancestor
110578772|NCT00835679|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110578773|NCT00835679|Cetuximab|cetuximab|mesh-list
110578774|NCT00835679|Dasatinib|dasatinib|mesh-list
110578775|NCT00835679|Antibodies|antibodies|mesh-list
110578776|NCT00835679|Immunoglobulins|immunoglobulins|mesh-list
110578777|NCT00835679|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110578778|NCT00835679|Immunologic Factors|immunologic factors|mesh-ancestor
110578779|NCT00835679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110578781|NCT00835679|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110578782|NCT00835679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110578783|NCT00835679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110578784|NCT00766506|Fentanyl|fentanyl|mesh-list
110578785|NCT00766506|Morphine|morphine|mesh-list
110578786|NCT00766506|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110578787|NCT00766506|Narcotics|narcotics|mesh-ancestor
110578788|NCT00766506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110578789|NCT00766506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110578790|NCT00766506|Analgesics|analgesics|mesh-ancestor
110578791|NCT00766506|Sensory System Agents|sensory system agents|mesh-ancestor
110578792|NCT00766506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110578793|NCT00766506|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110578794|NCT00766506|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110578795|NCT00766506|Anesthetics, General|anesthetics, general|mesh-ancestor
110578796|NCT00766506|Anesthetics|anesthetics|mesh-ancestor
110578797|NCT00770328|Pentoxifylline|pentoxifylline|mesh-list
110578798|NCT00770328|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110578799|NCT00770328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110578800|NCT00770328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110578801|NCT00770328|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110578802|NCT00770328|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110578803|NCT00770328|Protective Agents|protective agents|mesh-ancestor
110578804|NCT00770328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110578805|NCT00770328|Vasodilator Agents|vasodilator agents|mesh-ancestor
110578806|NCT00770328|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110578807|NCT00770328|Antioxidants|antioxidants|mesh-ancestor
110578808|NCT05500092|Cisplatin|cisplatin|mesh-list
110578809|NCT05500092|Gemcitabine|gemcitabine|mesh-list
110578810|NCT05500092|Docetaxel|docetaxel|mesh-list
110578811|NCT05500092|Nivolumab|nivolumab|mesh-list
110578812|NCT05500092|Pemetrexed|pemetrexed|mesh-list
110578813|NCT05500092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110578814|NCT05500092|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110578815|NCT05500092|Antimetabolites|antimetabolites|mesh-ancestor
110578816|NCT05500092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110578817|NCT05500092|Tubulin Modulators|tubulin modulators|mesh-ancestor
110578819|NCT05500092|Mitosis Modulators|mitosis modulators|mesh-ancestor
110578820|NCT05500092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110578821|NCT05500092|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110578822|NCT05500092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110578823|NCT05500092|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110578824|NCT05500092|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110578825|NCT00916500|Cisplatin|cisplatin|mesh-list
110578826|NCT00916500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110578827|NCT03110094|Adalimumab|adalimumab|mesh-list
110578828|NCT03110094|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110578829|NCT03110094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110578830|NCT03110094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110578831|NCT02600988|Vitamin D|vitamin d|mesh-list
110578832|NCT02600988|Ergocalciferols|ergocalciferols|mesh-list
110578833|NCT02600988|Cholecalciferol|cholecalciferol|mesh-list
110578834|NCT02600988|Vitamins|vitamins|mesh-list
110578835|NCT02600988|Micronutrients|micronutrients|mesh-ancestor
110578836|NCT02600988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110578837|NCT02600988|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110578838|NCT02600988|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110578839|NCT04097574|Menthol|menthol|mesh-list
110578840|NCT04097574|Antipruritics|antipruritics|mesh-ancestor
110578841|NCT04097574|Dermatologic Agents|dermatologic agents|mesh-ancestor
110578842|NCT00766038|Hormones|hormones|mesh-list
110578843|NCT00766038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110578844|NCT00766038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110578845|NCT00765882|Linaclotide|linaclotide|mesh-list
110578846|NCT00765882|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
110578847|NCT00765882|Enzyme Activators|enzyme activators|mesh-ancestor
110578848|NCT00765882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110578849|NCT00765882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110578850|NCT00913367|Insulin|insulin|mesh-list
110578851|NCT00913367|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110578852|NCT00913367|Metformin|metformin|mesh-list
110578853|NCT00913367|Insulin Glargine|insulin glargine|mesh-list
110578854|NCT00913367|Glimepiride|glimepiride|mesh-list
110578855|NCT00913367|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110578856|NCT00913367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110578858|NCT00913367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110578859|NCT00913367|Immunologic Factors|immunologic factors|mesh-ancestor
110578860|NCT00828113|Varenicline|varenicline|mesh-list
110578861|NCT00828113|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110578862|NCT00828113|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110578863|NCT00828113|Cholinergic Agents|cholinergic agents|mesh-ancestor
110578864|NCT00828113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110578865|NCT00828113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110578866|NCT00828113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110578867|NCT00707135|Sirolimus|sirolimus|mesh-list
110578868|NCT00707135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110578869|NCT00707135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110578870|NCT00707135|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110578871|NCT00707135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110578872|NCT00707135|Antifungal Agents|antifungal agents|mesh-ancestor
110578873|NCT00707135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110578874|NCT00707135|Immunologic Factors|immunologic factors|mesh-ancestor
110578875|NCT00707135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110578876|NCT00769704|Molgramostim|molgramostim|mesh-list
110578877|NCT00769704|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
110578878|NCT00769704|Sargramostim|sargramostim|mesh-list
110578879|NCT00769704|Immunologic Factors|immunologic factors|mesh-ancestor
110578880|NCT00769704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110578881|NCT00769704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110578882|NCT00769704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110578883|NCT00818753|Heparin|heparin|mesh-list
110578884|NCT00818753|Calcium heparin|calcium heparin|mesh-list
110578885|NCT00818753|Dabigatran|dabigatran|mesh-list
110578886|NCT00818753|Anticoagulants|anticoagulants|mesh-ancestor
110578887|NCT00818753|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110578888|NCT00818753|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110578889|NCT00818753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110578890|NCT00818753|Antithrombins|antithrombins|mesh-ancestor
110578891|NCT00818753|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110578892|NCT00818753|Protease Inhibitors|protease inhibitors|mesh-ancestor
110578893|NCT00818753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110578894|NCT00704249|Nevirapine|nevirapine|mesh-list
110578895|NCT00704249|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110578896|NCT00704249|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110578897|NCT00704249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110578898|NCT00704249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110578899|NCT00704249|Antiviral Agents|antiviral agents|mesh-ancestor
110578900|NCT00704249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110578901|NCT00704249|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110578902|NCT00704249|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110578903|NCT00704249|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110578904|NCT00704249|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110578905|NCT00765726|Factor VIII|factor viii|mesh-list
110578906|NCT00765726|Coagulants|coagulants|mesh-ancestor
110578907|NCT04100226|Vitamin D|vitamin d|mesh-list
110578908|NCT04100226|Cholecalciferol|cholecalciferol|mesh-list
110578909|NCT04100226|Calcium Carbonate|calcium carbonate|mesh-list
110578910|NCT04100226|Vitamins|vitamins|mesh-ancestor
110578911|NCT04100226|Micronutrients|micronutrients|mesh-ancestor
110578912|NCT04100226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110578913|NCT04100226|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110578914|NCT04100226|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110578915|NCT04100226|Antacids|antacids|mesh-ancestor
110578916|NCT04100226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110578917|NCT04100226|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110578918|NCT00765336|Minocycline|minocycline|mesh-list
110578919|NCT00765336|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110578920|NCT00765336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110578921|NCT00818519|Drospirenone|drospirenone|mesh-list
110578922|NCT00818519|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110578923|NCT00818519|Hormone Antagonists|hormone antagonists|mesh-ancestor
110578924|NCT00818519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110578925|NCT00818519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110578926|NCT00818519|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110578927|NCT00818519|Diuretics|diuretics|mesh-ancestor
110578928|NCT00818519|Natriuretic Agents|natriuretic agents|mesh-ancestor
110578929|NCT00827567|Everolimus|everolimus|mesh-list
110578930|NCT00827567|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110578931|NCT00827567|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110578932|NCT00827567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110578933|NCT00827567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110578934|NCT00827567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110578935|NCT00827567|Immunologic Factors|immunologic factors|mesh-ancestor
110578936|NCT00827567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110578937|NCT00827567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110578938|NCT00765102|Bortezomib|bortezomib|mesh-list
110578939|NCT00765102|Romidepsin|romidepsin|mesh-list
110578940|NCT00765102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110578941|NCT00765102|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110578942|NCT00765102|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110578943|NCT00765102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110578944|NCT00765102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110578945|NCT00809354|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
110578946|NCT00809354|Tanezumab|tanezumab|mesh-list
110578947|NCT00809354|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110578948|NCT00809354|Analgesics|analgesics|mesh-ancestor
110578949|NCT00809354|Sensory System Agents|sensory system agents|mesh-ancestor
110578950|NCT00809354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110578951|NCT00809354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110578952|NCT00809354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110578953|NCT00809354|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110578954|NCT00834899|Eptifibatide|eptifibatide|mesh-list
110578955|NCT00834899|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110578956|NCT00764946|Raltegravir Potassium|raltegravir potassium|mesh-list
110578957|NCT00764946|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110578958|NCT00764946|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110578959|NCT00764946|Antiviral Agents|antiviral agents|mesh-ancestor
110578960|NCT00764946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110578961|NCT00764946|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110578962|NCT00764946|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110578963|NCT00764946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110578964|NCT00764946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110578965|NCT00764868|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
110578966|NCT00764868|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110226385|NCT05536154|Etoposide|etoposide|mesh-list
110578967|NCT00764868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110578968|NCT00764868|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110578969|NCT00764868|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110578970|NCT00764868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110578971|NCT00764868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110578972|NCT00764868|Dopamine Agents|dopamine agents|mesh-ancestor
110578973|NCT00764868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110578974|NCT03990896|Talazoparib|talazoparib|mesh-list
110578975|NCT03990896|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110578976|NCT03990896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110578977|NCT03990896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110578978|NCT03990896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110578979|NCT00756444|Panitumumab|panitumumab|mesh-list
110578980|NCT00756444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110578981|NCT00756444|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110578982|NCT00753012|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
110578983|NCT00753012|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110578984|NCT00753012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110578985|NCT00753012|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110578986|NCT00753012|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110578987|NCT00753012|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110578988|NCT00753012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110578989|NCT00753012|Dopamine Agents|dopamine agents|mesh-ancestor
110578990|NCT00753012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110578991|NCT00806156|Etirinotecan pegol|etirinotecan pegol|mesh-list
110578992|NCT00806156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110578993|NCT00806156|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110578994|NCT00806156|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110578995|NCT00806156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110578996|NCT00806156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110578997|NCT00764478|Asenapine|asenapine|mesh-list
110578998|NCT00764478|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110578999|NCT00764478|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110579000|NCT00764478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110579001|NCT00764478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110579002|NCT00764478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110579003|NCT00805766|Infliximab|infliximab|mesh-list
110579004|NCT00805766|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110579005|NCT00805766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110579006|NCT00805766|Dermatologic Agents|dermatologic agents|mesh-ancestor
110579007|NCT00805766|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110579008|NCT00805766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110579009|NCT00764322|Tamoxifen|tamoxifen|mesh-list
110579010|NCT00764322|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110579011|NCT00764322|Hormone Antagonists|hormone antagonists|mesh-ancestor
110579012|NCT00764322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110579013|NCT00764322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110579014|NCT00764322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110579015|NCT00764322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110579016|NCT00764322|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110579017|NCT00764322|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110579018|NCT00764322|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110579019|NCT03908060|Morphine|morphine|mesh-list
110579020|NCT03908060|Methadone|methadone|mesh-list
110579021|NCT03908060|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110579022|NCT03908060|Narcotics|narcotics|mesh-ancestor
110579023|NCT03908060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110579024|NCT03908060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110579025|NCT03908060|Analgesics|analgesics|mesh-ancestor
110579026|NCT03908060|Sensory System Agents|sensory system agents|mesh-ancestor
110579027|NCT03908060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110579028|NCT03908060|Antitussive Agents|antitussive agents|mesh-ancestor
110579029|NCT03908060|Respiratory System Agents|respiratory system agents|mesh-ancestor
110579030|NCT00752856|Ritonavir|ritonavir|mesh-list
110579031|NCT00752856|Lopinavir|lopinavir|mesh-list
110579032|NCT00752856|Tenofovir|tenofovir|mesh-list
110579033|NCT00752856|Emtricitabine|emtricitabine|mesh-list
110579034|NCT00752856|Raltegravir Potassium|raltegravir potassium|mesh-list
110579035|NCT00752856|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110579036|NCT00752856|Efavirenz|efavirenz|mesh-list
110579037|NCT00752856|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110579038|NCT00752856|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110579039|NCT00752856|Protease Inhibitors|protease inhibitors|mesh-ancestor
110226458|NCT05488457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110579040|NCT00752856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110579041|NCT00752856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110579042|NCT00752856|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110579043|NCT00752856|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110579044|NCT00752856|Antiviral Agents|antiviral agents|mesh-ancestor
110579045|NCT00752856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110149203|NCT00006265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110579046|NCT00752856|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110579047|NCT00752856|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110579048|NCT00752856|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110579049|NCT00752856|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110579050|NCT00752856|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110579051|NCT00752856|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110579052|NCT00752856|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110579053|NCT00752856|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110579054|NCT00752856|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110579055|NCT00752856|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110579057|NCT00805142|Tapentadol|tapentadol|mesh-list
110579058|NCT00805142|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110579059|NCT00805142|Narcotics|narcotics|mesh-ancestor
110579060|NCT00805142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110579061|NCT00805142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110579062|NCT00805142|Analgesics|analgesics|mesh-ancestor
110579063|NCT00805142|Sensory System Agents|sensory system agents|mesh-ancestor
110579064|NCT00805142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110579065|NCT00805142|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110579066|NCT00805142|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110579067|NCT00805142|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110579068|NCT00805142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110579069|NCT00805142|Adrenergic Agents|adrenergic agents|mesh-ancestor
110579070|NCT00805142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110579071|NCT00761631|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110579072|NCT00761631|Immunologic Factors|immunologic factors|mesh-ancestor
110579073|NCT00761631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110579074|NCT00761319|Travoprost|travoprost|mesh-list
110579075|NCT00761319|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110579076|NCT00761319|Latanoprost|latanoprost|mesh-list
110579077|NCT00761319|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110579078|NCT00761319|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110579079|NCT00704639|Carboplatin|carboplatin|mesh-list
110579080|NCT00704639|Cetuximab|cetuximab|mesh-list
110579081|NCT00704639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110579082|NCT00704639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110579083|NCT00826943|Cetirizine|cetirizine|mesh-list
110579084|NCT00826943|Levocetirizine|levocetirizine|mesh-list
110579085|NCT00826943|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110579086|NCT00826943|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110579087|NCT00826943|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110579088|NCT00826943|Histamine Antagonists|histamine antagonists|mesh-ancestor
110579089|NCT00826943|Histamine Agents|histamine agents|mesh-ancestor
110579090|NCT00826943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110579091|NCT00826943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110579092|NCT00826943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110579093|NCT00707369|Amoxicillin|amoxicillin|mesh-list
110579094|NCT00707369|Metronidazole|metronidazole|mesh-list
110579095|NCT00707369|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110579096|NCT00707369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110579097|NCT00707369|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110579098|NCT00707369|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110579099|NCT00760929|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110579100|NCT00760929|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110579101|NCT00760929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110579102|NCT00760929|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110579103|NCT00760929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110579104|NCT00760929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110579105|NCT00760929|Immunologic Factors|immunologic factors|mesh-ancestor
110579106|NCT00760929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110579107|NCT00704951|Posaconazole|posaconazole|mesh-list
110579108|NCT00704951|Antifungal Agents|antifungal agents|mesh-ancestor
110579109|NCT00704951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110579110|NCT00704951|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
110579111|NCT00704951|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110579112|NCT00704951|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110579113|NCT00704951|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110579114|NCT00704951|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110579115|NCT00704951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110579116|NCT00704951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110579117|NCT00704951|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110579118|NCT00704951|Hormone Antagonists|hormone antagonists|mesh-ancestor
110579119|NCT00704951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110579120|NCT00704951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110579122|NCT00759915|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110579123|NCT00759915|Narcotics|narcotics|mesh-ancestor
110579124|NCT00759915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110579125|NCT00759915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110579126|NCT00759915|Analgesics|analgesics|mesh-ancestor
110579127|NCT00759915|Sensory System Agents|sensory system agents|mesh-ancestor
110579128|NCT00759915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110579129|NCT00759759|Morphine|morphine|mesh-list
110579130|NCT00759759|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110579131|NCT00759759|Narcotics|narcotics|mesh-ancestor
110579132|NCT00759759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110579133|NCT00759759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110579134|NCT00759759|Analgesics|analgesics|mesh-ancestor
110579135|NCT00759759|Sensory System Agents|sensory system agents|mesh-ancestor
110579136|NCT00759759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110579137|NCT00759681|Thrombin|thrombin|mesh-list
110579138|NCT00759681|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
110579139|NCT00759681|Hemostatics|hemostatics|mesh-ancestor
110579140|NCT00759681|Coagulants|coagulants|mesh-ancestor
110579141|NCT00826241|Temozolomide|temozolomide|mesh-list
110579142|NCT00826241|Lapatinib|lapatinib|mesh-list
110579143|NCT00826241|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110579144|NCT00826241|Alkylating Agents|alkylating agents|mesh-ancestor
110579145|NCT00826241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110579146|NCT00826241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110579147|NCT00826241|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110579148|NCT00826241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110579150|NCT04097847|Tocopherols|tocopherols|mesh-list
110579151|NCT04097847|Vitamin E|vitamin e|mesh-list
110579152|NCT04097847|Tocotrienols|tocotrienols|mesh-list
110579153|NCT04097847|alpha-Tocopherol|alpha-tocopherol|mesh-list
110579154|NCT04097847|Pentoxifylline|pentoxifylline|mesh-list
110579155|NCT04097847|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110579156|NCT04097847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110579157|NCT04097847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110579158|NCT04097847|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110579159|NCT04097847|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110579160|NCT04097847|Protective Agents|protective agents|mesh-ancestor
110579161|NCT04097847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110579162|NCT04097847|Vasodilator Agents|vasodilator agents|mesh-ancestor
110579163|NCT04097847|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110579164|NCT04097847|Antioxidants|antioxidants|mesh-ancestor
110579165|NCT04097847|Vitamins|vitamins|mesh-ancestor
110579166|NCT04097847|Micronutrients|micronutrients|mesh-ancestor
110579167|NCT04097847|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110579168|NCT00762372|Nitrous Oxide|nitrous oxide|mesh-list
110579169|NCT00762372|Sevoflurane|sevoflurane|mesh-list
110579170|NCT00762372|Desflurane|desflurane|mesh-list
110579171|NCT00762372|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110579172|NCT00762372|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110579173|NCT00762372|Anesthetics, General|anesthetics, general|mesh-ancestor
110579174|NCT00762372|Anesthetics|anesthetics|mesh-ancestor
110579175|NCT00762372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110579176|NCT00762372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110579177|NCT00762372|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110579178|NCT00762372|Analgesics|analgesics|mesh-ancestor
110579179|NCT00762372|Sensory System Agents|sensory system agents|mesh-ancestor
110375008|NCT04607525|Analgesics|analgesics|mesh-ancestor
110579180|NCT00762372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110579182|NCT00833261|Cetuximab|cetuximab|mesh-list
110579183|NCT00833261|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110579184|NCT00833261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110579185|NCT00833261|Tubulin Modulators|tubulin modulators|mesh-ancestor
110579186|NCT00833261|Antimitotic Agents|antimitotic agents|mesh-ancestor
110579187|NCT00833261|Mitosis Modulators|mitosis modulators|mesh-ancestor
110579188|NCT00833261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110579189|NCT00833261|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110579191|NCT00833027|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110579192|NCT00833027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110579193|NCT00833027|Incretins|incretins|mesh-ancestor
110579194|NCT00833027|Hormones|hormones|mesh-ancestor
110579195|NCT00833027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110579196|NCT00833027|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110579197|NCT00833027|Protease Inhibitors|protease inhibitors|mesh-ancestor
110579198|NCT00833027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110579199|NCT00833027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110579200|NCT00752622|Infliximab|infliximab|mesh-list
110579201|NCT00752622|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110579202|NCT00752622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110579203|NCT00752622|Dermatologic Agents|dermatologic agents|mesh-ancestor
110579204|NCT00752622|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110579205|NCT00752622|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110579206|NCT00754650|Bevacizumab|bevacizumab|mesh-list
110579207|NCT00754650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110579208|NCT00754650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110579209|NCT00754650|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110579210|NCT00754650|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110579211|NCT00754650|Growth Substances|growth substances|mesh-ancestor
110579212|NCT00754650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110579213|NCT00754650|Growth Inhibitors|growth inhibitors|mesh-ancestor
110579214|NCT02611271|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110579215|NCT02611271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110579216|NCT00825305|Vaccines|vaccines|mesh-list
110579217|NCT00825305|Immunologic Factors|immunologic factors|mesh-ancestor
110579218|NCT00825305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110579219|NCT00754572|Methotrexate|methotrexate|mesh-list
110579220|NCT00754572|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110579221|NCT00754572|Abortifacient Agents|abortifacient agents|mesh-ancestor
110579222|NCT00754572|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110579223|NCT00754572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110579224|NCT00754572|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110579225|NCT00754572|Antimetabolites|antimetabolites|mesh-ancestor
110579226|NCT00754572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110579227|NCT00754572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110579228|NCT00754572|Dermatologic Agents|dermatologic agents|mesh-ancestor
110579229|NCT00754572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110579230|NCT00754572|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110579231|NCT00754572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110579232|NCT00754572|Immunologic Factors|immunologic factors|mesh-ancestor
110579233|NCT00754572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110579234|NCT00754572|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110579235|NCT00824993|Ibandronic Acid|ibandronic acid|mesh-list
110579236|NCT00824993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110579237|NCT00824993|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110579238|NCT04095312|Pancrelipase|pancrelipase|mesh-list
110579239|NCT04095312|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110579240|NCT04095390|Capecitabine|capecitabine|mesh-list
110579242|NCT04095390|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110579243|NCT04095390|Antimetabolites|antimetabolites|mesh-ancestor
110579244|NCT04095390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110579245|NCT04095390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110579246|NCT04095390|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110579247|NCT04095390|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110579248|NCT04095390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110579249|NCT04095390|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110579250|NCT04095390|Hormone Antagonists|hormone antagonists|mesh-ancestor
110579251|NCT04095390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110579252|NCT04095390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110579259|NCT00708149|Lansoprazole|lansoprazole|mesh-list
110579260|NCT00708149|Dexlansoprazole|dexlansoprazole|mesh-list
110579261|NCT00708149|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110579262|NCT00708149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110579263|NCT00708149|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110579264|NCT00708149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110579265|NCT00708149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110579266|NCT04016051|Clarithromycin|clarithromycin|mesh-list
110579267|NCT04016051|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110579268|NCT04016051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110579269|NCT04016051|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110579270|NCT04016051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110579271|NCT04016051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110579272|NCT04016051|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110579273|NCT04016051|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110579275|NCT00761514|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110579276|NCT00761514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110579277|NCT00761514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110579278|NCT00831779|Dapagliflozin|dapagliflozin|mesh-list
110579279|NCT00831779|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110579280|NCT00831779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110579281|NCT00831779|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110579282|NCT00831779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110579283|NCT00758043|Ribavirin|ribavirin|mesh-list
110579284|NCT00758043|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110579285|NCT00758043|Antimetabolites|antimetabolites|mesh-ancestor
110579286|NCT00758043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110579287|NCT00758043|Antiviral Agents|antiviral agents|mesh-ancestor
110579288|NCT00758043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110579289|NCT00831701|Tamsulosin|tamsulosin|mesh-list
110579290|NCT00831701|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110579291|NCT00831701|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110579292|NCT00831701|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110579293|NCT00831701|Adrenergic Agents|adrenergic agents|mesh-ancestor
110579294|NCT00831701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110579295|NCT00831701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110579296|NCT00831701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110579297|NCT00831701|Urological Agents|urological agents|mesh-ancestor
110579298|NCT00705419|Tenofovir|tenofovir|mesh-list
110579299|NCT00705419|Emtricitabine|emtricitabine|mesh-list
110579300|NCT00705419|Maleic acid|maleic acid|mesh-list
110579301|NCT00705419|Antiviral Agents|antiviral agents|mesh-ancestor
110579302|NCT00705419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110579303|NCT00705419|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110579304|NCT00705419|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110579306|NCT00705419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110579307|NCT00705419|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110579308|NCT00705419|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110579310|NCT05425355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110579311|NCT05425355|Analgesics|analgesics|mesh-ancestor
110579312|NCT05425355|Sensory System Agents|sensory system agents|mesh-ancestor
110579313|NCT05425355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110579314|NCT05425355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110579315|NCT05425355|Antipyretics|antipyretics|mesh-ancestor
110579316|NCT04093713|Nordefrin|nordefrin|mesh-list
110579317|NCT04093713|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110579318|NCT00831311|Vaccines|vaccines|mesh-list
110579319|NCT00831311|Immunologic Factors|immunologic factors|mesh-ancestor
110579320|NCT00831311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110579321|NCT00831233|Goserelin|goserelin|mesh-list
110579322|NCT00831233|Bicalutamide|bicalutamide|mesh-list
110579323|NCT00831233|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110579324|NCT00831233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110579325|NCT00831233|Androgen Antagonists|androgen antagonists|mesh-ancestor
110579326|NCT00831233|Hormone Antagonists|hormone antagonists|mesh-ancestor
110579327|NCT00831233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110579328|NCT00831233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110579329|NCT05438277|Methylprednisolone|methylprednisolone|mesh-list
110579330|NCT05438277|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110579331|NCT05438277|Triamcinolone|triamcinolone|mesh-list
110579332|NCT05438277|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110579334|NCT05438277|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110579335|NCT05438277|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110579336|NCT05438277|Antiemetics|antiemetics|mesh-ancestor
110579337|NCT05438277|Autonomic Agents|autonomic agents|mesh-ancestor
110579338|NCT05438277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110579339|NCT05438277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110579340|NCT05438277|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110579341|NCT05438277|Glucocorticoids|glucocorticoids|mesh-ancestor
110579342|NCT05438277|Hormones|hormones|mesh-ancestor
110579343|NCT05438277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110579344|NCT05438277|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110579345|NCT05438277|Protective Agents|protective agents|mesh-ancestor
110579346|NCT05438277|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110579347|NCT05438277|Immunologic Factors|immunologic factors|mesh-ancestor
110579348|NCT05438277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110579349|NCT05438277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110579350|NCT00761280|Temozolomide|temozolomide|mesh-list
110579351|NCT00761280|Carmustine|carmustine|mesh-list
110579352|NCT00761280|Lomustine|lomustine|mesh-list
110579353|NCT00761280|Trabedersen|trabedersen|mesh-list
110579354|NCT00761280|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110579355|NCT00761280|Alkylating Agents|alkylating agents|mesh-ancestor
110579356|NCT00761280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110579357|NCT00761280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110579358|NCT00916890|Fentanyl|fentanyl|mesh-list
110579359|NCT00916890|Morphine|morphine|mesh-list
110579360|NCT00916890|Oxycodone|oxycodone|mesh-list
110579361|NCT00916890|Buprenorphine|buprenorphine|mesh-list
110579362|NCT00916890|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110579363|NCT00916890|Narcotics|narcotics|mesh-ancestor
110579364|NCT00916890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110579365|NCT00916890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110579366|NCT00916890|Analgesics|analgesics|mesh-ancestor
110579367|NCT00916890|Sensory System Agents|sensory system agents|mesh-ancestor
110579368|NCT00916890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110579369|NCT00916890|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110579370|NCT00916890|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110579371|NCT00916890|Anesthetics, General|anesthetics, general|mesh-ancestor
110579372|NCT00916890|Anesthetics|anesthetics|mesh-ancestor
110579373|NCT00916890|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110579374|NCT02599701|Gabapentin|gabapentin|mesh-list
110579375|NCT02599701|Analgesics|analgesics|mesh-ancestor
110579376|NCT02599701|Sensory System Agents|sensory system agents|mesh-ancestor
110579377|NCT02599701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110579378|NCT02599701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110579380|NCT02599701|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110579381|NCT02599701|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110579382|NCT02599701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110579383|NCT02599701|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110579384|NCT02599701|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110579385|NCT02599701|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110579386|NCT02599701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110579387|NCT02599701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110579388|NCT02599701|Antimanic Agents|antimanic agents|mesh-ancestor
110579389|NCT00824291|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
110579390|NCT00824291|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110579391|NCT00824291|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110579392|NCT00824291|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110579393|NCT00824291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110579394|NCT00824291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110579395|NCT00824291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110579396|NCT00824291|Antidepressive Agents|antidepressive agents|mesh-ancestor
110579397|NCT00824291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110579398|NCT00752232|Saponin QA-21V1|saponin qa-21v1|mesh-list
110579399|NCT00752232|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110579400|NCT00752232|Immunologic Factors|immunologic factors|mesh-ancestor
110579401|NCT00752232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110579402|NCT00760266|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110579403|NCT00760266|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110579404|NCT00760266|Diuretics|diuretics|mesh-ancestor
110579405|NCT00760266|Natriuretic Agents|natriuretic agents|mesh-ancestor
110579406|NCT00760266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110579407|NCT00760266|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110579408|NCT00760266|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110579409|NCT00760266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110579410|NCT00753714|Gemcitabine|gemcitabine|mesh-list
110579411|NCT00753714|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110579412|NCT00753714|Antimetabolites|antimetabolites|mesh-ancestor
110579413|NCT00753714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110579414|NCT00753714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110226833|NCT05321940|Interferons|interferons|mesh-list
110579416|NCT00759954|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110579417|NCT00759954|Narcotics|narcotics|mesh-ancestor
110579418|NCT00759954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110579419|NCT00759954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110579420|NCT00759954|Analgesics|analgesics|mesh-ancestor
110579421|NCT00759954|Sensory System Agents|sensory system agents|mesh-ancestor
110579422|NCT00759954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110579423|NCT00804908|Temozolomide|temozolomide|mesh-list
110579424|NCT00804908|Veliparib|veliparib|mesh-list
110579425|NCT00804908|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110579426|NCT00804908|Alkylating Agents|alkylating agents|mesh-ancestor
110579427|NCT00804908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110579428|NCT00804908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110579429|NCT00804908|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110579430|NCT00804908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110579431|NCT02608034|Itraconazole|itraconazole|mesh-list
110579432|NCT02608034|Rifampin|rifampin|mesh-list
110579433|NCT02608034|Vemurafenib|vemurafenib|mesh-list
110579434|NCT02608034|Antifungal Agents|antifungal agents|mesh-ancestor
110579435|NCT02608034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110579436|NCT02608034|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110579437|NCT02608034|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110579438|NCT02608034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110579439|NCT02608034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110579440|NCT02608034|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110579441|NCT02608034|Hormone Antagonists|hormone antagonists|mesh-ancestor
110579442|NCT02608034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110579443|NCT02608034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110579444|NCT02608034|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110579445|NCT02608034|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110579446|NCT02608034|Antitubercular Agents|antitubercular agents|mesh-ancestor
110579447|NCT02608034|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110579448|NCT02608034|Leprostatic Agents|leprostatic agents|mesh-ancestor
110579449|NCT02608034|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110579450|NCT02608034|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110579451|NCT02608034|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110579452|NCT02608034|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110579453|NCT02608034|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110579454|NCT02608034|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110579455|NCT02608034|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110579456|NCT02608034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110579457|NCT02608034|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110579459|NCT00589784|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-list
110579460|NCT00589784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110579461|NCT00589784|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110579462|NCT00589784|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110579463|NCT00589784|Growth Substances|growth substances|mesh-ancestor
110579464|NCT00589784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110579465|NCT00589784|Growth Inhibitors|growth inhibitors|mesh-ancestor
110579466|NCT00589784|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110579467|NCT00589784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110579468|NCT00589784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110579469|NCT00589784|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110579471|NCT05742854|Carbetocin|carbetocin|mesh-list
110579472|NCT05742854|Oxytocics|oxytocics|mesh-ancestor
110579473|NCT05742854|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110579474|NCT05742854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110579475|NCT00823979|Etravirine|etravirine|mesh-list
110579476|NCT00823979|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110579477|NCT00823979|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110579478|NCT00823979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110579479|NCT00823979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110579480|NCT00823979|Antiviral Agents|antiviral agents|mesh-ancestor
110579481|NCT00823979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110579482|NCT04094766|Immunomodulating Agents|immunomodulating agents|mesh-list
110579483|NCT04094766|Immunologic Factors|immunologic factors|mesh-ancestor
110579484|NCT04094766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110579485|NCT02606864|Nifurtimox|nifurtimox|mesh-list
110579486|NCT02606864|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
110579487|NCT02606864|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110579488|NCT02606864|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110579489|NCT02606864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110579490|NCT00823901|Clindamycin|clindamycin|mesh-list
110579491|NCT00823901|Clindamycin palmitate|clindamycin palmitate|mesh-list
110579492|NCT00823901|Clindamycin phosphate|clindamycin phosphate|mesh-list
110579493|NCT00823901|Tretinoin|tretinoin|mesh-list
110579494|NCT00823901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110579495|NCT00823901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110579496|NCT00823901|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110579497|NCT00823901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110579498|NCT00823901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110579499|NCT00823901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110579500|NCT00823901|Keratolytic Agents|keratolytic agents|mesh-ancestor
110579501|NCT00823901|Dermatologic Agents|dermatologic agents|mesh-ancestor
110579502|NCT00823823|Calpastatin|calpastatin|mesh-list
110579503|NCT00823823|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
110579504|NCT00823823|Protease Inhibitors|protease inhibitors|mesh-ancestor
110579505|NCT00823823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110579506|NCT00823823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110579507|NCT02926898|Fenfluramine|fenfluramine|mesh-list
110579508|NCT02926898|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110579509|NCT02926898|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110579510|NCT02926898|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110579511|NCT02926898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110579512|NCT02926898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110579513|NCT02926898|Serotonin Agents|serotonin agents|mesh-ancestor
110579514|NCT02926898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110579515|NCT00759564|Lactams|lactams|mesh-list
110579516|NCT00759564|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110579517|NCT00759564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110579518|NCT00816023|Ecallantide|ecallantide|mesh-list
110579519|NCT00816023|Analgesics|analgesics|mesh-ancestor
110579520|NCT00816023|Sensory System Agents|sensory system agents|mesh-ancestor
110579521|NCT00816023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110579522|NCT00816023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110579523|NCT00816023|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110579524|NCT00816023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110579525|NCT00816023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110579526|NCT00816023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110579528|NCT00815633|Dermatologic Agents|dermatologic agents|mesh-ancestor
110579529|NCT00815633|Immunologic Factors|immunologic factors|mesh-ancestor
110579530|NCT00815633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110579532|NCT02610881|Trace Elements|trace elements|mesh-list
110579533|NCT02610881|Folic Acid|folic acid|mesh-list
110579534|NCT02610881|Micronutrients|micronutrients|mesh-list
110579535|NCT02610881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110579536|NCT02610881|Hematinics|hematinics|mesh-ancestor
110579537|NCT02610881|Vitamin B Complex|vitamin b complex|mesh-ancestor
110579538|NCT02610881|Vitamins|vitamins|mesh-ancestor
110579539|NCT00830765|Progesterone|progesterone|mesh-list
110579540|NCT00830765|Progestins|progestins|mesh-ancestor
110579541|NCT00830765|Hormones|hormones|mesh-ancestor
110579542|NCT00830765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110579543|NCT00830765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110579544|NCT04093206|Vitamins|vitamins|mesh-list
110579545|NCT04093206|Ascorbic Acid|ascorbic acid|mesh-list
110579546|NCT04093206|Micronutrients|micronutrients|mesh-ancestor
110579547|NCT04093206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110579548|NCT04093206|Antioxidants|antioxidants|mesh-ancestor
110579549|NCT04093206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110579550|NCT04093206|Protective Agents|protective agents|mesh-ancestor
110579551|NCT00830375|Memantine|memantine|mesh-list
110579552|NCT00830375|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110579553|NCT00830375|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110579554|NCT00830375|Dopamine Agents|dopamine agents|mesh-ancestor
110579555|NCT00830375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110579556|NCT00830375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110579557|NCT00830375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110579558|NCT00830375|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110579559|NCT00830375|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110579560|NCT00708539|Progesterone|progesterone|mesh-list
110579561|NCT00708539|Progestins|progestins|mesh-ancestor
110579562|NCT00708539|Hormones|hormones|mesh-ancestor
110579563|NCT00708539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110579564|NCT00708539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110579566|NCT00914420|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110579567|NCT00914420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110579568|NCT00914420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110579569|NCT00914420|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110579570|NCT00914420|Vasodilator Agents|vasodilator agents|mesh-ancestor
110579571|NCT04094532|Bupivacaine|bupivacaine|mesh-list
110579572|NCT04094532|Anesthetics, Local|anesthetics, local|mesh-ancestor
110579573|NCT04094532|Anesthetics|anesthetics|mesh-ancestor
110579574|NCT04094532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110579575|NCT04094532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110579576|NCT04094532|Sensory System Agents|sensory system agents|mesh-ancestor
110579577|NCT04094532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110579578|NCT00708773|Irinotecan|irinotecan|mesh-list
110579579|NCT00708773|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110579580|NCT00708773|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110579581|NCT00708773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110579582|NCT00708773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110579583|NCT00708773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110579584|NCT05758259|Vitamin D|vitamin d|mesh-list
110579585|NCT05758259|Ergocalciferols|ergocalciferols|mesh-list
110579586|NCT05758259|Cholecalciferol|cholecalciferol|mesh-list
110579587|NCT05758259|Vitamins|vitamins|mesh-list
110579588|NCT05758259|Micronutrients|micronutrients|mesh-ancestor
110579589|NCT05758259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110579590|NCT05758259|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110579591|NCT05758259|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110579592|NCT00803738|Terconazole|terconazole|mesh-list
110579593|NCT00803738|Antifungal Agents|antifungal agents|mesh-ancestor
110579594|NCT00803738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110579595|NCT00591266|Amlodipine|amlodipine|mesh-list
110579596|NCT00591266|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
110579597|NCT00591266|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110579598|NCT00591266|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110579599|NCT00591266|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110579600|NCT00591266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110579601|NCT00591266|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110579602|NCT00591266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110579603|NCT00591266|Vasodilator Agents|vasodilator agents|mesh-ancestor
110579604|NCT00591266|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110579605|NCT00591266|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110579606|NCT04093050|Vasopressins|vasopressins|mesh-list
110579607|NCT04093050|Hemostatics|hemostatics|mesh-ancestor
110579608|NCT04093050|Coagulants|coagulants|mesh-ancestor
110579609|NCT04093050|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110579610|NCT04093050|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
110579611|NCT04093050|Natriuretic Agents|natriuretic agents|mesh-ancestor
110579612|NCT04093050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110579613|NCT00758394|Listerine|listerine|mesh-list
110579614|NCT00758394|Triclosan|triclosan|mesh-list
110579615|NCT00758394|Fluorides|fluorides|mesh-list
110579616|NCT00758394|Sodium Fluoride|sodium fluoride|mesh-list
110579617|NCT00758394|Fluorophosphate|fluorophosphate|mesh-list
110579618|NCT00758394|Cariostatic Agents|cariostatic agents|mesh-ancestor
110579619|NCT00758394|Protective Agents|protective agents|mesh-ancestor
110579620|NCT00758394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110579621|NCT00758394|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110579622|NCT00758394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110579623|NCT00758394|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
110579624|NCT00758394|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110579625|NCT00758394|Antimetabolites|antimetabolites|mesh-ancestor
110579626|NCT00758394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110579627|NCT00758394|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110579628|NCT04450394|Insulin|insulin|mesh-list
110579629|NCT04450394|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110579630|NCT04450394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110579631|NCT00758160|Methylphenidate|methylphenidate|mesh-list
110579632|NCT00758160|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110579633|NCT00758160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110579634|NCT00758160|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110579635|NCT00758160|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110579636|NCT00758160|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110579637|NCT00758160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110579638|NCT00758160|Dopamine Agents|dopamine agents|mesh-ancestor
110227057|NCT05061134|Durvalumab|durvalumab|mesh-list
110579640|NCT02606552|Aspirin|aspirin|mesh-list
110579641|NCT02606552|Clopidogrel|clopidogrel|mesh-list
110579642|NCT02606552|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110579643|NCT02606552|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110579644|NCT02606552|Analgesics|analgesics|mesh-ancestor
110579645|NCT02606552|Sensory System Agents|sensory system agents|mesh-ancestor
110579646|NCT02606552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110579647|NCT02606552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110579648|NCT02606552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110579649|NCT02606552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110579650|NCT02606552|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110579651|NCT02606552|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110149247|NCT00007605|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110579652|NCT02606552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110579654|NCT02606552|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110579655|NCT02606552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110579656|NCT02606552|Antipyretics|antipyretics|mesh-ancestor
110579657|NCT02606552|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110579658|NCT02606552|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110579659|NCT02606552|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110579660|NCT02606552|Purinergic Agents|purinergic agents|mesh-ancestor
110579661|NCT02606552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110579662|NCT02852486|Pioglitazone|pioglitazone|mesh-list
110579663|NCT02852486|Imatinib Mesylate|imatinib mesylate|mesh-list
110579664|NCT02852486|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110579665|NCT02852486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110579666|NCT02852486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110579667|NCT02852486|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110579668|NCT02852486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110579669|NCT02852486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110579670|NCT02608736|Valproic Acid|valproic acid|mesh-list
110579671|NCT02608736|Anticonvulsants|anticonvulsants|mesh-ancestor
110579672|NCT02608736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110579673|NCT02608736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110579674|NCT02608736|GABA Agents|gaba agents|mesh-ancestor
110579675|NCT02608736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110579676|NCT02608736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110579677|NCT02608736|Antimanic Agents|antimanic agents|mesh-ancestor
110579678|NCT02608736|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110579679|NCT02608736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110579680|NCT02608736|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110579682|NCT02607410|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110579683|NCT02607410|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110579684|NCT02607410|Insulin, Isophane|insulin, isophane|mesh-list
110579685|NCT02607410|Isophane Insulin, Human|isophane insulin, human|mesh-list
110579686|NCT02607410|Isophane insulin, beef|isophane insulin, beef|mesh-list
110579687|NCT02607410|Insulin, Long-Acting|insulin, long-acting|mesh-list
110579688|NCT02607410|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
110579689|NCT02607410|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110579690|NCT02607410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110579691|NCT02607410|Incretins|incretins|mesh-ancestor
110579692|NCT02607410|Hormones|hormones|mesh-ancestor
110579693|NCT02607410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110579694|NCT02607410|Protease Inhibitors|protease inhibitors|mesh-ancestor
110579695|NCT02607410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110579696|NCT02607410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110579697|NCT05693090|Osimertinib|osimertinib|mesh-list
110579698|NCT05693090|Tipifarnib|tipifarnib|mesh-list
110579699|NCT05693090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110579700|NCT05693090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110579701|NCT05693090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110579702|NCT05693090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110579703|NCT00751296|Lenalidomide|lenalidomide|mesh-list
110579704|NCT00751296|Immunologic Factors|immunologic factors|mesh-ancestor
110579705|NCT00751296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110579706|NCT00751296|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110579707|NCT00751296|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110579708|NCT00751296|Growth Substances|growth substances|mesh-ancestor
110579709|NCT00751296|Growth Inhibitors|growth inhibitors|mesh-ancestor
110579710|NCT00751296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110579711|NCT04093518|Estradiol|estradiol|mesh-list
110579712|NCT04093518|Estrogens|estrogens|mesh-ancestor
110579713|NCT04093518|Hormones|hormones|mesh-ancestor
110579714|NCT04093518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110579715|NCT04093518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110579716|NCT02606084|Esketamine|esketamine|mesh-list
110579717|NCT02606084|Antidepressive Agents|antidepressive agents|mesh-ancestor
110579718|NCT02606084|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110579719|NCT02607488|Lidocaine|lidocaine|mesh-list
110579720|NCT02607488|Anesthetics, Local|anesthetics, local|mesh-ancestor
110579721|NCT02607488|Anesthetics|anesthetics|mesh-ancestor
110579722|NCT02607488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110579723|NCT02607488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110579724|NCT02607488|Sensory System Agents|sensory system agents|mesh-ancestor
110579725|NCT02607488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110579726|NCT02607488|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110579727|NCT02607488|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110579728|NCT02607488|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110579729|NCT02607488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110579730|NCT02607488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110579731|NCT00914498|Lidocaine|lidocaine|mesh-list
110579732|NCT00914498|Anesthetics, Local|anesthetics, local|mesh-ancestor
110579733|NCT00914498|Anesthetics|anesthetics|mesh-ancestor
110579734|NCT00914498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110579735|NCT00914498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110375114|NCT00589953|Epoetin Alfa|epoetin alfa|mesh-list
110579736|NCT00914498|Sensory System Agents|sensory system agents|mesh-ancestor
110579737|NCT00914498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110579738|NCT00914498|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110579739|NCT00914498|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110579740|NCT00914498|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110579741|NCT00914498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110579742|NCT00914498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110579744|NCT00751881|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110579745|NCT00751881|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110579746|NCT00751881|Analgesics|analgesics|mesh-ancestor
110579747|NCT00751881|Sensory System Agents|sensory system agents|mesh-ancestor
110579748|NCT00751881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110579749|NCT00751881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110579750|NCT00751881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110579751|NCT00751881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110579752|NCT00751881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110579753|NCT00751881|Immunologic Factors|immunologic factors|mesh-ancestor
110579754|NCT02599779|Pembrolizumab|pembrolizumab|mesh-list
110579755|NCT02599779|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110579756|NCT02599779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110579757|NCT02599779|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110579758|NCT02599779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110579759|NCT02597556|Albendazole|albendazole|mesh-list
110579760|NCT02597556|Anthelmintics|anthelmintics|mesh-ancestor
110579761|NCT02597556|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110579762|NCT02597556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110579763|NCT02597556|Anticestodal Agents|anticestodal agents|mesh-ancestor
110579764|NCT02597556|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110579765|NCT02597556|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110579766|NCT02597556|Tubulin Modulators|tubulin modulators|mesh-ancestor
110579767|NCT02597556|Antimitotic Agents|antimitotic agents|mesh-ancestor
110579768|NCT02597556|Mitosis Modulators|mitosis modulators|mesh-ancestor
110579769|NCT02597556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110579770|NCT02597556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110579771|NCT02599857|Bisoprolol|bisoprolol|mesh-list
110579772|NCT02599857|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110579773|NCT02599857|Sympatholytics|sympatholytics|mesh-ancestor
110579774|NCT02599857|Autonomic Agents|autonomic agents|mesh-ancestor
110579775|NCT02599857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110579776|NCT02599857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110579777|NCT02599857|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110579778|NCT02599857|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110579779|NCT02599857|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110579780|NCT02599857|Adrenergic Agents|adrenergic agents|mesh-ancestor
110579781|NCT02599857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110579782|NCT02599857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110579783|NCT05406726|Palmidrol|palmidrol|mesh-list
110579784|NCT05406726|Analgesics|analgesics|mesh-ancestor
110579785|NCT05406726|Sensory System Agents|sensory system agents|mesh-ancestor
110227206|NCT04887935|Dapagliflozin|dapagliflozin|mesh-list
110579786|NCT05406726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110579787|NCT05406726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110579788|NCT05406726|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110579789|NCT05406726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110579790|NCT05406726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110579791|NCT05406726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110579793|NCT05406726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110579794|NCT05406726|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
110579795|NCT05406726|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110579796|NCT05406726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110579797|NCT05406726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110579798|NCT05406726|Hormones|hormones|mesh-ancestor
110579799|NCT05406726|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110579800|NCT02599623|Anesthetics|anesthetics|mesh-list
110579801|NCT02599623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110579802|NCT02599623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110579803|NCT02597400|Metformin|metformin|mesh-list
110579804|NCT02597400|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110579805|NCT02597400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110579806|NCT00830063|Naproxen|naproxen|mesh-list
110579807|NCT00830063|Tanezumab|tanezumab|mesh-list
110579808|NCT00830063|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110579809|NCT00830063|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110579810|NCT00830063|Analgesics|analgesics|mesh-ancestor
110579811|NCT00830063|Sensory System Agents|sensory system agents|mesh-ancestor
110579812|NCT00830063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110579813|NCT00830063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110579814|NCT00830063|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110579815|NCT00830063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110579816|NCT00830063|Gout Suppressants|gout suppressants|mesh-ancestor
110579817|NCT00830063|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110579818|NCT00830063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110579819|NCT00830063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110579820|NCT04092621|Amiodarone|amiodarone|mesh-list
110579821|NCT04092621|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110579822|NCT04092621|Vasodilator Agents|vasodilator agents|mesh-ancestor
110579823|NCT04092621|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
110579824|NCT04092621|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110579825|NCT04092621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110579826|NCT04092621|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110579827|NCT04092621|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110579828|NCT04092621|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110579829|NCT04092621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110579830|NCT04092621|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110579831|NCT04092621|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110579832|NCT04092621|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110579834|NCT00751101|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110579835|NCT00751101|Autonomic Agents|autonomic agents|mesh-ancestor
110579836|NCT00751101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110579837|NCT00751101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110579838|NCT00751101|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110579839|NCT00751101|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110579840|NCT00751101|Cholinergic Agents|cholinergic agents|mesh-ancestor
110579841|NCT00751101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110579842|NCT00751101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110579843|NCT04092309|Valsartan|valsartan|mesh-list
110579844|NCT04092309|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
110579845|NCT04092309|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
110579846|NCT04092309|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110579847|NCT04092309|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110579848|NCT04092309|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110579849|NCT04092309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110579850|NCT04092309|Protease Inhibitors|protease inhibitors|mesh-ancestor
110579851|NCT04092309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110579852|NCT02598414|Fluorophosphate|fluorophosphate|mesh-list
110579853|NCT02598414|Cariostatic Agents|cariostatic agents|mesh-ancestor
110579854|NCT02598414|Protective Agents|protective agents|mesh-ancestor
110579855|NCT02598414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110579856|NCT04020003|Simendan|simendan|mesh-list
110579864|NCT04020003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110579866|NCT03977142|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110579867|NCT03977142|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110579868|NCT03977142|Analgesics|analgesics|mesh-ancestor
110579869|NCT03977142|Sensory System Agents|sensory system agents|mesh-ancestor
110579870|NCT03977142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110579871|NCT03977142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110579872|NCT03977142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110375146|NCT00565097|Lanreotide|lanreotide|mesh-list
110579873|NCT03977142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110579875|NCT00751023|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110579876|NCT00751023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110579877|NCT00751023|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
110579878|NCT00751023|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110579879|NCT00751023|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110579880|NCT00751023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110579889|NCT04091412|3-n-butylphthalide|3-n-butylphthalide|mesh-list
110579890|NCT04091412|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110579891|NCT04091412|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110579892|NCT04091412|Protective Agents|protective agents|mesh-ancestor
110579893|NCT04091412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110579894|NCT02599311|Tolterodine Tartrate|tolterodine tartrate|mesh-list
110579895|NCT02599311|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110579896|NCT02599311|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110579897|NCT02599311|Cholinergic Agents|cholinergic agents|mesh-ancestor
110579898|NCT02599311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110579899|NCT02599311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110579900|NCT02599311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110579901|NCT02599311|Urological Agents|urological agents|mesh-ancestor
110579902|NCT00591773|Chlorthalidone|chlorthalidone|mesh-list
110579903|NCT00591773|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
110579904|NCT00591773|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110579905|NCT00591773|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110579906|NCT00591773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110579907|NCT00591773|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110579908|NCT00591773|Diuretics|diuretics|mesh-ancestor
110579909|NCT00591773|Natriuretic Agents|natriuretic agents|mesh-ancestor
110579910|NCT00591773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110579911|NCT00591773|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110579912|NCT00591773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110579913|NCT00750867|Immunoglobulins|immunoglobulins|mesh-list
110579914|NCT00750867|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110579915|NCT00750867|Antibodies|antibodies|mesh-list
110579916|NCT00750867|gamma-Globulins|gamma-globulins|mesh-list
110579917|NCT00750867|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110579918|NCT00750867|Immunologic Factors|immunologic factors|mesh-ancestor
110579919|NCT00750867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110579920|NCT00744042|Immunoglobulin G|immunoglobulin g|mesh-list
110579921|NCT00744042|Immunologic Factors|immunologic factors|mesh-ancestor
110579922|NCT00744042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110579923|NCT04091763|Polidocanol|polidocanol|mesh-list
110579924|NCT04091763|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
110579925|NCT04091763|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110579927|NCT00829829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110579928|NCT00829439|Levodopa|levodopa|mesh-list
110579929|NCT00829439|Carbidopa|carbidopa|mesh-list
110579930|NCT00829439|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110579931|NCT00829439|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110579932|NCT00829439|Dopamine Agents|dopamine agents|mesh-ancestor
110579933|NCT00829439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110579934|NCT00829439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110579935|NCT00829439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110579936|NCT00829439|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
110579937|NCT00829439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110579938|NCT02599077|Dienogest|dienogest|mesh-list
110579939|NCT02599077|Levonorgestrel|levonorgestrel|mesh-list
110579940|NCT02599077|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110579941|NCT02599077|Contraceptive Agents|contraceptive agents|mesh-ancestor
110579942|NCT02599077|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110579943|NCT02599077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110579944|NCT02599077|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110579945|NCT02599077|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110579946|NCT02599077|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110579947|NCT02599077|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110579948|NCT02599077|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110579949|NCT02599077|Hormone Antagonists|hormone antagonists|mesh-ancestor
110579950|NCT02599077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110579951|NCT02599077|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110579952|NCT02599077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110579953|NCT00829283|Orlistat|orlistat|mesh-list
110579954|NCT00829283|Sibutramine|sibutramine|mesh-list
110579955|NCT00829283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110579956|NCT00829283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110579957|NCT00829283|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110579958|NCT00829283|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110579959|NCT00829283|Antidepressive Agents|antidepressive agents|mesh-ancestor
110579960|NCT00829283|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110579961|NCT00829283|Appetite Depressants|appetite depressants|mesh-ancestor
110579962|NCT05758025|Parathyroid Hormone|parathyroid hormone|mesh-list
110579963|NCT05758025|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110579964|NCT05758025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110579965|NCT00706277|Fentanyl|fentanyl|mesh-list
110579966|NCT00706277|Remifentanil|remifentanil|mesh-list
110579967|NCT00706277|Nitrous Oxide|nitrous oxide|mesh-list
110579968|NCT00706277|Propofol|propofol|mesh-list
110579969|NCT00706277|Sevoflurane|sevoflurane|mesh-list
110579970|NCT00706277|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110579971|NCT00706277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110579972|NCT00706277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110579973|NCT00706277|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110579974|NCT00706277|Anesthetics, General|anesthetics, general|mesh-ancestor
110579975|NCT00706277|Anesthetics|anesthetics|mesh-ancestor
110579976|NCT00706277|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110579977|NCT00706277|Narcotics|narcotics|mesh-ancestor
110579978|NCT00706277|Analgesics|analgesics|mesh-ancestor
110579979|NCT00706277|Sensory System Agents|sensory system agents|mesh-ancestor
110579980|NCT00706277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110579981|NCT00706277|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110579982|NCT00706277|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110579983|NCT00706277|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110579984|NCT00706277|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110579985|NCT00749463|Nicotine|nicotine|mesh-list
110579986|NCT00749463|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110579987|NCT00749463|Autonomic Agents|autonomic agents|mesh-ancestor
110579988|NCT00749463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110579989|NCT00749463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110579990|NCT00749463|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110579991|NCT00749463|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110579992|NCT00749463|Cholinergic Agents|cholinergic agents|mesh-ancestor
110579993|NCT00749463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110579994|NCT00749463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110579995|NCT00821327|Gemcitabine|gemcitabine|mesh-list
110579996|NCT00821327|Sunitinib|sunitinib|mesh-list
110579997|NCT00821327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110579998|NCT00821327|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110579999|NCT00821327|Antimetabolites|antimetabolites|mesh-ancestor
110580000|NCT00821327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110580001|NCT00821327|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110580002|NCT00821327|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110580003|NCT00821327|Growth Substances|growth substances|mesh-ancestor
110227427|NCT04680052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110580004|NCT00821327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110580005|NCT00821327|Growth Inhibitors|growth inhibitors|mesh-ancestor
110580006|NCT00821327|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110580007|NCT00821327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110580008|NCT00709007|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
110580009|NCT00709007|Antiviral Agents|antiviral agents|mesh-ancestor
110580010|NCT00709007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110580011|NCT00821093|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110580012|NCT00821093|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110580013|NCT00821093|Autonomic Agents|autonomic agents|mesh-ancestor
110580014|NCT00821093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110580015|NCT00821093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110580016|NCT00821093|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110580017|NCT00821093|Respiratory System Agents|respiratory system agents|mesh-ancestor
110580018|NCT00821093|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110580019|NCT00821093|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110580020|NCT00821093|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110580021|NCT00821093|Adrenergic Agents|adrenergic agents|mesh-ancestor
110580022|NCT00821093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110580023|NCT00821093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110580024|NCT00709163|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
110580025|NCT00709163|Natriuretic Agents|natriuretic agents|mesh-ancestor
110580026|NCT00709163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110580027|NCT02611505|Esketamine|esketamine|mesh-list
110580028|NCT02611505|Antidepressive Agents|antidepressive agents|mesh-ancestor
110580029|NCT02611505|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110580030|NCT00743652|Vaccines|vaccines|mesh-list
110580031|NCT00743652|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110580032|NCT00743652|Immunologic Factors|immunologic factors|mesh-ancestor
110580033|NCT00743652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110580034|NCT00748215|Antidiarrheals|antidiarrheals|mesh-list
110580035|NCT00748215|Loperamide|loperamide|mesh-list
110580036|NCT00748215|Calcium Aluminosilicate|calcium aluminosilicate|mesh-list
110580037|NCT00748215|Calcium|calcium|mesh-list
110580038|NCT00748215|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110580039|NCT00748215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110580040|NCT00748215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110580041|NCT00917163|Sirolimus|sirolimus|mesh-list
110580042|NCT00917163|Everolimus|everolimus|mesh-list
110580043|NCT00917163|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110580044|NCT00917163|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110580045|NCT00917163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110580046|NCT00917163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110580047|NCT00917163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110580048|NCT00917163|Immunologic Factors|immunologic factors|mesh-ancestor
110580049|NCT00917163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110580050|NCT00917163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110580051|NCT00917163|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110580052|NCT00917163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110580053|NCT00917163|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110580054|NCT00917163|Antifungal Agents|antifungal agents|mesh-ancestor
110580055|NCT00749892|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110580056|NCT00749892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110580057|NCT00749892|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110580058|NCT00749892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110580059|NCT00749892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110580060|NCT00749580|Raltegravir Potassium|raltegravir potassium|mesh-list
110580061|NCT00749580|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110580062|NCT00749580|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110580063|NCT00749580|Antiviral Agents|antiviral agents|mesh-ancestor
110580064|NCT00749580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110580065|NCT00749580|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110580066|NCT00749580|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110580067|NCT00749580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110580068|NCT00749580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110580069|NCT00747006|Insulin Lispro|insulin lispro|mesh-list
110580070|NCT00747006|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110580071|NCT00747006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110580072|NCT04091178|Vitamin D|vitamin d|mesh-list
110580073|NCT04091178|Vitamins|vitamins|mesh-ancestor
110580074|NCT04091178|Micronutrients|micronutrients|mesh-ancestor
110580075|NCT04091178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110580076|NCT04091178|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110580077|NCT00917358|Interferons|interferons|mesh-list
110580078|NCT00917358|Interferon-alpha|interferon-alpha|mesh-list
110580079|NCT00917358|Interferon alpha-2|interferon alpha-2|mesh-list
110580080|NCT00917358|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110580081|NCT00917358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110227505|NCT04630756|Acalabrutinib|acalabrutinib|mesh-list
110580082|NCT00917358|Antiviral Agents|antiviral agents|mesh-ancestor
110580083|NCT00917358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110580084|NCT00917358|Immunologic Factors|immunologic factors|mesh-ancestor
110580085|NCT00917358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110580086|NCT00743340|Emtricitabine|emtricitabine|mesh-list
110580087|NCT00743340|Antiviral Agents|antiviral agents|mesh-ancestor
110580088|NCT00743340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110580089|NCT00743340|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110580090|NCT00743340|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110580091|NCT00743340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110580092|NCT00743340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110580093|NCT00743340|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110580094|NCT00743340|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110580095|NCT00749190|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110580096|NCT00749190|Empagliflozin|empagliflozin|mesh-list
110580097|NCT00749190|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110580098|NCT00749190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110580099|NCT00749190|Incretins|incretins|mesh-ancestor
110580100|NCT00749190|Hormones|hormones|mesh-ancestor
110580101|NCT00749190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110580102|NCT00749190|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110580103|NCT00749190|Protease Inhibitors|protease inhibitors|mesh-ancestor
110580104|NCT00749190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110580105|NCT00749190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110580106|NCT00749190|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110580107|NCT00748566|Ziprasidone|ziprasidone|mesh-list
110580108|NCT00748566|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110580109|NCT00748566|Serotonin Agents|serotonin agents|mesh-ancestor
110580110|NCT00748566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110580111|NCT00748566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110580112|NCT00748566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110580113|NCT00748566|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110580114|NCT00748566|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110580115|NCT00748566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110580116|NCT00748566|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110580117|NCT00748566|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110580118|NCT00748566|Dopamine Agents|dopamine agents|mesh-ancestor
110580119|NCT02597166|Sofosbuvir|sofosbuvir|mesh-list
110580120|NCT02597166|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
110580121|NCT02597166|Ledipasvir|ledipasvir|mesh-list
110580122|NCT02597166|Antiviral Agents|antiviral agents|mesh-ancestor
110580123|NCT02597166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110580124|NCT00743106|Fenoldopam|fenoldopam|mesh-list
110580125|NCT00743106|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110580126|NCT00743106|Vasodilator Agents|vasodilator agents|mesh-ancestor
110580127|NCT00743106|Dopamine Agonists|dopamine agonists|mesh-ancestor
110580128|NCT00743106|Dopamine Agents|dopamine agents|mesh-ancestor
110580129|NCT00743106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110580130|NCT00743106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110580131|NCT00743106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110580132|NCT02597322|Axitinib|axitinib|mesh-list
110580133|NCT02597322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110580134|NCT02597322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110580135|NCT02597322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110580136|NCT02597322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110580137|NCT00738699|Paclitaxel|paclitaxel|mesh-list
110580138|NCT00738699|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110580139|NCT00738699|Farletuzumab|farletuzumab|mesh-list
110580140|NCT00738699|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110580141|NCT00738699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110580142|NCT00738699|Tubulin Modulators|tubulin modulators|mesh-ancestor
110580144|NCT00738699|Mitosis Modulators|mitosis modulators|mesh-ancestor
110580145|NCT00738699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110580146|NCT00814307|Tofacitinib|tofacitinib|mesh-list
110580147|NCT00814307|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
110580148|NCT00814307|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110580149|NCT00814307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110580150|NCT00814307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110580151|NCT02596776|Deuterium Oxide|deuterium oxide|mesh-list
110580152|NCT02596776|Propranolol|propranolol|mesh-list
110580153|NCT02596776|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110580154|NCT02596776|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110580155|NCT02596776|Adrenergic Agents|adrenergic agents|mesh-ancestor
110580156|NCT02596776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110580157|NCT02596776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110580159|NCT02596776|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110580160|NCT02596776|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110580161|NCT02596776|Vasodilator Agents|vasodilator agents|mesh-ancestor
110580162|NCT02596776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110580163|NCT02596776|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110580164|NCT02596776|Protective Agents|protective agents|mesh-ancestor
110580165|NCT00748098|Gabapentin|gabapentin|mesh-list
110580166|NCT00748098|Analgesics|analgesics|mesh-ancestor
110580167|NCT00748098|Sensory System Agents|sensory system agents|mesh-ancestor
110580168|NCT00748098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110580169|NCT00748098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110580170|NCT00748098|Anticonvulsants|anticonvulsants|mesh-ancestor
110580171|NCT00748098|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110580172|NCT00748098|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110580173|NCT00748098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110580174|NCT00748098|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110580175|NCT00748098|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110580176|NCT00748098|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110580177|NCT00748098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110580178|NCT00748098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110580179|NCT00748098|Antimanic Agents|antimanic agents|mesh-ancestor
110580180|NCT00813995|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110580181|NCT00813995|Metformin|metformin|mesh-list
110580182|NCT00813995|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110580183|NCT00813995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110580184|NCT00813995|Incretins|incretins|mesh-ancestor
110580185|NCT00813995|Hormones|hormones|mesh-ancestor
110580186|NCT00813995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110580187|NCT00813995|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110580188|NCT00813995|Protease Inhibitors|protease inhibitors|mesh-ancestor
110580189|NCT00813995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110580190|NCT00813995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110580191|NCT00737529|Lenalidomide|lenalidomide|mesh-list
110580192|NCT00737529|Immunologic Factors|immunologic factors|mesh-ancestor
110580193|NCT00737529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110580194|NCT00737529|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110580195|NCT00737529|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110580196|NCT00737529|Growth Substances|growth substances|mesh-ancestor
110580197|NCT00737529|Growth Inhibitors|growth inhibitors|mesh-ancestor
110580198|NCT00737529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110580199|NCT00813917|Varenicline|varenicline|mesh-list
110580200|NCT00813917|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110580201|NCT00813917|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110580202|NCT00813917|Cholinergic Agents|cholinergic agents|mesh-ancestor
110580203|NCT00813917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110580204|NCT00813917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110580205|NCT00813917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110580207|NCT02598102|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110580208|NCT02598102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110580209|NCT02598102|Analgesics|analgesics|mesh-ancestor
110580210|NCT02598102|Sensory System Agents|sensory system agents|mesh-ancestor
110375190|NCT00477165|Serotonin Agents|serotonin agents|mesh-ancestor
110580211|NCT02598102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110580212|NCT02598102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110580213|NCT02598102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110580214|NCT02598102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110580215|NCT02598102|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110580216|NCT02598102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110580217|NCT02598102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110580218|NCT02610647|Anesthetics|anesthetics|mesh-list
110580219|NCT02610647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110580220|NCT02610647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110580221|NCT02595918|Nivolumab|nivolumab|mesh-list
110580222|NCT02595918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110580223|NCT02595918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110580224|NCT02595918|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110580225|NCT02595918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110580226|NCT02595840|Pemetrexed|pemetrexed|mesh-list
110580227|NCT02595840|Afatinib|afatinib|mesh-list
110580228|NCT02595840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110580229|NCT02595840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110580230|NCT02595840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110580231|NCT02595840|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110580232|NCT02595840|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110580233|NCT02595840|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110580234|NCT02594241|Prednisolone|prednisolone|mesh-list
110580235|NCT02594241|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110580236|NCT02594241|Methylprednisolone|methylprednisolone|mesh-list
110580237|NCT02594241|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110580238|NCT02594241|Prednisolone acetate|prednisolone acetate|mesh-list
110580239|NCT02594241|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110580240|NCT02594241|Prednisolone phosphate|prednisolone phosphate|mesh-list
110580241|NCT02594241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110580242|NCT02594241|Glucocorticoids|glucocorticoids|mesh-ancestor
110580243|NCT02594241|Hormones|hormones|mesh-ancestor
110580244|NCT02594241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110580245|NCT02594241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110580246|NCT02594241|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110580247|NCT02594241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110580248|NCT02594241|Antiemetics|antiemetics|mesh-ancestor
110580249|NCT02594241|Autonomic Agents|autonomic agents|mesh-ancestor
110580250|NCT02594241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110580251|NCT02594241|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110580252|NCT02594241|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110580253|NCT02594241|Protective Agents|protective agents|mesh-ancestor
110580254|NCT00585975|Bromfenac|bromfenac|mesh-list
110580255|NCT00585975|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110580256|NCT00585975|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110580257|NCT00585975|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110580258|NCT00585975|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110580259|NCT00585975|Analgesics|analgesics|mesh-ancestor
110580260|NCT00585975|Sensory System Agents|sensory system agents|mesh-ancestor
110580261|NCT00585975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110580262|NCT00585975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110580263|NCT00585975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110580264|NCT00585975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110580265|NCT00918021|Olanzapine|olanzapine|mesh-list
110580266|NCT00918021|Antiemetics|antiemetics|mesh-ancestor
110580267|NCT00918021|Autonomic Agents|autonomic agents|mesh-ancestor
110580268|NCT00918021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110580269|NCT00918021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110580270|NCT00918021|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110580271|NCT00918021|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110580272|NCT00918021|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110149302|NCT00007683|Antipyretics|antipyretics|mesh-ancestor
110580273|NCT00918021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110580274|NCT00918021|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110580275|NCT00918021|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110580276|NCT00918021|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110580277|NCT00918021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110580278|NCT00918021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110580279|NCT00918021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110580280|NCT00918021|Serotonin Agents|serotonin agents|mesh-ancestor
110580282|NCT00585585|Vasodilator Agents|vasodilator agents|mesh-ancestor
110580283|NCT00585585|Histamine Agonists|histamine agonists|mesh-ancestor
110580284|NCT00585585|Histamine Agents|histamine agents|mesh-ancestor
110580285|NCT00585585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110580286|NCT00585585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110580287|NCT00585585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110580288|NCT02593695|Fluoxetine|fluoxetine|mesh-list
110580289|NCT02593695|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110580290|NCT02593695|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110580291|NCT02593695|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110580292|NCT02593695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110580293|NCT02593695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110580294|NCT02593695|Serotonin Agents|serotonin agents|mesh-ancestor
110580295|NCT02593695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110580296|NCT02593695|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110580297|NCT02593695|Antidepressive Agents|antidepressive agents|mesh-ancestor
110580298|NCT02593695|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110580299|NCT02593695|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110580300|NCT02593695|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110580301|NCT02593695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110227750|NCT04404088|Rituximab|rituximab|mesh-list
110580302|NCT00734097|Esomeprazole|esomeprazole|mesh-list
110580303|NCT00734097|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110580304|NCT00734097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110580305|NCT00734097|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110580306|NCT00734097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110580307|NCT00734097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110580308|NCT00819767|Valsartan|valsartan|mesh-list
110580309|NCT00819767|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110580310|NCT00819767|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110580311|NCT00819767|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110580312|NCT00819767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110580313|NCT04088175|Menthol|menthol|mesh-list
110580314|NCT04088175|Nicotine|nicotine|mesh-list
110580315|NCT04088175|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110580316|NCT04088175|Autonomic Agents|autonomic agents|mesh-ancestor
110580317|NCT04088175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110580318|NCT04088175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110580319|NCT04088175|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110580320|NCT04088175|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110580321|NCT04088175|Cholinergic Agents|cholinergic agents|mesh-ancestor
110580322|NCT04088175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110580323|NCT04088175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110580324|NCT04088175|Antipruritics|antipruritics|mesh-ancestor
110580325|NCT04088175|Dermatologic Agents|dermatologic agents|mesh-ancestor
110580326|NCT00733005|Mometasone Furoate|mometasone furoate|mesh-list
110580327|NCT00733005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110580328|NCT00733005|Dermatologic Agents|dermatologic agents|mesh-ancestor
110580329|NCT00733005|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110580330|NCT05756621|Topiramate|topiramate|mesh-list
110580331|NCT05756621|Lacosamide|lacosamide|mesh-list
110580332|NCT05756621|Phenytoin|phenytoin|mesh-list
110580333|NCT05756621|Midazolam|midazolam|mesh-list
110580334|NCT05756621|Ketamine|ketamine|mesh-list
110580335|NCT05756621|Levetiracetam|levetiracetam|mesh-list
110580336|NCT05756621|Thiopental|thiopental|mesh-list
110580337|NCT05756621|Anticonvulsants|anticonvulsants|mesh-list
110580339|NCT05756621|Anesthetics|anesthetics|mesh-list
110580340|NCT05756621|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110580341|NCT05756621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110580342|NCT05756621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110580343|NCT05756621|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110580344|NCT05756621|Anesthetics, General|anesthetics, general|mesh-ancestor
110580345|NCT05756621|Analgesics|analgesics|mesh-ancestor
110580346|NCT05756621|Sensory System Agents|sensory system agents|mesh-ancestor
110580347|NCT05756621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110375203|NCT00476229|Immunologic Factors|immunologic factors|mesh-ancestor
110580348|NCT05756621|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110580349|NCT05756621|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110580350|NCT05756621|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110580351|NCT05756621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110580352|NCT05756621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110580353|NCT05756621|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110580354|NCT05756621|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110580355|NCT05756621|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110580356|NCT05756621|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110580357|NCT05756621|GABA Modulators|gaba modulators|mesh-ancestor
110580358|NCT05756621|GABA Agents|gaba agents|mesh-ancestor
110580359|NCT05756621|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110580360|NCT05756621|Nootropic Agents|nootropic agents|mesh-ancestor
110580361|NCT05756621|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110580362|NCT05756621|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110580363|NCT05756621|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110580364|NCT05756621|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110580365|NCT05756621|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110580366|NCT00732381|Mometasone Furoate|mometasone furoate|mesh-list
110580367|NCT00732381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110580368|NCT00732381|Dermatologic Agents|dermatologic agents|mesh-ancestor
110580369|NCT00732381|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110580371|NCT00732303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110580372|NCT00732303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110580373|NCT00732303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110580374|NCT00732303|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110580375|NCT00732303|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110580376|NCT00813761|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110227798|NCT04294628|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110580377|NCT00732069|Valsartan|valsartan|mesh-list
110580379|NCT00732069|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110580380|NCT00732069|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110580381|NCT00732069|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110580382|NCT00732069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110580383|NCT00732069|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110580384|NCT00732069|Protease Inhibitors|protease inhibitors|mesh-ancestor
110580385|NCT00732069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110580386|NCT02593383|Clindamycin|clindamycin|mesh-list
110580387|NCT02593383|Clindamycin palmitate|clindamycin palmitate|mesh-list
110580388|NCT02593383|Clindamycin phosphate|clindamycin phosphate|mesh-list
110580389|NCT02593383|Adapalene|adapalene|mesh-list
110580390|NCT02593383|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110580391|NCT02593383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110580392|NCT02593383|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110580393|NCT02593383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110580394|NCT02593383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110580395|NCT02593383|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110580396|NCT02593383|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110580397|NCT02593383|Analgesics|analgesics|mesh-ancestor
110580398|NCT02593383|Sensory System Agents|sensory system agents|mesh-ancestor
110580399|NCT02593383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110580400|NCT02593383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110580401|NCT02593383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110580402|NCT02593383|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110580403|NCT02593383|Dermatologic Agents|dermatologic agents|mesh-ancestor
110580404|NCT00731679|Rifaximin|rifaximin|mesh-list
110580405|NCT00731679|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110580406|NCT00731679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110580407|NCT00731679|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110580408|NCT02609087|Propofol|propofol|mesh-list
110580409|NCT02609087|Sevoflurane|sevoflurane|mesh-list
110580410|NCT02609087|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110191417|NCT00027833|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110580411|NCT02609087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110580412|NCT02609087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110580413|NCT02609087|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110580414|NCT02609087|Anesthetics, General|anesthetics, general|mesh-ancestor
110580415|NCT02609087|Anesthetics|anesthetics|mesh-ancestor
110580416|NCT02609087|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110580417|NCT02609087|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110580418|NCT00731133|Disulfiram|disulfiram|mesh-list
110580419|NCT00731133|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110580420|NCT00731133|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
110580421|NCT00731133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110580422|NCT00731133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110580424|NCT00730275|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110580425|NCT00730275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110580426|NCT00730275|Incretins|incretins|mesh-ancestor
110580427|NCT00730275|Hormones|hormones|mesh-ancestor
110580428|NCT00730275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110580429|NCT00730275|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110580430|NCT00730275|Protease Inhibitors|protease inhibitors|mesh-ancestor
110580431|NCT00730275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110580432|NCT00730275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110580433|NCT04793711|Decanoic acid|decanoic acid|mesh-list
110580434|NCT04793711|Antifungal Agents|antifungal agents|mesh-ancestor
110580435|NCT04793711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110580436|NCT00729651|Cholecalciferol|cholecalciferol|mesh-list
110580437|NCT00729651|Vitamin D|vitamin d|mesh-list
110580438|NCT00729651|Alendronate|alendronate|mesh-list
110580439|NCT00729651|Calcium|calcium|mesh-list
110580440|NCT00729651|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110580441|NCT00729651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110580442|NCT00729651|Vitamins|vitamins|mesh-ancestor
110580443|NCT00729651|Micronutrients|micronutrients|mesh-ancestor
110580444|NCT00729651|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110580445|NCT00729183|Calcium, Dietary|calcium, dietary|mesh-list
110580446|NCT00729183|Vitamin D|vitamin d|mesh-list
110580447|NCT00729183|Cholecalciferol|cholecalciferol|mesh-list
110580448|NCT00729183|Calcium Carbonate|calcium carbonate|mesh-list
110580449|NCT00729183|Calcium|calcium|mesh-list
110580450|NCT00729183|Vitamins|vitamins|mesh-ancestor
110580451|NCT00729183|Micronutrients|micronutrients|mesh-ancestor
110580452|NCT00729183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110580453|NCT00729183|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110580454|NCT00729183|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110580455|NCT00729183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110580456|NCT00729183|Antacids|antacids|mesh-ancestor
110580457|NCT00729183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110580458|NCT00811733|Ofatumumab|ofatumumab|mesh-list
110580459|NCT00811733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110580460|NCT00728949|Tamoxifen|tamoxifen|mesh-list
110580461|NCT00728949|Letrozole|letrozole|mesh-list
110580462|NCT00728949|Fulvestrant|fulvestrant|mesh-list
110580463|NCT00728949|Anastrozole|anastrozole|mesh-list
110580464|NCT00728949|Exemestane|exemestane|mesh-list
110580465|NCT00728949|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110580466|NCT00728949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110580467|NCT00728949|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110580468|NCT00728949|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110580469|NCT00728949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110580470|NCT00728949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110580471|NCT00728949|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110580472|NCT00728949|Hormone Antagonists|hormone antagonists|mesh-ancestor
110580473|NCT00728949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110580474|NCT00728949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110580475|NCT00728949|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110580476|NCT00728949|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110580477|NCT00728949|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110580478|NCT00728949|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110580479|NCT00728949|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110580480|NCT00728949|Immunologic Factors|immunologic factors|mesh-ancestor
110580481|NCT00918177|Levodopa|levodopa|mesh-list
110580482|NCT00918177|Carbidopa|carbidopa|mesh-list
110580483|NCT00918177|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
110580484|NCT00918177|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110580485|NCT00918177|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110580486|NCT00918177|Dopamine Agents|dopamine agents|mesh-ancestor
110580487|NCT00918177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110580488|NCT00918177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110580489|NCT00918177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110580490|NCT00918177|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
110580491|NCT00918177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110580492|NCT00918177|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110580493|NCT00918177|Immunologic Factors|immunologic factors|mesh-ancestor
110580494|NCT00918177|Dopamine Agonists|dopamine agonists|mesh-ancestor
110580496|NCT00728481|Esomeprazole|esomeprazole|mesh-list
110580497|NCT00728481|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110580498|NCT00728481|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110580499|NCT00728481|Autonomic Agents|autonomic agents|mesh-ancestor
110580501|NCT00728481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110580502|NCT00728481|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110580503|NCT00728481|Respiratory System Agents|respiratory system agents|mesh-ancestor
110580504|NCT00728481|Glucocorticoids|glucocorticoids|mesh-ancestor
110580505|NCT00728481|Hormones|hormones|mesh-ancestor
110580506|NCT00728481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110580507|NCT00728481|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110580508|NCT00728481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110580509|NCT00728481|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110580510|NCT00728481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110580511|NCT00728481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110580512|NCT02593227|Cyclophosphamide|cyclophosphamide|mesh-list
110580513|NCT02593227|Vaccines|vaccines|mesh-list
110580514|NCT02593227|Immunologic Factors|immunologic factors|mesh-ancestor
110580515|NCT02593227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110580516|NCT02593227|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110580517|NCT02593227|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110580518|NCT02593227|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110580519|NCT02593227|Alkylating Agents|alkylating agents|mesh-ancestor
110580520|NCT02593227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110580521|NCT02593227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110580522|NCT02593227|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110580523|NCT04030481|Anesthetics|anesthetics|mesh-list
110580524|NCT04030481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110580525|NCT04030481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110580526|NCT02592915|Clonidine|clonidine|mesh-list
110580527|NCT02592915|Anesthetics|anesthetics|mesh-list
110580528|NCT02592915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110580529|NCT02592915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110580530|NCT02592915|Analgesics|analgesics|mesh-ancestor
110580531|NCT02592915|Sensory System Agents|sensory system agents|mesh-ancestor
110580532|NCT02592915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110580533|NCT02592915|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110580534|NCT02592915|Sympatholytics|sympatholytics|mesh-ancestor
110580535|NCT02592915|Autonomic Agents|autonomic agents|mesh-ancestor
110580536|NCT02592915|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110580537|NCT02592915|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110580538|NCT02592915|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110580539|NCT02592915|Adrenergic Agents|adrenergic agents|mesh-ancestor
110580540|NCT02592915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110580541|NCT02592915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110580542|NCT00727311|Ribavirin|ribavirin|mesh-list
110580543|NCT00727311|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110580544|NCT00727311|Interferon-alpha|interferon-alpha|mesh-list
110580545|NCT00727311|Antimetabolites|antimetabolites|mesh-ancestor
110580546|NCT00727311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110580547|NCT00727311|Antiviral Agents|antiviral agents|mesh-ancestor
110580548|NCT00727311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110580549|NCT00727311|Immunologic Factors|immunologic factors|mesh-ancestor
110580550|NCT00727311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110580551|NCT00726999|Morphine|morphine|mesh-list
110580553|NCT00726999|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110580554|NCT00726999|Narcotics|narcotics|mesh-ancestor
110580555|NCT00726999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110580556|NCT00726999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110580557|NCT00726999|Analgesics|analgesics|mesh-ancestor
110580558|NCT00726999|Sensory System Agents|sensory system agents|mesh-ancestor
110580559|NCT00726999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110580560|NCT00726999|Anticonvulsants|anticonvulsants|mesh-ancestor
110580561|NCT00726999|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110580562|NCT00726999|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110580563|NCT00726999|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110580564|NCT00726999|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110580565|NCT00726999|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110580566|NCT00726999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110580567|NCT00726999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110580568|NCT00726999|Antimanic Agents|antimanic agents|mesh-ancestor
110580569|NCT00585351|Ranitidine|ranitidine|mesh-list
110580570|NCT00585351|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
110580571|NCT00585351|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110580572|NCT00585351|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110580573|NCT00585351|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110580574|NCT00585351|Histamine Antagonists|histamine antagonists|mesh-ancestor
110580576|NCT00585351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110580577|NCT00585351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110580578|NCT00585351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110580579|NCT00726609|Posaconazole|posaconazole|mesh-list
110580580|NCT00726609|Antifungal Agents|antifungal agents|mesh-ancestor
110580581|NCT00726609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110580582|NCT00726609|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
110580583|NCT00726609|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110580584|NCT00726609|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110580585|NCT00726609|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110580586|NCT00726609|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110580587|NCT00726609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110580588|NCT00726609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110580589|NCT00726609|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110580590|NCT00726609|Hormone Antagonists|hormone antagonists|mesh-ancestor
110580591|NCT00726609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110580592|NCT00726609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110580593|NCT00808028|Vaccines|vaccines|mesh-list
110580594|NCT00808028|Immunologic Factors|immunologic factors|mesh-ancestor
110580595|NCT00808028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110580596|NCT03466346|Fluoxetine|fluoxetine|mesh-list
110580597|NCT03466346|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110580598|NCT03466346|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110580599|NCT03466346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110580600|NCT03466346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110580601|NCT03466346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110580602|NCT03466346|Serotonin Agents|serotonin agents|mesh-ancestor
110580603|NCT03466346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110580604|NCT03466346|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110580605|NCT03466346|Antidepressive Agents|antidepressive agents|mesh-ancestor
110580606|NCT03466346|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110580607|NCT03466346|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110580608|NCT03466346|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110580609|NCT03466346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110580610|NCT05754242|Ascorbic Acid|ascorbic acid|mesh-list
110580611|NCT05754242|Vitamins|vitamins|mesh-ancestor
110580612|NCT05754242|Micronutrients|micronutrients|mesh-ancestor
110580613|NCT05754242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110580614|NCT05754242|Antioxidants|antioxidants|mesh-ancestor
110580615|NCT05754242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110580616|NCT05754242|Protective Agents|protective agents|mesh-ancestor
110580618|NCT00809783|Analgesics|analgesics|mesh-ancestor
110580619|NCT00809783|Sensory System Agents|sensory system agents|mesh-ancestor
110580620|NCT00809783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110580621|NCT00809783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110580622|NCT05675462|Lenvatinib|lenvatinib|mesh-list
110580623|NCT05675462|Tislelizumab|tislelizumab|mesh-list
110580624|NCT05675462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110580625|NCT05675462|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110580626|NCT05675462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110580627|NCT05675462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110580628|NCT05675462|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110580629|NCT02608658|Immunoglobulins|immunoglobulins|mesh-list
110580630|NCT02608658|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110580631|NCT02608658|Antibodies|antibodies|mesh-list
110580632|NCT02608658|Immunologic Factors|immunologic factors|mesh-ancestor
110580633|NCT02608658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110580634|NCT00807248|Gaboxadol|gaboxadol|mesh-list
110580635|NCT00807248|Dexetimide|dexetimide|mesh-list
110580636|NCT00807248|Citalopram|citalopram|mesh-list
110580637|NCT00807248|Escitalopram|escitalopram|mesh-list
110580638|NCT00807248|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110580639|NCT00807248|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110580640|NCT00807248|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110580641|NCT00807248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110580642|NCT00807248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110580643|NCT00807248|Serotonin Agents|serotonin agents|mesh-ancestor
110580644|NCT00807248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110580645|NCT00807248|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110580646|NCT00807248|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110580647|NCT00807248|Parasympatholytics|parasympatholytics|mesh-ancestor
110580648|NCT00807248|Autonomic Agents|autonomic agents|mesh-ancestor
110580649|NCT00807248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110580650|NCT00807248|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110580651|NCT00807248|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110580652|NCT00807248|Cholinergic Agents|cholinergic agents|mesh-ancestor
110580653|NCT00807248|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110580654|NCT00807248|Antidepressive Agents|antidepressive agents|mesh-ancestor
110580655|NCT00807248|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110580656|NCT00807248|Analgesics|analgesics|mesh-ancestor
110580657|NCT00807248|Sensory System Agents|sensory system agents|mesh-ancestor
110580658|NCT00807248|Anticonvulsants|anticonvulsants|mesh-ancestor
110580659|NCT00807248|GABA Agonists|gaba agonists|mesh-ancestor
110580660|NCT00807248|GABA Agents|gaba agents|mesh-ancestor
110580661|NCT02607332|Paclitaxel|paclitaxel|mesh-list
110580662|NCT02607332|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110580663|NCT02607332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110580664|NCT02607332|Tubulin Modulators|tubulin modulators|mesh-ancestor
110580665|NCT02607332|Antimitotic Agents|antimitotic agents|mesh-ancestor
110580666|NCT02607332|Mitosis Modulators|mitosis modulators|mesh-ancestor
110580667|NCT02607332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110580668|NCT03356756|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110580669|NCT03356756|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110580670|NCT03356756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110580671|NCT05297669|Biphenylylacetic acid|biphenylylacetic acid|mesh-list
110580672|NCT05297669|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110580673|NCT05297669|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110580674|NCT05297669|Analgesics|analgesics|mesh-ancestor
110580675|NCT05297669|Sensory System Agents|sensory system agents|mesh-ancestor
110580676|NCT05297669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110580677|NCT05297669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110580678|NCT05297669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110580679|NCT05297669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110580680|NCT00589628|Infliximab|infliximab|mesh-list
110580681|NCT00589628|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110580682|NCT00589628|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110580683|NCT00589628|Dermatologic Agents|dermatologic agents|mesh-ancestor
110580684|NCT00589628|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110580685|NCT00589628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110580686|NCT05754983|Immunomodulating Agents|immunomodulating agents|mesh-list
110580687|NCT05754983|Immunologic Factors|immunologic factors|mesh-ancestor
110580688|NCT05754983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110580689|NCT00914576|Vitamins|vitamins|mesh-list
110149333|NCT00006229|Paclitaxel|paclitaxel|mesh-list
110580690|NCT00914576|Micronutrients|micronutrients|mesh-ancestor
110580691|NCT00914576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110580692|NCT00914654|Formoterol Fumarate|formoterol fumarate|mesh-list
110580693|NCT00914654|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110580694|NCT00914654|Autonomic Agents|autonomic agents|mesh-ancestor
110580695|NCT00914654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110580696|NCT00914654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110580697|NCT00914654|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110580698|NCT00914654|Respiratory System Agents|respiratory system agents|mesh-ancestor
110580699|NCT00914654|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110580700|NCT00914654|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110580701|NCT00914654|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110580702|NCT00914654|Adrenergic Agents|adrenergic agents|mesh-ancestor
110580703|NCT00914654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110580704|NCT00914654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110580705|NCT02605772|Metformin|metformin|mesh-list
110580706|NCT02605772|Saxagliptin|saxagliptin|mesh-list
110580707|NCT02605772|Acarbose|acarbose|mesh-list
110580708|NCT02605772|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110580709|NCT02605772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110580710|NCT02605772|Incretins|incretins|mesh-ancestor
110580711|NCT02605772|Hormones|hormones|mesh-ancestor
110580712|NCT02605772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110580713|NCT02605772|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110580714|NCT02605772|Protease Inhibitors|protease inhibitors|mesh-ancestor
110580715|NCT02605772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110580716|NCT02605772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110580717|NCT02605772|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
110580718|NCT04115462|Morphine|morphine|mesh-list
110580719|NCT04115462|Histamine|histamine|mesh-list
110580720|NCT04115462|Histamine phosphate|histamine phosphate|mesh-list
110580721|NCT04115462|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110580722|NCT04115462|Narcotics|narcotics|mesh-ancestor
110580723|NCT04115462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110580724|NCT04115462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110580725|NCT04115462|Analgesics|analgesics|mesh-ancestor
110580726|NCT04115462|Sensory System Agents|sensory system agents|mesh-ancestor
110580727|NCT04115462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110580728|NCT04115462|Histamine Agonists|histamine agonists|mesh-ancestor
110580729|NCT04115462|Histamine Agents|histamine agents|mesh-ancestor
110580730|NCT04115462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110580731|NCT04115462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110580732|NCT02605460|Plerixafor|plerixafor|mesh-list
110580733|NCT02605460|Cyclophosphamide|cyclophosphamide|mesh-list
110580734|NCT02605460|Busulfan|busulfan|mesh-list
110580735|NCT02605460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110580736|NCT02605460|Immunologic Factors|immunologic factors|mesh-ancestor
110580737|NCT02605460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110580738|NCT02605460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110580739|NCT02605460|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110580740|NCT02605460|Alkylating Agents|alkylating agents|mesh-ancestor
110580741|NCT02605460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110580742|NCT02605460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110580743|NCT02605460|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110580744|NCT02605460|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110580745|NCT02605460|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110580746|NCT02605460|Antiviral Agents|antiviral agents|mesh-ancestor
110580747|NCT02605460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110580748|NCT00797108|Amoxicillin|amoxicillin|mesh-list
110580749|NCT00797108|Ceftriaxone|ceftriaxone|mesh-list
110580750|NCT00797108|Clavulanic Acid|clavulanic acid|mesh-list
110580752|NCT00797108|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
110580753|NCT00797108|Lactams|lactams|mesh-list
110580754|NCT00797108|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110580755|NCT00797108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110580756|NCT00797108|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110580757|NCT00797108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110580758|NCT00797108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110580759|NCT00742560|Dexamethasone|dexamethasone|mesh-list
110580760|NCT00742560|Dexamethasone acetate|dexamethasone acetate|mesh-list
110580761|NCT00742560|Lenalidomide|lenalidomide|mesh-list
110580762|NCT00742560|Elotuzumab|elotuzumab|mesh-list
110580763|NCT00742560|BB 1101|bb 1101|mesh-list
110580764|NCT00742560|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110580765|NCT00742560|Antiemetics|antiemetics|mesh-ancestor
110580766|NCT00742560|Autonomic Agents|autonomic agents|mesh-ancestor
110580767|NCT00742560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110580768|NCT00742560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110580769|NCT00742560|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110580770|NCT00742560|Glucocorticoids|glucocorticoids|mesh-ancestor
110580771|NCT00742560|Hormones|hormones|mesh-ancestor
110580772|NCT00742560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110580773|NCT00742560|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110580774|NCT00742560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110580775|NCT00742560|Protease Inhibitors|protease inhibitors|mesh-ancestor
110580776|NCT00742560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110580777|NCT00742560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110580778|NCT00742560|Immunologic Factors|immunologic factors|mesh-ancestor
110580779|NCT00742560|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110580780|NCT00742560|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110580781|NCT00742560|Growth Substances|growth substances|mesh-ancestor
110580782|NCT00742560|Growth Inhibitors|growth inhibitors|mesh-ancestor
110580783|NCT02604914|Levodopa|levodopa|mesh-list
110580784|NCT02604914|Carbidopa|carbidopa|mesh-list
110580785|NCT02604914|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
110580786|NCT02604914|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110580787|NCT02604914|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110580788|NCT02604914|Dopamine Agents|dopamine agents|mesh-ancestor
110580789|NCT02604914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110580790|NCT02604914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110580791|NCT02604914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110580792|NCT02604914|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
110580793|NCT02604914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110580794|NCT02604914|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110580795|NCT02604914|Immunologic Factors|immunologic factors|mesh-ancestor
110580796|NCT02604914|Dopamine Agonists|dopamine agonists|mesh-ancestor
110580797|NCT00796718|Capecitabine|capecitabine|mesh-list
110580798|NCT00796718|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110580799|NCT00796718|Antimetabolites|antimetabolites|mesh-ancestor
110580800|NCT00796718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110580801|NCT00796718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110580802|NCT00745368|Raltegravir Potassium|raltegravir potassium|mesh-list
110580803|NCT00745368|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110580804|NCT00745368|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110580805|NCT00745368|Antiviral Agents|antiviral agents|mesh-ancestor
110580806|NCT00745368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110580807|NCT00745368|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110580808|NCT00745368|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110580809|NCT00745368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110580810|NCT00745368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110580811|NCT04025840|Dexamethasone|dexamethasone|mesh-list
110580812|NCT04025840|Glucocorticoids|glucocorticoids|mesh-list
110580813|NCT04025840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110580814|NCT04025840|Antiemetics|antiemetics|mesh-ancestor
110580815|NCT04025840|Autonomic Agents|autonomic agents|mesh-ancestor
110580816|NCT04025840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110580817|NCT04025840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110580818|NCT04025840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110580819|NCT04025840|Hormones|hormones|mesh-ancestor
110580820|NCT04025840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110580821|NCT04025840|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110580823|NCT00589472|Vorinostat|vorinostat|mesh-list
110580824|NCT00589472|Leuprolide|leuprolide|mesh-list
110580825|NCT00589472|Goserelin|goserelin|mesh-list
110580826|NCT00589472|Bicalutamide|bicalutamide|mesh-list
110580827|NCT00589472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110580828|NCT00589472|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110580829|NCT00589472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110149344|NCT00006343|Imatinib Mesylate|imatinib mesylate|mesh-list
110580830|NCT00589472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110580832|NCT00589472|Fertility Agents|fertility agents|mesh-ancestor
110580833|NCT00589472|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110580834|NCT00589472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110580835|NCT00589472|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110580836|NCT00589472|Androgen Antagonists|androgen antagonists|mesh-ancestor
110580837|NCT00589472|Hormone Antagonists|hormone antagonists|mesh-ancestor
110580838|NCT00589472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110580839|NCT02608931|Dronabinol|dronabinol|mesh-list
110580840|NCT02608931|Hallucinogens|hallucinogens|mesh-ancestor
110580841|NCT02608931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110580842|NCT02608931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110580843|NCT02608931|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110580844|NCT02608931|Analgesics|analgesics|mesh-ancestor
110580845|NCT02608931|Sensory System Agents|sensory system agents|mesh-ancestor
110580846|NCT02608931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110580847|NCT02608931|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
110580848|NCT02608931|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110580849|NCT02608931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110580850|NCT02608931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110580851|NCT02608931|Hormones|hormones|mesh-ancestor
110580852|NCT02608931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110580853|NCT00744978|Varenicline|varenicline|mesh-list
110580854|NCT00744978|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110580855|NCT00744978|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110580856|NCT00744978|Cholinergic Agents|cholinergic agents|mesh-ancestor
110580857|NCT00744978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110580858|NCT00744978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110580859|NCT00744978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110580861|NCT02595606|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110580862|NCT02595606|Immunologic Factors|immunologic factors|mesh-ancestor
110580863|NCT02595606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110580864|NCT02595606|Viscosupplements|viscosupplements|mesh-ancestor
110580865|NCT02595606|Protective Agents|protective agents|mesh-ancestor
110580866|NCT02609945|Oxazolidinones|oxazolidinones|mesh-list
110580867|NCT02609945|Zolmitriptan|zolmitriptan|mesh-list
110580868|NCT02609945|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110580869|NCT02609945|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110580870|NCT02609945|Serotonin Agents|serotonin agents|mesh-ancestor
110580871|NCT02609945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110580872|NCT02609945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110580873|NCT02609945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110580874|NCT02609945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110580875|NCT02609945|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110580876|NCT02609945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110580877|NCT04570475|Vitamin D|vitamin d|mesh-list
110580878|NCT04570475|Vitamins|vitamins|mesh-ancestor
110580879|NCT04570475|Micronutrients|micronutrients|mesh-ancestor
110580880|NCT04570475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110580881|NCT04570475|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110580882|NCT02609165|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110580883|NCT02609165|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110580884|NCT00739596|Amlodipine|amlodipine|mesh-list
110580885|NCT00739596|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110580886|NCT00739596|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110580887|NCT00739596|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110580888|NCT00739596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110580889|NCT00739596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110580890|NCT00739596|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110580891|NCT00739596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110580892|NCT00739596|Vasodilator Agents|vasodilator agents|mesh-ancestor
110580893|NCT00739596|Diuretics|diuretics|mesh-ancestor
110580894|NCT00739596|Natriuretic Agents|natriuretic agents|mesh-ancestor
110580895|NCT00739596|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110580896|NCT00742326|Pioglitazone|pioglitazone|mesh-list
110580897|NCT00742326|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110580898|NCT00742326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110580900|NCT02597868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110580901|NCT02597868|Antimetabolites|antimetabolites|mesh-ancestor
110580902|NCT02597868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110580903|NCT02597868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110580904|NCT00811187|Lidocaine|lidocaine|mesh-list
110580905|NCT00811187|Anesthetics, Local|anesthetics, local|mesh-ancestor
110580906|NCT00811187|Anesthetics|anesthetics|mesh-ancestor
110580907|NCT00811187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110580908|NCT00811187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110580909|NCT00811187|Sensory System Agents|sensory system agents|mesh-ancestor
110580910|NCT00811187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110580911|NCT00811187|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110580912|NCT00811187|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110580913|NCT00811187|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110580914|NCT00811187|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110580915|NCT00811187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110580916|NCT00917748|Docetaxel|docetaxel|mesh-list
110580917|NCT00917748|Modafinil|modafinil|mesh-list
110580918|NCT00917748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110580919|NCT00917748|Tubulin Modulators|tubulin modulators|mesh-ancestor
110580920|NCT00917748|Antimitotic Agents|antimitotic agents|mesh-ancestor
110580921|NCT00917748|Mitosis Modulators|mitosis modulators|mesh-ancestor
110580922|NCT00917748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110580923|NCT00917748|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110580924|NCT00917748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110580925|NCT00917748|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
110580926|NCT00917748|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110580927|NCT00917748|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110580928|NCT02595138|Zoledronic Acid|zoledronic acid|mesh-list
110580929|NCT02595138|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110580930|NCT02595138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110580931|NCT00591149|Docetaxel|docetaxel|mesh-list
110580932|NCT00591149|Oxaliplatin|oxaliplatin|mesh-list
110580933|NCT00591149|Cetuximab|cetuximab|mesh-list
110580935|NCT00591149|Tubulin Modulators|tubulin modulators|mesh-ancestor
110580936|NCT00591149|Antimitotic Agents|antimitotic agents|mesh-ancestor
110580937|NCT00591149|Mitosis Modulators|mitosis modulators|mesh-ancestor
110580938|NCT00591149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110580939|NCT00591149|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110580940|NCT00735072|Maraviroc|maraviroc|mesh-list
110580941|NCT00735072|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110580942|NCT00735072|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110580943|NCT00735072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110580944|NCT00735072|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110580945|NCT00735072|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110580946|NCT00735072|Antiviral Agents|antiviral agents|mesh-ancestor
110580947|NCT00735072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110580948|NCT00735072|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
110580949|NCT00793598|Brincidofovir|brincidofovir|mesh-list
110580950|NCT00793598|Antiviral Agents|antiviral agents|mesh-ancestor
110580951|NCT00793598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110580952|NCT04115072|Praziquantel|praziquantel|mesh-list
110580953|NCT04115072|Anthelmintics|anthelmintics|mesh-ancestor
110580954|NCT04115072|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110580955|NCT04115072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110580956|NCT00796562|Cyclophosphamide|cyclophosphamide|mesh-list
110580957|NCT00796562|Busulfan|busulfan|mesh-list
110580958|NCT00796562|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110580959|NCT00796562|Immunologic Factors|immunologic factors|mesh-ancestor
110580960|NCT00796562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110580961|NCT00796562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110580962|NCT00796562|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110580963|NCT00796562|Alkylating Agents|alkylating agents|mesh-ancestor
110580964|NCT00796562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110580965|NCT00796562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110580966|NCT00796562|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110580968|NCT00801632|Methylprednisolone|methylprednisolone|mesh-list
110580969|NCT00801632|Cyclophosphamide|cyclophosphamide|mesh-list
110580970|NCT00801632|Rituximab|rituximab|mesh-list
110580971|NCT00801632|Tacrolimus|tacrolimus|mesh-list
110580972|NCT00801632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110580973|NCT00801632|Immunologic Factors|immunologic factors|mesh-ancestor
110580974|NCT00801632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110580975|NCT00801632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110580976|NCT00801632|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110580977|NCT00801632|Alkylating Agents|alkylating agents|mesh-ancestor
110580978|NCT00801632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110580979|NCT00801632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110580980|NCT00801632|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110580981|NCT00801632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110580982|NCT00801632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110580983|NCT00801632|Glucocorticoids|glucocorticoids|mesh-ancestor
110580984|NCT00801632|Hormones|hormones|mesh-ancestor
110580985|NCT00801632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110580986|NCT00801632|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110580987|NCT00801632|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110580988|NCT00801632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110580989|NCT00801632|Antiemetics|antiemetics|mesh-ancestor
110580990|NCT00801632|Autonomic Agents|autonomic agents|mesh-ancestor
110580991|NCT00801632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110580992|NCT00801632|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110580993|NCT00801632|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110580994|NCT00801632|Protective Agents|protective agents|mesh-ancestor
110580995|NCT04111484|Adrenomedullin|adrenomedullin|mesh-list
110580996|NCT04111484|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110580997|NCT04111484|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110580998|NCT04111484|Autonomic Agents|autonomic agents|mesh-ancestor
110580999|NCT04111484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110581000|NCT04111484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110581001|NCT04111484|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110581002|NCT04111484|Respiratory System Agents|respiratory system agents|mesh-ancestor
110581003|NCT04111484|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110581004|NCT04111484|Vasodilator Agents|vasodilator agents|mesh-ancestor
110581005|NCT04111484|Protective Agents|protective agents|mesh-ancestor
110581006|NCT04111328|Sufentanil|sufentanil|mesh-list
110581007|NCT04111328|Dexmedetomidine|dexmedetomidine|mesh-list
110581008|NCT04111328|Dsuvia|dsuvia|mesh-list
110581009|NCT04111328|Hydromorphone|hydromorphone|mesh-list
110581010|NCT04111328|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110581011|NCT04111328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110581013|NCT04111328|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110581014|NCT04111328|Analgesics|analgesics|mesh-ancestor
110581015|NCT04111328|Sensory System Agents|sensory system agents|mesh-ancestor
110581016|NCT04111328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110581017|NCT04111328|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110581018|NCT04111328|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110581019|NCT04111328|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110581020|NCT04111328|Adrenergic Agents|adrenergic agents|mesh-ancestor
110581021|NCT04111328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110581022|NCT04111328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110581023|NCT04111328|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110581024|NCT04111328|Narcotics|narcotics|mesh-ancestor
110581025|NCT04111328|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110581026|NCT04111328|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110581027|NCT04111328|Anesthetics, General|anesthetics, general|mesh-ancestor
110581028|NCT04111328|Anesthetics|anesthetics|mesh-ancestor
110581029|NCT00806819|Folic Acid|folic acid|mesh-list
110581030|NCT00806819|Vitamin B Complex|vitamin b complex|mesh-list
110581031|NCT00806819|Hydroxocobalamin|hydroxocobalamin|mesh-list
110581032|NCT00806819|Vitamin B 12|vitamin b 12|mesh-list
110581033|NCT00806819|Dexamethasone|dexamethasone|mesh-list
110581034|NCT00806819|Dexamethasone acetate|dexamethasone acetate|mesh-list
110581035|NCT00806819|Pemetrexed|pemetrexed|mesh-list
110581036|NCT00806819|Nintedanib|nintedanib|mesh-list
110581038|NCT00806819|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110581039|NCT00806819|Antiemetics|antiemetics|mesh-ancestor
110581040|NCT00806819|Autonomic Agents|autonomic agents|mesh-ancestor
110581041|NCT00806819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110581042|NCT00806819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110581043|NCT00806819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110581044|NCT00806819|Glucocorticoids|glucocorticoids|mesh-ancestor
110581045|NCT00806819|Hormones|hormones|mesh-ancestor
110581046|NCT00806819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110581047|NCT00806819|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110581048|NCT00806819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110581049|NCT00806819|Protease Inhibitors|protease inhibitors|mesh-ancestor
110581050|NCT00806819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110581051|NCT00806819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110581052|NCT00806819|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110581053|NCT00806819|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110581054|NCT00806819|Hematinics|hematinics|mesh-ancestor
110581055|NCT00806819|Vitamins|vitamins|mesh-ancestor
110581056|NCT00806819|Micronutrients|micronutrients|mesh-ancestor
110581057|NCT00806819|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110581058|NCT04109534|Methacholine Chloride|methacholine chloride|mesh-list
110581059|NCT04109534|Miotics|miotics|mesh-ancestor
110581060|NCT04109534|Autonomic Agents|autonomic agents|mesh-ancestor
110581061|NCT04109534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110581062|NCT04109534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110581063|NCT04109534|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110581064|NCT04109534|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
110581065|NCT04109534|Respiratory System Agents|respiratory system agents|mesh-ancestor
110581066|NCT04109534|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
110581067|NCT04109534|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110581068|NCT04109534|Cholinergic Agents|cholinergic agents|mesh-ancestor
110581069|NCT04109534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110581070|NCT04109534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110581071|NCT05326139|Tranexamic Acid|tranexamic acid|mesh-list
110581072|NCT05326139|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110581073|NCT05326139|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110581074|NCT05326139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110581075|NCT05326139|Hemostatics|hemostatics|mesh-ancestor
110581076|NCT05326139|Coagulants|coagulants|mesh-ancestor
110581077|NCT02605694|Prednisone|prednisone|mesh-list
110581078|NCT02605694|Rituximab|rituximab|mesh-list
110581079|NCT02605694|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110581080|NCT02605694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110581081|NCT02605694|Immunologic Factors|immunologic factors|mesh-ancestor
110581082|NCT02605694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110581083|NCT02605694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110581084|NCT02605694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110581085|NCT02605694|Glucocorticoids|glucocorticoids|mesh-ancestor
110581086|NCT02605694|Hormones|hormones|mesh-ancestor
110581087|NCT02605694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110581088|NCT02605694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110581089|NCT02604134|Silver Nitrate|silver nitrate|mesh-list
110581090|NCT02604134|Fluorides|fluorides|mesh-list
110581091|NCT02604134|Fluorides, Topical|fluorides, topical|mesh-list
110581092|NCT02604134|Cariostatic Agents|cariostatic agents|mesh-ancestor
110581093|NCT02604134|Protective Agents|protective agents|mesh-ancestor
110581094|NCT02604134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110581095|NCT02604134|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110581096|NCT02604134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110581098|NCT00800540|Brimonidine Tartrate|brimonidine tartrate|mesh-list
110581099|NCT00800540|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110581100|NCT00800540|Brinzolamide|brinzolamide|mesh-list
110581101|NCT00800540|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110581102|NCT00800540|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110581103|NCT00800540|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110581104|NCT00800540|Adrenergic Agents|adrenergic agents|mesh-ancestor
110581105|NCT00800540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110581106|NCT00800540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110581107|NCT00800540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110581109|NCT00800540|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110581110|NCT00800540|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110581111|NCT00800540|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110581112|NCT00800540|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110581113|NCT00800540|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110581114|NCT00800540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110581115|NCT00796328|Phenylephrine|phenylephrine|mesh-list
110581116|NCT00796328|Oxymetazoline|oxymetazoline|mesh-list
110581117|NCT00796328|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110581118|NCT00796328|Mydriatics|mydriatics|mesh-ancestor
110581119|NCT00796328|Autonomic Agents|autonomic agents|mesh-ancestor
110581120|NCT00796328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110581121|NCT00796328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110581122|NCT00796328|Sympathomimetics|sympathomimetics|mesh-ancestor
110581123|NCT00796328|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110581124|NCT00796328|Nasal Decongestants|nasal decongestants|mesh-ancestor
110581125|NCT00796328|Respiratory System Agents|respiratory system agents|mesh-ancestor
110581126|NCT00796328|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110581127|NCT00796328|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110581128|NCT00796328|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110581129|NCT00796328|Adrenergic Agents|adrenergic agents|mesh-ancestor
110581130|NCT00796328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110581131|NCT00796328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110581132|NCT00796328|Protective Agents|protective agents|mesh-ancestor
110581133|NCT02605382|Chlorhexidine|chlorhexidine|mesh-list
110581134|NCT02605382|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110581135|NCT02605382|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110581136|NCT02605382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110581137|NCT02605382|Disinfectants|disinfectants|mesh-ancestor
110581138|NCT02605382|Dermatologic Agents|dermatologic agents|mesh-ancestor
110581139|NCT04110860|Voriconazole|voriconazole|mesh-list
110581140|NCT04110860|Antifungal Agents|antifungal agents|mesh-ancestor
110581141|NCT04110860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110581142|NCT04110860|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110581143|NCT04110860|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110581144|NCT04110860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110581145|NCT04110860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110581146|NCT04110860|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110581147|NCT04110860|Hormone Antagonists|hormone antagonists|mesh-ancestor
110581148|NCT04110860|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110581149|NCT04110860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110581150|NCT04110860|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110581151|NCT02604836|Ibandronic Acid|ibandronic acid|mesh-list
110581152|NCT02604836|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110581153|NCT02604836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110581154|NCT04114526|Nicotine|nicotine|mesh-list
110581155|NCT04114526|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110581156|NCT04114526|Autonomic Agents|autonomic agents|mesh-ancestor
110581157|NCT04114526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110581158|NCT04114526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110581159|NCT04114526|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110581160|NCT04114526|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110581161|NCT04114526|Cholinergic Agents|cholinergic agents|mesh-ancestor
110581162|NCT04114526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110581163|NCT04114526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110581165|NCT00915200|Silybin|silybin|mesh-list
110581166|NCT00915200|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110581167|NCT00915200|Antiviral Agents|antiviral agents|mesh-ancestor
110581168|NCT00915200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110581169|NCT00915200|Expectorants|expectorants|mesh-ancestor
110581170|NCT00915200|Respiratory System Agents|respiratory system agents|mesh-ancestor
110581171|NCT00915200|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110581172|NCT00915200|Antioxidants|antioxidants|mesh-ancestor
110581173|NCT00915200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110581174|NCT00915200|Protective Agents|protective agents|mesh-ancestor
110581175|NCT00915200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110581176|NCT00915200|Antidotes|antidotes|mesh-ancestor
110581177|NCT00915200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110581178|NCT00915200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110581179|NCT00588146|Interferons|interferons|mesh-list
110581180|NCT00588146|Interferon-alpha|interferon-alpha|mesh-list
110581181|NCT00588146|Interferon alpha-2|interferon alpha-2|mesh-list
110581182|NCT00588146|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110581183|NCT00588146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110581184|NCT00588146|Antiviral Agents|antiviral agents|mesh-ancestor
110581185|NCT00588146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110581186|NCT00588146|Immunologic Factors|immunologic factors|mesh-ancestor
110581187|NCT00588146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110581188|NCT00444457|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110581189|NCT00444457|Immunologic Factors|immunologic factors|mesh-ancestor
110581190|NCT00444457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110581191|NCT00799058|Dapivirine|dapivirine|mesh-list
110581192|NCT00799058|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110581193|NCT00799058|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110581194|NCT00799058|Antiviral Agents|antiviral agents|mesh-ancestor
110581195|NCT00799058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110581196|NCT00725985|Cladribine|cladribine|mesh-list
110581197|NCT00725985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110581198|NCT00725985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110581199|NCT00725985|Immunologic Factors|immunologic factors|mesh-ancestor
110581200|NCT00725985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110581201|NCT00793910|Gabapentin|gabapentin|mesh-list
110581202|NCT00793910|Analgesics|analgesics|mesh-ancestor
110581203|NCT00793910|Sensory System Agents|sensory system agents|mesh-ancestor
110581204|NCT00793910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110581205|NCT00793910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110581206|NCT00793910|Anticonvulsants|anticonvulsants|mesh-ancestor
110581207|NCT00793910|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110581208|NCT00793910|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110581209|NCT00793910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110581210|NCT00793910|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110581211|NCT00793910|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110581212|NCT00793910|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110581213|NCT00793910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110581214|NCT00793910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110581215|NCT00793910|Antimanic Agents|antimanic agents|mesh-ancestor
110581216|NCT01019941|Docetaxel|docetaxel|mesh-list
110581217|NCT01019941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110581218|NCT01019941|Tubulin Modulators|tubulin modulators|mesh-ancestor
110581219|NCT01019941|Antimitotic Agents|antimitotic agents|mesh-ancestor
110581220|NCT01019941|Mitosis Modulators|mitosis modulators|mesh-ancestor
110581221|NCT01019941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110581222|NCT04113668|Diflunisal|diflunisal|mesh-list
110581223|NCT04113668|Deucravacitinib|deucravacitinib|mesh-list
110581224|NCT04113668|Dermatologic Agents|dermatologic agents|mesh-ancestor
110581225|NCT04113668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110581226|NCT04113668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110581227|NCT04113668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110581228|NCT04113668|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110581229|NCT04113668|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110581230|NCT04113668|Analgesics|analgesics|mesh-ancestor
110581231|NCT04113668|Sensory System Agents|sensory system agents|mesh-ancestor
110581232|NCT04113668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110581233|NCT04113668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110581234|NCT04113668|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110581235|NCT04113668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110581236|NCT04113668|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110581237|NCT00444145|Lansoprazole|lansoprazole|mesh-list
110581238|NCT00444145|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110581239|NCT00444145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110581240|NCT00444145|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110581241|NCT00444145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110581242|NCT00444145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110581244|NCT04107896|Silodosin|silodosin|mesh-list
110581245|NCT04107896|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110581246|NCT04107896|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110581247|NCT04107896|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110581248|NCT04107896|Adrenergic Agents|adrenergic agents|mesh-ancestor
110581249|NCT04107896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110581250|NCT04107896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110581251|NCT04107896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110581252|NCT04107896|Urological Agents|urological agents|mesh-ancestor
110581253|NCT01024777|Vitamin D|vitamin d|mesh-list
110581254|NCT01024777|Ergocalciferols|ergocalciferols|mesh-list
110581255|NCT01024777|Cholecalciferol|cholecalciferol|mesh-list
110581256|NCT01024777|Vitamins|vitamins|mesh-list
110581257|NCT01024777|Micronutrients|micronutrients|mesh-ancestor
110581258|NCT01024777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110581259|NCT01024777|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110581260|NCT01024777|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110581261|NCT00789854|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110581262|NCT00789854|Lithium Carbonate|lithium carbonate|mesh-list
110581263|NCT00789854|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
110581264|NCT00789854|Antidepressive Agents|antidepressive agents|mesh-ancestor
110581265|NCT00789854|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110581266|NCT00789854|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110581267|NCT00789854|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110581268|NCT00789854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110581269|NCT00789854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110581270|NCT00789854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110581271|NCT00789854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110581272|NCT00789854|Antimanic Agents|antimanic agents|mesh-ancestor
110581273|NCT00789854|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110581274|NCT00789854|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110581275|NCT00789854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110581276|NCT00789854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110581277|NCT00789854|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110581278|NCT00725205|Ribavirin|ribavirin|mesh-list
110581279|NCT00725205|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110581280|NCT00725205|Interferon-alpha|interferon-alpha|mesh-list
110581281|NCT00725205|Antimetabolites|antimetabolites|mesh-ancestor
110581282|NCT00725205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110581283|NCT00725205|Antiviral Agents|antiviral agents|mesh-ancestor
110581284|NCT00725205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110581285|NCT00725205|Immunologic Factors|immunologic factors|mesh-ancestor
110581286|NCT00725205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110581287|NCT00443755|Metformin|metformin|mesh-list
110581288|NCT00443755|Pioglitazone|pioglitazone|mesh-list
110581289|NCT00443755|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110581290|NCT00443755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110581291|NCT00724971|Rituximab|rituximab|mesh-list
110581292|NCT00724971|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
110581293|NCT00724971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110581294|NCT00724971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110581295|NCT00724971|Immunologic Factors|immunologic factors|mesh-ancestor
110581296|NCT00724971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110581297|NCT00724971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110581298|NCT00724971|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110581299|NCT00724971|Immunotoxins|immunotoxins|mesh-ancestor
110581300|NCT00724971|Immunoconjugates|immunoconjugates|mesh-ancestor
110581301|NCT00443599|Insulin|insulin|mesh-list
110581302|NCT00443599|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110581303|NCT00443599|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110581304|NCT00443599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110581305|NCT04107428|Somatostatin|somatostatin|mesh-list
110581306|NCT04107428|Hormones|hormones|mesh-ancestor
110581307|NCT04107428|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110581308|NCT04107428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110581309|NCT00455143|Dexmedetomidine|dexmedetomidine|mesh-list
110581310|NCT00455143|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110581311|NCT00455143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110581312|NCT00455143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110581313|NCT00455143|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110581314|NCT00455143|Analgesics|analgesics|mesh-ancestor
110581315|NCT00455143|Sensory System Agents|sensory system agents|mesh-ancestor
110581316|NCT00455143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110581317|NCT00455143|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110581318|NCT00455143|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110581319|NCT00455143|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110581320|NCT00455143|Adrenergic Agents|adrenergic agents|mesh-ancestor
110581321|NCT00455143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110581322|NCT00455143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110581323|NCT00724893|Interferons|interferons|mesh-list
110581324|NCT00724893|Ribavirin|ribavirin|mesh-list
110581325|NCT00724893|Interferon-alpha|interferon-alpha|mesh-list
110581326|NCT00724893|Interferon alpha-2|interferon alpha-2|mesh-list
110581327|NCT00724893|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110581328|NCT00724893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110581329|NCT00724893|Antiviral Agents|antiviral agents|mesh-ancestor
110581330|NCT00724893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110581331|NCT00724893|Antimetabolites|antimetabolites|mesh-ancestor
110581332|NCT00724893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110581333|NCT00724893|Immunologic Factors|immunologic factors|mesh-ancestor
110581334|NCT00724893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110581335|NCT00789698|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110581336|NCT00789698|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
110581337|NCT00789698|Antidepressive Agents|antidepressive agents|mesh-ancestor
110581338|NCT00789698|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110581339|NCT00789698|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110581340|NCT00789698|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110581341|NCT00789698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110581342|NCT00789698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110581343|NCT00789698|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
110581344|NCT00789698|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110581345|NCT00789698|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110581346|NCT00789698|Adrenergic Agents|adrenergic agents|mesh-ancestor
110581347|NCT00789698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110581348|NCT00789698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110581349|NCT00789698|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110581350|NCT00789698|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110581351|NCT00789698|Serotonin Agents|serotonin agents|mesh-ancestor
110581352|NCT00789698|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110581353|NCT00789698|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110581354|NCT00789698|Dopamine Agents|dopamine agents|mesh-ancestor
110581355|NCT00724815|Sumatriptan|sumatriptan|mesh-list
110581356|NCT00724815|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110581357|NCT00724815|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110581358|NCT00724815|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110581359|NCT00724815|Serotonin Agents|serotonin agents|mesh-ancestor
110581360|NCT00724815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110581361|NCT00724815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110581362|NCT00724815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110581363|NCT00798590|Glucagon|glucagon|mesh-list
110581364|NCT00798590|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
110581365|NCT00798590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110581366|NCT00798590|Hormones|hormones|mesh-ancestor
110581367|NCT00798590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110581368|NCT00798590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110581369|NCT00798590|Incretins|incretins|mesh-ancestor
110581370|NCT00481195|Modafinil|modafinil|mesh-list
110581371|NCT00481195|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110581372|NCT00481195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110581373|NCT00481195|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
110581374|NCT00481195|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110581375|NCT00481195|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110581376|NCT00481195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110581377|NCT03604549|Ethiodized Oil|ethiodized oil|mesh-list
110581378|NCT03604549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110581379|NCT01027429|Amoxicillin|amoxicillin|mesh-list
110581380|NCT01027429|Gentamicins|gentamicins|mesh-list
110581381|NCT01027429|Penicillins|penicillins|mesh-list
110581382|NCT01027429|Penicillin G Procaine|penicillin g procaine|mesh-list
110581383|NCT01027429|Penicillin G|penicillin g|mesh-list
110581384|NCT01027429|Penicillin G Benzathine|penicillin g benzathine|mesh-list
110581385|NCT01027429|Procaine|procaine|mesh-list
110581386|NCT01027429|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110581387|NCT01027429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110581388|NCT01027429|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110581389|NCT01027429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110581390|NCT01027429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110581391|NCT01027429|Anesthetics, Local|anesthetics, local|mesh-ancestor
110581392|NCT01027429|Anesthetics|anesthetics|mesh-ancestor
110581393|NCT01027429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110581394|NCT01027429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110581395|NCT01027429|Sensory System Agents|sensory system agents|mesh-ancestor
110581396|NCT01027429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110581397|NCT01020253|Alendronate|alendronate|mesh-list
110581398|NCT01020253|Alfacalcidol|alfacalcidol|mesh-list
110581399|NCT01020253|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
110581400|NCT01020253|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110581401|NCT01020253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110581402|NCT01020253|Vitamins|vitamins|mesh-ancestor
110581403|NCT01020253|Micronutrients|micronutrients|mesh-ancestor
110581404|NCT00454207|Sildenafil Citrate|sildenafil citrate|mesh-list
110581405|NCT00454207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110581406|NCT00454207|Vasodilator Agents|vasodilator agents|mesh-ancestor
110581407|NCT00454207|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110581408|NCT00454207|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110581409|NCT00454207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110581410|NCT00454207|Urological Agents|urological agents|mesh-ancestor
110581411|NCT01020331|Memantine|memantine|mesh-list
110581412|NCT01020331|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110581413|NCT01020331|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110581414|NCT01020331|Dopamine Agents|dopamine agents|mesh-ancestor
110581415|NCT01020331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110581416|NCT01020331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110581417|NCT01020331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110581418|NCT01020331|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110581419|NCT01020331|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110581420|NCT00738894|Dipyridamole|dipyridamole|mesh-list
110581421|NCT00738894|Clopidogrel|clopidogrel|mesh-list
110581422|NCT00738894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110581423|NCT00738894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110581424|NCT00738894|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110581425|NCT00738894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110581426|NCT00738894|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110581427|NCT00738894|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110581428|NCT00738894|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110581429|NCT00738894|Purinergic Agents|purinergic agents|mesh-ancestor
110581430|NCT00738894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110581431|NCT00738894|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110581432|NCT00738894|Vasodilator Agents|vasodilator agents|mesh-ancestor
110581433|NCT00734994|Mitomycins|mitomycins|mesh-list
110581434|NCT00734994|Mitomycin|mitomycin|mesh-list
110581435|NCT00734994|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110375391|NCT00473694|Glycopyrrolate|glycopyrrolate|mesh-list
110581436|NCT00734994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110581437|NCT00734994|Alkylating Agents|alkylating agents|mesh-ancestor
110581438|NCT00734994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110581439|NCT00734994|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110581440|NCT00734994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110581441|NCT02593734|Olanzapine|olanzapine|mesh-list
110581442|NCT02593734|Risperidone|risperidone|mesh-list
110581443|NCT02593734|Fluoxetine|fluoxetine|mesh-list
110581444|NCT02593734|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110581445|NCT02593734|Serotonin Agents|serotonin agents|mesh-ancestor
110581446|NCT02593734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110581447|NCT02593734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110581448|NCT02593734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110581449|NCT02593734|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110581450|NCT02593734|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110581451|NCT02593734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110581452|NCT02593734|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110581453|NCT02593734|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110581454|NCT02593734|Dopamine Agents|dopamine agents|mesh-ancestor
110581455|NCT02593734|Antiemetics|antiemetics|mesh-ancestor
110581456|NCT02593734|Autonomic Agents|autonomic agents|mesh-ancestor
110581457|NCT02593734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110581458|NCT02593734|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110581459|NCT02593734|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110581460|NCT02593734|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110581461|NCT02593734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110581462|NCT02593734|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110581463|NCT02593734|Antidepressive Agents|antidepressive agents|mesh-ancestor
110581464|NCT02593734|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110581465|NCT02593734|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110581466|NCT02593734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110581467|NCT00798434|Fesoterodine|fesoterodine|mesh-list
110581468|NCT00798434|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110581469|NCT00798434|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110581470|NCT00798434|Cholinergic Agents|cholinergic agents|mesh-ancestor
110581471|NCT00798434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110581472|NCT00798434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110581473|NCT00798434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110581474|NCT00798434|Urological Agents|urological agents|mesh-ancestor
110581475|NCT04106804|Abatacept|abatacept|mesh-list
110581476|NCT04106804|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110581477|NCT04106804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110581478|NCT04106804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110581479|NCT04106804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110581480|NCT04106804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110581481|NCT04106804|Immunologic Factors|immunologic factors|mesh-ancestor
110581482|NCT04106804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110581483|NCT04106804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110581484|NCT00791648|Atorvastatin|atorvastatin|mesh-list
110581485|NCT00791648|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110581486|NCT00791648|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110581487|NCT00791648|Antimetabolites|antimetabolites|mesh-ancestor
110581488|NCT00791648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110581489|NCT00791648|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110581490|NCT00791648|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110581491|NCT00791648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110581492|NCT05366595|Zinc Sulfate|zinc sulfate|mesh-list
110581493|NCT05366595|Astringents|astringents|mesh-ancestor
110581494|NCT05366595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110581495|NCT05366595|Dermatologic Agents|dermatologic agents|mesh-ancestor
110581496|NCT04087239|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
110581497|NCT04087239|Antiviral Agents|antiviral agents|mesh-ancestor
110581498|NCT04087239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110581499|NCT04017338|Ezetimibe|ezetimibe|mesh-list
110581500|NCT04017338|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110581501|NCT04017338|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110581502|NCT04017338|Antimetabolites|antimetabolites|mesh-ancestor
110581503|NCT04017338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110581504|NCT04017338|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110581506|NCT04106726|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110581507|NCT04106726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110581508|NCT03998774|Anti-Anxiety Agents|anti-anxiety agents|mesh-list
110581509|NCT03998774|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110581510|NCT03998774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110581511|NCT03998774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110581512|NCT03998774|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110581513|NCT00723957|Paclitaxel|paclitaxel|mesh-list
110581514|NCT00723957|Carboplatin|carboplatin|mesh-list
110581515|NCT00723957|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110581516|NCT00723957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110581517|NCT00723957|Tubulin Modulators|tubulin modulators|mesh-ancestor
110581518|NCT00723957|Antimitotic Agents|antimitotic agents|mesh-ancestor
110581519|NCT00723957|Mitosis Modulators|mitosis modulators|mesh-ancestor
110581520|NCT00723957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110581521|NCT02603822|Indomethacin|indomethacin|mesh-list
110581522|NCT02603822|Mannitol|mannitol|mesh-list
110581523|NCT02603822|Lactulose|lactulose|mesh-list
110581524|NCT02603822|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110581525|NCT02603822|Diuretics|diuretics|mesh-ancestor
110149471|NCT00006370|Edotreotide|edotreotide|mesh-list
110581526|NCT02603822|Natriuretic Agents|natriuretic agents|mesh-ancestor
110581527|NCT02603822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110581528|NCT02603822|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110581529|NCT02603822|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110581530|NCT02603822|Analgesics|analgesics|mesh-ancestor
110581531|NCT02603822|Sensory System Agents|sensory system agents|mesh-ancestor
110581532|NCT02603822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110581533|NCT02603822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110581535|NCT02603822|Gout Suppressants|gout suppressants|mesh-ancestor
110581536|NCT02603822|Tocolytic Agents|tocolytic agents|mesh-ancestor
110581537|NCT02603822|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110581538|NCT02603822|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110581539|NCT02603822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110581540|NCT02603822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110581541|NCT02603822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110581542|NCT02592057|Sofosbuvir|sofosbuvir|mesh-list
110581543|NCT02592057|Antiviral Agents|antiviral agents|mesh-ancestor
110581544|NCT02592057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110581545|NCT00723801|Losartan|losartan|mesh-list
110581546|NCT00723801|Atenolol|atenolol|mesh-list
110581547|NCT00723801|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110581548|NCT00723801|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110581549|NCT00723801|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110581550|NCT00723801|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110581551|NCT00723801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110581552|NCT00723801|Sympatholytics|sympatholytics|mesh-ancestor
110581553|NCT00723801|Autonomic Agents|autonomic agents|mesh-ancestor
110581554|NCT00723801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110581555|NCT00723801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110581556|NCT00723801|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110581557|NCT00723801|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110581558|NCT00723801|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110581559|NCT00723801|Adrenergic Agents|adrenergic agents|mesh-ancestor
110581560|NCT00723801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110581561|NCT00797966|Fluoxetine|fluoxetine|mesh-list
110581562|NCT00797966|Paroxetine|paroxetine|mesh-list
110581563|NCT00797966|Sertraline|sertraline|mesh-list
110581564|NCT00797966|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
110581565|NCT00797966|Escitalopram|escitalopram|mesh-list
110581566|NCT00797966|Brexpiprazole|brexpiprazole|mesh-list
110581567|NCT00797966|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110581568|NCT00797966|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110581569|NCT00797966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110581570|NCT00797966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110581571|NCT00797966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110581572|NCT00797966|Serotonin Agents|serotonin agents|mesh-ancestor
110581573|NCT00797966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110581574|NCT00797966|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110581575|NCT00797966|Antidepressive Agents|antidepressive agents|mesh-ancestor
110581576|NCT00797966|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110581577|NCT00797966|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110581578|NCT00797966|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110581579|NCT00797966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110581580|NCT00797966|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110581581|NCT00797966|Dopamine Agonists|dopamine agonists|mesh-ancestor
110581582|NCT00797966|Dopamine Agents|dopamine agents|mesh-ancestor
110581583|NCT05361837|Dexmedetomidine|dexmedetomidine|mesh-list
110581584|NCT05361837|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110581585|NCT05361837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110581586|NCT05361837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110581587|NCT05361837|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110581588|NCT05361837|Analgesics|analgesics|mesh-ancestor
110581589|NCT05361837|Sensory System Agents|sensory system agents|mesh-ancestor
110581590|NCT05361837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110581591|NCT05361837|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110581592|NCT05361837|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110581593|NCT05361837|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110581594|NCT05361837|Adrenergic Agents|adrenergic agents|mesh-ancestor
110581595|NCT05361837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110581596|NCT05361837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110581597|NCT00723255|Sirolimus|sirolimus|mesh-list
110581598|NCT00723255|Bevacizumab|bevacizumab|mesh-list
110581599|NCT00723255|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110581600|NCT00723255|Temsirolimus|temsirolimus|mesh-list
110581601|NCT00723255|MTOR Inhibitors|mtor inhibitors|mesh-list
110581602|NCT00723255|Antibodies|antibodies|mesh-list
110581603|NCT00723255|Immunoglobulins|immunoglobulins|mesh-list
110581604|NCT00723255|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110581605|NCT00723255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110581606|NCT00723255|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110581607|NCT00723255|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110581608|NCT00723255|Growth Substances|growth substances|mesh-ancestor
110581609|NCT00723255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110581610|NCT00723255|Growth Inhibitors|growth inhibitors|mesh-ancestor
110581611|NCT00723255|Immunologic Factors|immunologic factors|mesh-ancestor
110581612|NCT00723255|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110581613|NCT00723255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110581614|NCT00723255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110581615|NCT00723255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110581616|NCT00723255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110581617|NCT00723255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110581618|NCT00723255|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110581619|NCT00723255|Antifungal Agents|antifungal agents|mesh-ancestor
110581621|NCT00791258|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110581622|NCT00791258|Olmesartan|olmesartan|mesh-list
110581623|NCT00791258|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
110581624|NCT00791258|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110581625|NCT00791258|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110581626|NCT00791258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110581627|NCT00791258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110581628|NCT00791258|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110581629|NCT00791258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110581630|NCT00791258|Vasodilator Agents|vasodilator agents|mesh-ancestor
110581631|NCT00791258|Diuretics|diuretics|mesh-ancestor
110581632|NCT00791258|Natriuretic Agents|natriuretic agents|mesh-ancestor
110581633|NCT00791258|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110581634|NCT00791258|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110581635|NCT00791258|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110581636|NCT00808067|Dabigatran|dabigatran|mesh-list
110581637|NCT00808067|Antithrombins|antithrombins|mesh-ancestor
110581638|NCT00808067|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110581639|NCT00808067|Protease Inhibitors|protease inhibitors|mesh-ancestor
110581640|NCT00808067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110149492|NCT00006379|Cyclophosphamide|cyclophosphamide|mesh-list
110581641|NCT00808067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110581642|NCT00808067|Anticoagulants|anticoagulants|mesh-ancestor
110581643|NCT00723021|Zileuton|zileuton|mesh-list
110581644|NCT00723021|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110581645|NCT00723021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110581646|NCT00723021|Analgesics|analgesics|mesh-ancestor
110581647|NCT00723021|Sensory System Agents|sensory system agents|mesh-ancestor
110581648|NCT00723021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110581649|NCT00723021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110581650|NCT00723021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110581651|NCT00723021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110581652|NCT00723021|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
110581653|NCT00723021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110581654|NCT00723021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110581655|NCT00723021|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110581657|NCT00723021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110581658|NCT04087317|Acetaminophen|acetaminophen|mesh-list
110581659|NCT04087317|Ibuprofen|ibuprofen|mesh-list
110581660|NCT04087317|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110581661|NCT04087317|Analgesics|analgesics|mesh-ancestor
110581662|NCT04087317|Sensory System Agents|sensory system agents|mesh-ancestor
110581663|NCT04087317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110581664|NCT04087317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110581665|NCT04087317|Antipyretics|antipyretics|mesh-ancestor
110581666|NCT04087317|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110581667|NCT04087317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110581668|NCT04087317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110581669|NCT04087317|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110581670|NCT04087317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110581671|NCT04087317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110581672|NCT04309409|Nivolumab|nivolumab|mesh-list
110581674|NCT04309409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110581675|NCT04309409|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110581676|NCT04309409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110581677|NCT04086537|Hepcidins|hepcidins|mesh-list
110581678|NCT04086537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110581679|NCT02608619|Choline|choline|mesh-list
110581680|NCT02608619|Lipotropic Agents|lipotropic agents|mesh-ancestor
110581681|NCT02608619|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110581682|NCT02608619|Antimetabolites|antimetabolites|mesh-ancestor
110581683|NCT02608619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110581684|NCT02608619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110581685|NCT02608619|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110581686|NCT02608619|Nootropic Agents|nootropic agents|mesh-ancestor
110581687|NCT02591667|Bevacizumab|bevacizumab|mesh-list
110581688|NCT02591667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110581689|NCT02591667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110581690|NCT02591667|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110581691|NCT02591667|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110581692|NCT02591667|Growth Substances|growth substances|mesh-ancestor
110581693|NCT02591667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110581694|NCT02591667|Growth Inhibitors|growth inhibitors|mesh-ancestor
110581695|NCT00807599|Dexamethasone|dexamethasone|mesh-list
110581696|NCT00807599|Dexamethasone acetate|dexamethasone acetate|mesh-list
110581697|NCT00807599|Lenalidomide|lenalidomide|mesh-list
110581698|NCT00807599|Melphalan|melphalan|mesh-list
110581699|NCT00807599|BB 1101|bb 1101|mesh-list
110581700|NCT00807599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110581701|NCT00807599|Antiemetics|antiemetics|mesh-ancestor
110581702|NCT00807599|Autonomic Agents|autonomic agents|mesh-ancestor
110581703|NCT00807599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110375416|NCT04601324|Autonomic Agents|autonomic agents|mesh-ancestor
110581705|NCT00807599|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110581706|NCT00807599|Glucocorticoids|glucocorticoids|mesh-ancestor
110581708|NCT00807599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110581709|NCT00807599|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110581710|NCT00807599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110581711|NCT00807599|Protease Inhibitors|protease inhibitors|mesh-ancestor
110581712|NCT00807599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110581713|NCT00807599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110581714|NCT00807599|Immunologic Factors|immunologic factors|mesh-ancestor
110581715|NCT00807599|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110581716|NCT00807599|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110581717|NCT00807599|Growth Substances|growth substances|mesh-ancestor
110581718|NCT00807599|Growth Inhibitors|growth inhibitors|mesh-ancestor
110581719|NCT00807599|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110581720|NCT00807599|Alkylating Agents|alkylating agents|mesh-ancestor
110581721|NCT00807599|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110581722|NCT00807599|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110581723|NCT00788372|Fentanyl|fentanyl|mesh-list
110581724|NCT00788372|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110581725|NCT00788372|Narcotics|narcotics|mesh-ancestor
110581726|NCT00788372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110581727|NCT00788372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110581728|NCT00788372|Analgesics|analgesics|mesh-ancestor
110581729|NCT00788372|Sensory System Agents|sensory system agents|mesh-ancestor
110581730|NCT00788372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110581732|NCT00788372|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110581733|NCT00788372|Anesthetics, General|anesthetics, general|mesh-ancestor
110581734|NCT00788372|Anesthetics|anesthetics|mesh-ancestor
110581735|NCT00738582|Pemetrexed|pemetrexed|mesh-list
110581736|NCT00738582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110581737|NCT00738582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110581738|NCT00738582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110581739|NCT00738582|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110581740|NCT00738582|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110581741|NCT05753657|Pioglitazone|pioglitazone|mesh-list
110581742|NCT05753657|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110581743|NCT05753657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110581744|NCT00720759|Cycloserine|cycloserine|mesh-list
110581745|NCT00720759|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110581746|NCT00720759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110581747|NCT00720759|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110581748|NCT00720759|Antitubercular Agents|antitubercular agents|mesh-ancestor
110581749|NCT00720759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110581750|NCT00720759|Antimetabolites|antimetabolites|mesh-ancestor
110581751|NCT00720759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110581752|NCT00918411|Ramosetron|ramosetron|mesh-list
110581753|NCT00918411|Antiemetics|antiemetics|mesh-ancestor
110581754|NCT00918411|Autonomic Agents|autonomic agents|mesh-ancestor
110581755|NCT00918411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110581756|NCT00918411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110581757|NCT00918411|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110581758|NCT00918411|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110581759|NCT00918411|Serotonin Agents|serotonin agents|mesh-ancestor
110581760|NCT00918411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110581761|NCT00918411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110581762|NCT00810407|Rifabutin|rifabutin|mesh-list
110581763|NCT00810407|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110581764|NCT00810407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110581765|NCT00810407|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110581766|NCT00810407|Antitubercular Agents|antitubercular agents|mesh-ancestor
110581767|NCT00720057|Naproxen|naproxen|mesh-list
110581768|NCT00720057|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110581769|NCT00720057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110581770|NCT00720057|Analgesics|analgesics|mesh-ancestor
110581771|NCT00720057|Sensory System Agents|sensory system agents|mesh-ancestor
110581772|NCT00720057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110581773|NCT00720057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110581774|NCT00720057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110581775|NCT00720057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110581776|NCT00720057|Gout Suppressants|gout suppressants|mesh-ancestor
110581777|NCT00720057|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110581778|NCT00720057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110581779|NCT00720057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110581780|NCT00790868|Cycloserine|cycloserine|mesh-list
110581781|NCT00790868|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110581782|NCT00790868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110581783|NCT00790868|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110581784|NCT00790868|Antitubercular Agents|antitubercular agents|mesh-ancestor
110581785|NCT00790868|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110581786|NCT00790868|Antimetabolites|antimetabolites|mesh-ancestor
110581787|NCT00790868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110581788|NCT00719901|Bortezomib|bortezomib|mesh-list
110581789|NCT00719901|Obatoclax|obatoclax|mesh-list
110581790|NCT00719901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110581791|NCT00719901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110581792|NCT00719901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110581793|NCT02603276|Red yeast rice|red yeast rice|mesh-list
110581794|NCT02603276|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110581795|NCT02603276|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110581796|NCT02603276|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110581797|NCT02603276|Antimetabolites|antimetabolites|mesh-ancestor
110581798|NCT02603276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110581799|NCT02603276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110581800|NCT02603276|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110581801|NCT02591277|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
110581802|NCT02591277|Antiviral Agents|antiviral agents|mesh-ancestor
110581803|NCT02591277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110581804|NCT00807365|Hormones|hormones|mesh-list
110581805|NCT00807365|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
110581806|NCT00807365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110581807|NCT00807365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110581808|NCT02609711|Candesartan|candesartan|mesh-list
110581809|NCT02609711|Candesartan cilexetil|candesartan cilexetil|mesh-list
110581810|NCT02609711|Atorvastatin|atorvastatin|mesh-list
110581811|NCT02609711|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110581812|NCT02609711|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110581813|NCT02609711|Antimetabolites|antimetabolites|mesh-ancestor
110581814|NCT02609711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110581815|NCT02609711|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110581816|NCT02609711|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110581817|NCT02609711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110581818|NCT02609711|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110581819|NCT02609711|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110581820|NCT02609711|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110581821|NCT04016207|Guanfacine|guanfacine|mesh-list
110581822|NCT04016207|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110581823|NCT04016207|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110581824|NCT04016207|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110581825|NCT04016207|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110581826|NCT04016207|Adrenergic Agents|adrenergic agents|mesh-ancestor
110581827|NCT04016207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110581828|NCT04016207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110581829|NCT04016207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110581830|NCT04030091|Insulin|insulin|mesh-list
110581831|NCT04030091|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110581832|NCT04030091|Insulin, Isophane|insulin, isophane|mesh-list
110581833|NCT04030091|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110581834|NCT04030091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110581835|NCT00734604|Sildenafil Citrate|sildenafil citrate|mesh-list
110581836|NCT00734604|Tadalafil|tadalafil|mesh-list
110581837|NCT00734604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110581838|NCT00734604|Vasodilator Agents|vasodilator agents|mesh-ancestor
110581839|NCT00734604|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110581840|NCT00734604|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110581841|NCT00734604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110581842|NCT00734604|Urological Agents|urological agents|mesh-ancestor
110581843|NCT00590681|Bevacizumab|bevacizumab|mesh-list
110581845|NCT00590681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110581846|NCT00590681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110581847|NCT00590681|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110581848|NCT00590681|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110581849|NCT00590681|Growth Substances|growth substances|mesh-ancestor
110581850|NCT00590681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110581851|NCT00590681|Growth Inhibitors|growth inhibitors|mesh-ancestor
110581852|NCT00590681|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110581853|NCT00590681|Alkylating Agents|alkylating agents|mesh-ancestor
110581854|NCT00590681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110581855|NCT00727272|Quinine|quinine|mesh-list
110581856|NCT00727272|Antimalarials|antimalarials|mesh-ancestor
110581857|NCT00727272|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110581858|NCT00727272|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110581859|NCT00727272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110581860|NCT00727272|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110581861|NCT00727272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110581862|NCT00727272|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110581863|NCT00727272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110581864|NCT00727272|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110581865|NCT00727272|Analgesics|analgesics|mesh-ancestor
110581866|NCT00727272|Sensory System Agents|sensory system agents|mesh-ancestor
110581867|NCT02609477|Phentermine|phentermine|mesh-list
110581868|NCT02609477|Istradefylline|istradefylline|mesh-list
110581869|NCT02609477|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110581870|NCT02609477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110581871|NCT02609477|Appetite Depressants|appetite depressants|mesh-ancestor
110581872|NCT02609477|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110581873|NCT02609477|Sympathomimetics|sympathomimetics|mesh-ancestor
110581874|NCT02609477|Autonomic Agents|autonomic agents|mesh-ancestor
110581875|NCT02609477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110581876|NCT02609477|Adrenergic Agents|adrenergic agents|mesh-ancestor
110581877|NCT02609477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110581878|NCT02609477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110581879|NCT02609477|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
110581880|NCT02609477|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110581881|NCT02609477|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110581882|NCT02609477|Purinergic Agents|purinergic agents|mesh-ancestor
110581883|NCT02592720|Tenecteplase|tenecteplase|mesh-list
110581884|NCT02592720|Tirofiban|tirofiban|mesh-list
110581885|NCT02592720|Bivalirudin|bivalirudin|mesh-list
110581886|NCT02592720|Antithrombins|antithrombins|mesh-ancestor
110581887|NCT02592720|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110581888|NCT02592720|Protease Inhibitors|protease inhibitors|mesh-ancestor
110581889|NCT02592720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110581890|NCT02592720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110581891|NCT02592720|Anticoagulants|anticoagulants|mesh-ancestor
110581892|NCT02592720|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110581893|NCT02592720|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110581894|NCT02592720|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110581895|NCT02608073|Capecitabine|capecitabine|mesh-list
110581896|NCT02608073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110581897|NCT02608073|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110581898|NCT02608073|Antimetabolites|antimetabolites|mesh-ancestor
110375447|NCT00582920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110581899|NCT02608073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110581900|NCT04041791|Amoxicillin|amoxicillin|mesh-list
110581901|NCT04041791|Gentamicins|gentamicins|mesh-list
110581902|NCT04041791|Ceftriaxone|ceftriaxone|mesh-list
110581903|NCT04041791|Clavulanic Acid|clavulanic acid|mesh-list
110581904|NCT04041791|Clavulanic Acids|clavulanic acids|mesh-list
110581905|NCT04041791|Penicillins|penicillins|mesh-list
110581906|NCT04041791|Ampicillin|ampicillin|mesh-list
110581907|NCT04041791|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
110581908|NCT04041791|Penicillin G|penicillin g|mesh-list
110581909|NCT04041791|Penicillin G Benzathine|penicillin g benzathine|mesh-list
110581910|NCT04041791|Penicillin G Procaine|penicillin g procaine|mesh-list
110581911|NCT04041791|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110581912|NCT04041791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110581913|NCT04041791|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110581914|NCT04041791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110581915|NCT04041791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110581916|NCT04041791|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110581917|NCT02605226|Bicalutamide|bicalutamide|mesh-list
110581918|NCT02605226|Hormones|hormones|mesh-list
110581919|NCT02605226|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
110581920|NCT02605226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110581921|NCT02605226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110581922|NCT02605226|Androgen Antagonists|androgen antagonists|mesh-ancestor
110581923|NCT02605226|Hormone Antagonists|hormone antagonists|mesh-ancestor
110581924|NCT02605226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110581925|NCT05571878|Insulin Lispro|insulin lispro|mesh-list
110581926|NCT05571878|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110581927|NCT05571878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110581928|NCT04088448|Metformin|metformin|mesh-list
110581929|NCT04088448|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110581930|NCT04088448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110581931|NCT00806351|Caspofungin|caspofungin|mesh-list
110581932|NCT00806351|Anidulafungin|anidulafungin|mesh-list
110581933|NCT00806351|Antifungal Agents|antifungal agents|mesh-ancestor
110581934|NCT00806351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110581935|NCT00806351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110581936|NCT00806351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110581937|NCT03995251|Testosterone|testosterone|mesh-list
110581938|NCT03995251|Androgens|androgens|mesh-ancestor
110581939|NCT03995251|Hormones|hormones|mesh-ancestor
110581940|NCT03995251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110581941|NCT03995251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110581942|NCT01031017|Progesterone|progesterone|mesh-list
110581943|NCT01031017|Progestins|progestins|mesh-ancestor
110581944|NCT01031017|Hormones|hormones|mesh-ancestor
110581945|NCT01031017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110581946|NCT01031017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110581947|NCT03742531|Oxytocin|oxytocin|mesh-list
110581948|NCT03742531|Oxytocics|oxytocics|mesh-ancestor
110581949|NCT03742531|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110581950|NCT03742531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110581951|NCT00733902|Tanezumab|tanezumab|mesh-list
110581952|NCT00733902|Analgesics|analgesics|mesh-ancestor
110581953|NCT00733902|Sensory System Agents|sensory system agents|mesh-ancestor
110581954|NCT00733902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110581955|NCT00733902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110581956|NCT05737355|Red yeast rice|red yeast rice|mesh-list
110581957|NCT05737355|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110581958|NCT05737355|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110581959|NCT05737355|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110581960|NCT05737355|Antimetabolites|antimetabolites|mesh-ancestor
110581961|NCT05737355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110581962|NCT05737355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110581963|NCT05737355|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110581964|NCT03540017|Cisplatin|cisplatin|mesh-list
110581965|NCT03540017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110581966|NCT02606981|Vitamins|vitamins|mesh-list
110581967|NCT02606981|Ascorbic Acid|ascorbic acid|mesh-list
110581969|NCT02606981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110581970|NCT02606981|Antioxidants|antioxidants|mesh-ancestor
110581971|NCT02606981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110581972|NCT02606981|Protective Agents|protective agents|mesh-ancestor
110581973|NCT00914888|Metronidazole|metronidazole|mesh-list
110581974|NCT00914888|Clarithromycin|clarithromycin|mesh-list
110581975|NCT00914888|Ceftriaxone|ceftriaxone|mesh-list
110581976|NCT00914888|Tigecycline|tigecycline|mesh-list
110581977|NCT00914888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110581978|NCT00914888|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110581979|NCT00914888|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110581980|NCT00914888|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110581981|NCT00914888|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110581982|NCT00914888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110581983|NCT00914888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110581984|NCT00914888|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110581985|NCT00914888|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110581987|NCT02603198|Nordefrin|nordefrin|mesh-list
110581988|NCT02603198|Anesthetics|anesthetics|mesh-list
110581989|NCT02603198|Mepivacaine|mepivacaine|mesh-list
110581990|NCT02603198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110581991|NCT02603198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110581992|NCT02603198|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110581993|NCT02603198|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110581994|NCT02603198|Adrenergic Agents|adrenergic agents|mesh-ancestor
110581995|NCT02603198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110581996|NCT02603198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110581997|NCT02603198|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110581998|NCT02603198|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110581999|NCT02603198|Autonomic Agents|autonomic agents|mesh-ancestor
110582000|NCT02603198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110582001|NCT02603198|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110582002|NCT02603198|Respiratory System Agents|respiratory system agents|mesh-ancestor
110582003|NCT02603198|Mydriatics|mydriatics|mesh-ancestor
110582004|NCT02603198|Sympathomimetics|sympathomimetics|mesh-ancestor
110582005|NCT02603198|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110582006|NCT02603198|Anesthetics, Local|anesthetics, local|mesh-ancestor
110582007|NCT02603198|Sensory System Agents|sensory system agents|mesh-ancestor
110582008|NCT00719043|Vaccines|vaccines|mesh-list
110582009|NCT00719043|Immunologic Factors|immunologic factors|mesh-ancestor
110582010|NCT00719043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110582011|NCT00786422|Rivaroxaban|rivaroxaban|mesh-list
110582012|NCT00786422|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110582013|NCT00786422|Antithrombins|antithrombins|mesh-ancestor
110582014|NCT00786422|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110582015|NCT00786422|Protease Inhibitors|protease inhibitors|mesh-ancestor
110582016|NCT00786422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110582017|NCT00786422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110582018|NCT00786422|Anticoagulants|anticoagulants|mesh-ancestor
110582019|NCT00718887|Entecavir|entecavir|mesh-list
110582020|NCT00718887|Adefovir|adefovir|mesh-list
110582021|NCT00718887|Antiviral Agents|antiviral agents|mesh-ancestor
110582022|NCT00718887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110582023|NCT00718887|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110582024|NCT00718887|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110582025|NCT00718887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110582026|NCT00718887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110582027|NCT00786188|Paroxetine|paroxetine|mesh-list
110582028|NCT00786188|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110582029|NCT00786188|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110582030|NCT00786188|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110582031|NCT00786188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110582032|NCT00786188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110582033|NCT00786188|Serotonin Agents|serotonin agents|mesh-ancestor
110582034|NCT00786188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110582035|NCT00786188|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110582036|NCT00786188|Antidepressive Agents|antidepressive agents|mesh-ancestor
110582037|NCT00786188|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110582038|NCT00786188|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110582039|NCT00786188|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110582040|NCT00786188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110582042|NCT00733824|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110582043|NCT00733824|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110582044|NCT00733824|Antiviral Agents|antiviral agents|mesh-ancestor
110582045|NCT00733824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110582046|NCT00718809|Saracatinib|saracatinib|mesh-list
110582047|NCT00718809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110582048|NCT00718809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110582049|NCT00718809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110582050|NCT00585039|Albuterol|albuterol|mesh-list
110582051|NCT00585039|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110582052|NCT00585039|Autonomic Agents|autonomic agents|mesh-ancestor
110582053|NCT00585039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110582054|NCT00585039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110582055|NCT00585039|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110582056|NCT00585039|Respiratory System Agents|respiratory system agents|mesh-ancestor
110582057|NCT00585039|Tocolytic Agents|tocolytic agents|mesh-ancestor
110582058|NCT00585039|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110582059|NCT00585039|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110582060|NCT00585039|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110582061|NCT00585039|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110582062|NCT00585039|Adrenergic Agents|adrenergic agents|mesh-ancestor
110582063|NCT00585039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110582064|NCT00585039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110582065|NCT04085913|Lidocaine|lidocaine|mesh-list
110582066|NCT04085913|Epinephrine|epinephrine|mesh-list
110582067|NCT04085913|Racepinephrine|racepinephrine|mesh-list
110582068|NCT04085913|Bupivacaine|bupivacaine|mesh-list
110582069|NCT04085913|Epinephryl borate|epinephryl borate|mesh-list
110582070|NCT04085913|Anesthetics, Local|anesthetics, local|mesh-ancestor
110582071|NCT04085913|Anesthetics|anesthetics|mesh-ancestor
110582072|NCT04085913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110582073|NCT04085913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110582074|NCT04085913|Sensory System Agents|sensory system agents|mesh-ancestor
110582075|NCT04085913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110582076|NCT04085913|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110582077|NCT04085913|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110582078|NCT04085913|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110582079|NCT04085913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110582080|NCT04085913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110582081|NCT04085913|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110582082|NCT04085913|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110582083|NCT04085913|Adrenergic Agents|adrenergic agents|mesh-ancestor
110582084|NCT04085913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110582085|NCT04085913|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110582086|NCT04085913|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110582087|NCT04085913|Autonomic Agents|autonomic agents|mesh-ancestor
110582088|NCT04085913|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110582089|NCT04085913|Respiratory System Agents|respiratory system agents|mesh-ancestor
110582090|NCT04085913|Mydriatics|mydriatics|mesh-ancestor
110582091|NCT04085913|Sympathomimetics|sympathomimetics|mesh-ancestor
110582092|NCT04085913|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110582093|NCT00806195|Vaccines|vaccines|mesh-list
110582094|NCT00806195|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110582095|NCT00806195|Immunologic Factors|immunologic factors|mesh-ancestor
110582096|NCT00806195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110582097|NCT03462329|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110582098|NCT03462329|Doxycycline|doxycycline|mesh-list
110582099|NCT03462329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110582100|NCT03462329|Antimalarials|antimalarials|mesh-ancestor
110582101|NCT03462329|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110582102|NCT03462329|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110582103|NCT05728151|Epinephrine|epinephrine|mesh-list
110582104|NCT05728151|Levobupivacaine|levobupivacaine|mesh-list
110582105|NCT05728151|Mepivacaine|mepivacaine|mesh-list
110582106|NCT05728151|Carticaine|carticaine|mesh-list
110582107|NCT05728151|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110582108|NCT05728151|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110582109|NCT05728151|Adrenergic Agents|adrenergic agents|mesh-ancestor
110582110|NCT05728151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110582111|NCT05728151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110582112|NCT05728151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110582113|NCT05728151|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110582114|NCT05728151|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110582115|NCT05728151|Autonomic Agents|autonomic agents|mesh-ancestor
110582116|NCT05728151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110582117|NCT05728151|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110582118|NCT05728151|Respiratory System Agents|respiratory system agents|mesh-ancestor
110582119|NCT05728151|Mydriatics|mydriatics|mesh-ancestor
110582120|NCT05728151|Sympathomimetics|sympathomimetics|mesh-ancestor
110582122|NCT05728151|Anesthetics, Local|anesthetics, local|mesh-ancestor
110582123|NCT05728151|Anesthetics|anesthetics|mesh-ancestor
110582124|NCT05728151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110582125|NCT05728151|Sensory System Agents|sensory system agents|mesh-ancestor
110582126|NCT00733746|Gemcitabine|gemcitabine|mesh-list
110582127|NCT00733746|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110582128|NCT00733746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110582129|NCT00733746|Antimetabolites|antimetabolites|mesh-ancestor
110582130|NCT00733746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110582131|NCT00733746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110582132|NCT00733746|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110582133|NCT00733746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110582134|NCT03422705|Lisinopril|lisinopril|mesh-list
110582135|NCT03422705|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110582136|NCT03422705|Protease Inhibitors|protease inhibitors|mesh-ancestor
110582137|NCT03422705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110582138|NCT03422705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110582139|NCT03422705|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110582140|NCT03422705|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110582141|NCT03422705|Protective Agents|protective agents|mesh-ancestor
110582142|NCT03422705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110582143|NCT02607293|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
110582144|NCT02607293|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
110582145|NCT02607293|Hormones|hormones|mesh-ancestor
110582146|NCT02607293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110582147|NCT02607293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110582148|NCT02607371|Rivaroxaban|rivaroxaban|mesh-list
110582149|NCT02607371|Apixaban|apixaban|mesh-list
110582150|NCT02607371|Edoxaban|edoxaban|mesh-list
110582151|NCT02607371|Dabigatran|dabigatran|mesh-list
110582152|NCT02607371|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110582153|NCT02607371|Antithrombins|antithrombins|mesh-ancestor
110582154|NCT02607371|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110582155|NCT02607371|Protease Inhibitors|protease inhibitors|mesh-ancestor
110582156|NCT02607371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110582157|NCT02607371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110582158|NCT02607371|Anticoagulants|anticoagulants|mesh-ancestor
110582159|NCT04085757|Dinoprostone|dinoprostone|mesh-list
110582160|NCT04085757|Oxytocics|oxytocics|mesh-ancestor
110582161|NCT04085757|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110582162|NCT04085757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110582163|NCT00727194|Eculizumab|eculizumab|mesh-list
110582164|NCT00727194|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
110582165|NCT00727194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110582166|NCT00727194|Immunologic Factors|immunologic factors|mesh-ancestor
110582167|NCT00727194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110582168|NCT00717093|Varenicline|varenicline|mesh-list
110582169|NCT00717093|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110582170|NCT00717093|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110582171|NCT00717093|Cholinergic Agents|cholinergic agents|mesh-ancestor
110582172|NCT00717093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110582173|NCT00717093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110582174|NCT00717093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110582175|NCT00716859|Timolol|timolol|mesh-list
110582176|NCT00716859|Latanoprost|latanoprost|mesh-list
110582177|NCT00716859|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110582178|NCT00716859|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110582179|NCT00716859|Adrenergic Agents|adrenergic agents|mesh-ancestor
110582180|NCT00716859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110582181|NCT00716859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110582182|NCT00716859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110229615|NCT00314509|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110582183|NCT00716859|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110582184|NCT00716859|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110582185|NCT00716859|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110582186|NCT00716859|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110582188|NCT00590135|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110582189|NCT00590135|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110582190|NCT00590135|Antimetabolites|antimetabolites|mesh-ancestor
110582191|NCT00590135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110582193|NCT00590135|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110582194|NCT00590135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110582195|NCT00589667|Gemcitabine|gemcitabine|mesh-list
110582196|NCT00589667|Pemetrexed|pemetrexed|mesh-list
110582197|NCT00589667|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110582198|NCT00589667|Antimetabolites|antimetabolites|mesh-ancestor
110582199|NCT00589667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110582200|NCT00589667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110582201|NCT00589667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110582202|NCT00589667|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110582203|NCT00589667|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110582204|NCT00737568|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110582205|NCT00737568|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110582206|NCT00737568|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110582207|NCT00737568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110582208|NCT00737568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110582209|NCT00737568|Antiviral Agents|antiviral agents|mesh-ancestor
110582210|NCT00737568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110582211|NCT00737568|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110582212|NCT00737568|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110582213|NCT05752799|Analgesics, Opioid|analgesics, opioid|mesh-list
110582214|NCT05752799|Anesthetics|anesthetics|mesh-list
110582215|NCT05752799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110582216|NCT05752799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110582217|NCT05752799|Narcotics|narcotics|mesh-ancestor
110582218|NCT05752799|Analgesics|analgesics|mesh-ancestor
110582219|NCT05752799|Sensory System Agents|sensory system agents|mesh-ancestor
110582220|NCT05752799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110582221|NCT00737100|Bromides|bromides|mesh-list
110582222|NCT00737100|Tiotropium Bromide|tiotropium bromide|mesh-list
110582223|NCT00737100|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110582224|NCT00737100|Autonomic Agents|autonomic agents|mesh-ancestor
110582225|NCT00737100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110582226|NCT00737100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110582227|NCT00737100|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110582228|NCT00737100|Respiratory System Agents|respiratory system agents|mesh-ancestor
110582229|NCT00737100|Parasympatholytics|parasympatholytics|mesh-ancestor
110582230|NCT00737100|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110375497|NCT00583193|Analgesics|analgesics|mesh-ancestor
110582231|NCT00737100|Cholinergic Agents|cholinergic agents|mesh-ancestor
110582232|NCT00737100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110582233|NCT00737100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110582234|NCT00737100|Anticonvulsants|anticonvulsants|mesh-ancestor
110582235|NCT00732498|Cytarabine|cytarabine|mesh-list
110582236|NCT00732498|Methylprednisolone|methylprednisolone|mesh-list
110582237|NCT00732498|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110582238|NCT00732498|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110582239|NCT00732498|Prednisolone|prednisolone|mesh-list
110582240|NCT00732498|Prednisolone acetate|prednisolone acetate|mesh-list
110582241|NCT00732498|Rituximab|rituximab|mesh-list
110582242|NCT00732498|Etoposide|etoposide|mesh-list
110582243|NCT00732498|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110582244|NCT00732498|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110582245|NCT00732498|Prednisolone phosphate|prednisolone phosphate|mesh-list
110582246|NCT00732498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110582247|NCT00732498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110582248|NCT00732498|Immunologic Factors|immunologic factors|mesh-ancestor
110582249|NCT00732498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110582250|NCT00732498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110582251|NCT00732498|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110582252|NCT00732498|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110582253|NCT00732498|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110582254|NCT00732498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110582255|NCT00732498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110582256|NCT00732498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110582257|NCT00732498|Antimetabolites|antimetabolites|mesh-ancestor
110582258|NCT00732498|Antiviral Agents|antiviral agents|mesh-ancestor
110582259|NCT00732498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110582260|NCT00732498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110582261|NCT00732498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110582262|NCT00732498|Antiemetics|antiemetics|mesh-ancestor
110582263|NCT00732498|Autonomic Agents|autonomic agents|mesh-ancestor
110582264|NCT00732498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110582265|NCT00732498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110582266|NCT00732498|Glucocorticoids|glucocorticoids|mesh-ancestor
110582268|NCT00732498|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110582269|NCT00732498|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110582270|NCT00732498|Protective Agents|protective agents|mesh-ancestor
110582271|NCT00732498|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110582272|NCT00790400|Everolimus|everolimus|mesh-list
110582273|NCT00790400|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110582274|NCT00790400|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110582275|NCT00790400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110582276|NCT00790400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110582277|NCT00790400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110582278|NCT00790400|Immunologic Factors|immunologic factors|mesh-ancestor
110582279|NCT00790400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110582280|NCT00790400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110582281|NCT00915512|Paliperidone Palmitate|paliperidone palmitate|mesh-list
110582282|NCT00915512|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110582283|NCT00915512|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110582284|NCT00915512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110582285|NCT00915512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110582286|NCT00915512|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110582287|NCT00915512|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110582288|NCT00915512|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110582289|NCT00915512|Serotonin Agents|serotonin agents|mesh-ancestor
110582290|NCT00915512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110582291|NCT00915512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110582292|NCT00915512|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110582293|NCT00915512|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110582294|NCT00915512|Dopamine Agents|dopamine agents|mesh-ancestor
110582295|NCT02602652|Vaccines|vaccines|mesh-list
110582296|NCT02602652|Immunologic Factors|immunologic factors|mesh-ancestor
110582297|NCT02602652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110582298|NCT02593500|Budesonide|budesonide|mesh-list
110582299|NCT02593500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110582300|NCT02593500|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110582301|NCT02593500|Autonomic Agents|autonomic agents|mesh-ancestor
110582302|NCT02593500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110582303|NCT02593500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110582304|NCT02593500|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110582305|NCT02593500|Respiratory System Agents|respiratory system agents|mesh-ancestor
110582306|NCT02593500|Glucocorticoids|glucocorticoids|mesh-ancestor
110582307|NCT02593500|Hormones|hormones|mesh-ancestor
110582308|NCT02593500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110582309|NCT02594358|Caffeine|caffeine|mesh-list
110582310|NCT02594358|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110582311|NCT02594358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110582312|NCT02594358|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110582313|NCT02594358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110582314|NCT02594358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110582315|NCT02594358|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110582316|NCT02594358|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110582317|NCT02594358|Purinergic Agents|purinergic agents|mesh-ancestor
110582318|NCT02594358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110582319|NCT00785486|Quinine|quinine|mesh-list
110582320|NCT00785486|Midazolam|midazolam|mesh-list
110582321|NCT00785486|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110582322|NCT00785486|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110582323|NCT00785486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110582324|NCT00785486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110582325|NCT00785486|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110582326|NCT00785486|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110582327|NCT00785486|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110582328|NCT00785486|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110582329|NCT00785486|Anesthetics, General|anesthetics, general|mesh-ancestor
110582330|NCT00785486|Anesthetics|anesthetics|mesh-ancestor
110582331|NCT00785486|GABA Modulators|gaba modulators|mesh-ancestor
110582332|NCT00785486|GABA Agents|gaba agents|mesh-ancestor
110582333|NCT00785486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110582334|NCT00785486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110582335|NCT00785486|Antimalarials|antimalarials|mesh-ancestor
110582336|NCT00785486|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110582337|NCT00785486|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110582338|NCT00785486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110582339|NCT00785486|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110582340|NCT00785486|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110582341|NCT00785486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110582342|NCT00785486|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110582343|NCT00785486|Analgesics|analgesics|mesh-ancestor
110582344|NCT00785486|Sensory System Agents|sensory system agents|mesh-ancestor
110582345|NCT00917904|Dapivirine|dapivirine|mesh-list
110582346|NCT00917904|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110582347|NCT00917904|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110582348|NCT00917904|Antiviral Agents|antiviral agents|mesh-ancestor
110582349|NCT00917904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110582350|NCT00589979|Lidocaine|lidocaine|mesh-list
110582351|NCT00589979|Anesthetics, Local|anesthetics, local|mesh-ancestor
110582352|NCT00589979|Anesthetics|anesthetics|mesh-ancestor
110582353|NCT00589979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110582354|NCT00589979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110582355|NCT00589979|Sensory System Agents|sensory system agents|mesh-ancestor
110582356|NCT00589979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110582357|NCT00589979|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110582358|NCT00589979|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110582359|NCT00589979|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110582360|NCT00589979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110582361|NCT00589979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110582362|NCT02590653|Atorvastatin|atorvastatin|mesh-list
110582363|NCT02590653|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110582364|NCT02590653|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110582365|NCT02590653|Antimetabolites|antimetabolites|mesh-ancestor
110582366|NCT02590653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110582367|NCT02590653|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110582368|NCT02590653|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110582369|NCT02590653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110582370|NCT00915746|Ketoconazole|ketoconazole|mesh-list
110582371|NCT00915746|Antifungal Agents|antifungal agents|mesh-ancestor
110582372|NCT00915746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110582373|NCT00915746|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110582374|NCT00915746|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110582375|NCT00915746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110582376|NCT00915746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110582377|NCT00915746|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110582378|NCT00915746|Hormone Antagonists|hormone antagonists|mesh-ancestor
110582379|NCT00915746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110582380|NCT00915746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110582381|NCT00915746|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110582382|NCT00736944|Cisplatin|cisplatin|mesh-list
110582383|NCT00736944|Cetuximab|cetuximab|mesh-list
110582384|NCT00736944|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110582385|NCT00736944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110582386|NCT00736944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110582387|NCT02603510|Insulin Lispro|insulin lispro|mesh-list
110582388|NCT02603510|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110582389|NCT02603510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110582390|NCT04084977|Antibodies|antibodies|mesh-list
110582391|NCT04084977|Immunologic Factors|immunologic factors|mesh-ancestor
110582392|NCT04084977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110582393|NCT04107194|Amoxicillin|amoxicillin|mesh-list
110582394|NCT04107194|Metronidazole|metronidazole|mesh-list
110582395|NCT04107194|Clarithromycin|clarithromycin|mesh-list
110582396|NCT04107194|Levofloxacin|levofloxacin|mesh-list
110582397|NCT04107194|Tetracycline|tetracycline|mesh-list
110582399|NCT04107194|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
110582400|NCT04107194|Pantoprazole|pantoprazole|mesh-list
110582401|NCT04107194|Bismuth|bismuth|mesh-list
110582402|NCT04107194|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110582403|NCT04107194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110582404|NCT04107194|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110582405|NCT04107194|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110582406|NCT04107194|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110582407|NCT04107194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110582408|NCT04107194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110582409|NCT04107194|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110582410|NCT04107194|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110582411|NCT04107194|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110582412|NCT04107194|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110582413|NCT04107194|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110582414|NCT04107194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110582415|NCT04107194|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110582416|NCT04107194|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110582417|NCT04107194|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110582418|NCT04107194|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110582419|NCT04107194|Antacids|antacids|mesh-ancestor
110582420|NCT04107194|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110582421|NCT04107194|Antitubercular Agents|antitubercular agents|mesh-ancestor
110582422|NCT02590263|Temozolomide|temozolomide|mesh-list
110582423|NCT02590263|ABT-414|abt-414|mesh-list
110582424|NCT02590263|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110582425|NCT02590263|Alkylating Agents|alkylating agents|mesh-ancestor
110582426|NCT02590263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110582427|NCT02590263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110582428|NCT02590263|Immunoconjugates|immunoconjugates|mesh-ancestor
110582429|NCT02590263|Immunologic Factors|immunologic factors|mesh-ancestor
110582430|NCT02590263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110582431|NCT00736476|Vaccines|vaccines|mesh-list
110582432|NCT00736476|Immunologic Factors|immunologic factors|mesh-ancestor
110582433|NCT00736476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110582434|NCT02606357|Insulin Glargine|insulin glargine|mesh-list
110582435|NCT02606357|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110582436|NCT02606357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110582437|NCT04019496|Calcitonin|calcitonin|mesh-list
110582438|NCT04019496|Salmon calcitonin|salmon calcitonin|mesh-list
110582439|NCT04019496|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
110582440|NCT04019496|Antibodies|antibodies|mesh-list
110582441|NCT04019496|Katacalcin|katacalcin|mesh-list
110582442|NCT04019496|Immunologic Factors|immunologic factors|mesh-ancestor
110582443|NCT04019496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110582444|NCT04019496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110582445|NCT04019496|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110582446|NCT04019496|Vasodilator Agents|vasodilator agents|mesh-ancestor
110582447|NCT00918489|Vorinostat|vorinostat|mesh-list
110582448|NCT00918489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110582449|NCT00918489|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110582450|NCT00918489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110582451|NCT00918489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110582452|NCT02604992|Dronabinol|dronabinol|mesh-list
110582453|NCT02604992|Hallucinogens|hallucinogens|mesh-ancestor
110582454|NCT02604992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110582455|NCT02604992|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110582456|NCT02604992|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110582457|NCT02604992|Analgesics|analgesics|mesh-ancestor
110582458|NCT02604992|Sensory System Agents|sensory system agents|mesh-ancestor
110582459|NCT02604992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110582460|NCT02604992|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
110582461|NCT02604992|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110582462|NCT02604992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110582463|NCT02604992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110375560|NCT01133392|Insulin Lispro|insulin lispro|mesh-list
110582465|NCT02604992|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110582466|NCT03899597|Oxytocin|oxytocin|mesh-list
110582467|NCT03899597|Oxytocics|oxytocics|mesh-ancestor
110582468|NCT03899597|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110582469|NCT03899597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110582470|NCT00714285|Vaccines|vaccines|mesh-list
110582471|NCT00714285|Immunologic Factors|immunologic factors|mesh-ancestor
110582472|NCT00714285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110582473|NCT00776984|Tiotropium Bromide|tiotropium bromide|mesh-list
110582474|NCT00776984|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110582475|NCT00776984|Autonomic Agents|autonomic agents|mesh-ancestor
110582476|NCT00776984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110582477|NCT00776984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110582478|NCT00776984|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110582479|NCT00776984|Respiratory System Agents|respiratory system agents|mesh-ancestor
110582480|NCT00776984|Parasympatholytics|parasympatholytics|mesh-ancestor
110582481|NCT00776984|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110582482|NCT00776984|Cholinergic Agents|cholinergic agents|mesh-ancestor
110582483|NCT00776984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110582484|NCT00776984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110582485|NCT04015557|Acetaminophen|acetaminophen|mesh-list
110582486|NCT04015557|Acetylcysteine|acetylcysteine|mesh-list
110582487|NCT04015557|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110582488|NCT04015557|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110582489|NCT04015557|Analgesics|analgesics|mesh-ancestor
110582490|NCT04015557|Sensory System Agents|sensory system agents|mesh-ancestor
110582491|NCT04015557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110582492|NCT04015557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110582493|NCT04015557|Antipyretics|antipyretics|mesh-ancestor
110582494|NCT04015557|Antiviral Agents|antiviral agents|mesh-ancestor
110582495|NCT04015557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110582496|NCT04015557|Expectorants|expectorants|mesh-ancestor
110582497|NCT04015557|Respiratory System Agents|respiratory system agents|mesh-ancestor
110582498|NCT04015557|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110582499|NCT04015557|Antioxidants|antioxidants|mesh-ancestor
110582500|NCT04015557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110582501|NCT04015557|Protective Agents|protective agents|mesh-ancestor
110582502|NCT04015557|Antidotes|antidotes|mesh-ancestor
110582503|NCT00784784|Zanamivir|zanamivir|mesh-list
110582504|NCT00784784|Antiviral Agents|antiviral agents|mesh-ancestor
110582505|NCT00784784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110582506|NCT00784784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110582507|NCT00784784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110582508|NCT00587288|Reslizumab|reslizumab|mesh-list
110582509|NCT00587288|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110582510|NCT00587288|Respiratory System Agents|respiratory system agents|mesh-ancestor
110582511|NCT00800735|Interferons|interferons|mesh-list
110582512|NCT00800735|Ribavirin|ribavirin|mesh-list
110582513|NCT00800735|Interferon-alpha|interferon-alpha|mesh-list
110582514|NCT00800735|Interferon alpha-2|interferon alpha-2|mesh-list
110582515|NCT00800735|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110582516|NCT00800735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110582517|NCT00800735|Antiviral Agents|antiviral agents|mesh-ancestor
110582518|NCT00800735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110582519|NCT00800735|Antimetabolites|antimetabolites|mesh-ancestor
110582520|NCT00800735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110582521|NCT00800735|Immunologic Factors|immunologic factors|mesh-ancestor
110582522|NCT00800735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110582523|NCT05324163|Celecoxib|celecoxib|mesh-list
110582524|NCT05324163|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110582525|NCT05324163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110582526|NCT05324163|Analgesics|analgesics|mesh-ancestor
110582527|NCT05324163|Sensory System Agents|sensory system agents|mesh-ancestor
110582528|NCT05324163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110582529|NCT05324163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110582530|NCT05324163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110582531|NCT05324163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110582532|NCT05324163|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110582533|NCT05324163|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110582534|NCT05324163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110582535|NCT05324163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110582537|NCT00730158|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110582538|NCT00730158|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110582540|NCT00730158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110582541|NCT00730158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110582542|NCT04114643|Thrombin|thrombin|mesh-list
110582543|NCT04114643|Hemostatics|hemostatics|mesh-ancestor
110582544|NCT04114643|Coagulants|coagulants|mesh-ancestor
110582545|NCT02989662|Mifepristone|mifepristone|mesh-list
110582546|NCT02989662|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
110582547|NCT02989662|Abortifacient Agents|abortifacient agents|mesh-ancestor
110582548|NCT02989662|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110582549|NCT02989662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110582550|NCT02989662|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110582551|NCT02989662|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110582552|NCT02989662|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110582553|NCT02989662|Contraceptive Agents|contraceptive agents|mesh-ancestor
110582554|NCT02989662|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
110582555|NCT02989662|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
110582556|NCT02989662|Hormone Antagonists|hormone antagonists|mesh-ancestor
110229979|NCT00419887|Vildagliptin|vildagliptin|mesh-list
110582557|NCT02989662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110582558|NCT02989662|Luteolytic Agents|luteolytic agents|mesh-ancestor
110582559|NCT02989662|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110582560|NCT02989662|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
110582561|NCT00784550|Fluticasone|fluticasone|mesh-list
110582562|NCT00784550|Xhance|xhance|mesh-list
110582563|NCT00784550|Bromides|bromides|mesh-list
110582564|NCT00784550|Tiotropium Bromide|tiotropium bromide|mesh-list
110582565|NCT00784550|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110582566|NCT00784550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110582567|NCT00784550|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110582568|NCT00784550|Autonomic Agents|autonomic agents|mesh-ancestor
110582569|NCT00784550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110582570|NCT00784550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110582571|NCT00784550|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110582572|NCT00784550|Respiratory System Agents|respiratory system agents|mesh-ancestor
110582573|NCT00784550|Dermatologic Agents|dermatologic agents|mesh-ancestor
110582574|NCT00784550|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110582575|NCT00784550|Parasympatholytics|parasympatholytics|mesh-ancestor
110582576|NCT00784550|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110582577|NCT00784550|Cholinergic Agents|cholinergic agents|mesh-ancestor
110582578|NCT00784550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110582579|NCT00784550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110582580|NCT00784550|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110582581|NCT00784550|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110582582|NCT00784550|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110582583|NCT00784550|Adrenergic Agents|adrenergic agents|mesh-ancestor
110582584|NCT00784550|Anticonvulsants|anticonvulsants|mesh-ancestor
110582585|NCT00729690|Pregabalin|pregabalin|mesh-list
110582586|NCT00729690|Analgesics|analgesics|mesh-ancestor
110582587|NCT00729690|Sensory System Agents|sensory system agents|mesh-ancestor
110582588|NCT00729690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110582589|NCT00729690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110582590|NCT00729690|Anticonvulsants|anticonvulsants|mesh-ancestor
110582591|NCT00729690|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110582592|NCT00729690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110582593|NCT00729690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110582594|NCT00729690|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110582595|NCT00729690|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110582596|NCT00729690|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110582597|NCT00729690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110582598|NCT00729690|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110582599|NCT04027829|Dexmedetomidine|dexmedetomidine|mesh-list
110582600|NCT04027829|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110582601|NCT04027829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110582602|NCT04027829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110582603|NCT04027829|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110582604|NCT04027829|Analgesics|analgesics|mesh-ancestor
110582605|NCT04027829|Sensory System Agents|sensory system agents|mesh-ancestor
110582606|NCT04027829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110582607|NCT04027829|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110582608|NCT04027829|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110582610|NCT04027829|Adrenergic Agents|adrenergic agents|mesh-ancestor
110582611|NCT04027829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110582612|NCT04027829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110582613|NCT00784238|Paliperidone Palmitate|paliperidone palmitate|mesh-list
110582614|NCT00784238|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110582615|NCT00784238|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110582616|NCT00784238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110582617|NCT00784238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110582618|NCT00784238|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110582619|NCT00784238|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110582620|NCT00784238|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110582621|NCT00784238|Serotonin Agents|serotonin agents|mesh-ancestor
110582622|NCT00784238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110582623|NCT00784238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110582624|NCT00784238|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110582625|NCT00784238|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110582626|NCT00784238|Dopamine Agents|dopamine agents|mesh-ancestor
110582627|NCT00729612|Paclitaxel|paclitaxel|mesh-list
110582628|NCT00729612|Carboplatin|carboplatin|mesh-list
110582629|NCT00729612|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110582630|NCT00729612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110230053|NCT02965196|Dexamethasone|dexamethasone|mesh-list
110582631|NCT00729612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110582632|NCT00729612|Tubulin Modulators|tubulin modulators|mesh-ancestor
110582633|NCT00729612|Antimitotic Agents|antimitotic agents|mesh-ancestor
110582634|NCT00729612|Mitosis Modulators|mitosis modulators|mesh-ancestor
110582635|NCT00729612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110582637|NCT05684913|Coagulants|coagulants|mesh-ancestor
110582638|NCT00585546|Clenbuterol|clenbuterol|mesh-list
110582639|NCT00585546|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110582640|NCT00585546|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110582641|NCT00585546|Adrenergic Agents|adrenergic agents|mesh-ancestor
110582642|NCT00585546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110582643|NCT00585546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110582644|NCT00585546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110582645|NCT00585546|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110582646|NCT00585546|Autonomic Agents|autonomic agents|mesh-ancestor
110582647|NCT00585546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110582648|NCT00585546|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110582649|NCT00585546|Respiratory System Agents|respiratory system agents|mesh-ancestor
110582650|NCT00585546|Sympathomimetics|sympathomimetics|mesh-ancestor
110582651|NCT00768248|Ropivacaine|ropivacaine|mesh-list
110582652|NCT00768248|Anesthetics, Local|anesthetics, local|mesh-ancestor
110582653|NCT00768248|Anesthetics|anesthetics|mesh-ancestor
110582654|NCT00768248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110582655|NCT00768248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110582656|NCT00768248|Sensory System Agents|sensory system agents|mesh-ancestor
110582657|NCT00768248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110582658|NCT02589717|Atezolizumab|atezolizumab|mesh-list
110582659|NCT02589717|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110582660|NCT02589717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110582661|NCT02589717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110582662|NCT02589717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110582663|NCT02602028|Colchicine|colchicine|mesh-list
110582664|NCT02602028|Gout Suppressants|gout suppressants|mesh-ancestor
110582665|NCT02602028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110582666|NCT02602028|Tubulin Modulators|tubulin modulators|mesh-ancestor
110582667|NCT02602028|Antimitotic Agents|antimitotic agents|mesh-ancestor
110582668|NCT02602028|Mitosis Modulators|mitosis modulators|mesh-ancestor
110582669|NCT02602028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110582670|NCT02602028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110582672|NCT04103684|Methylprednisolone|methylprednisolone|mesh-list
110582673|NCT04103684|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110582674|NCT04103684|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110582675|NCT04103684|Prednisolone|prednisolone|mesh-list
110582676|NCT04103684|Prednisolone acetate|prednisolone acetate|mesh-list
110582677|NCT04103684|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110582678|NCT04103684|Prednisolone phosphate|prednisolone phosphate|mesh-list
110582679|NCT04103684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110582680|NCT04103684|Antiemetics|antiemetics|mesh-ancestor
110582681|NCT04103684|Autonomic Agents|autonomic agents|mesh-ancestor
110582682|NCT04103684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110582683|NCT04103684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110582684|NCT04103684|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110582685|NCT04103684|Glucocorticoids|glucocorticoids|mesh-ancestor
110582686|NCT04103684|Hormones|hormones|mesh-ancestor
110582687|NCT04103684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110582688|NCT04103684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110582689|NCT04103684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110582690|NCT04103684|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110582691|NCT04103684|Protective Agents|protective agents|mesh-ancestor
110582692|NCT00775268|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110582693|NCT00775268|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110582694|NCT00775268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110582695|NCT00775190|Moxifloxacin|moxifloxacin|mesh-list
110582696|NCT00775190|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
110582697|NCT00775190|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110582698|NCT00775190|Contraceptive Agents|contraceptive agents|mesh-ancestor
110582699|NCT00775190|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110582700|NCT00775190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110582701|NCT00775190|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110582702|NCT00775190|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110582703|NCT00775190|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110582704|NCT00775190|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110582705|NCT00775190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110582706|NCT00775190|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110582707|NCT00775190|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110582709|NCT00775190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110582710|NCT00775190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110582711|NCT00479557|Saponin QA-21V1|saponin qa-21v1|mesh-list
110582712|NCT00479557|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110582713|NCT00479557|Immunologic Factors|immunologic factors|mesh-ancestor
110582714|NCT00479557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110582715|NCT00774800|Insulin|insulin|mesh-list
110582716|NCT00774800|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110582717|NCT00774800|Insulin Lispro|insulin lispro|mesh-list
110582718|NCT00774800|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110582719|NCT00774800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110582720|NCT00439309|Thrombin|thrombin|mesh-list
110582721|NCT00439309|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
110582722|NCT00439309|Hemostatics|hemostatics|mesh-ancestor
110582723|NCT00439309|Coagulants|coagulants|mesh-ancestor
110582724|NCT00479167|Bortezomib|bortezomib|mesh-list
110582725|NCT00479167|Tositumomab I-131|tositumomab i-131|mesh-list
110582726|NCT00479167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110582727|NCT00725322|Botulinum Toxins|botulinum toxins|mesh-list
110582728|NCT00725322|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110582729|NCT00725322|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110582730|NCT00725322|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110582731|NCT00725322|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110582732|NCT00725322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110582733|NCT00725322|Cholinergic Agents|cholinergic agents|mesh-ancestor
110582734|NCT00725322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110582735|NCT00725322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110582736|NCT00725322|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110582737|NCT00725322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110582738|NCT00725010|Temozolomide|temozolomide|mesh-list
110582739|NCT00725010|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110582740|NCT00725010|Alkylating Agents|alkylating agents|mesh-ancestor
110582741|NCT00725010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110582742|NCT00725010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110582743|NCT05216055|Dexamethasone|dexamethasone|mesh-list
110582744|NCT05216055|Dexamethasone acetate|dexamethasone acetate|mesh-list
110582745|NCT05216055|Dexmedetomidine|dexmedetomidine|mesh-list
110582746|NCT05216055|Bupivacaine|bupivacaine|mesh-list
110582747|NCT05216055|Ropivacaine|ropivacaine|mesh-list
110582748|NCT05216055|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
110582749|NCT05216055|BB 1101|bb 1101|mesh-list
110582750|NCT05216055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110582751|NCT05216055|Antiemetics|antiemetics|mesh-ancestor
110582752|NCT05216055|Autonomic Agents|autonomic agents|mesh-ancestor
110582753|NCT05216055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110582754|NCT05216055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110582755|NCT05216055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110582756|NCT05216055|Glucocorticoids|glucocorticoids|mesh-ancestor
110582757|NCT05216055|Hormones|hormones|mesh-ancestor
110582758|NCT05216055|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110582759|NCT05216055|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110582760|NCT05216055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110582761|NCT05216055|Anesthetics, Local|anesthetics, local|mesh-ancestor
110582762|NCT05216055|Anesthetics|anesthetics|mesh-ancestor
110582763|NCT05216055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110582764|NCT05216055|Sensory System Agents|sensory system agents|mesh-ancestor
110582765|NCT05216055|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110582766|NCT05216055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110582767|NCT05216055|Analgesics|analgesics|mesh-ancestor
110582768|NCT05216055|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110582769|NCT05216055|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110582770|NCT05216055|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110582771|NCT05216055|Adrenergic Agents|adrenergic agents|mesh-ancestor
110582772|NCT05216055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110582773|NCT05216055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110582774|NCT05216055|Protease Inhibitors|protease inhibitors|mesh-ancestor
110582775|NCT05216055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110582776|NCT00767000|Metformin|metformin|mesh-list
110582777|NCT00767000|Insulin Glargine|insulin glargine|mesh-list
110582778|NCT00767000|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110582779|NCT00767000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110582780|NCT05194449|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
110582781|NCT05194449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110582782|NCT05194449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110582784|NCT00724932|Bromides|bromides|mesh-list
110582785|NCT00724932|Rocuronium|rocuronium|mesh-list
110582786|NCT00724932|Neostigmine|neostigmine|mesh-list
110582787|NCT00724932|Anticonvulsants|anticonvulsants|mesh-ancestor
110582788|NCT00724932|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110582789|NCT00724932|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110582790|NCT00724932|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110582791|NCT00724932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110582792|NCT00724932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110582793|NCT00724932|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110582794|NCT00724932|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110582795|NCT00724932|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110582796|NCT00724932|Autonomic Agents|autonomic agents|mesh-ancestor
110582797|NCT00724932|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110582798|NCT00724932|Respiratory System Agents|respiratory system agents|mesh-ancestor
110582799|NCT00724932|Mydriatics|mydriatics|mesh-ancestor
110582800|NCT00724932|Parasympatholytics|parasympatholytics|mesh-ancestor
110582801|NCT00724932|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110582802|NCT00724932|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110582803|NCT00724932|Cholinergic Agents|cholinergic agents|mesh-ancestor
110582804|NCT00724932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110582805|NCT00724932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110582806|NCT00724932|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110582807|NCT00724932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110582808|NCT00724932|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110582809|NCT00766532|Aromatase Inhibitors|aromatase inhibitors|mesh-list
110582810|NCT00766532|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110582811|NCT00766532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110582812|NCT00766532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110582813|NCT00766532|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110582815|NCT00766532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110582816|NCT00766532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110582817|NCT04083807|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
110582818|NCT04083807|Thrombin|thrombin|mesh-list
110582819|NCT04083807|Hemostatics|hemostatics|mesh-ancestor
110582820|NCT04083807|Coagulants|coagulants|mesh-ancestor
110582821|NCT05163483|Bevacizumab|bevacizumab|mesh-list
110582822|NCT05163483|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
110582823|NCT05163483|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110582824|NCT05163483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110582825|NCT05163483|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110582826|NCT05163483|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110582827|NCT05163483|Growth Substances|growth substances|mesh-ancestor
110582828|NCT05163483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110582829|NCT05163483|Growth Inhibitors|growth inhibitors|mesh-ancestor
110375622|NCT04570449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110582830|NCT05163483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110582831|NCT00766142|Leucovorin|leucovorin|mesh-list
110582832|NCT00766142|Fluorouracil|fluorouracil|mesh-list
110582833|NCT00766142|Oxaliplatin|oxaliplatin|mesh-list
110582834|NCT00766142|Cetuximab|cetuximab|mesh-list
110582835|NCT00766142|Calcium|calcium|mesh-list
110582836|NCT00766142|Levoleucovorin|levoleucovorin|mesh-list
110582837|NCT00766142|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110582838|NCT00766142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110582839|NCT00766142|Antimetabolites|antimetabolites|mesh-ancestor
110582840|NCT00766142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110582841|NCT00766142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110582842|NCT00766142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110582843|NCT00766142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110582844|NCT00766142|Immunologic Factors|immunologic factors|mesh-ancestor
110582845|NCT00766142|Antidotes|antidotes|mesh-ancestor
110582846|NCT00766142|Protective Agents|protective agents|mesh-ancestor
110582847|NCT00766142|Vitamin B Complex|vitamin b complex|mesh-ancestor
110582848|NCT00766142|Vitamins|vitamins|mesh-ancestor
110582849|NCT00766142|Micronutrients|micronutrients|mesh-ancestor
110582850|NCT00766142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110582851|NCT00916526|Mannitol|mannitol|mesh-list
110582852|NCT00916526|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110582853|NCT00916526|Diuretics|diuretics|mesh-ancestor
110582854|NCT00916526|Natriuretic Agents|natriuretic agents|mesh-ancestor
110582855|NCT00916526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110582856|NCT00724854|Ribavirin|ribavirin|mesh-list
110582857|NCT00724854|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110582858|NCT00724854|Interferon-alpha|interferon-alpha|mesh-list
110582859|NCT00724854|Antimetabolites|antimetabolites|mesh-ancestor
110582860|NCT00724854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110582862|NCT00724854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110582863|NCT00724854|Immunologic Factors|immunologic factors|mesh-ancestor
110582864|NCT00724854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110582865|NCT04083651|Bromides|bromides|mesh-list
110582866|NCT04083651|Methylnaltrexone|methylnaltrexone|mesh-list
110582867|NCT04083651|Anticonvulsants|anticonvulsants|mesh-ancestor
110582868|NCT04083651|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110582869|NCT04083651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110582870|NCT04083651|Sensory System Agents|sensory system agents|mesh-ancestor
110582871|NCT04083651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110582872|NCT00728988|Atorvastatin|atorvastatin|mesh-list
110582873|NCT00728988|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110582874|NCT00728988|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110582875|NCT00728988|Antimetabolites|antimetabolites|mesh-ancestor
110582876|NCT00728988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110582877|NCT00728988|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110582878|NCT00728988|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110582879|NCT00728988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110582880|NCT04087746|Ranibizumab|ranibizumab|mesh-list
110582881|NCT04087746|Aflibercept|aflibercept|mesh-list
110582882|NCT04087746|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110582883|NCT04087746|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110582884|NCT04087746|Growth Substances|growth substances|mesh-ancestor
110582885|NCT04087746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110582886|NCT04087746|Growth Inhibitors|growth inhibitors|mesh-ancestor
110582887|NCT04087746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110582888|NCT04083417|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110582889|NCT04083417|Penicillins|penicillins|mesh-list
110582890|NCT04083417|Penicillin V|penicillin v|mesh-list
110582891|NCT04083417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110582892|NCT02588937|Entecavir|entecavir|mesh-list
110582893|NCT02588937|Antiviral Agents|antiviral agents|mesh-ancestor
110582894|NCT02588937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110582895|NCT04083105|Midazolam|midazolam|mesh-list
110582896|NCT04083105|Nitrous Oxide|nitrous oxide|mesh-list
110582897|NCT04083105|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110582898|NCT04083105|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110582899|NCT04083105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110582900|NCT04083105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110582901|NCT04083105|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110582902|NCT04083105|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110582903|NCT04083105|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110582904|NCT04083105|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110582905|NCT04083105|Anesthetics, General|anesthetics, general|mesh-ancestor
110582906|NCT04083105|Anesthetics|anesthetics|mesh-ancestor
110582907|NCT04083105|GABA Modulators|gaba modulators|mesh-ancestor
110582908|NCT04083105|GABA Agents|gaba agents|mesh-ancestor
110582909|NCT04083105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110582910|NCT04083105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110582911|NCT04083105|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110582912|NCT04083105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110582913|NCT04083105|Analgesics|analgesics|mesh-ancestor
110582914|NCT04083105|Sensory System Agents|sensory system agents|mesh-ancestor
110582915|NCT04083105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110582916|NCT00735696|Paclitaxel|paclitaxel|mesh-list
110582917|NCT00735696|Carboplatin|carboplatin|mesh-list
110582918|NCT00735696|Ramucirumab|ramucirumab|mesh-list
110582919|NCT00735696|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110582920|NCT00735696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110582921|NCT00735696|Tubulin Modulators|tubulin modulators|mesh-ancestor
110582922|NCT00735696|Antimitotic Agents|antimitotic agents|mesh-ancestor
110582923|NCT00735696|Mitosis Modulators|mitosis modulators|mesh-ancestor
110582924|NCT00735696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110582925|NCT02593968|Interferons|interferons|mesh-list
110582926|NCT02593968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110582927|NCT02593968|Antiviral Agents|antiviral agents|mesh-ancestor
110582928|NCT02593968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110582929|NCT02588547|Granisetron|granisetron|mesh-list
110582930|NCT02588547|Antiemetics|antiemetics|mesh-ancestor
110582931|NCT02588547|Autonomic Agents|autonomic agents|mesh-ancestor
110582932|NCT02588547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110582933|NCT02588547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110582934|NCT02588547|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110582935|NCT02588547|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110582936|NCT02588547|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110582937|NCT02588547|Serotonin Agents|serotonin agents|mesh-ancestor
110582938|NCT02588547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110582939|NCT02588547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110582940|NCT00478231|Maraviroc|maraviroc|mesh-list
110582941|NCT00478231|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110582942|NCT00478231|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110582943|NCT00478231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110582944|NCT00478231|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110582945|NCT00478231|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110582946|NCT00478231|Antiviral Agents|antiviral agents|mesh-ancestor
110582947|NCT00478231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110582948|NCT00478231|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
110582949|NCT00474175|Benzocaine|benzocaine|mesh-list
110582950|NCT00474175|Anesthetics, Local|anesthetics, local|mesh-ancestor
110582951|NCT00474175|Anesthetics|anesthetics|mesh-ancestor
110582952|NCT00474175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110582953|NCT00474175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110582954|NCT00474175|Sensory System Agents|sensory system agents|mesh-ancestor
110149626|NCT00006427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110582955|NCT00474175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110582956|NCT03002389|Fluticasone|fluticasone|mesh-list
110582958|NCT03002389|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110582959|NCT03002389|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110582960|NCT03002389|Autonomic Agents|autonomic agents|mesh-ancestor
110582961|NCT03002389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110582962|NCT03002389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110582963|NCT03002389|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110582964|NCT03002389|Respiratory System Agents|respiratory system agents|mesh-ancestor
110582965|NCT03002389|Dermatologic Agents|dermatologic agents|mesh-ancestor
110582966|NCT03002389|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110582967|NCT04082949|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
110582968|NCT04082949|Hemostatics|hemostatics|mesh-ancestor
110582969|NCT04082949|Coagulants|coagulants|mesh-ancestor
110582970|NCT01020643|Propofol|propofol|mesh-list
110582971|NCT01020643|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110582972|NCT01020643|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110375659|NCT01133275|Hormones|hormones|mesh-ancestor
110582973|NCT01020643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110582974|NCT01020643|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110582975|NCT01020643|Anesthetics, General|anesthetics, general|mesh-ancestor
110582977|NCT03537391|Fluorides|fluorides|mesh-list
110582978|NCT03537391|Cariostatic Agents|cariostatic agents|mesh-ancestor
110582979|NCT03537391|Protective Agents|protective agents|mesh-ancestor
110582980|NCT03537391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110582981|NCT04082715|Celecoxib|celecoxib|mesh-list
110582982|NCT04082715|Levodopa|levodopa|mesh-list
110582983|NCT04082715|Carbidopa|carbidopa|mesh-list
110582984|NCT04082715|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
110582985|NCT04082715|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110582986|NCT04082715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110582987|NCT04082715|Analgesics|analgesics|mesh-ancestor
110582988|NCT04082715|Sensory System Agents|sensory system agents|mesh-ancestor
110582989|NCT04082715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110582990|NCT04082715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110582991|NCT04082715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110582992|NCT04082715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110582993|NCT04082715|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110582994|NCT04082715|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110582995|NCT04082715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110582996|NCT04082715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110582997|NCT04082715|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110582998|NCT04082715|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110582999|NCT04082715|Dopamine Agents|dopamine agents|mesh-ancestor
110583000|NCT04082715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110583001|NCT04082715|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
110583002|NCT04082715|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110583003|NCT04082715|Immunologic Factors|immunologic factors|mesh-ancestor
110583004|NCT04082715|Dopamine Agonists|dopamine agonists|mesh-ancestor
110583005|NCT00443209|Rizatriptan|rizatriptan|mesh-list
110583006|NCT00443209|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110583007|NCT00443209|Serotonin Agents|serotonin agents|mesh-ancestor
110583008|NCT00443209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110583009|NCT00443209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110583010|NCT00443209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110583011|NCT02588235|Atorvastatin|atorvastatin|mesh-list
110230429|NCT03352427|Immunologic Factors|immunologic factors|mesh-ancestor
110583012|NCT02588235|Ezetimibe|ezetimibe|mesh-list
110583013|NCT02588235|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110583014|NCT02588235|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110583015|NCT02588235|Antimetabolites|antimetabolites|mesh-ancestor
110583016|NCT02588235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110583017|NCT02588235|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110583018|NCT02588235|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110583019|NCT02588235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110583020|NCT01020955|Mecasermin|mecasermin|mesh-list
110583021|NCT01020955|Growth Substances|growth substances|mesh-ancestor
110583022|NCT01020955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110583023|NCT04082793|Diclofenac|diclofenac|mesh-list
110583024|NCT04082793|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110583025|NCT04082793|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110583026|NCT04082793|Analgesics|analgesics|mesh-ancestor
110583027|NCT04082793|Sensory System Agents|sensory system agents|mesh-ancestor
110583028|NCT04082793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110149633|NCT00008151|Cyclosporins|cyclosporins|mesh-list
110583029|NCT04082793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110583030|NCT04082793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110583031|NCT04082793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110583032|NCT04082793|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110583033|NCT04082793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110583034|NCT04082793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110583035|NCT00439231|Lenalidomide|lenalidomide|mesh-list
110583036|NCT00439231|Immunologic Factors|immunologic factors|mesh-ancestor
110583037|NCT00439231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110583038|NCT00439231|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110583039|NCT00439231|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110583040|NCT00439231|Growth Substances|growth substances|mesh-ancestor
110583041|NCT00439231|Growth Inhibitors|growth inhibitors|mesh-ancestor
110583042|NCT00439231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110583043|NCT00783692|Vedolizumab|vedolizumab|mesh-list
110583044|NCT00783692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110583045|NCT04992273|Casirivimab and imdevimab drug combination|casirivimab and imdevimab drug combination|mesh-list
110583046|NCT04992273|Antiviral Agents|antiviral agents|mesh-ancestor
110583047|NCT04992273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110583048|NCT00783224|Fluticasone|fluticasone|mesh-list
110583049|NCT00783224|Mometasone Furoate|mometasone furoate|mesh-list
110583050|NCT00783224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110583051|NCT00783224|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110583052|NCT00783224|Autonomic Agents|autonomic agents|mesh-ancestor
110583053|NCT00783224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110583054|NCT00783224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110583055|NCT00783224|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110583056|NCT00783224|Respiratory System Agents|respiratory system agents|mesh-ancestor
110583057|NCT00783224|Dermatologic Agents|dermatologic agents|mesh-ancestor
110583058|NCT00783224|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110583059|NCT04102124|Fluzoparib|fluzoparib|mesh-list
110583060|NCT04102124|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110583061|NCT04102124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110583062|NCT04102124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110583063|NCT04102124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110583064|NCT04082559|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110583065|NCT04082559|Metronidazole|metronidazole|mesh-list
110583066|NCT04082559|Doxycycline|doxycycline|mesh-list
110583067|NCT04082559|Ciprofloxacin|ciprofloxacin|mesh-list
110583068|NCT04082559|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
110583069|NCT04082559|Complement Factor H|complement factor h|mesh-list
110583070|NCT04082559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110583071|NCT04082559|Antitubercular Agents|antitubercular agents|mesh-ancestor
110583072|NCT04082559|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110583073|NCT04082559|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110583074|NCT04082559|Antimalarials|antimalarials|mesh-ancestor
110583075|NCT04082559|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110583076|NCT04082559|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110583077|NCT04082559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110583078|NCT04082559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110583079|NCT04082559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110583080|NCT04082559|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110583082|NCT04082559|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
110583083|NCT04082559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110583084|NCT04082559|Immunologic Factors|immunologic factors|mesh-ancestor
110583085|NCT04082559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110230531|NCT02959957|Cefotaxime|cefotaxime|mesh-list
110583087|NCT02587845|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110583088|NCT02587845|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110583089|NCT02587845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110583090|NCT02587845|Hemostatics|hemostatics|mesh-ancestor
110583091|NCT02587845|Coagulants|coagulants|mesh-ancestor
110583092|NCT00765674|Amlodipine|amlodipine|mesh-list
110583093|NCT00765674|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110583094|NCT00765674|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110583095|NCT00765674|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110583096|NCT00765674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110583097|NCT00765674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110149635|NCT00008151|Abortifacient Agents|abortifacient agents|mesh-ancestor
110036346|NCT01410747|Immunologic Factors|immunologic factors|mesh-ancestor
110583098|NCT00765674|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110583099|NCT00765674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110583100|NCT00765674|Vasodilator Agents|vasodilator agents|mesh-ancestor
110583101|NCT00765674|Diuretics|diuretics|mesh-ancestor
110583102|NCT00765674|Natriuretic Agents|natriuretic agents|mesh-ancestor
110583103|NCT00765674|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110583104|NCT00586898|Ketoconazole|ketoconazole|mesh-list
110583105|NCT00586898|Bicalutamide|bicalutamide|mesh-list
110583106|NCT00586898|Testosterone|testosterone|mesh-list
110583108|NCT00586898|Androgens|androgens|mesh-ancestor
110583109|NCT00586898|Hormones|hormones|mesh-ancestor
110583110|NCT00586898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110583111|NCT00586898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110583112|NCT00586898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110583113|NCT00586898|Antifungal Agents|antifungal agents|mesh-ancestor
110583114|NCT00586898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110583115|NCT00586898|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110583116|NCT00586898|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110583117|NCT00586898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110583118|NCT00586898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110583119|NCT00586898|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110583120|NCT00586898|Hormone Antagonists|hormone antagonists|mesh-ancestor
110583121|NCT00586898|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110583122|NCT00586898|Androgen Antagonists|androgen antagonists|mesh-ancestor
110583123|NCT02587455|Pembrolizumab|pembrolizumab|mesh-list
110583124|NCT02587455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110583125|NCT02587455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110583126|NCT02587455|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110583127|NCT02587455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110583128|NCT04099238|Warfarin|warfarin|mesh-list
110583129|NCT04099238|Rivaroxaban|rivaroxaban|mesh-list
110583130|NCT04099238|Dabigatran|dabigatran|mesh-list
110583131|NCT04099238|Apixaban|apixaban|mesh-list
110583132|NCT04099238|Anticoagulants|anticoagulants|mesh-list
110583133|NCT04099238|Edoxaban|edoxaban|mesh-list
110583134|NCT04099238|Acenocoumarol|acenocoumarol|mesh-list
110583135|NCT04099238|Phenindione|phenindione|mesh-list
110583136|NCT04099238|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110583137|NCT04099238|Antithrombins|antithrombins|mesh-ancestor
110583138|NCT04099238|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110583139|NCT04099238|Protease Inhibitors|protease inhibitors|mesh-ancestor
110583140|NCT04099238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110583141|NCT04099238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110583145|NCT04101812|Doxorubicin|doxorubicin|mesh-list
110583146|NCT04101812|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110583147|NCT04101812|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110583148|NCT04101812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110583149|NCT04101812|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110583150|NCT04101812|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110583151|NCT04101812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110583152|NCT04101812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110583153|NCT04923867|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110583154|NCT04923867|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110583155|NCT04923867|Estradiol|estradiol|mesh-list
110583156|NCT04923867|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110583157|NCT04923867|Estrogens|estrogens|mesh-ancestor
110583158|NCT04923867|Hormones|hormones|mesh-ancestor
110583159|NCT04923867|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110583160|NCT04923867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110583161|NCT04923867|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110583162|NCT04923867|Contraceptive Agents|contraceptive agents|mesh-ancestor
110583163|NCT04923867|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110583164|NCT04923867|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110583165|NCT02587533|Dopamine|dopamine|mesh-list
110583166|NCT02587533|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110583167|NCT02587533|Sympathomimetics|sympathomimetics|mesh-ancestor
110583168|NCT02587533|Autonomic Agents|autonomic agents|mesh-ancestor
110583169|NCT02587533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110149639|NCT00008151|Antimetabolites|antimetabolites|mesh-ancestor
110583170|NCT02587533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110583172|NCT02587533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110583173|NCT02587533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110583174|NCT02587533|Protective Agents|protective agents|mesh-ancestor
110583175|NCT04847661|Mefloquine|mefloquine|mesh-list
110583176|NCT04847661|Antimalarials|antimalarials|mesh-ancestor
110583177|NCT04847661|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110583178|NCT04847661|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110583179|NCT04847661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110583180|NCT00919815|Cyclosporine|cyclosporine|mesh-list
110583181|NCT00919815|Prednisolone|prednisolone|mesh-list
110583182|NCT00919815|Cyclosporins|cyclosporins|mesh-list
110583183|NCT00919815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110583184|NCT00919815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110583185|NCT00919815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110583186|NCT00919815|Immunologic Factors|immunologic factors|mesh-ancestor
110583187|NCT00919815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110583188|NCT00919815|Antifungal Agents|antifungal agents|mesh-ancestor
110583189|NCT00919815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110583190|NCT00919815|Dermatologic Agents|dermatologic agents|mesh-ancestor
110583191|NCT00919815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110583192|NCT00919815|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110583193|NCT00919815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110583194|NCT00919815|Glucocorticoids|glucocorticoids|mesh-ancestor
110583195|NCT00919815|Hormones|hormones|mesh-ancestor
110583196|NCT00919815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110583197|NCT00919815|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110583198|NCT00919815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110583199|NCT00796991|Paclitaxel|paclitaxel|mesh-list
110583200|NCT00796991|Carboplatin|carboplatin|mesh-list
110583201|NCT00796991|Ipilimumab|ipilimumab|mesh-list
110583202|NCT00796991|Dacarbazine|dacarbazine|mesh-list
110583203|NCT00796991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110583204|NCT00796991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110583205|NCT00796991|Tubulin Modulators|tubulin modulators|mesh-ancestor
110583206|NCT00796991|Antimitotic Agents|antimitotic agents|mesh-ancestor
110583207|NCT00796991|Mitosis Modulators|mitosis modulators|mesh-ancestor
110583208|NCT00796991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110583209|NCT00796991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110583210|NCT00796991|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110583211|NCT00796991|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110583212|NCT00796991|Alkylating Agents|alkylating agents|mesh-ancestor
110583213|NCT04112147|Ubiquinone|ubiquinone|mesh-list
110583214|NCT04112147|Micronutrients|micronutrients|mesh-ancestor
110583215|NCT04112147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110583216|NCT00914771|Vaccines|vaccines|mesh-list
110583217|NCT00914771|Immunologic Factors|immunologic factors|mesh-ancestor
110583218|NCT00914771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110583219|NCT02586987|Durvalumab|durvalumab|mesh-list
110583220|NCT02586987|Tremelimumab|tremelimumab|mesh-list
110583221|NCT02586987|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110583222|NCT02586987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110583223|NCT02586753|Paclitaxel|paclitaxel|mesh-list
110583224|NCT02586753|Cisplatin|cisplatin|mesh-list
110583225|NCT02586753|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110583226|NCT02586753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110583227|NCT02586753|Tubulin Modulators|tubulin modulators|mesh-ancestor
110583228|NCT02586753|Antimitotic Agents|antimitotic agents|mesh-ancestor
110583229|NCT02586753|Mitosis Modulators|mitosis modulators|mesh-ancestor
110583230|NCT02586753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110583231|NCT00799487|Methylphenidate|methylphenidate|mesh-list
110583232|NCT00799487|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110583233|NCT00799487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110583235|NCT00799487|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110583236|NCT00799487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110230663|NCT00420082|Cetirizine|cetirizine|mesh-list
110583237|NCT00799487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110583239|NCT00799487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110583240|NCT00799409|Methylphenidate|methylphenidate|mesh-list
110583241|NCT00799409|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110583242|NCT00799409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110583243|NCT00799409|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110583244|NCT00799409|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110583245|NCT00799409|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110583246|NCT00799409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110583247|NCT00799409|Dopamine Agents|dopamine agents|mesh-ancestor
110583248|NCT00799409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110583249|NCT00782210|Olodaterol|olodaterol|mesh-list
110583250|NCT00782210|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110583251|NCT00782210|Autonomic Agents|autonomic agents|mesh-ancestor
110583252|NCT00782210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110583253|NCT00782210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110583254|NCT00782210|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110583255|NCT00782210|Respiratory System Agents|respiratory system agents|mesh-ancestor
110583256|NCT01558115|Denosumab|denosumab|mesh-list
110583257|NCT01558115|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110583258|NCT01558115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110583259|NCT02605265|Capecitabine|capecitabine|mesh-list
110583260|NCT02605265|Oxaliplatin|oxaliplatin|mesh-list
110583261|NCT02605265|Irinotecan|irinotecan|mesh-list
110583262|NCT02605265|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110583263|NCT02605265|Antimetabolites|antimetabolites|mesh-ancestor
110583264|NCT02605265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110583265|NCT02605265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110583266|NCT02605265|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110583267|NCT02605265|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110583268|NCT02605265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110583269|NCT04101500|Aminophylline|aminophylline|mesh-list
110583270|NCT04101500|Bromides|bromides|mesh-list
110583271|NCT04101500|Ipratropium|ipratropium|mesh-list
110583272|NCT04101500|Anticonvulsants|anticonvulsants|mesh-ancestor
110583273|NCT04101500|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110583274|NCT04101500|Autonomic Agents|autonomic agents|mesh-ancestor
110583275|NCT04101500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110583276|NCT04101500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110583277|NCT04101500|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110583278|NCT04101500|Respiratory System Agents|respiratory system agents|mesh-ancestor
110583279|NCT04101500|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110583280|NCT04101500|Cholinergic Agents|cholinergic agents|mesh-ancestor
110583281|NCT04101500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110583282|NCT04101500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110583283|NCT04101500|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110583284|NCT04101500|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110375707|NCT00584636|Budesonide|budesonide|mesh-list
110583285|NCT04101500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110583286|NCT04101500|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110583287|NCT04101500|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110583288|NCT04101500|Purinergic Agents|purinergic agents|mesh-ancestor
110583289|NCT04101500|Protective Agents|protective agents|mesh-ancestor
110583290|NCT02586441|Bromides|bromides|mesh-list
110583291|NCT02586441|Propofol|propofol|mesh-list
110583292|NCT02586441|Rocuronium|rocuronium|mesh-list
110583293|NCT02586441|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110583294|NCT02586441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110583295|NCT02586441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110583296|NCT02586441|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110583297|NCT02586441|Anesthetics, General|anesthetics, general|mesh-ancestor
110583298|NCT02586441|Anesthetics|anesthetics|mesh-ancestor
110583299|NCT02586441|Anticonvulsants|anticonvulsants|mesh-ancestor
110583300|NCT02586441|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110583301|NCT02586441|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110583302|NCT02586441|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110583303|NCT02586441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110583304|NCT02586363|Entecavir|entecavir|mesh-list
110583305|NCT02586363|Antiviral Agents|antiviral agents|mesh-ancestor
110583306|NCT02586363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110583307|NCT02586129|Metformin|metformin|mesh-list
110583308|NCT02586129|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110583309|NCT02586129|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110583310|NCT02586129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110583311|NCT02586129|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110583312|NCT02586129|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110583313|NCT02586129|Antimetabolites|antimetabolites|mesh-ancestor
110583314|NCT02586129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110583315|NCT02586129|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110583316|NCT02586129|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110583317|NCT02586129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110583319|NCT04081077|Linezolid|linezolid|mesh-list
110583320|NCT04081077|Bedaquiline|bedaquiline|mesh-list
110583321|NCT04081077|Clofazimine|clofazimine|mesh-list
110583322|NCT04081077|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110583323|NCT04081077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110583324|NCT04081077|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110583325|NCT04081077|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110583326|NCT04081077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110583327|NCT04081077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110583328|NCT04081077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110583329|NCT04081077|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110583330|NCT04081077|Antitubercular Agents|antitubercular agents|mesh-ancestor
110583331|NCT04081077|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110583332|NCT04081077|Leprostatic Agents|leprostatic agents|mesh-ancestor
110583347|NCT02586051|Obinutuzumab|obinutuzumab|mesh-list
110583348|NCT02586051|Immunoglobulins|immunoglobulins|mesh-list
110583349|NCT02586051|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110583350|NCT02586051|Antibodies|antibodies|mesh-list
110583351|NCT02586051|gamma-Globulins|gamma-globulins|mesh-list
110583352|NCT02586051|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110583353|NCT02586051|Immunologic Factors|immunologic factors|mesh-ancestor
110583354|NCT02586051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110583355|NCT02586051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110583356|NCT02586051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110583357|NCT00763958|Buprenorphine|buprenorphine|mesh-list
110583358|NCT00763958|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110583359|NCT00763958|Narcotics|narcotics|mesh-ancestor
110583360|NCT00763958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110583361|NCT00763958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110583362|NCT00763958|Analgesics|analgesics|mesh-ancestor
110583363|NCT00763958|Sensory System Agents|sensory system agents|mesh-ancestor
110583364|NCT00763958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110583365|NCT00763958|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110583366|NCT04101578|Cyclosporine|cyclosporine|mesh-list
110583367|NCT04101578|Mycophenolic Acid|mycophenolic acid|mesh-list
110583368|NCT04101578|Prednisone|prednisone|mesh-list
110583369|NCT04101578|Methylprednisolone|methylprednisolone|mesh-list
110583370|NCT04101578|Cyclophosphamide|cyclophosphamide|mesh-list
110583371|NCT04101578|Methotrexate|methotrexate|mesh-list
110583372|NCT04101578|Azathioprine|azathioprine|mesh-list
110583373|NCT04101578|Bromides|bromides|mesh-list
110583374|NCT04101578|Tacrolimus|tacrolimus|mesh-list
110583375|NCT04101578|Cyclosporins|cyclosporins|mesh-list
110583376|NCT04101578|Immunosuppressive Agents|immunosuppressive agents|mesh-list
110583377|NCT04101578|Immunoglobulins|immunoglobulins|mesh-list
110583378|NCT04101578|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110583379|NCT04101578|gamma-Globulins|gamma-globulins|mesh-list
110583380|NCT04101578|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110583381|NCT04101578|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
110583382|NCT04101578|Immunologic Factors|immunologic factors|mesh-ancestor
110583383|NCT04101578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110583384|NCT04101578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110583385|NCT04101578|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110583386|NCT04101578|Alkylating Agents|alkylating agents|mesh-ancestor
110583387|NCT04101578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110583388|NCT04101578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110583389|NCT04101578|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110583390|NCT04101578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110583391|NCT04101578|Glucocorticoids|glucocorticoids|mesh-ancestor
110583393|NCT04101578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110583394|NCT04101578|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110583395|NCT04101578|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110583396|NCT04101578|Abortifacient Agents|abortifacient agents|mesh-ancestor
110583397|NCT04101578|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110583398|NCT04101578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110583399|NCT04101578|Antimetabolites|antimetabolites|mesh-ancestor
110583400|NCT04101578|Dermatologic Agents|dermatologic agents|mesh-ancestor
110583401|NCT04101578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110583402|NCT04101578|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110583403|NCT04101578|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110583404|NCT04101578|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110583405|NCT04101578|Antifungal Agents|antifungal agents|mesh-ancestor
110583406|NCT04101578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110583407|NCT04101578|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110583408|NCT04101578|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110583409|NCT04101578|Antitubercular Agents|antitubercular agents|mesh-ancestor
110583410|NCT04101578|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110583411|NCT04101578|Antiemetics|antiemetics|mesh-ancestor
110583412|NCT04101578|Autonomic Agents|autonomic agents|mesh-ancestor
110583413|NCT04101578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110583414|NCT04101578|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110583415|NCT04101578|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110583416|NCT04101578|Protective Agents|protective agents|mesh-ancestor
110583417|NCT04101578|Anticonvulsants|anticonvulsants|mesh-ancestor
110583418|NCT04101578|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110583419|NCT04101578|Cholinergic Agents|cholinergic agents|mesh-ancestor
110583420|NCT04101578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110583421|NCT00763256|Triclosan|triclosan|mesh-list
110583422|NCT00763256|Fluorides|fluorides|mesh-list
110583423|NCT00763256|Cariostatic Agents|cariostatic agents|mesh-ancestor
110583424|NCT00763256|Protective Agents|protective agents|mesh-ancestor
110583425|NCT00763256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110583426|NCT00763256|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110583427|NCT00763256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110583428|NCT00763256|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
110583429|NCT00763256|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110583430|NCT00763256|Antimetabolites|antimetabolites|mesh-ancestor
110583431|NCT00763256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110583432|NCT00763256|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110583433|NCT02585973|Cisplatin|cisplatin|mesh-list
110583434|NCT02585973|Adavosertib|adavosertib|mesh-list
110583435|NCT02585973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110583436|NCT02585973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110583437|NCT02585973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110583439|NCT00920283|Trace Elements|trace elements|mesh-ancestor
110583440|NCT00920283|Micronutrients|micronutrients|mesh-ancestor
110583441|NCT00920283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110583442|NCT00583947|Albuterol|albuterol|mesh-list
110583443|NCT00583947|Formoterol Fumarate|formoterol fumarate|mesh-list
110375733|NCT04575194|Bupropion|bupropion|mesh-list
110583444|NCT00583947|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110583445|NCT00583947|Autonomic Agents|autonomic agents|mesh-ancestor
110583446|NCT00583947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110583447|NCT00583947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110583448|NCT00583947|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110583449|NCT00583947|Respiratory System Agents|respiratory system agents|mesh-ancestor
110583450|NCT00583947|Tocolytic Agents|tocolytic agents|mesh-ancestor
110583451|NCT00583947|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110583452|NCT00583947|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110583453|NCT00583947|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110583454|NCT00583947|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110583455|NCT00583947|Adrenergic Agents|adrenergic agents|mesh-ancestor
110583457|NCT00583947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110583459|NCT00772928|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110583460|NCT00772928|Immunologic Factors|immunologic factors|mesh-ancestor
110583461|NCT00772928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110583462|NCT00762164|Simvastatin|simvastatin|mesh-list
110583463|NCT00762164|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
110583464|NCT00762164|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110583465|NCT00762164|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110583466|NCT00762164|Antimetabolites|antimetabolites|mesh-ancestor
110583467|NCT00762164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110583468|NCT00762164|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110583469|NCT00762164|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110583470|NCT00762164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110583471|NCT00761774|Brivaracetam|brivaracetam|mesh-list
110583472|NCT00761774|Anticonvulsants|anticonvulsants|mesh-ancestor
110583473|NCT04080375|Dinoprostone|dinoprostone|mesh-list
110583474|NCT04080375|Oxytocics|oxytocics|mesh-ancestor
110583475|NCT04080375|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110583476|NCT04080375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110583477|NCT00781274|Ribavirin|ribavirin|mesh-list
110583478|NCT00781274|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110583479|NCT00781274|Antimetabolites|antimetabolites|mesh-ancestor
110583480|NCT00781274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110583481|NCT00781274|Antiviral Agents|antiviral agents|mesh-ancestor
110583482|NCT00781274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110583483|NCT05520177|Ranibizumab|ranibizumab|mesh-list
110583484|NCT05520177|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110583485|NCT05520177|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110583486|NCT05520177|Growth Substances|growth substances|mesh-ancestor
110583487|NCT05520177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110583488|NCT05520177|Growth Inhibitors|growth inhibitors|mesh-ancestor
110583489|NCT05520177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110583490|NCT00780416|Ribavirin|ribavirin|mesh-list
110583491|NCT00780416|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110583492|NCT00780416|Interferon-alpha|interferon-alpha|mesh-list
110583493|NCT00780416|Antimetabolites|antimetabolites|mesh-ancestor
110583494|NCT00780416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110583495|NCT00780416|Antiviral Agents|antiviral agents|mesh-ancestor
110583496|NCT00780416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110583497|NCT00780416|Immunologic Factors|immunologic factors|mesh-ancestor
110583498|NCT00780416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110583499|NCT02584881|Analgesics, Opioid|analgesics, opioid|mesh-list
110583500|NCT02584881|Narcotics|narcotics|mesh-ancestor
110583501|NCT02584881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110583502|NCT02584881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110583503|NCT02584881|Analgesics|analgesics|mesh-ancestor
110583504|NCT02584881|Sensory System Agents|sensory system agents|mesh-ancestor
110583505|NCT02584881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110583506|NCT00761462|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110583507|NCT00761462|Ciprofloxacin|ciprofloxacin|mesh-list
110583508|NCT00761462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110583509|NCT00761462|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110583510|NCT00761462|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110583511|NCT00761462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110583512|NCT00761462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110583513|NCT00761462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110583514|NCT00761462|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110583515|NCT00761462|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110583516|NCT00761306|Vortioxetine|vortioxetine|mesh-list
110583517|NCT00761306|Antidepressive Agents|antidepressive agents|mesh-ancestor
110583518|NCT00761306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110583519|NCT00761306|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110583520|NCT00761306|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110583521|NCT00761306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110583522|NCT00761306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110583523|NCT00761306|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110583524|NCT00761306|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110583525|NCT00761306|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110583526|NCT00761306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110583527|NCT00761306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110583529|NCT00761306|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110583530|NCT00761306|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110583531|NCT00761306|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110583532|NCT00761306|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110583533|NCT00772538|Tiotropium Bromide|tiotropium bromide|mesh-list
110583534|NCT00772538|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110583535|NCT00772538|Autonomic Agents|autonomic agents|mesh-ancestor
110583536|NCT00772538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110583537|NCT00772538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110230957|NCT00323791|Gemcitabine|gemcitabine|mesh-list
110583538|NCT00772538|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110583539|NCT00772538|Respiratory System Agents|respiratory system agents|mesh-ancestor
110583540|NCT00772538|Parasympatholytics|parasympatholytics|mesh-ancestor
110583541|NCT00772538|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110583542|NCT00772538|Cholinergic Agents|cholinergic agents|mesh-ancestor
110583543|NCT00772538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110583544|NCT00772538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110583546|NCT04079517|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110583547|NCT04079517|Hormone Antagonists|hormone antagonists|mesh-ancestor
110583548|NCT04079517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110583549|NCT04079517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110583550|NCT04079517|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110583551|NCT04079517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110583552|NCT04079517|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110583553|NCT04079517|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110583554|NCT04079517|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110583555|NCT00761150|Acetaminophen|acetaminophen|mesh-list
110583556|NCT00761150|Hydrocodone|hydrocodone|mesh-list
110583557|NCT00761150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110583558|NCT00761150|Analgesics|analgesics|mesh-ancestor
110583559|NCT00761150|Sensory System Agents|sensory system agents|mesh-ancestor
110583560|NCT00761150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110583561|NCT00761150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110583562|NCT00761150|Antipyretics|antipyretics|mesh-ancestor
110583563|NCT00761150|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110583564|NCT00761150|Narcotics|narcotics|mesh-ancestor
110583565|NCT00761150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110583566|NCT00761150|Antitussive Agents|antitussive agents|mesh-ancestor
110583567|NCT00761150|Respiratory System Agents|respiratory system agents|mesh-ancestor
110583568|NCT00583557|Belimumab|belimumab|mesh-list
110583569|NCT00583557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110583570|NCT00583557|Immunologic Factors|immunologic factors|mesh-ancestor
110583571|NCT00583557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110583572|NCT00586820|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
110583573|NCT00586820|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110583574|NCT00586820|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
110583575|NCT00586820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110583576|NCT00760838|Azithromycin|azithromycin|mesh-list
110583577|NCT00760838|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110583578|NCT00760838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110583579|NCT00586664|Bepotastine besilate|bepotastine besilate|mesh-list
110583580|NCT00586664|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110583581|NCT00586664|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110583582|NCT00586664|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110583583|NCT02584335|Lidocaine|lidocaine|mesh-list
110583584|NCT02584335|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110583585|NCT02584335|Anesthetics, Local|anesthetics, local|mesh-ancestor
110583586|NCT02584335|Anesthetics|anesthetics|mesh-ancestor
110583587|NCT02584335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110583588|NCT02584335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110583589|NCT02584335|Sensory System Agents|sensory system agents|mesh-ancestor
110583590|NCT02584335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110583591|NCT02584335|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110583592|NCT02584335|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110583593|NCT02584335|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110583594|NCT02584335|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110583595|NCT02584335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110583596|NCT00437281|Pregabalin|pregabalin|mesh-list
110583597|NCT00437281|Analgesics|analgesics|mesh-ancestor
110583598|NCT00437281|Sensory System Agents|sensory system agents|mesh-ancestor
110583599|NCT00437281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110583600|NCT00437281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110583601|NCT00437281|Anticonvulsants|anticonvulsants|mesh-ancestor
110583602|NCT00437281|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110583603|NCT00437281|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110583604|NCT00437281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110583605|NCT00437281|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110583606|NCT00437281|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110583607|NCT00437281|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110583608|NCT00437281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110583609|NCT00437281|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110583610|NCT04544007|Poly ICLC|poly iclc|mesh-list
110583611|NCT04544007|Interferon Inducers|interferon inducers|mesh-ancestor
110583612|NCT04544007|Immunologic Factors|immunologic factors|mesh-ancestor
110583613|NCT04544007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110583614|NCT05468073|Aldesleukin|aldesleukin|mesh-list
110583615|NCT05468073|Interleukin-2|interleukin-2|mesh-list
110583616|NCT05468073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110583617|NCT05468073|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110583618|NCT05468073|Analgesics|analgesics|mesh-ancestor
110583619|NCT05468073|Sensory System Agents|sensory system agents|mesh-ancestor
110583620|NCT05468073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110583621|NCT05468073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110583622|NCT05468073|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110583623|NCT05468073|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110583624|NCT05468073|Antiviral Agents|antiviral agents|mesh-ancestor
110583625|NCT05468073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110583626|NCT05674695|Omalizumab|omalizumab|mesh-list
110583627|NCT05674695|Cyclosporine|cyclosporine|mesh-list
110583628|NCT05674695|Methotrexate|methotrexate|mesh-list
110583629|NCT05674695|Upadacitinib|upadacitinib|mesh-list
110583630|NCT05674695|Cyclosporins|cyclosporins|mesh-list
110583631|NCT05674695|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110583632|NCT05674695|Abortifacient Agents|abortifacient agents|mesh-ancestor
110583633|NCT05674695|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110583634|NCT05674695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110583635|NCT05674695|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110583636|NCT05674695|Antimetabolites|antimetabolites|mesh-ancestor
110583637|NCT05674695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110583638|NCT05674695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110583639|NCT05674695|Dermatologic Agents|dermatologic agents|mesh-ancestor
110583640|NCT05674695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110583641|NCT05674695|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110583642|NCT05674695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110583643|NCT05674695|Immunologic Factors|immunologic factors|mesh-ancestor
110583644|NCT05674695|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110583645|NCT05674695|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110583646|NCT05674695|Antifungal Agents|antifungal agents|mesh-ancestor
110583647|NCT05674695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110583648|NCT05674695|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110583649|NCT05674695|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110583650|NCT05674695|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110583651|NCT05674695|Respiratory System Agents|respiratory system agents|mesh-ancestor
110583652|NCT05674695|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
110583653|NCT05674695|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110583654|NCT02596269|Nefopam|nefopam|mesh-list
110583655|NCT02596269|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110583656|NCT02596269|Analgesics|analgesics|mesh-ancestor
110583657|NCT02596269|Sensory System Agents|sensory system agents|mesh-ancestor
110583658|NCT02596269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110583659|NCT02596269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110583660|NCT00741039|Vaccines|vaccines|mesh-list
110583661|NCT00741039|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110583662|NCT00741039|Immunologic Factors|immunologic factors|mesh-ancestor
110583663|NCT00741039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110583664|NCT02583321|Silver Sulfadiazine|silver sulfadiazine|mesh-list
110583665|NCT02583321|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110583666|NCT02583321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110583667|NCT04454229|Penicillins|penicillins|mesh-list
110583668|NCT04454229|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110583669|NCT04454229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110583670|NCT04078659|Lidocaine|lidocaine|mesh-list
110583671|NCT04078659|Magnesium Sulfate|magnesium sulfate|mesh-list
110583672|NCT04078659|Fentanyl|fentanyl|mesh-list
110583673|NCT04078659|Propofol|propofol|mesh-list
110583674|NCT04078659|Atracurium|atracurium|mesh-list
110583675|NCT04078659|Anesthetics, Local|anesthetics, local|mesh-ancestor
110583676|NCT04078659|Anesthetics|anesthetics|mesh-ancestor
110583677|NCT04078659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110583678|NCT04078659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110583679|NCT04078659|Sensory System Agents|sensory system agents|mesh-ancestor
110583680|NCT04078659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110583681|NCT04078659|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110583682|NCT04078659|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110583683|NCT04078659|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110583684|NCT04078659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110231106|NCT00317785|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110583685|NCT04078659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110583686|NCT04078659|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110583687|NCT04078659|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110583688|NCT04078659|Anesthetics, General|anesthetics, general|mesh-ancestor
110583689|NCT04078659|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110583690|NCT04078659|Narcotics|narcotics|mesh-ancestor
110583691|NCT04078659|Analgesics|analgesics|mesh-ancestor
110583692|NCT04078659|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110583693|NCT04078659|Anticonvulsants|anticonvulsants|mesh-ancestor
110583694|NCT04078659|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110583695|NCT04078659|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110583696|NCT04078659|Tocolytic Agents|tocolytic agents|mesh-ancestor
110583697|NCT04078659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110583698|NCT04078659|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110583699|NCT04078659|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110583700|NCT04078659|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110583701|NCT04078659|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
110583702|NCT04078659|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110583703|NCT04078659|Cholinergic Agents|cholinergic agents|mesh-ancestor
110583704|NCT04078659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110583705|NCT02583243|Buprenorphine|buprenorphine|mesh-list
110583706|NCT02583243|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110583707|NCT02583243|Narcotics|narcotics|mesh-ancestor
110583708|NCT02583243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110583709|NCT02583243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110583710|NCT02583243|Analgesics|analgesics|mesh-ancestor
110583711|NCT02583243|Sensory System Agents|sensory system agents|mesh-ancestor
110583712|NCT02583243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110583713|NCT02583243|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110583714|NCT00798707|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
110583715|NCT00798707|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110583716|NCT00798707|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110583717|NCT00798707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110583718|NCT00798707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110583719|NCT00798707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110583720|NCT00798707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110583721|NCT00798707|Antidepressive Agents|antidepressive agents|mesh-ancestor
110583722|NCT00798707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110583723|NCT00760214|Ramipril|ramipril|mesh-list
110583724|NCT00760214|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
110583725|NCT00760214|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110583726|NCT00760214|Protease Inhibitors|protease inhibitors|mesh-ancestor
110583727|NCT00760214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110583728|NCT00760214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110583729|NCT00760214|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110583730|NCT00760214|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110583731|NCT00760214|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110583732|NCT04078425|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
110583733|NCT04078425|Hormone Antagonists|hormone antagonists|mesh-ancestor
110583734|NCT04078425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110583735|NCT04078425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110583736|NCT04078425|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110583738|NCT04078425|Natriuretic Agents|natriuretic agents|mesh-ancestor
110583739|NCT00638391|Anastrozole|anastrozole|mesh-list
110583740|NCT00638391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110583741|NCT00638391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110583742|NCT00638391|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110583743|NCT00638391|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110583744|NCT00638391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110583745|NCT00638391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110583746|NCT00638391|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110583747|NCT00638391|Hormone Antagonists|hormone antagonists|mesh-ancestor
110583748|NCT00638391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110583749|NCT00638391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110583750|NCT02583633|Nifedipine|nifedipine|mesh-list
110583751|NCT02583633|Nitroglycerin|nitroglycerin|mesh-list
110583752|NCT02583633|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110583753|NCT02583633|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110583754|NCT02583633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110583755|NCT02583633|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110583756|NCT02583633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110583757|NCT02583633|Vasodilator Agents|vasodilator agents|mesh-ancestor
110583758|NCT02583633|Tocolytic Agents|tocolytic agents|mesh-ancestor
110583759|NCT02583633|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110583760|NCT02582307|Acetaminophen|acetaminophen|mesh-list
110583761|NCT02582307|Scopolamine|scopolamine|mesh-list
110583762|NCT02582307|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
110583763|NCT02582307|Analgesics|analgesics|mesh-list
110583764|NCT02582307|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
110583765|NCT02582307|Sensory System Agents|sensory system agents|mesh-ancestor
110583766|NCT02582307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110583767|NCT02582307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110583768|NCT02582307|Antipyretics|antipyretics|mesh-ancestor
110583769|NCT02582307|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110583770|NCT02582307|Antiemetics|antiemetics|mesh-ancestor
110583771|NCT02582307|Autonomic Agents|autonomic agents|mesh-ancestor
110583772|NCT02582307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110583773|NCT02582307|Mydriatics|mydriatics|mesh-ancestor
110583774|NCT02582307|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110583775|NCT02582307|Cholinergic Agents|cholinergic agents|mesh-ancestor
110583776|NCT02582307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110583777|NCT02582307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110583778|NCT02582307|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110583779|NCT02582307|Parasympatholytics|parasympatholytics|mesh-ancestor
110583780|NCT02689245|Tenofovir|tenofovir|mesh-list
110583781|NCT02689245|Antiviral Agents|antiviral agents|mesh-ancestor
110583782|NCT02689245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110583783|NCT02689245|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110583784|NCT02689245|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110583785|NCT02689245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110583786|NCT02689245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110583787|NCT02689245|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110583788|NCT02689245|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110583789|NCT00802841|Imatinib Mesylate|imatinib mesylate|mesh-list
110583790|NCT00802841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110583791|NCT00802841|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110583792|NCT00802841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110583793|NCT00802841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110583794|NCT00772148|Tacrolimus|tacrolimus|mesh-list
110583795|NCT00772148|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110583796|NCT00772148|Immunologic Factors|immunologic factors|mesh-ancestor
110583797|NCT00772148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110583798|NCT00772148|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110583799|NCT00772148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110583800|NCT00772148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110583801|NCT02689089|Rifapentine|rifapentine|mesh-list
110583802|NCT02689089|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110583803|NCT02689089|Antitubercular Agents|antitubercular agents|mesh-ancestor
110583804|NCT02689089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110583805|NCT02689089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110583806|NCT02689089|Leprostatic Agents|leprostatic agents|mesh-ancestor
110583807|NCT00759902|Morphine|morphine|mesh-list
110583808|NCT00759902|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110583809|NCT00759902|Narcotics|narcotics|mesh-ancestor
110583810|NCT00759902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110583811|NCT00759902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110583812|NCT00759902|Analgesics|analgesics|mesh-ancestor
110583813|NCT00759902|Sensory System Agents|sensory system agents|mesh-ancestor
110583814|NCT00759902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110583815|NCT04077957|Hydroxychloroquine|hydroxychloroquine|mesh-list
110583816|NCT04077957|Sulfasalazine|sulfasalazine|mesh-list
110583817|NCT04077957|Etanercept|etanercept|mesh-list
110583818|NCT04077957|Methotrexate|methotrexate|mesh-list
110583819|NCT04077957|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110583820|NCT04077957|Abortifacient Agents|abortifacient agents|mesh-ancestor
110583821|NCT04077957|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110583822|NCT04077957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110583823|NCT04077957|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110583824|NCT04077957|Antimetabolites|antimetabolites|mesh-ancestor
110583825|NCT04077957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110583826|NCT04077957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110583827|NCT04077957|Dermatologic Agents|dermatologic agents|mesh-ancestor
110583828|NCT04077957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110583829|NCT04077957|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110583830|NCT04077957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110583831|NCT04077957|Immunologic Factors|immunologic factors|mesh-ancestor
110583832|NCT04077957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110583833|NCT04077957|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110231252|NCT00325117|Vildagliptin|vildagliptin|mesh-list
110583834|NCT04077957|Antimalarials|antimalarials|mesh-ancestor
110583835|NCT04077957|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110583836|NCT04077957|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110583837|NCT04077957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110583838|NCT04077957|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110583839|NCT04077957|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110583840|NCT04077957|Analgesics|analgesics|mesh-ancestor
110583841|NCT04077957|Sensory System Agents|sensory system agents|mesh-ancestor
110583842|NCT04077957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110583843|NCT04077957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110583844|NCT04077957|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110583845|NCT04102670|Hyaluronic Acid|hyaluronic acid|mesh-list
110583846|NCT04102670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110583847|NCT04102670|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110583848|NCT04102670|Immunologic Factors|immunologic factors|mesh-ancestor
110583849|NCT04102670|Viscosupplements|viscosupplements|mesh-ancestor
110583850|NCT04102670|Protective Agents|protective agents|mesh-ancestor
110583851|NCT04114097|Betamethasone|betamethasone|mesh-list
110583852|NCT04114097|Betamethasone Valerate|betamethasone valerate|mesh-list
110583853|NCT04114097|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
110583854|NCT04114097|Betamethasone benzoate|betamethasone benzoate|mesh-list
110583855|NCT04114097|Tacrolimus|tacrolimus|mesh-list
110583856|NCT04114097|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
110583857|NCT04114097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110583858|NCT04114097|Immunologic Factors|immunologic factors|mesh-ancestor
110583859|NCT04114097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110583860|NCT04114097|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110583861|NCT04114097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110583862|NCT04114097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110149686|NCT00008190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110583864|NCT04114097|Glucocorticoids|glucocorticoids|mesh-ancestor
110583865|NCT04114097|Hormones|hormones|mesh-ancestor
110583866|NCT04114097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110583867|NCT04114097|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110583868|NCT04114097|Respiratory System Agents|respiratory system agents|mesh-ancestor
110583869|NCT04323189|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110583870|NCT04323189|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110583871|NCT04323189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110583872|NCT04323189|Incretins|incretins|mesh-ancestor
110583873|NCT04323189|Hormones|hormones|mesh-ancestor
110583874|NCT04323189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110583875|NCT04323189|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110583876|NCT04323189|Protease Inhibitors|protease inhibitors|mesh-ancestor
110583877|NCT04323189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110583878|NCT04323189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110583879|NCT00772070|Vaccines|vaccines|mesh-list
110583880|NCT00772070|Immunologic Factors|immunologic factors|mesh-ancestor
110583881|NCT00772070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110583882|NCT00796757|Interferons|interferons|mesh-list
110583883|NCT00796757|Interferon-alpha|interferon-alpha|mesh-list
110583884|NCT00796757|Interferon alpha-2|interferon alpha-2|mesh-list
110583885|NCT00796757|Bevacizumab|bevacizumab|mesh-list
110583886|NCT00796757|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110583887|NCT00796757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110583888|NCT00796757|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110583889|NCT00796757|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110583890|NCT00796757|Growth Substances|growth substances|mesh-ancestor
110583891|NCT00796757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110583892|NCT00796757|Growth Inhibitors|growth inhibitors|mesh-ancestor
110583893|NCT00796757|Antiviral Agents|antiviral agents|mesh-ancestor
110583894|NCT00796757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110583895|NCT00796757|Immunologic Factors|immunologic factors|mesh-ancestor
110583896|NCT00759356|Morphine|morphine|mesh-list
110583897|NCT00759356|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110583898|NCT00759356|Narcotics|narcotics|mesh-ancestor
110583899|NCT00759356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110583900|NCT00759356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110583901|NCT00759356|Analgesics|analgesics|mesh-ancestor
110583902|NCT00759356|Sensory System Agents|sensory system agents|mesh-ancestor
110583903|NCT00759356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110583905|NCT05637515|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110583906|NCT05637515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110583907|NCT05637515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110231327|NCT00093522|Antimetabolites|antimetabolites|mesh-ancestor
110583908|NCT04113941|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110583909|NCT04113941|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110583910|NCT04113941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110583911|NCT04113941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110583912|NCT04113941|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110583913|NCT04113941|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110583914|NCT04113941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110583915|NCT04113941|Cholinergic Agents|cholinergic agents|mesh-ancestor
110583916|NCT04113941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110583918|NCT04102592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110583919|NCT04102592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110583920|NCT04113551|Guanfacine|guanfacine|mesh-list
110583921|NCT04113551|Methylphenidate|methylphenidate|mesh-list
110583922|NCT04113551|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
110583923|NCT04113551|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110583924|NCT04113551|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110583925|NCT04113551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110583926|NCT04113551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110583927|NCT04113551|Adrenergic Agents|adrenergic agents|mesh-ancestor
110583928|NCT04113551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110583929|NCT04113551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110583930|NCT04113551|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110583931|NCT04113551|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110583932|NCT04113551|Dopamine Agents|dopamine agents|mesh-ancestor
110583933|NCT04113551|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110583934|NCT04113551|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110583935|NCT04113551|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110583936|NCT04113551|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110583937|NCT00798317|Plasminogen|plasminogen|mesh-list
110583938|NCT00798317|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110583939|NCT00798317|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110583940|NCT00798317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110583941|NCT00077285|Cyclophosphamide|cyclophosphamide|mesh-list
110583942|NCT00077285|Ifosfamide|ifosfamide|mesh-list
110583943|NCT00077285|Carboplatin|carboplatin|mesh-list
110583944|NCT00077285|Doxorubicin|doxorubicin|mesh-list
110583945|NCT00077285|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110583946|NCT00077285|Irinotecan|irinotecan|mesh-list
110583947|NCT00077285|Etoposide|etoposide|mesh-list
110583948|NCT00077285|Vincristine|vincristine|mesh-list
110583949|NCT00077285|Dexrazoxane|dexrazoxane|mesh-list
110583950|NCT00077285|Razoxane|razoxane|mesh-list
110583951|NCT00077285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110583952|NCT00077285|Immunologic Factors|immunologic factors|mesh-ancestor
110583953|NCT00077285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110583954|NCT00077285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110583955|NCT00077285|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110583956|NCT00077285|Alkylating Agents|alkylating agents|mesh-ancestor
110583957|NCT00077285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110583958|NCT00077285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110583959|NCT00077285|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110583960|NCT00077285|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110583961|NCT00077285|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110583962|NCT00077285|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110583963|NCT00077285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110583964|NCT00077285|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110583965|NCT00077285|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110583966|NCT00077285|Tubulin Modulators|tubulin modulators|mesh-ancestor
110583967|NCT00077285|Antimitotic Agents|antimitotic agents|mesh-ancestor
110583968|NCT00077285|Mitosis Modulators|mitosis modulators|mesh-ancestor
110583969|NCT00077285|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110583970|NCT00077285|Protective Agents|protective agents|mesh-ancestor
110583971|NCT00771914|Aspirin|aspirin|mesh-list
110583972|NCT00771914|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110583973|NCT00771914|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110583974|NCT00771914|Analgesics|analgesics|mesh-ancestor
110583975|NCT00771914|Sensory System Agents|sensory system agents|mesh-ancestor
110583977|NCT00771914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110583978|NCT00771914|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110583979|NCT00771914|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110583980|NCT00771914|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110583981|NCT00771914|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110583982|NCT00771914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110583983|NCT00771914|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110583984|NCT00771914|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110583985|NCT00771914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110583986|NCT00771914|Antipyretics|antipyretics|mesh-ancestor
110583987|NCT04307511|Aspirin|aspirin|mesh-list
110583988|NCT04307511|Ticagrelor|ticagrelor|mesh-list
110583989|NCT04307511|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110149712|NCT00006451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110583990|NCT04307511|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110583992|NCT04307511|Sensory System Agents|sensory system agents|mesh-ancestor
110583993|NCT04307511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110583994|NCT04307511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110583995|NCT04307511|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110583996|NCT04307511|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110583997|NCT04307511|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110583998|NCT04307511|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110583999|NCT04307511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110584000|NCT04307511|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110584001|NCT04307511|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110584002|NCT04307511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110584003|NCT04307511|Antipyretics|antipyretics|mesh-ancestor
110584004|NCT04307511|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110584005|NCT04307511|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110584006|NCT04307511|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110584007|NCT04307511|Purinergic Agents|purinergic agents|mesh-ancestor
110584008|NCT04307511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110584009|NCT00779324|Amantadine|amantadine|mesh-list
110584010|NCT00779324|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110584011|NCT00779324|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110584012|NCT00779324|Antiviral Agents|antiviral agents|mesh-ancestor
110584013|NCT00779324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110584014|NCT00779324|Dopamine Agents|dopamine agents|mesh-ancestor
110584015|NCT00779324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110584016|NCT00779324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110584018|NCT00779324|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110584019|NCT00779324|Analgesics|analgesics|mesh-ancestor
110584020|NCT00779324|Sensory System Agents|sensory system agents|mesh-ancestor
110584021|NCT00779324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110584022|NCT00779246|Chlorhexidine|chlorhexidine|mesh-list
110584023|NCT00779246|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110584024|NCT00779246|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110584025|NCT00779246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110584026|NCT00779246|Disinfectants|disinfectants|mesh-ancestor
110584027|NCT00779246|Dermatologic Agents|dermatologic agents|mesh-ancestor
110584028|NCT02581761|Misoprostol|misoprostol|mesh-list
110584029|NCT02581761|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110584030|NCT02581761|Abortifacient Agents|abortifacient agents|mesh-ancestor
110584031|NCT02581761|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110584032|NCT02581761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110584033|NCT02581761|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110584034|NCT02581761|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110584035|NCT02581761|Oxytocics|oxytocics|mesh-ancestor
110584036|NCT00771758|Oxycodone|oxycodone|mesh-list
110584037|NCT00771758|Tapentadol|tapentadol|mesh-list
110584038|NCT00771758|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110584039|NCT00771758|Narcotics|narcotics|mesh-ancestor
110584040|NCT00771758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110584041|NCT00771758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110584042|NCT00771758|Analgesics|analgesics|mesh-ancestor
110584043|NCT00771758|Sensory System Agents|sensory system agents|mesh-ancestor
110584044|NCT00771758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110584045|NCT00771758|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110584046|NCT00771758|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110584047|NCT00771758|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110584048|NCT00771758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110584049|NCT00771758|Adrenergic Agents|adrenergic agents|mesh-ancestor
110584050|NCT00771758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110584051|NCT02581371|Cerebrolysin|cerebrolysin|mesh-list
110584052|NCT02581371|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110584053|NCT02581371|Protective Agents|protective agents|mesh-ancestor
110584054|NCT02581371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110584055|NCT02581371|Nootropic Agents|nootropic agents|mesh-ancestor
110584056|NCT02688465|Apomorphine|apomorphine|mesh-list
110584057|NCT02688465|Emetics|emetics|mesh-ancestor
110149718|NCT00006451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110584058|NCT02688465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110584059|NCT02688465|Autonomic Agents|autonomic agents|mesh-ancestor
110584060|NCT02688465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110584061|NCT02688465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110584062|NCT02688465|Dopamine Agonists|dopamine agonists|mesh-ancestor
110584063|NCT02688465|Dopamine Agents|dopamine agents|mesh-ancestor
110584064|NCT02688465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110584065|NCT02688465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110584066|NCT00758498|Modafinil|modafinil|mesh-list
110584067|NCT00758498|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110584068|NCT00758498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110584069|NCT00758498|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
110584070|NCT00758498|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110584071|NCT00758498|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110584072|NCT00758498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110584073|NCT00798161|Metformin|metformin|mesh-list
110584074|NCT00798161|Linagliptin|linagliptin|mesh-list
110584075|NCT00798161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110584076|NCT00798161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110584077|NCT00798161|Incretins|incretins|mesh-ancestor
110584078|NCT00798161|Hormones|hormones|mesh-ancestor
110584079|NCT00798161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110584080|NCT00798161|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110584081|NCT00798161|Protease Inhibitors|protease inhibitors|mesh-ancestor
110375834|NCT01132807|Hormones|hormones|mesh-ancestor
110584082|NCT00798161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110584083|NCT00798161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110584084|NCT02581683|Magnesium Sulfate|magnesium sulfate|mesh-list
110584086|NCT02581683|Anesthetics, Local|anesthetics, local|mesh-ancestor
110584087|NCT02581683|Anesthetics|anesthetics|mesh-ancestor
110584088|NCT02581683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110584089|NCT02581683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110584090|NCT02581683|Sensory System Agents|sensory system agents|mesh-ancestor
110584091|NCT02581683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110584092|NCT02581683|Analgesics|analgesics|mesh-ancestor
110584093|NCT02581683|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110584094|NCT02581683|Anticonvulsants|anticonvulsants|mesh-ancestor
110584095|NCT02581683|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110584096|NCT02581683|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110584097|NCT02581683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110584098|NCT02581683|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110584099|NCT02581683|Tocolytic Agents|tocolytic agents|mesh-ancestor
110584100|NCT02581683|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110584101|NCT04170855|Furosemide|furosemide|mesh-list
110584102|NCT04170855|Diuretics|diuretics|mesh-ancestor
110584103|NCT04170855|Natriuretic Agents|natriuretic agents|mesh-ancestor
110584104|NCT04170855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110584105|NCT04170855|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110584106|NCT04170855|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110584107|NCT04170855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110584108|NCT04076709|Anesthetics|anesthetics|mesh-list
110584109|NCT04076709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110584110|NCT04076709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110260179|NCT02944201|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110584111|NCT00638781|Salivary plasminogen activator alpha 1, Desmodus rotundus|salivary plasminogen activator alpha 1, desmodus rotundus|mesh-list
110584112|NCT00638781|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110584113|NCT00638781|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110584114|NCT00638781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110584115|NCT04115423|Adalimumab|adalimumab|mesh-list
110584116|NCT04115423|Infliximab|infliximab|mesh-list
110584117|NCT04115423|Golimumab|golimumab|mesh-list
110584118|NCT04115423|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
110584119|NCT04115423|Etanercept|etanercept|mesh-list
110584120|NCT04115423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110584121|NCT04115423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110584122|NCT04115423|Dermatologic Agents|dermatologic agents|mesh-ancestor
110584123|NCT04115423|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110584124|NCT04115423|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110584125|NCT04115423|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110584126|NCT04115423|Analgesics|analgesics|mesh-ancestor
110584127|NCT04115423|Sensory System Agents|sensory system agents|mesh-ancestor
110584128|NCT04115423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110584129|NCT04115423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110584130|NCT04115423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110584131|NCT04115423|Immunologic Factors|immunologic factors|mesh-ancestor
110584132|NCT04113005|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
110584133|NCT04113005|Hemostatics|hemostatics|mesh-ancestor
110584135|NCT04113005|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
110584136|NCT04113005|Natriuretic Agents|natriuretic agents|mesh-ancestor
110584137|NCT04113005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110584138|NCT00588341|Temozolomide|temozolomide|mesh-list
110584139|NCT00588341|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110584140|NCT00588341|Alkylating Agents|alkylating agents|mesh-ancestor
110584141|NCT00588341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110584142|NCT00588341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110584143|NCT00914693|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110584145|NCT00914693|Femovan|femovan|mesh-list
110584146|NCT00914693|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110584147|NCT00914693|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110584148|NCT00914693|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110584149|NCT00914693|Contraceptive Agents|contraceptive agents|mesh-ancestor
110584150|NCT00914693|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110584151|NCT00914693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110584152|NCT00914693|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110584153|NCT00914693|Estrogens|estrogens|mesh-ancestor
110584154|NCT00914693|Hormones|hormones|mesh-ancestor
110584155|NCT00914693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110584156|NCT00914693|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110584157|NCT00914693|Progestins|progestins|mesh-ancestor
110584158|NCT00914693|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110584159|NCT00915083|Amrubicin|amrubicin|mesh-list
110584160|NCT00915083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110584161|NCT00802529|Gentamicins|gentamicins|mesh-list
110584162|NCT00802529|Methylprednisolone|methylprednisolone|mesh-list
110584163|NCT00802529|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110584164|NCT00802529|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110584165|NCT00802529|Prednisolone|prednisolone|mesh-list
110584166|NCT00802529|Prednisolone acetate|prednisolone acetate|mesh-list
110584167|NCT00802529|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110584168|NCT00802529|Prednisolone phosphate|prednisolone phosphate|mesh-list
110584169|NCT00802529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110584170|NCT00802529|Antiemetics|antiemetics|mesh-ancestor
110584171|NCT00802529|Autonomic Agents|autonomic agents|mesh-ancestor
110584172|NCT00802529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110584173|NCT00802529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110584174|NCT00802529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110584175|NCT00802529|Glucocorticoids|glucocorticoids|mesh-ancestor
110584176|NCT00802529|Hormones|hormones|mesh-ancestor
110584177|NCT00802529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110584178|NCT00802529|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110584179|NCT00802529|Protective Agents|protective agents|mesh-ancestor
110584180|NCT00802529|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110584181|NCT00802529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110584182|NCT00802529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110584183|NCT00802529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110584184|NCT00802529|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110584185|NCT00802529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110584186|NCT00802529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110584188|NCT02605811|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110584189|NCT02605811|Alkylating Agents|alkylating agents|mesh-ancestor
110584190|NCT02605811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110584191|NCT02605811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110584192|NCT00758264|Vaccines|vaccines|mesh-list
110584193|NCT00758264|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110584194|NCT00758264|Immunologic Factors|immunologic factors|mesh-ancestor
110584195|NCT00758264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110584196|NCT04027517|Darbepoetin alfa|darbepoetin alfa|mesh-list
110584197|NCT04027517|Hematinics|hematinics|mesh-ancestor
110584198|NCT00588731|Cannabidiol|cannabidiol|mesh-list
110584199|NCT00588731|Anticonvulsants|anticonvulsants|mesh-ancestor
110584200|NCT04111367|Sofosbuvir|sofosbuvir|mesh-list
110584201|NCT04111367|Antiviral Agents|antiviral agents|mesh-ancestor
110584202|NCT04111367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110584203|NCT05629949|Docetaxel|docetaxel|mesh-list
110584204|NCT05629949|Trastuzumab|trastuzumab|mesh-list
110584205|NCT05629949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110584206|NCT05629949|Tubulin Modulators|tubulin modulators|mesh-ancestor
110231622|NCT00085358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110584207|NCT05629949|Antimitotic Agents|antimitotic agents|mesh-ancestor
110584208|NCT05629949|Mitosis Modulators|mitosis modulators|mesh-ancestor
110584209|NCT05629949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110584210|NCT05629949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110584211|NCT05628233|Azasetron|azasetron|mesh-list
110584212|NCT05628233|Antiemetics|antiemetics|mesh-ancestor
110584213|NCT05628233|Autonomic Agents|autonomic agents|mesh-ancestor
110584214|NCT05628233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110584215|NCT05628233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110584216|NCT05628233|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110584217|NCT05628233|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110584218|NCT05628233|Serotonin Agents|serotonin agents|mesh-ancestor
110584219|NCT05628233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110584220|NCT05628233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110584222|NCT04109261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110584223|NCT04109261|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110584224|NCT04109261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110584225|NCT04109261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110584226|NCT04109339|Oxytocin|oxytocin|mesh-list
110584227|NCT04109339|Oxytocics|oxytocics|mesh-ancestor
110584228|NCT04109339|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110584229|NCT04109339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110584230|NCT00757172|Docetaxel|docetaxel|mesh-list
110584231|NCT00757172|Panitumumab|panitumumab|mesh-list
110584232|NCT00757172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110584233|NCT00757172|Tubulin Modulators|tubulin modulators|mesh-ancestor
110584234|NCT00757172|Antimitotic Agents|antimitotic agents|mesh-ancestor
110584235|NCT00757172|Mitosis Modulators|mitosis modulators|mesh-ancestor
110584236|NCT00757172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110584237|NCT00757172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110584238|NCT00797225|Leuprolide|leuprolide|mesh-list
110584239|NCT00797225|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110584240|NCT00797225|Fertility Agents|fertility agents|mesh-ancestor
110584241|NCT00797225|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110584242|NCT00797225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110584243|NCT00797225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110584244|NCT00797225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110584245|NCT05277285|Sodium thiosulfate|sodium thiosulfate|mesh-list
110584246|NCT05277285|Antidotes|antidotes|mesh-ancestor
110584247|NCT05277285|Protective Agents|protective agents|mesh-ancestor
110584248|NCT05277285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110584249|NCT05277285|Antioxidants|antioxidants|mesh-ancestor
110584250|NCT05277285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110584251|NCT05277285|Antitubercular Agents|antitubercular agents|mesh-ancestor
110584252|NCT05277285|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110584253|NCT05277285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110584254|NCT05277285|Chelating Agents|chelating agents|mesh-ancestor
110584255|NCT05277285|Sequestering Agents|sequestering agents|mesh-ancestor
110584256|NCT04110665|Acetaminophen|acetaminophen|mesh-list
110584257|NCT04110665|Morphine|morphine|mesh-list
110584258|NCT04110665|Oxycodone|oxycodone|mesh-list
110584259|NCT04110665|Tramadol|tramadol|mesh-list
110584260|NCT04110665|Nefopam|nefopam|mesh-list
110584261|NCT04110665|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110584262|NCT04110665|Narcotics|narcotics|mesh-ancestor
110584263|NCT04110665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110584264|NCT04110665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110584265|NCT04110665|Analgesics|analgesics|mesh-ancestor
110584266|NCT04110665|Sensory System Agents|sensory system agents|mesh-ancestor
110584267|NCT04110665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110584268|NCT04110665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110584269|NCT04110665|Antipyretics|antipyretics|mesh-ancestor
110584270|NCT04077333|Pulmonary Surfactants|pulmonary surfactants|mesh-list
110584271|NCT04077333|Respiratory System Agents|respiratory system agents|mesh-ancestor
110584272|NCT00638859|Telithromycin|telithromycin|mesh-list
110584273|NCT00638859|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110584274|NCT00638859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110584275|NCT02537847|Ertapenem|ertapenem|mesh-list
110584276|NCT02537847|Fluoroquinolones|fluoroquinolones|mesh-list
110584277|NCT02537847|Sitafloxacin|sitafloxacin|mesh-list
110584278|NCT02537847|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110584279|NCT02537847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110584280|NCT02537847|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110584281|NCT02537847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110584282|NCT02537847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110231697|NCT00085553|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110584283|NCT02537847|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110584284|NCT02537847|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110584285|NCT02537847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110584286|NCT04033029|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110584287|NCT04033029|Tazobactam|tazobactam|mesh-list
110584288|NCT04033029|Piperacillin|piperacillin|mesh-list
110584289|NCT04033029|Daptomycin|daptomycin|mesh-list
110584290|NCT04033029|Ceftazidime|ceftazidime|mesh-list
110584291|NCT04033029|Cefepime|cefepime|mesh-list
110584292|NCT04033029|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
110584293|NCT04033029|Ceftolozane|ceftolozane|mesh-list
110584294|NCT04033029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110584295|NCT04033029|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110584296|NCT04033029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110584297|NCT04033029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110584298|NCT02687841|Pentoxifylline|pentoxifylline|mesh-list
110584299|NCT02687841|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110584300|NCT02687841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110584301|NCT02687841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110584302|NCT02687841|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110584303|NCT02687841|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110584304|NCT02687841|Protective Agents|protective agents|mesh-ancestor
110584305|NCT02687841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110584306|NCT02687841|Vasodilator Agents|vasodilator agents|mesh-ancestor
110584307|NCT02687841|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110584308|NCT02687841|Antioxidants|antioxidants|mesh-ancestor
110584309|NCT00778622|Metformin|metformin|mesh-list
110584310|NCT00778622|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110584311|NCT00778622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110584312|NCT00777920|Ambrisentan|ambrisentan|mesh-list
110584313|NCT00777920|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110584314|NCT04236141|Rituximab|rituximab|mesh-list
110584315|NCT04236141|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110584316|NCT04236141|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
110584317|NCT04236141|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110584318|NCT04236141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110584319|NCT04236141|Immunologic Factors|immunologic factors|mesh-ancestor
110584320|NCT04236141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110584321|NCT04236141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110584322|NCT04236141|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110584323|NCT04236141|Alkylating Agents|alkylating agents|mesh-ancestor
110584324|NCT04236141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110584325|NCT04236141|Immunoconjugates|immunoconjugates|mesh-ancestor
110584326|NCT04097444|Leucovorin|leucovorin|mesh-list
110584327|NCT04097444|Bevacizumab|bevacizumab|mesh-list
110584328|NCT04097444|Fluorouracil|fluorouracil|mesh-list
110584329|NCT04097444|Capecitabine|capecitabine|mesh-list
110584330|NCT04097444|Oxaliplatin|oxaliplatin|mesh-list
110584331|NCT04097444|Irinotecan|irinotecan|mesh-list
110584332|NCT04097444|Calcium|calcium|mesh-list
110584333|NCT04097444|Levoleucovorin|levoleucovorin|mesh-list
110584334|NCT04097444|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110584335|NCT04097444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110584336|NCT04097444|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110584337|NCT04097444|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110584338|NCT04097444|Growth Substances|growth substances|mesh-ancestor
110584339|NCT04097444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110584340|NCT04097444|Growth Inhibitors|growth inhibitors|mesh-ancestor
110584341|NCT04097444|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110584342|NCT04097444|Antimetabolites|antimetabolites|mesh-ancestor
110584343|NCT04097444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110584344|NCT04097444|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110584345|NCT04097444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110584346|NCT04097444|Immunologic Factors|immunologic factors|mesh-ancestor
110584347|NCT04097444|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110584348|NCT04097444|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110584349|NCT04097444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110584350|NCT04097444|Antidotes|antidotes|mesh-ancestor
110584351|NCT04097444|Protective Agents|protective agents|mesh-ancestor
110584352|NCT04097444|Vitamin B Complex|vitamin b complex|mesh-ancestor
110584353|NCT04097444|Vitamins|vitamins|mesh-ancestor
110584354|NCT04097444|Micronutrients|micronutrients|mesh-ancestor
110584355|NCT04097288|Dexetimide|dexetimide|mesh-list
110584356|NCT04097288|Citalopram|citalopram|mesh-list
110584357|NCT04097288|Reboxetine|reboxetine|mesh-list
110584358|NCT04097288|Escitalopram|escitalopram|mesh-list
110584359|NCT04097288|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110584360|NCT04097288|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110584361|NCT04097288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110584362|NCT04097288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110584363|NCT04097288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110584364|NCT04097288|Serotonin Agents|serotonin agents|mesh-ancestor
110584365|NCT04097288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110584366|NCT04097288|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110584367|NCT04097288|Antidepressive Agents|antidepressive agents|mesh-ancestor
110584368|NCT04097288|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110584369|NCT04097288|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110584370|NCT04097288|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110584371|NCT04097288|Parasympatholytics|parasympatholytics|mesh-ancestor
110584372|NCT04097288|Autonomic Agents|autonomic agents|mesh-ancestor
110584373|NCT04097288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110584374|NCT04097288|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110584375|NCT04097288|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110584376|NCT04097288|Cholinergic Agents|cholinergic agents|mesh-ancestor
110584377|NCT04097288|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110584378|NCT04097288|Adrenergic Agents|adrenergic agents|mesh-ancestor
110584380|NCT04219449|Anticoagulants|anticoagulants|mesh-ancestor
110584381|NCT04219449|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110584382|NCT04219449|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110584383|NCT04219449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110584384|NCT04209855|Paclitaxel|paclitaxel|mesh-list
110584385|NCT04209855|Maytansine|maytansine|mesh-list
110584386|NCT04209855|Doxorubicin|doxorubicin|mesh-list
110584387|NCT04209855|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110584388|NCT04209855|Topotecan|topotecan|mesh-list
110584389|NCT04209855|Mirvetuximab soravtansine|mirvetuximab soravtansine|mesh-list
110584390|NCT04209855|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110584391|NCT04209855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110584392|NCT04209855|Tubulin Modulators|tubulin modulators|mesh-ancestor
110584393|NCT04209855|Antimitotic Agents|antimitotic agents|mesh-ancestor
110584394|NCT04209855|Mitosis Modulators|mitosis modulators|mesh-ancestor
110584395|NCT04209855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110584396|NCT04209855|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110584397|NCT04209855|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110584398|NCT04209855|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110584399|NCT04209855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110584400|NCT04209855|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110584401|NCT04209855|Immunoconjugates|immunoconjugates|mesh-ancestor
110584402|NCT04209855|Immunologic Factors|immunologic factors|mesh-ancestor
110584403|NCT04209855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110584404|NCT00756938|Losartan|losartan|mesh-list
110584405|NCT00756938|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110584406|NCT00756938|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110149749|NCT00006457|Oltipraz|oltipraz|mesh-list
110584407|NCT00756938|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110584408|NCT00756938|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110584409|NCT00756938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110584410|NCT04076865|Lidocaine|lidocaine|mesh-list
110584411|NCT04076865|Histamine|histamine|mesh-list
110584412|NCT04076865|Anesthetics, Local|anesthetics, local|mesh-ancestor
110584413|NCT04076865|Anesthetics|anesthetics|mesh-ancestor
110584414|NCT04076865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110584415|NCT04076865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110584416|NCT04076865|Sensory System Agents|sensory system agents|mesh-ancestor
110584417|NCT04076865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110584418|NCT04076865|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110584419|NCT04076865|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110584420|NCT04076865|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110584421|NCT04076865|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110584422|NCT04076865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110584423|NCT04076865|Histamine Agonists|histamine agonists|mesh-ancestor
110584424|NCT04076865|Histamine Agents|histamine agents|mesh-ancestor
110584426|NCT00770588|Gefitinib|gefitinib|mesh-list
110584427|NCT00770588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110584428|NCT00770588|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110584429|NCT00770588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110584430|NCT00770588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110584431|NCT02604719|Tranexamic Acid|tranexamic acid|mesh-list
110584432|NCT02604719|Ethamsylate|ethamsylate|mesh-list
110584433|NCT02604719|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110584434|NCT02604719|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110584435|NCT02604719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110584436|NCT02604719|Hemostatics|hemostatics|mesh-ancestor
110584437|NCT02604719|Coagulants|coagulants|mesh-ancestor
110584438|NCT02604797|Flurbiprofen|flurbiprofen|mesh-list
110584439|NCT02604797|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
110584441|NCT02604797|Dsuvia|dsuvia|mesh-list
110584442|NCT02604797|Nalbuphine|nalbuphine|mesh-list
110584443|NCT02604797|Ramosetron|ramosetron|mesh-list
110584444|NCT02604797|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110584445|NCT02604797|Narcotics|narcotics|mesh-ancestor
110584446|NCT02604797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110584447|NCT02604797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110584448|NCT02604797|Analgesics|analgesics|mesh-ancestor
110584449|NCT02604797|Sensory System Agents|sensory system agents|mesh-ancestor
110584450|NCT02604797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110584451|NCT02604797|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110584452|NCT02604797|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110584453|NCT02604797|Anesthetics, General|anesthetics, general|mesh-ancestor
110584454|NCT02604797|Anesthetics|anesthetics|mesh-ancestor
110584455|NCT02604797|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110584456|NCT02604797|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110584457|NCT02604797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110584458|NCT02604797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110584459|NCT02604797|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110584460|NCT02604797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110584461|NCT02604797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110584462|NCT02604797|Antiemetics|antiemetics|mesh-ancestor
110584463|NCT02604797|Autonomic Agents|autonomic agents|mesh-ancestor
110584464|NCT02604797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110584465|NCT02604797|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110584466|NCT02604797|Serotonin Agents|serotonin agents|mesh-ancestor
110584467|NCT02604797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110584468|NCT00777608|Donepezil|donepezil|mesh-list
110584469|NCT00777608|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110584470|NCT00777608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110584471|NCT00777608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110584472|NCT00777608|Cholinergic Agents|cholinergic agents|mesh-ancestor
110584473|NCT00777608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110584474|NCT00777608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110584475|NCT00777608|Nootropic Agents|nootropic agents|mesh-ancestor
110584476|NCT00792935|Metformin|metformin|mesh-list
110584477|NCT00792935|Glimepiride|glimepiride|mesh-list
110584478|NCT00792935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110584479|NCT00792935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110584480|NCT00792935|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110584481|NCT00792935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110584482|NCT00792935|Immunologic Factors|immunologic factors|mesh-ancestor
110584483|NCT03904563|Bevacizumab|bevacizumab|mesh-list
110584484|NCT03904563|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110584485|NCT03904563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110584486|NCT03904563|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110584487|NCT03904563|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110584489|NCT03904563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110584490|NCT03904563|Growth Inhibitors|growth inhibitors|mesh-ancestor
110584491|NCT00770510|Zolpidem|zolpidem|mesh-list
110584492|NCT00770510|Eszopiclone|eszopiclone|mesh-list
110584493|NCT00770510|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110584494|NCT00770510|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110584495|NCT00770510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110584496|NCT00770510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110584497|NCT00770510|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
110584498|NCT00770510|GABA Agonists|gaba agonists|mesh-ancestor
110584499|NCT00770510|GABA Agents|gaba agents|mesh-ancestor
110584500|NCT00770510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110584501|NCT00770510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110584502|NCT04077255|Paclitaxel|paclitaxel|mesh-list
110584503|NCT04077255|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110584504|NCT04077255|Antibodies|antibodies|mesh-list
110584505|NCT04077255|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110584506|NCT04077255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110584507|NCT04077255|Tubulin Modulators|tubulin modulators|mesh-ancestor
110584508|NCT04077255|Antimitotic Agents|antimitotic agents|mesh-ancestor
110584509|NCT04077255|Mitosis Modulators|mitosis modulators|mesh-ancestor
110584510|NCT04077255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110584511|NCT04077255|Immunologic Factors|immunologic factors|mesh-ancestor
110584512|NCT04077255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110584513|NCT00770432|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
110584514|NCT00770432|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110584515|NCT00770432|Laxatives|laxatives|mesh-ancestor
110584516|NCT00770432|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110584517|NCT00792701|Gemcitabine|gemcitabine|mesh-list
110584518|NCT00792701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110584519|NCT00792701|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110584520|NCT00792701|Antimetabolites|antimetabolites|mesh-ancestor
110584521|NCT00792701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110584522|NCT03772353|Letrozole|letrozole|mesh-list
110584523|NCT03772353|Fulvestrant|fulvestrant|mesh-list
110584524|NCT03772353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110584525|NCT03772353|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110584526|NCT03772353|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110584527|NCT03772353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110584528|NCT03772353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110584529|NCT03772353|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110584530|NCT03772353|Hormone Antagonists|hormone antagonists|mesh-ancestor
110584531|NCT03772353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110584532|NCT03772353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110584533|NCT03772353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110584534|NCT03772353|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110584535|NCT05559983|Aluminum phosphate|aluminum phosphate|mesh-list
110584536|NCT05559983|Vaccines|vaccines|mesh-list
110584537|NCT05559983|Immunologic Factors|immunologic factors|mesh-ancestor
110584538|NCT05559983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110584539|NCT05559983|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110584540|NCT05559983|Antacids|antacids|mesh-ancestor
110584541|NCT05559983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110584542|NCT05559983|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110584543|NCT03765567|Vancomycin|vancomycin|mesh-list
110584544|NCT03765567|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110584545|NCT03765567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110584546|NCT00777296|Amikacin|amikacin|mesh-list
110584547|NCT00777296|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110584548|NCT00777296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110584549|NCT00756470|Paclitaxel|paclitaxel|mesh-list
110584550|NCT00756470|Cyclophosphamide|cyclophosphamide|mesh-list
110584551|NCT00756470|Fluorouracil|fluorouracil|mesh-list
110584552|NCT00756470|Epirubicin|epirubicin|mesh-list
110584554|NCT00756470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110584555|NCT00756470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110584556|NCT00756470|Tubulin Modulators|tubulin modulators|mesh-ancestor
110584557|NCT00756470|Antimitotic Agents|antimitotic agents|mesh-ancestor
110584558|NCT00756470|Mitosis Modulators|mitosis modulators|mesh-ancestor
110584559|NCT00756470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110584560|NCT00756470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110584561|NCT00756470|Immunologic Factors|immunologic factors|mesh-ancestor
110584562|NCT00756470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110375887|NCT00586118|Anesthetics|anesthetics|mesh-ancestor
110584563|NCT00756470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110584564|NCT00756470|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110584565|NCT00756470|Alkylating Agents|alkylating agents|mesh-ancestor
110584566|NCT00756470|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110584568|NCT00756470|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110584569|NCT00756470|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110584570|NCT00756470|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110584571|NCT00756470|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110584572|NCT00756470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110584573|NCT00756470|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110584574|NCT00756314|Contraceptive Agents|contraceptive agents|mesh-list
110584575|NCT00756314|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110584576|NCT00756314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110584577|NCT00727506|Afatinib|afatinib|mesh-list
110584578|NCT00727506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110584579|NCT00727506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110584580|NCT00727506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110584581|NCT00727506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110584582|NCT00789815|Midazolam|midazolam|mesh-list
110584583|NCT00789815|Propofol|propofol|mesh-list
110584584|NCT00789815|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110584585|NCT00789815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110584586|NCT00789815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110584587|NCT00789815|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110584588|NCT00789815|Anesthetics, General|anesthetics, general|mesh-ancestor
110584589|NCT00789815|Anesthetics|anesthetics|mesh-ancestor
110584590|NCT00789815|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110584591|NCT00789815|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110584592|NCT00789815|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110584593|NCT00789815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110584594|NCT00789815|GABA Modulators|gaba modulators|mesh-ancestor
110584595|NCT00789815|GABA Agents|gaba agents|mesh-ancestor
110584596|NCT00789815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110584597|NCT00789815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110584598|NCT00721578|Voriconazole|voriconazole|mesh-list
110584599|NCT00721578|Antifungal Agents|antifungal agents|mesh-ancestor
110584600|NCT00721578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110584601|NCT00721578|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110584602|NCT00721578|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110584603|NCT00721578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110584604|NCT00721578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110584605|NCT00721578|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110584606|NCT00721578|Hormone Antagonists|hormone antagonists|mesh-ancestor
110584607|NCT00721578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110584608|NCT00721578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110584609|NCT00721578|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110584610|NCT00789737|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
110584611|NCT00789737|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110584612|NCT00789737|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110584613|NCT00789737|Antimetabolites|antimetabolites|mesh-ancestor
110584614|NCT00789737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110584615|NCT00789737|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110584616|NCT04019574|Moxifloxacin|moxifloxacin|mesh-list
110584617|NCT04019574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110584618|NCT04019574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110584619|NCT04019574|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110584620|NCT04019574|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110584621|NCT04019574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110584622|NCT04019574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110584623|NCT04019574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110584624|NCT00792467|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
110584625|NCT00792467|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
110584626|NCT00792467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110375891|NCT01088529|Leuprolide|leuprolide|mesh-list
110584627|NCT00792467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110584628|NCT00585468|Mycophenolic Acid|mycophenolic acid|mesh-list
110584629|NCT00585468|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110584630|NCT00585468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110584631|NCT00585468|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110584632|NCT00585468|Antitubercular Agents|antitubercular agents|mesh-ancestor
110584633|NCT00585468|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110584634|NCT00585468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110584635|NCT00585468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110584636|NCT00585468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110584637|NCT05600387|Empagliflozin|empagliflozin|mesh-list
110584638|NCT05600387|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110584639|NCT05600387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110584640|NCT05600387|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110584641|NCT05600387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110584643|NCT00721110|Ketamine|ketamine|mesh-list
110584644|NCT00721110|Anesthetics, Local|anesthetics, local|mesh-ancestor
110584645|NCT00721110|Anesthetics|anesthetics|mesh-ancestor
110584646|NCT00721110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110584647|NCT00721110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110584648|NCT00721110|Sensory System Agents|sensory system agents|mesh-ancestor
110584649|NCT00721110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110584650|NCT00721110|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110584651|NCT00721110|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110584652|NCT00721110|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110584653|NCT00721110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110584654|NCT00721110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110584655|NCT00721110|Analgesics|analgesics|mesh-ancestor
110584656|NCT00721110|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110584657|NCT00721110|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110584658|NCT00721110|Anesthetics, General|anesthetics, general|mesh-ancestor
110584659|NCT00721110|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110584660|NCT00721110|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110584661|NCT00721110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110584662|NCT02592096|Carbamide Peroxide|carbamide peroxide|mesh-list
110584663|NCT02592096|Pazufloxacin|pazufloxacin|mesh-list
110584664|NCT02592096|Fluoroquinolones|fluoroquinolones|mesh-list
110584665|NCT02592096|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110584666|NCT02592096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110584667|NCT02592096|Antitubercular Agents|antitubercular agents|mesh-ancestor
110584668|NCT02592096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110584669|NCT02592096|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110584670|NCT02592096|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110584671|NCT02592096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110584672|NCT02592096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110584673|NCT02592096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110584674|NCT02592096|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110584675|NCT00791999|Certolizumab Pegol|certolizumab pegol|mesh-list
110584676|NCT00791999|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110584677|NCT00791999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110584678|NCT00791999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110584679|NCT00791999|Immunologic Factors|immunologic factors|mesh-ancestor
110584680|NCT00791999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110584681|NCT00791999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110584682|NCT04085484|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-list
110584683|NCT04085484|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110584684|NCT04033263|Fluorides|fluorides|mesh-list
110584685|NCT04033263|Cariostatic Agents|cariostatic agents|mesh-ancestor
110584686|NCT04033263|Protective Agents|protective agents|mesh-ancestor
110584687|NCT04033263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110584688|NCT04075227|Loteprednol Etabonate|loteprednol etabonate|mesh-list
110584689|NCT04075227|Dexamethasone|dexamethasone|mesh-list
110584690|NCT04075227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110584691|NCT04075227|Antiemetics|antiemetics|mesh-ancestor
110584692|NCT04075227|Autonomic Agents|autonomic agents|mesh-ancestor
110584693|NCT04075227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110375900|NCT01088529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110584694|NCT04075227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110584695|NCT04075227|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110584696|NCT04075227|Glucocorticoids|glucocorticoids|mesh-ancestor
110584697|NCT04075227|Hormones|hormones|mesh-ancestor
110584698|NCT04075227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110584699|NCT04075227|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110584700|NCT04075227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110584701|NCT04075227|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110584702|NCT00585078|Capecitabine|capecitabine|mesh-list
110584703|NCT00585078|Oxaliplatin|oxaliplatin|mesh-list
110584704|NCT00585078|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110584705|NCT00585078|Antimetabolites|antimetabolites|mesh-ancestor
110584706|NCT00585078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110584707|NCT00585078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110584708|NCT00720876|Rituximab|rituximab|mesh-list
110584709|NCT00720876|Vorinostat|vorinostat|mesh-list
110584710|NCT00720876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110584711|NCT00720876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110584712|NCT00720876|Immunologic Factors|immunologic factors|mesh-ancestor
110584713|NCT00720876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110584714|NCT00720876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110584715|NCT00720876|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110584716|NCT00720876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110584717|NCT00720876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110584718|NCT00789581|Paclitaxel|paclitaxel|mesh-list
110584719|NCT00789581|Cyclophosphamide|cyclophosphamide|mesh-list
110584720|NCT00789581|Doxorubicin|doxorubicin|mesh-list
110584721|NCT00789581|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110584722|NCT00789581|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110584723|NCT00789581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110584724|NCT00789581|Tubulin Modulators|tubulin modulators|mesh-ancestor
110584725|NCT00789581|Antimitotic Agents|antimitotic agents|mesh-ancestor
110584726|NCT00789581|Mitosis Modulators|mitosis modulators|mesh-ancestor
110584727|NCT00789581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110584728|NCT00789581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110584729|NCT00789581|Immunologic Factors|immunologic factors|mesh-ancestor
110584730|NCT00789581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110584731|NCT00789581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110584732|NCT00789581|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110584733|NCT00789581|Alkylating Agents|alkylating agents|mesh-ancestor
110584734|NCT00789581|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110584735|NCT00789581|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110584736|NCT00789581|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110584737|NCT00789581|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110584738|NCT00789581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110584739|NCT00717756|Lenalidomide|lenalidomide|mesh-list
110584740|NCT00717756|Immunologic Factors|immunologic factors|mesh-ancestor
110584741|NCT00717756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110584742|NCT00717756|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110584743|NCT00717756|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110584744|NCT00717756|Growth Substances|growth substances|mesh-ancestor
110584745|NCT00717756|Growth Inhibitors|growth inhibitors|mesh-ancestor
110584746|NCT00717756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110584747|NCT04111289|Tirofiban|tirofiban|mesh-list
110584748|NCT04111289|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110584749|NCT04111289|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110584750|NCT04111289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110584751|NCT04111289|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110584752|NCT04108637|Penicillins|penicillins|mesh-list
110584753|NCT04108637|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110584754|NCT04108637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110584755|NCT05674539|Vidarabine|vidarabine|mesh-list
110584756|NCT05674539|Fludarabine|fludarabine|mesh-list
110584757|NCT05674539|Fludarabine phosphate|fludarabine phosphate|mesh-list
110584758|NCT05674539|Melphalan|melphalan|mesh-list
110584759|NCT05674539|Busulfan|busulfan|mesh-list
110584760|NCT05674539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110584761|NCT05674539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110584762|NCT05674539|Antimetabolites|antimetabolites|mesh-ancestor
110584763|NCT05674539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110584764|NCT05674539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110584765|NCT05674539|Immunologic Factors|immunologic factors|mesh-ancestor
110584766|NCT05674539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110584767|NCT05674539|Antiviral Agents|antiviral agents|mesh-ancestor
110584768|NCT05674539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110584769|NCT05674539|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110584770|NCT05674539|Alkylating Agents|alkylating agents|mesh-ancestor
110584771|NCT05674539|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110584772|NCT00717522|Pomalidomide|pomalidomide|mesh-list
110584773|NCT00717522|Immunologic Factors|immunologic factors|mesh-ancestor
110584774|NCT00717522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110584775|NCT00717522|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110584776|NCT00717522|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110584777|NCT00717522|Growth Substances|growth substances|mesh-ancestor
110584778|NCT00717522|Growth Inhibitors|growth inhibitors|mesh-ancestor
110584779|NCT00717522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110584780|NCT00791921|Certolizumab Pegol|certolizumab pegol|mesh-list
110584781|NCT00791921|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110584782|NCT00791921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110584783|NCT00791921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110584784|NCT00791921|Immunologic Factors|immunologic factors|mesh-ancestor
110584785|NCT00791921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110584786|NCT00791921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110584787|NCT04106843|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
110584788|NCT04106843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110584789|NCT04106843|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110584791|NCT03475953|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110584792|NCT03475953|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110584793|NCT03475953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110584794|NCT03475953|Immunologic Factors|immunologic factors|mesh-ancestor
110584795|NCT03475953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110584796|NCT00582933|Vidarabine|vidarabine|mesh-list
110584797|NCT00582933|Fludarabine|fludarabine|mesh-list
110584798|NCT00582933|Fludarabine phosphate|fludarabine phosphate|mesh-list
110584799|NCT00582933|Melphalan|melphalan|mesh-list
110584800|NCT00582933|Busulfan|busulfan|mesh-list
110584801|NCT00582933|Lenograstim|lenograstim|mesh-list
110584802|NCT00582933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110584803|NCT00582933|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110584804|NCT00582933|Antimetabolites|antimetabolites|mesh-ancestor
110584805|NCT00582933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110584806|NCT00582933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110584807|NCT00582933|Immunologic Factors|immunologic factors|mesh-ancestor
110584808|NCT00582933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110584809|NCT00582933|Antiviral Agents|antiviral agents|mesh-ancestor
110584810|NCT00582933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110584811|NCT00582933|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110584812|NCT00582933|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110584813|NCT00582933|Alkylating Agents|alkylating agents|mesh-ancestor
110584814|NCT00582933|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110584815|NCT00791765|Etanercept|etanercept|mesh-list
110584816|NCT00791765|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110584817|NCT00791765|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110584818|NCT00791765|Analgesics|analgesics|mesh-ancestor
110584819|NCT00791765|Sensory System Agents|sensory system agents|mesh-ancestor
110584820|NCT00791765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110584821|NCT00791765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110584822|NCT00791765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110584823|NCT00791765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110584824|NCT00791765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110584825|NCT00791765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110584826|NCT00791765|Immunologic Factors|immunologic factors|mesh-ancestor
110584827|NCT00789191|Metformin|metformin|mesh-list
110584828|NCT00789191|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110584829|NCT00789191|Insulin Detemir|insulin detemir|mesh-list
110375915|NCT00586430|Antiemetics|antiemetics|mesh-ancestor
110584830|NCT00789191|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110584831|NCT00789191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110584832|NCT00789191|Incretins|incretins|mesh-ancestor
110584834|NCT00789191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110584835|NCT00789191|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110584836|NCT00789191|Protease Inhibitors|protease inhibitors|mesh-ancestor
110584837|NCT00789191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110584838|NCT00789191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110584840|NCT02603315|Endothelial Growth Factors|endothelial growth factors|mesh-list
110584841|NCT02603315|Mitosis Modulators|mitosis modulators|mesh-ancestor
110584842|NCT02603315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110584843|NCT02603315|Growth Substances|growth substances|mesh-ancestor
110584844|NCT02603315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110584845|NCT00789035|Metformin|metformin|mesh-list
110584846|NCT00789035|Empagliflozin|empagliflozin|mesh-list
110584847|NCT00789035|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110584848|NCT00789035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110584849|NCT00789035|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110584850|NCT00789035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110584851|NCT04108013|Paclitaxel|paclitaxel|mesh-list
110584852|NCT04108013|Carboplatin|carboplatin|mesh-list
110584853|NCT04108013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110584854|NCT04108013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110584856|NCT04108013|Antimitotic Agents|antimitotic agents|mesh-ancestor
110584857|NCT04108013|Mitosis Modulators|mitosis modulators|mesh-ancestor
110584858|NCT04108013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110584859|NCT04105985|Oxymetazoline|oxymetazoline|mesh-list
110584860|NCT04105985|Tetracaine|tetracaine|mesh-list
110584861|NCT04105985|Carticaine|carticaine|mesh-list
110584862|NCT04105985|Anesthetics, Local|anesthetics, local|mesh-ancestor
110584863|NCT04105985|Anesthetics|anesthetics|mesh-ancestor
110584864|NCT04105985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110584865|NCT04105985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110584866|NCT04105985|Sensory System Agents|sensory system agents|mesh-ancestor
110584867|NCT04105985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110584868|NCT04105985|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110584869|NCT04105985|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110584870|NCT04105985|Adrenergic Agents|adrenergic agents|mesh-ancestor
110584871|NCT04105985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110584872|NCT04105985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110584873|NCT04105985|Sympathomimetics|sympathomimetics|mesh-ancestor
110584874|NCT04105985|Autonomic Agents|autonomic agents|mesh-ancestor
110584875|NCT04105985|Nasal Decongestants|nasal decongestants|mesh-ancestor
110584876|NCT04105985|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110584877|NCT04105985|Respiratory System Agents|respiratory system agents|mesh-ancestor
110584878|NCT04074213|Clozapine|clozapine|mesh-list
110584879|NCT04074213|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110584880|NCT04074213|Serotonin Agents|serotonin agents|mesh-ancestor
110584881|NCT04074213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110584882|NCT04074213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110584883|NCT04074213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110584884|NCT04074213|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110584885|NCT04074213|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110584886|NCT04074213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110584887|NCT04074213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110584888|NCT04074213|GABA Antagonists|gaba antagonists|mesh-ancestor
110584889|NCT04074213|GABA Agents|gaba agents|mesh-ancestor
110584890|NCT04110587|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110584891|NCT04110587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
110584893|NCT04110587|Hyaluronic Acid|hyaluronic acid|mesh-list
110584894|NCT04110587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110584895|NCT04110587|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110584896|NCT04110587|Immunologic Factors|immunologic factors|mesh-ancestor
110584897|NCT04110587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110584898|NCT04110587|Viscosupplements|viscosupplements|mesh-ancestor
110584899|NCT04110587|Protective Agents|protective agents|mesh-ancestor
110584900|NCT04110587|Sensory System Agents|sensory system agents|mesh-ancestor
110584901|NCT04110587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110584902|NCT04074915|Chlorhexidine|chlorhexidine|mesh-list
110584903|NCT04074915|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110584904|NCT04074915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110584905|NCT04074915|Disinfectants|disinfectants|mesh-ancestor
110584906|NCT02579733|Azathioprine|azathioprine|mesh-list
110584907|NCT02579733|Antimetabolites|antimetabolites|mesh-ancestor
110584908|NCT02579733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110584909|NCT02579733|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110584910|NCT02579733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110584911|NCT02579733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110584912|NCT02579733|Immunologic Factors|immunologic factors|mesh-ancestor
110584913|NCT02579733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110584914|NCT02579733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110584915|NCT03326193|Bevacizumab|bevacizumab|mesh-list
110584916|NCT03326193|Niraparib|niraparib|mesh-list
110584917|NCT03326193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110584918|NCT03326193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110584919|NCT03326193|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110584920|NCT03326193|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110584921|NCT03326193|Growth Substances|growth substances|mesh-ancestor
110584922|NCT03326193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110584923|NCT03326193|Growth Inhibitors|growth inhibitors|mesh-ancestor
110584924|NCT03326193|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110584925|NCT03326193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110584926|NCT03326193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110584927|NCT02517099|Azithromycin|azithromycin|mesh-list
110584928|NCT02517099|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
110584929|NCT02517099|Beclomethasone|beclomethasone|mesh-list
110584930|NCT02517099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110584931|NCT02517099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110584932|NCT02517099|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110584933|NCT02517099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110584934|NCT02517099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110584935|NCT02517099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110584936|NCT02517099|Glucocorticoids|glucocorticoids|mesh-ancestor
110584937|NCT02517099|Hormones|hormones|mesh-ancestor
110584938|NCT02517099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110584939|NCT02517099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110584940|NCT02517099|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110584941|NCT02517099|Respiratory System Agents|respiratory system agents|mesh-ancestor
110584942|NCT02478099|Atezolizumab|atezolizumab|mesh-list
110584943|NCT02478099|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110584944|NCT02478099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110584945|NCT02478099|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110584946|NCT02478099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110584947|NCT02473263|Ceftriaxone|ceftriaxone|mesh-list
110584948|NCT02473263|Tazobactam|tazobactam|mesh-list
110584949|NCT02473263|Piperacillin|piperacillin|mesh-list
110584950|NCT02473263|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
110584951|NCT02473263|Hydrocortisone|hydrocortisone|mesh-list
110584952|NCT02473263|Norepinephrine|norepinephrine|mesh-list
110584953|NCT02473263|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110584954|NCT02473263|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110584955|NCT02473263|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110584956|NCT02473263|Adrenergic Agents|adrenergic agents|mesh-ancestor
110584957|NCT02473263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110584958|NCT02473263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110584959|NCT02473263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110584960|NCT02473263|Sympathomimetics|sympathomimetics|mesh-ancestor
110584961|NCT02473263|Autonomic Agents|autonomic agents|mesh-ancestor
110584962|NCT02473263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110584963|NCT02473263|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110584964|NCT02473263|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110584965|NCT02473263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110584966|NCT02473263|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110584967|NCT02473263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110584969|NCT03249831|Cyclophosphamide|cyclophosphamide|mesh-list
110584970|NCT03249831|Pentostatin|pentostatin|mesh-list
110584971|NCT03249831|Tacrolimus|tacrolimus|mesh-list
110584972|NCT03249831|Thymoglobulin|thymoglobulin|mesh-list
110584973|NCT03249831|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110584974|NCT03249831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110584975|NCT03249831|Immunologic Factors|immunologic factors|mesh-ancestor
110584976|NCT03249831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110584977|NCT03249831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110584978|NCT03249831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110584979|NCT03249831|Alkylating Agents|alkylating agents|mesh-ancestor
110584980|NCT03249831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110584981|NCT03249831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110584982|NCT03249831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110584983|NCT03249831|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110584984|NCT03249831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110584985|NCT03249831|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110584986|NCT03249831|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110584987|NCT03249831|Antitubercular Agents|antitubercular agents|mesh-ancestor
110584988|NCT03249831|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110584989|NCT03249831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110584990|NCT03249831|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
110584991|NCT03222609|Navitoclax|navitoclax|mesh-list
110584992|NCT03222609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110584993|NCT00437203|Gemcitabine|gemcitabine|mesh-list
110584994|NCT00437203|PF 00477736|pf 00477736|mesh-list
110584995|NCT00437203|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110584996|NCT00437203|Antimetabolites|antimetabolites|mesh-ancestor
110584997|NCT00437203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110584998|NCT00437203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110584999|NCT00437203|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110585000|NCT00437203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110585002|NCT02419287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110585003|NCT02419287|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110585004|NCT02419287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110585005|NCT02419287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110585006|NCT00437125|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110585007|NCT00437125|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110585008|NCT00437125|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110585009|NCT00437125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110585010|NCT00437125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110585011|NCT00437125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110585012|NCT00437125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110585013|NCT00437125|Analgesics|analgesics|mesh-ancestor
110585014|NCT00437125|Sensory System Agents|sensory system agents|mesh-ancestor
110585015|NCT00437125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110585016|NCT00437125|Antidepressive Agents|antidepressive agents|mesh-ancestor
110585017|NCT00437125|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110585018|NCT00437125|Dopamine Agents|dopamine agents|mesh-ancestor
110585019|NCT01028287|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
110585020|NCT01028287|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
110585021|NCT01028287|beta-Endorphin|beta-endorphin|mesh-list
110585022|NCT01028287|Hormones|hormones|mesh-ancestor
110585023|NCT01028287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110585024|NCT01028287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110585025|NCT01028287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110585026|NCT01028287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110585027|NCT01028443|Cyclosporine|cyclosporine|mesh-list
110585028|NCT01028443|Antifungal Agents|antifungal agents|mesh-ancestor
110585029|NCT01028443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110585030|NCT01028443|Dermatologic Agents|dermatologic agents|mesh-ancestor
110585031|NCT01028443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110585032|NCT01028443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110585033|NCT01028443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110585034|NCT01028443|Immunologic Factors|immunologic factors|mesh-ancestor
110375936|NCT04569279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110585035|NCT01028443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110585037|NCT01028443|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110232441|NCT00419731|Naltrexone|naltrexone|mesh-list
110585039|NCT03116997|Neostigmine|neostigmine|mesh-list
110585040|NCT03116997|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110585041|NCT03116997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110585042|NCT03116997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110585043|NCT03116997|Cholinergic Agents|cholinergic agents|mesh-ancestor
110585044|NCT03116997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110585045|NCT03116997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110585046|NCT03116997|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110585047|NCT03116997|Autonomic Agents|autonomic agents|mesh-ancestor
110585048|NCT03116997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110585049|NCT03116997|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110585050|NCT03116997|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110585051|NCT03116997|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110585052|NCT02600780|Allopurinol|allopurinol|mesh-list
110585053|NCT02600780|Febuxostat|febuxostat|mesh-list
110585054|NCT02600780|Antimetabolites|antimetabolites|mesh-ancestor
110585055|NCT02600780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110585056|NCT02600780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110585057|NCT02600780|Gout Suppressants|gout suppressants|mesh-ancestor
110585058|NCT02600780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110585059|NCT02600780|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110585060|NCT02600780|Antioxidants|antioxidants|mesh-ancestor
110585061|NCT02600780|Protective Agents|protective agents|mesh-ancestor
110585062|NCT02600780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110585063|NCT00582309|Insulin|insulin|mesh-list
110585064|NCT00582309|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110585065|NCT00582309|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110585066|NCT00582309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110585067|NCT00443053|PENTA|penta|mesh-list
110585068|NCT00443053|Fondaparinux|fondaparinux|mesh-list
110585069|NCT00443053|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110585070|NCT00443053|Antithrombins|antithrombins|mesh-ancestor
110585071|NCT00443053|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110585072|NCT00443053|Protease Inhibitors|protease inhibitors|mesh-ancestor
110585073|NCT00443053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110585074|NCT00443053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110585075|NCT00443053|Anticoagulants|anticoagulants|mesh-ancestor
110585076|NCT00443053|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110585077|NCT00443053|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110585078|NCT00720798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
110585079|NCT00720798|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
110585080|NCT00720798|Antirheumatic Agents|antirheumatic agents|mesh-list
110585081|NCT00720798|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110585082|NCT00720798|Analgesics|analgesics|mesh-ancestor
110585083|NCT00720798|Sensory System Agents|sensory system agents|mesh-ancestor
110585084|NCT00720798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110585085|NCT00720798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110585086|NCT01816971|Dexamethasone|dexamethasone|mesh-list
110585087|NCT01816971|Lenalidomide|lenalidomide|mesh-list
110585088|NCT01816971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110585089|NCT01816971|Antiemetics|antiemetics|mesh-ancestor
110585090|NCT01816971|Autonomic Agents|autonomic agents|mesh-ancestor
110585091|NCT01816971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110585092|NCT01816971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110585093|NCT01816971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110585094|NCT01816971|Glucocorticoids|glucocorticoids|mesh-ancestor
110585096|NCT01816971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110585097|NCT01816971|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110585098|NCT01816971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110585099|NCT01816971|Immunologic Factors|immunologic factors|mesh-ancestor
110585100|NCT01816971|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110585101|NCT01816971|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110585102|NCT01816971|Growth Substances|growth substances|mesh-ancestor
110585103|NCT01816971|Growth Inhibitors|growth inhibitors|mesh-ancestor
110375944|NCT04312282|Itraconazole|itraconazole|mesh-list
110585105|NCT01021267|Urological Agents|urological agents|mesh-ancestor
110585106|NCT00717366|Epoetin Alfa|epoetin alfa|mesh-list
110585107|NCT00717366|Hematinics|hematinics|mesh-ancestor
110585108|NCT02939989|Ribavirin|ribavirin|mesh-list
110585109|NCT02939989|Sofosbuvir|sofosbuvir|mesh-list
110585110|NCT02939989|Antimetabolites|antimetabolites|mesh-ancestor
110585111|NCT02939989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110585112|NCT02939989|Antiviral Agents|antiviral agents|mesh-ancestor
110232520|NCT00087464|Tenofovir|tenofovir|mesh-list
110585113|NCT02939989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110585114|NCT04096742|Tretinoin|tretinoin|mesh-list
110585115|NCT04096742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110585116|NCT04096742|Keratolytic Agents|keratolytic agents|mesh-ancestor
110585117|NCT04096742|Dermatologic Agents|dermatologic agents|mesh-ancestor
110585118|NCT04085640|Ropivacaine|ropivacaine|mesh-list
110585119|NCT04085640|Anesthetics, Local|anesthetics, local|mesh-ancestor
110585120|NCT04085640|Anesthetics|anesthetics|mesh-ancestor
110585121|NCT04085640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110585122|NCT04085640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110585123|NCT04085640|Sensory System Agents|sensory system agents|mesh-ancestor
110585124|NCT04085640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110585125|NCT01031719|Vaccines|vaccines|mesh-list
110585126|NCT01031719|Immunologic Factors|immunologic factors|mesh-ancestor
110585127|NCT01031719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110585128|NCT00723606|Haloperidol|haloperidol|mesh-list
110585129|NCT00723606|Haloperidol decanoate|haloperidol decanoate|mesh-list
110585130|NCT00723606|Ziprasidone|ziprasidone|mesh-list
110585131|NCT00723606|Antiemetics|antiemetics|mesh-ancestor
110585132|NCT00723606|Autonomic Agents|autonomic agents|mesh-ancestor
110585133|NCT00723606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110585134|NCT00723606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110585135|NCT00723606|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110585136|NCT00723606|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110585137|NCT00723606|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110585138|NCT00723606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110585139|NCT00723606|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110585140|NCT00723606|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110585141|NCT00723606|Dopamine Agents|dopamine agents|mesh-ancestor
110585142|NCT00723606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110585143|NCT00723606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110585144|NCT00723606|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110585145|NCT00723606|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110585147|NCT01021501|Nifedipine|nifedipine|mesh-list
110585148|NCT01021501|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110585149|NCT01021501|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110585150|NCT01021501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110585151|NCT01021501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110585152|NCT01021501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110585153|NCT01021501|Vasodilator Agents|vasodilator agents|mesh-ancestor
110585154|NCT01021501|Tocolytic Agents|tocolytic agents|mesh-ancestor
110585155|NCT01021501|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110585156|NCT01021579|Metformin|metformin|mesh-list
110585157|NCT01021579|Simvastatin|simvastatin|mesh-list
110585158|NCT01021579|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110585159|NCT01021579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110585160|NCT01021579|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110585161|NCT01021579|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110585162|NCT01021579|Antimetabolites|antimetabolites|mesh-ancestor
110585163|NCT01021579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110585164|NCT01021579|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110585165|NCT01021579|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110585166|NCT01021579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110585167|NCT01031875|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110585168|NCT01031875|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110585169|NCT01031875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110585170|NCT01021735|Adalimumab|adalimumab|mesh-list
110585171|NCT01021735|Etanercept|etanercept|mesh-list
110585172|NCT01021735|Rituximab|rituximab|mesh-list
110585173|NCT01021735|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110585174|NCT01021735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110585175|NCT01021735|Immunologic Factors|immunologic factors|mesh-ancestor
110149804|NCT00008307|Antiemetics|antiemetics|mesh-ancestor
110585176|NCT01021735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110585177|NCT01021735|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110585178|NCT01021735|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110585179|NCT01021735|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110585180|NCT01021735|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110585181|NCT01021735|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110585182|NCT01021735|Analgesics|analgesics|mesh-ancestor
110585183|NCT01021735|Sensory System Agents|sensory system agents|mesh-ancestor
110585184|NCT01021735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110585185|NCT01021735|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110585186|NCT01021735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110585187|NCT00442351|Mometasone Furoate|mometasone furoate|mesh-list
110585188|NCT00442351|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110585189|NCT00442351|Dermatologic Agents|dermatologic agents|mesh-ancestor
110585190|NCT00442351|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110585191|NCT00436501|Docetaxel|docetaxel|mesh-list
110585192|NCT00436501|Aflibercept|aflibercept|mesh-list
110585193|NCT00436501|Endothelial Growth Factors|endothelial growth factors|mesh-list
110585194|NCT00436501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110585195|NCT00436501|Tubulin Modulators|tubulin modulators|mesh-ancestor
110585196|NCT00436501|Antimitotic Agents|antimitotic agents|mesh-ancestor
110585197|NCT00436501|Mitosis Modulators|mitosis modulators|mesh-ancestor
110585198|NCT00436501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110585199|NCT00436501|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110585200|NCT00436501|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110585201|NCT00436501|Growth Substances|growth substances|mesh-ancestor
110585202|NCT00436501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110585203|NCT00436501|Growth Inhibitors|growth inhibitors|mesh-ancestor
110585204|NCT00755846|Alogliptin|alogliptin|mesh-list
110585205|NCT00755846|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110585206|NCT00755846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110585207|NCT00755846|Incretins|incretins|mesh-ancestor
110585208|NCT00755846|Hormones|hormones|mesh-ancestor
110585209|NCT00755846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110585210|NCT00755846|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110585211|NCT00755846|Protease Inhibitors|protease inhibitors|mesh-ancestor
110585212|NCT00755846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110585213|NCT00755846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110585214|NCT03850093|Bisoprolol|bisoprolol|mesh-list
110585215|NCT03850093|Gabapentin|gabapentin|mesh-list
110585216|NCT03850093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110585217|NCT03850093|Analgesics|analgesics|mesh-ancestor
110585218|NCT03850093|Sensory System Agents|sensory system agents|mesh-ancestor
110585219|NCT03850093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110585220|NCT03850093|Anticonvulsants|anticonvulsants|mesh-ancestor
110585221|NCT03850093|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110585222|NCT03850093|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110585223|NCT03850093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110585224|NCT03850093|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110585225|NCT03850093|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110585226|NCT03850093|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110585227|NCT03850093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110585228|NCT03850093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110585229|NCT03850093|Antimanic Agents|antimanic agents|mesh-ancestor
110585230|NCT03850093|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110585231|NCT03850093|Sympatholytics|sympatholytics|mesh-ancestor
110585232|NCT03850093|Autonomic Agents|autonomic agents|mesh-ancestor
110585233|NCT03850093|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110585234|NCT03850093|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110585235|NCT03850093|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110585236|NCT03850093|Adrenergic Agents|adrenergic agents|mesh-ancestor
110585237|NCT00442117|Mometasone Furoate|mometasone furoate|mesh-list
110585239|NCT00442117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110585240|NCT00442117|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110585241|NCT00442117|Autonomic Agents|autonomic agents|mesh-ancestor
110585242|NCT00442117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110585243|NCT00442117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110585244|NCT00442117|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110585245|NCT00442117|Respiratory System Agents|respiratory system agents|mesh-ancestor
110585246|NCT00442117|Glucocorticoids|glucocorticoids|mesh-ancestor
110585247|NCT00442117|Hormones|hormones|mesh-ancestor
110585248|NCT00442117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110585249|NCT00442117|Dermatologic Agents|dermatologic agents|mesh-ancestor
110585250|NCT00442117|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110585251|NCT00752726|Orlistat|orlistat|mesh-list
110585252|NCT00752726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110585253|NCT00752726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110585254|NCT00752726|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110585255|NCT00752726|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110585256|NCT04072497|Vaccines|vaccines|mesh-list
110585257|NCT04072497|Immunologic Factors|immunologic factors|mesh-ancestor
110585258|NCT04072497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110585259|NCT04072263|Interferons|interferons|mesh-list
110585260|NCT04072263|Interferon-alpha|interferon-alpha|mesh-list
110585261|NCT04072263|Interferon alpha-2|interferon alpha-2|mesh-list
110585262|NCT04072263|Paclitaxel|paclitaxel|mesh-list
110585263|NCT04072263|Carboplatin|carboplatin|mesh-list
110585264|NCT04072263|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110585265|NCT04072263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110232670|NCT00331708|Artesunate|artesunate|mesh-list
110585266|NCT04072263|Tubulin Modulators|tubulin modulators|mesh-ancestor
110585268|NCT04072263|Mitosis Modulators|mitosis modulators|mesh-ancestor
110585269|NCT04072263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110585270|NCT04072263|Antiviral Agents|antiviral agents|mesh-ancestor
110585271|NCT04072263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110585272|NCT04072263|Immunologic Factors|immunologic factors|mesh-ancestor
110585273|NCT04072263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110585274|NCT00441727|Esomeprazole|esomeprazole|mesh-list
110585275|NCT00441727|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110585276|NCT00441727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110585277|NCT00441727|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110585278|NCT00441727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110585279|NCT00441727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110585280|NCT00770120|Everolimus|everolimus|mesh-list
110585281|NCT00770120|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110585282|NCT00770120|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110585283|NCT00770120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110585284|NCT00770120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110585285|NCT00770120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110585286|NCT00770120|Immunologic Factors|immunologic factors|mesh-ancestor
110585287|NCT00770120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110585288|NCT00770120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110585290|NCT03996655|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110585291|NCT03996655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110585292|NCT03996655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110585293|NCT03996655|Cholinergic Agents|cholinergic agents|mesh-ancestor
110585294|NCT03996655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110585295|NCT03996655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110585296|NCT03996655|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110585297|NCT03996655|Autonomic Agents|autonomic agents|mesh-ancestor
110585298|NCT03996655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110585299|NCT01032109|Bevacizumab|bevacizumab|mesh-list
110585300|NCT01032109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110585301|NCT01032109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110585302|NCT01032109|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110375968|NCT01087905|Nicotine|nicotine|mesh-list
110585303|NCT01032109|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110585304|NCT01032109|Growth Substances|growth substances|mesh-ancestor
110585305|NCT01032109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110585306|NCT01032109|Growth Inhibitors|growth inhibitors|mesh-ancestor
110585307|NCT04100330|Cytarabine|cytarabine|mesh-list
110585308|NCT04100330|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110585309|NCT04100330|Antimetabolites|antimetabolites|mesh-ancestor
110585310|NCT04100330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110585311|NCT04100330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110585312|NCT04100330|Antiviral Agents|antiviral agents|mesh-ancestor
110585313|NCT04100330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110585314|NCT04100330|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110585315|NCT04100330|Immunologic Factors|immunologic factors|mesh-ancestor
110585316|NCT04100330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110585317|NCT00436345|Remifentanil|remifentanil|mesh-list
110585318|NCT00436345|Propofol|propofol|mesh-list
110585319|NCT00436345|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110585320|NCT00436345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110585321|NCT00436345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110585322|NCT00436345|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110585323|NCT00436345|Anesthetics, General|anesthetics, general|mesh-ancestor
110585324|NCT00436345|Anesthetics|anesthetics|mesh-ancestor
110585325|NCT00436345|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110585326|NCT00436345|Narcotics|narcotics|mesh-ancestor
110585327|NCT00436345|Analgesics|analgesics|mesh-ancestor
110585328|NCT00436345|Sensory System Agents|sensory system agents|mesh-ancestor
110585329|NCT00436345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110585330|NCT00916448|Atazanavir Sulfate|atazanavir sulfate|mesh-list
110585331|NCT00916448|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110585332|NCT00916448|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110585333|NCT00916448|Protease Inhibitors|protease inhibitors|mesh-ancestor
110585334|NCT00916448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110585335|NCT00916448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110585336|NCT00916448|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110585337|NCT00916448|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110585338|NCT00916448|Antiviral Agents|antiviral agents|mesh-ancestor
110585339|NCT00916448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110585340|NCT01032187|Amphotericin B|amphotericin b|mesh-list
110585341|NCT01032187|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
110585342|NCT01032187|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
110585343|NCT01032187|Meglumine Antimoniate|meglumine antimoniate|mesh-list
110585344|NCT01032187|Deoxycholic Acid|deoxycholic acid|mesh-list
110585345|NCT01032187|Amebicides|amebicides|mesh-ancestor
110585346|NCT01032187|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110585347|NCT01032187|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110585348|NCT01032187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110585349|NCT01032187|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110585350|NCT01032187|Antifungal Agents|antifungal agents|mesh-ancestor
110585351|NCT01032187|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
110585352|NCT01032187|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110585353|NCT00769184|Clobetasol|clobetasol|mesh-list
110585354|NCT00769184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110585355|NCT00769184|Glucocorticoids|glucocorticoids|mesh-ancestor
110585356|NCT00769184|Hormones|hormones|mesh-ancestor
110585357|NCT00769184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110585358|NCT00769184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110585359|NCT00768560|Nifedipine|nifedipine|mesh-list
110585360|NCT00768560|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110585361|NCT00768560|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110585362|NCT00768560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110585363|NCT00768560|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110585364|NCT00768560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110585365|NCT00768560|Vasodilator Agents|vasodilator agents|mesh-ancestor
110585366|NCT00768560|Tocolytic Agents|tocolytic agents|mesh-ancestor
110585367|NCT00768560|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110585368|NCT00468559|Esomeprazole|esomeprazole|mesh-list
110585369|NCT00468559|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110585370|NCT00468559|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110585371|NCT00468559|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110585372|NCT00468559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110585373|NCT00468559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110585374|NCT00754442|Teriparatide|teriparatide|mesh-list
110585375|NCT00754442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110585376|NCT00754442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110585377|NCT00754442|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110585379|NCT00754052|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110585380|NCT00754052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110585381|NCT00754052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110585382|NCT00754052|Cholinergic Agents|cholinergic agents|mesh-ancestor
110585383|NCT00754052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110585384|NCT00754052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110585385|NCT00754052|Nootropic Agents|nootropic agents|mesh-ancestor
110585386|NCT04095182|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
110585387|NCT04095182|Anticonvulsants|anticonvulsants|mesh-ancestor
110585389|NCT04095182|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110585390|NCT04095182|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110585391|NCT04095182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110585392|NCT02927067|Valganciclovir|valganciclovir|mesh-list
110585393|NCT02927067|Maribavir|maribavir|mesh-list
110585394|NCT02927067|Antiviral Agents|antiviral agents|mesh-ancestor
110585395|NCT02927067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110585396|NCT02600468|Abatacept|abatacept|mesh-list
110585397|NCT02600468|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110585398|NCT02600468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110585399|NCT02600468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110585400|NCT02600468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110585401|NCT02600468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110585402|NCT02600468|Immunologic Factors|immunologic factors|mesh-ancestor
110585403|NCT02600468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110585404|NCT02600468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110585405|NCT02598596|Azathioprine|azathioprine|mesh-list
110585406|NCT02598596|Antimetabolites|antimetabolites|mesh-ancestor
110585407|NCT02598596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110585408|NCT02598596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110585409|NCT02598596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110585410|NCT02598596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110585411|NCT02598596|Immunologic Factors|immunologic factors|mesh-ancestor
110585412|NCT02598596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110585413|NCT02598596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110585414|NCT00586508|Bevacizumab|bevacizumab|mesh-list
110585415|NCT00586508|Anticonvulsants|anticonvulsants|mesh-list
110585416|NCT00586508|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110585417|NCT00586508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110585418|NCT00586508|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110585419|NCT00586508|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110585420|NCT00586508|Growth Substances|growth substances|mesh-ancestor
110585421|NCT00586508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110585422|NCT00586508|Growth Inhibitors|growth inhibitors|mesh-ancestor
110585423|NCT00581919|Acetylcarnitine|acetylcarnitine|mesh-list
110585424|NCT00581919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110585425|NCT00581919|Vitamin B Complex|vitamin b complex|mesh-ancestor
110585426|NCT00581919|Vitamins|vitamins|mesh-ancestor
110585427|NCT00581919|Micronutrients|micronutrients|mesh-ancestor
110585428|NCT00581919|Nootropic Agents|nootropic agents|mesh-ancestor
110585429|NCT00723528|Ustekinumab|ustekinumab|mesh-list
110585430|NCT00723528|Dermatologic Agents|dermatologic agents|mesh-ancestor
110585431|NCT00751790|Triptorelin Pamoate|triptorelin pamoate|mesh-list
110585432|NCT00751790|Luteolytic Agents|luteolytic agents|mesh-ancestor
110585433|NCT00751790|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110585434|NCT00751790|Contraceptive Agents|contraceptive agents|mesh-ancestor
110585435|NCT00751790|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110585436|NCT00751790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110585437|NCT00751790|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110585438|NCT00751790|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110585439|NCT00751790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110585440|NCT04020536|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110585441|NCT04020536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110585442|NCT00916760|Aluminum Hydroxide|aluminum hydroxide|mesh-list
110585443|NCT00916760|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110585444|NCT00916760|Immunologic Factors|immunologic factors|mesh-ancestor
110585445|NCT00916760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110375978|NCT01087788|Certolizumab Pegol|certolizumab pegol|mesh-list
110585447|NCT00916760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110585448|NCT00916760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110585449|NCT00723450|Lamotrigine|lamotrigine|mesh-list
110585450|NCT00723450|Anticonvulsants|anticonvulsants|mesh-ancestor
110585451|NCT00723450|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110585452|NCT00723450|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110585453|NCT00723450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110585454|NCT00723450|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110585455|NCT00723450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110585456|NCT00723450|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110585457|NCT00723450|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110585458|NCT00723450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110585459|NCT00723450|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110585460|NCT00723450|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110585462|NCT02599532|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110585463|NCT02599532|Antithrombins|antithrombins|mesh-ancestor
110585464|NCT02599532|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110585465|NCT02599532|Protease Inhibitors|protease inhibitors|mesh-ancestor
110585466|NCT02599532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110585467|NCT02599532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110585468|NCT02599532|Anticoagulants|anticoagulants|mesh-ancestor
110585469|NCT00751400|Naproxen|naproxen|mesh-list
110585470|NCT00751400|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110585471|NCT00751400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110585472|NCT00751400|Analgesics|analgesics|mesh-ancestor
110585473|NCT00751400|Sensory System Agents|sensory system agents|mesh-ancestor
110585474|NCT00751400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110585475|NCT00751400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110585476|NCT00751400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110585477|NCT00751400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110585478|NCT00751400|Gout Suppressants|gout suppressants|mesh-ancestor
110585479|NCT00751400|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110585480|NCT00751400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110585481|NCT00751400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110585482|NCT00585312|Celecoxib|celecoxib|mesh-list
110585483|NCT00585312|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110585484|NCT00585312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110585485|NCT00585312|Analgesics|analgesics|mesh-ancestor
110585486|NCT00585312|Sensory System Agents|sensory system agents|mesh-ancestor
110585487|NCT00585312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110585488|NCT00585312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110585489|NCT00585312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110232882|NCT05831566|Adrenergic Agents|adrenergic agents|mesh-ancestor
110585490|NCT00585312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110585491|NCT00585312|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110585492|NCT00585312|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110585493|NCT00585312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110585494|NCT00585312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110585496|NCT00753506|Artemisinin|artemisinin|mesh-list
110585497|NCT00753506|Antimalarials|antimalarials|mesh-ancestor
110585498|NCT00753506|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110585499|NCT00753506|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110585500|NCT00753506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110585501|NCT00720096|Doxorubicin|doxorubicin|mesh-list
110585502|NCT00720096|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110585503|NCT00720096|Topotecan|topotecan|mesh-list
110585504|NCT00720096|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110585505|NCT00720096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110585506|NCT00720096|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110585507|NCT00720096|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110585508|NCT00720096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110585509|NCT00720096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110585510|NCT00720096|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110585511|NCT04086108|gamma-Aminobutyric Acid|gamma-aminobutyric acid|mesh-list
110585513|NCT04086108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110375985|NCT00586976|Ropivacaine|ropivacaine|mesh-list
110585514|NCT04086108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110585515|NCT04086108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110585516|NCT02577783|Dexamethasone|dexamethasone|mesh-list
110585517|NCT02577783|Dexamethasone acetate|dexamethasone acetate|mesh-list
110585518|NCT02577783|Doxorubicin|doxorubicin|mesh-list
110585519|NCT02577783|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110585520|NCT02577783|BB 1101|bb 1101|mesh-list
110585521|NCT02577783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110585522|NCT02577783|Antiemetics|antiemetics|mesh-ancestor
110585523|NCT02577783|Autonomic Agents|autonomic agents|mesh-ancestor
110585524|NCT02577783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110585525|NCT02577783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110585526|NCT02577783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110585527|NCT02577783|Glucocorticoids|glucocorticoids|mesh-ancestor
110585528|NCT02577783|Hormones|hormones|mesh-ancestor
110585529|NCT02577783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110585530|NCT02577783|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110585531|NCT02577783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110585532|NCT02577783|Protease Inhibitors|protease inhibitors|mesh-ancestor
110585533|NCT02577783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110585534|NCT02577783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110585535|NCT02577783|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110585536|NCT02577783|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110585537|NCT02577783|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110585538|NCT00918450|Navitoclax|navitoclax|mesh-list
110585539|NCT00918450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110585540|NCT02591628|Chlorthalidone|chlorthalidone|mesh-list
110585541|NCT02591628|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110585542|NCT02591628|Diuretics|diuretics|mesh-ancestor
110585543|NCT02591628|Natriuretic Agents|natriuretic agents|mesh-ancestor
110585544|NCT02591628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110585545|NCT02591628|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110585546|NCT02591628|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110585547|NCT02591628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110585548|NCT04090112|Lidocaine|lidocaine|mesh-list
110585549|NCT04090112|Anesthetics, Local|anesthetics, local|mesh-ancestor
110585550|NCT04090112|Anesthetics|anesthetics|mesh-ancestor
110585551|NCT04090112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110585552|NCT04090112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110585553|NCT04090112|Sensory System Agents|sensory system agents|mesh-ancestor
110585554|NCT04090112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110585555|NCT04090112|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110585556|NCT04090112|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110585557|NCT04090112|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110585558|NCT04090112|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110585559|NCT04090112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110585560|NCT00747344|Ustekinumab|ustekinumab|mesh-list
110585561|NCT00747344|Dermatologic Agents|dermatologic agents|mesh-ancestor
110585562|NCT00580983|Paclitaxel|paclitaxel|mesh-list
110585563|NCT00580983|Carboplatin|carboplatin|mesh-list
110585564|NCT00580983|Fluorouracil|fluorouracil|mesh-list
110585565|NCT00580983|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110585566|NCT00580983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110585567|NCT00580983|Tubulin Modulators|tubulin modulators|mesh-ancestor
110585568|NCT00580983|Antimitotic Agents|antimitotic agents|mesh-ancestor
110585569|NCT00580983|Mitosis Modulators|mitosis modulators|mesh-ancestor
110585570|NCT00580983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110585571|NCT00580983|Antimetabolites|antimetabolites|mesh-ancestor
110585572|NCT00580983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110585573|NCT00580983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110585574|NCT00580983|Immunologic Factors|immunologic factors|mesh-ancestor
110585575|NCT00580983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110585576|NCT02576223|Ropivacaine|ropivacaine|mesh-list
110585577|NCT02576223|Anesthetics, Local|anesthetics, local|mesh-ancestor
110585578|NCT02576223|Anesthetics|anesthetics|mesh-ancestor
110585579|NCT02576223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110585580|NCT02576223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110585581|NCT02576223|Sensory System Agents|sensory system agents|mesh-ancestor
110585582|NCT02576223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110585583|NCT02309931|Antidiarrheals|antidiarrheals|mesh-list
110585584|NCT02309931|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110585585|NCT02577393|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
110585586|NCT02577393|Antioxidants|antioxidants|mesh-ancestor
110585587|NCT02577393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110585588|NCT02577393|Protective Agents|protective agents|mesh-ancestor
110585589|NCT02577393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110585590|NCT02577393|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
110585591|NCT02577393|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110585592|NCT02577393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110585593|NCT02577393|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110585594|NCT00753896|Exenatide|exenatide|mesh-list
110585595|NCT00753896|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110585596|NCT00753896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110585597|NCT00753896|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110585598|NCT00753896|Incretins|incretins|mesh-ancestor
110585599|NCT00753896|Hormones|hormones|mesh-ancestor
110585600|NCT00753896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110585601|NCT02597114|Insulin|insulin|mesh-list
110585602|NCT02597114|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110585604|NCT02597114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110585605|NCT00716976|Sodium thiosulfate|sodium thiosulfate|mesh-list
110585606|NCT00716976|Antidotes|antidotes|mesh-ancestor
110585607|NCT00716976|Protective Agents|protective agents|mesh-ancestor
110585608|NCT00716976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110585609|NCT00716976|Antioxidants|antioxidants|mesh-ancestor
110585610|NCT00716976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110585611|NCT00716976|Antitubercular Agents|antitubercular agents|mesh-ancestor
110585612|NCT00716976|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110585613|NCT00716976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110585614|NCT00716976|Chelating Agents|chelating agents|mesh-ancestor
110585615|NCT00716976|Sequestering Agents|sequestering agents|mesh-ancestor
110585616|NCT00743444|Lesogaberan|lesogaberan|mesh-list
110585617|NCT00743444|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110585618|NCT00743444|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
110585619|NCT00743444|GABA Agonists|gaba agonists|mesh-ancestor
110585620|NCT00743444|GABA Agents|gaba agents|mesh-ancestor
110585621|NCT00743444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110585622|NCT00743444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110585623|NCT00743444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110585624|NCT00743366|Riboflavin|riboflavin|mesh-list
110585625|NCT00743366|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110585626|NCT00743366|Antidepressive Agents|antidepressive agents|mesh-ancestor
110585627|NCT00743366|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110585628|NCT00743366|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110585629|NCT00743366|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110585630|NCT00743366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110585631|NCT00743366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110585632|NCT00743366|Vitamin B Complex|vitamin b complex|mesh-ancestor
110585633|NCT00743366|Vitamins|vitamins|mesh-ancestor
110585634|NCT00743366|Micronutrients|micronutrients|mesh-ancestor
110585635|NCT00743366|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110585636|NCT00743366|Dermatologic Agents|dermatologic agents|mesh-ancestor
110585637|NCT01760655|Mycophenolic Acid|mycophenolic acid|mesh-list
110585638|NCT01760655|Cyclophosphamide|cyclophosphamide|mesh-list
110585639|NCT01760655|Busulfan|busulfan|mesh-list
110585640|NCT01760655|Methyl Methanesulfonate|methyl methanesulfonate|mesh-list
110585641|NCT01760655|Fludarabine|fludarabine|mesh-list
110585642|NCT01760655|Fludarabine phosphate|fludarabine phosphate|mesh-list
110585643|NCT01760655|Tacrolimus|tacrolimus|mesh-list
110585644|NCT01760655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110585645|NCT01760655|Immunologic Factors|immunologic factors|mesh-ancestor
110585646|NCT01760655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110585647|NCT01760655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110585648|NCT01760655|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110375998|NCT04568772|Atovaquone|atovaquone|mesh-list
110585649|NCT01760655|Alkylating Agents|alkylating agents|mesh-ancestor
110585650|NCT01760655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110585651|NCT01760655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110585652|NCT01760655|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110585653|NCT01760655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110585654|NCT01760655|Antimetabolites|antimetabolites|mesh-ancestor
110585655|NCT01760655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110585656|NCT01760655|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110585657|NCT01760655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110585658|NCT01760655|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110585659|NCT01760655|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110585660|NCT01760655|Antitubercular Agents|antitubercular agents|mesh-ancestor
110585661|NCT01760655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110585662|NCT00743288|Melphalan|melphalan|mesh-list
110585663|NCT00743288|Panobinostat|panobinostat|mesh-list
110585664|NCT00743288|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110585665|NCT00743288|Alkylating Agents|alkylating agents|mesh-ancestor
110585666|NCT00743288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110585667|NCT00743288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110585668|NCT00743288|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110585669|NCT00743288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110585670|NCT00743288|Immunologic Factors|immunologic factors|mesh-ancestor
110585671|NCT00743288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110585672|NCT00743288|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110149838|NCT00006475|Imatinib Mesylate|imatinib mesylate|mesh-list
110585674|NCT02579187|Anesthetics|anesthetics|mesh-list
110585675|NCT02579187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110585676|NCT02579187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110585677|NCT02598440|Alendronate|alendronate|mesh-list
110585678|NCT02598440|Ibandronic Acid|ibandronic acid|mesh-list
110585679|NCT02598440|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110585680|NCT02598440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110585681|NCT00750308|Ramipril|ramipril|mesh-list
110585682|NCT00750308|Tadalafil|tadalafil|mesh-list
110585683|NCT00750308|Vasodilator Agents|vasodilator agents|mesh-ancestor
110585684|NCT00750308|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110585685|NCT00750308|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110585686|NCT00750308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110585687|NCT00750308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110585688|NCT00750308|Urological Agents|urological agents|mesh-ancestor
110585689|NCT00750308|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110585690|NCT00750308|Protease Inhibitors|protease inhibitors|mesh-ancestor
110585691|NCT00750308|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110585692|NCT05392790|Calcium|calcium|mesh-list
110585693|NCT05392790|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110585694|NCT05392790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110585695|NCT02597036|Zansecimab|zansecimab|mesh-list
110585696|NCT02597036|Paclitaxel|paclitaxel|mesh-list
110585697|NCT02597036|Ramucirumab|ramucirumab|mesh-list
110585698|NCT02597036|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110585699|NCT02597036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110585700|NCT02597036|Tubulin Modulators|tubulin modulators|mesh-ancestor
110585701|NCT02597036|Antimitotic Agents|antimitotic agents|mesh-ancestor
110585702|NCT02597036|Mitosis Modulators|mitosis modulators|mesh-ancestor
110585703|NCT02597036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110585704|NCT02597036|Antiviral Agents|antiviral agents|mesh-ancestor
110585705|NCT02597036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110585706|NCT04071639|Ubiquinone|ubiquinone|mesh-list
110585707|NCT04071639|Haloperidol|haloperidol|mesh-list
110585708|NCT04071639|Risperidone|risperidone|mesh-list
110585709|NCT04071639|Haloperidol decanoate|haloperidol decanoate|mesh-list
110585710|NCT04071639|Sertraline|sertraline|mesh-list
110585711|NCT04071639|Tetrabenazine|tetrabenazine|mesh-list
110585712|NCT04071639|Idebenone|idebenone|mesh-list
110585713|NCT04071639|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110585714|NCT04071639|Serotonin Agents|serotonin agents|mesh-ancestor
110585715|NCT04071639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110585716|NCT04071639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110585717|NCT04071639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110585718|NCT04071639|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110585719|NCT04071639|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110585720|NCT04071639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110585721|NCT04071639|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110585722|NCT04071639|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110585724|NCT04071639|Antidepressive Agents|antidepressive agents|mesh-ancestor
110585725|NCT04071639|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110585726|NCT04071639|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110585727|NCT04071639|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110585729|NCT04071639|Autonomic Agents|autonomic agents|mesh-ancestor
110585730|NCT04071639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110585731|NCT04071639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110585732|NCT04071639|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110585733|NCT04071639|Antioxidants|antioxidants|mesh-ancestor
110585734|NCT04071639|Protective Agents|protective agents|mesh-ancestor
110585735|NCT04071639|Micronutrients|micronutrients|mesh-ancestor
110585736|NCT04071639|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110585737|NCT04071639|Adrenergic Agents|adrenergic agents|mesh-ancestor
110585738|NCT04089176|Oxytocin|oxytocin|mesh-list
110585739|NCT04089176|Carbetocin|carbetocin|mesh-list
110585740|NCT04089176|Oxytocics|oxytocics|mesh-ancestor
110585741|NCT04089176|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110585742|NCT04089176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110585743|NCT02577159|Dapagliflozin|dapagliflozin|mesh-list
110585744|NCT02577159|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110585745|NCT02577159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110585746|NCT02577159|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110585747|NCT02577159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110585748|NCT00749684|Interferons|interferons|mesh-list
110585749|NCT00749684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110585750|NCT00749684|Antiviral Agents|antiviral agents|mesh-ancestor
110585751|NCT00749684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110585752|NCT02575755|Azithromycin|azithromycin|mesh-list
110585753|NCT02575755|Pyrimethamine|pyrimethamine|mesh-list
110585754|NCT02575755|Piperaquine|piperaquine|mesh-list
110585755|NCT02575755|Sulfadoxine|sulfadoxine|mesh-list
110585756|NCT02575755|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
110585757|NCT02575755|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110585758|NCT02575755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110585759|NCT02575755|Antimalarials|antimalarials|mesh-ancestor
110585760|NCT02575755|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110585761|NCT02575755|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110585762|NCT02575755|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110585763|NCT02575755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110585764|NCT02575755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110585765|NCT02575755|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110585766|NCT00746798|Vaccines|vaccines|mesh-list
110585767|NCT00746798|Immunologic Factors|immunologic factors|mesh-ancestor
110585768|NCT00746798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110585769|NCT00716274|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
110585770|NCT00716274|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110585771|NCT00716274|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110585772|NCT00716274|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110585773|NCT00716274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110585774|NCT00716274|Adrenergic Agents|adrenergic agents|mesh-ancestor
110585775|NCT00716274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110585776|NCT00716274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110585777|NCT01298193|Phenothiazine|phenothiazine|mesh-list
110585778|NCT01298193|Droperidol|droperidol|mesh-list
110585779|NCT01298193|Haloperidol|haloperidol|mesh-list
110585780|NCT01298193|Aprepitant|aprepitant|mesh-list
110585781|NCT01298193|Metoclopramide|metoclopramide|mesh-list
110585782|NCT01298193|Domperidone|domperidone|mesh-list
110585783|NCT01298193|Alizapride|alizapride|mesh-list
110585784|NCT01298193|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-list
110585785|NCT01298193|Antiemetics|antiemetics|mesh-ancestor
110585787|NCT01298193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110585788|NCT01298193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110585789|NCT01298193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110585790|NCT01298193|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110585791|NCT01298193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110585792|NCT01298193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110585793|NCT01298193|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110585794|NCT01298193|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110585795|NCT01298193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110585796|NCT01298193|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110585797|NCT01298193|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110585798|NCT01298193|Dopamine Agents|dopamine agents|mesh-ancestor
110585799|NCT01298193|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110585800|NCT01298193|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110585801|NCT01298193|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110585802|NCT01298193|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110585803|NCT01298193|Serotonin Agents|serotonin agents|mesh-ancestor
110585804|NCT01298193|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110585805|NCT01298193|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110585806|NCT01298193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110585807|NCT02590536|Sildenafil Citrate|sildenafil citrate|mesh-list
110585808|NCT02590536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110585809|NCT02590536|Vasodilator Agents|vasodilator agents|mesh-ancestor
110585810|NCT02590536|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110585811|NCT02590536|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110585812|NCT02590536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110585813|NCT02590536|Urological Agents|urological agents|mesh-ancestor
110585815|NCT00719862|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110585816|NCT00719862|Autonomic Agents|autonomic agents|mesh-ancestor
110585817|NCT00719862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110585818|NCT00719862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110585819|NCT00719862|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110585820|NCT00719862|Respiratory System Agents|respiratory system agents|mesh-ancestor
110585821|NCT00719862|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
110585822|NCT00719862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110585823|NCT00719862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110585824|NCT00719862|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110585825|NCT00719862|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110585826|NCT00719862|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110585827|NCT00719862|Histamine Antagonists|histamine antagonists|mesh-ancestor
110585828|NCT00719862|Histamine Agents|histamine agents|mesh-ancestor
110585829|NCT00719862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110585830|NCT02578953|Dutasteride|dutasteride|mesh-list
110585831|NCT02578953|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
110585832|NCT02578953|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110585833|NCT02578953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110585834|NCT02578953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110585835|NCT02578953|Hormone Antagonists|hormone antagonists|mesh-ancestor
110585836|NCT02578953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110585837|NCT02578953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110585838|NCT02578719|Bupivacaine|bupivacaine|mesh-list
110585839|NCT02578719|Anesthetics, Local|anesthetics, local|mesh-ancestor
110585840|NCT02578719|Anesthetics|anesthetics|mesh-ancestor
110585841|NCT02578719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110585842|NCT02578719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110585843|NCT02578719|Sensory System Agents|sensory system agents|mesh-ancestor
110585844|NCT02578719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110585845|NCT00742508|Carvedilol|carvedilol|mesh-list
110585846|NCT00742508|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110585847|NCT00742508|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110585848|NCT00742508|Adrenergic Agents|adrenergic agents|mesh-ancestor
110585849|NCT00742508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110585850|NCT00742508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110585851|NCT00742508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110585852|NCT00742508|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110585853|NCT00742508|Antioxidants|antioxidants|mesh-ancestor
110585854|NCT00742508|Protective Agents|protective agents|mesh-ancestor
110585855|NCT00742508|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110585856|NCT00742508|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110585857|NCT00742508|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110585858|NCT00742508|Vasodilator Agents|vasodilator agents|mesh-ancestor
110585859|NCT00742508|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110585860|NCT00742508|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110585861|NCT02590614|Vitamin D|vitamin d|mesh-list
110585862|NCT02590614|Vitamins|vitamins|mesh-ancestor
110585863|NCT02590614|Micronutrients|micronutrients|mesh-ancestor
110585864|NCT02590614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110585865|NCT02590614|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110585866|NCT02575443|Rocuronium|rocuronium|mesh-list
110585867|NCT02575443|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110585868|NCT02575443|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110585869|NCT02575443|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110585870|NCT02575443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110585871|NCT02575443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110585872|NCT02596334|Lamivudine|lamivudine|mesh-list
110585873|NCT02596334|Abacavir|abacavir|mesh-list
110585874|NCT02596334|Dolutegravir|dolutegravir|mesh-list
110585875|NCT02596334|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110585876|NCT02596334|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110585877|NCT02596334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110585878|NCT02596334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110585879|NCT02596334|Antiviral Agents|antiviral agents|mesh-ancestor
110585880|NCT02596334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110585882|NCT02596334|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110585883|NCT02596334|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110585884|NCT02596334|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110585885|NCT00719706|Acetylcarnitine|acetylcarnitine|mesh-list
110585886|NCT00719706|Vitamin B Complex|vitamin b complex|mesh-ancestor
110585887|NCT00719706|Vitamins|vitamins|mesh-ancestor
110585888|NCT00719706|Micronutrients|micronutrients|mesh-ancestor
110585889|NCT00719706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110585890|NCT00719706|Nootropic Agents|nootropic agents|mesh-ancestor
110585891|NCT02575521|Dexmedetomidine|dexmedetomidine|mesh-list
110585892|NCT02575521|Propofol|propofol|mesh-list
110585893|NCT02575521|Sevoflurane|sevoflurane|mesh-list
110585894|NCT02575521|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110585895|NCT02575521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110585896|NCT02575521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110585897|NCT02575521|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110585898|NCT02575521|Analgesics|analgesics|mesh-ancestor
110585899|NCT02575521|Sensory System Agents|sensory system agents|mesh-ancestor
110585900|NCT02575521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110585901|NCT02575521|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110585902|NCT02575521|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110585903|NCT02575521|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110585904|NCT02575521|Adrenergic Agents|adrenergic agents|mesh-ancestor
110585905|NCT02575521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110585906|NCT02575521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110585907|NCT02575521|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110585908|NCT02575521|Anesthetics, General|anesthetics, general|mesh-ancestor
110585909|NCT02575521|Anesthetics|anesthetics|mesh-ancestor
110585910|NCT02575521|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110585911|NCT02575521|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110585912|NCT02576457|BMS-936559|bms-936559|mesh-list
110585913|NCT02576457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110585914|NCT02576457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110585915|NCT05276102|Emollients|emollients|mesh-list
110585916|NCT05276102|Dermatologic Agents|dermatologic agents|mesh-ancestor
110585917|NCT01192971|Apatinib|apatinib|mesh-list
110585918|NCT01192971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110585919|NCT01192971|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110585920|NCT01192971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110585921|NCT01192971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110585922|NCT00719472|Antipyretics|antipyretics|mesh-list
110585923|NCT00719472|Prednisone|prednisone|mesh-list
110585924|NCT00719472|Cyclophosphamide|cyclophosphamide|mesh-list
110585925|NCT00719472|Rituximab|rituximab|mesh-list
110585926|NCT00719472|Doxorubicin|doxorubicin|mesh-list
110585927|NCT00719472|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110585928|NCT00719472|Vincristine|vincristine|mesh-list
110585929|NCT00719472|Analgesics|analgesics|mesh-list
110585930|NCT00719472|Histamine Antagonists|histamine antagonists|mesh-list
110585931|NCT00719472|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
110585932|NCT00719472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110585933|NCT00719472|Immunologic Factors|immunologic factors|mesh-ancestor
110585934|NCT00719472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110585935|NCT00719472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110585936|NCT00719472|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110585937|NCT00719472|Alkylating Agents|alkylating agents|mesh-ancestor
110585938|NCT00719472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110585939|NCT00719472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110585940|NCT00719472|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110585941|NCT00719472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110585942|NCT00719472|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110585943|NCT00719472|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110585944|NCT00719472|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110585946|NCT00719472|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110585947|NCT00719472|Glucocorticoids|glucocorticoids|mesh-ancestor
110585948|NCT00719472|Hormones|hormones|mesh-ancestor
110585949|NCT00719472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110585950|NCT00719472|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110585951|NCT00719472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110585952|NCT00719472|Tubulin Modulators|tubulin modulators|mesh-ancestor
110585953|NCT00719472|Antimitotic Agents|antimitotic agents|mesh-ancestor
110585955|NCT00719472|Sensory System Agents|sensory system agents|mesh-ancestor
110225503|NCT05952713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110585956|NCT00719472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110585957|NCT00719472|Histamine Agents|histamine agents|mesh-ancestor
110585958|NCT00719472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110585959|NCT00579501|Dexamethasone|dexamethasone|mesh-list
110585960|NCT00579501|Trabectedin|trabectedin|mesh-list
110585961|NCT00579501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110585962|NCT00579501|Antiemetics|antiemetics|mesh-ancestor
110585963|NCT00579501|Autonomic Agents|autonomic agents|mesh-ancestor
110585964|NCT00579501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110585965|NCT00579501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110585966|NCT00579501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110585967|NCT00579501|Glucocorticoids|glucocorticoids|mesh-ancestor
110585968|NCT00579501|Hormones|hormones|mesh-ancestor
110585969|NCT00579501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110585970|NCT00579501|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110585971|NCT00579501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110585972|NCT00579501|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110585973|NCT00579501|Alkylating Agents|alkylating agents|mesh-ancestor
110585974|NCT00579501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110585975|NCT02576301|Cytarabine|cytarabine|mesh-list
110585976|NCT02576301|Combretastatin|combretastatin|mesh-list
110585977|NCT02576301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110585978|NCT02576301|Antimetabolites|antimetabolites|mesh-ancestor
110585979|NCT02576301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110585980|NCT02576301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110585981|NCT02576301|Antiviral Agents|antiviral agents|mesh-ancestor
110585982|NCT02576301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110585983|NCT02576301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110585984|NCT02576301|Immunologic Factors|immunologic factors|mesh-ancestor
110585985|NCT02576301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110585986|NCT02576301|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110585987|NCT02576301|Tubulin Modulators|tubulin modulators|mesh-ancestor
110585988|NCT02576301|Antimitotic Agents|antimitotic agents|mesh-ancestor
110376042|NCT00587444|Heparin|heparin|mesh-list
110585990|NCT04086186|Bupivacaine|bupivacaine|mesh-list
110585991|NCT04086186|Anesthetics, Local|anesthetics, local|mesh-ancestor
110585992|NCT04086186|Anesthetics|anesthetics|mesh-ancestor
110585993|NCT04086186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110585994|NCT04086186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110585995|NCT04086186|Sensory System Agents|sensory system agents|mesh-ancestor
110585996|NCT04086186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110585997|NCT00741338|Cyclosporine|cyclosporine|mesh-list
110585998|NCT00741338|Azathioprine|azathioprine|mesh-list
110585999|NCT00741338|Cyclosporins|cyclosporins|mesh-list
110586000|NCT00741338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110586001|NCT00741338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110586002|NCT00741338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110586003|NCT00741338|Immunologic Factors|immunologic factors|mesh-ancestor
110586004|NCT00741338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110586005|NCT00741338|Antifungal Agents|antifungal agents|mesh-ancestor
110586006|NCT00741338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110586007|NCT00741338|Dermatologic Agents|dermatologic agents|mesh-ancestor
110586008|NCT00741338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110586009|NCT00741338|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110586010|NCT00741338|Antimetabolites|antimetabolites|mesh-ancestor
110586011|NCT00741338|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110586012|NCT00741338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110586014|NCT02598830|Cholecalciferol|cholecalciferol|mesh-list
110586015|NCT02598830|Vitamins|vitamins|mesh-ancestor
110586016|NCT02598830|Micronutrients|micronutrients|mesh-ancestor
110586017|NCT02598830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110586018|NCT02598830|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110233411|NCT04088604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110586019|NCT02598830|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110586021|NCT02578251|Meperidine|meperidine|mesh-list
110586022|NCT02578251|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110586023|NCT02578251|Analgesics|analgesics|mesh-ancestor
110586024|NCT02578251|Sensory System Agents|sensory system agents|mesh-ancestor
110586025|NCT02578251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110586026|NCT02578251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110586027|NCT02578251|Antipyretics|antipyretics|mesh-ancestor
110586028|NCT02578251|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110586029|NCT02578251|Narcotics|narcotics|mesh-ancestor
110586030|NCT02578251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110586031|NCT02578251|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110586033|NCT05285358|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110586034|NCT05285358|Cisplatin|cisplatin|mesh-list
110586035|NCT05285358|Gemcitabine|gemcitabine|mesh-list
110586036|NCT05285358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110586037|NCT05285358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110586038|NCT05285358|Tubulin Modulators|tubulin modulators|mesh-ancestor
110586039|NCT05285358|Antimitotic Agents|antimitotic agents|mesh-ancestor
110586040|NCT05285358|Mitosis Modulators|mitosis modulators|mesh-ancestor
110586041|NCT05285358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110586042|NCT05285358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110586043|NCT05285358|Antimetabolites|antimetabolites|mesh-ancestor
110586044|NCT00746330|Mometasone Furoate|mometasone furoate|mesh-list
110586045|NCT00746330|Formoterol Fumarate|formoterol fumarate|mesh-list
110586046|NCT00746330|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110586047|NCT00746330|Autonomic Agents|autonomic agents|mesh-ancestor
110586048|NCT00746330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110586049|NCT00746330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110586050|NCT00746330|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110586051|NCT00746330|Respiratory System Agents|respiratory system agents|mesh-ancestor
110586052|NCT00746330|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110586053|NCT00746330|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110586054|NCT00746330|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110586055|NCT00746330|Adrenergic Agents|adrenergic agents|mesh-ancestor
110586056|NCT00746330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110586057|NCT00746330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110586058|NCT00746330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110586059|NCT00746330|Dermatologic Agents|dermatologic agents|mesh-ancestor
110586060|NCT00746330|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110586061|NCT02590224|Glycine|glycine|mesh-list
110586062|NCT02590224|Glycine Agents|glycine agents|mesh-ancestor
110586063|NCT02590224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110586064|NCT02590224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110586065|NCT02590224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110586066|NCT00709449|Papaverine|papaverine|mesh-list
110586067|NCT00709449|Moxaverine|moxaverine|mesh-list
110586068|NCT00709449|Parasympatholytics|parasympatholytics|mesh-ancestor
110586069|NCT00709449|Autonomic Agents|autonomic agents|mesh-ancestor
110586070|NCT00709449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110586071|NCT00709449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110586072|NCT00709449|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110586073|NCT00709449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110586074|NCT00709449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110586075|NCT00709449|Vasodilator Agents|vasodilator agents|mesh-ancestor
110586076|NCT00709449|Urological Agents|urological agents|mesh-ancestor
110586077|NCT00746252|Risperidone|risperidone|mesh-list
110586078|NCT00746252|Aripiprazole|aripiprazole|mesh-list
110586079|NCT00746252|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110586080|NCT00746252|Serotonin Agents|serotonin agents|mesh-ancestor
110586081|NCT00746252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110586082|NCT00746252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110586083|NCT00746252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110586084|NCT00746252|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110586085|NCT00746252|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110586086|NCT00746252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110586087|NCT00746252|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110586088|NCT00746252|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110586089|NCT00746252|Dopamine Agents|dopamine agents|mesh-ancestor
110586090|NCT00746252|Antidepressive Agents|antidepressive agents|mesh-ancestor
110586091|NCT00746252|Dopamine Agonists|dopamine agonists|mesh-ancestor
110586092|NCT00746252|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110586093|NCT00746252|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110586094|NCT00746252|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110586095|NCT00746252|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110586096|NCT02574975|Budesonide|budesonide|mesh-list
110586097|NCT02574975|Adenosine|adenosine|mesh-list
110586098|NCT02574975|Formoterol Fumarate|formoterol fumarate|mesh-list
110586099|NCT02574975|Methacholine Chloride|methacholine chloride|mesh-list
110586100|NCT02574975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110586101|NCT02574975|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110586102|NCT02574975|Autonomic Agents|autonomic agents|mesh-ancestor
110586103|NCT02574975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110586104|NCT02574975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110586105|NCT02574975|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110586106|NCT02574975|Respiratory System Agents|respiratory system agents|mesh-ancestor
110586108|NCT02574975|Hormones|hormones|mesh-ancestor
110586109|NCT02574975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110586110|NCT02574975|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110586111|NCT02574975|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110586112|NCT02574975|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110586113|NCT02574975|Adrenergic Agents|adrenergic agents|mesh-ancestor
110586114|NCT02574975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110586115|NCT02574975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110586116|NCT02574975|Analgesics|analgesics|mesh-ancestor
110586117|NCT02574975|Sensory System Agents|sensory system agents|mesh-ancestor
110586118|NCT02574975|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110586119|NCT02574975|Vasodilator Agents|vasodilator agents|mesh-ancestor
110586120|NCT02574975|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
110586121|NCT02574975|Purinergic Agonists|purinergic agonists|mesh-ancestor
110586122|NCT02574975|Purinergic Agents|purinergic agents|mesh-ancestor
110586123|NCT02574975|Miotics|miotics|mesh-ancestor
110586124|NCT02574975|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110586125|NCT02574975|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
110586126|NCT02574975|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
110586127|NCT02574975|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110586128|NCT02574975|Cholinergic Agents|cholinergic agents|mesh-ancestor
110586129|NCT00718770|Bexarotene|bexarotene|mesh-list
110586130|NCT00718770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110586131|NCT04084158|Paclitaxel|paclitaxel|mesh-list
110586132|NCT04084158|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110586133|NCT04084158|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110586134|NCT04084158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110586135|NCT04084158|Tubulin Modulators|tubulin modulators|mesh-ancestor
110586136|NCT04084158|Antimitotic Agents|antimitotic agents|mesh-ancestor
110586137|NCT04084158|Mitosis Modulators|mitosis modulators|mesh-ancestor
110586138|NCT04084158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110586139|NCT00714519|Castor Oil|castor oil|mesh-list
110586140|NCT00714519|Cathartics|cathartics|mesh-ancestor
110586141|NCT00714519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110586142|NCT00714948|Gemcitabine|gemcitabine|mesh-list
110586143|NCT00714948|Sorafenib|sorafenib|mesh-list
110586144|NCT00714948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110376104|NCT02210598|Oxytocin|oxytocin|mesh-list
110586145|NCT00714948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110586146|NCT00714948|Antimetabolites|antimetabolites|mesh-ancestor
110586147|NCT00714948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110586148|NCT00714948|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110586149|NCT00714948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110586150|NCT00714714|Adapalene|adapalene|mesh-list
110586151|NCT00714714|Tretinoin|tretinoin|mesh-list
110586152|NCT00714714|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110586153|NCT00714714|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110586154|NCT00714714|Analgesics|analgesics|mesh-ancestor
110586155|NCT00714714|Sensory System Agents|sensory system agents|mesh-ancestor
110586156|NCT00714714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110586157|NCT00714714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110586158|NCT00714714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110586159|NCT00714714|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110586160|NCT00714714|Dermatologic Agents|dermatologic agents|mesh-ancestor
110586161|NCT00714714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110586162|NCT00714714|Keratolytic Agents|keratolytic agents|mesh-ancestor
110586163|NCT00441337|Nivolumab|nivolumab|mesh-list
110586164|NCT00441337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110586165|NCT00441337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110586166|NCT00441337|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110233559|NCT03513952|Atezolizumab|atezolizumab|mesh-list
110586167|NCT00441337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110586168|NCT00578877|Nonoxynol|nonoxynol|mesh-list
110586169|NCT00578877|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
110586170|NCT00578877|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
110586171|NCT00578877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110586172|NCT00578877|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110586173|NCT00578877|Contraceptive Agents|contraceptive agents|mesh-ancestor
110586174|NCT00578877|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110586175|NCT00578877|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110586176|NCT02573727|Terlipressin|terlipressin|mesh-list
110586177|NCT02573727|Epinephrine|epinephrine|mesh-list
110586178|NCT02573727|Racepinephrine|racepinephrine|mesh-list
110586179|NCT02573727|Norepinephrine|norepinephrine|mesh-list
110586180|NCT02573727|Epinephryl borate|epinephryl borate|mesh-list
110586181|NCT02573727|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110586182|NCT02573727|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110586183|NCT02573727|Adrenergic Agents|adrenergic agents|mesh-ancestor
110586184|NCT02573727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110586185|NCT02573727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110586186|NCT02573727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110586187|NCT02573727|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110586188|NCT02573727|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110586189|NCT02573727|Autonomic Agents|autonomic agents|mesh-ancestor
110586190|NCT02573727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110586191|NCT02573727|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110586192|NCT02573727|Respiratory System Agents|respiratory system agents|mesh-ancestor
110586193|NCT02573727|Mydriatics|mydriatics|mesh-ancestor
110586194|NCT02573727|Sympathomimetics|sympathomimetics|mesh-ancestor
110586195|NCT02573727|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110586196|NCT02573727|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110586198|NCT00709683|Biphasic Insulins|biphasic insulins|mesh-list
110586199|NCT00709683|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
110586200|NCT00709683|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110586201|NCT00709683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110586202|NCT00918840|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
110586203|NCT00918840|Antiviral Agents|antiviral agents|mesh-ancestor
110586204|NCT00918840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110586206|NCT00918528|Mitomycin|mitomycin|mesh-list
110586207|NCT00918528|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110586208|NCT00918528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110586209|NCT00918528|Alkylating Agents|alkylating agents|mesh-ancestor
110586210|NCT00918528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110586211|NCT00918528|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110586212|NCT00918528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110586213|NCT00468481|Drospirenone|drospirenone|mesh-list
110586214|NCT00468481|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110586215|NCT00468481|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
110586216|NCT00468481|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110586217|NCT00468481|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110586218|NCT00468481|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110586219|NCT00468481|Contraceptive Agents|contraceptive agents|mesh-ancestor
110586220|NCT00468481|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110586221|NCT00468481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110586222|NCT00468481|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110586223|NCT00468481|Estrogens|estrogens|mesh-ancestor
110586224|NCT00468481|Hormones|hormones|mesh-ancestor
110586225|NCT00468481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110586226|NCT00468481|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110586227|NCT00468481|Hormone Antagonists|hormone antagonists|mesh-ancestor
110586228|NCT00468481|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110586229|NCT00468481|Diuretics|diuretics|mesh-ancestor
110586230|NCT00468481|Natriuretic Agents|natriuretic agents|mesh-ancestor
110586231|NCT02574819|Methylnaltrexone|methylnaltrexone|mesh-list
110586232|NCT02574819|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110586233|NCT02574819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110586234|NCT02574819|Sensory System Agents|sensory system agents|mesh-ancestor
110586235|NCT02574819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110586236|NCT00709839|Hydrocortisone|hydrocortisone|mesh-list
110586237|NCT00709839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110586238|NCT03949153|Nivolumab|nivolumab|mesh-list
110586239|NCT03949153|Ipilimumab|ipilimumab|mesh-list
110586240|NCT03949153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110586241|NCT03949153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110586242|NCT03949153|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110586243|NCT03949153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110233636|NCT03002103|Paclitaxel|paclitaxel|mesh-list
110586245|NCT00709917|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110586246|NCT00709917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110586247|NCT02574741|Aripiprazole|aripiprazole|mesh-list
110586248|NCT02574741|Antidepressive Agents|antidepressive agents|mesh-ancestor
110586249|NCT02574741|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110586250|NCT02574741|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110586251|NCT02574741|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110586252|NCT02574741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110586253|NCT02574741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110586254|NCT02574741|Dopamine Agonists|dopamine agonists|mesh-ancestor
110586255|NCT02574741|Dopamine Agents|dopamine agents|mesh-ancestor
110586256|NCT02574741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110586257|NCT02574741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110586258|NCT02574741|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110586259|NCT02574741|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110586260|NCT02574741|Serotonin Agents|serotonin agents|mesh-ancestor
110586261|NCT02574741|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110586262|NCT02574741|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110586263|NCT02574741|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110586264|NCT02574741|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110586265|NCT00468169|Cetuximab|cetuximab|mesh-list
110586266|NCT00468169|Hydroxyurea|hydroxyurea|mesh-list
110586267|NCT00468169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110586268|NCT00468169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110586269|NCT00468169|Antisickling Agents|antisickling agents|mesh-ancestor
110586270|NCT00468169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110586271|NCT00468169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110586272|NCT00468169|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110586273|NCT05251974|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
110586274|NCT05251974|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110586275|NCT05251974|Adrenergic Agents|adrenergic agents|mesh-ancestor
110586276|NCT05251974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110586277|NCT05251974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110586278|NCT05251974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110586280|NCT02589444|Cholecalciferol|cholecalciferol|mesh-list
110586281|NCT02589444|Vitamins|vitamins|mesh-ancestor
110586282|NCT02589444|Micronutrients|micronutrients|mesh-ancestor
110586283|NCT02589444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110586284|NCT02589444|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110586285|NCT02589444|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110586286|NCT05325684|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
110586287|NCT05325684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110586288|NCT05325684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110586289|NCT05325684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110586290|NCT00435487|Heparin|heparin|mesh-list
110586291|NCT00435487|Calcium heparin|calcium heparin|mesh-list
110586292|NCT00435487|Dalteparin|dalteparin|mesh-list
110586293|NCT00435487|Tinzaparin|tinzaparin|mesh-list
110586294|NCT00435487|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
110586295|NCT00435487|Anticoagulants|anticoagulants|mesh-ancestor
110586296|NCT00435487|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110586297|NCT00435487|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110586298|NCT00435487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110586299|NCT02589678|Vaccines|vaccines|mesh-list
110586300|NCT02589678|Immunologic Factors|immunologic factors|mesh-ancestor
110586301|NCT02589678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110586302|NCT05328258|Triptorelin Pamoate|triptorelin pamoate|mesh-list
110586303|NCT05328258|Luteolytic Agents|luteolytic agents|mesh-ancestor
110586304|NCT05328258|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110586305|NCT05328258|Contraceptive Agents|contraceptive agents|mesh-ancestor
110586306|NCT05328258|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110586307|NCT05328258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110586308|NCT05328258|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110586309|NCT05328258|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110586310|NCT05328258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110586311|NCT02591004|Nifedipine|nifedipine|mesh-list
110586312|NCT02591004|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110586313|NCT02591004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110586314|NCT02591004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110586315|NCT02591004|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110586316|NCT02591004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110586317|NCT02591004|Vasodilator Agents|vasodilator agents|mesh-ancestor
110586318|NCT02591004|Tocolytic Agents|tocolytic agents|mesh-ancestor
110586319|NCT02591004|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110586320|NCT05310786|Analgesics, Opioid|analgesics, opioid|mesh-list
110586321|NCT05310786|Narcotics|narcotics|mesh-ancestor
110586322|NCT05310786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110586323|NCT05310786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110586324|NCT05310786|Analgesics|analgesics|mesh-ancestor
110586325|NCT05310786|Sensory System Agents|sensory system agents|mesh-ancestor
110586326|NCT05310786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110586327|NCT04085562|Amlodipine|amlodipine|mesh-list
110586328|NCT04085562|Bisoprolol|bisoprolol|mesh-list
110586329|NCT04085562|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110586330|NCT04085562|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110586331|NCT04085562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110586332|NCT04085562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110586333|NCT04085562|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110586334|NCT04085562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110149929|NCT00006877|Temozolomide|temozolomide|mesh-list
110586336|NCT04085562|Sympatholytics|sympatholytics|mesh-ancestor
110586337|NCT04085562|Autonomic Agents|autonomic agents|mesh-ancestor
110586338|NCT04085562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110586339|NCT04085562|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110586340|NCT04085562|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110586341|NCT04085562|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110586342|NCT04085562|Adrenergic Agents|adrenergic agents|mesh-ancestor
110586343|NCT04085562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110586344|NCT05048238|Tofacitinib|tofacitinib|mesh-list
110586345|NCT05048238|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
110586346|NCT05048238|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110586347|NCT05048238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110586348|NCT05048238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110586349|NCT05683626|Adalimumab|adalimumab|mesh-list
110586350|NCT05683626|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110586351|NCT05683626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110586352|NCT05683626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110586353|NCT04082988|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110586354|NCT04082988|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110586355|NCT04082988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110586356|NCT02588196|Dexamethasone|dexamethasone|mesh-list
110586357|NCT02588196|Dexamethasone acetate|dexamethasone acetate|mesh-list
110586358|NCT02588196|BB 1101|bb 1101|mesh-list
110586359|NCT02588196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110586360|NCT02588196|Antiemetics|antiemetics|mesh-ancestor
110586361|NCT02588196|Autonomic Agents|autonomic agents|mesh-ancestor
110586362|NCT02588196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110586363|NCT02588196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110586364|NCT02588196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110586365|NCT02588196|Glucocorticoids|glucocorticoids|mesh-ancestor
110586366|NCT02588196|Hormones|hormones|mesh-ancestor
110586367|NCT02588196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110586368|NCT02588196|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110586369|NCT02588196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110586370|NCT02588196|Protease Inhibitors|protease inhibitors|mesh-ancestor
110586371|NCT02588196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110586372|NCT02588196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110586373|NCT02588820|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
110586374|NCT02588820|Antiviral Agents|antiviral agents|mesh-ancestor
110586375|NCT02588820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110586376|NCT00579345|Vaccines|vaccines|mesh-list
110586377|NCT00579345|Immunologic Factors|immunologic factors|mesh-ancestor
110586378|NCT00579345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110586379|NCT00715377|Benztropine|benztropine|mesh-list
110586380|NCT00715377|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110586381|NCT00715377|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110586382|NCT00715377|Parasympatholytics|parasympatholytics|mesh-ancestor
110586383|NCT00715377|Autonomic Agents|autonomic agents|mesh-ancestor
110586384|NCT00715377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110586385|NCT00715377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110586386|NCT00715377|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110586387|NCT00715377|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110586388|NCT00715377|Cholinergic Agents|cholinergic agents|mesh-ancestor
110586389|NCT00715377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110586390|NCT00715377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110586391|NCT00715377|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110586392|NCT00715377|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110586393|NCT00715377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110586394|NCT00715377|Dopamine Agents|dopamine agents|mesh-ancestor
110586396|NCT00715455|Calcium heparin|calcium heparin|mesh-list
110586397|NCT00715455|Anticoagulants|anticoagulants|mesh-ancestor
110586398|NCT00715455|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110586399|NCT00715455|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110586400|NCT00715455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110586401|NCT02574663|Leucovorin|leucovorin|mesh-list
110586402|NCT02574663|Folic Acid|folic acid|mesh-list
110586403|NCT02574663|Paclitaxel|paclitaxel|mesh-list
110586404|NCT02574663|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110586405|NCT02574663|Bevacizumab|bevacizumab|mesh-list
110586406|NCT02574663|Gemcitabine|gemcitabine|mesh-list
110586407|NCT02574663|Fluorouracil|fluorouracil|mesh-list
110586408|NCT02574663|Oxaliplatin|oxaliplatin|mesh-list
110586409|NCT02574663|Levoleucovorin|levoleucovorin|mesh-list
110586410|NCT02574663|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110586411|NCT02574663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110586412|NCT02574663|Tubulin Modulators|tubulin modulators|mesh-ancestor
110586413|NCT02574663|Antimitotic Agents|antimitotic agents|mesh-ancestor
110586414|NCT02574663|Mitosis Modulators|mitosis modulators|mesh-ancestor
110586415|NCT02574663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110586416|NCT02574663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110586417|NCT02574663|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110586418|NCT02574663|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110586419|NCT02574663|Growth Substances|growth substances|mesh-ancestor
110586420|NCT02574663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110586421|NCT02574663|Growth Inhibitors|growth inhibitors|mesh-ancestor
110586422|NCT02574663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110586423|NCT02574663|Antimetabolites|antimetabolites|mesh-ancestor
110586424|NCT02574663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110586425|NCT02574663|Immunologic Factors|immunologic factors|mesh-ancestor
110586427|NCT02574663|Protective Agents|protective agents|mesh-ancestor
110586428|NCT02574663|Vitamin B Complex|vitamin b complex|mesh-ancestor
110586429|NCT02574663|Vitamins|vitamins|mesh-ancestor
110586430|NCT02574663|Micronutrients|micronutrients|mesh-ancestor
110586431|NCT02574663|Hematinics|hematinics|mesh-ancestor
110586432|NCT04069845|Doxorubicin|doxorubicin|mesh-list
110586433|NCT04069845|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110586434|NCT04069845|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110586435|NCT04069845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110586436|NCT04069845|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110586437|NCT04069845|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110586438|NCT04069845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110586439|NCT04069845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110586443|NCT00715689|Hormones|hormones|mesh-list
110586444|NCT00715689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110586445|NCT00715689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110586446|NCT00919542|Cyclosporine|cyclosporine|mesh-list
110586447|NCT00919542|Prednisolone|prednisolone|mesh-list
110586448|NCT00919542|Cyclosporins|cyclosporins|mesh-list
110586449|NCT00919542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110586450|NCT00919542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110586451|NCT00919542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110586452|NCT00919542|Immunologic Factors|immunologic factors|mesh-ancestor
110586453|NCT00919542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110586454|NCT00919542|Antifungal Agents|antifungal agents|mesh-ancestor
110586455|NCT00919542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110586456|NCT00919542|Dermatologic Agents|dermatologic agents|mesh-ancestor
110586457|NCT00919542|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110586458|NCT00919542|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110586459|NCT00919542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110586460|NCT00919542|Glucocorticoids|glucocorticoids|mesh-ancestor
110586461|NCT00919542|Hormones|hormones|mesh-ancestor
110586462|NCT00919542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110586463|NCT00919542|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110586464|NCT00919542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110586465|NCT00719121|Adapalene|adapalene|mesh-list
110586466|NCT00719121|R 115866|r 115866|mesh-list
110586467|NCT00719121|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110586468|NCT00719121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110586470|NCT00719121|Sensory System Agents|sensory system agents|mesh-ancestor
110586471|NCT00719121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110586473|NCT00719121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110586474|NCT00719121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110586475|NCT00719121|Dermatologic Agents|dermatologic agents|mesh-ancestor
110586476|NCT00719121|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110586477|NCT00719121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110586478|NCT00719121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110586479|NCT00719199|Cetuximab|cetuximab|mesh-list
110149936|NCT00007033|Sensory System Agents|sensory system agents|mesh-ancestor
110586480|NCT00719199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110586482|NCT02589288|Ropivacaine|ropivacaine|mesh-list
110586483|NCT02589288|Anesthetics, Local|anesthetics, local|mesh-ancestor
110586484|NCT02589288|Anesthetics|anesthetics|mesh-ancestor
110586485|NCT02589288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110586486|NCT02589288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110586487|NCT02589288|Sensory System Agents|sensory system agents|mesh-ancestor
110586488|NCT02589288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110586489|NCT00716001|Acetylcysteine|acetylcysteine|mesh-list
110586490|NCT00716001|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110586491|NCT00716001|Antiviral Agents|antiviral agents|mesh-ancestor
110586492|NCT00716001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110586493|NCT00716001|Expectorants|expectorants|mesh-ancestor
110586494|NCT00716001|Respiratory System Agents|respiratory system agents|mesh-ancestor
110586495|NCT00716001|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110586496|NCT00716001|Antioxidants|antioxidants|mesh-ancestor
110586497|NCT00716001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110586498|NCT00716001|Protective Agents|protective agents|mesh-ancestor
110586499|NCT00716001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110586500|NCT00716001|Antidotes|antidotes|mesh-ancestor
110586501|NCT05136846|Paclitaxel|paclitaxel|mesh-list
110586502|NCT05136846|Carboplatin|carboplatin|mesh-list
110586503|NCT05136846|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110586504|NCT05136846|Durvalumab|durvalumab|mesh-list
110586505|NCT05136846|Papaverine|papaverine|mesh-list
110586506|NCT05136846|Immunoglobulins|immunoglobulins|mesh-list
110586507|NCT05136846|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110586508|NCT05136846|Immunoglobulin G|immunoglobulin g|mesh-list
110586509|NCT05136846|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110586510|NCT05136846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110586511|NCT05136846|Tubulin Modulators|tubulin modulators|mesh-ancestor
110586512|NCT05136846|Antimitotic Agents|antimitotic agents|mesh-ancestor
110586513|NCT05136846|Mitosis Modulators|mitosis modulators|mesh-ancestor
110586514|NCT05136846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110586515|NCT05136846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110586516|NCT05136846|Immunologic Factors|immunologic factors|mesh-ancestor
110586517|NCT05136846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110586518|NCT05136846|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110586519|NCT05136846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110586520|NCT05136846|Vasodilator Agents|vasodilator agents|mesh-ancestor
110586521|NCT05136846|Urological Agents|urological agents|mesh-ancestor
110586522|NCT00710229|Bevacizumab|bevacizumab|mesh-list
110586523|NCT00710229|Ranibizumab|ranibizumab|mesh-list
110586524|NCT00710229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110586525|NCT00710229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110586526|NCT00710229|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110586527|NCT00710229|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110586528|NCT00710229|Growth Substances|growth substances|mesh-ancestor
110586529|NCT00710229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110586530|NCT00710229|Growth Inhibitors|growth inhibitors|mesh-ancestor
110586531|NCT00710619|Anti-inhibitor coagulant complex|anti-inhibitor coagulant complex|mesh-list
110586532|NCT00710619|Coagulants|coagulants|mesh-ancestor
110586533|NCT05192460|Vaccines|vaccines|mesh-list
110586534|NCT05192460|Immunologic Factors|immunologic factors|mesh-ancestor
110586535|NCT05192460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110586536|NCT00719433|Armin|armin|mesh-list
110586537|NCT00719433|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110586538|NCT00719433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110586539|NCT00719433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110586540|NCT00719433|Cholinergic Agents|cholinergic agents|mesh-ancestor
110586541|NCT00719433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110586542|NCT00719433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110586543|NCT04068519|Tislelizumab|tislelizumab|mesh-list
110586544|NCT04068519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110586545|NCT04068519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110586546|NCT04978272|Piperaquine|piperaquine|mesh-list
110586547|NCT04978272|Artenimol|artenimol|mesh-list
110586548|NCT04978272|Antimalarials|antimalarials|mesh-ancestor
110586549|NCT04978272|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110586550|NCT04978272|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110586551|NCT04978272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110586552|NCT04973124|Dexmedetomidine|dexmedetomidine|mesh-list
110586553|NCT04973124|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110586554|NCT04973124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110586555|NCT04973124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110586556|NCT04973124|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110586557|NCT04973124|Analgesics|analgesics|mesh-ancestor
110586558|NCT04973124|Sensory System Agents|sensory system agents|mesh-ancestor
110586559|NCT04973124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110586560|NCT04973124|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110376155|NCT00588926|Analgesics|analgesics|mesh-ancestor
110586561|NCT04973124|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110586562|NCT04973124|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110586563|NCT04973124|Adrenergic Agents|adrenergic agents|mesh-ancestor
110586564|NCT04973124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110586565|NCT04973124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110586567|NCT04971720|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
110586568|NCT04971720|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110586569|NCT04971720|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110586570|NCT04971720|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110586571|NCT04971720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110586572|NCT00711165|Mometasone Furoate|mometasone furoate|mesh-list
110586573|NCT00711165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110586574|NCT00711165|Dermatologic Agents|dermatologic agents|mesh-ancestor
110586575|NCT00711165|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110586576|NCT00719745|Tacrolimus|tacrolimus|mesh-list
110586577|NCT00719745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110586578|NCT00719745|Immunologic Factors|immunologic factors|mesh-ancestor
110586579|NCT00719745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110586580|NCT00719745|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110586581|NCT00719745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110586582|NCT00719745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110586583|NCT02587416|Atorvastatin|atorvastatin|mesh-list
110586584|NCT02587416|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110586585|NCT02587416|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110586586|NCT02587416|Antimetabolites|antimetabolites|mesh-ancestor
110586587|NCT02587416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110586588|NCT02587416|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110586589|NCT02587416|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110586590|NCT02587416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110586591|NCT00719823|Maraviroc|maraviroc|mesh-list
110586592|NCT00719823|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110586593|NCT00719823|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110586594|NCT00719823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110586595|NCT00719823|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110586596|NCT00719823|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110586597|NCT00719823|Antiviral Agents|antiviral agents|mesh-ancestor
110586598|NCT00719823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110586599|NCT00719823|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
110586600|NCT00919776|Cyclosporine|cyclosporine|mesh-list
110586601|NCT00919776|Prednisolone|prednisolone|mesh-list
110586602|NCT00919776|Cyclosporins|cyclosporins|mesh-list
110586603|NCT00919776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110586604|NCT00919776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110586605|NCT00919776|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110586606|NCT00919776|Immunologic Factors|immunologic factors|mesh-ancestor
110586607|NCT00919776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110586608|NCT00919776|Antifungal Agents|antifungal agents|mesh-ancestor
110586609|NCT00919776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110586610|NCT00919776|Dermatologic Agents|dermatologic agents|mesh-ancestor
110586611|NCT00919776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110586612|NCT00919776|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110586613|NCT00919776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110586614|NCT00919776|Glucocorticoids|glucocorticoids|mesh-ancestor
110586615|NCT00919776|Hormones|hormones|mesh-ancestor
110586616|NCT00919776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110586617|NCT00919776|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110586618|NCT00919776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110586619|NCT00720135|Rituximab|rituximab|mesh-list
110586620|NCT00720135|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110586621|NCT00720135|Interleukin-2|interleukin-2|mesh-list
110586622|NCT00720135|Antibodies|antibodies|mesh-list
110586623|NCT00720135|Immunoglobulins|immunoglobulins|mesh-list
110586624|NCT00720135|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110586625|NCT00720135|Immunologic Factors|immunologic factors|mesh-ancestor
110586626|NCT00720135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110586627|NCT00720135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110586628|NCT00720135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110586629|NCT00720135|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110586630|NCT00720135|Analgesics|analgesics|mesh-ancestor
110586631|NCT00720135|Sensory System Agents|sensory system agents|mesh-ancestor
110586632|NCT00720135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110586633|NCT02588118|Propofol|propofol|mesh-list
110586634|NCT02588118|Cisatracurium|cisatracurium|mesh-list
110586635|NCT02588118|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110586636|NCT02588118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110586637|NCT02588118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110586638|NCT02588118|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110586639|NCT02588118|Anesthetics, General|anesthetics, general|mesh-ancestor
110586640|NCT02588118|Anesthetics|anesthetics|mesh-ancestor
110586641|NCT02588118|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110586642|NCT02588118|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110586643|NCT02588118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110586644|NCT00716391|Cisplatin|cisplatin|mesh-list
110586645|NCT00716391|Cetuximab|cetuximab|mesh-list
110586646|NCT00716391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110586647|NCT00716391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110586648|NCT00716469|Talaporfin|talaporfin|mesh-list
110586649|NCT00716469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110586650|NCT00716469|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110586651|NCT00716469|Dermatologic Agents|dermatologic agents|mesh-ancestor
110586652|NCT04082598|Amoxicillin|amoxicillin|mesh-list
110586653|NCT04082598|Clavulanic Acid|clavulanic acid|mesh-list
110586655|NCT04082598|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
110586656|NCT04082598|Lactoferrin|lactoferrin|mesh-list
110586657|NCT04082598|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110586658|NCT04082598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110586659|NCT04082598|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110586660|NCT04082598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110586661|NCT04082598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110586662|NCT03895203|Adalimumab|adalimumab|mesh-list
110586663|NCT03895203|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110586664|NCT03895203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110586665|NCT03895203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110586666|NCT04958226|Midazolam|midazolam|mesh-list
110586667|NCT04958226|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110586668|NCT04958226|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110586669|NCT04958226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110586670|NCT04958226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110586671|NCT04958226|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110586672|NCT04958226|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110586673|NCT04958226|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110586674|NCT04958226|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110586675|NCT04958226|Anesthetics, General|anesthetics, general|mesh-ancestor
110586676|NCT04958226|Anesthetics|anesthetics|mesh-ancestor
110586677|NCT04958226|GABA Modulators|gaba modulators|mesh-ancestor
110586678|NCT04958226|GABA Agents|gaba agents|mesh-ancestor
110586679|NCT04958226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110586680|NCT04958226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110586681|NCT00716547|Celecoxib|celecoxib|mesh-list
110586682|NCT00716547|Ketoprofen|ketoprofen|mesh-list
110586683|NCT00716547|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110586684|NCT00716547|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110586685|NCT00716547|Analgesics|analgesics|mesh-ancestor
110586686|NCT00716547|Sensory System Agents|sensory system agents|mesh-ancestor
110586687|NCT00716547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110225551|NCT05908786|Growth Inhibitors|growth inhibitors|mesh-ancestor
110586688|NCT00716547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110225552|NCT05908786|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110225553|NCT05908786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110586689|NCT00716547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110586690|NCT00716547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110586691|NCT00716547|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110586692|NCT00716547|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110586693|NCT00716547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110586694|NCT00716547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110586696|NCT02573025|Interferon-alpha|interferon-alpha|mesh-list
110586698|NCT02573025|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
110586699|NCT02573025|Antiviral Agents|antiviral agents|mesh-ancestor
110586700|NCT02573025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110586701|NCT02573025|Immunologic Factors|immunologic factors|mesh-ancestor
110586702|NCT02573025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110586703|NCT02573025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110225590|NCT05896228|Glucocorticoids|glucocorticoids|mesh-ancestor
110225591|NCT05896228|Hormones|hormones|mesh-ancestor
110586704|NCT00720291|Metronidazole|metronidazole|mesh-list
110586705|NCT00720291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110586706|NCT00720291|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110586707|NCT00720291|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110586708|NCT00720291|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110586709|NCT00578643|Cyclosporine|cyclosporine|mesh-list
110586710|NCT00578643|Cyclophosphamide|cyclophosphamide|mesh-list
110586711|NCT00578643|Busulfan|busulfan|mesh-list
110586712|NCT00578643|Fludarabine|fludarabine|mesh-list
110586713|NCT00578643|Alemtuzumab|alemtuzumab|mesh-list
110586714|NCT00578643|Cyclosporins|cyclosporins|mesh-list
110586715|NCT00578643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110586716|NCT00578643|Immunologic Factors|immunologic factors|mesh-ancestor
110586717|NCT00578643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110586718|NCT00578643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110225650|NCT05888493|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110586719|NCT00578643|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110586720|NCT00578643|Alkylating Agents|alkylating agents|mesh-ancestor
110586721|NCT00578643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110586722|NCT00578643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110586723|NCT00578643|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110586724|NCT00578643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110586725|NCT00578643|Antifungal Agents|antifungal agents|mesh-ancestor
110586726|NCT00578643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110586727|NCT00578643|Dermatologic Agents|dermatologic agents|mesh-ancestor
110586728|NCT00578643|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110586729|NCT00578643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110586731|NCT04082286|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110586732|NCT04082286|Immunologic Factors|immunologic factors|mesh-ancestor
110586733|NCT04082286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110225711|NCT05843188|Vitamin B Complex|vitamin b complex|mesh-ancestor
110586735|NCT00720447|Etoposide|etoposide|mesh-list
110586736|NCT00720447|Melphalan|melphalan|mesh-list
110586737|NCT00720447|Alemtuzumab|alemtuzumab|mesh-list
110586738|NCT00720447|Carmustine|carmustine|mesh-list
110586739|NCT00720447|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110586740|NCT00720447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110586741|NCT00720447|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110586742|NCT00720447|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110586743|NCT00720447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110586744|NCT00720447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110586745|NCT00720447|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110586746|NCT00720447|Antimetabolites|antimetabolites|mesh-ancestor
110586747|NCT00720447|Antiviral Agents|antiviral agents|mesh-ancestor
110225773|NCT05826964|Temsirolimus|temsirolimus|mesh-list
110586748|NCT00720447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110586749|NCT00720447|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110586750|NCT00720447|Immunologic Factors|immunologic factors|mesh-ancestor
110586751|NCT00720447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110586752|NCT00720447|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110586753|NCT00720447|Alkylating Agents|alkylating agents|mesh-ancestor
110586754|NCT00720447|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110586755|NCT00720447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110586756|NCT04828824|Moxifloxacin|moxifloxacin|mesh-list
110586757|NCT04828824|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110586758|NCT04828824|Norgestimate|norgestimate|mesh-list
110586759|NCT04828824|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
110586760|NCT04828824|Estradiol|estradiol|mesh-list
110586761|NCT04828824|Estrogens|estrogens|mesh-ancestor
110586762|NCT04828824|Hormones|hormones|mesh-ancestor
110586763|NCT04828824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110586764|NCT04828824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110586765|NCT04828824|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110586766|NCT04828824|Contraceptive Agents|contraceptive agents|mesh-ancestor
110586767|NCT04828824|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110586768|NCT04828824|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110149955|NCT00007189|Analgesics|analgesics|mesh-ancestor
110586769|NCT04828824|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110586770|NCT04828824|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110225835|NCT05798663|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110586771|NCT04828824|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110586772|NCT04828824|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110586773|NCT04828824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110586774|NCT04828824|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110586775|NCT04828824|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110586776|NCT04828824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110586777|NCT04828824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110586778|NCT04828824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110586779|NCT04828824|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110586780|NCT00578565|Rituximab|rituximab|mesh-list
110586781|NCT00578565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110586782|NCT00578565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110586783|NCT00578565|Immunologic Factors|immunologic factors|mesh-ancestor
110586784|NCT00578565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110586785|NCT00578565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110586786|NCT02572089|Naloxone|naloxone|mesh-list
110586787|NCT02572089|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110586788|NCT02572089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110586789|NCT02572089|Sensory System Agents|sensory system agents|mesh-ancestor
110586790|NCT02572089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110586791|NCT02588742|Melatonin|melatonin|mesh-list
110586792|NCT02588742|Antioxidants|antioxidants|mesh-ancestor
110586793|NCT02588742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110586794|NCT02588742|Protective Agents|protective agents|mesh-ancestor
110586795|NCT02588742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110586796|NCT02588742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110586797|NCT00720603|Plerixafor|plerixafor|mesh-list
110586798|NCT00720603|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110225886|NCT05757167|Artemether|artemether|mesh-list
110586799|NCT00720603|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110586800|NCT00720603|Antiviral Agents|antiviral agents|mesh-ancestor
110586801|NCT00720603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110586802|NCT04936854|Sirolimus|sirolimus|mesh-list
110586803|NCT04936854|Methylprednisolone|methylprednisolone|mesh-list
110586804|NCT04936854|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110586805|NCT04936854|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110586806|NCT04936854|Prednisolone|prednisolone|mesh-list
110586807|NCT04936854|Prednisolone acetate|prednisolone acetate|mesh-list
110586808|NCT04936854|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110586809|NCT04936854|Prednisolone phosphate|prednisolone phosphate|mesh-list
110586810|NCT04936854|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110586811|NCT04936854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110586812|NCT04936854|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110586813|NCT04936854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110586814|NCT04936854|Antifungal Agents|antifungal agents|mesh-ancestor
110586815|NCT04936854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110586816|NCT04936854|Immunologic Factors|immunologic factors|mesh-ancestor
110586817|NCT04936854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110586818|NCT04936854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110586819|NCT04936854|Antiemetics|antiemetics|mesh-ancestor
110586820|NCT04936854|Autonomic Agents|autonomic agents|mesh-ancestor
110586821|NCT04936854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110586822|NCT04936854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110586823|NCT04936854|Glucocorticoids|glucocorticoids|mesh-ancestor
110586824|NCT04936854|Hormones|hormones|mesh-ancestor
110586825|NCT04936854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110586826|NCT04936854|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110586827|NCT04936854|Protective Agents|protective agents|mesh-ancestor
110586828|NCT04936854|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110586829|NCT00711789|Angiotensin II|angiotensin ii|mesh-list
110586830|NCT00711789|Giapreza|giapreza|mesh-list
110586831|NCT00711789|Angiotensinogen|angiotensinogen|mesh-list
110586832|NCT00711789|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110586833|NCT00711789|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110586834|NCT00711789|Protease Inhibitors|protease inhibitors|mesh-ancestor
110257054|NCT05731596|Vitamins|vitamins|mesh-ancestor
110225932|NCT05742607|Mitosis Modulators|mitosis modulators|mesh-ancestor
110586835|NCT00711789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110586836|NCT00711789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110586837|NCT00741260|Capecitabine|capecitabine|mesh-list
110586838|NCT00741260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110586840|NCT00741260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110586841|NCT00741260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110586842|NCT02587260|Clopidogrel|clopidogrel|mesh-list
110586843|NCT02587260|Ticagrelor|ticagrelor|mesh-list
110586844|NCT02587260|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
110586845|NCT02587260|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110586846|NCT02587260|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110586847|NCT02587260|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110586848|NCT02587260|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110586849|NCT02587260|Purinergic Agents|purinergic agents|mesh-ancestor
110586850|NCT02587260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110586851|NCT02587260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110586852|NCT02587260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110586854|NCT02596256|Apatinib|apatinib|mesh-list
110586855|NCT02596256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110586856|NCT02596256|Tubulin Modulators|tubulin modulators|mesh-ancestor
110586857|NCT02596256|Antimitotic Agents|antimitotic agents|mesh-ancestor
110586858|NCT02596256|Mitosis Modulators|mitosis modulators|mesh-ancestor
110586859|NCT02596256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110586860|NCT02596256|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110586861|NCT02596256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110586862|NCT04089722|Deoxycholic Acid|deoxycholic acid|mesh-list
110586863|NCT04089722|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
110586864|NCT04089722|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110586865|NCT00717561|Amoxicillin|amoxicillin|mesh-list
110586866|NCT00717561|Moxifloxacin|moxifloxacin|mesh-list
110586867|NCT00717561|Azithromycin|azithromycin|mesh-list
110586868|NCT00717561|Clarithromycin|clarithromycin|mesh-list
110586869|NCT00717561|Ceftriaxone|ceftriaxone|mesh-list
110586870|NCT00717561|Clavulanic Acid|clavulanic acid|mesh-list
110586871|NCT00717561|Clavulanic Acids|clavulanic acids|mesh-list
110225972|NCT05721027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110586872|NCT00717561|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
110586873|NCT00717561|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
110586874|NCT00717561|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110586875|NCT00717561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110586876|NCT00717561|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110586877|NCT00717561|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110586878|NCT00717561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110586879|NCT00717561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110586880|NCT00717561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110586881|NCT00717561|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110586882|NCT00717561|Contraceptive Agents|contraceptive agents|mesh-ancestor
110586883|NCT00717561|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110586884|NCT00717561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110586885|NCT00717561|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110586886|NCT00717561|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110586887|NCT00717561|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110586888|NCT00717561|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110586889|NCT00717561|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110586890|NCT00717561|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110586891|NCT00717561|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110586892|NCT00720915|Anticoagulants|anticoagulants|mesh-list
110586893|NCT00720915|Fibrin fragment D|fibrin fragment d|mesh-list
110586894|NCT00720915|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110586895|NCT00720915|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110586896|NCT00720915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110586897|NCT00720915|Hemostatics|hemostatics|mesh-ancestor
110586898|NCT00720915|Coagulants|coagulants|mesh-ancestor
110586899|NCT00712101|Abciximab|abciximab|mesh-list
110586900|NCT00712101|Anticoagulants|anticoagulants|mesh-ancestor
110586901|NCT00712101|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110586902|NCT00712257|Heparin|heparin|mesh-list
110586903|NCT00712257|Anticoagulants|anticoagulants|mesh-ancestor
110586904|NCT00712257|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110586905|NCT00712257|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110586906|NCT00712257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110586907|NCT00740792|Fluticasone|fluticasone|mesh-list
110586908|NCT00740792|Xhance|xhance|mesh-list
110586909|NCT00740792|Azelastine|azelastine|mesh-list
110586910|NCT00740792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110586911|NCT00740792|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110586912|NCT00740792|Autonomic Agents|autonomic agents|mesh-ancestor
110586913|NCT00740792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110586914|NCT00740792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110586916|NCT00740792|Respiratory System Agents|respiratory system agents|mesh-ancestor
110586917|NCT00740792|Dermatologic Agents|dermatologic agents|mesh-ancestor
110586918|NCT00740792|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110586919|NCT00740792|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
110586920|NCT00740792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110586921|NCT00740792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110586922|NCT00740792|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110234313|NCT05811390|Erythritol|erythritol|mesh-list
110586923|NCT00740792|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110586924|NCT00740792|Histamine Antagonists|histamine antagonists|mesh-ancestor
110586925|NCT00740792|Histamine Agents|histamine agents|mesh-ancestor
110586926|NCT00740792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110586928|NCT00721305|L 647318|l 647318|mesh-list
110586929|NCT00721305|Dihydromevinolin|dihydromevinolin|mesh-list
110586930|NCT00721305|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110586931|NCT00721305|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110586932|NCT00721305|Antimetabolites|antimetabolites|mesh-ancestor
110586933|NCT00721305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110586934|NCT00721305|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110586935|NCT00721305|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110586936|NCT00721305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110226042|NCT05704985|Fluorouracil|fluorouracil|mesh-list
110586937|NCT00717951|Capecitabine|capecitabine|mesh-list
110586938|NCT00717951|Docetaxel|docetaxel|mesh-list
110586939|NCT00717951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110586940|NCT00717951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110586941|NCT00717951|Antimetabolites|antimetabolites|mesh-ancestor
110586942|NCT00717951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110586943|NCT00717951|Tubulin Modulators|tubulin modulators|mesh-ancestor
110586944|NCT00717951|Antimitotic Agents|antimitotic agents|mesh-ancestor
110586945|NCT00717951|Mitosis Modulators|mitosis modulators|mesh-ancestor
110586946|NCT02572947|Dolutegravir|dolutegravir|mesh-list
110586947|NCT02572947|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110586948|NCT02572947|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110586949|NCT02572947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110586950|NCT02572947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110586951|NCT02572947|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110586952|NCT02572947|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110226092|NCT05688085|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110586953|NCT02572947|Antiviral Agents|antiviral agents|mesh-ancestor
110226094|NCT05688085|Vasodilator Agents|vasodilator agents|mesh-ancestor
110586954|NCT02572947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110586955|NCT00712491|Sirolimus|sirolimus|mesh-list
110586956|NCT00712491|Temsirolimus|temsirolimus|mesh-list
110586957|NCT00712491|MTOR Inhibitors|mtor inhibitors|mesh-list
110586958|NCT00712491|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110586959|NCT00712491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110586960|NCT00712491|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110586961|NCT00712491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110586962|NCT00712491|Antifungal Agents|antifungal agents|mesh-ancestor
110586963|NCT00712491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110586964|NCT00712491|Immunologic Factors|immunologic factors|mesh-ancestor
110586965|NCT00712491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110586966|NCT00712491|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110586967|NCT00712491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110586968|NCT00712491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110586969|NCT04083066|Cytarabine|cytarabine|mesh-list
110586970|NCT04083066|Dexamethasone|dexamethasone|mesh-list
110226149|NCT05660538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110226151|NCT05660538|Anticonvulsants|anticonvulsants|mesh-ancestor
110586972|NCT04083066|Methotrexate|methotrexate|mesh-list
110586973|NCT04083066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110586974|NCT04083066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110586975|NCT04083066|Immunologic Factors|immunologic factors|mesh-ancestor
110586976|NCT04083066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110586977|NCT04083066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110586978|NCT04083066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110586979|NCT04083066|Antiemetics|antiemetics|mesh-ancestor
110586980|NCT04083066|Autonomic Agents|autonomic agents|mesh-ancestor
110586981|NCT04083066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110586982|NCT04083066|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110586983|NCT04083066|Glucocorticoids|glucocorticoids|mesh-ancestor
110586985|NCT04083066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110586986|NCT04083066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110226233|NCT05597878|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110586987|NCT04083066|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110586988|NCT04083066|Abortifacient Agents|abortifacient agents|mesh-ancestor
110586989|NCT04083066|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110586990|NCT04083066|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110586991|NCT04083066|Antimetabolites|antimetabolites|mesh-ancestor
110586992|NCT04083066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110586993|NCT04083066|Dermatologic Agents|dermatologic agents|mesh-ancestor
110586994|NCT04083066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110586995|NCT04083066|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110586996|NCT04083066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110586997|NCT04083066|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110586998|NCT04083066|Antiviral Agents|antiviral agents|mesh-ancestor
110586999|NCT04083066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110587000|NCT05683782|Chitosan|chitosan|mesh-list
110587001|NCT05683782|Epoetin Alfa|epoetin alfa|mesh-list
110587002|NCT05683782|Hematinics|hematinics|mesh-ancestor
110587003|NCT05683782|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110226290|NCT05576662|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110587004|NCT05683782|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110587005|NCT05683782|Antimetabolites|antimetabolites|mesh-ancestor
110587006|NCT05683782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110587007|NCT05683782|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110587008|NCT05683782|Chelating Agents|chelating agents|mesh-ancestor
110587009|NCT05683782|Sequestering Agents|sequestering agents|mesh-ancestor
110587010|NCT05683782|Hemostatics|hemostatics|mesh-ancestor
110587011|NCT05683782|Coagulants|coagulants|mesh-ancestor
110587012|NCT00740714|Vitamins|vitamins|mesh-list
110587013|NCT00740714|Vitamin E|vitamin e|mesh-list
110587014|NCT00740714|Tocopherols|tocopherols|mesh-list
110587015|NCT00740714|Tocotrienols|tocotrienols|mesh-list
110587016|NCT00740714|alpha-Tocopherol|alpha-tocopherol|mesh-list
110587017|NCT00740714|Coenzyme Q10|coenzyme q10|mesh-list
110587018|NCT00740714|Ubiquinone|ubiquinone|mesh-list
110587019|NCT00740714|Micronutrients|micronutrients|mesh-ancestor
110587020|NCT00740714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110587021|NCT00740714|Antioxidants|antioxidants|mesh-ancestor
110587022|NCT00740714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110587023|NCT00740714|Protective Agents|protective agents|mesh-ancestor
110587024|NCT00721773|Valsartan|valsartan|mesh-list
110226365|NCT05546411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110226366|NCT05546411|Antimetabolites|antimetabolites|mesh-ancestor
110587025|NCT00721773|Benazepril|benazepril|mesh-list
110587026|NCT00721773|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110587027|NCT00721773|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110587028|NCT00721773|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110376220|NCT00589901|Cyclophosphamide|cyclophosphamide|mesh-list
110587029|NCT00721773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110587030|NCT00721773|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110587031|NCT00721773|Protease Inhibitors|protease inhibitors|mesh-ancestor
110587032|NCT00721773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110587033|NCT05676684|Dapagliflozin|dapagliflozin|mesh-list
110587034|NCT05676684|Spironolactone|spironolactone|mesh-list
110587035|NCT05676684|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110587036|NCT05676684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110587037|NCT05676684|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110587038|NCT05676684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110587039|NCT05676684|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110587040|NCT05676684|Hormone Antagonists|hormone antagonists|mesh-ancestor
110587041|NCT05676684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110587042|NCT05676684|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110587043|NCT05676684|Diuretics|diuretics|mesh-ancestor
110587044|NCT05676684|Natriuretic Agents|natriuretic agents|mesh-ancestor
110587045|NCT04070469|Amoxicillin|amoxicillin|mesh-list
110587046|NCT04070469|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110587047|NCT04070469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110587048|NCT00712647|Beta Carotene|beta carotene|mesh-list
110587049|NCT00712647|Vitamin A|vitamin a|mesh-list
110587050|NCT00712647|Carotenoids|carotenoids|mesh-list
110587051|NCT00712647|Antioxidants|antioxidants|mesh-ancestor
110587052|NCT00712647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110587053|NCT00712647|Protective Agents|protective agents|mesh-ancestor
110587054|NCT00712647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110587055|NCT00712647|Provitamins|provitamins|mesh-ancestor
110587056|NCT00712647|Vitamins|vitamins|mesh-ancestor
110587057|NCT00712647|Micronutrients|micronutrients|mesh-ancestor
110587058|NCT00788957|Panitumumab|panitumumab|mesh-list
110587059|NCT00788957|Rilotumumab|rilotumumab|mesh-list
110587060|NCT00788957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110587061|NCT00788957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110587062|NCT04067817|Phenylephrine|phenylephrine|mesh-list
110587063|NCT04067817|Oxymetazoline|oxymetazoline|mesh-list
110587064|NCT04067817|Norepinephrine|norepinephrine|mesh-list
110587065|NCT04067817|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
110226435|NCT05510089|Cytarabine|cytarabine|mesh-list
110587066|NCT04067817|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110587067|NCT04067817|Mydriatics|mydriatics|mesh-ancestor
110587068|NCT04067817|Autonomic Agents|autonomic agents|mesh-ancestor
110587069|NCT04067817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110587070|NCT04067817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110587071|NCT04067817|Sympathomimetics|sympathomimetics|mesh-ancestor
110587072|NCT04067817|Nasal Decongestants|nasal decongestants|mesh-ancestor
110587073|NCT04067817|Respiratory System Agents|respiratory system agents|mesh-ancestor
110587074|NCT04067817|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110587075|NCT04067817|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110587076|NCT04067817|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110587077|NCT04067817|Adrenergic Agents|adrenergic agents|mesh-ancestor
110587078|NCT04067817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110587079|NCT04067817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110587080|NCT04067817|Protective Agents|protective agents|mesh-ancestor
110587081|NCT00740636|Temozolomide|temozolomide|mesh-list
110587082|NCT00740636|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110587083|NCT00740636|Alkylating Agents|alkylating agents|mesh-ancestor
110587084|NCT00740636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110587085|NCT00740636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110587086|NCT02603159|Capecitabine|capecitabine|mesh-list
110587087|NCT02603159|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110587088|NCT02603159|Antimetabolites|antimetabolites|mesh-ancestor
110587089|NCT02603159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110587090|NCT02603159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110587091|NCT02595554|Paclitaxel|paclitaxel|mesh-list
110587092|NCT02595554|Cisplatin|cisplatin|mesh-list
110587093|NCT02595554|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110587094|NCT02595554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110587095|NCT02595554|Tubulin Modulators|tubulin modulators|mesh-ancestor
110587096|NCT02595554|Antimitotic Agents|antimitotic agents|mesh-ancestor
110587097|NCT02595554|Mitosis Modulators|mitosis modulators|mesh-ancestor
110587098|NCT02595554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110587099|NCT04069065|Tacrolimus|tacrolimus|mesh-list
110587100|NCT04069065|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110587101|NCT04069065|Immunologic Factors|immunologic factors|mesh-ancestor
110226588|NCT05401916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110261946|NCT05785585|Hydroxocobalamin|hydroxocobalamin|mesh-list
110226589|NCT05401916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110226590|NCT05401916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110226591|NCT05401916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110226592|NCT05401916|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110226593|NCT05401916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110226594|NCT05401916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110226595|NCT05401916|Antipyretics|antipyretics|mesh-ancestor
110226596|NCT05401916|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110226597|NCT05401916|Narcotics|narcotics|mesh-ancestor
110226598|NCT05401916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110226599|NCT05400265|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110226600|NCT05400265|Antibodies|antibodies|mesh-list
110226601|NCT05400265|Immunoglobulins|immunoglobulins|mesh-list
110226602|NCT05400265|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110587102|NCT04069065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110587103|NCT04069065|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110587104|NCT04069065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110587105|NCT04069065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110587106|NCT04070391|Vitamin B 6|vitamin b 6|mesh-list
110587107|NCT04070391|Pyridoxal|pyridoxal|mesh-list
110587108|NCT04070391|Pyridoxine|pyridoxine|mesh-list
110587109|NCT04070391|Vitamins|vitamins|mesh-ancestor
110587110|NCT04070391|Micronutrients|micronutrients|mesh-ancestor
110587111|NCT04070391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110587112|NCT04070391|Vitamin B Complex|vitamin b complex|mesh-ancestor
110587113|NCT00795509|Tolterodine Tartrate|tolterodine tartrate|mesh-list
110587114|NCT00795509|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110587115|NCT00795509|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110587116|NCT00795509|Cholinergic Agents|cholinergic agents|mesh-ancestor
110587117|NCT00795509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110587118|NCT00795509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110587119|NCT00795509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110587121|NCT02603003|Pemetrexed|pemetrexed|mesh-list
110587122|NCT02603003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110587123|NCT02603003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110587124|NCT02603003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110587125|NCT02603003|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110587126|NCT02603003|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110226683|NCT05375903|Gemcitabine|gemcitabine|mesh-list
110226684|NCT05375903|Imiquimod|imiquimod|mesh-list
110226685|NCT05375903|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110226694|NCT05375084|Nivolumab|nivolumab|mesh-list
110587127|NCT04106297|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110587128|NCT02603081|Ebselen|ebselen|mesh-list
110587129|NCT02603081|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110587130|NCT02603081|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110587131|NCT02603081|Analgesics|analgesics|mesh-ancestor
110587132|NCT02603081|Sensory System Agents|sensory system agents|mesh-ancestor
110587133|NCT02603081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110587134|NCT02603081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110587135|NCT02603081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110587136|NCT02603081|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110587137|NCT02603081|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110587138|NCT02603081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110587139|NCT02603081|Antioxidants|antioxidants|mesh-ancestor
110587140|NCT02603081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110587141|NCT02603081|Protective Agents|protective agents|mesh-ancestor
110587142|NCT02603081|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110587143|NCT02603081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110587144|NCT02603081|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110587145|NCT00787787|Capecitabine|capecitabine|mesh-list
110587146|NCT00787787|Sunitinib|sunitinib|mesh-list
110587147|NCT00787787|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110587148|NCT00787787|Antimetabolites|antimetabolites|mesh-ancestor
110587149|NCT00787787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110587150|NCT00787787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110587151|NCT00787787|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110587152|NCT00787787|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110587153|NCT00787787|Growth Substances|growth substances|mesh-ancestor
110587154|NCT00787787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110587155|NCT00787787|Growth Inhibitors|growth inhibitors|mesh-ancestor
110587156|NCT00787787|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110226791|NCT05331664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110226792|NCT05331664|Glucocorticoids|glucocorticoids|mesh-ancestor
110587157|NCT00787787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110587158|NCT00722475|Immunoglobulins|immunoglobulins|mesh-list
110587159|NCT00722475|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110587160|NCT00722475|Antibodies|antibodies|mesh-list
110587161|NCT00722475|gamma-Globulins|gamma-globulins|mesh-list
110587162|NCT00722475|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110587163|NCT00722475|Immunologic Factors|immunologic factors|mesh-ancestor
110587164|NCT00722475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110587170|NCT00915239|Pantoprazole|pantoprazole|mesh-list
110587171|NCT00915239|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110587172|NCT00915239|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110587173|NCT00915239|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110587174|NCT00915239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110587175|NCT00915239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110587176|NCT00722631|Pioglitazone|pioglitazone|mesh-list
110587177|NCT00722631|Glimepiride|glimepiride|mesh-list
110587178|NCT00722631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110587179|NCT00722631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110587180|NCT00722631|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110587181|NCT00722631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110587182|NCT00722631|Immunologic Factors|immunologic factors|mesh-ancestor
110587183|NCT02604095|Melatonin|melatonin|mesh-list
110587184|NCT02604095|Antioxidants|antioxidants|mesh-ancestor
110587185|NCT02604095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110587186|NCT02604095|Protective Agents|protective agents|mesh-ancestor
110587187|NCT02604095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110587188|NCT02604095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110587189|NCT02571543|Ibuprofen|ibuprofen|mesh-list
110587190|NCT02571543|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110587191|NCT02571543|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110587192|NCT02571543|Analgesics|analgesics|mesh-ancestor
110587193|NCT02571543|Sensory System Agents|sensory system agents|mesh-ancestor
110587194|NCT02571543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110587195|NCT02571543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110587196|NCT02571543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110587197|NCT02571543|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110587198|NCT02571543|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110587199|NCT02571543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110587200|NCT02571543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110587201|NCT04107779|Menthol|menthol|mesh-list
110587202|NCT04107779|Nicotine|nicotine|mesh-list
110587203|NCT04107779|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110587204|NCT04107779|Autonomic Agents|autonomic agents|mesh-ancestor
110587205|NCT04107779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110587206|NCT04107779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110587207|NCT04107779|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110226853|NCT05290129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110587208|NCT04107779|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110587209|NCT04107779|Cholinergic Agents|cholinergic agents|mesh-ancestor
110587210|NCT04107779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110587211|NCT04107779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110587212|NCT04107779|Antipruritics|antipruritics|mesh-ancestor
110587213|NCT04107779|Dermatologic Agents|dermatologic agents|mesh-ancestor
110587214|NCT04067505|Nadroparin|nadroparin|mesh-list
110587215|NCT04067505|Warfarin|warfarin|mesh-list
110587216|NCT04067505|Rivaroxaban|rivaroxaban|mesh-list
110587217|NCT04067505|Anticoagulants|anticoagulants|mesh-ancestor
110587218|NCT04067505|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110587219|NCT04067505|Antithrombins|antithrombins|mesh-ancestor
110226854|NCT05289830|Escitalopram|escitalopram|mesh-list
110587220|NCT04067505|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110587222|NCT04067505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110587223|NCT04067505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110587224|NCT04067505|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110587225|NCT04067505|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110587226|NCT00794963|Metformin|metformin|mesh-list
110587227|NCT00794963|Orlistat|orlistat|mesh-list
110587228|NCT00794963|Irbesartan|irbesartan|mesh-list
110587229|NCT00794963|Fenofibrate|fenofibrate|mesh-list
110587230|NCT00794963|Pravastatin|pravastatin|mesh-list
110587231|NCT00794963|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110587232|NCT00794963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110587233|NCT00794963|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110587234|NCT00794963|Antimetabolites|antimetabolites|mesh-ancestor
110587235|NCT00794963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110587236|NCT00794963|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110587237|NCT00794963|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110587238|NCT00794963|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110587239|NCT00794963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110587240|NCT00794963|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110587241|NCT00794963|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110226870|NCT05280405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110587242|NCT00794963|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110587243|NCT00794963|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110587245|NCT00713271|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110587246|NCT00713271|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110587247|NCT00713271|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110587248|NCT00713271|Adrenergic Agents|adrenergic agents|mesh-ancestor
110587249|NCT00713271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110587250|NCT00713271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110587251|NCT00713271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110587252|NCT05673135|Antihypertensive Agents|antihypertensive agents|mesh-list
110587253|NCT00722709|Ropivacaine|ropivacaine|mesh-list
110587254|NCT00722709|Anesthetics, Local|anesthetics, local|mesh-ancestor
110587255|NCT00722709|Anesthetics|anesthetics|mesh-ancestor
110587256|NCT00722709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110587257|NCT00722709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110587258|NCT00722709|Sensory System Agents|sensory system agents|mesh-ancestor
110587259|NCT00722709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110587260|NCT04105205|Apramycin|apramycin|mesh-list
110587261|NCT04105205|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110587262|NCT04105205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110587263|NCT00794573|Varenicline|varenicline|mesh-list
110587264|NCT00794573|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110226928|NCT05190471|Oblimersen|oblimersen|mesh-list
110587266|NCT00794573|Cholinergic Agents|cholinergic agents|mesh-ancestor
110587267|NCT00794573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110587268|NCT00794573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110587269|NCT00794573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110587270|NCT04070079|Tenofovir|tenofovir|mesh-list
110587271|NCT04070079|Antiviral Agents|antiviral agents|mesh-ancestor
110587272|NCT04070079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110587273|NCT04070079|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110587274|NCT04070079|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110587275|NCT04070079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110587276|NCT04070079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110587277|NCT04070079|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110587278|NCT04070079|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110587279|NCT00739934|Voriconazole|voriconazole|mesh-list
110587280|NCT00739934|Antifungal Agents|antifungal agents|mesh-ancestor
110587281|NCT00739934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110587282|NCT00739934|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110587283|NCT00739934|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110587284|NCT00739934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110226981|NCT05137067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110226982|NCT05111912|Liraglutide|liraglutide|mesh-list
110226983|NCT05111912|Glucagon|glucagon|mesh-list
110226984|NCT05111912|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
110226985|NCT05111912|Incretins|incretins|mesh-ancestor
110226986|NCT05111912|Hormones|hormones|mesh-ancestor
110226987|NCT05111912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110226988|NCT05111912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110226989|NCT05111912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110226990|NCT05111912|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110227002|NCT05068791|Dextromethorphan|dextromethorphan|mesh-list
110227004|NCT05068791|Hallucinogens|hallucinogens|mesh-ancestor
110587285|NCT00739934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110587286|NCT00739934|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110587287|NCT00739934|Hormone Antagonists|hormone antagonists|mesh-ancestor
110587288|NCT00739934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110587289|NCT00739934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110587290|NCT00739934|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110587291|NCT00723411|Aluminum sulfate|aluminum sulfate|mesh-list
110587292|NCT00723411|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110587293|NCT00723411|Immunologic Factors|immunologic factors|mesh-ancestor
110587294|NCT00723411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110587295|NCT02586636|Metformin|metformin|mesh-list
110587296|NCT02586636|Omeprazole|omeprazole|mesh-list
110587297|NCT02586636|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110587298|NCT02586636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110587299|NCT02586636|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110587300|NCT02586636|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110587301|NCT02586636|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110587302|NCT02586636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110227036|NCT05065424|Respiratory System Agents|respiratory system agents|mesh-ancestor
110227037|NCT05065424|Mydriatics|mydriatics|mesh-ancestor
110227038|NCT05065424|Parasympatholytics|parasympatholytics|mesh-ancestor
110227039|NCT05065424|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110227040|NCT05065424|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110227041|NCT05065424|Cholinergic Agents|cholinergic agents|mesh-ancestor
110227042|NCT05065424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110227043|NCT05063734|Aflibercept|aflibercept|mesh-list
110234691|NCT05074823|Anesthetics, General|anesthetics, general|mesh-ancestor
110587303|NCT02586636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110587305|NCT00713739|Doxazosin|doxazosin|mesh-list
110587306|NCT00713739|Nifedipine|nifedipine|mesh-list
110587307|NCT00713739|Alfuzosin|alfuzosin|mesh-list
110587308|NCT00713739|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110587309|NCT00713739|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110587310|NCT00713739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110587311|NCT00713739|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110587312|NCT00713739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110587313|NCT00713739|Vasodilator Agents|vasodilator agents|mesh-ancestor
110587314|NCT00713739|Tocolytic Agents|tocolytic agents|mesh-ancestor
110587315|NCT00713739|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110587316|NCT00713739|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110227093|NCT05035407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110587317|NCT00713739|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110587318|NCT00713739|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110587319|NCT00713739|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110587320|NCT00713739|Adrenergic Agents|adrenergic agents|mesh-ancestor
110587321|NCT00713739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110587322|NCT00713739|Urological Agents|urological agents|mesh-ancestor
110587323|NCT02595476|Remifentanil|remifentanil|mesh-list
110587324|NCT02595476|Propofol|propofol|mesh-list
110587325|NCT02595476|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110587326|NCT02595476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110587327|NCT02595476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110587328|NCT02595476|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110587329|NCT02595476|Anesthetics, General|anesthetics, general|mesh-ancestor
110587330|NCT02595476|Anesthetics|anesthetics|mesh-ancestor
110587331|NCT02595476|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110587332|NCT02595476|Narcotics|narcotics|mesh-ancestor
110587333|NCT02595476|Analgesics|analgesics|mesh-ancestor
110587334|NCT02595476|Sensory System Agents|sensory system agents|mesh-ancestor
110149995|NCT00007735|Doxycycline|doxycycline|mesh-list
110587335|NCT02595476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110587336|NCT02586402|Epoetin Alfa|epoetin alfa|mesh-list
110587337|NCT02586402|Hematinics|hematinics|mesh-ancestor
110587338|NCT00734630|Losartan|losartan|mesh-list
110587339|NCT00734630|Lisinopril|lisinopril|mesh-list
110587340|NCT00734630|Nebivolol|nebivolol|mesh-list
110587341|NCT00734630|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110587342|NCT00734630|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110587343|NCT00734630|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110587344|NCT00734630|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110587345|NCT00734630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110587346|NCT00734630|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110587347|NCT00734630|Protease Inhibitors|protease inhibitors|mesh-ancestor
110587348|NCT00734630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110587349|NCT00734630|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110587350|NCT00734630|Protective Agents|protective agents|mesh-ancestor
110587351|NCT00734630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110587352|NCT00734630|Vasodilator Agents|vasodilator agents|mesh-ancestor
110587353|NCT00734630|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
110587354|NCT00734630|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110587355|NCT00734630|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110587356|NCT00734630|Adrenergic Agents|adrenergic agents|mesh-ancestor
110587357|NCT00734630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110587358|NCT05636514|Decitabine|decitabine|mesh-list
110587359|NCT05636514|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110587360|NCT05636514|Antimetabolites|antimetabolites|mesh-ancestor
110587361|NCT05636514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110587362|NCT05636514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110587363|NCT05636514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110587364|NCT02586246|Certolizumab Pegol|certolizumab pegol|mesh-list
110587365|NCT02586246|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110587366|NCT02586246|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110587367|NCT02586246|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110587368|NCT02586246|Immunologic Factors|immunologic factors|mesh-ancestor
110587369|NCT02586246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110587370|NCT02586246|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110587371|NCT00920244|Atropine|atropine|mesh-list
110587372|NCT00920244|Amiodarone|amiodarone|mesh-list
110587373|NCT00920244|Epinephrine|epinephrine|mesh-list
110587374|NCT00920244|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110587375|NCT00920244|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110587376|NCT00920244|Adrenergic Agents|adrenergic agents|mesh-ancestor
110587377|NCT00920244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110234763|NCT04957485|Tecovirimat|tecovirimat|mesh-list
110587378|NCT00920244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110227153|NCT04938765|Anticonvulsants|anticonvulsants|mesh-ancestor
110227154|NCT04938765|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110587379|NCT00920244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110587380|NCT00920244|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110587381|NCT00920244|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110587382|NCT00920244|Autonomic Agents|autonomic agents|mesh-ancestor
110587383|NCT00920244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110587384|NCT00920244|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110587385|NCT00920244|Respiratory System Agents|respiratory system agents|mesh-ancestor
110587386|NCT00920244|Mydriatics|mydriatics|mesh-ancestor
110587387|NCT00920244|Sympathomimetics|sympathomimetics|mesh-ancestor
110587388|NCT00920244|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110587389|NCT00920244|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110587390|NCT00920244|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110587391|NCT00920244|Parasympatholytics|parasympatholytics|mesh-ancestor
110587392|NCT00920244|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110587393|NCT00920244|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110587394|NCT00920244|Cholinergic Agents|cholinergic agents|mesh-ancestor
110587395|NCT00920244|Vasodilator Agents|vasodilator agents|mesh-ancestor
110587396|NCT00920244|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
110587397|NCT00920244|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110587398|NCT00920244|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110587399|NCT00920244|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110587400|NCT00920244|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110587401|NCT00920244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110587402|NCT00920244|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110149998|NCT00007735|Antimalarials|antimalarials|mesh-ancestor
110587403|NCT00920244|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110587404|NCT00920244|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110587405|NCT00578175|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110587406|NCT00578175|Immunologic Factors|immunologic factors|mesh-ancestor
110587407|NCT00578175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110587409|NCT00723879|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110587410|NCT00723879|Antimetabolites|antimetabolites|mesh-ancestor
110587411|NCT00723879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110587412|NCT00723879|Antiviral Agents|antiviral agents|mesh-ancestor
110587413|NCT00723879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110587414|NCT03907605|Hormones|hormones|mesh-list
110587415|NCT03907605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110587416|NCT03907605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110587418|NCT00435409|Sunitinib|sunitinib|mesh-list
110587419|NCT00435409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110587420|NCT00435409|Antimetabolites|antimetabolites|mesh-ancestor
110587421|NCT00435409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110587422|NCT00435409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110587423|NCT00435409|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110587424|NCT00435409|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110587425|NCT00435409|Growth Substances|growth substances|mesh-ancestor
110587426|NCT00435409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110587427|NCT00435409|Growth Inhibitors|growth inhibitors|mesh-ancestor
110587428|NCT00435409|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110587429|NCT00435409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110587430|NCT00724035|Fentanyl|fentanyl|mesh-list
110587431|NCT00724035|Midazolam|midazolam|mesh-list
110587432|NCT00724035|Analgesics|analgesics|mesh-list
110587433|NCT00724035|Anesthetics|anesthetics|mesh-list
110587434|NCT00724035|Ropivacaine|ropivacaine|mesh-list
110587435|NCT00724035|Anesthetics, Local|anesthetics, local|mesh-list
110227277|NCT04872790|Dermatologic Agents|dermatologic agents|mesh-ancestor
110587436|NCT00724035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110587437|NCT00724035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110587438|NCT00724035|Sensory System Agents|sensory system agents|mesh-ancestor
110587439|NCT00724035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110587440|NCT00724035|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110587441|NCT00724035|Narcotics|narcotics|mesh-ancestor
110587442|NCT00724035|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110587443|NCT00724035|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110587444|NCT00724035|Anesthetics, General|anesthetics, general|mesh-ancestor
110587445|NCT00724035|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110587446|NCT00724035|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110587447|NCT00724035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110587448|NCT00724035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110587449|NCT00724035|GABA Modulators|gaba modulators|mesh-ancestor
110587450|NCT00724035|GABA Agents|gaba agents|mesh-ancestor
110587451|NCT00724035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110587452|NCT00724035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110587453|NCT04126824|Triamcinolone|triamcinolone|mesh-list
110587454|NCT04126824|Bupivacaine|bupivacaine|mesh-list
110587455|NCT04126824|Anesthetics, Local|anesthetics, local|mesh-ancestor
110587456|NCT04126824|Anesthetics|anesthetics|mesh-ancestor
110587457|NCT04126824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110587458|NCT04126824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110587459|NCT04126824|Sensory System Agents|sensory system agents|mesh-ancestor
110587460|NCT04126824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110587461|NCT04126824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110227395|NCT04708067|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110587462|NCT04126824|Glucocorticoids|glucocorticoids|mesh-ancestor
110587463|NCT04126824|Hormones|hormones|mesh-ancestor
110587464|NCT04126824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110587465|NCT00724113|Lidocaine|lidocaine|mesh-list
110587466|NCT00724113|Anesthetics, Local|anesthetics, local|mesh-ancestor
110587467|NCT00724113|Anesthetics|anesthetics|mesh-ancestor
110587468|NCT00724113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110587469|NCT00724113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110587470|NCT00724113|Sensory System Agents|sensory system agents|mesh-ancestor
110587471|NCT00724113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110587472|NCT00724113|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110587473|NCT00724113|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110587474|NCT00724113|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110587475|NCT00724113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110587476|NCT00724113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110587478|NCT04070001|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110587479|NCT04070001|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110587480|NCT04070001|Analgesics|analgesics|mesh-ancestor
110587481|NCT04070001|Sensory System Agents|sensory system agents|mesh-ancestor
110587482|NCT04070001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110587483|NCT04070001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110587484|NCT04070001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110587485|NCT04070001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110587486|NCT04070001|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110587487|NCT04070001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110587488|NCT04070001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110587489|NCT00435019|Insulin|insulin|mesh-list
110587490|NCT00435019|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110587491|NCT00435019|Insulin Aspart|insulin aspart|mesh-list
110587492|NCT00435019|Insulin Detemir|insulin detemir|mesh-list
110587493|NCT00435019|Isophane Insulin, Human|isophane insulin, human|mesh-list
110587494|NCT00435019|Insulin, Isophane|insulin, isophane|mesh-list
110587495|NCT00435019|Isophane insulin, beef|isophane insulin, beef|mesh-list
110587496|NCT00435019|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110587497|NCT00435019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110587498|NCT00724581|Amiodarone|amiodarone|mesh-list
110587499|NCT00724581|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110587500|NCT00724581|Vasodilator Agents|vasodilator agents|mesh-ancestor
110587501|NCT00724581|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
110587502|NCT00724581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110587503|NCT00724581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110587504|NCT00724581|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110587505|NCT00724581|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110587506|NCT00724581|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110587507|NCT00724581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110587508|NCT00724581|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110587509|NCT00724581|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110587510|NCT00724581|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110227578|NCT04569747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110587512|NCT02570841|Antipruritics|antipruritics|mesh-ancestor
110587513|NCT02570841|Dermatologic Agents|dermatologic agents|mesh-ancestor
110587514|NCT02570841|Sensory System Agents|sensory system agents|mesh-ancestor
110587515|NCT02570841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110587516|NCT02570841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110587517|NCT00577863|Teriparatide|teriparatide|mesh-list
110587518|NCT00577863|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110587519|NCT00577863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110587520|NCT00577863|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110587521|NCT04956627|Itraconazole|itraconazole|mesh-list
110587522|NCT04956627|Phenytoin|phenytoin|mesh-list
110587523|NCT04956627|Gemfibrozil|gemfibrozil|mesh-list
110587524|NCT04956627|Antifungal Agents|antifungal agents|mesh-ancestor
110587525|NCT04956627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110587526|NCT04956627|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110587527|NCT04956627|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110587529|NCT04956627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110587530|NCT04956627|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110587531|NCT04956627|Hormone Antagonists|hormone antagonists|mesh-ancestor
110150016|NCT00007774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110587532|NCT04956627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110587533|NCT04956627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110587534|NCT04956627|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110587536|NCT04956627|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110587537|NCT04956627|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110587538|NCT04956627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110587539|NCT04956627|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110587540|NCT04956627|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110587541|NCT04956627|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110587542|NCT04956627|Antimetabolites|antimetabolites|mesh-ancestor
110587543|NCT04956627|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110587544|NCT04956627|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
110587545|NCT00920088|Ritonavir|ritonavir|mesh-list
110587546|NCT00920088|Lopinavir|lopinavir|mesh-list
110587547|NCT00920088|Darunavir|darunavir|mesh-list
110587548|NCT00920088|Flurbiprofen|flurbiprofen|mesh-list
110587549|NCT00920088|Midazolam|midazolam|mesh-list
110587550|NCT00920088|Dextromethorphan|dextromethorphan|mesh-list
110587551|NCT00920088|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110587552|NCT00920088|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110587553|NCT00920088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110587554|NCT00920088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110587555|NCT00920088|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110587556|NCT00920088|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110587557|NCT00920088|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110587558|NCT00920088|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110587559|NCT00920088|Anesthetics, General|anesthetics, general|mesh-ancestor
110587560|NCT00920088|Anesthetics|anesthetics|mesh-ancestor
110587561|NCT00920088|GABA Modulators|gaba modulators|mesh-ancestor
110587562|NCT00920088|GABA Agents|gaba agents|mesh-ancestor
110587563|NCT00920088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110587564|NCT00920088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110587565|NCT00920088|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110587566|NCT00920088|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110587567|NCT00920088|Protease Inhibitors|protease inhibitors|mesh-ancestor
110587568|NCT00920088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110587569|NCT00920088|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110587570|NCT00920088|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110587571|NCT00920088|Antiviral Agents|antiviral agents|mesh-ancestor
110227682|NCT04447027|Romidepsin|romidepsin|mesh-list
110587572|NCT00920088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110587573|NCT00920088|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110587574|NCT00920088|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110587575|NCT00920088|Antitussive Agents|antitussive agents|mesh-ancestor
110587576|NCT00920088|Respiratory System Agents|respiratory system agents|mesh-ancestor
110587577|NCT00920088|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110587578|NCT00920088|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110587579|NCT00920088|Analgesics|analgesics|mesh-ancestor
110587580|NCT00920088|Sensory System Agents|sensory system agents|mesh-ancestor
110587581|NCT00920088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110587582|NCT00920088|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110587583|NCT00920088|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110587584|NCT00920088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110587585|NCT00920088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110587586|NCT00920088|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110587587|NCT04018833|Ranibizumab|ranibizumab|mesh-list
110587588|NCT04018833|Aflibercept|aflibercept|mesh-list
110587589|NCT04018833|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110587590|NCT04018833|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110587591|NCT04018833|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110587592|NCT04018833|Growth Substances|growth substances|mesh-ancestor
110587593|NCT04018833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110587594|NCT04018833|Growth Inhibitors|growth inhibitors|mesh-ancestor
110587595|NCT04018833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110587597|NCT04066803|Hematinics|hematinics|mesh-ancestor
110587598|NCT04066803|Vitamin B Complex|vitamin b complex|mesh-ancestor
110587599|NCT04066803|Vitamins|vitamins|mesh-ancestor
110587600|NCT04066803|Micronutrients|micronutrients|mesh-ancestor
110235000|NCT04153032|Diltiazem|diltiazem|mesh-list
110587601|NCT04066803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110587607|NCT00725439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110587608|NCT00725439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110587610|NCT03205761|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110587611|NCT03205761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110587612|NCT03205761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110587613|NCT03205761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110587614|NCT00725517|Icodextrin|icodextrin|mesh-list
110587615|NCT00725517|Dialysis Solutions|dialysis solutions|mesh-ancestor
110587616|NCT00725517|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110587617|NCT04066881|Vaccines|vaccines|mesh-list
110587618|NCT04066881|Immunologic Factors|immunologic factors|mesh-ancestor
110227715|NCT04434664|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110587619|NCT04066881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110587620|NCT04620291|UB-421|ub-421|mesh-list
110587621|NCT04620291|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110587622|NCT04620291|Antiviral Agents|antiviral agents|mesh-ancestor
110587623|NCT04620291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110587624|NCT00794417|Pemetrexed|pemetrexed|mesh-list
110587625|NCT00794417|Aflibercept|aflibercept|mesh-list
110587626|NCT00794417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110587627|NCT00794417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110587628|NCT00794417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110587629|NCT00794417|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110587630|NCT00794417|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110587631|NCT00794417|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110587632|NCT00794417|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110587633|NCT00794417|Growth Substances|growth substances|mesh-ancestor
110587634|NCT00794417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110587635|NCT00794417|Growth Inhibitors|growth inhibitors|mesh-ancestor
110587636|NCT04483206|Melphalan|melphalan|mesh-list
110587637|NCT04483206|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110587638|NCT04483206|Alkylating Agents|alkylating agents|mesh-ancestor
110587639|NCT04483206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110587640|NCT04483206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110587641|NCT04483206|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110587642|NCT04483206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110587643|NCT04483206|Immunologic Factors|immunologic factors|mesh-ancestor
110587644|NCT04483206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110587645|NCT00725829|Simvastatin|simvastatin|mesh-list
110587646|NCT00725829|Ezetimibe|ezetimibe|mesh-list
110587647|NCT00725829|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110587648|NCT00725829|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110587649|NCT00725829|Antimetabolites|antimetabolites|mesh-ancestor
110587650|NCT00725829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110587651|NCT00725829|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110587652|NCT00725829|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110587653|NCT00725829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110587654|NCT02583438|Saxagliptin|saxagliptin|mesh-list
110587655|NCT02583438|Incretins|incretins|mesh-ancestor
110587656|NCT02583438|Hormones|hormones|mesh-ancestor
110587657|NCT02583438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110587658|NCT02583438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110587659|NCT02583438|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110587660|NCT02583438|Protease Inhibitors|protease inhibitors|mesh-ancestor
110150038|NCT00007852|Cytarabine|cytarabine|mesh-list
110587661|NCT02583438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110587662|NCT02583438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110587663|NCT02583438|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110587665|NCT02603861|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110587666|NCT02603861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110587667|NCT02603861|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
110587668|NCT02603861|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110587669|NCT02603861|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110587670|NCT02603861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110587671|NCT02569905|Flurbiprofen|flurbiprofen|mesh-list
110587672|NCT02569905|Parecoxib|parecoxib|mesh-list
110587673|NCT02569905|Analgesics|analgesics|mesh-ancestor
110587674|NCT02569905|Sensory System Agents|sensory system agents|mesh-ancestor
110235079|NCT03671109|Artenimol|artenimol|mesh-list
110587675|NCT02569905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110587676|NCT02569905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110587677|NCT02569905|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110587678|NCT02569905|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110587679|NCT02569905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110587681|NCT02569905|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110587682|NCT02569905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110587683|NCT02569905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110587684|NCT02569905|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110587685|NCT02603783|Capsaicin|capsaicin|mesh-list
110587686|NCT02603783|Antipruritics|antipruritics|mesh-ancestor
110587687|NCT02603783|Dermatologic Agents|dermatologic agents|mesh-ancestor
110587688|NCT02603783|Sensory System Agents|sensory system agents|mesh-ancestor
110587689|NCT02603783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110587690|NCT02603783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110587691|NCT04110275|Plasminogen|plasminogen|mesh-list
110587692|NCT04110275|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
110587693|NCT04110275|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110587694|NCT04110275|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110227776|NCT04360551|Telmisartan|telmisartan|mesh-list
110227777|NCT04360551|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110227778|NCT04360551|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110227779|NCT04360551|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110227780|NCT04360551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110227781|NCT04341571|Metformin|metformin|mesh-list
110227782|NCT04341571|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110587695|NCT04110275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110587696|NCT04250883|Iodine|iodine|mesh-list
110587697|NCT04250883|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110587698|NCT04250883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110587699|NCT04250883|Trace Elements|trace elements|mesh-ancestor
110587701|NCT04250883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110587702|NCT04469634|Antibodies|antibodies|mesh-list
110587703|NCT04469634|Immunologic Factors|immunologic factors|mesh-ancestor
110587704|NCT04469634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110587705|NCT04209543|Progesterone|progesterone|mesh-list
110587706|NCT04209543|Progestins|progestins|mesh-ancestor
110587707|NCT04209543|Hormones|hormones|mesh-ancestor
110587708|NCT04209543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110587709|NCT04209543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110587710|NCT04465500|Androgens|androgens|mesh-list
110587711|NCT04465500|Hormones|hormones|mesh-ancestor
110587712|NCT04465500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110587713|NCT04465500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110587714|NCT04080726|Esomeprazole|esomeprazole|mesh-list
110587715|NCT04080726|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110587716|NCT04080726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110587717|NCT04080726|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110587718|NCT04080726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110587719|NCT04080726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110587720|NCT02583516|Vemurafenib|vemurafenib|mesh-list
110587721|NCT02583516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110227820|NCT04270409|Lenalidomide|lenalidomide|mesh-list
110587722|NCT02583516|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110587723|NCT02583516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110587724|NCT02583516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110587725|NCT00790907|Heparin|heparin|mesh-list
110587726|NCT00790907|PENTA|penta|mesh-list
110587727|NCT00790907|Fondaparinux|fondaparinux|mesh-list
110587728|NCT00790907|Anticoagulants|anticoagulants|mesh-ancestor
110587729|NCT00790907|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110587730|NCT00790907|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110587731|NCT00790907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110587732|NCT00790907|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110587733|NCT00790907|Antithrombins|antithrombins|mesh-ancestor
110587734|NCT00790907|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110587735|NCT00790907|Protease Inhibitors|protease inhibitors|mesh-ancestor
110587736|NCT00790907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110587737|NCT03109353|Aminolevulinic Acid|aminolevulinic acid|mesh-list
110587738|NCT03109353|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110587739|NCT03109353|Dermatologic Agents|dermatologic agents|mesh-ancestor
110587741|NCT04066179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110587742|NCT04066179|Glucocorticoids|glucocorticoids|mesh-ancestor
110587743|NCT04066179|Hormones|hormones|mesh-ancestor
110587744|NCT04066179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110587745|NCT04066179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110587746|NCT04066179|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110227872|NCT04246697|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110587747|NCT04066179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110587748|NCT04110119|Diclofenac|diclofenac|mesh-list
110235147|NCT03426891|Alkylating Agents|alkylating agents|mesh-ancestor
110587749|NCT04110119|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110587750|NCT04110119|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110587751|NCT04110119|Analgesics|analgesics|mesh-ancestor
110587752|NCT04110119|Sensory System Agents|sensory system agents|mesh-ancestor
110587753|NCT04110119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110587754|NCT04110119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110587755|NCT04110119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110587756|NCT04110119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110587757|NCT04110119|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110587758|NCT04110119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110587759|NCT04110119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110587760|NCT00726687|Capecitabine|capecitabine|mesh-list
110587761|NCT00726687|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110587762|NCT00726687|Antimetabolites|antimetabolites|mesh-ancestor
110587763|NCT00726687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110587764|NCT00726687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110587765|NCT00727077|Interferons|interferons|mesh-list
110587766|NCT00727077|Ribavirin|ribavirin|mesh-list
110587767|NCT00727077|Interferon-alpha|interferon-alpha|mesh-list
110227925|NCT04230265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110587769|NCT00727077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110587770|NCT00727077|Antiviral Agents|antiviral agents|mesh-ancestor
110587771|NCT00727077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110587772|NCT00727077|Antimetabolites|antimetabolites|mesh-ancestor
110587773|NCT00727077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110587774|NCT00727077|Immunologic Factors|immunologic factors|mesh-ancestor
110587775|NCT00727077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110587776|NCT04080336|Misoprostol|misoprostol|mesh-list
110587777|NCT04080336|Dinoprostone|dinoprostone|mesh-list
110587778|NCT04080336|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110587779|NCT04080336|Abortifacient Agents|abortifacient agents|mesh-ancestor
110587780|NCT04080336|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110587781|NCT04080336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110587782|NCT04080336|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110587783|NCT04080336|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110587784|NCT04080336|Oxytocics|oxytocics|mesh-ancestor
110587785|NCT00793871|Sunitinib|sunitinib|mesh-list
110587786|NCT00793871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110587787|NCT00793871|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110587788|NCT00793871|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110587789|NCT00793871|Growth Substances|growth substances|mesh-ancestor
110587790|NCT00793871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110587791|NCT00793871|Growth Inhibitors|growth inhibitors|mesh-ancestor
110587792|NCT00793871|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110587793|NCT00793871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110587794|NCT00793871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110587795|NCT05466474|Tislelizumab|tislelizumab|mesh-list
110587796|NCT05466474|Dacarbazine|dacarbazine|mesh-list
110587797|NCT05466474|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110587798|NCT05466474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110587799|NCT05466474|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110587800|NCT05466474|Alkylating Agents|alkylating agents|mesh-ancestor
110587801|NCT05466474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110587802|NCT00727233|Sorafenib|sorafenib|mesh-list
110587803|NCT00727233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110376345|NCT01085097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110587804|NCT00727233|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110587805|NCT00727233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110587806|NCT00727233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110227975|NCT04177706|Ketamine|ketamine|mesh-list
110587807|NCT04105283|Technetium Tc 99m Aggregated Albumin|technetium tc 99m aggregated albumin|mesh-list
110587808|NCT04105283|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110587809|NCT04105283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110587811|NCT04066257|Tetracycline|tetracycline|mesh-list
110587812|NCT04066257|Bismuth|bismuth|mesh-list
110587813|NCT04066257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110587814|NCT04066257|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110587815|NCT04066257|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110587816|NCT04066257|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110587817|NCT04066257|Antacids|antacids|mesh-ancestor
110587818|NCT04066257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110587819|NCT04066257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110587820|NCT04066257|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110587821|NCT04066257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110587822|NCT03655821|Pemetrexed|pemetrexed|mesh-list
110235223|NCT03043872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110587823|NCT03655821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110587824|NCT03655821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110587825|NCT03655821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110587826|NCT03655821|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110587827|NCT03655821|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110587829|NCT04524702|Paclitaxel|paclitaxel|mesh-list
110587830|NCT04524702|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110587831|NCT04524702|Gemcitabine|gemcitabine|mesh-list
110587832|NCT04524702|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110587833|NCT04524702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110587834|NCT04524702|Tubulin Modulators|tubulin modulators|mesh-ancestor
110587835|NCT04524702|Antimitotic Agents|antimitotic agents|mesh-ancestor
110587836|NCT04524702|Mitosis Modulators|mitosis modulators|mesh-ancestor
110587837|NCT04524702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110587838|NCT04524702|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110587839|NCT04524702|Antimetabolites|antimetabolites|mesh-ancestor
110587840|NCT04524702|Antimalarials|antimalarials|mesh-ancestor
110587841|NCT04524702|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110587842|NCT04524702|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110587843|NCT04524702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110587844|NCT04524702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110587845|NCT04524702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110587846|NCT00730197|Albuterol|albuterol|mesh-list
110587847|NCT00730197|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110587848|NCT00730197|Autonomic Agents|autonomic agents|mesh-ancestor
110587849|NCT00730197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110587850|NCT00730197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110587851|NCT00730197|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110587852|NCT00730197|Respiratory System Agents|respiratory system agents|mesh-ancestor
110587853|NCT00730197|Tocolytic Agents|tocolytic agents|mesh-ancestor
110587854|NCT00730197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110587855|NCT00730197|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110587856|NCT00730197|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110587857|NCT00730197|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110587858|NCT00730197|Adrenergic Agents|adrenergic agents|mesh-ancestor
110587859|NCT00730197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110587860|NCT00730197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110587861|NCT00727545|Chelating Agents|chelating agents|mesh-list
110587862|NCT00727545|Sequestering Agents|sequestering agents|mesh-ancestor
110587863|NCT00727545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110587864|NCT02582892|Vitamin D|vitamin d|mesh-list
110587865|NCT02582892|Vitamins|vitamins|mesh-ancestor
110587866|NCT02582892|Micronutrients|micronutrients|mesh-ancestor
110587867|NCT02582892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110587868|NCT02582892|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110587869|NCT00730509|Vitamin B 12|vitamin b 12|mesh-list
110587871|NCT00730509|Vitamins|vitamins|mesh-ancestor
110587872|NCT00730509|Micronutrients|micronutrients|mesh-ancestor
110587873|NCT00730509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110587874|NCT00730509|Vitamin B Complex|vitamin b complex|mesh-ancestor
110587875|NCT00730509|Hematinics|hematinics|mesh-ancestor
110587876|NCT02582736|Methotrimeprazine|methotrimeprazine|mesh-list
110587877|NCT02582736|Haloperidol|haloperidol|mesh-list
110587878|NCT02582736|Pimozide|pimozide|mesh-list
110587879|NCT02582736|Olanzapine|olanzapine|mesh-list
110587880|NCT02582736|Chlorpromazine|chlorpromazine|mesh-list
110587881|NCT02582736|Trifluoperazine|trifluoperazine|mesh-list
110587882|NCT02582736|Risperidone|risperidone|mesh-list
110587883|NCT02582736|Aripiprazole|aripiprazole|mesh-list
110587884|NCT02582736|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110587885|NCT02582736|Paliperidone Palmitate|paliperidone palmitate|mesh-list
110587886|NCT02582736|Ziprasidone|ziprasidone|mesh-list
110587887|NCT02582736|Antipsychotic Agents|antipsychotic agents|mesh-list
110587888|NCT02582736|Clozapine|clozapine|mesh-list
110587889|NCT02582736|Loxapine|loxapine|mesh-list
110587890|NCT02582736|Perphenazine|perphenazine|mesh-list
110587891|NCT02582736|Fluphenazine|fluphenazine|mesh-list
110587892|NCT02582736|Flupenthixol|flupenthixol|mesh-list
110587893|NCT02582736|Thioridazine|thioridazine|mesh-list
110587894|NCT02582736|Clopenthixol|clopenthixol|mesh-list
110587895|NCT02582736|Chlorprothixene|chlorprothixene|mesh-list
110587896|NCT02582736|Fluspirilene|fluspirilene|mesh-list
110587897|NCT02582736|Thiothixene|thiothixene|mesh-list
110587898|NCT02582736|Mesoridazine|mesoridazine|mesh-list
110587899|NCT02582736|Chlormezanone|chlormezanone|mesh-list
110587900|NCT02582736|Tetrabenazine|tetrabenazine|mesh-list
110587901|NCT02582736|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110587902|NCT02582736|Serotonin Agents|serotonin agents|mesh-ancestor
110587903|NCT02582736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110228109|NCT04115163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110587904|NCT02582736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110587905|NCT02582736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110587906|NCT02582736|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110587907|NCT02582736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110587908|NCT02582736|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110587909|NCT02582736|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110587911|NCT02582736|Antiemetics|antiemetics|mesh-ancestor
110587912|NCT02582736|Autonomic Agents|autonomic agents|mesh-ancestor
110587913|NCT02582736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110587914|NCT02582736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110587915|NCT02582736|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110587916|NCT02582736|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110587917|NCT02582736|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110587918|NCT02582736|Antidepressive Agents|antidepressive agents|mesh-ancestor
110587919|NCT02582736|Dopamine Agonists|dopamine agonists|mesh-ancestor
110587920|NCT02582736|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110587921|NCT02582736|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110587922|NCT02582736|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110587923|NCT02582736|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110587924|NCT02582736|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110587925|NCT02582736|GABA Antagonists|gaba antagonists|mesh-ancestor
110587926|NCT02582736|GABA Agents|gaba agents|mesh-ancestor
110587927|NCT02582736|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110587928|NCT02582736|Adrenergic Agents|adrenergic agents|mesh-ancestor
110587929|NCT02582736|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110587930|NCT02582736|Analgesics|analgesics|mesh-ancestor
110587931|NCT02582736|Sensory System Agents|sensory system agents|mesh-ancestor
110587932|NCT02582736|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110587933|NCT02582736|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110587934|NCT02582736|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110587935|NCT04019652|Moxifloxacin|moxifloxacin|mesh-list
110587936|NCT04019652|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
110587937|NCT04019652|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110587938|NCT04019652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110587939|NCT04019652|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110587940|NCT04019652|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110587942|NCT04019652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110587943|NCT04019652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110587944|NCT04019652|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110587945|NCT04019652|Contraceptive Agents|contraceptive agents|mesh-ancestor
110587946|NCT04019652|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110587947|NCT04019652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110587948|NCT04019652|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110587949|NCT04019652|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110587950|NCT04019652|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110587952|NCT00735345|Cetuximab|cetuximab|mesh-list
110587953|NCT00735345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110587954|NCT00735345|Tubulin Modulators|tubulin modulators|mesh-ancestor
110587955|NCT00735345|Antimitotic Agents|antimitotic agents|mesh-ancestor
110587956|NCT00735345|Mitosis Modulators|mitosis modulators|mesh-ancestor
110587957|NCT00735345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110587958|NCT00735345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110587959|NCT00735501|Insulin Detemir|insulin detemir|mesh-list
110587960|NCT00735501|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110587961|NCT00735501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110587962|NCT00727935|Lidocaine|lidocaine|mesh-list
110587963|NCT00727935|Ropivacaine|ropivacaine|mesh-list
110587964|NCT00727935|Anesthetics, Local|anesthetics, local|mesh-ancestor
110587965|NCT00727935|Anesthetics|anesthetics|mesh-ancestor
110587966|NCT00727935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110587967|NCT00727935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110587968|NCT00727935|Sensory System Agents|sensory system agents|mesh-ancestor
110587969|NCT00727935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110587970|NCT00727935|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110587971|NCT00727935|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110587972|NCT00727935|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110228191|NCT04024436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110587973|NCT00727935|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110587974|NCT00727935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110587975|NCT00728013|Atorvastatin|atorvastatin|mesh-list
110587976|NCT00728013|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110587977|NCT00728013|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110587978|NCT00728013|Antimetabolites|antimetabolites|mesh-ancestor
110587979|NCT00728013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110587980|NCT00728013|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110587981|NCT00728013|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110587982|NCT00728013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110587983|NCT00577707|Pemetrexed|pemetrexed|mesh-list
110587984|NCT00577707|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110587985|NCT00577707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110587986|NCT00577707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110587987|NCT00577707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110587988|NCT00577707|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110587989|NCT00577707|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110587990|NCT00577707|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110587991|NCT00730821|Nintedanib|nintedanib|mesh-list
110587992|NCT00730821|Afatinib|afatinib|mesh-list
110587993|NCT00730821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110587994|NCT00730821|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110587995|NCT00730821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110587996|NCT00730821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110587997|NCT00728559|Bupivacaine|bupivacaine|mesh-list
110587998|NCT00728559|Anesthetics, Local|anesthetics, local|mesh-ancestor
110587999|NCT00728559|Anesthetics|anesthetics|mesh-ancestor
110588000|NCT00728559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110588001|NCT00728559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110588002|NCT00728559|Sensory System Agents|sensory system agents|mesh-ancestor
110228230|NCT03908593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110150075|NCT00008008|Cyclophosphamide|cyclophosphamide|mesh-list
110588003|NCT00728559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110588004|NCT00735813|Heparin|heparin|mesh-list
110588005|NCT00735813|Anticoagulants|anticoagulants|mesh-ancestor
110588006|NCT00735813|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110588007|NCT00735813|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110588008|NCT00735813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110588009|NCT04064619|Solifenacin Succinate|solifenacin succinate|mesh-list
110588010|NCT04064619|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110588011|NCT04064619|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110588012|NCT04064619|Cholinergic Agents|cholinergic agents|mesh-ancestor
110588013|NCT04064619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110588014|NCT04064619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110588015|NCT04064619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110588016|NCT04064619|Urological Agents|urological agents|mesh-ancestor
110588017|NCT00730977|Mannitol|mannitol|mesh-list
110588018|NCT00730977|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110588019|NCT00730977|Diuretics|diuretics|mesh-ancestor
110588020|NCT00730977|Natriuretic Agents|natriuretic agents|mesh-ancestor
110228272|NCT03821792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110588021|NCT00730977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110588022|NCT00728715|Budesonide|budesonide|mesh-list
110588023|NCT00728715|Formoterol Fumarate|formoterol fumarate|mesh-list
110588024|NCT00728715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110588025|NCT00728715|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110588026|NCT00728715|Autonomic Agents|autonomic agents|mesh-ancestor
110588027|NCT00728715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110588028|NCT00728715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110588029|NCT00728715|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110588030|NCT00728715|Respiratory System Agents|respiratory system agents|mesh-ancestor
110588031|NCT00728715|Glucocorticoids|glucocorticoids|mesh-ancestor
110588032|NCT00728715|Hormones|hormones|mesh-ancestor
110588033|NCT00728715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110588034|NCT00728715|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110588035|NCT00728715|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110588036|NCT00728715|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110588037|NCT00728715|Adrenergic Agents|adrenergic agents|mesh-ancestor
110588038|NCT00728715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110588039|NCT00728715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110588040|NCT00731289|Triamcinolone|triamcinolone|mesh-list
110588041|NCT00731289|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110588042|NCT00731289|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110588043|NCT00731289|Hyaluronic Acid|hyaluronic acid|mesh-list
110588044|NCT00731289|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110588045|NCT00731289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110588046|NCT00731289|Glucocorticoids|glucocorticoids|mesh-ancestor
110588047|NCT00731289|Hormones|hormones|mesh-ancestor
110588048|NCT00731289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110588049|NCT00731289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110588050|NCT00731289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110588051|NCT00731289|Immunologic Factors|immunologic factors|mesh-ancestor
110588052|NCT00731289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110588053|NCT00731289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110588054|NCT00731289|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110588055|NCT00731289|Viscosupplements|viscosupplements|mesh-ancestor
110588056|NCT00731289|Protective Agents|protective agents|mesh-ancestor
110588057|NCT00736515|Insulin|insulin|mesh-list
110588058|NCT00736515|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110588059|NCT00736515|Insulin Glargine|insulin glargine|mesh-list
110588060|NCT00736515|Gliclazide|gliclazide|mesh-list
110228327|NCT03760822|Tubulin Modulators|tubulin modulators|mesh-ancestor
110588061|NCT00736515|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110588062|NCT00736515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110588063|NCT00731367|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
110588064|NCT00731367|Laxatives|laxatives|mesh-ancestor
110588065|NCT00731367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110588066|NCT00731523|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
110588067|NCT00731523|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
110588068|NCT00731523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110588069|NCT00731523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110588070|NCT00731523|Immunologic Factors|immunologic factors|mesh-ancestor
110588071|NCT00731523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110588072|NCT05601531|Calcitriol|calcitriol|mesh-list
110588073|NCT05601531|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110588074|NCT05601531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110588075|NCT05601531|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
110588076|NCT05601531|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110588077|NCT05601531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110588078|NCT05601531|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110588079|NCT05601531|Vitamins|vitamins|mesh-ancestor
110588080|NCT05601531|Micronutrients|micronutrients|mesh-ancestor
110588081|NCT05601531|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110588082|NCT02569125|Everolimus|everolimus|mesh-list
110588083|NCT02569125|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110588084|NCT02569125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110588085|NCT02569125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110228361|NCT03744793|Immunologic Factors|immunologic factors|mesh-ancestor
110588086|NCT02569125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110588087|NCT02569125|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110588088|NCT02569125|Immunologic Factors|immunologic factors|mesh-ancestor
110588089|NCT02569125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110588090|NCT02569125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110588091|NCT00731601|Pantoprazole|pantoprazole|mesh-list
110588092|NCT00731601|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110588093|NCT00731601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110588094|NCT00731601|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110588095|NCT00731601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110588096|NCT00731601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110588097|NCT00736905|Rilpivirine|rilpivirine|mesh-list
110588098|NCT00736905|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110588099|NCT00736905|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110588100|NCT00736905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110588101|NCT00736905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110588102|NCT00736905|Antiviral Agents|antiviral agents|mesh-ancestor
110588103|NCT00736905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110588104|NCT00736905|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110588105|NCT00736905|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110588106|NCT00736983|Ciprofloxacin|ciprofloxacin|mesh-list
110588107|NCT00736983|Adalimumab|adalimumab|mesh-list
110588108|NCT00736983|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110588109|NCT00736983|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110588110|NCT00736983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110588111|NCT00736983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110588112|NCT00736983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110228409|NCT03693677|Paclitaxel|paclitaxel|mesh-list
110588113|NCT00736983|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110588114|NCT00736983|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110588115|NCT00736983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110588116|NCT00736983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110588117|NCT00736983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110588118|NCT00736983|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110588119|NCT00736983|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110588120|NCT00729339|Mosapride|mosapride|mesh-list
110588121|NCT00729339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110588122|NCT00729339|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110588123|NCT00729339|Serotonin Agents|serotonin agents|mesh-ancestor
110588124|NCT00729339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110588125|NCT00729339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110588126|NCT00729339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110588127|NCT00737139|Epinephrine|epinephrine|mesh-list
110588128|NCT00737139|Bupivacaine|bupivacaine|mesh-list
110588129|NCT00737139|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110588130|NCT00737139|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110588131|NCT00737139|Adrenergic Agents|adrenergic agents|mesh-ancestor
110588132|NCT00737139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110588133|NCT00737139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110228455|NCT03626545|Docetaxel|docetaxel|mesh-list
110588134|NCT00737139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110588135|NCT00737139|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110588136|NCT00737139|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110588137|NCT00737139|Autonomic Agents|autonomic agents|mesh-ancestor
110588138|NCT00737139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110588139|NCT00737139|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110588140|NCT00737139|Respiratory System Agents|respiratory system agents|mesh-ancestor
110588142|NCT00737139|Sympathomimetics|sympathomimetics|mesh-ancestor
110588143|NCT00737139|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110588144|NCT00737139|Anesthetics, Local|anesthetics, local|mesh-ancestor
110588145|NCT00737139|Anesthetics|anesthetics|mesh-ancestor
110588146|NCT00737139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110588147|NCT00737139|Sensory System Agents|sensory system agents|mesh-ancestor
110588148|NCT00732147|Pramlintide|pramlintide|mesh-list
110588149|NCT00732147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110588150|NCT00732147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110588151|NCT02569515|Epoetin Alfa|epoetin alfa|mesh-list
110588152|NCT02569515|Hematinics|hematinics|mesh-ancestor
110588154|NCT00737373|Folic Acid|folic acid|mesh-list
110588155|NCT00737373|Docetaxel|docetaxel|mesh-list
110588156|NCT00737373|Fluorouracil|fluorouracil|mesh-list
110588157|NCT00737373|Oxaliplatin|oxaliplatin|mesh-list
110588158|NCT00737373|Levoleucovorin|levoleucovorin|mesh-list
110588159|NCT00737373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110588160|NCT00737373|Tubulin Modulators|tubulin modulators|mesh-ancestor
110588161|NCT00737373|Antimitotic Agents|antimitotic agents|mesh-ancestor
110588162|NCT00737373|Mitosis Modulators|mitosis modulators|mesh-ancestor
110588163|NCT00737373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110588164|NCT00737373|Antimetabolites|antimetabolites|mesh-ancestor
110588165|NCT00737373|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110588166|NCT00737373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110588167|NCT00737373|Immunologic Factors|immunologic factors|mesh-ancestor
110588168|NCT00737373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110588169|NCT00737373|Antidotes|antidotes|mesh-ancestor
110588170|NCT00737373|Protective Agents|protective agents|mesh-ancestor
110588171|NCT00737373|Vitamin B Complex|vitamin b complex|mesh-ancestor
110588172|NCT00737373|Vitamins|vitamins|mesh-ancestor
110588173|NCT00737373|Micronutrients|micronutrients|mesh-ancestor
110588174|NCT00737373|Hematinics|hematinics|mesh-ancestor
110588175|NCT00729495|Celecoxib|celecoxib|mesh-list
110588176|NCT00729495|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110228512|NCT03527108|Nivolumab|nivolumab|mesh-list
110588177|NCT00729495|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110588178|NCT00729495|Analgesics|analgesics|mesh-ancestor
110588179|NCT00729495|Sensory System Agents|sensory system agents|mesh-ancestor
110588180|NCT00729495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110588181|NCT00729495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110588182|NCT00729495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110588183|NCT00729495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110588184|NCT00729495|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110588185|NCT00729495|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110588186|NCT00729495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110588187|NCT00729495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110588188|NCT00737685|Cyclophosphamide|cyclophosphamide|mesh-list
110588189|NCT00737685|Fludarabine|fludarabine|mesh-list
110588190|NCT00737685|Thymoglobulin|thymoglobulin|mesh-list
110588191|NCT00737685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110588192|NCT00737685|Immunologic Factors|immunologic factors|mesh-ancestor
110588193|NCT00737685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110588194|NCT00737685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110588195|NCT00737685|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110588196|NCT00737685|Alkylating Agents|alkylating agents|mesh-ancestor
110588197|NCT00737685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110588198|NCT00737685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110588199|NCT00737685|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110588200|NCT00732537|Nitric Oxide|nitric oxide|mesh-list
110588201|NCT00732537|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110588202|NCT00732537|Autonomic Agents|autonomic agents|mesh-ancestor
110588203|NCT00732537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110588204|NCT00732537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110588205|NCT00732537|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110588206|NCT00732537|Respiratory System Agents|respiratory system agents|mesh-ancestor
110588207|NCT00732537|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110588208|NCT00732537|Antioxidants|antioxidants|mesh-ancestor
110588209|NCT00732537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110588210|NCT00732537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110588211|NCT00732537|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
110588212|NCT00732537|Vasodilator Agents|vasodilator agents|mesh-ancestor
110588213|NCT00732537|Gasotransmitters|gasotransmitters|mesh-ancestor
110588214|NCT00732537|Protective Agents|protective agents|mesh-ancestor
110588215|NCT00732693|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110588216|NCT00732693|Norethindrone|norethindrone|mesh-list
110150087|NCT00008047|Paclitaxel|paclitaxel|mesh-list
110588217|NCT00732693|Norethindrone Acetate|norethindrone acetate|mesh-list
110588218|NCT00732693|Estradiol|estradiol|mesh-list
110588219|NCT00732693|Progesterone|progesterone|mesh-list
110588220|NCT00732693|Estrogens|estrogens|mesh-ancestor
110588221|NCT00732693|Hormones|hormones|mesh-ancestor
110588222|NCT00732693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110588223|NCT00732693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110588224|NCT00732693|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110588225|NCT00732693|Contraceptive Agents|contraceptive agents|mesh-ancestor
110588226|NCT00732693|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110588227|NCT00732693|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110588228|NCT00732693|Progestins|progestins|mesh-ancestor
110588229|NCT00732693|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110588230|NCT00732693|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110588231|NCT00732693|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110588232|NCT00729963|Sibutramine|sibutramine|mesh-list
110588233|NCT00729963|Antidepressive Agents|antidepressive agents|mesh-ancestor
110588234|NCT00729963|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110588235|NCT00729963|Appetite Depressants|appetite depressants|mesh-ancestor
110588236|NCT00729963|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110588237|NCT00737997|Morphine|morphine|mesh-list
110588238|NCT00737997|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110588239|NCT00737997|Narcotics|narcotics|mesh-ancestor
110588240|NCT00737997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110588241|NCT00737997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110588242|NCT00737997|Analgesics|analgesics|mesh-ancestor
110588243|NCT00737997|Sensory System Agents|sensory system agents|mesh-ancestor
110588244|NCT00737997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110588245|NCT00732927|Aspirin|aspirin|mesh-list
110588246|NCT00732927|Parnaparin|parnaparin|mesh-list
110588247|NCT00732927|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110588248|NCT00732927|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110588249|NCT00732927|Analgesics|analgesics|mesh-ancestor
110588250|NCT00732927|Sensory System Agents|sensory system agents|mesh-ancestor
110588251|NCT00732927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110588252|NCT00732927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110588253|NCT00732927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110588254|NCT00732927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110588255|NCT00732927|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110588256|NCT00732927|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110588257|NCT00732927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110588258|NCT00732927|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110588259|NCT00732927|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110588260|NCT00732927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110588261|NCT00732927|Antipyretics|antipyretics|mesh-ancestor
110588262|NCT00732927|Anticoagulants|anticoagulants|mesh-ancestor
110588263|NCT00733083|Dexamethasone|dexamethasone|mesh-list
110588264|NCT00733083|Morphine|morphine|mesh-list
110588265|NCT00733083|Oxycodone|oxycodone|mesh-list
110228567|NCT03431350|Prednisone|prednisone|mesh-list
110588266|NCT00733083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110588267|NCT00733083|Antiemetics|antiemetics|mesh-ancestor
110588268|NCT00733083|Autonomic Agents|autonomic agents|mesh-ancestor
110588269|NCT00733083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110588270|NCT00733083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110588271|NCT00733083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110588272|NCT00733083|Glucocorticoids|glucocorticoids|mesh-ancestor
110588273|NCT00733083|Hormones|hormones|mesh-ancestor
110588274|NCT00733083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110588275|NCT00733083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110588276|NCT00733083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110588277|NCT00733083|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110588278|NCT00733083|Narcotics|narcotics|mesh-ancestor
110588279|NCT00733083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110588281|NCT00733083|Sensory System Agents|sensory system agents|mesh-ancestor
110588282|NCT00712335|Fluticasone|fluticasone|mesh-list
110588283|NCT00712335|Xhance|xhance|mesh-list
110588284|NCT00712335|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110588285|NCT00712335|Montelukast|montelukast|mesh-list
110588286|NCT00712335|Leukotriene Antagonists|leukotriene antagonists|mesh-list
110588287|NCT00712335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110588288|NCT00712335|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110588289|NCT00712335|Autonomic Agents|autonomic agents|mesh-ancestor
110588290|NCT00712335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110588291|NCT00712335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110588292|NCT00712335|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110588293|NCT00712335|Respiratory System Agents|respiratory system agents|mesh-ancestor
110588295|NCT00712335|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110588296|NCT00712335|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110588297|NCT00712335|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110588298|NCT00712335|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110588299|NCT00712335|Adrenergic Agents|adrenergic agents|mesh-ancestor
110588300|NCT00712335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110588301|NCT00712335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110588302|NCT00712335|Hormone Antagonists|hormone antagonists|mesh-ancestor
110588303|NCT00712335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110588304|NCT00712335|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110588305|NCT00712335|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110588306|NCT00738621|Dexamethasone|dexamethasone|mesh-list
110588307|NCT00738621|Dexamethasone acetate|dexamethasone acetate|mesh-list
110588308|NCT00738621|Ondansetron|ondansetron|mesh-list
110588309|NCT00738621|Aprepitant|aprepitant|mesh-list
110588310|NCT00738621|Fosaprepitant|fosaprepitant|mesh-list
110588311|NCT00738621|BB 1101|bb 1101|mesh-list
110588312|NCT00738621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110588313|NCT00738621|Antiemetics|antiemetics|mesh-ancestor
110588314|NCT00738621|Autonomic Agents|autonomic agents|mesh-ancestor
110588315|NCT00738621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110588316|NCT00738621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110588317|NCT00738621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110588318|NCT00738621|Glucocorticoids|glucocorticoids|mesh-ancestor
110588319|NCT00738621|Hormones|hormones|mesh-ancestor
110588320|NCT00738621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110588321|NCT00738621|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110588322|NCT00738621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110588323|NCT00738621|Protease Inhibitors|protease inhibitors|mesh-ancestor
110588324|NCT00738621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110588325|NCT00738621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110588326|NCT00738621|Antipruritics|antipruritics|mesh-ancestor
110588327|NCT00738621|Dermatologic Agents|dermatologic agents|mesh-ancestor
110588328|NCT00738621|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110588329|NCT00738621|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110588330|NCT00738621|Serotonin Agents|serotonin agents|mesh-ancestor
110588331|NCT00738621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110588332|NCT00738621|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110588333|NCT00733239|Cycloserine|cycloserine|mesh-list
110588334|NCT00733239|Verapamil|verapamil|mesh-list
110588335|NCT00733239|Diltiazem|diltiazem|mesh-list
110588336|NCT00733239|Isradipine|isradipine|mesh-list
110588337|NCT00733239|Nifedipine|nifedipine|mesh-list
110588338|NCT00733239|Gabapentin|gabapentin|mesh-list
110588339|NCT00733239|Naloxone|naloxone|mesh-list
110588340|NCT00733239|Analgesics|analgesics|mesh-ancestor
110588341|NCT00733239|Sensory System Agents|sensory system agents|mesh-ancestor
110588342|NCT00733239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110588343|NCT00733239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110588344|NCT00733239|Anticonvulsants|anticonvulsants|mesh-ancestor
110588345|NCT00733239|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110588346|NCT00733239|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110588347|NCT00733239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110588348|NCT00733239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110588349|NCT00733239|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110588350|NCT00733239|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110588351|NCT00733239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110588352|NCT00733239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110588353|NCT00733239|Antimanic Agents|antimanic agents|mesh-ancestor
110588354|NCT00733239|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110588355|NCT00733239|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110235744|NCT00334438|Rituximab|rituximab|mesh-list
110588356|NCT00733239|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110588357|NCT00733239|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110588358|NCT00733239|Vasodilator Agents|vasodilator agents|mesh-ancestor
110588359|NCT00733239|Tocolytic Agents|tocolytic agents|mesh-ancestor
110588360|NCT00733239|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110588361|NCT00733239|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110588362|NCT00733239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110588363|NCT00733239|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110588364|NCT00733239|Antitubercular Agents|antitubercular agents|mesh-ancestor
110228626|NCT03374085|Antiemetics|antiemetics|mesh-ancestor
110588365|NCT00733239|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110588366|NCT00733239|Antimetabolites|antimetabolites|mesh-ancestor
110588367|NCT00733239|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110588368|NCT00733239|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110588369|NCT00738153|Insulin Detemir|insulin detemir|mesh-list
110588370|NCT00738153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110588371|NCT00738153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110588372|NCT04065165|Lanreotide|lanreotide|mesh-list
110588373|NCT04065165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110588374|NCT00577629|Cytarabine|cytarabine|mesh-list
110588375|NCT00577629|Cyclophosphamide|cyclophosphamide|mesh-list
110588376|NCT00577629|Rituximab|rituximab|mesh-list
110588377|NCT00577629|Doxorubicin|doxorubicin|mesh-list
110588378|NCT00577629|Etoposide|etoposide|mesh-list
110588379|NCT00577629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110588380|NCT00577629|Immunologic Factors|immunologic factors|mesh-ancestor
110588381|NCT00577629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110588382|NCT00577629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110588383|NCT00577629|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110588384|NCT00577629|Alkylating Agents|alkylating agents|mesh-ancestor
110588385|NCT00577629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110588386|NCT00577629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110588387|NCT00577629|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110588388|NCT00577629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110588389|NCT00577629|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110588390|NCT00577629|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110588391|NCT00577629|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110588392|NCT00577629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110588393|NCT00577629|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110588394|NCT00577629|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110588395|NCT00577629|Antimetabolites|antimetabolites|mesh-ancestor
110588396|NCT00577629|Antiviral Agents|antiviral agents|mesh-ancestor
110588397|NCT00577629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110588398|NCT00733317|Budesonide|budesonide|mesh-list
110588399|NCT00733317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110588400|NCT00733317|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110588401|NCT00733317|Autonomic Agents|autonomic agents|mesh-ancestor
110588402|NCT00733317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110588403|NCT00733317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110588404|NCT00733317|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110588405|NCT00733317|Respiratory System Agents|respiratory system agents|mesh-ancestor
110588406|NCT00733317|Glucocorticoids|glucocorticoids|mesh-ancestor
110588407|NCT00733317|Hormones|hormones|mesh-ancestor
110588408|NCT00733317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110588409|NCT02568735|Etoricoxib|etoricoxib|mesh-list
110588410|NCT02568735|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
110588411|NCT02568735|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110588412|NCT02568735|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110588413|NCT02568735|Analgesics|analgesics|mesh-ancestor
110588414|NCT02568735|Sensory System Agents|sensory system agents|mesh-ancestor
110588415|NCT02568735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110588416|NCT02568735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110228657|NCT03336398|Ketamine|ketamine|mesh-list
110588418|NCT02568735|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110588419|NCT02568735|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110588420|NCT02568735|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110588421|NCT02568735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110588422|NCT02568735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110588423|NCT00733473|Budesonide|budesonide|mesh-list
110588424|NCT00733473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110588425|NCT00733473|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110588426|NCT00733473|Autonomic Agents|autonomic agents|mesh-ancestor
110588427|NCT00733473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110588428|NCT00733473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110588429|NCT00733473|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110588430|NCT00733473|Respiratory System Agents|respiratory system agents|mesh-ancestor
110588431|NCT00733473|Glucocorticoids|glucocorticoids|mesh-ancestor
110588432|NCT00733473|Hormones|hormones|mesh-ancestor
110588433|NCT00733473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110588434|NCT00710385|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
110588435|NCT00710385|Buprenorphine|buprenorphine|mesh-list
110588436|NCT00710385|Heroin|heroin|mesh-list
110588437|NCT00710385|Naloxone|naloxone|mesh-list
110588438|NCT00710385|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110588439|NCT00710385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110588440|NCT00710385|Sensory System Agents|sensory system agents|mesh-ancestor
110588441|NCT00710385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110588442|NCT00710385|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110588443|NCT00710385|Narcotics|narcotics|mesh-ancestor
110588444|NCT00710385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110588445|NCT00710385|Analgesics|analgesics|mesh-ancestor
110588446|NCT04063527|Paclitaxel|paclitaxel|mesh-list
110588447|NCT04063527|Carboplatin|carboplatin|mesh-list
110588448|NCT04063527|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110588449|NCT04063527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110588450|NCT04063527|Tubulin Modulators|tubulin modulators|mesh-ancestor
110588451|NCT04063527|Antimitotic Agents|antimitotic agents|mesh-ancestor
110588452|NCT04063527|Mitosis Modulators|mitosis modulators|mesh-ancestor
110588453|NCT04063527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110588454|NCT00738777|Tamoxifen|tamoxifen|mesh-list
110588455|NCT00738777|Fulvestrant|fulvestrant|mesh-list
110588456|NCT00738777|Anastrozole|anastrozole|mesh-list
110588457|NCT00738777|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110588458|NCT00738777|Hormone Antagonists|hormone antagonists|mesh-ancestor
110588459|NCT00738777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110588460|NCT00738777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110588461|NCT00738777|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110588462|NCT00738777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110588463|NCT00738777|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110588464|NCT00738777|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110588465|NCT00738777|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110228733|NCT03283384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110588466|NCT00738777|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110588467|NCT00738777|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110588468|NCT00738777|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110588469|NCT00738777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110588470|NCT00738777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110588471|NCT00733785|Rosiglitazone|rosiglitazone|mesh-list
110588472|NCT00733785|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110588473|NCT00733785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110588474|NCT04063449|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
110588475|NCT04063449|Endostar protein|endostar protein|mesh-list
110588476|NCT04063449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110588477|NCT04063449|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110588478|NCT04063449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110588479|NCT04063449|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110588480|NCT04063449|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110588481|NCT04063449|Growth Substances|growth substances|mesh-ancestor
110588482|NCT04063449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110588483|NCT04063449|Growth Inhibitors|growth inhibitors|mesh-ancestor
110588484|NCT00700011|Clofarabine|clofarabine|mesh-list
110588485|NCT00700011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110588486|NCT00700011|Antimetabolites|antimetabolites|mesh-ancestor
110588487|NCT00700011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110588488|NCT00700011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110588489|NCT05512767|Capecitabine|capecitabine|mesh-list
110588490|NCT05512767|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110588492|NCT05512767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110588493|NCT05512767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110588495|NCT02567955|Immunologic Factors|immunologic factors|mesh-ancestor
110588496|NCT02567955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110588497|NCT02568423|Mirikizumab|mirikizumab|mesh-list
110588498|NCT02568423|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110588499|NCT02568423|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110588500|NCT02568423|Analgesics|analgesics|mesh-ancestor
110588501|NCT02568423|Sensory System Agents|sensory system agents|mesh-ancestor
110588502|NCT02568423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110588503|NCT02568423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110588504|NCT02568423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110588505|NCT02568423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110588506|NCT02568423|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110588507|NCT02568423|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110588509|NCT00921063|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110588510|NCT00921063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110588511|NCT00921063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110588512|NCT00921063|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110588513|NCT00921063|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110588514|NCT00921063|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110588515|NCT00921063|GABA Modulators|gaba modulators|mesh-ancestor
110588516|NCT00921063|GABA Agents|gaba agents|mesh-ancestor
110588517|NCT00921063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110588518|NCT00921063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110588519|NCT00707031|Metformin|metformin|mesh-list
110588520|NCT00707031|Exenatide|exenatide|mesh-list
110588521|NCT00707031|Lixisenatide|lixisenatide|mesh-list
110588522|NCT00707031|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110588523|NCT00707031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110588524|NCT00707031|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110588525|NCT00707031|Incretins|incretins|mesh-ancestor
110588526|NCT00707031|Hormones|hormones|mesh-ancestor
110588527|NCT00707031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110588528|NCT00711477|Naltrexone|naltrexone|mesh-list
110588529|NCT00711477|Bupropion|bupropion|mesh-list
110588530|NCT00711477|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110588531|NCT00711477|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110588532|NCT00711477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110588533|NCT00711477|Sensory System Agents|sensory system agents|mesh-ancestor
110588534|NCT00711477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110588535|NCT00711477|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110588536|NCT00711477|Antidepressive Agents|antidepressive agents|mesh-ancestor
110588537|NCT00711477|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110588538|NCT00711477|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110588539|NCT00711477|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110588540|NCT00711477|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110588541|NCT00711477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110228821|NCT03182244|Analgesics|analgesics|mesh-ancestor
110588542|NCT00711477|Dopamine Agents|dopamine agents|mesh-ancestor
110588543|NCT00711477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110588544|NCT00711477|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110588545|NCT00711477|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110588546|NCT00711477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110588547|NCT00734474|Metformin|metformin|mesh-list
110588548|NCT00734474|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110588549|NCT00734474|Dulaglutide|dulaglutide|mesh-list
110588550|NCT00734474|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110588551|NCT00734474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110588552|NCT00734474|Incretins|incretins|mesh-ancestor
110588553|NCT00734474|Hormones|hormones|mesh-ancestor
110150119|NCT00008125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110588554|NCT00734474|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110588555|NCT00734474|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110588556|NCT00734474|Protease Inhibitors|protease inhibitors|mesh-ancestor
110588557|NCT00734474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110588558|NCT00734474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110588559|NCT00583362|Belimumab|belimumab|mesh-list
110588560|NCT00583362|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110588561|NCT00583362|Immunologic Factors|immunologic factors|mesh-ancestor
110588562|NCT00583362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110588563|NCT00577473|Mesalamine|mesalamine|mesh-list
110228857|NCT03118492|Melphalan|melphalan|mesh-list
110588564|NCT00577473|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110588565|NCT00577473|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110588566|NCT00577473|Analgesics|analgesics|mesh-ancestor
110588567|NCT00577473|Sensory System Agents|sensory system agents|mesh-ancestor
110588568|NCT00577473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110588569|NCT00577473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110588570|NCT00577473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110588571|NCT00577473|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110588573|NCT00740103|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110588574|NCT00740103|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110588575|NCT00740103|Analgesics|analgesics|mesh-ancestor
110588576|NCT00740103|Sensory System Agents|sensory system agents|mesh-ancestor
110588577|NCT00740103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110588578|NCT00740103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110588579|NCT00740103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110588580|NCT00740103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110588581|NCT00740103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110588582|NCT00740103|Immunologic Factors|immunologic factors|mesh-ancestor
110588583|NCT02583828|Cyclophosphamide|cyclophosphamide|mesh-list
110588585|NCT02583828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110588586|NCT02583828|Immunologic Factors|immunologic factors|mesh-ancestor
110588587|NCT02583828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110588588|NCT02583828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110588589|NCT02583828|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110588590|NCT02583828|Alkylating Agents|alkylating agents|mesh-ancestor
110228904|NCT02886962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110588591|NCT02583828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110588592|NCT02583828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110588593|NCT02583828|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110588594|NCT02583828|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110588595|NCT02583828|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110588596|NCT02583828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110588597|NCT02583828|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110588598|NCT02583828|Hormone Antagonists|hormone antagonists|mesh-ancestor
110588599|NCT02583828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110588600|NCT02568111|Interferons|interferons|mesh-list
110588601|NCT02568111|Interferon-beta|interferon-beta|mesh-list
110588602|NCT02568111|Interferon beta-1a|interferon beta-1a|mesh-list
110588603|NCT02568111|Brimonidine Tartrate|brimonidine tartrate|mesh-list
110588604|NCT02568111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110588605|NCT02568111|Antiviral Agents|antiviral agents|mesh-ancestor
110588606|NCT02568111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110588607|NCT02568111|Immunologic Factors|immunologic factors|mesh-ancestor
110588608|NCT02568111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110588609|NCT02568111|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110588610|NCT02568111|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110588611|NCT02568111|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110588612|NCT02568111|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110588613|NCT02568111|Adrenergic Agents|adrenergic agents|mesh-ancestor
110588614|NCT02568111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110376438|NCT02210754|Menthol|menthol|mesh-list
110588615|NCT02568111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110588616|NCT02568111|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110588617|NCT05711667|Acetic Acid|acetic acid|mesh-list
110588618|NCT05711667|Letermovir|letermovir|mesh-list
110588619|NCT05711667|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110588620|NCT05711667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110588621|NCT05711667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110228963|NCT02741323|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110588622|NCT05711667|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110588624|NCT05711667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110588625|NCT05711667|Antiviral Agents|antiviral agents|mesh-ancestor
110588626|NCT00785291|Paclitaxel|paclitaxel|mesh-list
110588627|NCT00785291|Epothilones|epothilones|mesh-list
110588628|NCT00785291|Epothilone B|epothilone b|mesh-list
110588629|NCT00785291|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110588630|NCT00785291|Bevacizumab|bevacizumab|mesh-list
110588631|NCT00785291|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110588632|NCT00785291|Endothelial Growth Factors|endothelial growth factors|mesh-list
110588633|NCT00785291|Antibodies|antibodies|mesh-list
110588634|NCT00785291|Immunoglobulins|immunoglobulins|mesh-list
110588635|NCT00785291|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110588636|NCT00785291|Immunoglobulin G|immunoglobulin g|mesh-list
110588637|NCT00785291|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110588638|NCT00785291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110588639|NCT00785291|Tubulin Modulators|tubulin modulators|mesh-ancestor
110588640|NCT00785291|Antimitotic Agents|antimitotic agents|mesh-ancestor
110588641|NCT00785291|Mitosis Modulators|mitosis modulators|mesh-ancestor
110588642|NCT00785291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110588643|NCT00785291|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110588644|NCT00785291|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110588645|NCT00785291|Growth Substances|growth substances|mesh-ancestor
110588646|NCT00785291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110588647|NCT00785291|Growth Inhibitors|growth inhibitors|mesh-ancestor
110588648|NCT00785291|Immunologic Factors|immunologic factors|mesh-ancestor
110588649|NCT00740259|Flunarizine|flunarizine|mesh-list
110588650|NCT00740259|Anticonvulsants|anticonvulsants|mesh-ancestor
110588651|NCT00740259|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110588652|NCT00740259|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110588653|NCT00740259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110588654|NCT00740259|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110588655|NCT00740259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110588656|NCT00740259|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110588657|NCT00740259|Histamine Antagonists|histamine antagonists|mesh-ancestor
110588658|NCT00740259|Histamine Agents|histamine agents|mesh-ancestor
110588659|NCT00740259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110588660|NCT00740259|Vasodilator Agents|vasodilator agents|mesh-ancestor
110588661|NCT04063839|Sofosbuvir|sofosbuvir|mesh-list
110588662|NCT04063839|Grazoprevir|grazoprevir|mesh-list
110588663|NCT04063839|Ledipasvir|ledipasvir|mesh-list
110588664|NCT04063839|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
110588665|NCT04063839|Antiviral Agents|antiviral agents|mesh-ancestor
110588666|NCT04063839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110588667|NCT00785213|Rosiglitazone|rosiglitazone|mesh-list
110588668|NCT00785213|Quinine|quinine|mesh-list
110588669|NCT00785213|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110588670|NCT00785213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110588671|NCT00785213|Antimalarials|antimalarials|mesh-ancestor
110588672|NCT00785213|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110588673|NCT00785213|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110588674|NCT00785213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110588675|NCT00785213|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110588676|NCT00785213|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110588677|NCT00785213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110588678|NCT00785213|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110588680|NCT00785213|Sensory System Agents|sensory system agents|mesh-ancestor
110588681|NCT02583594|Loratadine|loratadine|mesh-list
110588682|NCT02583594|Acyclovir|acyclovir|mesh-list
110588683|NCT02583594|Methylprednisolone|methylprednisolone|mesh-list
110588684|NCT02583594|Alemtuzumab|alemtuzumab|mesh-list
110588685|NCT02583594|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
110588686|NCT02583594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110588687|NCT02583594|Antiemetics|antiemetics|mesh-ancestor
110588688|NCT02583594|Autonomic Agents|autonomic agents|mesh-ancestor
110588689|NCT02583594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110588690|NCT02583594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110588691|NCT02583594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110588692|NCT02583594|Glucocorticoids|glucocorticoids|mesh-ancestor
110588694|NCT02583594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110588695|NCT02583594|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110588696|NCT02583594|Protective Agents|protective agents|mesh-ancestor
110588697|NCT02583594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110588698|NCT02583594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110588699|NCT02583594|Antiviral Agents|antiviral agents|mesh-ancestor
110588700|NCT02583594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110588701|NCT02583594|Antipruritics|antipruritics|mesh-ancestor
110588702|NCT02583594|Dermatologic Agents|dermatologic agents|mesh-ancestor
110588703|NCT02583594|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110588704|NCT02583594|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110588705|NCT02583594|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110588706|NCT02583594|Histamine Antagonists|histamine antagonists|mesh-ancestor
110588707|NCT02583594|Histamine Agents|histamine agents|mesh-ancestor
110588708|NCT02583594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110588709|NCT02583594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110588710|NCT00740415|Dexamethasone|dexamethasone|mesh-list
110588711|NCT00740415|Rituximab|rituximab|mesh-list
110588712|NCT00740415|Bortezomib|bortezomib|mesh-list
110588713|NCT00740415|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110588714|NCT00740415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110588715|NCT00740415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110588716|NCT00740415|Immunologic Factors|immunologic factors|mesh-ancestor
110588717|NCT00740415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110588718|NCT00740415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110588719|NCT00740415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110588720|NCT00740415|Antiemetics|antiemetics|mesh-ancestor
110588721|NCT00740415|Autonomic Agents|autonomic agents|mesh-ancestor
110588722|NCT00740415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110588723|NCT00740415|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110588724|NCT00740415|Glucocorticoids|glucocorticoids|mesh-ancestor
110588725|NCT00740415|Hormones|hormones|mesh-ancestor
110588726|NCT00740415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110588727|NCT00740415|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110229092|NCT02395497|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110588728|NCT00740415|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110588729|NCT00740415|Alkylating Agents|alkylating agents|mesh-ancestor
110588730|NCT00740415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110588731|NCT00734162|Tenofovir|tenofovir|mesh-list
110588732|NCT00734162|Antiviral Agents|antiviral agents|mesh-ancestor
110588733|NCT00734162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110588734|NCT00734162|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110588735|NCT00734162|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110588737|NCT00734162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110588738|NCT00734162|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110588739|NCT00734162|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110588740|NCT00740493|Warfarin|warfarin|mesh-list
110588741|NCT00740493|Anticoagulants|anticoagulants|mesh-ancestor
110588742|NCT00740571|Pregabalin|pregabalin|mesh-list
110588743|NCT00740571|Amitriptyline|amitriptyline|mesh-list
110588744|NCT00740571|Analgesics|analgesics|mesh-ancestor
110588745|NCT00740571|Sensory System Agents|sensory system agents|mesh-ancestor
110588746|NCT00740571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110588747|NCT00740571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110588748|NCT00740571|Anticonvulsants|anticonvulsants|mesh-ancestor
110588749|NCT00740571|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110588750|NCT00740571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110588751|NCT00740571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110588752|NCT00740571|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110588753|NCT00740571|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110588754|NCT00740571|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110588755|NCT00740571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110588756|NCT00740571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110588757|NCT00740571|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110588758|NCT00740571|Antidepressive Agents|antidepressive agents|mesh-ancestor
110588759|NCT00740571|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110588760|NCT00740571|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110588761|NCT00740571|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110588762|NCT00740571|Adrenergic Agents|adrenergic agents|mesh-ancestor
110588763|NCT00740571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110588764|NCT00784979|Immunoglobulins|immunoglobulins|mesh-list
110588765|NCT00784979|Immunologic Factors|immunologic factors|mesh-ancestor
110588766|NCT00784979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110588768|NCT02595242|Cyclophosphamide|cyclophosphamide|mesh-list
110588769|NCT02595242|Vincristine|vincristine|mesh-list
110588770|NCT02595242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110588771|NCT02595242|Immunologic Factors|immunologic factors|mesh-ancestor
110588772|NCT02595242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110588773|NCT02595242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110588774|NCT02595242|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110588775|NCT02595242|Alkylating Agents|alkylating agents|mesh-ancestor
110588776|NCT02595242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110588777|NCT02595242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110588778|NCT02595242|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110588779|NCT02595242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110588780|NCT02595242|Glucocorticoids|glucocorticoids|mesh-ancestor
110588781|NCT02595242|Hormones|hormones|mesh-ancestor
110588782|NCT02595242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110588783|NCT02595242|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110588784|NCT02595242|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110588785|NCT02595242|Tubulin Modulators|tubulin modulators|mesh-ancestor
110588786|NCT02595242|Antimitotic Agents|antimitotic agents|mesh-ancestor
110588787|NCT02595242|Mitosis Modulators|mitosis modulators|mesh-ancestor
110588788|NCT04487106|Azacitidine|azacitidine|mesh-list
110588789|NCT04487106|Venetoclax|venetoclax|mesh-list
110588790|NCT04487106|Trametinib|trametinib|mesh-list
110588791|NCT04487106|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110588792|NCT04487106|Antimetabolites|antimetabolites|mesh-ancestor
110588793|NCT04487106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110588794|NCT04487106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110588795|NCT04487106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110588796|NCT04487106|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110588797|NCT00740883|Warfarin|warfarin|mesh-list
110588798|NCT00740883|Anticoagulants|anticoagulants|mesh-ancestor
110588799|NCT02568033|Paclitaxel|paclitaxel|mesh-list
110588800|NCT02568033|Docetaxel|docetaxel|mesh-list
110588801|NCT02568033|Carboplatin|carboplatin|mesh-list
110588802|NCT02568033|Pemetrexed|pemetrexed|mesh-list
110588803|NCT02568033|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110588804|NCT02568033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110588805|NCT02568033|Tubulin Modulators|tubulin modulators|mesh-ancestor
110588806|NCT02568033|Antimitotic Agents|antimitotic agents|mesh-ancestor
110588807|NCT02568033|Mitosis Modulators|mitosis modulators|mesh-ancestor
110236195|NCT00402636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110588808|NCT02568033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110588809|NCT02568033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110588810|NCT02568033|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110588811|NCT02568033|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110588812|NCT00582972|Omeprazole|omeprazole|mesh-list
110588813|NCT00582972|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110588814|NCT00582972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110588815|NCT00582972|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110588816|NCT00582972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110588817|NCT00582972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110588818|NCT05224401|Amoxicillin|amoxicillin|mesh-list
110588819|NCT05224401|Ciprofloxacin|ciprofloxacin|mesh-list
110229214|NCT01861106|Fludarabine|fludarabine|mesh-list
110588820|NCT05224401|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
110588821|NCT05224401|Clavulanic Acids|clavulanic acids|mesh-list
110588822|NCT05224401|Clavulanic Acid|clavulanic acid|mesh-list
110588823|NCT05224401|Ertapenem|ertapenem|mesh-list
110588824|NCT05224401|Amdinocillin Pivoxil|amdinocillin pivoxil|mesh-list
110588825|NCT05224401|Trimethoprim|trimethoprim|mesh-list
110588826|NCT05224401|Sulfamethoxazole|sulfamethoxazole|mesh-list
110588827|NCT05224401|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110588828|NCT05224401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110588829|NCT05224401|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110588830|NCT05224401|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110588831|NCT05224401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110588832|NCT05224401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110588833|NCT05224401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110588834|NCT05224401|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110588835|NCT05224401|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110588836|NCT05224401|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110588837|NCT05224401|Antimalarials|antimalarials|mesh-ancestor
110588838|NCT05224401|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110588839|NCT05224401|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110588840|NCT05224401|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110588841|NCT05224401|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110588842|NCT05224401|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
110588843|NCT05224401|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110588845|NCT00918086|Vitamins|vitamins|mesh-ancestor
110588846|NCT00918086|Micronutrients|micronutrients|mesh-ancestor
110588847|NCT00918086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110588848|NCT00918086|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110588849|NCT02567487|Levobupivacaine|levobupivacaine|mesh-list
110588850|NCT02567487|Anesthetics, Local|anesthetics, local|mesh-ancestor
110588851|NCT02567487|Anesthetics|anesthetics|mesh-ancestor
110588852|NCT02567487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110588853|NCT02567487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110588854|NCT02567487|Sensory System Agents|sensory system agents|mesh-ancestor
110588855|NCT02567487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110588856|NCT04317066|Pembrolizumab|pembrolizumab|mesh-list
110588857|NCT04317066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110588858|NCT04317066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110588859|NCT04317066|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110588860|NCT04317066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110588861|NCT04366908|Calcifediol|calcifediol|mesh-list
110588862|NCT04366908|Vitamins|vitamins|mesh-ancestor
110588863|NCT04366908|Micronutrients|micronutrients|mesh-ancestor
110588864|NCT04366908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110588865|NCT04366908|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110588866|NCT00711243|Docetaxel|docetaxel|mesh-list
110588867|NCT00711243|Fluorouracil|fluorouracil|mesh-list
110588869|NCT00711243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110588871|NCT00711243|Antimitotic Agents|antimitotic agents|mesh-ancestor
110588872|NCT00711243|Mitosis Modulators|mitosis modulators|mesh-ancestor
110588873|NCT00711243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110588874|NCT00711243|Antimetabolites|antimetabolites|mesh-ancestor
110588875|NCT00711243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110588876|NCT00711243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110588877|NCT00711243|Immunologic Factors|immunologic factors|mesh-ancestor
110588878|NCT00711243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110588879|NCT04366518|Scopolamine|scopolamine|mesh-list
110588880|NCT04366518|Rivastigmine|rivastigmine|mesh-list
110588881|NCT04366518|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
110236279|NCT00127959|Tenofovir|tenofovir|mesh-list
110588882|NCT04366518|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110588883|NCT04366518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110588884|NCT04366518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110588885|NCT04366518|Cholinergic Agents|cholinergic agents|mesh-ancestor
110588886|NCT04366518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110588887|NCT04366518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110588888|NCT04366518|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110588889|NCT04366518|Protective Agents|protective agents|mesh-ancestor
110588890|NCT04366518|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110588891|NCT04366518|Antiemetics|antiemetics|mesh-ancestor
110588892|NCT04366518|Autonomic Agents|autonomic agents|mesh-ancestor
110588893|NCT04366518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110588894|NCT04366518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110588895|NCT04366518|Mydriatics|mydriatics|mesh-ancestor
110588896|NCT04366518|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110588897|NCT04366518|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110588898|NCT04366518|Parasympatholytics|parasympatholytics|mesh-ancestor
110588899|NCT00733226|Broncho-Vaxom|broncho-vaxom|mesh-list
110588900|NCT00733226|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110588901|NCT00733226|Immunologic Factors|immunologic factors|mesh-ancestor
110588902|NCT00733226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110588903|NCT04076436|Fosfomycin|fosfomycin|mesh-list
110588904|NCT04076436|Lactams|lactams|mesh-list
110588905|NCT04076436|beta-Lactams|beta-lactams|mesh-list
110588906|NCT04076436|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110588907|NCT04076436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110588908|NCT05526417|Coal Tar|coal tar|mesh-list
110588909|NCT05526417|Keratolytic Agents|keratolytic agents|mesh-ancestor
110588910|NCT05526417|Dermatologic Agents|dermatologic agents|mesh-ancestor
110588911|NCT04096170|Lidocaine|lidocaine|mesh-list
110588912|NCT04096170|Anesthetics, Local|anesthetics, local|mesh-ancestor
110588913|NCT04096170|Anesthetics|anesthetics|mesh-ancestor
110588914|NCT04096170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110588915|NCT04096170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110588916|NCT04096170|Sensory System Agents|sensory system agents|mesh-ancestor
110588917|NCT04096170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110588918|NCT04096170|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110588919|NCT04096170|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110588920|NCT04096170|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110588921|NCT04096170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110588922|NCT04096170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110588923|NCT00741117|Bilirubin|bilirubin|mesh-list
110588924|NCT00741117|Antioxidants|antioxidants|mesh-ancestor
110588925|NCT00741117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110588926|NCT00741117|Protective Agents|protective agents|mesh-ancestor
110588927|NCT00741117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110588928|NCT00732992|Pemetrexed|pemetrexed|mesh-list
110588929|NCT00732992|Sunitinib|sunitinib|mesh-list
110588930|NCT00732992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110588931|NCT00732992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110588932|NCT00732992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110588933|NCT00732992|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110588934|NCT00732992|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110588935|NCT00732992|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110588936|NCT00732992|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110588937|NCT00732992|Growth Substances|growth substances|mesh-ancestor
110588938|NCT00732992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110588939|NCT00732992|Growth Inhibitors|growth inhibitors|mesh-ancestor
110588940|NCT00732992|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110588941|NCT00741195|Bevacizumab|bevacizumab|mesh-list
110588942|NCT00741195|Docetaxel|docetaxel|mesh-list
110588943|NCT00741195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110588944|NCT00741195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110588945|NCT00741195|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110588946|NCT00741195|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110588947|NCT00741195|Growth Substances|growth substances|mesh-ancestor
110588948|NCT00741195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110588949|NCT00741195|Growth Inhibitors|growth inhibitors|mesh-ancestor
110588950|NCT00741195|Tubulin Modulators|tubulin modulators|mesh-ancestor
110588951|NCT00741195|Antimitotic Agents|antimitotic agents|mesh-ancestor
110588952|NCT00741195|Mitosis Modulators|mitosis modulators|mesh-ancestor
110588953|NCT00741195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110588954|NCT05338632|Naloxone|naloxone|mesh-list
110588955|NCT05338632|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110588956|NCT05338632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110229296|NCT01445509|Growth Inhibitors|growth inhibitors|mesh-ancestor
110588957|NCT05338632|Sensory System Agents|sensory system agents|mesh-ancestor
110588958|NCT05338632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110588959|NCT00732758|Vitamin D|vitamin d|mesh-list
110588960|NCT00732758|Cholecalciferol|cholecalciferol|mesh-list
110588961|NCT00732758|Vitamins|vitamins|mesh-ancestor
110588962|NCT00732758|Micronutrients|micronutrients|mesh-ancestor
110588963|NCT00732758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110588964|NCT00732758|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110588965|NCT00732758|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110588966|NCT00741351|Fentanyl|fentanyl|mesh-list
110588967|NCT00741351|Remifentanil|remifentanil|mesh-list
110588968|NCT00741351|Propofol|propofol|mesh-list
110588969|NCT00741351|Sevoflurane|sevoflurane|mesh-list
110588970|NCT00741351|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110588971|NCT00741351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110588972|NCT00741351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110588973|NCT00741351|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110588974|NCT00741351|Anesthetics, General|anesthetics, general|mesh-ancestor
110588975|NCT00741351|Anesthetics|anesthetics|mesh-ancestor
110588976|NCT00741351|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110588977|NCT00741351|Narcotics|narcotics|mesh-ancestor
110588978|NCT00741351|Analgesics|analgesics|mesh-ancestor
110588979|NCT00741351|Sensory System Agents|sensory system agents|mesh-ancestor
110588980|NCT00741351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110588981|NCT00741351|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110588982|NCT00741351|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110588983|NCT00741351|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110588985|NCT02582190|Gout Suppressants|gout suppressants|mesh-ancestor
110588986|NCT02582190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110588987|NCT02582190|Tubulin Modulators|tubulin modulators|mesh-ancestor
110588988|NCT02582190|Antimitotic Agents|antimitotic agents|mesh-ancestor
110588989|NCT02582190|Mitosis Modulators|mitosis modulators|mesh-ancestor
110588990|NCT02582190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110588991|NCT02582190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110588992|NCT00699153|Loteprednol Etabonate|loteprednol etabonate|mesh-list
110588993|NCT00699153|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110588994|NCT05742243|Insulin|insulin|mesh-list
110588995|NCT05742243|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110588996|NCT05742243|Abatacept|abatacept|mesh-list
110588997|NCT05742243|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110588998|NCT05742243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110588999|NCT05742243|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110589000|NCT05742243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110589001|NCT05742243|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110589002|NCT05742243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110229395|NCT00694850|Riociguat|riociguat|mesh-list
110589003|NCT05742243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110589004|NCT05742243|Immunologic Factors|immunologic factors|mesh-ancestor
110589005|NCT05742243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110589006|NCT04076748|Sufentanil|sufentanil|mesh-list
110589007|NCT04076748|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110589008|NCT04076748|Narcotics|narcotics|mesh-ancestor
110589009|NCT04076748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110589010|NCT04076748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110589011|NCT04076748|Analgesics|analgesics|mesh-ancestor
110589012|NCT04076748|Sensory System Agents|sensory system agents|mesh-ancestor
110589013|NCT04076748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110589014|NCT04076748|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110589015|NCT04076748|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110589016|NCT04076748|Anesthetics, General|anesthetics, general|mesh-ancestor
110589017|NCT04076748|Anesthetics|anesthetics|mesh-ancestor
110589018|NCT00711087|Botulinum Toxins|botulinum toxins|mesh-list
110589019|NCT00711087|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110589020|NCT00711087|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110589021|NCT00711087|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110589022|NCT00711087|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110589023|NCT00711087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110589024|NCT00711087|Cholinergic Agents|cholinergic agents|mesh-ancestor
110589025|NCT00711087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110589026|NCT00711087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110589027|NCT00711087|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110589028|NCT00711087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110589035|NCT04255602|Ticagrelor|ticagrelor|mesh-list
110589036|NCT04255602|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110589037|NCT04255602|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110589038|NCT04255602|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110589039|NCT04255602|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110589041|NCT04255602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110589042|NCT04255602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110589043|NCT04255602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110589044|NCT00738530|Interferons|interferons|mesh-list
110589045|NCT00738530|Interferon-alpha|interferon-alpha|mesh-list
110589046|NCT00738530|Interferon alpha-2|interferon alpha-2|mesh-list
110589047|NCT00738530|Bevacizumab|bevacizumab|mesh-list
110589048|NCT00738530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110589049|NCT00738530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110589050|NCT00738530|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110589051|NCT00738530|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110589052|NCT00738530|Growth Substances|growth substances|mesh-ancestor
110589053|NCT00738530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110589054|NCT00738530|Growth Inhibitors|growth inhibitors|mesh-ancestor
110589055|NCT00738530|Antiviral Agents|antiviral agents|mesh-ancestor
110589056|NCT00738530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110589057|NCT00738530|Immunologic Factors|immunologic factors|mesh-ancestor
110589058|NCT04077684|Interleukin-2|interleukin-2|mesh-list
110589059|NCT04077684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110589060|NCT04077684|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110589061|NCT04077684|Analgesics|analgesics|mesh-ancestor
110589062|NCT04077684|Sensory System Agents|sensory system agents|mesh-ancestor
110589063|NCT04077684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110589064|NCT04077684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110589065|NCT00711009|Ritonavir|ritonavir|mesh-list
110589066|NCT00711009|Lopinavir|lopinavir|mesh-list
110589067|NCT00711009|Tenofovir|tenofovir|mesh-list
110589068|NCT00711009|Emtricitabine|emtricitabine|mesh-list
110589069|NCT00711009|Raltegravir Potassium|raltegravir potassium|mesh-list
110589070|NCT00711009|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110589071|NCT00711009|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110589072|NCT00711009|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110589073|NCT00711009|Protease Inhibitors|protease inhibitors|mesh-ancestor
110589074|NCT00711009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110589075|NCT00711009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110589076|NCT00711009|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110150209|NCT00008398|Sargramostim|sargramostim|mesh-list
110589077|NCT00711009|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110589078|NCT00711009|Antiviral Agents|antiviral agents|mesh-ancestor
110589079|NCT00711009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110589080|NCT00711009|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110589081|NCT00711009|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110589082|NCT00711009|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110589083|NCT00711009|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110589084|NCT00711009|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110589085|NCT00711009|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110589087|NCT02567799|Carboplatin|carboplatin|mesh-list
110589088|NCT02567799|Genistein|genistein|mesh-list
110589089|NCT02567799|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110589090|NCT02567799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110589091|NCT02567799|Tubulin Modulators|tubulin modulators|mesh-ancestor
110589092|NCT02567799|Antimitotic Agents|antimitotic agents|mesh-ancestor
110589093|NCT02567799|Mitosis Modulators|mitosis modulators|mesh-ancestor
110589094|NCT02567799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110589095|NCT02567799|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110589096|NCT02567799|Protective Agents|protective agents|mesh-ancestor
110589097|NCT02567799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110589098|NCT02567799|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110589099|NCT02567799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110589100|NCT02567799|Phytoestrogens|phytoestrogens|mesh-ancestor
110589101|NCT02567799|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
110589102|NCT02567799|Estrogens|estrogens|mesh-ancestor
110589103|NCT02567799|Hormones|hormones|mesh-ancestor
110589104|NCT02567799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110589105|NCT00921219|Ivermectin|ivermectin|mesh-list
110589106|NCT00921219|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110589107|NCT00921219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110589108|NCT02567331|Capecitabine|capecitabine|mesh-list
110589109|NCT02567331|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110589110|NCT02567331|Antimetabolites|antimetabolites|mesh-ancestor
110589111|NCT02567331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110589112|NCT02567331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110589113|NCT00577005|Levetiracetam|levetiracetam|mesh-list
110589114|NCT00577005|Anticonvulsants|anticonvulsants|mesh-ancestor
110589115|NCT00577005|Nootropic Agents|nootropic agents|mesh-ancestor
110589116|NCT02581566|Dexmedetomidine|dexmedetomidine|mesh-list
110589117|NCT02581566|Bupivacaine|bupivacaine|mesh-list
110589118|NCT02581566|Anesthetics, Local|anesthetics, local|mesh-ancestor
110589119|NCT02581566|Anesthetics|anesthetics|mesh-ancestor
110589120|NCT02581566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110589121|NCT02581566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110589122|NCT02581566|Sensory System Agents|sensory system agents|mesh-ancestor
110589123|NCT02581566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110229594|NCT04984070|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110589125|NCT02581566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110589126|NCT02581566|Analgesics|analgesics|mesh-ancestor
110589127|NCT02581566|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110589128|NCT02581566|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110589129|NCT02581566|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110589130|NCT02581566|Adrenergic Agents|adrenergic agents|mesh-ancestor
110589131|NCT02581566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110589132|NCT02581566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110589133|NCT04003506|Bupivacaine|bupivacaine|mesh-list
110589134|NCT04003506|Anesthetics, Local|anesthetics, local|mesh-ancestor
110589135|NCT04003506|Anesthetics|anesthetics|mesh-ancestor
110589136|NCT04003506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110589137|NCT04003506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110589138|NCT04003506|Sensory System Agents|sensory system agents|mesh-ancestor
110589139|NCT04003506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110589140|NCT00698841|Cetuximab|cetuximab|mesh-list
110589141|NCT00698841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110589142|NCT00698841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110150221|NCT00008515|Hormones|hormones|mesh-ancestor
110589143|NCT00577395|Risedronic Acid|risedronic acid|mesh-list
110589144|NCT00577395|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110589145|NCT00577395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110589146|NCT00577395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110589147|NCT00577395|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110589148|NCT00577395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110589149|NCT00577395|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110589151|NCT04062357|Anesthetics, Local|anesthetics, local|mesh-ancestor
110589153|NCT04062357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110589154|NCT04062357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110589155|NCT04062357|Sensory System Agents|sensory system agents|mesh-ancestor
110589156|NCT04062357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110589157|NCT04062357|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110589158|NCT04062357|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110589159|NCT04062357|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110589160|NCT04062357|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110589161|NCT04062357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110589162|NCT05190120|Ropivacaine|ropivacaine|mesh-list
110589163|NCT05190120|Anesthetics, Local|anesthetics, local|mesh-ancestor
110589164|NCT05190120|Anesthetics|anesthetics|mesh-ancestor
110589165|NCT05190120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110589166|NCT05190120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110589167|NCT05190120|Sensory System Agents|sensory system agents|mesh-ancestor
110589168|NCT05190120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110589169|NCT00738374|Rituximab|rituximab|mesh-list
110589170|NCT00738374|Chlorambucil|chlorambucil|mesh-list
110229764|NCT04928339|Anesthetics, Local|anesthetics, local|mesh-ancestor
110589171|NCT00738374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110589172|NCT00738374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110589173|NCT00738374|Immunologic Factors|immunologic factors|mesh-ancestor
110589174|NCT00738374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110589175|NCT00738374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110589176|NCT00738374|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110589177|NCT00738374|Alkylating Agents|alkylating agents|mesh-ancestor
110589178|NCT00738374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110589179|NCT02581176|Apixaban|apixaban|mesh-list
110589180|NCT02581176|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110589181|NCT02581176|Antithrombins|antithrombins|mesh-ancestor
110589182|NCT02581176|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110589183|NCT02581176|Protease Inhibitors|protease inhibitors|mesh-ancestor
110589184|NCT02581176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110589185|NCT02581176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110589186|NCT02581176|Anticoagulants|anticoagulants|mesh-ancestor
110589187|NCT00697593|Antibodies|antibodies|mesh-list
110589188|NCT00697593|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110589189|NCT00697593|Immunologic Factors|immunologic factors|mesh-ancestor
110589190|NCT00697593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110589191|NCT04075578|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110589192|NCT04075578|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110589193|NCT04075578|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110589194|NCT04075578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110589195|NCT04075578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110589196|NCT04075578|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110229821|NCT00313885|SR 46349B|sr 46349b|mesh-list
110589197|NCT04075578|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110589198|NCT04075578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110589199|NCT04075578|Cholinergic Agents|cholinergic agents|mesh-ancestor
110589200|NCT04075578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110589201|NCT04445025|Leuprolide|leuprolide|mesh-list
110589202|NCT04445025|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110589203|NCT04445025|Fertility Agents|fertility agents|mesh-ancestor
110589204|NCT04445025|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110589205|NCT04445025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110589206|NCT04445025|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110589207|NCT04445025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110589208|NCT02580474|Asunaprevir|asunaprevir|mesh-list
110589209|NCT02580474|Protease Inhibitors|protease inhibitors|mesh-ancestor
110589210|NCT02580474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110589211|NCT02580474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110589217|NCT00738062|Droxidopa|droxidopa|mesh-list
110589218|NCT00738062|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110589219|NCT00738062|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110589220|NCT04156074|Vitamin D|vitamin d|mesh-list
110589221|NCT04156074|Ergocalciferols|ergocalciferols|mesh-list
110589222|NCT04156074|Cholecalciferol|cholecalciferol|mesh-list
110589223|NCT04156074|Vitamins|vitamins|mesh-list
110229870|NCT00122811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110229871|NCT00122811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110229872|NCT00122811|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110229873|NCT00122811|Diuretics|diuretics|mesh-ancestor
110229874|NCT00122811|Natriuretic Agents|natriuretic agents|mesh-ancestor
110229875|NCT00122811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110229876|NCT00122811|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110589224|NCT04156074|Micronutrients|micronutrients|mesh-ancestor
110589225|NCT04156074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110589226|NCT04156074|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110589227|NCT04156074|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110589228|NCT04062045|Ropivacaine|ropivacaine|mesh-list
110589229|NCT04062045|Anesthetics, Local|anesthetics, local|mesh-ancestor
110589230|NCT04062045|Anesthetics|anesthetics|mesh-ancestor
110589231|NCT04062045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110589232|NCT04062045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110589233|NCT04062045|Sensory System Agents|sensory system agents|mesh-ancestor
110589234|NCT04062045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110589235|NCT04064073|Metformin|metformin|mesh-list
110589236|NCT04064073|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110589237|NCT04064073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110589238|NCT04137354|Vitamins|vitamins|mesh-list
110589239|NCT04137354|Vitamin A|vitamin a|mesh-list
110589240|NCT04137354|Iron|iron|mesh-list
110589241|NCT04137354|Retinol palmitate|retinol palmitate|mesh-list
110589242|NCT04137354|Micronutrients|micronutrients|mesh-ancestor
110589243|NCT04137354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110589244|NCT04137354|Trace Elements|trace elements|mesh-ancestor
110229925|NCT00091377|Paclitaxel|paclitaxel|mesh-list
110376505|NCT04991103|Growth Substances|growth substances|mesh-ancestor
110589246|NCT04137354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110589247|NCT04137354|Protective Agents|protective agents|mesh-ancestor
110589248|NCT04137354|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110589249|NCT04137354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110589250|NCT04902729|Oxytocin|oxytocin|mesh-list
110589251|NCT04902729|Carbetocin|carbetocin|mesh-list
110589252|NCT04902729|Oxytocics|oxytocics|mesh-ancestor
110589253|NCT04902729|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110589254|NCT04902729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110589255|NCT03498378|Cetuximab|cetuximab|mesh-list
110589256|NCT03498378|Avelumab|avelumab|mesh-list
110589257|NCT03498378|Palbociclib|palbociclib|mesh-list
110589258|NCT03498378|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110589259|NCT03498378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110229966|NCT04729868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110589260|NCT03498378|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110150253|NCT05636566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110589262|NCT03498378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110589264|NCT00698685|Pentostatin|pentostatin|mesh-list
110589265|NCT00698685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110589266|NCT00698685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110589267|NCT00698685|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
110589268|NCT00698685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110589269|NCT00698685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110589270|NCT00737438|Bevacizumab|bevacizumab|mesh-list
110589271|NCT00737438|Docetaxel|docetaxel|mesh-list
110589272|NCT00737438|Capecitabine|capecitabine|mesh-list
110589273|NCT00737438|Irinotecan|irinotecan|mesh-list
110589274|NCT00737438|Epirubicin|epirubicin|mesh-list
110589275|NCT00737438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110589276|NCT00737438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110589277|NCT00737438|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110589278|NCT00737438|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110589279|NCT00737438|Growth Substances|growth substances|mesh-ancestor
110589280|NCT00737438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110589281|NCT00737438|Growth Inhibitors|growth inhibitors|mesh-ancestor
110589282|NCT00737438|Tubulin Modulators|tubulin modulators|mesh-ancestor
110589283|NCT00737438|Antimitotic Agents|antimitotic agents|mesh-ancestor
110589284|NCT00737438|Mitosis Modulators|mitosis modulators|mesh-ancestor
110589285|NCT00737438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110589286|NCT00737438|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110589287|NCT00737438|Antimetabolites|antimetabolites|mesh-ancestor
110589288|NCT00737438|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110589289|NCT00737438|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110589290|NCT00737438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110589291|NCT00737438|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110589292|NCT00737438|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110589293|NCT00737048|Acetaminophen|acetaminophen|mesh-list
110589294|NCT00737048|Tramadol|tramadol|mesh-list
110589295|NCT00737048|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110589296|NCT00737048|Analgesics|analgesics|mesh-ancestor
110589297|NCT00737048|Sensory System Agents|sensory system agents|mesh-ancestor
110589298|NCT00737048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110589299|NCT00737048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110589300|NCT00737048|Antipyretics|antipyretics|mesh-ancestor
110589301|NCT00737048|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110589302|NCT00737048|Narcotics|narcotics|mesh-ancestor
110589303|NCT00737048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110589304|NCT02593448|Anesthetics|anesthetics|mesh-list
110589305|NCT02593448|Propofol|propofol|mesh-list
110589306|NCT02593448|Sevoflurane|sevoflurane|mesh-list
110589307|NCT02593448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110589308|NCT02593448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110589309|NCT02593448|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110589310|NCT02593448|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110589311|NCT02593448|Anesthetics, General|anesthetics, general|mesh-ancestor
110589312|NCT02593448|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110589313|NCT02593448|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110589314|NCT02592746|Capecitabine|capecitabine|mesh-list
110589315|NCT02592746|Palbociclib|palbociclib|mesh-list
110589316|NCT02592746|Leuprolide|leuprolide|mesh-list
110589317|NCT02592746|Exemestane|exemestane|mesh-list
110589318|NCT02592746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110589320|NCT02592746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110230126|NCT00091650|Serotonin Agents|serotonin agents|mesh-ancestor
110589321|NCT02592746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110589322|NCT02592746|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110589323|NCT02592746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110589324|NCT02592746|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110589325|NCT02592746|Fertility Agents|fertility agents|mesh-ancestor
110589326|NCT02592746|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110589327|NCT02592746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110589328|NCT02592746|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110589329|NCT02592746|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110589330|NCT02592746|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110589331|NCT02592746|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110589332|NCT02592746|Hormone Antagonists|hormone antagonists|mesh-ancestor
110589333|NCT02592746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110589334|NCT03365622|Acetaminophen|acetaminophen|mesh-list
110589335|NCT03365622|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110589336|NCT03365622|Analgesics|analgesics|mesh-ancestor
110236718|NCT00346918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110589337|NCT03365622|Sensory System Agents|sensory system agents|mesh-ancestor
110589338|NCT03365622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110589339|NCT03365622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110589340|NCT03365622|Antipyretics|antipyretics|mesh-ancestor
110589341|NCT00731120|Vortioxetine|vortioxetine|mesh-list
110589342|NCT00731120|Antidepressive Agents|antidepressive agents|mesh-ancestor
110589343|NCT00731120|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110589344|NCT00731120|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110589345|NCT00731120|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110589346|NCT00731120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110589347|NCT00731120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110589348|NCT00731120|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110589349|NCT00731120|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110589350|NCT00731120|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110589351|NCT00731120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110589352|NCT00731120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110589353|NCT00731120|Serotonin Agents|serotonin agents|mesh-ancestor
110589354|NCT00731120|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110589355|NCT00731120|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110589356|NCT00731120|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110589357|NCT00731120|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110589358|NCT02580006|Epoetin Alfa|epoetin alfa|mesh-list
110589359|NCT02580006|Hematinics|hematinics|mesh-ancestor
110589360|NCT00731042|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110589361|NCT00731042|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110589362|NCT00731042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110589363|NCT00731042|Dermatologic Agents|dermatologic agents|mesh-ancestor
110589364|NCT02787642|Olaparib|olaparib|mesh-list
110589365|NCT02787642|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110589366|NCT02787642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110589367|NCT02787642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110589368|NCT02787642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110589369|NCT04075188|Aflibercept|aflibercept|mesh-list
110589370|NCT04075188|Verteporfin|verteporfin|mesh-list
110589371|NCT04075188|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110589372|NCT04075188|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110589373|NCT04075188|Growth Substances|growth substances|mesh-ancestor
110589374|NCT04075188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110589375|NCT04075188|Growth Inhibitors|growth inhibitors|mesh-ancestor
110589376|NCT04075188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110589377|NCT04075188|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110589378|NCT04075188|Dermatologic Agents|dermatologic agents|mesh-ancestor
110589379|NCT00726986|Etoposide|etoposide|mesh-list
110589380|NCT00726986|Sorafenib|sorafenib|mesh-list
110589381|NCT00726986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110230305|NCT00315367|Cholinergic Agents|cholinergic agents|mesh-ancestor
110589382|NCT00726986|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110589383|NCT00726986|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110376517|NCT03451019|Sevelamer|sevelamer|mesh-list
110589384|NCT00726986|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110589385|NCT00726986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110589386|NCT00726986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110589387|NCT00726986|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110589388|NCT00696657|Liraglutide|liraglutide|mesh-list
110589389|NCT00696657|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110589390|NCT00696657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110589391|NCT00696657|Incretins|incretins|mesh-ancestor
110589392|NCT00696657|Hormones|hormones|mesh-ancestor
110589393|NCT00696657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110589394|NCT00726752|Axitinib|axitinib|mesh-list
110589395|NCT00726752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110589396|NCT00726752|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110589397|NCT00726752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110589398|NCT00726752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110230355|NCT00315835|Analgesics|analgesics|mesh-ancestor
110589399|NCT02594462|Contraceptive Agents|contraceptive agents|mesh-list
110589400|NCT02594462|Etonogestrel|etonogestrel|mesh-list
110589401|NCT02594462|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110589402|NCT02594462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110589403|NCT02594462|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110589404|NCT02594462|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110589405|NCT02664558|Ubenimex|ubenimex|mesh-list
110589406|NCT02664558|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110589407|NCT02664558|Immunologic Factors|immunologic factors|mesh-ancestor
110589408|NCT02664558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110589409|NCT02664558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110589410|NCT02664558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110589411|NCT02664558|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110589412|NCT02664558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110589413|NCT02664558|Protease Inhibitors|protease inhibitors|mesh-ancestor
110589414|NCT02664558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110230412|NCT00123552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110589415|NCT02664558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110589417|NCT02664558|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110589418|NCT02664558|Antiviral Agents|antiviral agents|mesh-ancestor
110589420|NCT02566707|Atazanavir Sulfate|atazanavir sulfate|mesh-list
110589421|NCT02566707|Dolutegravir|dolutegravir|mesh-list
110589422|NCT02566707|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110589423|NCT02566707|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110589424|NCT02566707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110589425|NCT02566707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110589426|NCT02566707|Antiviral Agents|antiviral agents|mesh-ancestor
110589427|NCT02566707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110589428|NCT02566707|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110589429|NCT02566707|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110589430|NCT02566707|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110589431|NCT02566707|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110589432|NCT02566707|Protease Inhibitors|protease inhibitors|mesh-ancestor
110589433|NCT02566707|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110589434|NCT02566707|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110589435|NCT04063683|Paclitaxel|paclitaxel|mesh-list
110589436|NCT04063683|Cisplatin|cisplatin|mesh-list
110230471|NCT00092391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110230472|NCT00316849|Sirolimus|sirolimus|mesh-list
110589437|NCT04063683|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110589438|NCT04063683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110589439|NCT04063683|Tubulin Modulators|tubulin modulators|mesh-ancestor
110589440|NCT04063683|Antimitotic Agents|antimitotic agents|mesh-ancestor
110589441|NCT04063683|Mitosis Modulators|mitosis modulators|mesh-ancestor
110589442|NCT04063683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110589443|NCT00921531|Thalidomide|thalidomide|mesh-list
110589444|NCT00921531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110589445|NCT00921531|Immunologic Factors|immunologic factors|mesh-ancestor
110589446|NCT00921531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110230532|NCT02959957|Cefoxitin|cefoxitin|mesh-list
110589447|NCT00921531|Leprostatic Agents|leprostatic agents|mesh-ancestor
110589448|NCT00921531|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110589449|NCT00921531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110589450|NCT00921531|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110589451|NCT00921531|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110589452|NCT00921531|Growth Substances|growth substances|mesh-ancestor
110589453|NCT00921531|Growth Inhibitors|growth inhibitors|mesh-ancestor
110589454|NCT00921531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110589455|NCT00730028|Clindamycin|clindamycin|mesh-list
110589456|NCT00730028|Clindamycin palmitate|clindamycin palmitate|mesh-list
110589457|NCT00730028|Clindamycin phosphate|clindamycin phosphate|mesh-list
110589458|NCT00730028|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
110589459|NCT00730028|Trimethoprim|trimethoprim|mesh-list
110589461|NCT00730028|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110589462|NCT00730028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110589463|NCT00730028|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110589464|NCT00730028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110589465|NCT00730028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110589466|NCT00730028|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110589467|NCT00730028|Antimalarials|antimalarials|mesh-ancestor
110150263|NCT05637073|Dienogest|dienogest|mesh-list
110589468|NCT00730028|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110589469|NCT00730028|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110589470|NCT00730028|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110589471|NCT00730028|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110589472|NCT00730028|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
110589473|NCT00730028|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110589474|NCT04088084|Palmidrol|palmidrol|mesh-list
110589475|NCT04088084|Analgesics|analgesics|mesh-ancestor
110589476|NCT04088084|Sensory System Agents|sensory system agents|mesh-ancestor
110589477|NCT04088084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110589478|NCT04088084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110589479|NCT04088084|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110589480|NCT04088084|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110589481|NCT04088084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110589482|NCT04088084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110589483|NCT04088084|Antiviral Agents|antiviral agents|mesh-ancestor
110589484|NCT04088084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110589485|NCT04088084|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
110589486|NCT04088084|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110589487|NCT04088084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110589488|NCT04088084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110589489|NCT04088084|Hormones|hormones|mesh-ancestor
110230653|NCT00328822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110230654|NCT00328822|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110589490|NCT04088084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110589491|NCT02593370|Lidocaine|lidocaine|mesh-list
110589492|NCT02593370|Epinephrine|epinephrine|mesh-list
110589493|NCT02593370|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
110589494|NCT02593370|Anesthetics, Local|anesthetics, local|mesh-ancestor
110589495|NCT02593370|Anesthetics|anesthetics|mesh-ancestor
110589496|NCT02593370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110589497|NCT02593370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110589498|NCT02593370|Sensory System Agents|sensory system agents|mesh-ancestor
110589499|NCT02593370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110589500|NCT02593370|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110589501|NCT02593370|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110589502|NCT02593370|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110589503|NCT02593370|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110589504|NCT02593370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110589505|NCT02593370|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110589506|NCT02593370|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110589507|NCT02593370|Adrenergic Agents|adrenergic agents|mesh-ancestor
110589508|NCT02593370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110589509|NCT02593370|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110589510|NCT02593370|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110589511|NCT02593370|Autonomic Agents|autonomic agents|mesh-ancestor
110230697|NCT00328939|PENTA|penta|mesh-list
110589512|NCT02593370|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110589513|NCT02593370|Respiratory System Agents|respiratory system agents|mesh-ancestor
110589514|NCT02593370|Mydriatics|mydriatics|mesh-ancestor
110589515|NCT02593370|Sympathomimetics|sympathomimetics|mesh-ancestor
110589516|NCT02593370|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110589517|NCT02593370|Chelating Agents|chelating agents|mesh-ancestor
110589518|NCT02593370|Sequestering Agents|sequestering agents|mesh-ancestor
110589519|NCT00918320|Temozolomide|temozolomide|mesh-list
110589520|NCT00918320|Topotecan|topotecan|mesh-list
110589521|NCT00918320|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110589522|NCT00918320|Alkylating Agents|alkylating agents|mesh-ancestor
110589523|NCT00918320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110589524|NCT00918320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110589525|NCT00918320|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110589526|NCT00918320|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110589527|NCT00918320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110589528|NCT00729560|Flutamide|flutamide|mesh-list
110589529|NCT00729560|Androgen Antagonists|androgen antagonists|mesh-ancestor
110589530|NCT00729560|Hormone Antagonists|hormone antagonists|mesh-ancestor
110589531|NCT00729560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110589532|NCT00729560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110589533|NCT00729560|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110589534|NCT00729560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110589536|NCT00736190|Antiviral Agents|antiviral agents|mesh-ancestor
110589537|NCT00736190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110589538|NCT00736190|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110589539|NCT00736190|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110589540|NCT00736190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110589541|NCT00736190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110589542|NCT00736190|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110589543|NCT00736190|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110589544|NCT04686279|Tenofovir|tenofovir|mesh-list
110589545|NCT04686279|Antiviral Agents|antiviral agents|mesh-ancestor
110589546|NCT04686279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110589547|NCT04686279|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110230807|NCT00123903|Metoprolol|metoprolol|mesh-list
110230808|NCT00123903|Carvedilol|carvedilol|mesh-list
110589548|NCT04686279|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110589549|NCT04686279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110589550|NCT04686279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110589551|NCT04686279|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110589552|NCT04686279|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110589553|NCT00729326|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110589555|NCT00729326|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110589556|NCT00729326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110589557|NCT00729326|Incretins|incretins|mesh-ancestor
110589558|NCT00729326|Hormones|hormones|mesh-ancestor
110236947|NCT00426478|Amlodipine|amlodipine|mesh-list
110589559|NCT00729326|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110589560|NCT00729326|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110230863|NCT00092976|Factor VIII|factor viii|mesh-list
110589561|NCT00729326|Protease Inhibitors|protease inhibitors|mesh-ancestor
110589562|NCT00729326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110589563|NCT00729326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110589564|NCT00729326|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110589565|NCT02565303|Ropivacaine|ropivacaine|mesh-list
110589566|NCT02565303|Anesthetics, Local|anesthetics, local|mesh-ancestor
110589567|NCT02565303|Anesthetics|anesthetics|mesh-ancestor
110589568|NCT02565303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110589569|NCT02565303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110589570|NCT02565303|Sensory System Agents|sensory system agents|mesh-ancestor
110589571|NCT02565303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110589572|NCT00698451|Bevacizumab|bevacizumab|mesh-list
110589573|NCT00698451|Carboplatin|carboplatin|mesh-list
110589574|NCT00698451|Doxorubicin|doxorubicin|mesh-list
110589575|NCT00698451|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110150293|NCT05638087|Autonomic Agents|autonomic agents|mesh-ancestor
110589576|NCT00698451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110589577|NCT00698451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110589578|NCT00698451|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110589579|NCT00698451|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110589580|NCT00698451|Growth Substances|growth substances|mesh-ancestor
110589581|NCT00698451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110589582|NCT00698451|Growth Inhibitors|growth inhibitors|mesh-ancestor
110589583|NCT00698451|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110589584|NCT00698451|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110589585|NCT00698451|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110589586|NCT00698451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110589587|NCT00698451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110230925|NCT00330577|Latanoprost|latanoprost|mesh-list
110589589|NCT03980925|Nivolumab|nivolumab|mesh-list
110589590|NCT03980925|Etoposide|etoposide|mesh-list
110589591|NCT03980925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110589592|NCT03980925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110589593|NCT03980925|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110589594|NCT03980925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110589595|NCT03980925|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110589596|NCT03980925|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110589597|NCT03980925|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110589598|NCT03980925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110589599|NCT00693693|Hydrocortisone|hydrocortisone|mesh-list
110589600|NCT00693693|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
110589601|NCT00693693|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
110589602|NCT00693693|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
110589603|NCT00693693|Hydrocortisone-17-butyrate|hydrocortisone-17-butyrate|mesh-list
110589604|NCT00693693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110589605|NCT00693693|Dermatologic Agents|dermatologic agents|mesh-ancestor
110589606|NCT03966807|Nicotine|nicotine|mesh-list
110589607|NCT03966807|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110589608|NCT03966807|Autonomic Agents|autonomic agents|mesh-ancestor
110589609|NCT03966807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110589610|NCT03966807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110589611|NCT03966807|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110589612|NCT03966807|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110589613|NCT03966807|Cholinergic Agents|cholinergic agents|mesh-ancestor
110589614|NCT03966807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110589615|NCT03966807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110589616|NCT02565693|Aspirin|aspirin|mesh-list
110589617|NCT02565693|Carbaspirin calcium|carbaspirin calcium|mesh-list
110589618|NCT02565693|Dipyridamole|dipyridamole|mesh-list
110589619|NCT02565693|Apixaban|apixaban|mesh-list
110589620|NCT02565693|Clopidogrel|clopidogrel|mesh-list
110589621|NCT02565693|Calcium|calcium|mesh-list
110589622|NCT02565693|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110589623|NCT02565693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110589624|NCT02565693|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110589625|NCT02565693|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110589626|NCT02565693|Analgesics|analgesics|mesh-ancestor
110589627|NCT02565693|Sensory System Agents|sensory system agents|mesh-ancestor
110589628|NCT02565693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110589629|NCT02565693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110589630|NCT02565693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110589631|NCT02565693|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110589632|NCT02565693|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110237019|NCT00126360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110589633|NCT02565693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110589634|NCT02565693|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110589635|NCT02565693|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110589636|NCT02565693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110589637|NCT02565693|Antipyretics|antipyretics|mesh-ancestor
110589638|NCT02565693|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110589639|NCT02565693|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110589640|NCT02565693|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110589641|NCT02565693|Purinergic Agents|purinergic agents|mesh-ancestor
110589642|NCT02565693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110589643|NCT02565693|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110589644|NCT02565693|Antithrombins|antithrombins|mesh-ancestor
110589645|NCT02565693|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110231083|NCT00317785|Cyclosporine|cyclosporine|mesh-list
110589646|NCT02565693|Protease Inhibitors|protease inhibitors|mesh-ancestor
110589648|NCT02565693|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110589649|NCT02565693|Vasodilator Agents|vasodilator agents|mesh-ancestor
110589650|NCT04061655|Iron|iron|mesh-list
110589651|NCT04061655|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
110589652|NCT04061655|Trace Elements|trace elements|mesh-ancestor
110589653|NCT04061655|Micronutrients|micronutrients|mesh-ancestor
110589654|NCT04061655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110589655|NCT04061655|Hematinics|hematinics|mesh-ancestor
110589656|NCT04061265|Lidocaine|lidocaine|mesh-list
110589657|NCT04061265|Epinephrine|epinephrine|mesh-list
110589658|NCT04061265|Carticaine|carticaine|mesh-list
110589659|NCT04061265|Anesthetics, Local|anesthetics, local|mesh-ancestor
110589660|NCT04061265|Anesthetics|anesthetics|mesh-ancestor
110589661|NCT04061265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110589662|NCT04061265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110589663|NCT04061265|Sensory System Agents|sensory system agents|mesh-ancestor
110589664|NCT04061265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110589665|NCT04061265|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110589666|NCT04061265|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110589667|NCT04061265|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110589668|NCT04061265|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110589669|NCT04061265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110589670|NCT04061265|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110589671|NCT04061265|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110589672|NCT04061265|Adrenergic Agents|adrenergic agents|mesh-ancestor
110589673|NCT04061265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110589674|NCT04061265|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110589675|NCT04061265|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110589676|NCT04061265|Autonomic Agents|autonomic agents|mesh-ancestor
110589677|NCT04061265|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110589678|NCT04061265|Respiratory System Agents|respiratory system agents|mesh-ancestor
110589679|NCT04061265|Mydriatics|mydriatics|mesh-ancestor
110589680|NCT04061265|Sympathomimetics|sympathomimetics|mesh-ancestor
110589681|NCT04061265|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110589682|NCT02592980|Warfarin|warfarin|mesh-list
110589683|NCT02592980|Anticoagulants|anticoagulants|mesh-ancestor
110589684|NCT00727844|Linezolid|linezolid|mesh-list
110589685|NCT00727844|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110589686|NCT00727844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110589687|NCT00727844|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110589688|NCT00727844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110589689|NCT00727844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110589690|NCT00735878|Carboplatin|carboplatin|mesh-list
110589691|NCT00735878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110589692|NCT00695955|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110589693|NCT00695955|Chlorthalidone|chlorthalidone|mesh-list
110589694|NCT00695955|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
110589695|NCT00695955|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110589696|NCT00695955|Diuretics|diuretics|mesh-ancestor
110589697|NCT00695955|Natriuretic Agents|natriuretic agents|mesh-ancestor
110589698|NCT00695955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110589699|NCT00695955|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110589700|NCT00695955|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110231188|NCT00324766|Simendan|simendan|mesh-list
110589701|NCT00695955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110589702|NCT00695955|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110589703|NCT00695955|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110589704|NCT00693225|Omeprazole|omeprazole|mesh-list
110589705|NCT00693225|Omeprazole, sodium bicarbonate drug combination|omeprazole, sodium bicarbonate drug combination|mesh-list
110589706|NCT00693225|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110589707|NCT00693225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110589708|NCT00693225|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110589709|NCT00693225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110589710|NCT00693225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110589711|NCT00735644|Vaccines|vaccines|mesh-list
110589712|NCT00735644|Immunologic Factors|immunologic factors|mesh-ancestor
110589713|NCT00735644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110589714|NCT02591888|Bupivacaine|bupivacaine|mesh-list
110589715|NCT02591888|Anesthetics, Local|anesthetics, local|mesh-ancestor
110589716|NCT02591888|Anesthetics|anesthetics|mesh-ancestor
110589717|NCT02591888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110231234|NCT00325000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110231237|NCT00325000|Analgesics|analgesics|mesh-ancestor
110589718|NCT02591888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110589719|NCT02591888|Sensory System Agents|sensory system agents|mesh-ancestor
110589720|NCT02591888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110589722|NCT00724958|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110589723|NCT00724958|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110589724|NCT00724958|Dermatologic Agents|dermatologic agents|mesh-ancestor
110589725|NCT00724958|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110589726|NCT00724958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110589727|NCT04088006|Hyaluronic Acid|hyaluronic acid|mesh-list
110589728|NCT04088006|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110589729|NCT04088006|Immunologic Factors|immunologic factors|mesh-ancestor
110589730|NCT04088006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110589731|NCT04088006|Viscosupplements|viscosupplements|mesh-ancestor
110589732|NCT04088006|Protective Agents|protective agents|mesh-ancestor
110589733|NCT00695565|Clonidine|clonidine|mesh-list
110589734|NCT00695565|Analgesics|analgesics|mesh-ancestor
110589735|NCT00695565|Sensory System Agents|sensory system agents|mesh-ancestor
110589736|NCT00695565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110589737|NCT00695565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110589738|NCT00695565|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110589739|NCT00695565|Sympatholytics|sympatholytics|mesh-ancestor
110589740|NCT00695565|Autonomic Agents|autonomic agents|mesh-ancestor
110589741|NCT00695565|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110589742|NCT00695565|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110589743|NCT00695565|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110589744|NCT00695565|Adrenergic Agents|adrenergic agents|mesh-ancestor
110589745|NCT00695565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110589746|NCT00695565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110589747|NCT00727532|Sorafenib|sorafenib|mesh-list
110589748|NCT00727532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110589749|NCT00727532|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110231349|NCT00325546|Hormones|hormones|mesh-ancestor
110589751|NCT00727532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110589752|NCT00721214|Azacitidine|azacitidine|mesh-list
110589753|NCT00721214|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110589754|NCT00721214|Antimetabolites|antimetabolites|mesh-ancestor
110589755|NCT00721214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110589756|NCT00721214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110589757|NCT00721214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110589758|NCT03543813|CX-2029|cx-2029|mesh-list
110589759|NCT03543813|Immunoconjugates|immunoconjugates|mesh-ancestor
110589760|NCT03543813|Immunologic Factors|immunologic factors|mesh-ancestor
110589761|NCT03543813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110589763|NCT00720902|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
110589764|NCT00720902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110589765|NCT00720902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110589766|NCT02592278|Listerine|listerine|mesh-list
110589767|NCT02592278|Fluorides|fluorides|mesh-list
110589768|NCT02592278|Fluorides, Topical|fluorides, topical|mesh-list
110589769|NCT02592278|Sodium Fluoride|sodium fluoride|mesh-list
110589770|NCT02592278|Cariostatic Agents|cariostatic agents|mesh-ancestor
110589771|NCT02592278|Protective Agents|protective agents|mesh-ancestor
110589772|NCT02592278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110589773|NCT02592278|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110589774|NCT02592278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110589775|NCT00695019|Interferons|interferons|mesh-list
110589776|NCT00695019|Interferon-alpha|interferon-alpha|mesh-list
110589777|NCT00695019|Interferon alpha-2|interferon alpha-2|mesh-list
110231470|NCT00093600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110589778|NCT00695019|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
110589779|NCT00695019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110589780|NCT00695019|Antiviral Agents|antiviral agents|mesh-ancestor
110589781|NCT00695019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110589782|NCT00695019|Immunologic Factors|immunologic factors|mesh-ancestor
110589783|NCT00695019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110589784|NCT04019600|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
110589785|NCT04019600|Natriuretic Agents|natriuretic agents|mesh-ancestor
110589786|NCT04019600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110589789|NCT00742911|Trace Elements|trace elements|mesh-ancestor
110589790|NCT00742911|Micronutrients|micronutrients|mesh-ancestor
110589791|NCT00742911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110589792|NCT00742911|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110589793|NCT00742911|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
110589794|NCT00742911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110589795|NCT00742911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110589796|NCT00694707|Risperidone|risperidone|mesh-list
110589797|NCT00694707|Cariprazine|cariprazine|mesh-list
110589798|NCT00694707|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110589799|NCT00694707|Serotonin Agents|serotonin agents|mesh-ancestor
110589800|NCT00694707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110589801|NCT00694707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110589802|NCT00694707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110589803|NCT00694707|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110589804|NCT00694707|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110589805|NCT00694707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110589806|NCT00694707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110589807|NCT00694707|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110589808|NCT00694707|Dopamine Agents|dopamine agents|mesh-ancestor
110589809|NCT00692913|Cholecalciferol|cholecalciferol|mesh-list
110589810|NCT00692913|Vitamin D|vitamin d|mesh-list
110589811|NCT00692913|Alendronate|alendronate|mesh-list
110589812|NCT00692913|Calcium|calcium|mesh-list
110589813|NCT00692913|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110589814|NCT00692913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110589815|NCT00692913|Vitamins|vitamins|mesh-ancestor
110589816|NCT00692913|Micronutrients|micronutrients|mesh-ancestor
110589817|NCT00692913|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110231589|NCT00326248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110589819|NCT00694551|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
110589820|NCT00694551|Vaccines|vaccines|mesh-list
110589821|NCT00694551|Poly ICLC|poly iclc|mesh-list
110589822|NCT00694551|Immunologic Factors|immunologic factors|mesh-ancestor
110589823|NCT00694551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110589824|NCT00694551|Interferon Inducers|interferon inducers|mesh-ancestor
110589825|NCT00694551|Laxatives|laxatives|mesh-ancestor
110589826|NCT00694551|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110589827|NCT00694551|Antiviral Agents|antiviral agents|mesh-ancestor
110589828|NCT00694551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110589829|NCT02603705|Oxycodone|oxycodone|mesh-list
110589830|NCT02603705|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110589831|NCT02603705|Narcotics|narcotics|mesh-ancestor
110231641|NCT00093678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110589832|NCT02603705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110589833|NCT02603705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110589834|NCT02603705|Analgesics|analgesics|mesh-ancestor
110589835|NCT02603705|Sensory System Agents|sensory system agents|mesh-ancestor
110589836|NCT02603705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110589837|NCT00776555|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
110589838|NCT00776555|Dextroamphetamine|dextroamphetamine|mesh-list
110589839|NCT00776555|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110589840|NCT00776555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110589841|NCT00776555|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110589842|NCT00776555|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110589843|NCT00776555|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110376578|NCT04565184|Antiviral Agents|antiviral agents|mesh-ancestor
110589844|NCT00776555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110589846|NCT00776555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110231701|NCT00085553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110589847|NCT00915785|Azacitidine|azacitidine|mesh-list
110589848|NCT00915785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110589849|NCT00915785|Antimetabolites|antimetabolites|mesh-ancestor
110589850|NCT00915785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110589851|NCT00915785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110589852|NCT00915785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110589853|NCT00776009|Methylphenidate|methylphenidate|mesh-list
110589854|NCT00776009|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
110589855|NCT00776009|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110589856|NCT00776009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110589857|NCT00776009|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110589858|NCT00776009|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110589859|NCT00776009|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110589860|NCT00776009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110589861|NCT00776009|Dopamine Agents|dopamine agents|mesh-ancestor
110589862|NCT00776009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110589863|NCT00720356|Bevacizumab|bevacizumab|mesh-list
110589864|NCT00720356|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110589865|NCT00720356|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110589866|NCT00720356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110589867|NCT00720356|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110589868|NCT00720356|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110589870|NCT00720356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110589871|NCT00720356|Growth Inhibitors|growth inhibitors|mesh-ancestor
110589872|NCT00720356|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110589873|NCT00720356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110589874|NCT00720356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110589876|NCT00745953|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110589877|NCT00745953|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110589878|NCT00745953|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110589879|NCT00745953|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110589880|NCT00745953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110589881|NCT00745953|Diuretics|diuretics|mesh-ancestor
110231811|NCT00093912|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110231815|NCT00327145|Amlodipine|amlodipine|mesh-list
110589883|NCT00745953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110589884|NCT00745953|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110589885|NCT00745953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110589886|NCT00720278|Azelastine|azelastine|mesh-list
110589887|NCT00720278|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110589888|NCT00720278|Autonomic Agents|autonomic agents|mesh-ancestor
110589889|NCT00720278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110589890|NCT00720278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110589891|NCT00720278|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110589892|NCT00720278|Respiratory System Agents|respiratory system agents|mesh-ancestor
110589893|NCT00720278|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
110589894|NCT00720278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110589895|NCT00720278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110589896|NCT00720278|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110231871|NCT00327262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110589897|NCT00720278|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110589898|NCT00720278|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110589899|NCT00720278|Histamine Antagonists|histamine antagonists|mesh-ancestor
110589900|NCT00720278|Histamine Agents|histamine agents|mesh-ancestor
110589901|NCT00720278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110589902|NCT00746031|Goserelin|goserelin|mesh-list
110589903|NCT00746031|Cetrorelix|cetrorelix|mesh-list
110589904|NCT00746031|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
110589905|NCT00746031|Hormones|hormones|mesh-ancestor
110589906|NCT00746031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110589907|NCT00746031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110589908|NCT00746031|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110589909|NCT00746031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110589910|NCT00746031|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110589911|NCT00746031|Fertility Agents|fertility agents|mesh-ancestor
110589912|NCT00746031|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110589913|NCT00746031|Hormone Antagonists|hormone antagonists|mesh-ancestor
110589914|NCT00720122|Insulin|insulin|mesh-list
110150335|NCT05639218|Antimetabolites|antimetabolites|mesh-ancestor
110589915|NCT00720122|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110589916|NCT00720122|Mitogens|mitogens|mesh-list
110589917|NCT00720122|Mecasermin|mecasermin|mesh-list
110589918|NCT00720122|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110589919|NCT00720122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110589920|NCT00720122|Mitosis Modulators|mitosis modulators|mesh-ancestor
110589921|NCT00720122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110589922|NCT00720122|Growth Substances|growth substances|mesh-ancestor
110589923|NCT04085744|Mometasone Furoate|mometasone furoate|mesh-list
110589924|NCT04085744|Lidocaine|lidocaine|mesh-list
110589925|NCT04085744|Anesthetics, Local|anesthetics, local|mesh-ancestor
110589926|NCT04085744|Anesthetics|anesthetics|mesh-ancestor
110589927|NCT04085744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110589928|NCT04085744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110589929|NCT04085744|Sensory System Agents|sensory system agents|mesh-ancestor
110231986|NCT00086333|Antimitotic Agents|antimitotic agents|mesh-ancestor
110231987|NCT00086333|Mitosis Modulators|mitosis modulators|mesh-ancestor
110589930|NCT04085744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110589931|NCT04085744|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110589932|NCT04085744|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110589933|NCT04085744|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110237318|NCT00092339|Valdecoxib|valdecoxib|mesh-list
110589934|NCT04085744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110589935|NCT04085744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110589936|NCT04085744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110589937|NCT04085744|Dermatologic Agents|dermatologic agents|mesh-ancestor
110232045|NCT00094341|Analgesics|analgesics|mesh-ancestor
110589938|NCT04085744|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110589940|NCT00743847|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110589941|NCT00743847|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110589942|NCT00743847|Cholinergic Agents|cholinergic agents|mesh-ancestor
110589943|NCT00743847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110589944|NCT00743847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110589945|NCT00743847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110589946|NCT00717860|Caspofungin|caspofungin|mesh-list
110589947|NCT00717860|Micafungin|micafungin|mesh-list
110589948|NCT00717860|Antifungal Agents|antifungal agents|mesh-ancestor
110589949|NCT00717860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110017308|NCT02956044|Bexagliflozin|bexagliflozin|mesh-list
110589950|NCT00717860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110589951|NCT00717860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110589952|NCT00746499|Raltegravir Potassium|raltegravir potassium|mesh-list
110589953|NCT00746499|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110589954|NCT00746499|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110589955|NCT00746499|Antiviral Agents|antiviral agents|mesh-ancestor
110589956|NCT00746499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110589957|NCT00746499|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110589958|NCT00746499|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110589959|NCT00746499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110589960|NCT00746499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110589961|NCT02592122|Bromides|bromides|mesh-list
110589962|NCT02592122|Albuterol|albuterol|mesh-list
110589963|NCT02592122|Anticonvulsants|anticonvulsants|mesh-ancestor
110589964|NCT02592122|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110589965|NCT02592122|Autonomic Agents|autonomic agents|mesh-ancestor
110589966|NCT02592122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110589967|NCT02592122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110589968|NCT02592122|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110589969|NCT02592122|Respiratory System Agents|respiratory system agents|mesh-ancestor
110589970|NCT02592122|Tocolytic Agents|tocolytic agents|mesh-ancestor
110589971|NCT02592122|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110589972|NCT02592122|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110589973|NCT02592122|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110589974|NCT02592122|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110589975|NCT02592122|Adrenergic Agents|adrenergic agents|mesh-ancestor
110589976|NCT02592122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110589977|NCT02592122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110589978|NCT00923637|Oxaliplatin|oxaliplatin|mesh-list
110589980|NCT00923637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110589981|NCT00923637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110589982|NCT00923637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110589983|NCT00923637|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110232165|NCT00086645|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110376594|NCT04997850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110589984|NCT00923637|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110589986|NCT00717314|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110589987|NCT00717314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110589988|NCT00717314|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110589989|NCT00717314|Antitubercular Agents|antitubercular agents|mesh-ancestor
110589990|NCT00717314|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110589991|NCT00717314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110589992|NCT00717314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110589993|NCT00717314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110589994|NCT01090089|Dexamethasone|dexamethasone|mesh-list
110589995|NCT01090089|Dexamethasone acetate|dexamethasone acetate|mesh-list
110589996|NCT01090089|Lenalidomide|lenalidomide|mesh-list
110589997|NCT01090089|BB 1101|bb 1101|mesh-list
110589998|NCT01090089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110232213|NCT00124644|Tipifarnib|tipifarnib|mesh-list
110232214|NCT00124644|Enzyme Inhibitors|enzyme inhibitors|mesh-list
110589999|NCT01090089|Antiemetics|antiemetics|mesh-ancestor
110590000|NCT01090089|Autonomic Agents|autonomic agents|mesh-ancestor
110590001|NCT01090089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110590002|NCT01090089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110590003|NCT01090089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110590004|NCT01090089|Glucocorticoids|glucocorticoids|mesh-ancestor
110590005|NCT01090089|Hormones|hormones|mesh-ancestor
110590006|NCT01090089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110590007|NCT01090089|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110237443|NCT00093509|Mesna|mesna|mesh-list
110590009|NCT01090089|Protease Inhibitors|protease inhibitors|mesh-ancestor
110590010|NCT01090089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110590011|NCT01090089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110590012|NCT01090089|Immunologic Factors|immunologic factors|mesh-ancestor
110590013|NCT01090089|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110590014|NCT01090089|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110590015|NCT01090089|Growth Substances|growth substances|mesh-ancestor
110590016|NCT01090089|Growth Inhibitors|growth inhibitors|mesh-ancestor
110590017|NCT00689793|Iron|iron|mesh-list
110590018|NCT00689793|Trace Elements|trace elements|mesh-ancestor
110590019|NCT00689793|Micronutrients|micronutrients|mesh-ancestor
110590020|NCT00689793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110590021|NCT04086290|Androgens|androgens|mesh-list
110590022|NCT04086290|Hormones|hormones|mesh-ancestor
110590023|NCT04086290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110590024|NCT04086290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110590025|NCT00744393|Sodium Oxybate|sodium oxybate|mesh-list
110590026|NCT00744393|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110590027|NCT00744393|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110590028|NCT00744393|Anesthetics, General|anesthetics, general|mesh-ancestor
110590029|NCT00744393|Anesthetics|anesthetics|mesh-ancestor
110590030|NCT00744393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110232331|NCT00322114|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110590031|NCT00744393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110590032|NCT02563353|Teriparatide|teriparatide|mesh-list
110590033|NCT02563353|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110590034|NCT02563353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110590035|NCT02563353|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110590036|NCT00688701|Lixisenatide|lixisenatide|mesh-list
110590037|NCT00688701|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110590038|NCT00688701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110590039|NCT00744549|Vitamin D|vitamin d|mesh-list
110590040|NCT00744549|Cholecalciferol|cholecalciferol|mesh-list
110590041|NCT00744549|Vitamins|vitamins|mesh-list
110590042|NCT00744549|Vitamin E|vitamin e|mesh-list
110590043|NCT00744549|Selenium|selenium|mesh-list
110590044|NCT00744549|Lycopene|lycopene|mesh-list
110590045|NCT00744549|Micronutrients|micronutrients|mesh-ancestor
110376596|NCT04997850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110590046|NCT00744549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110590047|NCT00744549|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110590048|NCT00744549|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110590049|NCT00744549|Antioxidants|antioxidants|mesh-ancestor
110590050|NCT00744549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110590051|NCT00744549|Protective Agents|protective agents|mesh-ancestor
110590052|NCT00744549|Trace Elements|trace elements|mesh-ancestor
110590053|NCT00744549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110590054|NCT00744549|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110590055|NCT00744549|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110590056|NCT00744549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110590058|NCT00746655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110590059|NCT00741429|Insulin|insulin|mesh-list
110590060|NCT00741429|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110590061|NCT00741429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110590062|NCT00741507|Ethanol|ethanol|mesh-list
110590063|NCT00741507|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110590064|NCT00741507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110590065|NCT00741507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110232455|NCT00419731|Dopamine Agents|dopamine agents|mesh-ancestor
110590066|NCT00741507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110590067|NCT00688623|Everolimus|everolimus|mesh-list
110590068|NCT00688623|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110590069|NCT00688623|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110590070|NCT00688623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110590071|NCT00688623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110590072|NCT00688623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110590073|NCT00688623|Immunologic Factors|immunologic factors|mesh-ancestor
110590074|NCT00688623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110590075|NCT00688623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110590076|NCT02563821|Clonidine|clonidine|mesh-list
110590077|NCT02563821|Sufentanil|sufentanil|mesh-list
110590078|NCT02563821|Levobupivacaine|levobupivacaine|mesh-list
110590079|NCT02563821|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110590080|NCT02563821|Narcotics|narcotics|mesh-ancestor
110590081|NCT02563821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110590082|NCT02563821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110590083|NCT02563821|Analgesics|analgesics|mesh-ancestor
110590084|NCT02563821|Sensory System Agents|sensory system agents|mesh-ancestor
110590085|NCT02563821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110590086|NCT02563821|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110590087|NCT02563821|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110590088|NCT02563821|Anesthetics, General|anesthetics, general|mesh-ancestor
110590089|NCT02563821|Anesthetics|anesthetics|mesh-ancestor
110590090|NCT02563821|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110590091|NCT02563821|Sympatholytics|sympatholytics|mesh-ancestor
110590092|NCT02563821|Autonomic Agents|autonomic agents|mesh-ancestor
110590093|NCT02563821|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110590094|NCT02563821|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110590095|NCT02563821|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110590096|NCT02563821|Adrenergic Agents|adrenergic agents|mesh-ancestor
110590097|NCT02563821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110017349|NCT02956746|gamma-Globulins|gamma-globulins|mesh-list
110590098|NCT02563821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110590099|NCT02563821|Anesthetics, Local|anesthetics, local|mesh-ancestor
110590100|NCT00717236|Certolizumab Pegol|certolizumab pegol|mesh-list
110590101|NCT00717236|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110590102|NCT00717236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110590103|NCT00717236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110590104|NCT00717236|Immunologic Factors|immunologic factors|mesh-ancestor
110590105|NCT00717236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110590106|NCT00717236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110590107|NCT04085354|Vitamins|vitamins|mesh-list
110590108|NCT04085354|Folic Acid|folic acid|mesh-list
110590109|NCT04085354|Vitamin B 12|vitamin b 12|mesh-list
110590110|NCT04085354|Hydroxocobalamin|hydroxocobalamin|mesh-list
110590111|NCT04085354|Micronutrients|micronutrients|mesh-ancestor
110590112|NCT04085354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110590113|NCT04085354|Hematinics|hematinics|mesh-ancestor
110590114|NCT04085354|Vitamin B Complex|vitamin b complex|mesh-ancestor
110590115|NCT00719810|Tigecycline|tigecycline|mesh-list
110590116|NCT00719810|Fluoroquinolones|fluoroquinolones|mesh-list
110590117|NCT00719810|Delafloxacin|delafloxacin|mesh-list
110590118|NCT00719810|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110590119|NCT00719810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110232625|NCT00087581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110590120|NCT00719810|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110590121|NCT00719810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110590122|NCT00719810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110590123|NCT00719810|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110590124|NCT00723710|Interferons|interferons|mesh-list
110590125|NCT00723710|Interferon-alpha|interferon-alpha|mesh-list
110590126|NCT00723710|Interferon alpha-2|interferon alpha-2|mesh-list
110590127|NCT00723710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110590128|NCT00723710|Antiviral Agents|antiviral agents|mesh-ancestor
110590129|NCT00723710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110590130|NCT00723710|Immunologic Factors|immunologic factors|mesh-ancestor
110590131|NCT00723710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110590133|NCT00688545|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110232683|NCT00331708|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110590134|NCT00688545|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110590135|NCT00688545|Analgesics|analgesics|mesh-ancestor
110590136|NCT00688545|Sensory System Agents|sensory system agents|mesh-ancestor
110590137|NCT00688545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110590138|NCT00688545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110590139|NCT00688545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110590140|NCT00688545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110590141|NCT00688545|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110590142|NCT00688545|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110590143|NCT00688545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110590144|NCT00688545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110590145|NCT04060407|Nivolumab|nivolumab|mesh-list
110590146|NCT04060407|Ipilimumab|ipilimumab|mesh-list
110590147|NCT04060407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110590148|NCT04060407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110590149|NCT04060407|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110590150|NCT04060407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110590151|NCT00741585|Atenolol|atenolol|mesh-list
110590152|NCT00741585|Amlodipine|amlodipine|mesh-list
110590153|NCT00741585|Valsartan|valsartan|mesh-list
110590154|NCT00741585|Telmisartan|telmisartan|mesh-list
110590155|NCT00741585|Carvedilol|carvedilol|mesh-list
110590156|NCT00741585|Candesartan|candesartan|mesh-list
110590157|NCT00741585|Candesartan cilexetil|candesartan cilexetil|mesh-list
110590158|NCT00741585|Ramipril|ramipril|mesh-list
110590159|NCT00741585|Olmesartan|olmesartan|mesh-list
110237550|NCT01055314|Vincristine|vincristine|mesh-list
110590160|NCT00741585|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
110590161|NCT00741585|Enalapril|enalapril|mesh-list
110590162|NCT00741585|Enalaprilat|enalaprilat|mesh-list
110590163|NCT00741585|Lisinopril|lisinopril|mesh-list
110590164|NCT00741585|Irbesartan|irbesartan|mesh-list
110232808|NCT02965274|Serotonin Agents|serotonin agents|mesh-ancestor
110590165|NCT00741585|Antihypertensive Agents|antihypertensive agents|mesh-list
110590166|NCT00741585|Quinapril|quinapril|mesh-list
110590167|NCT00741585|Lercanidipine|lercanidipine|mesh-list
110590168|NCT00741585|Manidipine|manidipine|mesh-list
110590169|NCT00741585|Doxazosin|doxazosin|mesh-list
110590170|NCT00741585|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110590171|NCT00741585|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110590172|NCT00741585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110590173|NCT00741585|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110590174|NCT00741585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110590175|NCT00741585|Vasodilator Agents|vasodilator agents|mesh-ancestor
110590176|NCT00741585|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110590177|NCT00741585|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110590178|NCT00741585|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110590179|NCT00741585|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110590181|NCT00741585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110590182|NCT00741585|Antioxidants|antioxidants|mesh-ancestor
110590183|NCT00741585|Protective Agents|protective agents|mesh-ancestor
110590184|NCT00741585|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110590185|NCT00741585|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110232860|NCT05831761|Sensory System Agents|sensory system agents|mesh-ancestor
110232867|NCT05831566|Budesonide|budesonide|mesh-list
110590186|NCT00741585|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110590187|NCT00741585|Protease Inhibitors|protease inhibitors|mesh-ancestor
110590188|NCT00741585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110590189|NCT00741585|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110590190|NCT00741585|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110590191|NCT00741585|Sympatholytics|sympatholytics|mesh-ancestor
110590192|NCT00741585|Autonomic Agents|autonomic agents|mesh-ancestor
110590193|NCT00741585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110590194|NCT00741585|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110590195|NCT00746967|Sildenafil Citrate|sildenafil citrate|mesh-list
110590196|NCT00746967|Vasodilator Agents|vasodilator agents|mesh-ancestor
110590197|NCT00746967|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110590198|NCT00746967|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110590199|NCT00746967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110232914|NCT05831098|Immunologic Factors|immunologic factors|mesh-ancestor
110232916|NCT05830916|Antibodies|antibodies|mesh-list
110590200|NCT00746967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110590201|NCT00746967|Urological Agents|urological agents|mesh-ancestor
110590202|NCT02563041|Heparin|heparin|mesh-list
110590203|NCT02563041|Calcium heparin|calcium heparin|mesh-list
110590204|NCT02563041|Anticoagulants|anticoagulants|mesh-ancestor
110590205|NCT02563041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110590206|NCT02563041|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110590207|NCT02563041|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110590208|NCT00741663|Furosemide|furosemide|mesh-list
110590209|NCT00741663|Spironolactone|spironolactone|mesh-list
110232973|NCT05830071|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110232974|NCT05830071|Cholinergic Agents|cholinergic agents|mesh-ancestor
110232975|NCT05830071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110232976|NCT05830071|Glucocorticoids|glucocorticoids|mesh-ancestor
110232978|NCT05830071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110232980|NCT05828758|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110232981|NCT05828758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110590210|NCT00741663|Diuretics|diuretics|mesh-ancestor
110590211|NCT00741663|Natriuretic Agents|natriuretic agents|mesh-ancestor
110590212|NCT00741663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110590213|NCT00741663|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110590214|NCT00741663|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110590215|NCT00741663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110590216|NCT00741663|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110590217|NCT00741663|Hormone Antagonists|hormone antagonists|mesh-ancestor
110590218|NCT00741663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110590219|NCT00741663|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110590220|NCT00745017|Antidepressive Agents|antidepressive agents|mesh-list
110590221|NCT00745017|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110590222|NCT00741741|Rilpivirine|rilpivirine|mesh-list
110590223|NCT00741741|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110590224|NCT00741741|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110590225|NCT00741741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110590226|NCT00741741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110590227|NCT00741741|Antiviral Agents|antiviral agents|mesh-ancestor
110590228|NCT00741741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110590229|NCT00741741|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110590230|NCT00741741|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110590231|NCT00745173|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
110590232|NCT00745173|Estrogens|estrogens|mesh-ancestor
110233067|NCT05574400|Caffeine|caffeine|mesh-list
110590233|NCT00745173|Hormones|hormones|mesh-ancestor
110590234|NCT00745173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110590235|NCT00745173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110237627|NCT00094289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110590236|NCT04060095|Anesthetics|anesthetics|mesh-list
110376635|NCT04564638|Dermatologic Agents|dermatologic agents|mesh-ancestor
110590237|NCT04060095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110590238|NCT04060095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110590240|NCT00741897|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110590241|NCT00741897|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110590242|NCT00741897|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110590243|NCT00741897|Histamine Antagonists|histamine antagonists|mesh-ancestor
110590244|NCT00741897|Histamine Agents|histamine agents|mesh-ancestor
110590245|NCT00741897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110590246|NCT00741897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110590247|NCT00741897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110590248|NCT00745407|Fenofibrate|fenofibrate|mesh-list
110590249|NCT00745407|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110590250|NCT00745407|Antimetabolites|antimetabolites|mesh-ancestor
110590251|NCT00745407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110590252|NCT00745407|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110590253|NCT00745485|Zoledronic Acid|zoledronic acid|mesh-list
110590254|NCT00745485|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110590255|NCT00745485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110590257|NCT00747279|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110590258|NCT00747279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110590259|NCT00742287|Proanthocyanidin|proanthocyanidin|mesh-list
110590260|NCT00742287|Procyanidin|procyanidin|mesh-list
110590261|NCT00742287|Antioxidants|antioxidants|mesh-ancestor
110590262|NCT00742287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110590263|NCT00742287|Protective Agents|protective agents|mesh-ancestor
110590264|NCT00742287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110233118|NCT05413330|Hormones|hormones|mesh-ancestor
110590265|NCT00742287|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110590266|NCT00742287|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110590267|NCT00742287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110590268|NCT00747669|Lidocaine|lidocaine|mesh-list
110590269|NCT00747669|Tetracaine|tetracaine|mesh-list
110590270|NCT00747669|Anesthetics, Local|anesthetics, local|mesh-ancestor
110590271|NCT00747669|Anesthetics|anesthetics|mesh-ancestor
110590272|NCT00747669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110590273|NCT00747669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110590274|NCT00747669|Sensory System Agents|sensory system agents|mesh-ancestor
110590275|NCT00747669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110590276|NCT00747669|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110590277|NCT00747669|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110590278|NCT00747669|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110590279|NCT00747669|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110590280|NCT00747669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110590281|NCT00690573|Adalimumab|adalimumab|mesh-list
110590282|NCT00690573|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110590283|NCT00690573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110590284|NCT00690573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110590285|NCT00719264|Interferons|interferons|mesh-list
110590286|NCT00719264|Interferon-alpha|interferon-alpha|mesh-list
110233172|NCT05167734|Dextrans|dextrans|mesh-list
110590287|NCT00719264|Interferon alpha-2|interferon alpha-2|mesh-list
110590288|NCT00719264|Bevacizumab|bevacizumab|mesh-list
110590289|NCT00719264|Everolimus|everolimus|mesh-list
110590290|NCT00719264|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110590291|NCT00719264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110590292|NCT00719264|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110590293|NCT00719264|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110590294|NCT00719264|Growth Substances|growth substances|mesh-ancestor
110590295|NCT00719264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110590296|NCT00719264|Growth Inhibitors|growth inhibitors|mesh-ancestor
110590297|NCT00719264|Antiviral Agents|antiviral agents|mesh-ancestor
110590298|NCT00719264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110590299|NCT00719264|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110376649|NCT04564326|Anesthetics|anesthetics|mesh-ancestor
110590300|NCT00719264|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110590302|NCT00719264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110150379|NCT00000142|Cidofovir|cidofovir|mesh-list
110017447|NCT03020004|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110590303|NCT00719264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110590304|NCT00719264|Immunologic Factors|immunologic factors|mesh-ancestor
110590305|NCT00687609|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
110233211|NCT05126719|Antimetabolites|antimetabolites|mesh-ancestor
110590306|NCT00687609|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110590307|NCT00687609|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110590308|NCT00687609|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110590309|NCT00687609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110590311|NCT00687609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110590312|NCT00687609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110590314|NCT00751959|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
110590315|NCT00751959|Respiratory System Agents|respiratory system agents|mesh-ancestor
110590316|NCT00723554|Iloprost|iloprost|mesh-list
110590317|NCT00723554|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110590318|NCT00723554|Vasodilator Agents|vasodilator agents|mesh-ancestor
110590319|NCT00687219|Ribavirin|ribavirin|mesh-list
110590320|NCT00687219|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110590321|NCT00687219|Antimetabolites|antimetabolites|mesh-ancestor
110590322|NCT00687219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110590323|NCT00687219|Antiviral Agents|antiviral agents|mesh-ancestor
110590324|NCT00687219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110590325|NCT04085120|Dexamethasone|dexamethasone|mesh-list
110590326|NCT04085120|Dexamethasone acetate|dexamethasone acetate|mesh-list
110590328|NCT04085120|Ropivacaine|ropivacaine|mesh-list
110590329|NCT04085120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110590330|NCT04085120|Antiemetics|antiemetics|mesh-ancestor
110590331|NCT04085120|Autonomic Agents|autonomic agents|mesh-ancestor
110590332|NCT04085120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110590333|NCT04085120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110590334|NCT04085120|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110590335|NCT04085120|Glucocorticoids|glucocorticoids|mesh-ancestor
110590336|NCT04085120|Hormones|hormones|mesh-ancestor
110590337|NCT04085120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110590338|NCT04085120|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110590339|NCT04085120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110590340|NCT04085120|Anesthetics, Local|anesthetics, local|mesh-ancestor
110590341|NCT04085120|Anesthetics|anesthetics|mesh-ancestor
110590342|NCT04085120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110590343|NCT04085120|Sensory System Agents|sensory system agents|mesh-ancestor
110590344|NCT04085120|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110590345|NCT04085120|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110590346|NCT04085120|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110590347|NCT04085120|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110590348|NCT04085120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110590349|NCT00747903|Aminolevulinic Acid|aminolevulinic acid|mesh-list
110590350|NCT00747903|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110590351|NCT00747903|Dermatologic Agents|dermatologic agents|mesh-ancestor
110590352|NCT02562183|Kallikreins|kallikreins|mesh-list
110590353|NCT02562183|Coagulants|coagulants|mesh-ancestor
110590354|NCT02562183|Fertility Agents, Male|fertility agents, male|mesh-ancestor
110590355|NCT02562183|Fertility Agents|fertility agents|mesh-ancestor
110590356|NCT02562183|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110590357|NCT02562183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110590358|NCT00723398|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
110590359|NCT00723398|Pitavastatin|pitavastatin|mesh-list
110590360|NCT00723398|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110590361|NCT00723398|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110590362|NCT00723398|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110590363|NCT00723398|Antimetabolites|antimetabolites|mesh-ancestor
110590364|NCT00723398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110590365|NCT00723398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110590366|NCT00723398|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110590367|NCT00723398|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110590368|NCT00723398|Hormone Antagonists|hormone antagonists|mesh-ancestor
110590369|NCT00723398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110590370|NCT00723398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110590371|NCT00723398|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110590372|NCT00723398|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110590373|NCT00723398|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110590374|NCT00716456|Cetuximab|cetuximab|mesh-list
110590375|NCT00716456|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110017479|NCT03026556|Protease Inhibitors|protease inhibitors|mesh-ancestor
110590376|NCT00716456|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110590377|NCT00716456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110590378|NCT00716456|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110590379|NCT00716456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110590380|NCT00716456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110590382|NCT00684645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110590383|NCT00684645|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110590384|NCT00684645|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110590385|NCT00684645|Growth Substances|growth substances|mesh-ancestor
110590386|NCT00684645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110590387|NCT00684645|Growth Inhibitors|growth inhibitors|mesh-ancestor
110590388|NCT00684645|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110590389|NCT00684645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110590390|NCT00684645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110590391|NCT00752037|Ritonavir|ritonavir|mesh-list
110590392|NCT00752037|Lopinavir|lopinavir|mesh-list
110590393|NCT00752037|Raltegravir Potassium|raltegravir potassium|mesh-list
110233442|NCT04006288|Antipyretics|antipyretics|mesh-ancestor
110590394|NCT00752037|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110590395|NCT00752037|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110590396|NCT00752037|Protease Inhibitors|protease inhibitors|mesh-ancestor
110590397|NCT00752037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110590398|NCT00752037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110590399|NCT00752037|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110590400|NCT00752037|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110590401|NCT00752037|Antiviral Agents|antiviral agents|mesh-ancestor
110590402|NCT00752037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110590403|NCT00752037|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110590404|NCT00752037|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110590405|NCT00752037|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110590406|NCT00752037|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110590407|NCT00716144|R 115866|r 115866|mesh-list
110590408|NCT00716144|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110590409|NCT00716144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110590410|NCT00716144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110590411|NCT00752115|Paclitaxel|paclitaxel|mesh-list
110590412|NCT00752115|Carboplatin|carboplatin|mesh-list
110590413|NCT00752115|Sildenafil Citrate|sildenafil citrate|mesh-list
110590414|NCT00752115|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110590415|NCT00752115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110590416|NCT00752115|Tubulin Modulators|tubulin modulators|mesh-ancestor
110590417|NCT00752115|Antimitotic Agents|antimitotic agents|mesh-ancestor
110590418|NCT00752115|Mitosis Modulators|mitosis modulators|mesh-ancestor
110590419|NCT00752115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110590420|NCT00752115|Vasodilator Agents|vasodilator agents|mesh-ancestor
110590421|NCT00752115|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110590422|NCT00752115|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110590423|NCT00752115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110590424|NCT00752115|Urological Agents|urological agents|mesh-ancestor
110590425|NCT00918476|Contraceptive Agents|contraceptive agents|mesh-list
110590426|NCT00918476|Contraceptives, Oral|contraceptives, oral|mesh-list
110590427|NCT00918476|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110590428|NCT00918476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110590429|NCT00918476|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110590430|NCT00749385|Naproxen|naproxen|mesh-list
110590432|NCT00749385|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110590433|NCT00749385|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110590434|NCT00749385|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110590435|NCT00749385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110590436|NCT00749385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110590437|NCT00749385|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110590438|NCT00749385|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110590439|NCT00749385|Analgesics|analgesics|mesh-ancestor
110590440|NCT00749385|Sensory System Agents|sensory system agents|mesh-ancestor
110590441|NCT00749385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110590442|NCT00749385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110590443|NCT00749385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110590444|NCT00749385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110590445|NCT00749385|Gout Suppressants|gout suppressants|mesh-ancestor
110590446|NCT00749385|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110590447|NCT00748059|Propranolol|propranolol|mesh-list
110590448|NCT00748059|Atropine|atropine|mesh-list
110590449|NCT00748059|Clonidine|clonidine|mesh-list
110590450|NCT00748059|Nitroprusside|nitroprusside|mesh-list
110590451|NCT00748059|Methyldopa|methyldopa|mesh-list
110590452|NCT00748059|Phenylephrine|phenylephrine|mesh-list
110590453|NCT00748059|Isoproterenol|isoproterenol|mesh-list
110590454|NCT00748059|Metoclopramide|metoclopramide|mesh-list
110590455|NCT00748059|Yohimbine|yohimbine|mesh-list
110590456|NCT00748059|Tyramine|tyramine|mesh-list
110590457|NCT00748059|Edrophonium|edrophonium|mesh-list
110237848|NCT00429559|Topotecan|topotecan|mesh-list
110590458|NCT00748059|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110590459|NCT00748059|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110590460|NCT00748059|Adrenergic Agents|adrenergic agents|mesh-ancestor
110590461|NCT00748059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110590462|NCT00748059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110590463|NCT00748059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110590464|NCT00748059|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110590465|NCT00748059|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110590466|NCT00748059|Vasodilator Agents|vasodilator agents|mesh-ancestor
110590467|NCT00748059|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110590468|NCT00748059|Mydriatics|mydriatics|mesh-ancestor
110590469|NCT00748059|Autonomic Agents|autonomic agents|mesh-ancestor
110590470|NCT00748059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110590471|NCT00748059|Sympathomimetics|sympathomimetics|mesh-ancestor
110590472|NCT00748059|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110590473|NCT00748059|Nasal Decongestants|nasal decongestants|mesh-ancestor
110590474|NCT00748059|Respiratory System Agents|respiratory system agents|mesh-ancestor
110590475|NCT00748059|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110590476|NCT00748059|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110590477|NCT00748059|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110590478|NCT00748059|Protective Agents|protective agents|mesh-ancestor
110590479|NCT00748059|Analgesics|analgesics|mesh-ancestor
110590480|NCT00748059|Sensory System Agents|sensory system agents|mesh-ancestor
110590481|NCT00748059|Sympatholytics|sympatholytics|mesh-ancestor
110590482|NCT00748059|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110590483|NCT00748059|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110590484|NCT00748059|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110590485|NCT00748059|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110590486|NCT00748059|Parasympatholytics|parasympatholytics|mesh-ancestor
110590487|NCT00748059|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110590488|NCT00748059|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110590489|NCT00748059|Cholinergic Agents|cholinergic agents|mesh-ancestor
110590490|NCT00748059|Antiemetics|antiemetics|mesh-ancestor
110590491|NCT00748059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110590492|NCT00748059|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110590493|NCT00748059|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110590494|NCT00748059|Dopamine Agents|dopamine agents|mesh-ancestor
110590495|NCT00748059|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
110590496|NCT00748059|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
110590497|NCT00748059|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110590498|NCT00748059|Urological Agents|urological agents|mesh-ancestor
110590499|NCT00748059|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110590500|NCT00748059|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110590501|NCT00748059|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110376673|NCT02215122|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110590502|NCT00748059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110590503|NCT00748059|Antidotes|antidotes|mesh-ancestor
110590504|NCT00748059|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110590505|NCT00748059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110590506|NCT00576381|Dexmedetomidine|dexmedetomidine|mesh-list
110590507|NCT00576381|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110590508|NCT00576381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110590509|NCT00576381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110233625|NCT03063619|Tamoxifen|tamoxifen|mesh-list
110590510|NCT00576381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110590511|NCT00576381|Analgesics|analgesics|mesh-ancestor
110590512|NCT00576381|Sensory System Agents|sensory system agents|mesh-ancestor
110590513|NCT00576381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110590514|NCT00576381|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110590515|NCT00576381|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110590516|NCT00576381|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110590517|NCT00576381|Adrenergic Agents|adrenergic agents|mesh-ancestor
110590518|NCT00576381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110590519|NCT00576381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110590520|NCT02562417|Dexamethasone|dexamethasone|mesh-list
110590521|NCT02562417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110590522|NCT02562417|Antiemetics|antiemetics|mesh-ancestor
110590523|NCT02562417|Autonomic Agents|autonomic agents|mesh-ancestor
110590524|NCT02562417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110590525|NCT02562417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110590526|NCT02562417|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110590527|NCT02562417|Glucocorticoids|glucocorticoids|mesh-ancestor
110590528|NCT02562417|Hormones|hormones|mesh-ancestor
110590529|NCT02562417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110590530|NCT02562417|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110590531|NCT02562417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110590532|NCT00749619|Taurolidine|taurolidine|mesh-list
110590533|NCT00749619|Heparin|heparin|mesh-list
110590534|NCT00749619|Calcium heparin|calcium heparin|mesh-list
110237928|NCT00429832|Promethazine|promethazine|mesh-list
110590535|NCT00749619|Citric Acid|citric acid|mesh-list
110590536|NCT00749619|Sodium Citrate|sodium citrate|mesh-list
110590537|NCT00749619|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110590538|NCT00749619|Anticoagulants|anticoagulants|mesh-ancestor
110590539|NCT00749619|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110590540|NCT00749619|Chelating Agents|chelating agents|mesh-ancestor
110590541|NCT00749619|Sequestering Agents|sequestering agents|mesh-ancestor
110590542|NCT00749619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110590543|NCT00749619|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110590544|NCT00749619|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110590545|NCT00749619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110590546|NCT00749619|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110590547|NCT00749619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110590548|NCT00748371|Aspirin|aspirin|mesh-list
110590549|NCT00748371|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110590550|NCT00748371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110590551|NCT00748371|Analgesics|analgesics|mesh-ancestor
110590552|NCT00748371|Sensory System Agents|sensory system agents|mesh-ancestor
110590553|NCT00748371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110150446|NCT00000187|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110590554|NCT00748371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110590555|NCT00748371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110590556|NCT00748371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110590557|NCT00748371|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110590558|NCT00748371|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110590559|NCT00748371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110590560|NCT00748371|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110590561|NCT00748371|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110590562|NCT00748371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110590563|NCT00748371|Antipyretics|antipyretics|mesh-ancestor
110590564|NCT00749853|Buserelin|buserelin|mesh-list
110590565|NCT00749853|Hormones|hormones|mesh-list
110233813|NCT02394834|Leucovorin|leucovorin|mesh-list
110590566|NCT00749853|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
110590567|NCT00749853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110590568|NCT00749853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110590569|NCT00749853|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110590570|NCT00749853|Fertility Agents|fertility agents|mesh-ancestor
110590571|NCT00749853|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110590572|NCT00684567|Temozolomide|temozolomide|mesh-list
110590573|NCT00684567|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110590574|NCT00684567|Alkylating Agents|alkylating agents|mesh-ancestor
110590575|NCT00684567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110590576|NCT00684567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110590577|NCT00752427|Paliperidone Palmitate|paliperidone palmitate|mesh-list
110590578|NCT00752427|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110590579|NCT00752427|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110590580|NCT00752427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110590581|NCT00752427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110590582|NCT00752427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110590583|NCT00752427|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110590584|NCT00752427|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110590585|NCT00752427|Serotonin Agents|serotonin agents|mesh-ancestor
110590586|NCT00752427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110590587|NCT00752427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110590588|NCT00752427|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110590589|NCT00752427|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110590590|NCT00752427|Dopamine Agents|dopamine agents|mesh-ancestor
110590591|NCT04053621|Thiamine|thiamine|mesh-list
110590592|NCT04053621|Thiamine Pyrophosphate|thiamine pyrophosphate|mesh-list
110590593|NCT04053621|Metformin|metformin|mesh-list
110590594|NCT04053621|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110590595|NCT04053621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110590596|NCT04053621|Vitamin B Complex|vitamin b complex|mesh-ancestor
110590597|NCT04053621|Vitamins|vitamins|mesh-ancestor
110590598|NCT04053621|Micronutrients|micronutrients|mesh-ancestor
110590599|NCT00684411|Imatinib Mesylate|imatinib mesylate|mesh-list
110590600|NCT00684411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110590601|NCT00684411|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110590602|NCT00684411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110590603|NCT00684411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110590604|NCT02562651|Doxycycline|doxycycline|mesh-list
110590605|NCT02562651|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110590606|NCT02562651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110590607|NCT02562651|Antimalarials|antimalarials|mesh-ancestor
110590608|NCT02562651|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110238004|NCT00430144|Belotecan|belotecan|mesh-list
110590609|NCT02562651|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110590610|NCT00748527|Carboplatin|carboplatin|mesh-list
110590611|NCT00748527|Decitabine|decitabine|mesh-list
110590612|NCT00748527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110590613|NCT00748527|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110590614|NCT00748527|Antimetabolites|antimetabolites|mesh-ancestor
110590615|NCT00748527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110590616|NCT00748527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110590617|NCT00686829|Maleic acid|maleic acid|mesh-list
110590618|NCT00686829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110590619|NCT00686829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110590620|NCT00687297|Carboplatin|carboplatin|mesh-list
110233946|NCT01742299|Imatinib Mesylate|imatinib mesylate|mesh-list
110233947|NCT01742299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110590621|NCT00687297|Docetaxel|docetaxel|mesh-list
110590622|NCT00687297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110590623|NCT00687297|Tubulin Modulators|tubulin modulators|mesh-ancestor
110590624|NCT00687297|Antimitotic Agents|antimitotic agents|mesh-ancestor
110590625|NCT00687297|Mitosis Modulators|mitosis modulators|mesh-ancestor
110590626|NCT00687297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110590627|NCT00684177|Retapamulin|retapamulin|mesh-list
110590629|NCT00684177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110590630|NCT00752661|Tramadol|tramadol|mesh-list
110590631|NCT00752661|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110590632|NCT00752661|Narcotics|narcotics|mesh-ancestor
110590633|NCT00752661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110590634|NCT00752661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110590635|NCT00752661|Analgesics|analgesics|mesh-ancestor
110590636|NCT00752661|Sensory System Agents|sensory system agents|mesh-ancestor
110590637|NCT00752661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110590638|NCT00576303|Epoetin Alfa|epoetin alfa|mesh-list
110590639|NCT00576303|Hematinics|hematinics|mesh-ancestor
110590640|NCT00752739|Selenium|selenium|mesh-list
110590641|NCT00752739|Antioxidants|antioxidants|mesh-ancestor
110590642|NCT00752739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110590643|NCT00752739|Protective Agents|protective agents|mesh-ancestor
110590644|NCT00752739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110590645|NCT00752739|Trace Elements|trace elements|mesh-ancestor
110590646|NCT00752739|Micronutrients|micronutrients|mesh-ancestor
110590647|NCT00755781|Cyclosporine|cyclosporine|mesh-list
110234079|NCT05951725|Vaccines|vaccines|mesh-list
110590648|NCT00755781|Cyclosporins|cyclosporins|mesh-list
110590649|NCT00755781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110590650|NCT00755781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110590651|NCT00755781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110590652|NCT00755781|Immunologic Factors|immunologic factors|mesh-ancestor
110590653|NCT00755781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110590654|NCT00755781|Antifungal Agents|antifungal agents|mesh-ancestor
110590655|NCT00755781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110590656|NCT00755781|Dermatologic Agents|dermatologic agents|mesh-ancestor
110590657|NCT00755781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110590658|NCT00755781|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110590660|NCT00755859|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110590661|NCT00755859|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110590662|NCT00755859|Methylprednisolone|methylprednisolone|mesh-list
110590663|NCT00755859|Prednisolone|prednisolone|mesh-list
110590664|NCT00755859|Prednisolone acetate|prednisolone acetate|mesh-list
110590665|NCT00755859|Azathioprine|azathioprine|mesh-list
110590666|NCT00755859|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110017651|NCT03107754|Lidocaine|lidocaine|mesh-list
110590667|NCT00755859|Prednisolone phosphate|prednisolone phosphate|mesh-list
110590668|NCT00755859|Antimetabolites|antimetabolites|mesh-ancestor
110234139|NCT05951361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110590669|NCT00755859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110590670|NCT00755859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110590671|NCT00755859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110590672|NCT00755859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110590673|NCT00755859|Immunologic Factors|immunologic factors|mesh-ancestor
110590674|NCT00755859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110590675|NCT00755859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110590676|NCT00755859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110590677|NCT00755859|Glucocorticoids|glucocorticoids|mesh-ancestor
110590678|NCT00755859|Hormones|hormones|mesh-ancestor
110590679|NCT00755859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110590680|NCT00755859|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110590681|NCT00755859|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110590682|NCT00755859|Protective Agents|protective agents|mesh-ancestor
110590683|NCT00755859|Antiemetics|antiemetics|mesh-ancestor
110590684|NCT00755859|Autonomic Agents|autonomic agents|mesh-ancestor
110590685|NCT00755859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110590686|NCT00755859|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110234191|NCT05936671|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110234192|NCT05936671|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110234193|NCT05936671|Anesthetics, General|anesthetics, general|mesh-ancestor
110234194|NCT05936671|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110234195|NCT05936671|Narcotics|narcotics|mesh-ancestor
110234196|NCT05936671|Analgesics|analgesics|mesh-ancestor
110234197|NCT05936671|Sensory System Agents|sensory system agents|mesh-ancestor
110234198|NCT05936671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110234199|NCT05933499|Vitamin D|vitamin d|mesh-list
110234200|NCT05933499|Calcium|calcium|mesh-list
110234201|NCT05933499|Vitamins|vitamins|mesh-ancestor
110234202|NCT05933499|Micronutrients|micronutrients|mesh-ancestor
110590687|NCT00686517|Interferons|interferons|mesh-list
110590688|NCT00686517|Ribavirin|ribavirin|mesh-list
110590689|NCT00686517|Interferon-alpha|interferon-alpha|mesh-list
110590690|NCT00686517|Interferon alpha-2|interferon alpha-2|mesh-list
110590691|NCT00686517|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110590692|NCT00686517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110590693|NCT00686517|Antiviral Agents|antiviral agents|mesh-ancestor
110590694|NCT00686517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110590695|NCT00686517|Antimetabolites|antimetabolites|mesh-ancestor
110590696|NCT00686517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110590697|NCT00686517|Immunologic Factors|immunologic factors|mesh-ancestor
110590698|NCT00686517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110590699|NCT00571701|Celecoxib|celecoxib|mesh-list
110590700|NCT00571701|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110590701|NCT00571701|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110590703|NCT00571701|Sensory System Agents|sensory system agents|mesh-ancestor
110590704|NCT00571701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110590705|NCT00571701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110590706|NCT00571701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110590707|NCT00571701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110590708|NCT00571701|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110590709|NCT00571701|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110590710|NCT00571701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110590711|NCT00571701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110590712|NCT00686127|Lidocaine|lidocaine|mesh-list
110590713|NCT00686127|Anesthetics, Local|anesthetics, local|mesh-ancestor
110590714|NCT00686127|Anesthetics|anesthetics|mesh-ancestor
110590715|NCT00686127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110590716|NCT00686127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110590717|NCT00686127|Sensory System Agents|sensory system agents|mesh-ancestor
110590718|NCT00686127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110590719|NCT00686127|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110234309|NCT05819892|Tubulin Modulators|tubulin modulators|mesh-ancestor
110590720|NCT00686127|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110590721|NCT00686127|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110590722|NCT00686127|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110590723|NCT00686127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110590724|NCT00718718|Methotrexate|methotrexate|mesh-list
110590725|NCT00718718|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110590726|NCT00718718|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110590727|NCT00718718|Abortifacient Agents|abortifacient agents|mesh-ancestor
110590728|NCT00718718|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110590729|NCT00718718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110590730|NCT00718718|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110590731|NCT00718718|Antimetabolites|antimetabolites|mesh-ancestor
110590732|NCT00718718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110590733|NCT00718718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110590734|NCT00718718|Dermatologic Agents|dermatologic agents|mesh-ancestor
110590735|NCT00718718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110234453|NCT05645718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110234454|NCT05645718|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110234455|NCT05645718|Tubulin Modulators|tubulin modulators|mesh-ancestor
110234456|NCT05645718|Antimitotic Agents|antimitotic agents|mesh-ancestor
110234457|NCT05645718|Mitosis Modulators|mitosis modulators|mesh-ancestor
110234458|NCT05645718|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110590736|NCT00718718|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110590737|NCT00718718|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110590738|NCT00718718|Immunologic Factors|immunologic factors|mesh-ancestor
110590739|NCT00718718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110590740|NCT00718718|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110590741|NCT00683787|Docetaxel|docetaxel|mesh-list
110590742|NCT00683787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110590743|NCT00683787|Tubulin Modulators|tubulin modulators|mesh-ancestor
110590744|NCT00683787|Antimitotic Agents|antimitotic agents|mesh-ancestor
110590745|NCT00683787|Mitosis Modulators|mitosis modulators|mesh-ancestor
110590746|NCT00683787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110590747|NCT02560935|Hydroxyurea|hydroxyurea|mesh-list
110590748|NCT02560935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110590749|NCT02560935|Antisickling Agents|antisickling agents|mesh-ancestor
110590750|NCT02560935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110590751|NCT02560935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110590752|NCT02560935|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110590753|NCT00750399|Ranibizumab|ranibizumab|mesh-list
110590754|NCT00750399|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110234514|NCT05559931|Serotonin Agents|serotonin agents|mesh-ancestor
110234515|NCT05559931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110234516|NCT05559931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110234517|NCT05559931|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110234518|NCT05559879|Dostarlimab|dostarlimab|mesh-list
110234534|NCT05473585|Nicotine|nicotine|mesh-list
110590755|NCT00750399|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110590756|NCT00750399|Growth Substances|growth substances|mesh-ancestor
110590757|NCT00750399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110590758|NCT00750399|Growth Inhibitors|growth inhibitors|mesh-ancestor
110590759|NCT00750399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110590760|NCT00756171|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
110590761|NCT00756171|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110590762|NCT00756171|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110590763|NCT00756171|Antimetabolites|antimetabolites|mesh-ancestor
110590764|NCT00756171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110590765|NCT00756171|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110590766|NCT00718640|Dexamethasone|dexamethasone|mesh-list
110590767|NCT00718640|Bortezomib|bortezomib|mesh-list
110590768|NCT00718640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110590769|NCT00718640|Antiemetics|antiemetics|mesh-ancestor
110234563|NCT05381948|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110590771|NCT00718640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110590772|NCT00718640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110590773|NCT00718640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110590774|NCT00718640|Glucocorticoids|glucocorticoids|mesh-ancestor
110590775|NCT00718640|Hormones|hormones|mesh-ancestor
110590776|NCT00718640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110590777|NCT00718640|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110590778|NCT00718640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110590779|NCT00753051|Haloperidol|haloperidol|mesh-list
110234621|NCT05253833|Antimetabolites|antimetabolites|mesh-ancestor
110234632|NCT05222971|Durvalumab|durvalumab|mesh-list
110590780|NCT00753051|Haloperidol decanoate|haloperidol decanoate|mesh-list
110590782|NCT00753051|Antiemetics|antiemetics|mesh-ancestor
110590783|NCT00753051|Autonomic Agents|autonomic agents|mesh-ancestor
110590784|NCT00753051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110590785|NCT00753051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110590786|NCT00753051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110590787|NCT00753051|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110017698|NCT05093790|Ticagrelor|ticagrelor|mesh-list
110590788|NCT00753051|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110590789|NCT00753051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110590790|NCT00753051|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110590791|NCT00753051|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110590792|NCT00753051|Dopamine Agents|dopamine agents|mesh-ancestor
110590793|NCT00753051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110590794|NCT00753051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110590795|NCT00753051|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110234686|NCT05074823|Sensory System Agents|sensory system agents|mesh-ancestor
110590796|NCT00753051|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110590797|NCT00753051|Serotonin Agents|serotonin agents|mesh-ancestor
110590798|NCT00753051|GABA Antagonists|gaba antagonists|mesh-ancestor
110590799|NCT00753051|GABA Agents|gaba agents|mesh-ancestor
110590800|NCT00753207|Epirubicin|epirubicin|mesh-list
110590801|NCT00753207|Lapatinib|lapatinib|mesh-list
110590802|NCT00753207|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110590803|NCT00753207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110590804|NCT00753207|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110590805|NCT00753207|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110590806|NCT00753207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110590807|NCT00753207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110590808|NCT00753207|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110590809|NCT00715910|Vaccines|vaccines|mesh-list
110590810|NCT00715910|Immunologic Factors|immunologic factors|mesh-ancestor
110590811|NCT00715910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110590812|NCT00715676|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
110590813|NCT00715676|Vitamins|vitamins|mesh-ancestor
110590814|NCT00715676|Micronutrients|micronutrients|mesh-ancestor
110590815|NCT00715676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110590816|NCT00715676|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110590817|NCT00718328|Simvastatin|simvastatin|mesh-list
110590818|NCT00718328|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110590819|NCT00718328|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110590820|NCT00718328|Antimetabolites|antimetabolites|mesh-ancestor
110590821|NCT00718328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110376729|NCT00195494|Etanercept|etanercept|mesh-list
110590822|NCT00718328|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110590823|NCT00718328|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110590824|NCT00718328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110590825|NCT02590874|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110590826|NCT02590874|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110590827|NCT02590874|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110590828|NCT02590874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110590829|NCT02590874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110590830|NCT02590874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110234747|NCT04976855|Analgesics|analgesics|mesh-ancestor
110590831|NCT02590874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110590832|NCT02590874|Analgesics|analgesics|mesh-ancestor
110590833|NCT02590874|Sensory System Agents|sensory system agents|mesh-ancestor
110590834|NCT02590874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110590835|NCT02590874|Antidepressive Agents|antidepressive agents|mesh-ancestor
110238222|NCT00431080|Epirubicin|epirubicin|mesh-list
110590836|NCT02590874|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110590837|NCT02590874|Dopamine Agents|dopamine agents|mesh-ancestor
110590839|NCT00715520|Carbidopa|carbidopa|mesh-list
110590840|NCT00715520|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
110590841|NCT00715520|Methylphenidate|methylphenidate|mesh-list
110590842|NCT00715520|Amphetamine|amphetamine|mesh-list
110590843|NCT00715520|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110590844|NCT00715520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110590845|NCT00715520|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110590846|NCT00715520|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110590847|NCT00715520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110590848|NCT00715520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110590849|NCT00715520|Dopamine Agents|dopamine agents|mesh-ancestor
110590850|NCT00715520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110590851|NCT00715520|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110590852|NCT00715520|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110590853|NCT00715520|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
110590854|NCT00715520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110590855|NCT00715520|Sympathomimetics|sympathomimetics|mesh-ancestor
110590856|NCT00715520|Autonomic Agents|autonomic agents|mesh-ancestor
110590857|NCT00715520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110590858|NCT00715520|Adrenergic Agents|adrenergic agents|mesh-ancestor
110590859|NCT00715520|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110590860|NCT00715520|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110590861|NCT00715520|Immunologic Factors|immunologic factors|mesh-ancestor
110590862|NCT00715520|Dopamine Agonists|dopamine agonists|mesh-ancestor
110590863|NCT00756873|Etoricoxib|etoricoxib|mesh-list
110590864|NCT00756873|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110590865|NCT00756873|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110590866|NCT00756873|Analgesics|analgesics|mesh-ancestor
110590867|NCT00756873|Sensory System Agents|sensory system agents|mesh-ancestor
110590868|NCT00756873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110590869|NCT00756873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110590870|NCT00756873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110234846|NCT04608448|Dermatologic Agents|dermatologic agents|mesh-ancestor
110590871|NCT00756873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110590872|NCT00756873|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110590873|NCT00756873|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110590874|NCT00756873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110590875|NCT00756873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110590876|NCT00790205|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110590877|NCT00790205|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110590878|NCT00790205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110590879|NCT00790205|Incretins|incretins|mesh-ancestor
110590880|NCT00790205|Hormones|hormones|mesh-ancestor
110590881|NCT00790205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110590882|NCT00790205|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110590883|NCT00790205|Protease Inhibitors|protease inhibitors|mesh-ancestor
110234902|NCT04318405|Micronutrients|micronutrients|mesh-ancestor
110234903|NCT04318405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110234904|NCT04318405|Hematinics|hematinics|mesh-ancestor
110234905|NCT04313790|Heparin|heparin|mesh-list
110234906|NCT04313790|Calcium heparin|calcium heparin|mesh-list
110234907|NCT04313790|Anticoagulants|anticoagulants|mesh-ancestor
110234908|NCT04313790|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110590885|NCT00790205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110590886|NCT04056039|Colchicine|colchicine|mesh-list
110590887|NCT04056039|Atorvastatin|atorvastatin|mesh-list
110590888|NCT04056039|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110590889|NCT04056039|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110590890|NCT04056039|Antimetabolites|antimetabolites|mesh-ancestor
110590891|NCT04056039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110590892|NCT04056039|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110590893|NCT04056039|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110590894|NCT04056039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110590895|NCT04056039|Gout Suppressants|gout suppressants|mesh-ancestor
110590896|NCT04056039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110590897|NCT04056039|Tubulin Modulators|tubulin modulators|mesh-ancestor
110590898|NCT04056039|Antimitotic Agents|antimitotic agents|mesh-ancestor
110590899|NCT04056039|Mitosis Modulators|mitosis modulators|mesh-ancestor
110590900|NCT04056039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110590902|NCT00715208|Cyclophosphamide|cyclophosphamide|mesh-list
110590903|NCT00715208|Rituximab|rituximab|mesh-list
110590904|NCT00715208|Doxorubicin|doxorubicin|mesh-list
110590905|NCT00715208|Bortezomib|bortezomib|mesh-list
110590906|NCT00715208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110590907|NCT00715208|Immunologic Factors|immunologic factors|mesh-ancestor
110590908|NCT00715208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110590909|NCT00715208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110590910|NCT00715208|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110590912|NCT00715208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110590913|NCT00715208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110590914|NCT00715208|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110590915|NCT00715208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110590916|NCT00715208|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110590917|NCT00715208|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110590918|NCT00715208|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110590919|NCT00715208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110590920|NCT00715208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110590921|NCT00715208|Glucocorticoids|glucocorticoids|mesh-ancestor
110094940|NCT01711749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110235087|NCT03582774|Sequestering Agents|sequestering agents|mesh-ancestor
110235088|NCT03582774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110590923|NCT00715208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110590924|NCT00715208|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110590925|NCT00919178|Vaccines|vaccines|mesh-list
110590926|NCT00919178|Immunologic Factors|immunologic factors|mesh-ancestor
110590927|NCT00919178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110590928|NCT02590250|Botulinum Toxins|botulinum toxins|mesh-list
110590929|NCT02590250|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110590930|NCT02590250|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110590931|NCT02590250|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110590932|NCT02590250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110590933|NCT02590250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110590934|NCT02590250|Cholinergic Agents|cholinergic agents|mesh-ancestor
110590935|NCT02590250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110590936|NCT02590250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110590937|NCT02590250|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110590938|NCT02590250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110590939|NCT00775463|Treprostinil|treprostinil|mesh-list
110235146|NCT03426891|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110235150|NCT03422536|Cetuximab|cetuximab|mesh-list
110590940|NCT00775463|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110590941|NCT02589782|Moxifloxacin|moxifloxacin|mesh-list
110590942|NCT02589782|Linezolid|linezolid|mesh-list
110590943|NCT02589782|Bedaquiline|bedaquiline|mesh-list
110590944|NCT02589782|Clofazimine|clofazimine|mesh-list
110590945|NCT02589782|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110590946|NCT02589782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110590947|NCT02589782|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110590948|NCT02589782|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110590949|NCT02589782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110590950|NCT02589782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110590951|NCT02589782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110590952|NCT02589782|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110590953|NCT02589782|Antitubercular Agents|antitubercular agents|mesh-ancestor
110590954|NCT02589782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110590955|NCT02589782|Leprostatic Agents|leprostatic agents|mesh-ancestor
110590957|NCT00918554|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110235204|NCT03213977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110235205|NCT03213977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110235206|NCT03213977|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110235207|NCT03213977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110590958|NCT00918554|Abortifacient Agents|abortifacient agents|mesh-ancestor
110590959|NCT00918554|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110590960|NCT00918554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110590961|NCT00918554|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110590962|NCT00918554|Antimetabolites|antimetabolites|mesh-ancestor
110590963|NCT00918554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110590964|NCT00918554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110590965|NCT00918554|Dermatologic Agents|dermatologic agents|mesh-ancestor
110590966|NCT00918554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110590967|NCT00918554|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110590968|NCT00918554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110590969|NCT00918554|Immunologic Factors|immunologic factors|mesh-ancestor
110590970|NCT00918554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110590971|NCT00918554|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110590972|NCT02590016|Insulin|insulin|mesh-list
110590973|NCT02590016|Insulin Aspart|insulin aspart|mesh-list
110590974|NCT02590016|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110590975|NCT02590016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110590976|NCT00768053|Etanercept|etanercept|mesh-list
110590977|NCT00768053|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110590978|NCT00768053|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110590979|NCT00768053|Analgesics|analgesics|mesh-ancestor
110590980|NCT00768053|Sensory System Agents|sensory system agents|mesh-ancestor
110590981|NCT00768053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110590982|NCT00768053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110590983|NCT00768053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110590984|NCT00768053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110590985|NCT00768053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110590986|NCT00768053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110590987|NCT00768053|Immunologic Factors|immunologic factors|mesh-ancestor
110590989|NCT00683475|Mitoxantrone|mitoxantrone|mesh-list
110590990|NCT00683475|Ramucirumab|ramucirumab|mesh-list
110590991|NCT00683475|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110235318|NCT01176474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110590992|NCT00683475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110590993|NCT00683475|Glucocorticoids|glucocorticoids|mesh-ancestor
110590994|NCT00683475|Hormones|hormones|mesh-ancestor
110590995|NCT00683475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110590996|NCT00683475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110590997|NCT00683475|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110590998|NCT00683475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110590999|NCT00683475|Analgesics|analgesics|mesh-ancestor
110591000|NCT00683475|Sensory System Agents|sensory system agents|mesh-ancestor
110591001|NCT00683475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110591002|NCT00683475|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110591003|NCT00683475|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110591004|NCT00683475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110591005|NCT00683475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110591006|NCT00683475|Immunologic Factors|immunologic factors|mesh-ancestor
110591007|NCT02589158|Atazanavir Sulfate|atazanavir sulfate|mesh-list
110591008|NCT02589158|Darunavir|darunavir|mesh-list
110591009|NCT02589158|Cobicistat|cobicistat|mesh-list
110591010|NCT02589158|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110591011|NCT02589158|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110591012|NCT02589158|Protease Inhibitors|protease inhibitors|mesh-ancestor
110591013|NCT02589158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110591014|NCT02589158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110591015|NCT02589158|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110591016|NCT02589158|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110591017|NCT02589158|Antiviral Agents|antiviral agents|mesh-ancestor
110235440|NCT00125229|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110235441|NCT00125229|Diuretics|diuretics|mesh-ancestor
110235442|NCT00125229|Natriuretic Agents|natriuretic agents|mesh-ancestor
110235444|NCT00126906|Pyrimethamine|pyrimethamine|mesh-list
110591018|NCT02589158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110591019|NCT02589158|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110591020|NCT02589158|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110591021|NCT00916253|Modafinil|modafinil|mesh-list
110591022|NCT00916253|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110591023|NCT00916253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110591024|NCT00916253|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
110591025|NCT00916253|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110591026|NCT00916253|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110591027|NCT00916253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110591028|NCT00757029|Norepinephrine|norepinephrine|mesh-list
110591029|NCT00757029|Methylphenidate|methylphenidate|mesh-list
110591030|NCT00757029|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110591031|NCT00757029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110235498|NCT00332761|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
110591032|NCT00757029|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110591033|NCT00757029|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110591034|NCT00757029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110591035|NCT00757029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110591036|NCT00757029|Dopamine Agents|dopamine agents|mesh-ancestor
110591037|NCT00757029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110591038|NCT00757029|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110591039|NCT00757029|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110150487|NCT00000256|Analgesics|analgesics|mesh-ancestor
110591040|NCT00757029|Adrenergic Agents|adrenergic agents|mesh-ancestor
110591041|NCT00757029|Sympathomimetics|sympathomimetics|mesh-ancestor
110591042|NCT00757029|Autonomic Agents|autonomic agents|mesh-ancestor
110235555|NCT00333112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110235556|NCT00333112|Urological Agents|urological agents|mesh-ancestor
110235557|NCT00333112|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110591043|NCT00757029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110591044|NCT00757029|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110591046|NCT04101929|Apatinib|apatinib|mesh-list
110591047|NCT04101929|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110591048|NCT04101929|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110591049|NCT04101929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110591050|NCT04101929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110591051|NCT04101929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110591052|NCT04101929|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110591053|NCT00918632|Axitinib|axitinib|mesh-list
110591054|NCT00918632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110235618|NCT00127257|Anticonvulsants|anticonvulsants|mesh-ancestor
110591055|NCT00918632|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110591056|NCT00918632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110591057|NCT00918632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110591058|NCT00751257|Acetylcysteine|acetylcysteine|mesh-list
110591059|NCT00751257|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110591060|NCT00751257|Antiviral Agents|antiviral agents|mesh-ancestor
110591061|NCT00751257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110591062|NCT00751257|Expectorants|expectorants|mesh-ancestor
110591063|NCT00751257|Respiratory System Agents|respiratory system agents|mesh-ancestor
110591064|NCT00751257|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110591065|NCT00751257|Antioxidants|antioxidants|mesh-ancestor
110591066|NCT00751257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110591067|NCT00751257|Protective Agents|protective agents|mesh-ancestor
110235678|NCT00333931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110235681|NCT00334048|Ropinirole|ropinirole|mesh-list
110591068|NCT00751257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110591069|NCT00751257|Antidotes|antidotes|mesh-ancestor
110591070|NCT00757185|Methyltestosterone|methyltestosterone|mesh-list
110591071|NCT00757185|Testosterone|testosterone|mesh-list
110591072|NCT00757185|Testosterone undecanoate|testosterone undecanoate|mesh-list
110591073|NCT00757185|Testosterone enanthate|testosterone enanthate|mesh-list
110591074|NCT00757185|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
110591076|NCT00757185|Androgens|androgens|mesh-ancestor
110591078|NCT00757185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110591079|NCT00757185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110591080|NCT00757185|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110591081|NCT00757185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110591082|NCT00757185|Anabolic Agents|anabolic agents|mesh-ancestor
110591083|NCT00757185|Hormone Antagonists|hormone antagonists|mesh-ancestor
110235741|NCT00334399|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110591084|NCT00751491|Clopidogrel|clopidogrel|mesh-list
110591085|NCT00751491|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110591086|NCT00751491|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110591087|NCT00751491|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110591088|NCT00751491|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110591089|NCT00751491|Purinergic Agents|purinergic agents|mesh-ancestor
110591090|NCT00751491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110591091|NCT00751491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110591092|NCT00751491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110591093|NCT02561169|Oseltamivir|oseltamivir|mesh-list
110591094|NCT02561169|Calcium Carbonate|calcium carbonate|mesh-list
110591095|NCT02561169|Antacids|antacids|mesh-ancestor
110235802|NCT00334672|Busulfan|busulfan|mesh-list
110235803|NCT00334672|Methotrexate|methotrexate|mesh-list
110235804|NCT00334672|Etoposide|etoposide|mesh-list
110591096|NCT02561169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110591097|NCT02561169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110591098|NCT02561169|Antiviral Agents|antiviral agents|mesh-ancestor
110591099|NCT02561169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110591100|NCT02561169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110591101|NCT00753597|Rituximab|rituximab|mesh-list
110591102|NCT00753597|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110591103|NCT00753597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110591104|NCT00753597|Immunologic Factors|immunologic factors|mesh-ancestor
110591105|NCT00753597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110591106|NCT00753597|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110591107|NCT00757419|Lesogaberan|lesogaberan|mesh-list
110591108|NCT00757419|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110591109|NCT00757419|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
110591110|NCT00757419|GABA Agonists|gaba agonists|mesh-ancestor
110591111|NCT00757419|GABA Agents|gaba agents|mesh-ancestor
110591112|NCT00757419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110591113|NCT00757419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110591114|NCT00757419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110591115|NCT00757731|Milnacipran|milnacipran|mesh-list
110591116|NCT00757731|Levomilnacipran|levomilnacipran|mesh-list
110591117|NCT00757731|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110591118|NCT00757731|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110591119|NCT00757731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110591120|NCT00757731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110591121|NCT00757731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110591122|NCT00757731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110591123|NCT00757731|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110591124|NCT00757731|Analgesics|analgesics|mesh-ancestor
110235862|NCT00089453|Glucocorticoids|glucocorticoids|mesh-ancestor
110591125|NCT00757731|Sensory System Agents|sensory system agents|mesh-ancestor
110591126|NCT00757731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110591127|NCT00757731|Antidepressive Agents|antidepressive agents|mesh-ancestor
110591128|NCT00757731|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110591130|NCT00753909|Bevacizumab|bevacizumab|mesh-list
110591131|NCT00753909|Carboplatin|carboplatin|mesh-list
110591132|NCT00753909|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110591133|NCT00753909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110591134|NCT00753909|Tubulin Modulators|tubulin modulators|mesh-ancestor
110591135|NCT00753909|Antimitotic Agents|antimitotic agents|mesh-ancestor
110591136|NCT00753909|Mitosis Modulators|mitosis modulators|mesh-ancestor
110591137|NCT00753909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110591138|NCT00753909|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110591139|NCT00753909|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110591140|NCT00753909|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110591141|NCT00753909|Growth Substances|growth substances|mesh-ancestor
110591142|NCT00753909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110235908|NCT00334867|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110235909|NCT00334867|Alkylating Agents|alkylating agents|mesh-ancestor
110591143|NCT00753909|Growth Inhibitors|growth inhibitors|mesh-ancestor
110591145|NCT02560155|Mupirocin|mupirocin|mesh-list
110591146|NCT02560155|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110591147|NCT02560155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110591148|NCT02560155|Disinfectants|disinfectants|mesh-ancestor
110591149|NCT02560155|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110591150|NCT02560155|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110591151|NCT02560155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110591152|NCT02560155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110591153|NCT02559921|Vaccines|vaccines|mesh-list
110591154|NCT02559921|Immunologic Factors|immunologic factors|mesh-ancestor
110591155|NCT02559921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110591156|NCT00754143|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110591157|NCT00754143|Immunologic Factors|immunologic factors|mesh-ancestor
110235967|NCT00089687|Dopamine Agents|dopamine agents|mesh-ancestor
110591158|NCT00754143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110591160|NCT05266040|Antiviral Agents|antiviral agents|mesh-ancestor
110591162|NCT00773747|Bortezomib|bortezomib|mesh-list
110591163|NCT00773747|Vorinostat|vorinostat|mesh-list
110591164|NCT00773747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110591165|NCT00773747|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110591166|NCT00773747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110591167|NCT00773747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110591168|NCT00784277|Oxycodone|oxycodone|mesh-list
110591169|NCT00784277|Tapentadol|tapentadol|mesh-list
110591170|NCT00784277|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110591171|NCT00784277|Narcotics|narcotics|mesh-ancestor
110591172|NCT00784277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110591173|NCT00784277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110591174|NCT00784277|Analgesics|analgesics|mesh-ancestor
110591175|NCT00784277|Sensory System Agents|sensory system agents|mesh-ancestor
110591176|NCT00784277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110591177|NCT00784277|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110591178|NCT00784277|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110591179|NCT00784277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110591180|NCT00784277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110591181|NCT00784277|Adrenergic Agents|adrenergic agents|mesh-ancestor
110591182|NCT00784277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110591183|NCT02588534|Etanercept|etanercept|mesh-list
110236024|NCT00343135|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
110236025|NCT00343135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110236030|NCT00343174|Ancrod|ancrod|mesh-list
110591184|NCT02588534|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110591185|NCT02588534|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110591186|NCT02588534|Analgesics|analgesics|mesh-ancestor
110591187|NCT02588534|Sensory System Agents|sensory system agents|mesh-ancestor
110591188|NCT02588534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110591189|NCT02588534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110591190|NCT02588534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110591191|NCT02588534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110591192|NCT02588534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110591193|NCT02588534|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110591194|NCT02588534|Immunologic Factors|immunologic factors|mesh-ancestor
110591195|NCT00682929|Dronabinol|dronabinol|mesh-list
110591196|NCT00682929|Hallucinogens|hallucinogens|mesh-ancestor
110591197|NCT00682929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110591198|NCT00682929|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110591199|NCT00682929|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110591200|NCT00682929|Analgesics|analgesics|mesh-ancestor
110591201|NCT00682929|Sensory System Agents|sensory system agents|mesh-ancestor
110591202|NCT00682929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110236073|NCT00343369|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110236074|NCT00343369|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110591203|NCT00682929|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
110591204|NCT00682929|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110591206|NCT00682929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110591207|NCT00682929|Hormones|hormones|mesh-ancestor
110238600|NCT00403026|Growth Substances|growth substances|mesh-ancestor
110591208|NCT00682929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110591209|NCT00758199|Moxifloxacin|moxifloxacin|mesh-list
110591210|NCT00758199|Prednisolone|prednisolone|mesh-list
110591211|NCT00758199|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110591212|NCT00758199|Methylprednisolone|methylprednisolone|mesh-list
110591213|NCT00758199|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110591214|NCT00758199|Prednisolone acetate|prednisolone acetate|mesh-list
110591215|NCT00758199|Bromfenac|bromfenac|mesh-list
110591216|NCT00758199|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
110591217|NCT00758199|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110591218|NCT00758199|Prednisolone phosphate|prednisolone phosphate|mesh-list
110591219|NCT00758199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110591220|NCT00758199|Glucocorticoids|glucocorticoids|mesh-ancestor
110591221|NCT00758199|Hormones|hormones|mesh-ancestor
110591222|NCT00758199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110591223|NCT00758199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110591224|NCT00758199|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110591225|NCT00758199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110591226|NCT00758199|Antiemetics|antiemetics|mesh-ancestor
110591227|NCT00758199|Autonomic Agents|autonomic agents|mesh-ancestor
110591228|NCT00758199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110591229|NCT00758199|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110591230|NCT00758199|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110591231|NCT00758199|Protective Agents|protective agents|mesh-ancestor
110236127|NCT00127920|Bevacizumab|bevacizumab|mesh-list
110591233|NCT00758199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110591234|NCT00758199|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110591235|NCT00758199|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110591236|NCT00758199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110591237|NCT00758199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110591238|NCT00758199|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110591239|NCT00758199|Contraceptive Agents|contraceptive agents|mesh-ancestor
110591240|NCT00758199|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110591241|NCT00758199|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110591242|NCT00758199|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110591243|NCT00758199|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110591244|NCT00758199|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110591245|NCT00758199|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110591246|NCT00758199|Analgesics|analgesics|mesh-ancestor
110150502|NCT00000427|Alendronate|alendronate|mesh-list
110591247|NCT00758199|Sensory System Agents|sensory system agents|mesh-ancestor
110591248|NCT00758199|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110591249|NCT05683808|Apixaban|apixaban|mesh-list
110591250|NCT05683808|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110591251|NCT05683808|Antithrombins|antithrombins|mesh-ancestor
110591252|NCT05683808|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110591253|NCT05683808|Protease Inhibitors|protease inhibitors|mesh-ancestor
110591254|NCT05683808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110591255|NCT05683808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110591256|NCT05683808|Anticoagulants|anticoagulants|mesh-ancestor
110591257|NCT00680745|Metformin|metformin|mesh-list
110591259|NCT00680745|Dapagliflozin|dapagliflozin|mesh-list
110591260|NCT00680745|Glimepiride|glimepiride|mesh-list
110591261|NCT00680745|Rosiglitazone|rosiglitazone|mesh-list
110591262|NCT00680745|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110591263|NCT00680745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110591264|NCT00680745|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110591265|NCT00680745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110591266|NCT00680745|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110591267|NCT00680745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110591268|NCT00680745|Immunologic Factors|immunologic factors|mesh-ancestor
110591269|NCT05434377|Vitamin D|vitamin d|mesh-list
110591270|NCT05434377|Ergocalciferols|ergocalciferols|mesh-list
110591271|NCT05434377|Vitamins|vitamins|mesh-ancestor
110591272|NCT05434377|Micronutrients|micronutrients|mesh-ancestor
110591273|NCT05434377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110591274|NCT05434377|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110591275|NCT05434377|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110591277|NCT05428293|Ibuprofen|ibuprofen|mesh-list
110591278|NCT05428293|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110591279|NCT05428293|Analgesics|analgesics|mesh-ancestor
110238673|NCT00433225|Antiemetics|antiemetics|mesh-ancestor
110591280|NCT05428293|Sensory System Agents|sensory system agents|mesh-ancestor
110591281|NCT05428293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110591282|NCT05428293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110591283|NCT05428293|Antipyretics|antipyretics|mesh-ancestor
110591284|NCT05428293|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110591285|NCT05428293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110591286|NCT05428293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110591287|NCT05428293|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110591288|NCT05428293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110591289|NCT05428293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110591290|NCT05427825|Anesthetics|anesthetics|mesh-list
110591291|NCT05427825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110591292|NCT05427825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110591293|NCT00680121|Benphothiamine|benphothiamine|mesh-list
110591294|NCT00680121|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110591295|NCT00680121|Immunologic Factors|immunologic factors|mesh-ancestor
110591296|NCT00680121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110591297|NCT00680121|Chelating Agents|chelating agents|mesh-ancestor
110591298|NCT00680121|Sequestering Agents|sequestering agents|mesh-ancestor
110591299|NCT00680121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110591301|NCT00754689|Rimonabant|rimonabant|mesh-list
110591302|NCT00754689|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110236262|NCT00402792|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
110591303|NCT00754689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110591304|NCT00754689|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110591305|NCT00754689|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
110591306|NCT00754689|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110591307|NCT00754689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110591308|NCT00754689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110591309|NCT00754689|Hormones|hormones|mesh-ancestor
110591310|NCT00754689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110591311|NCT00767819|Everolimus|everolimus|mesh-list
110591312|NCT00767819|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110591313|NCT00767819|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110591314|NCT00767819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110591315|NCT00767819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110591316|NCT00767819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110591317|NCT00767819|Immunologic Factors|immunologic factors|mesh-ancestor
110591318|NCT00767819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110591319|NCT00767819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110591320|NCT00758277|Levetiracetam|levetiracetam|mesh-list
110236325|NCT00127998|Mefloquine|mefloquine|mesh-list
110591321|NCT00758277|Anticonvulsants|anticonvulsants|mesh-ancestor
110591322|NCT00758277|Nootropic Agents|nootropic agents|mesh-ancestor
110591323|NCT00584870|Naproxen|naproxen|mesh-list
110591324|NCT00584870|Tanezumab|tanezumab|mesh-list
110591325|NCT00584870|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110591326|NCT00584870|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110591327|NCT00584870|Analgesics|analgesics|mesh-ancestor
110591328|NCT00584870|Sensory System Agents|sensory system agents|mesh-ancestor
110591329|NCT00584870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110591330|NCT00584870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110591331|NCT00584870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110591332|NCT00584870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110591333|NCT00584870|Gout Suppressants|gout suppressants|mesh-ancestor
110376812|NCT00194675|Testosterone|testosterone|mesh-list
110591334|NCT00584870|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110591335|NCT00584870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110236378|NCT00344734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110591336|NCT00584870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110591338|NCT00679341|Trastuzumab|trastuzumab|mesh-list
110591339|NCT00679341|Maytansine|maytansine|mesh-list
110591340|NCT00679341|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
110591341|NCT00679341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110591342|NCT00679341|Tubulin Modulators|tubulin modulators|mesh-ancestor
110591343|NCT00679341|Antimitotic Agents|antimitotic agents|mesh-ancestor
110591344|NCT00679341|Mitosis Modulators|mitosis modulators|mesh-ancestor
110591345|NCT00679341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110591346|NCT00679341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110591347|NCT00679341|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110591348|NCT00679341|Immunotoxins|immunotoxins|mesh-ancestor
110591349|NCT00679341|Immunoconjugates|immunoconjugates|mesh-ancestor
110591350|NCT00679341|Immunologic Factors|immunologic factors|mesh-ancestor
110591351|NCT00679341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110591352|NCT00680043|Epoetin Alfa|epoetin alfa|mesh-list
110591353|NCT00680043|Hematinics|hematinics|mesh-ancestor
110591354|NCT05436093|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110591355|NCT05436093|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110591356|NCT05436093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110591357|NCT05058092|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110591358|NCT00682539|Triamcinolone|triamcinolone|mesh-list
110591359|NCT00682539|Bevacizumab|bevacizumab|mesh-list
110591360|NCT00682539|Ranibizumab|ranibizumab|mesh-list
110236440|NCT00345163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110591361|NCT00682539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110591362|NCT00682539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110591363|NCT00682539|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110591364|NCT00682539|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110591365|NCT00682539|Growth Substances|growth substances|mesh-ancestor
110591366|NCT00682539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110591367|NCT00682539|Growth Inhibitors|growth inhibitors|mesh-ancestor
110591368|NCT00682539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110591369|NCT00682539|Glucocorticoids|glucocorticoids|mesh-ancestor
110591370|NCT00682539|Hormones|hormones|mesh-ancestor
110591371|NCT00682539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110591372|NCT00682461|Nicotine|nicotine|mesh-list
110591373|NCT00682461|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110591374|NCT00682461|Autonomic Agents|autonomic agents|mesh-ancestor
110591375|NCT00682461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110591376|NCT00682461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110591377|NCT00682461|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110591378|NCT00682461|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110591379|NCT00682461|Cholinergic Agents|cholinergic agents|mesh-ancestor
110591380|NCT00682461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110591381|NCT00682461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110591382|NCT00921765|Ketamine|ketamine|mesh-list
110591383|NCT00921765|Naloxone|naloxone|mesh-list
110591384|NCT00921765|Analgesics|analgesics|mesh-ancestor
110591385|NCT00921765|Sensory System Agents|sensory system agents|mesh-ancestor
110591386|NCT00921765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110591387|NCT00921765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110236491|NCT00128232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110591388|NCT00921765|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110591389|NCT00921765|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110591390|NCT00921765|Anesthetics, General|anesthetics, general|mesh-ancestor
110591392|NCT00921765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110591393|NCT00921765|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110591394|NCT00921765|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110591395|NCT00921765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110591396|NCT00921765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110591397|NCT00921765|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110591398|NCT05435781|Hydrocortisone|hydrocortisone|mesh-list
110591399|NCT05435781|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
110236539|NCT00345982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110236541|NCT00345982|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110591400|NCT05435781|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
110591401|NCT05435781|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
110591402|NCT05435781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110591403|NCT00755157|Bevacizumab|bevacizumab|mesh-list
110591404|NCT00755157|Docetaxel|docetaxel|mesh-list
110591405|NCT00755157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110591406|NCT00755157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110591407|NCT00755157|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110591408|NCT00755157|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110591409|NCT00755157|Growth Substances|growth substances|mesh-ancestor
110591410|NCT00755157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110591411|NCT00755157|Growth Inhibitors|growth inhibitors|mesh-ancestor
110591412|NCT00755157|Tubulin Modulators|tubulin modulators|mesh-ancestor
110591413|NCT00755157|Antimitotic Agents|antimitotic agents|mesh-ancestor
110591414|NCT00755157|Mitosis Modulators|mitosis modulators|mesh-ancestor
110591415|NCT00755157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110591416|NCT00919880|Paclitaxel|paclitaxel|mesh-list
110591417|NCT00919880|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110591418|NCT00919880|Carboplatin|carboplatin|mesh-list
110591419|NCT00919880|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110591420|NCT00919880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110591421|NCT00919880|Tubulin Modulators|tubulin modulators|mesh-ancestor
110236600|NCT00125814|Immunologic Factors|immunologic factors|mesh-ancestor
110236601|NCT00125814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110236603|NCT00346567|Lamivudine|lamivudine|mesh-list
110236604|NCT00346567|Emtricitabine|emtricitabine|mesh-list
110236605|NCT00346567|Zidovudine|zidovudine|mesh-list
110236606|NCT00346567|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110236607|NCT00346567|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
110236609|NCT00346567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110236612|NCT00346567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110591422|NCT00919880|Antimitotic Agents|antimitotic agents|mesh-ancestor
110591423|NCT00919880|Mitosis Modulators|mitosis modulators|mesh-ancestor
110591424|NCT00919880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110591425|NCT00755313|Cyclophosphamide|cyclophosphamide|mesh-list
110591426|NCT00755313|Carboplatin|carboplatin|mesh-list
110591428|NCT00755313|Doxorubicin|doxorubicin|mesh-list
110591429|NCT00755313|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110591430|NCT00755313|Trastuzumab|trastuzumab|mesh-list
110238820|NCT00433927|Vitamins|vitamins|mesh-ancestor
110591431|NCT00755313|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110591432|NCT00755313|Aromatase Inhibitors|aromatase inhibitors|mesh-list
110591433|NCT00755313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110591434|NCT00755313|Immunologic Factors|immunologic factors|mesh-ancestor
110591435|NCT00755313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110236647|NCT04728932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110236648|NCT04728932|Protective Agents|protective agents|mesh-ancestor
110591436|NCT00755313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110591437|NCT00755313|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110591438|NCT00755313|Alkylating Agents|alkylating agents|mesh-ancestor
110591439|NCT00755313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110591440|NCT00755313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110591441|NCT00755313|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110591442|NCT00755313|Tubulin Modulators|tubulin modulators|mesh-ancestor
110591443|NCT00755313|Antimitotic Agents|antimitotic agents|mesh-ancestor
110591444|NCT00755313|Mitosis Modulators|mitosis modulators|mesh-ancestor
110591445|NCT00755313|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110591446|NCT00755313|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110591447|NCT00755313|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110591448|NCT00755313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110236706|NCT00126009|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110236712|NCT00346918|Sirolimus|sirolimus|mesh-list
110591449|NCT00755313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110591450|NCT00755313|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110591451|NCT00755313|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110591452|NCT00755313|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110591453|NCT00755313|Hormone Antagonists|hormone antagonists|mesh-ancestor
110591454|NCT00755313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110591456|NCT04082858|Ketamine|ketamine|mesh-list
110591457|NCT04082858|Analgesics|analgesics|mesh-ancestor
110591458|NCT04082858|Sensory System Agents|sensory system agents|mesh-ancestor
110236769|NCT00347152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110591459|NCT04082858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110591460|NCT04082858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110591461|NCT04082858|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110591462|NCT04082858|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110591463|NCT04082858|Anesthetics, General|anesthetics, general|mesh-ancestor
110591464|NCT04082858|Anesthetics|anesthetics|mesh-ancestor
110236837|NCT00347425|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110591465|NCT04082858|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110591466|NCT04082858|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110591467|NCT04082858|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110591468|NCT04082858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110591469|NCT04082858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110591470|NCT04082858|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110591471|NCT04082858|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110591472|NCT04082858|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110591473|NCT04082858|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110591474|NCT04082858|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110591477|NCT00679029|Cyclophosphamide|cyclophosphamide|mesh-list
110591478|NCT00679029|Bevacizumab|bevacizumab|mesh-list
110591479|NCT00679029|Gemcitabine|gemcitabine|mesh-list
110591480|NCT00679029|Doxorubicin|doxorubicin|mesh-list
110591481|NCT00679029|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110591482|NCT00679029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110236917|NCT00126204|Doxycycline|doxycycline|mesh-list
110591483|NCT00679029|Antibodies|antibodies|mesh-list
110591484|NCT00679029|Immunoglobulins|immunoglobulins|mesh-list
110591485|NCT00679029|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110591486|NCT00679029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110150558|NCT00000472|Plasminogen|plasminogen|mesh-list
110591487|NCT00679029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110591488|NCT00679029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110591489|NCT00679029|Immunologic Factors|immunologic factors|mesh-ancestor
110591490|NCT00679029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110591491|NCT00679029|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110591492|NCT00679029|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110591493|NCT00679029|Alkylating Agents|alkylating agents|mesh-ancestor
110236965|NCT04705519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110591494|NCT00679029|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110591495|NCT00679029|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110591496|NCT00679029|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110591497|NCT00679029|Growth Substances|growth substances|mesh-ancestor
110591498|NCT00679029|Growth Inhibitors|growth inhibitors|mesh-ancestor
110591499|NCT00679029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110591500|NCT00679029|Antimetabolites|antimetabolites|mesh-ancestor
110591501|NCT00679029|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110591502|NCT00679029|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110591503|NCT00679029|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110591504|NCT00679029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110591505|NCT00919022|Cyproterone Acetate|cyproterone acetate|mesh-list
110591507|NCT00919022|Androgen Antagonists|androgen antagonists|mesh-ancestor
110238893|NCT00434083|Gout Suppressants|gout suppressants|mesh-ancestor
110591508|NCT00919022|Hormone Antagonists|hormone antagonists|mesh-ancestor
110591509|NCT00919022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110591510|NCT00919022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110591511|NCT00919022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110237029|NCT01058863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110591513|NCT00919022|Contraceptive Agents|contraceptive agents|mesh-ancestor
110591514|NCT00919022|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110591515|NCT05004350|Fluorouracil|fluorouracil|mesh-list
110591516|NCT05004350|Irinotecan|irinotecan|mesh-list
110591517|NCT05004350|Cetuximab|cetuximab|mesh-list
110591518|NCT05004350|Antimetabolites|antimetabolites|mesh-ancestor
110591519|NCT05004350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110591520|NCT05004350|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110591521|NCT05004350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110591522|NCT05004350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110591523|NCT05004350|Immunologic Factors|immunologic factors|mesh-ancestor
110591524|NCT05004350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110591525|NCT05004350|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110237086|NCT01058005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110237087|NCT01058005|Immunologic Factors|immunologic factors|mesh-ancestor
110237088|NCT01058005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110591526|NCT05004350|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110591527|NCT05004350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110591528|NCT05004350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110591529|NCT05122221|Cyclophosphamide|cyclophosphamide|mesh-list
110591530|NCT05122221|Fludarabine|fludarabine|mesh-list
110591531|NCT05122221|Interleukin-2|interleukin-2|mesh-list
110591532|NCT05122221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110591533|NCT05122221|Immunologic Factors|immunologic factors|mesh-ancestor
110237145|NCT03929718|Natriuretic Agents|natriuretic agents|mesh-ancestor
110237146|NCT01056523|Cytarabine|cytarabine|mesh-list
110237147|NCT01056523|Ribavirin|ribavirin|mesh-list
110018012|NCT03341910|Tazarotene|tazarotene|mesh-list
110237148|NCT01056523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110237149|NCT01056523|Antimetabolites|antimetabolites|mesh-ancestor
110237150|NCT01056523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110237151|NCT01056523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110237157|NCT00091715|Bosentan|bosentan|mesh-list
110591534|NCT05122221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110591536|NCT05122221|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110591537|NCT05122221|Alkylating Agents|alkylating agents|mesh-ancestor
110591538|NCT05122221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110591539|NCT05122221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110591540|NCT05122221|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110591541|NCT05122221|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110591542|NCT05122221|Analgesics|analgesics|mesh-ancestor
110591543|NCT05122221|Sensory System Agents|sensory system agents|mesh-ancestor
110591544|NCT05122221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110591545|NCT03802305|Anesthetics|anesthetics|mesh-list
110591546|NCT03802305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110591547|NCT03802305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110591548|NCT02587052|Tacrolimus|tacrolimus|mesh-list
110591549|NCT02587052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110591550|NCT02587052|Immunologic Factors|immunologic factors|mesh-ancestor
110591551|NCT02587052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110591552|NCT02587052|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110591553|NCT02587052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110591554|NCT02587052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110591555|NCT02587130|Ketamine|ketamine|mesh-list
110591556|NCT02587130|Analgesics|analgesics|mesh-ancestor
110237278|NCT00428311|Androgen Antagonists|androgen antagonists|mesh-ancestor
110237282|NCT00092300|Valdecoxib|valdecoxib|mesh-list
110591557|NCT02587130|Sensory System Agents|sensory system agents|mesh-ancestor
110591558|NCT02587130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110591559|NCT02587130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110591560|NCT02587130|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110591561|NCT02587130|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110591562|NCT02587130|Anesthetics, General|anesthetics, general|mesh-ancestor
110591563|NCT02587130|Anesthetics|anesthetics|mesh-ancestor
110591564|NCT02587130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110591565|NCT02587130|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110591566|NCT02587130|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110591567|NCT02587130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110591568|NCT02587130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110591570|NCT02559141|Norepinephrine|norepinephrine|mesh-list
110591571|NCT02559141|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110591572|NCT02559141|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110591573|NCT02559141|Adrenergic Agents|adrenergic agents|mesh-ancestor
110591574|NCT02559141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110591575|NCT02559141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110591576|NCT02559141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110591577|NCT02559141|Sympathomimetics|sympathomimetics|mesh-ancestor
110591578|NCT02559141|Autonomic Agents|autonomic agents|mesh-ancestor
110591579|NCT02559141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110591580|NCT02559141|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110238968|NCT00099008|Hormones|hormones|mesh-ancestor
110591582|NCT02559141|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
110591583|NCT02559141|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110591584|NCT02559141|Protective Agents|protective agents|mesh-ancestor
110591585|NCT02561013|Monensin|monensin|mesh-list
110591586|NCT02561013|Antifungal Agents|antifungal agents|mesh-ancestor
110591587|NCT02561013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110591588|NCT02561013|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110591589|NCT02561013|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110591590|NCT02561013|Coccidiostats|coccidiostats|mesh-ancestor
110591591|NCT02561013|Proton Ionophores|proton ionophores|mesh-ancestor
110591592|NCT02561013|Uncoupling Agents|uncoupling agents|mesh-ancestor
110591593|NCT02561013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110591594|NCT02561013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110591595|NCT02561013|Ionophores|ionophores|mesh-ancestor
110591596|NCT02561013|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110591597|NCT02561013|Sodium Ionophores|sodium ionophores|mesh-ancestor
110591598|NCT00678795|Nabiximols|nabiximols|mesh-list
110591599|NCT00678795|Analgesics|analgesics|mesh-ancestor
110237403|NCT05561049|Immunologic Factors|immunologic factors|mesh-ancestor
110591600|NCT00678795|Sensory System Agents|sensory system agents|mesh-ancestor
110591601|NCT00678795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110591602|NCT00678795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110591603|NCT03417687|Xenon|xenon|mesh-list
110591604|NCT03417687|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110591605|NCT03417687|Anesthetics, General|anesthetics, general|mesh-ancestor
110591606|NCT03417687|Anesthetics|anesthetics|mesh-ancestor
110591607|NCT03417687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110591608|NCT03417687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110591609|NCT04767698|Belimumab|belimumab|mesh-list
110591610|NCT04767698|Ocrelizumab|ocrelizumab|mesh-list
110591611|NCT04767698|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110591612|NCT04767698|Immunologic Factors|immunologic factors|mesh-ancestor
110591613|NCT04767698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110591614|NCT04049253|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110591615|NCT03205137|Amlodipine|amlodipine|mesh-list
110591616|NCT03205137|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110591617|NCT03205137|Telmisartan|telmisartan|mesh-list
110591618|NCT03205137|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
110591619|NCT03205137|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
110591620|NCT03205137|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110591621|NCT03205137|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110591622|NCT03205137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110591623|NCT03205137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110591624|NCT03205137|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110591625|NCT03205137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110237445|NCT00093509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110237446|NCT00093509|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110237447|NCT00093509|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110237448|NCT00093509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110237449|NCT00093509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110237450|NCT00093509|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110591627|NCT03205137|Diuretics|diuretics|mesh-ancestor
110591628|NCT03205137|Natriuretic Agents|natriuretic agents|mesh-ancestor
110591629|NCT03205137|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110591630|NCT03205137|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110591631|NCT03205137|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110591632|NCT00678561|Tofacitinib|tofacitinib|mesh-list
110591633|NCT00678561|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
110591634|NCT00678561|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110591635|NCT00678561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110591636|NCT00678561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110591637|NCT05683340|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
110591638|NCT05683340|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110591639|NCT05683340|Antimetabolites|antimetabolites|mesh-ancestor
110591640|NCT05683340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110591641|NCT05683340|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110591642|NCT05683340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110591643|NCT05683340|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110591644|NCT05683340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110591645|NCT04081376|Hydromorphone|hydromorphone|mesh-list
110591646|NCT04081376|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110591647|NCT04081376|Narcotics|narcotics|mesh-ancestor
110591648|NCT04081376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110591649|NCT04081376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110591650|NCT04081376|Analgesics|analgesics|mesh-ancestor
110591651|NCT04081376|Sensory System Agents|sensory system agents|mesh-ancestor
110591652|NCT04081376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110591653|NCT02584400|Imidazole|imidazole|mesh-list
110591654|NCT02584400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110591655|NCT02584400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110591656|NCT02586194|Peficitinib|peficitinib|mesh-list
110591657|NCT02586194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110376864|NCT00192023|Adrenergic Agents|adrenergic agents|mesh-ancestor
110591658|NCT02586194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110591659|NCT02586194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110591661|NCT02586194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110591662|NCT00761241|Interferons|interferons|mesh-list
110591663|NCT00761241|Interferon-alpha|interferon-alpha|mesh-list
110591664|NCT00761241|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
110591665|NCT00761241|Gemcitabine|gemcitabine|mesh-list
110591667|NCT00761241|Oxaliplatin|oxaliplatin|mesh-list
110591668|NCT00761241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110591669|NCT00761241|Antimetabolites|antimetabolites|mesh-ancestor
110591670|NCT00761241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110591671|NCT00761241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110591672|NCT00761241|Tubulin Modulators|tubulin modulators|mesh-ancestor
110591673|NCT00761241|Antimitotic Agents|antimitotic agents|mesh-ancestor
110591674|NCT00761241|Mitosis Modulators|mitosis modulators|mesh-ancestor
110591675|NCT00761241|Antiviral Agents|antiviral agents|mesh-ancestor
110591676|NCT00761241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110591677|NCT00761241|Immunologic Factors|immunologic factors|mesh-ancestor
110591678|NCT00761241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110591679|NCT04585022|Cimetidine|cimetidine|mesh-list
110591680|NCT04585022|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110591681|NCT04585022|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110591682|NCT04585022|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110591683|NCT04585022|Histamine Antagonists|histamine antagonists|mesh-ancestor
110591684|NCT04585022|Histamine Agents|histamine agents|mesh-ancestor
110591685|NCT04585022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110591686|NCT04585022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110591687|NCT04585022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110591688|NCT04585022|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110591689|NCT04585022|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110591690|NCT04585022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110591691|NCT02981979|Prednisone|prednisone|mesh-list
110591692|NCT02981979|Leflunomide|leflunomide|mesh-list
110591693|NCT02981979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110591694|NCT02981979|Glucocorticoids|glucocorticoids|mesh-ancestor
110591695|NCT02981979|Hormones|hormones|mesh-ancestor
110591696|NCT02981979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110591697|NCT02981979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110591698|NCT02981979|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110591699|NCT02981979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110591700|NCT02981979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110591701|NCT02981979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110591702|NCT02981979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110591703|NCT02981979|Immunologic Factors|immunologic factors|mesh-ancestor
110591704|NCT04049409|Trastuzumab|trastuzumab|mesh-list
110591705|NCT04049409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110591706|NCT04049409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110591707|NCT00920660|Prednisolone|prednisolone|mesh-list
110591708|NCT00920660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110591709|NCT00920660|Glucocorticoids|glucocorticoids|mesh-ancestor
110591710|NCT00920660|Hormones|hormones|mesh-ancestor
110591711|NCT00920660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110591712|NCT00920660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110591713|NCT00920660|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110591714|NCT00920660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110591715|NCT02583464|Tenofovir|tenofovir|mesh-list
110591716|NCT02583464|Emtricitabine|emtricitabine|mesh-list
110591717|NCT02583464|Antiviral Agents|antiviral agents|mesh-ancestor
110591718|NCT02583464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110237647|NCT00094406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110237648|NCT00094484|Cinacalcet|cinacalcet|mesh-list
110237649|NCT00094484|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110237650|NCT00094484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110237651|NCT00094484|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
110237652|NCT00094484|Hormone Antagonists|hormone antagonists|mesh-ancestor
110591719|NCT02583464|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110591720|NCT02583464|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110591721|NCT02583464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110376866|NCT00192023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110591722|NCT02583464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110591724|NCT02583464|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110591725|NCT00675597|Bevacizumab|bevacizumab|mesh-list
110591726|NCT00675597|Docetaxel|docetaxel|mesh-list
110239117|NCT00099554|Sensory System Agents|sensory system agents|mesh-ancestor
110591727|NCT00675597|Vinorelbine|vinorelbine|mesh-list
110591728|NCT00675597|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110591729|NCT00675597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110591730|NCT00675597|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110591731|NCT00675597|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110591732|NCT00675597|Growth Substances|growth substances|mesh-ancestor
110591733|NCT00675597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110591734|NCT00675597|Growth Inhibitors|growth inhibitors|mesh-ancestor
110591735|NCT00675597|Tubulin Modulators|tubulin modulators|mesh-ancestor
110018099|NCT03453060|Thrombin|thrombin|mesh-list
110237702|NCT02415309|Melatonin|melatonin|mesh-list
110591736|NCT00675597|Antimitotic Agents|antimitotic agents|mesh-ancestor
110591737|NCT00675597|Mitosis Modulators|mitosis modulators|mesh-ancestor
110591738|NCT00675597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110591739|NCT00675597|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110591741|NCT02677545|Clopidogrel|clopidogrel|mesh-list
110591742|NCT02677545|Ticagrelor|ticagrelor|mesh-list
110591743|NCT02677545|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110591744|NCT02677545|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110591745|NCT02677545|Analgesics|analgesics|mesh-ancestor
110591746|NCT02677545|Sensory System Agents|sensory system agents|mesh-ancestor
110591747|NCT02677545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110591748|NCT02677545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110591749|NCT02677545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110591750|NCT02677545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110591751|NCT02677545|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110591752|NCT02677545|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110591753|NCT02677545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110237749|NCT00095225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110237750|NCT00095225|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110237751|NCT00095225|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110591754|NCT02677545|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110591755|NCT02677545|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110591756|NCT02677545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110591758|NCT02677545|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110591759|NCT02677545|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110591760|NCT02677545|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110591761|NCT02677545|Purinergic Agents|purinergic agents|mesh-ancestor
110591762|NCT02677545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110591763|NCT04079426|Dimercaprol|dimercaprol|mesh-list
110591764|NCT04079426|Chelating Agents|chelating agents|mesh-ancestor
110591765|NCT04079426|Sequestering Agents|sequestering agents|mesh-ancestor
110591766|NCT04079426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110591767|NCT00675441|Lenalidomide|lenalidomide|mesh-list
110591768|NCT00675441|Immunologic Factors|immunologic factors|mesh-ancestor
110591769|NCT00675441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110591770|NCT00675441|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110591771|NCT00675441|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110237804|NCT00429208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110591772|NCT00675441|Growth Substances|growth substances|mesh-ancestor
110591773|NCT00675441|Growth Inhibitors|growth inhibitors|mesh-ancestor
110591774|NCT00675441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110591775|NCT02559297|Sevoflurane|sevoflurane|mesh-list
110591776|NCT02559297|Desflurane|desflurane|mesh-list
110591777|NCT02559297|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110591778|NCT02559297|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110591779|NCT02559297|Anesthetics, General|anesthetics, general|mesh-ancestor
110591780|NCT02559297|Anesthetics|anesthetics|mesh-ancestor
110591781|NCT02559297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110591782|NCT02559297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110591783|NCT02558517|Prednisone|prednisone|mesh-list
110591784|NCT02558517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110591785|NCT02558517|Glucocorticoids|glucocorticoids|mesh-ancestor
110591786|NCT02558517|Hormones|hormones|mesh-ancestor
110237861|NCT00095810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110237909|NCT00095927|Amifostine|amifostine|mesh-list
110591787|NCT02558517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110591788|NCT02558517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110591789|NCT02558517|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110591790|NCT02558517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110591791|NCT00674973|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110591792|NCT00674973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110591793|NCT00674973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110591794|NCT00674973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110591795|NCT00674973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110591798|NCT00673179|Doxorubicin|doxorubicin|mesh-list
110591799|NCT00673179|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110591800|NCT00673179|Methotrexate|methotrexate|mesh-list
110591801|NCT00673179|Ifosfamide|ifosfamide|mesh-list
110591802|NCT00673179|Dexrazoxane|dexrazoxane|mesh-list
110591803|NCT00673179|Razoxane|razoxane|mesh-list
110591804|NCT00673179|Sargramostim|sargramostim|mesh-list
110237922|NCT00429754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110591805|NCT00673179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110591806|NCT00673179|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110591807|NCT00673179|Antimetabolites|antimetabolites|mesh-ancestor
110591808|NCT00673179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110591809|NCT00673179|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110591810|NCT00673179|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110591811|NCT00673179|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110237983|NCT01803594|Antimetabolites|antimetabolites|mesh-ancestor
110591812|NCT00673179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110591813|NCT00673179|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110591814|NCT00673179|Abortifacient Agents|abortifacient agents|mesh-ancestor
110591815|NCT00673179|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110591816|NCT00673179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110591817|NCT00673179|Dermatologic Agents|dermatologic agents|mesh-ancestor
110591818|NCT00673179|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110591819|NCT00673179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110591821|NCT00673179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110591822|NCT00673179|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110591823|NCT00673179|Antidotes|antidotes|mesh-ancestor
110591824|NCT00673179|Protective Agents|protective agents|mesh-ancestor
110591825|NCT00673179|Vitamin B Complex|vitamin b complex|mesh-ancestor
110591826|NCT00673179|Vitamins|vitamins|mesh-ancestor
110591827|NCT00673179|Micronutrients|micronutrients|mesh-ancestor
110591828|NCT00673179|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110591829|NCT00673179|Alkylating Agents|alkylating agents|mesh-ancestor
110591830|NCT00673179|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110591831|NCT00673179|Antimitotic Agents|antimitotic agents|mesh-ancestor
110591832|NCT00673179|Mitosis Modulators|mitosis modulators|mesh-ancestor
110238051|NCT01726452|Vitamins|vitamins|mesh-ancestor
110238052|NCT01726452|Micronutrients|micronutrients|mesh-ancestor
110591833|NCT00758433|Capsaicin|capsaicin|mesh-list
110591834|NCT00758433|Antipruritics|antipruritics|mesh-ancestor
110591835|NCT00758433|Dermatologic Agents|dermatologic agents|mesh-ancestor
110591836|NCT00758433|Sensory System Agents|sensory system agents|mesh-ancestor
110591837|NCT00758433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110591838|NCT00758433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110591839|NCT00584012|Docetaxel|docetaxel|mesh-list
110591840|NCT00584012|Lovastatin|lovastatin|mesh-list
110591841|NCT00584012|L 647318|l 647318|mesh-list
110591842|NCT00584012|Dihydromevinolin|dihydromevinolin|mesh-list
110591843|NCT00584012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110591844|NCT00584012|Tubulin Modulators|tubulin modulators|mesh-ancestor
110591845|NCT00584012|Antimitotic Agents|antimitotic agents|mesh-ancestor
110591846|NCT00584012|Mitosis Modulators|mitosis modulators|mesh-ancestor
110238105|NCT00130572|Pimecrolimus|pimecrolimus|mesh-list
110238106|NCT00130572|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110591847|NCT00584012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110591848|NCT00584012|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110591849|NCT00584012|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110591850|NCT00584012|Antimetabolites|antimetabolites|mesh-ancestor
110591851|NCT00584012|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110591852|NCT00584012|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110591853|NCT00584012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110591854|NCT05435846|Trametinib|trametinib|mesh-list
110591855|NCT05435846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110591856|NCT05435846|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110591857|NCT05435846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110591858|NCT05435846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110591859|NCT00920270|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110238166|NCT00430924|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110591861|NCT00920270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110591862|NCT04078724|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
110591863|NCT04078724|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110591864|NCT04078724|Antidepressive Agents|antidepressive agents|mesh-ancestor
110591865|NCT04078724|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110591867|NCT02585882|Cariostatic Agents|cariostatic agents|mesh-ancestor
110591868|NCT02585882|Protective Agents|protective agents|mesh-ancestor
110591869|NCT02585882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110591870|NCT02585648|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110591871|NCT02585648|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110238230|NCT00431080|Mitosis Modulators|mitosis modulators|mesh-ancestor
110591873|NCT02584010|Trace Elements|trace elements|mesh-ancestor
110591874|NCT02584010|Micronutrients|micronutrients|mesh-ancestor
110591875|NCT02584010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110591876|NCT02585804|Dapagliflozin|dapagliflozin|mesh-list
110591877|NCT02585804|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110591878|NCT02585804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110591879|NCT02585804|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110591880|NCT02585804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110239269|NCT00132561|Artesunate|artesunate|mesh-list
110591882|NCT02582996|Dihydroergotamine|dihydroergotamine|mesh-list
110591883|NCT02582996|Metoclopramide|metoclopramide|mesh-list
110591884|NCT02582996|Caffeine|caffeine|mesh-list
110591885|NCT02582996|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110591886|NCT02582996|Analgesics|analgesics|mesh-ancestor
110591887|NCT02582996|Sensory System Agents|sensory system agents|mesh-ancestor
110591888|NCT02582996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110591889|NCT02582996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110591890|NCT02582996|Antipyretics|antipyretics|mesh-ancestor
110591891|NCT02582996|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110238292|NCT00431236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110591892|NCT02582996|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110591893|NCT02582996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110591894|NCT02582996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110591895|NCT02582996|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110591896|NCT02582996|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110591897|NCT02582996|Purinergic Agents|purinergic agents|mesh-ancestor
110591898|NCT02582996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110591899|NCT02582996|Antiemetics|antiemetics|mesh-ancestor
110591900|NCT02582996|Autonomic Agents|autonomic agents|mesh-ancestor
110591901|NCT02582996|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110591902|NCT02582996|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110591903|NCT02582996|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110591904|NCT02582996|Dopamine Agents|dopamine agents|mesh-ancestor
110238344|NCT00431392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110591905|NCT02582996|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110591906|NCT02582996|Dopamine Agonists|dopamine agonists|mesh-ancestor
110591907|NCT02585570|Phenylephrine|phenylephrine|mesh-list
110591908|NCT02585570|Oxymetazoline|oxymetazoline|mesh-list
110591909|NCT02585570|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110591910|NCT02585570|Mydriatics|mydriatics|mesh-ancestor
110591911|NCT02585570|Autonomic Agents|autonomic agents|mesh-ancestor
110591912|NCT02585570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110591913|NCT02585570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110591914|NCT02585570|Sympathomimetics|sympathomimetics|mesh-ancestor
110591915|NCT02585570|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110591916|NCT02585570|Nasal Decongestants|nasal decongestants|mesh-ancestor
110591917|NCT02585570|Respiratory System Agents|respiratory system agents|mesh-ancestor
110591918|NCT02585570|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110591919|NCT02585570|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110591920|NCT02585570|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110591921|NCT02585570|Adrenergic Agents|adrenergic agents|mesh-ancestor
110591922|NCT02585570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110591923|NCT02585570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110591924|NCT02585570|Protective Agents|protective agents|mesh-ancestor
110591925|NCT02583854|Hemostatics|hemostatics|mesh-list
110591926|NCT02583854|Coagulants|coagulants|mesh-ancestor
110591927|NCT00764907|Leucovorin|leucovorin|mesh-list
110591928|NCT00764907|Cytarabine|cytarabine|mesh-list
110591929|NCT00764907|Dexamethasone|dexamethasone|mesh-list
110238468|NCT04711044|Menthol|menthol|mesh-list
110591930|NCT00764907|Prednisone|prednisone|mesh-list
110591931|NCT00764907|Cyclophosphamide|cyclophosphamide|mesh-list
110591932|NCT00764907|Ifosfamide|ifosfamide|mesh-list
110591933|NCT00764907|Doxorubicin|doxorubicin|mesh-list
110591934|NCT00764907|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110591935|NCT00764907|Methotrexate|methotrexate|mesh-list
110591936|NCT00764907|Etoposide|etoposide|mesh-list
110591937|NCT00764907|Vincristine|vincristine|mesh-list
110591938|NCT00764907|Daunorubicin|daunorubicin|mesh-list
110591939|NCT00764907|Asparaginase|asparaginase|mesh-list
110591940|NCT00764907|Mercaptopurine|mercaptopurine|mesh-list
110591941|NCT00764907|Thioguanine|thioguanine|mesh-list
110591942|NCT00764907|Vindesine|vindesine|mesh-list
110591943|NCT00764907|Levoleucovorin|levoleucovorin|mesh-list
110591944|NCT00764907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110591945|NCT00764907|Immunologic Factors|immunologic factors|mesh-ancestor
110591946|NCT00764907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110591947|NCT00764907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110591948|NCT00764907|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110591949|NCT00764907|Alkylating Agents|alkylating agents|mesh-ancestor
110591950|NCT00764907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110238602|NCT00403026|Growth Inhibitors|growth inhibitors|mesh-ancestor
110591951|NCT00764907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110591952|NCT00764907|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110591953|NCT00764907|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110591955|NCT00764907|Autonomic Agents|autonomic agents|mesh-ancestor
110239342|NCT00100646|Antimetabolites|antimetabolites|mesh-ancestor
110591956|NCT00764907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110591957|NCT00764907|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110591958|NCT00764907|Glucocorticoids|glucocorticoids|mesh-ancestor
110591959|NCT00764907|Hormones|hormones|mesh-ancestor
110591960|NCT00764907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110238665|NCT00433225|Prednisolone phosphate|prednisolone phosphate|mesh-list
110238668|NCT00433225|Hormones|hormones|mesh-ancestor
110591961|NCT00764907|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110591962|NCT00764907|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110591963|NCT00764907|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110591964|NCT00764907|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110591965|NCT00764907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110591966|NCT00764907|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110591967|NCT00764907|Abortifacient Agents|abortifacient agents|mesh-ancestor
110591968|NCT00764907|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110591969|NCT00764907|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110591970|NCT00764907|Antimetabolites|antimetabolites|mesh-ancestor
110591971|NCT00764907|Dermatologic Agents|dermatologic agents|mesh-ancestor
110591972|NCT00764907|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110591973|NCT00764907|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110591974|NCT00764907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110591975|NCT00764907|Antiviral Agents|antiviral agents|mesh-ancestor
110238726|NCT00433459|Tubulin Modulators|tubulin modulators|mesh-ancestor
110591976|NCT00764907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110591978|NCT00764907|Protective Agents|protective agents|mesh-ancestor
110591979|NCT00764907|Vitamin B Complex|vitamin b complex|mesh-ancestor
110591980|NCT00764907|Vitamins|vitamins|mesh-ancestor
110591981|NCT00764907|Micronutrients|micronutrients|mesh-ancestor
110591982|NCT00764907|Tubulin Modulators|tubulin modulators|mesh-ancestor
110591983|NCT00764907|Antimitotic Agents|antimitotic agents|mesh-ancestor
110591984|NCT00764907|Mitosis Modulators|mitosis modulators|mesh-ancestor
110591985|NCT02583698|Carvedilol|carvedilol|mesh-list
110238785|NCT00098423|Immunologic Factors|immunologic factors|mesh-ancestor
110591986|NCT02583698|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110591988|NCT02583698|Adrenergic Agents|adrenergic agents|mesh-ancestor
110591989|NCT02583698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110591990|NCT02583698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110591991|NCT02583698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110591992|NCT02583698|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110591993|NCT02583698|Antioxidants|antioxidants|mesh-ancestor
110238851|NCT00098501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110591994|NCT02583698|Protective Agents|protective agents|mesh-ancestor
110591995|NCT02583698|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110591996|NCT02583698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110591997|NCT02583698|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110591998|NCT02583698|Vasodilator Agents|vasodilator agents|mesh-ancestor
110591999|NCT02583698|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110592000|NCT02583698|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110592001|NCT00762099|Pregabalin|pregabalin|mesh-list
110592002|NCT00762099|Analgesics|analgesics|mesh-ancestor
110592003|NCT00762099|Sensory System Agents|sensory system agents|mesh-ancestor
110592004|NCT00762099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110592005|NCT00762099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110592007|NCT00762099|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110592008|NCT00762099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110592009|NCT00762099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110592010|NCT00762099|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110592011|NCT00762099|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110592012|NCT00762099|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110238918|NCT00098579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110238923|NCT00098618|Sorafenib|sorafenib|mesh-list
110592013|NCT00762099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110592014|NCT00762099|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110592016|NCT00762255|Irinotecan|irinotecan|mesh-list
110592017|NCT00762255|Vorinostat|vorinostat|mesh-list
110592018|NCT00762255|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110592019|NCT00762255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110592020|NCT00762255|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110592021|NCT00762255|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110592022|NCT00762255|Growth Substances|growth substances|mesh-ancestor
110592023|NCT00762255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110592024|NCT00762255|Growth Inhibitors|growth inhibitors|mesh-ancestor
110592025|NCT00762255|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110592026|NCT00762255|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110592027|NCT00762255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110592028|NCT00762255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110592029|NCT00762255|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110592030|NCT02585180|Silver Sulfadiazine|silver sulfadiazine|mesh-list
110592031|NCT02585180|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110592032|NCT02585180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110592033|NCT02557971|Botulinum Toxins|botulinum toxins|mesh-list
110592034|NCT02557971|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110592035|NCT02557971|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110592036|NCT02557971|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110592037|NCT02557971|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110239038|NCT04621149|Chlorine dioxide|chlorine dioxide|mesh-list
110239039|NCT04621149|Famotidine|famotidine|mesh-list
110592038|NCT02557971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110592039|NCT02557971|Cholinergic Agents|cholinergic agents|mesh-ancestor
110592040|NCT02557971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110592041|NCT02557971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110592042|NCT02557971|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110592043|NCT02557971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110592044|NCT05332730|Golimumab|golimumab|mesh-list
110592045|NCT05332730|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110592046|NCT05332730|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110592047|NCT05332730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110592048|NCT05332730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110592049|NCT05332730|Immunologic Factors|immunologic factors|mesh-ancestor
110592050|NCT05332730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110592051|NCT02581826|Silodosin|silodosin|mesh-list
110592052|NCT02581826|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110592053|NCT02581826|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110592054|NCT02581826|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110592055|NCT02581826|Adrenergic Agents|adrenergic agents|mesh-ancestor
110592056|NCT02581826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110592057|NCT02581826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110592058|NCT02581826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110592059|NCT02581826|Urological Agents|urological agents|mesh-ancestor
110592060|NCT04340882|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110592061|NCT04340882|Pembrolizumab|pembrolizumab|mesh-list
110592062|NCT04340882|Docetaxel|docetaxel|mesh-list
110592063|NCT04340882|Ramucirumab|ramucirumab|mesh-list
110592064|NCT04340882|Antibodies|antibodies|mesh-list
110592065|NCT04340882|Immunoglobulins|immunoglobulins|mesh-list
110592066|NCT04340882|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110239159|NCT00099788|Ranolazine|ranolazine|mesh-list
110592067|NCT04340882|Lexatumumab|lexatumumab|mesh-list
110592068|NCT04340882|Immunologic Factors|immunologic factors|mesh-ancestor
110592069|NCT04340882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110592070|NCT04340882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110592071|NCT04340882|Tubulin Modulators|tubulin modulators|mesh-ancestor
110592072|NCT04340882|Antimitotic Agents|antimitotic agents|mesh-ancestor
110592073|NCT04340882|Mitosis Modulators|mitosis modulators|mesh-ancestor
110592074|NCT04340882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110592075|NCT04340882|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110592077|NCT00765921|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110592078|NCT00765921|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110592079|NCT00765921|Growth Substances|growth substances|mesh-ancestor
110592080|NCT00765921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110592081|NCT00765921|Growth Inhibitors|growth inhibitors|mesh-ancestor
110592082|NCT00765921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110592083|NCT02583308|Silver Sulfadiazine|silver sulfadiazine|mesh-list
110592084|NCT02583308|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110592085|NCT02583308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110592086|NCT00672477|Methylnaltrexone|methylnaltrexone|mesh-list
110592087|NCT00672477|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110592088|NCT00672477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110592089|NCT00672477|Sensory System Agents|sensory system agents|mesh-ancestor
110592090|NCT00672477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110592092|NCT00766155|Oxaliplatin|oxaliplatin|mesh-list
110592093|NCT00766155|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110592094|NCT00766155|Antimetabolites|antimetabolites|mesh-ancestor
110592095|NCT00766155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110592096|NCT00766155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110592097|NCT00762567|Phenylephrine|phenylephrine|mesh-list
110592098|NCT00762567|Oxymetazoline|oxymetazoline|mesh-list
110592099|NCT00762567|Nasal Decongestants|nasal decongestants|mesh-list
110239277|NCT00132561|Antiviral Agents|antiviral agents|mesh-ancestor
110592100|NCT00762567|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110592101|NCT00762567|Mydriatics|mydriatics|mesh-ancestor
110592102|NCT00762567|Autonomic Agents|autonomic agents|mesh-ancestor
110592103|NCT00762567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110592104|NCT00762567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110592105|NCT00762567|Sympathomimetics|sympathomimetics|mesh-ancestor
110592106|NCT00762567|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110592107|NCT00762567|Respiratory System Agents|respiratory system agents|mesh-ancestor
110239490|NCT00133185|Losartan|losartan|mesh-list
110592108|NCT00762567|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110592109|NCT00762567|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110592110|NCT00762567|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110592111|NCT00762567|Adrenergic Agents|adrenergic agents|mesh-ancestor
110592112|NCT00762567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110592113|NCT00762567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110592114|NCT00762567|Protective Agents|protective agents|mesh-ancestor
110592115|NCT04338620|Paclitaxel|paclitaxel|mesh-list
110592116|NCT04338620|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110592117|NCT04338620|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110592118|NCT04338620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110592119|NCT04338620|Tubulin Modulators|tubulin modulators|mesh-ancestor
110592120|NCT04338620|Antimitotic Agents|antimitotic agents|mesh-ancestor
110592121|NCT04338620|Mitosis Modulators|mitosis modulators|mesh-ancestor
110592122|NCT04338620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110592123|NCT00923234|Lenalidomide|lenalidomide|mesh-list
110592124|NCT00923234|Azacitidine|azacitidine|mesh-list
110592125|NCT00923234|Immunologic Factors|immunologic factors|mesh-ancestor
110592126|NCT00923234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110592127|NCT00923234|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110592128|NCT00923234|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110239337|NCT00100646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110592129|NCT00923234|Growth Substances|growth substances|mesh-ancestor
110592130|NCT00923234|Growth Inhibitors|growth inhibitors|mesh-ancestor
110592131|NCT00923234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110592132|NCT00923234|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110592133|NCT00923234|Antimetabolites|antimetabolites|mesh-ancestor
110592134|NCT00923234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110592135|NCT00923234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110592136|NCT00674661|Riboflavin|riboflavin|mesh-list
110592137|NCT00674661|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110592138|NCT00674661|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110592139|NCT00674661|Vitamin B Complex|vitamin b complex|mesh-ancestor
110592140|NCT00674661|Vitamins|vitamins|mesh-ancestor
110592141|NCT00674661|Micronutrients|micronutrients|mesh-ancestor
110592142|NCT00674661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110592143|NCT00674661|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110239382|NCT00403182|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110592144|NCT00674661|Dermatologic Agents|dermatologic agents|mesh-ancestor
110592145|NCT00766545|Cilostazol|cilostazol|mesh-list
110592146|NCT00766545|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110592147|NCT00766545|Autonomic Agents|autonomic agents|mesh-ancestor
110592148|NCT00766545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110592149|NCT00766545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110592150|NCT00766545|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110592151|NCT00766545|Respiratory System Agents|respiratory system agents|mesh-ancestor
110592152|NCT00766545|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110592153|NCT00766545|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110592154|NCT00766545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110592155|NCT00766545|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110592156|NCT00766545|Vasodilator Agents|vasodilator agents|mesh-ancestor
110592157|NCT00766545|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110592158|NCT00766545|Protective Agents|protective agents|mesh-ancestor
110592159|NCT00766545|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110239447|NCT00135408|Hormones|hormones|mesh-ancestor
110592161|NCT00766545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110592162|NCT02558205|Liver Extracts|liver extracts|mesh-list
110592163|NCT02558205|Hematinics|hematinics|mesh-ancestor
110592164|NCT02557737|Botulinum Toxins|botulinum toxins|mesh-list
110592165|NCT02557737|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110592166|NCT02557737|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110592167|NCT02557737|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110592168|NCT02557737|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110592169|NCT02557737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110592170|NCT02557737|Cholinergic Agents|cholinergic agents|mesh-ancestor
110239501|NCT00133185|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110592171|NCT02557737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110592172|NCT02557737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110592173|NCT02557737|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110592174|NCT02557737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110592175|NCT00766857|Insulin|insulin|mesh-list
110592176|NCT00766857|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110592177|NCT00766857|Insulin Glargine|insulin glargine|mesh-list
110592178|NCT00766857|Exenatide|exenatide|mesh-list
110592179|NCT00766857|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110592180|NCT00766857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110592181|NCT00766857|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110592182|NCT00766857|Incretins|incretins|mesh-ancestor
110592183|NCT00766857|Hormones|hormones|mesh-ancestor
110592184|NCT00766857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110592186|NCT02558283|Anesthetics, Local|anesthetics, local|mesh-ancestor
110592187|NCT02558283|Anesthetics|anesthetics|mesh-ancestor
110592188|NCT02558283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110592189|NCT02558283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110592190|NCT02558283|Sensory System Agents|sensory system agents|mesh-ancestor
110592191|NCT02558283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110592192|NCT02558283|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110592193|NCT02558283|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110592194|NCT02558283|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110592195|NCT02558283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110592196|NCT02558283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110592197|NCT00767091|Rivastigmine|rivastigmine|mesh-list
110592198|NCT00767091|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
110592199|NCT00767091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110592200|NCT00767091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110592201|NCT00767091|Cholinergic Agents|cholinergic agents|mesh-ancestor
110592202|NCT00767091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110592203|NCT00767091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110592204|NCT00767091|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110592205|NCT00767091|Protective Agents|protective agents|mesh-ancestor
110592206|NCT00767169|Ibandronic Acid|ibandronic acid|mesh-list
110592207|NCT00767169|Pamidronate|pamidronate|mesh-list
110592208|NCT00767169|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110592209|NCT00767169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110592210|NCT05256381|Pembrolizumab|pembrolizumab|mesh-list
110592211|NCT05256381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110592212|NCT05256381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110592213|NCT05256381|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110592214|NCT05256381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110592215|NCT00767481|Travoprost|travoprost|mesh-list
110592216|NCT00767481|Brinzolamide|brinzolamide|mesh-list
110592217|NCT00767481|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110592218|NCT00767481|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110592219|NCT00767481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110592220|NCT00767481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110592221|NCT00671931|Dexmedetomidine|dexmedetomidine|mesh-list
110592222|NCT00671931|Propofol|propofol|mesh-list
110592223|NCT00671931|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110592224|NCT00671931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110592225|NCT00671931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110592226|NCT00671931|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110592227|NCT00671931|Analgesics|analgesics|mesh-ancestor
110592228|NCT00671931|Sensory System Agents|sensory system agents|mesh-ancestor
110592229|NCT00671931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110592230|NCT00671931|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110592231|NCT00671931|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110592232|NCT00671931|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110592233|NCT00671931|Adrenergic Agents|adrenergic agents|mesh-ancestor
110592234|NCT00671931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110239745|NCT00133419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110592235|NCT00671931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110592236|NCT00671931|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110592237|NCT00671931|Anesthetics, General|anesthetics, general|mesh-ancestor
110592238|NCT00671931|Anesthetics|anesthetics|mesh-ancestor
110592240|NCT00767559|Warfarin|warfarin|mesh-list
110592241|NCT00767559|Fondaparinux|fondaparinux|mesh-list
110592242|NCT00767559|Anticoagulants|anticoagulants|mesh-ancestor
110592243|NCT00767559|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110592244|NCT00767559|Antithrombins|antithrombins|mesh-ancestor
110592245|NCT00767559|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110592246|NCT00767559|Protease Inhibitors|protease inhibitors|mesh-ancestor
110239796|NCT00136110|Valproic Acid|valproic acid|mesh-list
110239807|NCT00136188|Folic Acid|folic acid|mesh-list
110592247|NCT00767559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110592248|NCT00767559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110592249|NCT00767559|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110592250|NCT00767559|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110592251|NCT00767715|Haloperidol|haloperidol|mesh-list
110592252|NCT00767715|Olanzapine|olanzapine|mesh-list
110592253|NCT00767715|Haloperidol decanoate|haloperidol decanoate|mesh-list
110592254|NCT00767715|Antiemetics|antiemetics|mesh-ancestor
110592255|NCT00767715|Autonomic Agents|autonomic agents|mesh-ancestor
110592256|NCT00767715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110592257|NCT00767715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110592258|NCT00767715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110592259|NCT00767715|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110592261|NCT00767715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110592262|NCT00767715|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110592263|NCT00767715|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110592264|NCT00767715|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110592265|NCT00767715|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110592266|NCT00767715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110239929|NCT00133731|Heparin|heparin|mesh-list
110592267|NCT00767715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110592268|NCT00767715|Serotonin Agents|serotonin agents|mesh-ancestor
110592269|NCT00767715|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110592270|NCT00767715|Dopamine Agents|dopamine agents|mesh-ancestor
110150689|NCT00000517|Warfarin|warfarin|mesh-list
110592271|NCT00767715|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110592272|NCT00762957|Metformin|metformin|mesh-list
110592273|NCT00762957|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110592274|NCT00762957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110592275|NCT00759993|Chromium|chromium|mesh-list
110592276|NCT00759993|Trace Elements|trace elements|mesh-ancestor
110592277|NCT00759993|Micronutrients|micronutrients|mesh-ancestor
110592278|NCT00759993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110592279|NCT00673881|Choline|choline|mesh-list
110592280|NCT00673881|Fenofibrate|fenofibrate|mesh-list
110239995|NCT00133887|Dermatologic Agents|dermatologic agents|mesh-ancestor
110592281|NCT00673881|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110592282|NCT00673881|Antimetabolites|antimetabolites|mesh-ancestor
110592283|NCT00673881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110592284|NCT00673881|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110592285|NCT00673881|Lipotropic Agents|lipotropic agents|mesh-ancestor
110592286|NCT00673881|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110592287|NCT00673881|Nootropic Agents|nootropic agents|mesh-ancestor
110592288|NCT00763347|Alogliptin|alogliptin|mesh-list
110592289|NCT00763347|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110592290|NCT00763347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110592291|NCT00763347|Incretins|incretins|mesh-ancestor
110592292|NCT00763347|Hormones|hormones|mesh-ancestor
110592293|NCT00763347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110592294|NCT00763347|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110592295|NCT00763347|Protease Inhibitors|protease inhibitors|mesh-ancestor
110592296|NCT00763347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110592297|NCT00763347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110592298|NCT00767871|Escitalopram|escitalopram|mesh-list
110592299|NCT00767871|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110592300|NCT00767871|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110240118|NCT04729088|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
110592301|NCT00767871|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110592302|NCT00767871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110592304|NCT00767871|Serotonin Agents|serotonin agents|mesh-ancestor
110592305|NCT00767871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110592306|NCT00760149|Rifampin|rifampin|mesh-list
110592307|NCT00760149|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110592308|NCT00760149|Antitubercular Agents|antitubercular agents|mesh-ancestor
110592309|NCT00760149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110592310|NCT00760149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110592311|NCT00760149|Leprostatic Agents|leprostatic agents|mesh-ancestor
110592312|NCT00760149|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110592313|NCT00760149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110592314|NCT00760149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110592315|NCT00760149|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110240179|NCT00104429|Antiviral Agents|antiviral agents|mesh-ancestor
110592316|NCT00760149|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110592317|NCT00760149|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110592318|NCT00760149|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110592319|NCT00760149|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110592320|NCT00760149|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110592321|NCT00671853|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110592322|NCT00671853|Antidepressive Agents|antidepressive agents|mesh-ancestor
110592323|NCT00671853|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110592324|NCT00671853|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110592325|NCT00671853|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110592326|NCT00671853|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110592327|NCT00671853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110592328|NCT00768183|Ethanol|ethanol|mesh-list
110592329|NCT00768183|Morphine|morphine|mesh-list
110592330|NCT00768183|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110592331|NCT00768183|Narcotics|narcotics|mesh-ancestor
110592332|NCT00768183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110592333|NCT00768183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110592334|NCT00768183|Analgesics|analgesics|mesh-ancestor
110592335|NCT00768183|Sensory System Agents|sensory system agents|mesh-ancestor
110592336|NCT00768183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110592337|NCT00768183|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110592338|NCT00768183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110592339|NCT02557581|Terbutaline|terbutaline|mesh-list
110592341|NCT02557581|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110592343|NCT02557581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110592344|NCT02557581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110592345|NCT02557581|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110592346|NCT02557581|Respiratory System Agents|respiratory system agents|mesh-ancestor
110592347|NCT02557581|Sympathomimetics|sympathomimetics|mesh-ancestor
110592348|NCT02557581|Tocolytic Agents|tocolytic agents|mesh-ancestor
110592349|NCT02557581|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110592350|NCT02557581|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110592351|NCT02557581|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110592352|NCT02557581|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110592353|NCT02557581|Adrenergic Agents|adrenergic agents|mesh-ancestor
110592354|NCT02557581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110592355|NCT02557581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110592356|NCT04077944|Trace Elements|trace elements|mesh-list
110592357|NCT04077944|Micronutrients|micronutrients|mesh-list
110240434|NCT00105326|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110592358|NCT04077944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110592360|NCT02558751|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110592361|NCT02558751|Immunologic Factors|immunologic factors|mesh-ancestor
110592362|NCT02558751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110592363|NCT00768573|Sildenafil Citrate|sildenafil citrate|mesh-list
110592364|NCT00768573|Vasodilator Agents|vasodilator agents|mesh-ancestor
110592365|NCT00768573|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110592366|NCT00768573|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110592367|NCT00768573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110592368|NCT00768573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110592369|NCT00768573|Urological Agents|urological agents|mesh-ancestor
110592370|NCT02558361|Apremilast|apremilast|mesh-list
110592371|NCT02558361|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110240505|NCT01054144|Prednisone|prednisone|mesh-list
110592372|NCT02558361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110592373|NCT02558361|Analgesics|analgesics|mesh-ancestor
110592374|NCT02558361|Sensory System Agents|sensory system agents|mesh-ancestor
110592375|NCT02558361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110592376|NCT02558361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110592377|NCT02558361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110592378|NCT02558361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110592379|NCT02558361|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
110592380|NCT02558361|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110592381|NCT02558361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110592382|NCT02558361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110240559|NCT00434746|Dermatologic Agents|dermatologic agents|mesh-ancestor
110592383|NCT02558595|Niacinamide|niacinamide|mesh-list
110592384|NCT02558595|Niacin|niacin|mesh-list
110592385|NCT02558595|Nicotinic Acids|nicotinic acids|mesh-list
110592386|NCT02558595|Vitamins|vitamins|mesh-ancestor
110592387|NCT02558595|Micronutrients|micronutrients|mesh-ancestor
110592388|NCT02558595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110592389|NCT02558595|Vitamin B Complex|vitamin b complex|mesh-ancestor
110592390|NCT02558595|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110592391|NCT02558595|Antimetabolites|antimetabolites|mesh-ancestor
110592392|NCT02558595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110592393|NCT02558595|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110592394|NCT02558595|Vasodilator Agents|vasodilator agents|mesh-ancestor
110592395|NCT00760695|Dronabinol|dronabinol|mesh-list
110240621|NCT00435058|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110592396|NCT00760695|Hallucinogens|hallucinogens|mesh-ancestor
110592397|NCT00760695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110592398|NCT00760695|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110592399|NCT00760695|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110592400|NCT00760695|Analgesics|analgesics|mesh-ancestor
110592401|NCT00760695|Sensory System Agents|sensory system agents|mesh-ancestor
110592402|NCT00760695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110592403|NCT00760695|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
110592404|NCT00760695|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110240683|NCT00435448|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110592405|NCT00760695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110376947|NCT00179660|Lenalidomide|lenalidomide|mesh-list
110592406|NCT00760695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110592407|NCT00760695|Hormones|hormones|mesh-ancestor
110592408|NCT00760695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110592409|NCT02582372|Fentanyl|fentanyl|mesh-list
110592410|NCT02582372|Dexmedetomidine|dexmedetomidine|mesh-list
110592412|NCT02582372|Anesthetics, Local|anesthetics, local|mesh-ancestor
110240749|NCT00436072|Cetuximab|cetuximab|mesh-list
110592413|NCT02582372|Anesthetics|anesthetics|mesh-ancestor
110240817|NCT00436267|Fluorouracil|fluorouracil|mesh-list
110240889|NCT00106496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110592414|NCT02582372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110592415|NCT02582372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110592416|NCT02582372|Sensory System Agents|sensory system agents|mesh-ancestor
110592417|NCT02582372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110592418|NCT02582372|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110592419|NCT02582372|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110592420|NCT02582372|Analgesics|analgesics|mesh-ancestor
110240962|NCT00401219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110592421|NCT02582372|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110592422|NCT02582372|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110592423|NCT02582372|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110592424|NCT02582372|Adrenergic Agents|adrenergic agents|mesh-ancestor
110592425|NCT02582372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110592426|NCT02582372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110592427|NCT02582372|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110592429|NCT02582372|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110592430|NCT02582372|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110592431|NCT02582372|Anesthetics, General|anesthetics, general|mesh-ancestor
110592432|NCT00768729|Sirolimus|sirolimus|mesh-list
110592433|NCT00768729|Azathioprine|azathioprine|mesh-list
110592434|NCT00768729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110592435|NCT00768729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110592436|NCT00768729|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110592437|NCT00768729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110592438|NCT00768729|Antifungal Agents|antifungal agents|mesh-ancestor
110592439|NCT00768729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110592440|NCT00768729|Immunologic Factors|immunologic factors|mesh-ancestor
110592441|NCT00768729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110592442|NCT00768729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110592443|NCT00768729|Antimetabolites|antimetabolites|mesh-ancestor
110592444|NCT00768729|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110592445|NCT00768729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110592446|NCT00768963|Ranibizumab|ranibizumab|mesh-list
110592447|NCT00768963|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110592448|NCT00768963|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110592449|NCT00768963|Growth Substances|growth substances|mesh-ancestor
110592450|NCT00768963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110592451|NCT00768963|Growth Inhibitors|growth inhibitors|mesh-ancestor
110592452|NCT00768963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110592453|NCT00769041|Moxifloxacin|moxifloxacin|mesh-list
110592454|NCT00769041|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110592455|NCT00769041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110592456|NCT00769041|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110241156|NCT00439699|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110592457|NCT00769041|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110592458|NCT00769041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110592459|NCT00769041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110592460|NCT00769041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110592461|NCT00770445|Insulin|insulin|mesh-list
110592462|NCT00770445|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110592464|NCT00770445|Pioglitazone|pioglitazone|mesh-list
110592465|NCT00770445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110592466|NCT00770445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110592467|NCT04077398|Ropivacaine|ropivacaine|mesh-list
110592468|NCT04077398|Anesthetics, Local|anesthetics, local|mesh-ancestor
110592469|NCT04077398|Anesthetics|anesthetics|mesh-ancestor
110592470|NCT04077398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110592471|NCT04077398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110592472|NCT04077398|Sensory System Agents|sensory system agents|mesh-ancestor
110592473|NCT04077398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110592474|NCT04239716|Anesthetics|anesthetics|mesh-list
110592475|NCT04239716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110592476|NCT04239716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110592477|NCT04048707|Octreotide|octreotide|mesh-list
110592478|NCT04048707|Midodrine|midodrine|mesh-list
110592479|NCT04048707|Angiotensin II|angiotensin ii|mesh-list
110592480|NCT04048707|Giapreza|giapreza|mesh-list
110592481|NCT04048707|Angiotensinogen|angiotensinogen|mesh-list
110592482|NCT04048707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110592483|NCT04048707|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110592484|NCT04048707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110592486|NCT04048707|Autonomic Agents|autonomic agents|mesh-ancestor
110592487|NCT04048707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110592488|NCT04048707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110592489|NCT04048707|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110592490|NCT04048707|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110241349|NCT00142779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110241358|NCT00440323|Zolpidem|zolpidem|mesh-list
110592491|NCT04048707|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110592492|NCT04048707|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110592493|NCT04048707|Adrenergic Agents|adrenergic agents|mesh-ancestor
110592494|NCT04048707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110592495|NCT04048707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110592496|NCT04048707|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110592497|NCT04048707|Protease Inhibitors|protease inhibitors|mesh-ancestor
110592498|NCT04048707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110592499|NCT00763893|Losartan|losartan|mesh-list
110592500|NCT00763893|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110592501|NCT00763893|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110592502|NCT00763893|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110592503|NCT00763893|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110592504|NCT00763893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110592505|NCT00770835|Metformin|metformin|mesh-list
110592506|NCT00770835|Pioglitazone|pioglitazone|mesh-list
110592507|NCT00770835|Glyburide|glyburide|mesh-list
110592508|NCT00770835|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110592509|NCT00770835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110592510|NCT00769587|Thalidomide|thalidomide|mesh-list
110592511|NCT00769587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110592512|NCT00769587|Immunologic Factors|immunologic factors|mesh-ancestor
110592513|NCT00769587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110592514|NCT00769587|Leprostatic Agents|leprostatic agents|mesh-ancestor
110592515|NCT00769587|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110592516|NCT00769587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110592517|NCT00769587|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110592518|NCT00769587|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110018241|NCT03615534|Fenofibrate|fenofibrate|mesh-list
110592519|NCT00769587|Growth Substances|growth substances|mesh-ancestor
110592520|NCT00769587|Growth Inhibitors|growth inhibitors|mesh-ancestor
110592521|NCT00769587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110592522|NCT00570921|Everolimus|everolimus|mesh-list
110592523|NCT00570921|Fulvestrant|fulvestrant|mesh-list
110592524|NCT00570921|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110592525|NCT00570921|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110592526|NCT00570921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110592527|NCT00570921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110592528|NCT00570921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110592529|NCT00570921|Immunologic Factors|immunologic factors|mesh-ancestor
110592530|NCT00570921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110592531|NCT00570921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110592532|NCT00570921|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110592533|NCT00570921|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110592534|NCT00570921|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110592535|NCT00570921|Hormone Antagonists|hormone antagonists|mesh-ancestor
110592536|NCT00570921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110592537|NCT04076930|Enzyme Inhibitors|enzyme inhibitors|mesh-list
110592538|NCT04076930|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
110592539|NCT04076930|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
110592540|NCT04076930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110592541|NCT04076930|Protease Inhibitors|protease inhibitors|mesh-ancestor
110592542|NCT04048317|Doxorubicin|doxorubicin|mesh-list
110592543|NCT04048317|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110592544|NCT04048317|Ethiodized Oil|ethiodized oil|mesh-list
110592545|NCT04048317|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110592546|NCT04048317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110592547|NCT04048317|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110592548|NCT04048317|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110592549|NCT04048317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110592550|NCT04048317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110592551|NCT04353986|Sofosbuvir|sofosbuvir|mesh-list
110592552|NCT04353986|Ledipasvir|ledipasvir|mesh-list
110592553|NCT04353986|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
110592554|NCT04353986|Antiviral Agents|antiviral agents|mesh-ancestor
110592555|NCT04353986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110592556|NCT00670449|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
110592557|NCT00670449|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
110592558|NCT00670449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110241498|NCT00142974|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110241499|NCT00142974|Serotonin Agents|serotonin agents|mesh-ancestor
110592559|NCT00670449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110592560|NCT00670449|Immunologic Factors|immunologic factors|mesh-ancestor
110592561|NCT00670449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110592562|NCT00771147|Sorafenib|sorafenib|mesh-list
110592563|NCT00771147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110592564|NCT00771147|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110592565|NCT00771147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110592566|NCT00771147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110592567|NCT04155710|Interleukin-2|interleukin-2|mesh-list
110592568|NCT04155710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110592569|NCT04155710|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110592570|NCT04155710|Analgesics|analgesics|mesh-ancestor
110592571|NCT04155710|Sensory System Agents|sensory system agents|mesh-ancestor
110592572|NCT04155710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110592573|NCT04155710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110592574|NCT00775047|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
110592575|NCT00775047|Medroxyprogesterone|medroxyprogesterone|mesh-list
110592576|NCT00775047|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110592577|NCT00775047|Contraceptive Agents|contraceptive agents|mesh-ancestor
110592578|NCT00775047|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110592579|NCT00775047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110592580|NCT00775047|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110592581|NCT00775047|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110592582|NCT00775047|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110592583|NCT00775047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110241561|NCT00442234|Monteplase|monteplase|mesh-list
110592584|NCT00775047|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110592585|NCT00775047|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110592586|NCT00775047|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110592587|NCT00775125|Ritonavir|ritonavir|mesh-list
110592588|NCT00775125|Darunavir|darunavir|mesh-list
110592589|NCT00775125|Fosamprenavir|fosamprenavir|mesh-list
110592590|NCT00775125|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110592591|NCT00775125|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110592592|NCT00775125|Protease Inhibitors|protease inhibitors|mesh-ancestor
110592593|NCT00775125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110592594|NCT00775125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110592595|NCT00775125|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110592596|NCT00775125|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110592597|NCT00775125|Antiviral Agents|antiviral agents|mesh-ancestor
110592598|NCT00775125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110241603|NCT00442312|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110592599|NCT00775125|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110592600|NCT00775125|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110592601|NCT02557503|Fluorouracil|fluorouracil|mesh-list
110592602|NCT02557503|Oxaliplatin|oxaliplatin|mesh-list
110592603|NCT02557503|Antimetabolites|antimetabolites|mesh-ancestor
110592604|NCT02557503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110592605|NCT02557503|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110592606|NCT02557503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110592607|NCT02557503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110592608|NCT02557503|Immunologic Factors|immunologic factors|mesh-ancestor
110592609|NCT02557503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110592610|NCT00764439|Nicotine|nicotine|mesh-list
110592611|NCT00764439|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110592612|NCT00764439|Autonomic Agents|autonomic agents|mesh-ancestor
110592613|NCT00764439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110592614|NCT00764439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110592615|NCT00764439|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110592616|NCT00764439|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110592617|NCT00764439|Cholinergic Agents|cholinergic agents|mesh-ancestor
110592618|NCT00764439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110592619|NCT00764439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110592620|NCT00771303|Fibrin fragment D|fibrin fragment d|mesh-list
110592621|NCT00771303|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110592622|NCT00771303|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110592623|NCT00771303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110592624|NCT00771303|Hemostatics|hemostatics|mesh-ancestor
110592625|NCT00771303|Coagulants|coagulants|mesh-ancestor
110592626|NCT05674526|Cetuximab|cetuximab|mesh-list
110592627|NCT05674526|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110592628|NCT05674526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110592629|NCT00771381|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
110592630|NCT00771381|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110592631|NCT00771381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110592633|NCT00771459|Anesthetics, Local|anesthetics, local|mesh-ancestor
110592634|NCT00771459|Anesthetics|anesthetics|mesh-ancestor
110592635|NCT00771459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110592636|NCT00771459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110592637|NCT00771459|Sensory System Agents|sensory system agents|mesh-ancestor
110592638|NCT00771459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110592639|NCT00775359|Fenofibrate|fenofibrate|mesh-list
110592640|NCT00775359|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110592641|NCT00775359|Antimetabolites|antimetabolites|mesh-ancestor
110241704|NCT00443170|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110592642|NCT00775359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110592643|NCT00775359|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110592644|NCT05338502|Omeprazole|omeprazole|mesh-list
110592645|NCT05338502|Ranitidine|ranitidine|mesh-list
110592646|NCT05338502|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
110592647|NCT05338502|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110592648|NCT05338502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110592649|NCT05338502|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110592650|NCT05338502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110592651|NCT05338502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110592652|NCT05338502|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110592653|NCT05338502|Histamine Antagonists|histamine antagonists|mesh-ancestor
110592654|NCT05338502|Histamine Agents|histamine agents|mesh-ancestor
110592655|NCT05338502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110592656|NCT05338502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110592657|NCT02557269|Mometasone Furoate|mometasone furoate|mesh-list
110592658|NCT02557269|Azelastine|azelastine|mesh-list
110592659|NCT02557269|Prednisolone|prednisolone|mesh-list
110592660|NCT02557269|Xylometazoline|xylometazoline|mesh-list
110592661|NCT02557269|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110592662|NCT02557269|Glucocorticoids|glucocorticoids|mesh-ancestor
110592663|NCT02557269|Hormones|hormones|mesh-ancestor
110592664|NCT02557269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110592665|NCT02557269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110592666|NCT02557269|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110592667|NCT02557269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110592668|NCT02557269|Autonomic Agents|autonomic agents|mesh-ancestor
110592669|NCT02557269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110592670|NCT02557269|Dermatologic Agents|dermatologic agents|mesh-ancestor
110592671|NCT02557269|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110592672|NCT02557269|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110592673|NCT02557269|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110592674|NCT02557269|Respiratory System Agents|respiratory system agents|mesh-ancestor
110592675|NCT02557269|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
110592676|NCT02557269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110592677|NCT02557269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110592678|NCT02557269|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110592679|NCT02557269|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110592680|NCT02557269|Histamine Antagonists|histamine antagonists|mesh-ancestor
110592681|NCT02557269|Histamine Agents|histamine agents|mesh-ancestor
110592682|NCT02557269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110592683|NCT02557269|Nasal Decongestants|nasal decongestants|mesh-ancestor
110592684|NCT02557269|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110592686|NCT02556411|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110592687|NCT02556411|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110592688|NCT02556411|Contraceptive Agents|contraceptive agents|mesh-ancestor
110592689|NCT02556411|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110592690|NCT02556411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110592691|NCT02556411|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110592692|NCT02556411|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110592693|NCT02556411|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110241811|NCT03278431|Tubulin Modulators|tubulin modulators|mesh-ancestor
110592694|NCT02556411|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110592696|NCT02556411|Hormones|hormones|mesh-ancestor
110592697|NCT02556411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110592698|NCT04085276|Paclitaxel|paclitaxel|mesh-list
110592699|NCT04085276|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110592700|NCT04085276|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110592701|NCT04085276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110592702|NCT04085276|Tubulin Modulators|tubulin modulators|mesh-ancestor
110592703|NCT04085276|Antimitotic Agents|antimitotic agents|mesh-ancestor
110592704|NCT04085276|Mitosis Modulators|mitosis modulators|mesh-ancestor
110592705|NCT04085276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110592706|NCT00775827|Fenofibrate|fenofibrate|mesh-list
110592707|NCT00775827|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110592708|NCT00775827|Antimetabolites|antimetabolites|mesh-ancestor
110592709|NCT00775827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110592710|NCT00775827|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110592711|NCT00775905|Amlodipine|amlodipine|mesh-list
110592712|NCT00775905|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110592713|NCT00775905|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110592714|NCT00775905|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110592715|NCT00775905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110592716|NCT00775905|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110592717|NCT00775905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110592718|NCT00775905|Vasodilator Agents|vasodilator agents|mesh-ancestor
110241853|NCT00443794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110592719|NCT00772161|Methylphenidate|methylphenidate|mesh-list
110592720|NCT00772161|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110592721|NCT00772161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110592722|NCT00772161|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110592723|NCT00772161|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110592724|NCT00772161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110592725|NCT00772161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110592726|NCT00772161|Dopamine Agents|dopamine agents|mesh-ancestor
110592727|NCT00772161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110592728|NCT00776139|Cetirizine|cetirizine|mesh-list
110592729|NCT00776139|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110592730|NCT00776139|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110592731|NCT00776139|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110592732|NCT00776139|Histamine Antagonists|histamine antagonists|mesh-ancestor
110592733|NCT00776139|Histamine Agents|histamine agents|mesh-ancestor
110592734|NCT00776139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110592735|NCT00776139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110592736|NCT00776139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110592737|NCT00779493|Curcumin|curcumin|mesh-list
110241899|NCT00443950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110241900|NCT00443950|Immunologic Factors|immunologic factors|mesh-ancestor
110241901|NCT00444184|Timolol|timolol|mesh-list
110241902|NCT00444184|Travoprost|travoprost|mesh-list
110241903|NCT00444184|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110241904|NCT00444184|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110241905|NCT00444184|Adrenergic Agents|adrenergic agents|mesh-ancestor
110241906|NCT00444184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110241907|NCT00444184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110241908|NCT00444184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110241909|NCT00444184|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110241910|NCT00444184|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110241911|NCT00444223|Fluorides|fluorides|mesh-list
110241912|NCT00444223|Cariostatic Agents|cariostatic agents|mesh-ancestor
110241913|NCT00444223|Protective Agents|protective agents|mesh-ancestor
110241914|NCT00444223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110241915|NCT03275701|Abacavir, dolutegravir, and lamivudine drug combination|abacavir, dolutegravir, and lamivudine drug combination|mesh-list
110241916|NCT03275701|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110241917|NCT03275701|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110241918|NCT03275701|Antiviral Agents|antiviral agents|mesh-ancestor
110241919|NCT03275701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110241921|NCT00451360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110241922|NCT00451399|Metformin|metformin|mesh-list
110241923|NCT00451399|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110241924|NCT00451399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110241925|NCT00108797|Anti-inhibitor coagulant complex|anti-inhibitor coagulant complex|mesh-list
110592738|NCT00779493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110592739|NCT00779493|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110592740|NCT00779493|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110592741|NCT00779493|Analgesics|analgesics|mesh-ancestor
110592742|NCT00779493|Sensory System Agents|sensory system agents|mesh-ancestor
110592743|NCT00779493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110592744|NCT00779493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110592745|NCT00779493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110592746|NCT00779493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110592747|NCT00779493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110592748|NCT00779493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110592750|NCT02580344|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110592751|NCT02580344|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110592752|NCT02580344|Analgesics|analgesics|mesh-ancestor
110592753|NCT02580344|Sensory System Agents|sensory system agents|mesh-ancestor
110592754|NCT02580344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110592755|NCT02580344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110592756|NCT02580344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110592757|NCT02580344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110592758|NCT02580344|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110592759|NCT02580344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110592760|NCT02580344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110592761|NCT00779649|Bisacodyl|bisacodyl|mesh-list
110592762|NCT00779649|Cathartics|cathartics|mesh-ancestor
110592763|NCT00779649|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110592764|NCT00779649|Laxatives|laxatives|mesh-ancestor
110592765|NCT00776217|Loratadine|loratadine|mesh-list
110592766|NCT00776217|Antipruritics|antipruritics|mesh-ancestor
110592767|NCT00776217|Dermatologic Agents|dermatologic agents|mesh-ancestor
110592768|NCT00776217|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110592769|NCT00776217|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110592770|NCT00776217|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110592771|NCT00776217|Histamine Antagonists|histamine antagonists|mesh-ancestor
110592773|NCT00776217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110592774|NCT00776217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110592775|NCT00776217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110592776|NCT04990232|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
110592777|NCT04990232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110592778|NCT00667875|Naltrexone|naltrexone|mesh-list
110592779|NCT00667875|Aripiprazole|aripiprazole|mesh-list
110592780|NCT00667875|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110592781|NCT00667875|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110592782|NCT00667875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110592783|NCT00667875|Sensory System Agents|sensory system agents|mesh-ancestor
110592784|NCT00667875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110592785|NCT00667875|Antidepressive Agents|antidepressive agents|mesh-ancestor
110592786|NCT00667875|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110592787|NCT00667875|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110592788|NCT00667875|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110592789|NCT00667875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110592790|NCT00667875|Dopamine Agonists|dopamine agonists|mesh-ancestor
110592791|NCT00667875|Dopamine Agents|dopamine agents|mesh-ancestor
110592792|NCT00667875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110592793|NCT00667875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110592794|NCT00667875|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110592795|NCT00667875|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110592796|NCT00667875|Serotonin Agents|serotonin agents|mesh-ancestor
110592797|NCT00667875|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110592798|NCT00667875|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110592799|NCT00667875|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110592800|NCT00667875|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110242106|NCT00109109|Vorinostat|vorinostat|mesh-list
110592801|NCT02579642|Ketamine|ketamine|mesh-list
110592802|NCT02579642|Analgesics|analgesics|mesh-ancestor
110592803|NCT02579642|Sensory System Agents|sensory system agents|mesh-ancestor
110592804|NCT02579642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110592805|NCT02579642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110592806|NCT02579642|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110592807|NCT02579642|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110592808|NCT02579642|Anesthetics, General|anesthetics, general|mesh-ancestor
110592809|NCT02579642|Anesthetics|anesthetics|mesh-ancestor
110592810|NCT02579642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110592811|NCT02579642|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110592812|NCT02579642|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110592813|NCT02579642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110592814|NCT02579642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110592815|NCT00779805|Pseudoephedrine|pseudoephedrine|mesh-list
110592816|NCT00779805|Ephedrine|ephedrine|mesh-list
110592817|NCT00779805|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110592818|NCT00779805|Autonomic Agents|autonomic agents|mesh-ancestor
110592819|NCT00779805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110592820|NCT00779805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110592821|NCT00779805|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110592822|NCT00779805|Respiratory System Agents|respiratory system agents|mesh-ancestor
110592823|NCT00779805|Nasal Decongestants|nasal decongestants|mesh-ancestor
110592824|NCT00779805|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110592825|NCT00779805|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110592826|NCT00779805|Sympathomimetics|sympathomimetics|mesh-ancestor
110592827|NCT00779805|Adrenergic Agents|adrenergic agents|mesh-ancestor
110592828|NCT00779805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110592829|NCT00779805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110592830|NCT00772395|Risedronic Acid|risedronic acid|mesh-list
110592831|NCT00772395|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110592832|NCT00772395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110592833|NCT00772395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110592834|NCT00772395|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110592835|NCT00772395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110592836|NCT00772395|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110592837|NCT00667251|Paclitaxel|paclitaxel|mesh-list
110592838|NCT00667251|Docetaxel|docetaxel|mesh-list
110592839|NCT00667251|Trastuzumab|trastuzumab|mesh-list
110592840|NCT00667251|Lapatinib|lapatinib|mesh-list
110592841|NCT00667251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110592842|NCT00667251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110592843|NCT00667251|Tubulin Modulators|tubulin modulators|mesh-ancestor
110592844|NCT00667251|Antimitotic Agents|antimitotic agents|mesh-ancestor
110592845|NCT00667251|Mitosis Modulators|mitosis modulators|mesh-ancestor
110592846|NCT00667251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110592847|NCT00667251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110592848|NCT00667251|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110592849|NCT00667251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110592850|NCT04063124|Dasatinib|dasatinib|mesh-list
110592851|NCT04063124|Quercetin|quercetin|mesh-list
110592852|NCT04063124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110240234|NCT00104546|Coagulants|coagulants|mesh-ancestor
110592853|NCT04063124|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110592854|NCT04063124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110592855|NCT04063124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110592856|NCT04063124|Antioxidants|antioxidants|mesh-ancestor
110242338|NCT00454402|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110592857|NCT04063124|Protective Agents|protective agents|mesh-ancestor
110592858|NCT04063124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110592859|NCT00772473|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-list
110592860|NCT00772473|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110592861|NCT00772473|Serotonin Agents|serotonin agents|mesh-ancestor
110592862|NCT00772473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110592863|NCT00772473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110592864|NCT00772473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110376998|NCT04559841|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110592865|NCT00776607|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
110592866|NCT00776607|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110592867|NCT00776607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110592868|NCT00780039|Carboplatin|carboplatin|mesh-list
110592869|NCT00780039|Doxorubicin|doxorubicin|mesh-list
110592870|NCT00780039|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110592871|NCT00780039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110592872|NCT00780039|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110592873|NCT00780039|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110592874|NCT00780039|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110592875|NCT00780039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110592876|NCT00780039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110592877|NCT00776763|Bevacizumab|bevacizumab|mesh-list
110592878|NCT00776763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110592879|NCT00776763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110592880|NCT00776763|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110592881|NCT00776763|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110592882|NCT00776763|Growth Substances|growth substances|mesh-ancestor
110592883|NCT00776763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110592884|NCT00776763|Growth Inhibitors|growth inhibitors|mesh-ancestor
110592885|NCT00772551|Raltegravir Potassium|raltegravir potassium|mesh-list
110592886|NCT00772551|Ezetimibe|ezetimibe|mesh-list
110592887|NCT00772551|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110592888|NCT00772551|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110592889|NCT00772551|Antimetabolites|antimetabolites|mesh-ancestor
110592890|NCT00772551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110592891|NCT00772551|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110592892|NCT00772551|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110592893|NCT00772551|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110592894|NCT00772551|Antiviral Agents|antiviral agents|mesh-ancestor
110592895|NCT00772551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110592896|NCT00772551|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110592897|NCT00772551|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110592898|NCT00772551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110592899|NCT00776841|Cholic Acids|cholic acids|mesh-list
110592900|NCT00776841|Bile Acids and Salts|bile acids and salts|mesh-list
110592901|NCT00776841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110592902|NCT02556879|Liver Extracts|liver extracts|mesh-list
110592903|NCT02556879|Antibodies|antibodies|mesh-list
110592904|NCT02556879|Immunologic Factors|immunologic factors|mesh-ancestor
110592905|NCT02556879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110592906|NCT02556879|Hematinics|hematinics|mesh-ancestor
110592907|NCT00772863|Docetaxel|docetaxel|mesh-list
110242601|NCT00113100|Estrogens|estrogens|mesh-ancestor
110592908|NCT00772863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110592909|NCT00772863|Tubulin Modulators|tubulin modulators|mesh-ancestor
110592910|NCT00772863|Antimitotic Agents|antimitotic agents|mesh-ancestor
110592911|NCT00772863|Mitosis Modulators|mitosis modulators|mesh-ancestor
110592912|NCT00772863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110592913|NCT04075760|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
110592914|NCT04075760|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110592915|NCT04075760|Adrenergic Agents|adrenergic agents|mesh-ancestor
110592916|NCT04075760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110592917|NCT04075760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110592918|NCT04075760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110592920|NCT00667719|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110592921|NCT00667719|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110592922|NCT00667719|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110592923|NCT00667719|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110592924|NCT00667719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110592925|NCT00667719|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110592926|NCT00667719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110592927|NCT00667719|Vasodilator Agents|vasodilator agents|mesh-ancestor
110592928|NCT00667719|Diuretics|diuretics|mesh-ancestor
110377019|NCT04559568|Anesthetics|anesthetics|mesh-ancestor
110592929|NCT00667719|Natriuretic Agents|natriuretic agents|mesh-ancestor
110592930|NCT00667719|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110592932|NCT00669669|Temozolomide|temozolomide|mesh-list
110592933|NCT00669669|Carmustine|carmustine|mesh-list
110592934|NCT00669669|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
110592935|NCT00669669|Lenograstim|lenograstim|mesh-list
110592936|NCT00669669|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110592937|NCT00669669|Immunologic Factors|immunologic factors|mesh-ancestor
110592938|NCT00669669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110592939|NCT00669669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110592940|NCT00669669|Alkylating Agents|alkylating agents|mesh-ancestor
110592941|NCT00669669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110592942|NCT00669669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110592943|NCT00669669|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110592944|NCT00669669|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110592945|NCT00669669|Antiviral Agents|antiviral agents|mesh-ancestor
110592946|NCT00669669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110592947|NCT00669669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110592948|NCT02579564|Paclitaxel|paclitaxel|mesh-list
110592949|NCT02579564|Vinorelbine|vinorelbine|mesh-list
110592950|NCT02579564|Gemcitabine|gemcitabine|mesh-list
110592951|NCT02579564|Pemetrexed|pemetrexed|mesh-list
110592952|NCT02579564|Endostar protein|endostar protein|mesh-list
110592953|NCT02579564|Endostatins|endostatins|mesh-list
110592954|NCT02579564|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110592955|NCT02579564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110592956|NCT02579564|Tubulin Modulators|tubulin modulators|mesh-ancestor
110592957|NCT02579564|Antimitotic Agents|antimitotic agents|mesh-ancestor
110592958|NCT02579564|Mitosis Modulators|mitosis modulators|mesh-ancestor
110592959|NCT02579564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110592960|NCT02579564|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110592961|NCT02579564|Antimetabolites|antimetabolites|mesh-ancestor
110592962|NCT02579564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110592963|NCT02579564|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110592964|NCT02579564|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110592965|NCT02579564|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110592966|NCT02579564|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110592967|NCT02579564|Growth Substances|growth substances|mesh-ancestor
110592968|NCT02579564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110592969|NCT02579564|Growth Inhibitors|growth inhibitors|mesh-ancestor
110592970|NCT00467779|Midazolam|midazolam|mesh-list
110592971|NCT00467779|Dextromethorphan|dextromethorphan|mesh-list
110592972|NCT00467779|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110592973|NCT00467779|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110592974|NCT00467779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110242892|NCT00144183|Antiviral Agents|antiviral agents|mesh-ancestor
110592975|NCT00467779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110592976|NCT00467779|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110592977|NCT00467779|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110592978|NCT00467779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110592979|NCT00467779|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110592980|NCT00467779|Anesthetics, General|anesthetics, general|mesh-ancestor
110592982|NCT00467779|GABA Modulators|gaba modulators|mesh-ancestor
110592983|NCT00467779|GABA Agents|gaba agents|mesh-ancestor
110592984|NCT00467779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110242956|NCT00466180|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110592985|NCT00467779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110592986|NCT00467779|Antitussive Agents|antitussive agents|mesh-ancestor
110592987|NCT00467779|Respiratory System Agents|respiratory system agents|mesh-ancestor
110592988|NCT00467779|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110592989|NCT00467779|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110592991|NCT03704480|Tremelimumab|tremelimumab|mesh-list
110592992|NCT03704480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110592993|NCT03704480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110592994|NCT00570687|Insulin|insulin|mesh-list
110592995|NCT00570687|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110592996|NCT00570687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110592997|NCT01021891|Insulin|insulin|mesh-list
110592998|NCT01021891|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110592999|NCT01021891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110240386|NCT00105209|Sensory System Agents|sensory system agents|mesh-ancestor
110593000|NCT01029223|Metoprolol|metoprolol|mesh-list
110593001|NCT01029223|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110593002|NCT01029223|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110593003|NCT01029223|Sympatholytics|sympatholytics|mesh-ancestor
110593004|NCT01029223|Autonomic Agents|autonomic agents|mesh-ancestor
110593005|NCT01029223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110593006|NCT01029223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110593007|NCT01029223|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110593008|NCT01029223|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110593009|NCT01029223|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110593010|NCT01029223|Adrenergic Agents|adrenergic agents|mesh-ancestor
110593011|NCT01029223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110593012|NCT01029223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110593014|NCT02556723|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110593015|NCT02556723|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110593016|NCT02556723|Growth Substances|growth substances|mesh-ancestor
110593017|NCT02556723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110593018|NCT02556723|Growth Inhibitors|growth inhibitors|mesh-ancestor
110593019|NCT02556723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110593020|NCT00777543|Ferulic acid|ferulic acid|mesh-list
110593021|NCT00777543|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110593022|NCT00777543|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110593023|NCT00777543|Analgesics|analgesics|mesh-ancestor
110593024|NCT00777543|Sensory System Agents|sensory system agents|mesh-ancestor
110593031|NCT00777543|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
110593032|NCT00777543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110593033|NCT00777543|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110593034|NCT00777543|Antioxidants|antioxidants|mesh-ancestor
110243068|NCT00144417|Leprostatic Agents|leprostatic agents|mesh-ancestor
110243078|NCT00144417|Antimetabolites|antimetabolites|mesh-ancestor
110593035|NCT00777543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110593036|NCT00777543|Protective Agents|protective agents|mesh-ancestor
110593038|NCT03410654|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110593039|NCT03410654|Immunologic Factors|immunologic factors|mesh-ancestor
110593040|NCT03410654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110593041|NCT03410654|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110593042|NCT03410654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110243126|NCT00348244|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110593043|NCT03410654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110593050|NCT01032499|Oxytetracycline|oxytetracycline|mesh-list
110593051|NCT01032499|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110593052|NCT01032499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110593053|NCT01022047|Budesonide|budesonide|mesh-list
110593054|NCT01022047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110593055|NCT01022047|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110593056|NCT01022047|Autonomic Agents|autonomic agents|mesh-ancestor
110593057|NCT01022047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110593058|NCT01022047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110593059|NCT01022047|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110593060|NCT01022047|Respiratory System Agents|respiratory system agents|mesh-ancestor
110593061|NCT01022047|Glucocorticoids|glucocorticoids|mesh-ancestor
110593062|NCT01022047|Hormones|hormones|mesh-ancestor
110243194|NCT00348985|Bortezomib|bortezomib|mesh-list
110094941|NCT01711749|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110243195|NCT00348985|Belinostat|belinostat|mesh-list
110593063|NCT01022047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110593064|NCT01022125|Simeprevir|simeprevir|mesh-list
110593065|NCT01022125|Antiviral Agents|antiviral agents|mesh-ancestor
110593066|NCT01022125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110593067|NCT01022125|Protease Inhibitors|protease inhibitors|mesh-ancestor
110593068|NCT01022125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110593069|NCT01022125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110593076|NCT05673980|Vitamin D|vitamin d|mesh-list
110593077|NCT05673980|Cholecalciferol|cholecalciferol|mesh-list
110593078|NCT05673980|Ergocalciferols|ergocalciferols|mesh-list
110593080|NCT05673980|Micronutrients|micronutrients|mesh-ancestor
110593081|NCT05673980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110593082|NCT05673980|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110593083|NCT05673980|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110593084|NCT02581124|Lapatinib|lapatinib|mesh-list
110593085|NCT02581124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110593086|NCT02581124|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110593087|NCT02581124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110593088|NCT02581124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110593089|NCT02580968|Flunarizine|flunarizine|mesh-list
110593090|NCT02580968|Anticonvulsants|anticonvulsants|mesh-ancestor
110593091|NCT02580968|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110593092|NCT02580968|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110593093|NCT02580968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110593094|NCT02580968|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110593095|NCT02580968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110593096|NCT02580968|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110593097|NCT02580968|Histamine Antagonists|histamine antagonists|mesh-ancestor
110593098|NCT02580968|Histamine Agents|histamine agents|mesh-ancestor
110593099|NCT02580968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110593100|NCT02580968|Vasodilator Agents|vasodilator agents|mesh-ancestor
110593102|NCT00441103|Interferon-beta|interferon-beta|mesh-list
110593103|NCT00441103|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110593104|NCT00441103|Immunologic Factors|immunologic factors|mesh-ancestor
110593105|NCT00441103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110593106|NCT00441103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110593107|NCT00441103|Antiviral Agents|antiviral agents|mesh-ancestor
110593108|NCT00441103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110593109|NCT01029613|Adalimumab|adalimumab|mesh-list
110593110|NCT01029613|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110593111|NCT01029613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110593112|NCT01029613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110593113|NCT03540212|Sofosbuvir|sofosbuvir|mesh-list
110593114|NCT03540212|Antiviral Agents|antiviral agents|mesh-ancestor
110593115|NCT03540212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110593116|NCT03268057|Avelumab|avelumab|mesh-list
110593117|NCT03268057|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110593118|NCT03268057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110593119|NCT01033903|Misoprostol|misoprostol|mesh-list
110593120|NCT01033903|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110593121|NCT01033903|Abortifacient Agents|abortifacient agents|mesh-ancestor
110593122|NCT01033903|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110593123|NCT01033903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110593124|NCT01033903|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110593125|NCT01033903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110593126|NCT01033903|Oxytocics|oxytocics|mesh-ancestor
110593127|NCT03281954|Atezolizumab|atezolizumab|mesh-list
110593128|NCT03281954|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110243516|NCT00351052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110243517|NCT00351052|Analgesics|analgesics|mesh-ancestor
110593129|NCT03281954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110593130|NCT03281954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110593131|NCT03281954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110593132|NCT00433537|Dexamethasone|dexamethasone|mesh-list
110593133|NCT00433537|Cyclophosphamide|cyclophosphamide|mesh-list
110593134|NCT00433537|Rituximab|rituximab|mesh-list
110593135|NCT00433537|Doxorubicin|doxorubicin|mesh-list
110593136|NCT00433537|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110593137|NCT00433537|Vincristine|vincristine|mesh-list
110593138|NCT00433537|Bortezomib|bortezomib|mesh-list
110593139|NCT00433537|Lenograstim|lenograstim|mesh-list
110593140|NCT00433537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110593141|NCT00433537|Immunologic Factors|immunologic factors|mesh-ancestor
110593142|NCT00433537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110593143|NCT00433537|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110593144|NCT00433537|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110593145|NCT00433537|Alkylating Agents|alkylating agents|mesh-ancestor
110593146|NCT00433537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110593147|NCT00433537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110593148|NCT00433537|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110593149|NCT00433537|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110593150|NCT00433537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110593151|NCT00433537|Antiemetics|antiemetics|mesh-ancestor
110593152|NCT00433537|Autonomic Agents|autonomic agents|mesh-ancestor
110593153|NCT00433537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110593154|NCT00433537|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110593155|NCT00433537|Glucocorticoids|glucocorticoids|mesh-ancestor
110593156|NCT00433537|Hormones|hormones|mesh-ancestor
110593157|NCT00433537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110593158|NCT00433537|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110018341|NCT04420572|Hormones|hormones|mesh-ancestor
110593159|NCT00433537|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110593160|NCT00433537|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110593161|NCT00433537|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110593162|NCT00433537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110593163|NCT00433537|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110593164|NCT00433537|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110593165|NCT00433537|Tubulin Modulators|tubulin modulators|mesh-ancestor
110243628|NCT00114387|Vitamins|vitamins|mesh-ancestor
110593166|NCT00433537|Antimitotic Agents|antimitotic agents|mesh-ancestor
110593167|NCT00433537|Mitosis Modulators|mitosis modulators|mesh-ancestor
110593168|NCT00570765|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
110593169|NCT00570765|Cathartics|cathartics|mesh-ancestor
110593170|NCT00570765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110593171|NCT00777699|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110593172|NCT00777699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110593173|NCT00777699|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110593174|NCT00777699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110593175|NCT00777699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110593177|NCT05118477|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110593178|NCT05118477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110593179|NCT05118477|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110593180|NCT05118477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110593181|NCT05118477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110593182|NCT05118477|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110593183|NCT05118477|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110593184|NCT05118477|Purinergic Agents|purinergic agents|mesh-ancestor
110593185|NCT05118477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110593186|NCT00667095|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110593187|NCT00667095|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
110593188|NCT00667095|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110593189|NCT00667095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110593190|NCT00667095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110593191|NCT00667095|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110593192|NCT00667095|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110593193|NCT00667095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110593194|NCT00667095|Cholinergic Agents|cholinergic agents|mesh-ancestor
110593195|NCT00667095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110593196|NCT00667095|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
110593197|NCT00667095|Protective Agents|protective agents|mesh-ancestor
110593198|NCT00667095|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110593199|NCT00667095|Antioxidants|antioxidants|mesh-ancestor
110593200|NCT00777933|Cyclosporine|cyclosporine|mesh-list
110593201|NCT00777933|Tacrolimus|tacrolimus|mesh-list
110593202|NCT00777933|Cyclosporins|cyclosporins|mesh-list
110593203|NCT00777933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110593204|NCT00777933|Immunologic Factors|immunologic factors|mesh-ancestor
110243814|NCT00352378|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110593205|NCT00777933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110593206|NCT00777933|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110593207|NCT00777933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110593208|NCT00777933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110593209|NCT00777933|Antifungal Agents|antifungal agents|mesh-ancestor
110593210|NCT00777933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110593211|NCT00777933|Dermatologic Agents|dermatologic agents|mesh-ancestor
110593212|NCT00777933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110593213|NCT00773331|Epoetin Alfa|epoetin alfa|mesh-list
110593214|NCT00773331|Hematinics|hematinics|mesh-ancestor
110593215|NCT00778011|Ondansetron|ondansetron|mesh-list
110593216|NCT00778011|Metoclopramide|metoclopramide|mesh-list
110593217|NCT00778011|Antiemetics|antiemetics|mesh-ancestor
110593218|NCT00778011|Autonomic Agents|autonomic agents|mesh-ancestor
110593219|NCT00778011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110593220|NCT00778011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110593221|NCT00778011|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110593222|NCT00778011|Antipruritics|antipruritics|mesh-ancestor
110593223|NCT00778011|Dermatologic Agents|dermatologic agents|mesh-ancestor
110377106|NCT00171314|Zoledronic Acid|zoledronic acid|mesh-list
110593224|NCT00778011|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110593226|NCT00778011|Serotonin Agents|serotonin agents|mesh-ancestor
110593227|NCT00778011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110593228|NCT00778011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110018358|NCT04399980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110593229|NCT00778011|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110593231|NCT00778011|Dopamine Agents|dopamine agents|mesh-ancestor
110593232|NCT00778089|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
110593233|NCT00778089|Vasodilator Agents|vasodilator agents|mesh-ancestor
110593234|NCT00778089|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
110243946|NCT00112892|Selenium|selenium|mesh-list
110593235|NCT00778089|Protective Agents|protective agents|mesh-ancestor
110593236|NCT00778089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110593237|NCT00433381|Bevacizumab|bevacizumab|mesh-list
110593238|NCT00433381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110593239|NCT00433381|Irinotecan|irinotecan|mesh-list
110593240|NCT00433381|Temozolomide|temozolomide|mesh-list
110593241|NCT00433381|Camptothecin|camptothecin|mesh-list
110593242|NCT00433381|Endothelial Growth Factors|endothelial growth factors|mesh-list
110593243|NCT00433381|Antibodies|antibodies|mesh-list
110593244|NCT00433381|Immunoglobulins|immunoglobulins|mesh-list
110593245|NCT00433381|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110593246|NCT00433381|Immunoglobulin G|immunoglobulin g|mesh-list
110593247|NCT00433381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110593248|NCT00433381|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110593249|NCT00433381|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110593250|NCT00433381|Growth Substances|growth substances|mesh-ancestor
110593251|NCT00433381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110593252|NCT00433381|Growth Inhibitors|growth inhibitors|mesh-ancestor
110593253|NCT00433381|Immunologic Factors|immunologic factors|mesh-ancestor
110593254|NCT00433381|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110593255|NCT00433381|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110593256|NCT00433381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110593257|NCT00433381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110593258|NCT00433381|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110593259|NCT00433381|Alkylating Agents|alkylating agents|mesh-ancestor
110593260|NCT00433381|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110593262|NCT00667017|Immunoconjugates|immunoconjugates|mesh-ancestor
110593263|NCT00667017|Immunologic Factors|immunologic factors|mesh-ancestor
110593264|NCT00667017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110593265|NCT00781131|Pregabalin|pregabalin|mesh-list
110593266|NCT00781131|Analgesics|analgesics|mesh-ancestor
110593267|NCT00781131|Sensory System Agents|sensory system agents|mesh-ancestor
110593268|NCT00781131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110593269|NCT00781131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110593270|NCT00781131|Anticonvulsants|anticonvulsants|mesh-ancestor
110593271|NCT00781131|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110593272|NCT00781131|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110244189|NCT00444418|Naltrexone|naltrexone|mesh-list
110593273|NCT00781131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110593274|NCT00781131|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110593275|NCT00781131|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110593276|NCT00781131|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110593277|NCT00781131|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110593278|NCT00781131|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110593280|NCT00778245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110593281|NCT00778245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110593282|NCT00778401|Gabapentin|gabapentin|mesh-list
110593283|NCT00778401|Analgesics|analgesics|mesh-ancestor
110593284|NCT00778401|Sensory System Agents|sensory system agents|mesh-ancestor
110593285|NCT00778401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110593286|NCT00778401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110593287|NCT00778401|Anticonvulsants|anticonvulsants|mesh-ancestor
110593288|NCT00778401|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110593289|NCT00778401|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110593290|NCT00778401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110593291|NCT00778401|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110593292|NCT00778401|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110244315|NCT00113984|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110593293|NCT00778401|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110593294|NCT00778401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110593295|NCT00778401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110593296|NCT00778401|Antimanic Agents|antimanic agents|mesh-ancestor
110593297|NCT00666705|Raltegravir Potassium|raltegravir potassium|mesh-list
110593299|NCT00666705|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110593300|NCT00666705|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110593301|NCT00666705|Antiviral Agents|antiviral agents|mesh-ancestor
110593302|NCT00666705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110593303|NCT00666705|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110593304|NCT00666705|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110593305|NCT00666705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110593306|NCT00666705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110593307|NCT00666705|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110593308|NCT00666705|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110593309|NCT00666705|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
110593310|NCT04047849|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110593311|NCT04047849|Amoxicillin|amoxicillin|mesh-list
110593312|NCT04047849|Azithromycin|azithromycin|mesh-list
110244442|NCT00446524|Valsartan|valsartan|mesh-list
110593313|NCT04047849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110593314|NCT00778557|Cefprozil|cefprozil|mesh-list
110593315|NCT00778557|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110593316|NCT00778557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110593317|NCT00778713|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110593318|NCT00778713|Fosinopril|fosinopril|mesh-list
110593319|NCT00778713|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110593320|NCT00778713|Diuretics|diuretics|mesh-ancestor
110593321|NCT00778713|Natriuretic Agents|natriuretic agents|mesh-ancestor
110593322|NCT00778713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110593323|NCT00778713|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110593324|NCT00778713|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110244509|NCT00446836|Mitosis Modulators|mitosis modulators|mesh-ancestor
110593325|NCT00778713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110593326|NCT00778713|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110593327|NCT00778713|Protease Inhibitors|protease inhibitors|mesh-ancestor
110593328|NCT00778713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110593329|NCT00781287|Raltegravir Potassium|raltegravir potassium|mesh-list
110593330|NCT00781287|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110593331|NCT00781287|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110593332|NCT00781287|Antiviral Agents|antiviral agents|mesh-ancestor
110593333|NCT00781287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110244570|NCT00447304|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110593334|NCT00781287|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110593335|NCT00781287|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110593336|NCT00781287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110593337|NCT00781287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110593338|NCT00774111|Dolutegravir|dolutegravir|mesh-list
110593339|NCT00774111|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110593340|NCT00774111|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110593341|NCT00774111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110593342|NCT00774111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110593343|NCT00774111|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110244638|NCT00401856|Hormone Antagonists|hormone antagonists|mesh-ancestor
110593344|NCT00774111|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110593345|NCT00774111|Antiviral Agents|antiviral agents|mesh-ancestor
110593346|NCT00774111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110593347|NCT00778791|Metformin|metformin|mesh-list
110593348|NCT00778791|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110593349|NCT00778791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110593350|NCT00774189|Clarithromycin|clarithromycin|mesh-list
110593351|NCT00774189|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110593352|NCT00774189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110593353|NCT00774189|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110593354|NCT00774189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110244702|NCT00448786|Imetelstat|imetelstat|mesh-list
110593355|NCT00774189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110593356|NCT00774189|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110593357|NCT00774189|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110593358|NCT00774423|Riluzole|riluzole|mesh-list
110593359|NCT00774423|Anticonvulsants|anticonvulsants|mesh-ancestor
110593360|NCT00774423|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110593361|NCT00774423|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110593362|NCT00774423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110593363|NCT00774423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110593364|NCT00774423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110593365|NCT00774423|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110593366|NCT00774423|Protective Agents|protective agents|mesh-ancestor
110593367|NCT00781521|Ofloxacin|ofloxacin|mesh-list
110593368|NCT00781521|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110593369|NCT00781521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110593370|NCT00781521|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110593371|NCT00781521|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110593372|NCT00781521|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110593373|NCT00781521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110593374|NCT00781521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110593375|NCT00781521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110593376|NCT00781521|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110593377|NCT00781521|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110593378|NCT00774501|Anesthetics|anesthetics|mesh-list
110593379|NCT00774501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110244770|NCT00115752|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110593380|NCT00774501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110593382|NCT00784485|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110593383|NCT00784485|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110593384|NCT00784485|Respiratory System Agents|respiratory system agents|mesh-ancestor
110593385|NCT00781755|Varenicline|varenicline|mesh-list
110593386|NCT00781755|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110593387|NCT00781755|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110593388|NCT00781755|Cholinergic Agents|cholinergic agents|mesh-ancestor
110593389|NCT00781755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110593390|NCT00781755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110593391|NCT00781755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110593392|NCT00774735|Dolutegravir|dolutegravir|mesh-list
110244887|NCT00449722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110593393|NCT00774735|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110593394|NCT00774735|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110593395|NCT00774735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110593396|NCT00774735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110593397|NCT00774735|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110593398|NCT00774735|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110593399|NCT00774735|Antiviral Agents|antiviral agents|mesh-ancestor
110593400|NCT00774735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110593401|NCT00666237|Mitomycins|mitomycins|mesh-list
110593402|NCT00666237|Mitomycin|mitomycin|mesh-list
110593403|NCT00666237|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110593404|NCT00666237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110593405|NCT00666237|Alkylating Agents|alkylating agents|mesh-ancestor
110593406|NCT00666237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110593407|NCT00666237|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110593408|NCT00666237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110593409|NCT00774813|Citalopram|citalopram|mesh-list
110377152|NCT00476606|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110593410|NCT00774813|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110593411|NCT00774813|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110245022|NCT00458458|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110593412|NCT00774813|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110593413|NCT00774813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110593414|NCT00774813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110593415|NCT00774813|Serotonin Agents|serotonin agents|mesh-ancestor
110593416|NCT00774813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110593417|NCT00774813|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110593418|NCT00774813|Antidepressive Agents|antidepressive agents|mesh-ancestor
110593419|NCT00774813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110593421|NCT00784797|Mifepristone|mifepristone|mesh-list
110593422|NCT00784797|Oxytocics|oxytocics|mesh-ancestor
110593423|NCT00784797|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110593424|NCT00784797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110593425|NCT00784797|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
110593426|NCT00784797|Abortifacient Agents|abortifacient agents|mesh-ancestor
110593427|NCT00784797|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110593428|NCT00784797|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110593429|NCT00784797|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110593430|NCT00784797|Contraceptive Agents|contraceptive agents|mesh-ancestor
110593431|NCT00784797|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
110245155|NCT00460252|Insulin|insulin|mesh-list
110593432|NCT00784797|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
110593433|NCT00784797|Hormone Antagonists|hormone antagonists|mesh-ancestor
110593434|NCT00784797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110593435|NCT00784797|Luteolytic Agents|luteolytic agents|mesh-ancestor
110593436|NCT00784797|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110593437|NCT00784797|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
110593438|NCT00774969|Metronidazole|metronidazole|mesh-list
110593439|NCT00774969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110593440|NCT00774969|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110593442|NCT00774969|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110593443|NCT00785109|Vitamin K|vitamin k|mesh-list
110593444|NCT00785109|Vitamins|vitamins|mesh-ancestor
110593445|NCT00785109|Micronutrients|micronutrients|mesh-ancestor
110593446|NCT00785109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110593447|NCT00785109|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110593448|NCT00785109|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110593449|NCT00785109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110593450|NCT00785109|Hemostatics|hemostatics|mesh-ancestor
110593451|NCT00785109|Coagulants|coagulants|mesh-ancestor
110593452|NCT00662025|Capecitabine|capecitabine|mesh-list
110240835|NCT00106379|Tenofovir|tenofovir|mesh-list
110593454|NCT00662025|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110593455|NCT00662025|Antimetabolites|antimetabolites|mesh-ancestor
110593456|NCT00662025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110593457|NCT00662025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110593458|NCT00662025|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110593459|NCT00662025|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110593460|NCT00662025|Growth Substances|growth substances|mesh-ancestor
110593461|NCT00662025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110593462|NCT00662025|Growth Inhibitors|growth inhibitors|mesh-ancestor
110593463|NCT00662025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110377166|NCT04562103|Epinephrine|epinephrine|mesh-list
110593464|NCT00662025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110593465|NCT00789945|Insulin|insulin|mesh-list
110593466|NCT00789945|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110593467|NCT00789945|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110593468|NCT00789945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110593469|NCT00790101|Risedronic Acid|risedronic acid|mesh-list
110593470|NCT00790101|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
110593471|NCT00790101|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110593472|NCT00790101|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110593473|NCT00790101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110593474|NCT00790101|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110593475|NCT00790101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110593476|NCT00790101|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110593477|NCT00790101|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110593478|NCT00790101|Hormone Antagonists|hormone antagonists|mesh-ancestor
110593479|NCT00790101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110593480|NCT00790101|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110593481|NCT00790101|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110593482|NCT00782301|Maraviroc|maraviroc|mesh-list
110593483|NCT00782301|Etravirine|etravirine|mesh-list
110593484|NCT00782301|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110593485|NCT00782301|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110593486|NCT00782301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110593487|NCT00782301|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110593488|NCT00782301|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110593489|NCT00782301|Antiviral Agents|antiviral agents|mesh-ancestor
110593490|NCT00782301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110593491|NCT00782301|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
110593492|NCT00782301|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110593493|NCT00782301|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110593494|NCT00782301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110593495|NCT00785421|Leucovorin|leucovorin|mesh-list
110593496|NCT00785421|Folic Acid|folic acid|mesh-list
110593497|NCT00785421|Cisplatin|cisplatin|mesh-list
110593498|NCT00785421|Gemcitabine|gemcitabine|mesh-list
110593499|NCT00785421|Enoxaparin|enoxaparin|mesh-list
110593500|NCT00785421|Enoxaparin sodium|enoxaparin sodium|mesh-list
110593501|NCT00785421|Levoleucovorin|levoleucovorin|mesh-list
110593502|NCT00785421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110593503|NCT00785421|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110593504|NCT00785421|Antimetabolites|antimetabolites|mesh-ancestor
110593505|NCT00785421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110593506|NCT00785421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110593507|NCT00785421|Antidotes|antidotes|mesh-ancestor
110245529|NCT00116259|Dopamine Agonists|dopamine agonists|mesh-ancestor
110593508|NCT00785421|Protective Agents|protective agents|mesh-ancestor
110150794|NCT00000559|Hormones|hormones|mesh-list
110593509|NCT00785421|Vitamin B Complex|vitamin b complex|mesh-ancestor
110593511|NCT00785421|Micronutrients|micronutrients|mesh-ancestor
110593512|NCT00785421|Hematinics|hematinics|mesh-ancestor
110593513|NCT00785421|Anticoagulants|anticoagulants|mesh-ancestor
110593514|NCT00785421|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110593515|NCT00785421|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110593516|NCT00790179|Ropivacaine|ropivacaine|mesh-list
110593517|NCT00790179|Anesthetics, Local|anesthetics, local|mesh-ancestor
110593518|NCT00790179|Anesthetics|anesthetics|mesh-ancestor
110593519|NCT00790179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110593520|NCT00790179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110593521|NCT00790179|Sensory System Agents|sensory system agents|mesh-ancestor
110593522|NCT00790179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110593523|NCT00790413|Rituximab|rituximab|mesh-list
110593524|NCT00790413|Fludarabine|fludarabine|mesh-list
110593525|NCT00790413|Thiotepa|thiotepa|mesh-list
110240907|NCT00437476|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
110593526|NCT00790413|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
110593527|NCT00790413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110593528|NCT00790413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110593529|NCT00790413|Immunologic Factors|immunologic factors|mesh-ancestor
110593530|NCT00790413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110593531|NCT00790413|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110593532|NCT00790413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110593533|NCT00790413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110593534|NCT00790413|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110593535|NCT00790413|Alkylating Agents|alkylating agents|mesh-ancestor
110593536|NCT00790413|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110593537|NCT00790413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110593538|NCT00790413|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110593539|NCT00785811|N-Methylaspartate|n-methylaspartate|mesh-list
110593540|NCT00785811|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
110593541|NCT00785811|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110593542|NCT00785811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110593543|NCT00785811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110593544|NCT00785811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110593545|NCT00440947|Ritonavir|ritonavir|mesh-list
110593546|NCT00440947|Atazanavir Sulfate|atazanavir sulfate|mesh-list
110593548|NCT00440947|Abacavir|abacavir|mesh-list
110593549|NCT00440947|Dideoxynucleosides|dideoxynucleosides|mesh-list
110593550|NCT00440947|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110593551|NCT00440947|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110593552|NCT00440947|Protease Inhibitors|protease inhibitors|mesh-ancestor
110593553|NCT00440947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110593554|NCT00440947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110593555|NCT00440947|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110593556|NCT00440947|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110593557|NCT00440947|Antiviral Agents|antiviral agents|mesh-ancestor
110593558|NCT00440947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110593559|NCT00440947|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110593560|NCT00440947|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110593561|NCT00440947|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110593562|NCT00440947|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110593563|NCT00440947|Antimetabolites|antimetabolites|mesh-ancestor
110593564|NCT00790881|Lumefantrine|lumefantrine|mesh-list
110593565|NCT00790881|Artemether|artemether|mesh-list
110593566|NCT00790881|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
110593567|NCT00790881|Antimalarials|antimalarials|mesh-ancestor
110593568|NCT00790881|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110593569|NCT00790881|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110593570|NCT00790881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110593571|NCT01029769|Olanzapine|olanzapine|mesh-list
110593572|NCT01029769|Amisulpride|amisulpride|mesh-list
110593573|NCT01029769|Antiemetics|antiemetics|mesh-ancestor
110593574|NCT01029769|Autonomic Agents|autonomic agents|mesh-ancestor
110593575|NCT01029769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110593576|NCT01029769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110593577|NCT01029769|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110593578|NCT01029769|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110593579|NCT01029769|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110593580|NCT01029769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110593581|NCT01029769|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110593582|NCT01029769|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110593583|NCT01029769|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110593584|NCT01029769|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110593585|NCT01029769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110593586|NCT01029769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110593587|NCT01029769|Serotonin Agents|serotonin agents|mesh-ancestor
110593588|NCT01029769|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110593589|NCT01029769|Dopamine Agents|dopamine agents|mesh-ancestor
110593590|NCT01029769|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110593591|NCT01029769|Antidepressive Agents|antidepressive agents|mesh-ancestor
110593592|NCT02557945|Gabapentin|gabapentin|mesh-list
110593593|NCT02557945|Analgesics|analgesics|mesh-ancestor
110593594|NCT02557945|Sensory System Agents|sensory system agents|mesh-ancestor
110593595|NCT02557945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110593596|NCT02557945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110593597|NCT02557945|Anticonvulsants|anticonvulsants|mesh-ancestor
110593598|NCT02557945|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110593599|NCT02557945|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110593600|NCT02557945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110593601|NCT02557945|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110593602|NCT02557945|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110240980|NCT00438178|Obatoclax|obatoclax|mesh-list
110593603|NCT02557945|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110593604|NCT02557945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110593605|NCT02557945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110593607|NCT00664521|Rituximab|rituximab|mesh-list
110593608|NCT00664521|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110593609|NCT00664521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110593610|NCT00664521|Immunologic Factors|immunologic factors|mesh-ancestor
110593611|NCT00664521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110593612|NCT00664521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110593613|NCT02581046|Dexamethasone|dexamethasone|mesh-list
110593614|NCT02581046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110593615|NCT02581046|Antiemetics|antiemetics|mesh-ancestor
110593616|NCT02581046|Autonomic Agents|autonomic agents|mesh-ancestor
110593617|NCT02581046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110593618|NCT02581046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110593619|NCT02581046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110593620|NCT02581046|Glucocorticoids|glucocorticoids|mesh-ancestor
110593621|NCT02581046|Hormones|hormones|mesh-ancestor
110593622|NCT02581046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110593623|NCT02581046|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110593624|NCT02581046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110593625|NCT00664209|Amoxicillin|amoxicillin|mesh-list
110593626|NCT00664209|Omeprazole|omeprazole|mesh-list
110593627|NCT00664209|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110593628|NCT00664209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110593629|NCT00664209|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110593630|NCT00664209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110593631|NCT00664209|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110593632|NCT00664209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110593633|NCT00664209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110593634|NCT03192332|Plasminogen|plasminogen|mesh-list
110593635|NCT03192332|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
110593636|NCT03192332|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110593637|NCT03192332|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110593638|NCT03192332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110593639|NCT02555943|Ritonavir|ritonavir|mesh-list
110593640|NCT02555943|Tenofovir|tenofovir|mesh-list
110593641|NCT02555943|Sofosbuvir|sofosbuvir|mesh-list
110593642|NCT02555943|Entecavir|entecavir|mesh-list
110593643|NCT02555943|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
110593644|NCT02555943|Ledipasvir|ledipasvir|mesh-list
110593645|NCT02555943|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110593646|NCT02555943|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110593647|NCT02555943|Protease Inhibitors|protease inhibitors|mesh-ancestor
110593648|NCT02555943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110593649|NCT02555943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110593650|NCT02555943|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110593651|NCT02555943|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110593652|NCT02555943|Antiviral Agents|antiviral agents|mesh-ancestor
110018436|NCT03962634|Tetracaine|tetracaine|mesh-list
110593653|NCT02555943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110593654|NCT02555943|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110593655|NCT02555943|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110593656|NCT02555943|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110593657|NCT02555943|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110245711|NCT00465205|Valacyclovir|valacyclovir|mesh-list
110593658|NCT00782847|Cyproterone Acetate|cyproterone acetate|mesh-list
110593659|NCT00782847|Cyproterone|cyproterone|mesh-list
110593660|NCT00782847|Androgen Antagonists|androgen antagonists|mesh-ancestor
110593661|NCT00782847|Hormone Antagonists|hormone antagonists|mesh-ancestor
110593662|NCT00782847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110593663|NCT00782847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110593664|NCT00782847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110593665|NCT00782847|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110593666|NCT00782847|Contraceptive Agents|contraceptive agents|mesh-ancestor
110593667|NCT00782847|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110593668|NCT00785967|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110593669|NCT00785967|Immunologic Factors|immunologic factors|mesh-ancestor
110593670|NCT00785967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110593671|NCT00440557|Epoetin Alfa|epoetin alfa|mesh-list
110593672|NCT00440557|Hematinics|hematinics|mesh-ancestor
110593673|NCT05673590|Docetaxel|docetaxel|mesh-list
110593674|NCT05673590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110593675|NCT05673590|Tubulin Modulators|tubulin modulators|mesh-ancestor
110593676|NCT05673590|Antimitotic Agents|antimitotic agents|mesh-ancestor
110593677|NCT05673590|Mitosis Modulators|mitosis modulators|mesh-ancestor
110593678|NCT05673590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110593679|NCT01029847|Adalimumab|adalimumab|mesh-list
110593680|NCT01029847|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110593681|NCT01029847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110593682|NCT01029847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110593683|NCT02452268|Spartalizumab|spartalizumab|mesh-list
110593684|NCT02452268|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110593685|NCT02452268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110593686|NCT02452268|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110593687|NCT02452268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110593688|NCT02524249|Caffeine|caffeine|mesh-list
110593689|NCT02524249|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110593690|NCT02524249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110593691|NCT02524249|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110593692|NCT02524249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110593693|NCT02524249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110593694|NCT02524249|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110593695|NCT02524249|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110593696|NCT02524249|Purinergic Agents|purinergic agents|mesh-ancestor
110593697|NCT02524249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110593698|NCT01033981|Sunitinib|sunitinib|mesh-list
110593699|NCT01033981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110593700|NCT01033981|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110593701|NCT01033981|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110593702|NCT01033981|Growth Substances|growth substances|mesh-ancestor
110593703|NCT01033981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110593704|NCT01033981|Growth Inhibitors|growth inhibitors|mesh-ancestor
110593705|NCT01033981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110593706|NCT01033981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110593707|NCT01033981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110593709|NCT02430194|Ritonavir|ritonavir|mesh-list
110593710|NCT02430194|Interferon-alpha|interferon-alpha|mesh-list
110593711|NCT02430194|Interferon alpha-2|interferon alpha-2|mesh-list
110593712|NCT02430194|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110593713|NCT02430194|Lonafarnib|lonafarnib|mesh-list
110593714|NCT02430194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110593715|NCT02430194|Antiviral Agents|antiviral agents|mesh-ancestor
110593716|NCT02430194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110593717|NCT02430194|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110593718|NCT02430194|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110593719|NCT02430194|Protease Inhibitors|protease inhibitors|mesh-ancestor
110593720|NCT02430194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110593721|NCT02430194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110593722|NCT02430194|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110593723|NCT02430194|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110593724|NCT02430194|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110245991|NCT00475072|Antimetabolites|antimetabolites|mesh-ancestor
110593725|NCT02430194|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110593726|NCT02430194|Immunologic Factors|immunologic factors|mesh-ancestor
110593727|NCT02430194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110593728|NCT00582608|N-(2-aminoethyl)-5-isoquinolinesulfonamide|n-(2-aminoethyl)-5-isoquinolinesulfonamide|mesh-list
110593729|NCT00582608|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110593730|NCT00582608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110593731|NCT00582608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110593732|NCT02400242|Dexamethasone|dexamethasone|mesh-list
110593733|NCT02400242|Pomalidomide|pomalidomide|mesh-list
110593734|NCT02400242|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
110593735|NCT02400242|Immunomodulating Agents|immunomodulating agents|mesh-list
110593736|NCT02400242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110593737|NCT02400242|Antiemetics|antiemetics|mesh-ancestor
110593738|NCT02400242|Autonomic Agents|autonomic agents|mesh-ancestor
110593739|NCT02400242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110593740|NCT02400242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110593741|NCT02400242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110593742|NCT02400242|Glucocorticoids|glucocorticoids|mesh-ancestor
110593744|NCT02400242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110593745|NCT02400242|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110593746|NCT02400242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110593747|NCT02400242|Immunologic Factors|immunologic factors|mesh-ancestor
110593748|NCT02400242|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110593749|NCT02400242|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110593751|NCT02400242|Growth Inhibitors|growth inhibitors|mesh-ancestor
110593752|NCT02400242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110593753|NCT02400242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110593754|NCT03087656|Levofloxacin|levofloxacin|mesh-list
110593755|NCT03087656|Ceftriaxone|ceftriaxone|mesh-list
110593756|NCT03087656|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110593757|NCT03087656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110593758|NCT03087656|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110593759|NCT03087656|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110593760|NCT03087656|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110593762|NCT03087656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110593763|NCT03087656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110593764|NCT03087656|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110593765|NCT03087656|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110593766|NCT04076228|Pembrolizumab|pembrolizumab|mesh-list
110593767|NCT04076228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110593768|NCT04076228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110593769|NCT04076228|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110593770|NCT04076228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110593771|NCT02580734|Melatonin|melatonin|mesh-list
110593772|NCT02580734|Antioxidants|antioxidants|mesh-ancestor
110246246|NCT05367336|Analgesics|analgesics|mesh-ancestor
110593773|NCT02580734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110593774|NCT02580734|Protective Agents|protective agents|mesh-ancestor
110593775|NCT02580734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110593776|NCT02580734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110593777|NCT00427999|Pioglitazone|pioglitazone|mesh-list
110593778|NCT00427999|Dexamethasone|dexamethasone|mesh-list
110593779|NCT00427999|Dexamethasone acetate|dexamethasone acetate|mesh-list
110593780|NCT00427999|Etoricoxib|etoricoxib|mesh-list
110593781|NCT00427999|Imatinib Mesylate|imatinib mesylate|mesh-list
110593782|NCT00427999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110246308|NCT00117767|Antifungal Agents|antifungal agents|mesh-ancestor
110593783|NCT00427999|Antiemetics|antiemetics|mesh-ancestor
110593784|NCT00427999|Autonomic Agents|autonomic agents|mesh-ancestor
110593785|NCT00427999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110593786|NCT00427999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110593787|NCT00427999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110593788|NCT00427999|Glucocorticoids|glucocorticoids|mesh-ancestor
110593789|NCT00427999|Hormones|hormones|mesh-ancestor
110593790|NCT00427999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110593791|NCT00427999|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110593792|NCT00427999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110593793|NCT00427999|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110593794|NCT00427999|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110593795|NCT00427999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110593796|NCT00427999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110593797|NCT00427999|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110593798|NCT00427999|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110593799|NCT00427999|Analgesics|analgesics|mesh-ancestor
110593800|NCT00427999|Sensory System Agents|sensory system agents|mesh-ancestor
110593801|NCT00427999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110593802|NCT00427999|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110593803|NCT00427999|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110593804|NCT04825652|177Lu-PSMA-617|177lu-psma-617|mesh-list
110593805|NCT04825652|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110246433|NCT00477802|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110246434|NCT00477802|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110593806|NCT04825652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110593807|NCT00661713|Vaccines|vaccines|mesh-list
110593808|NCT00661713|Immunologic Factors|immunologic factors|mesh-ancestor
110593809|NCT00661713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110593810|NCT02578472|Zolpidem|zolpidem|mesh-list
110593811|NCT02578472|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110593812|NCT02578472|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110593813|NCT02578472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110246494|NCT03271879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110593814|NCT02578472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110593815|NCT02578472|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
110593816|NCT02578472|GABA Agonists|gaba agonists|mesh-ancestor
110593817|NCT02578472|GABA Agents|gaba agents|mesh-ancestor
110377265|NCT00477464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110593818|NCT02578472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110593819|NCT02578472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110593820|NCT03840902|Paclitaxel|paclitaxel|mesh-list
110593821|NCT03840902|Etoposide|etoposide|mesh-list
110593822|NCT03840902|Carboplatin|carboplatin|mesh-list
110593823|NCT03840902|Pemetrexed|pemetrexed|mesh-list
110593824|NCT03840902|Durvalumab|durvalumab|mesh-list
110241203|NCT00138177|Vitamin B Complex|vitamin b complex|mesh-ancestor
110593825|NCT03840902|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110593826|NCT03840902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110593827|NCT03840902|Tubulin Modulators|tubulin modulators|mesh-ancestor
110246630|NCT00119210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110593828|NCT03840902|Antimitotic Agents|antimitotic agents|mesh-ancestor
110593829|NCT03840902|Mitosis Modulators|mitosis modulators|mesh-ancestor
110593830|NCT03840902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110593831|NCT03840902|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110593832|NCT03840902|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110593833|NCT03840902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110593834|NCT03840902|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110593835|NCT03840902|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110593836|NCT03840902|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110593837|NCT03835975|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110593838|NCT03835975|Immunologic Factors|immunologic factors|mesh-ancestor
110593839|NCT03835975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110593841|NCT04038086|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110593842|NCT04038086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110593843|NCT04072640|Voriconazole|voriconazole|mesh-list
110593844|NCT04072640|Amphotericin B|amphotericin b|mesh-list
110593845|NCT04072640|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
110593846|NCT04072640|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
110593847|NCT04072640|Deoxycholic Acid|deoxycholic acid|mesh-list
110593848|NCT04072640|Antifungal Agents|antifungal agents|mesh-ancestor
110593849|NCT04072640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110246703|NCT00480298|Prednisolone|prednisolone|mesh-list
110593851|NCT04072640|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110593852|NCT04072640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110593853|NCT04072640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110593854|NCT04072640|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110593855|NCT04072640|Hormone Antagonists|hormone antagonists|mesh-ancestor
110593856|NCT04072640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110593857|NCT04072640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110593858|NCT04072640|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110593859|NCT04072640|Amebicides|amebicides|mesh-ancestor
110593860|NCT04072640|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110593861|NCT04072640|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110593862|NCT04072640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110593863|NCT04072640|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
110593864|NCT04072640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110593865|NCT01566487|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110593866|NCT01566487|Antidepressive Agents|antidepressive agents|mesh-ancestor
110593867|NCT01566487|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110593868|NCT01566487|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110593869|NCT01566487|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110593870|NCT01566487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110593871|NCT01566487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110593872|NCT02576288|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110593873|NCT02576288|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110593874|NCT02576288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110593875|NCT02576288|Incretins|incretins|mesh-ancestor
110593877|NCT02576288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110593878|NCT02576288|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110593879|NCT02576288|Protease Inhibitors|protease inhibitors|mesh-ancestor
110593880|NCT02576288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110246804|NCT00480883|Antimetabolites|antimetabolites|mesh-ancestor
110593881|NCT02576288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110593882|NCT00427921|Adalimumab|adalimumab|mesh-list
110593883|NCT00427921|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110593884|NCT00427921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110593885|NCT00427921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110593886|NCT00432991|Ephedrine|ephedrine|mesh-list
110593887|NCT00432991|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110593888|NCT00432991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110593889|NCT00432991|Sympathomimetics|sympathomimetics|mesh-ancestor
110593890|NCT00432991|Autonomic Agents|autonomic agents|mesh-ancestor
110593891|NCT00432991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110593892|NCT00432991|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110593893|NCT00432991|Adrenergic Agents|adrenergic agents|mesh-ancestor
110593894|NCT00432991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110593895|NCT00432991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110593896|NCT00580970|Lovastatin|lovastatin|mesh-list
110593897|NCT00580970|L 647318|l 647318|mesh-list
110241282|NCT00440167|Gemcitabine|gemcitabine|mesh-list
110593898|NCT00580970|Dihydromevinolin|dihydromevinolin|mesh-list
110593899|NCT00580970|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110593900|NCT00580970|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110593901|NCT00580970|Antimetabolites|antimetabolites|mesh-ancestor
110593902|NCT00580970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110593903|NCT00580970|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110593904|NCT00580970|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110593905|NCT00580970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110593906|NCT01030081|Amlodipine|amlodipine|mesh-list
110593907|NCT01030081|Nifedipine|nifedipine|mesh-list
110593908|NCT01030081|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110593909|NCT01030081|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110593910|NCT01030081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110593911|NCT01030081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110593912|NCT01030081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110593913|NCT01030081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110593914|NCT01030081|Vasodilator Agents|vasodilator agents|mesh-ancestor
110593915|NCT01030081|Tocolytic Agents|tocolytic agents|mesh-ancestor
110593916|NCT01030081|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110593917|NCT00426751|Abciximab|abciximab|mesh-list
110593918|NCT00426751|Eptifibatide|eptifibatide|mesh-list
110593919|NCT00426751|Anticoagulants|anticoagulants|mesh-ancestor
110593920|NCT00426751|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110593921|NCT02576366|Rifampin|rifampin|mesh-list
110593922|NCT02576366|Voriconazole|voriconazole|mesh-list
110593923|NCT02576366|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110593924|NCT02576366|Antitubercular Agents|antitubercular agents|mesh-ancestor
110593925|NCT02576366|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110593926|NCT02576366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110593927|NCT02576366|Leprostatic Agents|leprostatic agents|mesh-ancestor
110593928|NCT02576366|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110593929|NCT02576366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110593930|NCT02576366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110593931|NCT02576366|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110593932|NCT02576366|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110593933|NCT02576366|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110593934|NCT02576366|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110593935|NCT02576366|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110593936|NCT02576366|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110017513|NCT03044418|Propofol|propofol|mesh-list
110593937|NCT02576366|Antifungal Agents|antifungal agents|mesh-ancestor
110593938|NCT02576366|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110593939|NCT02576366|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110593940|NCT02576366|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110593941|NCT02576366|Hormone Antagonists|hormone antagonists|mesh-ancestor
110593942|NCT02576366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110593943|NCT02576366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110593944|NCT02576366|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110593945|NCT01030237|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110593946|NCT01030237|Lubricant Eye Drops|lubricant eye drops|mesh-list
110593947|NCT01030237|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110593948|NCT04046679|Bleomycin|bleomycin|mesh-list
110593949|NCT04046679|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110593950|NCT04046679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110593951|NCT00786279|Ethanol|ethanol|mesh-list
110593952|NCT00786279|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110593953|NCT00786279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110593954|NCT00786279|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110593955|NCT00786279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110593956|NCT00791193|Paliperidone Palmitate|paliperidone palmitate|mesh-list
110593957|NCT00791193|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110593958|NCT00791193|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110593959|NCT00791193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110593960|NCT00791193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110593961|NCT00791193|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110593962|NCT00791193|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110593963|NCT00791193|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110593964|NCT00791193|Serotonin Agents|serotonin agents|mesh-ancestor
110593965|NCT00791193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110593966|NCT00791193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110593967|NCT00791193|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110593968|NCT00791193|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110593969|NCT00791193|Dopamine Agents|dopamine agents|mesh-ancestor
110593970|NCT00791271|Interferons|interferons|mesh-list
110593971|NCT00791271|Interferon-alpha|interferon-alpha|mesh-list
110593972|NCT00791271|Interferon alpha-2|interferon alpha-2|mesh-list
110593973|NCT00791271|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110593974|NCT00791271|Decitabine|decitabine|mesh-list
110593975|NCT00791271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110593976|NCT00791271|Antiviral Agents|antiviral agents|mesh-ancestor
110593977|NCT00791271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110593978|NCT00791271|Immunologic Factors|immunologic factors|mesh-ancestor
110593979|NCT00791271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110247246|NCT00484003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110593980|NCT00791271|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110593981|NCT00791271|Antimetabolites|antimetabolites|mesh-ancestor
110593982|NCT00791271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110593983|NCT00791271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110593984|NCT00791349|Paliperidone Palmitate|paliperidone palmitate|mesh-list
110593985|NCT00791349|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110593986|NCT00791349|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110593987|NCT00791349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110593988|NCT00791349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110593989|NCT00791349|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110593990|NCT00791349|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110593991|NCT00791349|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110593992|NCT00791349|Serotonin Agents|serotonin agents|mesh-ancestor
110593993|NCT00791349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110593994|NCT00791349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110593995|NCT00791349|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110593996|NCT00791349|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110593997|NCT00791349|Dopamine Agents|dopamine agents|mesh-ancestor
110593998|NCT00440401|Thrombin|thrombin|mesh-list
110593999|NCT00440401|Hemostatics|hemostatics|mesh-list
110594000|NCT00440401|Coagulants|coagulants|mesh-ancestor
110594001|NCT00791427|Ranibizumab|ranibizumab|mesh-list
110594002|NCT00791427|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110594003|NCT00791427|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110594004|NCT00791427|Growth Substances|growth substances|mesh-ancestor
110594005|NCT00791427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110247288|NCT00484237|Analgesics|analgesics|mesh-ancestor
110594006|NCT00791427|Growth Inhibitors|growth inhibitors|mesh-ancestor
110594007|NCT00791427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110594008|NCT00786513|Anti-Infective Agents|anti-infective agents|mesh-list
110594009|NCT00786513|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110594010|NCT00791505|Ciprofloxacin|ciprofloxacin|mesh-list
110594011|NCT00791505|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
110594012|NCT00791505|Fluoroquinolones|fluoroquinolones|mesh-list
110594013|NCT00791505|Trimethoprim|trimethoprim|mesh-list
110594014|NCT00791505|Sulfamethoxazole|sulfamethoxazole|mesh-list
110594015|NCT00791505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110594016|NCT00791505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110594017|NCT00791505|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110594018|NCT00791505|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110594019|NCT00791505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110594020|NCT00791505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110594021|NCT00791505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110594022|NCT00791505|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110594023|NCT00791505|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110594024|NCT00791505|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110594026|NCT00791505|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110594027|NCT00791505|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110594028|NCT00791505|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110594029|NCT00791505|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110594030|NCT00791505|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
110594031|NCT00791505|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110594033|NCT02598960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110594034|NCT02598960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110247481|NCT00485680|Olanzapine|olanzapine|mesh-list
110594035|NCT02598960|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110594036|NCT02598960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110594037|NCT00426361|Vaccines|vaccines|mesh-list
110594038|NCT00426361|Immunologic Factors|immunologic factors|mesh-ancestor
110594039|NCT00426361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110594040|NCT00665847|Etravirine|etravirine|mesh-list
110594041|NCT00665847|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110594042|NCT00665847|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110241428|NCT00441181|Travoprost|travoprost|mesh-list
110594043|NCT00665847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110594044|NCT00665847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110594045|NCT00665847|Antiviral Agents|antiviral agents|mesh-ancestor
110594046|NCT00665847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110594047|NCT01030393|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
110594048|NCT01030393|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110594049|NCT01030393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110594050|NCT00783081|Cilostazol|cilostazol|mesh-list
110594051|NCT00783081|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110594052|NCT00783081|Autonomic Agents|autonomic agents|mesh-ancestor
110594053|NCT00783081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110594054|NCT00783081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110594056|NCT00783081|Respiratory System Agents|respiratory system agents|mesh-ancestor
110594057|NCT00783081|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110594058|NCT00783081|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110594059|NCT00783081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110594060|NCT00783081|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110594061|NCT00783081|Vasodilator Agents|vasodilator agents|mesh-ancestor
110594062|NCT00783081|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110594063|NCT00783081|Protective Agents|protective agents|mesh-ancestor
110594064|NCT00783081|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110594065|NCT00783081|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110594066|NCT00783081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110594067|NCT00426127|Docetaxel|docetaxel|mesh-list
110594068|NCT00426127|Doxorubicin|doxorubicin|mesh-list
110594069|NCT00426127|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110594070|NCT00426127|Enoxaparin|enoxaparin|mesh-list
110594071|NCT00426127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110594072|NCT00426127|Tubulin Modulators|tubulin modulators|mesh-ancestor
110594073|NCT00426127|Antimitotic Agents|antimitotic agents|mesh-ancestor
110594074|NCT00426127|Mitosis Modulators|mitosis modulators|mesh-ancestor
110594075|NCT00426127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110594076|NCT00426127|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110247645|NCT00486694|Antimalarials|antimalarials|mesh-ancestor
110594077|NCT00426127|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110594078|NCT00426127|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110594079|NCT00426127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110594080|NCT00426127|Anticoagulants|anticoagulants|mesh-ancestor
110594081|NCT00426127|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110594082|NCT00426127|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110594087|NCT00425503|Bortezomib|bortezomib|mesh-list
110594088|NCT00425503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110594089|NCT00786669|Cefixime|cefixime|mesh-list
110594090|NCT00786669|Cefpodoxime|cefpodoxime|mesh-list
110594091|NCT00786669|Bevacizumab|bevacizumab|mesh-list
110594092|NCT00786669|Irinotecan|irinotecan|mesh-list
110594093|NCT00786669|Vincristine|vincristine|mesh-list
110594094|NCT00786669|Temozolomide|temozolomide|mesh-list
110594095|NCT00786669|Camptothecin|camptothecin|mesh-list
110594096|NCT00786669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110594097|NCT00786669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110594098|NCT00786669|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110594099|NCT00786669|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110594100|NCT00786669|Growth Substances|growth substances|mesh-ancestor
110594101|NCT00786669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110594102|NCT00786669|Growth Inhibitors|growth inhibitors|mesh-ancestor
110594103|NCT00786669|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110247770|NCT00488215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110247781|NCT00488566|Lamotrigine|lamotrigine|mesh-list
110594104|NCT00786669|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110594105|NCT00786669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110594106|NCT00786669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110594107|NCT00786669|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110594108|NCT00786669|Tubulin Modulators|tubulin modulators|mesh-ancestor
110594109|NCT00786669|Antimitotic Agents|antimitotic agents|mesh-ancestor
110594110|NCT00786669|Mitosis Modulators|mitosis modulators|mesh-ancestor
110594111|NCT00786669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110594112|NCT00786669|Alkylating Agents|alkylating agents|mesh-ancestor
110594113|NCT00786669|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110594114|NCT00786669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110594116|NCT00791739|Trazodone|trazodone|mesh-list
110594117|NCT00791739|Analgesics|analgesics|mesh-ancestor
110594118|NCT00791739|Sensory System Agents|sensory system agents|mesh-ancestor
110594119|NCT00791739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110594120|NCT00791739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110594121|NCT00791739|Anticonvulsants|anticonvulsants|mesh-ancestor
110594122|NCT00791739|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110150852|NCT00000637|Antimetabolites|antimetabolites|mesh-ancestor
110247895|NCT00489229|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110594124|NCT00791739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110594125|NCT00791739|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110594126|NCT00791739|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110594127|NCT00791739|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110594128|NCT00791739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110594129|NCT00791739|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110594130|NCT00791739|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110594131|NCT00791739|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110594132|NCT00791739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110594134|NCT00791739|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110594135|NCT00791739|Antidepressive Agents|antidepressive agents|mesh-ancestor
110594136|NCT00791895|Insulin Aspart|insulin aspart|mesh-list
110594137|NCT00791895|Biphasic Insulins|biphasic insulins|mesh-list
110248029|NCT00490243|Autonomic Agents|autonomic agents|mesh-ancestor
110594138|NCT00791895|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
110594139|NCT00791895|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110594140|NCT00791895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110594141|NCT02503722|Osimertinib|osimertinib|mesh-list
110594142|NCT02503722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110594143|NCT02503722|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110594144|NCT02503722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110248096|NCT00490789|Antifungal Agents|antifungal agents|mesh-ancestor
110594145|NCT02503722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110594147|NCT00430573|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110594148|NCT00430573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110594149|NCT00430573|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110594150|NCT00430573|Antitubercular Agents|antitubercular agents|mesh-ancestor
110594151|NCT00430573|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110594152|NCT00430573|Antimetabolites|antimetabolites|mesh-ancestor
110594153|NCT00430573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110594154|NCT00783393|Temozolomide|temozolomide|mesh-list
110248173|NCT00491920|Vitamin D|vitamin d|mesh-list
110594155|NCT00783393|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110594156|NCT00783393|Alkylating Agents|alkylating agents|mesh-ancestor
110594157|NCT00783393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110594158|NCT00783393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110594160|NCT00783471|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110594161|NCT00783471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110594162|NCT00783471|Tubulin Modulators|tubulin modulators|mesh-ancestor
110594163|NCT00783471|Antimitotic Agents|antimitotic agents|mesh-ancestor
110594164|NCT00783471|Mitosis Modulators|mitosis modulators|mesh-ancestor
110594165|NCT00783471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110594166|NCT00783471|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110594167|NCT00783471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110594168|NCT02460900|Varenicline|varenicline|mesh-list
110594169|NCT02460900|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110594170|NCT02460900|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110594171|NCT02460900|Cholinergic Agents|cholinergic agents|mesh-ancestor
110594172|NCT02460900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110594173|NCT02460900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110594174|NCT02460900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110594175|NCT00787371|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110594176|NCT00787371|Interferon-alpha|interferon-alpha|mesh-list
110594177|NCT00787371|Antiviral Agents|antiviral agents|mesh-ancestor
110594178|NCT00787371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110594180|NCT00787371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110594181|NCT02075840|Crizotinib|crizotinib|mesh-list
110594182|NCT02075840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110594183|NCT02075840|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110594184|NCT02075840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110594185|NCT02075840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110594186|NCT02554695|Denosumab|denosumab|mesh-list
110150859|NCT00000637|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110594187|NCT02554695|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110594188|NCT02554695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110594189|NCT00792363|Irinotecan|irinotecan|mesh-list
110594190|NCT00792363|Panitumumab|panitumumab|mesh-list
110594191|NCT00792363|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110594192|NCT00792363|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110241572|NCT00108095|Dermatologic Agents|dermatologic agents|mesh-ancestor
110594193|NCT00792363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110594194|NCT00792363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110594195|NCT00792363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110594196|NCT00792363|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110594197|NCT00425113|Metronidazole|metronidazole|mesh-list
110594198|NCT00425113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110594199|NCT00425113|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110594200|NCT00425113|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110594201|NCT00425113|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110594202|NCT04895280|Triamcinolone|triamcinolone|mesh-list
110594203|NCT04895280|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110594204|NCT04895280|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110594206|NCT04895280|Bupivacaine|bupivacaine|mesh-list
110594207|NCT04895280|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110594208|NCT04895280|Anesthetics, Local|anesthetics, local|mesh-ancestor
110594209|NCT04895280|Anesthetics|anesthetics|mesh-ancestor
110594210|NCT04895280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110594211|NCT04895280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110248495|NCT00146016|Amantadine|amantadine|mesh-list
110594212|NCT04895280|Sensory System Agents|sensory system agents|mesh-ancestor
110594213|NCT04895280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110594214|NCT04895280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110594215|NCT04895280|Glucocorticoids|glucocorticoids|mesh-ancestor
110594217|NCT04895280|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110594218|NCT04895280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110594219|NCT04895280|Immunologic Factors|immunologic factors|mesh-ancestor
110594220|NCT04895280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110248545|NCT00494572|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110594221|NCT04895280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110594222|NCT04895280|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110594223|NCT04895280|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110594225|NCT04895280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110594226|NCT04895280|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110594227|NCT03994783|Methylprednisolone|methylprednisolone|mesh-list
110594228|NCT03994783|Rituximab|rituximab|mesh-list
110594229|NCT03994783|Immunoglobulins|immunoglobulins|mesh-list
110594230|NCT03994783|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110594231|NCT03994783|gamma-Globulins|gamma-globulins|mesh-list
110594232|NCT03994783|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110594233|NCT03994783|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110594234|NCT03994783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110594235|NCT03994783|Immunologic Factors|immunologic factors|mesh-ancestor
110594236|NCT03994783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110594237|NCT03994783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110594238|NCT03994783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110594239|NCT03994783|Antiemetics|antiemetics|mesh-ancestor
110594240|NCT03994783|Autonomic Agents|autonomic agents|mesh-ancestor
110594241|NCT03994783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110594242|NCT03994783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110594244|NCT03994783|Hormones|hormones|mesh-ancestor
110594245|NCT03994783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110248824|NCT04726982|Acetazolamide|acetazolamide|mesh-list
110594246|NCT03994783|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110594248|NCT00440011|Bimatoprost|bimatoprost|mesh-list
110594249|NCT00440011|Travoprost|travoprost|mesh-list
110594250|NCT00440011|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110594251|NCT00440011|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110594252|NCT00440011|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110594253|NCT03105102|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110594254|NCT03105102|Immunologic Factors|immunologic factors|mesh-ancestor
110594255|NCT03105102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110248883|NCT00497536|Insulin Aspart|insulin aspart|mesh-list
110594256|NCT01937468|Interleukin-2|interleukin-2|mesh-list
110594257|NCT01937468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110594258|NCT01937468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110594259|NCT01937468|Analgesics|analgesics|mesh-ancestor
110594260|NCT01937468|Sensory System Agents|sensory system agents|mesh-ancestor
110594261|NCT01937468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110594262|NCT01937468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110594263|NCT00663117|Naltrexone|naltrexone|mesh-list
110594264|NCT00663117|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110594265|NCT00663117|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110594266|NCT00663117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110594267|NCT00663117|Sensory System Agents|sensory system agents|mesh-ancestor
110248956|NCT00402623|Quercetin|quercetin|mesh-list
110594268|NCT00663117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110241646|NCT00404586|Xhance|xhance|mesh-list
110594270|NCT04072328|Propofol|propofol|mesh-list
110594271|NCT04072328|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110594272|NCT04072328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110594273|NCT04072328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110594274|NCT04072328|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110594275|NCT04072328|Anesthetics, General|anesthetics, general|mesh-ancestor
110594277|NCT04072328|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110594278|NCT04072328|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110594279|NCT04072328|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110594280|NCT04072328|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110594281|NCT04072328|GABA Modulators|gaba modulators|mesh-ancestor
110594282|NCT04072328|GABA Agents|gaba agents|mesh-ancestor
110594283|NCT04072328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110594284|NCT04072328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110594285|NCT00495716|Acyclovir|acyclovir|mesh-list
110594286|NCT00495716|Antiviral Agents|antiviral agents|mesh-ancestor
110594287|NCT00495716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110249082|NCT01245205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110594288|NCT00784017|Asparaginase|asparaginase|mesh-list
110594289|NCT00784017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110594290|NCT04074122|Adenosine|adenosine|mesh-list
110594291|NCT04074122|Isoproterenol|isoproterenol|mesh-list
110594292|NCT04074122|Epinephrine|epinephrine|mesh-list
110594293|NCT04074122|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110594294|NCT04074122|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110594295|NCT04074122|Adrenergic Agents|adrenergic agents|mesh-ancestor
110594296|NCT04074122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110377308|NCT00475865|Immunologic Factors|immunologic factors|mesh-ancestor
110594297|NCT04074122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110594298|NCT04074122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110594299|NCT04074122|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110594300|NCT04074122|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110594301|NCT04074122|Autonomic Agents|autonomic agents|mesh-ancestor
110594302|NCT04074122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110594303|NCT04074122|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110594304|NCT04074122|Respiratory System Agents|respiratory system agents|mesh-ancestor
110594305|NCT04074122|Mydriatics|mydriatics|mesh-ancestor
110594306|NCT04074122|Sympathomimetics|sympathomimetics|mesh-ancestor
110594307|NCT04074122|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110594308|NCT04074122|Analgesics|analgesics|mesh-ancestor
110594309|NCT04074122|Sensory System Agents|sensory system agents|mesh-ancestor
110594310|NCT04074122|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110249206|NCT00424203|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110249207|NCT00424203|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110249208|NCT00424203|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110249209|NCT00424203|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110249210|NCT00424203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110249211|NCT01245556|Ipilimumab|ipilimumab|mesh-list
110249212|NCT01245556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110594311|NCT04074122|Vasodilator Agents|vasodilator agents|mesh-ancestor
110594312|NCT04074122|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
110594313|NCT04074122|Purinergic Agonists|purinergic agonists|mesh-ancestor
110594314|NCT04074122|Purinergic Agents|purinergic agents|mesh-ancestor
110594315|NCT04074122|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110594316|NCT04074122|Protective Agents|protective agents|mesh-ancestor
110594318|NCT02578550|Emtricitabine|emtricitabine|mesh-list
110594319|NCT02578550|Darunavir|darunavir|mesh-list
110594320|NCT02578550|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110594321|NCT02578550|Cobicistat|cobicistat|mesh-list
110594322|NCT02578550|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
110594323|NCT02578550|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
110594324|NCT02578550|Antiviral Agents|antiviral agents|mesh-ancestor
110594325|NCT02578550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110594326|NCT02578550|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110594327|NCT02578550|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110594328|NCT02578550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110249337|NCT01245946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110594329|NCT02578550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110594330|NCT02578550|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110594331|NCT02578550|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110594332|NCT02578550|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110594333|NCT02578550|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110594334|NCT02578550|Protease Inhibitors|protease inhibitors|mesh-ancestor
110594335|NCT02578550|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110594336|NCT02578550|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110594338|NCT00788463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110594339|NCT00788463|Glucocorticoids|glucocorticoids|mesh-ancestor
110594340|NCT00788463|Hormones|hormones|mesh-ancestor
110594341|NCT00788463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110594342|NCT00788463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110594343|NCT00788463|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110594344|NCT00788463|Respiratory System Agents|respiratory system agents|mesh-ancestor
110594345|NCT00579254|Amlodipine|amlodipine|mesh-list
110594346|NCT00579254|Atorvastatin|atorvastatin|mesh-list
110594347|NCT00579254|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110594348|NCT00579254|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110594349|NCT00579254|Antimetabolites|antimetabolites|mesh-ancestor
110594350|NCT00579254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110594351|NCT00579254|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110594352|NCT00579254|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110594354|NCT00579254|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110594355|NCT00579254|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110594356|NCT00579254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110594357|NCT00579254|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110594358|NCT00579254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110249533|NCT00502684|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110594359|NCT00579254|Vasodilator Agents|vasodilator agents|mesh-ancestor
110594360|NCT00793221|Sirolimus|sirolimus|mesh-list
110594361|NCT00793221|Everolimus|everolimus|mesh-list
110594362|NCT00793221|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110594363|NCT00793221|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110594364|NCT00793221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110594365|NCT00793221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110377314|NCT00475865|Analgesics|analgesics|mesh-ancestor
110594366|NCT00793221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110594367|NCT00793221|Immunologic Factors|immunologic factors|mesh-ancestor
110594368|NCT00793221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110594369|NCT00793221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110594370|NCT00793221|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110594371|NCT00793221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110594372|NCT00793221|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110594373|NCT00793221|Antifungal Agents|antifungal agents|mesh-ancestor
110594374|NCT00661089|Botulinum Toxins|botulinum toxins|mesh-list
110594375|NCT00661089|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110594376|NCT00661089|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110594377|NCT00661089|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110249661|NCT01246921|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110594378|NCT00661089|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110594379|NCT00661089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110249733|NCT03990467|Tazobactam|tazobactam|mesh-list
110594381|NCT00661089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110594382|NCT00661089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110594383|NCT00661089|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110594384|NCT00661089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110594386|NCT01773278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110594387|NCT01773278|Protective Agents|protective agents|mesh-ancestor
110594388|NCT01773278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110594389|NCT00788931|Paclitaxel|paclitaxel|mesh-list
110594391|NCT00788931|Panobinostat|panobinostat|mesh-list
110594392|NCT00788931|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110594393|NCT00788931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110594394|NCT00788931|Tubulin Modulators|tubulin modulators|mesh-ancestor
110594395|NCT00788931|Antimitotic Agents|antimitotic agents|mesh-ancestor
110594396|NCT00788931|Mitosis Modulators|mitosis modulators|mesh-ancestor
110594397|NCT00788931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110594398|NCT00788931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110594399|NCT00788931|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110594400|NCT00788931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110594401|NCT02577848|Liraglutide|liraglutide|mesh-list
110594402|NCT02577848|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110594403|NCT02577848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110594404|NCT02577848|Incretins|incretins|mesh-ancestor
110594405|NCT02577848|Hormones|hormones|mesh-ancestor
110594406|NCT02577848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110594407|NCT00582426|Octreotide|octreotide|mesh-list
110594408|NCT00582426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110594409|NCT00582426|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110594410|NCT00582426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110594411|NCT00709982|Folic Acid|folic acid|mesh-list
110594412|NCT00709982|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110594413|NCT00709982|Norgestimate|norgestimate|mesh-list
110594414|NCT00709982|Estradiol|estradiol|mesh-list
110594415|NCT00709982|Estrogens|estrogens|mesh-ancestor
110594416|NCT00709982|Hormones|hormones|mesh-ancestor
110594417|NCT00709982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110594418|NCT00709982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110594419|NCT00709982|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110594420|NCT00709982|Contraceptive Agents|contraceptive agents|mesh-ancestor
110241798|NCT03278431|Piperazine|piperazine|mesh-list
110250003|NCT03999723|Vitamins|vitamins|mesh-ancestor
110594421|NCT00709982|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110594422|NCT00709982|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110594424|NCT00709982|Vitamin B Complex|vitamin b complex|mesh-ancestor
110594425|NCT00709982|Vitamins|vitamins|mesh-ancestor
110594426|NCT00709982|Micronutrients|micronutrients|mesh-ancestor
110594427|NCT00709982|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110594428|NCT00709982|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110250058|NCT04725942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110594429|NCT00709982|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110594430|NCT04070690|Dialysis Solutions|dialysis solutions|mesh-list
110594431|NCT04070690|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110594432|NCT00710138|Vitamins|vitamins|mesh-list
110594433|NCT00710138|Vitamin B 12|vitamin b 12|mesh-list
110594434|NCT00710138|Hydroxocobalamin|hydroxocobalamin|mesh-list
110594435|NCT00710138|Vitamin B Complex|vitamin b complex|mesh-list
110594436|NCT00710138|Micronutrients|micronutrients|mesh-ancestor
110594437|NCT00710138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110594438|NCT00710138|Hematinics|hematinics|mesh-ancestor
110594439|NCT00580034|Alemtuzumab|alemtuzumab|mesh-list
110594440|NCT00580034|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110594441|NCT00580034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110594443|NCT00710216|Telbivudine|telbivudine|mesh-list
110594444|NCT00710216|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110594445|NCT00710216|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110594446|NCT00710216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110594447|NCT00710216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110594448|NCT00710216|Antiviral Agents|antiviral agents|mesh-ancestor
110594449|NCT00710216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110594450|NCT00710216|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110250207|NCT00403364|Tinidazole|tinidazole|mesh-list
110594451|NCT00710216|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110594452|NCT00773513|Epoetin Alfa|epoetin alfa|mesh-list
110594453|NCT00773513|Darbepoetin alfa|darbepoetin alfa|mesh-list
110594454|NCT00773513|Hematinics|hematinics|mesh-ancestor
110594456|NCT00710528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110594457|NCT00710528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110594458|NCT00710528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110250271|NCT01731236|Antipyretics|antipyretics|mesh-ancestor
110150891|NCT00000646|Vasodilator Agents|vasodilator agents|mesh-ancestor
110594459|NCT00711074|N-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-N-ethyl-2-(4-methanesulfonylphenyl)acetamide|n-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-n-ethyl-2-(4-methanesulfonylphenyl)acetamide|mesh-list
110594460|NCT00711074|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
110594461|NCT00711074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110594462|NCT00711074|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110594463|NCT00711074|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110594464|NCT00711074|Antiviral Agents|antiviral agents|mesh-ancestor
110594465|NCT00711074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110594466|NCT00711308|Vitamin K|vitamin k|mesh-list
110594467|NCT00711308|Tinzaparin|tinzaparin|mesh-list
110594468|NCT00711308|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
110594469|NCT00711308|Dalteparin|dalteparin|mesh-list
110594470|NCT00711308|Acenocoumarol|acenocoumarol|mesh-list
110594471|NCT00711308|Vitamins|vitamins|mesh-ancestor
110594472|NCT00711308|Micronutrients|micronutrients|mesh-ancestor
110594473|NCT00711308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110250398|NCT00131027|Cytarabine|cytarabine|mesh-list
110594474|NCT00711308|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110594475|NCT00711308|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110594476|NCT00711308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110594477|NCT00711308|Hemostatics|hemostatics|mesh-ancestor
110594478|NCT00711308|Coagulants|coagulants|mesh-ancestor
110594479|NCT00711308|Anticoagulants|anticoagulants|mesh-ancestor
110594480|NCT00711308|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110594481|NCT02601911|Acetaminophen|acetaminophen|mesh-list
110594482|NCT02601911|Ketorolac|ketorolac|mesh-list
110594483|NCT02601911|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
110594484|NCT02601911|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110594485|NCT02601911|Analgesics|analgesics|mesh-ancestor
110594486|NCT02601911|Sensory System Agents|sensory system agents|mesh-ancestor
110594487|NCT02601911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110594488|NCT02601911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110594489|NCT02601911|Antipyretics|antipyretics|mesh-ancestor
110594490|NCT02601911|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110594491|NCT02601911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110594492|NCT02601911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110594493|NCT02601911|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110594494|NCT02601911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110594495|NCT02601911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110594496|NCT00711620|Thymalfasin|thymalfasin|mesh-list
110594497|NCT00711620|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110594498|NCT00711620|Immunologic Factors|immunologic factors|mesh-ancestor
110250607|NCT01248364|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110594499|NCT00711620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110594500|NCT02577614|Coagulants|coagulants|mesh-list
110594501|NCT02577614|Anti-inhibitor coagulant complex|anti-inhibitor coagulant complex|mesh-list
110377329|NCT00475670|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110594502|NCT02577458|Everolimus|everolimus|mesh-list
110594503|NCT02577458|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110594504|NCT02577458|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110594505|NCT02577458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110594506|NCT02577458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110594507|NCT02577458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110594508|NCT02577458|Immunologic Factors|immunologic factors|mesh-ancestor
110594509|NCT02577458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110594510|NCT02577458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110594511|NCT00767039|Poractant alfa|poractant alfa|mesh-list
110594512|NCT00767039|Beractant|beractant|mesh-list
110594513|NCT00767039|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
110594514|NCT00767039|Respiratory System Agents|respiratory system agents|mesh-ancestor
110594515|NCT00662649|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
110250741|NCT04696783|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110594516|NCT00662649|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
110594517|NCT00662649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110594519|NCT00662649|Immunologic Factors|immunologic factors|mesh-ancestor
110594520|NCT00662649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110594521|NCT02577770|Caffeine|caffeine|mesh-list
110594522|NCT02577770|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110250802|NCT01245673|Immunologic Factors|immunologic factors|mesh-ancestor
110594523|NCT02577770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110594524|NCT02577770|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110594525|NCT02577770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110594526|NCT02577770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110150896|NCT00389038|Antidepressive Agents|antidepressive agents|mesh-ancestor
110594527|NCT02577770|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110594528|NCT02577770|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110594529|NCT02577770|Purinergic Agents|purinergic agents|mesh-ancestor
110594530|NCT02577770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110594532|NCT00129896|Doxorubicin|doxorubicin|mesh-list
110594533|NCT00129896|Trastuzumab|trastuzumab|mesh-list
110594534|NCT00129896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110250940|NCT01154439|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110594535|NCT00129896|Tubulin Modulators|tubulin modulators|mesh-ancestor
110594536|NCT00129896|Antimitotic Agents|antimitotic agents|mesh-ancestor
110594537|NCT00129896|Mitosis Modulators|mitosis modulators|mesh-ancestor
110594538|NCT00129896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110594539|NCT00129896|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110594540|NCT00129896|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110594541|NCT00129896|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110594542|NCT00129896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110594543|NCT00129896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110594545|NCT02574338|Misoprostol|misoprostol|mesh-list
110594546|NCT02574338|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110594547|NCT02574338|Abortifacient Agents|abortifacient agents|mesh-ancestor
110594548|NCT02574338|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110594549|NCT02574338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110594550|NCT02574338|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110594551|NCT02574338|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110594553|NCT02574338|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110594554|NCT02574338|Vasodilator Agents|vasodilator agents|mesh-ancestor
110594555|NCT02574338|Urological Agents|urological agents|mesh-ancestor
110594556|NCT03070392|Pembrolizumab|pembrolizumab|mesh-list
110594557|NCT03070392|Ipilimumab|ipilimumab|mesh-list
110594558|NCT03070392|Dacarbazine|dacarbazine|mesh-list
110594559|NCT03070392|Imidazole|imidazole|mesh-list
110594560|NCT03070392|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110594561|NCT03070392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110594562|NCT03070392|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110594563|NCT03070392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110251151|NCT00144846|Albuterol|albuterol|mesh-list
110594564|NCT03070392|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110594565|NCT03070392|Alkylating Agents|alkylating agents|mesh-ancestor
110594566|NCT03070392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110594567|NCT00711698|Analgesics, Opioid|analgesics, opioid|mesh-list
110594568|NCT00711698|Narcotics|narcotics|mesh-ancestor
110594569|NCT00711698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110594570|NCT00711698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110251200|NCT00134069|Sorafenib|sorafenib|mesh-list
110594572|NCT00711698|Sensory System Agents|sensory system agents|mesh-ancestor
110594573|NCT00711698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110594574|NCT00795171|Docetaxel|docetaxel|mesh-list
110594575|NCT00795171|Sunitinib|sunitinib|mesh-list
110594576|NCT00795171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110594577|NCT00795171|Tubulin Modulators|tubulin modulators|mesh-ancestor
110594578|NCT00795171|Antimitotic Agents|antimitotic agents|mesh-ancestor
110594579|NCT00795171|Mitosis Modulators|mitosis modulators|mesh-ancestor
110594580|NCT00795171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110594581|NCT00795171|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110594582|NCT00795171|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110594583|NCT00795171|Growth Substances|growth substances|mesh-ancestor
110594584|NCT00795171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110251268|NCT00134420|Mitogens|mitogens|mesh-list
110594585|NCT00795171|Growth Inhibitors|growth inhibitors|mesh-ancestor
110594586|NCT00795171|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110594587|NCT00795171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110594588|NCT00711854|Rifampin|rifampin|mesh-list
110594589|NCT00711854|Linezolid|linezolid|mesh-list
110594590|NCT00711854|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
110594591|NCT00711854|Trimethoprim|trimethoprim|mesh-list
110594592|NCT00711854|Sulfamethoxazole|sulfamethoxazole|mesh-list
110594593|NCT00711854|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110594594|NCT00711854|Antitubercular Agents|antitubercular agents|mesh-ancestor
110594595|NCT00711854|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110594596|NCT00711854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110594597|NCT00711854|Leprostatic Agents|leprostatic agents|mesh-ancestor
110594598|NCT00711854|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110594599|NCT00711854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110594600|NCT00711854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110594601|NCT00711854|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110594602|NCT00711854|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110251396|NCT00142155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110594603|NCT00711854|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110594604|NCT00711854|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110594605|NCT00711854|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110594606|NCT00711854|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110594607|NCT00711854|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110594608|NCT00711854|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110594609|NCT00711854|Antimalarials|antimalarials|mesh-ancestor
110594610|NCT00711854|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110594611|NCT00711854|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110594612|NCT00711854|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110594613|NCT00711854|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110594614|NCT00711854|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
110594615|NCT00711854|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110594616|NCT00795483|Zoledronic Acid|zoledronic acid|mesh-list
110594617|NCT00795483|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110594618|NCT00795483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110594619|NCT00712400|Latanoprost|latanoprost|mesh-list
110594620|NCT00712400|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110594621|NCT00712400|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110594622|NCT00712478|Insulin|insulin|mesh-list
110594623|NCT00712478|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110251625|NCT00152841|Vitamin E|vitamin e|mesh-list
110594624|NCT00712478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110594625|NCT03015792|Dexamethasone|dexamethasone|mesh-list
110594626|NCT03015792|Dexamethasone acetate|dexamethasone acetate|mesh-list
110594627|NCT03015792|Lenalidomide|lenalidomide|mesh-list
110594628|NCT03015792|Ichthammol|ichthammol|mesh-list
110594629|NCT03015792|BB 1101|bb 1101|mesh-list
110594630|NCT03015792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110594631|NCT03015792|Antiemetics|antiemetics|mesh-ancestor
110594632|NCT03015792|Autonomic Agents|autonomic agents|mesh-ancestor
110594633|NCT03015792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110594634|NCT03015792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110594635|NCT03015792|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110594636|NCT03015792|Glucocorticoids|glucocorticoids|mesh-ancestor
110594637|NCT03015792|Hormones|hormones|mesh-ancestor
110594638|NCT03015792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110594640|NCT03015792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110594641|NCT03015792|Protease Inhibitors|protease inhibitors|mesh-ancestor
110594642|NCT03015792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110594643|NCT03015792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110594644|NCT03015792|Immunologic Factors|immunologic factors|mesh-ancestor
110594645|NCT03015792|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110594646|NCT03015792|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110241992|NCT00139074|Valproic Acid|valproic acid|mesh-list
110594647|NCT03015792|Growth Substances|growth substances|mesh-ancestor
110594648|NCT03015792|Growth Inhibitors|growth inhibitors|mesh-ancestor
110594649|NCT03015792|Dermatologic Agents|dermatologic agents|mesh-ancestor
110594650|NCT00789165|Quinidine|quinidine|mesh-list
110594651|NCT00789165|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110594652|NCT00789165|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110594653|NCT00789165|Adrenergic Agents|adrenergic agents|mesh-ancestor
110594654|NCT00789165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110251804|NCT00136448|Cytarabine|cytarabine|mesh-list
110251827|NCT00136487|Celecoxib|celecoxib|mesh-list
110594655|NCT00789165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110594656|NCT00789165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110594657|NCT00789165|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110594658|NCT00789165|Antimalarials|antimalarials|mesh-ancestor
110594659|NCT00789165|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110594660|NCT00789165|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110594661|NCT00789165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110594662|NCT00789165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110594663|NCT00789165|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110594664|NCT00789165|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110594665|NCT00789165|Cholinergic Agents|cholinergic agents|mesh-ancestor
110594666|NCT00789165|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110594667|NCT00789165|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110594668|NCT00789165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110594669|NCT00789165|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110594670|NCT00789165|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110594672|NCT00712556|Cariostatic Agents|cariostatic agents|mesh-ancestor
110594673|NCT00712556|Protective Agents|protective agents|mesh-ancestor
110594674|NCT00712556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110594675|NCT00772967|Naproxen|naproxen|mesh-list
110251935|NCT00159705|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110594676|NCT00772967|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110594677|NCT00772967|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110594678|NCT00772967|Analgesics|analgesics|mesh-ancestor
110594679|NCT00772967|Sensory System Agents|sensory system agents|mesh-ancestor
110594680|NCT00772967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110594681|NCT00772967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110594682|NCT00772967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110594683|NCT00772967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110594684|NCT00772967|Gout Suppressants|gout suppressants|mesh-ancestor
110594685|NCT00772967|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110594686|NCT00772967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110594687|NCT00772967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110594689|NCT00793377|Cyclophosphamide|cyclophosphamide|mesh-list
110594690|NCT00793377|Docetaxel|docetaxel|mesh-list
110594691|NCT00793377|Doxorubicin|doxorubicin|mesh-list
110594692|NCT00793377|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110594693|NCT00793377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110594694|NCT00793377|Immunologic Factors|immunologic factors|mesh-ancestor
110594695|NCT00793377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110594696|NCT00793377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110594697|NCT00793377|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110594698|NCT00793377|Alkylating Agents|alkylating agents|mesh-ancestor
110252137|NCT00153972|Levodopa|levodopa|mesh-list
110594699|NCT00793377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110594700|NCT00793377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110594701|NCT00793377|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110594702|NCT00793377|Tubulin Modulators|tubulin modulators|mesh-ancestor
110594703|NCT00793377|Antimitotic Agents|antimitotic agents|mesh-ancestor
110594704|NCT00793377|Mitosis Modulators|mitosis modulators|mesh-ancestor
110594705|NCT00793377|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110594706|NCT00793377|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110594707|NCT00793377|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110594708|NCT00793377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110594709|NCT00793377|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110594710|NCT00793377|Hormone Antagonists|hormone antagonists|mesh-ancestor
110252194|NCT00160602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110594711|NCT00793377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110594712|NCT00793377|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110594713|NCT00793377|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110594714|NCT00793377|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110594715|NCT00793377|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110594716|NCT00662259|Alprazolam|alprazolam|mesh-list
110594717|NCT00662259|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110594718|NCT00662259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110594719|NCT00662259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110594720|NCT00662259|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110594721|NCT00662259|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110594722|NCT00662259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110594723|NCT00662259|GABA Modulators|gaba modulators|mesh-ancestor
110594724|NCT00662259|GABA Agents|gaba agents|mesh-ancestor
110252256|NCT00154206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110594725|NCT00662259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110594726|NCT00662259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110594727|NCT00712790|Sorafenib|sorafenib|mesh-list
110594728|NCT00712790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110594729|NCT00712790|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110594730|NCT00712790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110594731|NCT00712790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110594732|NCT00660699|Gemcitabine|gemcitabine|mesh-list
110594733|NCT00660699|Docetaxel|docetaxel|mesh-list
110594734|NCT00660699|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110594736|NCT00660699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110594737|NCT00660699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110594738|NCT00660699|Tubulin Modulators|tubulin modulators|mesh-ancestor
110594739|NCT00660699|Antimitotic Agents|antimitotic agents|mesh-ancestor
110594740|NCT00660699|Mitosis Modulators|mitosis modulators|mesh-ancestor
110594741|NCT02577068|Propacetamol|propacetamol|mesh-list
110594742|NCT02577068|Nefopam|nefopam|mesh-list
110594743|NCT02577068|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110594744|NCT02577068|Analgesics|analgesics|mesh-ancestor
110594745|NCT02577068|Sensory System Agents|sensory system agents|mesh-ancestor
110594746|NCT02577068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110594747|NCT02577068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110594748|NCT02577068|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110594749|NCT02577068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110252369|NCT00161070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110594750|NCT02577068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110594751|NCT00582114|Atenolol|atenolol|mesh-list
110594752|NCT00582114|Lisinopril|lisinopril|mesh-list
110594753|NCT00582114|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110594754|NCT00582114|Protease Inhibitors|protease inhibitors|mesh-ancestor
110594755|NCT00582114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110594756|NCT00582114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110594757|NCT00582114|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110594758|NCT00582114|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110594759|NCT00582114|Protective Agents|protective agents|mesh-ancestor
110594760|NCT00582114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110594761|NCT00582114|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110594762|NCT00582114|Sympatholytics|sympatholytics|mesh-ancestor
110594763|NCT00582114|Autonomic Agents|autonomic agents|mesh-ancestor
110594764|NCT00582114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110594765|NCT00582114|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110594766|NCT00582114|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110594767|NCT00582114|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110594768|NCT00582114|Adrenergic Agents|adrenergic agents|mesh-ancestor
110594769|NCT00582114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110594770|NCT00582036|Insulin|insulin|mesh-list
110594771|NCT00582036|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110594772|NCT00582036|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110594773|NCT00582036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110594774|NCT00581360|Doxorubicin|doxorubicin|mesh-list
110594775|NCT00581360|Bortezomib|bortezomib|mesh-list
110594776|NCT00581360|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110594777|NCT00581360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110594778|NCT00581360|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110594779|NCT00581360|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110594780|NCT00581360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110594781|NCT00581360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110594782|NCT01650792|Aspirin|aspirin|mesh-list
110252557|NCT00139685|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110594783|NCT01650792|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110594785|NCT01650792|Analgesics|analgesics|mesh-ancestor
110594786|NCT01650792|Sensory System Agents|sensory system agents|mesh-ancestor
110594787|NCT01650792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110594788|NCT01650792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110594789|NCT01650792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110594790|NCT01650792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110594791|NCT01650792|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110594792|NCT01650792|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110594793|NCT01650792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110594794|NCT01650792|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110594795|NCT01650792|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110252622|NCT00161655|Abortifacient Agents|abortifacient agents|mesh-ancestor
110594796|NCT01650792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110594797|NCT01650792|Antipyretics|antipyretics|mesh-ancestor
110594798|NCT00660387|Levodopa|levodopa|mesh-list
110594799|NCT00660387|Carbidopa|carbidopa|mesh-list
110018590|NCT02985840|Glucocorticoids|glucocorticoids|mesh-ancestor
110594800|NCT00660387|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
110594801|NCT00660387|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110594802|NCT00660387|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110594803|NCT00660387|Dopamine Agents|dopamine agents|mesh-ancestor
110594804|NCT00660387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110594805|NCT00660387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110594806|NCT00660387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110594807|NCT00660387|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
110594808|NCT00660387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110594809|NCT00660387|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110594810|NCT00660387|Immunologic Factors|immunologic factors|mesh-ancestor
110594811|NCT00660387|Dopamine Agonists|dopamine agonists|mesh-ancestor
110594812|NCT00582738|Everolimus|everolimus|mesh-list
110594813|NCT00582738|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110594814|NCT00582738|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110594815|NCT00582738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110594816|NCT00582738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110252753|NCT00161811|Vaccines|vaccines|mesh-list
110594818|NCT00582738|Immunologic Factors|immunologic factors|mesh-ancestor
110594819|NCT00582738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110594820|NCT00582738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110594821|NCT00713336|Moxifloxacin|moxifloxacin|mesh-list
110594822|NCT00713336|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
110594823|NCT00713336|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110594824|NCT00713336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110594825|NCT00713336|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110594826|NCT00713336|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110594827|NCT00713336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110594828|NCT00713336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110594829|NCT00713336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110594830|NCT00713336|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110594831|NCT00713336|Contraceptive Agents|contraceptive agents|mesh-ancestor
110594832|NCT00713336|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110594833|NCT00713336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110594834|NCT00713336|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110594835|NCT00713336|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110594836|NCT00713336|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110594837|NCT00789711|Insulin|insulin|mesh-list
110594839|NCT00789711|Insulin Aspart|insulin aspart|mesh-list
110594840|NCT00789711|Insulin Detemir|insulin detemir|mesh-list
110594841|NCT00789711|Biphasic Insulins|biphasic insulins|mesh-list
110594842|NCT00789711|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
110594843|NCT00789711|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110594844|NCT00789711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110594845|NCT00713726|Fentanyl|fentanyl|mesh-list
110594846|NCT00713726|Tramadol|tramadol|mesh-list
110594847|NCT00713726|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110594848|NCT00713726|Narcotics|narcotics|mesh-ancestor
110594849|NCT00713726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110252863|NCT00162201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110594850|NCT00713726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110594851|NCT00713726|Analgesics|analgesics|mesh-ancestor
110594852|NCT00713726|Sensory System Agents|sensory system agents|mesh-ancestor
110594853|NCT00713726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110594854|NCT00713726|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110594855|NCT00713726|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110594856|NCT00713726|Anesthetics, General|anesthetics, general|mesh-ancestor
110594857|NCT00713726|Anesthetics|anesthetics|mesh-ancestor
110594858|NCT00800553|Donepezil|donepezil|mesh-list
110594859|NCT00800553|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110594860|NCT00800553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110594861|NCT00800553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110594862|NCT00800553|Cholinergic Agents|cholinergic agents|mesh-ancestor
110594863|NCT00800553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110594864|NCT00800553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110594865|NCT00800553|Nootropic Agents|nootropic agents|mesh-ancestor
110594866|NCT00793767|Epoetin Alfa|epoetin alfa|mesh-list
110594867|NCT00793767|Hematinics|hematinics|mesh-ancestor
110594868|NCT00796029|Paliperidone Palmitate|paliperidone palmitate|mesh-list
110242209|NCT00452881|Antimetabolites|antimetabolites|mesh-ancestor
110594869|NCT00796029|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110594870|NCT00796029|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110594871|NCT00796029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110594872|NCT00796029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110594873|NCT00796029|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110150921|NCT00000676|Clotrimazole|clotrimazole|mesh-list
110594874|NCT00796029|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110594875|NCT00796029|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110594876|NCT00796029|Serotonin Agents|serotonin agents|mesh-ancestor
110594877|NCT00796029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110594878|NCT00796029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110594879|NCT00796029|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110594880|NCT00796029|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110594881|NCT00796029|Dopamine Agents|dopamine agents|mesh-ancestor
110253001|NCT00141245|Pregabalin|pregabalin|mesh-list
110594882|NCT00793845|Cyclophosphamide|cyclophosphamide|mesh-list
110594883|NCT00793845|Melphalan|melphalan|mesh-list
110594884|NCT00793845|Thiotepa|thiotepa|mesh-list
110594885|NCT00793845|Carboplatin|carboplatin|mesh-list
110594886|NCT00793845|Etoposide|etoposide|mesh-list
110594887|NCT00793845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110594888|NCT00793845|Immunologic Factors|immunologic factors|mesh-ancestor
110594889|NCT00793845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110594890|NCT00793845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110594891|NCT00793845|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110594892|NCT00793845|Alkylating Agents|alkylating agents|mesh-ancestor
110253038|NCT04518124|Propranolol|propranolol|mesh-list
110594893|NCT00793845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110594894|NCT00793845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110594895|NCT00793845|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110594896|NCT00793845|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110594897|NCT00793845|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110594898|NCT00793845|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110594899|NCT00793845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110594901|NCT00800709|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110594902|NCT00800709|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110594903|NCT00800709|Dopamine Agents|dopamine agents|mesh-ancestor
110253104|NCT00404417|Botulinum Toxins|botulinum toxins|mesh-list
110594904|NCT00800709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110594905|NCT00800709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110594906|NCT00800709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110594907|NCT00800709|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110594908|NCT00800709|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110594909|NCT00793923|Dexamethasone|dexamethasone|mesh-list
110594910|NCT00793923|Ranibizumab|ranibizumab|mesh-list
110594911|NCT00793923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110594912|NCT00793923|Antiemetics|antiemetics|mesh-ancestor
110594913|NCT00793923|Autonomic Agents|autonomic agents|mesh-ancestor
110594914|NCT00793923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110594915|NCT00793923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110594916|NCT00793923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110594917|NCT00793923|Glucocorticoids|glucocorticoids|mesh-ancestor
110594919|NCT00793923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110594920|NCT00793923|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110594921|NCT00793923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110594922|NCT00793923|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110594923|NCT00793923|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110594924|NCT00793923|Growth Substances|growth substances|mesh-ancestor
110594925|NCT00793923|Growth Inhibitors|growth inhibitors|mesh-ancestor
110594926|NCT01247324|Interferons|interferons|mesh-list
110594927|NCT01247324|Interferon-beta|interferon-beta|mesh-list
110594928|NCT01247324|Interferon beta-1a|interferon beta-1a|mesh-list
110594929|NCT01247324|Ocrelizumab|ocrelizumab|mesh-list
110594930|NCT01247324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110594931|NCT01247324|Antiviral Agents|antiviral agents|mesh-ancestor
110594932|NCT01247324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110594933|NCT01247324|Immunologic Factors|immunologic factors|mesh-ancestor
110594934|NCT01247324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110594935|NCT01247324|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110594936|NCT00772577|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110594937|NCT00772577|Ramipril|ramipril|mesh-list
110594938|NCT00772577|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110594939|NCT00772577|Diuretics|diuretics|mesh-ancestor
110594940|NCT00772577|Natriuretic Agents|natriuretic agents|mesh-ancestor
110594941|NCT00772577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110594942|NCT00772577|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110594943|NCT00772577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110253288|NCT04518163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110594944|NCT00772577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110017785|NCT03883074|Hyaluronic Acid|hyaluronic acid|mesh-list
110594945|NCT00772577|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110594946|NCT00772577|Protease Inhibitors|protease inhibitors|mesh-ancestor
110594947|NCT00772577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110594948|NCT02345850|Cyclophosphamide|cyclophosphamide|mesh-list
110594950|NCT02345850|Tacrolimus|tacrolimus|mesh-list
110594951|NCT02345850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110594952|NCT02345850|Immunologic Factors|immunologic factors|mesh-ancestor
110594953|NCT02345850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110594954|NCT02345850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110594955|NCT02345850|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110594956|NCT02345850|Alkylating Agents|alkylating agents|mesh-ancestor
110594957|NCT02345850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110594958|NCT02345850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110594959|NCT02345850|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110594960|NCT02345850|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110594961|NCT02345850|Abortifacient Agents|abortifacient agents|mesh-ancestor
110594962|NCT02345850|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110594963|NCT02345850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110594964|NCT02345850|Antimetabolites|antimetabolites|mesh-ancestor
110594965|NCT02345850|Dermatologic Agents|dermatologic agents|mesh-ancestor
110594966|NCT02345850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110594967|NCT02345850|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110594968|NCT02345850|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110594969|NCT02345850|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110594970|NCT00800787|Immunoglobulins|immunoglobulins|mesh-list
110594971|NCT00800787|Immunologic Factors|immunologic factors|mesh-ancestor
110594972|NCT00800787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110594973|NCT04073550|Topotecan|topotecan|mesh-list
110594974|NCT04073550|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110594975|NCT04073550|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110594976|NCT04073550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110594977|NCT04073550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110594978|NCT04073550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110594979|NCT02576600|Remifentanil|remifentanil|mesh-list
110594980|NCT02576600|Propofol|propofol|mesh-list
110594981|NCT02576600|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110594982|NCT02576600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110594983|NCT02576600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110594984|NCT02576600|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110594985|NCT02576600|Anesthetics, General|anesthetics, general|mesh-ancestor
110594986|NCT02576600|Anesthetics|anesthetics|mesh-ancestor
110594987|NCT02576600|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110253482|NCT04514419|Docetaxel|docetaxel|mesh-list
110594988|NCT02576600|Narcotics|narcotics|mesh-ancestor
110594989|NCT02576600|Analgesics|analgesics|mesh-ancestor
110594990|NCT02576600|Sensory System Agents|sensory system agents|mesh-ancestor
110594991|NCT02576600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110594992|NCT02863770|Pancrelipase|pancrelipase|mesh-list
110594993|NCT02863770|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110594994|NCT00796185|Paliperidone Palmitate|paliperidone palmitate|mesh-list
110594995|NCT00796185|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110253550|NCT00505843|Levodopa|levodopa|mesh-list
110594996|NCT00796185|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110594997|NCT00796185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110594998|NCT00796185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110594999|NCT00796185|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110595000|NCT00796185|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110595001|NCT00796185|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110595002|NCT00796185|Serotonin Agents|serotonin agents|mesh-ancestor
110595003|NCT00796185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110595004|NCT00796185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110595005|NCT00796185|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110595006|NCT00796185|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110595007|NCT00796185|Dopamine Agents|dopamine agents|mesh-ancestor
110595008|NCT00660309|Irbesartan|irbesartan|mesh-list
110595009|NCT00660309|Captopril|captopril|mesh-list
110595010|NCT00660309|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110595011|NCT00660309|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110595012|NCT00660309|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110595013|NCT00660309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110595014|NCT00660309|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110595015|NCT00660309|Protease Inhibitors|protease inhibitors|mesh-ancestor
110253657|NCT02275975|Fluconazole|fluconazole|mesh-list
110595016|NCT00660309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110595017|NCT04046133|Pembrolizumab|pembrolizumab|mesh-list
110595018|NCT04046133|Capecitabine|capecitabine|mesh-list
110595019|NCT04046133|Mitomycins|mitomycins|mesh-list
110595020|NCT04046133|Mitomycin|mitomycin|mesh-list
110595021|NCT04046133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110595022|NCT04046133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110595023|NCT04046133|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110595024|NCT04046133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110595025|NCT04046133|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110595026|NCT04046133|Antimetabolites|antimetabolites|mesh-ancestor
110595027|NCT04046133|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110595028|NCT04046133|Alkylating Agents|alkylating agents|mesh-ancestor
110377398|NCT00470366|Paclitaxel|paclitaxel|mesh-list
110253721|NCT00163137|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110595029|NCT04046133|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110595030|NCT04046133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110595032|NCT02573714|Analgesics|analgesics|mesh-ancestor
110595033|NCT02573714|Sensory System Agents|sensory system agents|mesh-ancestor
110595034|NCT02573714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110595035|NCT02573714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110595036|NCT02573714|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110595037|NCT02573714|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110595038|NCT02573714|Anesthetics, General|anesthetics, general|mesh-ancestor
110595039|NCT02573714|Anesthetics|anesthetics|mesh-ancestor
110595040|NCT02573714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110595041|NCT02573714|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110595042|NCT02573714|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110595043|NCT02573714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110595044|NCT02573714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110595045|NCT00794235|Sorafenib|sorafenib|mesh-list
110595046|NCT00794235|Dacarbazine|dacarbazine|mesh-list
110595047|NCT00794235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110595048|NCT00794235|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110595049|NCT00794235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110595050|NCT00794235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110595051|NCT00794235|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110595052|NCT00794235|Alkylating Agents|alkylating agents|mesh-ancestor
110595053|NCT00800943|Alemtuzumab|alemtuzumab|mesh-list
110595054|NCT00800943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110595055|NCT00800943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110595056|NCT02575664|Buprenorphine|buprenorphine|mesh-list
110595057|NCT02575664|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110595058|NCT02575664|Narcotics|narcotics|mesh-ancestor
110595059|NCT02575664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110595060|NCT02575664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110595061|NCT02575664|Analgesics|analgesics|mesh-ancestor
110595062|NCT02575664|Sensory System Agents|sensory system agents|mesh-ancestor
110595063|NCT02575664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110595064|NCT02575664|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110595065|NCT00796497|Ondansetron|ondansetron|mesh-list
110595066|NCT00796497|Antiemetics|antiemetics|mesh-ancestor
110595067|NCT00796497|Autonomic Agents|autonomic agents|mesh-ancestor
110595068|NCT00796497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110595069|NCT00796497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110595070|NCT00796497|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110595071|NCT00796497|Antipruritics|antipruritics|mesh-ancestor
110253903|NCT02598895|Carboplatin|carboplatin|mesh-list
110595072|NCT00796497|Dermatologic Agents|dermatologic agents|mesh-ancestor
110595073|NCT00796497|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110595074|NCT00796497|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110595075|NCT00796497|Serotonin Agents|serotonin agents|mesh-ancestor
110595076|NCT00796497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110595077|NCT00796497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110595078|NCT00801177|Necitumumab|necitumumab|mesh-list
110595079|NCT00801177|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110595080|NCT00801177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110595081|NCT00801177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110595082|NCT00801177|Immunologic Factors|immunologic factors|mesh-ancestor
110595083|NCT00801177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110595084|NCT00581100|Etanercept|etanercept|mesh-list
110595085|NCT00581100|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110595086|NCT00581100|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110595087|NCT00581100|Analgesics|analgesics|mesh-ancestor
110595088|NCT00581100|Sensory System Agents|sensory system agents|mesh-ancestor
110595089|NCT00581100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110595090|NCT00581100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110595091|NCT00581100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110595092|NCT00581100|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110595093|NCT00581100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110595094|NCT00581100|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110595096|NCT00579098|Atorvastatin|atorvastatin|mesh-list
110595097|NCT00579098|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110595098|NCT00579098|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110595099|NCT00579098|Antimetabolites|antimetabolites|mesh-ancestor
110595100|NCT00579098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110595101|NCT00579098|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110595102|NCT00579098|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110595103|NCT00579098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110595104|NCT00772109|Vaccines|vaccines|mesh-list
110254011|NCT00143975|Cytarabine|cytarabine|mesh-list
110595105|NCT00772109|Immunologic Factors|immunologic factors|mesh-ancestor
110595106|NCT00772109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110595107|NCT00801255|Lactams|lactams|mesh-list
110595108|NCT00801255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110595109|NCT00801255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110595110|NCT00794625|Valproic Acid|valproic acid|mesh-list
110595111|NCT00794625|Risperidone|risperidone|mesh-list
110595112|NCT00794625|Dextroamphetamine|dextroamphetamine|mesh-list
110595113|NCT00794625|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110595114|NCT00794625|Serotonin Agents|serotonin agents|mesh-ancestor
110595115|NCT00794625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110595116|NCT00794625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110595117|NCT00794625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110595118|NCT00794625|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110595119|NCT00794625|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110595120|NCT00794625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110595121|NCT00794625|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110595122|NCT00794625|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110595123|NCT00794625|Dopamine Agents|dopamine agents|mesh-ancestor
110595124|NCT00794625|Anticonvulsants|anticonvulsants|mesh-ancestor
110595125|NCT00794625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110595126|NCT00794625|GABA Agents|gaba agents|mesh-ancestor
110595127|NCT00794625|Antimanic Agents|antimanic agents|mesh-ancestor
110595128|NCT00794625|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110595129|NCT00794625|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110595130|NCT00794625|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110595131|NCT00794625|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110595132|NCT02577432|Fentanyl|fentanyl|mesh-list
110595133|NCT02577432|Bupivacaine|bupivacaine|mesh-list
110595134|NCT02577432|Anesthetics, Local|anesthetics, local|mesh-ancestor
110595135|NCT02577432|Anesthetics|anesthetics|mesh-ancestor
110254146|NCT00506935|Anticonvulsants|anticonvulsants|mesh-ancestor
110254149|NCT00506935|GABA Agents|gaba agents|mesh-ancestor
110595137|NCT02577432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110595138|NCT02577432|Sensory System Agents|sensory system agents|mesh-ancestor
110595139|NCT02577432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110595140|NCT02577432|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110595141|NCT02577432|Narcotics|narcotics|mesh-ancestor
110595142|NCT02577432|Analgesics|analgesics|mesh-ancestor
110595143|NCT02577432|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110595144|NCT02577432|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110254209|NCT00148083|Dopamine Agents|dopamine agents|mesh-ancestor
110595145|NCT02577432|Anesthetics, General|anesthetics, general|mesh-ancestor
110595146|NCT00794703|Itraconazole|itraconazole|mesh-list
110595147|NCT00794703|Micafungin|micafungin|mesh-list
110595148|NCT00794703|Antifungal Agents|antifungal agents|mesh-ancestor
110595149|NCT00794703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110595150|NCT00794703|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110595151|NCT00794703|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110595152|NCT00794703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110595153|NCT00794703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110595155|NCT00794703|Hormone Antagonists|hormone antagonists|mesh-ancestor
110595156|NCT00794703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110254274|NCT05148637|Narcotics|narcotics|mesh-ancestor
110595157|NCT00794703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110595158|NCT00794703|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110595160|NCT00772031|Propranolol|propranolol|mesh-list
110595161|NCT00772031|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110595162|NCT00772031|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110595163|NCT00772031|Adrenergic Agents|adrenergic agents|mesh-ancestor
110595164|NCT00772031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110260180|NCT02944201|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110595165|NCT00772031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110595166|NCT00772031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110595167|NCT00772031|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110595168|NCT00772031|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110595169|NCT00772031|Vasodilator Agents|vasodilator agents|mesh-ancestor
110595170|NCT00772031|Anticonvulsants|anticonvulsants|mesh-ancestor
110595171|NCT00772031|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110595172|NCT00801411|Cyclophosphamide|cyclophosphamide|mesh-list
110595173|NCT00801411|Docetaxel|docetaxel|mesh-list
110595174|NCT00801411|Doxorubicin|doxorubicin|mesh-list
110595175|NCT00801411|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110595176|NCT00801411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110595177|NCT00801411|Immunologic Factors|immunologic factors|mesh-ancestor
110254344|NCT00424281|PENTA|penta|mesh-list
110595178|NCT00801411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110595179|NCT00801411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110595180|NCT00801411|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110595181|NCT00801411|Alkylating Agents|alkylating agents|mesh-ancestor
110595182|NCT00801411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110595183|NCT00801411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110595184|NCT00801411|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110595185|NCT00801411|Tubulin Modulators|tubulin modulators|mesh-ancestor
110595186|NCT00801411|Antimitotic Agents|antimitotic agents|mesh-ancestor
110595187|NCT00801411|Mitosis Modulators|mitosis modulators|mesh-ancestor
110595188|NCT00801411|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110595189|NCT00801411|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110595190|NCT00801411|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110595191|NCT00801411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110595192|NCT00794859|Sorafenib|sorafenib|mesh-list
110595193|NCT00794859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110254458|NCT05594342|Dobutamine|dobutamine|mesh-list
110595194|NCT00794859|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110595196|NCT00794859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110595197|NCT04940013|Misoprostol|misoprostol|mesh-list
110595198|NCT04940013|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110595199|NCT04940013|Abortifacient Agents|abortifacient agents|mesh-ancestor
110595200|NCT04940013|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110595201|NCT04940013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110595202|NCT04940013|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110595203|NCT04940013|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110595204|NCT04940013|Oxytocics|oxytocics|mesh-ancestor
110595205|NCT00771953|Docetaxel|docetaxel|mesh-list
110595206|NCT00771953|Pemetrexed|pemetrexed|mesh-list
110595207|NCT00771953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110595208|NCT00771953|Tubulin Modulators|tubulin modulators|mesh-ancestor
110595209|NCT00771953|Antimitotic Agents|antimitotic agents|mesh-ancestor
110595210|NCT00771953|Mitosis Modulators|mitosis modulators|mesh-ancestor
110595211|NCT00771953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110595212|NCT00771953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110595213|NCT00771953|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110254529|NCT00148551|Hormones|hormones|mesh-ancestor
110595214|NCT00771953|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110595215|NCT00714584|Naltrexone|naltrexone|mesh-list
110595216|NCT00714584|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110595217|NCT00714584|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110595218|NCT00714584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110595219|NCT00714584|Sensory System Agents|sensory system agents|mesh-ancestor
110595220|NCT00714584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110595222|NCT00621244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110595223|NCT00621244|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110595224|NCT00621244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110595225|NCT00621244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110595226|NCT00916409|Temozolomide|temozolomide|mesh-list
110595227|NCT00916409|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110595228|NCT00916409|Alkylating Agents|alkylating agents|mesh-ancestor
110595229|NCT00916409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110595230|NCT00916409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110254590|NCT00508690|Kanamycin|kanamycin|mesh-list
110595231|NCT00714740|Acetazolamide|acetazolamide|mesh-list
110595232|NCT00714740|Anticonvulsants|anticonvulsants|mesh-ancestor
110595233|NCT00714740|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110595234|NCT00714740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110595235|NCT00714740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110595236|NCT00714740|Diuretics|diuretics|mesh-ancestor
110595237|NCT00714740|Natriuretic Agents|natriuretic agents|mesh-ancestor
110595238|NCT00714740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110595239|NCT00659529|Sildenafil Citrate|sildenafil citrate|mesh-list
110595240|NCT00659529|Vasodilator Agents|vasodilator agents|mesh-ancestor
110595241|NCT00659529|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110595242|NCT00659529|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110595243|NCT00659529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110595244|NCT00659529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110242589|NCT00110474|Acetaminophen|acetaminophen|mesh-list
110254714|NCT00466999|Misoprostol|misoprostol|mesh-list
110595245|NCT00659529|Urological Agents|urological agents|mesh-ancestor
110595246|NCT02575508|Fluorouracil|fluorouracil|mesh-list
110595247|NCT02575508|Oxaliplatin|oxaliplatin|mesh-list
110595248|NCT02575508|Irinotecan|irinotecan|mesh-list
110595249|NCT02575508|Camptothecin|camptothecin|mesh-list
110595250|NCT02575508|Infigratinib|infigratinib|mesh-list
110595251|NCT02575508|Antimetabolites|antimetabolites|mesh-ancestor
110595252|NCT02575508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110595253|NCT02575508|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110595254|NCT02575508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110595255|NCT02575508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110595256|NCT02575508|Immunologic Factors|immunologic factors|mesh-ancestor
110595257|NCT02575508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110595258|NCT02575508|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110595259|NCT02575508|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110595260|NCT02575508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110595261|NCT02575508|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110595263|NCT00795015|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110595264|NCT00795015|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110595265|NCT00795015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110595266|NCT00796887|Niacin|niacin|mesh-list
110595267|NCT00796887|Niacinamide|niacinamide|mesh-list
110595268|NCT00796887|Nicotinic Acids|nicotinic acids|mesh-list
110595269|NCT00796887|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110595270|NCT00796887|Antimetabolites|antimetabolites|mesh-ancestor
110595271|NCT00796887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110595272|NCT00796887|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110595273|NCT00796887|Vasodilator Agents|vasodilator agents|mesh-ancestor
110595274|NCT00796887|Vitamin B Complex|vitamin b complex|mesh-ancestor
110595275|NCT00796887|Vitamins|vitamins|mesh-ancestor
110595276|NCT00796887|Micronutrients|micronutrients|mesh-ancestor
110595277|NCT00796887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110595278|NCT00578942|Alemtuzumab|alemtuzumab|mesh-list
110595279|NCT00578942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110595280|NCT00578942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110595281|NCT00843934|Epirubicin|epirubicin|mesh-list
110595282|NCT00843934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110595283|NCT00843934|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110595284|NCT00843934|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110595285|NCT00843934|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110595286|NCT00843934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110595287|NCT00843934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110595289|NCT00805701|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
110254892|NCT00469261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110595290|NCT00805701|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110595291|NCT00805701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110595292|NCT00805701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110595293|NCT00805701|Hormone Antagonists|hormone antagonists|mesh-ancestor
110595294|NCT00805701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110595295|NCT00805701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110595297|NCT04042948|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110595298|NCT04042948|Analgesics|analgesics|mesh-ancestor
110595299|NCT04042948|Sensory System Agents|sensory system agents|mesh-ancestor
110595300|NCT04042948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110595301|NCT04042948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110595302|NCT04042948|Antipyretics|antipyretics|mesh-ancestor
110595303|NCT00765245|Rituximab|rituximab|mesh-list
110595304|NCT00765245|Lenalidomide|lenalidomide|mesh-list
110595305|NCT00765245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110254953|NCT00469768|Dapivirine|dapivirine|mesh-list
110595306|NCT00765245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110595307|NCT00765245|Immunologic Factors|immunologic factors|mesh-ancestor
110595308|NCT00765245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110595309|NCT00765245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110595310|NCT00765245|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110595311|NCT00765245|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110595312|NCT00765245|Growth Substances|growth substances|mesh-ancestor
110595313|NCT00765245|Growth Inhibitors|growth inhibitors|mesh-ancestor
110595314|NCT00801879|Mupirocin|mupirocin|mesh-list
110595315|NCT00801879|Calcium|calcium|mesh-list
110595316|NCT00801879|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110595317|NCT00801879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110595318|NCT00801879|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110595319|NCT00801879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110595320|NCT00801879|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110595321|NCT00801879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110595322|NCT00801879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110595323|NCT00718484|Doxorubicin|doxorubicin|mesh-list
110595324|NCT00718484|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110595325|NCT00718484|Isophosphamide mustard|isophosphamide mustard|mesh-list
110595327|NCT00718484|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110255076|NCT00470743|Indomethacin|indomethacin|mesh-list
110595328|NCT00718484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110595329|NCT00718484|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110595330|NCT00718484|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110595331|NCT00718484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110595332|NCT00718484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110595333|NCT00718484|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110595334|NCT00718484|Alkylating Agents|alkylating agents|mesh-ancestor
110595335|NCT00841126|Iron|iron|mesh-list
110595336|NCT00841126|Trace Elements|trace elements|mesh-ancestor
110595337|NCT00841126|Micronutrients|micronutrients|mesh-ancestor
110595338|NCT00841126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110595339|NCT00805857|Tipranavir|tipranavir|mesh-list
110595340|NCT00805857|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110595341|NCT00805857|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110595342|NCT00805857|Antiviral Agents|antiviral agents|mesh-ancestor
110595343|NCT00805857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110255145|NCT00157872|Rofecoxib|rofecoxib|mesh-list
110595344|NCT00801957|Hydrocortisone|hydrocortisone|mesh-list
110595345|NCT00801957|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
110595346|NCT00801957|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
110595347|NCT00801957|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
110595348|NCT00801957|Hydrocortisone-17-butyrate|hydrocortisone-17-butyrate|mesh-list
110595349|NCT00801957|Tacrolimus|tacrolimus|mesh-list
110595350|NCT00801957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110595351|NCT00801957|Immunologic Factors|immunologic factors|mesh-ancestor
110595352|NCT00801957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110595353|NCT00801957|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110595354|NCT00801957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110595355|NCT00801957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110595356|NCT00801957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110595357|NCT00801957|Dermatologic Agents|dermatologic agents|mesh-ancestor
110595358|NCT00836134|Bupivacaine|bupivacaine|mesh-list
110595359|NCT00836134|Anesthetics, Local|anesthetics, local|mesh-list
110595360|NCT00836134|Anesthetics|anesthetics|mesh-list
110595361|NCT00836134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110595362|NCT00836134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110595363|NCT00836134|Sensory System Agents|sensory system agents|mesh-ancestor
110595364|NCT00836134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110595365|NCT00782795|Pioglitazone|pioglitazone|mesh-list
110595366|NCT00782795|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110595367|NCT00782795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110595368|NCT02573558|Dexmedetomidine|dexmedetomidine|mesh-list
110595369|NCT02573558|Propofol|propofol|mesh-list
110595370|NCT02573558|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110595371|NCT02573558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110595372|NCT02573558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110595373|NCT02573558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110595374|NCT02573558|Analgesics|analgesics|mesh-ancestor
110255259|NCT00149604|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
110595375|NCT02573558|Sensory System Agents|sensory system agents|mesh-ancestor
110595376|NCT02573558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110595377|NCT02573558|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110595378|NCT02573558|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110595379|NCT02573558|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110595380|NCT02573558|Adrenergic Agents|adrenergic agents|mesh-ancestor
110595381|NCT02573558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110595382|NCT02573558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110595383|NCT02573558|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110595384|NCT02573558|Anesthetics, General|anesthetics, general|mesh-ancestor
110595385|NCT02573558|Anesthetics|anesthetics|mesh-ancestor
110595387|NCT00656799|Rocuronium|rocuronium|mesh-list
110255318|NCT00472225|Immunologic Factors|immunologic factors|mesh-ancestor
110595388|NCT00656799|Anticonvulsants|anticonvulsants|mesh-ancestor
110595389|NCT00656799|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110595390|NCT00656799|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110595391|NCT00656799|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110595392|NCT00656799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110595393|NCT00656799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110595394|NCT00764699|Mecasermin|mecasermin|mesh-list
110595395|NCT00764699|Growth Substances|growth substances|mesh-ancestor
110595396|NCT00764699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110595397|NCT00844012|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110595398|NCT00844012|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110595399|NCT00844012|Estradiol|estradiol|mesh-list
110595400|NCT00844012|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110595401|NCT00844012|Estrogens|estrogens|mesh-ancestor
110595402|NCT00844012|Hormones|hormones|mesh-ancestor
110595403|NCT00844012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110595404|NCT00844012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110595405|NCT00844012|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110595406|NCT00844012|Contraceptive Agents|contraceptive agents|mesh-ancestor
110595407|NCT00844012|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110595408|NCT00844012|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110595409|NCT02574962|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
110595410|NCT02574962|Hormones|hormones|mesh-ancestor
110595411|NCT02574962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110595412|NCT02574962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110595413|NCT00802035|Baclofen|baclofen|mesh-list
110595414|NCT00802035|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110595415|NCT00802035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110595416|NCT00802035|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110595417|NCT00802035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110595418|NCT00802035|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
110595419|NCT00802035|GABA Agonists|gaba agonists|mesh-ancestor
110595420|NCT00802035|GABA Agents|gaba agents|mesh-ancestor
110255446|NCT00337441|Epoetin Alfa|epoetin alfa|mesh-list
110595421|NCT00802035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110595422|NCT00802035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110595423|NCT00836212|Efavirenz|efavirenz|mesh-list
110595424|NCT00836212|Lopinavir|lopinavir|mesh-list
110595425|NCT00836212|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110595426|NCT00836212|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110595427|NCT00836212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110595428|NCT00836212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110595429|NCT00836212|Antiviral Agents|antiviral agents|mesh-ancestor
110595430|NCT00836212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110595431|NCT00836212|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110595432|NCT00836212|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110595433|NCT00836212|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110595434|NCT00836212|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110595435|NCT00836212|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110595436|NCT00836212|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110595437|NCT00836212|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110595438|NCT00836212|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110255495|NCT00509158|Antacids|antacids|mesh-ancestor
110595439|NCT00836212|Protease Inhibitors|protease inhibitors|mesh-ancestor
110595440|NCT00836212|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110595441|NCT00836212|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110595442|NCT00836212|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110595443|NCT00782717|Prednisolone|prednisolone|mesh-list
110595444|NCT00782717|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110595445|NCT00782717|Methylprednisolone|methylprednisolone|mesh-list
110595446|NCT00782717|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110595447|NCT00782717|Prednisolone acetate|prednisolone acetate|mesh-list
110595448|NCT00782717|Nepafenac|nepafenac|mesh-list
110595449|NCT00782717|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110595450|NCT00782717|Prednisolone phosphate|prednisolone phosphate|mesh-list
110595451|NCT00782717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110595452|NCT00782717|Glucocorticoids|glucocorticoids|mesh-ancestor
110595453|NCT00782717|Hormones|hormones|mesh-ancestor
110255549|NCT00337792|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110595454|NCT00782717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110595455|NCT00782717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110595456|NCT00782717|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110595458|NCT00782717|Antiemetics|antiemetics|mesh-ancestor
110595459|NCT00782717|Autonomic Agents|autonomic agents|mesh-ancestor
110595460|NCT00782717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110150995|NCT00000718|Zidovudine|zidovudine|mesh-list
110595461|NCT00782717|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110595462|NCT00782717|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110595463|NCT00782717|Protective Agents|protective agents|mesh-ancestor
110595464|NCT00782717|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110255613|NCT00509470|Telmisartan|telmisartan|mesh-list
110595465|NCT00782717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110595466|NCT00782717|Analgesics|analgesics|mesh-ancestor
110595467|NCT00782717|Sensory System Agents|sensory system agents|mesh-ancestor
110595468|NCT00782717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110595469|NCT00656175|Raltegravir Potassium|raltegravir potassium|mesh-list
110595470|NCT00656175|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110595471|NCT00656175|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110595472|NCT00656175|Antiviral Agents|antiviral agents|mesh-ancestor
110595473|NCT00656175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110595474|NCT00656175|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110595475|NCT00656175|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110595476|NCT00656175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110595477|NCT00656175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110595478|NCT02601677|Fluoxetine|fluoxetine|mesh-list
110595479|NCT02601677|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110595480|NCT02601677|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110595481|NCT02601677|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110595482|NCT02601677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110595483|NCT02601677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110595484|NCT02601677|Serotonin Agents|serotonin agents|mesh-ancestor
110595485|NCT02601677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110595486|NCT02601677|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110595487|NCT02601677|Antidepressive Agents|antidepressive agents|mesh-ancestor
110255747|NCT00509860|Irinotecan|irinotecan|mesh-list
110595488|NCT02601677|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110595489|NCT02601677|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110595490|NCT02601677|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110595491|NCT02601677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110595492|NCT00620776|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
110595493|NCT00620776|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110595494|NCT00620776|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110595495|NCT00620776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110595496|NCT00620776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110595497|NCT00620776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110255808|NCT00510016|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110595498|NCT00620776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110595499|NCT00620776|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110595500|NCT00620776|Antidepressive Agents|antidepressive agents|mesh-ancestor
110595501|NCT00620776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110595502|NCT05479097|Antihypertensive Agents|antihypertensive agents|mesh-list
110595504|NCT00656019|Calcipotriene|calcipotriene|mesh-list
110595505|NCT00656019|Vitamins|vitamins|mesh-ancestor
110595506|NCT00656019|Micronutrients|micronutrients|mesh-ancestor
110595507|NCT00656019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110595508|NCT00656019|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110595509|NCT00656019|Dermatologic Agents|dermatologic agents|mesh-ancestor
110595510|NCT00841438|Abciximab|abciximab|mesh-list
110595511|NCT00841438|Anticoagulants|anticoagulants|mesh-ancestor
110595512|NCT00841438|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110595513|NCT00841516|Immunomodulating Agents|immunomodulating agents|mesh-list
110595514|NCT00841516|Immunologic Factors|immunologic factors|mesh-ancestor
110595515|NCT00841516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110595516|NCT00841594|Nitroglycerin|nitroglycerin|mesh-list
110595517|NCT00841594|Vasodilator Agents|vasodilator agents|mesh-ancestor
110595518|NCT04068974|Apatinib|apatinib|mesh-list
110595519|NCT04068974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110595520|NCT04068974|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110595521|NCT04068974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110595522|NCT04068974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110595523|NCT00836368|Vitamin E|vitamin e|mesh-list
110595524|NCT00836368|Tocopherols|tocopherols|mesh-list
110595525|NCT00836368|Tocotrienols|tocotrienols|mesh-list
110595526|NCT00836368|alpha-Tocopherol|alpha-tocopherol|mesh-list
110595527|NCT00836368|gamma-Tocopherol|gamma-tocopherol|mesh-list
110595528|NCT00836368|Vitamins|vitamins|mesh-ancestor
110595529|NCT00836368|Micronutrients|micronutrients|mesh-ancestor
110595530|NCT00836368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110595531|NCT00836368|Antioxidants|antioxidants|mesh-ancestor
110595532|NCT00836368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110595533|NCT00836368|Protective Agents|protective agents|mesh-ancestor
110595534|NCT00718796|Coenzyme Q10|coenzyme q10|mesh-list
110595535|NCT00718796|Ubiquinone|ubiquinone|mesh-list
110595536|NCT00718796|Atorvastatin|atorvastatin|mesh-list
110595537|NCT00718796|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110595538|NCT00718796|Simvastatin|simvastatin|mesh-list
110595539|NCT00718796|Pravastatin|pravastatin|mesh-list
110595540|NCT00718796|Lovastatin|lovastatin|mesh-list
110595541|NCT00718796|L 647318|l 647318|mesh-list
110595542|NCT00718796|Dihydromevinolin|dihydromevinolin|mesh-list
110595543|NCT00718796|Anticholesteremic Agents|anticholesteremic agents|mesh-list
110595544|NCT00718796|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110595545|NCT00718796|Antimetabolites|antimetabolites|mesh-ancestor
110242878|NCT00465673|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110595546|NCT00718796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110595547|NCT00718796|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110595548|NCT00718796|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110595549|NCT00718796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110595550|NCT00718796|Vitamins|vitamins|mesh-ancestor
110595552|NCT00718796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110595553|NCT00844168|Sorafenib|sorafenib|mesh-list
110595554|NCT00844168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110595555|NCT00844168|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110595556|NCT00844168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110595557|NCT00844168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110595558|NCT02573168|Psychotropic Drugs|psychotropic drugs|mesh-list
110595559|NCT00764465|Ritonavir|ritonavir|mesh-list
110595560|NCT00764465|Fosamprenavir|fosamprenavir|mesh-list
110595561|NCT00764465|Maraviroc|maraviroc|mesh-list
110595562|NCT00764465|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110595563|NCT00764465|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110595564|NCT00764465|Protease Inhibitors|protease inhibitors|mesh-ancestor
110595565|NCT00764465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110595566|NCT00764465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110595567|NCT00764465|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110595568|NCT00764465|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110595569|NCT00764465|Antiviral Agents|antiviral agents|mesh-ancestor
110595570|NCT00764465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110595571|NCT00764465|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110595572|NCT00764465|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110595573|NCT00764465|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110595574|NCT00764465|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110595575|NCT00764465|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
110595577|NCT00655863|Alogliptin|alogliptin|mesh-list
110595578|NCT00655863|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110595579|NCT00655863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110595580|NCT00655863|Incretins|incretins|mesh-ancestor
110595581|NCT00655863|Hormones|hormones|mesh-ancestor
110595582|NCT00655863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110595583|NCT00655863|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110595584|NCT00655863|Protease Inhibitors|protease inhibitors|mesh-ancestor
110595585|NCT00655863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110595586|NCT00655863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110595587|NCT00718952|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
110595588|NCT00718952|Vasodilator Agents|vasodilator agents|mesh-ancestor
110595589|NCT00718952|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110256245|NCT00165828|Zonisamide|zonisamide|mesh-list
110256259|NCT00511576|Docetaxel|docetaxel|mesh-list
110595590|NCT00718952|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110595591|NCT00718952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110595592|NCT00718952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110595593|NCT00718952|Urological Agents|urological agents|mesh-ancestor
110595594|NCT00781937|Liraglutide|liraglutide|mesh-list
110595595|NCT00781937|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110595596|NCT00781937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110595597|NCT00781937|Incretins|incretins|mesh-ancestor
110595598|NCT00781937|Hormones|hormones|mesh-ancestor
110595599|NCT00781937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110595600|NCT00802581|Anesthetics|anesthetics|mesh-list
110595601|NCT00802581|Anesthetics, Local|anesthetics, local|mesh-list
110595602|NCT00802581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110595603|NCT00802581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110595604|NCT00802581|Sensory System Agents|sensory system agents|mesh-ancestor
110595605|NCT00802581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110595606|NCT00719108|Insulin|insulin|mesh-list
110595607|NCT00719108|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110595608|NCT00719108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110595609|NCT00719108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110595610|NCT00842140|Metformin|metformin|mesh-list
110595611|NCT00842140|Spironolactone|spironolactone|mesh-list
110595612|NCT00842140|Contraceptive Agents|contraceptive agents|mesh-list
110595613|NCT00842140|Contraceptives, Oral|contraceptives, oral|mesh-list
110256367|NCT02951962|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110595614|NCT00842140|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110595615|NCT00842140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110595616|NCT00842140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110595617|NCT00842140|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110595618|NCT00842140|Hormone Antagonists|hormone antagonists|mesh-ancestor
110595619|NCT00842140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110595620|NCT00842140|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110595621|NCT00842140|Diuretics|diuretics|mesh-ancestor
110595622|NCT00842140|Natriuretic Agents|natriuretic agents|mesh-ancestor
110595623|NCT00842140|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110595625|NCT00806169|Bevacizumab|bevacizumab|mesh-list
110595626|NCT00806169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110595627|NCT00806169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110595628|NCT00806169|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110256424|NCT00513643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110595629|NCT00806169|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110595630|NCT00806169|Growth Substances|growth substances|mesh-ancestor
110595631|NCT00806169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110595632|NCT00806169|Growth Inhibitors|growth inhibitors|mesh-ancestor
110595633|NCT00806169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110595634|NCT00806169|Glucocorticoids|glucocorticoids|mesh-ancestor
110595635|NCT00806169|Hormones|hormones|mesh-ancestor
110595636|NCT00806169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110595637|NCT00844324|Candesartan|candesartan|mesh-list
110595638|NCT00844324|Candesartan cilexetil|candesartan cilexetil|mesh-list
110595639|NCT00844324|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110595640|NCT00844324|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110595641|NCT00844324|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110595642|NCT00844324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110595643|NCT00802815|Etanercept|etanercept|mesh-list
110595644|NCT00802815|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110595645|NCT00802815|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110595646|NCT00802815|Analgesics|analgesics|mesh-ancestor
110595647|NCT00802815|Sensory System Agents|sensory system agents|mesh-ancestor
110595648|NCT00802815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110595649|NCT00802815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110595650|NCT00802815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110595651|NCT00802815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110595652|NCT00802815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110595653|NCT00802815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110595654|NCT00802815|Immunologic Factors|immunologic factors|mesh-ancestor
110595655|NCT04100759|Sildenafil Citrate|sildenafil citrate|mesh-list
110595656|NCT04100759|Vasodilator Agents|vasodilator agents|mesh-ancestor
110595657|NCT04100759|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110595658|NCT04100759|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110595659|NCT04100759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110595660|NCT04100759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110595661|NCT04100759|Urological Agents|urological agents|mesh-ancestor
110595662|NCT00836914|Idelalisib|idelalisib|mesh-list
110595663|NCT00836914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110595664|NCT00836914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110595665|NCT00836914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110595666|NCT00844402|Atorvastatin|atorvastatin|mesh-list
110595667|NCT00844402|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110595668|NCT00844402|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110595669|NCT00844402|Antimetabolites|antimetabolites|mesh-ancestor
110595670|NCT00844402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110595671|NCT00844402|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110595672|NCT00844402|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110595673|NCT00844402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110595674|NCT00806247|Tapentadol|tapentadol|mesh-list
110595675|NCT00806247|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110595676|NCT00806247|Narcotics|narcotics|mesh-ancestor
110595677|NCT00806247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110595678|NCT00806247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110595679|NCT00806247|Analgesics|analgesics|mesh-ancestor
110595680|NCT00806247|Sensory System Agents|sensory system agents|mesh-ancestor
110595681|NCT00806247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110595682|NCT00806247|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110595683|NCT00806247|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110595684|NCT00806247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110595685|NCT00806247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110595686|NCT00806247|Adrenergic Agents|adrenergic agents|mesh-ancestor
110595687|NCT00806247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110595688|NCT00797745|Ritonavir|ritonavir|mesh-list
110595689|NCT00797745|Ribavirin|ribavirin|mesh-list
110595690|NCT00797745|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110595691|NCT00797745|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110595692|NCT00797745|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110595693|NCT00797745|Protease Inhibitors|protease inhibitors|mesh-ancestor
110595694|NCT00797745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110243032|NCT00347854|Laxatives|laxatives|mesh-ancestor
110595695|NCT00797745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110595696|NCT00797745|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110595697|NCT00797745|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110595698|NCT00797745|Antiviral Agents|antiviral agents|mesh-ancestor
110595699|NCT00797745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110595700|NCT00797745|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110595701|NCT00797745|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110595702|NCT00797745|Antimetabolites|antimetabolites|mesh-ancestor
110595703|NCT00659373|Tamoxifen|tamoxifen|mesh-list
110595704|NCT00659373|Triptorelin Pamoate|triptorelin pamoate|mesh-list
110595705|NCT00659373|Exemestane|exemestane|mesh-list
110595706|NCT00659373|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110595707|NCT00659373|Hormone Antagonists|hormone antagonists|mesh-ancestor
110595708|NCT00659373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110595709|NCT00659373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110595710|NCT00659373|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110595711|NCT00659373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110595712|NCT00659373|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110595713|NCT00659373|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110256782|NCT05861466|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110256788|NCT05861336|Paclitaxel|paclitaxel|mesh-list
110595714|NCT00659373|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110595715|NCT00659373|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110595716|NCT00659373|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110595717|NCT00659373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110595718|NCT00659373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110595719|NCT00659373|Luteolytic Agents|luteolytic agents|mesh-ancestor
110256846|NCT05861063|Dezocine|dezocine|mesh-list
110595720|NCT00659373|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110595721|NCT00659373|Contraceptive Agents|contraceptive agents|mesh-ancestor
110595722|NCT00659373|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110595723|NCT00659373|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110595725|NCT00842452|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110595726|NCT00842452|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110595727|NCT00842452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110595728|NCT00842452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110595729|NCT00842452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110595730|NCT02552745|Parecoxib|parecoxib|mesh-list
110595731|NCT02552745|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110595732|NCT02552745|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110595733|NCT02552745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110595734|NCT02552745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110595735|NCT02552745|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110595736|NCT02552745|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110595737|NCT02552745|Analgesics|analgesics|mesh-ancestor
110595738|NCT02552745|Sensory System Agents|sensory system agents|mesh-ancestor
110595739|NCT02552745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110595740|NCT02552745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110595741|NCT02552745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110595742|NCT02552745|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110595743|NCT02547844|Tenofovir|tenofovir|mesh-list
110595744|NCT02547844|Efavirenz|efavirenz|mesh-list
110595745|NCT02547844|Emtricitabine|emtricitabine|mesh-list
110595746|NCT02547844|Antiviral Agents|antiviral agents|mesh-ancestor
110595747|NCT02547844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110595748|NCT02547844|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110595749|NCT02547844|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110595750|NCT02547844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110595751|NCT02547844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110595752|NCT02547844|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110595753|NCT02547844|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110595754|NCT02547844|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110595755|NCT02547844|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110595756|NCT02547844|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110595757|NCT02547844|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110595758|NCT02547844|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110595759|NCT02547844|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110595760|NCT00439777|Enoxaparin|enoxaparin|mesh-list
110595761|NCT00439777|Rivaroxaban|rivaroxaban|mesh-list
110256993|NCT05859412|Hormones|hormones|mesh-ancestor
110595762|NCT00439777|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110595763|NCT00439777|Antithrombins|antithrombins|mesh-ancestor
110595764|NCT00439777|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110595765|NCT00439777|Protease Inhibitors|protease inhibitors|mesh-ancestor
110595766|NCT00439777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110595767|NCT00439777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110595768|NCT00439777|Anticoagulants|anticoagulants|mesh-ancestor
110595769|NCT00439777|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110595770|NCT00439777|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110595771|NCT00842686|Bevacizumab|bevacizumab|mesh-list
110595772|NCT00842686|Capecitabine|capecitabine|mesh-list
110595773|NCT00842686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110595774|NCT00842686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110595775|NCT00842686|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110595776|NCT00842686|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110595777|NCT00842686|Growth Substances|growth substances|mesh-ancestor
110595778|NCT00842686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110595779|NCT00842686|Growth Inhibitors|growth inhibitors|mesh-ancestor
110595780|NCT00842686|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110595781|NCT00842686|Antimetabolites|antimetabolites|mesh-ancestor
110595782|NCT00842686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110595783|NCT04045821|Plerixafor|plerixafor|mesh-list
110595784|NCT04045821|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110595785|NCT04045821|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110595786|NCT04045821|Antiviral Agents|antiviral agents|mesh-ancestor
110595787|NCT04045821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110595789|NCT00803439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110595790|NCT00803439|Glucocorticoids|glucocorticoids|mesh-ancestor
110595791|NCT00803439|Hormones|hormones|mesh-ancestor
110595792|NCT00803439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110595793|NCT00803439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110595794|NCT00806481|Sevelamer|sevelamer|mesh-list
110595795|NCT00806481|Chelating Agents|chelating agents|mesh-ancestor
110595796|NCT00806481|Sequestering Agents|sequestering agents|mesh-ancestor
110595797|NCT00806481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110595798|NCT00709436|Ketamine|ketamine|mesh-list
110595799|NCT00709436|Analgesics|analgesics|mesh-ancestor
110595800|NCT00709436|Sensory System Agents|sensory system agents|mesh-ancestor
110595801|NCT00709436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110595802|NCT00709436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110257073|NCT05710328|Antimetabolites|antimetabolites|mesh-ancestor
110257074|NCT05710328|Antiviral Agents|antiviral agents|mesh-ancestor
110595803|NCT00709436|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110595804|NCT00709436|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110595805|NCT00709436|Anesthetics, General|anesthetics, general|mesh-ancestor
110595806|NCT00709436|Anesthetics|anesthetics|mesh-ancestor
110595807|NCT00709436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110595808|NCT00709436|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110595809|NCT00709436|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110595810|NCT00709436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110595811|NCT00709436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110595812|NCT00844792|Vitamin D|vitamin d|mesh-list
110595813|NCT00844792|Cholecalciferol|cholecalciferol|mesh-list
110595814|NCT00844792|Vitamins|vitamins|mesh-list
110595815|NCT00844792|Vitamin E|vitamin e|mesh-list
110595816|NCT00844792|Selenium|selenium|mesh-list
110595817|NCT00844792|Lycopene|lycopene|mesh-list
110595818|NCT00844792|Micronutrients|micronutrients|mesh-ancestor
110595819|NCT00844792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110595820|NCT00844792|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110595821|NCT00844792|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110595822|NCT00844792|Antioxidants|antioxidants|mesh-ancestor
110377567|NCT01088048|Rituximab|rituximab|mesh-list
110595823|NCT00844792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110595824|NCT00844792|Protective Agents|protective agents|mesh-ancestor
110595825|NCT00844792|Trace Elements|trace elements|mesh-ancestor
110595826|NCT00844792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110595827|NCT00844792|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110595828|NCT00844792|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110595829|NCT00844792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110595830|NCT00719420|Amoxicillin|amoxicillin|mesh-list
110595831|NCT00719420|Metronidazole|metronidazole|mesh-list
110595832|NCT00719420|Clarithromycin|clarithromycin|mesh-list
110595834|NCT00719420|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110595835|NCT00719420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110595836|NCT00719420|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110595837|NCT00719420|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110595838|NCT00719420|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110595839|NCT00719420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110595840|NCT00719420|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110595841|NCT00719420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110595842|NCT00719420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110595843|NCT00719420|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110595844|NCT00719420|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110595845|NCT00719420|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110595847|NCT00803829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110595848|NCT00803829|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110595849|NCT00803829|Antimalarials|antimalarials|mesh-ancestor
110595850|NCT00803829|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110595851|NCT00803829|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110595852|NCT00716612|Ubiquinone|ubiquinone|mesh-list
110595853|NCT00716612|Coenzyme Q10|coenzyme q10|mesh-list
110595854|NCT00716612|Micronutrients|micronutrients|mesh-ancestor
110595855|NCT00716612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110595856|NCT00716612|Vitamins|vitamins|mesh-ancestor
110595857|NCT00842920|Simvastatin|simvastatin|mesh-list
110595858|NCT00842920|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110595859|NCT00842920|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110595860|NCT00842920|Antimetabolites|antimetabolites|mesh-ancestor
110595861|NCT00842920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110595862|NCT00842920|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110595863|NCT00842920|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110595864|NCT00842920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110595865|NCT00842998|Trastuzumab|trastuzumab|mesh-list
110595866|NCT00842998|Lapatinib|lapatinib|mesh-list
110595867|NCT00842998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110595868|NCT00842998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110595869|NCT00842998|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110595870|NCT00842998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110595871|NCT00842998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110595872|NCT00716846|Atorvastatin|atorvastatin|mesh-list
110595873|NCT00716846|Simvastatin|simvastatin|mesh-list
110595874|NCT00716846|Pitavastatin|pitavastatin|mesh-list
110595875|NCT00716846|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110595876|NCT00716846|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110595877|NCT00716846|Antimetabolites|antimetabolites|mesh-ancestor
110595878|NCT00716846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110595879|NCT00716846|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110595880|NCT00716846|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110595881|NCT00716846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110595882|NCT00620854|Calcitonin|calcitonin|mesh-list
110595883|NCT00620854|Salmon calcitonin|salmon calcitonin|mesh-list
110595884|NCT00620854|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
110595885|NCT00620854|Katacalcin|katacalcin|mesh-list
110595886|NCT00620854|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110595887|NCT00620854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110257233|NCT05346562|Cannabidiol|cannabidiol|mesh-list
110595888|NCT00620854|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110595890|NCT00716924|Clopidogrel|clopidogrel|mesh-list
110595891|NCT00716924|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110595892|NCT00716924|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110595893|NCT00716924|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110595894|NCT00716924|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110595895|NCT00716924|Purinergic Agents|purinergic agents|mesh-ancestor
110595896|NCT00716924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110595897|NCT00716924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110595898|NCT00716924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110595899|NCT00430027|Capecitabine|capecitabine|mesh-list
110595900|NCT00430027|Oxaliplatin|oxaliplatin|mesh-list
110595901|NCT00430027|Cetuximab|cetuximab|mesh-list
110595902|NCT00430027|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110595903|NCT00430027|Antimetabolites|antimetabolites|mesh-ancestor
110595904|NCT00430027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110595905|NCT00430027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110595906|NCT00430027|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110595907|NCT04766229|Gabapentin|gabapentin|mesh-list
110595908|NCT04766229|Citalopram|citalopram|mesh-list
110595909|NCT04766229|Analgesics|analgesics|mesh-ancestor
110595910|NCT04766229|Sensory System Agents|sensory system agents|mesh-ancestor
110595911|NCT04766229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110595912|NCT04766229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110595913|NCT04766229|Anticonvulsants|anticonvulsants|mesh-ancestor
110257286|NCT05190705|BB 1101|bb 1101|mesh-list
110595914|NCT04766229|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110595915|NCT04766229|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110595916|NCT04766229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110595917|NCT04766229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110595918|NCT04766229|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110595919|NCT04766229|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110595920|NCT04766229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110595921|NCT04766229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110595922|NCT04766229|Antimanic Agents|antimanic agents|mesh-ancestor
110595923|NCT04766229|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110595924|NCT04766229|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110595925|NCT04766229|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110595926|NCT04766229|Serotonin Agents|serotonin agents|mesh-ancestor
110595927|NCT04766229|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110595928|NCT04766229|Antidepressive Agents|antidepressive agents|mesh-ancestor
110595930|NCT04068506|Analgesics|analgesics|mesh-ancestor
110257323|NCT05172908|Glucocorticoids|glucocorticoids|mesh-ancestor
110595931|NCT04068506|Sensory System Agents|sensory system agents|mesh-ancestor
110595932|NCT04068506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110595933|NCT04068506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110595934|NCT04068506|Anticonvulsants|anticonvulsants|mesh-ancestor
110595935|NCT04068506|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110595936|NCT04068506|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110595937|NCT04068506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110595938|NCT04068506|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110595939|NCT04068506|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110595940|NCT04068506|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110595941|NCT04068506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110595942|NCT04068506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110595943|NCT04068506|Antimanic Agents|antimanic agents|mesh-ancestor
110595944|NCT00803907|Imiquimod|imiquimod|mesh-list
110595945|NCT00803907|Immunologic Factors|immunologic factors|mesh-list
110595946|NCT00803907|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110595947|NCT00803907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110595948|NCT00803907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110595949|NCT00803907|Interferon Inducers|interferon inducers|mesh-ancestor
110595950|NCT00843154|Candesartan|candesartan|mesh-list
110595951|NCT00843154|Candesartan cilexetil|candesartan cilexetil|mesh-list
110595952|NCT00843154|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110595953|NCT00843154|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110595954|NCT00843154|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110595955|NCT00843154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110595956|NCT00429793|Sirolimus|sirolimus|mesh-list
110595957|NCT00429793|Temsirolimus|temsirolimus|mesh-list
110595958|NCT00429793|MTOR Inhibitors|mtor inhibitors|mesh-list
110595959|NCT00429793|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110595960|NCT00429793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110595961|NCT00429793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110257378|NCT04849026|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110257383|NCT04849026|GABA Agents|gaba agents|mesh-ancestor
110595962|NCT00429793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110595963|NCT00429793|Immunologic Factors|immunologic factors|mesh-ancestor
110595964|NCT00429793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110595965|NCT00429793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110595966|NCT00429793|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110595967|NCT00429793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110595968|NCT00429793|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110595969|NCT00429793|Antifungal Agents|antifungal agents|mesh-ancestor
110595970|NCT00806871|Methylprednisolone|methylprednisolone|mesh-list
110595971|NCT00806871|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110595972|NCT00806871|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110595974|NCT00806871|Prednisolone acetate|prednisolone acetate|mesh-list
110595975|NCT00806871|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110595976|NCT00806871|Prednisolone phosphate|prednisolone phosphate|mesh-list
110595977|NCT00806871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110257420|NCT04830462|Antimetabolites|antimetabolites|mesh-ancestor
110595980|NCT00806871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110595981|NCT00806871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110595982|NCT00806871|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110595983|NCT00806871|Glucocorticoids|glucocorticoids|mesh-ancestor
110595984|NCT00806871|Hormones|hormones|mesh-ancestor
110595985|NCT00806871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110595986|NCT00806871|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110595987|NCT00806871|Protective Agents|protective agents|mesh-ancestor
110595988|NCT00806871|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110595989|NCT00806871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110595990|NCT00798213|Gemtuzumab|gemtuzumab|mesh-list
110595991|NCT00798213|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110595992|NCT00798213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110243336|NCT00350038|Irbesartan|irbesartan|mesh-list
110595994|NCT00798213|Immunoconjugates|immunoconjugates|mesh-ancestor
110595995|NCT00798213|Immunologic Factors|immunologic factors|mesh-ancestor
110595996|NCT00798213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110595997|NCT04069208|Cytarabine|cytarabine|mesh-list
110595998|NCT04069208|Idarubicin|idarubicin|mesh-list
110595999|NCT04069208|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110596000|NCT04069208|Antimetabolites|antimetabolites|mesh-ancestor
110596001|NCT04069208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110596002|NCT04069208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110596003|NCT04069208|Antiviral Agents|antiviral agents|mesh-ancestor
110596004|NCT04069208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110596005|NCT04069208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110596006|NCT04069208|Immunologic Factors|immunologic factors|mesh-ancestor
110596007|NCT04069208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110596008|NCT04069208|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110596009|NCT04069208|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110596010|NCT04069208|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110596011|NCT04069208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110596013|NCT00845104|Rituximab|rituximab|mesh-list
110596014|NCT00845104|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110596015|NCT00845104|Fludarabine|fludarabine|mesh-list
110596016|NCT00845104|Fludarabine phosphate|fludarabine phosphate|mesh-list
110596017|NCT00845104|Antibodies|antibodies|mesh-list
110596018|NCT00845104|Immunoglobulins|immunoglobulins|mesh-list
110596019|NCT00845104|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110596020|NCT00845104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110596021|NCT00845104|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110596022|NCT00845104|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110596023|NCT00845104|Growth Substances|growth substances|mesh-ancestor
110596024|NCT00845104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110596025|NCT00845104|Growth Inhibitors|growth inhibitors|mesh-ancestor
110596026|NCT00845104|Immunologic Factors|immunologic factors|mesh-ancestor
110596027|NCT00845104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110596028|NCT00845104|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110257532|NCT04644016|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110596029|NCT00845104|Antimetabolites|antimetabolites|mesh-ancestor
110596030|NCT00845104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110596031|NCT00845104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110596033|NCT00763451|Lixisenatide|lixisenatide|mesh-list
110596034|NCT00763451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110596035|NCT00763451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110596036|NCT00762762|Triclosan|triclosan|mesh-list
110596037|NCT00762762|Fluorides|fluorides|mesh-list
110596038|NCT00762762|Cariostatic Agents|cariostatic agents|mesh-ancestor
110596039|NCT00762762|Protective Agents|protective agents|mesh-ancestor
110596040|NCT00762762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110596041|NCT00762762|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110596042|NCT00762762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110596043|NCT00762762|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
110596044|NCT00762762|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110596045|NCT00762762|Antimetabolites|antimetabolites|mesh-ancestor
110596046|NCT00762762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110257579|NCT04463680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110596048|NCT00424489|Methylprednisolone|methylprednisolone|mesh-list
110596049|NCT00424489|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110596050|NCT00424489|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110596051|NCT00424489|Prednisolone|prednisolone|mesh-list
110596052|NCT00424489|Prednisolone acetate|prednisolone acetate|mesh-list
110596053|NCT00424489|Cyclophosphamide|cyclophosphamide|mesh-list
110596054|NCT00424489|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110596055|NCT00424489|Prednisolone phosphate|prednisolone phosphate|mesh-list
110596056|NCT00424489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110596057|NCT00424489|Immunologic Factors|immunologic factors|mesh-ancestor
110596058|NCT00424489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110596059|NCT00424489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110596060|NCT00424489|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110596061|NCT00424489|Alkylating Agents|alkylating agents|mesh-ancestor
110257635|NCT04304014|Sulfalene|sulfalene|mesh-list
110257663|NCT04195633|Treosulfan|treosulfan|mesh-list
110596062|NCT00424489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110596063|NCT00424489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110596064|NCT00424489|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110596065|NCT00424489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110243410|NCT00350311|Nicotine|nicotine|mesh-list
110596067|NCT00424489|Autonomic Agents|autonomic agents|mesh-ancestor
110596068|NCT00424489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110596069|NCT00424489|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110596070|NCT00424489|Glucocorticoids|glucocorticoids|mesh-ancestor
110596071|NCT00424489|Hormones|hormones|mesh-ancestor
110596072|NCT00424489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110596073|NCT00424489|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110596074|NCT00424489|Protective Agents|protective agents|mesh-ancestor
110596075|NCT00424489|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110596076|NCT00578864|Cyclophosphamide|cyclophosphamide|mesh-list
110596077|NCT00578864|Doxorubicin|doxorubicin|mesh-list
110596078|NCT00578864|Etoposide|etoposide|mesh-list
110596079|NCT00578864|Etoposide phosphate|etoposide phosphate|mesh-list
110596080|NCT00578864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110257698|NCT04098081|Gemcitabine|gemcitabine|mesh-list
110596081|NCT00578864|Immunologic Factors|immunologic factors|mesh-ancestor
110596082|NCT00578864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110596083|NCT00578864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110596084|NCT00578864|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110596085|NCT00578864|Alkylating Agents|alkylating agents|mesh-ancestor
110596086|NCT00578864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110596087|NCT00578864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110596088|NCT00578864|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110596089|NCT00578864|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110596090|NCT00578864|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110596091|NCT00578864|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110596092|NCT00578864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110596093|NCT00578864|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110257749|NCT03897881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110596094|NCT01034683|Leucovorin|leucovorin|mesh-list
110596095|NCT01034683|Antidotes|antidotes|mesh-ancestor
110596096|NCT01034683|Protective Agents|protective agents|mesh-ancestor
110596097|NCT01034683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110596098|NCT01034683|Vitamin B Complex|vitamin b complex|mesh-ancestor
110596099|NCT01034683|Vitamins|vitamins|mesh-ancestor
110596100|NCT01034683|Micronutrients|micronutrients|mesh-ancestor
110596101|NCT00717470|Mycophenolic Acid|mycophenolic acid|mesh-list
110596102|NCT00717470|Prednisone|prednisone|mesh-list
110596103|NCT00717470|Methylprednisolone|methylprednisolone|mesh-list
110596104|NCT00717470|Tacrolimus|tacrolimus|mesh-list
110596105|NCT00717470|Basiliximab|basiliximab|mesh-list
110596106|NCT00717470|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110596107|NCT00717470|Glucocorticoids|glucocorticoids|mesh-ancestor
110596108|NCT00717470|Hormones|hormones|mesh-ancestor
110596109|NCT00717470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110596110|NCT00717470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110596111|NCT00717470|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110596112|NCT00717470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110596113|NCT00717470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110596114|NCT00717470|Immunologic Factors|immunologic factors|mesh-ancestor
110596115|NCT00717470|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110596116|NCT00717470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110596117|NCT00717470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110596118|NCT00717470|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110596119|NCT00717470|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110596120|NCT00717470|Antitubercular Agents|antitubercular agents|mesh-ancestor
110596121|NCT00717470|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110596122|NCT00717470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110596123|NCT00717470|Antiemetics|antiemetics|mesh-ancestor
110596124|NCT00717470|Autonomic Agents|autonomic agents|mesh-ancestor
110596125|NCT00717470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110596126|NCT00717470|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110596127|NCT00717470|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110596128|NCT00717470|Protective Agents|protective agents|mesh-ancestor
110596129|NCT00631566|Mupirocin|mupirocin|mesh-list
110596130|NCT00631566|Triclosan|triclosan|mesh-list
110596131|NCT00631566|Hexachlorophene|hexachlorophene|mesh-list
110596132|NCT00631566|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110596133|NCT00631566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110257859|NCT03216187|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110596134|NCT00631566|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110596135|NCT00631566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110596136|NCT00631566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110596137|NCT00631566|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110596138|NCT00631566|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
110596139|NCT00631566|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110596140|NCT00631566|Antimetabolites|antimetabolites|mesh-ancestor
110596141|NCT00631566|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110596142|NCT00722852|Ketoprofen|ketoprofen|mesh-list
110596143|NCT00722852|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110596144|NCT00722852|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110596145|NCT00722852|Analgesics|analgesics|mesh-ancestor
110596146|NCT00722852|Sensory System Agents|sensory system agents|mesh-ancestor
110596147|NCT00722852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110596148|NCT00722852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110596149|NCT00722852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110596150|NCT00722852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110596151|NCT00722852|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110596152|NCT00722852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110596153|NCT00722852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110596154|NCT05657444|Tenecteplase|tenecteplase|mesh-list
110596155|NCT05657444|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110596156|NCT05657444|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110596157|NCT05657444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110596158|NCT01410942|Methylphenidate|methylphenidate|mesh-list
110596159|NCT01410942|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110596160|NCT01410942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110596161|NCT01410942|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110596162|NCT01410942|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110596163|NCT01410942|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110596164|NCT01410942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110596166|NCT01410942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110596167|NCT04833426|Testosterone|testosterone|mesh-list
110596168|NCT04833426|Androgens|androgens|mesh-ancestor
110596169|NCT04833426|Hormones|hormones|mesh-ancestor
110596170|NCT04833426|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110596171|NCT04833426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110596172|NCT02576964|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110596173|NCT02576964|Capecitabine|capecitabine|mesh-list
110596174|NCT02576964|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110596175|NCT02576964|Antimetabolites|antimetabolites|mesh-ancestor
110596176|NCT02576964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110596177|NCT02576964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110596178|NCT02576964|Antiviral Agents|antiviral agents|mesh-ancestor
110596179|NCT02576964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110596180|NCT00763139|Pioglitazone|pioglitazone|mesh-list
110596181|NCT00763139|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110596182|NCT00763139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110596183|NCT01366092|Interleukin-2|interleukin-2|mesh-list
110596184|NCT01366092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110596185|NCT01366092|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110596186|NCT01366092|Analgesics|analgesics|mesh-ancestor
110596187|NCT01366092|Sensory System Agents|sensory system agents|mesh-ancestor
110596188|NCT01366092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110596189|NCT01366092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110596190|NCT00781859|Plasminogen|plasminogen|mesh-list
110596191|NCT00781859|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110596192|NCT00781859|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110596193|NCT00781859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110596194|NCT01344252|Lidocaine|lidocaine|mesh-list
110596195|NCT01344252|Anesthetics, Local|anesthetics, local|mesh-ancestor
110596196|NCT01344252|Anesthetics|anesthetics|mesh-ancestor
110596197|NCT01344252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110596198|NCT01344252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110596199|NCT01344252|Sensory System Agents|sensory system agents|mesh-ancestor
110596200|NCT01344252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110596201|NCT01344252|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110596202|NCT01344252|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110596203|NCT01344252|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110596204|NCT01344252|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110596205|NCT01344252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110596206|NCT04101383|Insulin|insulin|mesh-list
110596207|NCT04101383|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110596208|NCT04101383|Insulin Glargine|insulin glargine|mesh-list
110596209|NCT04101383|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110596210|NCT04101383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110596212|NCT02576808|Antipruritics|antipruritics|mesh-ancestor
110596213|NCT02576808|Dermatologic Agents|dermatologic agents|mesh-ancestor
110596214|NCT02576808|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110596215|NCT02576808|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110596216|NCT02576808|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110596217|NCT02576808|Histamine Antagonists|histamine antagonists|mesh-ancestor
110596218|NCT02576808|Histamine Agents|histamine agents|mesh-ancestor
110596219|NCT02576808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110596220|NCT02576808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110596221|NCT02576808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110596222|NCT00580788|Parathyroid Hormone|parathyroid hormone|mesh-list
110596223|NCT00580788|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
110596224|NCT00580788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110596225|NCT00580788|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110596226|NCT04073160|Durvalumab|durvalumab|mesh-list
110596227|NCT04073160|Tremelimumab|tremelimumab|mesh-list
110596228|NCT04073160|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110596229|NCT04073160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110596230|NCT00417079|Prednisone|prednisone|mesh-list
110596231|NCT00417079|Mitoxantrone|mitoxantrone|mesh-list
110596232|NCT00417079|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110596233|NCT00417079|Glucocorticoids|glucocorticoids|mesh-ancestor
110596234|NCT00417079|Hormones|hormones|mesh-ancestor
110258215|NCT00518479|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110258219|NCT00518479|Vasodilator Agents|vasodilator agents|mesh-ancestor
110596235|NCT00417079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110596236|NCT00417079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110596237|NCT00417079|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110377601|NCT01087814|Efavirenz|efavirenz|mesh-list
110596238|NCT00417079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110596239|NCT00417079|Analgesics|analgesics|mesh-ancestor
110596240|NCT00417079|Sensory System Agents|sensory system agents|mesh-ancestor
110596241|NCT00417079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110596242|NCT00417079|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110596243|NCT00417079|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110596244|NCT00417079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110596245|NCT00417079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110596246|NCT02578914|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110596247|NCT02578914|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110596248|NCT00429169|Bupropion|bupropion|mesh-list
110596249|NCT00429169|Paroxetine|paroxetine|mesh-list
110596250|NCT00429169|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110596251|NCT00429169|Antidepressive Agents|antidepressive agents|mesh-ancestor
110596252|NCT00429169|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110596253|NCT00429169|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110258278|NCT02949466|Triamcinolone|triamcinolone|mesh-list
110596254|NCT00429169|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110596255|NCT00429169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110596256|NCT00429169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110596257|NCT00429169|Dopamine Agents|dopamine agents|mesh-ancestor
110596258|NCT00429169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110596259|NCT00429169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110596260|NCT00429169|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110596261|NCT00429169|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110596262|NCT00429169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110596263|NCT00429169|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110596264|NCT00429169|Serotonin Agents|serotonin agents|mesh-ancestor
110596265|NCT01037491|Aspirin|aspirin|mesh-list
110596266|NCT01037491|Rabeprazole|rabeprazole|mesh-list
110596267|NCT01037491|Clopidogrel|clopidogrel|mesh-list
110596268|NCT01037491|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110596269|NCT01037491|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110596270|NCT01037491|Analgesics|analgesics|mesh-ancestor
110596271|NCT01037491|Sensory System Agents|sensory system agents|mesh-ancestor
110596272|NCT01037491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110596273|NCT01037491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110596274|NCT01037491|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110596275|NCT01037491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110596276|NCT01037491|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110596277|NCT01037491|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110596278|NCT01037491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110596279|NCT01037491|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110596280|NCT01037491|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110596281|NCT01037491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110596282|NCT01037491|Antipyretics|antipyretics|mesh-ancestor
110596283|NCT01037491|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110596284|NCT01037491|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110596285|NCT01037491|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110596286|NCT01037491|Purinergic Agents|purinergic agents|mesh-ancestor
110596287|NCT01037491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110596288|NCT01037491|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110596289|NCT01037491|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110596290|NCT01037491|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110596291|NCT01033279|Warfarin|warfarin|mesh-list
110596292|NCT01033279|Anticoagulants|anticoagulants|mesh-ancestor
110596293|NCT02576340|Octylonium|octylonium|mesh-list
110596295|NCT02576340|Anticonvulsants|anticonvulsants|mesh-ancestor
110596296|NCT02576340|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110596297|NCT02576340|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110596298|NCT02576340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110596299|NCT02576340|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110258436|NCT02948920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110596300|NCT02576340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110596302|NCT02576340|Parasympatholytics|parasympatholytics|mesh-ancestor
110596303|NCT02576340|Autonomic Agents|autonomic agents|mesh-ancestor
110596304|NCT02576340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110596305|NCT02576340|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110596306|NCT02576340|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110596307|NCT02576340|Cholinergic Agents|cholinergic agents|mesh-ancestor
110596308|NCT02576340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110596309|NCT02578602|Edetic Acid|edetic acid|mesh-list
110596310|NCT02578602|Pentetic Acid|pentetic acid|mesh-list
110596311|NCT02578602|Antidotes|antidotes|mesh-ancestor
110596312|NCT02578602|Protective Agents|protective agents|mesh-ancestor
110596313|NCT02578602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110596314|NCT02578602|Chelating Agents|chelating agents|mesh-ancestor
110596315|NCT02578602|Sequestering Agents|sequestering agents|mesh-ancestor
110596316|NCT02578602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110596317|NCT02578602|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110596318|NCT02578602|Anticoagulants|anticoagulants|mesh-ancestor
110596319|NCT02578602|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110596320|NCT00128856|Paclitaxel|paclitaxel|mesh-list
110596321|NCT00128856|Gemcitabine|gemcitabine|mesh-list
110596322|NCT00128856|Doxorubicin|doxorubicin|mesh-list
110596323|NCT00128856|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110596324|NCT00128856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110596325|NCT00128856|Tubulin Modulators|tubulin modulators|mesh-ancestor
110596326|NCT00128856|Antimitotic Agents|antimitotic agents|mesh-ancestor
110596327|NCT00128856|Mitosis Modulators|mitosis modulators|mesh-ancestor
110596328|NCT00128856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110596329|NCT00128856|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110596330|NCT00128856|Antimetabolites|antimetabolites|mesh-ancestor
110596331|NCT00128856|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110596332|NCT00128856|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110596333|NCT00128856|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110596334|NCT00128856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110596335|NCT00128778|Doxorubicin|doxorubicin|mesh-list
110596336|NCT00128778|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110596337|NCT00128778|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110596338|NCT00128778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110596339|NCT00128778|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110596340|NCT00128778|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110596341|NCT00128778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110596342|NCT00128778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110596344|NCT00709488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110596345|NCT00709488|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110596346|NCT00709488|Dermatologic Agents|dermatologic agents|mesh-ancestor
110596347|NCT00714246|Carboplatin|carboplatin|mesh-list
110596348|NCT00714246|Docetaxel|docetaxel|mesh-list
110596349|NCT00714246|Bortezomib|bortezomib|mesh-list
110258543|NCT00152022|Sympathomimetics|sympathomimetics|mesh-ancestor
110596350|NCT00714246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110596351|NCT00714246|Tubulin Modulators|tubulin modulators|mesh-ancestor
110596352|NCT00714246|Antimitotic Agents|antimitotic agents|mesh-ancestor
110596353|NCT00714246|Mitosis Modulators|mitosis modulators|mesh-ancestor
110596354|NCT00714246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110596355|NCT00416455|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110596356|NCT00416455|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110596357|NCT00416455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110596358|NCT00415909|Imatinib Mesylate|imatinib mesylate|mesh-list
110596359|NCT00415909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110596360|NCT00415909|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110258601|NCT00521248|Morphine|morphine|mesh-list
110596361|NCT00415909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110596362|NCT00415909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110596363|NCT00709644|Folic Acid|folic acid|mesh-list
110596364|NCT00709644|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110596365|NCT00709644|Norgestimate|norgestimate|mesh-list
110596366|NCT00709644|Estradiol|estradiol|mesh-list
110596367|NCT00709644|Estrogens|estrogens|mesh-ancestor
110596368|NCT00709644|Hormones|hormones|mesh-ancestor
110596369|NCT00709644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110596370|NCT00709644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110596371|NCT00709644|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110596372|NCT00709644|Contraceptive Agents|contraceptive agents|mesh-ancestor
110596373|NCT00709644|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110596374|NCT00709644|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110596376|NCT00709644|Vitamin B Complex|vitamin b complex|mesh-ancestor
110596377|NCT00709644|Vitamins|vitamins|mesh-ancestor
110596378|NCT00709644|Micronutrients|micronutrients|mesh-ancestor
110596379|NCT00709644|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110596380|NCT00709644|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110596381|NCT00709644|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110596383|NCT00415597|Morphine|morphine|mesh-list
110596384|NCT00415597|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110596385|NCT00415597|Narcotics|narcotics|mesh-ancestor
110596386|NCT00415597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110596387|NCT00415597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110596388|NCT00415597|Analgesics|analgesics|mesh-ancestor
110596389|NCT00415597|Sensory System Agents|sensory system agents|mesh-ancestor
110596390|NCT00415597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110596391|NCT00415597|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110596392|NCT00415597|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110596393|NCT00714480|Thymoglobulin|thymoglobulin|mesh-list
110596394|NCT00714480|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110596395|NCT00714480|Immunologic Factors|immunologic factors|mesh-ancestor
110596396|NCT00714480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110596397|NCT00714480|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110596398|NCT00714558|Fentanyl|fentanyl|mesh-list
110596399|NCT00714558|Naltrexone|naltrexone|mesh-list
110596400|NCT00714558|Naloxone|naloxone|mesh-list
110596401|NCT00714558|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110596402|NCT00714558|Narcotics|narcotics|mesh-ancestor
110596403|NCT00714558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110596404|NCT00714558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110596405|NCT00714558|Analgesics|analgesics|mesh-ancestor
110596406|NCT00714558|Sensory System Agents|sensory system agents|mesh-ancestor
110596407|NCT00714558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110596408|NCT00714558|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110596409|NCT00714558|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110596410|NCT00714558|Anesthetics, General|anesthetics, general|mesh-ancestor
110596411|NCT00714558|Anesthetics|anesthetics|mesh-ancestor
110596412|NCT00714558|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110596413|NCT00714558|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110596414|NCT02575638|Camptothecin|camptothecin|mesh-list
110596415|NCT02575638|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110596416|NCT02575638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110596417|NCT02575638|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110596418|NCT02575638|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110258699|NCT00522886|Cetuximab|cetuximab|mesh-list
110596420|NCT02575638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110596421|NCT02573610|Levofloxacin|levofloxacin|mesh-list
110596422|NCT02573610|Ofloxacin|ofloxacin|mesh-list
110596423|NCT02573610|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110596424|NCT02573610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110596425|NCT02573610|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110596426|NCT02573610|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110596427|NCT02573610|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110596428|NCT02573610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110596429|NCT02573610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110596430|NCT02573610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110596431|NCT02573610|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110596432|NCT02573610|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110596434|NCT02574468|Dexamethasone acetate|dexamethasone acetate|mesh-list
110596435|NCT02574468|BB 1101|bb 1101|mesh-list
110596436|NCT02574468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110596437|NCT02574468|Antiemetics|antiemetics|mesh-ancestor
110596438|NCT02574468|Autonomic Agents|autonomic agents|mesh-ancestor
110596439|NCT02574468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110596440|NCT02574468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110377625|NCT01087502|Hormones|hormones|mesh-ancestor
110596441|NCT02574468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110596442|NCT02574468|Glucocorticoids|glucocorticoids|mesh-ancestor
110596443|NCT02574468|Hormones|hormones|mesh-ancestor
110596444|NCT02574468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110243782|NCT00112658|Vitamins|vitamins|mesh-ancestor
110596445|NCT02574468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110596446|NCT02574468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110596447|NCT02574468|Protease Inhibitors|protease inhibitors|mesh-ancestor
110596448|NCT02574468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110596449|NCT02574468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110596450|NCT00710268|Bevacizumab|bevacizumab|mesh-list
110596451|NCT00710268|Olaparib|olaparib|mesh-list
110596452|NCT00710268|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110258820|NCT02952157|Lidocaine|lidocaine|mesh-list
110596453|NCT00710268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110596454|NCT00710268|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110596455|NCT00710268|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110596456|NCT00710268|Growth Substances|growth substances|mesh-ancestor
110596457|NCT00710268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110596458|NCT00710268|Growth Inhibitors|growth inhibitors|mesh-ancestor
110596459|NCT00710268|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110596460|NCT00710268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110596461|NCT00710268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110596462|NCT02575248|Dienogest|dienogest|mesh-list
110596463|NCT02575248|Clomiphene|clomiphene|mesh-list
110596464|NCT02575248|Enclomiphene|enclomiphene|mesh-list
110596465|NCT02575248|Zuclomiphene|zuclomiphene|mesh-list
110596466|NCT02575248|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110596467|NCT02575248|Hormone Antagonists|hormone antagonists|mesh-ancestor
110596468|NCT02575248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110596469|NCT02575248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110596470|NCT02575248|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110596471|NCT02575248|Fertility Agents|fertility agents|mesh-ancestor
110596472|NCT02575248|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110596473|NCT02575248|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110596474|NCT02575248|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110596475|NCT02575248|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110596476|NCT02575248|Contraceptive Agents|contraceptive agents|mesh-ancestor
110596477|NCT02575248|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110596478|NCT02575248|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110596479|NCT02575248|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110596480|NCT02575248|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110596481|NCT02575248|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110596482|NCT02575248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110596483|NCT02575170|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110596484|NCT00710736|Fluorouracil|fluorouracil|mesh-list
110596485|NCT00710736|Capecitabine|capecitabine|mesh-list
110596486|NCT00710736|Antimetabolites|antimetabolites|mesh-ancestor
110596487|NCT00710736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110596488|NCT00710736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110596489|NCT00710736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110596490|NCT00710736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110596491|NCT00710736|Immunologic Factors|immunologic factors|mesh-ancestor
110596492|NCT00710736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110596493|NCT00620542|Atorvastatin|atorvastatin|mesh-list
110596494|NCT00620542|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110596495|NCT00620542|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110596496|NCT00620542|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110596497|NCT00620542|Antimetabolites|antimetabolites|mesh-ancestor
110596498|NCT00620542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110596499|NCT00620542|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110596500|NCT00620542|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110596501|NCT00620542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110596502|NCT04070742|Minocycline|minocycline|mesh-list
110596503|NCT04070742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110596504|NCT04070742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110596506|NCT00851344|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110596507|NCT00851344|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110596508|NCT00851344|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110596509|NCT00851344|Histamine Antagonists|histamine antagonists|mesh-ancestor
110596510|NCT00851344|Histamine Agents|histamine agents|mesh-ancestor
110596511|NCT00851344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110596512|NCT00851344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110596513|NCT00851344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110596514|NCT04523922|Oxytocin|oxytocin|mesh-list
110596515|NCT04523922|Oxytocics|oxytocics|mesh-ancestor
110596516|NCT04523922|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110596517|NCT04523922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110596518|NCT00711204|Donepezil|donepezil|mesh-list
110596519|NCT00711204|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110596520|NCT00711204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110596521|NCT00711204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110596522|NCT00711204|Cholinergic Agents|cholinergic agents|mesh-ancestor
110596523|NCT00711204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110596524|NCT00711204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110596525|NCT00711204|Nootropic Agents|nootropic agents|mesh-ancestor
110596526|NCT05810792|Interleukin-2|interleukin-2|mesh-list
110596527|NCT05810792|Histamine|histamine|mesh-list
110596528|NCT05810792|Histamine phosphate|histamine phosphate|mesh-list
110596529|NCT05810792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110596530|NCT05810792|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110596531|NCT05810792|Analgesics|analgesics|mesh-ancestor
110596532|NCT05810792|Sensory System Agents|sensory system agents|mesh-ancestor
110596533|NCT05810792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110596534|NCT05810792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110596535|NCT05810792|Histamine Agonists|histamine agonists|mesh-ancestor
110596536|NCT05810792|Histamine Agents|histamine agents|mesh-ancestor
110596537|NCT05810792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110596538|NCT05810792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110596539|NCT05810571|Morphine|morphine|mesh-list
110596540|NCT05810571|Remifentanil|remifentanil|mesh-list
110596541|NCT05810571|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110596542|NCT05810571|Narcotics|narcotics|mesh-ancestor
110596543|NCT05810571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110596544|NCT05810571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110596545|NCT05810571|Analgesics|analgesics|mesh-ancestor
110596546|NCT05810571|Sensory System Agents|sensory system agents|mesh-ancestor
110596547|NCT05810571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110596549|NCT05810558|Glycine Agents|glycine agents|mesh-ancestor
110596550|NCT05810558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110596551|NCT05810558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110596552|NCT05810558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110596553|NCT05810389|Fluorides|fluorides|mesh-list
110596554|NCT05810389|Cariostatic Agents|cariostatic agents|mesh-ancestor
110596555|NCT05810389|Protective Agents|protective agents|mesh-ancestor
110596556|NCT05810389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110596557|NCT05809986|Ofatumumab|ofatumumab|mesh-list
110258928|NCT00167583|Antiviral Agents|antiviral agents|mesh-ancestor
110596558|NCT05809986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110596559|NCT05809869|Durvalumab|durvalumab|mesh-list
110596560|NCT05809869|Tremelimumab|tremelimumab|mesh-list
110596561|NCT05809869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110596562|NCT05809869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110596563|NCT05809843|Pancrelipase|pancrelipase|mesh-list
110596564|NCT05809843|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110596565|NCT05809804|Esketamine|esketamine|mesh-list
110596566|NCT05809804|Antidepressive Agents|antidepressive agents|mesh-ancestor
110596567|NCT05809804|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110596568|NCT05809609|Ketamine|ketamine|mesh-list
110596569|NCT05809609|Analgesics|analgesics|mesh-ancestor
110596570|NCT05809609|Sensory System Agents|sensory system agents|mesh-ancestor
110596571|NCT05809609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110596572|NCT05809609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110596573|NCT05809609|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110596574|NCT05809609|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110596576|NCT05809609|Anesthetics|anesthetics|mesh-ancestor
110596577|NCT05809609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110596578|NCT05809609|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110596579|NCT05809609|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110596580|NCT05809609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110596581|NCT05809609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110596582|NCT05809518|Dexmedetomidine|dexmedetomidine|mesh-list
110596583|NCT05809518|Propofol|propofol|mesh-list
110596584|NCT05809518|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110596585|NCT05809518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110596586|NCT05809518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110596587|NCT05809518|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110596588|NCT05809518|Analgesics|analgesics|mesh-ancestor
110596589|NCT05809518|Sensory System Agents|sensory system agents|mesh-ancestor
110596590|NCT05809518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110596591|NCT05809518|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110596592|NCT05809518|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110243927|NCT00353041|Lidocaine|lidocaine|mesh-list
110596593|NCT05809518|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110596594|NCT05809518|Adrenergic Agents|adrenergic agents|mesh-ancestor
110596595|NCT05809518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110596596|NCT05809518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110596597|NCT05809518|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110596598|NCT05809518|Anesthetics, General|anesthetics, general|mesh-ancestor
110596599|NCT05809518|Anesthetics|anesthetics|mesh-ancestor
110596600|NCT05809414|Amantadine|amantadine|mesh-list
110596601|NCT05809414|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110596602|NCT05809414|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110596603|NCT05809414|Antiviral Agents|antiviral agents|mesh-ancestor
110596604|NCT05809414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110596605|NCT05809414|Dopamine Agents|dopamine agents|mesh-ancestor
110596606|NCT05809414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110596607|NCT05809414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110596608|NCT05809414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110596609|NCT05809414|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110596610|NCT05809414|Analgesics|analgesics|mesh-ancestor
110596611|NCT05809414|Sensory System Agents|sensory system agents|mesh-ancestor
110596612|NCT05809414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110596613|NCT05809336|Pembrolizumab|pembrolizumab|mesh-list
110596614|NCT05809336|Atezolizumab|atezolizumab|mesh-list
110596615|NCT05809336|Tislelizumab|tislelizumab|mesh-list
110596616|NCT05809336|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
110596617|NCT05809336|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110596618|NCT05809336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110596619|NCT05809336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110596620|NCT05809336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110596621|NCT05809336|Immunologic Factors|immunologic factors|mesh-ancestor
110596622|NCT05809336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110596623|NCT05809271|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
110596624|NCT05809271|Hallucinogens|hallucinogens|mesh-ancestor
110596625|NCT05809271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110596626|NCT05809271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110596627|NCT05809271|Serotonin Agents|serotonin agents|mesh-ancestor
110596628|NCT05809271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110596629|NCT05809271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110596630|NCT05809271|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110596631|NCT05809271|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110596632|NCT05809271|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110596633|NCT05809271|Adrenergic Agents|adrenergic agents|mesh-ancestor
110596634|NCT05809024|Letrozole|letrozole|mesh-list
110596635|NCT05809024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110596636|NCT05809024|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110596637|NCT05809024|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110596638|NCT05809024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110596639|NCT05809024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110596640|NCT05809024|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110596641|NCT05809024|Hormone Antagonists|hormone antagonists|mesh-ancestor
110596642|NCT05809024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110596643|NCT05809024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110596644|NCT05808985|Butyric Acid|butyric acid|mesh-list
110596645|NCT05808985|Histamine Antagonists|histamine antagonists|mesh-ancestor
110596646|NCT05808985|Histamine Agents|histamine agents|mesh-ancestor
110596647|NCT05808985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110596648|NCT05808985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110596649|NCT05808985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110596650|NCT05808972|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110596651|NCT05808946|Thioctic Acid|thioctic acid|mesh-list
110596652|NCT05808946|Antioxidants|antioxidants|mesh-ancestor
110596653|NCT05808946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110596654|NCT05808946|Protective Agents|protective agents|mesh-ancestor
110596655|NCT05808946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110596656|NCT05808946|Vitamin B Complex|vitamin b complex|mesh-ancestor
110596658|NCT05808946|Micronutrients|micronutrients|mesh-ancestor
110596659|NCT05764876|Azithromycin|azithromycin|mesh-list
110596660|NCT05764876|Linezolid|linezolid|mesh-list
110596661|NCT05764876|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110596662|NCT05764876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110596663|NCT05764876|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110596664|NCT05764876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110596665|NCT05764876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110596667|NCT05737576|Insulin, Long-Acting|insulin, long-acting|mesh-list
110596668|NCT05737576|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
110596669|NCT05737576|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110596670|NCT05737576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110596672|NCT05720988|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110596673|NCT05720988|Antimetabolites|antimetabolites|mesh-ancestor
110596674|NCT05720988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110596675|NCT05720988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110596676|NCT05720988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110596677|NCT05716763|Tramadol|tramadol|mesh-list
110596678|NCT05716763|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110596679|NCT05716763|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110596680|NCT05716763|Narcotics|narcotics|mesh-ancestor
110259119|NCT02947711|Vasodilator Agents|vasodilator agents|mesh-ancestor
110259132|NCT04723563|Heparin|heparin|mesh-list
110596681|NCT05716763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110596682|NCT05716763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110596683|NCT05716763|Analgesics|analgesics|mesh-ancestor
110596684|NCT05716763|Sensory System Agents|sensory system agents|mesh-ancestor
110596685|NCT05716763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110596686|NCT05716503|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110596687|NCT05716503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110596695|NCT05696938|Niacinamide|niacinamide|mesh-list
110596696|NCT05696938|Niacin|niacin|mesh-list
110596697|NCT05696938|Nicotinic Acids|nicotinic acids|mesh-list
110596698|NCT05696938|Vitamin B Complex|vitamin b complex|mesh-ancestor
110596699|NCT05696938|Vitamins|vitamins|mesh-ancestor
110596700|NCT05696938|Micronutrients|micronutrients|mesh-ancestor
110596701|NCT05696938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110596702|NCT05696938|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110596703|NCT05696938|Antimetabolites|antimetabolites|mesh-ancestor
110596704|NCT05696938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110596705|NCT05696938|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110596706|NCT05696938|Vasodilator Agents|vasodilator agents|mesh-ancestor
110596707|NCT05695508|Dexamethasone|dexamethasone|mesh-list
110596708|NCT05695508|Lenalidomide|lenalidomide|mesh-list
110596709|NCT05695508|Bortezomib|bortezomib|mesh-list
110596710|NCT05695508|Daratumumab|daratumumab|mesh-list
110596711|NCT05695508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110596713|NCT05695508|Autonomic Agents|autonomic agents|mesh-ancestor
110596714|NCT05695508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110596715|NCT05695508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110596716|NCT05695508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110596717|NCT05695508|Glucocorticoids|glucocorticoids|mesh-ancestor
110596718|NCT05695508|Hormones|hormones|mesh-ancestor
110596719|NCT05695508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110596720|NCT05695508|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110596721|NCT05695508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110596722|NCT05695508|Immunologic Factors|immunologic factors|mesh-ancestor
110596723|NCT05695508|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110596724|NCT05695508|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110596725|NCT05695508|Growth Substances|growth substances|mesh-ancestor
110596726|NCT05695508|Growth Inhibitors|growth inhibitors|mesh-ancestor
110596727|NCT05679908|Oxytocin|oxytocin|mesh-list
110596728|NCT05679908|Oxytocics|oxytocics|mesh-ancestor
110596729|NCT05679908|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110596730|NCT05679908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110259216|NCT00168012|Antibodies|antibodies|mesh-list
110596731|NCT05648435|Lithium Carbonate|lithium carbonate|mesh-list
110596732|NCT05648435|Antidepressive Agents|antidepressive agents|mesh-ancestor
110596733|NCT05648435|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110596734|NCT05648435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110151238|NCT00000892|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110596735|NCT05648435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110596736|NCT05648435|Antimanic Agents|antimanic agents|mesh-ancestor
110596737|NCT05648435|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110596738|NCT05648435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110596739|NCT05648435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110596740|NCT05642767|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110596741|NCT05642767|Cetrimonium|cetrimonium|mesh-list
110596742|NCT05642767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110596743|NCT05642767|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110596744|NCT05624138|Leucovorin|leucovorin|mesh-list
110596745|NCT05624138|Ketotifen|ketotifen|mesh-list
110596746|NCT05624138|Fluorouracil|fluorouracil|mesh-list
110596747|NCT05624138|Oxaliplatin|oxaliplatin|mesh-list
110596748|NCT05624138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110596749|NCT05624138|Antimetabolites|antimetabolites|mesh-ancestor
110596750|NCT05624138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110596751|NCT05624138|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110596752|NCT05624138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110596753|NCT05624138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110596754|NCT05624138|Immunologic Factors|immunologic factors|mesh-ancestor
110596755|NCT05624138|Antidotes|antidotes|mesh-ancestor
110596756|NCT05624138|Protective Agents|protective agents|mesh-ancestor
110596757|NCT05624138|Vitamin B Complex|vitamin b complex|mesh-ancestor
110596758|NCT05624138|Vitamins|vitamins|mesh-ancestor
110596759|NCT05624138|Micronutrients|micronutrients|mesh-ancestor
110596760|NCT05624138|Antipruritics|antipruritics|mesh-ancestor
110596761|NCT05624138|Dermatologic Agents|dermatologic agents|mesh-ancestor
110596762|NCT05624138|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110596763|NCT05624138|Histamine Antagonists|histamine antagonists|mesh-ancestor
110596764|NCT05624138|Histamine Agents|histamine agents|mesh-ancestor
110596765|NCT05624138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110596766|NCT05624138|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110596767|NCT05610800|Exenatide|exenatide|mesh-list
110596768|NCT05610800|Nicotine|nicotine|mesh-list
110596769|NCT05610800|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110596770|NCT05610800|Autonomic Agents|autonomic agents|mesh-ancestor
110596771|NCT05610800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110596772|NCT05610800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110596773|NCT05610800|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110596774|NCT05610800|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110596775|NCT05610800|Cholinergic Agents|cholinergic agents|mesh-ancestor
110596776|NCT05610800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110596777|NCT05610800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110596778|NCT05610800|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110596779|NCT05610800|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110596781|NCT05610800|Hormones|hormones|mesh-ancestor
110596782|NCT05610800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110596783|NCT05605080|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
110596784|NCT05605080|Hemostatics|hemostatics|mesh-ancestor
110596785|NCT05605080|Coagulants|coagulants|mesh-ancestor
110596786|NCT05596383|Vitamin D|vitamin d|mesh-list
110596787|NCT05596383|Vitamins|vitamins|mesh-ancestor
110596788|NCT05596383|Micronutrients|micronutrients|mesh-ancestor
110596789|NCT05596383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110596790|NCT05596383|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110596791|NCT05594745|Lifitegrast|lifitegrast|mesh-list
110596792|NCT05594745|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110596793|NCT05594745|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110596794|NCT05568953|Vaccines|vaccines|mesh-list
110596795|NCT05568953|Immunologic Factors|immunologic factors|mesh-ancestor
110596796|NCT05568953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110596797|NCT05556200|Apatinib|apatinib|mesh-list
110596798|NCT05556200|Antibodies|antibodies|mesh-list
110596799|NCT05556200|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110596800|NCT05556200|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
110596801|NCT05556200|Immunologic Factors|immunologic factors|mesh-ancestor
110596802|NCT05556200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110596803|NCT05556200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110596804|NCT05556200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110596805|NCT05556200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110151242|NCT00000895|Azithromycin|azithromycin|mesh-list
110596806|NCT05556200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110596808|NCT05532215|Oxytocin|oxytocin|mesh-list
110596809|NCT05532215|Oxytocics|oxytocics|mesh-ancestor
110596810|NCT05532215|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110596811|NCT05532215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110596812|NCT05532215|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110596813|NCT05532215|Abortifacient Agents|abortifacient agents|mesh-ancestor
110596814|NCT05532215|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110596815|NCT05532215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110259436|NCT00527059|Diuretics|diuretics|mesh-ancestor
110596817|NCT05516654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110596818|NCT05505552|Vitamin K|vitamin k|mesh-list
110596819|NCT05505552|Vitamin K 1|vitamin k 1|mesh-list
110596820|NCT05505552|Vitamins|vitamins|mesh-ancestor
110596821|NCT05505552|Micronutrients|micronutrients|mesh-ancestor
110596822|NCT05505552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110596823|NCT05505552|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110596824|NCT05505552|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110596825|NCT05505552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110596826|NCT05505552|Hemostatics|hemostatics|mesh-ancestor
110596827|NCT05505552|Coagulants|coagulants|mesh-ancestor
110596828|NCT05471947|Glycolic acid|glycolic acid|mesh-list
110596829|NCT05471947|Keratolytic Agents|keratolytic agents|mesh-ancestor
110596830|NCT05471947|Dermatologic Agents|dermatologic agents|mesh-ancestor
110596831|NCT05463601|Tamoxifen|tamoxifen|mesh-list
110596832|NCT05463601|Letrozole|letrozole|mesh-list
110596833|NCT05463601|Fulvestrant|fulvestrant|mesh-list
110596834|NCT05463601|Exemestane|exemestane|mesh-list
110596835|NCT05463601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110596836|NCT05463601|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110596837|NCT05463601|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110596838|NCT05463601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110377682|NCT01085201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110596839|NCT05463601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110596840|NCT05463601|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110596841|NCT05463601|Hormone Antagonists|hormone antagonists|mesh-ancestor
110596842|NCT05463601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110596843|NCT05463601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110596844|NCT05463601|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110596845|NCT05463601|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110596846|NCT05463601|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110596847|NCT05463601|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110596848|NCT05463601|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110596849|NCT05438082|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110596850|NCT05438082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110596851|NCT05395195|Epoetin Alfa|epoetin alfa|mesh-list
110596852|NCT05395195|Hematinics|hematinics|mesh-ancestor
110596853|NCT05391360|Entecavir|entecavir|mesh-list
110596854|NCT05391360|Antiviral Agents|antiviral agents|mesh-ancestor
110596855|NCT05391360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110596856|NCT05372887|Cyclobenzaprine|cyclobenzaprine|mesh-list
110596857|NCT05372887|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110596858|NCT05372887|Antidepressive Agents|antidepressive agents|mesh-ancestor
110596859|NCT05372887|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110596860|NCT05372887|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110259533|NCT00516490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110596861|NCT05372887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110596863|NCT05372887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110596864|NCT05372887|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110596865|NCT05372887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110596866|NCT05366764|Albuterol|albuterol|mesh-list
110596867|NCT05366764|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110596868|NCT05366764|Autonomic Agents|autonomic agents|mesh-ancestor
110596869|NCT05366764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110596870|NCT05366764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110596871|NCT05366764|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110596872|NCT05366764|Respiratory System Agents|respiratory system agents|mesh-ancestor
110596873|NCT05366764|Tocolytic Agents|tocolytic agents|mesh-ancestor
110596874|NCT05366764|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110596875|NCT05366764|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110596876|NCT05366764|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110259587|NCT00173745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110596877|NCT05366764|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110596878|NCT05366764|Adrenergic Agents|adrenergic agents|mesh-ancestor
110596880|NCT05366764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110596882|NCT05359835|Calcium|calcium|mesh-list
110596883|NCT05359835|Pentetic Acid|pentetic acid|mesh-list
110596884|NCT05359835|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110596885|NCT05359835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110596886|NCT05359835|Antidotes|antidotes|mesh-ancestor
110596887|NCT05359835|Protective Agents|protective agents|mesh-ancestor
110596888|NCT05359835|Chelating Agents|chelating agents|mesh-ancestor
110596889|NCT05359835|Sequestering Agents|sequestering agents|mesh-ancestor
110596890|NCT05359835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110596891|NCT05359835|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110596892|NCT05359835|Anticoagulants|anticoagulants|mesh-ancestor
110596893|NCT05359835|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110596894|NCT05355051|Pembrolizumab|pembrolizumab|mesh-list
110596895|NCT05355051|Azacitidine|azacitidine|mesh-list
110596896|NCT05355051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110596897|NCT05355051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110596899|NCT05355051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110596900|NCT05355051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110596902|NCT05355051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110596904|NCT05335148|Gout Suppressants|gout suppressants|mesh-ancestor
110596905|NCT05335148|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110596906|NCT05335148|Tubulin Modulators|tubulin modulators|mesh-ancestor
110596907|NCT05335148|Antimitotic Agents|antimitotic agents|mesh-ancestor
110596908|NCT05335148|Mitosis Modulators|mitosis modulators|mesh-ancestor
110596909|NCT05335148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110596910|NCT05335148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110596911|NCT05314933|Deoxyglucose|deoxyglucose|mesh-list
110596912|NCT05314933|Antimetabolites|antimetabolites|mesh-ancestor
110596913|NCT05314933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110596914|NCT05314933|Antiviral Agents|antiviral agents|mesh-ancestor
110596915|NCT05314933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110596916|NCT05303844|Tislelizumab|tislelizumab|mesh-list
110596917|NCT05303844|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110596918|NCT05303844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110596919|NCT05260606|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110596920|NCT05260606|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110596921|NCT05260606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110596922|NCT05236946|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
110596923|NCT05236946|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110596924|NCT05236946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110596925|NCT05236946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110596926|NCT05222932|Avelumab|avelumab|mesh-list
110596927|NCT05222932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110596928|NCT05222932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110596929|NCT05216419|Cholecalciferol|cholecalciferol|mesh-list
110596930|NCT05216419|Vitamin D|vitamin d|mesh-list
110596931|NCT05216419|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110596932|NCT05216419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110596933|NCT05216419|Vitamins|vitamins|mesh-ancestor
110596934|NCT05216419|Micronutrients|micronutrients|mesh-ancestor
110596935|NCT05216419|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110596936|NCT05117034|Morphine|morphine|mesh-list
110596937|NCT05117034|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110596938|NCT05117034|Narcotics|narcotics|mesh-ancestor
110596939|NCT05117034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110596940|NCT05117034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110596941|NCT05117034|Analgesics|analgesics|mesh-ancestor
110596942|NCT05117034|Sensory System Agents|sensory system agents|mesh-ancestor
110596943|NCT05117034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110596944|NCT05093920|Doxorubicin|doxorubicin|mesh-list
110596945|NCT05093920|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110596946|NCT05093920|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110596947|NCT05093920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110596948|NCT05093920|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110596949|NCT05093920|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110596950|NCT05093920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110596951|NCT05093920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110596953|NCT05068752|Vemurafenib|vemurafenib|mesh-list
110596954|NCT05068752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110596955|NCT05068752|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110596956|NCT05068752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110596957|NCT05068752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110596958|NCT05052879|Tadalafil|tadalafil|mesh-list
110596959|NCT05052879|Vasodilator Agents|vasodilator agents|mesh-ancestor
110596960|NCT05052879|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110596961|NCT05052879|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110596962|NCT05052879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110596963|NCT05052879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110596964|NCT05052879|Urological Agents|urological agents|mesh-ancestor
110596965|NCT05049707|Magnesium Sulfate|magnesium sulfate|mesh-list
110596966|NCT05049707|Analgesics|analgesics|mesh-ancestor
110596967|NCT05049707|Sensory System Agents|sensory system agents|mesh-ancestor
110596968|NCT05049707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110596969|NCT05049707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110596970|NCT05049707|Anesthetics|anesthetics|mesh-ancestor
110596971|NCT05049707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110596972|NCT05049707|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110596973|NCT05049707|Anticonvulsants|anticonvulsants|mesh-ancestor
110596974|NCT05049707|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110596975|NCT05049707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110596976|NCT05049707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110596977|NCT05049707|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110596978|NCT05049707|Tocolytic Agents|tocolytic agents|mesh-ancestor
110596979|NCT05049707|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110596980|NCT05043805|Dextromethorphan|dextromethorphan|mesh-list
110596981|NCT05043805|Antitussive Agents|antitussive agents|mesh-ancestor
110596982|NCT05043805|Respiratory System Agents|respiratory system agents|mesh-ancestor
110596983|NCT05043805|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110259924|NCT00528151|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110596984|NCT05043805|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110596985|NCT05043805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110596986|NCT05043805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110596987|NCT05043805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110596988|NCT05042687|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
110596989|NCT05042687|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110596990|NCT05042687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110596991|NCT05036109|Aspirin|aspirin|mesh-list
110596992|NCT05036109|Vitamin D|vitamin d|mesh-list
110596993|NCT05036109|Vitamins|vitamins|mesh-ancestor
110596994|NCT05036109|Micronutrients|micronutrients|mesh-ancestor
110596995|NCT05036109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110596996|NCT05036109|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110596997|NCT05036109|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110596998|NCT05036109|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110596999|NCT05036109|Analgesics|analgesics|mesh-ancestor
110597000|NCT05036109|Sensory System Agents|sensory system agents|mesh-ancestor
110597001|NCT05036109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110597002|NCT05036109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110597003|NCT05036109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110597004|NCT05036109|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110597005|NCT05036109|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110597006|NCT05036109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110597007|NCT05036109|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110259983|NCT00144989|Cisplatin|cisplatin|mesh-list
110597008|NCT05036109|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110597009|NCT05036109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110597010|NCT05036109|Antipyretics|antipyretics|mesh-ancestor
110597011|NCT05033483|Ferrous fumarate|ferrous fumarate|mesh-list
110597012|NCT05033483|Trace Elements|trace elements|mesh-ancestor
110597013|NCT05033483|Micronutrients|micronutrients|mesh-ancestor
110597014|NCT05033483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110597015|NCT04999969|Paclitaxel|paclitaxel|mesh-list
110597016|NCT04999969|Gemcitabine|gemcitabine|mesh-list
110597017|NCT04999969|Durvalumab|durvalumab|mesh-list
110597018|NCT04999969|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110597019|NCT04999969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110597020|NCT04999969|Tubulin Modulators|tubulin modulators|mesh-ancestor
110597021|NCT04999969|Antimitotic Agents|antimitotic agents|mesh-ancestor
110597022|NCT04999969|Mitosis Modulators|mitosis modulators|mesh-ancestor
110597023|NCT04999969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110597024|NCT04999969|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110597025|NCT04999969|Antimetabolites|antimetabolites|mesh-ancestor
110597026|NCT04999969|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110597027|NCT04982913|Oseltamivir|oseltamivir|mesh-list
110597028|NCT04982913|Antiviral Agents|antiviral agents|mesh-ancestor
110597029|NCT04982913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110597030|NCT04982913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110597031|NCT04982913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110597033|NCT04981899|Nivolumab|nivolumab|mesh-list
110597035|NCT04981899|Ifosfamide|ifosfamide|mesh-list
110597036|NCT04981899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110597037|NCT04981899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110597038|NCT04981899|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110597039|NCT04981899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110597040|NCT04981899|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110597041|NCT04981899|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110597042|NCT04981899|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110597043|NCT04981899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110597044|NCT04981899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110597045|NCT04981899|Alkylating Agents|alkylating agents|mesh-ancestor
110597047|NCT04977830|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110597048|NCT04977830|Anesthetics, General|anesthetics, general|mesh-ancestor
110597049|NCT04977830|Anesthetics|anesthetics|mesh-ancestor
110597050|NCT04977830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110244396|NCT00446173|Busulfan|busulfan|mesh-list
110597051|NCT04977830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110597052|NCT04929600|Amlodipine|amlodipine|mesh-list
110597053|NCT04929600|Valsartan|valsartan|mesh-list
110597054|NCT04929600|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
110597055|NCT04929600|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110597056|NCT04929600|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110597057|NCT04929600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110597058|NCT04929600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110597059|NCT04929600|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110260142|NCT00530140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110597060|NCT04929600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110597061|NCT04929600|Vasodilator Agents|vasodilator agents|mesh-ancestor
110597062|NCT04929600|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110597063|NCT04929600|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110597064|NCT04925648|Dasatinib|dasatinib|mesh-list
110597065|NCT04925648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110597066|NCT04925648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110597067|NCT04925648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110597068|NCT04925648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110597069|NCT04904536|Atorvastatin|atorvastatin|mesh-list
110597070|NCT04904536|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110597071|NCT04904536|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110597072|NCT04904536|Antimetabolites|antimetabolites|mesh-ancestor
110597073|NCT04904536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110597074|NCT04904536|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110260273|NCT00531973|Epirubicin|epirubicin|mesh-list
110597075|NCT04904536|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110597076|NCT04904536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110597077|NCT04899479|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
110597078|NCT04899479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110597079|NCT04899479|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110597080|NCT04899479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110597081|NCT04852367|Doxorubicin|doxorubicin|mesh-list
110597082|NCT04852367|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110597083|NCT04852367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110597084|NCT04852367|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110597085|NCT04852367|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110597086|NCT04852367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110377732|NCT01084655|Tubulin Modulators|tubulin modulators|mesh-ancestor
110597087|NCT04852367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110597089|NCT04824417|Voriconazole|voriconazole|mesh-list
110597090|NCT04824417|Antifungal Agents|antifungal agents|mesh-ancestor
110597091|NCT04824417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110597092|NCT04824417|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110597093|NCT04824417|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110597094|NCT04824417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110597095|NCT04824417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110597096|NCT04824417|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110597097|NCT04824417|Hormone Antagonists|hormone antagonists|mesh-ancestor
110597098|NCT04824417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110597099|NCT04824417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110597100|NCT04824417|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110597101|NCT04727996|Tislelizumab|tislelizumab|mesh-list
110597102|NCT04727996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110597103|NCT04727996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110597104|NCT04720781|Esomeprazole|esomeprazole|mesh-list
110597105|NCT04720781|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110597106|NCT04720781|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110597107|NCT04720781|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110597108|NCT04720781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110260391|NCT00169182|Antimetabolites|antimetabolites|mesh-ancestor
110597109|NCT04720781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110597110|NCT04692623|Insulin|insulin|mesh-list
110597111|NCT04692623|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110597112|NCT04692623|Moxifloxacin|moxifloxacin|mesh-list
110597113|NCT04692623|Gemifloxacin|gemifloxacin|mesh-list
110597114|NCT04692623|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110597115|NCT04692623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110597116|NCT04692623|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110597117|NCT04692623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110597118|NCT04692623|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110597119|NCT04692623|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110597120|NCT04692623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110597121|NCT04692623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110597122|NCT04692623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110597123|NCT04690608|Triamcinolone|triamcinolone|mesh-list
110597124|NCT04690608|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110260456|NCT00145925|Diuretics|diuretics|mesh-ancestor
110597125|NCT04690608|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110597126|NCT04690608|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110597127|NCT04690608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110597128|NCT04690608|Glucocorticoids|glucocorticoids|mesh-ancestor
110597130|NCT04690608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110597131|NCT04690608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110597132|NCT04690608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110597133|NCT04690608|Immunologic Factors|immunologic factors|mesh-ancestor
110597134|NCT04690608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110597135|NCT04690608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110597136|NCT04684238|Midazolam|midazolam|mesh-list
110597137|NCT04684238|Isoflurane|isoflurane|mesh-list
110597138|NCT04684238|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110597139|NCT04684238|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110597140|NCT04684238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110597141|NCT04684238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110597142|NCT04684238|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110597143|NCT04684238|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110597144|NCT04684238|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110597145|NCT04684238|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110597147|NCT04684238|Anesthetics|anesthetics|mesh-ancestor
110597148|NCT04684238|GABA Modulators|gaba modulators|mesh-ancestor
110597149|NCT04684238|GABA Agents|gaba agents|mesh-ancestor
110597150|NCT04684238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110597151|NCT04684238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110597152|NCT04684238|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110597154|NCT04586348|Cadexomer iodine|cadexomer iodine|mesh-list
110597155|NCT04586348|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110597156|NCT04586348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110597157|NCT04586348|Trace Elements|trace elements|mesh-ancestor
110597158|NCT04586348|Micronutrients|micronutrients|mesh-ancestor
110597159|NCT04586348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110597160|NCT04577001|Letrozole|letrozole|mesh-list
110597161|NCT04577001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110597162|NCT04577001|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110597163|NCT04577001|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110597164|NCT04577001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110597165|NCT04577001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110597166|NCT04577001|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110597167|NCT04577001|Hormone Antagonists|hormone antagonists|mesh-ancestor
110597168|NCT04577001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110597169|NCT04577001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110597171|NCT04576078|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110597172|NCT04576078|Analgesics|analgesics|mesh-ancestor
110597173|NCT04576078|Sensory System Agents|sensory system agents|mesh-ancestor
110597174|NCT04576078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110597175|NCT04576078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110597176|NCT04561557|Cyclophosphamide|cyclophosphamide|mesh-list
110597177|NCT04561557|Fludarabine|fludarabine|mesh-list
110597178|NCT04561557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110597179|NCT04561557|Immunologic Factors|immunologic factors|mesh-ancestor
110597180|NCT04561557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110597181|NCT04561557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110260621|NCT00146276|Antimetabolites|antimetabolites|mesh-ancestor
110597182|NCT04561557|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110597183|NCT04561557|Alkylating Agents|alkylating agents|mesh-ancestor
110597184|NCT04561557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110597185|NCT04561557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110597186|NCT04561557|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110597188|NCT04561375|Sufentanil|sufentanil|mesh-list
110597189|NCT04561375|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110597190|NCT04561375|Narcotics|narcotics|mesh-ancestor
110597191|NCT04561375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110597192|NCT04561375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110597193|NCT04561375|Analgesics|analgesics|mesh-ancestor
110597194|NCT04561375|Sensory System Agents|sensory system agents|mesh-ancestor
110597195|NCT04561375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110597196|NCT04561375|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110244522|NCT00446953|Hormones|hormones|mesh-ancestor
110597197|NCT04561375|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110597198|NCT04561375|Anesthetics, General|anesthetics, general|mesh-ancestor
110597199|NCT04561375|Anesthetics|anesthetics|mesh-ancestor
110597200|NCT04560127|Apatinib|apatinib|mesh-list
110597201|NCT04560127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110597202|NCT04560127|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110597203|NCT04560127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110260681|NCT02940379|Anesthetics|anesthetics|mesh-ancestor
110597204|NCT04560127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110597206|NCT04536532|Antiviral Agents|antiviral agents|mesh-ancestor
110597207|NCT04536532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110597208|NCT04509115|Analgesics, Opioid|analgesics, opioid|mesh-list
110597209|NCT04509115|Narcotics|narcotics|mesh-ancestor
110597210|NCT04509115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110597211|NCT04509115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110597212|NCT04509115|Analgesics|analgesics|mesh-ancestor
110597213|NCT04509115|Sensory System Agents|sensory system agents|mesh-ancestor
110260740|NCT00175032|Celecoxib|celecoxib|mesh-list
110597214|NCT04509115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110597216|NCT04508634|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110597217|NCT04508634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110597218|NCT04489771|Belzutifan|belzutifan|mesh-list
110597220|NCT04480502|Ipilimumab|ipilimumab|mesh-list
110597221|NCT04480502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110597222|NCT04480502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110597223|NCT04480502|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110377755|NCT04552431|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110597224|NCT04480502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110597225|NCT04447092|Leucovorin|leucovorin|mesh-list
110597226|NCT04447092|Paclitaxel|paclitaxel|mesh-list
110597227|NCT04447092|Gemcitabine|gemcitabine|mesh-list
110597228|NCT04447092|Pembrolizumab|pembrolizumab|mesh-list
110597229|NCT04447092|Oxaliplatin|oxaliplatin|mesh-list
110597230|NCT04447092|Irinotecan|irinotecan|mesh-list
110597231|NCT04447092|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110597232|NCT04447092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110597234|NCT04447092|Antimitotic Agents|antimitotic agents|mesh-ancestor
110597235|NCT04447092|Mitosis Modulators|mitosis modulators|mesh-ancestor
110597236|NCT04447092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110597237|NCT04447092|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110597238|NCT04447092|Antimetabolites|antimetabolites|mesh-ancestor
110597239|NCT04447092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110597240|NCT04447092|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110597241|NCT04447092|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110597242|NCT04447092|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110597243|NCT04447092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110597244|NCT04447092|Antidotes|antidotes|mesh-ancestor
110597245|NCT04447092|Protective Agents|protective agents|mesh-ancestor
110597246|NCT04447092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110597247|NCT04447092|Vitamin B Complex|vitamin b complex|mesh-ancestor
110597248|NCT04447092|Vitamins|vitamins|mesh-ancestor
110597249|NCT04447092|Micronutrients|micronutrients|mesh-ancestor
110597250|NCT04398524|Cemiplimab|cemiplimab|mesh-list
110597251|NCT04398524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110597252|NCT04398524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110597253|NCT04371224|Leucovorin|leucovorin|mesh-list
110597254|NCT04371224|Fluorouracil|fluorouracil|mesh-list
110597255|NCT04371224|Capecitabine|capecitabine|mesh-list
110597256|NCT04371224|Irinotecan|irinotecan|mesh-list
110597257|NCT04371224|Antimetabolites|antimetabolites|mesh-ancestor
110597258|NCT04371224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110597259|NCT04371224|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110597260|NCT04371224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110597261|NCT04371224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110597262|NCT04371224|Immunologic Factors|immunologic factors|mesh-ancestor
110597263|NCT04371224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110597264|NCT04371224|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110597265|NCT04371224|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110597266|NCT04371224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110597267|NCT04371224|Antidotes|antidotes|mesh-ancestor
110597268|NCT04371224|Protective Agents|protective agents|mesh-ancestor
110597269|NCT04371224|Vitamin B Complex|vitamin b complex|mesh-ancestor
110597270|NCT04371224|Vitamins|vitamins|mesh-ancestor
110597271|NCT04371224|Micronutrients|micronutrients|mesh-ancestor
110597272|NCT04306900|Paclitaxel|paclitaxel|mesh-list
110597273|NCT04306900|Docetaxel|docetaxel|mesh-list
110597274|NCT04306900|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110597275|NCT04306900|Gemcitabine|gemcitabine|mesh-list
110597276|NCT04306900|Pembrolizumab|pembrolizumab|mesh-list
110597277|NCT04306900|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110597278|NCT04306900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110260899|NCT00175227|Diuretics|diuretics|mesh-ancestor
110597279|NCT04306900|Tubulin Modulators|tubulin modulators|mesh-ancestor
110597280|NCT04306900|Antimitotic Agents|antimitotic agents|mesh-ancestor
110597281|NCT04306900|Mitosis Modulators|mitosis modulators|mesh-ancestor
110597282|NCT04306900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110597283|NCT04306900|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110597284|NCT04306900|Antimetabolites|antimetabolites|mesh-ancestor
110597285|NCT04306900|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110597286|NCT04306900|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110597287|NCT04288687|Niraparib|niraparib|mesh-list
110597288|NCT04288687|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110597289|NCT04288687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110597290|NCT04288687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110597291|NCT04288687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110597292|NCT04231708|Hydrocortisone|hydrocortisone|mesh-list
110597293|NCT04231708|Yohimbine|yohimbine|mesh-list
110597294|NCT04231708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110597295|NCT04231708|Mydriatics|mydriatics|mesh-ancestor
110597296|NCT04231708|Autonomic Agents|autonomic agents|mesh-ancestor
110597297|NCT04231708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110597298|NCT04231708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110597299|NCT04231708|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
110597300|NCT04231708|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110597301|NCT04231708|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110597302|NCT04231708|Adrenergic Agents|adrenergic agents|mesh-ancestor
110597303|NCT04231708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110597304|NCT04231708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110597305|NCT04231708|Urological Agents|urological agents|mesh-ancestor
110597306|NCT04218786|Colchicine|colchicine|mesh-list
110597307|NCT04218786|Gout Suppressants|gout suppressants|mesh-ancestor
110597308|NCT04218786|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110597309|NCT04218786|Tubulin Modulators|tubulin modulators|mesh-ancestor
110597310|NCT04218786|Antimitotic Agents|antimitotic agents|mesh-ancestor
110597311|NCT04218786|Mitosis Modulators|mitosis modulators|mesh-ancestor
110597312|NCT04218786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110597313|NCT04218786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110597314|NCT04216524|Cytarabine|cytarabine|mesh-list
110597315|NCT04216524|Dexamethasone|dexamethasone|mesh-list
110597316|NCT04216524|Dexamethasone acetate|dexamethasone acetate|mesh-list
110597317|NCT04216524|Prednisone|prednisone|mesh-list
110597318|NCT04216524|Methylprednisolone|methylprednisolone|mesh-list
110597319|NCT04216524|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110597320|NCT04216524|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110597321|NCT04216524|Prednisolone|prednisolone|mesh-list
110597322|NCT04216524|Prednisolone acetate|prednisolone acetate|mesh-list
110597323|NCT04216524|Cortisone|cortisone|mesh-list
110597324|NCT04216524|Cyclophosphamide|cyclophosphamide|mesh-list
110597325|NCT04216524|Rituximab|rituximab|mesh-list
110597326|NCT04216524|Doxorubicin|doxorubicin|mesh-list
110597327|NCT04216524|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110597328|NCT04216524|Methotrexate|methotrexate|mesh-list
110597329|NCT04216524|Vincristine|vincristine|mesh-list
110597330|NCT04216524|Daunorubicin|daunorubicin|mesh-list
110597331|NCT04216524|Venetoclax|venetoclax|mesh-list
110597332|NCT04216524|Mercaptopurine|mercaptopurine|mesh-list
110597333|NCT04216524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110597334|NCT04216524|Antibodies|antibodies|mesh-list
110597335|NCT04216524|Immunoglobulins|immunoglobulins|mesh-list
110597336|NCT04216524|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110597337|NCT04216524|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110597338|NCT04216524|Prednisolone phosphate|prednisolone phosphate|mesh-list
110597339|NCT04216524|BB 1101|bb 1101|mesh-list
110597340|NCT04216524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110597341|NCT04216524|Immunologic Factors|immunologic factors|mesh-ancestor
110597342|NCT04216524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110597344|NCT04216524|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110597345|NCT04216524|Alkylating Agents|alkylating agents|mesh-ancestor
110597346|NCT04216524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110597347|NCT04216524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110597348|NCT04216524|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110597349|NCT04216524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110597350|NCT04216524|Antiemetics|antiemetics|mesh-ancestor
110597351|NCT04216524|Autonomic Agents|autonomic agents|mesh-ancestor
110597352|NCT04216524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110597353|NCT04216524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110597354|NCT04216524|Glucocorticoids|glucocorticoids|mesh-ancestor
110597356|NCT04216524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110597357|NCT04216524|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110597358|NCT04216524|Protease Inhibitors|protease inhibitors|mesh-ancestor
110597359|NCT04216524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110597360|NCT04216524|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110597361|NCT04216524|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110597362|NCT04216524|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110597363|NCT04216524|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110597364|NCT04216524|Abortifacient Agents|abortifacient agents|mesh-ancestor
110597365|NCT04216524|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110597366|NCT04216524|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110597368|NCT04216524|Dermatologic Agents|dermatologic agents|mesh-ancestor
110597369|NCT04216524|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110597370|NCT04216524|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110597371|NCT04216524|Antiviral Agents|antiviral agents|mesh-ancestor
110597372|NCT04216524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110597373|NCT04216524|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110261178|NCT02931136|Huperzine A|huperzine a|mesh-list
110597374|NCT04216524|Tubulin Modulators|tubulin modulators|mesh-ancestor
110597375|NCT04216524|Antimitotic Agents|antimitotic agents|mesh-ancestor
110597376|NCT04216524|Mitosis Modulators|mitosis modulators|mesh-ancestor
110597377|NCT04216524|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110597378|NCT04216524|Protective Agents|protective agents|mesh-ancestor
110597379|NCT04202692|Magnesium trisilicate|magnesium trisilicate|mesh-list
110597380|NCT04202692|Hyaluronic Acid|hyaluronic acid|mesh-list
110597381|NCT04202692|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110597382|NCT04202692|Immunologic Factors|immunologic factors|mesh-ancestor
110597383|NCT04202692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110597384|NCT04202692|Viscosupplements|viscosupplements|mesh-ancestor
110597385|NCT04202692|Protective Agents|protective agents|mesh-ancestor
110597386|NCT04202692|Antacids|antacids|mesh-ancestor
110597387|NCT04202692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110597388|NCT04202692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110597389|NCT04177758|Vitamin D|vitamin d|mesh-list
110597391|NCT04177758|Micronutrients|micronutrients|mesh-ancestor
110597392|NCT04177758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110597393|NCT04177758|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110597394|NCT04168112|Dexamethasone|dexamethasone|mesh-list
110597395|NCT04168112|Prednisolone|prednisolone|mesh-list
110597396|NCT04168112|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110597398|NCT04168112|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110597399|NCT04168112|Prednisolone acetate|prednisolone acetate|mesh-list
110597400|NCT04168112|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110597401|NCT04168112|Prednisolone phosphate|prednisolone phosphate|mesh-list
110597402|NCT04168112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110597403|NCT04168112|Antiemetics|antiemetics|mesh-ancestor
110597404|NCT04168112|Autonomic Agents|autonomic agents|mesh-ancestor
110597405|NCT04168112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110597406|NCT04168112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110597407|NCT04168112|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110597408|NCT04168112|Glucocorticoids|glucocorticoids|mesh-ancestor
110597409|NCT04168112|Hormones|hormones|mesh-ancestor
110597410|NCT04168112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110597411|NCT04168112|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110597412|NCT04168112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110597413|NCT04168112|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110597414|NCT04168112|Protective Agents|protective agents|mesh-ancestor
110597415|NCT04150458|Choline|choline|mesh-list
110597416|NCT04150458|Lipotropic Agents|lipotropic agents|mesh-ancestor
110597417|NCT04150458|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110597418|NCT04150458|Antimetabolites|antimetabolites|mesh-ancestor
110597419|NCT04150458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110597420|NCT04150458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110261291|NCT00148070|Erythromycin stearate|erythromycin stearate|mesh-list
110597421|NCT04150458|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110597422|NCT04150458|Nootropic Agents|nootropic agents|mesh-ancestor
110597423|NCT04147208|Ritonavir|ritonavir|mesh-list
110597424|NCT04147208|Entecavir|entecavir|mesh-list
110597425|NCT04147208|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110597426|NCT04147208|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110597427|NCT04147208|Protease Inhibitors|protease inhibitors|mesh-ancestor
110597428|NCT04147208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110377787|NCT00179010|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110597434|NCT04147208|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110597435|NCT04147208|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110597437|NCT04008706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110597438|NCT04003103|Islatravir|islatravir|mesh-list
110597439|NCT04003103|Antiviral Agents|antiviral agents|mesh-ancestor
110597440|NCT04003103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110597441|NCT04003103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110597442|NCT04003103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110597443|NCT04003103|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110597444|NCT04003103|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110597445|NCT04003103|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110597446|NCT03999216|Diuretics|diuretics|mesh-list
110261343|NCT00175734|Analgesics|analgesics|mesh-ancestor
110597447|NCT03999216|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
110597448|NCT03999216|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
110597449|NCT03999216|Natriuretic Agents|natriuretic agents|mesh-ancestor
110597450|NCT03999216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110597451|NCT03999216|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110597452|NCT03999216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110597459|NCT03945448|Fluconazole|fluconazole|mesh-list
110597460|NCT03945448|Amphotericin B|amphotericin b|mesh-list
110597461|NCT03945448|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
110597462|NCT03945448|Antifungal Agents|antifungal agents|mesh-ancestor
110597463|NCT03945448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110597464|NCT03945448|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110597465|NCT03945448|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110597466|NCT03945448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110597467|NCT03945448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110597468|NCT03945448|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110597469|NCT03945448|Hormone Antagonists|hormone antagonists|mesh-ancestor
110597470|NCT03945448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110597471|NCT03945448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110597472|NCT03945448|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110597473|NCT03945448|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110597474|NCT03945448|Amebicides|amebicides|mesh-ancestor
110597475|NCT03945448|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110597476|NCT03945448|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110597477|NCT03945448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110597478|NCT03941873|Tislelizumab|tislelizumab|mesh-list
110597479|NCT03941873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110597480|NCT03941873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110597481|NCT03941587|Aflibercept|aflibercept|mesh-list
110597482|NCT03941587|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110597483|NCT03941587|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110597484|NCT03941587|Growth Substances|growth substances|mesh-ancestor
110597485|NCT03941587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110597486|NCT03941587|Growth Inhibitors|growth inhibitors|mesh-ancestor
110597487|NCT03941587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110597488|NCT03917420|Tenofovir|tenofovir|mesh-list
110597489|NCT03917420|Emtricitabine|emtricitabine|mesh-list
110597490|NCT03917420|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110597491|NCT03917420|Antiviral Agents|antiviral agents|mesh-ancestor
110597492|NCT03917420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110261442|NCT03457597|Pioglitazone|pioglitazone|mesh-list
110597493|NCT03917420|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110597494|NCT03917420|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110597495|NCT03917420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110597496|NCT03917420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110597497|NCT03917420|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110597498|NCT03917420|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110597499|NCT03884556|Paclitaxel|paclitaxel|mesh-list
110597500|NCT03884556|Gemcitabine|gemcitabine|mesh-list
110597501|NCT03884556|Pembrolizumab|pembrolizumab|mesh-list
110597502|NCT03884556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110597503|NCT03884556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110597504|NCT03884556|Tubulin Modulators|tubulin modulators|mesh-ancestor
110597505|NCT03884556|Antimitotic Agents|antimitotic agents|mesh-ancestor
110597506|NCT03884556|Mitosis Modulators|mitosis modulators|mesh-ancestor
110597507|NCT03884556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110597508|NCT03884556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110597509|NCT03884556|Antimetabolites|antimetabolites|mesh-ancestor
110597510|NCT03884556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110597511|NCT03884556|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110597512|NCT03720119|Lidocaine|lidocaine|mesh-list
110597513|NCT03720119|Anesthetics, Local|anesthetics, local|mesh-ancestor
110597514|NCT03720119|Anesthetics|anesthetics|mesh-ancestor
110597515|NCT03720119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110597516|NCT03720119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110597517|NCT03720119|Sensory System Agents|sensory system agents|mesh-ancestor
110597518|NCT03720119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110597519|NCT03720119|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110597520|NCT03720119|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110597521|NCT03720119|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110597522|NCT03720119|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110597523|NCT03720119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110597524|NCT03713528|Vancomycin|vancomycin|mesh-list
110597525|NCT03713528|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110597526|NCT03713528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110597527|NCT03705845|Tocotrienols|tocotrienols|mesh-list
110597528|NCT03705845|Vitamin E|vitamin e|mesh-list
110597529|NCT03705845|Tocopherols|tocopherols|mesh-list
110597530|NCT03705845|Antioxidants|antioxidants|mesh-ancestor
110597531|NCT03705845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110261563|NCT00176046|Antiviral Agents|antiviral agents|mesh-ancestor
110597532|NCT03705845|Protective Agents|protective agents|mesh-ancestor
110597533|NCT03705845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110597534|NCT03705845|Vitamins|vitamins|mesh-ancestor
110597535|NCT03705845|Micronutrients|micronutrients|mesh-ancestor
110597536|NCT03669718|Cemiplimab|cemiplimab|mesh-list
110597537|NCT03669718|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110597538|NCT03669718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110597539|NCT03644966|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110597540|NCT03644966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110597541|NCT03642990|Niacinamide|niacinamide|mesh-list
110597542|NCT03642990|Niacin|niacin|mesh-list
110597543|NCT03642990|Nicotinic Acids|nicotinic acids|mesh-list
110597544|NCT03642990|Vitamin B Complex|vitamin b complex|mesh-ancestor
110597545|NCT03642990|Vitamins|vitamins|mesh-ancestor
110597546|NCT03642990|Micronutrients|micronutrients|mesh-ancestor
110597547|NCT03642990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110597548|NCT03642990|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110597549|NCT03642990|Antimetabolites|antimetabolites|mesh-ancestor
110597550|NCT03642990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110597552|NCT03642990|Vasodilator Agents|vasodilator agents|mesh-ancestor
110597553|NCT03582475|Cisplatin|cisplatin|mesh-list
110597554|NCT03582475|Carboplatin|carboplatin|mesh-list
110597555|NCT03582475|Docetaxel|docetaxel|mesh-list
110597556|NCT03582475|Pembrolizumab|pembrolizumab|mesh-list
110597557|NCT03582475|Etoposide|etoposide|mesh-list
110597558|NCT03582475|Etoposide phosphate|etoposide phosphate|mesh-list
110597559|NCT03582475|Podophyllotoxin|podophyllotoxin|mesh-list
110597560|NCT03582475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110597561|NCT03582475|Tubulin Modulators|tubulin modulators|mesh-ancestor
110597562|NCT03582475|Antimitotic Agents|antimitotic agents|mesh-ancestor
110597563|NCT03582475|Mitosis Modulators|mitosis modulators|mesh-ancestor
110597564|NCT03582475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110597565|NCT03582475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110597566|NCT03582475|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110597567|NCT03582475|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110597568|NCT03582475|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110597569|NCT03582475|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110597570|NCT03582475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110597571|NCT03582475|Keratolytic Agents|keratolytic agents|mesh-ancestor
110597572|NCT03582475|Dermatologic Agents|dermatologic agents|mesh-ancestor
110597573|NCT03579784|Paclitaxel|paclitaxel|mesh-list
110597574|NCT03579784|Durvalumab|durvalumab|mesh-list
110597575|NCT03579784|Olaparib|olaparib|mesh-list
110597576|NCT03579784|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110261667|NCT00149201|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110597577|NCT03579784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110597578|NCT03579784|Tubulin Modulators|tubulin modulators|mesh-ancestor
110597579|NCT03579784|Antimitotic Agents|antimitotic agents|mesh-ancestor
110597580|NCT03579784|Mitosis Modulators|mitosis modulators|mesh-ancestor
110597581|NCT03579784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110597582|NCT03579784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110597583|NCT03579784|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110597584|NCT03579784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110597585|NCT03564678|Folic Acid|folic acid|mesh-list
110597586|NCT03564678|Vitamin B Complex|vitamin b complex|mesh-list
110597587|NCT03564678|Vitamins|vitamins|mesh-ancestor
110597588|NCT03564678|Micronutrients|micronutrients|mesh-ancestor
110597589|NCT03564678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110597590|NCT03564678|Hematinics|hematinics|mesh-ancestor
110597591|NCT03553563|Esomeprazole|esomeprazole|mesh-list
110597592|NCT03553563|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110597593|NCT03553563|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110597594|NCT03553563|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110597595|NCT03553563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110597596|NCT03553563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110597597|NCT03542760|Methylene Blue|methylene blue|mesh-list
110597598|NCT03542760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110597599|NCT03542760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110597600|NCT03530397|Paclitaxel|paclitaxel|mesh-list
110597601|NCT03530397|Carboplatin|carboplatin|mesh-list
110597602|NCT03530397|Pembrolizumab|pembrolizumab|mesh-list
110261723|NCT00170781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110597603|NCT03530397|Pemetrexed|pemetrexed|mesh-list
110597604|NCT03530397|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110597605|NCT03530397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110597606|NCT03530397|Tubulin Modulators|tubulin modulators|mesh-ancestor
110597607|NCT03530397|Antimitotic Agents|antimitotic agents|mesh-ancestor
110597608|NCT03530397|Mitosis Modulators|mitosis modulators|mesh-ancestor
110597609|NCT03530397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110597610|NCT03530397|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110597611|NCT03530397|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110597612|NCT03530397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110597613|NCT03530397|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110597614|NCT03530397|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110597615|NCT03515304|Evolocumab|evolocumab|mesh-list
110151418|NCT00000970|Foscarnet|foscarnet|mesh-list
110597616|NCT03515304|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
110597617|NCT03515304|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110597618|NCT03515304|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110597619|NCT03515304|Antimetabolites|antimetabolites|mesh-ancestor
110597620|NCT03515304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110597621|NCT03515304|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110597622|NCT03515304|Protease Inhibitors|protease inhibitors|mesh-ancestor
110597623|NCT03515304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110597624|NCT03515304|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110597625|NCT03477292|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110597626|NCT03477292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110597628|NCT03465540|Azacitidine|azacitidine|mesh-list
110597629|NCT03465540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110597630|NCT03465540|Antiemetics|antiemetics|mesh-ancestor
110597631|NCT03465540|Autonomic Agents|autonomic agents|mesh-ancestor
110597632|NCT03465540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110597633|NCT03465540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110597634|NCT03465540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110597635|NCT03465540|Glucocorticoids|glucocorticoids|mesh-ancestor
110597636|NCT03465540|Hormones|hormones|mesh-ancestor
110597637|NCT03465540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110597638|NCT03465540|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110597639|NCT03465540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110597640|NCT03465540|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110597641|NCT03465540|Antimetabolites|antimetabolites|mesh-ancestor
110597642|NCT03465540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110261818|NCT00149708|Hormones|hormones|mesh-list
110597643|NCT03465540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110597644|NCT03368547|Edetic Acid|edetic acid|mesh-list
110597645|NCT03368547|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
110597646|NCT03368547|Chelating Agents|chelating agents|mesh-ancestor
110597647|NCT03368547|Sequestering Agents|sequestering agents|mesh-ancestor
110597648|NCT03368547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110597649|NCT03368547|Anticoagulants|anticoagulants|mesh-ancestor
110597650|NCT03368547|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110597651|NCT03368547|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110597652|NCT03217227|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
110597653|NCT03217227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110597654|NCT03217227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110597655|NCT03217227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110597656|NCT03217227|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110597657|NCT03152903|BCG Vaccine|bcg vaccine|mesh-list
110597658|NCT03152903|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110597659|NCT03152903|Immunologic Factors|immunologic factors|mesh-ancestor
110597660|NCT03152903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110261873|NCT00149903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110597661|NCT03152890|Insulin|insulin|mesh-list
110597662|NCT03152890|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110597663|NCT03152890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110597664|NCT03123029|Venetoclax|venetoclax|mesh-list
110597665|NCT03123029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110597666|NCT03117933|Paclitaxel|paclitaxel|mesh-list
110597667|NCT03117933|Olaparib|olaparib|mesh-list
110597668|NCT03117933|Cediranib|cediranib|mesh-list
110597669|NCT03117933|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110597670|NCT03117933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110597671|NCT03117933|Tubulin Modulators|tubulin modulators|mesh-ancestor
110597672|NCT03117933|Antimitotic Agents|antimitotic agents|mesh-ancestor
110597673|NCT03117933|Mitosis Modulators|mitosis modulators|mesh-ancestor
110597674|NCT03117933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110597675|NCT03117933|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110597676|NCT03117933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110597677|NCT03117933|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110597678|NCT03048877|Apatinib|apatinib|mesh-list
110261929|NCT05786365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110597679|NCT03048877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110597680|NCT03048877|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110597681|NCT03048877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110597682|NCT03048877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110597683|NCT02951351|Proxymetacaine|proxymetacaine|mesh-list
110597684|NCT02951351|Anesthetics, Local|anesthetics, local|mesh-ancestor
110597685|NCT02951351|Anesthetics|anesthetics|mesh-ancestor
110597686|NCT02951351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110597687|NCT02951351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110597688|NCT02951351|Sensory System Agents|sensory system agents|mesh-ancestor
110261989|NCT05785234|Analgesics|analgesics|mesh-ancestor
110597689|NCT02951351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110597690|NCT02940925|Cisplatin|cisplatin|mesh-list
110597691|NCT02940925|Fluorouracil|fluorouracil|mesh-list
110597692|NCT02940925|Capecitabine|capecitabine|mesh-list
110597693|NCT02940925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110597694|NCT02940925|Antimetabolites|antimetabolites|mesh-ancestor
110597695|NCT02940925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110597696|NCT02940925|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110597697|NCT02940925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110597698|NCT02940925|Immunologic Factors|immunologic factors|mesh-ancestor
110597699|NCT02940925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110597700|NCT02915705|Vitamin D|vitamin d|mesh-list
110597701|NCT02915705|Vitamins|vitamins|mesh-ancestor
110597702|NCT02915705|Micronutrients|micronutrients|mesh-ancestor
110597703|NCT02915705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110597704|NCT02915705|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110597705|NCT02891278|Cytarabine|cytarabine|mesh-list
110597706|NCT02891278|Sertraline|sertraline|mesh-list
110262054|NCT05782894|Narcotics|narcotics|mesh-ancestor
110262055|NCT05782894|Analgesics|analgesics|mesh-ancestor
110262056|NCT05782894|Sensory System Agents|sensory system agents|mesh-ancestor
110262057|NCT05782894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110262058|NCT05782712|Adenosine|adenosine|mesh-list
110262059|NCT05782712|Analgesics|analgesics|mesh-ancestor
110262060|NCT05782712|Sensory System Agents|sensory system agents|mesh-ancestor
110262061|NCT05782712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110262062|NCT05782712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110597707|NCT02891278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110597708|NCT02891278|Antimetabolites|antimetabolites|mesh-ancestor
110597709|NCT02891278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110597710|NCT02891278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110597711|NCT02891278|Antiviral Agents|antiviral agents|mesh-ancestor
110597712|NCT02891278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110597713|NCT02891278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110021272|NCT00002532|Leucovorin|leucovorin|mesh-list
110597714|NCT02891278|Immunologic Factors|immunologic factors|mesh-ancestor
110597715|NCT02891278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110597716|NCT02891278|Antidepressive Agents|antidepressive agents|mesh-ancestor
110597717|NCT02891278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110597718|NCT02891278|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110597719|NCT02891278|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110262114|NCT05764941|Vinorelbine|vinorelbine|mesh-list
110262115|NCT05764941|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110597720|NCT02891278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110597721|NCT02891278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110597722|NCT02891278|Serotonin Agents|serotonin agents|mesh-ancestor
110597723|NCT02807181|Cisplatin|cisplatin|mesh-list
110597724|NCT02807181|Gemcitabine|gemcitabine|mesh-list
110597725|NCT02807181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110597726|NCT02807181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110597727|NCT02807181|Antimetabolites|antimetabolites|mesh-ancestor
110597728|NCT02807181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110597729|NCT02454543|Androgens|androgens|mesh-list
110597730|NCT02454543|Hormones|hormones|mesh-ancestor
110245058|NCT00115947|Terlipressin|terlipressin|mesh-list
110597731|NCT02454543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110597732|NCT02454543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110597733|NCT02384512|Rasagiline|rasagiline|mesh-list
110597734|NCT02384512|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
110597735|NCT02384512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110597736|NCT02384512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110262180|NCT05334017|Cocaine|cocaine|mesh-list
110597737|NCT02384512|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110597738|NCT02384512|Protective Agents|protective agents|mesh-ancestor
110597739|NCT02384512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110597740|NCT02366494|Docetaxel|docetaxel|mesh-list
110597741|NCT02366494|Leuprolide|leuprolide|mesh-list
110597742|NCT02366494|Goserelin|goserelin|mesh-list
110597743|NCT02366494|Bicalutamide|bicalutamide|mesh-list
110597744|NCT02366494|Triptorelin Pamoate|triptorelin pamoate|mesh-list
110597745|NCT02366494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110597746|NCT02366494|Tubulin Modulators|tubulin modulators|mesh-ancestor
110597747|NCT02366494|Antimitotic Agents|antimitotic agents|mesh-ancestor
110597748|NCT02366494|Mitosis Modulators|mitosis modulators|mesh-ancestor
110597749|NCT02366494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110597750|NCT02366494|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110597751|NCT02366494|Fertility Agents|fertility agents|mesh-ancestor
110597752|NCT02366494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110597753|NCT02366494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110597754|NCT02366494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110597756|NCT02366494|Hormone Antagonists|hormone antagonists|mesh-ancestor
110597757|NCT02366494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110597759|NCT02366494|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110597760|NCT02366494|Contraceptive Agents|contraceptive agents|mesh-ancestor
110597761|NCT02366494|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110597762|NCT02157610|Nicotine|nicotine|mesh-list
110597763|NCT02157610|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110597764|NCT02157610|Autonomic Agents|autonomic agents|mesh-ancestor
110597765|NCT02157610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110597766|NCT02157610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110597767|NCT02157610|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110597768|NCT02157610|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110597769|NCT02157610|Cholinergic Agents|cholinergic agents|mesh-ancestor
110597770|NCT02157610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110597771|NCT02157610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110597772|NCT02078869|Progesterone|progesterone|mesh-list
110597773|NCT02078869|Progestins|progestins|mesh-ancestor
110597774|NCT02078869|Hormones|hormones|mesh-ancestor
110597775|NCT02078869|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110597776|NCT02078869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110597777|NCT01946815|Atorvastatin|atorvastatin|mesh-list
110597778|NCT01946815|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110597779|NCT01946815|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110597780|NCT01946815|Antimetabolites|antimetabolites|mesh-ancestor
110597781|NCT01946815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110597782|NCT01946815|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110597783|NCT01946815|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110597784|NCT01946815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110597785|NCT01937156|Granisetron|granisetron|mesh-list
110597786|NCT01937156|Antiemetics|antiemetics|mesh-ancestor
110597787|NCT01937156|Autonomic Agents|autonomic agents|mesh-ancestor
110597788|NCT01937156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110597789|NCT01937156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110597790|NCT01937156|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110597791|NCT01937156|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110597792|NCT01937156|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110597793|NCT01937156|Serotonin Agents|serotonin agents|mesh-ancestor
110597794|NCT01937156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110597795|NCT01937156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110597796|NCT01805804|Valsartan|valsartan|mesh-list
110597797|NCT01805804|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110597798|NCT01805804|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110597799|NCT01805804|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110597800|NCT01805804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110597801|NCT01718873|Leucovorin|leucovorin|mesh-list
110597802|NCT01718873|Folic Acid|folic acid|mesh-list
110597803|NCT01718873|Bevacizumab|bevacizumab|mesh-list
110597804|NCT01718873|Fluorouracil|fluorouracil|mesh-list
110597805|NCT01718873|Capecitabine|capecitabine|mesh-list
110597806|NCT01718873|Oxaliplatin|oxaliplatin|mesh-list
110245125|NCT00401804|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110597807|NCT01718873|Levoleucovorin|levoleucovorin|mesh-list
110262347|NCT04838808|Anticoagulants|anticoagulants|mesh-ancestor
110597808|NCT01718873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110597809|NCT01718873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110597810|NCT01718873|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110597811|NCT01718873|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110597812|NCT01718873|Growth Substances|growth substances|mesh-ancestor
110597813|NCT01718873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110597814|NCT01718873|Growth Inhibitors|growth inhibitors|mesh-ancestor
110597815|NCT01718873|Antimetabolites|antimetabolites|mesh-ancestor
110597816|NCT01718873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110597817|NCT01718873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110597818|NCT01718873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110597819|NCT01718873|Immunologic Factors|immunologic factors|mesh-ancestor
110597821|NCT01718873|Protective Agents|protective agents|mesh-ancestor
110597822|NCT01718873|Vitamin B Complex|vitamin b complex|mesh-ancestor
110597824|NCT01718873|Micronutrients|micronutrients|mesh-ancestor
110597825|NCT01718873|Hematinics|hematinics|mesh-ancestor
110597826|NCT01424566|Nabiximols|nabiximols|mesh-list
110597827|NCT01424566|Analgesics|analgesics|mesh-ancestor
110597828|NCT01424566|Sensory System Agents|sensory system agents|mesh-ancestor
110597829|NCT01424566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110597830|NCT01424566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110597831|NCT01367561|Naloxone|naloxone|mesh-list
110597832|NCT01367561|Methylnaltrexone|methylnaltrexone|mesh-list
110597833|NCT01367561|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110597834|NCT01367561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110262388|NCT04610658|Nivolumab|nivolumab|mesh-list
110597835|NCT01367561|Sensory System Agents|sensory system agents|mesh-ancestor
110597836|NCT01367561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110597837|NCT01361607|Nabiximols|nabiximols|mesh-list
110597838|NCT01361607|Analgesics|analgesics|mesh-ancestor
110597839|NCT01361607|Sensory System Agents|sensory system agents|mesh-ancestor
110597840|NCT01361607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110597841|NCT01361607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110597842|NCT01337089|Nabiximols|nabiximols|mesh-list
110597844|NCT01337089|Sensory System Agents|sensory system agents|mesh-ancestor
110597845|NCT01337089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110597846|NCT01337089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110597848|NCT01297400|Silver Sulfadiazine|silver sulfadiazine|mesh-list
110597849|NCT01297400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110597850|NCT01297400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110597851|NCT01297400|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110597852|NCT01297400|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110597853|NCT01297400|Coccidiostats|coccidiostats|mesh-ancestor
110597854|NCT01297400|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110597855|NCT01276587|Vitamin D|vitamin d|mesh-list
110597856|NCT01276587|Ergocalciferols|ergocalciferols|mesh-list
110597857|NCT01276587|Cholecalciferol|cholecalciferol|mesh-list
110597858|NCT01276587|Vitamins|vitamins|mesh-list
110597859|NCT01276587|Micronutrients|micronutrients|mesh-ancestor
110262433|NCT04532918|Gout Suppressants|gout suppressants|mesh-ancestor
110597860|NCT01276587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110597861|NCT01276587|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110597862|NCT01276587|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110597863|NCT01217580|Ropivacaine|ropivacaine|mesh-list
110597864|NCT01217580|Anesthetics, Local|anesthetics, local|mesh-ancestor
110597865|NCT01217580|Anesthetics|anesthetics|mesh-ancestor
110597866|NCT01217580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110597867|NCT01217580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110597868|NCT01217580|Sensory System Agents|sensory system agents|mesh-ancestor
110597869|NCT01217580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110597870|NCT00802646|Epinephrine|epinephrine|mesh-list
110597871|NCT00802646|Fentanyl|fentanyl|mesh-list
110597872|NCT00802646|Bupivacaine|bupivacaine|mesh-list
110597873|NCT00802646|Anesthetics, Local|anesthetics, local|mesh-ancestor
110597874|NCT00802646|Anesthetics|anesthetics|mesh-ancestor
110262489|NCT04335669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110597875|NCT00802646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110597876|NCT00802646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110597877|NCT00802646|Sensory System Agents|sensory system agents|mesh-ancestor
110597878|NCT00802646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110597879|NCT00802646|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110597880|NCT00802646|Narcotics|narcotics|mesh-ancestor
110597881|NCT00802646|Analgesics|analgesics|mesh-ancestor
110597882|NCT00802646|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110597883|NCT00802646|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110597884|NCT00802646|Anesthetics, General|anesthetics, general|mesh-ancestor
110597885|NCT00802646|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110597887|NCT00802646|Adrenergic Agents|adrenergic agents|mesh-ancestor
110597888|NCT00802646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110597889|NCT00802646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110597890|NCT00802646|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110597891|NCT00802646|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110597892|NCT00802646|Autonomic Agents|autonomic agents|mesh-ancestor
110597893|NCT00802646|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110597894|NCT00802646|Respiratory System Agents|respiratory system agents|mesh-ancestor
110597895|NCT00802646|Mydriatics|mydriatics|mesh-ancestor
110597896|NCT00802646|Sympathomimetics|sympathomimetics|mesh-ancestor
110597897|NCT00802646|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110597898|NCT00473707|Oxytocin|oxytocin|mesh-list
110597899|NCT00473707|Oxytocics|oxytocics|mesh-ancestor
110597900|NCT00473707|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110597901|NCT00473707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110597902|NCT00233675|Tiagabine|tiagabine|mesh-list
110597903|NCT00233675|Anticonvulsants|anticonvulsants|mesh-ancestor
110597904|NCT00233675|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
110597905|NCT00233675|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110597906|NCT00233675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110597907|NCT00233675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110597908|NCT00233675|GABA Agents|gaba agents|mesh-ancestor
110597909|NCT00233675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110597910|NCT00233675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110597911|NCT00202774|Fluorouracil|fluorouracil|mesh-list
110597912|NCT00202774|Capecitabine|capecitabine|mesh-list
110597913|NCT00202774|Oxaliplatin|oxaliplatin|mesh-list
110597914|NCT00202774|Antimetabolites|antimetabolites|mesh-ancestor
110597915|NCT00202774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110597916|NCT00202774|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110597917|NCT00202774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110597918|NCT00202774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110597919|NCT00202774|Immunologic Factors|immunologic factors|mesh-ancestor
110597920|NCT00202774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110597921|NCT00114530|Cyclophosphamide|cyclophosphamide|mesh-list
110597922|NCT00114530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110597923|NCT00114530|Immunologic Factors|immunologic factors|mesh-ancestor
110597924|NCT00114530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110597925|NCT00114530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110597926|NCT00114530|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110597927|NCT00114530|Alkylating Agents|alkylating agents|mesh-ancestor
110597928|NCT00114530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110597929|NCT00114530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110597930|NCT00114530|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110597931|NCT00107744|Caseins|caseins|mesh-list
110597932|NCT00107744|Chelating Agents|chelating agents|mesh-ancestor
110597933|NCT00107744|Sequestering Agents|sequestering agents|mesh-ancestor
110597934|NCT00107744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110597936|NCT00845338|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110597937|NCT00845338|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110597938|NCT00845338|Cholinergic Agents|cholinergic agents|mesh-ancestor
110597939|NCT00845338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110597940|NCT00845338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110597941|NCT00845338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110597942|NCT00845338|Urological Agents|urological agents|mesh-ancestor
110597943|NCT00923962|Adenosine|adenosine|mesh-list
110597944|NCT00923962|Glucagon|glucagon|mesh-list
110597945|NCT00923962|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
110597946|NCT00923962|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110597947|NCT00923962|Hormones|hormones|mesh-ancestor
110597948|NCT00923962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110597949|NCT00923962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110597950|NCT00923962|Incretins|incretins|mesh-ancestor
110597951|NCT00923962|Analgesics|analgesics|mesh-ancestor
110597952|NCT00923962|Sensory System Agents|sensory system agents|mesh-ancestor
110597953|NCT00923962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110597954|NCT00923962|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110597955|NCT00923962|Vasodilator Agents|vasodilator agents|mesh-ancestor
110597956|NCT00923962|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
110597957|NCT00923962|Purinergic Agonists|purinergic agonists|mesh-ancestor
110597958|NCT00923962|Purinergic Agents|purinergic agents|mesh-ancestor
110597959|NCT00923962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110245282|NCT03273595|Paclitaxel|paclitaxel|mesh-list
110597960|NCT00923962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110597961|NCT02575092|Folic Acid|folic acid|mesh-list
110597962|NCT02575092|Enalapril|enalapril|mesh-list
110597963|NCT02575092|Enalaprilat|enalaprilat|mesh-list
110597964|NCT02575092|Maleic acid|maleic acid|mesh-list
110597965|NCT02575092|Hematinics|hematinics|mesh-ancestor
110597966|NCT02575092|Vitamin B Complex|vitamin b complex|mesh-ancestor
110597967|NCT02575092|Vitamins|vitamins|mesh-ancestor
110597968|NCT02575092|Micronutrients|micronutrients|mesh-ancestor
110597969|NCT02575092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110597970|NCT02575092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110597971|NCT02575092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110597973|NCT02575092|Protease Inhibitors|protease inhibitors|mesh-ancestor
110597974|NCT02575092|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110597975|NCT04097470|Decitabine|decitabine|mesh-list
110597976|NCT04097470|Midostaurin|midostaurin|mesh-list
110597977|NCT04097470|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110597978|NCT04097470|Antimetabolites|antimetabolites|mesh-ancestor
110262622|NCT03762096|Resveratrol|resveratrol|mesh-list
110597979|NCT04097470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110597980|NCT04097470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110597981|NCT04097470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110597982|NCT04097470|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110597983|NCT04041934|Tryptophan|tryptophan|mesh-list
110597984|NCT04041934|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110597985|NCT04041934|Antidepressive Agents|antidepressive agents|mesh-ancestor
110597986|NCT04041934|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110597987|NCT00851734|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110597988|NCT00851734|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110597989|NCT00845572|Risperidone|risperidone|mesh-list
110597990|NCT00845572|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110597992|NCT00845572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110597993|NCT00845572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110597994|NCT00845572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110597995|NCT00845572|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110597996|NCT00845572|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110597997|NCT00845572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110597998|NCT00845572|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110597999|NCT00845572|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110598000|NCT00845572|Dopamine Agents|dopamine agents|mesh-ancestor
110598001|NCT00711906|Pyrimethamine|pyrimethamine|mesh-list
110598002|NCT00711906|Sulfadoxine|sulfadoxine|mesh-list
110151492|NCT05639127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110598003|NCT00711906|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
110598004|NCT00711906|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
110598005|NCT00711906|Antimalarials|antimalarials|mesh-ancestor
110598006|NCT00711906|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110598007|NCT00711906|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110598008|NCT00711906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110598009|NCT00711906|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110598010|NCT00711906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110598011|NCT00711906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110598012|NCT00711906|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110598013|NCT00711906|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110598014|NCT04502550|Propofol|propofol|mesh-list
110598015|NCT04502550|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110021636|NCT00002676|Cobalt|cobalt|mesh-list
110598016|NCT04502550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110598017|NCT04502550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110598018|NCT04502550|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110598019|NCT04502550|Anesthetics, General|anesthetics, general|mesh-ancestor
110598020|NCT04502550|Anesthetics|anesthetics|mesh-ancestor
110598021|NCT04227184|Trospium chloride|trospium chloride|mesh-list
110598022|NCT04227184|Parasympatholytics|parasympatholytics|mesh-ancestor
110598023|NCT04227184|Autonomic Agents|autonomic agents|mesh-ancestor
110598024|NCT04227184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110598025|NCT04227184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110598026|NCT04227184|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110598027|NCT04227184|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110598028|NCT04227184|Cholinergic Agents|cholinergic agents|mesh-ancestor
110598029|NCT04227184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110598030|NCT04227184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110598031|NCT04227184|Urological Agents|urological agents|mesh-ancestor
110598032|NCT04018950|Durlobactam|durlobactam|mesh-list
110598033|NCT04018950|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110598034|NCT04018950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110245365|NCT00116064|Lorazepam|lorazepam|mesh-list
110598035|NCT04018950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110598036|NCT04018950|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110598037|NCT04018950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110598038|NCT02545972|Tacrolimus|tacrolimus|mesh-list
110598039|NCT02545972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110598040|NCT02545972|Immunologic Factors|immunologic factors|mesh-ancestor
110377928|NCT04551768|Ribavirin|ribavirin|mesh-list
110598041|NCT02545972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110598042|NCT02545972|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110598043|NCT02545972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110598044|NCT02545972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110598045|NCT00852046|Dexmedetomidine|dexmedetomidine|mesh-list
110598046|NCT00852046|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110598047|NCT00852046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110598048|NCT00852046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110598049|NCT00852046|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110598050|NCT00852046|Analgesics|analgesics|mesh-ancestor
110598051|NCT00852046|Sensory System Agents|sensory system agents|mesh-ancestor
110598052|NCT00852046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110598053|NCT00852046|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110598054|NCT00852046|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110598055|NCT00852046|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110598056|NCT00852046|Adrenergic Agents|adrenergic agents|mesh-ancestor
110598057|NCT00852046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110598058|NCT00852046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110598059|NCT02573064|Vancomycin|vancomycin|mesh-list
110598060|NCT02573064|Colistin|colistin|mesh-list
110598061|NCT02573064|Tigecycline|tigecycline|mesh-list
110598062|NCT02573064|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110598063|NCT02573064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110598064|NCT02573064|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110598065|NCT02573064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110598066|NCT02573064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110598067|NCT00845884|Bevacizumab|bevacizumab|mesh-list
110598068|NCT00845884|Cisplatin|cisplatin|mesh-list
110598069|NCT00845884|Docetaxel|docetaxel|mesh-list
110598070|NCT00845884|Capecitabine|capecitabine|mesh-list
110598071|NCT00845884|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110598072|NCT00845884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110598073|NCT00845884|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110598074|NCT00845884|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110598075|NCT00845884|Growth Substances|growth substances|mesh-ancestor
110598076|NCT00845884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110598077|NCT00845884|Growth Inhibitors|growth inhibitors|mesh-ancestor
110598078|NCT00845884|Tubulin Modulators|tubulin modulators|mesh-ancestor
110598079|NCT00845884|Antimitotic Agents|antimitotic agents|mesh-ancestor
110598080|NCT00845884|Mitosis Modulators|mitosis modulators|mesh-ancestor
110598081|NCT00845884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110598082|NCT00845884|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110598084|NCT00923806|Aldesleukin|aldesleukin|mesh-list
110598085|NCT00923806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110598086|NCT00923806|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110598087|NCT00923806|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110598088|NCT00923806|Antiviral Agents|antiviral agents|mesh-ancestor
110598089|NCT00923806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110263122|NCT00150215|Olanzapine|olanzapine|mesh-list
110598090|NCT00848068|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110598091|NCT00848068|Lubricant Eye Drops|lubricant eye drops|mesh-list
110598092|NCT00848068|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110598093|NCT00718536|Raltegravir Potassium|raltegravir potassium|mesh-list
110598094|NCT00718536|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110598095|NCT00718536|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110598096|NCT00718536|Antiviral Agents|antiviral agents|mesh-ancestor
110598097|NCT00718536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110598098|NCT00718536|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110598099|NCT00718536|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110598100|NCT00718536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110598101|NCT00718536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110598102|NCT00712062|Pemetrexed|pemetrexed|mesh-list
110598103|NCT00712062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110598104|NCT00712062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110598105|NCT00712062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110598106|NCT00712062|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110263193|NCT00150293|Pregabalin|pregabalin|mesh-list
110598107|NCT00712062|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110598108|NCT00712140|Trastuzumab|trastuzumab|mesh-list
110598109|NCT00712140|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110598111|NCT02545738|Liraglutide|liraglutide|mesh-list
110377933|NCT04671563|Tenofovir|tenofovir|mesh-list
110598112|NCT02545738|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110598113|NCT02545738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110598115|NCT02545738|Hormones|hormones|mesh-ancestor
110598116|NCT02545738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110598117|NCT00848302|Nitric Oxide|nitric oxide|mesh-list
110598118|NCT00848302|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110598119|NCT00848302|Autonomic Agents|autonomic agents|mesh-ancestor
110598120|NCT00848302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110598121|NCT00848302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110598122|NCT00848302|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110263236|NCT02912494|Hematinics|hematinics|mesh-ancestor
110598123|NCT00848302|Respiratory System Agents|respiratory system agents|mesh-ancestor
110598124|NCT00848302|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110598125|NCT00848302|Antioxidants|antioxidants|mesh-ancestor
110598126|NCT00848302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110598127|NCT00848302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110598128|NCT00848302|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
110598129|NCT00848302|Vasodilator Agents|vasodilator agents|mesh-ancestor
110598130|NCT00848302|Gasotransmitters|gasotransmitters|mesh-ancestor
110598131|NCT00848302|Protective Agents|protective agents|mesh-ancestor
110598132|NCT02572596|Cyclophosphamide|cyclophosphamide|mesh-list
110598133|NCT02572596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110598134|NCT02572596|Immunologic Factors|immunologic factors|mesh-ancestor
110598135|NCT02572596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110598136|NCT02572596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110598137|NCT02572596|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110598138|NCT02572596|Alkylating Agents|alkylating agents|mesh-ancestor
110598139|NCT02572596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110598140|NCT02572596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110598141|NCT02572596|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110598144|NCT00712374|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
110598145|NCT00712374|Amodiaquine|amodiaquine|mesh-list
110598146|NCT00712374|Antimalarials|antimalarials|mesh-ancestor
110598147|NCT00712374|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110263357|NCT00171366|Vasodilator Agents|vasodilator agents|mesh-ancestor
110598148|NCT00712374|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110598149|NCT00712374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110598150|NCT00712374|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110598151|NCT00712374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110598152|NCT00712374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110598153|NCT00712374|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110598154|NCT02573220|Leucovorin|leucovorin|mesh-list
110598155|NCT02573220|Fluorouracil|fluorouracil|mesh-list
110598156|NCT02573220|Irinotecan|irinotecan|mesh-list
110598157|NCT02573220|Cetuximab|cetuximab|mesh-list
110263421|NCT00150761|Histamine Agents|histamine agents|mesh-ancestor
110598158|NCT02573220|Camptothecin|camptothecin|mesh-list
110598159|NCT02573220|Calcium|calcium|mesh-list
110598160|NCT02573220|Levoleucovorin|levoleucovorin|mesh-list
110598161|NCT02573220|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110598162|NCT02573220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110598163|NCT02573220|Antimetabolites|antimetabolites|mesh-ancestor
110598164|NCT02573220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110598165|NCT02573220|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110598166|NCT02573220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110598167|NCT02573220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110598168|NCT02573220|Immunologic Factors|immunologic factors|mesh-ancestor
110598169|NCT02573220|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110598170|NCT02573220|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110598171|NCT02573220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110598172|NCT02573220|Antidotes|antidotes|mesh-ancestor
110598173|NCT02573220|Protective Agents|protective agents|mesh-ancestor
110598174|NCT02573220|Vitamin B Complex|vitamin b complex|mesh-ancestor
110263490|NCT00532207|Teriparatide|teriparatide|mesh-list
110598176|NCT02573220|Micronutrients|micronutrients|mesh-ancestor
110598177|NCT02573220|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110598178|NCT02573220|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110598179|NCT00712452|Cyclophosphamide|cyclophosphamide|mesh-list
110598180|NCT00712452|Vinblastine|vinblastine|mesh-list
110598181|NCT00712452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110377943|NCT04551573|Rifampin|rifampin|mesh-list
110598182|NCT00712452|Immunologic Factors|immunologic factors|mesh-ancestor
110598183|NCT00712452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110598184|NCT00712452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110598185|NCT00712452|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110598186|NCT00712452|Alkylating Agents|alkylating agents|mesh-ancestor
110598187|NCT00712452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110598188|NCT00712452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110598189|NCT00712452|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110598190|NCT00712452|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110598191|NCT00712452|Tubulin Modulators|tubulin modulators|mesh-ancestor
110598192|NCT00712452|Antimitotic Agents|antimitotic agents|mesh-ancestor
110598193|NCT00712452|Mitosis Modulators|mitosis modulators|mesh-ancestor
110598194|NCT00618982|Sorafenib|sorafenib|mesh-list
110598195|NCT00618982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110598196|NCT00618982|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110598197|NCT00618982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110598198|NCT00618982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110598199|NCT02544880|Tadalafil|tadalafil|mesh-list
110263598|NCT00171600|Lisinopril|lisinopril|mesh-list
110263609|NCT05467384|Amlodipine|amlodipine|mesh-list
110598200|NCT02544880|Vaccines|vaccines|mesh-list
110598201|NCT02544880|Immunologic Factors|immunologic factors|mesh-ancestor
110598202|NCT02544880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110598203|NCT02544880|Vasodilator Agents|vasodilator agents|mesh-ancestor
110598204|NCT02544880|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110598205|NCT02544880|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110598206|NCT02544880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110598207|NCT02544880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110598208|NCT02544880|Urological Agents|urological agents|mesh-ancestor
110598209|NCT00856570|Warfarin|warfarin|mesh-list
110598210|NCT00856570|Mirabegron|mirabegron|mesh-list
110598211|NCT00856570|Anticoagulants|anticoagulants|mesh-ancestor
110263662|NCT05466019|Leucovorin|leucovorin|mesh-list
110263663|NCT05466019|Docetaxel|docetaxel|mesh-list
110598212|NCT00856570|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
110598213|NCT00856570|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110598214|NCT00856570|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110598215|NCT00856570|Adrenergic Agents|adrenergic agents|mesh-ancestor
110598216|NCT00856570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110598217|NCT00856570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110598218|NCT00856570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110598219|NCT00856570|Urological Agents|urological agents|mesh-ancestor
110598220|NCT04068870|Contraceptive Agents|contraceptive agents|mesh-list
110263726|NCT00171717|Cyclosporine|cyclosporine|mesh-list
110598221|NCT04068870|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110598222|NCT04068870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110598224|NCT00856804|Thalidomide|thalidomide|mesh-list
110598225|NCT00856804|Antimetabolites|antimetabolites|mesh-ancestor
110598226|NCT00856804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110598227|NCT00856804|Antiviral Agents|antiviral agents|mesh-ancestor
110598228|NCT00856804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110598229|NCT00856804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110598230|NCT00856804|Immunologic Factors|immunologic factors|mesh-ancestor
110263792|NCT00151541|Sensory System Agents|sensory system agents|mesh-ancestor
110263793|NCT00151541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110598231|NCT00856804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110598233|NCT00856804|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110598234|NCT00856804|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110598235|NCT00856804|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110598236|NCT00856804|Growth Substances|growth substances|mesh-ancestor
110598237|NCT00856804|Growth Inhibitors|growth inhibitors|mesh-ancestor
110598238|NCT00856804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110598239|NCT00856882|Caseins|caseins|mesh-list
110598240|NCT00856882|Chelating Agents|chelating agents|mesh-ancestor
110598241|NCT00856882|Sequestering Agents|sequestering agents|mesh-ancestor
110598242|NCT00856882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110598243|NCT00712686|Olanzapine|olanzapine|mesh-list
110263854|NCT05308030|Antithrombins|antithrombins|mesh-ancestor
110263855|NCT05308030|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110263856|NCT05308030|Protease Inhibitors|protease inhibitors|mesh-ancestor
110263857|NCT05308030|Anticoagulants|anticoagulants|mesh-ancestor
110263858|NCT05293600|Acetazolamide|acetazolamide|mesh-list
110263859|NCT05293600|Eszopiclone|eszopiclone|mesh-list
110263860|NCT05293600|Trazodone|trazodone|mesh-list
110263861|NCT05293600|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
110598244|NCT00712686|Aripiprazole|aripiprazole|mesh-list
110598245|NCT00712686|Antiemetics|antiemetics|mesh-ancestor
110598246|NCT00712686|Autonomic Agents|autonomic agents|mesh-ancestor
110598247|NCT00712686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110377945|NCT04551573|Antitubercular Agents|antitubercular agents|mesh-ancestor
110598248|NCT00712686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110598249|NCT00712686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110598250|NCT00712686|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110598251|NCT00712686|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110598252|NCT00712686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110598253|NCT00712686|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110598254|NCT00712686|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110598255|NCT00712686|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110263909|NCT00151736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110263910|NCT00151736|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110598256|NCT00712686|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110598257|NCT00712686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110598258|NCT00712686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110598259|NCT00712686|Serotonin Agents|serotonin agents|mesh-ancestor
110598260|NCT00712686|Antidepressive Agents|antidepressive agents|mesh-ancestor
110598261|NCT00712686|Dopamine Agonists|dopamine agonists|mesh-ancestor
110598263|NCT00712686|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110598264|NCT00712686|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110598265|NCT00712686|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110598266|NCT00712686|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110598267|NCT00712686|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110598268|NCT00712686|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110598269|NCT04041856|Povidone-Iodine|povidone-iodine|mesh-list
110598270|NCT04041856|Povidone|povidone|mesh-list
110598271|NCT04041856|Plasma Substitutes|plasma substitutes|mesh-ancestor
110598272|NCT04041856|Blood Substitutes|blood substitutes|mesh-ancestor
110598273|NCT04041856|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110598274|NCT04041856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110598275|NCT00856960|Losartan|losartan|mesh-list
110598276|NCT00856960|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110598277|NCT00856960|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110598278|NCT00856960|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110263970|NCT00172068|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110598279|NCT00856960|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110598280|NCT00856960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110598282|NCT00712764|Analgesics|analgesics|mesh-ancestor
110598283|NCT00712764|Sensory System Agents|sensory system agents|mesh-ancestor
110598284|NCT00712764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110598285|NCT00712764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110598286|NCT00712764|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110598287|NCT00712764|Vasodilator Agents|vasodilator agents|mesh-ancestor
110598288|NCT00712764|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
110598289|NCT00712764|Purinergic Agonists|purinergic agonists|mesh-ancestor
110598290|NCT00712764|Purinergic Agents|purinergic agents|mesh-ancestor
110598291|NCT00712764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110598292|NCT00712764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110598293|NCT00848458|Azelaic acid|azelaic acid|mesh-list
110598294|NCT00848458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110598295|NCT00848458|Dermatologic Agents|dermatologic agents|mesh-ancestor
110598296|NCT00578786|Ambrisentan|ambrisentan|mesh-list
110598297|NCT00578786|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110598298|NCT00424255|Lapatinib|lapatinib|mesh-list
110598299|NCT00424255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110598300|NCT00424255|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110598301|NCT00424255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110264088|NCT04922983|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110264091|NCT04922983|Cholinergic Agents|cholinergic agents|mesh-ancestor
110598302|NCT00424255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110598303|NCT02574156|Insulin|insulin|mesh-list
110598304|NCT02574156|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110598305|NCT02574156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110598306|NCT00848692|Rituximab|rituximab|mesh-list
110598307|NCT00848692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110598308|NCT00848692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110598309|NCT00848692|Immunologic Factors|immunologic factors|mesh-ancestor
110598310|NCT00848692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110598311|NCT00848692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110598312|NCT00848770|Norepinephrine|norepinephrine|mesh-list
110598313|NCT00848770|Esmolol|esmolol|mesh-list
110598314|NCT00848770|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110264147|NCT02937415|Antioxidants|antioxidants|mesh-list
110598315|NCT00848770|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110598316|NCT00848770|Adrenergic Agents|adrenergic agents|mesh-ancestor
110598317|NCT00848770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110598318|NCT00848770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110598319|NCT00848770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110598320|NCT00848770|Sympathomimetics|sympathomimetics|mesh-ancestor
110598321|NCT00848770|Autonomic Agents|autonomic agents|mesh-ancestor
110264209|NCT00152633|Losartan|losartan|mesh-list
110598323|NCT00848770|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110598324|NCT00848770|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110598325|NCT00848770|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110598326|NCT00848770|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110598327|NCT00717704|Dasatinib|dasatinib|mesh-list
110598328|NCT00717704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110598329|NCT00717704|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110598330|NCT00717704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110598331|NCT00717704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110598332|NCT00620074|Voriconazole|voriconazole|mesh-list
110598333|NCT00620074|Anidulafungin|anidulafungin|mesh-list
110598334|NCT00620074|Antifungal Agents|antifungal agents|mesh-ancestor
110598335|NCT00620074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110598336|NCT00620074|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110598337|NCT00620074|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110598338|NCT00620074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110598339|NCT00620074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110598340|NCT00620074|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110264279|NCT00165087|Doxorubicin|doxorubicin|mesh-list
110598341|NCT00620074|Hormone Antagonists|hormone antagonists|mesh-ancestor
110598342|NCT00620074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110598343|NCT00620074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110598344|NCT00620074|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110598345|NCT02571296|Progesterone|progesterone|mesh-list
110598346|NCT02571296|Progestins|progestins|mesh-ancestor
110598347|NCT02571296|Hormones|hormones|mesh-ancestor
110151521|NCT00001033|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110598348|NCT02571296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110598349|NCT02571296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110598350|NCT00857038|Doxycycline|doxycycline|mesh-list
110598351|NCT00857038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110598352|NCT00857038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110598353|NCT00857038|Antimalarials|antimalarials|mesh-ancestor
110598354|NCT00857038|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110598355|NCT00857038|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110598356|NCT00857116|Albendazole|albendazole|mesh-list
110598357|NCT00857116|Anthelmintics|anthelmintics|mesh-ancestor
110598358|NCT00857116|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110598359|NCT00857116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110598360|NCT00857116|Anticestodal Agents|anticestodal agents|mesh-ancestor
110598361|NCT00857116|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110598362|NCT00857116|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110598363|NCT00857116|Tubulin Modulators|tubulin modulators|mesh-ancestor
110598364|NCT00857116|Antimitotic Agents|antimitotic agents|mesh-ancestor
110598365|NCT00857116|Mitosis Modulators|mitosis modulators|mesh-ancestor
110598366|NCT00857116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110598367|NCT00857116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110598368|NCT00717782|Botulinum Toxins|botulinum toxins|mesh-list
110598369|NCT00717782|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110598370|NCT00717782|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110598371|NCT00717782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110598372|NCT00717782|Cholinergic Agents|cholinergic agents|mesh-ancestor
110598373|NCT00717782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110264463|NCT02935075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110264489|NCT00153023|Valsartan|valsartan|mesh-list
110598374|NCT00717782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110598375|NCT00717938|Carboplatin|carboplatin|mesh-list
110598376|NCT00717938|Etoposide|etoposide|mesh-list
110598377|NCT00717938|Etoposide phosphate|etoposide phosphate|mesh-list
110598378|NCT00717938|Cisplatin|cisplatin|mesh-list
110598379|NCT00717938|Enoxaparin|enoxaparin|mesh-list
110598380|NCT00717938|Enoxaparin sodium|enoxaparin sodium|mesh-list
110598381|NCT00717938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110377961|NCT01081145|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110598382|NCT00717938|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110598383|NCT00717938|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110598384|NCT00717938|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110598385|NCT00717938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110598386|NCT00717938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110598387|NCT00717938|Anticoagulants|anticoagulants|mesh-ancestor
110598388|NCT00717938|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110598389|NCT00717938|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110598390|NCT00857428|Oxymorphone|oxymorphone|mesh-list
110598391|NCT00857428|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110598392|NCT00857428|Narcotics|narcotics|mesh-ancestor
110598393|NCT00857428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110598394|NCT00857428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110598395|NCT00857428|Analgesics|analgesics|mesh-ancestor
110598396|NCT00857428|Sensory System Agents|sensory system agents|mesh-ancestor
110598397|NCT00857428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110598398|NCT00857428|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110598399|NCT04018768|Acetaminophen|acetaminophen|mesh-list
110598400|NCT04018768|Ibuprofen|ibuprofen|mesh-list
110598401|NCT04018768|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
110598402|NCT04018768|Oxycodone|oxycodone|mesh-list
110598403|NCT04018768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110264520|NCT04689958|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110598404|NCT04018768|Analgesics|analgesics|mesh-ancestor
110598405|NCT04018768|Sensory System Agents|sensory system agents|mesh-ancestor
110598406|NCT04018768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110598407|NCT04018768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110598408|NCT04018768|Antipyretics|antipyretics|mesh-ancestor
110598409|NCT04018768|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110598411|NCT04018768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110598412|NCT04018768|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110598413|NCT04018768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110598414|NCT04018768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110598415|NCT04018768|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110598416|NCT04018768|Narcotics|narcotics|mesh-ancestor
110598417|NCT04018768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110598418|NCT00848848|Vaccines|vaccines|mesh-list
110598419|NCT00848848|Immunologic Factors|immunologic factors|mesh-ancestor
110264565|NCT02934061|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110264566|NCT02934061|Parasympatholytics|parasympatholytics|mesh-ancestor
110598420|NCT00848848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110598421|NCT02573922|Oxycodone|oxycodone|mesh-list
110598423|NCT02573922|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110598424|NCT02573922|Narcotics|narcotics|mesh-ancestor
110598425|NCT02573922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110598426|NCT02573922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110598427|NCT02573922|Analgesics|analgesics|mesh-ancestor
110598428|NCT02573922|Sensory System Agents|sensory system agents|mesh-ancestor
110598429|NCT02573922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110598430|NCT02573922|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110264625|NCT00165399|Goserelin|goserelin|mesh-list
110598432|NCT00852436|Analgesics|analgesics|mesh-ancestor
110598433|NCT00852436|Sensory System Agents|sensory system agents|mesh-ancestor
110598434|NCT00852436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110598435|NCT00852436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110598436|NCT00852436|Anticonvulsants|anticonvulsants|mesh-ancestor
110598437|NCT00852436|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110598438|NCT00852436|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110598439|NCT00852436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110598440|NCT00852436|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110598441|NCT00852436|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110598442|NCT00852436|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110264690|NCT00165477|Lenalidomide|lenalidomide|mesh-list
110598443|NCT00852436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110598444|NCT00852436|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110598445|NCT00720512|Leucovorin|leucovorin|mesh-list
110598446|NCT00720512|Bevacizumab|bevacizumab|mesh-list
110598447|NCT00720512|Fluorouracil|fluorouracil|mesh-list
110598448|NCT00720512|Oxaliplatin|oxaliplatin|mesh-list
110598449|NCT00720512|Irinotecan|irinotecan|mesh-list
110598450|NCT00720512|Calcium|calcium|mesh-list
110598451|NCT00720512|Levoleucovorin|levoleucovorin|mesh-list
110377967|NCT00174915|Allopurinol|allopurinol|mesh-list
110598452|NCT00720512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110598453|NCT00720512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110598454|NCT00720512|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110598455|NCT00720512|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110598456|NCT00720512|Growth Substances|growth substances|mesh-ancestor
110598457|NCT00720512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110598458|NCT00720512|Growth Inhibitors|growth inhibitors|mesh-ancestor
110598459|NCT00720512|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110598460|NCT00720512|Antimetabolites|antimetabolites|mesh-ancestor
110598461|NCT00720512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110598462|NCT00720512|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110598463|NCT00720512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110598464|NCT00720512|Immunologic Factors|immunologic factors|mesh-ancestor
110598465|NCT00720512|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110598466|NCT00720512|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110598467|NCT00720512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110598468|NCT00720512|Antidotes|antidotes|mesh-ancestor
110598469|NCT00720512|Protective Agents|protective agents|mesh-ancestor
110598470|NCT00720512|Vitamin B Complex|vitamin b complex|mesh-ancestor
110598471|NCT00720512|Vitamins|vitamins|mesh-ancestor
110598472|NCT00720512|Micronutrients|micronutrients|mesh-ancestor
110598473|NCT04069286|Amoxicillin|amoxicillin|mesh-list
110598474|NCT04069286|Omeprazole|omeprazole|mesh-list
110598475|NCT04069286|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110598476|NCT04069286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110598477|NCT04069286|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110598478|NCT04069286|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110598479|NCT04069286|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110598480|NCT04069286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110598481|NCT04069286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110598482|NCT00713622|Zonisamide|zonisamide|mesh-list
110598483|NCT00713622|Valproic Acid|valproic acid|mesh-list
110598484|NCT00713622|Anticonvulsants|anticonvulsants|mesh-ancestor
110245799|NCT00465439|Mydriatics|mydriatics|mesh-ancestor
110598485|NCT00713622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110598486|NCT00713622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110598487|NCT00713622|GABA Agents|gaba agents|mesh-ancestor
110598488|NCT00713622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110598489|NCT00713622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110598490|NCT00713622|Antimanic Agents|antimanic agents|mesh-ancestor
110598491|NCT00713622|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110598492|NCT00713622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110598493|NCT00713622|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110598494|NCT00713622|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110598495|NCT00713622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110598496|NCT00713622|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110598498|NCT00718172|Antimetabolites|antimetabolites|mesh-ancestor
110598499|NCT00718172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110598500|NCT00718172|Antiviral Agents|antiviral agents|mesh-ancestor
110264865|NCT02924974|Sensory System Agents|sensory system agents|mesh-ancestor
110598501|NCT00718172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110598502|NCT00720018|Sumatriptan|sumatriptan|mesh-list
110598503|NCT00720018|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110598504|NCT00720018|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110598505|NCT00720018|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110598506|NCT00720018|Serotonin Agents|serotonin agents|mesh-ancestor
110598507|NCT00720018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110598508|NCT00720018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110598509|NCT00720018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110598510|NCT03992456|Trifluridine|trifluridine|mesh-list
110598511|NCT03992456|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110598512|NCT03992456|Panitumumab|panitumumab|mesh-list
110598513|NCT03992456|Antibodies|antibodies|mesh-list
110598514|NCT03992456|Immunoglobulins|immunoglobulins|mesh-list
110598515|NCT03992456|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110598516|NCT03992456|Immunologic Factors|immunologic factors|mesh-ancestor
110598517|NCT03992456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110598518|NCT03992456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110264920|NCT02924506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110598520|NCT03992456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110598521|NCT03992456|Antiviral Agents|antiviral agents|mesh-ancestor
110598522|NCT03992456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110598523|NCT00618826|Paclitaxel|paclitaxel|mesh-list
110598524|NCT00618826|Gemcitabine|gemcitabine|mesh-list
110598525|NCT00618826|Bevacizumab|bevacizumab|mesh-list
110598526|NCT00618826|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110598527|NCT00618826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110598528|NCT00618826|Tubulin Modulators|tubulin modulators|mesh-ancestor
110598529|NCT00618826|Antimitotic Agents|antimitotic agents|mesh-ancestor
110598530|NCT00618826|Mitosis Modulators|mitosis modulators|mesh-ancestor
110598531|NCT00618826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110598532|NCT00618826|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110598533|NCT00618826|Antimetabolites|antimetabolites|mesh-ancestor
110598534|NCT00618826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110598535|NCT00618826|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110598536|NCT00618826|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110264976|NCT00187941|Antitubercular Agents|antitubercular agents|mesh-ancestor
110598537|NCT00618826|Growth Substances|growth substances|mesh-ancestor
110598538|NCT00618826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110598539|NCT00618826|Growth Inhibitors|growth inhibitors|mesh-ancestor
110598540|NCT00720174|Doxorubicin|doxorubicin|mesh-list
110598541|NCT00720174|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110598542|NCT00720174|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110598543|NCT00720174|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110598544|NCT00720174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110598545|NCT00720174|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110598546|NCT00720174|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110598547|NCT00720174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110598548|NCT00720174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110598549|NCT00720174|Immunologic Factors|immunologic factors|mesh-ancestor
110598550|NCT00720174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110598551|NCT00722930|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110598552|NCT00722930|Immunologic Factors|immunologic factors|mesh-ancestor
110598553|NCT00722930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110598554|NCT03834740|Everolimus|everolimus|mesh-list
110598555|NCT03834740|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110598556|NCT03834740|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110598557|NCT03834740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110598558|NCT03834740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110598559|NCT03834740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110598560|NCT03834740|Immunologic Factors|immunologic factors|mesh-ancestor
110598561|NCT03834740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110598562|NCT03834740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110598563|NCT00849082|Goserelin|goserelin|mesh-list
110598564|NCT00849082|Cyproterone Acetate|cyproterone acetate|mesh-list
110598565|NCT00849082|Cyproterone|cyproterone|mesh-list
110598566|NCT00849082|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110598567|NCT00849082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110598568|NCT00849082|Androgen Antagonists|androgen antagonists|mesh-ancestor
110598569|NCT00849082|Hormone Antagonists|hormone antagonists|mesh-ancestor
110598570|NCT00849082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110598571|NCT00849082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110598572|NCT00849082|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110598573|NCT00849082|Contraceptive Agents|contraceptive agents|mesh-ancestor
110598574|NCT00849082|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110598575|NCT00849160|Darunavir|darunavir|mesh-list
110598576|NCT00849160|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110598577|NCT00849160|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110598578|NCT00849160|Protease Inhibitors|protease inhibitors|mesh-ancestor
110598579|NCT00849160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110598580|NCT00849160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110598581|NCT00849160|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110598582|NCT00849160|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110598583|NCT00849160|Antiviral Agents|antiviral agents|mesh-ancestor
110265085|NCT04689100|Antimetabolites|antimetabolites|mesh-ancestor
110598584|NCT00849160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110598585|NCT00720590|Ritonavir|ritonavir|mesh-list
110598587|NCT00720590|Atazanavir Sulfate|atazanavir sulfate|mesh-list
110598588|NCT00720590|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110598589|NCT00720590|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110598590|NCT00720590|Protease Inhibitors|protease inhibitors|mesh-ancestor
110598591|NCT00720590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110598592|NCT00720590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110598593|NCT00720590|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110598594|NCT00720590|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110598595|NCT00720590|Antiviral Agents|antiviral agents|mesh-ancestor
110598596|NCT00720590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110598597|NCT00720590|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110598598|NCT00720590|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110598599|NCT00718406|Metoprolol|metoprolol|mesh-list
110598600|NCT00718406|Morphine|morphine|mesh-list
110598601|NCT00718406|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110598602|NCT00718406|Narcotics|narcotics|mesh-ancestor
110598603|NCT00718406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110598604|NCT00718406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110598605|NCT00718406|Analgesics|analgesics|mesh-ancestor
110598606|NCT00718406|Sensory System Agents|sensory system agents|mesh-ancestor
110598607|NCT00718406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110265137|NCT02920801|Metformin|metformin|mesh-list
110598608|NCT00718406|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110598609|NCT00718406|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110598610|NCT00718406|Sympatholytics|sympatholytics|mesh-ancestor
110598611|NCT00718406|Autonomic Agents|autonomic agents|mesh-ancestor
110598612|NCT00718406|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110598613|NCT00718406|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110598614|NCT00718406|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110598615|NCT00718406|Adrenergic Agents|adrenergic agents|mesh-ancestor
110598616|NCT00718406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110598617|NCT00718406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110598618|NCT00849238|Mycophenolic Acid|mycophenolic acid|mesh-list
110598619|NCT00849238|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110598620|NCT00849238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110598621|NCT00849238|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110598622|NCT00849238|Antitubercular Agents|antitubercular agents|mesh-ancestor
110598623|NCT00849238|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110598624|NCT00849238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110598625|NCT00849238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110598626|NCT00849238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110598627|NCT00720408|Mycophenolic Acid|mycophenolic acid|mesh-list
110598628|NCT00720408|Tacrolimus|tacrolimus|mesh-list
110598629|NCT00720408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110598630|NCT00720408|Immunologic Factors|immunologic factors|mesh-ancestor
110598631|NCT00720408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110598632|NCT00720408|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110598633|NCT00720408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110598634|NCT00720408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110598635|NCT00720408|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110598636|NCT00720408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110598637|NCT00720408|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110265257|NCT00154739|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110598638|NCT00720408|Antitubercular Agents|antitubercular agents|mesh-ancestor
110598639|NCT00720408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110598640|NCT00720408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110598642|NCT00849316|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110598643|NCT00849316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110598644|NCT00852670|Ponesimod|ponesimod|mesh-list
110598645|NCT00852670|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
110598646|NCT00852670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110598647|NCT00852670|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110598648|NCT00852670|Immunologic Factors|immunologic factors|mesh-ancestor
110598649|NCT00852670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110598650|NCT00717210|Temozolomide|temozolomide|mesh-list
110598651|NCT00717210|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110598652|NCT00717210|Alkylating Agents|alkylating agents|mesh-ancestor
110598653|NCT00717210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110598654|NCT00717210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110598656|NCT00723086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110598657|NCT00723086|Tubulin Modulators|tubulin modulators|mesh-ancestor
110598658|NCT00723086|Antimitotic Agents|antimitotic agents|mesh-ancestor
110598659|NCT00723086|Mitosis Modulators|mitosis modulators|mesh-ancestor
110598660|NCT00723086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110598661|NCT04018378|Varenicline|varenicline|mesh-list
110598662|NCT04018378|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110598663|NCT04018378|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110598664|NCT04018378|Cholinergic Agents|cholinergic agents|mesh-ancestor
110598665|NCT04018378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110265379|NCT02939833|Ropivacaine|ropivacaine|mesh-list
110598666|NCT04018378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110598667|NCT04018378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110598668|NCT00849550|Bevacizumab|bevacizumab|mesh-list
110598669|NCT00849550|Capecitabine|capecitabine|mesh-list
110598670|NCT00849550|Oxaliplatin|oxaliplatin|mesh-list
110598672|NCT00849550|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110598673|NCT00849550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110598674|NCT00849550|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110598675|NCT00849550|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110598676|NCT00849550|Growth Substances|growth substances|mesh-ancestor
110598677|NCT00849550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110598678|NCT00849550|Growth Inhibitors|growth inhibitors|mesh-ancestor
110598679|NCT00849550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110598680|NCT00849550|Antimetabolites|antimetabolites|mesh-ancestor
110598681|NCT00849550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110265441|NCT00533416|ON 01910|on 01910|mesh-list
110598682|NCT00849550|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110598683|NCT00849550|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110598684|NCT00849550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110598685|NCT00849550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110598686|NCT00849550|Immunologic Factors|immunologic factors|mesh-ancestor
110598687|NCT03816488|Metformin|metformin|mesh-list
110598688|NCT03816488|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
110598689|NCT03816488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110598690|NCT03816488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110598691|NCT03816488|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110598692|NCT03816488|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110598693|NCT03816488|Analgesics|analgesics|mesh-ancestor
110598694|NCT03816488|Sensory System Agents|sensory system agents|mesh-ancestor
110598695|NCT03816488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110265501|NCT00155714|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110598696|NCT03816488|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110598697|NCT03816488|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110598698|NCT00858676|Acarbose|acarbose|mesh-list
110598699|NCT00858676|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
110598700|NCT00858676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110598701|NCT00858676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110598702|NCT00858676|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110598703|NCT00858676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110598704|NCT00858754|Methylnaltrexone|methylnaltrexone|mesh-list
110598705|NCT00858754|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110598706|NCT00858754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110598707|NCT00858754|Sensory System Agents|sensory system agents|mesh-ancestor
110598708|NCT00858754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110598710|NCT00723164|Midazolam|midazolam|mesh-list
110598711|NCT00723164|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110265558|NCT00409227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110598712|NCT00723164|Narcotics|narcotics|mesh-ancestor
110598713|NCT00723164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110598714|NCT00723164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110598715|NCT00723164|Analgesics|analgesics|mesh-ancestor
110598716|NCT00723164|Sensory System Agents|sensory system agents|mesh-ancestor
110598717|NCT00723164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110598718|NCT00723164|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110598719|NCT00723164|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110598720|NCT00723164|Anesthetics, General|anesthetics, general|mesh-ancestor
110598721|NCT00723164|Anesthetics|anesthetics|mesh-ancestor
110598722|NCT00723164|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110598723|NCT00723164|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110598724|NCT00723164|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110265616|NCT00181896|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110598725|NCT00723164|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110598727|NCT00723164|GABA Agents|gaba agents|mesh-ancestor
110598728|NCT00723164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110598729|NCT00723164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110598730|NCT00723242|Ribavirin|ribavirin|mesh-list
110598731|NCT00723242|Antimetabolites|antimetabolites|mesh-ancestor
110598732|NCT00723242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110598733|NCT00723242|Antiviral Agents|antiviral agents|mesh-ancestor
110598734|NCT00723242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110265679|NCT04883632|Sensory System Agents|sensory system agents|mesh-ancestor
110598736|NCT02545426|Calcium|calcium|mesh-list
110598737|NCT02545426|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110598738|NCT02545426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110598739|NCT02545426|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110598740|NCT00720824|Anesthetics|anesthetics|mesh-list
110598741|NCT00720824|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
110598742|NCT00720824|Anesthetics, Local|anesthetics, local|mesh-list
110598743|NCT00720824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110598744|NCT00720824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110598745|NCT00720824|Sensory System Agents|sensory system agents|mesh-ancestor
110598746|NCT00720824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110598747|NCT05373134|Pentoxifylline|pentoxifylline|mesh-list
110598748|NCT05373134|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110598749|NCT05373134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110598750|NCT05373134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110598751|NCT05373134|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110598752|NCT05373134|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110598753|NCT05373134|Protective Agents|protective agents|mesh-ancestor
110598754|NCT05373134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110598755|NCT05373134|Vasodilator Agents|vasodilator agents|mesh-ancestor
110598756|NCT05373134|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110598757|NCT05373134|Antioxidants|antioxidants|mesh-ancestor
110598758|NCT00723320|Atorvastatin|atorvastatin|mesh-list
110598759|NCT00723320|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110598760|NCT00723320|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110598761|NCT00723320|Antimetabolites|antimetabolites|mesh-ancestor
110598762|NCT00723320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110598763|NCT00723320|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110598764|NCT00723320|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110598765|NCT00723320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110598766|NCT00578448|Abatacept|abatacept|mesh-list
110598767|NCT00578448|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110598768|NCT00578448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110598769|NCT00578448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110598770|NCT00578448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110598771|NCT00578448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110598772|NCT00578448|Immunologic Factors|immunologic factors|mesh-ancestor
110598773|NCT00578448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110598774|NCT00578448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110598775|NCT00720564|Temozolomide|temozolomide|mesh-list
110598776|NCT00720564|Arsenic Trioxide|arsenic trioxide|mesh-list
110598777|NCT00720564|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110598778|NCT00720564|Alkylating Agents|alkylating agents|mesh-ancestor
110378002|NCT01080131|Triamcinolone|triamcinolone|mesh-list
110598779|NCT00720564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110598780|NCT00720564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110598781|NCT00714090|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
110598782|NCT00714090|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110598783|NCT00714090|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110598784|NCT00714090|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110598785|NCT00714090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110598786|NCT00714090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110598787|NCT00714090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110598788|NCT00714090|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110598789|NCT00714090|Antidepressive Agents|antidepressive agents|mesh-ancestor
110598790|NCT00714090|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110598791|NCT04067024|Anesthetics|anesthetics|mesh-list
110598792|NCT04067024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110598793|NCT04067024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110598795|NCT00618748|Antiemetics|antiemetics|mesh-ancestor
110598796|NCT00618748|Autonomic Agents|autonomic agents|mesh-ancestor
110598797|NCT00618748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110598798|NCT00618748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110598799|NCT00618748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110598800|NCT00618748|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110598801|NCT00618748|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110265921|NCT00156611|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110598802|NCT00618748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110598803|NCT00618748|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110598804|NCT00618748|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110598805|NCT00618748|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110598806|NCT00618748|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110598807|NCT00618748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110598808|NCT00618748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110598809|NCT00618748|Serotonin Agents|serotonin agents|mesh-ancestor
110598810|NCT04067102|Paclitaxel|paclitaxel|mesh-list
110598811|NCT04067102|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110598812|NCT04067102|Cyclophosphamide|cyclophosphamide|mesh-list
110598813|NCT04067102|Carboplatin|carboplatin|mesh-list
110598814|NCT04067102|Epirubicin|epirubicin|mesh-list
110598815|NCT04067102|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110598816|NCT04067102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110598817|NCT04067102|Tubulin Modulators|tubulin modulators|mesh-ancestor
110598818|NCT04067102|Antimitotic Agents|antimitotic agents|mesh-ancestor
110598819|NCT04067102|Mitosis Modulators|mitosis modulators|mesh-ancestor
110598820|NCT04067102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110598821|NCT04067102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110598822|NCT04067102|Immunologic Factors|immunologic factors|mesh-ancestor
110598823|NCT04067102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110598824|NCT04067102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110265976|NCT05468047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110598825|NCT04067102|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110598826|NCT04067102|Alkylating Agents|alkylating agents|mesh-ancestor
110598827|NCT04067102|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110598828|NCT04067102|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110598829|NCT04067102|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110598830|NCT04067102|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110598831|NCT04067102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110598832|NCT05659290|Bevacizumab|bevacizumab|mesh-list
110598833|NCT05659290|Capecitabine|capecitabine|mesh-list
110598834|NCT05659290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110598835|NCT05659290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110598836|NCT05659290|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110598837|NCT05659290|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110598838|NCT05659290|Growth Substances|growth substances|mesh-ancestor
110378023|NCT01087151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110598839|NCT05659290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110598840|NCT05659290|Growth Inhibitors|growth inhibitors|mesh-ancestor
110266028|NCT00536692|Cholinergic Agents|cholinergic agents|mesh-ancestor
110598841|NCT05659290|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110598843|NCT05659290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110598844|NCT00717678|Mycophenolic Acid|mycophenolic acid|mesh-list
110598845|NCT00717678|Tacrolimus|tacrolimus|mesh-list
110598846|NCT00717678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110598847|NCT00717678|Immunologic Factors|immunologic factors|mesh-ancestor
110598848|NCT00717678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110151547|NCT00001036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110598849|NCT00717678|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110598850|NCT00717678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110598851|NCT00717678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110598852|NCT00717678|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110598853|NCT00717678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110598854|NCT00717678|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110266085|NCT04685512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110598855|NCT00717678|Antitubercular Agents|antitubercular agents|mesh-ancestor
110598856|NCT00717678|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110598857|NCT00717678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110598858|NCT00859534|Afamelanotide|afamelanotide|mesh-list
110598859|NCT00859534|Dermatologic Agents|dermatologic agents|mesh-ancestor
110598860|NCT02571842|Prednisolone|prednisolone|mesh-list
110598862|NCT02571842|Enalapril|enalapril|mesh-list
110598863|NCT02571842|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110598864|NCT02571842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110598865|NCT02571842|Immunologic Factors|immunologic factors|mesh-ancestor
110598866|NCT02571842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110598867|NCT02571842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110598868|NCT02571842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110598869|NCT02571842|Glucocorticoids|glucocorticoids|mesh-ancestor
110598870|NCT02571842|Hormones|hormones|mesh-ancestor
110598871|NCT02571842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110266152|NCT00157235|Anticonvulsants|anticonvulsants|mesh-ancestor
110598872|NCT02571842|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110598873|NCT02571842|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110598874|NCT02571842|Protease Inhibitors|protease inhibitors|mesh-ancestor
110598875|NCT02571842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110022498|NCT00002892|Interferons|interferons|mesh-list
110598876|NCT02571842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110598877|NCT02571842|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110598878|NCT02546284|Lenzilumab|lenzilumab|mesh-list
110598879|NCT02546284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110598880|NCT00721448|Ticagrelor|ticagrelor|mesh-list
110598881|NCT00721448|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110598882|NCT00721448|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110598883|NCT00721448|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110598884|NCT00721448|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110598885|NCT00721448|Purinergic Agents|purinergic agents|mesh-ancestor
110598886|NCT00721448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110266207|NCT00189618|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110598887|NCT00721448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110598888|NCT00721448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110598889|NCT00853216|Oxycodone|oxycodone|mesh-list
110598890|NCT00853216|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110598891|NCT00853216|Narcotics|narcotics|mesh-ancestor
110598892|NCT00853216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110598893|NCT00853216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110598894|NCT00853216|Analgesics|analgesics|mesh-ancestor
110598895|NCT00853216|Sensory System Agents|sensory system agents|mesh-ancestor
110598896|NCT00853216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110598897|NCT04961528|Terlipressin|terlipressin|mesh-list
110598898|NCT04961528|Tranexamic Acid|tranexamic acid|mesh-list
110598899|NCT04961528|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110598900|NCT04961528|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110598901|NCT04961528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110598902|NCT04961528|Hemostatics|hemostatics|mesh-ancestor
110598903|NCT04961528|Coagulants|coagulants|mesh-ancestor
110598904|NCT04961528|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110598905|NCT04961528|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110598906|NCT00721032|Amiodarone|amiodarone|mesh-list
110598907|NCT00721032|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110598908|NCT00721032|Vasodilator Agents|vasodilator agents|mesh-ancestor
110378034|NCT04571996|Acetaminophen|acetaminophen|mesh-list
110598909|NCT00721032|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
110598910|NCT00721032|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110266264|NCT00182715|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110598911|NCT00721032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110598912|NCT00721032|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110598913|NCT00721032|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110598914|NCT00721032|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110598915|NCT00721032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110598916|NCT00721032|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110598917|NCT00721032|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110598918|NCT00721032|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110598919|NCT00723866|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110598920|NCT00723866|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110598921|NCT00723866|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110598922|NCT00723866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110598923|NCT00723866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110598924|NCT00723866|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110598925|NCT00723866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110598926|NCT00723866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110598927|NCT00723866|Cholinergic Agents|cholinergic agents|mesh-ancestor
110598928|NCT00723866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110598929|NCT00853294|Chlorpheniramine|chlorpheniramine|mesh-list
110266316|NCT00534625|Antisickling Agents|antisickling agents|mesh-ancestor
110266317|NCT00534625|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110266318|NCT00406874|Folic Acid|folic acid|mesh-list
110266319|NCT00406874|Hematinics|hematinics|mesh-ancestor
110266320|NCT00406874|Vitamin B Complex|vitamin b complex|mesh-ancestor
110266321|NCT00406874|Vitamins|vitamins|mesh-ancestor
110266322|NCT00406874|Micronutrients|micronutrients|mesh-ancestor
110266323|NCT00406874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110266324|NCT04106830|Mycophenolic Acid|mycophenolic acid|mesh-list
110266325|NCT04106830|Azathioprine|azathioprine|mesh-list
110266326|NCT04106830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110266327|NCT04106830|Immunologic Factors|immunologic factors|mesh-ancestor
110266328|NCT04106830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110266329|NCT04106830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110266330|NCT04106830|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110266331|NCT04106830|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110266332|NCT04106830|Antitubercular Agents|antitubercular agents|mesh-ancestor
110266333|NCT04106830|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110266334|NCT04106830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110266335|NCT04106830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110266336|NCT04106830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110266337|NCT04106830|Antimetabolites|antimetabolites|mesh-ancestor
110266338|NCT04106830|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110598931|NCT00853294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110598932|NCT00853294|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110598933|NCT00853294|Narcotics|narcotics|mesh-ancestor
110598934|NCT00853294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110598935|NCT00853294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110598936|NCT00853294|Analgesics|analgesics|mesh-ancestor
110598937|NCT00853294|Sensory System Agents|sensory system agents|mesh-ancestor
110598938|NCT00853294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110598939|NCT00853294|Antitussive Agents|antitussive agents|mesh-ancestor
110598940|NCT00853294|Respiratory System Agents|respiratory system agents|mesh-ancestor
110598941|NCT00853294|Antipruritics|antipruritics|mesh-ancestor
110598942|NCT00853294|Dermatologic Agents|dermatologic agents|mesh-ancestor
110598943|NCT00853294|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110598944|NCT00853294|Histamine Antagonists|histamine antagonists|mesh-ancestor
110598945|NCT00853294|Histamine Agents|histamine agents|mesh-ancestor
110598946|NCT00853294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110598947|NCT00853294|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110598948|NCT03246230|BCG Vaccine|bcg vaccine|mesh-list
110598949|NCT03246230|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110266352|NCT00406913|Mupirocin|mupirocin|mesh-list
110598950|NCT03246230|Immunologic Factors|immunologic factors|mesh-ancestor
110598951|NCT03246230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110598952|NCT00717834|Formaldehyde|formaldehyde|mesh-list
110598953|NCT00717834|Disinfectants|disinfectants|mesh-ancestor
110598954|NCT00717834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110598955|NCT00658359|Cyclosporine|cyclosporine|mesh-list
110598956|NCT00658359|Cyclosporins|cyclosporins|mesh-list
110598957|NCT00658359|Tofacitinib|tofacitinib|mesh-list
110598958|NCT00658359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110598959|NCT00658359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110598960|NCT00658359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110598961|NCT00658359|Immunologic Factors|immunologic factors|mesh-ancestor
110598962|NCT00658359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110598963|NCT00658359|Antifungal Agents|antifungal agents|mesh-ancestor
110598964|NCT00658359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110598965|NCT00658359|Dermatologic Agents|dermatologic agents|mesh-ancestor
110598966|NCT00658359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110598967|NCT00658359|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110598968|NCT00658359|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
110598969|NCT00658359|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110598970|NCT00853450|Clopidogrel|clopidogrel|mesh-list
110266404|NCT04061161|Parasympatholytics|parasympatholytics|mesh-ancestor
110266422|NCT00182871|Androgens|androgens|mesh-ancestor
110598971|NCT00853450|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110598972|NCT00853450|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110598973|NCT00853450|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110598974|NCT00853450|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110598975|NCT00853450|Purinergic Agents|purinergic agents|mesh-ancestor
110598976|NCT00853450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110598977|NCT00853450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110598978|NCT00853450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110598979|NCT04066790|Paclitaxel|paclitaxel|mesh-list
110598980|NCT04066790|Trastuzumab|trastuzumab|mesh-list
110266462|NCT03748810|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110266463|NCT03748810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110266464|NCT03748810|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110266465|NCT03748810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110266466|NCT03748810|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110266467|NCT03748810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110266471|NCT00157859|Chloroquine|chloroquine|mesh-list
110598981|NCT04066790|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110598982|NCT04066790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110598983|NCT04066790|Tubulin Modulators|tubulin modulators|mesh-ancestor
110598984|NCT04066790|Antimitotic Agents|antimitotic agents|mesh-ancestor
110598985|NCT04066790|Mitosis Modulators|mitosis modulators|mesh-ancestor
110598986|NCT04066790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110598987|NCT04066790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110598988|NCT00721604|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
110598989|NCT00721604|Plasma Substitutes|plasma substitutes|mesh-ancestor
110598990|NCT00721604|Blood Substitutes|blood substitutes|mesh-ancestor
110598991|NCT02571192|Volixibat|volixibat|mesh-list
110598992|NCT02571192|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110598993|NCT00724022|Mycophenolic Acid|mycophenolic acid|mesh-list
110598994|NCT00724022|Prednisolone|prednisolone|mesh-list
110598995|NCT00724022|Tacrolimus|tacrolimus|mesh-list
110598996|NCT00724022|Thymoglobulin|thymoglobulin|mesh-list
110266522|NCT00158093|Adrenergic Agents|adrenergic agents|mesh-ancestor
110266523|NCT00158093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110266524|NCT00158093|Vasodilator Agents|vasodilator agents|mesh-ancestor
110266525|NCT00158093|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
110598997|NCT00724022|Basiliximab|basiliximab|mesh-list
110598998|NCT00724022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110598999|NCT00724022|Immunologic Factors|immunologic factors|mesh-ancestor
110599000|NCT00724022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110599001|NCT00724022|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110599002|NCT00724022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110599003|NCT00724022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110599004|NCT00724022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110599006|NCT00724022|Hormones|hormones|mesh-ancestor
110266580|NCT00158210|Rivastigmine|rivastigmine|mesh-list
110599007|NCT00724022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110599008|NCT00724022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110599009|NCT00724022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110599010|NCT00724022|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110599011|NCT00724022|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110599012|NCT00724022|Antitubercular Agents|antitubercular agents|mesh-ancestor
110599013|NCT00724022|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110599014|NCT00724022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110599015|NCT00721344|Moxifloxacin|moxifloxacin|mesh-list
110599016|NCT00721344|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110599017|NCT00721344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110266645|NCT00158522|Immunologic Factors|immunologic factors|mesh-ancestor
110266646|NCT00158522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110266648|NCT00158561|Sulfadoxine|sulfadoxine|mesh-list
110266649|NCT00158561|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
110266651|NCT00158561|Chlorproguanil|chlorproguanil|mesh-list
110266652|NCT00158561|Antimalarials|antimalarials|mesh-ancestor
110599018|NCT00721344|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110599019|NCT00721344|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110599020|NCT00721344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110599021|NCT00721344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110599022|NCT00721344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110599023|NCT00717990|Bevacizumab|bevacizumab|mesh-list
110599024|NCT00717990|Capecitabine|capecitabine|mesh-list
110599025|NCT00717990|Irinotecan|irinotecan|mesh-list
110599026|NCT00717990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110599027|NCT00717990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110599028|NCT00717990|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110599029|NCT00717990|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110599030|NCT00717990|Growth Substances|growth substances|mesh-ancestor
110599031|NCT00717990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110599032|NCT00717990|Growth Inhibitors|growth inhibitors|mesh-ancestor
110599033|NCT00717990|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110599034|NCT00717990|Antimetabolites|antimetabolites|mesh-ancestor
110599035|NCT00717990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110599036|NCT00717990|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110599037|NCT00717990|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110599038|NCT00717990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110599039|NCT02572986|Permethrin|permethrin|mesh-list
110599040|NCT02572986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110599041|NCT02572986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110599042|NCT00853684|Capecitabine|capecitabine|mesh-list
110599043|NCT00853684|Endostar protein|endostar protein|mesh-list
110266712|NCT00538486|Amlodipine|amlodipine|mesh-list
110599044|NCT00853684|Endostatins|endostatins|mesh-list
110599045|NCT00853684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110599046|NCT00853684|Antimetabolites|antimetabolites|mesh-ancestor
110599047|NCT00853684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110599048|NCT00853684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110599049|NCT00853684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110599050|NCT00853684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110599051|NCT00853684|Growth Substances|growth substances|mesh-ancestor
110599052|NCT00853684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110599053|NCT00853684|Growth Inhibitors|growth inhibitors|mesh-ancestor
110599054|NCT00723060|Escitalopram|escitalopram|mesh-list
110599055|NCT00723060|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110599056|NCT00723060|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110599057|NCT00723060|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110599058|NCT00723060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110599059|NCT00723060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110599060|NCT00723060|Serotonin Agents|serotonin agents|mesh-ancestor
110266756|NCT00538603|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110266759|NCT00158834|Xhance|xhance|mesh-list
110599061|NCT00723060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110599062|NCT02571140|Teriparatide|teriparatide|mesh-list
110599063|NCT02571140|Parathyroid Hormone|parathyroid hormone|mesh-list
110599064|NCT02571140|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110599065|NCT02571140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110599066|NCT02571140|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110599067|NCT00723216|Enoxaparin|enoxaparin|mesh-list
110599068|NCT00723216|Anticoagulants|anticoagulants|mesh-ancestor
110599069|NCT00723216|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110599070|NCT00723216|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110599071|NCT00723216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110599072|NCT00724178|Vitamin D|vitamin d|mesh-list
110599073|NCT00724178|Cholecalciferol|cholecalciferol|mesh-list
110599074|NCT00724178|Calcium Carbonate|calcium carbonate|mesh-list
110599075|NCT00724178|Calcium|calcium|mesh-list
110266813|NCT00158873|GABA Agents|gaba agents|mesh-ancestor
110266814|NCT00158873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110266815|NCT00158873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110266817|NCT00158873|Antiemetics|antiemetics|mesh-ancestor
110266818|NCT00158873|Autonomic Agents|autonomic agents|mesh-ancestor
110266819|NCT00158873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110599076|NCT00724178|Vitamins|vitamins|mesh-ancestor
110599077|NCT00724178|Micronutrients|micronutrients|mesh-ancestor
110599078|NCT00724178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110599079|NCT00724178|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110599080|NCT00724178|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110599082|NCT00724178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110599083|NCT00724178|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110599084|NCT02546050|Metformin|metformin|mesh-list
110599085|NCT02546050|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110599086|NCT02546050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110599087|NCT04800224|Propolis|propolis|mesh-list
110599088|NCT04800224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110599089|NCT00718146|Vaccines|vaccines|mesh-list
110599090|NCT00718146|Immunologic Factors|immunologic factors|mesh-ancestor
110599091|NCT00718146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110599092|NCT00860626|Interferons|interferons|mesh-list
110599093|NCT00860626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110599094|NCT00860626|Antiviral Agents|antiviral agents|mesh-ancestor
110599095|NCT00860626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110599096|NCT00724256|Ceftibuten|ceftibuten|mesh-list
110266869|NCT00158990|Antidepressive Agents|antidepressive agents|mesh-ancestor
110266870|NCT00158990|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110599097|NCT00724256|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110599098|NCT00724256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110599100|NCT04742660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110599101|NCT01005914|Cytarabine|cytarabine|mesh-list
110599102|NCT01005914|Dexamethasone|dexamethasone|mesh-list
110599103|NCT01005914|Methylprednisolone|methylprednisolone|mesh-list
110599104|NCT01005914|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110599105|NCT01005914|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110599106|NCT01005914|Cyclophosphamide|cyclophosphamide|mesh-list
110599107|NCT01005914|Doxorubicin|doxorubicin|mesh-list
110599108|NCT01005914|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110599109|NCT01005914|Methotrexate|methotrexate|mesh-list
110599110|NCT01005914|Vincristine|vincristine|mesh-list
110599111|NCT01005914|Imatinib Mesylate|imatinib mesylate|mesh-list
110266922|NCT00537550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110599112|NCT01005914|Asparaginase|asparaginase|mesh-list
110599113|NCT01005914|Pegaspargase|pegaspargase|mesh-list
110599114|NCT01005914|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110599115|NCT01005914|Immunologic Factors|immunologic factors|mesh-ancestor
110599116|NCT01005914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110599117|NCT01005914|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110599118|NCT01005914|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110599119|NCT01005914|Alkylating Agents|alkylating agents|mesh-ancestor
110599120|NCT01005914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110599121|NCT01005914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110599122|NCT01005914|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110599123|NCT01005914|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110599124|NCT01005914|Antiemetics|antiemetics|mesh-ancestor
110599125|NCT01005914|Autonomic Agents|autonomic agents|mesh-ancestor
110599126|NCT01005914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110599127|NCT01005914|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110599128|NCT01005914|Glucocorticoids|glucocorticoids|mesh-ancestor
110266981|NCT00183807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110266982|NCT00183807|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110599130|NCT01005914|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110599131|NCT01005914|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110599133|NCT01005914|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110599134|NCT01005914|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110599135|NCT01005914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110599136|NCT01005914|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110599137|NCT01005914|Abortifacient Agents|abortifacient agents|mesh-ancestor
110599138|NCT01005914|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110599139|NCT01005914|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110599140|NCT01005914|Antimetabolites|antimetabolites|mesh-ancestor
110267039|NCT00540202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110267040|NCT00540202|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110267041|NCT00540202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110267053|NCT00159224|Ritonavir|ritonavir|mesh-list
110599141|NCT01005914|Dermatologic Agents|dermatologic agents|mesh-ancestor
110599142|NCT01005914|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110599143|NCT01005914|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110599144|NCT01005914|Antiviral Agents|antiviral agents|mesh-ancestor
110599145|NCT01005914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110599146|NCT01005914|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110599147|NCT01005914|Tubulin Modulators|tubulin modulators|mesh-ancestor
110599148|NCT01005914|Antimitotic Agents|antimitotic agents|mesh-ancestor
110599149|NCT01005914|Mitosis Modulators|mitosis modulators|mesh-ancestor
110599150|NCT01005914|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110599151|NCT01005914|Protective Agents|protective agents|mesh-ancestor
110267098|NCT00540631|Immunologic Factors|immunologic factors|mesh-ancestor
110267099|NCT00540631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110267100|NCT00183885|Mitomycins|mitomycins|mesh-list
110267101|NCT00183885|Mitomycin|mitomycin|mesh-list
110267102|NCT00183885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110267103|NCT00183885|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110267104|NCT00183885|Alkylating Agents|alkylating agents|mesh-ancestor
110267105|NCT00183885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110267106|NCT00183885|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110267112|NCT00540748|Oxytocics|oxytocics|mesh-ancestor
110599152|NCT01005914|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110599153|NCT00854230|Naltrexone|naltrexone|mesh-list
110599154|NCT00854230|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110599155|NCT00854230|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110599156|NCT00854230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110599157|NCT00854230|Sensory System Agents|sensory system agents|mesh-ancestor
110599158|NCT00854230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110599159|NCT00861016|Metoprolol|metoprolol|mesh-list
110599160|NCT00861016|Felodipine|felodipine|mesh-list
110599161|NCT00861016|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110599162|NCT00861016|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110599163|NCT00861016|Sympatholytics|sympatholytics|mesh-ancestor
110599164|NCT00861016|Autonomic Agents|autonomic agents|mesh-ancestor
110599165|NCT00861016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110599166|NCT00861016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110267151|NCT00540787|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110599167|NCT00861016|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110599168|NCT00861016|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110599169|NCT00861016|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110599170|NCT00861016|Adrenergic Agents|adrenergic agents|mesh-ancestor
110599171|NCT00861016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110599172|NCT00861016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110599173|NCT00861016|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110599174|NCT00861016|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110599175|NCT00861016|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110599176|NCT00861016|Vasodilator Agents|vasodilator agents|mesh-ancestor
110599177|NCT00721916|Leucovorin|leucovorin|mesh-list
110599178|NCT00721916|Oxaliplatin|oxaliplatin|mesh-list
110599179|NCT00721916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110599180|NCT00721916|Antidotes|antidotes|mesh-ancestor
110267212|NCT00541177|Mydriatics|mydriatics|mesh-ancestor
110267213|NCT00541177|Parasympatholytics|parasympatholytics|mesh-ancestor
110267214|NCT00541177|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110599181|NCT00721916|Protective Agents|protective agents|mesh-ancestor
110599182|NCT00721916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110599183|NCT00721916|Vitamin B Complex|vitamin b complex|mesh-ancestor
110599184|NCT00721916|Vitamins|vitamins|mesh-ancestor
110599185|NCT00721916|Micronutrients|micronutrients|mesh-ancestor
110599186|NCT00861250|Dexamethasone|dexamethasone|mesh-list
110599187|NCT00861250|Bortezomib|bortezomib|mesh-list
110599188|NCT00861250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110599189|NCT00861250|Antiemetics|antiemetics|mesh-ancestor
110599190|NCT00861250|Autonomic Agents|autonomic agents|mesh-ancestor
110599191|NCT00861250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110267271|NCT00541489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110267272|NCT00541489|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
110267273|NCT00190437|Amoxicillin|amoxicillin|mesh-list
110267274|NCT00190437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110599192|NCT00861250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110599193|NCT00861250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110599194|NCT00861250|Glucocorticoids|glucocorticoids|mesh-ancestor
110599195|NCT00861250|Hormones|hormones|mesh-ancestor
110599196|NCT00861250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110599197|NCT00861250|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110599198|NCT00861250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110599199|NCT00722150|Artesunate|artesunate|mesh-list
110599200|NCT00722150|Antimalarials|antimalarials|mesh-ancestor
110599201|NCT00722150|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110599202|NCT00722150|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110599203|NCT00722150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110599204|NCT00722150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110599205|NCT00722150|Antiviral Agents|antiviral agents|mesh-ancestor
110599206|NCT00722150|Schistosomicides|schistosomicides|mesh-ancestor
110599207|NCT00722150|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110599208|NCT00722150|Anthelmintics|anthelmintics|mesh-ancestor
110599209|NCT00861094|Leucovorin|leucovorin|mesh-list
110599210|NCT00861094|Folic Acid|folic acid|mesh-list
110599211|NCT00861094|Fluorouracil|fluorouracil|mesh-list
110599212|NCT00861094|Oxaliplatin|oxaliplatin|mesh-list
110599213|NCT00861094|Levoleucovorin|levoleucovorin|mesh-list
110599214|NCT00861094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110599215|NCT00861094|Antimetabolites|antimetabolites|mesh-ancestor
110267331|NCT00159653|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110267332|NCT00159653|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110599216|NCT00861094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110599217|NCT00861094|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110599218|NCT00861094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110599219|NCT00861094|Immunologic Factors|immunologic factors|mesh-ancestor
110599220|NCT00861094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110599221|NCT00861094|Antidotes|antidotes|mesh-ancestor
110599222|NCT00861094|Protective Agents|protective agents|mesh-ancestor
110599223|NCT00861094|Vitamin B Complex|vitamin b complex|mesh-ancestor
110599224|NCT00861094|Vitamins|vitamins|mesh-ancestor
110599225|NCT00861094|Micronutrients|micronutrients|mesh-ancestor
110599226|NCT00861094|Hematinics|hematinics|mesh-ancestor
110599227|NCT00807261|Gemcitabine|gemcitabine|mesh-list
110599228|NCT00807261|Docetaxel|docetaxel|mesh-list
110599229|NCT00807261|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110599230|NCT00807261|Antimetabolites|antimetabolites|mesh-ancestor
110599231|NCT00807261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110599232|NCT00807261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110599233|NCT00807261|Tubulin Modulators|tubulin modulators|mesh-ancestor
110599234|NCT00807261|Antimitotic Agents|antimitotic agents|mesh-ancestor
110599235|NCT00807261|Mitosis Modulators|mitosis modulators|mesh-ancestor
110599237|NCT04019106|Pulmonary Surfactants|pulmonary surfactants|mesh-list
110599238|NCT04019106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110599239|NCT04019106|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110599240|NCT04019106|Autonomic Agents|autonomic agents|mesh-ancestor
110599241|NCT04019106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110599242|NCT04019106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110599243|NCT04019106|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110599244|NCT04019106|Respiratory System Agents|respiratory system agents|mesh-ancestor
110599245|NCT04019106|Glucocorticoids|glucocorticoids|mesh-ancestor
110599246|NCT04019106|Hormones|hormones|mesh-ancestor
110599247|NCT04019106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110267445|NCT00159770|Antidepressive Agents|antidepressive agents|mesh-ancestor
110267455|NCT00542893|Oblimersen|oblimersen|mesh-list
110599249|NCT02571608|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110599250|NCT02571608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110599251|NCT00865072|Metformin|metformin|mesh-list
110599252|NCT00865072|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110599253|NCT00865072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110599254|NCT00804297|Octreotide|octreotide|mesh-list
110599255|NCT00804297|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110599256|NCT00804297|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110599257|NCT00804297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110599258|NCT00861328|Oxaliplatin|oxaliplatin|mesh-list
110599259|NCT00861328|Irinotecan|irinotecan|mesh-list
110599260|NCT00861328|Camptothecin|camptothecin|mesh-list
110599261|NCT00861328|ON 01910|on 01910|mesh-list
110599262|NCT00861328|Glycine|glycine|mesh-list
110599263|NCT00861328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110599264|NCT00861328|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110599265|NCT00861328|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110599266|NCT00861328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110599267|NCT00861328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110599268|NCT00861328|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110599269|NCT00861328|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110599270|NCT00861328|Glycine Agents|glycine agents|mesh-ancestor
110599271|NCT00861328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110599272|NCT00861328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110599273|NCT00861406|Interferons|interferons|mesh-list
110599274|NCT00861406|Interferon-alpha|interferon-alpha|mesh-list
110599275|NCT00861406|Interferon alpha-2|interferon alpha-2|mesh-list
110599276|NCT00861406|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110599277|NCT00861406|Vaccines|vaccines|mesh-list
110599278|NCT00861406|Immunologic Factors|immunologic factors|mesh-ancestor
110599279|NCT00861406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110599280|NCT00861406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110599281|NCT00861406|Antiviral Agents|antiviral agents|mesh-ancestor
110599282|NCT00861406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110599284|NCT00865384|Antidepressive Agents|antidepressive agents|mesh-ancestor
110599285|NCT00865384|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110599286|NCT00865384|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110599287|NCT00865384|Histamine Antagonists|histamine antagonists|mesh-ancestor
110599288|NCT00865384|Histamine Agents|histamine agents|mesh-ancestor
110599289|NCT00865384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110267505|NCT00543049|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110267506|NCT00543049|Growth Substances|growth substances|mesh-ancestor
110599290|NCT00865384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110599291|NCT00865384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110599293|NCT00865384|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110599294|NCT00865384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110599295|NCT00865384|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
110599296|NCT00865384|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110599297|NCT00865384|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110599298|NCT00865384|Adrenergic Agents|adrenergic agents|mesh-ancestor
110599299|NCT00865384|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110599300|NCT00865384|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110599301|NCT00865384|Serotonin Agents|serotonin agents|mesh-ancestor
110599302|NCT00865384|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110599303|NCT00724724|Aspirin|aspirin|mesh-list
110599304|NCT00724724|3-n-butylphthalide|3-n-butylphthalide|mesh-list
110599305|NCT00724724|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110599306|NCT00724724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110599307|NCT00724724|Analgesics|analgesics|mesh-ancestor
110599308|NCT00724724|Sensory System Agents|sensory system agents|mesh-ancestor
110599309|NCT00724724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110599310|NCT00724724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110267538|NCT00543166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110599311|NCT00724724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110378084|NCT00171054|Diuretics|diuretics|mesh-ancestor
110599312|NCT00724724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110599313|NCT00724724|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110599314|NCT00724724|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110599315|NCT00724724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110599316|NCT00724724|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110599317|NCT00724724|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110599318|NCT00724724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110599319|NCT00724724|Antipyretics|antipyretics|mesh-ancestor
110267589|NCT00159887|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110267590|NCT00159887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110599320|NCT00724724|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110599321|NCT00724724|Protective Agents|protective agents|mesh-ancestor
110599322|NCT00865462|Bupropion|bupropion|mesh-list
110599323|NCT00865462|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110599324|NCT00865462|Antidepressive Agents|antidepressive agents|mesh-ancestor
110599325|NCT00865462|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110599326|NCT00865462|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110599327|NCT00865462|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110599328|NCT00865462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110599329|NCT00865462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110267647|NCT00190827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110599330|NCT00865462|Dopamine Agents|dopamine agents|mesh-ancestor
110599331|NCT00865462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110599332|NCT00865462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110599333|NCT00865462|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110599334|NCT00865462|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110599335|NCT00865462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110599336|NCT04130204|Colchicine|colchicine|mesh-list
110599337|NCT04130204|Gout Suppressants|gout suppressants|mesh-ancestor
110599338|NCT04130204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110267709|NCT00190866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110599339|NCT04130204|Tubulin Modulators|tubulin modulators|mesh-ancestor
110599340|NCT04130204|Antimitotic Agents|antimitotic agents|mesh-ancestor
110599341|NCT04130204|Mitosis Modulators|mitosis modulators|mesh-ancestor
110599342|NCT04130204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110599343|NCT04130204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110599344|NCT00723918|Methadone|methadone|mesh-list
110599345|NCT00723918|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110599346|NCT00723918|Narcotics|narcotics|mesh-ancestor
110599347|NCT00723918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110599348|NCT00723918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110599349|NCT00723918|Analgesics|analgesics|mesh-ancestor
110599350|NCT00723918|Sensory System Agents|sensory system agents|mesh-ancestor
110599351|NCT00723918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110599352|NCT00723918|Antitussive Agents|antitussive agents|mesh-ancestor
110267773|NCT00544804|Lapatinib|lapatinib|mesh-list
110267774|NCT00544804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110599353|NCT00723918|Respiratory System Agents|respiratory system agents|mesh-ancestor
110599354|NCT00865540|Prednisolone|prednisolone|mesh-list
110599355|NCT00865540|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110599356|NCT00865540|Methylprednisolone|methylprednisolone|mesh-list
110599357|NCT00865540|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110599358|NCT00865540|Prednisolone acetate|prednisolone acetate|mesh-list
110599359|NCT00865540|Ketorolac|ketorolac|mesh-list
110599360|NCT00865540|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
110599361|NCT00865540|Nepafenac|nepafenac|mesh-list
110267828|NCT00190944|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110599362|NCT00865540|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110599363|NCT00865540|Prednisolone phosphate|prednisolone phosphate|mesh-list
110599364|NCT00865540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110599365|NCT00865540|Glucocorticoids|glucocorticoids|mesh-ancestor
110599367|NCT00865540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110599368|NCT00865540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110599369|NCT00865540|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110599370|NCT00865540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110599371|NCT00865540|Antiemetics|antiemetics|mesh-ancestor
110599372|NCT00865540|Autonomic Agents|autonomic agents|mesh-ancestor
110599373|NCT00865540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110599374|NCT00865540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110267886|NCT00545389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110267887|NCT00545467|Aripiprazole|aripiprazole|mesh-list
110599375|NCT00865540|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110599376|NCT00865540|Protective Agents|protective agents|mesh-ancestor
110599377|NCT00865540|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110599378|NCT00865540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110599380|NCT00865540|Sensory System Agents|sensory system agents|mesh-ancestor
110599381|NCT00865540|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110599382|NCT00865540|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110599383|NCT00865540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110599384|NCT00865540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110599385|NCT00865618|Eplerenone|eplerenone|mesh-list
110267948|NCT00546130|Irinotecan|irinotecan|mesh-list
110267949|NCT00546130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110267950|NCT00546130|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110599386|NCT00865618|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110599387|NCT00865618|Hormone Antagonists|hormone antagonists|mesh-ancestor
110599388|NCT00865618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110599389|NCT00865618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110599390|NCT00865618|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110599391|NCT00865618|Diuretics|diuretics|mesh-ancestor
110599392|NCT00865618|Natriuretic Agents|natriuretic agents|mesh-ancestor
110268013|NCT00191256|Gemcitabine|gemcitabine|mesh-list
110599393|NCT00865618|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110599394|NCT00655629|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
110599395|NCT00655629|Vasodilator Agents|vasodilator agents|mesh-ancestor
110599396|NCT00655629|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110599397|NCT00655629|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110599398|NCT00655629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110599399|NCT00655629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110599400|NCT00655629|Urological Agents|urological agents|mesh-ancestor
110599401|NCT00865696|Mirtazapine|mirtazapine|mesh-list
110599402|NCT00865696|Antidepressive Agents|antidepressive agents|mesh-ancestor
110599403|NCT00865696|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110599404|NCT00865696|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110599405|NCT00865696|Histamine Antagonists|histamine antagonists|mesh-ancestor
110599406|NCT00865696|Histamine Agents|histamine agents|mesh-ancestor
110599407|NCT00865696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110599408|NCT00865696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110599409|NCT00865696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110268078|NCT00547183|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110268079|NCT00547183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110599410|NCT00865696|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110599411|NCT00865696|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110599412|NCT00865696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110599413|NCT00865696|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
110599414|NCT00865696|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110599415|NCT00865696|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110599416|NCT00865696|Adrenergic Agents|adrenergic agents|mesh-ancestor
110599417|NCT00865696|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110599418|NCT00865696|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110599419|NCT00865696|Serotonin Agents|serotonin agents|mesh-ancestor
110599420|NCT00865696|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110599422|NCT00724802|Antifungal Agents|antifungal agents|mesh-ancestor
110599423|NCT00724802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110599424|NCT02545114|Tolvaptan|tolvaptan|mesh-list
110599425|NCT02545114|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
110599426|NCT02545114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110599427|NCT02545114|Natriuretic Agents|natriuretic agents|mesh-ancestor
110599428|NCT02545114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110268133|NCT00191373|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110599429|NCT00724880|Clopidogrel|clopidogrel|mesh-list
110599430|NCT00724880|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110599431|NCT00724880|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110599432|NCT00724880|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110599433|NCT00724880|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110599434|NCT00724880|Purinergic Agents|purinergic agents|mesh-ancestor
110599435|NCT00724880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110599436|NCT00724880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110599437|NCT00724880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110599438|NCT00724074|Bupivacaine|bupivacaine|mesh-list
110268187|NCT00547885|Analgesics|analgesics|mesh-ancestor
110268188|NCT00547885|Sensory System Agents|sensory system agents|mesh-ancestor
110599440|NCT00724074|Anesthetics|anesthetics|mesh-ancestor
110599441|NCT00724074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110599442|NCT00724074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110599443|NCT00724074|Sensory System Agents|sensory system agents|mesh-ancestor
110599444|NCT00724074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110599445|NCT00854776|Lansoprazole|lansoprazole|mesh-list
110599446|NCT00854776|Dexlansoprazole|dexlansoprazole|mesh-list
110599447|NCT00854776|Aluminum Hydroxide|aluminum hydroxide|mesh-list
110599448|NCT00854776|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110268252|NCT00184821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110268253|NCT00184821|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110268254|NCT00184821|Vasodilator Agents|vasodilator agents|mesh-ancestor
110599450|NCT00854776|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110599451|NCT00854776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110599452|NCT00854776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110599453|NCT00854776|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110599454|NCT00854776|Immunologic Factors|immunologic factors|mesh-ancestor
110599455|NCT00854776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110599456|NCT00854776|Antacids|antacids|mesh-ancestor
110599457|NCT00798525|Lepirudin|lepirudin|mesh-list
110599458|NCT00798525|Argatroban|argatroban|mesh-list
110599459|NCT00798525|Antithrombins|antithrombins|mesh-ancestor
110246784|NCT00119639|Sorafenib|sorafenib|mesh-list
110599460|NCT00798525|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110599461|NCT00798525|Protease Inhibitors|protease inhibitors|mesh-ancestor
110599462|NCT00798525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110599463|NCT00798525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110599464|NCT00798525|Anticoagulants|anticoagulants|mesh-ancestor
110599465|NCT00798525|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110599466|NCT00798525|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110599467|NCT00798525|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110599468|NCT00861640|Omeprazole|omeprazole|mesh-list
110599469|NCT00861640|Rabeprazole|rabeprazole|mesh-list
110599470|NCT00861640|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110599471|NCT00861640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110599472|NCT00861640|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110599473|NCT00861640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110268315|NCT00161291|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110599474|NCT00861640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110599475|NCT00724230|Ribavirin|ribavirin|mesh-list
110599476|NCT00724230|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110599477|NCT00724230|Interferon-alpha|interferon-alpha|mesh-list
110599478|NCT00724230|Antimetabolites|antimetabolites|mesh-ancestor
110599479|NCT00724230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110599480|NCT00724230|Antiviral Agents|antiviral agents|mesh-ancestor
110599481|NCT00724230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110599482|NCT00724230|Immunologic Factors|immunologic factors|mesh-ancestor
110268362|NCT00191607|Gemcitabine|gemcitabine|mesh-list
110268364|NCT00191607|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110268366|NCT00191607|Antimetabolites|antimetabolites|mesh-ancestor
110599483|NCT00724230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110599484|NCT00725036|Insulin|insulin|mesh-list
110599485|NCT00725036|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110599486|NCT00725036|Insulin Aspart|insulin aspart|mesh-list
110599487|NCT00725036|Isophane Insulin, Human|isophane insulin, human|mesh-list
110599488|NCT00725036|Insulin, Isophane|insulin, isophane|mesh-list
110599489|NCT00725036|Isophane insulin, beef|isophane insulin, beef|mesh-list
110599490|NCT00725036|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110599491|NCT00725036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110599492|NCT00724386|Paclitaxel|paclitaxel|mesh-list
110599493|NCT00724386|Vinorelbine|vinorelbine|mesh-list
110599494|NCT00724386|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110599495|NCT00724386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110599496|NCT00724386|Tubulin Modulators|tubulin modulators|mesh-ancestor
110599497|NCT00724386|Antimitotic Agents|antimitotic agents|mesh-ancestor
110599498|NCT00724386|Mitosis Modulators|mitosis modulators|mesh-ancestor
110599499|NCT00724386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110599500|NCT00865852|Metformin|metformin|mesh-list
110599501|NCT00865852|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110599502|NCT00865852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110599503|NCT00725114|Tetrodotoxin|tetrodotoxin|mesh-list
110268430|NCT00191685|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110268431|NCT00191685|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110268432|NCT00191685|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110599504|NCT00725114|Anesthetics, Local|anesthetics, local|mesh-ancestor
110599506|NCT00725114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110599507|NCT00725114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110599508|NCT00725114|Sensory System Agents|sensory system agents|mesh-ancestor
110599509|NCT00725114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110599510|NCT00725114|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110599511|NCT00725114|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110599512|NCT00725114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110599513|NCT00724542|Voglibose|voglibose|mesh-list
110599514|NCT00724542|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110599515|NCT00724542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110599516|NCT00724542|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
110599517|NCT00724542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110599518|NCT00724542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110599519|NCT00724620|Ribavirin|ribavirin|mesh-list
110599520|NCT00724620|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110599521|NCT00724620|Antimetabolites|antimetabolites|mesh-ancestor
110599522|NCT00724620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110599523|NCT00724620|Antiviral Agents|antiviral agents|mesh-ancestor
110599524|NCT00724620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110599525|NCT00866008|Triptorelin Pamoate|triptorelin pamoate|mesh-list
110599526|NCT00866008|Ganirelix|ganirelix|mesh-list
110599527|NCT00866008|Luteolytic Agents|luteolytic agents|mesh-ancestor
110599528|NCT00866008|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110599529|NCT00866008|Contraceptive Agents|contraceptive agents|mesh-ancestor
110599530|NCT00866008|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110599531|NCT00866008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110599532|NCT00866008|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110599533|NCT00866008|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110599534|NCT00866008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110599535|NCT00866008|Hormone Antagonists|hormone antagonists|mesh-ancestor
110268609|NCT00551005|Analgesics|analgesics|mesh-ancestor
110268610|NCT00551005|Sensory System Agents|sensory system agents|mesh-ancestor
110268611|NCT00551005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110273692|NCT00408174|Balsalazide|balsalazide|mesh-list
110268613|NCT00551005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110268614|NCT00551005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110268615|NCT00551005|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110268616|NCT00551005|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110268617|NCT00551044|Bicalutamide|bicalutamide|mesh-list
110268618|NCT00551044|Androgen Antagonists|androgen antagonists|mesh-ancestor
110268619|NCT00551044|Hormone Antagonists|hormone antagonists|mesh-ancestor
110268620|NCT00551044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110268621|NCT00551044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110268622|NCT00551044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110599536|NCT00866008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110599538|NCT02571426|Sevoflurane|sevoflurane|mesh-list
110599539|NCT02571426|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110599540|NCT02571426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110599541|NCT02571426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110599542|NCT02571426|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110599543|NCT02571426|Anesthetics, General|anesthetics, general|mesh-ancestor
110599544|NCT02571426|Anesthetics|anesthetics|mesh-ancestor
110599545|NCT02571426|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110599546|NCT02571426|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110599547|NCT03491540|Gentamicins|gentamicins|mesh-list
110599548|NCT03491540|Ornidazole|ornidazole|mesh-list
110599549|NCT03491540|Sennosides|sennosides|mesh-list
110599550|NCT03491540|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110599551|NCT03491540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110599552|NCT03491540|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110599553|NCT03491540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110599554|NCT03491540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110599556|NCT03491540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110599557|NCT03491540|Amebicides|amebicides|mesh-ancestor
110599558|NCT03491540|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110599559|NCT03491540|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110599560|NCT03491540|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
110599561|NCT00854932|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110599562|NCT00854932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110599563|NCT00578292|Cyclophosphamide|cyclophosphamide|mesh-list
110599564|NCT00578292|Busulfan|busulfan|mesh-list
110599565|NCT00578292|Fludarabine|fludarabine|mesh-list
110599566|NCT00578292|Alemtuzumab|alemtuzumab|mesh-list
110599567|NCT00578292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110599568|NCT00578292|Immunologic Factors|immunologic factors|mesh-ancestor
110599569|NCT00578292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110599570|NCT00578292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110599571|NCT00578292|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110599572|NCT00578292|Alkylating Agents|alkylating agents|mesh-ancestor
110599573|NCT00578292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110599574|NCT00578292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110599575|NCT00578292|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110599576|NCT00578292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110599577|NCT00861874|Sirolimus|sirolimus|mesh-list
110599578|NCT00861874|Decitabine|decitabine|mesh-list
110599579|NCT00861874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110599580|NCT00861874|Antimetabolites|antimetabolites|mesh-ancestor
110599581|NCT00861874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110599582|NCT00861874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110599583|NCT00861874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110599584|NCT00861874|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110599585|NCT00861874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110599586|NCT00861874|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110599587|NCT00861874|Antifungal Agents|antifungal agents|mesh-ancestor
110268718|NCT00185172|Olmesartan|olmesartan|mesh-list
110599588|NCT00861874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110599589|NCT00861874|Immunologic Factors|immunologic factors|mesh-ancestor
110599590|NCT00861874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110599591|NCT05372874|Antiviral Agents|antiviral agents|mesh-list
110599592|NCT05372874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110599593|NCT04067856|Dexamethasone|dexamethasone|mesh-list
110599594|NCT04067856|Bevacizumab|bevacizumab|mesh-list
110599595|NCT04067856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110599596|NCT04067856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110599597|NCT04067856|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110599598|NCT04067856|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110599599|NCT04067856|Growth Substances|growth substances|mesh-ancestor
110599600|NCT04067856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110268762|NCT00161993|Immunoglobulins|immunoglobulins|mesh-list
110268763|NCT00161993|Antibodies|antibodies|mesh-list
110268771|NCT00185328|Hormones|hormones|mesh-ancestor
110599601|NCT04067856|Growth Inhibitors|growth inhibitors|mesh-ancestor
110599602|NCT04067856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110599603|NCT04067856|Antiemetics|antiemetics|mesh-ancestor
110599604|NCT04067856|Autonomic Agents|autonomic agents|mesh-ancestor
110599605|NCT04067856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110599606|NCT04067856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110599607|NCT04067856|Glucocorticoids|glucocorticoids|mesh-ancestor
110599608|NCT04067856|Hormones|hormones|mesh-ancestor
110599609|NCT04067856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110599610|NCT04067856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110599611|NCT04042714|Trifluridine|trifluridine|mesh-list
110599612|NCT04042714|Antimetabolites|antimetabolites|mesh-ancestor
110599613|NCT04042714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110599614|NCT04042714|Antiviral Agents|antiviral agents|mesh-ancestor
110599615|NCT04042714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110268822|NCT00162227|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110268823|NCT00162227|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110599616|NCT03401918|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110599617|NCT03401918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110599619|NCT00725348|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110599620|NCT00725348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110599621|NCT00725348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110599622|NCT00577772|Rifaximin|rifaximin|mesh-list
110599623|NCT00577772|Lactulose|lactulose|mesh-list
110599624|NCT00577772|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110599625|NCT00577772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110599626|NCT00577772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110599627|NCT00578136|Bupivacaine|bupivacaine|mesh-list
110599628|NCT00578136|Anesthetics, Local|anesthetics, local|mesh-ancestor
110599629|NCT00578136|Anesthetics|anesthetics|mesh-ancestor
110599630|NCT00578136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110599631|NCT00578136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110599632|NCT00578136|Sensory System Agents|sensory system agents|mesh-ancestor
110599633|NCT00578136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110599634|NCT00861952|Mineral Oil|mineral oil|mesh-list
110599635|NCT00861952|Emollients|emollients|mesh-ancestor
110599636|NCT00861952|Dermatologic Agents|dermatologic agents|mesh-ancestor
110599637|NCT00655551|Lacosamide|lacosamide|mesh-list
110599638|NCT00655551|Anticonvulsants|anticonvulsants|mesh-ancestor
110268880|NCT00162383|Debrisoquin|debrisoquin|mesh-list
110599639|NCT00655551|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110599640|NCT00655551|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110599641|NCT00655551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110599642|NCT00655551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110599643|NCT00855088|Ritonavir|ritonavir|mesh-list
110599644|NCT00855088|Darunavir|darunavir|mesh-list
110599645|NCT00855088|Etravirine|etravirine|mesh-list
110599646|NCT00855088|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110599647|NCT00855088|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110599648|NCT00855088|Protease Inhibitors|protease inhibitors|mesh-ancestor
110599649|NCT00855088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110599650|NCT00855088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110599652|NCT00855088|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110599653|NCT00855088|Antiviral Agents|antiviral agents|mesh-ancestor
110599654|NCT00855088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110599655|NCT00855088|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110599656|NCT00855088|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110599657|NCT00855088|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110268933|NCT00185445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110599658|NCT00855088|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110599659|NCT02553603|Hormones|hormones|mesh-list
110599660|NCT02553603|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
110599661|NCT02553603|Tesamorelin|tesamorelin|mesh-list
110599662|NCT02553603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110599663|NCT02553603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110599664|NCT02553603|Growth Substances|growth substances|mesh-ancestor
110599665|NCT00804531|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110599666|NCT00804531|Methylprednisolone|methylprednisolone|mesh-list
110599667|NCT00804531|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110599668|NCT00804531|Prednisolone|prednisolone|mesh-list
110268973|NCT04095364|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110268974|NCT04095364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110599669|NCT00804531|Prednisolone acetate|prednisolone acetate|mesh-list
110599670|NCT00804531|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110599671|NCT00804531|Prednisolone phosphate|prednisolone phosphate|mesh-list
110599672|NCT00804531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110599673|NCT00804531|Antiemetics|antiemetics|mesh-ancestor
110599674|NCT00804531|Autonomic Agents|autonomic agents|mesh-ancestor
110599675|NCT00804531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110599676|NCT00804531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110599677|NCT00804531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110599678|NCT00804531|Glucocorticoids|glucocorticoids|mesh-ancestor
110599679|NCT00804531|Hormones|hormones|mesh-ancestor
110599680|NCT00804531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110599681|NCT00804531|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110599682|NCT00804531|Protective Agents|protective agents|mesh-ancestor
110599683|NCT00804531|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110269035|NCT00185835|Gefitinib|gefitinib|mesh-list
110269036|NCT00185835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110269037|NCT00185835|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110269038|NCT00185835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110269039|NCT00185835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110269040|NCT00162968|Escitalopram|escitalopram|mesh-list
110269041|NCT00162968|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110269042|NCT00162968|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110269043|NCT00162968|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110269044|NCT00162968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110269045|NCT00162968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110599685|NCT00866866|Acetylcysteine|acetylcysteine|mesh-list
110599686|NCT00866866|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110599687|NCT00866866|Antiviral Agents|antiviral agents|mesh-ancestor
110247067|NCT00482716|Iron|iron|mesh-list
110599689|NCT00866866|Expectorants|expectorants|mesh-ancestor
110599690|NCT00866866|Respiratory System Agents|respiratory system agents|mesh-ancestor
110599691|NCT00866866|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110599692|NCT00866866|Antioxidants|antioxidants|mesh-ancestor
110599693|NCT00866866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110599694|NCT00866866|Protective Agents|protective agents|mesh-ancestor
110599695|NCT00866866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110599696|NCT00866866|Antidotes|antidotes|mesh-ancestor
110599697|NCT00312728|Bevacizumab|bevacizumab|mesh-list
110599698|NCT00312728|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110599699|NCT00312728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110599700|NCT00312728|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110599701|NCT00312728|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110599702|NCT00312728|Growth Substances|growth substances|mesh-ancestor
110599703|NCT00312728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110599704|NCT00312728|Growth Inhibitors|growth inhibitors|mesh-ancestor
110599706|NCT00804921|Brimonidine Tartrate|brimonidine tartrate|mesh-list
110599707|NCT00804921|Acetazolamide|acetazolamide|mesh-list
110599708|NCT00804921|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110599709|NCT00804921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110599710|NCT00804921|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110599711|NCT00804921|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110599712|NCT00804921|Growth Substances|growth substances|mesh-ancestor
110599713|NCT00804921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110599714|NCT00804921|Growth Inhibitors|growth inhibitors|mesh-ancestor
110599715|NCT00804921|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110599716|NCT00804921|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110599717|NCT00804921|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110599718|NCT00804921|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110599719|NCT00804921|Adrenergic Agents|adrenergic agents|mesh-ancestor
110599720|NCT00804921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110023441|NCT00003744|Gemcitabine|gemcitabine|mesh-list
110599721|NCT00804921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110599722|NCT00804921|Anticonvulsants|anticonvulsants|mesh-ancestor
110599723|NCT00804921|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110599724|NCT00804921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110599725|NCT00804921|Diuretics|diuretics|mesh-ancestor
110599726|NCT00804921|Natriuretic Agents|natriuretic agents|mesh-ancestor
110599727|NCT00866944|Leucovorin|leucovorin|mesh-list
110599728|NCT00866944|Fluorouracil|fluorouracil|mesh-list
110599729|NCT00866944|Oxaliplatin|oxaliplatin|mesh-list
110599730|NCT00866944|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110599731|NCT00866944|Antimetabolites|antimetabolites|mesh-ancestor
110599732|NCT00866944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110599733|NCT00866944|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110599734|NCT00866944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110599735|NCT00866944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110599736|NCT00866944|Immunologic Factors|immunologic factors|mesh-ancestor
110599737|NCT00866944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110269133|NCT03516604|Citalopram|citalopram|mesh-list
110599738|NCT00866944|Antidotes|antidotes|mesh-ancestor
110599739|NCT00866944|Protective Agents|protective agents|mesh-ancestor
110599740|NCT00866944|Vitamin B Complex|vitamin b complex|mesh-ancestor
110599741|NCT00866944|Vitamins|vitamins|mesh-ancestor
110599742|NCT00866944|Micronutrients|micronutrients|mesh-ancestor
110599743|NCT00577824|Exenatide|exenatide|mesh-list
110599744|NCT00577824|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110599745|NCT00577824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110599746|NCT00577824|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110599747|NCT00577824|Incretins|incretins|mesh-ancestor
110599748|NCT00577824|Hormones|hormones|mesh-ancestor
110599749|NCT00577824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110269181|NCT00192660|Tenofovir|tenofovir|mesh-list
110269182|NCT00192660|Lamivudine|lamivudine|mesh-list
110599750|NCT04046289|Calcium, Dietary|calcium, dietary|mesh-list
110599751|NCT04046289|Calcium Carbonate|calcium carbonate|mesh-list
110599752|NCT04046289|Calcium|calcium|mesh-list
110599753|NCT04046289|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110599754|NCT04046289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110599755|NCT04046289|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110599756|NCT04046289|Antacids|antacids|mesh-ancestor
110269243|NCT00186264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110269244|NCT00186264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110269245|NCT00186264|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110269246|NCT00186264|Antidepressive Agents|antidepressive agents|mesh-ancestor
110269247|NCT00186264|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110269248|NCT00163319|Ciclesonide|ciclesonide|mesh-list
110269249|NCT00163319|Glucocorticoids|glucocorticoids|mesh-ancestor
110269250|NCT00163319|Hormones|hormones|mesh-ancestor
110269251|NCT00163319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110599757|NCT04046289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110599758|NCT04046289|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110599759|NCT00807807|Folic Acid|folic acid|mesh-list
110599760|NCT00807807|Vitamin B Complex|vitamin b complex|mesh-list
110247083|NCT00482989|Sifalimumab|sifalimumab|mesh-list
110599761|NCT00807807|Hematinics|hematinics|mesh-ancestor
110599762|NCT00807807|Vitamins|vitamins|mesh-ancestor
110599763|NCT00807807|Micronutrients|micronutrients|mesh-ancestor
110599765|NCT03011814|Lenalidomide|lenalidomide|mesh-list
110599766|NCT03011814|Durvalumab|durvalumab|mesh-list
110599767|NCT03011814|Immunoglobulins|immunoglobulins|mesh-list
110599768|NCT03011814|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110599769|NCT03011814|Immunoglobulin G|immunoglobulin g|mesh-list
110599770|NCT03011814|Immunologic Factors|immunologic factors|mesh-ancestor
110269304|NCT00186420|Docetaxel|docetaxel|mesh-list
110269305|NCT00186420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110269306|NCT00186420|Tubulin Modulators|tubulin modulators|mesh-ancestor
110599771|NCT03011814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110599772|NCT03011814|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110599773|NCT03011814|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110599774|NCT03011814|Growth Substances|growth substances|mesh-ancestor
110599775|NCT03011814|Growth Inhibitors|growth inhibitors|mesh-ancestor
110599776|NCT03011814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110599777|NCT03011814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110599779|NCT00870298|Sulfamethoxazole|sulfamethoxazole|mesh-list
110599780|NCT00870298|Warfarin|warfarin|mesh-list
110599781|NCT00870298|Anticoagulants|anticoagulants|mesh-ancestor
110599782|NCT00870298|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110599783|NCT00870298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110599784|NCT00870298|Antimalarials|antimalarials|mesh-ancestor
110599785|NCT00870298|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110599786|NCT00870298|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110599787|NCT00870298|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110269364|NCT00553072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110599789|NCT00870298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110599790|NCT00870298|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110599791|NCT00870298|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
110599792|NCT00870298|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110599793|NCT00805155|Mometasone Furoate|mometasone furoate|mesh-list
110599794|NCT00805155|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110599795|NCT00805155|Dermatologic Agents|dermatologic agents|mesh-ancestor
110599796|NCT00805155|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110599797|NCT00807963|Zoledronic Acid|zoledronic acid|mesh-list
110269421|NCT05807880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110269422|NCT05807880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110269423|NCT05807776|Lenvatinib|lenvatinib|mesh-list
110599798|NCT00807963|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110599799|NCT00807963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110599800|NCT00730418|Doxazosin|doxazosin|mesh-list
110599801|NCT00730418|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110599802|NCT00730418|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110599803|NCT00730418|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110599804|NCT00730418|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110599805|NCT00730418|Adrenergic Agents|adrenergic agents|mesh-ancestor
110599806|NCT00730418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110599807|NCT00730418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110599808|NCT00730418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110599809|NCT00805233|Bromfenac|bromfenac|mesh-list
110599810|NCT00805233|Ranibizumab|ranibizumab|mesh-list
110599811|NCT00805233|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110269481|NCT05807165|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110599812|NCT00805233|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110599813|NCT00805233|Growth Substances|growth substances|mesh-ancestor
110599814|NCT00805233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110599815|NCT00805233|Growth Inhibitors|growth inhibitors|mesh-ancestor
110599816|NCT00805233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110151623|NCT00001084|Antiviral Agents|antiviral agents|mesh-ancestor
110599817|NCT00805233|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110599818|NCT00805233|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110599819|NCT00805233|Analgesics|analgesics|mesh-ancestor
110599820|NCT00805233|Sensory System Agents|sensory system agents|mesh-ancestor
110599821|NCT00805233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110599822|NCT00805233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110599823|NCT00805233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110599824|NCT02569502|Enfuvirtide|enfuvirtide|mesh-list
110599825|NCT02569502|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110599826|NCT02569502|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110269542|NCT05693844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110269543|NCT05693844|Immunologic Factors|immunologic factors|mesh-ancestor
110599827|NCT02569502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110599828|NCT02569502|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110599829|NCT02569502|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110599830|NCT02569502|Antiviral Agents|antiviral agents|mesh-ancestor
110599831|NCT02569502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110599832|NCT00725400|Cetuximab|cetuximab|mesh-list
110599833|NCT00725400|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110599834|NCT00725400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110599835|NCT00798915|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
110599836|NCT00798915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110599837|NCT00798915|Incretins|incretins|mesh-ancestor
110599838|NCT00798915|Hormones|hormones|mesh-ancestor
110599839|NCT00798915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110599840|NCT00798915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110599841|NCT00798993|Cholecalciferol|cholecalciferol|mesh-list
110599842|NCT00798993|Vitamin D|vitamin d|mesh-list
110269601|NCT05617118|GABA Agonists|gaba agonists|mesh-ancestor
110599843|NCT00798993|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
110599845|NCT00798993|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110599846|NCT00798993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110599847|NCT00798993|Vitamins|vitamins|mesh-ancestor
110599848|NCT00798993|Micronutrients|micronutrients|mesh-ancestor
110599849|NCT00798993|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110599850|NCT00862108|Methylphenidate|methylphenidate|mesh-list
110599851|NCT00862108|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110599852|NCT00862108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110378134|NCT00479388|Atorvastatin|atorvastatin|mesh-list
110599853|NCT00862108|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110599854|NCT00862108|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110599855|NCT00862108|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110599856|NCT00862108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110599857|NCT00862108|Dopamine Agents|dopamine agents|mesh-ancestor
110599858|NCT00862108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110599859|NCT00862264|Beclomethasone|beclomethasone|mesh-list
110599860|NCT00862264|Norflurane|norflurane|mesh-list
110599861|NCT00862264|Formoterol Fumarate|formoterol fumarate|mesh-list
110599862|NCT00862264|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110599863|NCT00862264|Autonomic Agents|autonomic agents|mesh-ancestor
110599864|NCT00862264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110599865|NCT00862264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110599866|NCT00862264|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110599867|NCT00862264|Respiratory System Agents|respiratory system agents|mesh-ancestor
110599868|NCT00862264|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110599869|NCT00862264|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110599870|NCT00862264|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110599871|NCT00862264|Adrenergic Agents|adrenergic agents|mesh-ancestor
110599872|NCT00862264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110599873|NCT00862264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110599874|NCT00862264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110599875|NCT00862264|Glucocorticoids|glucocorticoids|mesh-ancestor
110269716|NCT05024214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110599877|NCT00862264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110599878|NCT00862264|Anesthetics|anesthetics|mesh-ancestor
110599879|NCT00862264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110599880|NCT00730574|Vitamins|vitamins|mesh-list
110599881|NCT00730574|Folic Acid|folic acid|mesh-list
110599882|NCT00730574|Vitamin B 12|vitamin b 12|mesh-list
110599883|NCT00730574|Hydroxocobalamin|hydroxocobalamin|mesh-list
110599884|NCT00730574|Vitamin B Complex|vitamin b complex|mesh-list
110599885|NCT00730574|Micronutrients|micronutrients|mesh-ancestor
110599886|NCT00730574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110599887|NCT00730574|Hematinics|hematinics|mesh-ancestor
110599888|NCT00870532|Sorafenib|sorafenib|mesh-list
110599889|NCT00870532|Vinorelbine|vinorelbine|mesh-list
110599890|NCT00870532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110599891|NCT00870532|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110599892|NCT00870532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110599893|NCT00870532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110599894|NCT00870532|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110599895|NCT00870532|Tubulin Modulators|tubulin modulators|mesh-ancestor
110269776|NCT04826562|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110599896|NCT00870532|Antimitotic Agents|antimitotic agents|mesh-ancestor
110599897|NCT00870532|Mitosis Modulators|mitosis modulators|mesh-ancestor
110599899|NCT00725478|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110599900|NCT00725478|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110599901|NCT00725478|Dopamine Agonists|dopamine agonists|mesh-ancestor
110599902|NCT00725478|Dopamine Agents|dopamine agents|mesh-ancestor
110599903|NCT00725478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110599904|NCT00725478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110599905|NCT00725478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110599906|NCT01951274|Serlopitant|serlopitant|mesh-list
110269831|NCT04577690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110269835|NCT04577690|Autonomic Agents|autonomic agents|mesh-ancestor
110599907|NCT01951274|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110599908|NCT01951274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110599909|NCT01951274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110599910|NCT01951274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110599911|NCT03355794|Everolimus|everolimus|mesh-list
110599912|NCT03355794|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110599913|NCT03355794|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110599914|NCT03355794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110599915|NCT03355794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110599916|NCT03355794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110599917|NCT03355794|Immunologic Factors|immunologic factors|mesh-ancestor
110599918|NCT03355794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110269895|NCT04311099|Ropivacaine|ropivacaine|mesh-list
110269896|NCT04311099|Anesthetics, Local|anesthetics, local|mesh-ancestor
110269897|NCT04311099|Anesthetics|anesthetics|mesh-ancestor
110269898|NCT04311099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110269899|NCT04311099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110269900|NCT04311099|Sensory System Agents|sensory system agents|mesh-ancestor
110269901|NCT04311099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110269902|NCT04303559|Antibodies, Bispecific|antibodies, bispecific|mesh-list
110599919|NCT03355794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110599920|NCT01487174|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110599921|NCT01487174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110599922|NCT01487174|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110599923|NCT01487174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110599924|NCT01487174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110599925|NCT00725634|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110599926|NCT00725634|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110599927|NCT00725634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110599928|NCT00725634|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110599929|NCT00725634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110599930|NCT00725634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110599931|NCT00725634|Immunologic Factors|immunologic factors|mesh-ancestor
110599932|NCT00725634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110599933|NCT00617344|Vaccines|vaccines|mesh-list
110599934|NCT00617344|Immunologic Factors|immunologic factors|mesh-ancestor
110599935|NCT00617344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110599936|NCT00862342|Bevacizumab|bevacizumab|mesh-list
110599937|NCT00862342|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110599938|NCT00862342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110599939|NCT00862342|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110599940|NCT00862342|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110599941|NCT00862342|Growth Substances|growth substances|mesh-ancestor
110151655|NCT00001087|Antimetabolites|antimetabolites|mesh-ancestor
110599942|NCT00862342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110599943|NCT00862342|Growth Inhibitors|growth inhibitors|mesh-ancestor
110599944|NCT00732212|Hemostatics|hemostatics|mesh-list
110599945|NCT00732212|Coagulants|coagulants|mesh-ancestor
110599946|NCT02544724|Interleukin-12|interleukin-12|mesh-list
110599947|NCT02544724|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110599948|NCT02544724|Immunologic Factors|immunologic factors|mesh-ancestor
110599949|NCT02544724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110270012|NCT03396445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110599951|NCT02544724|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110599952|NCT02544724|Growth Substances|growth substances|mesh-ancestor
110599953|NCT02544724|Growth Inhibitors|growth inhibitors|mesh-ancestor
110599954|NCT02544724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110599955|NCT00862420|Ticlopidine|ticlopidine|mesh-list
110599956|NCT00862420|Clopidogrel|clopidogrel|mesh-list
110599957|NCT00862420|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110599958|NCT00862420|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110599959|NCT00862420|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110599960|NCT00862420|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110270071|NCT03271866|Metformin|metformin|mesh-list
110270074|NCT03217565|Tedizolid|tedizolid|mesh-list
110599962|NCT00862420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110599963|NCT00862420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110599964|NCT00862420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110599965|NCT00862420|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110599966|NCT00862420|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110599967|NCT00862420|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110599968|NCT00862420|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110599969|NCT00862420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110599970|NCT00321698|Docetaxel|docetaxel|mesh-list
110599971|NCT00321698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110599972|NCT00321698|Tubulin Modulators|tubulin modulators|mesh-ancestor
110599973|NCT00321698|Antimitotic Agents|antimitotic agents|mesh-ancestor
110599974|NCT00321698|Mitosis Modulators|mitosis modulators|mesh-ancestor
110599975|NCT00321698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110599976|NCT02569970|Fluoxetine|fluoxetine|mesh-list
110599977|NCT02569970|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110599978|NCT02569970|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110599979|NCT02569970|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110270140|NCT02427620|Antibodies|antibodies|mesh-list
110378161|NCT00478881|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110599980|NCT02569970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110599982|NCT02569970|Serotonin Agents|serotonin agents|mesh-ancestor
110599983|NCT02569970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110599984|NCT02569970|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110599985|NCT02569970|Antidepressive Agents|antidepressive agents|mesh-ancestor
110599986|NCT02569970|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110599987|NCT02569970|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110599988|NCT02569970|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110599989|NCT02569970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110599990|NCT00725790|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
110599991|NCT00725790|Vasodilator Agents|vasodilator agents|mesh-ancestor
110599992|NCT00725790|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110599993|NCT00725790|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110270201|NCT02324387|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
110270202|NCT02324387|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110270203|NCT02324387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110270204|NCT02153944|Propranolol|propranolol|mesh-list
110270205|NCT02153944|Methylphenidate|methylphenidate|mesh-list
110599994|NCT00725790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110599995|NCT00725790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110599996|NCT00725790|Urological Agents|urological agents|mesh-ancestor
110599997|NCT00731276|Irinotecan|irinotecan|mesh-list
110599998|NCT00731276|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110599999|NCT00731276|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110600000|NCT00731276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110600001|NCT00731276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110600002|NCT00731276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110600003|NCT00725946|Iodine|iodine|mesh-list
110600004|NCT00725946|Cadexomer iodine|cadexomer iodine|mesh-list
110600005|NCT00725946|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110600006|NCT00725946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110270256|NCT01527149|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110270257|NCT01527149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110270259|NCT01527149|Abortifacient Agents|abortifacient agents|mesh-ancestor
110600007|NCT00725946|Trace Elements|trace elements|mesh-ancestor
110600008|NCT00725946|Micronutrients|micronutrients|mesh-ancestor
110600009|NCT00725946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110600010|NCT02569346|Abacavir, dolutegravir, and lamivudine drug combination|abacavir, dolutegravir, and lamivudine drug combination|mesh-list
110600012|NCT02569346|Abacavir|abacavir|mesh-list
110600013|NCT02569346|Dolutegravir|dolutegravir|mesh-list
110600014|NCT02569346|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110600015|NCT02569346|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110600016|NCT02569346|Antiviral Agents|antiviral agents|mesh-ancestor
110600017|NCT02569346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110600018|NCT02569346|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110600019|NCT02569346|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110600020|NCT02569346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110600021|NCT02569346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110600022|NCT02569346|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110600023|NCT02569346|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110600024|NCT00726804|Adalimumab|adalimumab|mesh-list
110600026|NCT00726804|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110600027|NCT00726804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110600028|NCT00726804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110600029|NCT00726804|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110600030|NCT00726804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110600031|NCT00726804|Analgesics|analgesics|mesh-ancestor
110600032|NCT00726804|Sensory System Agents|sensory system agents|mesh-ancestor
110600033|NCT00726804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110600034|NCT00726804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110600035|NCT00726804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110600036|NCT00726804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110270375|NCT00407186|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110270376|NCT00407186|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110600037|NCT00726804|Immunologic Factors|immunologic factors|mesh-ancestor
110600038|NCT00726960|Buprenorphine|buprenorphine|mesh-list
110600039|NCT00726960|Aprepitant|aprepitant|mesh-list
110600040|NCT00726960|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110600041|NCT00726960|Narcotics|narcotics|mesh-ancestor
110600042|NCT00726960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110600043|NCT00726960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110600044|NCT00726960|Analgesics|analgesics|mesh-ancestor
110600045|NCT00726960|Sensory System Agents|sensory system agents|mesh-ancestor
110600046|NCT00726960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110600047|NCT00726960|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110600048|NCT00726960|Antiemetics|antiemetics|mesh-ancestor
110600049|NCT00726960|Autonomic Agents|autonomic agents|mesh-ancestor
110600050|NCT00726960|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110600051|NCT00726960|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110270440|NCT00193284|Carboplatin|carboplatin|mesh-list
110600052|NCT00726960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110600053|NCT00726960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110600054|NCT00727038|Ranibizumab|ranibizumab|mesh-list
110600055|NCT00727038|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110600056|NCT00727038|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110600057|NCT00727038|Growth Substances|growth substances|mesh-ancestor
110600058|NCT00727038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110600059|NCT00727038|Growth Inhibitors|growth inhibitors|mesh-ancestor
110600060|NCT00727038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110270496|NCT00553189|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110600061|NCT00726258|Ketamine|ketamine|mesh-list
110600062|NCT00726258|Analgesics|analgesics|mesh-ancestor
110600063|NCT00726258|Sensory System Agents|sensory system agents|mesh-ancestor
110600064|NCT00726258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110600065|NCT00726258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110600066|NCT00726258|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110600067|NCT00726258|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110600068|NCT00726258|Anesthetics, General|anesthetics, general|mesh-ancestor
110600069|NCT00726258|Anesthetics|anesthetics|mesh-ancestor
110270566|NCT00409695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110270567|NCT04977232|Escitalopram|escitalopram|mesh-list
110270584|NCT00164411|Vaccines|vaccines|mesh-list
110600070|NCT00726258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110600071|NCT00726258|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110600072|NCT00726258|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110600073|NCT00726258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110600074|NCT00726258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110600076|NCT02950766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110600077|NCT02950766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110600078|NCT02950766|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110600079|NCT02950766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110600081|NCT02569814|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110600082|NCT02569814|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110600083|NCT02569814|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110270640|NCT00176241|Antimetabolites|antimetabolites|mesh-ancestor
110270641|NCT04742959|Paclitaxel|paclitaxel|mesh-list
110600084|NCT02569814|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110600085|NCT02569814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110600086|NCT02569814|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110600087|NCT02569814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110600088|NCT02569814|Vasodilator Agents|vasodilator agents|mesh-ancestor
110600089|NCT02569814|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110600090|NCT02569814|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110600091|NCT02569814|Antimetabolites|antimetabolites|mesh-ancestor
110600092|NCT02569814|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110600093|NCT02569814|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110600094|NCT02569814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110600095|NCT00726570|Heparin|heparin|mesh-list
110600096|NCT00726570|Calcium heparin|calcium heparin|mesh-list
110600097|NCT00726570|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
110600098|NCT00726570|Tinzaparin|tinzaparin|mesh-list
110600099|NCT00726570|Dalteparin|dalteparin|mesh-list
110600100|NCT00726570|Anticoagulants|anticoagulants|mesh-list
110270697|NCT00164840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110600101|NCT00726570|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110600102|NCT00726570|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110600103|NCT00726570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110600104|NCT00726726|Vitamin K|vitamin k|mesh-list
110600105|NCT00726726|Midazolam|midazolam|mesh-list
110600106|NCT00726726|Dextromethorphan|dextromethorphan|mesh-list
110600107|NCT00726726|Caffeine|caffeine|mesh-list
110600108|NCT00726726|Omeprazole|omeprazole|mesh-list
110600110|NCT00726726|BMS 708163|bms 708163|mesh-list
110600111|NCT00726726|Vitamins|vitamins|mesh-ancestor
110600112|NCT00726726|Micronutrients|micronutrients|mesh-ancestor
110600113|NCT00726726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110600114|NCT00726726|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110600115|NCT00726726|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110600116|NCT00726726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110600117|NCT00726726|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110600118|NCT00726726|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110600119|NCT00726726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110600120|NCT00726726|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110600121|NCT00726726|Anesthetics, General|anesthetics, general|mesh-ancestor
110600122|NCT00726726|Anesthetics|anesthetics|mesh-ancestor
110600123|NCT00726726|GABA Modulators|gaba modulators|mesh-ancestor
110600124|NCT00726726|GABA Agents|gaba agents|mesh-ancestor
110600125|NCT00726726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110600126|NCT00726726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110600127|NCT00726726|Anticoagulants|anticoagulants|mesh-ancestor
110600128|NCT00726726|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110270819|NCT00176553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110270820|NCT00176553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110270821|NCT00176553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110270823|NCT00165308|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110270824|NCT00165308|Hormone Antagonists|hormone antagonists|mesh-ancestor
110270825|NCT00165308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110270826|NCT00165308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110270827|NCT00165308|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110270828|NCT00165308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110270829|NCT00165308|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110274183|NCT00170729|Glucocorticoids|glucocorticoids|mesh-ancestor
110270834|NCT00165347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110600129|NCT00726726|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110600130|NCT00726726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110600131|NCT00726726|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110600132|NCT00726726|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110600133|NCT00726726|Purinergic Agents|purinergic agents|mesh-ancestor
110600134|NCT00726726|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110247450|NCT02274181|Enclomiphene|enclomiphene|mesh-list
110600135|NCT00726726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110600136|NCT00726726|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110600137|NCT00726726|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110600138|NCT00726726|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110600140|NCT00726726|Coagulants|coagulants|mesh-ancestor
110600141|NCT00726726|Antitussive Agents|antitussive agents|mesh-ancestor
110600142|NCT00726726|Respiratory System Agents|respiratory system agents|mesh-ancestor
110600143|NCT00726726|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110600144|NCT00726726|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110600145|NCT00726726|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
110600146|NCT00654381|Inositol|inositol|mesh-list
110600147|NCT00654381|Linagliptin|linagliptin|mesh-list
110600148|NCT00654381|Voglibose|voglibose|mesh-list
110600149|NCT00654381|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110600150|NCT00654381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110600151|NCT00654381|Incretins|incretins|mesh-ancestor
110600152|NCT00654381|Hormones|hormones|mesh-ancestor
110600153|NCT00654381|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110270928|NCT03789916|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110270940|NCT00165815|Donepezil|donepezil|mesh-list
110600154|NCT00654381|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110600155|NCT00654381|Protease Inhibitors|protease inhibitors|mesh-ancestor
110600156|NCT00654381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110600157|NCT00654381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110600158|NCT00654381|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
110600159|NCT00654381|Vitamin B Complex|vitamin b complex|mesh-ancestor
110600160|NCT00654381|Vitamins|vitamins|mesh-ancestor
110600161|NCT00654381|Micronutrients|micronutrients|mesh-ancestor
110600162|NCT04018482|Povidone-Iodine|povidone-iodine|mesh-list
110600163|NCT04018482|Povidone|povidone|mesh-list
110600164|NCT04018482|Plasma Substitutes|plasma substitutes|mesh-ancestor
110270992|NCT00177099|Immunologic Factors|immunologic factors|mesh-ancestor
110600165|NCT04018482|Blood Substitutes|blood substitutes|mesh-ancestor
110600166|NCT04018482|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110600167|NCT04018482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110600168|NCT00805311|Aspirin|aspirin|mesh-list
110600169|NCT00805311|Losartan|losartan|mesh-list
110600170|NCT00805311|Amlodipine|amlodipine|mesh-list
110600171|NCT00805311|Atorvastatin|atorvastatin|mesh-list
110600172|NCT00805311|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110600173|NCT00805311|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110600174|NCT00805311|Analgesics|analgesics|mesh-ancestor
110600175|NCT00805311|Sensory System Agents|sensory system agents|mesh-ancestor
110271055|NCT00194649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110600176|NCT00805311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110271119|NCT00166400|Adrenergic Agents|adrenergic agents|mesh-ancestor
110600177|NCT00805311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110600178|NCT00805311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110600180|NCT00805311|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110600181|NCT00805311|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110600182|NCT00805311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110600183|NCT00805311|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110023957|NCT00004176|Etoposide|etoposide|mesh-list
110600184|NCT00805311|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110600185|NCT00805311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110600186|NCT00805311|Antipyretics|antipyretics|mesh-ancestor
110600187|NCT00805311|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110600188|NCT00805311|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110600189|NCT00805311|Antimetabolites|antimetabolites|mesh-ancestor
110600190|NCT00805311|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110271192|NCT00408135|Telithromycin|telithromycin|mesh-list
110271193|NCT00408135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110600191|NCT00805311|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110600192|NCT00805311|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110600193|NCT00805311|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110600194|NCT00805311|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110600195|NCT00805311|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110600196|NCT00805311|Vasodilator Agents|vasodilator agents|mesh-ancestor
110600197|NCT00805311|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110600198|NCT00805311|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110600199|NCT00805311|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110600200|NCT00732290|Fluoxetine|fluoxetine|mesh-list
110600201|NCT00732290|Clopidogrel|clopidogrel|mesh-list
110600202|NCT00732290|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110600203|NCT00732290|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110600204|NCT00732290|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110600205|NCT00732290|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110600206|NCT00732290|Purinergic Agents|purinergic agents|mesh-ancestor
110600207|NCT00732290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110600208|NCT00732290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110271252|NCT00166829|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110600209|NCT00732290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110600210|NCT00732290|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110600211|NCT00732290|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110600212|NCT00732290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110600213|NCT00732290|Serotonin Agents|serotonin agents|mesh-ancestor
110600214|NCT00732290|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110600215|NCT00732290|Antidepressive Agents|antidepressive agents|mesh-ancestor
110600216|NCT00732290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110600217|NCT00732290|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110600218|NCT00732290|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110600219|NCT00732290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110600220|NCT02570334|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
110600221|NCT02570334|Antiviral Agents|antiviral agents|mesh-ancestor
110600222|NCT02570334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110600224|NCT00732446|Dexamethasone|dexamethasone|mesh-list
110600225|NCT00732446|Dexamethasone acetate|dexamethasone acetate|mesh-list
110600226|NCT00732446|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
110600227|NCT00732446|BB 1101|bb 1101|mesh-list
110600228|NCT00732446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110600229|NCT00732446|Antiemetics|antiemetics|mesh-ancestor
110600230|NCT00732446|Autonomic Agents|autonomic agents|mesh-ancestor
110600231|NCT00732446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110600232|NCT00732446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110600233|NCT00732446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110600234|NCT00732446|Glucocorticoids|glucocorticoids|mesh-ancestor
110600235|NCT00732446|Hormones|hormones|mesh-ancestor
110600236|NCT00732446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110271365|NCT00177567|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110271387|NCT00177567|GABA Agents|gaba agents|mesh-ancestor
110600237|NCT00732446|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110600238|NCT00732446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110600239|NCT00732446|Protease Inhibitors|protease inhibitors|mesh-ancestor
110600240|NCT00732446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110600241|NCT00732446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110600242|NCT00732446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110600243|NCT00732446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110378205|NCT00556127|Antimitotic Agents|antimitotic agents|mesh-ancestor
110600244|NCT00732446|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110600245|NCT00732446|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110271423|NCT00195195|Antifungal Agents|antifungal agents|mesh-ancestor
110600246|NCT00732446|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110151735|NCT00001213|Cysteamine|cysteamine|mesh-list
110600247|NCT00732446|Contraceptive Agents|contraceptive agents|mesh-ancestor
110600248|NCT00732446|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110600249|NCT00732446|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110600250|NCT00732446|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110600251|NCT00732446|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110600252|NCT00732524|Glipizide|glipizide|mesh-list
110600253|NCT00732524|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110600254|NCT00732524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110600255|NCT00657267|Temozolomide|temozolomide|mesh-list
110600256|NCT00657267|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110600257|NCT00657267|Alkylating Agents|alkylating agents|mesh-ancestor
110600258|NCT00657267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110600259|NCT00657267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110600260|NCT00733850|Gemcitabine|gemcitabine|mesh-list
110600261|NCT00733850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110600262|NCT00733850|Antimetabolites|antimetabolites|mesh-ancestor
110271497|NCT03888079|Anesthetics, Local|anesthetics, local|mesh-list
110600263|NCT00733850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110600264|NCT00733850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110600265|NCT00727766|Clofarabine|clofarabine|mesh-list
110600266|NCT00727766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110600267|NCT00727766|Antimetabolites|antimetabolites|mesh-ancestor
110600268|NCT00727766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110600269|NCT00727766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110600270|NCT00799071|Posaconazole|posaconazole|mesh-list
110600271|NCT00799071|Antifungal Agents|antifungal agents|mesh-ancestor
110600272|NCT00799071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110600273|NCT00799071|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
110600274|NCT00799071|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110600275|NCT00799071|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110600276|NCT00799071|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110600277|NCT00799071|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110600278|NCT00799071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110600279|NCT00799071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110271559|NCT00167765|Abciximab|abciximab|mesh-list
110600280|NCT00799071|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110600281|NCT00799071|Hormone Antagonists|hormone antagonists|mesh-ancestor
110600282|NCT00799071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110600283|NCT00799071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110600285|NCT00732836|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110600286|NCT00732836|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110600287|NCT00732836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110600288|NCT00732836|Tubulin Modulators|tubulin modulators|mesh-ancestor
110600289|NCT00732836|Antimitotic Agents|antimitotic agents|mesh-ancestor
110600290|NCT00732836|Mitosis Modulators|mitosis modulators|mesh-ancestor
110600291|NCT00732836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110600292|NCT00799149|Etoricoxib|etoricoxib|mesh-list
110600293|NCT00799149|Gabapentin|gabapentin|mesh-list
110600294|NCT00799149|Analgesics|analgesics|mesh-ancestor
110600295|NCT00799149|Sensory System Agents|sensory system agents|mesh-ancestor
110600296|NCT00799149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110271606|NCT00167882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110600297|NCT00799149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110600298|NCT00799149|Anticonvulsants|anticonvulsants|mesh-ancestor
110600299|NCT00799149|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110600300|NCT00799149|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110600301|NCT00799149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110600302|NCT00799149|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110600303|NCT00799149|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110600304|NCT00799149|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110271672|NCT02904772|Cyclosporine|cyclosporine|mesh-list
110600305|NCT00799149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110600306|NCT00799149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110600308|NCT00799149|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110600309|NCT00799149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110600310|NCT00799149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110600312|NCT00799149|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110600313|NCT00799149|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110600314|NCT00799149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110600316|NCT00732914|Sunitinib|sunitinib|mesh-list
110600317|NCT00732914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110600318|NCT00732914|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110600319|NCT00732914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110600320|NCT00732914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110600321|NCT00732914|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110600322|NCT00732914|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110600323|NCT00732914|Growth Substances|growth substances|mesh-ancestor
110600324|NCT00732914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110600325|NCT00732914|Growth Inhibitors|growth inhibitors|mesh-ancestor
110600326|NCT00808275|Calcium, Dietary|calcium, dietary|mesh-list
110600327|NCT00808275|Calcium|calcium|mesh-list
110600328|NCT00808275|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110600329|NCT00808275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110600330|NCT00808275|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110600331|NCT00809289|Moxifloxacin|moxifloxacin|mesh-list
110271730|NCT02904538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110271733|NCT02963103|Tacrolimus|tacrolimus|mesh-list
110600332|NCT00809289|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110600333|NCT00809289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110600334|NCT00809289|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110600335|NCT00809289|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110600336|NCT00809289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110600337|NCT00809289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110600338|NCT00809289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110600339|NCT00728000|Gemcitabine|gemcitabine|mesh-list
110600340|NCT00728000|Oxaliplatin|oxaliplatin|mesh-list
110600341|NCT00728000|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110600342|NCT00728000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110600343|NCT00728000|Antimetabolites|antimetabolites|mesh-ancestor
110600344|NCT00728000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110600345|NCT00728000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110600346|NCT00728000|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110600347|NCT00728000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110600348|NCT04065230|Tenofovir|tenofovir|mesh-list
110600349|NCT04065230|Antiviral Agents|antiviral agents|mesh-ancestor
110600350|NCT04065230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110600351|NCT04065230|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110600352|NCT04065230|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110600353|NCT04065230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110600354|NCT04065230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110600355|NCT04065230|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110600356|NCT04065230|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110271841|NCT02904109|Mannitol|mannitol|mesh-list
110600357|NCT00728078|Thalidomide|thalidomide|mesh-list
110600358|NCT00728078|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110600360|NCT00728078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110600361|NCT00728078|Leprostatic Agents|leprostatic agents|mesh-ancestor
110600362|NCT00728078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110600363|NCT00728078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110600364|NCT00728078|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110600365|NCT00728078|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110600366|NCT00728078|Growth Substances|growth substances|mesh-ancestor
110600367|NCT00728078|Growth Inhibitors|growth inhibitors|mesh-ancestor
110600368|NCT00728078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110600369|NCT04066088|Guanfacine|guanfacine|mesh-list
110600370|NCT04066088|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110600371|NCT04066088|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110271904|NCT05995912|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110600372|NCT04066088|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110600373|NCT04066088|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110600374|NCT04066088|Adrenergic Agents|adrenergic agents|mesh-ancestor
110600375|NCT04066088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110600376|NCT04066088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110600377|NCT04066088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110600378|NCT00733148|Insulin|insulin|mesh-list
110600379|NCT00733148|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110600380|NCT00733148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110600381|NCT00730392|Etanercept|etanercept|mesh-list
110271963|NCT05995054|Obinutuzumab|obinutuzumab|mesh-list
110271964|NCT05995054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110600382|NCT00730392|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110600383|NCT00730392|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110600384|NCT00730392|Analgesics|analgesics|mesh-ancestor
110600385|NCT00730392|Sensory System Agents|sensory system agents|mesh-ancestor
110600386|NCT00730392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110600387|NCT00730392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110600388|NCT00730392|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110600389|NCT00730392|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110600390|NCT00730392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110600391|NCT00730392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110600392|NCT00730392|Immunologic Factors|immunologic factors|mesh-ancestor
110600393|NCT01528046|Metformin|metformin|mesh-list
110600394|NCT01528046|Irinotecan|irinotecan|mesh-list
110600395|NCT01528046|Camptothecin|camptothecin|mesh-list
110600396|NCT01528046|Vincristine|vincristine|mesh-list
110600397|NCT01528046|Temozolomide|temozolomide|mesh-list
110600398|NCT01528046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110600399|NCT01528046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110600400|NCT01528046|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110600401|NCT01528046|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110272027|NCT05994456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110272028|NCT05994378|Ganirelix|ganirelix|mesh-list
110272029|NCT05994378|Hormone Antagonists|hormone antagonists|mesh-ancestor
110272030|NCT05994378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110272031|NCT05994378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110272032|NCT05994287|Aspirin|aspirin|mesh-list
110272033|NCT05994287|Celecoxib|celecoxib|mesh-list
110272034|NCT05994287|Ketorolac|ketorolac|mesh-list
110600402|NCT01528046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110600403|NCT01528046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110600404|NCT01528046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110600405|NCT01528046|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110600406|NCT01528046|Tubulin Modulators|tubulin modulators|mesh-ancestor
110600407|NCT01528046|Antimitotic Agents|antimitotic agents|mesh-ancestor
110600408|NCT01528046|Mitosis Modulators|mitosis modulators|mesh-ancestor
110600409|NCT01528046|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110600410|NCT01528046|Alkylating Agents|alkylating agents|mesh-ancestor
110600411|NCT00652899|Aldesleukin|aldesleukin|mesh-list
110600412|NCT00652899|Cyclophosphamide|cyclophosphamide|mesh-list
110600413|NCT00652899|Fludarabine|fludarabine|mesh-list
110600414|NCT00652899|Fludarabine phosphate|fludarabine phosphate|mesh-list
110600415|NCT00652899|Interleukin-2|interleukin-2|mesh-list
110600416|NCT00652899|Allopurinol|allopurinol|mesh-list
110600417|NCT00652899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110600418|NCT00652899|Immunologic Factors|immunologic factors|mesh-ancestor
110600419|NCT00652899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110600420|NCT00652899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110272088|NCT05983224|Quercetin|quercetin|mesh-list
110272089|NCT05983224|Antioxidants|antioxidants|mesh-ancestor
110272090|NCT05983224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110272091|NCT05983224|Protective Agents|protective agents|mesh-ancestor
110272092|NCT05983224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110272093|NCT05910801|Lenalidomide|lenalidomide|mesh-list
110600421|NCT00652899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110600422|NCT00652899|Alkylating Agents|alkylating agents|mesh-ancestor
110600423|NCT00652899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110600424|NCT00652899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110600425|NCT00652899|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110600426|NCT00652899|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110600427|NCT00652899|Antimetabolites|antimetabolites|mesh-ancestor
110600428|NCT00652899|Antiviral Agents|antiviral agents|mesh-ancestor
110600429|NCT00652899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110600430|NCT00652899|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110600431|NCT00652899|Analgesics|analgesics|mesh-ancestor
110600432|NCT00652899|Sensory System Agents|sensory system agents|mesh-ancestor
110600433|NCT00652899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110600434|NCT00652899|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110600435|NCT00652899|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110600436|NCT00652899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110600437|NCT00652899|Gout Suppressants|gout suppressants|mesh-ancestor
110600438|NCT00652899|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110600439|NCT00652899|Antioxidants|antioxidants|mesh-ancestor
110600440|NCT00652899|Protective Agents|protective agents|mesh-ancestor
110600441|NCT04066452|Immunoglobulins|immunoglobulins|mesh-list
110151757|NCT00001267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110600442|NCT04066452|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110600444|NCT04066452|Immunologic Factors|immunologic factors|mesh-ancestor
110272140|NCT05864417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110272141|NCT05864417|Dermatologic Agents|dermatologic agents|mesh-ancestor
110600445|NCT04066452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110600446|NCT00728520|Azacitidine|azacitidine|mesh-list
110600447|NCT00728520|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110600448|NCT00728520|Antimetabolites|antimetabolites|mesh-ancestor
110600449|NCT00728520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110378223|NCT00478608|Sirolimus|sirolimus|mesh-list
110600450|NCT00728520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110600451|NCT00728520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110600453|NCT04065308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110600454|NCT00733538|Zoledronic Acid|zoledronic acid|mesh-list
110600455|NCT00733538|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110600456|NCT00733538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110600457|NCT00728156|Clopidogrel|clopidogrel|mesh-list
110600458|NCT00728156|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110600459|NCT00728156|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110272191|NCT05788016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110600460|NCT00728156|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110600461|NCT00728156|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110600462|NCT00728156|Purinergic Agents|purinergic agents|mesh-ancestor
110600463|NCT00728156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110600464|NCT00728156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110600465|NCT00728156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110600466|NCT02569554|Rabeprazole|rabeprazole|mesh-list
110600467|NCT02569554|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110600468|NCT02569554|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110600469|NCT02569554|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110600470|NCT02569554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110600471|NCT02569554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110600472|NCT00734318|Fluticasone|fluticasone|mesh-list
110600473|NCT00734318|Xhance|xhance|mesh-list
110600474|NCT00734318|Formoterol Fumarate|formoterol fumarate|mesh-list
110600475|NCT00734318|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110600476|NCT00734318|Autonomic Agents|autonomic agents|mesh-ancestor
110600477|NCT00734318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110272276|NCT05668091|Ritonavir|ritonavir|mesh-list
110600478|NCT00734318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110600479|NCT00734318|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110600480|NCT00734318|Respiratory System Agents|respiratory system agents|mesh-ancestor
110600481|NCT00734318|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110600482|NCT00734318|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110600484|NCT00734318|Adrenergic Agents|adrenergic agents|mesh-ancestor
110600485|NCT00734318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110600486|NCT00734318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110600487|NCT00734318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110600488|NCT00734318|Dermatologic Agents|dermatologic agents|mesh-ancestor
110600489|NCT00734318|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110600490|NCT00733616|Docetaxel|docetaxel|mesh-list
110600491|NCT00733616|Capecitabine|capecitabine|mesh-list
110600492|NCT00733616|Oxaliplatin|oxaliplatin|mesh-list
110600493|NCT00733616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110600494|NCT00733616|Tubulin Modulators|tubulin modulators|mesh-ancestor
110272328|NCT05642026|Ropivacaine|ropivacaine|mesh-list
110272330|NCT05642026|Anesthetics|anesthetics|mesh-ancestor
110600495|NCT00733616|Antimitotic Agents|antimitotic agents|mesh-ancestor
110600496|NCT00733616|Mitosis Modulators|mitosis modulators|mesh-ancestor
110600497|NCT00733616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110600498|NCT00733616|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110600499|NCT00733616|Antimetabolites|antimetabolites|mesh-ancestor
110600500|NCT00728832|Morphine|morphine|mesh-list
110600501|NCT00728832|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110600502|NCT00728832|Narcotics|narcotics|mesh-ancestor
110600503|NCT00728832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110600504|NCT00728832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110600505|NCT00728832|Analgesics|analgesics|mesh-ancestor
110600506|NCT00728832|Sensory System Agents|sensory system agents|mesh-ancestor
110600507|NCT00728832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110600508|NCT03924804|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110600509|NCT00728312|Aripiprazole|aripiprazole|mesh-list
110600510|NCT00728312|Antidepressive Agents|antidepressive agents|mesh-ancestor
110600511|NCT00728312|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110600512|NCT00728312|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110600513|NCT00728312|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110600514|NCT00728312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110600515|NCT00728312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110600516|NCT00728312|Dopamine Agonists|dopamine agonists|mesh-ancestor
110600518|NCT00728312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110600519|NCT00728312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110600520|NCT00728312|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110600521|NCT00728312|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110600522|NCT00728312|Serotonin Agents|serotonin agents|mesh-ancestor
110600523|NCT00728312|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110600524|NCT00728312|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110600525|NCT00728312|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110600526|NCT00728312|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110600528|NCT00728546|Antitubercular Agents|antitubercular agents|mesh-ancestor
110600529|NCT00728546|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110600530|NCT00728546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110600531|NCT00728546|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
110272468|NCT05356897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110600532|NCT00728546|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110600533|NCT00728546|Antimetabolites|antimetabolites|mesh-ancestor
110600534|NCT00728546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110600535|NCT00728546|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110600536|NCT00617890|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110600537|NCT00617890|Immunologic Factors|immunologic factors|mesh-ancestor
110600538|NCT00617890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110600539|NCT00728780|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110600540|NCT00728780|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110600541|NCT00728780|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110600542|NCT00728780|Antimetabolites|antimetabolites|mesh-ancestor
110600543|NCT00728780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110600544|NCT00728780|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110600545|NCT00728780|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110272521|NCT05154747|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110600546|NCT00728780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110600548|NCT04066296|Anesthetics, Local|anesthetics, local|mesh-list
110600549|NCT04066296|Anesthetics|anesthetics|mesh-list
110600550|NCT04066296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110600551|NCT04066296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110600552|NCT04066296|Sensory System Agents|sensory system agents|mesh-ancestor
110600553|NCT04066296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110600554|NCT02341014|Lenalidomide|lenalidomide|mesh-list
110600555|NCT02341014|Romidepsin|romidepsin|mesh-list
110600556|NCT02341014|Immunologic Factors|immunologic factors|mesh-ancestor
110600557|NCT02341014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110600558|NCT02341014|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110600559|NCT02341014|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110600560|NCT02341014|Growth Substances|growth substances|mesh-ancestor
110600561|NCT02341014|Growth Inhibitors|growth inhibitors|mesh-ancestor
110600562|NCT02341014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110600563|NCT02341014|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110600564|NCT02341014|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110272579|NCT05106335|Mitosis Modulators|mitosis modulators|mesh-ancestor
110272580|NCT05106335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110272582|NCT05090085|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
110600565|NCT02341014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110600566|NCT02341014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110600568|NCT00868426|Formoterol Fumarate|formoterol fumarate|mesh-list
110600569|NCT00868426|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
110600571|NCT00868426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110600572|NCT00868426|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110600573|NCT00868426|Autonomic Agents|autonomic agents|mesh-ancestor
110600574|NCT00868426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110600575|NCT00868426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110600576|NCT00868426|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110600577|NCT00868426|Respiratory System Agents|respiratory system agents|mesh-ancestor
110600578|NCT00868426|Glucocorticoids|glucocorticoids|mesh-ancestor
110600579|NCT00868426|Hormones|hormones|mesh-ancestor
110600580|NCT00868426|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110600581|NCT00868426|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110600582|NCT00868426|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110378235|NCT00478023|Morphine|morphine|mesh-list
110600583|NCT00868426|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110600585|NCT00868426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110272630|NCT04929392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110600586|NCT00868426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110600587|NCT00868426|Antidotes|antidotes|mesh-ancestor
110600588|NCT00868426|Protective Agents|protective agents|mesh-ancestor
110600589|NCT03853746|Ocrelizumab|ocrelizumab|mesh-list
110600590|NCT03853746|Immunologic Factors|immunologic factors|mesh-ancestor
110600591|NCT03853746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110600592|NCT00868738|Vitamin D|vitamin d|mesh-list
110600593|NCT00868738|Vitamins|vitamins|mesh-ancestor
110600594|NCT00868738|Micronutrients|micronutrients|mesh-ancestor
110600595|NCT00868738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110600596|NCT00868738|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110600597|NCT00868816|Oxaliplatin|oxaliplatin|mesh-list
110600598|NCT00868816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110600599|NCT02569866|Cephalexin|cephalexin|mesh-list
110600600|NCT02569866|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110600601|NCT02569866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110600602|NCT00868894|Latanoprost|latanoprost|mesh-list
110600603|NCT00868894|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110600604|NCT00868894|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110600605|NCT00730938|Cefuroxime|cefuroxime|mesh-list
110600606|NCT00730938|Cefuroxime axetil|cefuroxime axetil|mesh-list
110600607|NCT00730938|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110600608|NCT00730938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110600609|NCT00712010|Caseins|caseins|mesh-list
110600610|NCT00712010|Chelating Agents|chelating agents|mesh-ancestor
110600611|NCT00712010|Sequestering Agents|sequestering agents|mesh-ancestor
110600612|NCT00712010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110600613|NCT00731016|Zoledronic Acid|zoledronic acid|mesh-list
110600614|NCT00731016|Pravastatin|pravastatin|mesh-list
110600615|NCT00731016|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110600616|NCT00731016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110600617|NCT00731016|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110600618|NCT00731016|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110600619|NCT00731016|Antimetabolites|antimetabolites|mesh-ancestor
110600620|NCT00731016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110600621|NCT00731016|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110600622|NCT00731016|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110600623|NCT00731016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110600624|NCT00799539|Prednisone|prednisone|mesh-list
110600625|NCT00799539|Bortezomib|bortezomib|mesh-list
110600626|NCT00799539|Melphalan|melphalan|mesh-list
110600627|NCT00799539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110272737|NCT04692077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110272746|NCT04563520|Coagulants|coagulants|mesh-list
110600628|NCT00799539|Glucocorticoids|glucocorticoids|mesh-ancestor
110600629|NCT00799539|Hormones|hormones|mesh-ancestor
110600630|NCT00799539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110600631|NCT00799539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110600632|NCT00799539|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110600633|NCT00799539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110600634|NCT00799539|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110600635|NCT00799539|Alkylating Agents|alkylating agents|mesh-ancestor
110600636|NCT00799539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110600637|NCT00799539|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110600638|NCT00799539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110600639|NCT00799539|Immunologic Factors|immunologic factors|mesh-ancestor
110600640|NCT00731172|Glatiramer Acetate|glatiramer acetate|mesh-list
110600641|NCT00731172|(T,G)-A-L|(t,g)-a-l|mesh-list
110600642|NCT00731172|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110600643|NCT00731172|Immunologic Factors|immunologic factors|mesh-ancestor
110600644|NCT00731172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110272795|NCT04464629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110272796|NCT04464629|Glucocorticoids|glucocorticoids|mesh-ancestor
110600645|NCT00731172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110600646|NCT00731172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110600647|NCT00738842|Ticagrelor|ticagrelor|mesh-list
110600648|NCT00738842|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110600649|NCT00738842|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110600650|NCT00738842|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110600651|NCT00738842|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110600652|NCT00738842|Purinergic Agents|purinergic agents|mesh-ancestor
110600653|NCT00738842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110600654|NCT00738842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110600655|NCT00738842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110247963|NCT00489775|Analgesics|analgesics|mesh-ancestor
110600656|NCT00809913|Ciprofloxacin|ciprofloxacin|mesh-list
110600657|NCT00809913|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110600658|NCT00809913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110600659|NCT00809913|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110600660|NCT00809913|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110600661|NCT00809913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110600662|NCT00809913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110600663|NCT00809913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110600664|NCT00809913|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110600665|NCT00809913|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110272922|NCT03989271|Quercetin|quercetin|mesh-list
110600666|NCT00729222|Rolofylline|rolofylline|mesh-list
110600667|NCT00729222|Diuretics|diuretics|mesh-ancestor
110600668|NCT00729222|Natriuretic Agents|natriuretic agents|mesh-ancestor
110600669|NCT00729222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110600670|NCT00808743|Celecoxib|celecoxib|mesh-list
110600671|NCT00808743|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
110600672|NCT00808743|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110600673|NCT00808743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110600674|NCT00808743|Analgesics|analgesics|mesh-ancestor
110600675|NCT00808743|Sensory System Agents|sensory system agents|mesh-ancestor
110600676|NCT00808743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110600677|NCT00808743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110600678|NCT00808743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110600679|NCT00808743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110600680|NCT00808743|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110600681|NCT00808743|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110600682|NCT00808743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110600683|NCT00808743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110600684|NCT00808743|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
110600685|NCT00808743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110600686|NCT00869596|Fluticasone|fluticasone|mesh-list
110600687|NCT00869596|Xhance|xhance|mesh-list
110600688|NCT00869596|Albuterol|albuterol|mesh-list
110600690|NCT00869596|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110600691|NCT00869596|Autonomic Agents|autonomic agents|mesh-ancestor
110600692|NCT00869596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110600693|NCT00869596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110600694|NCT00869596|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110600695|NCT00869596|Respiratory System Agents|respiratory system agents|mesh-ancestor
110600696|NCT00869596|Dermatologic Agents|dermatologic agents|mesh-ancestor
110600697|NCT00869596|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110272982|NCT03913104|Hormone Antagonists|hormone antagonists|mesh-ancestor
110600698|NCT00869596|Tocolytic Agents|tocolytic agents|mesh-ancestor
110600699|NCT00869596|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110600700|NCT00869596|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110600701|NCT00869596|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110600702|NCT00869596|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110600703|NCT00869596|Adrenergic Agents|adrenergic agents|mesh-ancestor
110600704|NCT00869596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110600705|NCT00869596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110600706|NCT03743376|UB-421|ub-421|mesh-list
110600707|NCT03743376|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110600708|NCT03743376|Antiviral Agents|antiviral agents|mesh-ancestor
110600709|NCT03743376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110600710|NCT00734864|Anticonvulsants|anticonvulsants|mesh-list
110600711|NCT03728478|Etanercept|etanercept|mesh-list
110600712|NCT03728478|Methotrexate|methotrexate|mesh-list
110600713|NCT03728478|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110273028|NCT03535298|Teriflunomide|teriflunomide|mesh-list
110273029|NCT03535298|Alemtuzumab|alemtuzumab|mesh-list
110600714|NCT03728478|Abortifacient Agents|abortifacient agents|mesh-ancestor
110600715|NCT03728478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110600716|NCT03728478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110600717|NCT03728478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110600718|NCT03728478|Antimetabolites|antimetabolites|mesh-ancestor
110600719|NCT03728478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110600720|NCT03728478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110600721|NCT03728478|Dermatologic Agents|dermatologic agents|mesh-ancestor
110600722|NCT03728478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110600723|NCT03728478|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110600724|NCT03728478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110600725|NCT03728478|Immunologic Factors|immunologic factors|mesh-ancestor
110600726|NCT03728478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110600727|NCT03728478|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110273091|NCT03346135|Alkylating Agents|alkylating agents|mesh-ancestor
110600728|NCT03728478|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110600729|NCT03728478|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110600730|NCT03728478|Analgesics|analgesics|mesh-ancestor
110600731|NCT03728478|Sensory System Agents|sensory system agents|mesh-ancestor
110600732|NCT03728478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110600733|NCT03728478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110600734|NCT03728478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110600735|NCT00653523|Simvastatin|simvastatin|mesh-list
110600736|NCT00653523|Ezetimibe|ezetimibe|mesh-list
110600737|NCT00653523|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110600738|NCT00653523|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110600739|NCT00653523|Antimetabolites|antimetabolites|mesh-ancestor
110600740|NCT00653523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110600741|NCT00653523|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110273150|NCT02905591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110600742|NCT00653523|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110600744|NCT00808977|Mesalamine|mesalamine|mesh-list
110600745|NCT00808977|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110600746|NCT00808977|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110600747|NCT00808977|Analgesics|analgesics|mesh-ancestor
110600748|NCT00808977|Sensory System Agents|sensory system agents|mesh-ancestor
110600749|NCT00808977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110600750|NCT00808977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110600751|NCT00808977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110273229|NCT01430390|Cyclophosphamide|cyclophosphamide|mesh-list
110273230|NCT01430390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110274761|NCT04534270|Dapagliflozin|dapagliflozin|mesh-list
110600752|NCT00808977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110600753|NCT00735020|Vaccines|vaccines|mesh-list
110600754|NCT00735020|Immunologic Factors|immunologic factors|mesh-ancestor
110600755|NCT00735020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110600756|NCT04065906|Methylphenidate|methylphenidate|mesh-list
110600757|NCT04065906|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
110600758|NCT04065906|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110600759|NCT04065906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110600760|NCT04065906|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110600761|NCT04065906|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110600762|NCT04065906|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110600763|NCT04065906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110600764|NCT04065906|Dopamine Agents|dopamine agents|mesh-ancestor
110600765|NCT04065906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110600766|NCT04065906|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110600767|NCT04065906|Adrenergic Agents|adrenergic agents|mesh-ancestor
110600769|NCT00739388|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110600770|NCT00739388|Antimetabolites|antimetabolites|mesh-ancestor
110600771|NCT00739388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110600772|NCT00739388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110600773|NCT00739388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110600774|NCT00862888|Sildenafil Citrate|sildenafil citrate|mesh-list
110600775|NCT00862888|Vasodilator Agents|vasodilator agents|mesh-ancestor
110600776|NCT00862888|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110600777|NCT00862888|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110600778|NCT00862888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110600779|NCT00862888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110600780|NCT00862888|Urological Agents|urological agents|mesh-ancestor
110600782|NCT00729170|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110600783|NCT00729170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110600785|NCT00862966|Anticoagulants|anticoagulants|mesh-ancestor
110600786|NCT00862966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110600787|NCT00862966|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110600788|NCT00862966|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110600789|NCT02569320|Dexamethasone|dexamethasone|mesh-list
110600790|NCT02569320|Dexamethasone acetate|dexamethasone acetate|mesh-list
110600791|NCT02569320|Pomalidomide|pomalidomide|mesh-list
110600792|NCT02569320|Ichthammol|ichthammol|mesh-list
110600793|NCT02569320|BB 1101|bb 1101|mesh-list
110600794|NCT02569320|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
110600795|NCT02569320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110600796|NCT02569320|Antiemetics|antiemetics|mesh-ancestor
110600797|NCT02569320|Autonomic Agents|autonomic agents|mesh-ancestor
110600798|NCT02569320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110600799|NCT02569320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110600800|NCT02569320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110600801|NCT02569320|Glucocorticoids|glucocorticoids|mesh-ancestor
110600802|NCT02569320|Hormones|hormones|mesh-ancestor
110600803|NCT02569320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110600804|NCT02569320|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110600805|NCT02569320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110600806|NCT02569320|Protease Inhibitors|protease inhibitors|mesh-ancestor
110600807|NCT02569320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110248110|NCT00490867|Vitamin B Complex|vitamin b complex|mesh-ancestor
110151827|NCT00388635|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110600808|NCT02569320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110600809|NCT02569320|Immunologic Factors|immunologic factors|mesh-ancestor
110600810|NCT02569320|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110600811|NCT02569320|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110273476|NCT00196131|Morphine|morphine|mesh-list
110273485|NCT00168896|Irinotecan|irinotecan|mesh-list
110600812|NCT02569320|Growth Substances|growth substances|mesh-ancestor
110600813|NCT02569320|Growth Inhibitors|growth inhibitors|mesh-ancestor
110600814|NCT02569320|Dermatologic Agents|dermatologic agents|mesh-ancestor
110600815|NCT00739466|Alendronate|alendronate|mesh-list
110600816|NCT00739466|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110600817|NCT00739466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110600818|NCT00869908|Insulin|insulin|mesh-list
110600819|NCT00869908|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110600820|NCT00869908|Insulin Aspart|insulin aspart|mesh-list
110600821|NCT00869908|Insulin, Long-Acting|insulin, long-acting|mesh-list
110600822|NCT00869908|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
110600823|NCT00869908|Insulin Detemir|insulin detemir|mesh-list
110600824|NCT00869908|Biphasic Insulins|biphasic insulins|mesh-list
110600825|NCT00869908|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110600826|NCT00869908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110600827|NCT00739622|Rilpivirine|rilpivirine|mesh-list
110600828|NCT00739622|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110600829|NCT00739622|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110600830|NCT00739622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110273537|NCT00169013|Anticonvulsants|anticonvulsants|mesh-ancestor
110600831|NCT00739622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110600832|NCT00739622|Antiviral Agents|antiviral agents|mesh-ancestor
110600833|NCT00739622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110600834|NCT00739622|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110600835|NCT00739622|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110600836|NCT00731562|Varenicline|varenicline|mesh-list
110600837|NCT00731562|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110600838|NCT00731562|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110600839|NCT00731562|Cholinergic Agents|cholinergic agents|mesh-ancestor
110600840|NCT00731562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110273592|NCT00169169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110600841|NCT00731562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110600842|NCT00731562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110600843|NCT00870142|Amlodipine|amlodipine|mesh-list
110600844|NCT00870142|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110600845|NCT00870142|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110600846|NCT00870142|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110600847|NCT00870142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110600848|NCT00870142|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110600849|NCT00870142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110600850|NCT00870142|Vasodilator Agents|vasodilator agents|mesh-ancestor
110600851|NCT00870220|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110600852|NCT00870220|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110600853|NCT00870220|Estradiol|estradiol|mesh-list
110600854|NCT00870220|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110600855|NCT00870220|Estrogens|estrogens|mesh-ancestor
110600856|NCT00870220|Hormones|hormones|mesh-ancestor
110600857|NCT00870220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110600858|NCT00870220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110273657|NCT02898961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110600859|NCT00870220|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110600860|NCT00870220|Contraceptive Agents|contraceptive agents|mesh-ancestor
110600861|NCT00870220|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110600862|NCT00870220|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110600864|NCT00729768|Mycophenolic Acid|mycophenolic acid|mesh-list
110600865|NCT00729768|Cyclosporins|cyclosporins|mesh-list
110600866|NCT00729768|Basiliximab|basiliximab|mesh-list
110600867|NCT00729768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110600868|NCT00729768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110600869|NCT00729768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110600870|NCT00729768|Immunologic Factors|immunologic factors|mesh-ancestor
110600871|NCT00729768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110378296|NCT00477633|Hormones|hormones|mesh-ancestor
110600872|NCT00729768|Antifungal Agents|antifungal agents|mesh-ancestor
110600873|NCT00729768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110600874|NCT00729768|Dermatologic Agents|dermatologic agents|mesh-ancestor
110600875|NCT00729768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110600876|NCT00729768|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110600877|NCT00729768|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110600878|NCT00729768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110600879|NCT00729768|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110600880|NCT00729768|Antitubercular Agents|antitubercular agents|mesh-ancestor
110600881|NCT00729768|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110248189|NCT00492037|Natriuretic Agents|natriuretic agents|mesh-ancestor
110600883|NCT00871156|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
110600884|NCT00871156|Tafenoquine|tafenoquine|mesh-list
110600885|NCT00871156|Amebicides|amebicides|mesh-ancestor
110600886|NCT00871156|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110600887|NCT00871156|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110600888|NCT00871156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110600889|NCT00871156|Antimalarials|antimalarials|mesh-ancestor
110600890|NCT00871156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110600891|NCT00871156|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110600892|NCT00871156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110600893|NCT00871156|Analgesics|analgesics|mesh-ancestor
110600894|NCT00871156|Sensory System Agents|sensory system agents|mesh-ancestor
110600895|NCT00871156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110600896|NCT00871156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110600897|NCT00871156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110600898|NCT00871156|Filaricides|filaricides|mesh-ancestor
110600899|NCT00871156|Antinematodal Agents|antinematodal agents|mesh-ancestor
110600900|NCT00871156|Anthelmintics|anthelmintics|mesh-ancestor
110600901|NCT00734448|Inositol|inositol|mesh-list
110600902|NCT00734448|Vitamin B Complex|vitamin b complex|mesh-ancestor
110600903|NCT00734448|Vitamins|vitamins|mesh-ancestor
110600904|NCT00734448|Micronutrients|micronutrients|mesh-ancestor
110600905|NCT00734448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110600906|NCT00734526|Temozolomide|temozolomide|mesh-list
110600907|NCT00734526|Sorafenib|sorafenib|mesh-list
110600908|NCT00734526|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110600909|NCT00734526|Alkylating Agents|alkylating agents|mesh-ancestor
110600910|NCT00734526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110600911|NCT00734526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110600912|NCT00734526|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110600913|NCT00734526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110600914|NCT00729404|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110600915|NCT00729404|Gestodene|gestodene|mesh-list
110600916|NCT00729404|Femovan|femovan|mesh-list
110378327|NCT00556361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110600917|NCT00729404|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110600918|NCT00729404|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110600919|NCT00729404|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110600920|NCT00729404|Contraceptive Agents|contraceptive agents|mesh-ancestor
110600921|NCT00729404|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110600922|NCT00729404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110600923|NCT00729404|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110600924|NCT00729404|Estrogens|estrogens|mesh-ancestor
110600925|NCT00729404|Hormones|hormones|mesh-ancestor
110600926|NCT00729404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110600927|NCT00729404|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110600928|NCT00729404|Progestins|progestins|mesh-ancestor
110600929|NCT00729404|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110600930|NCT00731952|Bortezomib|bortezomib|mesh-list
110600931|NCT00731952|Vorinostat|vorinostat|mesh-list
110600932|NCT00731952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110600933|NCT00731952|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110600934|NCT00731952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110600935|NCT00731952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110600936|NCT04065932|Deucravacitinib|deucravacitinib|mesh-list
110600937|NCT04065932|Famotidine|famotidine|mesh-list
110600938|NCT04065932|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110600939|NCT04065932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110600940|NCT04065932|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110600941|NCT04065932|Histamine Antagonists|histamine antagonists|mesh-ancestor
110600942|NCT04065932|Histamine Agents|histamine agents|mesh-ancestor
110600943|NCT04065932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110600944|NCT04065932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110600945|NCT04065932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110600946|NCT04065932|Dermatologic Agents|dermatologic agents|mesh-ancestor
110600947|NCT04065932|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110600948|NCT04065932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110600949|NCT00740090|Aluminum Hydroxide|aluminum hydroxide|mesh-list
110600950|NCT00740090|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110600951|NCT00740090|Immunologic Factors|immunologic factors|mesh-ancestor
110273887|NCT02896582|Glucocorticoids|glucocorticoids|mesh-ancestor
110600952|NCT00740090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110600953|NCT00740090|Antacids|antacids|mesh-ancestor
110600954|NCT00740090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110600955|NCT00740090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110600956|NCT00738660|Telmisartan|telmisartan|mesh-list
110600957|NCT00738660|Ramipril|ramipril|mesh-list
110378375|NCT04540926|Cyclosporine|cyclosporine|mesh-list
110600958|NCT00738660|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110600959|NCT00738660|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110600960|NCT00738660|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110600961|NCT00738660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110600962|NCT00738660|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110600963|NCT00738660|Protease Inhibitors|protease inhibitors|mesh-ancestor
110600964|NCT00738660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110600966|NCT00740168|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110600967|NCT00740168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110600968|NCT00740168|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110600969|NCT00740168|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110600970|NCT00740168|Growth Substances|growth substances|mesh-ancestor
110600971|NCT00740168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110600972|NCT00740168|Growth Inhibitors|growth inhibitors|mesh-ancestor
110600973|NCT05225974|Liraglutide|liraglutide|mesh-list
110600974|NCT05225974|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110600975|NCT05225974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110600976|NCT05225974|Incretins|incretins|mesh-ancestor
110600977|NCT05225974|Hormones|hormones|mesh-ancestor
110600978|NCT05225974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110600979|NCT00729638|Lenalidomide|lenalidomide|mesh-list
110600980|NCT00729638|Everolimus|everolimus|mesh-list
110600981|NCT00729638|Immunologic Factors|immunologic factors|mesh-ancestor
110600982|NCT00729638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110600983|NCT00729638|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110600984|NCT00729638|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110600985|NCT00729638|Growth Substances|growth substances|mesh-ancestor
110600986|NCT00729638|Growth Inhibitors|growth inhibitors|mesh-ancestor
110600987|NCT00729638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110600988|NCT00729638|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110600989|NCT00729638|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110600990|NCT00729638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110600991|NCT00729638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110600992|NCT00729638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110600993|NCT00734682|Irinotecan|irinotecan|mesh-list
110600994|NCT00734682|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110378396|NCT04570865|Dapagliflozin|dapagliflozin|mesh-list
110600995|NCT00734682|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110600996|NCT00734682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110600997|NCT00734682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110600998|NCT00734682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110600999|NCT00732108|Topiramate|topiramate|mesh-list
110601000|NCT00732108|Lactulose|lactulose|mesh-list
110601001|NCT00732108|Anticonvulsants|anticonvulsants|mesh-ancestor
110601002|NCT00732108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110601003|NCT00732108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110601004|NCT00732108|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110601005|NCT00876616|Mycophenolic Acid|mycophenolic acid|mesh-list
110601006|NCT00876616|Cyclophosphamide|cyclophosphamide|mesh-list
110601007|NCT00876616|Tacrolimus|tacrolimus|mesh-list
110601008|NCT00876616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110601009|NCT00876616|Immunologic Factors|immunologic factors|mesh-ancestor
110601010|NCT00876616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110601011|NCT00876616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110601012|NCT00876616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110601013|NCT00876616|Alkylating Agents|alkylating agents|mesh-ancestor
110601014|NCT00876616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110601015|NCT00876616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110601016|NCT00876616|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110601017|NCT00876616|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110601018|NCT00876616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110601019|NCT00876616|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110601020|NCT00876616|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110601021|NCT00876616|Antitubercular Agents|antitubercular agents|mesh-ancestor
110601022|NCT00876616|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110601024|NCT05575440|Fluorides|fluorides|mesh-list
110601025|NCT05575440|Cariostatic Agents|cariostatic agents|mesh-ancestor
110601026|NCT05575440|Protective Agents|protective agents|mesh-ancestor
110601027|NCT05575440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110601028|NCT00729794|Methylprednisolone|methylprednisolone|mesh-list
110601029|NCT00729794|Hydrocortisone|hydrocortisone|mesh-list
110601030|NCT00729794|Vasopressins|vasopressins|mesh-list
110601031|NCT00729794|Epinephrine|epinephrine|mesh-list
110248336|NCT01243801|Ketamine|ketamine|mesh-list
110601032|NCT00729794|Racepinephrine|racepinephrine|mesh-list
110601033|NCT00729794|Epinephryl borate|epinephryl borate|mesh-list
110601034|NCT00729794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110601036|NCT00729794|Autonomic Agents|autonomic agents|mesh-ancestor
110601037|NCT00729794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110601038|NCT00729794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110601039|NCT00729794|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110601040|NCT00729794|Glucocorticoids|glucocorticoids|mesh-ancestor
110601041|NCT00729794|Hormones|hormones|mesh-ancestor
110601042|NCT00729794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110601043|NCT00729794|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110601044|NCT00729794|Protective Agents|protective agents|mesh-ancestor
110601045|NCT00729794|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110601046|NCT00729794|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110601047|NCT00729794|Adrenergic Agents|adrenergic agents|mesh-ancestor
110601048|NCT00729794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110601049|NCT00729794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110601050|NCT00729794|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110601051|NCT00729794|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110601052|NCT00729794|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110601053|NCT00729794|Respiratory System Agents|respiratory system agents|mesh-ancestor
110601054|NCT00729794|Mydriatics|mydriatics|mesh-ancestor
110601055|NCT00729794|Sympathomimetics|sympathomimetics|mesh-ancestor
110601056|NCT00729794|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110601057|NCT00729794|Hemostatics|hemostatics|mesh-ancestor
110601058|NCT00729794|Coagulants|coagulants|mesh-ancestor
110601059|NCT00729794|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
110601060|NCT00729794|Natriuretic Agents|natriuretic agents|mesh-ancestor
110601061|NCT00871546|Bortezomib|bortezomib|mesh-list
110601062|NCT00871546|Alemtuzumab|alemtuzumab|mesh-list
110601063|NCT00871546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110601064|NCT00871546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110601065|NCT03778294|Temozolomide|temozolomide|mesh-list
110601066|NCT03778294|Levodopa|levodopa|mesh-list
110601067|NCT03778294|Fluorides|fluorides|mesh-list
110601068|NCT03778294|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110601069|NCT03778294|Alkylating Agents|alkylating agents|mesh-ancestor
110601070|NCT03778294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110601071|NCT03778294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110601072|NCT03778294|Cariostatic Agents|cariostatic agents|mesh-ancestor
110601073|NCT03778294|Protective Agents|protective agents|mesh-ancestor
110601074|NCT03778294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110601075|NCT03778294|Dopamine Agents|dopamine agents|mesh-ancestor
110601076|NCT03778294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110601077|NCT03778294|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110601078|NCT03778294|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110274256|NCT00170963|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110274257|NCT00170963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110274259|NCT00170963|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110274260|NCT00170963|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110274261|NCT02492776|Omeprazole|omeprazole|mesh-list
110601080|NCT00732186|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110601081|NCT00732186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110601082|NCT00732186|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110601083|NCT00732186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110601084|NCT04039828|Zinc|zinc|mesh-list
110601085|NCT04039828|Zinc Sulfate|zinc sulfate|mesh-list
110601086|NCT04039828|Trace Elements|trace elements|mesh-ancestor
110601087|NCT04039828|Micronutrients|micronutrients|mesh-ancestor
110601088|NCT04039828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110601089|NCT04039828|Astringents|astringents|mesh-ancestor
110601090|NCT04039828|Dermatologic Agents|dermatologic agents|mesh-ancestor
110601091|NCT00876772|Olanzapine|olanzapine|mesh-list
110601092|NCT00876772|Antiemetics|antiemetics|mesh-ancestor
110601093|NCT00876772|Autonomic Agents|autonomic agents|mesh-ancestor
110274322|NCT05349448|Triamcinolone|triamcinolone|mesh-list
110601094|NCT00876772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110601095|NCT00876772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110601096|NCT00876772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110601098|NCT00876772|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110601099|NCT00876772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110601100|NCT00876772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110601101|NCT00876772|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110601102|NCT00876772|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110601103|NCT00876772|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110601104|NCT00876772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110601105|NCT00876772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110248410|NCT00493480|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110601106|NCT00876772|Serotonin Agents|serotonin agents|mesh-ancestor
110601107|NCT00729950|Ipilimumab|ipilimumab|mesh-list
110601108|NCT00729950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110601109|NCT00729950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110601110|NCT00729950|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110601111|NCT00729950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110601112|NCT00616018|Acetaminophen|acetaminophen|mesh-list
110601113|NCT00616018|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110601114|NCT00616018|Analgesics|analgesics|mesh-ancestor
110601115|NCT00616018|Sensory System Agents|sensory system agents|mesh-ancestor
110601116|NCT00616018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110601117|NCT00616018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110601118|NCT00616018|Antipyretics|antipyretics|mesh-ancestor
110601119|NCT00740948|Rituximab|rituximab|mesh-list
110601120|NCT00740948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110601121|NCT00740948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110601122|NCT00740948|Immunologic Factors|immunologic factors|mesh-ancestor
110601123|NCT00740948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110601124|NCT00740948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110601126|NCT00876850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110601127|NCT00876850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110378505|NCT04560218|Misoprostol|misoprostol|mesh-list
110601128|NCT00876850|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110601129|NCT00876850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110601130|NCT00876850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110601131|NCT00734916|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
110601132|NCT00734916|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
110601133|NCT00734916|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
110601134|NCT00734916|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110601135|NCT05157412|Doxycycline|doxycycline|mesh-list
110601136|NCT05157412|Prednisolone|prednisolone|mesh-list
110601137|NCT05157412|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110601138|NCT05157412|Methylprednisolone|methylprednisolone|mesh-list
110601139|NCT05157412|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110601140|NCT05157412|Prednisolone acetate|prednisolone acetate|mesh-list
110601141|NCT05157412|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110601142|NCT05157412|Prednisolone phosphate|prednisolone phosphate|mesh-list
110601143|NCT05157412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110601144|NCT05157412|Glucocorticoids|glucocorticoids|mesh-ancestor
110601145|NCT05157412|Hormones|hormones|mesh-ancestor
110601146|NCT05157412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110601147|NCT05157412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110601148|NCT05157412|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110601149|NCT05157412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110601150|NCT05157412|Antiemetics|antiemetics|mesh-ancestor
110601151|NCT05157412|Autonomic Agents|autonomic agents|mesh-ancestor
110601152|NCT05157412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110601153|NCT05157412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110601154|NCT05157412|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110601155|NCT05157412|Protective Agents|protective agents|mesh-ancestor
110601156|NCT05157412|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110601157|NCT05157412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110601158|NCT05157412|Antimalarials|antimalarials|mesh-ancestor
110601159|NCT05157412|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110601160|NCT05157412|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110601161|NCT00732420|Topotecan|topotecan|mesh-list
110601162|NCT00732420|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110601163|NCT00732420|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110601164|NCT00732420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110601165|NCT00732420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110601166|NCT00732420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110601167|NCT00735228|Pancrelipase|pancrelipase|mesh-list
110601168|NCT00735228|Pancreatin|pancreatin|mesh-list
110601169|NCT00735228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110601170|NCT00739128|Vaccines|vaccines|mesh-list
110601171|NCT00739128|Immunologic Factors|immunologic factors|mesh-ancestor
110601172|NCT00739128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110601173|NCT00863668|Tenofovir|tenofovir|mesh-list
110601174|NCT00863668|Emtricitabine|emtricitabine|mesh-list
110601175|NCT00863668|Efavirenz|efavirenz|mesh-list
110601176|NCT00863668|Raltegravir Potassium|raltegravir potassium|mesh-list
110601177|NCT00863668|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110601178|NCT00863668|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
110601179|NCT00863668|Integrase Inhibitors|integrase inhibitors|mesh-list
110601180|NCT00863668|Antiviral Agents|antiviral agents|mesh-ancestor
110601181|NCT00863668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110601182|NCT00863668|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110601183|NCT00863668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110601184|NCT00863668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110601185|NCT00863668|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110601186|NCT00863668|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110601187|NCT00863668|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110601188|NCT00863668|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110601189|NCT00863668|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110601190|NCT00863668|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110601191|NCT00863668|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110601192|NCT00863668|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110601193|NCT00863668|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110601195|NCT00872248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110601196|NCT00872248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110601197|NCT00732576|Vitamin K 2|vitamin k 2|mesh-list
110601198|NCT00732576|Vitamin K|vitamin k|mesh-list
110601199|NCT00732576|Menaquinone 7|menaquinone 7|mesh-list
110601200|NCT00732576|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110601201|NCT00732576|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110601202|NCT00732576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110601203|NCT00732576|Hemostatics|hemostatics|mesh-ancestor
110601204|NCT00732576|Coagulants|coagulants|mesh-ancestor
110601205|NCT00732576|Vitamins|vitamins|mesh-ancestor
110601206|NCT00732576|Micronutrients|micronutrients|mesh-ancestor
110601207|NCT00732576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110601208|NCT00863902|Cetirizine|cetirizine|mesh-list
110601209|NCT00863902|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110601210|NCT00863902|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110601211|NCT00863902|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110601212|NCT00863902|Histamine Antagonists|histamine antagonists|mesh-ancestor
110601213|NCT00863902|Histamine Agents|histamine agents|mesh-ancestor
110601214|NCT00863902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110601215|NCT00863902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110601216|NCT00863902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110601217|NCT00732810|Capecitabine|capecitabine|mesh-list
110601218|NCT00732810|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110378557|NCT04311697|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110601220|NCT00732810|Antimetabolites|antimetabolites|mesh-ancestor
110601221|NCT00732810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110601222|NCT00732810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110601223|NCT00732810|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110601224|NCT00732810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110601225|NCT00732888|Calcium Carbonate|calcium carbonate|mesh-list
110601226|NCT00732888|Calcium|calcium|mesh-list
110601227|NCT00732888|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110601228|NCT00732888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110601229|NCT00732888|Antacids|antacids|mesh-ancestor
110601230|NCT00732888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110601231|NCT00732888|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110601232|NCT00732966|Losartan|losartan|mesh-list
110601233|NCT00732966|Valsartan|valsartan|mesh-list
110601234|NCT00732966|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110601235|NCT00732966|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110601236|NCT00732966|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110601237|NCT00732966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110601238|NCT00732966|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110601239|NCT00735852|Triptorelin Pamoate|triptorelin pamoate|mesh-list
110601240|NCT00735852|Luteolytic Agents|luteolytic agents|mesh-ancestor
110601241|NCT00735852|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110601242|NCT00735852|Contraceptive Agents|contraceptive agents|mesh-ancestor
110601243|NCT00735852|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110601244|NCT00735852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110601245|NCT00735852|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110601246|NCT00735852|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110601247|NCT00735852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110601248|NCT00424021|Ambrisentan|ambrisentan|mesh-list
110601249|NCT00424021|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110601250|NCT00735930|Lenalidomide|lenalidomide|mesh-list
110601252|NCT00735930|Immunologic Factors|immunologic factors|mesh-ancestor
110601253|NCT00735930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110601254|NCT00735930|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110601255|NCT00735930|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110601257|NCT00735930|Growth Inhibitors|growth inhibitors|mesh-ancestor
110601258|NCT00735930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110601259|NCT00735930|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110601260|NCT00735930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110601261|NCT00735930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110601262|NCT00617734|Cetuximab|cetuximab|mesh-list
110601263|NCT00617734|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110601264|NCT00617734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110378605|NCT02278419|Sofosbuvir|sofosbuvir|mesh-list
110601265|NCT00617734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110601266|NCT00617734|Immunologic Factors|immunologic factors|mesh-ancestor
110601267|NCT00617734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110601268|NCT00577460|Pramipexole|pramipexole|mesh-list
110601269|NCT00577460|Antioxidants|antioxidants|mesh-ancestor
110601270|NCT00577460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110601271|NCT00577460|Protective Agents|protective agents|mesh-ancestor
110601272|NCT00577460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110601273|NCT00577460|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110601274|NCT00577460|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110274677|NCT00202293|Olanzapine|olanzapine|mesh-list
110601275|NCT00577460|Dopamine Agonists|dopamine agonists|mesh-ancestor
110601276|NCT00577460|Dopamine Agents|dopamine agents|mesh-ancestor
110601277|NCT00577460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110601278|NCT00863980|Telmisartan|telmisartan|mesh-list
110601279|NCT00863980|Candesartan|candesartan|mesh-list
110601280|NCT00863980|Candesartan cilexetil|candesartan cilexetil|mesh-list
110601281|NCT00863980|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110601282|NCT00863980|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110601283|NCT00863980|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110601284|NCT00863980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110601285|NCT00415519|Edaravone|edaravone|mesh-list
110601286|NCT00415519|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110601287|NCT00415519|Antioxidants|antioxidants|mesh-ancestor
110601288|NCT00415519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110601289|NCT00415519|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110601290|NCT00415519|Protective Agents|protective agents|mesh-ancestor
110601291|NCT00415519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110601292|NCT02568176|Midazolam|midazolam|mesh-list
110601293|NCT02568176|Bupropion|bupropion|mesh-list
110601294|NCT02568176|Esketamine|esketamine|mesh-list
110601295|NCT02568176|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110601296|NCT02568176|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110601297|NCT02568176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110601298|NCT02568176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110601299|NCT02568176|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110601300|NCT02568176|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110601301|NCT02568176|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110601302|NCT02568176|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110601303|NCT02568176|Anesthetics, General|anesthetics, general|mesh-ancestor
110601304|NCT02568176|Anesthetics|anesthetics|mesh-ancestor
110601305|NCT02568176|GABA Modulators|gaba modulators|mesh-ancestor
110601306|NCT02568176|GABA Agents|gaba agents|mesh-ancestor
110601307|NCT02568176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110601308|NCT02568176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110601309|NCT02568176|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110601310|NCT02568176|Antidepressive Agents|antidepressive agents|mesh-ancestor
110601311|NCT02568176|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110601312|NCT02568176|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110601313|NCT02568176|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110601314|NCT02568176|Dopamine Agents|dopamine agents|mesh-ancestor
110601315|NCT02568176|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110601316|NCT02568176|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110601317|NCT02568176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110601318|NCT00741182|Teriparatide|teriparatide|mesh-list
110601319|NCT00741182|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110601320|NCT00741182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110601321|NCT00741182|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110601322|NCT00423943|Modafinil|modafinil|mesh-list
110601323|NCT00423943|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110601324|NCT00423943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110601325|NCT00423943|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
110601326|NCT00423943|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110025123|NCT00357864|Analgesics|analgesics|mesh-ancestor
110601327|NCT00423943|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110601328|NCT00423943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110601329|NCT00736346|Paroxetine|paroxetine|mesh-list
110601330|NCT00736346|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110601331|NCT00736346|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110601332|NCT00736346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110601333|NCT00736346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110601334|NCT00736346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110601335|NCT00736346|Serotonin Agents|serotonin agents|mesh-ancestor
110601336|NCT00736346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110601337|NCT00736346|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110601338|NCT00736346|Antidepressive Agents|antidepressive agents|mesh-ancestor
110601339|NCT00736346|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110601340|NCT00736346|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110601341|NCT00736346|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110601343|NCT00864058|Gabapentin|gabapentin|mesh-list
110601344|NCT00864058|Analgesics|analgesics|mesh-ancestor
110601345|NCT00864058|Sensory System Agents|sensory system agents|mesh-ancestor
110601346|NCT00864058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110601347|NCT00864058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110601348|NCT00864058|Anticonvulsants|anticonvulsants|mesh-ancestor
110601349|NCT00864058|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110601350|NCT00864058|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110601351|NCT00864058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110601352|NCT00864058|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110601353|NCT00864058|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110601354|NCT00864058|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110601355|NCT00864058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110601356|NCT00864058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110601357|NCT00864058|Antimanic Agents|antimanic agents|mesh-ancestor
110601358|NCT00864136|Levonorgestrel|levonorgestrel|mesh-list
110601359|NCT00864136|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110601360|NCT00864136|Contraceptive Agents|contraceptive agents|mesh-ancestor
110601361|NCT00864136|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110601362|NCT00864136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110601363|NCT00864136|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110601364|NCT00864136|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110601365|NCT00864136|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110601366|NCT00864214|Hormones|hormones|mesh-list
110601367|NCT00864214|Estradiol|estradiol|mesh-list
110274996|NCT02072863|Immunologic Factors|immunologic factors|mesh-ancestor
110601368|NCT00864214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110601369|NCT00864214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110601370|NCT00864214|Estrogens|estrogens|mesh-ancestor
110601371|NCT00872482|Nimotuzumab|nimotuzumab|mesh-list
110601372|NCT00872482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110601373|NCT00872482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110601374|NCT00428389|Rivastigmine|rivastigmine|mesh-list
110601375|NCT00428389|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110601376|NCT00428389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110601377|NCT00428389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110601378|NCT00428389|Cholinergic Agents|cholinergic agents|mesh-ancestor
110601379|NCT00428389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110601380|NCT00428389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110601381|NCT00428389|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110601382|NCT00428389|Protective Agents|protective agents|mesh-ancestor
110601383|NCT00616642|Rosiglitazone|rosiglitazone|mesh-list
110601384|NCT00616642|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110601385|NCT00616642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110601386|NCT02568488|Metformin|metformin|mesh-list
110601387|NCT02568488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110601388|NCT02568488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110601389|NCT01324063|Cytarabine|cytarabine|mesh-list
110601390|NCT01324063|Daunorubicin|daunorubicin|mesh-list
110601391|NCT01324063|Amsacrine|amsacrine|mesh-list
110601392|NCT01324063|Sargramostim|sargramostim|mesh-list
110601393|NCT01324063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110601394|NCT01324063|Antimetabolites|antimetabolites|mesh-ancestor
110601395|NCT01324063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110601396|NCT01324063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110601397|NCT01324063|Antiviral Agents|antiviral agents|mesh-ancestor
110601398|NCT01324063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110601399|NCT01324063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110601400|NCT01324063|Immunologic Factors|immunologic factors|mesh-ancestor
110601401|NCT01324063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110601402|NCT01324063|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110601403|NCT01324063|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110601404|NCT01324063|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110601405|NCT01324063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110601406|NCT00864448|Ramipril|ramipril|mesh-list
110601407|NCT00864448|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110601408|NCT00864448|Protease Inhibitors|protease inhibitors|mesh-ancestor
110601409|NCT00864448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110601410|NCT00864448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110601411|NCT00864448|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110601412|NCT00406315|Ziprasidone|ziprasidone|mesh-list
110378664|NCT00576017|Fentanyl|fentanyl|mesh-list
110601413|NCT00406315|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110601414|NCT00406315|Serotonin Agents|serotonin agents|mesh-ancestor
110601415|NCT00406315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110601416|NCT00406315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110601417|NCT00406315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110601418|NCT00406315|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110601419|NCT00406315|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110601420|NCT00406315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110601421|NCT00406315|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110601422|NCT00406315|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110601423|NCT00406315|Dopamine Agents|dopamine agents|mesh-ancestor
110601424|NCT00872716|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110601425|NCT00872716|Antidepressive Agents|antidepressive agents|mesh-ancestor
110601426|NCT00872716|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110601427|NCT00872716|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110601428|NCT00872716|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110601429|NCT00872716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110601430|NCT00872716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110601432|NCT00864526|Oxycodone|oxycodone|mesh-list
110601433|NCT00864526|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110151896|NCT00000147|Prednisone|prednisone|mesh-list
110601434|NCT00864526|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110601435|NCT00864526|Analgesics|analgesics|mesh-ancestor
110601436|NCT00864526|Sensory System Agents|sensory system agents|mesh-ancestor
110275231|NCT01874626|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110275232|NCT01874626|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110275242|NCT00410748|Hydromorphone|hydromorphone|mesh-list
110601437|NCT00864526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110601438|NCT00864526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110601439|NCT00864526|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110601440|NCT00864526|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110601441|NCT00864526|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110601442|NCT00864526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110601443|NCT00864526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110601444|NCT00864526|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110601445|NCT00864526|Narcotics|narcotics|mesh-ancestor
110601446|NCT00864526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110278342|NCT00180947|Vinorelbine|vinorelbine|mesh-list
110278343|NCT00180947|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110278344|NCT00180947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110278345|NCT00180947|Tubulin Modulators|tubulin modulators|mesh-ancestor
110278346|NCT00180947|Antimitotic Agents|antimitotic agents|mesh-ancestor
110278347|NCT00180947|Mitosis Modulators|mitosis modulators|mesh-ancestor
110278348|NCT00180947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110278349|NCT00581035|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110278350|NCT00581035|Immunologic Factors|immunologic factors|mesh-ancestor
110278351|NCT00581035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110278352|NCT00581425|Interferons|interferons|mesh-list
110278353|NCT00581425|Interferon-alpha|interferon-alpha|mesh-list
110278354|NCT00581425|Imiquimod|imiquimod|mesh-list
110278355|NCT00581425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110278356|NCT00581425|Antiviral Agents|antiviral agents|mesh-ancestor
110278357|NCT00581425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110278362|NCT00209079|Docetaxel|docetaxel|mesh-list
110601447|NCT00864604|Nabumetone|nabumetone|mesh-list
110601448|NCT00864604|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110601449|NCT00864604|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110601450|NCT00864604|Analgesics|analgesics|mesh-ancestor
110601451|NCT00864604|Sensory System Agents|sensory system agents|mesh-ancestor
110601452|NCT00864604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110601453|NCT00864604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110025266|NCT00361452|Epinephrine|epinephrine|mesh-list
110601454|NCT00864604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110601455|NCT00864604|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110601456|NCT00864604|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110601457|NCT00864604|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110275281|NCT00173888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110275282|NCT00173888|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110275283|NCT00173888|Antimetabolites|antimetabolites|mesh-ancestor
110275284|NCT00173888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110275285|NCT00173888|Tubulin Modulators|tubulin modulators|mesh-ancestor
110275286|NCT00173888|Antimitotic Agents|antimitotic agents|mesh-ancestor
110275287|NCT00173888|Mitosis Modulators|mitosis modulators|mesh-ancestor
110275288|NCT00555022|Bromides|bromides|mesh-list
110275289|NCT00555022|Tiotropium Bromide|tiotropium bromide|mesh-list
110275290|NCT00555022|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110275291|NCT00555022|Autonomic Agents|autonomic agents|mesh-ancestor
110275292|NCT00555022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110275293|NCT00555022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110275294|NCT00555022|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110275295|NCT00555022|Respiratory System Agents|respiratory system agents|mesh-ancestor
110275296|NCT00555022|Parasympatholytics|parasympatholytics|mesh-ancestor
110275297|NCT00555022|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110275298|NCT00555022|Cholinergic Agents|cholinergic agents|mesh-ancestor
110275299|NCT00555022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110280907|NCT00190268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110280908|NCT00190268|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
110280909|NCT00190268|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110280910|NCT00190268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110280912|NCT00220350|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110280913|NCT00220350|Fertility Agents|fertility agents|mesh-ancestor
110280914|NCT00220350|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110280915|NCT00220350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110280916|NCT00220350|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110280918|NCT00190307|Aspirin|aspirin|mesh-list
110601458|NCT00864604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110601459|NCT00864604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110601461|NCT04064138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110601462|NCT04064138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110601463|NCT01323751|Ricolinostat|ricolinostat|mesh-list
110601464|NCT01323751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110601465|NCT01323751|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110601466|NCT01323751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110601467|NCT01323751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110601468|NCT00711594|Afatinib|afatinib|mesh-list
110601469|NCT00711594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110601470|NCT00711594|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110601471|NCT00711594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110601472|NCT00711594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110601473|NCT00864760|Gabapentin|gabapentin|mesh-list
110601474|NCT00864760|Analgesics|analgesics|mesh-ancestor
110601475|NCT00864760|Sensory System Agents|sensory system agents|mesh-ancestor
110601476|NCT00864760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110601477|NCT00864760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110601478|NCT00864760|Anticonvulsants|anticonvulsants|mesh-ancestor
110601479|NCT00864760|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110601480|NCT00864760|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110601481|NCT00864760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110601482|NCT00864760|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110601483|NCT00864760|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110601484|NCT00864760|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110601485|NCT00864760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110601486|NCT00864760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110601487|NCT00864760|Antimanic Agents|antimanic agents|mesh-ancestor
110601488|NCT00710762|Nintedanib|nintedanib|mesh-list
110601489|NCT00710762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110601490|NCT00710762|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110601491|NCT00710762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110601492|NCT00710762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110601493|NCT05137912|Immunomodulating Agents|immunomodulating agents|mesh-list
110601494|NCT05137912|Immunologic Factors|immunologic factors|mesh-ancestor
110601495|NCT05137912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110601496|NCT00736814|Carboplatin|carboplatin|mesh-list
110601497|NCT00736814|Gemcitabine|gemcitabine|mesh-list
110601499|NCT00736814|Vinorelbine|vinorelbine|mesh-list
110601500|NCT00736814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110281441|NCT00191672|Mitosis Modulators|mitosis modulators|mesh-ancestor
110281444|NCT00191672|Antimetabolites|antimetabolites|mesh-ancestor
110601501|NCT00736814|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110601502|NCT00736814|Antimetabolites|antimetabolites|mesh-ancestor
110601503|NCT00736814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110601504|NCT00736814|Tubulin Modulators|tubulin modulators|mesh-ancestor
110601505|NCT00736814|Antimitotic Agents|antimitotic agents|mesh-ancestor
110601506|NCT00736814|Mitosis Modulators|mitosis modulators|mesh-ancestor
110601507|NCT00736814|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110601508|NCT04063904|Misoprostol|misoprostol|mesh-list
110601509|NCT04063904|Mifepristone|mifepristone|mesh-list
110601510|NCT04063904|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110601511|NCT04063904|Abortifacient Agents|abortifacient agents|mesh-ancestor
110601512|NCT04063904|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110601513|NCT04063904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110601514|NCT04063904|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110601515|NCT04063904|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110601516|NCT04063904|Oxytocics|oxytocics|mesh-ancestor
110601517|NCT04063904|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
110601518|NCT04063904|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110601519|NCT04063904|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110601520|NCT04063904|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110601521|NCT04063904|Contraceptive Agents|contraceptive agents|mesh-ancestor
110601522|NCT04063904|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
110601523|NCT04063904|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
110601524|NCT04063904|Hormone Antagonists|hormone antagonists|mesh-ancestor
110601525|NCT04063904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110601526|NCT04063904|Luteolytic Agents|luteolytic agents|mesh-ancestor
110601527|NCT04063904|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110601528|NCT04063904|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
110601529|NCT00573430|Candesartan|candesartan|mesh-list
110601530|NCT00573430|Candesartan cilexetil|candesartan cilexetil|mesh-list
110601531|NCT00573430|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110601532|NCT00573430|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110601533|NCT00573430|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110601534|NCT00573430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110601535|NCT00711516|Modafinil|modafinil|mesh-list
110601536|NCT00711516|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110601537|NCT00711516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110601538|NCT00711516|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
110601539|NCT00711516|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110601540|NCT00711516|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110601541|NCT00711516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110601542|NCT00864838|Brimonidine Tartrate|brimonidine tartrate|mesh-list
110601543|NCT00864838|Acetazolamide|acetazolamide|mesh-list
110601544|NCT00864838|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110281528|NCT00123851|Capecitabine|capecitabine|mesh-list
110601546|NCT00864838|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110601547|NCT00864838|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110601548|NCT00864838|Adrenergic Agents|adrenergic agents|mesh-ancestor
110601549|NCT00864838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110601550|NCT00864838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110601551|NCT00864838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110601552|NCT00864838|Anticonvulsants|anticonvulsants|mesh-ancestor
110601553|NCT00864838|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110601554|NCT00864838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110601555|NCT00864838|Diuretics|diuretics|mesh-ancestor
110601556|NCT00864838|Natriuretic Agents|natriuretic agents|mesh-ancestor
110601557|NCT04039516|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
110601558|NCT04039516|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110601559|NCT04039516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110601560|NCT00615550|Progesterone|progesterone|mesh-list
110601561|NCT00615550|Progestins|progestins|mesh-ancestor
110601562|NCT00615550|Hormones|hormones|mesh-ancestor
110601563|NCT00615550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110601564|NCT00615550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110601565|NCT00186888|Cyclophosphamide|cyclophosphamide|mesh-list
110601566|NCT00186888|Carboplatin|carboplatin|mesh-list
110601567|NCT00186888|Doxorubicin|doxorubicin|mesh-list
110601568|NCT00186888|Etoposide|etoposide|mesh-list
110601569|NCT00186888|Etoposide phosphate|etoposide phosphate|mesh-list
110601570|NCT00186888|Vincristine|vincristine|mesh-list
110601571|NCT00186888|Topotecan|topotecan|mesh-list
110025420|NCT00365586|Ketoprofen|ketoprofen|mesh-list
110601572|NCT00186888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110601573|NCT00186888|Immunologic Factors|immunologic factors|mesh-ancestor
110601574|NCT00186888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110275367|NCT01818076|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110601575|NCT00186888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110601576|NCT00186888|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110601577|NCT00186888|Alkylating Agents|alkylating agents|mesh-ancestor
110601578|NCT00186888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110601579|NCT00186888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110601580|NCT00186888|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110601581|NCT00186888|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110601582|NCT00186888|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110601583|NCT00186888|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110601584|NCT00186888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110601585|NCT00186888|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110601586|NCT00186888|Tubulin Modulators|tubulin modulators|mesh-ancestor
110601587|NCT00186888|Antimitotic Agents|antimitotic agents|mesh-ancestor
110601588|NCT00186888|Mitosis Modulators|mitosis modulators|mesh-ancestor
110601589|NCT00186888|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110601590|NCT00736164|Selenium|selenium|mesh-list
110601591|NCT00736164|Antioxidants|antioxidants|mesh-ancestor
110601592|NCT00736164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110601593|NCT00736164|Protective Agents|protective agents|mesh-ancestor
110601594|NCT00736164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110601595|NCT00736164|Trace Elements|trace elements|mesh-ancestor
110601596|NCT00736164|Micronutrients|micronutrients|mesh-ancestor
110601597|NCT00739830|Sirolimus|sirolimus|mesh-list
110601598|NCT00739830|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
110601599|NCT00739830|Megestrol|megestrol|mesh-list
110601600|NCT00739830|Megestrol Acetate|megestrol acetate|mesh-list
110601601|NCT00739830|Medroxyprogesterone|medroxyprogesterone|mesh-list
110601602|NCT00739830|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110601603|NCT00739830|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110601604|NCT00739830|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110601605|NCT00739830|Contraceptive Agents|contraceptive agents|mesh-ancestor
110601606|NCT00739830|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110601607|NCT00739830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110601608|NCT00739830|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110601609|NCT00739830|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110601610|NCT00739830|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110601611|NCT00739830|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110601612|NCT00739830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110601613|NCT00739830|Appetite Stimulants|appetite stimulants|mesh-ancestor
110601614|NCT00739830|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110601615|NCT00739830|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110601616|NCT00739830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110601617|NCT00739830|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110601618|NCT00739830|Antifungal Agents|antifungal agents|mesh-ancestor
110601619|NCT00739830|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110601620|NCT00739830|Immunologic Factors|immunologic factors|mesh-ancestor
110601622|NCT00577382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110601623|NCT00577382|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110601624|NCT00577382|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110601625|NCT00577382|Growth Substances|growth substances|mesh-ancestor
110275403|NCT01777555|Levodopa|levodopa|mesh-list
110601626|NCT00577382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110601627|NCT00577382|Growth Inhibitors|growth inhibitors|mesh-ancestor
110601628|NCT00577382|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110601629|NCT00577382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110601630|NCT00577382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110601632|NCT00733434|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110601633|NCT00733434|Vasodilator Agents|vasodilator agents|mesh-ancestor
110601634|NCT00733434|Urological Agents|urological agents|mesh-ancestor
110601635|NCT00736320|Vincristine|vincristine|mesh-list
110601636|NCT00736320|Doxorubicin|doxorubicin|mesh-list
110601637|NCT00736320|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110601638|NCT00736320|Dacarbazine|dacarbazine|mesh-list
110601639|NCT00736320|Bleomycin|bleomycin|mesh-list
110601640|NCT00736320|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110601641|NCT00736320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110601642|NCT00736320|Tubulin Modulators|tubulin modulators|mesh-ancestor
110601643|NCT00736320|Antimitotic Agents|antimitotic agents|mesh-ancestor
110601644|NCT00736320|Mitosis Modulators|mitosis modulators|mesh-ancestor
110601645|NCT00736320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110601646|NCT00736320|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110601647|NCT00736320|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110601648|NCT00736320|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110601649|NCT00736320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110601650|NCT00736320|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110601651|NCT00736320|Alkylating Agents|alkylating agents|mesh-ancestor
110601652|NCT04065282|Capecitabine|capecitabine|mesh-list
110601653|NCT04065282|Oxaliplatin|oxaliplatin|mesh-list
110275415|NCT01756924|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110601654|NCT04065282|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110601655|NCT04065282|Antimetabolites|antimetabolites|mesh-ancestor
110601656|NCT04065282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110601657|NCT04065282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110601658|NCT00873262|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110601659|NCT00873262|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110601660|NCT00873262|Estropipate|estropipate|mesh-list
110601662|NCT00873262|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110601663|NCT00873262|Estrone|estrone|mesh-list
110601664|NCT00873262|Progesterone|progesterone|mesh-list
110601665|NCT00873262|Estrogens|estrogens|mesh-ancestor
110601666|NCT00873262|Hormones|hormones|mesh-ancestor
110281919|NCT00192842|Antimetabolites|antimetabolites|mesh-ancestor
110281920|NCT00192842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110281921|NCT00192842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110281922|NCT00192842|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110601667|NCT00873262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110601668|NCT00873262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110601669|NCT00873262|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110601670|NCT00873262|Contraceptive Agents|contraceptive agents|mesh-ancestor
110601671|NCT00873262|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110601672|NCT00873262|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110601673|NCT00873262|Progestins|progestins|mesh-ancestor
110601674|NCT00739986|Semapimod|semapimod|mesh-list
110601675|NCT00739986|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110601676|NCT00739986|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110601677|NCT00739986|Analgesics|analgesics|mesh-ancestor
110601678|NCT00739986|Sensory System Agents|sensory system agents|mesh-ancestor
110601679|NCT00739986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110601680|NCT00739986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110601681|NCT00739986|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110601682|NCT00739986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110601683|NCT00739986|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110601684|NCT00739986|Immunologic Factors|immunologic factors|mesh-ancestor
110601685|NCT00736970|Sirolimus|sirolimus|mesh-list
110281966|NCT00192959|Propofol|propofol|mesh-list
110601687|NCT00736970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110601688|NCT00736970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110601689|NCT00736970|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110601690|NCT00736970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110601691|NCT00736970|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110601692|NCT00736970|Antifungal Agents|antifungal agents|mesh-ancestor
110601693|NCT00736970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110601694|NCT00736970|Immunologic Factors|immunologic factors|mesh-ancestor
110601695|NCT00736970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110601696|NCT00873340|Interferons|interferons|mesh-list
110601697|NCT00873340|Interferon beta-1b|interferon beta-1b|mesh-list
110282019|NCT00193193|Paclitaxel|paclitaxel|mesh-list
110601698|NCT00873340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110601699|NCT00873340|Antiviral Agents|antiviral agents|mesh-ancestor
110601700|NCT00873340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110601701|NCT00873340|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110601702|NCT00873340|Immunologic Factors|immunologic factors|mesh-ancestor
110601703|NCT00873340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110601704|NCT00740064|Lamivudine|lamivudine|mesh-list
110601705|NCT00740064|Abacavir|abacavir|mesh-list
110601706|NCT00740064|Raltegravir Potassium|raltegravir potassium|mesh-list
110601707|NCT00740064|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110601708|NCT00740064|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110601709|NCT00740064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110601710|NCT00740064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110601711|NCT00740064|Antiviral Agents|antiviral agents|mesh-ancestor
110601712|NCT00740064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110601713|NCT00740064|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110601714|NCT00740064|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110601715|NCT00740064|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110601716|NCT00740064|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110601717|NCT00614926|Modafinil|modafinil|mesh-list
110601718|NCT00614926|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110601719|NCT00614926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110601720|NCT00614926|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
110601721|NCT00614926|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110601722|NCT00614926|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110601723|NCT00614926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110601724|NCT00873496|Hydroxychloroquine|hydroxychloroquine|mesh-list
110601725|NCT00873496|Antimalarials|antimalarials|mesh-ancestor
110601726|NCT00873496|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110601727|NCT00873496|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110601728|NCT00873496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110601729|NCT00873496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110601730|NCT00873496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110601731|NCT00873496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110601732|NCT00879892|Xenon|xenon|mesh-list
110601733|NCT00879892|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110601734|NCT00879892|Anesthetics, General|anesthetics, general|mesh-ancestor
110601735|NCT00879892|Anesthetics|anesthetics|mesh-ancestor
110601736|NCT00879892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110601737|NCT00879892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110601738|NCT00740142|Lactulose|lactulose|mesh-list
110601739|NCT00740142|N-Methylaspartate|n-methylaspartate|mesh-list
110601740|NCT00740142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110601741|NCT00740142|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
110601742|NCT00740142|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110601743|NCT00740142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110601744|NCT00740142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110601745|NCT00740142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110601746|NCT00873652|Vaccines|vaccines|mesh-list
110601747|NCT00873652|Immunologic Factors|immunologic factors|mesh-ancestor
110601748|NCT00873652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110601749|NCT00423319|Enoxaparin|enoxaparin|mesh-list
110601750|NCT00423319|Enoxaparin sodium|enoxaparin sodium|mesh-list
110601751|NCT00423319|Apixaban|apixaban|mesh-list
110601752|NCT00423319|Anticoagulants|anticoagulants|mesh-ancestor
110601753|NCT00423319|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110601754|NCT00423319|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110601755|NCT00423319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110601756|NCT00423319|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110601757|NCT00423319|Antithrombins|antithrombins|mesh-ancestor
110601758|NCT00423319|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110601759|NCT00423319|Protease Inhibitors|protease inhibitors|mesh-ancestor
110275508|NCT01737892|Epinephrine|epinephrine|mesh-list
110601760|NCT00423319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110601761|NCT05224492|Sulforaphane|sulforaphane|mesh-list
110601762|NCT05224492|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110601763|NCT05224492|Protective Agents|protective agents|mesh-ancestor
110601764|NCT05224492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110601765|NCT05224492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110601766|NCT00733668|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110601767|NCT00733668|Antidepressive Agents|antidepressive agents|mesh-ancestor
110151934|NCT00001669|Mecasermin|mecasermin|mesh-list
110601768|NCT00733668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110601769|NCT00733668|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110601770|NCT00733668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110601771|NCT00733668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110601772|NCT00733668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110601774|NCT04039126|Cadexomer iodine|cadexomer iodine|mesh-list
110601775|NCT04039126|Povidone-Iodine|povidone-iodine|mesh-list
110601776|NCT04039126|Tetracycline|tetracycline|mesh-list
110601777|NCT04039126|Povidone|povidone|mesh-list
110601778|NCT04039126|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110601779|NCT04039126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110601780|NCT04039126|Trace Elements|trace elements|mesh-ancestor
110601781|NCT04039126|Micronutrients|micronutrients|mesh-ancestor
110249084|NCT01245244|Morphine|morphine|mesh-list
110601782|NCT04039126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110601784|NCT04039126|Blood Substitutes|blood substitutes|mesh-ancestor
110601785|NCT04039126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110601786|NCT04039126|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110601787|NCT04039126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110601788|NCT04039126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110601789|NCT00873808|Zoledronic Acid|zoledronic acid|mesh-list
110601790|NCT00873808|Ibandronic Acid|ibandronic acid|mesh-list
110601792|NCT00873808|Tetracycline|tetracycline|mesh-list
110601793|NCT00873808|Demeclocycline|demeclocycline|mesh-list
110282289|NCT00124787|Autonomic Agents|autonomic agents|mesh-ancestor
110282300|NCT00193661|Hormones|hormones|mesh-ancestor
110601794|NCT00873808|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110601795|NCT00873808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110601796|NCT00873808|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110601797|NCT00873808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110601798|NCT00873808|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110601799|NCT00873808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110601800|NCT00873808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110601801|NCT04064190|Durvalumab|durvalumab|mesh-list
110601802|NCT04064190|Vactosertib|vactosertib|mesh-list
110601803|NCT04064190|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110601804|NCT04064190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110601805|NCT04064190|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110601806|NCT04064190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110601807|NCT04064190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110601808|NCT00873886|Oseltamivir|oseltamivir|mesh-list
110601809|NCT00873886|Antiviral Agents|antiviral agents|mesh-ancestor
110601810|NCT00873886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110601811|NCT00873886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110601812|NCT00873886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110601813|NCT00880282|Sirolimus|sirolimus|mesh-list
110601814|NCT00880282|Temsirolimus|temsirolimus|mesh-list
110601815|NCT00880282|MTOR Inhibitors|mtor inhibitors|mesh-list
110282345|NCT00125021|Capecitabine|capecitabine|mesh-list
110601816|NCT00880282|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110601817|NCT00880282|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110601818|NCT00880282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110601819|NCT00880282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110601820|NCT00880282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110601821|NCT00880282|Immunologic Factors|immunologic factors|mesh-ancestor
110601822|NCT00880282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110601823|NCT00880282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110601824|NCT00880282|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110601825|NCT00880282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110601826|NCT00880282|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110601827|NCT00880282|Antifungal Agents|antifungal agents|mesh-ancestor
110601828|NCT00879268|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110601829|NCT00874042|Gemcitabine|gemcitabine|mesh-list
110282372|NCT00223509|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110601830|NCT00874042|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110601832|NCT00874042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110601833|NCT00874042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110601834|NCT00736866|Acetylcysteine|acetylcysteine|mesh-list
110601835|NCT00736866|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110601836|NCT00736866|Antiviral Agents|antiviral agents|mesh-ancestor
110601837|NCT00736866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110601838|NCT00736866|Expectorants|expectorants|mesh-ancestor
110601839|NCT00736866|Respiratory System Agents|respiratory system agents|mesh-ancestor
110601840|NCT00736866|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110601842|NCT00736866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110601843|NCT00736866|Protective Agents|protective agents|mesh-ancestor
110601844|NCT00736866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110601845|NCT00736866|Antidotes|antidotes|mesh-ancestor
110601846|NCT00879424|Vitamin D|vitamin d|mesh-list
110282429|NCT00411879|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110601847|NCT00879424|Cholecalciferol|cholecalciferol|mesh-list
110601848|NCT00879424|Vitamins|vitamins|mesh-ancestor
110601849|NCT00879424|Micronutrients|micronutrients|mesh-ancestor
110601850|NCT00879424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110601851|NCT00879424|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110601852|NCT00879424|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110601853|NCT00710684|Donepezil|donepezil|mesh-list
110601854|NCT00710684|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110601855|NCT00710684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110601856|NCT00710684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110601857|NCT00710684|Cholinergic Agents|cholinergic agents|mesh-ancestor
110601858|NCT00710684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110601859|NCT00710684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110601860|NCT00710684|Nootropic Agents|nootropic agents|mesh-ancestor
110601861|NCT00710606|NuvaRing|nuvaring|mesh-list
110601862|NCT00710606|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110282493|NCT00206466|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110601863|NCT00710606|Desogestrel|desogestrel|mesh-list
110601864|NCT00710606|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110601865|NCT00710606|Contraceptive Agents|contraceptive agents|mesh-ancestor
110601866|NCT00710606|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110601867|NCT00710606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110601868|NCT00710606|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110601869|NCT00710606|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110601870|NCT00710606|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110601871|NCT00710606|Estrogens|estrogens|mesh-ancestor
110601872|NCT00710606|Hormones|hormones|mesh-ancestor
110601873|NCT00710606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110601874|NCT00710606|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110601875|NCT00710606|Progestins|progestins|mesh-ancestor
110601876|NCT00713544|N-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-N-ethyl-2-(4-methanesulfonylphenyl)acetamide|n-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-n-ethyl-2-(4-methanesulfonylphenyl)acetamide|mesh-list
110601877|NCT00713544|Etanercept|etanercept|mesh-list
110601878|NCT00713544|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110601879|NCT00713544|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110601880|NCT00713544|Analgesics|analgesics|mesh-ancestor
110601881|NCT00713544|Sensory System Agents|sensory system agents|mesh-ancestor
110601882|NCT00713544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110601883|NCT00713544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110378990|NCT04579133|Durvalumab|durvalumab|mesh-list
110601884|NCT00713544|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110601885|NCT00713544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110601886|NCT00713544|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110601887|NCT00713544|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110601888|NCT00713544|Immunologic Factors|immunologic factors|mesh-ancestor
110601889|NCT00713544|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
110601890|NCT00713544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110601891|NCT00713544|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110601892|NCT00713544|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110601893|NCT00713544|Antiviral Agents|antiviral agents|mesh-ancestor
110601894|NCT00713544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110601896|NCT00737126|Hematinics|hematinics|mesh-ancestor
110601897|NCT00737126|Vitamin B Complex|vitamin b complex|mesh-ancestor
110601898|NCT00737126|Vitamins|vitamins|mesh-ancestor
110601899|NCT00737126|Micronutrients|micronutrients|mesh-ancestor
110601900|NCT00737126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110601901|NCT04063046|Anesthetics|anesthetics|mesh-list
110601902|NCT04063046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110601903|NCT04063046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110601904|NCT05529056|Atropine|atropine|mesh-list
110601905|NCT05529056|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110601906|NCT05529056|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110282648|NCT00125567|Levodopa|levodopa|mesh-list
110601907|NCT05529056|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110601908|NCT05529056|Autonomic Agents|autonomic agents|mesh-ancestor
110601909|NCT05529056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110601910|NCT05529056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110601911|NCT05529056|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110601912|NCT05529056|Respiratory System Agents|respiratory system agents|mesh-ancestor
110601914|NCT05529056|Parasympatholytics|parasympatholytics|mesh-ancestor
110601915|NCT05529056|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110601916|NCT05529056|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110601917|NCT05529056|Cholinergic Agents|cholinergic agents|mesh-ancestor
110601918|NCT05529056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110601919|NCT05529056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110601920|NCT00740922|Becaplermin|becaplermin|mesh-list
110275614|NCT00174434|Growth Substances|growth substances|mesh-ancestor
110601921|NCT00740922|Anticoagulants|anticoagulants|mesh-ancestor
110601922|NCT00740922|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
110601923|NCT00740922|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110601924|NCT00740922|Growth Substances|growth substances|mesh-ancestor
110601925|NCT00740922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110601927|NCT05523440|Niraparib|niraparib|mesh-list
110601928|NCT05523440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110601929|NCT05523440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110601930|NCT05523440|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110601931|NCT05523440|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110601932|NCT05523440|Growth Substances|growth substances|mesh-ancestor
110249234|NCT00499720|Aztreonam|aztreonam|mesh-list
110601933|NCT05523440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110601934|NCT05523440|Growth Inhibitors|growth inhibitors|mesh-ancestor
110601935|NCT05523440|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110601936|NCT05523440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110601937|NCT05523440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110601938|NCT00741078|Amlodipine|amlodipine|mesh-list
110601939|NCT00741078|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110601940|NCT00741078|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110601941|NCT00741078|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110601942|NCT00741078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110601943|NCT00741078|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110601944|NCT00741078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110601945|NCT00741078|Vasodilator Agents|vasodilator agents|mesh-ancestor
110601946|NCT02568800|Cefepime|cefepime|mesh-list
110282697|NCT00125645|Irbesartan|irbesartan|mesh-list
110601947|NCT02568800|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110601948|NCT02568800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110601949|NCT00741234|Azacitidine|azacitidine|mesh-list
110601950|NCT00741234|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110601951|NCT00741234|Antimetabolites|antimetabolites|mesh-ancestor
110601952|NCT00741234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110601953|NCT00741234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110601954|NCT00741234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110601955|NCT00713258|Alendronate|alendronate|mesh-list
110601956|NCT00713258|Hormones|hormones|mesh-list
110601957|NCT00713258|Parathyroid Hormone|parathyroid hormone|mesh-list
110601958|NCT00713258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110601959|NCT00713258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110601960|NCT00713258|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110601961|NCT00713258|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110601962|NCT00710034|Nicotine|nicotine|mesh-list
110601963|NCT00710034|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110601964|NCT00710034|Autonomic Agents|autonomic agents|mesh-ancestor
110601965|NCT00710034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110601966|NCT00710034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110601967|NCT00710034|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110601968|NCT00710034|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110601969|NCT00710034|Cholinergic Agents|cholinergic agents|mesh-ancestor
110601970|NCT00710034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110601971|NCT00710034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110601972|NCT02567942|Propofol|propofol|mesh-list
110601973|NCT02567942|Sevoflurane|sevoflurane|mesh-list
110601974|NCT02567942|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110275648|NCT00174512|Moxifloxacin|moxifloxacin|mesh-list
110601975|NCT02567942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110601976|NCT02567942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110601977|NCT02567942|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110601978|NCT02567942|Anesthetics, General|anesthetics, general|mesh-ancestor
110601980|NCT02567942|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110601981|NCT02567942|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110601982|NCT00414973|Teriparatide|teriparatide|mesh-list
110601983|NCT00414973|Calcitonin|calcitonin|mesh-list
110601984|NCT00414973|Salmon calcitonin|salmon calcitonin|mesh-list
110601985|NCT00414973|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
110601986|NCT00414973|Katacalcin|katacalcin|mesh-list
110601987|NCT00414973|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110601988|NCT00414973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110601989|NCT00414973|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110601990|NCT00414973|Vasodilator Agents|vasodilator agents|mesh-ancestor
110601991|NCT00423085|Rivastigmine|rivastigmine|mesh-list
110601992|NCT00423085|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110601993|NCT00423085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110601994|NCT00423085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110601995|NCT00423085|Cholinergic Agents|cholinergic agents|mesh-ancestor
110601996|NCT00423085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110601997|NCT00423085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110601998|NCT00423085|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110601999|NCT00423085|Protective Agents|protective agents|mesh-ancestor
110602000|NCT00414661|Tofacitinib|tofacitinib|mesh-list
110602001|NCT00414661|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
110602002|NCT00414661|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110602003|NCT00414661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110602004|NCT00414661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110602005|NCT01608451|Cholecalciferol|cholecalciferol|mesh-list
110602006|NCT01608451|Vitamin D|vitamin d|mesh-list
110602007|NCT01608451|Progesterone|progesterone|mesh-list
110602008|NCT01608451|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110602009|NCT01608451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110602010|NCT01608451|Vitamins|vitamins|mesh-ancestor
110602011|NCT01608451|Micronutrients|micronutrients|mesh-ancestor
110602012|NCT01608451|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110602013|NCT01608451|Progestins|progestins|mesh-ancestor
110602014|NCT01608451|Hormones|hormones|mesh-ancestor
110602015|NCT01608451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110602016|NCT00405067|Ezetimibe|ezetimibe|mesh-list
110602017|NCT00405067|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110602018|NCT00405067|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110602019|NCT00405067|Antimetabolites|antimetabolites|mesh-ancestor
110602020|NCT00405067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110602021|NCT00405067|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110602022|NCT00708708|Etanercept|etanercept|mesh-list
110602023|NCT00708708|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110602024|NCT00708708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110602025|NCT00708708|Analgesics|analgesics|mesh-ancestor
110602026|NCT00708708|Sensory System Agents|sensory system agents|mesh-ancestor
110602027|NCT00708708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110602028|NCT00708708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110602029|NCT00708708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110602030|NCT00708708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110282856|NCT00194948|Escitalopram|escitalopram|mesh-list
110602031|NCT00708708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110602032|NCT00708708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110602033|NCT00708708|Immunologic Factors|immunologic factors|mesh-ancestor
110602034|NCT00404755|Bupropion|bupropion|mesh-list
110602035|NCT00404755|Imipramine|imipramine|mesh-list
110602036|NCT00404755|Escitalopram|escitalopram|mesh-list
110602037|NCT00404755|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110602038|NCT00404755|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110602039|NCT00404755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110602040|NCT00404755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110602041|NCT00404755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110602042|NCT00404755|Serotonin Agents|serotonin agents|mesh-ancestor
110602043|NCT00404755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110602044|NCT00404755|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110602045|NCT00404755|Antidepressive Agents|antidepressive agents|mesh-ancestor
110602046|NCT00404755|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110379079|NCT01124422|Dermatologic Agents|dermatologic agents|mesh-ancestor
110602047|NCT00404755|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110602049|NCT00404755|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110602050|NCT00404755|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110602051|NCT00404755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110602052|NCT00404755|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110602053|NCT00404755|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110602054|NCT00404755|Adrenergic Agents|adrenergic agents|mesh-ancestor
110602055|NCT03904381|Fluorouracil|fluorouracil|mesh-list
110602056|NCT03904381|Antimetabolites|antimetabolites|mesh-ancestor
110602057|NCT03904381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110602058|NCT03904381|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110602059|NCT03904381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110602060|NCT03904381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110602061|NCT03904381|Immunologic Factors|immunologic factors|mesh-ancestor
110602062|NCT03904381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110602063|NCT00737256|Aripiprazole|aripiprazole|mesh-list
110602064|NCT00737256|Perphenazine|perphenazine|mesh-list
110602065|NCT00737256|Antidepressive Agents|antidepressive agents|mesh-ancestor
110602066|NCT00737256|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110602067|NCT00737256|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110602068|NCT00737256|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110602069|NCT00737256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110602070|NCT00737256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110602071|NCT00737256|Dopamine Agonists|dopamine agonists|mesh-ancestor
110602072|NCT00737256|Dopamine Agents|dopamine agents|mesh-ancestor
110602073|NCT00737256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110602074|NCT00737256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110602075|NCT00737256|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110602076|NCT00737256|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110602077|NCT00737256|Serotonin Agents|serotonin agents|mesh-ancestor
110602078|NCT00737256|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110602079|NCT00737256|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110602080|NCT00737256|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110602081|NCT00737256|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110602083|NCT00614614|Immunologic Factors|immunologic factors|mesh-ancestor
110602084|NCT00614614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110602085|NCT00713310|Mesalamine|mesalamine|mesh-list
110602086|NCT00713310|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110602087|NCT00713310|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110602088|NCT00713310|Analgesics|analgesics|mesh-ancestor
110379110|NCT04545099|Neostigmine|neostigmine|mesh-list
110602089|NCT00713310|Sensory System Agents|sensory system agents|mesh-ancestor
110602090|NCT00713310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110602091|NCT00713310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110282956|NCT00195104|Antimetabolites|antimetabolites|mesh-ancestor
110602092|NCT00713310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110602093|NCT00713310|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110602094|NCT05740488|Hormones|hormones|mesh-list
110602095|NCT05740488|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
110602096|NCT05740488|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110602097|NCT05740488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110602098|NCT05742126|Heparin|heparin|mesh-list
110602099|NCT05742126|Calcium heparin|calcium heparin|mesh-list
110602100|NCT05742126|Anticoagulants|anticoagulants|mesh-ancestor
110602101|NCT05742126|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110602102|NCT05742126|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110602103|NCT05742126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110602104|NCT00882856|Bisoprolol|bisoprolol|mesh-list
110602105|NCT00882856|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110602106|NCT00882856|Sympatholytics|sympatholytics|mesh-ancestor
110602107|NCT00882856|Autonomic Agents|autonomic agents|mesh-ancestor
110602108|NCT00882856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110602109|NCT00882856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110602110|NCT00882856|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110602111|NCT00882856|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110602112|NCT00882856|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110602113|NCT00882856|Adrenergic Agents|adrenergic agents|mesh-ancestor
110602114|NCT00882856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110602115|NCT00882856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110602116|NCT00880672|Dutasteride|dutasteride|mesh-list
110602117|NCT00880672|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
110602118|NCT00880672|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110602119|NCT00880672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110602120|NCT00880672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110602121|NCT00880672|Hormone Antagonists|hormone antagonists|mesh-ancestor
110602122|NCT00880672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110602123|NCT00880672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110602124|NCT00737724|Efavirenz|efavirenz|mesh-list
110602125|NCT00737724|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110602126|NCT00737724|Isoniazid|isoniazid|mesh-list
110602127|NCT00737724|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110602128|NCT00737724|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110602129|NCT00737724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110602130|NCT00737724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110602131|NCT00737724|Antiviral Agents|antiviral agents|mesh-ancestor
110602132|NCT00737724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110602133|NCT00737724|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110602134|NCT00737724|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110602135|NCT00737724|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110602136|NCT00737724|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110602137|NCT00737724|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110602138|NCT00737724|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110602140|NCT00737724|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110602141|NCT00737724|Antitubercular Agents|antitubercular agents|mesh-ancestor
110602142|NCT00737724|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110602143|NCT00737724|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
110602144|NCT00737724|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110602145|NCT00737724|Antimetabolites|antimetabolites|mesh-ancestor
110602146|NCT00737724|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110602147|NCT00880828|Acetaminophen|acetaminophen|mesh-list
110602148|NCT00880828|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110602149|NCT00880828|Analgesics|analgesics|mesh-ancestor
110602150|NCT00880828|Sensory System Agents|sensory system agents|mesh-ancestor
110602151|NCT00880828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110249461|NCT00502138|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110602152|NCT00880828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110602155|NCT00712920|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110602156|NCT00712920|Autonomic Agents|autonomic agents|mesh-ancestor
110602157|NCT00712920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110602158|NCT00712920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110602159|NCT00712920|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110602160|NCT00712920|Respiratory System Agents|respiratory system agents|mesh-ancestor
110602161|NCT00712920|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
110602162|NCT00712920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110602163|NCT00712920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110602164|NCT00712920|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110602165|NCT00712920|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110602166|NCT00712920|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110602167|NCT00712920|Histamine Antagonists|histamine antagonists|mesh-ancestor
110602168|NCT00712920|Histamine Agents|histamine agents|mesh-ancestor
110602169|NCT00712920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110602170|NCT00874744|Triamcinolone|triamcinolone|mesh-list
110602171|NCT00874744|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110602172|NCT00874744|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110602173|NCT00874744|Bevacizumab|bevacizumab|mesh-list
110602174|NCT00874744|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110602175|NCT00874744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110602176|NCT00874744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110602177|NCT00874744|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110602178|NCT00874744|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110602179|NCT00874744|Growth Substances|growth substances|mesh-ancestor
110602180|NCT00874744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110602181|NCT00874744|Growth Inhibitors|growth inhibitors|mesh-ancestor
110602182|NCT00874744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110602183|NCT00874744|Glucocorticoids|glucocorticoids|mesh-ancestor
110602184|NCT00874744|Hormones|hormones|mesh-ancestor
110602185|NCT00874744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110379175|NCT02216058|Sirolimus|sirolimus|mesh-list
110602187|NCT00874744|Immunologic Factors|immunologic factors|mesh-ancestor
110602188|NCT00874744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110602189|NCT00874744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110602190|NCT05736744|Magnesium Sulfate|magnesium sulfate|mesh-list
110602191|NCT05736744|Bromides|bromides|mesh-list
110602192|NCT05736744|Rocuronium|rocuronium|mesh-list
110602193|NCT05736744|Atracurium|atracurium|mesh-list
110602194|NCT05736744|Cisatracurium|cisatracurium|mesh-list
110602195|NCT05736744|Anticonvulsants|anticonvulsants|mesh-ancestor
110602196|NCT05736744|Analgesics|analgesics|mesh-ancestor
110602197|NCT05736744|Sensory System Agents|sensory system agents|mesh-ancestor
110602198|NCT05736744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110602199|NCT05736744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110602200|NCT05736744|Anesthetics|anesthetics|mesh-ancestor
110602201|NCT05736744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110602202|NCT05736744|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110602203|NCT05736744|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110602204|NCT05736744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110602205|NCT05736744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110602206|NCT05736744|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110602207|NCT05736744|Tocolytic Agents|tocolytic agents|mesh-ancestor
110602208|NCT05736744|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110602209|NCT05736744|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110602210|NCT05736744|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110602211|NCT05736744|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110602212|NCT05736744|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
110602213|NCT05736744|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110602214|NCT05736744|Cholinergic Agents|cholinergic agents|mesh-ancestor
110602215|NCT05736744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110602216|NCT00920868|Bevacizumab|bevacizumab|mesh-list
110602217|NCT00920868|Capecitabine|capecitabine|mesh-list
110602218|NCT00920868|Oxaliplatin|oxaliplatin|mesh-list
110602219|NCT00920868|Dasatinib|dasatinib|mesh-list
110602220|NCT00920868|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110602221|NCT00920868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110602222|NCT00920868|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110602223|NCT00920868|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110602224|NCT00920868|Growth Substances|growth substances|mesh-ancestor
110602225|NCT00920868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110602226|NCT00920868|Growth Inhibitors|growth inhibitors|mesh-ancestor
110602227|NCT00920868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110602228|NCT00920868|Antimetabolites|antimetabolites|mesh-ancestor
110602229|NCT00920868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110602230|NCT00920868|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110602231|NCT00920868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110602232|NCT05741814|Propofol|propofol|mesh-list
110602233|NCT05741814|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110602234|NCT05741814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110602235|NCT05741814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110602236|NCT05741814|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110602237|NCT05741814|Anesthetics, General|anesthetics, general|mesh-ancestor
110602238|NCT05741814|Anesthetics|anesthetics|mesh-ancestor
110602239|NCT04721626|Chlorhexidine|chlorhexidine|mesh-list
110602240|NCT04721626|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110602241|NCT04721626|Povidone-Iodine|povidone-iodine|mesh-list
110602242|NCT04721626|Tetracycline|tetracycline|mesh-list
110602243|NCT04721626|Doxycycline|doxycycline|mesh-list
110602244|NCT04721626|Povidone|povidone|mesh-list
110602245|NCT04721626|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110602246|NCT04721626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110602247|NCT04721626|Disinfectants|disinfectants|mesh-ancestor
110602248|NCT04721626|Dermatologic Agents|dermatologic agents|mesh-ancestor
110602249|NCT04721626|Plasma Substitutes|plasma substitutes|mesh-ancestor
110602250|NCT04721626|Blood Substitutes|blood substitutes|mesh-ancestor
110602251|NCT04721626|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110602252|NCT04721626|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110602253|NCT04721626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110602254|NCT04721626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110602255|NCT04721626|Antimalarials|antimalarials|mesh-ancestor
110602256|NCT04721626|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110602257|NCT04721626|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110602258|NCT00881140|Mifepristone|mifepristone|mesh-list
110602259|NCT00881140|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
110602260|NCT00881140|Abortifacient Agents|abortifacient agents|mesh-ancestor
110602261|NCT00881140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110602262|NCT00881140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110602263|NCT00881140|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110602265|NCT00881140|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110602266|NCT00881140|Contraceptive Agents|contraceptive agents|mesh-ancestor
110602267|NCT00881140|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
110602268|NCT00881140|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
110602269|NCT00881140|Hormone Antagonists|hormone antagonists|mesh-ancestor
110602270|NCT00881140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110602271|NCT00881140|Luteolytic Agents|luteolytic agents|mesh-ancestor
110602272|NCT00881140|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110602273|NCT00881140|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
110602275|NCT05733078|Ascorbic Acid|ascorbic acid|mesh-list
110602276|NCT05733078|Micronutrients|micronutrients|mesh-ancestor
110602277|NCT05733078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110602278|NCT05733078|Antioxidants|antioxidants|mesh-ancestor
110602279|NCT05733078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110602280|NCT05733078|Protective Agents|protective agents|mesh-ancestor
110602281|NCT00874978|Lenalidomide|lenalidomide|mesh-list
110602282|NCT00874978|Immunologic Factors|immunologic factors|mesh-ancestor
110602283|NCT00874978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110602284|NCT00874978|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110602285|NCT00874978|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110602286|NCT00874978|Growth Substances|growth substances|mesh-ancestor
110602287|NCT00874978|Growth Inhibitors|growth inhibitors|mesh-ancestor
110602288|NCT00874978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110602289|NCT00737880|Pancrelipase|pancrelipase|mesh-list
110602290|NCT00737880|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110602291|NCT05728632|Nebivolol|nebivolol|mesh-list
110602292|NCT05728632|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110602293|NCT05728632|Vasodilator Agents|vasodilator agents|mesh-ancestor
110602294|NCT05728632|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
110602295|NCT05728632|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110602296|NCT05728632|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110602297|NCT05728632|Adrenergic Agents|adrenergic agents|mesh-ancestor
110602298|NCT05728632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110249621|NCT00147615|Eplerenone|eplerenone|mesh-list
110602299|NCT05728632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110602300|NCT05728632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110602301|NCT00612586|Leucovorin|leucovorin|mesh-list
110602302|NCT00612586|Bevacizumab|bevacizumab|mesh-list
110602303|NCT00612586|Fluorouracil|fluorouracil|mesh-list
110602304|NCT00612586|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110602305|NCT00612586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110602306|NCT00612586|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110602307|NCT00612586|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110602308|NCT00612586|Growth Substances|growth substances|mesh-ancestor
110602309|NCT00612586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110602310|NCT00612586|Growth Inhibitors|growth inhibitors|mesh-ancestor
110602311|NCT00612586|Antimetabolites|antimetabolites|mesh-ancestor
110602312|NCT00612586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110602313|NCT00612586|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110602314|NCT00612586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110602315|NCT00612586|Immunologic Factors|immunologic factors|mesh-ancestor
110602316|NCT00612586|Antidotes|antidotes|mesh-ancestor
110602317|NCT00612586|Protective Agents|protective agents|mesh-ancestor
110602318|NCT00612586|Vitamin B Complex|vitamin b complex|mesh-ancestor
110602319|NCT00612586|Vitamins|vitamins|mesh-ancestor
110602320|NCT00612586|Micronutrients|micronutrients|mesh-ancestor
110602321|NCT00883870|Plasma-lyte 148|plasma-lyte 148|mesh-list
110602322|NCT00883870|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110602324|NCT00614380|Amlodipine|amlodipine|mesh-list
110602325|NCT00614380|Telmisartan|telmisartan|mesh-list
110602326|NCT00614380|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
110602327|NCT00614380|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110602328|NCT00614380|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110602330|NCT00614380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110602331|NCT00614380|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110602332|NCT00614380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110602333|NCT00614380|Vasodilator Agents|vasodilator agents|mesh-ancestor
110602334|NCT00614380|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110602335|NCT00614380|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110602337|NCT00738192|Sufentanil|sufentanil|mesh-list
110602338|NCT00738192|Dsuvia|dsuvia|mesh-list
110602339|NCT00738192|Butorphanol|butorphanol|mesh-list
110602340|NCT00738192|Citric Acid|citric acid|mesh-list
110602341|NCT00738192|Sodium Citrate|sodium citrate|mesh-list
110602342|NCT00738192|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110602343|NCT00738192|Narcotics|narcotics|mesh-ancestor
110602344|NCT00738192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110602345|NCT00738192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110602346|NCT00738192|Analgesics|analgesics|mesh-ancestor
110602347|NCT00738192|Sensory System Agents|sensory system agents|mesh-ancestor
110602348|NCT00738192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110602349|NCT00738192|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110602350|NCT00738192|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110602351|NCT00738192|Anesthetics, General|anesthetics, general|mesh-ancestor
110602352|NCT00738192|Anesthetics|anesthetics|mesh-ancestor
110602353|NCT00738192|Anticoagulants|anticoagulants|mesh-ancestor
110602354|NCT00738192|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110602355|NCT00738192|Chelating Agents|chelating agents|mesh-ancestor
110602356|NCT00738192|Sequestering Agents|sequestering agents|mesh-ancestor
110602357|NCT00738192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110602358|NCT00738192|Antitussive Agents|antitussive agents|mesh-ancestor
110602359|NCT00738192|Respiratory System Agents|respiratory system agents|mesh-ancestor
110602360|NCT00738192|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110602361|NCT00884104|Solifenacin Succinate|solifenacin succinate|mesh-list
110602362|NCT00884104|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110602363|NCT00884104|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110602364|NCT00884104|Cholinergic Agents|cholinergic agents|mesh-ancestor
110602365|NCT00884104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110602366|NCT00884104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110602367|NCT00884104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110602368|NCT00884104|Urological Agents|urological agents|mesh-ancestor
110602369|NCT04140214|Carbocysteine|carbocysteine|mesh-list
110602370|NCT04140214|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110602371|NCT04140214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110602372|NCT04140214|Expectorants|expectorants|mesh-ancestor
110602373|NCT04140214|Respiratory System Agents|respiratory system agents|mesh-ancestor
110602374|NCT00612508|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110602375|NCT00612508|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110602376|NCT00612508|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110602377|NCT00612508|Etonogestrel|etonogestrel|mesh-list
110602378|NCT00612508|Desogestrel|desogestrel|mesh-list
110602379|NCT00612508|NuvaRing|nuvaring|mesh-list
110602380|NCT00612508|Estradiol|estradiol|mesh-list
110602381|NCT00612508|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110602382|NCT00612508|Estrogens|estrogens|mesh-ancestor
110602383|NCT00612508|Hormones|hormones|mesh-ancestor
110602384|NCT00612508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110602385|NCT00612508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110602386|NCT00612508|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110602387|NCT00612508|Contraceptive Agents|contraceptive agents|mesh-ancestor
110602388|NCT00612508|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110602389|NCT00612508|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110602390|NCT00612508|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110602391|NCT00612508|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110602392|NCT00612508|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110602393|NCT00612508|Progestins|progestins|mesh-ancestor
110602394|NCT00881218|Regadenoson|regadenoson|mesh-list
110602395|NCT00881218|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
110602396|NCT00881218|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
110602397|NCT00881218|Purinergic Agonists|purinergic agonists|mesh-ancestor
110602398|NCT00881218|Purinergic Agents|purinergic agents|mesh-ancestor
110602399|NCT00881218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110602400|NCT00881218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110602401|NCT00881218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110602402|NCT00613834|Lidocaine|lidocaine|mesh-list
110602403|NCT00613834|Anesthetics, Local|anesthetics, local|mesh-ancestor
110602404|NCT00613834|Anesthetics|anesthetics|mesh-ancestor
110602405|NCT00613834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110602406|NCT00613834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110602407|NCT00613834|Sensory System Agents|sensory system agents|mesh-ancestor
110602408|NCT00613834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110602409|NCT00613834|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110602410|NCT00613834|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110602411|NCT00613834|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110379312|NCT04536558|Serotonin Agents|serotonin agents|mesh-ancestor
110602412|NCT00613834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110602413|NCT00613834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110602414|NCT00875368|Maraviroc|maraviroc|mesh-list
110602415|NCT00875368|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110602416|NCT00875368|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110602417|NCT00875368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110602418|NCT00875368|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110602419|NCT00875368|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110602420|NCT00875368|Antiviral Agents|antiviral agents|mesh-ancestor
110602421|NCT00875368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110602422|NCT00875368|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
110602423|NCT03912298|Analgesics, Opioid|analgesics, opioid|mesh-list
110602424|NCT03912298|Narcotics|narcotics|mesh-ancestor
110602425|NCT03912298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110602426|NCT03912298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110602427|NCT03912298|Analgesics|analgesics|mesh-ancestor
110602428|NCT03912298|Sensory System Agents|sensory system agents|mesh-ancestor
110602429|NCT03912298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110602430|NCT02543710|Taxane|taxane|mesh-list
110602431|NCT02543710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110602432|NCT00884260|Levonorgestrel|levonorgestrel|mesh-list
110602433|NCT00884260|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110602434|NCT00884260|Contraceptive Agents|contraceptive agents|mesh-ancestor
110602435|NCT00884260|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110602436|NCT00884260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110602437|NCT00884260|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110602438|NCT00884260|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110602439|NCT00884260|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110602440|NCT00881296|Carboplatin|carboplatin|mesh-list
110602441|NCT00881296|Gemcitabine|gemcitabine|mesh-list
110602442|NCT00881296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110602443|NCT00881296|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110602444|NCT00881296|Antimetabolites|antimetabolites|mesh-ancestor
110602445|NCT00881296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110602446|NCT00613366|Misoprostol|misoprostol|mesh-list
110602447|NCT00613366|Magnesium Oxide|magnesium oxide|mesh-list
110602448|NCT00613366|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110602449|NCT00613366|Abortifacient Agents|abortifacient agents|mesh-ancestor
110602450|NCT00613366|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110602451|NCT00613366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110602452|NCT00613366|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110602453|NCT00613366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110602454|NCT00613366|Oxytocics|oxytocics|mesh-ancestor
110602455|NCT00613366|Antacids|antacids|mesh-ancestor
110602456|NCT00613366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110602457|NCT00612352|Ethanol|ethanol|mesh-list
110602458|NCT00612352|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110602459|NCT00612352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110602460|NCT00612352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110602461|NCT00612352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110602462|NCT00884416|Sorafenib|sorafenib|mesh-list
110602463|NCT00884416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110602464|NCT00884416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110602465|NCT00884416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110602466|NCT00884416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110602467|NCT00884494|Insulin|insulin|mesh-list
110602468|NCT00884494|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110602469|NCT00884494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110602470|NCT00881686|Adenosine|adenosine|mesh-list
110602471|NCT00881686|Analgesics|analgesics|mesh-ancestor
110602472|NCT00881686|Sensory System Agents|sensory system agents|mesh-ancestor
110602473|NCT00881686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110602474|NCT00881686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110379379|NCT02216331|Leprostatic Agents|leprostatic agents|mesh-ancestor
110602475|NCT00881686|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110602476|NCT00881686|Vasodilator Agents|vasodilator agents|mesh-ancestor
110602477|NCT00881686|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
110602478|NCT00881686|Purinergic Agonists|purinergic agonists|mesh-ancestor
110602479|NCT00881686|Purinergic Agents|purinergic agents|mesh-ancestor
110602480|NCT00881686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110602481|NCT00881686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110602482|NCT00885508|Lenalidomide|lenalidomide|mesh-list
110602483|NCT00885508|Immunologic Factors|immunologic factors|mesh-ancestor
110602484|NCT00885508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110602485|NCT00885508|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110602486|NCT00885508|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110602487|NCT00885508|Growth Substances|growth substances|mesh-ancestor
110602488|NCT00885508|Growth Inhibitors|growth inhibitors|mesh-ancestor
110602489|NCT00885508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110602490|NCT02543086|Piperaquine|piperaquine|mesh-list
110602491|NCT02543086|Antimalarials|antimalarials|mesh-ancestor
110602492|NCT02543086|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110602493|NCT02543086|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110602494|NCT02543086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110602496|NCT00885586|Analgesics|analgesics|mesh-ancestor
110602497|NCT00885586|Sensory System Agents|sensory system agents|mesh-ancestor
110602498|NCT00885586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110602499|NCT00885586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110602500|NCT00885586|Anticonvulsants|anticonvulsants|mesh-ancestor
110602501|NCT00885586|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110602502|NCT00885586|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110602503|NCT00885586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110602504|NCT00885586|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110602505|NCT00885586|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110602506|NCT00885586|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110602507|NCT00885586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110602508|NCT00885586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110602509|NCT00885586|Antimanic Agents|antimanic agents|mesh-ancestor
110602510|NCT02542930|Thymalfasin|thymalfasin|mesh-list
110602511|NCT02542930|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110602512|NCT02542930|Immunologic Factors|immunologic factors|mesh-ancestor
110602513|NCT02542930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110602514|NCT00881764|Anesthetics|anesthetics|mesh-list
110379423|NCT04542213|Protease Inhibitors|protease inhibitors|mesh-ancestor
110602515|NCT00881764|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110602516|NCT00881764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110602518|NCT04038034|Vitamins|vitamins|mesh-ancestor
110602519|NCT04038034|Micronutrients|micronutrients|mesh-ancestor
110602520|NCT04038034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110602521|NCT04037878|Tramadol|tramadol|mesh-list
110602522|NCT04037878|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110602523|NCT04037878|Narcotics|narcotics|mesh-ancestor
110602524|NCT04037878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110602525|NCT04037878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110249834|NCT01249339|Nicotine|nicotine|mesh-list
110602526|NCT04037878|Analgesics|analgesics|mesh-ancestor
110602527|NCT04037878|Sensory System Agents|sensory system agents|mesh-ancestor
110602528|NCT04037878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110602529|NCT00651261|Cytarabine|cytarabine|mesh-list
110602531|NCT00651261|Dexamethasone acetate|dexamethasone acetate|mesh-list
110602532|NCT00651261|Daunorubicin|daunorubicin|mesh-list
110602533|NCT00651261|Midostaurin|midostaurin|mesh-list
110602534|NCT00651261|BB 1101|bb 1101|mesh-list
110026363|NCT02996916|Amlodipine|amlodipine|mesh-list
110602535|NCT00651261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110602536|NCT00651261|Antiemetics|antiemetics|mesh-ancestor
110602537|NCT00651261|Autonomic Agents|autonomic agents|mesh-ancestor
110602538|NCT00651261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110602539|NCT00651261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110602540|NCT00651261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110602541|NCT00651261|Glucocorticoids|glucocorticoids|mesh-ancestor
110602542|NCT00651261|Hormones|hormones|mesh-ancestor
110602543|NCT00651261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110602544|NCT00651261|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110602545|NCT00651261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110602546|NCT00651261|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110602547|NCT00651261|Antimetabolites|antimetabolites|mesh-ancestor
110602548|NCT00651261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110602549|NCT00651261|Antiviral Agents|antiviral agents|mesh-ancestor
110602550|NCT00651261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110602551|NCT00651261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110602552|NCT00651261|Immunologic Factors|immunologic factors|mesh-ancestor
110602553|NCT00651261|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110602554|NCT00651261|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110602555|NCT00651261|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110602556|NCT00651261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110602557|NCT00651261|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110602558|NCT00651261|Protease Inhibitors|protease inhibitors|mesh-ancestor
110602559|NCT00885820|Prednisone|prednisone|mesh-list
110602560|NCT00885820|Methylprednisolone|methylprednisolone|mesh-list
110602561|NCT00885820|Tacrolimus|tacrolimus|mesh-list
110602562|NCT00885820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110602563|NCT00885820|Glucocorticoids|glucocorticoids|mesh-ancestor
110602564|NCT00885820|Hormones|hormones|mesh-ancestor
110602565|NCT00885820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110602566|NCT00885820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110602567|NCT00885820|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110602568|NCT00885820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110602569|NCT00885820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110602570|NCT00885820|Immunologic Factors|immunologic factors|mesh-ancestor
110602571|NCT00885820|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110602572|NCT00885820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110602573|NCT00885820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110602574|NCT00885820|Antiemetics|antiemetics|mesh-ancestor
110602575|NCT00885820|Autonomic Agents|autonomic agents|mesh-ancestor
110602576|NCT00885820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110602577|NCT00885820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110602578|NCT00885820|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110602579|NCT00885820|Protective Agents|protective agents|mesh-ancestor
110602581|NCT02567838|Anesthetics, Local|anesthetics, local|mesh-ancestor
110602582|NCT02567838|Anesthetics|anesthetics|mesh-ancestor
110602583|NCT02567838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110602584|NCT02567838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110602585|NCT02567838|Sensory System Agents|sensory system agents|mesh-ancestor
110602586|NCT02567838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110602587|NCT02567838|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110602588|NCT02567838|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110602589|NCT02567838|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110602590|NCT02567838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110602591|NCT02567838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110602592|NCT00651183|Pramipexole|pramipexole|mesh-list
110602593|NCT00651183|Antioxidants|antioxidants|mesh-ancestor
110602594|NCT00651183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110602595|NCT00651183|Protective Agents|protective agents|mesh-ancestor
110602596|NCT00651183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110602597|NCT00651183|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110602598|NCT00651183|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110602599|NCT00651183|Dopamine Agonists|dopamine agonists|mesh-ancestor
110602601|NCT00651183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110602602|NCT00810381|Nitroprusside|nitroprusside|mesh-list
110602603|NCT00810381|Isosorbide|isosorbide|mesh-list
110602604|NCT00810381|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
110602605|NCT00810381|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
110602606|NCT00810381|Nitroglycerin|nitroglycerin|mesh-list
110602607|NCT00810381|Vasodilator Agents|vasodilator agents|mesh-ancestor
110602608|NCT00810381|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110602609|NCT00810381|Diuretics|diuretics|mesh-ancestor
110602610|NCT00810381|Natriuretic Agents|natriuretic agents|mesh-ancestor
110602611|NCT00810381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110283298|NCT00478972|Hormones|hormones|mesh-ancestor
110602612|NCT00810381|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
110602613|NCT00810381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110602614|NCT00810381|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110602616|NCT00800319|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110602617|NCT00800319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110602618|NCT00800319|Sensory System Agents|sensory system agents|mesh-ancestor
110602619|NCT00800319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110602620|NCT00813501|Immunosuppressive Agents|immunosuppressive agents|mesh-list
110602621|NCT00813501|Immunologic Factors|immunologic factors|mesh-ancestor
110602622|NCT00813501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110602623|NCT00800475|Gemfibrozil|gemfibrozil|mesh-list
110602624|NCT00800475|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110602625|NCT00800475|Antimetabolites|antimetabolites|mesh-ancestor
110602626|NCT00800475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110602627|NCT00800475|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110602628|NCT00800475|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
110602629|NCT00800475|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110602630|NCT00800475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110602631|NCT00810849|Prednisolone|prednisolone|mesh-list
110602632|NCT00810849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110602633|NCT00810849|Glucocorticoids|glucocorticoids|mesh-ancestor
110602634|NCT00810849|Hormones|hormones|mesh-ancestor
110602635|NCT00810849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110602636|NCT00810849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110602637|NCT00810849|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110602638|NCT00810849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110602639|NCT00811005|5-Methoxypsoralen|5-methoxypsoralen|mesh-list
110379546|NCT04532736|Hormones|hormones|mesh-ancestor
110602640|NCT00811005|Methoxsalen|methoxsalen|mesh-list
110602641|NCT00811005|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110602642|NCT00811005|Dermatologic Agents|dermatologic agents|mesh-ancestor
110602643|NCT00811005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110602644|NCT00813735|Dexetimide|dexetimide|mesh-list
110602645|NCT00813735|Eszopiclone|eszopiclone|mesh-list
110602646|NCT00813735|Citalopram|citalopram|mesh-list
110602647|NCT00813735|Escitalopram|escitalopram|mesh-list
110602648|NCT00813735|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110602649|NCT00813735|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110602650|NCT00813735|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110602651|NCT00813735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110602652|NCT00813735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110602653|NCT00813735|Serotonin Agents|serotonin agents|mesh-ancestor
110602654|NCT00813735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110602655|NCT00813735|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110602656|NCT00813735|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110602657|NCT00813735|Parasympatholytics|parasympatholytics|mesh-ancestor
110602658|NCT00813735|Autonomic Agents|autonomic agents|mesh-ancestor
110602659|NCT00813735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110602660|NCT00813735|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110602661|NCT00813735|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110602662|NCT00813735|Cholinergic Agents|cholinergic agents|mesh-ancestor
110602663|NCT00813735|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110602664|NCT00813735|Antidepressive Agents|antidepressive agents|mesh-ancestor
110602665|NCT00813735|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110602666|NCT00813735|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110602667|NCT00813735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110602668|NCT00811083|Succimer|succimer|mesh-list
110602669|NCT00811083|Antidotes|antidotes|mesh-ancestor
110602670|NCT00811083|Protective Agents|protective agents|mesh-ancestor
110602671|NCT00811083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110602672|NCT00811083|Chelating Agents|chelating agents|mesh-ancestor
110602673|NCT00811083|Sequestering Agents|sequestering agents|mesh-ancestor
110379559|NCT02216994|Mineral Oil|mineral oil|mesh-list
110602674|NCT00811083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110602676|NCT00642759|Bevacizumab|bevacizumab|mesh-list
110602677|NCT00642759|Carboplatin|carboplatin|mesh-list
110602678|NCT00642759|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110602679|NCT00642759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110602680|NCT00642759|Tubulin Modulators|tubulin modulators|mesh-ancestor
110602681|NCT00642759|Antimitotic Agents|antimitotic agents|mesh-ancestor
110602682|NCT00642759|Mitosis Modulators|mitosis modulators|mesh-ancestor
110602683|NCT00642759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110602684|NCT00642759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110602685|NCT00642759|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110602686|NCT00642759|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110602687|NCT00642759|Growth Substances|growth substances|mesh-ancestor
110602688|NCT00642759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110602689|NCT00642759|Growth Inhibitors|growth inhibitors|mesh-ancestor
110602690|NCT00813891|Ranibizumab|ranibizumab|mesh-list
110602691|NCT00813891|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110602692|NCT00813891|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110602693|NCT00813891|Growth Substances|growth substances|mesh-ancestor
110602694|NCT00813891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110602695|NCT00813891|Growth Inhibitors|growth inhibitors|mesh-ancestor
110602696|NCT00813891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110602697|NCT00817557|Loteprednol Etabonate|loteprednol etabonate|mesh-list
110602698|NCT00817557|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110602699|NCT00611026|Tolterodine Tartrate|tolterodine tartrate|mesh-list
110602700|NCT00611026|Fesoterodine|fesoterodine|mesh-list
110602701|NCT00611026|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110602702|NCT00611026|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110602703|NCT00611026|Cholinergic Agents|cholinergic agents|mesh-ancestor
110602704|NCT00611026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110602705|NCT00611026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110602706|NCT00611026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110602707|NCT00611026|Urological Agents|urological agents|mesh-ancestor
110602708|NCT02552589|Fluorides|fluorides|mesh-list
110602709|NCT02552589|Fluorophosphate|fluorophosphate|mesh-list
110602710|NCT02552589|Cariostatic Agents|cariostatic agents|mesh-ancestor
110602711|NCT02552589|Protective Agents|protective agents|mesh-ancestor
110602712|NCT02552589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110602713|NCT00811239|Antivenins|antivenins|mesh-list
110602714|NCT00811239|Immunologic Factors|immunologic factors|mesh-ancestor
110602715|NCT00811239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110602716|NCT00814047|Yohimbine|yohimbine|mesh-list
110602717|NCT00814047|Mydriatics|mydriatics|mesh-ancestor
110602718|NCT00814047|Autonomic Agents|autonomic agents|mesh-ancestor
110602719|NCT00814047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110602720|NCT00814047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110602721|NCT00814047|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
110602722|NCT00814047|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110602723|NCT00814047|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110602724|NCT00814047|Adrenergic Agents|adrenergic agents|mesh-ancestor
110602725|NCT00814047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110602726|NCT00814047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110602727|NCT00814047|Urological Agents|urological agents|mesh-ancestor
110602728|NCT00814125|Tamoxifen|tamoxifen|mesh-list
110602729|NCT00814125|Anastrozole|anastrozole|mesh-list
110602730|NCT00814125|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110602731|NCT00814125|Hormone Antagonists|hormone antagonists|mesh-ancestor
110602732|NCT00814125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110602733|NCT00814125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110602734|NCT00814125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110602735|NCT00814125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110602736|NCT00814125|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110602737|NCT00814125|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110602738|NCT00814125|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110602739|NCT00814125|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110602740|NCT00814125|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110602741|NCT00814125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110602742|NCT00814125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110602743|NCT00817713|Ivermectin|ivermectin|mesh-list
110602744|NCT00817713|Albendazole|albendazole|mesh-list
110602745|NCT00817713|Praziquantel|praziquantel|mesh-list
110379632|NCT04531332|Linezolid|linezolid|mesh-list
110602746|NCT00817713|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110602747|NCT00817713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110602748|NCT00817713|Anthelmintics|anthelmintics|mesh-ancestor
110602749|NCT00817713|Anticestodal Agents|anticestodal agents|mesh-ancestor
110602750|NCT00817713|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110602751|NCT00817713|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110602752|NCT00817713|Tubulin Modulators|tubulin modulators|mesh-ancestor
110602753|NCT00817713|Antimitotic Agents|antimitotic agents|mesh-ancestor
110602754|NCT00817713|Mitosis Modulators|mitosis modulators|mesh-ancestor
110602755|NCT00817713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110602756|NCT00817713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110602757|NCT00422383|Rituximab|rituximab|mesh-list
110602758|NCT00422383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110602759|NCT00422383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110602760|NCT00422383|Immunologic Factors|immunologic factors|mesh-ancestor
110602761|NCT00422383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110602762|NCT00422383|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110602763|NCT00814281|Montelukast|montelukast|mesh-list
110602764|NCT00814281|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110602765|NCT00814281|Respiratory System Agents|respiratory system agents|mesh-ancestor
110602766|NCT00814281|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110602767|NCT00814281|Hormone Antagonists|hormone antagonists|mesh-ancestor
110602768|NCT00814281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110602769|NCT00814281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110602770|NCT00814281|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110602771|NCT00814281|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110602772|NCT00814281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110602773|NCT00814359|Benzydamine|benzydamine|mesh-list
110602774|NCT00814359|Sucralfate|sucralfate|mesh-list
110602775|NCT00814359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110602776|NCT00814359|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110602777|NCT00814359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110602778|NCT00612040|Insulin|insulin|mesh-list
110602779|NCT00612040|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110602780|NCT00612040|Insulin Glargine|insulin glargine|mesh-list
110602781|NCT00612040|Insulin Aspart|insulin aspart|mesh-list
110602782|NCT00612040|Insulin, Long-Acting|insulin, long-acting|mesh-list
110602783|NCT00612040|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110602784|NCT00612040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110602785|NCT00422227|Hydroxychloroquine|hydroxychloroquine|mesh-list
110602786|NCT00422227|Sulfasalazine|sulfasalazine|mesh-list
110602787|NCT00422227|Etanercept|etanercept|mesh-list
110602788|NCT00422227|Methotrexate|methotrexate|mesh-list
110602789|NCT00422227|Leflunomide|leflunomide|mesh-list
110602790|NCT00422227|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110602791|NCT00422227|Abortifacient Agents|abortifacient agents|mesh-ancestor
110602792|NCT00422227|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110602793|NCT00422227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110602794|NCT00422227|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110602795|NCT00422227|Antimetabolites|antimetabolites|mesh-ancestor
110602796|NCT00422227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110602797|NCT00422227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110602798|NCT00422227|Dermatologic Agents|dermatologic agents|mesh-ancestor
110602799|NCT00422227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110602800|NCT00422227|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110602801|NCT00422227|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110602802|NCT00422227|Immunologic Factors|immunologic factors|mesh-ancestor
110602803|NCT00422227|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110602804|NCT00422227|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110602805|NCT00422227|Antimalarials|antimalarials|mesh-ancestor
110602806|NCT00422227|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110602807|NCT00422227|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110602808|NCT00422227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110602809|NCT00422227|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110602810|NCT00422227|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110602811|NCT00422227|Analgesics|analgesics|mesh-ancestor
110602812|NCT00422227|Sensory System Agents|sensory system agents|mesh-ancestor
110602813|NCT00422227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110602814|NCT00422227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110602815|NCT00422227|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110602817|NCT00811785|Trace Elements|trace elements|mesh-ancestor
110602818|NCT00811785|Micronutrients|micronutrients|mesh-ancestor
110602819|NCT00811785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110602820|NCT00814515|Cyclosporine|cyclosporine|mesh-list
110602821|NCT00814515|Cyclosporins|cyclosporins|mesh-list
110602822|NCT00814515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110602823|NCT00814515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110602824|NCT00814515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110602825|NCT00814515|Immunologic Factors|immunologic factors|mesh-ancestor
110602826|NCT00814515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110602827|NCT00814515|Antifungal Agents|antifungal agents|mesh-ancestor
110602828|NCT00814515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110602829|NCT00814515|Dermatologic Agents|dermatologic agents|mesh-ancestor
110602830|NCT00814515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110602831|NCT00814515|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110602832|NCT00814593|Carmustine|carmustine|mesh-list
110602833|NCT00814593|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110602834|NCT00814593|Alkylating Agents|alkylating agents|mesh-ancestor
110602835|NCT00814593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110602836|NCT00814593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110602837|NCT00421993|Adapalene|adapalene|mesh-list
110602838|NCT00421993|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
110602839|NCT00421993|Benzoyl Peroxide|benzoyl peroxide|mesh-list
110602840|NCT00421993|Dermatologic Agents|dermatologic agents|mesh-ancestor
110602841|NCT00421993|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110602842|NCT00421993|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110602843|NCT00421993|Analgesics|analgesics|mesh-ancestor
110602844|NCT00421993|Sensory System Agents|sensory system agents|mesh-ancestor
110602845|NCT00421993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110602846|NCT00421993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110602847|NCT00421993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110602848|NCT00421993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110602850|NCT00884884|Aripiprazole|aripiprazole|mesh-list
110602851|NCT00884884|Antidepressive Agents|antidepressive agents|mesh-ancestor
110602852|NCT00884884|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110602853|NCT00884884|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110602854|NCT00884884|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110602855|NCT00884884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110602856|NCT00884884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110602857|NCT00884884|Dopamine Agonists|dopamine agonists|mesh-ancestor
110602858|NCT00884884|Dopamine Agents|dopamine agents|mesh-ancestor
110602859|NCT00884884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110602860|NCT00884884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110602861|NCT00884884|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110602862|NCT00884884|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110602863|NCT00884884|Serotonin Agents|serotonin agents|mesh-ancestor
110602864|NCT00884884|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110602865|NCT00884884|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110602866|NCT00884884|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110602867|NCT00884884|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110602868|NCT00884884|Anticonvulsants|anticonvulsants|mesh-ancestor
110602869|NCT00884884|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110602870|NCT01037725|Oxazolidinones|oxazolidinones|mesh-list
110602871|NCT01037725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110602872|NCT01037725|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110602873|NCT01037725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110602874|NCT01037725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110602875|NCT02551029|Capsaicin|capsaicin|mesh-list
110602876|NCT02551029|Antipruritics|antipruritics|mesh-ancestor
110602877|NCT02551029|Dermatologic Agents|dermatologic agents|mesh-ancestor
110602878|NCT02551029|Sensory System Agents|sensory system agents|mesh-ancestor
110602879|NCT02551029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110602880|NCT02551029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110602881|NCT00812019|Vaccines|vaccines|mesh-list
110602882|NCT00812019|MF59 oil emulsion|mf59 oil emulsion|mesh-list
110602883|NCT00812019|Immunologic Factors|immunologic factors|mesh-ancestor
110602884|NCT00812019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110602885|NCT00812019|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110602886|NCT00413959|Dexamethasone|dexamethasone|mesh-list
110602887|NCT00413959|Cyclophosphamide|cyclophosphamide|mesh-list
110602889|NCT00413959|Bortezomib|bortezomib|mesh-list
110602890|NCT00413959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110602891|NCT00413959|Immunologic Factors|immunologic factors|mesh-ancestor
110602892|NCT00413959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110602893|NCT00413959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110602894|NCT00413959|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110602895|NCT00413959|Alkylating Agents|alkylating agents|mesh-ancestor
110602896|NCT00413959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110602897|NCT00413959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110602898|NCT00413959|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110602899|NCT00413959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110602900|NCT00413959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110602901|NCT00413959|Antiemetics|antiemetics|mesh-ancestor
110602902|NCT00413959|Autonomic Agents|autonomic agents|mesh-ancestor
110602903|NCT00413959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110602904|NCT00413959|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110602905|NCT00413959|Glucocorticoids|glucocorticoids|mesh-ancestor
110602906|NCT00413959|Hormones|hormones|mesh-ancestor
110602907|NCT00413959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110602908|NCT00413959|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110602909|NCT00814905|Clindamycin|clindamycin|mesh-list
110602910|NCT00814905|Clindamycin palmitate|clindamycin palmitate|mesh-list
110602911|NCT00814905|Clindamycin phosphate|clindamycin phosphate|mesh-list
110602912|NCT00814905|Gentamicins|gentamicins|mesh-list
110602913|NCT00814905|Ampicillin|ampicillin|mesh-list
110602914|NCT00814905|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110602915|NCT00814905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110602916|NCT00814905|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110602917|NCT00814905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110602918|NCT00814905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110602919|NCT00611884|Insulin|insulin|mesh-list
110602920|NCT00611884|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110602921|NCT00611884|Metformin|metformin|mesh-list
110602922|NCT00611884|Insulin Glargine|insulin glargine|mesh-list
110602923|NCT00611884|Insulin, Long-Acting|insulin, long-acting|mesh-list
110602924|NCT00611884|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110602925|NCT00611884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110602926|NCT00611806|Folic Acid|folic acid|mesh-list
110602927|NCT00611806|Vitamin B 12|vitamin b 12|mesh-list
110602928|NCT00611806|Hematinics|hematinics|mesh-ancestor
110602929|NCT00611806|Vitamin B Complex|vitamin b complex|mesh-ancestor
110602930|NCT00611806|Vitamins|vitamins|mesh-ancestor
110602931|NCT00611806|Micronutrients|micronutrients|mesh-ancestor
110602932|NCT00611806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110602933|NCT00413413|Amlodipine|amlodipine|mesh-list
110602934|NCT00413413|Valsartan|valsartan|mesh-list
110275759|NCT01652482|Vitamins|vitamins|mesh-ancestor
110602935|NCT00413413|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110602936|NCT00413413|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110602937|NCT00413413|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110602938|NCT00413413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110379761|NCT02212652|Vitamin D|vitamin d|mesh-list
110602939|NCT00413413|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110602941|NCT00413413|Vasodilator Agents|vasodilator agents|mesh-ancestor
110602942|NCT00413413|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110602943|NCT00413413|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110602944|NCT00886132|Sunitinib|sunitinib|mesh-list
110602945|NCT00886132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110602946|NCT00886132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110602947|NCT00886132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110602948|NCT00886132|Growth Substances|growth substances|mesh-ancestor
110602949|NCT00886132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110602950|NCT00886132|Growth Inhibitors|growth inhibitors|mesh-ancestor
110602951|NCT00886132|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110602952|NCT00886132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110602953|NCT00886132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110602954|NCT01040455|Lansoprazole|lansoprazole|mesh-list
110602955|NCT01040455|Dexlansoprazole|dexlansoprazole|mesh-list
110602956|NCT01040455|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110602957|NCT01040455|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110602958|NCT01040455|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110602959|NCT01040455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110602960|NCT01040455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110602961|NCT01041235|Docetaxel|docetaxel|mesh-list
110602962|NCT01041235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110602963|NCT01041235|Tubulin Modulators|tubulin modulators|mesh-ancestor
110602964|NCT01041235|Antimitotic Agents|antimitotic agents|mesh-ancestor
110602965|NCT01041235|Mitosis Modulators|mitosis modulators|mesh-ancestor
110602966|NCT01041235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110602967|NCT01041313|Memantine|memantine|mesh-list
110602968|NCT01041313|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110602969|NCT01041313|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110602970|NCT01041313|Dopamine Agents|dopamine agents|mesh-ancestor
110602971|NCT01041313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110602972|NCT01041313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110602973|NCT01041313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110602974|NCT01041313|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110602975|NCT01041313|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110602976|NCT00610714|Paclitaxel|paclitaxel|mesh-list
110602977|NCT00610714|Carboplatin|carboplatin|mesh-list
110602978|NCT00610714|Saracatinib|saracatinib|mesh-list
110602979|NCT00610714|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110602980|NCT00610714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110602981|NCT00610714|Tubulin Modulators|tubulin modulators|mesh-ancestor
110602982|NCT00610714|Antimitotic Agents|antimitotic agents|mesh-ancestor
110602983|NCT00610714|Mitosis Modulators|mitosis modulators|mesh-ancestor
110379788|NCT02217852|Protease Inhibitors|protease inhibitors|mesh-ancestor
110602984|NCT00610714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110602985|NCT00610714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110602986|NCT00403585|Adefovir|adefovir|mesh-list
110602987|NCT00403585|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
110602988|NCT00403585|Antiviral Agents|antiviral agents|mesh-ancestor
110602989|NCT00403585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110602990|NCT00403585|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110602991|NCT00403585|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110602992|NCT00403585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110602993|NCT00403585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110602994|NCT00645411|Vaccines|vaccines|mesh-list
110602995|NCT00645411|Immunologic Factors|immunologic factors|mesh-ancestor
110602996|NCT00645411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110602997|NCT00403273|Botulinum Toxins|botulinum toxins|mesh-list
110602998|NCT00403273|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110602999|NCT00403273|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110603000|NCT00403273|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110603001|NCT00403273|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110603002|NCT00403273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110603003|NCT00403273|Cholinergic Agents|cholinergic agents|mesh-ancestor
110603004|NCT00403273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110603005|NCT00403273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110603006|NCT00403273|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110603007|NCT00403273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110603008|NCT00885274|Magnesium Oxide|magnesium oxide|mesh-list
110603009|NCT00885274|Citric Acid|citric acid|mesh-list
110603010|NCT00885274|Antacids|antacids|mesh-ancestor
110603011|NCT00885274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110603012|NCT00885274|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110603013|NCT00885274|Anticoagulants|anticoagulants|mesh-ancestor
110603014|NCT00885274|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110603015|NCT00885274|Chelating Agents|chelating agents|mesh-ancestor
110603016|NCT00885274|Sequestering Agents|sequestering agents|mesh-ancestor
110603017|NCT00402727|Amoxicillin|amoxicillin|mesh-list
110603018|NCT00402727|Moxifloxacin|moxifloxacin|mesh-list
110603019|NCT00402727|Tazobactam|tazobactam|mesh-list
110603020|NCT00402727|Piperacillin|piperacillin|mesh-list
110603021|NCT00402727|Clavulanic Acids|clavulanic acids|mesh-list
110603022|NCT00402727|Clavulanic Acid|clavulanic acid|mesh-list
110603023|NCT00402727|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
110603024|NCT00402727|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
110603025|NCT00402727|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110603026|NCT00402727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110603027|NCT00402727|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110603028|NCT00402727|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110603029|NCT00402727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110603030|NCT00402727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110603031|NCT00402727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110603032|NCT00402727|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110603033|NCT00402727|Contraceptive Agents|contraceptive agents|mesh-ancestor
110603034|NCT00402727|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110603035|NCT00402727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110603036|NCT00402727|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110603037|NCT00402727|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110603038|NCT00402727|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110603039|NCT00402727|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110603040|NCT00923494|Ropivacaine|ropivacaine|mesh-list
110603041|NCT00923494|Anesthetics, Local|anesthetics, local|mesh-ancestor
110603042|NCT00923494|Anesthetics|anesthetics|mesh-ancestor
110603043|NCT00923494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110603044|NCT00923494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110603045|NCT00923494|Sensory System Agents|sensory system agents|mesh-ancestor
110603046|NCT00923494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110603047|NCT00888784|Propranolol|propranolol|mesh-list
110603048|NCT00888784|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
110603049|NCT00888784|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110603050|NCT00888784|Adrenergic Agents|adrenergic agents|mesh-ancestor
110603051|NCT00888784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110603052|NCT00888784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110603053|NCT00888784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110603054|NCT00888784|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110603055|NCT00888784|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110603056|NCT00888784|Vasodilator Agents|vasodilator agents|mesh-ancestor
110603057|NCT00886678|Carboplatin|carboplatin|mesh-list
110603059|NCT00886678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110603060|NCT00886678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110603061|NCT00886678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110603063|NCT00886678|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110603064|NCT00402337|Linaclotide|linaclotide|mesh-list
110603065|NCT00402337|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
110603066|NCT00402337|Enzyme Activators|enzyme activators|mesh-ancestor
110283366|NCT00195923|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110283369|NCT00225615|Verapamil|verapamil|mesh-list
110603067|NCT00402337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110603068|NCT00402337|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110603069|NCT00888862|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
110603070|NCT00888862|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110603071|NCT00888862|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110603072|NCT00888862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110603073|NCT00888862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110603074|NCT00888862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110603075|NCT00888862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110603076|NCT00888862|Antidepressive Agents|antidepressive agents|mesh-ancestor
110603077|NCT00888862|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110603079|NCT00886990|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110603080|NCT00886990|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110603081|NCT00886990|Protease Inhibitors|protease inhibitors|mesh-ancestor
110603082|NCT00886990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110603083|NCT00886990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110603085|NCT00886990|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110603086|NCT00886990|Antiviral Agents|antiviral agents|mesh-ancestor
110603087|NCT00886990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110603088|NCT00886990|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110603089|NCT00886990|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110603090|NCT00650091|Acetylcysteine|acetylcysteine|mesh-list
110603091|NCT00650091|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110603092|NCT00650091|Antiviral Agents|antiviral agents|mesh-ancestor
110603093|NCT00650091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110603094|NCT00650091|Expectorants|expectorants|mesh-ancestor
110603095|NCT00650091|Respiratory System Agents|respiratory system agents|mesh-ancestor
110603096|NCT00650091|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110603097|NCT00650091|Antioxidants|antioxidants|mesh-ancestor
110603098|NCT00650091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110603099|NCT00650091|Protective Agents|protective agents|mesh-ancestor
110603100|NCT00650091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110603101|NCT00650091|Antidotes|antidotes|mesh-ancestor
110603102|NCT00889018|Carboplatin|carboplatin|mesh-list
110603103|NCT00889018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110603104|NCT00889096|Propranolol|propranolol|mesh-list
110603105|NCT00889096|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110603106|NCT00889096|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110603107|NCT00889096|Adrenergic Agents|adrenergic agents|mesh-ancestor
110603108|NCT00889096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110603109|NCT00889096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110603110|NCT00889096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110603111|NCT00889096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110603112|NCT00889096|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110603113|NCT00889096|Vasodilator Agents|vasodilator agents|mesh-ancestor
110603114|NCT00818103|Interferons|interferons|mesh-list
110603115|NCT00818103|Atorvastatin|atorvastatin|mesh-list
110603116|NCT00818103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110603117|NCT00818103|Antiviral Agents|antiviral agents|mesh-ancestor
110603118|NCT00818103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110603119|NCT00818103|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110603120|NCT00818103|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110603121|NCT00818103|Antimetabolites|antimetabolites|mesh-ancestor
110603122|NCT00818103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110603123|NCT00818103|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110603124|NCT00818103|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110603125|NCT00818103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110603126|NCT00642369|Haloperidol|haloperidol|mesh-list
110603127|NCT00642369|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110603128|NCT00642369|Haloperidol decanoate|haloperidol decanoate|mesh-list
110603129|NCT00642369|Antidepressive Agents|antidepressive agents|mesh-ancestor
110603130|NCT00642369|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110603131|NCT00642369|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110603132|NCT00642369|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110603133|NCT00642369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110603134|NCT00642369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110603135|NCT00642369|Antiemetics|antiemetics|mesh-ancestor
110603136|NCT00642369|Autonomic Agents|autonomic agents|mesh-ancestor
110603137|NCT00642369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110603138|NCT00642369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110603139|NCT00642369|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110603140|NCT00642369|Dopamine Agents|dopamine agents|mesh-ancestor
110603141|NCT00642369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110603142|NCT00642369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110603143|NCT00642369|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110603144|NCT01154335|Everolimus|everolimus|mesh-list
110603145|NCT01154335|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110603146|NCT01154335|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110603147|NCT01154335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110379902|NCT02882191|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110603148|NCT01154335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110603149|NCT01154335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110603150|NCT01154335|Immunologic Factors|immunologic factors|mesh-ancestor
110603151|NCT01154335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110603152|NCT01154335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110603154|NCT00889642|Epinephrine|epinephrine|mesh-list
110603155|NCT00889642|Racepinephrine|racepinephrine|mesh-list
110603156|NCT00889642|Epinephryl borate|epinephryl borate|mesh-list
110603157|NCT00889642|Anesthetics, Local|anesthetics, local|mesh-ancestor
110603158|NCT00889642|Anesthetics|anesthetics|mesh-ancestor
110603159|NCT00889642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110603160|NCT00889642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110603161|NCT00889642|Sensory System Agents|sensory system agents|mesh-ancestor
110603162|NCT00889642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110603163|NCT00889642|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110603164|NCT00889642|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110603165|NCT00889642|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110603166|NCT00889642|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110603167|NCT00889642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110603168|NCT00889642|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110603169|NCT00889642|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110603170|NCT00889642|Adrenergic Agents|adrenergic agents|mesh-ancestor
110603171|NCT00889642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110603172|NCT00889642|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110603173|NCT00889642|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110603174|NCT00889642|Autonomic Agents|autonomic agents|mesh-ancestor
110603175|NCT00889642|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110603176|NCT00889642|Respiratory System Agents|respiratory system agents|mesh-ancestor
110603177|NCT00889642|Mydriatics|mydriatics|mesh-ancestor
110603178|NCT00889642|Sympathomimetics|sympathomimetics|mesh-ancestor
110603179|NCT00889642|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110603180|NCT02541526|Mirtazapine|mirtazapine|mesh-list
110603181|NCT02541526|Antidepressive Agents|antidepressive agents|mesh-ancestor
110603182|NCT02541526|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110603183|NCT02541526|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110603184|NCT02541526|Histamine Antagonists|histamine antagonists|mesh-ancestor
110603185|NCT02541526|Histamine Agents|histamine agents|mesh-ancestor
110603186|NCT02541526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110603187|NCT02541526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110603188|NCT02541526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110603189|NCT02541526|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110603190|NCT02541526|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110603191|NCT02541526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110379955|NCT01119859|Adalimumab|adalimumab|mesh-list
110283380|NCT00202553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110603192|NCT02541526|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
110603193|NCT02541526|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110603194|NCT02541526|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110603195|NCT02541526|Adrenergic Agents|adrenergic agents|mesh-ancestor
110603196|NCT02541526|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110603197|NCT02541526|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110603198|NCT02541526|Serotonin Agents|serotonin agents|mesh-ancestor
110603199|NCT02541526|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110603200|NCT01037959|Norfloxacin|norfloxacin|mesh-list
110603201|NCT01037959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110603202|NCT01037959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110603203|NCT01037959|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110603204|NCT01037959|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110603205|NCT01037959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110603206|NCT01037959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110603207|NCT01037959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110603208|NCT01037959|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110603209|NCT01037959|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110603211|NCT01038037|Vinorelbine|vinorelbine|mesh-list
110603212|NCT01038037|Panitumumab|panitumumab|mesh-list
110603213|NCT01038037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110603214|NCT01038037|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110603215|NCT01038037|Tubulin Modulators|tubulin modulators|mesh-ancestor
110603216|NCT01038037|Antimitotic Agents|antimitotic agents|mesh-ancestor
110603217|NCT01038037|Mitosis Modulators|mitosis modulators|mesh-ancestor
110603218|NCT01038037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110603219|NCT01038037|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110603221|NCT00645099|Paliperidone Palmitate|paliperidone palmitate|mesh-list
110603222|NCT00645099|Antiemetics|antiemetics|mesh-ancestor
110603223|NCT00645099|Autonomic Agents|autonomic agents|mesh-ancestor
110603224|NCT00645099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110603225|NCT00645099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110603226|NCT00645099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110603227|NCT00645099|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110603228|NCT00645099|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110603229|NCT00645099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110603230|NCT00645099|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110603231|NCT00645099|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110603232|NCT00645099|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110603233|NCT00645099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110603234|NCT00645099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110603235|NCT00645099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110603236|NCT00645099|Serotonin Agents|serotonin agents|mesh-ancestor
110603237|NCT00645099|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110603238|NCT00645099|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110603239|NCT00645099|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110603240|NCT00645099|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110603241|NCT00645099|Dopamine Agents|dopamine agents|mesh-ancestor
110603242|NCT04401982|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110603243|NCT04401982|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110603244|NCT01038349|Methotrexate|methotrexate|mesh-list
110603245|NCT01038349|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110603246|NCT01038349|Abortifacient Agents|abortifacient agents|mesh-ancestor
110603247|NCT01038349|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110603248|NCT01038349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110603249|NCT01038349|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110603250|NCT01038349|Antimetabolites|antimetabolites|mesh-ancestor
110603251|NCT01038349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110603252|NCT01038349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110603253|NCT01038349|Dermatologic Agents|dermatologic agents|mesh-ancestor
110603254|NCT01038349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110603255|NCT01038349|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110603256|NCT01038349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110603257|NCT01038349|Immunologic Factors|immunologic factors|mesh-ancestor
110603258|NCT01038349|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110603259|NCT01038349|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110603260|NCT00887770|Moxifloxacin|moxifloxacin|mesh-list
110603261|NCT00887770|N-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-N-ethyl-2-(4-methanesulfonylphenyl)acetamide|n-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-n-ethyl-2-(4-methanesulfonylphenyl)acetamide|mesh-list
110603262|NCT00887770|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110603263|NCT00887770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110603264|NCT00887770|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110603265|NCT00887770|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110603266|NCT00887770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110603267|NCT00887770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110603268|NCT00887770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110603269|NCT00887770|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
110603270|NCT00887770|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110603271|NCT00887770|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110603272|NCT00887770|Antiviral Agents|antiviral agents|mesh-ancestor
110603273|NCT01038505|Sirolimus|sirolimus|mesh-list
110603274|NCT01038505|Mycophenolic Acid|mycophenolic acid|mesh-list
110603275|NCT01038505|Tacrolimus|tacrolimus|mesh-list
110603276|NCT01038505|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110603277|NCT01038505|Immunologic Factors|immunologic factors|mesh-ancestor
110603278|NCT01038505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110250586|NCT00403637|Maleic acid|maleic acid|mesh-list
110603279|NCT01038505|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110603280|NCT01038505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110603281|NCT01038505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110603282|NCT01038505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110603283|NCT01038505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110603284|NCT01038505|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110603285|NCT01038505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110603286|NCT01038505|Antifungal Agents|antifungal agents|mesh-ancestor
110603287|NCT01038505|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110603288|NCT01038505|Antitubercular Agents|antitubercular agents|mesh-ancestor
110603290|NCT01038583|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110603291|NCT01038583|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110603292|NCT01038583|Analgesics|analgesics|mesh-ancestor
110603293|NCT01038583|Sensory System Agents|sensory system agents|mesh-ancestor
110603294|NCT01038583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110603295|NCT01038583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110603296|NCT01038583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110603297|NCT01038583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110603298|NCT01038583|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110603299|NCT01038583|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110603300|NCT01038583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110603301|NCT01038583|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110603302|NCT01038583|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110603303|NCT01038583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110603304|NCT01038583|Antipyretics|antipyretics|mesh-ancestor
110603305|NCT02551107|Nitric Oxide|nitric oxide|mesh-list
110603306|NCT02551107|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110603307|NCT02551107|Autonomic Agents|autonomic agents|mesh-ancestor
110603308|NCT02551107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110603309|NCT02551107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110603310|NCT02551107|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110603311|NCT02551107|Respiratory System Agents|respiratory system agents|mesh-ancestor
110603312|NCT02551107|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110603313|NCT02551107|Antioxidants|antioxidants|mesh-ancestor
110603314|NCT02551107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110603315|NCT02551107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110603316|NCT02551107|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
110603317|NCT02551107|Vasodilator Agents|vasodilator agents|mesh-ancestor
110603318|NCT02551107|Gasotransmitters|gasotransmitters|mesh-ancestor
110603319|NCT02551107|Protective Agents|protective agents|mesh-ancestor
110603320|NCT01038661|Docetaxel|docetaxel|mesh-list
110603321|NCT01038661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110603322|NCT01038661|Tubulin Modulators|tubulin modulators|mesh-ancestor
110603323|NCT01038661|Antimitotic Agents|antimitotic agents|mesh-ancestor
110603324|NCT01038661|Mitosis Modulators|mitosis modulators|mesh-ancestor
110603325|NCT01038661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110603326|NCT01038817|Sodium fluoride topical preparation|sodium fluoride topical preparation|mesh-list
110603327|NCT01038817|Cariostatic Agents|cariostatic agents|mesh-ancestor
110603328|NCT01038817|Protective Agents|protective agents|mesh-ancestor
110603329|NCT01038817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110603330|NCT00420511|Metformin|metformin|mesh-list
110603331|NCT00420511|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110603332|NCT00420511|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110603333|NCT00420511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110603334|NCT00420511|Incretins|incretins|mesh-ancestor
110603335|NCT00420511|Hormones|hormones|mesh-ancestor
110603336|NCT00420511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110603337|NCT00420511|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110603338|NCT00420511|Protease Inhibitors|protease inhibitors|mesh-ancestor
110603339|NCT00420511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110603340|NCT00420511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110603341|NCT01038895|Ramipril|ramipril|mesh-list
110603342|NCT01038895|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110603343|NCT01038895|Protease Inhibitors|protease inhibitors|mesh-ancestor
110603344|NCT01038895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110603345|NCT01038895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110603346|NCT01038895|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110603347|NCT00420199|Abatacept|abatacept|mesh-list
110603348|NCT00420199|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110603349|NCT00420199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110603350|NCT00420199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110250662|NCT00132158|Irinotecan|irinotecan|mesh-list
110603351|NCT00420199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110603352|NCT00420199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110603353|NCT00420199|Immunologic Factors|immunologic factors|mesh-ancestor
110603354|NCT00420199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110603355|NCT00420199|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110603356|NCT00649389|Amlodipine|amlodipine|mesh-list
110603357|NCT00649389|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110603358|NCT00649389|Olmesartan|olmesartan|mesh-list
110603359|NCT00649389|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
110603360|NCT00649389|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110603361|NCT00649389|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110603362|NCT00649389|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110603363|NCT00649389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110603364|NCT00649389|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110603365|NCT00649389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110603366|NCT00649389|Vasodilator Agents|vasodilator agents|mesh-ancestor
110603367|NCT00649389|Diuretics|diuretics|mesh-ancestor
110603368|NCT00649389|Natriuretic Agents|natriuretic agents|mesh-ancestor
110603369|NCT00649389|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110603370|NCT00649389|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110603371|NCT00649389|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110603372|NCT00402103|Amlodipine|amlodipine|mesh-list
110603373|NCT00402103|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110603374|NCT00402103|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110603375|NCT00402103|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110603376|NCT00402103|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110603377|NCT00402103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110603378|NCT00402103|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110603379|NCT00402103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110603380|NCT00402103|Vasodilator Agents|vasodilator agents|mesh-ancestor
110603381|NCT00402103|Diuretics|diuretics|mesh-ancestor
110603382|NCT00402103|Natriuretic Agents|natriuretic agents|mesh-ancestor
110603383|NCT00402103|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110603384|NCT00812175|Sorafenib|sorafenib|mesh-list
110603385|NCT00812175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110603386|NCT00812175|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110603387|NCT00812175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110275770|NCT00174629|Mitosis Modulators|mitosis modulators|mesh-ancestor
110603388|NCT00812175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110603389|NCT00815373|Timolol|timolol|mesh-list
110603390|NCT00815373|Dorzolamide|dorzolamide|mesh-list
110603391|NCT00815373|Latanoprost|latanoprost|mesh-list
110603392|NCT00815373|Maleic acid|maleic acid|mesh-list
110603393|NCT00815373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110603394|NCT00815373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110603395|NCT00815373|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110603396|NCT00815373|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110603397|NCT00815373|Adrenergic Agents|adrenergic agents|mesh-ancestor
110603398|NCT00815373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110603399|NCT00815373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110603400|NCT00815373|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110603401|NCT00815373|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110603402|NCT00815373|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110603403|NCT00815373|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110603404|NCT00815373|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110603405|NCT00641667|Fentanyl|fentanyl|mesh-list
110603406|NCT00641667|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110603407|NCT00641667|Narcotics|narcotics|mesh-ancestor
110603408|NCT00641667|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110603409|NCT00641667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110603410|NCT00641667|Analgesics|analgesics|mesh-ancestor
110603411|NCT00641667|Sensory System Agents|sensory system agents|mesh-ancestor
110603412|NCT00641667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110603413|NCT00641667|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110603414|NCT00641667|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110603415|NCT00641667|Anesthetics, General|anesthetics, general|mesh-ancestor
110603417|NCT00704184|Interferons|interferons|mesh-list
110603418|NCT00704184|Ribavirin|ribavirin|mesh-list
110603419|NCT00704184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110603420|NCT00704184|Antiviral Agents|antiviral agents|mesh-ancestor
110603421|NCT00704184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110603422|NCT00704184|Antimetabolites|antimetabolites|mesh-ancestor
110603423|NCT00704184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110603424|NCT00641043|Pioglitazone|pioglitazone|mesh-list
110603425|NCT00641043|Linagliptin|linagliptin|mesh-list
110603426|NCT00641043|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110603428|NCT00641043|Incretins|incretins|mesh-ancestor
110603429|NCT00641043|Hormones|hormones|mesh-ancestor
110260181|NCT02944201|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110603430|NCT00641043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110603431|NCT00641043|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110603432|NCT00641043|Protease Inhibitors|protease inhibitors|mesh-ancestor
110603433|NCT00641043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110603434|NCT00641043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110603435|NCT02567916|Propofol|propofol|mesh-list
110603436|NCT02567916|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110603437|NCT02567916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110603438|NCT02567916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110603439|NCT02567916|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110603440|NCT02567916|Anesthetics, General|anesthetics, general|mesh-ancestor
110603441|NCT02567916|Anesthetics|anesthetics|mesh-ancestor
110603442|NCT00402025|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
110603443|NCT00402025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110603444|NCT00402025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110603445|NCT00609622|Bevacizumab|bevacizumab|mesh-list
110603446|NCT00609622|Sunitinib|sunitinib|mesh-list
110603447|NCT00609622|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110603448|NCT00609622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110603449|NCT00609622|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110603450|NCT00609622|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110603451|NCT00609622|Growth Substances|growth substances|mesh-ancestor
110603452|NCT00609622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110603453|NCT00609622|Growth Inhibitors|growth inhibitors|mesh-ancestor
110603454|NCT00609622|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110603455|NCT00609622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110603456|NCT00609622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110603457|NCT00818415|Naproxen|naproxen|mesh-list
110603458|NCT00818415|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110603459|NCT00818415|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110603461|NCT00818415|Sensory System Agents|sensory system agents|mesh-ancestor
110603462|NCT00818415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110603463|NCT00818415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110380136|NCT04577027|Travoprost|travoprost|mesh-list
110603464|NCT00818415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110603465|NCT00818415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110603466|NCT00818415|Gout Suppressants|gout suppressants|mesh-ancestor
110603467|NCT00818415|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110603468|NCT00818415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110603469|NCT00818415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110603470|NCT00815841|Methylphenidate|methylphenidate|mesh-list
110603471|NCT00815841|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110603472|NCT00815841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110603473|NCT00815841|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110603474|NCT00815841|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110603475|NCT00815841|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110603476|NCT00815841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110603477|NCT00815841|Dopamine Agents|dopamine agents|mesh-ancestor
110603478|NCT00815841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110603479|NCT03897192|Bevacizumab|bevacizumab|mesh-list
110603480|NCT03897192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110603481|NCT03897192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110603482|NCT03897192|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110603483|NCT03897192|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110603484|NCT03897192|Growth Substances|growth substances|mesh-ancestor
110603485|NCT03897192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110603486|NCT03897192|Growth Inhibitors|growth inhibitors|mesh-ancestor
110603487|NCT02567214|Glycopyrrolate|glycopyrrolate|mesh-list
110603488|NCT02567214|Tiotropium Bromide|tiotropium bromide|mesh-list
110603489|NCT02567214|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110603490|NCT02567214|Autonomic Agents|autonomic agents|mesh-ancestor
110603491|NCT02567214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110603492|NCT02567214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110603493|NCT02567214|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110603494|NCT02567214|Respiratory System Agents|respiratory system agents|mesh-ancestor
110603495|NCT02567214|Parasympatholytics|parasympatholytics|mesh-ancestor
110603496|NCT02567214|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110603497|NCT02567214|Cholinergic Agents|cholinergic agents|mesh-ancestor
110603498|NCT02567214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110603499|NCT02567214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110603500|NCT02567214|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110603501|NCT02567214|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110603503|NCT00890110|Vaccines|vaccines|mesh-list
110603504|NCT00890110|Immunologic Factors|immunologic factors|mesh-ancestor
110603505|NCT00890110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110603506|NCT00890110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110603507|NCT00890110|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110603508|NCT00890110|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110603509|NCT00890110|Growth Substances|growth substances|mesh-ancestor
110603510|NCT00890110|Growth Inhibitors|growth inhibitors|mesh-ancestor
110603511|NCT00890110|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110603512|NCT00890110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110603513|NCT00890110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110603514|NCT02566824|Methylphenidate|methylphenidate|mesh-list
110603515|NCT02566824|Amphetamine|amphetamine|mesh-list
110603516|NCT02566824|Adderall|adderall|mesh-list
110603517|NCT02566824|Dextroamphetamine|dextroamphetamine|mesh-list
110380151|NCT04553393|Decitabine|decitabine|mesh-list
110603518|NCT02566824|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110603519|NCT02566824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110603520|NCT02566824|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110603521|NCT02566824|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110603522|NCT02566824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110603523|NCT02566824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110603524|NCT02566824|Dopamine Agents|dopamine agents|mesh-ancestor
110603525|NCT02566824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110603527|NCT02566824|Autonomic Agents|autonomic agents|mesh-ancestor
110603528|NCT02566824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110603529|NCT02566824|Adrenergic Agents|adrenergic agents|mesh-ancestor
110603530|NCT02566824|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110603531|NCT00890188|Thalidomide|thalidomide|mesh-list
110603532|NCT00890188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110603533|NCT00890188|Immunologic Factors|immunologic factors|mesh-ancestor
110603534|NCT00890188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110603535|NCT00890188|Leprostatic Agents|leprostatic agents|mesh-ancestor
110603536|NCT00890188|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110603537|NCT00890188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110603538|NCT00890188|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110603539|NCT00890188|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110603540|NCT00890188|Growth Substances|growth substances|mesh-ancestor
110603541|NCT00890188|Growth Inhibitors|growth inhibitors|mesh-ancestor
110603542|NCT00890188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110603543|NCT05388942|Nitrous Oxide|nitrous oxide|mesh-list
110603544|NCT05388942|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110603545|NCT05388942|Anesthetics, General|anesthetics, general|mesh-ancestor
110603546|NCT05388942|Anesthetics|anesthetics|mesh-ancestor
110603547|NCT05388942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110603548|NCT05388942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110603549|NCT05388942|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110603550|NCT05388942|Analgesics|analgesics|mesh-ancestor
110603551|NCT05388942|Sensory System Agents|sensory system agents|mesh-ancestor
110603552|NCT05388942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110603553|NCT04037566|Cyclophosphamide|cyclophosphamide|mesh-list
110603554|NCT04037566|Fludarabine|fludarabine|mesh-list
110603555|NCT04037566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110603556|NCT04037566|Immunologic Factors|immunologic factors|mesh-ancestor
110603557|NCT04037566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110603558|NCT04037566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110603559|NCT04037566|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110603560|NCT04037566|Alkylating Agents|alkylating agents|mesh-ancestor
110603561|NCT04037566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110603562|NCT04037566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110603563|NCT04037566|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110380172|NCT02219646|Urological Agents|urological agents|mesh-ancestor
110603565|NCT00888082|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110603566|NCT00888082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110603567|NCT00627705|Acetylcysteine|acetylcysteine|mesh-list
110603568|NCT00627705|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110603569|NCT00627705|Antiviral Agents|antiviral agents|mesh-ancestor
110603570|NCT00627705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110603571|NCT00627705|Expectorants|expectorants|mesh-ancestor
110603572|NCT00627705|Respiratory System Agents|respiratory system agents|mesh-ancestor
110603573|NCT00627705|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110603574|NCT00627705|Antioxidants|antioxidants|mesh-ancestor
110603575|NCT00627705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110603576|NCT00627705|Protective Agents|protective agents|mesh-ancestor
110603577|NCT00627705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110603578|NCT00627705|Antidotes|antidotes|mesh-ancestor
110603580|NCT00610168|Immunologic Factors|immunologic factors|mesh-ancestor
110603581|NCT00610168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110603582|NCT00921102|Atropine|atropine|mesh-list
110603583|NCT00921102|Morphine|morphine|mesh-list
110603584|NCT00921102|Bupivacaine|bupivacaine|mesh-list
110603585|NCT00921102|Anesthetics, Local|anesthetics, local|mesh-list
110603586|NCT00921102|Anesthetics|anesthetics|mesh-list
110603587|NCT00921102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110603588|NCT00921102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110603589|NCT00921102|Sensory System Agents|sensory system agents|mesh-ancestor
110283395|NCT00411333|Hormones|hormones|mesh-ancestor
110603590|NCT00921102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110603591|NCT00921102|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110603592|NCT00921102|Narcotics|narcotics|mesh-ancestor
110603593|NCT00921102|Analgesics|analgesics|mesh-ancestor
110603594|NCT00921102|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110603595|NCT00921102|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110603596|NCT00921102|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110603597|NCT00921102|Autonomic Agents|autonomic agents|mesh-ancestor
110603598|NCT00921102|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110603599|NCT00921102|Respiratory System Agents|respiratory system agents|mesh-ancestor
110603600|NCT00921102|Mydriatics|mydriatics|mesh-ancestor
110603601|NCT00921102|Parasympatholytics|parasympatholytics|mesh-ancestor
110603602|NCT00921102|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110603603|NCT00921102|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110603604|NCT00921102|Cholinergic Agents|cholinergic agents|mesh-ancestor
110603605|NCT00921102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110603606|NCT00921102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110603607|NCT00890500|Sirolimus|sirolimus|mesh-list
110603608|NCT00890500|Fludarabine|fludarabine|mesh-list
110603609|NCT00890500|Melphalan|melphalan|mesh-list
110603610|NCT00890500|Tacrolimus|tacrolimus|mesh-list
110603611|NCT00890500|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110603612|NCT00890500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110603613|NCT00890500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110603614|NCT00890500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110603615|NCT00890500|Immunologic Factors|immunologic factors|mesh-ancestor
110603616|NCT00890500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110603617|NCT00890500|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110603618|NCT00890500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110603619|NCT00890500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110603620|NCT00890500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110603621|NCT00890500|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110603622|NCT00890500|Antifungal Agents|antifungal agents|mesh-ancestor
110603623|NCT00890500|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110603624|NCT00890500|Alkylating Agents|alkylating agents|mesh-ancestor
110603625|NCT00890500|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110603626|NCT04061772|Prednisone|prednisone|mesh-list
110603627|NCT04061772|Cyclophosphamide|cyclophosphamide|mesh-list
110603628|NCT04061772|Etoposide|etoposide|mesh-list
110603629|NCT04061772|Bortezomib|bortezomib|mesh-list
110603630|NCT04061772|Epirubicin|epirubicin|mesh-list
110603631|NCT04061772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110603632|NCT04061772|Immunologic Factors|immunologic factors|mesh-ancestor
110603633|NCT04061772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110603634|NCT04061772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110603635|NCT04061772|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110603636|NCT04061772|Alkylating Agents|alkylating agents|mesh-ancestor
110603637|NCT04061772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110603638|NCT04061772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110603639|NCT04061772|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110603640|NCT04061772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110603641|NCT04061772|Glucocorticoids|glucocorticoids|mesh-ancestor
110603642|NCT04061772|Hormones|hormones|mesh-ancestor
110603643|NCT04061772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110603644|NCT04061772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110603645|NCT04061772|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110603646|NCT04061772|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110603647|NCT04061772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110603648|NCT04061772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110603649|NCT04061772|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110250963|NCT00141141|Atorvastatin|atorvastatin|mesh-list
110603650|NCT00644787|Fentanyl|fentanyl|mesh-list
110603651|NCT00644787|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110603652|NCT00644787|Narcotics|narcotics|mesh-ancestor
110603653|NCT00644787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110603654|NCT00644787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110603655|NCT00644787|Analgesics|analgesics|mesh-ancestor
110603656|NCT00644787|Sensory System Agents|sensory system agents|mesh-ancestor
110603657|NCT00644787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110283418|NCT00202787|Leucovorin|leucovorin|mesh-list
110603658|NCT00644787|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110603659|NCT00644787|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110603660|NCT00644787|Anesthetics, General|anesthetics, general|mesh-ancestor
110603661|NCT00644787|Anesthetics|anesthetics|mesh-ancestor
110603662|NCT00821301|Fluphenazine|fluphenazine|mesh-list
110603663|NCT00821301|Fluphenazine depot|fluphenazine depot|mesh-list
110603664|NCT00821301|Fluphenazine enanthate|fluphenazine enanthate|mesh-list
110603665|NCT00821301|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110603666|NCT00821301|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110603667|NCT00821301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110603668|NCT00821301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110603669|NCT00821301|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110603670|NCT00821301|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110603671|NCT00821301|Dopamine Agents|dopamine agents|mesh-ancestor
110603672|NCT00821301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110603673|NCT00821301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110603674|NCT00699348|Epoetin Alfa|epoetin alfa|mesh-list
110603675|NCT00699348|Hematinics|hematinics|mesh-ancestor
110603677|NCT00643851|Dapagliflozin|dapagliflozin|mesh-list
110603678|NCT00643851|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110603679|NCT00643851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110603680|NCT00643851|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110603681|NCT00643851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110603682|NCT00821457|Mitogens|mitogens|mesh-list
110603683|NCT00821457|Mitosis Modulators|mitosis modulators|mesh-ancestor
110603684|NCT00821457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110603685|NCT03667690|Fluconazole|fluconazole|mesh-list
110603686|NCT03667690|Caspofungin|caspofungin|mesh-list
110603687|NCT03667690|Rezafungin|rezafungin|mesh-list
110603688|NCT03667690|Antifungal Agents|antifungal agents|mesh-ancestor
110603689|NCT03667690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110603690|NCT03667690|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110603691|NCT03667690|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110603692|NCT03667690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110603693|NCT03667690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110603694|NCT03667690|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110603695|NCT03667690|Hormone Antagonists|hormone antagonists|mesh-ancestor
110603696|NCT03667690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110603697|NCT03667690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110603698|NCT03667690|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110603699|NCT03667690|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110603701|NCT00821535|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110603702|NCT00821535|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110603703|NCT00821535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110603704|NCT00821535|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110603705|NCT00821535|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110603706|NCT00821535|Antiviral Agents|antiviral agents|mesh-ancestor
110603707|NCT00821535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110603708|NCT00821535|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
110603709|NCT04062006|Aldesleukin|aldesleukin|mesh-list
110603710|NCT04062006|Interleukin-2|interleukin-2|mesh-list
110603711|NCT04062006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110603712|NCT04062006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110603713|NCT04062006|Analgesics|analgesics|mesh-ancestor
110603714|NCT04062006|Sensory System Agents|sensory system agents|mesh-ancestor
110603715|NCT04062006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110603716|NCT04062006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110603717|NCT04062006|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110603718|NCT04062006|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110603719|NCT04062006|Antiviral Agents|antiviral agents|mesh-ancestor
110603720|NCT04062006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110603721|NCT04872582|Bevacizumab|bevacizumab|mesh-list
110603722|NCT04872582|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
110603723|NCT04872582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110603724|NCT04872582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110603725|NCT04872582|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110603726|NCT04872582|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110603727|NCT04872582|Growth Substances|growth substances|mesh-ancestor
110603728|NCT04872582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110603729|NCT04872582|Growth Inhibitors|growth inhibitors|mesh-ancestor
110603730|NCT04872582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110603732|NCT04061538|Zinc Sulfate|zinc sulfate|mesh-list
110603733|NCT04061538|Trace Elements|trace elements|mesh-ancestor
110603734|NCT04061538|Micronutrients|micronutrients|mesh-ancestor
110603735|NCT04061538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110603736|NCT04061538|Astringents|astringents|mesh-ancestor
110603737|NCT04061538|Dermatologic Agents|dermatologic agents|mesh-ancestor
110603738|NCT04351620|Hydroxychloroquine|hydroxychloroquine|mesh-list
110603739|NCT04351620|Antimalarials|antimalarials|mesh-ancestor
110603740|NCT04351620|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110603741|NCT04351620|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110603742|NCT04351620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110603743|NCT04351620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110380296|NCT02218164|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110603744|NCT04351620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110603745|NCT04351620|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110603746|NCT00888394|Imidacloprid|imidacloprid|mesh-list
110603747|NCT00888394|Cholinergic Agents|cholinergic agents|mesh-ancestor
110603748|NCT00888394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110603749|NCT00888394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110603750|NCT00888394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110603751|NCT02541760|Mometasone Furoate|mometasone furoate|mesh-list
110603752|NCT02541760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110603753|NCT02541760|Dermatologic Agents|dermatologic agents|mesh-ancestor
110603754|NCT02541760|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110603755|NCT00627393|Anti-Infective Agents|anti-infective agents|mesh-list
110603756|NCT00627393|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110603757|NCT00627393|Dexamethasone|dexamethasone|mesh-list
110603758|NCT00627393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110603759|NCT00627393|Antiemetics|antiemetics|mesh-ancestor
110603760|NCT00627393|Autonomic Agents|autonomic agents|mesh-ancestor
110603761|NCT00627393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110603762|NCT00627393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110603763|NCT00627393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110603764|NCT00627393|Glucocorticoids|glucocorticoids|mesh-ancestor
110603765|NCT00627393|Hormones|hormones|mesh-ancestor
110603766|NCT00627393|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110603767|NCT00627393|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110603768|NCT00627393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110603769|NCT00577122|Cyclophosphamide|cyclophosphamide|mesh-list
110603770|NCT00577122|Methotrexate|methotrexate|mesh-list
110603771|NCT00577122|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
110603772|NCT00577122|Medroxyprogesterone|medroxyprogesterone|mesh-list
110603773|NCT00577122|Progesterone|progesterone|mesh-list
110603774|NCT00577122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110603775|NCT00577122|Immunologic Factors|immunologic factors|mesh-ancestor
110603776|NCT00577122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110603777|NCT00577122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110603778|NCT00577122|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110603779|NCT00577122|Alkylating Agents|alkylating agents|mesh-ancestor
110603780|NCT00577122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110603781|NCT00577122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110603782|NCT00577122|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110603783|NCT00577122|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110603784|NCT00577122|Abortifacient Agents|abortifacient agents|mesh-ancestor
110603785|NCT00577122|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110603786|NCT00577122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110603787|NCT00577122|Antimetabolites|antimetabolites|mesh-ancestor
110603788|NCT00577122|Dermatologic Agents|dermatologic agents|mesh-ancestor
110603789|NCT00577122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110603790|NCT00577122|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110603791|NCT00577122|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110603792|NCT00577122|Progestins|progestins|mesh-ancestor
110603793|NCT00577122|Hormones|hormones|mesh-ancestor
110603794|NCT00577122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110603795|NCT00577122|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110603796|NCT00577122|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110603797|NCT00577122|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110603798|NCT00577122|Contraceptive Agents|contraceptive agents|mesh-ancestor
110603799|NCT00577122|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110603800|NCT00577122|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110603801|NCT00577122|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110603802|NCT00577122|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110603803|NCT00822081|Timolol|timolol|mesh-list
110603804|NCT00822081|Brimonidine Tartrate|brimonidine tartrate|mesh-list
110603805|NCT00822081|Dorzolamide|dorzolamide|mesh-list
110603806|NCT00822081|Maleic acid|maleic acid|mesh-list
110603807|NCT00822081|Brimonidine Tartrate, Timolol Maleate Drug Combination|brimonidine tartrate, timolol maleate drug combination|mesh-list
110603808|NCT00822081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110603809|NCT00822081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110603810|NCT00822081|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110603811|NCT00822081|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110603812|NCT00822081|Adrenergic Agents|adrenergic agents|mesh-ancestor
110603813|NCT00822081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110603814|NCT00822081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110603815|NCT00822081|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110603816|NCT00822081|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110603817|NCT00822081|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110603818|NCT00822081|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110603819|NCT00822081|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110603820|NCT00822081|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110603821|NCT00696774|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110603822|NCT00696774|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110603823|NCT00696774|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110603824|NCT00696774|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110603825|NCT00696774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110603826|NCT00696774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110603827|NCT00696774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110603828|NCT00696774|Analgesics|analgesics|mesh-ancestor
110603829|NCT00696774|Sensory System Agents|sensory system agents|mesh-ancestor
110603830|NCT00696774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110603831|NCT00696774|Antidepressive Agents|antidepressive agents|mesh-ancestor
110603832|NCT00696774|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110603833|NCT00696774|Dopamine Agents|dopamine agents|mesh-ancestor
110603834|NCT00608842|Deoxycholic Acid|deoxycholic acid|mesh-list
110603835|NCT00608842|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
110603836|NCT00608842|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110603837|NCT00626925|Topiramate|topiramate|mesh-list
110603838|NCT00626925|Anticonvulsants|anticonvulsants|mesh-ancestor
110603839|NCT00626925|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110603840|NCT00626925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110603841|NCT00816543|Docetaxel|docetaxel|mesh-list
110603842|NCT00816543|Oxaliplatin|oxaliplatin|mesh-list
110603843|NCT00816543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110603844|NCT00816543|Tubulin Modulators|tubulin modulators|mesh-ancestor
110603845|NCT00816543|Antimitotic Agents|antimitotic agents|mesh-ancestor
110603846|NCT00816543|Mitosis Modulators|mitosis modulators|mesh-ancestor
110603847|NCT00816543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110603848|NCT00698646|Valsartan|valsartan|mesh-list
110603849|NCT00698646|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110603850|NCT00698646|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110603851|NCT00698646|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110603852|NCT00698646|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110603853|NCT00698646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110603854|NCT00698646|Diuretics|diuretics|mesh-ancestor
110603855|NCT00698646|Natriuretic Agents|natriuretic agents|mesh-ancestor
110603856|NCT00698646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110603857|NCT00698646|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110603858|NCT00698646|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110603859|NCT02565888|Ritonavir|ritonavir|mesh-list
110603860|NCT02565888|Atazanavir Sulfate|atazanavir sulfate|mesh-list
110603861|NCT02565888|Cobicistat|cobicistat|mesh-list
110603862|NCT02565888|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110603863|NCT02565888|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110603864|NCT02565888|Protease Inhibitors|protease inhibitors|mesh-ancestor
110603865|NCT02565888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110603866|NCT02565888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110603867|NCT02565888|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110603868|NCT02565888|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110603869|NCT02565888|Antiviral Agents|antiviral agents|mesh-ancestor
110603870|NCT02565888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110603871|NCT02565888|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110603872|NCT02565888|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110603874|NCT00609466|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110603875|NCT00609466|Narcotics|narcotics|mesh-ancestor
110603876|NCT00609466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110603877|NCT00609466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110603878|NCT00609466|Analgesics|analgesics|mesh-ancestor
110603879|NCT00609466|Sensory System Agents|sensory system agents|mesh-ancestor
110603880|NCT00609466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110603881|NCT00822315|Efavirenz|efavirenz|mesh-list
110603882|NCT00822315|Raltegravir Potassium|raltegravir potassium|mesh-list
110603883|NCT00822315|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110603884|NCT00822315|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110603885|NCT00822315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110603886|NCT00822315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110603887|NCT00822315|Antiviral Agents|antiviral agents|mesh-ancestor
110603888|NCT00822315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110603889|NCT00822315|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110603890|NCT00822315|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110603891|NCT00822315|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110603892|NCT00822315|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110603893|NCT00822315|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110603894|NCT00822315|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110603895|NCT00822315|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110603896|NCT00822315|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110603897|NCT00822315|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110603898|NCT00822315|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110603899|NCT00696696|Gemcitabine|gemcitabine|mesh-list
110603900|NCT00696696|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110603901|NCT00696696|Sorafenib|sorafenib|mesh-list
110603902|NCT00696696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110603903|NCT00696696|Antimetabolites|antimetabolites|mesh-ancestor
110603904|NCT00696696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110603905|NCT00696696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110603906|NCT00696696|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110603907|NCT00696696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110603908|NCT00822393|Busulfan|busulfan|mesh-list
110603909|NCT00822393|Treosulfan|treosulfan|mesh-list
110603910|NCT00822393|Alkylating Agents|alkylating agents|mesh-ancestor
110603911|NCT00822393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110603912|NCT00822393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110603913|NCT00822393|Immunologic Factors|immunologic factors|mesh-ancestor
110603914|NCT00822393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110603915|NCT00822393|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110603916|NCT00822393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110603917|NCT00822393|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110603918|NCT00819195|Glatiramer Acetate|glatiramer acetate|mesh-list
110603920|NCT00819195|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110603921|NCT00819195|Immunologic Factors|immunologic factors|mesh-ancestor
110603922|NCT00819195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110603923|NCT00819195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110603924|NCT00819195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110603925|NCT00892918|Moxifloxacin|moxifloxacin|mesh-list
110603926|NCT00892918|Gatifloxacin|gatifloxacin|mesh-list
110603927|NCT00892918|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110603928|NCT00892918|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110603929|NCT00892918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110603930|NCT00892918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110603931|NCT00892918|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110603932|NCT00892918|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110603933|NCT00892918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110603934|NCT00892918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110603935|NCT00892918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110603936|NCT02551185|Citarinostat|citarinostat|mesh-list
110603937|NCT02551185|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110603938|NCT02551185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110603939|NCT02551185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110603940|NCT00892996|Dexamethasone|dexamethasone|mesh-list
110603941|NCT00892996|Dexamethasone acetate|dexamethasone acetate|mesh-list
110603942|NCT00892996|BB 1101|bb 1101|mesh-list
110603943|NCT00892996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110603944|NCT00892996|Antiemetics|antiemetics|mesh-ancestor
110603945|NCT00892996|Autonomic Agents|autonomic agents|mesh-ancestor
110603946|NCT00892996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110603947|NCT00892996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110603948|NCT00892996|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110603949|NCT00892996|Glucocorticoids|glucocorticoids|mesh-ancestor
110603950|NCT00892996|Hormones|hormones|mesh-ancestor
110603951|NCT00892996|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110603952|NCT00892996|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110603953|NCT00892996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110603954|NCT00892996|Protease Inhibitors|protease inhibitors|mesh-ancestor
110603955|NCT00892996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110260182|NCT02944201|Vasodilator Agents|vasodilator agents|mesh-ancestor
110603956|NCT00892996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110603957|NCT00891670|Aspirin|aspirin|mesh-list
110603958|NCT00891670|Cilostazol|cilostazol|mesh-list
110603959|NCT00891670|Clopidogrel|clopidogrel|mesh-list
110603960|NCT00891670|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110603961|NCT00891670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110603962|NCT00891670|Analgesics|analgesics|mesh-ancestor
110603963|NCT00891670|Sensory System Agents|sensory system agents|mesh-ancestor
110603964|NCT00891670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110603965|NCT00891670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110603966|NCT00891670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110603967|NCT00891670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110603968|NCT00891670|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110603969|NCT00891670|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110603970|NCT00891670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110603971|NCT00891670|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110603972|NCT00891670|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110603973|NCT00891670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110603974|NCT00891670|Antipyretics|antipyretics|mesh-ancestor
110603975|NCT00891670|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110603976|NCT00891670|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110603977|NCT00891670|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110603978|NCT00891670|Purinergic Agents|purinergic agents|mesh-ancestor
110603979|NCT00891670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110603980|NCT00891670|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110603982|NCT00891670|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110603983|NCT00891670|Respiratory System Agents|respiratory system agents|mesh-ancestor
110603984|NCT00891670|Vasodilator Agents|vasodilator agents|mesh-ancestor
110603985|NCT00891670|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110603986|NCT00891670|Protective Agents|protective agents|mesh-ancestor
110603987|NCT00891670|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110603988|NCT00891670|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110603989|NCT00699192|Amlodipine|amlodipine|mesh-list
110603990|NCT00699192|Valsartan|valsartan|mesh-list
110603991|NCT00699192|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110603992|NCT00699192|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110603993|NCT00699192|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110380491|NCT04550351|Immunologic Factors|immunologic factors|mesh-ancestor
110603994|NCT00699192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110603995|NCT00699192|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110603996|NCT00699192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110603997|NCT00699192|Vasodilator Agents|vasodilator agents|mesh-ancestor
110603998|NCT00699192|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110603999|NCT00699192|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110604000|NCT00921180|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110604001|NCT00921180|Interferon-alpha|interferon-alpha|mesh-list
110604002|NCT00921180|Entecavir|entecavir|mesh-list
110604003|NCT00921180|Antiviral Agents|antiviral agents|mesh-ancestor
110604004|NCT00921180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110604005|NCT00921180|Immunologic Factors|immunologic factors|mesh-ancestor
110604006|NCT00921180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110604007|NCT00893542|Mycophenolic Acid|mycophenolic acid|mesh-list
110604008|NCT00893542|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110604009|NCT00893542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110604010|NCT00893542|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110604011|NCT00893542|Antitubercular Agents|antitubercular agents|mesh-ancestor
110604012|NCT00893542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110604013|NCT00893542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110604014|NCT00893542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110604015|NCT00893542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110604016|NCT00401245|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
110604017|NCT00401245|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110604018|NCT00401245|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110604019|NCT00401245|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110604020|NCT00401245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110604021|NCT00401245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110604022|NCT00401245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110604023|NCT00401245|Antidepressive Agents|antidepressive agents|mesh-ancestor
110604024|NCT00401245|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110604025|NCT04661280|Donepezil|donepezil|mesh-list
110604026|NCT04661280|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110604027|NCT04661280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110604028|NCT04661280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110604029|NCT04661280|Cholinergic Agents|cholinergic agents|mesh-ancestor
110604030|NCT04661280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110604031|NCT04661280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110604032|NCT04661280|Nootropic Agents|nootropic agents|mesh-ancestor
110604033|NCT00696384|Antihypertensive Agents|antihypertensive agents|mesh-list
110604034|NCT00696384|Chlorthalidone|chlorthalidone|mesh-list
110604035|NCT00696384|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
110604036|NCT00696384|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110604037|NCT00696384|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110604038|NCT00696384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110604039|NCT00696384|Diuretics|diuretics|mesh-ancestor
110604040|NCT00696384|Natriuretic Agents|natriuretic agents|mesh-ancestor
110604041|NCT00696384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110604042|NCT00696384|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110604043|NCT00696384|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110604044|NCT01041625|Apremilast|apremilast|mesh-list
110604045|NCT01041625|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110604046|NCT01041625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110604047|NCT01041625|Analgesics|analgesics|mesh-ancestor
110604048|NCT01041625|Sensory System Agents|sensory system agents|mesh-ancestor
110604049|NCT01041625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110604050|NCT01041625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110604051|NCT01041625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110604052|NCT01041625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110604053|NCT01041625|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
110604054|NCT01041625|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110604055|NCT01041625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110604056|NCT01041625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110604057|NCT02566356|Oxytocin|oxytocin|mesh-list
110604058|NCT02566356|Oxytocics|oxytocics|mesh-ancestor
110604059|NCT02566356|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110604060|NCT02566356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110604061|NCT00892450|Oxybutynin|oxybutynin|mesh-list
110604062|NCT00892450|Darifenacin|darifenacin|mesh-list
110604063|NCT00892450|Parasympatholytics|parasympatholytics|mesh-ancestor
110604064|NCT00892450|Autonomic Agents|autonomic agents|mesh-ancestor
110604065|NCT00892450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110604066|NCT00892450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110604067|NCT00892450|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110604068|NCT00892450|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110604069|NCT00892450|Cholinergic Agents|cholinergic agents|mesh-ancestor
110604070|NCT00892450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110604071|NCT00892450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110604072|NCT00892450|Urological Agents|urological agents|mesh-ancestor
110604073|NCT01566565|Theophylline|theophylline|mesh-list
110604074|NCT01566565|Bambuterol|bambuterol|mesh-list
110604076|NCT01566565|Autonomic Agents|autonomic agents|mesh-ancestor
110604077|NCT01566565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110604078|NCT01566565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110604079|NCT01566565|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110604080|NCT01566565|Respiratory System Agents|respiratory system agents|mesh-ancestor
110604081|NCT01566565|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110604082|NCT01566565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110604083|NCT01566565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110604084|NCT01566565|Vasodilator Agents|vasodilator agents|mesh-ancestor
110604085|NCT01566565|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110604086|NCT01566565|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110604087|NCT01566565|Purinergic Agents|purinergic agents|mesh-ancestor
110604088|NCT01566565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110604089|NCT01039363|Cytarabine|cytarabine|mesh-list
110604090|NCT01039363|Vorinostat|vorinostat|mesh-list
110604091|NCT01039363|Idarubicin|idarubicin|mesh-list
110604092|NCT01039363|Gemtuzumab|gemtuzumab|mesh-list
110604093|NCT01039363|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110604094|NCT01039363|Antimetabolites|antimetabolites|mesh-ancestor
110604095|NCT01039363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110604096|NCT01039363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110604097|NCT01039363|Antiviral Agents|antiviral agents|mesh-ancestor
110604098|NCT01039363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110604099|NCT01039363|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110380617|NCT01182181|Anastrozole|anastrozole|mesh-list
110604100|NCT01039363|Immunologic Factors|immunologic factors|mesh-ancestor
110604101|NCT01039363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110604102|NCT01039363|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110604103|NCT01039363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110604104|NCT01039363|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110604105|NCT01039363|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110604106|NCT01039363|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110604107|NCT01039363|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110604108|NCT01039363|Immunotoxins|immunotoxins|mesh-ancestor
110604109|NCT01039363|Immunoconjugates|immunoconjugates|mesh-ancestor
110604110|NCT01039441|Bupivacaine|bupivacaine|mesh-list
110604111|NCT01039441|Anesthetics, Local|anesthetics, local|mesh-ancestor
110604112|NCT01039441|Anesthetics|anesthetics|mesh-ancestor
110604113|NCT01039441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110604114|NCT01039441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110604115|NCT01039441|Sensory System Agents|sensory system agents|mesh-ancestor
110604116|NCT01039441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110604117|NCT01034917|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
110604118|NCT01034917|Etravirine|etravirine|mesh-list
110604119|NCT01034917|Antiviral Agents|antiviral agents|mesh-ancestor
110604120|NCT01034917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110604121|NCT01034917|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110604122|NCT01034917|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110604123|NCT01034917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110604124|NCT01034917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110604125|NCT00816699|Anesthetics|anesthetics|mesh-list
110604126|NCT00816699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110380645|NCT01181167|Enoxaparin|enoxaparin|mesh-list
110604127|NCT00816699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110604128|NCT00822549|Morphine|morphine|mesh-list
110604129|NCT00822549|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110604130|NCT00822549|Narcotics|narcotics|mesh-ancestor
110604131|NCT00822549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110604132|NCT00822549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110604133|NCT00822549|Analgesics|analgesics|mesh-ancestor
110604134|NCT00822549|Sensory System Agents|sensory system agents|mesh-ancestor
110604135|NCT00822549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110604136|NCT00819351|Asparaginase|asparaginase|mesh-list
110604137|NCT00819351|Pegaspargase|pegaspargase|mesh-list
110604138|NCT00819351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110604139|NCT00699998|Aspirin|aspirin|mesh-list
110604140|NCT00699998|Clopidogrel|clopidogrel|mesh-list
110604141|NCT00699998|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
110604142|NCT00699998|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110604143|NCT00699998|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110604144|NCT00699998|Analgesics|analgesics|mesh-ancestor
110604145|NCT00699998|Sensory System Agents|sensory system agents|mesh-ancestor
110275813|NCT00174707|Antimitotic Agents|antimitotic agents|mesh-ancestor
110604146|NCT00699998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110604147|NCT00699998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110604148|NCT00699998|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110604149|NCT00699998|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110604150|NCT00699998|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110604151|NCT00699998|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110604152|NCT00699998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110604153|NCT00699998|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110604154|NCT00699998|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110604155|NCT00699998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110604156|NCT00699998|Antipyretics|antipyretics|mesh-ancestor
110604157|NCT00699998|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110604158|NCT00699998|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110604159|NCT00699998|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110604160|NCT00699998|Purinergic Agents|purinergic agents|mesh-ancestor
110604161|NCT00699998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110604162|NCT00696072|Letrozole|letrozole|mesh-list
110604163|NCT00696072|Dasatinib|dasatinib|mesh-list
110604164|NCT00696072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110604165|NCT00696072|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110604166|NCT00696072|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110604167|NCT00696072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110604168|NCT00696072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110604169|NCT00696072|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110604170|NCT00696072|Hormone Antagonists|hormone antagonists|mesh-ancestor
110604171|NCT00696072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110251486|NCT00135317|Darbepoetin alfa|darbepoetin alfa|mesh-list
110604173|NCT00696072|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110604174|NCT00816855|Docetaxel|docetaxel|mesh-list
110604175|NCT00816855|Fluorouracil|fluorouracil|mesh-list
110604176|NCT00816855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110604177|NCT00816855|Tubulin Modulators|tubulin modulators|mesh-ancestor
110604178|NCT00816855|Antimitotic Agents|antimitotic agents|mesh-ancestor
110604179|NCT00816855|Mitosis Modulators|mitosis modulators|mesh-ancestor
110604180|NCT00816855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110604181|NCT00816855|Antimetabolites|antimetabolites|mesh-ancestor
110604182|NCT00816855|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110604183|NCT00816855|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110604184|NCT00816855|Immunologic Factors|immunologic factors|mesh-ancestor
110604185|NCT00816855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110604187|NCT00822783|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110604188|NCT00822783|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110604189|NCT00822783|Respiratory System Agents|respiratory system agents|mesh-ancestor
110604190|NCT00634647|Prednisone|prednisone|mesh-list
110604191|NCT00634647|Satraplatin|satraplatin|mesh-list
110604192|NCT00634647|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110604193|NCT00634647|Glucocorticoids|glucocorticoids|mesh-ancestor
110604194|NCT00634647|Hormones|hormones|mesh-ancestor
110604195|NCT00634647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110604196|NCT00634647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110604197|NCT00634647|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110604198|NCT00634647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110604199|NCT00576732|Risperidone|risperidone|mesh-list
110604200|NCT00576732|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110604201|NCT00576732|Serotonin Agents|serotonin agents|mesh-ancestor
110604202|NCT00576732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110604203|NCT00576732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110604204|NCT00576732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110604205|NCT00576732|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110604206|NCT00576732|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110604207|NCT00576732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110604208|NCT00576732|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110604209|NCT00576732|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110604210|NCT00576732|Dopamine Agents|dopamine agents|mesh-ancestor
110604211|NCT00817011|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110604212|NCT00817011|Mirtazapine|mirtazapine|mesh-list
110604213|NCT00817011|Trazodone|trazodone|mesh-list
110604214|NCT00817011|Bupropion|bupropion|mesh-list
110604215|NCT00817011|Fluoxetine|fluoxetine|mesh-list
110604216|NCT00817011|Paroxetine|paroxetine|mesh-list
110604217|NCT00817011|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
110604218|NCT00817011|Citalopram|citalopram|mesh-list
110604219|NCT00817011|Sertraline|sertraline|mesh-list
110604220|NCT00817011|Nortriptyline|nortriptyline|mesh-list
110604221|NCT00817011|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110604222|NCT00817011|Antidepressive Agents|antidepressive agents|mesh-ancestor
110604223|NCT00817011|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110604224|NCT00817011|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110604225|NCT00817011|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110604226|NCT00817011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110604227|NCT00817011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110604228|NCT00817011|Dopamine Agents|dopamine agents|mesh-ancestor
110604229|NCT00817011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110604230|NCT00817011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110604231|NCT00817011|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110604232|NCT00817011|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110604233|NCT00817011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110604234|NCT00817011|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110604235|NCT00817011|Analgesics|analgesics|mesh-ancestor
110604236|NCT00817011|Sensory System Agents|sensory system agents|mesh-ancestor
110604237|NCT00817011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110380760|NCT01181011|Vasodilator Agents|vasodilator agents|mesh-ancestor
110604238|NCT00817011|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110604239|NCT00817011|Serotonin Agents|serotonin agents|mesh-ancestor
110604240|NCT00817011|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110604241|NCT00817011|Histamine Antagonists|histamine antagonists|mesh-ancestor
110604242|NCT00817011|Histamine Agents|histamine agents|mesh-ancestor
110604243|NCT00817011|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110604244|NCT00817011|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110604245|NCT00817011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110251560|NCT00152724|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110604246|NCT00817011|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
110604247|NCT00817011|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110604248|NCT00817011|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110604249|NCT00817011|Adrenergic Agents|adrenergic agents|mesh-ancestor
110604250|NCT00817011|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110604251|NCT00817011|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110604252|NCT00817011|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110604253|NCT00817011|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110604254|NCT00817011|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110604255|NCT00697788|Dexmedetomidine|dexmedetomidine|mesh-list
110604256|NCT00697788|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110604257|NCT00697788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110152130|NCT00000375|Nortriptyline|nortriptyline|mesh-list
110604258|NCT00697788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110604259|NCT00697788|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110604261|NCT00697788|Sensory System Agents|sensory system agents|mesh-ancestor
110604262|NCT00697788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110604263|NCT00697788|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110604264|NCT00697788|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110604265|NCT00697788|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110604266|NCT00697788|Adrenergic Agents|adrenergic agents|mesh-ancestor
110604267|NCT00697788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110604268|NCT00697788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110604269|NCT00400153|Ipratropium|ipratropium|mesh-list
110604270|NCT00400153|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110604271|NCT00400153|Autonomic Agents|autonomic agents|mesh-ancestor
110604272|NCT00400153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110604273|NCT00400153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110604274|NCT00400153|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110604276|NCT00400153|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110604277|NCT00400153|Cholinergic Agents|cholinergic agents|mesh-ancestor
110604278|NCT00400153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110604279|NCT00400153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110604280|NCT04062890|Vigabatrin|vigabatrin|mesh-list
110604281|NCT04062890|Anticonvulsants|anticonvulsants|mesh-ancestor
110604282|NCT04062890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110604283|NCT04062890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110604284|NCT04062890|GABA Agents|gaba agents|mesh-ancestor
110604285|NCT04062890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110604286|NCT04062890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110604287|NCT00817245|Amoxicillin|amoxicillin|mesh-list
110604288|NCT00817245|Metronidazole|metronidazole|mesh-list
110604289|NCT00817245|Omeprazole|omeprazole|mesh-list
110604290|NCT00817245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110604291|NCT00817245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110604292|NCT00817245|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110604293|NCT00817245|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110604294|NCT00817245|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110604295|NCT00817245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110604296|NCT00817245|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110604297|NCT00817245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110604298|NCT00817245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110604300|NCT02550483|Lycopene|lycopene|mesh-list
110604301|NCT02550483|Carotenoids|carotenoids|mesh-list
110604302|NCT02550483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110604303|NCT02550483|Antioxidants|antioxidants|mesh-ancestor
110604304|NCT02550483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110604305|NCT02550483|Protective Agents|protective agents|mesh-ancestor
110604306|NCT02550483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110604307|NCT02550483|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110604308|NCT02550483|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110604309|NCT02550483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110604310|NCT02550483|Provitamins|provitamins|mesh-ancestor
110604311|NCT02550483|Vitamins|vitamins|mesh-ancestor
110604312|NCT02550483|Micronutrients|micronutrients|mesh-ancestor
110604313|NCT04608318|Venetoclax|venetoclax|mesh-list
110604314|NCT04608318|Obinutuzumab|obinutuzumab|mesh-list
110604315|NCT04608318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110604316|NCT04608318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110604317|NCT04063358|Ranibizumab|ranibizumab|mesh-list
110604318|NCT04063358|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110604319|NCT04063358|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110604320|NCT04063358|Growth Substances|growth substances|mesh-ancestor
110604321|NCT04063358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110604322|NCT04063358|Growth Inhibitors|growth inhibitors|mesh-ancestor
110604323|NCT04063358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110604325|NCT00631917|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110604326|NCT00631917|Protease Inhibitors|protease inhibitors|mesh-ancestor
110604327|NCT00631917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110604328|NCT00631917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110604330|NCT00419341|Immunoglobulins|immunoglobulins|mesh-list
110604331|NCT00419341|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110604332|NCT00419341|Antibodies|antibodies|mesh-list
110604333|NCT00419341|Immunologic Factors|immunologic factors|mesh-ancestor
110604334|NCT00419341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110604335|NCT00694122|Insulin Glargine|insulin glargine|mesh-list
110604336|NCT00694122|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110604337|NCT00694122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110604338|NCT03922620|Bupivacaine|bupivacaine|mesh-list
110604339|NCT03922620|Anesthetics, Local|anesthetics, local|mesh-ancestor
110604340|NCT03922620|Anesthetics|anesthetics|mesh-ancestor
110604341|NCT03922620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110604342|NCT03922620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110604343|NCT03922620|Sensory System Agents|sensory system agents|mesh-ancestor
110604344|NCT03922620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110604345|NCT00419263|Peramivir|peramivir|mesh-list
110604346|NCT00419263|Antiviral Agents|antiviral agents|mesh-ancestor
110604347|NCT00419263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110604348|NCT00419263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110283449|NCT00196352|Levonorgestrel|levonorgestrel|mesh-list
110604349|NCT00419263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110604350|NCT01034995|Escitalopram|escitalopram|mesh-list
110604351|NCT01034995|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110604352|NCT01034995|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110604353|NCT01034995|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110604354|NCT01034995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110604355|NCT01034995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110604356|NCT01034995|Serotonin Agents|serotonin agents|mesh-ancestor
110604357|NCT01034995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110604358|NCT00921414|Rituximab|rituximab|mesh-list
110604359|NCT00921414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110604360|NCT00921414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110604361|NCT00921414|Immunologic Factors|immunologic factors|mesh-ancestor
110604362|NCT00921414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110604363|NCT00921414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110604364|NCT04060914|Clopidogrel|clopidogrel|mesh-list
110604365|NCT04060914|Ticagrelor|ticagrelor|mesh-list
110604366|NCT04060914|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110604367|NCT04060914|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110604368|NCT04060914|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110604369|NCT04060914|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110604370|NCT04060914|Purinergic Agents|purinergic agents|mesh-ancestor
110604371|NCT04060914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110604372|NCT04060914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110604373|NCT04060914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110604374|NCT03894696|Antiviral Agents|antiviral agents|mesh-list
110604375|NCT03894696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110604376|NCT00399763|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
110604377|NCT00399763|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110604378|NCT00399763|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110604379|NCT00399763|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110604380|NCT00399763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110604381|NCT00399763|Adrenergic Agents|adrenergic agents|mesh-ancestor
110604382|NCT00399763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110604383|NCT00399763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110604384|NCT05324904|Vitamin D|vitamin d|mesh-list
110604385|NCT05324904|Acyclovir|acyclovir|mesh-list
110604386|NCT05324904|Vitamins|vitamins|mesh-ancestor
110604387|NCT05324904|Micronutrients|micronutrients|mesh-ancestor
110604388|NCT05324904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110604389|NCT05324904|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110604390|NCT05324904|Antiviral Agents|antiviral agents|mesh-ancestor
110604391|NCT05324904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110604392|NCT02085265|Telmisartan|telmisartan|mesh-list
110604393|NCT02085265|Perindopril|perindopril|mesh-list
110251711|NCT00152958|Pramipexole|pramipexole|mesh-list
110604394|NCT02085265|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110604395|NCT02085265|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110604396|NCT02085265|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110604397|NCT02085265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110604398|NCT02085265|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110604400|NCT02085265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110604401|NCT00699842|Lenalidomide|lenalidomide|mesh-list
110604402|NCT00699842|Immunologic Factors|immunologic factors|mesh-ancestor
110604403|NCT00699842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110604404|NCT00699842|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110604405|NCT00699842|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110604406|NCT00699842|Growth Substances|growth substances|mesh-ancestor
110381021|NCT01646775|Narcotics|narcotics|mesh-ancestor
110604407|NCT00699842|Growth Inhibitors|growth inhibitors|mesh-ancestor
110604408|NCT00699842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110604409|NCT00399529|Cyclophosphamide|cyclophosphamide|mesh-list
110604410|NCT00399529|Trastuzumab|trastuzumab|mesh-list
110604411|NCT00399529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110604412|NCT00399529|Immunologic Factors|immunologic factors|mesh-ancestor
110604413|NCT00399529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110604414|NCT00399529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110604415|NCT00399529|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110604416|NCT00399529|Alkylating Agents|alkylating agents|mesh-ancestor
110604417|NCT00399529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110604418|NCT00399529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110604419|NCT00399529|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110604420|NCT00399529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110604421|NCT00712712|Acetaminophen|acetaminophen|mesh-list
110604422|NCT00712712|Morphine|morphine|mesh-list
110604423|NCT00712712|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110604424|NCT00712712|Narcotics|narcotics|mesh-ancestor
110604425|NCT00712712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110604426|NCT00712712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110604427|NCT00712712|Analgesics|analgesics|mesh-ancestor
110604428|NCT00712712|Sensory System Agents|sensory system agents|mesh-ancestor
110604429|NCT00712712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110604430|NCT00712712|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110604431|NCT00712712|Antipyretics|antipyretics|mesh-ancestor
110604432|NCT00411151|Sunitinib|sunitinib|mesh-list
110604433|NCT00411151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110604434|NCT00411151|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110604435|NCT00411151|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110604436|NCT00411151|Growth Substances|growth substances|mesh-ancestor
110604437|NCT00411151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110604438|NCT00411151|Growth Inhibitors|growth inhibitors|mesh-ancestor
110604439|NCT00411151|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110604440|NCT00411151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110604441|NCT00411151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110604442|NCT00607048|Paclitaxel|paclitaxel|mesh-list
110604443|NCT00607048|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110604444|NCT00607048|Carboplatin|carboplatin|mesh-list
110604445|NCT00607048|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110381081|NCT04541147|Hormones|hormones|mesh-ancestor
110604446|NCT00607048|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110604447|NCT00607048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110604448|NCT00607048|Tubulin Modulators|tubulin modulators|mesh-ancestor
110604449|NCT00607048|Antimitotic Agents|antimitotic agents|mesh-ancestor
110604450|NCT00607048|Mitosis Modulators|mitosis modulators|mesh-ancestor
110604451|NCT00607048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110604452|NCT00607048|Immunologic Factors|immunologic factors|mesh-ancestor
110604453|NCT00607048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110604454|NCT03592576|Venetoclax|venetoclax|mesh-list
110604455|NCT03592576|Navitoclax|navitoclax|mesh-list
110604456|NCT03592576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110604457|NCT04035850|Vortioxetine|vortioxetine|mesh-list
110604458|NCT04035850|Antidepressive Agents|antidepressive agents|mesh-ancestor
110604459|NCT04035850|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110604460|NCT04035850|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110604461|NCT04035850|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110604462|NCT04035850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110604463|NCT04035850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110604464|NCT04035850|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110604465|NCT04035850|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110604466|NCT04035850|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110604467|NCT04035850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110604468|NCT04035850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110604469|NCT04035850|Serotonin Agents|serotonin agents|mesh-ancestor
110604470|NCT04035850|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110604471|NCT04035850|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110604472|NCT04035850|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110604473|NCT04035850|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110604474|NCT00699608|Zopiclone|zopiclone|mesh-list
110604475|NCT00699608|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110604476|NCT00699608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110604477|NCT00699608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110604478|NCT00895570|Modafinil|modafinil|mesh-list
110604479|NCT00895570|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110604480|NCT00895570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110275824|NCT01235923|Epoetin Alfa|epoetin alfa|mesh-list
110604481|NCT00895570|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
110604482|NCT00895570|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110604483|NCT00895570|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110604484|NCT00895570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110604485|NCT00895648|Pemetrexed|pemetrexed|mesh-list
110604486|NCT00895648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110604487|NCT00895648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110604488|NCT00895648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110604489|NCT00895648|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110604490|NCT00895648|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110604491|NCT00893854|Triamcinolone|triamcinolone|mesh-list
110604492|NCT00893854|Diclofenac|diclofenac|mesh-list
110604493|NCT00893854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110604494|NCT00893854|Glucocorticoids|glucocorticoids|mesh-ancestor
110604495|NCT00893854|Hormones|hormones|mesh-ancestor
110604496|NCT00893854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110604497|NCT00893854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110604498|NCT00893854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110604499|NCT00893854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110604500|NCT00893854|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110604501|NCT00893854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110604502|NCT00893854|Analgesics|analgesics|mesh-ancestor
110604503|NCT00893854|Sensory System Agents|sensory system agents|mesh-ancestor
110604504|NCT00893854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110604505|NCT00893854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110604506|NCT00893854|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110604507|NCT00895804|Pindolol|pindolol|mesh-list
110604508|NCT00895804|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110604509|NCT00895804|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110604510|NCT00895804|Adrenergic Agents|adrenergic agents|mesh-ancestor
110604511|NCT00895804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110604512|NCT00895804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110604513|NCT00895804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110604514|NCT00895804|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110604515|NCT00895804|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110604516|NCT00895804|Serotonin Agents|serotonin agents|mesh-ancestor
110604517|NCT00895804|Vasodilator Agents|vasodilator agents|mesh-ancestor
110604518|NCT00895882|Interferons|interferons|mesh-list
110604519|NCT00895882|Ribavirin|ribavirin|mesh-list
110604520|NCT00895882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110604521|NCT00895882|Antiviral Agents|antiviral agents|mesh-ancestor
110604522|NCT00895882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110604523|NCT00895882|Antimetabolites|antimetabolites|mesh-ancestor
110381160|NCT04543370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110604524|NCT00895882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110604525|NCT00706706|Sunitinib|sunitinib|mesh-list
110604526|NCT00706706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110604527|NCT00706706|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110604528|NCT00706706|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110604529|NCT00706706|Growth Substances|growth substances|mesh-ancestor
110604530|NCT00706706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110604531|NCT00706706|Growth Inhibitors|growth inhibitors|mesh-ancestor
110604532|NCT00706706|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110604533|NCT00706706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110604534|NCT00706706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110604535|NCT00894010|Carbamazepine|carbamazepine|mesh-list
110604536|NCT00894010|Levetiracetam|levetiracetam|mesh-list
110604537|NCT00894010|Anticonvulsants|anticonvulsants|mesh-ancestor
110604538|NCT00894010|Nootropic Agents|nootropic agents|mesh-ancestor
110604539|NCT00894010|Antimanic Agents|antimanic agents|mesh-ancestor
110604540|NCT00894010|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110604541|NCT00894010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110604542|NCT00894010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110604543|NCT00894010|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110604544|NCT00894010|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110604545|NCT00894010|Analgesics|analgesics|mesh-ancestor
110604546|NCT00894010|Sensory System Agents|sensory system agents|mesh-ancestor
110604547|NCT00894010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110604548|NCT00894010|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110604549|NCT00894010|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110604550|NCT00894010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110604551|NCT00894010|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110604552|NCT00894010|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110604553|NCT00895960|Temozolomide|temozolomide|mesh-list
110604554|NCT00895960|Dasatinib|dasatinib|mesh-list
110604555|NCT00895960|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110604556|NCT00895960|Alkylating Agents|alkylating agents|mesh-ancestor
110604557|NCT00895960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110604558|NCT00895960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110604559|NCT00895960|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110604560|NCT00895960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110604561|NCT00894088|Mycophenolic Acid|mycophenolic acid|mesh-list
110604562|NCT00894088|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110604563|NCT00894088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110604564|NCT00894088|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110604565|NCT00894088|Antitubercular Agents|antitubercular agents|mesh-ancestor
110604566|NCT00894088|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110604567|NCT00894088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110604568|NCT00894088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110604569|NCT00894088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110604570|NCT03818178|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
110604571|NCT03818178|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
110604572|NCT03818178|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
110604573|NCT03818178|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110604574|NCT00921128|Muscimol|muscimol|mesh-list
110604575|NCT00921128|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
110604576|NCT00921128|GABA Agonists|gaba agonists|mesh-ancestor
110604577|NCT00921128|GABA Agents|gaba agents|mesh-ancestor
110604578|NCT00921128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110604579|NCT00921128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110604580|NCT00921128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110604581|NCT05508776|Moxifloxacin|moxifloxacin|mesh-list
110604582|NCT05508776|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110604583|NCT05508776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110604584|NCT05508776|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110604585|NCT05508776|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110604586|NCT05508776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110604587|NCT05508776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110604588|NCT05508776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110604589|NCT00896428|Gallopamil|gallopamil|mesh-list
110604590|NCT00896428|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110604591|NCT00896428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110604592|NCT00896428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110604593|NCT00896428|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110604594|NCT00896428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110604595|NCT02962050|Capsaicin|capsaicin|mesh-list
110604596|NCT02962050|Antipruritics|antipruritics|mesh-ancestor
110604597|NCT02962050|Dermatologic Agents|dermatologic agents|mesh-ancestor
110604598|NCT02962050|Sensory System Agents|sensory system agents|mesh-ancestor
110604599|NCT02962050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110604600|NCT02962050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110604601|NCT04486716|Ofatumumab|ofatumumab|mesh-list
110604602|NCT04486716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110604603|NCT00410605|Dexamethasone|dexamethasone|mesh-list
110604604|NCT00410605|Bevacizumab|bevacizumab|mesh-list
110604605|NCT00410605|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110604606|NCT00410605|Lenalidomide|lenalidomide|mesh-list
110604607|NCT00410605|Antibodies|antibodies|mesh-list
110604608|NCT00410605|Immunoglobulins|immunoglobulins|mesh-list
110604609|NCT00410605|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110604610|NCT00410605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110604611|NCT00410605|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110604612|NCT00410605|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110604613|NCT00410605|Growth Substances|growth substances|mesh-ancestor
110604614|NCT00410605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110251939|NCT00136994|Ziprasidone|ziprasidone|mesh-list
110604615|NCT00410605|Growth Inhibitors|growth inhibitors|mesh-ancestor
110604616|NCT00410605|Immunologic Factors|immunologic factors|mesh-ancestor
110604617|NCT00410605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110604618|NCT00410605|Antiemetics|antiemetics|mesh-ancestor
110604619|NCT00410605|Autonomic Agents|autonomic agents|mesh-ancestor
110604620|NCT00410605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110604621|NCT00410605|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110604622|NCT00410605|Glucocorticoids|glucocorticoids|mesh-ancestor
110604623|NCT00410605|Hormones|hormones|mesh-ancestor
110604624|NCT00410605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110604625|NCT00410605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110604626|NCT00742638|Valproic Acid|valproic acid|mesh-list
110604627|NCT00742638|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110604628|NCT00742638|Antidepressive Agents|antidepressive agents|mesh-ancestor
110604629|NCT00742638|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110604630|NCT00742638|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110604631|NCT00742638|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110604632|NCT00742638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110604633|NCT00742638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110604634|NCT00742638|Anticonvulsants|anticonvulsants|mesh-ancestor
110604635|NCT00742638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110604636|NCT00742638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110604637|NCT00742638|GABA Agents|gaba agents|mesh-ancestor
110604638|NCT00742638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110604639|NCT00742638|Antimanic Agents|antimanic agents|mesh-ancestor
110604640|NCT00418717|Etanercept|etanercept|mesh-list
110604641|NCT00418717|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110604642|NCT00418717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110604643|NCT00418717|Analgesics|analgesics|mesh-ancestor
110604644|NCT00418717|Sensory System Agents|sensory system agents|mesh-ancestor
110604645|NCT00418717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110604646|NCT00418717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110604647|NCT00418717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110604648|NCT00418717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110604649|NCT00418717|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110604650|NCT00418717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110604651|NCT00418717|Immunologic Factors|immunologic factors|mesh-ancestor
110604652|NCT00572572|Aprepitant|aprepitant|mesh-list
110604653|NCT00572572|Antiemetics|antiemetics|mesh-ancestor
110604654|NCT00572572|Autonomic Agents|autonomic agents|mesh-ancestor
110604655|NCT00572572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110604656|NCT00572572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110604657|NCT00572572|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110604658|NCT00572572|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110604659|NCT00572572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110604660|NCT00572572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110604661|NCT00897130|Azacitidine|azacitidine|mesh-list
110604662|NCT00897130|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110604663|NCT00897130|Antimetabolites|antimetabolites|mesh-ancestor
110604664|NCT00897130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110604665|NCT00897130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110604666|NCT00897130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110604667|NCT00398047|Mitogens|mitogens|mesh-list
110604668|NCT00398047|Mitosis Modulators|mitosis modulators|mesh-ancestor
110604669|NCT00398047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110604670|NCT00631371|Interferons|interferons|mesh-list
110604671|NCT00631371|Interferon-alpha|interferon-alpha|mesh-list
110604672|NCT00631371|Sirolimus|sirolimus|mesh-list
110604673|NCT00631371|Bevacizumab|bevacizumab|mesh-list
110604674|NCT00631371|Temsirolimus|temsirolimus|mesh-list
110604675|NCT00631371|MTOR Inhibitors|mtor inhibitors|mesh-list
110604676|NCT00631371|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110604677|NCT00631371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110604678|NCT00631371|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110604679|NCT00631371|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110604680|NCT00631371|Growth Substances|growth substances|mesh-ancestor
110604681|NCT00631371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110604682|NCT00631371|Growth Inhibitors|growth inhibitors|mesh-ancestor
110604683|NCT00631371|Antiviral Agents|antiviral agents|mesh-ancestor
110604684|NCT00631371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110604685|NCT00631371|Immunologic Factors|immunologic factors|mesh-ancestor
110604686|NCT00631371|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110604687|NCT00631371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110604688|NCT00631371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110604689|NCT00631371|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110604690|NCT00631371|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110604691|NCT00631371|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110604692|NCT00631371|Antifungal Agents|antifungal agents|mesh-ancestor
110604693|NCT00409747|Minocycline|minocycline|mesh-list
110604694|NCT00409747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110604695|NCT00409747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110604696|NCT04016740|Dexmedetomidine|dexmedetomidine|mesh-list
110604698|NCT04016740|Remifentanil|remifentanil|mesh-list
110604699|NCT04016740|Propofol|propofol|mesh-list
110604700|NCT04016740|Ropivacaine|ropivacaine|mesh-list
110604701|NCT04016740|Sevoflurane|sevoflurane|mesh-list
110604702|NCT04016740|Rocuronium|rocuronium|mesh-list
110604703|NCT04016740|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110604704|NCT04016740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110604705|NCT04016740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110604706|NCT04016740|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110604707|NCT04016740|Analgesics|analgesics|mesh-ancestor
110604708|NCT04016740|Sensory System Agents|sensory system agents|mesh-ancestor
110604709|NCT04016740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110604710|NCT04016740|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110604711|NCT04016740|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110604712|NCT04016740|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110604713|NCT04016740|Adrenergic Agents|adrenergic agents|mesh-ancestor
110604714|NCT04016740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110604715|NCT04016740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110604716|NCT04016740|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110604717|NCT04016740|Anesthetics, General|anesthetics, general|mesh-ancestor
110604718|NCT04016740|Anesthetics|anesthetics|mesh-ancestor
110604719|NCT04016740|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110604720|NCT04016740|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110604721|NCT04016740|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110604722|NCT04016740|Anesthetics, Local|anesthetics, local|mesh-ancestor
110604723|NCT04016740|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110604724|NCT04016740|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110604725|NCT04016740|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110604727|NCT04016740|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110604728|NCT04016740|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110604729|NCT04016740|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110604730|NCT02540512|Acetaminophen|acetaminophen|mesh-list
110604731|NCT02540512|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
110604732|NCT02540512|Hydrocodone|hydrocodone|mesh-list
110604733|NCT02540512|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110604734|NCT02540512|Analgesics|analgesics|mesh-ancestor
110604735|NCT02540512|Sensory System Agents|sensory system agents|mesh-ancestor
110604736|NCT02540512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110604737|NCT02540512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110604738|NCT02540512|Antipyretics|antipyretics|mesh-ancestor
110604739|NCT02540512|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110604740|NCT02540512|Narcotics|narcotics|mesh-ancestor
110604741|NCT02540512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110604742|NCT02540512|Antitussive Agents|antitussive agents|mesh-ancestor
110604743|NCT02540512|Respiratory System Agents|respiratory system agents|mesh-ancestor
110604744|NCT02540512|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110604745|NCT02540512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110604746|NCT02540512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110604747|NCT00897520|Interferons|interferons|mesh-list
110604748|NCT00897520|Interferon-alpha|interferon-alpha|mesh-list
110604749|NCT00897520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110604750|NCT00897520|Antiviral Agents|antiviral agents|mesh-ancestor
110604751|NCT00897520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110604752|NCT00897520|Immunologic Factors|immunologic factors|mesh-ancestor
110152153|NCT03575208|Interferon-alpha|interferon-alpha|mesh-list
110604753|NCT00897520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110604754|NCT00894634|Brompheniramine|brompheniramine|mesh-list
110604755|NCT00894634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110604756|NCT00894634|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110604757|NCT00894634|Histamine Antagonists|histamine antagonists|mesh-ancestor
110604758|NCT00894634|Histamine Agents|histamine agents|mesh-ancestor
110604759|NCT00894634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110604760|NCT00894634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110604761|NCT00894634|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110604763|NCT00894712|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110604764|NCT00894712|Protective Agents|protective agents|mesh-ancestor
110604765|NCT00894712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110604766|NCT00894712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110604768|NCT00823641|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110604769|NCT00823641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110604770|NCT00823641|Dermatologic Agents|dermatologic agents|mesh-ancestor
110604771|NCT00823641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110604772|NCT00823641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110604773|NCT00823875|Cilostazol|cilostazol|mesh-list
110604774|NCT00823875|Probucol|probucol|mesh-list
110604775|NCT00823875|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110604776|NCT00823875|Autonomic Agents|autonomic agents|mesh-ancestor
110604777|NCT00823875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110604778|NCT00823875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110604779|NCT00823875|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110604780|NCT00823875|Respiratory System Agents|respiratory system agents|mesh-ancestor
110604781|NCT00823875|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110604782|NCT00823875|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110604783|NCT00823875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110604784|NCT00823875|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110604785|NCT00823875|Vasodilator Agents|vasodilator agents|mesh-ancestor
110604786|NCT00823875|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110604787|NCT00823875|Protective Agents|protective agents|mesh-ancestor
110604788|NCT00823875|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110604789|NCT00823875|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110604790|NCT00823875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110604791|NCT00823875|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110604792|NCT00823875|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110604793|NCT00823875|Antimetabolites|antimetabolites|mesh-ancestor
110604794|NCT00823875|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110604795|NCT00823875|Antioxidants|antioxidants|mesh-ancestor
110604796|NCT00397189|Melatonin|melatonin|mesh-list
110604797|NCT00397189|Antioxidants|antioxidants|mesh-ancestor
110604798|NCT00397189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110604799|NCT00397189|Protective Agents|protective agents|mesh-ancestor
110604800|NCT00397189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110604801|NCT00397189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110604802|NCT00824109|Anti-Infective Agents|anti-infective agents|mesh-list
110604803|NCT00824109|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110604804|NCT01035619|Moxidectin|moxidectin|mesh-list
110604805|NCT01035619|Anthelmintics|anthelmintics|mesh-ancestor
110604806|NCT01035619|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110604807|NCT01035619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110604808|NCT01035619|Antinematodal Agents|antinematodal agents|mesh-ancestor
110604809|NCT04044651|Nivolumab|nivolumab|mesh-list
110604810|NCT04044651|Lenvatinib|lenvatinib|mesh-list
110604811|NCT04044651|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110604812|NCT04044651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110604813|NCT04044651|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110381330|NCT01202227|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110604814|NCT04044651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110604815|NCT04044651|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110604816|NCT04044651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110604817|NCT00606034|Insulin|insulin|mesh-list
110604818|NCT00606034|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110604819|NCT00606034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110604820|NCT00819975|Caseins|caseins|mesh-list
110604821|NCT00819975|Chelating Agents|chelating agents|mesh-ancestor
110604822|NCT00819975|Sequestering Agents|sequestering agents|mesh-ancestor
110604823|NCT00819975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110604824|NCT04044417|Curcumin|curcumin|mesh-list
110604826|NCT04044417|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110604827|NCT04044417|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110604828|NCT04044417|Antimetabolites|antimetabolites|mesh-ancestor
110604829|NCT04044417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110604830|NCT04044417|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110604831|NCT04044417|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110604832|NCT04044417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110275831|NCT00199134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110275832|NCT00199134|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110604833|NCT04044417|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110604834|NCT04044417|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110604835|NCT04044417|Analgesics|analgesics|mesh-ancestor
110604836|NCT04044417|Sensory System Agents|sensory system agents|mesh-ancestor
110604837|NCT04044417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110604838|NCT04044417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110604839|NCT04044417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110604840|NCT04044417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110604841|NCT04044417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110604842|NCT00397033|Paliperidone Palmitate|paliperidone palmitate|mesh-list
110604843|NCT00397033|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110604844|NCT00397033|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110604845|NCT00397033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110604846|NCT00397033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110604847|NCT00397033|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110604848|NCT00397033|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110604849|NCT00397033|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110604850|NCT00397033|Serotonin Agents|serotonin agents|mesh-ancestor
110604851|NCT00397033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110604852|NCT00397033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110604853|NCT00397033|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110604854|NCT00397033|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110604855|NCT00397033|Dopamine Agents|dopamine agents|mesh-ancestor
110604856|NCT00820053|Epirubicin|epirubicin|mesh-list
110604857|NCT00820053|Ethiodized Oil|ethiodized oil|mesh-list
110604858|NCT00820053|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110604859|NCT00820053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110604860|NCT00820053|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110604861|NCT00820053|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110604862|NCT00820053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110604863|NCT00820053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110604864|NCT00572728|Alovudine|alovudine|mesh-list
110604865|NCT00572728|Dideoxynucleosides|dideoxynucleosides|mesh-list
110604866|NCT00572728|Antiviral Agents|antiviral agents|mesh-ancestor
110604867|NCT00572728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110604868|NCT00572728|Antimetabolites|antimetabolites|mesh-ancestor
110604869|NCT00572728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110604870|NCT00572728|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110604871|NCT00572728|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110604872|NCT00572728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110604873|NCT00699374|Sorafenib|sorafenib|mesh-list
110604874|NCT00699374|Sunitinib|sunitinib|mesh-list
110604875|NCT00699374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110604876|NCT00699374|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110604877|NCT00699374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110604878|NCT00699374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110604879|NCT00699374|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110604880|NCT00699374|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110604881|NCT00699374|Growth Substances|growth substances|mesh-ancestor
110604882|NCT00699374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110604883|NCT00699374|Growth Inhibitors|growth inhibitors|mesh-ancestor
110604884|NCT00898534|Chrysarobin|chrysarobin|mesh-list
110604885|NCT00898534|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110604886|NCT00898534|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110604887|NCT00898534|Analgesics|analgesics|mesh-ancestor
110604888|NCT00898534|Sensory System Agents|sensory system agents|mesh-ancestor
110604889|NCT00898534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110604890|NCT00898534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110604891|NCT00898534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110604892|NCT00898534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110604893|NCT00606892|Nicotine|nicotine|mesh-list
110604894|NCT00606892|Varenicline|varenicline|mesh-list
110604895|NCT00606892|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110604896|NCT00606892|Autonomic Agents|autonomic agents|mesh-ancestor
110604897|NCT00606892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110604898|NCT00606892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110604899|NCT00606892|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110604900|NCT00606892|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110604901|NCT00606892|Cholinergic Agents|cholinergic agents|mesh-ancestor
110604902|NCT00606892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110604903|NCT00606892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110604904|NCT00894946|Ethiodized Oil|ethiodized oil|mesh-list
110604905|NCT00894946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110604906|NCT01035853|Colistin|colistin|mesh-list
110604907|NCT01035853|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110604908|NCT01035853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110604909|NCT01042717|Plerixafor|plerixafor|mesh-list
110604910|NCT01042717|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110381389|NCT02279628|Morphine|morphine|mesh-list
110604911|NCT01042717|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110604912|NCT01042717|Antiviral Agents|antiviral agents|mesh-ancestor
110604913|NCT01042717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110604914|NCT03648385|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
110604915|NCT03648385|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110604916|NCT03648385|Immunologic Factors|immunologic factors|mesh-ancestor
110604917|NCT03648385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110604918|NCT00898846|Tegafur|tegafur|mesh-list
110604919|NCT00898846|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110604920|NCT00898846|Antimetabolites|antimetabolites|mesh-ancestor
110604921|NCT00898846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110604922|NCT00898846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110604923|NCT00826371|Ranibizumab|ranibizumab|mesh-list
110604924|NCT00826371|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110604925|NCT00826371|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110604926|NCT00826371|Growth Substances|growth substances|mesh-ancestor
110604927|NCT00826371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110604928|NCT00826371|Growth Inhibitors|growth inhibitors|mesh-ancestor
110604929|NCT00826371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110604930|NCT02540824|Apatinib|apatinib|mesh-list
110604931|NCT02540824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110604932|NCT02540824|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110604933|NCT02540824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110604934|NCT02540824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110604935|NCT00826527|Solifenacin Succinate|solifenacin succinate|mesh-list
110604936|NCT00826527|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110604937|NCT00826527|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110604938|NCT00826527|Cholinergic Agents|cholinergic agents|mesh-ancestor
110604939|NCT00826527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110604940|NCT00826527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110604941|NCT00826527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110604942|NCT00826527|Urological Agents|urological agents|mesh-ancestor
110604943|NCT02550717|Aspirin|aspirin|mesh-list
110604944|NCT02550717|Anticoagulants|anticoagulants|mesh-list
110604945|NCT02550717|Clopidogrel|clopidogrel|mesh-list
110604946|NCT02550717|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110604947|NCT02550717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110604948|NCT02550717|Analgesics|analgesics|mesh-ancestor
110604949|NCT02550717|Sensory System Agents|sensory system agents|mesh-ancestor
110604950|NCT02550717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110604951|NCT02550717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110604952|NCT02550717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110604953|NCT02550717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110604954|NCT02550717|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110604955|NCT02550717|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110604956|NCT02550717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110604957|NCT02550717|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110604958|NCT02550717|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110604959|NCT02550717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110604960|NCT02550717|Antipyretics|antipyretics|mesh-ancestor
110604961|NCT02550717|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110604962|NCT02550717|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110604963|NCT02550717|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110604964|NCT02550717|Purinergic Agents|purinergic agents|mesh-ancestor
110604965|NCT02550717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110604967|NCT02550249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110604968|NCT02550249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110604969|NCT02550249|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110604970|NCT02550249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110604971|NCT00824811|Fluorometholone|fluorometholone|mesh-list
110604972|NCT00824811|Cyclosporine|cyclosporine|mesh-list
110604973|NCT00824811|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110604974|NCT00824811|Lubricant Eye Drops|lubricant eye drops|mesh-list
110604975|NCT00824811|Cyclosporins|cyclosporins|mesh-list
110604976|NCT00824811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110604977|NCT00824811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110604978|NCT00824811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110604979|NCT00824811|Immunologic Factors|immunologic factors|mesh-ancestor
110604980|NCT00824811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110604981|NCT00824811|Antifungal Agents|antifungal agents|mesh-ancestor
110381460|NCT01201798|Hormones|hormones|mesh-ancestor
110604982|NCT00824811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110604983|NCT00824811|Dermatologic Agents|dermatologic agents|mesh-ancestor
110604984|NCT00824811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110604985|NCT00824811|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110604986|NCT00824811|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110604987|NCT00824811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110604988|NCT00824811|Glucocorticoids|glucocorticoids|mesh-ancestor
110252346|NCT00154401|Hormones|hormones|mesh-ancestor
110604989|NCT00824811|Hormones|hormones|mesh-ancestor
110604990|NCT00824811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110604991|NCT00824811|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110604992|NCT00606580|Paromomycin|paromomycin|mesh-list
110604993|NCT00606580|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110604995|NCT00606580|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110028805|NCT03833466|Metformin|metformin|mesh-list
110604996|NCT00606580|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110604997|NCT02550327|Paclitaxel|paclitaxel|mesh-list
110604998|NCT02550327|Gemcitabine|gemcitabine|mesh-list
110604999|NCT02550327|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
110605000|NCT02550327|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110605001|NCT02550327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110605002|NCT02550327|Tubulin Modulators|tubulin modulators|mesh-ancestor
110605003|NCT02550327|Antimitotic Agents|antimitotic agents|mesh-ancestor
110605004|NCT02550327|Mitosis Modulators|mitosis modulators|mesh-ancestor
110605005|NCT02550327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110605006|NCT02550327|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110605007|NCT02550327|Antimetabolites|antimetabolites|mesh-ancestor
110605008|NCT02550327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110605009|NCT00825045|Risperidone|risperidone|mesh-list
110605010|NCT00825045|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110605011|NCT00825045|Serotonin Agents|serotonin agents|mesh-ancestor
110605012|NCT00825045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110605013|NCT00825045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110605014|NCT00825045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110605015|NCT00825045|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110605016|NCT00825045|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110605017|NCT00825045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110605018|NCT00825045|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110605019|NCT00825045|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110605020|NCT00825045|Dopamine Agents|dopamine agents|mesh-ancestor
110605021|NCT00606502|Vitamins|vitamins|mesh-list
110605022|NCT00606502|Folic Acid|folic acid|mesh-list
110605023|NCT00606502|Vitamin B 12|vitamin b 12|mesh-list
110605024|NCT00606502|Vitamin B Complex|vitamin b complex|mesh-list
110605025|NCT00606502|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110605026|NCT00606502|10-deazaaminopterin|10-deazaaminopterin|mesh-list
110605027|NCT00606502|Micronutrients|micronutrients|mesh-ancestor
110605028|NCT00606502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110605029|NCT00606502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110605030|NCT00606502|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110605031|NCT00606502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110605032|NCT00606502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110605034|NCT00606502|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110605035|NCT00825123|Metoprolol|metoprolol|mesh-list
110605036|NCT00825123|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110605037|NCT00825123|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110605038|NCT00825123|Sympatholytics|sympatholytics|mesh-ancestor
110605039|NCT00825123|Autonomic Agents|autonomic agents|mesh-ancestor
110605040|NCT00825123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110605041|NCT00825123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110605042|NCT00825123|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110605043|NCT00825123|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110605044|NCT00825123|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110605045|NCT00825123|Adrenergic Agents|adrenergic agents|mesh-ancestor
110605046|NCT00825123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110605047|NCT00825123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110605048|NCT00826839|Leuprolide|leuprolide|mesh-list
110605049|NCT00826839|Contraceptive Agents|contraceptive agents|mesh-list
110605050|NCT00826839|Contraceptives, Oral|contraceptives, oral|mesh-list
110605051|NCT00826839|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
110605052|NCT00826839|Ganirelix|ganirelix|mesh-list
110605053|NCT00826839|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110605054|NCT00826839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110605055|NCT00826839|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110605056|NCT00826839|Fertility Agents|fertility agents|mesh-ancestor
110605057|NCT00826839|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110605058|NCT00826839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110605059|NCT00826839|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110605060|NCT00826839|Hormone Antagonists|hormone antagonists|mesh-ancestor
110605061|NCT00826839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110605062|NCT04017988|Ethanol|ethanol|mesh-list
110605063|NCT04017988|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110605064|NCT04017988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110605065|NCT04017988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110605066|NCT04017988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110605067|NCT00825201|Paclitaxel|paclitaxel|mesh-list
110605068|NCT00825201|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110605069|NCT00825201|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110605070|NCT00825201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110605071|NCT00825201|Tubulin Modulators|tubulin modulators|mesh-ancestor
110605072|NCT00825201|Antimitotic Agents|antimitotic agents|mesh-ancestor
110605073|NCT00825201|Mitosis Modulators|mitosis modulators|mesh-ancestor
110605074|NCT00825201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110605075|NCT00820911|Cyclosporine|cyclosporine|mesh-list
110605076|NCT00820911|Everolimus|everolimus|mesh-list
110605077|NCT00820911|Cyclosporins|cyclosporins|mesh-list
110605078|NCT00820911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110605079|NCT00820911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110605080|NCT00820911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110605081|NCT00820911|Immunologic Factors|immunologic factors|mesh-ancestor
110605082|NCT00820911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110605083|NCT00820911|Antifungal Agents|antifungal agents|mesh-ancestor
110605084|NCT00820911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110605085|NCT00820911|Dermatologic Agents|dermatologic agents|mesh-ancestor
110381503|NCT04532684|Dopamine Agents|dopamine agents|mesh-ancestor
110605086|NCT00820911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110605087|NCT00820911|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110605088|NCT00820911|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110605089|NCT00820911|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110605090|NCT00820911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110605091|NCT00605722|Bevacizumab|bevacizumab|mesh-list
110605092|NCT00605722|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110605093|NCT00605722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110605094|NCT00605722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110605095|NCT00605722|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110605096|NCT00605722|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110605097|NCT00605722|Growth Substances|growth substances|mesh-ancestor
110605098|NCT00605722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110605099|NCT00605722|Growth Inhibitors|growth inhibitors|mesh-ancestor
110605100|NCT00605722|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110605101|NCT00605722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110605102|NCT00605722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110605103|NCT00882076|Etoposide|etoposide|mesh-list
110605104|NCT00882076|Mitoxantrone|mitoxantrone|mesh-list
110605105|NCT00882076|Etoposide phosphate|etoposide phosphate|mesh-list
110605106|NCT00882076|Clofarabine|clofarabine|mesh-list
110605107|NCT00882076|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110605108|NCT00882076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110605109|NCT00882076|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110605110|NCT00882076|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110605111|NCT00882076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110605112|NCT00882076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110605113|NCT00882076|Analgesics|analgesics|mesh-ancestor
110605114|NCT00882076|Sensory System Agents|sensory system agents|mesh-ancestor
110605115|NCT00882076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110605116|NCT00882076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110605117|NCT00882076|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110605118|NCT00882076|Antimetabolites|antimetabolites|mesh-ancestor
110605119|NCT00827151|Estrogens|estrogens|mesh-list
110605120|NCT00827151|Hormones|hormones|mesh-ancestor
110605121|NCT00827151|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110605122|NCT00827151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110605123|NCT00882154|Cefdinir|cefdinir|mesh-list
110605124|NCT00882154|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110605125|NCT00882154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110605126|NCT00825591|Melatonin|melatonin|mesh-list
110605127|NCT00825591|Antioxidants|antioxidants|mesh-ancestor
110605128|NCT00825591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110605129|NCT00825591|Protective Agents|protective agents|mesh-ancestor
110605130|NCT00825591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110605131|NCT00825591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110605132|NCT00882232|Hyaluronic Acid|hyaluronic acid|mesh-list
110605133|NCT00882232|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110605134|NCT00882232|Immunologic Factors|immunologic factors|mesh-ancestor
110381525|NCT01683552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110605135|NCT00882232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110605136|NCT00882232|Viscosupplements|viscosupplements|mesh-ancestor
110605137|NCT00882232|Protective Agents|protective agents|mesh-ancestor
110605138|NCT00900172|Paclitaxel|paclitaxel|mesh-list
110605139|NCT00900172|Bevacizumab|bevacizumab|mesh-list
110605140|NCT00900172|Carboplatin|carboplatin|mesh-list
110605141|NCT00900172|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110605142|NCT00900172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110605143|NCT00900172|Tubulin Modulators|tubulin modulators|mesh-ancestor
110605144|NCT00900172|Antimitotic Agents|antimitotic agents|mesh-ancestor
110605145|NCT00900172|Mitosis Modulators|mitosis modulators|mesh-ancestor
110605146|NCT00900172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110605147|NCT00900172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110605148|NCT00900172|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110605149|NCT00900172|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110605150|NCT00900172|Growth Substances|growth substances|mesh-ancestor
110605151|NCT00900172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110605152|NCT00900172|Growth Inhibitors|growth inhibitors|mesh-ancestor
110605153|NCT00605566|Cyclophosphamide|cyclophosphamide|mesh-list
110605155|NCT00605566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110605156|NCT00605566|Immunologic Factors|immunologic factors|mesh-ancestor
110605157|NCT00605566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110605158|NCT00605566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110605159|NCT00605566|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110605160|NCT00605566|Alkylating Agents|alkylating agents|mesh-ancestor
110605161|NCT00605566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110605162|NCT00605566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110605163|NCT00605566|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110605164|NCT00605566|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110605165|NCT00605566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110605167|NCT00882388|Celecoxib|celecoxib|mesh-list
110605168|NCT00882388|Clopidogrel|clopidogrel|mesh-list
110605169|NCT00882388|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110605170|NCT00882388|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110605171|NCT00882388|Analgesics|analgesics|mesh-ancestor
110605172|NCT00882388|Sensory System Agents|sensory system agents|mesh-ancestor
110605173|NCT00882388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110605174|NCT00882388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110605175|NCT00882388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110605176|NCT00882388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110605177|NCT00882388|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110605178|NCT00882388|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110605179|NCT00882388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110605180|NCT00882388|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110605181|NCT00882388|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110605182|NCT00882388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110605183|NCT00882388|Antipyretics|antipyretics|mesh-ancestor
110605184|NCT00882388|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110605185|NCT00882388|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110605186|NCT00882388|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110605187|NCT00882388|Purinergic Agents|purinergic agents|mesh-ancestor
110605188|NCT00882388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110605189|NCT00882388|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110605190|NCT00396877|Clopidogrel|clopidogrel|mesh-list
110605191|NCT00396877|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110605192|NCT00396877|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110605193|NCT00396877|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110605194|NCT00396877|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110605195|NCT00396877|Purinergic Agents|purinergic agents|mesh-ancestor
110605196|NCT00396877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110605197|NCT00396877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110605198|NCT00396877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110605199|NCT00124891|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
110605200|NCT00882466|Epoetin Alfa|epoetin alfa|mesh-list
110605201|NCT00882466|Hematinics|hematinics|mesh-ancestor
110605202|NCT00901498|BMS 708163|bms 708163|mesh-list
110605203|NCT00901498|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
110605204|NCT00901498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110605205|NCT00901498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110605206|NCT00628251|Doxorubicin|doxorubicin|mesh-list
110605207|NCT00628251|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110605208|NCT00628251|Olaparib|olaparib|mesh-list
110605209|NCT00628251|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110605210|NCT00628251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110605211|NCT00628251|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110605212|NCT00628251|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110605213|NCT00628251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110605214|NCT00628251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110605215|NCT00628251|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110605216|NCT01036399|Lenalidomide|lenalidomide|mesh-list
110605217|NCT01036399|Immunologic Factors|immunologic factors|mesh-ancestor
110605218|NCT01036399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110605219|NCT01036399|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110605220|NCT01036399|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110605221|NCT01036399|Growth Substances|growth substances|mesh-ancestor
110605222|NCT01036399|Growth Inhibitors|growth inhibitors|mesh-ancestor
110605223|NCT01036399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110605224|NCT00901654|Vaccines|vaccines|mesh-list
110605225|NCT00901654|Immunologic Factors|immunologic factors|mesh-ancestor
110605226|NCT00901654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110605227|NCT00625131|Bupropion|bupropion|mesh-list
110605228|NCT00625131|Nicotine|nicotine|mesh-list
110605229|NCT00625131|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110605230|NCT00625131|Autonomic Agents|autonomic agents|mesh-ancestor
110152203|NCT00000381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110605231|NCT00625131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110605232|NCT00625131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110605233|NCT00625131|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110605234|NCT00625131|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110605235|NCT00625131|Cholinergic Agents|cholinergic agents|mesh-ancestor
110605236|NCT00625131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110605237|NCT00625131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110381573|NCT01683747|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110605238|NCT00625131|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110605239|NCT00625131|Antidepressive Agents|antidepressive agents|mesh-ancestor
110605240|NCT00625131|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110605241|NCT00625131|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110605242|NCT00625131|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110605243|NCT00625131|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110283463|NCT00202982|Glatiramer Acetate|glatiramer acetate|mesh-list
110605244|NCT00625131|Dopamine Agents|dopamine agents|mesh-ancestor
110605245|NCT00625131|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110605246|NCT00625131|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110605247|NCT00625131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110605249|NCT00901732|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110605250|NCT00901732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110605251|NCT00882700|Cefdinir|cefdinir|mesh-list
110605252|NCT00882700|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110605253|NCT00882700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110605254|NCT00408499|Cetuximab|cetuximab|mesh-list
110605255|NCT00408499|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110605256|NCT00408499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110605257|NCT00408499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110605258|NCT00408499|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110605259|NCT00408499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110605260|NCT00408499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110605261|NCT00837369|Regadenoson|regadenoson|mesh-list
110605262|NCT00837369|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
110605263|NCT00837369|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
110605264|NCT00837369|Purinergic Agonists|purinergic agonists|mesh-ancestor
110381602|NCT04532060|Nystatin|nystatin|mesh-list
110605265|NCT00837369|Purinergic Agents|purinergic agents|mesh-ancestor
110605266|NCT00837369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110605267|NCT00837369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110605268|NCT00837369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110605269|NCT00900874|Albuterol|albuterol|mesh-list
110605270|NCT00900874|Formoterol Fumarate|formoterol fumarate|mesh-list
110605271|NCT00900874|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110605272|NCT00900874|Autonomic Agents|autonomic agents|mesh-ancestor
110605273|NCT00900874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110605274|NCT00900874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110605275|NCT00900874|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110605276|NCT00900874|Respiratory System Agents|respiratory system agents|mesh-ancestor
110605277|NCT00900874|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110605278|NCT00900874|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110605279|NCT00900874|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110605280|NCT00900874|Adrenergic Agents|adrenergic agents|mesh-ancestor
110605281|NCT00900874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110605282|NCT00900874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110605283|NCT00900874|Tocolytic Agents|tocolytic agents|mesh-ancestor
110605284|NCT00900874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110605285|NCT02539810|Antihypertensive Agents|antihypertensive agents|mesh-list
110605286|NCT00901888|Nitroprusside|nitroprusside|mesh-list
110605287|NCT00901888|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110605288|NCT00901888|Vasodilator Agents|vasodilator agents|mesh-ancestor
110605289|NCT00901888|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
110605290|NCT00901888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110605291|NCT00908362|Fluticasone|fluticasone|mesh-list
110605293|NCT00908362|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110605294|NCT00908362|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
110283484|NCT00196391|Progestins|progestins|mesh-ancestor
110283485|NCT00196391|Hormones|hormones|mesh-ancestor
110605296|NCT00908362|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110605297|NCT00908362|Autonomic Agents|autonomic agents|mesh-ancestor
110605298|NCT00908362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110381642|NCT04531865|Mycophenolic Acid|mycophenolic acid|mesh-list
110605299|NCT00908362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110605300|NCT00908362|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110605301|NCT00908362|Respiratory System Agents|respiratory system agents|mesh-ancestor
110605302|NCT00908362|Dermatologic Agents|dermatologic agents|mesh-ancestor
110605303|NCT00908362|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110605304|NCT00908362|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110605305|NCT00908362|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110605306|NCT00908362|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110605307|NCT00908362|Adrenergic Agents|adrenergic agents|mesh-ancestor
110605308|NCT00908362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110605309|NCT00908362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110605310|NCT00908362|Glucocorticoids|glucocorticoids|mesh-ancestor
110605311|NCT00908362|Hormones|hormones|mesh-ancestor
110605312|NCT00908362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110605313|NCT00908362|Sympathomimetics|sympathomimetics|mesh-ancestor
110605314|NCT02549469|Naproxen|naproxen|mesh-list
110605315|NCT02549469|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110605316|NCT02549469|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110605317|NCT02549469|Analgesics|analgesics|mesh-ancestor
110605318|NCT02549469|Sensory System Agents|sensory system agents|mesh-ancestor
110605319|NCT02549469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110605320|NCT02549469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110605321|NCT02549469|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110605322|NCT02549469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110605323|NCT02549469|Gout Suppressants|gout suppressants|mesh-ancestor
110605324|NCT02549469|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110605325|NCT02549469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110605326|NCT02549469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110605327|NCT02548533|Lidocaine|lidocaine|mesh-list
110605328|NCT02548533|Epinephrine|epinephrine|mesh-list
110605329|NCT02548533|Prilocaine|prilocaine|mesh-list
110605330|NCT02548533|Carticaine|carticaine|mesh-list
110605331|NCT02548533|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
110605332|NCT02548533|Anesthetics, Local|anesthetics, local|mesh-ancestor
110605333|NCT02548533|Anesthetics|anesthetics|mesh-ancestor
110605334|NCT02548533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110605335|NCT02548533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110605336|NCT02548533|Sensory System Agents|sensory system agents|mesh-ancestor
110605337|NCT02548533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110605338|NCT02548533|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110605339|NCT02548533|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110605340|NCT02548533|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110605341|NCT02548533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110605342|NCT02548533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110605343|NCT02548533|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110605344|NCT02548533|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110605345|NCT02548533|Adrenergic Agents|adrenergic agents|mesh-ancestor
110605346|NCT02548533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110605347|NCT02548533|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110605348|NCT02548533|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110605349|NCT02548533|Autonomic Agents|autonomic agents|mesh-ancestor
110605350|NCT02548533|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110605351|NCT02548533|Respiratory System Agents|respiratory system agents|mesh-ancestor
110605352|NCT02548533|Mydriatics|mydriatics|mesh-ancestor
110605353|NCT02548533|Sympathomimetics|sympathomimetics|mesh-ancestor
110605354|NCT02548533|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110605355|NCT02548533|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
110605356|NCT02549391|Cinacalcet|cinacalcet|mesh-list
110605357|NCT02549391|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110605358|NCT02549391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110605359|NCT02549391|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
110605360|NCT02549391|Hormone Antagonists|hormone antagonists|mesh-ancestor
110605361|NCT02549391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110605362|NCT02538172|Valganciclovir|valganciclovir|mesh-list
110605363|NCT02538172|Antiviral Agents|antiviral agents|mesh-ancestor
110605364|NCT02538172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110605365|NCT00837837|Chlorpheniramine|chlorpheniramine|mesh-list
110605366|NCT00837837|Antipruritics|antipruritics|mesh-ancestor
110605369|NCT00837837|Histamine Antagonists|histamine antagonists|mesh-ancestor
110605370|NCT00837837|Histamine Agents|histamine agents|mesh-ancestor
110605371|NCT00837837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110605372|NCT00837837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110605373|NCT00837837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110605374|NCT00837837|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110605375|NCT00908674|Cyproterone Acetate|cyproterone acetate|mesh-list
110605376|NCT00908674|Cyproterone|cyproterone|mesh-list
110605377|NCT00908674|Androgen Antagonists|androgen antagonists|mesh-ancestor
110605378|NCT00908674|Hormone Antagonists|hormone antagonists|mesh-ancestor
110605379|NCT00908674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110605380|NCT00908674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110605381|NCT00908674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110605382|NCT00908674|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110381714|NCT04531397|Dapagliflozin|dapagliflozin|mesh-list
110605383|NCT00908674|Contraceptive Agents|contraceptive agents|mesh-ancestor
110605384|NCT00908674|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110605386|NCT00621777|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110605387|NCT00621777|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110605388|NCT00621777|Cholinergic Agents|cholinergic agents|mesh-ancestor
110605389|NCT00621777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110605390|NCT00621777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110605391|NCT00621777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110605392|NCT02538718|Ritodrine|ritodrine|mesh-list
110605393|NCT02538718|Sympathomimetics|sympathomimetics|mesh-ancestor
110605394|NCT02538718|Autonomic Agents|autonomic agents|mesh-ancestor
110605395|NCT02538718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110605396|NCT02538718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110605397|NCT02538718|Tocolytic Agents|tocolytic agents|mesh-ancestor
110605398|NCT02538718|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110605399|NCT02538718|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110605400|NCT02538718|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110605401|NCT02538718|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110605402|NCT02538718|Adrenergic Agents|adrenergic agents|mesh-ancestor
110605403|NCT02538718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110605404|NCT02538718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110605405|NCT00902512|Sildenafil Citrate|sildenafil citrate|mesh-list
110605406|NCT00902512|Vasodilator Agents|vasodilator agents|mesh-ancestor
110605407|NCT00902512|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110605408|NCT00902512|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110605409|NCT00902512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110605410|NCT00902512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110605411|NCT00902512|Urological Agents|urological agents|mesh-ancestor
110605412|NCT00827307|Tamoxifen|tamoxifen|mesh-list
110605413|NCT00827307|Goserelin|goserelin|mesh-list
110605414|NCT00827307|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110605415|NCT00827307|Hormone Antagonists|hormone antagonists|mesh-ancestor
110605416|NCT00827307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110605417|NCT00827307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110605418|NCT00827307|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110605419|NCT00827307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110605420|NCT00827307|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110605421|NCT00827307|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110605422|NCT00827307|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110605423|NCT00837915|Loratadine|loratadine|mesh-list
110605424|NCT00837915|Pseudoephedrine|pseudoephedrine|mesh-list
110605425|NCT00837915|Ephedrine|ephedrine|mesh-list
110605426|NCT00837915|Antipruritics|antipruritics|mesh-ancestor
110605427|NCT00837915|Dermatologic Agents|dermatologic agents|mesh-ancestor
110605428|NCT00837915|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110275854|NCT00712582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110605429|NCT00837915|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110605430|NCT00837915|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110605431|NCT00837915|Histamine Antagonists|histamine antagonists|mesh-ancestor
110605432|NCT00837915|Histamine Agents|histamine agents|mesh-ancestor
110605433|NCT00837915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110605434|NCT00837915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110605435|NCT00837915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110605436|NCT00837915|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110605437|NCT00837915|Autonomic Agents|autonomic agents|mesh-ancestor
110605438|NCT00837915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110605439|NCT00837915|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110605440|NCT00837915|Respiratory System Agents|respiratory system agents|mesh-ancestor
110605441|NCT00837915|Nasal Decongestants|nasal decongestants|mesh-ancestor
110605442|NCT00837915|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110605443|NCT00837915|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110605444|NCT00837915|Sympathomimetics|sympathomimetics|mesh-ancestor
110605445|NCT00837915|Adrenergic Agents|adrenergic agents|mesh-ancestor
110605447|NCT00908986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110605448|NCT00908986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110605449|NCT00908986|Immunologic Factors|immunologic factors|mesh-ancestor
110605450|NCT00908986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110605451|NCT00908986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110605452|NCT00909142|Clodronic Acid|clodronic acid|mesh-list
110605453|NCT00909142|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110605454|NCT00909142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110605455|NCT00838071|Immunoglobulins|immunoglobulins|mesh-list
110605456|NCT00838071|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110605457|NCT00838071|Antibodies|antibodies|mesh-list
110605458|NCT00838071|Immunologic Factors|immunologic factors|mesh-ancestor
110605459|NCT00838071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110605460|NCT02547519|Insulin|insulin|mesh-list
110605461|NCT02547519|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110605462|NCT02547519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110605463|NCT00909454|Vitamin D|vitamin d|mesh-list
110605464|NCT00909454|Ergocalciferols|ergocalciferols|mesh-list
110605465|NCT00909454|Cholecalciferol|cholecalciferol|mesh-list
110605466|NCT00909454|Vitamins|vitamins|mesh-list
110605467|NCT00909454|Micronutrients|micronutrients|mesh-ancestor
110605468|NCT00909454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110605469|NCT00909454|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110605470|NCT00909454|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110605471|NCT04035070|Clindamycin|clindamycin|mesh-list
110605472|NCT04035070|Clindamycin palmitate|clindamycin palmitate|mesh-list
110605473|NCT04035070|Clindamycin phosphate|clindamycin phosphate|mesh-list
110605474|NCT04035070|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
110605475|NCT04035070|Sodium Hypochlorite|sodium hypochlorite|mesh-list
110605476|NCT04035070|Eusol|eusol|mesh-list
110605477|NCT04035070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110605478|NCT04035070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110605479|NCT04035070|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110605480|NCT04035070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110605481|NCT04035070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110605482|NCT04035070|Disinfectants|disinfectants|mesh-ancestor
110605483|NCT04035070|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110605484|NCT00408421|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110605485|NCT00408421|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110605486|NCT00408421|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110605487|NCT00408421|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110605488|NCT00408421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110605489|NCT00408421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110605490|NCT00408421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110605491|NCT00408421|Analgesics|analgesics|mesh-ancestor
110605492|NCT00408421|Sensory System Agents|sensory system agents|mesh-ancestor
110605493|NCT00408421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110605494|NCT00408421|Antidepressive Agents|antidepressive agents|mesh-ancestor
110605495|NCT00408421|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110605496|NCT00408421|Dopamine Agents|dopamine agents|mesh-ancestor
110605497|NCT00604786|Omalizumab|omalizumab|mesh-list
110605498|NCT00604786|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110605499|NCT00604786|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110605500|NCT00604786|Respiratory System Agents|respiratory system agents|mesh-ancestor
110605501|NCT01042873|Dobutamine|dobutamine|mesh-list
110605502|NCT01042873|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110605503|NCT01042873|Sympathomimetics|sympathomimetics|mesh-ancestor
110605504|NCT01042873|Autonomic Agents|autonomic agents|mesh-ancestor
110605505|NCT01042873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110605506|NCT01042873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110605507|NCT01042873|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
110605509|NCT01042873|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110605510|NCT01042873|Adrenergic Agents|adrenergic agents|mesh-ancestor
110605511|NCT01042873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110605512|NCT01042873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110252824|NCT00154869|Ribavirin|ribavirin|mesh-list
110605513|NCT01042873|Protective Agents|protective agents|mesh-ancestor
110605514|NCT01042951|Vaccines|vaccines|mesh-list
110605515|NCT01042951|Immunologic Factors|immunologic factors|mesh-ancestor
110605516|NCT01042951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110605517|NCT01037023|Topotecan|topotecan|mesh-list
110605518|NCT01037023|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110605519|NCT01037023|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110605520|NCT01037023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110605521|NCT01037023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110605522|NCT01037023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110605523|NCT00604708|Vaccines|vaccines|mesh-list
110605524|NCT00604708|Immunologic Factors|immunologic factors|mesh-ancestor
110605525|NCT00604708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110605526|NCT00909688|BLI-489|bli-489|mesh-list
110605527|NCT00909688|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110605528|NCT00909688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110605529|NCT00909688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110605530|NCT00909688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110605531|NCT00909688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110605532|NCT00903214|Riluzole|riluzole|mesh-list
110605533|NCT00903214|Anticonvulsants|anticonvulsants|mesh-ancestor
110605534|NCT00903214|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110605535|NCT00903214|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110605536|NCT00903214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110605537|NCT00903214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110605538|NCT00903214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110605539|NCT00903214|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110605540|NCT00903214|Protective Agents|protective agents|mesh-ancestor
110605541|NCT04034836|Parecoxib|parecoxib|mesh-list
110605542|NCT04034836|Ropivacaine|ropivacaine|mesh-list
110605543|NCT04034836|Anesthetics, Local|anesthetics, local|mesh-ancestor
110605544|NCT04034836|Anesthetics|anesthetics|mesh-ancestor
110605545|NCT04034836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110605546|NCT04034836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110605547|NCT04034836|Sensory System Agents|sensory system agents|mesh-ancestor
110605548|NCT04034836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110605549|NCT04034836|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110605550|NCT04034836|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110605551|NCT04034836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110605552|NCT04034836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110605553|NCT04034836|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110605554|NCT04034836|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110605555|NCT04034836|Analgesics|analgesics|mesh-ancestor
110605556|NCT04034836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110605557|NCT04034836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110605558|NCT00407797|Pregabalin|pregabalin|mesh-list
110605559|NCT00407797|Analgesics|analgesics|mesh-ancestor
110605560|NCT00407797|Sensory System Agents|sensory system agents|mesh-ancestor
110605561|NCT00407797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110605562|NCT00407797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110605563|NCT00407797|Anticonvulsants|anticonvulsants|mesh-ancestor
110283505|NCT00226122|Tocolytic Agents|tocolytic agents|mesh-ancestor
110605564|NCT00407797|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110605565|NCT00407797|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110605566|NCT00407797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110605567|NCT00407797|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110605568|NCT00407797|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110605569|NCT00407797|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110605570|NCT00407797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110605571|NCT00407797|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110605572|NCT00903292|Pemetrexed|pemetrexed|mesh-list
110605573|NCT00903292|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110605574|NCT00903292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110605575|NCT00903292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110605576|NCT00903292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110605577|NCT00903292|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110605578|NCT00903292|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110605579|NCT00903292|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110605580|NCT00903838|Pramipexole|pramipexole|mesh-list
110605581|NCT00903838|Antioxidants|antioxidants|mesh-ancestor
110605582|NCT00903838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110605583|NCT00903838|Protective Agents|protective agents|mesh-ancestor
110605584|NCT00903838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110605585|NCT00903838|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110605586|NCT00903838|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110605587|NCT00903838|Dopamine Agonists|dopamine agonists|mesh-ancestor
110605588|NCT00903838|Dopamine Agents|dopamine agents|mesh-ancestor
110029437|NCT04677959|Xhance|xhance|mesh-list
110605589|NCT00903838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110605591|NCT00924430|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110605592|NCT00924430|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110605593|NCT00924430|Antimetabolites|antimetabolites|mesh-ancestor
110605594|NCT00924430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110605595|NCT00924430|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110605596|NCT00924430|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110605597|NCT00924430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110605598|NCT00924586|Landiolol|landiolol|mesh-list
110605599|NCT00924586|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110605600|NCT00924586|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110605601|NCT00924586|Adrenergic Agents|adrenergic agents|mesh-ancestor
110605602|NCT00924586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110605603|NCT00924586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110605604|NCT00924586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110605605|NCT00924586|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110605606|NCT00903994|Ketoprofen|ketoprofen|mesh-list
110605607|NCT00903994|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110605608|NCT00903994|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110605609|NCT00903994|Analgesics|analgesics|mesh-ancestor
110605610|NCT00903994|Sensory System Agents|sensory system agents|mesh-ancestor
110605611|NCT00903994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110605612|NCT00903994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110605613|NCT00903994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110605614|NCT00903994|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110605615|NCT00903994|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110605616|NCT00903994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110605617|NCT00903994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110605618|NCT00924742|Tazobactam|tazobactam|mesh-list
110605619|NCT00924742|Piperacillin|piperacillin|mesh-list
110605620|NCT00924742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110605621|NCT00924742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110605622|NCT00924742|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110605623|NCT00924742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110605624|NCT00924742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110605625|NCT00407563|Paclitaxel|paclitaxel|mesh-list
110605626|NCT00407563|Bevacizumab|bevacizumab|mesh-list
110605627|NCT00407563|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110605628|NCT00407563|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110605629|NCT00407563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110605630|NCT00407563|Tubulin Modulators|tubulin modulators|mesh-ancestor
110605631|NCT00407563|Antimitotic Agents|antimitotic agents|mesh-ancestor
110605632|NCT00407563|Mitosis Modulators|mitosis modulators|mesh-ancestor
110605633|NCT00407563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110605634|NCT00407563|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110605635|NCT00407563|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110605636|NCT00407563|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110605637|NCT00407563|Growth Substances|growth substances|mesh-ancestor
110605638|NCT00407563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110605639|NCT00407563|Growth Inhibitors|growth inhibitors|mesh-ancestor
110605640|NCT00906724|Insulin|insulin|mesh-list
110605641|NCT00906724|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110605642|NCT00906724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110605643|NCT01037101|Cycloserine|cycloserine|mesh-list
110605644|NCT01037101|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110605645|NCT01037101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110605646|NCT01037101|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110605648|NCT01037101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110605649|NCT01037101|Antimetabolites|antimetabolites|mesh-ancestor
110605650|NCT01037101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110605651|NCT00904306|Chromium|chromium|mesh-list
110605652|NCT00904306|Picolinic acid|picolinic acid|mesh-list
110605653|NCT00904306|Trace Elements|trace elements|mesh-ancestor
110605654|NCT00904306|Micronutrients|micronutrients|mesh-ancestor
110605655|NCT00904306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110605656|NCT00904306|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110605657|NCT00904306|Chelating Agents|chelating agents|mesh-ancestor
110605658|NCT00904306|Sequestering Agents|sequestering agents|mesh-ancestor
110605659|NCT00904306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110605660|NCT00623103|Rivastigmine|rivastigmine|mesh-list
110605661|NCT00623103|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110605662|NCT00623103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110605663|NCT00623103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110605664|NCT00623103|Cholinergic Agents|cholinergic agents|mesh-ancestor
110605665|NCT00623103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110605666|NCT00623103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110605667|NCT00623103|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110605668|NCT00623103|Protective Agents|protective agents|mesh-ancestor
110605669|NCT01043341|Vaccines|vaccines|mesh-list
110605670|NCT01043341|Immunologic Factors|immunologic factors|mesh-ancestor
110605671|NCT01043341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110605672|NCT01043419|Xenon|xenon|mesh-list
110605673|NCT01043419|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110605674|NCT01043419|Anesthetics, General|anesthetics, general|mesh-ancestor
110605675|NCT01043419|Anesthetics|anesthetics|mesh-ancestor
110605676|NCT01043419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110605677|NCT01043419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110605678|NCT01037335|Morphine|morphine|mesh-list
110605679|NCT01037335|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110605680|NCT01037335|Narcotics|narcotics|mesh-ancestor
110605681|NCT01037335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110605682|NCT01037335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110605683|NCT01037335|Analgesics|analgesics|mesh-ancestor
110605684|NCT01037335|Sensory System Agents|sensory system agents|mesh-ancestor
110605685|NCT01037335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110605686|NCT04015492|Factor VIII|factor viii|mesh-list
110605687|NCT04015492|BAX 855|bax 855|mesh-list
110605688|NCT04015492|Coagulants|coagulants|mesh-ancestor
110605689|NCT00904462|Lidocaine|lidocaine|mesh-list
110605690|NCT00904462|Anesthetics, Local|anesthetics, local|mesh-ancestor
110605691|NCT00904462|Anesthetics|anesthetics|mesh-ancestor
110605692|NCT00904462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110605693|NCT00904462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110605694|NCT00904462|Sensory System Agents|sensory system agents|mesh-ancestor
110605695|NCT00904462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110605696|NCT00904462|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110605697|NCT00904462|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110605698|NCT00904462|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110605699|NCT00904462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110605700|NCT00904462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110605701|NCT00396565|Olanzapine|olanzapine|mesh-list
110605702|NCT00396565|Paliperidone Palmitate|paliperidone palmitate|mesh-list
110605703|NCT00396565|Antiemetics|antiemetics|mesh-ancestor
110605704|NCT00396565|Autonomic Agents|autonomic agents|mesh-ancestor
110605705|NCT00396565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110605706|NCT00396565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110605707|NCT00396565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110605708|NCT00396565|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110605709|NCT00396565|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110605710|NCT00396565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110605711|NCT00396565|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110605712|NCT00396565|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110605713|NCT00396565|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110605714|NCT00396565|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110605715|NCT00396565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110605716|NCT00396565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110605717|NCT00396565|Serotonin Agents|serotonin agents|mesh-ancestor
110605718|NCT00396565|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110605719|NCT00396565|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110605720|NCT00396565|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110605722|NCT00396565|Dopamine Agents|dopamine agents|mesh-ancestor
110605723|NCT00904540|Lidocaine|lidocaine|mesh-list
110605724|NCT00904540|Anesthetics, Local|anesthetics, local|mesh-ancestor
110605725|NCT00904540|Anesthetics|anesthetics|mesh-ancestor
110605726|NCT00904540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110605727|NCT00904540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110605728|NCT00904540|Sensory System Agents|sensory system agents|mesh-ancestor
110605729|NCT00904540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110605730|NCT00904540|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110605731|NCT00904540|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110605732|NCT00904540|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110605733|NCT00904540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110605734|NCT00904540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110253048|NCT00141401|Pregabalin|pregabalin|mesh-list
110605735|NCT00906880|Eflornithine|eflornithine|mesh-list
110605736|NCT00906880|Nifurtimox|nifurtimox|mesh-list
110605737|NCT00906880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110605738|NCT00906880|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
110605739|NCT00906880|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110605740|NCT00906880|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110605741|NCT00906880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110605742|NCT00906880|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
110605743|NCT00906880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110605744|NCT00906880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110605746|NCT00904852|Temozolomide|temozolomide|mesh-list
110605747|NCT00904852|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110605748|NCT00904852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110605749|NCT00904852|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110605750|NCT00904852|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110605751|NCT00904852|Growth Substances|growth substances|mesh-ancestor
110605752|NCT00904852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110605753|NCT00904852|Growth Inhibitors|growth inhibitors|mesh-ancestor
110605754|NCT00904852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110605755|NCT00904852|Alkylating Agents|alkylating agents|mesh-ancestor
110605756|NCT00904852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110605757|NCT00394771|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110605758|NCT00394771|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110605759|NCT00394771|Levonorgestrel|levonorgestrel|mesh-list
110605760|NCT00394771|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110605761|NCT00394771|Estradiol|estradiol|mesh-list
110605762|NCT00394771|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110605763|NCT00394771|Estrogens|estrogens|mesh-ancestor
110605764|NCT00394771|Hormones|hormones|mesh-ancestor
110605765|NCT00394771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110605766|NCT00394771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110605767|NCT00394771|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110605768|NCT00394771|Contraceptive Agents|contraceptive agents|mesh-ancestor
110605769|NCT00394771|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110605770|NCT00394771|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110605771|NCT00394771|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110605772|NCT00394771|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110605773|NCT00394771|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110605774|NCT00396409|Omalizumab|omalizumab|mesh-list
110605775|NCT00396409|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110605776|NCT00396409|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110605777|NCT00396409|Respiratory System Agents|respiratory system agents|mesh-ancestor
110605778|NCT04060836|Factor VIII|factor viii|mesh-list
110605779|NCT04060836|Coagulants|coagulants|mesh-ancestor
110605780|NCT00693420|Bimatoprost|bimatoprost|mesh-list
110605781|NCT00693420|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110283510|NCT00196469|Heparin|heparin|mesh-list
110605782|NCT00693420|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110605784|NCT04034524|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110605785|NCT04034524|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110605786|NCT04034524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110605787|NCT00925912|Bupivacaine|bupivacaine|mesh-list
110605788|NCT00925912|Anesthetics, Local|anesthetics, local|mesh-ancestor
110605789|NCT00925912|Anesthetics|anesthetics|mesh-ancestor
110605790|NCT00925912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110605791|NCT00925912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110605792|NCT00925912|Sensory System Agents|sensory system agents|mesh-ancestor
110605793|NCT00925912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110605794|NCT00695136|Donepezil|donepezil|mesh-list
110605795|NCT00695136|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110605796|NCT00695136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110605797|NCT00695136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110605798|NCT00695136|Cholinergic Agents|cholinergic agents|mesh-ancestor
110605799|NCT00695136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110605800|NCT00695136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110605801|NCT00695136|Nootropic Agents|nootropic agents|mesh-ancestor
110605802|NCT00921570|Amlodipine|amlodipine|mesh-list
110605803|NCT00921570|Valsartan|valsartan|mesh-list
110605804|NCT00921570|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110605805|NCT00921570|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110605806|NCT00921570|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110605807|NCT00921570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110605808|NCT00921570|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110605809|NCT00921570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110605810|NCT00921570|Vasodilator Agents|vasodilator agents|mesh-ancestor
110605811|NCT00921570|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110605812|NCT00921570|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110605814|NCT02710890|Anticonvulsants|anticonvulsants|mesh-ancestor
110605815|NCT02710890|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110605816|NCT02710890|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110605817|NCT02710890|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110605818|NCT02710890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110605819|NCT00605176|Imiquimod|imiquimod|mesh-list
110605820|NCT00605176|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110605821|NCT00605176|Immunologic Factors|immunologic factors|mesh-ancestor
110605822|NCT00605176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110605823|NCT00605176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110605824|NCT00605176|Interferon Inducers|interferon inducers|mesh-ancestor
110605825|NCT00743028|Navitoclax|navitoclax|mesh-list
110605826|NCT00743028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110605827|NCT00926302|Levetiracetam|levetiracetam|mesh-list
110605828|NCT00926302|Anticonvulsants|anticonvulsants|mesh-ancestor
110605829|NCT00926302|Nootropic Agents|nootropic agents|mesh-ancestor
110605830|NCT00907036|Cyclosporine|cyclosporine|mesh-list
110605831|NCT00907036|Fludarabine|fludarabine|mesh-list
110605832|NCT00907036|Fludarabine phosphate|fludarabine phosphate|mesh-list
110605833|NCT00907036|Melphalan|melphalan|mesh-list
110605834|NCT00907036|Alemtuzumab|alemtuzumab|mesh-list
110605835|NCT00907036|Cyclosporins|cyclosporins|mesh-list
110605836|NCT00907036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110605837|NCT00907036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110605838|NCT00907036|Antimetabolites|antimetabolites|mesh-ancestor
110605839|NCT00907036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110605840|NCT00907036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110605841|NCT00907036|Immunologic Factors|immunologic factors|mesh-ancestor
110605842|NCT00907036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110605843|NCT00907036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110605844|NCT00907036|Antifungal Agents|antifungal agents|mesh-ancestor
110605845|NCT00907036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110605846|NCT00907036|Dermatologic Agents|dermatologic agents|mesh-ancestor
110605847|NCT00907036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110605848|NCT00907036|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110605849|NCT00907036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110605850|NCT00907036|Alkylating Agents|alkylating agents|mesh-ancestor
110605851|NCT00907036|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110605852|NCT00907036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110605853|NCT00926614|Pioglitazone|pioglitazone|mesh-list
110605854|NCT00926614|Atorvastatin|atorvastatin|mesh-list
110605855|NCT00926614|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110605856|NCT00926614|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110605857|NCT00926614|Antimetabolites|antimetabolites|mesh-ancestor
110605858|NCT00926614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110605859|NCT00926614|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110605860|NCT00926614|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110382075|NCT01688154|Procyanidin|procyanidin|mesh-list
110605861|NCT00926614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110605862|NCT00926614|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110605863|NCT00926614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110605864|NCT00907114|Ketorolac|ketorolac|mesh-list
110605865|NCT00907114|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
110605866|NCT00907114|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110605867|NCT00907114|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110605868|NCT00907114|Analgesics|analgesics|mesh-ancestor
110605869|NCT00907114|Sensory System Agents|sensory system agents|mesh-ancestor
110605870|NCT00907114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110605871|NCT00907114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110605872|NCT00907114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110605873|NCT00907114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110605874|NCT00907114|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110605875|NCT00907114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110605876|NCT00907114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110605877|NCT02564094|Epoetin Alfa|epoetin alfa|mesh-list
110605878|NCT02564094|Hematinics|hematinics|mesh-ancestor
110605879|NCT00745914|Pioglitazone|pioglitazone|mesh-list
110605880|NCT00745914|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110605881|NCT00745914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110605882|NCT00746070|Spironolactone|spironolactone|mesh-list
110605883|NCT00746070|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110605884|NCT00746070|Hormone Antagonists|hormone antagonists|mesh-ancestor
110605885|NCT00746070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110605886|NCT00746070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110605887|NCT00746070|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110605888|NCT00746070|Diuretics|diuretics|mesh-ancestor
110605889|NCT00746070|Natriuretic Agents|natriuretic agents|mesh-ancestor
110605890|NCT00396331|Plerixafor|plerixafor|mesh-list
110605891|NCT00396331|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110605892|NCT00396331|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110605893|NCT00396331|Antiviral Agents|antiviral agents|mesh-ancestor
110605894|NCT00396331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110605895|NCT00927550|Lithium Carbonate|lithium carbonate|mesh-list
110605896|NCT00927550|Antidepressive Agents|antidepressive agents|mesh-ancestor
110605897|NCT00927550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110605898|NCT00927550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110605899|NCT00927550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110605900|NCT00927550|Antimanic Agents|antimanic agents|mesh-ancestor
110605901|NCT00927550|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110605902|NCT00927550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110605903|NCT00927550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110605904|NCT00926926|Oxybutynin|oxybutynin|mesh-list
110605905|NCT00926926|Parasympatholytics|parasympatholytics|mesh-ancestor
110605906|NCT00926926|Autonomic Agents|autonomic agents|mesh-ancestor
110605907|NCT00926926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110605908|NCT00926926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110605909|NCT00926926|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110605910|NCT00926926|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110605911|NCT00926926|Cholinergic Agents|cholinergic agents|mesh-ancestor
110605912|NCT00926926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110605913|NCT00926926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110605914|NCT00926926|Urological Agents|urological agents|mesh-ancestor
110605915|NCT00396253|Tenecteplase|tenecteplase|mesh-list
110605916|NCT00396253|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110605917|NCT00396253|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110605918|NCT00396253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110605919|NCT00927004|Etoricoxib|etoricoxib|mesh-list
110605920|NCT00927004|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110605921|NCT00927004|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110605922|NCT00927004|Analgesics|analgesics|mesh-ancestor
110605923|NCT00927004|Sensory System Agents|sensory system agents|mesh-ancestor
110605924|NCT00927004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110605925|NCT00927004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110605926|NCT00927004|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110605927|NCT00927004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110605928|NCT00927004|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110605929|NCT00927004|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110605930|NCT00927004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110605931|NCT00927004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110605932|NCT00931450|Sunitinib|sunitinib|mesh-list
110605933|NCT00931450|Exemestane|exemestane|mesh-list
110605934|NCT00931450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110605935|NCT00931450|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110605936|NCT00931450|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110605937|NCT00931450|Growth Substances|growth substances|mesh-ancestor
110605938|NCT00931450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110605939|NCT00931450|Growth Inhibitors|growth inhibitors|mesh-ancestor
110605940|NCT00931450|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110605941|NCT00931450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110605942|NCT00931450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110605943|NCT00931450|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110605944|NCT00931450|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110605945|NCT00931450|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110605946|NCT00931450|Hormone Antagonists|hormone antagonists|mesh-ancestor
110605947|NCT00931450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110605948|NCT00928330|Trastuzumab|trastuzumab|mesh-list
110605949|NCT00928330|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
110605950|NCT00928330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110605951|NCT00928330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110605952|NCT00928330|Immunotoxins|immunotoxins|mesh-ancestor
110605953|NCT00928330|Immunoconjugates|immunoconjugates|mesh-ancestor
110605954|NCT00928330|Immunologic Factors|immunologic factors|mesh-ancestor
110605955|NCT00928330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110605956|NCT00928330|Tubulin Modulators|tubulin modulators|mesh-ancestor
110605957|NCT00928330|Antimitotic Agents|antimitotic agents|mesh-ancestor
110605958|NCT00928330|Mitosis Modulators|mitosis modulators|mesh-ancestor
110605959|NCT00928330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110605960|NCT00928798|Sirolimus|sirolimus|mesh-list
110605961|NCT00928798|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110605962|NCT00928798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110605963|NCT00928798|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110605964|NCT00928798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110605965|NCT00928798|Antifungal Agents|antifungal agents|mesh-ancestor
110605966|NCT00928798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110605967|NCT00928798|Immunologic Factors|immunologic factors|mesh-ancestor
110605968|NCT00928798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110605969|NCT00931840|Irinotecan|irinotecan|mesh-list
110605970|NCT00931840|Cetuximab|cetuximab|mesh-list
110605971|NCT00931840|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110605972|NCT00931840|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110605973|NCT00931840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110605974|NCT00931840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110605975|NCT00931840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110605976|NCT00931840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110605977|NCT04034368|Tenofovir|tenofovir|mesh-list
110605978|NCT04034368|Antiviral Agents|antiviral agents|mesh-ancestor
110605979|NCT04034368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110605980|NCT04034368|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110605981|NCT04034368|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110605982|NCT04034368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110605983|NCT04034368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110605984|NCT04034368|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110605985|NCT04034368|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110605986|NCT00907270|Cholecalciferol|cholecalciferol|mesh-list
110605987|NCT00907270|Vitamin D|vitamin d|mesh-list
110605988|NCT00907270|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110605989|NCT00907270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110605990|NCT00907270|Vitamins|vitamins|mesh-ancestor
110605991|NCT00907270|Micronutrients|micronutrients|mesh-ancestor
110605992|NCT00907270|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110283524|NCT00208065|Nasal Decongestants|nasal decongestants|mesh-ancestor
110605994|NCT00375505|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110605995|NCT00375505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110605996|NCT00928876|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
110605997|NCT00928876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110605998|NCT00907504|Cisplatin|cisplatin|mesh-list
110605999|NCT00907504|Gemcitabine|gemcitabine|mesh-list
110606000|NCT00907504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110606001|NCT00907504|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110606002|NCT00907504|Antimetabolites|antimetabolites|mesh-ancestor
110152244|NCT00000456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110606003|NCT00907504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110606005|NCT00932386|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110606006|NCT00932386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110606007|NCT00932386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110606008|NCT00932386|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110606009|NCT00932386|Analgesics|analgesics|mesh-ancestor
110606010|NCT00932386|Sensory System Agents|sensory system agents|mesh-ancestor
110606011|NCT00932386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110606012|NCT00932386|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110606013|NCT00932386|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110606014|NCT00932386|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110606015|NCT00932386|Adrenergic Agents|adrenergic agents|mesh-ancestor
110606016|NCT00932386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110606017|NCT00932386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110606018|NCT00932542|Lidocaine|lidocaine|mesh-list
110606019|NCT00932542|Prilocaine|prilocaine|mesh-list
110606020|NCT00932542|Anesthetics, Local|anesthetics, local|mesh-ancestor
110606021|NCT00932542|Anesthetics|anesthetics|mesh-ancestor
110606022|NCT00932542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110606023|NCT00932542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110606024|NCT00932542|Sensory System Agents|sensory system agents|mesh-ancestor
110606025|NCT00932542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110606026|NCT00932542|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110606027|NCT00932542|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110606028|NCT00932542|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110606029|NCT00932542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110606030|NCT00932542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110606031|NCT00375427|Zoledronic Acid|zoledronic acid|mesh-list
110606032|NCT00375427|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110606033|NCT00375427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110606034|NCT04014634|Methylprednisolone|methylprednisolone|mesh-list
110606035|NCT04014634|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110606036|NCT04014634|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110606037|NCT04014634|Prednisolone|prednisolone|mesh-list
110606038|NCT04014634|Prednisolone acetate|prednisolone acetate|mesh-list
110283536|NCT00203099|(T,G)-A-L|(t,g)-a-l|mesh-list
110606039|NCT04014634|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110606040|NCT04014634|Prednisolone phosphate|prednisolone phosphate|mesh-list
110606041|NCT04014634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110606042|NCT04014634|Antiemetics|antiemetics|mesh-ancestor
110606043|NCT04014634|Autonomic Agents|autonomic agents|mesh-ancestor
110606044|NCT04014634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110606045|NCT04014634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110606046|NCT04014634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110606047|NCT04014634|Glucocorticoids|glucocorticoids|mesh-ancestor
110606048|NCT04014634|Hormones|hormones|mesh-ancestor
110606049|NCT04014634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110606050|NCT04014634|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110606051|NCT04014634|Protective Agents|protective agents|mesh-ancestor
110606052|NCT04014634|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110606053|NCT04014634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110606054|NCT01043575|Rifampin|rifampin|mesh-list
110606055|NCT01043575|Rifapentine|rifapentine|mesh-list
110606056|NCT01043575|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110606057|NCT01043575|Antitubercular Agents|antitubercular agents|mesh-ancestor
110606058|NCT01043575|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110606059|NCT01043575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110606060|NCT01043575|Leprostatic Agents|leprostatic agents|mesh-ancestor
110606061|NCT01043575|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110606062|NCT01043575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110606063|NCT01043575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110606064|NCT01043575|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110382162|NCT02278913|Insulin|insulin|mesh-list
110606065|NCT01043575|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110606066|NCT01043575|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110606067|NCT01043575|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110606068|NCT01043575|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110606069|NCT01043575|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110606070|NCT01045837|Prednisolone|prednisolone|mesh-list
110606071|NCT01045837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110606073|NCT01045837|Hormones|hormones|mesh-ancestor
110606074|NCT01045837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110606075|NCT01045837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110606076|NCT01045837|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110606077|NCT01045837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110606078|NCT00567268|Gabapentin|gabapentin|mesh-list
110606079|NCT00567268|Analgesics|analgesics|mesh-ancestor
110606080|NCT00567268|Sensory System Agents|sensory system agents|mesh-ancestor
110606081|NCT00567268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110606082|NCT00567268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110606083|NCT00567268|Anticonvulsants|anticonvulsants|mesh-ancestor
110606084|NCT00567268|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110606085|NCT00567268|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110606086|NCT00567268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110606087|NCT00567268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110606088|NCT00567268|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110606089|NCT00567268|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110606090|NCT00567268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110606091|NCT00567268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110606092|NCT00567268|Antimanic Agents|antimanic agents|mesh-ancestor
110606093|NCT00907894|Telbivudine|telbivudine|mesh-list
110606094|NCT00907894|Antiviral Agents|antiviral agents|mesh-ancestor
110606095|NCT00907894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110606096|NCT00907894|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110606097|NCT00907894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110606098|NCT00907894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110606099|NCT04014556|Aflibercept|aflibercept|mesh-list
110606100|NCT04014556|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110606101|NCT04014556|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110606102|NCT04014556|Growth Substances|growth substances|mesh-ancestor
110606103|NCT04014556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110606104|NCT04014556|Growth Inhibitors|growth inhibitors|mesh-ancestor
110606105|NCT04014556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110606106|NCT00929812|Glucagon|glucagon|mesh-list
110606107|NCT00929812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110606109|NCT00929812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110606110|NCT00929812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110606111|NCT00907972|Vitamin D|vitamin d|mesh-list
110606112|NCT00907972|Ergocalciferols|ergocalciferols|mesh-list
110606113|NCT00907972|Cholecalciferol|cholecalciferol|mesh-list
110606114|NCT00907972|Vitamins|vitamins|mesh-list
110606115|NCT00907972|Micronutrients|micronutrients|mesh-ancestor
110606116|NCT00907972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110382185|NCT01198756|Vaccines|vaccines|mesh-list
110606117|NCT00907972|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110606118|NCT00907972|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110606119|NCT03799744|Durvalumab|durvalumab|mesh-list
110606120|NCT03799744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110606121|NCT03799744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110606122|NCT00933634|Propafenone|propafenone|mesh-list
110606123|NCT00933634|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110606124|NCT00933634|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110606125|NCT00933634|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110606126|NCT00933634|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110606127|NCT00933634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110606128|NCT00933790|Rifampin|rifampin|mesh-list
110606129|NCT00933790|Pyrazinamide|pyrazinamide|mesh-list
110606130|NCT00933790|Ethambutol|ethambutol|mesh-list
110606131|NCT00933790|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110606132|NCT00933790|Antitubercular Agents|antitubercular agents|mesh-ancestor
110606133|NCT00933790|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110606134|NCT00933790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110606135|NCT00933790|Leprostatic Agents|leprostatic agents|mesh-ancestor
110606136|NCT00933790|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110606137|NCT00933790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110606138|NCT00933790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110606139|NCT00933790|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110152255|NCT05442268|Acetaminophen|acetaminophen|mesh-list
110606140|NCT00933790|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110606141|NCT00933790|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110606142|NCT00933790|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110606143|NCT00933790|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110606144|NCT00933790|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110606145|NCT00566254|Zonisamide|zonisamide|mesh-list
110606146|NCT00566254|Anticonvulsants|anticonvulsants|mesh-ancestor
110606147|NCT00566254|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110606148|NCT00566254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110606149|NCT00566254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110606150|NCT00566254|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110606151|NCT00566254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110606152|NCT00930202|Conivaptan|conivaptan|mesh-list
110606153|NCT00930202|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
110606154|NCT00930202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110606155|NCT00930202|Natriuretic Agents|natriuretic agents|mesh-ancestor
110606156|NCT00930202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110606157|NCT00393367|Prednisone|prednisone|mesh-list
110606158|NCT00393367|Methylprednisolone|methylprednisolone|mesh-list
110606159|NCT00393367|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110606160|NCT00393367|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110606161|NCT00393367|Prednisolone|prednisolone|mesh-list
110606162|NCT00393367|Prednisolone acetate|prednisolone acetate|mesh-list
110606163|NCT00393367|Budesonide|budesonide|mesh-list
110606164|NCT00393367|Bromides|bromides|mesh-list
110606165|NCT00393367|Albuterol|albuterol|mesh-list
110606166|NCT00393367|Ipratropium|ipratropium|mesh-list
110606167|NCT00393367|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110606169|NCT00393367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110606170|NCT00393367|Glucocorticoids|glucocorticoids|mesh-ancestor
110606171|NCT00393367|Hormones|hormones|mesh-ancestor
110606172|NCT00393367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110606173|NCT00393367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110606174|NCT00393367|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110606175|NCT00393367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110606176|NCT00393367|Antiemetics|antiemetics|mesh-ancestor
110606177|NCT00393367|Autonomic Agents|autonomic agents|mesh-ancestor
110606178|NCT00393367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110606179|NCT00393367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110606180|NCT00393367|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110606181|NCT00393367|Protective Agents|protective agents|mesh-ancestor
110253491|NCT00142025|Oxcarbazepine|oxcarbazepine|mesh-list
110606183|NCT00393367|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110606184|NCT00393367|Respiratory System Agents|respiratory system agents|mesh-ancestor
110606185|NCT00393367|Anticonvulsants|anticonvulsants|mesh-ancestor
110606186|NCT00393367|Tocolytic Agents|tocolytic agents|mesh-ancestor
110606187|NCT00393367|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110606188|NCT00393367|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110606189|NCT00393367|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110606190|NCT00393367|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110606191|NCT00393367|Adrenergic Agents|adrenergic agents|mesh-ancestor
110606192|NCT00393367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110606193|NCT00393367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110606194|NCT00393367|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110606195|NCT00393367|Cholinergic Agents|cholinergic agents|mesh-ancestor
110606196|NCT00395629|Deferasirox|deferasirox|mesh-list
110606197|NCT00395629|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110606198|NCT00395629|Chelating Agents|chelating agents|mesh-ancestor
110606199|NCT00395629|Sequestering Agents|sequestering agents|mesh-ancestor
110606200|NCT00395629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110606202|NCT00392665|Bevacizumab|bevacizumab|mesh-list
110606203|NCT00392665|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110606204|NCT00392665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110606205|NCT00392665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110606206|NCT00392665|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110606207|NCT00392665|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110606208|NCT00392665|Growth Substances|growth substances|mesh-ancestor
110606209|NCT00392665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110606210|NCT00392665|Growth Inhibitors|growth inhibitors|mesh-ancestor
110606211|NCT00392665|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110606212|NCT00392665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110606213|NCT00392665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110606214|NCT00392665|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110606215|NCT00392665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110606216|NCT00392665|Analgesics|analgesics|mesh-ancestor
110606217|NCT00392665|Sensory System Agents|sensory system agents|mesh-ancestor
110606218|NCT00392665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110606219|NCT00392665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110606220|NCT00392665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110606221|NCT00392665|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110606222|NCT01043965|Metformin|metformin|mesh-list
110606223|NCT01043965|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110606224|NCT01043965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110606225|NCT00622869|Everolimus|everolimus|mesh-list
110606226|NCT00622869|Tacrolimus|tacrolimus|mesh-list
110606227|NCT00622869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110606228|NCT00622869|Immunologic Factors|immunologic factors|mesh-ancestor
110606229|NCT00622869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110606230|NCT00622869|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110606231|NCT00622869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110606232|NCT00622869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110606233|NCT00622869|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110606234|NCT00622869|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110606235|NCT00622869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110606236|NCT00366457|Bevacizumab|bevacizumab|mesh-list
110606237|NCT00366457|Gemcitabine|gemcitabine|mesh-list
110606238|NCT00366457|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110606239|NCT00366457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110606240|NCT00366457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110606241|NCT00366457|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110606242|NCT00366457|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110606243|NCT00366457|Growth Substances|growth substances|mesh-ancestor
110606244|NCT00366457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110606245|NCT00366457|Growth Inhibitors|growth inhibitors|mesh-ancestor
110606246|NCT00366457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110606248|NCT00366457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110606249|NCT00366457|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110606250|NCT00366457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110606251|NCT00624819|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110606252|NCT00624819|Immunologic Factors|immunologic factors|mesh-ancestor
110606253|NCT00624819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110606254|NCT01049347|Amitriptyline|amitriptyline|mesh-list
110606255|NCT01049347|Paroxetine|paroxetine|mesh-list
110606256|NCT01049347|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110606257|NCT01049347|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110606258|NCT01049347|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110606259|NCT01049347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110606260|NCT01049347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110606261|NCT01049347|Serotonin Agents|serotonin agents|mesh-ancestor
110606262|NCT01049347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110606263|NCT01049347|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110606264|NCT01049347|Antidepressive Agents|antidepressive agents|mesh-ancestor
110606265|NCT01049347|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110606266|NCT01049347|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110606267|NCT01049347|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110606268|NCT01049347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110606269|NCT01049347|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110606270|NCT01049347|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110606271|NCT01049347|Analgesics|analgesics|mesh-ancestor
110606272|NCT01049347|Sensory System Agents|sensory system agents|mesh-ancestor
110606273|NCT01049347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110606274|NCT01049347|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110606275|NCT01049347|Adrenergic Agents|adrenergic agents|mesh-ancestor
110606276|NCT01049425|Cyclophosphamide|cyclophosphamide|mesh-list
110606278|NCT01049425|Epirubicin|epirubicin|mesh-list
110606279|NCT01049425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110606280|NCT01049425|Immunologic Factors|immunologic factors|mesh-ancestor
110606281|NCT01049425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110606282|NCT01049425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110606283|NCT01049425|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110606284|NCT01049425|Alkylating Agents|alkylating agents|mesh-ancestor
110606285|NCT01049425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110606286|NCT01049425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110606287|NCT01049425|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110606288|NCT01049425|Tubulin Modulators|tubulin modulators|mesh-ancestor
110606289|NCT01049425|Antimitotic Agents|antimitotic agents|mesh-ancestor
110606290|NCT01049425|Mitosis Modulators|mitosis modulators|mesh-ancestor
110606291|NCT01049425|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110606292|NCT01049425|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110606293|NCT01049425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110606294|NCT01049425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110606295|NCT00838227|Modafinil|modafinil|mesh-list
110606296|NCT00838227|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110606297|NCT00838227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110606298|NCT00838227|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
110606299|NCT00838227|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110606300|NCT00838227|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110606301|NCT00838227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110606302|NCT00366301|Metformin|metformin|mesh-list
110606303|NCT00366301|Insulin Glargine|insulin glargine|mesh-list
110606304|NCT00366301|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110606305|NCT00366301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110606306|NCT00838305|Citalopram|citalopram|mesh-list
110606307|NCT00838305|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110606308|NCT00838305|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110606309|NCT00838305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110606310|NCT00838305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110606311|NCT00838305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110606312|NCT00838305|Serotonin Agents|serotonin agents|mesh-ancestor
110606313|NCT00838305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110606314|NCT00838305|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110606315|NCT00838305|Antidepressive Agents|antidepressive agents|mesh-ancestor
110606316|NCT00838305|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110606317|NCT00622713|Rivastigmine|rivastigmine|mesh-list
110606318|NCT00622713|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110606319|NCT00622713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110606320|NCT00622713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110606321|NCT00622713|Cholinergic Agents|cholinergic agents|mesh-ancestor
110606322|NCT00622713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110606323|NCT00622713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110606324|NCT00622713|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110606325|NCT00622713|Protective Agents|protective agents|mesh-ancestor
110606326|NCT01046227|Vaccines|vaccines|mesh-list
110606327|NCT01046227|Immunologic Factors|immunologic factors|mesh-ancestor
110606328|NCT01046227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110606329|NCT00392197|Aripiprazole|aripiprazole|mesh-list
110606330|NCT00392197|Antidepressive Agents|antidepressive agents|mesh-ancestor
110606331|NCT00392197|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110606332|NCT00392197|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110606333|NCT00392197|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110606334|NCT00392197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110606335|NCT00392197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110606336|NCT00392197|Dopamine Agonists|dopamine agonists|mesh-ancestor
110606337|NCT00392197|Dopamine Agents|dopamine agents|mesh-ancestor
110606338|NCT00392197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110606339|NCT00392197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110606340|NCT00392197|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110606341|NCT00392197|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110606342|NCT00392197|Serotonin Agents|serotonin agents|mesh-ancestor
110152267|NCT05442268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110606343|NCT00392197|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110606344|NCT00392197|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110606345|NCT00392197|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110606346|NCT00392197|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110606347|NCT00391807|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110606348|NCT00391807|Norethindrone|norethindrone|mesh-list
110606349|NCT00391807|Norethindrone Acetate|norethindrone acetate|mesh-list
110606351|NCT00391807|Estrogens|estrogens|mesh-ancestor
110606352|NCT00391807|Hormones|hormones|mesh-ancestor
110606353|NCT00391807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110606354|NCT00391807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110606355|NCT00391807|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110606356|NCT00391807|Contraceptive Agents|contraceptive agents|mesh-ancestor
110606357|NCT00391807|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110606358|NCT00391807|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110606359|NCT00391807|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110606360|NCT00391807|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110606361|NCT00391807|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110606362|NCT00624585|Dasatinib|dasatinib|mesh-list
110606363|NCT00624585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110606364|NCT00624585|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110606365|NCT00624585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110606366|NCT00624585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110606367|NCT01046383|Caseins|caseins|mesh-list
110606368|NCT01046383|Chelating Agents|chelating agents|mesh-ancestor
110606369|NCT01046383|Sequestering Agents|sequestering agents|mesh-ancestor
110606370|NCT01046383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110606371|NCT00831597|Rituximab|rituximab|mesh-list
110606372|NCT00831597|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110606373|NCT00831597|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110606374|NCT00831597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110606375|NCT00831597|Immunologic Factors|immunologic factors|mesh-ancestor
110606376|NCT00831597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110606377|NCT00831597|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110606378|NCT00831597|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110606379|NCT00831597|Alkylating Agents|alkylating agents|mesh-ancestor
110606380|NCT00831597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110606381|NCT00622635|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110606382|NCT00622635|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110606383|NCT00622635|Autonomic Agents|autonomic agents|mesh-ancestor
110283572|NCT00203177|Rasagiline|rasagiline|mesh-list
110606384|NCT00622635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110606385|NCT00622635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110606386|NCT00622635|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110606387|NCT00622635|Respiratory System Agents|respiratory system agents|mesh-ancestor
110606388|NCT00622635|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110606389|NCT00622635|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110606390|NCT00622635|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110606391|NCT00622635|Adrenergic Agents|adrenergic agents|mesh-ancestor
110606392|NCT00622635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110606393|NCT00622635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110606394|NCT00391027|Insulin|insulin|mesh-list
110606395|NCT00391027|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110606396|NCT00391027|Insulin Glargine|insulin glargine|mesh-list
110606397|NCT00391027|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110606398|NCT00391027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110606399|NCT00622401|Interleukin-12|interleukin-12|mesh-list
110606400|NCT00622401|Vaccines|vaccines|mesh-list
110606401|NCT00622401|Immunologic Factors|immunologic factors|mesh-ancestor
110606402|NCT00622401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110606403|NCT00622401|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110606404|NCT00622401|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110606405|NCT00622401|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110606406|NCT00622401|Growth Substances|growth substances|mesh-ancestor
110606407|NCT00622401|Growth Inhibitors|growth inhibitors|mesh-ancestor
110606408|NCT00622401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110606409|NCT04018365|Empagliflozin|empagliflozin|mesh-list
110606410|NCT04018365|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110606411|NCT04018365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110606412|NCT04018365|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110606413|NCT04018365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110606415|NCT00828087|Chromium|chromium|mesh-list
110606416|NCT00828087|Everolimus|everolimus|mesh-list
110606417|NCT00828087|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110606418|NCT00828087|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110606419|NCT00828087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110606420|NCT00828087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110606421|NCT00828087|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110606422|NCT00828087|Immunologic Factors|immunologic factors|mesh-ancestor
110606423|NCT00828087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110606424|NCT00828087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110606425|NCT00828087|Trace Elements|trace elements|mesh-ancestor
110606426|NCT00828087|Micronutrients|micronutrients|mesh-ancestor
110606427|NCT00839085|Ascorbic Acid|ascorbic acid|mesh-list
110606428|NCT00839085|Grape Seed Extract|grape seed extract|mesh-list
110606429|NCT00839085|Antioxidants|antioxidants|mesh-ancestor
110606430|NCT00839085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110606431|NCT00839085|Protective Agents|protective agents|mesh-ancestor
110606432|NCT00839085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110606433|NCT00839085|Vitamins|vitamins|mesh-ancestor
110606434|NCT00839085|Micronutrients|micronutrients|mesh-ancestor
110606435|NCT00839085|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110606436|NCT00839085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110606437|NCT00839163|Vitamin K|vitamin k|mesh-list
110606438|NCT00839163|Enoxaparin|enoxaparin|mesh-list
110606439|NCT00839163|Rivaroxaban|rivaroxaban|mesh-list
110606440|NCT00839163|Vitamins|vitamins|mesh-ancestor
110606441|NCT00839163|Micronutrients|micronutrients|mesh-ancestor
110606442|NCT00839163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110606443|NCT00839163|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110606444|NCT00839163|Antithrombins|antithrombins|mesh-ancestor
110606445|NCT00839163|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110606446|NCT00839163|Protease Inhibitors|protease inhibitors|mesh-ancestor
110606447|NCT00839163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110606448|NCT00839163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110606449|NCT00839163|Anticoagulants|anticoagulants|mesh-ancestor
110606450|NCT00839163|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110606451|NCT00839163|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110606452|NCT00839163|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110606453|NCT00839163|Hemostatics|hemostatics|mesh-ancestor
110606454|NCT00839163|Coagulants|coagulants|mesh-ancestor
110606455|NCT02549001|Amorolfine|amorolfine|mesh-list
110606456|NCT02549001|Antifungal Agents|antifungal agents|mesh-ancestor
110606457|NCT02549001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110606458|NCT00621543|Copper|copper|mesh-list
110606459|NCT00621543|Levonorgestrel|levonorgestrel|mesh-list
110606460|NCT00621543|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110606461|NCT00621543|Contraceptive Agents|contraceptive agents|mesh-ancestor
110606462|NCT00621543|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110606463|NCT00621543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110606464|NCT00621543|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110606465|NCT00621543|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110606466|NCT00621543|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110606467|NCT00621543|Trace Elements|trace elements|mesh-ancestor
110606468|NCT00621543|Micronutrients|micronutrients|mesh-ancestor
110606469|NCT00623805|Bevacizumab|bevacizumab|mesh-list
110606470|NCT00623805|Capecitabine|capecitabine|mesh-list
110606471|NCT00623805|Oxaliplatin|oxaliplatin|mesh-list
110606472|NCT00623805|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110606473|NCT00623805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110606474|NCT00623805|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110606475|NCT00623805|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110606476|NCT00623805|Growth Substances|growth substances|mesh-ancestor
110606477|NCT00623805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110606478|NCT00623805|Growth Inhibitors|growth inhibitors|mesh-ancestor
110606479|NCT00623805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110606480|NCT00623805|Antimetabolites|antimetabolites|mesh-ancestor
110606481|NCT00623805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110606482|NCT02548923|Dexmedetomidine|dexmedetomidine|mesh-list
110606483|NCT02548923|Propofol|propofol|mesh-list
110606484|NCT02548923|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110606485|NCT02548923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110606486|NCT02548923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110606488|NCT02548923|Analgesics|analgesics|mesh-ancestor
110606489|NCT02548923|Sensory System Agents|sensory system agents|mesh-ancestor
110606490|NCT02548923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110606491|NCT02548923|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110606492|NCT02548923|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110606493|NCT02548923|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110606494|NCT02548923|Adrenergic Agents|adrenergic agents|mesh-ancestor
110606495|NCT02548923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110606496|NCT02548923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110606497|NCT02548923|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110606498|NCT02548923|Anesthetics, General|anesthetics, general|mesh-ancestor
110606499|NCT02548923|Anesthetics|anesthetics|mesh-ancestor
110606500|NCT00832221|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110606501|NCT00832221|Raclopride|raclopride|mesh-list
110606502|NCT00832221|Antidepressive Agents|antidepressive agents|mesh-ancestor
110606503|NCT00832221|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110606504|NCT00832221|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110606505|NCT00832221|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110606506|NCT00832221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110606507|NCT00832221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110606508|NCT00832221|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110606509|NCT00832221|Dopamine Agents|dopamine agents|mesh-ancestor
110606510|NCT00832221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110606511|NCT00832221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110606512|NCT00839397|Paroxetine|paroxetine|mesh-list
110606513|NCT00839397|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110606514|NCT00839397|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110606515|NCT00839397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110606516|NCT00839397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110606517|NCT00839397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110606518|NCT00839397|Serotonin Agents|serotonin agents|mesh-ancestor
110606519|NCT00839397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110606520|NCT00839397|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110606521|NCT00839397|Antidepressive Agents|antidepressive agents|mesh-ancestor
110606522|NCT00839397|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110606523|NCT00839397|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110606524|NCT00839397|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110606525|NCT00839397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110606526|NCT00828477|Nepafenac|nepafenac|mesh-list
110606527|NCT00828477|Bromfenac|bromfenac|mesh-list
110606528|NCT00828477|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110606529|NCT00828477|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110606530|NCT00828477|Analgesics|analgesics|mesh-ancestor
110606531|NCT00828477|Sensory System Agents|sensory system agents|mesh-ancestor
110606532|NCT00828477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110606533|NCT00828477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110606534|NCT00828477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110606535|NCT00828477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110606536|NCT00621309|Rifampin|rifampin|mesh-list
110606537|NCT00621309|Rifamycins|rifamycins|mesh-list
110606538|NCT00621309|Sulforaphane|sulforaphane|mesh-list
110606539|NCT00621309|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110606540|NCT00621309|Antitubercular Agents|antitubercular agents|mesh-ancestor
110606541|NCT00621309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110606542|NCT00621309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110606543|NCT00621309|Leprostatic Agents|leprostatic agents|mesh-ancestor
110606544|NCT00621309|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110606545|NCT00621309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110606546|NCT00621309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110606547|NCT00621309|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110606548|NCT00621309|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110606549|NCT00621309|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110606550|NCT00621309|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110606551|NCT00621309|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110606552|NCT00621309|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110606553|NCT00621309|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110606554|NCT00621309|Protective Agents|protective agents|mesh-ancestor
110606555|NCT00621309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110152284|NCT02972476|Xhance|xhance|mesh-list
110606556|NCT00621309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110606558|NCT00839553|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110606559|NCT00839553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110606560|NCT00832689|Gemcitabine|gemcitabine|mesh-list
110606561|NCT00832689|Irinotecan|irinotecan|mesh-list
110606562|NCT00832689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110606563|NCT00832689|Antimetabolites|antimetabolites|mesh-ancestor
110606564|NCT00832689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110606565|NCT00832689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110606566|NCT00832689|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110606567|NCT00832689|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110606568|NCT00832689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110606569|NCT00567190|Docetaxel|docetaxel|mesh-list
110606570|NCT00567190|Trastuzumab|trastuzumab|mesh-list
110606571|NCT00567190|Pertuzumab|pertuzumab|mesh-list
110606572|NCT00567190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110606573|NCT00567190|Tubulin Modulators|tubulin modulators|mesh-ancestor
110606574|NCT00567190|Antimitotic Agents|antimitotic agents|mesh-ancestor
110606575|NCT00567190|Mitosis Modulators|mitosis modulators|mesh-ancestor
110606576|NCT00567190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110606577|NCT00567190|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110606578|NCT00922389|Lenograstim|lenograstim|mesh-list
110606579|NCT00922389|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110606580|NCT00922389|Immunologic Factors|immunologic factors|mesh-ancestor
110606581|NCT00922389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110606582|NCT00691938|Decitabine|decitabine|mesh-list
110606583|NCT00691938|Panobinostat|panobinostat|mesh-list
110606584|NCT00691938|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110606585|NCT00691938|Antimetabolites|antimetabolites|mesh-ancestor
110606586|NCT00691938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110606587|NCT00691938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110606588|NCT00691938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110606589|NCT00691938|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110606590|NCT00365365|Cyclophosphamide|cyclophosphamide|mesh-list
110606591|NCT00365365|Bevacizumab|bevacizumab|mesh-list
110606592|NCT00365365|Carboplatin|carboplatin|mesh-list
110606593|NCT00365365|Docetaxel|docetaxel|mesh-list
110606594|NCT00365365|Doxorubicin|doxorubicin|mesh-list
110606595|NCT00365365|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110606596|NCT00365365|Trastuzumab|trastuzumab|mesh-list
110606597|NCT00365365|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110606598|NCT00365365|Immunologic Factors|immunologic factors|mesh-ancestor
110606599|NCT00365365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110382433|NCT04532931|Amodiaquine|amodiaquine|mesh-list
110606600|NCT00365365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110606601|NCT00365365|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110606602|NCT00365365|Alkylating Agents|alkylating agents|mesh-ancestor
110606603|NCT00365365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110606604|NCT00365365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110606605|NCT00365365|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110606606|NCT00365365|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110606607|NCT00365365|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110606608|NCT00365365|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110606609|NCT00365365|Growth Substances|growth substances|mesh-ancestor
110606610|NCT00365365|Growth Inhibitors|growth inhibitors|mesh-ancestor
110606611|NCT00365365|Tubulin Modulators|tubulin modulators|mesh-ancestor
110606612|NCT00365365|Antimitotic Agents|antimitotic agents|mesh-ancestor
110606613|NCT00365365|Mitosis Modulators|mitosis modulators|mesh-ancestor
110606614|NCT00365365|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110606615|NCT00365365|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110606616|NCT00365365|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110606617|NCT00365365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110606618|NCT01046461|Dexamethasone|dexamethasone|mesh-list
110606619|NCT01046461|Aprepitant|aprepitant|mesh-list
110606620|NCT01046461|Ramosetron|ramosetron|mesh-list
110606621|NCT01046461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110606622|NCT01046461|Antiemetics|antiemetics|mesh-ancestor
110606623|NCT01046461|Autonomic Agents|autonomic agents|mesh-ancestor
110606624|NCT01046461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110606625|NCT01046461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110606626|NCT01046461|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110606627|NCT01046461|Glucocorticoids|glucocorticoids|mesh-ancestor
110606628|NCT01046461|Hormones|hormones|mesh-ancestor
110606629|NCT01046461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110152285|NCT02972476|Budesonide|budesonide|mesh-list
110606630|NCT01046461|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110606631|NCT01046461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110606632|NCT01046461|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110606633|NCT01046461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110606634|NCT01046461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110606635|NCT01046461|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110606636|NCT01046461|Serotonin Agents|serotonin agents|mesh-ancestor
110606637|NCT00623727|Factor VIII|factor viii|mesh-list
110606638|NCT00623727|Coagulants|coagulants|mesh-ancestor
110606639|NCT01046539|Buprenorphine|buprenorphine|mesh-list
110606640|NCT01046539|ALKS-33|alks-33|mesh-list
110606641|NCT01046539|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110606642|NCT01046539|Narcotics|narcotics|mesh-ancestor
110606643|NCT01046539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110606644|NCT01046539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110606646|NCT01046539|Sensory System Agents|sensory system agents|mesh-ancestor
110606647|NCT01046539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110606648|NCT01046539|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110606649|NCT01044199|Vaccines|vaccines|mesh-list
110606650|NCT01044199|Immunologic Factors|immunologic factors|mesh-ancestor
110606651|NCT01044199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110606652|NCT00828789|Tenofovir|tenofovir|mesh-list
110606653|NCT00828789|Efavirenz|efavirenz|mesh-list
110606654|NCT00828789|Antiviral Agents|antiviral agents|mesh-ancestor
110606655|NCT00828789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110606656|NCT00828789|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110606657|NCT00828789|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110606658|NCT00828789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110606659|NCT00828789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110606660|NCT00828789|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110606661|NCT00828789|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110606662|NCT00828789|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110606663|NCT00828789|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110606664|NCT00828789|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110606665|NCT00828789|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110606666|NCT00828789|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110606667|NCT00828789|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110606668|NCT00930358|Anesthetics|anesthetics|mesh-list
110606669|NCT00930358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110606670|NCT00930358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110606671|NCT00372775|Sunitinib|sunitinib|mesh-list
110606672|NCT00372775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110606673|NCT00372775|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110606674|NCT00372775|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110606675|NCT00372775|Growth Substances|growth substances|mesh-ancestor
110606676|NCT00372775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110606677|NCT00372775|Growth Inhibitors|growth inhibitors|mesh-ancestor
110606678|NCT00372775|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110606679|NCT00372775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110606680|NCT00372775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110606681|NCT00936676|Rasagiline|rasagiline|mesh-list
110606682|NCT00936676|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
110606683|NCT00936676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110606684|NCT00936676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110606685|NCT00936676|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110606686|NCT00936676|Protective Agents|protective agents|mesh-ancestor
110606687|NCT00936676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110606688|NCT00839787|Morphine|morphine|mesh-list
110606689|NCT00839787|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110606690|NCT00839787|Narcotics|narcotics|mesh-ancestor
110606691|NCT00839787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110606692|NCT00839787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110606693|NCT00839787|Analgesics|analgesics|mesh-ancestor
110606694|NCT00839787|Sensory System Agents|sensory system agents|mesh-ancestor
110382502|NCT02218619|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
110606695|NCT00839787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110606696|NCT00934258|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110606697|NCT00934258|Fenofibrate|fenofibrate|mesh-list
110606698|NCT00934258|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110152292|NCT02972476|Autonomic Agents|autonomic agents|mesh-ancestor
110606699|NCT00934258|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110606700|NCT00934258|Antimetabolites|antimetabolites|mesh-ancestor
110606701|NCT00934258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110606702|NCT00934258|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110606703|NCT00934258|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110606704|NCT00934258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110606705|NCT00372697|Octreotide|octreotide|mesh-list
110606706|NCT00372697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110606707|NCT00372697|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110606708|NCT00372697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110606709|NCT00934414|Insulin|insulin|mesh-list
110606710|NCT00934414|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110606711|NCT00934414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110606712|NCT00930514|Rituximab|rituximab|mesh-list
110606713|NCT00930514|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110606714|NCT00930514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110606715|NCT00930514|Immunologic Factors|immunologic factors|mesh-ancestor
110606716|NCT00930514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110606717|NCT00930514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110606718|NCT00936988|Cinacalcet|cinacalcet|mesh-list
110606719|NCT00936988|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110606720|NCT00936988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110606721|NCT00936988|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
110606722|NCT00936988|Hormone Antagonists|hormone antagonists|mesh-ancestor
110606723|NCT00936988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110606724|NCT00934492|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
110606725|NCT00934492|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110606726|NCT00934492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110606727|NCT00934492|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110606728|NCT00934492|Antimalarials|antimalarials|mesh-ancestor
110606729|NCT00934492|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110606730|NCT00934492|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110606731|NCT00934570|Metformin|metformin|mesh-list
110606732|NCT00934570|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110606733|NCT00934570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110606734|NCT00930670|Esomeprazole|esomeprazole|mesh-list
110606735|NCT00930670|Omeprazole|omeprazole|mesh-list
110606736|NCT00930670|Pantoprazole|pantoprazole|mesh-list
110606737|NCT00930670|Ranitidine|ranitidine|mesh-list
110606738|NCT00930670|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
110606739|NCT00930670|Atorvastatin|atorvastatin|mesh-list
110606740|NCT00930670|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110606741|NCT00930670|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110606742|NCT00930670|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110606743|NCT00930670|Antimetabolites|antimetabolites|mesh-ancestor
110606744|NCT00930670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110606745|NCT00930670|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110606746|NCT00930670|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110606747|NCT00930670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110606748|NCT00930670|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110606749|NCT00930670|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110606750|NCT00930670|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110606751|NCT00930670|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110606752|NCT00930670|Histamine Antagonists|histamine antagonists|mesh-ancestor
110606753|NCT00930670|Histamine Agents|histamine agents|mesh-ancestor
110606754|NCT00930670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110606755|NCT00930670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110606756|NCT00937144|Sildenafil Citrate|sildenafil citrate|mesh-list
110606757|NCT00937144|Vasodilator Agents|vasodilator agents|mesh-ancestor
110606758|NCT00937144|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110606759|NCT00937144|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110606760|NCT00937144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110606761|NCT00937144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110606762|NCT00937144|Urological Agents|urological agents|mesh-ancestor
110606763|NCT00937300|Cyclophosphamide|cyclophosphamide|mesh-list
110606764|NCT00937300|Fludarabine|fludarabine|mesh-list
110606765|NCT00937300|Fludarabine phosphate|fludarabine phosphate|mesh-list
110606766|NCT00937300|Interleukin-2|interleukin-2|mesh-list
110606767|NCT00937300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110606768|NCT00937300|Immunologic Factors|immunologic factors|mesh-ancestor
110606769|NCT00937300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110606770|NCT00937300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110606771|NCT00937300|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110606772|NCT00937300|Alkylating Agents|alkylating agents|mesh-ancestor
110606773|NCT00937300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110606774|NCT00937300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110606775|NCT00937300|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110606776|NCT00937300|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110606777|NCT00937300|Antimetabolites|antimetabolites|mesh-ancestor
110254087|NCT05149339|Vitamin D|vitamin d|mesh-list
110606778|NCT00937300|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110606779|NCT00937300|Analgesics|analgesics|mesh-ancestor
110606780|NCT00937300|Sensory System Agents|sensory system agents|mesh-ancestor
110606781|NCT00937300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110606782|NCT02226276|Copper|copper|mesh-list
110606783|NCT02226276|Trastuzumab|trastuzumab|mesh-list
110606784|NCT02226276|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
110606785|NCT02226276|Maytansine|maytansine|mesh-list
110606786|NCT02226276|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110606787|NCT02226276|Immunoconjugates|immunoconjugates|mesh-list
110606788|NCT02226276|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110606789|NCT02226276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110606790|NCT02226276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110606791|NCT02226276|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110606792|NCT02226276|Trace Elements|trace elements|mesh-ancestor
110606793|NCT02226276|Micronutrients|micronutrients|mesh-ancestor
110606794|NCT02226276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110606795|NCT02226276|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110606796|NCT02226276|Tubulin Modulators|tubulin modulators|mesh-ancestor
110606797|NCT02226276|Antimitotic Agents|antimitotic agents|mesh-ancestor
110606798|NCT02226276|Mitosis Modulators|mitosis modulators|mesh-ancestor
110606799|NCT02226276|Immunotoxins|immunotoxins|mesh-ancestor
110606800|NCT02226276|Immunologic Factors|immunologic factors|mesh-ancestor
110606801|NCT00935116|Etoricoxib|etoricoxib|mesh-list
110606802|NCT00935116|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110606803|NCT00935116|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110606804|NCT00935116|Analgesics|analgesics|mesh-ancestor
110606805|NCT00935116|Sensory System Agents|sensory system agents|mesh-ancestor
110606806|NCT00935116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110606807|NCT00935116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110606808|NCT00935116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110606809|NCT00935116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110606810|NCT00935116|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110606811|NCT00935116|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110606812|NCT00935116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110606813|NCT00935116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110606814|NCT00931138|Cytarabine|cytarabine|mesh-list
110606815|NCT00931138|Daunorubicin|daunorubicin|mesh-list
110606816|NCT00931138|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110606817|NCT00931138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110606818|NCT00931138|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110606819|NCT00931138|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110606820|NCT00931138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110606821|NCT00931138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110606822|NCT00931138|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110606823|NCT00931138|Antimetabolites|antimetabolites|mesh-ancestor
110283581|NCT00208143|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110606825|NCT00931138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110606826|NCT00931138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110606827|NCT00931138|Immunologic Factors|immunologic factors|mesh-ancestor
110606828|NCT00931138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110606829|NCT00935194|Oseltamivir|oseltamivir|mesh-list
110606830|NCT00935194|Antiviral Agents|antiviral agents|mesh-ancestor
110606831|NCT00935194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110606832|NCT00935194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110606833|NCT00935194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110606834|NCT00690378|Imipenem|imipenem|mesh-list
110606835|NCT00690378|Ceftazidime|ceftazidime|mesh-list
110606836|NCT00690378|Avibactam|avibactam|mesh-list
110606837|NCT00690378|Cilastatin|cilastatin|mesh-list
110606838|NCT00690378|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110152300|NCT02972476|Hormones|hormones|mesh-ancestor
110606839|NCT00690378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110606841|NCT00690378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110606842|NCT00690378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110606843|NCT00690378|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110606845|NCT00574275|Aflibercept|aflibercept|mesh-list
110606846|NCT00574275|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110606847|NCT00574275|Antimetabolites|antimetabolites|mesh-ancestor
110030641|NCT01387243|Orlistat|orlistat|mesh-list
110606848|NCT00574275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110606849|NCT00574275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110606850|NCT00574275|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110606851|NCT00574275|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110606852|NCT00574275|Growth Substances|growth substances|mesh-ancestor
110606853|NCT00574275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110606854|NCT00574275|Growth Inhibitors|growth inhibitors|mesh-ancestor
110606855|NCT01742832|Citalopram|citalopram|mesh-list
110606856|NCT01742832|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
110606857|NCT01742832|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110606858|NCT01742832|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110606859|NCT01742832|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110606860|NCT01742832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110606861|NCT01742832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110606862|NCT01742832|Serotonin Agents|serotonin agents|mesh-ancestor
110606863|NCT01742832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110606864|NCT01742832|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110606865|NCT01742832|Antidepressive Agents|antidepressive agents|mesh-ancestor
110606866|NCT01742832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110606867|NCT01742832|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110606868|NCT01742832|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110606870|NCT00833079|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110606871|NCT00833079|Immunologic Factors|immunologic factors|mesh-ancestor
110606872|NCT00833079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110606873|NCT00833079|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110606874|NCT00833079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110606875|NCT00833079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110606876|NCT00935506|Aspirin|aspirin|mesh-list
110606877|NCT00935506|Clopidogrel|clopidogrel|mesh-list
110606878|NCT00935506|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110606879|NCT00935506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110606880|NCT00935506|Analgesics|analgesics|mesh-ancestor
110606881|NCT00935506|Sensory System Agents|sensory system agents|mesh-ancestor
110606882|NCT00935506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110606883|NCT00935506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110606884|NCT00935506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110606885|NCT00935506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110606886|NCT00935506|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110606887|NCT00935506|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110606888|NCT00935506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110606889|NCT00935506|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110606890|NCT00935506|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110382602|NCT01642433|Prazosin|prazosin|mesh-list
110606891|NCT00935506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110606892|NCT00935506|Antipyretics|antipyretics|mesh-ancestor
110606893|NCT00935506|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110606894|NCT00935506|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110606895|NCT00935506|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110606896|NCT00935506|Purinergic Agents|purinergic agents|mesh-ancestor
110606897|NCT00935506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110606898|NCT00833157|Ibuprofen|ibuprofen|mesh-list
110606899|NCT00833157|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110606900|NCT00833157|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110606901|NCT00833157|Analgesics|analgesics|mesh-ancestor
110606902|NCT00833157|Sensory System Agents|sensory system agents|mesh-ancestor
110606903|NCT00833157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110606904|NCT00833157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110606905|NCT00833157|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110606906|NCT00833157|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110606907|NCT00833157|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110606908|NCT00833157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110606909|NCT00833157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110606910|NCT00833235|Lubricant Eye Drops|lubricant eye drops|mesh-list
110606911|NCT00833235|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110606912|NCT00833235|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110606913|NCT04285671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110606914|NCT04285671|Trastuzumab|trastuzumab|mesh-list
110606915|NCT04285671|Necitumumab|necitumumab|mesh-list
110606916|NCT04285671|Osimertinib|osimertinib|mesh-list
110606917|NCT04285671|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
110606918|NCT04285671|Antibodies|antibodies|mesh-list
110606919|NCT04285671|Immunoglobulins|immunoglobulins|mesh-list
110606920|NCT04285671|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110606921|NCT04285671|Immunologic Factors|immunologic factors|mesh-ancestor
110606922|NCT04285671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110606923|NCT04285671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110606924|NCT04285671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110606925|NCT04285671|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110606926|NCT04285671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110606927|NCT00931372|Lixisenatide|lixisenatide|mesh-list
110606928|NCT00931372|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110606929|NCT00931372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110606930|NCT00829257|Fluticasone|fluticasone|mesh-list
110606931|NCT00829257|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
110606932|NCT00829257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110606933|NCT00829257|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110606934|NCT00829257|Autonomic Agents|autonomic agents|mesh-ancestor
110606935|NCT00829257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110606936|NCT00829257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110606937|NCT00829257|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110606938|NCT00829257|Respiratory System Agents|respiratory system agents|mesh-ancestor
110606939|NCT00829257|Dermatologic Agents|dermatologic agents|mesh-ancestor
110606940|NCT00829257|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110606941|NCT00829257|Glucocorticoids|glucocorticoids|mesh-ancestor
110606943|NCT00829257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110606944|NCT00829257|Sympathomimetics|sympathomimetics|mesh-ancestor
110606945|NCT03978832|Risperidone|risperidone|mesh-list
110606946|NCT03978832|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110606947|NCT03978832|Serotonin Agents|serotonin agents|mesh-ancestor
110606948|NCT03978832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110606949|NCT03978832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110606950|NCT03978832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110606951|NCT03978832|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110606952|NCT03978832|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110606953|NCT03978832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110606954|NCT03978832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110606955|NCT03978832|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110606956|NCT03978832|Dopamine Agents|dopamine agents|mesh-ancestor
110606957|NCT00840333|Levofloxacin|levofloxacin|mesh-list
110606958|NCT00840333|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110606959|NCT00840333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110606960|NCT00840333|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110606961|NCT00840333|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110606962|NCT00840333|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110606963|NCT00840333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110606964|NCT00840333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110606965|NCT00840333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110606966|NCT00840333|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110606967|NCT00840333|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110606969|NCT00840489|Colchicine|colchicine|mesh-list
110606970|NCT00840489|Antimetabolites|antimetabolites|mesh-ancestor
110606971|NCT00840489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110606972|NCT00840489|Antiviral Agents|antiviral agents|mesh-ancestor
110606973|NCT00840489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110606974|NCT00840489|Gout Suppressants|gout suppressants|mesh-ancestor
110606975|NCT00840489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110606976|NCT00840489|Tubulin Modulators|tubulin modulators|mesh-ancestor
110382650|NCT01640990|GW 328267|gw 328267|mesh-list
110606978|NCT00840489|Mitosis Modulators|mitosis modulators|mesh-ancestor
110606979|NCT00840489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110606980|NCT00743496|Antibodies|antibodies|mesh-list
110606981|NCT00743496|Immunologic Factors|immunologic factors|mesh-ancestor
110606982|NCT00743496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110606983|NCT00829569|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
110606984|NCT00829569|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
110606985|NCT00829569|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
110606986|NCT00829569|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110606987|NCT00840645|Mirabegron|mirabegron|mesh-list
110606988|NCT00840645|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
110606989|NCT00840645|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110606990|NCT00840645|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110606991|NCT00840645|Adrenergic Agents|adrenergic agents|mesh-ancestor
110606992|NCT00840645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110606993|NCT00840645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110606994|NCT00840645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110606995|NCT00840645|Urological Agents|urological agents|mesh-ancestor
110606996|NCT00566722|Adalimumab|adalimumab|mesh-list
110606997|NCT00566722|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110606998|NCT00566722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110606999|NCT00566722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110607000|NCT00691704|Prednisone|prednisone|mesh-list
110607001|NCT00691704|Lenalidomide|lenalidomide|mesh-list
110607002|NCT00691704|Bortezomib|bortezomib|mesh-list
110607003|NCT00691704|Melphalan|melphalan|mesh-list
110254313|NCT00507247|Daptomycin|daptomycin|mesh-list
110607004|NCT00691704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110607005|NCT00691704|Glucocorticoids|glucocorticoids|mesh-ancestor
110607006|NCT00691704|Hormones|hormones|mesh-ancestor
110607007|NCT00691704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110607008|NCT00691704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110607009|NCT00691704|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110607010|NCT00691704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110607011|NCT00691704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110607012|NCT00691704|Immunologic Factors|immunologic factors|mesh-ancestor
110607013|NCT00691704|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110607014|NCT00691704|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110607015|NCT00691704|Growth Substances|growth substances|mesh-ancestor
110607016|NCT00691704|Growth Inhibitors|growth inhibitors|mesh-ancestor
110607017|NCT00691704|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110607018|NCT00691704|Alkylating Agents|alkylating agents|mesh-ancestor
110607019|NCT00691704|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110607020|NCT00691704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110607021|NCT00829647|Lenalidomide|lenalidomide|mesh-list
110607022|NCT00829647|Dasatinib|dasatinib|mesh-list
110607023|NCT00829647|Immunologic Factors|immunologic factors|mesh-ancestor
110607024|NCT00829647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110607025|NCT00829647|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110607026|NCT00829647|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110607027|NCT00829647|Growth Substances|growth substances|mesh-ancestor
110607028|NCT00829647|Growth Inhibitors|growth inhibitors|mesh-ancestor
110607029|NCT00829647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110607030|NCT00829647|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110607031|NCT00829647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110607032|NCT00829647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110607033|NCT00939328|Rituximab|rituximab|mesh-list
110607034|NCT00939328|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110607035|NCT00939328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110607036|NCT00939328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110607037|NCT00939328|Immunologic Factors|immunologic factors|mesh-ancestor
110607038|NCT00939328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110607039|NCT00939328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110607040|NCT00939328|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110607041|NCT00939328|Alkylating Agents|alkylating agents|mesh-ancestor
110607042|NCT00939328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110607044|NCT00829881|Vasodilator Agents|vasodilator agents|mesh-ancestor
110607045|NCT00829881|Histamine Agonists|histamine agonists|mesh-ancestor
110607046|NCT00829881|Histamine Agents|histamine agents|mesh-ancestor
110607047|NCT00829881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110607048|NCT00829881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110607049|NCT00829881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110607050|NCT04014244|Triamcinolone|triamcinolone|mesh-list
110607051|NCT04014244|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110607052|NCT04014244|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110607053|NCT04014244|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110607054|NCT04014244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110607055|NCT04014244|Glucocorticoids|glucocorticoids|mesh-ancestor
110607056|NCT04014244|Hormones|hormones|mesh-ancestor
110607057|NCT04014244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110607058|NCT04014244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110607059|NCT04014244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110607060|NCT04014244|Immunologic Factors|immunologic factors|mesh-ancestor
110607061|NCT04014244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110607062|NCT04014244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110607063|NCT02548611|Clopidogrel|clopidogrel|mesh-list
110382725|NCT01643252|Riboflavin|riboflavin|mesh-list
110607064|NCT02548611|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
110607065|NCT02548611|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110607066|NCT02548611|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110607067|NCT02548611|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110607068|NCT02548611|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110607069|NCT02548611|Purinergic Agents|purinergic agents|mesh-ancestor
110607070|NCT02548611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110607071|NCT02548611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110607072|NCT02548611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110607073|NCT00937924|Diphenhydramine|diphenhydramine|mesh-list
110607074|NCT00937924|Promethazine|promethazine|mesh-list
110607075|NCT00937924|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110607076|NCT00937924|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110607077|NCT00937924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110607078|NCT00937924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110607079|NCT00937924|Anesthetics, Local|anesthetics, local|mesh-ancestor
110607080|NCT00937924|Anesthetics|anesthetics|mesh-ancestor
110607081|NCT00937924|Sensory System Agents|sensory system agents|mesh-ancestor
110607082|NCT00937924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110607083|NCT00937924|Antiemetics|antiemetics|mesh-ancestor
110607084|NCT00937924|Autonomic Agents|autonomic agents|mesh-ancestor
110607085|NCT00937924|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110607086|NCT00937924|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110607087|NCT00937924|Histamine Antagonists|histamine antagonists|mesh-ancestor
110607088|NCT00937924|Histamine Agents|histamine agents|mesh-ancestor
110607089|NCT00937924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110607090|NCT00937924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110607091|NCT00937924|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110607092|NCT00937924|Antipruritics|antipruritics|mesh-ancestor
110607093|NCT00937924|Dermatologic Agents|dermatologic agents|mesh-ancestor
110607094|NCT00743886|Mitogens|mitogens|mesh-list
110607095|NCT00743886|Mitosis Modulators|mitosis modulators|mesh-ancestor
110607096|NCT00743886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110607097|NCT00830193|Acetylcysteine|acetylcysteine|mesh-list
110607098|NCT00830193|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110607099|NCT00830193|Antiviral Agents|antiviral agents|mesh-ancestor
110607100|NCT00830193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110607101|NCT00830193|Expectorants|expectorants|mesh-ancestor
110607102|NCT00830193|Respiratory System Agents|respiratory system agents|mesh-ancestor
110607103|NCT00830193|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110607104|NCT00830193|Antioxidants|antioxidants|mesh-ancestor
110607105|NCT00830193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110607106|NCT00830193|Protective Agents|protective agents|mesh-ancestor
110607107|NCT00830193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110607108|NCT00830193|Antidotes|antidotes|mesh-ancestor
110607109|NCT00938158|rGLP-1 protein|rglp-1 protein|mesh-list
110607110|NCT00938158|Incretins|incretins|mesh-ancestor
110607111|NCT00938158|Hormones|hormones|mesh-ancestor
110607112|NCT00938158|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110607113|NCT00938158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110607114|NCT00840957|Infliximab|infliximab|mesh-list
110607115|NCT00840957|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110607116|NCT00840957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110607117|NCT00840957|Dermatologic Agents|dermatologic agents|mesh-ancestor
110607118|NCT00840957|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110607119|NCT00840957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110607120|NCT00743964|Capecitabine|capecitabine|mesh-list
110607121|NCT00743964|Epirubicin|epirubicin|mesh-list
110607122|NCT00743964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110607123|NCT00743964|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110607124|NCT00743964|Antimetabolites|antimetabolites|mesh-ancestor
110607125|NCT00743964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110607126|NCT00743964|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110607127|NCT00743964|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110607128|NCT00743964|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110607129|NCT00743964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110607131|NCT00830349|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110607132|NCT00830349|Serotonin Agents|serotonin agents|mesh-ancestor
110607133|NCT00830349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110607134|NCT00830349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110607135|NCT00830349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110607136|NCT00830349|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110607137|NCT00830349|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110607138|NCT00830349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110607139|NCT00830349|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110607140|NCT00830349|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110607141|NCT00830349|Dopamine Agents|dopamine agents|mesh-ancestor
110607142|NCT00841113|Goserelin|goserelin|mesh-list
110607143|NCT00841113|Bicalutamide|bicalutamide|mesh-list
110607144|NCT00841113|Abarelix|abarelix|mesh-list
110607145|NCT00841113|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110607146|NCT00841113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110607147|NCT00841113|Androgen Antagonists|androgen antagonists|mesh-ancestor
110607148|NCT00841113|Hormone Antagonists|hormone antagonists|mesh-ancestor
110607149|NCT00841113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110607150|NCT00841113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110607151|NCT00830505|Fluticasone|fluticasone|mesh-list
110607152|NCT00830505|Xhance|xhance|mesh-list
110607153|NCT00830505|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110607154|NCT00830505|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
110607155|NCT00830505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110607156|NCT00830505|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110607157|NCT00830505|Autonomic Agents|autonomic agents|mesh-ancestor
110607158|NCT00830505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110607159|NCT00830505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110607160|NCT00830505|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110607161|NCT00830505|Respiratory System Agents|respiratory system agents|mesh-ancestor
110607162|NCT00830505|Dermatologic Agents|dermatologic agents|mesh-ancestor
110607163|NCT00830505|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110607164|NCT00830505|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110607165|NCT00830505|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110607166|NCT00830505|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110607167|NCT00830505|Adrenergic Agents|adrenergic agents|mesh-ancestor
110607168|NCT00830505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110607169|NCT00830505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110607170|NCT00830505|Glucocorticoids|glucocorticoids|mesh-ancestor
110607172|NCT00830505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110152338|NCT03164980|Trabectedin|trabectedin|mesh-list
110607173|NCT00830505|Sympathomimetics|sympathomimetics|mesh-ancestor
110607174|NCT00566020|Lamotrigine|lamotrigine|mesh-list
110607175|NCT00566020|Anticonvulsants|anticonvulsants|mesh-ancestor
110607176|NCT00566020|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110607177|NCT00566020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110607178|NCT00566020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110607179|NCT00566020|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110607180|NCT00566020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110607181|NCT00566020|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110607182|NCT00566020|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110607183|NCT00566020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110607184|NCT00566020|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110607185|NCT00566020|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110607186|NCT02563782|Mycophenolic Acid|mycophenolic acid|mesh-list
110607187|NCT02563782|Tacrolimus|tacrolimus|mesh-list
110607188|NCT02563782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110607189|NCT02563782|Immunologic Factors|immunologic factors|mesh-ancestor
110607190|NCT02563782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110607191|NCT02563782|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110607192|NCT02563782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110607193|NCT02563782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110607194|NCT02563782|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110607195|NCT02563782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110607196|NCT02563782|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110607197|NCT02563782|Antitubercular Agents|antitubercular agents|mesh-ancestor
110607198|NCT02563782|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110607199|NCT02563782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110607200|NCT00841191|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110607201|NCT00841191|Siltuximab|siltuximab|mesh-list
110607202|NCT00841191|Antibodies|antibodies|mesh-list
110607203|NCT00841191|Immunoglobulins|immunoglobulins|mesh-list
110607204|NCT00841191|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110607205|NCT00841191|Immunologic Factors|immunologic factors|mesh-ancestor
110607206|NCT00841191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110607207|NCT00841191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110607208|NCT00843453|Vitamin B 12|vitamin b 12|mesh-list
110607209|NCT00843453|Hydroxocobalamin|hydroxocobalamin|mesh-list
110607210|NCT00843453|Vitamin B Complex|vitamin b complex|mesh-ancestor
110607211|NCT00843453|Vitamins|vitamins|mesh-ancestor
110607212|NCT00843453|Micronutrients|micronutrients|mesh-ancestor
110607213|NCT00843453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110607214|NCT00843453|Hematinics|hematinics|mesh-ancestor
110607215|NCT00921726|Oseltamivir|oseltamivir|mesh-list
110607216|NCT00921726|Zanamivir|zanamivir|mesh-list
110607217|NCT00921726|Antiviral Agents|antiviral agents|mesh-ancestor
110607218|NCT00921726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110607219|NCT00921726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110607220|NCT00921726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110607221|NCT00938236|Cyclosporine|cyclosporine|mesh-list
110607222|NCT00938236|Cyclosporins|cyclosporins|mesh-list
110607224|NCT00938236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110607225|NCT00938236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110607226|NCT00938236|Immunologic Factors|immunologic factors|mesh-ancestor
110607227|NCT00938236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110254544|NCT05594186|Hemostatics|hemostatics|mesh-ancestor
110607228|NCT00938236|Antifungal Agents|antifungal agents|mesh-ancestor
110607229|NCT00938236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110607230|NCT00938236|Dermatologic Agents|dermatologic agents|mesh-ancestor
110607231|NCT00938236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110607232|NCT00938236|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110607233|NCT00741780|Plerixafor|plerixafor|mesh-list
110607234|NCT00741780|Lenograstim|lenograstim|mesh-list
110607235|NCT00741780|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110607236|NCT00741780|Immunologic Factors|immunologic factors|mesh-ancestor
110607237|NCT00741780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110607238|NCT00741780|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110607239|NCT00741780|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110607240|NCT00741780|Antiviral Agents|antiviral agents|mesh-ancestor
110607241|NCT00741780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110607242|NCT00936442|Anastrozole|anastrozole|mesh-list
110607243|NCT00936442|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110607244|NCT00936442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110607245|NCT00936442|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110607246|NCT00936442|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110607247|NCT00936442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110607248|NCT00936442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110607249|NCT00936442|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110607250|NCT00936442|Hormone Antagonists|hormone antagonists|mesh-ancestor
110607251|NCT00936442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110607252|NCT00936442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110607253|NCT00744354|Doxorubicin|doxorubicin|mesh-list
110607254|NCT00744354|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110607255|NCT00744354|Bortezomib|bortezomib|mesh-list
110607256|NCT00744354|Vorinostat|vorinostat|mesh-list
110607257|NCT00744354|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110607258|NCT00744354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110607259|NCT00744354|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110607260|NCT00744354|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110607261|NCT00744354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110607262|NCT00744354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110607263|NCT00744354|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110607264|NCT04043325|Antibodies|antibodies|mesh-list
110607265|NCT04043325|Immunologic Factors|immunologic factors|mesh-ancestor
110607266|NCT04043325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110607267|NCT00936520|Lifitegrast|lifitegrast|mesh-list
110607269|NCT00936520|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110607270|NCT00835029|Clotrimazole|clotrimazole|mesh-list
110607271|NCT00835029|Miconazole|miconazole|mesh-list
110607272|NCT00835029|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110607273|NCT00835029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110607274|NCT00835029|Antifungal Agents|antifungal agents|mesh-ancestor
110607275|NCT00835029|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110607276|NCT00835029|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110607277|NCT00835029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110607278|NCT00835029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110607279|NCT00835029|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110607280|NCT00835029|Hormone Antagonists|hormone antagonists|mesh-ancestor
110607281|NCT00835029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110607282|NCT00835029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110607283|NCT00835029|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110607284|NCT00835029|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110607285|NCT00835107|Ziprasidone|ziprasidone|mesh-list
110607286|NCT00835107|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110607287|NCT00835107|Serotonin Agents|serotonin agents|mesh-ancestor
110607288|NCT00835107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110607289|NCT00835107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110607290|NCT00835107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110607291|NCT00835107|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110607292|NCT00835107|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110607293|NCT00835107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110607294|NCT00835107|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110607295|NCT00835107|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110607296|NCT00835107|Dopamine Agents|dopamine agents|mesh-ancestor
110607297|NCT00690612|Candesartan|candesartan|mesh-list
110607298|NCT00690612|Candesartan cilexetil|candesartan cilexetil|mesh-list
110607299|NCT00690612|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110607300|NCT00690612|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110254625|NCT00148746|Hormones|hormones|mesh-ancestor
110607301|NCT00690612|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110607302|NCT00690612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110607303|NCT00742014|Sildenafil Citrate|sildenafil citrate|mesh-list
110607304|NCT00742014|Vasodilator Agents|vasodilator agents|mesh-ancestor
110607305|NCT00742014|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110607306|NCT00742014|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110607307|NCT00742014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110607308|NCT00742014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110607309|NCT00742014|Urological Agents|urological agents|mesh-ancestor
110607310|NCT00742092|Miglustat|miglustat|mesh-list
110607311|NCT00742092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110607312|NCT00742092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110607313|NCT00742092|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110607314|NCT00742092|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110607315|NCT00742092|Antiviral Agents|antiviral agents|mesh-ancestor
110607316|NCT00742092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110607317|NCT00742092|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
110607318|NCT00742092|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110607319|NCT00742092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110607321|NCT00841581|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110607322|NCT00841581|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110607323|NCT00841581|Growth Substances|growth substances|mesh-ancestor
110607324|NCT00841581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110607325|NCT00841581|Growth Inhibitors|growth inhibitors|mesh-ancestor
110607326|NCT00841581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110607327|NCT00742248|Formoterol Fumarate|formoterol fumarate|mesh-list
110607328|NCT00742248|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110607329|NCT00742248|Autonomic Agents|autonomic agents|mesh-ancestor
110607330|NCT00742248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110607331|NCT00742248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110607332|NCT00742248|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110607333|NCT00742248|Respiratory System Agents|respiratory system agents|mesh-ancestor
110607334|NCT00742248|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110607335|NCT00742248|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110607336|NCT00742248|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110607337|NCT00742248|Adrenergic Agents|adrenergic agents|mesh-ancestor
110607338|NCT00742248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110607339|NCT00742248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110607340|NCT04249167|Paclitaxel|paclitaxel|mesh-list
110607341|NCT04249167|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110607342|NCT04249167|Atezolizumab|atezolizumab|mesh-list
110607343|NCT04249167|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110607344|NCT04249167|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110607345|NCT04249167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110607346|NCT04249167|Tubulin Modulators|tubulin modulators|mesh-ancestor
110607347|NCT04249167|Antimitotic Agents|antimitotic agents|mesh-ancestor
110607348|NCT04249167|Mitosis Modulators|mitosis modulators|mesh-ancestor
110607349|NCT04249167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110607350|NCT04249167|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110607351|NCT04249167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110607352|NCT04249167|Immunologic Factors|immunologic factors|mesh-ancestor
110607353|NCT04249167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110607354|NCT00621153|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110607355|NCT00621153|Candesartan|candesartan|mesh-list
110607356|NCT00621153|Candesartan cilexetil|candesartan cilexetil|mesh-list
110607357|NCT00621153|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110607358|NCT00621153|Diuretics|diuretics|mesh-ancestor
110607359|NCT00621153|Natriuretic Agents|natriuretic agents|mesh-ancestor
110607360|NCT00621153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110607361|NCT00621153|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110607362|NCT00621153|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110607363|NCT00621153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110607364|NCT00621153|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110607365|NCT00621153|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110607366|NCT00574119|Spironolactone|spironolactone|mesh-list
110607367|NCT00574119|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110607368|NCT00574119|Hormone Antagonists|hormone antagonists|mesh-ancestor
110607369|NCT00574119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110607370|NCT00574119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110607371|NCT00574119|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110607372|NCT00574119|Diuretics|diuretics|mesh-ancestor
110607373|NCT00574119|Natriuretic Agents|natriuretic agents|mesh-ancestor
110607374|NCT00705614|Infliximab|infliximab|mesh-list
110607375|NCT00705614|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110607376|NCT00705614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110607377|NCT00705614|Dermatologic Agents|dermatologic agents|mesh-ancestor
110607378|NCT00705614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110607379|NCT00705614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110607380|NCT00844155|Oseltamivir|oseltamivir|mesh-list
110607381|NCT00844155|Antiviral Agents|antiviral agents|mesh-ancestor
110607382|NCT00844155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110607383|NCT00844155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110607384|NCT00844155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110607385|NCT05669924|Methylphenidate|methylphenidate|mesh-list
110607386|NCT05669924|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110607387|NCT05669924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110607388|NCT05669924|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110607389|NCT05669924|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110607390|NCT05669924|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110607391|NCT05669924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110607392|NCT05669924|Dopamine Agents|dopamine agents|mesh-ancestor
110607393|NCT05669924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110607395|NCT00844233|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110607396|NCT00844233|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110607397|NCT00844233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110607398|NCT00844233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110607399|NCT00844233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110607400|NCT00841893|Mechlorethamine|mechlorethamine|mesh-list
110607401|NCT00841893|Alkylating Agents|alkylating agents|mesh-ancestor
110607402|NCT00841893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110607403|NCT00841893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110607404|NCT00841893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110607405|NCT00844311|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
110607406|NCT00844311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110607407|NCT00844311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110607408|NCT00840801|Vaccines|vaccines|mesh-list
110607409|NCT00840801|Immunologic Factors|immunologic factors|mesh-ancestor
110607410|NCT00840801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110607411|NCT02547597|Atenolol|atenolol|mesh-list
110607412|NCT02547597|Carvedilol|carvedilol|mesh-list
110607413|NCT02547597|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110607414|NCT02547597|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110607415|NCT02547597|Adrenergic Agents|adrenergic agents|mesh-ancestor
110607416|NCT02547597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110607417|NCT02547597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110607418|NCT02547597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110607419|NCT02547597|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110607420|NCT02547597|Antioxidants|antioxidants|mesh-ancestor
110607421|NCT02547597|Protective Agents|protective agents|mesh-ancestor
110607422|NCT02547597|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110607423|NCT02547597|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110607424|NCT02547597|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110607425|NCT02547597|Vasodilator Agents|vasodilator agents|mesh-ancestor
110607426|NCT02547597|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110607427|NCT02547597|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110607428|NCT02547597|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110607429|NCT02547597|Sympatholytics|sympatholytics|mesh-ancestor
110607430|NCT02547597|Autonomic Agents|autonomic agents|mesh-ancestor
110607431|NCT02547597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110607432|NCT02547597|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110607433|NCT00842127|Methylphenidate|methylphenidate|mesh-list
110607434|NCT00842127|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110607435|NCT00842127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110607436|NCT00842127|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110607437|NCT00842127|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110607438|NCT00842127|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110283625|NCT00226317|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110607439|NCT00842127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110607440|NCT00842127|Dopamine Agents|dopamine agents|mesh-ancestor
110607441|NCT00842127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110607442|NCT00835965|Dexamethasone|dexamethasone|mesh-list
110607443|NCT00835965|Dexamethasone acetate|dexamethasone acetate|mesh-list
110607444|NCT00835965|Aprepitant|aprepitant|mesh-list
110607445|NCT00835965|Fosaprepitant|fosaprepitant|mesh-list
110607446|NCT00835965|BB 1101|bb 1101|mesh-list
110607447|NCT00835965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110607448|NCT00835965|Antiemetics|antiemetics|mesh-ancestor
110607449|NCT00835965|Autonomic Agents|autonomic agents|mesh-ancestor
110607450|NCT00835965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110607451|NCT00835965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110607452|NCT00835965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110607453|NCT00835965|Glucocorticoids|glucocorticoids|mesh-ancestor
110607454|NCT00835965|Hormones|hormones|mesh-ancestor
110607455|NCT00835965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110382912|NCT06048133|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110382913|NCT06048133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110382914|NCT06048107|Teniposide|teniposide|mesh-list
110382915|NCT06048107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110382916|NCT06048107|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110382917|NCT06048107|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110382918|NCT06048107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110382919|NCT06048107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110382936|NCT06047860|Interleukin-2|interleukin-2|mesh-list
110382937|NCT06047860|Endostatins|endostatins|mesh-list
110382938|NCT06047860|Molgramostim|molgramostim|mesh-list
110382939|NCT06047860|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
110382940|NCT06047860|Sargramostim|sargramostim|mesh-list
110382941|NCT06047860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110382942|NCT06047860|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110382943|NCT06047860|Analgesics|analgesics|mesh-ancestor
110607456|NCT00835965|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110607458|NCT00835965|Protease Inhibitors|protease inhibitors|mesh-ancestor
110607459|NCT00835965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110607460|NCT00835965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110607461|NCT00835965|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110607462|NCT00835965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110607463|NCT02567786|Plasma-lyte 148|plasma-lyte 148|mesh-list
110607464|NCT02567786|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110607465|NCT02567786|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110607466|NCT05667740|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110607467|NCT05667740|Immunologic Factors|immunologic factors|mesh-ancestor
110607468|NCT05667740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110607469|NCT00842205|Interferons|interferons|mesh-list
110607470|NCT00842205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110607471|NCT00842205|Antiviral Agents|antiviral agents|mesh-ancestor
110607472|NCT00842205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110607473|NCT00738296|Simvastatin|simvastatin|mesh-list
110607474|NCT00738296|Ezetimibe|ezetimibe|mesh-list
110607475|NCT00738296|Pravastatin|pravastatin|mesh-list
110607476|NCT00738296|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110607477|NCT00738296|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110607478|NCT00738296|Antimetabolites|antimetabolites|mesh-ancestor
110607479|NCT00738296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110607480|NCT00738296|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110607481|NCT00738296|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110607482|NCT00738296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110607483|NCT00836043|Alemtuzumab|alemtuzumab|mesh-list
110607484|NCT00836043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110607485|NCT00836043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110607486|NCT02567396|Talazoparib|talazoparib|mesh-list
110607487|NCT02567396|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110607488|NCT02567396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110607489|NCT02567396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110607490|NCT02567396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110607491|NCT00738452|Antibodies|antibodies|mesh-list
110607492|NCT00738452|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110607493|NCT00738452|Immunologic Factors|immunologic factors|mesh-ancestor
110607494|NCT00738452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110607495|NCT05667428|Leuprolide|leuprolide|mesh-list
110607496|NCT05667428|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110607497|NCT05667428|Fertility Agents|fertility agents|mesh-ancestor
110607498|NCT05667428|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110607499|NCT05667428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110607500|NCT05667428|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110607503|NCT05664542|Ropivacaine|ropivacaine|mesh-list
110607504|NCT05664542|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110607505|NCT05664542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110607506|NCT05664542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110607507|NCT05664542|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110607508|NCT05664542|Analgesics|analgesics|mesh-ancestor
110607509|NCT05664542|Sensory System Agents|sensory system agents|mesh-ancestor
110607510|NCT05664542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110607511|NCT05664542|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110607512|NCT05664542|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110607513|NCT05664542|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110607514|NCT05664542|Adrenergic Agents|adrenergic agents|mesh-ancestor
110607515|NCT05664542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110607516|NCT05664542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110607517|NCT05664542|Anesthetics, Local|anesthetics, local|mesh-ancestor
110607518|NCT05664542|Anesthetics|anesthetics|mesh-ancestor
110607519|NCT00562978|Cyclophosphamide|cyclophosphamide|mesh-list
110607520|NCT00562978|Etoposide|etoposide|mesh-list
110607521|NCT00562978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110254843|NCT00468364|Insulin|insulin|mesh-list
110607522|NCT00562978|Immunologic Factors|immunologic factors|mesh-ancestor
110607523|NCT00562978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110607524|NCT00562978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110382983|NCT06047483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110382984|NCT06047483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110382985|NCT06047483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110382986|NCT06047483|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110607525|NCT00562978|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110607526|NCT00562978|Alkylating Agents|alkylating agents|mesh-ancestor
110607527|NCT00562978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110607528|NCT00562978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110607529|NCT00562978|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110607530|NCT00562978|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110607531|NCT00562978|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110607532|NCT00562978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110607533|NCT00562978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110607534|NCT00842595|Prednisone|prednisone|mesh-list
110607535|NCT00842595|Rituximab|rituximab|mesh-list
110607536|NCT00842595|Vinorelbine|vinorelbine|mesh-list
110607537|NCT00842595|Ifosfamide|ifosfamide|mesh-list
110607538|NCT00842595|Mitoxantrone|mitoxantrone|mesh-list
110607539|NCT00842595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110607540|NCT00842595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110607541|NCT00842595|Immunologic Factors|immunologic factors|mesh-ancestor
110607542|NCT00842595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110607543|NCT00842595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110607544|NCT00842595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110607545|NCT00842595|Glucocorticoids|glucocorticoids|mesh-ancestor
110607546|NCT00842595|Hormones|hormones|mesh-ancestor
110607547|NCT00842595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110607548|NCT00842595|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110607549|NCT00842595|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110607550|NCT00842595|Tubulin Modulators|tubulin modulators|mesh-ancestor
110607551|NCT00842595|Antimitotic Agents|antimitotic agents|mesh-ancestor
110607552|NCT00842595|Mitosis Modulators|mitosis modulators|mesh-ancestor
110607553|NCT00842595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110607554|NCT00842595|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110607555|NCT00842595|Alkylating Agents|alkylating agents|mesh-ancestor
110607556|NCT00842595|Analgesics|analgesics|mesh-ancestor
110607557|NCT00842595|Sensory System Agents|sensory system agents|mesh-ancestor
110607558|NCT00842595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110607559|NCT00842595|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110607560|NCT00842595|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110607561|NCT00842595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110607562|NCT00938626|Antibodies|antibodies|mesh-list
110607563|NCT00938626|Antibodies, Bispecific|antibodies, bispecific|mesh-list
110607564|NCT00938626|Immunologic Factors|immunologic factors|mesh-ancestor
110607565|NCT00938626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110607566|NCT00836199|Vaccines|vaccines|mesh-list
110607567|NCT00836199|Immunologic Factors|immunologic factors|mesh-ancestor
110607568|NCT00836199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110607569|NCT04013386|Dexamethasone|dexamethasone|mesh-list
110607570|NCT04013386|Dexamethasone acetate|dexamethasone acetate|mesh-list
110607571|NCT04013386|Aprepitant|aprepitant|mesh-list
110607572|NCT04013386|Mirtazapine|mirtazapine|mesh-list
110607573|NCT04013386|BB 1101|bb 1101|mesh-list
110607574|NCT04013386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110607575|NCT04013386|Antiemetics|antiemetics|mesh-ancestor
110607576|NCT04013386|Autonomic Agents|autonomic agents|mesh-ancestor
110607577|NCT04013386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110607578|NCT04013386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110607579|NCT04013386|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110607580|NCT04013386|Glucocorticoids|glucocorticoids|mesh-ancestor
110607581|NCT04013386|Hormones|hormones|mesh-ancestor
110607582|NCT04013386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110607583|NCT04013386|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110607584|NCT04013386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110607585|NCT04013386|Protease Inhibitors|protease inhibitors|mesh-ancestor
110607586|NCT04013386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110607587|NCT04013386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110607588|NCT04013386|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110607589|NCT04013386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110607590|NCT04013386|Antidepressive Agents|antidepressive agents|mesh-ancestor
110607591|NCT04013386|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110607592|NCT04013386|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110607593|NCT04013386|Histamine Antagonists|histamine antagonists|mesh-ancestor
110607594|NCT04013386|Histamine Agents|histamine agents|mesh-ancestor
110607595|NCT04013386|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110607596|NCT04013386|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110607597|NCT04013386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110607598|NCT04013386|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
110607599|NCT04013386|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110607600|NCT04013386|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110607601|NCT04013386|Adrenergic Agents|adrenergic agents|mesh-ancestor
110607602|NCT04013386|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110607603|NCT04013386|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110607605|NCT04013386|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110607606|NCT00940420|Ribavirin|ribavirin|mesh-list
110607607|NCT00940420|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110607608|NCT00940420|Interferon-alpha|interferon-alpha|mesh-list
110607609|NCT00940420|Antimetabolites|antimetabolites|mesh-ancestor
110607610|NCT00940420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110607611|NCT00940420|Antiviral Agents|antiviral agents|mesh-ancestor
110607612|NCT00940420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110607613|NCT00940420|Immunologic Factors|immunologic factors|mesh-ancestor
110607614|NCT00940420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110607615|NCT00842907|Tretinoin|tretinoin|mesh-list
110607616|NCT00842907|Isotretinoin|isotretinoin|mesh-list
110607617|NCT00842907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110607618|NCT00842907|Keratolytic Agents|keratolytic agents|mesh-ancestor
110607619|NCT00842907|Dermatologic Agents|dermatologic agents|mesh-ancestor
110607620|NCT00620373|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
110607621|NCT00620373|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110607622|NCT00620373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110607623|NCT00940654|Acetaminophen|acetaminophen|mesh-list
110607624|NCT00940654|Antipyretics|antipyretics|mesh-list
110607625|NCT00940654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
110607626|NCT00940654|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110607627|NCT00940654|Analgesics|analgesics|mesh-ancestor
110607628|NCT00940654|Sensory System Agents|sensory system agents|mesh-ancestor
110607629|NCT00940654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110607630|NCT00940654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110607631|NCT00843063|Pantoprazole|pantoprazole|mesh-list
110607632|NCT00843063|Famotidine|famotidine|mesh-list
110383055|NCT06047327|Liver Extracts|liver extracts|mesh-list
110383056|NCT06047327|Hematinics|hematinics|mesh-ancestor
110607633|NCT00843063|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110607634|NCT00843063|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110607635|NCT00843063|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110607636|NCT00843063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110607637|NCT00843063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110607638|NCT00843063|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110607639|NCT00843063|Histamine Antagonists|histamine antagonists|mesh-ancestor
110607640|NCT00843063|Histamine Agents|histamine agents|mesh-ancestor
110607641|NCT00843063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110607642|NCT00843063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110607643|NCT04013464|Escitalopram|escitalopram|mesh-list
110607644|NCT04013464|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110607645|NCT04013464|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110607646|NCT04013464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110607647|NCT04013464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110607648|NCT04013464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110607649|NCT04013464|Serotonin Agents|serotonin agents|mesh-ancestor
110607650|NCT04013464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110607651|NCT04012918|Capecitabine|capecitabine|mesh-list
110607652|NCT04012918|Aromatase Inhibitors|aromatase inhibitors|mesh-list
110607653|NCT04012918|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110607654|NCT04012918|Antimetabolites|antimetabolites|mesh-ancestor
110607655|NCT04012918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110607656|NCT04012918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110607657|NCT04012918|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110607658|NCT04012918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110607659|NCT04012918|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110607660|NCT04012918|Hormone Antagonists|hormone antagonists|mesh-ancestor
110607661|NCT04012918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110607662|NCT04012918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110607663|NCT00939718|Vitamin B 12|vitamin b 12|mesh-list
110607664|NCT00939718|Hydroxocobalamin|hydroxocobalamin|mesh-list
110607665|NCT00939718|Vitamins|vitamins|mesh-ancestor
110607666|NCT00939718|Micronutrients|micronutrients|mesh-ancestor
110607667|NCT00939718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110607668|NCT00939718|Vitamin B Complex|vitamin b complex|mesh-ancestor
110607669|NCT00939718|Hematinics|hematinics|mesh-ancestor
110607670|NCT00836667|Sertraline|sertraline|mesh-list
110607671|NCT00836667|Antidepressive Agents|antidepressive agents|mesh-ancestor
110254994|NCT00470041|Antimetabolites|antimetabolites|mesh-ancestor
110607672|NCT00836667|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110607673|NCT00836667|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110607674|NCT00836667|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110607675|NCT00836667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110607676|NCT00836667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110607677|NCT00836667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110607678|NCT00836667|Serotonin Agents|serotonin agents|mesh-ancestor
110607679|NCT00836667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110607681|NCT00845559|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110607682|NCT00845559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110607683|NCT00845559|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110607684|NCT00845559|Incretins|incretins|mesh-ancestor
110607685|NCT00845559|Hormones|hormones|mesh-ancestor
110607686|NCT00845559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110607687|NCT00836823|Alfuzosin|alfuzosin|mesh-list
110607688|NCT00836823|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110607689|NCT00836823|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110607690|NCT00836823|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110607691|NCT00836823|Adrenergic Agents|adrenergic agents|mesh-ancestor
110607692|NCT00836823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110607693|NCT00836823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110607694|NCT00836823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110607695|NCT00836823|Urological Agents|urological agents|mesh-ancestor
110607696|NCT02567240|Carbon Monoxide|carbon monoxide|mesh-list
110607697|NCT02567240|Antimetabolites|antimetabolites|mesh-ancestor
110607698|NCT02567240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110607699|NCT02567240|Gasotransmitters|gasotransmitters|mesh-ancestor
110607700|NCT02567240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110607701|NCT02567240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110607702|NCT05107778|Entecavir|entecavir|mesh-list
110607703|NCT05107778|Antiviral Agents|antiviral agents|mesh-ancestor
110607704|NCT05107778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110607705|NCT00372619|Cytarabine|cytarabine|mesh-list
110607706|NCT00372619|Methotrexate|methotrexate|mesh-list
110607707|NCT00372619|Clofarabine|clofarabine|mesh-list
110607708|NCT00372619|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110607709|NCT00372619|Abortifacient Agents|abortifacient agents|mesh-ancestor
110607710|NCT00372619|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110607711|NCT00372619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110607712|NCT00372619|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110607713|NCT00372619|Antimetabolites|antimetabolites|mesh-ancestor
110607714|NCT00372619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110607715|NCT00372619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110607716|NCT00372619|Dermatologic Agents|dermatologic agents|mesh-ancestor
110607717|NCT00372619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110607718|NCT00372619|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110607719|NCT00372619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110607720|NCT00372619|Immunologic Factors|immunologic factors|mesh-ancestor
110607721|NCT00372619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110607722|NCT00372619|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110607723|NCT00372619|Antiviral Agents|antiviral agents|mesh-ancestor
110607724|NCT00372619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110607725|NCT00851175|Caffeine|caffeine|mesh-list
110607726|NCT00851175|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110607727|NCT00851175|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110607728|NCT00851175|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110607729|NCT00851175|Antimetabolites|antimetabolites|mesh-ancestor
110607736|NCT00851175|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110607737|NCT00851175|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110607738|NCT00851175|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110607739|NCT00851175|Purinergic Agents|purinergic agents|mesh-ancestor
110607740|NCT00851175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110607742|NCT02566226|Bupivacaine|bupivacaine|mesh-list
110607743|NCT02566226|Anesthetics, Local|anesthetics, local|mesh-ancestor
110607744|NCT02566226|Anesthetics|anesthetics|mesh-ancestor
110607745|NCT02566226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110607746|NCT02566226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110607747|NCT02566226|Sensory System Agents|sensory system agents|mesh-ancestor
110607748|NCT02566226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110607749|NCT02566226|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110607750|NCT02566226|Narcotics|narcotics|mesh-ancestor
110607751|NCT02566226|Analgesics|analgesics|mesh-ancestor
110607752|NCT00837135|Vaccines|vaccines|mesh-list
110607753|NCT00837135|Immunologic Factors|immunologic factors|mesh-ancestor
110607754|NCT00837135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110607755|NCT00562588|Dipyridamole|dipyridamole|mesh-list
110607756|NCT00562588|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
110607757|NCT00562588|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110607758|NCT00562588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110607759|NCT00562588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110607760|NCT00562588|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110607761|NCT00562588|Vasodilator Agents|vasodilator agents|mesh-ancestor
110607770|NCT02546349|Fluticasone|fluticasone|mesh-list
110607771|NCT02546349|Tiotropium Bromide|tiotropium bromide|mesh-list
110607772|NCT02546349|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110607773|NCT02546349|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
110607774|NCT02546349|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110607775|NCT02546349|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110607776|NCT02546349|Autonomic Agents|autonomic agents|mesh-ancestor
110607777|NCT02546349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110607778|NCT02546349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110607779|NCT02546349|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110607780|NCT02546349|Respiratory System Agents|respiratory system agents|mesh-ancestor
110607782|NCT02546349|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110607783|NCT02546349|Parasympatholytics|parasympatholytics|mesh-ancestor
110607784|NCT02546349|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110607785|NCT02546349|Cholinergic Agents|cholinergic agents|mesh-ancestor
110607786|NCT02546349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110607787|NCT02546349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110607788|NCT02546349|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110607789|NCT02546349|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110607790|NCT02546349|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110607791|NCT02546349|Adrenergic Agents|adrenergic agents|mesh-ancestor
110607792|NCT02546349|Glucocorticoids|glucocorticoids|mesh-ancestor
110607793|NCT02546349|Hormones|hormones|mesh-ancestor
110607794|NCT02546349|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110607795|NCT02546349|Sympathomimetics|sympathomimetics|mesh-ancestor
110607796|NCT00851487|Amoxicillin|amoxicillin|mesh-list
110607798|NCT00851487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110607799|NCT00372385|Interferons|interferons|mesh-list
110607800|NCT00372385|Ribavirin|ribavirin|mesh-list
110607801|NCT00372385|Interferon-alpha|interferon-alpha|mesh-list
110607802|NCT00372385|Interferon alpha-2|interferon alpha-2|mesh-list
110607803|NCT00372385|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110607804|NCT00372385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110607805|NCT00372385|Antiviral Agents|antiviral agents|mesh-ancestor
110607806|NCT00372385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110607807|NCT00372385|Antimetabolites|antimetabolites|mesh-ancestor
110607808|NCT00372385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110607809|NCT00372385|Immunologic Factors|immunologic factors|mesh-ancestor
110607810|NCT00372385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110607811|NCT03830281|Insulin|insulin|mesh-list
110607812|NCT03830281|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110607813|NCT03830281|Insulin Lispro|insulin lispro|mesh-list
110607814|NCT03830281|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110607815|NCT03830281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110607816|NCT00563368|Topiramate|topiramate|mesh-list
110607817|NCT00563368|Phentermine|phentermine|mesh-list
110607818|NCT00563368|Anticonvulsants|anticonvulsants|mesh-ancestor
110607819|NCT00563368|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110607820|NCT00563368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110255144|NCT00157872|Naproxen|naproxen|mesh-list
110607821|NCT00563368|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110607823|NCT00563368|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110607824|NCT00563368|Sympathomimetics|sympathomimetics|mesh-ancestor
110607825|NCT00563368|Autonomic Agents|autonomic agents|mesh-ancestor
110383160|NCT06046560|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110383162|NCT06046482|Docetaxel|docetaxel|mesh-list
110607826|NCT00563368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110607827|NCT00563368|Adrenergic Agents|adrenergic agents|mesh-ancestor
110607828|NCT00563368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110607829|NCT00563368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110607830|NCT00390013|Gabapentin|gabapentin|mesh-list
110607831|NCT00390013|Analgesics|analgesics|mesh-ancestor
110607832|NCT00390013|Sensory System Agents|sensory system agents|mesh-ancestor
110607833|NCT00390013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110607834|NCT00390013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110607835|NCT00390013|Anticonvulsants|anticonvulsants|mesh-ancestor
110607836|NCT00390013|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110607837|NCT00390013|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110607838|NCT00390013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110607839|NCT00390013|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110607840|NCT00390013|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110607841|NCT00390013|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110607842|NCT00390013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110607843|NCT00390013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110607844|NCT00390013|Antimanic Agents|antimanic agents|mesh-ancestor
110607845|NCT00562120|Fexofenadine|fexofenadine|mesh-list
110607846|NCT00562120|Terfenadine|terfenadine|mesh-list
110607847|NCT00562120|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110607848|NCT00562120|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110607849|NCT00562120|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110607850|NCT00562120|Histamine Antagonists|histamine antagonists|mesh-ancestor
110607851|NCT00562120|Histamine Agents|histamine agents|mesh-ancestor
110607852|NCT00562120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110607853|NCT00562120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110607854|NCT00562120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110607855|NCT00561730|Pantoprazole|pantoprazole|mesh-list
110607856|NCT00561730|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110607857|NCT00561730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110607858|NCT00561730|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110607859|NCT00561730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110607860|NCT00561730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110607861|NCT00697112|Sirolimus|sirolimus|mesh-list
110607862|NCT00697112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110607863|NCT00697112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110607864|NCT00697112|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110607865|NCT00697112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110607866|NCT00697112|Antifungal Agents|antifungal agents|mesh-ancestor
110607867|NCT00697112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110607868|NCT00697112|Immunologic Factors|immunologic factors|mesh-ancestor
110607869|NCT00697112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110607870|NCT00621855|Dabigatran|dabigatran|mesh-list
110607871|NCT00621855|Antithrombins|antithrombins|mesh-ancestor
110607872|NCT00621855|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110607873|NCT00621855|Protease Inhibitors|protease inhibitors|mesh-ancestor
110607874|NCT00621855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110607875|NCT00621855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110607876|NCT00621855|Anticoagulants|anticoagulants|mesh-ancestor
110607877|NCT00851565|Infliximab|infliximab|mesh-list
110607878|NCT00851565|Antibodies|antibodies|mesh-list
110607879|NCT00851565|Immunologic Factors|immunologic factors|mesh-ancestor
110607880|NCT00851565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110607881|NCT00851565|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110607882|NCT00851565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110607883|NCT00851565|Dermatologic Agents|dermatologic agents|mesh-ancestor
110607884|NCT00851565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110607885|NCT00851565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110607886|NCT00561574|Mirtazapine|mirtazapine|mesh-list
110607887|NCT00561574|Antidepressive Agents|antidepressive agents|mesh-ancestor
110607888|NCT00561574|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110607889|NCT00561574|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110607890|NCT00561574|Histamine Antagonists|histamine antagonists|mesh-ancestor
110607891|NCT00561574|Histamine Agents|histamine agents|mesh-ancestor
110607892|NCT00561574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110383237|NCT06045936|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110607893|NCT00561574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110607894|NCT00561574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110607895|NCT00561574|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110607896|NCT00561574|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110607897|NCT00561574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110607898|NCT00561574|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
110607899|NCT00561574|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110607900|NCT00561574|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110607901|NCT00561574|Adrenergic Agents|adrenergic agents|mesh-ancestor
110607902|NCT00561574|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110607903|NCT00561574|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110607904|NCT00561574|Serotonin Agents|serotonin agents|mesh-ancestor
110607905|NCT00561574|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110607906|NCT00619827|Immunomodulating Agents|immunomodulating agents|mesh-list
110607907|NCT00619827|Immunologic Factors|immunologic factors|mesh-ancestor
110607908|NCT00619827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110607909|NCT00687804|Ranibizumab|ranibizumab|mesh-list
110607910|NCT00687804|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110607911|NCT00687804|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110607912|NCT00687804|Growth Substances|growth substances|mesh-ancestor
110607913|NCT00687804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110607914|NCT00687804|Growth Inhibitors|growth inhibitors|mesh-ancestor
110607915|NCT00687804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110607916|NCT02563704|Artesunate|artesunate|mesh-list
110607917|NCT02563704|Quinine|quinine|mesh-list
110607918|NCT02563704|Antimalarials|antimalarials|mesh-ancestor
110607919|NCT02563704|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110607920|NCT02563704|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110607921|NCT02563704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110607922|NCT02563704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110607923|NCT02563704|Antiviral Agents|antiviral agents|mesh-ancestor
110607924|NCT02563704|Schistosomicides|schistosomicides|mesh-ancestor
110607925|NCT02563704|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110607926|NCT02563704|Anthelmintics|anthelmintics|mesh-ancestor
110607927|NCT02563704|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110607928|NCT02563704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110607929|NCT02563704|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110607930|NCT02563704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110607931|NCT02563704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110607932|NCT02563704|Analgesics|analgesics|mesh-ancestor
110607933|NCT02563704|Sensory System Agents|sensory system agents|mesh-ancestor
110607934|NCT00848523|Panobinostat|panobinostat|mesh-list
110607935|NCT00848523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110383279|NCT06045429|Disinfectants|disinfectants|mesh-ancestor
110383280|NCT06045429|Dermatologic Agents|dermatologic agents|mesh-ancestor
110383281|NCT06045364|Anisodamine|anisodamine|mesh-list
110607936|NCT00848523|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110152392|NCT00389935|Thalidomide|thalidomide|mesh-list
110607938|NCT00848523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110607940|NCT00742404|Doxorubicin|doxorubicin|mesh-list
110607941|NCT00742404|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110607942|NCT00742404|Bortezomib|bortezomib|mesh-list
110607943|NCT00742404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110607944|NCT00742404|Antiemetics|antiemetics|mesh-ancestor
110607945|NCT00742404|Autonomic Agents|autonomic agents|mesh-ancestor
110607946|NCT00742404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110607947|NCT00742404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110607948|NCT00742404|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110607949|NCT00742404|Glucocorticoids|glucocorticoids|mesh-ancestor
110607950|NCT00742404|Hormones|hormones|mesh-ancestor
110607951|NCT00742404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110607952|NCT00742404|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110607953|NCT00742404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110607954|NCT00742404|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110607955|NCT00742404|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110607956|NCT00742404|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110607957|NCT00742404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110607958|NCT00742404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110607959|NCT00744666|Prednisolone|prednisolone|mesh-list
110607960|NCT00744666|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110607961|NCT00744666|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110607962|NCT00744666|Glucocorticoids|glucocorticoids|mesh-ancestor
110607963|NCT00744666|Hormones|hormones|mesh-ancestor
110607964|NCT00744666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110607965|NCT00744666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110607966|NCT00744666|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110607967|NCT00744666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110607968|NCT00744666|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110607969|NCT04013620|Abatacept|abatacept|mesh-list
110607970|NCT04013620|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110607971|NCT04013620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110607972|NCT04013620|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110607973|NCT04013620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110607974|NCT04013620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110607975|NCT04013620|Immunologic Factors|immunologic factors|mesh-ancestor
110607976|NCT04013620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110607977|NCT04013620|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110607978|NCT00749112|Rituximab|rituximab|mesh-list
110383314|NCT06045299|Brimonidine Tartrate|brimonidine tartrate|mesh-list
110383315|NCT06045299|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110383317|NCT06045299|Aceclidine|aceclidine|mesh-list
110607979|NCT00749112|Alemtuzumab|alemtuzumab|mesh-list
110607980|NCT00749112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110607981|NCT00749112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110607982|NCT00749112|Immunologic Factors|immunologic factors|mesh-ancestor
110607983|NCT00749112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110607984|NCT00749112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110607985|NCT00848679|Lidocaine|lidocaine|mesh-list
110607986|NCT00848679|Anesthetics, Local|anesthetics, local|mesh-ancestor
110607987|NCT00848679|Anesthetics|anesthetics|mesh-ancestor
110607988|NCT00848679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110607989|NCT00848679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110607990|NCT00848679|Sensory System Agents|sensory system agents|mesh-ancestor
110607991|NCT00848679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110607992|NCT00848679|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110607993|NCT00848679|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110607994|NCT00848679|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110607995|NCT00848679|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110607996|NCT00848679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110607997|NCT04012606|Carboplatin|carboplatin|mesh-list
110607998|NCT04012606|Etoposide|etoposide|mesh-list
110607999|NCT04012606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110608000|NCT04012606|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110608001|NCT04012606|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110608002|NCT04012606|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110608003|NCT04012606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110275885|NCT00174902|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110608004|NCT04012606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110608005|NCT02545959|Methylprednisolone|methylprednisolone|mesh-list
110608006|NCT02545959|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110608007|NCT02545959|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110608008|NCT02545959|Prednisolone|prednisolone|mesh-list
110608009|NCT02545959|Prednisolone acetate|prednisolone acetate|mesh-list
110608010|NCT02545959|Rituximab|rituximab|mesh-list
110608011|NCT02545959|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110608012|NCT02545959|Prednisolone phosphate|prednisolone phosphate|mesh-list
110608013|NCT02545959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110608014|NCT02545959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110608015|NCT02545959|Immunologic Factors|immunologic factors|mesh-ancestor
110608016|NCT02545959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110608017|NCT02545959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110608018|NCT02545959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110608019|NCT02545959|Antiemetics|antiemetics|mesh-ancestor
110608020|NCT02545959|Autonomic Agents|autonomic agents|mesh-ancestor
110608021|NCT02545959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110608022|NCT02545959|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110608023|NCT02545959|Glucocorticoids|glucocorticoids|mesh-ancestor
110608024|NCT02545959|Hormones|hormones|mesh-ancestor
110608025|NCT02545959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110608026|NCT02545959|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110608027|NCT02545959|Protective Agents|protective agents|mesh-ancestor
110608028|NCT02545959|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110608029|NCT00744900|Pemetrexed|pemetrexed|mesh-list
110608030|NCT00744900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110608031|NCT00744900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110608032|NCT00744900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110608033|NCT00744900|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110608034|NCT00744900|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110608035|NCT00727090|Conivaptan|conivaptan|mesh-list
110608036|NCT00727090|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
110608037|NCT00727090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110608038|NCT00727090|Natriuretic Agents|natriuretic agents|mesh-ancestor
110383378|NCT06045013|Methylprednisolone|methylprednisolone|mesh-list
110608039|NCT00727090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110608041|NCT00689052|Antioxidants|antioxidants|mesh-ancestor
110608042|NCT00689052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110608043|NCT00689052|Protective Agents|protective agents|mesh-ancestor
110608044|NCT00689052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110608045|NCT00689052|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110608046|NCT00689052|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110608047|NCT00689052|Dopamine Agonists|dopamine agonists|mesh-ancestor
110608048|NCT00689052|Dopamine Agents|dopamine agents|mesh-ancestor
110608049|NCT00689052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110608050|NCT04012450|Anesthetics|anesthetics|mesh-list
110608051|NCT04012450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110608052|NCT04012450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110608053|NCT00945022|Anesthetics|anesthetics|mesh-list
110608054|NCT00945022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110608055|NCT00945022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110608056|NCT02565212|Montelukast|montelukast|mesh-list
110608057|NCT02565212|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110608058|NCT02565212|Respiratory System Agents|respiratory system agents|mesh-ancestor
110608059|NCT02565212|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110608060|NCT02565212|Hormone Antagonists|hormone antagonists|mesh-ancestor
110152403|NCT00389935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110608061|NCT02565212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110608062|NCT02565212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110608063|NCT02565212|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110608064|NCT02565212|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110608065|NCT02565212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110608066|NCT00747708|Lenograstim|lenograstim|mesh-list
110608067|NCT00747708|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110608068|NCT00747708|Immunologic Factors|immunologic factors|mesh-ancestor
110608069|NCT00747708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110608070|NCT05602064|Acetaminophen|acetaminophen|mesh-list
110608072|NCT05602064|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110608073|NCT05602064|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110608074|NCT05602064|Analgesics|analgesics|mesh-ancestor
110608075|NCT05602064|Sensory System Agents|sensory system agents|mesh-ancestor
110608076|NCT05602064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110608077|NCT05602064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110608078|NCT05602064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110608079|NCT05602064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110383429|NCT06044675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110383430|NCT06044675|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110383431|NCT06044675|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110383432|NCT06044675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110383433|NCT06044675|Adrenergic Agents|adrenergic agents|mesh-ancestor
110608081|NCT05602064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110608082|NCT05602064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110608083|NCT05602064|Antipyretics|antipyretics|mesh-ancestor
110608084|NCT00560950|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110608085|NCT00560950|Immunologic Factors|immunologic factors|mesh-ancestor
110608086|NCT00560950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110608088|NCT02562144|Anesthetics, Local|anesthetics, local|mesh-ancestor
110608089|NCT02562144|Anesthetics|anesthetics|mesh-ancestor
110608090|NCT02562144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110608091|NCT02562144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110608092|NCT02562144|Sensory System Agents|sensory system agents|mesh-ancestor
110608093|NCT02562144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110608094|NCT02562144|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110608095|NCT02562144|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110608096|NCT02562144|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110608097|NCT02562144|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110608098|NCT02562144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110608099|NCT02562300|Misoprostol|misoprostol|mesh-list
110608100|NCT02562300|Oxytocin|oxytocin|mesh-list
110608101|NCT02562300|Oxytocics|oxytocics|mesh-ancestor
110608102|NCT02562300|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110608103|NCT02562300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110608104|NCT02562300|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110608105|NCT02562300|Abortifacient Agents|abortifacient agents|mesh-ancestor
110608106|NCT02562300|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110608107|NCT02562300|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110608108|NCT00945178|Naproxen|naproxen|mesh-list
110608109|NCT00945178|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110608110|NCT00945178|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110608111|NCT00945178|Analgesics|analgesics|mesh-ancestor
110608112|NCT00945178|Sensory System Agents|sensory system agents|mesh-ancestor
110608113|NCT00945178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110608114|NCT00945178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110608115|NCT00945178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110608116|NCT00945178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110608117|NCT00945178|Gout Suppressants|gout suppressants|mesh-ancestor
110608118|NCT00945178|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110608119|NCT00945178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110608120|NCT00945178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110608121|NCT00749346|Pemetrexed|pemetrexed|mesh-list
110608122|NCT00749346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110608123|NCT00749346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110608124|NCT00749346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110608125|NCT00749346|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110608126|NCT00749346|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110383475|NCT06044493|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110383476|NCT06044493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110383477|NCT06044493|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110383478|NCT06044493|Antitubercular Agents|antitubercular agents|mesh-ancestor
110383479|NCT06044493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110383480|NCT06044493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110383481|NCT06044493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110383482|NCT06044493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110383483|NCT06044480|Dexamethasone|dexamethasone|mesh-list
110383484|NCT06044480|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110383485|NCT06044480|Antiemetics|antiemetics|mesh-ancestor
110383486|NCT06044480|Autonomic Agents|autonomic agents|mesh-ancestor
110608128|NCT02562690|Hemostatics|hemostatics|mesh-ancestor
110608129|NCT02562690|Coagulants|coagulants|mesh-ancestor
110608130|NCT00576758|Rituximab|rituximab|mesh-list
110608132|NCT00576758|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110608133|NCT00576758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110608134|NCT00576758|Immunologic Factors|immunologic factors|mesh-ancestor
110608135|NCT00576758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110608136|NCT00576758|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110608137|NCT00923676|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110608138|NCT00923676|Fenofibrate|fenofibrate|mesh-list
110608139|NCT00923676|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110608140|NCT00923676|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110608141|NCT00923676|Antimetabolites|antimetabolites|mesh-ancestor
110608142|NCT00923676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110608143|NCT00923676|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110608144|NCT00923676|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110608145|NCT00923676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110608146|NCT00921284|Dexmedetomidine|dexmedetomidine|mesh-list
110608147|NCT00921284|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110608148|NCT00921284|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110608149|NCT00921284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110608150|NCT00921284|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110608151|NCT00921284|Analgesics|analgesics|mesh-ancestor
110608152|NCT00921284|Sensory System Agents|sensory system agents|mesh-ancestor
110608153|NCT00921284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110608154|NCT00921284|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110608155|NCT00921284|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110608156|NCT00921284|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110608157|NCT00921284|Adrenergic Agents|adrenergic agents|mesh-ancestor
110608158|NCT00921284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110608159|NCT00921284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110608160|NCT00749502|Niraparib|niraparib|mesh-list
110608161|NCT00749502|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110608162|NCT00749502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110608163|NCT00749502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110608164|NCT00749502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110608165|NCT00560794|Blinatumomab|blinatumomab|mesh-list
110608166|NCT00560794|Antibodies, Bispecific|antibodies, bispecific|mesh-list
110608167|NCT00560794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110608168|NCT00560794|Immunologic Factors|immunologic factors|mesh-ancestor
110608169|NCT00560794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110383491|NCT06044480|Hormones|hormones|mesh-ancestor
110608170|NCT00749736|Cholecalciferol|cholecalciferol|mesh-list
110608171|NCT00749736|Vitamin D|vitamin d|mesh-list
110608172|NCT00749736|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
110608173|NCT00749736|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110608174|NCT00749736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110608175|NCT00749736|Vitamins|vitamins|mesh-ancestor
110608176|NCT00749736|Micronutrients|micronutrients|mesh-ancestor
110608177|NCT00749736|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110608178|NCT00950404|Sildenafil Citrate|sildenafil citrate|mesh-list
110608179|NCT00950404|Vasodilator Agents|vasodilator agents|mesh-ancestor
110608180|NCT00950404|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110608181|NCT00950404|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110608182|NCT00950404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110608183|NCT00950404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110608184|NCT00950404|Urological Agents|urological agents|mesh-ancestor
110608185|NCT00749814|Melatonin|melatonin|mesh-list
110608186|NCT00749814|Antioxidants|antioxidants|mesh-ancestor
110608187|NCT00749814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110608188|NCT00749814|Protective Agents|protective agents|mesh-ancestor
110608189|NCT00749814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110608190|NCT00749814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110608191|NCT00748176|Anesthetics|anesthetics|mesh-list
110608192|NCT00748176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110608193|NCT00748176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110608194|NCT00619359|Dexamethasone|dexamethasone|mesh-list
110608195|NCT00619359|Dexamethasone acetate|dexamethasone acetate|mesh-list
110608196|NCT00619359|Ondansetron|ondansetron|mesh-list
110608197|NCT00619359|Aprepitant|aprepitant|mesh-list
110608198|NCT00619359|Fosaprepitant|fosaprepitant|mesh-list
110608199|NCT00619359|BB 1101|bb 1101|mesh-list
110608200|NCT00619359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110608201|NCT00619359|Antiemetics|antiemetics|mesh-ancestor
110608202|NCT00619359|Autonomic Agents|autonomic agents|mesh-ancestor
110608203|NCT00619359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110608204|NCT00619359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110608205|NCT00619359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110608206|NCT00619359|Glucocorticoids|glucocorticoids|mesh-ancestor
110608207|NCT00619359|Hormones|hormones|mesh-ancestor
110608208|NCT00619359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110608209|NCT00619359|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110608210|NCT00619359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110608211|NCT00619359|Protease Inhibitors|protease inhibitors|mesh-ancestor
110608212|NCT00619359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110608213|NCT00619359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110608214|NCT00619359|Antipruritics|antipruritics|mesh-ancestor
110608215|NCT00619359|Dermatologic Agents|dermatologic agents|mesh-ancestor
110608216|NCT00619359|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110608218|NCT00619359|Serotonin Agents|serotonin agents|mesh-ancestor
110608219|NCT00619359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110608220|NCT00619359|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110608221|NCT00848991|Dexmedetomidine|dexmedetomidine|mesh-list
110608222|NCT00848991|Propofol|propofol|mesh-list
110608223|NCT00848991|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110608224|NCT00848991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110608225|NCT00848991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110608226|NCT00848991|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110608227|NCT00848991|Anesthetics, General|anesthetics, general|mesh-ancestor
110608228|NCT00848991|Anesthetics|anesthetics|mesh-ancestor
110608229|NCT00848991|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110608230|NCT00848991|Analgesics|analgesics|mesh-ancestor
110608231|NCT00848991|Sensory System Agents|sensory system agents|mesh-ancestor
110608232|NCT00848991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110608233|NCT00848991|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110608234|NCT00848991|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110608235|NCT00848991|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110608236|NCT00848991|Adrenergic Agents|adrenergic agents|mesh-ancestor
110608237|NCT00848991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110608238|NCT00848991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110608239|NCT00950794|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110608240|NCT00950794|Tulobuterol|tulobuterol|mesh-list
110608241|NCT00950794|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110608242|NCT00950794|Autonomic Agents|autonomic agents|mesh-ancestor
110608243|NCT00950794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110608244|NCT00950794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110608245|NCT00950794|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110608246|NCT00950794|Respiratory System Agents|respiratory system agents|mesh-ancestor
110608247|NCT00950794|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110608248|NCT00950794|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110608249|NCT00950794|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110608250|NCT00950794|Adrenergic Agents|adrenergic agents|mesh-ancestor
110608251|NCT00950794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110608252|NCT00950794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110608254|NCT00852189|Vitamin B Complex|vitamin b complex|mesh-list
110608255|NCT00852189|Vinca Alkaloids|vinca alkaloids|mesh-list
110608256|NCT00852189|Hematinics|hematinics|mesh-ancestor
110608257|NCT00852189|Vitamins|vitamins|mesh-ancestor
110608258|NCT00852189|Micronutrients|micronutrients|mesh-ancestor
110608259|NCT00852189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110608260|NCT00852189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110608261|NCT00852189|Tubulin Modulators|tubulin modulators|mesh-ancestor
110608262|NCT00852189|Antimitotic Agents|antimitotic agents|mesh-ancestor
110608263|NCT00852189|Mitosis Modulators|mitosis modulators|mesh-ancestor
110608264|NCT00852189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110608265|NCT00951106|Pyrimethamine|pyrimethamine|mesh-list
110608266|NCT00951106|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
110608267|NCT00951106|Antimalarials|antimalarials|mesh-ancestor
110255594|NCT04715737|Coagulants|coagulants|mesh-ancestor
110608268|NCT00951106|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110608269|NCT00951106|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110283649|NCT00226395|Narcotics|narcotics|mesh-ancestor
110608270|NCT00951106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110608271|NCT00951106|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110608272|NCT00951106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110608273|NCT00951106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110608274|NCT00372229|Valganciclovir|valganciclovir|mesh-list
110608275|NCT00372229|Ganciclovir|ganciclovir|mesh-list
110608276|NCT00372229|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
110608277|NCT00372229|Antiviral Agents|antiviral agents|mesh-ancestor
110608278|NCT00372229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110608279|NCT00372229|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110608280|NCT00372229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110608281|NCT00372229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110608282|NCT05301010|Docetaxel|docetaxel|mesh-list
110608283|NCT05301010|Trastuzumab|trastuzumab|mesh-list
110608284|NCT05301010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110608285|NCT05301010|Tubulin Modulators|tubulin modulators|mesh-ancestor
110608286|NCT05301010|Antimitotic Agents|antimitotic agents|mesh-ancestor
110608287|NCT05301010|Mitosis Modulators|mitosis modulators|mesh-ancestor
110608288|NCT05301010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110608289|NCT05301010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110608290|NCT00855699|Acamprosate|acamprosate|mesh-list
110608291|NCT00855699|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110608292|NCT00855777|Ibuprofen|ibuprofen|mesh-list
110608293|NCT00855777|Etoricoxib|etoricoxib|mesh-list
110608294|NCT00855777|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110608295|NCT00855777|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110608296|NCT00855777|Analgesics|analgesics|mesh-ancestor
110608297|NCT00855777|Sensory System Agents|sensory system agents|mesh-ancestor
110608298|NCT00855777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110608299|NCT00855777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110608300|NCT00855777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110608301|NCT00855777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110608302|NCT00855777|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110608303|NCT00855777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110608304|NCT00855777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110608305|NCT00855777|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110608306|NCT04012294|Allopurinol|allopurinol|mesh-list
110608307|NCT04012294|Antimetabolites|antimetabolites|mesh-ancestor
110608308|NCT04012294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110608309|NCT04012294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110608310|NCT04012294|Gout Suppressants|gout suppressants|mesh-ancestor
110608311|NCT04012294|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110608312|NCT04012294|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110608313|NCT04012294|Antioxidants|antioxidants|mesh-ancestor
110608314|NCT04012294|Protective Agents|protective agents|mesh-ancestor
110608315|NCT04012294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110608316|NCT00849459|Interleukin-12|interleukin-12|mesh-list
110608317|NCT00849459|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110608318|NCT00849459|Immunologic Factors|immunologic factors|mesh-ancestor
110608319|NCT00849459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110608320|NCT00849459|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110608321|NCT00849459|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110608322|NCT00849459|Growth Substances|growth substances|mesh-ancestor
110608323|NCT00849459|Growth Inhibitors|growth inhibitors|mesh-ancestor
110608324|NCT00849459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110383628|NCT06043310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110383629|NCT06043310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110383630|NCT06043297|Apixaban|apixaban|mesh-list
110383631|NCT06043297|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110383632|NCT06043297|Antithrombins|antithrombins|mesh-ancestor
110383633|NCT06043297|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110383634|NCT06043297|Protease Inhibitors|protease inhibitors|mesh-ancestor
110383635|NCT06043297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110383636|NCT06043297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110383637|NCT06043297|Anticoagulants|anticoagulants|mesh-ancestor
110383653|NCT06043024|Salicylic Acid|salicylic acid|mesh-list
110383654|NCT06043024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110383655|NCT06043024|Antifungal Agents|antifungal agents|mesh-ancestor
110383656|NCT06043024|Keratolytic Agents|keratolytic agents|mesh-ancestor
110383657|NCT06043024|Dermatologic Agents|dermatologic agents|mesh-ancestor
110383658|NCT06042985|Calcium, Dietary|calcium, dietary|mesh-list
110608325|NCT00852345|Clofazimine|clofazimine|mesh-list
110608326|NCT00852345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110283652|NCT00226395|Analgesics|analgesics|mesh-ancestor
110608327|NCT00852345|Leprostatic Agents|leprostatic agents|mesh-ancestor
110608328|NCT00852345|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110608329|NCT00852345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110608331|NCT00852423|Lumefantrine|lumefantrine|mesh-list
110608332|NCT00852423|Artemether|artemether|mesh-list
110608333|NCT00852423|Piperaquine|piperaquine|mesh-list
110608334|NCT00852423|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
110608335|NCT00852423|Amodiaquine|amodiaquine|mesh-list
110608336|NCT00852423|Artenimol|artenimol|mesh-list
110608337|NCT00852423|Mefloquine|mefloquine|mesh-list
110608338|NCT00852423|Antimalarials|antimalarials|mesh-ancestor
110608339|NCT00852423|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110608340|NCT00852423|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110608341|NCT00852423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110608342|NCT00852423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110608343|NCT00852423|Antiviral Agents|antiviral agents|mesh-ancestor
110608344|NCT00852423|Schistosomicides|schistosomicides|mesh-ancestor
110608345|NCT00852423|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110608346|NCT00852423|Anthelmintics|anthelmintics|mesh-ancestor
110608347|NCT00941824|Mycophenolic Acid|mycophenolic acid|mesh-list
110608348|NCT00941824|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110608349|NCT00941824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110608350|NCT00941824|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110608351|NCT00941824|Antitubercular Agents|antitubercular agents|mesh-ancestor
110608352|NCT00941824|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110608353|NCT00941824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110608354|NCT00941824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110608355|NCT00941824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110608356|NCT00849537|Triamcinolone|triamcinolone|mesh-list
110608357|NCT00849537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110608358|NCT00849537|Glucocorticoids|glucocorticoids|mesh-ancestor
110608359|NCT00849537|Hormones|hormones|mesh-ancestor
110608360|NCT00849537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110608361|NCT00849537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110608362|NCT01049815|Calcium Carbonate|calcium carbonate|mesh-list
110608363|NCT01049815|Calcium|calcium|mesh-list
110608364|NCT01049815|Sevelamer|sevelamer|mesh-list
110608365|NCT01049815|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110608366|NCT01049815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110608367|NCT01049815|Antacids|antacids|mesh-ancestor
110608368|NCT01049815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110608369|NCT01049815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110608370|NCT01049815|Chelating Agents|chelating agents|mesh-ancestor
110608371|NCT01049815|Sequestering Agents|sequestering agents|mesh-ancestor
110608372|NCT00849615|Leucovorin|leucovorin|mesh-list
110608373|NCT00849615|Folic Acid|folic acid|mesh-list
110608374|NCT00849615|Docetaxel|docetaxel|mesh-list
110608375|NCT00849615|Fluorouracil|fluorouracil|mesh-list
110608376|NCT00849615|Oxaliplatin|oxaliplatin|mesh-list
110608377|NCT00849615|Levoleucovorin|levoleucovorin|mesh-list
110608378|NCT00849615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110608379|NCT00849615|Tubulin Modulators|tubulin modulators|mesh-ancestor
110608380|NCT00849615|Antimitotic Agents|antimitotic agents|mesh-ancestor
110608381|NCT00849615|Mitosis Modulators|mitosis modulators|mesh-ancestor
110383671|NCT06042985|Antacids|antacids|mesh-ancestor
110608382|NCT00849615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110608383|NCT00849615|Antimetabolites|antimetabolites|mesh-ancestor
110608384|NCT00849615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110608385|NCT00849615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110608386|NCT00849615|Immunologic Factors|immunologic factors|mesh-ancestor
110608387|NCT00849615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110608388|NCT00849615|Antidotes|antidotes|mesh-ancestor
110608389|NCT00849615|Protective Agents|protective agents|mesh-ancestor
110608390|NCT00849615|Vitamin B Complex|vitamin b complex|mesh-ancestor
110608391|NCT00849615|Vitamins|vitamins|mesh-ancestor
110608392|NCT00849615|Micronutrients|micronutrients|mesh-ancestor
110608393|NCT00849615|Hematinics|hematinics|mesh-ancestor
110608394|NCT00946036|Sertraline|sertraline|mesh-list
110608395|NCT00946036|Antidepressive Agents|antidepressive agents|mesh-ancestor
110608396|NCT00946036|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110608397|NCT00946036|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110608398|NCT00946036|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110283656|NCT00208221|Telmisartan|telmisartan|mesh-list
110608399|NCT00946036|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110608400|NCT00946036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110608401|NCT00946036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110608402|NCT00946036|Serotonin Agents|serotonin agents|mesh-ancestor
110608403|NCT00946036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110608404|NCT00688740|Cyclophosphamide|cyclophosphamide|mesh-list
110608406|NCT00688740|Doxorubicin|doxorubicin|mesh-list
110608407|NCT00688740|Fluorouracil|fluorouracil|mesh-list
110608408|NCT00688740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110608409|NCT00688740|Immunologic Factors|immunologic factors|mesh-ancestor
110608410|NCT00688740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110608411|NCT00688740|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110608412|NCT00688740|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110608413|NCT00688740|Alkylating Agents|alkylating agents|mesh-ancestor
110608414|NCT00688740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110608415|NCT00688740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110608416|NCT00688740|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110608417|NCT00688740|Tubulin Modulators|tubulin modulators|mesh-ancestor
110608418|NCT00688740|Antimitotic Agents|antimitotic agents|mesh-ancestor
110383698|NCT06041932|Carvedilol|carvedilol|mesh-list
110608419|NCT00688740|Mitosis Modulators|mitosis modulators|mesh-ancestor
110608420|NCT00688740|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110608421|NCT00688740|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110255749|NCT00509860|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110608423|NCT00688740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110608424|NCT00688740|Antimetabolites|antimetabolites|mesh-ancestor
110608425|NCT00688740|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110608426|NCT05323058|Benzydamine|benzydamine|mesh-list
110608427|NCT05323058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110608428|NCT01046773|Cholecalciferol|cholecalciferol|mesh-list
110608429|NCT01046773|Vitamin D|vitamin d|mesh-list
110608430|NCT01046773|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110608431|NCT01046773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110608432|NCT01046773|Vitamins|vitamins|mesh-ancestor
110608433|NCT01046773|Micronutrients|micronutrients|mesh-ancestor
110608434|NCT01046773|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110608435|NCT00850005|Immunoglobulins|immunoglobulins|mesh-list
110608436|NCT00850005|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110608437|NCT00850005|Antibodies|antibodies|mesh-list
110608438|NCT00850005|gamma-Globulins|gamma-globulins|mesh-list
110608439|NCT00850005|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110608440|NCT00850005|Immunologic Factors|immunologic factors|mesh-ancestor
110608441|NCT00850005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110608443|NCT00852579|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110608444|NCT00852579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110608445|NCT00942136|Dolutegravir|dolutegravir|mesh-list
110608446|NCT00942136|Omeprazole|omeprazole|mesh-list
110608447|NCT00942136|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110608448|NCT00942136|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110608449|NCT00942136|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110608450|NCT00942136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110608451|NCT00942136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110608452|NCT00942136|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110608453|NCT00942136|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110608454|NCT00942136|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110608455|NCT00942136|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110608456|NCT00942136|Antiviral Agents|antiviral agents|mesh-ancestor
110608457|NCT00942136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110608458|NCT05300932|Cyclophosphamide|cyclophosphamide|mesh-list
110608459|NCT05300932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110608460|NCT05300932|Immunologic Factors|immunologic factors|mesh-ancestor
110608461|NCT05300932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110608462|NCT05300932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110608463|NCT05300932|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110608464|NCT05300932|Alkylating Agents|alkylating agents|mesh-ancestor
110608465|NCT05300932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110608466|NCT05300932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110608467|NCT05300932|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110608468|NCT00942214|Natalizumab|natalizumab|mesh-list
110608469|NCT00942214|Immunologic Factors|immunologic factors|mesh-ancestor
110608470|NCT00942214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110608471|NCT00850161|Insulin|insulin|mesh-list
110608472|NCT00850161|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110608473|NCT00850161|Insulin Aspart|insulin aspart|mesh-list
110608474|NCT00850161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110608475|NCT00850161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110608478|NCT00951574|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110608479|NCT00951574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110608480|NCT00951574|Anticoagulants|anticoagulants|mesh-ancestor
110608481|NCT00951574|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110608482|NCT00951574|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110608483|NCT00951574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110608484|NCT00686790|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110608485|NCT00686790|Interferon-alpha|interferon-alpha|mesh-list
110608486|NCT00686790|Antiviral Agents|antiviral agents|mesh-ancestor
110608487|NCT00686790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110608488|NCT00686790|Immunologic Factors|immunologic factors|mesh-ancestor
110608489|NCT00686790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110608490|NCT00856089|Retapamulin|retapamulin|mesh-list
110608491|NCT00856089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110608492|NCT00856089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110608493|NCT00686712|Insulin|insulin|mesh-list
110608494|NCT00686712|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110608495|NCT00686712|Insulin Glargine|insulin glargine|mesh-list
110608496|NCT00686712|Insulin, Isophane|insulin, isophane|mesh-list
110608497|NCT00686712|Isophane Insulin, Human|isophane insulin, human|mesh-list
110608498|NCT00686712|Isophane insulin, beef|isophane insulin, beef|mesh-list
110608499|NCT00686712|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110608500|NCT00686712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110608501|NCT00748644|Rituximab|rituximab|mesh-list
110608502|NCT00748644|Azathioprine|azathioprine|mesh-list
110608503|NCT00748644|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110608504|NCT00748644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110608505|NCT00748644|Immunologic Factors|immunologic factors|mesh-ancestor
110608506|NCT00748644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110608507|NCT00748644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110608508|NCT00748644|Antimetabolites|antimetabolites|mesh-ancestor
110608509|NCT00748644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110608510|NCT00748644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110608511|NCT00748644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110608512|NCT00686634|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110608513|NCT00686634|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110608514|NCT00686634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110608515|NCT00686634|Incretins|incretins|mesh-ancestor
110608516|NCT00686634|Hormones|hormones|mesh-ancestor
110608517|NCT00686634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110608518|NCT00686634|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110608519|NCT00686634|Protease Inhibitors|protease inhibitors|mesh-ancestor
110608520|NCT00686634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110608521|NCT00686634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110608522|NCT00856401|Parathyroid Hormone|parathyroid hormone|mesh-list
110608523|NCT00856401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110608524|NCT00856401|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110608525|NCT00560404|Epoetin Alfa|epoetin alfa|mesh-list
110608526|NCT00560404|Hematinics|hematinics|mesh-ancestor
110608527|NCT00942526|Nystatin|nystatin|mesh-list
110608528|NCT00942526|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110608529|NCT00942526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110608530|NCT00942526|Antifungal Agents|antifungal agents|mesh-ancestor
110608531|NCT00942526|Ionophores|ionophores|mesh-ancestor
110608532|NCT00942526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110608533|NCT00942526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110608534|NCT03967444|Hyaluronic Acid|hyaluronic acid|mesh-list
110608535|NCT03967444|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110608536|NCT03967444|Immunologic Factors|immunologic factors|mesh-ancestor
110608537|NCT03967444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110608538|NCT03967444|Viscosupplements|viscosupplements|mesh-ancestor
110608539|NCT03967444|Protective Agents|protective agents|mesh-ancestor
110608540|NCT05300854|Anesthetics|anesthetics|mesh-list
110608541|NCT05300854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110608542|NCT05300854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110608544|NCT00946504|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110608545|NCT00946504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110608546|NCT00619983|Gabapentin|gabapentin|mesh-list
110608547|NCT00619983|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110608548|NCT00619983|Donepezil|donepezil|mesh-list
110608549|NCT00619983|Analgesics|analgesics|mesh-ancestor
110608550|NCT00619983|Sensory System Agents|sensory system agents|mesh-ancestor
110608551|NCT00619983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110608552|NCT00619983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110608553|NCT00619983|Anticonvulsants|anticonvulsants|mesh-ancestor
110608554|NCT00619983|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110608555|NCT00619983|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110608556|NCT00619983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110608557|NCT00619983|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110608558|NCT00619983|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110608559|NCT00619983|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110608560|NCT00619983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110608561|NCT00619983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110608562|NCT00619983|Antimanic Agents|antimanic agents|mesh-ancestor
110608563|NCT00619983|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110152448|NCT00000522|Diuretics|diuretics|mesh-ancestor
110608564|NCT00619983|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110608565|NCT00619983|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110608566|NCT00619983|Antidepressive Agents|antidepressive agents|mesh-ancestor
110608567|NCT00619983|Dopamine Agents|dopamine agents|mesh-ancestor
110608568|NCT00619983|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110608569|NCT00619983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110608570|NCT00619983|Cholinergic Agents|cholinergic agents|mesh-ancestor
110608571|NCT00619983|Nootropic Agents|nootropic agents|mesh-ancestor
110608572|NCT00942682|Sorafenib|sorafenib|mesh-list
110608573|NCT00942682|Everolimus|everolimus|mesh-list
110608574|NCT00942682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110608575|NCT00942682|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110608576|NCT00942682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110608577|NCT00942682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110608578|NCT00942682|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110608579|NCT00942682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110608580|NCT00942682|Immunologic Factors|immunologic factors|mesh-ancestor
110608581|NCT00942682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110608582|NCT00853983|Saracatinib|saracatinib|mesh-list
110608583|NCT00853983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110608584|NCT00853983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110608585|NCT00853983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110608586|NCT00750048|Acetaminophen|acetaminophen|mesh-list
110608587|NCT00750048|Naloxone|naloxone|mesh-list
110608588|NCT00750048|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110608589|NCT00750048|Analgesics|analgesics|mesh-ancestor
110608590|NCT00750048|Sensory System Agents|sensory system agents|mesh-ancestor
110608591|NCT00750048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110608592|NCT00750048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110608593|NCT00750048|Antipyretics|antipyretics|mesh-ancestor
110608594|NCT00750048|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110608595|NCT00942838|Cisplatin|cisplatin|mesh-list
110608596|NCT00942838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110608597|NCT04057014|Amoxicillin|amoxicillin|mesh-list
110608598|NCT04057014|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110608599|NCT04057014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110608600|NCT00364351|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110608601|NCT00364351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110608602|NCT00364351|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110608603|NCT00364351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110608604|NCT00364351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110608605|NCT05279872|Zanubrutinib|zanubrutinib|mesh-list
110608606|NCT05279872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110608607|NCT05279872|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110608608|NCT05279872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110608609|NCT05279872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110608610|NCT00854139|Cyclosporine|cyclosporine|mesh-list
110608611|NCT00854139|Cyclophosphamide|cyclophosphamide|mesh-list
110608612|NCT00854139|Cyclosporins|cyclosporins|mesh-list
110608613|NCT00854139|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110608614|NCT00854139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110608615|NCT00854139|Immunologic Factors|immunologic factors|mesh-ancestor
110608616|NCT00854139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110608617|NCT00854139|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110608618|NCT00854139|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110608619|NCT00854139|Alkylating Agents|alkylating agents|mesh-ancestor
110608620|NCT00854139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110383880|NCT06010810|Hemostatics|hemostatics|mesh-ancestor
110283669|NCT00196625|Protease Inhibitors|protease inhibitors|mesh-ancestor
110608633|NCT00755820|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110608634|NCT00755820|Antimetabolites|antimetabolites|mesh-ancestor
110608635|NCT00755820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110608648|NCT00943228|Mycophenolic Acid|mycophenolic acid|mesh-list
110608649|NCT00943228|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110608650|NCT00943228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110608651|NCT00943228|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110608652|NCT00943228|Antitubercular Agents|antitubercular agents|mesh-ancestor
110608653|NCT00943228|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110608654|NCT00943228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110608655|NCT00943228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110608656|NCT00943228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110608657|NCT00755898|Amantadine|amantadine|mesh-list
110608658|NCT00755898|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110608659|NCT00755898|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110608660|NCT00755898|Antiviral Agents|antiviral agents|mesh-ancestor
110608661|NCT00755898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110608662|NCT00755898|Dopamine Agents|dopamine agents|mesh-ancestor
110608663|NCT00755898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110608664|NCT00755898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110608665|NCT00755898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110608666|NCT00755898|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110608667|NCT00755898|Analgesics|analgesics|mesh-ancestor
110608668|NCT00755898|Sensory System Agents|sensory system agents|mesh-ancestor
110608669|NCT00755898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110608670|NCT00750126|Fludarabine|fludarabine|mesh-list
110608671|NCT00750126|Busulfan|busulfan|mesh-list
110608672|NCT00750126|Thymoglobulin|thymoglobulin|mesh-list
110608673|NCT00750126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110608674|NCT00750126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110608675|NCT00750126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110608676|NCT00750126|Immunologic Factors|immunologic factors|mesh-ancestor
110608677|NCT00750126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110608678|NCT00750126|Alkylating Agents|alkylating agents|mesh-ancestor
110608679|NCT00750126|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110608680|NCT00750126|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110608681|NCT00755976|Sulindac|sulindac|mesh-list
110608682|NCT00755976|Epirubicin|epirubicin|mesh-list
110608683|NCT00755976|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110608684|NCT00755976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110608685|NCT00755976|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110608686|NCT00755976|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110608687|NCT00755976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110608688|NCT00755976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110152457|NCT00000522|Sympathomimetics|sympathomimetics|mesh-ancestor
110608689|NCT00755976|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110608690|NCT00755976|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110608692|NCT00755976|Sensory System Agents|sensory system agents|mesh-ancestor
110608693|NCT00755976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110608694|NCT00755976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110608695|NCT00755976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110608696|NCT00755976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110608697|NCT00755976|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110608698|NCT00752310|Darunavir|darunavir|mesh-list
110608699|NCT00752310|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110608700|NCT00752310|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110608701|NCT00752310|Protease Inhibitors|protease inhibitors|mesh-ancestor
110608702|NCT00752310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110608703|NCT00752310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110608704|NCT00752310|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110608705|NCT00752310|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110608706|NCT00752310|Antiviral Agents|antiviral agents|mesh-ancestor
110608707|NCT00752310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110608708|NCT00943462|Temozolomide|temozolomide|mesh-list
110608709|NCT00943462|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110608710|NCT00943462|Alkylating Agents|alkylating agents|mesh-ancestor
110608711|NCT00943462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110608712|NCT00943462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110608713|NCT02560974|Capecitabine|capecitabine|mesh-list
110608714|NCT02560974|Oxaliplatin|oxaliplatin|mesh-list
110608715|NCT02560974|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110608716|NCT02560974|Antimetabolites|antimetabolites|mesh-ancestor
110608717|NCT02560974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110608718|NCT02560974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110608719|NCT00854451|Amoxicillin|amoxicillin|mesh-list
110608720|NCT00854451|Omeprazole|omeprazole|mesh-list
110608721|NCT00854451|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110608722|NCT00854451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110608723|NCT00854451|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110608724|NCT00854451|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110608725|NCT00854451|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110608726|NCT00854451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110608727|NCT00854451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110608728|NCT00854529|Bevacizumab|bevacizumab|mesh-list
110608729|NCT00854529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110608730|NCT00854529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110608731|NCT00854529|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110608732|NCT00854529|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110608733|NCT00854529|Growth Substances|growth substances|mesh-ancestor
110608734|NCT00854529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110608735|NCT00854529|Growth Inhibitors|growth inhibitors|mesh-ancestor
110608736|NCT00952432|Carbamazepine|carbamazepine|mesh-list
110608737|NCT00952432|Anticonvulsants|anticonvulsants|mesh-ancestor
110608738|NCT00952432|Antimanic Agents|antimanic agents|mesh-ancestor
110608739|NCT00952432|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110608740|NCT00952432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110608741|NCT00952432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110608742|NCT00952432|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110608743|NCT00952432|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110608744|NCT00952432|Analgesics|analgesics|mesh-ancestor
110608745|NCT00952432|Sensory System Agents|sensory system agents|mesh-ancestor
110608746|NCT00952432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110608747|NCT00952432|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110608748|NCT00952432|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110608749|NCT00952432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110608750|NCT00952432|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110608751|NCT00952432|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110608752|NCT00861315|Amikacin|amikacin|mesh-list
110608753|NCT00861315|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110608754|NCT00861315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110608755|NCT00943540|Lamivudine|lamivudine|mesh-list
110608756|NCT00943540|Emtricitabine|emtricitabine|mesh-list
110608757|NCT00943540|Raltegravir Potassium|raltegravir potassium|mesh-list
110608758|NCT00943540|Atazanavir Sulfate|atazanavir sulfate|mesh-list
110608759|NCT00943540|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110608760|NCT00943540|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110608761|NCT00943540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110608762|NCT00943540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110608763|NCT00943540|Antiviral Agents|antiviral agents|mesh-ancestor
110608764|NCT00943540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110608765|NCT00943540|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110608766|NCT00943540|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110608767|NCT00943540|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110608768|NCT00943540|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110608769|NCT00943540|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110608770|NCT00943540|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110608771|NCT00943540|Protease Inhibitors|protease inhibitors|mesh-ancestor
110608774|NCT00861627|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110608775|NCT00861627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110608776|NCT00861627|Tubulin Modulators|tubulin modulators|mesh-ancestor
110608777|NCT00861627|Antimitotic Agents|antimitotic agents|mesh-ancestor
110608778|NCT00861627|Mitosis Modulators|mitosis modulators|mesh-ancestor
110608779|NCT00861627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110608780|NCT00943930|Dronabinol|dronabinol|mesh-list
110608781|NCT00943930|Amphetamine|amphetamine|mesh-list
110608782|NCT00943930|Dextroamphetamine|dextroamphetamine|mesh-list
110608783|NCT00943930|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110608784|NCT00943930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110608785|NCT00943930|Sympathomimetics|sympathomimetics|mesh-ancestor
110608786|NCT00943930|Autonomic Agents|autonomic agents|mesh-ancestor
110608787|NCT00943930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110608788|NCT00943930|Dopamine Agents|dopamine agents|mesh-ancestor
110608789|NCT00943930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110608790|NCT00943930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110608791|NCT00943930|Adrenergic Agents|adrenergic agents|mesh-ancestor
110608792|NCT00943930|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110608793|NCT00943930|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110608794|NCT00943930|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110608795|NCT00943930|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110608796|NCT00943930|Hallucinogens|hallucinogens|mesh-ancestor
110608797|NCT00943930|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110608798|NCT00943930|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110608799|NCT00943930|Analgesics|analgesics|mesh-ancestor
110608801|NCT00943930|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
110608802|NCT00943930|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110608804|NCT00943930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110608805|NCT00854763|Olmesartan|olmesartan|mesh-list
110608806|NCT00854763|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110608807|NCT00854763|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110608808|NCT00854763|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110608809|NCT00854763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110608810|NCT00854841|Imatinib Mesylate|imatinib mesylate|mesh-list
110608811|NCT00854841|Dasatinib|dasatinib|mesh-list
110608812|NCT00854841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110608813|NCT00854841|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110608814|NCT00854841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110608815|NCT00854841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110608816|NCT00854919|Antipsychotic Agents|antipsychotic agents|mesh-list
110608817|NCT00854919|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110608818|NCT00854919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110608819|NCT00854919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110608820|NCT00854919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110608821|NCT00861783|Oxaliplatin|oxaliplatin|mesh-list
110608822|NCT00861783|Irinotecan|irinotecan|mesh-list
110608823|NCT00861783|Camptothecin|camptothecin|mesh-list
110608824|NCT00861783|ON 01910|on 01910|mesh-list
110608825|NCT00861783|Glycine|glycine|mesh-list
110608826|NCT00861783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110608827|NCT00861783|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110608828|NCT00861783|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110608829|NCT00861783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110608830|NCT00861783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110608831|NCT00861783|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110608832|NCT00861783|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110608833|NCT00861783|Glycine Agents|glycine agents|mesh-ancestor
110608834|NCT00861783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110384096|NCT05934253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110384097|NCT05934253|Sensory System Agents|sensory system agents|mesh-ancestor
110384099|NCT05927649|Moxifloxacin|moxifloxacin|mesh-list
110608835|NCT00861783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110608836|NCT00947128|Ondansetron|ondansetron|mesh-list
110608837|NCT00947128|Antiemetics|antiemetics|mesh-ancestor
110608838|NCT00947128|Autonomic Agents|autonomic agents|mesh-ancestor
110608839|NCT00947128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110608840|NCT00947128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110608841|NCT00947128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110608842|NCT00947128|Antipruritics|antipruritics|mesh-ancestor
110608843|NCT00947128|Dermatologic Agents|dermatologic agents|mesh-ancestor
110608844|NCT00947128|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110608845|NCT00947128|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110608846|NCT00947128|Serotonin Agents|serotonin agents|mesh-ancestor
110608847|NCT00947128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110608848|NCT00947128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110608849|NCT00861861|Atorvastatin|atorvastatin|mesh-list
110608850|NCT00861861|Pitavastatin|pitavastatin|mesh-list
110608851|NCT00861861|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110608852|NCT00861861|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110608853|NCT00861861|Antimetabolites|antimetabolites|mesh-ancestor
110608854|NCT00861861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110608855|NCT00861861|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110608856|NCT00861861|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110608857|NCT00861861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110608858|NCT00686166|Capecitabine|capecitabine|mesh-list
110608859|NCT00686166|Oxaliplatin|oxaliplatin|mesh-list
110608860|NCT00686166|Cetuximab|cetuximab|mesh-list
110608861|NCT00686166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110608862|NCT00686166|Antimetabolites|antimetabolites|mesh-ancestor
110608863|NCT00686166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110608864|NCT00686166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110608865|NCT00686166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110608866|NCT04280536|Trifluridine|trifluridine|mesh-list
110608867|NCT04280536|Antimetabolites|antimetabolites|mesh-ancestor
110608868|NCT04280536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110608869|NCT04280536|Antiviral Agents|antiviral agents|mesh-ancestor
110608870|NCT04280536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110608871|NCT00944242|Sertraline|sertraline|mesh-list
110608872|NCT00944242|Antidepressive Agents|antidepressive agents|mesh-ancestor
110608873|NCT00944242|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110608874|NCT00944242|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110608875|NCT00944242|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110608876|NCT00944242|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110384134|NCT05909644|Efavirenz|efavirenz|mesh-list
110608877|NCT00944242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110608878|NCT00944242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110608879|NCT00944242|Serotonin Agents|serotonin agents|mesh-ancestor
110608880|NCT00944242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110608881|NCT00363649|Interferons|interferons|mesh-list
110608882|NCT00363649|Interferon-alpha|interferon-alpha|mesh-list
110608883|NCT00363649|Sargramostim|sargramostim|mesh-list
110608884|NCT00363649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110608885|NCT00363649|Antiviral Agents|antiviral agents|mesh-ancestor
110608886|NCT00363649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110608887|NCT00363649|Immunologic Factors|immunologic factors|mesh-ancestor
110608888|NCT00363649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110608889|NCT00855153|Cycloserine|cycloserine|mesh-list
110608890|NCT00855153|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110032660|NCT05273944|Doxorubicin|doxorubicin|mesh-list
110608891|NCT00855153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110608892|NCT00855153|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110608893|NCT00855153|Antitubercular Agents|antitubercular agents|mesh-ancestor
110608894|NCT00855153|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110608895|NCT00855153|Antimetabolites|antimetabolites|mesh-ancestor
110608896|NCT00855153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110608898|NCT00952978|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110608899|NCT00952978|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110608900|NCT00952978|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110608901|NCT00952978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110608902|NCT00952978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110608903|NCT00861939|Bupropion|bupropion|mesh-list
110608904|NCT00861939|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110608905|NCT00861939|Antidepressive Agents|antidepressive agents|mesh-ancestor
110608906|NCT00861939|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110608907|NCT00861939|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110608908|NCT00861939|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110608909|NCT00861939|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110608910|NCT00861939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110608911|NCT00861939|Dopamine Agents|dopamine agents|mesh-ancestor
110608912|NCT00861939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110608913|NCT00861939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110608914|NCT00861939|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110608915|NCT00861939|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110608916|NCT00861939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110608917|NCT00953134|Folic Acid|folic acid|mesh-list
110608918|NCT00953134|Micronutrients|micronutrients|mesh-list
110608919|NCT00953134|Ferrous fumarate|ferrous fumarate|mesh-list
110608920|NCT00953134|Trace Elements|trace elements|mesh-list
110608921|NCT00953134|Hematinics|hematinics|mesh-ancestor
110608922|NCT00953134|Vitamin B Complex|vitamin b complex|mesh-ancestor
110608923|NCT00953134|Vitamins|vitamins|mesh-ancestor
110608924|NCT00953134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110608925|NCT00944398|Vitamins|vitamins|mesh-list
110608926|NCT00944398|Zinc|zinc|mesh-list
110608927|NCT00944398|Vitamin B Complex|vitamin b complex|mesh-list
110608928|NCT00944398|Zinc Sulfate|zinc sulfate|mesh-list
110608929|NCT00944398|Micronutrients|micronutrients|mesh-ancestor
110608930|NCT00944398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110608931|NCT00944398|Trace Elements|trace elements|mesh-ancestor
110608932|NCT00944398|Astringents|astringents|mesh-ancestor
110608933|NCT00944398|Dermatologic Agents|dermatologic agents|mesh-ancestor
110608934|NCT00855387|Pancrelipase|pancrelipase|mesh-list
110608935|NCT00855387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110608936|NCT00947596|Atropine|atropine|mesh-list
110608937|NCT00947596|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110608938|NCT00947596|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110608939|NCT00947596|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110608940|NCT00947596|Autonomic Agents|autonomic agents|mesh-ancestor
110608941|NCT00947596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110608942|NCT00947596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110608943|NCT00947596|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110608944|NCT00947596|Respiratory System Agents|respiratory system agents|mesh-ancestor
110608945|NCT00947596|Mydriatics|mydriatics|mesh-ancestor
110608946|NCT00947596|Parasympatholytics|parasympatholytics|mesh-ancestor
110608947|NCT00947596|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110608948|NCT00947596|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110608949|NCT00947596|Cholinergic Agents|cholinergic agents|mesh-ancestor
110608950|NCT00947596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110608951|NCT00947596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110608953|NCT00865059|Analgesics|analgesics|mesh-ancestor
110608954|NCT00865059|Sensory System Agents|sensory system agents|mesh-ancestor
110608955|NCT00865059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110608956|NCT00865059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110608957|NCT00865059|Anticonvulsants|anticonvulsants|mesh-ancestor
110608958|NCT00865059|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110608959|NCT00865059|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110608960|NCT00865059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110608961|NCT00865059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110608962|NCT00865059|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110608963|NCT00865059|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110608965|NCT00865059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110608966|NCT00865059|Antimanic Agents|antimanic agents|mesh-ancestor
110608967|NCT00865137|Tacrolimus|tacrolimus|mesh-list
110608968|NCT00865137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110608969|NCT00865137|Immunologic Factors|immunologic factors|mesh-ancestor
110608970|NCT00865137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110608971|NCT00865137|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110608972|NCT00865137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110608973|NCT00865137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110608974|NCT00862095|Topiramate|topiramate|mesh-list
110608975|NCT00862095|Propranolol|propranolol|mesh-list
110608976|NCT00862095|Amitriptyline|amitriptyline|mesh-list
110608977|NCT00862095|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110608978|NCT00862095|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110608979|NCT00862095|Adrenergic Agents|adrenergic agents|mesh-ancestor
110608980|NCT00862095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110608981|NCT00862095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110608982|NCT00862095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110608983|NCT00862095|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110608984|NCT00862095|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110608985|NCT00862095|Vasodilator Agents|vasodilator agents|mesh-ancestor
110608987|NCT00862095|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110608988|NCT00862095|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110608989|NCT00862095|Antidepressive Agents|antidepressive agents|mesh-ancestor
110608990|NCT00862095|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110608991|NCT00862095|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110608992|NCT00862095|Analgesics|analgesics|mesh-ancestor
110608993|NCT00862095|Sensory System Agents|sensory system agents|mesh-ancestor
110608994|NCT00862095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110608995|NCT00862095|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110608996|NCT00862095|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110608997|NCT00862095|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110608998|NCT04054128|Heparin|heparin|mesh-list
110608999|NCT04054128|Calcium heparin|calcium heparin|mesh-list
110609000|NCT04054128|Anticoagulants|anticoagulants|mesh-ancestor
110609001|NCT04054128|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110609002|NCT04054128|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110609003|NCT04054128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110609004|NCT00865215|Propranolol|propranolol|mesh-list
110609005|NCT00865215|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110609006|NCT00865215|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110609007|NCT00865215|Adrenergic Agents|adrenergic agents|mesh-ancestor
110609008|NCT00865215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110609009|NCT00865215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110609010|NCT00865215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110609011|NCT00865215|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110609012|NCT00865215|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110384241|NCT05882214|Niacin|niacin|mesh-list
110609013|NCT00865215|Vasodilator Agents|vasodilator agents|mesh-ancestor
110609014|NCT00865371|Bupropion|bupropion|mesh-list
110609015|NCT00865371|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110609016|NCT00865371|Antidepressive Agents|antidepressive agents|mesh-ancestor
110609017|NCT00865371|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110609018|NCT00865371|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110609019|NCT00865371|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110609020|NCT00865371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110609021|NCT00865371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110609022|NCT00865371|Dopamine Agents|dopamine agents|mesh-ancestor
110609023|NCT00865371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110609024|NCT00865371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110152505|NCT00000531|Adrenergic Agents|adrenergic agents|mesh-ancestor
110609025|NCT00865371|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110609026|NCT00865371|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110609027|NCT00865371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110609028|NCT00865449|Spironolactone|spironolactone|mesh-list
110609029|NCT00865449|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110609030|NCT00865449|Hormone Antagonists|hormone antagonists|mesh-ancestor
110609031|NCT00865449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110609032|NCT00865449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110609033|NCT00865449|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110609034|NCT00865449|Diuretics|diuretics|mesh-ancestor
110609035|NCT00865449|Natriuretic Agents|natriuretic agents|mesh-ancestor
110609036|NCT00858195|Indomethacin|indomethacin|mesh-list
110609037|NCT00858195|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110609038|NCT00858195|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110609039|NCT00858195|Analgesics|analgesics|mesh-ancestor
110609040|NCT00858195|Sensory System Agents|sensory system agents|mesh-ancestor
110609041|NCT00858195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110609042|NCT00858195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110609043|NCT00858195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110609044|NCT00858195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110609045|NCT00858195|Gout Suppressants|gout suppressants|mesh-ancestor
110609046|NCT00858195|Tocolytic Agents|tocolytic agents|mesh-ancestor
110609047|NCT00858195|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110609048|NCT00858195|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110609049|NCT00858195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110609050|NCT00858195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110609051|NCT00618813|Cyclophosphamide|cyclophosphamide|mesh-list
110609052|NCT00618813|Ifosfamide|ifosfamide|mesh-list
110609053|NCT00618813|Doxorubicin|doxorubicin|mesh-list
110609054|NCT00618813|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110609055|NCT00618813|Etoposide|etoposide|mesh-list
110609056|NCT00618813|Vincristine|vincristine|mesh-list
110609057|NCT00618813|Etoposide phosphate|etoposide phosphate|mesh-list
110609058|NCT00618813|Topotecan|topotecan|mesh-list
110609059|NCT00618813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110609060|NCT00618813|Immunologic Factors|immunologic factors|mesh-ancestor
110609061|NCT00618813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110609062|NCT00618813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110609063|NCT00618813|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110609064|NCT00618813|Alkylating Agents|alkylating agents|mesh-ancestor
110609065|NCT00618813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110609066|NCT00618813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110609067|NCT00618813|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110609068|NCT00618813|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110609069|NCT00618813|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110609070|NCT00618813|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110609071|NCT00618813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110609072|NCT00618813|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110609073|NCT00618813|Tubulin Modulators|tubulin modulators|mesh-ancestor
110609074|NCT00618813|Antimitotic Agents|antimitotic agents|mesh-ancestor
110609075|NCT00618813|Mitosis Modulators|mitosis modulators|mesh-ancestor
110609076|NCT00618813|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110609077|NCT00554788|Cyclophosphamide|cyclophosphamide|mesh-list
110609079|NCT00554788|Cisplatin|cisplatin|mesh-list
110609080|NCT00554788|Carboplatin|carboplatin|mesh-list
110609081|NCT00554788|Etoposide|etoposide|mesh-list
110609082|NCT00554788|Vincristine|vincristine|mesh-list
110609083|NCT00554788|Etoposide phosphate|etoposide phosphate|mesh-list
110609084|NCT00554788|Podophyllotoxin|podophyllotoxin|mesh-list
110609085|NCT00554788|Lenograstim|lenograstim|mesh-list
110609086|NCT00554788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110609087|NCT00554788|Immunologic Factors|immunologic factors|mesh-ancestor
110609088|NCT00554788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110609089|NCT00554788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110609090|NCT00554788|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110609091|NCT00554788|Alkylating Agents|alkylating agents|mesh-ancestor
110152514|NCT04935814|Vasopressins|vasopressins|mesh-list
110609092|NCT00554788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110609093|NCT00554788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110609094|NCT00554788|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110609095|NCT00554788|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110609096|NCT00554788|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110609097|NCT00554788|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110609098|NCT00554788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110609099|NCT00554788|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110609100|NCT00554788|Tubulin Modulators|tubulin modulators|mesh-ancestor
110609101|NCT00554788|Antimitotic Agents|antimitotic agents|mesh-ancestor
110609102|NCT00554788|Mitosis Modulators|mitosis modulators|mesh-ancestor
110609103|NCT00554788|Keratolytic Agents|keratolytic agents|mesh-ancestor
110609104|NCT00554788|Dermatologic Agents|dermatologic agents|mesh-ancestor
110609105|NCT00685698|Nemonoxacin|nemonoxacin|mesh-list
110609106|NCT00685698|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110609107|NCT00685698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110609108|NCT00858429|Capecitabine|capecitabine|mesh-list
110609109|NCT00858429|Doxifluridine|doxifluridine|mesh-list
110609110|NCT00858429|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110609111|NCT00858429|Antimetabolites|antimetabolites|mesh-ancestor
110609112|NCT00858429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110609113|NCT00858429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110609114|NCT00858429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110609115|NCT00858429|Immunologic Factors|immunologic factors|mesh-ancestor
110609116|NCT00858429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110609117|NCT00858429|Appetite Stimulants|appetite stimulants|mesh-ancestor
110609118|NCT00858429|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110609119|NCT02566928|Chlorhexidine|chlorhexidine|mesh-list
110609120|NCT02566928|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110609121|NCT02566928|Bacitracin|bacitracin|mesh-list
110609122|NCT02566928|Mupirocin|mupirocin|mesh-list
110609123|NCT02566928|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110609124|NCT02566928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110609125|NCT02566928|Disinfectants|disinfectants|mesh-ancestor
110609126|NCT02566928|Dermatologic Agents|dermatologic agents|mesh-ancestor
110609127|NCT02566928|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110609128|NCT02566928|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110609129|NCT02566928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110609130|NCT02566928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110609131|NCT00865605|Clobetasol|clobetasol|mesh-list
110609132|NCT00865605|Halobetasol|halobetasol|mesh-list
110609133|NCT00865605|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110609134|NCT00865605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110609135|NCT00865605|Glucocorticoids|glucocorticoids|mesh-ancestor
110609136|NCT00865605|Hormones|hormones|mesh-ancestor
110609137|NCT00865605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110609138|NCT00865605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110609139|NCT00956644|Amlodipine|amlodipine|mesh-list
110609140|NCT00956644|Irbesartan|irbesartan|mesh-list
110609141|NCT00956644|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110609142|NCT00956644|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110609143|NCT00956644|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110609144|NCT00956644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110609145|NCT00956644|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110609146|NCT00956644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110609147|NCT00956644|Vasodilator Agents|vasodilator agents|mesh-ancestor
110609148|NCT00956644|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110609149|NCT00956644|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110609150|NCT00858663|Everolimus|everolimus|mesh-list
110609151|NCT00858663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110609152|NCT00858663|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110609153|NCT00858663|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110609154|NCT00858663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110609155|NCT00858663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110609156|NCT00858663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110609157|NCT00858663|Immunologic Factors|immunologic factors|mesh-ancestor
110609158|NCT00858663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110609159|NCT02544789|Clofarabine|clofarabine|mesh-list
110609160|NCT02544789|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110609161|NCT02544789|Antimetabolites|antimetabolites|mesh-ancestor
110609162|NCT02544789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110609163|NCT02544789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110609165|NCT02565836|Anti-inhibitor coagulant complex|anti-inhibitor coagulant complex|mesh-list
110609167|NCT02565836|Coagulants|coagulants|mesh-ancestor
110609168|NCT00865761|Alprazolam|alprazolam|mesh-list
110609169|NCT00865761|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110609170|NCT00865761|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110609171|NCT00865761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110609172|NCT00865761|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110609173|NCT00865761|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110609174|NCT00865761|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110609175|NCT00865761|GABA Modulators|gaba modulators|mesh-ancestor
110609176|NCT00865761|GABA Agents|gaba agents|mesh-ancestor
110609177|NCT00865761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110609178|NCT00865761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110609179|NCT00865839|Metformin|metformin|mesh-list
110609180|NCT00865839|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110609181|NCT00865839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110609182|NCT00865917|Metoprolol|metoprolol|mesh-list
110609183|NCT00865917|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
110609184|NCT00865917|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110609185|NCT00865917|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110609186|NCT00865917|Sympatholytics|sympatholytics|mesh-ancestor
110609187|NCT00865917|Autonomic Agents|autonomic agents|mesh-ancestor
110609188|NCT00865917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110609189|NCT00865917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110609190|NCT00865917|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110609191|NCT00865917|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110609192|NCT00865917|Adrenergic Agents|adrenergic agents|mesh-ancestor
110609193|NCT00865917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110609194|NCT00865917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110609195|NCT00696410|Zinc|zinc|mesh-list
110609196|NCT00696410|Trace Elements|trace elements|mesh-ancestor
110609197|NCT00696410|Micronutrients|micronutrients|mesh-ancestor
110609198|NCT00696410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110609199|NCT00683904|Carboplatin|carboplatin|mesh-list
110609200|NCT00683904|Epothilones|epothilones|mesh-list
110609201|NCT00683904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110609202|NCT00683904|Tubulin Modulators|tubulin modulators|mesh-ancestor
110609203|NCT00683904|Antimitotic Agents|antimitotic agents|mesh-ancestor
110609204|NCT00683904|Mitosis Modulators|mitosis modulators|mesh-ancestor
110609205|NCT00683904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110609206|NCT00862329|Caseins|caseins|mesh-list
110609207|NCT00862329|Chelating Agents|chelating agents|mesh-ancestor
110609208|NCT00862329|Sequestering Agents|sequestering agents|mesh-ancestor
110609209|NCT00862329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110609210|NCT00866073|Decitabine|decitabine|mesh-list
110609211|NCT00866073|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110609212|NCT00866073|Antimetabolites|antimetabolites|mesh-ancestor
110609213|NCT00866073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110609214|NCT00866073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110609215|NCT00866073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110609217|NCT00752466|Flunarizine|flunarizine|mesh-list
110609218|NCT00752466|Anticonvulsants|anticonvulsants|mesh-ancestor
110609219|NCT00752466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110609220|NCT00752466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110609221|NCT00752466|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110609222|NCT00752466|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110609223|NCT00752466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110609224|NCT00752466|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110609225|NCT00752466|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110609226|NCT00752466|Histamine Antagonists|histamine antagonists|mesh-ancestor
110609227|NCT00752466|Histamine Agents|histamine agents|mesh-ancestor
110609228|NCT00752466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110609229|NCT00752466|Vasodilator Agents|vasodilator agents|mesh-ancestor
110609230|NCT00957190|Timolol|timolol|mesh-list
110609231|NCT00957190|Dorzolamide|dorzolamide|mesh-list
110609232|NCT00957190|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110609233|NCT00957190|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110609234|NCT00957190|Adrenergic Agents|adrenergic agents|mesh-ancestor
110609235|NCT00957190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110152526|NCT00000555|Vitamin E|vitamin e|mesh-list
110609236|NCT00957190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110609237|NCT00957190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110609238|NCT00957190|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110609239|NCT00957190|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110609240|NCT00957190|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110609241|NCT00957190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110609242|NCT00866229|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110609243|NCT00866229|Simvastatin|simvastatin|mesh-list
110609244|NCT00866229|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110609245|NCT00866229|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110609246|NCT00866229|Antimetabolites|antimetabolites|mesh-ancestor
110609247|NCT00866229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110609248|NCT00866229|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110609249|NCT00866229|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110256570|NCT00515320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110609250|NCT00866229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110609251|NCT00953914|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
110609252|NCT00953914|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110609253|NCT00953914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110609254|NCT00953914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110609255|NCT00953914|Cholinergic Agents|cholinergic agents|mesh-ancestor
110609256|NCT00953914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110609257|NCT00953914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110609259|NCT00948220|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110609260|NCT00948220|Antimetabolites|antimetabolites|mesh-ancestor
110609261|NCT00948220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110609262|NCT00948220|Antiviral Agents|antiviral agents|mesh-ancestor
110609263|NCT00948220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110609264|NCT00756990|Naltrexone|naltrexone|mesh-list
110609265|NCT00756990|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110609266|NCT00756990|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110609267|NCT00756990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110609268|NCT00756990|Sensory System Agents|sensory system agents|mesh-ancestor
110609269|NCT00756990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110609270|NCT00957346|Misoprostol|misoprostol|mesh-list
110609271|NCT00957346|Mifepristone|mifepristone|mesh-list
110609272|NCT00957346|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110609273|NCT00957346|Abortifacient Agents|abortifacient agents|mesh-ancestor
110609274|NCT00957346|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110609275|NCT00957346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110609276|NCT00957346|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110609277|NCT00957346|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110609278|NCT00957346|Oxytocics|oxytocics|mesh-ancestor
110609279|NCT00957346|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
110609280|NCT00957346|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110609281|NCT00957346|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110609282|NCT00957346|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110609283|NCT00957346|Contraceptive Agents|contraceptive agents|mesh-ancestor
110609284|NCT00957346|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
110609285|NCT00957346|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
110609286|NCT00957346|Hormone Antagonists|hormone antagonists|mesh-ancestor
110609287|NCT00957346|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110609288|NCT00957346|Luteolytic Agents|luteolytic agents|mesh-ancestor
110609289|NCT00957346|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110609290|NCT00957346|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
110609291|NCT00752544|Simeprevir|simeprevir|mesh-list
110609292|NCT00752544|Antiviral Agents|antiviral agents|mesh-ancestor
110609293|NCT00752544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110609294|NCT00752544|Protease Inhibitors|protease inhibitors|mesh-ancestor
110609295|NCT00752544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110609296|NCT00752544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110609297|NCT00751062|Timolol|timolol|mesh-list
110609298|NCT00751062|Latanoprost|latanoprost|mesh-list
110609299|NCT00751062|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110609300|NCT00751062|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110609301|NCT00751062|Adrenergic Agents|adrenergic agents|mesh-ancestor
110609302|NCT00751062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110609303|NCT00751062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110609304|NCT00751062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110609305|NCT00751062|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110609306|NCT00751062|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110609307|NCT00751062|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110609308|NCT00751062|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110609309|NCT04030052|Factor VIII|factor viii|mesh-list
110609310|NCT04030052|Coagulants|coagulants|mesh-ancestor
110609311|NCT00751374|Gentamicins|gentamicins|mesh-list
110609312|NCT00751374|Mupirocin|mupirocin|mesh-list
110609313|NCT00751374|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110609314|NCT00751374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110609315|NCT00751374|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110609316|NCT00751374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110609317|NCT00751374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110609318|NCT00954304|Loperamide|loperamide|mesh-list
110609319|NCT00954304|Antidiarrheals|antidiarrheals|mesh-list
110609320|NCT00954304|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110609321|NCT00363415|Carboplatin|carboplatin|mesh-list
110609322|NCT00363415|Etoposide|etoposide|mesh-list
110609323|NCT00363415|Pemetrexed|pemetrexed|mesh-list
110609324|NCT00363415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110256644|NCT02950870|Protease Inhibitors|protease inhibitors|mesh-ancestor
110609325|NCT00363415|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110609326|NCT00363415|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110609327|NCT00363415|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110609328|NCT00363415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110609329|NCT00363415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110609330|NCT00363415|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110609331|NCT00363415|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110609332|NCT00757380|Diminazene aceturate|diminazene aceturate|mesh-list
110609333|NCT00757380|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110609334|NCT00757380|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110609335|NCT00757380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110609336|NCT00757380|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
110609337|NCT00752934|Baclofen|baclofen|mesh-list
110609338|NCT00752934|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110609339|NCT00752934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110609340|NCT00752934|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110609341|NCT00752934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110609342|NCT00752934|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
110609343|NCT00752934|GABA Agonists|gaba agonists|mesh-ancestor
110609344|NCT00752934|GABA Agents|gaba agents|mesh-ancestor
110609345|NCT00752934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110609346|NCT00752934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110609347|NCT00696020|Bromides|bromides|mesh-list
110609348|NCT00696020|Tiotropium Bromide|tiotropium bromide|mesh-list
110609349|NCT00696020|Olodaterol|olodaterol|mesh-list
110609350|NCT00696020|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110609351|NCT00696020|Autonomic Agents|autonomic agents|mesh-ancestor
110609352|NCT00696020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110609353|NCT00696020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110609354|NCT00696020|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110609355|NCT00696020|Respiratory System Agents|respiratory system agents|mesh-ancestor
110609356|NCT00696020|Parasympatholytics|parasympatholytics|mesh-ancestor
110609357|NCT00696020|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110609358|NCT00696020|Cholinergic Agents|cholinergic agents|mesh-ancestor
110609359|NCT00696020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110609360|NCT00696020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110609361|NCT00696020|Anticonvulsants|anticonvulsants|mesh-ancestor
110609362|NCT00576576|Atorvastatin|atorvastatin|mesh-list
110609363|NCT00576576|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110609364|NCT00576576|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110609365|NCT00576576|Antimetabolites|antimetabolites|mesh-ancestor
110609366|NCT00576576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110609367|NCT00576576|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110609368|NCT00576576|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110609369|NCT00576576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110609370|NCT00751764|Moxidectin|moxidectin|mesh-list
110609371|NCT00751764|Anthelmintics|anthelmintics|mesh-ancestor
110609372|NCT00751764|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110609373|NCT00751764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110609374|NCT00751764|Antinematodal Agents|antinematodal agents|mesh-ancestor
110609375|NCT00757458|Propofol|propofol|mesh-list
110609376|NCT00757458|Edetic Acid|edetic acid|mesh-list
110609377|NCT00757458|Pentetic Acid|pentetic acid|mesh-list
110609378|NCT00757458|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110609379|NCT00757458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110609380|NCT00757458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110609381|NCT00757458|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110609382|NCT00757458|Anesthetics, General|anesthetics, general|mesh-ancestor
110609384|NCT00757458|Anticoagulants|anticoagulants|mesh-ancestor
110609385|NCT00757458|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
110609386|NCT00757458|Chelating Agents|chelating agents|mesh-ancestor
110609387|NCT00757458|Sequestering Agents|sequestering agents|mesh-ancestor
110609388|NCT00757458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110609389|NCT00757458|Antidotes|antidotes|mesh-ancestor
110609390|NCT00757458|Protective Agents|protective agents|mesh-ancestor
110609391|NCT00757458|Iron Chelating Agents|iron chelating agents|mesh-ancestor
110609392|NCT00923247|Bortezomib|bortezomib|mesh-list
110609393|NCT00923247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110609394|NCT02866136|Carboplatin|carboplatin|mesh-list
110609395|NCT02866136|Etoposide|etoposide|mesh-list
110609396|NCT02866136|Etoposide phosphate|etoposide phosphate|mesh-list
110609397|NCT02866136|Melphalan|melphalan|mesh-list
110609398|NCT02866136|Vincristine|vincristine|mesh-list
110609399|NCT02866136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110609400|NCT02866136|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110609401|NCT02866136|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110609402|NCT02866136|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110609403|NCT02866136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110609404|NCT02866136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110609405|NCT02866136|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110609406|NCT02866136|Alkylating Agents|alkylating agents|mesh-ancestor
110609407|NCT02866136|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110609408|NCT02866136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110283724|NCT00196664|Paroxetine|paroxetine|mesh-list
110609409|NCT02866136|Immunologic Factors|immunologic factors|mesh-ancestor
110609410|NCT02866136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110609411|NCT02866136|Tubulin Modulators|tubulin modulators|mesh-ancestor
110609412|NCT02866136|Antimitotic Agents|antimitotic agents|mesh-ancestor
110609413|NCT02866136|Mitosis Modulators|mitosis modulators|mesh-ancestor
110609414|NCT00757692|Bicalutamide|bicalutamide|mesh-list
110609415|NCT00757692|Androgen Antagonists|androgen antagonists|mesh-ancestor
110609416|NCT00757692|Hormone Antagonists|hormone antagonists|mesh-ancestor
110609417|NCT00757692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110609418|NCT00757692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110384487|NCT05746520|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110384488|NCT05746520|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
110384489|NCT05746520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110384490|NCT05746520|Antitubercular Agents|antitubercular agents|mesh-ancestor
110384491|NCT05741905|Levofloxacin|levofloxacin|mesh-list
110384492|NCT05741905|Ofloxacin|ofloxacin|mesh-list
110384493|NCT05741905|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110384494|NCT05741905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110384495|NCT05741905|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110609419|NCT00757692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110609420|NCT00753168|Timolol|timolol|mesh-list
110609421|NCT00753168|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110609422|NCT00753168|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110609423|NCT00753168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110609424|NCT00753168|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110609425|NCT00753168|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110609426|NCT00753168|Adrenergic Agents|adrenergic agents|mesh-ancestor
110609427|NCT00753168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110609428|NCT00753168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110609429|NCT00753168|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110609430|NCT00753168|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110609431|NCT02565602|Vitamin D|vitamin d|mesh-list
110609432|NCT02565602|Cholecalciferol|cholecalciferol|mesh-list
110609433|NCT02565602|Vitamins|vitamins|mesh-ancestor
110609434|NCT02565602|Micronutrients|micronutrients|mesh-ancestor
110609435|NCT02565602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110609436|NCT02565602|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110609437|NCT02565602|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110609438|NCT00866463|Sildenafil Citrate|sildenafil citrate|mesh-list
110609439|NCT00866463|Vasodilator Agents|vasodilator agents|mesh-ancestor
110609440|NCT00866463|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110609441|NCT00866463|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110609442|NCT00866463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110609443|NCT00866463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110609444|NCT00866463|Urological Agents|urological agents|mesh-ancestor
110609445|NCT00695864|Ondansetron|ondansetron|mesh-list
110609446|NCT00695864|Antiemetics|antiemetics|mesh-ancestor
110609447|NCT00695864|Autonomic Agents|autonomic agents|mesh-ancestor
110609448|NCT00695864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110609449|NCT00695864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110609450|NCT00695864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110609451|NCT00695864|Antipruritics|antipruritics|mesh-ancestor
110609452|NCT00695864|Dermatologic Agents|dermatologic agents|mesh-ancestor
110609453|NCT00695864|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110609454|NCT00695864|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110609455|NCT00695864|Serotonin Agents|serotonin agents|mesh-ancestor
110609456|NCT00695864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110609457|NCT00695864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110609458|NCT00684996|Bevacizumab|bevacizumab|mesh-list
110609459|NCT00684996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110609460|NCT00684996|Antibodies|antibodies|mesh-list
110609461|NCT00684996|Immunoglobulins|immunoglobulins|mesh-list
110384525|NCT05734105|Sunitinib|sunitinib|mesh-list
110384526|NCT05734105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110384527|NCT05734105|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110384528|NCT05734105|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110609462|NCT00684996|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110609463|NCT00684996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110609464|NCT00684996|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110609465|NCT00684996|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110609466|NCT00684996|Growth Substances|growth substances|mesh-ancestor
110609467|NCT00684996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110609468|NCT00684996|Growth Inhibitors|growth inhibitors|mesh-ancestor
110609469|NCT00684996|Immunologic Factors|immunologic factors|mesh-ancestor
110609470|NCT05325008|Immunoglobulins|immunoglobulins|mesh-list
110609471|NCT05325008|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110609472|NCT05325008|Antibodies|antibodies|mesh-list
110609473|NCT05325008|gamma-Globulins|gamma-globulins|mesh-list
110609474|NCT05325008|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110609475|NCT05325008|Immunologic Factors|immunologic factors|mesh-ancestor
110609476|NCT05325008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110609477|NCT00684762|Cilostazol|cilostazol|mesh-list
110609478|NCT00684762|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110609479|NCT00684762|Autonomic Agents|autonomic agents|mesh-ancestor
110609480|NCT00684762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110033259|NCT04368091|Antifungal Agents|antifungal agents|mesh-ancestor
110609481|NCT00684762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110609482|NCT00684762|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110609483|NCT00684762|Respiratory System Agents|respiratory system agents|mesh-ancestor
110609484|NCT00684762|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110609485|NCT00684762|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110609486|NCT00684762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110609487|NCT00684762|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110609488|NCT00684762|Vasodilator Agents|vasodilator agents|mesh-ancestor
110609489|NCT00684762|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110609490|NCT00684762|Protective Agents|protective agents|mesh-ancestor
110609491|NCT00684762|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110609492|NCT00684762|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110609493|NCT00684762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110609494|NCT00753246|Nimotuzumab|nimotuzumab|mesh-list
110609495|NCT00753246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110609496|NCT00753246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110609497|NCT00695786|Rituximab|rituximab|mesh-list
110609498|NCT00695786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110609499|NCT00695786|Lenalidomide|lenalidomide|mesh-list
110609500|NCT00695786|Antibodies|antibodies|mesh-list
110609501|NCT00695786|Immunoglobulins|immunoglobulins|mesh-list
110609502|NCT00695786|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110384559|NCT05698147|Rituximab|rituximab|mesh-list
110609503|NCT00695786|Immunologic Factors|immunologic factors|mesh-ancestor
110609504|NCT00695786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110609505|NCT00695786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110609506|NCT00695786|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110609507|NCT00695786|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110609508|NCT00695786|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110609509|NCT00695786|Growth Substances|growth substances|mesh-ancestor
110609510|NCT00695786|Growth Inhibitors|growth inhibitors|mesh-ancestor
110609511|NCT00753324|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
110609512|NCT00753324|Antiviral Agents|antiviral agents|mesh-ancestor
110609513|NCT00753324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110609514|NCT02561520|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110609515|NCT02561520|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110609516|NCT00387127|Lapatinib|lapatinib|mesh-list
110609517|NCT00387127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110609518|NCT00387127|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110609519|NCT00387127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110609520|NCT00387127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110609521|NCT00683592|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
110609522|NCT00683592|Antidepressive Agents|antidepressive agents|mesh-ancestor
110609523|NCT00683592|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110609524|NCT00683592|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110609525|NCT00683592|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110609526|NCT00683592|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110609527|NCT00683592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110609528|NCT00683592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110609529|NCT00683592|Serotonin Agents|serotonin agents|mesh-ancestor
110609530|NCT00683592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110609531|NCT00683592|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110609532|NCT00683592|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110609533|NCT00695396|Epoetin Alfa|epoetin alfa|mesh-list
110609534|NCT00695396|Hematinics|hematinics|mesh-ancestor
110609535|NCT00753402|Epinephrine|epinephrine|mesh-list
110609536|NCT00753402|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110609537|NCT00753402|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110384587|NCT05691478|Doxorubicin|doxorubicin|mesh-list
110609541|NCT00753402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110609542|NCT00753402|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110609543|NCT00753402|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110609544|NCT00753402|Autonomic Agents|autonomic agents|mesh-ancestor
110609545|NCT00753402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110609546|NCT00753402|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110609547|NCT00753402|Respiratory System Agents|respiratory system agents|mesh-ancestor
110609548|NCT00753402|Mydriatics|mydriatics|mesh-ancestor
110609549|NCT00753402|Sympathomimetics|sympathomimetics|mesh-ancestor
110609550|NCT00753402|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110609551|NCT05434884|Salicylic Acid|salicylic acid|mesh-list
110609552|NCT05434884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110609553|NCT05434884|Antifungal Agents|antifungal agents|mesh-ancestor
110609554|NCT05434884|Keratolytic Agents|keratolytic agents|mesh-ancestor
110609555|NCT05434884|Dermatologic Agents|dermatologic agents|mesh-ancestor
110609556|NCT00758004|Atorvastatin|atorvastatin|mesh-list
110609557|NCT00758004|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110609558|NCT00758004|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110609559|NCT00758004|Antimetabolites|antimetabolites|mesh-ancestor
110609560|NCT00758004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110609561|NCT00758004|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110609562|NCT00758004|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110609563|NCT00758004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110609564|NCT02656706|Nivolumab|nivolumab|mesh-list
110609565|NCT02656706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110609566|NCT02656706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110609567|NCT02656706|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110609568|NCT02656706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110609569|NCT04049916|Artesunate|artesunate|mesh-list
110609570|NCT04049916|Primaquine|primaquine|mesh-list
110609571|NCT04049916|Piperaquine|piperaquine|mesh-list
110609572|NCT04049916|Artenimol|artenimol|mesh-list
110609573|NCT04049916|Pyronaridine|pyronaridine|mesh-list
110609574|NCT04049916|Antimalarials|antimalarials|mesh-ancestor
110609575|NCT04049916|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110609576|NCT04049916|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110609577|NCT04049916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110609578|NCT04049916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110609579|NCT04049916|Antiviral Agents|antiviral agents|mesh-ancestor
110609580|NCT04049916|Schistosomicides|schistosomicides|mesh-ancestor
110609581|NCT04049916|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110609582|NCT04049916|Anthelmintics|anthelmintics|mesh-ancestor
110609583|NCT00753558|Gentamicins|gentamicins|mesh-list
110609584|NCT00753558|Polymyxins|polymyxins|mesh-list
110609585|NCT00753558|Colistin|colistin|mesh-list
110609586|NCT00753558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110609587|NCT00753558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110609588|NCT00753558|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110609589|NCT00753558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110384625|NCT05688475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110384626|NCT05688475|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110384627|NCT05688475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110384628|NCT05687721|Avelumab|avelumab|mesh-list
110384629|NCT05687721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110384630|NCT05687721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110609590|NCT00753558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110609591|NCT00753792|Methylprednisolone|methylprednisolone|mesh-list
110609592|NCT00753792|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110609593|NCT00753792|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110609594|NCT00753792|Prednisolone|prednisolone|mesh-list
110609595|NCT00753792|Prednisolone acetate|prednisolone acetate|mesh-list
110609596|NCT00753792|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110609597|NCT00753792|Prednisolone phosphate|prednisolone phosphate|mesh-list
110609598|NCT00753792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110609599|NCT00753792|Antiemetics|antiemetics|mesh-ancestor
110609600|NCT00753792|Autonomic Agents|autonomic agents|mesh-ancestor
110609601|NCT00753792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110283728|NCT00196664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110609602|NCT00753792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110609603|NCT00753792|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110609604|NCT00753792|Glucocorticoids|glucocorticoids|mesh-ancestor
110609606|NCT00753792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110609607|NCT00753792|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110609608|NCT00753792|Protective Agents|protective agents|mesh-ancestor
110609609|NCT00753792|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110609610|NCT00753792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110609611|NCT00575094|Tigecycline|tigecycline|mesh-list
110609612|NCT00575094|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110609613|NCT00575094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110609614|NCT00575094|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110609615|NCT00575094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110609616|NCT00575094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110609617|NCT00553696|Sunitinib|sunitinib|mesh-list
110609618|NCT00553696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110609619|NCT00553696|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110033408|NCT03704285|Propofol|propofol|mesh-list
110609620|NCT00553696|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110609621|NCT00553696|Growth Substances|growth substances|mesh-ancestor
110609622|NCT00553696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110609623|NCT00553696|Growth Inhibitors|growth inhibitors|mesh-ancestor
110609624|NCT00553696|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110609625|NCT00553696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110609626|NCT00553696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110609627|NCT05430126|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-list
110256960|NCT05859750|Paclitaxel|paclitaxel|mesh-list
110609628|NCT05430126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110609629|NCT05430126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110609630|NCT00958204|Fluoxetine|fluoxetine|mesh-list
110609631|NCT00958204|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110609632|NCT00958204|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110609633|NCT00958204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110609634|NCT00958204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110609635|NCT00958204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110609636|NCT00958204|Serotonin Agents|serotonin agents|mesh-ancestor
110609637|NCT00958204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110609638|NCT00958204|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110609639|NCT00958204|Antidepressive Agents|antidepressive agents|mesh-ancestor
110609640|NCT00958204|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110609641|NCT00958204|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110609642|NCT00958204|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110609643|NCT00958204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110609644|NCT00617409|Paclitaxel|paclitaxel|mesh-list
110609645|NCT00617409|Tretinoin|tretinoin|mesh-list
110609646|NCT00617409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110609647|NCT00617409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110609648|NCT00617409|Tubulin Modulators|tubulin modulators|mesh-ancestor
110609649|NCT00617409|Antimitotic Agents|antimitotic agents|mesh-ancestor
110609650|NCT00617409|Mitosis Modulators|mitosis modulators|mesh-ancestor
110609651|NCT00617409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110609652|NCT00617409|Keratolytic Agents|keratolytic agents|mesh-ancestor
110609653|NCT00617409|Dermatologic Agents|dermatologic agents|mesh-ancestor
110609654|NCT00695318|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
110609655|NCT00695318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110609656|NCT00695318|Glucocorticoids|glucocorticoids|mesh-ancestor
110609657|NCT00695318|Hormones|hormones|mesh-ancestor
110609658|NCT00695318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110609659|NCT00695318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110609660|NCT00754104|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110609661|NCT00754104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110609662|NCT00754104|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110609663|NCT00754104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110609664|NCT00754104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110609665|NCT00386425|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
110609666|NCT00386425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110609667|NCT05396898|Tacrolimus|tacrolimus|mesh-list
110609668|NCT05396898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110609669|NCT05396898|Immunologic Factors|immunologic factors|mesh-ancestor
110609670|NCT05396898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110609671|NCT05396898|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110609672|NCT05396898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110609673|NCT05396898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110609675|NCT00694304|Antidepressive Agents|antidepressive agents|mesh-ancestor
110609676|NCT00694304|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110609677|NCT00694304|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110609678|NCT00694304|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110609679|NCT00694304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110609680|NCT00694304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110609681|NCT00694304|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110609682|NCT00694304|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110609683|NCT00694304|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110609684|NCT00694304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110609685|NCT00694304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110609686|NCT00694304|Serotonin Agents|serotonin agents|mesh-ancestor
110609687|NCT00694304|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110609688|NCT00694304|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110609689|NCT00694304|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110609690|NCT00694304|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110609691|NCT00866853|Simeprevir|simeprevir|mesh-list
110609692|NCT00866853|Antiviral Agents|antiviral agents|mesh-ancestor
110609693|NCT00866853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110609694|NCT00866853|Protease Inhibitors|protease inhibitors|mesh-ancestor
110609695|NCT00866853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110609696|NCT00866853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110609697|NCT04685876|Bupivacaine|bupivacaine|mesh-list
110609698|NCT04685876|Anesthetics, Local|anesthetics, local|mesh-ancestor
110609699|NCT04685876|Anesthetics|anesthetics|mesh-ancestor
110609700|NCT04685876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110609701|NCT04685876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110609702|NCT04685876|Sensory System Agents|sensory system agents|mesh-ancestor
110609703|NCT04685876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110609704|NCT00682890|Metformin|metformin|mesh-list
110609705|NCT00682890|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110609706|NCT00682890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110609707|NCT02565368|Metformin|metformin|mesh-list
110609708|NCT02565368|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110609709|NCT02565368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110609710|NCT03992365|Bisacodyl|bisacodyl|mesh-list
110609711|NCT03992365|Sodium sulfate|sodium sulfate|mesh-list
110609712|NCT03992365|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
110609713|NCT03992365|Cathartics|cathartics|mesh-ancestor
110609714|NCT03992365|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110609715|NCT03992365|Laxatives|laxatives|mesh-ancestor
110609716|NCT00921804|Risperidone|risperidone|mesh-list
110609717|NCT00921804|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110609718|NCT00921804|Serotonin Agents|serotonin agents|mesh-ancestor
110609719|NCT00921804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110609720|NCT00921804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110609721|NCT00921804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110609722|NCT00921804|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110609723|NCT00921804|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110609724|NCT00921804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110609725|NCT00921804|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110609726|NCT00921804|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110609727|NCT00921804|Dopamine Agents|dopamine agents|mesh-ancestor
110609728|NCT00859911|Micronutrients|micronutrients|mesh-list
110609729|NCT00859911|Trace Elements|trace elements|mesh-list
110609730|NCT00859911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110609731|NCT00698516|Bevacizumab|bevacizumab|mesh-list
110609732|NCT00698516|Topotecan|topotecan|mesh-list
110609733|NCT00698516|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110609734|NCT00698516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110609735|NCT00698516|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110609736|NCT00698516|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110609737|NCT00698516|Growth Substances|growth substances|mesh-ancestor
110609738|NCT00698516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110609739|NCT00698516|Growth Inhibitors|growth inhibitors|mesh-ancestor
110609740|NCT00698516|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110609741|NCT00698516|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110609742|NCT00698516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110609743|NCT00698516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110609744|NCT00679302|Trimethoprim|trimethoprim|mesh-list
110609745|NCT00679302|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
110609746|NCT00679302|Sulfamethoxazole|sulfamethoxazole|mesh-list
110609747|NCT00679302|Simethicone|simethicone|mesh-list
110609748|NCT00679302|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110609749|NCT00679302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110609750|NCT00679302|Antimalarials|antimalarials|mesh-ancestor
110609751|NCT00679302|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110609752|NCT00679302|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110609753|NCT00679302|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110609754|NCT00679302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110609755|NCT00679302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110609756|NCT00679302|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110609757|NCT00679302|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
110609758|NCT00679302|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110609759|NCT00679302|Antifoaming Agents|antifoaming agents|mesh-ancestor
110609760|NCT00679302|Emollients|emollients|mesh-ancestor
110609761|NCT00679302|Dermatologic Agents|dermatologic agents|mesh-ancestor
110609762|NCT00679302|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110609764|NCT04011124|Fluzoparib|fluzoparib|mesh-list
110609765|NCT04011124|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110609766|NCT04011124|Antitubercular Agents|antitubercular agents|mesh-ancestor
110609767|NCT04011124|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110609768|NCT04011124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110609769|NCT04011124|Leprostatic Agents|leprostatic agents|mesh-ancestor
110609770|NCT04011124|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110609771|NCT04011124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110609772|NCT04011124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110609773|NCT04011124|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110609774|NCT04011124|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110257106|NCT05678114|Inositol|inositol|mesh-list
110609775|NCT04011124|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110609776|NCT04011124|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110609777|NCT04011124|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110609778|NCT04011124|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110609779|NCT04011124|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110609780|NCT04011124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110609782|NCT00862875|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110609783|NCT00862875|Insulin Detemir|insulin detemir|mesh-list
110609784|NCT00862875|Insulin, Long-Acting|insulin, long-acting|mesh-list
110609785|NCT00862875|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110609786|NCT00862875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110609787|NCT02544165|Caffeine|caffeine|mesh-list
110609788|NCT02544165|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110609789|NCT02544165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110609790|NCT02544165|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110609791|NCT02544165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110609792|NCT02544165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110609793|NCT02544165|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110609794|NCT02544165|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110609795|NCT02544165|Purinergic Agents|purinergic agents|mesh-ancestor
110609796|NCT02544165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110609797|NCT05343156|Dexamethasone|dexamethasone|mesh-list
110609798|NCT05343156|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110609799|NCT05343156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110609800|NCT05343156|Antiemetics|antiemetics|mesh-ancestor
110609801|NCT05343156|Autonomic Agents|autonomic agents|mesh-ancestor
110609802|NCT05343156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110609803|NCT05343156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110609804|NCT05343156|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110609805|NCT05343156|Glucocorticoids|glucocorticoids|mesh-ancestor
110609806|NCT05343156|Hormones|hormones|mesh-ancestor
110609807|NCT05343156|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110609808|NCT05343156|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110609809|NCT05343156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110609810|NCT05343156|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110609811|NCT00955162|Buprenorphine|buprenorphine|mesh-list
110609812|NCT00955162|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
110609813|NCT00955162|Naloxone|naloxone|mesh-list
110609814|NCT00955162|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110609816|NCT00955162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110609817|NCT00955162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110609818|NCT00955162|Analgesics|analgesics|mesh-ancestor
110609819|NCT00955162|Sensory System Agents|sensory system agents|mesh-ancestor
110609820|NCT00955162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110609821|NCT00955162|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110609822|NCT00949546|Etanercept|etanercept|mesh-list
110609823|NCT00949546|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110609824|NCT00949546|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110609825|NCT00949546|Analgesics|analgesics|mesh-ancestor
110609826|NCT00949546|Sensory System Agents|sensory system agents|mesh-ancestor
110609827|NCT00949546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110609828|NCT00949546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110609829|NCT00949546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110609830|NCT00949546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110609831|NCT00949546|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110609832|NCT00949546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110609833|NCT00949546|Immunologic Factors|immunologic factors|mesh-ancestor
110609834|NCT00949624|Docetaxel|docetaxel|mesh-list
110609835|NCT00949624|Axitinib|axitinib|mesh-list
110609836|NCT00949624|Crenolanib|crenolanib|mesh-list
110609837|NCT00949624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110609838|NCT00949624|Tubulin Modulators|tubulin modulators|mesh-ancestor
110609839|NCT00949624|Antimitotic Agents|antimitotic agents|mesh-ancestor
110609840|NCT00949624|Mitosis Modulators|mitosis modulators|mesh-ancestor
110609841|NCT00949624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110609842|NCT00949624|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110609843|NCT00949624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110609844|NCT04019379|Calcium, Dietary|calcium, dietary|mesh-list
110609845|NCT04019379|Calcium|calcium|mesh-list
110609846|NCT04019379|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110609847|NCT04019379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110609848|NCT04019379|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110609849|NCT05351788|Carboplatin|carboplatin|mesh-list
110609850|NCT05351788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110609851|NCT04005339|Leucovorin|leucovorin|mesh-list
110609852|NCT04005339|Fluorouracil|fluorouracil|mesh-list
110609853|NCT04005339|Irinotecan|irinotecan|mesh-list
110609854|NCT04005339|Antimetabolites|antimetabolites|mesh-ancestor
110609855|NCT04005339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110609856|NCT04005339|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110609857|NCT04005339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110609858|NCT04005339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110609859|NCT04005339|Immunologic Factors|immunologic factors|mesh-ancestor
110384872|NCT05590585|Emollients|emollients|mesh-list
110609860|NCT04005339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110609861|NCT04005339|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110609862|NCT04005339|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110609863|NCT04005339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110609864|NCT04005339|Antidotes|antidotes|mesh-ancestor
110609865|NCT04005339|Protective Agents|protective agents|mesh-ancestor
110609866|NCT04005339|Vitamin B Complex|vitamin b complex|mesh-ancestor
110609867|NCT04005339|Vitamins|vitamins|mesh-ancestor
110609868|NCT04005339|Micronutrients|micronutrients|mesh-ancestor
110609869|NCT00949780|Chloral Hydrate|chloral hydrate|mesh-list
110609870|NCT00949780|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110609871|NCT00949780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110609872|NCT00949780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110609873|NCT02544243|Gemcitabine|gemcitabine|mesh-list
110609874|NCT02544243|Vinorelbine|vinorelbine|mesh-list
110609875|NCT02544243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110609876|NCT02544243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110609877|NCT02544243|Antimetabolites|antimetabolites|mesh-ancestor
110609878|NCT02544243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110609879|NCT02544243|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110609880|NCT02544243|Tubulin Modulators|tubulin modulators|mesh-ancestor
110275918|NCT00555412|Loxapine|loxapine|mesh-list
110609882|NCT02544243|Mitosis Modulators|mitosis modulators|mesh-ancestor
110609883|NCT04011670|Caffeine|caffeine|mesh-list
110609884|NCT04011670|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110609885|NCT04011670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110609886|NCT04011670|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110609887|NCT04011670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110609888|NCT04011670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110609889|NCT04011670|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110609890|NCT04011670|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110609891|NCT04011670|Purinergic Agents|purinergic agents|mesh-ancestor
110609892|NCT04011670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110609893|NCT01581073|Darbepoetin alfa|darbepoetin alfa|mesh-list
110609894|NCT01581073|Hematinics|hematinics|mesh-ancestor
110384904|NCT05581706|Calcium|calcium|mesh-list
110609895|NCT00742820|Calcium, Dietary|calcium, dietary|mesh-list
110609896|NCT00742820|Calcium|calcium|mesh-list
110609897|NCT00742820|Calcium acetate|calcium acetate|mesh-list
110609898|NCT00742820|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110609899|NCT00742820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110609900|NCT00742820|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110609901|NCT00742820|Chelating Agents|chelating agents|mesh-ancestor
110609902|NCT00742820|Sequestering Agents|sequestering agents|mesh-ancestor
110609903|NCT00742820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110609904|NCT01324843|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
110609905|NCT01324843|Anesthetics, Local|anesthetics, local|mesh-ancestor
110609906|NCT01324843|Anesthetics|anesthetics|mesh-ancestor
110609907|NCT01324843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110609908|NCT01324843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110609909|NCT01324843|Sensory System Agents|sensory system agents|mesh-ancestor
110609910|NCT01324843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110609911|NCT01324843|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
110609913|NCT00742976|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110609914|NCT00742976|Insulin Detemir|insulin detemir|mesh-list
110609915|NCT00742976|Isophane Insulin, Human|isophane insulin, human|mesh-list
110609916|NCT00742976|Insulin, Isophane|insulin, isophane|mesh-list
110609917|NCT00742976|Isophane insulin, beef|isophane insulin, beef|mesh-list
110609918|NCT00742976|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110609919|NCT00742976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110609920|NCT00571662|Cyclosporine|cyclosporine|mesh-list
110609921|NCT00571662|Mycophenolic Acid|mycophenolic acid|mesh-list
110609922|NCT00571662|Pentostatin|pentostatin|mesh-list
110609923|NCT00571662|Cyclosporins|cyclosporins|mesh-list
110609924|NCT00571662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110609925|NCT00571662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110609926|NCT00571662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110609927|NCT00571662|Immunologic Factors|immunologic factors|mesh-ancestor
110609928|NCT00571662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110609929|NCT00571662|Antifungal Agents|antifungal agents|mesh-ancestor
110609930|NCT00571662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110609931|NCT00571662|Dermatologic Agents|dermatologic agents|mesh-ancestor
110609932|NCT00571662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110609933|NCT00571662|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110609934|NCT00571662|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110609935|NCT00571662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110609936|NCT00571662|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110609937|NCT00571662|Antitubercular Agents|antitubercular agents|mesh-ancestor
110609938|NCT00571662|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110384942|NCT05554380|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110609939|NCT00571662|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
110609941|NCT00955240|Cetuximab|cetuximab|mesh-list
110609942|NCT00955240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110609943|NCT00955240|Antimetabolites|antimetabolites|mesh-ancestor
110609944|NCT00955240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110609945|NCT00955240|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110609946|NCT00955240|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110609947|NCT00955240|Immunologic Factors|immunologic factors|mesh-ancestor
110609948|NCT00955240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110609949|NCT00955240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110152608|NCT00000588|Vitamins|vitamins|mesh-ancestor
110609982|NCT00867867|Ferrous fumarate|ferrous fumarate|mesh-list
110609983|NCT00867867|Trace Elements|trace elements|mesh-ancestor
110609984|NCT00867867|Micronutrients|micronutrients|mesh-ancestor
110609985|NCT00867867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110609986|NCT00955318|Apomorphine|apomorphine|mesh-list
110609987|NCT00955318|Emetics|emetics|mesh-ancestor
110609988|NCT00955318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110609989|NCT00955318|Autonomic Agents|autonomic agents|mesh-ancestor
110609990|NCT00955318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110609991|NCT00955318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110609992|NCT00955318|Dopamine Agonists|dopamine agonists|mesh-ancestor
110609993|NCT00955318|Dopamine Agents|dopamine agents|mesh-ancestor
110609994|NCT00955318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110609995|NCT00955318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110609996|NCT00860223|Digoxin|digoxin|mesh-list
110609997|NCT00860223|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110609998|NCT00860223|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110609999|NCT00860223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110610000|NCT00860223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110610001|NCT00860223|Protective Agents|protective agents|mesh-ancestor
110610002|NCT00860223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110610004|NCT00698204|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110610005|NCT00698204|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110610006|NCT00698204|Analgesics|analgesics|mesh-ancestor
110610007|NCT00698204|Sensory System Agents|sensory system agents|mesh-ancestor
110610008|NCT00698204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110610009|NCT00698204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110610010|NCT00698204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110610011|NCT00698204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110610012|NCT00698204|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110610013|NCT00698204|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110610014|NCT00698204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110610015|NCT00698204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110610016|NCT00549718|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
110610017|NCT00549718|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110610018|NCT00549718|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110610019|NCT00549718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110033756|NCT02810457|Growth Inhibitors|growth inhibitors|mesh-ancestor
110610020|NCT00549718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110610021|NCT00549718|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110610022|NCT00549718|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
110610023|NCT00549718|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110610024|NCT00549718|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110610025|NCT00549718|Adrenergic Agents|adrenergic agents|mesh-ancestor
110610026|NCT00549718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110610027|NCT00549718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110610028|NCT00549718|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110610029|NCT00549718|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110610030|NCT00549718|Serotonin Agents|serotonin agents|mesh-ancestor
110610031|NCT00549718|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110610032|NCT00549718|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110610033|NCT00549718|Dopamine Agents|dopamine agents|mesh-ancestor
110610034|NCT00863187|Rituximab|rituximab|mesh-list
110610035|NCT00863187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110610036|NCT00863187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110610037|NCT00863187|Immunologic Factors|immunologic factors|mesh-ancestor
110610038|NCT00863187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110610039|NCT00863187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110610040|NCT00754884|Calcitonin|calcitonin|mesh-list
110610041|NCT00754884|Salmon calcitonin|salmon calcitonin|mesh-list
110610042|NCT00754884|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
110610043|NCT00754884|Glycerol|glycerol|mesh-list
110610044|NCT00754884|Katacalcin|katacalcin|mesh-list
110610045|NCT00754884|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
110610046|NCT00754884|Protective Agents|protective agents|mesh-ancestor
110610047|NCT00754884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110610048|NCT00754884|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110610049|NCT00754884|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110610050|NCT00754884|Vasodilator Agents|vasodilator agents|mesh-ancestor
110610051|NCT00371761|Interferons|interferons|mesh-list
110610052|NCT00371761|Interferon-alpha|interferon-alpha|mesh-list
110610053|NCT00371761|Interferon alpha-2|interferon alpha-2|mesh-list
110610054|NCT00371761|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110610055|NCT00371761|Adefovir|adefovir|mesh-list
110610056|NCT00371761|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
110610057|NCT00371761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110610058|NCT00371761|Antiviral Agents|antiviral agents|mesh-ancestor
110610059|NCT00371761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110610061|NCT00371761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110610062|NCT00371761|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110610063|NCT00371761|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110610064|NCT00371761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110610065|NCT00371761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110610066|NCT00754962|Protriptyline|protriptyline|mesh-list
110610067|NCT00754962|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110610068|NCT00754962|Antidepressive Agents|antidepressive agents|mesh-ancestor
110610069|NCT00754962|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110610070|NCT00754962|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110610071|NCT00754962|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110610072|NCT00754962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110610073|NCT00754962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110610074|NCT00754962|Adrenergic Agents|adrenergic agents|mesh-ancestor
110610075|NCT00754962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110257402|NCT04830462|Rifampin|rifampin|mesh-list
110610076|NCT00754962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110610077|NCT00868023|Formoterol Fumarate|formoterol fumarate|mesh-list
110610078|NCT00868023|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110610079|NCT00868023|Autonomic Agents|autonomic agents|mesh-ancestor
110610080|NCT00868023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110610081|NCT00868023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110385052|NCT05516914|Cisplatin|cisplatin|mesh-list
110610082|NCT00868023|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110610083|NCT00868023|Respiratory System Agents|respiratory system agents|mesh-ancestor
110610084|NCT00868023|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110610085|NCT00868023|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110610086|NCT00868023|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110610087|NCT00868023|Adrenergic Agents|adrenergic agents|mesh-ancestor
110610088|NCT00868023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110610089|NCT00868023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110610091|NCT05300386|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110610092|NCT05300386|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110610093|NCT05300386|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110610094|NCT05300386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110610095|NCT05300386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110610096|NCT05300386|Serotonin Agents|serotonin agents|mesh-ancestor
110610097|NCT05300386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110610098|NCT00863499|Methylphenidate|methylphenidate|mesh-list
110610099|NCT00863499|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110610100|NCT00863499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110610101|NCT00863499|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110610102|NCT00863499|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110610103|NCT00863499|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110610104|NCT00863499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110610105|NCT00863499|Dopamine Agents|dopamine agents|mesh-ancestor
110610106|NCT00863499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110610107|NCT00755118|Leucovorin|leucovorin|mesh-list
110610108|NCT00755118|Bevacizumab|bevacizumab|mesh-list
110610109|NCT00755118|Cetuximab|cetuximab|mesh-list
110610110|NCT00755118|Fluorouracil|fluorouracil|mesh-list
110610111|NCT00755118|Oxaliplatin|oxaliplatin|mesh-list
110610112|NCT00755118|Irinotecan|irinotecan|mesh-list
110610113|NCT00755118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110385090|NCT05509569|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110610114|NCT00755118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110610115|NCT00755118|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110610116|NCT00755118|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110610117|NCT00755118|Growth Substances|growth substances|mesh-ancestor
110610118|NCT00755118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110610119|NCT00755118|Growth Inhibitors|growth inhibitors|mesh-ancestor
110610120|NCT00755118|Antimetabolites|antimetabolites|mesh-ancestor
110610121|NCT00755118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110610122|NCT00755118|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110610123|NCT00755118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110610125|NCT00755118|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110610126|NCT00755118|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110610127|NCT00755118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110610128|NCT00755118|Antidotes|antidotes|mesh-ancestor
110610129|NCT00755118|Protective Agents|protective agents|mesh-ancestor
110610130|NCT00755118|Vitamin B Complex|vitamin b complex|mesh-ancestor
110610132|NCT00755118|Micronutrients|micronutrients|mesh-ancestor
110610133|NCT00755352|Pravastatin|pravastatin|mesh-list
110610134|NCT00755352|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
110610135|NCT00755352|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110610136|NCT00755352|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110610137|NCT00755352|Antimetabolites|antimetabolites|mesh-ancestor
110610138|NCT00755352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110385130|NCT05500170|Niacin|niacin|mesh-list
110610139|NCT00755352|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110610140|NCT00755352|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110610141|NCT00755352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110610143|NCT00549640|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110610144|NCT00549640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110610145|NCT00549640|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110610146|NCT00549640|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110610147|NCT00549640|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110610148|NCT00549640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110610149|NCT00549640|Dopamine Agents|dopamine agents|mesh-ancestor
110610150|NCT00549640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110610151|NCT04444804|Rivaroxaban|rivaroxaban|mesh-list
110610152|NCT04444804|Phenprocoumon|phenprocoumon|mesh-list
110610153|NCT04444804|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110610154|NCT04444804|Antithrombins|antithrombins|mesh-ancestor
110610155|NCT04444804|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110610156|NCT04444804|Protease Inhibitors|protease inhibitors|mesh-ancestor
110610157|NCT04444804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110610158|NCT04444804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110610159|NCT04444804|Anticoagulants|anticoagulants|mesh-ancestor
110610161|NCT00863577|Anticoagulants|anticoagulants|mesh-ancestor
110610162|NCT00868413|Cyclophosphamide|cyclophosphamide|mesh-list
110610163|NCT00868413|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110610164|NCT00868413|Rituximab|rituximab|mesh-list
110610165|NCT00868413|Fludarabine|fludarabine|mesh-list
110610166|NCT00868413|Navitoclax|navitoclax|mesh-list
110610167|NCT00868413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110610168|NCT00868413|Immunologic Factors|immunologic factors|mesh-ancestor
110610169|NCT00868413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110610170|NCT00868413|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110385176|NCT05434689|Dexamethasone|dexamethasone|mesh-list
110610171|NCT00868413|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110610172|NCT00868413|Alkylating Agents|alkylating agents|mesh-ancestor
110610173|NCT00868413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110610174|NCT00868413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110610175|NCT00868413|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110610176|NCT00868413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110610177|NCT03897348|Lacosamide|lacosamide|mesh-list
110610178|NCT03897348|Anticonvulsants|anticonvulsants|mesh-ancestor
110610179|NCT03897348|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110610180|NCT03897348|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110610181|NCT03897348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110610182|NCT03897348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110610183|NCT00868491|Cisplatin|cisplatin|mesh-list
110610184|NCT00868491|Docetaxel|docetaxel|mesh-list
110610185|NCT00868491|Fluorouracil|fluorouracil|mesh-list
110610186|NCT00868491|Cetuximab|cetuximab|mesh-list
110610187|NCT00868491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110610188|NCT00868491|Tubulin Modulators|tubulin modulators|mesh-ancestor
110610189|NCT00868491|Antimitotic Agents|antimitotic agents|mesh-ancestor
110610190|NCT00868491|Mitosis Modulators|mitosis modulators|mesh-ancestor
110610191|NCT00868491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110610192|NCT00868491|Antimetabolites|antimetabolites|mesh-ancestor
110610193|NCT00868491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110610194|NCT00868491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110610195|NCT00868491|Immunologic Factors|immunologic factors|mesh-ancestor
110610196|NCT00868491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110610197|NCT00868491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110610198|NCT00955630|Ranibizumab|ranibizumab|mesh-list
110610199|NCT00955630|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110610200|NCT00955630|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110610201|NCT00955630|Growth Substances|growth substances|mesh-ancestor
110610202|NCT00955630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110610203|NCT00955630|Growth Inhibitors|growth inhibitors|mesh-ancestor
110610204|NCT00955630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110610205|NCT00868569|Leucovorin|leucovorin|mesh-list
110610206|NCT00868569|Fluorouracil|fluorouracil|mesh-list
110610207|NCT00868569|Oxaliplatin|oxaliplatin|mesh-list
110610208|NCT00868569|Antimetabolites|antimetabolites|mesh-ancestor
110610209|NCT00868569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110610210|NCT00868569|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110610211|NCT00868569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110610212|NCT00868569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110610213|NCT00868569|Immunologic Factors|immunologic factors|mesh-ancestor
110610214|NCT00868569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110610215|NCT00868569|Antidotes|antidotes|mesh-ancestor
110610216|NCT00868569|Protective Agents|protective agents|mesh-ancestor
110610217|NCT00868569|Vitamin B Complex|vitamin b complex|mesh-ancestor
110610218|NCT00868569|Vitamins|vitamins|mesh-ancestor
110610219|NCT00868569|Micronutrients|micronutrients|mesh-ancestor
110385218|NCT05418244|Ondansetron|ondansetron|mesh-list
110610220|NCT00863733|Acetic Acid|acetic acid|mesh-list
110610221|NCT00863733|Vadimezan|vadimezan|mesh-list
110610222|NCT00863733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110610223|NCT00863733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110610224|NCT00863733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110610225|NCT00549562|Paliperidone Palmitate|paliperidone palmitate|mesh-list
110610226|NCT00549562|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110610227|NCT00549562|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110610228|NCT00549562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110610229|NCT00549562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110610230|NCT00549562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110610231|NCT00549562|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110610232|NCT00549562|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110610233|NCT00549562|Serotonin Agents|serotonin agents|mesh-ancestor
110610234|NCT00549562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110610235|NCT00549562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110610236|NCT00549562|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110610237|NCT00549562|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110610238|NCT00549562|Dopamine Agents|dopamine agents|mesh-ancestor
110610239|NCT00860925|Clonidine|clonidine|mesh-list
110610240|NCT00860925|Analgesics|analgesics|mesh-ancestor
110610241|NCT00860925|Sensory System Agents|sensory system agents|mesh-ancestor
110610242|NCT00860925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110610243|NCT00860925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110610244|NCT00860925|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110610245|NCT00860925|Sympatholytics|sympatholytics|mesh-ancestor
110610246|NCT00860925|Autonomic Agents|autonomic agents|mesh-ancestor
110610247|NCT00860925|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110610248|NCT00860925|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110610249|NCT00860925|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110610250|NCT00860925|Adrenergic Agents|adrenergic agents|mesh-ancestor
110610251|NCT00860925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110610252|NCT00860925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110610253|NCT04237012|Dexamethasone|dexamethasone|mesh-list
110610254|NCT04237012|Lubricant Eye Drops|lubricant eye drops|mesh-list
110610255|NCT04237012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110610256|NCT04237012|Antiemetics|antiemetics|mesh-ancestor
110610257|NCT04237012|Autonomic Agents|autonomic agents|mesh-ancestor
110610258|NCT04237012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110610259|NCT04237012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110610260|NCT04237012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110610261|NCT04237012|Glucocorticoids|glucocorticoids|mesh-ancestor
110610262|NCT04237012|Hormones|hormones|mesh-ancestor
110610263|NCT04237012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110610264|NCT04237012|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110610265|NCT04237012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110610266|NCT04237012|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110610267|NCT04237012|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110610268|NCT00863889|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110152621|NCT00390091|Abetimus|abetimus|mesh-list
110610270|NCT00863889|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110610271|NCT00863889|Prednisolone|prednisolone|mesh-list
110610272|NCT00863889|Prednisolone acetate|prednisolone acetate|mesh-list
110610273|NCT00863889|Lidocaine|lidocaine|mesh-list
110610274|NCT00863889|Bupivacaine|bupivacaine|mesh-list
110610275|NCT00863889|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110610276|NCT00863889|Prednisolone phosphate|prednisolone phosphate|mesh-list
110610277|NCT00863889|Anesthetics, Local|anesthetics, local|mesh-ancestor
110610278|NCT00863889|Anesthetics|anesthetics|mesh-ancestor
110610279|NCT00863889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110610280|NCT00863889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110610281|NCT00863889|Sensory System Agents|sensory system agents|mesh-ancestor
110610282|NCT00863889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110610283|NCT00863889|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110610284|NCT00863889|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110610285|NCT00863889|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110610286|NCT00863889|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110610287|NCT00863889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110610288|NCT00863889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110610289|NCT00863889|Antiemetics|antiemetics|mesh-ancestor
110610290|NCT00863889|Autonomic Agents|autonomic agents|mesh-ancestor
110610291|NCT00863889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110610292|NCT00863889|Glucocorticoids|glucocorticoids|mesh-ancestor
110610293|NCT00863889|Hormones|hormones|mesh-ancestor
110610294|NCT00863889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110610295|NCT00863889|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110610296|NCT00863889|Protective Agents|protective agents|mesh-ancestor
110610297|NCT00863889|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110610298|NCT00863889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110610299|NCT00677352|Sertraline|sertraline|mesh-list
110610300|NCT00677352|Paroxetine|paroxetine|mesh-list
110610301|NCT00677352|Antidepressive Agents|antidepressive agents|mesh-ancestor
110610302|NCT00677352|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110610303|NCT00677352|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110610304|NCT00677352|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110610305|NCT00677352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110610306|NCT00677352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110610307|NCT00677352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110610308|NCT00677352|Serotonin Agents|serotonin agents|mesh-ancestor
110610309|NCT00677352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110610310|NCT00677352|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110610311|NCT00677352|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110610312|NCT00677352|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110034033|NCT01595620|Capsaicin|capsaicin|mesh-list
110610313|NCT00677352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110610314|NCT00864045|Olanzapine|olanzapine|mesh-list
110610315|NCT00864045|Sertindole|sertindole|mesh-list
110610316|NCT00864045|Antiemetics|antiemetics|mesh-ancestor
110610317|NCT00864045|Autonomic Agents|autonomic agents|mesh-ancestor
110610318|NCT00864045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110610319|NCT00864045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110610320|NCT00864045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110610321|NCT00864045|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110610322|NCT00864045|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110610323|NCT00864045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110610324|NCT00864045|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110610325|NCT00864045|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110610326|NCT00864045|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110610327|NCT00864045|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110610328|NCT00864045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110610329|NCT00864045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110610330|NCT00864045|Serotonin Agents|serotonin agents|mesh-ancestor
110610331|NCT00755508|Gabapentin|gabapentin|mesh-list
110610332|NCT00755508|Analgesics|analgesics|mesh-ancestor
110610333|NCT00755508|Sensory System Agents|sensory system agents|mesh-ancestor
110610334|NCT00755508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110610335|NCT00755508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110610336|NCT00755508|Anticonvulsants|anticonvulsants|mesh-ancestor
110610337|NCT00755508|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110610338|NCT00755508|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110610339|NCT00755508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110610340|NCT00755508|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110610341|NCT00755508|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110610342|NCT00755508|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110610343|NCT00755508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110610344|NCT00755508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110610345|NCT00755508|Antimanic Agents|antimanic agents|mesh-ancestor
110610346|NCT03680352|Cefepime|cefepime|mesh-list
110610347|NCT03680352|Enmetazobactam|enmetazobactam|mesh-list
110610348|NCT03680352|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110610349|NCT03680352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110610350|NCT03680352|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110610351|NCT03680352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110610352|NCT03680352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110610353|NCT00864201|Bosentan|bosentan|mesh-list
110610354|NCT00864201|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110610355|NCT00864201|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
110610356|NCT00864201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110610357|NCT00864279|Cetirizine|cetirizine|mesh-list
110610358|NCT00864279|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110610359|NCT00864279|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110610360|NCT00864279|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110610361|NCT00864279|Histamine Antagonists|histamine antagonists|mesh-ancestor
110610362|NCT00864279|Histamine Agents|histamine agents|mesh-ancestor
110610363|NCT00864279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110610364|NCT00864279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110610365|NCT00864279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110610366|NCT02559648|Denosumab|denosumab|mesh-list
110610367|NCT02559648|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110610368|NCT02559648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110610369|NCT00864357|Ibuprofen|ibuprofen|mesh-list
110610370|NCT00864357|Oxycodone|oxycodone|mesh-list
110610371|NCT00864357|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110610372|NCT00864357|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110610373|NCT00864357|Analgesics|analgesics|mesh-ancestor
110610374|NCT00864357|Sensory System Agents|sensory system agents|mesh-ancestor
110610375|NCT00864357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110610376|NCT00864357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110610377|NCT00864357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110610378|NCT00864357|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110610379|NCT00864357|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110610380|NCT00864357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110610381|NCT00864357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110610382|NCT00864357|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110610384|NCT00864357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110610385|NCT00864435|Carvedilol|carvedilol|mesh-list
110610386|NCT00864435|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110610387|NCT00864435|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110610388|NCT00864435|Adrenergic Agents|adrenergic agents|mesh-ancestor
110610389|NCT00864435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110610390|NCT00864435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110385332|NCT05389527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110610391|NCT00864435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110610392|NCT00864435|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110610393|NCT00864435|Antioxidants|antioxidants|mesh-ancestor
110610394|NCT00864435|Protective Agents|protective agents|mesh-ancestor
110610395|NCT00864435|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110610396|NCT00864435|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110610397|NCT00864435|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110610398|NCT00864435|Vasodilator Agents|vasodilator agents|mesh-ancestor
110610399|NCT00864435|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110610400|NCT00864435|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110610401|NCT00755664|Vitamins|vitamins|mesh-list
110610402|NCT00755664|Vitamin B Complex|vitamin b complex|mesh-list
110610403|NCT00755664|Micronutrients|micronutrients|mesh-ancestor
110610404|NCT00755664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110610405|NCT00956098|Oltipraz|oltipraz|mesh-list
110610406|NCT00956098|Antiviral Agents|antiviral agents|mesh-ancestor
110610407|NCT00956098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110610408|NCT00956098|Schistosomicides|schistosomicides|mesh-ancestor
110610409|NCT00956098|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110610410|NCT00956098|Anthelmintics|anthelmintics|mesh-ancestor
110610411|NCT00956098|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110610412|NCT00956098|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110610413|NCT00956098|Protective Agents|protective agents|mesh-ancestor
110610414|NCT00956098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110610415|NCT00956098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110610416|NCT00956098|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110610417|NCT00956098|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110610418|NCT00956098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110283749|NCT00413322|Antimetabolites|antimetabolites|mesh-ancestor
110610419|NCT00956098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110610422|NCT00864591|Sensory System Agents|sensory system agents|mesh-ancestor
110610423|NCT00864591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110610424|NCT00864591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110610425|NCT00864591|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110610426|NCT00864591|Vasodilator Agents|vasodilator agents|mesh-ancestor
110610427|NCT00864591|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
110610428|NCT00864591|Purinergic Agonists|purinergic agonists|mesh-ancestor
110610429|NCT00864591|Purinergic Agents|purinergic agents|mesh-ancestor
110610430|NCT00864591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110610431|NCT00864591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110610432|NCT05350384|Methylprednisolone|methylprednisolone|mesh-list
110610433|NCT05350384|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110610434|NCT05350384|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110610435|NCT05350384|Prednisolone|prednisolone|mesh-list
110610436|NCT05350384|Prednisolone acetate|prednisolone acetate|mesh-list
110610437|NCT05350384|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110385391|NCT05366166|Cisplatin|cisplatin|mesh-list
110610438|NCT05350384|Prednisolone phosphate|prednisolone phosphate|mesh-list
110610439|NCT05350384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110610440|NCT05350384|Antiemetics|antiemetics|mesh-ancestor
110610441|NCT05350384|Autonomic Agents|autonomic agents|mesh-ancestor
110610442|NCT05350384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110610443|NCT05350384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110610444|NCT05350384|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110610445|NCT05350384|Glucocorticoids|glucocorticoids|mesh-ancestor
110610446|NCT05350384|Hormones|hormones|mesh-ancestor
110610447|NCT05350384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110610448|NCT05350384|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110610449|NCT05350384|Protective Agents|protective agents|mesh-ancestor
110610450|NCT05350384|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110610451|NCT05350384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110610452|NCT00870441|Valacyclovir|valacyclovir|mesh-list
110610453|NCT00870441|Antiviral Agents|antiviral agents|mesh-ancestor
110610454|NCT00870441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110610455|NCT04079452|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
110610456|NCT04079452|Antiviral Agents|antiviral agents|mesh-ancestor
110610457|NCT04079452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110610458|NCT04079452|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110610459|NCT04079452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110610460|NCT04079452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110610461|NCT04079452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110610462|NCT04079452|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110610463|NCT04079452|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110610464|NCT00864669|Metformin|metformin|mesh-list
110610465|NCT00864669|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110610466|NCT00864669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110610467|NCT00864747|Propranolol|propranolol|mesh-list
110610468|NCT00864747|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110610469|NCT00864747|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110610470|NCT00864747|Adrenergic Agents|adrenergic agents|mesh-ancestor
110610471|NCT00864747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110610472|NCT00864747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110610473|NCT00864747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110610474|NCT00864747|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110610475|NCT00864747|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110152633|NCT04601077|Nitric Oxide|nitric oxide|mesh-list
110610476|NCT00864747|Vasodilator Agents|vasodilator agents|mesh-ancestor
110610477|NCT05279716|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110610478|NCT05279716|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110610479|NCT02559102|Dexmedetomidine|dexmedetomidine|mesh-list
110610480|NCT02559102|Anesthetics|anesthetics|mesh-list
110610481|NCT02559102|Sevoflurane|sevoflurane|mesh-list
110610482|NCT02559102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110610483|NCT02559102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110610484|NCT02559102|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110610485|NCT02559102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110610486|NCT02559102|Analgesics|analgesics|mesh-ancestor
110610487|NCT02559102|Sensory System Agents|sensory system agents|mesh-ancestor
110610488|NCT02559102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110610489|NCT02559102|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110610490|NCT02559102|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110610491|NCT02559102|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110610492|NCT02559102|Adrenergic Agents|adrenergic agents|mesh-ancestor
110610493|NCT02559102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110610494|NCT02559102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110610495|NCT02559102|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110610496|NCT02559102|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110610497|NCT02559102|Anesthetics, General|anesthetics, general|mesh-ancestor
110610498|NCT05348668|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
110610499|NCT05348668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110610500|NCT05348668|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110610501|NCT05348668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110610502|NCT00864825|Allopurinol|allopurinol|mesh-list
110610503|NCT00864825|Antimetabolites|antimetabolites|mesh-ancestor
110610504|NCT00864825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110610505|NCT00864825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110610506|NCT00864825|Gout Suppressants|gout suppressants|mesh-ancestor
110610507|NCT00864825|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110610508|NCT00864825|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110610509|NCT00864825|Antioxidants|antioxidants|mesh-ancestor
110610510|NCT00864825|Protective Agents|protective agents|mesh-ancestor
110610511|NCT00864825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110610512|NCT00956176|Cidofovir|cidofovir|mesh-list
110610513|NCT00956176|Antiviral Agents|antiviral agents|mesh-ancestor
110610514|NCT00956176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110610515|NCT00956176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110610516|NCT00956176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110610517|NCT00864981|Bupropion|bupropion|mesh-list
110610518|NCT00864981|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110610519|NCT00864981|Antidepressive Agents|antidepressive agents|mesh-ancestor
110610520|NCT00864981|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110610521|NCT00864981|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110610522|NCT00864981|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110610523|NCT00864981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110610524|NCT00864981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110610525|NCT00864981|Dopamine Agents|dopamine agents|mesh-ancestor
110610526|NCT00864981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110152638|NCT04601077|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110610527|NCT00864981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110610528|NCT00864981|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110610529|NCT00864981|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110610530|NCT00864981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110610532|NCT00371683|Apixaban|apixaban|mesh-list
110610533|NCT00371683|Anticoagulants|anticoagulants|mesh-ancestor
110610534|NCT00371683|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110610535|NCT00371683|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110610536|NCT00371683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110610537|NCT00371683|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110610539|NCT00371683|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110610540|NCT00371683|Protease Inhibitors|protease inhibitors|mesh-ancestor
110610541|NCT00371683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110610542|NCT00876135|Albuterol|albuterol|mesh-list
110610543|NCT00876135|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110610544|NCT00876135|Autonomic Agents|autonomic agents|mesh-ancestor
110610545|NCT00876135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110610546|NCT00876135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110610547|NCT00876135|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110610548|NCT00876135|Respiratory System Agents|respiratory system agents|mesh-ancestor
110610549|NCT00876135|Tocolytic Agents|tocolytic agents|mesh-ancestor
110610550|NCT00876135|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110610551|NCT00876135|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110610552|NCT00876135|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110610553|NCT00876135|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110610554|NCT00876135|Adrenergic Agents|adrenergic agents|mesh-ancestor
110610555|NCT00876135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110610556|NCT00876135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110610557|NCT04039815|Ascorbic Acid|ascorbic acid|mesh-list
110610558|NCT04039815|Thiamine|thiamine|mesh-list
110610559|NCT04039815|Hydrocortisone|hydrocortisone|mesh-list
110610560|NCT04039815|Vitamins|vitamins|mesh-ancestor
110610561|NCT04039815|Micronutrients|micronutrients|mesh-ancestor
110610562|NCT04039815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110610563|NCT04039815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110610564|NCT04039815|Vitamin B Complex|vitamin b complex|mesh-ancestor
110610565|NCT04039815|Antioxidants|antioxidants|mesh-ancestor
110610566|NCT04039815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110610567|NCT04039815|Protective Agents|protective agents|mesh-ancestor
110610568|NCT00870987|Vaccines|vaccines|mesh-list
110610569|NCT00870987|Immunologic Factors|immunologic factors|mesh-ancestor
110610570|NCT00870987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110610571|NCT00962026|Rilonacept|rilonacept|mesh-list
110610572|NCT00962026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110610573|NCT00616239|Salicylic Acid|salicylic acid|mesh-list
110610574|NCT00616239|Salicylates|salicylates|mesh-list
110610575|NCT00616239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110610576|NCT00616239|Antifungal Agents|antifungal agents|mesh-ancestor
110610577|NCT00616239|Keratolytic Agents|keratolytic agents|mesh-ancestor
110610578|NCT00616239|Dermatologic Agents|dermatologic agents|mesh-ancestor
110610579|NCT00616239|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110610580|NCT00616239|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110610581|NCT00616239|Analgesics|analgesics|mesh-ancestor
110610582|NCT00616239|Sensory System Agents|sensory system agents|mesh-ancestor
110610583|NCT00616239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110610584|NCT00616239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110610585|NCT00616239|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110610586|NCT00616239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110610587|NCT00616239|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110610588|NCT00616239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110610589|NCT00616239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110610590|NCT00547534|Rituximab|rituximab|mesh-list
110610591|NCT00547534|Bortezomib|bortezomib|mesh-list
110610592|NCT00547534|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110610593|NCT00547534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110610594|NCT00547534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110610595|NCT00547534|Immunologic Factors|immunologic factors|mesh-ancestor
110610596|NCT00547534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110610598|NCT00547534|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110610599|NCT00547534|Alkylating Agents|alkylating agents|mesh-ancestor
110610600|NCT00547534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110610601|NCT00871455|Baclofen|baclofen|mesh-list
110610602|NCT00871455|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
110610603|NCT00871455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110610604|NCT00871455|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110610605|NCT00871455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110610606|NCT00871455|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
110610607|NCT00871455|GABA Agonists|gaba agonists|mesh-ancestor
110610608|NCT00871455|GABA Agents|gaba agents|mesh-ancestor
110610609|NCT00871455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110610610|NCT00871455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110610611|NCT00871533|Interferon-alpha|interferon-alpha|mesh-list
110610612|NCT00871533|Interferon alpha-2|interferon alpha-2|mesh-list
110610613|NCT00871533|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
110610614|NCT00871533|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110610615|NCT00871533|Antiviral Agents|antiviral agents|mesh-ancestor
110610616|NCT00871533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110610617|NCT00871533|Immunologic Factors|immunologic factors|mesh-ancestor
110610618|NCT00871533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110610619|NCT00871533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110610620|NCT00877149|Telbivudine|telbivudine|mesh-list
110610621|NCT00877149|Antiviral Agents|antiviral agents|mesh-ancestor
110610622|NCT00877149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110610623|NCT00877149|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110610624|NCT00877149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110610625|NCT00877149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110610626|NCT00877227|Leucovorin|leucovorin|mesh-list
110610627|NCT00877227|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
110610628|NCT00877227|Levoleucovorin|levoleucovorin|mesh-list
110610629|NCT00877227|Antidotes|antidotes|mesh-ancestor
110610630|NCT00877227|Protective Agents|protective agents|mesh-ancestor
110610631|NCT00877227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110610632|NCT00877227|Vitamin B Complex|vitamin b complex|mesh-ancestor
110610633|NCT00877227|Vitamins|vitamins|mesh-ancestor
110610634|NCT00877227|Micronutrients|micronutrients|mesh-ancestor
110610635|NCT00871767|N-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-N-ethyl-2-(4-methanesulfonylphenyl)acetamide|n-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-n-ethyl-2-(4-methanesulfonylphenyl)acetamide|mesh-list
110610636|NCT00871767|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
110610637|NCT00871767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110610638|NCT00871767|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110610639|NCT00871767|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110610640|NCT00871767|Antiviral Agents|antiviral agents|mesh-ancestor
110610641|NCT00871767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110610642|NCT00384397|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110610643|NCT00384397|Immunologic Factors|immunologic factors|mesh-ancestor
110610644|NCT00384397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110610645|NCT05119894|Brexpiprazole|brexpiprazole|mesh-list
110610646|NCT05119894|Serotonin Agents|serotonin agents|mesh-ancestor
110610647|NCT05119894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110610648|NCT05119894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110610649|NCT05119894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110610650|NCT05119894|Dopamine Agonists|dopamine agonists|mesh-ancestor
110610651|NCT05119894|Dopamine Agents|dopamine agents|mesh-ancestor
110610652|NCT00877539|Fluticasone|fluticasone|mesh-list
110610653|NCT00877539|Xhance|xhance|mesh-list
110610654|NCT00877539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110610655|NCT00877539|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110610656|NCT00877539|Autonomic Agents|autonomic agents|mesh-ancestor
110610657|NCT00877539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110610658|NCT00877539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110610659|NCT00877539|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110610660|NCT00877539|Respiratory System Agents|respiratory system agents|mesh-ancestor
110610661|NCT00877539|Dermatologic Agents|dermatologic agents|mesh-ancestor
110610662|NCT00877539|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110610663|NCT00872235|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110610664|NCT00872235|Quinapril|quinapril|mesh-list
110610665|NCT00872235|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110610666|NCT00872235|Diuretics|diuretics|mesh-ancestor
110610667|NCT00872235|Natriuretic Agents|natriuretic agents|mesh-ancestor
110610668|NCT00872235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110610669|NCT00872235|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110610670|NCT00872235|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110610671|NCT00872235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110610672|NCT00872235|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110610673|NCT00872235|Protease Inhibitors|protease inhibitors|mesh-ancestor
110610674|NCT00872235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110610675|NCT00872469|Tranexamic Acid|tranexamic acid|mesh-list
110610676|NCT00872469|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110610677|NCT00872469|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110610678|NCT00872469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110610679|NCT00872469|Hemostatics|hemostatics|mesh-ancestor
110610680|NCT00872469|Coagulants|coagulants|mesh-ancestor
110610681|NCT00872625|Cyclophosphamide|cyclophosphamide|mesh-list
110610682|NCT00872625|Docetaxel|docetaxel|mesh-list
110610683|NCT00872625|Fluorouracil|fluorouracil|mesh-list
110610684|NCT00872625|Epirubicin|epirubicin|mesh-list
110610685|NCT00872625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110610686|NCT00872625|Immunologic Factors|immunologic factors|mesh-ancestor
110610687|NCT00872625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110610688|NCT00872625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110610689|NCT00872625|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110610690|NCT00872625|Alkylating Agents|alkylating agents|mesh-ancestor
110610691|NCT00872625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110610692|NCT00872625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110610693|NCT00872625|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110610694|NCT00872625|Tubulin Modulators|tubulin modulators|mesh-ancestor
110610695|NCT00872625|Antimitotic Agents|antimitotic agents|mesh-ancestor
110610696|NCT00872625|Mitosis Modulators|mitosis modulators|mesh-ancestor
110610697|NCT00872625|Antimetabolites|antimetabolites|mesh-ancestor
110610698|NCT00872625|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110610699|NCT00872625|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110610700|NCT00872625|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110610701|NCT00872625|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110610702|NCT00872625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110385572|NCT05276219|Furosemide|furosemide|mesh-list
110385573|NCT05276219|Isosorbide|isosorbide|mesh-list
110385574|NCT05276219|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
110385575|NCT05276219|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
110385576|NCT05276219|Diuretics|diuretics|mesh-ancestor
110385577|NCT05276219|Natriuretic Agents|natriuretic agents|mesh-ancestor
110385578|NCT05276219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110385579|NCT05276219|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110385580|NCT05276219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110385581|NCT05276219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110610703|NCT00872781|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110610704|NCT00872781|Quinapril|quinapril|mesh-list
110610705|NCT00872781|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110610706|NCT00872781|Diuretics|diuretics|mesh-ancestor
110610707|NCT00872781|Natriuretic Agents|natriuretic agents|mesh-ancestor
110610708|NCT00872781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110610709|NCT00872781|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110610710|NCT00872781|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110610711|NCT00872781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110610712|NCT00872781|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110610713|NCT00872781|Protease Inhibitors|protease inhibitors|mesh-ancestor
110610714|NCT00872781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110610715|NCT00384085|Insulin|insulin|mesh-list
110610716|NCT00384085|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110610717|NCT00384085|Insulin Glargine|insulin glargine|mesh-list
110610718|NCT00384085|Insulin glulisine|insulin glulisine|mesh-list
110610719|NCT00384085|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110610720|NCT00384085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110610721|NCT00361231|Bevacizumab|bevacizumab|mesh-list
110610722|NCT00361231|Gemcitabine|gemcitabine|mesh-list
110610723|NCT00361231|Oxaliplatin|oxaliplatin|mesh-list
110610724|NCT00361231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110610725|NCT00361231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110610726|NCT00361231|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110610727|NCT00361231|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110610728|NCT00361231|Growth Substances|growth substances|mesh-ancestor
110610729|NCT00361231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110610730|NCT00361231|Growth Inhibitors|growth inhibitors|mesh-ancestor
110610731|NCT00361231|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110610732|NCT00361231|Antimetabolites|antimetabolites|mesh-ancestor
110385592|NCT05263206|Fexofenadine|fexofenadine|mesh-list
110610733|NCT00361231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110610734|NCT00676650|Prednisone|prednisone|mesh-list
110610735|NCT00676650|Sunitinib|sunitinib|mesh-list
110610736|NCT00676650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110610737|NCT00676650|Glucocorticoids|glucocorticoids|mesh-ancestor
110610738|NCT00676650|Hormones|hormones|mesh-ancestor
110610739|NCT00676650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110610740|NCT00676650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110610741|NCT00676650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110610742|NCT00676650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110610743|NCT00676650|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110610744|NCT00676650|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110610745|NCT00676650|Growth Substances|growth substances|mesh-ancestor
110610746|NCT00676650|Growth Inhibitors|growth inhibitors|mesh-ancestor
110610747|NCT00676650|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110610748|NCT00676650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110610749|NCT00676650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110610750|NCT01045369|Etravirine|etravirine|mesh-list
110610751|NCT01045369|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110610752|NCT01045369|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110610753|NCT01045369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110610754|NCT01045369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110610755|NCT01045369|Antiviral Agents|antiviral agents|mesh-ancestor
110610756|NCT01045369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110610757|NCT00615459|Tiotropium Bromide|tiotropium bromide|mesh-list
110610758|NCT00615459|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110610759|NCT00615459|Autonomic Agents|autonomic agents|mesh-ancestor
110610760|NCT00615459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110610761|NCT00615459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110610762|NCT00615459|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110610763|NCT00615459|Respiratory System Agents|respiratory system agents|mesh-ancestor
110610764|NCT00615459|Parasympatholytics|parasympatholytics|mesh-ancestor
110610765|NCT00615459|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110610766|NCT00615459|Cholinergic Agents|cholinergic agents|mesh-ancestor
110610767|NCT00615459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110610768|NCT00615459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110610769|NCT03839511|Hypoglycemic Agents|hypoglycemic agents|mesh-list
110610770|NCT03839511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110610771|NCT00383149|Cetuximab|cetuximab|mesh-list
110610772|NCT00383149|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110610773|NCT00383149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110610774|NCT00878631|Dextrans|dextrans|mesh-list
110610775|NCT00878631|Anticoagulants|anticoagulants|mesh-ancestor
110610776|NCT00878631|Plasma Substitutes|plasma substitutes|mesh-ancestor
110610777|NCT00878631|Blood Substitutes|blood substitutes|mesh-ancestor
110610778|NCT00382993|Naproxen|naproxen|mesh-list
110610779|NCT00382993|Sumatriptan|sumatriptan|mesh-list
110610780|NCT00382993|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110610781|NCT00382993|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110385639|NCT05231629|Hormones|hormones|mesh-ancestor
110610782|NCT00382993|Analgesics|analgesics|mesh-ancestor
110610783|NCT00382993|Sensory System Agents|sensory system agents|mesh-ancestor
110610784|NCT00382993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110610785|NCT00382993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110610786|NCT00382993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110610787|NCT00382993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110610788|NCT00382993|Gout Suppressants|gout suppressants|mesh-ancestor
110610789|NCT00382993|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110610790|NCT00382993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110610791|NCT00382993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110610792|NCT00382993|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110610793|NCT00382993|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110610794|NCT00382993|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110610795|NCT00382993|Serotonin Agents|serotonin agents|mesh-ancestor
110610796|NCT00382993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110610797|NCT00760968|Methotrexate|methotrexate|mesh-list
110610798|NCT00760968|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110610799|NCT00760968|Abortifacient Agents|abortifacient agents|mesh-ancestor
110610800|NCT00760968|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110610801|NCT00760968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110610802|NCT00760968|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110610803|NCT00760968|Antimetabolites|antimetabolites|mesh-ancestor
110610804|NCT00760968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110610805|NCT00760968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110610806|NCT00760968|Dermatologic Agents|dermatologic agents|mesh-ancestor
110610807|NCT00760968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110610808|NCT00760968|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110610809|NCT00760968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110610810|NCT00760968|Immunologic Factors|immunologic factors|mesh-ancestor
110610811|NCT00760968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110610812|NCT00760968|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110610813|NCT00369967|Contraceptive Agents|contraceptive agents|mesh-list
110610815|NCT00369967|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110610816|NCT00369967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110610817|NCT00369967|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110610818|NCT00878865|Alprazolam|alprazolam|mesh-list
110610819|NCT00878865|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110610820|NCT00878865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110610821|NCT00878865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110610822|NCT00878865|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110610823|NCT00878865|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110610824|NCT00878865|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110610825|NCT00878865|GABA Modulators|gaba modulators|mesh-ancestor
110610826|NCT00878865|GABA Agents|gaba agents|mesh-ancestor
110610827|NCT00878865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110610828|NCT00878865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110610829|NCT00873483|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110610831|NCT00873483|Femovan|femovan|mesh-list
110610832|NCT00873483|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110610833|NCT00873483|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110610834|NCT00873483|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110610835|NCT00873483|Contraceptive Agents|contraceptive agents|mesh-ancestor
110610836|NCT00873483|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110610837|NCT00873483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110610838|NCT00873483|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110610839|NCT00873483|Estrogens|estrogens|mesh-ancestor
110610840|NCT00873483|Hormones|hormones|mesh-ancestor
110610841|NCT00873483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110610842|NCT00873483|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110610843|NCT00873483|Progestins|progestins|mesh-ancestor
110610844|NCT00873483|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110610845|NCT01050517|Ivermectin|ivermectin|mesh-list
110610846|NCT01050517|Albendazole|albendazole|mesh-list
110610847|NCT01050517|Praziquantel|praziquantel|mesh-list
110610848|NCT01050517|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110610849|NCT01050517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110610850|NCT01050517|Anthelmintics|anthelmintics|mesh-ancestor
110610851|NCT01050517|Anticestodal Agents|anticestodal agents|mesh-ancestor
110610852|NCT01050517|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110610853|NCT01050517|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110610854|NCT01050517|Tubulin Modulators|tubulin modulators|mesh-ancestor
110610855|NCT01050517|Antimitotic Agents|antimitotic agents|mesh-ancestor
110610856|NCT01050517|Mitosis Modulators|mitosis modulators|mesh-ancestor
110610857|NCT01050517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110610858|NCT01050517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110610859|NCT02534467|Montelukast|montelukast|mesh-list
110610860|NCT02534467|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110610861|NCT02534467|Respiratory System Agents|respiratory system agents|mesh-ancestor
110610862|NCT02534467|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110610863|NCT02534467|Hormone Antagonists|hormone antagonists|mesh-ancestor
110610864|NCT02534467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110610865|NCT02534467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110610866|NCT02534467|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110610867|NCT02534467|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110610868|NCT02534467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110610869|NCT01050595|Naltrexone|naltrexone|mesh-list
110610870|NCT01050595|Bromides|bromides|mesh-list
110610871|NCT01050595|Methylnaltrexone|methylnaltrexone|mesh-list
110610872|NCT01050595|Anticonvulsants|anticonvulsants|mesh-ancestor
110610873|NCT01050595|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110610874|NCT01050595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110610875|NCT01050595|Sensory System Agents|sensory system agents|mesh-ancestor
110610876|NCT01050595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110610877|NCT01050595|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110610878|NCT00878943|Sildenafil Citrate|sildenafil citrate|mesh-list
110610879|NCT00878943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110610880|NCT00878943|Vasodilator Agents|vasodilator agents|mesh-ancestor
110610881|NCT00878943|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110610882|NCT00878943|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110610883|NCT00878943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110610884|NCT00878943|Urological Agents|urological agents|mesh-ancestor
110610885|NCT00873639|Insulin|insulin|mesh-list
110610886|NCT00873639|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110610887|NCT00873639|Insulin Aspart|insulin aspart|mesh-list
110610888|NCT00873639|Insulin Detemir|insulin detemir|mesh-list
110610889|NCT00873639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110610890|NCT00873639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110610891|NCT00879021|Pregabalin|pregabalin|mesh-list
110610892|NCT00879021|Analgesics|analgesics|mesh-ancestor
110610893|NCT00879021|Sensory System Agents|sensory system agents|mesh-ancestor
110610894|NCT00879021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110610895|NCT00879021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110610896|NCT00879021|Anticonvulsants|anticonvulsants|mesh-ancestor
110610897|NCT00879021|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110610898|NCT00879021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110034629|NCT01400646|Vitamin K|vitamin k|mesh-list
110610899|NCT00879021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110610900|NCT00879021|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110610901|NCT00879021|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110610902|NCT00879021|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110610903|NCT00879021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110610904|NCT00879021|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110610905|NCT00879099|Timolol|timolol|mesh-list
110610906|NCT00879099|Paroxetine|paroxetine|mesh-list
110610907|NCT00879099|Maleic acid|maleic acid|mesh-list
110610908|NCT00879099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110610909|NCT00879099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110610910|NCT00879099|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110610911|NCT00879099|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110610912|NCT00879099|Adrenergic Agents|adrenergic agents|mesh-ancestor
110610913|NCT00879099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110610914|NCT00879099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110610915|NCT00879099|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110610916|NCT00879099|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110610917|NCT00879099|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110610918|NCT00879099|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110610919|NCT00879099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110610920|NCT00879099|Serotonin Agents|serotonin agents|mesh-ancestor
110610921|NCT00879099|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110610922|NCT00879099|Antidepressive Agents|antidepressive agents|mesh-ancestor
110610923|NCT00879099|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110610924|NCT00879099|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110610925|NCT00879099|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110610926|NCT00369655|Aflibercept|aflibercept|mesh-list
110610927|NCT00369655|Endothelial Growth Factors|endothelial growth factors|mesh-list
110610928|NCT00369655|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110610929|NCT00369655|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110610930|NCT00369655|Growth Substances|growth substances|mesh-ancestor
110610931|NCT00369655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110610932|NCT00369655|Growth Inhibitors|growth inhibitors|mesh-ancestor
110610933|NCT00369655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110610934|NCT00879177|Varenicline|varenicline|mesh-list
110610935|NCT00879177|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110610936|NCT00879177|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110610937|NCT00879177|Cholinergic Agents|cholinergic agents|mesh-ancestor
110385771|NCT05181527|Serotonin Agents|serotonin agents|mesh-ancestor
110610938|NCT00879177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110610939|NCT00879177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110610940|NCT00879177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110610942|NCT00676338|Pioglitazone|pioglitazone|mesh-list
110610943|NCT00676338|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110610944|NCT00676338|Exenatide|exenatide|mesh-list
110610945|NCT00676338|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110610946|NCT00676338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110610947|NCT00676338|Incretins|incretins|mesh-ancestor
110610948|NCT00676338|Hormones|hormones|mesh-ancestor
110610949|NCT00676338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110610950|NCT00676338|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110610951|NCT00676338|Protease Inhibitors|protease inhibitors|mesh-ancestor
110610952|NCT00676338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110610953|NCT00676338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110610954|NCT00676338|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110610955|NCT02534623|Fentanyl|fentanyl|mesh-list
110610956|NCT02534623|Bupivacaine|bupivacaine|mesh-list
110610957|NCT02534623|Anesthetics|anesthetics|mesh-list
110610958|NCT02534623|Propofol|propofol|mesh-list
110610959|NCT02534623|Sevoflurane|sevoflurane|mesh-list
110610960|NCT02534623|Anesthetics, Local|anesthetics, local|mesh-ancestor
110610961|NCT02534623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110610962|NCT02534623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110610963|NCT02534623|Sensory System Agents|sensory system agents|mesh-ancestor
110610964|NCT02534623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110610965|NCT02534623|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110610966|NCT02534623|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110610967|NCT02534623|Anesthetics, General|anesthetics, general|mesh-ancestor
110610968|NCT02534623|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110610969|NCT02534623|Narcotics|narcotics|mesh-ancestor
110610970|NCT02534623|Analgesics|analgesics|mesh-ancestor
110610971|NCT02534623|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110610972|NCT02534623|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110610973|NCT02534623|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110610975|NCT00873795|Sertraline|sertraline|mesh-list
110610976|NCT00873795|Antidepressive Agents|antidepressive agents|mesh-ancestor
110610977|NCT00873795|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110610978|NCT00873795|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110610979|NCT00873795|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110610980|NCT00873795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110610981|NCT00873795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110610982|NCT00873795|Dopamine Agonists|dopamine agonists|mesh-ancestor
110610983|NCT00873795|Dopamine Agents|dopamine agents|mesh-ancestor
110610984|NCT00873795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110610985|NCT00873795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110610986|NCT00873795|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110610987|NCT00873795|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110610988|NCT00873795|Serotonin Agents|serotonin agents|mesh-ancestor
110610989|NCT00873795|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110610990|NCT00873795|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110610991|NCT00873795|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110610992|NCT00873795|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110610993|NCT00873795|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110610994|NCT00873795|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110610995|NCT00873795|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110610996|NCT00873951|Caseins|caseins|mesh-list
110610997|NCT00873951|Chelating Agents|chelating agents|mesh-ancestor
110610998|NCT00873951|Sequestering Agents|sequestering agents|mesh-ancestor
110610999|NCT00873951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110611001|NCT00874107|Bevacizumab|bevacizumab|mesh-list
110611002|NCT00874107|Carboplatin|carboplatin|mesh-list
110611003|NCT00874107|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110611004|NCT00874107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110611005|NCT00874107|Tubulin Modulators|tubulin modulators|mesh-ancestor
110611006|NCT00874107|Antimitotic Agents|antimitotic agents|mesh-ancestor
110611007|NCT00874107|Mitosis Modulators|mitosis modulators|mesh-ancestor
110611008|NCT00874107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110611009|NCT00874107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110611010|NCT00874107|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110611011|NCT00874107|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110611012|NCT00874107|Growth Substances|growth substances|mesh-ancestor
110611013|NCT00874107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110611014|NCT00874107|Growth Inhibitors|growth inhibitors|mesh-ancestor
110611015|NCT00761358|Z 338|z 338|mesh-list
110611016|NCT00761358|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110611017|NCT00761358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110611018|NCT00761358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110611019|NCT00761358|Cholinergic Agents|cholinergic agents|mesh-ancestor
110611020|NCT00761358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110611021|NCT00761358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110611022|NCT00761358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110611023|NCT00879723|Vitamins|vitamins|mesh-list
110611024|NCT00879723|Micronutrients|micronutrients|mesh-ancestor
110611025|NCT00879723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110611026|NCT00874419|Carboplatin|carboplatin|mesh-list
110611027|NCT00874419|Gemcitabine|gemcitabine|mesh-list
110611028|NCT00874419|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110611029|NCT00874419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110611030|NCT00874419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110611031|NCT00874419|Antimetabolites|antimetabolites|mesh-ancestor
110611032|NCT00874419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110611033|NCT00874419|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110611034|NCT00874419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110611035|NCT00381043|Acamprosate|acamprosate|mesh-list
110611036|NCT00381043|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110611038|NCT01050985|Capecitabine|capecitabine|mesh-list
110611039|NCT01050985|Temsirolimus|temsirolimus|mesh-list
110611040|NCT01050985|MTOR Inhibitors|mtor inhibitors|mesh-list
110611041|NCT01050985|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110611042|NCT01050985|Antimetabolites|antimetabolites|mesh-ancestor
110611043|NCT01050985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110611044|NCT01050985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110611045|NCT01050985|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110611046|NCT01050985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110611047|NCT01050985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110258372|NCT00519298|Donepezil|donepezil|mesh-list
110611048|NCT01050985|Immunologic Factors|immunologic factors|mesh-ancestor
110611049|NCT01050985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110611050|NCT01050985|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110611051|NCT01050985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110611052|NCT01050985|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110611053|NCT01050985|Antifungal Agents|antifungal agents|mesh-ancestor
110611054|NCT00614991|Ritonavir|ritonavir|mesh-list
110611055|NCT00614991|Fosamprenavir|fosamprenavir|mesh-list
110611056|NCT00614991|Raltegravir Potassium|raltegravir potassium|mesh-list
110611057|NCT00614991|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110611058|NCT00614991|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110611059|NCT00614991|Protease Inhibitors|protease inhibitors|mesh-ancestor
110611060|NCT00614991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110611061|NCT00614991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110611062|NCT00614991|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110611063|NCT00614991|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110611064|NCT00614991|Antiviral Agents|antiviral agents|mesh-ancestor
110611065|NCT00614991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110611066|NCT00614991|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110611067|NCT00614991|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110611068|NCT00614991|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110611069|NCT00614991|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110611070|NCT00874575|Vitamin D|vitamin d|mesh-list
110611071|NCT00874575|Ergocalciferols|ergocalciferols|mesh-list
110611072|NCT00874575|Cholecalciferol|cholecalciferol|mesh-list
110611073|NCT00874575|Vitamins|vitamins|mesh-list
110611074|NCT00874575|Micronutrients|micronutrients|mesh-ancestor
110611075|NCT00874575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110611076|NCT00874575|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110611077|NCT00874575|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110611078|NCT00874653|Levonorgestrel|levonorgestrel|mesh-list
110611079|NCT00874653|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110611080|NCT00874653|Contraceptive Agents|contraceptive agents|mesh-ancestor
110611081|NCT00874653|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110611082|NCT00874653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110385863|NCT05116007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110385864|NCT05116007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110385871|NCT05095376|Temozolomide|temozolomide|mesh-list
110385872|NCT05095376|Lomustine|lomustine|mesh-list
110385873|NCT05095376|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110385874|NCT05095376|Alkylating Agents|alkylating agents|mesh-ancestor
110611083|NCT00874653|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110611084|NCT00874653|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110611085|NCT00874653|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110611086|NCT00369577|Loxapine|loxapine|mesh-list
110611087|NCT00369577|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110611088|NCT00369577|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110611089|NCT00369577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110611090|NCT00369577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110611091|NCT00369577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110611092|NCT00369577|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110611093|NCT00369577|Dopamine Agents|dopamine agents|mesh-ancestor
110611094|NCT00369577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110611095|NCT00369577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110611096|NCT00879957|Heparin|heparin|mesh-list
110611097|NCT00879957|Calcium heparin|calcium heparin|mesh-list
110611098|NCT00879957|Anticoagulants|anticoagulants|mesh-ancestor
110611099|NCT00879957|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110611100|NCT00879957|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110611101|NCT00879957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110611102|NCT00874809|Insulin|insulin|mesh-list
110611103|NCT00874809|Insulin, Short-Acting|insulin, short-acting|mesh-list
110611104|NCT00874809|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110611105|NCT00874809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110611106|NCT00875355|Temozolomide|temozolomide|mesh-list
110611107|NCT00875355|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110611108|NCT00875355|Alkylating Agents|alkylating agents|mesh-ancestor
110611109|NCT00875355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110611110|NCT00875355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110611111|NCT00678288|Interferons|interferons|mesh-list
110611112|NCT00678288|Sorafenib|sorafenib|mesh-list
110611113|NCT00678288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110611114|NCT00678288|Antiviral Agents|antiviral agents|mesh-ancestor
110611115|NCT00678288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110611116|NCT00678288|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110611117|NCT00678288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110611118|NCT00678288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110611119|NCT00880815|Rituximab|rituximab|mesh-list
110611120|NCT00880815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110611121|NCT00880815|Methotrexate|methotrexate|mesh-list
110611122|NCT00880815|Fludarabine|fludarabine|mesh-list
110611123|NCT00880815|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110611124|NCT00880815|Antibodies|antibodies|mesh-list
110611125|NCT00880815|Immunoglobulins|immunoglobulins|mesh-list
110611126|NCT00880815|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110611127|NCT00880815|Lenograstim|lenograstim|mesh-list
110611129|NCT00880815|Thymoglobulin|thymoglobulin|mesh-list
110611130|NCT00880815|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110611131|NCT00880815|Immunologic Factors|immunologic factors|mesh-ancestor
110611132|NCT00880815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110611133|NCT00880815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110611134|NCT00880815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110611135|NCT00880815|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110611136|NCT00880815|Abortifacient Agents|abortifacient agents|mesh-ancestor
110611137|NCT00880815|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110611138|NCT00880815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110611139|NCT00880815|Antimetabolites|antimetabolites|mesh-ancestor
110611140|NCT00880815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110611141|NCT00880815|Dermatologic Agents|dermatologic agents|mesh-ancestor
110611142|NCT00880815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110611143|NCT00880815|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110611144|NCT00880815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110611145|NCT00880815|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110611146|NCT00880815|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110611147|NCT00880815|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110611148|NCT00880815|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110611149|NCT00880815|Alkylating Agents|alkylating agents|mesh-ancestor
110611150|NCT00369343|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
110611151|NCT00369343|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110611152|NCT00369343|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110611153|NCT00369343|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110611154|NCT00369343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110611155|NCT00369343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110611156|NCT00369343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110611157|NCT00369343|Antidepressive Agents|antidepressive agents|mesh-ancestor
110611158|NCT00369343|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110611159|NCT00881049|Imatinib Mesylate|imatinib mesylate|mesh-list
110611160|NCT00881049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110611161|NCT00881049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110611162|NCT00881049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110611163|NCT00881049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110611165|NCT00881127|Pseudoephedrine|pseudoephedrine|mesh-list
110611166|NCT00881127|Ephedrine|ephedrine|mesh-list
110611167|NCT00881127|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110611168|NCT00881127|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110611169|NCT00881127|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110611170|NCT00881127|Histamine Antagonists|histamine antagonists|mesh-ancestor
110611171|NCT00881127|Histamine Agents|histamine agents|mesh-ancestor
110611172|NCT00881127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110611173|NCT00881127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110611174|NCT00881127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110611175|NCT00881127|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110611176|NCT00881127|Autonomic Agents|autonomic agents|mesh-ancestor
110611177|NCT00881127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110611178|NCT00881127|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110611179|NCT00881127|Respiratory System Agents|respiratory system agents|mesh-ancestor
110611180|NCT00881127|Nasal Decongestants|nasal decongestants|mesh-ancestor
110611181|NCT00881127|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110611182|NCT00881127|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110611183|NCT00881127|Sympathomimetics|sympathomimetics|mesh-ancestor
110611184|NCT00881127|Adrenergic Agents|adrenergic agents|mesh-ancestor
110611185|NCT00369265|Lansoprazole|lansoprazole|mesh-list
110611186|NCT00369265|Dexlansoprazole|dexlansoprazole|mesh-list
110611187|NCT00369265|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110611188|NCT00369265|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110611189|NCT00369265|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110611190|NCT00369265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110611191|NCT00369265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110611193|NCT00875745|Vorinostat|vorinostat|mesh-list
110611194|NCT00875745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110611195|NCT00875745|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110258516|NCT04694365|Fluzoparib|fluzoparib|mesh-list
110611196|NCT00875745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110611197|NCT00875745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110611198|NCT00875745|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110611199|NCT00368875|Paclitaxel|paclitaxel|mesh-list
110385965|NCT05059522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110385966|NCT05059522|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110385967|NCT05059522|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110385968|NCT05059522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110385969|NCT05059522|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110385970|NCT05059522|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110385971|NCT05058859|Dapagliflozin|dapagliflozin|mesh-list
110385972|NCT05058859|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110385973|NCT05058859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110385974|NCT05058859|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110385975|NCT05058859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110611200|NCT00368875|Bevacizumab|bevacizumab|mesh-list
110611201|NCT00368875|Vorinostat|vorinostat|mesh-list
110611202|NCT00368875|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110611203|NCT00368875|Antibodies|antibodies|mesh-list
110611204|NCT00368875|Immunoglobulins|immunoglobulins|mesh-list
110611205|NCT00368875|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110611206|NCT00368875|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110611207|NCT00368875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110611208|NCT00368875|Tubulin Modulators|tubulin modulators|mesh-ancestor
110611209|NCT00368875|Antimitotic Agents|antimitotic agents|mesh-ancestor
110611210|NCT00368875|Mitosis Modulators|mitosis modulators|mesh-ancestor
110611211|NCT00368875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110611212|NCT00368875|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110611213|NCT00368875|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110611214|NCT00368875|Growth Substances|growth substances|mesh-ancestor
110611215|NCT00368875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110611216|NCT00368875|Growth Inhibitors|growth inhibitors|mesh-ancestor
110611217|NCT00368875|Immunologic Factors|immunologic factors|mesh-ancestor
110611218|NCT00368875|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110611219|NCT00368875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110611220|NCT00614055|Insulin|insulin|mesh-list
110611221|NCT00614055|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110611222|NCT00614055|Metformin|metformin|mesh-list
110611223|NCT00614055|Insulin Glargine|insulin glargine|mesh-list
110611224|NCT00614055|Insulin Aspart|insulin aspart|mesh-list
110611225|NCT00614055|Insulin, Long-Acting|insulin, long-acting|mesh-list
110611226|NCT00614055|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
110611227|NCT00614055|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110611228|NCT00614055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110611229|NCT00613821|Lidocaine|lidocaine|mesh-list
110611230|NCT00613821|Anesthetics, Local|anesthetics, local|mesh-ancestor
110611231|NCT00613821|Anesthetics|anesthetics|mesh-ancestor
110611232|NCT00613821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110611233|NCT00613821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110611234|NCT00613821|Sensory System Agents|sensory system agents|mesh-ancestor
110611235|NCT00613821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110611236|NCT00613821|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110611237|NCT00613821|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110611238|NCT00613821|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110611239|NCT00613821|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110611240|NCT00613821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110611241|NCT00882765|Genistein|genistein|mesh-list
110611242|NCT00882765|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110611243|NCT00882765|Protective Agents|protective agents|mesh-ancestor
110611244|NCT00882765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110611245|NCT00882765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110611246|NCT00882765|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110040269|NCT01432223|Paclitaxel|paclitaxel|mesh-list
110385998|NCT05057247|Docetaxel|docetaxel|mesh-list
110385999|NCT05057247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110386000|NCT05057247|Tubulin Modulators|tubulin modulators|mesh-ancestor
110386001|NCT05057247|Antimitotic Agents|antimitotic agents|mesh-ancestor
110386004|NCT05053152|Relugolix|relugolix|mesh-list
110611247|NCT00882765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110611248|NCT00882765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110611249|NCT00882765|Phytoestrogens|phytoestrogens|mesh-ancestor
110611250|NCT00882765|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
110611251|NCT00882765|Estrogens|estrogens|mesh-ancestor
110611252|NCT00882765|Hormones|hormones|mesh-ancestor
110611253|NCT00882765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110611254|NCT00548548|Bevacizumab|bevacizumab|mesh-list
110611255|NCT00548548|Fluorouracil|fluorouracil|mesh-list
110611256|NCT00548548|Capecitabine|capecitabine|mesh-list
110611257|NCT00548548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110611258|NCT00548548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110611259|NCT00548548|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110611260|NCT00548548|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110611261|NCT00548548|Growth Substances|growth substances|mesh-ancestor
110611262|NCT00548548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110611263|NCT00548548|Growth Inhibitors|growth inhibitors|mesh-ancestor
110611264|NCT00548548|Antimetabolites|antimetabolites|mesh-ancestor
110611265|NCT00548548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110611266|NCT00548548|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110611267|NCT00548548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110611268|NCT00548548|Immunologic Factors|immunologic factors|mesh-ancestor
110611269|NCT00613509|Interferons|interferons|mesh-list
110611270|NCT00613509|Interferon-alpha|interferon-alpha|mesh-list
110611271|NCT00613509|Vaccines|vaccines|mesh-list
110611272|NCT00613509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110611273|NCT00613509|Antiviral Agents|antiviral agents|mesh-ancestor
110611274|NCT00613509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110611275|NCT00613509|Immunologic Factors|immunologic factors|mesh-ancestor
110611276|NCT00613509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110611277|NCT00881517|Immunoglobulins|immunoglobulins|mesh-list
110611278|NCT00881517|Immunologic Factors|immunologic factors|mesh-ancestor
110611279|NCT00881517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110611280|NCT00881595|Temozolomide|temozolomide|mesh-list
110611281|NCT00881595|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110611282|NCT00881595|Alkylating Agents|alkylating agents|mesh-ancestor
110611283|NCT00881595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110611284|NCT00881595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110611285|NCT00883155|Bupropion|bupropion|mesh-list
110611286|NCT00883155|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110611287|NCT00883155|Antidepressive Agents|antidepressive agents|mesh-ancestor
110611288|NCT00883155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110611289|NCT00883155|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110611290|NCT00883155|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110611291|NCT00883155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110611292|NCT00883155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110611293|NCT00883155|Dopamine Agents|dopamine agents|mesh-ancestor
110611294|NCT00883155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110611295|NCT00883155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110611296|NCT00883155|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110611297|NCT00883155|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110611298|NCT00883155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110611299|NCT00881673|Dexamethasone|dexamethasone|mesh-list
110611300|NCT00881673|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110611301|NCT00881673|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110611302|NCT00881673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110611303|NCT00881673|Antiemetics|antiemetics|mesh-ancestor
110611304|NCT00881673|Autonomic Agents|autonomic agents|mesh-ancestor
110611305|NCT00881673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110611306|NCT00881673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110611307|NCT00881673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110611308|NCT00881673|Glucocorticoids|glucocorticoids|mesh-ancestor
110611309|NCT00881673|Hormones|hormones|mesh-ancestor
110611310|NCT00881673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110611311|NCT00881673|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110611312|NCT00881673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110611313|NCT04638465|Cisplatin|cisplatin|mesh-list
110611314|NCT04638465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110611315|NCT00881907|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110611316|NCT00881907|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
110611317|NCT00881907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110611318|NCT00881907|Antitubercular Agents|antitubercular agents|mesh-ancestor
110611319|NCT04487925|Hormones|hormones|mesh-list
110611320|NCT04487925|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
110611321|NCT04487925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110611322|NCT04487925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110611323|NCT00547300|Metoprolol|metoprolol|mesh-list
110611324|NCT00547300|Nebivolol|nebivolol|mesh-list
110611325|NCT00547300|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110611326|NCT00547300|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110611327|NCT00547300|Sympatholytics|sympatholytics|mesh-ancestor
110611328|NCT00547300|Autonomic Agents|autonomic agents|mesh-ancestor
110611329|NCT00547300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110611330|NCT00547300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110611331|NCT00547300|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110611332|NCT00547300|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110611333|NCT00547300|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110611334|NCT00547300|Adrenergic Agents|adrenergic agents|mesh-ancestor
110611335|NCT00547300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110611336|NCT00547300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110611337|NCT00547300|Vasodilator Agents|vasodilator agents|mesh-ancestor
110611338|NCT00547300|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
110611339|NCT00547300|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110611340|NCT00547300|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110611341|NCT00612807|Tranylcypromine|tranylcypromine|mesh-list
110611342|NCT00612807|Bupropion|bupropion|mesh-list
110611343|NCT00612807|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
110611344|NCT00612807|Sertraline|sertraline|mesh-list
110611345|NCT00612807|Nortriptyline|nortriptyline|mesh-list
110611346|NCT00612807|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110611347|NCT00612807|Antidepressive Agents|antidepressive agents|mesh-ancestor
110611348|NCT00612807|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110611349|NCT00612807|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110611350|NCT00612807|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110611351|NCT00612807|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110611352|NCT00612807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110611353|NCT00612807|Dopamine Agents|dopamine agents|mesh-ancestor
110611354|NCT00612807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110611355|NCT00612807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110611356|NCT00612807|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110611357|NCT00612807|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110611358|NCT00612807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110611359|NCT00612807|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110611360|NCT00612807|Serotonin Agents|serotonin agents|mesh-ancestor
110611361|NCT00612807|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110611362|NCT00612807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110611363|NCT00612807|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110611364|NCT00612807|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110611365|NCT00612807|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110611366|NCT00612807|Adrenergic Agents|adrenergic agents|mesh-ancestor
110611367|NCT00612807|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
110611368|NCT00612807|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110611369|NCT00958750|Minoxidil|minoxidil|mesh-list
110611370|NCT00958750|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110611371|NCT00958750|Vasodilator Agents|vasodilator agents|mesh-ancestor
110611372|NCT00958906|Infliximab|infliximab|mesh-list
110611373|NCT00958906|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110611374|NCT00958906|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110611375|NCT00958906|Dermatologic Agents|dermatologic agents|mesh-ancestor
110611376|NCT00958906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110611377|NCT00958906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110611378|NCT00959062|Clonidine|clonidine|mesh-list
110611379|NCT00959062|Analgesics|analgesics|mesh-ancestor
110611380|NCT00959062|Sensory System Agents|sensory system agents|mesh-ancestor
110611381|NCT00959062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110611382|NCT00959062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110611383|NCT00959062|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110611384|NCT00959062|Sympatholytics|sympatholytics|mesh-ancestor
110611385|NCT00959062|Autonomic Agents|autonomic agents|mesh-ancestor
110611386|NCT00959062|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110611387|NCT00959062|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110611388|NCT00959062|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110611389|NCT00959062|Adrenergic Agents|adrenergic agents|mesh-ancestor
110611390|NCT00959062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110611391|NCT00959062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110611392|NCT04038411|Etoposide|etoposide|mesh-list
110611393|NCT04038411|Lenalidomide|lenalidomide|mesh-list
110611394|NCT04038411|Antibodies|antibodies|mesh-list
110611395|NCT04038411|Immunologic Factors|immunologic factors|mesh-ancestor
110611396|NCT04038411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110611397|NCT04038411|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110611398|NCT04038411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110611399|NCT04038411|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110611400|NCT04038411|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110611401|NCT04038411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110611402|NCT04038411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110611403|NCT04038411|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110611404|NCT04038411|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110611405|NCT04038411|Growth Substances|growth substances|mesh-ancestor
110611406|NCT04038411|Growth Inhibitors|growth inhibitors|mesh-ancestor
110611407|NCT00882375|Nicotine|nicotine|mesh-list
110611408|NCT00882375|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110611409|NCT00882375|Autonomic Agents|autonomic agents|mesh-ancestor
110611410|NCT00882375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110611411|NCT00882375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110611412|NCT00882375|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110611413|NCT00882375|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110611414|NCT00882375|Cholinergic Agents|cholinergic agents|mesh-ancestor
110611415|NCT00882375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110611416|NCT00882375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110611418|NCT00882453|Interferon-beta|interferon-beta|mesh-list
110611419|NCT00882453|Interferon beta-1b|interferon beta-1b|mesh-list
110611420|NCT00882453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110258745|NCT00523120|Diclofenac|diclofenac|mesh-list
110611421|NCT00882453|Antiviral Agents|antiviral agents|mesh-ancestor
110611422|NCT00882453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110611423|NCT00882453|Immunologic Factors|immunologic factors|mesh-ancestor
110611424|NCT00882453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110611425|NCT00882453|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110611426|NCT00882531|Isotretinoin|isotretinoin|mesh-list
110611427|NCT00882531|Dermatologic Agents|dermatologic agents|mesh-ancestor
110611428|NCT00963274|Bortezomib|bortezomib|mesh-list
110611429|NCT00963274|Romidepsin|romidepsin|mesh-list
110611430|NCT00963274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110611431|NCT00963274|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110611432|NCT00963274|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110611433|NCT00963274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110611434|NCT00963274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110611435|NCT00882609|Fluorides|fluorides|mesh-list
110611436|NCT00882609|Cariostatic Agents|cariostatic agents|mesh-ancestor
110611437|NCT00882609|Protective Agents|protective agents|mesh-ancestor
110611438|NCT00882609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110611439|NCT00883623|Lenalidomide|lenalidomide|mesh-list
110611440|NCT00883623|Immunologic Factors|immunologic factors|mesh-ancestor
110611441|NCT00883623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110611442|NCT00883623|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110611443|NCT00883623|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110611444|NCT00883623|Growth Substances|growth substances|mesh-ancestor
110611445|NCT00883623|Growth Inhibitors|growth inhibitors|mesh-ancestor
110611446|NCT00883623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110611447|NCT00959218|Dronabinol|dronabinol|mesh-list
110611448|NCT00959218|Hallucinogens|hallucinogens|mesh-ancestor
110611449|NCT00959218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110611450|NCT00959218|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110611451|NCT00959218|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110611452|NCT00959218|Analgesics|analgesics|mesh-ancestor
110611453|NCT00959218|Sensory System Agents|sensory system agents|mesh-ancestor
110611454|NCT00959218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110611455|NCT00959218|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
110611456|NCT00959218|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110386234|NCT04947631|Vasodilator Agents|vasodilator agents|mesh-ancestor
110386235|NCT04947631|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110611457|NCT00959218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110611458|NCT00959218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110611459|NCT00959218|Hormones|hormones|mesh-ancestor
110611460|NCT00959218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110611461|NCT00678210|Tofacitinib|tofacitinib|mesh-list
110611462|NCT00678210|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
110611463|NCT00678210|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110611464|NCT00678210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110611465|NCT00678210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110611466|NCT00611715|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110611468|NCT00611715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110611469|NCT00611715|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110611470|NCT00611715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110611471|NCT00611715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110611472|NCT00611715|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110611473|NCT00611715|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110611474|NCT00611715|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110611475|NCT00611715|Hormone Antagonists|hormone antagonists|mesh-ancestor
110611476|NCT00611715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110611477|NCT00611715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110611478|NCT04722718|Paclitaxel|paclitaxel|mesh-list
110611479|NCT04722718|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110611480|NCT04722718|Carboplatin|carboplatin|mesh-list
110611481|NCT04722718|Apatinib|apatinib|mesh-list
110611482|NCT04722718|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110611483|NCT04722718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110611484|NCT04722718|Tubulin Modulators|tubulin modulators|mesh-ancestor
110611485|NCT04722718|Antimitotic Agents|antimitotic agents|mesh-ancestor
110611486|NCT04722718|Mitosis Modulators|mitosis modulators|mesh-ancestor
110611487|NCT04722718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110611488|NCT04722718|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110611489|NCT04722718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110611490|NCT00761670|Risperidone|risperidone|mesh-list
110611491|NCT00761670|Amisulpride|amisulpride|mesh-list
110611492|NCT00761670|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110611493|NCT00761670|Serotonin Agents|serotonin agents|mesh-ancestor
110611494|NCT00761670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110611495|NCT00761670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110258812|NCT02948101|Immunologic Factors|immunologic factors|mesh-ancestor
110611496|NCT00761670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110611497|NCT00761670|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110611498|NCT00761670|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110611499|NCT00761670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110611500|NCT00761670|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110611501|NCT00761670|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110611502|NCT00761670|Dopamine Agents|dopamine agents|mesh-ancestor
110611503|NCT00761670|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110386268|NCT04907851|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110386269|NCT04907851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110386270|NCT04907851|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110386271|NCT04907851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110386289|NCT04903197|Lenalidomide|lenalidomide|mesh-list
110386290|NCT04903197|Immunologic Factors|immunologic factors|mesh-ancestor
110386291|NCT04903197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110386292|NCT04903197|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110611506|NCT00963664|Interferon-alpha|interferon-alpha|mesh-list
110611507|NCT00963664|Interferon alpha-2|interferon alpha-2|mesh-list
110611508|NCT00963664|Lovastatin|lovastatin|mesh-list
110611509|NCT00963664|L 647318|l 647318|mesh-list
110611510|NCT00963664|Dihydromevinolin|dihydromevinolin|mesh-list
110611511|NCT00963664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110611512|NCT00963664|Antiviral Agents|antiviral agents|mesh-ancestor
110611513|NCT00963664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110611514|NCT00963664|Immunologic Factors|immunologic factors|mesh-ancestor
110611515|NCT00963664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110611516|NCT00963664|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110611517|NCT00963664|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110611518|NCT00963664|Antimetabolites|antimetabolites|mesh-ancestor
110611519|NCT00963664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110611520|NCT00963664|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110611521|NCT00963664|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110611522|NCT00963664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110611523|NCT00611559|PENTA|penta|mesh-list
110611524|NCT00611559|Anticoagulants|anticoagulants|mesh-ancestor
110611525|NCT00611559|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110611526|NCT00611559|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110611527|NCT00611559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110611528|NCT00761904|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110611529|NCT00761904|Simvastatin|simvastatin|mesh-list
110611530|NCT00761904|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110611531|NCT00761904|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110611532|NCT00761904|Antimetabolites|antimetabolites|mesh-ancestor
110611533|NCT00761904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110611534|NCT00761904|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110611535|NCT00761904|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110611536|NCT00761904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110611537|NCT00761904|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110611538|NCT00761904|Diuretics|diuretics|mesh-ancestor
110611539|NCT00761904|Natriuretic Agents|natriuretic agents|mesh-ancestor
110611540|NCT00761904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110611541|NCT00761904|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110611542|NCT00761904|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110611543|NCT00963976|Enalapril|enalapril|mesh-list
110611544|NCT00963976|Labetalol|labetalol|mesh-list
110611545|NCT00963976|Hydralazine|hydralazine|mesh-list
110611546|NCT00963976|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110611548|NCT00963976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110611549|NCT00963976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110611550|NCT00963976|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110611551|NCT00963976|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110611552|NCT00963976|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110611553|NCT00963976|Adrenergic Agents|adrenergic agents|mesh-ancestor
110611554|NCT00963976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110611555|NCT00963976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110611556|NCT00963976|Sympathomimetics|sympathomimetics|mesh-ancestor
110611557|NCT00963976|Autonomic Agents|autonomic agents|mesh-ancestor
110611558|NCT00963976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110611559|NCT00963976|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110611560|NCT00963976|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110611561|NCT00963976|Vasodilator Agents|vasodilator agents|mesh-ancestor
110611562|NCT02558868|Oxaliplatin|oxaliplatin|mesh-list
110611563|NCT02558868|Irinotecan|irinotecan|mesh-list
110611564|NCT02558868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110611565|NCT02558868|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110611566|NCT02558868|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110611567|NCT02558868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110611568|NCT02558868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110611569|NCT00611247|Temozolomide|temozolomide|mesh-list
110611570|NCT00611247|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110611571|NCT00611247|Alkylating Agents|alkylating agents|mesh-ancestor
110611572|NCT00611247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110611573|NCT00611247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110611574|NCT00883935|Ritonavir|ritonavir|mesh-list
110611575|NCT00883935|Atazanavir Sulfate|atazanavir sulfate|mesh-list
110611576|NCT00883935|Dolutegravir|dolutegravir|mesh-list
110611577|NCT00883935|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110611578|NCT00883935|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110611579|NCT00883935|Protease Inhibitors|protease inhibitors|mesh-ancestor
110611580|NCT00883935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110611581|NCT00883935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110611582|NCT00883935|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110611583|NCT00883935|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110611584|NCT00883935|Antiviral Agents|antiviral agents|mesh-ancestor
110611585|NCT00883935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110611586|NCT00883935|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110611587|NCT00883935|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110611588|NCT00883935|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110611589|NCT00883935|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110611590|NCT00675948|Nabiximols|nabiximols|mesh-list
110611591|NCT00675948|Analgesics|analgesics|mesh-ancestor
110611592|NCT00675948|Sensory System Agents|sensory system agents|mesh-ancestor
110611593|NCT00675948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110611594|NCT00675948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110611595|NCT00885885|Panitumumab|panitumumab|mesh-list
110611596|NCT00885885|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110611597|NCT00885885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110611598|NCT00610935|Peramivir|peramivir|mesh-list
110611599|NCT00610935|Antiviral Agents|antiviral agents|mesh-ancestor
110611600|NCT00610935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110611601|NCT00610935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110611602|NCT00610935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110611603|NCT02303028|Topotecan|topotecan|mesh-list
110611604|NCT02303028|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110611605|NCT02303028|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110611606|NCT02303028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110611607|NCT02303028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110611608|NCT02303028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110611609|NCT02287818|Febuxostat|febuxostat|mesh-list
110611610|NCT02287818|Gout Suppressants|gout suppressants|mesh-ancestor
110611611|NCT02287818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110611612|NCT00762060|Anesthetics|anesthetics|mesh-list
110611613|NCT00762060|Anesthetics, Local|anesthetics, local|mesh-list
110611614|NCT00762060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110035397|NCT01404741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110611615|NCT00762060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110611616|NCT00762060|Sensory System Agents|sensory system agents|mesh-ancestor
110611617|NCT00762060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110611618|NCT00610857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110611619|NCT00610857|Antibodies|antibodies|mesh-list
110611620|NCT00610857|Immunoglobulins|immunoglobulins|mesh-list
110611621|NCT00610857|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110611622|NCT00610857|Immunologic Factors|immunologic factors|mesh-ancestor
110611623|NCT00610857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110611624|NCT00610857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110611625|NCT00672984|Moxifloxacin|moxifloxacin|mesh-list
110611626|NCT00672984|Guanfacine|guanfacine|mesh-list
110611627|NCT00672984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110611628|NCT00672984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110611629|NCT00672984|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110611630|NCT00672984|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110611631|NCT00672984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110611632|NCT00672984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110611633|NCT00672984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110611634|NCT00672984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110611635|NCT00672984|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110611636|NCT00672984|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110611637|NCT00672984|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110611638|NCT00672984|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110611639|NCT00672984|Adrenergic Agents|adrenergic agents|mesh-ancestor
110611640|NCT00672984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110611641|NCT02543697|Epinephrine|epinephrine|mesh-list
110611642|NCT02543697|Racepinephrine|racepinephrine|mesh-list
110611643|NCT02543697|Epinephryl borate|epinephryl borate|mesh-list
110611644|NCT02543697|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110611645|NCT02543697|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110611646|NCT02543697|Adrenergic Agents|adrenergic agents|mesh-ancestor
110611647|NCT02543697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110611648|NCT02543697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110611649|NCT02543697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110611650|NCT02543697|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110611651|NCT02543697|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110611653|NCT02543697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110611654|NCT02543697|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110611655|NCT02543697|Respiratory System Agents|respiratory system agents|mesh-ancestor
110611656|NCT02543697|Mydriatics|mydriatics|mesh-ancestor
110611657|NCT02543697|Sympathomimetics|sympathomimetics|mesh-ancestor
110611658|NCT02543697|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110611659|NCT00886275|Midazolam|midazolam|mesh-list
110611660|NCT00886275|Dexmedetomidine|dexmedetomidine|mesh-list
110611661|NCT00886275|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110611662|NCT00886275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110611663|NCT00886275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110611664|NCT00886275|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110611665|NCT00886275|Analgesics|analgesics|mesh-ancestor
110611666|NCT00886275|Sensory System Agents|sensory system agents|mesh-ancestor
110611667|NCT00886275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110611668|NCT00886275|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110611669|NCT00886275|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110611670|NCT00886275|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110152788|NCT00000651|Antiviral Agents|antiviral agents|mesh-ancestor
110611671|NCT00886275|Adrenergic Agents|adrenergic agents|mesh-ancestor
110611672|NCT00886275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110386406|NCT04825496|Fludarabine|fludarabine|mesh-list
110611673|NCT00886275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110611674|NCT00886275|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110611675|NCT00886275|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110611676|NCT00886275|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110611677|NCT00886275|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110611678|NCT00886275|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110611679|NCT00886275|Anesthetics, General|anesthetics, general|mesh-ancestor
110611680|NCT00886275|Anesthetics|anesthetics|mesh-ancestor
110611681|NCT00886275|GABA Modulators|gaba modulators|mesh-ancestor
110611682|NCT00886275|GABA Agents|gaba agents|mesh-ancestor
110611683|NCT04017897|Pembrolizumab|pembrolizumab|mesh-list
110611684|NCT04017897|Nivolumab|nivolumab|mesh-list
110611685|NCT04017897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110611686|NCT04017897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110611687|NCT04017897|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110611688|NCT04017897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110611689|NCT02542137|Thymalfasin|thymalfasin|mesh-list
110611690|NCT02542137|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110611691|NCT02542137|Immunologic Factors|immunologic factors|mesh-ancestor
110611692|NCT02542137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110611693|NCT00886509|Lenograstim|lenograstim|mesh-list
110611694|NCT00886509|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110611695|NCT00886509|Immunologic Factors|immunologic factors|mesh-ancestor
110611696|NCT00886509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110611697|NCT02543385|Ketamine|ketamine|mesh-list
110611698|NCT02543385|Esketamine|esketamine|mesh-list
110611699|NCT02543385|Analgesics|analgesics|mesh-ancestor
110611700|NCT02543385|Sensory System Agents|sensory system agents|mesh-ancestor
110611701|NCT02543385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110611702|NCT02543385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110611703|NCT02543385|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110611704|NCT02543385|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110611705|NCT02543385|Anesthetics, General|anesthetics, general|mesh-ancestor
110611706|NCT02543385|Anesthetics|anesthetics|mesh-ancestor
110611707|NCT02543385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110611708|NCT02543385|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110611709|NCT02543385|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110611710|NCT02543385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110152790|NCT00000651|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110611711|NCT02543385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110611712|NCT02543385|Antidepressive Agents|antidepressive agents|mesh-ancestor
110611713|NCT02543385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110611714|NCT00884481|Natalizumab|natalizumab|mesh-list
110611715|NCT00884481|Immunologic Factors|immunologic factors|mesh-ancestor
110611716|NCT00884481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110611717|NCT02543229|Ranibizumab|ranibizumab|mesh-list
110611718|NCT02543229|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110611719|NCT02543229|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110386433|NCT04800471|Insulin|insulin|mesh-list
110611720|NCT02543229|Growth Substances|growth substances|mesh-ancestor
110611721|NCT02543229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110611723|NCT02543229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110611724|NCT02543073|Glucocorticoids|glucocorticoids|mesh-list
110611725|NCT02543073|Hormones|hormones|mesh-ancestor
110611726|NCT02543073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110611727|NCT02543073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110611728|NCT00546364|Docetaxel|docetaxel|mesh-list
110611729|NCT00546364|Capecitabine|capecitabine|mesh-list
110611730|NCT00546364|Epothilones|epothilones|mesh-list
110611731|NCT00546364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110611732|NCT00546364|Tubulin Modulators|tubulin modulators|mesh-ancestor
110611733|NCT00546364|Antimitotic Agents|antimitotic agents|mesh-ancestor
110611734|NCT00546364|Mitosis Modulators|mitosis modulators|mesh-ancestor
110611735|NCT00546364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110611736|NCT00546364|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110611737|NCT00546364|Antimetabolites|antimetabolites|mesh-ancestor
110611738|NCT00887211|Sirolimus|sirolimus|mesh-list
110611739|NCT00887211|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110611740|NCT00887211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110611741|NCT00887211|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110611742|NCT00887211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110611743|NCT00887211|Antifungal Agents|antifungal agents|mesh-ancestor
110611744|NCT00887211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110611745|NCT00887211|Immunologic Factors|immunologic factors|mesh-ancestor
110611746|NCT00887211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110611747|NCT00887367|Ethanol|ethanol|mesh-list
110611748|NCT00887367|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110611749|NCT00887367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110611750|NCT00887367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110611751|NCT00887367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110611752|NCT00964288|Lidocaine|lidocaine|mesh-list
110611753|NCT00964288|Anesthetics, Local|anesthetics, local|mesh-ancestor
110611754|NCT00964288|Anesthetics|anesthetics|mesh-ancestor
110611755|NCT00964288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110611756|NCT00964288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110611757|NCT00964288|Sensory System Agents|sensory system agents|mesh-ancestor
110611758|NCT00964288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110611759|NCT00964288|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110611760|NCT00964288|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110611761|NCT00964288|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110611762|NCT00964288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110611763|NCT00964288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110611764|NCT05955040|Labetalol|labetalol|mesh-list
110611765|NCT05955040|Nifedipine|nifedipine|mesh-list
110611766|NCT05955040|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110611767|NCT05955040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110611768|NCT05955040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110611769|NCT05955040|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110611770|NCT05955040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110611771|NCT05955040|Vasodilator Agents|vasodilator agents|mesh-ancestor
110611772|NCT05955040|Tocolytic Agents|tocolytic agents|mesh-ancestor
110611773|NCT05955040|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110611774|NCT05955040|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110611776|NCT05955040|Adrenergic Agents|adrenergic agents|mesh-ancestor
110611777|NCT05955040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110611778|NCT05955040|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110611779|NCT05955040|Sympathomimetics|sympathomimetics|mesh-ancestor
110611780|NCT05955040|Autonomic Agents|autonomic agents|mesh-ancestor
110611781|NCT05955040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110611782|NCT05955040|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110611783|NCT05955040|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110611784|NCT05955001|Tadalafil|tadalafil|mesh-list
110611785|NCT05955001|Vasodilator Agents|vasodilator agents|mesh-ancestor
110611786|NCT05955001|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110611787|NCT05955001|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110611788|NCT05955001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110611789|NCT05955001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110611790|NCT05955001|Urological Agents|urological agents|mesh-ancestor
110611791|NCT05954897|Lenvatinib|lenvatinib|mesh-list
110611792|NCT05954897|Tislelizumab|tislelizumab|mesh-list
110611793|NCT05954897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110611794|NCT05954897|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110611795|NCT05954897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110611796|NCT05954897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110611797|NCT05954897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110611798|NCT05954806|Antivenins|antivenins|mesh-list
110611799|NCT05954806|Immunologic Factors|immunologic factors|mesh-ancestor
110611800|NCT05954806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110611801|NCT05954624|Itraconazole|itraconazole|mesh-list
110611802|NCT05954624|Probenecid|probenecid|mesh-list
110611803|NCT05954624|Digoxin|digoxin|mesh-list
110611804|NCT05954624|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110611805|NCT05954624|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110611806|NCT05954624|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110611807|NCT05954624|Antimetabolites|antimetabolites|mesh-ancestor
110611808|NCT05954624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110611809|NCT05954624|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110611810|NCT05954624|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110611811|NCT05954624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110611812|NCT05954624|Antifungal Agents|antifungal agents|mesh-ancestor
110611813|NCT05954624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110611814|NCT05954624|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110611815|NCT05954624|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110611816|NCT05954624|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110611817|NCT05954624|Hormone Antagonists|hormone antagonists|mesh-ancestor
110611818|NCT05954624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110386537|NCT04744883|Naloxone|naloxone|mesh-list
110611819|NCT05954624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110611820|NCT05954624|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110611821|NCT05954624|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110611822|NCT05954624|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110611823|NCT05954624|Protective Agents|protective agents|mesh-ancestor
110611824|NCT05954624|Uricosuric Agents|uricosuric agents|mesh-ancestor
110611825|NCT05954624|Gout Suppressants|gout suppressants|mesh-ancestor
110611826|NCT05954624|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110611827|NCT05954078|Leucovorin|leucovorin|mesh-list
110611828|NCT05954078|Fluorouracil|fluorouracil|mesh-list
110611829|NCT05954078|Oxaliplatin|oxaliplatin|mesh-list
110611830|NCT05954078|Irinotecan|irinotecan|mesh-list
110611831|NCT05954078|Levoleucovorin|levoleucovorin|mesh-list
110611832|NCT05954078|Antimetabolites|antimetabolites|mesh-ancestor
110611833|NCT05954078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110611834|NCT05954078|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110611835|NCT05954078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110611836|NCT05954078|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110611837|NCT05954078|Immunologic Factors|immunologic factors|mesh-ancestor
110611838|NCT05954078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110611839|NCT05954078|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110611840|NCT05954078|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110611841|NCT05954078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110611842|NCT05954078|Antidotes|antidotes|mesh-ancestor
110611843|NCT05954078|Protective Agents|protective agents|mesh-ancestor
110611844|NCT05954078|Vitamin B Complex|vitamin b complex|mesh-ancestor
110611845|NCT05954078|Vitamins|vitamins|mesh-ancestor
110611846|NCT05954078|Micronutrients|micronutrients|mesh-ancestor
110611847|NCT05953909|Paclitaxel|paclitaxel|mesh-list
110611848|NCT05953909|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110611849|NCT05953909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110611850|NCT05953909|Tubulin Modulators|tubulin modulators|mesh-ancestor
110611851|NCT05953909|Antimitotic Agents|antimitotic agents|mesh-ancestor
110611852|NCT05953909|Mitosis Modulators|mitosis modulators|mesh-ancestor
110611853|NCT05953909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110611854|NCT05953896|Hyaluronic Acid|hyaluronic acid|mesh-list
110611855|NCT05953896|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110611856|NCT05953896|Immunologic Factors|immunologic factors|mesh-ancestor
110611857|NCT05953896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110611858|NCT05953896|Viscosupplements|viscosupplements|mesh-ancestor
110611859|NCT05953896|Protective Agents|protective agents|mesh-ancestor
110611860|NCT05953714|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
110611861|NCT05953714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110611862|NCT05953675|Ethanol|ethanol|mesh-list
110611863|NCT05953675|Heparin|heparin|mesh-list
110611864|NCT05953675|Anticoagulants|anticoagulants|mesh-ancestor
110611865|NCT05953675|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110611866|NCT05953675|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110611867|NCT05953675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110611868|NCT05953675|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110611869|NCT05953675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110611870|NCT05953675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110611871|NCT05953675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110611872|NCT05953610|Acetazolamide|acetazolamide|mesh-list
110611873|NCT05953610|Eszopiclone|eszopiclone|mesh-list
110611874|NCT05953610|Anticonvulsants|anticonvulsants|mesh-ancestor
110611875|NCT05953610|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110611876|NCT05953610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110611877|NCT05953610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110611878|NCT05953610|Diuretics|diuretics|mesh-ancestor
110611879|NCT05953610|Natriuretic Agents|natriuretic agents|mesh-ancestor
110611880|NCT05953610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110611881|NCT05953610|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110152857|NCT00000681|Sargramostim|sargramostim|mesh-list
110611882|NCT05953610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110611891|NCT05953376|Calcium, Dietary|calcium, dietary|mesh-list
110611892|NCT05953376|Calcium|calcium|mesh-list
110611893|NCT05953376|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110611894|NCT05953376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110611895|NCT05953376|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110611896|NCT05953350|Hydroxychloroquine|hydroxychloroquine|mesh-list
110611897|NCT05953350|Palbociclib|palbociclib|mesh-list
110611898|NCT05953350|Antimalarials|antimalarials|mesh-ancestor
110611899|NCT05953350|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110611900|NCT05953350|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110611901|NCT05953350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110611902|NCT05953350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110611903|NCT05953350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110611904|NCT05953350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110611905|NCT05953350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110611906|NCT05953350|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110611908|NCT05950802|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110611909|NCT05950802|Immunologic Factors|immunologic factors|mesh-ancestor
110611910|NCT05950802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110611911|NCT05950802|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110611912|NCT05950802|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110611913|NCT05950802|Alkylating Agents|alkylating agents|mesh-ancestor
110611914|NCT05950802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110611915|NCT05950802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110611916|NCT05950802|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110611917|NCT05938608|Primaquine|primaquine|mesh-list
110611918|NCT05938608|Antimalarials|antimalarials|mesh-ancestor
110611919|NCT05938608|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110611920|NCT05938608|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110611921|NCT05938608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110611922|NCT05928312|Oxaliplatin|oxaliplatin|mesh-list
110611923|NCT05928312|Irinotecan|irinotecan|mesh-list
110611924|NCT05928312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110611925|NCT05928312|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110611926|NCT05928312|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110611927|NCT05928312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110611928|NCT05928312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110611929|NCT05921760|Nivolumab|nivolumab|mesh-list
110611930|NCT05921760|Ipilimumab|ipilimumab|mesh-list
110611931|NCT05921760|Ivosidenib|ivosidenib|mesh-list
110611932|NCT05921760|Glycine|glycine|mesh-list
110611933|NCT05921760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110386663|NCT04614909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110611934|NCT05921760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110611935|NCT05921760|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110611936|NCT05921760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110611937|NCT05921760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110611938|NCT05921760|Glycine Agents|glycine agents|mesh-ancestor
110611939|NCT05921760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110611940|NCT05921760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110611941|NCT05919147|Pioglitazone|pioglitazone|mesh-list
110611942|NCT05919147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110611943|NCT05919147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110611944|NCT05919030|Paclitaxel|paclitaxel|mesh-list
110611945|NCT05919030|Tislelizumab|tislelizumab|mesh-list
110611946|NCT05919030|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110611947|NCT05919030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110611948|NCT05919030|Tubulin Modulators|tubulin modulators|mesh-ancestor
110611949|NCT05919030|Antimitotic Agents|antimitotic agents|mesh-ancestor
110611950|NCT05919030|Mitosis Modulators|mitosis modulators|mesh-ancestor
110611951|NCT05919030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110611952|NCT05919030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110611953|NCT05917509|Rilpivirine|rilpivirine|mesh-list
110611954|NCT05917509|Cabotegravir|cabotegravir|mesh-list
110611955|NCT05917509|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110152882|NCT00000687|Interferon-alpha|interferon-alpha|mesh-list
110611956|NCT05917509|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110611957|NCT05917509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110611958|NCT05917509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110611959|NCT05917509|Antiviral Agents|antiviral agents|mesh-ancestor
110611960|NCT05917509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110611961|NCT05917509|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110611962|NCT05917509|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110611963|NCT05917509|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110611964|NCT05917509|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110611965|NCT05895201|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110611966|NCT05895201|Cyclophosphamide|cyclophosphamide|mesh-list
110611967|NCT05895201|Bortezomib|bortezomib|mesh-list
110611968|NCT05895201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110611969|NCT05895201|Immunologic Factors|immunologic factors|mesh-ancestor
110611970|NCT05895201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110611971|NCT05895201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110611973|NCT05895201|Alkylating Agents|alkylating agents|mesh-ancestor
110611974|NCT05895201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110611975|NCT05895201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110611976|NCT05895201|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110611977|NCT05895201|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110611978|NCT05895201|Incretins|incretins|mesh-ancestor
110611979|NCT05895201|Hormones|hormones|mesh-ancestor
110611980|NCT05895201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110611981|NCT05895201|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110611982|NCT05895201|Protease Inhibitors|protease inhibitors|mesh-ancestor
110611983|NCT05895201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110611984|NCT05890027|Phenylephrine|phenylephrine|mesh-list
110611985|NCT05890027|Oxymetazoline|oxymetazoline|mesh-list
110611986|NCT05890027|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110611987|NCT05890027|Mydriatics|mydriatics|mesh-ancestor
110611988|NCT05890027|Autonomic Agents|autonomic agents|mesh-ancestor
110611989|NCT05890027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110611990|NCT05890027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110611991|NCT05890027|Sympathomimetics|sympathomimetics|mesh-ancestor
110611992|NCT05890027|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110611993|NCT05890027|Nasal Decongestants|nasal decongestants|mesh-ancestor
110611994|NCT05890027|Respiratory System Agents|respiratory system agents|mesh-ancestor
110611995|NCT05890027|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110611996|NCT05890027|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110611997|NCT05890027|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110611998|NCT05890027|Adrenergic Agents|adrenergic agents|mesh-ancestor
110611999|NCT05890027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110612000|NCT05890027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110612001|NCT05890027|Protective Agents|protective agents|mesh-ancestor
110612002|NCT05870956|Nintedanib|nintedanib|mesh-list
110612003|NCT05870956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110612004|NCT05870956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110612005|NCT05870956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110612006|NCT05870956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110612007|NCT05866354|Tisotumab vedotin|tisotumab vedotin|mesh-list
110612008|NCT05866354|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110612009|NCT05866354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110612010|NCT05864209|Bisphenol A|bisphenol a|mesh-list
110612011|NCT05864209|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
110612012|NCT05864209|Estrogens|estrogens|mesh-ancestor
110612013|NCT05864209|Hormones|hormones|mesh-ancestor
110612014|NCT05864209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110612015|NCT05864209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110612016|NCT05864209|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110612017|NCT05864209|Antioxidants|antioxidants|mesh-ancestor
110612018|NCT05864209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110612019|NCT05864209|Protective Agents|protective agents|mesh-ancestor
110612020|NCT05848765|Prednisone|prednisone|mesh-list
110612021|NCT05848765|Cyclophosphamide|cyclophosphamide|mesh-list
110612022|NCT05848765|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110612023|NCT05848765|Rituximab|rituximab|mesh-list
110612024|NCT05848765|Doxorubicin|doxorubicin|mesh-list
110612025|NCT05848765|Vincristine|vincristine|mesh-list
110612026|NCT05848765|Lenalidomide|lenalidomide|mesh-list
110612027|NCT05848765|Obinutuzumab|obinutuzumab|mesh-list
110612028|NCT05848765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110612029|NCT05848765|Immunologic Factors|immunologic factors|mesh-ancestor
110612030|NCT05848765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110612031|NCT05848765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110612032|NCT05848765|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110612033|NCT05848765|Alkylating Agents|alkylating agents|mesh-ancestor
110612034|NCT05848765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110612035|NCT05848765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110612036|NCT05848765|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110612037|NCT05848765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110612038|NCT05848765|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110612039|NCT05848765|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110612040|NCT05848765|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110612041|NCT05848765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110612042|NCT05848765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110612043|NCT05848765|Glucocorticoids|glucocorticoids|mesh-ancestor
110612044|NCT05848765|Hormones|hormones|mesh-ancestor
110612045|NCT05848765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110612046|NCT05848765|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110612047|NCT05848765|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110612048|NCT05848765|Tubulin Modulators|tubulin modulators|mesh-ancestor
110612049|NCT05848765|Antimitotic Agents|antimitotic agents|mesh-ancestor
110612050|NCT05848765|Mitosis Modulators|mitosis modulators|mesh-ancestor
110612051|NCT05848765|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110612052|NCT05848765|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110612053|NCT05848765|Growth Substances|growth substances|mesh-ancestor
110612054|NCT05848765|Growth Inhibitors|growth inhibitors|mesh-ancestor
110612055|NCT05847348|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
110612056|NCT05847348|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110612057|NCT05847348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110612058|NCT05843383|Propofol|propofol|mesh-list
110612059|NCT05843383|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110612060|NCT05843383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110612061|NCT05843383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110612062|NCT05843383|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110612063|NCT05843383|Anesthetics, General|anesthetics, general|mesh-ancestor
110612064|NCT05843383|Anesthetics|anesthetics|mesh-ancestor
110386823|NCT04545242|Antiemetics|antiemetics|mesh-ancestor
110386824|NCT04545242|Autonomic Agents|autonomic agents|mesh-ancestor
110386825|NCT04545242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110386826|NCT04545242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110386827|NCT04545242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110386828|NCT04545242|Glucocorticoids|glucocorticoids|mesh-ancestor
110386829|NCT04545242|Hormones|hormones|mesh-ancestor
110386830|NCT04545242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110386831|NCT04545242|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110386832|NCT04545242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110386833|NCT04542382|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110386834|NCT04542382|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110386835|NCT04542382|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110386836|NCT04542382|Antimetabolites|antimetabolites|mesh-ancestor
110386837|NCT04542382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110386838|NCT04542382|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110386839|NCT04542382|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110386840|NCT04542382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110612065|NCT05836753|Sarecycline|sarecycline|mesh-list
110612066|NCT05836753|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110612067|NCT05836753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110612068|NCT05836753|Dermatologic Agents|dermatologic agents|mesh-ancestor
110612069|NCT05827211|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110612070|NCT05827211|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
110612071|NCT05827211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110612072|NCT05827211|Antitubercular Agents|antitubercular agents|mesh-ancestor
110612073|NCT05822063|Lidocaine|lidocaine|mesh-list
110612074|NCT05822063|Anesthetics, Local|anesthetics, local|mesh-ancestor
110612075|NCT05822063|Anesthetics|anesthetics|mesh-ancestor
110612076|NCT05822063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110612077|NCT05822063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110612078|NCT05822063|Sensory System Agents|sensory system agents|mesh-ancestor
110612079|NCT05822063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110612080|NCT05822063|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110612081|NCT05822063|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110612082|NCT05822063|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110612083|NCT05822063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110612084|NCT05822063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110612085|NCT05820503|Anesthetics|anesthetics|mesh-list
110612086|NCT05820503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110612087|NCT05820503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110612088|NCT05817097|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
110612089|NCT05817097|Protease Inhibitors|protease inhibitors|mesh-ancestor
110612090|NCT05817097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110612091|NCT05817097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110612092|NCT05817097|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110386901|NCT04524871|Bevacizumab|bevacizumab|mesh-list
110386902|NCT04524871|Atezolizumab|atezolizumab|mesh-list
110386903|NCT04524871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110386904|NCT04524871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110386905|NCT04524871|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110386906|NCT04524871|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110386907|NCT04524871|Growth Substances|growth substances|mesh-ancestor
110386908|NCT04524871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110386909|NCT04524871|Growth Inhibitors|growth inhibitors|mesh-ancestor
110386910|NCT04524871|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110386911|NCT04524871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110386912|NCT04521478|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110386913|NCT04521478|Antidepressive Agents|antidepressive agents|mesh-ancestor
110386914|NCT04521478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110386915|NCT04521478|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110386916|NCT04521478|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110386917|NCT04521478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110386918|NCT04521478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110386919|NCT04516447|Paclitaxel|paclitaxel|mesh-list
110386920|NCT04516447|Carboplatin|carboplatin|mesh-list
110386921|NCT04516447|Gemcitabine|gemcitabine|mesh-list
110612093|NCT05817097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110612094|NCT05814354|Paclitaxel|paclitaxel|mesh-list
110612095|NCT05814354|Gemcitabine|gemcitabine|mesh-list
110612096|NCT05814354|Capecitabine|capecitabine|mesh-list
110612097|NCT05814354|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110612098|NCT05814354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110612099|NCT05814354|Tubulin Modulators|tubulin modulators|mesh-ancestor
110612100|NCT05814354|Antimitotic Agents|antimitotic agents|mesh-ancestor
110612101|NCT05814354|Mitosis Modulators|mitosis modulators|mesh-ancestor
110612102|NCT05814354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110612103|NCT05814354|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110612104|NCT05814354|Antimetabolites|antimetabolites|mesh-ancestor
110612106|NCT05794659|Carboplatin|carboplatin|mesh-list
110612107|NCT05794659|Molgramostim|molgramostim|mesh-list
110612108|NCT05794659|Sargramostim|sargramostim|mesh-list
110612109|NCT05794659|Immunologic Factors|immunologic factors|mesh-ancestor
110612110|NCT05794659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110612111|NCT05794659|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110612112|NCT05794659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110612113|NCT05794659|Tubulin Modulators|tubulin modulators|mesh-ancestor
110612114|NCT05794659|Antimitotic Agents|antimitotic agents|mesh-ancestor
110612115|NCT05794659|Mitosis Modulators|mitosis modulators|mesh-ancestor
110612116|NCT05794659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110612117|NCT05791565|Norflurane|norflurane|mesh-list
110612118|NCT05791565|Albuterol|albuterol|mesh-list
110612119|NCT05791565|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110612120|NCT05791565|Autonomic Agents|autonomic agents|mesh-ancestor
110612121|NCT05791565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110612122|NCT05791565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110612123|NCT05791565|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110612124|NCT05791565|Respiratory System Agents|respiratory system agents|mesh-ancestor
110612125|NCT05791565|Tocolytic Agents|tocolytic agents|mesh-ancestor
110612126|NCT05791565|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110612127|NCT05791565|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110612128|NCT05791565|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110612129|NCT05791565|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110612130|NCT05791565|Adrenergic Agents|adrenergic agents|mesh-ancestor
110612131|NCT05791565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110152894|NCT00000687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110612132|NCT05791565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110612133|NCT05791565|Anesthetics|anesthetics|mesh-ancestor
110386943|NCT04513717|Leuprolide|leuprolide|mesh-list
110612134|NCT05791565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110612136|NCT05771584|Immunologic Factors|immunologic factors|mesh-ancestor
110612137|NCT05771584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110612138|NCT05761041|Listerine|listerine|mesh-list
110612139|NCT05761041|Fluorides|fluorides|mesh-list
110612140|NCT05761041|Sodium Fluoride|sodium fluoride|mesh-list
110612141|NCT05761041|Fluorides, Topical|fluorides, topical|mesh-list
110612142|NCT05761041|Cariostatic Agents|cariostatic agents|mesh-ancestor
110612143|NCT05761041|Protective Agents|protective agents|mesh-ancestor
110612144|NCT05761041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110612145|NCT05761041|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110612146|NCT05761041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110612147|NCT05753436|Curcumin|curcumin|mesh-list
110612148|NCT05753436|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110612149|NCT05753436|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110612150|NCT05753436|Analgesics|analgesics|mesh-ancestor
110612151|NCT05753436|Sensory System Agents|sensory system agents|mesh-ancestor
110612152|NCT05753436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110612153|NCT05753436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110612154|NCT05753436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110612155|NCT05753436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110612156|NCT05753436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110612157|NCT05753436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110612158|NCT05753436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110612159|NCT05750966|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110612160|NCT05750966|Ciprofloxacin|ciprofloxacin|mesh-list
110612161|NCT05750966|Gentamicins|gentamicins|mesh-list
110612162|NCT05750966|Ceftriaxone|ceftriaxone|mesh-list
110612163|NCT05750966|Cefuroxime|cefuroxime|mesh-list
110612164|NCT05750966|Cefuroxime axetil|cefuroxime axetil|mesh-list
110612165|NCT05750966|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
110612166|NCT05750966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110612167|NCT05750966|Antitubercular Agents|antitubercular agents|mesh-ancestor
110612168|NCT05750966|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110612169|NCT05750966|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110612170|NCT05750966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110612171|NCT05750966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110612172|NCT05750966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110612173|NCT05750966|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110612174|NCT05750966|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110612175|NCT05750966|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110612176|NCT05679921|Pembrolizumab|pembrolizumab|mesh-list
110612177|NCT05679921|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110612178|NCT05679921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110612179|NCT05679921|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110612180|NCT05679921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110612181|NCT05660746|Infliximab|infliximab|mesh-list
110612182|NCT05660746|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110612183|NCT05660746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110386967|NCT04505254|Obinutuzumab|obinutuzumab|mesh-list
110612184|NCT05660746|Dermatologic Agents|dermatologic agents|mesh-ancestor
110612185|NCT05660746|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110612186|NCT05660746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110612187|NCT05658380|Atropine|atropine|mesh-list
110612188|NCT05658380|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110612189|NCT05658380|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110612190|NCT05658380|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110612191|NCT05658380|Autonomic Agents|autonomic agents|mesh-ancestor
110612192|NCT05658380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110612193|NCT05658380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110612194|NCT05658380|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110612195|NCT05658380|Respiratory System Agents|respiratory system agents|mesh-ancestor
110612196|NCT05658380|Mydriatics|mydriatics|mesh-ancestor
110612197|NCT05658380|Parasympatholytics|parasympatholytics|mesh-ancestor
110612198|NCT05658380|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110612199|NCT05658380|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110612200|NCT05658380|Cholinergic Agents|cholinergic agents|mesh-ancestor
110612201|NCT05658380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110612202|NCT05658380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110612203|NCT05551104|Labetalol|labetalol|mesh-list
110612204|NCT05551104|Nifedipine|nifedipine|mesh-list
110152935|NCT00000708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110612205|NCT05551104|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110612206|NCT05551104|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110612207|NCT05551104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110612208|NCT05551104|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110612209|NCT05551104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110612210|NCT05551104|Vasodilator Agents|vasodilator agents|mesh-ancestor
110612211|NCT05551104|Tocolytic Agents|tocolytic agents|mesh-ancestor
110612212|NCT05551104|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110612213|NCT05551104|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110612214|NCT05551104|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110612215|NCT05551104|Adrenergic Agents|adrenergic agents|mesh-ancestor
110612216|NCT05551104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110612217|NCT05551104|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110612218|NCT05551104|Sympathomimetics|sympathomimetics|mesh-ancestor
110612219|NCT05551104|Autonomic Agents|autonomic agents|mesh-ancestor
110612220|NCT05551104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110612221|NCT05551104|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110612222|NCT05551104|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110612223|NCT05539872|Insulin|insulin|mesh-list
110612224|NCT05539872|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110612225|NCT05539872|Insulin Aspart|insulin aspart|mesh-list
110612226|NCT05539872|Insulin, Long-Acting|insulin, long-acting|mesh-list
110612227|NCT05539872|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
110612228|NCT05539872|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110612229|NCT05539872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110612230|NCT05527418|Dasatinib|dasatinib|mesh-list
110612231|NCT05527418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110612232|NCT05527418|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110612233|NCT05527418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110612234|NCT05527418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110612235|NCT05512481|Temozolomide|temozolomide|mesh-list
110612236|NCT05512481|Apatinib|apatinib|mesh-list
110612237|NCT05512481|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110612238|NCT05512481|Alkylating Agents|alkylating agents|mesh-ancestor
110612239|NCT05512481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110612240|NCT05512481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110612241|NCT05512481|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110612242|NCT05512481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110612243|NCT05494762|Tislelizumab|tislelizumab|mesh-list
110612244|NCT05494762|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110612245|NCT05494762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110612246|NCT05473273|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110612247|NCT05473273|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110612249|NCT05473273|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110612250|NCT05473273|Progesterone|progesterone|mesh-list
110612251|NCT05473273|Estrogens|estrogens|mesh-ancestor
110612252|NCT05473273|Hormones|hormones|mesh-ancestor
110612253|NCT05473273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110612254|NCT05473273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110612255|NCT05473273|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110612256|NCT05473273|Contraceptive Agents|contraceptive agents|mesh-ancestor
110612257|NCT05473273|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110612258|NCT05473273|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110612259|NCT05473273|Progestins|progestins|mesh-ancestor
110612260|NCT05464680|Dimercaprol|dimercaprol|mesh-list
110612261|NCT05464680|Chelating Agents|chelating agents|mesh-ancestor
110612262|NCT05464680|Sequestering Agents|sequestering agents|mesh-ancestor
110612263|NCT05464680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110612264|NCT05389813|Pregabalin|pregabalin|mesh-list
110612265|NCT05389813|Oxycodone|oxycodone|mesh-list
110612266|NCT05389813|Analgesics|analgesics|mesh-ancestor
110612267|NCT05389813|Sensory System Agents|sensory system agents|mesh-ancestor
110612268|NCT05389813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110612269|NCT05389813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110612270|NCT05389813|Anticonvulsants|anticonvulsants|mesh-ancestor
110612271|NCT05389813|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110612272|NCT05389813|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110612273|NCT05389813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110612274|NCT05389813|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110612275|NCT05389813|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110612276|NCT05389813|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110612277|NCT05389813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110612278|NCT05389813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110612279|NCT05389813|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110612281|NCT05387811|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
110612283|NCT05387811|Natriuretic Agents|natriuretic agents|mesh-ancestor
110612284|NCT05387811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110612285|NCT05341167|Phenylephrine|phenylephrine|mesh-list
110612286|NCT05341167|Oxymetazoline|oxymetazoline|mesh-list
110612287|NCT05341167|Norepinephrine|norepinephrine|mesh-list
110612288|NCT05341167|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110612289|NCT05341167|Mydriatics|mydriatics|mesh-ancestor
110612290|NCT05341167|Autonomic Agents|autonomic agents|mesh-ancestor
110612291|NCT05341167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110612292|NCT05341167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110612293|NCT05341167|Sympathomimetics|sympathomimetics|mesh-ancestor
110612294|NCT05341167|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110612295|NCT05341167|Nasal Decongestants|nasal decongestants|mesh-ancestor
110612296|NCT05341167|Respiratory System Agents|respiratory system agents|mesh-ancestor
110612297|NCT05341167|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110612298|NCT05341167|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110612299|NCT05341167|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110612300|NCT05341167|Adrenergic Agents|adrenergic agents|mesh-ancestor
110612301|NCT05341167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110612302|NCT05341167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110612303|NCT05341167|Protective Agents|protective agents|mesh-ancestor
110612304|NCT05308979|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110612305|NCT05308979|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110612306|NCT05308979|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110612307|NCT05308979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110612308|NCT05308979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110612309|NCT05308979|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110612310|NCT05308979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110612311|NCT05308979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110612312|NCT05308979|Cholinergic Agents|cholinergic agents|mesh-ancestor
110612313|NCT05308979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110612314|NCT05293132|Coenzyme Q10|coenzyme q10|mesh-list
110612315|NCT05293132|Ubiquinone|ubiquinone|mesh-list
110612316|NCT05293132|Montelukast|montelukast|mesh-list
110612317|NCT05293132|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110612318|NCT05293132|Respiratory System Agents|respiratory system agents|mesh-ancestor
110612319|NCT05293132|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110612320|NCT05293132|Hormone Antagonists|hormone antagonists|mesh-ancestor
110612321|NCT05293132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110612322|NCT05293132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110612323|NCT05293132|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110612324|NCT05293132|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110612325|NCT05293132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110612326|NCT05293132|Vitamins|vitamins|mesh-ancestor
110612327|NCT05293132|Micronutrients|micronutrients|mesh-ancestor
110612328|NCT05288361|Acetylcholine|acetylcholine|mesh-list
110612329|NCT05288361|Vasodilator Agents|vasodilator agents|mesh-ancestor
110612330|NCT05288361|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110612331|NCT05288361|Cholinergic Agents|cholinergic agents|mesh-ancestor
110612332|NCT05288361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110612333|NCT05288361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110612334|NCT05288361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110612335|NCT05257590|Nivolumab|nivolumab|mesh-list
110612336|NCT05257590|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110612337|NCT05257590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110612338|NCT05257590|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110612339|NCT05257590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110612340|NCT05239169|Capecitabine|capecitabine|mesh-list
110612341|NCT05239169|Durvalumab|durvalumab|mesh-list
110612342|NCT05239169|Tremelimumab|tremelimumab|mesh-list
110283815|NCT00203372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110612343|NCT05239169|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110612344|NCT05239169|Antimetabolites|antimetabolites|mesh-ancestor
110612345|NCT05239169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110612346|NCT05239169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110387088|NCT04408625|Immunologic Factors|immunologic factors|mesh-ancestor
110612347|NCT05239169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110612348|NCT05231980|Thioctic Acid|thioctic acid|mesh-list
110612349|NCT05231980|Pentoxifylline|pentoxifylline|mesh-list
110612350|NCT05231980|Clomiphene|clomiphene|mesh-list
110612351|NCT05231980|Enclomiphene|enclomiphene|mesh-list
110612352|NCT05231980|Zuclomiphene|zuclomiphene|mesh-list
110612353|NCT05231980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110612354|NCT05231980|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110612355|NCT05231980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110612356|NCT05231980|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110612357|NCT05231980|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110612358|NCT05231980|Protective Agents|protective agents|mesh-ancestor
110612359|NCT05231980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110612360|NCT05231980|Vasodilator Agents|vasodilator agents|mesh-ancestor
110612361|NCT05231980|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110612362|NCT05231980|Antioxidants|antioxidants|mesh-ancestor
110612363|NCT05231980|Vitamin B Complex|vitamin b complex|mesh-ancestor
110612364|NCT05231980|Vitamins|vitamins|mesh-ancestor
110612365|NCT05231980|Micronutrients|micronutrients|mesh-ancestor
110612366|NCT05231980|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110612367|NCT05231980|Hormone Antagonists|hormone antagonists|mesh-ancestor
110612368|NCT05231980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110612369|NCT05231980|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110612370|NCT05231980|Fertility Agents|fertility agents|mesh-ancestor
110612371|NCT05231980|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110612372|NCT05231980|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110612373|NCT05231980|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110612374|NCT05215158|Dexmedetomidine|dexmedetomidine|mesh-list
110612375|NCT05215158|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110612376|NCT05215158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110612377|NCT05215158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110612378|NCT05215158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110612379|NCT05215158|Analgesics|analgesics|mesh-ancestor
110612380|NCT05215158|Sensory System Agents|sensory system agents|mesh-ancestor
110612381|NCT05215158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110612382|NCT05215158|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110612383|NCT05215158|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110612384|NCT05215158|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110612385|NCT05215158|Adrenergic Agents|adrenergic agents|mesh-ancestor
110612386|NCT05215158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110612387|NCT05215158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110612388|NCT05171062|Pembrolizumab|pembrolizumab|mesh-list
110612389|NCT05171062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110612390|NCT05171062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110612391|NCT05171062|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110612392|NCT05171062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110612393|NCT05169554|Amoxicillin|amoxicillin|mesh-list
110612394|NCT05169554|Clarithromycin|clarithromycin|mesh-list
110612395|NCT05169554|Rifampin|rifampin|mesh-list
110612396|NCT05169554|Clavulanic Acid|clavulanic acid|mesh-list
110612397|NCT05169554|Clavulanic Acids|clavulanic acids|mesh-list
110612398|NCT05169554|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
110612399|NCT05169554|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110612400|NCT05169554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110612401|NCT05169554|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110612402|NCT05169554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110612403|NCT05169554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110612404|NCT05169554|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110612405|NCT05169554|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110612406|NCT05169554|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110612407|NCT05169554|Antitubercular Agents|antitubercular agents|mesh-ancestor
110612408|NCT05169554|Leprostatic Agents|leprostatic agents|mesh-ancestor
110612409|NCT05169554|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110612410|NCT05169554|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110612411|NCT05169554|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110612412|NCT05169554|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110612413|NCT05169554|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110153012|NCT00000741|Hormones|hormones|mesh-ancestor
110612414|NCT05169554|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110612415|NCT05169554|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110612416|NCT05169554|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110612417|NCT05148962|Vaccines|vaccines|mesh-list
110612418|NCT05148962|Immunologic Factors|immunologic factors|mesh-ancestor
110612419|NCT05148962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110612420|NCT05140941|Sofosbuvir|sofosbuvir|mesh-list
110612421|NCT05140941|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
110612422|NCT05140941|Velpatasvir|velpatasvir|mesh-list
110612423|NCT05140941|Antiviral Agents|antiviral agents|mesh-ancestor
110612424|NCT05140941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110612425|NCT05068440|Zanubrutinib|zanubrutinib|mesh-list
110612426|NCT05068440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110612427|NCT05068440|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110612428|NCT05068440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110387164|NCT04356729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110387165|NCT04356729|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110387166|NCT04356729|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110387167|NCT04356729|Growth Substances|growth substances|mesh-ancestor
110387168|NCT04356729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110387169|NCT04356729|Growth Inhibitors|growth inhibitors|mesh-ancestor
110612429|NCT05068440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110612431|NCT05050305|Pomalidomide|pomalidomide|mesh-list
110612432|NCT05050305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110612433|NCT05050305|Antiemetics|antiemetics|mesh-ancestor
110612434|NCT05050305|Autonomic Agents|autonomic agents|mesh-ancestor
110612435|NCT05050305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110612436|NCT05050305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110612437|NCT05050305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110612438|NCT05050305|Glucocorticoids|glucocorticoids|mesh-ancestor
110612439|NCT05050305|Hormones|hormones|mesh-ancestor
110612440|NCT05050305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110612441|NCT05050305|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110612442|NCT05050305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110612443|NCT05050305|Immunologic Factors|immunologic factors|mesh-ancestor
110612444|NCT05050305|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110612445|NCT05050305|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110612446|NCT05050305|Growth Substances|growth substances|mesh-ancestor
110612447|NCT05050305|Growth Inhibitors|growth inhibitors|mesh-ancestor
110612448|NCT05020327|Amoxicillin|amoxicillin|mesh-list
110612449|NCT05020327|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110612450|NCT05020327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110612459|NCT04981951|Dexmedetomidine|dexmedetomidine|mesh-list
110612460|NCT04981951|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110612461|NCT04981951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110612462|NCT04981951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110612463|NCT04981951|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110612464|NCT04981951|Analgesics|analgesics|mesh-ancestor
110612465|NCT04981951|Sensory System Agents|sensory system agents|mesh-ancestor
110387188|NCT04329650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110387189|NCT04329650|Antiemetics|antiemetics|mesh-ancestor
110387190|NCT04329650|Autonomic Agents|autonomic agents|mesh-ancestor
110387191|NCT04329650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110387192|NCT04329650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110387193|NCT04329650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110387194|NCT04329650|Glucocorticoids|glucocorticoids|mesh-ancestor
110612467|NCT04981951|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110612468|NCT04981951|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110612469|NCT04981951|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110612470|NCT04981951|Adrenergic Agents|adrenergic agents|mesh-ancestor
110612471|NCT04981951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110612472|NCT04981951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110612473|NCT04947527|Fluorides|fluorides|mesh-list
110612474|NCT04947527|Fluorides, Topical|fluorides, topical|mesh-list
110612475|NCT04947527|Cariostatic Agents|cariostatic agents|mesh-ancestor
110612476|NCT04947527|Protective Agents|protective agents|mesh-ancestor
110612477|NCT04947527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110612478|NCT04939935|Metformin|metformin|mesh-list
110612479|NCT04939935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110612480|NCT04939935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110612482|NCT04910815|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110612483|NCT04910815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110612484|NCT04910815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110612485|NCT04907214|Empagliflozin|empagliflozin|mesh-list
110612486|NCT04907214|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110612487|NCT04907214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110612488|NCT04907214|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110612489|NCT04907214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110612490|NCT04907032|Mirabegron|mirabegron|mesh-list
110612491|NCT04907032|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
110612492|NCT04907032|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110612493|NCT04907032|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110612494|NCT04907032|Adrenergic Agents|adrenergic agents|mesh-ancestor
110612495|NCT04907032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110612496|NCT04907032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110612497|NCT04907032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110612498|NCT04907032|Urological Agents|urological agents|mesh-ancestor
110612499|NCT04891289|Dexamethasone|dexamethasone|mesh-list
110612500|NCT04891289|Gemcitabine|gemcitabine|mesh-list
110612501|NCT04891289|Oxaliplatin|oxaliplatin|mesh-list
110612502|NCT04891289|Floxuridine|floxuridine|mesh-list
110612503|NCT04891289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110612504|NCT04891289|Antiemetics|antiemetics|mesh-ancestor
110612505|NCT04891289|Autonomic Agents|autonomic agents|mesh-ancestor
110612506|NCT04891289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110612507|NCT04891289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110612508|NCT04891289|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110612509|NCT04891289|Glucocorticoids|glucocorticoids|mesh-ancestor
110612510|NCT04891289|Hormones|hormones|mesh-ancestor
110612511|NCT04891289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110612512|NCT04891289|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110612513|NCT04891289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110612514|NCT04891289|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110612515|NCT04891289|Antimetabolites|antimetabolites|mesh-ancestor
110612516|NCT04891289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110612517|NCT04879368|Trifluridine|trifluridine|mesh-list
110612518|NCT04879368|Paclitaxel|paclitaxel|mesh-list
110612519|NCT04879368|Docetaxel|docetaxel|mesh-list
110612520|NCT04879368|Nivolumab|nivolumab|mesh-list
110612521|NCT04879368|Irinotecan|irinotecan|mesh-list
110612522|NCT04879368|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110612523|NCT04879368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110612524|NCT04879368|Tubulin Modulators|tubulin modulators|mesh-ancestor
110612525|NCT04879368|Antimitotic Agents|antimitotic agents|mesh-ancestor
110612526|NCT04879368|Mitosis Modulators|mitosis modulators|mesh-ancestor
110612527|NCT04879368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110612528|NCT04879368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110612529|NCT04879368|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110612530|NCT04879368|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110612531|NCT04879368|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110612532|NCT04879368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110612533|NCT04879368|Antimetabolites|antimetabolites|mesh-ancestor
110612534|NCT04879368|Antiviral Agents|antiviral agents|mesh-ancestor
110612535|NCT04879368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110612536|NCT04861051|Ketamine|ketamine|mesh-list
110612537|NCT04861051|Analgesics|analgesics|mesh-ancestor
110612538|NCT04861051|Sensory System Agents|sensory system agents|mesh-ancestor
110612539|NCT04861051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110612540|NCT04861051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110612541|NCT04861051|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110612542|NCT04861051|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110612543|NCT04861051|Anesthetics, General|anesthetics, general|mesh-ancestor
110612544|NCT04861051|Anesthetics|anesthetics|mesh-ancestor
110612545|NCT04861051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110612546|NCT04861051|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110612547|NCT04861051|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110612549|NCT04861051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110612550|NCT04834375|Dexamethasone|dexamethasone|mesh-list
110612551|NCT04834375|Dexamethasone acetate|dexamethasone acetate|mesh-list
110612552|NCT04834375|BB 1101|bb 1101|mesh-list
110612553|NCT04834375|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110612554|NCT04834375|Antiemetics|antiemetics|mesh-ancestor
110612555|NCT04834375|Autonomic Agents|autonomic agents|mesh-ancestor
110612556|NCT04834375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110612557|NCT04834375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110612558|NCT04834375|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110612559|NCT04834375|Glucocorticoids|glucocorticoids|mesh-ancestor
110612560|NCT04834375|Hormones|hormones|mesh-ancestor
110612561|NCT04834375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110612562|NCT04834375|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110612563|NCT04834375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110612564|NCT04834375|Protease Inhibitors|protease inhibitors|mesh-ancestor
110612565|NCT04834375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110612566|NCT04834375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110612567|NCT04788745|Trimetazidine|trimetazidine|mesh-list
110612568|NCT04788745|Vasodilator Agents|vasodilator agents|mesh-ancestor
110612569|NCT04712903|Carboplatin|carboplatin|mesh-list
110612570|NCT04712903|Etoposide|etoposide|mesh-list
110612571|NCT04712903|Durvalumab|durvalumab|mesh-list
110612572|NCT04712903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110612573|NCT04712903|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110612574|NCT04712903|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110612575|NCT04712903|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110612576|NCT04712903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110612577|NCT04712903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110612578|NCT04712903|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110612579|NCT04710927|Fluorides|fluorides|mesh-list
110612580|NCT04710927|Cariostatic Agents|cariostatic agents|mesh-ancestor
110612581|NCT04710927|Protective Agents|protective agents|mesh-ancestor
110612582|NCT04710927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110612583|NCT04694976|Vitamin D|vitamin d|mesh-list
110612584|NCT04694976|Vitamins|vitamins|mesh-ancestor
110612585|NCT04694976|Micronutrients|micronutrients|mesh-ancestor
110387314|NCT04220684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110387315|NCT04220684|Antiviral Agents|antiviral agents|mesh-ancestor
110387316|NCT04220684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110387338|NCT04215978|Tislelizumab|tislelizumab|mesh-list
110387339|NCT04215978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110612586|NCT04694976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110612587|NCT04694976|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110612589|NCT04683627|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110612590|NCT04683627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110612591|NCT04683627|Analgesics|analgesics|mesh-ancestor
110612592|NCT04683627|Sensory System Agents|sensory system agents|mesh-ancestor
110612593|NCT04683627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110612594|NCT04683627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110612595|NCT04683627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110612596|NCT04683627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110612597|NCT04683627|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110612598|NCT04683627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110612599|NCT04683627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110612600|NCT04657666|Nabiximols|nabiximols|mesh-list
110612601|NCT04657666|Analgesics|analgesics|mesh-ancestor
110612602|NCT04657666|Sensory System Agents|sensory system agents|mesh-ancestor
110612603|NCT04657666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110612604|NCT04657666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110612605|NCT04646967|Acetaminophen|acetaminophen|mesh-list
110612606|NCT04646967|Ibuprofen|ibuprofen|mesh-list
110612607|NCT04646967|Ketorolac|ketorolac|mesh-list
110612608|NCT04646967|Bupivacaine|bupivacaine|mesh-list
110612609|NCT04646967|Sevoflurane|sevoflurane|mesh-list
110612610|NCT04646967|Anesthetics, Local|anesthetics, local|mesh-ancestor
110612611|NCT04646967|Anesthetics|anesthetics|mesh-ancestor
110612612|NCT04646967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110612613|NCT04646967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110612614|NCT04646967|Sensory System Agents|sensory system agents|mesh-ancestor
110612615|NCT04646967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110612616|NCT04646967|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110612617|NCT04646967|Analgesics|analgesics|mesh-ancestor
110612618|NCT04646967|Antipyretics|antipyretics|mesh-ancestor
110612619|NCT04646967|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110612620|NCT04646967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110612621|NCT04646967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110612622|NCT04646967|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110612623|NCT04646967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110612624|NCT04646967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110612625|NCT04646967|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110612626|NCT04646967|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110612627|NCT04646967|Anesthetics, General|anesthetics, general|mesh-ancestor
110612628|NCT04563754|Proflavine|proflavine|mesh-list
110387340|NCT04215978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110387349|NCT04204798|Dexmedetomidine|dexmedetomidine|mesh-list
110387350|NCT04204798|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110387351|NCT04204798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110387352|NCT04204798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110387353|NCT04204798|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110387354|NCT04204798|Analgesics|analgesics|mesh-ancestor
110387355|NCT04204798|Sensory System Agents|sensory system agents|mesh-ancestor
110387356|NCT04204798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110387357|NCT04204798|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110387358|NCT04204798|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110612638|NCT04551521|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110612639|NCT04551521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110612640|NCT04551521|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110612641|NCT04551521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110612642|NCT04551521|Immunologic Factors|immunologic factors|mesh-ancestor
110612643|NCT04551521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110612644|NCT04551521|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110612645|NCT04551521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110612646|NCT04551521|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
110612647|NCT04539249|Magnesium Sulfate|magnesium sulfate|mesh-list
110612648|NCT04539249|Pentazocine|pentazocine|mesh-list
110612649|NCT04539249|Analgesics|analgesics|mesh-ancestor
110612650|NCT04539249|Sensory System Agents|sensory system agents|mesh-ancestor
110612651|NCT04539249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110612652|NCT04539249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110612653|NCT04539249|Anesthetics|anesthetics|mesh-ancestor
110612654|NCT04539249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110612655|NCT04539249|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110612656|NCT04539249|Anticonvulsants|anticonvulsants|mesh-ancestor
110612657|NCT04539249|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110612658|NCT04539249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110612659|NCT04539249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110612660|NCT04539249|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110612661|NCT04539249|Tocolytic Agents|tocolytic agents|mesh-ancestor
110612662|NCT04539249|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110612663|NCT04539249|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110612664|NCT04539249|Narcotics|narcotics|mesh-ancestor
110612665|NCT04539249|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110612666|NCT04539249|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110612674|NCT04492891|Cyclosporine|cyclosporine|mesh-list
110612675|NCT04492891|Cyclosporins|cyclosporins|mesh-list
110612676|NCT04492891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110612677|NCT04492891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110612678|NCT04492891|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110612679|NCT04492891|Immunologic Factors|immunologic factors|mesh-ancestor
110387372|NCT04171843|Cyclophosphamide|cyclophosphamide|mesh-list
110387373|NCT04171843|Fludarabine|fludarabine|mesh-list
110387374|NCT04171843|Nirogacestat|nirogacestat|mesh-list
110283845|NCT00226551|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110612680|NCT04492891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110612681|NCT04492891|Antifungal Agents|antifungal agents|mesh-ancestor
110612682|NCT04492891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110612683|NCT04492891|Dermatologic Agents|dermatologic agents|mesh-ancestor
110612684|NCT04492891|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110612685|NCT04492891|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110612686|NCT04449198|Resveratrol|resveratrol|mesh-list
110612687|NCT04449198|Antioxidants|antioxidants|mesh-ancestor
110612688|NCT04449198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110612689|NCT04449198|Protective Agents|protective agents|mesh-ancestor
110612690|NCT04449198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110612691|NCT04449198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110612692|NCT04449198|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110612693|NCT04271189|Metformin|metformin|mesh-list
110612694|NCT04271189|Pioglitazone|pioglitazone|mesh-list
110612695|NCT04271189|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110612696|NCT04271189|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110612697|NCT04271189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110612698|NCT04271189|Incretins|incretins|mesh-ancestor
110612699|NCT04271189|Hormones|hormones|mesh-ancestor
110612700|NCT04271189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110612701|NCT04271189|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110612703|NCT04271189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110612704|NCT04271189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110612705|NCT04221945|Cisplatin|cisplatin|mesh-list
110612706|NCT04221945|Pembrolizumab|pembrolizumab|mesh-list
110612707|NCT04221945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110612708|NCT04221945|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110612709|NCT04221945|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110612710|NCT04221945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110612711|NCT04199325|Uric Acid|uric acid|mesh-list
110612712|NCT04199325|Antioxidants|antioxidants|mesh-ancestor
110387395|NCT04165993|Tubulin Modulators|tubulin modulators|mesh-ancestor
110387396|NCT04165993|Antimitotic Agents|antimitotic agents|mesh-ancestor
110387397|NCT04165993|Mitosis Modulators|mitosis modulators|mesh-ancestor
110387398|NCT04165993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110387407|NCT04148911|Paclitaxel|paclitaxel|mesh-list
110387408|NCT04148911|Atezolizumab|atezolizumab|mesh-list
110387409|NCT04148911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110387410|NCT04148911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110387411|NCT04148911|Tubulin Modulators|tubulin modulators|mesh-ancestor
110387412|NCT04148911|Antimitotic Agents|antimitotic agents|mesh-ancestor
110387413|NCT04148911|Mitosis Modulators|mitosis modulators|mesh-ancestor
110387414|NCT04148911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110387415|NCT04148911|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110387416|NCT04148911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110612713|NCT04199325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110612714|NCT04199325|Protective Agents|protective agents|mesh-ancestor
110612715|NCT04199325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110612716|NCT04189133|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
110612717|NCT04189133|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110612718|NCT04189133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110612719|NCT04166396|Resveratrol|resveratrol|mesh-list
110612720|NCT04166396|Antioxidants|antioxidants|mesh-ancestor
110612721|NCT04166396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110612722|NCT04166396|Protective Agents|protective agents|mesh-ancestor
110612723|NCT04166396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110612724|NCT04166396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110612725|NCT04166396|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110612726|NCT04160494|Atezolizumab|atezolizumab|mesh-list
110612727|NCT04160494|D2C7-(scdsFv)-PE38KDEL|d2c7-(scdsfv)-pe38kdel|mesh-list
110612728|NCT04160494|Immunoconjugates|immunoconjugates|mesh-list
110612729|NCT04160494|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110612730|NCT04160494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110612731|NCT04160494|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110612732|NCT04160494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110612733|NCT04160494|Immunologic Factors|immunologic factors|mesh-ancestor
110612734|NCT04160494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110612735|NCT04157725|Clomiphene|clomiphene|mesh-list
110612736|NCT04157725|Enclomiphene|enclomiphene|mesh-list
110612737|NCT04157725|Zuclomiphene|zuclomiphene|mesh-list
110612738|NCT04157725|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110612739|NCT04157725|Hormone Antagonists|hormone antagonists|mesh-ancestor
110612740|NCT04157725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110612741|NCT04157725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110612742|NCT04157725|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110612743|NCT04157725|Fertility Agents|fertility agents|mesh-ancestor
110612744|NCT04157725|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110612745|NCT04157725|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110612746|NCT04157725|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110612747|NCT04145518|Naproxen|naproxen|mesh-list
110612748|NCT04145518|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110612749|NCT04145518|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110612750|NCT04145518|Analgesics|analgesics|mesh-ancestor
110387440|NCT04111133|Adrenergic Agents|adrenergic agents|mesh-ancestor
110612751|NCT04145518|Sensory System Agents|sensory system agents|mesh-ancestor
110612752|NCT04145518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110612753|NCT04145518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110612754|NCT04145518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110612755|NCT04145518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110612756|NCT04145518|Gout Suppressants|gout suppressants|mesh-ancestor
110612757|NCT04145518|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110612758|NCT04145518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110612759|NCT04145518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110612760|NCT04140903|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110612761|NCT04140903|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
110612762|NCT04140903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110612763|NCT04140903|Antitubercular Agents|antitubercular agents|mesh-ancestor
110612765|NCT04101721|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110612766|NCT04101721|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110612767|NCT04101721|Growth Substances|growth substances|mesh-ancestor
110612768|NCT04101721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110612769|NCT04101721|Growth Inhibitors|growth inhibitors|mesh-ancestor
110612770|NCT04101721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110612771|NCT04055012|Metformin|metformin|mesh-list
110260090|NCT00145106|Minocycline|minocycline|mesh-list
110612772|NCT04055012|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110612773|NCT04055012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110612774|NCT04009668|Adalimumab|adalimumab|mesh-list
110612775|NCT04009668|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110612776|NCT04009668|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110612777|NCT04009668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110612778|NCT03968640|Coenzyme Q10|coenzyme q10|mesh-list
110612779|NCT03968640|Vitamins|vitamins|mesh-ancestor
110612780|NCT03968640|Micronutrients|micronutrients|mesh-ancestor
110612781|NCT03968640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110612782|NCT03948074|Dronabinol|dronabinol|mesh-list
110612783|NCT03948074|Cannabidiol|cannabidiol|mesh-list
110612784|NCT03948074|Anticonvulsants|anticonvulsants|mesh-ancestor
110612785|NCT03948074|Hallucinogens|hallucinogens|mesh-ancestor
110612786|NCT03948074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110612787|NCT03948074|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110612788|NCT03948074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110612789|NCT03948074|Analgesics|analgesics|mesh-ancestor
110612790|NCT03948074|Sensory System Agents|sensory system agents|mesh-ancestor
110612791|NCT03948074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110612792|NCT03948074|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
110612793|NCT03948074|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110612794|NCT03948074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110612795|NCT03948074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110612796|NCT03948074|Hormones|hormones|mesh-ancestor
110612797|NCT03948074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110612798|NCT03942328|Bevacizumab|bevacizumab|mesh-list
110612799|NCT03942328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110612800|NCT03942328|Atezolizumab|atezolizumab|mesh-list
110612801|NCT03942328|Vaccines|vaccines|mesh-list
110612802|NCT03942328|Antibodies|antibodies|mesh-list
110612803|NCT03942328|Immunoglobulins|immunoglobulins|mesh-list
110612804|NCT03942328|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110612805|NCT03942328|Immunoglobulin G|immunoglobulin g|mesh-list
110612806|NCT03942328|Endothelial Growth Factors|endothelial growth factors|mesh-list
110612807|NCT03942328|Immunologic Factors|immunologic factors|mesh-ancestor
110612808|NCT03942328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110612809|NCT03942328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110612810|NCT03942328|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110612811|NCT03942328|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110612813|NCT03942328|Growth Inhibitors|growth inhibitors|mesh-ancestor
110612814|NCT03942328|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110612815|NCT03942328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110612816|NCT03939104|Artesunate|artesunate|mesh-list
110612817|NCT03939104|Lumefantrine|lumefantrine|mesh-list
110612818|NCT03939104|Artemether|artemether|mesh-list
110612819|NCT03939104|Piperaquine|piperaquine|mesh-list
110612820|NCT03939104|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
110612821|NCT03939104|Amodiaquine|amodiaquine|mesh-list
110612822|NCT03939104|Mefloquine|mefloquine|mesh-list
110612823|NCT03939104|Antimalarials|antimalarials|mesh-ancestor
110612824|NCT03939104|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110612825|NCT03939104|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110612826|NCT03939104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110612827|NCT03939104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110612828|NCT03939104|Antiviral Agents|antiviral agents|mesh-ancestor
110612829|NCT03939104|Schistosomicides|schistosomicides|mesh-ancestor
110612830|NCT03939104|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110612831|NCT03939104|Anthelmintics|anthelmintics|mesh-ancestor
110612832|NCT03932318|Azacitidine|azacitidine|mesh-list
110612833|NCT03932318|Venetoclax|venetoclax|mesh-list
110612834|NCT03932318|Lintuzumab|lintuzumab|mesh-list
110612835|NCT03932318|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110612836|NCT03932318|Antimetabolites|antimetabolites|mesh-ancestor
110612837|NCT03932318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110612838|NCT03932318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110612839|NCT03932318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110612840|NCT03932318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110612841|NCT03923725|Artesunate|artesunate|mesh-list
110612842|NCT03923725|Lumefantrine|lumefantrine|mesh-list
110612843|NCT03923725|Artemether|artemether|mesh-list
110612844|NCT03923725|Piperaquine|piperaquine|mesh-list
110612845|NCT03923725|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
110612846|NCT03923725|Amodiaquine|amodiaquine|mesh-list
110612847|NCT03923725|Mefloquine|mefloquine|mesh-list
110612848|NCT03923725|Antimalarials|antimalarials|mesh-ancestor
110612849|NCT03923725|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110612850|NCT03923725|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110612851|NCT03923725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110612852|NCT03923725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110612853|NCT03923725|Antiviral Agents|antiviral agents|mesh-ancestor
110612854|NCT03923725|Schistosomicides|schistosomicides|mesh-ancestor
110612855|NCT03923725|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110612856|NCT03923725|Anthelmintics|anthelmintics|mesh-ancestor
110612858|NCT03864926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110612859|NCT03864926|Immunologic Factors|immunologic factors|mesh-ancestor
110612860|NCT03864926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110612861|NCT03864926|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110612862|NCT03864926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110612863|NCT03864926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110612864|NCT03836261|Venetoclax|venetoclax|mesh-list
110612865|NCT03836261|Obinutuzumab|obinutuzumab|mesh-list
110612866|NCT03836261|Acalabrutinib|acalabrutinib|mesh-list
110612867|NCT03836261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110612868|NCT03836261|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110612869|NCT03809533|Sofosbuvir|sofosbuvir|mesh-list
110612870|NCT03809533|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
110612871|NCT03809533|Velpatasvir|velpatasvir|mesh-list
110612872|NCT03809533|Antiviral Agents|antiviral agents|mesh-ancestor
110612873|NCT03809533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110612874|NCT03718234|Hydrocortisone|hydrocortisone|mesh-list
110612875|NCT03718234|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
110612876|NCT03718234|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
110612877|NCT03718234|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
110612878|NCT03718234|Glucocorticoids|glucocorticoids|mesh-list
110612879|NCT03718234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110612880|NCT03718234|Hormones|hormones|mesh-ancestor
110612881|NCT03718234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110612882|NCT03718234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110612883|NCT03643107|Prednisolone|prednisolone|mesh-list
110612884|NCT03643107|Irofulven|irofulven|mesh-list
110612885|NCT03643107|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110612886|NCT03643107|Glucocorticoids|glucocorticoids|mesh-ancestor
110612887|NCT03643107|Hormones|hormones|mesh-ancestor
110612888|NCT03643107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110612890|NCT03643107|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110387531|NCT04044690|Antibodies|antibodies|mesh-list
110612891|NCT03643107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110612892|NCT03643107|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110612893|NCT03643107|Alkylating Agents|alkylating agents|mesh-ancestor
110612894|NCT03643107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110612895|NCT03623243|Siponimod|siponimod|mesh-list
110612896|NCT03623243|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
110612897|NCT03623243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110612898|NCT03623243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110612899|NCT03623243|Immunologic Factors|immunologic factors|mesh-ancestor
110612900|NCT03623243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110612901|NCT03619707|Progesterone|progesterone|mesh-list
110612902|NCT03619707|Progestins|progestins|mesh-ancestor
110612903|NCT03619707|Hormones|hormones|mesh-ancestor
110612904|NCT03619707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110612905|NCT03619707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110612906|NCT03597568|Resveratrol|resveratrol|mesh-list
110612907|NCT03597568|Antioxidants|antioxidants|mesh-ancestor
110612908|NCT03597568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110612909|NCT03597568|Protective Agents|protective agents|mesh-ancestor
110612910|NCT03597568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110612911|NCT03597568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110612912|NCT03597568|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110612913|NCT03593408|Fentanyl|fentanyl|mesh-list
110612914|NCT03593408|Midazolam|midazolam|mesh-list
110612915|NCT03593408|Dexmedetomidine|dexmedetomidine|mesh-list
110612916|NCT03593408|Morphine|morphine|mesh-list
110612917|NCT03593408|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110612918|NCT03593408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110612919|NCT03593408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110612920|NCT03593408|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110612921|NCT03593408|Analgesics|analgesics|mesh-ancestor
110612922|NCT03593408|Sensory System Agents|sensory system agents|mesh-ancestor
110612923|NCT03593408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110612924|NCT03593408|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110612925|NCT03593408|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110612926|NCT03593408|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110612928|NCT03593408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110612929|NCT03593408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110612930|NCT03593408|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110612931|NCT03593408|Narcotics|narcotics|mesh-ancestor
110612932|NCT03593408|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110612933|NCT03593408|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110612934|NCT03593408|Anesthetics, General|anesthetics, general|mesh-ancestor
110612935|NCT03593408|Anesthetics|anesthetics|mesh-ancestor
110612936|NCT03593408|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110612937|NCT03593408|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110612938|NCT03593408|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110612939|NCT03593408|GABA Modulators|gaba modulators|mesh-ancestor
110612940|NCT03593408|GABA Agents|gaba agents|mesh-ancestor
110612950|NCT03572582|Nivolumab|nivolumab|mesh-list
110612951|NCT03572582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110612952|NCT03572582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110612953|NCT03572582|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110612954|NCT03572582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110612955|NCT03562832|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
110612956|NCT03562832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110612957|NCT03562832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110612958|NCT03562832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110612959|NCT03432871|Niacinamide|niacinamide|mesh-list
110612960|NCT03432871|Niacin|niacin|mesh-list
110612961|NCT03432871|Nicotinic Acids|nicotinic acids|mesh-list
110612962|NCT03432871|Vitamin B Complex|vitamin b complex|mesh-ancestor
110612963|NCT03432871|Vitamins|vitamins|mesh-ancestor
110612964|NCT03432871|Micronutrients|micronutrients|mesh-ancestor
110612965|NCT03432871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110612966|NCT03432871|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110612967|NCT03432871|Antimetabolites|antimetabolites|mesh-ancestor
110612968|NCT03432871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110612969|NCT03432871|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110612970|NCT03432871|Vasodilator Agents|vasodilator agents|mesh-ancestor
110612971|NCT03399318|Acetaminophen|acetaminophen|mesh-list
110612972|NCT03399318|Ibuprofen|ibuprofen|mesh-list
110612973|NCT03399318|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110612974|NCT03399318|Analgesics|analgesics|mesh-ancestor
110387598|NCT04000529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110387599|NCT03994874|Furosemide|furosemide|mesh-list
110387600|NCT03994874|Dialysis Solutions|dialysis solutions|mesh-list
110387601|NCT03994874|Diuretics|diuretics|mesh-list
110387602|NCT03994874|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
110387603|NCT03994874|Natriuretic Agents|natriuretic agents|mesh-ancestor
110387604|NCT03994874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110387605|NCT03994874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110387607|NCT03994874|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110612976|NCT03399318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110612977|NCT03399318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110612978|NCT03399318|Antipyretics|antipyretics|mesh-ancestor
110153064|NCT04020172|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110612979|NCT03399318|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110612980|NCT03399318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110612981|NCT03399318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110612982|NCT03399318|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110612983|NCT03399318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110612984|NCT03399318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110612985|NCT03389139|Anesthetics|anesthetics|mesh-list
110612986|NCT03389139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110612987|NCT03389139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110612988|NCT03382938|Dexmedetomidine|dexmedetomidine|mesh-list
110612989|NCT03382938|Ropivacaine|ropivacaine|mesh-list
110612990|NCT03382938|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110612991|NCT03382938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110612992|NCT03382938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110612993|NCT03382938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110612994|NCT03382938|Analgesics|analgesics|mesh-ancestor
110612995|NCT03382938|Sensory System Agents|sensory system agents|mesh-ancestor
110612996|NCT03382938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110612997|NCT03382938|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110612998|NCT03382938|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110612999|NCT03382938|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110613000|NCT03382938|Adrenergic Agents|adrenergic agents|mesh-ancestor
110613001|NCT03382938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110613002|NCT03382938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110613003|NCT03382938|Anesthetics, Local|anesthetics, local|mesh-ancestor
110613004|NCT03382938|Anesthetics|anesthetics|mesh-ancestor
110613005|NCT03380468|Pemetrexed|pemetrexed|mesh-list
110613006|NCT03380468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110387648|NCT03943901|Prednisone|prednisone|mesh-list
110613008|NCT03380468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110613009|NCT03380468|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110613010|NCT03380468|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110613011|NCT03279952|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
110613012|NCT03279952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110613013|NCT03258853|Pancrelipase|pancrelipase|mesh-list
110613014|NCT03258853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110613015|NCT03246347|Docetaxel|docetaxel|mesh-list
110613016|NCT03246347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110613017|NCT03246347|Tubulin Modulators|tubulin modulators|mesh-ancestor
110613018|NCT03246347|Antimitotic Agents|antimitotic agents|mesh-ancestor
110613019|NCT03246347|Mitosis Modulators|mitosis modulators|mesh-ancestor
110613020|NCT03246347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110613021|NCT03236155|Analgesics, Opioid|analgesics, opioid|mesh-list
110613022|NCT03236155|Narcotics|narcotics|mesh-ancestor
110613023|NCT03236155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110613024|NCT03236155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110613025|NCT03236155|Analgesics|analgesics|mesh-ancestor
110613026|NCT03236155|Sensory System Agents|sensory system agents|mesh-ancestor
110613027|NCT03236155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110613028|NCT03177122|Inositol|inositol|mesh-list
110613029|NCT03177122|Vitamin B Complex|vitamin b complex|mesh-ancestor
110613030|NCT03177122|Vitamins|vitamins|mesh-ancestor
110613031|NCT03177122|Micronutrients|micronutrients|mesh-ancestor
110283858|NCT00208533|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110613032|NCT03177122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110613033|NCT03169166|Triptorelin Pamoate|triptorelin pamoate|mesh-list
110613034|NCT03169166|Luteolytic Agents|luteolytic agents|mesh-ancestor
110613035|NCT03169166|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110613036|NCT03169166|Contraceptive Agents|contraceptive agents|mesh-ancestor
110613037|NCT03169166|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110613038|NCT03169166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110613039|NCT03169166|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110613040|NCT03169166|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110613041|NCT03169166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110613043|NCT03165994|Carboplatin|carboplatin|mesh-list
110613044|NCT03165994|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110613045|NCT03165994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110613046|NCT03165994|Tubulin Modulators|tubulin modulators|mesh-ancestor
110613047|NCT03165994|Antimitotic Agents|antimitotic agents|mesh-ancestor
110153070|NCT00000747|Nevirapine|nevirapine|mesh-list
110613048|NCT03165994|Mitosis Modulators|mitosis modulators|mesh-ancestor
110613049|NCT03165994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110613050|NCT03089606|Pembrolizumab|pembrolizumab|mesh-list
110613051|NCT03089606|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110613052|NCT03089606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110613053|NCT03089606|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110613054|NCT03089606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110613055|NCT03032172|Risdiplam|risdiplam|mesh-list
110613056|NCT03032172|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110613057|NCT03032172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110613058|NCT03032172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110613059|NCT03006848|Avelumab|avelumab|mesh-list
110613060|NCT03006848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110613061|NCT03006848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110613062|NCT02981069|Dapagliflozin|dapagliflozin|mesh-list
110613063|NCT02981069|Exenatide|exenatide|mesh-list
110613064|NCT02981069|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
110613065|NCT02981069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110613066|NCT02981069|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110613067|NCT02981069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110613068|NCT02981069|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110613070|NCT02981069|Hormones|hormones|mesh-ancestor
110613071|NCT02981069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110613072|NCT02980991|Pemetrexed|pemetrexed|mesh-list
110613073|NCT02980991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110613074|NCT02980991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110613075|NCT02980991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110260379|NCT00169182|Niacin|niacin|mesh-list
110613076|NCT02980991|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110613077|NCT02980991|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110613079|NCT02942355|Anastrozole|anastrozole|mesh-list
110613080|NCT02942355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110613081|NCT02942355|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110613082|NCT02942355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110613083|NCT02942355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110613084|NCT02942355|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110613085|NCT02942355|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110613086|NCT02942355|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110613087|NCT02942355|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110613088|NCT02942355|Hormone Antagonists|hormone antagonists|mesh-ancestor
110613089|NCT02942355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110613090|NCT02942355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110613091|NCT02923128|Sufentanil|sufentanil|mesh-list
110613092|NCT02923128|Dexmedetomidine|dexmedetomidine|mesh-list
110613093|NCT02923128|Dsuvia|dsuvia|mesh-list
110613094|NCT02923128|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110613095|NCT02923128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110613096|NCT02923128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110613097|NCT02923128|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110613098|NCT02923128|Analgesics|analgesics|mesh-ancestor
110613099|NCT02923128|Sensory System Agents|sensory system agents|mesh-ancestor
110613100|NCT02923128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110613101|NCT02923128|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110613102|NCT02923128|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110613103|NCT02923128|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110613104|NCT02923128|Adrenergic Agents|adrenergic agents|mesh-ancestor
110613105|NCT02923128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110613106|NCT02923128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110613107|NCT02923128|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110613108|NCT02923128|Narcotics|narcotics|mesh-ancestor
110613109|NCT02923128|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110613110|NCT02923128|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110613111|NCT02923128|Anesthetics, General|anesthetics, general|mesh-ancestor
110613112|NCT02923128|Anesthetics|anesthetics|mesh-ancestor
110613113|NCT02839642|Rivastigmine|rivastigmine|mesh-list
110613114|NCT02839642|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110613115|NCT02839642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110613116|NCT02839642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110613117|NCT02839642|Cholinergic Agents|cholinergic agents|mesh-ancestor
110613118|NCT02839642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110613119|NCT02839642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110613120|NCT02839642|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110613121|NCT02839642|Protective Agents|protective agents|mesh-ancestor
110613122|NCT02828358|Calcium, Dietary|calcium, dietary|mesh-list
110613123|NCT02828358|Leucovorin|leucovorin|mesh-list
110613124|NCT02828358|Folic Acid|folic acid|mesh-list
110613125|NCT02828358|Cytarabine|cytarabine|mesh-list
110613126|NCT02828358|Dexamethasone|dexamethasone|mesh-list
110613127|NCT02828358|Dexamethasone acetate|dexamethasone acetate|mesh-list
110613128|NCT02828358|Prednisolone|prednisolone|mesh-list
110613129|NCT02828358|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110613130|NCT02828358|Methylprednisolone|methylprednisolone|mesh-list
110613131|NCT02828358|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110613132|NCT02828358|Prednisolone acetate|prednisolone acetate|mesh-list
110613133|NCT02828358|Hydrocortisone|hydrocortisone|mesh-list
110613134|NCT02828358|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
110613135|NCT02828358|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
110613136|NCT02828358|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
110613137|NCT02828358|Cortisone|cortisone|mesh-list
110613138|NCT02828358|Cyclophosphamide|cyclophosphamide|mesh-list
110613139|NCT02828358|Methotrexate|methotrexate|mesh-list
110613140|NCT02828358|Vincristine|vincristine|mesh-list
110613141|NCT02828358|Azacitidine|azacitidine|mesh-list
110613142|NCT02828358|Daunorubicin|daunorubicin|mesh-list
110613143|NCT02828358|Asparaginase|asparaginase|mesh-list
110613144|NCT02828358|Mercaptopurine|mercaptopurine|mesh-list
110613145|NCT02828358|Pegaspargase|pegaspargase|mesh-list
110613146|NCT02828358|Thioguanine|thioguanine|mesh-list
110613147|NCT02828358|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110613148|NCT02828358|Prednisolone phosphate|prednisolone phosphate|mesh-list
110613149|NCT02828358|BB 1101|bb 1101|mesh-list
110613150|NCT02828358|Calcium|calcium|mesh-list
110613151|NCT02828358|2-Aminopurine|2-aminopurine|mesh-list
110613152|NCT02828358|Levoleucovorin|levoleucovorin|mesh-list
110613153|NCT02828358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110613154|NCT02828358|Immunologic Factors|immunologic factors|mesh-ancestor
110613155|NCT02828358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110613156|NCT02828358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110613157|NCT02828358|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110613158|NCT02828358|Alkylating Agents|alkylating agents|mesh-ancestor
110613159|NCT02828358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110613160|NCT02828358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110387856|NCT03710772|Antiemetics|antiemetics|mesh-ancestor
110613162|NCT02828358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110613163|NCT02828358|Antiemetics|antiemetics|mesh-ancestor
110613164|NCT02828358|Autonomic Agents|autonomic agents|mesh-ancestor
110613165|NCT02828358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110613166|NCT02828358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110613167|NCT02828358|Glucocorticoids|glucocorticoids|mesh-ancestor
110613168|NCT02828358|Hormones|hormones|mesh-ancestor
110613169|NCT02828358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110613170|NCT02828358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110613171|NCT02828358|Protease Inhibitors|protease inhibitors|mesh-ancestor
110613172|NCT02828358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110613173|NCT02828358|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110613174|NCT02828358|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110613175|NCT02828358|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110613176|NCT02828358|Abortifacient Agents|abortifacient agents|mesh-ancestor
110613177|NCT02828358|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110613178|NCT02828358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110613179|NCT02828358|Antimetabolites|antimetabolites|mesh-ancestor
110613180|NCT02828358|Dermatologic Agents|dermatologic agents|mesh-ancestor
110613181|NCT02828358|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110613182|NCT02828358|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110613183|NCT02828358|Antiviral Agents|antiviral agents|mesh-ancestor
110613184|NCT02828358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110613185|NCT02828358|Antidotes|antidotes|mesh-ancestor
110613186|NCT02828358|Protective Agents|protective agents|mesh-ancestor
110613187|NCT02828358|Vitamin B Complex|vitamin b complex|mesh-ancestor
110613188|NCT02828358|Vitamins|vitamins|mesh-ancestor
110613189|NCT02828358|Micronutrients|micronutrients|mesh-ancestor
110613190|NCT02828358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110613191|NCT02828358|Tubulin Modulators|tubulin modulators|mesh-ancestor
110613192|NCT02828358|Antimitotic Agents|antimitotic agents|mesh-ancestor
110613193|NCT02828358|Mitosis Modulators|mitosis modulators|mesh-ancestor
110613194|NCT02828358|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110613195|NCT02828358|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110613196|NCT02828358|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110613197|NCT02828358|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110613198|NCT02828358|Hematinics|hematinics|mesh-ancestor
110613199|NCT02810444|Immunoglobulins|immunoglobulins|mesh-list
110613200|NCT02810444|gamma-Globulins|gamma-globulins|mesh-list
110613201|NCT02810444|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110613202|NCT02810444|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110613203|NCT02810444|Immunologic Factors|immunologic factors|mesh-ancestor
110613204|NCT02810444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110613205|NCT02612311|Obinutuzumab|obinutuzumab|mesh-list
110613206|NCT02612311|Chlorambucil|chlorambucil|mesh-list
110613207|NCT02612311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110613208|NCT02612311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110613209|NCT02612311|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110613210|NCT02612311|Alkylating Agents|alkylating agents|mesh-ancestor
110613211|NCT02612311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110613212|NCT02607319|Bemiparin|bemiparin|mesh-list
110613213|NCT02607319|Anticoagulants|anticoagulants|mesh-ancestor
110613214|NCT02581085|Tocotrienols|tocotrienols|mesh-list
110613215|NCT02581085|Vitamin E|vitamin e|mesh-list
110613216|NCT02581085|Tocopherols|tocopherols|mesh-list
110613217|NCT02581085|Antioxidants|antioxidants|mesh-ancestor
110613218|NCT02581085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110613219|NCT02581085|Protective Agents|protective agents|mesh-ancestor
110613220|NCT02581085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110613221|NCT02581085|Vitamins|vitamins|mesh-ancestor
110613222|NCT02581085|Micronutrients|micronutrients|mesh-ancestor
110613223|NCT02575963|Cytarabine|cytarabine|mesh-list
110613224|NCT02575963|Lintuzumab|lintuzumab|mesh-list
110613225|NCT02575963|Furosemide|furosemide|mesh-list
110613226|NCT02575963|Spironolactone|spironolactone|mesh-list
110613227|NCT02575963|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110613228|NCT02575963|Antimetabolites|antimetabolites|mesh-ancestor
110613229|NCT02575963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110613230|NCT02575963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110613231|NCT02575963|Antiviral Agents|antiviral agents|mesh-ancestor
110613232|NCT02575963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110613233|NCT02575963|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110613235|NCT02575963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110613236|NCT02575963|Diuretics|diuretics|mesh-ancestor
110613237|NCT02575963|Natriuretic Agents|natriuretic agents|mesh-ancestor
110613238|NCT02575963|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110613239|NCT02575963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110613240|NCT02575963|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110613241|NCT02575963|Hormone Antagonists|hormone antagonists|mesh-ancestor
110613242|NCT02575963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110613243|NCT02575963|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110613244|NCT02575963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110613245|NCT02546661|Durvalumab|durvalumab|mesh-list
110613246|NCT02546661|Olaparib|olaparib|mesh-list
110613247|NCT02546661|Adavosertib|adavosertib|mesh-list
110613248|NCT02546661|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110613249|NCT02546661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110613250|NCT02546661|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110613251|NCT02546661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110613252|NCT02546661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110613253|NCT02507284|SRX246|srx246|mesh-list
110613254|NCT02507284|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
110613255|NCT02507284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110613256|NCT02507284|Natriuretic Agents|natriuretic agents|mesh-ancestor
110613257|NCT02507284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110613258|NCT02501096|Pembrolizumab|pembrolizumab|mesh-list
110613259|NCT02501096|Lenvatinib|lenvatinib|mesh-list
110613260|NCT02501096|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110613261|NCT02501096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110613262|NCT02501096|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110613263|NCT02501096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110613264|NCT02501096|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110613265|NCT02501096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110613266|NCT02432248|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
110613267|NCT02432248|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110613268|NCT02432248|Immunologic Factors|immunologic factors|mesh-ancestor
110613269|NCT02432248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110613270|NCT02364089|Epinephrine|epinephrine|mesh-list
110613271|NCT02364089|Racepinephrine|racepinephrine|mesh-list
110387984|NCT03577431|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110387985|NCT03577431|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110387986|NCT03577431|Alkylating Agents|alkylating agents|mesh-ancestor
110387987|NCT03577431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110387988|NCT03577431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110387989|NCT03577431|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110387990|NCT03577431|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110387991|NCT03577431|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110387992|NCT03577431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110613273|NCT02364089|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110613274|NCT02364089|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110613275|NCT02364089|Adrenergic Agents|adrenergic agents|mesh-ancestor
110613276|NCT02364089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110613277|NCT02364089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110613278|NCT02364089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110613279|NCT02364089|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110613280|NCT02364089|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110613281|NCT02364089|Autonomic Agents|autonomic agents|mesh-ancestor
110613282|NCT02364089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110613283|NCT02364089|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110613284|NCT02364089|Respiratory System Agents|respiratory system agents|mesh-ancestor
110613285|NCT02364089|Mydriatics|mydriatics|mesh-ancestor
110613286|NCT02364089|Sympathomimetics|sympathomimetics|mesh-ancestor
110613287|NCT02364089|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110613288|NCT02193425|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110613289|NCT02193425|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110613290|NCT02193425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110613291|NCT02122562|Ketamine|ketamine|mesh-list
110613292|NCT02122562|Analgesics|analgesics|mesh-ancestor
110613293|NCT02122562|Sensory System Agents|sensory system agents|mesh-ancestor
110613294|NCT02122562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110613295|NCT02122562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110613296|NCT02122562|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110613297|NCT02122562|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110613298|NCT02122562|Anesthetics, General|anesthetics, general|mesh-ancestor
110613299|NCT02122562|Anesthetics|anesthetics|mesh-ancestor
110613300|NCT02122562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110613301|NCT02122562|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110613302|NCT02122562|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110613303|NCT02122562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110260610|NCT02277067|Misoprostol|misoprostol|mesh-list
110613304|NCT02122562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110613305|NCT02115724|Vitamins|vitamins|mesh-list
110613306|NCT02115724|Vitamin E|vitamin e|mesh-list
110613307|NCT02115724|Thioctic Acid|thioctic acid|mesh-list
110613308|NCT02115724|Nitroglycerin|nitroglycerin|mesh-list
110613309|NCT02115724|Antioxidants|antioxidants|mesh-list
110613310|NCT02115724|Micronutrients|micronutrients|mesh-ancestor
110613311|NCT02115724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110388019|NCT03565783|Cemiplimab|cemiplimab|mesh-list
110275968|NCT00555607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110388020|NCT03565783|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110388021|NCT03565783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110613312|NCT02115724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110613313|NCT02115724|Protective Agents|protective agents|mesh-ancestor
110613314|NCT02115724|Vitamin B Complex|vitamin b complex|mesh-ancestor
110613315|NCT02115724|Vasodilator Agents|vasodilator agents|mesh-ancestor
110613317|NCT02036372|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110613318|NCT02036372|Liraglutide|liraglutide|mesh-list
110613319|NCT02036372|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110613320|NCT02036372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110613321|NCT02036372|Incretins|incretins|mesh-ancestor
110613322|NCT02036372|Hormones|hormones|mesh-ancestor
110613323|NCT02036372|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110613324|NCT01991977|Temozolomide|temozolomide|mesh-list
110613325|NCT01991977|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110613326|NCT01991977|Alkylating Agents|alkylating agents|mesh-ancestor
110613327|NCT01991977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110613328|NCT01991977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110613329|NCT01633541|Carboplatin|carboplatin|mesh-list
110613330|NCT01633541|Docetaxel|docetaxel|mesh-list
110613331|NCT01633541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110613332|NCT01633541|Tubulin Modulators|tubulin modulators|mesh-ancestor
110613333|NCT01633541|Antimitotic Agents|antimitotic agents|mesh-ancestor
110613334|NCT01633541|Mitosis Modulators|mitosis modulators|mesh-ancestor
110613335|NCT01633541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110613336|NCT01399372|Cytarabine|cytarabine|mesh-list
110613337|NCT01399372|Rituximab|rituximab|mesh-list
110613338|NCT01399372|Methotrexate|methotrexate|mesh-list
110613339|NCT01399372|Vincristine|vincristine|mesh-list
110613340|NCT01399372|Procarbazine|procarbazine|mesh-list
110613341|NCT01399372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110613342|NCT01399372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110613343|NCT01399372|Immunologic Factors|immunologic factors|mesh-ancestor
110613344|NCT01399372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110613345|NCT01399372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110613346|NCT01399372|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110613347|NCT01399372|Abortifacient Agents|abortifacient agents|mesh-ancestor
110613348|NCT01399372|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110613349|NCT01399372|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110613350|NCT01399372|Antimetabolites|antimetabolites|mesh-ancestor
110613351|NCT01399372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110388053|NCT03519971|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110613353|NCT01399372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110613354|NCT01399372|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110613355|NCT01399372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110613356|NCT01399372|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110613357|NCT01399372|Antiviral Agents|antiviral agents|mesh-ancestor
110613358|NCT01399372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110613359|NCT01399372|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110613360|NCT01399372|Tubulin Modulators|tubulin modulators|mesh-ancestor
110613361|NCT01399372|Antimitotic Agents|antimitotic agents|mesh-ancestor
110613362|NCT01399372|Mitosis Modulators|mitosis modulators|mesh-ancestor
110613363|NCT01267604|Inositol|inositol|mesh-list
110613364|NCT01267604|Melatonin|melatonin|mesh-list
110613365|NCT01267604|Antioxidants|antioxidants|mesh-ancestor
110613366|NCT01267604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110613367|NCT01267604|Protective Agents|protective agents|mesh-ancestor
110613368|NCT01267604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110613369|NCT01267604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110613370|NCT01267604|Vitamin B Complex|vitamin b complex|mesh-ancestor
110613371|NCT01267604|Vitamins|vitamins|mesh-ancestor
110613372|NCT01267604|Micronutrients|micronutrients|mesh-ancestor
110613373|NCT01244399|Inositol|inositol|mesh-list
110613374|NCT01244399|Vitamin B Complex|vitamin b complex|mesh-ancestor
110613375|NCT01244399|Vitamins|vitamins|mesh-ancestor
110613376|NCT01244399|Micronutrients|micronutrients|mesh-ancestor
110613377|NCT01244399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110613378|NCT01063517|Paclitaxel|paclitaxel|mesh-list
110613379|NCT01063517|Olaparib|olaparib|mesh-list
110613380|NCT01063517|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110613381|NCT01063517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110613382|NCT01063517|Tubulin Modulators|tubulin modulators|mesh-ancestor
110613383|NCT01063517|Antimitotic Agents|antimitotic agents|mesh-ancestor
110613384|NCT01063517|Mitosis Modulators|mitosis modulators|mesh-ancestor
110613385|NCT01063517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110613386|NCT01063517|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110613387|NCT01063517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110613390|NCT00920621|Cholecalciferol|cholecalciferol|mesh-list
110613391|NCT00920621|Vitamins|vitamins|mesh-list
110613392|NCT00920621|Micronutrients|micronutrients|mesh-ancestor
110613393|NCT00920621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110613394|NCT00920621|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110613395|NCT00920621|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110613396|NCT00964756|Ganciclovir|ganciclovir|mesh-list
110613397|NCT00964756|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
110613398|NCT00964756|Antiviral Agents|antiviral agents|mesh-ancestor
110388091|NCT03487809|Hormones|hormones|mesh-ancestor
110613399|NCT00964756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110613400|NCT00964756|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110613401|NCT00964756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110613402|NCT00964756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110613403|NCT00964834|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110613404|NCT00964834|Doxycycline|doxycycline|mesh-list
110613405|NCT00964834|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
110613406|NCT00964834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110613407|NCT00964834|Antitubercular Agents|antitubercular agents|mesh-ancestor
110613408|NCT00964834|Antimalarials|antimalarials|mesh-ancestor
110613409|NCT00964834|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110613410|NCT00964834|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110613412|NCT00612105|Anticonvulsants|anticonvulsants|mesh-ancestor
110613413|NCT00612105|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110613414|NCT00612105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110613415|NCT04017741|Methylprednisolone|methylprednisolone|mesh-list
110613416|NCT04017741|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110613417|NCT04017741|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110613418|NCT04017741|Prednisolone|prednisolone|mesh-list
110613419|NCT04017741|Prednisolone acetate|prednisolone acetate|mesh-list
110613420|NCT04017741|Lidocaine|lidocaine|mesh-list
110613421|NCT04017741|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110613422|NCT04017741|Prednisolone phosphate|prednisolone phosphate|mesh-list
110388134|NCT03456076|Carboplatin|carboplatin|mesh-list
110613423|NCT04017741|Anesthetics, Local|anesthetics, local|mesh-ancestor
110613424|NCT04017741|Anesthetics|anesthetics|mesh-ancestor
110613425|NCT04017741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110613426|NCT04017741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110613427|NCT04017741|Sensory System Agents|sensory system agents|mesh-ancestor
110613428|NCT04017741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110613429|NCT04017741|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110613430|NCT04017741|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110613431|NCT04017741|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110613432|NCT04017741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110613433|NCT04017741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110613434|NCT04017741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110613435|NCT04017741|Antiemetics|antiemetics|mesh-ancestor
110613436|NCT04017741|Autonomic Agents|autonomic agents|mesh-ancestor
110613437|NCT04017741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110613438|NCT04017741|Glucocorticoids|glucocorticoids|mesh-ancestor
110613439|NCT04017741|Hormones|hormones|mesh-ancestor
110613440|NCT04017741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110613441|NCT04017741|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110613442|NCT04017741|Protective Agents|protective agents|mesh-ancestor
110613443|NCT04017741|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110613444|NCT04017741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110613445|NCT00546052|Losartan|losartan|mesh-list
110613446|NCT00546052|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110613447|NCT00546052|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110613448|NCT00546052|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110613449|NCT00546052|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110613450|NCT00546052|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110613451|NCT00546052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110613452|NCT00546052|Diuretics|diuretics|mesh-ancestor
110283869|NCT00208533|Serotonin Agents|serotonin agents|mesh-ancestor
110613453|NCT00546052|Natriuretic Agents|natriuretic agents|mesh-ancestor
110153115|NCT00000789|Antiviral Agents|antiviral agents|mesh-ancestor
110613454|NCT00546052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110613455|NCT00546052|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110613456|NCT00546052|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110613457|NCT00887601|Donepezil|donepezil|mesh-list
110613458|NCT00887601|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110613459|NCT00887601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110613460|NCT00887601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110613461|NCT00887601|Cholinergic Agents|cholinergic agents|mesh-ancestor
110613462|NCT00887601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110613463|NCT00887601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110613464|NCT00887601|Nootropic Agents|nootropic agents|mesh-ancestor
110613465|NCT00887757|Gemcitabine|gemcitabine|mesh-list
110613466|NCT00887757|Navitoclax|navitoclax|mesh-list
110613467|NCT00887757|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110613468|NCT00887757|Antimetabolites|antimetabolites|mesh-ancestor
110613469|NCT00887757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110613470|NCT00887757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110613471|NCT00965224|Immunomodulating Agents|immunomodulating agents|mesh-list
110613472|NCT00965224|Immunologic Factors|immunologic factors|mesh-ancestor
110613473|NCT00965224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110613474|NCT04392921|Amiodarone|amiodarone|mesh-list
110613475|NCT04392921|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110613476|NCT04392921|Vasodilator Agents|vasodilator agents|mesh-ancestor
110613477|NCT04392921|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
110613478|NCT04392921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110613479|NCT04392921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110613480|NCT04392921|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110388230|NCT03368664|Immunologic Factors|immunologic factors|mesh-ancestor
110613481|NCT04392921|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110613482|NCT04392921|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110613483|NCT04392921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110613484|NCT04392921|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110613485|NCT04392921|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110613486|NCT04392921|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110613487|NCT00673920|Methotrexate|methotrexate|mesh-list
110613488|NCT00673920|Ocrelizumab|ocrelizumab|mesh-list
110613489|NCT00673920|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110613490|NCT00673920|Abortifacient Agents|abortifacient agents|mesh-ancestor
110613491|NCT00673920|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110613492|NCT00673920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110613493|NCT00673920|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110613494|NCT00673920|Antimetabolites|antimetabolites|mesh-ancestor
110613495|NCT00673920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110613496|NCT00673920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110613497|NCT00673920|Dermatologic Agents|dermatologic agents|mesh-ancestor
110613498|NCT00673920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110613499|NCT00673920|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110613500|NCT00673920|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110613501|NCT00673920|Immunologic Factors|immunologic factors|mesh-ancestor
110613502|NCT00673920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110613503|NCT00673920|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110613504|NCT00959686|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110613505|NCT00959686|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110613506|NCT00959686|Alkylating Agents|alkylating agents|mesh-ancestor
110613507|NCT00959686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110613508|NCT00959686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110613509|NCT00379795|Ranibizumab|ranibizumab|mesh-list
110613510|NCT00379795|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110613511|NCT00379795|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110613512|NCT00379795|Growth Substances|growth substances|mesh-ancestor
110613513|NCT00379795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110613514|NCT00379795|Growth Inhibitors|growth inhibitors|mesh-ancestor
110613515|NCT00379795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110613516|NCT04588948|Aflibercept|aflibercept|mesh-list
110613517|NCT04588948|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110613518|NCT04588948|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110283875|NCT00203450|Anticonvulsants|anticonvulsants|mesh-ancestor
110613520|NCT04588948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110613521|NCT04588948|Growth Inhibitors|growth inhibitors|mesh-ancestor
110613522|NCT04588948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110613523|NCT00765024|Ivermectin|ivermectin|mesh-list
110613524|NCT00765024|Albendazole|albendazole|mesh-list
110613525|NCT00765024|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110613526|NCT00765024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110613527|NCT00765024|Anthelmintics|anthelmintics|mesh-ancestor
110613528|NCT00765024|Anticestodal Agents|anticestodal agents|mesh-ancestor
110613529|NCT00765024|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110613530|NCT00765024|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110613531|NCT00765024|Tubulin Modulators|tubulin modulators|mesh-ancestor
110613532|NCT00765024|Antimitotic Agents|antimitotic agents|mesh-ancestor
110613533|NCT00765024|Mitosis Modulators|mitosis modulators|mesh-ancestor
110613534|NCT00765024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110613535|NCT00765024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110613536|NCT02557932|Bismuth|bismuth|mesh-list
110613537|NCT02557932|Antacids|antacids|mesh-ancestor
110613538|NCT02557932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110613539|NCT02557932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110613540|NCT00960232|Cholecalciferol|cholecalciferol|mesh-list
110613541|NCT00960232|Vitamin D|vitamin d|mesh-list
110613542|NCT00960232|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110613543|NCT00960232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110613544|NCT00960232|Vitamins|vitamins|mesh-ancestor
110613545|NCT00960232|Micronutrients|micronutrients|mesh-ancestor
110613546|NCT00960232|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110613547|NCT05282550|Trazodone|trazodone|mesh-list
110613548|NCT05282550|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110613549|NCT05282550|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110613550|NCT05282550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110613551|NCT05282550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110613552|NCT05282550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110613553|NCT05282550|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110613554|NCT05282550|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110613555|NCT05282550|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110613556|NCT05282550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110613557|NCT05282550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110613558|NCT05282550|Serotonin Agents|serotonin agents|mesh-ancestor
110613559|NCT05282550|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110613560|NCT05282550|Antidepressive Agents|antidepressive agents|mesh-ancestor
110613561|NCT00960310|Bicalutamide|bicalutamide|mesh-list
110613562|NCT00960310|Androgen Antagonists|androgen antagonists|mesh-ancestor
110613563|NCT00960310|Hormone Antagonists|hormone antagonists|mesh-ancestor
110613564|NCT00960310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110613565|NCT00960310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110613566|NCT00960310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110613567|NCT00610155|Pregabalin|pregabalin|mesh-list
110613568|NCT00610155|Tramadol|tramadol|mesh-list
110613569|NCT00610155|Analgesics|analgesics|mesh-ancestor
110613570|NCT00610155|Sensory System Agents|sensory system agents|mesh-ancestor
110613571|NCT00610155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110613572|NCT00610155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110613573|NCT00610155|Anticonvulsants|anticonvulsants|mesh-ancestor
110613574|NCT00610155|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110613575|NCT00610155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110613576|NCT00610155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110613577|NCT00610155|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110613578|NCT00610155|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110613579|NCT00610155|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110613580|NCT00610155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110613581|NCT00610155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110613582|NCT00610155|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110613583|NCT00610155|Narcotics|narcotics|mesh-ancestor
110613584|NCT00759018|Remestemcel-l|remestemcel-l|mesh-list
110613585|NCT00759018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110613586|NCT00759018|Antiviral Agents|antiviral agents|mesh-ancestor
110613587|NCT00759018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110613588|NCT00960544|Capecitabine|capecitabine|mesh-list
110613589|NCT00960544|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110613590|NCT00960544|Antimetabolites|antimetabolites|mesh-ancestor
110613591|NCT00960544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110613592|NCT00960544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110613594|NCT04488952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110613595|NCT04488952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110613597|NCT00888303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110613598|NCT00888303|Antiemetics|antiemetics|mesh-ancestor
110613599|NCT00888303|Autonomic Agents|autonomic agents|mesh-ancestor
110613600|NCT00888303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110613601|NCT00888303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110613602|NCT00888303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110613603|NCT00888303|Glucocorticoids|glucocorticoids|mesh-ancestor
110613604|NCT00888303|Hormones|hormones|mesh-ancestor
110613605|NCT00888303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110613606|NCT00888303|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110613607|NCT00888303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110613608|NCT00967642|Insulin|insulin|mesh-list
110613609|NCT00967642|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110613610|NCT00967642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110613611|NCT00674700|Immunomodulating Agents|immunomodulating agents|mesh-list
110613612|NCT00674700|Immunologic Factors|immunologic factors|mesh-list
110613613|NCT00674700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110613614|NCT00762918|Vitamin D|vitamin d|mesh-list
110613615|NCT00762918|Cholecalciferol|cholecalciferol|mesh-list
110613616|NCT00762918|Vitamins|vitamins|mesh-ancestor
110613617|NCT00762918|Micronutrients|micronutrients|mesh-ancestor
110613618|NCT00762918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110613619|NCT00762918|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110613620|NCT00762918|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110613621|NCT00546910|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
110613622|NCT00546910|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110613623|NCT00546910|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110613624|NCT00546910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110613625|NCT00546910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110613626|NCT00546910|Adrenergic Agents|adrenergic agents|mesh-ancestor
110613627|NCT00546910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110613628|NCT00546910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110613629|NCT00759720|Glyburide|glyburide|mesh-list
110613630|NCT00759720|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110613631|NCT00759720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110613632|NCT00379639|Gemcitabine|gemcitabine|mesh-list
110613633|NCT00379639|Romidepsin|romidepsin|mesh-list
110613634|NCT00379639|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110613635|NCT00379639|Antimetabolites|antimetabolites|mesh-ancestor
110613636|NCT00379639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110613637|NCT00379639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110613638|NCT00379639|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110613639|NCT00379639|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110613640|NCT00379639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110613641|NCT00609765|Dexamethasone|dexamethasone|mesh-list
110613642|NCT00609765|Bevacizumab|bevacizumab|mesh-list
110613643|NCT00609765|Doxorubicin|doxorubicin|mesh-list
110613644|NCT00609765|Fluorouracil|fluorouracil|mesh-list
110613645|NCT00609765|Streptozocin|streptozocin|mesh-list
110613646|NCT00609765|Ondansetron|ondansetron|mesh-list
110613647|NCT00609765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110613648|NCT00609765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110613649|NCT00609765|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110613650|NCT00609765|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110613651|NCT00609765|Growth Substances|growth substances|mesh-ancestor
110613652|NCT00609765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110613653|NCT00609765|Growth Inhibitors|growth inhibitors|mesh-ancestor
110613654|NCT00609765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110613655|NCT00609765|Antiemetics|antiemetics|mesh-ancestor
110613656|NCT00609765|Autonomic Agents|autonomic agents|mesh-ancestor
110613657|NCT00609765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110613658|NCT00609765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110613659|NCT00609765|Glucocorticoids|glucocorticoids|mesh-ancestor
110613660|NCT00609765|Hormones|hormones|mesh-ancestor
110613661|NCT00609765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110613662|NCT00609765|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110613663|NCT00609765|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110613664|NCT00609765|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110613665|NCT00609765|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110613666|NCT00609765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110613667|NCT00609765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110613668|NCT00609765|Antimetabolites|antimetabolites|mesh-ancestor
110613669|NCT00609765|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110613670|NCT00609765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110613671|NCT00609765|Immunologic Factors|immunologic factors|mesh-ancestor
110613672|NCT00609765|Antipruritics|antipruritics|mesh-ancestor
110613673|NCT00609765|Dermatologic Agents|dermatologic agents|mesh-ancestor
110613674|NCT00609765|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110613675|NCT00609765|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110613676|NCT00609765|Serotonin Agents|serotonin agents|mesh-ancestor
110613677|NCT00609765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110613678|NCT01051219|Losartan|losartan|mesh-list
110613679|NCT01051219|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110613680|NCT01051219|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110613681|NCT01051219|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110613682|NCT01051219|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110613683|NCT01051219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110613684|NCT00961324|Insulin|insulin|mesh-list
110613685|NCT00961324|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110613686|NCT00961324|Insulin Glargine|insulin glargine|mesh-list
110613687|NCT00961324|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110613688|NCT00961324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110613689|NCT00766350|Amitriptyline|amitriptyline|mesh-list
110613690|NCT00766350|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110613691|NCT00766350|Antidepressive Agents|antidepressive agents|mesh-ancestor
110613692|NCT00766350|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110613693|NCT00766350|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110613694|NCT00766350|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110613695|NCT00766350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110613696|NCT00766350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110613697|NCT00766350|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110388479|NCT03136146|Hormones|hormones|mesh-ancestor
110613698|NCT00766350|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110613700|NCT00766350|Sensory System Agents|sensory system agents|mesh-ancestor
110613701|NCT00766350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110613702|NCT00766350|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110613703|NCT00766350|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110613704|NCT00766350|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110613705|NCT00766350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110613706|NCT00766350|Adrenergic Agents|adrenergic agents|mesh-ancestor
110613707|NCT00766350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110613708|NCT00889161|Curcumin|curcumin|mesh-list
110613709|NCT00889161|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110613710|NCT00889161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110613711|NCT00889161|Analgesics|analgesics|mesh-ancestor
110613712|NCT00889161|Sensory System Agents|sensory system agents|mesh-ancestor
110613713|NCT00889161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110613714|NCT00889161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110613715|NCT00889161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110613716|NCT00889161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110613717|NCT00889161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110613718|NCT00889161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110613719|NCT00889161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110613720|NCT03992755|Treprostinil|treprostinil|mesh-list
110613721|NCT03992755|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110613722|NCT01563328|Dolutegravir|dolutegravir|mesh-list
110613723|NCT01563328|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
110613724|NCT01563328|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
110613725|NCT01563328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110613726|NCT01563328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110613727|NCT01563328|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110613728|NCT01563328|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110613729|NCT01563328|Antiviral Agents|antiviral agents|mesh-ancestor
110613730|NCT01563328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110613732|NCT00760032|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110613733|NCT00760032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110613734|NCT00760032|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110613735|NCT00760032|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110613736|NCT00760032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110613737|NCT00760032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110613738|NCT00760032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110613739|NCT00760032|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110388500|NCT03128866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110388501|NCT03128866|Hemostatics|hemostatics|mesh-ancestor
110388502|NCT03128866|Coagulants|coagulants|mesh-ancestor
110042725|NCT01443572|Desflurane|desflurane|mesh-list
110388503|NCT03127631|Atorvastatin|atorvastatin|mesh-list
110613740|NCT00760032|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110613742|NCT00961480|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110613743|NCT00961480|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110613744|NCT00961480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110613745|NCT00961480|Incretins|incretins|mesh-ancestor
110613746|NCT00961480|Hormones|hormones|mesh-ancestor
110613747|NCT00961480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110613748|NCT00961480|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110613749|NCT00961480|Protease Inhibitors|protease inhibitors|mesh-ancestor
110613750|NCT00961480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110613751|NCT00961480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110261047|NCT00147563|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110613752|NCT00766662|Pyrimethamine|pyrimethamine|mesh-list
110613753|NCT00766662|Sulfadoxine|sulfadoxine|mesh-list
110613754|NCT00766662|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
110613755|NCT00766662|Antimalarials|antimalarials|mesh-ancestor
110613756|NCT00766662|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110613757|NCT00766662|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110613758|NCT00766662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110613759|NCT00766662|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110613760|NCT00766662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110613761|NCT00766662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110613762|NCT00766662|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110613763|NCT00965926|Mirabegron|mirabegron|mesh-list
110613764|NCT00965926|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
110613765|NCT00965926|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110613766|NCT00965926|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110613767|NCT00965926|Adrenergic Agents|adrenergic agents|mesh-ancestor
110613768|NCT00965926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110613769|NCT00965926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110613770|NCT00965926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110613771|NCT00965926|Urological Agents|urological agents|mesh-ancestor
110613772|NCT00966004|Mirabegron|mirabegron|mesh-list
110613773|NCT00966004|Tolterodine Tartrate|tolterodine tartrate|mesh-list
110613774|NCT00966004|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
110613775|NCT00966004|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110613776|NCT00966004|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110613777|NCT00966004|Adrenergic Agents|adrenergic agents|mesh-ancestor
110613778|NCT00966004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110613779|NCT00966004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110613780|NCT00966004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110388538|NCT03021460|Pembrolizumab|pembrolizumab|mesh-list
110388539|NCT03021460|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110388540|NCT03021460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110388541|NCT03021460|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110388542|NCT03021460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110388543|NCT03020199|Betamethasone|betamethasone|mesh-list
110388544|NCT03020199|Calcipotriene|calcipotriene|mesh-list
110388545|NCT03020199|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110388548|NCT03020199|Hormones|hormones|mesh-ancestor
110613781|NCT00966004|Urological Agents|urological agents|mesh-ancestor
110613782|NCT00966004|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110613783|NCT00966004|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110613784|NCT00966004|Cholinergic Agents|cholinergic agents|mesh-ancestor
110613785|NCT00966082|Propranolol|propranolol|mesh-list
110613786|NCT00966082|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110613787|NCT00966082|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110613788|NCT00966082|Adrenergic Agents|adrenergic agents|mesh-ancestor
110613789|NCT00966082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110613790|NCT00966082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110613791|NCT00966082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110613792|NCT00966082|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110613793|NCT00966082|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110613794|NCT00966082|Vasodilator Agents|vasodilator agents|mesh-ancestor
110613795|NCT00889629|Vitamin D|vitamin d|mesh-list
110613796|NCT00889629|Cholecalciferol|cholecalciferol|mesh-list
110613797|NCT00889629|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
110613798|NCT00889629|Ergocalciferols|ergocalciferols|mesh-list
110613799|NCT00889629|Vitamins|vitamins|mesh-ancestor
110613800|NCT00889629|Micronutrients|micronutrients|mesh-ancestor
110613801|NCT00889629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110613802|NCT00889629|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110613803|NCT00889629|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110613804|NCT00966160|Ritonavir|ritonavir|mesh-list
110613805|NCT00966160|Lopinavir|lopinavir|mesh-list
110613806|NCT00966160|Lamivudine|lamivudine|mesh-list
110613807|NCT00966160|Zidovudine|zidovudine|mesh-list
110613808|NCT00966160|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
110613809|NCT00966160|Efavirenz|efavirenz|mesh-list
110613810|NCT00966160|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110613811|NCT00966160|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110613812|NCT00966160|Protease Inhibitors|protease inhibitors|mesh-ancestor
110613813|NCT00966160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110613814|NCT00966160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110613815|NCT00966160|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110613816|NCT00966160|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110613817|NCT00966160|Antiviral Agents|antiviral agents|mesh-ancestor
110613818|NCT00966160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110613819|NCT00966160|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110613820|NCT00966160|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110613821|NCT00966160|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110613822|NCT00966160|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110613823|NCT00966160|Antimetabolites|antimetabolites|mesh-ancestor
110613824|NCT00966160|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110613825|NCT00966160|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110613826|NCT00966160|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110613827|NCT00966160|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110613828|NCT00966160|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110613829|NCT00766818|Lopinavir|lopinavir|mesh-list
110613830|NCT00766818|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110613831|NCT00766818|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110613832|NCT00766818|Protease Inhibitors|protease inhibitors|mesh-ancestor
110613833|NCT00766818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110388621|NCT02911142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110388622|NCT02911142|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110388623|NCT02911142|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110388624|NCT02911142|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110388625|NCT02911142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110388626|NCT02911142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110388627|NCT02911142|Glucocorticoids|glucocorticoids|mesh-ancestor
110388628|NCT02911142|Hormones|hormones|mesh-ancestor
110388629|NCT02911142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110388630|NCT02911142|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110388631|NCT02911142|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110388632|NCT02911142|Tubulin Modulators|tubulin modulators|mesh-ancestor
110388633|NCT02911142|Antimitotic Agents|antimitotic agents|mesh-ancestor
110388634|NCT02911142|Mitosis Modulators|mitosis modulators|mesh-ancestor
110388635|NCT02911142|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110388636|NCT02911142|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110388637|NCT02911142|Growth Substances|growth substances|mesh-ancestor
110613834|NCT00766818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110613836|NCT00766818|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110613837|NCT00766818|Antiviral Agents|antiviral agents|mesh-ancestor
110613838|NCT00766818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110613839|NCT00766818|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110613840|NCT00766818|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110613841|NCT00966316|Aspirin|aspirin|mesh-list
110613842|NCT00966316|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110613843|NCT00966316|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110613844|NCT00966316|Analgesics|analgesics|mesh-ancestor
110613845|NCT00966316|Sensory System Agents|sensory system agents|mesh-ancestor
110613846|NCT00966316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110613847|NCT00966316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110613848|NCT00966316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110613849|NCT00966316|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110613850|NCT00966316|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110613851|NCT00966316|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110613852|NCT00966316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110613853|NCT00966316|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110613854|NCT00966316|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110613855|NCT00966316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110613856|NCT00966316|Antipyretics|antipyretics|mesh-ancestor
110613857|NCT00892827|Rituximab|rituximab|mesh-list
110613858|NCT00892827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110613859|NCT00892827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110613860|NCT00892827|Immunologic Factors|immunologic factors|mesh-ancestor
110613861|NCT00892827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110613862|NCT00892827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110613863|NCT00766896|Aspirin|aspirin|mesh-list
110613864|NCT00766896|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110613865|NCT00766896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110613866|NCT00766896|Analgesics|analgesics|mesh-ancestor
110613867|NCT00766896|Sensory System Agents|sensory system agents|mesh-ancestor
110613868|NCT00766896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110613869|NCT00766896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110613870|NCT00766896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110613871|NCT00766896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110613872|NCT00766896|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110613873|NCT00766896|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110613874|NCT00766896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110613875|NCT00766896|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110613876|NCT00766896|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110613877|NCT00766896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110613878|NCT00766896|Antipyretics|antipyretics|mesh-ancestor
110613879|NCT00763620|Dimercaprol|dimercaprol|mesh-list
110613880|NCT00763620|Chelating Agents|chelating agents|mesh-ancestor
110613881|NCT00763620|Sequestering Agents|sequestering agents|mesh-ancestor
110613882|NCT00763620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110613883|NCT00973804|Sirolimus|sirolimus|mesh-list
110613884|NCT00973804|Tacrolimus|tacrolimus|mesh-list
110613885|NCT00973804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110613886|NCT00973804|Immunologic Factors|immunologic factors|mesh-ancestor
110613887|NCT00973804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110613888|NCT00973804|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110613889|NCT00973804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110613890|NCT00973804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110613891|NCT00973804|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110613892|NCT00973804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110613893|NCT00973804|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110613894|NCT00973804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110613895|NCT00973804|Antifungal Agents|antifungal agents|mesh-ancestor
110613896|NCT04018131|Cimetidine|cimetidine|mesh-list
110613897|NCT04018131|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110613898|NCT04018131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110613899|NCT04018131|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110613900|NCT04018131|Histamine Antagonists|histamine antagonists|mesh-ancestor
110613901|NCT04018131|Histamine Agents|histamine agents|mesh-ancestor
110613902|NCT04018131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110613903|NCT04018131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110613904|NCT04018131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110613905|NCT04018131|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110613906|NCT04018131|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110613907|NCT04018131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110613908|NCT00973882|Carboplatin|carboplatin|mesh-list
110613909|NCT00973882|Etoposide|etoposide|mesh-list
110613910|NCT00973882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110613911|NCT00973882|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110613912|NCT00973882|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110613913|NCT00973882|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110613914|NCT00973882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110613915|NCT00973882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110613916|NCT02558088|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110613917|NCT02558088|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110613918|NCT02558088|Autonomic Agents|autonomic agents|mesh-ancestor
110283885|NCT00208572|Citalopram|citalopram|mesh-list
110613919|NCT02558088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110613920|NCT02558088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110613921|NCT02558088|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110613922|NCT02558088|Respiratory System Agents|respiratory system agents|mesh-ancestor
110613923|NCT02558088|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110613924|NCT02558088|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110613925|NCT02558088|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110613926|NCT02558088|Adrenergic Agents|adrenergic agents|mesh-ancestor
110613927|NCT02558088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110613928|NCT02558088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110613931|NCT05279482|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110613932|NCT05279482|Prednisolone|prednisolone|mesh-list
110613933|NCT05279482|Prednisolone acetate|prednisolone acetate|mesh-list
110613934|NCT05279482|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110613935|NCT05279482|Prednisolone phosphate|prednisolone phosphate|mesh-list
110613936|NCT05279482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110613937|NCT05279482|Antiemetics|antiemetics|mesh-ancestor
110613938|NCT05279482|Autonomic Agents|autonomic agents|mesh-ancestor
110613939|NCT05279482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110613940|NCT05279482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110613941|NCT05279482|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110613942|NCT05279482|Glucocorticoids|glucocorticoids|mesh-ancestor
110613943|NCT05279482|Hormones|hormones|mesh-ancestor
110613944|NCT05279482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110613945|NCT05279482|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110613946|NCT05279482|Protective Agents|protective agents|mesh-ancestor
110613947|NCT05279482|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110613948|NCT05279482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110613949|NCT00890175|Loxapine|loxapine|mesh-list
110613950|NCT00890175|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110613951|NCT00890175|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110613952|NCT00890175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110613953|NCT00890175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110613954|NCT00890175|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110613955|NCT00890175|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110613956|NCT00890175|Dopamine Agents|dopamine agents|mesh-ancestor
110613957|NCT00890175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110613958|NCT00890175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110613959|NCT00966472|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110613960|NCT00966472|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110613961|NCT00966472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110613962|NCT00966472|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110613963|NCT00966472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110613964|NCT00966472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110613965|NCT00966472|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110613966|NCT00966472|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110613967|NCT00966472|Antimetabolites|antimetabolites|mesh-ancestor
110613968|NCT00966472|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110613969|NCT00966472|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110613970|NCT00890253|Mycophenolic Acid|mycophenolic acid|mesh-list
110613971|NCT00890253|Prednisone|prednisone|mesh-list
110613972|NCT00890253|Prednisolone|prednisolone|mesh-list
110613973|NCT00890253|Everolimus|everolimus|mesh-list
110613974|NCT00890253|Basiliximab|basiliximab|mesh-list
110261273|NCT00148031|Interferons|interferons|mesh-list
110613975|NCT00890253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110613977|NCT00890253|Hormones|hormones|mesh-ancestor
110613978|NCT00890253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110613979|NCT00890253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110613980|NCT00890253|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110613981|NCT00890253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110613982|NCT00890253|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110613983|NCT00890253|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110613984|NCT00890253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110613985|NCT00890253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110613986|NCT00890253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110613987|NCT00890253|Immunologic Factors|immunologic factors|mesh-ancestor
110613988|NCT00890253|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110613989|NCT00890253|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110613990|NCT00890253|Antitubercular Agents|antitubercular agents|mesh-ancestor
110613991|NCT00890253|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110613992|NCT00890253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110613993|NCT00674154|Vitamin D|vitamin d|mesh-list
110613994|NCT00674154|Cholecalciferol|cholecalciferol|mesh-list
110613995|NCT00674154|Vitamins|vitamins|mesh-ancestor
110613996|NCT00674154|Micronutrients|micronutrients|mesh-ancestor
110613997|NCT00674154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110613998|NCT00674154|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110388717|NCT02876107|Paclitaxel|paclitaxel|mesh-list
110388718|NCT02876107|Carboplatin|carboplatin|mesh-list
110388719|NCT02876107|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110388720|NCT02876107|Panitumumab|panitumumab|mesh-list
110613999|NCT00674154|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110614001|NCT00967954|Androgen Antagonists|androgen antagonists|mesh-list
110614002|NCT00967954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110614003|NCT00967954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110614004|NCT00967954|Hormone Antagonists|hormone antagonists|mesh-ancestor
110614005|NCT00767286|Cobalt|cobalt|mesh-list
110614006|NCT00767286|Goserelin|goserelin|mesh-list
110614007|NCT00767286|Flutamide|flutamide|mesh-list
110614008|NCT00767286|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110614009|NCT00767286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110614010|NCT00767286|Trace Elements|trace elements|mesh-ancestor
110614011|NCT00767286|Micronutrients|micronutrients|mesh-ancestor
110614012|NCT00767286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110614013|NCT00767286|Androgen Antagonists|androgen antagonists|mesh-ancestor
110614014|NCT00767286|Hormone Antagonists|hormone antagonists|mesh-ancestor
110614015|NCT00767286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110614016|NCT00968110|Omalizumab|omalizumab|mesh-list
110614017|NCT00968110|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110614018|NCT00968110|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110614019|NCT00968110|Respiratory System Agents|respiratory system agents|mesh-ancestor
110614020|NCT00608517|Methylprednisolone|methylprednisolone|mesh-list
110614021|NCT00608517|Cyclophosphamide|cyclophosphamide|mesh-list
110614022|NCT00608517|Fludarabine|fludarabine|mesh-list
110614023|NCT00608517|Fludarabine phosphate|fludarabine phosphate|mesh-list
110614024|NCT00608517|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110614025|NCT00608517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110614026|NCT00608517|Immunologic Factors|immunologic factors|mesh-ancestor
110614027|NCT00608517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110614028|NCT00608517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110614029|NCT00608517|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110614030|NCT00608517|Alkylating Agents|alkylating agents|mesh-ancestor
110614031|NCT00608517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110614032|NCT00608517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110614033|NCT00608517|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110614034|NCT00608517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110614035|NCT00608517|Antimetabolites|antimetabolites|mesh-ancestor
110614036|NCT00608517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110614037|NCT00608517|Antiemetics|antiemetics|mesh-ancestor
110614038|NCT00608517|Autonomic Agents|autonomic agents|mesh-ancestor
110614039|NCT00608517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110614040|NCT00608517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110614041|NCT00608517|Glucocorticoids|glucocorticoids|mesh-ancestor
110614042|NCT00608517|Hormones|hormones|mesh-ancestor
110614043|NCT00608517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110614044|NCT00608517|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110614045|NCT00608517|Protective Agents|protective agents|mesh-ancestor
110614046|NCT00966706|Gemcitabine|gemcitabine|mesh-list
110614047|NCT00966706|Docetaxel|docetaxel|mesh-list
110614048|NCT00966706|Capecitabine|capecitabine|mesh-list
110614049|NCT00966706|Epirubicin|epirubicin|mesh-list
110614050|NCT00966706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110614051|NCT00966706|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110614053|NCT00966706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110614054|NCT00966706|Tubulin Modulators|tubulin modulators|mesh-ancestor
110614055|NCT00966706|Antimitotic Agents|antimitotic agents|mesh-ancestor
110614056|NCT00966706|Mitosis Modulators|mitosis modulators|mesh-ancestor
110614057|NCT00966706|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110614058|NCT00966706|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110614059|NCT00966706|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110614060|NCT00966706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110614061|NCT00893061|Tamoxifen|tamoxifen|mesh-list
110614062|NCT00893061|Letrozole|letrozole|mesh-list
110614063|NCT00893061|Anastrozole|anastrozole|mesh-list
110614064|NCT00893061|Exemestane|exemestane|mesh-list
110153191|NCT03801031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110614065|NCT00893061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110614066|NCT00893061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110388754|NCT02872259|Trametinib|trametinib|mesh-list
110614067|NCT00893061|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110614068|NCT00893061|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110614069|NCT00893061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110614070|NCT00893061|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110614071|NCT00893061|Hormone Antagonists|hormone antagonists|mesh-ancestor
110614072|NCT00893061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110614073|NCT00893061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110614074|NCT00893061|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110614075|NCT00893061|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110614076|NCT00893061|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110614077|NCT00893061|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110614078|NCT00974272|Exenatide|exenatide|mesh-list
110614079|NCT00974272|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110614080|NCT00974272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110614081|NCT00974272|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110614082|NCT00974272|Incretins|incretins|mesh-ancestor
110614083|NCT00974272|Hormones|hormones|mesh-ancestor
110614084|NCT00974272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110614085|NCT00974428|Wobenzym|wobenzym|mesh-list
110614086|NCT00974428|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110614087|NCT00974428|Immunologic Factors|immunologic factors|mesh-ancestor
110614088|NCT00974428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110614089|NCT00974584|Paclitaxel|paclitaxel|mesh-list
110614090|NCT00974584|Bevacizumab|bevacizumab|mesh-list
110614091|NCT00974584|Carboplatin|carboplatin|mesh-list
110614092|NCT00974584|Pemetrexed|pemetrexed|mesh-list
110614093|NCT00974584|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110614094|NCT00974584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110614095|NCT00974584|Tubulin Modulators|tubulin modulators|mesh-ancestor
110614096|NCT00974584|Antimitotic Agents|antimitotic agents|mesh-ancestor
110614097|NCT00974584|Mitosis Modulators|mitosis modulators|mesh-ancestor
110614098|NCT00974584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110614099|NCT00974584|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110614100|NCT00974584|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110614101|NCT00974584|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110614102|NCT00974584|Growth Substances|growth substances|mesh-ancestor
110614103|NCT00974584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110614104|NCT00974584|Growth Inhibitors|growth inhibitors|mesh-ancestor
110614105|NCT00974584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110614106|NCT00974584|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110614107|NCT00974584|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110614108|NCT00608205|Fluorouracil|fluorouracil|mesh-list
110614109|NCT00608205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110614110|NCT00608205|Antimetabolites|antimetabolites|mesh-ancestor
110614111|NCT00608205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110614112|NCT00608205|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110614113|NCT00608205|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110614114|NCT00608205|Immunologic Factors|immunologic factors|mesh-ancestor
110614115|NCT00608205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110614116|NCT00974740|Atorvastatin|atorvastatin|mesh-list
110614117|NCT00974740|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110614118|NCT00974740|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110614119|NCT00974740|Antimetabolites|antimetabolites|mesh-ancestor
110614120|NCT00974740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110614121|NCT00974740|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110614122|NCT00974740|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110614123|NCT00974740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110614124|NCT00967096|Rifaximin|rifaximin|mesh-list
110614125|NCT00967096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110614126|NCT00967096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110614127|NCT00967096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110614128|NCT05227300|Lidocaine|lidocaine|mesh-list
110614129|NCT05227300|Epinephrine|epinephrine|mesh-list
110614130|NCT05227300|Anesthetics, Local|anesthetics, local|mesh-ancestor
110614131|NCT05227300|Anesthetics|anesthetics|mesh-ancestor
110614132|NCT05227300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110614133|NCT05227300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110614134|NCT05227300|Sensory System Agents|sensory system agents|mesh-ancestor
110614135|NCT05227300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110614136|NCT05227300|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110614137|NCT05227300|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110614138|NCT05227300|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110614139|NCT05227300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110614140|NCT05227300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110614141|NCT05227300|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110614142|NCT05227300|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110614143|NCT05227300|Adrenergic Agents|adrenergic agents|mesh-ancestor
110614144|NCT05227300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110614145|NCT05227300|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110614146|NCT05227300|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110614147|NCT05227300|Autonomic Agents|autonomic agents|mesh-ancestor
110614148|NCT05227300|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110614149|NCT05227300|Respiratory System Agents|respiratory system agents|mesh-ancestor
110614150|NCT05227300|Mydriatics|mydriatics|mesh-ancestor
110614151|NCT05227300|Sympathomimetics|sympathomimetics|mesh-ancestor
110614152|NCT05227300|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110614153|NCT00890487|Hyaluronic Acid|hyaluronic acid|mesh-list
110614154|NCT00890487|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110614155|NCT00890487|Immunologic Factors|immunologic factors|mesh-ancestor
110614156|NCT00890487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110614157|NCT00890487|Viscosupplements|viscosupplements|mesh-ancestor
110614158|NCT00890487|Protective Agents|protective agents|mesh-ancestor
110614159|NCT00890565|Granisetron|granisetron|mesh-list
110614160|NCT00890565|Antiemetics|antiemetics|mesh-ancestor
110614161|NCT00890565|Autonomic Agents|autonomic agents|mesh-ancestor
110614162|NCT00890565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110614163|NCT00890565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110614164|NCT00890565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110614165|NCT00890565|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110614166|NCT00890565|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110614167|NCT00890565|Serotonin Agents|serotonin agents|mesh-ancestor
110614168|NCT00890565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110614169|NCT00890565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110614170|NCT00890643|Prazosin|prazosin|mesh-list
110614171|NCT00890643|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110614172|NCT00890643|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110614173|NCT00890643|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110388842|NCT02739035|Analgesics|analgesics|mesh-ancestor
110614174|NCT00890643|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110614175|NCT00890643|Adrenergic Agents|adrenergic agents|mesh-ancestor
110614176|NCT00890643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110614177|NCT00890643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110614178|NCT00890643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110614180|NCT00893217|Interferon-beta|interferon-beta|mesh-list
110614181|NCT00893217|Interferon beta-1b|interferon beta-1b|mesh-list
110614182|NCT00893217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110614183|NCT00893217|Antiviral Agents|antiviral agents|mesh-ancestor
110614184|NCT00893217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110614185|NCT00893217|Immunologic Factors|immunologic factors|mesh-ancestor
110614186|NCT00893217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110614187|NCT00893217|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110614188|NCT00767598|Sildenafil Citrate|sildenafil citrate|mesh-list
110614189|NCT00767598|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
110614190|NCT00767598|Udenafil|udenafil|mesh-list
110614191|NCT00767598|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
110614192|NCT00767598|Vasodilator Agents|vasodilator agents|mesh-ancestor
110614193|NCT00767598|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110614194|NCT00767598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110614195|NCT00767598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110614196|NCT00767598|Urological Agents|urological agents|mesh-ancestor
110614197|NCT00670800|Metformin|metformin|mesh-list
110614198|NCT00670800|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110614199|NCT00670800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110614200|NCT00764166|Docetaxel|docetaxel|mesh-list
110614201|NCT00764166|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
110614202|NCT00764166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110614203|NCT00764166|Tubulin Modulators|tubulin modulators|mesh-ancestor
110614204|NCT00764166|Antimitotic Agents|antimitotic agents|mesh-ancestor
110614205|NCT00764166|Mitosis Modulators|mitosis modulators|mesh-ancestor
110614206|NCT00764166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110614207|NCT00764166|Hormones|hormones|mesh-ancestor
110614208|NCT00764166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110614209|NCT00764166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110614210|NCT00770406|Botulinum Toxins|botulinum toxins|mesh-list
110614211|NCT00770406|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110614212|NCT00770406|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110614213|NCT00770406|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110614214|NCT00770406|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110614215|NCT00770406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110614216|NCT00770406|Cholinergic Agents|cholinergic agents|mesh-ancestor
110614217|NCT00770406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110614218|NCT00770406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110614219|NCT00770406|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110614220|NCT00770406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110614221|NCT02557542|Polidocanol|polidocanol|mesh-list
110614222|NCT02557542|Sodium Tetradecyl Sulfate|sodium tetradecyl sulfate|mesh-list
110614223|NCT02557542|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
110614224|NCT02557542|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110614225|NCT00767754|Paroxetine|paroxetine|mesh-list
110614226|NCT00767754|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110614227|NCT00767754|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110614228|NCT00767754|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110614229|NCT00767754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110614230|NCT00767754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110614231|NCT00767754|Serotonin Agents|serotonin agents|mesh-ancestor
110614232|NCT00767754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110614233|NCT00767754|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110614234|NCT00767754|Antidepressive Agents|antidepressive agents|mesh-ancestor
110614235|NCT00767754|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110614236|NCT00767754|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110614237|NCT00767754|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110614238|NCT00767754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110614239|NCT00764244|Triamcinolone|triamcinolone|mesh-list
110614240|NCT00764244|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110614241|NCT00764244|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110614242|NCT00764244|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110614243|NCT00764244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110614244|NCT00764244|Glucocorticoids|glucocorticoids|mesh-ancestor
110614245|NCT00764244|Hormones|hormones|mesh-ancestor
110614246|NCT00764244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110614247|NCT00764244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110614248|NCT00764244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110614249|NCT00764244|Immunologic Factors|immunologic factors|mesh-ancestor
110614250|NCT00764244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110614251|NCT00764244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110614252|NCT00770640|Insulin|insulin|mesh-list
110614253|NCT00770640|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110614254|NCT00770640|Pioglitazone|pioglitazone|mesh-list
110614255|NCT00770640|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110614256|NCT00770640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110614257|NCT00770718|Thrombin|thrombin|mesh-list
110614258|NCT00770718|Hemostatics|hemostatics|mesh-ancestor
110614259|NCT00770718|Coagulants|coagulants|mesh-ancestor
110614260|NCT00770796|Atorvastatin|atorvastatin|mesh-list
110614261|NCT00770796|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110614262|NCT00770796|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110614263|NCT00770796|Antimetabolites|antimetabolites|mesh-ancestor
110614264|NCT00770796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110614265|NCT00770796|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110614266|NCT00770796|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110614267|NCT00770796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110614268|NCT00545740|Mesalamine|mesalamine|mesh-list
110614269|NCT00545740|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110614270|NCT00545740|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110614271|NCT00545740|Analgesics|analgesics|mesh-ancestor
110614272|NCT00545740|Sensory System Agents|sensory system agents|mesh-ancestor
110614273|NCT00545740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110614274|NCT00545740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110614275|NCT00545740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110614276|NCT00545740|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110388854|NCT02730416|Tubulin Modulators|tubulin modulators|mesh-ancestor
110614278|NCT05208190|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110614279|NCT05208190|Serotonin Agents|serotonin agents|mesh-ancestor
110614280|NCT05208190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110614281|NCT05208190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110614282|NCT05208190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110614283|NCT05208190|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110614284|NCT05208190|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110614285|NCT05208190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110614286|NCT05208190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110614287|NCT05208190|GABA Antagonists|gaba antagonists|mesh-ancestor
110614288|NCT05208190|GABA Agents|gaba agents|mesh-ancestor
110614289|NCT00609609|Methylprednisolone|methylprednisolone|mesh-list
110614290|NCT00609609|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110614291|NCT00609609|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110614292|NCT00609609|Prednisolone|prednisolone|mesh-list
110614293|NCT00609609|Prednisolone acetate|prednisolone acetate|mesh-list
110614294|NCT00609609|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110614295|NCT00609609|Prednisolone phosphate|prednisolone phosphate|mesh-list
110614296|NCT00609609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110614297|NCT00609609|Antiemetics|antiemetics|mesh-ancestor
110614298|NCT00609609|Autonomic Agents|autonomic agents|mesh-ancestor
110614299|NCT00609609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110614300|NCT00609609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110614301|NCT00609609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110614302|NCT00609609|Glucocorticoids|glucocorticoids|mesh-ancestor
110614303|NCT00609609|Hormones|hormones|mesh-ancestor
110614304|NCT00609609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110614305|NCT00609609|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110614306|NCT00609609|Protective Agents|protective agents|mesh-ancestor
110614307|NCT00609609|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110614308|NCT00609609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110614309|NCT00673452|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110614310|NCT00673452|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110614311|NCT00673452|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110614312|NCT00673452|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110614313|NCT00673452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110614314|NCT00673452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110614315|NCT00673452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110614316|NCT00673452|Analgesics|analgesics|mesh-ancestor
110614317|NCT00673452|Sensory System Agents|sensory system agents|mesh-ancestor
110614318|NCT00673452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110614319|NCT00673452|Antidepressive Agents|antidepressive agents|mesh-ancestor
110614320|NCT00673452|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110614321|NCT00673452|Dopamine Agents|dopamine agents|mesh-ancestor
110614322|NCT00967174|Nicotine|nicotine|mesh-list
110614323|NCT00967174|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110614324|NCT00967174|Autonomic Agents|autonomic agents|mesh-ancestor
110614325|NCT00967174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110614326|NCT00967174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110614327|NCT00967174|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110614328|NCT00967174|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110614329|NCT00967174|Cholinergic Agents|cholinergic agents|mesh-ancestor
110614330|NCT00967174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110614331|NCT00967174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110614333|NCT00967252|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110614334|NCT00967252|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110614335|NCT00967252|Antimetabolites|antimetabolites|mesh-ancestor
110614336|NCT00967252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110614337|NCT00967252|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110153224|NCT03797560|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110614338|NCT00967252|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110614339|NCT00967252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110614340|NCT00890955|Cyclophosphamide|cyclophosphamide|mesh-list
110614341|NCT00890955|Amrubicin|amrubicin|mesh-list
110614342|NCT00890955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110614343|NCT00890955|Immunologic Factors|immunologic factors|mesh-ancestor
110614344|NCT00890955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110614345|NCT00890955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110614346|NCT00890955|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110261652|NCT00149162|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110614347|NCT00890955|Alkylating Agents|alkylating agents|mesh-ancestor
110614348|NCT00890955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110614349|NCT00890955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110614350|NCT00890955|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110614352|NCT00975052|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110614353|NCT00975052|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110614354|NCT00975052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110614355|NCT00975052|Incretins|incretins|mesh-ancestor
110614356|NCT00975052|Hormones|hormones|mesh-ancestor
110614357|NCT00975052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110614358|NCT00975052|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110614359|NCT00975052|Protease Inhibitors|protease inhibitors|mesh-ancestor
110614360|NCT00975052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110614361|NCT00975052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110614362|NCT00891033|Bortezomib|bortezomib|mesh-list
110614363|NCT00891033|Panobinostat|panobinostat|mesh-list
110614364|NCT00891033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110614365|NCT00891033|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110614366|NCT00891033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110614367|NCT00891033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110614368|NCT00770952|Pioglitazone|pioglitazone|mesh-list
110614369|NCT00770952|Glimepiride|glimepiride|mesh-list
110614370|NCT00770952|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110614371|NCT00770952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110614372|NCT00770952|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110614373|NCT00770952|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110614374|NCT00770952|Immunologic Factors|immunologic factors|mesh-ancestor
110614375|NCT00764556|Insulin|insulin|mesh-list
110614376|NCT00764556|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110614377|NCT00764556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110614378|NCT00968578|Methylprednisolone|methylprednisolone|mesh-list
110614379|NCT00968578|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110614380|NCT00968578|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110614381|NCT00968578|Prednisolone|prednisolone|mesh-list
110614382|NCT00968578|Prednisolone acetate|prednisolone acetate|mesh-list
110614383|NCT00968578|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110614384|NCT00968578|Prednisolone phosphate|prednisolone phosphate|mesh-list
110614385|NCT00968578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110614386|NCT00968578|Antiemetics|antiemetics|mesh-ancestor
110614387|NCT00968578|Autonomic Agents|autonomic agents|mesh-ancestor
110614388|NCT00968578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110614389|NCT00968578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110614390|NCT00968578|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110614391|NCT00968578|Glucocorticoids|glucocorticoids|mesh-ancestor
110614392|NCT00968578|Hormones|hormones|mesh-ancestor
110614393|NCT00968578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110614394|NCT00968578|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110614395|NCT00968578|Protective Agents|protective agents|mesh-ancestor
110614396|NCT00968578|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110614397|NCT00968578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110614398|NCT00893373|Sorafenib|sorafenib|mesh-list
110614399|NCT00893373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110614400|NCT00893373|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110614401|NCT00893373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110614402|NCT00893373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110614403|NCT00891267|Amlodipine|amlodipine|mesh-list
110614404|NCT00891267|Olmesartan|olmesartan|mesh-list
110388943|NCT02659930|Immunologic Factors|immunologic factors|mesh-ancestor
110388944|NCT02659930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110388945|NCT02659930|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110388946|NCT02659930|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110388947|NCT02659930|Growth Substances|growth substances|mesh-ancestor
110388948|NCT02659930|Growth Inhibitors|growth inhibitors|mesh-ancestor
110388949|NCT02627846|Lidocaine|lidocaine|mesh-list
110388950|NCT02627846|Epinephrine|epinephrine|mesh-list
110388951|NCT02627846|Racepinephrine|racepinephrine|mesh-list
110388952|NCT02627846|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110614405|NCT00891267|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
110614406|NCT00891267|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110614407|NCT00891267|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110614408|NCT00891267|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110614409|NCT00891267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110614410|NCT00891267|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110614411|NCT00891267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110614413|NCT00891267|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110614414|NCT00891267|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110614415|NCT00545584|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110614416|NCT00545584|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110614417|NCT00545584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110614418|NCT00545584|Incretins|incretins|mesh-ancestor
110614420|NCT00545584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110614421|NCT00545584|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110614422|NCT00545584|Protease Inhibitors|protease inhibitors|mesh-ancestor
110614423|NCT00545584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110614424|NCT00545584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110614425|NCT00378703|Sirolimus|sirolimus|mesh-list
110614426|NCT00378703|Bevacizumab|bevacizumab|mesh-list
110614427|NCT00378703|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110614428|NCT00378703|Sorafenib|sorafenib|mesh-list
110614429|NCT00378703|Temsirolimus|temsirolimus|mesh-list
110614430|NCT00378703|MTOR Inhibitors|mtor inhibitors|mesh-list
110614431|NCT00378703|Endothelial Growth Factors|endothelial growth factors|mesh-list
110614432|NCT00378703|Antibodies|antibodies|mesh-list
110614433|NCT00378703|Immunoglobulins|immunoglobulins|mesh-list
110614434|NCT00378703|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110614435|NCT00378703|Immunoglobulin G|immunoglobulin g|mesh-list
110614436|NCT00378703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110614437|NCT00378703|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110614438|NCT00378703|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110614439|NCT00378703|Growth Substances|growth substances|mesh-ancestor
110614440|NCT00378703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110614441|NCT00378703|Growth Inhibitors|growth inhibitors|mesh-ancestor
110614442|NCT00378703|Immunologic Factors|immunologic factors|mesh-ancestor
110614443|NCT00378703|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110614444|NCT00378703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110614445|NCT00378703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110614446|NCT00378703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110614447|NCT00378703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110614448|NCT00378703|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110614449|NCT00378703|Antifungal Agents|antifungal agents|mesh-ancestor
110614450|NCT00378703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110614451|NCT00893451|Vitamin D|vitamin d|mesh-list
110614452|NCT00893451|Cholecalciferol|cholecalciferol|mesh-list
110614453|NCT00893451|Vitamins|vitamins|mesh-ancestor
110614454|NCT00893451|Micronutrients|micronutrients|mesh-ancestor
110614455|NCT00893451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110614456|NCT00893451|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110614457|NCT00893451|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110614458|NCT00967408|Escitalopram|escitalopram|mesh-list
110614459|NCT00967408|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110614460|NCT00967408|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110614461|NCT00967408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110614462|NCT00967408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110614463|NCT00967408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110614464|NCT00967408|Serotonin Agents|serotonin agents|mesh-ancestor
110614465|NCT00967408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110614466|NCT00891423|Meropenem|meropenem|mesh-list
110614467|NCT00891423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110614468|NCT00891423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110614469|NCT04035382|Misoprostol|misoprostol|mesh-list
110614470|NCT04035382|Oxytocin|oxytocin|mesh-list
110614471|NCT04035382|Oxytocics|oxytocics|mesh-ancestor
110614472|NCT04035382|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110614473|NCT04035382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110614474|NCT04035382|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110614475|NCT04035382|Abortifacient Agents|abortifacient agents|mesh-ancestor
110614476|NCT04035382|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110614477|NCT04035382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110614478|NCT02541045|Metadoxine|metadoxine|mesh-list
110614479|NCT02541045|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110389021|NCT02567435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110614480|NCT00891579|Pemetrexed|pemetrexed|mesh-list
110614481|NCT00891579|Gefitinib|gefitinib|mesh-list
110614482|NCT00891579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110614483|NCT00891579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110614484|NCT00891579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110614485|NCT00891579|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110614486|NCT00891579|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110614487|NCT00891579|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110614488|NCT00968734|Cholecalciferol|cholecalciferol|mesh-list
110614489|NCT00968734|Vitamin D|vitamin d|mesh-list
110614490|NCT00968734|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110614491|NCT00968734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110614492|NCT00968734|Vitamins|vitamins|mesh-ancestor
110614493|NCT00968734|Micronutrients|micronutrients|mesh-ancestor
110614494|NCT00968734|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110614495|NCT03620643|Fulvestrant|fulvestrant|mesh-list
110614496|NCT03620643|Crizotinib|crizotinib|mesh-list
110614497|NCT03620643|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110614498|NCT03620643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110614499|NCT03620643|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110614500|NCT03620643|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110614501|NCT03620643|Hormone Antagonists|hormone antagonists|mesh-ancestor
110614502|NCT03620643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110614503|NCT03620643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110614504|NCT03620643|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110614505|NCT03620643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110614506|NCT03620643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110614508|NCT04008316|Gout Suppressants|gout suppressants|mesh-ancestor
110614509|NCT04008316|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110614510|NCT04008316|Tubulin Modulators|tubulin modulators|mesh-ancestor
110614511|NCT04008316|Antimitotic Agents|antimitotic agents|mesh-ancestor
110614512|NCT04008316|Mitosis Modulators|mitosis modulators|mesh-ancestor
110614513|NCT04008316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110614514|NCT04008316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110614515|NCT00893607|Methoxamine|methoxamine|mesh-list
110614516|NCT00893607|Sympathomimetics|sympathomimetics|mesh-ancestor
110614517|NCT00893607|Autonomic Agents|autonomic agents|mesh-ancestor
110614518|NCT00893607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110614519|NCT00893607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110614520|NCT00893607|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110614521|NCT00893607|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110614522|NCT00893607|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110614523|NCT00893607|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110614524|NCT00893607|Adrenergic Agents|adrenergic agents|mesh-ancestor
110614525|NCT00893607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110614526|NCT00893607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110614527|NCT00969046|Epothilone B|epothilone b|mesh-list
110614528|NCT00969046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110614529|NCT00969046|Tubulin Modulators|tubulin modulators|mesh-ancestor
110614530|NCT00969046|Antimitotic Agents|antimitotic agents|mesh-ancestor
110614531|NCT00969046|Mitosis Modulators|mitosis modulators|mesh-ancestor
110614532|NCT00969046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110614533|NCT05008354|Pyridoxine|pyridoxine|mesh-list
110614534|NCT05008354|Vitamin B Complex|vitamin b complex|mesh-ancestor
110614535|NCT05008354|Vitamins|vitamins|mesh-ancestor
110614536|NCT05008354|Micronutrients|micronutrients|mesh-ancestor
110614537|NCT05008354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110614538|NCT00975754|Budesonide|budesonide|mesh-list
110614539|NCT00975754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110614540|NCT00975754|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110614541|NCT00975754|Autonomic Agents|autonomic agents|mesh-ancestor
110614542|NCT00975754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110614543|NCT00975754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110614544|NCT00975754|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110153240|NCT03574402|Maleic acid|maleic acid|mesh-list
110614545|NCT00975754|Respiratory System Agents|respiratory system agents|mesh-ancestor
110614546|NCT00975754|Glucocorticoids|glucocorticoids|mesh-ancestor
110614547|NCT00975754|Hormones|hormones|mesh-ancestor
110614548|NCT00975754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110614549|NCT01045681|Dexamethasone|dexamethasone|mesh-list
110614550|NCT01045681|Dexamethasone acetate|dexamethasone acetate|mesh-list
110614551|NCT01045681|Bortezomib|bortezomib|mesh-list
110614552|NCT01045681|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110614553|NCT01045681|BB 1101|bb 1101|mesh-list
110614554|NCT01045681|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110614555|NCT01045681|Antiemetics|antiemetics|mesh-ancestor
110614556|NCT01045681|Autonomic Agents|autonomic agents|mesh-ancestor
110614557|NCT01045681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110614558|NCT01045681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110614559|NCT01045681|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110614560|NCT01045681|Glucocorticoids|glucocorticoids|mesh-ancestor
110614561|NCT01045681|Hormones|hormones|mesh-ancestor
110614562|NCT01045681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110614563|NCT01045681|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110614564|NCT01045681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110614565|NCT01045681|Protease Inhibitors|protease inhibitors|mesh-ancestor
110614566|NCT01045681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110614567|NCT01045681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110614568|NCT01045681|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110261876|NCT04688632|Moxifloxacin|moxifloxacin|mesh-list
110614569|NCT01045681|Alkylating Agents|alkylating agents|mesh-ancestor
110614570|NCT00975910|Lidocaine|lidocaine|mesh-list
110614571|NCT00975910|Anesthetics, Local|anesthetics, local|mesh-ancestor
110614572|NCT00975910|Anesthetics|anesthetics|mesh-ancestor
110614573|NCT00975910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110614574|NCT00975910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110614575|NCT00975910|Sensory System Agents|sensory system agents|mesh-ancestor
110614576|NCT00975910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110614577|NCT00975910|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110614578|NCT00975910|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110614579|NCT00975910|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110614580|NCT00975910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110614581|NCT00975910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110614582|NCT03617913|Cisplatin|cisplatin|mesh-list
110614583|NCT03617913|Fluorouracil|fluorouracil|mesh-list
110614584|NCT03617913|Mitomycins|mitomycins|mesh-list
110614585|NCT03617913|Mitomycin|mitomycin|mesh-list
110614586|NCT03617913|Avelumab|avelumab|mesh-list
110614587|NCT03617913|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110614588|NCT03617913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110614589|NCT03617913|Antimetabolites|antimetabolites|mesh-ancestor
110614590|NCT03617913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110614591|NCT03617913|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110614592|NCT03617913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110614594|NCT03617913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110614595|NCT03617913|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110614596|NCT03617913|Alkylating Agents|alkylating agents|mesh-ancestor
110614597|NCT03617913|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110614598|NCT03617913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110614599|NCT03617913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110614600|NCT00975988|Lapatinib|lapatinib|mesh-list
110614601|NCT00975988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110614602|NCT00975988|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110614603|NCT00975988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110614604|NCT00975988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110614605|NCT00976066|Naltrexone|naltrexone|mesh-list
110614606|NCT00976066|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110614607|NCT00976066|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110614608|NCT00976066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110614609|NCT00976066|Sensory System Agents|sensory system agents|mesh-ancestor
110614610|NCT00976066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110614611|NCT00969592|Insulin|insulin|mesh-list
110614612|NCT00969592|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110614613|NCT00969592|Insulin Aspart|insulin aspart|mesh-list
110614614|NCT00969592|Insulin, Long-Acting|insulin, long-acting|mesh-list
110614615|NCT00969592|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
110614616|NCT00969592|Insulin glulisine|insulin glulisine|mesh-list
110614617|NCT00969592|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110614618|NCT00969592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110614619|NCT00368641|Icodextrin|icodextrin|mesh-list
110614620|NCT00368641|Dialysis Solutions|dialysis solutions|mesh-ancestor
110614621|NCT00368641|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110614622|NCT00976222|Ranibizumab|ranibizumab|mesh-list
110614623|NCT00976222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110614624|NCT00976222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110614625|NCT00976222|Growth Substances|growth substances|mesh-ancestor
110614626|NCT00976222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110614627|NCT00976222|Growth Inhibitors|growth inhibitors|mesh-ancestor
110614628|NCT00976222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110614629|NCT00976300|Cyclosporine|cyclosporine|mesh-list
110614630|NCT00976300|Cyclophosphamide|cyclophosphamide|mesh-list
110614631|NCT00976300|Cyclosporins|cyclosporins|mesh-list
110614632|NCT00976300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110614633|NCT00976300|Immunologic Factors|immunologic factors|mesh-ancestor
110614634|NCT00976300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110614635|NCT00976300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110614636|NCT00976300|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110614637|NCT00976300|Alkylating Agents|alkylating agents|mesh-ancestor
110614638|NCT00976300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110614639|NCT00976300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110614640|NCT00976300|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110614641|NCT00976300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110614642|NCT00976300|Antifungal Agents|antifungal agents|mesh-ancestor
110614643|NCT00976300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110614644|NCT00976300|Dermatologic Agents|dermatologic agents|mesh-ancestor
110614645|NCT00976300|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110614646|NCT00979966|Sirolimus|sirolimus|mesh-list
110261945|NCT05785585|Vitamin B 12|vitamin b 12|mesh-list
110614647|NCT00979966|Sunitinib|sunitinib|mesh-list
110614648|NCT00979966|Temsirolimus|temsirolimus|mesh-list
110614649|NCT00979966|MTOR Inhibitors|mtor inhibitors|mesh-list
110614650|NCT00979966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110614651|NCT00979966|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110614652|NCT00979966|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110614654|NCT00979966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110614655|NCT00979966|Growth Inhibitors|growth inhibitors|mesh-ancestor
110614656|NCT00979966|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110614657|NCT00979966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110614658|NCT00979966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110614659|NCT00979966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110614660|NCT00979966|Immunologic Factors|immunologic factors|mesh-ancestor
110614661|NCT00979966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110614662|NCT00979966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110614663|NCT00979966|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110614664|NCT00979966|Antifungal Agents|antifungal agents|mesh-ancestor
110614665|NCT00969904|Acetylcysteine|acetylcysteine|mesh-list
110614666|NCT00969904|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110614667|NCT00969904|Antiviral Agents|antiviral agents|mesh-ancestor
110614668|NCT00969904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110614669|NCT00969904|Expectorants|expectorants|mesh-ancestor
110614670|NCT00969904|Respiratory System Agents|respiratory system agents|mesh-ancestor
110614671|NCT00969904|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110614672|NCT00969904|Antioxidants|antioxidants|mesh-ancestor
110614673|NCT00969904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110614674|NCT00969904|Protective Agents|protective agents|mesh-ancestor
110614675|NCT00969904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110614676|NCT00969904|Antidotes|antidotes|mesh-ancestor
110614677|NCT00976690|Mesalamine|mesalamine|mesh-list
110614678|NCT00976690|Azathioprine|azathioprine|mesh-list
110614679|NCT00976690|Antimetabolites|antimetabolites|mesh-ancestor
110614680|NCT00976690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110614681|NCT00976690|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110614682|NCT00976690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110614683|NCT00976690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110614684|NCT00976690|Immunologic Factors|immunologic factors|mesh-ancestor
110614685|NCT00976690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110614686|NCT00976690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110153250|NCT03574402|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110614687|NCT00976690|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110614688|NCT00976690|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110614689|NCT00976690|Analgesics|analgesics|mesh-ancestor
110614690|NCT00976690|Sensory System Agents|sensory system agents|mesh-ancestor
110614691|NCT00976690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110614692|NCT00976690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110614693|NCT00976768|Fluorouracil|fluorouracil|mesh-list
110614695|NCT00976768|Antimetabolites|antimetabolites|mesh-ancestor
110614696|NCT00976768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110614697|NCT00976768|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110614698|NCT00976768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110614699|NCT00976768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110614700|NCT00976768|Immunologic Factors|immunologic factors|mesh-ancestor
110614701|NCT00976768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110614703|NCT00608985|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110614704|NCT00608985|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110614705|NCT00608985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110614706|NCT00608985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110614707|NCT00608985|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
110614708|NCT00608985|GABA Agonists|gaba agonists|mesh-ancestor
110614709|NCT00608985|GABA Agents|gaba agents|mesh-ancestor
110614710|NCT00608985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110614711|NCT00608985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110614712|NCT00969982|Misoprostol|misoprostol|mesh-list
110614713|NCT00969982|Mifepristone|mifepristone|mesh-list
110614714|NCT00969982|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110614715|NCT00969982|Abortifacient Agents|abortifacient agents|mesh-ancestor
110614716|NCT00969982|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110614717|NCT00969982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110614718|NCT00969982|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110614719|NCT00969982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110614720|NCT00969982|Oxytocics|oxytocics|mesh-ancestor
110262024|NCT05784987|Analgesics|analgesics|mesh-ancestor
110614721|NCT00969982|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
110614722|NCT00969982|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110614723|NCT00969982|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110614724|NCT00969982|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110614725|NCT00969982|Contraceptive Agents|contraceptive agents|mesh-ancestor
110614726|NCT00969982|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
110614727|NCT00969982|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
110614728|NCT00969982|Hormone Antagonists|hormone antagonists|mesh-ancestor
110614729|NCT00969982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110614730|NCT00969982|Luteolytic Agents|luteolytic agents|mesh-ancestor
110614731|NCT00969982|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110614732|NCT00969982|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
110614733|NCT00970138|Apatinib|apatinib|mesh-list
110614734|NCT00970138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110614735|NCT00970138|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110614736|NCT00970138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110614737|NCT00970138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110614738|NCT00892125|Carbamazepine|carbamazepine|mesh-list
110614739|NCT00892125|Paliperidone Palmitate|paliperidone palmitate|mesh-list
110614740|NCT00892125|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110614741|NCT00892125|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110614742|NCT00892125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110614743|NCT00892125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110614744|NCT00892125|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110614745|NCT00892125|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110614746|NCT00892125|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110614747|NCT00892125|Serotonin Agents|serotonin agents|mesh-ancestor
110614748|NCT00892125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110614749|NCT00892125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110614750|NCT00892125|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110614751|NCT00892125|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110614752|NCT00892125|Dopamine Agents|dopamine agents|mesh-ancestor
110614753|NCT00892125|Anticonvulsants|anticonvulsants|mesh-ancestor
110614754|NCT00892125|Antimanic Agents|antimanic agents|mesh-ancestor
110614755|NCT00892125|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110614756|NCT00892125|Analgesics|analgesics|mesh-ancestor
110614757|NCT00892125|Sensory System Agents|sensory system agents|mesh-ancestor
110614758|NCT00892125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110614759|NCT00892125|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110614760|NCT00892125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110614761|NCT00892125|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110614762|NCT00892125|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110614764|NCT00980356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110614765|NCT00980356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110614766|NCT00980356|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110614767|NCT00980356|Protease Inhibitors|protease inhibitors|mesh-ancestor
110614768|NCT00980356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110614769|NCT00980356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110614770|NCT00368251|Brivaracetam|brivaracetam|mesh-list
110614771|NCT00368251|Anticonvulsants|anticonvulsants|mesh-ancestor
110614772|NCT00893841|Pramipexole|pramipexole|mesh-list
110614773|NCT00893841|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110614774|NCT00893841|Antidepressive Agents|antidepressive agents|mesh-ancestor
110614775|NCT00893841|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110614776|NCT00893841|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110614777|NCT00893841|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110614778|NCT00893841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110614779|NCT00893841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110614780|NCT00893841|Antioxidants|antioxidants|mesh-ancestor
110614781|NCT00893841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110614782|NCT00893841|Protective Agents|protective agents|mesh-ancestor
110614783|NCT00893841|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110614784|NCT00893841|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110614785|NCT00893841|Dopamine Agonists|dopamine agonists|mesh-ancestor
110614786|NCT00893841|Dopamine Agents|dopamine agents|mesh-ancestor
110614787|NCT00893841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110614788|NCT00378079|Methadone|methadone|mesh-list
110614789|NCT00378079|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110614790|NCT00378079|Narcotics|narcotics|mesh-ancestor
110614791|NCT00378079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110614792|NCT00378079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110614793|NCT00378079|Analgesics|analgesics|mesh-ancestor
110614794|NCT00378079|Sensory System Agents|sensory system agents|mesh-ancestor
110614795|NCT00378079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110614797|NCT00378079|Respiratory System Agents|respiratory system agents|mesh-ancestor
110614798|NCT00970450|Acetaminophen|acetaminophen|mesh-list
110614799|NCT00970450|Tropisetron|tropisetron|mesh-list
110614800|NCT00970450|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110614801|NCT00970450|Analgesics|analgesics|mesh-ancestor
110614802|NCT00970450|Sensory System Agents|sensory system agents|mesh-ancestor
110614803|NCT00970450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110614804|NCT00970450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110614805|NCT00970450|Antipyretics|antipyretics|mesh-ancestor
110614806|NCT00970450|Antiemetics|antiemetics|mesh-ancestor
110614807|NCT00970450|Autonomic Agents|autonomic agents|mesh-ancestor
110614808|NCT00970450|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110614809|NCT00970450|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110614810|NCT00970450|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110614811|NCT00970450|Serotonin Agents|serotonin agents|mesh-ancestor
110614812|NCT00970450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110614813|NCT00970450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110614814|NCT00970528|Acarbose|acarbose|mesh-list
110614815|NCT00970528|Voglibose|voglibose|mesh-list
110614816|NCT00970528|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
110614817|NCT00970528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110614818|NCT00970528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110614819|NCT00970528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110614820|NCT00970528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110614821|NCT00970762|Rocuronium|rocuronium|mesh-list
110614822|NCT00970762|Vecuronium Bromide|vecuronium bromide|mesh-list
110017947|NCT03285984|Listerine|listerine|mesh-list
110614823|NCT00970762|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110614824|NCT00970762|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110614825|NCT00970762|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110614826|NCT00970762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110614827|NCT00970762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110153257|NCT00000831|Lamivudine|lamivudine|mesh-list
110614828|NCT00970762|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
110614829|NCT00970762|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110614830|NCT00970762|Cholinergic Agents|cholinergic agents|mesh-ancestor
110614831|NCT00970762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110614832|NCT00970762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110614833|NCT00978172|Artesunate|artesunate|mesh-list
110614834|NCT00978172|Mefloquine|mefloquine|mesh-list
110614835|NCT00978172|Antimalarials|antimalarials|mesh-ancestor
110614836|NCT00978172|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110614837|NCT00978172|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110614838|NCT00978172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110614839|NCT00978172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110614840|NCT00978172|Antiviral Agents|antiviral agents|mesh-ancestor
110614841|NCT00978172|Schistosomicides|schistosomicides|mesh-ancestor
110614842|NCT00978172|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110389434|NCT01959139|Vitamins|vitamins|mesh-ancestor
110614844|NCT03923530|Eplerenone|eplerenone|mesh-list
110614845|NCT03923530|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110614846|NCT03923530|Hormone Antagonists|hormone antagonists|mesh-ancestor
110614847|NCT03923530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110614848|NCT03923530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110614849|NCT03923530|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110614850|NCT03923530|Diuretics|diuretics|mesh-ancestor
110614851|NCT03923530|Natriuretic Agents|natriuretic agents|mesh-ancestor
110614852|NCT03923530|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110614853|NCT00608907|Rifampin|rifampin|mesh-list
110614854|NCT00608907|Dexamethasone|dexamethasone|mesh-list
110614855|NCT00608907|Dexamethasone acetate|dexamethasone acetate|mesh-list
110614856|NCT00608907|Bortezomib|bortezomib|mesh-list
110614857|NCT00608907|BB 1101|bb 1101|mesh-list
110614858|NCT00608907|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110614859|NCT00608907|Antiemetics|antiemetics|mesh-ancestor
110614860|NCT00608907|Autonomic Agents|autonomic agents|mesh-ancestor
110614861|NCT00608907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110614862|NCT00608907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110614863|NCT00608907|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110614864|NCT00608907|Glucocorticoids|glucocorticoids|mesh-ancestor
110614865|NCT00608907|Hormones|hormones|mesh-ancestor
110614866|NCT00608907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110614867|NCT00608907|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110614868|NCT00608907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110614869|NCT00608907|Protease Inhibitors|protease inhibitors|mesh-ancestor
110614870|NCT00608907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110614871|NCT00608907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110614872|NCT00608907|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110614873|NCT00608907|Antitubercular Agents|antitubercular agents|mesh-ancestor
110614874|NCT00608907|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110614875|NCT00608907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110614876|NCT00608907|Leprostatic Agents|leprostatic agents|mesh-ancestor
110614877|NCT00608907|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110614878|NCT00608907|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110614879|NCT00608907|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110614880|NCT00608907|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110614881|NCT00608907|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110614882|NCT00608907|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110614883|NCT00608907|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110614884|NCT00970996|Interferons|interferons|mesh-list
110614885|NCT00970996|Interferon-alpha|interferon-alpha|mesh-list
110614886|NCT00970996|Interferon alpha-2|interferon alpha-2|mesh-list
110614887|NCT00970996|Paclitaxel|paclitaxel|mesh-list
110614888|NCT00970996|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110614889|NCT00970996|Cisplatin|cisplatin|mesh-list
110614890|NCT00970996|Temozolomide|temozolomide|mesh-list
110614891|NCT00970996|Interleukin-2|interleukin-2|mesh-list
110614892|NCT00970996|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110614893|NCT00970996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110614894|NCT00970996|Tubulin Modulators|tubulin modulators|mesh-ancestor
110614895|NCT00970996|Antimitotic Agents|antimitotic agents|mesh-ancestor
110614896|NCT00970996|Mitosis Modulators|mitosis modulators|mesh-ancestor
110614897|NCT00970996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110614898|NCT00970996|Antiviral Agents|antiviral agents|mesh-ancestor
110614899|NCT00970996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110614900|NCT00970996|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110614901|NCT00970996|Alkylating Agents|alkylating agents|mesh-ancestor
110614902|NCT00970996|Immunologic Factors|immunologic factors|mesh-ancestor
110614903|NCT00970996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110614904|NCT00970996|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110614905|NCT00970996|Analgesics|analgesics|mesh-ancestor
110614906|NCT00970996|Sensory System Agents|sensory system agents|mesh-ancestor
110614907|NCT00970996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110614908|NCT00869193|Grape Seed Extract|grape seed extract|mesh-list
110614909|NCT00869193|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110614910|NCT00869193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110614912|NCT00869193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110614913|NCT00869193|Protective Agents|protective agents|mesh-ancestor
110614914|NCT00869193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110614915|NCT04009018|Anesthetics|anesthetics|mesh-list
110614916|NCT04009018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110614917|NCT04009018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110614919|NCT00869271|Fluorouracil|fluorouracil|mesh-list
110614920|NCT00869271|Oxaliplatin|oxaliplatin|mesh-list
110614921|NCT00869271|Antimetabolites|antimetabolites|mesh-ancestor
110614922|NCT00869271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110614923|NCT00869271|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110614924|NCT00869271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110614925|NCT00869271|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110614926|NCT00869271|Immunologic Factors|immunologic factors|mesh-ancestor
110614927|NCT00869271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110614928|NCT00869271|Antidotes|antidotes|mesh-ancestor
110614929|NCT00869271|Protective Agents|protective agents|mesh-ancestor
110614930|NCT00869271|Vitamin B Complex|vitamin b complex|mesh-ancestor
110614931|NCT00869271|Vitamins|vitamins|mesh-ancestor
110614932|NCT00869271|Micronutrients|micronutrients|mesh-ancestor
110614934|NCT00971074|Viscosupplements|viscosupplements|mesh-ancestor
110614935|NCT00971074|Protective Agents|protective agents|mesh-ancestor
110614936|NCT00971074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110614937|NCT00971152|Menotropins|menotropins|mesh-list
110614938|NCT00971152|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110614939|NCT00971152|Fertility Agents|fertility agents|mesh-ancestor
110614940|NCT00971152|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110614941|NCT00971152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110614942|NCT00893919|Mycophenolic Acid|mycophenolic acid|mesh-list
110614943|NCT00893919|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110614944|NCT00893919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110614945|NCT00893919|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110614946|NCT00893919|Antitubercular Agents|antitubercular agents|mesh-ancestor
110614947|NCT00893919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110614948|NCT00893919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110614949|NCT00893919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110614950|NCT00893919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110614951|NCT00978328|Oxycodone|oxycodone|mesh-list
110614952|NCT00978328|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110614953|NCT00978328|Narcotics|narcotics|mesh-ancestor
110614954|NCT00978328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110614955|NCT00978328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110614956|NCT00978328|Analgesics|analgesics|mesh-ancestor
110614957|NCT00978328|Sensory System Agents|sensory system agents|mesh-ancestor
110614958|NCT00978328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110614959|NCT00892359|Anidulafungin|anidulafungin|mesh-list
110614960|NCT00892359|Antifungal Agents|antifungal agents|mesh-ancestor
110614961|NCT00892359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110614962|NCT01051531|Paliperidone Palmitate|paliperidone palmitate|mesh-list
110614963|NCT01051531|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110614964|NCT01051531|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110614965|NCT01051531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110614966|NCT01051531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110614967|NCT01051531|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110614968|NCT01051531|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110614969|NCT01051531|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110614970|NCT01051531|Serotonin Agents|serotonin agents|mesh-ancestor
110614971|NCT01051531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110614972|NCT01051531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110614973|NCT01051531|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110614975|NCT01051531|Dopamine Agents|dopamine agents|mesh-ancestor
110614976|NCT03992911|Carboplatin|carboplatin|mesh-list
110614977|NCT03992911|Etoposide|etoposide|mesh-list
110614978|NCT03992911|Etoposide phosphate|etoposide phosphate|mesh-list
110614979|NCT03992911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110614980|NCT03992911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110614981|NCT03992911|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110614982|NCT03992911|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110614983|NCT03992911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110614984|NCT03992911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110614985|NCT00545272|Formoterol Fumarate|formoterol fumarate|mesh-list
110614986|NCT00545272|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110614987|NCT00545272|Autonomic Agents|autonomic agents|mesh-ancestor
110614988|NCT00545272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110614989|NCT00545272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110614990|NCT00545272|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110614991|NCT00545272|Respiratory System Agents|respiratory system agents|mesh-ancestor
110614992|NCT00545272|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110614993|NCT00545272|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110614994|NCT00545272|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110614995|NCT00545272|Adrenergic Agents|adrenergic agents|mesh-ancestor
110614996|NCT00545272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110614997|NCT00545272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110614999|NCT00377455|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110615000|NCT00377455|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
110615001|NCT00377455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110615002|NCT00895557|Varenicline|varenicline|mesh-list
110615003|NCT00895557|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110615004|NCT00895557|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110615005|NCT00895557|Cholinergic Agents|cholinergic agents|mesh-ancestor
110615006|NCT00895557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110615007|NCT00895557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110615008|NCT00895557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110615009|NCT00869973|Dexamethasone|dexamethasone|mesh-list
110615010|NCT00869973|Aprepitant|aprepitant|mesh-list
110615011|NCT00869973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110615012|NCT00869973|Antiemetics|antiemetics|mesh-ancestor
110615013|NCT00869973|Autonomic Agents|autonomic agents|mesh-ancestor
110615014|NCT00869973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110615015|NCT00869973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110615016|NCT00869973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110615017|NCT00869973|Glucocorticoids|glucocorticoids|mesh-ancestor
110615018|NCT00869973|Hormones|hormones|mesh-ancestor
110615019|NCT00869973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110615020|NCT00869973|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110615021|NCT00869973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110615022|NCT00869973|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110615023|NCT00869973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110615024|NCT00869973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110615026|NCT04008784|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110615027|NCT04008784|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110615028|NCT04008784|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110615029|NCT04008784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110615030|NCT04008784|Glucocorticoids|glucocorticoids|mesh-ancestor
110615031|NCT04008784|Hormones|hormones|mesh-ancestor
110615032|NCT04008784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110615033|NCT04008784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110615034|NCT04008784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110615035|NCT04008784|Immunologic Factors|immunologic factors|mesh-ancestor
110615036|NCT04008784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110615037|NCT04008784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110615038|NCT01051687|Botulinum Toxins|botulinum toxins|mesh-list
110615039|NCT01051687|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110615040|NCT01051687|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110615041|NCT01051687|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110615042|NCT01051687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110615043|NCT01051687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110615044|NCT01051687|Cholinergic Agents|cholinergic agents|mesh-ancestor
110615045|NCT01051687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110615046|NCT01051687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110615047|NCT01051687|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110615048|NCT01051687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110615049|NCT00978718|Selenium|selenium|mesh-list
110615050|NCT00978718|Antioxidants|antioxidants|mesh-ancestor
110615051|NCT00978718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110615052|NCT00978718|Protective Agents|protective agents|mesh-ancestor
110615053|NCT00978718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110615054|NCT00978718|Trace Elements|trace elements|mesh-ancestor
110615055|NCT00978718|Micronutrients|micronutrients|mesh-ancestor
110615056|NCT00895713|Immunoglobulins|immunoglobulins|mesh-list
110615057|NCT00895713|Antibodies|antibodies|mesh-list
110615058|NCT00895713|gamma-Globulins|gamma-globulins|mesh-list
110615059|NCT00895713|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110615060|NCT00895713|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110615061|NCT00895713|Immunologic Factors|immunologic factors|mesh-ancestor
110615062|NCT00895713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110615063|NCT01051765|Irinotecan|irinotecan|mesh-list
110615064|NCT01051765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110615065|NCT01051765|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110615066|NCT01051765|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110615067|NCT01051765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110615068|NCT01051765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110615069|NCT00978796|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110615070|NCT00978796|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110615071|NCT00978796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110615072|NCT00978796|Incretins|incretins|mesh-ancestor
110615073|NCT00978796|Hormones|hormones|mesh-ancestor
110615074|NCT00978796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110615075|NCT00978796|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110615076|NCT00978796|Protease Inhibitors|protease inhibitors|mesh-ancestor
110615077|NCT00978796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110615078|NCT00978796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110615079|NCT00894231|Levocetirizine|levocetirizine|mesh-list
110615080|NCT00894231|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110615081|NCT00894231|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110615082|NCT00894231|Histamine Antagonists|histamine antagonists|mesh-ancestor
110615083|NCT00894231|Histamine Agents|histamine agents|mesh-ancestor
110615084|NCT00894231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110615085|NCT00894231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110615086|NCT00894231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110615087|NCT00377299|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
110615088|NCT00377299|Nootropic Agents|nootropic agents|mesh-ancestor
110615089|NCT03472365|Capecitabine|capecitabine|mesh-list
110615090|NCT03472365|Oxaliplatin|oxaliplatin|mesh-list
110615091|NCT03472365|Apatinib|apatinib|mesh-list
110615092|NCT03472365|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110615093|NCT03472365|Antimetabolites|antimetabolites|mesh-ancestor
110615094|NCT03472365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110615096|NCT03472365|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110615097|NCT03472365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110615098|NCT00894621|Norepinephrine|norepinephrine|mesh-list
110615099|NCT00894621|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110615100|NCT00894621|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110615101|NCT00894621|Adrenergic Agents|adrenergic agents|mesh-ancestor
110615102|NCT00894621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110615103|NCT00894621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110615104|NCT00894621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110615105|NCT00894621|Sympathomimetics|sympathomimetics|mesh-ancestor
110615107|NCT00894621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110615108|NCT00894621|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110615109|NCT00376675|Methylphenidate|methylphenidate|mesh-list
110615110|NCT00376675|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110615111|NCT00376675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110615112|NCT00376675|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110389626|NCT01289171|Dermatologic Agents|dermatologic agents|mesh-ancestor
110615113|NCT00376675|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110615114|NCT00376675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110615115|NCT00376675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110615116|NCT00376675|Dopamine Agents|dopamine agents|mesh-ancestor
110615117|NCT00376675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110615118|NCT00979186|Hemostatics|hemostatics|mesh-list
110615119|NCT00979186|Coagulants|coagulants|mesh-ancestor
110615121|NCT05178628|Gemcitabine|gemcitabine|mesh-list
110615122|NCT05178628|Tinzaparin|tinzaparin|mesh-list
110615123|NCT05178628|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110615124|NCT05178628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110615125|NCT05178628|Tubulin Modulators|tubulin modulators|mesh-ancestor
110615126|NCT05178628|Antimitotic Agents|antimitotic agents|mesh-ancestor
110615127|NCT05178628|Mitosis Modulators|mitosis modulators|mesh-ancestor
110615128|NCT05178628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110615129|NCT05178628|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110615130|NCT05178628|Antimetabolites|antimetabolites|mesh-ancestor
110615131|NCT05178628|Anticoagulants|anticoagulants|mesh-ancestor
110615132|NCT05178628|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110615133|NCT05178628|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110615134|NCT00896571|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110615135|NCT00896571|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110615136|NCT00896571|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110615137|NCT00896571|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110615138|NCT00896571|Contraceptive Agents|contraceptive agents|mesh-ancestor
110615139|NCT00896571|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110615140|NCT00896571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110615141|NCT00896571|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110615142|NCT00896571|Estrogens|estrogens|mesh-ancestor
110615143|NCT00896571|Hormones|hormones|mesh-ancestor
110615144|NCT00896571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110615145|NCT00896727|Antibodies|antibodies|mesh-list
110615146|NCT00896727|Immunologic Factors|immunologic factors|mesh-ancestor
110615147|NCT00896727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110615148|NCT00981838|Rituximab|rituximab|mesh-list
110615149|NCT00981838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110615150|NCT00981838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110615151|NCT00981838|Immunologic Factors|immunologic factors|mesh-ancestor
110615152|NCT00981838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110615153|NCT00981838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110615154|NCT02533765|Olaparib|olaparib|mesh-list
110615155|NCT02533765|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110615156|NCT02533765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110615157|NCT02533765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110389653|NCT01190930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110615158|NCT02533765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110615159|NCT04035993|Hypoglycemic Agents|hypoglycemic agents|mesh-list
110615160|NCT04035993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110615161|NCT00367237|Infliximab|infliximab|mesh-list
110615162|NCT00367237|Methotrexate|methotrexate|mesh-list
110615163|NCT00367237|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110615164|NCT00367237|Abortifacient Agents|abortifacient agents|mesh-ancestor
110615165|NCT00367237|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110615166|NCT00367237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110615167|NCT00367237|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110615168|NCT00367237|Antimetabolites|antimetabolites|mesh-ancestor
110615169|NCT00367237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110615170|NCT00367237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110615171|NCT00367237|Dermatologic Agents|dermatologic agents|mesh-ancestor
110615172|NCT00367237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110615173|NCT00367237|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110615174|NCT00367237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110615175|NCT00367237|Immunologic Factors|immunologic factors|mesh-ancestor
110615176|NCT00367237|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110615177|NCT00367237|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110615178|NCT00367237|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110615179|NCT00367237|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110615180|NCT00367237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110615181|NCT00901407|Lamotrigine|lamotrigine|mesh-list
110615182|NCT00901407|Paroxetine|paroxetine|mesh-list
110615183|NCT00901407|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110615184|NCT00901407|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110615185|NCT00901407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110615186|NCT00901407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110615187|NCT00901407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110615188|NCT00901407|Serotonin Agents|serotonin agents|mesh-ancestor
110615189|NCT00901407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110615190|NCT00901407|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110615191|NCT00901407|Antidepressive Agents|antidepressive agents|mesh-ancestor
110615192|NCT00901407|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110615193|NCT00901407|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110615194|NCT00901407|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110615195|NCT00901407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110615196|NCT00901407|Anticonvulsants|anticonvulsants|mesh-ancestor
110615197|NCT00901407|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110615198|NCT00901407|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110615199|NCT00901407|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110615200|NCT00901407|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110615201|NCT00901407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110615202|NCT00901407|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110615203|NCT00984724|Nicotine|nicotine|mesh-list
110615204|NCT00984724|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110615205|NCT00984724|Autonomic Agents|autonomic agents|mesh-ancestor
110615206|NCT00984724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110615207|NCT00984724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110615208|NCT00984724|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110615209|NCT00984724|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110615210|NCT00984724|Cholinergic Agents|cholinergic agents|mesh-ancestor
110615211|NCT00984724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110615212|NCT00984724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110615213|NCT00901719|Nitroprusside|nitroprusside|mesh-list
110615214|NCT00901719|Acetylcholine|acetylcholine|mesh-list
110615215|NCT00901719|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110615216|NCT00901719|Vasodilator Agents|vasodilator agents|mesh-ancestor
110615217|NCT00901719|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
110615218|NCT00901719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110615219|NCT00901719|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110615220|NCT00901719|Cholinergic Agents|cholinergic agents|mesh-ancestor
110615221|NCT00901719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110615222|NCT00901719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110615223|NCT00972712|Bortezomib|bortezomib|mesh-list
110615225|NCT00972712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110615226|NCT02539641|Hormones|hormones|mesh-list
110615227|NCT02539641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110615228|NCT02539641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110615229|NCT00544882|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110615230|NCT00544882|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110615231|NCT00544882|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110615232|NCT00544882|Desogestrel|desogestrel|mesh-list
110615233|NCT00544882|Oviol|oviol|mesh-list
110615234|NCT00544882|Estradiol|estradiol|mesh-list
110615235|NCT00544882|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110615236|NCT00544882|Estrogens|estrogens|mesh-ancestor
110615237|NCT00544882|Hormones|hormones|mesh-ancestor
110615238|NCT00544882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110615239|NCT00544882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110615240|NCT00544882|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110615241|NCT00544882|Contraceptive Agents|contraceptive agents|mesh-ancestor
110615242|NCT00544882|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110615243|NCT00544882|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110615244|NCT00544882|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110615246|NCT00544882|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110615247|NCT00544882|Progestins|progestins|mesh-ancestor
110615248|NCT00544882|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110615249|NCT04035603|Cycloserine|cycloserine|mesh-list
110615250|NCT04035603|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110615251|NCT04035603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110615252|NCT04035603|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110615253|NCT04035603|Antitubercular Agents|antitubercular agents|mesh-ancestor
110615254|NCT04035603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110615255|NCT04035603|Antimetabolites|antimetabolites|mesh-ancestor
110615256|NCT04035603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110615257|NCT00606801|Galantamine|galantamine|mesh-list
110615258|NCT00606801|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110615259|NCT00606801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110615260|NCT00606801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110615261|NCT00606801|Cholinergic Agents|cholinergic agents|mesh-ancestor
110615262|NCT00606801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110615263|NCT00606801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110615264|NCT00606801|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110615265|NCT00606801|Autonomic Agents|autonomic agents|mesh-ancestor
110615266|NCT00606801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110615267|NCT00606801|Nootropic Agents|nootropic agents|mesh-ancestor
110615268|NCT00972790|Bupivacaine|bupivacaine|mesh-list
110615269|NCT00972790|Anesthetics, Local|anesthetics, local|mesh-ancestor
110615270|NCT00972790|Anesthetics|anesthetics|mesh-ancestor
110615271|NCT00972790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110615272|NCT00972790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110615273|NCT00972790|Sensory System Agents|sensory system agents|mesh-ancestor
110615274|NCT00972790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110615275|NCT00901875|Buprenorphine|buprenorphine|mesh-list
110615276|NCT00901875|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
110615277|NCT00901875|Naloxone|naloxone|mesh-list
110615278|NCT00901875|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110615279|NCT00901875|Narcotics|narcotics|mesh-ancestor
110615280|NCT00901875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110615281|NCT00901875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110615282|NCT00901875|Analgesics|analgesics|mesh-ancestor
110615283|NCT00901875|Sensory System Agents|sensory system agents|mesh-ancestor
110615284|NCT00901875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110615285|NCT00901875|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110615286|NCT00972946|Dextrans|dextrans|mesh-list
110615287|NCT00972946|Anticoagulants|anticoagulants|mesh-ancestor
110615288|NCT00972946|Plasma Substitutes|plasma substitutes|mesh-ancestor
110615289|NCT00972946|Blood Substitutes|blood substitutes|mesh-ancestor
110615290|NCT00606177|Aripiprazole|aripiprazole|mesh-list
110615291|NCT00606177|Antidepressive Agents|antidepressive agents|mesh-ancestor
110615292|NCT00606177|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110615293|NCT00606177|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110615294|NCT00606177|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110615295|NCT00606177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110615296|NCT00606177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110615297|NCT00606177|Dopamine Agonists|dopamine agonists|mesh-ancestor
110615298|NCT00606177|Dopamine Agents|dopamine agents|mesh-ancestor
110615299|NCT00606177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110615300|NCT00606177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110615301|NCT00606177|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110615302|NCT00606177|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110615303|NCT00606177|Serotonin Agents|serotonin agents|mesh-ancestor
110615304|NCT00606177|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110615305|NCT00606177|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110615306|NCT00606177|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110615307|NCT00606177|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110615308|NCT00985270|Rifampin|rifampin|mesh-list
110615309|NCT00985270|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110615310|NCT00985270|Antitubercular Agents|antitubercular agents|mesh-ancestor
110615311|NCT00985270|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110615312|NCT00985270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110389783|NCT00217737|Fluorouracil|fluorouracil|mesh-list
110389784|NCT00217737|Oxaliplatin|oxaliplatin|mesh-list
110389785|NCT00217737|Endothelial Growth Factors|endothelial growth factors|mesh-list
110389786|NCT00217737|Antibodies|antibodies|mesh-list
110389787|NCT00217737|Immunoglobulins|immunoglobulins|mesh-list
110389788|NCT00217737|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110389789|NCT00217737|Immunoglobulin G|immunoglobulin g|mesh-list
110389790|NCT00217737|Calcium|calcium|mesh-list
110389791|NCT00217737|Levoleucovorin|levoleucovorin|mesh-list
110389792|NCT00217737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110389793|NCT00217737|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110389794|NCT00217737|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110389795|NCT00217737|Growth Substances|growth substances|mesh-ancestor
110389796|NCT00217737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110389797|NCT00217737|Growth Inhibitors|growth inhibitors|mesh-ancestor
110389798|NCT00217737|Immunologic Factors|immunologic factors|mesh-ancestor
110389799|NCT00217737|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110389800|NCT00217737|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110389805|NCT00217737|Antidotes|antidotes|mesh-ancestor
110615314|NCT00985270|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110615315|NCT00985270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110615316|NCT00985270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110615317|NCT00985270|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110615318|NCT00985270|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110615319|NCT00985270|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110615320|NCT00985270|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110615321|NCT00985270|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110615322|NCT00985270|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110615323|NCT00359281|Niacin|niacin|mesh-list
110615324|NCT00359281|Dextromethorphan|dextromethorphan|mesh-list
110615325|NCT00359281|Atorvastatin|atorvastatin|mesh-list
110615326|NCT00359281|Simvastatin|simvastatin|mesh-list
110615327|NCT00359281|Ezetimibe|ezetimibe|mesh-list
110615328|NCT00359281|Fenofibrate|fenofibrate|mesh-list
110615329|NCT00359281|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110615330|NCT00359281|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110615331|NCT00359281|Antimetabolites|antimetabolites|mesh-ancestor
110615332|NCT00359281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110615333|NCT00359281|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110615334|NCT00359281|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110615335|NCT00359281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110615336|NCT00359281|Vasodilator Agents|vasodilator agents|mesh-ancestor
110615337|NCT00359281|Vitamin B Complex|vitamin b complex|mesh-ancestor
110615338|NCT00359281|Vitamins|vitamins|mesh-ancestor
110615339|NCT00359281|Micronutrients|micronutrients|mesh-ancestor
110615340|NCT00359281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110615341|NCT00359281|Antitussive Agents|antitussive agents|mesh-ancestor
110615342|NCT00359281|Respiratory System Agents|respiratory system agents|mesh-ancestor
110615343|NCT00359281|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110615344|NCT00359281|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110615345|NCT00359281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110615346|NCT00902031|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
110615347|NCT00902031|Sennosides|sennosides|mesh-list
110615348|NCT00902031|Senna Extract|senna extract|mesh-list
110615349|NCT00902031|Antidiarrheals|antidiarrheals|mesh-ancestor
110615350|NCT00902031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110615351|NCT00902031|Laxatives|laxatives|mesh-ancestor
110615352|NCT00902031|Cathartics|cathartics|mesh-ancestor
110615353|NCT00985348|Levetiracetam|levetiracetam|mesh-list
110615354|NCT00985348|Anticonvulsants|anticonvulsants|mesh-ancestor
110615355|NCT00985348|Nootropic Agents|nootropic agents|mesh-ancestor
110615356|NCT00973336|Vitamin D|vitamin d|mesh-list
110615357|NCT00973336|Calcium|calcium|mesh-list
110615358|NCT00973336|Vitamins|vitamins|mesh-ancestor
110615359|NCT00973336|Micronutrients|micronutrients|mesh-ancestor
110615360|NCT00973336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110615361|NCT00973336|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110615362|NCT00973336|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110615363|NCT00902187|Fesoterodine|fesoterodine|mesh-list
110615364|NCT00902187|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110615365|NCT00902187|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110615366|NCT00902187|Cholinergic Agents|cholinergic agents|mesh-ancestor
110615367|NCT00902187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110389834|NCT00024622|Levodopa|levodopa|mesh-list
110389835|NCT00024622|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110389836|NCT00024622|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110615368|NCT00902187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110615369|NCT00902187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110615370|NCT00902187|Urological Agents|urological agents|mesh-ancestor
110615372|NCT01052311|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110615373|NCT01052311|Antimetabolites|antimetabolites|mesh-ancestor
110615374|NCT01052311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110615375|NCT01052311|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110615376|NCT01052311|Vasodilator Agents|vasodilator agents|mesh-ancestor
110615377|NCT01052311|Vitamin B Complex|vitamin b complex|mesh-ancestor
110615378|NCT01052311|Vitamins|vitamins|mesh-ancestor
110615379|NCT01052311|Micronutrients|micronutrients|mesh-ancestor
110615380|NCT01052311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110615381|NCT00988078|Metformin|metformin|mesh-list
110615382|NCT00988078|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110615383|NCT00988078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110615384|NCT00895089|Moxifloxacin|moxifloxacin|mesh-list
110615385|NCT00895089|Ceftriaxone|ceftriaxone|mesh-list
110615386|NCT00895089|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
110615387|NCT00895089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110615388|NCT00895089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110615389|NCT00895089|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110615390|NCT00895089|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110262698|NCT03460314|Buprenorphine|buprenorphine|mesh-list
110615391|NCT00895089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110615392|NCT00895089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110615393|NCT00895089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110615394|NCT00895089|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110615395|NCT00895089|Contraceptive Agents|contraceptive agents|mesh-ancestor
110615396|NCT00895089|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110615397|NCT00895089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110615398|NCT00895089|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110615399|NCT00895089|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110615400|NCT00895089|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110615402|NCT00982540|Antifungal Agents|antifungal agents|mesh-list
110615403|NCT00982540|Clotrimazole|clotrimazole|mesh-list
110615405|NCT00982540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110615406|NCT00982540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110615407|NCT00982540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110615408|NCT00982540|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110615409|NCT00982540|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110615410|NCT00982540|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110615411|NCT00982540|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110615412|NCT00982540|Hormone Antagonists|hormone antagonists|mesh-ancestor
110615413|NCT00982540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110615414|NCT00982540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110615415|NCT00982540|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110615416|NCT00982540|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110615417|NCT04674358|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110615418|NCT04674358|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110615419|NCT00366535|Neurotropin|neurotropin|mesh-list
110615420|NCT00366535|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110615421|NCT00366535|Immunologic Factors|immunologic factors|mesh-ancestor
110615422|NCT00366535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110615423|NCT00366535|Analgesics|analgesics|mesh-ancestor
110615424|NCT00366535|Sensory System Agents|sensory system agents|mesh-ancestor
110615425|NCT00366535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110615426|NCT00366535|Anticonvulsants|anticonvulsants|mesh-ancestor
110615427|NCT00982618|Lidocaine|lidocaine|mesh-list
110615428|NCT00982618|Morphine|morphine|mesh-list
110615429|NCT00982618|Anesthetics, Local|anesthetics, local|mesh-list
110615430|NCT00982618|Anesthetics|anesthetics|mesh-list
110615431|NCT00982618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110615432|NCT00982618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110615433|NCT00982618|Sensory System Agents|sensory system agents|mesh-ancestor
110615434|NCT00982618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110615435|NCT00982618|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110615436|NCT00982618|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110615437|NCT00982618|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110615438|NCT00982618|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110615439|NCT00982618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110615440|NCT00982618|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110615441|NCT00982618|Narcotics|narcotics|mesh-ancestor
110615442|NCT00982618|Analgesics|analgesics|mesh-ancestor
110615443|NCT00895167|Curcumin|curcumin|mesh-list
110615444|NCT00895167|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110615445|NCT00895167|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110615446|NCT00895167|Analgesics|analgesics|mesh-ancestor
110615447|NCT00895167|Sensory System Agents|sensory system agents|mesh-ancestor
110615448|NCT00895167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110615449|NCT00895167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110615450|NCT00895167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110615451|NCT00895167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110615452|NCT00895167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110615453|NCT00895167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110615454|NCT00895167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110615455|NCT00902421|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
110615456|NCT00902421|Serotonin|serotonin|mesh-list
110615457|NCT00902421|Muscarinic Antagonists|muscarinic antagonists|mesh-list
110615458|NCT00902421|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110615459|NCT00902421|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110615460|NCT00902421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110615461|NCT00902421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110615462|NCT00902421|Serotonin Agents|serotonin agents|mesh-ancestor
110615463|NCT00902421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110615464|NCT00902421|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110615465|NCT00902421|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110615466|NCT00902421|Cholinergic Agents|cholinergic agents|mesh-ancestor
110615467|NCT00985660|Nisoldipine|nisoldipine|mesh-list
110615468|NCT00985660|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110615469|NCT00985660|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110615470|NCT00985660|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110615471|NCT00985660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110615472|NCT00985660|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110615473|NCT00985660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110615474|NCT00985660|Vasodilator Agents|vasodilator agents|mesh-ancestor
110615475|NCT00350545|Cyclosporine|cyclosporine|mesh-list
110615476|NCT00350545|Prednisone|prednisone|mesh-list
110615477|NCT00350545|Rituximab|rituximab|mesh-list
110615478|NCT00350545|Tacrolimus|tacrolimus|mesh-list
110615479|NCT00350545|Cyclosporins|cyclosporins|mesh-list
110615480|NCT00350545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110615481|NCT00350545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110615482|NCT00350545|Immunologic Factors|immunologic factors|mesh-ancestor
110615483|NCT00350545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110615484|NCT00350545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110615485|NCT00350545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110615486|NCT00350545|Glucocorticoids|glucocorticoids|mesh-ancestor
110615487|NCT00350545|Hormones|hormones|mesh-ancestor
110615488|NCT00350545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110615489|NCT00350545|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110615490|NCT00350545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110615491|NCT00350545|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110615492|NCT00350545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110615493|NCT00350545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110615494|NCT00350545|Antifungal Agents|antifungal agents|mesh-ancestor
110615495|NCT00350545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110615496|NCT00350545|Dermatologic Agents|dermatologic agents|mesh-ancestor
110615497|NCT04006054|Midazolam|midazolam|mesh-list
110615498|NCT04006054|Dexmedetomidine|dexmedetomidine|mesh-list
110615499|NCT04006054|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110615500|NCT04006054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110615501|NCT04006054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110615502|NCT04006054|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110615504|NCT04006054|Sensory System Agents|sensory system agents|mesh-ancestor
110615505|NCT04006054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110615506|NCT04006054|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110615507|NCT04006054|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110615508|NCT04006054|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110615509|NCT04006054|Adrenergic Agents|adrenergic agents|mesh-ancestor
110615510|NCT04006054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110153326|NCT00390832|Epoetin Alfa|epoetin alfa|mesh-list
110615511|NCT04006054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110615512|NCT04006054|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110615513|NCT04006054|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110615514|NCT04006054|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110615515|NCT04006054|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110615516|NCT04006054|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110615517|NCT04006054|Anesthetics, General|anesthetics, general|mesh-ancestor
110615519|NCT04006054|GABA Modulators|gaba modulators|mesh-ancestor
110615520|NCT04006054|GABA Agents|gaba agents|mesh-ancestor
110615521|NCT00897975|Red yeast rice|red yeast rice|mesh-list
110615522|NCT00897975|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110615523|NCT00897975|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110615524|NCT00897975|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110615525|NCT00897975|Antimetabolites|antimetabolites|mesh-ancestor
110615526|NCT00897975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110615527|NCT00897975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110615528|NCT00897975|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110615529|NCT01052389|Haloperidol|haloperidol|mesh-list
110615530|NCT01052389|Olanzapine|olanzapine|mesh-list
110615531|NCT01052389|Aripiprazole|aripiprazole|mesh-list
110615532|NCT01052389|Haloperidol decanoate|haloperidol decanoate|mesh-list
110615533|NCT01052389|Antiemetics|antiemetics|mesh-ancestor
110615534|NCT01052389|Autonomic Agents|autonomic agents|mesh-ancestor
110615535|NCT01052389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110615536|NCT01052389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110615537|NCT01052389|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110615538|NCT01052389|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110615539|NCT01052389|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110615540|NCT01052389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110615541|NCT01052389|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110262846|NCT02295722|Gemcitabine|gemcitabine|mesh-list
110615542|NCT01052389|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110615543|NCT01052389|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110615544|NCT01052389|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110615545|NCT01052389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110615546|NCT01052389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110615547|NCT01052389|Serotonin Agents|serotonin agents|mesh-ancestor
110615548|NCT01052389|Antidepressive Agents|antidepressive agents|mesh-ancestor
110615549|NCT01052389|Dopamine Agonists|dopamine agonists|mesh-ancestor
110615550|NCT01052389|Dopamine Agents|dopamine agents|mesh-ancestor
110615551|NCT01052389|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110615552|NCT01052389|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110615553|NCT01052389|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110615554|NCT01052389|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110615555|NCT01052389|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110615556|NCT01052389|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110615557|NCT01052389|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110615558|NCT00895323|Antibodies|antibodies|mesh-list
110615559|NCT00895323|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110615560|NCT00895323|Antibodies, Bispecific|antibodies, bispecific|mesh-list
110615561|NCT00895323|Immunologic Factors|immunologic factors|mesh-ancestor
110615562|NCT00895323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110615563|NCT00349921|Adenosine|adenosine|mesh-list
110615564|NCT00349921|Clonidine|clonidine|mesh-list
110615565|NCT00349921|Analgesics|analgesics|mesh-ancestor
110615566|NCT00349921|Sensory System Agents|sensory system agents|mesh-ancestor
110615567|NCT00349921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110389990|NCT06031233|Growth Substances|growth substances|mesh-ancestor
110615568|NCT00349921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110615569|NCT00349921|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110615570|NCT00349921|Sympatholytics|sympatholytics|mesh-ancestor
110615571|NCT00349921|Autonomic Agents|autonomic agents|mesh-ancestor
110615572|NCT00349921|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110615573|NCT00349921|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110615574|NCT00349921|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110615575|NCT00349921|Adrenergic Agents|adrenergic agents|mesh-ancestor
110615576|NCT00349921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110615577|NCT00349921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110615578|NCT00349921|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110615580|NCT00349921|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
110615581|NCT00349921|Purinergic Agonists|purinergic agonists|mesh-ancestor
110615582|NCT00349921|Purinergic Agents|purinergic agents|mesh-ancestor
110615583|NCT00902655|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
110615584|NCT00902655|Hemostatics|hemostatics|mesh-ancestor
110615585|NCT00902655|Coagulants|coagulants|mesh-ancestor
110615586|NCT00902655|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
110615587|NCT00902655|Natriuretic Agents|natriuretic agents|mesh-ancestor
110615588|NCT00902655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110615589|NCT01052623|Clonidine|clonidine|mesh-list
110615590|NCT01052623|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110615591|NCT01052623|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110615592|NCT01052623|Estradiol|estradiol|mesh-list
110615593|NCT01052623|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110615594|NCT01052623|Hormones|hormones|mesh-ancestor
110615595|NCT01052623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110615596|NCT01052623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110615597|NCT01052623|Estrogens|estrogens|mesh-ancestor
110615598|NCT01052623|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110615599|NCT01052623|Contraceptive Agents|contraceptive agents|mesh-ancestor
110615600|NCT01052623|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110615601|NCT01052623|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110615602|NCT01052623|Analgesics|analgesics|mesh-ancestor
110615603|NCT01052623|Sensory System Agents|sensory system agents|mesh-ancestor
110615604|NCT01052623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110615605|NCT01052623|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110615606|NCT01052623|Sympatholytics|sympatholytics|mesh-ancestor
110615607|NCT01052623|Autonomic Agents|autonomic agents|mesh-ancestor
110615608|NCT01052623|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110615609|NCT01052623|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110615610|NCT01052623|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110615611|NCT01052623|Adrenergic Agents|adrenergic agents|mesh-ancestor
110615612|NCT01052623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110615613|NCT01052623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110615614|NCT00902811|Artesunate|artesunate|mesh-list
110390027|NCT06031090|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110390029|NCT06031012|Thalidomide|thalidomide|mesh-list
110262925|NCT00582075|Temozolomide|temozolomide|mesh-list
110615616|NCT00902811|Antimalarials|antimalarials|mesh-ancestor
110615618|NCT00902811|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110615619|NCT00902811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110615620|NCT00902811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110615621|NCT00902811|Antiviral Agents|antiviral agents|mesh-ancestor
110615622|NCT00902811|Schistosomicides|schistosomicides|mesh-ancestor
110615623|NCT00902811|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
110615624|NCT00902811|Anthelmintics|anthelmintics|mesh-ancestor
110615625|NCT00898287|Gemcitabine|gemcitabine|mesh-list
110615626|NCT00898287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110615627|NCT00898287|Antimetabolites|antimetabolites|mesh-ancestor
110615628|NCT00898287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110615629|NCT00898287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110615631|NCT04034823|Trastuzumab|trastuzumab|mesh-list
110615632|NCT04034823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110615633|NCT04034823|Tubulin Modulators|tubulin modulators|mesh-ancestor
110615634|NCT04034823|Antimitotic Agents|antimitotic agents|mesh-ancestor
110615635|NCT04034823|Mitosis Modulators|mitosis modulators|mesh-ancestor
110615636|NCT04034823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110615637|NCT04034823|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110615638|NCT00606021|Pemetrexed|pemetrexed|mesh-list
110615639|NCT00606021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110615640|NCT00606021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110615641|NCT00606021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110615642|NCT00606021|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110615643|NCT00606021|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110615644|NCT00337675|Montelukast|montelukast|mesh-list
110615645|NCT00337675|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110615646|NCT00337675|Respiratory System Agents|respiratory system agents|mesh-ancestor
110615647|NCT00337675|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110615648|NCT00337675|Hormone Antagonists|hormone antagonists|mesh-ancestor
110615649|NCT00337675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110615650|NCT00337675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110615651|NCT00337675|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
110615652|NCT00337675|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110615653|NCT00337675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110615654|NCT00902967|Atorvastatin|atorvastatin|mesh-list
110615655|NCT00902967|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110615656|NCT00902967|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110615657|NCT00902967|Antimetabolites|antimetabolites|mesh-ancestor
110615658|NCT00902967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110615659|NCT00902967|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110615660|NCT00902967|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110615661|NCT00902967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110390071|NCT06030557|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110390072|NCT06030557|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110390073|NCT06030557|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110390074|NCT06030557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110390075|NCT06030557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110390076|NCT06030557|Antiviral Agents|antiviral agents|mesh-ancestor
110390077|NCT06030557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110390078|NCT06030557|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110283942|NCT00203567|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110390079|NCT06030557|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110390080|NCT06030492|Hydrogen Peroxide|hydrogen peroxide|mesh-list
110390081|NCT06030492|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110390082|NCT06030492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110615662|NCT00903045|Propiverine|propiverine|mesh-list
110615663|NCT00903045|Parasympatholytics|parasympatholytics|mesh-ancestor
110615664|NCT00903045|Autonomic Agents|autonomic agents|mesh-ancestor
110615665|NCT00903045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110615666|NCT00903045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110615667|NCT00903045|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110615668|NCT00903045|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110615669|NCT00903045|Cholinergic Agents|cholinergic agents|mesh-ancestor
110615670|NCT00903045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110615671|NCT00903045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110615672|NCT00903045|Urological Agents|urological agents|mesh-ancestor
110615673|NCT00337285|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
110615674|NCT00337285|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110615675|NCT00337285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110615676|NCT00337285|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110615677|NCT00337285|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110615678|NCT00337285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110615679|NCT00337285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110615680|NCT00337285|Dopamine Agents|dopamine agents|mesh-ancestor
110615681|NCT00337285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110615682|NCT04035525|Coenzyme Q10|coenzyme q10|mesh-list
110615683|NCT04035525|Ubiquinone|ubiquinone|mesh-list
110615684|NCT04035525|Vitamins|vitamins|mesh-ancestor
110615685|NCT04035525|Micronutrients|micronutrients|mesh-ancestor
110615686|NCT04035525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110615687|NCT00905853|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
110615688|NCT00905853|Amiodarone|amiodarone|mesh-list
110615689|NCT00905853|Vasodilator Agents|vasodilator agents|mesh-ancestor
110615690|NCT00905853|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
110615691|NCT00905853|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110615692|NCT00905853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110615693|NCT00905853|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110615694|NCT00905853|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110615695|NCT00905853|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110615696|NCT00905853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110615697|NCT00905853|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110615698|NCT00905853|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110615699|NCT00905853|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110615700|NCT00905931|Lycopene|lycopene|mesh-list
110615701|NCT00905931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110615702|NCT00905931|Antioxidants|antioxidants|mesh-ancestor
110615703|NCT00905931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110615704|NCT00905931|Protective Agents|protective agents|mesh-ancestor
110615705|NCT00905931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110615706|NCT00905931|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110615707|NCT00905931|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110615708|NCT00905931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110615709|NCT04035135|Immunoglobulins|immunoglobulins|mesh-list
110615710|NCT04035135|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110615711|NCT04035135|Antibodies|antibodies|mesh-list
110615712|NCT04035135|gamma-Globulins|gamma-globulins|mesh-list
110615713|NCT04035135|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110615714|NCT04035135|Immunologic Factors|immunologic factors|mesh-ancestor
110615715|NCT04035135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110615716|NCT00903279|Retapamulin|retapamulin|mesh-list
110615717|NCT00903279|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110615718|NCT00903279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110615719|NCT02539017|Immunomodulating Agents|immunomodulating agents|mesh-list
110615720|NCT02539017|Immunologic Factors|immunologic factors|mesh-ancestor
110615721|NCT02539017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110615722|NCT00605865|Sertraline|sertraline|mesh-list
110615723|NCT00605865|Antidepressive Agents|antidepressive agents|mesh-ancestor
110615724|NCT00605865|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110615725|NCT00605865|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110615726|NCT00605865|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110615727|NCT00605865|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110615728|NCT00605865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110615729|NCT00605865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110615730|NCT00605865|Serotonin Agents|serotonin agents|mesh-ancestor
110615731|NCT00605865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110615732|NCT00922467|Esmolol|esmolol|mesh-list
110615733|NCT00922467|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
110615734|NCT00922467|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110615735|NCT00922467|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110615736|NCT00922467|Adrenergic Agents|adrenergic agents|mesh-ancestor
110615737|NCT00922467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110615738|NCT00922467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110615739|NCT00922467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110390122|NCT06027099|Tizanidine|tizanidine|mesh-list
110615740|NCT00903747|Moxifloxacin|moxifloxacin|mesh-list
110615741|NCT00903747|Prucalopride|prucalopride|mesh-list
110615742|NCT00903747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110615743|NCT00903747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110615744|NCT00903747|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110615745|NCT00903747|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110615746|NCT00903747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110615747|NCT00903747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110615748|NCT00903747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110615749|NCT00903747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110615750|NCT00903747|Laxatives|laxatives|mesh-ancestor
110615751|NCT00903747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110615752|NCT00903747|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
110615753|NCT00903747|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110615754|NCT00903747|Serotonin Agents|serotonin agents|mesh-ancestor
110615755|NCT00903747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110615756|NCT02538627|Trametinib|trametinib|mesh-list
110615757|NCT02538627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110615758|NCT02538627|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110615759|NCT02538627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110615760|NCT02538627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110615761|NCT00903825|Lidocaine|lidocaine|mesh-list
110615762|NCT00903825|Anesthetics, Local|anesthetics, local|mesh-list
110615763|NCT00903825|Anesthetics|anesthetics|mesh-list
110615764|NCT00903825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110615765|NCT00903825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110615766|NCT00903825|Sensory System Agents|sensory system agents|mesh-ancestor
110615767|NCT00903825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110615768|NCT00903825|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110615769|NCT00903825|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110615770|NCT00903825|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110615771|NCT00903825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110615772|NCT00903825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110615773|NCT00904059|Asunaprevir|asunaprevir|mesh-list
110615774|NCT00904059|Protease Inhibitors|protease inhibitors|mesh-ancestor
110615775|NCT00904059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110615776|NCT00904059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110615777|NCT00337207|Bevacizumab|bevacizumab|mesh-list
110615778|NCT00337207|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110615779|NCT00337207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110615780|NCT00337207|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110390155|NCT06014073|Fludarabine|fludarabine|mesh-list
110615781|NCT00337207|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110615782|NCT00337207|Growth Substances|growth substances|mesh-ancestor
110615783|NCT00337207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110615784|NCT00337207|Growth Inhibitors|growth inhibitors|mesh-ancestor
110615785|NCT01055743|Fluorouracil|fluorouracil|mesh-list
110615786|NCT01055743|Antimetabolites|antimetabolites|mesh-ancestor
110615787|NCT01055743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110615788|NCT01055743|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110615789|NCT01055743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110615790|NCT01055743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110615791|NCT01055743|Immunologic Factors|immunologic factors|mesh-ancestor
110615792|NCT01055743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110615793|NCT00604695|Tenecteplase|tenecteplase|mesh-list
110615794|NCT00604695|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110615795|NCT00604695|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110615796|NCT00604695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110615797|NCT01055821|Interferons|interferons|mesh-list
110615799|NCT01055821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110615800|NCT01055821|Antiviral Agents|antiviral agents|mesh-ancestor
110615801|NCT01055821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110615802|NCT01055821|Antimetabolites|antimetabolites|mesh-ancestor
110615803|NCT01055821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110615804|NCT00904293|Warfarin|warfarin|mesh-list
110615805|NCT00904293|Anticoagulants|anticoagulants|mesh-ancestor
110615806|NCT00904449|Oxymorphone|oxymorphone|mesh-list
110615807|NCT00904449|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110615808|NCT00904449|Narcotics|narcotics|mesh-ancestor
110153401|NCT00000891|Protease Inhibitors|protease inhibitors|mesh-ancestor
110615809|NCT00904449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110615810|NCT00904449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110615812|NCT00904449|Sensory System Agents|sensory system agents|mesh-ancestor
110615813|NCT00904449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110615814|NCT00904449|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110615815|NCT00348595|Lenalidomide|lenalidomide|mesh-list
110615816|NCT00348595|Immunologic Factors|immunologic factors|mesh-ancestor
110615817|NCT00348595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110284002|NCT00226824|Autonomic Agents|autonomic agents|mesh-ancestor
110615818|NCT00348595|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110615819|NCT00348595|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110615820|NCT00348595|Growth Substances|growth substances|mesh-ancestor
110615821|NCT00348595|Growth Inhibitors|growth inhibitors|mesh-ancestor
110615822|NCT00348595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110615823|NCT02538939|Sodium thiosulfate|sodium thiosulfate|mesh-list
110615824|NCT02538939|Antidotes|antidotes|mesh-ancestor
110615825|NCT02538939|Protective Agents|protective agents|mesh-ancestor
110390190|NCT05989828|Analgesics|analgesics|mesh-ancestor
110615826|NCT02538939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110615827|NCT02538939|Antioxidants|antioxidants|mesh-ancestor
110615828|NCT02538939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110615829|NCT02538939|Antitubercular Agents|antitubercular agents|mesh-ancestor
110615830|NCT02538939|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110615831|NCT02538939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110615832|NCT02538939|Chelating Agents|chelating agents|mesh-ancestor
110615833|NCT02538939|Sequestering Agents|sequestering agents|mesh-ancestor
110615834|NCT00904605|Celecoxib|celecoxib|mesh-list
110615835|NCT00904605|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110615836|NCT00904605|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110263143|NCT02913430|Tamoxifen|tamoxifen|mesh-list
110615837|NCT00904605|Analgesics|analgesics|mesh-ancestor
110615838|NCT00904605|Sensory System Agents|sensory system agents|mesh-ancestor
110615839|NCT00904605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110615840|NCT00904605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110615841|NCT00904605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110615842|NCT00904605|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110615843|NCT00904605|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110615844|NCT00904605|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110615845|NCT00904605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110615846|NCT00904605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110615847|NCT00905073|Cyclosporine|cyclosporine|mesh-list
110615848|NCT00905073|Methotrexate|methotrexate|mesh-list
110615849|NCT00905073|Cyclosporins|cyclosporins|mesh-list
110615850|NCT00905073|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110615851|NCT00905073|Abortifacient Agents|abortifacient agents|mesh-ancestor
110615852|NCT00905073|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110615853|NCT00905073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110615854|NCT00905073|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110615855|NCT00905073|Antimetabolites|antimetabolites|mesh-ancestor
110615856|NCT00905073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110615857|NCT00905073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110615858|NCT00905073|Dermatologic Agents|dermatologic agents|mesh-ancestor
110615859|NCT00905073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110615860|NCT00905073|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110615861|NCT00905073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110615862|NCT00905073|Immunologic Factors|immunologic factors|mesh-ancestor
110615863|NCT00905073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110615864|NCT00905073|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110615865|NCT00905073|Antifungal Agents|antifungal agents|mesh-ancestor
110615866|NCT00905073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110615867|NCT00905073|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110615870|NCT00905229|Vitamin K 1|vitamin k 1|mesh-list
110615871|NCT00905229|Micronutrients|micronutrients|mesh-ancestor
110615872|NCT00905229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110615873|NCT00905229|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110615874|NCT00905229|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110615875|NCT00905229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110615876|NCT00905229|Hemostatics|hemostatics|mesh-ancestor
110615877|NCT00905229|Coagulants|coagulants|mesh-ancestor
110615878|NCT00905541|Simvastatin|simvastatin|mesh-list
110615879|NCT00905541|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110615880|NCT00905541|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110615881|NCT00905541|Antimetabolites|antimetabolites|mesh-ancestor
110615882|NCT00905541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110615883|NCT00905541|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110615884|NCT00905541|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110615885|NCT00905541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110615886|NCT00348283|Adalimumab|adalimumab|mesh-list
110615887|NCT00348283|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110615888|NCT00348283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110615889|NCT00348283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110615890|NCT00336895|Mycophenolic Acid|mycophenolic acid|mesh-list
110615891|NCT00336895|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110615892|NCT00336895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110615893|NCT00336895|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110615894|NCT00336895|Antitubercular Agents|antitubercular agents|mesh-ancestor
110615895|NCT00336895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110615896|NCT00336895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110615897|NCT00336895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110615898|NCT00336895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110615899|NCT00336583|Cytarabine|cytarabine|mesh-list
110615900|NCT00336583|Methylprednisolone|methylprednisolone|mesh-list
110390263|NCT05931276|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110390264|NCT05903339|MEDI9197|medi9197|mesh-list
110390265|NCT05903339|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110390266|NCT05903339|Immunologic Factors|immunologic factors|mesh-ancestor
110390267|NCT05903339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110390278|NCT05898672|Ritonavir|ritonavir|mesh-list
110390279|NCT05898672|Nirmatrelvir|nirmatrelvir|mesh-list
110390280|NCT05898672|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
110390281|NCT05898672|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110390282|NCT05898672|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110615901|NCT00336583|Oxaliplatin|oxaliplatin|mesh-list
110615902|NCT00336583|Etoposide|etoposide|mesh-list
110615903|NCT00336583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110615904|NCT00336583|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110615905|NCT00336583|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110615906|NCT00336583|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110615907|NCT00336583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110615908|NCT00336583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110615909|NCT00336583|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110615910|NCT00336583|Antimetabolites|antimetabolites|mesh-ancestor
110615911|NCT00336583|Antiviral Agents|antiviral agents|mesh-ancestor
110263221|NCT00150332|Linezolid|linezolid|mesh-list
110615913|NCT00336583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110615914|NCT00336583|Immunologic Factors|immunologic factors|mesh-ancestor
110615915|NCT00336583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110615916|NCT00336583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110615917|NCT00336583|Antiemetics|antiemetics|mesh-ancestor
110615918|NCT00336583|Autonomic Agents|autonomic agents|mesh-ancestor
110615919|NCT00336583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110615920|NCT00336583|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110615921|NCT00336583|Glucocorticoids|glucocorticoids|mesh-ancestor
110615922|NCT00336583|Hormones|hormones|mesh-ancestor
110615923|NCT00336583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110615924|NCT00336583|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110615925|NCT00336583|Protective Agents|protective agents|mesh-ancestor
110615926|NCT00336505|Clarithromycin|clarithromycin|mesh-list
110615927|NCT00336505|Cethromycin|cethromycin|mesh-list
110615928|NCT00336505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110615929|NCT00336505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110615930|NCT00336505|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110615931|NCT00336505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110615932|NCT00336505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110615933|NCT00336505|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110615934|NCT00336505|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110615935|NCT00357877|Chlorhexidine|chlorhexidine|mesh-list
110615936|NCT00357877|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110615937|NCT00357877|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110615938|NCT00357877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110615939|NCT00357877|Disinfectants|disinfectants|mesh-ancestor
110615940|NCT00357877|Dermatologic Agents|dermatologic agents|mesh-ancestor
110615941|NCT03987529|Propofol|propofol|mesh-list
110615942|NCT03987529|Sevoflurane|sevoflurane|mesh-list
110615943|NCT03987529|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110615944|NCT03987529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110615945|NCT03987529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110615946|NCT03987529|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110615947|NCT03987529|Anesthetics, General|anesthetics, general|mesh-ancestor
110615948|NCT03987529|Anesthetics|anesthetics|mesh-ancestor
110615949|NCT03987529|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110615950|NCT03987529|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110615951|NCT00335959|Capecitabine|capecitabine|mesh-list
110615952|NCT00335959|Oxaliplatin|oxaliplatin|mesh-list
110615953|NCT00335959|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110615954|NCT00335959|Antimetabolites|antimetabolites|mesh-ancestor
110615955|NCT00335959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110615956|NCT00335959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110615957|NCT01053169|Thrombin|thrombin|mesh-list
110615958|NCT01053169|Hemostatics|hemostatics|mesh-ancestor
110615959|NCT01053169|Coagulants|coagulants|mesh-ancestor
110615960|NCT01059331|Pregabalin|pregabalin|mesh-list
110615961|NCT01059331|Analgesics|analgesics|mesh-ancestor
110615962|NCT01059331|Sensory System Agents|sensory system agents|mesh-ancestor
110615963|NCT01059331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110615964|NCT01059331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110615965|NCT01059331|Anticonvulsants|anticonvulsants|mesh-ancestor
110615966|NCT01059331|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110615967|NCT01059331|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110615968|NCT01059331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110615969|NCT01059331|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110615970|NCT01059331|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110615971|NCT01059331|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110615972|NCT01059331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110615973|NCT01059331|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110615974|NCT01059955|Dexamethasone|dexamethasone|mesh-list
110284048|NCT00203801|Artesunate|artesunate|mesh-list
110615975|NCT01059955|Dexamethasone acetate|dexamethasone acetate|mesh-list
110615976|NCT01059955|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110615977|NCT01059955|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110615978|NCT01059955|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
110615980|NCT01059955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110615981|NCT01059955|Antiemetics|antiemetics|mesh-ancestor
110615982|NCT01059955|Autonomic Agents|autonomic agents|mesh-ancestor
110615983|NCT01059955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110615984|NCT01059955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110615985|NCT01059955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110615986|NCT01059955|Glucocorticoids|glucocorticoids|mesh-ancestor
110615987|NCT01059955|Hormones|hormones|mesh-ancestor
110615988|NCT01059955|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110615989|NCT01059955|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110615990|NCT01059955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110615991|NCT01059955|Protease Inhibitors|protease inhibitors|mesh-ancestor
110615992|NCT01059955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110615993|NCT01059955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110615994|NCT01060189|Tranexamic Acid|tranexamic acid|mesh-list
110615995|NCT01060189|Urinastatin|urinastatin|mesh-list
110615996|NCT01060189|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110615997|NCT01060189|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110615998|NCT01060189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110616000|NCT01060189|Coagulants|coagulants|mesh-ancestor
110616001|NCT01060189|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
110616002|NCT01060189|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110616003|NCT01060189|Protease Inhibitors|protease inhibitors|mesh-ancestor
110616004|NCT01060189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110616005|NCT01060267|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110616006|NCT01060267|Erythromycin|erythromycin|mesh-list
110616007|NCT01060267|Erythromycin Estolate|erythromycin estolate|mesh-list
110616008|NCT01060267|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
110616009|NCT01060267|Erythromycin stearate|erythromycin stearate|mesh-list
110616010|NCT01060267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110616011|NCT01060267|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110616012|NCT01060267|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110616013|NCT01060267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110616014|NCT01060267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110616015|NCT01060423|Irinotecan|irinotecan|mesh-list
110616016|NCT01060423|Cetuximab|cetuximab|mesh-list
110616017|NCT01060423|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110616018|NCT01060423|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110616019|NCT01060423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110616020|NCT01060423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110616021|NCT01060423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110616022|NCT01060423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110616023|NCT01060501|Leucovorin|leucovorin|mesh-list
110616024|NCT01060501|Folic Acid|folic acid|mesh-list
110616025|NCT01060501|Interferons|interferons|mesh-list
110616026|NCT01060501|Interferon-alpha|interferon-alpha|mesh-list
110616027|NCT01060501|Levoleucovorin|levoleucovorin|mesh-list
110616028|NCT01060501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110616029|NCT01060501|Antiviral Agents|antiviral agents|mesh-ancestor
110616030|NCT01060501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110616031|NCT01060501|Immunologic Factors|immunologic factors|mesh-ancestor
110616032|NCT01060501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110616033|NCT01060501|Antidotes|antidotes|mesh-ancestor
110616034|NCT01060501|Protective Agents|protective agents|mesh-ancestor
110616035|NCT01060501|Vitamin B Complex|vitamin b complex|mesh-ancestor
110616036|NCT01060501|Vitamins|vitamins|mesh-ancestor
110616037|NCT01060501|Micronutrients|micronutrients|mesh-ancestor
110616038|NCT01060501|Hematinics|hematinics|mesh-ancestor
110616039|NCT00671658|Cytarabine|cytarabine|mesh-list
110616040|NCT00671658|Dexamethasone|dexamethasone|mesh-list
110616041|NCT00671658|Methylprednisolone|methylprednisolone|mesh-list
110616042|NCT00671658|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110616043|NCT00671658|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110616044|NCT00671658|Prednisolone|prednisolone|mesh-list
110616045|NCT00671658|Prednisolone acetate|prednisolone acetate|mesh-list
110616047|NCT00671658|Rituximab|rituximab|mesh-list
110616048|NCT00671658|Doxorubicin|doxorubicin|mesh-list
110616049|NCT00671658|Methotrexate|methotrexate|mesh-list
110616050|NCT00671658|Vincristine|vincristine|mesh-list
110616051|NCT00671658|Asparaginase|asparaginase|mesh-list
110616052|NCT00671658|Pegaspargase|pegaspargase|mesh-list
110616053|NCT00671658|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110616054|NCT00671658|Prednisolone phosphate|prednisolone phosphate|mesh-list
110616055|NCT00671658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110616056|NCT00671658|Immunologic Factors|immunologic factors|mesh-ancestor
110616057|NCT00671658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110616058|NCT00671658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110616059|NCT00671658|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110616060|NCT00671658|Alkylating Agents|alkylating agents|mesh-ancestor
110616061|NCT00671658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110616062|NCT00671658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110616063|NCT00671658|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110616064|NCT00671658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110616065|NCT00671658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110616066|NCT00671658|Antiemetics|antiemetics|mesh-ancestor
110616067|NCT00671658|Autonomic Agents|autonomic agents|mesh-ancestor
110616068|NCT00671658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110616069|NCT00671658|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110616070|NCT00671658|Glucocorticoids|glucocorticoids|mesh-ancestor
110616071|NCT00671658|Hormones|hormones|mesh-ancestor
110616072|NCT00671658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110616073|NCT00671658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110616074|NCT00671658|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110616075|NCT00671658|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110616076|NCT00671658|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110616077|NCT00671658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110616078|NCT00671658|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110616079|NCT00671658|Abortifacient Agents|abortifacient agents|mesh-ancestor
110616080|NCT00671658|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110616081|NCT00671658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110616082|NCT00671658|Antimetabolites|antimetabolites|mesh-ancestor
110616083|NCT00671658|Dermatologic Agents|dermatologic agents|mesh-ancestor
110616084|NCT00671658|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110616085|NCT00671658|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110616086|NCT00671658|Antiviral Agents|antiviral agents|mesh-ancestor
110616087|NCT00671658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110616088|NCT00671658|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110616089|NCT00671658|Tubulin Modulators|tubulin modulators|mesh-ancestor
110616090|NCT00671658|Antimitotic Agents|antimitotic agents|mesh-ancestor
110616091|NCT00671658|Mitosis Modulators|mitosis modulators|mesh-ancestor
110616092|NCT00671658|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110616093|NCT00671658|Protective Agents|protective agents|mesh-ancestor
110616094|NCT00764712|Insulin|insulin|mesh-list
110616095|NCT00764712|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110616096|NCT00764712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110616097|NCT00768456|Ropivacaine|ropivacaine|mesh-list
110616098|NCT00768456|Anesthetics, Local|anesthetics, local|mesh-ancestor
110616099|NCT00768456|Anesthetics|anesthetics|mesh-ancestor
110616100|NCT00768456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110616101|NCT00768456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110616102|NCT00768456|Sensory System Agents|sensory system agents|mesh-ancestor
110616103|NCT00768456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110616104|NCT00768612|Risperidone|risperidone|mesh-list
110616105|NCT00768612|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110616106|NCT00768612|Serotonin Agents|serotonin agents|mesh-ancestor
110616107|NCT00768612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110616108|NCT00768612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110616109|NCT00768612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110616110|NCT00768612|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110616111|NCT00768612|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110616112|NCT00768612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110616113|NCT00768612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110616114|NCT00768612|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110616115|NCT00768612|Dopamine Agents|dopamine agents|mesh-ancestor
110616116|NCT00604383|Ruboxistaurin|ruboxistaurin|mesh-list
110616117|NCT00604383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110616118|NCT00604383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110616119|NCT04048200|Fentanyl|fentanyl|mesh-list
110616120|NCT04048200|Dexmedetomidine|dexmedetomidine|mesh-list
110616121|NCT04048200|Ketamine|ketamine|mesh-list
110616122|NCT04048200|Analgesics, Opioid|analgesics, opioid|mesh-list
110616123|NCT04048200|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110616124|NCT04048200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110616125|NCT04048200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110616126|NCT04048200|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110616127|NCT04048200|Analgesics|analgesics|mesh-ancestor
110616128|NCT04048200|Sensory System Agents|sensory system agents|mesh-ancestor
110616129|NCT04048200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110616130|NCT04048200|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110616131|NCT04048200|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110616132|NCT04048200|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110616133|NCT04048200|Adrenergic Agents|adrenergic agents|mesh-ancestor
110616134|NCT04048200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110616135|NCT04048200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110616136|NCT04048200|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110616137|NCT04048200|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110616138|NCT04048200|Anesthetics, General|anesthetics, general|mesh-ancestor
110616139|NCT04048200|Anesthetics|anesthetics|mesh-ancestor
110616140|NCT04048200|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110616141|NCT04048200|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110616142|NCT04048200|Narcotics|narcotics|mesh-ancestor
110616143|NCT04048200|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110616144|NCT04034589|Fulvestrant|fulvestrant|mesh-list
110616145|NCT04034589|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110616146|NCT04034589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110616147|NCT04034589|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110616148|NCT04034589|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110616149|NCT04034589|Hormone Antagonists|hormone antagonists|mesh-ancestor
110616150|NCT04034589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110616151|NCT04034589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110616152|NCT00988312|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
110616153|NCT00988312|Immunologic Factors|immunologic factors|mesh-ancestor
110616154|NCT00988312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110616155|NCT00906867|Methacholine Chloride|methacholine chloride|mesh-list
110616156|NCT00906867|Miotics|miotics|mesh-ancestor
110616157|NCT00906867|Autonomic Agents|autonomic agents|mesh-ancestor
110616158|NCT00906867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110616159|NCT00906867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110616160|NCT00906867|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110616161|NCT00906867|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
110616162|NCT00906867|Respiratory System Agents|respiratory system agents|mesh-ancestor
110616163|NCT00906867|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
110616164|NCT00906867|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110616165|NCT00906867|Cholinergic Agents|cholinergic agents|mesh-ancestor
110616166|NCT00906867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110616167|NCT00906867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110616168|NCT00768690|Ketoconazole|ketoconazole|mesh-list
110616169|NCT00768690|Antifungal Agents|antifungal agents|mesh-ancestor
110616170|NCT00768690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110616171|NCT00768690|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110616172|NCT00768690|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110616173|NCT00768690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110616174|NCT00768690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110276024|NCT04675372|Anesthetics|anesthetics|mesh-ancestor
110616175|NCT00768690|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110616176|NCT00768690|Hormone Antagonists|hormone antagonists|mesh-ancestor
110616177|NCT00768690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110616178|NCT00768690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110616179|NCT00768690|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110616180|NCT00768768|Terbinafine|terbinafine|mesh-list
110616181|NCT00768768|Antifungal Agents|antifungal agents|mesh-ancestor
110616182|NCT00768768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110616183|NCT00768768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110616184|NCT00768768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110616185|NCT00775086|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110616186|NCT00775086|Norelgestromin|norelgestromin|mesh-list
110616187|NCT00775086|Contraceptive Agents|contraceptive agents|mesh-list
110616188|NCT00775086|Estradiol|estradiol|mesh-list
110616189|NCT00775086|Estrogens|estrogens|mesh-ancestor
110616190|NCT00775086|Hormones|hormones|mesh-ancestor
110616191|NCT00775086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110616192|NCT00775086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110616193|NCT00775086|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110616194|NCT00775086|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110616195|NCT00775086|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110616196|NCT00775086|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110616197|NCT00775086|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110616198|NCT02557854|Doxorubicin|doxorubicin|mesh-list
110616199|NCT02557854|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110616200|NCT02557854|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110616201|NCT02557854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110616202|NCT02557854|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110616203|NCT02557854|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110616204|NCT02557854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110616205|NCT02557854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110616206|NCT02557386|Levobupivacaine|levobupivacaine|mesh-list
110616207|NCT02557386|Anesthetics, Local|anesthetics, local|mesh-ancestor
110616208|NCT02557386|Anesthetics|anesthetics|mesh-ancestor
110616209|NCT02557386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110616210|NCT02557386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110616211|NCT02557386|Sensory System Agents|sensory system agents|mesh-ancestor
110616212|NCT02557386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110616213|NCT00986050|Sirolimus|sirolimus|mesh-list
110616214|NCT00986050|Abciximab|abciximab|mesh-list
110616215|NCT00986050|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110616216|NCT00986050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110616217|NCT00986050|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110616218|NCT00986050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110616219|NCT00986050|Antifungal Agents|antifungal agents|mesh-ancestor
110616220|NCT00986050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110616221|NCT00986050|Immunologic Factors|immunologic factors|mesh-ancestor
110616222|NCT00986050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110616223|NCT00986050|Anticoagulants|anticoagulants|mesh-ancestor
110616224|NCT00986050|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110616225|NCT00986128|Topiramate|topiramate|mesh-list
110616226|NCT00986128|Anticonvulsants|anticonvulsants|mesh-ancestor
110616227|NCT00986128|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110616228|NCT00986128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110616229|NCT00771342|Nitric Oxide|nitric oxide|mesh-list
110616230|NCT00771342|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110616231|NCT00771342|Autonomic Agents|autonomic agents|mesh-ancestor
110616232|NCT00771342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110616233|NCT00771342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110616234|NCT00771342|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110616235|NCT00771342|Respiratory System Agents|respiratory system agents|mesh-ancestor
110616236|NCT00771342|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110616237|NCT00771342|Antioxidants|antioxidants|mesh-ancestor
110616238|NCT00771342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110616239|NCT00771342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110616240|NCT00771342|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
110616241|NCT00771342|Vasodilator Agents|vasodilator agents|mesh-ancestor
110616242|NCT00771342|Gasotransmitters|gasotransmitters|mesh-ancestor
110616243|NCT00771342|Protective Agents|protective agents|mesh-ancestor
110616244|NCT00775164|Metformin|metformin|mesh-list
110616245|NCT00775164|Pioglitazone|pioglitazone|mesh-list
110616246|NCT00775164|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110616247|NCT00775164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110616248|NCT00771420|Mavrilimumab|mavrilimumab|mesh-list
110616249|NCT00771420|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110616250|NCT00771420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110616251|NCT00771420|Immunologic Factors|immunologic factors|mesh-ancestor
110616252|NCT00771420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110616253|NCT04767256|Dexamethasone|dexamethasone|mesh-list
110616254|NCT04767256|Dexmedetomidine|dexmedetomidine|mesh-list
110616255|NCT04767256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110616256|NCT04767256|Antiemetics|antiemetics|mesh-ancestor
110616257|NCT04767256|Autonomic Agents|autonomic agents|mesh-ancestor
110616258|NCT04767256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110616259|NCT04767256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110616260|NCT04767256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110616261|NCT04767256|Glucocorticoids|glucocorticoids|mesh-ancestor
110616262|NCT04767256|Hormones|hormones|mesh-ancestor
110616263|NCT04767256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110616264|NCT04767256|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110616265|NCT04767256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110616266|NCT04767256|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110616267|NCT04767256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110616268|NCT04767256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110616269|NCT04767256|Analgesics|analgesics|mesh-ancestor
110616270|NCT04767256|Sensory System Agents|sensory system agents|mesh-ancestor
110616271|NCT04767256|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110616272|NCT04767256|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110616273|NCT04767256|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110616274|NCT04767256|Adrenergic Agents|adrenergic agents|mesh-ancestor
110616275|NCT04767256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110616276|NCT04767256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110616277|NCT00771498|Lopinavir|lopinavir|mesh-list
110616278|NCT00771498|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110616279|NCT00771498|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110616280|NCT00771498|Protease Inhibitors|protease inhibitors|mesh-ancestor
110616281|NCT00771498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110616282|NCT00771498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110616283|NCT00771498|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110616284|NCT00771498|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110616285|NCT00771498|Antiviral Agents|antiviral agents|mesh-ancestor
110616286|NCT00771498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110285284|NCT00233025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110616287|NCT00771498|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110616288|NCT00771498|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110616289|NCT00986284|Gefitinib|gefitinib|mesh-list
110616290|NCT00986284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110263585|NCT00151112|Anesthetics|anesthetics|mesh-list
110616291|NCT00986284|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110616292|NCT00986284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110616293|NCT00986284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110616294|NCT00988780|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110616295|NCT00988780|Efavirenz|efavirenz|mesh-list
110616296|NCT00988780|Maraviroc|maraviroc|mesh-list
110616297|NCT00988780|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110616298|NCT00988780|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110616299|NCT00988780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110390539|NCT05465317|Hormones|hormones|mesh-ancestor
110616300|NCT00988780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110616301|NCT00988780|Antiviral Agents|antiviral agents|mesh-ancestor
110616302|NCT00988780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110616303|NCT00988780|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110616304|NCT00988780|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110616305|NCT00988780|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
110616306|NCT00988780|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
110616307|NCT00988780|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
110616308|NCT00988780|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110616309|NCT00988780|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110616310|NCT00988780|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110616311|NCT00988780|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110616312|NCT00988780|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110616313|NCT00988780|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110616314|NCT00775242|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110616315|NCT00775242|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110616316|NCT00775242|Estradiol|estradiol|mesh-list
110616317|NCT00775242|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110616318|NCT00775242|Estrogens|estrogens|mesh-list
110616319|NCT00775242|Progesterone|progesterone|mesh-list
110616320|NCT00775242|Progestins|progestins|mesh-list
110616321|NCT00775242|Hormones|hormones|mesh-ancestor
110616322|NCT00775242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110616323|NCT00775242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110616324|NCT00775242|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110616325|NCT00775242|Contraceptive Agents|contraceptive agents|mesh-ancestor
110616326|NCT00775242|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110616327|NCT00775242|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110616328|NCT00986518|Immunomodulating Agents|immunomodulating agents|mesh-list
110616329|NCT00986518|Immunologic Factors|immunologic factors|mesh-ancestor
110616330|NCT00986518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110616331|NCT00769158|Topiramate|topiramate|mesh-list
110616332|NCT00769158|Naltrexone|naltrexone|mesh-list
110616333|NCT00769158|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110616334|NCT00769158|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110616335|NCT00769158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110616336|NCT00769158|Sensory System Agents|sensory system agents|mesh-ancestor
110616337|NCT00769158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110616338|NCT00769158|Anticonvulsants|anticonvulsants|mesh-ancestor
110616339|NCT00769158|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110616340|NCT00983164|Antioxidants|antioxidants|mesh-list
110616341|NCT00983164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110616342|NCT00983164|Protective Agents|protective agents|mesh-ancestor
110616343|NCT00983164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110616344|NCT00333775|Bevacizumab|bevacizumab|mesh-list
110616345|NCT00333775|Docetaxel|docetaxel|mesh-list
110616346|NCT00333775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110616347|NCT00333775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110616348|NCT00333775|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110390571|NCT05338190|Immunologic Factors|immunologic factors|mesh-ancestor
110616349|NCT00333775|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110616350|NCT00333775|Growth Substances|growth substances|mesh-ancestor
110616351|NCT00333775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110616352|NCT00333775|Growth Inhibitors|growth inhibitors|mesh-ancestor
110616353|NCT00333775|Tubulin Modulators|tubulin modulators|mesh-ancestor
110616354|NCT00333775|Antimitotic Agents|antimitotic agents|mesh-ancestor
110616355|NCT00333775|Mitosis Modulators|mitosis modulators|mesh-ancestor
110616356|NCT00333775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110616357|NCT03860428|Acetaminophen|acetaminophen|mesh-list
110616358|NCT03860428|Ibuprofen|ibuprofen|mesh-list
110616359|NCT03860428|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-list
110616360|NCT03860428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110616361|NCT03860428|Analgesics|analgesics|mesh-ancestor
110616362|NCT03860428|Sensory System Agents|sensory system agents|mesh-ancestor
110616363|NCT03860428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110616364|NCT03860428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110616365|NCT03860428|Antipyretics|antipyretics|mesh-ancestor
110616366|NCT03860428|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110616367|NCT03860428|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110616368|NCT03860428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110616369|NCT03860428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110616370|NCT03860428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110616371|NCT00771888|Lanreotide|lanreotide|mesh-list
110616372|NCT00771888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110616373|NCT00605475|Metformin|metformin|mesh-list
110616374|NCT00605475|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110616375|NCT00605475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110616376|NCT00986596|Vitamin D|vitamin d|mesh-list
110616377|NCT00986596|Cholecalciferol|cholecalciferol|mesh-list
110616378|NCT00986596|Vitamins|vitamins|mesh-ancestor
110616379|NCT00986596|Micronutrients|micronutrients|mesh-ancestor
110616380|NCT00986596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110616381|NCT00986596|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110616382|NCT00986596|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110616383|NCT00769470|Carboplatin|carboplatin|mesh-list
110616384|NCT00769470|Docetaxel|docetaxel|mesh-list
110616385|NCT00769470|Trastuzumab|trastuzumab|mesh-list
110616386|NCT00769470|Lapatinib|lapatinib|mesh-list
110616387|NCT00769470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110616388|NCT00769470|Tubulin Modulators|tubulin modulators|mesh-ancestor
110616389|NCT00769470|Antimitotic Agents|antimitotic agents|mesh-ancestor
110616390|NCT00769470|Mitosis Modulators|mitosis modulators|mesh-ancestor
110616391|NCT00769470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110616392|NCT00769470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110616393|NCT00769470|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110616394|NCT00769470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110616395|NCT00605319|Fesoterodine|fesoterodine|mesh-list
110616396|NCT00605319|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110616397|NCT00605319|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110616399|NCT00605319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110616400|NCT00605319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110616401|NCT00605319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110616402|NCT00605319|Urological Agents|urological agents|mesh-ancestor
110616403|NCT00983320|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110616404|NCT00983320|Antidepressive Agents|antidepressive agents|mesh-ancestor
110616405|NCT00983320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110616406|NCT00983320|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110616407|NCT00983320|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110616408|NCT00983320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110616409|NCT00983320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110616410|NCT00908661|Cellulose, Oxidized|cellulose, oxidized|mesh-list
110616411|NCT00908661|Hemostatics|hemostatics|mesh-ancestor
110616412|NCT00908661|Coagulants|coagulants|mesh-ancestor
110616413|NCT00983398|Sodium thiosulfate|sodium thiosulfate|mesh-list
110616414|NCT00983398|Carboplatin|carboplatin|mesh-list
110616415|NCT00983398|Melphalan|melphalan|mesh-list
110616416|NCT00983398|Mechlorethamine|mechlorethamine|mesh-list
110616417|NCT00983398|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
110616418|NCT00983398|Mannitol|mannitol|mesh-list
110616419|NCT00983398|Antidotes|antidotes|mesh-list
110616420|NCT00983398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110616421|NCT00983398|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110616422|NCT00983398|Alkylating Agents|alkylating agents|mesh-ancestor
110616423|NCT00983398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110616424|NCT00983398|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110616425|NCT00983398|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110616426|NCT00983398|Immunologic Factors|immunologic factors|mesh-ancestor
110616427|NCT00983398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110616428|NCT00983398|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
110616429|NCT00983398|Diuretics|diuretics|mesh-ancestor
110616430|NCT00983398|Natriuretic Agents|natriuretic agents|mesh-ancestor
110616431|NCT00983398|Protective Agents|protective agents|mesh-ancestor
110616432|NCT00983398|Antioxidants|antioxidants|mesh-ancestor
110616433|NCT00983398|Antitubercular Agents|antitubercular agents|mesh-ancestor
110616434|NCT00983398|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110616435|NCT00983398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110616436|NCT00983398|Chelating Agents|chelating agents|mesh-ancestor
110616437|NCT00983398|Sequestering Agents|sequestering agents|mesh-ancestor
110616438|NCT00333229|Zoledronic Acid|zoledronic acid|mesh-list
110616439|NCT00333229|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110263738|NCT00151502|Atorvastatin|atorvastatin|mesh-list
110616440|NCT00333229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110616441|NCT00769548|Goserelin|goserelin|mesh-list
110616442|NCT00769548|Flutamide|flutamide|mesh-list
110616443|NCT00769548|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110616444|NCT00769548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110616445|NCT00769548|Androgen Antagonists|androgen antagonists|mesh-ancestor
110616446|NCT00769548|Hormone Antagonists|hormone antagonists|mesh-ancestor
110616447|NCT00769548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110616448|NCT00769548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110616449|NCT05277675|Bevacizumab|bevacizumab|mesh-list
110616450|NCT05277675|Tislelizumab|tislelizumab|mesh-list
110616451|NCT05277675|Lenvatinib|lenvatinib|mesh-list
110616452|NCT05277675|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110390625|NCT05239741|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110390626|NCT05239741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110390627|NCT05239741|Immunologic Factors|immunologic factors|mesh-ancestor
110390630|NCT05239741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110285316|NCT00207584|Antimalarials|antimalarials|mesh-ancestor
110616453|NCT05277675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110616454|NCT05277675|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110616455|NCT05277675|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110616456|NCT05277675|Growth Substances|growth substances|mesh-ancestor
110616457|NCT05277675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110616458|NCT05277675|Growth Inhibitors|growth inhibitors|mesh-ancestor
110616459|NCT05277675|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110616460|NCT05277675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110616461|NCT05277675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110616462|NCT03984409|Potassium Citrate|potassium citrate|mesh-list
110616463|NCT03984409|Diuretics|diuretics|mesh-ancestor
110616464|NCT03984409|Natriuretic Agents|natriuretic agents|mesh-ancestor
110616465|NCT03984409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110616466|NCT03984409|Expectorants|expectorants|mesh-ancestor
110616467|NCT03984409|Respiratory System Agents|respiratory system agents|mesh-ancestor
110616468|NCT00983554|Anastrozole|anastrozole|mesh-list
110616469|NCT00983554|Testosterone|testosterone|mesh-list
110616470|NCT00983554|Dutasteride|dutasteride|mesh-list
110616471|NCT00983554|Androgens|androgens|mesh-ancestor
110616472|NCT00983554|Hormones|hormones|mesh-ancestor
110616473|NCT00983554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110616474|NCT00983554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110616475|NCT00983554|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110616476|NCT00983554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110616477|NCT00983554|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
110616478|NCT00983554|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110616479|NCT00983554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110616480|NCT00983554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110616481|NCT00983554|Hormone Antagonists|hormone antagonists|mesh-ancestor
110616482|NCT00983554|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110616483|NCT00983554|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110616484|NCT05004987|Dexetimide|dexetimide|mesh-list
110616485|NCT05004987|Citalopram|citalopram|mesh-list
110616486|NCT05004987|Escitalopram|escitalopram|mesh-list
110616487|NCT05004987|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110616488|NCT05004987|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110616489|NCT05004987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110616490|NCT05004987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110616491|NCT05004987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110616492|NCT05004987|Serotonin Agents|serotonin agents|mesh-ancestor
110616493|NCT05004987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110616494|NCT05004987|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110390659|NCT05222529|Glycopyrrolate|glycopyrrolate|mesh-list
110390660|NCT05222529|Bromides|bromides|mesh-list
110390661|NCT05222529|Anticonvulsants|anticonvulsants|mesh-ancestor
110390662|NCT05222529|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110390663|NCT05222529|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110390664|NCT05222529|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110390665|NCT05222529|Cholinergic Agents|cholinergic agents|mesh-ancestor
110390666|NCT05222529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110390667|NCT05222529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110390668|NCT05222529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110390669|NCT05212571|Ketamine|ketamine|mesh-list
110390670|NCT05212571|Esketamine|esketamine|mesh-list
110390671|NCT05212571|Analgesics|analgesics|mesh-ancestor
110390672|NCT05212571|Sensory System Agents|sensory system agents|mesh-ancestor
110616495|NCT05004987|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110616496|NCT05004987|Parasympatholytics|parasympatholytics|mesh-ancestor
110616497|NCT05004987|Autonomic Agents|autonomic agents|mesh-ancestor
110616498|NCT05004987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110616499|NCT05004987|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110616500|NCT05004987|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110616501|NCT05004987|Cholinergic Agents|cholinergic agents|mesh-ancestor
110616502|NCT05004987|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110616503|NCT05004987|Antidepressive Agents|antidepressive agents|mesh-ancestor
110616504|NCT05004987|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110616505|NCT00908817|Chlorhexidine|chlorhexidine|mesh-list
110616506|NCT00908817|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
110616507|NCT00908817|Triamcinolone|triamcinolone|mesh-list
110616508|NCT00908817|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110616509|NCT00908817|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110616510|NCT00908817|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110616511|NCT00908817|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110616512|NCT00908817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110616513|NCT00908817|Disinfectants|disinfectants|mesh-ancestor
110616514|NCT00908817|Dermatologic Agents|dermatologic agents|mesh-ancestor
110616515|NCT00908817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110616516|NCT00908817|Glucocorticoids|glucocorticoids|mesh-ancestor
110263816|NCT00151619|Amlodipine|amlodipine|mesh-list
110616517|NCT00908817|Hormones|hormones|mesh-ancestor
110616518|NCT00908817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110616519|NCT00908817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110616520|NCT00908817|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110616521|NCT00908817|Immunologic Factors|immunologic factors|mesh-ancestor
110616522|NCT00908817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110616523|NCT00908817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110616524|NCT00332839|Cyclosporine|cyclosporine|mesh-list
110616525|NCT00332839|Mycophenolic Acid|mycophenolic acid|mesh-list
110616526|NCT00332839|Everolimus|everolimus|mesh-list
110616527|NCT00332839|Tacrolimus|tacrolimus|mesh-list
110616528|NCT00332839|Cyclosporins|cyclosporins|mesh-list
110616529|NCT00332839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110616530|NCT00332839|Immunologic Factors|immunologic factors|mesh-ancestor
110616531|NCT00332839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110616532|NCT00332839|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110616533|NCT00332839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110616534|NCT00332839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110616535|NCT00332839|Antifungal Agents|antifungal agents|mesh-ancestor
110616536|NCT00332839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110616537|NCT00332839|Dermatologic Agents|dermatologic agents|mesh-ancestor
110616538|NCT00332839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110616539|NCT00332839|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110390685|NCT05212571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110616540|NCT00332839|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110616541|NCT00332839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110616542|NCT00332839|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110616543|NCT00332839|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110616544|NCT00332839|Antitubercular Agents|antitubercular agents|mesh-ancestor
110616545|NCT00332839|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110616546|NCT00927147|Cetuximab|cetuximab|mesh-list
110616547|NCT00927147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110616548|NCT00927147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110616549|NCT05712616|Strontium ranelate|strontium ranelate|mesh-list
110616550|NCT05712616|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110616551|NCT05712616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110616552|NCT00927225|Ropivacaine|ropivacaine|mesh-list
110616553|NCT00927225|Anesthetics, Local|anesthetics, local|mesh-ancestor
110616554|NCT00927225|Anesthetics|anesthetics|mesh-ancestor
110616555|NCT00927225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110616556|NCT00927225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110616557|NCT00927225|Sensory System Agents|sensory system agents|mesh-ancestor
110616558|NCT00927225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110616560|NCT00357097|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110616561|NCT00357097|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110616562|NCT00357097|Dopamine Agonists|dopamine agonists|mesh-ancestor
110616563|NCT00357097|Dopamine Agents|dopamine agents|mesh-ancestor
110616564|NCT00357097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110616565|NCT00357097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110616566|NCT00357097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110616567|NCT00983788|Bezafibrate|bezafibrate|mesh-list
110616568|NCT00983788|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110616569|NCT00983788|Antimetabolites|antimetabolites|mesh-ancestor
110616570|NCT00983788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110616571|NCT00983788|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110616573|NCT00983944|Cyclophosphamide|cyclophosphamide|mesh-list
110616574|NCT00983944|Rituximab|rituximab|mesh-list
110616575|NCT00983944|Doxorubicin|doxorubicin|mesh-list
110616576|NCT00983944|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110616577|NCT00983944|Etoposide|etoposide|mesh-list
110616578|NCT00983944|Vincristine|vincristine|mesh-list
110616579|NCT00983944|Bleomycin|bleomycin|mesh-list
110616580|NCT00983944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110616581|NCT00983944|Immunologic Factors|immunologic factors|mesh-ancestor
110616582|NCT00983944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110390709|NCT05189223|Buprenorphine|buprenorphine|mesh-list
110616583|NCT00983944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110616584|NCT00983944|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110276042|NCT00199407|Istradefylline|istradefylline|mesh-list
110616585|NCT00983944|Alkylating Agents|alkylating agents|mesh-ancestor
110616586|NCT00983944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110616587|NCT00983944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110616588|NCT00983944|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110616589|NCT00983944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110616590|NCT00983944|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110263883|NCT00151697|Insulin Aspart|insulin aspart|mesh-list
110616591|NCT00983944|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110616592|NCT00983944|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110616593|NCT00983944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110616594|NCT00983944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110616595|NCT00983944|Glucocorticoids|glucocorticoids|mesh-ancestor
110616596|NCT00983944|Hormones|hormones|mesh-ancestor
110616597|NCT00983944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110616598|NCT00983944|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110616599|NCT00983944|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110616600|NCT00983944|Tubulin Modulators|tubulin modulators|mesh-ancestor
110616601|NCT00983944|Antimitotic Agents|antimitotic agents|mesh-ancestor
110616602|NCT00983944|Mitosis Modulators|mitosis modulators|mesh-ancestor
110616603|NCT00927537|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110616604|NCT00927537|Telmisartan|telmisartan|mesh-list
110616605|NCT00927537|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110616606|NCT00927537|Diuretics|diuretics|mesh-ancestor
110616607|NCT00927537|Natriuretic Agents|natriuretic agents|mesh-ancestor
110616608|NCT00927537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110616609|NCT00927537|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110616610|NCT00927537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110616611|NCT00927537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110616612|NCT00927537|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110616613|NCT00927537|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110616614|NCT02538003|Delpazolid|delpazolid|mesh-list
110616615|NCT02538003|Oxazolidinones|oxazolidinones|mesh-list
110616616|NCT02538003|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110616617|NCT02538003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110616618|NCT02538003|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110616619|NCT02538003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110616620|NCT02538003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110616622|NCT00909129|Ribavirin|ribavirin|mesh-list
110616623|NCT00909129|Interferon-alpha|interferon-alpha|mesh-list
110616624|NCT00909129|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110616625|NCT00909129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110616626|NCT00909129|Antiviral Agents|antiviral agents|mesh-ancestor
110616627|NCT00909129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110616628|NCT00909129|Antimetabolites|antimetabolites|mesh-ancestor
110616629|NCT00909129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110616630|NCT00909129|Immunologic Factors|immunologic factors|mesh-ancestor
110616631|NCT00909129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110616632|NCT01053325|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
110616633|NCT01053325|Antimalarials|antimalarials|mesh-ancestor
110616634|NCT01053325|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110616635|NCT01053325|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110616636|NCT01053325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110616637|NCT01053325|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110616638|NCT01053325|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110616639|NCT01053403|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
110616640|NCT01053403|Hallucinogens|hallucinogens|mesh-ancestor
110616641|NCT01053403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110616642|NCT01053403|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110616643|NCT01053403|Serotonin Agents|serotonin agents|mesh-ancestor
110616644|NCT01053403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110616645|NCT01053403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110616646|NCT01053403|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110616647|NCT01053403|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110616648|NCT01053403|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110616649|NCT01053403|Adrenergic Agents|adrenergic agents|mesh-ancestor
110616650|NCT00927615|Abciximab|abciximab|mesh-list
110616651|NCT00927615|Anticoagulants|anticoagulants|mesh-ancestor
110616652|NCT00927615|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110616653|NCT03990103|Paclitaxel|paclitaxel|mesh-list
110616654|NCT03990103|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110616655|NCT03990103|Bevacizumab|bevacizumab|mesh-list
110616657|NCT03990103|Tegafur|tegafur|mesh-list
110616658|NCT03990103|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110616659|NCT03990103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110616660|NCT03990103|Tubulin Modulators|tubulin modulators|mesh-ancestor
110616661|NCT03990103|Antimitotic Agents|antimitotic agents|mesh-ancestor
110616662|NCT03990103|Mitosis Modulators|mitosis modulators|mesh-ancestor
110616663|NCT03990103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110616664|NCT03990103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110616665|NCT03990103|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110616666|NCT03990103|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110616667|NCT03990103|Growth Substances|growth substances|mesh-ancestor
110616668|NCT03990103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110616669|NCT03990103|Growth Inhibitors|growth inhibitors|mesh-ancestor
110616670|NCT03990103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110616671|NCT03990103|Antimetabolites|antimetabolites|mesh-ancestor
110616673|NCT00927693|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110616674|NCT00927693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110616675|NCT00987220|Donepezil|donepezil|mesh-list
110616676|NCT00987220|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110616677|NCT00987220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110616678|NCT00987220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110616679|NCT00987220|Cholinergic Agents|cholinergic agents|mesh-ancestor
110616680|NCT00987220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110616681|NCT00987220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110616682|NCT00987220|Nootropic Agents|nootropic agents|mesh-ancestor
110616683|NCT01581151|Dexamethasone|dexamethasone|mesh-list
110616684|NCT01581151|Ranibizumab|ranibizumab|mesh-list
110616685|NCT01581151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110616686|NCT01581151|Antiemetics|antiemetics|mesh-ancestor
110616687|NCT01581151|Autonomic Agents|autonomic agents|mesh-ancestor
110616688|NCT01581151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110616689|NCT01581151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110616690|NCT01581151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110616691|NCT01581151|Glucocorticoids|glucocorticoids|mesh-ancestor
110616692|NCT01581151|Hormones|hormones|mesh-ancestor
110616693|NCT01581151|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110616694|NCT01581151|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110616695|NCT01581151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110616696|NCT01581151|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110616697|NCT01581151|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110616698|NCT01581151|Growth Substances|growth substances|mesh-ancestor
110616699|NCT01581151|Growth Inhibitors|growth inhibitors|mesh-ancestor
110616701|NCT01053481|Vitamins|vitamins|mesh-ancestor
110616702|NCT01053481|Micronutrients|micronutrients|mesh-ancestor
110616703|NCT01053481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110616704|NCT01053481|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110616705|NCT00927771|Azelaic acid|azelaic acid|mesh-list
110390811|NCT04966299|Erythritol|erythritol|mesh-list
110616707|NCT00927771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110616708|NCT00927771|Dermatologic Agents|dermatologic agents|mesh-ancestor
110616709|NCT00927771|Antioxidants|antioxidants|mesh-ancestor
110616710|NCT00927771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110616711|NCT00927771|Protective Agents|protective agents|mesh-ancestor
110616712|NCT00927771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110616713|NCT00927771|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110616714|NCT01053559|Certolizumab Pegol|certolizumab pegol|mesh-list
110616715|NCT01053559|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110616716|NCT01053559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110616717|NCT01053559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110616718|NCT01053559|Immunologic Factors|immunologic factors|mesh-ancestor
110616719|NCT01053559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110616720|NCT01053559|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110616721|NCT01053637|Acetaminophen|acetaminophen|mesh-list
110616722|NCT01053637|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
110616723|NCT01053637|Hydrocodone|hydrocodone|mesh-list
110616724|NCT01053637|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110616725|NCT01053637|Analgesics|analgesics|mesh-ancestor
110616726|NCT01053637|Sensory System Agents|sensory system agents|mesh-ancestor
110616727|NCT01053637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110616728|NCT01053637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110616729|NCT01053637|Antipyretics|antipyretics|mesh-ancestor
110616730|NCT01053637|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110616731|NCT01053637|Narcotics|narcotics|mesh-ancestor
110616732|NCT01053637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110616733|NCT01053637|Antitussive Agents|antitussive agents|mesh-ancestor
110616734|NCT01053637|Respiratory System Agents|respiratory system agents|mesh-ancestor
110616735|NCT01053637|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110616736|NCT01053637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110616737|NCT01053637|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110616738|NCT00928161|Dexlansoprazole|dexlansoprazole|mesh-list
110616739|NCT00928161|Lansoprazole|lansoprazole|mesh-list
110616740|NCT00928161|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110616741|NCT00928161|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110616742|NCT00928161|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110616743|NCT00928161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110616744|NCT00928161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110616745|NCT00909519|Naproxen|naproxen|mesh-list
110616746|NCT00909519|Furosemide|furosemide|mesh-list
110616747|NCT00909519|Naproxen-n-butyl nitrate|naproxen-n-butyl nitrate|mesh-list
110616748|NCT00909519|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110616749|NCT00909519|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110616750|NCT00909519|Analgesics|analgesics|mesh-ancestor
110616751|NCT00909519|Sensory System Agents|sensory system agents|mesh-ancestor
110616752|NCT00909519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110616753|NCT00909519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110616754|NCT00909519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110616755|NCT00909519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110616756|NCT00909519|Gout Suppressants|gout suppressants|mesh-ancestor
110616757|NCT00909519|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110616758|NCT00909519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110616759|NCT00909519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110616760|NCT00909519|Diuretics|diuretics|mesh-ancestor
110616761|NCT00909519|Natriuretic Agents|natriuretic agents|mesh-ancestor
110616762|NCT00909519|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
110616763|NCT00909519|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110616764|NCT00909519|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
110616765|NCT00355615|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
110616766|NCT00355615|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110616767|NCT00355615|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110616768|NCT00355615|Antimetabolites|antimetabolites|mesh-ancestor
110616769|NCT00355615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110616770|NCT00355615|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110616771|NCT00355615|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110616772|NCT00355615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110616773|NCT00907179|Pemetrexed|pemetrexed|mesh-list
110616774|NCT00907179|Panobinostat|panobinostat|mesh-list
110616775|NCT00907179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110616776|NCT00907179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110616777|NCT00907179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110616778|NCT00907179|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110616779|NCT00907179|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110616780|NCT00907179|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110616781|NCT00347269|Psychotropic Drugs|psychotropic drugs|mesh-list
110616782|NCT00544648|Paclitaxel|paclitaxel|mesh-list
110616783|NCT00544648|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110616784|NCT00544648|Carboplatin|carboplatin|mesh-list
110616785|NCT00544648|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110616786|NCT00544648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110616787|NCT00544648|Tubulin Modulators|tubulin modulators|mesh-ancestor
110616788|NCT00544648|Antimitotic Agents|antimitotic agents|mesh-ancestor
110616789|NCT00544648|Mitosis Modulators|mitosis modulators|mesh-ancestor
110616790|NCT00544648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110616791|NCT01053871|Fentanyl|fentanyl|mesh-list
110616792|NCT01053871|Midazolam|midazolam|mesh-list
110616793|NCT01053871|Propofol|propofol|mesh-list
110616794|NCT01053871|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110616795|NCT01053871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110616796|NCT01053871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110616797|NCT01053871|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110616798|NCT01053871|Anesthetics, General|anesthetics, general|mesh-ancestor
110616799|NCT01053871|Anesthetics|anesthetics|mesh-ancestor
110616800|NCT01053871|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110616801|NCT01053871|Narcotics|narcotics|mesh-ancestor
110616802|NCT01053871|Analgesics|analgesics|mesh-ancestor
110616803|NCT01053871|Sensory System Agents|sensory system agents|mesh-ancestor
110616804|NCT01053871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110616805|NCT01053871|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110616807|NCT01053871|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110616808|NCT01053871|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110616809|NCT01053871|GABA Modulators|gaba modulators|mesh-ancestor
110616810|NCT01053871|GABA Agents|gaba agents|mesh-ancestor
110390936|NCT04670471|Remifentanil|remifentanil|mesh-list
110616811|NCT01053871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110616812|NCT01053871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110616813|NCT01053949|Thalidomide|thalidomide|mesh-list
110616814|NCT01053949|Pomalidomide|pomalidomide|mesh-list
110616815|NCT01053949|Immunologic Factors|immunologic factors|mesh-ancestor
110616816|NCT01053949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110616817|NCT01053949|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110616818|NCT01053949|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110616819|NCT01053949|Growth Substances|growth substances|mesh-ancestor
110616820|NCT01053949|Growth Inhibitors|growth inhibitors|mesh-ancestor
110616821|NCT01053949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110616822|NCT01053949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110616823|NCT01053949|Leprostatic Agents|leprostatic agents|mesh-ancestor
110616824|NCT01053949|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110616825|NCT01053949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110616826|NCT00987376|Choline|choline|mesh-list
110616827|NCT00987376|Lipotropic Agents|lipotropic agents|mesh-ancestor
110616828|NCT00987376|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110616829|NCT00987376|Antimetabolites|antimetabolites|mesh-ancestor
110616830|NCT00987376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110616831|NCT00987376|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110616832|NCT00987376|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110616833|NCT00987376|Nootropic Agents|nootropic agents|mesh-ancestor
110616835|NCT00987454|Hematinics|hematinics|mesh-ancestor
110616836|NCT04005664|Phenylephrine|phenylephrine|mesh-list
110616837|NCT04005664|Oxymetazoline|oxymetazoline|mesh-list
110616838|NCT04005664|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110616839|NCT04005664|Mydriatics|mydriatics|mesh-ancestor
110616840|NCT04005664|Autonomic Agents|autonomic agents|mesh-ancestor
110616841|NCT04005664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110616842|NCT04005664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110616843|NCT04005664|Sympathomimetics|sympathomimetics|mesh-ancestor
110616844|NCT04005664|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110616845|NCT04005664|Nasal Decongestants|nasal decongestants|mesh-ancestor
110616846|NCT04005664|Respiratory System Agents|respiratory system agents|mesh-ancestor
110616847|NCT04005664|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110616848|NCT04005664|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110616849|NCT04005664|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110616850|NCT04005664|Adrenergic Agents|adrenergic agents|mesh-ancestor
110616851|NCT04005664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110616852|NCT04005664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110616853|NCT04005664|Protective Agents|protective agents|mesh-ancestor
110616854|NCT00330967|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
110616855|NCT00330967|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
110616856|NCT00330967|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
110616857|NCT00330967|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110616858|NCT00924573|Metformin|metformin|mesh-list
110616859|NCT00924573|Glimepiride|glimepiride|mesh-list
110616860|NCT00924573|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110616861|NCT00924573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110616862|NCT00924573|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110616863|NCT00924573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110616864|NCT00924573|Immunologic Factors|immunologic factors|mesh-ancestor
110616865|NCT01054027|Phenylephrine|phenylephrine|mesh-list
110616866|NCT01054027|Oxymetazoline|oxymetazoline|mesh-list
110616867|NCT01054027|Cyclopentolate|cyclopentolate|mesh-list
110616868|NCT01054027|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110616869|NCT01054027|Mydriatics|mydriatics|mesh-ancestor
110616870|NCT01054027|Autonomic Agents|autonomic agents|mesh-ancestor
110616871|NCT01054027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110616872|NCT01054027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110616873|NCT01054027|Sympathomimetics|sympathomimetics|mesh-ancestor
110616874|NCT01054027|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110616875|NCT01054027|Nasal Decongestants|nasal decongestants|mesh-ancestor
110616876|NCT01054027|Respiratory System Agents|respiratory system agents|mesh-ancestor
110616877|NCT01054027|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110616878|NCT01054027|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110616879|NCT01054027|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110616880|NCT01054027|Adrenergic Agents|adrenergic agents|mesh-ancestor
110616881|NCT01054027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110616882|NCT01054027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110616883|NCT01054027|Protective Agents|protective agents|mesh-ancestor
110616884|NCT01054027|Parasympatholytics|parasympatholytics|mesh-ancestor
110616885|NCT01054027|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110616886|NCT01054027|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110616887|NCT01054027|Cholinergic Agents|cholinergic agents|mesh-ancestor
110616889|NCT01054105|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110616890|NCT01054105|Vasodilator Agents|vasodilator agents|mesh-ancestor
110616891|NCT00330343|Naloxone|naloxone|mesh-list
110616892|NCT00330343|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110264174|NCT04725422|Zoledronic Acid|zoledronic acid|mesh-list
110616893|NCT00330343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110616894|NCT00330343|Sensory System Agents|sensory system agents|mesh-ancestor
110616895|NCT00330343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110616896|NCT00987766|Gemcitabine|gemcitabine|mesh-list
110616897|NCT00987766|Oxaliplatin|oxaliplatin|mesh-list
110616898|NCT00987766|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110616899|NCT00987766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110616900|NCT00987766|Antimetabolites|antimetabolites|mesh-ancestor
110616901|NCT00987766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110616902|NCT00987766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110616903|NCT00987766|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110616904|NCT00987766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110616905|NCT04005430|Dexamethasone|dexamethasone|mesh-list
110616906|NCT04005430|Dexamethasone acetate|dexamethasone acetate|mesh-list
110616907|NCT04005430|BB 1101|bb 1101|mesh-list
110616908|NCT04005430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110616909|NCT04005430|Antiemetics|antiemetics|mesh-ancestor
110616910|NCT04005430|Autonomic Agents|autonomic agents|mesh-ancestor
110616911|NCT04005430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110616912|NCT04005430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110616913|NCT04005430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110616914|NCT04005430|Glucocorticoids|glucocorticoids|mesh-ancestor
110616915|NCT04005430|Hormones|hormones|mesh-ancestor
110616916|NCT04005430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110616917|NCT04005430|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110616918|NCT04005430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110616919|NCT04005430|Protease Inhibitors|protease inhibitors|mesh-ancestor
110616920|NCT04005430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110616921|NCT04005430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110616922|NCT00330187|Bupropion|bupropion|mesh-list
110616923|NCT00330187|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110616924|NCT00330187|Antidepressive Agents|antidepressive agents|mesh-ancestor
110616925|NCT00330187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110616926|NCT00330187|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110616927|NCT00330187|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110616928|NCT00330187|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110616929|NCT00330187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110616930|NCT00330187|Dopamine Agents|dopamine agents|mesh-ancestor
110616931|NCT00330187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110616932|NCT00330187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110616933|NCT00330187|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110616934|NCT00330187|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110616935|NCT00330187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110616936|NCT00987844|Prucalopride|prucalopride|mesh-list
110616937|NCT00987844|Laxatives|laxatives|mesh-ancestor
110616938|NCT00987844|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110616939|NCT00987844|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
110616940|NCT00987844|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110616941|NCT00987844|Serotonin Agents|serotonin agents|mesh-ancestor
110616942|NCT00987844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110616943|NCT00987844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110616944|NCT00987844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110616945|NCT03986905|Scopolamine|scopolamine|mesh-list
110616946|NCT03986905|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
110616947|NCT03986905|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110616949|NCT03986905|Autonomic Agents|autonomic agents|mesh-ancestor
110616950|NCT03986905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110616951|NCT03986905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110616952|NCT03986905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110616954|NCT03986905|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110616955|NCT03986905|Cholinergic Agents|cholinergic agents|mesh-ancestor
110616956|NCT03986905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110616957|NCT03986905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110616958|NCT03986905|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110616959|NCT03986905|Parasympatholytics|parasympatholytics|mesh-ancestor
110616960|NCT00329797|Vitamin D|vitamin d|mesh-list
110616961|NCT00329797|Zoledronic Acid|zoledronic acid|mesh-list
110616962|NCT00329797|Calcium|calcium|mesh-list
110616963|NCT00329797|Vitamins|vitamins|mesh-ancestor
110616964|NCT00329797|Micronutrients|micronutrients|mesh-ancestor
110616965|NCT00329797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110616966|NCT00329797|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110616967|NCT00329797|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110616968|NCT00541450|Metformin|metformin|mesh-list
110616969|NCT00541450|Pioglitazone|pioglitazone|mesh-list
110616970|NCT00541450|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110616971|NCT00541450|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110616972|NCT00541450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110616973|NCT00541450|Incretins|incretins|mesh-ancestor
110616974|NCT00541450|Hormones|hormones|mesh-ancestor
110616975|NCT00541450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110616976|NCT00541450|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110616977|NCT00541450|Protease Inhibitors|protease inhibitors|mesh-ancestor
110616978|NCT00541450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110616979|NCT00541450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110616980|NCT01056679|Doxorubicin|doxorubicin|mesh-list
110616981|NCT01056679|Lenalidomide|lenalidomide|mesh-list
110616982|NCT01056679|Vinblastine|vinblastine|mesh-list
110616983|NCT01056679|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110391060|NCT04464070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110391061|NCT04464070|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110391062|NCT04464070|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110391063|NCT04464070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110391064|NCT04464070|Antipyretics|antipyretics|mesh-ancestor
110391065|NCT04464070|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110391066|NCT04464070|Antimetabolites|antimetabolites|mesh-ancestor
110616984|NCT01056679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110616985|NCT01056679|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110616986|NCT01056679|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110616987|NCT01056679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110616988|NCT01056679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110616989|NCT01056679|Immunologic Factors|immunologic factors|mesh-ancestor
110616990|NCT01056679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110616991|NCT01056679|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110616992|NCT01056679|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110616993|NCT01056679|Growth Substances|growth substances|mesh-ancestor
110616994|NCT01056679|Growth Inhibitors|growth inhibitors|mesh-ancestor
110616995|NCT01056679|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110616996|NCT01056679|Tubulin Modulators|tubulin modulators|mesh-ancestor
110616997|NCT01056679|Antimitotic Agents|antimitotic agents|mesh-ancestor
110616998|NCT01056679|Mitosis Modulators|mitosis modulators|mesh-ancestor
110616999|NCT04769362|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
110617000|NCT04769362|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110617001|NCT04769362|Adrenergic Agents|adrenergic agents|mesh-ancestor
110617002|NCT04769362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110617003|NCT04769362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110617004|NCT04769362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110617005|NCT03983551|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
110617006|NCT03983551|Protease Inhibitors|protease inhibitors|mesh-ancestor
110617007|NCT03983551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110617008|NCT03983551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110617009|NCT03983551|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110617010|NCT03983551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110617011|NCT05709574|Tadalafil|tadalafil|mesh-list
110617012|NCT05709574|Vasodilator Agents|vasodilator agents|mesh-ancestor
110617013|NCT05709574|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110617014|NCT05709574|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110617015|NCT05709574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110617016|NCT05709574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110617017|NCT05709574|Urological Agents|urological agents|mesh-ancestor
110617018|NCT04690504|Melatonin|melatonin|mesh-list
110617019|NCT04690504|Antioxidants|antioxidants|mesh-ancestor
110617020|NCT04690504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110617021|NCT04690504|Protective Agents|protective agents|mesh-ancestor
110391103|NCT04441138|Durvalumab|durvalumab|mesh-list
110391104|NCT04441138|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110391106|NCT04395222|Fludarabine|fludarabine|mesh-list
110391107|NCT04395222|Melphalan|melphalan|mesh-list
110391108|NCT04395222|Thymoglobulin|thymoglobulin|mesh-list
110391109|NCT04395222|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110391110|NCT04395222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110391120|NCT04311502|Pyridoxine|pyridoxine|mesh-list
110617022|NCT04690504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110617023|NCT04690504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110617024|NCT00540124|Tadalafil|tadalafil|mesh-list
110617025|NCT00540124|Tamsulosin|tamsulosin|mesh-list
110617026|NCT00540124|Vasodilator Agents|vasodilator agents|mesh-ancestor
110617027|NCT00540124|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110617028|NCT00540124|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110617029|NCT00540124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110617030|NCT00540124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110617031|NCT00540124|Urological Agents|urological agents|mesh-ancestor
110617032|NCT00540124|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110617033|NCT00540124|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110617034|NCT00540124|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110617035|NCT00540124|Adrenergic Agents|adrenergic agents|mesh-ancestor
110617036|NCT00540124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110617037|NCT00540124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110617039|NCT00540046|Trace Elements|trace elements|mesh-ancestor
110617040|NCT00540046|Micronutrients|micronutrients|mesh-ancestor
110617041|NCT00540046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110617042|NCT04613830|Tramadol|tramadol|mesh-list
110617043|NCT04613830|Bupivacaine|bupivacaine|mesh-list
110264324|NCT02935933|Dexmedetomidine|dexmedetomidine|mesh-list
110617044|NCT04613830|Anesthetics, Local|anesthetics, local|mesh-ancestor
110617045|NCT04613830|Anesthetics|anesthetics|mesh-ancestor
110617046|NCT04613830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110617047|NCT04613830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110617048|NCT04613830|Sensory System Agents|sensory system agents|mesh-ancestor
110391137|NCT04311502|Leprostatic Agents|leprostatic agents|mesh-ancestor
110617049|NCT04613830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110617050|NCT04613830|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110617051|NCT04613830|Narcotics|narcotics|mesh-ancestor
110617052|NCT04613830|Analgesics|analgesics|mesh-ancestor
110617053|NCT00689936|Thalidomide|thalidomide|mesh-list
110617054|NCT00689936|Dexamethasone|dexamethasone|mesh-list
110617055|NCT00689936|Dexamethasone acetate|dexamethasone acetate|mesh-list
110617056|NCT00689936|Prednisone|prednisone|mesh-list
110617057|NCT00689936|Lenalidomide|lenalidomide|mesh-list
110617058|NCT00689936|Melphalan|melphalan|mesh-list
110617059|NCT00689936|BB 1101|bb 1101|mesh-list
110617060|NCT00689936|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110617061|NCT00689936|Antiemetics|antiemetics|mesh-ancestor
110617062|NCT00689936|Autonomic Agents|autonomic agents|mesh-ancestor
110617063|NCT00689936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110617064|NCT00689936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110617065|NCT00689936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110617066|NCT00689936|Glucocorticoids|glucocorticoids|mesh-ancestor
110617067|NCT00689936|Hormones|hormones|mesh-ancestor
110617068|NCT00689936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110617069|NCT00689936|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110617070|NCT00689936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110617071|NCT00689936|Protease Inhibitors|protease inhibitors|mesh-ancestor
110617072|NCT00689936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110617073|NCT00689936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110617074|NCT00689936|Immunologic Factors|immunologic factors|mesh-ancestor
110617075|NCT00689936|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110617076|NCT00689936|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110617077|NCT00689936|Growth Substances|growth substances|mesh-ancestor
110617078|NCT00689936|Growth Inhibitors|growth inhibitors|mesh-ancestor
110617079|NCT00689936|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110617080|NCT00689936|Alkylating Agents|alkylating agents|mesh-ancestor
110617081|NCT00689936|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110617082|NCT00689936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110617084|NCT00689936|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110617085|NCT00689936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110617086|NCT01563718|Naltrexone|naltrexone|mesh-list
110617087|NCT01563718|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110617088|NCT01563718|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110617089|NCT01563718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110617090|NCT01563718|Sensory System Agents|sensory system agents|mesh-ancestor
110617091|NCT01563718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110617092|NCT05473234|Amoxicillin|amoxicillin|mesh-list
110617093|NCT05473234|Azithromycin|azithromycin|mesh-list
110617094|NCT05473234|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110617095|NCT05473234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110617096|NCT04500418|Cenicriviroc|cenicriviroc|mesh-list
110617097|NCT04500418|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
110617098|NCT04500418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110391182|NCT04261790|Ocrelizumab|ocrelizumab|mesh-list
110391183|NCT04261790|Immunologic Factors|immunologic factors|mesh-ancestor
110391184|NCT04261790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110391193|NCT04241185|Gemcitabine|gemcitabine|mesh-list
110391194|NCT04241185|Pembrolizumab|pembrolizumab|mesh-list
110391195|NCT04241185|Fluorouracil|fluorouracil|mesh-list
110391196|NCT04241185|Mitomycins|mitomycins|mesh-list
110391197|NCT04241185|Mitomycin|mitomycin|mesh-list
110391198|NCT04241185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110617099|NCT04500418|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110617100|NCT04500418|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110617101|NCT04500418|Antiviral Agents|antiviral agents|mesh-ancestor
110617102|NCT04500418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110617103|NCT00671034|Cytarabine|cytarabine|mesh-list
110617104|NCT00671034|Dexamethasone|dexamethasone|mesh-list
110617105|NCT00671034|Dexamethasone acetate|dexamethasone acetate|mesh-list
110617106|NCT00671034|Prednisone|prednisone|mesh-list
110617107|NCT00671034|Cortisone|cortisone|mesh-list
110617108|NCT00671034|Cyclophosphamide|cyclophosphamide|mesh-list
110617109|NCT00671034|Doxorubicin|doxorubicin|mesh-list
110617110|NCT00671034|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110617111|NCT00671034|Methotrexate|methotrexate|mesh-list
110617112|NCT00671034|Vincristine|vincristine|mesh-list
110617113|NCT00671034|Daunorubicin|daunorubicin|mesh-list
110617114|NCT00671034|Asparaginase|asparaginase|mesh-list
110617116|NCT00671034|Pegaspargase|pegaspargase|mesh-list
110617117|NCT00671034|Thioguanine|thioguanine|mesh-list
110617118|NCT00671034|BB 1101|bb 1101|mesh-list
110617119|NCT00671034|2-Aminopurine|2-aminopurine|mesh-list
110617120|NCT00671034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110617121|NCT00671034|Immunologic Factors|immunologic factors|mesh-ancestor
110617122|NCT00671034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110617123|NCT00671034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110617124|NCT00671034|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110617125|NCT00671034|Alkylating Agents|alkylating agents|mesh-ancestor
110617126|NCT00671034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110617127|NCT00671034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110617128|NCT00671034|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110617129|NCT00671034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110617130|NCT00671034|Antiemetics|antiemetics|mesh-ancestor
110617131|NCT00671034|Autonomic Agents|autonomic agents|mesh-ancestor
110617132|NCT00671034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110617133|NCT00671034|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110617134|NCT00671034|Glucocorticoids|glucocorticoids|mesh-ancestor
110617135|NCT00671034|Hormones|hormones|mesh-ancestor
110617136|NCT00671034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110617137|NCT00671034|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110617138|NCT00671034|Protease Inhibitors|protease inhibitors|mesh-ancestor
110617139|NCT00671034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110617140|NCT00671034|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110617141|NCT00671034|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110617142|NCT00671034|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110617143|NCT00671034|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110617144|NCT00671034|Abortifacient Agents|abortifacient agents|mesh-ancestor
110617145|NCT00671034|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110617146|NCT00671034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110617147|NCT00671034|Antimetabolites|antimetabolites|mesh-ancestor
110617148|NCT00671034|Dermatologic Agents|dermatologic agents|mesh-ancestor
110617149|NCT00671034|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110617150|NCT00671034|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110617151|NCT00671034|Antiviral Agents|antiviral agents|mesh-ancestor
110617152|NCT00671034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110617153|NCT00671034|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110617154|NCT00671034|Tubulin Modulators|tubulin modulators|mesh-ancestor
110617155|NCT00671034|Antimitotic Agents|antimitotic agents|mesh-ancestor
110617156|NCT00671034|Mitosis Modulators|mitosis modulators|mesh-ancestor
110617157|NCT04425070|Carboplatin|carboplatin|mesh-list
110617158|NCT04425070|Gemcitabine|gemcitabine|mesh-list
110617159|NCT04425070|Oxaliplatin|oxaliplatin|mesh-list
110617160|NCT04425070|Etoposide|etoposide|mesh-list
110617161|NCT04425070|Ifosfamide|ifosfamide|mesh-list
110617162|NCT04425070|Tislelizumab|tislelizumab|mesh-list
110617163|NCT04425070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110617164|NCT04425070|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110617165|NCT04425070|Antimetabolites|antimetabolites|mesh-ancestor
110617166|NCT04425070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110617167|NCT04425070|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110617168|NCT04425070|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110617169|NCT04425070|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110617170|NCT04425070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110617171|NCT04425070|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110617172|NCT04425070|Alkylating Agents|alkylating agents|mesh-ancestor
110617173|NCT04425070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110617174|NCT00743678|Cetuximab|cetuximab|mesh-list
110617175|NCT00743678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110617176|NCT00743678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110617177|NCT02679508|Lansoprazole|lansoprazole|mesh-list
110617178|NCT02679508|Dexlansoprazole|dexlansoprazole|mesh-list
110617179|NCT02679508|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110617180|NCT02679508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110617181|NCT02679508|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110617182|NCT02679508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110617183|NCT02679508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110617184|NCT00775632|Cyclosporine|cyclosporine|mesh-list
110617185|NCT00775632|Methotrexate|methotrexate|mesh-list
110617186|NCT00775632|Alemtuzumab|alemtuzumab|mesh-list
110617187|NCT00775632|Cyclosporins|cyclosporins|mesh-list
110617188|NCT00775632|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110617189|NCT00775632|Abortifacient Agents|abortifacient agents|mesh-ancestor
110617190|NCT00775632|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110617191|NCT00775632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110617192|NCT00775632|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110617193|NCT00775632|Antimetabolites|antimetabolites|mesh-ancestor
110617194|NCT00775632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110617195|NCT00775632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110617196|NCT00775632|Dermatologic Agents|dermatologic agents|mesh-ancestor
110617197|NCT00775632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110264476|NCT02934919|Nalmefene|nalmefene|mesh-list
110617198|NCT00775632|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110617199|NCT00775632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110617200|NCT00775632|Immunologic Factors|immunologic factors|mesh-ancestor
110617201|NCT00775632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110617202|NCT00775632|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110617203|NCT00775632|Antifungal Agents|antifungal agents|mesh-ancestor
110617204|NCT00775632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110617205|NCT00775632|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110617206|NCT00775632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110617207|NCT04047654|Anticoagulants|anticoagulants|mesh-list
110617208|NCT00772356|Insulin|insulin|mesh-list
110617209|NCT00772356|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110617210|NCT00772356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110617211|NCT00772356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110617212|NCT04394182|Ritonavir|ritonavir|mesh-list
110617213|NCT04394182|Lopinavir|lopinavir|mesh-list
110617214|NCT04394182|Azithromycin|azithromycin|mesh-list
110617215|NCT04394182|Hydroxychloroquine|hydroxychloroquine|mesh-list
110617216|NCT04394182|Tazobactam|tazobactam|mesh-list
110617217|NCT04394182|Piperacillin|piperacillin|mesh-list
110617218|NCT04394182|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
110617219|NCT04394182|Heparin|heparin|mesh-list
110617220|NCT04394182|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
110617221|NCT04394182|Tinzaparin|tinzaparin|mesh-list
110617222|NCT04394182|Dalteparin|dalteparin|mesh-list
110617223|NCT04394182|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110617224|NCT04394182|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110617225|NCT04394182|Protease Inhibitors|protease inhibitors|mesh-ancestor
110617226|NCT04394182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110617227|NCT04394182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110617228|NCT04394182|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110617229|NCT04394182|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110617230|NCT04394182|Antiviral Agents|antiviral agents|mesh-ancestor
110617231|NCT04394182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110617232|NCT04394182|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110617233|NCT04394182|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110617234|NCT04394182|Anticoagulants|anticoagulants|mesh-ancestor
110617235|NCT04394182|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110617236|NCT04394182|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110617237|NCT04394182|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110617238|NCT04394182|Antimalarials|antimalarials|mesh-ancestor
110617239|NCT04394182|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110617240|NCT04394182|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110617241|NCT04394182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110617242|NCT04394182|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110617244|NCT05386576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110617245|NCT05325580|Magnesium Sulfate|magnesium sulfate|mesh-list
110617246|NCT05325580|Analgesics|analgesics|mesh-ancestor
110617247|NCT05325580|Sensory System Agents|sensory system agents|mesh-ancestor
110617248|NCT05325580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110617249|NCT05325580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110617250|NCT05325580|Anesthetics|anesthetics|mesh-ancestor
110617251|NCT05325580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110617252|NCT05325580|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110617253|NCT05325580|Anticonvulsants|anticonvulsants|mesh-ancestor
110617254|NCT05325580|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110617255|NCT05325580|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110617256|NCT05325580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110617257|NCT05325580|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110617258|NCT05325580|Tocolytic Agents|tocolytic agents|mesh-ancestor
110617259|NCT05325580|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110617260|NCT00539734|Ranibizumab|ranibizumab|mesh-list
110617261|NCT00539734|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110617262|NCT00539734|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110617263|NCT00539734|Growth Substances|growth substances|mesh-ancestor
110617264|NCT00539734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110617265|NCT00539734|Growth Inhibitors|growth inhibitors|mesh-ancestor
110617266|NCT00539734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110617267|NCT04004572|Pegaspargase|pegaspargase|mesh-list
110617268|NCT04004572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110617269|NCT04050436|Cemiplimab|cemiplimab|mesh-list
110617270|NCT04050436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110617271|NCT04050436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110617272|NCT01093976|Dronabinol|dronabinol|mesh-list
110617273|NCT01093976|Hallucinogens|hallucinogens|mesh-ancestor
110617274|NCT01093976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110264546|NCT02934295|Antibodies|antibodies|mesh-list
110617275|NCT01093976|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110617276|NCT01093976|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110617277|NCT01093976|Analgesics|analgesics|mesh-ancestor
110617278|NCT01093976|Sensory System Agents|sensory system agents|mesh-ancestor
110617279|NCT01093976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110617280|NCT01093976|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
110617281|NCT01093976|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110617282|NCT01093976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110617283|NCT01093976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110617284|NCT01093976|Hormones|hormones|mesh-ancestor
110617285|NCT01093976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110617286|NCT00329719|Sirolimus|sirolimus|mesh-list
110617287|NCT00329719|Sorafenib|sorafenib|mesh-list
110617288|NCT00329719|Temsirolimus|temsirolimus|mesh-list
110617289|NCT00329719|MTOR Inhibitors|mtor inhibitors|mesh-list
110617290|NCT00329719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110617291|NCT00329719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110617292|NCT00329719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110617293|NCT00329719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110617294|NCT00329719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110617295|NCT00329719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110617296|NCT00329719|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110617297|NCT00329719|Antifungal Agents|antifungal agents|mesh-ancestor
110617298|NCT00329719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110617299|NCT00329719|Immunologic Factors|immunologic factors|mesh-ancestor
110617300|NCT00329719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110617301|NCT04008628|Nitrous Oxide|nitrous oxide|mesh-list
110617302|NCT04008628|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110617303|NCT04008628|Anesthetics, General|anesthetics, general|mesh-ancestor
110617304|NCT04008628|Anesthetics|anesthetics|mesh-ancestor
110617305|NCT04008628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110617306|NCT04008628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110617307|NCT04008628|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110617308|NCT04008628|Analgesics|analgesics|mesh-ancestor
110617309|NCT04008628|Sensory System Agents|sensory system agents|mesh-ancestor
110617310|NCT04008628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110617311|NCT00743834|Fluvoxamine|fluvoxamine|mesh-list
110617312|NCT00743834|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110617313|NCT00743834|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110617314|NCT00743834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110617315|NCT00743834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110617316|NCT00743834|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110617317|NCT00743834|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110617318|NCT00743834|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110617319|NCT00743834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110617320|NCT00743834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110617321|NCT00743834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110617322|NCT00743834|Serotonin Agents|serotonin agents|mesh-ancestor
110617323|NCT00743834|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110617324|NCT00743834|Antidepressive Agents|antidepressive agents|mesh-ancestor
110617325|NCT00743834|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110617326|NCT00743834|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110617327|NCT00743834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110617328|NCT00743834|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110617330|NCT00743912|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110617331|NCT00743912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110617332|NCT00743912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110617333|NCT04060472|Paclitaxel|paclitaxel|mesh-list
110617334|NCT04060472|Oxaliplatin|oxaliplatin|mesh-list
110617335|NCT04060472|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110617336|NCT04060472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110617337|NCT04060472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110617338|NCT04060472|Tubulin Modulators|tubulin modulators|mesh-ancestor
110617339|NCT04060472|Antimitotic Agents|antimitotic agents|mesh-ancestor
110617340|NCT04060472|Mitosis Modulators|mitosis modulators|mesh-ancestor
110617341|NCT04060472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110617342|NCT00329641|Paclitaxel|paclitaxel|mesh-list
110617343|NCT00329641|Carboplatin|carboplatin|mesh-list
110617344|NCT00329641|Sorafenib|sorafenib|mesh-list
110617345|NCT00329641|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110617346|NCT00329641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110617347|NCT00329641|Tubulin Modulators|tubulin modulators|mesh-ancestor
110617348|NCT00329641|Antimitotic Agents|antimitotic agents|mesh-ancestor
110617349|NCT00329641|Mitosis Modulators|mitosis modulators|mesh-ancestor
110617350|NCT00329641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110617351|NCT00329641|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110617352|NCT00329641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110617353|NCT02533219|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
110617354|NCT02533219|Dopamine Agents|dopamine agents|mesh-ancestor
110617355|NCT02533219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110617356|NCT02533219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110617357|NCT02533219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110617358|NCT00743990|Camphor|camphor|mesh-list
110617359|NCT00743990|Menthol|menthol|mesh-list
110617360|NCT00743990|Petrolatum|petrolatum|mesh-list
110617361|NCT00743990|Antipruritics|antipruritics|mesh-ancestor
110617362|NCT00743990|Dermatologic Agents|dermatologic agents|mesh-ancestor
110617363|NCT00743990|Emollients|emollients|mesh-ancestor
110617364|NCT00743990|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110617365|NCT00743990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110617367|NCT00329407|Anticonvulsants|anticonvulsants|mesh-ancestor
110617368|NCT00329407|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110617369|NCT00329407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110617370|NCT01056757|Ribavirin|ribavirin|mesh-list
110617371|NCT01056757|Antimetabolites|antimetabolites|mesh-ancestor
110052812|NCT01482117|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110617372|NCT01056757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110617373|NCT01056757|Antiviral Agents|antiviral agents|mesh-ancestor
110617374|NCT01056757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110617375|NCT01056835|Epoprostenol|epoprostenol|mesh-list
110617376|NCT01056835|Tezosentan|tezosentan|mesh-list
110617377|NCT01056835|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110617378|NCT01056835|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110617379|NCT01056835|Vasodilator Agents|vasodilator agents|mesh-ancestor
110617380|NCT03986515|Apatinib|apatinib|mesh-list
110617381|NCT03986515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110617382|NCT03986515|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110617383|NCT03986515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110617384|NCT03986515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110617385|NCT00567489|Icodextrin|icodextrin|mesh-list
110617386|NCT00567489|Dialysis Solutions|dialysis solutions|mesh-ancestor
110617387|NCT00567489|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110617388|NCT02538393|Sorafenib|sorafenib|mesh-list
110617389|NCT02538393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110617390|NCT02538393|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110617391|NCT02538393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110617392|NCT02538393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110617393|NCT00924963|Lidocaine|lidocaine|mesh-list
110617394|NCT00924963|Anesthetics, Local|anesthetics, local|mesh-ancestor
110617395|NCT00924963|Anesthetics|anesthetics|mesh-ancestor
110617396|NCT00924963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110617397|NCT00924963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110617398|NCT00924963|Sensory System Agents|sensory system agents|mesh-ancestor
110617399|NCT00924963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110617400|NCT00924963|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110617401|NCT00924963|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110617402|NCT00924963|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110617403|NCT00924963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110617404|NCT00924963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110617406|NCT00669864|Insulin Aspart|insulin aspart|mesh-list
110617407|NCT00669864|Biphasic Insulins|biphasic insulins|mesh-list
110617408|NCT00669864|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
110617409|NCT00669864|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110617410|NCT00669864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110617411|NCT00770172|Lenograstim|lenograstim|mesh-list
110617412|NCT00770172|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110617413|NCT00770172|Immunologic Factors|immunologic factors|mesh-ancestor
110617414|NCT00770172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110617416|NCT00776022|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110617417|NCT00776022|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110617418|NCT00776022|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110617419|NCT00776022|Histamine Antagonists|histamine antagonists|mesh-ancestor
110617420|NCT00776022|Histamine Agents|histamine agents|mesh-ancestor
110617421|NCT00776022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110617422|NCT00776022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110617423|NCT00776022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110617424|NCT00772902|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
110617425|NCT00772902|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110617426|NCT00772902|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110617428|NCT00772902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110617429|NCT00772902|Antiviral Agents|antiviral agents|mesh-ancestor
110617430|NCT00772902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110617431|NCT00772902|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110617432|NCT00772902|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110617433|NCT00779220|Methotrexate|methotrexate|mesh-list
110617434|NCT00779220|Ocrelizumab|ocrelizumab|mesh-list
110617435|NCT00779220|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110617436|NCT00779220|Abortifacient Agents|abortifacient agents|mesh-ancestor
110617437|NCT00779220|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110617438|NCT00779220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110617439|NCT00779220|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110617440|NCT00779220|Antimetabolites|antimetabolites|mesh-ancestor
110617441|NCT00779220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110617442|NCT00779220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110617443|NCT00779220|Dermatologic Agents|dermatologic agents|mesh-ancestor
110617444|NCT00779220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110617445|NCT00779220|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110617446|NCT00779220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110617447|NCT00779220|Immunologic Factors|immunologic factors|mesh-ancestor
110617448|NCT00779220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110617449|NCT00779220|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110617450|NCT00779376|Zidovudine|zidovudine|mesh-list
110617451|NCT00779376|Antimetabolites|antimetabolites|mesh-ancestor
110617452|NCT00779376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110617453|NCT00779376|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110617454|NCT00779376|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110617455|NCT00779376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110617456|NCT00779376|Antiviral Agents|antiviral agents|mesh-ancestor
110617457|NCT00779376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110617458|NCT00779376|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110617459|NCT00779376|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110617460|NCT00779454|Gemcitabine|gemcitabine|mesh-list
110617461|NCT00779454|Capecitabine|capecitabine|mesh-list
110617462|NCT00779454|Oxaliplatin|oxaliplatin|mesh-list
110617463|NCT00779454|Panitumumab|panitumumab|mesh-list
110617464|NCT00779454|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110617465|NCT00779454|Antimetabolites|antimetabolites|mesh-ancestor
110617466|NCT00779454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110617467|NCT00779454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110617468|NCT00779454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110617469|NCT00773058|Hydrocortisone|hydrocortisone|mesh-list
110617470|NCT00773058|Glucocorticoids|glucocorticoids|mesh-list
110617471|NCT00773058|Hormones|hormones|mesh-ancestor
110617472|NCT00773058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110617473|NCT00773058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110617474|NCT00773058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110617475|NCT00776334|Fosinopril|fosinopril|mesh-list
110617476|NCT00776334|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110617477|NCT00776334|Protease Inhibitors|protease inhibitors|mesh-ancestor
110617478|NCT00776334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110617479|NCT00776334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110617480|NCT00776334|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110617481|NCT00668148|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110617482|NCT00668148|Immunologic Factors|immunologic factors|mesh-ancestor
110617483|NCT00668148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110617484|NCT00667992|Budesonide|budesonide|mesh-list
110617485|NCT00667992|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110617486|NCT00667992|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110617487|NCT00667992|Autonomic Agents|autonomic agents|mesh-ancestor
110617488|NCT00667992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110617489|NCT00667992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110617490|NCT00667992|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110617491|NCT00667992|Respiratory System Agents|respiratory system agents|mesh-ancestor
110617492|NCT00667992|Glucocorticoids|glucocorticoids|mesh-ancestor
110617493|NCT00667992|Hormones|hormones|mesh-ancestor
110391383|NCT03912818|Carboplatin|carboplatin|mesh-list
110617494|NCT00667992|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110617495|NCT00776490|Glimepiride|glimepiride|mesh-list
110617496|NCT00776490|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110617497|NCT00776490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110617498|NCT00776490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110264770|NCT00180102|Antiviral Agents|antiviral agents|mesh-ancestor
110617499|NCT00776490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110617500|NCT00776490|Immunologic Factors|immunologic factors|mesh-ancestor
110617501|NCT00776568|Antihypertensive Agents|antihypertensive agents|mesh-list
110617502|NCT00779922|Lenalidomide|lenalidomide|mesh-list
110617503|NCT00779922|Immunologic Factors|immunologic factors|mesh-ancestor
110617504|NCT00779922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110617505|NCT00779922|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110617506|NCT00779922|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110617507|NCT00779922|Growth Substances|growth substances|mesh-ancestor
110617508|NCT00779922|Growth Inhibitors|growth inhibitors|mesh-ancestor
110617509|NCT00779922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110617510|NCT00776646|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
110617511|NCT00776646|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110617513|NCT00776646|Natriuretic Agents|natriuretic agents|mesh-ancestor
110617514|NCT00776646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110617515|NCT00776646|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110617516|NCT00776646|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110617517|NCT00776646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110617518|NCT00776724|Docetaxel|docetaxel|mesh-list
110617519|NCT00776724|Epirubicin|epirubicin|mesh-list
110617520|NCT00776724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110617521|NCT00776724|Tubulin Modulators|tubulin modulators|mesh-ancestor
110617522|NCT00776724|Antimitotic Agents|antimitotic agents|mesh-ancestor
110617523|NCT00776724|Mitosis Modulators|mitosis modulators|mesh-ancestor
110617524|NCT00776724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110617525|NCT00776724|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110617526|NCT00776724|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110617527|NCT00776724|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110617528|NCT00776724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110617529|NCT00776802|Dexamethasone|dexamethasone|mesh-list
110617530|NCT00776802|Etoposide|etoposide|mesh-list
110617531|NCT00776802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110617532|NCT00776802|Antiemetics|antiemetics|mesh-ancestor
110617533|NCT00776802|Autonomic Agents|autonomic agents|mesh-ancestor
110153537|NCT00000978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110617534|NCT00776802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110617535|NCT00776802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110617536|NCT00776802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110617537|NCT00776802|Glucocorticoids|glucocorticoids|mesh-ancestor
110617538|NCT00776802|Hormones|hormones|mesh-ancestor
110617539|NCT00776802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110617540|NCT00776802|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110617541|NCT00776802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110617542|NCT00776802|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110617543|NCT00776802|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110617544|NCT00776802|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110617545|NCT00776802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110391421|NCT03865992|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110617546|NCT00776802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110617547|NCT00773916|Methylphenidate|methylphenidate|mesh-list
110617548|NCT00773916|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110617549|NCT00773916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110617550|NCT00773916|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110617551|NCT00773916|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110617552|NCT00773916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110617553|NCT00773916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110617554|NCT00773916|Dopamine Agents|dopamine agents|mesh-ancestor
110617555|NCT00773916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110617556|NCT00774072|Tobramycin|tobramycin|mesh-list
110617557|NCT00774072|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110617558|NCT00774072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110617559|NCT00780780|Triamcinolone|triamcinolone|mesh-list
110617560|NCT00780780|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110617561|NCT00780780|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110617562|NCT00780780|Nepafenac|nepafenac|mesh-list
110617563|NCT00780780|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110617564|NCT00780780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110617565|NCT00780780|Glucocorticoids|glucocorticoids|mesh-ancestor
110617566|NCT00780780|Hormones|hormones|mesh-ancestor
110617567|NCT00780780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110617568|NCT00780780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110617569|NCT00780780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110617570|NCT00780780|Immunologic Factors|immunologic factors|mesh-ancestor
110617571|NCT00780780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110617572|NCT00780780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110617573|NCT00780780|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110617574|NCT00780780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110617575|NCT00780780|Analgesics|analgesics|mesh-ancestor
110617576|NCT00780780|Sensory System Agents|sensory system agents|mesh-ancestor
110617577|NCT00780780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110617578|NCT00780780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110617579|NCT00780858|Ganirelix|ganirelix|mesh-list
110285363|NCT00411320|Hormones|hormones|mesh-ancestor
110617580|NCT00780858|Hormone Antagonists|hormone antagonists|mesh-ancestor
110617581|NCT00780858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110617582|NCT00780858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110617583|NCT00777114|Bortezomib|bortezomib|mesh-list
110617584|NCT00777114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110617586|NCT00669396|Levonorgestrel|levonorgestrel|mesh-list
110617587|NCT00669396|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110617588|NCT00669396|Contraceptive Agents|contraceptive agents|mesh-ancestor
110617589|NCT00669396|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110617590|NCT00669396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110617591|NCT00669396|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110617592|NCT00669396|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110617593|NCT00669396|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110617594|NCT00669396|Trace Elements|trace elements|mesh-ancestor
110617595|NCT00669396|Micronutrients|micronutrients|mesh-ancestor
110617596|NCT00774462|Rituximab|rituximab|mesh-list
110617597|NCT00774462|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110617598|NCT00774462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110617599|NCT00774462|Immunologic Factors|immunologic factors|mesh-ancestor
110617600|NCT00774462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110617601|NCT00774462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110617602|NCT00669318|Rituximab|rituximab|mesh-list
110617603|NCT00669318|Alemtuzumab|alemtuzumab|mesh-list
110617604|NCT00669318|Pentostatin|pentostatin|mesh-list
110617605|NCT00669318|Sargramostim|sargramostim|mesh-list
110617606|NCT00669318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110617607|NCT00669318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110617608|NCT00669318|Immunologic Factors|immunologic factors|mesh-ancestor
110617609|NCT00669318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110617610|NCT00669318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110617611|NCT00669318|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
110617612|NCT00669318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110617613|NCT00669318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110617614|NCT00774540|Ketorolac|ketorolac|mesh-list
110617615|NCT00774540|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
110617616|NCT00774540|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110617617|NCT00774540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110617618|NCT00774540|Analgesics|analgesics|mesh-ancestor
110617619|NCT00774540|Sensory System Agents|sensory system agents|mesh-ancestor
110617620|NCT00774540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110617621|NCT00774540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110617622|NCT00774540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110617623|NCT00774540|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110617624|NCT00774540|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110617625|NCT00774540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110617626|NCT00774540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110617627|NCT00669240|Varenicline|varenicline|mesh-list
110617628|NCT00669240|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110617629|NCT00669240|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110617630|NCT00669240|Cholinergic Agents|cholinergic agents|mesh-ancestor
110617631|NCT00669240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110617632|NCT00669240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110617633|NCT00669240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110617634|NCT00669162|Docetaxel|docetaxel|mesh-list
110617635|NCT00669162|Leuprolide|leuprolide|mesh-list
110617636|NCT00669162|Goserelin|goserelin|mesh-list
110617637|NCT00669162|Bicalutamide|bicalutamide|mesh-list
110617638|NCT00669162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110617639|NCT00669162|Tubulin Modulators|tubulin modulators|mesh-ancestor
110617640|NCT00669162|Antimitotic Agents|antimitotic agents|mesh-ancestor
110617641|NCT00669162|Mitosis Modulators|mitosis modulators|mesh-ancestor
110617642|NCT00669162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110617643|NCT00669162|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110617644|NCT00669162|Fertility Agents|fertility agents|mesh-ancestor
110264922|NCT02924311|Aflibercept|aflibercept|mesh-list
110617645|NCT00669162|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110617646|NCT00669162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110617647|NCT00669162|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110617648|NCT00669162|Androgen Antagonists|androgen antagonists|mesh-ancestor
110617649|NCT00669162|Hormone Antagonists|hormone antagonists|mesh-ancestor
110617650|NCT00669162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110617651|NCT00774696|Clarithromycin|clarithromycin|mesh-list
110617652|NCT00774696|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110617653|NCT00774696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110617654|NCT00774696|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110617655|NCT00774696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110617656|NCT00774696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110617657|NCT00774696|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110617658|NCT00774696|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110617660|NCT02556060|Anticonvulsants|anticonvulsants|mesh-ancestor
110617661|NCT02556060|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110617662|NCT02556060|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110617663|NCT02556060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110617664|NCT02556060|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110617665|NCT02556060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110617666|NCT02556060|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110617667|NCT02556060|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110617668|NCT02556060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110617669|NCT02556060|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110617670|NCT02556060|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110617671|NCT00400946|Leucovorin|leucovorin|mesh-list
110617673|NCT00400946|Dexamethasone|dexamethasone|mesh-list
110617674|NCT00400946|Methylprednisolone|methylprednisolone|mesh-list
110617675|NCT00400946|Prednisolone|prednisolone|mesh-list
110617676|NCT00400946|Hydrocortisone|hydrocortisone|mesh-list
110617677|NCT00400946|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
110617678|NCT00400946|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
110617679|NCT00400946|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
110617680|NCT00400946|Cyclophosphamide|cyclophosphamide|mesh-list
110617681|NCT00400946|Doxorubicin|doxorubicin|mesh-list
110617682|NCT00400946|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110617683|NCT00400946|Methotrexate|methotrexate|mesh-list
110617684|NCT00400946|Etoposide|etoposide|mesh-list
110617685|NCT00400946|Vincristine|vincristine|mesh-list
110617686|NCT00400946|Asparaginase|asparaginase|mesh-list
110617687|NCT00400946|Mercaptopurine|mercaptopurine|mesh-list
110617688|NCT00400946|Pegaspargase|pegaspargase|mesh-list
110617689|NCT00400946|Dexrazoxane|dexrazoxane|mesh-list
110617690|NCT00400946|Razoxane|razoxane|mesh-list
110617691|NCT00400946|Levoleucovorin|levoleucovorin|mesh-list
110617692|NCT00400946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110617693|NCT00400946|Immunologic Factors|immunologic factors|mesh-ancestor
110617694|NCT00400946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110617695|NCT00400946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110617696|NCT00400946|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110617697|NCT00400946|Alkylating Agents|alkylating agents|mesh-ancestor
110617698|NCT00400946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110617699|NCT00400946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110617700|NCT00400946|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110617701|NCT00400946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110617703|NCT00400946|Autonomic Agents|autonomic agents|mesh-ancestor
110617704|NCT00400946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110617705|NCT00400946|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110617706|NCT00400946|Glucocorticoids|glucocorticoids|mesh-ancestor
110617707|NCT00400946|Hormones|hormones|mesh-ancestor
110617708|NCT00400946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110617709|NCT00400946|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110617710|NCT00400946|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110617711|NCT00400946|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110617712|NCT00400946|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110617713|NCT00400946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110617714|NCT00400946|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110617715|NCT00400946|Abortifacient Agents|abortifacient agents|mesh-ancestor
110617716|NCT00400946|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110617717|NCT00400946|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110617718|NCT00400946|Antimetabolites|antimetabolites|mesh-ancestor
110617719|NCT00400946|Dermatologic Agents|dermatologic agents|mesh-ancestor
110265059|NCT02922166|SRX246|srx246|mesh-list
110617720|NCT00400946|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110617721|NCT00400946|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110617722|NCT00400946|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110617723|NCT00400946|Antiviral Agents|antiviral agents|mesh-ancestor
110617724|NCT00400946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110617725|NCT00400946|Antidotes|antidotes|mesh-ancestor
110285367|NCT00233337|Artemether|artemether|mesh-list
110617726|NCT00400946|Protective Agents|protective agents|mesh-ancestor
110617727|NCT00400946|Vitamin B Complex|vitamin b complex|mesh-ancestor
110617728|NCT00400946|Vitamins|vitamins|mesh-ancestor
110617729|NCT00400946|Micronutrients|micronutrients|mesh-ancestor
110617730|NCT00400946|Tubulin Modulators|tubulin modulators|mesh-ancestor
110617731|NCT00400946|Antimitotic Agents|antimitotic agents|mesh-ancestor
110617732|NCT00400946|Mitosis Modulators|mitosis modulators|mesh-ancestor
110617733|NCT00400946|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110617734|NCT00400946|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110617735|NCT00354770|Acetylcysteine|acetylcysteine|mesh-list
110617736|NCT00354770|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110617737|NCT00354770|Antiviral Agents|antiviral agents|mesh-ancestor
110617738|NCT00354770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110617739|NCT00354770|Expectorants|expectorants|mesh-ancestor
110617740|NCT00354770|Respiratory System Agents|respiratory system agents|mesh-ancestor
110617741|NCT00354770|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110617742|NCT00354770|Antioxidants|antioxidants|mesh-ancestor
110617743|NCT00354770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110617744|NCT00354770|Protective Agents|protective agents|mesh-ancestor
110617745|NCT00354770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110617746|NCT00354770|Antidotes|antidotes|mesh-ancestor
110617747|NCT00744224|Exenatide|exenatide|mesh-list
110617748|NCT00744224|Prednisolone|prednisolone|mesh-list
110617749|NCT00744224|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110391514|NCT03630211|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110391515|NCT03630211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110391516|NCT03630211|Immunologic Factors|immunologic factors|mesh-ancestor
110391517|NCT03630211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110391518|NCT03630211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110391519|NCT03630211|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110391520|NCT03630211|Alkylating Agents|alkylating agents|mesh-ancestor
110391521|NCT03630211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110391522|NCT03630211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110391523|NCT03630211|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110391524|NCT03630211|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110391538|NCT03599635|Bupivacaine|bupivacaine|mesh-list
110617750|NCT00744224|Methylprednisolone|methylprednisolone|mesh-list
110617751|NCT00744224|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110617752|NCT00744224|Prednisolone acetate|prednisolone acetate|mesh-list
110617753|NCT00744224|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110617754|NCT00744224|Prednisolone phosphate|prednisolone phosphate|mesh-list
110617755|NCT00744224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110617756|NCT00744224|Glucocorticoids|glucocorticoids|mesh-ancestor
110617757|NCT00744224|Hormones|hormones|mesh-ancestor
110617758|NCT00744224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110617759|NCT00744224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110617760|NCT00744224|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110617761|NCT00744224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110617762|NCT00744224|Antiemetics|antiemetics|mesh-ancestor
110617763|NCT00744224|Autonomic Agents|autonomic agents|mesh-ancestor
110617764|NCT00744224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110617765|NCT00744224|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110617766|NCT00744224|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110617767|NCT00744224|Protective Agents|protective agents|mesh-ancestor
110617768|NCT00744224|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110617769|NCT00744224|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110617770|NCT00744224|Incretins|incretins|mesh-ancestor
110617771|NCT00744302|Dialysis Solutions|dialysis solutions|mesh-list
110617772|NCT00744302|Calcium|calcium|mesh-list
110617773|NCT00744302|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110617774|NCT00744302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110617775|NCT00744302|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110617776|NCT00666588|Cytarabine|cytarabine|mesh-list
110617777|NCT00666588|Etoposide|etoposide|mesh-list
110617778|NCT00666588|Idarubicin|idarubicin|mesh-list
110617779|NCT00666588|Etoposide phosphate|etoposide phosphate|mesh-list
110617780|NCT00666588|Bortezomib|bortezomib|mesh-list
110617781|NCT00666588|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110617782|NCT00666588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110617783|NCT00666588|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110617784|NCT00666588|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110617785|NCT00666588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110617786|NCT00666588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110617787|NCT00666588|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110617788|NCT00666588|Antimetabolites|antimetabolites|mesh-ancestor
110617789|NCT00666588|Antiviral Agents|antiviral agents|mesh-ancestor
110617790|NCT00666588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110617791|NCT00666588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110617792|NCT00666588|Immunologic Factors|immunologic factors|mesh-ancestor
110617793|NCT00666588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110617794|NCT00666588|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110617796|NCT00689390|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110617797|NCT00689390|Antimetabolites|antimetabolites|mesh-ancestor
110617798|NCT00689390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110617799|NCT00689390|Antiviral Agents|antiviral agents|mesh-ancestor
110617800|NCT00689390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110617801|NCT00567879|Trastuzumab|trastuzumab|mesh-list
110617803|NCT00567879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110617804|NCT00567879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110617805|NCT00567879|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110617806|NCT00567879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110617807|NCT00567879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110617808|NCT00781404|Adenosine|adenosine|mesh-list
110617809|NCT00781404|Analgesics|analgesics|mesh-ancestor
110617810|NCT00781404|Sensory System Agents|sensory system agents|mesh-ancestor
110617811|NCT00781404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110617812|NCT00781404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110617813|NCT00781404|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110617814|NCT00781404|Vasodilator Agents|vasodilator agents|mesh-ancestor
110617815|NCT00781404|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
110617816|NCT00781404|Purinergic Agonists|purinergic agonists|mesh-ancestor
110617817|NCT00781404|Purinergic Agents|purinergic agents|mesh-ancestor
110617818|NCT00781404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110617819|NCT00781404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110617820|NCT00777504|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
110617821|NCT00777504|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110174270|NCT02967211|Insulin Detemir|insulin detemir|mesh-list
110174271|NCT02967211|Insulin, Isophane|insulin, isophane|mesh-list
110174272|NCT02967211|Isophane Insulin, Human|isophane insulin, human|mesh-list
110174273|NCT02967211|Isophane insulin, beef|isophane insulin, beef|mesh-list
110174274|NCT02967211|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110174275|NCT02967211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110174277|NCT00064636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110174278|NCT05113394|Immunomodulating Agents|immunomodulating agents|mesh-list
110174279|NCT05113394|Immunologic Factors|immunologic factors|mesh-list
110174280|NCT05113394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110174282|NCT00065143|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110174283|NCT00065143|Antimetabolites|antimetabolites|mesh-ancestor
110174284|NCT00065143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110174285|NCT00065143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110174286|NCT00398749|Epoetin Alfa|epoetin alfa|mesh-list
110174287|NCT00398749|Hematinics|hematinics|mesh-ancestor
110174288|NCT00398788|Hydromorphone|hydromorphone|mesh-list
110174289|NCT00398788|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110174290|NCT00398788|Narcotics|narcotics|mesh-ancestor
110174291|NCT00398788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110174292|NCT00398788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110174293|NCT00398788|Analgesics|analgesics|mesh-ancestor
110174294|NCT00398788|Sensory System Agents|sensory system agents|mesh-ancestor
110174295|NCT00398788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110174296|NCT00398827|Dexmedetomidine|dexmedetomidine|mesh-list
110174297|NCT00398827|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110174298|NCT00398827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110174299|NCT00398827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110174300|NCT00398827|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110174301|NCT00398827|Analgesics|analgesics|mesh-ancestor
110174302|NCT00398827|Sensory System Agents|sensory system agents|mesh-ancestor
110174303|NCT00398827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110174304|NCT00398827|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110174305|NCT00398827|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110174306|NCT00398827|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110174307|NCT00398827|Adrenergic Agents|adrenergic agents|mesh-ancestor
110174308|NCT00398827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110174309|NCT00398827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110174311|NCT00065455|Vitamins|vitamins|mesh-ancestor
110174312|NCT00065455|Micronutrients|micronutrients|mesh-ancestor
110174313|NCT00065455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110174314|NCT04488081|Cyproheptadine|cyproheptadine|mesh-list
110174315|NCT04488081|Cyclosporine|cyclosporine|mesh-list
110174316|NCT04488081|Remdesivir|remdesivir|mesh-list
110174317|NCT04488081|Cenicriviroc|cenicriviroc|mesh-list
110174318|NCT04488081|Dexamethasone|dexamethasone|mesh-list
110174319|NCT04488081|Celecoxib|celecoxib|mesh-list
110174320|NCT04488081|Apremilast|apremilast|mesh-list
110174321|NCT04488081|Icatibant|icatibant|mesh-list
110174322|NCT04488081|Imatinib Mesylate|imatinib mesylate|mesh-list
110174323|NCT04488081|Famotidine|famotidine|mesh-list
110174324|NCT04488081|Cyclosporins|cyclosporins|mesh-list
110174325|NCT04488081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110174326|NCT04488081|Antiemetics|antiemetics|mesh-ancestor
110174327|NCT04488081|Autonomic Agents|autonomic agents|mesh-ancestor
110174328|NCT04488081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110174329|NCT04488081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110174330|NCT04488081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110174331|NCT04488081|Glucocorticoids|glucocorticoids|mesh-ancestor
110174332|NCT04488081|Hormones|hormones|mesh-ancestor
110174333|NCT04488081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110174334|NCT04488081|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110174335|NCT04488081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110174336|NCT04488081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110174337|NCT04488081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110174338|NCT04488081|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110174340|NCT04488081|Antifungal Agents|antifungal agents|mesh-ancestor
110174341|NCT04488081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110174342|NCT04488081|Dermatologic Agents|dermatologic agents|mesh-ancestor
110174343|NCT04488081|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110174344|NCT04488081|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110174345|NCT04488081|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110174346|NCT04488081|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110174347|NCT04488081|Analgesics|analgesics|mesh-ancestor
110174348|NCT04488081|Sensory System Agents|sensory system agents|mesh-ancestor
110034021|NCT01729754|Immunologic Factors|immunologic factors|mesh-ancestor
110174349|NCT04488081|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110174350|NCT04488081|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110174351|NCT04488081|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110174352|NCT04488081|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
110174353|NCT04488081|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110174354|NCT04488081|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110174355|NCT04488081|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110174356|NCT04488081|Histamine Antagonists|histamine antagonists|mesh-ancestor
110174357|NCT04488081|Histamine Agents|histamine agents|mesh-ancestor
110174358|NCT04488081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110174359|NCT04488081|Antimetabolites|antimetabolites|mesh-ancestor
110174360|NCT04488081|Antiviral Agents|antiviral agents|mesh-ancestor
110174361|NCT04488081|Antipruritics|antipruritics|mesh-ancestor
110174362|NCT04488081|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110174363|NCT04488081|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110174364|NCT04488081|Serotonin Agents|serotonin agents|mesh-ancestor
110174365|NCT04488081|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110174366|NCT04488081|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
110174367|NCT04488081|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
110174368|NCT04488081|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
110174369|NCT04488081|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
110174370|NCT04488081|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110174371|NCT04488081|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110174372|NCT00065767|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
110174373|NCT00065767|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110174374|NCT00065767|Hormone Antagonists|hormone antagonists|mesh-ancestor
110174375|NCT00065767|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110174376|NCT00065767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110174377|NCT00065767|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110174378|NCT00065767|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110174379|NCT00065767|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110174380|NCT00065884|Valproic Acid|valproic acid|mesh-list
110174381|NCT00065884|Anticonvulsants|anticonvulsants|mesh-ancestor
110174382|NCT00065884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110174383|NCT00065884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110174384|NCT00065884|GABA Agents|gaba agents|mesh-ancestor
110174385|NCT00065884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110174386|NCT00065884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110174387|NCT00065884|Antimanic Agents|antimanic agents|mesh-ancestor
110174388|NCT00065884|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110174389|NCT00065884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110174390|NCT00065884|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110174392|NCT00065923|Anticonvulsants|anticonvulsants|mesh-ancestor
110174393|NCT00065923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110174394|NCT00065923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110174395|NCT00065962|Secretin|secretin|mesh-list
110174396|NCT00065962|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110174397|NCT00065962|Hormones|hormones|mesh-ancestor
110174398|NCT00065962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110174399|NCT00065962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110174400|NCT05083754|Temozolomide|temozolomide|mesh-list
110174401|NCT05083754|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110174402|NCT05083754|Alkylating Agents|alkylating agents|mesh-ancestor
110174403|NCT05083754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110174404|NCT05083754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110174405|NCT00066001|Metronidazole|metronidazole|mesh-list
110174406|NCT00066001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110174407|NCT00066001|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110054797|NCT01494363|Oxaliplatin|oxaliplatin|mesh-list
110174408|NCT00066001|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110174409|NCT00066001|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110174410|NCT00066157|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
110174411|NCT00066157|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110174412|NCT00066157|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110174413|NCT00066157|Medroxyprogesterone|medroxyprogesterone|mesh-list
110174414|NCT00066157|Estradiol|estradiol|mesh-list
110174415|NCT00066157|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110174416|NCT00066157|Estrogens|estrogens|mesh-list
110174417|NCT00066157|Progesterone|progesterone|mesh-list
110174418|NCT00066157|Hormones|hormones|mesh-ancestor
110174419|NCT00066157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110174420|NCT00066157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110174421|NCT00066157|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110174422|NCT00066157|Contraceptive Agents|contraceptive agents|mesh-ancestor
110193271|NCT00062283|Alanosine|alanosine|mesh-list
110174423|NCT00066157|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110174424|NCT00066157|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110174425|NCT00066157|Progestins|progestins|mesh-ancestor
110174426|NCT00066157|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110174427|NCT00066157|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110174428|NCT00066157|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110174429|NCT00066157|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110174430|NCT00066157|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110174431|NCT00066157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110174432|NCT00066196|Dacarbazine|dacarbazine|mesh-list
110174433|NCT00066196|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110174434|NCT00066196|Alkylating Agents|alkylating agents|mesh-ancestor
110174435|NCT00066196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110174436|NCT00066196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110174437|NCT00066274|Leucovorin|leucovorin|mesh-list
110174438|NCT00066274|Fluorouracil|fluorouracil|mesh-list
110174439|NCT00066274|Oxaliplatin|oxaliplatin|mesh-list
110174440|NCT00066274|Irinotecan|irinotecan|mesh-list
110174441|NCT00066274|Calcium|calcium|mesh-list
110174442|NCT00066274|Levoleucovorin|levoleucovorin|mesh-list
110174443|NCT00066274|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110174444|NCT00066274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110174445|NCT00066274|Antimetabolites|antimetabolites|mesh-ancestor
110174446|NCT00066274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110174447|NCT00066274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110174448|NCT00066274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110174449|NCT00066274|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110174450|NCT00066274|Immunologic Factors|immunologic factors|mesh-ancestor
110174451|NCT00066274|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110174452|NCT00066274|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110174453|NCT00066274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110174454|NCT00066274|Antidotes|antidotes|mesh-ancestor
110174455|NCT00066274|Protective Agents|protective agents|mesh-ancestor
110174456|NCT00066274|Vitamin B Complex|vitamin b complex|mesh-ancestor
110174457|NCT00066274|Vitamins|vitamins|mesh-ancestor
110174458|NCT00066274|Micronutrients|micronutrients|mesh-ancestor
110174459|NCT04401150|Ascorbic Acid|ascorbic acid|mesh-list
110174460|NCT04401150|Vitamins|vitamins|mesh-ancestor
110174461|NCT04401150|Micronutrients|micronutrients|mesh-ancestor
110174462|NCT04401150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110174463|NCT04401150|Antioxidants|antioxidants|mesh-ancestor
110174464|NCT04401150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110174465|NCT04401150|Protective Agents|protective agents|mesh-ancestor
110174466|NCT05077280|Immunomodulating Agents|immunomodulating agents|mesh-list
110174467|NCT05077280|Immunologic Factors|immunologic factors|mesh-ancestor
110174468|NCT05077280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110174469|NCT00066352|Bortezomib|bortezomib|mesh-list
110174470|NCT00066352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110174471|NCT00066391|Irinotecan|irinotecan|mesh-list
110174472|NCT00066391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110174473|NCT00066391|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110174474|NCT00066391|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110174475|NCT00066391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110174476|NCT00066391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110174477|NCT04388475|Temozolomide|temozolomide|mesh-list
110174478|NCT04388475|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110174479|NCT04388475|Alkylating Agents|alkylating agents|mesh-ancestor
110174480|NCT04388475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110174481|NCT04388475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110174482|NCT00389987|Tazobactam|tazobactam|mesh-list
110174483|NCT00389987|Piperacillin|piperacillin|mesh-list
110174484|NCT00389987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110174485|NCT00389987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110193306|NCT00035165|Epothilones|epothilones|mesh-list
110174487|NCT00389987|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
110174488|NCT00389987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110174490|NCT00066508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110174491|NCT00066547|Antibodies|antibodies|mesh-list
110174492|NCT00066547|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110174493|NCT00066547|Immunologic Factors|immunologic factors|mesh-ancestor
110174494|NCT00066547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110174495|NCT00066586|Exemestane|exemestane|mesh-list
110174496|NCT00066586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110174497|NCT00066586|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110174498|NCT00066586|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110174499|NCT00066586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110174500|NCT00066586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110174501|NCT00066586|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110174502|NCT00066586|Hormone Antagonists|hormone antagonists|mesh-ancestor
110174503|NCT00066586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110174504|NCT00066586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110174505|NCT00066625|Oxaliplatin|oxaliplatin|mesh-list
110174507|NCT00066625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110174508|NCT00066859|Sertraline|sertraline|mesh-list
110174510|NCT00066859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110174511|NCT00066859|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110174512|NCT00066859|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110174513|NCT00066859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110174514|NCT00066859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110174515|NCT00066859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110174516|NCT00066859|Serotonin Agents|serotonin agents|mesh-ancestor
110174517|NCT00066859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110174518|NCT04235673|Melatonin|melatonin|mesh-list
110174519|NCT04235673|Antioxidants|antioxidants|mesh-ancestor
110174520|NCT04235673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110174521|NCT04235673|Protective Agents|protective agents|mesh-ancestor
110174522|NCT04235673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110034266|NCT01398033|Paclitaxel|paclitaxel|mesh-list
110174523|NCT04235673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110174524|NCT00067015|Goserelin|goserelin|mesh-list
110174525|NCT00067015|Bicalutamide|bicalutamide|mesh-list
110174526|NCT00067015|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110174527|NCT00067015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110174528|NCT00067015|Androgen Antagonists|androgen antagonists|mesh-ancestor
110174529|NCT00067015|Hormone Antagonists|hormone antagonists|mesh-ancestor
110174530|NCT00067015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110174531|NCT00067015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110174532|NCT00067093|Vitamin K|vitamin k|mesh-list
110174533|NCT00067093|Heparin|heparin|mesh-list
110174534|NCT00067093|Calcium heparin|calcium heparin|mesh-list
110174535|NCT00067093|Idraparinux|idraparinux|mesh-list
110174536|NCT00067093|Vitamins|vitamins|mesh-ancestor
110174537|NCT00067093|Micronutrients|micronutrients|mesh-ancestor
110174538|NCT00067093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110174539|NCT00067093|Anticoagulants|anticoagulants|mesh-ancestor
110174540|NCT00067093|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110174541|NCT00067093|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110174542|NCT00067093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110174543|NCT00067093|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110174544|NCT00067093|Hemostatics|hemostatics|mesh-ancestor
110174545|NCT00067093|Coagulants|coagulants|mesh-ancestor
110174546|NCT00067093|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110174547|NCT00067093|Antithrombins|antithrombins|mesh-ancestor
110174548|NCT00067093|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110174549|NCT00067093|Protease Inhibitors|protease inhibitors|mesh-ancestor
110174550|NCT00067093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110174551|NCT00398905|Enoxaparin|enoxaparin|mesh-list
110174552|NCT00398905|Rivaroxaban|rivaroxaban|mesh-list
110174553|NCT00398905|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110174554|NCT00398905|Antithrombins|antithrombins|mesh-ancestor
110174555|NCT00398905|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110174556|NCT00398905|Protease Inhibitors|protease inhibitors|mesh-ancestor
110174557|NCT00398905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110034324|NCT01398189|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110174558|NCT00398905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110174559|NCT00398905|Anticoagulants|anticoagulants|mesh-ancestor
110174560|NCT00398905|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110174561|NCT00398905|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110174562|NCT00067405|Micronutrients|micronutrients|mesh-list
110174563|NCT00067405|Trace Elements|trace elements|mesh-list
110174564|NCT00067405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110034374|NCT01398371|Digoxin|digoxin|mesh-list
110174566|NCT00067444|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110174567|NCT00067444|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110174568|NCT00067444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110174569|NCT00067444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110174570|NCT00067444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110174571|NCT00067444|Serotonin Agents|serotonin agents|mesh-ancestor
110174572|NCT00067444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110174573|NCT00067444|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110174574|NCT00067444|Antidepressive Agents|antidepressive agents|mesh-ancestor
110174575|NCT00067444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110174576|NCT00067444|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110174577|NCT00067444|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110174578|NCT00067444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110174579|NCT00399022|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110174580|NCT00399022|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110174581|NCT00399022|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110174582|NCT00399022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110174583|NCT00399022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110174584|NCT00399022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110174585|NCT00399022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110174586|NCT00399022|Analgesics|analgesics|mesh-ancestor
110174587|NCT00399022|Sensory System Agents|sensory system agents|mesh-ancestor
110174588|NCT00399022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110174589|NCT00399022|Antidepressive Agents|antidepressive agents|mesh-ancestor
110174590|NCT00399022|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110174591|NCT00399022|Dopamine Agents|dopamine agents|mesh-ancestor
110174592|NCT00065533|Pemetrexed|pemetrexed|mesh-list
110174593|NCT00065533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110174594|NCT00065533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110174595|NCT00065533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110174596|NCT00065533|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110174597|NCT00065533|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110174598|NCT02967094|Expectorants|expectorants|mesh-list
110174599|NCT02967094|Respiratory System Agents|respiratory system agents|mesh-ancestor
110174600|NCT00067561|Alosetron|alosetron|mesh-list
110174601|NCT00067561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110174602|NCT00067561|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110174603|NCT00067561|Serotonin Agents|serotonin agents|mesh-ancestor
110174604|NCT00067561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110174605|NCT00067561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110193323|NCT00035204|Nootropic Agents|nootropic agents|mesh-ancestor
110174606|NCT00067561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110174607|NCT00067600|Calcium|calcium|mesh-list
110034560|NCT01400165|Antidepressive Agents|antidepressive agents|mesh-ancestor
110174608|NCT00067600|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110174609|NCT00067600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110174611|NCT05010707|Hormones|hormones|mesh-list
110174612|NCT05010707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110174613|NCT05010707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110174614|NCT05010707|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110174615|NCT05010707|Hormone Antagonists|hormone antagonists|mesh-ancestor
110174616|NCT05010707|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
110174617|NCT05010707|Diuretics|diuretics|mesh-ancestor
110174618|NCT05010707|Natriuretic Agents|natriuretic agents|mesh-ancestor
110174619|NCT00067756|Butyric Acid|butyric acid|mesh-list
110174620|NCT00067756|Histamine Antagonists|histamine antagonists|mesh-ancestor
110174621|NCT00067756|Histamine Agents|histamine agents|mesh-ancestor
110174622|NCT00067756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110174623|NCT00067756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110174624|NCT00067756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110174626|NCT04091880|Immunologic Factors|immunologic factors|mesh-ancestor
110174627|NCT04091880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110174628|NCT00067912|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110174629|NCT00067912|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
110174630|NCT00067912|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110174631|NCT00067912|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110174632|NCT00067912|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110174633|NCT00067912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110174634|NCT00067912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110174635|NCT00067912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110174637|NCT00067912|Sensory System Agents|sensory system agents|mesh-ancestor
110174638|NCT00067912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110174639|NCT00067912|Antidepressive Agents|antidepressive agents|mesh-ancestor
110174640|NCT00067912|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110174641|NCT00067912|Dopamine Agents|dopamine agents|mesh-ancestor
110174642|NCT00067912|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110174643|NCT04074096|Pembrolizumab|pembrolizumab|mesh-list
110174644|NCT04074096|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110174645|NCT04074096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110174646|NCT04074096|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110034611|NCT01400568|Fluticasone|fluticasone|mesh-list
110285390|NCT01089556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110174647|NCT04074096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110174649|NCT00067951|Rosiglitazone|rosiglitazone|mesh-list
110174650|NCT00067951|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110174651|NCT00067951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110174652|NCT00392457|Ketoconazole|ketoconazole|mesh-list
110174654|NCT00392457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110174655|NCT00392457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110174656|NCT00392457|Antifungal Agents|antifungal agents|mesh-ancestor
110174657|NCT00392457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110174658|NCT00392457|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110174659|NCT00392457|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110174660|NCT00392457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110174661|NCT00392457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110174662|NCT00392457|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110174663|NCT00392457|Hormone Antagonists|hormone antagonists|mesh-ancestor
110174664|NCT00392457|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110174665|NCT00068029|Octreotide|octreotide|mesh-list
110174666|NCT00068029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110174667|NCT00068029|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110174668|NCT00068029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110174669|NCT00068068|Talaporfin|talaporfin|mesh-list
110174670|NCT00068068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110174671|NCT00068068|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110174672|NCT00068068|Dermatologic Agents|dermatologic agents|mesh-ancestor
110174674|NCT00068302|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110174675|NCT00068302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110174676|NCT00068302|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110174677|NCT00068302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110174678|NCT00068302|Antifungal Agents|antifungal agents|mesh-ancestor
110174679|NCT00068302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110174680|NCT00068302|Immunologic Factors|immunologic factors|mesh-ancestor
110174681|NCT00068302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110174682|NCT00068458|Calcium, Dietary|calcium, dietary|mesh-list
110174683|NCT00068458|Calcium|calcium|mesh-list
110174684|NCT00068458|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110174685|NCT00068458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110174686|NCT00068458|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110174688|NCT00068497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110174689|NCT00068497|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110174690|NCT00068497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110174691|NCT00068497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110174692|NCT00068653|Celecoxib|celecoxib|mesh-list
110174693|NCT00068653|Gefitinib|gefitinib|mesh-list
110174694|NCT00068653|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110174695|NCT00068653|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110174697|NCT00068653|Sensory System Agents|sensory system agents|mesh-ancestor
110174698|NCT00068653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110174699|NCT00068653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110174700|NCT00068653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110174701|NCT00068653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110174702|NCT00068653|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110174703|NCT00068653|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110174704|NCT00068653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110174705|NCT00068653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110174706|NCT00068653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110174707|NCT00068653|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110174708|NCT00068731|Lycopene|lycopene|mesh-list
110174709|NCT00068731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110174710|NCT00068731|Antioxidants|antioxidants|mesh-ancestor
110174711|NCT00068731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110174712|NCT00068731|Protective Agents|protective agents|mesh-ancestor
110174713|NCT00068731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110174714|NCT00068731|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110174715|NCT00068731|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110174716|NCT00068731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110174717|NCT00068809|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
110174718|NCT00068809|Antiviral Agents|antiviral agents|mesh-ancestor
110174719|NCT00068809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110174720|NCT00068848|Contraceptive Agents|contraceptive agents|mesh-list
110174721|NCT00068848|Contraceptives, Oral|contraceptives, oral|mesh-list
110174722|NCT00068848|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110174723|NCT00068848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110174724|NCT00068848|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110174726|NCT00399061|Cyclosporins|cyclosporins|mesh-list
110174727|NCT00399061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110174728|NCT00399061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110174729|NCT00399061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110174730|NCT00399061|Immunologic Factors|immunologic factors|mesh-ancestor
110174731|NCT00399061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110174732|NCT00399061|Antifungal Agents|antifungal agents|mesh-ancestor
110174733|NCT00399061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110174734|NCT00399061|Dermatologic Agents|dermatologic agents|mesh-ancestor
110174735|NCT00399061|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110174736|NCT00399061|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110174737|NCT00069355|Propranolol|propranolol|mesh-list
110174738|NCT00069355|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110174739|NCT00069355|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110174740|NCT00069355|Adrenergic Agents|adrenergic agents|mesh-ancestor
110174741|NCT00069355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110174742|NCT00069355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110174743|NCT00069355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110174744|NCT00069355|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110174745|NCT00069355|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110174746|NCT00069355|Vasodilator Agents|vasodilator agents|mesh-ancestor
110174747|NCT00069550|Dextromethorphan|dextromethorphan|mesh-list
110174749|NCT00069550|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110174750|NCT00069550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110174751|NCT00069550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110034889|NCT01402245|Vaccines|vaccines|mesh-list
110174752|NCT00069550|Cholinergic Agents|cholinergic agents|mesh-ancestor
110174753|NCT00069550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110174754|NCT00069550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110174755|NCT00069550|Nootropic Agents|nootropic agents|mesh-ancestor
110174756|NCT00069550|Antitussive Agents|antitussive agents|mesh-ancestor
110174757|NCT00069550|Respiratory System Agents|respiratory system agents|mesh-ancestor
110174758|NCT00069550|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110174759|NCT00069550|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110174760|NCT02966587|Durvalumab|durvalumab|mesh-list
110174761|NCT02966587|Immunoglobulins|immunoglobulins|mesh-list
110174762|NCT02966587|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110174763|NCT02966587|Immunoglobulin G|immunoglobulin g|mesh-list
110174764|NCT02966587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110174765|NCT02966587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110174766|NCT02966587|Immunologic Factors|immunologic factors|mesh-ancestor
110174767|NCT02966587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110174768|NCT04958720|Immunomodulating Agents|immunomodulating agents|mesh-list
110174769|NCT04958720|Immunologic Factors|immunologic factors|mesh-ancestor
110285434|NCT00424580|Cholinergic Agents|cholinergic agents|mesh-ancestor
110174770|NCT04958720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110174771|NCT00069706|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110174772|NCT00069706|Latanoprost|latanoprost|mesh-list
110174773|NCT00069706|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110174774|NCT00069901|Paclitaxel|paclitaxel|mesh-list
110174775|NCT00069901|Carboplatin|carboplatin|mesh-list
110174776|NCT00069901|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
110174777|NCT00069901|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110174778|NCT00069901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110174779|NCT00069901|Tubulin Modulators|tubulin modulators|mesh-ancestor
110174780|NCT00069901|Antimitotic Agents|antimitotic agents|mesh-ancestor
110174781|NCT00069901|Mitosis Modulators|mitosis modulators|mesh-ancestor
110174782|NCT00069901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110174783|NCT00069940|Sargramostim|sargramostim|mesh-list
110174784|NCT00069940|Immunologic Factors|immunologic factors|mesh-ancestor
110174785|NCT00069940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110174786|NCT00390026|Bevacizumab|bevacizumab|mesh-list
110174787|NCT00390026|Verteporfin|verteporfin|mesh-list
110174788|NCT00390026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110174789|NCT00390026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110174791|NCT00390026|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110174792|NCT00390026|Growth Substances|growth substances|mesh-ancestor
110174793|NCT00390026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110174794|NCT00390026|Growth Inhibitors|growth inhibitors|mesh-ancestor
110174795|NCT00390026|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110174796|NCT00390026|Dermatologic Agents|dermatologic agents|mesh-ancestor
110174797|NCT00070057|Celecoxib|celecoxib|mesh-list
110174798|NCT00070057|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110174799|NCT00070057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110174800|NCT00070057|Analgesics|analgesics|mesh-ancestor
110174801|NCT00070057|Sensory System Agents|sensory system agents|mesh-ancestor
110174802|NCT00070057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110174803|NCT00070057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110174804|NCT00070057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110174805|NCT00070057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110174806|NCT00070057|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110174807|NCT00070057|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110174808|NCT00070057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110174809|NCT00070057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110174811|NCT00070174|Cyclosporine|cyclosporine|mesh-list
110174813|NCT00070174|Busulfan|busulfan|mesh-list
110174814|NCT00070174|Methotrexate|methotrexate|mesh-list
110174815|NCT00070174|Etoposide|etoposide|mesh-list
110174816|NCT00070174|Daunorubicin|daunorubicin|mesh-list
110174817|NCT00070174|Asparaginase|asparaginase|mesh-list
110174818|NCT00070174|Mitoxantrone|mitoxantrone|mesh-list
110174819|NCT00070174|Gemtuzumab|gemtuzumab|mesh-list
110174820|NCT00070174|Cyclosporins|cyclosporins|mesh-list
110174821|NCT00070174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110174822|NCT00070174|Immunologic Factors|immunologic factors|mesh-ancestor
110174823|NCT00070174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110174824|NCT00070174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110174825|NCT00070174|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110174826|NCT00070174|Alkylating Agents|alkylating agents|mesh-ancestor
110174827|NCT00070174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110174828|NCT00070174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110174829|NCT00070174|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110174830|NCT00070174|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110174831|NCT00070174|Abortifacient Agents|abortifacient agents|mesh-ancestor
110174832|NCT00070174|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110174833|NCT00070174|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110174834|NCT00070174|Antimetabolites|antimetabolites|mesh-ancestor
110174835|NCT00070174|Dermatologic Agents|dermatologic agents|mesh-ancestor
110174836|NCT00070174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110174837|NCT00070174|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110174838|NCT00070174|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110174839|NCT00070174|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110174840|NCT00070174|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110034939|NCT01402596|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110174841|NCT00070174|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110174842|NCT00070174|Antiviral Agents|antiviral agents|mesh-ancestor
110174843|NCT00070174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110174844|NCT00070174|Antifungal Agents|antifungal agents|mesh-ancestor
110174845|NCT00070174|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110174846|NCT00070174|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110174847|NCT00070174|Analgesics|analgesics|mesh-ancestor
110174848|NCT00070174|Sensory System Agents|sensory system agents|mesh-ancestor
110174849|NCT00070174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110174850|NCT00070174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110174851|NCT00070174|Immunotoxins|immunotoxins|mesh-ancestor
110174852|NCT00070174|Immunoconjugates|immunoconjugates|mesh-ancestor
110174854|NCT00070213|Fluorouracil|fluorouracil|mesh-list
110174855|NCT00070213|Capecitabine|capecitabine|mesh-list
110174856|NCT00070213|Oxaliplatin|oxaliplatin|mesh-list
110174857|NCT00070213|Calcium|calcium|mesh-list
110174858|NCT00070213|Levoleucovorin|levoleucovorin|mesh-list
110174859|NCT00070213|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110174860|NCT00070213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110174861|NCT00070213|Antimetabolites|antimetabolites|mesh-ancestor
110174862|NCT00070213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110174863|NCT00070213|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110174864|NCT00070213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110174865|NCT00070213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110174866|NCT00070213|Immunologic Factors|immunologic factors|mesh-ancestor
110174867|NCT00070213|Antidotes|antidotes|mesh-ancestor
110174868|NCT00070213|Protective Agents|protective agents|mesh-ancestor
110174869|NCT00070213|Vitamin B Complex|vitamin b complex|mesh-ancestor
110174870|NCT00070213|Vitamins|vitamins|mesh-ancestor
110174871|NCT00070213|Micronutrients|micronutrients|mesh-ancestor
110174872|NCT00070252|Docetaxel|docetaxel|mesh-list
110174873|NCT00070252|Capecitabine|capecitabine|mesh-list
110174875|NCT00070252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110174876|NCT00070252|Tubulin Modulators|tubulin modulators|mesh-ancestor
110174877|NCT00070252|Antimitotic Agents|antimitotic agents|mesh-ancestor
110174878|NCT00070252|Mitosis Modulators|mitosis modulators|mesh-ancestor
110174879|NCT00070252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110035019|NCT01403285|Alkylating Agents|alkylating agents|mesh-ancestor
110174880|NCT00070252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110174882|NCT00070447|Prednisone|prednisone|mesh-list
110174883|NCT00070447|Cyclophosphamide|cyclophosphamide|mesh-list
110174884|NCT00070447|Rituximab|rituximab|mesh-list
110174885|NCT00070447|Doxorubicin|doxorubicin|mesh-list
110174886|NCT00070447|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110174887|NCT00070447|Vincristine|vincristine|mesh-list
110174888|NCT00070447|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110174889|NCT00070447|Immunologic Factors|immunologic factors|mesh-ancestor
110174890|NCT00070447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110174891|NCT00070447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110174892|NCT00070447|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110174893|NCT00070447|Alkylating Agents|alkylating agents|mesh-ancestor
110174894|NCT00070447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110174895|NCT00070447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110174896|NCT00070447|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110174897|NCT00070447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110174898|NCT00070447|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110174899|NCT00070447|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110174900|NCT00070447|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110174901|NCT00070447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110174902|NCT00070447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110174903|NCT00070447|Glucocorticoids|glucocorticoids|mesh-ancestor
110174904|NCT00070447|Hormones|hormones|mesh-ancestor
110174905|NCT00070447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110174906|NCT00070447|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110174907|NCT00070447|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110174908|NCT00070447|Tubulin Modulators|tubulin modulators|mesh-ancestor
110174909|NCT00070447|Antimitotic Agents|antimitotic agents|mesh-ancestor
110174910|NCT00070447|Mitosis Modulators|mitosis modulators|mesh-ancestor
110174912|NCT03959865|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
110174913|NCT03959865|Incretins|incretins|mesh-ancestor
110174914|NCT03959865|Hormones|hormones|mesh-ancestor
110174915|NCT03959865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110174916|NCT03959865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110174917|NCT03959865|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110174919|NCT00070486|Zileuton|zileuton|mesh-list
110174920|NCT00070486|Carboplatin|carboplatin|mesh-list
110174921|NCT00070486|Gemcitabine|gemcitabine|mesh-list
110174922|NCT00070486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110174923|NCT00070486|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110174924|NCT00070486|Antimetabolites|antimetabolites|mesh-ancestor
110174925|NCT00070486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110174926|NCT00070486|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110174928|NCT00070486|Analgesics|analgesics|mesh-ancestor
110174929|NCT00070486|Sensory System Agents|sensory system agents|mesh-ancestor
110174930|NCT00070486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110174931|NCT00070486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110174932|NCT00070486|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110174933|NCT00070486|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110174934|NCT00070486|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110174935|NCT00070486|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110174936|NCT00070486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110174937|NCT00070486|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
110174938|NCT00070486|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
110174939|NCT00070486|Hormone Antagonists|hormone antagonists|mesh-ancestor
110174940|NCT00070486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110174942|NCT00070525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110174943|NCT00070642|Dacarbazine|dacarbazine|mesh-list
110174944|NCT00070642|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110174945|NCT00070642|Alkylating Agents|alkylating agents|mesh-ancestor
110174946|NCT00070642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110174947|NCT00070642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110174948|NCT00070759|Daclizumab|daclizumab|mesh-list
110174949|NCT00070759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110174950|NCT00070759|Immunologic Factors|immunologic factors|mesh-ancestor
110174951|NCT00070759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110174953|NCT00070837|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110174954|NCT00070837|Immunologic Factors|immunologic factors|mesh-ancestor
110174955|NCT00070837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110174957|NCT00071188|Carboplatin|carboplatin|mesh-list
110174958|NCT00071188|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110174959|NCT00071188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110174960|NCT00071188|Tubulin Modulators|tubulin modulators|mesh-ancestor
110174961|NCT00071188|Antimitotic Agents|antimitotic agents|mesh-ancestor
110174962|NCT00071188|Mitosis Modulators|mitosis modulators|mesh-ancestor
110174963|NCT00071188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110174965|NCT00071227|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110174966|NCT00071227|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
110174967|NCT00071227|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
110174968|NCT00071227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110174969|NCT00071227|Glucocorticoids|glucocorticoids|mesh-ancestor
110174970|NCT00071227|Hormones|hormones|mesh-ancestor
110174971|NCT00071227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110174972|NCT00071227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110174973|NCT00071227|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110174974|NCT00071227|Immunologic Factors|immunologic factors|mesh-ancestor
110174975|NCT00071227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110174976|NCT00071227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110174979|NCT00071266|L 647318|l 647318|mesh-list
110174980|NCT00071266|Dihydromevinolin|dihydromevinolin|mesh-list
110174981|NCT00071266|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110174982|NCT00071266|Antimetabolites|antimetabolites|mesh-ancestor
110035226|NCT01404156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110174983|NCT00071266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110174984|NCT00071266|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110174985|NCT00071266|Vasodilator Agents|vasodilator agents|mesh-ancestor
110174986|NCT00071266|Vitamin B Complex|vitamin b complex|mesh-ancestor
110174988|NCT00071266|Micronutrients|micronutrients|mesh-ancestor
110174989|NCT00071266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110174990|NCT00071266|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110174991|NCT00071266|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110174992|NCT00071266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110174993|NCT02966743|Midazolam|midazolam|mesh-list
110174994|NCT02966743|Dexmedetomidine|dexmedetomidine|mesh-list
110174995|NCT02966743|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110174996|NCT02966743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110174997|NCT02966743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110174998|NCT02966743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110174999|NCT02966743|Analgesics|analgesics|mesh-ancestor
110175000|NCT02966743|Sensory System Agents|sensory system agents|mesh-ancestor
110175001|NCT02966743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110175002|NCT02966743|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110175003|NCT02966743|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110175004|NCT02966743|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110175005|NCT02966743|Adrenergic Agents|adrenergic agents|mesh-ancestor
110175006|NCT02966743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110175007|NCT02966743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110175008|NCT02966743|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110175009|NCT02966743|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110175010|NCT02966743|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110175011|NCT02966743|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110175012|NCT02966743|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110175013|NCT02966743|Anesthetics, General|anesthetics, general|mesh-ancestor
110175014|NCT02966743|Anesthetics|anesthetics|mesh-ancestor
110175016|NCT02966743|GABA Agents|gaba agents|mesh-ancestor
110175017|NCT00071539|Immunotoxins|immunotoxins|mesh-list
110175018|NCT00071539|Immunoconjugates|immunoconjugates|mesh-ancestor
110175019|NCT00071539|Immunologic Factors|immunologic factors|mesh-ancestor
110175020|NCT00071539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110175021|NCT00071695|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110175022|NCT00071695|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
110175023|NCT00071695|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110175024|NCT00071695|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110276054|NCT00199446|Purinergic Agents|purinergic agents|mesh-ancestor
110175025|NCT00071695|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110175026|NCT00071695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110175027|NCT00071695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110175028|NCT00071695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110175029|NCT00071695|Analgesics|analgesics|mesh-ancestor
110175030|NCT00071695|Sensory System Agents|sensory system agents|mesh-ancestor
110175031|NCT00071695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110175032|NCT00071695|Antidepressive Agents|antidepressive agents|mesh-ancestor
110175033|NCT00071695|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110175034|NCT00071695|Dopamine Agents|dopamine agents|mesh-ancestor
110175035|NCT00071695|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110175036|NCT00071929|Oxaliplatin|oxaliplatin|mesh-list
110175037|NCT00071929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110175038|NCT00071968|Sirolimus|sirolimus|mesh-list
110175039|NCT00071968|Temsirolimus|temsirolimus|mesh-list
110175040|NCT00071968|MTOR Inhibitors|mtor inhibitors|mesh-list
110175041|NCT00071968|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110175042|NCT00071968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110175043|NCT00071968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110175044|NCT00071968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110175045|NCT00071968|Immunologic Factors|immunologic factors|mesh-ancestor
110175046|NCT00071968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110175047|NCT00071968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110175048|NCT00071968|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110175049|NCT00071968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110175050|NCT00071968|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110175051|NCT00071968|Antifungal Agents|antifungal agents|mesh-ancestor
110175052|NCT00390065|Nitric Oxide|nitric oxide|mesh-list
110175053|NCT00390065|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110175054|NCT00390065|Autonomic Agents|autonomic agents|mesh-ancestor
110175055|NCT00390065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110175056|NCT00390065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110175058|NCT00390065|Respiratory System Agents|respiratory system agents|mesh-ancestor
110175059|NCT00390065|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110175060|NCT00390065|Antioxidants|antioxidants|mesh-ancestor
110175061|NCT00390065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110175062|NCT00390065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110175063|NCT00390065|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
110175064|NCT00390065|Vasodilator Agents|vasodilator agents|mesh-ancestor
110175065|NCT00390065|Gasotransmitters|gasotransmitters|mesh-ancestor
110175066|NCT00390065|Protective Agents|protective agents|mesh-ancestor
110175067|NCT00072007|Prednisone|prednisone|mesh-list
110175068|NCT00072007|Cyclophosphamide|cyclophosphamide|mesh-list
110175069|NCT00072007|Rituximab|rituximab|mesh-list
110175070|NCT00072007|Doxorubicin|doxorubicin|mesh-list
110175071|NCT00072007|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110175072|NCT00072007|Vincristine|vincristine|mesh-list
110175073|NCT00072007|Cladribine|cladribine|mesh-list
110175074|NCT00072007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110175075|NCT00072007|Immunologic Factors|immunologic factors|mesh-ancestor
110175076|NCT00072007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110175077|NCT00072007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110175078|NCT00072007|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110175079|NCT00072007|Alkylating Agents|alkylating agents|mesh-ancestor
110175080|NCT00072007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110175081|NCT00072007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110175082|NCT00072007|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110175083|NCT00072007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110175084|NCT00072007|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110175085|NCT00072007|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110175086|NCT00072007|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110175087|NCT00072007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110175088|NCT00072007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110175089|NCT00072007|Glucocorticoids|glucocorticoids|mesh-ancestor
110175090|NCT00072007|Hormones|hormones|mesh-ancestor
110175091|NCT00072007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110175092|NCT00072007|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110193504|NCT00063453|Vitamin E|vitamin e|mesh-list
110175093|NCT00072007|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110175094|NCT00072007|Tubulin Modulators|tubulin modulators|mesh-ancestor
110175095|NCT00072007|Antimitotic Agents|antimitotic agents|mesh-ancestor
110175096|NCT00072007|Mitosis Modulators|mitosis modulators|mesh-ancestor
110175098|NCT00072046|Interferon-alpha|interferon-alpha|mesh-list
110175099|NCT00072046|Bevacizumab|bevacizumab|mesh-list
110175100|NCT00072046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110175101|NCT00072046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110175102|NCT00072046|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110175103|NCT00072046|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110175104|NCT00072046|Growth Substances|growth substances|mesh-ancestor
110175105|NCT00072046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110175106|NCT00072046|Growth Inhibitors|growth inhibitors|mesh-ancestor
110175107|NCT00072046|Antiviral Agents|antiviral agents|mesh-ancestor
110175108|NCT00072046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110175109|NCT00072046|Immunologic Factors|immunologic factors|mesh-ancestor
110175110|NCT03959514|Insulin Aspart|insulin aspart|mesh-list
110175111|NCT03959514|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110175112|NCT03959514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110175113|NCT04730596|Dexmedetomidine|dexmedetomidine|mesh-list
110175115|NCT04730596|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110175116|NCT04730596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110175117|NCT04730596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110175118|NCT04730596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110175119|NCT04730596|Analgesics|analgesics|mesh-ancestor
110175120|NCT04730596|Sensory System Agents|sensory system agents|mesh-ancestor
110175121|NCT04730596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110175122|NCT04730596|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110175123|NCT04730596|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110175124|NCT04730596|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110175125|NCT04730596|Adrenergic Agents|adrenergic agents|mesh-ancestor
110175126|NCT04730596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110175127|NCT04730596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110175128|NCT04730596|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110175129|NCT04730596|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110175130|NCT04730596|Anesthetics, General|anesthetics, general|mesh-ancestor
110175131|NCT04730596|Anesthetics|anesthetics|mesh-ancestor
110175132|NCT04730596|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110175133|NCT04730596|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110175134|NCT00072085|Aldesleukin|aldesleukin|mesh-list
110175135|NCT00072085|Freund's Adjuvant|freund's adjuvant|mesh-list
110175136|NCT00072085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110175137|NCT00072085|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110175138|NCT00072085|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110035548|NCT01405326|Adalimumab|adalimumab|mesh-list
110175139|NCT00072085|Antiviral Agents|antiviral agents|mesh-ancestor
110175140|NCT00072085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110175141|NCT00072085|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110175142|NCT00072085|Immunologic Factors|immunologic factors|mesh-ancestor
110175143|NCT00072085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110175144|NCT04730674|Tetracycline|tetracycline|mesh-list
110175146|NCT04730674|Anesthetics, Local|anesthetics, local|mesh-ancestor
110175147|NCT04730674|Anesthetics|anesthetics|mesh-ancestor
110175148|NCT04730674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110175149|NCT04730674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110175150|NCT04730674|Sensory System Agents|sensory system agents|mesh-ancestor
110175151|NCT04730674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110175152|NCT04730674|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110175153|NCT04730674|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110175154|NCT04730674|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110175155|NCT04730674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110175156|NCT04730674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110175157|NCT04730674|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110175158|NCT04730674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110175159|NCT04730674|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110175160|NCT04730674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110175162|NCT03959436|Oxytocics|oxytocics|mesh-ancestor
110175163|NCT03959436|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110175164|NCT03959436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110175165|NCT00072124|Dacarbazine|dacarbazine|mesh-list
110175166|NCT00072124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110175167|NCT00072124|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110175168|NCT00072124|Alkylating Agents|alkylating agents|mesh-ancestor
110175169|NCT00072124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110175171|NCT00072163|Temozolomide|temozolomide|mesh-list
110175172|NCT00072163|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110175173|NCT00072163|Alkylating Agents|alkylating agents|mesh-ancestor
110175174|NCT00072163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110175175|NCT00072163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110175176|NCT00072163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110175177|NCT00072163|Immunologic Factors|immunologic factors|mesh-ancestor
110175178|NCT00072163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110175179|NCT00072163|Leprostatic Agents|leprostatic agents|mesh-ancestor
110175180|NCT00072163|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110175181|NCT00072163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110175182|NCT00072163|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110175183|NCT00072163|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110175184|NCT00072163|Growth Substances|growth substances|mesh-ancestor
110175186|NCT00072319|Paclitaxel|paclitaxel|mesh-list
110175187|NCT00072319|Cyclophosphamide|cyclophosphamide|mesh-list
110175188|NCT00072319|Epirubicin|epirubicin|mesh-list
110175189|NCT00072319|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110175190|NCT00072319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110175191|NCT00072319|Tubulin Modulators|tubulin modulators|mesh-ancestor
110175192|NCT00072319|Antimitotic Agents|antimitotic agents|mesh-ancestor
110175193|NCT00072319|Mitosis Modulators|mitosis modulators|mesh-ancestor
110175194|NCT00072319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110175195|NCT00072319|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110175196|NCT00072319|Immunologic Factors|immunologic factors|mesh-ancestor
110175197|NCT00072319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110175198|NCT00072319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110193561|NCT02967276|Glucocorticoids|glucocorticoids|mesh-ancestor
110175199|NCT00072319|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110175200|NCT00072319|Alkylating Agents|alkylating agents|mesh-ancestor
110175201|NCT00072319|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110175202|NCT00072319|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110175203|NCT00072319|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110175204|NCT00072319|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110175205|NCT00072319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110175207|NCT03959397|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110175208|NCT03959397|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110175209|NCT03959397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110175211|NCT03959397|Antimitotic Agents|antimitotic agents|mesh-ancestor
110175212|NCT03959397|Mitosis Modulators|mitosis modulators|mesh-ancestor
110175213|NCT03959397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110175214|NCT00072436|Gemcitabine|gemcitabine|mesh-list
110175215|NCT00072436|Alvocidib|alvocidib|mesh-list
110175216|NCT00072436|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110175217|NCT00072436|Antimetabolites|antimetabolites|mesh-ancestor
110175218|NCT00072436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110175219|NCT00072436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110175220|NCT00072436|Growth Inhibitors|growth inhibitors|mesh-ancestor
110175221|NCT00072436|Growth Substances|growth substances|mesh-ancestor
110175222|NCT00072436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110175223|NCT00072436|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110175224|NCT00072436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110175225|NCT00072553|Leucovorin|leucovorin|mesh-list
110175226|NCT00072553|Celecoxib|celecoxib|mesh-list
110175227|NCT00072553|Fluorouracil|fluorouracil|mesh-list
110175228|NCT00072553|Oxaliplatin|oxaliplatin|mesh-list
110175229|NCT00072553|Calcium|calcium|mesh-list
110175230|NCT00072553|Levoleucovorin|levoleucovorin|mesh-list
110175231|NCT00072553|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110175232|NCT00072553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110175233|NCT00072553|Antimetabolites|antimetabolites|mesh-ancestor
110175234|NCT00072553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110193584|NCT00063687|Oxypurinol|oxypurinol|mesh-list
110175236|NCT00072553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110175237|NCT00072553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110175238|NCT00072553|Immunologic Factors|immunologic factors|mesh-ancestor
110175239|NCT00072553|Antidotes|antidotes|mesh-ancestor
110175240|NCT00072553|Protective Agents|protective agents|mesh-ancestor
110175241|NCT00072553|Vitamin B Complex|vitamin b complex|mesh-ancestor
110175242|NCT00072553|Vitamins|vitamins|mesh-ancestor
110175243|NCT00072553|Micronutrients|micronutrients|mesh-ancestor
110175244|NCT00072553|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110175245|NCT00072553|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110175246|NCT00072553|Analgesics|analgesics|mesh-ancestor
110175247|NCT00072553|Sensory System Agents|sensory system agents|mesh-ancestor
110175248|NCT00072553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110175249|NCT00072553|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110175250|NCT00072553|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110175251|NCT00072553|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110175252|NCT00072553|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110175253|NCT00072553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110175255|NCT00072592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110175256|NCT00072592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110175257|NCT00072592|Immunologic Factors|immunologic factors|mesh-ancestor
110175258|NCT00072592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110175259|NCT00072592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110175260|NCT00072631|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110175261|NCT00072631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110175262|NCT00072631|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110175263|NCT00072631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110175264|NCT00072631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110175265|NCT00072670|Trabectedin|trabectedin|mesh-list
110175266|NCT00072670|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110175267|NCT00072670|Alkylating Agents|alkylating agents|mesh-ancestor
110175268|NCT00072670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110175269|NCT00072670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110175270|NCT02966704|Caseins|caseins|mesh-list
110175271|NCT02966704|Chelating Agents|chelating agents|mesh-ancestor
110175272|NCT02966704|Sequestering Agents|sequestering agents|mesh-ancestor
110175273|NCT02966704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110175274|NCT00072748|EKB 569|ekb 569|mesh-list
110175275|NCT00072748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110175276|NCT00072748|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110175277|NCT00072748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110175278|NCT00072748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110175279|NCT00072787|Cisplatin|cisplatin|mesh-list
110175280|NCT00072787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110175281|NCT00072826|Acetylcholine|acetylcholine|mesh-list
110175282|NCT00072826|Oxypurinol|oxypurinol|mesh-list
110175283|NCT00072826|Vasodilator Agents|vasodilator agents|mesh-ancestor
110175284|NCT00072826|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110175285|NCT00072826|Cholinergic Agents|cholinergic agents|mesh-ancestor
110175286|NCT00072826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110175287|NCT00072826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110175288|NCT00072826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110035935|NCT01408160|Cytarabine|cytarabine|mesh-list
110175290|NCT00072865|Carboplatin|carboplatin|mesh-list
110175292|NCT00072865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110175293|NCT00072865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110175294|NCT00072865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110175295|NCT00072865|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110175296|NCT00072865|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110175297|NCT00072904|Repaglinide|repaglinide|mesh-list
110175298|NCT00072904|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110175299|NCT00072904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110175300|NCT00072943|Interferons|interferons|mesh-list
110175301|NCT00072943|Interferon-gamma|interferon-gamma|mesh-list
110175302|NCT00072943|Antibodies|antibodies|mesh-list
110175303|NCT00072943|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110175304|NCT00072943|Immunologic Factors|immunologic factors|mesh-ancestor
110175305|NCT00072943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110175306|NCT00072943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110175308|NCT00072943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110175309|NCT00072982|Borage oil|borage oil|mesh-list
110175310|NCT00072982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110175311|NCT03959124|Memantine|memantine|mesh-list
110175312|NCT03959124|Rivastigmine|rivastigmine|mesh-list
110175313|NCT03959124|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110175314|NCT03959124|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110175315|NCT03959124|Dopamine Agents|dopamine agents|mesh-ancestor
110175316|NCT03959124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110175317|NCT03959124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110175318|NCT03959124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110175319|NCT03959124|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110175320|NCT03959124|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110175321|NCT03959124|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110175322|NCT03959124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110175323|NCT03959124|Cholinergic Agents|cholinergic agents|mesh-ancestor
110175324|NCT03959124|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110175325|NCT03959124|Protective Agents|protective agents|mesh-ancestor
110175326|NCT02966236|Tranexamic Acid|tranexamic acid|mesh-list
110175327|NCT02966236|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
110175328|NCT02966236|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110175329|NCT02966236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110175330|NCT02966236|Hemostatics|hemostatics|mesh-ancestor
110175331|NCT02966236|Coagulants|coagulants|mesh-ancestor
110175333|NCT04711291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110175334|NCT04711291|Immunologic Factors|immunologic factors|mesh-ancestor
110175335|NCT04711291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110175336|NCT04711291|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110175337|NCT04711291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110175338|NCT04711291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110175339|NCT00073372|Abciximab|abciximab|mesh-list
110175340|NCT00073372|Anticoagulants|anticoagulants|mesh-ancestor
110175341|NCT00073372|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110175342|NCT04821830|Levodopa|levodopa|mesh-list
110175343|NCT04821830|Carbidopa|carbidopa|mesh-list
110175344|NCT04821830|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
110175345|NCT04821830|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110175346|NCT04821830|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110175347|NCT04821830|Dopamine Agents|dopamine agents|mesh-ancestor
110175348|NCT04821830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110175349|NCT04821830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110175350|NCT04821830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110175351|NCT04821830|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
110175353|NCT04821830|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110175354|NCT04821830|Immunologic Factors|immunologic factors|mesh-ancestor
110175355|NCT04821830|Dopamine Agonists|dopamine agonists|mesh-ancestor
110175356|NCT00073411|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
110175357|NCT00073411|Escitalopram|escitalopram|mesh-list
110175358|NCT00073411|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110175359|NCT00073411|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110175360|NCT00073411|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110175361|NCT00073411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110175362|NCT00073411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110175363|NCT00073411|Serotonin Agents|serotonin agents|mesh-ancestor
110175364|NCT00073411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110175365|NCT00073411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110175366|NCT00073411|Antidepressive Agents|antidepressive agents|mesh-ancestor
110175367|NCT00073411|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110175368|NCT00073411|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110175369|NCT00073411|Analgesics|analgesics|mesh-ancestor
110175370|NCT00073411|Sensory System Agents|sensory system agents|mesh-ancestor
110175371|NCT00073411|Dopamine Agents|dopamine agents|mesh-ancestor
110175372|NCT02966041|Ondansetron|ondansetron|mesh-list
110175373|NCT02966041|Antiemetics|antiemetics|mesh-ancestor
110175374|NCT02966041|Autonomic Agents|autonomic agents|mesh-ancestor
110175375|NCT02966041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110175376|NCT02966041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110175377|NCT02966041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110175378|NCT02966041|Antipruritics|antipruritics|mesh-ancestor
110175379|NCT02966041|Dermatologic Agents|dermatologic agents|mesh-ancestor
110175380|NCT02966041|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110175382|NCT02966041|Serotonin Agents|serotonin agents|mesh-ancestor
110175383|NCT02966041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110175384|NCT02966041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110175385|NCT00073723|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110175386|NCT00073723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110175387|NCT00073840|Albuterol|albuterol|mesh-list
110175388|NCT00073840|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110175389|NCT00073840|Autonomic Agents|autonomic agents|mesh-ancestor
110175390|NCT00073840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110175391|NCT00073840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110175392|NCT00073840|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110175393|NCT00073840|Respiratory System Agents|respiratory system agents|mesh-ancestor
110175394|NCT00073840|Tocolytic Agents|tocolytic agents|mesh-ancestor
110175395|NCT00073840|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110175396|NCT00073840|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110175397|NCT00073840|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110175398|NCT00073840|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110175399|NCT00073840|Adrenergic Agents|adrenergic agents|mesh-ancestor
110193641|NCT00064194|Vitamin E|vitamin e|mesh-list
110175401|NCT00073840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110175402|NCT00073879|Cyclophosphamide|cyclophosphamide|mesh-list
110175403|NCT00073879|Fludarabine|fludarabine|mesh-list
110175404|NCT00073879|Fludarabine phosphate|fludarabine phosphate|mesh-list
110175405|NCT00073879|Alemtuzumab|alemtuzumab|mesh-list
110175407|NCT00073879|Immunologic Factors|immunologic factors|mesh-ancestor
110175408|NCT00073879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110175409|NCT00073879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110175410|NCT00073879|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110175411|NCT00073879|Alkylating Agents|alkylating agents|mesh-ancestor
110175412|NCT00073879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110175413|NCT00073879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110175414|NCT00073879|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110175415|NCT00073879|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110175416|NCT00073879|Antimetabolites|antimetabolites|mesh-ancestor
110175417|NCT00073879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110175418|NCT00074074|Infliximab|infliximab|mesh-list
110175419|NCT00074074|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110175420|NCT00074074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110175421|NCT00074074|Dermatologic Agents|dermatologic agents|mesh-ancestor
110175422|NCT00074074|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110175423|NCT00074074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110175424|NCT00392652|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
110175425|NCT00392652|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110175426|NCT00392652|Protective Agents|protective agents|mesh-ancestor
110175427|NCT00392652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110175428|NCT00392652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110175429|NCT00074191|Cytarabine|cytarabine|mesh-list
110175430|NCT00074191|Dexamethasone|dexamethasone|mesh-list
110175431|NCT00074191|Methotrexate|methotrexate|mesh-list
110175432|NCT00074191|Lomustine|lomustine|mesh-list
110175433|NCT00074191|Procarbazine|procarbazine|mesh-list
110175434|NCT00074191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110175435|NCT00074191|Antiemetics|antiemetics|mesh-ancestor
110175436|NCT00074191|Autonomic Agents|autonomic agents|mesh-ancestor
110175437|NCT00074191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110175438|NCT00074191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110175439|NCT00074191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110175440|NCT00074191|Glucocorticoids|glucocorticoids|mesh-ancestor
110175442|NCT00074191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110175443|NCT00074191|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110175444|NCT00074191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110175445|NCT00074191|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110175446|NCT00074191|Abortifacient Agents|abortifacient agents|mesh-ancestor
110175447|NCT00074191|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110175448|NCT00074191|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110175450|NCT00074191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110175451|NCT00074191|Dermatologic Agents|dermatologic agents|mesh-ancestor
110175452|NCT00074191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110175453|NCT00074191|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110175454|NCT00074191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110175455|NCT00074191|Immunologic Factors|immunologic factors|mesh-ancestor
110175456|NCT00074191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110175457|NCT00074191|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110175459|NCT00074191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110193662|NCT00037115|Methotrexate|methotrexate|mesh-list
110175460|NCT00074191|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110175461|NCT00074191|Alkylating Agents|alkylating agents|mesh-ancestor
110175462|NCT00074230|BIRC5 protein, human|birc5 protein, human|mesh-list
110175463|NCT00074230|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
110175464|NCT00074230|Protease Inhibitors|protease inhibitors|mesh-ancestor
110175465|NCT00074230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110175466|NCT00074230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110175467|NCT00392691|Rituximab|rituximab|mesh-list
110175468|NCT00392691|Melphalan|melphalan|mesh-list
110175469|NCT00392691|Vinorelbine|vinorelbine|mesh-list
110175470|NCT00392691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110175471|NCT00392691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110175472|NCT00392691|Immunologic Factors|immunologic factors|mesh-ancestor
110175473|NCT00392691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110175474|NCT00392691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110175475|NCT00392691|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110175476|NCT00392691|Alkylating Agents|alkylating agents|mesh-ancestor
110175477|NCT00392691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110175478|NCT00392691|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110175479|NCT00392691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110175481|NCT00392691|Tubulin Modulators|tubulin modulators|mesh-ancestor
110175482|NCT00392691|Antimitotic Agents|antimitotic agents|mesh-ancestor
110175483|NCT00392691|Mitosis Modulators|mitosis modulators|mesh-ancestor
110175484|NCT02966080|Heparin|heparin|mesh-list
110175485|NCT02966080|Anticoagulants|anticoagulants|mesh-ancestor
110175486|NCT02966080|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110175487|NCT02966080|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110175488|NCT02966080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110175489|NCT04767776|Rivaroxaban|rivaroxaban|mesh-list
110175490|NCT04767776|Charcoal|charcoal|mesh-list
110175491|NCT04767776|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110175492|NCT04767776|Antithrombins|antithrombins|mesh-ancestor
110175493|NCT04767776|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110175495|NCT04767776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110175496|NCT04767776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110175497|NCT04767776|Anticoagulants|anticoagulants|mesh-ancestor
110175498|NCT04767776|Antidotes|antidotes|mesh-ancestor
110175499|NCT04767776|Protective Agents|protective agents|mesh-ancestor
110175500|NCT04767776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110175501|NCT04754321|Pembrolizumab|pembrolizumab|mesh-list
110175502|NCT04754321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110175503|NCT04754321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110175504|NCT04754321|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110175505|NCT04754321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110175507|NCT04730245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110175508|NCT04730245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110175509|NCT04730245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110175510|NCT00074620|Hirudins|hirudins|mesh-list
110175511|NCT00074620|Antithrombins|antithrombins|mesh-ancestor
110175512|NCT00074620|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110175513|NCT00074620|Protease Inhibitors|protease inhibitors|mesh-ancestor
110175514|NCT00074620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110175515|NCT00074620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110175516|NCT00074620|Anticoagulants|anticoagulants|mesh-ancestor
110175517|NCT00074620|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110175518|NCT00074620|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110175519|NCT02972333|Osimertinib|osimertinib|mesh-list
110175520|NCT02972333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110175521|NCT02972333|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110175522|NCT02972333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110175523|NCT02972333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110175524|NCT00074737|Cytarabine|cytarabine|mesh-list
110175525|NCT00074737|Idarubicin|idarubicin|mesh-list
110175526|NCT00074737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110175527|NCT00074737|Antimetabolites|antimetabolites|mesh-ancestor
110175528|NCT00074737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110175529|NCT00074737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110175530|NCT00074737|Antiviral Agents|antiviral agents|mesh-ancestor
110175531|NCT00074737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110175532|NCT00074737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110175533|NCT00074737|Immunologic Factors|immunologic factors|mesh-ancestor
110175534|NCT00074737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110175535|NCT00074737|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110175536|NCT00074737|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110175537|NCT00074737|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110175538|NCT00074737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110175539|NCT00074776|Lamotrigine|lamotrigine|mesh-list
110175540|NCT00074776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110175541|NCT00074776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110175542|NCT00074776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110175543|NCT00074776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110175544|NCT00074776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110175545|NCT00074776|Anticonvulsants|anticonvulsants|mesh-ancestor
110175546|NCT00074776|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110175547|NCT00074776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110175548|NCT00074776|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110175550|NCT00074776|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110175552|NCT00075010|Valproic Acid|valproic acid|mesh-list
110175553|NCT00075010|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110175554|NCT00075010|Antimetabolites|antimetabolites|mesh-ancestor
110175555|NCT00075010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110175556|NCT00075010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110175557|NCT00075010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110175558|NCT00075010|Anticonvulsants|anticonvulsants|mesh-ancestor
110175559|NCT00075010|GABA Agents|gaba agents|mesh-ancestor
110175560|NCT00075010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110175561|NCT00075010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110175562|NCT00075010|Antimanic Agents|antimanic agents|mesh-ancestor
110175563|NCT00075010|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110175564|NCT00075010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110175565|NCT00075010|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110175567|NCT04729595|Antioxidants|antioxidants|mesh-ancestor
110175568|NCT04729595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110175569|NCT04729595|Protective Agents|protective agents|mesh-ancestor
110175570|NCT04729595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110175571|NCT04729595|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110175572|NCT04729595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110175573|NCT04729595|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110175574|NCT04729595|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110175575|NCT00075205|Rimonabant|rimonabant|mesh-list
110175576|NCT00075205|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110175577|NCT00075205|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
110175578|NCT00075205|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
110175579|NCT00075205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110175580|NCT00075205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110175581|NCT00075205|Hormones|hormones|mesh-ancestor
110175582|NCT00075205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110175583|NCT00075205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110175584|NCT00075439|Gefitinib|gefitinib|mesh-list
110175586|NCT00075439|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110175587|NCT00075439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110175588|NCT00075439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110175589|NCT00075517|Gemcitabine|gemcitabine|mesh-list
110175590|NCT00075517|Docetaxel|docetaxel|mesh-list
110175591|NCT00075517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110175592|NCT00075517|Antimetabolites|antimetabolites|mesh-ancestor
110175593|NCT00075517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110175594|NCT00075517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110175595|NCT00075517|Tubulin Modulators|tubulin modulators|mesh-ancestor
110175596|NCT00075517|Antimitotic Agents|antimitotic agents|mesh-ancestor
110175597|NCT00075517|Mitosis Modulators|mitosis modulators|mesh-ancestor
110175598|NCT00075556|Capecitabine|capecitabine|mesh-list
110175599|NCT00075556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110175600|NCT00075556|Antimetabolites|antimetabolites|mesh-ancestor
110175601|NCT00075556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110175602|NCT00075556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110175603|NCT00075595|Leucovorin|leucovorin|mesh-list
110175604|NCT00075595|Fluorouracil|fluorouracil|mesh-list
110175605|NCT00075595|Irinotecan|irinotecan|mesh-list
110175606|NCT00075595|Calcium|calcium|mesh-list
110175607|NCT00075595|Levoleucovorin|levoleucovorin|mesh-list
110175608|NCT00075595|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110175609|NCT00075595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110175610|NCT00075595|Antimetabolites|antimetabolites|mesh-ancestor
110175611|NCT00075595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110175612|NCT00075595|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110175613|NCT00075595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110175614|NCT00075595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110175615|NCT00075595|Immunologic Factors|immunologic factors|mesh-ancestor
110175616|NCT00075595|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110175617|NCT00075595|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110175618|NCT00075595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110175619|NCT00075595|Antidotes|antidotes|mesh-ancestor
110175620|NCT00075595|Protective Agents|protective agents|mesh-ancestor
110175621|NCT00075595|Vitamin B Complex|vitamin b complex|mesh-ancestor
110175623|NCT00075595|Micronutrients|micronutrients|mesh-ancestor
110175624|NCT00075634|Cyclophosphamide|cyclophosphamide|mesh-list
110175625|NCT00075634|Doxorubicin|doxorubicin|mesh-list
110175626|NCT00075634|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110175627|NCT00075634|Decitabine|decitabine|mesh-list
110175628|NCT00075634|Azacitidine|azacitidine|mesh-list
110175630|NCT00075634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110175631|NCT00075634|Immunologic Factors|immunologic factors|mesh-ancestor
110175632|NCT00075634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110175633|NCT00075634|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110175634|NCT00075634|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110175635|NCT00075634|Alkylating Agents|alkylating agents|mesh-ancestor
110175636|NCT00075634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110175637|NCT00075634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110175638|NCT00075634|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110175639|NCT00075634|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110175640|NCT00075634|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110175641|NCT00075634|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110175642|NCT00075634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110175643|NCT00075634|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110175644|NCT00075634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110175646|NCT00075673|Celecoxib|celecoxib|mesh-list
110175647|NCT00075673|Vinorelbine|vinorelbine|mesh-list
110175648|NCT00075673|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110175649|NCT00075673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110175650|NCT00075673|Analgesics|analgesics|mesh-ancestor
110175651|NCT00075673|Sensory System Agents|sensory system agents|mesh-ancestor
110175652|NCT00075673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110175653|NCT00075673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110175654|NCT00075673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110175655|NCT00075673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110175656|NCT00075673|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110175657|NCT00075673|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110175658|NCT00075673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110175659|NCT00075673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110175661|NCT00075673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110175662|NCT00075673|Tubulin Modulators|tubulin modulators|mesh-ancestor
110175663|NCT00075673|Antimitotic Agents|antimitotic agents|mesh-ancestor
110175664|NCT00075673|Mitosis Modulators|mitosis modulators|mesh-ancestor
110175665|NCT00075712|Paclitaxel|paclitaxel|mesh-list
110175666|NCT00075712|Carboplatin|carboplatin|mesh-list
110175667|NCT00075712|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110175668|NCT00075712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110175669|NCT00075712|Tubulin Modulators|tubulin modulators|mesh-ancestor
110175670|NCT00075712|Antimitotic Agents|antimitotic agents|mesh-ancestor
110175671|NCT00075712|Mitosis Modulators|mitosis modulators|mesh-ancestor
110175672|NCT00075712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110285508|NCT01087723|Heparin|heparin|mesh-list
110175673|NCT03958500|Methylene Blue|methylene blue|mesh-list
110175674|NCT03958500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110175675|NCT03958500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110175676|NCT00075751|Carboplatin|carboplatin|mesh-list
110175677|NCT00075751|Gemcitabine|gemcitabine|mesh-list
110175678|NCT00075751|Bortezomib|bortezomib|mesh-list
110175679|NCT00075751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110175680|NCT00075751|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110175681|NCT00075751|Antimetabolites|antimetabolites|mesh-ancestor
110175682|NCT00075751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110175684|NCT00075868|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110175685|NCT00075868|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110175686|NCT00075868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110175687|NCT00075907|Ritonavir|ritonavir|mesh-list
110175688|NCT00075907|Lopinavir|lopinavir|mesh-list
110175689|NCT00075907|Efavirenz|efavirenz|mesh-list
110175690|NCT00075907|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110175691|NCT00075907|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110175692|NCT00075907|Protease Inhibitors|protease inhibitors|mesh-ancestor
110175693|NCT00075907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110175694|NCT00075907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110175695|NCT00075907|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110175696|NCT00075907|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110175697|NCT00075907|Antiviral Agents|antiviral agents|mesh-ancestor
110175698|NCT00075907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110175699|NCT00075907|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110175700|NCT00075907|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110175701|NCT00075907|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110175702|NCT00075907|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110175703|NCT00075907|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110175704|NCT00075907|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110175705|NCT00075907|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110175706|NCT00075907|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110175707|NCT00075907|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110193759|NCT00037622|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110175710|NCT03958383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110175711|NCT03958383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110175712|NCT03958383|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110175713|NCT03958383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110175714|NCT00076414|Acetylcholine|acetylcholine|mesh-list
110175715|NCT00076414|Vasodilator Agents|vasodilator agents|mesh-ancestor
110175716|NCT00076414|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110175717|NCT00076414|Cholinergic Agents|cholinergic agents|mesh-ancestor
110175718|NCT00076414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110175719|NCT00076414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110175720|NCT00076414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110175721|NCT00399256|Acetylcysteine|acetylcysteine|mesh-list
110175722|NCT00399256|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110175723|NCT00399256|Antiviral Agents|antiviral agents|mesh-ancestor
110175724|NCT00399256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110175725|NCT00399256|Expectorants|expectorants|mesh-ancestor
110175726|NCT00399256|Respiratory System Agents|respiratory system agents|mesh-ancestor
110175727|NCT00399256|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110175728|NCT00399256|Antioxidants|antioxidants|mesh-ancestor
110175729|NCT00399256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110175730|NCT00399256|Protective Agents|protective agents|mesh-ancestor
110175731|NCT00399256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110175732|NCT00399256|Antidotes|antidotes|mesh-ancestor
110175733|NCT00399295|Naltrexone|naltrexone|mesh-list
110175734|NCT00399295|Hydromorphone|hydromorphone|mesh-list
110175735|NCT00399295|Narcotic Antagonists|narcotic antagonists|mesh-list
110175736|NCT00399295|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110175737|NCT00399295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110175738|NCT00399295|Sensory System Agents|sensory system agents|mesh-ancestor
110285511|NCT01087723|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110175739|NCT00399295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110193782|NCT00037817|Celecoxib|celecoxib|mesh-list
110175740|NCT00399295|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110175741|NCT00399295|Narcotics|narcotics|mesh-ancestor
110175742|NCT00399295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110175743|NCT00399295|Analgesics|analgesics|mesh-ancestor
110175744|NCT00399334|Antipsychotic Agents|antipsychotic agents|mesh-list
110175745|NCT00399334|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110175746|NCT00399334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110175747|NCT00399334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110175748|NCT00399334|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110175749|NCT00076492|Coenzyme Q10|coenzyme q10|mesh-list
110175751|NCT00076492|Micronutrients|micronutrients|mesh-ancestor
110175752|NCT00076492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110175754|NCT00076531|Fertility Agents, Female|fertility agents, female|mesh-ancestor
110175755|NCT00076531|Fertility Agents|fertility agents|mesh-ancestor
110175756|NCT00076531|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110175757|NCT00076531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110175758|NCT00076531|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110175759|NCT00076531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110175761|NCT00076609|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110175762|NCT00076609|Antimetabolites|antimetabolites|mesh-ancestor
110175763|NCT00076609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110175764|NCT00076609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110175765|NCT00076726|Infliximab|infliximab|mesh-list
110175766|NCT00076726|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110175767|NCT00076726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110175768|NCT00076726|Dermatologic Agents|dermatologic agents|mesh-ancestor
110175769|NCT00076726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110175770|NCT00076726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110175771|NCT00076960|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
110175772|NCT00076960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110175773|NCT00076960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110175774|NCT00077077|Capecitabine|capecitabine|mesh-list
110175775|NCT00077077|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110175776|NCT00077077|Antimetabolites|antimetabolites|mesh-ancestor
110175777|NCT00077077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110175778|NCT00077077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110175779|NCT00077116|Cytarabine|cytarabine|mesh-list
110175780|NCT00077116|Cyclophosphamide|cyclophosphamide|mesh-list
110175781|NCT00077116|Busulfan|busulfan|mesh-list
110175782|NCT00077116|Idarubicin|idarubicin|mesh-list
110175783|NCT00077116|Gemtuzumab|gemtuzumab|mesh-list
110175784|NCT00077116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110175785|NCT00077116|Immunologic Factors|immunologic factors|mesh-ancestor
110175786|NCT00077116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110175787|NCT00077116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110175788|NCT00077116|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110175789|NCT00077116|Alkylating Agents|alkylating agents|mesh-ancestor
110175790|NCT00077116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110175791|NCT00077116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110175792|NCT00077116|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110175793|NCT00077116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110175794|NCT00077116|Antimetabolites|antimetabolites|mesh-ancestor
110175795|NCT00077116|Antiviral Agents|antiviral agents|mesh-ancestor
110175796|NCT00077116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110175797|NCT00077116|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110175798|NCT00077116|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110175799|NCT00077116|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110175800|NCT00077116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110175801|NCT00077116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110175802|NCT00077116|Immunotoxins|immunotoxins|mesh-ancestor
110175804|NCT03951207|Amlodipine|amlodipine|mesh-list
110175805|NCT03951207|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
110175806|NCT03951207|Atorvastatin|atorvastatin|mesh-list
110175807|NCT03951207|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110175808|NCT03951207|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110175809|NCT03951207|Antimetabolites|antimetabolites|mesh-ancestor
110175810|NCT03951207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110175812|NCT03951207|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110175813|NCT03951207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110175814|NCT03951207|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110175815|NCT03951207|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110193817|NCT00065169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110175816|NCT03951207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110175817|NCT03951207|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110175818|NCT03951207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110175819|NCT03951207|Vasodilator Agents|vasodilator agents|mesh-ancestor
110175821|NCT00077194|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110175822|NCT00077194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110175823|NCT00077194|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
110175824|NCT00077194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110175825|NCT00077194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110175826|NCT00077233|Leucovorin|leucovorin|mesh-list
110175827|NCT00077233|Fluorouracil|fluorouracil|mesh-list
110175829|NCT00077233|Irinotecan|irinotecan|mesh-list
110175830|NCT00077233|Cetuximab|cetuximab|mesh-list
110175831|NCT00077233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110175833|NCT00077233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110175834|NCT00077233|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110175835|NCT00077233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110175836|NCT00077233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110175837|NCT00077233|Immunologic Factors|immunologic factors|mesh-ancestor
110175838|NCT00077233|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110175839|NCT00077233|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110175840|NCT00077233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110175842|NCT00077233|Protective Agents|protective agents|mesh-ancestor
110175843|NCT00077233|Vitamin B Complex|vitamin b complex|mesh-ancestor
110175845|NCT00077233|Micronutrients|micronutrients|mesh-ancestor
110175846|NCT00077233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110175847|NCT02958631|Losartan|losartan|mesh-list
110175848|NCT02958631|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110175849|NCT02958631|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110175850|NCT02958631|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110175851|NCT02958631|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110175852|NCT02958631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110175853|NCT00077311|Docetaxel|docetaxel|mesh-list
110175854|NCT00077311|Darbepoetin alfa|darbepoetin alfa|mesh-list
110175855|NCT00077311|2,2'-dithiodiethanesulfonic acid|2,2'-dithiodiethanesulfonic acid|mesh-list
110175856|NCT00077311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110175857|NCT00077311|Tubulin Modulators|tubulin modulators|mesh-ancestor
110175858|NCT00077311|Antimitotic Agents|antimitotic agents|mesh-ancestor
110175859|NCT00077311|Mitosis Modulators|mitosis modulators|mesh-ancestor
110175860|NCT00077311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110175861|NCT00077311|Hematinics|hematinics|mesh-ancestor
110175862|NCT00077311|Protective Agents|protective agents|mesh-ancestor
110175863|NCT00077311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110175864|NCT00077350|Gemcitabine|gemcitabine|mesh-list
110175865|NCT00077350|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110175866|NCT00077350|Antimetabolites|antimetabolites|mesh-ancestor
110175867|NCT00077350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110175868|NCT00077350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110175869|NCT00077389|Carboplatin|carboplatin|mesh-list
110175870|NCT00077389|Doxorubicin|doxorubicin|mesh-list
110175871|NCT00077389|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110175872|NCT00077389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110193866|NCT00038168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110175873|NCT00077389|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110175874|NCT00077389|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110175875|NCT00077389|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110175876|NCT00077389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110175877|NCT00077389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110175878|NCT00077428|Doxorubicin|doxorubicin|mesh-list
110175879|NCT00077428|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110175880|NCT00077428|Bortezomib|bortezomib|mesh-list
110175881|NCT00077428|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110175882|NCT00077428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110175883|NCT00077428|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110175884|NCT00077428|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110175885|NCT00077428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110175886|NCT00077428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110175887|NCT00077467|Bortezomib|bortezomib|mesh-list
110175888|NCT00077467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110175889|NCT04551482|Oxytocin|oxytocin|mesh-list
110175890|NCT04551482|Oxytocics|oxytocics|mesh-ancestor
110175891|NCT04551482|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110175892|NCT04551482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110175893|NCT00077545|Cisplatin|cisplatin|mesh-list
110175894|NCT00077545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110175897|NCT00077584|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
110175898|NCT00077584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110175899|NCT00077779|Adalimumab|adalimumab|mesh-list
110175900|NCT00077779|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
110175901|NCT00077779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110175902|NCT00077779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110175903|NCT00077818|Enoxaparin|enoxaparin|mesh-list
110175904|NCT00077818|Enoxaparin sodium|enoxaparin sodium|mesh-list
110175905|NCT00077818|Anticoagulants|anticoagulants|mesh-ancestor
110175906|NCT00077818|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110175907|NCT00077818|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110175908|NCT00077818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110175909|NCT00078130|Buprenorphine|buprenorphine|mesh-list
110175910|NCT00078130|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
110175911|NCT00078130|Naloxone|naloxone|mesh-list
110175912|NCT00078130|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110175913|NCT00078130|Narcotics|narcotics|mesh-ancestor
110175914|NCT00078130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110175915|NCT00078130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110175916|NCT00078130|Analgesics|analgesics|mesh-ancestor
110175917|NCT00078130|Sensory System Agents|sensory system agents|mesh-ancestor
110175918|NCT00078130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110175919|NCT00078130|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110175920|NCT00399451|Polidocanol|polidocanol|mesh-list
110175921|NCT00399451|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
110175922|NCT00399451|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110175923|NCT04711213|Dexamethasone|dexamethasone|mesh-list
110175924|NCT04711213|Dexamethasone acetate|dexamethasone acetate|mesh-list
110175925|NCT04711213|BB 1101|bb 1101|mesh-list
110175926|NCT04711213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110175927|NCT04711213|Antiemetics|antiemetics|mesh-ancestor
110175928|NCT04711213|Autonomic Agents|autonomic agents|mesh-ancestor
110175929|NCT04711213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110175930|NCT04711213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110175931|NCT04711213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110175933|NCT04711213|Hormones|hormones|mesh-ancestor
110194110|NCT00070161|Donepezil|donepezil|mesh-list
110175934|NCT04711213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110175935|NCT04711213|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110175936|NCT04711213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110175937|NCT04711213|Protease Inhibitors|protease inhibitors|mesh-ancestor
110175938|NCT04711213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110175939|NCT04711213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110175940|NCT00078247|Lamivudine|lamivudine|mesh-list
110175941|NCT00078247|Zidovudine|zidovudine|mesh-list
110175942|NCT00078247|Abacavir|abacavir|mesh-list
110175943|NCT00078247|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110175944|NCT00078247|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110175945|NCT00078247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110194162|NCT00070278|Gemcitabine|gemcitabine|mesh-list
110175946|NCT00078247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110175947|NCT00078247|Antiviral Agents|antiviral agents|mesh-ancestor
110175948|NCT00078247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110175949|NCT00078247|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110175950|NCT00078247|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110175951|NCT00078247|Antimetabolites|antimetabolites|mesh-ancestor
110175953|NCT00078442|Interferon-alpha|interferon-alpha|mesh-list
110175955|NCT00078442|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110175956|NCT00078442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110175957|NCT00078442|Antiviral Agents|antiviral agents|mesh-ancestor
110175958|NCT00078442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110175959|NCT00078442|Immunologic Factors|immunologic factors|mesh-ancestor
110175960|NCT00078442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110175961|NCT00078481|Idebenone|idebenone|mesh-list
110175962|NCT00078481|Antioxidants|antioxidants|mesh-ancestor
110175963|NCT00078481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110175964|NCT00078481|Protective Agents|protective agents|mesh-ancestor
110175965|NCT00078481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110175966|NCT00078598|Rituximab|rituximab|mesh-list
110175967|NCT00078598|Tositumomab I-131|tositumomab i-131|mesh-list
110175968|NCT00078598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110175969|NCT00078598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110175970|NCT00078598|Immunologic Factors|immunologic factors|mesh-ancestor
110175971|NCT00078598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110175972|NCT00078598|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110175974|NCT00078793|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110175975|NCT00078793|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110175978|NCT00078793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110175979|NCT00078793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110175980|NCT00078793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110175981|NCT00078793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110175982|NCT00078793|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110175983|NCT00078793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110175984|NCT00078793|Immunologic Factors|immunologic factors|mesh-ancestor
110175985|NCT00078832|Anastrozole|anastrozole|mesh-list
110175986|NCT00078832|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110175987|NCT00078832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110175988|NCT00078832|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110175989|NCT00078832|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110175990|NCT00078832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110175991|NCT00078832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110175992|NCT00078832|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110175994|NCT00078832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110175995|NCT00078832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110175996|NCT01350128|Bromides|bromides|mesh-list
110175997|NCT01350128|Ipratropium|ipratropium|mesh-list
110175998|NCT01350128|Anticonvulsants|anticonvulsants|mesh-ancestor
110175999|NCT01350128|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110176000|NCT01350128|Autonomic Agents|autonomic agents|mesh-ancestor
110176001|NCT01350128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110176002|NCT01350128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110176003|NCT01350128|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110176004|NCT01350128|Respiratory System Agents|respiratory system agents|mesh-ancestor
110176005|NCT01350128|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110176007|NCT01350128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110194405|NCT04732598|Paclitaxel|paclitaxel|mesh-list
110176008|NCT01350128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110176010|NCT00078910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110176011|NCT00078910|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110176012|NCT00078910|Protective Agents|protective agents|mesh-ancestor
110176013|NCT00078910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110176014|NCT00078910|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110176016|NCT00078910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110176017|NCT00078910|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110176018|NCT00078910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110176019|NCT00078910|Analgesics|analgesics|mesh-ancestor
110176021|NCT00078910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110176022|NCT00078910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110176023|NCT00078910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110176024|NCT00078988|Carboplatin|carboplatin|mesh-list
110176025|NCT00078988|Etoposide|etoposide|mesh-list
110176026|NCT00078988|Thiotepa|thiotepa|mesh-list
110176027|NCT00078988|Isotretinoin|isotretinoin|mesh-list
110176028|NCT00078988|Lenograstim|lenograstim|mesh-list
110176029|NCT00078988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110176030|NCT00078988|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110276071|NCT04306393|Gasotransmitters|gasotransmitters|mesh-ancestor
110176031|NCT00078988|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110176032|NCT00078988|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110176033|NCT00078988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110176034|NCT00078988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110176035|NCT00078988|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110176036|NCT00078988|Immunologic Factors|immunologic factors|mesh-ancestor
110176037|NCT00078988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110176038|NCT00078988|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110176039|NCT00078988|Alkylating Agents|alkylating agents|mesh-ancestor
110176040|NCT00078988|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110176041|NCT00078988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110176042|NCT00078988|Dermatologic Agents|dermatologic agents|mesh-ancestor
110176043|NCT00079027|Doxorubicin|doxorubicin|mesh-list
110176044|NCT00079027|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110176045|NCT00079027|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110176046|NCT00079027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110176047|NCT00079027|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110176048|NCT00079027|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110176049|NCT00079027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110176050|NCT00079027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110176051|NCT00079105|Prednisolone|prednisolone|mesh-list
110176052|NCT00079105|Cyclophosphamide|cyclophosphamide|mesh-list
110176053|NCT00079105|Etoposide|etoposide|mesh-list
110176054|NCT00079105|Vincristine|vincristine|mesh-list
110176055|NCT00079105|Mitoxantrone|mitoxantrone|mesh-list
110176057|NCT00079105|Vinblastine|vinblastine|mesh-list
110176058|NCT00079105|Procarbazine|procarbazine|mesh-list
110176059|NCT00079105|Prednisolone phosphate|prednisolone phosphate|mesh-list
110176060|NCT00079105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110176061|NCT00079105|Immunologic Factors|immunologic factors|mesh-ancestor
110176062|NCT00079105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110176063|NCT00079105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110176064|NCT00079105|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110176065|NCT00079105|Alkylating Agents|alkylating agents|mesh-ancestor
110176066|NCT00079105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110176067|NCT00079105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110176068|NCT00079105|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110176069|NCT00079105|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110176070|NCT00079105|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110176071|NCT00079105|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110176072|NCT00079105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110176073|NCT00079105|Tubulin Modulators|tubulin modulators|mesh-ancestor
110176075|NCT00079105|Mitosis Modulators|mitosis modulators|mesh-ancestor
110176076|NCT00079105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110176077|NCT00079105|Glucocorticoids|glucocorticoids|mesh-ancestor
110176079|NCT00079105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110176080|NCT00079105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110176081|NCT00079105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110176083|NCT00079105|Sensory System Agents|sensory system agents|mesh-ancestor
110176084|NCT00079105|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110176085|NCT03647124|Lenalidomide|lenalidomide|mesh-list
110176086|NCT03647124|Immunologic Factors|immunologic factors|mesh-ancestor
110176087|NCT03647124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110176088|NCT03647124|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110176089|NCT03647124|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110176090|NCT03647124|Growth Substances|growth substances|mesh-ancestor
110176091|NCT03647124|Growth Inhibitors|growth inhibitors|mesh-ancestor
110176092|NCT03647124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110176093|NCT00079144|Aldesleukin|aldesleukin|mesh-list
110194618|NCT00071448|Insulin|insulin|mesh-list
110176094|NCT00079144|Cyclophosphamide|cyclophosphamide|mesh-list
110176095|NCT00079144|Fludarabine|fludarabine|mesh-list
110176096|NCT00079144|Fludarabine phosphate|fludarabine phosphate|mesh-list
110176097|NCT00079144|Freund's Adjuvant|freund's adjuvant|mesh-list
110176098|NCT00079144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110176099|NCT00079144|Immunologic Factors|immunologic factors|mesh-ancestor
110176100|NCT00079144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110176101|NCT00079144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110176102|NCT00079144|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110176103|NCT00079144|Alkylating Agents|alkylating agents|mesh-ancestor
110176104|NCT00079144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110176105|NCT00079144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110176106|NCT00079144|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110176107|NCT00079144|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110176108|NCT00079144|Antimetabolites|antimetabolites|mesh-ancestor
110176109|NCT00079144|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110176110|NCT00079144|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110176111|NCT00079144|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110176112|NCT00079144|Antiviral Agents|antiviral agents|mesh-ancestor
110176113|NCT00079144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110176114|NCT00079222|Itraconazole|itraconazole|mesh-list
110176116|NCT00079222|Antifungal Agents|antifungal agents|mesh-ancestor
110176117|NCT00079222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110176118|NCT00079222|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110176119|NCT00079222|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110176120|NCT00079222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110176121|NCT00079222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110176122|NCT00079222|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110176123|NCT00079222|Hormone Antagonists|hormone antagonists|mesh-ancestor
110176124|NCT00079222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110176125|NCT00079222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110176126|NCT00079222|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110176128|NCT00079261|Cyclophosphamide|cyclophosphamide|mesh-list
110176129|NCT00079261|Gemcitabine|gemcitabine|mesh-list
110176130|NCT00079261|Doxorubicin|doxorubicin|mesh-list
110176131|NCT00079261|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110176132|NCT00079261|Vincristine|vincristine|mesh-list
110176133|NCT00079261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110176134|NCT00079261|Immunologic Factors|immunologic factors|mesh-ancestor
110176135|NCT00079261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110176137|NCT00079261|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110176138|NCT00079261|Alkylating Agents|alkylating agents|mesh-ancestor
110176139|NCT00079261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110176140|NCT00079261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110176141|NCT00079261|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110176142|NCT00079261|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110176144|NCT00079261|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110176145|NCT00079261|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110176146|NCT00079261|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110176147|NCT00079261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110176148|NCT00079261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110176149|NCT00079261|Glucocorticoids|glucocorticoids|mesh-ancestor
110176151|NCT00079261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110176153|NCT00079261|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110176154|NCT00079261|Tubulin Modulators|tubulin modulators|mesh-ancestor
110176155|NCT00079261|Antimitotic Agents|antimitotic agents|mesh-ancestor
110176156|NCT00079261|Mitosis Modulators|mitosis modulators|mesh-ancestor
110176158|NCT00079300|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110176159|NCT00079300|Immunologic Factors|immunologic factors|mesh-ancestor
110176160|NCT00079300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110176161|NCT00079300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110176164|NCT00079378|Azacitidine|azacitidine|mesh-list
110176165|NCT00079378|Valproic Acid|valproic acid|mesh-list
110176166|NCT00079378|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110176167|NCT00079378|Antimetabolites|antimetabolites|mesh-ancestor
110176168|NCT00079378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110176170|NCT00079378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110176172|NCT00079378|GABA Agents|gaba agents|mesh-ancestor
110176173|NCT00079378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110176174|NCT00079378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110176175|NCT00079378|Antimanic Agents|antimanic agents|mesh-ancestor
110176176|NCT00079378|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110176177|NCT00079378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110176178|NCT00079378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110285529|NCT00208208|Dopamine Agents|dopamine agents|mesh-ancestor
110176179|NCT00079456|Sirolimus|sirolimus|mesh-list
110176180|NCT00079456|Temsirolimus|temsirolimus|mesh-list
110176181|NCT00079456|MTOR Inhibitors|mtor inhibitors|mesh-list
110176182|NCT00079456|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110176183|NCT00079456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110176184|NCT00079456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110176185|NCT00079456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110176186|NCT00079456|Immunologic Factors|immunologic factors|mesh-ancestor
110176187|NCT00079456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110176188|NCT00079456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110176189|NCT00079456|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110176190|NCT00079456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110176191|NCT00079456|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110176192|NCT00079456|Antifungal Agents|antifungal agents|mesh-ancestor
110176193|NCT04467086|Propranolol|propranolol|mesh-list
110194966|NCT00071994|Gefitinib|gefitinib|mesh-list
110176194|NCT04467086|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110176196|NCT04467086|Adrenergic Agents|adrenergic agents|mesh-ancestor
110176197|NCT04467086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110176198|NCT04467086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110176199|NCT04467086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110176200|NCT04467086|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110176201|NCT04467086|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110176202|NCT04467086|Vasodilator Agents|vasodilator agents|mesh-ancestor
110176204|NCT00079612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110176205|NCT00079612|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110176206|NCT00079612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110176207|NCT00079612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110176208|NCT03526107|Theobromine|theobromine|mesh-list
110176209|NCT03526107|Caffeine|caffeine|mesh-list
110176210|NCT03526107|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110176211|NCT03526107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110176212|NCT03526107|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110176213|NCT03526107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110176214|NCT03526107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110176215|NCT03526107|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110176216|NCT03526107|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110176217|NCT03526107|Purinergic Agents|purinergic agents|mesh-ancestor
110176218|NCT03526107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110176219|NCT03526107|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110176220|NCT03526107|Autonomic Agents|autonomic agents|mesh-ancestor
110176221|NCT03526107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110176222|NCT03526107|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110176223|NCT03526107|Respiratory System Agents|respiratory system agents|mesh-ancestor
110176224|NCT03526107|Vasodilator Agents|vasodilator agents|mesh-ancestor
110176225|NCT00079768|Alemtuzumab|alemtuzumab|mesh-list
110176227|NCT00079768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110176228|NCT00079807|Thioctic Acid|thioctic acid|mesh-list
110176229|NCT00079807|Antioxidants|antioxidants|mesh-ancestor
110176230|NCT00079807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110176231|NCT00079807|Protective Agents|protective agents|mesh-ancestor
110176232|NCT00079807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110176233|NCT00079807|Vitamin B Complex|vitamin b complex|mesh-ancestor
110176234|NCT00079807|Vitamins|vitamins|mesh-ancestor
110176235|NCT00079807|Micronutrients|micronutrients|mesh-ancestor
110176236|NCT00079885|Tigecycline|tigecycline|mesh-list
110176237|NCT00079885|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110176238|NCT00079885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110176239|NCT00079885|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110176240|NCT00079885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110176241|NCT00079885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110176243|NCT00079924|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
110176244|NCT00079924|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110176245|NCT00079924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110176246|NCT00079924|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110176247|NCT00079924|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110176248|NCT00079924|Hormone Antagonists|hormone antagonists|mesh-ancestor
110176249|NCT00079924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110176250|NCT00079924|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110176251|NCT00079924|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110176254|NCT00079963|Micronutrients|micronutrients|mesh-ancestor
110176255|NCT00079963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110176256|NCT00079963|Antioxidants|antioxidants|mesh-ancestor
110176257|NCT00079963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110176258|NCT00079963|Protective Agents|protective agents|mesh-ancestor
110176259|NCT00392886|Cyclophosphamide|cyclophosphamide|mesh-list
110176260|NCT00392886|Temozolomide|temozolomide|mesh-list
110176262|NCT00392886|Carboplatin|carboplatin|mesh-list
110176263|NCT00392886|Methotrexate|methotrexate|mesh-list
110176264|NCT00392886|Etoposide|etoposide|mesh-list
110176265|NCT00392886|Vincristine|vincristine|mesh-list
110195114|NCT00072150|Bortezomib|bortezomib|mesh-list
110176266|NCT00392886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110176267|NCT00392886|Immunologic Factors|immunologic factors|mesh-ancestor
110176268|NCT00392886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110176269|NCT00392886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110176270|NCT00392886|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110176271|NCT00392886|Alkylating Agents|alkylating agents|mesh-ancestor
110176272|NCT00392886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110176273|NCT00392886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110176274|NCT00392886|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110176275|NCT00392886|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110176276|NCT00392886|Abortifacient Agents|abortifacient agents|mesh-ancestor
110176277|NCT00392886|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110176278|NCT00392886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110176280|NCT00392886|Dermatologic Agents|dermatologic agents|mesh-ancestor
110176281|NCT00392886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110176282|NCT00392886|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110176283|NCT00392886|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110176284|NCT00392886|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110176285|NCT00392886|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110176286|NCT00392886|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110176287|NCT00392886|Tubulin Modulators|tubulin modulators|mesh-ancestor
110176288|NCT00392886|Antimitotic Agents|antimitotic agents|mesh-ancestor
110176289|NCT00392886|Mitosis Modulators|mitosis modulators|mesh-ancestor
110176290|NCT00080041|Motexafin gadolinium|motexafin gadolinium|mesh-list
110176291|NCT00080041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110176292|NCT00080041|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110176293|NCT00080041|Dermatologic Agents|dermatologic agents|mesh-ancestor
110176294|NCT00080080|Docetaxel|docetaxel|mesh-list
110176296|NCT00080080|Tubulin Modulators|tubulin modulators|mesh-ancestor
110176297|NCT00080080|Antimitotic Agents|antimitotic agents|mesh-ancestor
110176298|NCT00080080|Mitosis Modulators|mitosis modulators|mesh-ancestor
110176299|NCT00080080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110176300|NCT00080158|Mirtazapine|mirtazapine|mesh-list
110176302|NCT00080158|Bupropion|bupropion|mesh-list
110176303|NCT00080158|Fluoxetine|fluoxetine|mesh-list
110176304|NCT00080158|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
110176305|NCT00080158|Sertraline|sertraline|mesh-list
110176306|NCT00080158|Escitalopram|escitalopram|mesh-list
110176307|NCT00080158|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110176308|NCT00080158|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110176309|NCT00080158|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110176310|NCT00080158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110176311|NCT00080158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110176312|NCT00080158|Serotonin Agents|serotonin agents|mesh-ancestor
110176313|NCT00080158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110176314|NCT00080158|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110176315|NCT00080158|Antidepressive Agents|antidepressive agents|mesh-ancestor
110176316|NCT00080158|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110176317|NCT00080158|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110176319|NCT00080158|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110176320|NCT00080158|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110176321|NCT00080158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110176322|NCT00080158|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110176323|NCT00080158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110285534|NCT01085812|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110176324|NCT00080158|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110176325|NCT00080158|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110176326|NCT00080158|Histamine Antagonists|histamine antagonists|mesh-ancestor
110176328|NCT00080158|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110176329|NCT00080158|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
110176330|NCT00080158|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110176331|NCT00080158|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110176332|NCT00080158|Adrenergic Agents|adrenergic agents|mesh-ancestor
110176333|NCT00080158|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110176334|NCT00080158|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110176335|NCT00080158|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110176336|NCT00080197|N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|mesh-list
110176337|NCT00080197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110176338|NCT00080197|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110176339|NCT00080197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110176340|NCT00080197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110176342|NCT00080275|Simvastatin|simvastatin|mesh-list
110176343|NCT00080275|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110176344|NCT00080275|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110176345|NCT00080275|Antimetabolites|antimetabolites|mesh-ancestor
110176346|NCT00080275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110176347|NCT00080275|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110176348|NCT00080275|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110176349|NCT00080275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110176350|NCT00080275|Vasodilator Agents|vasodilator agents|mesh-ancestor
110176351|NCT00080275|Vitamin B Complex|vitamin b complex|mesh-ancestor
110176352|NCT00080275|Vitamins|vitamins|mesh-ancestor
110176353|NCT00080275|Micronutrients|micronutrients|mesh-ancestor
110176354|NCT00080275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110176356|NCT00393003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110176357|NCT00393003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110176359|NCT00080314|Antidepressive Agents|antidepressive agents|mesh-ancestor
110176360|NCT00080314|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110176361|NCT00080314|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110176362|NCT00080314|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110176363|NCT00080314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110176364|NCT00080314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110176365|NCT00080314|Dopamine Agonists|dopamine agonists|mesh-ancestor
110176367|NCT00080314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110176368|NCT00080314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110176369|NCT00080314|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110176370|NCT00080314|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110176371|NCT00080314|Serotonin Agents|serotonin agents|mesh-ancestor
110176372|NCT00080314|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110176373|NCT00080314|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110176374|NCT00080314|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110176375|NCT00080314|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110176376|NCT00080353|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
110176377|NCT00080353|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110176378|NCT00080353|Immunologic Factors|immunologic factors|mesh-ancestor
110176379|NCT00080353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110176380|NCT00080431|Daclizumab|daclizumab|mesh-list
110176381|NCT00080431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110176382|NCT00080431|Immunologic Factors|immunologic factors|mesh-ancestor
110176383|NCT00080431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110176385|NCT00080509|Tubulin Modulators|tubulin modulators|mesh-ancestor
110176386|NCT00080509|Antimitotic Agents|antimitotic agents|mesh-ancestor
110176387|NCT00080509|Mitosis Modulators|mitosis modulators|mesh-ancestor
110176388|NCT00080509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110176389|NCT00080509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110176390|NCT03506373|Ixazomib|ixazomib|mesh-list
110176391|NCT03506373|Glycine|glycine|mesh-list
110176392|NCT03506373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110176393|NCT03506373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110176394|NCT03506373|Protease Inhibitors|protease inhibitors|mesh-ancestor
110176395|NCT03506373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110176396|NCT03506373|Glycine Agents|glycine agents|mesh-ancestor
110176397|NCT03506373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110176398|NCT03506373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110176399|NCT02972411|Acetazolamide|acetazolamide|mesh-list
110176400|NCT02972411|Anticonvulsants|anticonvulsants|mesh-ancestor
110176401|NCT02972411|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
110176402|NCT02972411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110176403|NCT02972411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110176405|NCT02972411|Natriuretic Agents|natriuretic agents|mesh-ancestor
110176406|NCT02972411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110176408|NCT00080626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110176409|NCT00080626|Tubulin Modulators|tubulin modulators|mesh-ancestor
110176410|NCT00080626|Antimitotic Agents|antimitotic agents|mesh-ancestor
110176411|NCT00080626|Mitosis Modulators|mitosis modulators|mesh-ancestor
110176412|NCT00080626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110176414|NCT00080665|Imatinib Mesylate|imatinib mesylate|mesh-list
110176415|NCT00080665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110176416|NCT00080665|Tubulin Modulators|tubulin modulators|mesh-ancestor
110176417|NCT00080665|Antimitotic Agents|antimitotic agents|mesh-ancestor
110176418|NCT00080665|Mitosis Modulators|mitosis modulators|mesh-ancestor
110176419|NCT00080665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110195433|NCT00411268|Analgesics|analgesics|mesh-ancestor
110176420|NCT00080665|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110176421|NCT00080665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110176424|NCT00080743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110176425|NCT00080743|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110176426|NCT00080743|Hormone Antagonists|hormone antagonists|mesh-ancestor
110176427|NCT00080743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110176428|NCT00080743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110176429|NCT00080743|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110176430|NCT00080743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110176431|NCT00080743|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110176432|NCT00080743|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110176433|NCT00080743|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110176434|NCT00080743|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110176435|NCT00080743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110176436|NCT04423367|Dexamethasone|dexamethasone|mesh-list
110176437|NCT04423367|Bortezomib|bortezomib|mesh-list
110176438|NCT04423367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110176439|NCT04423367|Antiemetics|antiemetics|mesh-ancestor
110176440|NCT04423367|Autonomic Agents|autonomic agents|mesh-ancestor
110176441|NCT04423367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110176442|NCT04423367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110176443|NCT04423367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110176444|NCT04423367|Glucocorticoids|glucocorticoids|mesh-ancestor
110176445|NCT04423367|Hormones|hormones|mesh-ancestor
110176446|NCT04423367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110176447|NCT04423367|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110176449|NCT00080782|Celecoxib|celecoxib|mesh-list
110176450|NCT00080782|Doxorubicin|doxorubicin|mesh-list
110176451|NCT00080782|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110176452|NCT00080782|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110176453|NCT00080782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110176454|NCT00080782|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110176455|NCT00080782|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110176456|NCT00080782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110176457|NCT00080782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110176458|NCT00080782|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110176460|NCT00080782|Analgesics|analgesics|mesh-ancestor
110176461|NCT00080782|Sensory System Agents|sensory system agents|mesh-ancestor
110176462|NCT00080782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110176463|NCT00080782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110176464|NCT00080782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110176465|NCT00080782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110176466|NCT00080782|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110176467|NCT00080782|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110176468|NCT00080860|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
110176469|NCT00080860|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110176470|NCT00080860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110176471|NCT00080977|Aldesleukin|aldesleukin|mesh-list
110195607|NCT00207532|Micronutrients|micronutrients|mesh-ancestor
110176472|NCT00080977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110176473|NCT00080977|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110176474|NCT00080977|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110176475|NCT00080977|Antiviral Agents|antiviral agents|mesh-ancestor
110176476|NCT00080977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110176477|NCT00081055|Cyclosporine|cyclosporine|mesh-list
110176478|NCT00081055|Cyclophosphamide|cyclophosphamide|mesh-list
110176480|NCT00081055|Methotrexate|methotrexate|mesh-list
110176481|NCT00081055|Cyclosporins|cyclosporins|mesh-list
110176482|NCT00081055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110176483|NCT00081055|Immunologic Factors|immunologic factors|mesh-ancestor
110176484|NCT00081055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110176485|NCT00081055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110176486|NCT00081055|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110176487|NCT00081055|Alkylating Agents|alkylating agents|mesh-ancestor
110176488|NCT00081055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110176489|NCT00081055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110176490|NCT00081055|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110176491|NCT00081055|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110176492|NCT00081055|Abortifacient Agents|abortifacient agents|mesh-ancestor
110176493|NCT00081055|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110176494|NCT00081055|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110176495|NCT00081055|Antimetabolites|antimetabolites|mesh-ancestor
110176496|NCT00081055|Dermatologic Agents|dermatologic agents|mesh-ancestor
110176497|NCT00081055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110176498|NCT00081055|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110176499|NCT00081055|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110176500|NCT00081055|Antifungal Agents|antifungal agents|mesh-ancestor
110176501|NCT00081055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110176502|NCT00081055|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110176503|NCT00081094|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110176504|NCT00081094|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110176505|NCT00081094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110176506|NCT00081133|Imatinib Mesylate|imatinib mesylate|mesh-list
110176507|NCT00081133|Arsenic Trioxide|arsenic trioxide|mesh-list
110176508|NCT00081133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110176509|NCT00081133|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110176510|NCT00081133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110176511|NCT00081133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110176512|NCT00081172|Antibodies|antibodies|mesh-list
110176513|NCT00081172|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110176514|NCT00081172|Immunologic Factors|immunologic factors|mesh-ancestor
110176515|NCT00081172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110176516|NCT03187080|Bupivacaine|bupivacaine|mesh-list
110176517|NCT03187080|Anesthetics, Local|anesthetics, local|mesh-list
110176518|NCT03187080|Anesthetics|anesthetics|mesh-list
110176519|NCT03187080|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110195794|NCT00208273|Letrozole|letrozole|mesh-list
110176520|NCT03187080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110176521|NCT03187080|Sensory System Agents|sensory system agents|mesh-ancestor
110176522|NCT03187080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110176523|NCT00081484|Epoetin Alfa|epoetin alfa|mesh-list
110176524|NCT00081484|Hematinics|hematinics|mesh-ancestor
110176525|NCT00390260|Acetaminophen|acetaminophen|mesh-list
110176526|NCT00390260|Rofecoxib|rofecoxib|mesh-list
110176527|NCT00390260|Hydrocodone|hydrocodone|mesh-list
110176528|NCT00390260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110176529|NCT00390260|Analgesics|analgesics|mesh-ancestor
110176530|NCT00390260|Sensory System Agents|sensory system agents|mesh-ancestor
110176531|NCT00390260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110176532|NCT00390260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110176533|NCT00390260|Antipyretics|antipyretics|mesh-ancestor
110176534|NCT00390260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110176535|NCT00390260|Respiratory System Agents|respiratory system agents|mesh-ancestor
110176536|NCT00390260|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110176537|NCT00390260|Narcotics|narcotics|mesh-ancestor
110176538|NCT00390260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110176539|NCT00390260|Antitussive Agents|antitussive agents|mesh-ancestor
110176540|NCT00390260|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110176541|NCT00390260|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110176542|NCT00390260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110176543|NCT00390260|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110176544|NCT00390260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110176545|NCT00390260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110176547|NCT00081757|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110176548|NCT00081757|Immunologic Factors|immunologic factors|mesh-ancestor
110176549|NCT00081757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110176550|NCT00081757|Leprostatic Agents|leprostatic agents|mesh-ancestor
110176551|NCT00081757|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110176552|NCT00081757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110176553|NCT00081757|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110176554|NCT00081757|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110176555|NCT00081757|Growth Substances|growth substances|mesh-ancestor
110176556|NCT00081757|Growth Inhibitors|growth inhibitors|mesh-ancestor
110176557|NCT00081757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110176560|NCT00081796|Antimetabolites|antimetabolites|mesh-ancestor
110176561|NCT00081796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110176562|NCT00081796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110176563|NCT03152175|Propranolol|propranolol|mesh-list
110176564|NCT03152175|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110176565|NCT03152175|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110176566|NCT03152175|Adrenergic Agents|adrenergic agents|mesh-ancestor
110176567|NCT03152175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110176568|NCT03152175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110176569|NCT03152175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110176570|NCT03152175|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110176571|NCT03152175|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110176572|NCT03152175|Vasodilator Agents|vasodilator agents|mesh-ancestor
110176573|NCT00399685|Efavirenz|efavirenz|mesh-list
110176574|NCT00399685|Moxifloxacin|moxifloxacin|mesh-list
110196026|NCT00041093|Mitosis Modulators|mitosis modulators|mesh-ancestor
110176575|NCT00399685|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
110176576|NCT00399685|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110176578|NCT00399685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110176579|NCT00399685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110176580|NCT00399685|Antiviral Agents|antiviral agents|mesh-ancestor
110176581|NCT00399685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110176582|NCT00399685|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110176583|NCT00399685|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110176584|NCT00399685|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110176585|NCT00399685|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110176586|NCT00399685|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110176587|NCT00399685|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110176588|NCT00399685|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110176589|NCT00399685|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110176590|NCT00399685|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110176591|NCT00399685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110176592|NCT00399685|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110176593|NCT00399685|Contraceptive Agents|contraceptive agents|mesh-ancestor
110176594|NCT00399685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110176595|NCT00399685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110176596|NCT00399685|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
110176597|NCT00399685|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110176598|NCT00399685|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110176599|NCT00081835|Immunoglobulins|immunoglobulins|mesh-list
110176600|NCT00081835|Antibodies|antibodies|mesh-list
110176601|NCT00081835|gamma-Globulins|gamma-globulins|mesh-list
110176602|NCT00081835|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110176603|NCT00081835|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110176604|NCT00081835|Immunologic Factors|immunologic factors|mesh-ancestor
110176605|NCT00081835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110176607|NCT00081874|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
110176608|NCT00081874|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110176609|NCT00081874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110176610|NCT00081874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110176611|NCT00081874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110176612|NCT00081874|Immunologic Factors|immunologic factors|mesh-ancestor
110176613|NCT00081874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110176614|NCT00081874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110176615|NCT03152097|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
110176616|NCT03152097|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110176618|NCT03152097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110176619|NCT03152097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110176620|NCT00082186|Bosentan|bosentan|mesh-list
110176621|NCT00082186|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110176622|NCT00082186|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
110176623|NCT00082186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110176625|NCT00082225|Immunologic Factors|immunologic factors|mesh-ancestor
110176626|NCT00082225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110176627|NCT00082537|Caspofungin|caspofungin|mesh-list
110176628|NCT00082537|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
110176629|NCT00082537|Antifungal Agents|antifungal agents|mesh-ancestor
110176630|NCT00082537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110176631|NCT00082537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110176632|NCT00082537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110176633|NCT00082537|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110176634|NCT00082537|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110176635|NCT00082576|Azithromycin|azithromycin|mesh-list
110176636|NCT00082576|Chloroquine|chloroquine|mesh-list
110176637|NCT00082576|Mefloquine|mefloquine|mesh-list
110176638|NCT00082576|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110176639|NCT00082576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110176640|NCT00082576|Amebicides|amebicides|mesh-ancestor
110176641|NCT00082576|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110176643|NCT00082576|Antimalarials|antimalarials|mesh-ancestor
110176644|NCT00082576|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110176645|NCT00082927|Ibandronic Acid|ibandronic acid|mesh-list
110176646|NCT00082927|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110176647|NCT00082927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110176650|NCT00083005|Thalidomide|thalidomide|mesh-list
110176651|NCT00083005|Docetaxel|docetaxel|mesh-list
110176652|NCT00083005|Estramustine|estramustine|mesh-list
110176653|NCT00083005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110176654|NCT00083005|Tubulin Modulators|tubulin modulators|mesh-ancestor
110176655|NCT00083005|Antimitotic Agents|antimitotic agents|mesh-ancestor
110176656|NCT00083005|Mitosis Modulators|mitosis modulators|mesh-ancestor
110176657|NCT00083005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110176658|NCT00083005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110176659|NCT00083005|Immunologic Factors|immunologic factors|mesh-ancestor
110176660|NCT00083005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110176661|NCT00083005|Leprostatic Agents|leprostatic agents|mesh-ancestor
110196399|NCT00210847|Acetaminophen|acetaminophen|mesh-list
110176662|NCT00083005|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110176663|NCT00083005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110176664|NCT00083005|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110176665|NCT00083005|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110176666|NCT00083005|Growth Substances|growth substances|mesh-ancestor
110176667|NCT00083005|Growth Inhibitors|growth inhibitors|mesh-ancestor
110176668|NCT00083005|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110176669|NCT00083005|Alkylating Agents|alkylating agents|mesh-ancestor
110176670|NCT00083005|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110176671|NCT00083083|Paclitaxel|paclitaxel|mesh-list
110176672|NCT00083083|Etoposide|etoposide|mesh-list
110176673|NCT00083083|Vinorelbine|vinorelbine|mesh-list
110176674|NCT00083083|Vinblastine|vinblastine|mesh-list
110176675|NCT00083083|Docetaxel|docetaxel|mesh-list
110176676|NCT00083083|Carboplatin|carboplatin|mesh-list
110176677|NCT00083083|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110176678|NCT00083083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110176679|NCT00083083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110176680|NCT00083083|Tubulin Modulators|tubulin modulators|mesh-ancestor
110176681|NCT00083083|Antimitotic Agents|antimitotic agents|mesh-ancestor
110176682|NCT00083083|Mitosis Modulators|mitosis modulators|mesh-ancestor
110176684|NCT00083083|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110176685|NCT00083083|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110176686|NCT00083083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110176687|NCT00083083|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110176688|NCT03151863|Dexmedetomidine|dexmedetomidine|mesh-list
110176689|NCT03151863|Analgesics, Opioid|analgesics, opioid|mesh-list
110176690|NCT03151863|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110176691|NCT03151863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110176692|NCT03151863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110176693|NCT03151863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110176694|NCT03151863|Analgesics|analgesics|mesh-ancestor
110176695|NCT03151863|Sensory System Agents|sensory system agents|mesh-ancestor
110176696|NCT03151863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110176697|NCT03151863|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110176698|NCT03151863|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110176700|NCT03151863|Adrenergic Agents|adrenergic agents|mesh-ancestor
110176701|NCT03151863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110176702|NCT03151863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110176704|NCT00083161|Cyclophosphamide|cyclophosphamide|mesh-list
110176706|NCT00083161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110176707|NCT00083161|Immunologic Factors|immunologic factors|mesh-ancestor
110176708|NCT00083161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110176709|NCT00083161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110176710|NCT00083161|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110176711|NCT00083161|Alkylating Agents|alkylating agents|mesh-ancestor
110176712|NCT00083161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110176713|NCT00083161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110176714|NCT00083161|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110176715|NCT00083161|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110176716|NCT00083161|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110176717|NCT00083161|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110176719|NCT00083278|Ipilimumab|ipilimumab|mesh-list
110176720|NCT00083278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110176721|NCT00083278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110176722|NCT00083278|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110176723|NCT00083278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110176724|NCT00083434|Epoetin Alfa|epoetin alfa|mesh-list
110176725|NCT00083434|Hematinics|hematinics|mesh-ancestor
110176726|NCT00083590|Huperzine A|huperzine a|mesh-list
110176727|NCT00083590|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110176728|NCT00083590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110176729|NCT00083590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110176730|NCT00083590|Cholinergic Agents|cholinergic agents|mesh-ancestor
110176731|NCT00083590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110176732|NCT00083590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110176733|NCT00083590|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110176734|NCT00083590|Protective Agents|protective agents|mesh-ancestor
110176736|NCT03151746|Analgesics|analgesics|mesh-ancestor
110176737|NCT03151746|Sensory System Agents|sensory system agents|mesh-ancestor
110176738|NCT03151746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110176739|NCT03151746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110176740|NCT03151746|Anticonvulsants|anticonvulsants|mesh-ancestor
110176741|NCT03151746|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110176742|NCT03151746|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110176743|NCT03151746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110176744|NCT03151746|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110176745|NCT03151746|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110176746|NCT03151746|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110176747|NCT03151746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110176748|NCT03151746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110176749|NCT03151746|Antimanic Agents|antimanic agents|mesh-ancestor
110176750|NCT00399724|Insulin Glargine|insulin glargine|mesh-list
110176751|NCT00399724|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110176752|NCT00399724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110176753|NCT00083668|Paliperidone Palmitate|paliperidone palmitate|mesh-list
110176754|NCT00083668|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110176755|NCT00083668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110176756|NCT00083668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110176757|NCT00083668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110176758|NCT00083668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110176759|NCT00083668|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110176760|NCT00083668|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110176761|NCT00083668|Serotonin Agents|serotonin agents|mesh-ancestor
110176762|NCT00083668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110176763|NCT00083668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110176764|NCT00083668|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110196656|NCT00213694|Analgesics|analgesics|mesh-ancestor
110176765|NCT00083668|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110176766|NCT00083668|Dopamine Agents|dopamine agents|mesh-ancestor
110176768|NCT00083707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110176769|NCT00083707|Immunologic Factors|immunologic factors|mesh-ancestor
110176770|NCT00083707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110176771|NCT00083707|Leprostatic Agents|leprostatic agents|mesh-ancestor
110176772|NCT00083707|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110176773|NCT00083707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110176774|NCT00083707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110176775|NCT00083707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110176776|NCT00083707|Growth Substances|growth substances|mesh-ancestor
110176777|NCT00083707|Growth Inhibitors|growth inhibitors|mesh-ancestor
110176778|NCT00083707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110176780|NCT00083785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110176781|NCT00083785|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110176782|NCT00083785|Dermatologic Agents|dermatologic agents|mesh-ancestor
110176785|NCT03151707|Nicotinic Acids|nicotinic acids|mesh-list
110176786|NCT03151707|Vitamin B Complex|vitamin b complex|mesh-ancestor
110176787|NCT03151707|Vitamins|vitamins|mesh-ancestor
110176789|NCT03151707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110176790|NCT03151707|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110176792|NCT03151707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110176793|NCT03151707|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110176794|NCT03151707|Vasodilator Agents|vasodilator agents|mesh-ancestor
110176795|NCT03151668|Dexmedetomidine|dexmedetomidine|mesh-list
110176796|NCT03151668|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110176797|NCT03151668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110176798|NCT03151668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110176799|NCT03151668|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110176801|NCT03151668|Sensory System Agents|sensory system agents|mesh-ancestor
110176802|NCT03151668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110176803|NCT03151668|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110176804|NCT03151668|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110176805|NCT03151668|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110176806|NCT03151668|Adrenergic Agents|adrenergic agents|mesh-ancestor
110176807|NCT03151668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110176808|NCT03151668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110176809|NCT05568082|Itraconazole|itraconazole|mesh-list
110176811|NCT05568082|Antifungal Agents|antifungal agents|mesh-ancestor
110176812|NCT05568082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110176813|NCT05568082|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110196975|NCT00216190|Anesthetics|anesthetics|mesh-ancestor
110176814|NCT05568082|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110176815|NCT05568082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110176816|NCT05568082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110176817|NCT05568082|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110176819|NCT05568082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110176820|NCT05568082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110176821|NCT05568082|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110176822|NCT05568082|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110176823|NCT05568082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110176824|NCT05568082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110176826|NCT05567653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110176827|NCT05567653|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110176828|NCT05567653|Antimalarials|antimalarials|mesh-ancestor
110176829|NCT05567653|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110176830|NCT05567653|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110176831|NCT04733508|Exenatide|exenatide|mesh-list
110176832|NCT04733508|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110176833|NCT04733508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110176834|NCT04733508|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110176836|NCT04733508|Hormones|hormones|mesh-ancestor
110176837|NCT04733508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110176838|NCT05567536|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
110176839|NCT00135304|Vitamin D|vitamin d|mesh-list
110176840|NCT00135304|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
110176841|NCT00135304|Cinacalcet|cinacalcet|mesh-list
110176842|NCT00135304|Vitamins|vitamins|mesh-ancestor
110176843|NCT00135304|Micronutrients|micronutrients|mesh-ancestor
110176844|NCT00135304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110176845|NCT00135304|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110176846|NCT00135304|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110176848|NCT00135304|Hormone Antagonists|hormone antagonists|mesh-ancestor
110176849|NCT00135304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110176850|NCT00135499|Prednisone|prednisone|mesh-list
110176851|NCT00135499|Cyclophosphamide|cyclophosphamide|mesh-list
110176853|NCT00135499|Doxorubicin|doxorubicin|mesh-list
110176854|NCT00135499|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110176855|NCT00135499|Vincristine|vincristine|mesh-list
110176856|NCT00135499|Bleomycin|bleomycin|mesh-list
110176857|NCT00135499|Vindesine|vindesine|mesh-list
110176858|NCT00135499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110176859|NCT00135499|Immunologic Factors|immunologic factors|mesh-ancestor
110176860|NCT00135499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110176861|NCT00135499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110176863|NCT00135499|Alkylating Agents|alkylating agents|mesh-ancestor
110176864|NCT00135499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110176865|NCT00135499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110176866|NCT00135499|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110176867|NCT00135499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110176868|NCT00135499|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110176869|NCT00135499|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110176870|NCT00135499|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110176871|NCT00135499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110176872|NCT00135499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110176874|NCT00135499|Hormones|hormones|mesh-ancestor
110176875|NCT00135499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110176876|NCT00135499|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110176877|NCT00135499|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110176878|NCT00135499|Tubulin Modulators|tubulin modulators|mesh-ancestor
110176879|NCT00135499|Antimitotic Agents|antimitotic agents|mesh-ancestor
110176880|NCT00135499|Mitosis Modulators|mitosis modulators|mesh-ancestor
110176881|NCT03151434|Hydromorphone|hydromorphone|mesh-list
110176882|NCT03151434|Bupivacaine|bupivacaine|mesh-list
110176883|NCT03151434|Anesthetics, Local|anesthetics, local|mesh-ancestor
110176884|NCT03151434|Anesthetics|anesthetics|mesh-ancestor
110176885|NCT03151434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110176886|NCT03151434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110176887|NCT03151434|Sensory System Agents|sensory system agents|mesh-ancestor
110197287|NCT00218413|Vaccines|vaccines|mesh-list
110176888|NCT03151434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110176889|NCT03151434|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110176891|NCT03151434|Analgesics|analgesics|mesh-ancestor
110176892|NCT00135577|Alvimopan|alvimopan|mesh-list
110176893|NCT00135577|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110176894|NCT00135733|Alefacept|alefacept|mesh-list
110176895|NCT00135733|Dermatologic Agents|dermatologic agents|mesh-ancestor
110176896|NCT00135733|Immunologic Factors|immunologic factors|mesh-ancestor
110176897|NCT00135733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110176898|NCT04061798|Heparin|heparin|mesh-list
110176900|NCT04061798|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110176901|NCT04061798|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110176902|NCT04061798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110176906|NCT00135811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110176907|NCT00135811|Antiemetics|antiemetics|mesh-ancestor
110176909|NCT00135811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110176910|NCT00135811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110176911|NCT00135811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110176912|NCT00135811|Glucocorticoids|glucocorticoids|mesh-ancestor
110176913|NCT00135811|Hormones|hormones|mesh-ancestor
110176914|NCT00135811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110176915|NCT00135811|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110176916|NCT00135811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110176917|NCT00135811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110176918|NCT00135811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110176919|NCT00135811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110176921|NCT00135811|Antifungal Agents|antifungal agents|mesh-ancestor
110176922|NCT00135811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110176923|NCT00135811|Dermatologic Agents|dermatologic agents|mesh-ancestor
110176924|NCT00135811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110176925|NCT00135811|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110176926|NCT00135928|Lenograstim|lenograstim|mesh-list
110176927|NCT00135928|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110176928|NCT00135928|Immunologic Factors|immunologic factors|mesh-ancestor
110176929|NCT00135928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110176930|NCT00135967|Mycophenolic Acid|mycophenolic acid|mesh-list
110176931|NCT00135967|Prednisone|prednisone|mesh-list
110176932|NCT00135967|Methylprednisolone|methylprednisolone|mesh-list
110176933|NCT00135967|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110176934|NCT00135967|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110176935|NCT00135967|Prednisolone|prednisolone|mesh-list
110176936|NCT00135967|Prednisolone acetate|prednisolone acetate|mesh-list
110176937|NCT00135967|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110176938|NCT00135967|Prednisolone phosphate|prednisolone phosphate|mesh-list
110176939|NCT00135967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110176940|NCT00135967|Glucocorticoids|glucocorticoids|mesh-ancestor
110176941|NCT00135967|Hormones|hormones|mesh-ancestor
110176942|NCT00135967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110176943|NCT00135967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110176944|NCT00135967|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110176945|NCT00135967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110176946|NCT00135967|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110176947|NCT00135967|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110176948|NCT00135967|Antitubercular Agents|antitubercular agents|mesh-ancestor
110176949|NCT00135967|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110176950|NCT00135967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110176951|NCT00135967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110176952|NCT00135967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110176954|NCT00135967|Autonomic Agents|autonomic agents|mesh-ancestor
110176955|NCT00135967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110176956|NCT00135967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110176957|NCT00135967|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110176958|NCT00135967|Protective Agents|protective agents|mesh-ancestor
110176959|NCT00136045|Rotigotine|rotigotine|mesh-list
110176960|NCT00136045|Dopamine Agonists|dopamine agonists|mesh-ancestor
110176961|NCT00136045|Dopamine Agents|dopamine agents|mesh-ancestor
110176962|NCT00136045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110176963|NCT00136045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110176964|NCT00136045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110176966|NCT00136201|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110176967|NCT00136201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110176968|NCT00136201|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110176969|NCT00136201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110176970|NCT00136201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110176971|NCT03151239|Niacinamide|niacinamide|mesh-list
110176972|NCT03151239|Vitamin B Complex|vitamin b complex|mesh-ancestor
110176973|NCT03151239|Vitamins|vitamins|mesh-ancestor
110176974|NCT03151239|Micronutrients|micronutrients|mesh-ancestor
110176975|NCT03151239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110176976|NCT00136396|Rituximab|rituximab|mesh-list
110176977|NCT00136396|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110176978|NCT00136396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110176979|NCT00136396|Immunologic Factors|immunologic factors|mesh-ancestor
110176980|NCT00136396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110176981|NCT00136396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110176983|NCT00136474|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110176984|NCT00136474|Protective Agents|protective agents|mesh-ancestor
110176985|NCT00136474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110176986|NCT00136552|Rituximab|rituximab|mesh-list
110176987|NCT00136552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110176988|NCT00136552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110176989|NCT00136552|Immunologic Factors|immunologic factors|mesh-ancestor
110176990|NCT00136552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110176991|NCT00136552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110176992|NCT00136591|Bortezomib|bortezomib|mesh-list
110176993|NCT00136591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110176994|NCT03151161|Carboplatin|carboplatin|mesh-list
110176995|NCT03151161|Pemetrexed|pemetrexed|mesh-list
110176996|NCT03151161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110176997|NCT03151161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110176998|NCT03151161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110176999|NCT03151161|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110177000|NCT03151161|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110177001|NCT00404053|Clopidogrel|clopidogrel|mesh-list
110177002|NCT00404053|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110177003|NCT00404053|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110177004|NCT00404053|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110177006|NCT00404053|Purinergic Agents|purinergic agents|mesh-ancestor
110177007|NCT00404053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110177008|NCT00404053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110177009|NCT00404053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110177010|NCT03991130|Nivolumab|nivolumab|mesh-list
110177011|NCT03991130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110177012|NCT03991130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110177013|NCT03991130|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110177014|NCT03991130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110177015|NCT00136747|Memantine|memantine|mesh-list
110177016|NCT00136747|Bupropion|bupropion|mesh-list
110177017|NCT00136747|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110177018|NCT00136747|Antidepressive Agents|antidepressive agents|mesh-ancestor
110177019|NCT00136747|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110177020|NCT00136747|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110177021|NCT00136747|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110177022|NCT00136747|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110177023|NCT00136747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110177024|NCT00136747|Dopamine Agents|dopamine agents|mesh-ancestor
110177025|NCT00136747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110177026|NCT00136747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110177027|NCT00136747|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110177028|NCT00136747|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110177030|NCT00136747|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110177031|NCT00136747|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110177032|NCT00136747|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110177033|NCT00136747|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110177034|NCT00136786|Memantine|memantine|mesh-list
110177035|NCT00136786|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110177036|NCT00136786|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110177037|NCT00136786|Dopamine Agents|dopamine agents|mesh-ancestor
110177038|NCT00136786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110177039|NCT00136786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110177040|NCT00136786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110177041|NCT00136786|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110177042|NCT00136786|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110177043|NCT00136825|Acetylcysteine|acetylcysteine|mesh-list
110177044|NCT00136825|N-monoacetylcystine|n-monoacetylcystine|mesh-list
110177045|NCT00136825|Antiviral Agents|antiviral agents|mesh-ancestor
110177046|NCT00136825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110177047|NCT00136825|Expectorants|expectorants|mesh-ancestor
110177048|NCT00136825|Respiratory System Agents|respiratory system agents|mesh-ancestor
110177049|NCT00136825|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110177050|NCT00136825|Antioxidants|antioxidants|mesh-ancestor
110177051|NCT00136825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110177053|NCT00136825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110177054|NCT00136825|Antidotes|antidotes|mesh-ancestor
110177055|NCT00393198|Misoprostol|misoprostol|mesh-list
110177056|NCT00393198|Levonorgestrel|levonorgestrel|mesh-list
110177057|NCT00393198|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110177058|NCT00393198|Contraceptive Agents|contraceptive agents|mesh-ancestor
110177059|NCT00393198|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110177060|NCT00393198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110177061|NCT00393198|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110177062|NCT00393198|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110177063|NCT00393198|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110177064|NCT00393198|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110177065|NCT00393198|Abortifacient Agents|abortifacient agents|mesh-ancestor
110177066|NCT00393198|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110177067|NCT00393198|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110177068|NCT00393198|Oxytocics|oxytocics|mesh-ancestor
110177069|NCT03968822|Lidocaine|lidocaine|mesh-list
110177070|NCT03968822|Bupivacaine|bupivacaine|mesh-list
110177071|NCT03968822|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
110177072|NCT03968822|Anesthetics, Local|anesthetics, local|mesh-ancestor
110177073|NCT03968822|Anesthetics|anesthetics|mesh-ancestor
110177074|NCT03968822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110177075|NCT03968822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110177076|NCT03968822|Sensory System Agents|sensory system agents|mesh-ancestor
110177077|NCT03968822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110177078|NCT03968822|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110177079|NCT03968822|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110177080|NCT03968822|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110177081|NCT03968822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110177083|NCT00136942|Atorvastatin|atorvastatin|mesh-list
110177084|NCT00136942|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110177085|NCT00136942|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110177086|NCT00136942|Antimetabolites|antimetabolites|mesh-ancestor
110177087|NCT00136942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110177088|NCT00136942|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110177089|NCT00136942|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110177090|NCT00136942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110177091|NCT00136981|Atorvastatin|atorvastatin|mesh-list
110177092|NCT00136981|Torcetrapib|torcetrapib|mesh-list
110177093|NCT00136981|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110177094|NCT00136981|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110177095|NCT00136981|Antimetabolites|antimetabolites|mesh-ancestor
110177096|NCT00136981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110177097|NCT00136981|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110177098|NCT00136981|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110177099|NCT00136981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110177100|NCT00137020|Ziprasidone|ziprasidone|mesh-list
110177101|NCT00137020|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110177102|NCT00137020|Serotonin Agents|serotonin agents|mesh-ancestor
110177103|NCT00137020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110177104|NCT00137020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110177105|NCT00137020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110177106|NCT00137020|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110177107|NCT00137020|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110177108|NCT00137020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110177109|NCT00137020|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110177110|NCT00137020|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110177111|NCT00137020|Dopamine Agents|dopamine agents|mesh-ancestor
110177112|NCT00137059|Acetaminophen|acetaminophen|mesh-list
110177113|NCT00137059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110177114|NCT00137059|Analgesics|analgesics|mesh-ancestor
110177115|NCT00137059|Sensory System Agents|sensory system agents|mesh-ancestor
110177116|NCT00137059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110177117|NCT00137059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110177118|NCT00137059|Antipyretics|antipyretics|mesh-ancestor
110177119|NCT00137098|Caffeine|caffeine|mesh-list
110177121|NCT00137098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110177122|NCT00137098|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110177123|NCT00137098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110177124|NCT00137098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110177125|NCT00137098|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110177126|NCT00137098|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110177127|NCT00137098|Purinergic Agents|purinergic agents|mesh-ancestor
110177128|NCT00137098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110177130|NCT00137254|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110177131|NCT00137254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110177132|NCT03151044|Rituximab|rituximab|mesh-list
110177133|NCT03151044|Epirubicin|epirubicin|mesh-list
110177134|NCT03151044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110177135|NCT03151044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110177136|NCT03151044|Immunologic Factors|immunologic factors|mesh-ancestor
110177137|NCT03151044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110177138|NCT03151044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110177139|NCT03151044|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110177140|NCT03151044|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110177141|NCT03151044|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110177142|NCT03151044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110177143|NCT03151044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110177144|NCT00137410|Celecoxib|celecoxib|mesh-list
110177145|NCT00137410|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110177146|NCT00137410|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110177147|NCT00137410|Analgesics|analgesics|mesh-ancestor
110177148|NCT00137410|Sensory System Agents|sensory system agents|mesh-ancestor
110177149|NCT00137410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110177150|NCT00137410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110177151|NCT00137410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110177152|NCT00137410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110198553|NCT00127114|Amantadine|amantadine|mesh-list
110177153|NCT00137410|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110177154|NCT00137410|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110177155|NCT00137410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110177156|NCT00137410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110177158|NCT03151005|Liraglutide|liraglutide|mesh-list
110177159|NCT03151005|Exenatide|exenatide|mesh-list
110177160|NCT03151005|Contraceptive Agents|contraceptive agents|mesh-list
110177161|NCT03151005|Contraceptives, Oral|contraceptives, oral|mesh-list
110177162|NCT03151005|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110177163|NCT03151005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110177164|NCT03151005|Incretins|incretins|mesh-ancestor
110177165|NCT03151005|Hormones|hormones|mesh-ancestor
110198613|NCT00127387|Etanercept|etanercept|mesh-list
110198616|NCT00127387|Analgesics|analgesics|mesh-ancestor
110177166|NCT03151005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110177167|NCT03151005|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
110177168|NCT03151005|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110177169|NCT03151005|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110177171|NCT00137527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110177172|NCT00137527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110177173|NCT00137566|Acetaminophen|acetaminophen|mesh-list
110177174|NCT00137566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110177175|NCT00137566|Analgesics|analgesics|mesh-ancestor
110177176|NCT00137566|Sensory System Agents|sensory system agents|mesh-ancestor
110177177|NCT00137566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110177178|NCT00137566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110177180|NCT00137605|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110177181|NCT00137605|Immunologic Factors|immunologic factors|mesh-ancestor
110177182|NCT00137605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110177185|NCT00137761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110177186|NCT00137761|Tubulin Modulators|tubulin modulators|mesh-ancestor
110177187|NCT00137761|Antimitotic Agents|antimitotic agents|mesh-ancestor
110177188|NCT00137761|Mitosis Modulators|mitosis modulators|mesh-ancestor
110177189|NCT00137761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110177190|NCT00137761|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110177191|NCT00137761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110177192|NCT00137800|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110177193|NCT00137800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110177194|NCT00137800|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110177195|NCT00137800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110177196|NCT00137800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110177197|NCT00137995|Cytarabine|cytarabine|mesh-list
110177198|NCT00137995|Dexamethasone|dexamethasone|mesh-list
110177199|NCT00137995|Rituximab|rituximab|mesh-list
110177200|NCT00137995|Etoposide|etoposide|mesh-list
110177201|NCT00137995|Etoposide phosphate|etoposide phosphate|mesh-list
110177202|NCT00137995|Melphalan|melphalan|mesh-list
110177203|NCT00137995|Ifosfamide|ifosfamide|mesh-list
110177204|NCT00137995|Carboplatin|carboplatin|mesh-list
110177205|NCT00137995|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110177206|NCT00137995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110177207|NCT00137995|Immunologic Factors|immunologic factors|mesh-ancestor
110198790|NCT05561725|Hormones|hormones|mesh-ancestor
110177208|NCT00137995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110177209|NCT00137995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110177210|NCT00137995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110177212|NCT00137995|Autonomic Agents|autonomic agents|mesh-ancestor
110177213|NCT00137995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110177214|NCT00137995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110177216|NCT00137995|Hormones|hormones|mesh-ancestor
110198848|NCT05519917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110177217|NCT00137995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110177218|NCT00137995|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110177219|NCT00137995|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110177220|NCT00137995|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110177221|NCT00137995|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110177222|NCT00137995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110177223|NCT00137995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110177224|NCT00137995|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110177226|NCT00137995|Antiviral Agents|antiviral agents|mesh-ancestor
110177227|NCT00137995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110177228|NCT00137995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110177229|NCT00137995|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110177230|NCT00137995|Alkylating Agents|alkylating agents|mesh-ancestor
110177231|NCT00137995|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110177232|NCT03150888|Antihypertensive Agents|antihypertensive agents|mesh-list
110177234|NCT00138112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110177235|NCT00138112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110177236|NCT00138229|Aldesleukin|aldesleukin|mesh-list
110177237|NCT00138229|Cyclophosphamide|cyclophosphamide|mesh-list
110177238|NCT00138229|Fludarabine|fludarabine|mesh-list
110177239|NCT00138229|Fludarabine phosphate|fludarabine phosphate|mesh-list
110177240|NCT00138229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110177241|NCT00138229|Immunologic Factors|immunologic factors|mesh-ancestor
110177242|NCT00138229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110177243|NCT00138229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110177244|NCT00138229|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110177246|NCT00138229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110199059|NCT00397475|Vitamin D|vitamin d|mesh-list
110177248|NCT00138229|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110177249|NCT00138229|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110177250|NCT00138229|Antimetabolites|antimetabolites|mesh-ancestor
110177251|NCT00138229|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110177252|NCT00138229|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110177254|NCT00138229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110199127|NCT00044993|Docetaxel|docetaxel|mesh-list
110177255|NCT00404131|Ophthalmic Solutions|ophthalmic solutions|mesh-list
110177256|NCT00404131|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110177257|NCT02826161|Paclitaxel|paclitaxel|mesh-list
110177258|NCT02826161|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110177259|NCT02826161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110177260|NCT02826161|Tubulin Modulators|tubulin modulators|mesh-ancestor
110177261|NCT02826161|Antimitotic Agents|antimitotic agents|mesh-ancestor
110177262|NCT02826161|Mitosis Modulators|mitosis modulators|mesh-ancestor
110177263|NCT02826161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110177264|NCT00138541|Vildagliptin|vildagliptin|mesh-list
110177265|NCT00138541|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110177266|NCT00138541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110177267|NCT00138541|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110177268|NCT00138541|Protease Inhibitors|protease inhibitors|mesh-ancestor
110177269|NCT00138541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110177270|NCT00138541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110177271|NCT00138580|Vildagliptin|vildagliptin|mesh-list
110177272|NCT00138580|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110177273|NCT00138580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110177274|NCT00138580|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110177275|NCT00138580|Protease Inhibitors|protease inhibitors|mesh-ancestor
110177276|NCT00138580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110177277|NCT00138580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110177279|NCT03150771|Antidepressive Agents|antidepressive agents|mesh-ancestor
110177280|NCT03150771|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110177281|NCT03150771|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110177282|NCT03150771|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110177283|NCT03150771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110177284|NCT03150771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110177286|NCT03150771|Dopamine Agents|dopamine agents|mesh-ancestor
110177287|NCT03150771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110177288|NCT03150771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110177289|NCT03150771|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110177290|NCT03150771|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110177291|NCT03150771|Serotonin Agents|serotonin agents|mesh-ancestor
110177292|NCT03150771|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110177293|NCT03150771|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110177294|NCT03150771|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110177295|NCT03150771|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110177296|NCT00138619|Vildagliptin|vildagliptin|mesh-list
110177297|NCT00138619|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110177298|NCT00138619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110177299|NCT00138619|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110177301|NCT00138619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110177302|NCT00138619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110177303|NCT03150732|Nalbuphine|nalbuphine|mesh-list
110177304|NCT03150732|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110177305|NCT03150732|Narcotics|narcotics|mesh-ancestor
110199358|NCT00045539|Antidotes|antidotes|mesh-ancestor
110177306|NCT03150732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110177307|NCT03150732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110177308|NCT03150732|Analgesics|analgesics|mesh-ancestor
110177309|NCT03150732|Sensory System Agents|sensory system agents|mesh-ancestor
110177310|NCT03150732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110177311|NCT03893825|Risperidone|risperidone|mesh-list
110177312|NCT03893825|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110177313|NCT03893825|Serotonin Agents|serotonin agents|mesh-ancestor
110177314|NCT03893825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110177315|NCT03893825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110177316|NCT03893825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110177321|NCT03893825|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110177322|NCT03893825|Dopamine Agents|dopamine agents|mesh-ancestor
110177323|NCT00138970|Mycophenolic Acid|mycophenolic acid|mesh-list
110177324|NCT00138970|Cyclosporine|cyclosporine|mesh-list
110177325|NCT00138970|Prednisolone|prednisolone|mesh-list
110177326|NCT00138970|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110177327|NCT00138970|Methylprednisolone|methylprednisolone|mesh-list
110177328|NCT00138970|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110177329|NCT00138970|Prednisolone acetate|prednisolone acetate|mesh-list
110177330|NCT00138970|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110177331|NCT00138970|Prednisolone phosphate|prednisolone phosphate|mesh-list
110177332|NCT00138970|Daclizumab|daclizumab|mesh-list
110177333|NCT00138970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110177334|NCT00138970|Glucocorticoids|glucocorticoids|mesh-ancestor
110177335|NCT00138970|Hormones|hormones|mesh-ancestor
110177336|NCT00138970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110177337|NCT00138970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110177338|NCT00138970|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110177339|NCT00138970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110177340|NCT00138970|Antiemetics|antiemetics|mesh-ancestor
110177341|NCT00138970|Autonomic Agents|autonomic agents|mesh-ancestor
110177342|NCT00138970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110177343|NCT00138970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110177344|NCT00138970|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110177345|NCT00138970|Protective Agents|protective agents|mesh-ancestor
110177346|NCT00138970|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110177347|NCT00138970|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110177348|NCT00138970|Antitubercular Agents|antitubercular agents|mesh-ancestor
110177349|NCT00138970|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110177350|NCT00138970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110177351|NCT00138970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110177352|NCT00138970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110177355|NCT00138970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110177356|NCT00138970|Immunologic Factors|immunologic factors|mesh-ancestor
110177357|NCT00138970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110177358|NCT00138970|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110177360|NCT00139009|Cyclosporins|cyclosporins|mesh-list
110177361|NCT00139009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110177362|NCT00139009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110177363|NCT00139009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110177364|NCT00139009|Immunologic Factors|immunologic factors|mesh-ancestor
110177365|NCT00139009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110177366|NCT00139009|Antifungal Agents|antifungal agents|mesh-ancestor
110177367|NCT00139009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110177368|NCT00139009|Dermatologic Agents|dermatologic agents|mesh-ancestor
110177369|NCT00139009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110199606|NCT00130546|Sirolimus|sirolimus|mesh-list
110177370|NCT00139009|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110177372|NCT03890666|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110177373|NCT03890666|Autonomic Agents|autonomic agents|mesh-ancestor
110177374|NCT03890666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110177375|NCT03890666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110177376|NCT03890666|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110177377|NCT03890666|Respiratory System Agents|respiratory system agents|mesh-ancestor
110177378|NCT03890666|Tocolytic Agents|tocolytic agents|mesh-ancestor
110177379|NCT03890666|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110177380|NCT03890666|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110177381|NCT03890666|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110177382|NCT03890666|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110177383|NCT03890666|Adrenergic Agents|adrenergic agents|mesh-ancestor
110177384|NCT03890666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110177385|NCT03890666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110177386|NCT00139165|Budesonide|budesonide|mesh-list
110177387|NCT00139165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110177388|NCT00139165|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110177389|NCT00139165|Autonomic Agents|autonomic agents|mesh-ancestor
110177390|NCT00139165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110177391|NCT00139165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110177392|NCT00139165|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110177393|NCT00139165|Respiratory System Agents|respiratory system agents|mesh-ancestor
110177394|NCT00139165|Glucocorticoids|glucocorticoids|mesh-ancestor
110177396|NCT00139165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110177397|NCT00139204|Carbon-11 methionine|carbon-11 methionine|mesh-list
110276098|NCT04230187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110177399|NCT00139204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110177400|NCT00139243|Leucovorin|leucovorin|mesh-list
110177401|NCT00139243|Fluorouracil|fluorouracil|mesh-list
110177402|NCT00139243|Docetaxel|docetaxel|mesh-list
110177403|NCT00139243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110177404|NCT00139243|Antimetabolites|antimetabolites|mesh-ancestor
110177405|NCT00139243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110177406|NCT00139243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110177407|NCT00139243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110177408|NCT00139243|Immunologic Factors|immunologic factors|mesh-ancestor
110177409|NCT00139243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110177410|NCT00139243|Antidotes|antidotes|mesh-ancestor
110177411|NCT00139243|Protective Agents|protective agents|mesh-ancestor
110177412|NCT00139243|Vitamin B Complex|vitamin b complex|mesh-ancestor
110177413|NCT00139243|Vitamins|vitamins|mesh-ancestor
110177414|NCT00139243|Micronutrients|micronutrients|mesh-ancestor
110177415|NCT00139243|Tubulin Modulators|tubulin modulators|mesh-ancestor
110177416|NCT00139243|Antimitotic Agents|antimitotic agents|mesh-ancestor
110177417|NCT00139243|Mitosis Modulators|mitosis modulators|mesh-ancestor
110177418|NCT00139282|Squalamine|squalamine|mesh-list
110177419|NCT00139282|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110177420|NCT00139282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110177421|NCT00139282|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110177422|NCT00139282|Protective Agents|protective agents|mesh-ancestor
110177423|NCT00139282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110177424|NCT00139282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110177425|NCT00139282|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110177426|NCT00139282|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110177427|NCT00139282|Growth Substances|growth substances|mesh-ancestor
110177428|NCT00139282|Growth Inhibitors|growth inhibitors|mesh-ancestor
110177429|NCT03861767|Metformin|metformin|mesh-list
110177430|NCT03861767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110177431|NCT03861767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110177432|NCT00139360|Bevacizumab|bevacizumab|mesh-list
110177433|NCT00139360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110177434|NCT00139360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110177435|NCT00139360|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110177436|NCT00139360|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110177437|NCT00139360|Growth Substances|growth substances|mesh-ancestor
110177438|NCT00139360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110177439|NCT00139360|Growth Inhibitors|growth inhibitors|mesh-ancestor
110177441|NCT00139516|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110177442|NCT00139516|Autonomic Agents|autonomic agents|mesh-ancestor
110177443|NCT00139516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110177444|NCT00139516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110177445|NCT00139516|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110177446|NCT00139516|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110177447|NCT00139516|Cholinergic Agents|cholinergic agents|mesh-ancestor
110177448|NCT00139516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110177449|NCT00139516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110177450|NCT00139555|Amlodipine|amlodipine|mesh-list
110177451|NCT00139555|Benazepril|benazepril|mesh-list
110177452|NCT00139555|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110199788|NCT00397709|Leprostatic Agents|leprostatic agents|mesh-ancestor
110177454|NCT00139555|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110177455|NCT00139555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110177456|NCT00139555|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110177457|NCT00139555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110177458|NCT00139555|Vasodilator Agents|vasodilator agents|mesh-ancestor
110177459|NCT00139555|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110177461|NCT00139555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110177463|NCT03844412|Nortriptyline|nortriptyline|mesh-list
110177465|NCT03844412|Anesthetics, Local|anesthetics, local|mesh-ancestor
110177466|NCT03844412|Anesthetics|anesthetics|mesh-ancestor
110177467|NCT03844412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110177468|NCT03844412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110177469|NCT03844412|Sensory System Agents|sensory system agents|mesh-ancestor
110177470|NCT03844412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110177471|NCT03844412|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110177472|NCT03844412|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110177473|NCT03844412|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110177474|NCT03844412|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110177475|NCT03844412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110177478|NCT03844412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110177479|NCT03844412|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
110177481|NCT03844412|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110177482|NCT03844412|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
110177483|NCT03844412|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110177484|NCT03844412|Adrenergic Agents|adrenergic agents|mesh-ancestor
110177485|NCT03844412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110177486|NCT00139633|Carboplatin|carboplatin|mesh-list
110177487|NCT00139633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110177488|NCT00139711|Docetaxel|docetaxel|mesh-list
110177489|NCT00139711|Irinotecan|irinotecan|mesh-list
110177490|NCT00139711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110177491|NCT00139711|Tubulin Modulators|tubulin modulators|mesh-ancestor
110177492|NCT00139711|Antimitotic Agents|antimitotic agents|mesh-ancestor
110177493|NCT00139711|Mitosis Modulators|mitosis modulators|mesh-ancestor
110177494|NCT00139711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110177495|NCT00139711|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110177496|NCT00139711|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110177497|NCT00139711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110177498|NCT03837977|Leucovorin|leucovorin|mesh-list
110177500|NCT03837977|Docetaxel|docetaxel|mesh-list
110177501|NCT03837977|Fluorouracil|fluorouracil|mesh-list
110177502|NCT03837977|Irinotecan|irinotecan|mesh-list
110177503|NCT03837977|Levoleucovorin|levoleucovorin|mesh-list
110177504|NCT03837977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110177505|NCT03837977|Tubulin Modulators|tubulin modulators|mesh-ancestor
110177506|NCT03837977|Antimitotic Agents|antimitotic agents|mesh-ancestor
110177507|NCT03837977|Mitosis Modulators|mitosis modulators|mesh-ancestor
110177508|NCT03837977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110177509|NCT03837977|Antimetabolites|antimetabolites|mesh-ancestor
110177510|NCT03837977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110177512|NCT03837977|Immunologic Factors|immunologic factors|mesh-ancestor
110177513|NCT03837977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110177514|NCT03837977|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110177515|NCT03837977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110177516|NCT03837977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110177518|NCT03837977|Protective Agents|protective agents|mesh-ancestor
110177519|NCT03837977|Vitamin B Complex|vitamin b complex|mesh-ancestor
110177520|NCT03837977|Vitamins|vitamins|mesh-ancestor
110177521|NCT03837977|Micronutrients|micronutrients|mesh-ancestor
110177522|NCT03837977|Hematinics|hematinics|mesh-ancestor
110177523|NCT00404326|Hydralazine|hydralazine|mesh-list
110177524|NCT00404326|Valproic Acid|valproic acid|mesh-list
110177525|NCT00404326|Anticonvulsants|anticonvulsants|mesh-ancestor
110177526|NCT00404326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110177527|NCT00404326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110177530|NCT00404326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110177531|NCT00404326|Antimanic Agents|antimanic agents|mesh-ancestor
110177532|NCT00404326|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110177533|NCT00404326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110177534|NCT00404326|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110177535|NCT00404326|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110177536|NCT00404326|Vasodilator Agents|vasodilator agents|mesh-ancestor
110177537|NCT00139750|Varenicline|varenicline|mesh-list
110177539|NCT00139750|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110177540|NCT00139750|Cholinergic Agents|cholinergic agents|mesh-ancestor
110177541|NCT00139750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110177542|NCT00139750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110177543|NCT00139750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110177544|NCT00139867|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
110177545|NCT00139867|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110177546|NCT00139867|Immunologic Factors|immunologic factors|mesh-ancestor
110177547|NCT00139867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110177548|NCT00139867|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110177549|NCT00139867|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110177550|NCT00139867|Dopamine Agonists|dopamine agonists|mesh-ancestor
110177551|NCT00139867|Dopamine Agents|dopamine agents|mesh-ancestor
110177552|NCT00139867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110177553|NCT00139867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110177555|NCT03150459|Simvastatin|simvastatin|mesh-list
110177556|NCT03150459|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110177558|NCT03150459|Antimetabolites|antimetabolites|mesh-ancestor
110177559|NCT03150459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110177560|NCT03150459|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110177561|NCT03150459|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110177562|NCT03150459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110177563|NCT03150459|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110177564|NCT03150459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110177565|NCT03150459|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110177566|NCT00140023|Azithromycin|azithromycin|mesh-list
110177567|NCT00140023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110177568|NCT00140023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110177569|NCT00140062|Latanoprost|latanoprost|mesh-list
110177570|NCT00140062|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
110177571|NCT00140062|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
110177572|NCT00140101|Paclitaxel|paclitaxel|mesh-list
110177573|NCT00140101|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110177575|NCT00140101|Tubulin Modulators|tubulin modulators|mesh-ancestor
110177576|NCT00140101|Antimitotic Agents|antimitotic agents|mesh-ancestor
110177577|NCT00140101|Mitosis Modulators|mitosis modulators|mesh-ancestor
110177578|NCT00140101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110177579|NCT03150420|Sodium thiosulfate|sodium thiosulfate|mesh-list
110177580|NCT03150420|Antidotes|antidotes|mesh-ancestor
110177581|NCT03150420|Protective Agents|protective agents|mesh-ancestor
110177582|NCT03150420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110177583|NCT03150420|Antioxidants|antioxidants|mesh-ancestor
110177584|NCT03150420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110177585|NCT03150420|Antitubercular Agents|antitubercular agents|mesh-ancestor
110177586|NCT03150420|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110177587|NCT03150420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110177588|NCT03150420|Chelating Agents|chelating agents|mesh-ancestor
110177589|NCT03150420|Sequestering Agents|sequestering agents|mesh-ancestor
110177590|NCT00140218|Pramipexole|pramipexole|mesh-list
110177591|NCT00140218|Antioxidants|antioxidants|mesh-ancestor
110177592|NCT00140218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110177593|NCT00140218|Protective Agents|protective agents|mesh-ancestor
110177594|NCT00140218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110177595|NCT00140218|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110177596|NCT00140218|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110177597|NCT00140218|Dopamine Agonists|dopamine agonists|mesh-ancestor
110177598|NCT00140218|Dopamine Agents|dopamine agents|mesh-ancestor
110177599|NCT00140218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110177600|NCT00140257|Escitalopram|escitalopram|mesh-list
110177601|NCT00140257|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110177602|NCT00140257|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110177603|NCT00140257|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110177604|NCT00140257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110177605|NCT00140257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110177606|NCT00140257|Serotonin Agents|serotonin agents|mesh-ancestor
110177607|NCT00140257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110177608|NCT00140296|Contraceptive Agents|contraceptive agents|mesh-list
110177609|NCT00140296|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110177610|NCT00140296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110177611|NCT00140374|Immunomodulating Agents|immunomodulating agents|mesh-list
110177612|NCT00140374|Immunologic Factors|immunologic factors|mesh-ancestor
110177613|NCT00140374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110177615|NCT00140452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110177616|NCT00140452|Immunologic Factors|immunologic factors|mesh-ancestor
110177617|NCT00140452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110177618|NCT00140452|Leprostatic Agents|leprostatic agents|mesh-ancestor
110177619|NCT00140452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110177620|NCT00140452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110177621|NCT00140452|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110177622|NCT00140452|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110177623|NCT00140452|Growth Substances|growth substances|mesh-ancestor
110177624|NCT00140452|Growth Inhibitors|growth inhibitors|mesh-ancestor
110177625|NCT00140452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110177626|NCT00140530|Sirolimus|sirolimus|mesh-list
110177627|NCT00140530|Paclitaxel|paclitaxel|mesh-list
110177628|NCT00140530|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110177629|NCT00140530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110177630|NCT00140530|Tubulin Modulators|tubulin modulators|mesh-ancestor
110177632|NCT00140530|Mitosis Modulators|mitosis modulators|mesh-ancestor
110177633|NCT00140530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110177634|NCT00140530|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110200413|NCT00080925|Glucocorticoids|glucocorticoids|mesh-ancestor
110177635|NCT00140530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110177636|NCT00140530|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110177637|NCT00140530|Antifungal Agents|antifungal agents|mesh-ancestor
110177638|NCT00140530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110177639|NCT00140530|Immunologic Factors|immunologic factors|mesh-ancestor
110177640|NCT00140530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110177641|NCT00140569|Interferons|interferons|mesh-list
110177642|NCT00140569|Fludarabine|fludarabine|mesh-list
110177643|NCT00140569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110177644|NCT00140569|Antiviral Agents|antiviral agents|mesh-ancestor
110177645|NCT00140569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110177646|NCT00140647|Rosiglitazone|rosiglitazone|mesh-list
110177649|NCT00140647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110200490|NCT00042822|Romidepsin|romidepsin|mesh-list
110177650|NCT00140647|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110177651|NCT00140647|Protease Inhibitors|protease inhibitors|mesh-ancestor
110177652|NCT00140647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110177653|NCT00140647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110177654|NCT00140647|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110177655|NCT00140725|Interferons|interferons|mesh-list
110177656|NCT00140725|Interferon-alpha|interferon-alpha|mesh-list
110177657|NCT00140725|Lamivudine|lamivudine|mesh-list
110177658|NCT00140725|Interferon alpha-2|interferon alpha-2|mesh-list
110177659|NCT00140725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110177660|NCT00140725|Antiviral Agents|antiviral agents|mesh-ancestor
110177661|NCT00140725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110177662|NCT00140725|Immunologic Factors|immunologic factors|mesh-ancestor
110177663|NCT00140725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110177664|NCT00140725|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110177665|NCT00140725|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110177666|NCT00140725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110177667|NCT00140725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110177668|NCT00140725|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110177669|NCT00140725|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110177670|NCT00140764|Metronidazole|metronidazole|mesh-list
110177671|NCT00140764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110177672|NCT00140764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110177673|NCT00140764|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110177674|NCT00140764|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110177676|NCT00138736|Agglutinins|agglutinins|mesh-ancestor
110177677|NCT00138736|Immunologic Factors|immunologic factors|mesh-ancestor
110177678|NCT00138736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110177679|NCT00138736|Coagulants|coagulants|mesh-ancestor
110177681|NCT00140920|Rofecoxib|rofecoxib|mesh-list
110177682|NCT00140920|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110177683|NCT00140920|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110177684|NCT00140920|Analgesics|analgesics|mesh-ancestor
110177685|NCT00140920|Sensory System Agents|sensory system agents|mesh-ancestor
110177686|NCT00140920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110177687|NCT00140920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110177688|NCT00140920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110177689|NCT00140920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110177690|NCT00140920|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110177691|NCT00140920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110177692|NCT00140920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110177693|NCT00140920|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110177694|NCT03136497|Rituximab|rituximab|mesh-list
110177695|NCT03136497|Venetoclax|venetoclax|mesh-list
110177696|NCT03136497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110177697|NCT03136497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110177698|NCT03136497|Immunologic Factors|immunologic factors|mesh-ancestor
110177699|NCT03136497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110177700|NCT03136497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110177701|NCT00140998|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
110177702|NCT00140998|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
110177703|NCT00140998|Estradiol|estradiol|mesh-list
110177704|NCT00140998|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
110177705|NCT00140998|Estrogens|estrogens|mesh-ancestor
110177706|NCT00140998|Hormones|hormones|mesh-ancestor
110177707|NCT00140998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110177708|NCT00140998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110177709|NCT00140998|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110177710|NCT00140998|Contraceptive Agents|contraceptive agents|mesh-ancestor
110177711|NCT00140998|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110177712|NCT00140998|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110177713|NCT00141154|Celecoxib|celecoxib|mesh-list
110177714|NCT00141154|Loxoprofen|loxoprofen|mesh-list
110177715|NCT00141154|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110177716|NCT00141154|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110177717|NCT00141154|Analgesics|analgesics|mesh-ancestor
110177718|NCT00141154|Sensory System Agents|sensory system agents|mesh-ancestor
110177719|NCT00141154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110177720|NCT00141154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110177721|NCT00141154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110177722|NCT00141154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110177723|NCT00141154|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110177724|NCT00141154|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110177725|NCT00141154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110177726|NCT00141154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110177728|NCT00141193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110177729|NCT00141193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110177731|NCT00141193|Sensory System Agents|sensory system agents|mesh-ancestor
110177732|NCT00141193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110177733|NCT00141193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110177734|NCT00141193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110177735|NCT00141193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110177736|NCT00141193|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110177737|NCT00141193|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110177738|NCT00141193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110177739|NCT00141193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110177740|NCT00141232|Atorvastatin|atorvastatin|mesh-list
110177741|NCT00141232|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110177742|NCT00141232|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110177743|NCT00141232|Antimetabolites|antimetabolites|mesh-ancestor
110177744|NCT00141232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110177745|NCT00141232|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110177746|NCT00141232|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110177747|NCT00141232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110177748|NCT02315534|Temozolomide|temozolomide|mesh-list
110177749|NCT02315534|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110177750|NCT02315534|Alkylating Agents|alkylating agents|mesh-ancestor
110200806|NCT00146341|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110177751|NCT02315534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110177752|NCT02315534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110177753|NCT00141310|Sildenafil Citrate|sildenafil citrate|mesh-list
110177754|NCT00141310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110177755|NCT00141310|Vasodilator Agents|vasodilator agents|mesh-ancestor
110177756|NCT00141310|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110177757|NCT00141310|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110177758|NCT00141310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110177759|NCT00141310|Urological Agents|urological agents|mesh-ancestor
110177761|NCT00141388|Analgesics|analgesics|mesh-ancestor
110177762|NCT00141388|Sensory System Agents|sensory system agents|mesh-ancestor
110200868|NCT00146575|Antifungal Agents|antifungal agents|mesh-ancestor
110177763|NCT00141388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110177764|NCT00141388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110177765|NCT00141388|Anticonvulsants|anticonvulsants|mesh-ancestor
110177766|NCT00141388|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110177767|NCT00141388|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110177768|NCT00141388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110177769|NCT00141388|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110177770|NCT00141388|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110177771|NCT00141388|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110177772|NCT00141388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110177773|NCT00141388|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110177775|NCT00404404|Bevacizumab|bevacizumab|mesh-list
110177777|NCT00404404|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110177778|NCT00404404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110177779|NCT00404404|Tubulin Modulators|tubulin modulators|mesh-ancestor
110177780|NCT00404404|Antimitotic Agents|antimitotic agents|mesh-ancestor
110177781|NCT00404404|Mitosis Modulators|mitosis modulators|mesh-ancestor
110177782|NCT00404404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110177783|NCT00404404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110177784|NCT00404404|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110177785|NCT00404404|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110177786|NCT00404404|Growth Substances|growth substances|mesh-ancestor
110177787|NCT00404404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110177788|NCT00404404|Growth Inhibitors|growth inhibitors|mesh-ancestor
110177789|NCT00404482|Cyclosporine|cyclosporine|mesh-list
110177790|NCT00404482|Cyclosporins|cyclosporins|mesh-list
110177791|NCT00404482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110177792|NCT00404482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110177793|NCT00404482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110177794|NCT00404482|Immunologic Factors|immunologic factors|mesh-ancestor
110177795|NCT00404482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110177797|NCT00404482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110177798|NCT00404482|Dermatologic Agents|dermatologic agents|mesh-ancestor
110177799|NCT00404482|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110177800|NCT00404482|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110177801|NCT03073941|Cimetidine|cimetidine|mesh-list
110177802|NCT03073941|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110201054|NCT00147355|Serotonin Agents|serotonin agents|mesh-ancestor
110177803|NCT03073941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110177804|NCT03073941|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110177805|NCT03073941|Histamine Antagonists|histamine antagonists|mesh-ancestor
110177806|NCT03073941|Histamine Agents|histamine agents|mesh-ancestor
110177807|NCT03073941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110177808|NCT03073941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110177809|NCT03073941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110177810|NCT03073941|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110177811|NCT03073941|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110177812|NCT03073941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110177814|NCT00141427|Analgesics|analgesics|mesh-ancestor
110177815|NCT00141427|Sensory System Agents|sensory system agents|mesh-ancestor
110177816|NCT00141427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110177817|NCT00141427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110177818|NCT00141427|Anticonvulsants|anticonvulsants|mesh-ancestor
110177819|NCT00141427|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110177820|NCT00141427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110177821|NCT00141427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110177822|NCT00141427|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110201183|NCT02957851|Nitrous Oxide|nitrous oxide|mesh-list
110177824|NCT00141427|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110177825|NCT00141427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110177826|NCT00141427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110177827|NCT00141544|Methyltestosterone|methyltestosterone|mesh-list
110177829|NCT00141544|Estrogens, Esterified (USP)|estrogens, esterified (usp)|mesh-list
110177831|NCT00141544|Testosterone|testosterone|mesh-list
110177832|NCT00141544|Testosterone undecanoate|testosterone undecanoate|mesh-list
110177833|NCT00141544|Testosterone enanthate|testosterone enanthate|mesh-list
110177834|NCT00141544|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
110177836|NCT00141544|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110201239|NCT00399711|Metformin|metformin|mesh-list
110177837|NCT00141544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110177838|NCT00141544|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110177840|NCT00141544|Anabolic Agents|anabolic agents|mesh-ancestor
110177841|NCT00141544|Androgens|androgens|mesh-ancestor
110177842|NCT00141583|Candesartan|candesartan|mesh-list
110177843|NCT00141583|Candesartan cilexetil|candesartan cilexetil|mesh-list
110177844|NCT00141583|Enalapril|enalapril|mesh-list
110177845|NCT00141583|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110177846|NCT00141583|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110177847|NCT00141583|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110177848|NCT00141583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110177849|NCT00141583|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
110177850|NCT00141583|Protease Inhibitors|protease inhibitors|mesh-ancestor
110177851|NCT00141583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110177852|NCT00141700|Rituximab|rituximab|mesh-list
110177853|NCT00141700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110177854|NCT00141700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110177855|NCT00141700|Immunologic Factors|immunologic factors|mesh-ancestor
110177856|NCT00141700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110177857|NCT00141700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110177858|NCT00141895|Misoprostol|misoprostol|mesh-list
110177859|NCT00141895|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110201356|NCT00148681|Trastuzumab|trastuzumab|mesh-list
110177860|NCT00141895|Abortifacient Agents|abortifacient agents|mesh-ancestor
110177862|NCT00141895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110177863|NCT00141895|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110177864|NCT00141895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110177866|NCT00142051|Nitric Oxide|nitric oxide|mesh-list
110177867|NCT00142051|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110177868|NCT00142051|Autonomic Agents|autonomic agents|mesh-ancestor
110177869|NCT00142051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110201422|NCT00149149|Polaprezinc|polaprezinc|mesh-list
110177870|NCT00142051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110177872|NCT00142051|Respiratory System Agents|respiratory system agents|mesh-ancestor
110177873|NCT00142051|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110177874|NCT00142051|Antioxidants|antioxidants|mesh-ancestor
110177875|NCT00142051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110177876|NCT00142051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110177877|NCT00142051|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
110177878|NCT00142051|Vasodilator Agents|vasodilator agents|mesh-ancestor
110177879|NCT00142051|Gasotransmitters|gasotransmitters|mesh-ancestor
110177880|NCT00142051|Protective Agents|protective agents|mesh-ancestor
110177882|NCT00142129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110177883|NCT02825979|Sotalol|sotalol|mesh-list
110177885|NCT02825979|Dronedarone|dronedarone|mesh-list
110177886|NCT02825979|Propafenone|propafenone|mesh-list
110177887|NCT02825979|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
110177888|NCT02825979|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110177889|NCT02825979|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110177890|NCT02825979|Adrenergic Agents|adrenergic agents|mesh-ancestor
110177891|NCT02825979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110177893|NCT02825979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110177894|NCT02825979|Sympatholytics|sympatholytics|mesh-ancestor
110177895|NCT02825979|Autonomic Agents|autonomic agents|mesh-ancestor
110177896|NCT02825979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110177897|NCT02825979|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110177898|NCT02825979|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110177899|NCT02825979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110177900|NCT00142207|Pyrimethamine|pyrimethamine|mesh-list
110177901|NCT00142207|Sulfadoxine|sulfadoxine|mesh-list
110177902|NCT00142207|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
110177904|NCT00142207|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110177905|NCT00142207|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110177906|NCT00142207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110177907|NCT00142207|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110177908|NCT00142207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110177909|NCT00142207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110177910|NCT00142207|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110177911|NCT00142246|Amodiaquine|amodiaquine|mesh-list
110177912|NCT00142246|Antimalarials|antimalarials|mesh-ancestor
110177913|NCT00142246|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110177914|NCT00142246|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110177915|NCT00142246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110177916|NCT00142324|Donepezil|donepezil|mesh-list
110177917|NCT00142324|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110177918|NCT00142324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110177919|NCT00142324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110177920|NCT00142324|Cholinergic Agents|cholinergic agents|mesh-ancestor
110177921|NCT00142324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110177922|NCT00142324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110177923|NCT00142324|Nootropic Agents|nootropic agents|mesh-ancestor
110177924|NCT00142402|Modafinil|modafinil|mesh-list
110177925|NCT00142402|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110177926|NCT00142402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110177927|NCT00142402|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
110177928|NCT00142402|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110177929|NCT00142402|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110177930|NCT00142402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110177932|NCT00142480|Capecitabine|capecitabine|mesh-list
110177933|NCT00142480|Oxaliplatin|oxaliplatin|mesh-list
110177934|NCT00142480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110201608|NCT00150046|Everolimus|everolimus|mesh-list
110177935|NCT00142480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110177936|NCT00142480|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110177938|NCT00142480|Growth Substances|growth substances|mesh-ancestor
110177939|NCT00142480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110177940|NCT00142480|Growth Inhibitors|growth inhibitors|mesh-ancestor
110177941|NCT00142480|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110177942|NCT00142480|Antimetabolites|antimetabolites|mesh-ancestor
110177943|NCT00142480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110177944|NCT02806050|Letrozole|letrozole|mesh-list
110177945|NCT02806050|Palbociclib|palbociclib|mesh-list
110177946|NCT02806050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110177947|NCT02806050|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110177948|NCT02806050|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110177949|NCT02806050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110177950|NCT02806050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110177951|NCT02806050|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110177952|NCT02806050|Hormone Antagonists|hormone antagonists|mesh-ancestor
110177953|NCT02806050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110177954|NCT02806050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110177955|NCT02806050|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110177956|NCT02781792|Temozolomide|temozolomide|mesh-list
110177957|NCT02781792|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110177958|NCT02781792|Alkylating Agents|alkylating agents|mesh-ancestor
110177960|NCT02781792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110177961|NCT00142870|Bupropion|bupropion|mesh-list
110177962|NCT00142870|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110177963|NCT00142870|Antidepressive Agents|antidepressive agents|mesh-ancestor
110177964|NCT00142870|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110177965|NCT00142870|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110177966|NCT00142870|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110177967|NCT00142870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110177968|NCT00142870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110177969|NCT00142870|Dopamine Agents|dopamine agents|mesh-ancestor
110177970|NCT00142870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110177971|NCT00142870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110177972|NCT00142870|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110177973|NCT00142870|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110177974|NCT00142870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110177975|NCT00142948|Naltrexone|naltrexone|mesh-list
110177976|NCT00142948|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110177977|NCT00142948|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110201912|NCT00151450|Pregabalin|pregabalin|mesh-list
110177979|NCT00142948|Sensory System Agents|sensory system agents|mesh-ancestor
110177980|NCT00142948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110177981|NCT02780427|Dexmedetomidine|dexmedetomidine|mesh-list
110177982|NCT02780427|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110177983|NCT02780427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110177984|NCT02780427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110177985|NCT02780427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110177988|NCT02780427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110177989|NCT02780427|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110177990|NCT02780427|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110177991|NCT02780427|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110177992|NCT02780427|Adrenergic Agents|adrenergic agents|mesh-ancestor
110177993|NCT02780427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110177994|NCT02780427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110177996|NCT00142987|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110177997|NCT00142987|Serotonin Agents|serotonin agents|mesh-ancestor
110177998|NCT00142987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110177999|NCT00142987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110178000|NCT00142987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110178001|NCT00143026|Levodopa|levodopa|mesh-list
110178002|NCT00143026|Carbidopa|carbidopa|mesh-list
110178003|NCT00143026|Entacapone|entacapone|mesh-list
110178004|NCT00143026|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110178005|NCT00143026|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110178006|NCT00143026|Dopamine Agents|dopamine agents|mesh-ancestor
110178007|NCT00143026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110178008|NCT00143026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110178009|NCT00143026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110178010|NCT00143026|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
110178011|NCT00143026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110178012|NCT00143026|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
110178013|NCT00404599|Simvastatin|simvastatin|mesh-list
110178014|NCT00404599|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110178015|NCT00404599|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110178016|NCT00404599|Antimetabolites|antimetabolites|mesh-ancestor
110178017|NCT00404599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110178018|NCT00404599|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110178019|NCT00404599|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110178020|NCT00404599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110178021|NCT00143065|Rituximab|rituximab|mesh-list
110178022|NCT00143065|Alemtuzumab|alemtuzumab|mesh-list
110178023|NCT00143065|Fludarabine|fludarabine|mesh-list
110178024|NCT00143065|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110178025|NCT00143065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110178026|NCT00143065|Immunologic Factors|immunologic factors|mesh-ancestor
110178027|NCT00143065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110178028|NCT00143065|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110178029|NCT00143104|Insulin|insulin|mesh-list
110178030|NCT00143104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110178031|NCT00143104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110178032|NCT00143143|Pregabalin|pregabalin|mesh-list
110178033|NCT00143143|Analgesics|analgesics|mesh-ancestor
110178034|NCT00143143|Sensory System Agents|sensory system agents|mesh-ancestor
110178035|NCT00143143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110178036|NCT00143143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110178037|NCT00143143|Anticonvulsants|anticonvulsants|mesh-ancestor
110178038|NCT00143143|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110178039|NCT00143143|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110178040|NCT00143143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110178041|NCT00143143|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110178042|NCT00143143|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110178043|NCT00143143|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110178044|NCT00143143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110178045|NCT00143143|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110178046|NCT00143221|Sildenafil Citrate|sildenafil citrate|mesh-list
110202121|NCT00049946|Risperidone|risperidone|mesh-list
110178048|NCT00143221|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110178049|NCT00143221|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110178050|NCT00143221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110178051|NCT00143221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110178052|NCT00143221|Urological Agents|urological agents|mesh-ancestor
110178053|NCT00143260|Sildenafil Citrate|sildenafil citrate|mesh-list
110178054|NCT00143260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110178055|NCT00143260|Vasodilator Agents|vasodilator agents|mesh-ancestor
110178056|NCT00143260|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
110178057|NCT00143260|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110178058|NCT00143260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110178059|NCT00143260|Urological Agents|urological agents|mesh-ancestor
110178060|NCT00143299|Varenicline|varenicline|mesh-list
110178061|NCT00143299|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110178062|NCT00143299|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110178063|NCT00143299|Cholinergic Agents|cholinergic agents|mesh-ancestor
110178064|NCT00143299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110178065|NCT00143299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110178066|NCT00143299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110178067|NCT00143338|Insulin|insulin|mesh-list
110178068|NCT00143338|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110178069|NCT00143338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110178070|NCT00143377|Tolterodine Tartrate|tolterodine tartrate|mesh-list
110178071|NCT00143377|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110178072|NCT00143377|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110178073|NCT00143377|Cholinergic Agents|cholinergic agents|mesh-ancestor
110178074|NCT00143377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110202177|NCT00152230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110178075|NCT00143377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110178076|NCT00143377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110178078|NCT02972216|Docetaxel|docetaxel|mesh-list
110178079|NCT02972216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110178080|NCT02972216|Tubulin Modulators|tubulin modulators|mesh-ancestor
110178081|NCT02972216|Antimitotic Agents|antimitotic agents|mesh-ancestor
110178082|NCT02972216|Mitosis Modulators|mitosis modulators|mesh-ancestor
110178083|NCT02972216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110178085|NCT04726345|Terfenadine|terfenadine|mesh-list
110178086|NCT04726345|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110178087|NCT04726345|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
110178088|NCT04726345|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110178089|NCT04726345|Histamine Antagonists|histamine antagonists|mesh-ancestor
110178090|NCT04726345|Histamine Agents|histamine agents|mesh-ancestor
110178091|NCT04726345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110178092|NCT04726345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110202223|NCT00152542|Antioxidants|antioxidants|mesh-ancestor
110178093|NCT04726345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110178095|NCT00143533|Cefpodoxime proxetil|cefpodoxime proxetil|mesh-list
110178097|NCT00143533|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110178098|NCT00143533|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110178099|NCT00143533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110178100|NCT00143533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110178101|NCT00143533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110178102|NCT00143533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110178103|NCT00143533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110178104|NCT00143572|Hydroxyurea|hydroxyurea|mesh-list
110178105|NCT00143572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110178106|NCT00143572|Antisickling Agents|antisickling agents|mesh-ancestor
110178107|NCT00143572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110178108|NCT00143572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110178109|NCT00143572|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110178111|NCT00393315|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110178112|NCT00393315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110178113|NCT00393315|Tubulin Modulators|tubulin modulators|mesh-ancestor
110178114|NCT00393315|Antimitotic Agents|antimitotic agents|mesh-ancestor
110202283|NCT00050180|Indinavir|indinavir|mesh-list
110178115|NCT00393315|Mitosis Modulators|mitosis modulators|mesh-ancestor
110178116|NCT00393315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110178118|NCT00143689|Lopinavir|lopinavir|mesh-list
110178120|NCT00143689|Zidovudine|zidovudine|mesh-list
110178121|NCT00143689|Nevirapine|nevirapine|mesh-list
110178122|NCT00143689|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110178123|NCT00143689|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110178124|NCT00143689|Protease Inhibitors|protease inhibitors|mesh-ancestor
110178125|NCT00143689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110178126|NCT00143689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110178127|NCT00143689|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110178128|NCT00143689|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110178129|NCT00143689|Antiviral Agents|antiviral agents|mesh-ancestor
110178130|NCT00143689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110178131|NCT00143689|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110178132|NCT00143689|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110178133|NCT00143689|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110178134|NCT00143689|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110178135|NCT00143689|Antimetabolites|antimetabolites|mesh-ancestor
110178136|NCT00143689|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110178137|NCT00143689|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110178138|NCT00143728|Lamivudine|lamivudine|mesh-list
110178139|NCT00143728|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110178140|NCT00143728|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110178141|NCT00143728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110178142|NCT00143728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110178143|NCT00143728|Antiviral Agents|antiviral agents|mesh-ancestor
110178144|NCT00143728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110178145|NCT00143728|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110178146|NCT00143728|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110202384|NCT00043758|Tolvaptan|tolvaptan|mesh-list
110178147|NCT00140803|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
110178148|NCT00140803|Verteporfin|verteporfin|mesh-list
110178149|NCT00140803|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110178150|NCT00140803|Glucocorticoids|glucocorticoids|mesh-ancestor
110178151|NCT00140803|Hormones|hormones|mesh-ancestor
110178152|NCT00140803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110178153|NCT00140803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110178154|NCT00140803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110178155|NCT00140803|Immunologic Factors|immunologic factors|mesh-ancestor
110178156|NCT00140803|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110178157|NCT00140803|Dermatologic Agents|dermatologic agents|mesh-ancestor
110178159|NCT00143806|Alefacept|alefacept|mesh-list
110178160|NCT00143806|Cyclosporins|cyclosporins|mesh-list
110178161|NCT00143806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110178162|NCT00143806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110178163|NCT00143806|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110178164|NCT00143806|Immunologic Factors|immunologic factors|mesh-ancestor
110178165|NCT00143806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110178166|NCT00143806|Antifungal Agents|antifungal agents|mesh-ancestor
110178167|NCT00143806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110178168|NCT00143806|Dermatologic Agents|dermatologic agents|mesh-ancestor
110178170|NCT00143806|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110178171|NCT00390728|Insulin Glargine|insulin glargine|mesh-list
110178172|NCT00390728|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110178173|NCT00390728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110178174|NCT00144040|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
110178175|NCT00144040|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
110178176|NCT00144040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110178177|NCT00144040|Antitubercular Agents|antitubercular agents|mesh-ancestor
110178178|NCT00144118|Sevoflurane|sevoflurane|mesh-list
110202504|NCT00153517|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110178180|NCT00144118|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110178181|NCT00144118|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110178183|NCT00144118|Anesthetics|anesthetics|mesh-ancestor
110178184|NCT00144118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110178185|NCT00144118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110178188|NCT00144157|Antimetabolites|antimetabolites|mesh-ancestor
110178189|NCT00144157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110178190|NCT00144157|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110178191|NCT00144157|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110178192|NCT00144157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110178194|NCT00144157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110178196|NCT00144157|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110178197|NCT00144157|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110178198|NCT00144157|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110178200|NCT00144196|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110178201|NCT00144196|Autonomic Agents|autonomic agents|mesh-ancestor
110178202|NCT00144196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110178203|NCT00144196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110178204|NCT00144196|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110178205|NCT00144196|Respiratory System Agents|respiratory system agents|mesh-ancestor
110178206|NCT00144196|Parasympatholytics|parasympatholytics|mesh-ancestor
110178207|NCT00144196|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110178208|NCT00144196|Cholinergic Agents|cholinergic agents|mesh-ancestor
110178209|NCT00144196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110178210|NCT00144196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110178211|NCT03276572|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
110178212|NCT03276572|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110178213|NCT03276572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110178214|NCT00144274|Ambroxol|ambroxol|mesh-list
110178215|NCT00144274|Expectorants|expectorants|mesh-ancestor
110178216|NCT00144274|Respiratory System Agents|respiratory system agents|mesh-ancestor
110178217|NCT00144352|Pyrimethamine|pyrimethamine|mesh-list
110178219|NCT00144352|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
110178222|NCT00144352|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110178223|NCT00144352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110178224|NCT00144352|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110178225|NCT00144352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110178226|NCT00144352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110178227|NCT00144352|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110178228|NCT00144430|Pentostatin|pentostatin|mesh-list
110178229|NCT00144430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110178230|NCT00144430|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
110178231|NCT00144430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110178232|NCT00144430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110178233|NCT00144469|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
110178234|NCT00144469|Antiviral Agents|antiviral agents|mesh-ancestor
110178235|NCT00144469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110178236|NCT00404716|Cilostazol|cilostazol|mesh-list
110178237|NCT00404716|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110178238|NCT00404716|Autonomic Agents|autonomic agents|mesh-ancestor
110178239|NCT00404716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110178240|NCT00404716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110178241|NCT00404716|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110178242|NCT00404716|Respiratory System Agents|respiratory system agents|mesh-ancestor
110178243|NCT00404716|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110202669|NCT00154336|Antimetabolites|antimetabolites|mesh-ancestor
110178244|NCT00404716|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110178245|NCT00404716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110178246|NCT00404716|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110178248|NCT00404716|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110178249|NCT00404716|Protective Agents|protective agents|mesh-ancestor
110178250|NCT00404716|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110178251|NCT00404716|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110178252|NCT00404716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110178253|NCT00404794|Mycophenolic Acid|mycophenolic acid|mesh-list
110178255|NCT00404794|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110178256|NCT00404794|Methylprednisolone|methylprednisolone|mesh-list
110178257|NCT00404794|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110178258|NCT00404794|Prednisolone acetate|prednisolone acetate|mesh-list
110178259|NCT00404794|Tacrolimus|tacrolimus|mesh-list
110178260|NCT00404794|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110178261|NCT00404794|Prednisolone phosphate|prednisolone phosphate|mesh-list
110178262|NCT00404794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110178263|NCT00404794|Immunologic Factors|immunologic factors|mesh-ancestor
110178264|NCT00404794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110178265|NCT00404794|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110178266|NCT00404794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110178267|NCT00404794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110178268|NCT00404794|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110178269|NCT00404794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110178270|NCT00404794|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110178271|NCT00404794|Antitubercular Agents|antitubercular agents|mesh-ancestor
110178272|NCT00404794|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110178273|NCT00404794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110178274|NCT00404794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110178275|NCT00404794|Glucocorticoids|glucocorticoids|mesh-ancestor
110178277|NCT00404794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110202782|NCT00083460|Dexamethasone|dexamethasone|mesh-list
110178279|NCT00404794|Antiemetics|antiemetics|mesh-ancestor
110178280|NCT00404794|Autonomic Agents|autonomic agents|mesh-ancestor
110178281|NCT00404794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110178282|NCT00404794|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110178283|NCT00404794|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110178284|NCT00404794|Protective Agents|protective agents|mesh-ancestor
110178285|NCT00404833|Mycophenolic Acid|mycophenolic acid|mesh-list
110178286|NCT00404833|Prednisolone|prednisolone|mesh-list
110178287|NCT00404833|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
110178288|NCT00404833|Methylprednisolone|methylprednisolone|mesh-list
110178289|NCT00404833|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
110178290|NCT00404833|Prednisolone acetate|prednisolone acetate|mesh-list
110178292|NCT00404833|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
110178293|NCT00404833|Prednisolone phosphate|prednisolone phosphate|mesh-list
110178294|NCT00404833|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110178295|NCT00404833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110178296|NCT00404833|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110202846|NCT00043953|Antimetabolites|antimetabolites|mesh-ancestor
110178297|NCT00404833|Antitubercular Agents|antitubercular agents|mesh-ancestor
110178298|NCT00404833|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110178299|NCT00404833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110178300|NCT00404833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110178301|NCT00404833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110178302|NCT00404833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110178303|NCT00404833|Glucocorticoids|glucocorticoids|mesh-ancestor
110178304|NCT00404833|Hormones|hormones|mesh-ancestor
110178305|NCT00404833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110178306|NCT00404833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110178307|NCT00404833|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110178308|NCT00404833|Antiemetics|antiemetics|mesh-ancestor
110178309|NCT00404833|Autonomic Agents|autonomic agents|mesh-ancestor
110178310|NCT00404833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110178311|NCT00404833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110178312|NCT00404833|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110178313|NCT00404833|Protective Agents|protective agents|mesh-ancestor
110178314|NCT00404833|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110178315|NCT00404833|Alkylating Agents|alkylating agents|mesh-ancestor
110178316|NCT05595109|Silymarin|silymarin|mesh-list
110178317|NCT05595109|Antioxidants|antioxidants|mesh-ancestor
110178318|NCT05595109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110178319|NCT05595109|Protective Agents|protective agents|mesh-ancestor
110178320|NCT05595109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110178321|NCT03128021|Milnacipran|milnacipran|mesh-list
110178322|NCT03128021|Levomilnacipran|levomilnacipran|mesh-list
110178323|NCT03128021|Escitalopram|escitalopram|mesh-list
110178324|NCT03128021|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110178325|NCT03128021|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110178326|NCT03128021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110178327|NCT03128021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110276113|NCT04230187|Antidotes|antidotes|mesh-ancestor
110178328|NCT03128021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110178329|NCT03128021|Serotonin Agents|serotonin agents|mesh-ancestor
110178330|NCT03128021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110178331|NCT03128021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110178332|NCT03128021|Antidepressive Agents|antidepressive agents|mesh-ancestor
110178333|NCT03128021|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110178334|NCT03128021|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
110178335|NCT03128021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110178336|NCT03128021|Analgesics|analgesics|mesh-ancestor
110178337|NCT03128021|Sensory System Agents|sensory system agents|mesh-ancestor
110178338|NCT01807494|Cimetidine|cimetidine|mesh-list
110178339|NCT01807494|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110178340|NCT01807494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110178341|NCT01807494|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
110178342|NCT01807494|Histamine Antagonists|histamine antagonists|mesh-ancestor
110178343|NCT01807494|Histamine Agents|histamine agents|mesh-ancestor
110178344|NCT01807494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110178345|NCT01807494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110178346|NCT01807494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110178347|NCT01807494|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110178348|NCT01807494|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110178351|NCT01807455|Anesthetics, Local|anesthetics, local|mesh-ancestor
110178352|NCT01807455|Anesthetics|anesthetics|mesh-ancestor
110178353|NCT01807455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110178354|NCT01807455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110178355|NCT01807455|Sensory System Agents|sensory system agents|mesh-ancestor
110178356|NCT01807455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110178357|NCT01807455|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110178358|NCT01807455|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110178359|NCT01807455|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110178360|NCT01807455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110178361|NCT01807455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110178362|NCT05594017|Scopolamine|scopolamine|mesh-list
110178363|NCT05594017|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
110178364|NCT05594017|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110178365|NCT05594017|Antiemetics|antiemetics|mesh-ancestor
110178366|NCT05594017|Autonomic Agents|autonomic agents|mesh-ancestor
110178367|NCT05594017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110178368|NCT05594017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110178369|NCT05594017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110178370|NCT05594017|Mydriatics|mydriatics|mesh-ancestor
110178371|NCT05594017|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
110178372|NCT05594017|Cholinergic Agents|cholinergic agents|mesh-ancestor
110178373|NCT05594017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110178374|NCT05594017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110178375|NCT05594017|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
110178376|NCT05594017|Parasympatholytics|parasympatholytics|mesh-ancestor
110178377|NCT03092453|Cyclophosphamide|cyclophosphamide|mesh-list
110178378|NCT03092453|Pembrolizumab|pembrolizumab|mesh-list
110178379|NCT03092453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110178380|NCT03092453|Immunologic Factors|immunologic factors|mesh-ancestor
110178381|NCT03092453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110178382|NCT03092453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110178383|NCT03092453|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110178384|NCT03092453|Alkylating Agents|alkylating agents|mesh-ancestor
110178385|NCT03092453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110178386|NCT03092453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110178387|NCT03092453|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110178388|NCT03092453|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110178389|NCT03092453|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110178390|NCT01807377|Midazolam|midazolam|mesh-list
110178391|NCT01807377|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110178392|NCT01807377|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110178393|NCT01807377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110178394|NCT01807377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110178395|NCT01807377|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110178396|NCT01807377|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110178397|NCT01807377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110178398|NCT01807377|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110178399|NCT01807377|Anesthetics, General|anesthetics, general|mesh-ancestor
110178400|NCT01807377|Anesthetics|anesthetics|mesh-ancestor
110178401|NCT01807377|GABA Modulators|gaba modulators|mesh-ancestor
110178402|NCT01807377|GABA Agents|gaba agents|mesh-ancestor
110178403|NCT01807377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110178404|NCT01807377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110178406|NCT03090737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110178407|NCT03090737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110178408|NCT03090737|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110178409|NCT03090737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110178410|NCT02972255|Meropenem|meropenem|mesh-list
110178411|NCT02972255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110178412|NCT02972255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110178413|NCT05468671|Remifentanil|remifentanil|mesh-list
110178414|NCT05468671|Oxycodone|oxycodone|mesh-list
110178415|NCT05468671|Propofol|propofol|mesh-list
110178416|NCT05468671|Rocuronium|rocuronium|mesh-list
110178417|NCT05468671|Flumazenil|flumazenil|mesh-list
110178418|NCT05468671|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110178419|NCT05468671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110178420|NCT05468671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110178421|NCT05468671|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110178422|NCT05468671|Anesthetics, General|anesthetics, general|mesh-ancestor
110178423|NCT05468671|Anesthetics|anesthetics|mesh-ancestor
110178424|NCT05468671|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110178425|NCT05468671|Narcotics|narcotics|mesh-ancestor
110178426|NCT05468671|Analgesics|analgesics|mesh-ancestor
110178427|NCT05468671|Sensory System Agents|sensory system agents|mesh-ancestor
110178428|NCT05468671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110178429|NCT05468671|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
110178430|NCT05468671|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
110178431|NCT05468671|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110178432|NCT05468671|Antidotes|antidotes|mesh-ancestor
110178433|NCT05468671|Protective Agents|protective agents|mesh-ancestor
110178434|NCT05468671|GABA Modulators|gaba modulators|mesh-ancestor
110178435|NCT05468671|GABA Agents|gaba agents|mesh-ancestor
110178436|NCT05468671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110178439|NCT05461807|Apixaban|apixaban|mesh-list
110178440|NCT05461807|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110178441|NCT05461807|Antithrombins|antithrombins|mesh-ancestor
110178442|NCT05461807|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110178443|NCT05461807|Protease Inhibitors|protease inhibitors|mesh-ancestor
110178444|NCT05461807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110178445|NCT05461807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110178446|NCT05461807|Anticoagulants|anticoagulants|mesh-ancestor
110178447|NCT03079427|Cisplatin|cisplatin|mesh-list
110178448|NCT03079427|Gemcitabine|gemcitabine|mesh-list
110178449|NCT03079427|Capecitabine|capecitabine|mesh-list
110178450|NCT03079427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110178451|NCT03079427|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110178452|NCT03079427|Antimetabolites|antimetabolites|mesh-ancestor
110178453|NCT03079427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110178454|NCT00390923|Selegiline|selegiline|mesh-list
110178455|NCT00390923|Nicotine|nicotine|mesh-list
110178456|NCT00390923|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110178457|NCT00390923|Autonomic Agents|autonomic agents|mesh-ancestor
110178458|NCT00390923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110178459|NCT00390923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110178460|NCT00390923|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110178461|NCT00390923|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110178462|NCT00390923|Cholinergic Agents|cholinergic agents|mesh-ancestor
110178463|NCT00390923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110178464|NCT00390923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110285631|NCT00233805|Immunologic Factors|immunologic factors|mesh-ancestor
110178465|NCT00390923|Antidepressive Agents|antidepressive agents|mesh-ancestor
110178466|NCT00390923|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110178467|NCT00390923|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110178468|NCT00390923|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110178469|NCT00390923|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
110178470|NCT00390923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110178471|NCT00390923|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110178472|NCT00390923|Protective Agents|protective agents|mesh-ancestor
110178473|NCT00425425|Fluorouracil|fluorouracil|mesh-list
110178474|NCT00425425|Oxaliplatin|oxaliplatin|mesh-list
110178475|NCT00425425|Cetuximab|cetuximab|mesh-list
110178476|NCT00425425|Antimetabolites|antimetabolites|mesh-ancestor
110178477|NCT00425425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110178478|NCT00425425|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110178479|NCT00425425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110178480|NCT00425425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110178481|NCT00425425|Immunologic Factors|immunologic factors|mesh-ancestor
110178482|NCT00425425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110178483|NCT00425425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110178486|NCT01806948|Autonomic Agents|autonomic agents|mesh-ancestor
110178487|NCT01806948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110178488|NCT01806948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110203482|NCT00159952|Insulin|insulin|mesh-list
110178489|NCT01806948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110178490|NCT01806948|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110178491|NCT01806948|Serotonin Agents|serotonin agents|mesh-ancestor
110178492|NCT01806948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110178493|NCT01806948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110178495|NCT02958163|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110178496|NCT02958163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110178497|NCT02958163|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110178498|NCT02958163|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110178499|NCT02958163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110178500|NCT02958163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110178502|NCT00424138|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110178503|NCT00424138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110178504|NCT02985866|Pancrelipase|pancrelipase|mesh-list
110178505|NCT02985866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110178506|NCT01806792|Cholecalciferol|cholecalciferol|mesh-list
110178507|NCT01806792|Risedronic Acid|risedronic acid|mesh-list
110178508|NCT01806792|Etidronic Acid|etidronic acid|mesh-list
110178509|NCT01806792|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110178510|NCT01806792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110178512|NCT01806792|Micronutrients|micronutrients|mesh-ancestor
110178513|NCT01806792|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110178517|NCT05228431|Capecitabine|capecitabine|mesh-list
110178518|NCT05228431|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110203600|NCT00160849|Lopinavir|lopinavir|mesh-list
110178519|NCT05228431|Antimetabolites|antimetabolites|mesh-ancestor
110178520|NCT05228431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110178521|NCT05228431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110178522|NCT05227456|Etonogestrel|etonogestrel|mesh-list
110178523|NCT05227456|Desogestrel|desogestrel|mesh-list
110178524|NCT05227456|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110203674|NCT00044577|Tenofovir|tenofovir|mesh-list
110178525|NCT05227456|Contraceptive Agents|contraceptive agents|mesh-ancestor
110178526|NCT05227456|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110178527|NCT05227456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110178528|NCT05227456|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110178529|NCT05227456|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110178530|NCT05227456|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110178531|NCT05227456|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110178532|NCT05227456|Progestins|progestins|mesh-ancestor
110178533|NCT05227456|Hormones|hormones|mesh-ancestor
110178534|NCT05227456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110178535|NCT01806753|Midazolam|midazolam|mesh-list
110178536|NCT01806753|Propofol|propofol|mesh-list
110178537|NCT01806753|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110178538|NCT01806753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110178539|NCT01806753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110178540|NCT01806753|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110178541|NCT01806753|Anesthetics, General|anesthetics, general|mesh-ancestor
110178543|NCT01806753|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110178544|NCT01806753|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110178545|NCT01806753|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110178546|NCT01806753|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110178547|NCT01806753|GABA Modulators|gaba modulators|mesh-ancestor
110178548|NCT01806753|GABA Agents|gaba agents|mesh-ancestor
110203735|NCT00044616|Fluoxetine|fluoxetine|mesh-list
110178549|NCT01806753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110178550|NCT01806753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110178551|NCT01806675|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
110178552|NCT01806675|Glycine|glycine|mesh-list
110178553|NCT01806675|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
110178554|NCT01806675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110178557|NCT01806675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110178558|NCT02762981|Paclitaxel|paclitaxel|mesh-list
110178559|NCT02762981|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
110178560|NCT02762981|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110178561|NCT02762981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110178562|NCT02762981|Tubulin Modulators|tubulin modulators|mesh-ancestor
110178563|NCT02762981|Antimitotic Agents|antimitotic agents|mesh-ancestor
110178564|NCT02762981|Mitosis Modulators|mitosis modulators|mesh-ancestor
110178565|NCT02762981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110178566|NCT05065567|Droperidol|droperidol|mesh-list
110178567|NCT05065567|Haloperidol|haloperidol|mesh-list
110178568|NCT05065567|Ondansetron|ondansetron|mesh-list
110178569|NCT05065567|Haloperidol decanoate|haloperidol decanoate|mesh-list
110178570|NCT05065567|Antiemetics|antiemetics|mesh-ancestor
110178571|NCT05065567|Autonomic Agents|autonomic agents|mesh-ancestor
110178572|NCT05065567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110203844|NCT00407056|Hormones|hormones|mesh-ancestor
110178573|NCT05065567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110178574|NCT05065567|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110178576|NCT05065567|Dermatologic Agents|dermatologic agents|mesh-ancestor
110178577|NCT05065567|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
110178578|NCT05065567|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110178579|NCT05065567|Serotonin Agents|serotonin agents|mesh-ancestor
110178580|NCT05065567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110178581|NCT05065567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110178582|NCT05065567|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110178583|NCT05065567|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110178584|NCT05065567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110178585|NCT05065567|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110178586|NCT05065567|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110178587|NCT05065567|Dopamine Agents|dopamine agents|mesh-ancestor
110178588|NCT05065567|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110178589|NCT05065567|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110178590|NCT05065567|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110178591|NCT04958044|Calcium|calcium|mesh-list
110178592|NCT04958044|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110178593|NCT04958044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110178594|NCT04871308|Dexmedetomidine|dexmedetomidine|mesh-list
110178595|NCT04871308|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110178596|NCT04871308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110178597|NCT04871308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110178598|NCT04871308|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110178600|NCT04871308|Sensory System Agents|sensory system agents|mesh-ancestor
110178601|NCT04871308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110178602|NCT04871308|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
110178603|NCT04871308|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110178604|NCT04871308|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110178605|NCT04871308|Adrenergic Agents|adrenergic agents|mesh-ancestor
110178606|NCT04871308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110178607|NCT04871308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110178608|NCT01806363|Telmisartan|telmisartan|mesh-list
110178609|NCT01806363|Chlorthalidone|chlorthalidone|mesh-list
110178610|NCT01806363|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110178611|NCT01806363|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110285646|NCT01083316|Antiemetics|antiemetics|mesh-ancestor
110178612|NCT01806363|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110178613|NCT01806363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110178614|NCT01806363|Diuretics|diuretics|mesh-ancestor
110178616|NCT01806363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110178617|NCT01806363|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
110178618|NCT01806363|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110178619|NCT04846855|Anesthetics|anesthetics|mesh-list
110178620|NCT04846855|Anesthetics, Local|anesthetics, local|mesh-list
110178621|NCT04846855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110178622|NCT04846855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110178623|NCT04846855|Sensory System Agents|sensory system agents|mesh-ancestor
110178624|NCT04846855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110178626|NCT02964403|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110178627|NCT02964403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110178628|NCT02964403|Analgesics|analgesics|mesh-ancestor
110178629|NCT02964403|Sensory System Agents|sensory system agents|mesh-ancestor
110178630|NCT02964403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110178631|NCT02964403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110178632|NCT02964403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110178633|NCT02964403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110178634|NCT02964403|Gout Suppressants|gout suppressants|mesh-ancestor
110178635|NCT02964403|Tocolytic Agents|tocolytic agents|mesh-ancestor
110178636|NCT02964403|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110178637|NCT02964403|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110178638|NCT02964403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110178639|NCT02964403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110178642|NCT04749043|Anesthetics, General|anesthetics, general|mesh-ancestor
110178644|NCT04749043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110178645|NCT04749043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110178646|NCT04749043|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110178647|NCT04749043|Analgesics|analgesics|mesh-ancestor
110178648|NCT04749043|Sensory System Agents|sensory system agents|mesh-ancestor
110178649|NCT04749043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110178650|NCT00393393|Hylan|hylan|mesh-list
110178651|NCT00393393|Viscosupplements|viscosupplements|mesh-ancestor
110178652|NCT00393393|Protective Agents|protective agents|mesh-ancestor
110178653|NCT00393393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110178654|NCT00405262|Ketorolac|ketorolac|mesh-list
110178655|NCT00405262|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
110178656|NCT00405262|Bupivacaine|bupivacaine|mesh-list
110178657|NCT00405262|Anesthetics, Local|anesthetics, local|mesh-ancestor
110178658|NCT00405262|Anesthetics|anesthetics|mesh-ancestor
110178659|NCT00405262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110178660|NCT00405262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110178661|NCT00405262|Sensory System Agents|sensory system agents|mesh-ancestor
110178662|NCT00405262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110178663|NCT00405262|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110178664|NCT00405262|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110178666|NCT00405262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110178667|NCT00405262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110178668|NCT00405262|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110178669|NCT00405262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110178670|NCT00405262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110178671|NCT00405301|Rifampin|rifampin|mesh-list
110178672|NCT00405301|Pyrazinamide|pyrazinamide|mesh-list
110178673|NCT00405301|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110178674|NCT00405301|Antitubercular Agents|antitubercular agents|mesh-ancestor
110178675|NCT00405301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110178676|NCT00405301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110178677|NCT00405301|Leprostatic Agents|leprostatic agents|mesh-ancestor
110178678|NCT00405301|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110178679|NCT00405301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110178680|NCT00405301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110178681|NCT00405301|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110285650|NCT01083316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110178682|NCT00405301|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110178683|NCT00405301|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
110178684|NCT00405301|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
110178685|NCT00405301|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
110178686|NCT00405301|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110178687|NCT00405340|Rituximab|rituximab|mesh-list
110178688|NCT00405340|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110178689|NCT00405340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110178690|NCT00405340|Immunologic Factors|immunologic factors|mesh-ancestor
110178691|NCT00405340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110178692|NCT00405340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110178693|NCT04713319|Calcium|calcium|mesh-list
110178694|NCT04713319|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110178695|NCT04713319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110178696|NCT00393471|Etanercept|etanercept|mesh-list
110178697|NCT00393471|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110178698|NCT00393471|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110178699|NCT00393471|Analgesics|analgesics|mesh-ancestor
110178700|NCT00393471|Sensory System Agents|sensory system agents|mesh-ancestor
110178701|NCT00393471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110178702|NCT00393471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110178703|NCT00393471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110178704|NCT00393471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110178705|NCT00393471|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110178706|NCT00393471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110178707|NCT00393471|Immunologic Factors|immunologic factors|mesh-ancestor
110178709|NCT02647892|Anesthetics, Local|anesthetics, local|mesh-ancestor
110178710|NCT02647892|Anesthetics|anesthetics|mesh-ancestor
110178711|NCT02647892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110178712|NCT02647892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110178713|NCT02647892|Sensory System Agents|sensory system agents|mesh-ancestor
110178714|NCT02647892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110178715|NCT02647892|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110178716|NCT02647892|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110178717|NCT02647892|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110178718|NCT02647892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110178719|NCT02647892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110178720|NCT01806090|Clopidogrel|clopidogrel|mesh-list
110178721|NCT01806090|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110178722|NCT01806090|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
110204363|NCT00165139|Cyclophosphamide|cyclophosphamide|mesh-list
110178723|NCT01806090|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
110178724|NCT01806090|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110178725|NCT01806090|Purinergic Agents|purinergic agents|mesh-ancestor
110178726|NCT01806090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110178727|NCT01806090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110178728|NCT01806090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110178729|NCT02505893|Sirolimus|sirolimus|mesh-list
110178730|NCT02505893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110178731|NCT02505893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110178732|NCT02505893|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110178733|NCT02505893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110178734|NCT02505893|Antifungal Agents|antifungal agents|mesh-ancestor
110178735|NCT02505893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110178736|NCT02505893|Immunologic Factors|immunologic factors|mesh-ancestor
110178737|NCT02505893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110178738|NCT04341181|Trastuzumab|trastuzumab|mesh-list
110178739|NCT04341181|Atezolizumab|atezolizumab|mesh-list
110178740|NCT04341181|Pertuzumab|pertuzumab|mesh-list
110178741|NCT04341181|Avelumab|avelumab|mesh-list
110178742|NCT04341181|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
110178743|NCT04341181|Niraparib|niraparib|mesh-list
110178744|NCT04341181|Axitinib|axitinib|mesh-list
110178745|NCT04341181|Vemurafenib|vemurafenib|mesh-list
110178746|NCT04341181|Maytansine|maytansine|mesh-list
110178747|NCT04341181|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110178748|NCT04341181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110178749|NCT04341181|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110178750|NCT04341181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110178751|NCT04341181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110178752|NCT04341181|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110204429|NCT00165178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110178753|NCT04341181|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
110178754|NCT04341181|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110178755|NCT04341181|Tubulin Modulators|tubulin modulators|mesh-ancestor
110178756|NCT04341181|Antimitotic Agents|antimitotic agents|mesh-ancestor
110178757|NCT04341181|Mitosis Modulators|mitosis modulators|mesh-ancestor
110178759|NCT04341181|Immunoconjugates|immunoconjugates|mesh-ancestor
110178760|NCT04341181|Immunologic Factors|immunologic factors|mesh-ancestor
110178761|NCT04341181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110178762|NCT01806324|Losartan|losartan|mesh-list
110178763|NCT01806324|Atorvastatin|atorvastatin|mesh-list
110178764|NCT01806324|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110178765|NCT01806324|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110178766|NCT01806324|Antimetabolites|antimetabolites|mesh-ancestor
110178767|NCT01806324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110178768|NCT01806324|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110178769|NCT01806324|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110178770|NCT01806324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110178771|NCT01806324|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110178772|NCT01806324|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110178773|NCT01806324|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
110178774|NCT01806324|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
110178776|NCT02423876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110178777|NCT02423876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110178778|NCT02423876|Sensory System Agents|sensory system agents|mesh-ancestor
110178779|NCT02423876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110178780|NCT02423876|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110178781|NCT02423876|Narcotics|narcotics|mesh-ancestor
110178782|NCT02423876|Analgesics|analgesics|mesh-ancestor
110178783|NCT02316002|Pembrolizumab|pembrolizumab|mesh-list
110178784|NCT02316002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110178785|NCT02316002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110178786|NCT02316002|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110178787|NCT02316002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110178789|NCT01805895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110178790|NCT01805895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110178791|NCT01805856|Cefazolin|cefazolin|mesh-list
110178792|NCT01805856|Piperacillin|piperacillin|mesh-list
110178793|NCT01805856|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110178794|NCT01805856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110178795|NCT01805817|Copper|copper|mesh-list
110178796|NCT01805817|Drospirenone|drospirenone|mesh-list
110178797|NCT01805817|Levonorgestrel|levonorgestrel|mesh-list
110178798|NCT01805817|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110178799|NCT01805817|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
110178800|NCT01805817|Estradiol|estradiol|mesh-list
110178802|NCT01805817|Hormones|hormones|mesh-ancestor
110178803|NCT01805817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110178804|NCT01805817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110178805|NCT01805817|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110178806|NCT01805817|Contraceptive Agents|contraceptive agents|mesh-ancestor
110178807|NCT01805817|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110178808|NCT01805817|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110178809|NCT01805817|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110178810|NCT01805817|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110178811|NCT01805817|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110178812|NCT01805817|Trace Elements|trace elements|mesh-ancestor
110178813|NCT01805817|Micronutrients|micronutrients|mesh-ancestor
110178814|NCT01805817|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
110178815|NCT01805817|Hormone Antagonists|hormone antagonists|mesh-ancestor
110178817|NCT01805817|Diuretics|diuretics|mesh-ancestor
110204652|NCT00166621|Serotonin Agents|serotonin agents|mesh-ancestor
110178818|NCT01805817|Natriuretic Agents|natriuretic agents|mesh-ancestor
110178819|NCT04206046|Anesthetics|anesthetics|mesh-list
110178820|NCT04206046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110178821|NCT04206046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110178822|NCT00405418|Insulin|insulin|mesh-list
110178823|NCT00405418|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110178824|NCT00405418|Insulin Glargine|insulin glargine|mesh-list
110178825|NCT00405418|Insulin Detemir|insulin detemir|mesh-list
110178826|NCT00405418|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110178827|NCT00405418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110178828|NCT02157077|Aflibercept|aflibercept|mesh-list
110178829|NCT02157077|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110178830|NCT02157077|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110178831|NCT02157077|Growth Substances|growth substances|mesh-ancestor
110178832|NCT02157077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110178833|NCT02157077|Growth Inhibitors|growth inhibitors|mesh-ancestor
110178834|NCT02157077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110178836|NCT01805700|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110178837|NCT01805700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110178838|NCT01805700|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110178839|NCT01805700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110178840|NCT01805700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110178841|NCT01805700|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110178842|NCT01805700|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110178843|NCT01805700|Purinergic Agents|purinergic agents|mesh-ancestor
110178844|NCT01805700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110178845|NCT04033276|Rituximab|rituximab|mesh-list
110178846|NCT04033276|Immunoglobulins|immunoglobulins|mesh-list
110178847|NCT04033276|Antibodies|antibodies|mesh-list
110178848|NCT04033276|gamma-Globulins|gamma-globulins|mesh-list
110178849|NCT04033276|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
110178850|NCT04033276|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
110178851|NCT04033276|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110178852|NCT04033276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110178853|NCT04033276|Immunologic Factors|immunologic factors|mesh-ancestor
110178854|NCT04033276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110178855|NCT04033276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110178856|NCT03969823|Osimertinib|osimertinib|mesh-list
110178857|NCT03969823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110178858|NCT03969823|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110178859|NCT03969823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110178860|NCT03969823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110178861|NCT00391157|Dexamethasone|dexamethasone|mesh-list
110178862|NCT00391157|Bortezomib|bortezomib|mesh-list
110178863|NCT00391157|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110178864|NCT00391157|Antiemetics|antiemetics|mesh-ancestor
110178865|NCT00391157|Autonomic Agents|autonomic agents|mesh-ancestor
110178866|NCT00391157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110178867|NCT00391157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110178868|NCT00391157|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110178869|NCT00391157|Glucocorticoids|glucocorticoids|mesh-ancestor
110178870|NCT00391157|Hormones|hormones|mesh-ancestor
110178871|NCT00391157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110178872|NCT00391157|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110178873|NCT00391157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110178874|NCT03781063|Fulvestrant|fulvestrant|mesh-list
110178875|NCT03781063|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110178876|NCT03781063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110178877|NCT03781063|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
110204890|NCT00407251|Epothilone B|epothilone b|mesh-list
110178878|NCT03781063|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110178879|NCT03781063|Hormone Antagonists|hormone antagonists|mesh-ancestor
110178880|NCT03781063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110178881|NCT03781063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110178882|NCT01805544|Rivaroxaban|rivaroxaban|mesh-list
110178883|NCT01805544|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
110178884|NCT01805544|Antithrombins|antithrombins|mesh-ancestor
110178885|NCT01805544|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110178886|NCT01805544|Protease Inhibitors|protease inhibitors|mesh-ancestor
110178887|NCT01805544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110178888|NCT01805544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110178889|NCT01805544|Anticoagulants|anticoagulants|mesh-ancestor
110178891|NCT01903421|Bupivacaine|bupivacaine|mesh-list
110178892|NCT01903421|Anesthetics|anesthetics|mesh-list
110178894|NCT01903421|Sevoflurane|sevoflurane|mesh-list
110178895|NCT01903421|Isoflurane|isoflurane|mesh-list
110178896|NCT01903421|Anesthetics, Local|anesthetics, local|mesh-ancestor
110178897|NCT01903421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110178898|NCT01903421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110178899|NCT01903421|Sensory System Agents|sensory system agents|mesh-ancestor
110178900|NCT01903421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110178901|NCT01903421|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110178902|NCT01903421|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110178903|NCT01903421|Anesthetics, General|anesthetics, general|mesh-ancestor
110178904|NCT01903421|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110178905|NCT01903421|Narcotics|narcotics|mesh-ancestor
110178906|NCT01903421|Analgesics|analgesics|mesh-ancestor
110178907|NCT01903421|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
110178908|NCT01903421|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110178909|NCT01903421|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
110178910|NCT03734731|Analgesics, Opioid|analgesics, opioid|mesh-list
110178911|NCT03734731|Narcotics|narcotics|mesh-ancestor
110178912|NCT03734731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110178913|NCT03734731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110178914|NCT03734731|Analgesics|analgesics|mesh-ancestor
110178915|NCT03734731|Sensory System Agents|sensory system agents|mesh-ancestor
110178916|NCT03734731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110178917|NCT01723839|Cyclophosphamide|cyclophosphamide|mesh-list
110178919|NCT01723839|Fludarabine|fludarabine|mesh-list
110178920|NCT01723839|Lenalidomide|lenalidomide|mesh-list
110178921|NCT01723839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110178922|NCT01723839|Immunologic Factors|immunologic factors|mesh-ancestor
110178923|NCT01723839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110178924|NCT01723839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110178925|NCT01723839|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110178926|NCT01723839|Alkylating Agents|alkylating agents|mesh-ancestor
110178927|NCT01723839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110178928|NCT01723839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110178929|NCT01723839|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110178930|NCT01723839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110178931|NCT01723839|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110178932|NCT01723839|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110178933|NCT01723839|Growth Substances|growth substances|mesh-ancestor
110178934|NCT01723839|Growth Inhibitors|growth inhibitors|mesh-ancestor
110178935|NCT03421483|Folic Acid|folic acid|mesh-list
110178936|NCT03421483|Hematinics|hematinics|mesh-ancestor
110178937|NCT03421483|Vitamin B Complex|vitamin b complex|mesh-ancestor
110178938|NCT03421483|Vitamins|vitamins|mesh-ancestor
110178939|NCT03421483|Micronutrients|micronutrients|mesh-ancestor
110178940|NCT03421483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110178941|NCT03363217|Trametinib|trametinib|mesh-list
110178942|NCT03363217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110178943|NCT03363217|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110178944|NCT03363217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110178945|NCT03363217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110178947|NCT03341143|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110178948|NCT03341143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110178949|NCT03341143|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
110178950|NCT03341143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110178951|NCT03205696|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
110178952|NCT03205696|Antiviral Agents|antiviral agents|mesh-ancestor
110178953|NCT03205696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110178954|NCT00405496|Difluprednate|difluprednate|mesh-list
110178955|NCT00405496|Glucocorticoids|glucocorticoids|mesh-ancestor
110178956|NCT00405496|Hormones|hormones|mesh-ancestor
110178957|NCT00405496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110178958|NCT00405496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110178960|NCT00405535|Glycine Agents|glycine agents|mesh-ancestor
110178961|NCT00405535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110178962|NCT00405535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110178963|NCT00405535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110178964|NCT00405574|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
110178965|NCT00405574|Chelating Agents|chelating agents|mesh-ancestor
110178966|NCT00405574|Sequestering Agents|sequestering agents|mesh-ancestor
110178967|NCT00405574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110178968|NCT00405574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110178969|NCT00405574|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110178970|NCT00405574|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110178971|NCT00405574|Growth Substances|growth substances|mesh-ancestor
110178972|NCT00405574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110178973|NCT00405574|Growth Inhibitors|growth inhibitors|mesh-ancestor
110178974|NCT00405574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110178975|NCT02993029|Celecoxib|celecoxib|mesh-list
110178976|NCT02993029|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110178977|NCT02993029|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110178979|NCT02993029|Sensory System Agents|sensory system agents|mesh-ancestor
110178980|NCT02993029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110178981|NCT02993029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110178982|NCT02993029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110178983|NCT02993029|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110178984|NCT02993029|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110178985|NCT02993029|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110178987|NCT02993029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110178989|NCT02825641|Dinoprostone|dinoprostone|mesh-list
110178990|NCT02825641|Oxytocics|oxytocics|mesh-ancestor
110178991|NCT02825641|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110178992|NCT02825641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110178993|NCT01646034|Paclitaxel|paclitaxel|mesh-list
110178994|NCT01646034|Docetaxel|docetaxel|mesh-list
110178995|NCT01646034|Cyclophosphamide|cyclophosphamide|mesh-list
110178996|NCT01646034|Carboplatin|carboplatin|mesh-list
110178997|NCT01646034|Gemcitabine|gemcitabine|mesh-list
110178998|NCT01646034|Doxorubicin|doxorubicin|mesh-list
110205294|NCT00170872|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110178999|NCT01646034|Thiotepa|thiotepa|mesh-list
110179000|NCT01646034|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110179001|NCT01646034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110179002|NCT01646034|Tubulin Modulators|tubulin modulators|mesh-ancestor
110179003|NCT01646034|Antimitotic Agents|antimitotic agents|mesh-ancestor
110179004|NCT01646034|Mitosis Modulators|mitosis modulators|mesh-ancestor
110179005|NCT01646034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110179006|NCT01646034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110179007|NCT01646034|Immunologic Factors|immunologic factors|mesh-ancestor
110179008|NCT01646034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110179009|NCT01646034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110179010|NCT01646034|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110179011|NCT01646034|Alkylating Agents|alkylating agents|mesh-ancestor
110179012|NCT01646034|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110179013|NCT01646034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110179014|NCT01646034|Antimetabolites|antimetabolites|mesh-ancestor
110179015|NCT01646034|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110179016|NCT01646034|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110179017|NCT01646034|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110179018|NCT01646034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110179020|NCT00391313|Amebicides|amebicides|mesh-ancestor
110179021|NCT00391313|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110179022|NCT00391313|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110179023|NCT00391313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110179024|NCT00391313|Antimalarials|antimalarials|mesh-ancestor
110179025|NCT00391313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110179027|NCT01466517|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110179028|NCT01466517|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110179029|NCT01466517|Analgesics|analgesics|mesh-ancestor
110179030|NCT01466517|Sensory System Agents|sensory system agents|mesh-ancestor
110179031|NCT01466517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110179032|NCT01466517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110179033|NCT01466517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110179034|NCT01466517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110179035|NCT01466517|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110179036|NCT01466517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110179037|NCT01466517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110179038|NCT01466478|Calcitriol|calcitriol|mesh-list
110179039|NCT01466478|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
110179040|NCT01466478|Calcipotriene|calcipotriene|mesh-list
110179042|NCT01466478|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110179043|NCT01466478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110179044|NCT01466478|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
110179045|NCT01466478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110179046|NCT01466478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110179047|NCT01466478|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110179049|NCT01466478|Micronutrients|micronutrients|mesh-ancestor
110179050|NCT01466478|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110179051|NCT01466478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110179052|NCT00063830|Alicaforsen|alicaforsen|mesh-list
110179053|NCT00063830|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110179054|NCT00063830|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110179055|NCT00063830|Immunologic Factors|immunologic factors|mesh-ancestor
110179056|NCT00063830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110179057|NCT00062816|Ribavirin|ribavirin|mesh-list
110179058|NCT00062816|Antimetabolites|antimetabolites|mesh-ancestor
110179059|NCT00062816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110179060|NCT00062816|Antiviral Agents|antiviral agents|mesh-ancestor
110179061|NCT00062816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110179062|NCT00048113|Alicaforsen|alicaforsen|mesh-list
110179063|NCT00048113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110179064|NCT00048113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110179065|NCT00048113|Immunologic Factors|immunologic factors|mesh-ancestor
110179066|NCT00048113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110179067|NCT01466361|Nicotine|nicotine|mesh-list
110179069|NCT01466361|Autonomic Agents|autonomic agents|mesh-ancestor
110179070|NCT01466361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110179071|NCT01466361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110179072|NCT01466361|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110179073|NCT01466361|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110205594|NCT00407719|Bevacizumab|bevacizumab|mesh-list
110179074|NCT01466361|Cholinergic Agents|cholinergic agents|mesh-ancestor
110179075|NCT01466361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110179076|NCT01466361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110179077|NCT00001832|Cyclophosphamide|cyclophosphamide|mesh-list
110179079|NCT00001832|Interleukin-2|interleukin-2|mesh-list
110179080|NCT00001832|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
110179081|NCT00001832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110179082|NCT00001832|Immunologic Factors|immunologic factors|mesh-ancestor
110179083|NCT00001832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110179084|NCT00001832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110179085|NCT00001832|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110179086|NCT00001832|Alkylating Agents|alkylating agents|mesh-ancestor
110179087|NCT00001832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110179088|NCT00001832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110205645|NCT04631484|Riboflavin|riboflavin|mesh-list
110179089|NCT00001832|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110179091|NCT00001832|Analgesics|analgesics|mesh-ancestor
110179092|NCT00001832|Sensory System Agents|sensory system agents|mesh-ancestor
110179093|NCT00001832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110179094|NCT00001832|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110179095|NCT01466244|Cetuximab|cetuximab|mesh-list
110179096|NCT01466244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110179097|NCT01466244|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110179098|NCT01466205|Dihydrexidine|dihydrexidine|mesh-list
110179099|NCT01466205|Dopamine Agonists|dopamine agonists|mesh-ancestor
110179100|NCT01466205|Dopamine Agents|dopamine agents|mesh-ancestor
110179101|NCT01466205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110179102|NCT01466205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110205704|NCT00174226|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110179103|NCT01466205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110179105|NCT01466127|Oxytocics|oxytocics|mesh-ancestor
110179106|NCT01466127|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110179107|NCT01466127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110179109|NCT00009191|Antidepressive Agents|antidepressive agents|mesh-ancestor
110179110|NCT00009191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110179111|NCT00009191|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110179112|NCT00009191|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110179113|NCT00009191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110179114|NCT00009191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110179115|NCT00009191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110179116|NCT00009191|Serotonin Agents|serotonin agents|mesh-ancestor
110179117|NCT00009191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110179118|NCT01466088|Donepezil|donepezil|mesh-list
110179119|NCT01466088|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110179120|NCT01466088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110179121|NCT01466088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110179122|NCT01466088|Cholinergic Agents|cholinergic agents|mesh-ancestor
110179123|NCT01466088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110179124|NCT01466088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110179125|NCT01466088|Nootropic Agents|nootropic agents|mesh-ancestor
110179126|NCT00009230|Celecoxib|celecoxib|mesh-list
110179127|NCT00009230|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110179128|NCT00009230|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110179130|NCT00009230|Sensory System Agents|sensory system agents|mesh-ancestor
110179131|NCT00009230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110179132|NCT00009230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110179133|NCT00009230|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110179134|NCT00009230|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110179135|NCT00009230|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
110179136|NCT00009230|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110179137|NCT00009230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110179138|NCT00009230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110179139|NCT00009581|Acetylcholine|acetylcholine|mesh-list
110179140|NCT00009581|Vasodilator Agents|vasodilator agents|mesh-ancestor
110179141|NCT00009581|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110179142|NCT00009581|Cholinergic Agents|cholinergic agents|mesh-ancestor
110179143|NCT00009581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110179144|NCT00009581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110179145|NCT00009581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110179146|NCT00009620|Phenobarbital|phenobarbital|mesh-list
110179147|NCT00009620|Anticonvulsants|anticonvulsants|mesh-ancestor
110179148|NCT00009620|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110179149|NCT00009620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110179150|NCT00009620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110179151|NCT00009620|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110179152|NCT00009620|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110205951|NCT00056537|Immunoconjugates|immunoconjugates|mesh-ancestor
110179153|NCT00009620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110179154|NCT00009620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110179155|NCT00009620|GABA Modulators|gaba modulators|mesh-ancestor
110179156|NCT00009620|GABA Agents|gaba agents|mesh-ancestor
110179157|NCT00009620|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110179158|NCT00009620|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110179159|NCT00009620|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110179160|NCT00009659|Ulipristal acetate|ulipristal acetate|mesh-list
110206013|NCT00175981|Vasodilator Agents|vasodilator agents|mesh-ancestor
110179161|NCT00009659|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110179162|NCT00009659|Contraceptive Agents|contraceptive agents|mesh-ancestor
110179163|NCT00009659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110179164|NCT00009659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110179165|NCT00009659|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110179166|NCT00009698|Aldesleukin|aldesleukin|mesh-list
110179168|NCT00009698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110179169|NCT00009698|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110179171|NCT00009698|Sensory System Agents|sensory system agents|mesh-ancestor
110179172|NCT00009698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110179173|NCT00009698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110179174|NCT00009698|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110179175|NCT00009698|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110179176|NCT00009698|Antiviral Agents|antiviral agents|mesh-ancestor
110179177|NCT00009698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110179178|NCT01465893|Vitamin D|vitamin d|mesh-list
110179179|NCT01465893|Ergocalciferols|ergocalciferols|mesh-list
110179180|NCT01465893|Cholecalciferol|cholecalciferol|mesh-list
110179181|NCT01465893|Vitamins|vitamins|mesh-list
110179182|NCT01465893|Micronutrients|micronutrients|mesh-ancestor
110285661|NCT01083316|Immunologic Factors|immunologic factors|mesh-ancestor
110179183|NCT01465893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110179184|NCT01465893|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110179185|NCT01465893|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110179186|NCT00009776|Cyclosporine|cyclosporine|mesh-list
110179188|NCT00009776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110179189|NCT00009776|Antibodies|antibodies|mesh-list
110179190|NCT00009776|Immunoglobulins|immunoglobulins|mesh-list
110179191|NCT00009776|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110179192|NCT00009776|Cyclosporins|cyclosporins|mesh-list
110179193|NCT00009776|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110179194|NCT00009776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110179196|NCT00009776|Antimitotic Agents|antimitotic agents|mesh-ancestor
110179197|NCT00009776|Mitosis Modulators|mitosis modulators|mesh-ancestor
110179198|NCT00009776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110179199|NCT00009776|Immunologic Factors|immunologic factors|mesh-ancestor
110179200|NCT00009776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110179201|NCT00009776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110179202|NCT00009776|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110179203|NCT00009776|Antifungal Agents|antifungal agents|mesh-ancestor
110179204|NCT00009776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110179205|NCT00009776|Dermatologic Agents|dermatologic agents|mesh-ancestor
110179206|NCT00009776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110179207|NCT00009776|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110179209|NCT00009815|Etoposide|etoposide|mesh-list
110179210|NCT00009815|Tegafur|tegafur|mesh-list
110179211|NCT00009815|Calcium|calcium|mesh-list
110179212|NCT00009815|Levoleucovorin|levoleucovorin|mesh-list
110179213|NCT00009815|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110179214|NCT00009815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110179215|NCT00009815|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110179216|NCT00009815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110179217|NCT00009815|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110179218|NCT00009815|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110179219|NCT00009815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110179220|NCT00009815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110179221|NCT00009815|Antidotes|antidotes|mesh-ancestor
110179222|NCT00009815|Protective Agents|protective agents|mesh-ancestor
110179223|NCT00009815|Vitamin B Complex|vitamin b complex|mesh-ancestor
110179224|NCT00009815|Vitamins|vitamins|mesh-ancestor
110179225|NCT00009815|Micronutrients|micronutrients|mesh-ancestor
110179226|NCT00009815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110179227|NCT00009815|Antimetabolites|antimetabolites|mesh-ancestor
110179228|NCT01465815|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110179229|NCT01465815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110179230|NCT01465815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110179232|NCT01465815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110179235|NCT00009854|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
110179236|NCT00009854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110179237|NCT00009854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110179238|NCT00009854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110179239|NCT00009854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110179241|NCT00009854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110179242|NCT00009854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110179243|NCT00009893|Leucovorin|leucovorin|mesh-list
110179244|NCT00009893|Gemcitabine|gemcitabine|mesh-list
110179245|NCT00009893|Fluorouracil|fluorouracil|mesh-list
110179246|NCT00009893|Calcium|calcium|mesh-list
110179247|NCT00009893|Levoleucovorin|levoleucovorin|mesh-list
110206357|NCT00179023|Ephedrine|ephedrine|mesh-list
110179248|NCT00009893|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110179249|NCT00009893|Antimetabolites|antimetabolites|mesh-ancestor
110179250|NCT00009893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110179251|NCT00009893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110179252|NCT00009893|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110179253|NCT00009893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110179254|NCT00009893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110179255|NCT00009893|Immunologic Factors|immunologic factors|mesh-ancestor
110179256|NCT00009893|Antidotes|antidotes|mesh-ancestor
110179257|NCT00009893|Protective Agents|protective agents|mesh-ancestor
110179258|NCT00009893|Vitamin B Complex|vitamin b complex|mesh-ancestor
110179259|NCT00009893|Vitamins|vitamins|mesh-ancestor
110179260|NCT00009893|Micronutrients|micronutrients|mesh-ancestor
110179261|NCT00009971|Fenretinide|fenretinide|mesh-list
110179262|NCT00009971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110179264|NCT00009971|Protective Agents|protective agents|mesh-ancestor
110179265|NCT00009971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110179266|NCT00010010|Exemestane|exemestane|mesh-list
110179267|NCT00010010|Goserelin|goserelin|mesh-list
110179268|NCT00010010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110179269|NCT00010010|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
110179270|NCT00010010|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110179271|NCT00010010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110179272|NCT00010010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110179273|NCT00010010|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110179274|NCT00010010|Hormone Antagonists|hormone antagonists|mesh-ancestor
110179275|NCT00010010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110179276|NCT00010010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110179277|NCT00010010|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110179278|NCT00010049|Imatinib Mesylate|imatinib mesylate|mesh-list
110179279|NCT00010049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110179280|NCT00010049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110179281|NCT00010049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110206533|NCT00180115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110179282|NCT00010049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110179283|NCT00010088|Leucovorin|leucovorin|mesh-list
110179284|NCT00010088|Gemcitabine|gemcitabine|mesh-list
110179285|NCT00010088|Fluorouracil|fluorouracil|mesh-list
110179286|NCT00010088|Calcium|calcium|mesh-list
110179287|NCT00010088|Levoleucovorin|levoleucovorin|mesh-list
110179288|NCT00010088|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110179289|NCT00010088|Antimetabolites|antimetabolites|mesh-ancestor
110179290|NCT00010088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110179291|NCT00010088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110179292|NCT00010088|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110179293|NCT00010088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110179294|NCT00010088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110179295|NCT00010088|Immunologic Factors|immunologic factors|mesh-ancestor
110179296|NCT00010088|Antidotes|antidotes|mesh-ancestor
110179297|NCT00010088|Protective Agents|protective agents|mesh-ancestor
110179298|NCT00010088|Vitamin B Complex|vitamin b complex|mesh-ancestor
110179301|NCT01465503|Heparin|heparin|mesh-list
110179302|NCT01465503|Calcium heparin|calcium heparin|mesh-list
110179303|NCT01465503|Hirudins|hirudins|mesh-list
110179304|NCT01465503|Bivalirudin|bivalirudin|mesh-list
110179305|NCT01465503|Anticoagulants|anticoagulants|mesh-ancestor
110179306|NCT01465503|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110179307|NCT01465503|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110179308|NCT01465503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110179309|NCT01465503|Antithrombins|antithrombins|mesh-ancestor
110179310|NCT01465503|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
110179312|NCT01465503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110179314|NCT00010166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110179315|NCT00010166|Antimetabolites|antimetabolites|mesh-ancestor
110179316|NCT00010166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110179317|NCT00010166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110179319|NCT01465152|Repaglinide|repaglinide|mesh-list
110179320|NCT01465152|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110179321|NCT01465152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110179322|NCT01465113|Vitamin D|vitamin d|mesh-list
110179323|NCT01465113|Ergocalciferols|ergocalciferols|mesh-list
110179324|NCT01465113|Cholecalciferol|cholecalciferol|mesh-list
110179326|NCT01465113|Metformin|metformin|mesh-list
110179327|NCT01465113|Omeprazole|omeprazole|mesh-list
110179328|NCT01465113|Micronutrients|micronutrients|mesh-ancestor
110179329|NCT01465113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110179330|NCT01465113|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110179331|NCT01465113|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110179332|NCT01465113|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110179333|NCT01465113|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
110179334|NCT01465113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110179335|NCT01465113|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
110179336|NCT01465113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110179337|NCT01465113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110179338|NCT01465074|Nicotine|nicotine|mesh-list
110179339|NCT01465074|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
110179342|NCT01465074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110179343|NCT01465074|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
110179344|NCT01465074|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
110179345|NCT01465074|Cholinergic Agents|cholinergic agents|mesh-ancestor
110179346|NCT01465074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110179347|NCT01465074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110179348|NCT00010283|Beclomethasone|beclomethasone|mesh-list
110179349|NCT00010283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110179350|NCT00010283|Glucocorticoids|glucocorticoids|mesh-ancestor
110179351|NCT00010283|Hormones|hormones|mesh-ancestor
110179352|NCT00010283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110179353|NCT00010283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110179355|NCT00010283|Respiratory System Agents|respiratory system agents|mesh-ancestor
110179356|NCT00010322|Toremifene|toremifene|mesh-list
110179358|NCT00010322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110179359|NCT00010322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110179360|NCT00010322|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110179361|NCT00010322|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110179362|NCT00010322|Hormone Antagonists|hormone antagonists|mesh-ancestor
110179363|NCT00010322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110179364|NCT00010322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110179365|NCT00010322|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110179366|NCT00010322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110179367|NCT00010322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110179368|NCT00010361|Cyclosporine|cyclosporine|mesh-list
110179369|NCT00010361|Mycophenolic Acid|mycophenolic acid|mesh-list
110179370|NCT00010361|Fludarabine|fludarabine|mesh-list
110179371|NCT00010361|Cyclosporins|cyclosporins|mesh-list
110179372|NCT00010361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110179373|NCT00010361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110179374|NCT00010361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110179375|NCT00010361|Immunologic Factors|immunologic factors|mesh-ancestor
110179376|NCT00010361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110179377|NCT00010361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110179378|NCT00010361|Antifungal Agents|antifungal agents|mesh-ancestor
110179379|NCT00010361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110179380|NCT00010361|Dermatologic Agents|dermatologic agents|mesh-ancestor
110179381|NCT00010361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110179382|NCT00010361|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110179383|NCT00010361|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110179384|NCT00010361|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110179385|NCT00010361|Antitubercular Agents|antitubercular agents|mesh-ancestor
110179387|NCT00010400|Cyclophosphamide|cyclophosphamide|mesh-list
110285669|NCT00208793|Calcium, Dietary|calcium, dietary|mesh-list
110179388|NCT00010400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110179389|NCT00010400|Immunologic Factors|immunologic factors|mesh-ancestor
110179390|NCT00010400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110179391|NCT00010400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110179392|NCT00010400|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110179393|NCT00010400|Alkylating Agents|alkylating agents|mesh-ancestor
110179394|NCT00010400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110179395|NCT00010400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110206866|NCT00057512|Masoprocol|masoprocol|mesh-list
110179396|NCT00010400|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110179398|NCT01464840|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110179399|NCT01464840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110179400|NCT01464801|Resveratrol|resveratrol|mesh-list
110179401|NCT01464801|Antioxidants|antioxidants|mesh-ancestor
110179402|NCT01464801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110179403|NCT01464801|Protective Agents|protective agents|mesh-ancestor
110179404|NCT01464801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110179405|NCT01464801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110179406|NCT01464801|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110179407|NCT01464762|Bedaquiline|bedaquiline|mesh-list
110179408|NCT01464762|Antitubercular Agents|antitubercular agents|mesh-ancestor
110179409|NCT01464762|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110179410|NCT01464762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110179411|NCT02035358|Immunomodulating Agents|immunomodulating agents|mesh-list
110179412|NCT02035358|Immunologic Factors|immunologic factors|mesh-ancestor
110179413|NCT02035358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110179414|NCT01464723|Ranibizumab|ranibizumab|mesh-list
110179415|NCT01464723|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110179416|NCT01464723|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110179417|NCT01464723|Growth Substances|growth substances|mesh-ancestor
110179418|NCT01464723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110179419|NCT01464723|Growth Inhibitors|growth inhibitors|mesh-ancestor
110179420|NCT01464723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110179421|NCT01464606|Dactinomycin|dactinomycin|mesh-list
110179422|NCT01464606|Cyclophosphamide|cyclophosphamide|mesh-list
110179423|NCT01464606|Ifosfamide|ifosfamide|mesh-list
110179424|NCT01464606|Doxorubicin|doxorubicin|mesh-list
110179425|NCT01464606|Vincristine|vincristine|mesh-list
110179426|NCT01464606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110179427|NCT01464606|Immunologic Factors|immunologic factors|mesh-ancestor
110179428|NCT01464606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110179429|NCT01464606|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110179430|NCT01464606|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110179431|NCT01464606|Alkylating Agents|alkylating agents|mesh-ancestor
110206914|NCT00183820|Paclitaxel|paclitaxel|mesh-list
110179432|NCT01464606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110179433|NCT01464606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110179434|NCT01464606|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110179435|NCT01464606|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110179436|NCT01464606|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110179437|NCT01464606|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110179438|NCT01464606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110179439|NCT01464606|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110179440|NCT01464606|Tubulin Modulators|tubulin modulators|mesh-ancestor
110179441|NCT01464606|Antimitotic Agents|antimitotic agents|mesh-ancestor
110179442|NCT01464606|Mitosis Modulators|mitosis modulators|mesh-ancestor
110179443|NCT01464606|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110179444|NCT01464606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110179445|NCT01464606|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
110179446|NCT01464606|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110179447|NCT01464528|Hyaluronic Acid|hyaluronic acid|mesh-list
110179448|NCT01464528|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110179449|NCT01464528|Immunologic Factors|immunologic factors|mesh-ancestor
110179450|NCT01464528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110179451|NCT01464528|Viscosupplements|viscosupplements|mesh-ancestor
110179452|NCT01464528|Protective Agents|protective agents|mesh-ancestor
110179453|NCT00393744|Amoxicillin|amoxicillin|mesh-list
110179454|NCT00393744|Pristinamycin|pristinamycin|mesh-list
110179455|NCT00393744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110179456|NCT00393744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110179458|NCT00011297|Lorazepam|lorazepam|mesh-list
110179459|NCT00011297|Analgesics|analgesics|mesh-ancestor
110179460|NCT00011297|Sensory System Agents|sensory system agents|mesh-ancestor
110179461|NCT00011297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110179462|NCT00011297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110179464|NCT00011297|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110179465|NCT00011297|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110179466|NCT00011297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110179468|NCT00011297|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110179469|NCT00011297|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110179470|NCT00011297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110179471|NCT00011297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110179472|NCT00011297|Antimanic Agents|antimanic agents|mesh-ancestor
110179474|NCT00011297|Autonomic Agents|autonomic agents|mesh-ancestor
110179475|NCT00011297|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110179476|NCT00011297|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110179477|NCT00011297|GABA Modulators|gaba modulators|mesh-ancestor
110179478|NCT00011297|GABA Agents|gaba agents|mesh-ancestor
110179479|NCT00011375|Rolipram|rolipram|mesh-list
110179480|NCT00011375|Antidepressive Agents|antidepressive agents|mesh-ancestor
110179481|NCT00011375|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110179482|NCT00011375|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
110179483|NCT00011375|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110179484|NCT00011375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110179485|NCT00011375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110179486|NCT00847938|Neostigmine|neostigmine|mesh-list
110179487|NCT00847938|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110179488|NCT00847938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110179489|NCT00847938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110179490|NCT00847938|Cholinergic Agents|cholinergic agents|mesh-ancestor
110179491|NCT00847938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110179492|NCT00847938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110179493|NCT00847938|Parasympathomimetics|parasympathomimetics|mesh-ancestor
110179494|NCT00847938|Autonomic Agents|autonomic agents|mesh-ancestor
110179495|NCT00847938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110179496|NCT00847899|1-(1-acetyl-piperidine-4-yl)-3-adamantan-1-yl-urea|1-(1-acetyl-piperidine-4-yl)-3-adamantan-1-yl-urea|mesh-list
110179497|NCT00847899|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110179498|NCT00847899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110179500|NCT00847860|Aspirin|aspirin|mesh-list
110179501|NCT00847860|Cilostazol|cilostazol|mesh-list
110207060|NCT00058292|Melphalan|melphalan|mesh-list
110179502|NCT00847860|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110179503|NCT00847860|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110179505|NCT00847860|Sensory System Agents|sensory system agents|mesh-ancestor
110179506|NCT00847860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110179507|NCT00847860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110179508|NCT00847860|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110179509|NCT00847860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110179510|NCT00847860|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110179511|NCT00847860|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110179512|NCT00847860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110179513|NCT00847860|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
110179514|NCT00847860|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110179515|NCT00847860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110179516|NCT00847860|Antipyretics|antipyretics|mesh-ancestor
110179517|NCT00847860|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110179518|NCT00847860|Autonomic Agents|autonomic agents|mesh-ancestor
110179519|NCT00847860|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110207106|NCT00184990|Pimagedine|pimagedine|mesh-list
110179520|NCT00847860|Respiratory System Agents|respiratory system agents|mesh-ancestor
110179521|NCT00847860|Vasodilator Agents|vasodilator agents|mesh-ancestor
110179522|NCT00847860|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110179523|NCT00847860|Protective Agents|protective agents|mesh-ancestor
110179524|NCT00847860|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
110179525|NCT00847860|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110179526|NCT00847821|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
110179527|NCT00847821|Bazedoxifene|bazedoxifene|mesh-list
110179528|NCT00847821|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
110179529|NCT00847821|Hormone Antagonists|hormone antagonists|mesh-ancestor
110179530|NCT00847821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110179531|NCT00847821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110179532|NCT00847821|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
110179533|NCT00847821|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
110179534|NCT00847821|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110179536|NCT00009932|Fenretinide|fenretinide|mesh-list
110207174|NCT00185302|Entinostat|entinostat|mesh-list
110179537|NCT00009932|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110179538|NCT00009932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110179539|NCT00009932|Tubulin Modulators|tubulin modulators|mesh-ancestor
110179540|NCT00009932|Antimitotic Agents|antimitotic agents|mesh-ancestor
110179541|NCT00009932|Mitosis Modulators|mitosis modulators|mesh-ancestor
110179542|NCT00009932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110179543|NCT00009932|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
110179544|NCT00009932|Protective Agents|protective agents|mesh-ancestor
110179545|NCT00009932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110179546|NCT00847587|Contraceptive Agents|contraceptive agents|mesh-list
110179547|NCT00847587|Etonogestrel|etonogestrel|mesh-list
110179548|NCT00847587|Desogestrel|desogestrel|mesh-list
110179549|NCT00847587|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110179550|NCT00847587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110179551|NCT00847587|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110179552|NCT00847587|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110179553|NCT00847587|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110179554|NCT00847587|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110179555|NCT00847587|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110179556|NCT00847587|Progestins|progestins|mesh-ancestor
110179557|NCT00847587|Hormones|hormones|mesh-ancestor
110179558|NCT00847587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110179559|NCT00011765|Fluoxetine|fluoxetine|mesh-list
110179560|NCT00011765|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110207354|NCT00186979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110179561|NCT00011765|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110179562|NCT00011765|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110179563|NCT00011765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110179564|NCT00011765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110179565|NCT00011765|Serotonin Agents|serotonin agents|mesh-ancestor
110179566|NCT00011765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110179567|NCT00011765|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110179568|NCT00011765|Antidepressive Agents|antidepressive agents|mesh-ancestor
110179569|NCT00011765|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110179570|NCT00011765|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110179571|NCT00011765|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110179572|NCT00011765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110179573|NCT00011804|Topiramate|topiramate|mesh-list
110179574|NCT00011804|Anticonvulsants|anticonvulsants|mesh-ancestor
110179575|NCT00011804|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110179576|NCT00011804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110179577|NCT00011921|Paclitaxel|paclitaxel|mesh-list
110179579|NCT00011921|Carboplatin|carboplatin|mesh-list
110179580|NCT00011921|Etoposide phosphate|etoposide phosphate|mesh-list
110179581|NCT00011921|Epirubicin|epirubicin|mesh-list
110179582|NCT00011921|Ifosfamide|ifosfamide|mesh-list
110179583|NCT00011921|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110179584|NCT00011921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110179585|NCT00011921|Tubulin Modulators|tubulin modulators|mesh-ancestor
110179586|NCT00011921|Antimitotic Agents|antimitotic agents|mesh-ancestor
110179588|NCT00011921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110179589|NCT00011921|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110179590|NCT00011921|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110179591|NCT00011921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110179592|NCT00011921|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110179593|NCT00011921|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110179594|NCT00011921|Alkylating Agents|alkylating agents|mesh-ancestor
110179596|NCT00011960|Cisplatin|cisplatin|mesh-list
110179597|NCT00011960|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110179598|NCT00011960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110179599|NCT00011960|Tubulin Modulators|tubulin modulators|mesh-ancestor
110179600|NCT00011960|Antimitotic Agents|antimitotic agents|mesh-ancestor
110179601|NCT00011960|Mitosis Modulators|mitosis modulators|mesh-ancestor
110179602|NCT00011960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110179603|NCT00847314|Methyltestosterone|methyltestosterone|mesh-list
110179604|NCT00847314|Testosterone|testosterone|mesh-list
110179605|NCT00847314|Testosterone undecanoate|testosterone undecanoate|mesh-list
110179606|NCT00847314|Testosterone enanthate|testosterone enanthate|mesh-list
110179607|NCT00847314|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
110179609|NCT00847314|Hormones|hormones|mesh-ancestor
110207681|NCT00188773|Protective Agents|protective agents|mesh-ancestor
110179610|NCT00847314|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110179611|NCT00847314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110179612|NCT00847314|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110179614|NCT00847314|Anabolic Agents|anabolic agents|mesh-ancestor
110179615|NCT00011999|Paclitaxel|paclitaxel|mesh-list
110179616|NCT00011999|Cisplatin|cisplatin|mesh-list
110179617|NCT00011999|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110179618|NCT00011999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110179619|NCT00011999|Tubulin Modulators|tubulin modulators|mesh-ancestor
110179620|NCT00011999|Antimitotic Agents|antimitotic agents|mesh-ancestor
110179621|NCT00011999|Mitosis Modulators|mitosis modulators|mesh-ancestor
110207817|NCT00189709|Hormone Antagonists|hormone antagonists|mesh-ancestor
110179622|NCT00011999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110179624|NCT00012038|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110179625|NCT00012038|Alkylating Agents|alkylating agents|mesh-ancestor
110179626|NCT00012038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110179627|NCT00012038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110179628|NCT00012116|Temozolomide|temozolomide|mesh-list
110179629|NCT00012116|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110179630|NCT00012116|Alkylating Agents|alkylating agents|mesh-ancestor
110179631|NCT00012116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110179632|NCT00012116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110179634|NCT00847119|Capecitabine|capecitabine|mesh-list
110179635|NCT00847119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110179636|NCT00847119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110179637|NCT00847119|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110179638|NCT00847119|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110179639|NCT00847119|Growth Substances|growth substances|mesh-ancestor
110179640|NCT00847119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110179641|NCT00847119|Growth Inhibitors|growth inhibitors|mesh-ancestor
110208087|NCT00190996|Analgesics|analgesics|mesh-ancestor
110179642|NCT00847119|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110179643|NCT00847119|Antimetabolites|antimetabolites|mesh-ancestor
110179644|NCT00847119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110179645|NCT00847080|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
110179646|NCT00847080|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110179647|NCT00847080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110179648|NCT00847080|Incretins|incretins|mesh-ancestor
110179649|NCT00847080|Hormones|hormones|mesh-ancestor
110179650|NCT00847080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110179651|NCT00847080|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
110179652|NCT00847080|Protease Inhibitors|protease inhibitors|mesh-ancestor
110179653|NCT00847080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110179654|NCT00847080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110179655|NCT00012194|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
110179656|NCT00012194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110179657|NCT00012194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110179658|NCT00012194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110179659|NCT00012194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110179661|NCT01818323|Immunologic Factors|immunologic factors|mesh-ancestor
110179662|NCT01818323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110179663|NCT00012311|Cyclophosphamide|cyclophosphamide|mesh-list
110179664|NCT00012311|Ifosfamide|ifosfamide|mesh-list
110179665|NCT00012311|Thiotepa|thiotepa|mesh-list
110179666|NCT00012311|Carboplatin|carboplatin|mesh-list
110179667|NCT00012311|Docetaxel|docetaxel|mesh-list
110179668|NCT00012311|Doxorubicin|doxorubicin|mesh-list
110179669|NCT00012311|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110179670|NCT00012311|Fluorouracil|fluorouracil|mesh-list
110179671|NCT00012311|Methotrexate|methotrexate|mesh-list
110179672|NCT00012311|Etoposide|etoposide|mesh-list
110179673|NCT00012311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110179674|NCT00012311|Immunologic Factors|immunologic factors|mesh-ancestor
110179675|NCT00012311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110179676|NCT00012311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110179677|NCT00012311|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110179678|NCT00012311|Alkylating Agents|alkylating agents|mesh-ancestor
110179679|NCT00012311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110208271|NCT00192088|Oxaliplatin|oxaliplatin|mesh-list
110179680|NCT00012311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110179681|NCT00012311|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110179682|NCT00012311|Tubulin Modulators|tubulin modulators|mesh-ancestor
110179683|NCT00012311|Antimitotic Agents|antimitotic agents|mesh-ancestor
110179684|NCT00012311|Mitosis Modulators|mitosis modulators|mesh-ancestor
110179685|NCT00012311|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110179686|NCT00012311|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110179687|NCT00012311|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110179688|NCT00012311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110179689|NCT00012311|Antimetabolites|antimetabolites|mesh-ancestor
110179690|NCT00012311|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110208330|NCT00192595|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110179691|NCT00012311|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110179692|NCT00012311|Abortifacient Agents|abortifacient agents|mesh-ancestor
110179693|NCT00012311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110179694|NCT00012311|Dermatologic Agents|dermatologic agents|mesh-ancestor
110179695|NCT00012311|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110179696|NCT00012311|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110179697|NCT00012311|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110179698|NCT00847002|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
110179700|NCT00847002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110179702|NCT00012350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110179703|NCT00846963|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
110179704|NCT00846963|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
110179705|NCT00846963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110179706|NCT00012389|Oxaliplatin|oxaliplatin|mesh-list
110179708|NCT00012389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110179709|NCT00012389|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110179710|NCT00012389|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110179711|NCT00012389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110179712|NCT00012389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110179713|NCT00846885|Sumatriptan|sumatriptan|mesh-list
110179714|NCT00846885|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110179715|NCT00846885|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110179716|NCT00846885|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110179717|NCT00846885|Serotonin Agents|serotonin agents|mesh-ancestor
110179718|NCT00846885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110208532|NCT00194038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110179719|NCT00846885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110179720|NCT00846885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110179721|NCT00012467|Interferons|interferons|mesh-list
110179722|NCT00012467|Interferon-gamma|interferon-gamma|mesh-list
110179723|NCT00012467|Itraconazole|itraconazole|mesh-list
110179724|NCT00012467|Fluconazole|fluconazole|mesh-list
110179725|NCT00012467|Amphotericin B|amphotericin b|mesh-list
110179726|NCT00012467|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
110179727|NCT00012467|Flucytosine|flucytosine|mesh-list
110179728|NCT00012467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110179729|NCT00012467|Antiviral Agents|antiviral agents|mesh-ancestor
110179730|NCT00012467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110179731|NCT00012467|Antifungal Agents|antifungal agents|mesh-ancestor
110179732|NCT00012467|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110179733|NCT00012467|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110179734|NCT00012467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110179735|NCT00012467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110179736|NCT00012467|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110179737|NCT00012467|Hormone Antagonists|hormone antagonists|mesh-ancestor
110179738|NCT00012467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110179739|NCT00012467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110179740|NCT00012467|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110179741|NCT00012467|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110179742|NCT00012467|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110179744|NCT00012467|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110179745|NCT00012467|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110179746|NCT00012467|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110179747|NCT00012467|Antimetabolites|antimetabolites|mesh-ancestor
110179748|NCT00012506|Etanercept|etanercept|mesh-list
110179749|NCT00012506|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110179750|NCT00012506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110179751|NCT00012506|Analgesics|analgesics|mesh-ancestor
110179752|NCT00012506|Sensory System Agents|sensory system agents|mesh-ancestor
110179753|NCT00012506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110179754|NCT00012506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110179755|NCT00012506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110179756|NCT00012506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110179757|NCT00012506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110179758|NCT00012506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110179759|NCT00012506|Immunologic Factors|immunologic factors|mesh-ancestor
110179760|NCT00012584|Fluvoxamine|fluvoxamine|mesh-list
110179761|NCT00012584|Methylphenidate|methylphenidate|mesh-list
110179762|NCT00012584|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110179763|NCT00012584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110179764|NCT00012584|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110179765|NCT00012584|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110179766|NCT00012584|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110208793|NCT00195871|Glucocorticoids|glucocorticoids|mesh-ancestor
110179767|NCT00012584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110179768|NCT00012584|Dopamine Agents|dopamine agents|mesh-ancestor
110179769|NCT00012584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110179770|NCT00012584|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110179771|NCT00012584|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110179772|NCT00012584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110179773|NCT00012584|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110179774|NCT00012584|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110179775|NCT00012584|Serotonin Agents|serotonin agents|mesh-ancestor
110179776|NCT00012584|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110179777|NCT00012584|Antidepressive Agents|antidepressive agents|mesh-ancestor
110179778|NCT00012584|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
110179779|NCT00012584|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110179780|NCT00012584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110179781|NCT00012584|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110179782|NCT00846690|Lidocaine|lidocaine|mesh-list
110179783|NCT00846690|Phenylephrine|phenylephrine|mesh-list
110179784|NCT00846690|Benzocaine|benzocaine|mesh-list
110179785|NCT00846690|Tetracaine|tetracaine|mesh-list
110179786|NCT00846690|Anesthetics, Local|anesthetics, local|mesh-ancestor
110179787|NCT00846690|Anesthetics|anesthetics|mesh-ancestor
110179788|NCT00846690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110179789|NCT00846690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110179790|NCT00846690|Sensory System Agents|sensory system agents|mesh-ancestor
110179791|NCT00846690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110179792|NCT00846690|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
110179793|NCT00846690|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110179794|NCT00846690|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110179795|NCT00846690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110179796|NCT00846690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110179797|NCT00846690|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110179799|NCT00846690|Autonomic Agents|autonomic agents|mesh-ancestor
110179800|NCT00846690|Sympathomimetics|sympathomimetics|mesh-ancestor
110179801|NCT00846690|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110179802|NCT00846690|Nasal Decongestants|nasal decongestants|mesh-ancestor
110209119|NCT00060866|Vasodilator Agents|vasodilator agents|mesh-ancestor
110179803|NCT00846690|Respiratory System Agents|respiratory system agents|mesh-ancestor
110179804|NCT00846690|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110179805|NCT00846690|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110179806|NCT00846690|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110179807|NCT00846690|Adrenergic Agents|adrenergic agents|mesh-ancestor
110179808|NCT00846690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110179809|NCT00846690|Protective Agents|protective agents|mesh-ancestor
110179810|NCT00846651|Phenylephrine|phenylephrine|mesh-list
110179811|NCT00846651|Oxymetazoline|oxymetazoline|mesh-list
110179812|NCT00846651|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
110179813|NCT00846651|Mydriatics|mydriatics|mesh-ancestor
110179814|NCT00846651|Autonomic Agents|autonomic agents|mesh-ancestor
110179815|NCT00846651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110179816|NCT00846651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110179817|NCT00846651|Sympathomimetics|sympathomimetics|mesh-ancestor
110179818|NCT00846651|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110179819|NCT00846651|Nasal Decongestants|nasal decongestants|mesh-ancestor
110179820|NCT00846651|Respiratory System Agents|respiratory system agents|mesh-ancestor
110179821|NCT00846651|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
110179822|NCT00846651|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
110179823|NCT00846651|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110179824|NCT00846651|Adrenergic Agents|adrenergic agents|mesh-ancestor
110179825|NCT00846651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110179826|NCT00846651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110179827|NCT00846651|Protective Agents|protective agents|mesh-ancestor
110179828|NCT00846612|Bevacizumab|bevacizumab|mesh-list
110179829|NCT00846612|Doxorubicin|doxorubicin|mesh-list
110179830|NCT00846612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110179831|NCT00846612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110179832|NCT00846612|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110179833|NCT00846612|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110179834|NCT00846612|Growth Substances|growth substances|mesh-ancestor
110179835|NCT00846612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110179836|NCT00846612|Growth Inhibitors|growth inhibitors|mesh-ancestor
110179837|NCT00846612|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110179838|NCT00846612|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110179839|NCT00846612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110179840|NCT00846612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110179841|NCT00846612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110179842|NCT00012857|Acetaminophen|acetaminophen|mesh-list
110179843|NCT00012857|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110179844|NCT00012857|Analgesics|analgesics|mesh-ancestor
110179845|NCT00012857|Sensory System Agents|sensory system agents|mesh-ancestor
110179846|NCT00012857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110179847|NCT00012857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110179848|NCT00012857|Antipyretics|antipyretics|mesh-ancestor
110179849|NCT00394056|Paroxetine|paroxetine|mesh-list
110179850|NCT00394056|Vestipitant|vestipitant|mesh-list
110179851|NCT00394056|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110179852|NCT00394056|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110179853|NCT00394056|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110179854|NCT00394056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110179855|NCT00394056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110179856|NCT00394056|Serotonin Agents|serotonin agents|mesh-ancestor
110179857|NCT00394056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110179858|NCT00394056|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110179859|NCT00394056|Antidepressive Agents|antidepressive agents|mesh-ancestor
110179860|NCT00394056|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110179861|NCT00394056|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110179862|NCT00394056|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110179863|NCT00394056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110179864|NCT00394056|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
110179866|NCT00846339|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110179867|NCT00846339|Antidepressive Agents|antidepressive agents|mesh-ancestor
110179868|NCT00846339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110179869|NCT00846339|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110179870|NCT00846339|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110179871|NCT00846339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110179872|NCT00846339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110179873|NCT00846339|Dopamine Agents|dopamine agents|mesh-ancestor
110179874|NCT00846339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110179875|NCT00846339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110179876|NCT00846339|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110179877|NCT00846339|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110179878|NCT00846339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110179879|NCT00846144|Copper|copper|mesh-list
110179880|NCT00846144|Copper Sulfate|copper sulfate|mesh-list
110179881|NCT00846144|Trace Elements|trace elements|mesh-ancestor
110179882|NCT00846144|Micronutrients|micronutrients|mesh-ancestor
110179883|NCT00846144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110179884|NCT00846144|Antidotes|antidotes|mesh-ancestor
110179885|NCT00846144|Protective Agents|protective agents|mesh-ancestor
110179886|NCT00846144|Emetics|emetics|mesh-ancestor
110179887|NCT00846144|Autonomic Agents|autonomic agents|mesh-ancestor
110179888|NCT00846144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110179889|NCT00846144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110179890|NCT00845988|Aripiprazole|aripiprazole|mesh-list
110179891|NCT00845988|Antidepressive Agents|antidepressive agents|mesh-ancestor
110179892|NCT00845988|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110179893|NCT00845988|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110179894|NCT00845988|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110179895|NCT00845988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110179896|NCT00845988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110179897|NCT00845988|Dopamine Agonists|dopamine agonists|mesh-ancestor
110179898|NCT00845988|Dopamine Agents|dopamine agents|mesh-ancestor
110179899|NCT00845988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110179900|NCT00845988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110179901|NCT00845988|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110209553|NCT00200512|Dopamine Agonists|dopamine agonists|mesh-ancestor
110179902|NCT00845988|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110179903|NCT00845988|Serotonin Agents|serotonin agents|mesh-ancestor
110179904|NCT00845988|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110179905|NCT00845988|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110179906|NCT00845988|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110179907|NCT00845988|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110179908|NCT00845910|Bevacizumab|bevacizumab|mesh-list
110179909|NCT00845910|Docetaxel|docetaxel|mesh-list
110179910|NCT00845910|Capecitabine|capecitabine|mesh-list
110179911|NCT00845910|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110179912|NCT00845910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110179913|NCT00845910|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110179914|NCT00845910|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110179915|NCT00845910|Growth Substances|growth substances|mesh-ancestor
110179916|NCT00845910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110179917|NCT00845910|Growth Inhibitors|growth inhibitors|mesh-ancestor
110179918|NCT00845910|Tubulin Modulators|tubulin modulators|mesh-ancestor
110179919|NCT00845910|Antimitotic Agents|antimitotic agents|mesh-ancestor
110179920|NCT00845910|Mitosis Modulators|mitosis modulators|mesh-ancestor
110179921|NCT00845910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110179922|NCT00845910|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110179923|NCT00845910|Antimetabolites|antimetabolites|mesh-ancestor
110179925|NCT00680628|Tenecteplase|tenecteplase|mesh-list
110179926|NCT00680628|Enoxaparin sodium|enoxaparin sodium|mesh-list
110179927|NCT00680628|Anticoagulants|anticoagulants|mesh-ancestor
110179928|NCT00680628|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
110179929|NCT00680628|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
110209669|NCT00410371|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110179930|NCT00680628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110179931|NCT00013520|Lamivudine|lamivudine|mesh-list
110179932|NCT00013520|Zidovudine|zidovudine|mesh-list
110179933|NCT00013520|Efavirenz|efavirenz|mesh-list
110179934|NCT00013520|Nevirapine|nevirapine|mesh-list
110179935|NCT00013520|Abacavir|abacavir|mesh-list
110179936|NCT00013520|Dideoxynucleosides|dideoxynucleosides|mesh-list
110179937|NCT00013520|Stavudine|stavudine|mesh-list
110179938|NCT00013520|Didanosine|didanosine|mesh-list
110179939|NCT00013520|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
110179940|NCT00013520|Atazanavir Sulfate|atazanavir sulfate|mesh-list
110179941|NCT00013520|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110179942|NCT00013520|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110179943|NCT00013520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110179944|NCT00013520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110179945|NCT00013520|Antiviral Agents|antiviral agents|mesh-ancestor
110179946|NCT00013520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110179947|NCT00013520|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110179948|NCT00013520|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110179949|NCT00013520|Antimetabolites|antimetabolites|mesh-ancestor
110179950|NCT00013520|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110179951|NCT00013520|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110179952|NCT00013520|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110179953|NCT00013520|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110179954|NCT00013520|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110179955|NCT00013520|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110179956|NCT00013520|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110179957|NCT00013520|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110179958|NCT00013520|Protease Inhibitors|protease inhibitors|mesh-ancestor
110179959|NCT00013598|Pioglitazone|pioglitazone|mesh-list
110179960|NCT00013598|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110179961|NCT00013598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110179962|NCT00277017|Interferons|interferons|mesh-list
110179963|NCT00277017|Thalidomide|thalidomide|mesh-list
110179964|NCT00277017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110179965|NCT00277017|Antiviral Agents|antiviral agents|mesh-ancestor
110179966|NCT00277017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110179967|NCT00277017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110179968|NCT00277017|Immunologic Factors|immunologic factors|mesh-ancestor
110179969|NCT00277017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110179970|NCT00277017|Leprostatic Agents|leprostatic agents|mesh-ancestor
110179971|NCT00277017|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110179972|NCT00277017|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110179973|NCT00277017|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110179974|NCT00277017|Growth Substances|growth substances|mesh-ancestor
110179975|NCT00277017|Growth Inhibitors|growth inhibitors|mesh-ancestor
110179976|NCT00276978|Aripiprazole|aripiprazole|mesh-list
110179977|NCT00276978|Antidepressive Agents|antidepressive agents|mesh-ancestor
110179979|NCT00276978|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110179980|NCT00276978|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110179981|NCT00276978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110179982|NCT00276978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110179983|NCT00276978|Dopamine Agonists|dopamine agonists|mesh-ancestor
110179984|NCT00276978|Dopamine Agents|dopamine agents|mesh-ancestor
110179985|NCT00276978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110179986|NCT00276978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110179987|NCT00276978|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
110179988|NCT00276978|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
110179989|NCT00276978|Serotonin Agents|serotonin agents|mesh-ancestor
110179990|NCT00276978|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
110209904|NCT02968082|Mydriatics|mydriatics|mesh-ancestor
110179991|NCT00276978|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110179992|NCT00276978|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110179994|NCT00276900|Sertraline|sertraline|mesh-list
110179995|NCT00276900|Antidepressive Agents|antidepressive agents|mesh-ancestor
110179996|NCT00276900|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110179997|NCT00276900|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110179998|NCT00276900|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110179999|NCT00276900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110285709|NCT01081795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110180000|NCT00276900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110180001|NCT00276900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110180002|NCT00276900|Serotonin Agents|serotonin agents|mesh-ancestor
110180003|NCT00276900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110180004|NCT00276861|Gemcitabine|gemcitabine|mesh-list
110180005|NCT00276861|Oxaliplatin|oxaliplatin|mesh-list
110180006|NCT00276861|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110180007|NCT00276861|Antimetabolites|antimetabolites|mesh-ancestor
110180008|NCT00276861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110180009|NCT00276861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110180010|NCT00013871|Vaccines|vaccines|mesh-list
110180011|NCT00013871|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
110180012|NCT00013871|Immunologic Factors|immunologic factors|mesh-ancestor
110180013|NCT00013871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110180014|NCT00276783|Pemetrexed|pemetrexed|mesh-list
110180015|NCT00276783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110180016|NCT00276783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110180017|NCT00276783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110180018|NCT00276783|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110180019|NCT00276783|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110180020|NCT00276705|Thalidomide|thalidomide|mesh-list
110180021|NCT00276705|Cyclophosphamide|cyclophosphamide|mesh-list
110180022|NCT00276705|Doxorubicin|doxorubicin|mesh-list
110180023|NCT00276705|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110180024|NCT00276705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110180025|NCT00276705|Immunologic Factors|immunologic factors|mesh-ancestor
110180026|NCT00276705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110180027|NCT00276705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110180028|NCT00276705|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110180029|NCT00276705|Alkylating Agents|alkylating agents|mesh-ancestor
110180030|NCT00276705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110180031|NCT00276705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110180032|NCT00276705|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110210173|NCT00224185|Dimercaprol|dimercaprol|mesh-list
110180034|NCT00276705|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110180035|NCT00276705|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110180036|NCT00276705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110180037|NCT00276705|Leprostatic Agents|leprostatic agents|mesh-ancestor
110180038|NCT00276705|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110180039|NCT00276705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110180040|NCT00276705|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110180041|NCT00276705|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110180042|NCT00276705|Growth Substances|growth substances|mesh-ancestor
110180043|NCT00276705|Growth Inhibitors|growth inhibitors|mesh-ancestor
110180044|NCT00276666|Vincristine|vincristine|mesh-list
110180045|NCT00276666|Lomustine|lomustine|mesh-list
110180046|NCT00276666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110210232|NCT00224458|Efavirenz|efavirenz|mesh-list
110180047|NCT00276666|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110180048|NCT00276666|Tubulin Modulators|tubulin modulators|mesh-ancestor
110180049|NCT00276666|Antimitotic Agents|antimitotic agents|mesh-ancestor
110180050|NCT00276666|Mitosis Modulators|mitosis modulators|mesh-ancestor
110180051|NCT00276666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110180052|NCT00276666|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110180053|NCT00276666|Alkylating Agents|alkylating agents|mesh-ancestor
110180054|NCT00014066|Hematoporphyrin Derivative|hematoporphyrin derivative|mesh-list
110180055|NCT00014066|Hematoporphyrins|hematoporphyrins|mesh-list
110180056|NCT00014066|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
110180057|NCT00014066|Dermatologic Agents|dermatologic agents|mesh-ancestor
110180058|NCT00014066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110180059|NCT00014105|Carboplatin|carboplatin|mesh-list
110180060|NCT00014105|Temozolomide|temozolomide|mesh-list
110180061|NCT00014105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110180062|NCT00014105|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110180063|NCT00014105|Alkylating Agents|alkylating agents|mesh-ancestor
110180064|NCT00014105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110180066|NCT00014144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110180067|NCT00014144|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110180068|NCT00014144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110180069|NCT00014144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110180070|NCT00276588|Paclitaxel|paclitaxel|mesh-list
110180071|NCT00276588|Carboplatin|carboplatin|mesh-list
110180072|NCT00276588|Gemcitabine|gemcitabine|mesh-list
110180073|NCT00276588|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110180074|NCT00276588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110180075|NCT00276588|Tubulin Modulators|tubulin modulators|mesh-ancestor
110180076|NCT00276588|Antimitotic Agents|antimitotic agents|mesh-ancestor
110180077|NCT00276588|Mitosis Modulators|mitosis modulators|mesh-ancestor
110180078|NCT00276588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110180079|NCT00276588|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110180080|NCT00276588|Antimetabolites|antimetabolites|mesh-ancestor
110180081|NCT00276549|Gemcitabine|gemcitabine|mesh-list
110180082|NCT00276549|Docetaxel|docetaxel|mesh-list
110180083|NCT00276549|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110180084|NCT00276549|Antimetabolites|antimetabolites|mesh-ancestor
110180085|NCT00276549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110180086|NCT00276549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110180087|NCT00276549|Tubulin Modulators|tubulin modulators|mesh-ancestor
110180088|NCT00276549|Antimitotic Agents|antimitotic agents|mesh-ancestor
110180089|NCT00276549|Mitosis Modulators|mitosis modulators|mesh-ancestor
110180090|NCT00014183|Gefitinib|gefitinib|mesh-list
110180091|NCT00014183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110180092|NCT00014183|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110180093|NCT00014183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110180094|NCT00014183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110180095|NCT00014261|Interferons|interferons|mesh-list
110180096|NCT00014261|Interferon-alpha|interferon-alpha|mesh-list
110180097|NCT00014261|Interferon alpha-2|interferon alpha-2|mesh-list
110180098|NCT00014261|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
110180099|NCT00014261|Temozolomide|temozolomide|mesh-list
110180100|NCT00014261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110180101|NCT00014261|Antiviral Agents|antiviral agents|mesh-ancestor
110180102|NCT00014261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110180103|NCT00014261|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110180104|NCT00014261|Alkylating Agents|alkylating agents|mesh-ancestor
110180105|NCT00014261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110180106|NCT00014261|Immunologic Factors|immunologic factors|mesh-ancestor
110180107|NCT00014261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110180108|NCT00014339|Prednisone|prednisone|mesh-list
110180109|NCT00014339|Melphalan|melphalan|mesh-list
110180110|NCT00014339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110180111|NCT00014339|Glucocorticoids|glucocorticoids|mesh-ancestor
110180112|NCT00014339|Hormones|hormones|mesh-ancestor
110180113|NCT00014339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110180114|NCT00014339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110180115|NCT00014339|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110180116|NCT00014339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110180117|NCT00014339|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110180118|NCT00014339|Alkylating Agents|alkylating agents|mesh-ancestor
110180119|NCT00014339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110180120|NCT00014339|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110180121|NCT00014339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110180122|NCT00014339|Immunologic Factors|immunologic factors|mesh-ancestor
110180123|NCT00014456|Gemcitabine|gemcitabine|mesh-list
110180124|NCT00014456|Docetaxel|docetaxel|mesh-list
110180125|NCT00014456|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110180126|NCT00014456|Antimetabolites|antimetabolites|mesh-ancestor
110180127|NCT00014456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110180128|NCT00014456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110180129|NCT00014456|Tubulin Modulators|tubulin modulators|mesh-ancestor
110180130|NCT00014456|Antimitotic Agents|antimitotic agents|mesh-ancestor
110180131|NCT00014456|Mitosis Modulators|mitosis modulators|mesh-ancestor
110180133|NCT00276393|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110180134|NCT00276393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110180135|NCT00014534|Gemcitabine|gemcitabine|mesh-list
110180136|NCT00014534|Doxorubicin|doxorubicin|mesh-list
110180138|NCT00014534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110180139|NCT00014534|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110180140|NCT00014534|Antimetabolites|antimetabolites|mesh-ancestor
110285713|NCT00233961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110180141|NCT00014534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110180143|NCT00014534|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110180144|NCT00014534|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110180145|NCT00014534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110180146|NCT00014573|Aldesleukin|aldesleukin|mesh-list
110180148|NCT00014573|Cyclophosphamide|cyclophosphamide|mesh-list
110180149|NCT00014573|Carmustine|carmustine|mesh-list
110180150|NCT00014573|Sargramostim|sargramostim|mesh-list
110180151|NCT00014573|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110180152|NCT00014573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110180153|NCT00014573|Tubulin Modulators|tubulin modulators|mesh-ancestor
110180154|NCT00014573|Antimitotic Agents|antimitotic agents|mesh-ancestor
110180155|NCT00014573|Mitosis Modulators|mitosis modulators|mesh-ancestor
110180156|NCT00014573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110180157|NCT00014573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110180158|NCT00014573|Immunologic Factors|immunologic factors|mesh-ancestor
110180159|NCT00014573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110180161|NCT00014573|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110180162|NCT00014573|Alkylating Agents|alkylating agents|mesh-ancestor
110180163|NCT00014573|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110180164|NCT00014573|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110180165|NCT00014573|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110180166|NCT00014573|Antiviral Agents|antiviral agents|mesh-ancestor
110180167|NCT00014573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110180168|NCT00276315|Botulinum Toxins|botulinum toxins|mesh-list
110180169|NCT00276315|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
110180170|NCT00276315|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
110180171|NCT00276315|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
110180172|NCT00276315|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110180173|NCT00276315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110180174|NCT00276315|Cholinergic Agents|cholinergic agents|mesh-ancestor
110180175|NCT00276315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110180176|NCT00276315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110180177|NCT00276315|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
110180178|NCT00276315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110180180|NCT00276276|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110211199|NCT00229333|Serotonin Agents|serotonin agents|mesh-ancestor
110180181|NCT00276276|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110180182|NCT00276276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110180183|NCT00276276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110180184|NCT00276276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110180186|NCT00014651|Analgesics|analgesics|mesh-ancestor
110180187|NCT00014651|Sensory System Agents|sensory system agents|mesh-ancestor
110180188|NCT00014651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110211358|NCT00230035|Antiemetics|antiemetics|mesh-ancestor
110180189|NCT00014651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110180190|NCT00014651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110180191|NCT00014690|Topotecan|topotecan|mesh-list
110180192|NCT00014690|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110180193|NCT00014690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110180194|NCT00014690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110180195|NCT00014690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110180197|NCT00014729|Isotretinoin|isotretinoin|mesh-list
110180198|NCT00014729|Dermatologic Agents|dermatologic agents|mesh-ancestor
110180199|NCT00276198|Vitamin D|vitamin d|mesh-list
110180200|NCT00276198|Vitamin A|vitamin a|mesh-list
110180201|NCT00276198|Vitamins|vitamins|mesh-ancestor
110180202|NCT00276198|Micronutrients|micronutrients|mesh-ancestor
110180203|NCT00276198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110180204|NCT00276198|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
110180205|NCT00276081|Gabapentin|gabapentin|mesh-list
110180206|NCT00276081|Estrogens|estrogens|mesh-list
110180207|NCT00276081|Analgesics|analgesics|mesh-ancestor
110180208|NCT00276081|Sensory System Agents|sensory system agents|mesh-ancestor
110211412|NCT00063479|Zoledronic Acid|zoledronic acid|mesh-list
110180209|NCT00276081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110180210|NCT00276081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110180211|NCT00276081|Anticonvulsants|anticonvulsants|mesh-ancestor
110180212|NCT00276081|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110180213|NCT00276081|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110180214|NCT00276081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110180215|NCT00276081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110180216|NCT00276081|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110180217|NCT00276081|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110180218|NCT00276081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110180220|NCT00276081|Antimanic Agents|antimanic agents|mesh-ancestor
110180221|NCT00276081|Hormones|hormones|mesh-ancestor
110180222|NCT00276081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110180223|NCT00276003|Gemcitabine|gemcitabine|mesh-list
110180224|NCT00276003|Irinotecan|irinotecan|mesh-list
110180225|NCT00276003|Allopurinol|allopurinol|mesh-list
110180226|NCT00276003|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110180227|NCT00276003|Antimetabolites|antimetabolites|mesh-ancestor
110180228|NCT00276003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110180229|NCT00276003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110180230|NCT00276003|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110180231|NCT00276003|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110180232|NCT00276003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110180233|NCT00276003|Gout Suppressants|gout suppressants|mesh-ancestor
110180234|NCT00276003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110180235|NCT00276003|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110180236|NCT00276003|Antioxidants|antioxidants|mesh-ancestor
110180237|NCT00276003|Protective Agents|protective agents|mesh-ancestor
110180238|NCT00276003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110180240|NCT00275925|Anticonvulsants|anticonvulsants|mesh-ancestor
110180241|NCT00275925|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
110180242|NCT00275925|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
110180243|NCT00275925|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110180244|NCT00275925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110180245|NCT00275925|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110180246|NCT00275925|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110180247|NCT00015041|Buprenorphine|buprenorphine|mesh-list
110180248|NCT00015041|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
110180249|NCT00015041|Narcotics|narcotics|mesh-ancestor
110180250|NCT00015041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110180251|NCT00015041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110180252|NCT00015041|Analgesics|analgesics|mesh-ancestor
110180253|NCT00015041|Sensory System Agents|sensory system agents|mesh-ancestor
110180254|NCT00015041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110180255|NCT00015041|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110180256|NCT00015080|Naltrexone|naltrexone|mesh-list
110180257|NCT00015080|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110180258|NCT00015080|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110180259|NCT00015080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110180260|NCT00015080|Sensory System Agents|sensory system agents|mesh-ancestor
110180261|NCT00015080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110180262|NCT00015236|Amantadine|amantadine|mesh-list
110180263|NCT00015236|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110180264|NCT00015236|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110180265|NCT00015236|Antiviral Agents|antiviral agents|mesh-ancestor
110180266|NCT00015236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110180267|NCT00015236|Dopamine Agents|dopamine agents|mesh-ancestor
110180268|NCT00015236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110212178|NCT00234871|Vasodilator Agents|vasodilator agents|mesh-ancestor
110180269|NCT00015236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110180270|NCT00015236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110180271|NCT00015236|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110180272|NCT00015236|Analgesics|analgesics|mesh-ancestor
110180273|NCT00015236|Sensory System Agents|sensory system agents|mesh-ancestor
110180274|NCT00015236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110180276|NCT00015275|Anesthetics, Local|anesthetics, local|mesh-ancestor
110180277|NCT00015275|Anesthetics|anesthetics|mesh-ancestor
110180278|NCT00015275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110180279|NCT00015275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110180280|NCT00015275|Sensory System Agents|sensory system agents|mesh-ancestor
110212239|NCT00235222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110180281|NCT00015275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110180282|NCT00015275|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
110180283|NCT00015275|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110180284|NCT00015275|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110180285|NCT00015275|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110180286|NCT00015275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110180287|NCT00015275|Dopamine Agents|dopamine agents|mesh-ancestor
110180288|NCT00015275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110180290|NCT00275730|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
110180291|NCT00275730|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
110180292|NCT00275730|Analgesics|analgesics|mesh-ancestor
110180293|NCT00275730|Sensory System Agents|sensory system agents|mesh-ancestor
110180294|NCT00275730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110180295|NCT00275730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110180296|NCT00275730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110212297|NCT00235651|Amebicides|amebicides|mesh-ancestor
110180297|NCT00275730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110180298|NCT00275730|Gout Suppressants|gout suppressants|mesh-ancestor
110180299|NCT00275730|Tocolytic Agents|tocolytic agents|mesh-ancestor
110180300|NCT00275730|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110180301|NCT00275730|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
110180302|NCT00275730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110180303|NCT00275730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110180304|NCT00275652|Lamivudine|lamivudine|mesh-list
110180305|NCT00275652|Telbivudine|telbivudine|mesh-list
110180306|NCT00275652|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110180307|NCT00275652|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110180308|NCT00275652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110212422|NCT00236548|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110180309|NCT00275652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110180310|NCT00275652|Antiviral Agents|antiviral agents|mesh-ancestor
110180311|NCT00275652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110180312|NCT00275652|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110212496|NCT00065117|Leucovorin|leucovorin|mesh-list
110180313|NCT00275652|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110180314|NCT00275613|Rituximab|rituximab|mesh-list
110180315|NCT00275613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110180316|NCT00275613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110180317|NCT00275613|Immunologic Factors|immunologic factors|mesh-ancestor
110180318|NCT00275613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110180319|NCT00275613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110180320|NCT00015548|Olanzapine|olanzapine|mesh-list
110180321|NCT00015548|Risperidone|risperidone|mesh-list
110180322|NCT00015548|Quetiapine Fumarate|quetiapine fumarate|mesh-list
110180323|NCT00015548|Citalopram|citalopram|mesh-list
110180324|NCT00015548|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
110180325|NCT00015548|Serotonin Agents|serotonin agents|mesh-ancestor
110180326|NCT00015548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110180327|NCT00015548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110180328|NCT00015548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110180329|NCT00015548|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
110180330|NCT00015548|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110212567|NCT00237367|Rabeprazole|rabeprazole|mesh-list
110180331|NCT00015548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110180332|NCT00015548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110180333|NCT00015548|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110180334|NCT00015548|Dopamine Agents|dopamine agents|mesh-ancestor
110180335|NCT00015548|Antiemetics|antiemetics|mesh-ancestor
110180336|NCT00015548|Autonomic Agents|autonomic agents|mesh-ancestor
110180337|NCT00015548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110180338|NCT00015548|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110180339|NCT00015548|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110180340|NCT00015548|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110180341|NCT00015548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110180342|NCT00015548|Antidepressive Agents|antidepressive agents|mesh-ancestor
110180343|NCT00015548|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110180344|NCT00275535|Mycophenolic Acid|mycophenolic acid|mesh-list
110180346|NCT00275535|Prednisone|prednisone|mesh-list
110180347|NCT00275535|Tacrolimus|tacrolimus|mesh-list
110180348|NCT00275535|Thymoglobulin|thymoglobulin|mesh-list
110180349|NCT00275535|Antilymphocyte Serum|antilymphocyte serum|mesh-list
110180350|NCT00275535|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110180351|NCT00275535|Glucocorticoids|glucocorticoids|mesh-ancestor
110180352|NCT00275535|Hormones|hormones|mesh-ancestor
110180353|NCT00275535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110180354|NCT00275535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110180355|NCT00275535|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110180356|NCT00275535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110180357|NCT00275535|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110180359|NCT00275535|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
110180360|NCT00275535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110180361|NCT00275535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110180362|NCT00275535|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110180363|NCT00275535|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
110180364|NCT00275535|Antitubercular Agents|antitubercular agents|mesh-ancestor
110180365|NCT00275535|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110180366|NCT00275535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110180367|NCT00275535|Antifungal Agents|antifungal agents|mesh-ancestor
110180369|NCT00015626|Pioglitazone|pioglitazone|mesh-list
110180370|NCT00015626|Rosiglitazone|rosiglitazone|mesh-list
110180371|NCT00015626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110180372|NCT00015626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110180373|NCT00015665|Voriconazole|voriconazole|mesh-list
110180374|NCT00015665|Antifungal Agents|antifungal agents|mesh-ancestor
110180375|NCT00015665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110180376|NCT00015665|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
110180377|NCT00015665|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110180378|NCT00015665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110180379|NCT00015665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110180380|NCT00015665|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
110180381|NCT00015665|Hormone Antagonists|hormone antagonists|mesh-ancestor
110180382|NCT00015665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110180383|NCT00015665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110180384|NCT00015665|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110180385|NCT00275457|Pramipexole|pramipexole|mesh-list
110180386|NCT00275457|Antioxidants|antioxidants|mesh-ancestor
110180387|NCT00275457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110180388|NCT00275457|Protective Agents|protective agents|mesh-ancestor
110180389|NCT00275457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110180390|NCT00275457|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
110180391|NCT00275457|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
110180392|NCT00275457|Dopamine Agonists|dopamine agonists|mesh-ancestor
110180393|NCT00275457|Dopamine Agents|dopamine agents|mesh-ancestor
110180394|NCT00275457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110180395|NCT00015704|Aldesleukin|aldesleukin|mesh-list
110180396|NCT00015704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110180397|NCT00015704|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110180398|NCT00015704|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110180399|NCT00015704|Antiviral Agents|antiviral agents|mesh-ancestor
110180400|NCT00015704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110180401|NCT00275418|Beta Carotene|beta carotene|mesh-list
110180402|NCT00275418|Carotenoids|carotenoids|mesh-list
110180403|NCT00275418|Antioxidants|antioxidants|mesh-ancestor
110212878|NCT00239044|Mycophenolic Acid|mycophenolic acid|mesh-list
110180404|NCT00275418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110180405|NCT00275418|Protective Agents|protective agents|mesh-ancestor
110180406|NCT00275418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110180407|NCT00275418|Provitamins|provitamins|mesh-ancestor
110180408|NCT00275418|Vitamins|vitamins|mesh-ancestor
110180409|NCT00275418|Micronutrients|micronutrients|mesh-ancestor
110180410|NCT00015821|Thalidomide|thalidomide|mesh-list
110180411|NCT00015821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110180412|NCT00015821|Immunologic Factors|immunologic factors|mesh-ancestor
110180413|NCT00015821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110180414|NCT00015821|Leprostatic Agents|leprostatic agents|mesh-ancestor
110180415|NCT00015821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110180416|NCT00015821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110180417|NCT00015821|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110180418|NCT00015821|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110180419|NCT00015821|Growth Substances|growth substances|mesh-ancestor
110180420|NCT00015821|Growth Inhibitors|growth inhibitors|mesh-ancestor
110180421|NCT00015821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110180422|NCT00275184|Metoclopramide|metoclopramide|mesh-list
110180423|NCT00275184|Antiemetics|antiemetics|mesh-ancestor
110180424|NCT00275184|Autonomic Agents|autonomic agents|mesh-ancestor
110180425|NCT00275184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110180426|NCT00275184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110180427|NCT00275184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110180428|NCT00275184|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
110180429|NCT00275184|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
110180430|NCT00275184|Dopamine Agents|dopamine agents|mesh-ancestor
110180431|NCT00275184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110180432|NCT00275184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110180434|NCT00015860|Vincristine|vincristine|mesh-list
110180436|NCT00015860|Daunorubicin|daunorubicin|mesh-list
110180437|NCT00015860|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110180438|NCT00015860|Glucocorticoids|glucocorticoids|mesh-ancestor
110180439|NCT00015860|Hormones|hormones|mesh-ancestor
110180440|NCT00015860|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110180441|NCT00015860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110180442|NCT00015860|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110180443|NCT00015860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110180444|NCT00015860|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110180445|NCT00015860|Tubulin Modulators|tubulin modulators|mesh-ancestor
110180446|NCT00015860|Antimitotic Agents|antimitotic agents|mesh-ancestor
110180447|NCT00015860|Mitosis Modulators|mitosis modulators|mesh-ancestor
110180448|NCT00015860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110180449|NCT00015860|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110180450|NCT00015860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110180451|NCT00015860|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110180452|NCT00015860|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110180453|NCT00015860|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110180454|NCT00015899|Lonafarnib|lonafarnib|mesh-list
110180455|NCT00015899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110180456|NCT00015899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110180457|NCT00275106|Leucovorin|leucovorin|mesh-list
110180458|NCT00275106|Cytarabine|cytarabine|mesh-list
110180459|NCT00275106|Dexamethasone|dexamethasone|mesh-list
110180460|NCT00275106|Prednisolone|prednisolone|mesh-list
110180461|NCT00275106|Cyclophosphamide|cyclophosphamide|mesh-list
110180462|NCT00275106|Doxorubicin|doxorubicin|mesh-list
110180463|NCT00275106|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110180464|NCT00275106|Methotrexate|methotrexate|mesh-list
110180465|NCT00275106|Vincristine|vincristine|mesh-list
110180466|NCT00275106|Daunorubicin|daunorubicin|mesh-list
110180467|NCT00275106|Asparaginase|asparaginase|mesh-list
110180468|NCT00275106|Mercaptopurine|mercaptopurine|mesh-list
110180469|NCT00275106|Thioguanine|thioguanine|mesh-list
110180470|NCT00275106|Levoleucovorin|levoleucovorin|mesh-list
110180471|NCT00275106|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110180472|NCT00275106|Immunologic Factors|immunologic factors|mesh-ancestor
110180473|NCT00275106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110180474|NCT00275106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110180475|NCT00275106|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110180476|NCT00275106|Alkylating Agents|alkylating agents|mesh-ancestor
110180477|NCT00275106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110180478|NCT00275106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110180479|NCT00275106|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110180480|NCT00275106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110180482|NCT00275106|Autonomic Agents|autonomic agents|mesh-ancestor
110180483|NCT00275106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110180484|NCT00275106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110213393|NCT00098982|Leucovorin|leucovorin|mesh-list
110180485|NCT00275106|Glucocorticoids|glucocorticoids|mesh-ancestor
110180486|NCT00275106|Hormones|hormones|mesh-ancestor
110180487|NCT00275106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110213441|NCT00066482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110180488|NCT00275106|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110180489|NCT00275106|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110180490|NCT00275106|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110180491|NCT00275106|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110180492|NCT00275106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110180493|NCT00275106|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
110180494|NCT00275106|Abortifacient Agents|abortifacient agents|mesh-ancestor
110180496|NCT00275106|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110180497|NCT00275106|Antimetabolites|antimetabolites|mesh-ancestor
110180498|NCT00275106|Dermatologic Agents|dermatologic agents|mesh-ancestor
110180499|NCT00275106|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110180500|NCT00275106|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110180501|NCT00275106|Antiviral Agents|antiviral agents|mesh-ancestor
110180502|NCT00275106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110180503|NCT00275106|Antidotes|antidotes|mesh-ancestor
110180504|NCT00275106|Protective Agents|protective agents|mesh-ancestor
110180505|NCT00275106|Vitamin B Complex|vitamin b complex|mesh-ancestor
110180506|NCT00275106|Vitamins|vitamins|mesh-ancestor
110180507|NCT00275106|Micronutrients|micronutrients|mesh-ancestor
110180508|NCT00275106|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110180509|NCT00275106|Tubulin Modulators|tubulin modulators|mesh-ancestor
110180510|NCT00275106|Antimitotic Agents|antimitotic agents|mesh-ancestor
110180511|NCT00275106|Mitosis Modulators|mitosis modulators|mesh-ancestor
110180512|NCT00015938|Docetaxel|docetaxel|mesh-list
110180513|NCT00015938|Vinorelbine|vinorelbine|mesh-list
110180514|NCT00015938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110180515|NCT00015938|Tubulin Modulators|tubulin modulators|mesh-ancestor
110180516|NCT00015938|Antimitotic Agents|antimitotic agents|mesh-ancestor
110180517|NCT00015938|Mitosis Modulators|mitosis modulators|mesh-ancestor
110180518|NCT00015938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110180519|NCT00015938|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110180521|NCT00275067|Arsenic Trioxide|arsenic trioxide|mesh-list
110180522|NCT00275067|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110180523|NCT00275067|Alkylating Agents|alkylating agents|mesh-ancestor
110180524|NCT00275067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110180525|NCT00275067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110180527|NCT00274989|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
110180528|NCT00274989|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110180529|NCT00274989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110180530|NCT00274989|Immunologic Factors|immunologic factors|mesh-ancestor
110180531|NCT00274989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110180532|NCT00274989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110180533|NCT00274989|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110180534|NCT00274989|Alkylating Agents|alkylating agents|mesh-ancestor
110180535|NCT00274989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110180537|NCT00015977|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110180538|NCT00015977|Immunologic Factors|immunologic factors|mesh-ancestor
110180539|NCT00015977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110180540|NCT00015977|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110180541|NCT00015977|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110180542|NCT00015977|Growth Substances|growth substances|mesh-ancestor
110180543|NCT00015977|Growth Inhibitors|growth inhibitors|mesh-ancestor
110180544|NCT00015977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110180545|NCT01678586|Diphenhydramine|diphenhydramine|mesh-list
110180546|NCT01678586|Gabapentin|gabapentin|mesh-list
110180547|NCT01678586|Analgesics|analgesics|mesh-ancestor
110180548|NCT01678586|Sensory System Agents|sensory system agents|mesh-ancestor
110180549|NCT01678586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110180550|NCT01678586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110180552|NCT01678586|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
110180553|NCT01678586|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
110180554|NCT01678586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110213762|NCT00077220|Paclitaxel|paclitaxel|mesh-list
110180555|NCT01678586|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110180556|NCT01678586|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110180557|NCT01678586|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110180558|NCT01678586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110180559|NCT01678586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110180560|NCT01678586|Antimanic Agents|antimanic agents|mesh-ancestor
110180561|NCT01678586|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
110180562|NCT01678586|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
110180563|NCT01678586|Anesthetics, Local|anesthetics, local|mesh-ancestor
110180564|NCT01678586|Anesthetics|anesthetics|mesh-ancestor
110180565|NCT01678586|Antiemetics|antiemetics|mesh-ancestor
110180566|NCT01678586|Autonomic Agents|autonomic agents|mesh-ancestor
110180567|NCT01678586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110180568|NCT01678586|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
110180569|NCT01678586|Histamine Antagonists|histamine antagonists|mesh-ancestor
110180571|NCT01678586|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110180573|NCT00274950|Etoposide|etoposide|mesh-list
110180574|NCT00274950|Ifosfamide|ifosfamide|mesh-list
110180575|NCT00274950|Bleomycin|bleomycin|mesh-list
110180576|NCT00274950|Vinblastine|vinblastine|mesh-list
110180577|NCT00274950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110180578|NCT00274950|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110285730|NCT00209222|Cytarabine|cytarabine|mesh-list
110180579|NCT00274950|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110180580|NCT00274950|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110180581|NCT00274950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110180582|NCT00274950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110180583|NCT00274950|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110180584|NCT00274950|Alkylating Agents|alkylating agents|mesh-ancestor
110180585|NCT00274950|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110214023|NCT00246064|Infliximab|infliximab|mesh-list
110180586|NCT00274950|Tubulin Modulators|tubulin modulators|mesh-ancestor
110180587|NCT00274950|Antimitotic Agents|antimitotic agents|mesh-ancestor
110180588|NCT00274950|Mitosis Modulators|mitosis modulators|mesh-ancestor
110180590|NCT00016016|Mitoxantrone|mitoxantrone|mesh-list
110180591|NCT00016016|Alvocidib|alvocidib|mesh-list
110180592|NCT00016016|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110214100|NCT00102882|Hormones|hormones|mesh-ancestor
110180593|NCT00016016|Antimetabolites|antimetabolites|mesh-ancestor
110180594|NCT00016016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110180595|NCT00016016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110180596|NCT00016016|Antiviral Agents|antiviral agents|mesh-ancestor
110180597|NCT00016016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110180598|NCT00016016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110180599|NCT00016016|Immunologic Factors|immunologic factors|mesh-ancestor
110180600|NCT00016016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110180601|NCT00016016|Analgesics|analgesics|mesh-ancestor
110018266|NCT03655080|Paclitaxel|paclitaxel|mesh-list
110180602|NCT00016016|Sensory System Agents|sensory system agents|mesh-ancestor
110180603|NCT00016016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110180604|NCT00016016|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110180605|NCT00016016|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110180606|NCT00016016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110180607|NCT00016016|Growth Inhibitors|growth inhibitors|mesh-ancestor
110180608|NCT00016016|Growth Substances|growth substances|mesh-ancestor
110180609|NCT00016016|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110180610|NCT00130455|Escitalopram|escitalopram|mesh-list
110180611|NCT00130455|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
110180612|NCT00130455|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110180613|NCT00130455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110180614|NCT00130455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110180615|NCT00130455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110180616|NCT00130455|Serotonin Agents|serotonin agents|mesh-ancestor
110180617|NCT00130455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110180618|NCT00016055|Temozolomide|temozolomide|mesh-list
110180619|NCT00016055|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110180620|NCT00016055|Alkylating Agents|alkylating agents|mesh-ancestor
110180621|NCT00016055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110180622|NCT00016055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110180623|NCT00016094|Bevacizumab|bevacizumab|mesh-list
110180624|NCT00016094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
110180625|NCT00016094|Antibodies|antibodies|mesh-list
110180626|NCT00016094|Immunoglobulins|immunoglobulins|mesh-list
110180627|NCT00016094|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110180628|NCT00016094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110180629|NCT00016094|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110180630|NCT00016094|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110180631|NCT00016094|Growth Substances|growth substances|mesh-ancestor
110180632|NCT00016094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110180633|NCT00016094|Growth Inhibitors|growth inhibitors|mesh-ancestor
110180634|NCT00016094|Immunologic Factors|immunologic factors|mesh-ancestor
110180635|NCT00130338|Rivastigmine|rivastigmine|mesh-list
110214417|NCT02967224|Insulin Detemir|insulin detemir|mesh-list
110180636|NCT00130338|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
110180637|NCT00130338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110180638|NCT00130338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110180639|NCT00130338|Cholinergic Agents|cholinergic agents|mesh-ancestor
110180640|NCT00130338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110180641|NCT00130338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110180642|NCT00130338|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
110180643|NCT00130338|Protective Agents|protective agents|mesh-ancestor
110214494|NCT00068276|Vitamin D|vitamin d|mesh-list
110180645|NCT00016133|Fluorouracil|fluorouracil|mesh-list
110180646|NCT00016133|Vaccines|vaccines|mesh-list
110180647|NCT00016133|BCG Vaccine|bcg vaccine|mesh-list
110180648|NCT00016133|Calcium|calcium|mesh-list
110180649|NCT00016133|Levoleucovorin|levoleucovorin|mesh-list
110180650|NCT00016133|Immunologic Factors|immunologic factors|mesh-ancestor
110180651|NCT00016133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110180652|NCT00016133|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110180653|NCT00016133|Antimetabolites|antimetabolites|mesh-ancestor
110180654|NCT00016133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110180655|NCT00016133|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110180656|NCT00016133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110180657|NCT00016133|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110180658|NCT00016133|Antidotes|antidotes|mesh-ancestor
110180659|NCT00016133|Protective Agents|protective agents|mesh-ancestor
110180660|NCT00016133|Vitamin B Complex|vitamin b complex|mesh-ancestor
110180661|NCT00016133|Vitamins|vitamins|mesh-ancestor
110180662|NCT00016133|Micronutrients|micronutrients|mesh-ancestor
110180663|NCT00016133|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110180664|NCT00016172|Doxorubicin|doxorubicin|mesh-list
110180665|NCT00016172|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110180666|NCT00016172|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110180667|NCT00016172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110214614|NCT00250354|Dopamine Agents|dopamine agents|mesh-ancestor
110180668|NCT00016172|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110180670|NCT00016172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110180671|NCT00016172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110180672|NCT01470716|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
110180673|NCT01470716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110180674|NCT01470716|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110180675|NCT01470716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110180676|NCT01470716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110180677|NCT00394368|Fluticasone|fluticasone|mesh-list
110180678|NCT00394368|Xhance|xhance|mesh-list
110180679|NCT00394368|Beclomethasone|beclomethasone|mesh-list
110180680|NCT00394368|Formoterol Fumarate|formoterol fumarate|mesh-list
110180681|NCT00394368|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
110180682|NCT00394368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110180683|NCT00394368|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110180685|NCT00394368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110180686|NCT00394368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110180687|NCT00394368|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110180688|NCT00394368|Respiratory System Agents|respiratory system agents|mesh-ancestor
110180690|NCT00394368|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
110180691|NCT00394368|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
110180692|NCT00394368|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
110180693|NCT00394368|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
110180694|NCT00394368|Adrenergic Agents|adrenergic agents|mesh-ancestor
110180695|NCT00394368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110180696|NCT00394368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110180697|NCT00394368|Glucocorticoids|glucocorticoids|mesh-ancestor
110180698|NCT00394368|Hormones|hormones|mesh-ancestor
110180699|NCT00394368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110180700|NCT01441349|Simvastatin|simvastatin|mesh-list
110180701|NCT01441349|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
110180702|NCT01441349|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
110180703|NCT01441349|Antimetabolites|antimetabolites|mesh-ancestor
110180704|NCT01441349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110180705|NCT01441349|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
110180706|NCT01441349|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
110180707|NCT01441349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110180708|NCT00394407|Insulin|insulin|mesh-list
110180709|NCT00394407|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
110180710|NCT00394407|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
110180711|NCT00394407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110180712|NCT00130143|Amifostine|amifostine|mesh-list
110180713|NCT00130143|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
110180714|NCT00130143|Protective Agents|protective agents|mesh-ancestor
110180715|NCT00130143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110180716|NCT00016289|Interleukin-12|interleukin-12|mesh-list
110180717|NCT00016289|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110180718|NCT00016289|Immunologic Factors|immunologic factors|mesh-ancestor
110180719|NCT00016289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110180720|NCT00016289|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
110180721|NCT00016289|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
110180722|NCT00016289|Growth Substances|growth substances|mesh-ancestor
110180723|NCT00016289|Growth Inhibitors|growth inhibitors|mesh-ancestor
110180724|NCT00016289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110180727|NCT00130065|Sulfadoxine|sulfadoxine|mesh-list
110180728|NCT00130065|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
110180729|NCT00130065|Hematinics|hematinics|mesh-ancestor
110180730|NCT00130065|Vitamin B Complex|vitamin b complex|mesh-ancestor
110180731|NCT00130065|Vitamins|vitamins|mesh-ancestor
110180732|NCT00130065|Micronutrients|micronutrients|mesh-ancestor
110180733|NCT00130065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110180734|NCT00130065|Antimalarials|antimalarials|mesh-ancestor
110180735|NCT00130065|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110180736|NCT00130065|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110180737|NCT00130065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110180738|NCT00130065|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
110180739|NCT00130065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110180740|NCT00130065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110180741|NCT00130065|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
110180742|NCT00016328|Sirolimus|sirolimus|mesh-list
110180743|NCT00016328|Temsirolimus|temsirolimus|mesh-list
110180744|NCT00016328|MTOR Inhibitors|mtor inhibitors|mesh-list
110180745|NCT00016328|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110180746|NCT00016328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110180747|NCT00016328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110180748|NCT00016328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110180749|NCT00016328|Immunologic Factors|immunologic factors|mesh-ancestor
110180750|NCT00016328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110180751|NCT00016328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110180752|NCT00016328|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110180753|NCT00016328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110180754|NCT00016328|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110180755|NCT00016328|Antifungal Agents|antifungal agents|mesh-ancestor
110180757|NCT00130026|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110180758|NCT00130026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110180759|NCT00130026|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
110180760|NCT00130026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110180761|NCT00130026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110180762|NCT00130026|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
110180763|NCT00130026|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
110180764|NCT00130026|Purinergic Agents|purinergic agents|mesh-ancestor
110180765|NCT00130026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110180768|NCT00016367|Trastuzumab|trastuzumab|mesh-list
110180769|NCT00016367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110180770|NCT00016367|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110180771|NCT00016367|Antimetabolites|antimetabolites|mesh-ancestor
110180772|NCT00016367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110180773|NCT00016367|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110180774|NCT00129948|Troxacitabine|troxacitabine|mesh-list
110180775|NCT00129948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110180776|NCT00129948|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110180777|NCT00129948|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110180778|NCT00129948|Antiviral Agents|antiviral agents|mesh-ancestor
110180779|NCT00129948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110180780|NCT00016406|Paclitaxel|paclitaxel|mesh-list
110180781|NCT00016406|Cyclophosphamide|cyclophosphamide|mesh-list
110180782|NCT00016406|Doxorubicin|doxorubicin|mesh-list
110180784|NCT00016406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110180785|NCT00016406|Tubulin Modulators|tubulin modulators|mesh-ancestor
110180786|NCT00016406|Antimitotic Agents|antimitotic agents|mesh-ancestor
110180787|NCT00016406|Mitosis Modulators|mitosis modulators|mesh-ancestor
110180788|NCT00016406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110180789|NCT00016406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110180790|NCT00016406|Immunologic Factors|immunologic factors|mesh-ancestor
110180791|NCT00016406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110180792|NCT00016406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110215301|NCT00254956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110180793|NCT00016406|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110180794|NCT00016406|Alkylating Agents|alkylating agents|mesh-ancestor
110180795|NCT00016406|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110180796|NCT00016406|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110180797|NCT00016406|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110180798|NCT00016406|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110180799|NCT00016406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110180800|NCT00129870|Oxaliplatin|oxaliplatin|mesh-list
110180801|NCT00129870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110215441|NCT00070187|Interferons|interferons|mesh-list
110180803|NCT00016445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110180804|NCT00016445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110180805|NCT00129753|Alemtuzumab|alemtuzumab|mesh-list
110180806|NCT00129753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110180807|NCT00129753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110215514|NCT00104598|Bupropion|bupropion|mesh-list
110180808|NCT00016523|Nitric Oxide|nitric oxide|mesh-list
110180809|NCT00016523|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110180810|NCT00016523|Autonomic Agents|autonomic agents|mesh-ancestor
110180811|NCT00016523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110180812|NCT00016523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110180813|NCT00016523|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110180814|NCT00016523|Respiratory System Agents|respiratory system agents|mesh-ancestor
110215582|NCT00104715|Antimitotic Agents|antimitotic agents|mesh-ancestor
110180815|NCT00016523|Free Radical Scavengers|free radical scavengers|mesh-ancestor
110180816|NCT00016523|Antioxidants|antioxidants|mesh-ancestor
110180817|NCT00016523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110180818|NCT00016523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110180819|NCT00016523|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
110180820|NCT00016523|Vasodilator Agents|vasodilator agents|mesh-ancestor
110180821|NCT00016523|Gasotransmitters|gasotransmitters|mesh-ancestor
110180822|NCT00016523|Protective Agents|protective agents|mesh-ancestor
110180823|NCT00129597|Ketamine|ketamine|mesh-list
110180824|NCT00129597|Analgesics|analgesics|mesh-ancestor
110180825|NCT00129597|Sensory System Agents|sensory system agents|mesh-ancestor
110180826|NCT00129597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110180827|NCT00129597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110180828|NCT00129597|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
110180829|NCT00129597|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
110180830|NCT00129597|Anesthetics, General|anesthetics, general|mesh-ancestor
110180831|NCT00129597|Anesthetics|anesthetics|mesh-ancestor
110215722|NCT00257491|Telmisartan|telmisartan|mesh-list
110180832|NCT00129597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
110180833|NCT00129597|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
110180834|NCT00129597|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
110180835|NCT00129597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110180836|NCT00129597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110180837|NCT00016601|Ritonavir|ritonavir|mesh-list
110180839|NCT00016601|Indinavir|indinavir|mesh-list
110180840|NCT00016601|Nevirapine|nevirapine|mesh-list
110180841|NCT00016601|Efavirenz|efavirenz|mesh-list
110180842|NCT00016601|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
110180843|NCT00016601|Medroxyprogesterone|medroxyprogesterone|mesh-list
110180844|NCT00016601|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
110180845|NCT00016601|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
110215780|NCT00401115|Sirolimus|sirolimus|mesh-list
110180846|NCT00016601|Protease Inhibitors|protease inhibitors|mesh-ancestor
110180847|NCT00016601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110180848|NCT00016601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110180849|NCT00016601|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
110180850|NCT00016601|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
110180851|NCT00016601|Antiviral Agents|antiviral agents|mesh-ancestor
110180852|NCT00016601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110285748|NCT00209222|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110180853|NCT00016601|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
110180854|NCT00016601|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110180855|NCT00016601|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
110215840|NCT00258193|Linaclotide|linaclotide|mesh-list
110180856|NCT00016601|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110180857|NCT00016601|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
110180858|NCT00016601|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
110180859|NCT00016601|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
110180860|NCT00016601|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110180861|NCT00016601|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110180862|NCT00016601|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110180863|NCT00016601|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110180864|NCT00016601|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110180865|NCT00016601|Contraceptive Agents|contraceptive agents|mesh-ancestor
110180866|NCT00016601|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110215909|NCT00423761|Midazolam|midazolam|mesh-list
110180867|NCT00016601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110180868|NCT00016601|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110180869|NCT00016601|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110180870|NCT00016601|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
110180871|NCT00016601|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110180872|NCT00016601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110180873|NCT00957086|Nimotuzumab|nimotuzumab|mesh-list
110180874|NCT00957086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110180875|NCT00957086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110180876|NCT00129519|Imiquimod|imiquimod|mesh-list
110180877|NCT00129519|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110180878|NCT00129519|Immunologic Factors|immunologic factors|mesh-ancestor
110180879|NCT00129519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110180880|NCT00129519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110180881|NCT00129519|Interferon Inducers|interferon inducers|mesh-ancestor
110180882|NCT00016835|Metronidazole|metronidazole|mesh-list
110180883|NCT00016835|Doxycycline|doxycycline|mesh-list
110180884|NCT00016835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110180885|NCT00016835|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
110180886|NCT00016835|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
110180887|NCT00016835|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
110180888|NCT00016835|Antimalarials|antimalarials|mesh-ancestor
110180889|NCT00016874|Paclitaxel|paclitaxel|mesh-list
110180890|NCT00016874|Cisplatin|cisplatin|mesh-list
110180891|NCT00016874|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110180892|NCT00016874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110180893|NCT00016874|Tubulin Modulators|tubulin modulators|mesh-ancestor
110180894|NCT00016874|Antimitotic Agents|antimitotic agents|mesh-ancestor
110180895|NCT00016874|Mitosis Modulators|mitosis modulators|mesh-ancestor
110180896|NCT00016874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110180897|NCT00016952|Leucovorin|leucovorin|mesh-list
110180898|NCT00016952|Fluorouracil|fluorouracil|mesh-list
110180899|NCT00016952|Irinotecan|irinotecan|mesh-list
110180900|NCT00016952|Calcium|calcium|mesh-list
110180901|NCT00016952|Levoleucovorin|levoleucovorin|mesh-list
110180902|NCT00016952|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110180903|NCT00016952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110180904|NCT00016952|Antimetabolites|antimetabolites|mesh-ancestor
110180905|NCT00016952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110180906|NCT00016952|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110180907|NCT00016952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110180908|NCT00016952|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110180909|NCT00016952|Immunologic Factors|immunologic factors|mesh-ancestor
110180910|NCT00016952|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
110180911|NCT00016952|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110180912|NCT00016952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110180913|NCT00016952|Antidotes|antidotes|mesh-ancestor
110180914|NCT00016952|Protective Agents|protective agents|mesh-ancestor
110180916|NCT00016952|Vitamins|vitamins|mesh-ancestor
110180917|NCT00016952|Micronutrients|micronutrients|mesh-ancestor
110180918|NCT00129363|Carvedilol|carvedilol|mesh-list
110180919|NCT00129363|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
110180920|NCT00129363|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
110180921|NCT00129363|Adrenergic Agents|adrenergic agents|mesh-ancestor
110180922|NCT00129363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110285753|NCT00209222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110180923|NCT00129363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110180924|NCT00129363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110180925|NCT00129363|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
110180927|NCT00129363|Protective Agents|protective agents|mesh-ancestor
110180928|NCT00129363|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
110180930|NCT00129363|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
110180931|NCT00129363|Vasodilator Agents|vasodilator agents|mesh-ancestor
110180932|NCT00129363|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
110180933|NCT00129363|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
110180935|NCT00016991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110180936|NCT00016991|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110180937|NCT00016991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110180938|NCT00016991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110180939|NCT00017030|Trabectedin|trabectedin|mesh-list
110180940|NCT00017030|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110180941|NCT00017030|Alkylating Agents|alkylating agents|mesh-ancestor
110180942|NCT00017030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110180943|NCT00017030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110180944|NCT00017069|Dexamethasone|dexamethasone|mesh-list
110180945|NCT00017069|Arsenic Trioxide|arsenic trioxide|mesh-list
110180946|NCT00017069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110180947|NCT00017069|Antiemetics|antiemetics|mesh-ancestor
110180948|NCT00017069|Autonomic Agents|autonomic agents|mesh-ancestor
110180949|NCT00017069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110180950|NCT00017069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110180951|NCT00017069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
110180952|NCT00017069|Glucocorticoids|glucocorticoids|mesh-ancestor
110180953|NCT00017069|Hormones|hormones|mesh-ancestor
110180954|NCT00017069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110180955|NCT00017069|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
110180956|NCT00017069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110180957|NCT00129285|Modafinil|modafinil|mesh-list
110180958|NCT00129285|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
110180959|NCT00129285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110180960|NCT00129285|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
110180961|NCT00129285|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
110180962|NCT00129285|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
110180963|NCT00129285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110180965|NCT00017108|Chlorambucil|chlorambucil|mesh-list
110180966|NCT00017108|Fludarabine|fludarabine|mesh-list
110180967|NCT00017108|Fludarabine phosphate|fludarabine phosphate|mesh-list
110180968|NCT00017108|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110180969|NCT00017108|Immunologic Factors|immunologic factors|mesh-ancestor
110180970|NCT00017108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110180971|NCT00017108|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110180973|NCT00017108|Alkylating Agents|alkylating agents|mesh-ancestor
110180974|NCT00017108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110180975|NCT00017108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110180976|NCT00017108|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110180977|NCT00017108|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110180978|NCT00017108|Antimetabolites|antimetabolites|mesh-ancestor
110180979|NCT00129246|Naltrexone|naltrexone|mesh-list
110180980|NCT00129246|Bupropion|bupropion|mesh-list
110180981|NCT00129246|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
110180982|NCT00129246|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
110180983|NCT00129246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110180984|NCT00129246|Sensory System Agents|sensory system agents|mesh-ancestor
110180985|NCT00129246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110180986|NCT00129246|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
110180987|NCT00129246|Antidepressive Agents|antidepressive agents|mesh-ancestor
110180988|NCT00129246|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
110180989|NCT00129246|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
110180990|NCT00129246|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
110180991|NCT00129246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
110285756|NCT00209222|Hormones|hormones|mesh-ancestor
110180992|NCT00129246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110180993|NCT00129246|Dopamine Agents|dopamine agents|mesh-ancestor
110180994|NCT00129246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
110216372|NCT00262210|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110180995|NCT00129246|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
110180996|NCT00129246|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
110180997|NCT00129246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110180999|NCT00017147|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
110181000|NCT00017147|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110181001|NCT00017147|Alkylating Agents|alkylating agents|mesh-ancestor
110181002|NCT00017147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110181003|NCT00017147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110181004|NCT00017147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110181006|NCT00129207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110181007|NCT00129168|Cytarabine|cytarabine|mesh-list
110181008|NCT00129168|Daunorubicin|daunorubicin|mesh-list
110181009|NCT00129168|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110181010|NCT00129168|Antimetabolites|antimetabolites|mesh-ancestor
110181011|NCT00129168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110181012|NCT00129168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110181013|NCT00129168|Antiviral Agents|antiviral agents|mesh-ancestor
110181014|NCT00129168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110181015|NCT00129168|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110181016|NCT00129168|Immunologic Factors|immunologic factors|mesh-ancestor
110181017|NCT00129168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110181018|NCT00129168|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110181019|NCT00129168|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110181020|NCT00129168|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110181021|NCT00129168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110181022|NCT00017186|Gemcitabine|gemcitabine|mesh-list
110181023|NCT00017186|Epirubicin|epirubicin|mesh-list
110181024|NCT00017186|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110181025|NCT00017186|Antimetabolites|antimetabolites|mesh-ancestor
110181027|NCT00017186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110181028|NCT00017186|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110181029|NCT00017186|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110181030|NCT00017186|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110216506|NCT00263185|Vitamin D|vitamin d|mesh-list
110181031|NCT00017186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110181032|NCT00017225|Cyclophosphamide|cyclophosphamide|mesh-list
110181034|NCT00017225|Ifosfamide|ifosfamide|mesh-list
110181035|NCT00017225|Dacarbazine|dacarbazine|mesh-list
110181037|NCT00017225|Doxorubicin|doxorubicin|mesh-list
110181038|NCT00017225|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
110181039|NCT00017225|Etoposide|etoposide|mesh-list
110181040|NCT00017225|Vincristine|vincristine|mesh-list
110181041|NCT00017225|Tretinoin|tretinoin|mesh-list
110181042|NCT00017225|Vindesine|vindesine|mesh-list
110181043|NCT00017225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110181044|NCT00017225|Immunologic Factors|immunologic factors|mesh-ancestor
110181045|NCT00017225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110181046|NCT00017225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110181047|NCT00017225|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110181048|NCT00017225|Alkylating Agents|alkylating agents|mesh-ancestor
110181049|NCT00017225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110181050|NCT00017225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110181051|NCT00017225|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110181052|NCT00017225|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
110181053|NCT00017225|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
110181054|NCT00017225|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
110181055|NCT00017225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110052849|NCT01482338|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110181056|NCT00017225|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110181057|NCT00017225|Tubulin Modulators|tubulin modulators|mesh-ancestor
110181058|NCT00017225|Antimitotic Agents|antimitotic agents|mesh-ancestor
110181059|NCT00017225|Mitosis Modulators|mitosis modulators|mesh-ancestor
110181060|NCT00017225|Keratolytic Agents|keratolytic agents|mesh-ancestor
110181061|NCT00017225|Dermatologic Agents|dermatologic agents|mesh-ancestor
110181062|NCT00128934|Levonorgestrel|levonorgestrel|mesh-list
110181063|NCT00128934|Ethinyl Estradiol|ethinyl estradiol|mesh-list
110181064|NCT00128934|Estradiol|estradiol|mesh-list
110181065|NCT00128934|Estrogens|estrogens|mesh-ancestor
110181066|NCT00128934|Hormones|hormones|mesh-ancestor
110285762|NCT00209222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110181067|NCT00128934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110181068|NCT00128934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110181069|NCT00128934|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
110181070|NCT00128934|Contraceptive Agents|contraceptive agents|mesh-ancestor
110181071|NCT00128934|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110181072|NCT00128934|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110181073|NCT00128934|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110181075|NCT00128934|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
110181077|NCT00017264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110181078|NCT00017264|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
110181079|NCT00017264|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
110181080|NCT00017264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110181082|NCT00128895|Antimetabolites|antimetabolites|mesh-ancestor
110181083|NCT00128895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110181084|NCT00128895|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110181085|NCT00128895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110181086|NCT00128895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110181087|NCT00128895|Immunologic Factors|immunologic factors|mesh-ancestor
110181088|NCT00128895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110181089|NCT00128895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110181090|NCT00017303|Paclitaxel|paclitaxel|mesh-list
110181091|NCT00017303|Carboplatin|carboplatin|mesh-list
110181092|NCT00017303|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110181093|NCT00017303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110181094|NCT00017303|Tubulin Modulators|tubulin modulators|mesh-ancestor
110181095|NCT00017303|Antimitotic Agents|antimitotic agents|mesh-ancestor
110181096|NCT00017303|Mitosis Modulators|mitosis modulators|mesh-ancestor
110181097|NCT00017303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110181098|NCT00017342|Cytarabine|cytarabine|mesh-list
110181099|NCT00017342|Bryostatin 1|bryostatin 1|mesh-list
110181100|NCT00017342|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110181101|NCT00017342|Antimetabolites|antimetabolites|mesh-ancestor
110181102|NCT00017342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110181103|NCT00017342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110181104|NCT00017342|Antiviral Agents|antiviral agents|mesh-ancestor
110181105|NCT00017342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110181106|NCT00017342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110181107|NCT00017342|Immunologic Factors|immunologic factors|mesh-ancestor
110181108|NCT00017342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110181109|NCT00017342|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
110181110|NCT00128739|Budesonide|budesonide|mesh-list
110181111|NCT00128739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
110181112|NCT00128739|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
110181113|NCT00128739|Autonomic Agents|autonomic agents|mesh-ancestor
110181114|NCT00128739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
110181115|NCT00128739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110181116|NCT00128739|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
110181117|NCT00128739|Respiratory System Agents|respiratory system agents|mesh-ancestor
110181118|NCT00128739|Glucocorticoids|glucocorticoids|mesh-ancestor
110181119|NCT00128739|Hormones|hormones|mesh-ancestor
110181120|NCT00128739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
110181121|NCT00017381|Cyclophosphamide|cyclophosphamide|mesh-list
110181122|NCT00017381|Rituximab|rituximab|mesh-list
110181123|NCT00017381|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
110181124|NCT00017381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
110181125|NCT00017381|Immunologic Factors|immunologic factors|mesh-ancestor
110181126|NCT00017381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110181127|NCT00017381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
110181128|NCT00017381|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110181129|NCT00017381|Alkylating Agents|alkylating agents|mesh-ancestor
110181130|NCT00017381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110181131|NCT00017381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110181132|NCT00017381|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
110181133|NCT00017381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
110181134|NCT00128700|Temozolomide|temozolomide|mesh-list
110181135|NCT00128700|Vatalanib|vatalanib|mesh-list
110181136|NCT00128700|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
110181137|NCT00128700|Alkylating Agents|alkylating agents|mesh-ancestor
110216576|NCT00263965|Metformin|metformin|mesh-list
110181138|NCT00128700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110181139|NCT00128700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110181140|NCT00128700|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
110181142|NCT00017459|Vinorelbine|vinorelbine|mesh-list
110181143|NCT00017459|Tirapazamine|tirapazamine|mesh-list
110181144|NCT00017459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110181145|NCT00017459|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
110181146|NCT00017459|Tubulin Modulators|tubulin modulators|mesh-ancestor
110181147|NCT00017459|Antimitotic Agents|antimitotic agents|mesh-ancestor
110181148|NCT00017459|Mitosis Modulators|mitosis modulators|mesh-ancestor
110181149|NCT00017459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110181150|NCT00128622|Denileukin diftitox|denileukin diftitox|mesh-list
110181151|NCT00128622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110181152|NCT00017498|Gemcitabine|gemcitabine|mesh-list
110181153|NCT00017498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
110181154|NCT00017498|Antimetabolites|antimetabolites|mesh-ancestor
110181155|NCT00017498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110181156|NCT00017498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
110181157|NCT00128544|Telbivudine|telbivudine|mesh-list
110181158|NCT00128544|Antiviral Agents|antiviral agents|mesh-ancestor
110181159|NCT00128544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
110181160|NCT00128544|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
110181161|NCT00128544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
110181162|NCT00128544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
110181163|NCT00128505|Mifepristone|mifepristone|mesh-list
110181164|NCT00128505|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
110181165|NCT00128505|Abortifacient Agents|abortifacient agents|mesh-ancestor
110181166|NCT00128505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
110181167|NCT00128505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
110181168|NCT00128505|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
110181169|NCT00128505|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
110181170|NCT00128505|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
110181171|NCT00128505|Contraceptive Agents|contraceptive agents|mesh-ancestor
110181172|NCT00128505|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
110181173|NCT00128505|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
110181174|NCT00128505|Hormone Antagonists|hormone antagonists|mesh-ancestor
11018